id|nct_id|mesh_term|downcase_mesh_term|mesh_type
25538840|NCT00564889|Antiemetics|antiemetics|mesh-ancestor
24498697|NCT00515957|Antibodies|antibodies|mesh-list
25539511|NCT05362019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25539512|NCT05361915|Abivertinib|abivertinib|mesh-list
25539513|NCT05361915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25539514|NCT05361915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539515|NCT05361915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539530|NCT05361772|Colchicine|colchicine|mesh-list
25539531|NCT05361772|Gout Suppressants|gout suppressants|mesh-ancestor
25539532|NCT05361772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25539533|NCT05361772|Tubulin Modulators|tubulin modulators|mesh-ancestor
25539534|NCT05361772|Antimitotic Agents|antimitotic agents|mesh-ancestor
25539535|NCT05361772|Mitosis Modulators|mitosis modulators|mesh-ancestor
25539536|NCT05361772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539537|NCT05361772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539538|NCT05361655|Palbociclib|palbociclib|mesh-list
25435812|NCT04769258|Vaccines|vaccines|mesh-list
25436058|NCT04766684|Anesthetics|anesthetics|mesh-ancestor
25540539|NCT02471391|Venetoclax|venetoclax|mesh-list
25540691|NCT00006256|Paclitaxel|paclitaxel|mesh-list
25540988|NCT00571493|Cytarabine|cytarabine|mesh-list
25437393|NCT04748276|Serotonin|serotonin|mesh-list
25541905|NCT00577707|Cisplatin|cisplatin|mesh-list
25542842|NCT00582556|Leuprolide|leuprolide|mesh-list
25543448|NCT00586898|Estrogens|estrogens|mesh-list
25544054|NCT04514211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25544055|NCT04514211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25544056|NCT04507204|Methylphenidate|methylphenidate|mesh-list
25544057|NCT04507204|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25544058|NCT04507204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544059|NCT04507204|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25544063|NCT04507204|Dopamine Agents|dopamine agents|mesh-ancestor
25544146|NCT04333459|Vaccines|vaccines|mesh-list
25440885|NCT04721899|Vitamin D|vitamin d|mesh-list
25544917|NCT00651560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545117|NCT00588094|Etoposide|etoposide|mesh-list
25545311|NCT00588900|Irinotecan|irinotecan|mesh-list
25545877|NCT00592319|Celecoxib|celecoxib|mesh-list
25546597|NCT00598078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25442759|NCT04702698|Peposertib|peposertib|mesh-list
25546807|NCT00600353|Aprepitant|aprepitant|mesh-list
25547194|NCT00603018|Fluoxetine|fluoxetine|mesh-list
25547314|NCT00603733|Mesalamine|mesalamine|mesh-list
25443678|NCT04690647|Analgesics|analgesics|mesh-ancestor
25547875|NCT00607789|Analgesics|analgesics|mesh-ancestor
25548210|NCT00609674|Xhance|xhance|mesh-list
25548614|NCT00611897|Expectorants|expectorants|mesh-ancestor
25548704|NCT00612313|Fluoxetine|fluoxetine|mesh-list
25169496|NCT01836432|Gemcitabine|gemcitabine|mesh-list
25651117|NCT01512108|Incretins|incretins|mesh-ancestor
25444951|NCT04672928|Paclitaxel|paclitaxel|mesh-list
25549129|NCT00614484|Paclitaxel|paclitaxel|mesh-list
25161752|NCT02474368|Cisplatin|cisplatin|mesh-list
25549280|NCT00615472|Isoflurane|isoflurane|mesh-list
25549430|NCT00616772|Choline|choline|mesh-list
25549479|NCT00617097|Analgesics|analgesics|mesh-ancestor
25549634|NCT00617942|Paclitaxel|paclitaxel|mesh-list
25549962|NCT00619645|Busulfan|busulfan|mesh-list
25550146|NCT00620659|Modafinil|modafinil|mesh-list
25446107|NCT04658355|Plasma Substitutes|plasma substitutes|mesh-ancestor
25446108|NCT04658355|Blood Substitutes|blood substitutes|mesh-ancestor
25299976|NCT00584246|Anticonvulsants|anticonvulsants|mesh-ancestor
25550555|NCT00623012|Sirolimus|sirolimus|mesh-list
25551000|NCT00626210|Modafinil|modafinil|mesh-list
25551275|NCT00628251|Doxorubicin|doxorubicin|mesh-list
25551619|NCT00631371|Bevacizumab|bevacizumab|mesh-list
25551701|NCT00631696|Pregabalin|pregabalin|mesh-list
25551921|NCT00633217|Xhance|xhance|mesh-list
25447861|NCT04631341|Melatonin|melatonin|mesh-list
25552531|NCT00636649|Citalopram|citalopram|mesh-list
25552720|NCT00638456|Budesonide|budesonide|mesh-list
25552776|NCT00638820|Busulfan|busulfan|mesh-list
25553050|NCT00641563|Dexmedetomidine|dexmedetomidine|mesh-list
25553203|NCT00642278|Canagliflozin|canagliflozin|mesh-list
25554289|NCT00654238|Sorafenib|sorafenib|mesh-list
25554504|NCT00655473|Dalcetrapib|dalcetrapib|mesh-list
25450267|NCT04602273|Azacitidine|azacitidine|mesh-list
25555161|NCT00659581|Telmisartan|telmisartan|mesh-list
25555268|NCT00660400|Azacitidine|azacitidine|mesh-list
25450782|NCT04595591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25555724|NCT00662532|Minocycline|minocycline|mesh-list
25556051|NCT00665457|Analgesics|analgesics|mesh-ancestor
25556239|NCT00666757|Sertraline|sertraline|mesh-list
25307706|NCT03465592|Nivolumab|nivolumab|mesh-list
25452388|NCT04574791|Sensory System Agents|sensory system agents|mesh-ancestor
25557297|NCT00672958|Serotonin Agents|serotonin agents|mesh-ancestor
25557368|NCT00673231|Dapagliflozin|dapagliflozin|mesh-list
25557622|NCT00675025|Donepezil|donepezil|mesh-list
25557696|NCT00675792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453077|NCT04564456|Hormones|hormones|mesh-ancestor
25453243|NCT04561921|Analgesics|analgesics|mesh-ancestor
25558292|NCT00681668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25558532|NCT00683644|Zinc|zinc|mesh-list
25558877|NCT00685945|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25559400|NCT00688753|Everolimus|everolimus|mesh-list
25559585|NCT00690430|Octreotide|octreotide|mesh-list
25559732|NCT00691210|Vitamins|vitamins|mesh-ancestor
25559955|NCT00693992|Sunitinib|sunitinib|mesh-list
25560028|NCT00695019|Interferons|interferons|mesh-list
25455354|NCT04535271|Alkylating Agents|alkylating agents|mesh-ancestor
25560880|NCT00701779|Urological Agents|urological agents|mesh-ancestor
25561323|NCT00705289|Infliximab|infliximab|mesh-list
25456592|NCT04488237|Vitamin D|vitamin d|mesh-list
25456593|NCT04488237|Vitamins|vitamins|mesh-ancestor
25456594|NCT04488237|Micronutrients|micronutrients|mesh-ancestor
25456595|NCT04488237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456596|NCT04488237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25456604|NCT04482361|Antibodies|antibodies|mesh-list
25456605|NCT04482361|Immunologic Factors|immunologic factors|mesh-ancestor
25456606|NCT04482361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456673|NCT04381091|Idebenone|idebenone|mesh-list
25456689|NCT04367688|Tenofovir|tenofovir|mesh-list
25456690|NCT04367688|Emtricitabine|emtricitabine|mesh-list
25105864|NCT04844905|Artenimol|artenimol|mesh-list
25456955|NCT04112277|Morphine|morphine|mesh-list
25456957|NCT04112277|Narcotics|narcotics|mesh-ancestor
25457001|NCT03994419|Anesthetics|anesthetics|mesh-list
25457130|NCT03894696|Antiviral Agents|antiviral agents|mesh-list
25457137|NCT03851965|Plasminogen|plasminogen|mesh-list
25562539|NCT00715676|Vitamins|vitamins|mesh-ancestor
25563072|NCT00719862|Azelastine|azelastine|mesh-list
25563271|NCT00720382|Azelastine|azelastine|mesh-list
25563649|NCT00723125|Paclitaxel|paclitaxel|mesh-list
25564154|NCT00726414|Quinine|quinine|mesh-list
25564580|NCT00729612|Paclitaxel|paclitaxel|mesh-list
25564653|NCT00729924|Antiviral Agents|antiviral agents|mesh-ancestor
25564985|NCT00732498|Hormones|hormones|mesh-ancestor
25565095|NCT00733356|Dopamine Agents|dopamine agents|mesh-ancestor
25565398|NCT00735072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25565503|NCT00735787|Adalimumab|adalimumab|mesh-list
25565878|NCT00738881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25566143|NCT00741338|Cyclosporine|cyclosporine|mesh-list
25566900|NCT00746863|Sensory System Agents|sensory system agents|mesh-ancestor
25567049|NCT00748709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25567124|NCT00749515|Siderophores|siderophores|mesh-ancestor
25567421|NCT00752973|Malathion|malathion|mesh-list
25567496|NCT00753896|Exenatide|exenatide|mesh-list
25567808|NCT00756470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25462791|NCT01904136|Tacrolimus|tacrolimus|mesh-list
25567964|NCT00758342|Travoprost|travoprost|mesh-list
25462953|NCT03768115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25462966|NCT03751397|Cystatins|cystatins|mesh-list
25568163|NCT00759759|Narcotics|narcotics|mesh-ancestor
25463369|NCT04078737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568684|NCT00762528|Cariostatic Agents|cariostatic agents|mesh-ancestor
25569189|NCT00766363|Donepezil|donepezil|mesh-list
25569488|NCT00768755|Pemetrexed|pemetrexed|mesh-list
25570795|NCT00779467|Fentanyl|fentanyl|mesh-list
25570875|NCT00780208|Dopamine Agents|dopamine agents|mesh-ancestor
25570959|NCT00781274|Ribavirin|ribavirin|mesh-list
25571017|NCT00781768|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25571068|NCT00782275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25571119|NCT00782717|Prednisolone|prednisolone|mesh-list
25571196|NCT00783614|Aspirin|aspirin|mesh-list
25571279|NCT00784277|Oxycodone|oxycodone|mesh-list
25571405|NCT00784875|Zolpidem|zolpidem|mesh-list
25571485|NCT00785512|Nebivolol|nebivolol|mesh-list
25466109|NCT05369091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25571868|NCT00788593|Pancreatin|pancreatin|mesh-list
25466629|NCT03617666|Avelumab|avelumab|mesh-list
25466848|NCT01744912|Lenalidomide|lenalidomide|mesh-list
25572519|NCT00792298|Suvorexant|suvorexant|mesh-list
25652374|NCT01526148|Antimanic Agents|antimanic agents|mesh-ancestor
25572909|NCT00795288|Simvastatin|simvastatin|mesh-list
25573134|NCT00796822|Pentoxifylline|pentoxifylline|mesh-list
25573278|NCT00797966|Dopamine Agents|dopamine agents|mesh-ancestor
25573344|NCT00798577|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25573364|NCT00798694|Travoprost|travoprost|mesh-list
25573736|NCT00802100|Metformin|metformin|mesh-list
25573896|NCT00803023|Sodium Oxybate|sodium oxybate|mesh-list
25574273|NCT00806221|Emollients|emollients|mesh-list
25574574|NCT00807846|Naproxen|naproxen|mesh-list
25575508|NCT00814632|Apremilast|apremilast|mesh-list
25575761|NCT00817206|Tacrolimus|tacrolimus|mesh-list
25470570|NCT03884556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25576353|NCT05236569|Coagulants|coagulants|mesh-ancestor
25576354|NCT05236504|Melatonin|melatonin|mesh-list
25576355|NCT05236504|Antioxidants|antioxidants|mesh-ancestor
25576356|NCT05236504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576357|NCT05236504|Protective Agents|protective agents|mesh-ancestor
25576358|NCT05236504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576359|NCT05236504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25576361|NCT05235256|Dexamethasone|dexamethasone|mesh-list
25576596|NCT04634071|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25576862|NCT03500731|Rituximab|rituximab|mesh-list
25576899|NCT03410030|Ascorbic Acid|ascorbic acid|mesh-list
25577294|NCT01061151|Ritonavir|ritonavir|mesh-list
25652783|NCT01532089|Antibodies|antibodies|mesh-list
25577694|NCT00824382|Olodaterol|olodaterol|mesh-list
25577753|NCT00824746|Gefitinib|gefitinib|mesh-list
25577824|NCT00825565|Allantoin|allantoin|mesh-list
25577892|NCT00826241|Lapatinib|lapatinib|mesh-list
25578405|NCT00830128|Pregabalin|pregabalin|mesh-list
25578474|NCT00830804|Protease Inhibitors|protease inhibitors|mesh-ancestor
25578552|NCT00831441|Apixaban|apixaban|mesh-list
25578744|NCT00833040|Sufentanil|sufentanil|mesh-list
25578890|NCT00833755|Ketamine|ketamine|mesh-list
25580085|NCT00844857|Fluoxetine|fluoxetine|mesh-list
25580236|NCT00845728|Parasympatholytics|parasympatholytics|mesh-ancestor
25580532|NCT00848393|Fentanyl|fentanyl|mesh-list
25580677|NCT00849251|Antiemetics|antiemetics|mesh-ancestor
25475385|NCT00069095|Vitamins|vitamins|mesh-ancestor
25581395|NCT00855920|Indomethacin|indomethacin|mesh-list
25581810|NCT00858013|Glimepiride|glimepiride|mesh-list
25581883|NCT00858845|Autonomic Agents|autonomic agents|mesh-ancestor
25581957|NCT00859339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582105|NCT00860405|Blood Substitutes|blood substitutes|mesh-ancestor
25582185|NCT00861341|Antipyretics|antipyretics|mesh-ancestor
25582257|NCT00862563|Topiramate|topiramate|mesh-list
25582451|NCT00863356|Chitosan|chitosan|mesh-list
25582506|NCT00863746|Sorafenib|sorafenib|mesh-list
25582584|NCT00864513|Pemetrexed|pemetrexed|mesh-list
25582725|NCT00866034|Fertility Agents|fertility agents|mesh-ancestor
25583081|NCT00867932|Eculizumab|eculizumab|mesh-list
25583277|NCT00869440|Midazolam|midazolam|mesh-list
25583346|NCT00869791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25822728|NCT00004585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25822729|NCT00004585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25478300|NCT00091949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25478301|NCT00091949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478302|NCT00092417|Vaccines|vaccines|mesh-list
25478303|NCT00092417|Immunologic Factors|immunologic factors|mesh-ancestor
25583583|NCT00871780|Natalizumab|natalizumab|mesh-list
25584292|NCT00879411|Telmisartan|telmisartan|mesh-list
25584364|NCT00879996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24626734|NCT01088555|Antidotes|antidotes|mesh-ancestor
25584665|NCT00883103|Lidocaine|lidocaine|mesh-list
25585254|NCT00887575|Paclitaxel|paclitaxel|mesh-list
25585535|NCT00890162|Epinephrine|epinephrine|mesh-list
25585611|NCT00890656|Antiemetics|antiemetics|mesh-ancestor
25585691|NCT00891462|Bromides|bromides|mesh-list
25586004|NCT00894543|Citalopram|citalopram|mesh-list
25586070|NCT00895245|Dexamethasone|dexamethasone|mesh-list
25586442|NCT00899431|Antioxidants|antioxidants|mesh-ancestor
25586767|NCT00902564|Citalopram|citalopram|mesh-list
25586855|NCT00903617|Niacin|niacin|mesh-list
25587134|NCT00905489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482778|NCT00127218|Vitamins|vitamins|mesh-ancestor
25588199|NCT00915655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25588943|NCT00924209|Cisplatin|cisplatin|mesh-list
25589006|NCT00924469|Fertility Agents|fertility agents|mesh-ancestor
25589228|NCT00925990|Antiviral Agents|antiviral agents|mesh-ancestor
25589302|NCT00926380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25589388|NCT00927758|Xhance|xhance|mesh-list
25589452|NCT00928018|Immunologic Factors|immunologic factors|mesh-ancestor
25589909|NCT00931242|Apremilast|apremilast|mesh-list
25589961|NCT00931489|Ranibizumab|ranibizumab|mesh-list
25653376|NCT01536886|Betamethasone|betamethasone|mesh-list
25590262|NCT00934050|Inositol|inositol|mesh-list
25590520|NCT00936377|Analgesics|analgesics|mesh-ancestor
25590741|NCT00938860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25591465|NCT00944645|Niacin|niacin|mesh-list
25591506|NCT00944697|Oxycodone|oxycodone|mesh-list
25591736|NCT00946348|Dronabinol|dronabinol|mesh-list
25592509|NCT00953147|Hormones|hormones|mesh-ancestor
25592781|NCT00955266|Calcium|calcium|mesh-list
25593862|NCT00964496|Thalidomide|thalidomide|mesh-list
25593957|NCT00965081|Analgesics|analgesics|mesh-ancestor
25594074|NCT00966355|Hormones|hormones|mesh-ancestor
25594404|NCT00969878|Antacids|antacids|mesh-ancestor
25594581|NCT00971841|Paclitaxel|paclitaxel|mesh-list
25595034|NCT00976027|Vaccines|vaccines|mesh-list
25595113|NCT00976521|Abciximab|abciximab|mesh-list
25595377|NCT00978731|Dasatinib|dasatinib|mesh-list
25595748|NCT00982072|Hormones|hormones|mesh-ancestor
25595949|NCT00983385|Tapentadol|tapentadol|mesh-list
25596018|NCT00983580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596393|NCT00986401|Metformin|metformin|mesh-list
25596615|NCT00988208|Prednisone|prednisone|mesh-list
25597066|NCT00992407|Dopamine Agents|dopamine agents|mesh-ancestor
25597274|NCT00993473|Protamines|protamines|mesh-list
25597656|NCT00996801|Antacids|antacids|mesh-ancestor
25597735|NCT00997204|Icatibant|icatibant|mesh-list
25597924|NCT00998309|Azithromycin|azithromycin|mesh-list
25598414|NCT01002105|Baclofen|baclofen|mesh-list
25598978|NCT01005901|Glycopyrrolate|glycopyrrolate|mesh-list
25599202|NCT01008059|Alfentanil|alfentanil|mesh-list
25494212|NCT00267865|Rituximab|rituximab|mesh-list
25599898|NCT01012622|Dopamine Agents|dopamine agents|mesh-ancestor
25600204|NCT01015560|Antibodies|antibodies|mesh-list
25600397|NCT01017146|Tazarotene|tazarotene|mesh-list
25653833|NCT01543178|Rifaximin|rifaximin|mesh-list
25600889|NCT05388500|Paclitaxel|paclitaxel|mesh-list
25600983|NCT05086224|Lidocaine|lidocaine|mesh-list
25150435|NCT05242081|Sufentanil|sufentanil|mesh-list
25601229|NCT04021264|Sufentanil|sufentanil|mesh-list
25601307|NCT03747484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25601308|NCT03747484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25601309|NCT03747484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601310|NCT03747484|Immunologic Factors|immunologic factors|mesh-ancestor
25601311|NCT03747484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601317|NCT03688178|Temozolomide|temozolomide|mesh-list
25601483|NCT02955823|Rituximab|rituximab|mesh-list
25601893|NCT01021761|Ketorolac|ketorolac|mesh-list
25601932|NCT01022424|Tolvaptan|tolvaptan|mesh-list
25602330|NCT01026454|Valacyclovir|valacyclovir|mesh-list
25602481|NCT01027793|Tretinoin|tretinoin|mesh-list
25602625|NCT01028820|Serotonin Agents|serotonin agents|mesh-ancestor
25602630|NCT01029054|Dexamethasone|dexamethasone|mesh-list
25602822|NCT01031069|Vaccines|vaccines|mesh-list
25603298|NCT01035749|Vaccines|vaccines|mesh-list
25603494|NCT01040260|Nicotine|nicotine|mesh-list
25603586|NCT01040871|Prednisone|prednisone|mesh-list
25603809|NCT01042392|Ramipril|ramipril|mesh-list
25604351|NCT01048697|Ethambutol|ethambutol|mesh-list
25604526|NCT01050153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25604669|NCT01051557|Sirolimus|sirolimus|mesh-list
25605280|NCT01057225|Dexamethasone|dexamethasone|mesh-list
25605637|NCT01060059|Exenatide|exenatide|mesh-list
25605780|NCT01061736|Folic Acid|folic acid|mesh-list
25606112|NCT01064687|Exenatide|exenatide|mesh-list
25606642|NCT01070979|Estradiol|estradiol|mesh-list
25501167|NCT00323297|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25606910|NCT01073865|Goserelin|goserelin|mesh-list
25607117|NCT01075321|Lenalidomide|lenalidomide|mesh-list
25608512|NCT01088048|Rituximab|rituximab|mesh-list
25608805|NCT01090752|Metformin|metformin|mesh-list
25608945|NCT01092663|Incretins|incretins|mesh-ancestor
25609009|NCT01093183|Immunologic Factors|immunologic factors|mesh-ancestor
25609295|NCT01095835|Interferons|interferons|mesh-list
25609792|NCT01100606|Pancrelipase|pancrelipase|mesh-list
25504436|NCT00354432|Caseins|caseins|mesh-list
25609980|NCT01102426|Hormones|hormones|mesh-ancestor
25610280|NCT01105377|Azacitidine|azacitidine|mesh-list
25504947|NCT00357552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25610669|NCT01108445|Sunitinib|sunitinib|mesh-list
25610813|NCT01110135|Dexamethasone|dexamethasone|mesh-list
25611103|NCT01112358|Cetrorelix|cetrorelix|mesh-list
25612179|NCT01122160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25612183|NCT01122238|Nicotine|nicotine|mesh-list
25506952|NCT05143502|Xhance|xhance|mesh-list
25612361|NCT01124422|Autonomic Agents|autonomic agents|mesh-ancestor
25612575|NCT05307042|Coagulants|coagulants|mesh-ancestor
25613019|NCT04037241|Vitamins|vitamins|mesh-ancestor
25613145|NCT03697356|Antiemetics|antiemetics|mesh-ancestor
25613313|NCT03110315|Suvorexant|suvorexant|mesh-list
25613413|NCT02451943|Olaratumab|olaratumab|mesh-list
25614089|NCT01132807|Prednisone|prednisone|mesh-list
25614903|NCT01140906|Analgesics|analgesics|mesh-ancestor
25615029|NCT01142726|Methotrexate|methotrexate|mesh-list
25615173|NCT01143714|Petrolatum|petrolatum|mesh-list
25615711|NCT01148225|Adalimumab|adalimumab|mesh-list
25615853|NCT01149616|Dexamethasone|dexamethasone|mesh-list
25616211|NCT01153425|Zoledronic Acid|zoledronic acid|mesh-list
25616282|NCT01153763|Dabrafenib|dabrafenib|mesh-list
25616365|NCT01154192|Hormones|hormones|mesh-ancestor
25616501|NCT01155583|Antimetabolites|antimetabolites|mesh-ancestor
25616649|NCT01157351|Olanzapine|olanzapine|mesh-list
25616852|NCT01159171|Capecitabine|capecitabine|mesh-list
25616918|NCT01159600|Empagliflozin|empagliflozin|mesh-list
25616979|NCT01160354|Plerixafor|plerixafor|mesh-list
25617128|NCT01161537|Ivacaftor|ivacaftor|mesh-list
25617202|NCT01162486|Rifampin|rifampin|mesh-list
25617866|NCT01169636|Carboplatin|carboplatin|mesh-list
25618137|NCT01172418|Daclizumab|daclizumab|mesh-list
25618243|NCT01172847|Oseltamivir|oseltamivir|mesh-list
25618353|NCT01173848|Cholecalciferol|cholecalciferol|mesh-list
25618763|NCT01177956|Cetuximab|cetuximab|mesh-list
25619563|NCT01184898|Antiviral Agents|antiviral agents|mesh-ancestor
25619781|NCT01186406|Alkylating Agents|alkylating agents|mesh-ancestor
25619984|NCT01188577|Mydriatics|mydriatics|mesh-ancestor
25620539|NCT01193335|Vaccines|vaccines|mesh-list
25620827|NCT01195779|Vaccines|vaccines|mesh-list
25620978|NCT01197560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25621008|NCT01197833|Polidocanol|polidocanol|mesh-list
25621483|NCT01201785|Aspirin|aspirin|mesh-list
25516163|NCT00426361|Vaccines|vaccines|mesh-list
25621608|NCT01202279|Adrenergic Agents|adrenergic agents|mesh-ancestor
25621874|NCT01204905|Antiviral Agents|antiviral agents|mesh-ancestor
25622371|NCT01211522|Serotonin Agents|serotonin agents|mesh-ancestor
25622750|NCT01214421|Tolvaptan|tolvaptan|mesh-list
25622874|NCT01215344|Diphosphonates|diphosphonates|mesh-list
25622963|NCT01215916|Pemetrexed|pemetrexed|mesh-list
25517733|NCT00438360|Cyclosporine|cyclosporine|mesh-list
25623136|NCT01217307|Metformin|metformin|mesh-list
25623356|NCT01218516|Paclitaxel|paclitaxel|mesh-list
25623434|NCT01219738|Budesonide|budesonide|mesh-list
25623548|NCT01220180|Pregabalin|pregabalin|mesh-list
25623624|NCT01220973|Antimetabolites|antimetabolites|mesh-ancestor
25623699|NCT01221753|Mitosis Modulators|mitosis modulators|mesh-ancestor
25623858|NCT01222832|Bacitracin|bacitracin|mesh-list
25624082|NCT01225991|Milnacipran|milnacipran|mesh-list
25624760|NCT01231581|Antimetabolites|antimetabolites|mesh-ancestor
25624862|NCT01232296|Sorafenib|sorafenib|mesh-list
25624947|NCT01232946|Insulin|insulin|mesh-list
25625398|NCT01237678|Etoposide|etoposide|mesh-list
25625528|NCT01239342|Everolimus|everolimus|mesh-list
25626238|NCT01248468|Antipyretics|antipyretics|mesh-ancestor
25626385|NCT01250119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521150|NCT00460109|Rituximab|rituximab|mesh-list
25626749|NCT01253187|Diuretics|diuretics|mesh-ancestor
25626823|NCT01253642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25627227|NCT01257542|Dextromethorphan|dextromethorphan|mesh-list
25521929|NCT00465894|Urological Agents|urological agents|mesh-ancestor
25521930|NCT00465972|Doxepin|doxepin|mesh-list
25627327|NCT01258387|Mitogens|mitogens|mesh-list
25627394|NCT01259089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25627785|NCT01263197|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25628256|NCT01267292|Dopamine Agents|dopamine agents|mesh-ancestor
25628708|NCT01272934|Diclofenac|diclofenac|mesh-list
25628856|NCT01275170|Anesthetics|anesthetics|mesh-ancestor
25523575|NCT00476996|Methotrexate|methotrexate|mesh-list
25629190|NCT01277523|Tiotropium Bromide|tiotropium bromide|mesh-list
25629605|NCT01282463|Docetaxel|docetaxel|mesh-list
25629897|NCT01285609|Paclitaxel|paclitaxel|mesh-list
25629914|NCT01285908|Norepinephrine|norepinephrine|mesh-list
25629986|NCT01286753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630469|NCT01291784|Antibodies|antibodies|mesh-list
25631027|NCT01296646|Naltrexone|naltrexone|mesh-list
25631256|NCT01298570|Vitamins|vitamins|mesh-ancestor
25631402|NCT01300247|Immunologic Factors|immunologic factors|mesh-ancestor
25631602|NCT01302080|Sertraline|sertraline|mesh-list
25631734|NCT01303445|Omeprazole|omeprazole|mesh-list
25631806|NCT01303965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25631953|NCT01305772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632027|NCT01306656|Vitamin D|vitamin d|mesh-list
25632274|NCT01309243|Antiviral Agents|antiviral agents|mesh-ancestor
25632552|NCT01312766|Fertility Agents|fertility agents|mesh-ancestor
25632699|NCT01313494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25632953|NCT01315574|Travoprost|travoprost|mesh-list
25633215|NCT01318499|Nepafenac|nepafenac|mesh-list
25633363|NCT01320722|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25633522|NCT01323478|Vortioxetine|vortioxetine|mesh-list
25633930|NCT01327300|Mesalamine|mesalamine|mesh-list
25634037|NCT01328002|Milnacipran|milnacipran|mesh-list
25634269|NCT01330043|Dopamine Agents|dopamine agents|mesh-ancestor
25529344|NCT00519636|Xhance|xhance|mesh-list
25634777|NCT01333488|Magnesium Sulfate|magnesium sulfate|mesh-list
25634848|NCT01334086|Aprepitant|aprepitant|mesh-list
25635061|NCT01336608|Xhance|xhance|mesh-list
25635137|NCT01337336|Xhance|xhance|mesh-list
25635339|NCT01339260|Dexamethasone|dexamethasone|mesh-list
25635368|NCT01339559|Brivaracetam|brivaracetam|mesh-list
25635460|NCT01340300|Metformin|metformin|mesh-list
25635565|NCT01341782|Calcitriol|calcitriol|mesh-list
25635822|NCT01344161|Vitamin D|vitamin d|mesh-list
25635891|NCT01345019|Denosumab|denosumab|mesh-list
25635957|NCT01345669|Afatinib|afatinib|mesh-list
25636023|NCT01346475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25636243|NCT01349660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25637320|NCT01362491|Ibuprofen|ibuprofen|mesh-list
25637780|NCT01365611|Xhance|xhance|mesh-list
25638828|NCT01376310|Trametinib|trametinib|mesh-list
25638846|NCT01376349|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25639086|NCT01379508|Tenofovir|tenofovir|mesh-list
25639536|NCT01383759|BB 1101|bb 1101|mesh-list
25639759|NCT01387022|Tenofovir|tenofovir|mesh-list
25640135|NCT01390441|Antipruritics|antipruritics|mesh-ancestor
25640432|NCT01392573|Insulin|insulin|mesh-list
25640577|NCT01393730|Prednisone|prednisone|mesh-list
25640651|NCT01394185|Sensory System Agents|sensory system agents|mesh-ancestor
25640761|NCT01395329|BQ 788|bq 788|mesh-list
25640799|NCT01395537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25640903|NCT01396083|Dexamethasone|dexamethasone|mesh-list
25640993|NCT01397422|Amantadine|amantadine|mesh-list
25641065|NCT01398514|Citalopram|citalopram|mesh-list
25641130|NCT01399190|Growth Substances|growth substances|mesh-ancestor
25641595|NCT01404260|Gefitinib|gefitinib|mesh-list
25641835|NCT01407094|Sertraline|sertraline|mesh-list
25537103|NCT05028075|Cobalt|cobalt|mesh-list
25642363|NCT01414010|Amoxicillin|amoxicillin|mesh-list
25642401|NCT01414855|Prednisone|prednisone|mesh-list
25642475|NCT01415518|Purinergic Agents|purinergic agents|mesh-ancestor
25642476|NCT01415531|Nebivolol|nebivolol|mesh-list
25642551|NCT01416441|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25642773|NCT01419977|Dalteparin|dalteparin|mesh-list
25642921|NCT01421355|Protease Inhibitors|protease inhibitors|mesh-ancestor
25643023|NCT01422304|Atropine|atropine|mesh-list
25643400|NCT01427309|Vaccines|vaccines|mesh-list
25643475|NCT01427803|Naproxen|naproxen|mesh-list
25434989|NCT04782388|GABA Agents|gaba agents|mesh-ancestor
25643493|NCT01427881|Cyclosporins|cyclosporins|mesh-list
25822755|NCT00004643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25643505|NCT01427881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25643506|NCT01427881|Antifungal Agents|antifungal agents|mesh-ancestor
25643508|NCT01427881|Dermatologic Agents|dermatologic agents|mesh-ancestor
25435692|NCT04772287|Antimitotic Agents|antimitotic agents|mesh-ancestor
25643518|NCT01427920|Insulin Aspart|insulin aspart|mesh-list
25436184|NCT04764851|Dopamine Agents|dopamine agents|mesh-ancestor
25436405|NCT04762784|Hormones|hormones|mesh-ancestor
25643525|NCT01427972|Eplerenone|eplerenone|mesh-list
25436635|NCT04759079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25436719|NCT04757532|Bupropion|bupropion|mesh-list
25436899|NCT04755647|Antioxidants|antioxidants|mesh-ancestor
25643529|NCT01427972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437577|NCT04745273|Ondansetron|ondansetron|mesh-list
25437725|NCT04744571|Antipyretics|antipyretics|mesh-ancestor
25438185|NCT04737278|Niacin|niacin|mesh-list
25438602|NCT05292976|Miotics|miotics|mesh-ancestor
25438744|NCT05034952|Acetaminophen|acetaminophen|mesh-list
25438875|NCT04403516|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25438876|NCT04403516|Prednisolone phosphate|prednisolone phosphate|mesh-list
25438877|NCT04403516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25438878|NCT04403516|Antiemetics|antiemetics|mesh-ancestor
25439032|NCT03996148|Remifentanil|remifentanil|mesh-list
25439113|NCT03808480|Nivolumab|nivolumab|mesh-list
25440118|NCT04730245|Rifaximin|rifaximin|mesh-list
25440178|NCT04729465|Propofol|propofol|mesh-list
25440261|NCT04728659|Desogestrel|desogestrel|mesh-list
25440322|NCT04728308|Bupivacaine|bupivacaine|mesh-list
25440859|NCT04723238|Analgesics|analgesics|mesh-ancestor
25441325|NCT04716868|Levan|levan|mesh-list
25441459|NCT04715165|Bupivacaine|bupivacaine|mesh-list
25442117|NCT04709081|Midazolam|midazolam|mesh-list
25442180|NCT04708821|Analgesics|analgesics|mesh-ancestor
25643664|NCT01429272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25643681|NCT01429298|Analgesics|analgesics|mesh-ancestor
25643709|NCT01430104|Teriparatide|teriparatide|mesh-list
25643713|NCT01430182|Morphine|morphine|mesh-list
25643730|NCT01430403|Autonomic Agents|autonomic agents|mesh-ancestor
25643746|NCT01430455|Tranylcypromine|tranylcypromine|mesh-list
25443626|NCT04691076|Fentanyl|fentanyl|mesh-list
25443716|NCT04689412|Resveratrol|resveratrol|mesh-list
25643769|NCT01430585|Letrozole|letrozole|mesh-list
25443913|NCT04687098|Idarubicin|idarubicin|mesh-list
25297135|NCT03683069|Diuretics|diuretics|mesh-ancestor
25444455|NCT04679597|Capecitabine|capecitabine|mesh-list
25444524|NCT04679103|Immunologic Factors|immunologic factors|mesh-ancestor
25444664|NCT04676763|Histamine|histamine|mesh-list
25643817|NCT01431170|Renal Agents|renal agents|mesh-ancestor
25444878|NCT04674332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25643833|NCT01431274|Olodaterol|olodaterol|mesh-list
25445543|NCT04665076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25445639|NCT04663763|Antimetabolites|antimetabolites|mesh-ancestor
25445697|NCT04662866|Metformin|metformin|mesh-list
25445759|NCT04662125|Hormones|hormones|mesh-ancestor
25446043|NCT04659057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446291|NCT04654962|Anesthetics|anesthetics|mesh-list
25643915|NCT01431950|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25447075|NCT04644484|Vaccines|vaccines|mesh-list
25447338|NCT04639804|Celecoxib|celecoxib|mesh-list
25643951|NCT01432015|Aprepitant|aprepitant|mesh-list
25447528|NCT04637204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447675|NCT04634500|Dapagliflozin|dapagliflozin|mesh-list
25447885|NCT04630873|Botulinum Toxins|botulinum toxins|mesh-list
25302827|NCT04991571|Dapagliflozin|dapagliflozin|mesh-list
25643994|NCT01432236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25448628|NCT04621617|Midodrine|midodrine|mesh-list
25448682|NCT04621227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25448683|NCT04621227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448684|NCT04621513|Montelukast|montelukast|mesh-list
25448685|NCT04621513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25448686|NCT04621513|Respiratory System Agents|respiratory system agents|mesh-ancestor
25448687|NCT04621513|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25448688|NCT04621513|Hormone Antagonists|hormone antagonists|mesh-ancestor
25448689|NCT04621513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25448690|NCT04621513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448691|NCT04621513|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25448692|NCT04621513|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25448693|NCT04621513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449702|NCT04610125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25449762|NCT04609189|Antacids|antacids|mesh-ancestor
25449834|NCT04608253|Antimetabolites|antimetabolites|mesh-ancestor
25449964|NCT04606537|Hormone Antagonists|hormone antagonists|mesh-ancestor
25450020|NCT04605952|Antibodies|antibodies|mesh-list
25450083|NCT04604678|Metformin|metformin|mesh-list
25450348|NCT04601675|Ranibizumab|ranibizumab|mesh-list
25450422|NCT04601259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25450499|NCT04600089|Anesthetics|anesthetics|mesh-ancestor
25644111|NCT01433081|Tocolytic Agents|tocolytic agents|mesh-ancestor
25644121|NCT01433913|Metformin|metformin|mesh-list
25451117|NCT04590612|Dopamine Agents|dopamine agents|mesh-ancestor
25644132|NCT01434121|Ascorbic Acid|ascorbic acid|mesh-list
25307110|NCT04941573|Xenon|xenon|mesh-list
25644140|NCT01434186|Saxagliptin|saxagliptin|mesh-list
25644150|NCT01434342|Nicotine|nicotine|mesh-list
25644155|NCT01434342|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25452082|NCT04577443|Adenosine|adenosine|mesh-list
25452453|NCT04573049|Simendan|simendan|mesh-list
25452807|NCT04568863|Melatonin|melatonin|mesh-list
25453187|NCT04563494|Hormones|hormones|mesh-ancestor
25453317|NCT04561219|Nitazoxanide|nitazoxanide|mesh-list
25453385|NCT04560673|Analgesics|analgesics|mesh-ancestor
25644268|NCT01435616|Insulin Glargine|insulin glargine|mesh-list
25310365|NCT03867110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25822855|NCT00004686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25644329|NCT01436110|Autonomic Agents|autonomic agents|mesh-ancestor
25454190|NCT04549012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25644386|NCT01436266|Oxytocics|oxytocics|mesh-ancestor
25455242|NCT04536493|Lidocaine|lidocaine|mesh-list
25314802|NCT05014711|Analgesics|analgesics|mesh-ancestor
25457410|NCT05325229|Bevacizumab|bevacizumab|mesh-list
25644536|NCT01437605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644543|NCT01437995|Xhance|xhance|mesh-list
25644544|NCT01437995|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25458225|NCT05127304|Bromides|bromides|mesh-list
25459006|NCT05282771|Vitamins|vitamins|mesh-ancestor
25459090|NCT05281276|Celecoxib|celecoxib|mesh-list
25459309|NCT05279482|Glucocorticoids|glucocorticoids|mesh-ancestor
25459383|NCT05254808|Fosfomycin|fosfomycin|mesh-list
25644577|NCT01438060|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25318835|NCT04956939|Levodopa|levodopa|mesh-list
25459998|NCT04762472|Montelukast|montelukast|mesh-list
25319496|NCT04947241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25319497|NCT04947241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319498|NCT04947241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25319499|NCT04947241|Antimetabolites|antimetabolites|mesh-ancestor
25319500|NCT04947241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319501|NCT04947241|Antiviral Agents|antiviral agents|mesh-ancestor
25319507|NCT04946825|Nicotine|nicotine|mesh-list
25460402|NCT04432376|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25822874|NCT00004688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25644578|NCT01438060|Serotonin Agents|serotonin agents|mesh-ancestor
25644579|NCT01438060|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25319570|NCT04946383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319581|NCT04945954|Cyclophosphamide|cyclophosphamide|mesh-list
25319582|NCT04945954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25319583|NCT04945954|Immunologic Factors|immunologic factors|mesh-ancestor
25319584|NCT04945954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460473|NCT04338529|Calcium Carbonate|calcium carbonate|mesh-list
25460474|NCT04338529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25460475|NCT04338529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460476|NCT04338529|Vitamins|vitamins|mesh-ancestor
25460477|NCT04338529|Micronutrients|micronutrients|mesh-ancestor
25460478|NCT04338529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25644587|NCT01438177|Chloroquine|chloroquine|mesh-list
25461214|NCT03376672|Dexamethasone|dexamethasone|mesh-list
25461436|NCT02932579|Ibuprofen|ibuprofen|mesh-list
25461913|NCT01232283|Apremilast|apremilast|mesh-list
25461958|NCT01193842|Vorinostat|vorinostat|mesh-list
25462039|NCT05285605|Ulipristal acetate|ulipristal acetate|mesh-list
25462040|NCT05285605|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25462041|NCT05285605|Contraceptive Agents|contraceptive agents|mesh-ancestor
25462042|NCT05285605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25462043|NCT05285605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462044|NCT05285605|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25462045|NCT05285449|Cannabidiol|cannabidiol|mesh-list
25462190|NCT05283954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321859|NCT04916080|Antidotes|antidotes|mesh-ancestor
25462549|NCT04090190|Urological Agents|urological agents|mesh-ancestor
25462787|NCT01904136|Melphalan|melphalan|mesh-list
25463139|NCT04963283|Nivolumab|nivolumab|mesh-list
25463289|NCT04431518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25463453|NCT03471624|Tenofovir|tenofovir|mesh-list
25323470|NCT04896359|Ascorbic Acid|ascorbic acid|mesh-list
25323552|NCT04895800|Caffeine|caffeine|mesh-list
25463648|NCT02477384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25463740|NCT01131169|Vidarabine|vidarabine|mesh-list
25463811|NCT00735657|Iodine|iodine|mesh-list
25464012|NCT00000620|Vasodilator Agents|vasodilator agents|mesh-ancestor
25644631|NCT01438814|Incretins|incretins|mesh-ancestor
25324446|NCT04884503|Anticonvulsants|anticonvulsants|mesh-ancestor
25324921|NCT05257395|Letrozole|letrozole|mesh-list
25324922|NCT05257395|Anastrozole|anastrozole|mesh-list
25324923|NCT05257395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25324924|NCT05257395|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25324925|NCT05257395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25464718|NCT04940338|BB 1101|bb 1101|mesh-list
25464819|NCT04487145|Artenimol|artenimol|mesh-list
25465091|NCT03834519|Hormones|hormones|mesh-ancestor
25465258|NCT03246906|Sirolimus|sirolimus|mesh-list
25325880|NCT04877509|Selenium|selenium|mesh-list
25465496|NCT01612351|Paclitaxel|paclitaxel|mesh-list
25326079|NCT04875858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326080|NCT04875611|Nivolumab|nivolumab|mesh-list
25326081|NCT04875611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25326082|NCT04875611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25326083|NCT04875611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25326084|NCT04875611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326093|NCT04874844|Antibodies|antibodies|mesh-list
25326094|NCT04874844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25326154|NCT04874506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326155|NCT04874506|Protective Agents|protective agents|mesh-ancestor
25326156|NCT04874506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326157|NCT04874506|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25326158|NCT04874246|Vasopressins|vasopressins|mesh-list
25326159|NCT04874246|Arginine Vasopressin|arginine vasopressin|mesh-list
25326160|NCT04874246|Hemostatics|hemostatics|mesh-ancestor
25326161|NCT04874246|Coagulants|coagulants|mesh-ancestor
25326166|NCT04874428|Rivaroxaban|rivaroxaban|mesh-list
25465664|NCT05233735|Betamethasone|betamethasone|mesh-list
25465702|NCT05233358|Nivolumab|nivolumab|mesh-list
25465767|NCT05232123|Cannabidiol|cannabidiol|mesh-list
25465846|NCT05184777|Estradiol|estradiol|mesh-list
25466364|NCT04303390|Cefuroxime axetil|cefuroxime axetil|mesh-list
25466438|NCT04266340|Analgesics|analgesics|mesh-ancestor
25466758|NCT02677324|Venetoclax|venetoclax|mesh-list
25327545|NCT04856852|Iodine|iodine|mesh-list
25467114|NCT04504864|Antipyretics|antipyretics|mesh-ancestor
25467259|NCT04326738|Anesthetics|anesthetics|mesh-ancestor
25467365|NCT03882047|Xhance|xhance|mesh-list
25467440|NCT03855189|Hormones|hormones|mesh-ancestor
25467571|NCT03645408|Exenatide|exenatide|mesh-list
25467794|NCT03167242|Lumefantrine|lumefantrine|mesh-list
25467870|NCT03101046|Docetaxel|docetaxel|mesh-list
25468273|NCT02299505|Ceritinib|ceritinib|mesh-list
25468389|NCT01916967|Histamine Agents|histamine agents|mesh-ancestor
25468564|NCT01471340|Prednisone|prednisone|mesh-list
25468802|NCT00945035|Analgesics|analgesics|mesh-ancestor
25329902|NCT04830410|Levan|levan|mesh-list
25329905|NCT04829773|Midazolam|midazolam|mesh-list
25469064|NCT00568178|Losartan|losartan|mesh-list
25469409|NCT00003389|Hormones|hormones|mesh-ancestor
25469786|NCT00004228|Daunorubicin|daunorubicin|mesh-list
25471251|NCT00008138|Paclitaxel|paclitaxel|mesh-list
25471616|NCT00022698|Capecitabine|capecitabine|mesh-list
25471683|NCT00024167|Prednisone|prednisone|mesh-list
25471810|NCT00026208|Prednisone|prednisone|mesh-list
25472539|NCT00040664|Protease Inhibitors|protease inhibitors|mesh-ancestor
25472610|NCT00041067|Tubulin Modulators|tubulin modulators|mesh-ancestor
25472681|NCT00041132|Glucocorticoids|glucocorticoids|mesh-ancestor
25472758|NCT00042939|Docetaxel|docetaxel|mesh-list
25472969|NCT00045305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25644790|NCT01440803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644791|NCT01440803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25644792|NCT01440816|Interleukin-12|interleukin-12|mesh-list
25473044|NCT00045942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473045|NCT00045942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25473046|NCT00045942|Hormone Antagonists|hormone antagonists|mesh-ancestor
25473047|NCT00045942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25473050|NCT00045942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473573|NCT00051636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25473712|NCT00053898|Hormone Antagonists|hormone antagonists|mesh-ancestor
25473714|NCT00053898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473787|NCT00054132|Immunologic Factors|immunologic factors|mesh-ancestor
25473788|NCT00054132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25473789|NCT00054132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473791|NCT00054275|Docetaxel|docetaxel|mesh-list
25473860|NCT00054665|Bortezomib|bortezomib|mesh-list
25474230|NCT00058123|Poly ICLC|poly iclc|mesh-list
25474843|NCT00064337|Hormones|hormones|mesh-ancestor
25475127|NCT00066781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25475205|NCT00068250|Rituximab|rituximab|mesh-list
25475346|NCT00068692|Antidotes|antidotes|mesh-ancestor
25475662|NCT00072514|Rituximab|rituximab|mesh-list
25475811|NCT00073983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475896|NCT00074308|Bevacizumab|bevacizumab|mesh-list
25476124|NCT00075725|Leucovorin|leucovorin|mesh-list
25476249|NCT00076024|Axitinib|axitinib|mesh-list
25476499|NCT00078559|Antipyretics|antipyretics|mesh-ancestor
25476572|NCT00078754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25476573|NCT00078754|Anticonvulsants|anticonvulsants|mesh-ancestor
25476574|NCT00078754|GABA Agents|gaba agents|mesh-ancestor
25476575|NCT00078754|Antimanic Agents|antimanic agents|mesh-ancestor
25476578|NCT00078767|Sertraline|sertraline|mesh-list
25476988|NCT00082888|Tipifarnib|tipifarnib|mesh-list
25477137|NCT00084149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477138|NCT00084149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477139|NCT00084149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25477333|NCT00085436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25477405|NCT00086190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477406|NCT00086190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25477407|NCT00086190|Serotonin Agents|serotonin agents|mesh-ancestor
25477408|NCT00086190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477409|NCT00086190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25477410|NCT00086190|Antidepressive Agents|antidepressive agents|mesh-ancestor
25477494|NCT00086411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25477567|NCT00086996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25477640|NCT00087607|Antimetabolites|antimetabolites|mesh-ancestor
25477933|NCT00089102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25477934|NCT00089102|Immunologic Factors|immunologic factors|mesh-ancestor
25477935|NCT00089102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477936|NCT00089102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25478014|NCT00089583|Ritonavir|ritonavir|mesh-list
25478076|NCT00089778|Analgesics|analgesics|mesh-ancestor
25478145|NCT00090402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478146|NCT00090402|Vitamin B Complex|vitamin b complex|mesh-ancestor
25478147|NCT00090402|Vitamins|vitamins|mesh-ancestor
25478148|NCT00090402|Micronutrients|micronutrients|mesh-ancestor
25478149|NCT00090519|Ruboxistaurin|ruboxistaurin|mesh-list
25478150|NCT00090519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478151|NCT00090519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478152|NCT00090545|Sorafenib|sorafenib|mesh-list
25478283|NCT00091572|Dacarbazine|dacarbazine|mesh-list
25478285|NCT00091572|Alkylating Agents|alkylating agents|mesh-ancestor
25478437|NCT00094328|Androgen Antagonists|androgen antagonists|mesh-ancestor
25479248|NCT00098839|Glucocorticoids|glucocorticoids|mesh-ancestor
25479313|NCT00099268|Levodopa|levodopa|mesh-list
24852031|NCT02260024|Pramipexole|pramipexole|mesh-list
24590618|NCT00913341|Alprazolam|alprazolam|mesh-list
24934018|NCT04065165|Lanreotide|lanreotide|mesh-list
25479897|NCT00104247|Verapamil|verapamil|mesh-list
25480170|NCT00106002|Pemetrexed|pemetrexed|mesh-list
25480243|NCT00106704|Protease Inhibitors|protease inhibitors|mesh-ancestor
25480318|NCT00107783|Nitisinone|nitisinone|mesh-list
25822979|NCT00004728|Warfarin|warfarin|mesh-list
25822980|NCT00004728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25822981|NCT00004728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25644908|NCT01441635|Estrogens|estrogens|mesh-ancestor
25480604|NCT00109837|Antimalarials|antimalarials|mesh-ancestor
25480788|NCT00110890|Cinacalcet|cinacalcet|mesh-list
25644909|NCT01441635|Hormones|hormones|mesh-ancestor
25480948|NCT00112502|Thalidomide|thalidomide|mesh-list
25481009|NCT00112723|Alvocidib|alvocidib|mesh-list
25481076|NCT00112918|Vitamins|vitamins|mesh-ancestor
25481077|NCT00112918|Micronutrients|micronutrients|mesh-ancestor
25823035|NCT00004736|Nelfinavir|nelfinavir|mesh-list
24826206|NCT02133287|Sirolimus|sirolimus|mesh-list
25203458|NCT02714179|Acetaminophen|acetaminophen|mesh-list
25481858|NCT00119106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25482107|NCT00121251|Gemcitabine|gemcitabine|mesh-list
25482462|NCT00124943|Paclitaxel|paclitaxel|mesh-list
25482761|NCT00127205|Clodronic Acid|clodronic acid|mesh-list
25482847|NCT00128180|Hormones|hormones|mesh-ancestor
25482929|NCT00129246|Naltrexone|naltrexone|mesh-list
25483101|NCT00130039|Cilostazol|cilostazol|mesh-list
25483238|NCT00131248|Antiemetics|antiemetics|mesh-ancestor
25483371|NCT00132691|Infliximab|infliximab|mesh-list
25483500|NCT00134004|Fludarabine phosphate|fludarabine phosphate|mesh-list
25644968|NCT01442155|Antimetabolites|antimetabolites|mesh-ancestor
25484015|NCT00141037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25484086|NCT00141453|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25484087|NCT00141453|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25484088|NCT00141453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484089|NCT00141518|Levodopa|levodopa|mesh-list
25484090|NCT00141518|Carbidopa|carbidopa|mesh-list
25484091|NCT00141518|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25484092|NCT00141518|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25484093|NCT00141518|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25484094|NCT00141518|Dopamine Agents|dopamine agents|mesh-ancestor
25484095|NCT00141518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25484097|NCT00141518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644972|NCT01442376|Palonosetron|palonosetron|mesh-list
25644973|NCT01442376|Antiemetics|antiemetics|mesh-ancestor
25644974|NCT01442376|Autonomic Agents|autonomic agents|mesh-ancestor
25484149|NCT00141921|Etanercept|etanercept|mesh-list
25484745|NCT00150969|Vitamin K|vitamin k|mesh-list
25644995|NCT01442493|Analgesics|analgesics|mesh-ancestor
25823120|NCT00004755|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25645077|NCT01443130|Renal Agents|renal agents|mesh-ancestor
25645084|NCT01443442|Bepotastine besilate|bepotastine besilate|mesh-list
25486478|NCT00178919|Autonomic Agents|autonomic agents|mesh-ancestor
25486829|NCT00183430|Prazosin|prazosin|mesh-list
25486889|NCT00183677|Citalopram|citalopram|mesh-list
25487028|NCT00185614|Cyclosporine|cyclosporine|mesh-list
25645162|NCT01444924|Anesthetics|anesthetics|mesh-ancestor
25645167|NCT01445028|Isotretinoin|isotretinoin|mesh-list
25488906|NCT00203307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25645175|NCT01445535|Cyclophosphamide|cyclophosphamide|mesh-list
25645176|NCT01445535|Rituximab|rituximab|mesh-list
25489620|NCT00216086|Irinotecan|irinotecan|mesh-list
25645203|NCT01445548|Sirolimus|sirolimus|mesh-list
25489935|NCT00218491|Antidotes|antidotes|mesh-ancestor
25490309|NCT00224107|Silodosin|silodosin|mesh-list
25490465|NCT00225732|Ibuprofen|ibuprofen|mesh-list
25490668|NCT00227617|Antidotes|antidotes|mesh-ancestor
25491143|NCT00236899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25645279|NCT01445886|Vitamins|vitamins|mesh-ancestor
25491962|NCT00246571|Sunitinib|sunitinib|mesh-list
25645299|NCT01446159|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24648772|NCT01216709|Iron|iron|mesh-list
25493440|NCT00262522|Ritonavir|ritonavir|mesh-list
25493500|NCT00262847|Paclitaxel|paclitaxel|mesh-list
25493572|NCT00262925|Antidotes|antidotes|mesh-ancestor
25493781|NCT00265083|Golimumab|golimumab|mesh-list
25645361|NCT01447446|Ribavirin|ribavirin|mesh-list
25645403|NCT01447706|Paclitaxel|paclitaxel|mesh-list
25494280|NCT00268983|Iodine|iodine|mesh-list
25645411|NCT01447849|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25494777|NCT00275561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25495176|NCT00280397|Lenvatinib|lenvatinib|mesh-list
25495278|NCT00281840|Growth Substances|growth substances|mesh-ancestor
25495417|NCT00282347|Antitubercular Agents|antitubercular agents|mesh-ancestor
25495481|NCT00282568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495561|NCT00283595|Hormones|hormones|mesh-list
25496039|NCT00288639|Pregabalin|pregabalin|mesh-list
25496422|NCT00292162|Metoprolol|metoprolol|mesh-list
25496475|NCT00292227|Moxifloxacin|moxifloxacin|mesh-list
25496622|NCT00293293|Taxane|taxane|mesh-list
25645449|NCT01448057|Mydriatics|mydriatics|mesh-ancestor
25496711|NCT00293722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645451|NCT01448057|Sympathomimetics|sympathomimetics|mesh-ancestor
25497219|NCT00298233|Oseltamivir|oseltamivir|mesh-list
25498050|NCT00303719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25498051|NCT00303719|Alkylating Agents|alkylating agents|mesh-ancestor
25498073|NCT00303862|Cediranib|cediranib|mesh-list
25645490|NCT01448486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25645498|NCT01448525|Bimatoprost|bimatoprost|mesh-list
25498497|NCT04493931|Anesthetics|anesthetics|mesh-ancestor
24571776|NCT00811785|Copper|copper|mesh-list
25499047|NCT02578732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499178|NCT00549978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499375|NCT00306384|Incretins|incretins|mesh-ancestor
25645518|NCT01448707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25499848|NCT00311246|Adalimumab|adalimumab|mesh-list
25500100|NCT00313612|Topotecan|topotecan|mesh-list
25500322|NCT00315458|Buprenorphine|buprenorphine|mesh-list
25645556|NCT01449279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168392|NCT02206087|Heparin|heparin|mesh-list
25501222|NCT00323622|Renal Agents|renal agents|mesh-ancestor
25501599|NCT00327015|Hormones|hormones|mesh-ancestor
25501674|NCT00328614|Ethylene|ethylene|mesh-list
25645647|NCT01450007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645664|NCT01450137|Hormones|hormones|mesh-ancestor
25502224|NCT00332839|Dermatologic Agents|dermatologic agents|mesh-ancestor
25502301|NCT00333814|Hormones|hormones|mesh-ancestor
25502590|NCT00335829|Bevacizumab|bevacizumab|mesh-list
25502949|NCT00338286|Hematinics|hematinics|mesh-ancestor
25503311|NCT00344305|Vaccines|vaccines|mesh-list
25068521|NCT03432871|Niacin|niacin|mesh-list
25504052|NCT00352053|Tenofovir|tenofovir|mesh-list
25645720|NCT01450761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25645721|NCT01450761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645722|NCT01450761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645725|NCT01450800|Nitrofurantoin|nitrofurantoin|mesh-list
25645728|NCT01450800|Renal Agents|renal agents|mesh-ancestor
25645739|NCT01450826|Aprepitant|aprepitant|mesh-list
25645809|NCT01451645|Colchicine|colchicine|mesh-list
25505244|NCT00360360|Bevacizumab|bevacizumab|mesh-list
25505314|NCT00360685|Mycophenolic Acid|mycophenolic acid|mesh-list
25505533|NCT00362232|Anticoagulants|anticoagulants|mesh-ancestor
25505679|NCT00363545|Vaccines|vaccines|mesh-list
25505754|NCT00364611|Bevacizumab|bevacizumab|mesh-list
25505896|NCT00365365|Docetaxel|docetaxel|mesh-list
25505966|NCT00365456|Hormones|hormones|mesh-list
25506500|NCT00369577|Loxapine|loxapine|mesh-list
25507033|NCT04901975|Spironolactone|spironolactone|mesh-list
25645850|NCT01451762|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25645863|NCT01451814|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25645889|NCT01452126|Sensory System Agents|sensory system agents|mesh-ancestor
25508713|NCT00375830|Listerine|listerine|mesh-list
25508942|NCT00377520|Pemetrexed|pemetrexed|mesh-list
25509006|NCT00377962|Everolimus|everolimus|mesh-list
25509269|NCT00379821|Amebicides|amebicides|mesh-ancestor
25509762|NCT00382993|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25509770|NCT00383149|Cetuximab|cetuximab|mesh-list
25645943|NCT01453153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645944|NCT01453153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645945|NCT01453153|Antiviral Agents|antiviral agents|mesh-ancestor
25645946|NCT01453153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25645947|NCT01453153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509826|NCT00383448|Dermatologic Agents|dermatologic agents|mesh-ancestor
25509827|NCT00383448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25509828|NCT00383448|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25509829|NCT00383448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25509830|NCT00383448|Alkylating Agents|alkylating agents|mesh-ancestor
25509831|NCT00383448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509832|NCT00383448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25509833|NCT00383448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25510103|NCT00385593|Adrenergic Agents|adrenergic agents|mesh-ancestor
25510104|NCT00385593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25645949|NCT01453153|Immunologic Factors|immunologic factors|mesh-ancestor
25645950|NCT01453153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645951|NCT01453205|Rituximab|rituximab|mesh-list
25510167|NCT00385788|Vidarabine|vidarabine|mesh-list
25510168|NCT00385788|Methotrexate|methotrexate|mesh-list
25510169|NCT00385788|Fludarabine phosphate|fludarabine phosphate|mesh-list
25510170|NCT00385788|Fludarabine|fludarabine|mesh-list
25510171|NCT00385788|Melphalan|melphalan|mesh-list
25510172|NCT00385788|Tacrolimus|tacrolimus|mesh-list
25510173|NCT00385788|Thymoglobulin|thymoglobulin|mesh-list
25510174|NCT00385788|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25510175|NCT00385788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25510176|NCT00385788|Antimetabolites|antimetabolites|mesh-ancestor
25510177|NCT00385788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510178|NCT00385788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510222|NCT00385827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25510287|NCT00386477|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25510288|NCT00386477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25510431|NCT00387790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510432|NCT00387790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25510433|NCT00387790|Dermatologic Agents|dermatologic agents|mesh-ancestor
25510434|NCT00387829|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25510435|NCT00387829|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25510436|NCT00387829|Estradiol|estradiol|mesh-list
25510437|NCT00387829|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25510438|NCT00387829|Estrogens|estrogens|mesh-ancestor
25510439|NCT00387829|Hormones|hormones|mesh-ancestor
25510505|NCT00388037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25510506|NCT00388037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510509|NCT00388154|Cisplatin|cisplatin|mesh-list
25645955|NCT01453205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510992|NCT00391586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25510993|NCT00391586|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25510994|NCT00391586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25510995|NCT00391586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25510996|NCT00391716|Gabapentin|gabapentin|mesh-list
25510997|NCT00391716|Analgesics|analgesics|mesh-ancestor
25510998|NCT00391716|Sensory System Agents|sensory system agents|mesh-ancestor
25510999|NCT00391716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25511059|NCT00391846|Hormone Antagonists|hormone antagonists|mesh-ancestor
25511060|NCT00391846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25511061|NCT00391846|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25511062|NCT00391846|Natriuretic Agents|natriuretic agents|mesh-ancestor
25511127|NCT00392197|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25511128|NCT00392197|Serotonin Agents|serotonin agents|mesh-ancestor
25511129|NCT00392197|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25511130|NCT00392197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25511131|NCT00392197|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25511132|NCT00392197|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25511139|NCT00392288|Hormones|hormones|mesh-ancestor
25511244|NCT00392769|Cetuximab|cetuximab|mesh-list
25511383|NCT00393029|Antimetabolites|antimetabolites|mesh-ancestor
25511477|NCT00393458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25511789|NCT00395304|Hormones|hormones|mesh-ancestor
25511845|NCT00395850|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25511927|NCT00396383|Plerixafor|plerixafor|mesh-list
25513880|NCT00410605|Hormones|hormones|mesh-ancestor
25514206|NCT00412984|Warfarin|warfarin|mesh-list
25646031|NCT01454102|Growth Substances|growth substances|mesh-ancestor
25514464|NCT00414310|Anticonvulsants|anticonvulsants|mesh-ancestor
25646055|NCT01454362|Cholinergic Agents|cholinergic agents|mesh-ancestor
25646063|NCT01454596|Fludarabine|fludarabine|mesh-list
25514709|NCT00417170|Amlodipine|amlodipine|mesh-list
25515017|NCT00419926|Cyclosporine|cyclosporine|mesh-list
25515142|NCT00420342|Estrogens|estrogens|mesh-ancestor
24507224|NCT00549146|Hormones|hormones|mesh-ancestor
25515261|NCT00420849|Growth Inhibitors|growth inhibitors|mesh-ancestor
25646155|NCT01455428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25646171|NCT01456039|Romidepsin|romidepsin|mesh-list
25515607|NCT00423293|Fluorouracil|fluorouracil|mesh-list
25515831|NCT00424372|Pregabalin|pregabalin|mesh-list
25516455|NCT00428220|Sunitinib|sunitinib|mesh-list
25646412|NCT01458639|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25646435|NCT01459614|Docetaxel|docetaxel|mesh-list
24515169|NCT00595140|Dopamine Agents|dopamine agents|mesh-ancestor
25646448|NCT01459614|Antimitotic Agents|antimitotic agents|mesh-ancestor
25646470|NCT01459913|Ribavirin|ribavirin|mesh-list
25646491|NCT01460342|Tadalafil|tadalafil|mesh-list
25646505|NCT01460368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646546|NCT01460875|Interferons|interferons|mesh-list
25517803|NCT00438854|Dasatinib|dasatinib|mesh-list
25646575|NCT01461096|Vaccines|vaccines|mesh-list
25517983|NCT00439608|Paclitaxel|paclitaxel|mesh-list
25646592|NCT01461538|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25646593|NCT01461538|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25518408|NCT00442936|Oxazolidinones|oxazolidinones|mesh-list
25518480|NCT00443430|Etanercept|etanercept|mesh-list
25518554|NCT00443703|Lopinavir|lopinavir|mesh-list
25518693|NCT00444626|Prilocaine|prilocaine|mesh-list
25518771|NCT00445003|Hormones|hormones|mesh-ancestor
25519315|NCT00448201|Methotrexate|methotrexate|mesh-list
25519406|NCT00448591|Taxane|taxane|mesh-list
25520143|NCT00452790|Vaccines|vaccines|mesh-list
25520706|NCT00457366|Haloperidol|haloperidol|mesh-list
25521452|NCT00462462|Ethanol|ethanol|mesh-list
24813873|NCT02060669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521708|NCT00463866|Glucocorticoids|glucocorticoids|mesh-ancestor
25521779|NCT00464620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521926|NCT00465894|Cholinergic Agents|cholinergic agents|mesh-ancestor
25522032|NCT00466752|Sorafenib|sorafenib|mesh-list
25522081|NCT00467077|Interferon-alpha|interferon-alpha|mesh-list
25522148|NCT00467584|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25522291|NCT00468169|Antisickling Agents|antisickling agents|mesh-ancestor
25522385|NCT00468728|Vancomycin|vancomycin|mesh-list
25522712|NCT00471315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25522845|NCT00472303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523345|NCT00475306|Antipruritics|antipruritics|mesh-ancestor
25523473|NCT00476086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25523644|NCT00477295|Carbamazepine|carbamazepine|mesh-list
25523645|NCT00477295|Zonisamide|zonisamide|mesh-list
25646736|NCT01462344|Dermatologic Agents|dermatologic agents|mesh-ancestor
25524061|NCT00479388|Niacin|niacin|mesh-list
25524139|NCT00480441|Dronabinol|dronabinol|mesh-list
25646753|NCT01462565|Tezosentan|tezosentan|mesh-list
25646770|NCT01462773|Bortezomib|bortezomib|mesh-list
25646784|NCT01462877|Fenofibrate|fenofibrate|mesh-list
25646789|NCT01462929|Bromides|bromides|mesh-list
25524793|NCT00485485|Imatinib Mesylate|imatinib mesylate|mesh-list
25524794|NCT00485485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823457|NCT00004833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525136|NCT00488475|Etanercept|etanercept|mesh-list
25646829|NCT01463098|GABA Agents|gaba agents|mesh-ancestor
25525256|NCT00489411|Sensory System Agents|sensory system agents|mesh-ancestor
25525711|NCT00492232|GABA Agents|gaba agents|mesh-ancestor
25646848|NCT01463111|GABA Agents|gaba agents|mesh-ancestor
25526460|NCT00498485|Anesthetics|anesthetics|mesh-ancestor
25527030|NCT00502203|Mitosis Modulators|mitosis modulators|mesh-ancestor
25646868|NCT01463306|Anticonvulsants|anticonvulsants|mesh-ancestor
25527749|NCT00507026|Diclofenac|diclofenac|mesh-list
25527988|NCT00509028|Hormones|hormones|mesh-ancestor
25646876|NCT01463306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25528116|NCT00509366|Antimitotic Agents|antimitotic agents|mesh-ancestor
25528195|NCT00510068|Immunologic Factors|immunologic factors|mesh-ancestor
25528267|NCT00510809|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25528417|NCT00512252|Plerixafor|plerixafor|mesh-list
25528586|NCT00513500|Antimalarials|antimalarials|mesh-ancestor
25528744|NCT00514852|Glycerol|glycerol|mesh-list
25528971|NCT00515827|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25529046|NCT00516295|Growth Substances|growth substances|mesh-ancestor
25529266|NCT00518973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25646893|NCT01464190|Sevelamer|sevelamer|mesh-list
25529517|NCT00520845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25530348|NCT00527397|Insulin|insulin|mesh-list
25530430|NCT00527826|Xhance|xhance|mesh-list
25530622|NCT00528957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25530835|NCT00530270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530936|NCT00530842|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25531006|NCT00531206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531081|NCT00531518|Lamotrigine|lamotrigine|mesh-list
25531228|NCT00532480|Analgesics|analgesics|mesh-ancestor
25531512|NCT00535288|Mirtazapine|mirtazapine|mesh-list
25532044|NCT00537823|Leucovorin|leucovorin|mesh-list
25532320|NCT00539526|Bimatoprost|bimatoprost|mesh-list
25532481|NCT00540982|Lidocaine|lidocaine|mesh-list
25532619|NCT00541970|Vaccines|vaccines|mesh-list
25646982|NCT01464931|Denosumab|denosumab|mesh-list
25533276|NCT00546351|Lacosamide|lacosamide|mesh-list
25823583|NCT00004858|Protective Agents|protective agents|mesh-ancestor
25657203|NCT01584388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25534049|NCT00551642|Nitric Oxide|nitric oxide|mesh-list
25647030|NCT01465659|Temozolomide|temozolomide|mesh-list
25535314|NCT00559468|Rocuronium|rocuronium|mesh-list
25535394|NCT00560066|Vaccines|vaccines|mesh-list
25535466|NCT00560573|Antimetabolites|antimetabolites|mesh-ancestor
25535687|NCT00562159|Xhance|xhance|mesh-list
25536019|NCT05560373|Cholinergic Agents|cholinergic agents|mesh-ancestor
25536020|NCT05560373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25536021|NCT05560373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536022|NCT05560373|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25536023|NCT05560373|Protective Agents|protective agents|mesh-ancestor
25536024|NCT05560360|Efavirenz|efavirenz|mesh-list
25536025|NCT05560360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25536026|NCT05560360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25536027|NCT05560360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25536164|NCT05559164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25536165|NCT05559164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25536166|NCT05559112|Vitamin D|vitamin d|mesh-list
25536167|NCT05559112|Vitamins|vitamins|mesh-ancestor
25536168|NCT05559112|Micronutrients|micronutrients|mesh-ancestor
25536169|NCT05559112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536170|NCT05559112|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25536171|NCT05559008|Azacitidine|azacitidine|mesh-list
25536172|NCT05559008|Apatinib|apatinib|mesh-list
25536173|NCT05559008|Dasatinib|dasatinib|mesh-list
25536174|NCT05559008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25536175|NCT05559008|Antimetabolites|antimetabolites|mesh-ancestor
25536176|NCT05559008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536177|NCT05559008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536178|NCT05559008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25536179|NCT05559008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25536180|NCT05558982|Pembrolizumab|pembrolizumab|mesh-list
25536183|NCT05558878|Ambroxol|ambroxol|mesh-list
25647048|NCT01465802|Hormones|hormones|mesh-ancestor
25536245|NCT05533580|Sufentanil|sufentanil|mesh-list
25536246|NCT05533580|Dsuvia|dsuvia|mesh-list
25536247|NCT05533580|Propofol|propofol|mesh-list
25536248|NCT05533580|Cisatracurium|cisatracurium|mesh-list
25536249|NCT05533580|Atracurium|atracurium|mesh-list
25536250|NCT05533580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25536251|NCT05533580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25536252|NCT05533580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647049|NCT01465802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25536321|NCT05503979|Sofosbuvir|sofosbuvir|mesh-list
25536322|NCT05503979|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25536323|NCT05503979|Velpatasvir|velpatasvir|mesh-list
25536324|NCT05503979|Antiviral Agents|antiviral agents|mesh-ancestor
25536325|NCT05503979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25536326|NCT05503797|Cobicistat|cobicistat|mesh-list
25536327|NCT05503797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25536328|NCT05503797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25536329|NCT05503797|Antiviral Agents|antiviral agents|mesh-ancestor
25536330|NCT05503797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25536331|NCT05503797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25536332|NCT05503797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25536394|NCT05440942|Trametinib|trametinib|mesh-list
25536395|NCT05440942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536396|NCT05440942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25536397|NCT05440942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25536398|NCT05440942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536417|NCT05425732|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25536418|NCT05425732|Immunologic Factors|immunologic factors|mesh-ancestor
25536419|NCT05425732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536420|NCT05425056|Sirolimus|sirolimus|mesh-list
25536421|NCT05425056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25536422|NCT05425056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25536423|NCT05425056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25536424|NCT05425056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536425|NCT05425056|Antifungal Agents|antifungal agents|mesh-ancestor
25536426|NCT05425056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25536427|NCT05425056|Immunologic Factors|immunologic factors|mesh-ancestor
25536428|NCT05425056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823618|NCT00004861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823619|NCT00004861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25647051|NCT01465958|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25536466|NCT05415397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647052|NCT01465958|gamma-Globulins|gamma-globulins|mesh-list
25647053|NCT01465958|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25647054|NCT01465958|Immunoglobulin G|immunoglobulin g|mesh-list
25536474|NCT05409716|Hemostatics|hemostatics|mesh-list
25647056|NCT01465958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536534|NCT05389046|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25536535|NCT05389046|Antidepressive Agents|antidepressive agents|mesh-ancestor
25536536|NCT05389046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25536537|NCT05389046|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25536538|NCT05389046|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25536539|NCT05389046|Parasympatholytics|parasympatholytics|mesh-ancestor
25536540|NCT05389046|Autonomic Agents|autonomic agents|mesh-ancestor
25647057|NCT01465997|Lacosamide|lacosamide|mesh-list
25647058|NCT01465997|Carbamazepine|carbamazepine|mesh-list
25647059|NCT01465997|Anticonvulsants|anticonvulsants|mesh-ancestor
25647060|NCT01465997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25647061|NCT01465997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25647062|NCT01465997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25647063|NCT01465997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647064|NCT01465997|Antimanic Agents|antimanic agents|mesh-ancestor
25536610|NCT05366816|Sunitinib|sunitinib|mesh-list
25536675|NCT05337137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536676|NCT05328908|Trifluridine|trifluridine|mesh-list
25536677|NCT05328908|Nivolumab|nivolumab|mesh-list
25536678|NCT05328908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25536679|NCT05328908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536680|NCT05328908|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25536681|NCT05328908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536682|NCT05328908|Antimetabolites|antimetabolites|mesh-ancestor
25536683|NCT05328908|Antiviral Agents|antiviral agents|mesh-ancestor
25536684|NCT05328908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25536685|NCT05301062|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25536686|NCT05301062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24860569|NCT02311088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24860570|NCT02311101|Mitomycins|mitomycins|mesh-list
24860571|NCT02311101|Mitomycin|mitomycin|mesh-list
25536725|NCT05284747|Evolocumab|evolocumab|mesh-list
25536726|NCT05284747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25536727|NCT05284747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25536728|NCT05284747|Antimetabolites|antimetabolites|mesh-ancestor
25536729|NCT05284747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536730|NCT05284747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25536731|NCT05281562|Ascorbic Acid|ascorbic acid|mesh-list
25536732|NCT05281562|Vitamins|vitamins|mesh-ancestor
25536733|NCT05281562|Micronutrients|micronutrients|mesh-ancestor
25536734|NCT05281562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536735|NCT05281562|Antioxidants|antioxidants|mesh-ancestor
25536736|NCT05281562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536737|NCT05281562|Protective Agents|protective agents|mesh-ancestor
25536738|NCT05259787|Propofol|propofol|mesh-list
25536739|NCT05259787|Etomidate|etomidate|mesh-list
25536740|NCT05259787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25536741|NCT05259787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25536742|NCT05259787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536743|NCT05259787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25536744|NCT05259787|Anesthetics, General|anesthetics, general|mesh-ancestor
25536745|NCT05259787|Anesthetics|anesthetics|mesh-ancestor
25647066|NCT01465997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25647067|NCT01465997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647068|NCT01465997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25647069|NCT01465997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25647070|NCT01465997|Analgesics|analgesics|mesh-ancestor
25647071|NCT01465997|Sensory System Agents|sensory system agents|mesh-ancestor
25647072|NCT01465997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25536826|NCT05227716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25647073|NCT01465997|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25536895|NCT05198934|Antimetabolites|antimetabolites|mesh-ancestor
25536896|NCT05198934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536897|NCT05198934|Antiviral Agents|antiviral agents|mesh-ancestor
25536898|NCT05198934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25536899|NCT05193994|Lamivudine|lamivudine|mesh-list
25536900|NCT05193994|Abacavir|abacavir|mesh-list
25536901|NCT05193994|Dolutegravir|dolutegravir|mesh-list
25536902|NCT05193994|Triumeq|triumeq|mesh-list
25536903|NCT05193994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25536904|NCT05193994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25536905|NCT05193994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25536906|NCT05193994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647074|NCT01465997|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25647075|NCT01466062|Palivizumab|palivizumab|mesh-list
25647076|NCT01466062|Antiviral Agents|antiviral agents|mesh-ancestor
25647077|NCT01466062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25647078|NCT01466127|Oxytocin|oxytocin|mesh-list
25647079|NCT01466127|Oxytocics|oxytocics|mesh-ancestor
25647080|NCT01466127|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25536970|NCT05111626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536971|NCT05107219|Linaclotide|linaclotide|mesh-list
25536972|NCT05107219|Plecanatide|plecanatide|mesh-list
25536973|NCT05107219|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25536974|NCT05107219|Enzyme Activators|enzyme activators|mesh-ancestor
25536975|NCT05107219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536976|NCT05107219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25536977|NCT05094336|Docetaxel|docetaxel|mesh-list
25536978|NCT05094336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536979|NCT05094336|Tubulin Modulators|tubulin modulators|mesh-ancestor
25536980|NCT05094336|Antimitotic Agents|antimitotic agents|mesh-ancestor
25536981|NCT05094336|Mitosis Modulators|mitosis modulators|mesh-ancestor
25536983|NCT05085665|Ivermectin|ivermectin|mesh-list
25537043|NCT05054998|Deoxyglucose|deoxyglucose|mesh-list
25537044|NCT05054998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25537045|NCT05054998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25537046|NCT05054998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537047|NCT05054998|Antimetabolites|antimetabolites|mesh-ancestor
25537048|NCT05054998|Antiviral Agents|antiviral agents|mesh-ancestor
25537049|NCT05054998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25537050|NCT05052801|Bemarituzumab|bemarituzumab|mesh-list
25537051|NCT05052801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25537052|NCT05052801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537053|NCT05051735|Acetaminophen|acetaminophen|mesh-list
25537128|NCT05014438|Branebrutinib|branebrutinib|mesh-list
25537129|NCT05014438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25537130|NCT05014438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25537131|NCT05014438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537132|NCT05004896|Midazolam|midazolam|mesh-list
25537133|NCT05004896|Ketamine|ketamine|mesh-list
25537134|NCT05004896|Analgesics|analgesics|mesh-ancestor
25537135|NCT05004896|Sensory System Agents|sensory system agents|mesh-ancestor
25537136|NCT05004896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25537137|NCT05004896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537138|NCT05004896|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25537139|NCT05004896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25537140|NCT05004896|Anesthetics, General|anesthetics, general|mesh-ancestor
25537198|NCT04926285|Venetoclax|venetoclax|mesh-list
25537199|NCT04926285|Homoharringtonine|homoharringtonine|mesh-list
25537200|NCT04926285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537201|NCT04926285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25537202|NCT04926285|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25537203|NCT04926285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25537204|NCT04926285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537216|NCT04912115|Midazolam|midazolam|mesh-list
25647082|NCT01466153|Rituximab|rituximab|mesh-list
25647083|NCT01466153|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25647084|NCT01466153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25537267|NCT04901377|Dienogest|dienogest|mesh-list
25537268|NCT04901377|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25537269|NCT04901377|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25537270|NCT04901377|Estradiol|estradiol|mesh-list
25537271|NCT04901377|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25537272|NCT04901377|Estrogens|estrogens|mesh-ancestor
25537273|NCT04901377|Hormones|hormones|mesh-ancestor
25537274|NCT04901377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25537275|NCT04901377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537276|NCT04901377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25537277|NCT04901377|Contraceptive Agents|contraceptive agents|mesh-ancestor
25537411|NCT04729959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25537412|NCT04729959|Immunoglobulin G|immunoglobulin g|mesh-list
25537413|NCT04729959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537414|NCT04729959|Immunologic Factors|immunologic factors|mesh-ancestor
25537415|NCT04729959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537416|NCT04711135|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25537417|NCT04711135|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25537418|NCT04711135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537419|NCT04703621|Daratumumab|daratumumab|mesh-list
25537420|NCT04703621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537421|NCT04699240|Clotrimazole|clotrimazole|mesh-list
25537422|NCT04699240|Miconazole|miconazole|mesh-list
25647085|NCT01466153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537486|NCT04521231|Blinatumomab|blinatumomab|mesh-list
25537487|NCT04521231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537488|NCT04518228|Ritonavir|ritonavir|mesh-list
25537489|NCT04518228|Lopinavir|lopinavir|mesh-list
25537490|NCT04518228|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25537491|NCT04518228|Darunavir|darunavir|mesh-list
25537492|NCT04518228|Tenofovir|tenofovir|mesh-list
25537493|NCT04518228|Dolutegravir|dolutegravir|mesh-list
25537494|NCT04518228|Cobicistat|cobicistat|mesh-list
25537495|NCT04518228|Cabotegravir|cabotegravir|mesh-list
25537496|NCT04518228|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25537497|NCT04518228|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25537498|NCT04518228|Protease Inhibitors|protease inhibitors|mesh-ancestor
25537499|NCT04518228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25537501|NCT04518228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25537560|NCT04356989|Rivaroxaban|rivaroxaban|mesh-list
25537561|NCT04356989|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25537562|NCT04356989|Antithrombins|antithrombins|mesh-ancestor
25537563|NCT04356989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25537564|NCT04356989|Protease Inhibitors|protease inhibitors|mesh-ancestor
25537565|NCT04356989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25537566|NCT04356989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537567|NCT04356989|Anticoagulants|anticoagulants|mesh-ancestor
25537568|NCT04345471|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25537569|NCT04345471|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25537570|NCT04345471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25537571|NCT04345471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25537572|NCT04345471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537631|NCT04175613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25537632|NCT04175613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537633|NCT04174859|Rivaroxaban|rivaroxaban|mesh-list
25537634|NCT04174859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25537635|NCT04174859|Antithrombins|antithrombins|mesh-ancestor
25537636|NCT04174859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25537637|NCT04174859|Protease Inhibitors|protease inhibitors|mesh-ancestor
25537638|NCT04174859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25537639|NCT04174859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537640|NCT04174859|Anticoagulants|anticoagulants|mesh-ancestor
25537641|NCT04166331|Dobutamine|dobutamine|mesh-list
25537642|NCT04166331|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25537643|NCT04166331|Sympathomimetics|sympathomimetics|mesh-ancestor
25537644|NCT04166331|Autonomic Agents|autonomic agents|mesh-ancestor
25537645|NCT04166331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25647087|NCT01466153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647088|NCT01466153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25537708|NCT04092283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25537709|NCT04092283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25537710|NCT04092283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25537711|NCT04092283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25537712|NCT04092283|Immunologic Factors|immunologic factors|mesh-ancestor
25537713|NCT04092283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647089|NCT01466153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25647090|NCT01466153|Alkylating Agents|alkylating agents|mesh-ancestor
25647091|NCT01466153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647092|NCT01466179|Blinatumomab|blinatumomab|mesh-list
25537780|NCT03925025|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25537781|NCT03925025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25537782|NCT03925025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537783|NCT03925025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25537784|NCT03925025|Tocolytic Agents|tocolytic agents|mesh-ancestor
25537785|NCT03925025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25537849|NCT03841110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537850|NCT03841110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25537851|NCT03841110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25537852|NCT03841110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25537853|NCT03841110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25537854|NCT03841110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25537855|NCT03841110|Antiviral Agents|antiviral agents|mesh-ancestor
25537856|NCT03841110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25537857|NCT03836040|Erenumab|erenumab|mesh-list
25537858|NCT03836040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25537859|NCT03836040|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25537860|NCT03836040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537861|NCT03836040|Analgesics|analgesics|mesh-ancestor
25537862|NCT03836040|Sensory System Agents|sensory system agents|mesh-ancestor
25537922|NCT03700476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25537923|NCT03700476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25537924|NCT03700476|Immunologic Factors|immunologic factors|mesh-ancestor
25538150|NCT03236792|Antiemetics|antiemetics|mesh-ancestor
25647096|NCT01466192|Antimetabolites|antimetabolites|mesh-ancestor
25538223|NCT03121677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25538224|NCT03121677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538225|NCT03121677|Interferon Inducers|interferon inducers|mesh-ancestor
25538226|NCT03121677|Laxatives|laxatives|mesh-ancestor
25538227|NCT03121677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25538228|NCT03121677|Antiviral Agents|antiviral agents|mesh-ancestor
25538229|NCT03121677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25538230|NCT03092518|Sodium thiosulfate|sodium thiosulfate|mesh-list
25538231|NCT03092518|Cisplatin|cisplatin|mesh-list
25538232|NCT03092518|Mitomycins|mitomycins|mesh-list
25538233|NCT03092518|Mitomycin|mitomycin|mesh-list
25538234|NCT03092518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538235|NCT03092518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25538236|NCT03092518|Alkylating Agents|alkylating agents|mesh-ancestor
25538237|NCT03092518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538238|NCT03092518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25538239|NCT03092518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538240|NCT03092518|Antidotes|antidotes|mesh-ancestor
25538241|NCT03092518|Protective Agents|protective agents|mesh-ancestor
25538242|NCT03092518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538243|NCT03092518|Antioxidants|antioxidants|mesh-ancestor
25538244|NCT03092518|Antitubercular Agents|antitubercular agents|mesh-ancestor
25538249|NCT03065387|Everolimus|everolimus|mesh-list
25647097|NCT01466192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647098|NCT01466192|Antiviral Agents|antiviral agents|mesh-ancestor
25647099|NCT01466192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25538368|NCT02675452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25538369|NCT02675452|Antimetabolites|antimetabolites|mesh-ancestor
25538370|NCT02675452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538371|NCT02675452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538372|NCT02675452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538373|NCT02675452|Antifungal Agents|antifungal agents|mesh-ancestor
25538374|NCT02675452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25538375|NCT02675452|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25538376|NCT02675452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25538377|NCT02675452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25538378|NCT02675452|Hormone Antagonists|hormone antagonists|mesh-ancestor
25538379|NCT02675452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25538380|NCT02675452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538381|NCT02675452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25538382|NCT02646982|Candesartan|candesartan|mesh-list
25538383|NCT02646982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25538384|NCT02646982|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25538385|NCT02646982|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25538386|NCT02646982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538387|NCT02592551|Durvalumab|durvalumab|mesh-list
25538388|NCT02592551|Tremelimumab|tremelimumab|mesh-list
25538389|NCT02592551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25538390|NCT02592551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538391|NCT02481830|Nivolumab|nivolumab|mesh-list
25538392|NCT02481830|Topotecan|topotecan|mesh-list
25538393|NCT02481830|Amrubicin|amrubicin|mesh-list
25538394|NCT02481830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25538395|NCT02481830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538396|NCT02481830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25538397|NCT02481830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538446|NCT02367040|Immunologic Factors|immunologic factors|mesh-ancestor
25538447|NCT02367040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538448|NCT02367040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25538449|NCT02346526|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25538450|NCT02346526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538451|NCT02298348|Cyclophosphamide|cyclophosphamide|mesh-list
25538452|NCT02298348|Sorafenib|sorafenib|mesh-list
25538453|NCT02298348|Topotecan|topotecan|mesh-list
25538454|NCT02298348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25538455|NCT02298348|Immunologic Factors|immunologic factors|mesh-ancestor
25538456|NCT02298348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538457|NCT02298348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25538458|NCT02298348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25538459|NCT02298348|Alkylating Agents|alkylating agents|mesh-ancestor
25538460|NCT02298348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538461|NCT02298348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538462|NCT02298348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25538463|NCT02298348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25538464|NCT02298348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538465|NCT02298348|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25538466|NCT02298348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25538467|NCT02247349|Nivolumab|nivolumab|mesh-list
25538468|NCT02247349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25647105|NCT01466270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25647106|NCT01466270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647107|NCT01466270|Nootropic Agents|nootropic agents|mesh-ancestor
25647108|NCT01466348|Acetaminophen|acetaminophen|mesh-list
25538590|NCT01996865|Immunologic Factors|immunologic factors|mesh-ancestor
25538597|NCT01962948|Paclitaxel|paclitaxel|mesh-list
25538664|NCT01659151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25647110|NCT01466348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25647111|NCT01466348|Analgesics|analgesics|mesh-ancestor
25538739|NCT00634166|Antifungal Agents|antifungal agents|mesh-list
25538740|NCT00634166|Amebicides|amebicides|mesh-ancestor
25538741|NCT00634166|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25538742|NCT00634166|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25538743|NCT00634166|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25538744|NCT00634166|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24480134|NCT00429897|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
25647118|NCT01466348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25647119|NCT01466348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401813|NCT00154050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24539475|NCT00664001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823764|NCT00004878|Dermatologic Agents|dermatologic agents|mesh-ancestor
25165303|NCT04927780|Fluorouracil|fluorouracil|mesh-list
25823765|NCT00004878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823766|NCT00004878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25823767|NCT00004878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25823768|NCT00004878|Immunologic Factors|immunologic factors|mesh-ancestor
25823769|NCT00004878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25823770|NCT00004878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24811777|NCT02048358|Methylprednisolone|methylprednisolone|mesh-list
24811778|NCT02048358|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24811779|NCT02048358|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24811780|NCT02048358|Prednisolone|prednisolone|mesh-list
24811781|NCT02048358|Prednisolone acetate|prednisolone acetate|mesh-list
25823780|NCT00004880|Vaccines|vaccines|mesh-list
25823781|NCT00004880|Immunologic Factors|immunologic factors|mesh-ancestor
24405815|NCT00168480|Cholinergic Agents|cholinergic agents|mesh-ancestor
24405816|NCT00168480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24405895|NCT00168740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647123|NCT01466348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25647131|NCT01466361|Cholinergic Agents|cholinergic agents|mesh-ancestor
25647134|NCT01466387|Vaccines|vaccines|mesh-list
25647137|NCT01466491|Lidocaine|lidocaine|mesh-list
25647139|NCT01466491|Anesthetics|anesthetics|mesh-ancestor
25166305|NCT04173364|Anesthetics, Local|anesthetics, local|mesh-ancestor
25166306|NCT04173364|Anesthetics|anesthetics|mesh-ancestor
25166307|NCT04173364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25166308|NCT04173364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166309|NCT04173364|Sensory System Agents|sensory system agents|mesh-ancestor
25166311|NCT04171453|Pregabalin|pregabalin|mesh-list
24806235|NCT02014558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24810114|NCT02037919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25823983|NCT00004905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820141|NCT02098889|Cholinergic Agents|cholinergic agents|mesh-ancestor
24421509|NCT00219388|Protective Agents|protective agents|mesh-ancestor
25647149|NCT01466595|Rifaximin|rifaximin|mesh-list
24903892|NCT04359966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24903893|NCT04359966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24903894|NCT04359966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24903895|NCT04359966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903897|NCT04359966|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24904344|NCT04356417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905218|NCT04350281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881905|NCT00593567|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25647154|NCT01466660|Afatinib|afatinib|mesh-list
25647155|NCT01466660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824066|NCT00004919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824067|NCT00004919|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25824068|NCT00004919|Protective Agents|protective agents|mesh-ancestor
25824069|NCT00004919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824070|NCT00004920|Cisplatin|cisplatin|mesh-list
25824071|NCT00004920|Raltitrexed|raltitrexed|mesh-list
25824072|NCT00004920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824073|NCT00004920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24958131|NCT03836781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958132|NCT03836781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24958409|NCT03833596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24958569|NCT03831984|Analgesics|analgesics|mesh-ancestor
24958570|NCT03831984|Sensory System Agents|sensory system agents|mesh-ancestor
25824075|NCT00004920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824076|NCT00004920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24786334|NCT01919255|Picosulfate sodium|picosulfate sodium|mesh-list
24760575|NCT01758666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24964374|NCT03783754|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24893408|NCT04449952|Listerine|listerine|mesh-list
24964387|NCT03783494|Propofol|propofol|mesh-list
24964388|NCT03783494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24964389|NCT03783494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24964391|NCT03783494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25824079|NCT00004921|Cyclophosphamide|cyclophosphamide|mesh-list
24694561|NCT05386160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694564|NCT05386121|Fentanyl|fentanyl|mesh-list
25647188|NCT01466764|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25647189|NCT01466764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25647190|NCT01466790|Ribavirin|ribavirin|mesh-list
24698554|NCT01441869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698555|NCT01441869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424317|NCT00228852|Busulfan|busulfan|mesh-list
24999689|NCT03502577|Fludarabine|fludarabine|mesh-list
24938896|NCT04015375|Dapsone|dapsone|mesh-list
25001986|NCT04950764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24645532|NCT01198496|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25049528|NCT00595426|Anticoagulants|anticoagulants|mesh-ancestor
25647200|NCT01467076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24846803|NCT02244112|Midazolam|midazolam|mesh-list
25647209|NCT01467479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647210|NCT01467479|Antiviral Agents|antiviral agents|mesh-ancestor
25647219|NCT01467492|Interferon alpha-2|interferon alpha-2|mesh-list
24546799|NCT00700466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24828854|NCT02147964|Anabolic Agents|anabolic agents|mesh-ancestor
24828855|NCT02147964|Antifungal Agents|antifungal agents|mesh-ancestor
25824244|NCT00004981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824245|NCT00004981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268026|NCT02418624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824246|NCT00004981|Antiviral Agents|antiviral agents|mesh-ancestor
25824247|NCT00004981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25824248|NCT00004981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25268365|NCT02416141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268367|NCT02416141|Sensory System Agents|sensory system agents|mesh-ancestor
25268368|NCT02416141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24779210|NCT01874717|Midazolam|midazolam|mesh-list
24422309|NCT00221975|GABA Agents|gaba agents|mesh-ancestor
25170207|NCT01661634|Diuretics|diuretics|mesh-ancestor
25824388|NCT00005007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25824389|NCT00005007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25824390|NCT00005007|Analgesics|analgesics|mesh-ancestor
25824391|NCT00005007|Sensory System Agents|sensory system agents|mesh-ancestor
25824392|NCT00005007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25824393|NCT00005007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824394|NCT00005007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25203667|NCT02712957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24446248|NCT00304226|Amlodipine|amlodipine|mesh-list
25203696|NCT02712775|Minocycline|minocycline|mesh-list
25824442|NCT00005015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24944239|NCT03962296|Calcium|calcium|mesh-list
25170734|NCT02894268|Antacids|antacids|mesh-ancestor
25170803|NCT02893280|Anticoagulants|anticoagulants|mesh-ancestor
24784516|NCT01908348|Vasodilator Agents|vasodilator agents|mesh-ancestor
25824662|NCT00005042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824663|NCT00005042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824664|NCT00005045|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
25824665|NCT00005045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824666|NCT00005045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25824667|NCT00005045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25824668|NCT00005045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966947|NCT03764163|Xenon|xenon|mesh-list
24541706|NCT00674713|Autonomic Agents|autonomic agents|mesh-ancestor
24541707|NCT00674713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24541708|NCT00674713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541709|NCT00674713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24541710|NCT00674713|Antipruritics|antipruritics|mesh-ancestor
24541711|NCT00674713|Dermatologic Agents|dermatologic agents|mesh-ancestor
24541796|NCT00675246|Glucocorticoids|glucocorticoids|mesh-ancestor
25824669|NCT00005045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25824670|NCT00005045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967167|NCT03762317|Clonidine|clonidine|mesh-list
24952158|NCT03896893|Emollients|emollients|mesh-list
24862187|NCT02323451|Hemostatics|hemostatics|mesh-ancestor
24862188|NCT02323451|Coagulants|coagulants|mesh-ancestor
25055773|NCT03517943|Loratadine|loratadine|mesh-list
24482846|NCT00440739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824724|NCT00005054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171223|NCT02890082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171224|NCT02890082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25171225|NCT02890082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647385|NCT01468909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065820|NCT05184335|RP5063|rp5063|mesh-list
25203782|NCT02712476|Furosemide|furosemide|mesh-list
25824780|NCT00005067|Motexafin lutetium|motexafin lutetium|mesh-list
24839641|NCT02205554|Tramadol|tramadol|mesh-list
25824781|NCT00005067|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25824782|NCT00005067|Dermatologic Agents|dermatologic agents|mesh-ancestor
24405934|NCT00168779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25824802|NCT00005068|Vitamin B Complex|vitamin b complex|mesh-ancestor
25824803|NCT00005068|Vitamins|vitamins|mesh-ancestor
25824842|NCT00005078|Tirapazamine|tirapazamine|mesh-list
25824843|NCT00005078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25824899|NCT00005089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25824900|NCT00005089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25824901|NCT00005089|Alkylating Agents|alkylating agents|mesh-ancestor
25824902|NCT00005089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824903|NCT00005089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824904|NCT00005089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25824905|NCT00005089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25824906|NCT00005089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25824907|NCT00005089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25824908|NCT00005089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25824909|NCT00005089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824910|NCT00005089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24474986|NCT00408369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25203872|NCT02711917|Anesthetics, General|anesthetics, general|mesh-ancestor
25171625|NCT02886195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25171626|NCT02886299|Simvastatin|simvastatin|mesh-list
25171627|NCT02886299|Fenofibrate|fenofibrate|mesh-list
24500659|NCT00525408|Mitosis Modulators|mitosis modulators|mesh-ancestor
24749550|NCT00866918|Abortifacient Agents|abortifacient agents|mesh-ancestor
24749562|NCT00866918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25171670|NCT02885961|Dabigatran|dabigatran|mesh-list
24413565|NCT00194402|Niacin|niacin|mesh-list
24427556|NCT00238368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25824975|NCT00005093|Immunologic Factors|immunologic factors|mesh-ancestor
25172017|NCT02883439|Xhance|xhance|mesh-list
24481128|NCT00433459|Prednisone|prednisone|mesh-list
24542068|NCT00676702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25189303|NCT02798874|Clopidogrel|clopidogrel|mesh-list
25172182|NCT02882191|Levonorgestrel|levonorgestrel|mesh-list
25193108|NCT02772107|Temozolomide|temozolomide|mesh-list
25193166|NCT02771925|Antimanic Agents|antimanic agents|mesh-ancestor
24434326|NCT00262210|Immunologic Factors|immunologic factors|mesh-ancestor
24434327|NCT00262210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434815|NCT00263744|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24434900|NCT00264225|Codeine|codeine|mesh-list
25194278|NCT02766348|Cisplatin|cisplatin|mesh-list
25194639|NCT02763137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25194790|NCT02762617|Tenofovir|tenofovir|mesh-list
25194892|NCT02761486|Aspirin|aspirin|mesh-list
25195105|NCT02760355|Ribavirin|ribavirin|mesh-list
25195551|NCT02757703|Hormones|hormones|mesh-ancestor
25195731|NCT02757443|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25043517|NCT01248975|Montelukast|montelukast|mesh-list
24465260|NCT00368394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567206|NCT00790101|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24619787|NCT01053806|Azacitidine|azacitidine|mesh-list
24696667|NCT01430910|Avibactam|avibactam|mesh-list
24619809|NCT01053871|Narcotics|narcotics|mesh-ancestor
24619810|NCT01053871|Analgesics|analgesics|mesh-ancestor
25825128|NCT00005571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25207809|NCT03312907|Immunologic Factors|immunologic factors|mesh-ancestor
25207810|NCT03312907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207811|NCT03312907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25048391|NCT00709371|Anticonvulsants|anticonvulsants|mesh-ancestor
25172817|NCT02876770|Melatonin|melatonin|mesh-list
25825149|NCT00005576|Interleukin-2|interleukin-2|mesh-list
24827171|NCT02137681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825150|NCT00005576|Dinutuximab|dinutuximab|mesh-list
24863345|NCT05146245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24863346|NCT05146245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25052118|NCT00330369|Darusentan|darusentan|mesh-list
25825162|NCT00005576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24547897|NCT00706576|Mitogens|mitogens|mesh-list
24872183|NCT05398679|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24872184|NCT05398679|Antimalarials|antimalarials|mesh-ancestor
25825282|NCT00005584|Mitosis Modulators|mitosis modulators|mesh-ancestor
25173251|NCT02873650|Dabrafenib|dabrafenib|mesh-list
25173252|NCT02873650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291590|NCT05102045|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
25291676|NCT05092074|Sofosbuvir|sofosbuvir|mesh-list
25204145|NCT02710409|Vaccines|vaccines|mesh-list
25292204|NCT02675842|Hallucinogens|hallucinogens|mesh-ancestor
25292205|NCT02675842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292341|NCT05103254|Ezetimibe|ezetimibe|mesh-list
25292484|NCT04716114|Fludarabine|fludarabine|mesh-list
25292955|NCT05087732|Sensory System Agents|sensory system agents|mesh-ancestor
25293035|NCT04681105|Anesthetics|anesthetics|mesh-ancestor
25293701|NCT03701711|Lenalidomide|lenalidomide|mesh-list
25294370|NCT03540901|Anticonvulsants|anticonvulsants|mesh-ancestor
25294447|NCT02991807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25294448|NCT02991807|Immunologic Factors|immunologic factors|mesh-ancestor
25294459|NCT02784262|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25294460|NCT02784262|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25294461|NCT02784262|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25294462|NCT02784262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25294464|NCT02784262|Cholinergic Agents|cholinergic agents|mesh-ancestor
25175067|NCT02861222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25295027|NCT05116007|Etoposide|etoposide|mesh-list
25295731|NCT04071457|Growth Substances|growth substances|mesh-ancestor
25295732|NCT04071457|Growth Inhibitors|growth inhibitors|mesh-ancestor
25295733|NCT04071457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295739|NCT04038346|Acetaminophen|acetaminophen|mesh-list
25295740|NCT04038346|Naproxen|naproxen|mesh-list
25295741|NCT04038346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25295943|NCT03418961|Antioxidants|antioxidants|mesh-ancestor
25204537|NCT02707445|Clopidogrel|clopidogrel|mesh-list
25176035|NCT02854787|Mydriatics|mydriatics|mesh-ancestor
25204586|NCT02707328|Gemcitabine|gemcitabine|mesh-list
25296473|NCT04753437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296474|NCT04753437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25296475|NCT04753437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25296476|NCT04753437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25296477|NCT04753437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25296478|NCT04753437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25296479|NCT04753437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25296480|NCT04753437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25296483|NCT04753437|Antacids|antacids|mesh-ancestor
25296729|NCT03717129|Elvitegravir|elvitegravir|mesh-list
25176558|NCT05382182|Androgens|androgens|mesh-list
25204691|NCT02707250|Narcotics|narcotics|mesh-ancestor
25825336|NCT00005586|Leucovorin|leucovorin|mesh-list
25298549|NCT03771157|Vaccines|vaccines|mesh-list
25177453|NCT05083052|Propolis|propolis|mesh-list
25298876|NCT02737046|Belinostat|belinostat|mesh-list
25177658|NCT04937881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25177659|NCT04937881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25177681|NCT04925284|Nivolumab|nivolumab|mesh-list
25298980|NCT01976169|Mitosis Modulators|mitosis modulators|mesh-ancestor
25298981|NCT01827111|Paclitaxel|paclitaxel|mesh-list
25298982|NCT01827111|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25298983|NCT01827111|Ipilimumab|ipilimumab|mesh-list
25207928|NCT00981656|Mitomycins|mitomycins|mesh-list
25178138|NCT04643093|Ezetimibe|ezetimibe|mesh-list
25178331|NCT04476550|Lenograstim|lenograstim|mesh-list
24945180|NCT03953001|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25178374|NCT04407754|Inositol|inositol|mesh-list
25178386|NCT04404049|UB-421|ub-421|mesh-list
25178671|NCT04166877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25178672|NCT04166877|Anticonvulsants|anticonvulsants|mesh-ancestor
25178673|NCT04166877|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25178674|NCT04166877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25178870|NCT04042753|Nivolumab|nivolumab|mesh-list
25178977|NCT03923725|Antiviral Agents|antiviral agents|mesh-ancestor
25300917|NCT05089942|Insulin|insulin|mesh-list
25301472|NCT03805841|Anticonvulsants|anticonvulsants|mesh-ancestor
25180331|NCT02007512|Exemestane|exemestane|mesh-list
25205141|NCT05174598|Calcitriol|calcitriol|mesh-list
25180882|NCT02848768|Sunitinib|sunitinib|mesh-list
25303212|NCT05134298|Meropenem|meropenem|mesh-list
25181190|NCT02846493|Hormones|hormones|mesh-ancestor
25303909|NCT05122169|Povidone|povidone|mesh-list
25304287|NCT04094298|FX006|fx006|mesh-list
25181839|NCT04646655|Enoxaparin|enoxaparin|mesh-list
25182019|NCT04345796|Empagliflozin|empagliflozin|mesh-list
25182374|NCT02153645|Amantadine|amantadine|mesh-list
25305313|NCT05281549|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25305471|NCT05205499|Sirolimus|sirolimus|mesh-list
25305571|NCT05100862|Rituximab|rituximab|mesh-list
25305652|NCT05043714|Nivolumab|nivolumab|mesh-list
25305996|NCT04698057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306472|NCT04163900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25306562|NCT04079738|Ixazomib|ixazomib|mesh-list
25307161|NCT04833907|Prednisone|prednisone|mesh-list
25307267|NCT04622917|Prednisolone|prednisolone|mesh-list
25307401|NCT04196413|Cyclophosphamide|cyclophosphamide|mesh-list
25183782|NCT02839694|Antimetabolites|antimetabolites|mesh-ancestor
25308180|NCT03995641|Sensory System Agents|sensory system agents|mesh-ancestor
25308282|NCT03867357|Goserelin|goserelin|mesh-list
25308525|NCT03600090|Antimitotic Agents|antimitotic agents|mesh-ancestor
25308621|NCT03379207|Chelating Agents|chelating agents|mesh-ancestor
25308622|NCT03379207|Sequestering Agents|sequestering agents|mesh-ancestor
25308787|NCT03104270|Elotuzumab|elotuzumab|mesh-list
25308865|NCT03083067|Anticonvulsants|anticonvulsants|mesh-ancestor
25308969|NCT02804022|Morphine|morphine|mesh-list
25184494|NCT02836002|Renal Agents|renal agents|mesh-ancestor
25309487|NCT05103215|Lidocaine|lidocaine|mesh-list
25184897|NCT02832999|Hormones|hormones|mesh-ancestor
25310477|NCT03449888|Calcium|calcium|mesh-list
25310557|NCT03308396|Durvalumab|durvalumab|mesh-list
25185955|NCT02824094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311180|NCT03991832|Durvalumab|durvalumab|mesh-list
25205757|NCT04246541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25312559|NCT05049603|Atorvastatin|atorvastatin|mesh-list
25205865|NCT04083950|Aspirin|aspirin|mesh-list
25313188|NCT05040724|Ivermectin|ivermectin|mesh-list
25825393|NCT00005591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25313654|NCT05032001|Biguanides|biguanides|mesh-list
25187995|NCT02808949|Dapivirine|dapivirine|mesh-list
25188267|NCT02806804|Vaccines|vaccines|mesh-list
25314288|NCT05021887|Fluticasone|fluticasone|mesh-list
25188511|NCT02804815|Aspirin|aspirin|mesh-list
25314868|NCT05014581|Norepinephrine|norepinephrine|mesh-list
25315019|NCT05010876|Icatibant|icatibant|mesh-list
25189312|NCT02798874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189313|NCT02799264|Cabotegravir|cabotegravir|mesh-list
25189314|NCT02799264|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24977439|NCT00159588|Sensory System Agents|sensory system agents|mesh-ancestor
25189606|NCT02796378|Ubiquinone|ubiquinone|mesh-list
25189706|NCT02795754|Protease Inhibitors|protease inhibitors|mesh-ancestor
25189707|NCT02795754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25189708|NCT02795754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189709|NCT02795754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25316158|NCT04996550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25316159|NCT04996550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25316160|NCT04996550|Vasodilator Agents|vasodilator agents|mesh-ancestor
25316161|NCT04996550|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25316162|NCT04996550|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25316163|NCT04996485|Ustekinumab|ustekinumab|mesh-list
25316164|NCT04996485|Dermatologic Agents|dermatologic agents|mesh-ancestor
25316165|NCT04996433|Antidepressive Agents|antidepressive agents|mesh-list
24422832|NCT00223717|Hydralazine|hydralazine|mesh-list
25316849|NCT04986982|Opicapone|opicapone|mesh-list
25190256|NCT02790684|Firuglipel|firuglipel|mesh-list
25190547|NCT02788851|Guanfacine|guanfacine|mesh-list
25190979|NCT02785718|Coagulants|coagulants|mesh-ancestor
25318373|NCT04965662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25191305|NCT02783989|Antioxidants|antioxidants|mesh-ancestor
25318710|NCT04960657|Glyburide|glyburide|mesh-list
24546790|NCT00700362|Insulin|insulin|mesh-list
25318806|NCT04957927|Hormone Antagonists|hormone antagonists|mesh-ancestor
25318807|NCT04957927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25318808|NCT04957927|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25318809|NCT04957927|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25318810|NCT04957927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318816|NCT04957420|Rotigotine|rotigotine|mesh-list
25191515|NCT02782338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25191516|NCT02782338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25191517|NCT02782338|Analgesics|analgesics|mesh-ancestor
25318991|NCT04952792|Anticoagulants|anticoagulants|mesh-ancestor
25318992|NCT04952571|Bevacizumab|bevacizumab|mesh-list
25318993|NCT04952571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25318994|NCT04952571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318995|NCT04952571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25318996|NCT04952571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25318997|NCT04952571|Growth Substances|growth substances|mesh-ancestor
25318998|NCT04952571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318999|NCT04952571|Growth Inhibitors|growth inhibitors|mesh-ancestor
25319014|NCT04952194|Carbidopa|carbidopa|mesh-list
25319015|NCT04952194|Entacapone|entacapone|mesh-list
25319016|NCT04952194|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25319017|NCT04952194|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25191717|NCT02781753|Interferon-alpha|interferon-alpha|mesh-list
25191824|NCT02780505|Vitamins|vitamins|mesh-ancestor
25191894|NCT02779959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25319554|NCT04946669|Abatacept|abatacept|mesh-list
25319968|NCT04942301|Growth Inhibitors|growth inhibitors|mesh-ancestor
25319969|NCT04942301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319970|NCT04941976|Benzydamine|benzydamine|mesh-list
25319971|NCT04941976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25319975|NCT04942002|Prednisolone|prednisolone|mesh-list
24429030|NCT00242411|Formoterol Fumarate|formoterol fumarate|mesh-list
25320183|NCT04939649|Midazolam|midazolam|mesh-list
25320184|NCT04939649|Ketamine|ketamine|mesh-list
25320185|NCT04939649|Analgesics|analgesics|mesh-ancestor
25320186|NCT04939649|Sensory System Agents|sensory system agents|mesh-ancestor
25192576|NCT02775734|Antioxidants|antioxidants|mesh-ancestor
25192577|NCT02775734|Protective Agents|protective agents|mesh-ancestor
25320325|NCT04937907|Hydroxychloroquine|hydroxychloroquine|mesh-list
25320663|NCT04933292|Glucocorticoids|glucocorticoids|mesh-ancestor
25320818|NCT04930211|Autonomic Agents|autonomic agents|mesh-ancestor
25321201|NCT04922567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321288|NCT04921657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24393359|NCT00129844|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25321358|NCT04920968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321359|NCT04920968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25321361|NCT04920747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321363|NCT04920760|Vitamins|vitamins|mesh-ancestor
25321364|NCT04920760|Micronutrients|micronutrients|mesh-ancestor
25321380|NCT04920669|Adrenergic Agents|adrenergic agents|mesh-ancestor
25321541|NCT04918524|Antipyretics|antipyretics|mesh-ancestor
25193514|NCT02770222|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25193515|NCT02770222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25193516|NCT02770222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25193517|NCT02770443|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25321662|NCT04917458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25321663|NCT04917458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25321665|NCT04917484|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25321666|NCT04917484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25321667|NCT04917484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25321668|NCT04917484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321671|NCT04917406|Dexamethasone|dexamethasone|mesh-list
25321750|NCT04916886|Vaccines|vaccines|mesh-list
25322017|NCT04913389|Diuretics|diuretics|mesh-ancestor
25193901|NCT02768168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25322133|NCT04912258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322134|NCT04912258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322379|NCT04907708|Metformin|metformin|mesh-list
25206983|NCT05136846|Durvalumab|durvalumab|mesh-list
25324355|NCT04885413|Niraparib|niraparib|mesh-list
25195622|NCT02757365|Analgesics|analgesics|mesh-ancestor
25325026|NCT05256173|Melatonin|melatonin|mesh-list
25325123|NCT05197842|Prednisone|prednisone|mesh-list
25196105|NCT02754362|Interferon Inducers|interferon inducers|mesh-ancestor
25208257|NCT02727998|Midazolam|midazolam|mesh-list
25196408|NCT02752841|Vitamin D|vitamin d|mesh-list
25196478|NCT02752308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25325932|NCT04876716|Posaconazole|posaconazole|mesh-list
25196554|NCT02752477|Anesthetics|anesthetics|mesh-list
25326049|NCT04875819|Vaccines|vaccines|mesh-list
25207214|NCT04593680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25326435|NCT04871633|Hormones|hormones|mesh-ancestor
25649104|NCT01488578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649105|NCT01488578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196921|NCT05130086|Islatravir|islatravir|mesh-list
25197003|NCT04911062|Epinephrine|epinephrine|mesh-list
25197004|NCT04911062|Bupivacaine|bupivacaine|mesh-list
25197005|NCT04911062|Anesthetics, Local|anesthetics, local|mesh-ancestor
25197006|NCT04911062|Anesthetics|anesthetics|mesh-ancestor
25197007|NCT04911062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25197008|NCT04911062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326584|NCT04870502|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25326585|NCT04870502|Hormone Antagonists|hormone antagonists|mesh-ancestor
25326587|NCT04870502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207324|NCT04229615|Apatinib|apatinib|mesh-list
25197526|NCT03508570|Nivolumab|nivolumab|mesh-list
25327399|NCT04859283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25327400|NCT04859283|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25327401|NCT04859283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25327577|NCT04856644|Rifapentine|rifapentine|mesh-list
25327578|NCT04856644|Rifampin|rifampin|mesh-list
25327579|NCT04856644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25327580|NCT04856644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25327581|NCT04856644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25327582|NCT04856644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25327646|NCT04856111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25327647|NCT04856111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327989|NCT04851158|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25328091|NCT04850417|Purinergic Agents|purinergic agents|mesh-ancestor
24473139|NCT00402181|Dexamethasone|dexamethasone|mesh-list
25328466|NCT04846634|Gemcitabine|gemcitabine|mesh-list
25328646|NCT04843553|Niacin|niacin|mesh-list
25198934|NCT02744378|Hormones|hormones|mesh-ancestor
24948741|NCT03917082|Tamoxifen|tamoxifen|mesh-list
25199133|NCT02743104|Propofol|propofol|mesh-list
25329429|NCT04835064|Paclitaxel|paclitaxel|mesh-list
25051758|NCT00382096|Metformin|metformin|mesh-list
25329923|NCT04829695|Artesunate|artesunate|mesh-list
24454766|NCT03715972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330055|NCT04827966|Listerine|listerine|mesh-list
25330056|NCT04827966|Calcium|calcium|mesh-list
25825572|NCT00005603|Tubulin Modulators|tubulin modulators|mesh-ancestor
25330245|NCT04824586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330332|NCT04823390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25330333|NCT04823390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25330334|NCT04823390|Anesthetics, General|anesthetics, general|mesh-ancestor
25330557|NCT04820751|Histamine Antagonists|histamine antagonists|mesh-ancestor
25330630|NCT04819503|Anesthetics|anesthetics|mesh-list
24500225|NCT00523354|Dermatologic Agents|dermatologic agents|mesh-ancestor
25331914|NCT04802967|Ketoprofen|ketoprofen|mesh-list
24525738|NCT02799134|Dexamethasone|dexamethasone|mesh-list
24742504|NCT05257447|Baclofen|baclofen|mesh-list
25332610|NCT04792333|Firibastat|firibastat|mesh-list
25332739|NCT04790838|Hormones|hormones|mesh-ancestor
25825580|NCT00005604|Analgesics|analgesics|mesh-ancestor
25825581|NCT00005604|Sensory System Agents|sensory system agents|mesh-ancestor
24551374|NCT00725829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25007998|NCT02343224|Interferon alpha-2|interferon alpha-2|mesh-list
24698556|NCT01441908|Pravastatin|pravastatin|mesh-list
24634747|NCT01134861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24635063|NCT01136759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635064|NCT01136759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24635323|NCT01138449|Vitamins|vitamins|mesh-ancestor
24635508|NCT01139749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24635509|NCT01139749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24635510|NCT01139749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24608053|NCT02509312|Analgesics|analgesics|mesh-ancestor
24637149|NCT01149018|Dronabinol|dronabinol|mesh-list
24551674|NCT05203445|Olaparib|olaparib|mesh-list
24557880|NCT00754689|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24557881|NCT00754689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24557883|NCT00754689|Hormones|hormones|mesh-ancestor
25825738|NCT00005631|Etoposide|etoposide|mesh-list
25100605|NCT03181464|Anesthetics|anesthetics|mesh-ancestor
24561526|NCT00761241|Antimetabolites|antimetabolites|mesh-ancestor
25825772|NCT00005636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25825773|NCT00005637|Temozolomide|temozolomide|mesh-list
25825774|NCT00005637|Carmustine|carmustine|mesh-list
25825775|NCT00005637|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25825776|NCT00005637|Alkylating Agents|alkylating agents|mesh-ancestor
25825777|NCT00005637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825778|NCT00005637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825779|NCT00005638|Cisplatin|cisplatin|mesh-list
25825780|NCT00005638|Irinotecan|irinotecan|mesh-list
24456827|NCT00332345|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24791585|NCT03873246|Varenicline|varenicline|mesh-list
24791587|NCT03873246|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24791588|NCT03873246|Cholinergic Agents|cholinergic agents|mesh-ancestor
24791589|NCT03873246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24563468|NCT00771706|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24447554|NCT00308945|Latanoprost|latanoprost|mesh-list
25825796|NCT00005641|Leucovorin|leucovorin|mesh-list
25825797|NCT00005641|Cyclosporine|cyclosporine|mesh-list
25825798|NCT00005641|Methylprednisolone|methylprednisolone|mesh-list
25825799|NCT00005641|Cyclophosphamide|cyclophosphamide|mesh-list
25825828|NCT00005641|Antifungal Agents|antifungal agents|mesh-ancestor
25649493|NCT01491958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825829|NCT00005641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25825830|NCT00005641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25825831|NCT00005641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25825832|NCT00005641|Antiemetics|antiemetics|mesh-ancestor
25825833|NCT00005641|Autonomic Agents|autonomic agents|mesh-ancestor
25825834|NCT00005641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25825836|NCT00005641|Glucocorticoids|glucocorticoids|mesh-ancestor
24564682|NCT00777517|Atorvastatin|atorvastatin|mesh-list
24564683|NCT00777517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24564692|NCT00777543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24564693|NCT00777543|Analgesics|analgesics|mesh-ancestor
24564694|NCT00777543|Sensory System Agents|sensory system agents|mesh-ancestor
24464611|NCT00365586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464612|NCT00365586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464613|NCT00365612|Tenofovir|tenofovir|mesh-list
24464614|NCT00365612|Emtricitabine|emtricitabine|mesh-list
25825864|NCT00005644|Mitosis Modulators|mitosis modulators|mesh-ancestor
25825865|NCT00005644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008738|NCT04577638|Nivolumab|nivolumab|mesh-list
24566031|NCT00784017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566032|NCT00784082|Hydroxyurea|hydroxyurea|mesh-list
25826032|NCT00005768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25826033|NCT00005768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826034|NCT00005769|Hormones|hormones|mesh-list
24567461|NCT00791271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050801|NCT00467025|Sorafenib|sorafenib|mesh-list
24957195|NCT03846583|Trastuzumab|trastuzumab|mesh-list
25826084|NCT00005779|Interleukin-12|interleukin-12|mesh-list
25826085|NCT00005779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25826086|NCT00005779|Immunologic Factors|immunologic factors|mesh-ancestor
25826087|NCT00005779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957215|NCT03846180|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24957216|NCT03846180|Hormones|hormones|mesh-ancestor
24957217|NCT03846180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24799859|NCT01971658|Thalidomide|thalidomide|mesh-list
24715015|NCT01533740|Vitamins|vitamins|mesh-ancestor
25826088|NCT00005779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25826089|NCT00005779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25826090|NCT00005779|Growth Substances|growth substances|mesh-ancestor
25826091|NCT00005779|Growth Inhibitors|growth inhibitors|mesh-ancestor
25826092|NCT00005779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466137|NCT00372229|Ganciclovir|ganciclovir|mesh-list
24466138|NCT00372229|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
24466139|NCT00372229|Antiviral Agents|antiviral agents|mesh-ancestor
24422937|NCT00224146|Oxybutynin|oxybutynin|mesh-list
25826093|NCT00005782|Lenograstim|lenograstim|mesh-list
24568344|NCT00795756|Cytarabine|cytarabine|mesh-list
25826099|NCT00005787|Epoetin Alfa|epoetin alfa|mesh-list
24569391|NCT00800423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24569392|NCT00800423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045526|NCT00945646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24569756|NCT00801853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24569790|NCT00801918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569791|NCT00801918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24569792|NCT00801918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25009087|NCT03637491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009088|NCT03582618|Sorafenib|sorafenib|mesh-list
25009089|NCT03582618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009090|NCT03582618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24570583|NCT00805311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475642|NCT00410982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836832|NCT02187562|Antipyretics|antipyretics|mesh-ancestor
25102819|NCT03166111|Lidocaine|lidocaine|mesh-list
24571521|NCT00810563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571522|NCT00810563|Sensory System Agents|sensory system agents|mesh-ancestor
24571523|NCT00810563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24571525|NCT00810589|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24456953|NCT00332774|Sensory System Agents|sensory system agents|mesh-ancestor
24477441|NCT00418600|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
24477442|NCT00418600|Ergocalciferols|ergocalciferols|mesh-list
24585242|NCT00884546|Autonomic Agents|autonomic agents|mesh-ancestor
24478380|NCT00422604|Autonomic Agents|autonomic agents|mesh-ancestor
24457110|NCT00333125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25826219|NCT00005800|Doxorubicin|doxorubicin|mesh-list
24574164|NCT00823940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489056|NCT00471341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24489094|NCT00471432|Tubulin Modulators|tubulin modulators|mesh-ancestor
24514689|NCT00592241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24514690|NCT00592241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514691|NCT00592280|Pancrelipase|pancrelipase|mesh-list
25826254|NCT00005802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24514719|NCT00592566|Antiemetics|antiemetics|mesh-ancestor
25649589|NCT01493531|Lesinurad|lesinurad|mesh-list
25826305|NCT00005810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25826306|NCT00005810|Alkylating Agents|alkylating agents|mesh-ancestor
24578465|NCT00849095|Adrenergic Agents|adrenergic agents|mesh-ancestor
24578466|NCT00849095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24578468|NCT00849095|Sympathomimetics|sympathomimetics|mesh-ancestor
25105150|NCT03148522|Analgesics|analgesics|mesh-ancestor
25826482|NCT00005831|Mitosis Modulators|mitosis modulators|mesh-ancestor
24580024|NCT00859703|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24580025|NCT00859703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24580026|NCT00859703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083990|NCT03311178|Autonomic Agents|autonomic agents|mesh-ancestor
25119766|NCT05258110|Midazolam|midazolam|mesh-list
25119767|NCT05258110|BI 425809|bi 425809|mesh-list
25826568|NCT00005840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25826569|NCT00005840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826570|NCT00005840|Tubulin Modulators|tubulin modulators|mesh-ancestor
25826571|NCT00005840|Antimitotic Agents|antimitotic agents|mesh-ancestor
25826572|NCT00005840|Mitosis Modulators|mitosis modulators|mesh-ancestor
25829671|NCT00006247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24833205|NCT02173132|Acetylcarnitine|acetylcarnitine|mesh-list
24833206|NCT02173132|Vitamin B Complex|vitamin b complex|mesh-ancestor
24833207|NCT02173132|Vitamins|vitamins|mesh-ancestor
24833208|NCT02173132|Micronutrients|micronutrients|mesh-ancestor
24833209|NCT02173132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826573|NCT00005840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826574|NCT00005841|Freund's Adjuvant|freund's adjuvant|mesh-list
24833219|NCT02173262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24833227|NCT02173262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833228|NCT02173288|Furosemide|furosemide|mesh-list
24833229|NCT02173288|Spironolactone|spironolactone|mesh-list
25063005|NCT03237611|Aprepitant|aprepitant|mesh-list
24744984|NCT04055818|Niacin|niacin|mesh-list
24835090|NCT02182245|Nintedanib|nintedanib|mesh-list
24835097|NCT02182245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24835101|NCT02182258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24835214|NCT02182505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24835358|NCT02182713|Ipratropium|ipratropium|mesh-list
24835415|NCT02182765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24835416|NCT02182765|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25055028|NCT03525509|Morphine|morphine|mesh-list
24586362|NCT00890318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586363|NCT00890318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24581477|NCT00865319|Antiviral Agents|antiviral agents|mesh-ancestor
25042982|NCT01339689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25042983|NCT01339689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826582|NCT00005843|Tipifarnib|tipifarnib|mesh-list
25090881|NCT03253133|Oxaliplatin|oxaliplatin|mesh-list
24746989|NCT02333292|Ritonavir|ritonavir|mesh-list
24581859|NCT00866528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581919|NCT00866684|Azathioprine|azathioprine|mesh-list
24581921|NCT00866684|Cyclosporins|cyclosporins|mesh-list
24581922|NCT00866684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24837224|NCT02190318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583204|NCT00873756|Bevacizumab|bevacizumab|mesh-list
24583205|NCT00873756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24583206|NCT00873756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583207|NCT00873756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24583208|NCT00873756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24583209|NCT00873756|Growth Substances|growth substances|mesh-ancestor
24583412|NCT00874419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583413|NCT00874419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24583414|NCT00874419|Antimetabolites|antimetabolites|mesh-ancestor
24977330|NCT02467582|Antipyretics|antipyretics|mesh-ancestor
24839822|NCT02206308|Immunologic Factors|immunologic factors|mesh-ancestor
24839823|NCT02206308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839824|NCT02206425|Ascorbic Acid|ascorbic acid|mesh-list
24839830|NCT02206425|Doxorubicin|doxorubicin|mesh-list
24839831|NCT02206425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24839832|NCT02206425|Lenalidomide|lenalidomide|mesh-list
24839833|NCT02206425|Pomalidomide|pomalidomide|mesh-list
24839834|NCT02206425|BB 1101|bb 1101|mesh-list
24839841|NCT02206425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839849|NCT02206425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24839852|NCT02206425|Hormones|hormones|mesh-ancestor
24840673|NCT02211729|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24840674|NCT02211729|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24840733|NCT02212210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840734|NCT02212210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24840735|NCT02212210|Glucocorticoids|glucocorticoids|mesh-ancestor
24840752|NCT02212340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24840753|NCT02212340|Narcotics|narcotics|mesh-ancestor
24840816|NCT02212652|Vitamins|vitamins|mesh-list
24520453|NCT01657500|Anticoagulants|anticoagulants|mesh-ancestor
24520454|NCT01657500|Plasma Substitutes|plasma substitutes|mesh-ancestor
24841489|NCT02216227|Dermatologic Agents|dermatologic agents|mesh-ancestor
24841490|NCT02216227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24841491|NCT02216227|Trace Elements|trace elements|mesh-ancestor
25826623|NCT00005849|Mitosis Modulators|mitosis modulators|mesh-ancestor
24536651|NCT00651976|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24536652|NCT00651976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24819615|NCT02096250|Fe(III)-EDTA|fe(iii)-edta|mesh-list
24819616|NCT02096250|Trace Elements|trace elements|mesh-ancestor
24819617|NCT02096250|Micronutrients|micronutrients|mesh-ancestor
24819618|NCT02096250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819619|NCT02096250|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24819620|NCT02096250|Chelating Agents|chelating agents|mesh-ancestor
24819621|NCT02096250|Sequestering Agents|sequestering agents|mesh-ancestor
25065421|NCT05322499|Docetaxel|docetaxel|mesh-list
25065423|NCT05322499|Irinotecan|irinotecan|mesh-list
24915553|NCT00529113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915554|NCT00529113|Antiviral Agents|antiviral agents|mesh-ancestor
24915555|NCT00529113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24915643|NCT04249713|Brodalumab|brodalumab|mesh-list
24844298|NCT02232269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24844301|NCT02232308|Lisinopril|lisinopril|mesh-list
24844366|NCT02232516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24844397|NCT02232581|Alovudine|alovudine|mesh-list
24844590|NCT02233387|Imidazole|imidazole|mesh-list
24915770|NCT04248608|Analgesics|analgesics|mesh-ancestor
24915771|NCT04248608|Sensory System Agents|sensory system agents|mesh-ancestor
24915772|NCT04248608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24915773|NCT04248348|Heparin|heparin|mesh-list
24915774|NCT04248348|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24915775|NCT04248348|Tinzaparin|tinzaparin|mesh-list
24915776|NCT04248348|Dalteparin|dalteparin|mesh-list
24819715|NCT02096965|Natriuretic Agents|natriuretic agents|mesh-ancestor
24846380|NCT02242474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24846381|NCT02242474|Dermatologic Agents|dermatologic agents|mesh-ancestor
24846382|NCT02242474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24460695|NCT00349245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25044078|NCT01160601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25044079|NCT01160601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044080|NCT01160601|Tubulin Modulators|tubulin modulators|mesh-ancestor
25044129|NCT01137968|Imetelstat|imetelstat|mesh-list
24916117|NCT04244591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24916118|NCT04244591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065839|NCT05147415|Adrenergic Agents|adrenergic agents|mesh-ancestor
25826644|NCT00005850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25044287|NCT01116141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846568|NCT02243124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25826645|NCT00005850|Serotonin Agents|serotonin agents|mesh-ancestor
25826651|NCT00005851|Cyclosporine|cyclosporine|mesh-list
24916199|NCT04243733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24916200|NCT04243811|Anesthetics|anesthetics|mesh-list
24916269|NCT04242914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916270|NCT04242914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24916271|NCT04242914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24739562|NCT01682421|Hormones|hormones|mesh-ancestor
24916272|NCT04242914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24916273|NCT04242914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24916274|NCT04242914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24464854|NCT00367120|Amoxicillin|amoxicillin|mesh-list
24916684|NCT04238169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24916719|NCT04237987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24916720|NCT04237987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25066239|NCT04033237|Nicotine|nicotine|mesh-list
24453166|NCT05238831|Carboplatin|carboplatin|mesh-list
24453167|NCT05238831|Capecitabine|capecitabine|mesh-list
24846955|NCT02244437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24846957|NCT02244437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649745|NCT01495793|Dopamine Agonists|dopamine agonists|mesh-ancestor
25066411|NCT03399539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066441|NCT03205605|Cholinergic Agents|cholinergic agents|mesh-ancestor
25066442|NCT03205605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24520548|NCT05337332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24444535|NCT00298415|Paclitaxel|paclitaxel|mesh-list
24898138|NCT04417920|Mitomycins|mitomycins|mesh-list
24847110|NCT02245191|Adrenergic Agents|adrenergic agents|mesh-ancestor
24847111|NCT02245191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24473521|NCT00403156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473522|NCT00403156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473531|NCT00403182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24473532|NCT00403182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473533|NCT00403247|Vitamin B 12|vitamin b 12|mesh-list
24473534|NCT00403247|Hydroxocobalamin|hydroxocobalamin|mesh-list
24473535|NCT00403247|Pyridoxine|pyridoxine|mesh-list
25826671|NCT00005851|Antitubercular Agents|antitubercular agents|mesh-ancestor
24473537|NCT00403247|Micronutrients|micronutrients|mesh-ancestor
24473538|NCT00403247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847112|NCT02245191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473703|NCT00403858|Lactulose|lactulose|mesh-list
25066504|NCT03047330|Fertility Agents|fertility agents|mesh-ancestor
25066505|NCT03047330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25649750|NCT01495819|Nicotine|nicotine|mesh-list
25044456|NCT01094262|Narcotics|narcotics|mesh-ancestor
24582376|NCT00869310|BB 1101|bb 1101|mesh-list
25826673|NCT00005852|Cyclosporine|cyclosporine|mesh-list
25826674|NCT00005852|Methylprednisolone|methylprednisolone|mesh-list
25826675|NCT00005852|Cyclophosphamide|cyclophosphamide|mesh-list
25826676|NCT00005852|Cyclosporins|cyclosporins|mesh-list
25826677|NCT00005852|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25063423|NCT01453101|Bortezomib|bortezomib|mesh-list
24917381|NCT04230330|Dexamethasone|dexamethasone|mesh-list
24917382|NCT04230330|Nivolumab|nivolumab|mesh-list
24618185|NCT01047072|Rituximab|rituximab|mesh-list
24917383|NCT04230330|Asparaginase|asparaginase|mesh-list
24917384|NCT04230330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917385|NCT04230330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24917888|NCT04224922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917889|NCT04224922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24917890|NCT04224922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25199529|NCT02740712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25121654|NCT03100565|Lidocaine|lidocaine|mesh-list
24917891|NCT04224922|Alkylating Agents|alkylating agents|mesh-ancestor
24917892|NCT04224922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25826691|NCT00005852|Dermatologic Agents|dermatologic agents|mesh-ancestor
24518341|NCT05214807|Hylan|hylan|mesh-list
24918315|NCT04220996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24918316|NCT04220996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25199530|NCT02740712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25199531|NCT02740712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24520903|NCT05243940|Anesthetics|anesthetics|mesh-ancestor
25826706|NCT00005853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25826707|NCT00005853|Analgesics|analgesics|mesh-ancestor
25826708|NCT00005853|Sensory System Agents|sensory system agents|mesh-ancestor
24954057|NCT03879590|Budesonide|budesonide|mesh-list
24919176|NCT04213833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24919177|NCT04213833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919178|NCT04213833|Sensory System Agents|sensory system agents|mesh-ancestor
24919180|NCT04213833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25826716|NCT00005854|Cyclosporine|cyclosporine|mesh-list
25826717|NCT00005854|Cyclophosphamide|cyclophosphamide|mesh-list
24847393|NCT02246712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24847394|NCT02246816|Opium|opium|mesh-list
24847396|NCT02246816|Narcotics|narcotics|mesh-ancestor
25826720|NCT00005854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25199532|NCT02740712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25199533|NCT02740712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25121892|NCT03098407|Buprenorphine|buprenorphine|mesh-list
24538279|NCT00658268|Clodronic Acid|clodronic acid|mesh-list
24521611|NCT04637529|Ibuprofen|ibuprofen|mesh-list
24521613|NCT04637529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24623909|NCT01073904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199534|NCT02740712|Anesthetics, General|anesthetics, general|mesh-ancestor
24623910|NCT01073904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24623911|NCT01073904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24623912|NCT01073904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25067158|NCT03446625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067159|NCT03446625|Protective Agents|protective agents|mesh-ancestor
24523602|NCT05341401|Budesonide|budesonide|mesh-list
24952315|NCT03895411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24636164|NCT01143545|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24508958|NCT00557921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24508959|NCT00557921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24508961|NCT00557921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24636165|NCT01143545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24847852|NCT05353192|Hormones|hormones|mesh-list
24636222|NCT01144000|Daptomycin|daptomycin|mesh-list
24920605|NCT04201249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920606|NCT04201249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24920607|NCT04201249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24920608|NCT04201249|Analgesics|analgesics|mesh-ancestor
24920609|NCT04201249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25067329|NCT03444506|Histamine Agents|histamine agents|mesh-ancestor
25067330|NCT03444506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25199549|NCT02740712|Purinergic Agents|purinergic agents|mesh-ancestor
25044825|NCT01033292|Iniparib|iniparib|mesh-list
25040159|NCT03340974|Antioxidants|antioxidants|mesh-ancestor
25040160|NCT03340974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040161|NCT03340974|Protective Agents|protective agents|mesh-ancestor
25040216|NCT03318393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25040217|NCT03315143|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25040218|NCT03315143|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25067410|NCT03443843|Xhance|xhance|mesh-list
25826740|NCT00005854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25826741|NCT00005855|Carmustine|carmustine|mesh-list
24848517|NCT03993912|Lenalidomide|lenalidomide|mesh-list
24848518|NCT03993912|Daratumumab|daratumumab|mesh-list
24607716|NCT03971409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24607717|NCT03971409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24607718|NCT03971409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595139|NCT00936923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607719|NCT03971409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607720|NCT03971409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24607721|NCT03971409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24819220|NCT02094274|Xhance|xhance|mesh-list
24530837|NCT00632645|Antiemetics|antiemetics|mesh-ancestor
24530838|NCT00632645|Autonomic Agents|autonomic agents|mesh-ancestor
24487396|NCT00462878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24532033|NCT00637884|Histamine Agents|histamine agents|mesh-ancestor
24532197|NCT00638482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532199|NCT00638534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24532200|NCT00638534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24608092|NCT02360280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24610089|NCT00999791|Growth Inhibitors|growth inhibitors|mesh-ancestor
24608109|NCT02315326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24608110|NCT02315326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25826758|NCT00005858|Immunotoxins|immunotoxins|mesh-list
24608490|NCT00992329|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25826759|NCT00005858|Immunologic Factors|immunologic factors|mesh-ancestor
24608512|NCT00992355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24608527|NCT00992381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24608528|NCT00992381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24788572|NCT01932268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24788573|NCT01932268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701602|NCT01459640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701603|NCT01459640|Viscosupplements|viscosupplements|mesh-ancestor
24701604|NCT01459640|Protective Agents|protective agents|mesh-ancestor
24701605|NCT01459809|Metformin|metformin|mesh-list
24701606|NCT01459809|Glimepiride|glimepiride|mesh-list
24702133|NCT01464112|Hormones|hormones|mesh-ancestor
24702135|NCT01464112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24702725|NCT01467375|Insulin Aspart|insulin aspart|mesh-list
24702726|NCT01467375|Biphasic Insulins|biphasic insulins|mesh-list
24702727|NCT01467375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24702728|NCT01467375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702729|NCT01467401|Insulin|insulin|mesh-list
24702730|NCT01467401|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24702752|NCT01467518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702753|NCT01467518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24702754|NCT01467518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24609638|NCT00997581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24848648|NCT03838484|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24848649|NCT03838484|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24848650|NCT03838484|Cholinergic Agents|cholinergic agents|mesh-ancestor
24848651|NCT03838484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24848652|NCT03838484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848674|NCT03715127|Hallucinogens|hallucinogens|mesh-ancestor
24848675|NCT03715127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848676|NCT03715127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24848808|NCT03466151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707289|NCT01495117|Iodine|iodine|mesh-list
25826775|NCT00005860|Micronutrients|micronutrients|mesh-ancestor
25826776|NCT00005860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24488080|NCT00466518|Incretins|incretins|mesh-ancestor
24848858|NCT03360721|Glucocorticoids|glucocorticoids|mesh-ancestor
24848860|NCT03360721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24848861|NCT03360721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848925|NCT03283488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25154948|NCT05468372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24849023|NCT03043924|Estradiol|estradiol|mesh-list
25155079|NCT05467826|Velpatasvir|velpatasvir|mesh-list
24849174|NCT02506959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24849196|NCT02185417|Chlorthalidone|chlorthalidone|mesh-list
24849347|NCT00559936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24710028|NCT01508104|Dactolisib|dactolisib|mesh-list
25045001|NCT01007721|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25155101|NCT05466305|Cobalt|cobalt|mesh-list
24710201|NCT01508884|Vaccines|vaccines|mesh-list
24849443|NCT02248753|Digoxin|digoxin|mesh-list
24849444|NCT02248753|Amiodarone|amiodarone|mesh-list
24849445|NCT02248753|Verapamil|verapamil|mesh-list
24849446|NCT02248753|Flecainide|flecainide|mesh-list
24849455|NCT02248753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24849456|NCT02248753|Adrenergic Agents|adrenergic agents|mesh-ancestor
24711104|NCT01513564|Analgesics|analgesics|mesh-ancestor
24711105|NCT01513564|Sensory System Agents|sensory system agents|mesh-ancestor
24711106|NCT01513564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24711107|NCT01513603|Cytarabine|cytarabine|mesh-list
24711108|NCT01513603|Mitoxantrone|mitoxantrone|mesh-list
25005852|NCT01822652|Fludarabine|fludarabine|mesh-list
24849625|NCT02249416|Antimetabolites|antimetabolites|mesh-ancestor
24849626|NCT02249416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24849627|NCT02249416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24849629|NCT02249442|Tipranavir|tipranavir|mesh-list
24849630|NCT02249442|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24849631|NCT02249442|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24714828|NCT01533090|Bisacodyl|bisacodyl|mesh-list
25005973|NCT00070564|Doxorubicin|doxorubicin|mesh-list
24662722|NCT01296464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045091|NCT01001091|Autonomic Agents|autonomic agents|mesh-ancestor
25045092|NCT01001091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045094|NCT01001091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25045096|NCT01001091|Hormones|hormones|mesh-ancestor
25045097|NCT01001091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25045098|NCT01001091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25045100|NCT01000922|Insulin|insulin|mesh-list
24715962|NCT01539174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24715963|NCT01539174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24715964|NCT01539174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24849742|NCT02250118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24849743|NCT02250118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24849744|NCT02250118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24849745|NCT02250118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24849746|NCT02250118|Growth Substances|growth substances|mesh-ancestor
24716186|NCT01540500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716188|NCT01540500|Serotonin Agents|serotonin agents|mesh-ancestor
24716598|NCT01542697|Anticonvulsants|anticonvulsants|mesh-ancestor
24716657|NCT01542918|Growth Substances|growth substances|mesh-ancestor
24849755|NCT02250209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490768|NCT00480064|Alkylating Agents|alkylating agents|mesh-ancestor
25826789|NCT00005862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25826790|NCT00005862|Growth Substances|growth substances|mesh-ancestor
25826791|NCT00005862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826792|NCT00005862|Growth Inhibitors|growth inhibitors|mesh-ancestor
25826793|NCT00005862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826794|NCT00005862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24717674|NCT01549418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24849851|NCT02250833|Vasodilator Agents|vasodilator agents|mesh-ancestor
24491470|NCT00482690|Autonomic Agents|autonomic agents|mesh-ancestor
25826805|NCT00005863|Antimetabolites|antimetabolites|mesh-ancestor
24811986|NCT02049073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811987|NCT02049073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24674260|NCT01342692|GABA Agents|gaba agents|mesh-ancestor
25826834|NCT00005866|Immunologic Factors|immunologic factors|mesh-ancestor
24850000|NCT02251184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24850001|NCT02251184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24676495|NCT01350622|Diclofenac|diclofenac|mesh-list
24680025|NCT01372670|Hydroxyzine|hydroxyzine|mesh-list
24852399|NCT02262520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24596255|NCT00942565|Analgesics|analgesics|mesh-ancestor
24511159|NCT00567606|Risedronic Acid|risedronic acid|mesh-list
24934778|NCT04058522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24934779|NCT04058522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934825|NCT04057989|Ketamine|ketamine|mesh-list
24935039|NCT04055506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531016|NCT00633568|Cisplatin|cisplatin|mesh-list
24456366|NCT00330993|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24532297|NCT00639119|Ropinirole|ropinirole|mesh-list
25826998|NCT00005880|Hormones|hormones|mesh-ancestor
25826999|NCT00005880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24639459|NCT01161667|Serotonin Agents|serotonin agents|mesh-ancestor
24515971|NCT00600158|Lidocaine|lidocaine|mesh-list
25827068|NCT00005893|Alkylating Agents|alkylating agents|mesh-ancestor
25827069|NCT00005893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827070|NCT00005893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827071|NCT00005893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25827072|NCT00005896|Lenograstim|lenograstim|mesh-list
25827073|NCT00005896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25827074|NCT00005896|Immunologic Factors|immunologic factors|mesh-ancestor
25827075|NCT00005896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827076|NCT00005898|Cyclosporine|cyclosporine|mesh-list
25827077|NCT00005898|Methylprednisolone|methylprednisolone|mesh-list
25827110|NCT00005912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25827111|NCT00005912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827112|NCT00005912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827113|NCT00005912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25827114|NCT00005912|Hormone Antagonists|hormone antagonists|mesh-ancestor
25827115|NCT00005912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25827116|NCT00005912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827117|NCT00005912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24854980|NCT02276677|Oxytocin|oxytocin|mesh-list
25827146|NCT00005925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827147|NCT00005925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456784|NCT00332293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24456785|NCT00332293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24764101|NCT01779401|Autonomic Agents|autonomic agents|mesh-ancestor
25827148|NCT00005926|Gemcitabine|gemcitabine|mesh-list
25827149|NCT00005926|Trastuzumab|trastuzumab|mesh-list
24660600|NCT01284725|Immunosuppressive Agents|immunosuppressive agents|mesh-list
24660602|NCT01284725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660603|NCT01284725|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24660633|NCT01284868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25827183|NCT00005935|Cyclosporine|cyclosporine|mesh-list
25827184|NCT00005935|Mycophenolic Acid|mycophenolic acid|mesh-list
25827185|NCT00005935|Cyclosporins|cyclosporins|mesh-list
25827186|NCT00005935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920406|NCT04203485|Paclitaxel|paclitaxel|mesh-list
24684116|NCT01395654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684117|NCT01395654|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24684118|NCT01395654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24684119|NCT01395654|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24684120|NCT01395654|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24855035|NCT02276989|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24855036|NCT02276989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855080|NCT02277171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25033838|NCT03570710|Hemostatics|hemostatics|mesh-ancestor
24855081|NCT02277171|Respiratory System Agents|respiratory system agents|mesh-ancestor
24549054|NCT00713193|Hormones|hormones|mesh-ancestor
24685238|NCT00667329|Rituximab|rituximab|mesh-list
25827262|NCT00005941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25827263|NCT00005942|Daunorubicin|daunorubicin|mesh-list
25827264|NCT00005942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826378|NCT02134249|Dopamine Agonists|dopamine agonists|mesh-ancestor
24686208|NCT04997759|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25052760|NCT00162279|Abatacept|abatacept|mesh-list
24687214|NCT04238845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687226|NCT04223037|Immunologic Factors|immunologic factors|mesh-ancestor
24687228|NCT04212013|Rituximab|rituximab|mesh-list
24645940|NCT01200784|Niacin|niacin|mesh-list
24612085|NCT01011920|Immunologic Factors|immunologic factors|mesh-ancestor
25827692|NCT00005977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25827693|NCT00005977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25827694|NCT00005977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25827748|NCT00005979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25827749|NCT00005979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443510|NCT00295308|Sympatholytics|sympatholytics|mesh-ancestor
25827929|NCT00005991|Immunologic Factors|immunologic factors|mesh-ancestor
25013365|NCT02992015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828034|NCT00006003|Semaxinib|semaxinib|mesh-list
25828166|NCT00006015|Levoleucovorin|levoleucovorin|mesh-list
25828269|NCT00006028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828270|NCT00006028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25828271|NCT00006028|Antimetabolites|antimetabolites|mesh-ancestor
24665001|NCT01309633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24665032|NCT01309776|Serotonin Agents|serotonin agents|mesh-ancestor
24665033|NCT01309776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828467|NCT00006045|Immunologic Factors|immunologic factors|mesh-ancestor
24520171|NCT03608657|Analgesics|analgesics|mesh-ancestor
24528401|NCT00621036|Thiotepa|thiotepa|mesh-list
25828518|NCT00006050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25053121|NCT00102466|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25828580|NCT00006054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25015418|NCT02432209|Orlistat|orlistat|mesh-list
25828655|NCT00006066|Aldesleukin|aldesleukin|mesh-list
24999091|NCT05214235|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24999092|NCT05214235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042507|NCT01425970|Interferon-alpha|interferon-alpha|mesh-list
25042508|NCT01425970|Interferon alpha-2|interferon alpha-2|mesh-list
25042509|NCT01425970|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24935617|NCT04048707|Octreotide|octreotide|mesh-list
25828745|NCT00006084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24452015|NCT00325715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828746|NCT00006086|Carboplatin|carboplatin|mesh-list
25015858|NCT00803790|Vitamin D|vitamin d|mesh-list
24549445|NCT00715273|Vasodilator Agents|vasodilator agents|mesh-ancestor
25828748|NCT00006088|Vinorelbine|vinorelbine|mesh-list
24549446|NCT00715273|Vitamin B Complex|vitamin b complex|mesh-ancestor
24549447|NCT00715273|Vitamins|vitamins|mesh-ancestor
24549448|NCT00715273|Micronutrients|micronutrients|mesh-ancestor
25043819|NCT01198834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043821|NCT01198834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25043822|NCT01198834|Analgesics|analgesics|mesh-ancestor
25828749|NCT00006088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25828750|NCT00006088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828751|NCT00006088|Tubulin Modulators|tubulin modulators|mesh-ancestor
25044290|NCT01116141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044292|NCT01116141|Dermatologic Agents|dermatologic agents|mesh-ancestor
25044293|NCT01116141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25061876|NCT05390307|Glucagon|glucagon|mesh-list
25828752|NCT00006088|Antimitotic Agents|antimitotic agents|mesh-ancestor
25828753|NCT00006088|Mitosis Modulators|mitosis modulators|mesh-ancestor
25062139|NCT05255900|Metyrapone|metyrapone|mesh-list
25016279|NCT00092118|Respiratory System Agents|respiratory system agents|mesh-ancestor
25828758|NCT00006089|Antibodies|antibodies|mesh-list
25828759|NCT00006089|Immunoglobulins|immunoglobulins|mesh-list
25154943|NCT05468450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24848844|NCT03391466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848845|NCT03391466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24848846|NCT03391466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24848847|NCT03391466|Alkylating Agents|alkylating agents|mesh-ancestor
24848848|NCT03391466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801966|NCT01986582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549967|NCT00718406|Metoprolol|metoprolol|mesh-list
25065906|NCT04946630|Hormones|hormones|mesh-ancestor
24586632|NCT00891475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25016297|NCT00092092|Budesonide|budesonide|mesh-list
25155036|NCT05468073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25155037|NCT05468073|Antiviral Agents|antiviral agents|mesh-ancestor
25155038|NCT05468073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25155040|NCT05468047|Analgesics|analgesics|mesh-ancestor
25155041|NCT05468047|Sensory System Agents|sensory system agents|mesh-ancestor
25650025|NCT01498679|Xhance|xhance|mesh-list
24445813|NCT00302666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597918|NCT00952796|Sulbactam|sulbactam|mesh-list
24590237|NCT00911287|Narcotics|narcotics|mesh-ancestor
25072739|NCT03399526|Betamethasone benzoate|betamethasone benzoate|mesh-list
24450060|NCT00317733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701716|NCT01460563|Analgesics|analgesics|mesh-ancestor
24600329|NCT01026220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24600330|NCT01026220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24600332|NCT01026220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24600333|NCT01026220|Glucocorticoids|glucocorticoids|mesh-ancestor
24600334|NCT01026220|Hormones|hormones|mesh-ancestor
24759027|NCT01749085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203467|NCT02714361|Vitamins|vitamins|mesh-ancestor
24600367|NCT00567567|Carboplatin|carboplatin|mesh-list
24601043|NCT00962312|Lapatinib|lapatinib|mesh-list
24704106|NCT01476605|Sodium Morrhuate|sodium morrhuate|mesh-list
24603773|NCT00975533|Insulin|insulin|mesh-list
24812527|NCT02053142|Acyclovir|acyclovir|mesh-list
24912492|NCT04275180|Argatroban|argatroban|mesh-list
25650065|NCT01498978|Ipilimumab|ipilimumab|mesh-list
24711652|NCT01516554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941074|NCT03995147|Hormones|hormones|mesh-ancestor
24670241|NCT03181100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24670242|NCT03181100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456552|NCT00331695|Hormone Antagonists|hormone antagonists|mesh-ancestor
24714459|NCT01530620|Cholinergic Agents|cholinergic agents|mesh-ancestor
25019406|NCT03691636|Lifitegrast|lifitegrast|mesh-list
24715726|NCT01538329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24717236|NCT01546935|Oseltamivir|oseltamivir|mesh-list
25026804|NCT03625050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24719363|NCT01560962|Tobramycin|tobramycin|mesh-list
25029641|NCT03601624|Hormones|hormones|mesh-ancestor
25036134|NCT03549832|Sofosbuvir|sofosbuvir|mesh-list
24720879|NCT01571063|Vitamin D|vitamin d|mesh-list
25039730|NCT03704584|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25039731|NCT03704584|Protective Agents|protective agents|mesh-ancestor
25039732|NCT03704584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24457945|NCT00335699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457946|NCT00335699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25828967|NCT00006116|Antimetabolites|antimetabolites|mesh-ancestor
25050918|NCT00460317|Paclitaxel|paclitaxel|mesh-list
25041218|NCT02602353|Loxoprofen|loxoprofen|mesh-list
24589273|NCT00906386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24589274|NCT00906386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589275|NCT00906386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589277|NCT00906451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25042029|NCT01516307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042030|NCT01516307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042031|NCT01516307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25042032|NCT01516203|Rifampin|rifampin|mesh-list
25042033|NCT01516203|Isoniazid|isoniazid|mesh-list
24730603|NCT01629225|Candesartan|candesartan|mesh-list
24999554|NCT04052334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731452|NCT01634789|Estrogens|estrogens|mesh-list
25023724|NCT03652233|Nivolumab|nivolumab|mesh-list
25045418|NCT00955981|Renal Agents|renal agents|mesh-ancestor
24733763|NCT01648517|Carboplatin|carboplatin|mesh-list
24890819|NCT04479865|Donepezil|donepezil|mesh-list
25117889|NCT04669197|Paclitaxel|paclitaxel|mesh-list
25122117|NCT03096340|Irinotecan|irinotecan|mesh-list
24868325|NCT05156892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25127721|NCT03053947|Anesthetics|anesthetics|mesh-ancestor
24943644|NCT03967964|Testosterone undecanoate|testosterone undecanoate|mesh-list
25130621|NCT03032315|Amlodipine|amlodipine|mesh-list
24618398|NCT01048177|Lidocaine|lidocaine|mesh-list
25133370|NCT03013010|Tegafur|tegafur|mesh-list
25133804|NCT03010202|Rituximab|rituximab|mesh-list
24751069|NCT01701882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24751718|NCT01705743|Nitrous Oxide|nitrous oxide|mesh-list
25136966|NCT02987920|Antimanic Agents|antimanic agents|mesh-ancestor
24944799|NCT03957291|Chlorhexidine|chlorhexidine|mesh-list
25829182|NCT00006152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25144342|NCT02936830|Listerine|listerine|mesh-list
25047599|NCT00788541|Anecortave|anecortave|mesh-list
25146991|NCT02917525|Micronutrients|micronutrients|mesh-ancestor
24945448|NCT03950518|Antinematodal Agents|antinematodal agents|mesh-ancestor
24394606|NCT00133731|Anticoagulants|anticoagulants|mesh-ancestor
25029699|NCT03600974|Citalopram|citalopram|mesh-list
24399023|NCT00146523|Mifepristone|mifepristone|mesh-list
24399647|NCT00148330|Hormones|hormones|mesh-ancestor
25098586|NCT03196882|Iron|iron|mesh-list
24407055|NCT00171756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24946991|NCT03933605|GABA Agents|gaba agents|mesh-ancestor
25154059|NCT01703949|Antibodies|antibodies|mesh-list
25154060|NCT01703949|Immunoglobulins|immunoglobulins|mesh-list
25154061|NCT01703949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25154092|NCT01480154|Hydroxychloroquine|hydroxychloroquine|mesh-list
25154093|NCT01480154|Antimalarials|antimalarials|mesh-ancestor
25154094|NCT01480154|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25154095|NCT01480154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25154096|NCT01480154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25154097|NCT01480154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24997826|NCT04311632|Mycophenolic Acid|mycophenolic acid|mesh-list
24424151|NCT00228033|Calcium|calcium|mesh-list
24434982|NCT00264628|Antiemetics|antiemetics|mesh-ancestor
24434983|NCT00264628|Autonomic Agents|autonomic agents|mesh-ancestor
24433211|NCT00257959|Amiodarone|amiodarone|mesh-list
25650416|NCT01502644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24442094|NCT00290017|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24442546|NCT00291408|Antioxidants|antioxidants|mesh-ancestor
24947539|NCT03927807|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24947540|NCT03927807|Abortifacient Agents|abortifacient agents|mesh-ancestor
24957571|NCT03843736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24958793|NCT03829774|Acetaminophen|acetaminophen|mesh-list
25829249|NCT00006167|Androgens|androgens|mesh-ancestor
24760372|NCT01757756|Anesthetics|anesthetics|mesh-ancestor
24765994|NCT01791881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166892|NCT03570983|Cytarabine|cytarabine|mesh-list
24460766|NCT00349440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25035611|NCT03554304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25035612|NCT03554304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25035614|NCT03554304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25166988|NCT03478488|Gemcitabine|gemcitabine|mesh-list
25166989|NCT03478488|Oxaliplatin|oxaliplatin|mesh-list
25166990|NCT03478488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25166991|NCT03478488|Antimetabolites|antimetabolites|mesh-ancestor
25166992|NCT03478488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166993|NCT03478488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25035736|NCT03553329|Trametinib|trametinib|mesh-list
25829321|NCT00006195|Antiemetics|antiemetics|mesh-ancestor
24550895|NCT00723164|Narcotics|narcotics|mesh-ancestor
24551331|NCT00725439|R 115866|r 115866|mesh-list
24552247|NCT03743376|UB-421|ub-421|mesh-list
25203519|NCT02714075|Iron|iron|mesh-list
25168231|NCT02271334|Albuterol|albuterol|mesh-list
24772376|NCT01833312|Narcotics|narcotics|mesh-ancestor
25829392|NCT00006204|Serotonin Agents|serotonin agents|mesh-ancestor
25158542|NCT04249596|Tianeptine|tianeptine|mesh-list
25650556|NCT01504867|Antipyretics|antipyretics|mesh-ancestor
25168817|NCT02058420|Antioxidants|antioxidants|mesh-ancestor
24979984|NCT04767776|Charcoal|charcoal|mesh-list
24559580|NCT04643574|Analgesics|analgesics|mesh-ancestor
24754605|NCT01721798|Copper|copper|mesh-list
24561394|NCT00759993|Chromium|chromium|mesh-list
24802291|NCT01989312|GABA Agents|gaba agents|mesh-ancestor
25125619|NCT03067753|Hormones|hormones|mesh-list
25162250|NCT02906150|Cisplatin|cisplatin|mesh-list
25106083|NCT04509973|Antiemetics|antiemetics|mesh-ancestor
24448490|NCT00311987|Hormones|hormones|mesh-ancestor
24948702|NCT03917628|Adalimumab|adalimumab|mesh-list
24948907|NCT05401071|Rifapentine|rifapentine|mesh-list
25200154|NCT02735928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24574643|NCT00826644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451931|NCT00325325|Everolimus|everolimus|mesh-list
25127823|NCT03052673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25127824|NCT03052673|Narcotics|narcotics|mesh-ancestor
25127825|NCT03052673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25830337|NCT00006372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25127854|NCT03052348|Hormones|hormones|mesh-ancestor
25830338|NCT00006372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24981605|NCT02343042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981607|NCT02343042|Glucocorticoids|glucocorticoids|mesh-ancestor
24981609|NCT02343042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24981610|NCT02343042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25162415|NCT02905045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25830339|NCT00006372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25127880|NCT03052400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25127881|NCT03052400|Luteolytic Agents|luteolytic agents|mesh-ancestor
25127882|NCT03052400|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25127883|NCT03052400|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25127884|NCT03052361|Ondansetron|ondansetron|mesh-list
25127885|NCT03052361|Antiemetics|antiemetics|mesh-ancestor
24981629|NCT02317991|Tubulin Modulators|tubulin modulators|mesh-ancestor
24981630|NCT02317991|Antimitotic Agents|antimitotic agents|mesh-ancestor
24981631|NCT02317991|Mitosis Modulators|mitosis modulators|mesh-ancestor
24981632|NCT02317991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981635|NCT02260193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24981636|NCT02260193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981637|NCT02260193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981645|NCT02220985|Thiotepa|thiotepa|mesh-list
25404142|NCT03682068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830340|NCT00006372|Immunologic Factors|immunologic factors|mesh-ancestor
25830341|NCT00006372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830342|NCT00006372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25830343|NCT00006372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25830344|NCT00006372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25830345|NCT00006372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24949503|NCT04620382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24949504|NCT04620382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949515|NCT04603911|Dexamethasone|dexamethasone|mesh-list
24949516|NCT04603911|Clonidine|clonidine|mesh-list
24949517|NCT04603911|Epinephrine|epinephrine|mesh-list
24949524|NCT04603911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24949525|NCT04603911|Glucocorticoids|glucocorticoids|mesh-ancestor
24949526|NCT04603911|Hormones|hormones|mesh-ancestor
24573454|NCT00820053|Epirubicin|epirubicin|mesh-list
24879494|NCT04715633|Apatinib|apatinib|mesh-list
24981656|NCT02220985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127903|NCT03051932|Acetaminophen|acetaminophen|mesh-list
25657456|NCT01586962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25657457|NCT01586962|Respiratory System Agents|respiratory system agents|mesh-ancestor
25830346|NCT00006372|Tubulin Modulators|tubulin modulators|mesh-ancestor
24575743|NCT00833768|Sequestering Agents|sequestering agents|mesh-ancestor
24575895|NCT00835107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25830347|NCT00006372|Antimitotic Agents|antimitotic agents|mesh-ancestor
24949718|NCT03807765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028451|NCT03610685|Glucocorticoids|glucocorticoids|mesh-ancestor
24575896|NCT00835107|Serotonin Agents|serotonin agents|mesh-ancestor
24949759|NCT03733145|Angiotensin II|angiotensin ii|mesh-list
24949760|NCT03733145|Giapreza|giapreza|mesh-list
24949838|NCT03530800|Analgesics|analgesics|mesh-ancestor
25048091|NCT00743002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542064|NCT00676702|Pancrelipase|pancrelipase|mesh-list
24784070|NCT01905696|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25106186|NCT04229095|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25106187|NCT04229095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25106188|NCT04229095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106198|NCT04175886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25106230|NCT04031729|Aspirin|aspirin|mesh-list
24576071|NCT00836537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576072|NCT00836537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24576073|NCT00836576|Benazepril|benazepril|mesh-list
24576074|NCT00836576|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24576100|NCT00836823|Alfuzosin|alfuzosin|mesh-list
24950143|NCT02452983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24950144|NCT02452983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24950145|NCT02452983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950146|NCT02452983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24950148|NCT02452983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950150|NCT02348203|Zileuton|zileuton|mesh-list
24950151|NCT02348203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24950411|NCT03916432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24981777|NCT01832402|Sensory System Agents|sensory system agents|mesh-ancestor
24981778|NCT01832402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24981779|NCT01832402|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24981780|NCT01832402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24981781|NCT01832402|Anesthetics, General|anesthetics, general|mesh-ancestor
24981782|NCT01832402|Anesthetics|anesthetics|mesh-ancestor
24981783|NCT01759238|Bevacizumab|bevacizumab|mesh-list
24981784|NCT01759238|Capecitabine|capecitabine|mesh-list
24981785|NCT01759238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24981786|NCT01759238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24981804|NCT01320280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830354|NCT00006373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24950714|NCT03912727|Vitamins|vitamins|mesh-ancestor
24950729|NCT03912740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24950730|NCT03912740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950767|NCT03912415|Growth Substances|growth substances|mesh-ancestor
24950768|NCT03912415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576823|NCT00840580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24576825|NCT00840606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25128299|NCT03048942|Paclitaxel|paclitaxel|mesh-list
24784109|NCT01906125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24784110|NCT01906125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784111|NCT01906216|Sorafenib|sorafenib|mesh-list
24784112|NCT01906216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784113|NCT01906216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25657494|NCT01587001|Antioxidants|antioxidants|mesh-ancestor
24576947|NCT00841113|Hormone Antagonists|hormone antagonists|mesh-ancestor
24576948|NCT00841113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24576949|NCT00841113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576950|NCT00841126|Iron|iron|mesh-list
24576951|NCT00841126|Trace Elements|trace elements|mesh-ancestor
24576952|NCT00841126|Micronutrients|micronutrients|mesh-ancestor
24576954|NCT00841139|Perhexiline|perhexiline|mesh-list
24577172|NCT00842205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577182|NCT00842400|Renal Agents|renal agents|mesh-ancestor
24981922|NCT00852696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24981923|NCT00852696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24981924|NCT00852696|Cholinergic Agents|cholinergic agents|mesh-ancestor
25162428|NCT02904772|Prednisolone|prednisolone|mesh-list
24981944|NCT00788671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24981945|NCT00788671|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24981997|NCT04499950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24981998|NCT04499950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830371|NCT00006374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25830372|NCT00006374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25830373|NCT00006374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830374|NCT00006374|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25162429|NCT02904772|Cyclosporins|cyclosporins|mesh-list
24982026|NCT04454411|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25106275|NCT03573817|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25106276|NCT03573817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25106277|NCT03573817|Adrenergic Agents|adrenergic agents|mesh-ancestor
25106278|NCT03573817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25830384|NCT00006377|Antimitotic Agents|antimitotic agents|mesh-ancestor
24997625|NCT04550546|Nystatin|nystatin|mesh-list
25830385|NCT00006377|Mitosis Modulators|mitosis modulators|mesh-ancestor
25106291|NCT03117933|Paclitaxel|paclitaxel|mesh-list
25106292|NCT03117933|Olaparib|olaparib|mesh-list
25106293|NCT03117933|Cediranib|cediranib|mesh-list
25106294|NCT03117933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25106295|NCT03117933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106296|NCT03117933|Tubulin Modulators|tubulin modulators|mesh-ancestor
25830391|NCT00006378|Paclitaxel|paclitaxel|mesh-list
25162431|NCT02904772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162432|NCT02904772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25162433|NCT02904772|Immunologic Factors|immunologic factors|mesh-ancestor
25162434|NCT02904772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162435|NCT02904772|Antifungal Agents|antifungal agents|mesh-ancestor
25162436|NCT02904772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25162437|NCT02904772|Dermatologic Agents|dermatologic agents|mesh-ancestor
25162438|NCT02904772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24935587|NCT04049045|Empagliflozin|empagliflozin|mesh-list
25830395|NCT00006378|Tubulin Modulators|tubulin modulators|mesh-ancestor
24982074|NCT04266665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982075|NCT04266665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24982077|NCT04266665|Sensory System Agents|sensory system agents|mesh-ancestor
24982078|NCT04266665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24982079|NCT04266665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24982080|NCT04266665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24982085|NCT04259749|Menthol|menthol|mesh-list
24578221|NCT00847678|Amphotericin B|amphotericin b|mesh-list
25830397|NCT00006378|Mitosis Modulators|mitosis modulators|mesh-ancestor
24794068|NCT05414058|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24982136|NCT04221997|Antidepressive Agents|antidepressive agents|mesh-ancestor
24982137|NCT04221997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24982138|NCT04221997|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24982139|NCT04221997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24982140|NCT04221997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24578546|NCT00849459|Growth Inhibitors|growth inhibitors|mesh-ancestor
25830400|NCT00006379|Fludarabine|fludarabine|mesh-list
25830401|NCT00006379|Fludarabine phosphate|fludarabine phosphate|mesh-list
25830402|NCT00006379|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24982222|NCT03450629|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24982223|NCT03450629|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24982224|NCT03450629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25129148|NCT03043066|Antitubercular Agents|antitubercular agents|mesh-ancestor
25129149|NCT03043014|Misoprostol|misoprostol|mesh-list
24982225|NCT03450629|Adrenergic Agents|adrenergic agents|mesh-ancestor
24982226|NCT03450629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24474851|NCT00407719|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24982253|NCT03379727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25051993|NCT00356681|Growth Inhibitors|growth inhibitors|mesh-ancestor
25051994|NCT00356681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25830403|NCT00006379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25830404|NCT00006379|Immunologic Factors|immunologic factors|mesh-ancestor
25830405|NCT00006379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830406|NCT00006379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25830407|NCT00006379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25830408|NCT00006379|Alkylating Agents|alkylating agents|mesh-ancestor
25830413|NCT00006379|Antimetabolites|antimetabolites|mesh-ancestor
25830414|NCT00006380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25830415|NCT00006380|Antibodies|antibodies|mesh-list
25830416|NCT00006380|Immunoglobulins|immunoglobulins|mesh-list
25830417|NCT00006380|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25106412|NCT02790138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25106413|NCT02790138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25106414|NCT02790138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25106415|NCT02790138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106416|NCT02790138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830425|NCT00006381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25830426|NCT00006381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25106426|NCT02744053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830427|NCT00006381|Analgesics|analgesics|mesh-ancestor
25162477|NCT02904499|Antithrombins|antithrombins|mesh-ancestor
25830446|NCT00006384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830447|NCT00006384|Antiviral Agents|antiviral agents|mesh-ancestor
25129529|NCT03040401|Histamine|histamine|mesh-list
25830448|NCT00006384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25830449|NCT00006384|Immunologic Factors|immunologic factors|mesh-ancestor
25830450|NCT00006384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830451|NCT00006385|Interferons|interferons|mesh-list
25830452|NCT00006385|Interferon-alpha|interferon-alpha|mesh-list
25162484|NCT02904369|Emtricitabine|emtricitabine|mesh-list
25162485|NCT02904369|Antiviral Agents|antiviral agents|mesh-ancestor
24784370|NCT01907594|Antimetabolites|antimetabolites|mesh-ancestor
25830466|NCT00006388|Tamoxifen|tamoxifen|mesh-list
24580563|NCT00862329|Sequestering Agents|sequestering agents|mesh-ancestor
24581245|NCT00864799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24983269|NCT01512888|Busulfan|busulfan|mesh-list
24951299|NCT03905837|Narcotics|narcotics|mesh-ancestor
25830525|NCT00006397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24983400|NCT00085202|Vincristine|vincristine|mesh-list
24582161|NCT00868426|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24983658|NCT05182138|Zinc|zinc|mesh-list
24805310|NCT02008786|Ramipril|ramipril|mesh-list
24445479|NCT00301639|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24795907|NCT01946607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24583892|NCT00877422|Micronutrients|micronutrients|mesh-ancestor
24584043|NCT00878306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24584049|NCT00878306|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24984207|NCT04734535|Thrombin|thrombin|mesh-list
24585589|NCT00886275|Dexmedetomidine|dexmedetomidine|mesh-list
25830701|NCT00006453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24984594|NCT04356209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626295|NCT01086527|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24984828|NCT03988920|Chelating Agents|chelating agents|mesh-ancestor
25000853|NCT02906332|Growth Inhibitors|growth inhibitors|mesh-ancestor
25200395|NCT02734173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24576944|NCT00841113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24576945|NCT00841113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951615|NCT03902782|Dexamethasone|dexamethasone|mesh-list
25041308|NCT02580305|Donepezil|donepezil|mesh-list
24588544|NCT00903084|Tenofovir|tenofovir|mesh-list
25830934|NCT00006482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25831024|NCT00006591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25162694|NCT02902653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24589887|NCT00909519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24966796|NCT03765021|Tranexamic Acid|tranexamic acid|mesh-list
24966797|NCT03765021|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24966798|NCT03765021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24966799|NCT03765021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589940|NCT00909948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505775|NCT00542412|Riluzole|riluzole|mesh-list
24590155|NCT00910897|Bortezomib|bortezomib|mesh-list
24777475|NCT01864213|Tetracaine|tetracaine|mesh-list
24951823|NCT03900858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24600633|NCT00959621|Aspirin|aspirin|mesh-list
24591670|NCT00918177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591671|NCT00918177|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24591672|NCT00918177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591673|NCT00918177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24796393|NCT01949805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24924056|NCT04164264|Anesthetics|anesthetics|mesh-ancestor
24986333|NCT01854385|Sumatriptan|sumatriptan|mesh-list
24986334|NCT01854385|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24509972|NCT00562952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24509973|NCT00563017|Risperidone|risperidone|mesh-list
25162733|NCT02902354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049267|NCT00625651|Conatumumab|conatumumab|mesh-list
24591997|NCT00920088|Lopinavir|lopinavir|mesh-list
24951915|NCT03899337|Cyclophosphamide|cyclophosphamide|mesh-list
24593320|NCT00927875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24593519|NCT00929955|Simvastatin|simvastatin|mesh-list
24583748|NCT00876772|Olanzapine|olanzapine|mesh-list
24987617|NCT05190562|Zinc Sulfate|zinc sulfate|mesh-list
24596760|NCT00945347|Miglustat|miglustat|mesh-list
24597582|NCT00950105|Analgesics|analgesics|mesh-ancestor
25657853|NCT01590797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24863078|NCT03594162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863080|NCT03594162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25162898|NCT02901288|Ethambutol|ethambutol|mesh-list
25049483|NCT00602329|Leucovorin|leucovorin|mesh-list
25200930|NCT02730949|Micronutrients|micronutrients|mesh-ancestor
25200932|NCT02731040|Ibandronic Acid|ibandronic acid|mesh-list
24813646|NCT02059759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813647|NCT02059759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24517185|NCT00606450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24862514|NCT05143723|Hormones|hormones|mesh-list
25657949|NCT01592006|Ribavirin|ribavirin|mesh-list
24572457|NCT00815022|Morphine|morphine|mesh-list
24988676|NCT02017964|Carboplatin|carboplatin|mesh-list
25163007|NCT02900352|Zonisamide|zonisamide|mesh-list
24602142|NCT00967408|Citalopram|citalopram|mesh-list
24518168|NCT05330390|Anticonvulsants|anticonvulsants|mesh-ancestor
24609580|NCT00997399|Panobinostat|panobinostat|mesh-list
25202929|NCT02717871|Cyclopentolate|cyclopentolate|mesh-list
25658060|NCT01592708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25139386|NCT02971475|Sensory System Agents|sensory system agents|mesh-ancestor
24525001|NCT04115644|Anesthetics|anesthetics|mesh-ancestor
24814078|NCT02062255|Sensory System Agents|sensory system agents|mesh-ancestor
24865217|NCT04177654|Albendazole|albendazole|mesh-list
25139588|NCT02970097|Midazolam|midazolam|mesh-list
24865527|NCT01291004|Progestins|progestins|mesh-ancestor
25140113|NCT02966457|Colistin|colistin|mesh-list
25658120|NCT01592851|Fluorides|fluorides|mesh-list
24865835|NCT04891991|Infliximab|infliximab|mesh-list
24808504|NCT02027454|Antiviral Agents|antiviral agents|mesh-ancestor
25831798|NCT00008034|Capecitabine|capecitabine|mesh-list
24808813|NCT02029313|Montelukast|montelukast|mesh-list
24866543|NCT04702256|Histamine Agents|histamine agents|mesh-ancestor
25831989|NCT00008203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25054930|NCT03526107|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24809209|NCT02031965|Autonomic Agents|autonomic agents|mesh-ancestor
24867165|NCT03306979|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24867166|NCT03306979|Antiviral Agents|antiviral agents|mesh-ancestor
24938205|NCT04021017|Estrogens|estrogens|mesh-ancestor
25832015|NCT00008242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25832016|NCT00008242|Antiemetics|antiemetics|mesh-ancestor
25832017|NCT00008242|Autonomic Agents|autonomic agents|mesh-ancestor
25832018|NCT00008242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24991179|NCT02354703|Dermatologic Agents|dermatologic agents|mesh-ancestor
24991180|NCT02354703|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25832019|NCT00008242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832020|NCT00008242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25832021|NCT00008242|Glucocorticoids|glucocorticoids|mesh-ancestor
25832022|NCT00008242|Hormones|hormones|mesh-ancestor
25832023|NCT00008242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25832024|NCT00008242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25832025|NCT00008242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809302|NCT02032836|Vasodilator Agents|vasodilator agents|mesh-ancestor
24809303|NCT02032927|Acetaminophen|acetaminophen|mesh-list
24809304|NCT02032927|Oxycodone|oxycodone|mesh-list
24809305|NCT02032927|Codeine|codeine|mesh-list
24809306|NCT02032927|Naloxone|naloxone|mesh-list
24508055|NCT00554125|Sirolimus|sirolimus|mesh-list
24449674|NCT00316472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449675|NCT00316472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24449676|NCT00316472|Vasodilator Agents|vasodilator agents|mesh-ancestor
24449678|NCT00316498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449679|NCT00316498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449680|NCT00316498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24449681|NCT00316498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24449682|NCT00316498|Antiviral Agents|antiviral agents|mesh-ancestor
24449683|NCT00316498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24449684|NCT00316498|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24449685|NCT00316498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24449688|NCT00316563|Hallucinogens|hallucinogens|mesh-ancestor
25832062|NCT00008281|Antidotes|antidotes|mesh-ancestor
24867674|NCT03194165|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24867785|NCT00308516|Leucovorin|leucovorin|mesh-list
24991350|NCT05194904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24991351|NCT05194904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25201183|NCT02729935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201184|NCT02729935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25201185|NCT02729935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25201186|NCT02729935|Analgesics|analgesics|mesh-ancestor
25055071|NCT03524846|Protective Agents|protective agents|mesh-ancestor
25055072|NCT03524833|Amoxicillin|amoxicillin|mesh-list
25055073|NCT03524833|Metronidazole|metronidazole|mesh-list
24868156|NCT03202667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24865130|NCT04388501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25832185|NCT00008450|Antitubercular Agents|antitubercular agents|mesh-ancestor
25832186|NCT00008450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25832187|NCT00008463|Interferons|interferons|mesh-list
25832188|NCT00008463|Ribavirin|ribavirin|mesh-list
25832189|NCT00008463|Interferon-alpha|interferon-alpha|mesh-list
24996628|NCT03104413|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25832199|NCT00008476|Capsaicin|capsaicin|mesh-list
25832200|NCT00008476|Antipruritics|antipruritics|mesh-ancestor
25832201|NCT00008476|Dermatologic Agents|dermatologic agents|mesh-ancestor
25832202|NCT00008476|Sensory System Agents|sensory system agents|mesh-ancestor
25658341|NCT01594931|Pyronaridine|pyronaridine|mesh-list
25832248|NCT00008736|Autonomic Agents|autonomic agents|mesh-ancestor
25832249|NCT00008736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25658342|NCT01594931|Antimalarials|antimalarials|mesh-ancestor
25832250|NCT00008736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832251|NCT00008736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25832252|NCT00008736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25832253|NCT00008736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25142038|NCT02953106|Azelastine|azelastine|mesh-list
25142039|NCT02953106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25142040|NCT02953106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25142041|NCT02953106|Autonomic Agents|autonomic agents|mesh-ancestor
25142042|NCT02953106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25142043|NCT02953106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142044|NCT02953106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25163046|NCT02900105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24991387|NCT05193838|Protective Agents|protective agents|mesh-ancestor
24991389|NCT05193747|Anesthetics|anesthetics|mesh-list
25832261|NCT00008866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809401|NCT02033538|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25832262|NCT00008866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868463|NCT04560725|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24868464|NCT04560725|Nootropic Agents|nootropic agents|mesh-ancestor
24868465|NCT04549051|Anesthetics|anesthetics|mesh-list
24814600|NCT02065739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24868552|NCT04325659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055142|NCT03523754|Isosorbide|isosorbide|mesh-list
25142235|NCT02951962|Amlodipine|amlodipine|mesh-list
25142236|NCT02951962|Telmisartan|telmisartan|mesh-list
24821793|NCT02107950|Carboplatin|carboplatin|mesh-list
24821794|NCT02107950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411980|NCT00190580|Valsartan|valsartan|mesh-list
25832322|NCT00009191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832323|NCT00009204|Perphenazine|perphenazine|mesh-list
25832324|NCT00009204|Citalopram|citalopram|mesh-list
24809439|NCT02033707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25832349|NCT00009217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25142286|NCT02951234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25142287|NCT02951234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25142288|NCT02951234|Antipyretics|antipyretics|mesh-ancestor
25142289|NCT02951234|Immunologic Factors|immunologic factors|mesh-ancestor
25832350|NCT00009217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24991545|NCT05139875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24991546|NCT05139875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991547|NCT05139875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24868802|NCT02259517|Guanfacine|guanfacine|mesh-list
24868803|NCT02259517|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
24868830|NCT01147822|Sunitinib|sunitinib|mesh-list
25201229|NCT02729467|Antitubercular Agents|antitubercular agents|mesh-ancestor
25201230|NCT02729467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25201231|NCT02729467|Leprostatic Agents|leprostatic agents|mesh-ancestor
25201232|NCT02729467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25832374|NCT00009581|Acetylcholine|acetylcholine|mesh-list
25832384|NCT00009620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25832385|NCT00009620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832386|NCT00009620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25832387|NCT00009620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25832388|NCT00009620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25832389|NCT00009620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832390|NCT00009620|GABA Modulators|gaba modulators|mesh-ancestor
25832391|NCT00009620|GABA Agents|gaba agents|mesh-ancestor
24991740|NCT05032950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25832392|NCT00009620|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25832393|NCT00009620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25832416|NCT00009672|Morphine|morphine|mesh-list
25658378|NCT01595438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24869111|NCT04761614|Antimetabolites|antimetabolites|mesh-ancestor
25832480|NCT00009763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832481|NCT00009763|Immunologic Factors|immunologic factors|mesh-ancestor
25163056|NCT02899702|Immunologic Factors|immunologic factors|mesh-ancestor
25832482|NCT00009763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832483|NCT00009763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25832484|NCT00009763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24594187|NCT00933023|Hormones|hormones|mesh-ancestor
24991906|NCT04750824|Afatinib|afatinib|mesh-list
25658386|NCT01595438|Renal Agents|renal agents|mesh-ancestor
24869576|NCT02820961|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25832732|NCT00010049|Imatinib Mesylate|imatinib mesylate|mesh-list
25658398|NCT01595516|Kininogens|kininogens|mesh-list
24809621|NCT02035371|Insulin|insulin|mesh-list
25107661|NCT03138499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25107662|NCT03138499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24495343|NCT00499668|Dermatologic Agents|dermatologic agents|mesh-ancestor
24495344|NCT00499668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24495345|NCT00499668|Serotonin Agents|serotonin agents|mesh-ancestor
24495346|NCT00499668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24495348|NCT00499668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24797570|NCT01956604|Clonidine|clonidine|mesh-list
24809759|NCT02036125|Hormones|hormones|mesh-ancestor
24992944|NCT02303431|Edoxaban|edoxaban|mesh-list
24993052|NCT01358201|Cytarabine|cytarabine|mesh-list
25055704|NCT03518112|Immunoglobulins|immunoglobulins|mesh-list
24993351|NCT05110781|Atezolizumab|atezolizumab|mesh-list
24870960|NCT00983437|Modafinil|modafinil|mesh-list
24871037|NCT05163704|Adrenergic Agents|adrenergic agents|mesh-ancestor
25833129|NCT00011960|Paclitaxel|paclitaxel|mesh-list
25056083|NCT03515577|Chelating Agents|chelating agents|mesh-ancestor
24873448|NCT05222828|Mepivacaine|mepivacaine|mesh-list
25833495|NCT00012584|Antidepressive Agents|antidepressive agents|mesh-ancestor
24873642|NCT05101070|Pembrolizumab|pembrolizumab|mesh-list
25833542|NCT00013520|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25833543|NCT00013520|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25833544|NCT00013520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25833545|NCT00013520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25833546|NCT00013520|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25833547|NCT00013520|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25108006|NCT03135171|Pertuzumab|pertuzumab|mesh-list
25833549|NCT00013585|Selegiline|selegiline|mesh-list
24995056|NCT05418309|Paclitaxel|paclitaxel|mesh-list
25025118|NCT03639714|Nivolumab|nivolumab|mesh-list
24874368|NCT04777994|Mitogens|mitogens|mesh-list
24874432|NCT04751500|Oxytocics|oxytocics|mesh-ancestor
25833688|NCT00014118|Carboplatin|carboplatin|mesh-list
25658849|NCT01601132|Autonomic Agents|autonomic agents|mesh-ancestor
25833715|NCT00014196|Mitosis Modulators|mitosis modulators|mesh-ancestor
25833716|NCT00014196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658874|NCT01601535|Irinotecan|irinotecan|mesh-list
25658878|NCT01601535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201418|NCT02727881|Ranibizumab|ranibizumab|mesh-list
24983448|NCT05186649|Warfarin|warfarin|mesh-list
24876581|NCT03367741|Nivolumab|nivolumab|mesh-list
24877531|NCT02568553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24877532|NCT02568553|Lenalidomide|lenalidomide|mesh-list
24877533|NCT02568553|Blinatumomab|blinatumomab|mesh-list
25834166|NCT00015067|Dopamine Agents|dopamine agents|mesh-ancestor
25056667|NCT03510338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056668|NCT03510338|Urological Agents|urological agents|mesh-ancestor
25056669|NCT03510325|Olanzapine|olanzapine|mesh-list
25056670|NCT03510325|Risperidone|risperidone|mesh-list
25056671|NCT03510325|Aripiprazole|aripiprazole|mesh-list
25056672|NCT03510325|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24815697|NCT02071589|Tocolytic Agents|tocolytic agents|mesh-ancestor
24815698|NCT02071589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24879186|NCT04963530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659085|NCT01603602|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24879262|NCT04921943|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25834569|NCT00016042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25834613|NCT00016107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25834614|NCT00016107|Growth Substances|growth substances|mesh-ancestor
25834616|NCT00016107|Growth Inhibitors|growth inhibitors|mesh-ancestor
25056842|NCT03509168|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24811201|NCT02045667|Mexiletine|mexiletine|mesh-list
25835315|NCT00017225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25835363|NCT00017290|Immunologic Factors|immunologic factors|mesh-ancestor
25659296|NCT01606202|Nabiximols|nabiximols|mesh-list
25659297|NCT01606202|Analgesics|analgesics|mesh-ancestor
25835701|NCT00017992|Ritonavir|ritonavir|mesh-list
25659347|NCT01606319|Acetaminophen|acetaminophen|mesh-list
25030632|NCT03594240|Folic Acid|folic acid|mesh-list
25659370|NCT01606748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881796|NCT01239797|Lenalidomide|lenalidomide|mesh-list
25659405|NCT01607073|Verapamil|verapamil|mesh-list
25836268|NCT00019357|Aldesleukin|aldesleukin|mesh-list
25836335|NCT00019409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25836336|NCT00019422|Carboplatin|carboplatin|mesh-list
25836405|NCT00019513|Antidotes|antidotes|mesh-ancestor
25659459|NCT01607645|Cytarabine|cytarabine|mesh-list
24436162|NCT00269217|Niacin|niacin|mesh-list
24816173|NCT02074800|Siltuximab|siltuximab|mesh-list
25659490|NCT01607853|Vitamins|vitamins|mesh-ancestor
25837150|NCT00021034|Taurolidine|taurolidine|mesh-list
24883495|NCT05239286|Anesthetics|anesthetics|mesh-list
25838375|NCT00023699|Gefitinib|gefitinib|mesh-list
25659612|NCT01609933|Ribavirin|ribavirin|mesh-list
24859481|NCT02303847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24505247|NCT00540748|Oxytocin|oxytocin|mesh-list
24820103|NCT02098824|Methylphenidate|methylphenidate|mesh-list
24884183|NCT02813200|Hormones|hormones|mesh-ancestor
25058220|NCT03498326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859961|NCT02306889|Fenofibrate|fenofibrate|mesh-list
25838805|NCT00024336|Hormone Antagonists|hormone antagonists|mesh-ancestor
24860037|NCT02307305|Analgesics|analgesics|mesh-ancestor
25036814|NCT03542955|Etoricoxib|etoricoxib|mesh-list
25838872|NCT00024440|Oblimersen|oblimersen|mesh-list
25839037|NCT00025103|Carboplatin|carboplatin|mesh-list
24860408|NCT02309879|Lidocaine|lidocaine|mesh-list
25058840|NCT03492710|Antibodies|antibodies|mesh-list
25839439|NCT00025545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839727|NCT00026143|Antiviral Agents|antiviral agents|mesh-ancestor
25839728|NCT00026143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24933885|NCT04066296|Bupivacaine|bupivacaine|mesh-list
25839862|NCT00026364|Leucovorin|leucovorin|mesh-list
25839907|NCT00026403|Cisplatin|cisplatin|mesh-list
25839935|NCT00026442|Capecitabine|capecitabine|mesh-list
25839936|NCT00026442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25839937|NCT00026442|Antimetabolites|antimetabolites|mesh-ancestor
25839938|NCT00026442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839939|NCT00026442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839940|NCT00026468|Sulindac sulfone|sulindac sulfone|mesh-list
25839941|NCT00026468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839942|NCT00026468|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25839943|NCT00026468|Protective Agents|protective agents|mesh-ancestor
25839944|NCT00026468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938224|NCT04020653|Lumefantrine|lumefantrine|mesh-list
24813341|NCT02057926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24625860|NCT01083992|Protease Inhibitors|protease inhibitors|mesh-ancestor
24625861|NCT01083992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625862|NCT01083992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059562|NCT03487172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059563|NCT03487133|Dexamethasone|dexamethasone|mesh-list
25059565|NCT03487133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25059566|NCT03487133|Antiemetics|antiemetics|mesh-ancestor
25059567|NCT03487133|Autonomic Agents|autonomic agents|mesh-ancestor
25059568|NCT03487133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25059571|NCT03487133|Glucocorticoids|glucocorticoids|mesh-ancestor
24813374|NCT02058199|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24656962|NCT01264783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24656963|NCT01264783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24656964|NCT01264783|Analgesics|analgesics|mesh-ancestor
24656965|NCT01264783|Sensory System Agents|sensory system agents|mesh-ancestor
25839977|NCT00026533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25839978|NCT00026533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25839979|NCT00026533|Growth Substances|growth substances|mesh-ancestor
25839980|NCT00026533|Growth Inhibitors|growth inhibitors|mesh-ancestor
25839981|NCT00026533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839982|NCT00026585|Tamoxifen|tamoxifen|mesh-list
25659737|NCT01611090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659738|NCT01611090|Immunologic Factors|immunologic factors|mesh-ancestor
25659739|NCT01611090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659740|NCT01611090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25659741|NCT01611090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25659742|NCT01611090|Alkylating Agents|alkylating agents|mesh-ancestor
25659743|NCT01611090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659744|NCT01611155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25659745|NCT01611155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25839983|NCT00026585|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25839984|NCT00026585|Hormone Antagonists|hormone antagonists|mesh-ancestor
25875643|NCT04248829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059617|NCT03487003|Bromides|bromides|mesh-list
25059618|NCT03487003|Rocuronium|rocuronium|mesh-list
25059619|NCT03487003|Anticonvulsants|anticonvulsants|mesh-ancestor
25059620|NCT03487003|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25059621|NCT03487003|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25059622|NCT03487003|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25059623|NCT03487003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25059624|NCT03487003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509435|NCT00560300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24509437|NCT00560300|Antacids|antacids|mesh-ancestor
25839985|NCT00026585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25839986|NCT00026585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839987|NCT00026585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25839988|NCT00026585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839989|NCT00026585|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24451498|NCT00323947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24451500|NCT00323973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24682938|NCT01389388|Antimetabolites|antimetabolites|mesh-ancestor
24861307|NCT02316964|Aldesleukin|aldesleukin|mesh-list
24861308|NCT02316964|Decitabine|decitabine|mesh-list
24861309|NCT02316964|Azacitidine|azacitidine|mesh-list
24861310|NCT02316964|Interleukin-2|interleukin-2|mesh-list
24861311|NCT02316964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24861312|NCT02316964|Antimetabolites|antimetabolites|mesh-ancestor
24861313|NCT02316964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861314|NCT02316964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861315|NCT02316964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541623|NCT00674167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839990|NCT00026585|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25839991|NCT00026585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25659746|NCT01611155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25659747|NCT01611155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24657211|NCT01266187|Vitamins|vitamins|mesh-ancestor
25839992|NCT00026624|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
25840006|NCT00026819|Rofecoxib|rofecoxib|mesh-list
25840007|NCT00026819|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25840008|NCT00026819|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24541701|NCT00674687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541702|NCT00674687|Antimanic Agents|antimanic agents|mesh-ancestor
25840009|NCT00026819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059729|NCT03485625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25059730|NCT03485625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24509597|NCT00561106|Antiviral Agents|antiviral agents|mesh-ancestor
24861653|NCT02319278|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24861654|NCT02319278|Hematinics|hematinics|mesh-ancestor
24541789|NCT00675207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541791|NCT00675220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24541792|NCT00675220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541793|NCT00675246|Betamethasone|betamethasone|mesh-list
24541794|NCT00675246|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
24668518|NCT04889547|Hormones|hormones|mesh-ancestor
24861750|NCT02319941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24861751|NCT02319941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24861752|NCT02319941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24861753|NCT02319941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24861754|NCT02319941|Purinergic Agents|purinergic agents|mesh-ancestor
24861755|NCT02319941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24541809|NCT00675285|Respiratory System Agents|respiratory system agents|mesh-ancestor
25840018|NCT00026819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25840019|NCT00026962|Estradiol|estradiol|mesh-list
25840020|NCT00026962|Progesterone|progesterone|mesh-list
25840021|NCT00026962|Estrogens|estrogens|mesh-ancestor
25840022|NCT00026962|Hormones|hormones|mesh-ancestor
25840023|NCT00026962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25003306|NCT03830866|Durvalumab|durvalumab|mesh-list
25840024|NCT00026962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840025|NCT00026962|Progestins|progestins|mesh-ancestor
25840026|NCT00027014|Fentanyl|fentanyl|mesh-list
25840027|NCT00027014|Oxycodone|oxycodone|mesh-list
25840028|NCT00027014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25163339|NCT02897037|Heparin|heparin|mesh-list
25840029|NCT00027014|Narcotics|narcotics|mesh-ancestor
25840030|NCT00027014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25840031|NCT00027014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840032|NCT00027014|Analgesics|analgesics|mesh-ancestor
25840033|NCT00027014|Sensory System Agents|sensory system agents|mesh-ancestor
24509680|NCT00561613|Spermatocidal Agents|spermatocidal agents|mesh-list
24885112|NCT02593123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885113|NCT02593123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24885114|NCT02593123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885115|NCT02593123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24885116|NCT02593123|Antitubercular Agents|antitubercular agents|mesh-ancestor
25059755|NCT03485456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24822054|NCT02109614|Vitamins|vitamins|mesh-ancestor
24885117|NCT02593123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24885118|NCT02593123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24464171|NCT00363610|Pegaspargase|pegaspargase|mesh-list
25840034|NCT00027014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25840035|NCT00027014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25840036|NCT00027014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25840037|NCT00027014|Anesthetics, General|anesthetics, general|mesh-ancestor
25840038|NCT00027014|Anesthetics|anesthetics|mesh-ancestor
25840039|NCT00027040|Selegiline|selegiline|mesh-list
25840040|NCT00027040|Antidepressive Agents|antidepressive agents|mesh-ancestor
25840041|NCT00027040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25840042|NCT00027040|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25840043|NCT00027040|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25840044|NCT00027040|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25840045|NCT00027040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24509755|NCT00562055|Antidepressive Agents|antidepressive agents|mesh-ancestor
25840050|NCT00027053|Trazodone|trazodone|mesh-list
24509880|NCT00562419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25003717|NCT03113422|Venetoclax|venetoclax|mesh-list
24541858|NCT00675701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24861929|NCT02321384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24885152|NCT01964807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24885153|NCT01964807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885154|NCT01964807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25059782|NCT03485300|Warfarin|warfarin|mesh-list
24813435|NCT02058485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24813436|NCT02058485|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24813437|NCT02058485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24813438|NCT02058485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24510012|NCT00563069|Anesthetics|anesthetics|mesh-ancestor
25840061|NCT00027053|Serotonin Agents|serotonin agents|mesh-ancestor
25840062|NCT00027053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25840063|NCT00027053|Antidepressive Agents|antidepressive agents|mesh-ancestor
25840064|NCT00027066|Aspirin|aspirin|mesh-list
24942445|NCT03980990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24935470|NCT04050059|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24935471|NCT04050059|Anesthetics, Local|anesthetics, local|mesh-ancestor
24935472|NCT04050059|Anesthetics|anesthetics|mesh-ancestor
25840065|NCT00027066|Warfarin|warfarin|mesh-list
25840066|NCT00027066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24645103|NCT01195766|Ofatumumab|ofatumumab|mesh-list
25840067|NCT00027066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24444663|NCT00298857|Anticonvulsants|anticonvulsants|mesh-ancestor
25840068|NCT00027066|Analgesics|analgesics|mesh-ancestor
24862114|NCT02323230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24862115|NCT02323230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24862116|NCT02323269|Dimethyl Fumarate|dimethyl fumarate|mesh-list
24862117|NCT02323269|Dermatologic Agents|dermatologic agents|mesh-ancestor
24862118|NCT02323269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24862119|NCT02323269|Immunologic Factors|immunologic factors|mesh-ancestor
24862120|NCT02323269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542005|NCT00676416|Propofol|propofol|mesh-list
25840069|NCT00027066|Sensory System Agents|sensory system agents|mesh-ancestor
25840070|NCT00027066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25840071|NCT00027066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840072|NCT00027066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25840073|NCT00027066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24862131|NCT02323347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24542018|NCT00676429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25052121|NCT00327743|Capecitabine|capecitabine|mesh-list
24542019|NCT00676429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24542023|NCT00676429|Dopamine Agents|dopamine agents|mesh-ancestor
24850267|NCT02252497|Hemostatics|hemostatics|mesh-ancestor
24531741|NCT00637065|Bosentan|bosentan|mesh-list
25840076|NCT00027066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542035|NCT00676533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24542036|NCT00676533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24542037|NCT00676533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24862156|NCT02323399|Protective Agents|protective agents|mesh-ancestor
24862158|NCT02323412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24862159|NCT02323412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24862177|NCT02323451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862178|NCT02323451|Viscosupplements|viscosupplements|mesh-ancestor
24862179|NCT02323451|Protective Agents|protective agents|mesh-ancestor
24862180|NCT02323451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24862181|NCT02323451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24862182|NCT02323451|Antimetabolites|antimetabolites|mesh-ancestor
24850766|NCT02253953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24862183|NCT02323451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862184|NCT02323451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24862185|NCT02323451|Chelating Agents|chelating agents|mesh-ancestor
25163343|NCT02897037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24862186|NCT02323451|Sequestering Agents|sequestering agents|mesh-ancestor
24812145|NCT02049970|Sensory System Agents|sensory system agents|mesh-ancestor
24850534|NCT02253446|Sensory System Agents|sensory system agents|mesh-ancestor
24862202|NCT02323516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862203|NCT02323516|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24862204|NCT02323516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24862205|NCT02323516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24862206|NCT02323516|Antipyretics|antipyretics|mesh-ancestor
24862207|NCT02323516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24862209|NCT02323529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542063|NCT00676702|Vitamin K|vitamin k|mesh-list
24451588|NCT00324363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840077|NCT00027066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25840078|NCT00027066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25840079|NCT00027066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885212|NCT01481272|Abortifacient Agents|abortifacient agents|mesh-ancestor
24451589|NCT00324363|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24451590|NCT00324363|Incretins|incretins|mesh-ancestor
24451591|NCT00324363|Hormones|hormones|mesh-ancestor
24451592|NCT00324363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24451593|NCT00324376|Sevelamer|sevelamer|mesh-list
24451594|NCT00324376|Chelating Agents|chelating agents|mesh-ancestor
24451595|NCT00324376|Sequestering Agents|sequestering agents|mesh-ancestor
24451596|NCT00324376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451597|NCT00324389|Interferons|interferons|mesh-list
24451598|NCT00324389|Interferon-alpha|interferon-alpha|mesh-list
24451599|NCT00324389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451600|NCT00324389|Antiviral Agents|antiviral agents|mesh-ancestor
24850586|NCT02253784|Dexamethasone|dexamethasone|mesh-list
24451601|NCT00324389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24451602|NCT00324389|Immunologic Factors|immunologic factors|mesh-ancestor
24451604|NCT00324454|Levetiracetam|levetiracetam|mesh-list
24935325|NCT04051853|Anesthetics, General|anesthetics, general|mesh-ancestor
24850587|NCT02253784|Bupivacaine|bupivacaine|mesh-list
24850769|NCT02253953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25840086|NCT00027079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840087|NCT00027079|Sensory System Agents|sensory system agents|mesh-ancestor
25840088|NCT00027079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25659801|NCT01611857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25659802|NCT01611857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659803|NCT01611857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25840089|NCT00027079|Antiemetics|antiemetics|mesh-ancestor
25840090|NCT00027079|Autonomic Agents|autonomic agents|mesh-ancestor
25840091|NCT00027079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25840092|NCT00027079|Antipruritics|antipruritics|mesh-ancestor
25840093|NCT00027079|Dermatologic Agents|dermatologic agents|mesh-ancestor
25840094|NCT00027079|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25840095|NCT00027079|Serotonin Agents|serotonin agents|mesh-ancestor
25840096|NCT00027079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25840097|NCT00027079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840098|NCT00027079|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25840099|NCT00027079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24885242|NCT01380028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059872|NCT03484507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25059873|NCT03484507|Disinfectants|disinfectants|mesh-ancestor
24943728|NCT03967496|Hydralazine|hydralazine|mesh-list
25059906|NCT03484221|Oxaliplatin|oxaliplatin|mesh-list
25059907|NCT03484221|Irinotecan|irinotecan|mesh-list
25059908|NCT03484221|Antimetabolites|antimetabolites|mesh-ancestor
25201525|NCT02727205|Rotigotine|rotigotine|mesh-list
24862243|NCT02323906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24862245|NCT02323906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862246|NCT02323971|Ticagrelor|ticagrelor|mesh-list
24862247|NCT02323971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24862248|NCT02323971|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24850902|NCT02254187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840109|NCT00027287|Antioxidants|antioxidants|mesh-ancestor
25659812|NCT01611935|Arginine Vasopressin|arginine vasopressin|mesh-list
25840110|NCT00027287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840111|NCT00027287|Protective Agents|protective agents|mesh-ancestor
24851120|NCT02255578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24851123|NCT02255578|Fertility Agents|fertility agents|mesh-ancestor
24542119|NCT00677001|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25840112|NCT00027300|Natalizumab|natalizumab|mesh-list
25840113|NCT00027300|Immunologic Factors|immunologic factors|mesh-ancestor
24862285|NCT02324166|Lidocaine|lidocaine|mesh-list
24862286|NCT02324166|Anesthetics, Local|anesthetics, local|mesh-ancestor
24862287|NCT02324166|Anesthetics|anesthetics|mesh-ancestor
24862288|NCT02324166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24862289|NCT02324166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862290|NCT02324166|Sensory System Agents|sensory system agents|mesh-ancestor
24862291|NCT02324166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24862292|NCT02324166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24862293|NCT02324166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24862294|NCT02324166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24862295|NCT02324166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24542120|NCT00677001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542121|NCT00677001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542122|NCT00677027|Lentinan|lentinan|mesh-list
24542123|NCT00677027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24542124|NCT00677027|Immunologic Factors|immunologic factors|mesh-ancestor
24542125|NCT00677027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542126|NCT00677027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542127|NCT00677118|Cisplatin|cisplatin|mesh-list
24862333|NCT02324452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862334|NCT02324452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25060012|NCT03483389|Ethanol|ethanol|mesh-list
25163354|NCT02897011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25163355|NCT02897011|Antimetabolites|antimetabolites|mesh-ancestor
25163356|NCT02897011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163357|NCT02897011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163358|NCT02897011|Dermatologic Agents|dermatologic agents|mesh-ancestor
25163359|NCT02897011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163365|NCT02896621|Amlodipine|amlodipine|mesh-list
24952978|NCT03890094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24514799|NCT00593008|Sirolimus|sirolimus|mesh-list
24542182|NCT00677339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456467|NCT00331214|Androgens|androgens|mesh-ancestor
24862374|NCT02324933|Sensory System Agents|sensory system agents|mesh-ancestor
24862375|NCT02324933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24862376|NCT02324933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24862377|NCT02324933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24862378|NCT02324933|Anesthetics, General|anesthetics, general|mesh-ancestor
24542183|NCT00677339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24542184|NCT00677339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24542185|NCT00677391|Sibutramine|sibutramine|mesh-list
24542186|NCT00677391|Antidepressive Agents|antidepressive agents|mesh-ancestor
24542187|NCT00677391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24542188|NCT00677391|Appetite Depressants|appetite depressants|mesh-ancestor
24542189|NCT00677391|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24542190|NCT00677443|Capecitabine|capecitabine|mesh-list
25840135|NCT00027391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25840136|NCT00027391|Autonomic Agents|autonomic agents|mesh-ancestor
25840137|NCT00027391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24862383|NCT02324998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862384|NCT02324998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24862385|NCT02325011|Fluconazole|fluconazole|mesh-list
24862386|NCT02325011|Nabiximols|nabiximols|mesh-list
24862387|NCT02325011|Dronabinol|dronabinol|mesh-list
24862388|NCT02325011|Cannabidiol|cannabidiol|mesh-list
24862389|NCT02325011|Antifungal Agents|antifungal agents|mesh-ancestor
24862390|NCT02325011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25163407|NCT02896582|Antiviral Agents|antiviral agents|mesh-ancestor
24982783|NCT00400218|Diuretics|diuretics|mesh-ancestor
24862398|NCT02325011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862399|NCT02325011|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25659818|NCT01611935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414915|NCT03033758|Adrenergic Agents|adrenergic agents|mesh-ancestor
25840138|NCT00027391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464416|NCT00364806|Antiemetics|antiemetics|mesh-ancestor
24862400|NCT02325011|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25840144|NCT00027391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25840145|NCT00027391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25840146|NCT00027391|Adrenergic Agents|adrenergic agents|mesh-ancestor
25840147|NCT00027391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25840148|NCT00027391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840149|NCT00027391|Androgens|androgens|mesh-ancestor
25840150|NCT00027391|Hormones|hormones|mesh-ancestor
25840151|NCT00027391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24532505|NCT00640159|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24862411|NCT02325011|Hormones|hormones|mesh-ancestor
24862412|NCT02325024|Nabiximols|nabiximols|mesh-list
24862413|NCT02325024|Analgesics|analgesics|mesh-ancestor
24862414|NCT02325024|Sensory System Agents|sensory system agents|mesh-ancestor
24862415|NCT02325024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24862416|NCT02325024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862417|NCT02325063|Botulinum Toxins|botulinum toxins|mesh-list
24862418|NCT02325063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24862419|NCT02325063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24862449|NCT02325362|Antiviral Agents|antiviral agents|mesh-ancestor
24862450|NCT02325362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24862451|NCT02325362|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24862452|NCT02325362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24542239|NCT00677755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24542240|NCT00677755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542241|NCT00677755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24542242|NCT00677755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24542243|NCT00677755|Oxytocics|oxytocics|mesh-ancestor
25659827|NCT01611948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510869|NCT00566124|Insulin|insulin|mesh-list
25840152|NCT00027391|Anabolic Agents|anabolic agents|mesh-ancestor
25840153|NCT00027404|Fluoxetine|fluoxetine|mesh-list
25840154|NCT00027404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25840155|NCT00027404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25840156|NCT00027404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25840157|NCT00027404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840158|NCT00027404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24862487|NCT02325882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24542280|NCT00678145|Sensory System Agents|sensory system agents|mesh-ancestor
25840159|NCT00027404|Serotonin Agents|serotonin agents|mesh-ancestor
25840160|NCT00027404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840161|NCT00027404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25840162|NCT00027404|Antidepressive Agents|antidepressive agents|mesh-ancestor
25840163|NCT00027404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25840164|NCT00027404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25060092|NCT03482544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25060093|NCT03482544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25060094|NCT03482544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25060095|NCT03482544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25060096|NCT03482544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25060097|NCT03482492|Acetaminophen|acetaminophen|mesh-list
25060098|NCT03482492|Tramadol|tramadol|mesh-list
25060099|NCT03482492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25060100|NCT03482492|Analgesics|analgesics|mesh-ancestor
25060101|NCT03482492|Sensory System Agents|sensory system agents|mesh-ancestor
25060102|NCT03482492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24862506|NCT02325934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24862507|NCT02325934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24862508|NCT02325934|Antiviral Agents|antiviral agents|mesh-ancestor
25840190|NCT00027495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840191|NCT00027495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163409|NCT02896582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25163410|NCT02896582|Immunologic Factors|immunologic factors|mesh-ancestor
25163411|NCT02896582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25840210|NCT00027547|Fludarabine|fludarabine|mesh-list
25840211|NCT00027547|Cyclosporins|cyclosporins|mesh-list
25060129|NCT03482232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25060130|NCT03482232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25060131|NCT03482232|Hypolipidemic Agents|hypolipidemic agents|mesh-list
24862530|NCT05143281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24862548|NCT05142865|Etoposide|etoposide|mesh-list
24885529|NCT05164653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24885530|NCT05164653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24796340|NCT01949454|Hormones|hormones|mesh-ancestor
24862646|NCT04850222|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24862647|NCT04850222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24862648|NCT04850222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24862649|NCT04850222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862650|NCT04850222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24862651|NCT04850222|Serotonin Agents|serotonin agents|mesh-ancestor
24862653|NCT04850222|Antidepressive Agents|antidepressive agents|mesh-ancestor
24885717|NCT04671030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24885814|NCT04537026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24885816|NCT04537026|Hormones|hormones|mesh-ancestor
24885817|NCT04537026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24885819|NCT04537026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659854|NCT01612221|Antioxidants|antioxidants|mesh-ancestor
24862759|NCT04532502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862760|NCT04532502|Anesthetics, General|anesthetics, general|mesh-ancestor
24862761|NCT04496908|Misoprostol|misoprostol|mesh-list
24862774|NCT04384107|Immunologic Factors|immunologic factors|mesh-ancestor
24862775|NCT04384107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862776|NCT04382924|Ifenprodil|ifenprodil|mesh-list
24862777|NCT04382924|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24862778|NCT04382924|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24862927|NCT04034459|Micronutrients|micronutrients|mesh-ancestor
24862928|NCT04034459|Hematinics|hematinics|mesh-ancestor
24862929|NCT04030052|Factor VIII|factor viii|mesh-list
24862930|NCT04030052|Coagulants|coagulants|mesh-ancestor
24862931|NCT04005729|Cangrelor|cangrelor|mesh-list
24862932|NCT04005729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24862933|NCT04005729|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24862934|NCT04005729|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24862935|NCT04005729|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24862936|NCT04005729|Purinergic Agents|purinergic agents|mesh-ancestor
25840244|NCT00027573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25840245|NCT00027573|Alkylating Agents|alkylating agents|mesh-ancestor
24862967|NCT03823534|Acetaminophen|acetaminophen|mesh-list
24862968|NCT03823534|Ketorolac|ketorolac|mesh-list
24862969|NCT03823534|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
24542772|NCT00680329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24542773|NCT00680329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24542774|NCT00680355|Carotenoids|carotenoids|mesh-list
24862995|NCT03812991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862996|NCT03812991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24862997|NCT03812991|Vasodilator Agents|vasodilator agents|mesh-ancestor
24862998|NCT03779243|Melatonin|melatonin|mesh-list
24863003|NCT03779243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24863004|NCT03757013|Apremilast|apremilast|mesh-list
24863005|NCT03757013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24863006|NCT03757013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24863007|NCT03757013|Analgesics|analgesics|mesh-ancestor
24863008|NCT03757013|Sensory System Agents|sensory system agents|mesh-ancestor
24863009|NCT03757013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24863010|NCT03757013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840256|NCT00027573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24464914|NCT00367302|Buprenorphine|buprenorphine|mesh-list
24886089|NCT03387774|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24475530|NCT00410657|Hormones|hormones|mesh-ancestor
24806295|NCT02014831|Cetuximab|cetuximab|mesh-list
24806361|NCT02015403|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25840384|NCT00027820|Mycophenolic Acid|mycophenolic acid|mesh-list
24806941|NCT02018965|Niacin|niacin|mesh-list
24477034|NCT00417053|Melphalan|melphalan|mesh-list
24816528|NCT02077556|Antiemetics|antiemetics|mesh-ancestor
24886966|NCT04521491|Immunologic Factors|immunologic factors|mesh-ancestor
25060700|NCT03477864|Ipilimumab|ipilimumab|mesh-list
24887510|NCT04515979|Pembrolizumab|pembrolizumab|mesh-list
25060735|NCT03477344|Adrenergic Agents|adrenergic agents|mesh-ancestor
24512605|NCT00575861|Analgesics|analgesics|mesh-ancestor
25006889|NCT04549376|Iodine|iodine|mesh-list
24479639|NCT00427570|Alkylating Agents|alkylating agents|mesh-ancestor
25840696|NCT00028405|Talaporfin|talaporfin|mesh-list
25840755|NCT00028561|Carboplatin|carboplatin|mesh-list
24667730|NCT05320107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24482598|NCT00439972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25061094|NCT03473964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061330|NCT03472261|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25660140|NCT01617447|Antidepressive Agents|antidepressive agents|mesh-ancestor
24486818|NCT00460226|Lamotrigine|lamotrigine|mesh-list
25840932|NCT00028756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24488574|NCT00469430|Metronidazole|metronidazole|mesh-list
24490066|NCT00476216|Anticoagulants|anticoagulants|mesh-ancestor
25163898|NCT05426486|Carboplatin|carboplatin|mesh-list
25163919|NCT05425914|Vitamin D|vitamin d|mesh-list
24492249|NCT00485771|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24893295|NCT04452214|Pembrolizumab|pembrolizumab|mesh-list
25163971|NCT05425576|Pembrolizumab|pembrolizumab|mesh-list
24893904|NCT04446091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824490|NCT02123615|Antibodies|antibodies|mesh-list
24496602|NCT00505700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24894473|NCT04440267|Glucocorticoids|glucocorticoids|mesh-ancestor
24513837|NCT00585559|Acetaminophen|acetaminophen|mesh-list
24497696|NCT00511446|Capecitabine|capecitabine|mesh-list
24497697|NCT00511446|Oxaliplatin|oxaliplatin|mesh-list
24498440|NCT00514618|Oxytocics|oxytocics|mesh-ancestor
24894825|NCT05387187|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24498792|NCT00516399|Natamycin|natamycin|mesh-list
24472042|NCT00397800|Fludarabine phosphate|fludarabine phosphate|mesh-list
24499919|NCT00521612|Isoflurane|isoflurane|mesh-list
24896028|NCT02601313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25841455|NCT00030407|Sensory System Agents|sensory system agents|mesh-ancestor
25841456|NCT00030407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24896098|NCT02378805|Ramipril|ramipril|mesh-list
24896348|NCT04437654|Apixaban|apixaban|mesh-list
24606020|NCT00988715|Cyclosporine|cyclosporine|mesh-list
25062666|NCT04231877|Hormones|hormones|mesh-ancestor
24504737|NCT00537966|Dolutegravir|dolutegravir|mesh-list
24504738|NCT00537966|Abacavir|abacavir|mesh-list
25841725|NCT00030849|Bexarotene|bexarotene|mesh-list
24953223|NCT03887416|Dapagliflozin|dapagliflozin|mesh-list
24504989|NCT00538876|Antimetabolites|antimetabolites|mesh-ancestor
24516085|NCT00600587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841814|NCT00031070|Immunologic Factors|immunologic factors|mesh-ancestor
25062916|NCT03449901|Gemcitabine|gemcitabine|mesh-list
24410265|NCT00184977|Xhance|xhance|mesh-list
24461549|NCT00352625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841862|NCT00031148|Mitosis Modulators|mitosis modulators|mesh-ancestor
25841911|NCT00031317|GABA Agents|gaba agents|mesh-ancestor
25841920|NCT00031395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25841923|NCT00031395|Dopamine Agents|dopamine agents|mesh-ancestor
24474337|NCT00405717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25063133|NCT03112044|Antiviral Agents|antiviral agents|mesh-ancestor
25041544|NCT02488408|Cytarabine|cytarabine|mesh-list
24630483|NCT01111942|Cisplatin|cisplatin|mesh-list
25063298|NCT02186847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25842015|NCT00031655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475578|NCT00410787|Hydromorphone|hydromorphone|mesh-list
24475777|NCT00411333|Immunologic Factors|immunologic factors|mesh-ancestor
25063443|NCT00753532|Tocotrienols|tocotrienols|mesh-list
24825999|NCT02131506|Doxorubicin|doxorubicin|mesh-list
24396230|NCT00138177|Vitamins|vitamins|mesh-ancestor
24524491|NCT04807348|Metformin|metformin|mesh-list
24899736|NCT04400916|Hemostatics|hemostatics|mesh-ancestor
24899939|NCT04398771|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24900189|NCT04396743|Clotrimazole|clotrimazole|mesh-list
24518596|NCT04786275|Anesthetics, General|anesthetics, general|mesh-ancestor
24518598|NCT04785651|Tranexamic Acid|tranexamic acid|mesh-list
24900693|NCT04391998|Tubulin Modulators|tubulin modulators|mesh-ancestor
24900694|NCT04391998|Antimitotic Agents|antimitotic agents|mesh-ancestor
25063966|NCT03464435|Tobramycin|tobramycin|mesh-list
24903030|NCT04367831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24903032|NCT04367818|Anesthetics|anesthetics|mesh-list
24399464|NCT00147875|Doxorubicin|doxorubicin|mesh-list
24399465|NCT00147875|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24399466|NCT00147875|Vinblastine|vinblastine|mesh-list
25842331|NCT00032084|Nicotine|nicotine|mesh-list
25842332|NCT00032084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25842333|NCT00032084|Autonomic Agents|autonomic agents|mesh-ancestor
25842334|NCT00032084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25201857|NCT02724904|Antimetabolites|antimetabolites|mesh-ancestor
25201859|NCT02724904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24909477|NCT04308317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24484329|NCT00447759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484330|NCT00447759|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25165192|NCT05011123|Vaccines|vaccines|mesh-list
24911419|NCT04288349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065188|NCT03452475|Artemether|artemether|mesh-list
24912063|NCT04281628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24401876|NCT00154180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24401878|NCT00154180|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24401879|NCT00154180|Contraceptive Agents|contraceptive agents|mesh-ancestor
24401880|NCT00154180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25842480|NCT00032786|Natalizumab|natalizumab|mesh-list
25093325|NCT03235869|Durvalumab|durvalumab|mesh-list
24912344|NCT04276649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24912346|NCT04276636|Antacids|antacids|mesh-ancestor
24912786|NCT04272320|Bupivacaine|bupivacaine|mesh-list
24913575|NCT04262999|Anticonvulsants|anticonvulsants|mesh-ancestor
25165322|NCT04927780|Vitamins|vitamins|mesh-ancestor
25842637|NCT00033098|Metyrapone|metyrapone|mesh-list
24837511|NCT02191709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24910534|NCT04296578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064812|NCT03456661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24403094|NCT00159224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842654|NCT00033163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25842660|NCT00033176|Thioctic Acid|thioctic acid|mesh-list
24838468|NCT02198170|Lenvatinib|lenvatinib|mesh-list
25842681|NCT00033241|Antimetabolites|antimetabolites|mesh-ancestor
24403785|NCT00161486|Anabolic Agents|anabolic agents|mesh-ancestor
24403902|NCT00162110|Cetuximab|cetuximab|mesh-list
24811526|NCT02047136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24811527|NCT02047136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842784|NCT00033358|Contraceptive Agents|contraceptive agents|mesh-ancestor
25064962|NCT03455049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25064963|NCT03455049|Antiviral Agents|antiviral agents|mesh-ancestor
25064964|NCT03455049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24843215|NCT02226328|Anesthetics|anesthetics|mesh-ancestor
25099278|NCT03192644|Antidotes|antidotes|mesh-ancestor
25203381|NCT02714699|Analgesics|analgesics|mesh-ancestor
24844614|NCT02233452|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24874111|NCT04920981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24844817|NCT02234544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844818|NCT02234544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24844819|NCT02234739|Voriconazole|voriconazole|mesh-list
24844820|NCT02234739|Antifungal Agents|antifungal agents|mesh-ancestor
25661219|NCT01631825|Dopamine Agents|dopamine agents|mesh-ancestor
25661220|NCT01631825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25661221|NCT01631825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661222|NCT01631825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661223|NCT01631864|Amlodipine|amlodipine|mesh-list
25661224|NCT01631864|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25661225|NCT01631864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25661226|NCT01631864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25842845|NCT00033553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24845107|NCT02236169|Bromides|bromides|mesh-list
25165503|NCT04766996|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25165543|NCT04752696|Leucovorin|leucovorin|mesh-list
24845875|NCT02239900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758953|NCT01748630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24847559|NCT02247596|Antioxidants|antioxidants|mesh-ancestor
24847560|NCT02247596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847561|NCT02247596|Protective Agents|protective agents|mesh-ancestor
24811766|NCT02048293|Sensory System Agents|sensory system agents|mesh-ancestor
24811767|NCT02048293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24811768|NCT02048319|Ethanol|ethanol|mesh-list
24811769|NCT02048319|Pasireotide|pasireotide|mesh-list
24811770|NCT02048319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24811771|NCT02048319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24811772|NCT02048319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24405679|NCT00167921|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24405680|NCT00167921|Estrogens|estrogens|mesh-ancestor
24405705|NCT00167960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24405706|NCT00167960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24405707|NCT00167960|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24405708|NCT00167960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405709|NCT00167960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405710|NCT00167986|Vancomycin|vancomycin|mesh-list
24405711|NCT00167986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24405712|NCT00167986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24911120|NCT04290793|Taxane|taxane|mesh-list
24405808|NCT00168467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24405812|NCT00168480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25842879|NCT00033618|Epothilone B|epothilone b|mesh-list
25842880|NCT00033618|Tubulin Modulators|tubulin modulators|mesh-ancestor
25842881|NCT00033618|Antimitotic Agents|antimitotic agents|mesh-ancestor
25842882|NCT00033618|Mitosis Modulators|mitosis modulators|mesh-ancestor
24405817|NCT00168480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405818|NCT00168480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24405819|NCT00168480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24405820|NCT00168493|Antidepressive Agents|antidepressive agents|mesh-list
24405835|NCT00168519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405836|NCT00168532|Trimethoprim|trimethoprim|mesh-list
24405837|NCT00168532|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24405838|NCT00168532|Sulfamethoxazole|sulfamethoxazole|mesh-list
24405839|NCT00168532|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24405840|NCT00168532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24405841|NCT00168532|Renal Agents|renal agents|mesh-ancestor
24405842|NCT00168532|Antimalarials|antimalarials|mesh-ancestor
24405843|NCT00168532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25842883|NCT00033618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405844|NCT00168532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24405845|NCT00168532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24405846|NCT00168532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405847|NCT00168532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842889|NCT00033644|Mitomycin|mitomycin|mesh-list
24405891|NCT00168714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100979|NCT03178539|Ketorolac|ketorolac|mesh-list
25842890|NCT00033644|Dacarbazine|dacarbazine|mesh-list
25842891|NCT00033644|Sargramostim|sargramostim|mesh-list
25842892|NCT00033644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842893|NCT00033644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25842894|NCT00033644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25842895|NCT00033644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25101081|NCT03177980|Anesthetics|anesthetics|mesh-ancestor
25842896|NCT00033644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811803|NCT02048384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24811804|NCT02048384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24811805|NCT02048384|Antifungal Agents|antifungal agents|mesh-ancestor
24811806|NCT02048384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24811807|NCT02048384|Immunologic Factors|immunologic factors|mesh-ancestor
24811808|NCT02048423|Ketamine|ketamine|mesh-list
24811809|NCT02048423|Analgesics|analgesics|mesh-ancestor
24811810|NCT02048423|Sensory System Agents|sensory system agents|mesh-ancestor
24702541|NCT01466478|Calcitriol|calcitriol|mesh-list
24811894|NCT02048865|Antithrombins|antithrombins|mesh-ancestor
24811895|NCT02048865|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25101342|NCT03175705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24541357|NCT00672399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24541358|NCT00672399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24541359|NCT00672399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24861777|NCT02320045|Exenatide|exenatide|mesh-list
24862028|NCT02322346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24637570|NCT01151592|Hematinics|hematinics|mesh-ancestor
24406502|NCT00170677|Topotecan|topotecan|mesh-list
24406503|NCT00170677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24406504|NCT00170677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24406505|NCT00170677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24406507|NCT00170677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864440|NCT04339140|Hormone Antagonists|hormone antagonists|mesh-ancestor
24864441|NCT04339140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24864442|NCT04339140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813885|NCT02060734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201948|NCT02724358|Hormones|hormones|mesh-ancestor
25201949|NCT02724358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24813886|NCT02060786|Clopidogrel|clopidogrel|mesh-list
24789664|NCT01938300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102276|NCT03169790|Immunologic Factors|immunologic factors|mesh-ancestor
25102306|NCT03169777|Cyclophosphamide|cyclophosphamide|mesh-list
25102307|NCT03169777|Bevacizumab|bevacizumab|mesh-list
24406594|NCT00170859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406595|NCT00170872|Lumiracoxib|lumiracoxib|mesh-list
24565628|NCT00781482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24565699|NCT00781846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24565700|NCT00781846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24565701|NCT00781846|Antifungal Agents|antifungal agents|mesh-ancestor
24565702|NCT00781846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24565703|NCT00781846|Immunologic Factors|immunologic factors|mesh-ancestor
25842957|NCT00033709|Alkylating Agents|alkylating agents|mesh-ancestor
25842958|NCT00033709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842959|NCT00033709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842960|NCT00033709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25842961|NCT00033709|Immunologic Factors|immunologic factors|mesh-ancestor
25842962|NCT00033709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842963|NCT00033709|Leprostatic Agents|leprostatic agents|mesh-ancestor
24875754|NCT03878095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24875778|NCT03839823|Vinorelbine|vinorelbine|mesh-list
24875779|NCT03839823|Docetaxel|docetaxel|mesh-list
24875791|NCT03839823|Antimetabolites|antimetabolites|mesh-ancestor
24876729|NCT03263078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24877909|NCT02227199|Etoposide|etoposide|mesh-list
24880472|NCT03654274|Relugolix|relugolix|mesh-list
24886555|NCT04525235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24887045|NCT04520503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25843154|NCT00034463|Folic Acid|folic acid|mesh-list
24887047|NCT04520503|Anesthetics|anesthetics|mesh-ancestor
24816714|NCT02078336|Dopamine Agents|dopamine agents|mesh-ancestor
24877985|NCT02181413|Ixazomib|ixazomib|mesh-list
25165872|NCT04589325|Ixekizumab|ixekizumab|mesh-list
24891376|NCT04472689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819219|NCT02094274|Fluticasone|fluticasone|mesh-list
25843504|NCT00035009|Antidepressive Agents|antidepressive agents|mesh-ancestor
24786773|NCT01921790|Dexamethasone|dexamethasone|mesh-list
25661481|NCT01634100|Renal Agents|renal agents|mesh-ancestor
24815819|NCT02072135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899872|NCT04399148|Ketotifen|ketotifen|mesh-list
24900121|NCT04397393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25108945|NCT03128515|Hydroxyurea|hydroxyurea|mesh-list
25843958|NCT00036218|Dopamine Agents|dopamine agents|mesh-ancestor
24393328|NCT00129753|Alemtuzumab|alemtuzumab|mesh-list
25844143|NCT00036790|Doxorubicin|doxorubicin|mesh-list
24844974|NCT02235428|Anticonvulsants|anticonvulsants|mesh-ancestor
25229287|NCT02603679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25229288|NCT02603679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25229289|NCT02603679|Tubulin Modulators|tubulin modulators|mesh-ancestor
25229290|NCT02603679|Antimitotic Agents|antimitotic agents|mesh-ancestor
25229291|NCT02603679|Mitosis Modulators|mitosis modulators|mesh-ancestor
25229292|NCT02603679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229293|NCT02603679|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25844526|NCT00038090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25844527|NCT00038090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25844616|NCT00038246|Paclitaxel|paclitaxel|mesh-list
25844631|NCT00038246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25844632|NCT00038246|Growth Substances|growth substances|mesh-ancestor
25844633|NCT00038246|Growth Inhibitors|growth inhibitors|mesh-ancestor
24858369|NCT02296671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25844690|NCT05433532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25844691|NCT05433532|Antimetabolites|antimetabolites|mesh-ancestor
25844692|NCT05433532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844693|NCT05433532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844694|NCT05433532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844696|NCT05433480|Fulvestrant|fulvestrant|mesh-list
25844697|NCT05433480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25844698|NCT05433480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24545636|NCT00694187|Zaleplon|zaleplon|mesh-list
25166185|NCT04306393|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25166186|NCT04306393|Vasodilator Agents|vasodilator agents|mesh-ancestor
25166187|NCT04306393|Gasotransmitters|gasotransmitters|mesh-ancestor
25166188|NCT04306393|Protective Agents|protective agents|mesh-ancestor
25166209|NCT04299438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166210|NCT04299438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25166211|NCT04299438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25166212|NCT04299438|Vasodilator Agents|vasodilator agents|mesh-ancestor
25044289|NCT01116141|Antimetabolites|antimetabolites|mesh-ancestor
25844793|NCT05428683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25844803|NCT05428683|Hormones|hormones|mesh-ancestor
25844830|NCT05382546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25844831|NCT05382546|Analgesics|analgesics|mesh-ancestor
25844836|NCT05382546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24845283|NCT02237365|Aspirin|aspirin|mesh-list
25844975|NCT05116059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25844976|NCT05116059|Antifungal Agents|antifungal agents|mesh-ancestor
25844977|NCT05098704|Clopidogrel|clopidogrel|mesh-list
25844986|NCT05083975|Anesthetics|anesthetics|mesh-list
24545767|NCT00694759|Metformin|metformin|mesh-list
25845262|NCT04198662|Mydriatics|mydriatics|mesh-ancestor
25845331|NCT04002258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25845332|NCT04002258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25845333|NCT04002258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845401|NCT03430596|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25845497|NCT03062826|Antipyretics|antipyretics|mesh-ancestor
25661546|NCT01634191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25845617|NCT01331018|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25845618|NCT01331018|Prednisolone|prednisolone|mesh-list
25845619|NCT01331018|Prednisolone acetate|prednisolone acetate|mesh-list
25845620|NCT01331018|Cortisone|cortisone|mesh-list
25845621|NCT01331018|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25845754|NCT00038454|Chrysarobin|chrysarobin|mesh-list
25845797|NCT00038519|Ritonavir|ritonavir|mesh-list
24546215|NCT00697138|Sympathomimetics|sympathomimetics|mesh-ancestor
25845955|NCT00038844|Alkylating Agents|alkylating agents|mesh-ancestor
24858820|NCT02299687|Omeprazole|omeprazole|mesh-list
24546423|NCT00698269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846344|NCT00039975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24459612|NCT00345358|Immunologic Factors|immunologic factors|mesh-ancestor
24547348|NCT00703586|Maraviroc|maraviroc|mesh-list
25846746|NCT00040885|Dermatologic Agents|dermatologic agents|mesh-ancestor
25846909|NCT00041288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25847117|NCT00042003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25847168|NCT00042302|Paclitaxel|paclitaxel|mesh-list
24845925|NCT02240043|Hormones|hormones|mesh-list
25230070|NCT02598791|Incretins|incretins|mesh-ancestor
25230071|NCT02598791|Hormones|hormones|mesh-ancestor
25230072|NCT02598791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24484757|NCT00449813|Pantoprazole|pantoprazole|mesh-list
25847366|NCT00042848|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25847367|NCT00042848|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25847368|NCT00042848|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24548572|NCT00710268|Bevacizumab|bevacizumab|mesh-list
25847554|NCT00043134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230122|NCT02598362|Ciprofloxacin|ciprofloxacin|mesh-list
25847739|NCT00043810|Vidarabine|vidarabine|mesh-list
24859440|NCT02303639|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25847900|NCT00044187|Sibutramine|sibutramine|mesh-list
24859915|NCT02306564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25847987|NCT00044473|Ofloxacin|ofloxacin|mesh-list
25848022|NCT00044564|IDN 5109|idn 5109|mesh-list
24654275|NCT01248442|Vitamin D|vitamin d|mesh-list
24655410|NCT01256580|Antiemetics|antiemetics|mesh-ancestor
25848262|NCT00044993|Docetaxel|docetaxel|mesh-list
25848263|NCT00044993|Doxorubicin|doxorubicin|mesh-list
24656947|NCT01264692|Amlodipine|amlodipine|mesh-list
24541592|NCT00674050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24541593|NCT00674050|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24541594|NCT00674050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24541595|NCT00674050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24541596|NCT00674050|Adrenergic Agents|adrenergic agents|mesh-ancestor
24451504|NCT00323973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451505|NCT00323973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24451506|NCT00323973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24451507|NCT00323973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24451508|NCT00323973|Adrenergic Agents|adrenergic agents|mesh-ancestor
24451509|NCT00323973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24451510|NCT00323973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451511|NCT00323986|Azithromycin|azithromycin|mesh-list
24451512|NCT00323986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24451513|NCT00323986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24451514|NCT00324012|Docetaxel|docetaxel|mesh-list
24451515|NCT00324012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451516|NCT00324012|Tubulin Modulators|tubulin modulators|mesh-ancestor
25041725|NCT01591473|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
24657156|NCT01266005|Entecavir|entecavir|mesh-list
24861412|NCT02317601|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24861414|NCT02317601|Prednisolone acetate|prednisolone acetate|mesh-list
24861415|NCT02317601|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24861416|NCT02317601|Prednisolone phosphate|prednisolone phosphate|mesh-list
24861417|NCT02317601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24861418|NCT02317601|Antiemetics|antiemetics|mesh-ancestor
24861419|NCT02317601|Autonomic Agents|autonomic agents|mesh-ancestor
25848278|NCT00045006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419337|NCT02713997|Protease Inhibitors|protease inhibitors|mesh-ancestor
25848279|NCT00045045|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25848280|NCT00045045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25848281|NCT00045045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848282|NCT00045136|Melphalan|melphalan|mesh-list
25848283|NCT00045136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25848284|NCT00045136|Alkylating Agents|alkylating agents|mesh-ancestor
25876058|NCT03914625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801398|NCT01983449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550042|NCT00718757|Antimitotic Agents|antimitotic agents|mesh-ancestor
24550043|NCT00718757|Mitosis Modulators|mitosis modulators|mesh-ancestor
25848294|NCT00045149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25848295|NCT00045149|Antiviral Agents|antiviral agents|mesh-ancestor
25848296|NCT00045149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25848297|NCT00045175|Topotecan|topotecan|mesh-list
25848298|NCT00045175|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
25848299|NCT00045175|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25848300|NCT00045175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25848301|NCT00045175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601456|NCT00964262|Hormones|hormones|mesh-ancestor
24393172|NCT00128947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393173|NCT00129038|Aspirin|aspirin|mesh-list
24393174|NCT00129038|Dipyridamole|dipyridamole|mesh-list
24393175|NCT00129038|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
24813460|NCT02058576|Urological Agents|urological agents|mesh-ancestor
24813461|NCT02058576|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24813462|NCT02058576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24813464|NCT02058576|Hormone Antagonists|hormone antagonists|mesh-ancestor
24541963|NCT00676117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24541964|NCT00676117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541965|NCT00676117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24541966|NCT00676117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24541967|NCT00676156|Thioctic Acid|thioctic acid|mesh-list
24541968|NCT00676156|Antioxidants|antioxidants|mesh-ancestor
25848302|NCT00045175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813471|NCT02058667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24813472|NCT02058667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813473|NCT02058667|Tubulin Modulators|tubulin modulators|mesh-ancestor
24727889|NCT01613170|Hormones|hormones|mesh-ancestor
24802218|NCT01988831|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24802220|NCT01988831|Adrenergic Agents|adrenergic agents|mesh-ancestor
24813474|NCT02058667|Antimitotic Agents|antimitotic agents|mesh-ancestor
24813475|NCT02058667|Mitosis Modulators|mitosis modulators|mesh-ancestor
24541971|NCT00676156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658234|NCT01270997|Etanercept|etanercept|mesh-list
24813486|NCT02058693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813487|NCT02058693|Adrenergic Agents|adrenergic agents|mesh-ancestor
24813488|NCT02058693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24813489|NCT02058693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24813490|NCT02058693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25848303|NCT00045175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848304|NCT00045175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25848305|NCT00045188|Imatinib Mesylate|imatinib mesylate|mesh-list
25848306|NCT00045188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848307|NCT00045188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25848308|NCT00045188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848309|NCT00045188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802227|NCT01988896|Atezolizumab|atezolizumab|mesh-list
25848310|NCT00045227|Docetaxel|docetaxel|mesh-list
25127924|NCT03051906|Cetuximab|cetuximab|mesh-list
25848311|NCT00045227|Vaccines|vaccines|mesh-list
25848312|NCT00045227|Sargramostim|sargramostim|mesh-list
25848313|NCT00045227|Immunologic Factors|immunologic factors|mesh-ancestor
25848314|NCT00045227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848315|NCT00045227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542029|NCT00676468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24542030|NCT00676468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542031|NCT00676468|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24862132|NCT02323347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658490|NCT01272089|Analgesics|analgesics|mesh-ancestor
25848316|NCT00045227|Tubulin Modulators|tubulin modulators|mesh-ancestor
24862193|NCT02323516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24862194|NCT02323516|Analgesics|analgesics|mesh-ancestor
24862195|NCT02323516|Sensory System Agents|sensory system agents|mesh-ancestor
24542044|NCT00676559|Ranibizumab|ranibizumab|mesh-list
24542045|NCT00676559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24542046|NCT00676559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24542047|NCT00676559|Growth Substances|growth substances|mesh-ancestor
24542049|NCT00676559|Growth Inhibitors|growth inhibitors|mesh-ancestor
25848317|NCT00045227|Antimitotic Agents|antimitotic agents|mesh-ancestor
24658646|NCT01273441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24542062|NCT00676637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24542065|NCT00676702|Pancreatin|pancreatin|mesh-list
24542066|NCT00676702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24542067|NCT00676702|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25848318|NCT00045227|Mitosis Modulators|mitosis modulators|mesh-ancestor
25041706|NCT01593228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24862219|NCT02323607|Antimetabolites|antimetabolites|mesh-ancestor
24862220|NCT02323607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802252|NCT01989052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041726|NCT01591473|Poly I-C|poly i-c|mesh-list
25848319|NCT00045227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862226|NCT02323607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862227|NCT02323607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24658877|NCT01274325|Autonomic Agents|autonomic agents|mesh-ancestor
25848320|NCT00045266|Aflibercept|aflibercept|mesh-list
25848321|NCT00045266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25848322|NCT00045266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25848323|NCT00045266|Growth Substances|growth substances|mesh-ancestor
25848324|NCT00045266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658946|NCT01274780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24658998|NCT01275248|Ondansetron|ondansetron|mesh-list
24862252|NCT02323971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24862253|NCT02323971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862254|NCT02323971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684037|NCT01395251|Prednisolone|prednisolone|mesh-list
24862255|NCT02324010|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24862256|NCT02324010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24862257|NCT02324010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862258|NCT02324010|Incretins|incretins|mesh-ancestor
24542094|NCT00676845|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24542095|NCT00676845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542096|NCT00676871|Blinatumomab|blinatumomab|mesh-list
24542097|NCT00676871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542098|NCT00676936|Methylprednisolone|methylprednisolone|mesh-list
24542099|NCT00676936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24542100|NCT00676936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25848325|NCT00045266|Growth Inhibitors|growth inhibitors|mesh-ancestor
24542101|NCT00676936|Prednisolone|prednisolone|mesh-list
24542102|NCT00676936|Prednisolone acetate|prednisolone acetate|mesh-list
25848326|NCT00045266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848327|NCT00045279|Interferons|interferons|mesh-list
25848328|NCT00045279|Interferon-alpha|interferon-alpha|mesh-list
25848329|NCT00045279|Interferon alpha-2|interferon alpha-2|mesh-list
24862276|NCT02324088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24862277|NCT02324088|Tubulin Modulators|tubulin modulators|mesh-ancestor
24862278|NCT02324088|Antimitotic Agents|antimitotic agents|mesh-ancestor
24862279|NCT02324088|Mitosis Modulators|mitosis modulators|mesh-ancestor
24601773|NCT00965900|Vasodilator Agents|vasodilator agents|mesh-ancestor
24542110|NCT00676936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24542111|NCT00676936|Glucocorticoids|glucocorticoids|mesh-ancestor
24542112|NCT00676936|Hormones|hormones|mesh-ancestor
24542113|NCT00676936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24659141|NCT01275885|Micronutrients|micronutrients|mesh-ancestor
24451634|NCT00324467|Antiemetics|antiemetics|mesh-ancestor
24451635|NCT00324467|Autonomic Agents|autonomic agents|mesh-ancestor
24451636|NCT00324467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24542162|NCT00677300|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24542163|NCT00677300|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24542167|NCT00677300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25848337|NCT00045292|Acyclovir|acyclovir|mesh-list
24862380|NCT02324998|Olaparib|olaparib|mesh-list
24862381|NCT02324998|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24451673|NCT00324467|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24659604|NCT01278784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24862407|NCT02325011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24862408|NCT02325011|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24542211|NCT00677664|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24542212|NCT00677664|Diuretics|diuretics|mesh-ancestor
24542213|NCT00677664|Natriuretic Agents|natriuretic agents|mesh-ancestor
24542214|NCT00677664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661632|NCT01635504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25661633|NCT01635504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848338|NCT00045292|Antiviral Agents|antiviral agents|mesh-ancestor
25848339|NCT00045292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25848340|NCT00045318|Exatecan|exatecan|mesh-list
25848341|NCT00045318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25848342|NCT00045318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25848343|NCT00045318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848344|NCT00045318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801464|NCT01983735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24801465|NCT01983735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24862409|NCT02325011|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24862410|NCT02325011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24542222|NCT00677729|Autonomic Agents|autonomic agents|mesh-ancestor
24542223|NCT00677729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24542225|NCT00677729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25128421|NCT03047538|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25128422|NCT03047538|Protease Inhibitors|protease inhibitors|mesh-ancestor
25128426|NCT03047499|Botulinum Toxins|botulinum toxins|mesh-list
24862436|NCT02325206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24452327|NCT00327132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24862437|NCT02325206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862438|NCT02325245|Metformin|metformin|mesh-list
24862439|NCT02325245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24862440|NCT02325245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862443|NCT02325362|Miglustat|miglustat|mesh-list
24862444|NCT02325362|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
24862445|NCT02325362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24862446|NCT02325362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862447|NCT02325362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24862448|NCT02325362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25848345|NCT00045318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24862458|NCT02325440|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24862459|NCT02325440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848359|NCT00045396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848360|NCT00045422|Interferons|interferons|mesh-list
25848361|NCT00045422|Interferon-alpha|interferon-alpha|mesh-list
25848362|NCT00045422|Imatinib Mesylate|imatinib mesylate|mesh-list
25848363|NCT00045422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848364|NCT00045422|Antiviral Agents|antiviral agents|mesh-ancestor
25848365|NCT00045422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25848366|NCT00045422|Immunologic Factors|immunologic factors|mesh-ancestor
25848367|NCT00045422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848368|NCT00045422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25848369|NCT00045422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848370|NCT00045422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848371|NCT00045448|Docetaxel|docetaxel|mesh-list
25848372|NCT00045448|Alvocidib|alvocidib|mesh-list
24660283|NCT01282541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24802407|NCT01989923|Autonomic Agents|autonomic agents|mesh-ancestor
24862606|NCT05021913|Hyaluronic Acid|hyaluronic acid|mesh-list
24862608|NCT05021913|Anesthetics|anesthetics|mesh-ancestor
24542380|NCT00678457|Serotonin Agents|serotonin agents|mesh-ancestor
24542381|NCT00678457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24542382|NCT00678457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542383|NCT00678457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24660534|NCT01284205|BCG Vaccine|bcg vaccine|mesh-list
24542458|NCT00678769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24542459|NCT00678769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24542460|NCT00678769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542461|NCT00678769|Antifungal Agents|antifungal agents|mesh-ancestor
24542462|NCT00678769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24542480|NCT00678964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542481|NCT00678964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24542483|NCT00678964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542549|NCT00679237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25041707|NCT01593228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542550|NCT00679237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24542551|NCT00679237|Antimetabolites|antimetabolites|mesh-ancestor
25848374|NCT00045448|Tubulin Modulators|tubulin modulators|mesh-ancestor
24813532|NCT02058875|Antifungal Agents|antifungal agents|mesh-ancestor
24542553|NCT00679237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24542554|NCT00679237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24542555|NCT00679237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24542556|NCT00679237|Immunologic Factors|immunologic factors|mesh-ancestor
25848375|NCT00045448|Antimitotic Agents|antimitotic agents|mesh-ancestor
25848376|NCT00045448|Mitosis Modulators|mitosis modulators|mesh-ancestor
25848377|NCT00045448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848378|NCT00045448|Growth Inhibitors|growth inhibitors|mesh-ancestor
25848379|NCT00045448|Growth Substances|growth substances|mesh-ancestor
25848380|NCT00045448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542563|NCT00679250|Histamine Agents|histamine agents|mesh-ancestor
24542564|NCT00679250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24660828|NCT01286090|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24542576|NCT00679315|Urological Agents|urological agents|mesh-ancestor
24813556|NCT02059018|Nitroglycerin|nitroglycerin|mesh-list
24813557|NCT02059018|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24813558|NCT02059018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24813559|NCT02059018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24813560|NCT02059018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25661635|NCT01635504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24813561|NCT02059018|Analgesics|analgesics|mesh-ancestor
25128653|NCT03045484|Oxycodone|oxycodone|mesh-list
24813563|NCT02059018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24813564|NCT02059018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813565|NCT02059018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24813566|NCT02059018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24813567|NCT02059018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813568|NCT02059018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813569|NCT02059018|Vasodilator Agents|vasodilator agents|mesh-ancestor
24813572|NCT02059031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24813573|NCT02059031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813574|NCT02059031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862786|NCT04371640|Sirolimus|sirolimus|mesh-list
24862791|NCT04371640|Antifungal Agents|antifungal agents|mesh-ancestor
25230490|NCT02595463|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25230491|NCT02595463|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25230492|NCT02595463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24463701|NCT00361907|Insulin|insulin|mesh-list
24862857|NCT04120454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24862858|NCT04120454|Pembrolizumab|pembrolizumab|mesh-list
24542649|NCT00679653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25848381|NCT00045448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25848383|NCT00045461|Carboplatin|carboplatin|mesh-list
25230528|NCT02595203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25230529|NCT02595190|Gabapentin|gabapentin|mesh-list
24862915|NCT04034459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24862916|NCT04034459|Growth Substances|growth substances|mesh-ancestor
24862917|NCT04034459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862918|NCT04034459|Growth Inhibitors|growth inhibitors|mesh-ancestor
24806138|NCT02013986|Propofol|propofol|mesh-list
25044098|NCT01156415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848415|NCT00045526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24454276|NCT04207086|Lenvatinib|lenvatinib|mesh-list
25848429|NCT00045539|Antimetabolites|antimetabolites|mesh-ancestor
24806329|NCT02015260|Anticoagulants|anticoagulants|mesh-ancestor
24806330|NCT02015260|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24806489|NCT02016261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25230719|NCT02593734|Antiemetics|antiemetics|mesh-ancestor
24806780|NCT02018094|Plasma Substitutes|plasma substitutes|mesh-ancestor
24806781|NCT02018094|Blood Substitutes|blood substitutes|mesh-ancestor
24806783|NCT02018133|Vitamin D|vitamin d|mesh-list
24477462|NCT00418704|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24477463|NCT00418704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24664627|NCT01308086|Leucovorin|leucovorin|mesh-list
25848497|NCT00045682|Tubulin Modulators|tubulin modulators|mesh-ancestor
24575989|NCT00836134|Bupivacaine|bupivacaine|mesh-list
24478282|NCT00422123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478284|NCT00422175|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24478669|NCT00423969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24576725|NCT00840229|Triamcinolone|triamcinolone|mesh-list
24807641|NCT02022930|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24807642|NCT02022930|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24807643|NCT02022930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24666620|NCT01320007|Furosemide|furosemide|mesh-list
24807679|NCT02023086|Autonomic Agents|autonomic agents|mesh-ancestor
24481168|NCT00433498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25848587|NCT00045916|Nortriptyline|nortriptyline|mesh-list
24808073|NCT02025023|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24808074|NCT02025023|Fluorouracil|fluorouracil|mesh-list
25848615|NCT00045955|Histamine Agents|histamine agents|mesh-ancestor
25848616|NCT00045955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25848617|NCT00046020|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24432928|NCT00257023|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24483499|NCT00443794|Antimetabolites|antimetabolites|mesh-ancestor
24483500|NCT00443794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24808289|NCT02026310|Metformin|metformin|mesh-list
24805250|NCT02008214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808532|NCT02027792|Diclofenac|diclofenac|mesh-list
24737362|NCT01668615|Tretinoin|tretinoin|mesh-list
24805346|NCT02008981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24470839|NCT00392106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24808601|NCT02028260|Modafinil|modafinil|mesh-list
24485040|NCT00451139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485041|NCT00451139|Antimetabolites|antimetabolites|mesh-ancestor
25848657|NCT00046137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848658|NCT00046137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25848659|NCT00046137|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25848660|NCT00046137|Hormone Antagonists|hormone antagonists|mesh-ancestor
25848668|NCT00046163|Sympathomimetics|sympathomimetics|mesh-ancestor
24485915|NCT00455416|Trace Elements|trace elements|mesh-ancestor
24485916|NCT00455416|Micronutrients|micronutrients|mesh-ancestor
24485917|NCT00455416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24808864|NCT02029586|Antiviral Agents|antiviral agents|mesh-ancestor
24622431|NCT01066962|Antiviral Agents|antiviral agents|mesh-ancestor
24622432|NCT01066962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24801644|NCT01984749|Febuxostat|febuxostat|mesh-list
24808905|NCT02029625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848692|NCT00046241|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25848693|NCT00046241|Antidepressive Agents|antidepressive agents|mesh-ancestor
25848696|NCT00046241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25848697|NCT00046241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24486827|NCT00460226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25848698|NCT00046241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848699|NCT00046241|Dopamine Agents|dopamine agents|mesh-ancestor
25848700|NCT00046241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25848701|NCT00046241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848702|NCT00046241|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25848703|NCT00046241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25848704|NCT00046241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487197|NCT00461916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24906014|NCT04343170|Folic Acid|folic acid|mesh-list
24488287|NCT00467545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24488288|NCT00467545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488289|NCT00467545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488290|NCT00467571|Amoxicillin|amoxicillin|mesh-list
24488328|NCT00467909|Trace Elements|trace elements|mesh-list
24618242|NCT01047488|Pregabalin|pregabalin|mesh-list
24489180|NCT00471640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24489181|NCT00471640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490315|NCT00477737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490344|NCT00477789|Allopurinol|allopurinol|mesh-list
24490933|NCT00480584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25661754|NCT01637402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25848727|NCT00046345|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25848728|NCT00046345|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25848729|NCT00046345|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24880854|NCT03270176|Avelumab|avelumab|mesh-list
24491265|NCT00481819|Antitubercular Agents|antitubercular agents|mesh-ancestor
24491266|NCT00481819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24491267|NCT00481819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24487593|NCT00463983|Octreotide|octreotide|mesh-list
24492256|NCT00485797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492420|NCT00486213|Vitamins|vitamins|mesh-ancestor
24492421|NCT00486213|Micronutrients|micronutrients|mesh-ancestor
24492422|NCT00486213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492423|NCT00486317|Calcitonin|calcitonin|mesh-list
24492502|NCT00486486|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24492503|NCT00486486|Adrenergic Agents|adrenergic agents|mesh-ancestor
24492504|NCT00486486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25848738|NCT00046358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24604630|NCT00980551|Vincristine|vincristine|mesh-list
25661773|NCT01637623|Losartan|losartan|mesh-list
25661774|NCT01637623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24493352|NCT00490659|Antiviral Agents|antiviral agents|mesh-ancestor
24493353|NCT00490659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493634|NCT00491855|Paclitaxel|paclitaxel|mesh-list
24881093|NCT03069638|Analgesics|analgesics|mesh-ancestor
24493833|NCT00492518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493834|NCT00492518|Antidotes|antidotes|mesh-ancestor
24493835|NCT00492518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24493836|NCT00492518|Autonomic Agents|autonomic agents|mesh-ancestor
24493837|NCT00492518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24493838|NCT00492518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24493839|NCT00492518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25848764|NCT00046384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24598699|NCT00957346|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25848798|NCT00046553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24809522|NCT02034292|APD791|apd791|mesh-list
24809536|NCT02034292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809537|NCT02034292|Antipyretics|antipyretics|mesh-ancestor
24809538|NCT02034292|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24809539|NCT02034292|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25848819|NCT00046800|Lurtotecan|lurtotecan|mesh-list
24494926|NCT00497523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24494952|NCT00497562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24494953|NCT00497562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24494954|NCT00497562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25848820|NCT00046800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848821|NCT00046813|Nicotine|nicotine|mesh-list
25848832|NCT00046826|Docetaxel|docetaxel|mesh-list
25848833|NCT00046826|Estramustine|estramustine|mesh-list
24454839|NCT03474029|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24454840|NCT03474029|Antitubercular Agents|antitubercular agents|mesh-ancestor
24495432|NCT00500253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25848885|NCT00046917|Irinotecan|irinotecan|mesh-list
24846598|NCT02243241|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24478418|NCT00422682|Antiviral Agents|antiviral agents|mesh-ancestor
24809830|NCT02036437|Abortifacient Agents|abortifacient agents|mesh-ancestor
24809831|NCT02036437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24809855|NCT02036489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809856|NCT02036489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24448257|NCT00310908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448258|NCT00310908|Analgesics|analgesics|mesh-ancestor
24448259|NCT00310908|Sensory System Agents|sensory system agents|mesh-ancestor
25848926|NCT00047021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231651|NCT02587390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24846618|NCT02243254|Sensory System Agents|sensory system agents|mesh-ancestor
24846619|NCT02243254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24846620|NCT02243254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061943|NCT05389813|Anticonvulsants|anticonvulsants|mesh-ancestor
25061944|NCT05389813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24810066|NCT02037672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24496853|NCT00507065|Autonomic Agents|autonomic agents|mesh-ancestor
25231677|NCT02587260|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24496878|NCT00507091|Vitamin B Complex|vitamin b complex|mesh-ancestor
24496879|NCT00507091|Vitamins|vitamins|mesh-ancestor
24496880|NCT00507091|Micronutrients|micronutrients|mesh-ancestor
24496881|NCT00507117|Eszopiclone|eszopiclone|mesh-list
24496882|NCT00507117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24496883|NCT00507117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24496919|NCT00507221|Tubulin Modulators|tubulin modulators|mesh-ancestor
25231681|NCT02587260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25231682|NCT02587260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231683|NCT02587260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904793|NCT04353024|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24904794|NCT04353024|Serotonin Agents|serotonin agents|mesh-ancestor
25848945|NCT00047047|Antiviral Agents|antiviral agents|mesh-ancestor
25231687|NCT02587741|Metformin|metformin|mesh-list
24497228|NCT00508963|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24497229|NCT00508963|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24497230|NCT00508963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24497298|NCT00509379|Bortezomib|bortezomib|mesh-list
25848951|NCT00047073|Sirolimus|sirolimus|mesh-list
25231709|NCT02587130|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24498185|NCT00513487|Miotics|miotics|mesh-ancestor
25848977|NCT00047099|Mitosis Modulators|mitosis modulators|mesh-ancestor
25848978|NCT00047099|Antimetabolites|antimetabolites|mesh-ancestor
25848979|NCT00047099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25848980|NCT00047099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25231879|NCT02586129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25231880|NCT02586129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231881|NCT02586129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24498759|NCT00516191|Bortezomib|bortezomib|mesh-list
25661974|NCT01640197|Antioxidants|antioxidants|mesh-ancestor
25062206|NCT05133674|Tamoxifen|tamoxifen|mesh-list
24500784|NCT00525694|Anesthetics|anesthetics|mesh-ancestor
24500785|NCT00525694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24714173|NCT01529242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24500786|NCT00525694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500787|NCT00525694|Sensory System Agents|sensory system agents|mesh-ancestor
24500788|NCT00525694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24501148|NCT00527059|Simendan|simendan|mesh-list
24503195|NCT02843230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503235|NCT02503839|Analgesics|analgesics|mesh-ancestor
24810605|NCT02040909|Anesthetics, General|anesthetics, general|mesh-ancestor
24810625|NCT02041117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24810627|NCT02041143|Chelating Agents|chelating agents|mesh-ancestor
24810628|NCT02041143|Sequestering Agents|sequestering agents|mesh-ancestor
24810629|NCT02041143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810707|NCT02041819|Nimotuzumab|nimotuzumab|mesh-list
24504754|NCT00537966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24504755|NCT00537966|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24759319|NCT01750541|Anticonvulsants|anticonvulsants|mesh-ancestor
24462397|NCT00355966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24811055|NCT02044549|Methylergonovine|methylergonovine|mesh-list
24811056|NCT02044549|Syntometrine|syntometrine|mesh-list
25849196|NCT00047554|Travoprost|travoprost|mesh-list
24631875|NCT01120665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24632095|NCT01122004|Anticonvulsants|anticonvulsants|mesh-ancestor
24632096|NCT01122004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25849200|NCT00047567|Zonisamide|zonisamide|mesh-list
25849201|NCT00047567|Anticonvulsants|anticonvulsants|mesh-ancestor
25849205|NCT00047567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25849206|NCT00047567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849207|NCT00047580|Tizanidine|tizanidine|mesh-list
25232273|NCT02583594|Alemtuzumab|alemtuzumab|mesh-list
25849236|NCT00047658|Antiviral Agents|antiviral agents|mesh-ancestor
25662029|NCT01641081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404917|NCT00165178|Hormones|hormones|mesh-ancestor
24404949|NCT00165191|Doxorubicin|doxorubicin|mesh-list
24405149|NCT00165568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405161|NCT00165633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24405162|NCT00165633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405163|NCT00165633|Vitamins|vitamins|mesh-ancestor
24405164|NCT00165633|Micronutrients|micronutrients|mesh-ancestor
24405165|NCT00165633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405287|NCT00166413|Growth Inhibitors|growth inhibitors|mesh-ancestor
24405289|NCT00166426|Sulindac sulfone|sulindac sulfone|mesh-list
24405290|NCT00166426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405291|NCT00166426|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24405292|NCT00166426|Protective Agents|protective agents|mesh-ancestor
24405293|NCT00166426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405294|NCT00166426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24405295|NCT00166426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405296|NCT00166426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405297|NCT00166426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24405298|NCT00166426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24405299|NCT00166426|Analgesics|analgesics|mesh-ancestor
24405300|NCT00166426|Sensory System Agents|sensory system agents|mesh-ancestor
24405301|NCT00166426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24405429|NCT00166842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405430|NCT00166842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24405431|NCT00166842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405440|NCT00166868|Neomycin|neomycin|mesh-list
24405441|NCT00166868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25849273|NCT00047749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24405445|NCT00166868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405446|NCT00166881|Docetaxel|docetaxel|mesh-list
24405447|NCT00166881|Irinotecan|irinotecan|mesh-list
24405448|NCT00166881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405449|NCT00166881|Tubulin Modulators|tubulin modulators|mesh-ancestor
24405450|NCT00166881|Antimitotic Agents|antimitotic agents|mesh-ancestor
24405451|NCT00166881|Mitosis Modulators|mitosis modulators|mesh-ancestor
24405452|NCT00166881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743112|NCT04989621|Rituximab|rituximab|mesh-list
24405479|NCT00167297|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24405480|NCT00167297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24405481|NCT00167297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24405482|NCT00167297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405483|NCT00167297|Adrenergic Agents|adrenergic agents|mesh-ancestor
24405484|NCT00167297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24405485|NCT00167297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405486|NCT00167375|Eszopiclone|eszopiclone|mesh-list
24405487|NCT00167375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24405489|NCT00167375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405490|NCT00167401|Docetaxel|docetaxel|mesh-list
24540662|NCT00668941|Calcium|calcium|mesh-list
25849285|NCT00047762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25849286|NCT00047762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24540671|NCT00668967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24540672|NCT00668967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540673|NCT00668967|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24540675|NCT00668967|Vasodilator Agents|vasodilator agents|mesh-ancestor
24811740|NCT02048215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811741|NCT02048215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24811742|NCT02048215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24811743|NCT02048215|Purinergic Agents|purinergic agents|mesh-ancestor
24811744|NCT02048215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24811746|NCT02048215|Autonomic Agents|autonomic agents|mesh-ancestor
24678214|NCT01360190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24405541|NCT00167583|Immunologic Factors|immunologic factors|mesh-ancestor
24540688|NCT00669149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24540689|NCT00669149|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24405580|NCT00167687|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24405581|NCT00167687|Adrenergic Agents|adrenergic agents|mesh-ancestor
24405582|NCT00167687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25849287|NCT00047762|Growth Substances|growth substances|mesh-ancestor
25849288|NCT00047762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849289|NCT00047762|Growth Inhibitors|growth inhibitors|mesh-ancestor
25849290|NCT00047762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25849291|NCT00047762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849292|NCT00047762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849293|NCT00047801|Docetaxel|docetaxel|mesh-list
24405660|NCT00167856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405661|NCT00167856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24405686|NCT00167947|Cyclosporins|cyclosporins|mesh-list
24405953|NCT00168870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24405954|NCT00168870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405955|NCT00168870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24405956|NCT00168870|Immunologic Factors|immunologic factors|mesh-ancestor
24405957|NCT00168870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405958|NCT00168870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24405959|NCT00168870|Alkylating Agents|alkylating agents|mesh-ancestor
24405960|NCT00168883|Paclitaxel|paclitaxel|mesh-list
24405961|NCT00168883|Vinorelbine|vinorelbine|mesh-list
24405962|NCT00168883|Carboplatin|carboplatin|mesh-list
24405963|NCT00168883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24405964|NCT00168883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405965|NCT00168883|Tubulin Modulators|tubulin modulators|mesh-ancestor
24405971|NCT00168896|Etoposide|etoposide|mesh-list
24405972|NCT00168896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405973|NCT00168896|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24405974|NCT00168896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24811854|NCT02048644|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24811855|NCT02048644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24540865|NCT00669812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24540867|NCT00669812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25849301|NCT00047827|Micafungin|micafungin|mesh-list
25232348|NCT02583685|Ribavirin|ribavirin|mesh-list
24406311|NCT00169585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406313|NCT00169585|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24406314|NCT00169585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25849305|NCT00047827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25849306|NCT00047827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25849307|NCT00047827|Antifungal Agents|antifungal agents|mesh-ancestor
24556721|NCT00749359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556927|NCT00750386|Antimitotic Agents|antimitotic agents|mesh-ancestor
24557381|NCT00752466|Topiramate|topiramate|mesh-list
24679269|NCT01367613|Methylnaltrexone|methylnaltrexone|mesh-list
25849308|NCT00047840|Docetaxel|docetaxel|mesh-list
24406339|NCT00169845|Vitamin E|vitamin e|mesh-list
24406340|NCT00169845|alpha-Tocopherol|alpha-tocopherol|mesh-list
24406341|NCT00169845|Beta Carotene|beta carotene|mesh-list
24406342|NCT00169845|Carotenoids|carotenoids|mesh-list
24406343|NCT00169845|Antioxidants|antioxidants|mesh-ancestor
24565371|NCT00779922|Growth Substances|growth substances|mesh-ancestor
24407024|NCT00171717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24407025|NCT00171717|Dermatologic Agents|dermatologic agents|mesh-ancestor
24820131|NCT02098889|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25849334|NCT00048126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24408342|NCT00177411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24408343|NCT00177411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408344|NCT00177411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24408346|NCT00177424|Antidepressive Agents|antidepressive agents|mesh-ancestor
24408347|NCT00177424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24820188|NCT02099240|Clarithromycin|clarithromycin|mesh-list
24820189|NCT02099240|Doxycycline|doxycycline|mesh-list
24820190|NCT02099240|Ciprofloxacin|ciprofloxacin|mesh-list
24820191|NCT02099240|Levofloxacin|levofloxacin|mesh-list
24820192|NCT02099240|Ofloxacin|ofloxacin|mesh-list
24820193|NCT02099240|Minocycline|minocycline|mesh-list
24820194|NCT02099240|Rifampin|rifampin|mesh-list
24820195|NCT02099240|Clindamycin|clindamycin|mesh-list
24820196|NCT02099240|Clindamycin palmitate|clindamycin palmitate|mesh-list
24408473|NCT00177853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24408474|NCT00177853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24408476|NCT00177996|Antidepressive Agents|antidepressive agents|mesh-ancestor
24408477|NCT00177996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24408478|NCT00177996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24408479|NCT00177996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24408480|NCT00177996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25849344|NCT00048139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24846813|NCT02244112|Anesthetics|anesthetics|mesh-ancestor
24479844|NCT00428558|Cytarabine|cytarabine|mesh-list
25849345|NCT00048139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820284|NCT02099240|Methicillin|methicillin|mesh-list
24820285|NCT02099240|Sulfacetamide|sulfacetamide|mesh-list
24820286|NCT02099240|Bacampicillin|bacampicillin|mesh-list
24820287|NCT02099240|Carbenicillin|carbenicillin|mesh-list
24820288|NCT02099240|Carbenicillin indanyl|carbenicillin indanyl|mesh-list
24408656|NCT00179023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408657|NCT00179023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24408658|NCT00179023|Respiratory System Agents|respiratory system agents|mesh-ancestor
24408678|NCT00179062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408679|NCT00179062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408681|NCT00179062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24408682|NCT00179062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24408683|NCT00179062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24541945|NCT00676039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24408801|NCT00179699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24408802|NCT00179699|Immunologic Factors|immunologic factors|mesh-ancestor
24408803|NCT00179699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820401|NCT02099331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820402|NCT02099331|Protective Agents|protective agents|mesh-ancestor
24820403|NCT02099331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820404|NCT02099331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24820405|NCT02099357|Vitamin D|vitamin d|mesh-list
24820406|NCT02099357|Vitamins|vitamins|mesh-ancestor
24397499|NCT00141648|Hormones|hormones|mesh-ancestor
24408972|NCT00180128|Cytarabine|cytarabine|mesh-list
25849387|NCT00048360|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25849388|NCT00048360|Antidepressive Agents|antidepressive agents|mesh-ancestor
24820625|NCT02100462|Natriuretic Agents|natriuretic agents|mesh-ancestor
24820626|NCT02100462|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24820627|NCT02100462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24820629|NCT02100488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24820630|NCT02100488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24682166|NCT01384578|Vitamins|vitamins|mesh-list
24409189|NCT00181246|Fentanyl|fentanyl|mesh-list
24409190|NCT00181246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24409191|NCT00181246|Narcotics|narcotics|mesh-ancestor
24409192|NCT00181246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24409194|NCT00181246|Analgesics|analgesics|mesh-ancestor
24820692|NCT02101047|Sympathomimetics|sympathomimetics|mesh-ancestor
24820693|NCT02101047|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24409284|NCT00181675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24409318|NCT00181740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409319|NCT00181740|Adrenergic Agents|adrenergic agents|mesh-ancestor
24409320|NCT00181740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24409321|NCT00181740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409322|NCT00181779|Aripiprazole|aripiprazole|mesh-list
24409323|NCT00181779|Antidepressive Agents|antidepressive agents|mesh-ancestor
24409442|NCT00182013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409443|NCT00182013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409458|NCT00182039|Metoprolol|metoprolol|mesh-list
24451828|NCT00324922|Vancomycin|vancomycin|mesh-list
24820853|NCT02102295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409739|NCT00182819|Temozolomide|temozolomide|mesh-list
25876120|NCT03907488|Antibodies|antibodies|mesh-list
24410147|NCT00184795|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24821079|NCT02103374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821210|NCT02103777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24410406|NCT00185185|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24410408|NCT00185185|Adrenergic Agents|adrenergic agents|mesh-ancestor
24410432|NCT00185237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410433|NCT00185250|Interferons|interferons|mesh-list
24410434|NCT00185250|Interferon-beta|interferon-beta|mesh-list
24410436|NCT00185250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24410437|NCT00185250|Antiviral Agents|antiviral agents|mesh-ancestor
24410504|NCT00185575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410506|NCT00185575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410507|NCT00185575|Analgesics|analgesics|mesh-ancestor
24410508|NCT00185575|Sensory System Agents|sensory system agents|mesh-ancestor
24410509|NCT00185575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24410511|NCT00185575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24410698|NCT00186966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24410711|NCT00186979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662078|NCT01641367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24465153|NCT00368030|Eszopiclone|eszopiclone|mesh-list
24821318|NCT02104609|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24465350|NCT00369148|Nateglinide|nateglinide|mesh-list
24821421|NCT02105090|Anesthetics, Local|anesthetics, local|mesh-list
24821429|NCT02105155|Tacrolimus|tacrolimus|mesh-list
25849426|NCT00048425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849427|NCT00048425|Protective Agents|protective agents|mesh-ancestor
25849428|NCT00048425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465446|NCT00369603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24465447|NCT00369603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465448|NCT00369603|Nootropic Agents|nootropic agents|mesh-ancestor
25662083|NCT01641367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25662084|NCT01641367|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24821802|NCT02107950|Immunologic Factors|immunologic factors|mesh-ancestor
24550996|NCT00723515|Calcium|calcium|mesh-list
25849461|NCT00048607|Antiemetics|antiemetics|mesh-ancestor
24822139|NCT02109965|Propofol|propofol|mesh-list
24822243|NCT02110719|Oxycodone|oxycodone|mesh-list
25232913|NCT02579590|Hormones|hormones|mesh-ancestor
24822605|NCT02112721|Vitamins|vitamins|mesh-ancestor
24466788|NCT00374894|Sequestering Agents|sequestering agents|mesh-ancestor
24822623|NCT02112864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822624|NCT02112903|Vortioxetine|vortioxetine|mesh-list
24822625|NCT02112903|Antidepressive Agents|antidepressive agents|mesh-ancestor
24822626|NCT02112903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24822627|NCT02112903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24415749|NCT00200590|Nalbuphine|nalbuphine|mesh-list
25232992|NCT02579187|Anesthetics|anesthetics|mesh-list
24822704|NCT02112916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24822705|NCT02112916|Antiviral Agents|antiviral agents|mesh-ancestor
24822854|NCT02113813|Anesthetics|anesthetics|mesh-ancestor
24418231|NCT00209014|Thalidomide|thalidomide|mesh-list
24823022|NCT02114528|Adrenergic Agents|adrenergic agents|mesh-ancestor
24419553|NCT00212602|Fosaprepitant|fosaprepitant|mesh-list
24420164|NCT00215345|Celecoxib|celecoxib|mesh-list
24420996|NCT00217503|Zidovudine|zidovudine|mesh-list
24421654|NCT00219856|Desflurane|desflurane|mesh-list
24578621|NCT00849992|Imiquimod|imiquimod|mesh-list
24545543|NCT00693732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24471159|NCT00393562|Modafinil|modafinil|mesh-list
25876127|NCT03907488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876128|NCT03907488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24426471|NCT00236106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24824397|NCT02123121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824398|NCT02123121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24426901|NCT00236808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24426902|NCT00236808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24426903|NCT00236808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24427034|NCT00237224|Letrozole|letrozole|mesh-list
24805603|NCT02010970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547458|NCT00704106|Entecavir|entecavir|mesh-list
24427926|NCT00239304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849600|NCT00049062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24429583|NCT00244426|Antipyretics|antipyretics|mesh-ancestor
24429695|NCT00244907|Hormones|hormones|mesh-ancestor
24430434|NCT00247663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24430435|NCT00247663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430437|NCT00247702|Anticoagulants|anticoagulants|mesh-ancestor
24430439|NCT00247715|Ranitidine|ranitidine|mesh-list
24430440|NCT00247715|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
24430441|NCT00247715|Magnesium Oxide|magnesium oxide|mesh-list
24430442|NCT00247715|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24430694|NCT00249119|Risperidone|risperidone|mesh-list
24430907|NCT00249704|Vitamins|vitamins|mesh-list
25233567|NCT02576327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662199|NCT01642212|Hormones|hormones|mesh-ancestor
25849651|NCT00049114|Cyclophosphamide|cyclophosphamide|mesh-list
24432874|NCT00256711|Gefitinib|gefitinib|mesh-list
25849655|NCT00049114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24433330|NCT00258232|Antimetabolites|antimetabolites|mesh-ancestor
25233719|NCT02575547|Docetaxel|docetaxel|mesh-list
25233792|NCT02574962|Hormones|hormones|mesh-ancestor
24434748|NCT00263393|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25233828|NCT02574975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25233860|NCT02574741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25233861|NCT02574741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24907677|NCT04328636|Anesthetics|anesthetics|mesh-ancestor
25849692|NCT00049218|Carboplatin|carboplatin|mesh-list
25662264|NCT01642485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623680|NCT01073150|Tea Tree Oil|tea tree oil|mesh-list
24439256|NCT00278213|Alkylating Agents|alkylating agents|mesh-ancestor
24439261|NCT00278213|Antimetabolites|antimetabolites|mesh-ancestor
24909188|NCT04312152|Vitamins|vitamins|mesh-list
24909370|NCT04309838|Treprostinil|treprostinil|mesh-list
25662278|NCT01642589|Vaccines|vaccines|mesh-list
24484357|NCT00447967|Leucovorin|leucovorin|mesh-list
25154605|NCT05470465|Oxycodone|oxycodone|mesh-list
24441833|NCT00288483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24442176|NCT00290264|Budesonide|budesonide|mesh-list
25063861|NCT03465345|Protective Agents|protective agents|mesh-ancestor
24911958|NCT04283110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273622|NCT02384746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442933|NCT00293332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24442934|NCT00293332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442935|NCT00293332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25849733|NCT00049335|Antimetabolites|antimetabolites|mesh-ancestor
25849734|NCT00049335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849735|NCT00049335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25234163|NCT02573064|Vancomycin|vancomycin|mesh-list
25234171|NCT02573220|Leucovorin|leucovorin|mesh-list
25849898|NCT00049595|Prednisone|prednisone|mesh-list
25849950|NCT00049634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24914913|NCT05253066|Goserelin|goserelin|mesh-list
24489587|NCT00474110|Narcotics|narcotics|mesh-ancestor
24914941|NCT05253014|Sensory System Agents|sensory system agents|mesh-ancestor
25850006|NCT00049790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25850007|NCT00049790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25850008|NCT00049790|Growth Substances|growth substances|mesh-ancestor
25850010|NCT00049790|Growth Inhibitors|growth inhibitors|mesh-ancestor
25850057|NCT00050154|Tipifarnib|tipifarnib|mesh-list
25850058|NCT00050154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850059|NCT00050180|Indinavir|indinavir|mesh-list
24915841|NCT04247646|Melatonin|melatonin|mesh-list
25850112|NCT00050271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850113|NCT00050271|Nootropic Agents|nootropic agents|mesh-ancestor
24915879|NCT04247087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25850212|NCT00050531|Sargramostim|sargramostim|mesh-list
24916692|NCT04238195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25850283|NCT00050804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25850314|NCT00050843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25850315|NCT00050843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25850316|NCT00050843|Growth Substances|growth substances|mesh-ancestor
25234375|NCT02571712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24895349|NCT04478734|Biotin|biotin|mesh-list
25850439|NCT00051155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25850440|NCT00051155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24922245|NCT04182828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24922247|NCT04182828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24922248|NCT04182828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922250|NCT04182191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24922251|NCT04182191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24922252|NCT04182191|Analgesics|analgesics|mesh-ancestor
24922322|NCT04181749|Antipyretics|antipyretics|mesh-ancestor
25154656|NCT05470270|Hydroxyurea|hydroxyurea|mesh-list
25154657|NCT05470270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25154658|NCT05470270|Antisickling Agents|antisickling agents|mesh-ancestor
24881983|NCT00006455|Vinblastine|vinblastine|mesh-list
24881984|NCT00006455|Levoleucovorin|levoleucovorin|mesh-list
24881985|NCT00006455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24881986|NCT00006455|Immunologic Factors|immunologic factors|mesh-ancestor
24881987|NCT00006455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881988|NCT00006455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25202033|NCT02724163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498271|NCT00513864|Analgesics|analgesics|mesh-ancestor
24954404|NCT03877003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24954405|NCT03877003|Nootropic Agents|nootropic agents|mesh-ancestor
24954406|NCT03876899|Evening primrose oil|evening primrose oil|mesh-list
24954407|NCT03876899|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25076056|NCT03376178|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25076063|NCT03376139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268759|NCT02414529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076076|NCT03375996|Mydriatics|mydriatics|mesh-ancestor
25076077|NCT03375996|Autonomic Agents|autonomic agents|mesh-ancestor
25076078|NCT03375996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076079|NCT03375996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076080|NCT03375996|Parasympatholytics|parasympatholytics|mesh-ancestor
25076081|NCT03375996|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25076082|NCT03375996|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25076083|NCT03375996|Cholinergic Agents|cholinergic agents|mesh-ancestor
25202034|NCT02724163|Analgesics|analgesics|mesh-ancestor
25076108|NCT03375671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25076109|NCT03375671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25076110|NCT03375671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076111|NCT03375671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25076122|NCT03375671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25076123|NCT03375671|Dopamine Agents|dopamine agents|mesh-ancestor
25076124|NCT03375671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25076125|NCT03375632|Dotinurad|dotinurad|mesh-list
25076220|NCT03374722|Analgesics|analgesics|mesh-ancestor
25076221|NCT03374722|Sensory System Agents|sensory system agents|mesh-ancestor
25076222|NCT03374722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076223|NCT03374709|Oxcarbazepine|oxcarbazepine|mesh-list
25076224|NCT03374709|Anticonvulsants|anticonvulsants|mesh-ancestor
25076225|NCT03374709|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25076226|NCT03374709|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25076227|NCT03374709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25076228|NCT03374709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076229|NCT03374709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24924003|NCT04164459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24924004|NCT04164719|Cyclobenzaprine|cyclobenzaprine|mesh-list
25076308|NCT03374163|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25076309|NCT03374163|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25076310|NCT03374163|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25076311|NCT03374163|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25076312|NCT03374007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25076313|NCT03374007|Antibodies|antibodies|mesh-list
25076314|NCT03374007|Immunoglobulins|immunoglobulins|mesh-list
25850466|NCT00051272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25850502|NCT00051389|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24954413|NCT03876899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24954414|NCT03876899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24954415|NCT03876899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24954416|NCT03876899|Antimetabolites|antimetabolites|mesh-ancestor
25850503|NCT00051389|Protease Inhibitors|protease inhibitors|mesh-ancestor
24954422|NCT03876704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954423|NCT03876938|Olanzapine|olanzapine|mesh-list
24954424|NCT03876938|Aprepitant|aprepitant|mesh-list
24954425|NCT03876938|Antiemetics|antiemetics|mesh-ancestor
24954426|NCT03876938|Autonomic Agents|autonomic agents|mesh-ancestor
24954429|NCT03876938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25076393|NCT03373669|Immunologic Factors|immunologic factors|mesh-ancestor
25076394|NCT03373669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076395|NCT03373409|Albuterol|albuterol|mesh-list
25076396|NCT03373409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25076397|NCT03373409|Autonomic Agents|autonomic agents|mesh-ancestor
25076400|NCT03373409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25076401|NCT03373409|Respiratory System Agents|respiratory system agents|mesh-ancestor
25076402|NCT03373409|Tocolytic Agents|tocolytic agents|mesh-ancestor
25076403|NCT03373409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25076404|NCT03373409|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24450527|NCT00319488|Hormones|hormones|mesh-ancestor
24916163|NCT04244097|Bupivacaine|bupivacaine|mesh-list
24882389|NCT00950989|Micronutrients|micronutrients|mesh-ancestor
24882390|NCT00904046|Pioglitazone|pioglitazone|mesh-list
25850505|NCT00051389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850506|NCT00051389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24624369|NCT01075880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850521|NCT00051545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25850522|NCT00051545|Immunologic Factors|immunologic factors|mesh-ancestor
25850523|NCT00051545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076454|NCT03372850|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25076455|NCT03372850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850524|NCT00051571|Docetaxel|docetaxel|mesh-list
25076456|NCT03372850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076458|NCT03372837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25076459|NCT03372837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25076460|NCT03372837|Immunologic Factors|immunologic factors|mesh-ancestor
25076463|NCT03372785|Aspirin|aspirin|mesh-list
25234558|NCT02570789|Sunitinib|sunitinib|mesh-list
25850529|NCT00051571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850530|NCT00051584|Gemcitabine|gemcitabine|mesh-list
25850531|NCT00051584|Doxorubicin|doxorubicin|mesh-list
25850532|NCT00051584|Immunoconjugates|immunoconjugates|mesh-list
25850533|NCT00051584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25850534|NCT00051584|Antimetabolites|antimetabolites|mesh-ancestor
25850535|NCT00051584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850536|NCT00051584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850537|NCT00051584|Antiviral Agents|antiviral agents|mesh-ancestor
25076586|NCT03371953|Vecuronium Bromide|vecuronium bromide|mesh-list
24882522|NCT05169593|Adalimumab|adalimumab|mesh-list
25850538|NCT00051584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25850549|NCT00051597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850550|NCT00051623|Infliximab|infliximab|mesh-list
24928040|NCT04126993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850551|NCT00051623|Dermatologic Agents|dermatologic agents|mesh-ancestor
25850552|NCT00051623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24957250|NCT03846102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24957251|NCT03846102|Antipyretics|antipyretics|mesh-ancestor
24957252|NCT03846102|Anesthetics, Local|anesthetics, local|mesh-ancestor
24957253|NCT03846102|Anesthetics|anesthetics|mesh-ancestor
25202063|NCT02723903|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25202064|NCT02723903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25202065|NCT02723903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25202066|NCT02723903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202067|NCT02723903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25076712|NCT03370848|Aspirin|aspirin|mesh-list
24847373|NCT02246595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847386|NCT02246712|Tramadol|tramadol|mesh-list
24847387|NCT02246712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24847388|NCT02246712|Narcotics|narcotics|mesh-ancestor
24847389|NCT02246712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24847390|NCT02246712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847391|NCT02246712|Analgesics|analgesics|mesh-ancestor
24847392|NCT02246712|Sensory System Agents|sensory system agents|mesh-ancestor
24929814|NCT04108468|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24929815|NCT04108468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24916601|NCT04238923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25076780|NCT03370705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076781|NCT03370705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25076782|NCT03370705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25076783|NCT03370705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25076784|NCT03370705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25076785|NCT03370705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24705092|NCT01482117|Clopidogrel|clopidogrel|mesh-list
25850645|NCT00052039|Interferons|interferons|mesh-list
25850646|NCT00052039|Interferon-gamma|interferon-gamma|mesh-list
25850647|NCT00052039|Azathioprine|azathioprine|mesh-list
25850648|NCT00052039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24916634|NCT04238884|Voriconazole|voriconazole|mesh-list
25076837|NCT03370406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25076838|NCT03370406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25076839|NCT03370406|Immunologic Factors|immunologic factors|mesh-ancestor
25076840|NCT03370406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076841|NCT03370406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25076842|NCT03370406|Interferon Inducers|interferon inducers|mesh-ancestor
25076843|NCT03370380|Aflibercept|aflibercept|mesh-list
25076844|NCT03370380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25076845|NCT03370380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25076846|NCT03370380|Growth Substances|growth substances|mesh-ancestor
25076847|NCT03370380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850658|NCT00052052|Interferons|interferons|mesh-list
24931079|NCT04093648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24931080|NCT04093648|Immunologic Factors|immunologic factors|mesh-ancestor
24931081|NCT04093648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931082|NCT04093648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24931085|NCT04093648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076912|NCT03369808|Immunologic Factors|immunologic factors|mesh-ancestor
25076913|NCT03369808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076914|NCT03369808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25076915|NCT03369808|Antacids|antacids|mesh-ancestor
25202079|NCT02723578|Pemetrexed|pemetrexed|mesh-list
24882983|NCT04673617|Rituximab|rituximab|mesh-list
25850663|NCT00052117|Capravirine|capravirine|mesh-list
25850664|NCT00052117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25077040|NCT03368391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25077041|NCT03368391|Adrenergic Agents|adrenergic agents|mesh-ancestor
25077042|NCT03368391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24916881|NCT04236115|Carticaine|carticaine|mesh-list
25077050|NCT03368391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25077051|NCT03368391|Nasal Decongestants|nasal decongestants|mesh-ancestor
25077052|NCT03368391|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25202080|NCT02723578|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25077053|NCT03368391|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25077054|NCT03368391|Protective Agents|protective agents|mesh-ancestor
25850665|NCT00052117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25109588|NCT03122561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25109589|NCT03122561|Analgesics|analgesics|mesh-ancestor
25109605|NCT03122730|Epoprostenol|epoprostenol|mesh-list
25109606|NCT03122730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25109607|NCT03122730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25077111|NCT03367377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25077112|NCT03367377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077113|NCT03367195|Omeprazole|omeprazole|mesh-list
25077114|NCT03367195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25077115|NCT03367195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25850675|NCT00052169|Tubulin Modulators|tubulin modulators|mesh-ancestor
25077133|NCT03367182|Growth Substances|growth substances|mesh-ancestor
24963125|NCT03792906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25850676|NCT00052169|Antimitotic Agents|antimitotic agents|mesh-ancestor
25850677|NCT00052169|Mitosis Modulators|mitosis modulators|mesh-ancestor
25850678|NCT00052169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850679|NCT00052169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25066318|NCT03707028|Antimitotic Agents|antimitotic agents|mesh-ancestor
25066319|NCT03707028|Mitosis Modulators|mitosis modulators|mesh-ancestor
25066321|NCT03707028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25850680|NCT00052169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876162|NCT03864406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25876163|NCT03864406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25876164|NCT03864406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25077154|NCT03367143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25077155|NCT03367143|Growth Substances|growth substances|mesh-ancestor
25077156|NCT03367143|Growth Inhibitors|growth inhibitors|mesh-ancestor
24816207|NCT02075086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25876165|NCT03864406|Antiviral Agents|antiviral agents|mesh-ancestor
25662493|NCT01645930|Glucocorticoids|glucocorticoids|mesh-ancestor
24957615|NCT03843281|Antipyretics|antipyretics|mesh-ancestor
24932777|NCT04077125|Rifaximin|rifaximin|mesh-list
25850681|NCT00052208|Gefitinib|gefitinib|mesh-list
25850682|NCT00052208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850683|NCT00052208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25850684|NCT00052208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850685|NCT00052208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850686|NCT00052221|Epoetin Alfa|epoetin alfa|mesh-list
25202081|NCT02723578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626542|NCT01087749|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24626543|NCT01087749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626544|NCT01087749|Diuretics|diuretics|mesh-ancestor
24626545|NCT01087749|Natriuretic Agents|natriuretic agents|mesh-ancestor
25077265|NCT03366246|Lidocaine|lidocaine|mesh-list
25154663|NCT05470244|Sensory System Agents|sensory system agents|mesh-ancestor
25154664|NCT05470244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25154665|NCT05470244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154666|NCT05470166|Lidocaine|lidocaine|mesh-list
25154667|NCT05470166|Anesthetics, Local|anesthetics, local|mesh-ancestor
25154668|NCT05470166|Anesthetics|anesthetics|mesh-ancestor
25154669|NCT05470166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24634393|NCT01133353|Adrenergic Agents|adrenergic agents|mesh-ancestor
25850708|NCT00052299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24933264|NCT04072263|Tubulin Modulators|tubulin modulators|mesh-ancestor
24933265|NCT04072263|Antimitotic Agents|antimitotic agents|mesh-ancestor
24933266|NCT04072263|Mitosis Modulators|mitosis modulators|mesh-ancestor
24869510|NCT03193931|Methotrexate|methotrexate|mesh-list
25850709|NCT00052299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850710|NCT00052299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077456|NCT03364530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850718|NCT00052299|Analgesics|analgesics|mesh-ancestor
25077563|NCT03363815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25077564|NCT03363815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25077565|NCT03363815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25202082|NCT02723578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917061|NCT04234191|Buprenorphine|buprenorphine|mesh-list
25850719|NCT00052299|Sensory System Agents|sensory system agents|mesh-ancestor
25850720|NCT00052299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24448316|NCT00311129|Immunologic Factors|immunologic factors|mesh-ancestor
25077629|NCT03363425|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25077630|NCT03363425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25077631|NCT03363425|Analgesics|analgesics|mesh-ancestor
25077632|NCT03363425|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25077633|NCT03363425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25077634|NCT03363425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25077635|NCT03363425|Adrenergic Agents|adrenergic agents|mesh-ancestor
25077636|NCT03363425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25234794|NCT02568995|Epinephrine|epinephrine|mesh-list
25234795|NCT02568995|Racepinephrine|racepinephrine|mesh-list
25234796|NCT02568995|Ropivacaine|ropivacaine|mesh-list
24625357|NCT01081938|Insulin|insulin|mesh-list
25077688|NCT03362905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077689|NCT03362853|Moxifloxacin|moxifloxacin|mesh-list
25077690|NCT03362853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25077691|NCT03362853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25077692|NCT03362853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25077693|NCT03362853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24934973|NCT04056702|Elexacaftor|elexacaftor|mesh-list
24934974|NCT04056702|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25234807|NCT02568995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25234808|NCT02568995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25234809|NCT02568995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24883812|NCT04760626|Insulin|insulin|mesh-list
25234817|NCT02568995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25234818|NCT02568995|Autonomic Agents|autonomic agents|mesh-ancestor
25004658|NCT02600923|Letrozole|letrozole|mesh-list
24456402|NCT00331084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24456403|NCT00331084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456404|NCT00331084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24456405|NCT00331084|Glucocorticoids|glucocorticoids|mesh-ancestor
24456406|NCT00331084|Hormones|hormones|mesh-ancestor
24456407|NCT00331084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24456408|NCT00331084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25077894|NCT03361124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077895|NCT03361098|Dapagliflozin|dapagliflozin|mesh-list
25077896|NCT03361098|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25077897|NCT03361098|Exenatide|exenatide|mesh-list
25077898|NCT03361098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077899|NCT03361098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24513580|NCT00583869|Analgesics|analgesics|mesh-ancestor
25850828|NCT00052416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24670261|NCT03117049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24670262|NCT03117049|Tubulin Modulators|tubulin modulators|mesh-ancestor
24787690|NCT01926587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24787691|NCT01926587|Antimetabolites|antimetabolites|mesh-ancestor
24787701|NCT01926639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24787702|NCT01926652|Amlodipine|amlodipine|mesh-list
24787703|NCT01926652|Candesartan|candesartan|mesh-list
24787704|NCT01926652|Candesartan cilexetil|candesartan cilexetil|mesh-list
24787705|NCT01926652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25850829|NCT00052416|Leprostatic Agents|leprostatic agents|mesh-ancestor
25077917|NCT03360760|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25077918|NCT03360760|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25077919|NCT03360760|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25004715|NCT01988883|Modafinil|modafinil|mesh-list
25004716|NCT01988883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25004717|NCT01988883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25004718|NCT01988883|Adrenergic Agents|adrenergic agents|mesh-ancestor
25004719|NCT01988883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25004720|NCT01988883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004721|NCT01988883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004722|NCT01988883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25004723|NCT01988883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25078012|NCT03359837|Metformin|metformin|mesh-list
25850848|NCT00052455|Alkylating Agents|alkylating agents|mesh-ancestor
24670611|NCT02201108|Sensory System Agents|sensory system agents|mesh-ancestor
24670612|NCT02201108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24670613|NCT02201108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24670614|NCT02201108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25850849|NCT00052468|Gemcitabine|gemcitabine|mesh-list
24670615|NCT02201108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24670616|NCT02201108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24670751|NCT01998971|Leprostatic Agents|leprostatic agents|mesh-ancestor
24670752|NCT01998971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24670753|NCT01998971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24670754|NCT01998971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25234892|NCT02568176|Anesthetics, General|anesthetics, general|mesh-ancestor
25234893|NCT02568176|Anesthetics|anesthetics|mesh-ancestor
25234894|NCT02568176|GABA Modulators|gaba modulators|mesh-ancestor
25234895|NCT02568176|GABA Agents|gaba agents|mesh-ancestor
25234896|NCT02568176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25234897|NCT02568176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958507|NCT03832621|Alkylating Agents|alkylating agents|mesh-ancestor
25234898|NCT02568176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25234899|NCT02568176|Antidepressive Agents|antidepressive agents|mesh-ancestor
25234900|NCT02568176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25234901|NCT02568176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25850868|NCT00052494|Irinotecan|irinotecan|mesh-list
25850869|NCT00052494|Imatinib Mesylate|imatinib mesylate|mesh-list
24626766|NCT01088659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626767|NCT01088659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24626768|NCT01088659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24626769|NCT01088724|Cyclophosphamide|cyclophosphamide|mesh-list
24626770|NCT01088724|Rituximab|rituximab|mesh-list
24626771|NCT01088724|Doxorubicin|doxorubicin|mesh-list
24626772|NCT01088724|Fludarabine|fludarabine|mesh-list
24626773|NCT01088724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24626774|NCT01088724|Immunologic Factors|immunologic factors|mesh-ancestor
24954777|NCT03872232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24954778|NCT03872232|Antimetabolites|antimetabolites|mesh-ancestor
24954779|NCT03872232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492591|NCT00487032|Fluticasone|fluticasone|mesh-list
24520772|NCT05326360|Autonomic Agents|autonomic agents|mesh-ancestor
24954780|NCT03872232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24706538|NCT01490437|Hormones|hormones|mesh-ancestor
25850898|NCT00052585|Gefitinib|gefitinib|mesh-list
25066777|NCT00493896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066779|NCT00493896|Antithrombins|antithrombins|mesh-ancestor
25850923|NCT00052611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25850924|NCT00052611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850925|NCT00052611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25850926|NCT00052611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25850927|NCT00052611|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25850928|NCT00052611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25850929|NCT00052611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850930|NCT00052611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850935|NCT00052689|Bortezomib|bortezomib|mesh-list
25850966|NCT00052780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850967|NCT00052780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850968|NCT00052780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850969|NCT00052832|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
25850970|NCT00052832|Vitamins|vitamins|mesh-ancestor
24541043|NCT00670618|Fluorides|fluorides|mesh-list
25850971|NCT00052832|Micronutrients|micronutrients|mesh-ancestor
25850972|NCT00052832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850974|NCT00052845|Sulindac sulfone|sulindac sulfone|mesh-list
25850997|NCT00052884|Melphalan|melphalan|mesh-list
25850998|NCT00052884|Amifostine|amifostine|mesh-list
25850999|NCT00052884|Immunologic Factors|immunologic factors|mesh-ancestor
25851000|NCT00052884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455149|NCT02645149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24455150|NCT02645149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851001|NCT00052884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25851002|NCT00052884|Alkylating Agents|alkylating agents|mesh-ancestor
25234999|NCT02567838|Lidocaine|lidocaine|mesh-list
24455180|NCT02448771|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24455184|NCT02448771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455185|NCT02448771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25851042|NCT00052936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24455197|NCT02329080|Etoposide|etoposide|mesh-list
24955279|NCT03866447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24955280|NCT03866447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24955281|NCT03866447|Dermatologic Agents|dermatologic agents|mesh-ancestor
25851043|NCT00052936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24781144|NCT01888250|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24781147|NCT01888263|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24781148|NCT01888263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24781150|NCT01888263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25851044|NCT00052936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24955692|NCT03862404|Anesthetics|anesthetics|mesh-ancestor
24393180|NCT00129038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24393181|NCT00129038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393182|NCT00129038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24393183|NCT00129038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24393184|NCT00129038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24393185|NCT00129038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24393186|NCT00129038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078203|NCT03358277|Dopamine Agents|dopamine agents|mesh-ancestor
25154691|NCT05469984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918269|NCT04221256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24918319|NCT04220996|Serotonin Agents|serotonin agents|mesh-ancestor
24955411|NCT03865147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955412|NCT03865147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24955413|NCT03865147|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24955414|NCT03865147|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24955415|NCT03865147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24955416|NCT03865147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955417|NCT03865147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24955418|NCT03865147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24955419|NCT03865147|Analgesics|analgesics|mesh-ancestor
24393302|NCT00129506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24393305|NCT00129519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24393306|NCT00129519|Immunologic Factors|immunologic factors|mesh-ancestor
24393307|NCT00129519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393308|NCT00129519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24621468|NCT01062516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24467211|NCT00376519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24467212|NCT00376519|Antimetabolites|antimetabolites|mesh-ancestor
24393731|NCT00130871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393732|NCT00130884|Simendan|simendan|mesh-list
24393733|NCT00130884|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24393734|NCT00130884|Vasodilator Agents|vasodilator agents|mesh-ancestor
24393735|NCT00130884|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24955803|NCT03860870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955804|NCT03860870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24955805|NCT03860870|Respiratory System Agents|respiratory system agents|mesh-ancestor
24955806|NCT03860870|Sympathomimetics|sympathomimetics|mesh-ancestor
24955807|NCT03860831|Midazolam|midazolam|mesh-list
24955808|NCT03860831|Ketamine|ketamine|mesh-list
24955809|NCT03860831|Analgesics|analgesics|mesh-ancestor
24955810|NCT03860831|Sensory System Agents|sensory system agents|mesh-ancestor
24955811|NCT03860831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955812|NCT03860831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955813|NCT03860831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24955830|NCT03860662|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24955831|NCT03860662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955832|NCT03860662|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24955833|NCT03860662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955834|NCT03860662|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24955835|NCT03860662|GABA Agonists|gaba agonists|mesh-ancestor
24918507|NCT04218981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24918508|NCT04218981|Serotonin Agents|serotonin agents|mesh-ancestor
24521000|NCT05210374|Disulfiram|disulfiram|mesh-list
25202118|NCT02723513|Anesthetics, General|anesthetics, general|mesh-ancestor
24393969|NCT00131430|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
25851082|NCT00053027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25851083|NCT00053092|Cyclophosphamide|cyclophosphamide|mesh-list
25851084|NCT00053092|Rituximab|rituximab|mesh-list
25851085|NCT00053092|Fludarabine|fludarabine|mesh-list
25851086|NCT00053092|Fludarabine phosphate|fludarabine phosphate|mesh-list
24955894|NCT03859908|Ethanol|ethanol|mesh-list
24787902|NCT01928160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393999|NCT00131703|Chloroquine|chloroquine|mesh-list
25202119|NCT02723513|Anesthetics|anesthetics|mesh-ancestor
24394000|NCT00131703|Pyrimethamine|pyrimethamine|mesh-list
24394001|NCT00131703|Sulfadoxine|sulfadoxine|mesh-list
24394002|NCT00131703|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24394003|NCT00131703|Amodiaquine|amodiaquine|mesh-list
24394004|NCT00131703|Amebicides|amebicides|mesh-ancestor
24394005|NCT00131703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24394006|NCT00131703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24394007|NCT00131703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24394008|NCT00131703|Antimalarials|antimalarials|mesh-ancestor
25851090|NCT00053092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24658226|NCT01270932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24394024|NCT00131716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394025|NCT00131716|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24394027|NCT00131742|Lamivudine|lamivudine|mesh-list
24394029|NCT00131742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25851091|NCT00053092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24394037|NCT00131755|Diazoxide|diazoxide|mesh-list
24394038|NCT00131755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24394039|NCT00131755|Vasodilator Agents|vasodilator agents|mesh-ancestor
24394041|NCT00131768|Viscosupplements|viscosupplements|mesh-ancestor
25851092|NCT00053092|Alkylating Agents|alkylating agents|mesh-ancestor
24394048|NCT00131846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24394049|NCT00131846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394051|NCT00131963|Cyclophosphamide|cyclophosphamide|mesh-list
24476895|NCT00416819|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24476896|NCT00416819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24519473|NCT01134250|Paclitaxel|paclitaxel|mesh-list
24476940|NCT00416845|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24870066|NCT04142983|Vaccines|vaccines|mesh-list
24476946|NCT00416858|Fluorouracil|fluorouracil|mesh-list
24476947|NCT00416858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25235078|NCT02567799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25235080|NCT02567799|Tubulin Modulators|tubulin modulators|mesh-ancestor
24955937|NCT03859570|Antioxidants|antioxidants|mesh-ancestor
24814728|NCT02066454|Apixaban|apixaban|mesh-list
25235093|NCT02567799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24479140|NCT00425724|Prednisone|prednisone|mesh-list
25202129|NCT02723487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25202130|NCT02723487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202131|NCT02723487|Sensory System Agents|sensory system agents|mesh-ancestor
25202132|NCT02723487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202133|NCT02723448|Aclarubicin|aclarubicin|mesh-list
24847654|NCT02248181|Dopamine Agents|dopamine agents|mesh-ancestor
25851118|NCT00053105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24956031|NCT03858387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24956032|NCT03858387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24918968|NCT04214938|Sensory System Agents|sensory system agents|mesh-ancestor
24918969|NCT04214938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24481246|NCT00433927|Folic Acid|folic acid|mesh-list
24481247|NCT00433927|Bevacizumab|bevacizumab|mesh-list
24956232|NCT03856112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956233|NCT03856112|Protease Inhibitors|protease inhibitors|mesh-ancestor
24956234|NCT03856112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078299|NCT03357757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078300|NCT03357757|Antimanic Agents|antimanic agents|mesh-ancestor
25078301|NCT03357757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25078302|NCT03357757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25078303|NCT03357757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25078304|NCT03357718|Midazolam|midazolam|mesh-list
25078305|NCT03357718|Dexmedetomidine|dexmedetomidine|mesh-list
25078306|NCT03357718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25078307|NCT03357718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24626648|NCT01088178|Contraceptive Agents|contraceptive agents|mesh-ancestor
25851127|NCT00053118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24862382|NCT02324998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24956272|NCT03855579|Simendan|simendan|mesh-list
25851139|NCT00053131|Antiviral Agents|antiviral agents|mesh-ancestor
24462995|NCT00358293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24462997|NCT00358319|Valproic Acid|valproic acid|mesh-list
25851154|NCT00053144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851155|NCT00053144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482785|NCT00440622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24521098|NCT05112081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24956921|NCT03849404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24956922|NCT03849404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24956923|NCT03849209|Pancrelipase|pancrelipase|mesh-list
24574862|NCT00828087|Cobalt|cobalt|mesh-list
24457352|NCT00334126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24457353|NCT00334126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24463064|NCT00358488|Respiratory System Agents|respiratory system agents|mesh-ancestor
24463065|NCT00358488|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24919267|NCT04213287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24919268|NCT04213287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24919269|NCT04213287|Analgesics|analgesics|mesh-ancestor
24919270|NCT04213287|Sensory System Agents|sensory system agents|mesh-ancestor
24494261|NCT00494598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24463066|NCT00358488|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24463078|NCT00358566|Antimetabolites|antimetabolites|mesh-ancestor
24463079|NCT00358566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957101|NCT03847363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782871|NCT01898624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782872|NCT01898624|Urological Agents|urological agents|mesh-ancestor
24463101|NCT00358696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24463104|NCT00358696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24522510|NCT03673956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483899|NCT00445796|Anthelmintics|anthelmintics|mesh-ancestor
24483900|NCT00445861|Docetaxel|docetaxel|mesh-list
24483901|NCT00445861|Cetuximab|cetuximab|mesh-list
24522623|NCT03567720|Antimitotic Agents|antimitotic agents|mesh-ancestor
24452285|NCT00326859|Narcotics|narcotics|mesh-ancestor
24452286|NCT00326859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24452287|NCT00326859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452288|NCT00326859|Analgesics|analgesics|mesh-ancestor
24452289|NCT00326859|Sensory System Agents|sensory system agents|mesh-ancestor
24452290|NCT00326859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24452291|NCT00327080|Acetylcholine|acetylcholine|mesh-list
24452292|NCT00327080|Vasodilator Agents|vasodilator agents|mesh-ancestor
24452293|NCT00327080|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25078334|NCT03357640|Contraceptive Agents|contraceptive agents|mesh-list
25078335|NCT03357640|Contraceptives, Oral|contraceptives, oral|mesh-list
24886256|NCT02090998|Anesthetics|anesthetics|mesh-ancestor
24463134|NCT00358969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463135|NCT00359112|Metformin|metformin|mesh-list
25851184|NCT00053196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851185|NCT00053196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25851186|NCT00053196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25851187|NCT00053196|Immunologic Factors|immunologic factors|mesh-ancestor
25851188|NCT00053196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25851189|NCT00053196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25851190|NCT00053196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25851191|NCT00053196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25851192|NCT00053196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25851193|NCT00053196|Antitubercular Agents|antitubercular agents|mesh-ancestor
25851194|NCT00053196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25851198|NCT00053196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24463149|NCT00359125|Hormone Antagonists|hormone antagonists|mesh-ancestor
24463163|NCT00359151|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24463164|NCT00359151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25078347|NCT03357575|Protective Agents|protective agents|mesh-ancestor
25078348|NCT03357133|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25078350|NCT03357133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25078351|NCT03357133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25078352|NCT03357133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078353|NCT03357133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25078354|NCT03357055|Ketamine|ketamine|mesh-list
24521227|NCT04958538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202149|NCT02723279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202150|NCT02723279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774728|NCT01847521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078383|NCT03356899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25078384|NCT03356899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078385|NCT03356899|Sensory System Agents|sensory system agents|mesh-ancestor
25078386|NCT03356899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078387|NCT03356873|Vitamin D|vitamin d|mesh-list
25078388|NCT03356873|Ergocalciferols|ergocalciferols|mesh-list
25202157|NCT02723253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25202158|NCT02723253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24957113|NCT03847155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957115|NCT03847155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24886305|NCT00902044|Fludarabine|fludarabine|mesh-list
24886306|NCT00902044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25851217|NCT00053222|Arsenic Trioxide|arsenic trioxide|mesh-list
25851218|NCT00053222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851219|NCT00053248|Imatinib Mesylate|imatinib mesylate|mesh-list
25851220|NCT00053248|Arsenic Trioxide|arsenic trioxide|mesh-list
24957158|NCT03846843|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24957159|NCT03846843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24957160|NCT03846843|Antimetabolites|antimetabolites|mesh-ancestor
24957161|NCT03846843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957176|NCT03846765|Respiratory System Agents|respiratory system agents|mesh-ancestor
24957177|NCT03846765|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24957179|NCT03846765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24463214|NCT00359333|Tubulin Modulators|tubulin modulators|mesh-ancestor
24463215|NCT00359333|Antimitotic Agents|antimitotic agents|mesh-ancestor
24463216|NCT00359333|Mitosis Modulators|mitosis modulators|mesh-ancestor
24463217|NCT00359359|Sagopilone|sagopilone|mesh-list
24463218|NCT00359359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463223|NCT00359567|Granisetron|granisetron|mesh-list
25851232|NCT00053287|Antimetabolites|antimetabolites|mesh-ancestor
24463225|NCT00359567|Autonomic Agents|autonomic agents|mesh-ancestor
24463226|NCT00359567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24463231|NCT00359567|Serotonin Agents|serotonin agents|mesh-ancestor
24787992|NCT01928888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24787993|NCT01928888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957685|NCT03842631|Timolol|timolol|mesh-list
24957686|NCT03842631|Maleic acid|maleic acid|mesh-list
24957687|NCT03842631|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24957688|NCT03842631|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24493937|NCT00493116|Hormones|hormones|mesh-ancestor
25851262|NCT00053326|Protective Agents|protective agents|mesh-ancestor
25851263|NCT00053326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496385|NCT00504413|Respiratory System Agents|respiratory system agents|mesh-ancestor
24496554|NCT00505492|Paclitaxel|paclitaxel|mesh-list
24847766|NCT02248506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24847767|NCT02248506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847768|NCT02248506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24847769|NCT02248506|Hormone Antagonists|hormone antagonists|mesh-ancestor
24958540|NCT03832452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24958541|NCT03832452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24958687|NCT03830164|Antimetabolites|antimetabolites|mesh-ancestor
24958688|NCT03830164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958689|NCT03830164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24501495|NCT00528892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24501496|NCT00528892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25235453|NCT02564237|Immunologic Factors|immunologic factors|mesh-ancestor
25235454|NCT02564237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235455|NCT02564094|Epoetin Alfa|epoetin alfa|mesh-list
25235456|NCT02564094|Hematinics|hematinics|mesh-ancestor
25235457|NCT02564107|Ibandronic Acid|ibandronic acid|mesh-list
25235458|NCT02564107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25235460|NCT02564146|Gemcitabine|gemcitabine|mesh-list
24959804|NCT03822091|Sympathomimetics|sympathomimetics|mesh-ancestor
24959805|NCT03822091|Autonomic Agents|autonomic agents|mesh-ancestor
24959806|NCT03822091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24959874|NCT03821714|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24959917|NCT03821168|Bevacizumab|bevacizumab|mesh-list
24788018|NCT01929070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24505579|NCT00541489|Sensory System Agents|sensory system agents|mesh-ancestor
24960541|NCT03816046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24960542|NCT03816046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960543|NCT03816046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24960545|NCT03815864|Antibodies|antibodies|mesh-list
24807168|NCT02020161|Methotrexate|methotrexate|mesh-list
24920085|NCT04205240|Immunologic Factors|immunologic factors|mesh-ancestor
24920086|NCT04205240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920087|NCT04205240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24920088|NCT04205240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24920089|NCT04205240|Alkylating Agents|alkylating agents|mesh-ancestor
24920091|NCT04205240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851304|NCT00053612|Vitamins|vitamins|mesh-ancestor
24463608|NCT00361621|Vincristine|vincristine|mesh-list
24463610|NCT00361621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24463611|NCT00361621|Immunologic Factors|immunologic factors|mesh-ancestor
24463612|NCT00361621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463613|NCT00361621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25202187|NCT02722902|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25851305|NCT00053612|Micronutrients|micronutrients|mesh-ancestor
25851306|NCT00053612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851307|NCT00053638|Tenofovir|tenofovir|mesh-list
25851308|NCT00053638|Lamivudine|lamivudine|mesh-list
25851309|NCT00053638|Efavirenz|efavirenz|mesh-list
24960619|NCT03815279|Lenalidomide|lenalidomide|mesh-list
24960620|NCT03815279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24960621|NCT03815279|Antiemetics|antiemetics|mesh-ancestor
24960622|NCT03815279|Autonomic Agents|autonomic agents|mesh-ancestor
25235472|NCT02564146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25235477|NCT02564003|Oxycodone|oxycodone|mesh-list
25235483|NCT02564003|Sensory System Agents|sensory system agents|mesh-ancestor
25235484|NCT02564003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25235485|NCT02563951|Granisetron|granisetron|mesh-list
25235486|NCT02563951|Antiemetics|antiemetics|mesh-ancestor
24960945|NCT03813043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25851326|NCT00053716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25851327|NCT00053716|Vasodilator Agents|vasodilator agents|mesh-ancestor
24509054|NCT00558181|Autonomic Agents|autonomic agents|mesh-ancestor
25851328|NCT00053716|Urological Agents|urological agents|mesh-ancestor
24457712|NCT00334932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25235521|NCT02563795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24619357|NCT01052129|Gout Suppressants|gout suppressants|mesh-ancestor
24463754|NCT00362037|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24463756|NCT00362063|Hormones|hormones|mesh-list
24961200|NCT03809949|Anesthetics|anesthetics|mesh-list
24817034|NCT02080416|Nelfinavir|nelfinavir|mesh-list
24961201|NCT03809949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961202|NCT03809949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961203|NCT03809949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24961205|NCT03809949|Analgesics|analgesics|mesh-ancestor
24961206|NCT03809949|Sensory System Agents|sensory system agents|mesh-ancestor
24961207|NCT03809949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961208|NCT03809949|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24961209|NCT03809949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24961210|NCT03809949|Anesthetics, General|anesthetics, general|mesh-ancestor
24961212|NCT03809793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25005124|NCT04782687|Dexamethasone|dexamethasone|mesh-list
25005125|NCT04782687|Lenalidomide|lenalidomide|mesh-list
25005126|NCT04782687|Daratumumab|daratumumab|mesh-list
25005127|NCT04782687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25005128|NCT04782687|Antiemetics|antiemetics|mesh-ancestor
25005129|NCT04782687|Autonomic Agents|autonomic agents|mesh-ancestor
25005130|NCT04782687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961152|NCT03810547|Ketamine|ketamine|mesh-list
25005131|NCT04782687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961354|NCT03809065|Nitroglycerin|nitroglycerin|mesh-list
24961355|NCT03809065|Vasodilator Agents|vasodilator agents|mesh-ancestor
24961356|NCT03809065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24920334|NCT04203212|Goserelin|goserelin|mesh-list
24512446|NCT00575224|Ribavirin|ribavirin|mesh-list
24961623|NCT03806582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961624|NCT03806582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961625|NCT03806582|Sympathomimetics|sympathomimetics|mesh-ancestor
24962070|NCT03802838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24962071|NCT03802838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24962072|NCT03802838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24962073|NCT03802838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962109|NCT03802422|Vitamin B Complex|vitamin b complex|mesh-ancestor
24962110|NCT03802422|Hematinics|hematinics|mesh-ancestor
24962144|NCT03801746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24962145|NCT03801746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962146|NCT03801746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24962147|NCT03801746|Immunologic Factors|immunologic factors|mesh-ancestor
24962148|NCT03801746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962149|NCT03801746|Antifungal Agents|antifungal agents|mesh-ancestor
24788220|NCT01930318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788221|NCT01930318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24788222|NCT01930318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24962777|NCT03795259|Rocuronium|rocuronium|mesh-list
24396742|NCT00139841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005193|NCT04467723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25005194|NCT04467723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25005195|NCT04467723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25235588|NCT02563821|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25235589|NCT02563821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25235590|NCT02563821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25235595|NCT02563405|Doxazosin|doxazosin|mesh-list
24963255|NCT03791905|Antimitotic Agents|antimitotic agents|mesh-ancestor
25202200|NCT02722811|Immunologic Factors|immunologic factors|mesh-ancestor
24963256|NCT03791905|Mitosis Modulators|mitosis modulators|mesh-ancestor
25078857|NCT03353103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25078858|NCT03353103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25078859|NCT03353025|Dopamine|dopamine|mesh-list
25078860|NCT03353025|Dopamine Agonists|dopamine agonists|mesh-list
25078861|NCT03353025|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25078862|NCT03353025|Sympathomimetics|sympathomimetics|mesh-ancestor
25078863|NCT03353025|Autonomic Agents|autonomic agents|mesh-ancestor
25078864|NCT03353025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078865|NCT03353025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235647|NCT02563327|Rifapentine|rifapentine|mesh-list
24963461|NCT03790605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24963491|NCT03790566|Anesthetics, Local|anesthetics, local|mesh-ancestor
24963492|NCT03790566|Anesthetics|anesthetics|mesh-ancestor
24963493|NCT03790566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25067346|NCT03444246|Iodine|iodine|mesh-list
24963494|NCT03790566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963598|NCT03790085|Antiemetics|antiemetics|mesh-ancestor
25039963|NCT03546907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25235695|NCT02562950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25235696|NCT02562950|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25235697|NCT02562950|Anesthetics, General|anesthetics, general|mesh-ancestor
25010019|NCT04780724|Nitrox|nitrox|mesh-list
25235756|NCT02562508|Vaccines|vaccines|mesh-list
25235757|NCT02562508|Immunologic Factors|immunologic factors|mesh-ancestor
25235758|NCT02562508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235759|NCT02562326|Insulin Lispro|insulin lispro|mesh-list
25235760|NCT02562326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25235762|NCT02562144|Lidocaine|lidocaine|mesh-list
25235794|NCT02562118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25235795|NCT02562183|Kallikreins|kallikreins|mesh-list
25235796|NCT02562183|Coagulants|coagulants|mesh-ancestor
24964473|NCT03782987|Hormone Antagonists|hormone antagonists|mesh-ancestor
24964474|NCT03782987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24964475|NCT03782987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964476|NCT03782987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24964477|NCT03783065|Propranolol|propranolol|mesh-list
24964503|NCT03782805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964504|NCT03782805|Vitamins|vitamins|mesh-ancestor
24964505|NCT03782805|Micronutrients|micronutrients|mesh-ancestor
24964507|NCT03782662|Itraconazole|itraconazole|mesh-list
24964603|NCT03781687|Morphine|morphine|mesh-list
25044720|NCT01055444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25044721|NCT01055444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044722|NCT01055444|Sensory System Agents|sensory system agents|mesh-ancestor
24964919|NCT03779516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24964920|NCT03779516|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24964921|NCT03779516|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24964922|NCT03779516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24767087|NCT01798602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24558153|NCT00755560|Albendazole|albendazole|mesh-list
24965163|NCT03778359|Levonorgestrel|levonorgestrel|mesh-list
24965191|NCT03778502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583836|NCT00877123|Vitamin D|vitamin d|mesh-list
24627129|NCT01090700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24627130|NCT01090700|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24627131|NCT01090700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24627132|NCT01090700|Cholinergic Agents|cholinergic agents|mesh-ancestor
24627133|NCT01090700|Antiviral Agents|antiviral agents|mesh-ancestor
25079018|NCT03351296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079019|NCT03351296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25079020|NCT03351296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25079021|NCT03351296|Growth Substances|growth substances|mesh-ancestor
25079022|NCT03351296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236026|NCT02560220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236027|NCT02560220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25236028|NCT02560220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627162|NCT01090830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24627163|NCT01090830|Growth Substances|growth substances|mesh-ancestor
24627167|NCT01090830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627168|NCT01090882|Bupivacaine|bupivacaine|mesh-list
24965197|NCT03778281|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24965198|NCT03778281|GABA Agonists|gaba agonists|mesh-ancestor
24965199|NCT03778281|GABA Agents|gaba agents|mesh-ancestor
24965203|NCT03778567|Telbivudine|telbivudine|mesh-list
24965204|NCT03778567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24894469|NCT04440267|Antiemetics|antiemetics|mesh-ancestor
25236078|NCT02559674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24962728|NCT03795571|Antiemetics|antiemetics|mesh-ancestor
24962784|NCT03795272|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24966110|NCT03771222|Decitabine|decitabine|mesh-list
24966111|NCT03771222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24966112|NCT03771222|Antimetabolites|antimetabolites|mesh-ancestor
24966113|NCT03771222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966114|NCT03771222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24966115|NCT03771222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24792048|NCT05413096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24792049|NCT05413096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966198|NCT03770637|Glucagon|glucagon|mesh-list
24966199|NCT03770637|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24966200|NCT03770637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24966201|NCT03770637|Hormones|hormones|mesh-ancestor
25851397|NCT00053872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25851398|NCT00053872|Tubulin Modulators|tubulin modulators|mesh-ancestor
25851399|NCT00053872|Antimitotic Agents|antimitotic agents|mesh-ancestor
25851400|NCT00053872|Mitosis Modulators|mitosis modulators|mesh-ancestor
25851401|NCT00053872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851402|NCT00053872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25851403|NCT00053872|Alkylating Agents|alkylating agents|mesh-ancestor
25851404|NCT00053885|Vatalanib|vatalanib|mesh-list
25851405|NCT00053885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24966455|NCT03767920|Antiemetics|antiemetics|mesh-ancestor
25079078|NCT03350633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079079|NCT03350633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25079080|NCT03350633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079081|NCT03350633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25079082|NCT03350633|Immunologic Factors|immunologic factors|mesh-ancestor
25079083|NCT03350633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079084|NCT03350633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25079085|NCT03350399|Mitogens|mitogens|mesh-list
25079086|NCT03350399|Mitosis Modulators|mitosis modulators|mesh-ancestor
25079087|NCT03350399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202227|NCT02722746|Sensory System Agents|sensory system agents|mesh-ancestor
25236142|NCT02559154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25236143|NCT02559154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25851418|NCT00053911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25851419|NCT00053911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25851420|NCT00053911|Alkylating Agents|alkylating agents|mesh-ancestor
25851421|NCT00053911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851422|NCT00053911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851423|NCT00053911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24464666|NCT00365755|Antimitotic Agents|antimitotic agents|mesh-ancestor
24464678|NCT00365898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851424|NCT00053911|Tubulin Modulators|tubulin modulators|mesh-ancestor
25851425|NCT00053911|Antimitotic Agents|antimitotic agents|mesh-ancestor
25851426|NCT00053911|Mitosis Modulators|mitosis modulators|mesh-ancestor
25851427|NCT00053911|Antimetabolites|antimetabolites|mesh-ancestor
25851428|NCT00053911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25851429|NCT00053911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25851430|NCT00053911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25851431|NCT00053911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24848092|NCT05147233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25851432|NCT00053911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851433|NCT00053911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24637285|NCT01149577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24637286|NCT01149577|Serotonin Agents|serotonin agents|mesh-ancestor
25851436|NCT00053911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25851437|NCT00053911|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25851438|NCT00053911|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25851439|NCT00053911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24637420|NCT01150162|Antioxidants|antioxidants|mesh-ancestor
24963121|NCT03792906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966613|NCT03766867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24966614|NCT03766867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24966615|NCT03766867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966616|NCT03766867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24966617|NCT03766867|Serotonin Agents|serotonin agents|mesh-ancestor
24966618|NCT03766867|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25154806|NCT05469204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24848180|NCT05000736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24637481|NCT01150630|Epirubicin|epirubicin|mesh-list
25236345|NCT02558036|Pyrithione zinc|pyrithione zinc|mesh-list
25236349|NCT02558023|Urapidil|urapidil|mesh-list
24524573|NCT04701476|Tirapazamine|tirapazamine|mesh-list
24465866|NCT00370851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24465867|NCT00370851|Growth Substances|growth substances|mesh-ancestor
24465868|NCT00370851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465869|NCT00370851|Growth Inhibitors|growth inhibitors|mesh-ancestor
24465870|NCT00370968|Zinc Sulfate|zinc sulfate|mesh-list
24465871|NCT00370968|Astringents|astringents|mesh-ancestor
24489525|NCT00473915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24627554|NCT01093300|Immunologic Factors|immunologic factors|mesh-ancestor
24627555|NCT01093300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627563|NCT01093638|Insulin|insulin|mesh-list
24848272|NCT04710030|Antiviral Agents|antiviral agents|mesh-ancestor
24524731|NCT04480918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24524732|NCT04480918|Anesthetics, General|anesthetics, general|mesh-ancestor
24524733|NCT04480918|Anesthetics|anesthetics|mesh-ancestor
25851487|NCT00054041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851488|NCT00054054|Cisplatin|cisplatin|mesh-list
25851489|NCT00054054|Docetaxel|docetaxel|mesh-list
24465977|NCT00371410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24465978|NCT00371410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851490|NCT00054054|Fluorouracil|fluorouracil|mesh-list
24465979|NCT00371488|Lapatinib|lapatinib|mesh-list
25851503|NCT00054106|Flutamide|flutamide|mesh-list
25851504|NCT00054106|Buserelin|buserelin|mesh-list
25851505|NCT00054106|Androgen Antagonists|androgen antagonists|mesh-ancestor
25851506|NCT00054106|Hormone Antagonists|hormone antagonists|mesh-ancestor
25851507|NCT00054106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25236570|NCT02556931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25236571|NCT02556931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25236572|NCT02556905|Dexamethasone|dexamethasone|mesh-list
25236573|NCT02556905|Lenalidomide|lenalidomide|mesh-list
25236574|NCT02556905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25236575|NCT02556905|Antiemetics|antiemetics|mesh-ancestor
25236576|NCT02556905|Autonomic Agents|autonomic agents|mesh-ancestor
25236577|NCT02556905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25236600|NCT02556970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25236601|NCT02556970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25236602|NCT02556970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25236603|NCT02556970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25236604|NCT02556970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236605|NCT02556970|Anesthetics, Local|anesthetics, local|mesh-ancestor
24628151|NCT01096745|Cisplatin|cisplatin|mesh-list
25851557|NCT00054184|Antimitotic Agents|antimitotic agents|mesh-ancestor
25851558|NCT00054184|Mitosis Modulators|mitosis modulators|mesh-ancestor
25851559|NCT00054184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851560|NCT00054197|Gemcitabine|gemcitabine|mesh-list
25851561|NCT00054197|Paclitaxel|paclitaxel|mesh-list
25851562|NCT00054197|Vinorelbine|vinorelbine|mesh-list
24805439|NCT02009449|Levoleucovorin|levoleucovorin|mesh-list
24628291|NCT01097902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24805440|NCT02009449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24805441|NCT02009449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525518|NCT03195374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25662945|NCT01652040|Methyltestosterone|methyltestosterone|mesh-list
24394220|NCT00132561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525543|NCT03181789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24525544|NCT03181789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24446797|NCT00306020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24398409|NCT00144326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24805913|NCT02012777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805914|NCT02012777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24805915|NCT02012777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24600662|NCT00959881|Donepezil|donepezil|mesh-list
25851565|NCT00054197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851566|NCT00054197|Tubulin Modulators|tubulin modulators|mesh-ancestor
24525890|NCT02519777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24525891|NCT02519777|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24525892|NCT02519777|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24467665|NCT00378443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24467666|NCT00378443|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25851567|NCT00054197|Antimitotic Agents|antimitotic agents|mesh-ancestor
24628395|NCT01098526|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25005333|NCT04196010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25005334|NCT04196010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25005335|NCT04196010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25005336|NCT04196010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25005337|NCT04196010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24788249|NCT01930552|Antimetabolites|antimetabolites|mesh-ancestor
25851569|NCT00054197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851570|NCT00054197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24788259|NCT01930552|Antidotes|antidotes|mesh-ancestor
24467947|NCT00379249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25851581|NCT00054210|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
25851582|NCT00054210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24468005|NCT00379457|Etoposide|etoposide|mesh-list
24468006|NCT00379457|Vincristine|vincristine|mesh-list
24493616|NCT00491790|Hormone Antagonists|hormone antagonists|mesh-ancestor
24468041|NCT00379509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24468043|NCT00379522|Vasopressins|vasopressins|mesh-list
24526809|NCT00613457|Prednisone|prednisone|mesh-list
24526810|NCT00613457|Cyclophosphamide|cyclophosphamide|mesh-list
24526836|NCT00613457|Hormones|hormones|mesh-ancestor
24807428|NCT02021851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24807429|NCT02021851|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24807430|NCT02021851|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24628423|NCT01098994|Vitamin E|vitamin e|mesh-list
24628424|NCT01098994|Tocopherols|tocopherols|mesh-list
24628425|NCT01098994|alpha-Tocopherol|alpha-tocopherol|mesh-list
24628426|NCT01098994|Vitamins|vitamins|mesh-ancestor
24468959|NCT00384020|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24468960|NCT00384020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24468961|NCT00384020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24468962|NCT00384046|Testosterone|testosterone|mesh-list
24468963|NCT00384046|Androgens|androgens|mesh-ancestor
24468964|NCT00384046|Hormones|hormones|mesh-ancestor
24468988|NCT00384202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24468989|NCT00384202|Immunologic Factors|immunologic factors|mesh-ancestor
24808087|NCT02025023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808089|NCT02025036|Oxaliplatin|oxaliplatin|mesh-list
24808090|NCT02025036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24808091|NCT02025036|Antimetabolites|antimetabolites|mesh-ancestor
24808092|NCT02025036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808093|NCT02025036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808094|NCT02025140|Anesthetics|anesthetics|mesh-list
25236831|NCT02555761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25236832|NCT02555761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25236833|NCT02555761|Histamine Antagonists|histamine antagonists|mesh-ancestor
25236834|NCT02555761|Histamine Agents|histamine agents|mesh-ancestor
24469445|NCT00385931|Simvastatin|simvastatin|mesh-list
25851614|NCT00054288|Gemcitabine|gemcitabine|mesh-list
25851615|NCT00054288|Irinotecan|irinotecan|mesh-list
25851616|NCT00054288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24809938|NCT02036827|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24809939|NCT02036827|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24809940|NCT02036827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24486420|NCT00457808|Sirolimus|sirolimus|mesh-list
24528169|NCT00620178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528170|NCT00620204|Atorvastatin|atorvastatin|mesh-list
24457857|NCT00335439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24469596|NCT00386516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791251|NCT04887389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24791252|NCT04871191|Rituximab|rituximab|mesh-list
24791253|NCT04871191|Abatacept|abatacept|mesh-list
24610541|NCT01003002|Levodopa|levodopa|mesh-list
24791254|NCT04871191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24848355|NCT04553003|Prednisone|prednisone|mesh-list
24848356|NCT04553003|Methylprednisolone|methylprednisolone|mesh-list
25079383|NCT03348098|Tubulin Modulators|tubulin modulators|mesh-ancestor
25079384|NCT03348098|Antimitotic Agents|antimitotic agents|mesh-ancestor
25079385|NCT03348098|Mitosis Modulators|mitosis modulators|mesh-ancestor
24896620|NCT04434365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24469805|NCT00387400|Temozolomide|temozolomide|mesh-list
24469806|NCT00387400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469807|NCT00387400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24469863|NCT00387582|Growth Substances|growth substances|mesh-ancestor
24469864|NCT00387582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469865|NCT00387582|Growth Inhibitors|growth inhibitors|mesh-ancestor
24469872|NCT00387699|Bevacizumab|bevacizumab|mesh-list
25851636|NCT00054340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851637|NCT00054340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25851638|NCT00054340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25851639|NCT00054340|Alkylating Agents|alkylating agents|mesh-ancestor
25851640|NCT00054340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851641|NCT00054340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24848403|NCT04458311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24848404|NCT04458311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24848405|NCT04458311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848406|NCT04458311|Hormone Antagonists|hormone antagonists|mesh-ancestor
24848407|NCT04458311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24848408|NCT04458311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848424|NCT04422795|Anesthetics|anesthetics|mesh-ancestor
24471295|NCT00394394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24471296|NCT00394394|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24471297|NCT00394394|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24471298|NCT00394407|Insulin|insulin|mesh-list
24471300|NCT00394407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24471328|NCT00394537|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24471329|NCT00394537|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24471330|NCT00394537|Adrenergic Agents|adrenergic agents|mesh-ancestor
24628522|NCT01099527|Capecitabine|capecitabine|mesh-list
24471586|NCT00396045|Growth Inhibitors|growth inhibitors|mesh-ancestor
24471587|NCT00396045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24471588|NCT00396058|Methylphenidate|methylphenidate|mesh-list
24471591|NCT00396058|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24471594|NCT00396058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471595|NCT00396058|Dopamine Agents|dopamine agents|mesh-ancestor
24471596|NCT00396058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25237076|NCT02552745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25237077|NCT02552745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237078|NCT02552745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237079|NCT02552745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25237080|NCT02552745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25237081|NCT02552745|Analgesics|analgesics|mesh-ancestor
25237082|NCT02552745|Sensory System Agents|sensory system agents|mesh-ancestor
25237087|NCT02553044|Vitamin D|vitamin d|mesh-list
24453991|NCT04575233|Ropivacaine|ropivacaine|mesh-list
24496495|NCT00505102|Everolimus|everolimus|mesh-list
25851659|NCT00054392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851660|NCT00054392|Tubulin Modulators|tubulin modulators|mesh-ancestor
24471944|NCT00397501|Sequestering Agents|sequestering agents|mesh-ancestor
24471945|NCT00397553|Insulin glulisine|insulin glulisine|mesh-list
25202276|NCT02722694|Dermatologic Agents|dermatologic agents|mesh-ancestor
24472036|NCT00397787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24472037|NCT00397787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24472038|NCT00397787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472039|NCT00397800|Cyclophosphamide|cyclophosphamide|mesh-list
24472040|NCT00397800|Rituximab|rituximab|mesh-list
24472204|NCT00398528|(T,G)-A-L|(t,g)-a-l|mesh-list
24472205|NCT00398528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25851666|NCT00054392|Antiviral Agents|antiviral agents|mesh-ancestor
24472240|NCT00398580|Testosterone|testosterone|mesh-list
24472241|NCT00398580|Testosterone undecanoate|testosterone undecanoate|mesh-list
25851667|NCT00054392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24472258|NCT00398658|Clindamycin palmitate|clindamycin palmitate|mesh-list
24472259|NCT00398658|Clindamycin phosphate|clindamycin phosphate|mesh-list
24675629|NCT01344252|Lidocaine|lidocaine|mesh-list
24472260|NCT00398658|Gentamicins|gentamicins|mesh-list
24810120|NCT02037919|Progestins|progestins|mesh-ancestor
24472291|NCT00398775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25079442|NCT03347760|Octreotide|octreotide|mesh-list
25079443|NCT03347760|Edotreotide|edotreotide|mesh-list
25079444|NCT03347760|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25079445|NCT03347760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813987|NCT02061657|Misoprostol|misoprostol|mesh-list
25851668|NCT00054392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25079447|NCT03347760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24472420|NCT00399126|Tubulin Modulators|tubulin modulators|mesh-ancestor
24472421|NCT00399126|Antimitotic Agents|antimitotic agents|mesh-ancestor
24472422|NCT00399126|Mitosis Modulators|mitosis modulators|mesh-ancestor
24472423|NCT00399126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472424|NCT00399152|Sunitinib|sunitinib|mesh-list
24472425|NCT00399152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472426|NCT00399152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24472428|NCT00399152|Growth Substances|growth substances|mesh-ancestor
24788346|NCT01930864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813653|NCT02059759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24813654|NCT02059759|Antiviral Agents|antiviral agents|mesh-ancestor
25202282|NCT02722694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24813976|NCT02061631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24813977|NCT02061631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24813978|NCT02061631|Protease Inhibitors|protease inhibitors|mesh-ancestor
24813979|NCT02061631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813980|NCT02061631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813984|NCT02061644|Anesthetics|anesthetics|mesh-list
24472779|NCT00400530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472780|NCT00400530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24814535|NCT02065128|Dermatologic Agents|dermatologic agents|mesh-ancestor
24814536|NCT02065128|Sensory System Agents|sensory system agents|mesh-ancestor
24814537|NCT02065128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24814538|NCT02065128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814539|NCT02065219|Bupivacaine|bupivacaine|mesh-list
24814540|NCT02065219|Anesthetics, Local|anesthetics, local|mesh-ancestor
24814541|NCT02065219|Anesthetics|anesthetics|mesh-ancestor
24814543|NCT02065219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851675|NCT00054405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851676|NCT00054405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25851677|NCT00054405|Analgesics|analgesics|mesh-ancestor
25851678|NCT00054405|Sensory System Agents|sensory system agents|mesh-ancestor
25851679|NCT00054405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25851680|NCT00054405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851681|NCT00054405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25079468|NCT03347591|polysaccharide-K|polysaccharide-k|mesh-list
25851682|NCT00054405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25851683|NCT00054405|Antiviral Agents|antiviral agents|mesh-ancestor
24528875|NCT00623207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24528879|NCT00623220|Nitrous Oxide|nitrous oxide|mesh-list
25079467|NCT03347708|Protective Agents|protective agents|mesh-ancestor
25079469|NCT03347591|Hemostatics|hemostatics|mesh-list
25079470|NCT03347591|Coagulants|coagulants|mesh-ancestor
24815477|NCT02070458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24815478|NCT02070458|Antimetabolites|antimetabolites|mesh-ancestor
25851688|NCT00054405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25851689|NCT00054405|Growth Substances|growth substances|mesh-ancestor
25851690|NCT00054405|Growth Inhibitors|growth inhibitors|mesh-ancestor
24752912|NCT01712828|Sensory System Agents|sensory system agents|mesh-ancestor
24752913|NCT01712828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24752914|NCT01712828|Antiemetics|antiemetics|mesh-ancestor
24752915|NCT01712828|Autonomic Agents|autonomic agents|mesh-ancestor
25851691|NCT00054418|Vitamin D|vitamin d|mesh-list
24854163|NCT02272478|Decitabine|decitabine|mesh-list
24530533|NCT00630929|Celecoxib|celecoxib|mesh-list
24788526|NCT01932177|Everolimus|everolimus|mesh-list
24457925|NCT00335686|Nevirapine|nevirapine|mesh-list
25851730|NCT00054470|Trastuzumab|trastuzumab|mesh-list
25851742|NCT00054522|Dexamethasone|dexamethasone|mesh-list
25237365|NCT02550756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25237366|NCT02550756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701812|NCT01461174|Nootropic Agents|nootropic agents|mesh-ancestor
24701813|NCT01461174|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25851787|NCT00054561|Antiviral Agents|antiviral agents|mesh-ancestor
25080087|NCT03342300|Pirarubicin|pirarubicin|mesh-list
25237478|NCT02550262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24705323|NCT01484184|Levodopa|levodopa|mesh-list
25005706|NCT02817659|Glucagon|glucagon|mesh-list
24848840|NCT03391466|Cyclophosphamide|cyclophosphamide|mesh-list
25237729|NCT02549118|Tenoxicam|tenoxicam|mesh-list
24772423|NCT01833715|Narcotics|narcotics|mesh-ancestor
25237963|NCT02547792|Vaccines|vaccines|mesh-list
25237966|NCT02547870|Rilpivirine|rilpivirine|mesh-list
25238021|NCT02547402|CXA-10|cxa-10|mesh-list
25066036|NCT04375228|Rituximab|rituximab|mesh-list
25067581|NCT03442491|Coagulants|coagulants|mesh-ancestor
24830017|NCT02156726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24921007|NCT04195321|Mydriatics|mydriatics|mesh-ancestor
24921577|NCT04189094|Etoposide|etoposide|mesh-list
25238218|NCT02545712|Ethanol|ethanol|mesh-list
24922552|NCT04178850|Dermatologic Agents|dermatologic agents|mesh-ancestor
24922807|NCT04176887|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24601827|NCT00966082|Vasodilator Agents|vasodilator agents|mesh-ancestor
24602852|NCT00971165|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24602853|NCT00971165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24602854|NCT00971165|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24602855|NCT00971165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25851879|NCT00054938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24602952|NCT00971763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602953|NCT00971763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409227|NCT00181558|Atrasentan|atrasentan|mesh-list
24710714|NCT01511692|Incretins|incretins|mesh-ancestor
25238674|NCT05224492|Sulforaphane|sulforaphane|mesh-list
25238710|NCT05157412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25851913|NCT00055107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25851914|NCT00055120|Ritonavir|ritonavir|mesh-list
24672810|NCT01333878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688480|NCT03055390|Mydriatics|mydriatics|mesh-ancestor
24672811|NCT01333878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672812|NCT01333878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24672813|NCT01333878|Immunologic Factors|immunologic factors|mesh-ancestor
24672814|NCT01333878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672815|NCT01333878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24672838|NCT01333917|Curcumin|curcumin|mesh-list
24672847|NCT01333917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672848|NCT01333917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672849|NCT01333917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672850|NCT01333982|Amoxicillin|amoxicillin|mesh-list
24672985|NCT01334645|Hemostatics|hemostatics|mesh-ancestor
24672986|NCT01334645|Coagulants|coagulants|mesh-ancestor
24672987|NCT01334645|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24672988|NCT01334645|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25851915|NCT00055120|Lopinavir|lopinavir|mesh-list
24849572|NCT02249130|Zidovudine|zidovudine|mesh-list
25851916|NCT00055120|Tenofovir|tenofovir|mesh-list
24788807|NCT01933971|Lenograstim|lenograstim|mesh-list
24673222|NCT01336218|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24673223|NCT01336218|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24673224|NCT01336218|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24673225|NCT01336218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25851917|NCT00055120|Emtricitabine|emtricitabine|mesh-list
24711316|NCT01514721|Travoprost|travoprost|mesh-list
25238864|NCT04812366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25238897|NCT04649203|Riboflavin|riboflavin|mesh-list
24678118|NCT01359826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25238997|NCT04390581|Lidocaine|lidocaine|mesh-list
25238998|NCT04390581|Anesthetics, Local|anesthetics, local|mesh-ancestor
25238999|NCT04390581|Anesthetics|anesthetics|mesh-ancestor
25239000|NCT04390581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25239001|NCT04390581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239002|NCT04390581|Sensory System Agents|sensory system agents|mesh-ancestor
25239003|NCT04390581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239004|NCT04390581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25239005|NCT04390581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25068576|NCT03432767|Analgesics|analgesics|mesh-ancestor
24684340|NCT01396733|Antioxidants|antioxidants|mesh-ancestor
25851950|NCT00055198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24716319|NCT01541085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716320|NCT01541085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716357|NCT01541189|Valsartan|valsartan|mesh-list
24688078|NCT03410355|Cortisone|cortisone|mesh-list
24822747|NCT02113150|Analgesics|analgesics|mesh-ancestor
24691376|NCT01406301|PENTA|penta|mesh-list
24721019|NCT01571908|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24692239|NCT01412307|Lenalidomide|lenalidomide|mesh-list
25851986|NCT00055393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24693525|NCT01421043|Triazolam|triazolam|mesh-list
25202497|NCT02720978|Oxytocin|oxytocin|mesh-list
24693837|NCT01422603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24693838|NCT01422616|Metoprolol|metoprolol|mesh-list
25239745|NCT02540369|Aflibercept|aflibercept|mesh-list
24760426|NCT01758029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24694413|NCT01425424|Vitamins|vitamins|mesh-list
24760627|NCT01759108|Antioxidants|antioxidants|mesh-ancestor
24760629|NCT01759108|Protective Agents|protective agents|mesh-ancestor
24694662|NCT05385185|Growth Inhibitors|growth inhibitors|mesh-ancestor
25070023|NCT03422510|CXA-10|cxa-10|mesh-list
24612433|NCT01013987|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25852007|NCT00055432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25070080|NCT03421860|Phenylephrine|phenylephrine|mesh-list
24695217|NCT04203472|Budesonide|budesonide|mesh-list
24695357|NCT03757689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852031|NCT00055549|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24723086|NCT01584778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723175|NCT01585623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24723176|NCT01585623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723177|NCT01585623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25240005|NCT02538302|Urological Agents|urological agents|mesh-ancestor
25240015|NCT02538432|Antiviral Agents|antiviral agents|mesh-ancestor
25240041|NCT02538172|Valganciclovir|valganciclovir|mesh-list
24697308|NCT01434134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24697309|NCT01434134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24697310|NCT01434134|Adrenergic Agents|adrenergic agents|mesh-ancestor
24697311|NCT01434134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24697312|NCT01434134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697314|NCT01434134|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24697528|NCT01435343|Idarubicin|idarubicin|mesh-list
25663624|NCT01660893|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25663628|NCT01660906|Dasatinib|dasatinib|mesh-list
24698383|NCT01440933|Magnesium Sulfate|magnesium sulfate|mesh-list
24699985|NCT01450046|Vitamins|vitamins|mesh-ancestor
25071607|NCT03407404|GABA Modulators|gaba modulators|mesh-ancestor
25071842|NCT03405584|Bismuth|bismuth|mesh-list
25072013|NCT03404310|Zinc Sulfate|zinc sulfate|mesh-list
25006560|NCT04892420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24727795|NCT01612871|Tamoxifen|tamoxifen|mesh-list
24428774|NCT00241163|Thrombin|thrombin|mesh-list
24728332|NCT01615601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24728333|NCT01615601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24728334|NCT01615601|Protease Inhibitors|protease inhibitors|mesh-ancestor
25072679|NCT03399955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852121|NCT00055653|Glucocorticoids|glucocorticoids|mesh-ancestor
24953998|NCT03880045|Natriuretic Agents|natriuretic agents|mesh-ancestor
24633869|NCT01131468|Antioxidants|antioxidants|mesh-ancestor
25072890|NCT03398837|Dronabinol|dronabinol|mesh-list
24634541|NCT01133886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24634735|NCT01134848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240650|NCT05298020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24635065|NCT01136759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24635066|NCT01136850|Azithromycin|azithromycin|mesh-list
24635067|NCT01136850|Chloroquine|chloroquine|mesh-list
24635068|NCT01136850|Pyrimethamine|pyrimethamine|mesh-list
24635069|NCT01136850|Sulfadoxine|sulfadoxine|mesh-list
24635070|NCT01136850|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25240657|NCT05297994|Vaccines|vaccines|mesh-list
24850277|NCT02252523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24850278|NCT02252523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24850280|NCT02252523|Adrenergic Agents|adrenergic agents|mesh-ancestor
24789620|NCT01938183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24731388|NCT01634412|Sensory System Agents|sensory system agents|mesh-ancestor
24731389|NCT01634412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24395335|NCT00135785|Bupropion|bupropion|mesh-list
24616946|NCT01040078|Immunologic Factors|immunologic factors|mesh-ancestor
24616947|NCT01040078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616950|NCT01040091|Efavirenz|efavirenz|mesh-list
24637972|NCT01154426|Gemcitabine|gemcitabine|mesh-list
25073683|NCT03393780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732533|NCT01640002|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25073864|NCT03392623|Tretinoin|tretinoin|mesh-list
25006740|NCT04671810|Eculizumab|eculizumab|mesh-list
25006745|NCT04671615|Palbociclib|palbociclib|mesh-list
24641023|NCT01171378|Ofatumumab|ofatumumab|mesh-list
24617537|NCT01043666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25240875|NCT04576546|Inositol|inositol|mesh-list
24736529|NCT01662804|Antibodies|antibodies|mesh-list
24643026|NCT01183364|Docetaxel|docetaxel|mesh-list
25240914|NCT04498832|Vaccines|vaccines|mesh-list
24954252|NCT03877718|Anesthetics|anesthetics|mesh-ancestor
24740385|NCT01688154|Protective Agents|protective agents|mesh-ancestor
24741347|NCT01693445|Oxaliplatin|oxaliplatin|mesh-list
24743170|NCT04973930|Citalopram|citalopram|mesh-list
24744333|NCT04353284|Camostat|camostat|mesh-list
24744334|NCT04353284|Protease Inhibitors|protease inhibitors|mesh-ancestor
24744335|NCT04353284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663868|NCT01663012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411108|NCT00187915|Cyclosporine|cyclosporine|mesh-list
24748101|NCT02908334|Sertraline|sertraline|mesh-list
24748102|NCT02908334|Antidepressive Agents|antidepressive agents|mesh-ancestor
24748103|NCT02908334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24748104|NCT02908334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24748188|NCT02810743|Olaparib|olaparib|mesh-list
24999048|NCT05317468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007027|NCT04349371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24643851|NCT01187849|Metformin|metformin|mesh-list
25048881|NCT00658762|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25202631|NCT02720367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755810|NCT01729260|Piperazine|piperazine|mesh-list
25000619|NCT04140396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25000620|NCT04140396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25000717|NCT03777319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24756669|NCT01735058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25241372|NCT02864407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852342|NCT00055978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757852|NCT01742689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24758169|NCT01744236|Exenatide|exenatide|mesh-list
24939881|NCT04005872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202673|NCT02719834|Sensory System Agents|sensory system agents|mesh-ancestor
25202674|NCT02719834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25049230|NCT00626106|Fulvestrant|fulvestrant|mesh-list
25202698|NCT02719405|Caseins|caseins|mesh-list
24645619|NCT01198938|Melatonin|melatonin|mesh-list
25852394|NCT00056082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24646117|NCT01202097|Fluticasone|fluticasone|mesh-list
24941036|NCT03995563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24941037|NCT03995563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049522|NCT00595699|Serotonin Agents|serotonin agents|mesh-ancestor
24648618|NCT01216020|Cisplatin|cisplatin|mesh-list
25004151|NCT02591953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004434|NCT01704859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004462|NCT01142284|Probucol|probucol|mesh-list
24649156|NCT01218724|Losartan|losartan|mesh-list
24649241|NCT01219062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651063|NCT01229189|Vitamin D|vitamin d|mesh-list
25852529|NCT00056693|Growth Inhibitors|growth inhibitors|mesh-ancestor
24652720|NCT01239875|Vaccines|vaccines|mesh-list
25269325|NCT02410746|Analgesics|analgesics|mesh-ancestor
25269326|NCT02410746|Sensory System Agents|sensory system agents|mesh-ancestor
25852558|NCT00056875|Mitogens|mitogens|mesh-list
24653951|NCT01246362|Sensory System Agents|sensory system agents|mesh-ancestor
24653952|NCT01246362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24653953|NCT01246362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654363|NCT01248923|Mitosis Modulators|mitosis modulators|mesh-ancestor
24467859|NCT00378976|Antiviral Agents|antiviral agents|mesh-ancestor
25664127|NCT01666314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24946269|NCT03942458|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24946270|NCT03942458|Purinergic Agents|purinergic agents|mesh-ancestor
24654482|NCT01249690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24654497|NCT01249846|Chlorhexidine|chlorhexidine|mesh-list
24654587|NCT01250496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654589|NCT01250496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25852647|NCT00057343|Rituximab|rituximab|mesh-list
24654789|NCT01251458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654790|NCT01251471|Citalopram|citalopram|mesh-list
24654791|NCT01251471|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24799087|NCT01967017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24654794|NCT01251471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654795|NCT01251471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24654898|NCT01251991|Cathartics|cathartics|mesh-ancestor
24655009|NCT01253473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24655184|NCT01254825|Ropivacaine|ropivacaine|mesh-list
24655264|NCT01255410|Vaccines|vaccines|mesh-list
25852661|NCT00057382|Doxorubicin|doxorubicin|mesh-list
24655318|NCT01255852|Antimetabolites|antimetabolites|mesh-ancestor
24655324|NCT01255878|Analgesics|analgesics|mesh-ancestor
24655755|NCT01257867|Antimanic Agents|antimanic agents|mesh-ancestor
24947640|NCT03927313|Antipyretics|antipyretics|mesh-ancestor
24947641|NCT03927313|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24947642|NCT03927313|Antitubercular Agents|antitubercular agents|mesh-ancestor
24947643|NCT03927313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24947644|NCT03927313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24947645|NCT03927313|Leprostatic Agents|leprostatic agents|mesh-ancestor
24656196|NCT01260506|Growth Inhibitors|growth inhibitors|mesh-ancestor
24656198|NCT01260519|Calcium heparin|calcium heparin|mesh-list
24656199|NCT01260519|Anticoagulants|anticoagulants|mesh-ancestor
24656200|NCT01260519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24656201|NCT01260519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24656202|NCT01260519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852668|NCT00057395|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
25852669|NCT00057395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656311|NCT01261065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24656312|NCT01261065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24947891|NCT03925233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24656342|NCT01261117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24947910|NCT03925233|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24948001|NCT03923803|Katacalcin|katacalcin|mesh-list
24948075|NCT03923075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24948076|NCT03923075|Analgesics|analgesics|mesh-ancestor
24948077|NCT03923075|Sensory System Agents|sensory system agents|mesh-ancestor
24948078|NCT03923075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24948079|NCT03923075|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25031079|NCT03590587|Hormones|hormones|mesh-ancestor
25852681|NCT00057408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24469056|NCT00384475|Hormones|hormones|mesh-ancestor
24469065|NCT00384540|Dobutamine|dobutamine|mesh-list
24657054|NCT01265342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25852683|NCT00057408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852684|NCT00057408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25852685|NCT00057408|Serotonin Agents|serotonin agents|mesh-ancestor
25852686|NCT00057421|Prednisolone|prednisolone|mesh-list
24657096|NCT01265641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24657097|NCT01265641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24657098|NCT01265641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852690|NCT00057421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24799197|NCT01967758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24774699|NCT01847404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24657728|NCT01269021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24657729|NCT01269021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24657731|NCT01269021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658002|NCT01269827|Vasodilator Agents|vasodilator agents|mesh-ancestor
24658003|NCT01269827|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24659279|NCT01276691|Sensory System Agents|sensory system agents|mesh-ancestor
24659315|NCT01276769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469474|NCT00385970|Vitamin B Complex|vitamin b complex|mesh-ancestor
24950103|NCT02633059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950104|NCT02633059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24950106|NCT02633059|Hormones|hormones|mesh-ancestor
24950107|NCT02633059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24950108|NCT02633059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24950109|NCT02633059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950139|NCT02452983|Sertraline|sertraline|mesh-list
24950675|NCT03912974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24950676|NCT03912974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950677|NCT03912974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24659988|NCT01281514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25852727|NCT00057564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852728|NCT00057564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25852729|NCT00057564|Glucocorticoids|glucocorticoids|mesh-ancestor
25852730|NCT00057564|Hormones|hormones|mesh-ancestor
24659998|NCT01281527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24659999|NCT01281527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24660000|NCT01281527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799449|NCT01969032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24799450|NCT01969032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24660242|NCT01282385|Simvastatin|simvastatin|mesh-list
24660884|NCT01286896|Growth Substances|growth substances|mesh-ancestor
25852749|NCT00057616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25852758|NCT00057642|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24452249|NCT00326664|Cediranib|cediranib|mesh-list
24833451|NCT02173964|Bromides|bromides|mesh-list
24799921|NCT01972113|Vitamin K|vitamin k|mesh-list
25852761|NCT00057642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592130|NCT00920283|Cobalt|cobalt|mesh-list
24800011|NCT01972828|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24800013|NCT01972828|Blood Substitutes|blood substitutes|mesh-ancestor
24941824|NCT03987529|Sevoflurane|sevoflurane|mesh-list
24941825|NCT03987529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24800014|NCT01972880|Ipragliflozin|ipragliflozin|mesh-list
25075927|NCT03377257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662869|NCT01297179|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24662870|NCT01297179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24662871|NCT01297179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24834007|NCT02176499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24743710|NCT04655144|Dexamethasone|dexamethasone|mesh-list
24663006|NCT01297907|Methacholine Chloride|methacholine chloride|mesh-list
24834124|NCT02177318|Tiotropium Bromide|tiotropium bromide|mesh-list
24592529|NCT00922519|Listerine|listerine|mesh-list
24663568|NCT01302236|Hormone Antagonists|hormone antagonists|mesh-ancestor
24663571|NCT01302236|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24663593|NCT01302340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24834491|NCT02179099|Botulinum Toxins|botulinum toxins|mesh-list
25269768|NCT02408185|Colistin|colistin|mesh-list
24951445|NCT03904732|Analgesics|analgesics|mesh-ancestor
24951446|NCT03904732|Sensory System Agents|sensory system agents|mesh-ancestor
24951447|NCT03904732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24951448|NCT03904732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951449|NCT03904732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24951451|NCT03904732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24663743|NCT01303549|Amphotericin B|amphotericin b|mesh-list
24663954|NCT01304264|Maleic acid|maleic acid|mesh-list
24800146|NCT01973790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800228|NCT01974037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24800230|NCT01974167|Alfacalcidol|alfacalcidol|mesh-list
25269806|NCT02408419|Bupivacaine|bupivacaine|mesh-list
24664514|NCT01307475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24664709|NCT01308255|Hematinics|hematinics|mesh-ancestor
24664908|NCT01309178|Adrenergic Agents|adrenergic agents|mesh-ancestor
24683227|NCT01390883|PENTA|penta|mesh-list
24935421|NCT04050826|Lidocaine|lidocaine|mesh-list
24935422|NCT04050826|Prilocaine|prilocaine|mesh-list
24835428|NCT02182778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24835429|NCT02182778|Immunologic Factors|immunologic factors|mesh-ancestor
24835430|NCT02182778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935527|NCT04049539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24456075|NCT00329810|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24666204|NCT01318005|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24666205|NCT01318005|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24935817|NCT04047797|Ixazomib|ixazomib|mesh-list
24666327|NCT01318590|Anesthetics|anesthetics|mesh-ancestor
24935904|NCT04046861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935905|NCT04046861|Protective Agents|protective agents|mesh-ancestor
24935906|NCT04046822|Liraglutide|liraglutide|mesh-list
24935907|NCT04046822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24935908|NCT04046822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667103|NCT01322191|Analgesics|analgesics|mesh-ancestor
25852840|NCT00058006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533503|NCT00644215|Mitomycin|mitomycin|mesh-list
24836149|NCT02184273|Antipyretics|antipyretics|mesh-ancestor
24836216|NCT02184364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836241|NCT02184637|Antimalarials|antimalarials|mesh-ancestor
24836245|NCT02184819|Riboflavin|riboflavin|mesh-list
25852968|NCT00058292|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25852969|NCT00058292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25852970|NCT00058292|Alkylating Agents|alkylating agents|mesh-ancestor
25852971|NCT00058292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25852972|NCT00058305|Vincristine|vincristine|mesh-list
25852973|NCT00058305|Bryostatin 1|bryostatin 1|mesh-list
25852996|NCT00058331|Hematinics|hematinics|mesh-ancestor
25852997|NCT00058357|Lidocaine|lidocaine|mesh-list
25852998|NCT00058357|Anesthetics, Local|anesthetics, local|mesh-ancestor
25852999|NCT00058357|Anesthetics|anesthetics|mesh-ancestor
24936598|NCT04038619|Loperamide|loperamide|mesh-list
25664249|NCT01667926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269984|NCT02407340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25664258|NCT01667926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853024|NCT00058461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25853026|NCT00058461|Immunologic Factors|immunologic factors|mesh-ancestor
24937307|NCT04030741|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24937308|NCT04030442|Morphine|morphine|mesh-list
24937309|NCT04030442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24937310|NCT04030442|Narcotics|narcotics|mesh-ancestor
24850933|NCT02254239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850935|NCT02254447|Candesartan|candesartan|mesh-list
24937715|NCT04026022|Anesthetics|anesthetics|mesh-ancestor
25853181|NCT00059306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25853182|NCT00059306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853190|NCT00059358|Ribavirin|ribavirin|mesh-list
25853221|NCT00059631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25853222|NCT00059631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25270060|NCT02406872|Anesthetics|anesthetics|mesh-ancestor
24534824|NCT00648063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853415|NCT00060385|Prednisone|prednisone|mesh-list
25853505|NCT00060476|Rofecoxib|rofecoxib|mesh-list
25853512|NCT00060476|Analgesics|analgesics|mesh-ancestor
24938413|NCT04019106|Hormones|hormones|mesh-ancestor
24938758|NCT04016116|Pembrolizumab|pembrolizumab|mesh-list
24841931|NCT02219100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24841932|NCT02219100|Luteolytic Agents|luteolytic agents|mesh-ancestor
24841933|NCT02219100|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24841971|NCT02219191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24841973|NCT02219191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841987|NCT02219217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24842009|NCT02219412|Aspirin|aspirin|mesh-list
24537636|NCT00655603|Hormones|hormones|mesh-list
25854256|NCT00062426|Growth Inhibitors|growth inhibitors|mesh-ancestor
24843156|NCT02225886|Ascorbic Acid|ascorbic acid|mesh-list
24955131|NCT03867994|Carvedilol|carvedilol|mesh-list
24843752|NCT02229201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730544|NCT01628770|Hematinics|hematinics|mesh-ancestor
24939152|NCT04012775|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25854500|NCT00063791|Bortezomib|bortezomib|mesh-list
25854546|NCT00063947|Immunologic Factors|immunologic factors|mesh-ancestor
25854547|NCT00063947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844910|NCT02235246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25854600|NCT00064116|Immunologic Factors|immunologic factors|mesh-ancestor
25854659|NCT00064194|Vitamins|vitamins|mesh-ancestor
25854662|NCT00064194|Antioxidants|antioxidants|mesh-ancestor
24845486|NCT02238145|Ipratropium|ipratropium|mesh-list
25854755|NCT00064467|Bupropion|bupropion|mesh-list
25854860|NCT00065273|Olanzapine|olanzapine|mesh-list
24540284|NCT00667160|Tacrolimus|tacrolimus|mesh-list
24833280|NCT02173652|Linagliptin|linagliptin|mesh-list
25854963|NCT00065741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855027|NCT00066040|Chlorhexidine|chlorhexidine|mesh-list
24846514|NCT02242864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846515|NCT02242877|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24846516|NCT02242877|Telmisartan|telmisartan|mesh-list
25855083|NCT00066248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24859039|NCT02301286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25855084|NCT00066248|Antipruritics|antipruritics|mesh-ancestor
24764359|NCT01780909|Paromomycin|paromomycin|mesh-list
24764360|NCT01780909|Domperidone|domperidone|mesh-list
24764361|NCT01780909|Loperamide|loperamide|mesh-list
24764362|NCT01780909|Antidiarrheals|antidiarrheals|mesh-list
24764363|NCT01780909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24846599|NCT02243241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24846600|NCT02243241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24939634|NCT04008186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939635|NCT04008186|Antifungal Agents|antifungal agents|mesh-ancestor
24939636|NCT04008186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25855098|NCT00066274|Irinotecan|irinotecan|mesh-list
25664412|NCT01669785|Protective Agents|protective agents|mesh-ancestor
25664413|NCT01669785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855137|NCT00066378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25855138|NCT00066378|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24733096|NCT01643278|Ipilimumab|ipilimumab|mesh-list
24733097|NCT01643278|Dasatinib|dasatinib|mesh-list
25855139|NCT00066378|Hormone Antagonists|hormone antagonists|mesh-ancestor
25855140|NCT00066378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25855141|NCT00066378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855142|NCT00066391|Cisplatin|cisplatin|mesh-list
25855204|NCT00066482|Mesna|mesna|mesh-list
24846733|NCT02243566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846735|NCT02243566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24846737|NCT02243618|Polaprezinc|polaprezinc|mesh-list
24846738|NCT02243618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25855220|NCT00066482|Protective Agents|protective agents|mesh-ancestor
25855249|NCT00066612|Irinotecan|irinotecan|mesh-list
25270432|NCT02404454|Protective Agents|protective agents|mesh-ancestor
25270433|NCT02404337|Betaine|betaine|mesh-list
25855295|NCT00066768|Immunologic Factors|immunologic factors|mesh-ancestor
24545510|NCT00693589|Vitamins|vitamins|mesh-ancestor
24545511|NCT00693589|Micronutrients|micronutrients|mesh-ancestor
24545876|NCT00695604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24545877|NCT00695604|Respiratory System Agents|respiratory system agents|mesh-ancestor
25855458|NCT00067262|GABA Agents|gaba agents|mesh-ancestor
25270495|NCT02404142|Atracurium|atracurium|mesh-list
24546250|NCT00697372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24625637|NCT01082731|Schistosomicides|schistosomicides|mesh-ancestor
24846929|NCT02244307|Adrenergic Agents|adrenergic agents|mesh-list
24546740|NCT00699946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161713|NCT02540330|Fulvestrant|fulvestrant|mesh-list
25855520|NCT00067496|Modafinil|modafinil|mesh-list
25855544|NCT00067535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202818|NCT02718742|Antimitotic Agents|antimitotic agents|mesh-ancestor
24605332|NCT00984633|Anesthetics|anesthetics|mesh-ancestor
24478985|NCT00425191|Docetaxel|docetaxel|mesh-list
25855582|NCT00067860|Hormones|hormones|mesh-list
25270594|NCT02403804|Betaine|betaine|mesh-list
25855615|NCT00067938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734948|NCT01654965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25267453|NCT02423096|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25267454|NCT02423096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25267455|NCT02423096|Antidepressive Agents|antidepressive agents|mesh-ancestor
25267456|NCT02423096|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25267457|NCT02423096|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25267458|NCT02423018|Pregabalin|pregabalin|mesh-list
25267459|NCT02423018|Analgesics|analgesics|mesh-ancestor
25267460|NCT02423018|Sensory System Agents|sensory system agents|mesh-ancestor
24827130|NCT02137616|Olanzapine|olanzapine|mesh-list
25267485|NCT02422563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267486|NCT02422563|Tubulin Modulators|tubulin modulators|mesh-ancestor
25267487|NCT02422563|Antimitotic Agents|antimitotic agents|mesh-ancestor
25267488|NCT02422563|Mitosis Modulators|mitosis modulators|mesh-ancestor
25267489|NCT02422563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267490|NCT02422563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25267491|NCT02422563|Alkylating Agents|alkylating agents|mesh-ancestor
25855671|NCT00068315|Bortezomib|bortezomib|mesh-list
25855673|NCT00068315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24940179|NCT04003350|Antipyretics|antipyretics|mesh-ancestor
25855779|NCT00068653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855780|NCT00068653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680752|NCT01376128|Serotonin Agents|serotonin agents|mesh-ancestor
25855830|NCT00068809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25855831|NCT00068848|Contraceptive Agents|contraceptive agents|mesh-list
25855832|NCT00068848|Contraceptives, Oral|contraceptives, oral|mesh-list
25855833|NCT00068848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24447058|NCT00307307|Simvastatin|simvastatin|mesh-list
25855881|NCT00069459|Bupropion|bupropion|mesh-list
25855916|NCT00069550|Nootropic Agents|nootropic agents|mesh-ancestor
25855917|NCT00069550|Antitussive Agents|antitussive agents|mesh-ancestor
25855918|NCT00069550|Respiratory System Agents|respiratory system agents|mesh-ancestor
25855919|NCT00069550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25855924|NCT00069836|Metformin|metformin|mesh-list
25855925|NCT00069836|Rosiglitazone|rosiglitazone|mesh-list
25855926|NCT00069836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25855927|NCT00069836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855928|NCT00069875|Gemcitabine|gemcitabine|mesh-list
25855929|NCT00069875|Cisplatin|cisplatin|mesh-list
25855971|NCT00069927|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25855972|NCT00069940|Sargramostim|sargramostim|mesh-list
25855973|NCT00069940|Immunologic Factors|immunologic factors|mesh-ancestor
25855974|NCT00069940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847170|NCT02245438|Protease Inhibitors|protease inhibitors|mesh-ancestor
24847171|NCT02245438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683121|NCT01390012|Hormones|hormones|mesh-ancestor
25855975|NCT00069966|Cytarabine|cytarabine|mesh-list
25855976|NCT00069966|Methylprednisolone|methylprednisolone|mesh-list
25856010|NCT00070057|Analgesics|analgesics|mesh-ancestor
25856011|NCT00070057|Sensory System Agents|sensory system agents|mesh-ancestor
25856012|NCT00070057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25856013|NCT00070057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847193|NCT02245451|Methadone|methadone|mesh-list
25856070|NCT00070122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25856071|NCT00070122|Antidotes|antidotes|mesh-ancestor
25856072|NCT00070122|Protective Agents|protective agents|mesh-ancestor
25856073|NCT00070122|Vitamin B Complex|vitamin b complex|mesh-ancestor
25856074|NCT00070122|Vitamins|vitamins|mesh-ancestor
25856075|NCT00070122|Micronutrients|micronutrients|mesh-ancestor
25856076|NCT00070148|Megestrol|megestrol|mesh-list
25856077|NCT00070148|Megestrol Acetate|megestrol acetate|mesh-list
25856078|NCT00070148|Oxandrolone|oxandrolone|mesh-list
25856118|NCT00070174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25856119|NCT00070174|Alkylating Agents|alkylating agents|mesh-ancestor
25856120|NCT00070174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856121|NCT00070174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856122|NCT00070174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24683723|NCT01393769|Melphalan|melphalan|mesh-list
25856123|NCT00070174|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25267647|NCT02421289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25267655|NCT02420938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25267656|NCT02420938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267657|NCT02420938|Immunologic Factors|immunologic factors|mesh-ancestor
24516837|NCT00604006|Diuretics|diuretics|mesh-ancestor
25856356|NCT00070447|Antimitotic Agents|antimitotic agents|mesh-ancestor
25856357|NCT00070447|Mitosis Modulators|mitosis modulators|mesh-ancestor
25856358|NCT00070473|Pemetrexed|pemetrexed|mesh-list
25856359|NCT00070473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856360|NCT00070473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24827663|NCT02140632|Hormones|hormones|mesh-ancestor
24827664|NCT02140632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24827665|NCT02140632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25856390|NCT00070486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25856391|NCT00070525|Tipifarnib|tipifarnib|mesh-list
25267676|NCT02421029|Pentetic Acid|pentetic acid|mesh-list
24479935|NCT00429065|Rituximab|rituximab|mesh-list
25856539|NCT00071253|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25856587|NCT00071643|Citalopram|citalopram|mesh-list
25856588|NCT00071643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24685927|NCT05138029|BB 1101|bb 1101|mesh-list
25856589|NCT00071643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25856606|NCT00071695|Analgesics|analgesics|mesh-ancestor
24483873|NCT00445523|Interferons|interferons|mesh-list
25856671|NCT00072007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25856672|NCT00072007|Alkylating Agents|alkylating agents|mesh-ancestor
25856673|NCT00072007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856674|NCT00072007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856675|NCT00072007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25856676|NCT00072007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24847503|NCT02247414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25856716|NCT00072072|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25856717|NCT00072072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856718|NCT00072072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25856719|NCT00072072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856720|NCT00072072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856721|NCT00072072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25856722|NCT00072072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25856723|NCT00072072|Analgesics|analgesics|mesh-ancestor
25856724|NCT00072072|Sensory System Agents|sensory system agents|mesh-ancestor
25856725|NCT00072072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25856726|NCT00072072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847622|NCT02248142|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24847623|NCT02248142|Dopamine Agonists|dopamine agonists|mesh-ancestor
25856746|NCT00072098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25856747|NCT00072098|Growth Substances|growth substances|mesh-ancestor
25856748|NCT00072098|Growth Inhibitors|growth inhibitors|mesh-ancestor
24686771|NCT04583501|Omalizumab|omalizumab|mesh-list
24827857|NCT02142036|Panitumumab|panitumumab|mesh-list
24827858|NCT02142036|Everolimus|everolimus|mesh-list
24827859|NCT02142036|Sunitinib|sunitinib|mesh-list
24827860|NCT02142036|Dasatinib|dasatinib|mesh-list
24827861|NCT02142036|Lapatinib|lapatinib|mesh-list
24827862|NCT02142036|Gefitinib|gefitinib|mesh-list
24827863|NCT02142036|Afatinib|afatinib|mesh-list
25856754|NCT00072124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24847819|NCT05353361|Paclitaxel|paclitaxel|mesh-list
24827895|NCT02142140|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24827897|NCT02142166|Dialysis Solutions|dialysis solutions|mesh-list
24827898|NCT02142166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25856792|NCT00072215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512511|NCT00575523|Atropine|atropine|mesh-list
25856818|NCT00072267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25856819|NCT00072319|Paclitaxel|paclitaxel|mesh-list
25856820|NCT00072319|Cyclophosphamide|cyclophosphamide|mesh-list
25856821|NCT00072319|Epirubicin|epirubicin|mesh-list
25856822|NCT00072319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25856823|NCT00072319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856824|NCT00072319|Tubulin Modulators|tubulin modulators|mesh-ancestor
25856825|NCT00072319|Antimitotic Agents|antimitotic agents|mesh-ancestor
25856826|NCT00072319|Mitosis Modulators|mitosis modulators|mesh-ancestor
24847963|NCT05330364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847969|NCT05299242|Adalimumab|adalimumab|mesh-list
24847970|NCT05299242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24847971|NCT05299242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24828228|NCT02144246|Hormones|hormones|mesh-ancestor
25856869|NCT00072436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856870|NCT00072436|Growth Inhibitors|growth inhibitors|mesh-ancestor
25856871|NCT00072436|Growth Substances|growth substances|mesh-ancestor
25856872|NCT00072436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24848055|NCT05223582|Prednisone|prednisone|mesh-list
24848056|NCT05223582|Abiraterone Acetate|abiraterone acetate|mesh-list
24848057|NCT05223582|Androgens|androgens|mesh-list
24848058|NCT05223582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24848059|NCT05223582|Glucocorticoids|glucocorticoids|mesh-ancestor
24848060|NCT05223582|Hormones|hormones|mesh-ancestor
24848062|NCT05223582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848093|NCT05147233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24848095|NCT05124457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25270966|NCT02402348|Metformin|metformin|mesh-list
24828424|NCT02145559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828425|NCT02145559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24721714|NCT01576640|Bupropion|bupropion|mesh-list
25856953|NCT00072618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856954|NCT00072618|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24848220|NCT04876066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267835|NCT02420002|Analgesics|analgesics|mesh-ancestor
25267836|NCT02420002|Sensory System Agents|sensory system agents|mesh-ancestor
25267837|NCT02420002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24848319|NCT04574713|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25267854|NCT02419651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267855|NCT02419651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25267856|NCT02419651|Narcotics|narcotics|mesh-ancestor
25267857|NCT02419651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25856995|NCT00072787|Cisplatin|cisplatin|mesh-list
25857011|NCT00072852|Irinotecan|irinotecan|mesh-list
25857012|NCT00072852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25857013|NCT00072852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25857014|NCT00072852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857015|NCT00072852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857016|NCT00072852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857062|NCT00073164|Olanzapine|olanzapine|mesh-list
25876392|NCT03576547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267895|NCT02419638|Immunologic Factors|immunologic factors|mesh-ancestor
25267896|NCT02419638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267897|NCT02419443|Gabapentin|gabapentin|mesh-list
25267898|NCT02419443|Analgesics|analgesics|mesh-ancestor
25267899|NCT02419443|Sensory System Agents|sensory system agents|mesh-ancestor
25267900|NCT02419443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25857117|NCT00073385|Docetaxel|docetaxel|mesh-list
25857118|NCT00073385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857119|NCT00073385|Tubulin Modulators|tubulin modulators|mesh-ancestor
25857136|NCT00073411|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25857137|NCT00073411|Analgesics|analgesics|mesh-ancestor
24943685|NCT03968042|Antioxidants|antioxidants|mesh-ancestor
24829049|NCT02149459|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24829050|NCT02149459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829051|NCT02149628|Propofol|propofol|mesh-list
24829052|NCT02149628|Desflurane|desflurane|mesh-list
24829053|NCT02149628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25271055|NCT02401425|Oxytocics|oxytocics|mesh-ancestor
24829095|NCT02149901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24829096|NCT02149901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829097|NCT02149901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25857212|NCT00073710|Vitamins|vitamins|mesh-ancestor
25271075|NCT02401269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271114|NCT02401139|Ketamine|ketamine|mesh-list
25857283|NCT00073879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857284|NCT00073879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25857285|NCT00073879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25857286|NCT00073879|Antimetabolites|antimetabolites|mesh-ancestor
25857287|NCT00073879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25664661|NCT01673490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25857288|NCT00073905|Gemcitabine|gemcitabine|mesh-list
25857289|NCT00073905|Capecitabine|capecitabine|mesh-list
25271390|NCT02399397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739055|NCT01678963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24739057|NCT01678963|Growth Substances|growth substances|mesh-ancestor
25271458|NCT02398929|Bisoprolol|bisoprolol|mesh-list
25857706|NCT00075517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857716|NCT00075543|Docetaxel|docetaxel|mesh-list
25268103|NCT02417493|Respiratory System Agents|respiratory system agents|mesh-ancestor
25268104|NCT02417493|Mydriatics|mydriatics|mesh-ancestor
25857758|NCT00075634|Cyclophosphamide|cyclophosphamide|mesh-list
25857759|NCT00075634|Doxorubicin|doxorubicin|mesh-list
24692087|NCT01411124|Anesthetics|anesthetics|mesh-ancestor
24448609|NCT00312325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24448619|NCT00312416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448620|NCT00312481|Ascorbic Acid|ascorbic acid|mesh-list
24448621|NCT00312481|Picosulfate sodium|picosulfate sodium|mesh-list
24448622|NCT00312481|Magnesium citrate|magnesium citrate|mesh-list
25268114|NCT02417467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25271558|NCT02398201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271567|NCT02398136|Midazolam|midazolam|mesh-list
25857896|NCT00075868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25857897|NCT00075868|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25857898|NCT00075868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857899|NCT00075894|Alanosine|alanosine|mesh-list
25857900|NCT00075894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25857901|NCT00075894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857902|NCT00075894|Chelating Agents|chelating agents|mesh-ancestor
25857903|NCT00075894|Sequestering Agents|sequestering agents|mesh-ancestor
25857904|NCT00075894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268119|NCT02417467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25268120|NCT02417467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271596|NCT02397720|Nivolumab|nivolumab|mesh-list
24653534|NCT01244230|Fexofenadine|fexofenadine|mesh-list
24618099|NCT01046786|Protective Agents|protective agents|mesh-ancestor
24618100|NCT01046786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25857912|NCT00075907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857913|NCT00075907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24848887|NCT03289351|Tazobactam|tazobactam|mesh-list
24848888|NCT03289351|Piperacillin|piperacillin|mesh-list
24848889|NCT03289351|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25271606|NCT02397772|Albendazole|albendazole|mesh-list
25271607|NCT02397772|Anthelmintics|anthelmintics|mesh-ancestor
25271626|NCT02398058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25271627|NCT02398058|Alkylating Agents|alkylating agents|mesh-ancestor
25271628|NCT02397382|Midazolam|midazolam|mesh-list
25271629|NCT02397382|Dextromethorphan|dextromethorphan|mesh-list
25268162|NCT02417298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25268163|NCT02417298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740318|NCT01687751|Adrenergic Agents|adrenergic agents|mesh-ancestor
24740319|NCT01687751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24740320|NCT01687751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740321|NCT01687751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24740322|NCT01687751|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24654396|NCT01249430|Cytarabine|cytarabine|mesh-list
24740330|NCT01687868|Dexmedetomidine|dexmedetomidine|mesh-list
24454788|NCT03690544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25858054|NCT00076544|Protective Agents|protective agents|mesh-ancestor
24482615|NCT00440076|Bortezomib|bortezomib|mesh-list
24482616|NCT00440076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657510|NCT01267734|Clopidogrel|clopidogrel|mesh-list
24448744|NCT00312988|Immunologic Factors|immunologic factors|mesh-ancestor
24448745|NCT00312988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448746|NCT00312988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24448747|NCT00312988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24448749|NCT00313001|Exenatide|exenatide|mesh-list
24448750|NCT00313001|Biphasic Insulins|biphasic insulins|mesh-list
24448753|NCT00313001|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24448755|NCT00313001|Hormones|hormones|mesh-ancestor
25268182|NCT02417337|Mefenamic Acid|mefenamic acid|mesh-list
25858155|NCT00077116|Busulfan|busulfan|mesh-list
25858156|NCT00077116|Idarubicin|idarubicin|mesh-list
25858157|NCT00077116|Gemtuzumab|gemtuzumab|mesh-list
25268212|NCT02416765|Hormones|hormones|mesh-ancestor
25664773|NCT01675050|Antipruritics|antipruritics|mesh-ancestor
25858215|NCT00077220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858216|NCT00077220|Tubulin Modulators|tubulin modulators|mesh-ancestor
25858217|NCT00077220|Antimitotic Agents|antimitotic agents|mesh-ancestor
25858218|NCT00077220|Mitosis Modulators|mitosis modulators|mesh-ancestor
25858219|NCT00077220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858220|NCT00077233|Leucovorin|leucovorin|mesh-list
25858241|NCT00077246|Paclitaxel|paclitaxel|mesh-list
25858242|NCT00077246|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25664788|NCT01675128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609750|NCT00998036|Sirolimus|sirolimus|mesh-list
25271876|NCT02396043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271877|NCT02396043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25271878|NCT02396043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25271879|NCT02396043|Alkylating Agents|alkylating agents|mesh-ancestor
25271900|NCT02396043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25858330|NCT00077415|Immunologic Factors|immunologic factors|mesh-ancestor
24830053|NCT02157012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741188|NCT01692704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24741189|NCT01692704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25858374|NCT00077558|Fludarabine phosphate|fludarabine phosphate|mesh-list
25858375|NCT00077558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858376|NCT00077558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25858377|NCT00077558|Antimetabolites|antimetabolites|mesh-ancestor
25858378|NCT00077558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858379|NCT00077558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25858380|NCT00077558|Immunologic Factors|immunologic factors|mesh-ancestor
25858381|NCT00077558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858382|NCT00077584|Bosentan|bosentan|mesh-list
25858383|NCT00077584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25858384|NCT00077584|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24830099|NCT02157311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830101|NCT02157311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25858406|NCT00077714|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25858407|NCT00077714|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25858408|NCT00077714|Dopamine Agents|dopamine agents|mesh-ancestor
25858409|NCT00077727|Galantamine|galantamine|mesh-list
25858410|NCT00077727|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24830116|NCT02157337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830117|NCT02157337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25070326|NCT03420534|Iloperidone|iloperidone|mesh-list
25070327|NCT03420534|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25070328|NCT03420534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25070329|NCT03420534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25070331|NCT03420534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25858523|NCT00078117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25858578|NCT00078351|Hylan|hylan|mesh-list
25664848|NCT01675635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483902|NCT00445861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24483903|NCT00445861|Tubulin Modulators|tubulin modulators|mesh-ancestor
24648388|NCT01213992|Iron|iron|mesh-list
24490134|NCT00476515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24490135|NCT00476515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24830395|NCT02159131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24830396|NCT02159131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830397|NCT02159131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24830398|NCT02159131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24830399|NCT02159131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25858760|NCT00079053|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25272188|NCT02394054|Hemostatics|hemostatics|mesh-ancestor
24830455|NCT02159248|Hormone Antagonists|hormone antagonists|mesh-ancestor
24830456|NCT02159248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24830457|NCT02159248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24830458|NCT02159248|Serotonin Agents|serotonin agents|mesh-ancestor
24830459|NCT02159248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24830460|NCT02159287|Heparin|heparin|mesh-list
24830512|NCT02159599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24830514|NCT02159651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24830515|NCT02159651|Immunologic Factors|immunologic factors|mesh-ancestor
24830516|NCT02159651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830517|NCT02159651|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24830518|NCT02159651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728689|NCT01617707|Midazolam|midazolam|mesh-list
25858813|NCT00079105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24940827|NCT03997279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24448976|NCT00313742|Insulin, Isophane|insulin, isophane|mesh-list
24448977|NCT00313742|Isophane insulin, beef|isophane insulin, beef|mesh-list
25858875|NCT00079222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25268374|NCT02416115|Morphine|morphine|mesh-list
25268375|NCT02416115|Ramosetron|ramosetron|mesh-list
25268376|NCT02416115|Naloxone|naloxone|mesh-list
25858923|NCT00079261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25858924|NCT00079261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25858925|NCT00079261|Glucocorticoids|glucocorticoids|mesh-ancestor
24830604|NCT02160184|Pancrelipase|pancrelipase|mesh-list
25272316|NCT02393196|Plasma Substitutes|plasma substitutes|mesh-ancestor
25272317|NCT02393196|Blood Substitutes|blood substitutes|mesh-ancestor
25272318|NCT02393144|Meperidine|meperidine|mesh-list
24612861|NCT01015547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24612862|NCT01015547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24612863|NCT01015547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24612865|NCT01015547|Analgesics|analgesics|mesh-ancestor
25859032|NCT00079443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25859033|NCT00079443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859034|NCT00079443|Immunologic Factors|immunologic factors|mesh-ancestor
24830633|NCT02160275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830634|NCT02160275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24830635|NCT02160301|Acetaminophen|acetaminophen|mesh-list
24830636|NCT02160301|Dexamethasone|dexamethasone|mesh-list
24830637|NCT02160301|Celecoxib|celecoxib|mesh-list
25859061|NCT00079469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859062|NCT00079469|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25859063|NCT00079469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25859299|NCT00080327|Dopamine Agents|dopamine agents|mesh-ancestor
25859300|NCT00080327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25859301|NCT00080327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859302|NCT00080327|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25859303|NCT00080327|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24830742|NCT02160743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24830744|NCT02160743|Antimetabolites|antimetabolites|mesh-ancestor
24830746|NCT02160743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25859339|NCT00080444|Autonomic Agents|autonomic agents|mesh-ancestor
25859340|NCT00080444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851232|NCT02256124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24851234|NCT02256124|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25859713|NCT00081172|Antibodies|antibodies|mesh-list
25272496|NCT02391805|Antiviral Agents|antiviral agents|mesh-ancestor
25272497|NCT02391805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25272498|NCT02391805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24487665|NCT00464373|Botulinum Toxins|botulinum toxins|mesh-list
25859789|NCT00081575|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25859875|NCT00081874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25859876|NCT00081874|Immunologic Factors|immunologic factors|mesh-ancestor
25268726|NCT02414568|Glucocorticoids|glucocorticoids|mesh-ancestor
25169585|NCT01804829|Antibodies|antibodies|mesh-list
24592253|NCT00921102|Atropine|atropine|mesh-list
24592651|NCT00923572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25860020|NCT00082485|GABA Agonists|gaba agonists|mesh-ancestor
25171052|NCT02891018|Paclitaxel|paclitaxel|mesh-list
24489170|NCT00471640|Dexamethasone|dexamethasone|mesh-list
25203764|NCT02712502|Ofloxacin|ofloxacin|mesh-list
24749352|NCT01166113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24596312|NCT00942747|Immunologic Factors|immunologic factors|mesh-ancestor
24596745|NCT00945178|Naproxen|naproxen|mesh-list
24852874|NCT02264587|Antiemetics|antiemetics|mesh-ancestor
24852881|NCT02264587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25204004|NCT02711215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172695|NCT02877615|S44819|s44819|mesh-list
24605127|NCT00983398|Antidotes|antidotes|mesh-list
24605228|NCT00983944|Hormones|hormones|mesh-ancestor
25860139|NCT00082823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25876450|NCT03463460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24863057|NCT03635788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25665057|NCT01679002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25665058|NCT01679002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25665059|NCT01679002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25173194|NCT02874820|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25173195|NCT02874820|Adrenergic Agents|adrenergic agents|mesh-ancestor
25173196|NCT02874820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25173197|NCT02874820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173198|NCT02874820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605799|NCT00987376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25208701|NCT01246310|Inositol|inositol|mesh-list
25173464|NCT02871869|Epirubicin|epirubicin|mesh-list
25173465|NCT02871869|Vindesine|vindesine|mesh-list
25173647|NCT02870634|Copper|copper|mesh-list
25173666|NCT02870478|Cholinergic Agents|cholinergic agents|mesh-ancestor
25173667|NCT02870478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25173668|NCT02870478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173669|NCT02870673|Triamcinolone|triamcinolone|mesh-list
25173670|NCT02870673|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25173671|NCT02870673|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25173672|NCT02870673|Lidocaine|lidocaine|mesh-list
25173673|NCT02870673|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25173674|NCT02870673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25173675|NCT02870673|Glucocorticoids|glucocorticoids|mesh-ancestor
25173692|NCT02870361|Insulin|insulin|mesh-list
25860145|NCT00082836|Rituximab|rituximab|mesh-list
24491279|NCT00481884|Petrolatum|petrolatum|mesh-list
25860147|NCT00082836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860148|NCT00082836|Immunologic Factors|immunologic factors|mesh-ancestor
25860149|NCT00082836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607056|NCT05268614|Cisplatin|cisplatin|mesh-list
24607057|NCT05268614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860150|NCT00082836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25860151|NCT00082862|Gemcitabine|gemcitabine|mesh-list
25860152|NCT00082862|Interferons|interferons|mesh-list
25860153|NCT00082862|Interferon-alpha|interferon-alpha|mesh-list
25860154|NCT00082862|Cisplatin|cisplatin|mesh-list
24542235|NCT00677755|Misoprostol|misoprostol|mesh-list
25173929|NCT02868437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173930|NCT02868437|Viscosupplements|viscosupplements|mesh-ancestor
25173931|NCT02868437|Protective Agents|protective agents|mesh-ancestor
24752777|NCT01711957|Liver Extracts|liver extracts|mesh-list
25173932|NCT02868151|Ascorbic Acid|ascorbic acid|mesh-list
25173933|NCT02868151|Vitamins|vitamins|mesh-ancestor
25173934|NCT02868151|Micronutrients|micronutrients|mesh-ancestor
25173935|NCT02868151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860161|NCT00082862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25174193|NCT02867345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24974165|NCT05156684|Antioxidants|antioxidants|mesh-ancestor
24533643|NCT00644709|Atorvastatin|atorvastatin|mesh-list
25174545|NCT02865018|Cetirizine|cetirizine|mesh-list
24450125|NCT00317811|Bortezomib|bortezomib|mesh-list
24492833|NCT00488189|Tazobactam|tazobactam|mesh-list
25174962|NCT02862210|Antimanic Agents|antimanic agents|mesh-ancestor
25207828|NCT03079102|Gasotransmitters|gasotransmitters|mesh-ancestor
24922995|NCT04174131|Lidocaine|lidocaine|mesh-list
24923665|NCT04168099|Cefoxitin|cefoxitin|mesh-list
24500403|NCT00524160|Fentanyl|fentanyl|mesh-list
24523472|NCT00467142|Micronutrients|micronutrients|mesh-ancestor
25176170|NCT02852837|Daratumumab|daratumumab|mesh-list
25860197|NCT00083031|Methotrexate|methotrexate|mesh-list
24926330|NCT04142762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24524963|NCT04171258|Botulinum Toxins|botulinum toxins|mesh-list
24927825|NCT04128787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24927826|NCT04128787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25177121|NCT05303909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177122|NCT05298085|Oxytocin|oxytocin|mesh-list
25177123|NCT05298085|Oxytocics|oxytocics|mesh-ancestor
25177124|NCT05298085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25177125|NCT05298085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177126|NCT05293964|Palbociclib|palbociclib|mesh-list
25177127|NCT05293964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25177128|NCT05293964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25177129|NCT05293964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604287|NCT00978315|Vitamins|vitamins|mesh-ancestor
25177130|NCT05293964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177153|NCT05291598|Ketorolac|ketorolac|mesh-list
25177154|NCT05291598|Meloxicam|meloxicam|mesh-list
25177155|NCT05291598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25177156|NCT05291598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25177157|NCT05291598|Analgesics|analgesics|mesh-ancestor
25177158|NCT05291598|Sensory System Agents|sensory system agents|mesh-ancestor
25177159|NCT05291598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25177160|NCT05291598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177161|NCT05291598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25204790|NCT05265442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25177501|NCT05049863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24929213|NCT04114630|Erenumab|erenumab|mesh-list
24929414|NCT04113005|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25177640|NCT04951323|Immunologic Factors|immunologic factors|mesh-ancestor
24499652|NCT00520442|Codeine|codeine|mesh-list
24499723|NCT00520754|Histamine Agents|histamine agents|mesh-ancestor
24499734|NCT00520819|Protective Agents|protective agents|mesh-ancestor
24499741|NCT00520897|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25860216|NCT00083031|Antimetabolites|antimetabolites|mesh-ancestor
25860219|NCT00083031|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25860220|NCT00083031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25860221|NCT00083057|Paclitaxel|paclitaxel|mesh-list
25860222|NCT00083057|Gefitinib|gefitinib|mesh-list
25860223|NCT00083057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25860224|NCT00083057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860225|NCT00083057|Tubulin Modulators|tubulin modulators|mesh-ancestor
25860226|NCT00083057|Antimitotic Agents|antimitotic agents|mesh-ancestor
24457643|NCT00334854|Ifosfamide|ifosfamide|mesh-list
24933963|NCT04065919|Autonomic Agents|autonomic agents|mesh-ancestor
24934282|NCT04062201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25178846|NCT04047641|Cytarabine|cytarabine|mesh-list
24934359|NCT04062019|Antiviral Agents|antiviral agents|mesh-ancestor
24497746|NCT00511654|Anesthetics|anesthetics|mesh-ancestor
24509401|NCT00560170|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24509403|NCT00560170|Antimetabolites|antimetabolites|mesh-ancestor
24934732|NCT04059523|Tretinoin|tretinoin|mesh-list
25179979|NCT02789657|Paclitaxel|paclitaxel|mesh-list
25180052|NCT02630628|Tacrolimus|tacrolimus|mesh-list
24531183|NCT00634413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24511851|NCT00571246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25180348|NCT01999179|Heparin|heparin|mesh-list
25180389|NCT01868269|Antiemetics|antiemetics|mesh-ancestor
25180720|NCT02850289|Ribavirin|ribavirin|mesh-list
25210194|NCT02698969|Anesthetics|anesthetics|mesh-ancestor
25210275|NCT02698553|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24669788|NCT03613181|Antimetabolites|antimetabolites|mesh-ancestor
24452830|NCT05420402|Anesthetics|anesthetics|mesh-ancestor
24669803|NCT03611010|Antimetabolites|antimetabolites|mesh-ancestor
24669807|NCT03611010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860277|NCT00083135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860278|NCT00083135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860279|NCT00083135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860299|NCT00083161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24670725|NCT01998971|Montelukast|montelukast|mesh-list
25210358|NCT02698306|Glucocorticoids|glucocorticoids|mesh-ancestor
25860301|NCT00083161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24455929|NCT00329394|Analgesics|analgesics|mesh-ancestor
24456143|NCT00330252|Alemtuzumab|alemtuzumab|mesh-list
25860306|NCT00083187|Hydroxyurea|hydroxyurea|mesh-list
25182291|NCT03213457|Hormones|hormones|mesh-ancestor
25860314|NCT00083213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25860319|NCT00083252|Cisplatin|cisplatin|mesh-list
25860337|NCT00083408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182671|NCT00779532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182746|NCT00653913|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25182747|NCT00653913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25182748|NCT00653523|Simvastatin|simvastatin|mesh-list
25182749|NCT00653523|Ezetimibe|ezetimibe|mesh-list
25182750|NCT00653523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25182751|NCT00653523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25182752|NCT00653523|Antimetabolites|antimetabolites|mesh-ancestor
25182753|NCT00653523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182794|NCT00650819|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25205406|NCT04747847|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25205407|NCT04747847|Atorvastatin|atorvastatin|mesh-list
25205408|NCT04747847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25205409|NCT04747847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25183114|NCT00140972|Analgesics|analgesics|mesh-ancestor
25860345|NCT00083408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860346|NCT00083408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25860347|NCT00083434|Epoetin Alfa|epoetin alfa|mesh-list
25860348|NCT00083434|Hematinics|hematinics|mesh-ancestor
25860349|NCT00083460|Thalidomide|thalidomide|mesh-list
25860352|NCT00083460|Antiemetics|antiemetics|mesh-ancestor
24449804|NCT00317031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210555|NCT05324462|Hormones|hormones|mesh-ancestor
25183589|NCT02840994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25183590|NCT02840994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25183591|NCT02840994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25183592|NCT02840994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183593|NCT02841202|Contraceptive Agents|contraceptive agents|mesh-list
25183594|NCT02841202|Contraceptives, Oral|contraceptives, oral|mesh-list
25183595|NCT02841202|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25183635|NCT02840539|Protease Inhibitors|protease inhibitors|mesh-ancestor
25183636|NCT02840539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183637|NCT02840539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183638|NCT02840539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25183639|NCT02840539|Antimetabolites|antimetabolites|mesh-ancestor
24519581|NCT05332314|Ibuprofen|ibuprofen|mesh-list
25272659|NCT02390843|Cyclophosphamide|cyclophosphamide|mesh-list
25183756|NCT02839941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24520508|NCT00630565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24517061|NCT00605774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25183921|NCT02839122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25183922|NCT02839122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183923|NCT02839135|Scopolamine|scopolamine|mesh-list
25183924|NCT02839135|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25183925|NCT02839135|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25860381|NCT00083538|Etoposide|etoposide|mesh-list
25860382|NCT00083538|Doxorubicin|doxorubicin|mesh-list
25860384|NCT00083538|Cisplatin|cisplatin|mesh-list
25860385|NCT00083538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25184110|NCT02837978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184111|NCT02837978|Dermatologic Agents|dermatologic agents|mesh-ancestor
25184122|NCT02837965|Doxycycline|doxycycline|mesh-list
25184157|NCT02837874|Antidiarrheals|antidiarrheals|mesh-list
25184250|NCT02837185|Botulinum Toxins|botulinum toxins|mesh-list
25184424|NCT02836184|Vitamins|vitamins|mesh-ancestor
25184468|NCT02835833|Nintedanib|nintedanib|mesh-list
24523740|NCT05340790|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24524176|NCT05206110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25205588|NCT04519164|Diuretics|diuretics|mesh-ancestor
25860398|NCT00083538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25860399|NCT00083538|Glucocorticoids|glucocorticoids|mesh-ancestor
25860400|NCT00083538|Hormones|hormones|mesh-ancestor
25860401|NCT00083538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25860402|NCT00083538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24510979|NCT00566865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25860403|NCT00083538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25860406|NCT00083538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24514786|NCT00592930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25665878|NCT01688739|Analgesics|analgesics|mesh-ancestor
25185598|NCT02826759|Insulin|insulin|mesh-list
25211384|NCT04409834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25211385|NCT04409834|Purinergic Agents|purinergic agents|mesh-ancestor
25211386|NCT04409834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25211387|NCT04409834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211388|NCT04409834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211389|NCT04409834|Anticoagulants|anticoagulants|mesh-ancestor
25211390|NCT04409834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25211391|NCT04409834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25211420|NCT04360681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25211421|NCT04360681|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25211422|NCT04360681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211423|NCT04360681|Sensory System Agents|sensory system agents|mesh-ancestor
25185946|NCT02824458|Apatinib|apatinib|mesh-list
25185947|NCT02824458|Gefitinib|gefitinib|mesh-list
25185948|NCT02824458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25185949|NCT02824458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25185950|NCT02824458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185952|NCT02824094|Crizotinib|crizotinib|mesh-list
25211471|NCT04315350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211472|NCT04315350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25211473|NCT04315350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25211474|NCT04315350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25211477|NCT04315350|Analgesics|analgesics|mesh-ancestor
24527345|NCT00616031|Antimitotic Agents|antimitotic agents|mesh-ancestor
24527602|NCT00617656|Cisplatin|cisplatin|mesh-list
25186286|NCT02821689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24527825|NCT00618423|Ketamine|ketamine|mesh-list
25205826|NCT04175626|Sirolimus|sirolimus|mesh-list
25187046|NCT02817113|Cetuximab|cetuximab|mesh-list
25187201|NCT02815449|Iron|iron|mesh-list
25211944|NCT03244059|Belimumab|belimumab|mesh-list
25666047|NCT01691092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24542697|NCT00679744|Antimalarials|antimalarials|mesh-ancestor
25187474|NCT02812693|Pembrolizumab|pembrolizumab|mesh-list
25212170|NCT02407119|Omeprazole|omeprazole|mesh-list
24412865|NCT00192608|Saquinavir|saquinavir|mesh-list
25187897|NCT02809729|Cefazolin|cefazolin|mesh-list
25188452|NCT02805868|Siltuximab|siltuximab|mesh-list
25188688|NCT02802995|Hemostatics|hemostatics|mesh-ancestor
25188767|NCT02802696|Furosemide|furosemide|mesh-list
25115320|NCT03116893|Rifampin|rifampin|mesh-list
24824033|NCT02120872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24424588|NCT00229996|Leuprolide|leuprolide|mesh-list
24424945|NCT00231452|Antimalarials|antimalarials|mesh-ancestor
25212785|NCT05367479|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25666401|NCT01695668|Dermatologic Agents|dermatologic agents|mesh-ancestor
25190386|NCT02789865|Ofloxacin|ofloxacin|mesh-list
24971288|NCT03726788|Hormones|hormones|mesh-ancestor
24428328|NCT00240214|Sirolimus|sirolimus|mesh-list
24775200|NCT01850979|Tacrolimus|tacrolimus|mesh-list
25191073|NCT02785003|Ketamine|ketamine|mesh-list
24776101|NCT01856621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25213014|NCT05212311|Hemostatics|hemostatics|mesh-ancestor
25191621|NCT02782221|Hormones|hormones|mesh-list
24486703|NCT00459563|Vitamins|vitamins|mesh-ancestor
25156894|NCT04899778|Iron|iron|mesh-list
24800288|NCT01974648|Propofol|propofol|mesh-list
25192610|NCT02775474|Fentanyl|fentanyl|mesh-list
25206706|NCT05343546|Copper|copper|mesh-list
24778090|NCT01869010|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25192958|NCT02773251|Laxatives|laxatives|mesh-ancestor
24778573|NCT01871675|Rituximab|rituximab|mesh-list
25157074|NCT04824911|Sensory System Agents|sensory system agents|mesh-ancestor
24665974|NCT01316445|Midazolam|midazolam|mesh-list
25193520|NCT02770443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25193788|NCT02768519|OTS167|ots167|mesh-list
24779752|NCT01878539|Anticoagulants|anticoagulants|mesh-list
24798332|NCT01962636|Cyclosporins|cyclosporins|mesh-list
24779845|NCT01879241|Rasagiline|rasagiline|mesh-list
25051520|NCT00397293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25194409|NCT02765022|Hormones|hormones|mesh-ancestor
25194619|NCT02764008|Anesthetics, Local|anesthetics, local|mesh-ancestor
24780478|NCT01884506|Trace Elements|trace elements|mesh-ancestor
24573023|NCT00817622|Vitamin E|vitamin e|mesh-list
25206955|NCT05176470|Pembrolizumab|pembrolizumab|mesh-list
25194949|NCT02761317|Bisacodyl|bisacodyl|mesh-list
24489404|NCT00473005|Capecitabine|capecitabine|mesh-list
25195471|NCT02758249|Propofol|propofol|mesh-list
24781685|NCT01891292|Protease Inhibitors|protease inhibitors|mesh-ancestor
24781896|NCT01892813|Bupropion|bupropion|mesh-list
24782126|NCT01894334|Tranexamic Acid|tranexamic acid|mesh-list
24491557|NCT00483054|Efavirenz|efavirenz|mesh-list
25860671|NCT00084240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25667110|NCT01702558|Tubulin Modulators|tubulin modulators|mesh-ancestor
25667111|NCT01702558|Antimitotic Agents|antimitotic agents|mesh-ancestor
25197208|NCT04384692|Tacrolimus|tacrolimus|mesh-list
25197209|NCT04384692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25197210|NCT04384692|Immunologic Factors|immunologic factors|mesh-ancestor
25197211|NCT04384692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197212|NCT04384692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25197213|NCT04384692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25197214|NCT04384692|Alkylating Agents|alkylating agents|mesh-ancestor
25197215|NCT04384692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782919|NCT01899066|Carboplatin|carboplatin|mesh-list
25272756|NCT02389972|Dasatinib|dasatinib|mesh-list
25667143|NCT01702987|Coenzyme Q10|coenzyme q10|mesh-list
25157580|NCT04641247|Niraparib|niraparib|mesh-list
24783205|NCT01900639|Analgesics|analgesics|mesh-ancestor
24492177|NCT00485576|Eculizumab|eculizumab|mesh-list
25198204|NCT02750254|Melphalan|melphalan|mesh-list
24784168|NCT01906762|Acetaminophen|acetaminophen|mesh-list
25198755|NCT02745691|Gefitinib|gefitinib|mesh-list
24785210|NCT01912755|Lidocaine|lidocaine|mesh-list
24785918|NCT01917097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24786023|NCT01917617|Gemcitabine|gemcitabine|mesh-list
24493108|NCT00489593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25213990|NCT03847506|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25213991|NCT03847506|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24786798|NCT01921790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24786799|NCT01921790|Growth Substances|growth substances|mesh-ancestor
24447860|NCT00309712|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24447861|NCT00309712|Antimetabolites|antimetabolites|mesh-ancestor
24447862|NCT00309712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787266|NCT01924234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25157749|NCT04592419|Aflibercept|aflibercept|mesh-list
25157750|NCT04592419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25157751|NCT04592419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25157752|NCT04592419|Growth Substances|growth substances|mesh-ancestor
25667321|NCT01705288|Analgesics|analgesics|mesh-ancestor
25667322|NCT01705288|Sensory System Agents|sensory system agents|mesh-ancestor
25667323|NCT01705288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25157753|NCT04592419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25157754|NCT04592419|Growth Inhibitors|growth inhibitors|mesh-ancestor
24557963|NCT00755014|Ethanol|ethanol|mesh-list
24787394|NCT01924832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787432|NCT01925287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24787434|NCT01925287|Analgesics|analgesics|mesh-ancestor
24787451|NCT01925300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787452|NCT01925300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25860867|NCT00084708|Calcitriol|calcitriol|mesh-list
24579906|NCT00858676|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24579907|NCT00858676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621437|NCT01062360|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24621438|NCT01062360|Autonomic Agents|autonomic agents|mesh-ancestor
24621439|NCT01062360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25157755|NCT04592419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24722249|NCT01579227|Micronutrients|micronutrients|mesh-ancestor
24722319|NCT01579630|Pemetrexed|pemetrexed|mesh-list
24454674|NCT03818607|Eculizumab|eculizumab|mesh-list
25860886|NCT00084708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24787773|NCT01927406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787774|NCT01927406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24787775|NCT01927406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24787776|NCT01927406|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24787777|NCT01927406|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24787778|NCT01927484|Methotrexate|methotrexate|mesh-list
24787779|NCT01927484|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24787784|NCT01927484|Antimetabolites|antimetabolites|mesh-ancestor
24621464|NCT01062516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621465|NCT01062516|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24621466|NCT01062516|Histamine Antagonists|histamine antagonists|mesh-ancestor
24621467|NCT01062516|Histamine Agents|histamine agents|mesh-ancestor
24621473|NCT01062529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621475|NCT01062633|Sorbitol|sorbitol|mesh-list
24621476|NCT01062633|Vasodilator Agents|vasodilator agents|mesh-ancestor
24621477|NCT01062633|Cathartics|cathartics|mesh-ancestor
24595487|NCT00938899|Simeprevir|simeprevir|mesh-list
25085100|NCT03301207|Bupropion|bupropion|mesh-list
25085126|NCT03301207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085159|NCT03301181|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25082306|NCT03323593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25082307|NCT03323593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082309|NCT03323567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25082310|NCT03323567|Anesthetics, Local|anesthetics, local|mesh-ancestor
25082311|NCT03323567|Anesthetics|anesthetics|mesh-ancestor
25082312|NCT03323567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25082313|NCT03323567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860951|NCT00084877|Irinotecan|irinotecan|mesh-list
24787960|NCT01928563|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24787961|NCT01928563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787962|NCT01928563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787963|NCT01928628|Valsartan|valsartan|mesh-list
24787964|NCT01928628|Lercanidipine|lercanidipine|mesh-list
24787965|NCT01928628|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24787966|NCT01928628|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25860984|NCT00084942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616192|NCT01034917|Etravirine|etravirine|mesh-list
25860985|NCT00084981|Decitabine|decitabine|mesh-list
24448698|NCT00312650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24448700|NCT00312650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726384|NCT01603030|Hormones|hormones|mesh-ancestor
25860986|NCT00084981|Azacitidine|azacitidine|mesh-list
25860987|NCT00084981|Valproic Acid|valproic acid|mesh-list
25860989|NCT00084981|Antimetabolites|antimetabolites|mesh-ancestor
24788118|NCT01929577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788119|NCT01929590|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24788120|NCT01929590|Laxatives|laxatives|mesh-ancestor
24800737|NCT01978301|Triamcinolone|triamcinolone|mesh-list
24788121|NCT01929590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24788122|NCT01929603|Rifampin|rifampin|mesh-list
24788123|NCT01929603|Olaparib|olaparib|mesh-list
24788124|NCT01929603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24788125|NCT01929603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550678|NCT00721604|Blood Substitutes|blood substitutes|mesh-ancestor
24788126|NCT01929603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788136|NCT01929603|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24788137|NCT01929603|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24788168|NCT01929824|Gasotransmitters|gasotransmitters|mesh-ancestor
24788169|NCT01929824|Protective Agents|protective agents|mesh-ancestor
24788170|NCT01929941|Gemcitabine|gemcitabine|mesh-list
24788171|NCT01929941|Paclitaxel|paclitaxel|mesh-list
24788172|NCT01929941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24788173|NCT01929941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393278|NCT00129363|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24788291|NCT01930682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24788292|NCT01930682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24788293|NCT01930682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788295|NCT01930708|Dermatologic Agents|dermatologic agents|mesh-ancestor
24788296|NCT01930708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24788297|NCT01930708|Immunologic Factors|immunologic factors|mesh-ancestor
24788298|NCT01930708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082320|NCT03323567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082322|NCT03323541|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25082323|NCT03323541|Immunologic Factors|immunologic factors|mesh-ancestor
25082324|NCT03323541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082325|NCT03323528|Benzalkonium Compounds|benzalkonium compounds|mesh-list
25082326|NCT03323528|Benzocaine|benzocaine|mesh-list
25082327|NCT03323528|Anesthetics, Local|anesthetics, local|mesh-ancestor
25082328|NCT03323528|Anesthetics|anesthetics|mesh-ancestor
25082329|NCT03323528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25861040|NCT00085163|Celecoxib|celecoxib|mesh-list
25861041|NCT00085163|Fluorouracil|fluorouracil|mesh-list
24788402|NCT01931215|Narcotics|narcotics|mesh-ancestor
25861042|NCT00085163|Calcium|calcium|mesh-list
24788403|NCT01931215|Analgesics|analgesics|mesh-ancestor
24788404|NCT01931215|Sensory System Agents|sensory system agents|mesh-ancestor
24788405|NCT01931215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24788406|NCT01931215|Anesthetics, Local|anesthetics, local|mesh-ancestor
24788407|NCT01931215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24788408|NCT01931215|Sympatholytics|sympatholytics|mesh-ancestor
24788439|NCT01931332|Narcotics|narcotics|mesh-ancestor
24788440|NCT01931332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24788603|NCT01932372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24788604|NCT01932372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24788605|NCT01932372|Immunologic Factors|immunologic factors|mesh-ancestor
24788606|NCT01932372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24788607|NCT01932372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788608|NCT01932372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788609|NCT01932385|Sorafenib|sorafenib|mesh-list
24788614|NCT01932424|Propofol|propofol|mesh-list
24802574|NCT01990937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802575|NCT01991028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24950056|NCT02713386|Paclitaxel|paclitaxel|mesh-list
25087414|NCT03279679|Ropivacaine|ropivacaine|mesh-list
24464781|NCT00366834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464782|NCT00366834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24464801|NCT00366834|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24731660|NCT01635972|Isavuconazole|isavuconazole|mesh-list
24802634|NCT01991288|Epinephryl borate|epinephryl borate|mesh-list
25861049|NCT00085163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861050|NCT00085163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25861051|NCT00085163|Immunologic Factors|immunologic factors|mesh-ancestor
25861052|NCT00085163|Antidotes|antidotes|mesh-ancestor
25861053|NCT00085163|Protective Agents|protective agents|mesh-ancestor
25861054|NCT00085163|Vitamin B Complex|vitamin b complex|mesh-ancestor
25861055|NCT00085163|Vitamins|vitamins|mesh-ancestor
25861056|NCT00085163|Micronutrients|micronutrients|mesh-ancestor
25861057|NCT00085163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25861058|NCT00085163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25861059|NCT00085163|Analgesics|analgesics|mesh-ancestor
25861060|NCT00085163|Sensory System Agents|sensory system agents|mesh-ancestor
25861061|NCT00085163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25861062|NCT00085163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25861063|NCT00085163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24731821|NCT01636609|Cytarabine|cytarabine|mesh-list
25667446|NCT01706328|Respiratory System Agents|respiratory system agents|mesh-ancestor
24465008|NCT00367497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24465010|NCT00367497|Protective Agents|protective agents|mesh-ancestor
24465011|NCT00367536|Bazedoxifene|bazedoxifene|mesh-list
24465012|NCT00367536|Estrogens|estrogens|mesh-list
24465013|NCT00367536|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24465014|NCT00367536|Hormones|hormones|mesh-ancestor
24465015|NCT00367536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24465058|NCT00367718|Bortezomib|bortezomib|mesh-list
24789039|NCT01935492|Bevacizumab|bevacizumab|mesh-list
24789040|NCT01935492|Doxorubicin|doxorubicin|mesh-list
24789041|NCT01935492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25082373|NCT03323047|Acetaminophen|acetaminophen|mesh-list
25082374|NCT03323047|Dexamethasone|dexamethasone|mesh-list
25082375|NCT03323047|Dexamethasone acetate|dexamethasone acetate|mesh-list
25082376|NCT03323047|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25082377|NCT03323047|BB 1101|bb 1101|mesh-list
25082378|NCT03323047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25082379|NCT03323047|Antiemetics|antiemetics|mesh-ancestor
25082380|NCT03323047|Autonomic Agents|autonomic agents|mesh-ancestor
25082381|NCT03323047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082382|NCT03323047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082385|NCT03323047|Hormones|hormones|mesh-ancestor
24465279|NCT00368602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24465280|NCT00368602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24732579|NCT01640496|Vitamins|vitamins|mesh-ancestor
25861071|NCT00085189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861072|NCT00085228|Docetaxel|docetaxel|mesh-list
24438026|NCT00274898|Analgesics|analgesics|mesh-ancestor
25861073|NCT00085228|Oblimersen|oblimersen|mesh-list
25861074|NCT00085228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861075|NCT00085228|Tubulin Modulators|tubulin modulators|mesh-ancestor
25087736|NCT03277209|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25861076|NCT00085228|Antimitotic Agents|antimitotic agents|mesh-ancestor
24802718|NCT01991873|Vitamins|vitamins|mesh-ancestor
24465433|NCT00369551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465434|NCT00369551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24465435|NCT00369551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24465436|NCT00369551|Growth Substances|growth substances|mesh-ancestor
24465437|NCT00369551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861085|NCT00085306|Interferon-beta|interferon-beta|mesh-list
25861086|NCT00085306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861087|NCT00085306|Antiviral Agents|antiviral agents|mesh-ancestor
24790598|NCT01943812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24790599|NCT01943812|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25861096|NCT00085332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861097|NCT00085345|Ascorbic Acid|ascorbic acid|mesh-list
24938070|NCT04022785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24938071|NCT04022993|Insulin Glargine|insulin glargine|mesh-list
25861098|NCT00085345|Melphalan|melphalan|mesh-list
24621618|NCT01063192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621619|NCT01063192|Antidotes|antidotes|mesh-ancestor
24621620|NCT01063192|Protective Agents|protective agents|mesh-ancestor
24467424|NCT00377559|Antimitotic Agents|antimitotic agents|mesh-ancestor
24467516|NCT00377975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24467517|NCT00377975|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24619397|NCT01052311|Niacin|niacin|mesh-list
25082449|NCT03322488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24787519|NCT01925729|Respiratory System Agents|respiratory system agents|mesh-ancestor
24787520|NCT01925729|Nasal Decongestants|nasal decongestants|mesh-ancestor
24787521|NCT01925729|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24787522|NCT01925729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24787523|NCT01925729|Sympathomimetics|sympathomimetics|mesh-ancestor
24787524|NCT01925729|Adrenergic Agents|adrenergic agents|mesh-ancestor
25005788|NCT02560805|Atenolol|atenolol|mesh-list
25214238|NCT02436707|Etoposide|etoposide|mesh-list
24889145|NCT04496882|Tenofovir|tenofovir|mesh-list
24890169|NCT04485429|Anticoagulants|anticoagulants|mesh-ancestor
24791489|NCT04150614|Antiemetics|antiemetics|mesh-ancestor
25214318|NCT02173405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24397495|NCT00141648|Antimitotic Agents|antimitotic agents|mesh-ancestor
24397496|NCT00141648|Mitosis Modulators|mitosis modulators|mesh-ancestor
24397497|NCT00141648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24441432|NCT00287378|Omalizumab|omalizumab|mesh-list
24429601|NCT00244517|Remifentanil|remifentanil|mesh-list
24440582|NCT00283790|Zolpidem|zolpidem|mesh-list
24792375|NCT05275894|Metronidazole|metronidazole|mesh-list
25214442|NCT01524926|Crizotinib|crizotinib|mesh-list
25214455|NCT01517802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552538|NCT02688530|Dexamethasone|dexamethasone|mesh-list
24793497|NCT03427736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24791575|NCT03920007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24565348|NCT00779831|Pseudoephedrine|pseudoephedrine|mesh-list
24804633|NCT02004171|Nicotine|nicotine|mesh-list
24569398|NCT00800423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24967968|NCT03755557|Budesonide|budesonide|mesh-list
24572140|NCT00813332|Docetaxel|docetaxel|mesh-list
24572531|NCT00815282|Vaccines|vaccines|mesh-list
24574439|NCT00825188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575307|NCT00830505|Sympathomimetics|sympathomimetics|mesh-ancestor
24793876|NCT00572169|Thalidomide|thalidomide|mesh-list
25010011|NCT04789304|Anesthetics|anesthetics|mesh-ancestor
25010139|NCT04617821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25214803|NCT02695745|Analgesics|analgesics|mesh-ancestor
24582384|NCT00869310|Hormones|hormones|mesh-ancestor
24969141|NCT03745261|Bromides|bromides|mesh-list
24969385|NCT03743428|Apatinib|apatinib|mesh-list
25065786|NCT05231603|Ivermectin|ivermectin|mesh-list
25214960|NCT02693769|Anticonvulsants|anticonvulsants|mesh-ancestor
24918190|NCT04222088|Antimalarials|antimalarials|mesh-ancestor
24593590|NCT00930202|Conivaptan|conivaptan|mesh-list
24443656|NCT00295672|Tubulin Modulators|tubulin modulators|mesh-ancestor
25861420|NCT00086528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673983|NCT01341353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673984|NCT01341353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24673985|NCT01341353|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24674264|NCT01342692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25199615|NCT02739711|polysaccharide-K|polysaccharide-k|mesh-list
24675438|NCT01343173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24677021|NCT01353794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24677587|NCT01356862|Hormones|hormones|mesh-ancestor
24677589|NCT01356862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610920|NCT01005758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25216034|NCT02686645|Metronidazole|metronidazole|mesh-list
24678618|NCT01363271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24678619|NCT01363271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24678621|NCT01363271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24679250|NCT01367561|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25216163|NCT02686021|Analgesics|analgesics|mesh-ancestor
24969737|NCT03740373|Budesonide|budesonide|mesh-list
24681693|NCT01381601|Sunitinib|sunitinib|mesh-list
25861451|NCT00086645|Dexetimide|dexetimide|mesh-list
25216538|NCT02684318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24686400|NCT04870333|Hormones|hormones|mesh-ancestor
25216837|NCT02682225|Antidepressive Agents|antidepressive agents|mesh-ancestor
24691800|NCT01409148|Antibodies|antibodies|mesh-list
24692470|NCT01414556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24831344|NCT02164825|Anesthetics|anesthetics|mesh-ancestor
25217006|NCT02680977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25217041|NCT02680717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25217042|NCT02680717|Glucocorticoids|glucocorticoids|mesh-ancestor
25217061|NCT02680548|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24635123|NCT01137084|Prednisolone phosphate|prednisolone phosphate|mesh-list
24637676|NCT01152476|Remifentanil|remifentanil|mesh-list
25861491|NCT00086736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640404|NCT01167920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24644213|NCT01189773|Analgesics|analgesics|mesh-ancestor
24855962|NCT02282059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856223|NCT02283242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24856253|NCT02283372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24856254|NCT02283372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856255|NCT02283372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24856256|NCT02283372|Immunologic Factors|immunologic factors|mesh-ancestor
24856258|NCT02283424|Carboplatin|carboplatin|mesh-list
24501844|NCT00531323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621886|NCT01064453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928394|NCT04122716|Hormones|hormones|mesh-ancestor
24501945|NCT00531674|Micronutrients|micronutrients|mesh-ancestor
24667704|NCT05323214|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24667705|NCT05323214|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25861506|NCT00086801|Gemcitabine|gemcitabine|mesh-list
25861609|NCT00087048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970148|NCT03735563|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24970149|NCT03735563|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24970150|NCT03735563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25083078|NCT03318211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25861672|NCT00087256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861673|NCT00087269|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25861674|NCT00087269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861675|NCT00087269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25861729|NCT00087412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861766|NCT00087542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25861810|NCT00087711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861872|NCT00087867|Bortezomib|bortezomib|mesh-list
24502316|NCT05302388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24502317|NCT05302388|Histamine Antagonists|histamine antagonists|mesh-ancestor
24502318|NCT05302388|Histamine Agents|histamine agents|mesh-ancestor
25862016|NCT00088478|Serotonin Agents|serotonin agents|mesh-ancestor
25862017|NCT00088491|Olanzapine|olanzapine|mesh-list
24970305|NCT03734562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25862110|NCT00088894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24970483|NCT03732703|Autonomic Agents|autonomic agents|mesh-ancestor
24832158|NCT02170792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24970544|NCT03732469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24970545|NCT03732469|Anesthetics, General|anesthetics, general|mesh-ancestor
24970546|NCT03732469|Anesthetics|anesthetics|mesh-ancestor
24970547|NCT03732469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24970548|NCT03732469|Narcotics|narcotics|mesh-ancestor
24970549|NCT03732469|Analgesics|analgesics|mesh-ancestor
25083159|NCT03317717|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24807408|NCT02021851|Autonomic Agents|autonomic agents|mesh-ancestor
24970550|NCT03732469|Sensory System Agents|sensory system agents|mesh-ancestor
24970551|NCT03732469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970552|NCT03732469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25862212|NCT00089089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550325|NCT00720291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24794095|NCT05413902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794120|NCT05413902|Mydriatics|mydriatics|mesh-ancestor
25199697|NCT02739399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24609347|NCT00996177|Morphine|morphine|mesh-list
25862233|NCT00089167|Dexamethasone|dexamethasone|mesh-list
25862234|NCT00089167|Melphalan|melphalan|mesh-list
25862235|NCT00089167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25862236|NCT00089167|Antiemetics|antiemetics|mesh-ancestor
25862237|NCT00089167|Autonomic Agents|autonomic agents|mesh-ancestor
25862238|NCT00089167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25862239|NCT00089167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862240|NCT00089167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25862241|NCT00089167|Glucocorticoids|glucocorticoids|mesh-ancestor
25199698|NCT02739399|Adrenergic Agents|adrenergic agents|mesh-ancestor
25862242|NCT00089167|Hormones|hormones|mesh-ancestor
25862243|NCT00089167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25668180|NCT01712516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668181|NCT01712516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668182|NCT01712984|Fluconazole|fluconazole|mesh-list
25668183|NCT01712984|Vaccines|vaccines|mesh-list
25668184|NCT01712984|Immunologic Factors|immunologic factors|mesh-ancestor
25668185|NCT01712984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970592|NCT03732040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970593|NCT03732001|Docetaxel|docetaxel|mesh-list
24970594|NCT03732001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970595|NCT03732001|Tubulin Modulators|tubulin modulators|mesh-ancestor
24970596|NCT03732001|Antimitotic Agents|antimitotic agents|mesh-ancestor
24970597|NCT03732001|Mitosis Modulators|mitosis modulators|mesh-ancestor
24940324|NCT04002141|Letrozole|letrozole|mesh-list
24940325|NCT04002141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24940326|NCT04002141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25862244|NCT00089167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25862245|NCT00089167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862246|NCT00089167|Immunologic Factors|immunologic factors|mesh-ancestor
25862247|NCT00089167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25862248|NCT00089167|Alkylating Agents|alkylating agents|mesh-ancestor
25862249|NCT00089167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862250|NCT00089167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24458266|NCT00337298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24458267|NCT00337298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24533337|NCT00643227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24437339|NCT00273442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24437348|NCT00273455|Timolol|timolol|mesh-list
24794167|NCT05413551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24794169|NCT05413343|Avibactam|avibactam|mesh-list
24702357|NCT01465373|Progesterone|progesterone|mesh-list
24794211|NCT05378880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24613535|NCT01019603|Nicotinic Acids|nicotinic acids|mesh-list
25862351|NCT00089453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24503365|NCT01655225|Pemetrexed|pemetrexed|mesh-list
24971175|NCT03727646|Niacin|niacin|mesh-list
24971357|NCT03726281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24971479|NCT03725904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503773|NCT00532857|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24445987|NCT00303433|Memantine|memantine|mesh-list
24971702|NCT03723187|Heparin|heparin|mesh-list
25862374|NCT00089557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740820|NCT01690338|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24794430|NCT05216952|Oxytocics|oxytocics|mesh-ancestor
24709921|NCT01507558|Glucocorticoids|glucocorticoids|mesh-ancestor
25862386|NCT00089622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972538|NCT03716804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24972539|NCT03716804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24711803|NCT01517009|Antimetabolites|antimetabolites|mesh-ancestor
24711931|NCT01517724|Bortezomib|bortezomib|mesh-list
24712516|NCT01521130|Anticonvulsants|anticonvulsants|mesh-ancestor
25083321|NCT03316690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547302|NCT00703352|Diuretics|diuretics|mesh-ancestor
25668335|NCT01715896|Mavrilimumab|mavrilimumab|mesh-list
24973166|NCT03711474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24714593|NCT01531569|Hormones|hormones|mesh-ancestor
24715392|NCT01536223|Cisplatin|cisplatin|mesh-list
24941276|NCT03992820|Anesthetics|anesthetics|mesh-ancestor
25218033|NCT02673606|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25218035|NCT02673606|Hormones|hormones|mesh-ancestor
24973747|NCT03707457|Nivolumab|nivolumab|mesh-list
25862412|NCT00089726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24615258|NCT01028534|Angiotensin II|angiotensin ii|mesh-list
25862413|NCT00089765|Ranibizumab|ranibizumab|mesh-list
25862419|NCT00089765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218312|NCT02670954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24548455|NCT00709553|GABA Modulators|gaba modulators|mesh-ancestor
25042351|NCT01460511|Mydriatics|mydriatics|mesh-ancestor
24974119|NCT05173441|Antibodies|antibodies|mesh-list
24974256|NCT05035277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24974334|NCT04944368|Paraproteins|paraproteins|mesh-list
24974520|NCT04511078|Panitumumab|panitumumab|mesh-list
24472884|NCT00400998|Xhance|xhance|mesh-list
24724676|NCT01594099|Mitosis Modulators|mitosis modulators|mesh-ancestor
24724682|NCT01594177|Afatinib|afatinib|mesh-list
24419381|NCT00211978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668512|NCT01718353|Prednisone|prednisone|mesh-list
25083454|NCT03315533|Analgesics|analgesics|mesh-ancestor
25084206|NCT03308890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25862494|NCT00090025|Leucovorin|leucovorin|mesh-list
24942847|NCT03977792|Docosanol|docosanol|mesh-list
25862518|NCT00090155|Aprepitant|aprepitant|mesh-list
24737189|NCT01667523|Cinnamaldehyde|cinnamaldehyde|mesh-list
25199844|NCT02738177|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25199845|NCT02738177|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
24943581|NCT03968861|Xenon|xenon|mesh-list
24738292|NCT01674686|Atorvastatin|atorvastatin|mesh-list
24486880|NCT00460447|Gemtuzumab|gemtuzumab|mesh-list
24743683|NCT04659382|Bevacizumab|bevacizumab|mesh-list
24748555|NCT02368301|Dexamethasone|dexamethasone|mesh-list
24629631|NCT01106872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219090|NCT02665832|Antimetabolites|antimetabolites|mesh-ancestor
24979260|NCT04938024|Ascorbic Acid|ascorbic acid|mesh-list
25051267|NCT00427154|Insulin|insulin|mesh-list
25668651|NCT01720602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753518|NCT01715701|Iodine|iodine|mesh-list
24753702|NCT01717118|Vaccines|vaccines|mesh-list
24944730|NCT03958045|Nivolumab|nivolumab|mesh-list
25086184|NCT03291158|Minocycline|minocycline|mesh-list
24757482|NCT01740271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219791|NCT02660762|BB 1101|bb 1101|mesh-list
24858198|NCT02295787|Anesthetics, General|anesthetics, general|mesh-ancestor
25862760|NCT00091312|Vitamins|vitamins|mesh-ancestor
25862788|NCT00091468|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24396126|NCT00137826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396128|NCT00137852|Celecoxib|celecoxib|mesh-list
24945794|NCT03946826|Petrolatum|petrolatum|mesh-list
25086636|NCT03287505|Aripiprazole|aripiprazole|mesh-list
25219949|NCT02659917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24630579|NCT01112462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25086820|NCT03285607|Tubulin Modulators|tubulin modulators|mesh-ancestor
25086821|NCT03285607|Antimitotic Agents|antimitotic agents|mesh-ancestor
25219989|NCT02659384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220013|NCT02659527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220021|NCT02659293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25220022|NCT02659293|Glucocorticoids|glucocorticoids|mesh-ancestor
25220023|NCT02659293|Hormones|hormones|mesh-ancestor
24416611|NCT00203567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24416870|NCT00204321|Antifungal Agents|antifungal agents|mesh-ancestor
25087394|NCT03279757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24431047|NCT00250120|Camptothecin|camptothecin|mesh-list
24432098|NCT00253552|Antimetabolites|antimetabolites|mesh-ancestor
24434670|NCT00263133|Serotonin Agents|serotonin agents|mesh-ancestor
24435841|NCT00268359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24435842|NCT00268359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435843|NCT00268359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25051508|NCT00401011|Glucocorticoids|glucocorticoids|mesh-ancestor
24438769|NCT00276731|Tubulin Modulators|tubulin modulators|mesh-ancestor
24438770|NCT00276731|Antimitotic Agents|antimitotic agents|mesh-ancestor
24438771|NCT00276731|Mitosis Modulators|mitosis modulators|mesh-ancestor
24438989|NCT00277043|Taxane|taxane|mesh-list
25668906|NCT01723904|Dopamine Agonists|dopamine agonists|mesh-ancestor
24440862|NCT00285090|Vitamins|vitamins|mesh-list
24440863|NCT00285090|Calcium|calcium|mesh-list
24440864|NCT00285090|Micronutrients|micronutrients|mesh-ancestor
24440865|NCT00285090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440867|NCT00285090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25668912|NCT01724021|Prednisolone|prednisolone|mesh-list
24442117|NCT00290069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25862997|NCT00092313|Rofecoxib|rofecoxib|mesh-list
25088392|NCT04669561|Lifitegrast|lifitegrast|mesh-list
24443057|NCT00293527|Interferons|interferons|mesh-list
25863173|NCT00093184|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25863174|NCT00093184|Protease Inhibitors|protease inhibitors|mesh-ancestor
25220490|NCT02655913|Vitamins|vitamins|mesh-ancestor
25863177|NCT00093223|Paclitaxel|paclitaxel|mesh-list
24589278|NCT00906451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25200013|NCT02737059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200014|NCT02737059|Analgesics|analgesics|mesh-ancestor
25863257|NCT00093418|Tipifarnib|tipifarnib|mesh-list
25863296|NCT00093509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25668976|NCT01724489|Hormones|hormones|mesh-list
25088459|NCT04427904|Sympathomimetics|sympathomimetics|mesh-ancestor
25051537|NCT00396357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051538|NCT00394563|Tanezumab|tanezumab|mesh-list
25051539|NCT00394563|Analgesics|analgesics|mesh-ancestor
24832962|NCT02172456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24461018|NCT00350480|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
24461019|NCT00350480|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25200023|NCT02736604|Nitrous Oxide|nitrous oxide|mesh-list
25863505|NCT00093951|(3-aminopropyl)(n-butyl)phosphinic acid|(3-aminopropyl)(n-butyl)phosphinic acid|mesh-list
25863509|NCT00093951|GABA Antagonists|gaba antagonists|mesh-ancestor
24947722|NCT03926559|Morphine|morphine|mesh-list
24553235|NCT00730054|Clonidine|clonidine|mesh-list
24632069|NCT01121835|Insulin|insulin|mesh-list
24947805|NCT03925779|Narcotics|narcotics|mesh-ancestor
25088990|NCT03270033|Analgesics|analgesics|mesh-ancestor
24554372|NCT00736164|Antioxidants|antioxidants|mesh-ancestor
24555017|NCT00739414|Panobinostat|panobinostat|mesh-list
25863558|NCT00094315|Anesthetics|anesthetics|mesh-ancestor
24555665|NCT00742638|Anticonvulsants|anticonvulsants|mesh-ancestor
24556320|NCT00747097|Antimetabolites|antimetabolites|mesh-ancestor
25056456|NCT03512574|Anticonvulsants|anticonvulsants|mesh-ancestor
24632554|NCT01124500|Dopamine Agents|dopamine agents|mesh-ancestor
24875885|NCT03816332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557578|NCT00753051|Clozapine|clozapine|mesh-list
24557690|NCT00753402|Sympathomimetics|sympathomimetics|mesh-ancestor
25221101|NCT02652312|Sensory System Agents|sensory system agents|mesh-ancestor
24632848|NCT01125904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24561808|NCT00762944|Histamine Antagonists|histamine antagonists|mesh-ancestor
24633062|NCT01127100|Narcotics|narcotics|mesh-ancestor
24633173|NCT01127529|Protein C|protein c|mesh-list
24981359|NCT03638947|Plasma Substitutes|plasma substitutes|mesh-ancestor
24566200|NCT00784745|Glucocorticoids|glucocorticoids|mesh-ancestor
24566822|NCT00788060|Everolimus|everolimus|mesh-list
24567912|NCT00793377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24567913|NCT00793429|Prucalopride|prucalopride|mesh-list
24948553|NCT03918590|Laxatives|laxatives|mesh-ancestor
24570234|NCT00803933|Pafuramidine|pafuramidine|mesh-list
24570235|NCT00803933|Antifungal Agents|antifungal agents|mesh-ancestor
24671064|NCT01323465|Nabiximols|nabiximols|mesh-list
24671065|NCT01323465|Omeprazole|omeprazole|mesh-list
24572595|NCT00815646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25221578|NCT02649504|Hormones|hormones|mesh-ancestor
25221619|NCT02649179|Ropivacaine|ropivacaine|mesh-list
25221658|NCT02648958|Adrenergic Agents|adrenergic agents|mesh-ancestor
25221659|NCT02648958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25221660|NCT02648958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950196|NCT01967238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009692|NCT05210153|Sertraline|sertraline|mesh-list
25221833|NCT02648048|Sensory System Agents|sensory system agents|mesh-ancestor
24834195|NCT02177409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24834236|NCT02177461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25089867|NCT03262727|Hormones|hormones|mesh-ancestor
25273137|NCT02387138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579708|NCT00857116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579709|NCT00857142|Oxymorphone|oxymorphone|mesh-list
24581130|NCT00864500|Hormones|hormones|mesh-ancestor
24581914|NCT00866645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24583533|NCT00875069|Ethanol|ethanol|mesh-list
25090100|NCT03260439|Tramadol|tramadol|mesh-list
24835143|NCT02182336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24835144|NCT02182336|Purinergic Agents|purinergic agents|mesh-ancestor
25042896|NCT01356160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951360|NCT03905486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24835354|NCT02182700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24835355|NCT02182700|Cholinergic Agents|cholinergic agents|mesh-ancestor
24588682|NCT00903942|Paclitaxel|paclitaxel|mesh-list
24753825|NCT01717963|Naloxone|naloxone|mesh-list
24590384|NCT00912392|Carboplatin|carboplatin|mesh-list
24590900|NCT00914160|Sensory System Agents|sensory system agents|mesh-ancestor
24402848|NCT00158561|Renal Agents|renal agents|mesh-ancestor
25090657|NCT03255330|Antipyretics|antipyretics|mesh-ancestor
25200827|NCT02731846|Xhance|xhance|mesh-list
25222835|NCT02643212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25222836|NCT02643212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222838|NCT02642900|Nystatin|nystatin|mesh-list
25222852|NCT02642861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24594493|NCT00934167|Calcium heparin|calcium heparin|mesh-list
25052109|NCT00332657|Growth Substances|growth substances|mesh-ancestor
24777640|NCT01865331|Insulin|insulin|mesh-list
24952003|NCT03899077|Contraceptive Agents|contraceptive agents|mesh-ancestor
24404424|NCT00163410|Glucocorticoids|glucocorticoids|mesh-ancestor
24983714|NCT05177939|Protective Agents|protective agents|mesh-ancestor
24598547|NCT00956462|Analgesics|analgesics|mesh-ancestor
24598548|NCT00956462|Sensory System Agents|sensory system agents|mesh-ancestor
24598549|NCT00956462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25222944|NCT02642484|Antacids|antacids|mesh-ancestor
25863881|NCT00095459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25863882|NCT00095459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25090862|NCT03253250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090863|NCT03253250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090864|NCT03253250|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25200911|NCT02731105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200912|NCT02731105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25153754|NCT02430480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626350|NCT01086878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24626351|NCT01086878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24863116|NCT03088059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24863117|NCT03088059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863118|NCT03088059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24863119|NCT03088059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24863120|NCT03088059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863121|NCT03088059|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24863123|NCT03065244|Immunoglobulins|immunoglobulins|mesh-list
25863883|NCT00095459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24863124|NCT03065244|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24863125|NCT03065244|gamma-Globulins|gamma-globulins|mesh-list
24405969|NCT00168896|Carboplatin|carboplatin|mesh-list
25153830|NCT02213068|Antitubercular Agents|antitubercular agents|mesh-ancestor
25153831|NCT02213068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25153832|NCT02213068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25153833|NCT02213068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25153834|NCT02213068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25153868|NCT02175173|Rufinamide|rufinamide|mesh-list
25153869|NCT02175173|Anticonvulsants|anticonvulsants|mesh-ancestor
25153870|NCT02175173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25153871|NCT02175173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25153872|NCT02175173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25153873|NCT02175173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863200|NCT02774421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24863201|NCT02774421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863202|NCT02774421|Immunologic Factors|immunologic factors|mesh-ancestor
24863203|NCT02774421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863213|NCT02681302|Nivolumab|nivolumab|mesh-list
24863214|NCT02681302|Ipilimumab|ipilimumab|mesh-list
24863215|NCT02681302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24863226|NCT02590094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407240|NCT00173862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24407241|NCT00173862|Immunologic Factors|immunologic factors|mesh-ancestor
24952157|NCT03897062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200948|NCT02730845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25200949|NCT02730845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863900|NCT00095511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207709|NCT03479502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806231|NCT02014558|Voriconazole|voriconazole|mesh-list
24863251|NCT02431702|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24863252|NCT02431702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24863253|NCT02431702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24863254|NCT02431702|Antidepressive Agents|antidepressive agents|mesh-ancestor
24863255|NCT02431702|Dopamine Agonists|dopamine agonists|mesh-ancestor
24863256|NCT02431702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24863257|NCT02431702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24863258|NCT02431702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25090905|NCT03252665|Urological Agents|urological agents|mesh-ancestor
24543121|NCT00681980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24543122|NCT00681993|Cyclophosphamide|cyclophosphamide|mesh-list
24543123|NCT00681993|Carboplatin|carboplatin|mesh-list
24543124|NCT00681993|Docetaxel|docetaxel|mesh-list
24543125|NCT00681993|Trastuzumab|trastuzumab|mesh-list
24952194|NCT03896646|Iminodiacetic acid|iminodiacetic acid|mesh-list
24952195|NCT03896646|Chelating Agents|chelating agents|mesh-ancestor
24952196|NCT03896646|Sequestering Agents|sequestering agents|mesh-ancestor
24952197|NCT03896646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952198|NCT03896321|Anticoagulants|anticoagulants|mesh-list
25200996|NCT02730624|Piperacillin|piperacillin|mesh-list
25200997|NCT02730624|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25200998|NCT02730624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25200999|NCT02730624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25201000|NCT02730624|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25201001|NCT02730624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052117|NCT00330473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052119|NCT00330369|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24952219|NCT03896113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24952220|NCT03896113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223076|NCT02641847|Antimitotic Agents|antimitotic agents|mesh-ancestor
25052533|NCT00260078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25052534|NCT00260078|Antiviral Agents|antiviral agents|mesh-ancestor
24760306|NCT01757236|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25052768|NCT00157339|Insulin|insulin|mesh-list
25863936|NCT00095654|Ramipril|ramipril|mesh-list
24952329|NCT03894904|Urological Agents|urological agents|mesh-ancestor
25201022|NCT02730442|Miconazole|miconazole|mesh-list
25223428|NCT02639741|Ascorbic Acid|ascorbic acid|mesh-list
25223429|NCT02639741|Melatonin|melatonin|mesh-list
25223466|NCT02639598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25223467|NCT02639598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25053800|NCT00004181|Busulfan|busulfan|mesh-list
25864003|NCT00095758|Aripiprazole|aripiprazole|mesh-list
25091563|NCT03248401|Aspirin|aspirin|mesh-list
25054218|NCT03531281|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25669360|NCT01729845|Cytarabine|cytarabine|mesh-list
25091692|NCT03247413|Antiemetics|antiemetics|mesh-ancestor
25054453|NCT03529643|Dexmedetomidine|dexmedetomidine|mesh-list
25091768|NCT03246776|Triclosan|triclosan|mesh-list
25091817|NCT03246620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091818|NCT03246620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24454671|NCT03852992|Minoxidil|minoxidil|mesh-list
24547440|NCT00703989|Thioctic Acid|thioctic acid|mesh-list
24867599|NCT03761277|Narcotics|narcotics|mesh-ancestor
25018506|NCT03698695|Mefloquine|mefloquine|mesh-list
24814456|NCT02064556|Vasodilator Agents|vasodilator agents|mesh-ancestor
24412460|NCT00191464|Insulin|insulin|mesh-list
24548624|NCT00710788|Calcium|calcium|mesh-list
24868786|NCT02824679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25092629|NCT03240471|Protease Inhibitors|protease inhibitors|mesh-ancestor
24809676|NCT02035904|Morphine|morphine|mesh-list
25093360|NCT03235531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604944|NCT00982540|Caspofungin|caspofungin|mesh-list
25094030|NCT03229616|Cyclophosphamide|cyclophosphamide|mesh-list
25094081|NCT03228901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094201|NCT03228355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25094202|NCT03228355|Autonomic Agents|autonomic agents|mesh-ancestor
25094203|NCT03228355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24814784|NCT02066675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24814785|NCT02066675|Alkylating Agents|alkylating agents|mesh-ancestor
25864317|NCT00096655|Infliximab|infliximab|mesh-list
24870783|NCT03942224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25094693|NCT03223896|Naloxone|naloxone|mesh-list
25224379|NCT02633709|Risdiplam|risdiplam|mesh-list
24814934|NCT02067416|Taxane|taxane|mesh-list
25095510|NCT03218852|Prednisone|prednisone|mesh-list
24872434|NCT05385705|Trastuzumab|trastuzumab|mesh-list
25024302|NCT03647423|Cetuximab|cetuximab|mesh-list
25864438|NCT00097045|Interferons|interferons|mesh-list
25864482|NCT00097214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513659|NCT00584389|Rimonabant|rimonabant|mesh-list
25864587|NCT00097825|Zoledronic Acid|zoledronic acid|mesh-list
25096372|NCT03212352|Contraceptive Agents|contraceptive agents|mesh-ancestor
24875154|NCT04408586|Sympathomimetics|sympathomimetics|mesh-ancestor
25096661|NCT03210064|Apatinib|apatinib|mesh-list
25864618|NCT00097942|Memantine|memantine|mesh-list
24875776|NCT03839823|Gemcitabine|gemcitabine|mesh-list
24876131|NCT03719001|Calcium|calcium|mesh-list
24837763|NCT02193256|Cholinergic Agents|cholinergic agents|mesh-ancestor
24877589|NCT02529852|Hormones|hormones|mesh-ancestor
25097223|NCT03206021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25097224|NCT03206008|Magnesium Sulfate|magnesium sulfate|mesh-list
25097225|NCT03206008|Analgesics|analgesics|mesh-ancestor
24877891|NCT02237183|Iloprost|iloprost|mesh-list
24877892|NCT02237183|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25864695|NCT00098358|Analgesics|analgesics|mesh-ancestor
24878488|NCT01660971|Gemcitabine|gemcitabine|mesh-list
25056702|NCT03510221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056703|NCT03510208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24887171|NCT04519151|Pembrolizumab|pembrolizumab|mesh-list
24879100|NCT05054868|Analgesics|analgesics|mesh-ancestor
24879269|NCT04921943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25056775|NCT03509688|Resveratrol|resveratrol|mesh-list
25056776|NCT03509688|Antiviral Agents|antiviral agents|mesh-ancestor
25056777|NCT03509688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25056778|NCT03509688|Antioxidants|antioxidants|mesh-ancestor
25056779|NCT03509688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056780|NCT03509688|Protective Agents|protective agents|mesh-ancestor
25056850|NCT03509142|Antifungal Agents|antifungal agents|mesh-ancestor
25097997|NCT03199976|Bromides|bromides|mesh-list
25060768|NCT03476772|Narcotics|narcotics|mesh-ancestor
25056893|NCT03508882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24811131|NCT02045017|Hormones|hormones|mesh-ancestor
24879768|NCT04439799|Testosterone enanthate|testosterone enanthate|mesh-list
24880618|NCT03560934|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24880627|NCT03541902|Sunitinib|sunitinib|mesh-list
25864809|NCT00098683|Amifostine|amifostine|mesh-list
24815988|NCT02073227|Metformin|metformin|mesh-list
24881443|NCT02367456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881444|NCT02367456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881447|NCT02345733|Amoxicillin|amoxicillin|mesh-list
24881771|NCT01358877|Trastuzumab|trastuzumab|mesh-list
24838109|NCT02195336|Mitosis Modulators|mitosis modulators|mesh-ancestor
24838110|NCT02195336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882278|NCT01850108|Sirolimus|sirolimus|mesh-list
24882548|NCT05169554|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24838217|NCT02196155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838288|NCT02196805|Antioxidants|antioxidants|mesh-ancestor
25100960|NCT03178422|Nicotine|nicotine|mesh-list
24891312|NCT04473261|Iodine|iodine|mesh-list
24838322|NCT02197156|Acetaminophen|acetaminophen|mesh-list
24838381|NCT02197442|Valsartan|valsartan|mesh-list
24838386|NCT02197494|Valsartan|valsartan|mesh-list
25102012|NCT03171220|Fludarabine|fludarabine|mesh-list
25865426|NCT00100893|Procyanidin|procyanidin|mesh-list
25102369|NCT03169504|Cholinergic Agents|cholinergic agents|mesh-ancestor
25102779|NCT03166254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102780|NCT03166254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25103361|NCT03162185|Citalopram|citalopram|mesh-list
25225125|NCT02629146|Fentanyl|fentanyl|mesh-list
24884203|NCT02687386|Mitoxantrone|mitoxantrone|mesh-list
25058201|NCT03498456|Dexlansoprazole|dexlansoprazole|mesh-list
25201500|NCT02727296|Propofol|propofol|mesh-list
25865870|NCT00102375|Topotecan|topotecan|mesh-list
25058534|NCT03495804|Mannitol|mannitol|mesh-list
25105099|NCT03148535|Lithium Carbonate|lithium carbonate|mesh-list
24952785|NCT03892148|Furosemide|furosemide|mesh-list
25105333|NCT03146533|Fludarabine|fludarabine|mesh-list
24975074|NCT04756427|Citric Acid|citric acid|mesh-list
25865905|NCT00102453|Antioxidants|antioxidants|mesh-ancestor
24794967|NCT04131504|Infliximab|infliximab|mesh-list
24508304|NCT00555022|Tiotropium Bromide|tiotropium bromide|mesh-list
24976107|NCT01411267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25059431|NCT03487939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24434360|NCT00262275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25225521|NCT02626559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225522|NCT02626559|Sensory System Agents|sensory system agents|mesh-ancestor
25225523|NCT02626559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25225524|NCT02626247|Vitamin A|vitamin a|mesh-list
25225525|NCT02626247|Vitamins|vitamins|mesh-ancestor
25225526|NCT02626247|Micronutrients|micronutrients|mesh-ancestor
24976557|NCT03171480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976558|NCT03171480|Vasodilator Agents|vasodilator agents|mesh-ancestor
25059548|NCT03487211|Analgesics|analgesics|mesh-ancestor
24884966|NCT03090997|Vitamins|vitamins|mesh-list
24588524|NCT00902954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24990178|NCT03557359|Nivolumab|nivolumab|mesh-list
24976924|NCT04817189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25225568|NCT02626481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24732569|NCT01640444|Cetuximab|cetuximab|mesh-list
24977078|NCT03708003|Venetoclax|venetoclax|mesh-list
24839254|NCT02203175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839257|NCT02203175|Anesthetics|anesthetics|mesh-ancestor
24839288|NCT02203253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24510592|NCT00565123|Ofloxacin|ofloxacin|mesh-list
24510866|NCT00566046|Levetiracetam|levetiracetam|mesh-list
24885481|NCT05172115|Enoxaparin|enoxaparin|mesh-list
24885516|NCT05171660|Antimetabolites|antimetabolites|mesh-ancestor
25866123|NCT00102882|Xhance|xhance|mesh-list
24511565|NCT00569712|Budesonide|budesonide|mesh-list
24511714|NCT00570440|Estradiol|estradiol|mesh-list
24511905|NCT00571675|Prednisone|prednisone|mesh-list
25670276|NCT04514653|Growth Inhibitors|growth inhibitors|mesh-ancestor
24797390|NCT01955317|Disinfectants|disinfectants|mesh-ancestor
25225992|NCT02623673|Dexamethasone|dexamethasone|mesh-list
25866330|NCT00103727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25060928|NCT03475459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060930|NCT03475407|Dexamethasone|dexamethasone|mesh-list
25866464|NCT00104403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24549433|NCT00715273|Niacin|niacin|mesh-list
25226534|NCT02620345|Hormones|hormones|mesh-ancestor
24840738|NCT02212210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24894580|NCT04439396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24894582|NCT04439396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24894583|NCT04439396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24894584|NCT04439396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717072|NCT01545297|Narcotics|narcotics|mesh-ancestor
24894585|NCT04438980|Methylprednisolone|methylprednisolone|mesh-list
24894586|NCT04438980|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24894587|NCT04438980|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25062217|NCT05131867|Milrinone|milrinone|mesh-list
25057893|NCT03500874|Antidotes|antidotes|mesh-ancestor
25062234|NCT05085782|Adrenergic Agents|adrenergic agents|mesh-ancestor
25226753|NCT02619019|Glucocorticoids|glucocorticoids|mesh-ancestor
24514418|NCT00590343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24514419|NCT00590343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24514420|NCT00590343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514421|NCT00590408|Ubiquinone|ubiquinone|mesh-list
25866593|NCT00104780|Freund's Adjuvant|freund's adjuvant|mesh-list
24717866|NCT01550432|Expectorants|expectorants|mesh-ancestor
24514849|NCT00593138|Dopamine Agents|dopamine agents|mesh-ancestor
24895820|NCT03006705|Tegafur|tegafur|mesh-list
25866699|NCT00105144|Antifungal Agents|antifungal agents|mesh-ancestor
25866730|NCT00105287|Analgesics|analgesics|mesh-ancestor
24900734|NCT04391660|Eusol|eusol|mesh-list
25866808|NCT00106054|Leucovorin|leucovorin|mesh-list
25062649|NCT04231877|Lenograstim|lenograstim|mesh-list
24539102|NCT00662337|Histamine Agents|histamine agents|mesh-ancestor
24896719|NCT04433741|Oxytocics|oxytocics|mesh-ancestor
24541183|NCT00671372|Irinotecan|irinotecan|mesh-list
25867225|NCT00107848|Modafinil|modafinil|mesh-list
24825565|NCT02129127|Paclitaxel|paclitaxel|mesh-list
24613689|NCT01020331|Memantine|memantine|mesh-list
25867467|NCT00108667|Dopamine Agents|dopamine agents|mesh-ancestor
25063157|NCT02949284|Prednisone|prednisone|mesh-list
25227768|NCT02612181|Sensory System Agents|sensory system agents|mesh-ancestor
25201804|NCT02725229|Anesthetics, Local|anesthetics, local|mesh-ancestor
24475059|NCT00408772|Capecitabine|capecitabine|mesh-list
25227893|NCT02611492|Cytarabine|cytarabine|mesh-list
25063451|NCT00003857|Tamoxifen|tamoxifen|mesh-list
25063506|NCT03468335|Irinotecan|irinotecan|mesh-list
24817874|NCT02085967|Dopamine Agents|dopamine agents|mesh-ancestor
24899958|NCT04398589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24899982|NCT04398290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25670629|NCT04107051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670630|NCT04107051|Sensory System Agents|sensory system agents|mesh-ancestor
25228111|NCT02609997|Sensory System Agents|sensory system agents|mesh-ancestor
24843613|NCT02228473|Cholinergic Agents|cholinergic agents|mesh-ancestor
24518727|NCT04432623|Benserazide|benserazide|mesh-list
25867754|NCT00109824|GABA Agents|gaba agents|mesh-ancestor
24818175|NCT02087215|Boron|boron|mesh-list
24519094|NCT03432949|Dexamethasone|dexamethasone|mesh-list
25867766|NCT00109941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670692|NCT04005079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228300|NCT02608736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24903546|NCT04362384|Vitamin E|vitamin e|mesh-list
25228350|NCT02608242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25228353|NCT02608242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064190|NCT03462446|Hemostatics|hemostatics|mesh-ancestor
24905066|NCT04350931|BCG Vaccine|bcg vaccine|mesh-list
24544366|NCT00688805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25867785|NCT00109993|Immunologic Factors|immunologic factors|mesh-ancestor
24858029|NCT02294656|Growth Inhibitors|growth inhibitors|mesh-ancestor
24844233|NCT02231931|Digoxin|digoxin|mesh-list
24844234|NCT02231931|Furosemide|furosemide|mesh-list
24844235|NCT02231931|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24911885|NCT04283526|Antimetabolites|antimetabolites|mesh-ancestor
24911887|NCT04283526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912005|NCT04282096|Caseins|caseins|mesh-list
24912081|NCT04281290|Bleomycin|bleomycin|mesh-list
24913212|NCT04267913|Immunologic Factors|immunologic factors|mesh-ancestor
24913213|NCT04267913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913214|NCT04267913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24913215|NCT04267913|Antiemetics|antiemetics|mesh-ancestor
24913216|NCT04267913|Autonomic Agents|autonomic agents|mesh-ancestor
24913217|NCT04267913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24913372|NCT04265456|Antipyretics|antipyretics|mesh-ancestor
24913373|NCT04265456|Anticonvulsants|anticonvulsants|mesh-ancestor
24844396|NCT02232555|Dopamine Agents|dopamine agents|mesh-ancestor
25867907|NCT00110240|Vildagliptin|vildagliptin|mesh-list
24839350|NCT02203500|Lacidipine|lacidipine|mesh-list
24841401|NCT02215733|Diuretics|diuretics|mesh-list
24619490|NCT01052623|Analgesics|analgesics|mesh-ancestor
24910797|NCT04294056|Propofol|propofol|mesh-list
24845949|NCT02240199|Lidocaine|lidocaine|mesh-list
24911159|NCT04291118|Hormones|hormones|mesh-ancestor
24541355|NCT00672399|Moxifloxacin|moxifloxacin|mesh-list
24814577|NCT02065492|Amlodipine|amlodipine|mesh-list
25201960|NCT02724202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24871155|NCT04658173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24874314|NCT04830215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125848|NCT03066076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125849|NCT03066076|Hormone Antagonists|hormone antagonists|mesh-ancestor
24623430|NCT01071369|Anesthetics|anesthetics|mesh-ancestor
24886752|NCT04523272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816831|NCT02079194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25868244|NCT00111267|Folic Acid|folic acid|mesh-list
25868245|NCT00111267|Hydroxocobalamin|hydroxocobalamin|mesh-list
25868263|NCT00111345|Daunorubicin|daunorubicin|mesh-list
25126198|NCT03063671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25126200|NCT03063671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24899738|NCT04400890|Vitamin D|vitamin d|mesh-list
24552459|NCT02916862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25202010|NCT02724163|Cytarabine|cytarabine|mesh-list
24553611|NCT00732290|Serotonin Agents|serotonin agents|mesh-ancestor
24553629|NCT00732420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25126714|NCT03060070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25126715|NCT03059888|Abatacept|abatacept|mesh-list
25126716|NCT03059888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25126718|NCT03059888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25126809|NCT03059667|Carboplatin|carboplatin|mesh-list
25868329|NCT00111631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868330|NCT00111631|Protease Inhibitors|protease inhibitors|mesh-ancestor
25868331|NCT00111631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868332|NCT00111631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868333|NCT00111644|Ceftriaxone|ceftriaxone|mesh-list
25868334|NCT00111644|Lactams|lactams|mesh-list
25868335|NCT00111644|beta-Lactams|beta-lactams|mesh-list
25229209|NCT02603822|Gout Suppressants|gout suppressants|mesh-ancestor
25229210|NCT02603822|Tocolytic Agents|tocolytic agents|mesh-ancestor
25229211|NCT02603822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25229212|NCT02603822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24460780|NCT00349492|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24813143|NCT02056730|Calcium|calcium|mesh-list
25670940|NCT03573921|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25670941|NCT03535506|Palbociclib|palbociclib|mesh-list
25670942|NCT03535506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670943|NCT03535506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24844957|NCT02235402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24844958|NCT02235402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844973|NCT02235428|Ipratropium|ipratropium|mesh-list
25229294|NCT02603679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229295|NCT02603679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25229296|NCT02603679|Hormone Antagonists|hormone antagonists|mesh-ancestor
25868434|NCT00112034|Prednisolone|prednisolone|mesh-list
24545512|NCT00693589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868444|NCT00112034|Antimetabolites|antimetabolites|mesh-ancestor
24554849|NCT00738556|Mitosis Modulators|mitosis modulators|mesh-ancestor
24554850|NCT00738556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554851|NCT00738556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24554852|NCT00738556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24845016|NCT02235584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24845017|NCT02235584|Glucocorticoids|glucocorticoids|mesh-ancestor
24845018|NCT02235584|Hormones|hormones|mesh-ancestor
24858375|NCT02296671|Vitamins|vitamins|mesh-ancestor
25868523|NCT00112476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25868524|NCT00112476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868525|NCT00112476|Antifungal Agents|antifungal agents|mesh-ancestor
25868526|NCT00112476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25127410|NCT03055663|Midazolam|midazolam|mesh-list
24838578|NCT02198482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838579|NCT02198495|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24838580|NCT02198495|Hematinics|hematinics|mesh-ancestor
24858399|NCT02296762|Immunologic Factors|immunologic factors|mesh-ancestor
24858400|NCT02296762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858446|NCT02297529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858447|NCT02297568|Vitamin D|vitamin d|mesh-list
24858448|NCT02297568|Ergocalciferols|ergocalciferols|mesh-list
25868583|NCT00112619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868584|NCT00112632|Imatinib Mesylate|imatinib mesylate|mesh-list
25868585|NCT00112632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447351|NCT00308321|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24447353|NCT00308321|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24447354|NCT00308321|Prednisolone acetate|prednisolone acetate|mesh-list
24447355|NCT00308321|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24447356|NCT00308321|Prednisolone phosphate|prednisolone phosphate|mesh-list
24447357|NCT00308321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24447358|NCT00308321|Glucocorticoids|glucocorticoids|mesh-ancestor
24447360|NCT00308321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24447361|NCT00308321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858460|NCT02297620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24858462|NCT02297763|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24557773|NCT00753792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24557774|NCT00753883|Simvastatin|simvastatin|mesh-list
24557775|NCT00753883|Ezetimibe|ezetimibe|mesh-list
24557818|NCT00754351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25868625|NCT00112645|Alkylating Agents|alkylating agents|mesh-ancestor
25868627|NCT00112658|Leucovorin|leucovorin|mesh-list
24558488|NCT00757458|Anticoagulants|anticoagulants|mesh-ancestor
25229530|NCT02602301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25229531|NCT02602301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127625|NCT03054220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25127768|NCT03053622|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25127769|NCT03053622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25127770|NCT03053583|Pyrithione zinc|pyrithione zinc|mesh-list
25127771|NCT03053583|Keratolytic Agents|keratolytic agents|mesh-ancestor
25108400|NCT03132142|Cinnamaldehyde|cinnamaldehyde|mesh-list
25868687|NCT00112749|Dermatologic Agents|dermatologic agents|mesh-ancestor
25868688|NCT00112749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25868689|NCT00112749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25868690|NCT00112775|Imatinib Mesylate|imatinib mesylate|mesh-list
25670987|NCT03453489|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25868691|NCT00112775|Dasatinib|dasatinib|mesh-list
24845583|NCT02238288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845584|NCT02238288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24845585|NCT02238288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24845586|NCT02238288|Autonomic Agents|autonomic agents|mesh-ancestor
24845587|NCT02238288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25868743|NCT00112892|Antioxidants|antioxidants|mesh-ancestor
24845607|NCT02238314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25868767|NCT00113048|Alemtuzumab|alemtuzumab|mesh-list
25868768|NCT00113048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25868769|NCT00113048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868770|NCT00113074|Nicotine|nicotine|mesh-list
25868771|NCT00113074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25868772|NCT00113074|Autonomic Agents|autonomic agents|mesh-ancestor
25868773|NCT00113074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858649|NCT02298660|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24858667|NCT02298985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24858668|NCT02298985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24858669|NCT02298985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858670|NCT02298985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868775|NCT00113074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25868788|NCT00113100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868789|NCT00113100|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25868790|NCT00113100|Contraceptive Agents|contraceptive agents|mesh-ancestor
25868791|NCT00113100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25868792|NCT00113100|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25868793|NCT00113100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25868794|NCT00113100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25868795|NCT00113100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24546131|NCT00696956|Antimitotic Agents|antimitotic agents|mesh-ancestor
25128208|NCT03049176|Antiviral Agents|antiviral agents|mesh-ancestor
25128209|NCT03049176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24858696|NCT02299115|Prednisolone|prednisolone|mesh-list
24546168|NCT00697021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24546170|NCT00697021|Sensory System Agents|sensory system agents|mesh-ancestor
24546171|NCT00697021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24546172|NCT00697021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546173|NCT00697021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24546174|NCT00697021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24546175|NCT00697021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25868808|NCT00113165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868809|NCT00113165|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25868810|NCT00113165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25868811|NCT00113165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24546186|NCT00697021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24546188|NCT00697034|Antipruritics|antipruritics|mesh-ancestor
25128281|NCT03048877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128301|NCT03048942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868822|NCT00113282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25671010|NCT03336216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868823|NCT00113282|Analgesics|analgesics|mesh-ancestor
25128356|NCT03047837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25128375|NCT03048136|Nivolumab|nivolumab|mesh-list
24546280|NCT00697476|Topotecan|topotecan|mesh-list
24546281|NCT00697476|Vorinostat|vorinostat|mesh-list
24546285|NCT00697476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546286|NCT00697476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24546287|NCT00697476|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25868824|NCT00113282|Sensory System Agents|sensory system agents|mesh-ancestor
24858711|NCT02299115|Antiemetics|antiemetics|mesh-ancestor
24546291|NCT00697502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546292|NCT00697502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24546293|NCT00697554|Vaccines|vaccines|mesh-list
24546294|NCT00697554|Immunologic Factors|immunologic factors|mesh-ancestor
25128546|NCT03046017|Anesthetics, Local|anesthetics, local|mesh-ancestor
25128547|NCT03046017|Anesthetics|anesthetics|mesh-ancestor
25128548|NCT03046017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25868836|NCT00113503|Azathioprine|azathioprine|mesh-list
25868837|NCT00113503|Antimetabolites|antimetabolites|mesh-ancestor
24546332|NCT00697671|Sensory System Agents|sensory system agents|mesh-ancestor
24546333|NCT00697671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24546334|NCT00697671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24546335|NCT00697671|Antimetabolites|antimetabolites|mesh-ancestor
24546337|NCT00697775|Immunologic Factors|immunologic factors|mesh-ancestor
24546338|NCT00697775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546339|NCT00697814|Clomiphene|clomiphene|mesh-list
24546340|NCT00697814|Enclomiphene|enclomiphene|mesh-list
25868868|NCT00113594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25868869|NCT00113594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868870|NCT00113594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25868871|NCT00113594|Serotonin Agents|serotonin agents|mesh-ancestor
24858786|NCT02299518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24858787|NCT02299518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858788|NCT02299518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24546381|NCT00697892|Antimalarials|antimalarials|mesh-ancestor
24546382|NCT00697892|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24858816|NCT02299557|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24858817|NCT02299557|Mydriatics|mydriatics|mesh-ancestor
24858818|NCT02299557|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24858819|NCT02299557|Protective Agents|protective agents|mesh-ancestor
24858821|NCT02299687|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24858822|NCT02299687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24858823|NCT02299687|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25129122|NCT03042923|Mannitol|mannitol|mesh-list
24546447|NCT00698425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546482|NCT00698724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546483|NCT00698724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24546484|NCT00698724|Glucocorticoids|glucocorticoids|mesh-ancestor
24546486|NCT00698724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24546578|NCT00699114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24546579|NCT00699114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24546580|NCT00699114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24546581|NCT00699114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24546582|NCT00699114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546583|NCT00699114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24546584|NCT00699114|Narcotics|narcotics|mesh-ancestor
24546613|NCT00699322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24546614|NCT00699322|Immunologic Factors|immunologic factors|mesh-ancestor
24546615|NCT00699361|Pantoprazole|pantoprazole|mesh-list
24546773|NCT00700154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546774|NCT00700193|Vaccines|vaccines|mesh-list
24546775|NCT00700193|Immunologic Factors|immunologic factors|mesh-ancestor
24546776|NCT00700193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546777|NCT00700284|Dapivirine|dapivirine|mesh-list
25868946|NCT00113984|Ipilimumab|ipilimumab|mesh-list
25129870|NCT03037775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25129872|NCT03037736|Bevacizumab|bevacizumab|mesh-list
25129909|NCT03038009|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25129910|NCT03038009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25129911|NCT03038009|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25129912|NCT03038009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25129964|NCT03036995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25129965|NCT03036995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129966|NCT03036826|Meropenem|meropenem|mesh-list
25129967|NCT03036826|Tazobactam|tazobactam|mesh-list
25129968|NCT03036826|Piperacillin|piperacillin|mesh-list
24566573|NCT00786396|Antiviral Agents|antiviral agents|mesh-ancestor
25129972|NCT03036826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25129974|NCT03036826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129975|NCT03037073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25129976|NCT03037073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24595156|NCT00937079|Exenatide|exenatide|mesh-list
25130598|NCT03032458|Narcotics|narcotics|mesh-ancestor
24801037|NCT01980498|Fentanyl|fentanyl|mesh-list
24548345|NCT00709189|Hormones|hormones|mesh-ancestor
25130912|NCT03031262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130913|NCT03031262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25130919|NCT03030131|Durvalumab|durvalumab|mesh-list
25131050|NCT03029351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25131052|NCT03029273|Fludarabine|fludarabine|mesh-list
24548703|NCT00711789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25869256|NCT00115115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869257|NCT00115115|Dopamine Agents|dopamine agents|mesh-ancestor
25869258|NCT00115115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25869259|NCT00115115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869260|NCT00115115|Protective Agents|protective agents|mesh-ancestor
25869261|NCT00115128|Lenograstim|lenograstim|mesh-list
25869262|NCT00115128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25869263|NCT00115128|Immunologic Factors|immunologic factors|mesh-ancestor
25869264|NCT00115128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869265|NCT00115154|Imiquimod|imiquimod|mesh-list
25869266|NCT00115154|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24548737|NCT00711854|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24548738|NCT00711854|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24548739|NCT00711854|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24548751|NCT00711906|Pyrimethamine|pyrimethamine|mesh-list
24548752|NCT00711906|Sulfadoxine|sulfadoxine|mesh-list
24548753|NCT00711906|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24548755|NCT00711906|Antimalarials|antimalarials|mesh-ancestor
25869281|NCT00115219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25869282|NCT00115219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24548846|NCT00712439|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24548847|NCT00712439|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24548848|NCT00712439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24548849|NCT00712439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548850|NCT00712439|Antimanic Agents|antimanic agents|mesh-ancestor
24548856|NCT00712452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25131439|NCT03025958|Nimotuzumab|nimotuzumab|mesh-list
25131534|NCT03025295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25230178|NCT02597699|Dsuvia|dsuvia|mesh-list
24572099|NCT00813072|Tubulin Modulators|tubulin modulators|mesh-ancestor
24572100|NCT00813072|Antimitotic Agents|antimitotic agents|mesh-ancestor
24572101|NCT00813072|Mitosis Modulators|mitosis modulators|mesh-ancestor
24572102|NCT00813072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572104|NCT00813072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24572299|NCT00814125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25230189|NCT02597699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869462|NCT00115700|Rituximab|rituximab|mesh-list
25230219|NCT02597400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25132009|NCT03022123|Prednisone|prednisone|mesh-list
24846211|NCT02242149|Diacetylrhein|diacetylrhein|mesh-list
25230271|NCT02597140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24846228|NCT02242227|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24846229|NCT02242227|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24846230|NCT02242227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24846231|NCT02242227|Adrenergic Agents|adrenergic agents|mesh-ancestor
24846232|NCT02242227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24801326|NCT01982799|Gout Suppressants|gout suppressants|mesh-ancestor
24801328|NCT01982799|Narcotics|narcotics|mesh-ancestor
25132214|NCT03020329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25132215|NCT03020329|Immunologic Factors|immunologic factors|mesh-ancestor
25132216|NCT03020329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132225|NCT03020134|Ritonavir|ritonavir|mesh-list
25132226|NCT03020134|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25132227|NCT03020134|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25132228|NCT03020134|Protease Inhibitors|protease inhibitors|mesh-ancestor
25132229|NCT03020134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25132231|NCT03020134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25869586|NCT00116259|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25869587|NCT00116259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25230294|NCT02596984|Antifungal Agents|antifungal agents|mesh-ancestor
25230295|NCT02596984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25230296|NCT02596984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230297|NCT02596984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230298|NCT02597322|Axitinib|axitinib|mesh-list
25230299|NCT02597322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25869606|NCT00116350|Abortifacient Agents|abortifacient agents|mesh-ancestor
24846242|NCT02242240|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25869607|NCT00116350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25869608|NCT00116350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25869609|NCT00116389|Gemcitabine|gemcitabine|mesh-list
25869610|NCT00116389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25869611|NCT00116389|Antimetabolites|antimetabolites|mesh-ancestor
25671175|NCT02841371|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25230313|NCT02597036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25230314|NCT02596880|Ribavirin|ribavirin|mesh-list
25230315|NCT02596880|Sofosbuvir|sofosbuvir|mesh-list
24549664|NCT00716612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549666|NCT00716846|Atorvastatin|atorvastatin|mesh-list
24549667|NCT00716846|Simvastatin|simvastatin|mesh-list
24549668|NCT00716846|Pitavastatin|pitavastatin|mesh-list
24549669|NCT00716846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25869635|NCT00116402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25869636|NCT00116402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476801|NCT00416533|Mitosis Modulators|mitosis modulators|mesh-ancestor
24476806|NCT00416533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24447789|NCT00309569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447790|NCT00309569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24549784|NCT00717561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24549785|NCT00717561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24549786|NCT00717561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24549787|NCT00717561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549788|NCT00717561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132546|NCT03018301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25132547|NCT03018301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25132548|NCT03018301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25132549|NCT03018301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25132550|NCT03018301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574420|NCT00825149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25132619|NCT03017703|Eplerenone|eplerenone|mesh-list
25132633|NCT03017807|Immunologic Factors|immunologic factors|mesh-ancestor
25132634|NCT03017807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132635|NCT03017729|Botulinum Toxins|botulinum toxins|mesh-list
25132636|NCT03017729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24846323|NCT02242357|Telmisartan|telmisartan|mesh-list
24846324|NCT02242357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24447799|NCT00309569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24801404|NCT01983462|Natriuretic Agents|natriuretic agents|mesh-ancestor
24801405|NCT01983462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550279|NCT00720135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24550280|NCT00720135|Interleukin-2|interleukin-2|mesh-list
24550281|NCT00720135|Antibodies|antibodies|mesh-list
24550282|NCT00720135|Immunoglobulins|immunoglobulins|mesh-list
24550283|NCT00720135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24550284|NCT00720135|Immunologic Factors|immunologic factors|mesh-ancestor
24550285|NCT00720135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550286|NCT00720135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550287|NCT00720135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24550288|NCT00720135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24550289|NCT00720135|Analgesics|analgesics|mesh-ancestor
24550292|NCT00720148|Bortezomib|bortezomib|mesh-list
25869750|NCT00116935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25869751|NCT00116935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24550451|NCT00720577|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25869771|NCT00116961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24447869|NCT00309725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447871|NCT00309725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24573127|NCT00817973|Caseins|caseins|mesh-list
25869772|NCT00116961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869773|NCT00116961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25869774|NCT00116961|Glucocorticoids|glucocorticoids|mesh-ancestor
25869775|NCT00116961|Hormones|hormones|mesh-ancestor
25869776|NCT00116961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25869777|NCT00116961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25869778|NCT00116961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25869779|NCT00117000|Methyltestosterone|methyltestosterone|mesh-list
25230403|NCT02596334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25230404|NCT02596334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25230405|NCT02596334|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25230406|NCT02596334|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25230408|NCT02596100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25230409|NCT02596100|Antithrombins|antithrombins|mesh-ancestor
25230410|NCT02596100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25230411|NCT02596100|Protease Inhibitors|protease inhibitors|mesh-ancestor
25230412|NCT02596100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230413|NCT02596100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230414|NCT02596100|Anticoagulants|anticoagulants|mesh-ancestor
25230415|NCT02596217|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25230416|NCT02596217|Immunologic Factors|immunologic factors|mesh-ancestor
25230417|NCT02596217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846341|NCT02242383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846342|NCT02242383|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24801417|NCT01983462|Adrenergic Agents|adrenergic agents|mesh-ancestor
24801418|NCT01983462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24801419|NCT01983475|Denosumab|denosumab|mesh-list
24801420|NCT01983475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24801421|NCT01983475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869780|NCT00117000|Testosterone|testosterone|mesh-list
24877954|NCT02208375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801435|NCT01983527|Prednisolone acetate|prednisolone acetate|mesh-list
24801436|NCT01983527|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24801437|NCT01983527|Prednisolone phosphate|prednisolone phosphate|mesh-list
24801438|NCT01983527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24801440|NCT01983527|Autonomic Agents|autonomic agents|mesh-ancestor
24801441|NCT01983527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24801442|NCT01983527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230418|NCT02596243|Vaccines|vaccines|mesh-list
25230419|NCT02596243|Immunologic Factors|immunologic factors|mesh-ancestor
25230420|NCT02596243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230421|NCT02596269|Nefopam|nefopam|mesh-list
25230422|NCT02596269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25230423|NCT02596269|Analgesics|analgesics|mesh-ancestor
25230424|NCT02596269|Sensory System Agents|sensory system agents|mesh-ancestor
25869781|NCT00117000|Testosterone undecanoate|testosterone undecanoate|mesh-list
25869782|NCT00117000|Testosterone enanthate|testosterone enanthate|mesh-list
24801443|NCT01983527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24801444|NCT01983527|Glucocorticoids|glucocorticoids|mesh-ancestor
24801445|NCT01983527|Hormones|hormones|mesh-ancestor
24801446|NCT01983527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24801447|NCT01983527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24801448|NCT01983527|Protective Agents|protective agents|mesh-ancestor
24801449|NCT01983527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24801450|NCT01983527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25869783|NCT00117000|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25869784|NCT00117000|Androgens|androgens|mesh-ancestor
25869785|NCT00117000|Hormones|hormones|mesh-ancestor
25869786|NCT00117000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25869787|NCT00117000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869788|NCT00117000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25869789|NCT00117000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25869790|NCT00117000|Anabolic Agents|anabolic agents|mesh-ancestor
25869791|NCT00117013|Topotecan|topotecan|mesh-list
25869792|NCT00117013|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24801451|NCT01983540|Vaccines|vaccines|mesh-list
24801452|NCT01983540|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24555721|NCT00742846|Glucocorticoids|glucocorticoids|mesh-ancestor
24555722|NCT00742846|Hormones|hormones|mesh-ancestor
25869795|NCT00117013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869796|NCT00117013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25869797|NCT00117026|Benphothiamine|benphothiamine|mesh-list
25869798|NCT00117026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25869799|NCT00117026|Immunologic Factors|immunologic factors|mesh-ancestor
25869800|NCT00117026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869801|NCT00117026|Chelating Agents|chelating agents|mesh-ancestor
25869802|NCT00117026|Sequestering Agents|sequestering agents|mesh-ancestor
25869803|NCT00117026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869804|NCT00117039|Darbepoetin alfa|darbepoetin alfa|mesh-list
25869805|NCT00117039|Hematinics|hematinics|mesh-ancestor
25869806|NCT00117052|Cinacalcet|cinacalcet|mesh-list
25869807|NCT00117052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25869808|NCT00117052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869809|NCT00117052|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25869810|NCT00117052|Hormone Antagonists|hormone antagonists|mesh-ancestor
24573429|NCT00819962|Bupivacaine|bupivacaine|mesh-list
25230425|NCT02596269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25230426|NCT02596269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230427|NCT02596256|Docetaxel|docetaxel|mesh-list
25230428|NCT02596256|Apatinib|apatinib|mesh-list
25230429|NCT02596256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230430|NCT02596256|Tubulin Modulators|tubulin modulators|mesh-ancestor
25230431|NCT02596256|Antimitotic Agents|antimitotic agents|mesh-ancestor
25230432|NCT02596256|Mitosis Modulators|mitosis modulators|mesh-ancestor
25230433|NCT02596256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230434|NCT02596256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25230435|NCT02596256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230436|NCT02595658|Insulin, Short-Acting|insulin, short-acting|mesh-list
25230437|NCT02595658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25869811|NCT00117052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25869812|NCT00117065|Darbepoetin alfa|darbepoetin alfa|mesh-list
25869816|NCT00117091|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25869817|NCT00117091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25869818|NCT00117104|Darbepoetin alfa|darbepoetin alfa|mesh-list
25869819|NCT00117104|Hematinics|hematinics|mesh-ancestor
25869820|NCT00117117|Darbepoetin alfa|darbepoetin alfa|mesh-list
25869821|NCT00117117|Hematinics|hematinics|mesh-ancestor
25869822|NCT00117130|Darbepoetin alfa|darbepoetin alfa|mesh-list
25869823|NCT00117130|Hematinics|hematinics|mesh-ancestor
25869824|NCT00117182|Budesonide|budesonide|mesh-list
25869825|NCT00117182|Mannitol|mannitol|mesh-list
25869826|NCT00117182|Bromides|bromides|mesh-list
25869827|NCT00117182|Albuterol|albuterol|mesh-list
24801466|NCT01983735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24801467|NCT01983735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801468|NCT01983735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24801469|NCT01983735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801470|NCT01983735|Vasodilator Agents|vasodilator agents|mesh-ancestor
24801471|NCT01983735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24801473|NCT01983735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25230440|NCT02595918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25230441|NCT02595918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230442|NCT02595918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25230444|NCT02595840|Pemetrexed|pemetrexed|mesh-list
25133211|NCT03013751|Udenafil|udenafil|mesh-list
25869851|NCT00117182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25869852|NCT00117182|Cholinergic Agents|cholinergic agents|mesh-ancestor
24801485|NCT01983761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24801486|NCT01983761|Immunologic Factors|immunologic factors|mesh-ancestor
24801487|NCT01983761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801488|NCT01983761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24801489|NCT01983761|Antimetabolites|antimetabolites|mesh-ancestor
25230466|NCT02595346|Hydroxychloroquine|hydroxychloroquine|mesh-list
24801490|NCT01983761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801491|NCT01983761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24801492|NCT01983761|Antiviral Agents|antiviral agents|mesh-ancestor
24801493|NCT01983761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24556094|NCT00744913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556095|NCT00745004|Ondansetron|ondansetron|mesh-list
24556098|NCT00745004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25230449|NCT02595840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25230450|NCT02595840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25230451|NCT02595840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25230452|NCT02595606|Hyaluronic Acid|hyaluronic acid|mesh-list
25230453|NCT02595606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24846356|NCT02242409|Gemcitabine|gemcitabine|mesh-list
24846357|NCT02242409|Paclitaxel|paclitaxel|mesh-list
24846358|NCT02242409|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24846359|NCT02242409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24846360|NCT02242409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24846361|NCT02242409|Tubulin Modulators|tubulin modulators|mesh-ancestor
24846362|NCT02242409|Antimitotic Agents|antimitotic agents|mesh-ancestor
24846363|NCT02242409|Mitosis Modulators|mitosis modulators|mesh-ancestor
25060915|NCT03475615|Antimetabolites|antimetabolites|mesh-ancestor
25060916|NCT03475589|Apatinib|apatinib|mesh-list
25671196|NCT02620865|Folic Acid|folic acid|mesh-list
25869853|NCT00117208|Mannitol|mannitol|mesh-list
25869854|NCT00117208|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25869855|NCT00117208|Diuretics|diuretics|mesh-ancestor
25869856|NCT00117208|Natriuretic Agents|natriuretic agents|mesh-ancestor
25869857|NCT00117208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133385|NCT03013075|Anesthetics, Local|anesthetics, local|mesh-ancestor
25133388|NCT03013075|Sensory System Agents|sensory system agents|mesh-ancestor
25230473|NCT02595346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25230474|NCT02595359|Moxifloxacin|moxifloxacin|mesh-list
25230475|NCT02595359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25230476|NCT02595359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25230477|NCT02595359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25230478|NCT02595359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25230479|NCT02595359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24846364|NCT02242409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846365|NCT02242409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24846366|NCT02242409|Antimetabolites|antimetabolites|mesh-ancestor
24846367|NCT02242409|Antiviral Agents|antiviral agents|mesh-ancestor
24846368|NCT02242409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24846369|NCT02242409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24846370|NCT02242409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24574035|NCT00823121|Buserelin|buserelin|mesh-list
25869864|NCT00117260|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25869865|NCT00117260|Estradiol|estradiol|mesh-list
25869866|NCT00117260|Estrogens|estrogens|mesh-ancestor
25869867|NCT00117260|Hormones|hormones|mesh-ancestor
25869868|NCT00117260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25869869|NCT00117260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869870|NCT00117260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25869871|NCT00117260|Contraceptive Agents|contraceptive agents|mesh-ancestor
25869872|NCT00117260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25230480|NCT02595359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230481|NCT02595359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230482|NCT02595463|Lidocaine|lidocaine|mesh-list
25230483|NCT02595463|Anesthetics, Local|anesthetics, local|mesh-ancestor
25230484|NCT02595463|Anesthetics|anesthetics|mesh-ancestor
25230485|NCT02595463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25133493|NCT03012321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133494|NCT03012321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25133495|NCT03012321|Hormone Antagonists|hormone antagonists|mesh-ancestor
25230486|NCT02595463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846371|NCT02242409|Immunologic Factors|immunologic factors|mesh-ancestor
25060947|NCT03475394|Chlorhexidine|chlorhexidine|mesh-list
24574260|NCT00824668|Insulin glulisine|insulin glulisine|mesh-list
25230487|NCT02595463|Sensory System Agents|sensory system agents|mesh-ancestor
25230488|NCT02595463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25230489|NCT02595463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25230527|NCT02595268|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25230493|NCT02595463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230494|NCT02595476|Remifentanil|remifentanil|mesh-list
25230495|NCT02595476|Propofol|propofol|mesh-list
25230496|NCT02595476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25230497|NCT02595476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25230498|NCT02595476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230499|NCT02595476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25230500|NCT02595476|Anesthetics, General|anesthetics, general|mesh-ancestor
25230507|NCT02595541|Milrinone|milrinone|mesh-list
24576721|NCT00840125|Mitosis Modulators|mitosis modulators|mesh-ancestor
24576722|NCT00840125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576723|NCT00840125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24576724|NCT00840125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24576726|NCT00840229|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24576727|NCT00840229|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24576728|NCT00840229|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25133586|NCT03012113|Mirabegron|mirabegron|mesh-list
25133588|NCT03012113|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24846372|NCT02242409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846373|NCT02242474|Adalimumab|adalimumab|mesh-list
24846374|NCT02242474|Etanercept|etanercept|mesh-list
25230543|NCT02595190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230544|NCT02595190|Antimanic Agents|antimanic agents|mesh-ancestor
25230545|NCT02595190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25230546|NCT02595190|Narcotics|narcotics|mesh-ancestor
25230547|NCT02595138|Zoledronic Acid|zoledronic acid|mesh-list
25273491|NCT02385058|Mitosis Modulators|mitosis modulators|mesh-ancestor
24801520|NCT01983800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24801521|NCT01983943|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
24801522|NCT01983943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24801524|NCT01983943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574542|NCT00825942|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25671240|NCT02620865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25671241|NCT02585375|Latanoprost|latanoprost|mesh-list
25671242|NCT02585375|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24444661|NCT00298779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044084|NCT01160601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25044086|NCT01159249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25044087|NCT01159249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044088|NCT01159249|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25044089|NCT01159249|Protease Inhibitors|protease inhibitors|mesh-ancestor
25230595|NCT02594800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230596|NCT02594800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25230597|NCT02594800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25230598|NCT02594800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24892325|NCT04464005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24892326|NCT04464005|Tocolytic Agents|tocolytic agents|mesh-ancestor
25230607|NCT02594358|Caffeine|caffeine|mesh-list
25230608|NCT02594358|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25230609|NCT02594358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273495|NCT02385227|Nicotine|nicotine|mesh-list
25133884|NCT03009604|Emollients|emollients|mesh-ancestor
25230627|NCT02594293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25230628|NCT02594410|Lercanidipine|lercanidipine|mesh-list
25230629|NCT02594410|Clopidogrel|clopidogrel|mesh-list
25230630|NCT02594410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25230631|NCT02594410|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25230632|NCT02594410|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25230633|NCT02594410|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25230635|NCT02594410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25230636|NCT02594410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230637|NCT02594410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230638|NCT02594410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25230639|NCT02594410|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25230640|NCT02594410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25230641|NCT02594410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25230642|NCT02594462|Contraceptive Agents|contraceptive agents|mesh-list
25230643|NCT02594462|Etonogestrel|etonogestrel|mesh-list
24892457|NCT04462822|Xhance|xhance|mesh-list
25230644|NCT02594462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25230645|NCT02594462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230646|NCT02594462|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25230647|NCT02594462|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25230648|NCT02594241|Prednisolone|prednisolone|mesh-list
25230649|NCT02594241|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25230650|NCT02594241|Methylprednisolone|methylprednisolone|mesh-list
25230651|NCT02594241|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24801531|NCT01984008|Sodium Citrate|sodium citrate|mesh-list
24454277|NCT04207086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24454278|NCT04207086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24454307|NCT04109482|Immunologic Factors|immunologic factors|mesh-ancestor
25230653|NCT02594241|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25230654|NCT02594241|Prednisolone phosphate|prednisolone phosphate|mesh-list
25230655|NCT02594241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25230656|NCT02594241|Glucocorticoids|glucocorticoids|mesh-ancestor
25230667|NCT02594241|Protective Agents|protective agents|mesh-ancestor
25230668|NCT02594449|Benzalkonium Compounds|benzalkonium compounds|mesh-list
25230669|NCT02594449|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24846396|NCT02242513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846397|NCT02242513|Sensory System Agents|sensory system agents|mesh-ancestor
24846398|NCT02242513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24846399|NCT02242513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24846400|NCT02242513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24892755|NCT04459676|Mitogens|mitogens|mesh-list
25134063|NCT03008876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25134064|NCT03008876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134065|NCT03008655|Tranexamic Acid|tranexamic acid|mesh-list
25134066|NCT03008655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25134067|NCT03008655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25134068|NCT03008655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134069|NCT03008655|Hemostatics|hemostatics|mesh-ancestor
25134070|NCT03008655|Coagulants|coagulants|mesh-ancestor
25134071|NCT03008512|Paclitaxel|paclitaxel|mesh-list
25134072|NCT03008512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25134073|NCT03008512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24801581|NCT01984099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801582|NCT01984099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24575145|NCT00829699|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25869917|NCT00117377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869918|NCT00117403|Vitamins|vitamins|mesh-list
25869919|NCT00117403|Vitamin E|vitamin e|mesh-list
25869920|NCT00117403|Thioctic Acid|thioctic acid|mesh-list
25869921|NCT00117403|Ubiquinone|ubiquinone|mesh-list
25869922|NCT00117403|Micronutrients|micronutrients|mesh-ancestor
25869923|NCT00117403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230686|NCT02593942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25230687|NCT02594072|Goserelin|goserelin|mesh-list
25671245|NCT02566395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25671246|NCT02566395|Immunologic Factors|immunologic factors|mesh-ancestor
25671247|NCT02566395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671248|NCT02566395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25671249|NCT02566395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25671250|NCT02566395|Alkylating Agents|alkylating agents|mesh-ancestor
25671251|NCT02566395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671252|NCT02566395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671253|NCT02566395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25671254|NCT02556099|Hydroxyurea|hydroxyurea|mesh-list
25671255|NCT02556099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25869924|NCT00117403|Antioxidants|antioxidants|mesh-ancestor
25876669|NCT02997228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25134197|NCT03007381|Ketorolac|ketorolac|mesh-list
25134198|NCT03007381|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25134199|NCT03007381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25134200|NCT03007381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25134201|NCT03007381|Analgesics|analgesics|mesh-ancestor
25134202|NCT03007381|Sensory System Agents|sensory system agents|mesh-ancestor
25134203|NCT03007381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25134216|NCT03007303|Serotonin Agents|serotonin agents|mesh-ancestor
25230725|NCT02593734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25230726|NCT02593734|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25230727|NCT02593734|Antidepressive Agents|antidepressive agents|mesh-ancestor
25230728|NCT02593734|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25230729|NCT02593734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25230730|NCT02593734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230731|NCT02593708|Paclitaxel|paclitaxel|mesh-list
25230732|NCT02593708|Trastuzumab|trastuzumab|mesh-list
25230733|NCT02593708|Pertuzumab|pertuzumab|mesh-list
25230734|NCT02593708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25230735|NCT02593708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230736|NCT02593708|Tubulin Modulators|tubulin modulators|mesh-ancestor
25230737|NCT02593708|Antimitotic Agents|antimitotic agents|mesh-ancestor
25230738|NCT02593708|Mitosis Modulators|mitosis modulators|mesh-ancestor
25230739|NCT02593708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230740|NCT02593708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25869935|NCT00117442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801617|NCT01984463|Sensory System Agents|sensory system agents|mesh-ancestor
24801618|NCT01984463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24801619|NCT01984463|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24557152|NCT00751517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25230753|NCT02593695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25230754|NCT02593695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230755|NCT02593721|Ibuprofen|ibuprofen|mesh-list
25230756|NCT02593721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25230757|NCT02593721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25230758|NCT02593721|Analgesics|analgesics|mesh-ancestor
25230759|NCT02593721|Sensory System Agents|sensory system agents|mesh-ancestor
25230760|NCT02593721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25230761|NCT02593721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230773|NCT02593526|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25230774|NCT02593526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25230775|NCT02593526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230776|NCT02593643|Midazolam|midazolam|mesh-list
25230777|NCT02593643|Ketamine|ketamine|mesh-list
25230778|NCT02593643|Analgesics|analgesics|mesh-ancestor
25230779|NCT02593643|Sensory System Agents|sensory system agents|mesh-ancestor
25230780|NCT02593643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108836|NCT03130270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230781|NCT02593643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230782|NCT02593643|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25230783|NCT02593643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25230784|NCT02593643|Anesthetics, General|anesthetics, general|mesh-ancestor
25230785|NCT02593643|Anesthetics|anesthetics|mesh-ancestor
25230786|NCT02593643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25230787|NCT02593643|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25230788|NCT02593643|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25230789|NCT02593643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25230790|NCT02593643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230791|NCT02593643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25230792|NCT02593643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25230793|NCT02593643|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25044120|NCT01138163|Docetaxel|docetaxel|mesh-list
25230806|NCT02593669|Hormones|hormones|mesh-ancestor
25230807|NCT02593669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25230808|NCT02593669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25230809|NCT02593669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230810|NCT02593500|Budesonide|budesonide|mesh-list
25230811|NCT02593500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25230812|NCT02593500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25230813|NCT02593500|Autonomic Agents|autonomic agents|mesh-ancestor
25230814|NCT02593500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25230815|NCT02593500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230816|NCT02593500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25230817|NCT02593500|Respiratory System Agents|respiratory system agents|mesh-ancestor
25230818|NCT02593500|Glucocorticoids|glucocorticoids|mesh-ancestor
25230819|NCT02593500|Hormones|hormones|mesh-ancestor
25230820|NCT02593500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25230821|NCT02593383|Clindamycin|clindamycin|mesh-list
25230822|NCT02593383|Clindamycin palmitate|clindamycin palmitate|mesh-list
25134671|NCT03005483|Antimanic Agents|antimanic agents|mesh-ancestor
25134672|NCT03005522|Dexamethasone|dexamethasone|mesh-list
25134673|NCT03005522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25134674|NCT03005522|Antiemetics|antiemetics|mesh-ancestor
25134675|NCT03005522|Autonomic Agents|autonomic agents|mesh-ancestor
25134676|NCT03005522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24817094|NCT02080858|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24894006|NCT04445194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230835|NCT02593383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230836|NCT02593383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25230837|NCT02593383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25230838|NCT02593383|Dermatologic Agents|dermatologic agents|mesh-ancestor
25230839|NCT02593409|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25230840|NCT02593409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25230841|NCT02593409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25230842|NCT02593409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25061302|NCT03472378|Celecoxib|celecoxib|mesh-list
25869997|NCT00117689|Thymoglobulin|thymoglobulin|mesh-list
25869998|NCT00117689|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25869999|NCT00117689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25870000|NCT00117689|Immunologic Factors|immunologic factors|mesh-ancestor
25870001|NCT00117689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870002|NCT00117689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25870003|NCT00117689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870004|NCT00117689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671268|NCT02498392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671269|NCT02478775|Cetrorelix|cetrorelix|mesh-list
25671270|NCT02478775|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25671271|NCT02478775|Fertility Agents|fertility agents|mesh-ancestor
25671272|NCT02478775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25671273|NCT02478775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134745|NCT03005184|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25134746|NCT03005184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25134747|NCT03005184|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25134748|NCT03005184|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25134749|NCT03005184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134750|NCT03005184|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25134751|NCT03005184|Protease Inhibitors|protease inhibitors|mesh-ancestor
25134752|NCT03005184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25134753|NCT03005184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25134754|NCT03005184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25134755|NCT03005184|Analgesics|analgesics|mesh-ancestor
25134756|NCT03005184|Sensory System Agents|sensory system agents|mesh-ancestor
25134757|NCT03005184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25134759|NCT03005184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25870005|NCT00117689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25870006|NCT00117689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870007|NCT00117689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25870008|NCT00117689|Antitubercular Agents|antitubercular agents|mesh-ancestor
25870009|NCT00117689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25870010|NCT00117689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25870011|NCT00117702|Everolimus|everolimus|mesh-list
25870012|NCT00117702|Tacrolimus|tacrolimus|mesh-list
25870013|NCT00117702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25230843|NCT02593409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230844|NCT02593409|Antiviral Agents|antiviral agents|mesh-ancestor
25230846|NCT02593409|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24577811|NCT00845910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577812|NCT00845910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24577813|NCT00845910|Antimetabolites|antimetabolites|mesh-ancestor
24577842|NCT00845988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24577843|NCT00846079|Regadenoson|regadenoson|mesh-list
24577844|NCT00846079|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
24577845|NCT00846079|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24577846|NCT00846079|Purinergic Agonists|purinergic agonists|mesh-ancestor
25134878|NCT03004105|Durvalumab|durvalumab|mesh-list
25134879|NCT03004105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25134880|NCT03004105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25134881|NCT03004339|Betamethasone|betamethasone|mesh-list
25134882|NCT03004339|Betamethasone Valerate|betamethasone valerate|mesh-list
25134883|NCT03004339|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25134884|NCT03004339|Betamethasone benzoate|betamethasone benzoate|mesh-list
24588119|NCT00901069|Azacitidine|azacitidine|mesh-list
24588120|NCT00901069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24588122|NCT00901069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588123|NCT00901069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24588125|NCT00901069|Alkylating Agents|alkylating agents|mesh-ancestor
25134974|NCT03003637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25134975|NCT03003637|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25134977|NCT03003611|Anesthetics|anesthetics|mesh-list
25870023|NCT00117728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870024|NCT00117728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870025|NCT00117728|Antiviral Agents|antiviral agents|mesh-ancestor
25870026|NCT00117728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25870027|NCT00117728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25870028|NCT00117728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25870029|NCT00117728|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25870030|NCT00117728|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25870031|NCT00117754|Terbinafine|terbinafine|mesh-list
25870032|NCT00117754|Antifungal Agents|antifungal agents|mesh-ancestor
25870033|NCT00117754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25870034|NCT00117754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230847|NCT02593409|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25230848|NCT02593474|Naltrexone|naltrexone|mesh-list
25230849|NCT02593474|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25230850|NCT02593474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25230851|NCT02593474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230852|NCT02593474|Sensory System Agents|sensory system agents|mesh-ancestor
24846430|NCT02242695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24846431|NCT02242695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846432|NCT02242695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24846433|NCT02242695|Hormone Antagonists|hormone antagonists|mesh-ancestor
24846434|NCT02242695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24801636|NCT01984606|Incretins|incretins|mesh-ancestor
24801637|NCT01984606|Hormones|hormones|mesh-ancestor
24859004|NCT02301000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25671312|NCT02382575|Immunologic Factors|immunologic factors|mesh-ancestor
25671313|NCT02382575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671314|NCT02382575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24576607|NCT00839397|Paroxetine|paroxetine|mesh-list
25230853|NCT02593474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25230854|NCT02593448|Anesthetics|anesthetics|mesh-list
25230855|NCT02593448|Propofol|propofol|mesh-list
25230856|NCT02593448|Sevoflurane|sevoflurane|mesh-list
25230857|NCT02593448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25230858|NCT02593448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894292|NCT04442984|Leucovorin|leucovorin|mesh-list
25230859|NCT02593448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25230860|NCT02593448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25230861|NCT02593448|Anesthetics, General|anesthetics, general|mesh-ancestor
24846435|NCT02242695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606607|NCT00991211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24846436|NCT02242734|Hydrocodone|hydrocodone|mesh-list
24846437|NCT02242734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24846438|NCT02242734|Narcotics|narcotics|mesh-ancestor
24846439|NCT02242734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25870035|NCT00117754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870036|NCT00117767|Terbinafine|terbinafine|mesh-list
25230951|NCT02592772|Autonomic Agents|autonomic agents|mesh-ancestor
24801641|NCT01984606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24801642|NCT01984606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801643|NCT01984606|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24595939|NCT00940953|Histamine Agents|histamine agents|mesh-ancestor
24595940|NCT00940953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24622328|NCT01066663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622329|NCT01066663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622330|NCT01066676|Ibuprofen|ibuprofen|mesh-list
24557799|NCT00754039|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
25870037|NCT00117767|Griseofulvin|griseofulvin|mesh-list
25870038|NCT00117767|Antifungal Agents|antifungal agents|mesh-ancestor
25870039|NCT00117767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25870040|NCT00117767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230862|NCT02593448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25230863|NCT02593448|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25230864|NCT02593487|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25230865|NCT02593487|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25230866|NCT02593487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25230867|NCT02593487|Antimetabolites|antimetabolites|mesh-ancestor
25230868|NCT02593487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230869|NCT02593487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25230870|NCT02593487|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25870051|NCT00117832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25870052|NCT00117832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870053|NCT00117832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25870054|NCT00117832|Respiratory System Agents|respiratory system agents|mesh-ancestor
25870055|NCT00117832|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25870056|NCT00117832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870057|NCT00117832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870058|NCT00117832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24894590|NCT04438980|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25870059|NCT00117832|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25870060|NCT00117832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25870061|NCT00117832|Histamine Antagonists|histamine antagonists|mesh-ancestor
25870062|NCT00117832|Histamine Agents|histamine agents|mesh-ancestor
25870063|NCT00117832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25870064|NCT00117897|Lenograstim|lenograstim|mesh-list
25230871|NCT02593487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230872|NCT02593370|Lidocaine|lidocaine|mesh-list
25230873|NCT02593370|Epinephrine|epinephrine|mesh-list
25230874|NCT02593370|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
25230875|NCT02593370|Anesthetics, Local|anesthetics, local|mesh-ancestor
25230876|NCT02593370|Anesthetics|anesthetics|mesh-ancestor
24578154|NCT00847093|Lidocaine|lidocaine|mesh-list
25230887|NCT02593370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25230888|NCT02593370|Adrenergic Agents|adrenergic agents|mesh-ancestor
25230889|NCT02593370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25230890|NCT02593370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25230891|NCT02593370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25230892|NCT02593370|Autonomic Agents|autonomic agents|mesh-ancestor
24645840|NCT01200212|Taxane|taxane|mesh-list
24846440|NCT02242734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846442|NCT02242734|Sensory System Agents|sensory system agents|mesh-ancestor
24846443|NCT02242734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25870065|NCT00117897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24622331|NCT01066676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24622332|NCT01066676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24622333|NCT01066676|Analgesics|analgesics|mesh-ancestor
24622334|NCT01066676|Sensory System Agents|sensory system agents|mesh-ancestor
25870066|NCT00117897|Immunologic Factors|immunologic factors|mesh-ancestor
25870068|NCT00117936|Mitogens|mitogens|mesh-list
25230919|NCT02592941|Immunologic Factors|immunologic factors|mesh-ancestor
24477746|NCT00419835|Losartan|losartan|mesh-list
25870083|NCT00118014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25870084|NCT00118014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25870085|NCT00118014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870086|NCT00118014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25870087|NCT00118014|Serotonin Agents|serotonin agents|mesh-ancestor
25870088|NCT00118014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230922|NCT02593227|Vaccines|vaccines|mesh-list
25230923|NCT02593227|Immunologic Factors|immunologic factors|mesh-ancestor
25230924|NCT02593227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230925|NCT02593227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25230926|NCT02593227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25230927|NCT02593227|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25230928|NCT02593227|Alkylating Agents|alkylating agents|mesh-ancestor
25230929|NCT02593227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230930|NCT02593227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230931|NCT02593227|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25230937|NCT02592863|Pentoxifylline|pentoxifylline|mesh-list
25230938|NCT02592863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25230939|NCT02592863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230940|NCT02592863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230941|NCT02592863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25230942|NCT02592863|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25230943|NCT02592863|Protective Agents|protective agents|mesh-ancestor
25230944|NCT02592863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230945|NCT02592863|Vasodilator Agents|vasodilator agents|mesh-ancestor
25230946|NCT02592863|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25230947|NCT02592863|Antioxidants|antioxidants|mesh-ancestor
25230948|NCT02592772|Menthol|menthol|mesh-list
25870089|NCT00118027|Pyrimethamine|pyrimethamine|mesh-list
24475071|NCT00408785|Botulinum Toxins|botulinum toxins|mesh-list
24475072|NCT00408785|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24475073|NCT00408785|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24475074|NCT00408785|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24475077|NCT00408785|Cholinergic Agents|cholinergic agents|mesh-ancestor
24475087|NCT00408798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475088|NCT00408798|Cholinergic Agents|cholinergic agents|mesh-ancestor
25273512|NCT02385188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273513|NCT02385188|Sensory System Agents|sensory system agents|mesh-ancestor
25273514|NCT02385188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24846445|NCT02242734|Respiratory System Agents|respiratory system agents|mesh-ancestor
24846446|NCT02242799|Artesunate|artesunate|mesh-list
24846447|NCT02242799|Lumefantrine|lumefantrine|mesh-list
24846448|NCT02242799|Artemether|artemether|mesh-list
24846449|NCT02242799|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25870100|NCT00118027|Renal Agents|renal agents|mesh-ancestor
25870101|NCT00118066|Calcitriol|calcitriol|mesh-list
25870102|NCT00118066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25870103|NCT00118066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870104|NCT00118066|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25870105|NCT00118066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25870106|NCT00118066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870107|NCT00118066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25230977|NCT02592720|Tenecteplase|tenecteplase|mesh-list
25230978|NCT02592720|Tirofiban|tirofiban|mesh-list
25230980|NCT02592720|Antithrombins|antithrombins|mesh-ancestor
25230981|NCT02592720|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25230982|NCT02592720|Protease Inhibitors|protease inhibitors|mesh-ancestor
25230983|NCT02592720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230984|NCT02592720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230985|NCT02592720|Anticoagulants|anticoagulants|mesh-ancestor
25230986|NCT02592720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25230987|NCT02592720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25230988|NCT02592720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25230989|NCT02592746|Capecitabine|capecitabine|mesh-list
25230990|NCT02592746|Palbociclib|palbociclib|mesh-list
25230991|NCT02592746|Leuprolide|leuprolide|mesh-list
25230992|NCT02592746|Exemestane|exemestane|mesh-list
25230993|NCT02592746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25230994|NCT02592746|Antimetabolites|antimetabolites|mesh-ancestor
25230995|NCT02592746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230996|NCT02592746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230997|NCT02592746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25230998|NCT02592746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230999|NCT02592746|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25231000|NCT02592746|Fertility Agents|fertility agents|mesh-ancestor
25870108|NCT00118066|Vitamins|vitamins|mesh-ancestor
25870109|NCT00118066|Micronutrients|micronutrients|mesh-ancestor
25870110|NCT00118066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25870111|NCT00118105|Bevacizumab|bevacizumab|mesh-list
25135558|NCT02997800|Anesthetics|anesthetics|mesh-ancestor
25231001|NCT02592746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25231002|NCT02592746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231003|NCT02592746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25231004|NCT02592746|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25231005|NCT02592746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25231006|NCT02592746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25231007|NCT02592746|Hormone Antagonists|hormone antagonists|mesh-ancestor
25231008|NCT02592746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25231009|NCT02592694|Tenecteplase|tenecteplase|mesh-list
25231010|NCT02592694|Tirofiban|tirofiban|mesh-list
25231011|NCT02592694|Bivalirudin|bivalirudin|mesh-list
25231012|NCT02592694|Antithrombins|antithrombins|mesh-ancestor
25231013|NCT02592694|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25231053|NCT02592122|Bromides|bromides|mesh-list
25231054|NCT02592122|Albuterol|albuterol|mesh-list
25231055|NCT02592122|Anticonvulsants|anticonvulsants|mesh-ancestor
25231056|NCT02592122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25231057|NCT02592122|Autonomic Agents|autonomic agents|mesh-ancestor
25231058|NCT02592122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25135713|NCT02995954|Amlodipine|amlodipine|mesh-list
25870150|NCT00118222|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
25870151|NCT00118222|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
25870152|NCT00118222|Ether|ether|mesh-list
25870153|NCT00118222|Trioxsalen|trioxsalen|mesh-list
25870154|NCT00118222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870155|NCT00118222|Dermatologic Agents|dermatologic agents|mesh-ancestor
25870156|NCT00118222|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25870157|NCT00118222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25870158|NCT00118222|Anesthetics, General|anesthetics, general|mesh-ancestor
25870159|NCT00118222|Anesthetics|anesthetics|mesh-ancestor
25870160|NCT00118222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25870161|NCT00118222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870162|NCT00118235|Bevacizumab|bevacizumab|mesh-list
25870163|NCT00118235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24578346|NCT00848692|Rituximab|rituximab|mesh-list
25870196|NCT00118261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870197|NCT00118261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25870198|NCT00118261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25870199|NCT00118261|Immunologic Factors|immunologic factors|mesh-ancestor
24476565|NCT00415766|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25870200|NCT00118261|Antidotes|antidotes|mesh-ancestor
25870201|NCT00118261|Protective Agents|protective agents|mesh-ancestor
25870202|NCT00118261|Vitamin B Complex|vitamin b complex|mesh-ancestor
25870203|NCT00118261|Vitamins|vitamins|mesh-ancestor
25870204|NCT00118261|Micronutrients|micronutrients|mesh-ancestor
25870205|NCT00118261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25870206|NCT00118261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870207|NCT00118300|Capecitabine|capecitabine|mesh-list
25870208|NCT00118300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25870209|NCT00118300|Antimetabolites|antimetabolites|mesh-ancestor
25870210|NCT00118300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870211|NCT00118300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870212|NCT00118313|Imiquimod|imiquimod|mesh-list
25870213|NCT00118313|Sargramostim|sargramostim|mesh-list
25231091|NCT02591914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25231092|NCT02591914|Growth Substances|growth substances|mesh-ancestor
25870227|NCT00118326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25870228|NCT00118326|Immunologic Factors|immunologic factors|mesh-ancestor
25870229|NCT00118326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870230|NCT00118508|Risedronic Acid|risedronic acid|mesh-list
25870231|NCT00118508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25870232|NCT00118508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25870233|NCT00118508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870234|NCT00118508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25870235|NCT00118508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870236|NCT00118508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25231105|NCT02591615|Antimitotic Agents|antimitotic agents|mesh-ancestor
25231106|NCT02591615|Mitosis Modulators|mitosis modulators|mesh-ancestor
25870257|NCT00118768|Interferons|interferons|mesh-list
25870258|NCT00118768|Interferon-alpha|interferon-alpha|mesh-list
25870259|NCT00118768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870260|NCT00118768|Antiviral Agents|antiviral agents|mesh-ancestor
25870261|NCT00118768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25870262|NCT00118768|Immunologic Factors|immunologic factors|mesh-ancestor
25870263|NCT00118768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231128|NCT02591771|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25231129|NCT02591771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25231130|NCT02591771|Autonomic Agents|autonomic agents|mesh-ancestor
25231131|NCT02591771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25231132|NCT02591771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25231133|NCT02591771|Respiratory System Agents|respiratory system agents|mesh-ancestor
25231134|NCT02591771|Mydriatics|mydriatics|mesh-ancestor
25231135|NCT02591771|Sympathomimetics|sympathomimetics|mesh-ancestor
25231136|NCT02591771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25273519|NCT02385188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273520|NCT02385188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25273521|NCT02385188|Analgesics|analgesics|mesh-ancestor
25273522|NCT02385188|Antipyretics|antipyretics|mesh-ancestor
25273523|NCT02385188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25273524|NCT02385188|Immunologic Factors|immunologic factors|mesh-ancestor
25273525|NCT02385188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25273526|NCT02385188|Interferon Inducers|interferon inducers|mesh-ancestor
25273527|NCT02385188|Emollients|emollients|mesh-ancestor
25273528|NCT02385188|Dermatologic Agents|dermatologic agents|mesh-ancestor
25273529|NCT02385032|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25870264|NCT00118794|Lumefantrine|lumefantrine|mesh-list
25273530|NCT02385032|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25273531|NCT02385032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25273532|NCT02385136|Temozolomide|temozolomide|mesh-list
25870265|NCT00118794|Artemether|artemether|mesh-list
25135878|NCT02995304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25135879|NCT02995304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25135880|NCT02995304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25135881|NCT02995304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25135882|NCT02995304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25135883|NCT02995304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25135884|NCT02995304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25135975|NCT02994719|Ropinirole|ropinirole|mesh-list
25870281|NCT00118807|Sulfadoxine|sulfadoxine|mesh-list
25870282|NCT00118807|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25870283|NCT00118807|Amodiaquine|amodiaquine|mesh-list
25870284|NCT00118807|Antimalarials|antimalarials|mesh-ancestor
25870285|NCT00118807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25870286|NCT00118807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25870287|NCT00118807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24817930|NCT02086019|Adrenergic Agents|adrenergic agents|mesh-ancestor
24817931|NCT02086019|Sympatholytics|sympatholytics|mesh-ancestor
24817932|NCT02086019|Autonomic Agents|autonomic agents|mesh-ancestor
25870288|NCT00118807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870289|NCT00118807|Antiviral Agents|antiviral agents|mesh-ancestor
25870290|NCT00118807|Schistosomicides|schistosomicides|mesh-ancestor
25870291|NCT00118807|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25870292|NCT00118807|Anthelmintics|anthelmintics|mesh-ancestor
25870293|NCT00118807|Amebicides|amebicides|mesh-ancestor
25231137|NCT02591836|Atorvastatin|atorvastatin|mesh-list
24622348|NCT01066689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231153|NCT02591667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25231154|NCT02591667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231155|NCT02591667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25231156|NCT02591667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25231157|NCT02591667|Growth Substances|growth substances|mesh-ancestor
25231158|NCT02591667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231159|NCT02591667|Growth Inhibitors|growth inhibitors|mesh-ancestor
25231160|NCT02591628|Chlorthalidone|chlorthalidone|mesh-list
25231161|NCT02591628|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25231162|NCT02591628|Diuretics|diuretics|mesh-ancestor
25231163|NCT02591628|Natriuretic Agents|natriuretic agents|mesh-ancestor
25231164|NCT02591628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231165|NCT02591628|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25231166|NCT02591628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25231167|NCT02591628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231168|NCT02591277|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25231169|NCT02591277|Antiviral Agents|antiviral agents|mesh-ancestor
25231170|NCT02591277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25231171|NCT02591225|Phenprocoumon|phenprocoumon|mesh-list
25231172|NCT02591225|Anticoagulants|anticoagulants|mesh-ancestor
25870297|NCT00118807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870298|NCT00118807|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25870299|NCT00118807|Renal Agents|renal agents|mesh-ancestor
25870300|NCT00118820|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25870302|NCT00118937|Metformin|metformin|mesh-list
25870303|NCT00118937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25870304|NCT00118937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870305|NCT00118950|Metformin|metformin|mesh-list
25870306|NCT00118950|Repaglinide|repaglinide|mesh-list
24622349|NCT01066689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24622350|NCT01066689|Anticoagulants|anticoagulants|mesh-ancestor
24622351|NCT01066689|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24622352|NCT01066689|Chelating Agents|chelating agents|mesh-ancestor
24622353|NCT01066689|Sequestering Agents|sequestering agents|mesh-ancestor
25231180|NCT02590900|Acetaminophen|acetaminophen|mesh-list
25231181|NCT02590900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25231182|NCT02590900|Analgesics|analgesics|mesh-ancestor
25231183|NCT02590900|Sensory System Agents|sensory system agents|mesh-ancestor
25231184|NCT02590900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25231185|NCT02590900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231186|NCT02590900|Antipyretics|antipyretics|mesh-ancestor
25273533|NCT02385136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25136170|NCT02993094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136171|NCT02993094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136172|NCT02993159|Tamoxifen|tamoxifen|mesh-list
25870326|NCT00119002|Autonomic Agents|autonomic agents|mesh-ancestor
25870327|NCT00119002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25870328|NCT00119002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870329|NCT00119002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25870330|NCT00119002|Glucocorticoids|glucocorticoids|mesh-ancestor
25870331|NCT00119002|Hormones|hormones|mesh-ancestor
25870332|NCT00119002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25870333|NCT00119002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25870334|NCT00119002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231187|NCT02591173|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
25231188|NCT02591173|Angiotensin II|angiotensin ii|mesh-list
25231189|NCT02591173|Angiotensinogen|angiotensinogen|mesh-list
25231190|NCT02591173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25231191|NCT02591173|Vasodilator Agents|vasodilator agents|mesh-ancestor
25231192|NCT02591173|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25231193|NCT02591173|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25231194|NCT02591173|Protease Inhibitors|protease inhibitors|mesh-ancestor
25231195|NCT02591173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870361|NCT00119132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870362|NCT00119132|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25231198|NCT02590874|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25231199|NCT02590874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24846493|NCT02242825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846494|NCT02242838|Telmisartan|telmisartan|mesh-list
24846495|NCT02242838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25870370|NCT00119145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25870371|NCT00119145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870372|NCT00119145|Antiviral Agents|antiviral agents|mesh-ancestor
24880033|NCT04175925|Famotidine|famotidine|mesh-list
24448003|NCT00310011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24448004|NCT00310011|Antimetabolites|antimetabolites|mesh-ancestor
24448005|NCT00310011|Antiviral Agents|antiviral agents|mesh-ancestor
25870373|NCT00119145|Schistosomicides|schistosomicides|mesh-ancestor
25870374|NCT00119145|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25870375|NCT00119145|Anthelmintics|anthelmintics|mesh-ancestor
25870376|NCT00119171|Capecitabine|capecitabine|mesh-list
25870377|NCT00119171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25870378|NCT00119171|Antimetabolites|antimetabolites|mesh-ancestor
25870379|NCT00119171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870380|NCT00119171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870381|NCT00119184|Anesthetics|anesthetics|mesh-list
25870382|NCT00119184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25870383|NCT00119184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870384|NCT00119210|Bupropion|bupropion|mesh-list
25870385|NCT00119210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25870386|NCT00119210|Antidepressive Agents|antidepressive agents|mesh-ancestor
24627962|NCT01095822|Valsartan|valsartan|mesh-list
25231243|NCT02591004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231244|NCT02591004|Vasodilator Agents|vasodilator agents|mesh-ancestor
25231245|NCT02591004|Tocolytic Agents|tocolytic agents|mesh-ancestor
25231246|NCT02591004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25231247|NCT02590653|Atorvastatin|atorvastatin|mesh-list
25231248|NCT02590653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25231249|NCT02590653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25231250|NCT02590653|Antimetabolites|antimetabolites|mesh-ancestor
25231251|NCT02590653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231252|NCT02590653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25231253|NCT02590653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25231254|NCT02590653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25231255|NCT02590536|Sildenafil Citrate|sildenafil citrate|mesh-list
25231256|NCT02590536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231257|NCT02590536|Vasodilator Agents|vasodilator agents|mesh-ancestor
25231258|NCT02590536|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25231259|NCT02590536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25231260|NCT02590536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25231261|NCT02590536|Urological Agents|urological agents|mesh-ancestor
25231262|NCT02590705|Lidocaine|lidocaine|mesh-list
25231263|NCT02590705|Anesthetics, Local|anesthetics, local|mesh-ancestor
25231264|NCT02590705|Anesthetics|anesthetics|mesh-ancestor
25870408|NCT00119249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870409|NCT00119301|Leucovorin|leucovorin|mesh-list
25870410|NCT00119301|Trimetrexate|trimetrexate|mesh-list
25870411|NCT00119301|Methotrexate|methotrexate|mesh-list
24801671|NCT01984931|Dopamine Agents|dopamine agents|mesh-ancestor
24801672|NCT01984931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24801673|NCT01984931|Parasympatholytics|parasympatholytics|mesh-ancestor
24801674|NCT01984931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24801675|NCT01984931|Serotonin Agents|serotonin agents|mesh-ancestor
24801676|NCT01984931|Antifoaming Agents|antifoaming agents|mesh-ancestor
25870412|NCT00119301|Calcium|calcium|mesh-list
25231266|NCT02590705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231267|NCT02590705|Sensory System Agents|sensory system agents|mesh-ancestor
25231268|NCT02590705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25231269|NCT02590705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25231270|NCT02590705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25231271|NCT02590705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25231272|NCT02590705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25231273|NCT02590705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231274|NCT02590601|Bromocriptine|bromocriptine|mesh-list
25231275|NCT02590601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25231276|NCT02590601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25231277|NCT02590601|Hormone Antagonists|hormone antagonists|mesh-ancestor
25870413|NCT00119301|Levoleucovorin|levoleucovorin|mesh-list
24818163|NCT02087202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24818164|NCT02087202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24818165|NCT02087202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25136587|NCT02990286|Antitubercular Agents|antitubercular agents|mesh-ancestor
25136592|NCT02990312|Sirolimus|sirolimus|mesh-list
25061726|NCT03468946|Caffeine|caffeine|mesh-list
25231315|NCT02590263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25231316|NCT02590263|Alkylating Agents|alkylating agents|mesh-ancestor
25231317|NCT02590263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231318|NCT02590263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231319|NCT02590224|Glycine|glycine|mesh-list
25231320|NCT02590224|Glycine Agents|glycine agents|mesh-ancestor
25231321|NCT02590224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25231322|NCT02590224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136757|NCT02989129|Antioxidants|antioxidants|mesh-ancestor
25136758|NCT02989129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136759|NCT02989129|Protective Agents|protective agents|mesh-ancestor
25136760|NCT02989129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136761|NCT02988999|Erythritol|erythritol|mesh-list
25136762|NCT02988999|Vasodilator Agents|vasodilator agents|mesh-ancestor
25870428|NCT00119301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24902191|NCT04376528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25231344|NCT02590250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231345|NCT02590250|Cholinergic Agents|cholinergic agents|mesh-ancestor
25231346|NCT02590250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25231347|NCT02590250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231348|NCT02590250|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25061745|NCT03468907|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25061746|NCT03468907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25061751|NCT03468829|Gontivimab|gontivimab|mesh-list
25671343|NCT02115997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671344|NCT02115997|Immunologic Factors|immunologic factors|mesh-ancestor
25671345|NCT02115997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671346|NCT02115997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25671347|NCT02115997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25671348|NCT02115997|Glucocorticoids|glucocorticoids|mesh-ancestor
25870429|NCT00119301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25870430|NCT00119301|Antidotes|antidotes|mesh-ancestor
25870431|NCT00119301|Protective Agents|protective agents|mesh-ancestor
25870432|NCT00119301|Vitamin B Complex|vitamin b complex|mesh-ancestor
25870433|NCT00119301|Vitamins|vitamins|mesh-ancestor
25870434|NCT00119301|Micronutrients|micronutrients|mesh-ancestor
25870435|NCT00119301|Antifungal Agents|antifungal agents|mesh-ancestor
25870436|NCT00119301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25870437|NCT00119314|Gemcitabine|gemcitabine|mesh-list
25870438|NCT00119314|Capecitabine|capecitabine|mesh-list
25870439|NCT00119314|Docetaxel|docetaxel|mesh-list
25870440|NCT00119314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25870441|NCT00119314|Antimetabolites|antimetabolites|mesh-ancestor
25870442|NCT00119314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870443|NCT00119314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870444|NCT00119314|Antiviral Agents|antiviral agents|mesh-ancestor
25870445|NCT00119314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25870446|NCT00119314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870447|NCT00119314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25870448|NCT00119314|Immunologic Factors|immunologic factors|mesh-ancestor
25870449|NCT00119314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870450|NCT00119314|Tubulin Modulators|tubulin modulators|mesh-ancestor
25870451|NCT00119314|Antimitotic Agents|antimitotic agents|mesh-ancestor
25870452|NCT00119314|Mitosis Modulators|mitosis modulators|mesh-ancestor
25870453|NCT00119340|Cyclosporine|cyclosporine|mesh-list
25870454|NCT00119340|Mycophenolic Acid|mycophenolic acid|mesh-list
25870455|NCT00119340|Fludarabine|fludarabine|mesh-list
25231349|NCT02590250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25231350|NCT02590055|Gemcitabine|gemcitabine|mesh-list
25231351|NCT02590055|Docetaxel|docetaxel|mesh-list
25231352|NCT02590055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25231353|NCT02590055|Antimetabolites|antimetabolites|mesh-ancestor
25231354|NCT02590055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231355|NCT02590055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231356|NCT02590055|Antiviral Agents|antiviral agents|mesh-ancestor
25231357|NCT02590055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25231358|NCT02590055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25231359|NCT02590055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25231360|NCT02590055|Immunologic Factors|immunologic factors|mesh-ancestor
25231361|NCT02590055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231362|NCT02590055|Tubulin Modulators|tubulin modulators|mesh-ancestor
25870456|NCT00119340|Fludarabine phosphate|fludarabine phosphate|mesh-list
25870457|NCT00119340|Cyclosporins|cyclosporins|mesh-list
25870458|NCT00119340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870459|NCT00119340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24902540|NCT04372264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25870460|NCT00119340|Antimetabolites|antimetabolites|mesh-ancestor
24801685|NCT01984931|Anticonvulsants|anticonvulsants|mesh-ancestor
25231363|NCT02590055|Antimitotic Agents|antimitotic agents|mesh-ancestor
25231364|NCT02590055|Mitosis Modulators|mitosis modulators|mesh-ancestor
25231365|NCT02590016|Insulin|insulin|mesh-list
25231366|NCT02590016|Insulin Aspart|insulin aspart|mesh-list
25231367|NCT02590016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25231368|NCT02590016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231369|NCT02589782|Moxifloxacin|moxifloxacin|mesh-list
25231370|NCT02589782|Linezolid|linezolid|mesh-list
25231371|NCT02589782|Bedaquiline|bedaquiline|mesh-list
25231372|NCT02589782|Clofazimine|clofazimine|mesh-list
25231373|NCT02589782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25231374|NCT02589782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25231375|NCT02589782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25231376|NCT02589782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25231377|NCT02589782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274030|NCT02381470|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25870461|NCT00119340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870462|NCT00119340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25870463|NCT00119340|Immunologic Factors|immunologic factors|mesh-ancestor
25870464|NCT00119340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870465|NCT00119340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870466|NCT00119340|Antifungal Agents|antifungal agents|mesh-ancestor
25870467|NCT00119340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25870468|NCT00119340|Dermatologic Agents|dermatologic agents|mesh-ancestor
24448019|NCT00310089|Doxorubicin|doxorubicin|mesh-list
25870469|NCT00119340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25870470|NCT00119340|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25870471|NCT00119340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25870472|NCT00119340|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25870473|NCT00119340|Antitubercular Agents|antitubercular agents|mesh-ancestor
25870474|NCT00119340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25870475|NCT00119431|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25870476|NCT00119431|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25870477|NCT00119431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25870478|NCT00119431|Immunologic Factors|immunologic factors|mesh-ancestor
24902610|NCT04372082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902612|NCT04372082|Anticestodal Agents|anticestodal agents|mesh-ancestor
25137132|NCT02986347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25870479|NCT00119431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870480|NCT00119483|Methyltestosterone|methyltestosterone|mesh-list
25870481|NCT00119483|Testosterone|testosterone|mesh-list
25870482|NCT00119483|Testosterone undecanoate|testosterone undecanoate|mesh-list
25870483|NCT00119483|Testosterone enanthate|testosterone enanthate|mesh-list
25870484|NCT00119483|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25870485|NCT00119483|Androgens|androgens|mesh-ancestor
25870486|NCT00119483|Hormones|hormones|mesh-ancestor
25870487|NCT00119483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25870488|NCT00119483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870489|NCT00119483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25870490|NCT00119483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870491|NCT00119483|Anabolic Agents|anabolic agents|mesh-ancestor
25870492|NCT00119496|Rosiglitazone|rosiglitazone|mesh-list
25231378|NCT02589782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231379|NCT02589782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231380|NCT02589782|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25231381|NCT02589782|Antitubercular Agents|antitubercular agents|mesh-ancestor
25231382|NCT02589782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25231383|NCT02589782|Leprostatic Agents|leprostatic agents|mesh-ancestor
25231384|NCT02589717|Atezolizumab|atezolizumab|mesh-list
25231385|NCT02589717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231386|NCT02589457|Tenofovir|tenofovir|mesh-list
25231387|NCT02589457|Antiviral Agents|antiviral agents|mesh-ancestor
25870493|NCT00119496|Beclomethasone|beclomethasone|mesh-list
24448032|NCT00310089|Antimitotic Agents|antimitotic agents|mesh-ancestor
24448033|NCT00310089|Mitosis Modulators|mitosis modulators|mesh-ancestor
24448034|NCT00310089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24448035|NCT00310089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24448036|NCT00310089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24448037|NCT00310089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448038|NCT00310089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24448040|NCT00310128|Methylprednisolone|methylprednisolone|mesh-list
24818273|NCT02087579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24614485|NCT01024491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25870495|NCT00119496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870496|NCT00119496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870497|NCT00119496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25870498|NCT00119496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870499|NCT00119496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25870500|NCT00119496|Glucocorticoids|glucocorticoids|mesh-ancestor
25870501|NCT00119496|Hormones|hormones|mesh-ancestor
25870502|NCT00119496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25870503|NCT00119496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25870504|NCT00119496|Respiratory System Agents|respiratory system agents|mesh-ancestor
25870505|NCT00119496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25870506|NCT00119496|Autonomic Agents|autonomic agents|mesh-ancestor
24801688|NCT01984931|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24902755|NCT04370782|Hydroxychloroquine|hydroxychloroquine|mesh-list
25231388|NCT02589457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25231389|NCT02589457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25231390|NCT02589457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25231391|NCT02589457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25231392|NCT02589457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231393|NCT02589457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25231394|NCT02589457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25231395|NCT02589496|Pembrolizumab|pembrolizumab|mesh-list
25870507|NCT00119496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24801691|NCT01985061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870508|NCT00119496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25870509|NCT00119496|Vasodilator Agents|vasodilator agents|mesh-ancestor
25870510|NCT00119496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25870511|NCT00119496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25870512|NCT00119496|Purinergic Agents|purinergic agents|mesh-ancestor
25870513|NCT00119496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25870514|NCT00119587|Darbepoetin alfa|darbepoetin alfa|mesh-list
24880726|NCT03418038|Antiviral Agents|antiviral agents|mesh-ancestor
25231396|NCT02589496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25231397|NCT02589496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231398|NCT02589444|Vitamin D|vitamin d|mesh-list
25231399|NCT02589444|Cholecalciferol|cholecalciferol|mesh-list
25231400|NCT02589444|Vitamins|vitamins|mesh-ancestor
25231401|NCT02589444|Micronutrients|micronutrients|mesh-ancestor
25870515|NCT00119587|Hematinics|hematinics|mesh-ancestor
25870516|NCT00119613|Darbepoetin alfa|darbepoetin alfa|mesh-list
25870517|NCT00119613|Hematinics|hematinics|mesh-ancestor
25870518|NCT00119626|Disufenton sodium|disufenton sodium|mesh-list
25870519|NCT00119626|Antioxidants|antioxidants|mesh-ancestor
25870520|NCT00119626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061783|NCT03468777|Lansoprazole|lansoprazole|mesh-list
25870521|NCT00119626|Protective Agents|protective agents|mesh-ancestor
25870522|NCT00119626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870523|NCT00119639|Sorafenib|sorafenib|mesh-list
25870524|NCT00119639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870525|NCT00119639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25870526|NCT00119639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870527|NCT00119639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870528|NCT00119652|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25870529|NCT00119652|Paroxetine|paroxetine|mesh-list
25870530|NCT00119652|Antidepressive Agents|antidepressive agents|mesh-ancestor
25870531|NCT00119652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24579316|NCT00854451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25870532|NCT00119652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25870533|NCT00119652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25870534|NCT00119652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24801698|NCT01985087|Temozolomide|temozolomide|mesh-list
24581632|NCT00865631|Anticonvulsants|anticonvulsants|mesh-ancestor
24801701|NCT01985087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801702|NCT01985087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231402|NCT02589444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231403|NCT02589444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25231404|NCT02589444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25231405|NCT02589678|Vaccines|vaccines|mesh-list
25231406|NCT02589678|Immunologic Factors|immunologic factors|mesh-ancestor
25231407|NCT02589678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231408|NCT02589652|Interferons|interferons|mesh-list
25231409|NCT02589652|Interferon-alpha|interferon-alpha|mesh-list
25231410|NCT02589652|Interferon alpha-2|interferon alpha-2|mesh-list
25231411|NCT02589652|Entecavir|entecavir|mesh-list
25231412|NCT02589652|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25870536|NCT00119652|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25870537|NCT00119652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25870538|NCT00119652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25870539|NCT00119652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870540|NCT00119652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25870541|NCT00119652|Serotonin Agents|serotonin agents|mesh-ancestor
25870542|NCT00119652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24880810|NCT03274752|Paroxetine|paroxetine|mesh-list
25137265|NCT02985697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25137266|NCT02985697|Adrenergic Agents|adrenergic agents|mesh-ancestor
25137267|NCT02985697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25137268|NCT02985697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137269|NCT02985697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25137270|NCT02985697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25137275|NCT02985697|Anesthetics|anesthetics|mesh-ancestor
25231414|NCT02589652|Antiviral Agents|antiviral agents|mesh-ancestor
25231415|NCT02589652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25231416|NCT02589652|Immunologic Factors|immunologic factors|mesh-ancestor
25231417|NCT02589652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273550|NCT02384915|Prilocaine|prilocaine|mesh-list
25273551|NCT02384915|Mepivacaine|mepivacaine|mesh-list
25273552|NCT02384915|Anesthetics|anesthetics|mesh-ancestor
25273553|NCT02384915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25870557|NCT00119704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870558|NCT00119704|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25870559|NCT00119704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25870560|NCT00119730|Rituximab|rituximab|mesh-list
25870561|NCT00119730|Fludarabine|fludarabine|mesh-list
25870562|NCT00119730|Mitoxantrone|mitoxantrone|mesh-list
25870563|NCT00119730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25870564|NCT00119730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870565|NCT00119730|Immunologic Factors|immunologic factors|mesh-ancestor
25870566|NCT00119730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870567|NCT00119730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25870568|NCT00119730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870569|NCT00119730|Analgesics|analgesics|mesh-ancestor
24801707|NCT01985152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24454568|NCT03878524|Oxaliplatin|oxaliplatin|mesh-list
25671350|NCT02115997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25671351|NCT02115997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25671352|NCT02115997|Antiemetics|antiemetics|mesh-ancestor
25137334|NCT02985671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25137336|NCT02985593|Dermatologic Agents|dermatologic agents|mesh-ancestor
24880888|NCT03221257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880889|NCT03221257|Analgesics|analgesics|mesh-ancestor
24880890|NCT03221257|Sensory System Agents|sensory system agents|mesh-ancestor
24880891|NCT03221257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25870570|NCT00119730|Sensory System Agents|sensory system agents|mesh-ancestor
25870571|NCT00119730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25870572|NCT00119730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25870573|NCT00119730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25870574|NCT00119730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870575|NCT00119756|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25870576|NCT00119756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24580939|NCT00864058|Gabapentin|gabapentin|mesh-list
25231418|NCT02589340|Buspirone|buspirone|mesh-list
25231419|NCT02589340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25231420|NCT02589340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25231421|NCT02589340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25231422|NCT02589340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231423|NCT02589340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25231424|NCT02589340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25231425|NCT02589340|Serotonin Agents|serotonin agents|mesh-ancestor
25870577|NCT00119756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25870578|NCT00119756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25870579|NCT00119756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870580|NCT00119756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24801711|NCT01985152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24801712|NCT01985152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24801713|NCT01985152|Nootropic Agents|nootropic agents|mesh-ancestor
24801714|NCT01985256|Flucytosine|flucytosine|mesh-list
25434775|NCT00006436|Prednisone|prednisone|mesh-list
25671361|NCT01746238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671362|NCT01746238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25671363|NCT01746238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25231426|NCT02589340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25231427|NCT02589340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231431|NCT02589288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25231432|NCT02589288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231433|NCT02589288|Sensory System Agents|sensory system agents|mesh-ancestor
25231434|NCT02589288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24454626|NCT03878524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24454627|NCT03878524|Antidotes|antidotes|mesh-ancestor
24454628|NCT03878524|Protective Agents|protective agents|mesh-ancestor
24454629|NCT03878524|Vitamin B Complex|vitamin b complex|mesh-ancestor
24454630|NCT03878524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24454631|NCT03878524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25870581|NCT00119756|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25870582|NCT00119756|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25870583|NCT00119756|Serotonin Agents|serotonin agents|mesh-ancestor
25870584|NCT00119756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25870585|NCT00119756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870586|NCT00119756|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25870587|NCT00119756|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25870588|NCT00119756|Dopamine Agents|dopamine agents|mesh-ancestor
25870589|NCT00119769|Hormones|hormones|mesh-list
25870590|NCT00119769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25870591|NCT00119769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903409|NCT04364139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25137478|NCT02985281|Ribavirin|ribavirin|mesh-list
25137479|NCT02985281|Sofosbuvir|sofosbuvir|mesh-list
25231435|NCT02589041|Ropivacaine|ropivacaine|mesh-list
25231436|NCT02589041|Anesthetics, Local|anesthetics, local|mesh-ancestor
25231437|NCT02589041|Anesthetics|anesthetics|mesh-ancestor
25231438|NCT02589041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25870592|NCT00119886|Botulinum Toxins|botulinum toxins|mesh-list
25870593|NCT00119886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25274031|NCT02381470|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24903504|NCT04363255|Etoposide phosphate|etoposide phosphate|mesh-list
24903505|NCT04363255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24722297|NCT01579539|Prednisolone|prednisolone|mesh-list
25870594|NCT00119886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25870595|NCT00119886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870596|NCT00119886|Cholinergic Agents|cholinergic agents|mesh-ancestor
25870597|NCT00119886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25870598|NCT00119886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870599|NCT00119990|Dialysis Solutions|dialysis solutions|mesh-list
25870600|NCT00119990|Icodextrin|icodextrin|mesh-list
24880959|NCT03177291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24880960|NCT03177291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880961|NCT03177291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25870601|NCT00119990|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25231439|NCT02589041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231440|NCT02589041|Sensory System Agents|sensory system agents|mesh-ancestor
25231441|NCT02589041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25231442|NCT02588820|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25231443|NCT02588820|Antiviral Agents|antiviral agents|mesh-ancestor
25231444|NCT02588820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25231445|NCT02589158|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25231446|NCT02589158|Darunavir|darunavir|mesh-list
25231447|NCT02589158|Cobicistat|cobicistat|mesh-list
25231448|NCT02589158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24581439|NCT00865111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903511|NCT04363359|Vaccines|vaccines|mesh-list
24903557|NCT04362384|Protective Agents|protective agents|mesh-ancestor
25434776|NCT00006436|Cyclophosphamide|cyclophosphamide|mesh-list
25671364|NCT01746238|Growth Substances|growth substances|mesh-ancestor
25137566|NCT02984696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137567|NCT02984657|Anesthetics|anesthetics|mesh-list
24581596|NCT00865540|Antiemetics|antiemetics|mesh-ancestor
24903558|NCT04362384|Antioxidants|antioxidants|mesh-ancestor
25231449|NCT02589158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25231450|NCT02589158|Protease Inhibitors|protease inhibitors|mesh-ancestor
25231451|NCT02589158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25231452|NCT02589158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231453|NCT02589158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25231454|NCT02589158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25231455|NCT02589158|Antiviral Agents|antiviral agents|mesh-ancestor
25231456|NCT02589158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25231457|NCT02589158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25870602|NCT00120003|Candesartan|candesartan|mesh-list
25409611|NCT03366298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25671365|NCT01746238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671366|NCT01746238|Growth Inhibitors|growth inhibitors|mesh-ancestor
25870603|NCT00120003|Candesartan cilexetil|candesartan cilexetil|mesh-list
25870604|NCT00120003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25870605|NCT00120003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25870606|NCT00120003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25870607|NCT00120003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870608|NCT00120055|Atorvastatin|atorvastatin|mesh-list
24801747|NCT01985477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24801748|NCT01985477|Growth Substances|growth substances|mesh-ancestor
24801749|NCT01985477|Growth Inhibitors|growth inhibitors|mesh-ancestor
24801750|NCT01985477|Keratolytic Agents|keratolytic agents|mesh-ancestor
24801751|NCT01985477|Dermatologic Agents|dermatologic agents|mesh-ancestor
24801752|NCT01985594|Nifedipine|nifedipine|mesh-list
24801753|NCT01985594|Progesterone|progesterone|mesh-list
24801754|NCT01985594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24801755|NCT01985594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24801756|NCT01985594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801757|NCT01985594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24722525|NCT01581242|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
24722526|NCT01581242|Clevudine|clevudine|mesh-list
24722527|NCT01581242|Antiviral Agents|antiviral agents|mesh-ancestor
25231458|NCT02589158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25231459|NCT02588755|Chlorotrianisene|chlorotrianisene|mesh-list
25061843|NCT05390749|Growth Substances|growth substances|mesh-ancestor
25870609|NCT00120055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24722558|NCT01581411|Plasminogen|plasminogen|mesh-list
25870610|NCT00120055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24801758|NCT01985594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801759|NCT01985594|Vasodilator Agents|vasodilator agents|mesh-ancestor
24801760|NCT01985594|Tocolytic Agents|tocolytic agents|mesh-ancestor
24801761|NCT01985594|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25870611|NCT00120055|Antimetabolites|antimetabolites|mesh-ancestor
25870612|NCT00120055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870613|NCT00120055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25870614|NCT00120055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25870615|NCT00120055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870616|NCT00120081|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25870617|NCT00120081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25870618|NCT00120081|Immunologic Factors|immunologic factors|mesh-ancestor
25046152|NCT00871481|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25046153|NCT00871481|Antiviral Agents|antiviral agents|mesh-ancestor
25046154|NCT00871481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25046155|NCT00871182|Tiotropium Bromide|tiotropium bromide|mesh-list
25046156|NCT00871182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25046157|NCT00871182|Autonomic Agents|autonomic agents|mesh-ancestor
25046158|NCT00871182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25046159|NCT00871182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583234|NCT00873795|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24583235|NCT00873795|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24583236|NCT00873795|Serotonin Agents|serotonin agents|mesh-ancestor
24583237|NCT00873795|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24583238|NCT00873795|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24583239|NCT00873795|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24583268|NCT00873834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25870619|NCT00120081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870635|NCT00120133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870636|NCT00120133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25870637|NCT00120133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25870638|NCT00120133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870639|NCT00120172|Bevacizumab|bevacizumab|mesh-list
25870640|NCT00120172|Capecitabine|capecitabine|mesh-list
25870641|NCT00120172|Oxaliplatin|oxaliplatin|mesh-list
25231468|NCT02588755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25231469|NCT02588755|Antimetabolites|antimetabolites|mesh-ancestor
25231470|NCT02588755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881102|NCT03052608|Crizotinib|crizotinib|mesh-list
24903819|NCT04360759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25044256|NCT01124552|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25044257|NCT01124552|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25044258|NCT01124552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25044259|NCT01124552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044260|NCT01124552|Cholinergic Agents|cholinergic agents|mesh-ancestor
25044261|NCT01124552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25044262|NCT01124552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870642|NCT00120172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25870643|NCT00120172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870644|NCT00120172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25870645|NCT00120172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24454783|NCT03690544|Apremilast|apremilast|mesh-list
24454787|NCT03690544|Sensory System Agents|sensory system agents|mesh-ancestor
24454790|NCT03690544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24454791|NCT03690544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24454792|NCT03690544|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24454793|NCT03690544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24454794|NCT03690544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24454795|NCT03690544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24454814|NCT03535350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24454815|NCT03535350|Alkylating Agents|alkylating agents|mesh-ancestor
24454816|NCT03535350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24454817|NCT03535350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585278|NCT00884676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25870646|NCT00120172|Growth Substances|growth substances|mesh-ancestor
25870647|NCT00120172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870648|NCT00120172|Growth Inhibitors|growth inhibitors|mesh-ancestor
25870649|NCT00120172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25870650|NCT00120172|Antimetabolites|antimetabolites|mesh-ancestor
25870651|NCT00120172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870652|NCT00120185|Interleukin-2|interleukin-2|mesh-list
25870653|NCT00120185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870654|NCT00120185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25870655|NCT00120185|Analgesics|analgesics|mesh-ancestor
25231472|NCT02588937|Antiviral Agents|antiviral agents|mesh-ancestor
24586493|NCT00890955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870682|NCT00120302|Dermatologic Agents|dermatologic agents|mesh-ancestor
25870683|NCT00120302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25870684|NCT00120302|Immunologic Factors|immunologic factors|mesh-ancestor
25870685|NCT00120302|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25870686|NCT00120302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24801783|NCT01985724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24801784|NCT01985724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24801785|NCT01985724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24801787|NCT01985724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24801789|NCT01985750|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25231484|NCT02588534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25231485|NCT02588534|Immunologic Factors|immunologic factors|mesh-ancestor
25231486|NCT02588547|Granisetron|granisetron|mesh-list
25231487|NCT02588547|Antiemetics|antiemetics|mesh-ancestor
25231488|NCT02588547|Autonomic Agents|autonomic agents|mesh-ancestor
25231489|NCT02588547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25231490|NCT02588547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231491|NCT02588547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25231492|NCT02588547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25231493|NCT02588547|Serotonin Agents|serotonin agents|mesh-ancestor
25231494|NCT02588547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25231495|NCT02588547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044276|NCT01117584|Metformin|metformin|mesh-list
25044277|NCT01117584|Ipragliflozin|ipragliflozin|mesh-list
25044282|NCT01116141|Folic Acid|folic acid|mesh-list
25137894|NCT02981836|Vaccines|vaccines|mesh-list
25137895|NCT02981836|Immunologic Factors|immunologic factors|mesh-ancestor
25137896|NCT02981836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586913|NCT00892541|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24586914|NCT00892541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24448093|NCT00310232|Epoetin Alfa|epoetin alfa|mesh-list
24448094|NCT00310232|Hematinics|hematinics|mesh-ancestor
24448122|NCT00310336|Antimetabolites|antimetabolites|mesh-ancestor
24448123|NCT00310336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448124|NCT00310336|Immunologic Factors|immunologic factors|mesh-ancestor
24448125|NCT00310336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448126|NCT00310336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24448127|NCT00310336|Lipotropic Agents|lipotropic agents|mesh-ancestor
24448128|NCT00310336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24448129|NCT00310336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24448137|NCT00310505|Amphotericin B|amphotericin b|mesh-list
24448138|NCT00310505|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24448139|NCT00310505|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
24801791|NCT01985750|Renal Agents|renal agents|mesh-ancestor
24801792|NCT01985750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24801793|NCT01985750|Antitubercular Agents|antitubercular agents|mesh-ancestor
25870714|NCT00120367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870715|NCT00120367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870716|NCT00120367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25870717|NCT00120367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25870718|NCT00120367|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25870719|NCT00120367|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25870720|NCT00120380|Iloprost|iloprost|mesh-list
25870721|NCT00120380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25870722|NCT00120380|Vasodilator Agents|vasodilator agents|mesh-ancestor
25870723|NCT00120419|Mycophenolic Acid|mycophenolic acid|mesh-list
25870724|NCT00120419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25870725|NCT00120419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870726|NCT00120419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25870727|NCT00120419|Antitubercular Agents|antitubercular agents|mesh-ancestor
25870728|NCT00120419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25870729|NCT00120419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25870730|NCT00120419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870731|NCT00120419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231512|NCT02588742|Melatonin|melatonin|mesh-list
24904096|NCT04358614|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25231513|NCT02588742|Antioxidants|antioxidants|mesh-ancestor
25231514|NCT02588742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231515|NCT02588742|Protective Agents|protective agents|mesh-ancestor
25231516|NCT02588742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231517|NCT02588742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25231518|NCT02588716|Terlipressin|terlipressin|mesh-list
25231519|NCT02588716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25231520|NCT02588716|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25231521|NCT02588417|Dexamethasone|dexamethasone|mesh-list
24846562|NCT02243098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24846563|NCT02243098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24846564|NCT02243098|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24846565|NCT02243098|Protective Agents|protective agents|mesh-ancestor
25137942|NCT02981290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870738|NCT00120432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24801801|NCT01985789|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24801802|NCT01985789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25870739|NCT00120432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870740|NCT00120432|Sympathomimetics|sympathomimetics|mesh-ancestor
25870741|NCT00120432|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25870742|NCT00120432|Nasal Decongestants|nasal decongestants|mesh-ancestor
25870743|NCT00120432|Respiratory System Agents|respiratory system agents|mesh-ancestor
25870744|NCT00120432|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25870745|NCT00120432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25870746|NCT00120432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25870747|NCT00120432|Adrenergic Agents|adrenergic agents|mesh-ancestor
25870748|NCT00120432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25870749|NCT00120432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870750|NCT00120432|Protective Agents|protective agents|mesh-ancestor
25231522|NCT02588417|Levobupivacaine|levobupivacaine|mesh-list
25231523|NCT02588417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25231524|NCT02588417|Antiemetics|antiemetics|mesh-ancestor
25231525|NCT02588417|Autonomic Agents|autonomic agents|mesh-ancestor
25231526|NCT02588417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25231527|NCT02588417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231528|NCT02588417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25231529|NCT02588417|Glucocorticoids|glucocorticoids|mesh-ancestor
24846569|NCT02243124|Antiemetics|antiemetics|mesh-ancestor
24846570|NCT02243124|Autonomic Agents|autonomic agents|mesh-ancestor
24846571|NCT02243124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24846572|NCT02243124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846573|NCT02243124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24846574|NCT02243124|Glucocorticoids|glucocorticoids|mesh-ancestor
24846575|NCT02243124|Hormones|hormones|mesh-ancestor
24846576|NCT02243124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24846577|NCT02243124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24846579|NCT02243137|Aspirin|aspirin|mesh-list
24966472|NCT03767660|Sirolimus|sirolimus|mesh-list
24454843|NCT03474029|Leprostatic Agents|leprostatic agents|mesh-ancestor
25870754|NCT00120471|Tenofovir|tenofovir|mesh-list
25870755|NCT00120471|Antiviral Agents|antiviral agents|mesh-ancestor
25870756|NCT00120471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25870757|NCT00120471|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25870758|NCT00120471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25870759|NCT00120471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870760|NCT00120471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870761|NCT00120471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25870762|NCT00120471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25876693|NCT02960022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25876694|NCT02960022|Glucocorticoids|glucocorticoids|mesh-ancestor
25876695|NCT02960022|Hormones|hormones|mesh-ancestor
25876696|NCT02960022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25876697|NCT02960022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231530|NCT02588417|Hormones|hormones|mesh-ancestor
25231535|NCT02588417|Anesthetics|anesthetics|mesh-ancestor
25137974|NCT02981264|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25137975|NCT02981264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25137977|NCT02981459|Mirabegron|mirabegron|mesh-list
25870763|NCT00120484|Vitamin B 12|vitamin b 12|mesh-list
25870764|NCT00120484|Hydroxocobalamin|hydroxocobalamin|mesh-list
25870765|NCT00120484|Vitamins|vitamins|mesh-ancestor
25870766|NCT00120484|Micronutrients|micronutrients|mesh-ancestor
25870767|NCT00120484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870768|NCT00120484|Vitamin B Complex|vitamin b complex|mesh-ancestor
25870769|NCT00120484|Hematinics|hematinics|mesh-ancestor
25870770|NCT00120497|Hormones|hormones|mesh-list
25870771|NCT00120497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25870772|NCT00120497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870773|NCT00120510|Lamivudine|lamivudine|mesh-list
25870774|NCT00120510|Zidovudine|zidovudine|mesh-list
25870775|NCT00120510|Efavirenz|efavirenz|mesh-list
25870776|NCT00120510|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25231548|NCT02588287|Antiviral Agents|antiviral agents|mesh-ancestor
25231549|NCT02588287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25231550|NCT02588287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25231551|NCT02588287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25231552|NCT02588287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25231553|NCT02588287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231554|NCT02588287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25231555|NCT02588287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25231556|NCT02588235|Atorvastatin|atorvastatin|mesh-list
25231557|NCT02588235|Ezetimibe|ezetimibe|mesh-list
25138017|NCT02981030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25138018|NCT02981030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25138028|NCT02980809|Topotecan|topotecan|mesh-list
25138029|NCT02980809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231563|NCT02588235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25231564|NCT02588235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25231565|NCT02588196|Dexamethasone|dexamethasone|mesh-list
25231566|NCT02588196|Dexamethasone acetate|dexamethasone acetate|mesh-list
25231567|NCT02588196|BB 1101|bb 1101|mesh-list
25231568|NCT02588196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25231569|NCT02588196|Antiemetics|antiemetics|mesh-ancestor
25231570|NCT02588196|Autonomic Agents|autonomic agents|mesh-ancestor
25231571|NCT02588196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25231572|NCT02588196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231573|NCT02588196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25231574|NCT02588196|Glucocorticoids|glucocorticoids|mesh-ancestor
25231575|NCT02588196|Hormones|hormones|mesh-ancestor
25231576|NCT02588196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25231577|NCT02588196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25231578|NCT02588196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870787|NCT00120510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25870788|NCT00120510|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25870789|NCT00120510|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25870790|NCT00120510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25870791|NCT00120510|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24589339|NCT00906880|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24589340|NCT00906880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24589341|NCT00906880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24448200|NCT00310765|Sensory System Agents|sensory system agents|mesh-ancestor
24448201|NCT00310765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25870801|NCT00120601|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25231598|NCT02587845|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25231599|NCT02587845|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25231600|NCT02587845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231601|NCT02587845|Hemostatics|hemostatics|mesh-ancestor
25231602|NCT02587845|Coagulants|coagulants|mesh-ancestor
25231603|NCT02587871|Cytarabine|cytarabine|mesh-list
25231604|NCT02587871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25231605|NCT02587871|Antimetabolites|antimetabolites|mesh-ancestor
25044303|NCT01114698|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25044304|NCT01114698|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25044305|NCT01114698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25044306|NCT01114698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25044307|NCT01114698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801820|NCT01985789|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24801821|NCT01985789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25870802|NCT00120601|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25870803|NCT00120601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584443|NCT00880373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25870804|NCT00120601|Sensory System Agents|sensory system agents|mesh-ancestor
25870805|NCT00120601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24904302|NCT04356872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904303|NCT04356872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24818439|NCT02088866|Anesthetics|anesthetics|mesh-ancestor
25870806|NCT00120640|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
25870807|NCT00120640|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
24801833|NCT01985841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231606|NCT02587871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231607|NCT02587871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231608|NCT02587871|Antiviral Agents|antiviral agents|mesh-ancestor
25231609|NCT02587871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25231610|NCT02587871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25231611|NCT02587871|Immunologic Factors|immunologic factors|mesh-ancestor
25044308|NCT01114698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25044309|NCT01114698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044310|NCT01114698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25044311|NCT01114698|Antidepressive Agents|antidepressive agents|mesh-ancestor
25044312|NCT01114698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25044313|NCT01114308|Buprenorphine|buprenorphine|mesh-list
25044314|NCT01114308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25044315|NCT01114308|Narcotics|narcotics|mesh-ancestor
25870813|NCT00120640|Hormones|hormones|mesh-ancestor
25231621|NCT02587533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231622|NCT02587533|Dopamine Agents|dopamine agents|mesh-ancestor
25231623|NCT02587533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25231624|NCT02587533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231625|NCT02587533|Protective Agents|protective agents|mesh-ancestor
25870831|NCT00120705|Darbepoetin alfa|darbepoetin alfa|mesh-list
25870832|NCT00120705|Hematinics|hematinics|mesh-ancestor
25273554|NCT02384915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273555|NCT02384915|Anesthetics, Local|anesthetics, local|mesh-ancestor
24846597|NCT02243241|Moxifloxacin|moxifloxacin|mesh-list
25870833|NCT00120718|Fasudil|fasudil|mesh-list
25870834|NCT00120718|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25870835|NCT00120718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25870836|NCT00120718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870837|NCT00120718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25870838|NCT00120718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870839|NCT00120718|Vasodilator Agents|vasodilator agents|mesh-ancestor
25870840|NCT00120718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25870841|NCT00120718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870842|NCT00120731|Acetazolamide|acetazolamide|mesh-list
25870843|NCT00120731|Potassium Citrate|potassium citrate|mesh-list
25870844|NCT00120731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870845|NCT00120731|Anticonvulsants|anticonvulsants|mesh-ancestor
24801837|NCT01985841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801838|NCT01985841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870846|NCT00120731|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24448256|NCT00310908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25231626|NCT02587312|Nicotine|nicotine|mesh-list
25231627|NCT02587312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25231628|NCT02587312|Autonomic Agents|autonomic agents|mesh-ancestor
25231629|NCT02587312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25231630|NCT02587312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231631|NCT02587312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25231632|NCT02587312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25870847|NCT00120731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870848|NCT00120731|Diuretics|diuretics|mesh-ancestor
25870849|NCT00120731|Natriuretic Agents|natriuretic agents|mesh-ancestor
25870850|NCT00120731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870851|NCT00120731|Expectorants|expectorants|mesh-ancestor
25870852|NCT00120731|Respiratory System Agents|respiratory system agents|mesh-ancestor
25870853|NCT00120744|Ondansetron|ondansetron|mesh-list
25870854|NCT00120744|Antiemetics|antiemetics|mesh-ancestor
25870855|NCT00120744|Autonomic Agents|autonomic agents|mesh-ancestor
24904481|NCT04355416|Analgesics|analgesics|mesh-ancestor
24591033|NCT00914693|Hormones|hormones|mesh-ancestor
25138321|NCT02978482|Durvalumab|durvalumab|mesh-list
25138322|NCT02978482|Tremelimumab|tremelimumab|mesh-list
25138323|NCT02978482|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25138324|NCT02978482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25138325|NCT02978482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24801851|NCT01985854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24801852|NCT01985854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24801853|NCT01985854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801854|NCT01985854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24801855|NCT01985854|Anesthetics, General|anesthetics, general|mesh-ancestor
24801856|NCT01985854|Anesthetics|anesthetics|mesh-ancestor
24801857|NCT01985854|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24562795|NCT00768209|Adrenergic Agents|adrenergic agents|mesh-ancestor
25109057|NCT03127631|Antimetabolites|antimetabolites|mesh-ancestor
25109058|NCT03127631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25109059|NCT03127631|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25671423|NCT01091831|Dexamethasone|dexamethasone|mesh-list
24591620|NCT00917891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24591621|NCT00917891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24591667|NCT00918177|Dopamine Agents|dopamine agents|mesh-ancestor
24591718|NCT00918307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591719|NCT00918320|Temozolomide|temozolomide|mesh-list
24591721|NCT00918320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25870908|NCT00120809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870909|NCT00120809|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25231661|NCT02587273|Fentanyl|fentanyl|mesh-list
25231662|NCT02587273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25231663|NCT02587273|Narcotics|narcotics|mesh-ancestor
25231664|NCT02587273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25231665|NCT02587273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231666|NCT02587273|Analgesics|analgesics|mesh-ancestor
25231667|NCT02587273|Sensory System Agents|sensory system agents|mesh-ancestor
25231668|NCT02587273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25231669|NCT02587273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25231672|NCT02587273|Anesthetics|anesthetics|mesh-ancestor
25231673|NCT02587260|Clopidogrel|clopidogrel|mesh-list
25231674|NCT02587260|Ticagrelor|ticagrelor|mesh-list
25231675|NCT02587260|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25231676|NCT02587260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25870910|NCT00120809|Renal Agents|renal agents|mesh-ancestor
24859012|NCT02301091|Pirarubicin|pirarubicin|mesh-list
25870911|NCT00120822|Folic Acid|folic acid|mesh-list
25870912|NCT00120822|Hematinics|hematinics|mesh-ancestor
25870913|NCT00120822|Vitamin B Complex|vitamin b complex|mesh-ancestor
25870914|NCT00120822|Vitamins|vitamins|mesh-ancestor
25870915|NCT00120822|Micronutrients|micronutrients|mesh-ancestor
25870916|NCT00120822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870917|NCT00120835|Interferons|interferons|mesh-list
25870918|NCT00120835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671424|NCT01091831|Cyclophosphamide|cyclophosphamide|mesh-list
25671425|NCT01091831|Melphalan|melphalan|mesh-list
25671426|NCT01091831|Lenalidomide|lenalidomide|mesh-list
25671427|NCT01091831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25671428|NCT01091831|Immunologic Factors|immunologic factors|mesh-ancestor
25671429|NCT01091831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061953|NCT05389813|Narcotics|narcotics|mesh-ancestor
25870920|NCT00120835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25870921|NCT00120861|Interferons|interferons|mesh-list
25870922|NCT00120861|Ribavirin|ribavirin|mesh-list
25870923|NCT00120861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870924|NCT00120861|Antiviral Agents|antiviral agents|mesh-ancestor
25870925|NCT00120861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25870926|NCT00120861|Antimetabolites|antimetabolites|mesh-ancestor
25870927|NCT00120861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870928|NCT00120887|Atorvastatin|atorvastatin|mesh-list
25870929|NCT00120887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25870930|NCT00120887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25870931|NCT00120887|Antimetabolites|antimetabolites|mesh-ancestor
24801898|NCT01986270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24801899|NCT01986270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24801900|NCT01986270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24801901|NCT01986270|Serotonin Agents|serotonin agents|mesh-ancestor
24801902|NCT01986270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25231704|NCT02587130|Analgesics|analgesics|mesh-ancestor
25870932|NCT00120887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870933|NCT00120887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25870934|NCT00120887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25870935|NCT00120887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870936|NCT00120913|Contraceptives, Oral|contraceptives, oral|mesh-list
25870937|NCT00120913|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25870938|NCT00120913|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25870939|NCT00120913|Contraceptive Agents|contraceptive agents|mesh-ancestor
25870940|NCT00120913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25870941|NCT00120913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870942|NCT00120939|Motexafin gadolinium|motexafin gadolinium|mesh-list
25870943|NCT00120939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870944|NCT00120939|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25870945|NCT00120939|Dermatologic Agents|dermatologic agents|mesh-ancestor
25870946|NCT00120952|Cobalt|cobalt|mesh-list
25870947|NCT00120952|Chromium|chromium|mesh-list
25870948|NCT00120952|Trace Elements|trace elements|mesh-ancestor
24801908|NCT01986283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24801909|NCT01986283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870949|NCT00120952|Micronutrients|micronutrients|mesh-ancestor
24904974|NCT04351919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24904975|NCT04351919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24904976|NCT04351919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904977|NCT04351919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904978|NCT04351919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25870950|NCT00120952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870951|NCT00120978|Fluticasone|fluticasone|mesh-list
25870952|NCT00120978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25870953|NCT00120978|Autonomic Agents|autonomic agents|mesh-ancestor
25870954|NCT00120978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25870955|NCT00120978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870956|NCT00120978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25870957|NCT00120978|Respiratory System Agents|respiratory system agents|mesh-ancestor
25870958|NCT00120978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25870959|NCT00120978|Dermatologic Agents|dermatologic agents|mesh-ancestor
25870960|NCT00120978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25870961|NCT00121017|Ritonavir|ritonavir|mesh-list
25870962|NCT00121017|Lopinavir|lopinavir|mesh-list
25870963|NCT00121017|Tenofovir|tenofovir|mesh-list
24904979|NCT04351867|Docetaxel|docetaxel|mesh-list
25870964|NCT00121017|Emtricitabine|emtricitabine|mesh-list
25870965|NCT00121017|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24563463|NCT00771680|Insulin Detemir|insulin detemir|mesh-list
24563464|NCT00771680|Biphasic Insulins|biphasic insulins|mesh-list
24563475|NCT00771823|Maraviroc|maraviroc|mesh-list
25870966|NCT00121017|Efavirenz|efavirenz|mesh-list
25870967|NCT00121017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25231692|NCT02587741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231693|NCT02587741|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25231694|NCT02587741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905041|NCT04351516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24905042|NCT04351256|Durvalumab|durvalumab|mesh-list
25109096|NCT03127345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25231695|NCT02587741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231696|NCT02587052|Tacrolimus|tacrolimus|mesh-list
24894388|NCT04441112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24801921|NCT01986309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24801922|NCT01986309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24801923|NCT01986309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24801924|NCT01986309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801925|NCT01986322|Vaccines|vaccines|mesh-list
24801926|NCT01986322|Immunologic Factors|immunologic factors|mesh-ancestor
24801927|NCT01986322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801928|NCT01986426|Pembrolizumab|pembrolizumab|mesh-list
24801929|NCT01986426|Ipilimumab|ipilimumab|mesh-list
24801930|NCT01986426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25870969|NCT00121017|Protease Inhibitors|protease inhibitors|mesh-ancestor
25870980|NCT00121017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25870981|NCT00121017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25870982|NCT00121017|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25870983|NCT00121017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25870984|NCT00121017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25870985|NCT00121030|Epoetin Alfa|epoetin alfa|mesh-list
25870986|NCT00121030|Darbepoetin alfa|darbepoetin alfa|mesh-list
25870987|NCT00121030|Hematinics|hematinics|mesh-ancestor
25870999|NCT00121069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871000|NCT00121069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25871001|NCT00121069|Antidepressive Agents|antidepressive agents|mesh-ancestor
25871002|NCT00121069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25871003|NCT00121095|Docetaxel|docetaxel|mesh-list
25871004|NCT00121095|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
25871005|NCT00121095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25871006|NCT00121095|Tubulin Modulators|tubulin modulators|mesh-ancestor
25871007|NCT00121095|Antimitotic Agents|antimitotic agents|mesh-ancestor
25871008|NCT00121095|Mitosis Modulators|mitosis modulators|mesh-ancestor
25871009|NCT00121095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871010|NCT00121095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25871011|NCT00121095|Analgesics|analgesics|mesh-ancestor
25871012|NCT00121095|Sensory System Agents|sensory system agents|mesh-ancestor
25871013|NCT00121095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25871014|NCT00121095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871015|NCT00121147|Travoprost|travoprost|mesh-list
25871016|NCT00121147|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24448317|NCT00311129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905224|NCT04349930|Cannabidiol|cannabidiol|mesh-list
25138629|NCT02976246|Vitamins|vitamins|mesh-ancestor
24846643|NCT02243436|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24846644|NCT02243436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24846645|NCT02243436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24846646|NCT02243436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24846647|NCT02243436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25062006|NCT05389176|Esmolol|esmolol|mesh-list
24801968|NCT01986582|Autonomic Agents|autonomic agents|mesh-ancestor
24801969|NCT01986582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24801970|NCT01986582|Nasal Decongestants|nasal decongestants|mesh-ancestor
24801971|NCT01986582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24586880|NCT00892476|Calcium|calcium|mesh-list
25231756|NCT02586961|Hormones|hormones|mesh-ancestor
25231757|NCT02586961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25231758|NCT02586961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231759|NCT02586961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25231760|NCT02586961|Respiratory System Agents|respiratory system agents|mesh-ancestor
25231761|NCT02586961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25231762|NCT02586961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25231763|NCT02586961|Adrenergic Agents|adrenergic agents|mesh-ancestor
25231764|NCT02586961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25231789|NCT02586649|Respiratory System Agents|respiratory system agents|mesh-ancestor
25231790|NCT02586649|Parasympatholytics|parasympatholytics|mesh-ancestor
25231791|NCT02586649|Cholinergic Agents|cholinergic agents|mesh-ancestor
25231792|NCT02586649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25231793|NCT02586649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231794|NCT02586649|Anticonvulsants|anticonvulsants|mesh-ancestor
25231795|NCT02586636|Metformin|metformin|mesh-list
25231796|NCT02586636|Omeprazole|omeprazole|mesh-list
25231797|NCT02586636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25231799|NCT02586636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24594295|NCT00933387|Cetuximab|cetuximab|mesh-list
25871047|NCT00121303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25871048|NCT00121303|Immunologic Factors|immunologic factors|mesh-ancestor
25231842|NCT02586454|Narcotics|narcotics|mesh-ancestor
25231843|NCT02586454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25231910|NCT02585973|Adavosertib|adavosertib|mesh-list
25231855|NCT02586246|Immunologic Factors|immunologic factors|mesh-ancestor
25231856|NCT02586246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231857|NCT02586246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25231858|NCT02586194|Peficitinib|peficitinib|mesh-list
25231859|NCT02586194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25231860|NCT02586194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231861|NCT02586194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25231862|NCT02586194|Immunologic Factors|immunologic factors|mesh-ancestor
25231863|NCT02586194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871049|NCT00121303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231864|NCT02586181|Calcium, Dietary|calcium, dietary|mesh-list
25231865|NCT02586181|Vitamin D|vitamin d|mesh-list
25231866|NCT02586181|Ergocalciferols|ergocalciferols|mesh-list
25231895|NCT02586051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231896|NCT02586051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25231897|NCT02586051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231898|NCT02586142|Botulinum Toxins|botulinum toxins|mesh-list
25231899|NCT02586142|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25231900|NCT02586142|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25231901|NCT02586142|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25871057|NCT00121316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24478775|NCT00424333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478776|NCT00424411|Insulin|insulin|mesh-list
24478777|NCT00424411|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24478778|NCT00424411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24478779|NCT00424411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478780|NCT00424437|Insulin|insulin|mesh-list
24478781|NCT00424437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24478782|NCT00424437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24478784|NCT00424580|Montelukast|montelukast|mesh-list
25871058|NCT00121316|Analgesics|analgesics|mesh-ancestor
25871059|NCT00121316|Sensory System Agents|sensory system agents|mesh-ancestor
25871060|NCT00121316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25871061|NCT00121316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871062|NCT00121316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25871063|NCT00121316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25871064|NCT00121316|Dermatologic Agents|dermatologic agents|mesh-ancestor
25871065|NCT00121316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25871066|NCT00121316|Immunologic Factors|immunologic factors|mesh-ancestor
25871067|NCT00121316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25871068|NCT00121316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634074|NCT01131975|Lamotrigine|lamotrigine|mesh-list
25871071|NCT00121329|Anesthetics, Local|anesthetics, local|mesh-ancestor
25871072|NCT00121329|Anesthetics|anesthetics|mesh-ancestor
24801991|NCT01986660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24801992|NCT01986660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24801993|NCT01986660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24801994|NCT01986660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801995|NCT01986673|Sildenafil Citrate|sildenafil citrate|mesh-list
24801996|NCT01986673|Vasodilator Agents|vasodilator agents|mesh-ancestor
24801997|NCT01986673|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24801998|NCT01986673|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24801999|NCT01986673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564021|NCT00774813|Citalopram|citalopram|mesh-list
25871073|NCT00121329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25871074|NCT00121329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871075|NCT00121329|Sensory System Agents|sensory system agents|mesh-ancestor
25871076|NCT00121329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25871077|NCT00121329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25871078|NCT00121329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24905561|NCT04346407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24905562|NCT04346589|Antibodies|antibodies|mesh-list
25871079|NCT00121329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25871080|NCT00121329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25871081|NCT00121329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871082|NCT00121381|Pimecrolimus|pimecrolimus|mesh-list
25871083|NCT00121381|Tacrolimus|tacrolimus|mesh-list
24505112|NCT00539890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25871089|NCT00121381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871090|NCT00121381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25871091|NCT00121381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24622436|NCT01066962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24622437|NCT01066962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24622438|NCT01066962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24622439|NCT01066988|Emollients|emollients|mesh-list
24622440|NCT01066988|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24622441|NCT01066988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24622442|NCT01066988|Dermatologic Agents|dermatologic agents|mesh-ancestor
24622443|NCT01067053|Bevacizumab|bevacizumab|mesh-list
24622444|NCT01067053|Capecitabine|capecitabine|mesh-list
25231959|NCT02585531|Glucocorticoids|glucocorticoids|mesh-ancestor
25671437|NCT01091831|Antiemetics|antiemetics|mesh-ancestor
25871100|NCT00121394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25871101|NCT00121394|Disinfectants|disinfectants|mesh-ancestor
24598272|NCT00954889|Adrenergic Agents|adrenergic agents|mesh-ancestor
24598273|NCT00954889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24598274|NCT00954889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598275|NCT00954889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598276|NCT00954889|Urological Agents|urological agents|mesh-ancestor
24598277|NCT00954902|Antioxidants|antioxidants|mesh-list
24598278|NCT00954902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598279|NCT00954902|Protective Agents|protective agents|mesh-ancestor
24598280|NCT00954902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598281|NCT00955045|Istradefylline|istradefylline|mesh-list
25871102|NCT00121407|Verteporfin|verteporfin|mesh-list
24599236|NCT04966663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24599237|NCT04966663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24599316|NCT04770493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25138808|NCT02975037|Hormone Antagonists|hormone antagonists|mesh-ancestor
25138809|NCT02975037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25138810|NCT02975037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861270|NCT02316379|Anesthetics|anesthetics|mesh-ancestor
25138811|NCT02975037|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25138812|NCT02975037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24599830|NCT03581240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599856|NCT03449758|Azathioprine|azathioprine|mesh-list
24953888|NCT03880968|Analgesics|analgesics|mesh-ancestor
24846695|NCT02243553|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24846696|NCT02243553|Protease Inhibitors|protease inhibitors|mesh-ancestor
24846697|NCT02243553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24846698|NCT02243553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24846699|NCT02243553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24846700|NCT02243553|Antiviral Agents|antiviral agents|mesh-ancestor
24846701|NCT02243553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24846702|NCT02243553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24846704|NCT02243553|Anticoagulants|anticoagulants|mesh-ancestor
24846705|NCT02243553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24452989|NCT05371964|Motesanib diphosphate|motesanib diphosphate|mesh-list
24452990|NCT05371964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25071868|NCT03405272|Antibodies|antibodies|mesh-list
24452991|NCT05371964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062216|NCT05131867|Nimodipine|nimodipine|mesh-list
25871131|NCT00121498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24622477|NCT01067235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24622478|NCT01067235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25671466|NCT00773695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671467|NCT00773695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25671468|NCT00773695|Immunologic Factors|immunologic factors|mesh-ancestor
25671469|NCT00773695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671470|NCT00773695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24900898|NCT04390334|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25671471|NCT00773695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25871140|NCT00121511|Fluorouracil|fluorouracil|mesh-list
25871141|NCT00121511|Antimetabolites|antimetabolites|mesh-ancestor
25871142|NCT00121511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871143|NCT00121511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25871144|NCT00121511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25871145|NCT00121511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24626498|NCT01087593|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25871146|NCT00121511|Immunologic Factors|immunologic factors|mesh-ancestor
25871147|NCT00121511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871148|NCT00121524|Atropine|atropine|mesh-list
25871149|NCT00121524|Amiodarone|amiodarone|mesh-list
25871150|NCT00121524|Epinephrine|epinephrine|mesh-list
25871151|NCT00121524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25871152|NCT00121524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25871153|NCT00121524|Adrenergic Agents|adrenergic agents|mesh-ancestor
25871154|NCT00121524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24454975|NCT03089606|Pembrolizumab|pembrolizumab|mesh-list
24454976|NCT03089606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24454978|NCT03031483|Clarithromycin|clarithromycin|mesh-list
25871155|NCT00121524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871156|NCT00121524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871157|NCT00121524|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25876781|NCT02794571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232029|NCT02585388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25232030|NCT02585388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232031|NCT02585388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232032|NCT02585388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25232033|NCT02585388|Hormone Antagonists|hormone antagonists|mesh-ancestor
24846706|NCT02243553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24846707|NCT02243553|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24846708|NCT02243553|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24846709|NCT02243553|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25871158|NCT00121524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25871159|NCT00121524|Autonomic Agents|autonomic agents|mesh-ancestor
25871160|NCT00121524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25871161|NCT00121524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24802002|NCT01986764|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
24802004|NCT01986764|Estrogens|estrogens|mesh-list
24802005|NCT01986764|Hormones|hormones|mesh-ancestor
24802006|NCT01986764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24564533|NCT00776672|Fosinopril|fosinopril|mesh-list
25871162|NCT00121524|Respiratory System Agents|respiratory system agents|mesh-ancestor
25871163|NCT00121524|Mydriatics|mydriatics|mesh-ancestor
25871164|NCT00121524|Sympathomimetics|sympathomimetics|mesh-ancestor
25871165|NCT00121524|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25871166|NCT00121524|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25871167|NCT00121524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25871168|NCT00121524|Parasympatholytics|parasympatholytics|mesh-ancestor
25871169|NCT00121524|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25871170|NCT00121524|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25871171|NCT00121524|Cholinergic Agents|cholinergic agents|mesh-ancestor
25871172|NCT00121524|Vasodilator Agents|vasodilator agents|mesh-ancestor
25871173|NCT00121524|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25232034|NCT02585388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25232035|NCT02585388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232037|NCT02585388|Tubulin Modulators|tubulin modulators|mesh-ancestor
25871180|NCT00121524|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25871181|NCT00121524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24505113|NCT00539890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871182|NCT00121550|Clarithromycin|clarithromycin|mesh-list
24802011|NCT01986764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24802012|NCT01986764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802013|NCT01986764|Dopamine Agents|dopamine agents|mesh-ancestor
25871183|NCT00121550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25871184|NCT00121550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25871185|NCT00121550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25871186|NCT00121550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871187|NCT00121550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871188|NCT00121550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25871189|NCT00121550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25232046|NCT02585141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25232047|NCT02585141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232048|NCT02585141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232049|NCT02585011|Epinephrine|epinephrine|mesh-list
25232050|NCT02585011|Ropivacaine|ropivacaine|mesh-list
25232051|NCT02585011|Anesthetics, Local|anesthetics, local|mesh-ancestor
25232052|NCT02585011|Anesthetics|anesthetics|mesh-ancestor
25232053|NCT02585011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25232054|NCT02585011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871190|NCT00121563|Thalidomide|thalidomide|mesh-list
25871191|NCT00121563|Ibuprofen|ibuprofen|mesh-list
25871192|NCT00121563|Diazepam|diazepam|mesh-list
25871193|NCT00121563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25871194|NCT00121563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25871195|NCT00121563|Analgesics|analgesics|mesh-ancestor
25871196|NCT00121563|Sensory System Agents|sensory system agents|mesh-ancestor
25871197|NCT00121563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25871198|NCT00121563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871199|NCT00121563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25871200|NCT00121563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25871201|NCT00121563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25871202|NCT00121563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871203|NCT00121563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871204|NCT00121563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25871205|NCT00121563|Immunologic Factors|immunologic factors|mesh-ancestor
24454980|NCT03031483|Immunologic Factors|immunologic factors|mesh-ancestor
25138974|NCT02974348|Acetaminophen|acetaminophen|mesh-list
24448508|NCT00312039|Dexelvucitabine|dexelvucitabine|mesh-list
25871221|NCT00121563|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25871222|NCT00121563|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25871223|NCT00121563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25871224|NCT00121563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25871225|NCT00121563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25871226|NCT00121563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25871249|NCT00121628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802021|NCT01986777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802022|NCT01986777|Dopamine Agents|dopamine agents|mesh-ancestor
25871250|NCT00121680|Lenvatinib|lenvatinib|mesh-list
25871251|NCT00121680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25871252|NCT00121680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25871253|NCT00121680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871254|NCT00121680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871255|NCT00121784|Mycophenolic Acid|mycophenolic acid|mesh-list
24588389|NCT00902460|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25871284|NCT00121914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25871285|NCT00121914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25871286|NCT00121914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25871287|NCT00121914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871288|NCT00121953|Rosiglitazone|rosiglitazone|mesh-list
25871289|NCT00121953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25871290|NCT00121953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871291|NCT00121966|Insulin|insulin|mesh-list
25871292|NCT00121966|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25871293|NCT00121966|Metformin|metformin|mesh-list
25871294|NCT00121966|Insulin Aspart|insulin aspart|mesh-list
25671473|NCT00773695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24863533|NCT04635943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25871319|NCT00122018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871320|NCT00122018|Antidotes|antidotes|mesh-ancestor
24505119|NCT00539968|Mitosis Modulators|mitosis modulators|mesh-ancestor
25232101|NCT02584738|Prednisolone|prednisolone|mesh-list
25232102|NCT02584738|Magnesium Sulfate|magnesium sulfate|mesh-list
25232103|NCT02584738|Bromides|bromides|mesh-list
25232104|NCT02584738|Albuterol|albuterol|mesh-list
25232105|NCT02584738|Ipratropium|ipratropium|mesh-list
25232110|NCT02584738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871321|NCT00122018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25871322|NCT00122018|Vasodilator Agents|vasodilator agents|mesh-ancestor
25871323|NCT00122018|Dopamine Agonists|dopamine agonists|mesh-ancestor
24802049|NCT01986998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24802050|NCT01986998|Antiemetics|antiemetics|mesh-ancestor
24588684|NCT00903942|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25871324|NCT00122018|Dopamine Agents|dopamine agents|mesh-ancestor
25871325|NCT00122018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25871326|NCT00122044|Trihexyphenidyl|trihexyphenidyl|mesh-list
25871327|NCT00122044|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24802059|NCT01986998|Protective Agents|protective agents|mesh-ancestor
24802060|NCT01986998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25871328|NCT00122044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25139172|NCT02973035|Amlodipine|amlodipine|mesh-list
25139173|NCT02973035|Valsartan|valsartan|mesh-list
25139174|NCT02973035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25079295|NCT03348917|Disinfectants|disinfectants|mesh-ancestor
25232117|NCT02584738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25871337|NCT00122070|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25871338|NCT00122070|Antidepressive Agents|antidepressive agents|mesh-ancestor
25871339|NCT00122070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25871340|NCT00122070|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25871341|NCT00122070|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25871342|NCT00122070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25871343|NCT00122070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076322|NCT03373955|Pembrolizumab|pembrolizumab|mesh-list
25871344|NCT00122096|Valdecoxib|valdecoxib|mesh-list
25139206|NCT02972866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25139207|NCT02972866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139208|NCT02972866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25139210|NCT02972866|Glucocorticoids|glucocorticoids|mesh-ancestor
25139284|NCT02972346|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
25139285|NCT02972346|beta-Endorphin|beta-endorphin|mesh-list
25139287|NCT02972346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25139303|NCT02972268|Tamsulosin|tamsulosin|mesh-list
24802075|NCT01987128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802076|NCT01987128|Sensory System Agents|sensory system agents|mesh-ancestor
24589307|NCT00906724|Insulin|insulin|mesh-list
25871364|NCT00122226|Protease Inhibitors|protease inhibitors|mesh-ancestor
25871365|NCT00122226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871366|NCT00122226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871367|NCT00122226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25871368|NCT00122226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25671503|NCT01732809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25671504|NCT01732809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671505|NCT01732809|Cholinergic Agents|cholinergic agents|mesh-ancestor
25046485|NCT00841815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25046488|NCT00841815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232164|NCT02584465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25232165|NCT02584465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232166|NCT02584465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25871411|NCT00122434|Respiratory System Agents|respiratory system agents|mesh-ancestor
25871412|NCT00122434|Parasympatholytics|parasympatholytics|mesh-ancestor
25871413|NCT00122434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25871414|NCT00122434|Cholinergic Agents|cholinergic agents|mesh-ancestor
25871415|NCT00122434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25871436|NCT00122499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871437|NCT00122499|Urological Agents|urological agents|mesh-ancestor
25671527|NCT01733316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671528|NCT01733329|Folic Acid|folic acid|mesh-list
25671529|NCT01733329|Misoprostol|misoprostol|mesh-list
25671530|NCT01733329|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25871438|NCT00122512|Tenofovir|tenofovir|mesh-list
25871439|NCT00122512|Antiviral Agents|antiviral agents|mesh-ancestor
24863856|NCT03190174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863857|NCT03190174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24863858|NCT03190174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863859|NCT03190174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24863879|NCT03136627|Nivolumab|nivolumab|mesh-list
24863880|NCT03136627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24863881|NCT03136627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863882|NCT03136627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25232173|NCT02584400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232174|NCT02584335|Lidocaine|lidocaine|mesh-list
25139426|NCT02971540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25139427|NCT02971540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25139429|NCT02971397|Cytarabine|cytarabine|mesh-list
25139430|NCT02971397|Daunorubicin|daunorubicin|mesh-list
25139431|NCT02971397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25139432|NCT02971397|Antimetabolites|antimetabolites|mesh-ancestor
25139433|NCT02971397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076432|NCT03373266|Anesthetics|anesthetics|mesh-list
25871496|NCT00122590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25232186|NCT02584335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232187|NCT02584075|Metformin|metformin|mesh-list
25232188|NCT02584075|Exenatide|exenatide|mesh-list
25871528|NCT00122629|Antimetabolites|antimetabolites|mesh-ancestor
24455135|NCT02819843|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
24455136|NCT02819843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25871529|NCT00122629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871530|NCT00122629|Immunologic Factors|immunologic factors|mesh-ancestor
25871531|NCT00122629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871532|NCT00122629|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24544132|NCT00687388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24544133|NCT00687388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25871570|NCT00122733|Loxapine|loxapine|mesh-list
25871571|NCT00122733|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25871572|NCT00122733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25232199|NCT02584231|Natriuretic Agents|natriuretic agents|mesh-ancestor
25232200|NCT02584231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273578|NCT02384876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139484|NCT02970773|Antithrombins|antithrombins|mesh-ancestor
25232207|NCT02584010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232208|NCT02583958|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25232209|NCT02583958|Laxatives|laxatives|mesh-ancestor
25232210|NCT02583958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25232211|NCT02583854|Hemostatics|hemostatics|mesh-list
25232212|NCT02583854|Coagulants|coagulants|mesh-ancestor
25232213|NCT02583828|Cyclophosphamide|cyclophosphamide|mesh-list
25871611|NCT00122811|Indapamide|indapamide|mesh-list
25871612|NCT00122811|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25871636|NCT00122837|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25871637|NCT00122837|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25871638|NCT00122837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25871639|NCT00122837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25871640|NCT00122837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871641|NCT00122837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25871642|NCT00122837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871643|NCT00122837|Analgesics|analgesics|mesh-ancestor
25871644|NCT00122837|Sensory System Agents|sensory system agents|mesh-ancestor
25871645|NCT00122837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25871646|NCT00122837|Antidepressive Agents|antidepressive agents|mesh-ancestor
25871647|NCT00122837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25871648|NCT00122837|Dopamine Agents|dopamine agents|mesh-ancestor
25871649|NCT00122837|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25139539|NCT02970604|Aspirin|aspirin|mesh-list
25871658|NCT00122850|Analgesics|analgesics|mesh-ancestor
25871659|NCT00122850|Sensory System Agents|sensory system agents|mesh-ancestor
25871660|NCT00122850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25871661|NCT00122850|Antidepressive Agents|antidepressive agents|mesh-ancestor
25871662|NCT00122850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25871663|NCT00122850|Dopamine Agents|dopamine agents|mesh-ancestor
25871664|NCT00122850|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25871665|NCT00122863|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25871667|NCT00122863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25671559|NCT01733680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25871685|NCT00122889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871686|NCT00122889|Protective Agents|protective agents|mesh-ancestor
25871687|NCT00122889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871688|NCT00122889|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25871689|NCT00122889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544915|NCT00690937|Sevelamer|sevelamer|mesh-list
24824966|NCT02126462|Antacids|antacids|mesh-ancestor
24455195|NCT02329080|Rituximab|rituximab|mesh-list
24455196|NCT02329080|Methotrexate|methotrexate|mesh-list
25871708|NCT00123175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25871709|NCT00123175|Contraceptive Agents|contraceptive agents|mesh-ancestor
25871710|NCT00123175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25871711|NCT00123175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871712|NCT00123175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25871713|NCT00123175|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25871714|NCT00123175|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25232250|NCT02583893|Antifungal Agents|antifungal agents|mesh-ancestor
25871733|NCT00123227|Rosiglitazone|rosiglitazone|mesh-list
25871734|NCT00123227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25871735|NCT00123227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871736|NCT00123253|Tesamorelin|tesamorelin|mesh-list
25871737|NCT00123253|Growth Substances|growth substances|mesh-ancestor
25871738|NCT00123253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871739|NCT00123266|Plasminogen|plasminogen|mesh-list
25871740|NCT00123266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25871741|NCT00123266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25871742|NCT00123266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882675|NCT05148975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871743|NCT00123279|Plasminogen|plasminogen|mesh-list
25871744|NCT00123279|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25871745|NCT00123279|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25871746|NCT00123279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871747|NCT00123292|Plasminogen|plasminogen|mesh-list
25871748|NCT00123292|Fibrinolysin|fibrinolysin|mesh-list
25871749|NCT00123292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25871750|NCT00123292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24802195|NCT01988545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24802196|NCT01988545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25139675|NCT02969629|Apomorphine|apomorphine|mesh-list
25139676|NCT02969629|Emetics|emetics|mesh-ancestor
25139677|NCT02969629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24669253|NCT04164212|Immunologic Factors|immunologic factors|mesh-ancestor
25139678|NCT02969629|Autonomic Agents|autonomic agents|mesh-ancestor
25139679|NCT02969629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25871751|NCT00123292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802208|NCT01988610|Hormone Antagonists|hormone antagonists|mesh-ancestor
25671570|NCT01733745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671571|NCT01733745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25671572|NCT01733758|Liraglutide|liraglutide|mesh-list
24814102|NCT02062333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24814103|NCT02062333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25139692|NCT02969564|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
25139693|NCT02969564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25139694|NCT02969564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139695|NCT02969447|Oxytocin|oxytocin|mesh-list
25062447|NCT04659928|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25062448|NCT04659928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25062449|NCT04642261|Empagliflozin|empagliflozin|mesh-list
25062450|NCT04642261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25062451|NCT04642261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871762|NCT00123318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846787|NCT02243852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25871763|NCT00123318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25871764|NCT00123318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25871765|NCT00123318|Immunologic Factors|immunologic factors|mesh-ancestor
24567498|NCT00791349|Serotonin Agents|serotonin agents|mesh-ancestor
24567499|NCT00791349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24567501|NCT00791349|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25871766|NCT00123318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671589|NCT01734161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25671590|NCT01734161|Antiemetics|antiemetics|mesh-ancestor
25671591|NCT01734161|Autonomic Agents|autonomic agents|mesh-ancestor
25671592|NCT01734161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25671593|NCT01734161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671594|NCT01734161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24865637|NCT05151679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865638|NCT05151679|Hematinics|hematinics|mesh-ancestor
25232323|NCT02583451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25871774|NCT00123331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871775|NCT00123331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871776|NCT00123331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25871777|NCT00123331|Immunologic Factors|immunologic factors|mesh-ancestor
25871778|NCT00123331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393317|NCT00129597|Anesthetics, General|anesthetics, general|mesh-ancestor
24393344|NCT00129805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24393346|NCT00129805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24393347|NCT00129805|Antipyretics|antipyretics|mesh-ancestor
24393348|NCT00129805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24393349|NCT00129805|Serotonin Agents|serotonin agents|mesh-ancestor
24393350|NCT00129805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24393352|NCT00129818|Antiviral Agents|antiviral agents|mesh-ancestor
24802239|NCT01989000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802240|NCT01989000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671598|NCT01734161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25671599|NCT01734161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671600|NCT01734239|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25671601|NCT01734239|Immunologic Factors|immunologic factors|mesh-ancestor
25671602|NCT01734239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871784|NCT00123331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25871785|NCT00123331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25871786|NCT00123331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393558|NCT00130351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24393559|NCT00130351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046576|NCT00840411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25046577|NCT00840411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25876782|NCT02794571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24393595|NCT00130455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24802249|NCT01989052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24802250|NCT01989052|Alkylating Agents|alkylating agents|mesh-ancestor
24962813|NCT03794843|Vasodilator Agents|vasodilator agents|mesh-ancestor
24393641|NCT00130546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24393642|NCT00130546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24393643|NCT00130546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24393644|NCT00130546|Antifungal Agents|antifungal agents|mesh-ancestor
24393645|NCT00130546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24393646|NCT00130546|Immunologic Factors|immunologic factors|mesh-ancestor
24393647|NCT00130546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393648|NCT00130572|Pimecrolimus|pimecrolimus|mesh-list
24393649|NCT00130572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24393650|NCT00130572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24393652|NCT00130572|Sensory System Agents|sensory system agents|mesh-ancestor
24393653|NCT00130572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24393654|NCT00130572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393655|NCT00130572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24810334|NCT02039661|Lidocaine|lidocaine|mesh-list
24814265|NCT02063529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232339|NCT02583438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25232340|NCT02583438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273583|NCT02384876|Adrenergic Agents|adrenergic agents|mesh-ancestor
25062471|NCT04594915|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24393744|NCT00130897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24393745|NCT00130897|Growth Substances|growth substances|mesh-ancestor
24393746|NCT00130897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393747|NCT00130897|Growth Inhibitors|growth inhibitors|mesh-ancestor
24393748|NCT00130897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24393749|NCT00130897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871808|NCT00123539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24393761|NCT00130910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393763|NCT00130936|Carboplatin|carboplatin|mesh-list
24393775|NCT00130975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24393776|NCT00130975|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24393777|NCT00130975|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24592945|NCT00926614|Pioglitazone|pioglitazone|mesh-list
24393967|NCT00131404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24393968|NCT00131404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452030|NCT00325767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24452031|NCT00325767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452032|NCT00325793|Nicardipine|nicardipine|mesh-list
25871809|NCT00123539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802261|NCT01989078|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24802262|NCT01989078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568102|NCT00794638|Immunologic Factors|immunologic factors|mesh-ancestor
24452034|NCT00325793|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24452036|NCT00325793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452037|NCT00325793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24452038|NCT00325793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452039|NCT00325793|Vasodilator Agents|vasodilator agents|mesh-ancestor
24452041|NCT00325806|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24452047|NCT00325845|Viscosupplements|viscosupplements|mesh-ancestor
24452048|NCT00325845|Protective Agents|protective agents|mesh-ancestor
24452049|NCT00325845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871816|NCT00123552|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25076789|NCT03370601|Mercaptopurine|mercaptopurine|mesh-list
24593195|NCT00927498|Cytarabine|cytarabine|mesh-list
25871817|NCT00123552|Antimalarials|antimalarials|mesh-ancestor
25871818|NCT00123552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24596624|NCT00944502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596625|NCT00944502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24596626|NCT00944502|Glucocorticoids|glucocorticoids|mesh-ancestor
25871819|NCT00123552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24394030|NCT00131742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24394031|NCT00131742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394032|NCT00131742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394034|NCT00131742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24394035|NCT00131742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24394036|NCT00131742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25232352|NCT02583685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25232353|NCT02583685|Immunologic Factors|immunologic factors|mesh-ancestor
25232354|NCT02583685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232355|NCT02583685|Antimetabolites|antimetabolites|mesh-ancestor
25232356|NCT02583685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232357|NCT02583685|Protease Inhibitors|protease inhibitors|mesh-ancestor
25232358|NCT02583685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232359|NCT02583516|Vemurafenib|vemurafenib|mesh-list
25871822|NCT00123552|Antiviral Agents|antiviral agents|mesh-ancestor
24866377|NCT05152940|Ertugliflozin|ertugliflozin|mesh-list
25871828|NCT00123552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871829|NCT00123552|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25232362|NCT02583516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232363|NCT02583516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232364|NCT02583321|Silver Sulfadiazine|silver sulfadiazine|mesh-list
25232365|NCT02583321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25232366|NCT02583321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25232367|NCT02582996|Acetaminophen|acetaminophen|mesh-list
25232368|NCT02582996|Dihydroergotamine|dihydroergotamine|mesh-list
25232369|NCT02582996|Metoclopramide|metoclopramide|mesh-list
25232370|NCT02582996|Caffeine|caffeine|mesh-list
25232371|NCT02582996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25232372|NCT02582996|Analgesics|analgesics|mesh-ancestor
25232375|NCT02582996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232376|NCT02582996|Antipyretics|antipyretics|mesh-ancestor
24394110|NCT00132158|Gefitinib|gefitinib|mesh-list
24394111|NCT00132158|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24728690|NCT01617707|Propofol|propofol|mesh-list
24394113|NCT00132158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871830|NCT00123552|Renal Agents|renal agents|mesh-ancestor
24452086|NCT00325962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24452107|NCT00326053|Respiratory System Agents|respiratory system agents|mesh-ancestor
24452108|NCT00326053|Glucocorticoids|glucocorticoids|mesh-ancestor
24452109|NCT00326053|Hormones|hormones|mesh-ancestor
24452110|NCT00326053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24452111|NCT00326053|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24452112|NCT00326053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24452113|NCT00326053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24452114|NCT00326053|Adrenergic Agents|adrenergic agents|mesh-ancestor
24452115|NCT00326053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24452116|NCT00326053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452117|NCT00326092|Timolol|timolol|mesh-list
25046628|NCT00839930|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25046629|NCT00839930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046631|NCT00838799|Analgesics|analgesics|mesh-ancestor
25046632|NCT00838799|Sensory System Agents|sensory system agents|mesh-ancestor
25046633|NCT00838799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24814296|NCT02063789|Immunoglobulins|immunoglobulins|mesh-list
24596632|NCT00944515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24596633|NCT00944515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24596634|NCT00944541|Maraviroc|maraviroc|mesh-list
24596635|NCT00944541|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24596636|NCT00944541|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24596637|NCT00944541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596638|NCT00944541|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24596639|NCT00944541|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25232377|NCT02582996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25232378|NCT02582996|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25232379|NCT02582996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232380|NCT02582996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394126|NCT00132236|Nicotine|nicotine|mesh-list
25871854|NCT00123656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25871855|NCT00123656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871856|NCT00123656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25046650|NCT00838630|Respiratory System Agents|respiratory system agents|mesh-ancestor
25046651|NCT00838630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25046652|NCT00838630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25046653|NCT00838630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811662|NCT02047552|Hormones|hormones|mesh-ancestor
25871857|NCT00123656|Respiratory System Agents|respiratory system agents|mesh-ancestor
25871858|NCT00123656|Dermatologic Agents|dermatologic agents|mesh-ancestor
25871859|NCT00123656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25232389|NCT02582996|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25232390|NCT02582996|Dopamine Agents|dopamine agents|mesh-ancestor
25232391|NCT02582996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25232393|NCT02583217|Ketamine|ketamine|mesh-list
24866898|NCT03954899|Melatonin|melatonin|mesh-list
24866899|NCT03954899|Antioxidants|antioxidants|mesh-ancestor
25671629|NCT01734551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25671630|NCT01734551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24866900|NCT03954899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671631|NCT01734551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24866901|NCT03954899|Protective Agents|protective agents|mesh-ancestor
24866902|NCT03954899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866903|NCT03954899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24867093|NCT03520842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139873|NCT02968082|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25139874|NCT02968082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25139876|NCT02968082|Autonomic Agents|autonomic agents|mesh-ancestor
25139877|NCT02968082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25139878|NCT02968082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871864|NCT00123656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871865|NCT00123669|Progesterone|progesterone|mesh-list
25139879|NCT02968082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25139880|NCT02968082|Mydriatics|mydriatics|mesh-ancestor
24867256|NCT02549092|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24867294|NCT02323126|Nivolumab|nivolumab|mesh-list
25871874|NCT00123825|Gemcitabine|gemcitabine|mesh-list
25871875|NCT00123825|Cisplatin|cisplatin|mesh-list
24463205|NCT00359333|Antimetabolites|antimetabolites|mesh-ancestor
24802282|NCT01989312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232420|NCT02583243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25232421|NCT02583191|Rivaroxaban|rivaroxaban|mesh-list
25232422|NCT02583191|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25871876|NCT00123825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24802283|NCT01989312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24802284|NCT01989312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24802285|NCT01989312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24452328|NCT00327132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24452331|NCT00327145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24452332|NCT00327145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24452333|NCT00327145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25871877|NCT00123825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25871878|NCT00123825|Antimetabolites|antimetabolites|mesh-ancestor
25871879|NCT00123825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871880|NCT00123825|Antiviral Agents|antiviral agents|mesh-ancestor
25871881|NCT00123825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25871882|NCT00123825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24452334|NCT00327145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24452335|NCT00327145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452336|NCT00327145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24452350|NCT00327197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24452351|NCT00327197|Glucocorticoids|glucocorticoids|mesh-ancestor
24802295|NCT01989312|Adrenergic Agents|adrenergic agents|mesh-ancestor
24802296|NCT01989312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24802297|NCT01989312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24802299|NCT01989312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25139946|NCT02967341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24867368|NCT00821587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24867369|NCT00821587|Dermatologic Agents|dermatologic agents|mesh-ancestor
24867371|NCT00585195|Itraconazole|itraconazole|mesh-list
25232423|NCT02583191|Antithrombins|antithrombins|mesh-ancestor
25232424|NCT02583191|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25232425|NCT02583191|Protease Inhibitors|protease inhibitors|mesh-ancestor
25232426|NCT02583191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232427|NCT02583191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232428|NCT02583191|Anticoagulants|anticoagulants|mesh-ancestor
25232429|NCT02583308|Silver Sulfadiazine|silver sulfadiazine|mesh-list
25871884|NCT00123825|Immunologic Factors|immunologic factors|mesh-ancestor
24867500|NCT04312971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24867501|NCT04312971|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24867502|NCT04282278|Apatinib|apatinib|mesh-list
24867503|NCT04282278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24867504|NCT04282278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25232436|NCT02583282|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24846806|NCT02244112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25871894|NCT00123851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24802396|NCT01989897|Histamine Agents|histamine agents|mesh-ancestor
24802397|NCT01989897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24802399|NCT01989897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463282|NCT00359814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463283|NCT00359814|Antifungal Agents|antifungal agents|mesh-ancestor
24463284|NCT00359814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24463285|NCT00359814|Dermatologic Agents|dermatologic agents|mesh-ancestor
24463286|NCT00359814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25871895|NCT00123877|Esorubicin|esorubicin|mesh-list
25871896|NCT00123877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25871897|NCT00123877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25871898|NCT00123890|Aplaviroc|aplaviroc|mesh-list
25871899|NCT00123890|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24463291|NCT00359853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24463292|NCT00359853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24802405|NCT01989923|Nicotine|nicotine|mesh-list
25232458|NCT02582736|Methotrimeprazine|methotrimeprazine|mesh-list
25232459|NCT02582736|Haloperidol|haloperidol|mesh-list
25232460|NCT02582736|Pimozide|pimozide|mesh-list
25232461|NCT02582736|Olanzapine|olanzapine|mesh-list
25232462|NCT02582736|Chlorpromazine|chlorpromazine|mesh-list
25232463|NCT02582736|Trifluoperazine|trifluoperazine|mesh-list
25232464|NCT02582736|Risperidone|risperidone|mesh-list
25232465|NCT02582736|Aripiprazole|aripiprazole|mesh-list
25232466|NCT02582736|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25232467|NCT02582736|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25232468|NCT02582736|Ziprasidone|ziprasidone|mesh-list
25871900|NCT00123890|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24479899|NCT00428818|Renal Agents|renal agents|mesh-ancestor
24846833|NCT02244164|Incretins|incretins|mesh-ancestor
24802412|NCT01989923|Cholinergic Agents|cholinergic agents|mesh-ancestor
25671671|NCT01734889|Nitisinone|nitisinone|mesh-list
24802413|NCT01989923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24802414|NCT01989923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802415|NCT01989936|Eletriptan|eletriptan|mesh-list
24802416|NCT01989936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24802417|NCT01989936|Serotonin Agents|serotonin agents|mesh-ancestor
25671672|NCT01734889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871902|NCT00123890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24623242|NCT01070706|Tubulin Modulators|tubulin modulators|mesh-ancestor
24623243|NCT01070706|Antimitotic Agents|antimitotic agents|mesh-ancestor
24446503|NCT00304980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446504|NCT00304980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24446505|NCT00304980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24802418|NCT01989936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24802419|NCT01989936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802420|NCT01989936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596758|NCT00945308|Eptifibatide|eptifibatide|mesh-list
25871903|NCT00123890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25871904|NCT00123890|Antiviral Agents|antiviral agents|mesh-ancestor
25077045|NCT03368391|Autonomic Agents|autonomic agents|mesh-ancestor
25077055|NCT03368352|Melatonin|melatonin|mesh-list
25077056|NCT03368352|Antioxidants|antioxidants|mesh-ancestor
25871905|NCT00123890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25871906|NCT00123903|Metoprolol|metoprolol|mesh-list
25871907|NCT00123903|Carvedilol|carvedilol|mesh-list
25871908|NCT00123903|Lisinopril|lisinopril|mesh-list
25871909|NCT00123903|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25871910|NCT00123903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25871911|NCT00123903|Sympatholytics|sympatholytics|mesh-ancestor
24463340|NCT00360178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24463348|NCT00360178|Natriuretic Agents|natriuretic agents|mesh-ancestor
24463349|NCT00360178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24463350|NCT00360191|Buspirone|buspirone|mesh-list
24463357|NCT00360191|Serotonin Agents|serotonin agents|mesh-ancestor
24867895|NCT05052710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25140037|NCT02967211|Insulin Glargine|insulin glargine|mesh-list
25140038|NCT02967211|Insulin Detemir|insulin detemir|mesh-list
24463449|NCT00361023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24463450|NCT00361023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24463451|NCT00361023|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24463452|NCT00361023|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24463453|NCT00361023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463454|NCT00361075|Estradiol|estradiol|mesh-list
24463455|NCT00361075|Estrogens|estrogens|mesh-list
24463456|NCT00361075|Progesterone|progesterone|mesh-list
25871914|NCT00123903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871915|NCT00123903|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25871916|NCT00123903|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25871917|NCT00123903|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25871918|NCT00123903|Adrenergic Agents|adrenergic agents|mesh-ancestor
24463467|NCT00361114|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24463468|NCT00361114|Chlorproguanil|chlorproguanil|mesh-list
24463469|NCT00361114|Antimalarials|antimalarials|mesh-ancestor
25232482|NCT02582736|Tetrabenazine|tetrabenazine|mesh-list
25232483|NCT02582736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25232484|NCT02582736|Serotonin Agents|serotonin agents|mesh-ancestor
25232485|NCT02582736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24463470|NCT00361114|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24463471|NCT00361114|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24463472|NCT00361114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24463489|NCT00361166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24463490|NCT00361166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24802431|NCT01990079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671678|NCT01734902|Autonomic Agents|autonomic agents|mesh-ancestor
25671679|NCT01734902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25671680|NCT01734902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671681|NCT01734902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25671682|NCT01734902|Mydriatics|mydriatics|mesh-ancestor
25140066|NCT02967224|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25140067|NCT02967224|Insulin Glargine|insulin glargine|mesh-list
25140068|NCT02967224|Insulin Detemir|insulin detemir|mesh-list
25140069|NCT02967224|Insulin, Isophane|insulin, isophane|mesh-list
25140070|NCT02967224|Isophane Insulin, Human|isophane insulin, human|mesh-list
25140071|NCT02967224|Isophane insulin, beef|isophane insulin, beef|mesh-list
25140072|NCT02967224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25088611|NCT03536429|Diuretics|diuretics|mesh-ancestor
25140073|NCT02967224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868069|NCT03887936|Hormones|hormones|mesh-ancestor
24868070|NCT03887936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24868071|NCT03887936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868072|NCT03884439|Infliximab|infliximab|mesh-list
24868073|NCT03884439|Dermatologic Agents|dermatologic agents|mesh-ancestor
24868074|NCT03884439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24868075|NCT03884439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24868076|NCT03831711|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
24868077|NCT03831711|Bombesin|bombesin|mesh-list
24463540|NCT00361322|Sensory System Agents|sensory system agents|mesh-ancestor
24463541|NCT00361322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24802445|NCT01990118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569577|NCT00801151|Tubulin Modulators|tubulin modulators|mesh-ancestor
24463543|NCT00361322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24596409|NCT00943501|Liraglutide|liraglutide|mesh-list
25871930|NCT00123903|Protease Inhibitors|protease inhibitors|mesh-ancestor
24802446|NCT01990118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24802447|NCT01990118|Immunologic Factors|immunologic factors|mesh-ancestor
24802448|NCT01990118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802449|NCT01990118|Antifungal Agents|antifungal agents|mesh-ancestor
24802450|NCT01990118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25077142|NCT03367143|Etoposide|etoposide|mesh-list
25871931|NCT00123903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25671696|NCT01735396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671697|NCT01735396|Hormone Antagonists|hormone antagonists|mesh-ancestor
25671698|NCT01735396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25671699|NCT01735396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671700|NCT01735396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25671701|NCT01735617|Hydrocortisone|hydrocortisone|mesh-list
25671702|NCT01735617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25671703|NCT01735630|Inositol|inositol|mesh-list
25871932|NCT00123903|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25871933|NCT00123916|Benzonidazole|benzonidazole|mesh-list
25140103|NCT02966522|Growth Substances|growth substances|mesh-ancestor
25140104|NCT02966522|Growth Inhibitors|growth inhibitors|mesh-ancestor
25140105|NCT02966587|Durvalumab|durvalumab|mesh-list
25140106|NCT02966587|Immunoglobulins|immunoglobulins|mesh-list
25140107|NCT02966587|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25140108|NCT02966587|Immunoglobulin G|immunoglobulin g|mesh-list
25140109|NCT02966587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24548149|NCT00707876|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24868178|NCT02782702|Botulinum Toxins|botulinum toxins|mesh-list
25871942|NCT00123929|Doxorubicin|doxorubicin|mesh-list
25871943|NCT00123929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25871944|NCT00123929|Tubulin Modulators|tubulin modulators|mesh-ancestor
25871945|NCT00123929|Antimitotic Agents|antimitotic agents|mesh-ancestor
24463623|NCT00361621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24463624|NCT00361621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24463625|NCT00361621|Glucocorticoids|glucocorticoids|mesh-ancestor
25871946|NCT00123929|Mitosis Modulators|mitosis modulators|mesh-ancestor
24463629|NCT00361621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24463630|NCT00361621|Tubulin Modulators|tubulin modulators|mesh-ancestor
24463631|NCT00361621|Antimitotic Agents|antimitotic agents|mesh-ancestor
24463632|NCT00361621|Mitosis Modulators|mitosis modulators|mesh-ancestor
24463633|NCT00361686|Tramadol|tramadol|mesh-list
24463634|NCT00361686|Remifentanil|remifentanil|mesh-list
24463635|NCT00361686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24463636|NCT00361686|Narcotics|narcotics|mesh-ancestor
25140132|NCT02966665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25140133|NCT02966665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25140134|NCT02966665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25140135|NCT02966665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140136|NCT02966665|Antioxidants|antioxidants|mesh-ancestor
25140137|NCT02966665|Protective Agents|protective agents|mesh-ancestor
25140138|NCT02966665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24463741|NCT00361985|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24463742|NCT00361985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24463743|NCT00361985|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24463744|NCT00361985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24463745|NCT00361985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463746|NCT00361998|Nitrofurantoin|nitrofurantoin|mesh-list
24463758|NCT00362063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463759|NCT00362089|Dronabinol|dronabinol|mesh-list
25871950|NCT00123929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24463774|NCT00362102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25871951|NCT00123929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871952|NCT00124059|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24802494|NCT01990586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802495|NCT01990690|Antioxidants|antioxidants|mesh-list
24802496|NCT01990690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802497|NCT01990690|Protective Agents|protective agents|mesh-ancestor
25232492|NCT02582736|Dopamine Agents|dopamine agents|mesh-ancestor
25232493|NCT02582736|Antiemetics|antiemetics|mesh-ancestor
25671713|NCT01736085|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25671714|NCT01736085|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25671715|NCT01736085|Cholinergic Agents|cholinergic agents|mesh-ancestor
25671716|NCT01736085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25671718|NCT01736176|Levodopa|levodopa|mesh-list
25671719|NCT01736176|Carbidopa|carbidopa|mesh-list
25671721|NCT01736176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24626547|NCT01087749|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24626548|NCT01087749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24802498|NCT01990690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463813|NCT00362271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24463814|NCT00362271|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24463815|NCT00362271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24463816|NCT00362271|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24463817|NCT00362271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25871960|NCT00124098|Hematinics|hematinics|mesh-ancestor
25871961|NCT00124111|Cyclophosphamide|cyclophosphamide|mesh-list
24802519|NCT01990781|Lidocaine|lidocaine|mesh-list
24802520|NCT01990781|BB 1101|bb 1101|mesh-list
24802521|NCT01990781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24452505|NCT05458479|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24452506|NCT05458479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24452507|NCT05458479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463889|NCT00362687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24463890|NCT00362687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24463891|NCT00362687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232495|NCT02582736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25232496|NCT02582736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25671722|NCT01736176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25871962|NCT00124111|Fluorouracil|fluorouracil|mesh-list
25871963|NCT00124111|Methotrexate|methotrexate|mesh-list
25871964|NCT00124111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25871965|NCT00124111|Immunologic Factors|immunologic factors|mesh-ancestor
25871966|NCT00124111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871967|NCT00124111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25871968|NCT00124111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25140222|NCT02966236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140224|NCT02966236|Coagulants|coagulants|mesh-ancestor
25140235|NCT02966067|Anesthetics|anesthetics|mesh-list
25140236|NCT02966067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25140237|NCT02966067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25871969|NCT00124111|Alkylating Agents|alkylating agents|mesh-ancestor
24548371|NCT00709254|Analgesics|analgesics|mesh-ancestor
25871970|NCT00124111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871971|NCT00124111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25871972|NCT00124111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25871973|NCT00124111|Antimetabolites|antimetabolites|mesh-ancestor
25871974|NCT00124111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25871975|NCT00124111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25871976|NCT00124111|Abortifacient Agents|abortifacient agents|mesh-ancestor
25871977|NCT00124111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25871978|NCT00124111|Dermatologic Agents|dermatologic agents|mesh-ancestor
24463910|NCT00362726|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24463911|NCT00362726|Protease Inhibitors|protease inhibitors|mesh-ancestor
24802528|NCT01990781|Hormones|hormones|mesh-ancestor
25871979|NCT00124111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871980|NCT00124111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25871981|NCT00124111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25871982|NCT00124124|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25871983|NCT00124124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25871984|NCT00124124|Immunologic Factors|immunologic factors|mesh-ancestor
25871985|NCT00124124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871986|NCT00124137|Diuretics|diuretics|mesh-list
25871987|NCT00124137|Natriuretic Agents|natriuretic agents|mesh-ancestor
25871988|NCT00124137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871989|NCT00124150|Magnesium Sulfate|magnesium sulfate|mesh-list
25871990|NCT00124150|Analgesics|analgesics|mesh-ancestor
24868504|NCT04503707|Hormones|hormones|mesh-ancestor
25232497|NCT02582736|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25232498|NCT02582736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25232499|NCT02582736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25232500|NCT02582736|Antidepressive Agents|antidepressive agents|mesh-ancestor
25232501|NCT02582736|Dopamine Agonists|dopamine agonists|mesh-ancestor
25232502|NCT02582736|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25232503|NCT02582736|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25232504|NCT02582736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24463991|NCT00362921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463992|NCT00362921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463993|NCT00362921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24463994|NCT00362934|Atorvastatin|atorvastatin|mesh-list
24463995|NCT00362934|Simvastatin|simvastatin|mesh-list
25046763|NCT00835705|Amoxicillin|amoxicillin|mesh-list
25046764|NCT00835705|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25140265|NCT02966249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140266|NCT02966249|Sensory System Agents|sensory system agents|mesh-ancestor
25140267|NCT02966249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25140268|NCT02966080|Heparin|heparin|mesh-list
24846836|NCT02244164|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24846837|NCT02244164|Protease Inhibitors|protease inhibitors|mesh-ancestor
24846838|NCT02244164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515694|NCT00598793|Metformin|metformin|mesh-list
24802552|NCT01990872|Vitamins|vitamins|mesh-ancestor
24802553|NCT01990872|Micronutrients|micronutrients|mesh-ancestor
24802554|NCT01990872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802555|NCT01990872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24802556|NCT01990872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24464138|NCT00363389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24464139|NCT00363389|Oxytocics|oxytocics|mesh-ancestor
24464140|NCT00363519|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24464141|NCT00363519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25872001|NCT00124150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24452634|NCT05457946|Immunologic Factors|immunologic factors|mesh-ancestor
25872002|NCT00124150|Tocolytic Agents|tocolytic agents|mesh-ancestor
25872003|NCT00124150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25872004|NCT00124241|Lamivudine|lamivudine|mesh-list
25872005|NCT00124241|Telbivudine|telbivudine|mesh-list
25872006|NCT00124241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25872007|NCT00124241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24464142|NCT00363519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464143|NCT00363519|Incretins|incretins|mesh-ancestor
25140301|NCT02965677|Mitosis Modulators|mitosis modulators|mesh-ancestor
25140302|NCT02965677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140303|NCT02965443|Dapagliflozin|dapagliflozin|mesh-list
25140304|NCT02965443|Saxagliptin|saxagliptin|mesh-list
25140305|NCT02965443|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25140306|NCT02965443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872010|NCT00124241|Antiviral Agents|antiviral agents|mesh-ancestor
24464227|NCT00363857|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25872011|NCT00124241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24464228|NCT00363857|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25232509|NCT02582736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25232510|NCT02582736|Adrenergic Agents|adrenergic agents|mesh-ancestor
25232511|NCT02582736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24465002|NCT00367497|Antiemetics|antiemetics|mesh-ancestor
24596974|NCT00946621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596976|NCT00946673|Vorinostat|vorinostat|mesh-list
24596977|NCT00946673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596978|NCT00946673|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24596979|NCT00946673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596980|NCT00946673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596981|NCT00946686|Leflunomide|leflunomide|mesh-list
24452682|NCT05457829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872012|NCT00124241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24464253|NCT00363909|Cholinergic Agents|cholinergic agents|mesh-ancestor
24464254|NCT00363935|Dexmedetomidine|dexmedetomidine|mesh-list
24596982|NCT00946686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596984|NCT00946686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25671747|NCT01736358|Ketorolac|ketorolac|mesh-list
25671748|NCT01736358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25671749|NCT01736358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25671750|NCT01736358|Analgesics|analgesics|mesh-ancestor
25671751|NCT01736358|Sensory System Agents|sensory system agents|mesh-ancestor
25671754|NCT01736358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24869146|NCT04694248|Antipyretics|antipyretics|mesh-ancestor
25232512|NCT02582736|Analgesics|analgesics|mesh-ancestor
25232513|NCT02582736|Sensory System Agents|sensory system agents|mesh-ancestor
25232514|NCT02582736|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25232515|NCT02582736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25232516|NCT02582736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25872019|NCT00124267|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24464261|NCT00363935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24464262|NCT00363935|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24464263|NCT00363935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24464264|NCT00363935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24464265|NCT00363935|Adrenergic Agents|adrenergic agents|mesh-ancestor
24464266|NCT00363935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24464267|NCT00363935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464268|NCT00363948|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24464269|NCT00363948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24464291|NCT00364052|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
24464292|NCT00364052|Antiviral Agents|antiviral agents|mesh-ancestor
25872020|NCT00124267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872021|NCT00124267|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24452738|NCT05455944|Analgesics|analgesics|mesh-ancestor
24869318|NCT04278404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24869319|NCT04278404|Antifungal Agents|antifungal agents|mesh-ancestor
24869320|NCT04278404|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24869321|NCT04278404|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24869322|NCT04278404|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24869323|NCT04278404|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24869324|NCT04278404|GABA Agonists|gaba agonists|mesh-ancestor
24869325|NCT04278404|GABA Agents|gaba agents|mesh-ancestor
24869326|NCT04278404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24869327|NCT04278404|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25140362|NCT02965274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464329|NCT00364273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622500|NCT01067365|Enclomiphene|enclomiphene|mesh-list
24622501|NCT01067365|Clomiphene|clomiphene|mesh-list
25872030|NCT00124280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464399|NCT00364702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24464400|NCT00364702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464401|NCT00364702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24464412|NCT00364754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872031|NCT00124306|Amitriptyline|amitriptyline|mesh-list
25872032|NCT00124306|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25872033|NCT00124306|Antidepressive Agents|antidepressive agents|mesh-ancestor
25872034|NCT00124306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25872035|NCT00124306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25872036|NCT00124306|Analgesics|analgesics|mesh-ancestor
25872037|NCT00124306|Sensory System Agents|sensory system agents|mesh-ancestor
25671765|NCT01736579|Antibodies|antibodies|mesh-list
25872044|NCT00124306|Adrenergic Agents|adrenergic agents|mesh-ancestor
24863188|NCT02934529|Vitamins|vitamins|mesh-ancestor
25872045|NCT00124306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25872046|NCT00124332|Rimonabant|rimonabant|mesh-list
24464449|NCT00364988|Pioglitazone|pioglitazone|mesh-list
24464451|NCT00364988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24464452|NCT00364988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464453|NCT00364988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24464454|NCT00364988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25872047|NCT00124332|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24464514|NCT00365287|Immunologic Factors|immunologic factors|mesh-ancestor
25232534|NCT02582372|Fentanyl|fentanyl|mesh-list
25232535|NCT02582372|Dexmedetomidine|dexmedetomidine|mesh-list
25232536|NCT02582372|Bupivacaine|bupivacaine|mesh-list
25232537|NCT02582372|Anesthetics, Local|anesthetics, local|mesh-ancestor
25232538|NCT02582372|Anesthetics|anesthetics|mesh-ancestor
25232539|NCT02582372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25232540|NCT02582372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232541|NCT02582372|Sensory System Agents|sensory system agents|mesh-ancestor
25062640|NCT04231877|Doxorubicin|doxorubicin|mesh-list
24464515|NCT00365287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464516|NCT00365287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24464517|NCT00365287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24464518|NCT00365287|Alkylating Agents|alkylating agents|mesh-ancestor
24464519|NCT00365287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623268|NCT01070745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24623269|NCT01070745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24623270|NCT01070745|Analgesics|analgesics|mesh-ancestor
24464653|NCT00365755|Immunologic Factors|immunologic factors|mesh-ancestor
24464654|NCT00365755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464655|NCT00365755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24464656|NCT00365755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24464657|NCT00365755|Alkylating Agents|alkylating agents|mesh-ancestor
24464658|NCT00365755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24454314|NCT04109482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25872064|NCT00124384|Modafinil|modafinil|mesh-list
25872065|NCT00124384|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25872066|NCT00124384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872067|NCT00124384|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25046803|NCT00835588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24869848|NCT05142098|Hormones|hormones|mesh-ancestor
24802582|NCT01991054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24802583|NCT01991119|Dronedarone|dronedarone|mesh-list
24802584|NCT01991119|Propafenone|propafenone|mesh-list
25872068|NCT00124384|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25872069|NCT00124384|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25872070|NCT00124384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872071|NCT00124397|Atorvastatin|atorvastatin|mesh-list
25872072|NCT00124397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24464852|NCT00367094|Protease Inhibitors|protease inhibitors|mesh-ancestor
25077440|NCT03364764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24464853|NCT00367094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232548|NCT02582372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25232549|NCT02582372|Adrenergic Agents|adrenergic agents|mesh-ancestor
25232550|NCT02582372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25232551|NCT02582372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232552|NCT02582372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25232553|NCT02582372|Narcotics|narcotics|mesh-ancestor
25232554|NCT02582372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25232555|NCT02582372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24464973|NCT00367471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24464975|NCT00367471|Tubulin Modulators|tubulin modulators|mesh-ancestor
24464976|NCT00367471|Antimitotic Agents|antimitotic agents|mesh-ancestor
24464983|NCT00367497|Methylprednisolone|methylprednisolone|mesh-list
24464984|NCT00367497|Rituximab|rituximab|mesh-list
24464985|NCT00367497|Etoposide|etoposide|mesh-list
24464986|NCT00367497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24464987|NCT00367497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25872073|NCT00124397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24453199|NCT05238831|Growth Inhibitors|growth inhibitors|mesh-ancestor
24453200|NCT05238831|Immunologic Factors|immunologic factors|mesh-ancestor
25872074|NCT00124397|Antimetabolites|antimetabolites|mesh-ancestor
25232561|NCT02582437|Analgesics|analgesics|mesh-ancestor
25232562|NCT02582437|Sensory System Agents|sensory system agents|mesh-ancestor
25232563|NCT02582437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25273584|NCT02384876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25273585|NCT02384876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872075|NCT00124397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872076|NCT00124397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24464995|NCT00367497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464996|NCT00367497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24464997|NCT00367497|Antimetabolites|antimetabolites|mesh-ancestor
24464998|NCT00367497|Antiviral Agents|antiviral agents|mesh-ancestor
24464999|NCT00367497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24465000|NCT00367497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24465001|NCT00367497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24465004|NCT00367497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24465005|NCT00367497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24465006|NCT00367497|Glucocorticoids|glucocorticoids|mesh-ancestor
25872077|NCT00124397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25872078|NCT00124397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872079|NCT00124436|Alitretinoin|alitretinoin|mesh-list
25872080|NCT00124436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872081|NCT00124436|Dermatologic Agents|dermatologic agents|mesh-ancestor
25872082|NCT00124475|Alitretinoin|alitretinoin|mesh-list
25872083|NCT00124475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872084|NCT00124475|Dermatologic Agents|dermatologic agents|mesh-ancestor
25872085|NCT00124527|Capecitabine|capecitabine|mesh-list
24475115|NCT00408941|Sensory System Agents|sensory system agents|mesh-ancestor
25872086|NCT00124527|Irofulven|irofulven|mesh-list
25872087|NCT00124527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24446630|NCT00305500|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25140470|NCT02963779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25140472|NCT02963779|Sensory System Agents|sensory system agents|mesh-ancestor
25140473|NCT02963779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25140474|NCT02963779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140475|NCT02963779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25140476|NCT02963779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25140477|NCT02963779|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25140478|NCT02963779|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25140479|NCT02963779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25140481|NCT02963896|Gentamicins|gentamicins|mesh-list
24572268|NCT00814021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25232564|NCT02582307|Acetaminophen|acetaminophen|mesh-list
25232565|NCT02582307|Scopolamine|scopolamine|mesh-list
25232566|NCT02582307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
25232567|NCT02582307|Analgesics|analgesics|mesh-list
25232568|NCT02582307|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25232569|NCT02582307|Sensory System Agents|sensory system agents|mesh-ancestor
25232570|NCT02582307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24846847|NCT02244190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24630936|NCT01115127|Inositol|inositol|mesh-list
25872088|NCT00124527|Antimetabolites|antimetabolites|mesh-ancestor
24954585|NCT03874832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24954615|NCT03874364|Lidocaine|lidocaine|mesh-list
24465026|NCT00367562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465029|NCT00367562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24465030|NCT00367614|Pantoprazole|pantoprazole|mesh-list
24465031|NCT00367614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24465032|NCT00367614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24465033|NCT00367614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25872093|NCT00124540|Misoprostol|misoprostol|mesh-list
24863404|NCT05131386|Trabectedin|trabectedin|mesh-list
25232571|NCT02582307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232572|NCT02582307|Antipyretics|antipyretics|mesh-ancestor
25232573|NCT02582307|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25232574|NCT02582307|Antiemetics|antiemetics|mesh-ancestor
25232575|NCT02582307|Autonomic Agents|autonomic agents|mesh-ancestor
25232576|NCT02582307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25232577|NCT02582307|Mydriatics|mydriatics|mesh-ancestor
25232578|NCT02582307|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25232579|NCT02582307|Cholinergic Agents|cholinergic agents|mesh-ancestor
24465091|NCT00367874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465093|NCT00367874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24802644|NCT01991288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24802645|NCT01991288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802646|NCT01991288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24802647|NCT01991288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25872094|NCT00124540|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25872095|NCT00124540|Abortifacient Agents|abortifacient agents|mesh-ancestor
25872096|NCT00124540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25872097|NCT00124540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872098|NCT00124540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25872099|NCT00124540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25872100|NCT00124540|Oxytocics|oxytocics|mesh-ancestor
25140534|NCT02963168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25140535|NCT02963168|Tubulin Modulators|tubulin modulators|mesh-ancestor
25140536|NCT02963168|Antimitotic Agents|antimitotic agents|mesh-ancestor
25140537|NCT02963168|Mitosis Modulators|mitosis modulators|mesh-ancestor
25140538|NCT02963168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140539|NCT02963181|Melatonin|melatonin|mesh-list
25140540|NCT02963181|Yohimbine|yohimbine|mesh-list
25140541|NCT02963181|Antioxidants|antioxidants|mesh-ancestor
25872101|NCT00124566|Prednisone|prednisone|mesh-list
24465127|NCT00367939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465143|NCT00367978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465144|NCT00367978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24465145|NCT00367978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572789|NCT00816712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465146|NCT00367978|Vasodilator Agents|vasodilator agents|mesh-ancestor
24465147|NCT00367978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24465148|NCT00367978|Protease Inhibitors|protease inhibitors|mesh-ancestor
25872102|NCT00124566|Capecitabine|capecitabine|mesh-list
25872117|NCT00124566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25872118|NCT00124566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25872119|NCT00124566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25872120|NCT00124566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872121|NCT00124566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25872122|NCT00124566|Alkylating Agents|alkylating agents|mesh-ancestor
24870871|NCT03158857|Sofosbuvir|sofosbuvir|mesh-list
24870872|NCT03158857|Antiviral Agents|antiviral agents|mesh-ancestor
24870873|NCT03158857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25872123|NCT00124605|Pamidronate|pamidronate|mesh-list
25872124|NCT00124605|Arsenic Trioxide|arsenic trioxide|mesh-list
25872125|NCT00124605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872126|NCT00124605|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25872127|NCT00124605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872128|NCT00124644|Cytarabine|cytarabine|mesh-list
25872129|NCT00124644|Etoposide|etoposide|mesh-list
25872130|NCT00124644|Daunorubicin|daunorubicin|mesh-list
25872131|NCT00124644|Tipifarnib|tipifarnib|mesh-list
25872132|NCT00124644|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25872133|NCT00124644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25872134|NCT00124644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872135|NCT00124644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24871319|NCT03765632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465300|NCT00368862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24465301|NCT00368862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24465302|NCT00368862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872136|NCT00124644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25872137|NCT00124644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872138|NCT00124644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25872139|NCT00124644|Antimetabolites|antimetabolites|mesh-ancestor
25872140|NCT00124644|Antiviral Agents|antiviral agents|mesh-ancestor
25872141|NCT00124644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25872144|NCT00124644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872145|NCT00124644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25046843|NCT00835406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25046844|NCT00835406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140604|NCT02962986|Oxymetazoline|oxymetazoline|mesh-list
25140605|NCT02962986|Norepinephrine|norepinephrine|mesh-list
25140606|NCT02962986|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25140607|NCT02962986|Mydriatics|mydriatics|mesh-ancestor
25140608|NCT02962986|Autonomic Agents|autonomic agents|mesh-ancestor
25872146|NCT00124683|Bupropion|bupropion|mesh-list
25872147|NCT00124683|Nicotine|nicotine|mesh-list
25872148|NCT00124683|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25872153|NCT00124683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25671841|NCT01737840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140646|NCT02962830|Sensory System Agents|sensory system agents|mesh-ancestor
25872154|NCT00124683|Cholinergic Agents|cholinergic agents|mesh-ancestor
25872155|NCT00124683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25671842|NCT01737879|Epoetin Alfa|epoetin alfa|mesh-list
24802722|NCT01991951|Warfarin|warfarin|mesh-list
25140698|NCT02962518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25140699|NCT02962518|Glucocorticoids|glucocorticoids|mesh-ancestor
25140700|NCT02962518|Hormones|hormones|mesh-ancestor
25140702|NCT02962518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102807|NCT03166397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24475971|NCT00412191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25872168|NCT00124696|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25872169|NCT00124696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25872170|NCT00124696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25872171|NCT00124696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671868|NCT01737931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872172|NCT00124696|Dopamine Agents|dopamine agents|mesh-ancestor
25671869|NCT01737931|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25872173|NCT00124696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25671870|NCT01737931|Antipruritics|antipruritics|mesh-ancestor
25671878|NCT01737944|Antimetabolites|antimetabolites|mesh-ancestor
25046855|NCT00835367|Protease Inhibitors|protease inhibitors|mesh-ancestor
25046856|NCT00835367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046857|NCT00835354|Cefprozil|cefprozil|mesh-list
25140812|NCT02961829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25140813|NCT02961842|Ephedrine|ephedrine|mesh-list
25140814|NCT02961842|Fentanyl|fentanyl|mesh-list
25140815|NCT02961842|Bupivacaine|bupivacaine|mesh-list
24876343|NCT03594123|Dopamine Agents|dopamine agents|mesh-ancestor
25140851|NCT02962037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24465892|NCT00371033|Pregabalin|pregabalin|mesh-list
24465893|NCT00371033|Analgesics|analgesics|mesh-ancestor
24465894|NCT00371033|Sensory System Agents|sensory system agents|mesh-ancestor
24465895|NCT00371033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25872192|NCT00124787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24465904|NCT00371033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25232680|NCT02581696|Histamine Antagonists|histamine antagonists|mesh-ancestor
25232681|NCT02581696|Histamine Agents|histamine agents|mesh-ancestor
25232682|NCT02581696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25872194|NCT00124813|Thalidomide|thalidomide|mesh-list
25046858|NCT00835354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25046859|NCT00835354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25046860|NCT00835276|Fexofenadine|fexofenadine|mesh-list
25046861|NCT00835276|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24465907|NCT00371072|Mitomycin|mitomycin|mesh-list
24465908|NCT00371072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24465909|NCT00371072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25141015|NCT02960126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141016|NCT02960126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25141017|NCT02960126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25141018|NCT02960126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25141019|NCT02960126|Antipyretics|antipyretics|mesh-ancestor
25141020|NCT02960126|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25141021|NCT02960126|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24597612|NCT00950261|Cisplatin|cisplatin|mesh-list
24877081|NCT02965716|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25141055|NCT02960035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25141056|NCT02960035|Immunologic Factors|immunologic factors|mesh-ancestor
25141058|NCT02959879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25141059|NCT02959905|Vidarabine|vidarabine|mesh-list
25141060|NCT02959905|Cyclophosphamide|cyclophosphamide|mesh-list
25141061|NCT02959905|Fludarabine|fludarabine|mesh-list
25141062|NCT02959905|Fludarabine phosphate|fludarabine phosphate|mesh-list
25141063|NCT02959905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25141064|NCT02959905|Immunologic Factors|immunologic factors|mesh-ancestor
25141065|NCT02959905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141067|NCT02959905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25141068|NCT02959905|Alkylating Agents|alkylating agents|mesh-ancestor
24803223|NCT01995084|Imidazole|imidazole|mesh-list
25141100|NCT02959749|Growth Inhibitors|growth inhibitors|mesh-ancestor
25077698|NCT03362814|Ribavirin|ribavirin|mesh-list
24803315|NCT01995370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24803316|NCT01995656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25046979|NCT00834756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25141162|NCT02959411|Diuretics|diuretics|mesh-list
25141163|NCT02959411|Natriuretic Agents|natriuretic agents|mesh-ancestor
25141164|NCT02959411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995693|NCT04870957|Antidepressive Agents|antidepressive agents|mesh-ancestor
25141165|NCT02959411|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25141166|NCT02959411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803506|NCT01996501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24803582|NCT01997190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24803584|NCT01997203|Interferons|interferons|mesh-list
24803585|NCT01997203|Ribavirin|ribavirin|mesh-list
24803586|NCT01997203|Vitamins|vitamins|mesh-ancestor
25872223|NCT00124930|Autonomic Agents|autonomic agents|mesh-ancestor
25671947|NCT01739335|Hormone Antagonists|hormone antagonists|mesh-ancestor
25872224|NCT00124930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24807025|NCT02019355|Petrolatum|petrolatum|mesh-list
24878327|NCT01915810|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25141213|NCT02958917|Pirfenidone|pirfenidone|mesh-list
25141256|NCT02958800|Serotonin Agents|serotonin agents|mesh-ancestor
25141257|NCT02958800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25141258|NCT02958800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141259|NCT02958800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872225|NCT00124930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803705|NCT01998113|Glyburide|glyburide|mesh-list
25872235|NCT00124930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25872236|NCT00124930|Serotonin Agents|serotonin agents|mesh-ancestor
24878991|NCT05183880|Antioxidants|antioxidants|mesh-ancestor
24878992|NCT05183880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878993|NCT05183880|Protective Agents|protective agents|mesh-ancestor
24879066|NCT05082155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879067|NCT05082155|Sensory System Agents|sensory system agents|mesh-ancestor
24879068|NCT05082155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25872238|NCT00124956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24476411|NCT00414921|Analgesics|analgesics|mesh-ancestor
25872239|NCT00124956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466164|NCT00372294|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24466165|NCT00372294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466166|NCT00372294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466167|NCT00372294|Antimalarials|antimalarials|mesh-ancestor
24466168|NCT00372294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24466169|NCT00372294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24466170|NCT00372294|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24466171|NCT00372294|Coccidiostats|coccidiostats|mesh-ancestor
24803926|NCT01999673|Immunologic Factors|immunologic factors|mesh-ancestor
24466239|NCT00372658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24466242|NCT00372710|Zoledronic Acid|zoledronic acid|mesh-list
25872256|NCT00124995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872257|NCT00124995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24664268|NCT01305733|Anesthetics|anesthetics|mesh-ancestor
24664269|NCT01305733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25141486|NCT02957448|Antitubercular Agents|antitubercular agents|mesh-ancestor
24846981|NCT02244515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24466435|NCT00373542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24466436|NCT00373542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804174|NCT02001311|Dermatologic Agents|dermatologic agents|mesh-ancestor
24804175|NCT02001363|Liraglutide|liraglutide|mesh-list
24804176|NCT02001363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24804177|NCT02001363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804428|NCT02002403|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24804429|NCT02002403|Hormone Antagonists|hormone antagonists|mesh-ancestor
24804430|NCT02002403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24804431|NCT02002403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141725|NCT02955927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25672012|NCT01739933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25141726|NCT02955927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141727|NCT02955927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25141728|NCT02955927|Respiratory System Agents|respiratory system agents|mesh-ancestor
25141729|NCT02955927|Mydriatics|mydriatics|mesh-ancestor
24880377|NCT03811886|Immunologic Factors|immunologic factors|mesh-ancestor
24880378|NCT03811886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141730|NCT02955927|Parasympatholytics|parasympatholytics|mesh-ancestor
25872278|NCT00125021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872279|NCT00125047|Vaccines|vaccines|mesh-list
25872280|NCT00125047|Immunologic Factors|immunologic factors|mesh-ancestor
25872281|NCT00125047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872282|NCT00125060|Simvastatin|simvastatin|mesh-list
25141920|NCT02953457|Tremelimumab|tremelimumab|mesh-list
25141921|NCT02953457|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25141932|NCT02953405|Clopidogrel|clopidogrel|mesh-list
24466724|NCT00374764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466725|NCT00374764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466726|NCT00374764|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24466727|NCT00374764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24466732|NCT00374777|Nitrazepam|nitrazepam|mesh-list
24466789|NCT00374894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466790|NCT00374959|Ceftriaxone|ceftriaxone|mesh-list
25872294|NCT00125151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466810|NCT00375076|Anticoagulants|anticoagulants|mesh-ancestor
24466813|NCT00375076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466814|NCT00375232|Montelukast|montelukast|mesh-list
24466815|NCT00375232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25232978|NCT02579434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25232979|NCT02579434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232980|NCT02579356|Telmisartan|telmisartan|mesh-list
25232981|NCT02579356|Atorvastatin|atorvastatin|mesh-list
25232982|NCT02579356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25232983|NCT02579356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25232984|NCT02579356|Antimetabolites|antimetabolites|mesh-ancestor
25232985|NCT02579356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232986|NCT02579356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25232987|NCT02579356|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25232988|NCT02579356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25062995|NCT03307759|Pembrolizumab|pembrolizumab|mesh-list
24466816|NCT00375232|Respiratory System Agents|respiratory system agents|mesh-ancestor
25872295|NCT00125203|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
24805012|NCT02006849|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24805014|NCT02006849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24805016|NCT02006914|Chromium|chromium|mesh-list
25142060|NCT02953041|Bromides|bromides|mesh-list
25232989|NCT02579356|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25232990|NCT02579356|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25232991|NCT02579356|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25232993|NCT02579187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25232994|NCT02579187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232995|NCT02579161|Metronidazole|metronidazole|mesh-list
25232996|NCT02579161|Clindamycin|clindamycin|mesh-list
25232997|NCT02579161|Clindamycin palmitate|clindamycin palmitate|mesh-list
25232998|NCT02579161|Clindamycin phosphate|clindamycin phosphate|mesh-list
25232999|NCT02579161|Sulbactam|sulbactam|mesh-list
25233000|NCT02579161|Cephalosporins|cephalosporins|mesh-list
25233001|NCT02579161|Fluoroquinolones|fluoroquinolones|mesh-list
24466925|NCT00375622|Tamoxifen|tamoxifen|mesh-list
24466926|NCT00375622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24466927|NCT00375622|Hormone Antagonists|hormone antagonists|mesh-ancestor
24466953|NCT00375687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24466954|NCT00375687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466955|NCT00375687|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24466956|NCT00375687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25047142|NCT00833521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047143|NCT00833521|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25047153|NCT00833495|Prednisone|prednisone|mesh-list
25233005|NCT02579161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25872321|NCT00125255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25233006|NCT02579161|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25233007|NCT02579161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233008|NCT02579161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233009|NCT02579161|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25672057|NCT01740323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872332|NCT00125294|Sensory System Agents|sensory system agents|mesh-ancestor
24467270|NCT00376831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24467271|NCT00376831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24467272|NCT00376831|Anesthetics, General|anesthetics, general|mesh-ancestor
25672063|NCT01740362|Tofacitinib|tofacitinib|mesh-list
25142202|NCT02951728|Hormones|hormones|mesh-ancestor
24805144|NCT02007837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24805145|NCT02007837|Antipyretics|antipyretics|mesh-ancestor
24805146|NCT02007850|Ropivacaine|ropivacaine|mesh-list
25872340|NCT00125307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24467414|NCT00377546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24805147|NCT02007850|Anesthetics, Local|anesthetics, local|mesh-ancestor
24805148|NCT02007850|Anesthetics|anesthetics|mesh-ancestor
24805149|NCT02007850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25872341|NCT00125307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872342|NCT00125307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872343|NCT00125346|Tobramycin|tobramycin|mesh-list
25872344|NCT00125346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25872345|NCT00125346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24805150|NCT02007850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805151|NCT02007850|Sensory System Agents|sensory system agents|mesh-ancestor
24805152|NCT02007850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24599759|NCT03913559|Antiviral Agents|antiviral agents|mesh-ancestor
24805154|NCT02007915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24805155|NCT02007915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805156|NCT02007928|Olanzapine|olanzapine|mesh-list
24805157|NCT02007928|Risperidone|risperidone|mesh-list
25872346|NCT00125385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25872347|NCT00125385|Immunologic Factors|immunologic factors|mesh-ancestor
24467531|NCT00377988|Contraceptives, Oral|contraceptives, oral|mesh-list
24467532|NCT00377988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24467546|NCT00378027|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24467547|NCT00378027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25233021|NCT02578953|Dutasteride|dutasteride|mesh-list
25047209|NCT00830102|Xhance|xhance|mesh-list
24816307|NCT02076230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672067|NCT01740388|Besifloxacin|besifloxacin|mesh-list
25672068|NCT01740388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24816308|NCT02076373|Epoetin Alfa|epoetin alfa|mesh-list
25233032|NCT02578849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233033|NCT02578849|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25233034|NCT02578849|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25233035|NCT02578849|Dopamine Agonists|dopamine agonists|mesh-ancestor
24467550|NCT00378066|Oxaliplatin|oxaliplatin|mesh-list
25872348|NCT00125385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876714|NCT02884206|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25876715|NCT02884206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25876716|NCT02884206|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25876717|NCT02884206|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24467551|NCT00378066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25876718|NCT02884206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876719|NCT02839915|Leucovorin|leucovorin|mesh-list
25876720|NCT02839915|Folic Acid|folic acid|mesh-list
25876721|NCT02839915|Levoleucovorin|levoleucovorin|mesh-list
25876722|NCT02839915|Antidotes|antidotes|mesh-ancestor
25876723|NCT02839915|Protective Agents|protective agents|mesh-ancestor
25876724|NCT02839915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876725|NCT02839915|Vitamin B Complex|vitamin b complex|mesh-ancestor
25876726|NCT02839915|Vitamins|vitamins|mesh-ancestor
25876727|NCT02839915|Micronutrients|micronutrients|mesh-ancestor
25876728|NCT02839915|Hematinics|hematinics|mesh-ancestor
24881359|NCT02636387|Natriuretic Agents|natriuretic agents|mesh-ancestor
24881360|NCT02636387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881361|NCT02576574|Gemcitabine|gemcitabine|mesh-list
25233036|NCT02578849|Dopamine Agents|dopamine agents|mesh-ancestor
25233037|NCT02578849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25872349|NCT00125398|Fospropofol|fospropofol|mesh-list
24847020|NCT02244671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847021|NCT02244671|Cholinergic Agents|cholinergic agents|mesh-ancestor
24847022|NCT02244671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24847023|NCT02244671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872350|NCT00125398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25872351|NCT00125398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25872352|NCT00125398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872353|NCT00125411|Docetaxel|docetaxel|mesh-list
25872354|NCT00125411|Satraplatin|satraplatin|mesh-list
25872355|NCT00125411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872356|NCT00125411|Tubulin Modulators|tubulin modulators|mesh-ancestor
25872357|NCT00125411|Antimitotic Agents|antimitotic agents|mesh-ancestor
24467751|NCT00378638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24599834|NCT03581240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24599835|NCT03581240|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
24599836|NCT03581240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24599838|NCT03559192|Aticaprant|aticaprant|mesh-list
25063047|NCT03229408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24467774|NCT00378716|Leucovorin|leucovorin|mesh-list
24467775|NCT00378716|Fluorouracil|fluorouracil|mesh-list
24467776|NCT00378716|Tegafur|tegafur|mesh-list
24467777|NCT00378716|Calcium|calcium|mesh-list
25047242|NCT00829998|GABA Modulators|gaba modulators|mesh-ancestor
25047243|NCT00829998|GABA Agents|gaba agents|mesh-ancestor
25047244|NCT00829998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24847045|NCT02244827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24467987|NCT00379431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24847054|NCT02244879|Protective Agents|protective agents|mesh-ancestor
24847055|NCT02244879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468136|NCT00380133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24468354|NCT00381173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24468355|NCT00381173|Alkylating Agents|alkylating agents|mesh-ancestor
24468356|NCT00381173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872378|NCT00125437|Hormone Antagonists|hormone antagonists|mesh-ancestor
24468357|NCT00381173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872379|NCT00125437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25872380|NCT00125437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468358|NCT00381173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24468359|NCT00381199|Amitriptyline|amitriptyline|mesh-list
24468360|NCT00381199|Nabilone|nabilone|mesh-list
24468361|NCT00381199|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24468362|NCT00381199|Antidepressive Agents|antidepressive agents|mesh-ancestor
24468363|NCT00381199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25872381|NCT00125437|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25872382|NCT00125437|Diuretics|diuretics|mesh-ancestor
24468454|NCT00381589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24417916|NCT00208169|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24417917|NCT00208169|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24417918|NCT00208169|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24468455|NCT00381589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468456|NCT00381589|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24468457|NCT00381589|Respiratory System Agents|respiratory system agents|mesh-ancestor
24468458|NCT00381589|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24468459|NCT00381589|Cholinergic Agents|cholinergic agents|mesh-ancestor
24847065|NCT02245022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24805253|NCT02008214|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24864826|NCT00943618|Dopamine Agents|dopamine agents|mesh-ancestor
24468478|NCT00381758|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24468479|NCT00381758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25872386|NCT00125463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24468533|NCT00382083|Anesthetics, Local|anesthetics, local|mesh-ancestor
24468534|NCT00382083|Anesthetics|anesthetics|mesh-ancestor
24468535|NCT00382083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24468536|NCT00382083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468537|NCT00382083|Sensory System Agents|sensory system agents|mesh-ancestor
24468538|NCT00382083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24468539|NCT00382083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24468540|NCT00382083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24468541|NCT00382083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25872387|NCT00125463|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24805264|NCT02008422|Endostar protein|endostar protein|mesh-list
25233079|NCT02578550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25233080|NCT02578550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25233081|NCT02578550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25142710|NCT02947815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479193|NCT00425997|Amlodipine|amlodipine|mesh-list
25142711|NCT02947815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25142713|NCT02947737|Gentamicins|gentamicins|mesh-list
25672105|NCT01740726|Fluoxetine|fluoxetine|mesh-list
24761327|NCT01762306|Analgesics|analgesics|mesh-ancestor
25872399|NCT00125489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25872400|NCT00125489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25872401|NCT00125489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25872402|NCT00125489|Analgesics|analgesics|mesh-ancestor
25142784|NCT02947243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25142824|NCT02947061|Antimitotic Agents|antimitotic agents|mesh-ancestor
25142825|NCT02947061|Mitosis Modulators|mitosis modulators|mesh-ancestor
25142829|NCT02946671|Nivolumab|nivolumab|mesh-list
25063106|NCT03188172|Hormones|hormones|mesh-ancestor
24469444|NCT00385931|Valsartan|valsartan|mesh-list
25872403|NCT00125489|Sensory System Agents|sensory system agents|mesh-ancestor
24469465|NCT00385970|Leucovorin|leucovorin|mesh-list
25233110|NCT02578537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25233111|NCT02578537|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25233112|NCT02578537|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25233113|NCT02578537|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25233114|NCT02578537|Purinergic Agents|purinergic agents|mesh-ancestor
25233115|NCT02578537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24469677|NCT00386750|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24469678|NCT00386750|Antimalarials|antimalarials|mesh-ancestor
24469679|NCT00386750|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24469711|NCT00386828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24469712|NCT00386828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469713|NCT00386828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24469716|NCT00386828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469717|NCT00386828|Growth Inhibitors|growth inhibitors|mesh-ancestor
24469719|NCT00386841|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25672114|NCT01740726|Antidepressive Agents|antidepressive agents|mesh-ancestor
25672115|NCT01740726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25233117|NCT02578537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233118|NCT02578472|Zolpidem|zolpidem|mesh-list
25233119|NCT02578472|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25233120|NCT02578472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25233121|NCT02578472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25063118|NCT03158805|Liraglutide|liraglutide|mesh-list
25872428|NCT00125567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25872429|NCT00125567|Dopamine Agents|dopamine agents|mesh-ancestor
25872430|NCT00125567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25872431|NCT00125567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469963|NCT00388167|Caspofungin|caspofungin|mesh-list
24469964|NCT00388167|Antifungal Agents|antifungal agents|mesh-ancestor
25672116|NCT01740726|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25672117|NCT01740726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24470062|NCT00388700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25233122|NCT02578472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233123|NCT02578472|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25233124|NCT02578472|GABA Agonists|gaba agonists|mesh-ancestor
25233125|NCT02578472|GABA Agents|gaba agents|mesh-ancestor
25233126|NCT02578472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25233127|NCT02578472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233128|NCT02578511|Ixazomib|ixazomib|mesh-list
24470076|NCT00388739|Prednisolone|prednisolone|mesh-list
25047285|NCT00829673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25047286|NCT00829673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047287|NCT00829673|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25047288|NCT00829673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25047289|NCT00829673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25047293|NCT00829530|Ramipril|ramipril|mesh-list
24470236|NCT00389311|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
24470237|NCT00389311|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
24470238|NCT00389311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470239|NCT00389311|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24470240|NCT00389311|Contraceptive Agents|contraceptive agents|mesh-ancestor
25233129|NCT02578511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25233130|NCT02578511|Protease Inhibitors|protease inhibitors|mesh-ancestor
25233131|NCT02578511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872444|NCT00125684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25233146|NCT02578108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25233147|NCT02578108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883276|NCT04058990|Paclitaxel|paclitaxel|mesh-list
24470474|NCT00390247|Leprostatic Agents|leprostatic agents|mesh-ancestor
25872461|NCT00125801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470475|NCT00390247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24470476|NCT00390247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24470477|NCT00390247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24470478|NCT00390247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25233168|NCT02578121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25233169|NCT02578121|Glucocorticoids|glucocorticoids|mesh-ancestor
25233170|NCT02578121|Hormones|hormones|mesh-ancestor
25273603|NCT02384889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25072866|NCT03398993|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25872462|NCT00125801|Analgesics|analgesics|mesh-ancestor
24470643|NCT00390871|Sensory System Agents|sensory system agents|mesh-ancestor
24470644|NCT00390871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24470645|NCT00390871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24470646|NCT00390871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24470647|NCT00390871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24470652|NCT00390871|Narcotics|narcotics|mesh-ancestor
24470655|NCT00390897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470656|NCT00390897|Antiviral Agents|antiviral agents|mesh-ancestor
25233172|NCT02578121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25143171|NCT02944357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24470742|NCT00391404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470762|NCT00391638|Antiviral Agents|antiviral agents|mesh-ancestor
24470763|NCT00391638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24470764|NCT00391638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24470765|NCT00391638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24470766|NCT00391638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24470767|NCT00391638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233183|NCT02577848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25233184|NCT02577848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233185|NCT02577848|Incretins|incretins|mesh-ancestor
25233186|NCT02577848|Hormones|hormones|mesh-ancestor
25233187|NCT02577848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25233188|NCT02577809|Indomethacin|indomethacin|mesh-list
25233189|NCT02577809|Fentanyl|fentanyl|mesh-list
25233190|NCT02577809|Morphine|morphine|mesh-list
25233191|NCT02577809|Bupivacaine|bupivacaine|mesh-list
25143219|NCT02944201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25143220|NCT02944201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143221|NCT02944201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471132|NCT00393445|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24954944|NCT03870503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24954945|NCT03870490|Cefepime|cefepime|mesh-list
24954946|NCT03870490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24954947|NCT03870490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24954948|NCT03870256|Misoprostol|misoprostol|mesh-list
24954949|NCT03870256|Carbetocin|carbetocin|mesh-list
24954950|NCT03870256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24471317|NCT00394485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471318|NCT00394485|Sympathomimetics|sympathomimetics|mesh-ancestor
24471319|NCT00394485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24471320|NCT00394485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24471323|NCT00394498|Lenograstim|lenograstim|mesh-list
24805420|NCT02009410|Pancreatin|pancreatin|mesh-list
25143434|NCT02942758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25044450|NCT01096862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25044451|NCT01096862|Immunologic Factors|immunologic factors|mesh-ancestor
25233278|NCT02577770|Caffeine|caffeine|mesh-list
24805457|NCT02009449|Protective Agents|protective agents|mesh-ancestor
24805458|NCT02009449|Vitamin B Complex|vitamin b complex|mesh-ancestor
24805460|NCT02009449|Micronutrients|micronutrients|mesh-ancestor
24805461|NCT02009462|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
24805462|NCT02009462|Vasodilator Agents|vasodilator agents|mesh-ancestor
24805463|NCT02009462|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24805464|NCT02009462|Protective Agents|protective agents|mesh-ancestor
24805465|NCT02009462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805466|NCT02009488|Canagliflozin|canagliflozin|mesh-list
24805467|NCT02009488|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24579166|NCT00853684|Growth Substances|growth substances|mesh-ancestor
25872511|NCT00125905|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24471589|NCT00396058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25143562|NCT02941562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143563|NCT02941562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25143564|NCT02941562|Immunologic Factors|immunologic factors|mesh-ancestor
25143566|NCT02941562|Antidotes|antidotes|mesh-ancestor
24471720|NCT00396682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24471721|NCT00396682|Immunologic Factors|immunologic factors|mesh-ancestor
24471722|NCT00396682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471723|NCT00396682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24471854|NCT00397098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24471855|NCT00397098|Adrenergic Agents|adrenergic agents|mesh-ancestor
24471856|NCT00397098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24471857|NCT00397098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471858|NCT00397098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471859|NCT00397176|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24805476|NCT02009540|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24805477|NCT02009540|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24628410|NCT01098656|Growth Substances|growth substances|mesh-ancestor
25233312|NCT02577250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25233313|NCT02577250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25233314|NCT02577250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25233315|NCT02577250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233316|NCT02577185|Botulinum Toxins|botulinum toxins|mesh-list
25233317|NCT02577185|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25233318|NCT02577185|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25233319|NCT02577185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25233320|NCT02577185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25233321|NCT02577185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233322|NCT02577185|Cholinergic Agents|cholinergic agents|mesh-ancestor
25154512|NCT05470972|Ethanol|ethanol|mesh-list
25154513|NCT05470972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25154514|NCT05470972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25154515|NCT05470972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24947752|NCT03926000|Pregabalin|pregabalin|mesh-list
24471964|NCT00397657|Antimetabolites|antimetabolites|mesh-ancestor
24471979|NCT00397709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24471980|NCT00397709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872552|NCT00126009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25233323|NCT02577185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25233324|NCT02577185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233325|NCT02577185|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25233326|NCT02577185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25233327|NCT02576964|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25233328|NCT02576964|Capecitabine|capecitabine|mesh-list
25233329|NCT02576964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25233330|NCT02576964|Antimetabolites|antimetabolites|mesh-ancestor
25233331|NCT02576964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233340|NCT02576782|Antiemetics|antiemetics|mesh-ancestor
25233353|NCT02576782|Anesthetics, Local|anesthetics, local|mesh-ancestor
25233354|NCT02576782|Anesthetics|anesthetics|mesh-ancestor
25233355|NCT02576782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25233356|NCT02576782|Sensory System Agents|sensory system agents|mesh-ancestor
25233357|NCT02577094|Fludarabine|fludarabine|mesh-list
25233358|NCT02577094|Busulfan|busulfan|mesh-list
25078165|NCT03358888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25078166|NCT03358888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078167|NCT03358888|Analgesics|analgesics|mesh-ancestor
25078168|NCT03358888|Sensory System Agents|sensory system agents|mesh-ancestor
25078169|NCT03358888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078170|NCT03358719|Poly I-C|poly i-c|mesh-list
25233359|NCT02577094|Epratuzumab|epratuzumab|mesh-list
25233360|NCT02577094|Thymoglobulin|thymoglobulin|mesh-list
25233361|NCT02577094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872578|NCT00126061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233366|NCT02577094|Alkylating Agents|alkylating agents|mesh-ancestor
25233367|NCT02577094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25233368|NCT02577094|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25233369|NCT02577094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25233370|NCT02577068|Propacetamol|propacetamol|mesh-list
25233371|NCT02577068|Nefopam|nefopam|mesh-list
25233372|NCT02577068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25233373|NCT02577068|Analgesics|analgesics|mesh-ancestor
25233380|NCT02577159|Dapagliflozin|dapagliflozin|mesh-list
25233381|NCT02577159|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25233382|NCT02577159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472521|NCT00399425|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24472522|NCT00399425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472535|NCT00399477|Levodopa|levodopa|mesh-list
24472536|NCT00399477|Pramipexole|pramipexole|mesh-list
24472537|NCT00399477|Rasagiline|rasagiline|mesh-list
24472538|NCT00399477|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24472539|NCT00399477|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24472540|NCT00399477|Dopamine Agents|dopamine agents|mesh-ancestor
24472646|NCT00400075|Immunologic Factors|immunologic factors|mesh-ancestor
24472647|NCT00400075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472648|NCT00400075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24472649|NCT00400075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24472650|NCT00400075|Alkylating Agents|alkylating agents|mesh-ancestor
24472651|NCT00400075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472652|NCT00400075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872593|NCT00126087|Protective Agents|protective agents|mesh-ancestor
24805546|NCT02010788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24472743|NCT00400387|Vitamin B Complex|vitamin b complex|mesh-list
24472744|NCT00400387|Tocopherols|tocopherols|mesh-list
24472746|NCT00400387|Tocotrienols|tocotrienols|mesh-list
24472747|NCT00400387|alpha-Tocopherol|alpha-tocopherol|mesh-list
24472748|NCT00400387|Heparin|heparin|mesh-list
24472749|NCT00400387|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24472750|NCT00400387|Tinzaparin|tinzaparin|mesh-list
24472751|NCT00400387|Dalteparin|dalteparin|mesh-list
24472752|NCT00400387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472753|NCT00400387|Anticoagulants|anticoagulants|mesh-ancestor
24472782|NCT00400556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24472783|NCT00400556|Immunologic Factors|immunologic factors|mesh-ancestor
24472784|NCT00400556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472785|NCT00400582|Candesartan|candesartan|mesh-list
25872605|NCT00126204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24472821|NCT00400647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24472822|NCT00400647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472849|NCT00400777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472850|NCT00400777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24545315|NCT00693030|Antifungal Agents|antifungal agents|mesh-ancestor
25872606|NCT00126204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25872607|NCT00126230|Docetaxel|docetaxel|mesh-list
25872608|NCT00126230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472875|NCT00400855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24472876|NCT00400855|Autonomic Agents|autonomic agents|mesh-ancestor
24472877|NCT00400855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24472878|NCT00400855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872618|NCT00126243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24472890|NCT00400998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24472891|NCT00400998|Respiratory System Agents|respiratory system agents|mesh-ancestor
24472892|NCT00400998|Dermatologic Agents|dermatologic agents|mesh-ancestor
24472893|NCT00400998|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24472894|NCT00401024|Imatinib Mesylate|imatinib mesylate|mesh-list
24472895|NCT00401024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472896|NCT00401024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24472897|NCT00401024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24472898|NCT00401024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805574|NCT02010944|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24805575|NCT02010944|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24805576|NCT02010944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24805577|NCT02010944|Adrenergic Agents|adrenergic agents|mesh-ancestor
24805578|NCT02010957|Etomidate|etomidate|mesh-list
24805579|NCT02010957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24805580|NCT02010957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24805601|NCT02010970|GABA Agents|gaba agents|mesh-ancestor
25872640|NCT00126269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24444279|NCT00297336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444349|NCT00297570|Antiviral Agents|antiviral agents|mesh-ancestor
24444350|NCT00297570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24444351|NCT00297570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24444352|NCT00297570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444353|NCT00297570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444354|NCT00297583|Insulin glulisine|insulin glulisine|mesh-list
24444355|NCT00297583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24444356|NCT00297583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444357|NCT00297661|Sirolimus|sirolimus|mesh-list
24473280|NCT00402493|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25144615|NCT02935231|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25144616|NCT02935231|Autonomic Agents|autonomic agents|mesh-ancestor
25144617|NCT02935231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25144618|NCT02935231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144619|NCT02935231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25144620|NCT02935231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25144621|NCT02935231|Cholinergic Agents|cholinergic agents|mesh-ancestor
24622852|NCT01068847|Analgesics|analgesics|mesh-ancestor
24473570|NCT00403325|Ranibizumab|ranibizumab|mesh-list
25144794|NCT02934035|Paroxetine|paroxetine|mesh-list
25144795|NCT02934035|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25144796|NCT02934035|Antidepressive Agents|antidepressive agents|mesh-list
24473790|NCT00404222|Hydrocodone|hydrocodone|mesh-list
24473791|NCT00404222|Oxycodone|oxycodone|mesh-list
24473792|NCT00404222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24473793|NCT00404222|Analgesics|analgesics|mesh-ancestor
24473794|NCT00404222|Sensory System Agents|sensory system agents|mesh-ancestor
24473797|NCT00404222|Antipyretics|antipyretics|mesh-ancestor
24473798|NCT00404222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24473799|NCT00404222|Narcotics|narcotics|mesh-ancestor
25144858|NCT02934061|Tizanidine|tizanidine|mesh-list
25144862|NCT02934061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144954|NCT02933658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25144955|NCT02933658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144956|NCT02933658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25144957|NCT02933658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473966|NCT00404573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25233510|NCT02576288|Hormones|hormones|mesh-ancestor
24805917|NCT02012920|Seviteronel|seviteronel|mesh-list
24805918|NCT02012920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446397|NCT00304629|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24474151|NCT00405119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24474152|NCT00405119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24955433|NCT03865147|Respiratory System Agents|respiratory system agents|mesh-ancestor
25145318|NCT02930954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25872776|NCT00126633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25872777|NCT00126633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872778|NCT00126633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25872779|NCT00126633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24805954|NCT02013089|Imatinib Mesylate|imatinib mesylate|mesh-list
25233568|NCT02576327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25872840|NCT00126789|Anesthetics|anesthetics|mesh-ancestor
25047703|NCT00770081|Incretins|incretins|mesh-ancestor
25154545|NCT05470816|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25154546|NCT05470816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154547|NCT05470816|Hemostatics|hemostatics|mesh-ancestor
24474540|NCT00406432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24474541|NCT00406432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474543|NCT00406471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25233695|NCT02575521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25233696|NCT02575521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233697|NCT02575521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25233811|NCT02575001|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24607422|NCT04649229|Autonomic Agents|autonomic agents|mesh-ancestor
24847160|NCT02245373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24847161|NCT02245438|Ritonavir|ritonavir|mesh-list
24847162|NCT02245438|Tipranavir|tipranavir|mesh-list
24847163|NCT02245438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24847164|NCT02245438|Norethindrone|norethindrone|mesh-list
25145837|NCT02926846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047716|NCT00769795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25047717|NCT00769795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233725|NCT02575664|Buprenorphine|buprenorphine|mesh-list
25233726|NCT02575664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25233727|NCT02575664|Narcotics|narcotics|mesh-ancestor
25872946|NCT00127257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872947|NCT00127270|Darifenacin|darifenacin|mesh-list
25872948|NCT00127270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25872949|NCT00127270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25233728|NCT02575664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25872950|NCT00127270|Cholinergic Agents|cholinergic agents|mesh-ancestor
25872951|NCT00127270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25872952|NCT00127270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872953|NCT00127270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872954|NCT00127270|Urological Agents|urological agents|mesh-ancestor
25872955|NCT00127335|Atorvastatin|atorvastatin|mesh-list
25872956|NCT00127335|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25872957|NCT00127335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25872958|NCT00127335|Antimetabolites|antimetabolites|mesh-ancestor
24474676|NCT00407017|Moxifloxacin|moxifloxacin|mesh-list
24884536|NCT00398151|Hormone Antagonists|hormone antagonists|mesh-ancestor
24393723|NCT00130871|Simendan|simendan|mesh-list
25233748|NCT02575508|Immunologic Factors|immunologic factors|mesh-ancestor
25872968|NCT00127387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25872969|NCT00127387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872970|NCT00127387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25872975|NCT00127478|Atrasentan|atrasentan|mesh-list
25233795|NCT02575092|Folic Acid|folic acid|mesh-list
24906121|NCT04342650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24906122|NCT04342650|Analgesics|analgesics|mesh-ancestor
25233824|NCT02574975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25233825|NCT02574975|Autonomic Agents|autonomic agents|mesh-ancestor
25233826|NCT02574975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25233827|NCT02574975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047766|NCT00765700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047768|NCT00765323|Octreotide|octreotide|mesh-list
25146324|NCT02922660|Narcotics|narcotics|mesh-ancestor
25233833|NCT02574975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24906686|NCT04338438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24906687|NCT04338438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906688|NCT04338438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906689|NCT04338126|Tranexamic Acid|tranexamic acid|mesh-list
24906690|NCT04338126|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24906691|NCT04338126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24906859|NCT04336332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906898|NCT04336046|Bupivacaine|bupivacaine|mesh-list
24906937|NCT04335006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24906938|NCT04335006|Tubulin Modulators|tubulin modulators|mesh-ancestor
24906939|NCT04335006|Antimitotic Agents|antimitotic agents|mesh-ancestor
24906940|NCT04335006|Mitosis Modulators|mitosis modulators|mesh-ancestor
24906941|NCT04335006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906942|NCT04335006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25873013|NCT00127595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818750|NCT02090673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24818751|NCT02090673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818752|NCT02090673|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24482509|NCT00439283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24907181|NCT04331834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25146612|NCT02920489|Ropivacaine|ropivacaine|mesh-list
25233888|NCT02574663|Mitosis Modulators|mitosis modulators|mesh-ancestor
25233889|NCT02574663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233890|NCT02574663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25233891|NCT02574663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25233892|NCT02574663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24847209|NCT02245451|Analgesics|analgesics|mesh-ancestor
24847210|NCT02245451|Sensory System Agents|sensory system agents|mesh-ancestor
24908016|NCT04325425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908017|NCT04325113|Levobupivacaine|levobupivacaine|mesh-list
24908018|NCT04325113|Anesthetics, Local|anesthetics, local|mesh-ancestor
24908074|NCT04324307|Fluorouracil|fluorouracil|mesh-list
25146863|NCT02918747|Prednisone|prednisone|mesh-list
25063663|NCT03466749|Antimitotic Agents|antimitotic agents|mesh-ancestor
24908517|NCT04319588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908518|NCT04319588|Sensory System Agents|sensory system agents|mesh-ancestor
24908519|NCT04319588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24908520|NCT04319770|Hyaluronic Acid|hyaluronic acid|mesh-list
24908521|NCT04319770|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24908522|NCT04319770|Immunologic Factors|immunologic factors|mesh-ancestor
24908523|NCT04319770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908524|NCT04319770|Viscosupplements|viscosupplements|mesh-ancestor
24908525|NCT04319770|Protective Agents|protective agents|mesh-ancestor
24908526|NCT04319484|Lenvatinib|lenvatinib|mesh-list
24908527|NCT04319484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908528|NCT04319484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25873051|NCT00127829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873052|NCT00127868|Selenium|selenium|mesh-list
25873053|NCT00127868|Ketoconazole|ketoconazole|mesh-list
25873054|NCT00127868|Ciclopirox|ciclopirox|mesh-list
25873055|NCT00127868|Griseofulvin|griseofulvin|mesh-list
25873056|NCT00127868|Selenium disulfide|selenium disulfide|mesh-list
25873057|NCT00127868|Antifungal Agents|antifungal agents|mesh-ancestor
25873058|NCT00127868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25873059|NCT00127868|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25873060|NCT00127868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25233924|NCT02574468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233925|NCT02574468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233926|NCT02574611|Glycopyrrolate|glycopyrrolate|mesh-list
25233927|NCT02574611|Neostigmine|neostigmine|mesh-list
25233928|NCT02574611|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25233929|NCT02574611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233930|NCT02574611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233931|NCT02574611|Cholinergic Agents|cholinergic agents|mesh-ancestor
25233932|NCT02574611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25233933|NCT02574611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233934|NCT02574611|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25233938|NCT02574611|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25233939|NCT02574611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25233940|NCT02574754|Warfarin|warfarin|mesh-list
25154572|NCT05470647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483855|NCT00445497|Clavulanic Acid|clavulanic acid|mesh-list
24483856|NCT00445497|Clavulanic Acids|clavulanic acids|mesh-list
24908988|NCT04314193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25047887|NCT00755287|Hormones|hormones|mesh-ancestor
25147312|NCT02914158|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24847219|NCT02245477|Mitogens|mitogens|mesh-list
24491860|NCT00484237|Etanercept|etanercept|mesh-list
25234041|NCT02573701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234042|NCT02573701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25234043|NCT02573701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25234044|NCT02573701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25234045|NCT02573701|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25154607|NCT05470465|Paroxetine|paroxetine|mesh-list
25154608|NCT05470465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25154609|NCT05470465|Narcotics|narcotics|mesh-ancestor
24847220|NCT02245477|Endothelial Growth Factors|endothelial growth factors|mesh-list
24847221|NCT02245477|Mitosis Modulators|mitosis modulators|mesh-ancestor
24847222|NCT02245477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147696|NCT02911701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25147697|NCT02911701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147698|NCT02911701|Antipyretics|antipyretics|mesh-ancestor
24492407|NCT00486122|Adrenergic Agents|adrenergic agents|mesh-ancestor
25147699|NCT02911701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25147700|NCT02911701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25147701|NCT02911701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24847229|NCT02245490|Adrenergic Agents|adrenergic agents|mesh-ancestor
25047987|NCT00750295|Ferric Compounds|ferric compounds|mesh-list
25234104|NCT02573727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234105|NCT02573727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25234106|NCT02573727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25234107|NCT02573727|Autonomic Agents|autonomic agents|mesh-ancestor
25234108|NCT02573727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234109|NCT02573727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25234110|NCT02573727|Respiratory System Agents|respiratory system agents|mesh-ancestor
25234111|NCT02573727|Mydriatics|mydriatics|mesh-ancestor
25234112|NCT02573727|Sympathomimetics|sympathomimetics|mesh-ancestor
25234113|NCT02573727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25234127|NCT02573558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25234128|NCT02573558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25234129|NCT02573558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25234139|NCT02573363|Antiviral Agents|antiviral agents|mesh-ancestor
25234140|NCT02573363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25234141|NCT02573363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25234142|NCT02573363|Immunologic Factors|immunologic factors|mesh-ancestor
25234143|NCT02573363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234144|NCT02573363|Analgesics|analgesics|mesh-ancestor
25234145|NCT02573363|Sensory System Agents|sensory system agents|mesh-ancestor
25234146|NCT02573363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25048077|NCT00743925|Antimetabolites|antimetabolites|mesh-ancestor
25148172|NCT05311774|Narcotics|narcotics|mesh-ancestor
24956041|NCT03858270|Dopamine Agents|dopamine agents|mesh-ancestor
24956042|NCT03858270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24956043|NCT03858270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956044|NCT03858270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956047|NCT03858062|Insulin|insulin|mesh-list
25148326|NCT05214976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148327|NCT05214976|Tubulin Modulators|tubulin modulators|mesh-ancestor
25148328|NCT05214976|Antimitotic Agents|antimitotic agents|mesh-ancestor
25148329|NCT05214976|Mitosis Modulators|mitosis modulators|mesh-ancestor
25148330|NCT05214976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148331|NCT05194592|Dapagliflozin|dapagliflozin|mesh-list
25148332|NCT05194592|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25148357|NCT05148195|Calcium|calcium|mesh-list
25048152|NCT00734435|Serotonin Agents|serotonin agents|mesh-ancestor
25048153|NCT00734435|Anticonvulsants|anticonvulsants|mesh-ancestor
25048154|NCT00734435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25048156|NCT00734292|Fluticasone|fluticasone|mesh-list
25148549|NCT04943757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148663|NCT04823845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25148806|NCT04607252|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25148807|NCT04573556|Lemborexant|lemborexant|mesh-list
25148808|NCT04573556|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25148809|NCT04573556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25148811|NCT04573556|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24914942|NCT05253014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25148915|NCT04390698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148916|NCT04390698|Narcotics|narcotics|mesh-ancestor
25148917|NCT04390698|Analgesics|analgesics|mesh-ancestor
25148918|NCT04390698|Sensory System Agents|sensory system agents|mesh-ancestor
25148919|NCT04390698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25148920|NCT04366713|Capecitabine|capecitabine|mesh-list
25148921|NCT04366713|Loperamide|loperamide|mesh-list
25148936|NCT04356326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25048242|NCT00722592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25048243|NCT00722592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048244|NCT00722592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048245|NCT00722358|Asunaprevir|asunaprevir|mesh-list
25048246|NCT00722358|Protease Inhibitors|protease inhibitors|mesh-ancestor
25048247|NCT00722358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048248|NCT00722358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048249|NCT00721760|Enoxaparin|enoxaparin|mesh-list
25149303|NCT03138733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25098863|NCT03195023|Amlodipine|amlodipine|mesh-list
25149331|NCT02867813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149332|NCT02867813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25149426|NCT05467670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25149427|NCT05467670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25149428|NCT05467670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149498|NCT05467189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24497122|NCT00508287|Incretins|incretins|mesh-ancestor
25149726|NCT05465733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25048349|NCT00711555|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25048350|NCT00710580|Etanercept|etanercept|mesh-list
25048351|NCT00710580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25048352|NCT00710580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25048353|NCT00710580|Analgesics|analgesics|mesh-ancestor
25048354|NCT00710580|Sensory System Agents|sensory system agents|mesh-ancestor
25048355|NCT00710580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25048356|NCT00710580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048357|NCT00710580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25048358|NCT00710580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25109364|NCT03125746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109365|NCT03125746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25109366|NCT03125746|Hormone Antagonists|hormone antagonists|mesh-ancestor
25109367|NCT03125746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24956578|NCT03853200|Edetic Acid|edetic acid|mesh-list
24956579|NCT03853200|Pentetic Acid|pentetic acid|mesh-list
25109369|NCT03125616|Vaccines|vaccines|mesh-list
25048384|NCT00709371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048385|NCT00709371|Dopamine Agents|dopamine agents|mesh-ancestor
25048386|NCT00709371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25048387|NCT00709371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048388|NCT00709371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25150027|NCT05357482|Antiviral Agents|antiviral agents|mesh-ancestor
25150029|NCT05356104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25150032|NCT05356104|Incretins|incretins|mesh-ancestor
24997295|NCT05207644|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24997296|NCT05207644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24997297|NCT05207644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997298|NCT05207644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24997299|NCT05207644|Hormone Antagonists|hormone antagonists|mesh-ancestor
24997300|NCT05207644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24997301|NCT05207644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25150178|NCT05314569|Isoflurane|isoflurane|mesh-list
25150179|NCT05314569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25150180|NCT05314569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25150181|NCT05314569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25150182|NCT05314569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25150183|NCT05314569|Analgesics|analgesics|mesh-ancestor
25150184|NCT05314569|Sensory System Agents|sensory system agents|mesh-ancestor
25150185|NCT05314569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25150187|NCT05314569|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25150306|NCT05293600|Acetazolamide|acetazolamide|mesh-list
25150307|NCT05293600|Eszopiclone|eszopiclone|mesh-list
25150308|NCT05293600|Trazodone|trazodone|mesh-list
25150309|NCT05293600|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25080514|NCT03337672|Anesthetics|anesthetics|mesh-ancestor
24508984|NCT00557934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150456|NCT05240274|Metformin|metformin|mesh-list
25151128|NCT04885686|Antiemetics|antiemetics|mesh-ancestor
25151129|NCT04885686|Autonomic Agents|autonomic agents|mesh-ancestor
25151130|NCT04885686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25151134|NCT04885686|Hormones|hormones|mesh-ancestor
24997360|NCT05131828|Histamine Agents|histamine agents|mesh-ancestor
24997361|NCT05131828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24997365|NCT05101551|Topotecan|topotecan|mesh-list
25151773|NCT04484610|Analgesics, Opioid|analgesics, opioid|mesh-list
25151956|NCT04312503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25873201|NCT00128037|Tubulin Modulators|tubulin modulators|mesh-ancestor
24509121|NCT00558623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24509122|NCT00558662|Monensin|monensin|mesh-list
24997572|NCT04592744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25152817|NCT03786081|Bevacizumab|bevacizumab|mesh-list
25152818|NCT03786081|Pembrolizumab|pembrolizumab|mesh-list
25152819|NCT03786081|Tisotumab vedotin|tisotumab vedotin|mesh-list
25152820|NCT03786081|Carboplatin|carboplatin|mesh-list
25152821|NCT03786081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24997626|NCT04550546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24997627|NCT04550546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24997628|NCT04550546|Antifungal Agents|antifungal agents|mesh-ancestor
25153239|NCT03374956|Autonomic Agents|autonomic agents|mesh-ancestor
25153240|NCT03374956|Adrenergic Agents|adrenergic agents|mesh-ancestor
25153254|NCT03370783|Ethanol|ethanol|mesh-list
25153395|NCT03138512|Nivolumab|nivolumab|mesh-list
25153396|NCT03138512|Ipilimumab|ipilimumab|mesh-list
25153397|NCT03138512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25153398|NCT03138512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25153399|NCT03138512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25153400|NCT03138512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153401|NCT03126591|Pembrolizumab|pembrolizumab|mesh-list
24886439|NCT04526119|Z 338|z 338|mesh-list
25873264|NCT00128414|Colchicine|colchicine|mesh-list
25153676|NCT02569645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25153924|NCT02081755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25153925|NCT02081755|Antimetabolites|antimetabolites|mesh-ancestor
25153926|NCT02081755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25153927|NCT02081755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25873275|NCT00128427|Tubulin Modulators|tubulin modulators|mesh-ancestor
25154240|NCT01241786|Lenalidomide|lenalidomide|mesh-list
25154241|NCT01241786|Azacitidine|azacitidine|mesh-list
25154242|NCT01241786|Immunologic Factors|immunologic factors|mesh-ancestor
25154243|NCT01241786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154244|NCT01241786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25154250|NCT01241786|Antimetabolites|antimetabolites|mesh-ancestor
24931086|NCT04093648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931087|NCT04093648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24931088|NCT04093206|Vitamins|vitamins|mesh-list
24931089|NCT04093206|Ascorbic Acid|ascorbic acid|mesh-list
24931090|NCT04093206|Micronutrients|micronutrients|mesh-ancestor
24931146|NCT04092595|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24931147|NCT04092595|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25109148|NCT03126877|Mitomycin|mitomycin|mesh-list
25154384|NCT00606294|Misonidazole|misonidazole|mesh-list
25154385|NCT00606294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25154386|NCT00606294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24502495|NCT05034536|Infliximab|infliximab|mesh-list
24997997|NCT04038255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24997998|NCT04038255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998077|NCT03841565|Growth Substances|growth substances|mesh-ancestor
24998078|NCT03841565|Growth Inhibitors|growth inhibitors|mesh-ancestor
25048504|NCT00694135|Protease Inhibitors|protease inhibitors|mesh-ancestor
25048505|NCT00694135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24982232|NCT03445858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25234706|NCT02569463|Interleukin-2|interleukin-2|mesh-list
25234707|NCT02569463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25234708|NCT02569463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25234709|NCT02569463|Analgesics|analgesics|mesh-ancestor
25234710|NCT02569463|Sensory System Agents|sensory system agents|mesh-ancestor
25234711|NCT02569463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234712|NCT02569463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234713|NCT02569463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25234714|NCT02569463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25234715|NCT02569463|Antiviral Agents|antiviral agents|mesh-ancestor
25234716|NCT02569463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25234717|NCT02569502|Enfuvirtide|enfuvirtide|mesh-list
24992779|NCT02876510|Vidarabine|vidarabine|mesh-list
24841527|NCT02216383|Oxytocin|oxytocin|mesh-list
24998269|NCT03243058|Analgesics|analgesics|mesh-ancestor
24840423|NCT02210117|Nivolumab|nivolumab|mesh-list
25234755|NCT02569073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234756|NCT02569073|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25064243|NCT03461718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24621425|NCT01062360|Sensory System Agents|sensory system agents|mesh-ancestor
24621426|NCT01062360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24621427|NCT01062360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004580|NCT02786329|Sevoflurane|sevoflurane|mesh-list
25004581|NCT02786329|Anesthetics, Local|anesthetics, local|mesh-ancestor
25004582|NCT02786329|Anesthetics|anesthetics|mesh-ancestor
25004583|NCT02786329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25004584|NCT02786329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936289|NCT04042558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933942|NCT04065906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24625353|NCT01081847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945310|NCT03951753|Hormones|hormones|mesh-ancestor
25234830|NCT02568839|Trastuzumab|trastuzumab|mesh-list
25234831|NCT02568839|Pertuzumab|pertuzumab|mesh-list
25234832|NCT02568839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25234833|NCT02568839|Tubulin Modulators|tubulin modulators|mesh-ancestor
25234834|NCT02568839|Antimitotic Agents|antimitotic agents|mesh-ancestor
25234835|NCT02568839|Mitosis Modulators|mitosis modulators|mesh-ancestor
25234836|NCT02568839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456399|NCT00331084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24456400|NCT00331084|Antiemetics|antiemetics|mesh-ancestor
24456401|NCT00331084|Autonomic Agents|autonomic agents|mesh-ancestor
24456409|NCT00331084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24456410|NCT00331084|Protease Inhibitors|protease inhibitors|mesh-ancestor
24456411|NCT00331084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456476|NCT00331240|Adrenergic Agents|adrenergic agents|mesh-ancestor
24946062|NCT03943407|Histamine Agents|histamine agents|mesh-ancestor
24787714|NCT01926665|Dexamethasone|dexamethasone|mesh-list
25234845|NCT02568735|Etoricoxib|etoricoxib|mesh-list
24946417|NCT03939923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946418|NCT03939923|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24946419|NCT03939923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885001|NCT02969928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24949367|NCT04916392|Anesthetics|anesthetics|mesh-ancestor
24949368|NCT04916392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24949631|NCT04006288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24949632|NCT04006288|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24949633|NCT04006288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24949634|NCT04006288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004785|NCT01670539|Hormones|hormones|mesh-ancestor
25234953|NCT02568111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24966068|NCT03772067|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24966069|NCT03772067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24966070|NCT03772067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966071|NCT03772067|Incretins|incretins|mesh-ancestor
24966072|NCT03772067|Hormones|hormones|mesh-ancestor
24966073|NCT03772067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24966074|NCT03771677|Interferons|interferons|mesh-list
25235001|NCT02567838|Anesthetics|anesthetics|mesh-ancestor
25235002|NCT02567838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25235003|NCT02567838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064404|NCT03460743|Hemagglutinins|hemagglutinins|mesh-list
25064405|NCT03460743|Immunologic Factors|immunologic factors|mesh-ancestor
25064406|NCT03460743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064407|NCT03460743|Agglutinins|agglutinins|mesh-ancestor
25004824|NCT01416935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004826|NCT01416935|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25004827|NCT01416935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25004828|NCT01416935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004829|NCT01416935|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25004830|NCT01416935|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25004831|NCT01416935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25672861|NCT01750697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24495847|NCT00502164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495848|NCT00502190|Silicon|silicon|mesh-list
24495849|NCT00502190|Trace Elements|trace elements|mesh-ancestor
24809895|NCT02036554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873378|NCT00128700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25873379|NCT00128700|Alkylating Agents|alkylating agents|mesh-ancestor
25873380|NCT00128700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873381|NCT00128700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24959020|NCT03827876|Hormones|hormones|mesh-ancestor
24454638|NCT03878524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24454639|NCT03878524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24454640|NCT03878524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24454641|NCT03878524|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24454672|NCT03852992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24454673|NCT03852992|Vasodilator Agents|vasodilator agents|mesh-ancestor
25235030|NCT02567487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235031|NCT02567487|Sensory System Agents|sensory system agents|mesh-ancestor
25235032|NCT02567487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25235033|NCT02567383|Docetaxel|docetaxel|mesh-list
25235034|NCT02567383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25004887|NCT05202665|Fluorides|fluorides|mesh-list
25062055|NCT05345691|Denosumab|denosumab|mesh-list
24453483|NCT04998669|Immunologic Factors|immunologic factors|mesh-ancestor
25109632|NCT03122678|Thiamine|thiamine|mesh-list
25235102|NCT02567032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235103|NCT02567149|Cidofovir|cidofovir|mesh-list
24847655|NCT02248181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25873441|NCT00128856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25873442|NCT00128856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873443|NCT00128856|Tubulin Modulators|tubulin modulators|mesh-ancestor
25873444|NCT00128856|Antimitotic Agents|antimitotic agents|mesh-ancestor
25873445|NCT00128856|Mitosis Modulators|mitosis modulators|mesh-ancestor
25873446|NCT00128856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873447|NCT00128856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25873448|NCT00128856|Antimetabolites|antimetabolites|mesh-ancestor
25873449|NCT00128856|Antiviral Agents|antiviral agents|mesh-ancestor
25873450|NCT00128856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24480334|NCT00430651|Carboplatin|carboplatin|mesh-list
25873454|NCT00128856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873455|NCT00128856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25873456|NCT00128856|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24481059|NCT00433225|Methylprednisolone|methylprednisolone|mesh-list
24481060|NCT00433225|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24481061|NCT00433225|Prednisolone acetate|prednisolone acetate|mesh-list
24481063|NCT00433225|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24481134|NCT00433459|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24481135|NCT00433459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24481136|NCT00433459|Immunologic Factors|immunologic factors|mesh-ancestor
24481137|NCT00433459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481138|NCT00433459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24481139|NCT00433459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24481140|NCT00433459|Alkylating Agents|alkylating agents|mesh-ancestor
24481141|NCT00433459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481142|NCT00433459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481189|NCT00433641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24481190|NCT00433641|Appetite Depressants|appetite depressants|mesh-ancestor
24481191|NCT00433641|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25235119|NCT02567175|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24810831|NCT02042690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25075538|NCT03380442|Analgesics|analgesics|mesh-ancestor
25873485|NCT05562466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873486|NCT05562466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25873487|NCT05562466|Respiratory System Agents|respiratory system agents|mesh-ancestor
25873488|NCT05562466|Glucocorticoids|glucocorticoids|mesh-ancestor
25873489|NCT05562466|Hormones|hormones|mesh-ancestor
24847689|NCT02248259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24847690|NCT02248259|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24847691|NCT02248259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24847692|NCT02248259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24847693|NCT02248259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847694|NCT02248259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25064486|NCT03459417|Morphine|morphine|mesh-list
25873490|NCT05562466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24998609|NCT02448329|Mitosis Modulators|mitosis modulators|mesh-ancestor
25672927|NCT01751113|Xhance|xhance|mesh-list
24937391|NCT04029350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24937392|NCT04029350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798406|NCT01963442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798461|NCT01963754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24798462|NCT01963754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798463|NCT01963754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25078582|NCT03355248|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25235228|NCT02566252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24635917|NCT01141894|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24635919|NCT01141894|Mydriatics|mydriatics|mesh-ancestor
25048862|NCT00662506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25001096|NCT05461261|Antimitotic Agents|antimitotic agents|mesh-ancestor
25001097|NCT05461261|Mitosis Modulators|mitosis modulators|mesh-ancestor
25001829|NCT05021315|Povidone|povidone|mesh-list
25049363|NCT00612820|Xhance|xhance|mesh-list
24845407|NCT02237859|Vancomycin|vancomycin|mesh-list
25049479|NCT00602602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25003915|NCT02923128|Dexmedetomidine|dexmedetomidine|mesh-list
25004315|NCT02151981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24635974|NCT01142258|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24707635|NCT01497093|Thalidomide|thalidomide|mesh-list
24885263|NCT01164995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885264|NCT01164995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510407|NCT00564538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24524547|NCT04739592|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24497562|NCT00510445|Motesanib diphosphate|motesanib diphosphate|mesh-list
24497563|NCT00510445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497564|NCT00510445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497565|NCT00510445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24497566|NCT00510471|Immunoglobulins|immunoglobulins|mesh-list
24524583|NCT04688658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497839|NCT00512070|Protective Agents|protective agents|mesh-ancestor
24497842|NCT00512070|Antiemetics|antiemetics|mesh-ancestor
25873515|NCT05562297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25873519|NCT05562089|Paclitaxel|paclitaxel|mesh-list
24885374|NCT05173584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25873536|NCT05561972|Protective Agents|protective agents|mesh-ancestor
25873537|NCT05561959|Nitroglycerin|nitroglycerin|mesh-list
25673053|NCT01753115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25673054|NCT01753115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871148|NCT04698603|Serotonin Agents|serotonin agents|mesh-ancestor
24501047|NCT00526409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24774480|NCT01845701|Amodiaquine|amodiaquine|mesh-list
24982517|NCT02441686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982518|NCT02441686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24982519|NCT02441686|Glucocorticoids|glucocorticoids|mesh-ancestor
24982520|NCT02441686|Hormones|hormones|mesh-ancestor
24982956|NCT00092690|Atorvastatin|atorvastatin|mesh-list
25873552|NCT05561751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24507230|NCT00549289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795967|NCT01947062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984568|NCT04386616|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24984569|NCT04386616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24796441|NCT01950000|Fentanyl|fentanyl|mesh-list
24796442|NCT01950000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24986883|NCT05017545|Immunologic Factors|immunologic factors|mesh-ancestor
24513219|NCT00579995|Respiratory System Agents|respiratory system agents|mesh-ancestor
24513220|NCT00579995|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24457729|NCT00335088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24457730|NCT00335088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24457731|NCT00335088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24932385|NCT04080310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24622099|NCT01065649|Adrenergic Agents|adrenergic agents|mesh-ancestor
24622103|NCT01065662|Cediranib|cediranib|mesh-list
24987477|NCT01362374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987478|NCT01362374|Tubulin Modulators|tubulin modulators|mesh-ancestor
24987479|NCT01362374|Antimitotic Agents|antimitotic agents|mesh-ancestor
24987480|NCT01362374|Mitosis Modulators|mitosis modulators|mesh-ancestor
24987481|NCT01362374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987483|NCT01362374|Protective Agents|protective agents|mesh-ancestor
24987484|NCT01362374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987485|NCT01362374|Vitamin B Complex|vitamin b complex|mesh-ancestor
24987486|NCT01362374|Vitamins|vitamins|mesh-ancestor
25873588|NCT05561673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873589|NCT05561673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25873590|NCT05561660|Aspirin|aspirin|mesh-list
25005197|NCT04400838|Immunologic Factors|immunologic factors|mesh-ancestor
25005198|NCT04400838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396743|NCT00139841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396745|NCT00139854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24518587|NCT04786275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24518588|NCT04786275|Narcotics|narcotics|mesh-ancestor
24518589|NCT04786275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24518590|NCT04786275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518630|NCT04623944|Cyclophosphamide|cyclophosphamide|mesh-list
24518631|NCT04623944|Fludarabine|fludarabine|mesh-list
24518632|NCT04623944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24518633|NCT04623944|Immunologic Factors|immunologic factors|mesh-ancestor
24518634|NCT04623944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518635|NCT04623944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24518636|NCT04623944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24518637|NCT04623944|Alkylating Agents|alkylating agents|mesh-ancestor
24518638|NCT04623944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107408|NCT03140332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25107409|NCT03140332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107410|NCT03140332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107411|NCT03140397|8-prenylnaringenin|8-prenylnaringenin|mesh-list
25107412|NCT03140397|Phytoestrogens|phytoestrogens|mesh-ancestor
25107413|NCT03140397|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25235629|NCT02563288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25235630|NCT02563288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235631|NCT02563288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25235632|NCT02563288|Analgesics|analgesics|mesh-ancestor
25235633|NCT02563288|Sensory System Agents|sensory system agents|mesh-ancestor
24992646|NCT03255083|Osimertinib|osimertinib|mesh-list
24518663|NCT04562090|Mirabegron|mirabegron|mesh-list
24993067|NCT01358201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24993068|NCT01358201|Abortifacient Agents|abortifacient agents|mesh-ancestor
24993069|NCT01358201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24993070|NCT01358201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24994081|NCT04930744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24994699|NCT03347617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24994700|NCT03347617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994701|NCT03347617|Hematinics|hematinics|mesh-ancestor
24994704|NCT03315741|Pirfenidone|pirfenidone|mesh-list
24996015|NCT04421248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24996016|NCT04397354|Dexamethasone|dexamethasone|mesh-list
24996017|NCT04397354|Dexamethasone acetate|dexamethasone acetate|mesh-list
24996018|NCT04397354|BB 1101|bb 1101|mesh-list
24996019|NCT04397354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24996020|NCT04397354|Antiemetics|antiemetics|mesh-ancestor
24996021|NCT04397354|Autonomic Agents|autonomic agents|mesh-ancestor
24996091|NCT04306900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996092|NCT04306900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24996093|NCT04303403|Trametinib|trametinib|mesh-list
24996094|NCT04303403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996095|NCT04303403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24996099|NCT04249310|Olodaterol|olodaterol|mesh-list
24996766|NCT02038868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24996767|NCT02038868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235807|NCT02562287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25235808|NCT02562287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235809|NCT02562287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235810|NCT02562287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25235811|NCT02562287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24527467|NCT00616785|Irinotecan|irinotecan|mesh-list
24520250|NCT03425812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
24520251|NCT03425812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24520253|NCT03425812|Sensory System Agents|sensory system agents|mesh-ancestor
24520342|NCT02771249|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
24520343|NCT02771249|Antitubercular Agents|antitubercular agents|mesh-ancestor
24520344|NCT02771249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24527546|NCT00617253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527548|NCT00617370|Cyclophosphamide|cyclophosphamide|mesh-list
24520671|NCT05334316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24520672|NCT05334316|Antiemetics|antiemetics|mesh-ancestor
24520673|NCT05334316|Autonomic Agents|autonomic agents|mesh-ancestor
24520706|NCT05334043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24997173|NCT05344495|GABA Modulators|gaba modulators|mesh-ancestor
24997174|NCT05344495|GABA Agents|gaba agents|mesh-ancestor
24636582|NCT01146093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636583|NCT01146093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24962167|NCT03801746|Renal Agents|renal agents|mesh-ancestor
24953336|NCT03885947|Fludarabine|fludarabine|mesh-list
24953338|NCT03885947|Thiotepa|thiotepa|mesh-list
24521319|NCT04876937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24521320|NCT04876937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521321|NCT04876937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24521322|NCT04876937|Analgesics|analgesics|mesh-ancestor
24521323|NCT04876937|Sensory System Agents|sensory system agents|mesh-ancestor
24521324|NCT04876937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24521327|NCT04876937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24858893|NCT02300350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786191|NCT01918488|Natriuretic Agents|natriuretic agents|mesh-ancestor
24786192|NCT01918488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786193|NCT01918488|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24858962|NCT02300649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873647|NCT05561361|Diuretics|diuretics|mesh-ancestor
25873655|NCT05561309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25873656|NCT05561257|Ascorbic Acid|ascorbic acid|mesh-list
24598399|NCT00956059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25873657|NCT05561257|Vitamins|vitamins|mesh-ancestor
25873658|NCT05561257|Micronutrients|micronutrients|mesh-ancestor
24636673|NCT01146626|Antimetabolites|antimetabolites|mesh-ancestor
24485300|NCT00452556|Hormones|hormones|mesh-ancestor
24847983|NCT05298696|Vasodilator Agents|vasodilator agents|mesh-ancestor
24807613|NCT02022722|Sensory System Agents|sensory system agents|mesh-ancestor
24807614|NCT02022722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24807615|NCT02022722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24807616|NCT02022722|Glucocorticoids|glucocorticoids|mesh-ancestor
24807619|NCT02022722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25235938|NCT02561013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25235939|NCT02561013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25235940|NCT02561013|Coccidiostats|coccidiostats|mesh-ancestor
25235941|NCT02561013|Proton Ionophores|proton ionophores|mesh-ancestor
25236168|NCT02559141|Dobutamine|dobutamine|mesh-list
24848014|NCT05248633|Dexamethasone|dexamethasone|mesh-list
24838168|NCT02195661|Antioxidants|antioxidants|mesh-ancestor
24838169|NCT02195661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838170|NCT02195661|Protective Agents|protective agents|mesh-ancestor
24751203|NCT01702714|Gemcitabine|gemcitabine|mesh-list
25154785|NCT05469204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25154786|NCT05469204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25154787|NCT05469204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25154788|NCT05469204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522154|NCT04205136|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24522155|NCT04205136|Hormone Antagonists|hormone antagonists|mesh-ancestor
24522189|NCT04123262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522190|NCT04123262|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24522191|NCT04123262|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25235996|NCT02560649|Interferon-alpha|interferon-alpha|mesh-list
25235997|NCT02560649|Entecavir|entecavir|mesh-list
25235998|NCT02560649|Adefovir|adefovir|mesh-list
25235999|NCT02560649|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
24840766|NCT02212392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24840767|NCT02212431|Cysteamine|cysteamine|mesh-list
24840768|NCT02212431|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
24840769|NCT02212431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840770|NCT02212535|Plerixafor|plerixafor|mesh-list
24840983|NCT02213497|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24841065|NCT02213887|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24753554|NCT01715935|Everolimus|everolimus|mesh-list
24841099|NCT02213913|Mitosis Modulators|mitosis modulators|mesh-ancestor
25673228|NCT01754623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843136|NCT02225795|Cyclophosphamide|cyclophosphamide|mesh-list
24843137|NCT02225795|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24621366|NCT01061996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24621367|NCT01061996|Immunologic Factors|immunologic factors|mesh-ancestor
24621368|NCT01061996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621369|NCT01062048|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24621370|NCT01062048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25236056|NCT02559908|Hyaluronic Acid|hyaluronic acid|mesh-list
25236057|NCT02559908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25236058|NCT02559908|Immunologic Factors|immunologic factors|mesh-ancestor
24962595|NCT03797443|Ascorbic Acid|ascorbic acid|mesh-list
24962596|NCT03797443|Gemcitabine|gemcitabine|mesh-list
24580600|NCT00862420|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24522773|NCT03127592|Antidepressive Agents|antidepressive agents|mesh-ancestor
24522774|NCT03127592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24522925|NCT03044613|Tubulin Modulators|tubulin modulators|mesh-ancestor
24522926|NCT03044613|Antimitotic Agents|antimitotic agents|mesh-ancestor
24522927|NCT03044613|Mitosis Modulators|mitosis modulators|mesh-ancestor
25236065|NCT02559674|Gemcitabine|gemcitabine|mesh-list
25236066|NCT02559674|Paclitaxel|paclitaxel|mesh-list
25236067|NCT02559674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25236068|NCT02559674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236069|NCT02559674|Tubulin Modulators|tubulin modulators|mesh-ancestor
25236070|NCT02559674|Antimitotic Agents|antimitotic agents|mesh-ancestor
25236071|NCT02559674|Mitosis Modulators|mitosis modulators|mesh-ancestor
25236072|NCT02559674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236074|NCT02559674|Antimetabolites|antimetabolites|mesh-ancestor
24962824|NCT03794505|Anesthetics|anesthetics|mesh-ancestor
25078783|NCT03353857|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24523585|NCT05341817|Abortifacient Agents|abortifacient agents|mesh-ancestor
24523586|NCT05341817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25236108|NCT02559388|Respiratory System Agents|respiratory system agents|mesh-ancestor
25236109|NCT02559388|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25236110|NCT02559388|Hormone Antagonists|hormone antagonists|mesh-ancestor
25236111|NCT02559388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25236112|NCT02559388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236113|NCT02559388|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25236114|NCT02559388|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25236115|NCT02559388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236116|NCT02559297|Sevoflurane|sevoflurane|mesh-list
25236117|NCT02559297|Desflurane|desflurane|mesh-list
25236118|NCT02559297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25873671|NCT05561205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25873672|NCT05561205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673235|NCT01754909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25873673|NCT05561205|Dopamine Agents|dopamine agents|mesh-ancestor
24459536|NCT00344981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24459537|NCT00344981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25873674|NCT05561205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24861947|NCT02321384|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24861948|NCT02321397|Oxycodone|oxycodone|mesh-list
24861949|NCT02321397|Naloxone|naloxone|mesh-list
24861950|NCT02321397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24861951|NCT02321397|Narcotics|narcotics|mesh-ancestor
24861952|NCT02321397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24861953|NCT02321397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861954|NCT02321397|Analgesics|analgesics|mesh-ancestor
24861955|NCT02321397|Sensory System Agents|sensory system agents|mesh-ancestor
24875238|NCT04316702|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24523919|NCT05338502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24523920|NCT05338502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24523921|NCT05338502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24814494|NCT02064829|Paclitaxel|paclitaxel|mesh-list
24872747|NCT05232461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24872748|NCT05232461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24872749|NCT05232461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24872750|NCT05232461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872751|NCT05232461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24876155|NCT03719001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24876653|NCT03323658|Bexarotene|bexarotene|mesh-list
24876394|NCT03579446|Oxycodone|oxycodone|mesh-list
24876395|NCT03579446|Hydromorphone|hydromorphone|mesh-list
24876396|NCT03579446|Hydrocodone|hydrocodone|mesh-list
24876397|NCT03579446|Levorphanol|levorphanol|mesh-list
24876398|NCT03579446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24876467|NCT03512756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24876468|NCT03512756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25236275|NCT02558387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25236276|NCT02558387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25236277|NCT02558387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236278|NCT02558205|Liver Extracts|liver extracts|mesh-list
25236279|NCT02558205|Hematinics|hematinics|mesh-ancestor
25236280|NCT02558283|Lidocaine|lidocaine|mesh-list
25236281|NCT02558283|Anesthetics, Local|anesthetics, local|mesh-ancestor
24877295|NCT02856451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24877296|NCT02856451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24456959|NCT00332774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24878677|NCT01258933|Ofatumumab|ofatumumab|mesh-list
24700927|NCT01455909|Exenatide|exenatide|mesh-list
25673286|NCT01755234|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24623431|NCT01071369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24882385|NCT00950989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24816128|NCT02074267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24887371|NCT04517188|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24887372|NCT04517188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24887435|NCT04516603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24465668|NCT00370539|Triamcinolone|triamcinolone|mesh-list
24887464|NCT04516395|Antitubercular Agents|antitubercular agents|mesh-ancestor
24787916|NCT01928407|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24787918|NCT01928407|Protease Inhibitors|protease inhibitors|mesh-ancestor
24887557|NCT04515238|Alkylating Agents|alkylating agents|mesh-ancestor
24524576|NCT04688658|Nivolumab|nivolumab|mesh-list
24815599|NCT02071303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815600|NCT02071303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888417|NCT04505657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24848239|NCT04856007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154822|NCT05469165|Histamine Antagonists|histamine antagonists|mesh-ancestor
25044748|NCT01046422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25236407|NCT02557867|Adrenergic Agents|adrenergic agents|mesh-ancestor
25236408|NCT02557867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25236409|NCT02557867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236410|NCT02557737|Botulinum Toxins|botulinum toxins|mesh-list
24889616|NCT04491474|Lidocaine|lidocaine|mesh-list
24399113|NCT00146614|Sirolimus|sirolimus|mesh-list
24889617|NCT04491474|Anesthetics, Local|anesthetics, local|mesh-ancestor
24889740|NCT04490421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815666|NCT02071537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815668|NCT02071537|Antimetabolites|antimetabolites|mesh-ancestor
24891718|NCT04467892|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24963599|NCT03790085|Autonomic Agents|autonomic agents|mesh-ancestor
25236464|NCT02557594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236465|NCT02557594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24848274|NCT04704050|Dronedarone|dronedarone|mesh-list
24894149|NCT04443556|Sensory System Agents|sensory system agents|mesh-ancestor
24815745|NCT02071888|Dexamethasone|dexamethasone|mesh-list
24879106|NCT05054868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24879107|NCT05054868|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24879108|NCT05054868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24879109|NCT05054868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879110|NCT05039177|Cetuximab|cetuximab|mesh-list
25154823|NCT05469165|Histamine Agents|histamine agents|mesh-ancestor
25005233|NCT04368559|Antimalarials|antimalarials|mesh-ancestor
25005234|NCT04368559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25005235|NCT04368559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25005236|NCT04368559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25005241|NCT04364048|Cisplatin|cisplatin|mesh-list
24898856|NCT04410211|Midazolam|midazolam|mesh-list
24898857|NCT04410211|Sevoflurane|sevoflurane|mesh-list
24898858|NCT04410211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24879462|NCT04752813|Hemostatics|hemostatics|mesh-ancestor
25236510|NCT02557269|Glucocorticoids|glucocorticoids|mesh-ancestor
25236511|NCT02557269|Hormones|hormones|mesh-ancestor
25236512|NCT02557269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25236513|NCT02557269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236514|NCT02557269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25236516|NCT02557269|Autonomic Agents|autonomic agents|mesh-ancestor
24723596|NCT01588314|Antimanic Agents|antimanic agents|mesh-ancestor
24900652|NCT04392128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24900653|NCT04392128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24900654|NCT04392128|Antimalarials|antimalarials|mesh-ancestor
24900655|NCT04392128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24900656|NCT04392128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24900657|NCT04392128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900658|NCT04392128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044749|NCT01046422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044750|NCT01044381|Luliconazole|luliconazole|mesh-list
25154849|NCT05469022|Lazertinib|lazertinib|mesh-list
25873697|NCT05561049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873698|NCT05561049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25236627|NCT02556723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25236628|NCT02556723|Growth Substances|growth substances|mesh-ancestor
25236629|NCT02556723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236630|NCT02556723|Growth Inhibitors|growth inhibitors|mesh-ancestor
25236634|NCT02556658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236636|NCT02556814|Caffeic acid|caffeic acid|mesh-list
25236637|NCT02556814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25236638|NCT02556814|Antiemetics|antiemetics|mesh-ancestor
25236639|NCT02556814|Autonomic Agents|autonomic agents|mesh-ancestor
25236640|NCT02556814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076610|NCT03371849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236671|NCT02556411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25236672|NCT02556463|Durvalumab|durvalumab|mesh-list
25236673|NCT02556463|MEDI9197|medi9197|mesh-list
25236674|NCT02556463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25236675|NCT02556463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236676|NCT02556463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24957168|NCT03846765|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24957169|NCT03846765|Mydriatics|mydriatics|mesh-ancestor
24957170|NCT03846765|Autonomic Agents|autonomic agents|mesh-ancestor
24957171|NCT03846765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24525677|NCT02927938|Antimetabolites|antimetabolites|mesh-ancestor
24957635|NCT03843060|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25005321|NCT04196010|Lenograstim|lenograstim|mesh-list
24958106|NCT03836885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24526200|NCT00771654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24526201|NCT00771654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526202|NCT00765310|Thioctic Acid|thioctic acid|mesh-list
24526203|NCT00765310|Antioxidants|antioxidants|mesh-ancestor
24526204|NCT00765310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526205|NCT00765310|Protective Agents|protective agents|mesh-ancestor
24526206|NCT00765310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526207|NCT00765310|Vitamin B Complex|vitamin b complex|mesh-ancestor
24526208|NCT00765310|Vitamins|vitamins|mesh-ancestor
25078470|NCT03356054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25078471|NCT03356054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24394222|NCT00132561|Renal Agents|renal agents|mesh-ancestor
24526803|NCT00613392|Antioxidants|antioxidants|mesh-list
24526804|NCT00613392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526805|NCT00613392|Protective Agents|protective agents|mesh-ancestor
24526806|NCT00613392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236759|NCT02555813|Paclitaxel|paclitaxel|mesh-list
24959139|NCT03826875|Antidepressive Agents|antidepressive agents|mesh-ancestor
24959140|NCT03826875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24959141|NCT03826875|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24959142|NCT03826875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24959610|NCT03823950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527415|NCT00616538|Fluticasone|fluticasone|mesh-list
24960551|NCT03815942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24960552|NCT03815942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24961499|NCT03807999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24961500|NCT03807999|Immunologic Factors|immunologic factors|mesh-ancestor
24961501|NCT03807999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961556|NCT03806816|Antioxidants|antioxidants|mesh-ancestor
24961557|NCT03806816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961558|NCT03806816|Protective Agents|protective agents|mesh-ancestor
24528225|NCT00620438|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24528226|NCT00620438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24528227|NCT00620438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25236902|NCT02555150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236903|NCT02555150|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25236922|NCT02554955|Daclizumab|daclizumab|mesh-list
25273717|NCT02384187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848375|NCT04553003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848376|NCT04553003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24848377|NCT04553003|Nootropic Agents|nootropic agents|mesh-ancestor
24848378|NCT04541888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24848379|NCT04541888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24848380|NCT04509336|Orphenadrine|orphenadrine|mesh-list
24528387|NCT00620971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24528388|NCT00620971|Immunologic Factors|immunologic factors|mesh-ancestor
24528389|NCT00620971|Tubulin Modulators|tubulin modulators|mesh-ancestor
24528390|NCT00620971|Antimitotic Agents|antimitotic agents|mesh-ancestor
24528391|NCT00620971|Mitosis Modulators|mitosis modulators|mesh-ancestor
24528392|NCT00620971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24457860|NCT00335439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24528393|NCT00620997|Proxymetacaine|proxymetacaine|mesh-list
24528469|NCT00621361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236971|NCT02554357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25236972|NCT02554357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891902|NCT04466917|Paclitaxel|paclitaxel|mesh-list
24962932|NCT03794440|Sorafenib|sorafenib|mesh-list
25078818|NCT03353480|Azithromycin|azithromycin|mesh-list
25078819|NCT03353480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25078820|NCT03353480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25078821|NCT03353441|Glycine|glycine|mesh-list
25078822|NCT03353441|Glycine Agents|glycine agents|mesh-ancestor
25078823|NCT03353441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25078824|NCT03353441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078825|NCT03353441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078826|NCT03353363|Bupivacaine|bupivacaine|mesh-list
24963557|NCT03790020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24963558|NCT03790020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963559|NCT03790020|Sensory System Agents|sensory system agents|mesh-ancestor
24446810|NCT00306046|Diphosphonates|diphosphonates|mesh-list
24963653|NCT03789695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963690|NCT03789123|Dienogest|dienogest|mesh-list
25237053|NCT02553083|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25237054|NCT02553083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25237055|NCT02553083|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25237056|NCT02553083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237057|NCT02553083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237058|NCT02553018|Methotrexate|methotrexate|mesh-list
25237059|NCT02553018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25237060|NCT02553018|Abortifacient Agents|abortifacient agents|mesh-ancestor
24886260|NCT02090998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25237093|NCT02553044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25237094|NCT02552654|Hydrocortisone|hydrocortisone|mesh-list
25237095|NCT02552654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25237109|NCT02552459|Sufentanil|sufentanil|mesh-list
25237110|NCT02552459|Dexmedetomidine|dexmedetomidine|mesh-list
25237111|NCT02552459|Dsuvia|dsuvia|mesh-list
25237112|NCT02552459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25237113|NCT02552459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25237114|NCT02552459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237115|NCT02552459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24848494|NCT04042155|Apixaban|apixaban|mesh-list
24848495|NCT04042155|Edoxaban|edoxaban|mesh-list
24848496|NCT04042155|Dabigatran|dabigatran|mesh-list
24848497|NCT04042155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24848498|NCT04042155|Antithrombins|antithrombins|mesh-ancestor
24848499|NCT04042155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24848500|NCT04042155|Protease Inhibitors|protease inhibitors|mesh-ancestor
24848501|NCT04042155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859048|NCT02301481|Oxaliplatin|oxaliplatin|mesh-list
25237116|NCT02552459|Analgesics|analgesics|mesh-ancestor
25237117|NCT02552459|Sensory System Agents|sensory system agents|mesh-ancestor
24964232|NCT03784443|Glucocorticoids|glucocorticoids|mesh-ancestor
24964233|NCT03784443|Hormones|hormones|mesh-ancestor
25237142|NCT02552342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237143|NCT02552342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25237144|NCT02552342|Glucocorticoids|glucocorticoids|mesh-ancestor
25237145|NCT02552342|Hormones|hormones|mesh-ancestor
25237146|NCT02552342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25237147|NCT02552342|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25237148|NCT02552342|Protective Agents|protective agents|mesh-ancestor
25237149|NCT02552342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25237150|NCT02552342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25237151|NCT02552537|Mannitol|mannitol|mesh-list
25237152|NCT02552537|Omeprazole|omeprazole|mesh-list
25237153|NCT02552537|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25873824|NCT05554393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24848504|NCT04014387|Zolpidem|zolpidem|mesh-list
25273750|NCT02383121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24511876|NCT00571298|Antidotes|antidotes|mesh-ancestor
24511976|NCT00571870|Cetrorelix|cetrorelix|mesh-list
25237193|NCT02551523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237194|NCT02551523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25873901|NCT05544110|Antidepressive Agents|antidepressive agents|mesh-ancestor
25873902|NCT05544110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25873905|NCT05544110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237216|NCT02551796|Ofloxacin|ofloxacin|mesh-list
24965599|NCT03775655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24965600|NCT03775655|Analgesics|analgesics|mesh-ancestor
24529479|NCT00626223|Folic Acid|folic acid|mesh-list
24965997|NCT03772223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24965998|NCT03772223|Adrenergic Agents|adrenergic agents|mesh-ancestor
24966001|NCT03772106|Propofol|propofol|mesh-list
24529823|NCT00627952|Amlodipine|amlodipine|mesh-list
24530127|NCT00629200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530128|NCT00629200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24761243|NCT01761916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005493|NCT03947216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25005494|NCT03947216|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25673468|NCT01759407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25673469|NCT01759407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531546|NCT00636311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079931|NCT03343873|Midazolam|midazolam|mesh-list
25873961|NCT05533164|Rituximab|rituximab|mesh-list
25873996|NCT05516628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25237298|NCT02550977|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25874009|NCT05497336|Cetuximab|cetuximab|mesh-list
24512525|NCT00575523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24816617|NCT02077946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763477|NCT01773876|Micafungin|micafungin|mesh-list
25874088|NCT05413161|Omalizumab|omalizumab|mesh-list
24765216|NCT01786655|Neosaxitoxin|neosaxitoxin|mesh-list
24765387|NCT01788280|Bevacizumab|bevacizumab|mesh-list
25237394|NCT02550717|Analgesics|analgesics|mesh-ancestor
24404379|NCT00163306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404381|NCT00163319|Ciclesonide|ciclesonide|mesh-list
24704505|NCT01478568|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24704506|NCT01478568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24704507|NCT01478568|Adrenergic Agents|adrenergic agents|mesh-ancestor
24704508|NCT01478568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24627378|NCT01092481|Oxaliplatin|oxaliplatin|mesh-list
24704509|NCT01478568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704510|NCT01478568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704511|NCT01478568|Urological Agents|urological agents|mesh-ancestor
24705197|NCT01482754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24705198|NCT01482897|Prednisolone|prednisolone|mesh-list
24705199|NCT01482897|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24705200|NCT01482897|Methylprednisolone|methylprednisolone|mesh-list
24705201|NCT01482897|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24705202|NCT01482897|Prednisolone acetate|prednisolone acetate|mesh-list
24705203|NCT01482897|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24705204|NCT01482897|Prednisolone phosphate|prednisolone phosphate|mesh-list
24705205|NCT01482897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24705206|NCT01482897|Glucocorticoids|glucocorticoids|mesh-ancestor
24705207|NCT01482897|Hormones|hormones|mesh-ancestor
24705208|NCT01482897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24705209|NCT01482897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705210|NCT01482897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24705211|NCT01482897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705212|NCT01482897|Antiemetics|antiemetics|mesh-ancestor
24705213|NCT01482897|Autonomic Agents|autonomic agents|mesh-ancestor
24705214|NCT01482897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25237510|NCT02550249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237511|NCT02550028|Levetiracetam|levetiracetam|mesh-list
25237512|NCT02550028|Phenobarbital|phenobarbital|mesh-list
25237513|NCT02550028|Anticonvulsants|anticonvulsants|mesh-ancestor
25237514|NCT02550028|Nootropic Agents|nootropic agents|mesh-ancestor
25237515|NCT02550028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25237516|NCT02550028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25237523|NCT02550028|GABA Agents|gaba agents|mesh-ancestor
24705891|NCT01487369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705892|NCT01487382|Insulin Aspart|insulin aspart|mesh-list
24705893|NCT01487382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24705894|NCT01487382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705895|NCT01487395|Donepezil|donepezil|mesh-list
25237561|NCT02549742|Bleomycin|bleomycin|mesh-list
24707291|NCT01495117|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24707292|NCT01495117|Povidone-Iodine|povidone-iodine|mesh-list
24707451|NCT01495910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24707452|NCT01495910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707453|NCT01495910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24707454|NCT01495949|Thiopental|thiopental|mesh-list
24707455|NCT01495949|Etomidate|etomidate|mesh-list
25874181|NCT05364944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24707489|NCT01496105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404710|NCT00164710|Chlorproguanil|chlorproguanil|mesh-list
24404711|NCT00164710|Antimalarials|antimalarials|mesh-ancestor
24404712|NCT00164710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24888469|NCT04504851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24767248|NCT01799460|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24767249|NCT01799460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767263|NCT01799603|Simeprevir|simeprevir|mesh-list
25874194|NCT05361824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25874195|NCT05361824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874197|NCT05357989|Phenserine|phenserine|mesh-list
24848880|NCT03319745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24848881|NCT03319745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24848882|NCT03298893|Nivolumab|nivolumab|mesh-list
24848914|NCT03283488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24848915|NCT03283488|Serotonin Agents|serotonin agents|mesh-ancestor
25237671|NCT02549391|Cinacalcet|cinacalcet|mesh-list
24888865|NCT04499898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888866|NCT04499898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25155001|NCT05468242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25155002|NCT05468242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25155003|NCT05468242|Growth Substances|growth substances|mesh-ancestor
25155004|NCT05468242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237806|NCT02548741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237807|NCT02548741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25237808|NCT02548780|Doxorubicin|doxorubicin|mesh-list
25237809|NCT02548780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25237810|NCT02548780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25237811|NCT02548780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25237812|NCT02548780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25237813|NCT02548780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237814|NCT02548780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768070|NCT01805570|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24768071|NCT01805570|Purinergic Agents|purinergic agents|mesh-ancestor
24768072|NCT01805570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24768243|NCT01806753|GABA Agents|gaba agents|mesh-ancestor
24768244|NCT01806753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24512912|NCT00577421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25237878|NCT02548533|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25273786|NCT02383030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25273787|NCT02383030|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24622461|NCT01067118|Insulin|insulin|mesh-list
25273788|NCT02383030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25273789|NCT02383030|Hormone Antagonists|hormone antagonists|mesh-ancestor
24768390|NCT01807741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24768446|NCT01808300|Sensory System Agents|sensory system agents|mesh-ancestor
24768447|NCT01808300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24768448|NCT01808300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768449|NCT01808300|Anticonvulsants|anticonvulsants|mesh-ancestor
24768450|NCT01808300|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25237900|NCT02548117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237901|NCT02548117|Hormone Antagonists|hormone antagonists|mesh-ancestor
25237902|NCT02548117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25237903|NCT02548117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237904|NCT02548117|Urological Agents|urological agents|mesh-ancestor
25237905|NCT02548195|Gemcitabine|gemcitabine|mesh-list
25237906|NCT02548195|Capecitabine|capecitabine|mesh-list
25237907|NCT02548195|Oxaliplatin|oxaliplatin|mesh-list
25237908|NCT02548195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25237909|NCT02548195|Antimetabolites|antimetabolites|mesh-ancestor
25237910|NCT02548195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237911|NCT02548195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25237912|NCT02548195|Antiviral Agents|antiviral agents|mesh-ancestor
25237913|NCT02548195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25237914|NCT02548195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237915|NCT02548195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25237916|NCT02548195|Immunologic Factors|immunologic factors|mesh-ancestor
25237917|NCT02548195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237919|NCT02548286|Candesartan|candesartan|mesh-list
25874210|NCT05350774|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25874211|NCT05350774|Antibodies|antibodies|mesh-list
24768725|NCT01810393|Trastuzumab|trastuzumab|mesh-list
24768807|NCT01810601|Progesterone|progesterone|mesh-list
24768808|NCT01810601|Progestins|progestins|mesh-ancestor
24768809|NCT01810601|Hormones|hormones|mesh-ancestor
24906141|NCT04342065|Anticonvulsants|anticonvulsants|mesh-ancestor
25237988|NCT02547896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25237989|NCT02547896|Narcotics|narcotics|mesh-ancestor
25237991|NCT02547896|Antitussive Agents|antitussive agents|mesh-ancestor
24769079|NCT01812369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24769080|NCT01812369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24769081|NCT01812369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24769082|NCT01812369|Tubulin Modulators|tubulin modulators|mesh-ancestor
24769083|NCT01812369|Antimitotic Agents|antimitotic agents|mesh-ancestor
25238017|NCT02547350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25238018|NCT02547350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25238019|NCT02547350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238020|NCT02547350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238022|NCT02547402|Simvastatin|simvastatin|mesh-list
25238023|NCT02547402|Ezetimibe|ezetimibe|mesh-list
24769176|NCT01812954|Antifungal Agents|antifungal agents|mesh-ancestor
24769177|NCT01812954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24769178|NCT01812954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24782219|NCT01894867|Antacids|antacids|mesh-ancestor
25155052|NCT05468047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25155068|NCT05467878|Anesthetics|anesthetics|mesh-list
25155069|NCT05467878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25155070|NCT05467878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769326|NCT01813656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708804|NCT01502943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620502|NCT01057329|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24708937|NCT01503437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24708938|NCT01503437|Serotonin Agents|serotonin agents|mesh-ancestor
24708939|NCT01503450|Olanzapine|olanzapine|mesh-list
24708968|NCT01503580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708970|NCT01503593|Calcium|calcium|mesh-list
25238144|NCT02546440|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25238149|NCT02546401|Insulin Aspart|insulin aspart|mesh-list
24709058|NCT01503905|Mitosis Modulators|mitosis modulators|mesh-ancestor
24709059|NCT01503905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24709060|NCT01503905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24709061|NCT01503905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24709062|NCT01503905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24709063|NCT01503905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709064|NCT01503905|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24709065|NCT01503905|Hormone Antagonists|hormone antagonists|mesh-ancestor
24709066|NCT01503905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24709093|NCT01504074|Glucocorticoids|glucocorticoids|mesh-ancestor
25874232|NCT05323435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769748|NCT01815658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25874244|NCT05319587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25874245|NCT05308446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25874246|NCT05308446|Nivolumab|nivolumab|mesh-list
25874247|NCT05308446|Cetuximab|cetuximab|mesh-list
25874248|NCT05308446|Antibodies|antibodies|mesh-list
25874249|NCT05308446|Immunoglobulins|immunoglobulins|mesh-list
25874250|NCT05308446|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25874251|NCT05308446|Immunologic Factors|immunologic factors|mesh-ancestor
25874252|NCT05308446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874253|NCT05308446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874254|NCT05308446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25874255|NCT05308446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874256|NCT05305885|Pemetrexed|pemetrexed|mesh-list
25874257|NCT05305885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24709106|NCT01504126|Propranolol|propranolol|mesh-list
24709148|NCT01504256|Docetaxel|docetaxel|mesh-list
24709149|NCT01504256|Fluorouracil|fluorouracil|mesh-list
24709192|NCT01504347|Vaccines|vaccines|mesh-list
24709475|NCT01505946|Hemostatics|hemostatics|mesh-ancestor
24890900|NCT04478474|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
24890901|NCT04478474|Antiviral Agents|antiviral agents|mesh-ancestor
25874259|NCT05305885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874260|NCT05305885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25874261|NCT05305885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25874262|NCT05303532|Durvalumab|durvalumab|mesh-list
25874263|NCT05303532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25238326|NCT02545452|Contraceptive Agents|contraceptive agents|mesh-ancestor
25238327|NCT02545452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25238328|NCT02545452|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24469039|NCT00384410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25238329|NCT02545452|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25238330|NCT02545452|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25238331|NCT02545452|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
25238332|NCT02545452|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
25874265|NCT05303064|Olanzapine|olanzapine|mesh-list
24709662|NCT01506622|Anesthetics, General|anesthetics, general|mesh-ancestor
24709663|NCT01506622|Anesthetics|anesthetics|mesh-ancestor
24449985|NCT00317538|Etanercept|etanercept|mesh-list
24709690|NCT01506739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709691|NCT01506739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709692|NCT01506739|Cholinergic Agents|cholinergic agents|mesh-ancestor
24709693|NCT01506739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24709694|NCT01506739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709695|NCT01506739|Nootropic Agents|nootropic agents|mesh-ancestor
24709697|NCT01506752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24709698|NCT01506752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709699|NCT01506752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709829|NCT01507285|Hormones|hormones|mesh-ancestor
24709830|NCT01507285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24709832|NCT01507311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24709833|NCT01507311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709834|NCT01507311|Incretins|incretins|mesh-ancestor
24709835|NCT01507311|Hormones|hormones|mesh-ancestor
24709836|NCT01507311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24709870|NCT01507428|Carboplatin|carboplatin|mesh-list
24709871|NCT01507428|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24816891|NCT02079506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25080899|NCT03335059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24710078|NCT01508260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710079|NCT01508260|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24770848|NCT01822730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25238425|NCT02544776|Zuclomiphene|zuclomiphene|mesh-list
25238426|NCT02544776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238427|NCT02544776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24771069|NCT01824433|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24771070|NCT01824433|Antidepressive Agents|antidepressive agents|mesh-ancestor
24771071|NCT01824433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24771072|NCT01824433|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25238475|NCT02544529|Cholinergic Agents|cholinergic agents|mesh-ancestor
25238476|NCT02544529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24771138|NCT01825031|Isoniazid|isoniazid|mesh-list
24771140|NCT01825031|Fluconazole|fluconazole|mesh-list
24771141|NCT01825031|Albendazole|albendazole|mesh-list
24771142|NCT01825031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25238517|NCT02544282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25238518|NCT02544282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25238519|NCT02544282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238520|NCT02544282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24849391|NCT02248571|Everolimus|everolimus|mesh-list
24849392|NCT02248571|Exemestane|exemestane|mesh-list
24849393|NCT02248571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24710202|NCT01508884|Immunologic Factors|immunologic factors|mesh-ancestor
24710203|NCT01508884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710204|NCT01508884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24710215|NCT01508923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788715|NCT01933022|Fertility Agents|fertility agents|mesh-ancestor
24788716|NCT01933022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24788717|NCT01933022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005774|NCT02586675|Goserelin|goserelin|mesh-list
25005775|NCT02586675|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25005776|NCT02586675|Hormone Antagonists|hormone antagonists|mesh-ancestor
25005778|NCT02586675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710266|NCT01509300|Mycophenolic Acid|mycophenolic acid|mesh-list
24891607|NCT04469114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24620628|NCT01057966|Vitamins|vitamins|mesh-list
24710767|NCT01511757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24710768|NCT01511757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238633|NCT05226013|Rasburicase|rasburicase|mesh-list
25238634|NCT05226013|Gout Suppressants|gout suppressants|mesh-ancestor
25238635|NCT05226013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25238636|NCT05225974|Liraglutide|liraglutide|mesh-list
25238637|NCT05225974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25238639|NCT05225974|Incretins|incretins|mesh-ancestor
24772788|NCT01835691|Vitamins|vitamins|mesh-list
24772789|NCT01835691|Micronutrients|micronutrients|mesh-ancestor
24620690|NCT01058291|Autonomic Agents|autonomic agents|mesh-ancestor
24816927|NCT02079974|Antimetabolites|antimetabolites|mesh-ancestor
24816929|NCT02079974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24614321|NCT01023464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24711048|NCT01513070|Analgesics|analgesics|mesh-ancestor
24711049|NCT01513070|Sensory System Agents|sensory system agents|mesh-ancestor
25238669|NCT05225753|Sensory System Agents|sensory system agents|mesh-ancestor
25238670|NCT05225753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25238671|NCT05225753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238672|NCT05225753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25238673|NCT05225753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25238688|NCT05162131|Ticagrelor|ticagrelor|mesh-list
25238689|NCT05162131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25238690|NCT05162131|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25238691|NCT05162131|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25238692|NCT05162131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25238693|NCT05162131|Purinergic Agents|purinergic agents|mesh-ancestor
24892156|NCT04465175|Magnesium Sulfate|magnesium sulfate|mesh-list
24407089|NCT00171821|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24892157|NCT04465175|Analgesics|analgesics|mesh-ancestor
24892158|NCT04465175|Sensory System Agents|sensory system agents|mesh-ancestor
24892159|NCT04465175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24892160|NCT04465175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892161|NCT04465175|Anesthetics|anesthetics|mesh-ancestor
24892262|NCT04464629|Antiemetics|antiemetics|mesh-ancestor
24892263|NCT04464629|Autonomic Agents|autonomic agents|mesh-ancestor
24892264|NCT04464629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24711095|NCT01513525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711096|NCT01513525|Incretins|incretins|mesh-ancestor
24788799|NCT01933906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24788801|NCT01933906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788802|NCT01933945|Sorafenib|sorafenib|mesh-list
24788803|NCT01933945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24788804|NCT01933945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24849566|NCT02249039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24849567|NCT02249039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849594|NCT02249234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24628584|NCT01100060|Chloroquine|chloroquine|mesh-list
24628585|NCT01100060|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24628586|NCT01100060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24628587|NCT01100060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25273834|NCT02382263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25273835|NCT02382263|Immunologic Factors|immunologic factors|mesh-ancestor
25273836|NCT02382263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273837|NCT02382354|Remifentanil|remifentanil|mesh-list
25273838|NCT02382354|Propofol|propofol|mesh-list
24711229|NCT01514123|Growth Inhibitors|growth inhibitors|mesh-ancestor
24711233|NCT01514175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24892299|NCT04464642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24775188|NCT01850940|Tolvaptan|tolvaptan|mesh-list
24711509|NCT01515813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892448|NCT04462588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24712355|NCT01520103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620810|NCT01059136|Spironolactone|spironolactone|mesh-list
25066843|NCT03450161|Anesthetics|anesthetics|mesh-ancestor
25874394|NCT05285813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25874395|NCT05285813|Antipruritics|antipruritics|mesh-ancestor
25874396|NCT05285813|Dermatologic Agents|dermatologic agents|mesh-ancestor
25874397|NCT05284552|Tinzaparin|tinzaparin|mesh-list
25239006|NCT04390581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25239021|NCT04366115|Dexamethasone|dexamethasone|mesh-list
24712491|NCT01520831|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24777252|NCT01863199|Ranibizumab|ranibizumab|mesh-list
24712854|NCT01523015|Antimitotic Agents|antimitotic agents|mesh-ancestor
24712862|NCT01523041|Insulin|insulin|mesh-list
24777421|NCT01863888|Sensory System Agents|sensory system agents|mesh-ancestor
24777422|NCT01863888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24408339|NCT00177411|Hormones|hormones|mesh-list
24893565|NCT04448015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24893573|NCT04448028|Esomeprazole|esomeprazole|mesh-list
24893939|NCT04446130|Decitabine|decitabine|mesh-list
24713584|NCT01526564|Vitamin B Complex|vitamin b complex|mesh-ancestor
25005936|NCT01178814|Growth Inhibitors|growth inhibitors|mesh-ancestor
25239082|NCT04115774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239083|NCT04034004|Naloxone|naloxone|mesh-list
25239084|NCT04034004|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24490422|NCT00478075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24849701|NCT02249702|Antimitotic Agents|antimitotic agents|mesh-ancestor
24849702|NCT02249702|Mitosis Modulators|mitosis modulators|mesh-ancestor
24849703|NCT02249702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24714683|NCT01531829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24714684|NCT01531829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714685|NCT01531842|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24714686|NCT01531842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714688|NCT01531855|Insulin Lispro|insulin lispro|mesh-list
25239106|NCT04012138|Tocolytic Agents|tocolytic agents|mesh-ancestor
24490464|NCT00478504|Letrozole|letrozole|mesh-list
24829373|NCT02151916|Fluorides|fluorides|mesh-list
24714724|NCT01532232|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24714725|NCT01532232|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24714726|NCT01532232|Cholinergic Agents|cholinergic agents|mesh-ancestor
24714727|NCT01532232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24714728|NCT01532232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714729|NCT01532232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501156|NCT00527059|Diuretics|diuretics|mesh-ancestor
24714771|NCT01532804|Growth Substances|growth substances|mesh-ancestor
24715231|NCT01535170|Lactoferrin|lactoferrin|mesh-list
24786270|NCT01918878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24786271|NCT01918904|Sodium thiosulfate|sodium thiosulfate|mesh-list
24786404|NCT01919879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24786406|NCT01919879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24786407|NCT01919879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24786408|NCT01919879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786442|NCT01920022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24786443|NCT01920022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24786444|NCT01920022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24786445|NCT01920022|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24787466|NCT01925352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789094|NCT01935531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24789124|NCT01935596|Anesthetics, Local|anesthetics, local|mesh-ancestor
24789125|NCT01935596|Anesthetics|anesthetics|mesh-ancestor
24789126|NCT01935596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24789127|NCT01935596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716826|NCT01544140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24789526|NCT01937728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24789527|NCT01937728|Antimetabolites|antimetabolites|mesh-ancestor
24789528|NCT01937728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789529|NCT01937728|Immunologic Factors|immunologic factors|mesh-ancestor
24621636|NCT01063218|Emollients|emollients|mesh-list
24550504|NCT00720824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
24550505|NCT00720824|Anesthetics, Local|anesthetics, local|mesh-list
24550506|NCT00720824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24550507|NCT00720824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550508|NCT00720824|Sensory System Agents|sensory system agents|mesh-ancestor
24550509|NCT00720824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24717388|NCT01547416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24717389|NCT01547416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24717390|NCT01547416|Anesthetics, General|anesthetics, general|mesh-ancestor
24717391|NCT01547455|Atorvastatin|atorvastatin|mesh-list
24788116|NCT01929577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25874494|NCT05201248|Immunologic Factors|immunologic factors|mesh-ancestor
24514742|NCT00592618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24895316|NCT04552782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24790512|NCT01943240|Ropivacaine|ropivacaine|mesh-list
24790682|NCT01944215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717587|NCT01548807|Immunologic Factors|immunologic factors|mesh-ancestor
24717615|NCT01548924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24717616|NCT01548924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24717617|NCT01548924|Tubulin Modulators|tubulin modulators|mesh-ancestor
24717618|NCT01548924|Antimitotic Agents|antimitotic agents|mesh-ancestor
24717619|NCT01548924|Mitosis Modulators|mitosis modulators|mesh-ancestor
24717620|NCT01548924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717621|NCT01548950|Bosentan|bosentan|mesh-list
25239368|NCT02542111|Bortezomib|bortezomib|mesh-list
24967585|NCT03758469|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24615147|NCT01028092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24615149|NCT01028170|Diuretics|diuretics|mesh-ancestor
24615150|NCT01028170|Natriuretic Agents|natriuretic agents|mesh-ancestor
24967985|NCT03755479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24967986|NCT03755479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967987|NCT03755466|Tofacitinib|tofacitinib|mesh-list
25006176|NCT05204524|Alkylating Agents|alkylating agents|mesh-ancestor
24758795|NCT01747746|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24587569|NCT00895687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24587570|NCT00895687|Bortezomib|bortezomib|mesh-list
24732104|NCT01637766|Melphalan|melphalan|mesh-list
24971048|NCT03728946|Bupivacaine|bupivacaine|mesh-list
24971049|NCT03728946|Anesthetics, Local|anesthetics, local|mesh-ancestor
24621662|NCT01063426|Enoxaparin|enoxaparin|mesh-list
24971093|NCT03728777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971094|NCT03728777|Protective Agents|protective agents|mesh-ancestor
24971095|NCT03728777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971096|NCT03728777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24971097|NCT03728777|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24971503|NCT03725709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25874548|NCT05161468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25874549|NCT05161468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25874550|NCT05161468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24972861|NCT03714594|Dapagliflozin|dapagliflozin|mesh-list
24972862|NCT03714594|Saxagliptin|saxagliptin|mesh-list
24794588|NCT04910386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794589|NCT04910386|Antiviral Agents|antiviral agents|mesh-ancestor
24794590|NCT04910386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24794591|NCT04910386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973383|NCT03709927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24973384|NCT03709927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24973385|NCT03709927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25006253|NCT05203588|Vitamin D|vitamin d|mesh-list
24974234|NCT05051436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974235|NCT05051436|Urological Agents|urological agents|mesh-ancestor
24974236|NCT05051436|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24974237|NCT05051436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24974375|NCT04763928|Decitabine|decitabine|mesh-list
24974376|NCT04763928|Venetoclax|venetoclax|mesh-list
24790557|NCT01943526|Natalizumab|natalizumab|mesh-list
24933001|NCT04075201|Vaccines|vaccines|mesh-list
24974570|NCT04394481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25083833|NCT03312244|Bromides|bromides|mesh-list
24720773|NCT01570582|Tubulin Modulators|tubulin modulators|mesh-ancestor
24759723|NCT01754181|Insulin|insulin|mesh-list
24920420|NCT04202887|Fentanyl|fentanyl|mesh-list
24621594|NCT01063179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109759|NCT03122002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25109760|NCT03122002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24721117|NCT01572285|BB 1101|bb 1101|mesh-list
24721270|NCT01572857|Antibodies|antibodies|mesh-list
25085930|NCT03294161|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25874615|NCT05123599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874616|NCT05123599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673840|NCT01765582|Levoleucovorin|levoleucovorin|mesh-list
25874617|NCT05123599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25874618|NCT05123599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25673841|NCT01765582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25085931|NCT03294161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25874619|NCT05120349|Osimertinib|osimertinib|mesh-list
25874620|NCT05120349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006310|NCT05172050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25006312|NCT05167370|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25006313|NCT05167370|Protective Agents|protective agents|mesh-ancestor
25086564|NCT03288428|Analgesics|analgesics|mesh-ancestor
25273879|NCT02382432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25273881|NCT02382432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25087095|NCT03282838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087096|NCT03282825|Paclitaxel|paclitaxel|mesh-list
25087097|NCT03282825|Decitabine|decitabine|mesh-list
25087098|NCT03282825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25087151|NCT03282110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25087152|NCT03282006|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
25087153|NCT03282006|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25087154|NCT03282006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25087156|NCT03282006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25087159|NCT03281941|Capsaicin|capsaicin|mesh-list
25087489|NCT03279133|Antiviral Agents|antiviral agents|mesh-ancestor
25087490|NCT03279133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25087492|NCT03279120|Levonorgestrel|levonorgestrel|mesh-list
25874650|NCT05076617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25673862|NCT01765764|Bimatoprost|bimatoprost|mesh-list
24760125|NCT01756443|Sensory System Agents|sensory system agents|mesh-ancestor
24721664|NCT01576185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721666|NCT01576263|Anesthetics, Local|anesthetics, local|mesh-ancestor
24721667|NCT01576263|Anesthetics|anesthetics|mesh-ancestor
24721668|NCT01576263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24721701|NCT01576419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721703|NCT01576458|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24721705|NCT01576627|Zinc|zinc|mesh-list
24615535|NCT01030094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24615536|NCT01030094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24615537|NCT01030120|Etanercept|etanercept|mesh-list
24615538|NCT01030120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24721804|NCT01577121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24721839|NCT01577368|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24721841|NCT01577368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721842|NCT01577407|Nefopam|nefopam|mesh-list
24646964|NCT01205880|Vitamins|vitamins|mesh-ancestor
24721912|NCT01577914|Vasodilator Agents|vasodilator agents|mesh-ancestor
25239843|NCT02539316|SMOFlipid|smoflipid|mesh-list
25093677|NCT03232710|Aripiprazole|aripiprazole|mesh-list
25006438|NCT05079841|Oxytocin|oxytocin|mesh-list
25673934|NCT01766219|Thioctic Acid|thioctic acid|mesh-list
24789575|NCT01937806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25095444|NCT03219008|Histamine Agents|histamine agents|mesh-ancestor
24726254|NCT01602588|Hydroxychloroquine|hydroxychloroquine|mesh-list
25097593|NCT03202875|Insulin|insulin|mesh-list
25240337|NCT02536742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25098485|NCT03197740|Donepezil|donepezil|mesh-list
25240396|NCT02536014|Dexmedetomidine|dexmedetomidine|mesh-list
25006564|NCT04892420|Analgesics|analgesics|mesh-ancestor
24727881|NCT01613105|Acarbose|acarbose|mesh-list
24728747|NCT01617928|Veliparib|veliparib|mesh-list
24729180|NCT01620320|Dobutamine|dobutamine|mesh-list
24621677|NCT01063439|Melphalan|melphalan|mesh-list
25101552|NCT03174041|Simvastatin|simvastatin|mesh-list
25101845|NCT03171974|Hormones|hormones|mesh-ancestor
24395683|NCT00136565|Hormones|hormones|mesh-ancestor
25006711|NCT04688177|Nicotine|nicotine|mesh-list
24900297|NCT04395612|Niraparib|niraparib|mesh-list
25875121|NCT04734730|Prednisone|prednisone|mesh-list
25102618|NCT03167216|Cetirizine|cetirizine|mesh-list
25241774|NCT05299580|Trametinib|trametinib|mesh-list
24395611|NCT00136487|Celecoxib|celecoxib|mesh-list
25081344|NCT03330990|Anesthetics|anesthetics|mesh-ancestor
24735782|NCT01658553|Trametinib|trametinib|mesh-list
25242050|NCT05022654|Irinotecan|irinotecan|mesh-list
25240877|NCT04576546|Vitamins|vitamins|mesh-ancestor
25240890|NCT04530058|Metformin|metformin|mesh-list
24401352|NCT00152750|Clonidine|clonidine|mesh-list
24742871|NCT05146778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24742999|NCT05083572|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24743000|NCT05083572|Rifaximin|rifaximin|mesh-list
24743001|NCT05083572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24743002|NCT05083572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24407609|NCT00174811|Telithromycin|telithromycin|mesh-list
24618395|NCT01048138|Cholinergic Agents|cholinergic agents|mesh-ancestor
24427107|NCT00237445|Azithromycin|azithromycin|mesh-list
24438712|NCT00276692|Irinotecan|irinotecan|mesh-list
24439365|NCT00278408|Cyclophosphamide|cyclophosphamide|mesh-list
25242523|NCT04377503|Prednisolone|prednisolone|mesh-list
25241364|NCT02866747|Durvalumab|durvalumab|mesh-list
25241365|NCT02866747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25241366|NCT02866747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25241367|NCT02864407|Tiotropium Bromide|tiotropium bromide|mesh-list
25241368|NCT02864407|Olodaterol|olodaterol|mesh-list
24756099|NCT01731184|Midazolam|midazolam|mesh-list
24756100|NCT01731184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24756101|NCT01731184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24756102|NCT01731184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24756103|NCT01731184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420846|NCT00216892|Hormones|hormones|mesh-ancestor
24851345|NCT02256722|Bisoprolol|bisoprolol|mesh-list
25007674|NCT03011307|Oxytocin|oxytocin|mesh-list
25876917|NCT02194738|Nivolumab|nivolumab|mesh-list
25876936|NCT02194738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25876981|NCT02005471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876982|NCT01990911|Diuretics|diuretics|mesh-list
25876983|NCT01990911|Natriuretic Agents|natriuretic agents|mesh-ancestor
25268823|NCT02414399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25877091|NCT01409161|Keratolytic Agents|keratolytic agents|mesh-ancestor
25080854|NCT03335124|Thiamine|thiamine|mesh-list
25538757|NCT00564278|Antidepressive Agents|antidepressive agents|mesh-list
25538758|NCT00564278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25538759|NCT00564395|Insulin|insulin|mesh-list
25538760|NCT00564395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25538761|NCT00564395|Insulin Detemir|insulin detemir|mesh-list
25538762|NCT00564395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25538763|NCT00564395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538764|NCT00564447|Azithromycin|azithromycin|mesh-list
25538765|NCT00564447|Moxifloxacin|moxifloxacin|mesh-list
25538766|NCT00564447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25538767|NCT00564447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25538768|NCT00564447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25538769|NCT00564447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25538770|NCT00564447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538771|NCT00564447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538772|NCT00564447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538773|NCT00564486|Acetaminophen|acetaminophen|mesh-list
25538774|NCT00564486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25538775|NCT00564486|Analgesics|analgesics|mesh-ancestor
25538776|NCT00564486|Sensory System Agents|sensory system agents|mesh-ancestor
25538777|NCT00564486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25538778|NCT00564486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538779|NCT00564486|Antipyretics|antipyretics|mesh-ancestor
25538780|NCT00564629|Acetaminophen|acetaminophen|mesh-list
25538781|NCT00564629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25538782|NCT00564629|Analgesics|analgesics|mesh-ancestor
25538783|NCT00564629|Sensory System Agents|sensory system agents|mesh-ancestor
25538784|NCT00564629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25538785|NCT00564629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538786|NCT00564629|Antipyretics|antipyretics|mesh-ancestor
25538787|NCT00564681|Botulinum Toxins|botulinum toxins|mesh-list
25538788|NCT00564681|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25538789|NCT00564681|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25538790|NCT00564681|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25538791|NCT00564681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25538792|NCT00564681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538793|NCT00564681|Cholinergic Agents|cholinergic agents|mesh-ancestor
25538794|NCT00564681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25538795|NCT00564681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538796|NCT00564681|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25538797|NCT00564681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25538798|NCT00564733|Gemcitabine|gemcitabine|mesh-list
25538799|NCT00564733|Paclitaxel|paclitaxel|mesh-list
25538800|NCT00564733|Docetaxel|docetaxel|mesh-list
25538801|NCT00564733|Carboplatin|carboplatin|mesh-list
25538802|NCT00564733|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25538803|NCT00564733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24851586|NCT02257398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538804|NCT00564733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538805|NCT00564733|Tubulin Modulators|tubulin modulators|mesh-ancestor
25538806|NCT00564733|Antimitotic Agents|antimitotic agents|mesh-ancestor
25538807|NCT00564733|Mitosis Modulators|mitosis modulators|mesh-ancestor
25538808|NCT00564733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538809|NCT00564733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25538810|NCT00564733|Antimetabolites|antimetabolites|mesh-ancestor
25538811|NCT00564733|Antiviral Agents|antiviral agents|mesh-ancestor
25538812|NCT00564733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25538813|NCT00564733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538814|NCT00564733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25538815|NCT00564733|Immunologic Factors|immunologic factors|mesh-ancestor
25538816|NCT00564733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538817|NCT00564733|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25538818|NCT00564850|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25538819|NCT00564850|Luteolytic Agents|luteolytic agents|mesh-ancestor
25538820|NCT00564850|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25538821|NCT00564850|Contraceptive Agents|contraceptive agents|mesh-ancestor
25538822|NCT00564850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25538823|NCT00564850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538824|NCT00564850|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25538825|NCT00564850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25538826|NCT00564850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538827|NCT00564889|Dexamethasone|dexamethasone|mesh-list
25538828|NCT00564889|Cyclophosphamide|cyclophosphamide|mesh-list
25538829|NCT00564889|Lenalidomide|lenalidomide|mesh-list
25538830|NCT00564889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25538831|NCT00564889|Immunologic Factors|immunologic factors|mesh-ancestor
25538832|NCT00564889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538833|NCT00564889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25538834|NCT00564889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25538835|NCT00564889|Alkylating Agents|alkylating agents|mesh-ancestor
25538836|NCT00564889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538837|NCT00564889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538838|NCT00564889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25538839|NCT00564889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25538841|NCT00564889|Autonomic Agents|autonomic agents|mesh-ancestor
25538842|NCT00564889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25538843|NCT00564889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25538844|NCT00564889|Glucocorticoids|glucocorticoids|mesh-ancestor
25538845|NCT00564889|Hormones|hormones|mesh-ancestor
25538846|NCT00564889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25538847|NCT00564889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25538848|NCT00564889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25538849|NCT00564889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25538850|NCT00564889|Growth Substances|growth substances|mesh-ancestor
25538851|NCT00564889|Growth Inhibitors|growth inhibitors|mesh-ancestor
25538852|NCT00564954|Methylphenidate|methylphenidate|mesh-list
25538853|NCT00564954|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
25538854|NCT00564954|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25538855|NCT00564954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538856|NCT00564954|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25538857|NCT00564954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25538858|NCT00564954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25538859|NCT00564954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538860|NCT00564954|Dopamine Agents|dopamine agents|mesh-ancestor
25538861|NCT00564954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25538862|NCT00565084|Ibuprofen|ibuprofen|mesh-list
25538863|NCT00565084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25538864|NCT00565084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25538865|NCT00565084|Analgesics|analgesics|mesh-ancestor
25538866|NCT00565084|Sensory System Agents|sensory system agents|mesh-ancestor
25538867|NCT00565084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25538868|NCT00565084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538869|NCT00565084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25538870|NCT00565084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25538871|NCT00565084|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25538872|NCT00565084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538873|NCT00565084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831503|NCT02166229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831505|NCT02166229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24831554|NCT02166853|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25538874|NCT00565266|Beclomethasone|beclomethasone|mesh-list
25538875|NCT00565266|Bromides|bromides|mesh-list
25538876|NCT00565266|Tiotropium Bromide|tiotropium bromide|mesh-list
25538877|NCT00565266|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25538878|NCT00565266|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25538879|NCT00565266|Autonomic Agents|autonomic agents|mesh-ancestor
25538880|NCT00565266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25538881|NCT00565266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538882|NCT00565266|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25538883|NCT00565266|Respiratory System Agents|respiratory system agents|mesh-ancestor
25538884|NCT00565266|Parasympatholytics|parasympatholytics|mesh-ancestor
25538885|NCT00565266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25538886|NCT00565266|Cholinergic Agents|cholinergic agents|mesh-ancestor
25538887|NCT00565266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25538888|NCT00565266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538889|NCT00565266|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25538890|NCT00565266|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25538891|NCT00565266|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25538892|NCT00565266|Adrenergic Agents|adrenergic agents|mesh-ancestor
25538893|NCT00565266|Anticonvulsants|anticonvulsants|mesh-ancestor
25538894|NCT00565266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25538895|NCT00565266|Glucocorticoids|glucocorticoids|mesh-ancestor
25538896|NCT00565266|Hormones|hormones|mesh-ancestor
25538897|NCT00565266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25538898|NCT00565370|Cisplatin|cisplatin|mesh-list
25538899|NCT00565370|Capecitabine|capecitabine|mesh-list
25538900|NCT00565370|Sorafenib|sorafenib|mesh-list
25538901|NCT00565370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538902|NCT00565370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25538903|NCT00565370|Antimetabolites|antimetabolites|mesh-ancestor
25007941|NCT02420821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24551609|NCT05358587|Anesthetics|anesthetics|mesh-list
25538904|NCT00565370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538905|NCT00565370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25434932|NCT04783753|Antimanic Agents|antimanic agents|mesh-ancestor
25538906|NCT00565370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538907|NCT00565409|Etanercept|etanercept|mesh-list
25538908|NCT00565409|Methotrexate|methotrexate|mesh-list
25538909|NCT00565409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25538910|NCT00565409|Abortifacient Agents|abortifacient agents|mesh-ancestor
25538911|NCT00565409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25538912|NCT00565409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538913|NCT00565409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25538914|NCT00565409|Antimetabolites|antimetabolites|mesh-ancestor
25538915|NCT00565409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538916|NCT00565409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538917|NCT00565409|Dermatologic Agents|dermatologic agents|mesh-ancestor
25538918|NCT00565409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538919|NCT00565409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25538920|NCT00565409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25538921|NCT00565409|Immunologic Factors|immunologic factors|mesh-ancestor
25538922|NCT00565409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25538923|NCT00565409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25538924|NCT00565409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25538925|NCT00565409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25538926|NCT00565409|Analgesics|analgesics|mesh-ancestor
24551796|NCT04984811|Atezolizumab|atezolizumab|mesh-list
24551824|NCT04956627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24551825|NCT04956627|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24551826|NCT04956627|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24551827|NCT04956627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24551828|NCT04956627|Antimetabolites|antimetabolites|mesh-ancestor
24551829|NCT04956627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25538927|NCT00565409|Sensory System Agents|sensory system agents|mesh-ancestor
25538928|NCT00565409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25538929|NCT00565409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25538930|NCT00565409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25538931|NCT00565448|Cisplatin|cisplatin|mesh-list
25538932|NCT00565448|Docetaxel|docetaxel|mesh-list
25538933|NCT00565448|Fluorouracil|fluorouracil|mesh-list
25538934|NCT00565448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538935|NCT00565448|Tubulin Modulators|tubulin modulators|mesh-ancestor
25538936|NCT00565448|Antimitotic Agents|antimitotic agents|mesh-ancestor
25538937|NCT00565448|Mitosis Modulators|mitosis modulators|mesh-ancestor
25538938|NCT00565448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538939|NCT00565448|Antimetabolites|antimetabolites|mesh-ancestor
25538940|NCT00565448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25538941|NCT00565448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25538942|NCT00565448|Immunologic Factors|immunologic factors|mesh-ancestor
25538943|NCT00565448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538944|NCT00565643|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25538945|NCT00565643|Hyaluronic Acid|hyaluronic acid|mesh-list
25538946|NCT00565643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25538947|NCT00565643|Immunologic Factors|immunologic factors|mesh-ancestor
25538948|NCT00565643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538949|NCT00565643|Viscosupplements|viscosupplements|mesh-ancestor
25538950|NCT00565643|Protective Agents|protective agents|mesh-ancestor
25538951|NCT00565643|Laxatives|laxatives|mesh-ancestor
25538952|NCT00565643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25538953|NCT00565669|Cyclosporine|cyclosporine|mesh-list
25538954|NCT00565669|Cyclosporins|cyclosporins|mesh-list
25538955|NCT00565669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538956|NCT00565669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538957|NCT00565669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25538958|NCT00565669|Immunologic Factors|immunologic factors|mesh-ancestor
25538959|NCT00565669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538960|NCT00565669|Antifungal Agents|antifungal agents|mesh-ancestor
25538961|NCT00565669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25538962|NCT00565669|Dermatologic Agents|dermatologic agents|mesh-ancestor
25538963|NCT00565669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25538964|NCT00565669|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25538965|NCT00565773|Sirolimus|sirolimus|mesh-list
25538966|NCT00565773|Alemtuzumab|alemtuzumab|mesh-list
25538967|NCT00565773|Abatacept|abatacept|mesh-list
25538968|NCT00565773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25538969|NCT00565773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25538970|NCT00565773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25538971|NCT00565773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538972|NCT00565773|Antifungal Agents|antifungal agents|mesh-ancestor
25538973|NCT00565773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25538974|NCT00565773|Immunologic Factors|immunologic factors|mesh-ancestor
25435005|NCT04782089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25435006|NCT04782115|RC28-E protein|rc28-e protein|mesh-list
25435007|NCT04782115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25538975|NCT00565773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538976|NCT00565773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25538977|NCT00565773|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24552670|NCT00321698|Mitosis Modulators|mitosis modulators|mesh-ancestor
24790899|NCT05410483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24790900|NCT05410483|Tubulin Modulators|tubulin modulators|mesh-ancestor
24790901|NCT05410483|Antimitotic Agents|antimitotic agents|mesh-ancestor
24790902|NCT05410483|Mitosis Modulators|mitosis modulators|mesh-ancestor
24790903|NCT05410483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790905|NCT05410314|Vitamin B Complex|vitamin b complex|mesh-ancestor
25538978|NCT00565773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538979|NCT00565773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25538980|NCT00565916|Estradiol|estradiol|mesh-list
25538981|NCT00565916|Estrogens|estrogens|mesh-list
25538982|NCT00565916|Progesterone|progesterone|mesh-list
25538983|NCT00565916|Hormones|hormones|mesh-ancestor
25538984|NCT00565916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25538985|NCT00565916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538986|NCT00565916|Progestins|progestins|mesh-ancestor
25538987|NCT00566020|Lamotrigine|lamotrigine|mesh-list
25538988|NCT00566020|Anticonvulsants|anticonvulsants|mesh-ancestor
25538989|NCT00566020|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25538990|NCT00566020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25538991|NCT00566020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538992|NCT00566020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25538993|NCT00566020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538994|NCT00566020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25538995|NCT00566020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25538996|NCT00566020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25538997|NCT00566020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25538998|NCT00566020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25538999|NCT00566098|Melphalan|melphalan|mesh-list
25539000|NCT00566098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25539001|NCT00566098|Alkylating Agents|alkylating agents|mesh-ancestor
25539002|NCT00566098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539003|NCT00566098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539004|NCT00566098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25539005|NCT00566098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25539006|NCT00566098|Immunologic Factors|immunologic factors|mesh-ancestor
25539007|NCT00566098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539008|NCT00566111|Ceftriaxone|ceftriaxone|mesh-list
25539009|NCT00566111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25539010|NCT00566111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25539011|NCT00566150|Levetiracetam|levetiracetam|mesh-list
25539012|NCT00566150|Anticonvulsants|anticonvulsants|mesh-ancestor
25539013|NCT00566150|Nootropic Agents|nootropic agents|mesh-ancestor
25539014|NCT00566254|Zonisamide|zonisamide|mesh-list
25539015|NCT00566254|Anticonvulsants|anticonvulsants|mesh-ancestor
25539016|NCT00566254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25539017|NCT00566254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25539018|NCT00566254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539019|NCT00566254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25539020|NCT00566254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539021|NCT00566501|Donepezil|donepezil|mesh-list
25539022|NCT00566501|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25539023|NCT00566501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539024|NCT00566501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539025|NCT00566501|Cholinergic Agents|cholinergic agents|mesh-ancestor
25539026|NCT00566501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25539027|NCT00566501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539028|NCT00566501|Nootropic Agents|nootropic agents|mesh-ancestor
25539029|NCT00566540|Paclitaxel|paclitaxel|mesh-list
25539030|NCT00566540|Cisplatin|cisplatin|mesh-list
25539031|NCT00566540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25539032|NCT00566540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539033|NCT00566540|Tubulin Modulators|tubulin modulators|mesh-ancestor
25539034|NCT00566540|Antimitotic Agents|antimitotic agents|mesh-ancestor
25539035|NCT00566540|Mitosis Modulators|mitosis modulators|mesh-ancestor
25539036|NCT00566540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539037|NCT00566631|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25539038|NCT00566631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25539039|NCT00566631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25539040|NCT00566631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25539041|NCT00566631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539042|NCT00566631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25539043|NCT00566631|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25539044|NCT00566631|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25539045|NCT00566631|Serotonin Agents|serotonin agents|mesh-ancestor
25539046|NCT00566631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25539047|NCT00566631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539048|NCT00566631|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25539049|NCT00566631|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25539050|NCT00566631|Dopamine Agents|dopamine agents|mesh-ancestor
25539051|NCT00566696|Mycophenolic Acid|mycophenolic acid|mesh-list
25539052|NCT00566696|Cyclophosphamide|cyclophosphamide|mesh-list
25539053|NCT00566696|Melphalan|melphalan|mesh-list
25539054|NCT00566696|Mechlorethamine|mechlorethamine|mesh-list
25539055|NCT00566696|Thiotepa|thiotepa|mesh-list
25539056|NCT00566696|Rituximab|rituximab|mesh-list
25539057|NCT00566696|Fludarabine|fludarabine|mesh-list
25539058|NCT00566696|Alemtuzumab|alemtuzumab|mesh-list
25539059|NCT00566696|Thymoglobulin|thymoglobulin|mesh-list
25539060|NCT00566696|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25539061|NCT00566696|Muromonab-CD3|muromonab-cd3|mesh-list
25539062|NCT00566696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25539063|NCT00566696|Immunologic Factors|immunologic factors|mesh-ancestor
25539064|NCT00566696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539065|NCT00566696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25539066|NCT00566696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25539067|NCT00566696|Alkylating Agents|alkylating agents|mesh-ancestor
25539068|NCT00566696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539069|NCT00566696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539070|NCT00566696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25539071|NCT00566696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25539072|NCT00566696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25539073|NCT00566696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25539074|NCT00566696|Antitubercular Agents|antitubercular agents|mesh-ancestor
25539075|NCT00566696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24831856|NCT02169609|Interleukin-2|interleukin-2|mesh-list
25539076|NCT00566696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25539077|NCT00566696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539078|NCT00566722|Adalimumab|adalimumab|mesh-list
25539079|NCT00566722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25539080|NCT00566722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25539081|NCT00566735|Galantamine|galantamine|mesh-list
25539082|NCT00566735|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25539083|NCT00566735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539084|NCT00566735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539085|NCT00566735|Cholinergic Agents|cholinergic agents|mesh-ancestor
25539086|NCT00566735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25539087|NCT00566735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539088|NCT00566735|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25539089|NCT00566735|Autonomic Agents|autonomic agents|mesh-ancestor
25539090|NCT00566735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25539091|NCT00566735|Nootropic Agents|nootropic agents|mesh-ancestor
25539092|NCT00566813|Exenatide|exenatide|mesh-list
25539093|NCT00566813|Etanercept|etanercept|mesh-list
25539094|NCT00566813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25539095|NCT00566813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25539096|NCT00566813|Analgesics|analgesics|mesh-ancestor
25539097|NCT00566813|Sensory System Agents|sensory system agents|mesh-ancestor
25539098|NCT00566813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25539099|NCT00566813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539100|NCT00566813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25539101|NCT00566813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25539102|NCT00566813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25539103|NCT00566813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25539104|NCT00566813|Immunologic Factors|immunologic factors|mesh-ancestor
25539105|NCT00566813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25539106|NCT00566813|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25539107|NCT00566813|Incretins|incretins|mesh-ancestor
25539108|NCT00566813|Hormones|hormones|mesh-ancestor
24423003|NCT00224419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25539109|NCT00566813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25539110|NCT00566852|Memantine|memantine|mesh-list
25539111|NCT00566852|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25539112|NCT00566852|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25539113|NCT00566852|Dopamine Agents|dopamine agents|mesh-ancestor
25539114|NCT00566852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25539115|NCT00566852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539116|NCT00566852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539117|NCT00566852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25539118|NCT00566852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25539119|NCT00566969|Carvedilol|carvedilol|mesh-list
25539120|NCT00566969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25539121|NCT00566969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25539122|NCT00566969|Adrenergic Agents|adrenergic agents|mesh-ancestor
25539123|NCT00566969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25539124|NCT00566969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539125|NCT00566969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539126|NCT00566969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25435141|NCT04780347|Paclitaxel|paclitaxel|mesh-list
25435142|NCT04780347|Capecitabine|capecitabine|mesh-list
25539127|NCT00566969|Antioxidants|antioxidants|mesh-ancestor
25539128|NCT00566969|Protective Agents|protective agents|mesh-ancestor
25539129|NCT00566969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25539130|NCT00566969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25539131|NCT00566969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25539132|NCT00566969|Vasodilator Agents|vasodilator agents|mesh-ancestor
25539133|NCT00566969|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25539134|NCT00566969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25539135|NCT00567008|Varenicline|varenicline|mesh-list
25539136|NCT00567008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25539137|NCT00567008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25539138|NCT00567008|Cholinergic Agents|cholinergic agents|mesh-ancestor
25539139|NCT00567008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25539140|NCT00567008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539141|NCT00567008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539142|NCT00567164|Drospirenone|drospirenone|mesh-list
25539143|NCT00567164|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25539144|NCT00567164|Hormone Antagonists|hormone antagonists|mesh-ancestor
25539145|NCT00567164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25539146|NCT00567164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539147|NCT00567164|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25539148|NCT00567164|Diuretics|diuretics|mesh-ancestor
25539149|NCT00567164|Natriuretic Agents|natriuretic agents|mesh-ancestor
25539150|NCT00567190|Docetaxel|docetaxel|mesh-list
25539151|NCT00567190|Trastuzumab|trastuzumab|mesh-list
25539152|NCT00567190|Pertuzumab|pertuzumab|mesh-list
25539153|NCT00567190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539154|NCT00567190|Tubulin Modulators|tubulin modulators|mesh-ancestor
25539155|NCT00567190|Antimitotic Agents|antimitotic agents|mesh-ancestor
25539156|NCT00567190|Mitosis Modulators|mitosis modulators|mesh-ancestor
25539157|NCT00567190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539158|NCT00567190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25539159|NCT00567229|Rituximab|rituximab|mesh-list
25539160|NCT00567229|Lenalidomide|lenalidomide|mesh-list
24772050|NCT01831323|Psyllium|psyllium|mesh-list
25539161|NCT00567229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25539162|NCT00567229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539163|NCT00567229|Immunologic Factors|immunologic factors|mesh-ancestor
25539164|NCT00567229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539165|NCT00567229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25539166|NCT00567229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25539167|NCT00567229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24851641|NCT02257671|Hormones|hormones|mesh-ancestor
25539168|NCT00567229|Growth Substances|growth substances|mesh-ancestor
25539169|NCT00567229|Growth Inhibitors|growth inhibitors|mesh-ancestor
25539170|NCT00567255|Naltrexone|naltrexone|mesh-list
25539171|NCT00567255|Bupropion|bupropion|mesh-list
25539172|NCT00567255|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25539173|NCT00567255|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25539174|NCT00567255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539175|NCT00567255|Sensory System Agents|sensory system agents|mesh-ancestor
25539176|NCT00567255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25539177|NCT00567255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25539178|NCT00567255|Antidepressive Agents|antidepressive agents|mesh-ancestor
25539179|NCT00567255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25539180|NCT00567255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25539181|NCT00567255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25539182|NCT00567255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25539183|NCT00567255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539184|NCT00567255|Dopamine Agents|dopamine agents|mesh-ancestor
25539185|NCT00567255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25539186|NCT00567255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25539187|NCT00567255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25539188|NCT00567255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539189|NCT00567268|Gabapentin|gabapentin|mesh-list
25539190|NCT00567268|Analgesics|analgesics|mesh-ancestor
25539191|NCT00567268|Sensory System Agents|sensory system agents|mesh-ancestor
25539192|NCT00567268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25539193|NCT00567268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539194|NCT00567268|Anticonvulsants|anticonvulsants|mesh-ancestor
24967078|NCT03762967|Hormones|hormones|mesh-list
25539195|NCT00567268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25539196|NCT00567268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25539197|NCT00567268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25539198|NCT00567268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25539199|NCT00567268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25539200|NCT00567268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25539201|NCT00567268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25539202|NCT00567268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539203|NCT00567268|Antimanic Agents|antimanic agents|mesh-ancestor
25539204|NCT00567320|Varenicline|varenicline|mesh-list
25539205|NCT00567320|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25539206|NCT00567320|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25539207|NCT00567320|Cholinergic Agents|cholinergic agents|mesh-ancestor
25539208|NCT00567320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25539209|NCT00567320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539210|NCT00567320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539211|NCT00567359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25539212|NCT00567359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539213|NCT00567359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25539214|NCT00567359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539215|NCT00567359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539216|NCT00567398|Icodextrin|icodextrin|mesh-list
25539217|NCT00567398|Dialysis Solutions|dialysis solutions|mesh-ancestor
25539218|NCT00567398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25539219|NCT00567476|Omalizumab|omalizumab|mesh-list
25539220|NCT00567476|Terbutaline|terbutaline|mesh-list
25539221|NCT00567476|Adrenergic Agents|adrenergic agents|mesh-list
25539222|NCT00567476|Adrenergic Agonists|adrenergic agonists|mesh-list
25539223|NCT00567476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25539224|NCT00567476|Autonomic Agents|autonomic agents|mesh-ancestor
25539225|NCT00567476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25539226|NCT00567476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539227|NCT00567476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25539228|NCT00567476|Respiratory System Agents|respiratory system agents|mesh-ancestor
25539229|NCT00567476|Tocolytic Agents|tocolytic agents|mesh-ancestor
25539230|NCT00567476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25539231|NCT00567476|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25539232|NCT00567476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25539233|NCT00567476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25539234|NCT00567476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539235|NCT00567476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25539236|NCT00567476|Sympathomimetics|sympathomimetics|mesh-ancestor
25539237|NCT00567489|Icodextrin|icodextrin|mesh-list
25539238|NCT00567489|Dialysis Solutions|dialysis solutions|mesh-ancestor
25539239|NCT00567489|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25539240|NCT00567593|Rosiglitazone|rosiglitazone|mesh-list
25539241|NCT00567593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25539242|NCT00567593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539243|NCT00567879|Trastuzumab|trastuzumab|mesh-list
25539244|NCT00567879|Panobinostat|panobinostat|mesh-list
25539245|NCT00567879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25539246|NCT00567879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539247|NCT00567879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25539248|NCT00567879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539249|NCT00567879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539250|NCT00567996|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25539251|NCT00567996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25539252|NCT00567996|Autonomic Agents|autonomic agents|mesh-ancestor
25539253|NCT00567996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25539254|NCT00567996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539255|NCT00567996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25539256|NCT00567996|Respiratory System Agents|respiratory system agents|mesh-ancestor
25539257|NCT00567996|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25539258|NCT00567996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25539259|NCT00567996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25539260|NCT00567996|Adrenergic Agents|adrenergic agents|mesh-ancestor
25539261|NCT00567996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25539262|NCT00567996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539263|NCT00568022|Capecitabine|capecitabine|mesh-list
25539264|NCT00568022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25539265|NCT00568022|Antimetabolites|antimetabolites|mesh-ancestor
25539266|NCT00568022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539267|NCT00568022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539268|NCT00568061|Nitric Oxide|nitric oxide|mesh-list
25539269|NCT00568061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25539270|NCT00568061|Autonomic Agents|autonomic agents|mesh-ancestor
25539271|NCT00568061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25539272|NCT00568061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539273|NCT00568061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25539274|NCT00568061|Respiratory System Agents|respiratory system agents|mesh-ancestor
25539275|NCT00568061|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25539276|NCT00568061|Antioxidants|antioxidants|mesh-ancestor
25539277|NCT00568061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539278|NCT00568061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25539279|NCT00568061|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25539280|NCT00568061|Vasodilator Agents|vasodilator agents|mesh-ancestor
25539281|NCT00568061|Gasotransmitters|gasotransmitters|mesh-ancestor
25539282|NCT00568061|Protective Agents|protective agents|mesh-ancestor
25539283|NCT00568087|Acetylcysteine|acetylcysteine|mesh-list
25539284|NCT00568087|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25539285|NCT00568087|Antiviral Agents|antiviral agents|mesh-ancestor
25539286|NCT00568087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25539287|NCT00568087|Expectorants|expectorants|mesh-ancestor
25539288|NCT00568087|Respiratory System Agents|respiratory system agents|mesh-ancestor
25539289|NCT00568087|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25539290|NCT00568087|Antioxidants|antioxidants|mesh-ancestor
25539291|NCT00568087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539292|NCT00568087|Protective Agents|protective agents|mesh-ancestor
25539293|NCT00568087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539294|NCT00568087|Antidotes|antidotes|mesh-ancestor
25539295|NCT00568321|Tanezumab|tanezumab|mesh-list
25539296|NCT00568321|Analgesics|analgesics|mesh-ancestor
25539297|NCT00568321|Sensory System Agents|sensory system agents|mesh-ancestor
25539298|NCT00568321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25539299|NCT00568321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539300|NCT00568386|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25539301|NCT00568386|Lubricant Eye Drops|lubricant eye drops|mesh-list
25539302|NCT00568386|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25539303|NCT00568399|Sodium thiosulfate|sodium thiosulfate|mesh-list
25539304|NCT00568399|Antidotes|antidotes|mesh-ancestor
25539305|NCT00568399|Protective Agents|protective agents|mesh-ancestor
25539306|NCT00568399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539307|NCT00568399|Antioxidants|antioxidants|mesh-ancestor
25539308|NCT00568399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539309|NCT00568399|Antitubercular Agents|antitubercular agents|mesh-ancestor
25539310|NCT00568399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25539311|NCT00568399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25539312|NCT00568399|Chelating Agents|chelating agents|mesh-ancestor
25539313|NCT00568399|Sequestering Agents|sequestering agents|mesh-ancestor
25539314|NCT00568451|Paclitaxel|paclitaxel|mesh-list
25539315|NCT00568451|Carboplatin|carboplatin|mesh-list
25539316|NCT00568451|Temozolomide|temozolomide|mesh-list
25539317|NCT00568451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25539318|NCT00568451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539319|NCT00568451|Tubulin Modulators|tubulin modulators|mesh-ancestor
25539320|NCT00568451|Antimitotic Agents|antimitotic agents|mesh-ancestor
24885828|NCT04498780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24559183|NCT05222438|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
24559265|NCT05122221|Cyclophosphamide|cyclophosphamide|mesh-list
25539321|NCT00568451|Mitosis Modulators|mitosis modulators|mesh-ancestor
25539322|NCT00568451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539323|NCT00568451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25539324|NCT00568451|Alkylating Agents|alkylating agents|mesh-ancestor
25539325|NCT00568555|Naltrexone|naltrexone|mesh-list
25539326|NCT00568555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25539327|NCT00568555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25539328|NCT00568555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539329|NCT00568555|Sensory System Agents|sensory system agents|mesh-ancestor
25539330|NCT00568555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25539331|NCT00568633|Cyclosporine|cyclosporine|mesh-list
25539332|NCT00568633|Mycophenolic Acid|mycophenolic acid|mesh-list
25539333|NCT00568633|Methylprednisolone|methylprednisolone|mesh-list
25539334|NCT00568633|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25539335|NCT00568633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25539336|NCT00568633|Prednisolone|prednisolone|mesh-list
25539337|NCT00568633|Prednisolone acetate|prednisolone acetate|mesh-list
25539338|NCT00568633|Cyclosporins|cyclosporins|mesh-list
25539339|NCT00568633|Thymoglobulin|thymoglobulin|mesh-list
25539340|NCT00568633|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25539341|NCT00568633|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25539342|NCT00568633|Prednisolone phosphate|prednisolone phosphate|mesh-list
25539343|NCT00568633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539344|NCT00568633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539345|NCT00568633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25539346|NCT00568633|Immunologic Factors|immunologic factors|mesh-ancestor
25539347|NCT00568633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008465|NCT05207683|Antibodies|antibodies|mesh-list
25539348|NCT00568633|Antifungal Agents|antifungal agents|mesh-ancestor
25539349|NCT00568633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25539350|NCT00568633|Dermatologic Agents|dermatologic agents|mesh-ancestor
25539351|NCT00568633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25539352|NCT00568633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25539353|NCT00568633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25539354|NCT00568633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25435417|NCT04777110|Esketamine|esketamine|mesh-list
25435418|NCT04777110|Antidepressive Agents|antidepressive agents|mesh-ancestor
25435419|NCT04777110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25435420|NCT04776889|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25435421|NCT04776889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25435422|NCT04776889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25435423|NCT04776889|Antimetabolites|antimetabolites|mesh-ancestor
25435424|NCT04776889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435425|NCT04776889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25435426|NCT04776889|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25435427|NCT04776889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25435428|NCT04776772|Complement System Proteins|complement system proteins|mesh-list
25435429|NCT04776772|Immunologic Factors|immunologic factors|mesh-ancestor
25435430|NCT04776772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435431|NCT04776512|Bupivacaine|bupivacaine|mesh-list
25435432|NCT04776512|Anesthetics, Local|anesthetics, local|mesh-ancestor
25435433|NCT04776512|Anesthetics|anesthetics|mesh-ancestor
25435434|NCT04776512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25435435|NCT04776512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24559840|NCT04285229|Dermatologic Agents|dermatologic agents|mesh-ancestor
25435436|NCT04776512|Sensory System Agents|sensory system agents|mesh-ancestor
25435437|NCT04776512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25048743|NCT00673062|Adrenergic Agents|adrenergic agents|mesh-ancestor
24445668|NCT00301990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25131852|NCT03023059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131853|NCT03023059|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25131855|NCT03023059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25131856|NCT03023059|Immunologic Factors|immunologic factors|mesh-ancestor
25131857|NCT03023059|Dopamine Agonists|dopamine agonists|mesh-ancestor
25131858|NCT03023020|Aspirin|aspirin|mesh-list
25131859|NCT03023020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25131862|NCT03023020|Analgesics|analgesics|mesh-ancestor
25282714|NCT03978767|Sensory System Agents|sensory system agents|mesh-ancestor
25282715|NCT03978767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25282716|NCT03978767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282719|NCT03978767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25132138|NCT03020979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25132139|NCT03020979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132140|NCT03020953|Estrogens|estrogens|mesh-list
25132141|NCT03020953|Hormones|hormones|mesh-ancestor
25132142|NCT03020953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25132143|NCT03020953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132172|NCT03020706|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25132178|NCT03020602|Ubiquinone|ubiquinone|mesh-list
24775749|NCT01854515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24775750|NCT01854515|Respiratory System Agents|respiratory system agents|mesh-ancestor
24775782|NCT01854762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775784|NCT01854762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24775785|NCT01854762|Antiviral Agents|antiviral agents|mesh-ancestor
25168850|NCT02057315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25539355|NCT00568633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25539356|NCT00568633|Antitubercular Agents|antitubercular agents|mesh-ancestor
25539357|NCT00568633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25539358|NCT00568633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25539359|NCT00568633|Antiemetics|antiemetics|mesh-ancestor
25539360|NCT00568633|Autonomic Agents|autonomic agents|mesh-ancestor
25539361|NCT00568633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25539362|NCT00568633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25539363|NCT00568633|Glucocorticoids|glucocorticoids|mesh-ancestor
25539364|NCT00568633|Hormones|hormones|mesh-ancestor
25539365|NCT00568633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25539366|NCT00568633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25539367|NCT00568633|Protective Agents|protective agents|mesh-ancestor
25539368|NCT00568633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25539369|NCT00568685|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25539370|NCT00568685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25539371|NCT00568685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25539372|NCT00568685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25539373|NCT00568685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539374|NCT00568685|Adrenergic Agents|adrenergic agents|mesh-ancestor
25539375|NCT00568685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25539376|NCT00568685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539377|NCT00568776|Inositol|inositol|mesh-list
25539378|NCT00568776|Vitamin B Complex|vitamin b complex|mesh-ancestor
25539379|NCT00568776|Vitamins|vitamins|mesh-ancestor
25539380|NCT00568776|Micronutrients|micronutrients|mesh-ancestor
25539381|NCT00568776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539382|NCT05363449|Naftifine|naftifine|mesh-list
25539383|NCT05363449|Antifungal Agents|antifungal agents|mesh-ancestor
25539384|NCT05363449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25539385|NCT05363436|Oxycodone|oxycodone|mesh-list
25539386|NCT05363436|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25539387|NCT05363436|Narcotics|narcotics|mesh-ancestor
24553713|NCT00732576|Hemostatics|hemostatics|mesh-ancestor
25539388|NCT05363436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25539389|NCT05363436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539390|NCT05363436|Analgesics|analgesics|mesh-ancestor
25539391|NCT05363436|Sensory System Agents|sensory system agents|mesh-ancestor
25539392|NCT05363436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25539393|NCT05363202|Fluticasone|fluticasone|mesh-list
25539394|NCT05363202|Xhance|xhance|mesh-list
25539395|NCT05363202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25539396|NCT05363202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25539397|NCT05363202|Autonomic Agents|autonomic agents|mesh-ancestor
25539398|NCT05363202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25539399|NCT05363202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539400|NCT05363202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25539401|NCT05363202|Respiratory System Agents|respiratory system agents|mesh-ancestor
25539402|NCT05363202|Dermatologic Agents|dermatologic agents|mesh-ancestor
25539403|NCT05363202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25539404|NCT05362942|Cytarabine|cytarabine|mesh-list
25539405|NCT05362942|Azacitidine|azacitidine|mesh-list
25539406|NCT05362942|Decitabine|decitabine|mesh-list
25539407|NCT05362942|Venetoclax|venetoclax|mesh-list
25539408|NCT05362942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25539409|NCT05362942|Antimetabolites|antimetabolites|mesh-ancestor
25539410|NCT05362942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539411|NCT05362942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539412|NCT05362942|Antiviral Agents|antiviral agents|mesh-ancestor
25539413|NCT05362942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25539414|NCT05362942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25539415|NCT05362942|Immunologic Factors|immunologic factors|mesh-ancestor
25539416|NCT05362942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539417|NCT05362942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650569|NCT01505114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25650570|NCT01505114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650571|NCT01505114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650572|NCT01505114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25650573|NCT01505114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25650574|NCT01505114|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25650575|NCT01505114|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25650576|NCT01505114|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25650577|NCT01505179|Ranolazine|ranolazine|mesh-list
25650578|NCT01505179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25650579|NCT01505179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25650580|NCT01505179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650581|NCT01505491|Adalimumab|adalimumab|mesh-list
25650582|NCT01505491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25650583|NCT01505491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25650584|NCT01505634|Ciprofloxacin|ciprofloxacin|mesh-list
25650585|NCT01505634|Imipenem|imipenem|mesh-list
25650586|NCT01505634|Relebactam|relebactam|mesh-list
25650587|NCT01505634|Cilastatin|cilastatin|mesh-list
25650588|NCT01505634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25650589|NCT01505634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25650590|NCT01505634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25650591|NCT01505634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25650592|NCT01505634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650593|NCT01505634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650594|NCT01505634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25650595|NCT01505634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25650596|NCT01505634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25650597|NCT01505634|Protease Inhibitors|protease inhibitors|mesh-ancestor
25650598|NCT01505634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25650599|NCT01505647|Vaccines|vaccines|mesh-list
25650600|NCT01505647|Immunologic Factors|immunologic factors|mesh-ancestor
25435438|NCT04776655|Leucovorin|leucovorin|mesh-list
25650601|NCT01505647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650602|NCT01505673|Liraglutide|liraglutide|mesh-list
25650603|NCT01505673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25539418|NCT05362877|Salicylic Acid|salicylic acid|mesh-list
25539419|NCT05362877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25539420|NCT05362877|Antifungal Agents|antifungal agents|mesh-ancestor
25539421|NCT05362877|Keratolytic Agents|keratolytic agents|mesh-ancestor
25539422|NCT05362877|Dermatologic Agents|dermatologic agents|mesh-ancestor
25539423|NCT05362851|Celecoxib|celecoxib|mesh-list
25539424|NCT05362851|Tramadol|tramadol|mesh-list
25539425|NCT05362851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25539426|NCT05362851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25539427|NCT05362851|Analgesics|analgesics|mesh-ancestor
25539428|NCT05362851|Sensory System Agents|sensory system agents|mesh-ancestor
25539429|NCT05362851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25539430|NCT05362851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539431|NCT05362851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25539432|NCT05362851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24561409|NCT00760045|Hyaluronic Acid|hyaluronic acid|mesh-list
25539433|NCT05362851|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25539434|NCT05362851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25539435|NCT05362851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539436|NCT05362851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539437|NCT05362851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25539438|NCT05362851|Narcotics|narcotics|mesh-ancestor
25539439|NCT05362851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25539440|NCT05362799|Metformin|metformin|mesh-list
25539441|NCT05362799|Letrozole|letrozole|mesh-list
25539442|NCT05362799|Lactitol|lactitol|mesh-list
25539443|NCT05362799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25539444|NCT05362799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539445|NCT05362799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539446|NCT05362799|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25539447|NCT05362799|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25539448|NCT05362799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539449|NCT05362799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539450|NCT05362799|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25539451|NCT05362799|Hormone Antagonists|hormone antagonists|mesh-ancestor
25539452|NCT05362799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25539453|NCT05362799|Cathartics|cathartics|mesh-ancestor
25539454|NCT05362799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25539455|NCT05362513|Ivermectin|ivermectin|mesh-list
25539456|NCT05362513|Permethrin|permethrin|mesh-list
25539457|NCT05362513|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25539458|NCT05362513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25539459|NCT05362513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539460|NCT05362513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539461|NCT05362500|Tranylcypromine|tranylcypromine|mesh-list
25539462|NCT05362500|Glycolic acid|glycolic acid|mesh-list
25539463|NCT05362500|Tranexamic Acid|tranexamic acid|mesh-list
25539464|NCT05362500|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25539465|NCT05362500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25539466|NCT05362500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539467|NCT05362500|Hemostatics|hemostatics|mesh-ancestor
25539468|NCT05362500|Coagulants|coagulants|mesh-ancestor
25539469|NCT05362500|Antidepressive Agents|antidepressive agents|mesh-ancestor
25539470|NCT05362500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25539471|NCT05362500|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25539472|NCT05362500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539473|NCT05362500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25539474|NCT05362500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25539475|NCT05362500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25539476|NCT05362500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539477|NCT05362500|Keratolytic Agents|keratolytic agents|mesh-ancestor
25539478|NCT05362500|Dermatologic Agents|dermatologic agents|mesh-ancestor
25539479|NCT05362318|Nicotine|nicotine|mesh-list
25539480|NCT05362318|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25539481|NCT05362318|Autonomic Agents|autonomic agents|mesh-ancestor
25539482|NCT05362318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25539483|NCT05362318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772767|NCT01835665|Nimodipine|nimodipine|mesh-list
25539484|NCT05362318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25539485|NCT05362318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25539486|NCT05362318|Cholinergic Agents|cholinergic agents|mesh-ancestor
25539487|NCT05362318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25539488|NCT05362318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539489|NCT05362188|Niacinamide|niacinamide|mesh-list
25539490|NCT05362188|Niacin|niacin|mesh-list
25539491|NCT05362188|Nicotinic Acids|nicotinic acids|mesh-list
25539492|NCT05362188|Vitamin B Complex|vitamin b complex|mesh-ancestor
25539493|NCT05362188|Vitamins|vitamins|mesh-ancestor
25539494|NCT05362188|Micronutrients|micronutrients|mesh-ancestor
25435573|NCT04774029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25435574|NCT04774029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435575|NCT04774029|Sensory System Agents|sensory system agents|mesh-ancestor
25435576|NCT04774029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25435577|NCT04774029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25435578|NCT04774029|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24449329|NCT00315016|Eplerenone|eplerenone|mesh-list
25435579|NCT04774029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25435580|NCT04774029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25435581|NCT04774029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049351|NCT00615251|Hormones|hormones|mesh-ancestor
24515148|NCT00594867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24515230|NCT00596050|Midazolam|midazolam|mesh-list
24500671|NCT00525447|Hormones|hormones|mesh-ancestor
24515570|NCT00598234|Celecoxib|celecoxib|mesh-list
25003921|NCT02923128|Analgesics|analgesics|mesh-ancestor
25003937|NCT02921022|Paclitaxel|paclitaxel|mesh-list
25168851|NCT02057315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168852|NCT02057315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25168853|NCT02057315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25168854|NCT02057315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25168855|NCT02057315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168856|NCT02057315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168857|NCT02057172|Liraglutide|liraglutide|mesh-list
25168858|NCT02057172|Exenatide|exenatide|mesh-list
25168859|NCT02057172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25168860|NCT02057172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168861|NCT02057172|Incretins|incretins|mesh-ancestor
25168862|NCT02057172|Hormones|hormones|mesh-ancestor
25168863|NCT02057172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25168864|NCT02057172|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25168865|NCT02052778|Futibatinib|futibatinib|mesh-list
25168866|NCT02052778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168867|NCT02052648|Bevacizumab|bevacizumab|mesh-list
25168868|NCT02052648|Temozolomide|temozolomide|mesh-list
25168869|NCT02052648|Tryptophan|tryptophan|mesh-list
25168870|NCT02052648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25168871|NCT02052648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168872|NCT02052648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25168873|NCT02052648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25168874|NCT02052648|Growth Substances|growth substances|mesh-ancestor
25168875|NCT02052648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822483|NCT00004488|Cholecalciferol|cholecalciferol|mesh-list
25822484|NCT00004488|Vitamin D|vitamin d|mesh-list
25133046|NCT03015675|Ascorbic Acid|ascorbic acid|mesh-list
25822485|NCT00004488|Alendronate|alendronate|mesh-list
25822486|NCT00004488|Calcium Carbonate|calcium carbonate|mesh-list
25822487|NCT00004488|Calcium|calcium|mesh-list
25822488|NCT00004488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25168876|NCT02052648|Growth Inhibitors|growth inhibitors|mesh-ancestor
25168877|NCT02052648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25168878|NCT02052648|Alkylating Agents|alkylating agents|mesh-ancestor
25168879|NCT02052648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168880|NCT02052648|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25168881|NCT02052648|Antidepressive Agents|antidepressive agents|mesh-ancestor
25168882|NCT02052648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25168883|NCT02050828|Ranibizumab|ranibizumab|mesh-list
25168884|NCT02050828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25168885|NCT02050828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25539495|NCT05362188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539496|NCT05362188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25539497|NCT05362188|Antimetabolites|antimetabolites|mesh-ancestor
24423004|NCT00224419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539498|NCT05362188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539499|NCT05362188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25539500|NCT05362188|Vasodilator Agents|vasodilator agents|mesh-ancestor
25539501|NCT05362019|Norethindrone|norethindrone|mesh-list
25539502|NCT05362019|Norethindrone enanthate|norethindrone enanthate|mesh-list
25539503|NCT05362019|Norethindrone Acetate|norethindrone acetate|mesh-list
25539504|NCT05362019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25539505|NCT05362019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25539506|NCT05362019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25539507|NCT05362019|Contraceptive Agents|contraceptive agents|mesh-ancestor
25539508|NCT05362019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25539509|NCT05362019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539510|NCT05362019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25539539|NCT05361655|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25539540|NCT05361655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539541|NCT05361655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25539542|NCT05361655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539543|NCT05361655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539544|NCT05361655|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25539545|NCT05361655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25539546|NCT05361655|Hormone Antagonists|hormone antagonists|mesh-ancestor
25539547|NCT05361655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25539548|NCT05361655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539549|NCT05361291|Dexamethasone|dexamethasone|mesh-list
25539550|NCT05361291|Lidocaine|lidocaine|mesh-list
25539551|NCT05361291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25539552|NCT05361291|Antiemetics|antiemetics|mesh-ancestor
25539553|NCT05361291|Autonomic Agents|autonomic agents|mesh-ancestor
25539554|NCT05361291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25539555|NCT05361291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539556|NCT05361291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25539557|NCT05361291|Glucocorticoids|glucocorticoids|mesh-ancestor
25539558|NCT05361291|Hormones|hormones|mesh-ancestor
25539559|NCT05361291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25539560|NCT05361291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25539561|NCT05361291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539562|NCT05361291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539563|NCT05361291|Anesthetics, Local|anesthetics, local|mesh-ancestor
25539564|NCT05361291|Anesthetics|anesthetics|mesh-ancestor
25539565|NCT05361291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25539566|NCT05361291|Sensory System Agents|sensory system agents|mesh-ancestor
25539567|NCT05361291|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25539568|NCT05361291|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25539569|NCT05361291|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25539570|NCT05361291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25539571|NCT05355740|Chlorhexidine|chlorhexidine|mesh-list
25539572|NCT05355740|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25539573|NCT05355740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25539574|NCT05355740|Disinfectants|disinfectants|mesh-ancestor
25539575|NCT05355311|Acetylcarnitine|acetylcarnitine|mesh-list
25539576|NCT05355311|Vitamin B Complex|vitamin b complex|mesh-ancestor
25539577|NCT05355311|Vitamins|vitamins|mesh-ancestor
25539578|NCT05355311|Micronutrients|micronutrients|mesh-ancestor
25539579|NCT05355311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539580|NCT05355311|Nootropic Agents|nootropic agents|mesh-ancestor
25539581|NCT05355168|Nimotuzumab|nimotuzumab|mesh-list
25539582|NCT05355168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25539583|NCT05355168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25435582|NCT04773756|Sofosbuvir|sofosbuvir|mesh-list
25539584|NCT05353374|Fusidic Acid|fusidic acid|mesh-list
25539585|NCT05353374|Petrolatum|petrolatum|mesh-list
25539586|NCT05353374|Emollients|emollients|mesh-ancestor
25539587|NCT05353374|Dermatologic Agents|dermatologic agents|mesh-ancestor
25539588|NCT05353374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25539589|NCT05353374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25539590|NCT05353374|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25539591|NCT05353374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539592|NCT05353374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539593|NCT05324449|Cannabidiol|cannabidiol|mesh-list
25539594|NCT05324449|Anticonvulsants|anticonvulsants|mesh-ancestor
25539595|NCT05305313|Propofol|propofol|mesh-list
25539596|NCT05305313|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25539597|NCT05305313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25539598|NCT05305313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539599|NCT05305313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25539600|NCT05305313|Anesthetics, General|anesthetics, general|mesh-ancestor
25539601|NCT05305313|Anesthetics|anesthetics|mesh-ancestor
25539602|NCT05291156|Cetuximab|cetuximab|mesh-list
25539603|NCT05291156|Avelumab|avelumab|mesh-list
25539604|NCT05291156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25539605|NCT05291156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539606|NCT05290740|Norepinephrine|norepinephrine|mesh-list
25539607|NCT05290740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25539608|NCT05290740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25539609|NCT05290740|Adrenergic Agents|adrenergic agents|mesh-ancestor
25539610|NCT05290740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25539611|NCT05290740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539612|NCT05290740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539613|NCT05290740|Sympathomimetics|sympathomimetics|mesh-ancestor
25539614|NCT05290740|Autonomic Agents|autonomic agents|mesh-ancestor
25539615|NCT05290740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25539616|NCT05290740|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25539617|NCT05236894|Nicotine|nicotine|mesh-list
25539618|NCT05236894|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25539619|NCT05236894|Autonomic Agents|autonomic agents|mesh-ancestor
25539620|NCT05236894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25539621|NCT05236894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539622|NCT05236894|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25539623|NCT05236894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25539624|NCT05236894|Cholinergic Agents|cholinergic agents|mesh-ancestor
25539625|NCT05236894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25539626|NCT05236894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539627|NCT05214339|Bevacizumab|bevacizumab|mesh-list
25539628|NCT05214339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25539629|NCT05214339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539630|NCT05214339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25539631|NCT05214339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25539632|NCT05214339|Growth Substances|growth substances|mesh-ancestor
25539633|NCT05214339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539634|NCT05214339|Growth Inhibitors|growth inhibitors|mesh-ancestor
25539635|NCT05198232|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
25539636|NCT05198232|TEMPO|tempo|mesh-list
25539637|NCT05198232|Antioxidants|antioxidants|mesh-ancestor
25539638|NCT05198232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539639|NCT05198232|Protective Agents|protective agents|mesh-ancestor
25539640|NCT05198232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539641|NCT05198232|Antacids|antacids|mesh-ancestor
25539642|NCT05198232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25539643|NCT05183854|Vaccines|vaccines|mesh-list
25539644|NCT05183854|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25539645|NCT05183854|Immunologic Factors|immunologic factors|mesh-ancestor
25539646|NCT05183854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539647|NCT05183828|Letrozole|letrozole|mesh-list
25539648|NCT05183828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539649|NCT05183828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25539650|NCT05183828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25539651|NCT05183828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539652|NCT05183828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539653|NCT05183828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25539654|NCT05183828|Hormone Antagonists|hormone antagonists|mesh-ancestor
25539655|NCT05183828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25539656|NCT05183828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650604|NCT01505673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650605|NCT01505673|Incretins|incretins|mesh-ancestor
25650606|NCT01505673|Hormones|hormones|mesh-ancestor
25539657|NCT05183191|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25435727|NCT04771884|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25435728|NCT04771884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25435729|NCT04771884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435730|NCT04771754|Dolutegravir|dolutegravir|mesh-list
25435731|NCT04771754|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25435732|NCT04771754|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25435733|NCT04771754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25435734|NCT04771754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435735|NCT04771754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25435736|NCT04771754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25435737|NCT04771754|Antiviral Agents|antiviral agents|mesh-ancestor
25435738|NCT04771754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25435739|NCT04771559|Antibodies|antibodies|mesh-list
25435740|NCT04771559|Immunologic Factors|immunologic factors|mesh-ancestor
25435741|NCT04771559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435742|NCT04771390|Selitrectinib|selitrectinib|mesh-list
25435743|NCT04771390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25435744|NCT04771390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932905|NCT04075474|Listerine|listerine|mesh-list
24995058|NCT05418309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24995059|NCT05418309|Tubulin Modulators|tubulin modulators|mesh-ancestor
24995060|NCT05418309|Antimitotic Agents|antimitotic agents|mesh-ancestor
24995061|NCT05418309|Mitosis Modulators|mitosis modulators|mesh-ancestor
24995062|NCT05418309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995063|NCT05418244|Ondansetron|ondansetron|mesh-list
24995064|NCT05418244|Antiemetics|antiemetics|mesh-ancestor
24995175|NCT05417659|Vitamins|vitamins|mesh-ancestor
25168886|NCT02050828|Growth Substances|growth substances|mesh-ancestor
25168887|NCT02050828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168889|NCT02050828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168890|NCT02047214|Bevacizumab|bevacizumab|mesh-list
25168891|NCT02047214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25168892|NCT02047214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168893|NCT02047214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25168894|NCT02047214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25168895|NCT02047214|Growth Substances|growth substances|mesh-ancestor
25168896|NCT02047214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168897|NCT02047214|Growth Inhibitors|growth inhibitors|mesh-ancestor
25168898|NCT02046694|Allopurinol|allopurinol|mesh-list
25168899|NCT02046694|Antimetabolites|antimetabolites|mesh-ancestor
25168900|NCT02046694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168901|NCT02046694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168903|NCT02046694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25168904|NCT02046694|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25168905|NCT02046694|Antioxidants|antioxidants|mesh-ancestor
25168906|NCT02046694|Protective Agents|protective agents|mesh-ancestor
25134622|NCT03005704|Analgesics|analgesics|mesh-ancestor
25135119|NCT03002259|Hormones|hormones|mesh-ancestor
25539658|NCT05183191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539659|NCT05163223|Pembrolizumab|pembrolizumab|mesh-list
25539660|NCT05163223|Capecitabine|capecitabine|mesh-list
25539661|NCT05163223|Sargramostim|sargramostim|mesh-list
25539662|NCT05163223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25539663|NCT05163223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449408|NCT00315523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25539664|NCT05163223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25539665|NCT05163223|Antimetabolites|antimetabolites|mesh-ancestor
25539666|NCT05163223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539667|NCT05163223|Immunologic Factors|immunologic factors|mesh-ancestor
25539668|NCT05163223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539669|NCT05099185|Trace Elements|trace elements|mesh-list
25539670|NCT05099185|Micronutrients|micronutrients|mesh-list
25539671|NCT05099185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539672|NCT05096195|Calcium, Dietary|calcium, dietary|mesh-list
25539673|NCT05096195|Vitamin D|vitamin d|mesh-list
25539674|NCT05096195|Denosumab|denosumab|mesh-list
25539675|NCT05096195|Calcium|calcium|mesh-list
25539676|NCT05096195|Vitamins|vitamins|mesh-ancestor
25539677|NCT05096195|Micronutrients|micronutrients|mesh-ancestor
25539678|NCT05096195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539679|NCT05096195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25539680|NCT05096195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25539681|NCT05092412|Cisplatin|cisplatin|mesh-list
25539682|NCT05092412|Carboplatin|carboplatin|mesh-list
25539683|NCT05092412|Etoposide|etoposide|mesh-list
25539684|NCT05092412|Durvalumab|durvalumab|mesh-list
25539685|NCT05092412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829445|NCT00006211|Nelfinavir|nelfinavir|mesh-list
25539686|NCT05092412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25539687|NCT05092412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25539688|NCT05092412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25539689|NCT05092412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539690|NCT05092412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539691|NCT05092412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25539692|NCT05076292|Glucagon|glucagon|mesh-list
25539693|NCT05076292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25539694|NCT05076292|Hormones|hormones|mesh-ancestor
25539695|NCT05076292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25539696|NCT05076292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539697|NCT05068609|Nivolumab|nivolumab|mesh-list
25539698|NCT05068609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25539699|NCT05068609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539700|NCT05068609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25539701|NCT05068609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539702|NCT05065671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25539703|NCT05065671|Tolcapone|tolcapone|mesh-list
25539704|NCT05065671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25539705|NCT05065671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25539706|NCT05065671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25539707|NCT05065671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539708|NCT05065671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25539709|NCT05065671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539710|NCT05065671|Analgesics|analgesics|mesh-ancestor
25539711|NCT05065671|Sensory System Agents|sensory system agents|mesh-ancestor
25539712|NCT05065671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25539713|NCT05065671|Antidepressive Agents|antidepressive agents|mesh-ancestor
25539714|NCT05065671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25539715|NCT05065671|Dopamine Agents|dopamine agents|mesh-ancestor
25539716|NCT05065671|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25539717|NCT05065671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25539718|NCT05065671|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25539719|NCT05065671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539720|NCT05038462|Lactoferrin|lactoferrin|mesh-list
25539721|NCT05038462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25539722|NCT05017194|Emodepside|emodepside|mesh-list
25539723|NCT05017194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25539724|NCT05017194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25539725|NCT04866602|Atovaquone|atovaquone|mesh-list
25539726|NCT04866602|Proguanil|proguanil|mesh-list
25539727|NCT04866602|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
25539728|NCT04866602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25539729|NCT04866602|Antimalarials|antimalarials|mesh-ancestor
25539730|NCT04866602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25539731|NCT04866602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25539732|NCT04866602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539733|NCT04866602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539734|NCT04866602|Antimetabolites|antimetabolites|mesh-ancestor
25539735|NCT04839042|Cloricromen|cloricromen|mesh-list
25539736|NCT04839042|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25539737|NCT04838041|Imatinib Mesylate|imatinib mesylate|mesh-list
25539738|NCT04838041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539739|NCT04838041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25539740|NCT04838041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539741|NCT04838041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539742|NCT04789330|Phenylephrine|phenylephrine|mesh-list
25539743|NCT04789330|Oxymetazoline|oxymetazoline|mesh-list
25539744|NCT04789330|Norepinephrine|norepinephrine|mesh-list
25539745|NCT04789330|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25539746|NCT04789330|Mydriatics|mydriatics|mesh-ancestor
25539747|NCT04789330|Autonomic Agents|autonomic agents|mesh-ancestor
25539748|NCT04789330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25539749|NCT04789330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539750|NCT04789330|Sympathomimetics|sympathomimetics|mesh-ancestor
25539751|NCT04789330|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25539752|NCT04789330|Nasal Decongestants|nasal decongestants|mesh-ancestor
25539753|NCT04789330|Respiratory System Agents|respiratory system agents|mesh-ancestor
25539754|NCT04789330|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25539755|NCT04789330|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25539756|NCT04789330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25539757|NCT04789330|Adrenergic Agents|adrenergic agents|mesh-ancestor
25539758|NCT04789330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25657191|NCT01583985|Sensory System Agents|sensory system agents|mesh-ancestor
25435813|NCT04769258|Immunologic Factors|immunologic factors|mesh-ancestor
25435814|NCT04769258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435815|NCT04769297|Ketamine|ketamine|mesh-list
25435816|NCT04769297|Analgesics|analgesics|mesh-ancestor
25435817|NCT04769297|Sensory System Agents|sensory system agents|mesh-ancestor
25435818|NCT04769297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25435819|NCT04769297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435820|NCT04769297|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25435821|NCT04769297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25435822|NCT04769297|Anesthetics, General|anesthetics, general|mesh-ancestor
25435823|NCT04769297|Anesthetics|anesthetics|mesh-ancestor
25435824|NCT04769297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25435825|NCT04769297|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25435826|NCT04769297|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25435827|NCT04769297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25435828|NCT04769297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435829|NCT04769076|Paclitaxel|paclitaxel|mesh-list
25435830|NCT04769076|Cisplatin|cisplatin|mesh-list
25435831|NCT04769076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25435832|NCT04769076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25435833|NCT04769076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25435834|NCT04769076|Tubulin Modulators|tubulin modulators|mesh-ancestor
25435835|NCT04769076|Antimitotic Agents|antimitotic agents|mesh-ancestor
25435836|NCT04769076|Mitosis Modulators|mitosis modulators|mesh-ancestor
25435837|NCT04769076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435838|NCT04769271|Tea Tree Oil|tea tree oil|mesh-list
25435839|NCT04769271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25435840|NCT04769271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25435841|NCT04768764|Bupivacaine|bupivacaine|mesh-list
25435842|NCT04768764|Anesthetics|anesthetics|mesh-list
25435843|NCT04768764|Anesthetics, Local|anesthetics, local|mesh-ancestor
25435844|NCT04768764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25435845|NCT04768764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435846|NCT04768764|Sensory System Agents|sensory system agents|mesh-ancestor
25435847|NCT04768764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24450347|NCT00318825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25135300|NCT03000127|Testosterone|testosterone|mesh-list
25539759|NCT04789330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539760|NCT04789330|Protective Agents|protective agents|mesh-ancestor
25539761|NCT04720781|Esomeprazole|esomeprazole|mesh-list
25539762|NCT04720781|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25539763|NCT04720781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25539764|NCT04720781|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25539765|NCT04720781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539766|NCT04720781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539767|NCT04704505|Androgens|androgens|mesh-list
25539768|NCT04704505|Hormones|hormones|mesh-ancestor
25539769|NCT04704505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25539770|NCT04704505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539771|NCT04606576|Insulin|insulin|mesh-list
25539772|NCT04606576|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25539773|NCT04606576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25539774|NCT04606576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539775|NCT04560179|Tobramycin|tobramycin|mesh-list
25539776|NCT04560179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25539777|NCT04560179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25539778|NCT04560179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25539779|NCT04544111|Trametinib|trametinib|mesh-list
25539780|NCT04544111|Dabrafenib|dabrafenib|mesh-list
25539781|NCT04544111|Spartalizumab|spartalizumab|mesh-list
25539782|NCT04544111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539783|NCT04544111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25539784|NCT04544111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539785|NCT04544111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539786|NCT04544111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25539787|NCT04509622|Cytarabine|cytarabine|mesh-list
25539788|NCT04509622|Venetoclax|venetoclax|mesh-list
25539789|NCT04509622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25539790|NCT04509622|Antimetabolites|antimetabolites|mesh-ancestor
25539791|NCT04509622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539792|NCT04509622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539793|NCT04509622|Antiviral Agents|antiviral agents|mesh-ancestor
25539794|NCT04509622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25539795|NCT04509622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25539796|NCT04509622|Immunologic Factors|immunologic factors|mesh-ancestor
25539797|NCT04509622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539798|NCT04501380|Rifamycins|rifamycins|mesh-list
24564053|NCT00774982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564054|NCT00774982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24564101|NCT00775125|Ritonavir|ritonavir|mesh-list
25539799|NCT04501380|Rifamycin SV|rifamycin sv|mesh-list
25539800|NCT04501380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25539801|NCT04501380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25539802|NCT04501380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25539803|NCT04465734|Sorafenib|sorafenib|mesh-list
25539804|NCT04465734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539805|NCT04465734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25539806|NCT04465734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539807|NCT04465734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539808|NCT04415905|Propofol|propofol|mesh-list
25539809|NCT04415905|Sevoflurane|sevoflurane|mesh-list
25539810|NCT04415905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25539811|NCT04415905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25539812|NCT04415905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539813|NCT04415905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25539814|NCT04415905|Anesthetics, General|anesthetics, general|mesh-ancestor
25539815|NCT04415905|Anesthetics|anesthetics|mesh-ancestor
25539816|NCT04415905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25539817|NCT04415905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25539818|NCT04402073|Cisplatin|cisplatin|mesh-list
25539819|NCT04402073|Vincristine|vincristine|mesh-list
25539820|NCT04402073|Lomustine|lomustine|mesh-list
25539821|NCT04402073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539822|NCT04402073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25539823|NCT04402073|Tubulin Modulators|tubulin modulators|mesh-ancestor
25539824|NCT04402073|Antimitotic Agents|antimitotic agents|mesh-ancestor
25539825|NCT04402073|Mitosis Modulators|mitosis modulators|mesh-ancestor
25539826|NCT04402073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539827|NCT04402073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25539828|NCT04402073|Alkylating Agents|alkylating agents|mesh-ancestor
25539829|NCT04925648|Dasatinib|dasatinib|mesh-list
25539830|NCT04925648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539831|NCT04925648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25539832|NCT04925648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539833|NCT04925648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539834|NCT04384367|Naproxen|naproxen|mesh-list
25539835|NCT04384367|Rizatriptan|rizatriptan|mesh-list
25539836|NCT04384367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25539837|NCT04384367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25539838|NCT04384367|Analgesics|analgesics|mesh-ancestor
25539839|NCT04384367|Sensory System Agents|sensory system agents|mesh-ancestor
25539840|NCT04384367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25539841|NCT04384367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539842|NCT04384367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25539843|NCT04384367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25539844|NCT04384367|Gout Suppressants|gout suppressants|mesh-ancestor
25539845|NCT04384367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25539846|NCT04384367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539847|NCT04384367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539848|NCT04384367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25539849|NCT04384367|Serotonin Agents|serotonin agents|mesh-ancestor
25539850|NCT04384367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25539851|NCT04348747|Pembrolizumab|pembrolizumab|mesh-list
25539852|NCT04348747|Vaccines|vaccines|mesh-list
24564179|NCT00775489|Glucocorticoids|glucocorticoids|mesh-ancestor
25539853|NCT04348747|Immunologic Factors|immunologic factors|mesh-ancestor
25539854|NCT04348747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539855|NCT04348747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25539856|NCT04348747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539857|NCT04341311|Panobinostat|panobinostat|mesh-list
25539858|NCT04341311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539859|NCT04341311|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25539860|NCT04341311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539861|NCT04341311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650607|NCT01505673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25650608|NCT01505868|Carboplatin|carboplatin|mesh-list
25650609|NCT01505868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25650610|NCT01505881|Warfarin|warfarin|mesh-list
25650611|NCT01505881|Dabigatran|dabigatran|mesh-list
25650612|NCT01505881|Anticoagulants|anticoagulants|mesh-ancestor
25650613|NCT01505881|Antithrombins|antithrombins|mesh-ancestor
25650614|NCT01505881|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25650615|NCT01505881|Protease Inhibitors|protease inhibitors|mesh-ancestor
25539862|NCT04315233|Belinostat|belinostat|mesh-list
25539863|NCT04315233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539864|NCT04315233|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25539865|NCT04315233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539866|NCT04315233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539867|NCT04286178|Coenzyme Q10|coenzyme q10|mesh-list
25539868|NCT04286178|Micronutrients|micronutrients|mesh-ancestor
25539869|NCT04286178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539870|NCT04286178|Vitamins|vitamins|mesh-ancestor
25539871|NCT04268199|Bortezomib|bortezomib|mesh-list
25539872|NCT04268199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539873|NCT04259398|Propofol|propofol|mesh-list
25539874|NCT04259398|Sevoflurane|sevoflurane|mesh-list
25539875|NCT04259398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25539876|NCT04259398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25539877|NCT04259398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539878|NCT04259398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25539879|NCT04259398|Anesthetics, General|anesthetics, general|mesh-ancestor
25539880|NCT04259398|Anesthetics|anesthetics|mesh-ancestor
25539881|NCT04259398|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25539882|NCT04259398|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25539883|NCT04257188|Anesthetics|anesthetics|mesh-list
25539884|NCT04257188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25539885|NCT04257188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539886|NCT04224428|Fexofenadine|fexofenadine|mesh-list
25539887|NCT04224428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25539888|NCT04224428|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25539889|NCT04224428|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25539890|NCT04224428|Histamine Antagonists|histamine antagonists|mesh-ancestor
25539891|NCT04224428|Histamine Agents|histamine agents|mesh-ancestor
25539892|NCT04224428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25539893|NCT04224428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539894|NCT04224428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539895|NCT04224194|Adalimumab|adalimumab|mesh-list
25539896|NCT04224194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25539897|NCT04224194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25539898|NCT04200833|Golimumab|golimumab|mesh-list
25539899|NCT04200833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25539900|NCT04200833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25539901|NCT04200833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25539902|NCT04200833|Immunologic Factors|immunologic factors|mesh-ancestor
25539903|NCT04200833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539904|NCT04191889|Apatinib|apatinib|mesh-list
25539905|NCT04191889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539906|NCT04191889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25539907|NCT04191889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539908|NCT04191889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539909|NCT04173507|Avelumab|avelumab|mesh-list
25539910|NCT04173507|Talazoparib|talazoparib|mesh-list
25539911|NCT04173507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25539912|NCT04173507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25539913|NCT04173507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539914|NCT04173507|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25539915|NCT04173507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539916|NCT04173507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539917|NCT04173507|Immunologic Factors|immunologic factors|mesh-ancestor
25539918|NCT04173507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539919|NCT04165135|Factor VIII|factor viii|mesh-list
25539920|NCT04165135|Coagulants|coagulants|mesh-ancestor
25539921|NCT04150640|Pembrolizumab|pembrolizumab|mesh-list
25539922|NCT04150640|Nivolumab|nivolumab|mesh-list
25539923|NCT04150640|Trastuzumab|trastuzumab|mesh-list
25539924|NCT04150640|Fluorouracil|fluorouracil|mesh-list
25539925|NCT04150640|Oxaliplatin|oxaliplatin|mesh-list
25539926|NCT04150640|Irinotecan|irinotecan|mesh-list
25539927|NCT04150640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25539928|NCT04150640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539929|NCT04150640|Antimetabolites|antimetabolites|mesh-ancestor
25539930|NCT04150640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539931|NCT04150640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25539932|NCT04150640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25539933|NCT04150640|Immunologic Factors|immunologic factors|mesh-ancestor
25539934|NCT04150640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539935|NCT04150640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25539936|NCT04150640|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25539937|NCT04150640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25539938|NCT04150640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539939|NCT04091750|Nivolumab|nivolumab|mesh-list
25539940|NCT04091750|Ipilimumab|ipilimumab|mesh-list
25539941|NCT04091750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25539942|NCT04091750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539943|NCT04091750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25539944|NCT04091750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539945|NCT04068753|Niraparib|niraparib|mesh-list
25539946|NCT04068753|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25539947|NCT04068753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539948|NCT04068753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539949|NCT04068753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539950|NCT04066114|Mycophenolic Acid|mycophenolic acid|mesh-list
25539951|NCT04066114|Prednisone|prednisone|mesh-list
25539952|NCT04066114|Methylprednisolone|methylprednisolone|mesh-list
25539953|NCT04066114|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25539954|NCT04066114|Everolimus|everolimus|mesh-list
25539955|NCT04066114|Abatacept|abatacept|mesh-list
25539956|NCT04066114|Thymoglobulin|thymoglobulin|mesh-list
25539957|NCT04066114|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25539958|NCT04066114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25539959|NCT04066114|Glucocorticoids|glucocorticoids|mesh-ancestor
25539960|NCT04066114|Hormones|hormones|mesh-ancestor
25539961|NCT04066114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25539962|NCT04066114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539963|NCT04066114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25539964|NCT04066114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539965|NCT04066114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25539966|NCT04066114|Immunologic Factors|immunologic factors|mesh-ancestor
25539967|NCT04066114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25539968|NCT04066114|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25539969|NCT04066114|Antitubercular Agents|antitubercular agents|mesh-ancestor
25539970|NCT04066114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25539971|NCT04066114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25539972|NCT04066114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25539973|NCT04066114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539974|NCT04066114|Antiemetics|antiemetics|mesh-ancestor
25539975|NCT04066114|Autonomic Agents|autonomic agents|mesh-ancestor
25539976|NCT04066114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25539977|NCT04066114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25539978|NCT04066114|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25539979|NCT04066114|Protective Agents|protective agents|mesh-ancestor
25539980|NCT04066114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25539981|NCT04066114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25539982|NCT04064294|Levodopa|levodopa|mesh-list
25539983|NCT04064294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25539984|NCT04064294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25539985|NCT04064294|Dopamine Agents|dopamine agents|mesh-ancestor
25539986|NCT04064294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25539987|NCT04064294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25539988|NCT04064294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539989|NCT04004442|Avelumab|avelumab|mesh-list
25539990|NCT04004442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25539991|NCT04004442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539992|NCT03952403|Bevacizumab|bevacizumab|mesh-list
25539993|NCT03952403|Carboplatin|carboplatin|mesh-list
25539994|NCT03952403|Pemetrexed|pemetrexed|mesh-list
25539995|NCT03952403|Antibodies|antibodies|mesh-list
25539996|NCT03952403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25539997|NCT03952403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25539998|NCT03952403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25675003|NCT01779700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25539999|NCT03952403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25540000|NCT03952403|Growth Substances|growth substances|mesh-ancestor
25540001|NCT03952403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540002|NCT03952403|Growth Inhibitors|growth inhibitors|mesh-ancestor
25540003|NCT03952403|Immunologic Factors|immunologic factors|mesh-ancestor
25540004|NCT03952403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540005|NCT03952403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540006|NCT03952403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25540007|NCT03952403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25540008|NCT03944902|Niraparib|niraparib|mesh-list
25540009|NCT03944902|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25540010|NCT03944902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540011|NCT03944902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540012|NCT03944902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436059|NCT04766684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25436060|NCT04766684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436061|NCT04766684|Sensory System Agents|sensory system agents|mesh-ancestor
25436062|NCT04766684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25436063|NCT04766684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25436064|NCT04766684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25436065|NCT04766684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25436066|NCT04766684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25436067|NCT04766684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436068|NCT04765904|Fluorides|fluorides|mesh-list
25436069|NCT04765904|Cariostatic Agents|cariostatic agents|mesh-ancestor
25436070|NCT04765904|Protective Agents|protective agents|mesh-ancestor
25436071|NCT04765904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168907|NCT02046694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168908|NCT02046395|Amlodipine|amlodipine|mesh-list
25168909|NCT02046395|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25168910|NCT02046395|Hydralazine|hydralazine|mesh-list
25168911|NCT02046395|Terazosin|terazosin|mesh-list
25168912|NCT02046395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25168913|NCT02046395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25269533|NCT02409849|Octreotide|octreotide|mesh-list
25168914|NCT02046395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25168915|NCT02046395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168916|NCT02046395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25168917|NCT02046395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168918|NCT02046395|Vasodilator Agents|vasodilator agents|mesh-ancestor
25168919|NCT02046395|Diuretics|diuretics|mesh-ancestor
25168920|NCT02046395|Natriuretic Agents|natriuretic agents|mesh-ancestor
25168921|NCT02046395|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25168922|NCT02046395|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25168923|NCT02046395|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25168924|NCT02046395|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25168925|NCT02046395|Adrenergic Agents|adrenergic agents|mesh-ancestor
24459003|NCT00343369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459015|NCT00343369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24459016|NCT00343369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24459017|NCT00343369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822489|NCT00004488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822490|NCT00004488|Vitamins|vitamins|mesh-ancestor
25822491|NCT00004488|Micronutrients|micronutrients|mesh-ancestor
25822492|NCT00004488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25822493|NCT00004488|Antacids|antacids|mesh-ancestor
25822494|NCT00004488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822495|NCT00004488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25822496|NCT00004489|Cholecalciferol|cholecalciferol|mesh-list
25822497|NCT00004489|Vitamin D|vitamin d|mesh-list
25168926|NCT02046395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25168927|NCT02046395|Urological Agents|urological agents|mesh-ancestor
25168928|NCT02044341|Benzocaine|benzocaine|mesh-list
25168929|NCT02044341|Glycerol|glycerol|mesh-list
25168930|NCT02044341|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25168931|NCT02044341|Protective Agents|protective agents|mesh-ancestor
25168932|NCT02044341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168933|NCT02044341|Anesthetics, Local|anesthetics, local|mesh-ancestor
25168934|NCT02044341|Anesthetics|anesthetics|mesh-ancestor
25168935|NCT02044341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25168936|NCT02044341|Sensory System Agents|sensory system agents|mesh-ancestor
25168937|NCT02044341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25168938|NCT02042378|Rucaparib|rucaparib|mesh-list
25540013|NCT03916094|Trastuzumab|trastuzumab|mesh-list
25540014|NCT03916094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25540015|NCT03916094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540016|NCT03901339|Gemcitabine|gemcitabine|mesh-list
25274113|NCT02380625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445277|NCT00301054|Renal Agents|renal agents|mesh-ancestor
24773911|NCT01842893|Sensory System Agents|sensory system agents|mesh-ancestor
24773916|NCT01842893|Anesthetics|anesthetics|mesh-ancestor
25269579|NCT02409563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269580|NCT02409563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24456927|NCT00332735|Anesthetics|anesthetics|mesh-ancestor
24456928|NCT00332735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24456929|NCT00332735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456930|NCT00332735|Sensory System Agents|sensory system agents|mesh-ancestor
24773968|NCT01843153|Sensory System Agents|sensory system agents|mesh-ancestor
24773969|NCT01843153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773970|NCT01843166|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24773971|NCT01843166|Estrogens|estrogens|mesh-ancestor
24773972|NCT01843166|Hormones|hormones|mesh-ancestor
24773973|NCT01843166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24773974|NCT01843166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773976|NCT01843179|Sulindac|sulindac|mesh-list
24773978|NCT01843179|Antimetabolites|antimetabolites|mesh-ancestor
25675022|NCT01780324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25675023|NCT01780324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675024|NCT01780337|Oxytocin|oxytocin|mesh-list
25008717|NCT04626024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24700255|NCT01451593|Phenytoin|phenytoin|mesh-list
25269581|NCT02409563|Respiratory System Agents|respiratory system agents|mesh-ancestor
25269582|NCT02409563|Glucocorticoids|glucocorticoids|mesh-ancestor
25269583|NCT02409563|Hormones|hormones|mesh-ancestor
25269584|NCT02409563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25269585|NCT02409433|Lacosamide|lacosamide|mesh-list
25269586|NCT02409433|Phenytoin|phenytoin|mesh-list
24700283|NCT01451710|Hormones|hormones|mesh-ancestor
25540017|NCT03901339|Capecitabine|capecitabine|mesh-list
25540018|NCT03901339|Vinorelbine|vinorelbine|mesh-list
25540019|NCT03901339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25540020|NCT03901339|Antimetabolites|antimetabolites|mesh-ancestor
25540021|NCT03901339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540022|NCT03901339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540023|NCT03901339|Antiviral Agents|antiviral agents|mesh-ancestor
25540024|NCT03901339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24565089|NCT00778713|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24565090|NCT00778713|Protease Inhibitors|protease inhibitors|mesh-ancestor
24565093|NCT00778726|Benazepril|benazepril|mesh-list
25269588|NCT02409433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25269589|NCT02409433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25269590|NCT02409433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24468885|NCT00383851|Chelating Agents|chelating agents|mesh-ancestor
24468886|NCT00383851|Sequestering Agents|sequestering agents|mesh-ancestor
24468887|NCT00383851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24468888|NCT00383851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24468889|NCT00383851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24468890|NCT00383851|Growth Substances|growth substances|mesh-ancestor
24468891|NCT00383851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468892|NCT00383851|Growth Inhibitors|growth inhibitors|mesh-ancestor
24468925|NCT00383916|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24468926|NCT00383916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24468927|NCT00383916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774064|NCT01843647|Antimitotic Agents|antimitotic agents|mesh-ancestor
25675029|NCT01780389|Levomilnacipran|levomilnacipran|mesh-list
25675030|NCT01780389|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25269591|NCT02409433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269592|NCT02409433|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25269593|NCT02409433|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25269594|NCT02409017|Insulin|insulin|mesh-list
25675031|NCT01780389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25675032|NCT01780389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25540025|NCT03901339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540026|NCT03901339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25540027|NCT03901339|Immunologic Factors|immunologic factors|mesh-ancestor
25822498|NCT00004489|Alendronate|alendronate|mesh-list
25540028|NCT03901339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540029|NCT03901339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25540030|NCT03901339|Tubulin Modulators|tubulin modulators|mesh-ancestor
25540031|NCT03901339|Antimitotic Agents|antimitotic agents|mesh-ancestor
25540032|NCT03901339|Mitosis Modulators|mitosis modulators|mesh-ancestor
25540033|NCT03895840|Triamcinolone|triamcinolone|mesh-list
25540034|NCT03895840|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25540035|NCT03895840|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25540036|NCT03895840|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25243338|NCT05346224|Pertuzumab|pertuzumab|mesh-list
25243339|NCT05346224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25243340|NCT05346224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24565271|NCT00779454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24565273|NCT00779493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565274|NCT00779493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24565275|NCT00779493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24565276|NCT00779493|Analgesics|analgesics|mesh-ancestor
24565277|NCT00779493|Sensory System Agents|sensory system agents|mesh-ancestor
24565278|NCT00779493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24565284|NCT00779649|Bisacodyl|bisacodyl|mesh-list
25269595|NCT02409017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25269596|NCT02409017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269597|NCT02408991|Lenograstim|lenograstim|mesh-list
25269598|NCT02408991|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25269599|NCT02408991|Immunologic Factors|immunologic factors|mesh-ancestor
25269600|NCT02408991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269601|NCT02409004|Rifampin|rifampin|mesh-list
25675042|NCT01780454|Rituximab|rituximab|mesh-list
25540037|NCT03895840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25540038|NCT03895840|Glucocorticoids|glucocorticoids|mesh-ancestor
25540039|NCT03895840|Hormones|hormones|mesh-ancestor
25540040|NCT03895840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25540041|NCT03895840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540042|NCT03895840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25540043|NCT03895840|Immunologic Factors|immunologic factors|mesh-ancestor
25540044|NCT03895840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540045|NCT03895840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540046|NCT03895762|Fentanyl|fentanyl|mesh-list
25540047|NCT03895762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25540048|NCT03895762|Narcotics|narcotics|mesh-ancestor
25540049|NCT03895762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25540050|NCT03895762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540051|NCT03895762|Analgesics|analgesics|mesh-ancestor
25540052|NCT03895762|Sensory System Agents|sensory system agents|mesh-ancestor
25540053|NCT03895762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25540054|NCT03895762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25540055|NCT03895762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25540056|NCT03895762|Anesthetics, General|anesthetics, general|mesh-ancestor
25540057|NCT03895762|Anesthetics|anesthetics|mesh-ancestor
25540058|NCT03874338|Colchicine|colchicine|mesh-list
25540059|NCT03874338|Gout Suppressants|gout suppressants|mesh-ancestor
25540060|NCT03874338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25540061|NCT03874338|Tubulin Modulators|tubulin modulators|mesh-ancestor
25540062|NCT03874338|Antimitotic Agents|antimitotic agents|mesh-ancestor
25540063|NCT03874338|Mitosis Modulators|mitosis modulators|mesh-ancestor
25540064|NCT03874338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540065|NCT03874338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540066|NCT03869034|Leucovorin|leucovorin|mesh-list
25540067|NCT03869034|Fluorouracil|fluorouracil|mesh-list
25540068|NCT03869034|Oxaliplatin|oxaliplatin|mesh-list
25540069|NCT03869034|Antimetabolites|antimetabolites|mesh-ancestor
25540070|NCT03869034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540071|NCT03869034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25540072|NCT03869034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540073|NCT03869034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25540074|NCT03869034|Immunologic Factors|immunologic factors|mesh-ancestor
25540075|NCT03869034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540076|NCT03869034|Antidotes|antidotes|mesh-ancestor
25540077|NCT03869034|Protective Agents|protective agents|mesh-ancestor
25540078|NCT03869034|Vitamin B Complex|vitamin b complex|mesh-ancestor
25540079|NCT03869034|Vitamins|vitamins|mesh-ancestor
25540080|NCT03869034|Micronutrients|micronutrients|mesh-ancestor
25540081|NCT03856632|Liraglutide|liraglutide|mesh-list
25540082|NCT03856632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
25540083|NCT03856632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25540084|NCT03856632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540085|NCT03856632|Incretins|incretins|mesh-ancestor
25540086|NCT03856632|Hormones|hormones|mesh-ancestor
25540087|NCT03856632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25269605|NCT02409004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25540088|NCT03840421|Gemcitabine|gemcitabine|mesh-list
25540089|NCT03840421|Cisplatin|cisplatin|mesh-list
25540090|NCT03840421|Fluorouracil|fluorouracil|mesh-list
25540091|NCT03840421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540092|NCT03840421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25540093|NCT03840421|Antimetabolites|antimetabolites|mesh-ancestor
25540094|NCT03840421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540095|NCT03840421|Antiviral Agents|antiviral agents|mesh-ancestor
25540096|NCT03840421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24484468|NCT00448552|Antimetabolites|antimetabolites|mesh-ancestor
24451949|NCT00325390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24469053|NCT00384436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24469054|NCT00384475|Ciclesonide|ciclesonide|mesh-list
24484469|NCT00448552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484470|NCT00448552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484471|NCT00448578|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24451950|NCT00325390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451952|NCT00325429|Vildagliptin|vildagliptin|mesh-list
24451980|NCT00325637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451981|NCT00325637|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24451982|NCT00325637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24451983|NCT00325637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24832900|NCT02172404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24832901|NCT02172404|Respiratory System Agents|respiratory system agents|mesh-ancestor
24832902|NCT02172404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24774209|NCT01844427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24565564|NCT00781261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24565565|NCT00781261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565566|NCT00781287|Raltegravir Potassium|raltegravir potassium|mesh-list
24565567|NCT00781287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25269612|NCT02409004|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25269613|NCT02409004|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25269616|NCT02409290|Moxifloxacin|moxifloxacin|mesh-list
25269617|NCT02409290|Levofloxacin|levofloxacin|mesh-list
24469055|NCT00384475|Glucocorticoids|glucocorticoids|mesh-ancestor
25540097|NCT03840421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540098|NCT03840421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25540099|NCT03840421|Immunologic Factors|immunologic factors|mesh-ancestor
25540100|NCT03840421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650616|NCT01505881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650617|NCT01505881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650618|NCT01505933|Dexmedetomidine|dexmedetomidine|mesh-list
25650619|NCT01505933|Propofol|propofol|mesh-list
25540101|NCT03818399|Buprenorphine|buprenorphine|mesh-list
25540102|NCT03818399|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25540103|NCT03818399|Narcotics|narcotics|mesh-ancestor
24565679|NCT00781755|Cholinergic Agents|cholinergic agents|mesh-ancestor
24565680|NCT00781755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24565681|NCT00781755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565682|NCT00781755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565683|NCT00781781|Alemtuzumab|alemtuzumab|mesh-list
24565684|NCT00781781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24565685|NCT00781781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24832919|NCT02172417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24740716|NCT01689987|Alkylating Agents|alkylating agents|mesh-ancestor
24700748|NCT01454700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25269618|NCT02409290|Isoniazid|isoniazid|mesh-list
25269619|NCT02409290|Pyrazinamide|pyrazinamide|mesh-list
25269620|NCT02409290|Ethambutol|ethambutol|mesh-list
25269621|NCT02409290|Bedaquiline|bedaquiline|mesh-list
25269622|NCT02409290|Clofazimine|clofazimine|mesh-list
25269623|NCT02409290|Kanamycin|kanamycin|mesh-list
25269624|NCT02409290|Prothionamide|prothionamide|mesh-list
25269625|NCT02409290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25269626|NCT02409290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25269627|NCT02409290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25269628|NCT02409290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24469097|NCT00384566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469099|NCT00384566|Protective Agents|protective agents|mesh-ancestor
25540104|NCT03818399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25540105|NCT03818399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540106|NCT03818399|Analgesics|analgesics|mesh-ancestor
25540107|NCT03818399|Sensory System Agents|sensory system agents|mesh-ancestor
25540108|NCT03818399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25540109|NCT03818399|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25540110|NCT03810287|Domperidone|domperidone|mesh-list
25540111|NCT03810287|Antiemetics|antiemetics|mesh-ancestor
25540112|NCT03810287|Autonomic Agents|autonomic agents|mesh-ancestor
25540113|NCT03810287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25540114|NCT03810287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851822|NCT02259426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24851823|NCT02259426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24851824|NCT02259491|Calcium|calcium|mesh-list
24851825|NCT02259491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24851826|NCT02259491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851827|NCT02259530|Psychotropic Drugs|psychotropic drugs|mesh-list
24851828|NCT02259543|Tetracycline|tetracycline|mesh-list
24851829|NCT02259543|Citric Acid|citric acid|mesh-list
24851830|NCT02259543|Sodium Citrate|sodium citrate|mesh-list
24851831|NCT02259543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24851832|NCT02259543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24565758|NCT00782327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24565769|NCT00782405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832935|NCT02172430|Respiratory System Agents|respiratory system agents|mesh-ancestor
24832936|NCT02172430|Parasympatholytics|parasympatholytics|mesh-ancestor
24832937|NCT02172430|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25269629|NCT02409290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25269630|NCT02409290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269635|NCT02409290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25269636|NCT02409290|Antitubercular Agents|antitubercular agents|mesh-ancestor
24941729|NCT03988452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24613195|NCT01017666|Purinergic Agents|purinergic agents|mesh-ancestor
25675055|NCT01780662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25675056|NCT01780662|Antibodies|antibodies|mesh-list
25675057|NCT01780662|Immunoglobulins|immunoglobulins|mesh-list
25675058|NCT01780662|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25675059|NCT01780662|Immunoconjugates|immunoconjugates|mesh-list
25675060|NCT01780662|Immunologic Factors|immunologic factors|mesh-ancestor
25675063|NCT01780662|Antimetabolites|antimetabolites|mesh-ancestor
24791685|NCT03580928|Obinutuzumab|obinutuzumab|mesh-list
24565850|NCT00783081|Cilostazol|cilostazol|mesh-list
24832939|NCT02172430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24832940|NCT02172430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832941|NCT02172443|Tiotropium Bromide|tiotropium bromide|mesh-list
24700992|NCT01456260|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24832964|NCT02172456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24701106|NCT01456689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25269637|NCT02409290|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25269638|NCT02409290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24832973|NCT02172469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24832974|NCT02172469|Respiratory System Agents|respiratory system agents|mesh-ancestor
24832975|NCT02172469|Parasympatholytics|parasympatholytics|mesh-ancestor
24832976|NCT02172469|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24832977|NCT02172469|Cholinergic Agents|cholinergic agents|mesh-ancestor
25675068|NCT01780662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540115|NCT03810287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25540116|NCT03810287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25540117|NCT03810287|Dopamine Agents|dopamine agents|mesh-ancestor
25540118|NCT03810287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25540119|NCT03810287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540120|NCT03805477|Nintedanib|nintedanib|mesh-list
25540121|NCT03805477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540122|NCT03805477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24565979|NCT00783653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565980|NCT00783653|Growth Inhibitors|growth inhibitors|mesh-ancestor
24565990|NCT00783731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24565991|NCT00783731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24565992|NCT00783731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24565993|NCT00783731|Anesthetics, General|anesthetics, general|mesh-ancestor
24565995|NCT00783731|GABA Modulators|gaba modulators|mesh-ancestor
24565996|NCT00783731|GABA Agents|gaba agents|mesh-ancestor
24565997|NCT00783731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24565998|NCT00783731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741255|NCT01693081|Apomorphine|apomorphine|mesh-list
24452076|NCT00325949|Antipyretics|antipyretics|mesh-ancestor
24452081|NCT00325949|Respiratory System Agents|respiratory system agents|mesh-ancestor
24452082|NCT00325949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24452083|NCT00325949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24452084|NCT00325949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24452085|NCT00325962|Verapamil|verapamil|mesh-list
25081328|NCT03331211|Ponatinib|ponatinib|mesh-list
25081329|NCT03331211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081330|NCT03331211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24774442|NCT01845532|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25269643|NCT02409290|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25269644|NCT02409199|Docetaxel|docetaxel|mesh-list
25269645|NCT02409199|Apatinib|apatinib|mesh-list
24833007|NCT02172495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675070|NCT01780831|Raltegravir Potassium|raltegravir potassium|mesh-list
25675071|NCT01780831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25675072|NCT01780831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25675073|NCT01780831|Antiviral Agents|antiviral agents|mesh-ancestor
25675074|NCT01780831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675075|NCT01780831|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25675076|NCT01780831|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25675077|NCT01780831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540123|NCT03805477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540124|NCT03805477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540125|NCT03781128|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
25540126|NCT03781128|Hallucinogens|hallucinogens|mesh-ancestor
25540127|NCT03781128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540128|NCT03781128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25540129|NCT03781128|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25540130|NCT03781128|Serotonin Agents|serotonin agents|mesh-ancestor
25540131|NCT03781128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25540132|NCT03781128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540133|NCT03781128|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25540134|NCT03725384|Ascorbic Acid|ascorbic acid|mesh-list
25540135|NCT03725384|Iron|iron|mesh-list
25540136|NCT03725384|Vitamins|vitamins|mesh-ancestor
25243527|NCT05307198|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25243528|NCT05307198|Immunologic Factors|immunologic factors|mesh-ancestor
25243529|NCT05307198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566110|NCT00784446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566112|NCT00784446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24791688|NCT03580928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24833050|NCT02172547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24833051|NCT02172547|Autonomic Agents|autonomic agents|mesh-ancestor
24833052|NCT02172547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25269648|NCT02409199|Antimitotic Agents|antimitotic agents|mesh-ancestor
25269649|NCT02409199|Mitosis Modulators|mitosis modulators|mesh-ancestor
25269650|NCT02409199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269651|NCT02409199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25269652|NCT02409199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25269653|NCT02409147|Aspirin|aspirin|mesh-list
24469409|NCT00385645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24469410|NCT00385645|Antiviral Agents|antiviral agents|mesh-ancestor
24469411|NCT00385645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24469414|NCT00385645|Antimetabolites|antimetabolites|mesh-ancestor
24469475|NCT00385970|Vitamins|vitamins|mesh-ancestor
25675080|NCT01780935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25675081|NCT01780935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25675082|NCT01780935|Growth Substances|growth substances|mesh-ancestor
25675083|NCT01780935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675084|NCT01780935|Growth Inhibitors|growth inhibitors|mesh-ancestor
25675085|NCT01780935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675086|NCT01780974|Thioctic Acid|thioctic acid|mesh-list
25540137|NCT03725384|Micronutrients|micronutrients|mesh-ancestor
25540138|NCT03725384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540139|NCT03725384|Trace Elements|trace elements|mesh-ancestor
25540140|NCT03725384|Antioxidants|antioxidants|mesh-ancestor
25540141|NCT03725384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540142|NCT03725384|Protective Agents|protective agents|mesh-ancestor
25540143|NCT03674827|Vaccines|vaccines|mesh-list
25540144|NCT03674827|Immunologic Factors|immunologic factors|mesh-ancestor
25540145|NCT03674827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540146|NCT03642366|Tadalafil|tadalafil|mesh-list
25540147|NCT03642366|Vasodilator Agents|vasodilator agents|mesh-ancestor
25540148|NCT03642366|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25540149|NCT03642366|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25540150|NCT03642366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540151|NCT03642366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540152|NCT03642366|Urological Agents|urological agents|mesh-ancestor
25540153|NCT03641846|Tadalafil|tadalafil|mesh-list
25540154|NCT03641846|Vasodilator Agents|vasodilator agents|mesh-ancestor
24423005|NCT00224419|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24566121|NCT00784472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24566122|NCT00784472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008803|NCT04365985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008804|NCT04365985|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24774588|NCT01846559|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24774589|NCT01846559|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24774591|NCT01846559|Purinergic Agents|purinergic agents|mesh-ancestor
24774592|NCT01846559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24774593|NCT01846559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774594|NCT01846559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269654|NCT02409147|Nystatin|nystatin|mesh-list
25269655|NCT02409147|Prednisone|prednisone|mesh-list
25269656|NCT02409147|Thymoglobulin|thymoglobulin|mesh-list
25269657|NCT02409147|Basiliximab|basiliximab|mesh-list
25269658|NCT02409147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25269659|NCT02409147|Glucocorticoids|glucocorticoids|mesh-ancestor
25540155|NCT03641846|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25540156|NCT03641846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25540157|NCT03641846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540158|NCT03641846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540159|NCT03641846|Urological Agents|urological agents|mesh-ancestor
25540160|NCT03603496|Nicotine|nicotine|mesh-list
25540161|NCT03603496|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25540162|NCT03603496|Autonomic Agents|autonomic agents|mesh-ancestor
25540163|NCT03603496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25540164|NCT03603496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274150|NCT02380313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25274151|NCT02380313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452159|NCT00326235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452160|NCT00326248|Casopitant|casopitant|mesh-list
24452161|NCT00326248|Antiemetics|antiemetics|mesh-ancestor
24833065|NCT02172560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833066|NCT02172560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24833067|NCT02172560|Respiratory System Agents|respiratory system agents|mesh-ancestor
24833068|NCT02172560|Parasympatholytics|parasympatholytics|mesh-ancestor
24833069|NCT02172560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24833070|NCT02172560|Cholinergic Agents|cholinergic agents|mesh-ancestor
24833073|NCT02172573|Pramipexole|pramipexole|mesh-list
24833091|NCT02172586|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24833092|NCT02172586|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24833103|NCT02172729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833104|NCT02172729|Sensory System Agents|sensory system agents|mesh-ancestor
24833105|NCT02172729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24833106|NCT02172729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24833107|NCT02172729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24833108|NCT02172729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25540165|NCT03603496|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25540166|NCT03603496|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25540167|NCT03603496|Cholinergic Agents|cholinergic agents|mesh-ancestor
25540168|NCT03603496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25540169|NCT03603496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540170|NCT03558373|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25540171|NCT03558373|Immunologic Factors|immunologic factors|mesh-ancestor
25540172|NCT03558373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540173|NCT03548454|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25436147|NCT04764825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25540174|NCT03548454|Desipramine|desipramine|mesh-list
25822499|NCT00004489|Calcium Carbonate|calcium carbonate|mesh-list
25540175|NCT03548454|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25540176|NCT03548454|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25540177|NCT03548454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24566244|NCT00784862|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24566245|NCT00784862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24566246|NCT00784862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566266|NCT00784940|Anastrozole|anastrozole|mesh-list
24833117|NCT02172781|Autonomic Agents|autonomic agents|mesh-ancestor
24620540|NCT01057498|RNS60|rns60|mesh-list
24833122|NCT02172781|Parasympatholytics|parasympatholytics|mesh-ancestor
24833123|NCT02172781|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24701546|NCT01459445|Hormones|hormones|mesh-ancestor
25269677|NCT02409147|Antipyretics|antipyretics|mesh-ancestor
25269678|NCT02409147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25269679|NCT02409147|Immunologic Factors|immunologic factors|mesh-ancestor
25269680|NCT02409147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25269681|NCT02409147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25269682|NCT02409147|Antifungal Agents|antifungal agents|mesh-ancestor
24469495|NCT00386061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24469496|NCT00386061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469498|NCT00386074|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24469499|NCT00386074|Chelating Agents|chelating agents|mesh-ancestor
24469500|NCT00386074|Sequestering Agents|sequestering agents|mesh-ancestor
24633739|NCT01131000|Analgesics|analgesics|mesh-ancestor
25279168|NCT02346110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25675104|NCT01780987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25675105|NCT01780987|Protease Inhibitors|protease inhibitors|mesh-ancestor
25675106|NCT01780987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675107|NCT01781169|Vitamin D|vitamin d|mesh-list
25540178|NCT03548454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540179|NCT03548454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25540180|NCT03548454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540181|NCT03548454|Analgesics|analgesics|mesh-ancestor
25540182|NCT03548454|Sensory System Agents|sensory system agents|mesh-ancestor
25540183|NCT03548454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25540184|NCT03548454|Antidepressive Agents|antidepressive agents|mesh-ancestor
25540185|NCT03548454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25540186|NCT03548454|Dopamine Agents|dopamine agents|mesh-ancestor
25540187|NCT03548454|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25540188|NCT03548454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540189|NCT03548454|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25540190|NCT03548454|Adrenergic Agents|adrenergic agents|mesh-ancestor
24566396|NCT00785460|Immunologic Factors|immunologic factors|mesh-ancestor
24566397|NCT00785460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566398|NCT00785460|Chelating Agents|chelating agents|mesh-ancestor
24833196|NCT02173106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833197|NCT02173106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24833198|NCT02173106|Immunologic Factors|immunologic factors|mesh-ancestor
24833210|NCT02173132|Nootropic Agents|nootropic agents|mesh-ancestor
24833212|NCT02173145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25269683|NCT02409147|Ionophores|ionophores|mesh-ancestor
25269684|NCT02409147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25269685|NCT02409186|Paclitaxel|paclitaxel|mesh-list
25269686|NCT02409186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25269687|NCT02409186|Cisplatin|cisplatin|mesh-list
25269688|NCT02409186|Nimotuzumab|nimotuzumab|mesh-list
25269689|NCT02409186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25269690|NCT02409186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25269691|NCT02409186|Tubulin Modulators|tubulin modulators|mesh-ancestor
24452182|NCT00326352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452183|NCT00326352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24452184|NCT00326352|Anesthetics, General|anesthetics, general|mesh-ancestor
24452186|NCT00326352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24452188|NCT00326352|Analgesics|analgesics|mesh-ancestor
24452189|NCT00326352|Sensory System Agents|sensory system agents|mesh-ancestor
24452190|NCT00326352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24452191|NCT00326378|Docetaxel|docetaxel|mesh-list
24452192|NCT00326378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24452193|NCT00326378|Tubulin Modulators|tubulin modulators|mesh-ancestor
24452194|NCT00326378|Antimitotic Agents|antimitotic agents|mesh-ancestor
24452195|NCT00326378|Mitosis Modulators|mitosis modulators|mesh-ancestor
25675108|NCT01781169|Vitamins|vitamins|mesh-ancestor
25540191|NCT03526900|Atezolizumab|atezolizumab|mesh-list
25540192|NCT03526900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540193|NCT03526887|Pembrolizumab|pembrolizumab|mesh-list
25540194|NCT03526887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25540195|NCT03526887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540196|NCT03517137|Cyclophosphamide|cyclophosphamide|mesh-list
25540197|NCT03517137|Dacarbazine|dacarbazine|mesh-list
25540198|NCT03517137|Etoposide|etoposide|mesh-list
25540199|NCT03517137|Doxorubicin|doxorubicin|mesh-list
25540200|NCT03517137|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25540201|NCT03517137|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25540202|NCT03517137|Vinblastine|vinblastine|mesh-list
25540203|NCT03517137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25540204|NCT03517137|Immunologic Factors|immunologic factors|mesh-ancestor
25540205|NCT03517137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540206|NCT03517137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25540207|NCT03517137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25540208|NCT03517137|Alkylating Agents|alkylating agents|mesh-ancestor
25540209|NCT03517137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540210|NCT03517137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540211|NCT03517137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25540212|NCT03517137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25540213|NCT03517137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25540214|NCT03517137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25540215|NCT03517137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540216|NCT03517137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25540217|NCT03517137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25540218|NCT03517137|Tubulin Modulators|tubulin modulators|mesh-ancestor
25540219|NCT03517137|Antimitotic Agents|antimitotic agents|mesh-ancestor
25540220|NCT03517137|Mitosis Modulators|mitosis modulators|mesh-ancestor
25540221|NCT03513211|Hydroxychloroquine|hydroxychloroquine|mesh-list
25540222|NCT03513211|Itraconazole|itraconazole|mesh-list
25540223|NCT03513211|Antimalarials|antimalarials|mesh-ancestor
25540224|NCT03513211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24566645|NCT00786851|Growth Inhibitors|growth inhibitors|mesh-ancestor
24566646|NCT00786851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566648|NCT00787007|Phytoestrogens|phytoestrogens|mesh-ancestor
24566649|NCT00787007|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24566650|NCT00787007|Estrogens|estrogens|mesh-ancestor
24566651|NCT00787007|Hormones|hormones|mesh-ancestor
25243614|NCT05276219|Natriuretic Agents|natriuretic agents|mesh-ancestor
25243615|NCT05276219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243619|NCT05276219|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25269703|NCT02408978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25269704|NCT02408978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25269705|NCT02408978|Gout Suppressants|gout suppressants|mesh-ancestor
25269706|NCT02408978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25269707|NCT02408978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25269708|NCT02408978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269709|NCT02409238|Metformin|metformin|mesh-list
25269710|NCT02409238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25269711|NCT02409238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275481|NCT02372149|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25275482|NCT02372149|Antibodies|antibodies|mesh-list
25275483|NCT02372149|gamma-Globulins|gamma-globulins|mesh-list
25275484|NCT02372149|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25275485|NCT02372149|Immunologic Factors|immunologic factors|mesh-ancestor
25275486|NCT02372149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275487|NCT02371941|Cromolyn Sodium|cromolyn sodium|mesh-list
25275488|NCT02371941|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
25275489|NCT02371941|Immunologic Factors|immunologic factors|mesh-ancestor
24634312|NCT01132768|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25675119|NCT01781403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675120|NCT01781403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675122|NCT01781403|Alkylating Agents|alkylating agents|mesh-ancestor
25540225|NCT03513211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25540226|NCT03513211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25540227|NCT03513211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540228|NCT03513211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540229|NCT03513211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25540230|NCT03513211|Antifungal Agents|antifungal agents|mesh-ancestor
25540231|NCT03513211|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25540232|NCT03513211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25540233|NCT03513211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25243651|NCT05265910|Dermatologic Agents|dermatologic agents|mesh-ancestor
25243652|NCT05265910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25243653|NCT05265910|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25243654|NCT05265910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25243655|NCT05265910|Histamine Antagonists|histamine antagonists|mesh-ancestor
25243656|NCT05265910|Histamine Agents|histamine agents|mesh-ancestor
24833278|NCT02173639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24833279|NCT02173639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833281|NCT02173652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24833282|NCT02173652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833284|NCT02173652|Hormones|hormones|mesh-ancestor
24833285|NCT02173652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24591426|NCT00916500|Cisplatin|cisplatin|mesh-list
24833286|NCT02173652|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24833287|NCT02173652|Protease Inhibitors|protease inhibitors|mesh-ancestor
24833288|NCT02173652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24833289|NCT02173652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833290|NCT02173665|Linagliptin|linagliptin|mesh-list
24833291|NCT02173665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24833292|NCT02173665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833293|NCT02173665|Incretins|incretins|mesh-ancestor
24833294|NCT02173665|Hormones|hormones|mesh-ancestor
24920912|NCT04196608|Ceftolozane|ceftolozane|mesh-list
24920913|NCT04196608|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
25269739|NCT02408939|Hydrocortisone|hydrocortisone|mesh-list
25269712|NCT02408679|Vitamin D|vitamin d|mesh-list
25269713|NCT02408679|Vitamins|vitamins|mesh-ancestor
25269714|NCT02408679|Micronutrients|micronutrients|mesh-ancestor
25675126|NCT01781468|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25675127|NCT01781468|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25675130|NCT01781611|Aspirin|aspirin|mesh-list
25540234|NCT03513211|Hormone Antagonists|hormone antagonists|mesh-ancestor
25540235|NCT03513211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25540236|NCT03513211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540237|NCT03513211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25540238|NCT03481972|Doxycycline|doxycycline|mesh-list
25540239|NCT03481972|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
25540240|NCT03481972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25540241|NCT03481972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25540242|NCT03481972|Antimalarials|antimalarials|mesh-ancestor
25243699|NCT05254548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25243700|NCT05254548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25243701|NCT05254548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25243702|NCT05254548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25243703|NCT05254548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25243704|NCT05246982|Capecitabine|capecitabine|mesh-list
25243705|NCT05246982|Oxaliplatin|oxaliplatin|mesh-list
25243706|NCT05246982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25243707|NCT05246982|Antimetabolites|antimetabolites|mesh-ancestor
25243708|NCT05246982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243709|NCT05246982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25243710|NCT05246943|Fibrin fragment D|fibrin fragment d|mesh-list
25243711|NCT05246943|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25540243|NCT03481972|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25540244|NCT03481972|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25540245|NCT03481972|Antiviral Agents|antiviral agents|mesh-ancestor
25540246|NCT03481972|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25540247|NCT03481972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25540248|NCT03480802|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25540249|NCT03480802|Immunologic Factors|immunologic factors|mesh-ancestor
25540250|NCT03480802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540251|NCT03474458|Doxycycline|doxycycline|mesh-list
25243766|NCT05226351|Dronabinol|dronabinol|mesh-list
25243767|NCT05226351|Hallucinogens|hallucinogens|mesh-ancestor
25243768|NCT05226351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243769|NCT05226351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25243770|NCT05226351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25243771|NCT05226351|Analgesics|analgesics|mesh-ancestor
25243772|NCT05226351|Sensory System Agents|sensory system agents|mesh-ancestor
25243773|NCT05226351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25243774|NCT05226351|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24452247|NCT00326586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24452248|NCT00326586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920972|NCT04195373|Flucytosine|flucytosine|mesh-list
24452251|NCT00326664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24452252|NCT00326664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452253|NCT00326664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24452254|NCT00326664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24452255|NCT00326768|Telmisartan|telmisartan|mesh-list
25675149|NCT01781806|Tenofovir|tenofovir|mesh-list
25675170|NCT01782131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675171|NCT01782131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675172|NCT01782131|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25070986|NCT03414333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070987|NCT03414164|Procyanidin|procyanidin|mesh-list
25070988|NCT03414164|Antioxidants|antioxidants|mesh-ancestor
25070989|NCT03414164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070990|NCT03414164|Protective Agents|protective agents|mesh-ancestor
25540252|NCT03474458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25540253|NCT03474458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25540254|NCT03474458|Antimalarials|antimalarials|mesh-ancestor
25540255|NCT03474458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25540256|NCT03474458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25540257|NCT03472521|Gabapentin|gabapentin|mesh-list
25540258|NCT03472521|Analgesics|analgesics|mesh-ancestor
25540259|NCT03472521|Sensory System Agents|sensory system agents|mesh-ancestor
25540260|NCT03472521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24445793|NCT00302627|Calcium Carbonate|calcium carbonate|mesh-list
24445795|NCT00302627|Micronutrients|micronutrients|mesh-ancestor
24445799|NCT00302627|Antacids|antacids|mesh-ancestor
24445800|NCT00302627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540261|NCT03472521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540262|NCT03472521|Anticonvulsants|anticonvulsants|mesh-ancestor
25540263|NCT03472521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25540264|NCT03472521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25540265|NCT03472521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25540266|NCT03472521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25540267|NCT03472521|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25540268|NCT03472521|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25540269|NCT03472521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25540270|NCT03472521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675197|NCT01782495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25675199|NCT01782495|Antimetabolites|antimetabolites|mesh-ancestor
25540271|NCT03472521|Antimanic Agents|antimanic agents|mesh-ancestor
25540272|NCT03439280|Dexamethasone|dexamethasone|mesh-list
25540273|NCT03439280|Pomalidomide|pomalidomide|mesh-list
25540274|NCT03439280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25540275|NCT03439280|Antiemetics|antiemetics|mesh-ancestor
25540276|NCT03439280|Autonomic Agents|autonomic agents|mesh-ancestor
25540277|NCT03439280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25540278|NCT03439280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540279|NCT03439280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25540280|NCT03439280|Glucocorticoids|glucocorticoids|mesh-ancestor
25540281|NCT03439280|Hormones|hormones|mesh-ancestor
24423006|NCT00224419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25540282|NCT03439280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25540283|NCT03439280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25540284|NCT03439280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540285|NCT03439280|Immunologic Factors|immunologic factors|mesh-ancestor
25540286|NCT03439280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25540287|NCT03439280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25540288|NCT03439280|Growth Substances|growth substances|mesh-ancestor
25540289|NCT03439280|Growth Inhibitors|growth inhibitors|mesh-ancestor
25244106|NCT05038410|Wobenzym|wobenzym|mesh-list
25540290|NCT03430011|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25540291|NCT03430011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25540292|NCT03363217|Trametinib|trametinib|mesh-list
25540293|NCT03363217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24834679|NCT02180425|Analgesics|analgesics|mesh-ancestor
25540294|NCT03363217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25540295|NCT03363217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540296|NCT03363217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540297|NCT03357159|Cyclophosphamide|cyclophosphamide|mesh-list
25540298|NCT03357159|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25540299|NCT03357159|Immunoglobulins|immunoglobulins|mesh-list
25540300|NCT03357159|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25540301|NCT03357159|Antibodies|antibodies|mesh-list
25540302|NCT03357159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25540303|NCT03357159|Immunologic Factors|immunologic factors|mesh-ancestor
25540304|NCT03357159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540305|NCT03357159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25540306|NCT03357159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25540307|NCT03357159|Alkylating Agents|alkylating agents|mesh-ancestor
25540308|NCT03357159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540309|NCT03357159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24423007|NCT00224419|Cholinergic Agents|cholinergic agents|mesh-ancestor
25675260|NCT01782963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25675261|NCT01782963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25675262|NCT01782963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675263|NCT01782963|Immunologic Factors|immunologic factors|mesh-ancestor
25675264|NCT01782963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25675265|NCT01782963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25244324|NCT04836429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244327|NCT04828083|Lidocaine|lidocaine|mesh-list
25540310|NCT03357159|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25540311|NCT03337919|Nivolumab|nivolumab|mesh-list
25540312|NCT03337919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25540313|NCT03337919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540314|NCT03337919|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25540315|NCT03337919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540316|NCT03316859|Naloxegol|naloxegol|mesh-list
25540317|NCT03316859|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25540318|NCT03316859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675277|NCT01783054|Immunologic Factors|immunologic factors|mesh-ancestor
25675278|NCT01783054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675279|NCT01783236|Acetaminophen|acetaminophen|mesh-list
25675280|NCT01783236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25675281|NCT01783236|Analgesics|analgesics|mesh-ancestor
25675282|NCT01783236|Sensory System Agents|sensory system agents|mesh-ancestor
25675283|NCT01783236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851979|NCT02259946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24812309|NCT02051387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25540319|NCT03316859|Sensory System Agents|sensory system agents|mesh-ancestor
25540320|NCT03316859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25540321|NCT03309137|Chlorhexidine|chlorhexidine|mesh-list
25540322|NCT03309137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25540323|NCT03309137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25540324|NCT03309137|Disinfectants|disinfectants|mesh-ancestor
25540325|NCT03303950|Cyclophosphamide|cyclophosphamide|mesh-list
25540326|NCT03303950|Busulfan|busulfan|mesh-list
25540327|NCT03303950|Fludarabine|fludarabine|mesh-list
25540328|NCT03303950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25540329|NCT03303950|Immunologic Factors|immunologic factors|mesh-ancestor
25540330|NCT03303950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540331|NCT03303950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25540332|NCT03303950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25540333|NCT03303950|Alkylating Agents|alkylating agents|mesh-ancestor
25540334|NCT03303950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244413|NCT04754945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25244414|NCT04754945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25244415|NCT04754945|Antiemetics|antiemetics|mesh-ancestor
25244416|NCT04754945|Autonomic Agents|autonomic agents|mesh-ancestor
25244417|NCT04754945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25244418|NCT04754945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25244419|NCT04754945|Glucocorticoids|glucocorticoids|mesh-ancestor
25244420|NCT04754945|Hormones|hormones|mesh-ancestor
25244421|NCT04754945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25244426|NCT04748848|Azacitidine|azacitidine|mesh-list
24835008|NCT02182024|Protease Inhibitors|protease inhibitors|mesh-ancestor
24637092|NCT01148576|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24835055|NCT02182167|Respiratory System Agents|respiratory system agents|mesh-ancestor
24835056|NCT02182167|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25269794|NCT02408328|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25269795|NCT02408328|Purinergic Agents|purinergic agents|mesh-ancestor
25269796|NCT02408328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25269797|NCT02408289|Proanthocyanidin|proanthocyanidin|mesh-list
25269798|NCT02408289|Procyanidin|procyanidin|mesh-list
24470402|NCT00390039|Sensory System Agents|sensory system agents|mesh-ancestor
24835072|NCT02182219|Nintedanib|nintedanib|mesh-list
25540335|NCT03303950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540336|NCT03303950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25540337|NCT03293680|Pembrolizumab|pembrolizumab|mesh-list
25540338|NCT03293680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25540339|NCT03293680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540340|NCT03258320|Docetaxel|docetaxel|mesh-list
25540341|NCT03258320|Mitoxantrone|mitoxantrone|mesh-list
25540342|NCT03258320|Satraplatin|satraplatin|mesh-list
25540343|NCT03258320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540344|NCT03258320|Tubulin Modulators|tubulin modulators|mesh-ancestor
25540345|NCT03258320|Antimitotic Agents|antimitotic agents|mesh-ancestor
24812350|NCT02051738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24812351|NCT02051738|Tubulin Modulators|tubulin modulators|mesh-ancestor
24812352|NCT02051738|Antimitotic Agents|antimitotic agents|mesh-ancestor
24812353|NCT02051738|Mitosis Modulators|mitosis modulators|mesh-ancestor
24812354|NCT02051738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812355|NCT02051738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812356|NCT02051738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812357|NCT02051751|Paclitaxel|paclitaxel|mesh-list
24812358|NCT02051751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24812359|NCT02051751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24851980|NCT02259946|Cholinergic Agents|cholinergic agents|mesh-ancestor
25269799|NCT02408289|Antioxidants|antioxidants|mesh-ancestor
25269800|NCT02408289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269801|NCT02408289|Protective Agents|protective agents|mesh-ancestor
25269803|NCT02408289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25540346|NCT03258320|Mitosis Modulators|mitosis modulators|mesh-ancestor
25540347|NCT03258320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540348|NCT03258320|Analgesics|analgesics|mesh-ancestor
25540349|NCT03258320|Sensory System Agents|sensory system agents|mesh-ancestor
25540350|NCT03258320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25540351|NCT03258320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540352|NCT03258320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25540353|NCT03258320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25540354|NCT03258320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540355|NCT03169101|Nicotine|nicotine|mesh-list
25540356|NCT03169101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25540357|NCT03169101|Autonomic Agents|autonomic agents|mesh-ancestor
25675331|NCT01783574|Testosterone|testosterone|mesh-list
25540358|NCT03169101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25540359|NCT03169101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540360|NCT03169101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25540361|NCT03169101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25540362|NCT03169101|Cholinergic Agents|cholinergic agents|mesh-ancestor
25540363|NCT03169101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25540364|NCT03169101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675348|NCT01783821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25675349|NCT01783821|Autonomic Agents|autonomic agents|mesh-ancestor
25675350|NCT01783821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25675351|NCT01783821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675352|NCT01783821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25675353|NCT01783821|Respiratory System Agents|respiratory system agents|mesh-ancestor
25675354|NCT01783821|Glucocorticoids|glucocorticoids|mesh-ancestor
24655178|NCT01254799|Doxycycline|doxycycline|mesh-list
24470612|NCT00390793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24835134|NCT02182336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835135|NCT02182336|Anticoagulants|anticoagulants|mesh-ancestor
24623102|NCT01070225|Hydrocortisone|hydrocortisone|mesh-list
24921940|NCT04185077|Anticoagulants|anticoagulants|mesh-ancestor
25269818|NCT02408172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269819|NCT02408172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25269820|NCT02408172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269821|NCT02408172|Vasodilator Agents|vasodilator agents|mesh-ancestor
25269822|NCT02408172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25269823|NCT02408172|Sympatholytics|sympatholytics|mesh-ancestor
25269824|NCT02408172|Autonomic Agents|autonomic agents|mesh-ancestor
25269825|NCT02408172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25269826|NCT02408172|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25269834|NCT02408146|Ondansetron|ondansetron|mesh-list
24470649|NCT00390871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24470650|NCT00390871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470651|NCT00390871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24470653|NCT00390871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24470654|NCT00390897|Interferons|interferons|mesh-list
24470722|NCT00391157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24470724|NCT00391157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675355|NCT01783821|Hormones|hormones|mesh-ancestor
25650620|NCT01505933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25650621|NCT01505933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25650622|NCT01505933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650623|NCT01505933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25650624|NCT01505933|Anesthetics, General|anesthetics, general|mesh-ancestor
25650625|NCT01505933|Anesthetics|anesthetics|mesh-ancestor
25650626|NCT01505933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25650627|NCT01505933|Analgesics|analgesics|mesh-ancestor
25650628|NCT01505933|Sensory System Agents|sensory system agents|mesh-ancestor
25650629|NCT01505933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650630|NCT01505933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25650631|NCT01505933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25650632|NCT01505933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25650633|NCT01505933|Adrenergic Agents|adrenergic agents|mesh-ancestor
25650634|NCT01505933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25650635|NCT01505933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650636|NCT01506193|Vaccines|vaccines|mesh-list
25650637|NCT01506193|Immunologic Factors|immunologic factors|mesh-ancestor
25650638|NCT01506193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650639|NCT01506271|Imipenem|imipenem|mesh-list
25244656|NCT04545762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244657|NCT04545762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25244658|NCT04545762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25244659|NCT04545762|Alkylating Agents|alkylating agents|mesh-ancestor
25244660|NCT04545762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244661|NCT04545762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244662|NCT04545762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25244664|NCT04545762|Antimetabolites|antimetabolites|mesh-ancestor
25650640|NCT01506271|Relebactam|relebactam|mesh-list
25650641|NCT01506271|Cilastatin|cilastatin|mesh-list
25650642|NCT01506271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25650643|NCT01506271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25650644|NCT01506271|Protease Inhibitors|protease inhibitors|mesh-ancestor
25650645|NCT01506271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650646|NCT01506271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650647|NCT01506271|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25650648|NCT01506453|Gabapentin|gabapentin|mesh-list
25650649|NCT01506453|Analgesics|analgesics|mesh-ancestor
25650650|NCT01506453|Sensory System Agents|sensory system agents|mesh-ancestor
25650651|NCT01506453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650652|NCT01506453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650653|NCT01506453|Anticonvulsants|anticonvulsants|mesh-ancestor
25650654|NCT01506453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25540365|NCT03094286|Durvalumab|durvalumab|mesh-list
25675373|NCT01783847|Hormones|hormones|mesh-ancestor
25244667|NCT04541680|Nintedanib|nintedanib|mesh-list
25244668|NCT04541680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244669|NCT04541680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25244670|NCT04541680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25244716|NCT04502095|Levofloxacin|levofloxacin|mesh-list
25244717|NCT04502095|Ofloxacin|ofloxacin|mesh-list
25244718|NCT04502095|Trimethoprim|trimethoprim|mesh-list
25244720|NCT04502095|Nitrofurantoin|nitrofurantoin|mesh-list
25540366|NCT03094286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25540367|NCT03094286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540368|NCT03072771|Cytarabine|cytarabine|mesh-list
25540369|NCT03072771|Etoposide|etoposide|mesh-list
25540370|NCT03072771|Melphalan|melphalan|mesh-list
25540371|NCT03072771|Carmustine|carmustine|mesh-list
25540372|NCT03072771|Blinatumomab|blinatumomab|mesh-list
25540373|NCT03072771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25540374|NCT03072771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540375|NCT03072771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25244745|NCT04492254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25244746|NCT04492254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835546|NCT02183077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24835547|NCT02183077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24835555|NCT02183077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24835556|NCT02183077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835557|NCT02183077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835558|NCT02183090|Meloxicam|meloxicam|mesh-list
24835559|NCT02183090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24835560|NCT02183090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24835561|NCT02183090|Analgesics|analgesics|mesh-ancestor
24835562|NCT02183090|Sensory System Agents|sensory system agents|mesh-ancestor
24835563|NCT02183090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835564|NCT02183090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835565|NCT02183090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25269867|NCT02407899|Cholecalciferol|cholecalciferol|mesh-list
25269868|NCT02407899|Insulin|insulin|mesh-list
25269869|NCT02407899|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25269870|NCT02407899|Metformin|metformin|mesh-list
25269871|NCT02407899|Saxagliptin|saxagliptin|mesh-list
25269872|NCT02407899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25269873|NCT02407899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25269874|NCT02407899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269875|NCT02407899|Vitamins|vitamins|mesh-ancestor
24470910|NCT00392457|Ketoconazole|ketoconazole|mesh-list
24470960|NCT00392691|Immunologic Factors|immunologic factors|mesh-ancestor
24470961|NCT00392691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540376|NCT03072771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25540377|NCT03072771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540378|NCT03072771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540379|NCT03072771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25540380|NCT03072771|Antimetabolites|antimetabolites|mesh-ancestor
25540381|NCT03072771|Antiviral Agents|antiviral agents|mesh-ancestor
25540382|NCT03072771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25540383|NCT03072771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25244801|NCT04453137|Adalimumab|adalimumab|mesh-list
25540384|NCT03072771|Immunologic Factors|immunologic factors|mesh-ancestor
25540385|NCT03072771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540386|NCT03072771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25540387|NCT03072771|Alkylating Agents|alkylating agents|mesh-ancestor
25540388|NCT03072771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25540389|NCT03071666|Vitamin B 12|vitamin b 12|mesh-list
25540390|NCT03071666|Vitamins|vitamins|mesh-ancestor
25540391|NCT03071666|Micronutrients|micronutrients|mesh-ancestor
25540392|NCT03071666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540393|NCT03071666|Vitamin B Complex|vitamin b complex|mesh-ancestor
25540394|NCT03069924|Nicotine|nicotine|mesh-list
25540395|NCT03069924|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25675417|NCT01783990|Antisickling Agents|antisickling agents|mesh-ancestor
25675418|NCT01783990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675419|NCT01783990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675420|NCT01783990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24852162|NCT02261025|Sensory System Agents|sensory system agents|mesh-ancestor
25269876|NCT02407899|Micronutrients|micronutrients|mesh-ancestor
24922212|NCT04182568|Alkylating Agents|alkylating agents|mesh-ancestor
25269877|NCT02407899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25269878|NCT02407899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24835750|NCT02183337|Protease Inhibitors|protease inhibitors|mesh-ancestor
24835751|NCT02183337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835752|NCT02183337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835772|NCT02183363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835775|NCT02183376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835776|NCT02183376|Incretins|incretins|mesh-ancestor
24835777|NCT02183376|Hormones|hormones|mesh-ancestor
24835778|NCT02183376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24835779|NCT02183376|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24835780|NCT02183376|Protease Inhibitors|protease inhibitors|mesh-ancestor
24835781|NCT02183376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618605|NCT01049204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24835784|NCT02183389|Warfarin|warfarin|mesh-list
24835800|NCT02183402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835801|NCT02183402|Protective Agents|protective agents|mesh-ancestor
24835802|NCT02183402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835803|NCT02183402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25540396|NCT03069924|Autonomic Agents|autonomic agents|mesh-ancestor
25540397|NCT03069924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25540398|NCT03069924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540399|NCT03069924|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25540400|NCT03069924|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25540401|NCT03069924|Cholinergic Agents|cholinergic agents|mesh-ancestor
25540402|NCT03069924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25540403|NCT03069924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540404|NCT03031210|Amoxicillin|amoxicillin|mesh-list
25540405|NCT03031210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25540406|NCT03031210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25540407|NCT03026790|Buprenorphine|buprenorphine|mesh-list
25675428|NCT01784211|Insulin Glargine|insulin glargine|mesh-list
25540408|NCT03026790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25540409|NCT03026790|Naloxone|naloxone|mesh-list
25540410|NCT03026790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25540411|NCT03026790|Narcotics|narcotics|mesh-ancestor
25540412|NCT03026790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25540413|NCT03026790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540414|NCT03026790|Analgesics|analgesics|mesh-ancestor
25540415|NCT03026790|Sensory System Agents|sensory system agents|mesh-ancestor
25540416|NCT03026790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25540417|NCT03026790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25540418|NCT03018366|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25540419|NCT03018366|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25540420|NCT03018366|Estradiol|estradiol|mesh-list
25540421|NCT03018366|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25540422|NCT03018366|Progesterone|progesterone|mesh-list
25540423|NCT03018366|Estrogens|estrogens|mesh-ancestor
25675434|NCT01784419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540424|NCT03018366|Hormones|hormones|mesh-ancestor
25540425|NCT03018366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25540426|NCT03018366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540427|NCT03018366|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25540428|NCT03018366|Contraceptive Agents|contraceptive agents|mesh-ancestor
25540429|NCT03018366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25540430|NCT03018366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25540431|NCT03018366|Progestins|progestins|mesh-ancestor
25540432|NCT03001882|Nivolumab|nivolumab|mesh-list
25540433|NCT03001882|Ipilimumab|ipilimumab|mesh-list
25540434|NCT03001882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25540435|NCT03001882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675444|NCT01784666|Isradipine|isradipine|mesh-list
25675445|NCT01784666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25675446|NCT01784666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25675447|NCT01784666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25675448|NCT01784666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675449|NCT01784666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25675450|NCT01784666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675451|NCT01784666|Vasodilator Agents|vasodilator agents|mesh-ancestor
25675452|NCT01784770|Azithromycin|azithromycin|mesh-list
25675453|NCT01784770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25675454|NCT01784770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675455|NCT01784861|Everolimus|everolimus|mesh-list
25675456|NCT01784861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675457|NCT01784861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25540436|NCT03001882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25540437|NCT03001882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540438|NCT02958514|Tobramycin|tobramycin|mesh-list
25540439|NCT02958514|Dexamethasone|dexamethasone|mesh-list
25540440|NCT02958514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25540441|NCT02958514|Antiemetics|antiemetics|mesh-ancestor
25540442|NCT02958514|Autonomic Agents|autonomic agents|mesh-ancestor
25822500|NCT00004489|Calcium|calcium|mesh-list
25822501|NCT00004489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25436512|NCT04761029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25244983|NCT04314570|Ropivacaine|ropivacaine|mesh-list
25244984|NCT04314570|Anesthetics, Local|anesthetics, local|mesh-ancestor
25244985|NCT04314570|Anesthetics|anesthetics|mesh-ancestor
25244986|NCT04314570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25244987|NCT04314570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244988|NCT04314570|Sensory System Agents|sensory system agents|mesh-ancestor
25244989|NCT04314570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25244990|NCT04313985|Immunologic Factors|immunologic factors|mesh-list
25008871|NCT04094519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008872|NCT04080531|Vaccines|vaccines|mesh-list
25008873|NCT04080531|Immunologic Factors|immunologic factors|mesh-ancestor
25008874|NCT04080531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008875|NCT04064359|Antibodies|antibodies|mesh-list
24567162|NCT00789763|Immunologic Factors|immunologic factors|mesh-ancestor
25436513|NCT04760821|Trimetazidine|trimetazidine|mesh-list
25436514|NCT04760821|Vasodilator Agents|vasodilator agents|mesh-ancestor
25436515|NCT04760860|Prazosin|prazosin|mesh-list
25436516|NCT04760860|Terazosin|terazosin|mesh-list
25436517|NCT04760860|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25436518|NCT04760860|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25436519|NCT04760860|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25436520|NCT04760860|Adrenergic Agents|adrenergic agents|mesh-ancestor
25436521|NCT04760860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25244995|NCT04311177|Losartan|losartan|mesh-list
25244996|NCT04311177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25244997|NCT04311177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25245001|NCT04303507|Hydroxychloroquine|hydroxychloroquine|mesh-list
24452408|NCT00327418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25269905|NCT02408003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25269906|NCT02408003|Vasodilator Agents|vasodilator agents|mesh-ancestor
25269907|NCT02408003|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25269908|NCT02408003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25269909|NCT02408003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275491|NCT02371941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25436522|NCT04760860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436523|NCT04760860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436524|NCT04760860|Urological Agents|urological agents|mesh-ancestor
25436525|NCT04760860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25822502|NCT00004489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822503|NCT00004489|Vitamins|vitamins|mesh-ancestor
24401311|NCT00152698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24401312|NCT00152698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24401314|NCT00152724|Aspirin|aspirin|mesh-list
25168939|NCT02042378|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25822504|NCT00004489|Micronutrients|micronutrients|mesh-ancestor
25168940|NCT02042378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168941|NCT02042378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168942|NCT02042378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25245040|NCT04293562|Abortifacient Agents|abortifacient agents|mesh-ancestor
25269912|NCT02408003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269913|NCT02408003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25269914|NCT02407821|Citalopram|citalopram|mesh-list
24836190|NCT02184312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836191|NCT02184312|Antiviral Agents|antiviral agents|mesh-ancestor
24836192|NCT02184312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24836193|NCT02184312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24836194|NCT02184312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24639710|NCT01164046|Vitamin K|vitamin k|mesh-list
25068166|NCT03436121|GABA Modulators|gaba modulators|mesh-ancestor
24836214|NCT02184364|Hormones|hormones|mesh-ancestor
24836215|NCT02184364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24836218|NCT02184429|Dopamine Agonists|dopamine agonists|mesh-ancestor
25269918|NCT02407821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269919|NCT02407821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25269920|NCT02407821|Serotonin Agents|serotonin agents|mesh-ancestor
25269921|NCT02407821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471145|NCT00393471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24471146|NCT00393471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24624091|NCT01074697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24624092|NCT01074697|Glucocorticoids|glucocorticoids|mesh-ancestor
24624093|NCT01074697|Hormones|hormones|mesh-ancestor
25168943|NCT02032277|Paclitaxel|paclitaxel|mesh-list
25168944|NCT02032277|Cyclophosphamide|cyclophosphamide|mesh-list
25168945|NCT02032277|Carboplatin|carboplatin|mesh-list
25168948|NCT02032277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25168949|NCT02032277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168950|NCT02032277|Tubulin Modulators|tubulin modulators|mesh-ancestor
25168951|NCT02032277|Antimitotic Agents|antimitotic agents|mesh-ancestor
25168952|NCT02032277|Mitosis Modulators|mitosis modulators|mesh-ancestor
25168953|NCT02032277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168954|NCT02032277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25168955|NCT02032277|Immunologic Factors|immunologic factors|mesh-ancestor
24836219|NCT02184429|Dopamine Agents|dopamine agents|mesh-ancestor
24836220|NCT02184429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24836221|NCT02184429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836222|NCT02184429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836224|NCT02184533|Sodium Selenite|sodium selenite|mesh-list
24836225|NCT02184533|Trace Elements|trace elements|mesh-ancestor
24836226|NCT02184533|Micronutrients|micronutrients|mesh-ancestor
24836227|NCT02184533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836229|NCT02184559|Anesthetics, Local|anesthetics, local|mesh-ancestor
24836230|NCT02184559|Anesthetics|anesthetics|mesh-ancestor
24836231|NCT02184559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24836232|NCT02184559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836233|NCT02184559|Sensory System Agents|sensory system agents|mesh-ancestor
24836235|NCT02184637|Lumefantrine|lumefantrine|mesh-list
25141415|NCT02957903|Ropivacaine|ropivacaine|mesh-list
25168956|NCT02032277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168957|NCT02032277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25168958|NCT02032277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25168959|NCT02032277|Alkylating Agents|alkylating agents|mesh-ancestor
25168960|NCT02032277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25168961|NCT02032277|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25168962|NCT02032277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25168963|NCT02032277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25168964|NCT02032277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168965|NCT02032277|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25168966|NCT02030860|Gemcitabine|gemcitabine|mesh-list
25168967|NCT02030860|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25168968|NCT02030860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25245108|NCT04266275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25245109|NCT04266275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24836290|NCT02185066|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24836291|NCT02185066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24836303|NCT02185118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24836304|NCT02185118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836305|NCT02185196|Vitamin D|vitamin d|mesh-list
25269934|NCT02407782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25269935|NCT02407782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25269936|NCT02407782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269937|NCT02407470|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24471352|NCT00394745|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24471354|NCT00394745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471356|NCT00394810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24836378|NCT02185547|Sertraline|sertraline|mesh-list
25269938|NCT02407470|Immunologic Factors|immunologic factors|mesh-ancestor
25269939|NCT02407470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675478|NCT01785160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675479|NCT01785186|Pyridoxine|pyridoxine|mesh-list
25269940|NCT02407470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25269941|NCT02407600|Aprepitant|aprepitant|mesh-list
25675480|NCT01785186|Moxifloxacin|moxifloxacin|mesh-list
25675481|NCT01785186|Rifampin|rifampin|mesh-list
25168969|NCT02030860|Antimetabolites|antimetabolites|mesh-ancestor
25168970|NCT02030860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168971|NCT02030860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540443|NCT02958514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25540444|NCT02958514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540445|NCT02958514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25540446|NCT02958514|Glucocorticoids|glucocorticoids|mesh-ancestor
25540447|NCT02958514|Hormones|hormones|mesh-ancestor
25540448|NCT02958514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25245162|NCT04239092|Cyclophosphamide|cyclophosphamide|mesh-list
25245163|NCT04239092|Temozolomide|temozolomide|mesh-list
25245164|NCT04239092|Irinotecan|irinotecan|mesh-list
24852293|NCT02261779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852294|NCT02261779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852295|NCT02261779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24852296|NCT02261779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24859058|NCT02301494|Glucocorticoids|glucocorticoids|mesh-ancestor
25675482|NCT01785186|Isoniazid|isoniazid|mesh-list
25269942|NCT02407600|Fosaprepitant|fosaprepitant|mesh-list
25269943|NCT02407600|Antiemetics|antiemetics|mesh-ancestor
24471374|NCT00394992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471375|NCT00394992|Growth Inhibitors|growth inhibitors|mesh-ancestor
24471376|NCT00394992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24471377|NCT00394992|Antimetabolites|antimetabolites|mesh-ancestor
24471378|NCT00394992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471379|NCT00395031|Ziprasidone|ziprasidone|mesh-list
24836391|NCT02185651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836392|NCT02185651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836393|NCT02185651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24836394|NCT02185651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24836410|NCT02185716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24836411|NCT02185716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540449|NCT02958514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25540450|NCT02958514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540451|NCT02958514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25540452|NCT02958514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25540453|NCT02897700|Cyclophosphamide|cyclophosphamide|mesh-list
25540454|NCT02897700|Doxorubicin|doxorubicin|mesh-list
25540455|NCT02897700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25540456|NCT02897700|Fluorouracil|fluorouracil|mesh-list
25540457|NCT02897700|Methotrexate|methotrexate|mesh-list
25540458|NCT02897700|Epirubicin|epirubicin|mesh-list
25540459|NCT02897700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25245176|NCT04239092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24852305|NCT02261844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24852306|NCT02261896|Ciprofloxacin|ciprofloxacin|mesh-list
24852307|NCT02261896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24852308|NCT02261896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24852309|NCT02261896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24852310|NCT02261896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24852311|NCT02261896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852312|NCT02261896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540460|NCT02897700|Immunologic Factors|immunologic factors|mesh-ancestor
25540461|NCT02897700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540462|NCT02897700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25540463|NCT02897700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25540464|NCT02897700|Alkylating Agents|alkylating agents|mesh-ancestor
25540465|NCT02897700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540466|NCT02897700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540467|NCT02897700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25269978|NCT02407340|Benzalkonium Compounds|benzalkonium compounds|mesh-list
25269979|NCT02407340|Oxytocin|oxytocin|mesh-list
25269980|NCT02407340|Oxytocics|oxytocics|mesh-ancestor
25269981|NCT02407340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25269982|NCT02407340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269983|NCT02407340|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25269985|NCT02407548|Vitamin E|vitamin e|mesh-list
25269986|NCT02407548|Coenzyme Q10|coenzyme q10|mesh-list
25269987|NCT02407548|Ubiquinone|ubiquinone|mesh-list
25269988|NCT02407548|Vitamins|vitamins|mesh-ancestor
24836452|NCT02185898|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24836453|NCT02185898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24836454|NCT02185898|Cholinergic Agents|cholinergic agents|mesh-ancestor
24836455|NCT02185898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24836456|NCT02185898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601302|NCT00963833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24836457|NCT02185898|Antipruritics|antipruritics|mesh-ancestor
24836458|NCT02185898|Dermatologic Agents|dermatologic agents|mesh-ancestor
24836460|NCT02185924|Ropivacaine|ropivacaine|mesh-list
24836461|NCT02185924|Anesthetics, Local|anesthetics, local|mesh-ancestor
24836462|NCT02185924|Anesthetics|anesthetics|mesh-ancestor
24836463|NCT02185924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24836464|NCT02185924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836465|NCT02185924|Sensory System Agents|sensory system agents|mesh-ancestor
24836466|NCT02185924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24836467|NCT02185924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25540468|NCT02897700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25540469|NCT02897700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25540470|NCT02897700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25540471|NCT02897700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540472|NCT02897700|Antimetabolites|antimetabolites|mesh-ancestor
25540473|NCT02897700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25540474|NCT02897700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25540475|NCT02897700|Abortifacient Agents|abortifacient agents|mesh-ancestor
25540476|NCT02897700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25540477|NCT02897700|Dermatologic Agents|dermatologic agents|mesh-ancestor
25540478|NCT02897700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25269993|NCT02407548|Protective Agents|protective agents|mesh-ancestor
25269994|NCT02407171|Pembrolizumab|pembrolizumab|mesh-list
25269995|NCT02407171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25269996|NCT02407171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25269997|NCT02407210|Olmesartan|olmesartan|mesh-list
24836485|NCT02186028|Vitamins|vitamins|mesh-ancestor
24836503|NCT02186132|Atropine|atropine|mesh-list
24836504|NCT02186132|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24836505|NCT02186132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24836506|NCT02186132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24601732|NCT00965796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24836533|NCT02186145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24836535|NCT02186145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24836554|NCT02186275|Vitamin D|vitamin d|mesh-list
24836555|NCT02186275|Ergocalciferols|ergocalciferols|mesh-list
24836556|NCT02186275|Cholecalciferol|cholecalciferol|mesh-list
24836557|NCT02186275|Vitamins|vitamins|mesh-list
24836558|NCT02186275|Micronutrients|micronutrients|mesh-ancestor
24836559|NCT02186275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836560|NCT02186275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24836561|NCT02186275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24836562|NCT02186366|Buspirone|buspirone|mesh-list
24836563|NCT02186366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24836564|NCT02186366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24836565|NCT02186366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24836566|NCT02186366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836567|NCT02186366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24836568|NCT02186366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25269998|NCT02407210|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25269999|NCT02407210|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25270000|NCT02407210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25540479|NCT02897700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25540480|NCT02889666|Gemcitabine|gemcitabine|mesh-list
25540481|NCT02889666|Cisplatin|cisplatin|mesh-list
25540482|NCT02889666|Carboplatin|carboplatin|mesh-list
25540483|NCT02889666|Docetaxel|docetaxel|mesh-list
25540484|NCT02889666|Oxaliplatin|oxaliplatin|mesh-list
25540485|NCT02889666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540486|NCT02889666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25540487|NCT02889666|Antimetabolites|antimetabolites|mesh-ancestor
25675512|NCT01785472|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24452451|NCT05458765|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
24452452|NCT05458765|Antiviral Agents|antiviral agents|mesh-ancestor
24452453|NCT05458765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24452454|NCT05458765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24452455|NCT05458765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24452456|NCT05458765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25270001|NCT02407210|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25270002|NCT02407210|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25270003|NCT02407210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275492|NCT02371941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25275493|NCT02371941|Respiratory System Agents|respiratory system agents|mesh-ancestor
25275494|NCT02371993|Choline|choline|mesh-list
25275495|NCT02371993|Lipotropic Agents|lipotropic agents|mesh-ancestor
25275496|NCT02371993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25275497|NCT02371993|Antimetabolites|antimetabolites|mesh-ancestor
24472202|NCT00398515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24472203|NCT00398528|Glatiramer Acetate|glatiramer acetate|mesh-list
24836621|NCT02186600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836622|NCT02186600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24836623|NCT02186600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24836625|NCT02186600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836626|NCT02186600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24836627|NCT02186600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24836628|NCT02186600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24836629|NCT02186769|Risperidone|risperidone|mesh-list
24836630|NCT02186769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24836631|NCT02186769|Serotonin Agents|serotonin agents|mesh-ancestor
24836632|NCT02186769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25540488|NCT02889666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540489|NCT02889666|Antiviral Agents|antiviral agents|mesh-ancestor
25540490|NCT02889666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25540491|NCT02889666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540492|NCT02889666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25540493|NCT02889666|Immunologic Factors|immunologic factors|mesh-ancestor
25540494|NCT02889666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540495|NCT02889666|Tubulin Modulators|tubulin modulators|mesh-ancestor
25540496|NCT02889666|Antimitotic Agents|antimitotic agents|mesh-ancestor
25540497|NCT02889666|Mitosis Modulators|mitosis modulators|mesh-ancestor
25540498|NCT02870829|Vitamin K 2|vitamin k 2|mesh-list
25540499|NCT02870829|Vitamin K|vitamin k|mesh-list
25540500|NCT02870829|Vitamin MK 7|vitamin mk 7|mesh-list
25540501|NCT02870829|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25540502|NCT02870829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25540503|NCT02870829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540504|NCT02870829|Hemostatics|hemostatics|mesh-ancestor
25540505|NCT02870829|Coagulants|coagulants|mesh-ancestor
25540506|NCT02870829|Vitamins|vitamins|mesh-ancestor
25540507|NCT02870829|Micronutrients|micronutrients|mesh-ancestor
25540508|NCT02870829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540509|NCT02864251|Cisplatin|cisplatin|mesh-list
25540510|NCT02864251|Carboplatin|carboplatin|mesh-list
25540511|NCT02864251|Nivolumab|nivolumab|mesh-list
25540512|NCT02864251|Pemetrexed|pemetrexed|mesh-list
25540513|NCT02864251|Ipilimumab|ipilimumab|mesh-list
25540514|NCT02864251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540515|NCT02864251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25540516|NCT02864251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25540517|NCT02864251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540518|NCT02864251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540519|NCT02864251|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25540520|NCT02864251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25540521|NCT02738229|Valacyclovir|valacyclovir|mesh-list
25540522|NCT02738229|Antiviral Agents|antiviral agents|mesh-ancestor
25540523|NCT02738229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25540524|NCT02664441|Exenatide|exenatide|mesh-list
25270004|NCT02407314|Aspirin|aspirin|mesh-list
25270005|NCT02407314|Ticagrelor|ticagrelor|mesh-list
25270006|NCT02407314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25270007|NCT02407314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25270008|NCT02407314|Analgesics|analgesics|mesh-ancestor
25270009|NCT02407314|Sensory System Agents|sensory system agents|mesh-ancestor
25270010|NCT02407314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24602586|NCT00969592|Insulin|insulin|mesh-list
25270011|NCT02407314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270012|NCT02407314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24471996|NCT00397722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724244|NCT01592019|Diclofenac|diclofenac|mesh-list
24836655|NCT02186782|Estrogens|estrogens|mesh-ancestor
24836656|NCT02186782|Hormones|hormones|mesh-ancestor
24836657|NCT02186782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24618782|NCT01049646|Giapreza|giapreza|mesh-list
25540525|NCT02664441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25540526|NCT02664441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540527|NCT02664441|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25540528|NCT02664441|Incretins|incretins|mesh-ancestor
25540529|NCT02664441|Hormones|hormones|mesh-ancestor
25540530|NCT02664441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25540531|NCT02513472|Pembrolizumab|pembrolizumab|mesh-list
25540532|NCT02513472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25245314|NCT04101461|Hepcidins|hepcidins|mesh-list
25270013|NCT02407314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25270014|NCT02407314|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25270015|NCT02407314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24471997|NCT00397722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24471998|NCT00397722|Serotonin Agents|serotonin agents|mesh-ancestor
24471999|NCT00397722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472000|NCT00397722|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24472001|NCT00397722|Antidepressive Agents|antidepressive agents|mesh-ancestor
24472002|NCT00397722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24472003|NCT00397722|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24472004|NCT00397722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24472005|NCT00397722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24472006|NCT00397735|Acetylcysteine|acetylcysteine|mesh-list
24472007|NCT00397735|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24472590|NCT00399685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24472592|NCT00399685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24472593|NCT00399685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472594|NCT00399685|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24473437|NCT00402766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24473439|NCT00402792|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
24473440|NCT00402792|Hydrocodone|hydrocodone|mesh-list
24473441|NCT00402792|Oxycodone|oxycodone|mesh-list
25270017|NCT02407314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25270018|NCT02407314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25270019|NCT02407314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25270020|NCT02407314|Antipyretics|antipyretics|mesh-ancestor
25540533|NCT02513472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540534|NCT02476409|Tolvaptan|tolvaptan|mesh-list
25540535|NCT02476409|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25540536|NCT02476409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540537|NCT02476409|Natriuretic Agents|natriuretic agents|mesh-ancestor
25540538|NCT02476409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436526|NCT04760704|Antibodies|antibodies|mesh-list
25540540|NCT02471391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540541|NCT02460887|Gemcitabine|gemcitabine|mesh-list
25540542|NCT02460887|Cisplatin|cisplatin|mesh-list
25540543|NCT02460887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540544|NCT02460887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25540545|NCT02460887|Antimetabolites|antimetabolites|mesh-ancestor
25540546|NCT02460887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270030|NCT02407080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270031|NCT02407080|Antiviral Agents|antiviral agents|mesh-ancestor
25270032|NCT02407080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25270033|NCT02407080|Immunologic Factors|immunologic factors|mesh-ancestor
25270034|NCT02407080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270035|NCT02406950|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24836698|NCT02187068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24836700|NCT02187068|Sensory System Agents|sensory system agents|mesh-ancestor
24836701|NCT02187068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24836702|NCT02187068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24836703|NCT02187068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24836704|NCT02187068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24836705|NCT02187068|Adrenergic Agents|adrenergic agents|mesh-ancestor
24836706|NCT02187068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24836707|NCT02187068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836708|NCT02187081|Sorafenib|sorafenib|mesh-list
24836709|NCT02187081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642182|NCT01178034|Warfarin|warfarin|mesh-list
24836721|NCT02187107|Antiviral Agents|antiviral agents|mesh-ancestor
24836722|NCT02187107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24836723|NCT02187120|Tranexamic Acid|tranexamic acid|mesh-list
24836724|NCT02187120|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24603959|NCT00976300|Alkylating Agents|alkylating agents|mesh-ancestor
24836725|NCT02187120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24836726|NCT02187120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836727|NCT02187120|Hemostatics|hemostatics|mesh-ancestor
24472404|NCT00399087|Prednisone|prednisone|mesh-list
24472405|NCT00399087|Docetaxel|docetaxel|mesh-list
25270036|NCT02406950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25270037|NCT02406950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540547|NCT02460887|Antiviral Agents|antiviral agents|mesh-ancestor
25540548|NCT02460887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25540549|NCT02460887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540550|NCT02460887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25540551|NCT02460887|Immunologic Factors|immunologic factors|mesh-ancestor
25540552|NCT02460887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540553|NCT02454322|Magnesium Sulfate|magnesium sulfate|mesh-list
25540554|NCT02454322|Analgesics|analgesics|mesh-ancestor
25540555|NCT02454322|Sensory System Agents|sensory system agents|mesh-ancestor
24589429|NCT00907452|Prednisone|prednisone|mesh-list
24836731|NCT02187133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24836740|NCT02187211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24748765|NCT02168829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642355|NCT01179009|Antiemetics|antiemetics|mesh-ancestor
24836741|NCT02187211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24836743|NCT02187250|Liraglutide|liraglutide|mesh-list
24836744|NCT02187250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24836745|NCT02187250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836746|NCT02187250|Incretins|incretins|mesh-ancestor
24836747|NCT02187250|Hormones|hormones|mesh-ancestor
24836748|NCT02187250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24836749|NCT02187276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
24836750|NCT02187276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836751|NCT02187276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836754|NCT02187276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642531|NCT01179828|GABA Agents|gaba agents|mesh-ancestor
24836760|NCT02187367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24836761|NCT02187367|Immunologic Factors|immunologic factors|mesh-ancestor
25270039|NCT02406950|Hormones|hormones|mesh-ancestor
25540556|NCT02454322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25540557|NCT02454322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540558|NCT02454322|Anesthetics|anesthetics|mesh-ancestor
25540559|NCT02454322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25540560|NCT02454322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25540561|NCT02454322|Anticonvulsants|anticonvulsants|mesh-ancestor
25540562|NCT02454322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24589473|NCT00907751|Immunologic Factors|immunologic factors|mesh-ancestor
24836811|NCT02187536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24836813|NCT02187536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24836814|NCT02187536|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25270040|NCT02406950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25270041|NCT02406950|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25270042|NCT02406950|Protease Inhibitors|protease inhibitors|mesh-ancestor
24643030|NCT01183364|Mitosis Modulators|mitosis modulators|mesh-ancestor
24836828|NCT02187562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836829|NCT02187562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24836830|NCT02187562|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24836831|NCT02187562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836833|NCT02187562|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24836839|NCT02187588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24836840|NCT02187588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836841|NCT02187588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24836842|NCT02187588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24836843|NCT02187588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24836844|NCT02187588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836845|NCT02187588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836846|NCT02187614|Acetaminophen|acetaminophen|mesh-list
24836848|NCT02187614|Morphine|morphine|mesh-list
24643075|NCT01183611|Vaccines|vaccines|mesh-list
25675519|NCT01785615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24605510|NCT00985647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25675520|NCT01785615|Antimetabolites|antimetabolites|mesh-ancestor
25675521|NCT01785615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675522|NCT01785615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25675523|NCT01785615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25540563|NCT02454322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25540564|NCT02454322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540565|NCT02454322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25540566|NCT02454322|Tocolytic Agents|tocolytic agents|mesh-ancestor
25540567|NCT02454322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25540568|NCT02446236|Rituximab|rituximab|mesh-list
25540569|NCT02446236|Lenalidomide|lenalidomide|mesh-list
25540570|NCT02446236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24634514|NCT01133795|Midodrine|midodrine|mesh-list
24634515|NCT01133795|Sympathomimetics|sympathomimetics|mesh-ancestor
24634516|NCT01133795|Autonomic Agents|autonomic agents|mesh-ancestor
24634517|NCT01133795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24634518|NCT01133795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634519|NCT01133795|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24634520|NCT01133795|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24634521|NCT01133795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24634522|NCT01133795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24634523|NCT01133795|Adrenergic Agents|adrenergic agents|mesh-ancestor
24444117|NCT00296751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589478|NCT00907764|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24589480|NCT00907764|Purinergic Agents|purinergic agents|mesh-ancestor
24836855|NCT02187614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24836856|NCT02187614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24836858|NCT02187614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24836859|NCT02187614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24836860|NCT02187614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24836861|NCT02187614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24836862|NCT02187614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540571|NCT02446236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540572|NCT02446236|Immunologic Factors|immunologic factors|mesh-ancestor
25540573|NCT02446236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540574|NCT02446236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25540575|NCT02446236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25540576|NCT02446236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25540577|NCT02446236|Growth Substances|growth substances|mesh-ancestor
25540578|NCT02446236|Growth Inhibitors|growth inhibitors|mesh-ancestor
25540579|NCT02431845|Fluoxetine|fluoxetine|mesh-list
25540580|NCT02431845|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25540581|NCT02431845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25540582|NCT02431845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25540583|NCT02431845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540584|NCT02431845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25540585|NCT02431845|Serotonin Agents|serotonin agents|mesh-ancestor
25540586|NCT02431845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540587|NCT02431845|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25540588|NCT02431845|Antidepressive Agents|antidepressive agents|mesh-ancestor
25540589|NCT02431845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25540590|NCT02431845|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24589532|NCT00908050|Botulinum Toxins|botulinum toxins|mesh-list
24836878|NCT02187705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605652|NCT00986609|Poly I-C|poly i-c|mesh-list
24836879|NCT02187718|Anesthetics|anesthetics|mesh-list
24836880|NCT02187718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24448418|NCT00311740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24836890|NCT02187900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24836891|NCT02187900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24836892|NCT02187900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24836893|NCT02187900|Antitubercular Agents|antitubercular agents|mesh-ancestor
24836894|NCT02187900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24836895|NCT02187900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675539|NCT01786109|Analgesics|analgesics|mesh-ancestor
25675540|NCT01786109|Sensory System Agents|sensory system agents|mesh-ancestor
25692348|NCT01998919|Antiviral Agents|antiviral agents|mesh-ancestor
25540591|NCT02431845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25540592|NCT02431845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540593|NCT02429570|Meclofenamic Acid|meclofenamic acid|mesh-list
25540594|NCT02429570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25540595|NCT02429570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25540596|NCT02429570|Analgesics|analgesics|mesh-ancestor
25540597|NCT02429570|Sensory System Agents|sensory system agents|mesh-ancestor
25540598|NCT02429570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25540599|NCT02429570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540600|NCT02429570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25540601|NCT02429570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25540602|NCT02429570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25540603|NCT02429570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540604|NCT02429570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540605|NCT02191488|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25540606|NCT02191488|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24789897|NCT01939574|Growth Substances|growth substances|mesh-ancestor
24589622|NCT00908180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24589623|NCT00908219|Bevacizumab|bevacizumab|mesh-list
24852384|NCT02262455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852385|NCT02262481|Dydrogesterone|dydrogesterone|mesh-list
24836915|NCT02188173|Dexamethasone|dexamethasone|mesh-list
24836916|NCT02188173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24836917|NCT02188173|Antiemetics|antiemetics|mesh-ancestor
24836918|NCT02188173|Autonomic Agents|autonomic agents|mesh-ancestor
24836919|NCT02188173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24836920|NCT02188173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270052|NCT02406911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270053|NCT02406911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270054|NCT02406872|Propofol|propofol|mesh-list
25270055|NCT02406872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25540607|NCT02191488|Dermatologic Agents|dermatologic agents|mesh-ancestor
25540608|NCT02184416|Everolimus|everolimus|mesh-list
25540609|NCT02184416|Sorafenib|sorafenib|mesh-list
25540610|NCT02184416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540611|NCT02184416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25436604|NCT04758936|Clonidine|clonidine|mesh-list
25822505|NCT00004489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25540612|NCT02184416|Immunologic Factors|immunologic factors|mesh-ancestor
25822506|NCT00004489|Antacids|antacids|mesh-ancestor
25436671|NCT04758728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25436672|NCT04758728|Respiratory System Agents|respiratory system agents|mesh-ancestor
25436673|NCT04758728|Mydriatics|mydriatics|mesh-ancestor
25436674|NCT04758728|Sympathomimetics|sympathomimetics|mesh-ancestor
24836987|NCT02188368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24836988|NCT02188368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836989|NCT02188368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24643574|NCT01186146|Aspirin|aspirin|mesh-list
24606006|NCT00988520|Anticonvulsants|anticonvulsants|mesh-ancestor
25270061|NCT02406781|Pembrolizumab|pembrolizumab|mesh-list
24472808|NCT00400621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24472809|NCT00400621|Analgesics|analgesics|mesh-ancestor
24472810|NCT00400621|Sensory System Agents|sensory system agents|mesh-ancestor
24472813|NCT00400621|Antipyretics|antipyretics|mesh-ancestor
24837030|NCT02188472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24837032|NCT02188511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24837033|NCT02188511|Autonomic Agents|autonomic agents|mesh-ancestor
24837034|NCT02188511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25675548|NCT01786161|Vancomycin|vancomycin|mesh-list
24837035|NCT02188511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675549|NCT01786161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24567903|NCT00793377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24567930|NCT00793468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24567931|NCT00793468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567933|NCT00793559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24567934|NCT00793559|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24567935|NCT00793663|Dexamethasone|dexamethasone|mesh-list
24567936|NCT00793663|Dexamethasone acetate|dexamethasone acetate|mesh-list
24567937|NCT00793663|Ondansetron|ondansetron|mesh-list
24567938|NCT00793663|Sevoflurane|sevoflurane|mesh-list
24567939|NCT00793663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25245552|NCT03898986|Vaccines|vaccines|mesh-list
25245555|NCT03891264|Cannabidiol|cannabidiol|mesh-list
25436675|NCT04758728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25436676|NCT04758260|Antioxidants|antioxidants|mesh-list
25436677|NCT04758260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436678|NCT04758260|Protective Agents|protective agents|mesh-ancestor
25436679|NCT04758260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822507|NCT00004489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822508|NCT00004489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24567977|NCT00793754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24567978|NCT00793754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24567979|NCT00793754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24567980|NCT00793754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24557753|NCT00753779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567983|NCT00793754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24567984|NCT00793754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567985|NCT00793754|Antipyretics|antipyretics|mesh-ancestor
25245571|NCT03877809|Sirolimus|sirolimus|mesh-list
25245572|NCT03877809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25245573|NCT03877809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25245574|NCT03877809|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25245575|NCT03877809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24837053|NCT02188537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24837055|NCT02188537|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24837056|NCT02188537|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24837057|NCT02188537|Protease Inhibitors|protease inhibitors|mesh-ancestor
24837058|NCT02188537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837059|NCT02188537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675571|NCT01786252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675572|NCT01786343|Decitabine|decitabine|mesh-list
25675573|NCT01786343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25675574|NCT01786343|Antimetabolites|antimetabolites|mesh-ancestor
25675575|NCT01786343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675576|NCT01786343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675577|NCT01786343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675578|NCT01786551|Eplerenone|eplerenone|mesh-list
25675579|NCT01786551|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25675580|NCT01786551|Hormone Antagonists|hormone antagonists|mesh-ancestor
25675581|NCT01786551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25675582|NCT01786551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168972|NCT02030860|Antiviral Agents|antiviral agents|mesh-ancestor
25168973|NCT02030860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25168974|NCT02030860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168975|NCT02030860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25168976|NCT02030860|Immunologic Factors|immunologic factors|mesh-ancestor
25168977|NCT02030860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168978|NCT02026349|Favipiravir|favipiravir|mesh-list
25168979|NCT02026349|Antiviral Agents|antiviral agents|mesh-ancestor
25168980|NCT02026349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25168981|NCT02026232|Hydroxychloroquine|hydroxychloroquine|mesh-list
25168982|NCT02026232|Antimalarials|antimalarials|mesh-ancestor
25168983|NCT02026232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25168984|NCT02026232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24790469|NCT01942889|Protective Agents|protective agents|mesh-ancestor
24568007|NCT00793845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24568008|NCT00793845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24568009|NCT00793845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24568010|NCT00793845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24568011|NCT00793858|Ciclesonide|ciclesonide|mesh-list
24568012|NCT00793858|Glucocorticoids|glucocorticoids|mesh-ancestor
24568013|NCT00793858|Hormones|hormones|mesh-ancestor
24629119|NCT01103336|Nicorandil|nicorandil|mesh-list
24568014|NCT00793858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24568015|NCT00793858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568017|NCT00793897|Paclitaxel|paclitaxel|mesh-list
24607961|NCT03077698|Megestrol Acetate|megestrol acetate|mesh-list
24643909|NCT01187888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25270066|NCT02406781|Immunologic Factors|immunologic factors|mesh-ancestor
25168985|NCT02026232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25168986|NCT02026232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203621|NCT02713191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25822509|NCT00004492|Clotrimazole|clotrimazole|mesh-list
25822510|NCT00004492|Miconazole|miconazole|mesh-list
25822511|NCT00004492|Hydroxyurea|hydroxyurea|mesh-list
25822512|NCT00004492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25822513|NCT00004492|Antisickling Agents|antisickling agents|mesh-ancestor
25822514|NCT00004492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822515|NCT00004492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047342|NCT00821977|Protease Inhibitors|protease inhibitors|mesh-ancestor
25822516|NCT00004492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25822517|NCT00004492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25822518|NCT00004492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25245631|NCT03823287|Aflibercept|aflibercept|mesh-list
25245632|NCT03823287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25245633|NCT03823287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25245634|NCT03823287|Growth Substances|growth substances|mesh-ancestor
25245635|NCT03823287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245636|NCT03823287|Growth Inhibitors|growth inhibitors|mesh-ancestor
25245637|NCT03823287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25245638|NCT03815175|Aspirin|aspirin|mesh-list
25270070|NCT02406781|Alkylating Agents|alkylating agents|mesh-ancestor
25270071|NCT02406781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270072|NCT02406781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25270073|NCT02406508|Sorafenib|sorafenib|mesh-list
25270074|NCT02406508|Melphalan|melphalan|mesh-list
25675595|NCT01786668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25675596|NCT01786668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675597|NCT01786668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675598|NCT01786707|Metformin|metformin|mesh-list
25675599|NCT01786707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25675600|NCT01786707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675601|NCT01786902|Hormones|hormones|mesh-list
25692349|NCT01998919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25822519|NCT00004492|Antifungal Agents|antifungal agents|mesh-ancestor
25822520|NCT00004492|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25168987|NCT02026232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168988|NCT02026232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25168989|NCT02019589|Progesterone|progesterone|mesh-list
25168990|NCT02019589|Progestins|progestins|mesh-ancestor
25168991|NCT02019589|Hormones|hormones|mesh-ancestor
25168992|NCT02019589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25168993|NCT02019589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168994|NCT02018926|Azacitidine|azacitidine|mesh-list
25168995|NCT02018926|Mocetinostat|mocetinostat|mesh-list
25245661|NCT03804944|Pembrolizumab|pembrolizumab|mesh-list
25245662|NCT03804944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25245663|NCT03804944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25245664|NCT03802058|Paclitaxel|paclitaxel|mesh-list
25245665|NCT03802058|Carboplatin|carboplatin|mesh-list
25245666|NCT03802058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25245667|NCT03802058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25245668|NCT03802058|Tubulin Modulators|tubulin modulators|mesh-ancestor
24837138|NCT02189343|Dexamethasone|dexamethasone|mesh-list
24837139|NCT02189343|Dexamethasone acetate|dexamethasone acetate|mesh-list
24837140|NCT02189343|Pomalidomide|pomalidomide|mesh-list
24837141|NCT02189343|Ricolinostat|ricolinostat|mesh-list
24837142|NCT02189343|BB 1101|bb 1101|mesh-list
24837143|NCT02189343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24837147|NCT02189343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837148|NCT02189343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24837178|NCT02189577|Cholinergic Agents|cholinergic agents|mesh-ancestor
24837179|NCT02189577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24837180|NCT02189577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837181|NCT02189577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837183|NCT02189655|Anesthetics, Local|anesthetics, local|mesh-ancestor
24837184|NCT02189655|Anesthetics|anesthetics|mesh-ancestor
24837185|NCT02189655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24616104|NCT01034020|Nicotine|nicotine|mesh-list
24837186|NCT02189655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837187|NCT02189655|Sensory System Agents|sensory system agents|mesh-ancestor
25168996|NCT02018926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25168997|NCT02018926|Antimetabolites|antimetabolites|mesh-ancestor
25168998|NCT02018926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168999|NCT02018926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169000|NCT02018926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169001|NCT02018926|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25169016|NCT02014649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169018|NCT02014142|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25169019|NCT02014142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25169020|NCT02010333|Benzyl Alcohol|benzyl alcohol|mesh-list
25169021|NCT02010333|Anesthetics, Local|anesthetics, local|mesh-ancestor
25169022|NCT02010333|Anesthetics|anesthetics|mesh-ancestor
25169023|NCT02010333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25245680|NCT03795194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25245681|NCT03783442|Paclitaxel|paclitaxel|mesh-list
25245682|NCT03783442|Fluorouracil|fluorouracil|mesh-list
25245683|NCT03783442|Capecitabine|capecitabine|mesh-list
25245684|NCT03783442|Oxaliplatin|oxaliplatin|mesh-list
25245686|NCT03783442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24837191|NCT02189681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837192|NCT02189694|Hormones|hormones|mesh-list
24837193|NCT02189694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837195|NCT02189720|Amifampridine|amifampridine|mesh-list
25540613|NCT02184416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540614|NCT02184416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25540615|NCT02184416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25245737|NCT03746275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25245738|NCT03746275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25245739|NCT03746275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25245740|NCT03746275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25245741|NCT03746275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245742|NCT03746275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25540616|NCT02184416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540617|NCT01980355|Tranexamic Acid|tranexamic acid|mesh-list
25540618|NCT01980355|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25540619|NCT01980355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25540620|NCT01980355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540621|NCT01980355|Hemostatics|hemostatics|mesh-ancestor
25540622|NCT01980355|Coagulants|coagulants|mesh-ancestor
25540623|NCT01941641|Capecitabine|capecitabine|mesh-list
25540624|NCT01941641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25540625|NCT01941641|Antimetabolites|antimetabolites|mesh-ancestor
25245780|NCT03724175|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25245781|NCT03724175|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25245782|NCT03724175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25540626|NCT01941641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540627|NCT01941641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540628|NCT01711242|Capecitabine|capecitabine|mesh-list
25540629|NCT01711242|Oxaliplatin|oxaliplatin|mesh-list
25540630|NCT01711242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25540631|NCT01711242|Antimetabolites|antimetabolites|mesh-ancestor
25540632|NCT01711242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540633|NCT01711242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540634|NCT01559935|Clarithromycin|clarithromycin|mesh-list
25540635|NCT01559935|Dexamethasone|dexamethasone|mesh-list
25540636|NCT01559935|Dexamethasone acetate|dexamethasone acetate|mesh-list
25540637|NCT01559935|Lenalidomide|lenalidomide|mesh-list
25540638|NCT01559935|BB 1101|bb 1101|mesh-list
25540639|NCT01559935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25540640|NCT01559935|Antiemetics|antiemetics|mesh-ancestor
25540641|NCT01559935|Autonomic Agents|autonomic agents|mesh-ancestor
25540642|NCT01559935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25540643|NCT01559935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540644|NCT01559935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24838197|NCT02195973|Paclitaxel|paclitaxel|mesh-list
25540645|NCT01559935|Glucocorticoids|glucocorticoids|mesh-ancestor
25540646|NCT01559935|Hormones|hormones|mesh-ancestor
25540647|NCT01559935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25540648|NCT01559935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24838500|NCT02198261|Minoxidil|minoxidil|mesh-list
25540649|NCT01559935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540650|NCT01559935|Protease Inhibitors|protease inhibitors|mesh-ancestor
25540651|NCT01559935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540652|NCT01559935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540653|NCT01559935|Immunologic Factors|immunologic factors|mesh-ancestor
25540654|NCT01559935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25540655|NCT01559935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25540656|NCT01559935|Growth Substances|growth substances|mesh-ancestor
25540657|NCT01559935|Growth Inhibitors|growth inhibitors|mesh-ancestor
25540658|NCT01559935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25540659|NCT01559935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25540660|NCT01559935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25540661|NCT01559935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25540662|NCT01559935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25540663|NCT01067144|Gabapentin|gabapentin|mesh-list
24590582|NCT00913250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270120|NCT02406300|Bupivacaine|bupivacaine|mesh-list
25270121|NCT02406300|Ropivacaine|ropivacaine|mesh-list
25270122|NCT02406300|Levobupivacaine|levobupivacaine|mesh-list
25270123|NCT02406300|Sevoflurane|sevoflurane|mesh-list
25540664|NCT01067144|Lorazepam|lorazepam|mesh-list
25540665|NCT01067144|Analgesics|analgesics|mesh-ancestor
25540666|NCT01067144|Sensory System Agents|sensory system agents|mesh-ancestor
25540667|NCT01067144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25540668|NCT01067144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540669|NCT01067144|Anticonvulsants|anticonvulsants|mesh-ancestor
25540670|NCT01067144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25540671|NCT01067144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25540672|NCT01067144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25540673|NCT01067144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25540674|NCT01067144|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25540675|NCT01067144|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25540676|NCT01067144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25540677|NCT01067144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540678|NCT01067144|Antimanic Agents|antimanic agents|mesh-ancestor
25540679|NCT01067144|Antiemetics|antiemetics|mesh-ancestor
25540680|NCT01067144|Autonomic Agents|autonomic agents|mesh-ancestor
25540681|NCT01067144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25540682|NCT01067144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25540683|NCT01067144|GABA Modulators|gaba modulators|mesh-ancestor
25540684|NCT01067144|GABA Agents|gaba agents|mesh-ancestor
25540685|NCT00600483|Gentamicins|gentamicins|mesh-list
25540686|NCT00600483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25540687|NCT00600483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25540688|NCT00600483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25540689|NCT00600483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590661|NCT00913484|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
24590662|NCT00913484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590663|NCT00913484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590664|NCT00913497|Insulin|insulin|mesh-list
24590665|NCT00913497|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24590666|NCT00913497|Insulin Aspart|insulin aspart|mesh-list
24840138|NCT02207920|Immunologic Factors|immunologic factors|mesh-ancestor
25540690|NCT00600483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650655|NCT01506453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24590883|NCT00914121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24590884|NCT00914121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24590885|NCT00914121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24590924|NCT00914368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24590925|NCT00914368|Purinergic Agents|purinergic agents|mesh-ancestor
24840852|NCT02212795|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24840853|NCT02212795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24840920|NCT02213159|Narcotics|narcotics|mesh-ancestor
24591000|NCT00914654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24591001|NCT00914654|Autonomic Agents|autonomic agents|mesh-ancestor
25650656|NCT01506453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25650657|NCT01506453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25650658|NCT01506453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25650659|NCT01506453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25650660|NCT01506453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25657192|NCT01583985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25540692|NCT00006256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25540693|NCT00006256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540694|NCT00006256|Tubulin Modulators|tubulin modulators|mesh-ancestor
25540695|NCT00006256|Antimitotic Agents|antimitotic agents|mesh-ancestor
25540696|NCT00006256|Mitosis Modulators|mitosis modulators|mesh-ancestor
25540697|NCT00006256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540698|NCT00568958|Naltrexone|naltrexone|mesh-list
25540699|NCT00568958|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25540700|NCT00568958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25540701|NCT00568958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540702|NCT00568958|Sensory System Agents|sensory system agents|mesh-ancestor
24841690|NCT02217553|Vitamins|vitamins|mesh-ancestor
24841691|NCT02217553|Micronutrients|micronutrients|mesh-ancestor
24841693|NCT02217631|Prednisolone|prednisolone|mesh-list
24841695|NCT02217631|Methylprednisolone|methylprednisolone|mesh-list
24841696|NCT02217631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24841697|NCT02217631|Prednisolone acetate|prednisolone acetate|mesh-list
24841698|NCT02217631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25270190|NCT02405910|Antiviral Agents|antiviral agents|mesh-ancestor
25270191|NCT02405910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25270192|NCT02405910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841701|NCT02217631|Glucocorticoids|glucocorticoids|mesh-ancestor
24841703|NCT02217631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24678453|NCT01361997|Disinfectants|disinfectants|mesh-ancestor
24841726|NCT02217683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24841727|NCT02217683|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24841728|NCT02217683|Vasodilator Agents|vasodilator agents|mesh-ancestor
24841729|NCT02217683|Gasotransmitters|gasotransmitters|mesh-ancestor
24841730|NCT02217683|Protective Agents|protective agents|mesh-ancestor
24647046|NCT01206036|Sirolimus|sirolimus|mesh-list
25675675|NCT01787279|Antiviral Agents|antiviral agents|mesh-ancestor
25675676|NCT01787279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675677|NCT01787331|Itraconazole|itraconazole|mesh-list
25540703|NCT00568958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25540704|NCT00569010|Cytarabine|cytarabine|mesh-list
25540705|NCT00569010|Azacitidine|azacitidine|mesh-list
25540706|NCT00569010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25540707|NCT00569010|Antimetabolites|antimetabolites|mesh-ancestor
25540708|NCT00569010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540709|NCT00569010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540710|NCT00569010|Antiviral Agents|antiviral agents|mesh-ancestor
25540711|NCT00569010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25540712|NCT00569010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25540713|NCT00569010|Immunologic Factors|immunologic factors|mesh-ancestor
25540714|NCT00569010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540715|NCT00569010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24568824|NCT00797745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24568825|NCT00797745|Antimetabolites|antimetabolites|mesh-ancestor
24568827|NCT00797771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24568828|NCT00797771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568829|NCT00797784|Etanercept|etanercept|mesh-list
24568830|NCT00797784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24512915|NCT00577668|Thalidomide|thalidomide|mesh-list
24569049|NCT00798785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24569050|NCT00798785|Immunologic Factors|immunologic factors|mesh-ancestor
24569051|NCT00798785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569052|NCT00798785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24569054|NCT00798876|Vitamins|vitamins|mesh-ancestor
24569055|NCT00798876|Micronutrients|micronutrients|mesh-ancestor
24569056|NCT00798876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540716|NCT00569309|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25540717|NCT00569309|Immunologic Factors|immunologic factors|mesh-ancestor
25540718|NCT00569309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540719|NCT00569374|Modafinil|modafinil|mesh-list
25540720|NCT00569374|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24842285|NCT02220400|Anesthetics|anesthetics|mesh-ancestor
25540721|NCT00569374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540722|NCT00569374|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25540723|NCT00569374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25540724|NCT00569374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24569192|NCT00799201|Naloxone|naloxone|mesh-list
24791896|NCT02553460|Antiemetics|antiemetics|mesh-ancestor
24791897|NCT02553460|Autonomic Agents|autonomic agents|mesh-ancestor
24791898|NCT02553460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25008943|NCT03775200|Psilocybin|psilocybin|mesh-list
24842659|NCT02222519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842660|NCT02222623|Isophane Insulin, Human|isophane insulin, human|mesh-list
24842661|NCT02222623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25540725|NCT00569374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540726|NCT00569530|Calfactant|calfactant|mesh-list
25540727|NCT00569530|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
25540728|NCT00569530|Respiratory System Agents|respiratory system agents|mesh-ancestor
25540729|NCT00569582|Mifepristone|mifepristone|mesh-list
25540730|NCT00569582|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25540731|NCT00569582|Abortifacient Agents|abortifacient agents|mesh-ancestor
25540732|NCT00569582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25540733|NCT00569582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540734|NCT00569582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25540735|NCT00569582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25540736|NCT00569582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25540737|NCT00569582|Contraceptive Agents|contraceptive agents|mesh-ancestor
25540738|NCT00569582|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25540739|NCT00569582|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25540740|NCT00569582|Hormone Antagonists|hormone antagonists|mesh-ancestor
25540741|NCT00569582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25540742|NCT00569582|Luteolytic Agents|luteolytic agents|mesh-ancestor
25246409|NCT02983045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25246420|NCT02943993|Edoxaban|edoxaban|mesh-list
25246421|NCT02943993|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25246422|NCT02943993|Antithrombins|antithrombins|mesh-ancestor
25246423|NCT02943993|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25246424|NCT02943993|Protease Inhibitors|protease inhibitors|mesh-ancestor
25246425|NCT02943993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25246426|NCT02943993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246427|NCT02943993|Anticoagulants|anticoagulants|mesh-ancestor
25246428|NCT02939989|Ribavirin|ribavirin|mesh-list
24843122|NCT02225756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24843124|NCT02225756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25540743|NCT00569582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25540744|NCT00569582|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25540745|NCT00569660|Azacitidine|azacitidine|mesh-list
25540746|NCT00569660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25540747|NCT00569660|Antimetabolites|antimetabolites|mesh-ancestor
25540748|NCT00569660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540749|NCT00569660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540750|NCT00569660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540751|NCT00569673|Docetaxel|docetaxel|mesh-list
25540752|NCT00569673|Trabectedin|trabectedin|mesh-list
25540753|NCT00569673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540754|NCT00569673|Tubulin Modulators|tubulin modulators|mesh-ancestor
24843290|NCT02226913|Epinephrine|epinephrine|mesh-list
24843312|NCT02226913|Sympathomimetics|sympathomimetics|mesh-ancestor
24680839|NCT01376271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24843313|NCT02226913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24843314|NCT02226926|Aspirin|aspirin|mesh-list
24843315|NCT02226926|Dipyridamole|dipyridamole|mesh-list
24843316|NCT02226926|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
24843317|NCT02226926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24843319|NCT02226926|Analgesics|analgesics|mesh-ancestor
25540755|NCT00569673|Antimitotic Agents|antimitotic agents|mesh-ancestor
25540756|NCT00569673|Mitosis Modulators|mitosis modulators|mesh-ancestor
25540757|NCT00569673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540758|NCT00569673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25540759|NCT00569673|Alkylating Agents|alkylating agents|mesh-ancestor
25540760|NCT00569777|Ketotifen|ketotifen|mesh-list
25540761|NCT00569777|Antipruritics|antipruritics|mesh-ancestor
25540762|NCT00569777|Dermatologic Agents|dermatologic agents|mesh-ancestor
25540763|NCT00569777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25540764|NCT00569777|Histamine Antagonists|histamine antagonists|mesh-ancestor
25540765|NCT00569777|Histamine Agents|histamine agents|mesh-ancestor
25540766|NCT00569777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25540767|NCT00569777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540768|NCT00569777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540769|NCT00569777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25540770|NCT00569803|Abatacept|abatacept|mesh-list
25540771|NCT00569803|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25540772|NCT00569803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540773|NCT00569803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540774|NCT00569803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25540775|NCT00569803|Immunologic Factors|immunologic factors|mesh-ancestor
25540776|NCT00569803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540777|NCT00569803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25540778|NCT00569855|Phenoxybenzamine|phenoxybenzamine|mesh-list
24569509|NCT00800826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24569510|NCT00800826|Analgesics|analgesics|mesh-ancestor
24569534|NCT00800930|Butyric Acid|butyric acid|mesh-list
24452616|NCT05457959|Poly I-C|poly i-c|mesh-list
24452617|NCT05457959|Nivolumab|nivolumab|mesh-list
24843716|NCT02228928|Antipruritics|antipruritics|mesh-ancestor
24843717|NCT02228928|Dermatologic Agents|dermatologic agents|mesh-ancestor
24843718|NCT02228928|Sensory System Agents|sensory system agents|mesh-ancestor
24843719|NCT02228928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24843720|NCT02228928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843722|NCT02229045|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25540779|NCT00569855|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25540780|NCT00569855|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25540781|NCT00569855|Adrenergic Agents|adrenergic agents|mesh-ancestor
25540782|NCT00569855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25540783|NCT00569855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540784|NCT00569855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540785|NCT00569855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25540786|NCT00569855|Vasodilator Agents|vasodilator agents|mesh-ancestor
25540787|NCT00569946|Axitinib|axitinib|mesh-list
25540788|NCT00569946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540789|NCT00569946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25540790|NCT00569946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540791|NCT00569946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009060|NCT03700658|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25009061|NCT03700658|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24791982|NCT02035137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24791983|NCT02035137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24792007|NCT00777036|Dasatinib|dasatinib|mesh-list
25009062|NCT03700658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25009063|NCT03700658|Contraceptive Agents|contraceptive agents|mesh-ancestor
25009064|NCT03700658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25246485|NCT02732288|Melatonin|melatonin|mesh-list
25436829|NCT04756206|Hormone Antagonists|hormone antagonists|mesh-ancestor
25436830|NCT04756206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25436831|NCT04756206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436832|NCT04756128|Colchicine|colchicine|mesh-list
25436833|NCT04756128|Naltrexone|naltrexone|mesh-list
25436834|NCT04756128|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25436835|NCT04756128|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25436836|NCT04756128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436837|NCT04756128|Sensory System Agents|sensory system agents|mesh-ancestor
25436838|NCT04756128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24569703|NCT00801515|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24569704|NCT00801528|Diclofenac|diclofenac|mesh-list
24843871|NCT02229812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843872|NCT02229825|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24843873|NCT02229825|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24843874|NCT02229825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24843875|NCT02229825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24843876|NCT02229825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843877|NCT02229825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24843878|NCT02229825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843879|NCT02229825|Analgesics|analgesics|mesh-ancestor
24844778|NCT02234466|Autonomic Agents|autonomic agents|mesh-ancestor
25270247|NCT02405988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24569748|NCT00801788|Analgesics|analgesics|mesh-ancestor
24569749|NCT00801788|Sensory System Agents|sensory system agents|mesh-ancestor
25246506|NCT02726581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25246507|NCT02726581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25246508|NCT02726581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246509|NCT02726581|Immunologic Factors|immunologic factors|mesh-ancestor
25246510|NCT02726581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25246511|NCT02726581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25246517|NCT02672098|Carboplatin|carboplatin|mesh-list
24844127|NCT02231333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569859|NCT00802048|Sensory System Agents|sensory system agents|mesh-ancestor
24569860|NCT00802048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25246525|NCT02631759|Levetiracetam|levetiracetam|mesh-list
25246526|NCT02631759|Anticonvulsants|anticonvulsants|mesh-ancestor
25246527|NCT02631759|Nootropic Agents|nootropic agents|mesh-ancestor
25246528|NCT02624518|Bombesin|bombesin|mesh-list
25246529|NCT02624518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25246530|NCT02624518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246531|NCT02624518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844248|NCT02231931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25246547|NCT02594384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25246548|NCT02557945|Gabapentin|gabapentin|mesh-list
25246549|NCT02557945|Analgesics|analgesics|mesh-ancestor
24844487|NCT02232945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24844531|NCT02233075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270259|NCT02405858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270260|NCT02405858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25270261|NCT02405858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270262|NCT02405858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24844766|NCT02234193|Mydriatics|mydriatics|mesh-ancestor
25436839|NCT04756128|Gout Suppressants|gout suppressants|mesh-ancestor
25436840|NCT04756128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25436841|NCT04756128|Tubulin Modulators|tubulin modulators|mesh-ancestor
25436842|NCT04756128|Antimitotic Agents|antimitotic agents|mesh-ancestor
25436843|NCT04756128|Mitosis Modulators|mitosis modulators|mesh-ancestor
25436844|NCT04756128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436845|NCT04756128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436846|NCT04756089|Oxytocin|oxytocin|mesh-list
25246572|NCT02524249|Caffeine|caffeine|mesh-list
25246573|NCT02524249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25246582|NCT02501954|Paclitaxel|paclitaxel|mesh-list
24844824|NCT02234739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24845089|NCT02236026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845090|NCT02236026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24845091|NCT02236052|Vaccines|vaccines|mesh-list
24845092|NCT02236052|Immunologic Factors|immunologic factors|mesh-ancestor
24845093|NCT02236052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845094|NCT02236065|Lenograstim|lenograstim|mesh-list
24845111|NCT02236169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24845112|NCT02236169|Autonomic Agents|autonomic agents|mesh-ancestor
24845149|NCT02236403|Ivermectin|ivermectin|mesh-list
25436847|NCT04756089|Oxytocics|oxytocics|mesh-ancestor
25436848|NCT04756089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25436849|NCT04756089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436850|NCT04755868|Talazoparib|talazoparib|mesh-list
25436851|NCT04755868|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25436852|NCT04755868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540792|NCT00570089|Ranolazine|ranolazine|mesh-list
25540793|NCT00570089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24845260|NCT02237326|Acetic Acid|acetic acid|mesh-list
24845261|NCT02237326|Retinol acetate|retinol acetate|mesh-list
24845262|NCT02237326|Lugol's solution|lugol's solution|mesh-list
24650167|NCT01224418|Tacrolimus|tacrolimus|mesh-list
24845324|NCT02237495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24845325|NCT02237495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25540794|NCT00570089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25540795|NCT00570089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540796|NCT00570128|Donepezil|donepezil|mesh-list
25540797|NCT00570128|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25540798|NCT00570128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540799|NCT00570128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540800|NCT00570128|Cholinergic Agents|cholinergic agents|mesh-ancestor
25540801|NCT00570128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25540802|NCT00570128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540803|NCT00570128|Nootropic Agents|nootropic agents|mesh-ancestor
25246638|NCT02420717|Dexamethasone acetate|dexamethasone acetate|mesh-list
25246639|NCT02420717|Prednisone|prednisone|mesh-list
25246640|NCT02420717|Cortisone|cortisone|mesh-list
25246641|NCT02420717|Cyclophosphamide|cyclophosphamide|mesh-list
25246642|NCT02420717|Rituximab|rituximab|mesh-list
24845471|NCT02238119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845472|NCT02238119|Parasympatholytics|parasympatholytics|mesh-ancestor
24845473|NCT02238119|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24845474|NCT02238119|Cholinergic Agents|cholinergic agents|mesh-ancestor
24845475|NCT02238132|Ipratropium|ipratropium|mesh-list
24845476|NCT02238132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24845477|NCT02238132|Autonomic Agents|autonomic agents|mesh-ancestor
24845478|NCT02238132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845479|NCT02238132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845480|NCT02238132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24845481|NCT02238132|Respiratory System Agents|respiratory system agents|mesh-ancestor
24845482|NCT02238132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24845483|NCT02238132|Cholinergic Agents|cholinergic agents|mesh-ancestor
24845484|NCT02238132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845485|NCT02238132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540804|NCT00570232|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25540805|NCT00570232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540806|NCT00570232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25540807|NCT00570232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540808|NCT00570232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540809|NCT00570310|Pregabalin|pregabalin|mesh-list
25540810|NCT00570310|Analgesics|analgesics|mesh-ancestor
25540811|NCT00570310|Sensory System Agents|sensory system agents|mesh-ancestor
24845639|NCT02238353|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24845640|NCT02238353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24845641|NCT02238353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845642|NCT02238353|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24845643|NCT02238353|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24845644|NCT02238353|Histamine Antagonists|histamine antagonists|mesh-ancestor
24845671|NCT02238418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845672|NCT02238418|Vitamins|vitamins|mesh-ancestor
25270279|NCT02405598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25270280|NCT02405598|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25270281|NCT02405598|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24477212|NCT00417833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24477213|NCT00417833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24845691|NCT02238444|Analgesics|analgesics|mesh-ancestor
24845756|NCT02238717|Analgesics|analgesics|mesh-ancestor
24845757|NCT02238717|Sensory System Agents|sensory system agents|mesh-ancestor
24845758|NCT02238717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845776|NCT02238808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845794|NCT02239107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845795|NCT02239107|Protective Agents|protective agents|mesh-ancestor
24845822|NCT02239458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24845823|NCT02239458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845824|NCT02239458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24845826|NCT02239484|Tamsulosin|tamsulosin|mesh-list
24845827|NCT02239484|Vasodilator Agents|vasodilator agents|mesh-ancestor
24845828|NCT02239484|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24845829|NCT02239484|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24845830|NCT02239484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24845834|NCT02239484|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24845835|NCT02239484|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24845836|NCT02239484|Adrenergic Agents|adrenergic agents|mesh-ancestor
25540812|NCT00570310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25540813|NCT00570310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540814|NCT00570310|Anticonvulsants|anticonvulsants|mesh-ancestor
25540815|NCT00570310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25540816|NCT00570310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25540817|NCT00570310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540818|NCT00570310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25246664|NCT02420717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24845918|NCT02240017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845940|NCT02240173|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24845941|NCT02240173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24476635|NCT00415935|Abortifacient Agents|abortifacient agents|mesh-ancestor
24846012|NCT02240602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24846013|NCT02240602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846014|NCT02240602|Analgesics|analgesics|mesh-ancestor
24846015|NCT02240602|Sensory System Agents|sensory system agents|mesh-ancestor
24846016|NCT02240602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24846017|NCT02240641|Antihypertensive Agents|antihypertensive agents|mesh-list
24846018|NCT02240641|Lacidipine|lacidipine|mesh-list
24846019|NCT02240641|Diuretics|diuretics|mesh-list
24846020|NCT02240641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24846021|NCT02240641|Enzyme Inhibitors|enzyme inhibitors|mesh-list
24846022|NCT02240641|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25540819|NCT00570310|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25540820|NCT00570310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25540821|NCT00570310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25540822|NCT00570310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25540823|NCT00570323|Fulvestrant|fulvestrant|mesh-list
25540824|NCT00570323|Anastrozole|anastrozole|mesh-list
25540825|NCT00570323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25540826|NCT00570323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540827|NCT00570323|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25540828|NCT00570323|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25246693|NCT02420717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25246694|NCT02420717|Tubulin Modulators|tubulin modulators|mesh-ancestor
25246695|NCT02420717|Antimitotic Agents|antimitotic agents|mesh-ancestor
24592142|NCT00920296|Antiviral Agents|antiviral agents|mesh-ancestor
24592148|NCT00920413|Micronutrients|micronutrients|mesh-ancestor
24846143|NCT02241460|Lidocaine|lidocaine|mesh-list
24846190|NCT02241876|Acetylcysteine|acetylcysteine|mesh-list
24846191|NCT02241876|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24846192|NCT02241876|Antiviral Agents|antiviral agents|mesh-ancestor
24846193|NCT02241876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24476796|NCT00416533|Doxorubicin|doxorubicin|mesh-list
24476797|NCT00416533|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24476798|NCT00416533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476799|NCT00416533|Tubulin Modulators|tubulin modulators|mesh-ancestor
24476800|NCT00416533|Antimitotic Agents|antimitotic agents|mesh-ancestor
25270286|NCT02405793|Meloxicam|meloxicam|mesh-list
25270287|NCT02405793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25540829|NCT00570323|Hormone Antagonists|hormone antagonists|mesh-ancestor
25540830|NCT00570323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25540831|NCT00570323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540832|NCT00570323|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25540833|NCT00570323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25540834|NCT00570323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540835|NCT00570323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540836|NCT00570349|Nitric Oxide|nitric oxide|mesh-list
24650744|NCT01227798|Interferons|interferons|mesh-list
24846298|NCT02242292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846299|NCT02242292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24846301|NCT02242292|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24846302|NCT02242292|Cholinergic Agents|cholinergic agents|mesh-ancestor
24846303|NCT02242292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24846304|NCT02242292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846305|NCT02242292|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24846325|NCT02242357|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24846326|NCT02242357|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24846327|NCT02242357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846328|NCT02242370|Telmisartan|telmisartan|mesh-list
24846329|NCT02242370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24846330|NCT02242370|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24846331|NCT02242370|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24846332|NCT02242370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846333|NCT02242383|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24846334|NCT02242383|Telmisartan|telmisartan|mesh-list
25540837|NCT00570349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25540838|NCT00570349|Autonomic Agents|autonomic agents|mesh-ancestor
25540839|NCT00570349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25540840|NCT00570349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540841|NCT00570349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25540842|NCT00570349|Respiratory System Agents|respiratory system agents|mesh-ancestor
25540843|NCT00570349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25540844|NCT00570349|Antioxidants|antioxidants|mesh-ancestor
25540845|NCT00570349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540846|NCT00570349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25540847|NCT00570349|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25540848|NCT00570349|Vasodilator Agents|vasodilator agents|mesh-ancestor
25246714|NCT02407509|Everolimus|everolimus|mesh-list
24846350|NCT02242396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846351|NCT02242396|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24846352|NCT02242396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24846353|NCT02242396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846354|NCT02242396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24846355|NCT02242396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24759625|NCT01753128|Imipramine|imipramine|mesh-list
25270321|NCT02405364|Dexamethasone|dexamethasone|mesh-list
25270322|NCT02405364|Lenalidomide|lenalidomide|mesh-list
25270323|NCT02405364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25270324|NCT02405364|Antiemetics|antiemetics|mesh-ancestor
25270325|NCT02405364|Autonomic Agents|autonomic agents|mesh-ancestor
25270326|NCT02405364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24456954|NCT00332774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25068734|NCT03431909|Aspirin|aspirin|mesh-list
24456955|NCT00332774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456956|NCT00332774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24477411|NCT00418509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25050925|NCT00460317|Mitosis Modulators|mitosis modulators|mesh-ancestor
25675816|NCT01789606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25675817|NCT01789606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675818|NCT01789606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25675819|NCT01789606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25675820|NCT01789606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25675821|NCT01789606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540849|NCT00570349|Gasotransmitters|gasotransmitters|mesh-ancestor
25540850|NCT00570349|Protective Agents|protective agents|mesh-ancestor
25540851|NCT00570401|Dasatinib|dasatinib|mesh-list
25540852|NCT00570401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540853|NCT00570401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25540854|NCT00570401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540855|NCT00570401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540856|NCT00570492|Fluticasone|fluticasone|mesh-list
25540857|NCT00570492|Xhance|xhance|mesh-list
25540858|NCT00570492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24592326|NCT00921284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24592327|NCT00921284|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24592328|NCT00921284|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24592417|NCT00921700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24592418|NCT00921700|Analgesics|analgesics|mesh-ancestor
24592419|NCT00921700|Sensory System Agents|sensory system agents|mesh-ancestor
24635397|NCT01138904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635399|NCT01138956|Acetylcysteine|acetylcysteine|mesh-list
24592428|NCT00921700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540859|NCT00570492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25540860|NCT00570492|Autonomic Agents|autonomic agents|mesh-ancestor
25540861|NCT00570492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25540862|NCT00570492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540863|NCT00570492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25540864|NCT00570492|Respiratory System Agents|respiratory system agents|mesh-ancestor
25540865|NCT00570492|Dermatologic Agents|dermatologic agents|mesh-ancestor
25540866|NCT00570492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25540867|NCT00570661|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
24846391|NCT02242474|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24846392|NCT02242513|Lidocaine|lidocaine|mesh-list
24846393|NCT02242513|Anesthetics, Local|anesthetics, local|mesh-ancestor
24846394|NCT02242513|Anesthetics|anesthetics|mesh-ancestor
24846395|NCT02242513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24452748|NCT05455944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24452749|NCT05455944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24452750|NCT05455944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24846404|NCT02242591|Ropivacaine|ropivacaine|mesh-list
25270338|NCT02405364|Growth Inhibitors|growth inhibitors|mesh-ancestor
25270339|NCT02405156|Letrozole|letrozole|mesh-list
25270340|NCT02405156|Misoprostol|misoprostol|mesh-list
25270341|NCT02405156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270342|NCT02405156|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25270343|NCT02405156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25270344|NCT02405156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25270345|NCT02405156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456968|NCT00332787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456969|NCT00332787|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24456975|NCT00332826|Insulin|insulin|mesh-list
24477448|NCT00418639|Nitazoxanide|nitazoxanide|mesh-list
24477449|NCT00418639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24477450|NCT00418639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24477451|NCT00418678|Nabilone|nabilone|mesh-list
24477452|NCT00418678|Antiemetics|antiemetics|mesh-ancestor
24477453|NCT00418678|Autonomic Agents|autonomic agents|mesh-ancestor
24477454|NCT00418678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24477455|NCT00418678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477456|NCT00418678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24477457|NCT00418678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25540868|NCT00570661|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
25540869|NCT00570661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540870|NCT00570661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540871|NCT00570674|Paclitaxel|paclitaxel|mesh-list
25540872|NCT00570674|Carboplatin|carboplatin|mesh-list
25540873|NCT00570674|Cetuximab|cetuximab|mesh-list
25540874|NCT00570674|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25540875|NCT00570674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25540876|NCT00570674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009161|NCT03269344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25009162|NCT03269344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25009210|NCT02953093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109932|NCT03120962|Gabapentin|gabapentin|mesh-list
25270346|NCT02405156|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25270347|NCT02405156|Hormone Antagonists|hormone antagonists|mesh-ancestor
25270348|NCT02405156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25270349|NCT02405156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270350|NCT02405156|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25270351|NCT02405156|Abortifacient Agents|abortifacient agents|mesh-ancestor
25270352|NCT02405156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25270354|NCT02405156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25270356|NCT02405130|Epinephrine|epinephrine|mesh-list
25270357|NCT02405130|Racepinephrine|racepinephrine|mesh-list
25270358|NCT02405130|Epinephryl borate|epinephryl borate|mesh-list
25270359|NCT02405130|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25270360|NCT02405130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25270361|NCT02405130|Adrenergic Agents|adrenergic agents|mesh-ancestor
25270362|NCT02405130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25540877|NCT00570674|Tubulin Modulators|tubulin modulators|mesh-ancestor
25540878|NCT00570674|Antimitotic Agents|antimitotic agents|mesh-ancestor
25540879|NCT00570674|Mitosis Modulators|mitosis modulators|mesh-ancestor
25540880|NCT00570674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540881|NCT00570674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25540882|NCT00570687|Insulin|insulin|mesh-list
25540883|NCT00570687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24592608|NCT00923234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270367|NCT02405130|Autonomic Agents|autonomic agents|mesh-ancestor
25270368|NCT02405130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25270369|NCT02405130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25270370|NCT02405130|Respiratory System Agents|respiratory system agents|mesh-ancestor
25270371|NCT02405130|Mydriatics|mydriatics|mesh-ancestor
25270372|NCT02405130|Sympathomimetics|sympathomimetics|mesh-ancestor
25270373|NCT02405130|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25270374|NCT02405104|Chlorzoxazone|chlorzoxazone|mesh-list
25270375|NCT02405104|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25270376|NCT02405104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270377|NCT02405104|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25270378|NCT02405104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25270379|NCT02405078|Deoxyglucose|deoxyglucose|mesh-list
25270380|NCT02405078|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25270381|NCT02405078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25270385|NCT02405078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25270387|NCT02404844|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24846488|NCT02242825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846489|NCT02242825|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24846490|NCT02242825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25675843|NCT01789970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675844|NCT01789970|Analgesics|analgesics|mesh-ancestor
25540884|NCT00570687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540885|NCT00570700|Dasatinib|dasatinib|mesh-list
25436890|NCT04755647|Nitric Oxide|nitric oxide|mesh-list
25540886|NCT00570700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540887|NCT00570700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25540888|NCT00570700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540889|NCT00570700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540890|NCT00570713|Gemcitabine|gemcitabine|mesh-list
25540891|NCT00570713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25540892|NCT00570713|Antimetabolites|antimetabolites|mesh-ancestor
24651211|NCT01230463|Ketorolac|ketorolac|mesh-list
25068768|NCT03431831|Naltrexone|naltrexone|mesh-list
24452761|NCT05453045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452762|NCT05453045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270388|NCT02404844|Hormone Antagonists|hormone antagonists|mesh-ancestor
25270389|NCT02404844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25270390|NCT02404844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270391|NCT02404844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25270392|NCT02404844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270393|NCT02404844|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25270394|NCT02404844|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24846509|NCT02242864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846510|NCT02242864|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24846511|NCT02242864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24846512|NCT02242864|Diuretics|diuretics|mesh-ancestor
24846513|NCT02242864|Natriuretic Agents|natriuretic agents|mesh-ancestor
24846525|NCT02242877|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24846527|NCT02242929|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24846528|NCT02242929|Immunologic Factors|immunologic factors|mesh-ancestor
24846529|NCT02242929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846530|NCT02242929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540893|NCT00570713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540894|NCT00570713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540895|NCT00570713|Antiviral Agents|antiviral agents|mesh-ancestor
25540896|NCT00570713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25540897|NCT00570713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540898|NCT00570713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25540899|NCT00570713|Immunologic Factors|immunologic factors|mesh-ancestor
25540900|NCT00570713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540901|NCT00570739|Metformin|metformin|mesh-list
25540902|NCT00570739|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
25540903|NCT00570739|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25540904|NCT00570739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540905|NCT00570739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25270395|NCT02404844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25270396|NCT02404779|Cisatracurium|cisatracurium|mesh-list
24477990|NCT00421109|Histamine Antagonists|histamine antagonists|mesh-ancestor
24846537|NCT02242955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24846538|NCT02242955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846539|NCT02242955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24846540|NCT02242955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24846541|NCT02242955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24846542|NCT02242955|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24846543|NCT02242955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24846544|NCT02242955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24846545|NCT02242955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24846546|NCT02242955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24846547|NCT02242955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24846548|NCT02242955|Anesthetics, General|anesthetics, general|mesh-ancestor
24846550|NCT02242955|GABA Modulators|gaba modulators|mesh-ancestor
24462685|NCT00357240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24651421|NCT01231529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24846561|NCT02243098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25270397|NCT02404779|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25270398|NCT02404779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25270399|NCT02404779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25270400|NCT02404779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270401|NCT02405013|Ribavirin|ribavirin|mesh-list
25270402|NCT02405013|Sofosbuvir|sofosbuvir|mesh-list
25270404|NCT02405013|Ledipasvir|ledipasvir|mesh-list
25540906|NCT00570739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25540907|NCT00570739|Antimetabolites|antimetabolites|mesh-ancestor
25540908|NCT00570739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540909|NCT00570739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25540910|NCT00570765|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
25540911|NCT00570765|Cathartics|cathartics|mesh-ancestor
25540912|NCT00570765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25540913|NCT00570778|Glycopyrrolate|glycopyrrolate|mesh-list
25540914|NCT00570778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25540915|NCT00570778|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25540916|NCT00570778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24792176|NCT05411744|Vitamin B 6|vitamin b 6|mesh-list
24846584|NCT02243137|Analgesics|analgesics|mesh-ancestor
24846610|NCT02243241|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24846611|NCT02243241|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24846612|NCT02243241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24846614|NCT02243254|Remifentanil|remifentanil|mesh-list
24846615|NCT02243254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25068788|NCT03431805|Tranexamic Acid|tranexamic acid|mesh-list
24846616|NCT02243254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24846617|NCT02243254|Analgesics|analgesics|mesh-ancestor
24846624|NCT02243254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24846625|NCT02243254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846626|NCT02243254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24846627|NCT02243254|Narcotics|narcotics|mesh-ancestor
24846628|NCT02243254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24846629|NCT02243358|Gemcitabine|gemcitabine|mesh-list
24846630|NCT02243358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24846631|NCT02243358|Antimetabolites|antimetabolites|mesh-ancestor
24846632|NCT02243358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846633|NCT02243358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540917|NCT00570778|Cholinergic Agents|cholinergic agents|mesh-ancestor
25540918|NCT00570778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25540919|NCT00570778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540920|NCT00570778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540921|NCT00570908|Capecitabine|capecitabine|mesh-list
25540922|NCT00570908|Sunitinib|sunitinib|mesh-list
25540923|NCT00570908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25540924|NCT00570908|Antimetabolites|antimetabolites|mesh-ancestor
25540925|NCT00570908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270420|NCT02404688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25270421|NCT02404688|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24846683|NCT02243553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24629363|NCT01104844|Antipyretics|antipyretics|mesh-ancestor
24452978|NCT05378113|Dermatologic Agents|dermatologic agents|mesh-ancestor
24452979|NCT05378113|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24452980|NCT05378113|Serotonin Agents|serotonin agents|mesh-ancestor
24452981|NCT05378113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24846684|NCT02243553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25270422|NCT02404688|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25270423|NCT02404688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25540926|NCT00570908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540927|NCT00570908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25540928|NCT00570908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25540929|NCT00570908|Growth Substances|growth substances|mesh-ancestor
25540930|NCT00570908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540931|NCT00570908|Growth Inhibitors|growth inhibitors|mesh-ancestor
25540932|NCT00570908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25540933|NCT00570908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540934|NCT00570921|Everolimus|everolimus|mesh-list
25540935|NCT00570921|Fulvestrant|fulvestrant|mesh-list
25540936|NCT00570921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540937|NCT00570921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25540938|NCT00570921|Immunologic Factors|immunologic factors|mesh-ancestor
25540939|NCT00570921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540940|NCT00570921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25540941|NCT00570921|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25540942|NCT00570921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24571964|NCT00812396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571965|NCT00812396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24571966|NCT00812396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24571967|NCT00812396|Anabolic Agents|anabolic agents|mesh-ancestor
24571968|NCT00812422|Ibuprofen|ibuprofen|mesh-list
24571969|NCT00812422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24478810|NCT00424606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24846686|NCT02243553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24846687|NCT02243553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24846688|NCT02243553|Anesthetics, General|anesthetics, general|mesh-ancestor
24846689|NCT02243553|Anesthetics|anesthetics|mesh-ancestor
24846690|NCT02243553|GABA Modulators|gaba modulators|mesh-ancestor
24846691|NCT02243553|GABA Agents|gaba agents|mesh-ancestor
24453018|NCT05360264|Antimetabolites|antimetabolites|mesh-ancestor
25270424|NCT02404688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270425|NCT02404688|Hormones|hormones|mesh-ancestor
25270426|NCT02404688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24731105|NCT01632436|Pixantrone|pixantrone|mesh-list
24453019|NCT05360264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24453020|NCT05360264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24453021|NCT05360264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540943|NCT00570921|Hormone Antagonists|hormone antagonists|mesh-ancestor
25540944|NCT00570921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25540945|NCT00570960|Dextrans|dextrans|mesh-list
25540946|NCT00570960|Anticoagulants|anticoagulants|mesh-ancestor
25540947|NCT00570960|Plasma Substitutes|plasma substitutes|mesh-ancestor
25540948|NCT00570960|Blood Substitutes|blood substitutes|mesh-ancestor
25540949|NCT00571064|Donepezil|donepezil|mesh-list
25540950|NCT00571064|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25540951|NCT00571064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540952|NCT00571064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846712|NCT02243553|Purinergic Agents|purinergic agents|mesh-ancestor
24846713|NCT02243553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24846714|NCT02243553|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24846715|NCT02243553|Protective Agents|protective agents|mesh-ancestor
24846716|NCT02243553|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24846717|NCT02243553|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24846718|NCT02243553|Hemostatics|hemostatics|mesh-ancestor
24846719|NCT02243553|Coagulants|coagulants|mesh-ancestor
24846720|NCT02243553|Antitussive Agents|antitussive agents|mesh-ancestor
24859040|NCT02301286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25270427|NCT02404454|Hyaluronic Acid|hyaluronic acid|mesh-list
25270428|NCT02404454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24478376|NCT00422578|Urological Agents|urological agents|mesh-ancestor
24478377|NCT00422604|Tiotropium Bromide|tiotropium bromide|mesh-list
24401608|NCT00153491|Lumefantrine|lumefantrine|mesh-list
24652140|NCT01236651|Drotaverin|drotaverin|mesh-list
24846750|NCT02243644|Albendazole|albendazole|mesh-list
24846751|NCT02243644|Anthelmintics|anthelmintics|mesh-ancestor
24846752|NCT02243644|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24846753|NCT02243644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24846754|NCT02243644|Anticestodal Agents|anticestodal agents|mesh-ancestor
24846755|NCT02243644|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24846756|NCT02243644|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24846757|NCT02243644|Tubulin Modulators|tubulin modulators|mesh-ancestor
24846758|NCT02243644|Antimitotic Agents|antimitotic agents|mesh-ancestor
24561084|NCT00485693|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24572144|NCT00813332|Tubulin Modulators|tubulin modulators|mesh-ancestor
24572145|NCT00813332|Antimitotic Agents|antimitotic agents|mesh-ancestor
24572146|NCT00813332|Mitosis Modulators|mitosis modulators|mesh-ancestor
24572147|NCT00813332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572148|NCT00813332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24572192|NCT00813696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24572193|NCT00813696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25270429|NCT02404454|Immunologic Factors|immunologic factors|mesh-ancestor
25270430|NCT02404454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270431|NCT02404454|Viscosupplements|viscosupplements|mesh-ancestor
24846763|NCT02243735|Trace Elements|trace elements|mesh-ancestor
24846764|NCT02243735|Micronutrients|micronutrients|mesh-ancestor
24846765|NCT02243735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675858|NCT01790438|Insulin|insulin|mesh-list
25540953|NCT00571064|Cholinergic Agents|cholinergic agents|mesh-ancestor
25540954|NCT00571064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25540955|NCT00571064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540956|NCT00571064|Nootropic Agents|nootropic agents|mesh-ancestor
25540957|NCT00571103|Acamprosate|acamprosate|mesh-list
25540958|NCT00571103|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25540959|NCT00571259|Gentamicins|gentamicins|mesh-list
25540960|NCT00571259|Heparin|heparin|mesh-list
25436953|NCT04754763|Propolis|propolis|mesh-list
25540961|NCT00571259|Citric Acid|citric acid|mesh-list
25540962|NCT00571259|Sodium Citrate|sodium citrate|mesh-list
25540963|NCT00571259|Anticoagulants|anticoagulants|mesh-ancestor
25540964|NCT00571259|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25270434|NCT02404337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25270435|NCT02404337|Lipotropic Agents|lipotropic agents|mesh-ancestor
25270436|NCT02404337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24456996|NCT00332904|Spironolactone|spironolactone|mesh-list
24456997|NCT00332904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24456998|NCT00332904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25050985|NCT00455156|Estradiol|estradiol|mesh-list
24479551|NCT00427271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479552|NCT00427271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24479553|NCT00427271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24479554|NCT00427271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25270437|NCT02404337|Antimetabolites|antimetabolites|mesh-ancestor
25270438|NCT02404337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270439|NCT02404337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25270440|NCT02404376|Exenatide|exenatide|mesh-list
25270441|NCT02404376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25270442|NCT02404376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540965|NCT00571259|Chelating Agents|chelating agents|mesh-ancestor
25540966|NCT00571259|Sequestering Agents|sequestering agents|mesh-ancestor
25540967|NCT00571259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540968|NCT00571259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25540969|NCT00571259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25540970|NCT00571259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25540971|NCT00571259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25540972|NCT00571259|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25540973|NCT00571259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25540974|NCT00571428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24572441|NCT00814905|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25270443|NCT02404376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25270444|NCT02404376|Incretins|incretins|mesh-ancestor
25270445|NCT02404376|Hormones|hormones|mesh-ancestor
25270446|NCT02404376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25270447|NCT02404623|Vitamin D|vitamin d|mesh-list
25270448|NCT02404623|Vitamins|vitamins|mesh-ancestor
24457003|NCT00332904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24457004|NCT00332904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24457005|NCT00332904|Vasodilator Agents|vasodilator agents|mesh-ancestor
24846777|NCT02243826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24846778|NCT02243826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846779|NCT02243826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24846780|NCT02243826|Analgesics|analgesics|mesh-ancestor
24846781|NCT02243826|Sensory System Agents|sensory system agents|mesh-ancestor
25270449|NCT02404623|Micronutrients|micronutrients|mesh-ancestor
25270450|NCT02404623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270451|NCT02404623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25270452|NCT02404363|Clopidogrel|clopidogrel|mesh-list
25270453|NCT02404363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25270454|NCT02404363|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25270455|NCT02404363|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25270456|NCT02404363|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24457010|NCT00332904|Diuretics|diuretics|mesh-ancestor
25540975|NCT00571428|Formoterol Fumarate|formoterol fumarate|mesh-list
25540976|NCT00571428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25540977|NCT00571428|Autonomic Agents|autonomic agents|mesh-ancestor
25540978|NCT00571428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25540979|NCT00571428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25540980|NCT00571428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25540981|NCT00571428|Respiratory System Agents|respiratory system agents|mesh-ancestor
25540982|NCT00571428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25540983|NCT00571428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24572644|NCT00816049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24572706|NCT00816413|Dermatologic Agents|dermatologic agents|mesh-ancestor
24572707|NCT00816413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24572794|NCT00816790|Piperacillin|piperacillin|mesh-list
24846814|NCT02244112|GABA Modulators|gaba modulators|mesh-ancestor
24846815|NCT02244112|GABA Agents|gaba agents|mesh-ancestor
24846816|NCT02244112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24846817|NCT02244112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630600|NCT01112722|Histamine|histamine|mesh-list
25270459|NCT02404363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270460|NCT02404363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270461|NCT02404519|Vitamin K 2|vitamin k 2|mesh-list
25270462|NCT02404519|Vitamin K|vitamin k|mesh-list
25270463|NCT02404519|Vitamin MK 7|vitamin mk 7|mesh-list
25270464|NCT02404519|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25270465|NCT02404519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24478438|NCT00422825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478439|NCT00422825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478441|NCT00422864|Fluorouracil|fluorouracil|mesh-list
24478442|NCT00422864|Oxaliplatin|oxaliplatin|mesh-list
24478443|NCT00422864|Antimetabolites|antimetabolites|mesh-ancestor
24478444|NCT00422864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675870|NCT01790490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675871|NCT01790490|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25675872|NCT01790490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25675873|NCT01790490|Anesthetics, General|anesthetics, general|mesh-ancestor
25675874|NCT01790490|Anesthetics|anesthetics|mesh-ancestor
25540984|NCT00571428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25540985|NCT00571428|Adrenergic Agents|adrenergic agents|mesh-ancestor
25540986|NCT00571428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25540987|NCT00571428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540989|NCT00571493|Etoposide|etoposide|mesh-list
25540990|NCT00571493|Bortezomib|bortezomib|mesh-list
25540991|NCT00571493|Melphalan|melphalan|mesh-list
25540992|NCT00571493|Carmustine|carmustine|mesh-list
25540993|NCT00571493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25540994|NCT00571493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25540995|NCT00571493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25540996|NCT00571493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25540997|NCT00571493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478445|NCT00422864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24478446|NCT00422864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478447|NCT00422864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25051014|NCT00449605|Metformin|metformin|mesh-list
24846818|NCT02244151|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24846819|NCT02244151|Luteolytic Agents|luteolytic agents|mesh-ancestor
24846820|NCT02244151|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24846821|NCT02244151|Contraceptive Agents|contraceptive agents|mesh-ancestor
24859041|NCT02301286|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25270466|NCT02404519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270467|NCT02404519|Hemostatics|hemostatics|mesh-ancestor
25270468|NCT02404519|Coagulants|coagulants|mesh-ancestor
25270469|NCT02404519|Vitamins|vitamins|mesh-ancestor
25270470|NCT02404519|Micronutrients|micronutrients|mesh-ancestor
25270471|NCT02404519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270472|NCT02404259|Ritonavir|ritonavir|mesh-list
25270473|NCT02404259|Lopinavir|lopinavir|mesh-list
25270474|NCT02404259|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25270475|NCT02404259|Tenofovir|tenofovir|mesh-list
25270476|NCT02404259|Efavirenz|efavirenz|mesh-list
25270477|NCT02404259|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25270478|NCT02404259|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25270479|NCT02404259|Protease Inhibitors|protease inhibitors|mesh-ancestor
24457030|NCT00333008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24457031|NCT00333008|Immunologic Factors|immunologic factors|mesh-ancestor
24457032|NCT00333008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478456|NCT00422955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24478457|NCT00422955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478459|NCT00422994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24478460|NCT00422994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25540998|NCT00571493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25540999|NCT00571493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25541000|NCT00571493|Antimetabolites|antimetabolites|mesh-ancestor
25541001|NCT00571493|Antiviral Agents|antiviral agents|mesh-ancestor
25541002|NCT00571493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25541003|NCT00571493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25541004|NCT00571493|Immunologic Factors|immunologic factors|mesh-ancestor
25541005|NCT00571493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541006|NCT00571493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25541007|NCT00571493|Alkylating Agents|alkylating agents|mesh-ancestor
25541008|NCT00571493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25541009|NCT00571519|Metformin|metformin|mesh-list
25541010|NCT00571519|Pioglitazone|pioglitazone|mesh-list
25541011|NCT00571519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25541012|NCT00571519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541013|NCT00571649|Enoxaparin|enoxaparin|mesh-list
25541014|NCT00571649|Rivaroxaban|rivaroxaban|mesh-list
25541015|NCT00571649|Enoxaparin sodium|enoxaparin sodium|mesh-list
25541016|NCT00571649|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25541017|NCT00571649|Antithrombins|antithrombins|mesh-ancestor
25541018|NCT00571649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25541019|NCT00571649|Protease Inhibitors|protease inhibitors|mesh-ancestor
25541020|NCT00571649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541021|NCT00571649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541022|NCT00571649|Anticoagulants|anticoagulants|mesh-ancestor
25541023|NCT00571649|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25541024|NCT00571649|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25541025|NCT00571662|Cyclosporine|cyclosporine|mesh-list
25541026|NCT00571662|Mycophenolic Acid|mycophenolic acid|mesh-list
25541027|NCT00571662|Pentostatin|pentostatin|mesh-list
25541028|NCT00571662|Cyclosporins|cyclosporins|mesh-list
25541029|NCT00571662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541030|NCT00571662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541031|NCT00571662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25541032|NCT00571662|Immunologic Factors|immunologic factors|mesh-ancestor
25541033|NCT00571662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541034|NCT00571662|Antifungal Agents|antifungal agents|mesh-ancestor
25541035|NCT00571662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25541036|NCT00571662|Dermatologic Agents|dermatologic agents|mesh-ancestor
25541037|NCT00571662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25541038|NCT00571662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24846840|NCT02244190|Ritonavir|ritonavir|mesh-list
25241754|NCT05300009|Dermatologic Agents|dermatologic agents|mesh-ancestor
25270480|NCT02404259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25270481|NCT02404259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270482|NCT02404259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25270483|NCT02404259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25270484|NCT02404259|Antiviral Agents|antiviral agents|mesh-ancestor
25270485|NCT02404259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25270486|NCT02404259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25270487|NCT02404259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25270488|NCT02404259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25270489|NCT02404259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24652944|NCT01241006|Hormones|hormones|mesh-ancestor
24688861|NCT02619552|Prednisone|prednisone|mesh-list
25541039|NCT00571662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25541040|NCT00571662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541041|NCT00571662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25541042|NCT00571662|Antitubercular Agents|antitubercular agents|mesh-ancestor
25541043|NCT00571662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25541044|NCT00571662|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25541045|NCT00571688|Risperidone|risperidone|mesh-list
25541046|NCT00571688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25541047|NCT00571688|Serotonin Agents|serotonin agents|mesh-ancestor
25541048|NCT00571688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24573463|NCT00820092|Hormones|hormones|mesh-ancestor
25270490|NCT02404259|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25270491|NCT02404259|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25270492|NCT02404259|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25270493|NCT02404259|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25270494|NCT02404259|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25270497|NCT02404142|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25270498|NCT02404142|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25270499|NCT02404142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25270500|NCT02404142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25270501|NCT02404142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270502|NCT02404142|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25270503|NCT02404142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25270504|NCT02404142|Cholinergic Agents|cholinergic agents|mesh-ancestor
25270505|NCT02404142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25541049|NCT00571688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541050|NCT00571688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541051|NCT00571688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25541052|NCT00571688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25541053|NCT00571688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25541054|NCT00571688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25541055|NCT00571688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25541056|NCT00571688|Dopamine Agents|dopamine agents|mesh-ancestor
25541057|NCT00571701|Celecoxib|celecoxib|mesh-list
25541058|NCT00571701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24573822|NCT00822133|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24573823|NCT00822133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24573825|NCT00822211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24573826|NCT00822211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573831|NCT00822263|Acetylcysteine|acetylcysteine|mesh-list
25675878|NCT01790490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24457038|NCT00333008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24478742|NCT00424203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24478743|NCT00424203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24846924|NCT02244294|Adrenergic Agents|adrenergic agents|mesh-ancestor
24846925|NCT02244294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24846926|NCT02244294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846927|NCT02244294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846928|NCT02244294|Urological Agents|urological agents|mesh-ancestor
24846930|NCT02244307|Adrenergic Antagonists|adrenergic antagonists|mesh-list
25270514|NCT02404077|Autonomic Agents|autonomic agents|mesh-ancestor
25270515|NCT02404077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25270516|NCT02404077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25270517|NCT02404077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25270521|NCT02404233|Darunavir|darunavir|mesh-list
25541059|NCT00571701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25541060|NCT00571701|Analgesics|analgesics|mesh-ancestor
25541061|NCT00571701|Sensory System Agents|sensory system agents|mesh-ancestor
25541062|NCT00571701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25541063|NCT00571701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541064|NCT00571701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25541065|NCT00571701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25541066|NCT00571701|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24562209|NCT00764972|Vinorelbine|vinorelbine|mesh-list
24562210|NCT00764972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562211|NCT00764972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24562212|NCT00764972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24891292|NCT04473820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247064|NCT00655993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675887|NCT01790490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25675888|NCT01790490|GABA Modulators|gaba modulators|mesh-ancestor
25675889|NCT01790490|GABA Agents|gaba agents|mesh-ancestor
25675890|NCT01790503|Temozolomide|temozolomide|mesh-list
25675891|NCT01790503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25675892|NCT01790503|Alkylating Agents|alkylating agents|mesh-ancestor
25675893|NCT01790503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675894|NCT01790503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675895|NCT01790516|Cisplatin|cisplatin|mesh-list
25675896|NCT01790516|Cetuximab|cetuximab|mesh-list
25675897|NCT01790516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675898|NCT01790516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25675899|NCT01790568|Methotrexate|methotrexate|mesh-list
25541067|NCT00571701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25541068|NCT00571701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541069|NCT00571701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541070|NCT00571961|Ritonavir|ritonavir|mesh-list
25541071|NCT00571961|Lopinavir|lopinavir|mesh-list
25541072|NCT00571961|Buprenorphine|buprenorphine|mesh-list
25541073|NCT00571961|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25541074|NCT00571961|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25541075|NCT00571961|Protease Inhibitors|protease inhibitors|mesh-ancestor
25541076|NCT00571961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574150|NCT00823875|Protective Agents|protective agents|mesh-ancestor
25009524|NCT05213884|Cisplatin|cisplatin|mesh-list
24574152|NCT00823875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24574153|NCT00823875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574154|NCT00823875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24574155|NCT00823875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24574156|NCT00823875|Antimetabolites|antimetabolites|mesh-ancestor
24574157|NCT00823875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24630059|NCT01109264|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24574244|NCT00824239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574245|NCT00824317|Methylphenidate|methylphenidate|mesh-list
24574344|NCT00825058|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24574345|NCT00825058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24574346|NCT00825058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24574347|NCT00825058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574348|NCT00825058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24574350|NCT00825058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541077|NCT00571961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541078|NCT00571961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25541079|NCT00571961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25541080|NCT00571961|Antiviral Agents|antiviral agents|mesh-ancestor
25541081|NCT00571961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25541082|NCT00571961|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25541083|NCT00571961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25541084|NCT00571961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25541085|NCT00571961|Narcotics|narcotics|mesh-ancestor
24574508|NCT00825851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24574509|NCT00825851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574510|NCT00825851|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24574511|NCT00825851|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24574512|NCT00825851|Cholinergic Agents|cholinergic agents|mesh-ancestor
24574513|NCT00825851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24574514|NCT00825851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574515|NCT00825864|Dexamethasone|dexamethasone|mesh-list
25247105|NCT00492050|Rituximab|rituximab|mesh-list
25247106|NCT00492050|Bortezomib|bortezomib|mesh-list
25247107|NCT00492050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25270539|NCT02404064|Cefotaxime|cefotaxime|mesh-list
25541086|NCT00571961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25541087|NCT00571961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541088|NCT00571961|Analgesics|analgesics|mesh-ancestor
25541089|NCT00571961|Sensory System Agents|sensory system agents|mesh-ancestor
25541090|NCT00571961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25541091|NCT00571961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25541092|NCT00571974|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25541093|NCT00571974|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25541094|NCT00571974|Dermatologic Agents|dermatologic agents|mesh-ancestor
25541095|NCT00572117|Topiramate|topiramate|mesh-list
25541096|NCT00572117|Anticonvulsants|anticonvulsants|mesh-ancestor
25541097|NCT00572117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25541098|NCT00572117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574702|NCT00826930|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
25069259|NCT03427554|Tretinoin|tretinoin|mesh-list
24846982|NCT02244515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24846983|NCT02244515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25270553|NCT02404038|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25270554|NCT02404038|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25270555|NCT02404038|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
25270556|NCT02404038|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25270557|NCT02404038|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25270558|NCT02404051|Everolimus|everolimus|mesh-list
25270559|NCT02404051|Fulvestrant|fulvestrant|mesh-list
24478873|NCT00424814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478874|NCT00424814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478875|NCT00424814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24478876|NCT00424814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24478877|NCT00424814|Antiviral Agents|antiviral agents|mesh-ancestor
24478878|NCT00424814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24478879|NCT00424814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24478880|NCT00424814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24457064|NCT00333034|Sensory System Agents|sensory system agents|mesh-ancestor
24457065|NCT00333034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25541099|NCT00572156|Mecasermin|mecasermin|mesh-list
25541100|NCT00572156|Growth Substances|growth substances|mesh-ancestor
25541101|NCT00572156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541102|NCT00572234|Bupropion|bupropion|mesh-list
25541103|NCT00572234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25541104|NCT00572234|Antidepressive Agents|antidepressive agents|mesh-ancestor
25541105|NCT00572234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25541106|NCT00572234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24847010|NCT02244632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847011|NCT02244632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25270560|NCT02404051|Exemestane|exemestane|mesh-list
25270561|NCT02404051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270562|NCT02404051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25270563|NCT02404051|Immunologic Factors|immunologic factors|mesh-ancestor
25270564|NCT02404051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270565|NCT02404051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25270566|NCT02404051|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25270567|NCT02404051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25270568|NCT02404051|Hormone Antagonists|hormone antagonists|mesh-ancestor
25270569|NCT02404051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25270570|NCT02404051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25270571|NCT02404051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24478972|NCT00425152|Immunologic Factors|immunologic factors|mesh-ancestor
24478974|NCT00425152|Protective Agents|protective agents|mesh-ancestor
24478975|NCT00425152|Vitamin B Complex|vitamin b complex|mesh-ancestor
24478976|NCT00425152|Vitamins|vitamins|mesh-ancestor
24478977|NCT00425152|Micronutrients|micronutrients|mesh-ancestor
24478978|NCT00425152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25541107|NCT00572234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25541108|NCT00572234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25541109|NCT00572234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437101|NCT04753008|Dopamine|dopamine|mesh-list
25437102|NCT04753008|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25437111|NCT04753294|Diazepam|diazepam|mesh-list
25541110|NCT00572234|Dopamine Agents|dopamine agents|mesh-ancestor
25541111|NCT00572234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25541112|NCT00572234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541113|NCT00572234|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25541114|NCT00572234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25541115|NCT00572234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541116|NCT00572455|Latanoprost|latanoprost|mesh-list
25541117|NCT00572455|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25247164|NCT00345345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25247165|NCT00345345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247166|NCT00215813|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
25247167|NCT00215813|Poly I-C|poly i-c|mesh-list
25247168|NCT00215813|Antiviral Agents|antiviral agents|mesh-ancestor
25247169|NCT00215813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25247170|NCT00215813|Interferon Inducers|interferon inducers|mesh-ancestor
25270630|NCT02403687|Anesthetics, Local|anesthetics, local|mesh-ancestor
25270572|NCT02404051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25270573|NCT02404051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270574|NCT02403856|Methylprednisolone|methylprednisolone|mesh-list
25270575|NCT02403856|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25270576|NCT02403856|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25270577|NCT02403856|Prednisolone|prednisolone|mesh-list
25270578|NCT02403856|Prednisolone acetate|prednisolone acetate|mesh-list
25270579|NCT02403856|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25270580|NCT02403856|Prednisolone phosphate|prednisolone phosphate|mesh-list
25270581|NCT02403856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25270582|NCT02403856|Antiemetics|antiemetics|mesh-ancestor
24478982|NCT00425152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24478983|NCT00425152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24478984|NCT00425191|Gemcitabine|gemcitabine|mesh-list
24429081|NCT00242593|Rosiglitazone|rosiglitazone|mesh-list
24478986|NCT00425191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541118|NCT00572455|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25541119|NCT00572468|Simvastatin|simvastatin|mesh-list
25541120|NCT00572468|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25541121|NCT00572468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25541122|NCT00572468|Antimetabolites|antimetabolites|mesh-ancestor
25541123|NCT00572468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541124|NCT00572468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25541125|NCT00572468|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25541126|NCT00572468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541127|NCT00572572|Aprepitant|aprepitant|mesh-list
25541128|NCT00572572|Antiemetics|antiemetics|mesh-ancestor
25270583|NCT02403856|Autonomic Agents|autonomic agents|mesh-ancestor
25270584|NCT02403856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25270585|NCT02403856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270586|NCT02403856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25270587|NCT02403856|Glucocorticoids|glucocorticoids|mesh-ancestor
25270588|NCT02403856|Hormones|hormones|mesh-ancestor
25270589|NCT02403856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25270590|NCT02403856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25270591|NCT02403856|Protective Agents|protective agents|mesh-ancestor
25270592|NCT02403856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25270593|NCT02403856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270595|NCT02403804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25270596|NCT02403804|Lipotropic Agents|lipotropic agents|mesh-ancestor
25270597|NCT02403804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24478993|NCT00425191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24478994|NCT00425191|Immunologic Factors|immunologic factors|mesh-ancestor
24478995|NCT00425191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479023|NCT00425243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24479024|NCT00425243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24479025|NCT00425243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479026|NCT00425243|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24479028|NCT00425243|GABA Agents|gaba agents|mesh-ancestor
24479029|NCT00425243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24847026|NCT02244710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24847027|NCT02244710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24847051|NCT02244879|Resveratrol|resveratrol|mesh-list
25541129|NCT00572572|Autonomic Agents|autonomic agents|mesh-ancestor
25541130|NCT00572572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25541131|NCT00572572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541132|NCT00572572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25541133|NCT00572572|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25541134|NCT00572572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25541135|NCT00572572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247224|NCT00075387|Antitubercular Agents|antitubercular agents|mesh-ancestor
25270598|NCT02403804|Antimetabolites|antimetabolites|mesh-ancestor
25270599|NCT02403804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270600|NCT02403804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25275500|NCT02371993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25275501|NCT02371993|Nootropic Agents|nootropic agents|mesh-ancestor
25275502|NCT02371577|Lenalidomide|lenalidomide|mesh-list
25275503|NCT02371577|Immunologic Factors|immunologic factors|mesh-ancestor
25275504|NCT02371577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275505|NCT02371577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25275506|NCT02371577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24479031|NCT00425334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24479033|NCT00425347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24457074|NCT00333047|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24457075|NCT00333047|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24457076|NCT00333047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457077|NCT00333047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520197|NCT03573648|Avelumab|avelumab|mesh-list
24479070|NCT00425451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24479071|NCT00425451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24479072|NCT00425451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24479073|NCT00425451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24479074|NCT00425451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479075|NCT00425451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479076|NCT00425490|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24479077|NCT00425490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25541136|NCT00572728|Alovudine|alovudine|mesh-list
25541137|NCT00572728|Dideoxynucleosides|dideoxynucleosides|mesh-list
25541138|NCT00572728|Antiviral Agents|antiviral agents|mesh-ancestor
25541139|NCT00572728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25541140|NCT00572728|Antimetabolites|antimetabolites|mesh-ancestor
25541141|NCT00572728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541142|NCT00572728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25541143|NCT00572728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25541144|NCT00572728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541145|NCT00572832|Vaccines|vaccines|mesh-list
25541146|NCT00572832|Immunologic Factors|immunologic factors|mesh-ancestor
25541147|NCT00572832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541148|NCT00572897|Fludarabine|fludarabine|mesh-list
25541149|NCT00572897|Melphalan|melphalan|mesh-list
25541150|NCT00572897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247241|NCT00061945|Asparaginase|asparaginase|mesh-list
25270606|NCT02403596|Coagulants|coagulants|mesh-ancestor
25270607|NCT02403544|Capecitabine|capecitabine|mesh-list
25270608|NCT02403544|Oxaliplatin|oxaliplatin|mesh-list
25270609|NCT02403544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25270610|NCT02403544|Antimetabolites|antimetabolites|mesh-ancestor
25270611|NCT02403544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270612|NCT02403544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270613|NCT02403687|Topiramate|topiramate|mesh-list
25270614|NCT02403687|Diclofenac|diclofenac|mesh-list
25270615|NCT02403687|Meloxicam|meloxicam|mesh-list
25270616|NCT02403687|Flurbiprofen|flurbiprofen|mesh-list
25270617|NCT02403687|Lidocaine|lidocaine|mesh-list
25270618|NCT02403687|Clonidine|clonidine|mesh-list
25270619|NCT02403687|Sumatriptan|sumatriptan|mesh-list
25270620|NCT02403687|Ketamine|ketamine|mesh-list
25270621|NCT02403687|Gabapentin|gabapentin|mesh-list
25270622|NCT02403687|Amitriptyline|amitriptyline|mesh-list
25270623|NCT02403687|Tizanidine|tizanidine|mesh-list
25270624|NCT02403687|Bupivacaine|bupivacaine|mesh-list
25270625|NCT02403687|Prilocaine|prilocaine|mesh-list
25270626|NCT02403687|Cyclobenzaprine|cyclobenzaprine|mesh-list
25270627|NCT02403687|Baclofen|baclofen|mesh-list
25270628|NCT02403687|Capsaicin|capsaicin|mesh-list
25270629|NCT02403687|Menthol|menthol|mesh-list
25270631|NCT02403687|Anesthetics|anesthetics|mesh-ancestor
24479114|NCT00425594|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24479115|NCT00425594|Cathartics|cathartics|mesh-ancestor
25675941|NCT01790594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24653804|NCT01245855|Alprostadil|alprostadil|mesh-list
25675942|NCT01790594|Glucocorticoids|glucocorticoids|mesh-ancestor
25675943|NCT01790594|Hormones|hormones|mesh-ancestor
25675944|NCT01790594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25675945|NCT01790594|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25541151|NCT00572897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541152|NCT00572897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25541153|NCT00572897|Immunologic Factors|immunologic factors|mesh-ancestor
25541154|NCT00572897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541155|NCT00572897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25541156|NCT00572897|Alkylating Agents|alkylating agents|mesh-ancestor
25541157|NCT00572897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25541158|NCT00572936|Timolol|timolol|mesh-list
25541159|NCT00572936|Dorzolamide|dorzolamide|mesh-list
25541160|NCT00572936|Latanoprost|latanoprost|mesh-list
25541161|NCT00572936|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25541162|NCT00572936|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25541163|NCT00572936|Adrenergic Agents|adrenergic agents|mesh-ancestor
25541164|NCT00572936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25541165|NCT00572936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847098|NCT02245191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24847099|NCT02245191|Mydriatics|mydriatics|mesh-ancestor
24847100|NCT02245191|Autonomic Agents|autonomic agents|mesh-ancestor
25270632|NCT02403687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25270633|NCT02403687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270634|NCT02403687|Sensory System Agents|sensory system agents|mesh-ancestor
25270635|NCT02403687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25270636|NCT02403687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25270637|NCT02403687|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25270638|NCT02403687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25270639|NCT02403687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25275507|NCT02371577|Growth Substances|growth substances|mesh-ancestor
24457078|NCT00333047|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24457079|NCT00333047|Hormone Antagonists|hormone antagonists|mesh-ancestor
24457080|NCT00333047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24457081|NCT00333047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457082|NCT00333060|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24457083|NCT00333060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24632513|NCT01124383|GABA Modulators|gaba modulators|mesh-ancestor
24481658|NCT00436241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24847101|NCT02245191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24847102|NCT02245191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653870|NCT01246037|Bisoprolol|bisoprolol|mesh-list
25270709|NCT02403531|Docetaxel|docetaxel|mesh-list
25541166|NCT00572936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541167|NCT00572936|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25541168|NCT00572936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25541169|NCT00572936|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25541170|NCT00572936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25541171|NCT00572936|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25541172|NCT00572936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541173|NCT00573066|Dexmedetomidine|dexmedetomidine|mesh-list
25541174|NCT00573066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25541175|NCT00573066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25541176|NCT00573066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541177|NCT00573066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25541178|NCT00573066|Analgesics|analgesics|mesh-ancestor
25541179|NCT00573066|Sensory System Agents|sensory system agents|mesh-ancestor
25541180|NCT00573066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25541181|NCT00573066|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25270640|NCT02403687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270641|NCT02403687|Analgesics|analgesics|mesh-ancestor
25270642|NCT02403687|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25270643|NCT02403687|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25270644|NCT02403687|Anesthetics, General|anesthetics, general|mesh-ancestor
25270645|NCT02403687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25270646|NCT02403687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25270647|NCT02403687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25270648|NCT02403687|Anticonvulsants|anticonvulsants|mesh-ancestor
25270649|NCT02403687|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25270650|NCT02403687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25270651|NCT02403687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24479135|NCT00425646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457089|NCT00333086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457090|NCT00333086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24457091|NCT00333086|Hormone Antagonists|hormone antagonists|mesh-ancestor
24457092|NCT00333086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24457093|NCT00333086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457095|NCT00333112|Solifenacin Succinate|solifenacin succinate|mesh-list
24942424|NCT03981094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24847117|NCT02245256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24632650|NCT01125020|Antimetabolites|antimetabolites|mesh-ancestor
25270652|NCT02403687|Antimanic Agents|antimanic agents|mesh-ancestor
25541182|NCT00573066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25541183|NCT00573066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25541184|NCT00573066|Adrenergic Agents|adrenergic agents|mesh-ancestor
25541185|NCT00573066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25541186|NCT00573066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541187|NCT00573144|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25541188|NCT00573144|Natriuretic Agents|natriuretic agents|mesh-ancestor
25541189|NCT00573144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541190|NCT00573248|Nicotine|nicotine|mesh-list
25541191|NCT00573248|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25541192|NCT00573248|Autonomic Agents|autonomic agents|mesh-ancestor
25541193|NCT00573248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25541194|NCT00573248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541195|NCT00573248|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25541196|NCT00573248|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25541197|NCT00573248|Cholinergic Agents|cholinergic agents|mesh-ancestor
25541198|NCT00573248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25541199|NCT00573248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541200|NCT00573261|Pregabalin|pregabalin|mesh-list
25541201|NCT00573261|Analgesics|analgesics|mesh-ancestor
25541202|NCT00573261|Sensory System Agents|sensory system agents|mesh-ancestor
25541203|NCT00573261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25541204|NCT00573261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541205|NCT00573261|Anticonvulsants|anticonvulsants|mesh-ancestor
25541206|NCT00573261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25541207|NCT00573261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25541208|NCT00573261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541209|NCT00573261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25541210|NCT00573261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25541211|NCT00573261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25541212|NCT00573261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25541213|NCT00573261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25541214|NCT00573287|Risperidone|risperidone|mesh-list
25541215|NCT00573287|Clozapine|clozapine|mesh-list
25541216|NCT00573287|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25541217|NCT00573287|Serotonin Agents|serotonin agents|mesh-ancestor
25541218|NCT00573287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25541219|NCT00573287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541220|NCT00573287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541221|NCT00573287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25541222|NCT00573287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25541223|NCT00573287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25541224|NCT00573287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25541225|NCT00573287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25541226|NCT00573287|Dopamine Agents|dopamine agents|mesh-ancestor
25541227|NCT00573287|GABA Antagonists|gaba antagonists|mesh-ancestor
25541228|NCT00573287|GABA Agents|gaba agents|mesh-ancestor
25541229|NCT00573430|Candesartan|candesartan|mesh-list
25541230|NCT00573430|Candesartan cilexetil|candesartan cilexetil|mesh-list
25541231|NCT00573430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25541232|NCT00573430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25541233|NCT00573430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25541234|NCT00573430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541235|NCT00573443|Quinidine|quinidine|mesh-list
25541236|NCT00573443|Quinidine gluconate|quinidine gluconate|mesh-list
25541237|NCT00573443|Dextromethorphan|dextromethorphan|mesh-list
25541238|NCT00573443|Antitussive Agents|antitussive agents|mesh-ancestor
24594956|NCT00936195|Antimetabolites|antimetabolites|mesh-ancestor
25069615|NCT03425448|Anticoagulants|anticoagulants|mesh-ancestor
25069616|NCT03425448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25069617|NCT03425448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25069618|NCT03425448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069619|NCT03425162|Morphine|morphine|mesh-list
24779462|NCT01876290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25069620|NCT03425162|Bupivacaine|bupivacaine|mesh-list
24832289|NCT02171039|Dabigatran|dabigatran|mesh-list
24479219|NCT00426023|Cyclosporine|cyclosporine|mesh-list
24612022|NCT01011660|Natriuretic Agents|natriuretic agents|mesh-ancestor
24847129|NCT02245269|Ritonavir|ritonavir|mesh-list
25541239|NCT00573443|Respiratory System Agents|respiratory system agents|mesh-ancestor
25541240|NCT00573443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25541241|NCT00573443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25541242|NCT00573443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25541243|NCT00573443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541244|NCT00573443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437249|NCT04750603|Albuterol|albuterol|mesh-list
25437250|NCT04750603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25437251|NCT04750603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25437252|NCT04750603|Autonomic Agents|autonomic agents|mesh-ancestor
24595226|NCT00937300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25074145|NCT03390465|Amlodipine|amlodipine|mesh-list
24576300|NCT00837941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24576301|NCT00837941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576302|NCT00837941|Anticonvulsants|anticonvulsants|mesh-ancestor
24576303|NCT00837941|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24631985|NCT01121354|Cefazolin|cefazolin|mesh-list
24576305|NCT00837941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576306|NCT00837941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25270687|NCT02403713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25270688|NCT02403713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25270689|NCT02403713|Autonomic Agents|autonomic agents|mesh-ancestor
24479296|NCT00426296|Antiviral Agents|antiviral agents|mesh-ancestor
24847145|NCT02245269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24847146|NCT02245269|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24847147|NCT02245269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24847149|NCT02245295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25675953|NCT01790659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25675954|NCT01790659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675955|NCT01790659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675956|NCT01790659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25675957|NCT01790659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25675958|NCT01790685|Dexamethasone|dexamethasone|mesh-list
25675959|NCT01790685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25675960|NCT01790685|Antiemetics|antiemetics|mesh-ancestor
25675961|NCT01790685|Autonomic Agents|autonomic agents|mesh-ancestor
25437253|NCT04750603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437254|NCT04750603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437255|NCT04750603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25541245|NCT00573443|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25541246|NCT00573443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25541247|NCT00573443|Adrenergic Agents|adrenergic agents|mesh-ancestor
25541248|NCT00573443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25541249|NCT00573443|Antimalarials|antimalarials|mesh-ancestor
25541250|NCT00573443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25541251|NCT00573443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25541252|NCT00573443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25541253|NCT00573443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541254|NCT00573443|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25541255|NCT00573443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25541256|NCT00573443|Cholinergic Agents|cholinergic agents|mesh-ancestor
25270690|NCT02403713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25270691|NCT02403713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270692|NCT02403713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25270693|NCT02403713|Respiratory System Agents|respiratory system agents|mesh-ancestor
25270694|NCT02403713|Dermatologic Agents|dermatologic agents|mesh-ancestor
25270695|NCT02403713|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25270696|NCT02403713|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25270697|NCT02403713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24479298|NCT00426296|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24479299|NCT00426296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24479300|NCT00426348|Valsartan|valsartan|mesh-list
24479301|NCT00426348|Probucol|probucol|mesh-list
24479302|NCT00426348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24479303|NCT00426348|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24479304|NCT00426348|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24479305|NCT00426348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479306|NCT00426348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24479307|NCT00426348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24479308|NCT00426348|Antimetabolites|antimetabolites|mesh-ancestor
24479309|NCT00426348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24479332|NCT00426478|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24453221|NCT05222932|Avelumab|avelumab|mesh-list
24453222|NCT05222932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24453223|NCT05222932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24453224|NCT05222152|Hydrocortisone|hydrocortisone|mesh-list
24453226|NCT05222152|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25541257|NCT00573443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25541258|NCT00573443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25541259|NCT00573443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25541260|NCT00573443|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25541261|NCT00573443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25541262|NCT00573508|Solifenacin Succinate|solifenacin succinate|mesh-list
25541263|NCT00573508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25541264|NCT00573508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25541265|NCT00573508|Cholinergic Agents|cholinergic agents|mesh-ancestor
24595323|NCT00937924|Histamine Agents|histamine agents|mesh-ancestor
24595324|NCT00937924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25074167|NCT03390387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24576665|NCT00839605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576667|NCT00839657|Anticoagulants|anticoagulants|mesh-ancestor
24576668|NCT00839683|Dapagliflozin|dapagliflozin|mesh-list
24576669|NCT00839683|Valsartan|valsartan|mesh-list
24576670|NCT00839683|Simvastatin|simvastatin|mesh-list
25270701|NCT02403713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270702|NCT02403648|Glucagon|glucagon|mesh-list
25270703|NCT02403648|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25270704|NCT02403648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25270705|NCT02403648|Hormones|hormones|mesh-ancestor
25270706|NCT02403648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25270707|NCT02403648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270708|NCT02403648|Incretins|incretins|mesh-ancestor
25270710|NCT02403531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270711|NCT02403531|Tubulin Modulators|tubulin modulators|mesh-ancestor
25270712|NCT02403531|Antimitotic Agents|antimitotic agents|mesh-ancestor
25270713|NCT02403531|Mitosis Modulators|mitosis modulators|mesh-ancestor
24479335|NCT00426478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24479336|NCT00426478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541266|NCT00573508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25541267|NCT00573508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541268|NCT00573508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541269|NCT00573508|Urological Agents|urological agents|mesh-ancestor
25541270|NCT00573534|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25541271|NCT00573534|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25541272|NCT00573534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541273|NCT00573534|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25541274|NCT00573534|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25541275|NCT00573534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25270714|NCT02403531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270715|NCT02403349|Atenolol|atenolol|mesh-list
25270716|NCT02403349|Valsartan|valsartan|mesh-list
25270717|NCT02403349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25270718|NCT02403349|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25270719|NCT02403349|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24479348|NCT00426491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24479349|NCT00426491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479350|NCT00426491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24479351|NCT00426491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24479352|NCT00426491|Oxytocics|oxytocics|mesh-ancestor
24479353|NCT00426530|Everolimus|everolimus|mesh-list
24942480|NCT03980249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24453267|NCT05198960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24453268|NCT05198960|Antipyretics|antipyretics|mesh-ancestor
24453276|NCT05181007|Valproic Acid|valproic acid|mesh-list
24453277|NCT05181007|Anticonvulsants|anticonvulsants|mesh-ancestor
24453278|NCT05181007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24453279|NCT05181007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24453280|NCT05181007|GABA Agents|gaba agents|mesh-ancestor
24453281|NCT05181007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24453282|NCT05181007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24453283|NCT05181007|Antimanic Agents|antimanic agents|mesh-ancestor
24453284|NCT05181007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24453285|NCT05181007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24453286|NCT05181007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25270720|NCT02403349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270721|NCT02403349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25270722|NCT02403349|Sympatholytics|sympatholytics|mesh-ancestor
25270723|NCT02403349|Autonomic Agents|autonomic agents|mesh-ancestor
25270724|NCT02403349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25541276|NCT00573534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541277|NCT00573534|Dopamine Agents|dopamine agents|mesh-ancestor
25541278|NCT00573534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25541279|NCT00573755|Sorafenib|sorafenib|mesh-list
25541280|NCT00573755|Letrozole|letrozole|mesh-list
25541281|NCT00573755|Anastrozole|anastrozole|mesh-list
25541282|NCT00573755|Exemestane|exemestane|mesh-list
25541283|NCT00573755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541284|NCT00573755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25270726|NCT02403349|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25270727|NCT02403349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25270728|NCT02403349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25270729|NCT02403349|Adrenergic Agents|adrenergic agents|mesh-ancestor
25270730|NCT02403349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25270731|NCT02403401|Levonorgestrel|levonorgestrel|mesh-list
24479381|NCT00426608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24479382|NCT00426608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24479383|NCT00426608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24479384|NCT00426608|GABA Modulators|gaba modulators|mesh-ancestor
24479385|NCT00426608|GABA Agents|gaba agents|mesh-ancestor
24479386|NCT00426608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24457098|NCT00333112|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24457099|NCT00333112|Adrenergic Agents|adrenergic agents|mesh-ancestor
24479387|NCT00426608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479388|NCT00426608|Antimetabolites|antimetabolites|mesh-ancestor
24479389|NCT00426608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479390|NCT00426621|Diclofenac|diclofenac|mesh-list
25541285|NCT00573755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541286|NCT00573755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541287|NCT00573755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25541288|NCT00573755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25541289|NCT00573755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25541290|NCT00573755|Hormone Antagonists|hormone antagonists|mesh-ancestor
25541291|NCT00573755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25541292|NCT00573755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541293|NCT00573755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25541294|NCT00573768|Diclofenac|diclofenac|mesh-list
24691404|NCT01406431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25270758|NCT02403128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25270759|NCT02403128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25270760|NCT02403128|Growth Substances|growth substances|mesh-ancestor
25270761|NCT02403128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270762|NCT02403128|Growth Inhibitors|growth inhibitors|mesh-ancestor
25270763|NCT02403128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270764|NCT02403063|Neostigmine|neostigmine|mesh-list
25270765|NCT02403063|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25270766|NCT02403063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25270767|NCT02403063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270768|NCT02403063|Cholinergic Agents|cholinergic agents|mesh-ancestor
24479458|NCT00426985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24479459|NCT00426985|Analgesics|analgesics|mesh-ancestor
24479460|NCT00426985|Sensory System Agents|sensory system agents|mesh-ancestor
24479461|NCT00426985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24479462|NCT00426985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479463|NCT00426985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25051056|NCT00445198|Navitoclax|navitoclax|mesh-list
24847212|NCT02245451|Antitussive Agents|antitussive agents|mesh-ancestor
24847213|NCT02245451|Respiratory System Agents|respiratory system agents|mesh-ancestor
24847215|NCT02245464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24847216|NCT02245464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24633775|NCT01131039|Growth Inhibitors|growth inhibitors|mesh-ancestor
25541295|NCT00573768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25541296|NCT00573768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25541297|NCT00573768|Analgesics|analgesics|mesh-ancestor
25541298|NCT00573768|Sensory System Agents|sensory system agents|mesh-ancestor
25541299|NCT00573768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25541300|NCT00573768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541301|NCT00573768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24595411|NCT00938405|Antimetabolites|antimetabolites|mesh-ancestor
24595413|NCT00938405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25270769|NCT02403063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25270770|NCT02403063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270771|NCT02403063|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25270772|NCT02403063|Autonomic Agents|autonomic agents|mesh-ancestor
25270773|NCT02403063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25270774|NCT02403037|Dexamethasone|dexamethasone|mesh-list
25270775|NCT02403037|Dexamethasone acetate|dexamethasone acetate|mesh-list
25270776|NCT02403037|Antiemetics|antiemetics|mesh-list
25270777|NCT02403037|Emetics|emetics|mesh-list
25270778|NCT02403037|BB 1101|bb 1101|mesh-list
25270779|NCT02403037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25270780|NCT02403037|Autonomic Agents|autonomic agents|mesh-ancestor
24479556|NCT00427271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479558|NCT00427271|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24479559|NCT00427271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479560|NCT00427271|Antipyretics|antipyretics|mesh-ancestor
24479561|NCT00427310|Fluorouracil|fluorouracil|mesh-list
24479562|NCT00427310|Heparin|heparin|mesh-list
24479563|NCT00427310|Calcium heparin|calcium heparin|mesh-list
24654515|NCT01249937|Glucocorticoids|glucocorticoids|mesh-ancestor
24847239|NCT02245503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24847240|NCT02245503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847241|NCT02245503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24453347|NCT05126836|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24453348|NCT05126836|Autonomic Agents|autonomic agents|mesh-ancestor
24453349|NCT05126836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25541302|NCT00573768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25541303|NCT00573768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25541304|NCT00573768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541305|NCT00573768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541306|NCT00573794|Adalimumab|adalimumab|mesh-list
25541307|NCT00573794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25541308|NCT00573794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25541309|NCT00573859|Methylphenidate|methylphenidate|mesh-list
24578575|NCT00849550|Immunologic Factors|immunologic factors|mesh-ancestor
24578576|NCT00849602|Chloroquine|chloroquine|mesh-list
24792934|NCT04339101|Sirolimus|sirolimus|mesh-list
24792935|NCT04339101|Fludarabine|fludarabine|mesh-list
24792936|NCT04339101|Melphalan|melphalan|mesh-list
24847246|NCT02245529|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24847247|NCT02245529|Adrenergic Agents|adrenergic agents|mesh-ancestor
24847248|NCT02245529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24691673|NCT01408524|Diltiazem|diltiazem|mesh-list
24847249|NCT02245529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847250|NCT02245529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847251|NCT02245529|Urological Agents|urological agents|mesh-ancestor
24847252|NCT02245555|Tamsulosin|tamsulosin|mesh-list
24847253|NCT02245555|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24847254|NCT02245555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24847255|NCT02245555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24847256|NCT02245555|Adrenergic Agents|adrenergic agents|mesh-ancestor
25270781|NCT02403037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25270782|NCT02403037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270783|NCT02403037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25270784|NCT02403037|Glucocorticoids|glucocorticoids|mesh-ancestor
25270785|NCT02403037|Hormones|hormones|mesh-ancestor
25270788|NCT02403037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541310|NCT00573859|Amphetamine|amphetamine|mesh-list
25541311|NCT00573859|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25541312|NCT00573859|Dextroamphetamine|dextroamphetamine|mesh-list
25541313|NCT00573859|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25541314|NCT00573859|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25541315|NCT00573859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541316|NCT00573859|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25541317|NCT00573859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25541318|NCT00573859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25541319|NCT00573859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541320|NCT00573859|Dopamine Agents|dopamine agents|mesh-ancestor
24578850|NCT00852332|Curcumin|curcumin|mesh-list
25270792|NCT02402972|Leucovorin|leucovorin|mesh-list
25270793|NCT02402972|Oxaliplatin|oxaliplatin|mesh-list
25270794|NCT02402972|Floxuridine|floxuridine|mesh-list
25270795|NCT02402972|Levoleucovorin|levoleucovorin|mesh-list
25270796|NCT02402972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270797|NCT02402972|Antidotes|antidotes|mesh-ancestor
25270798|NCT02402972|Protective Agents|protective agents|mesh-ancestor
25270799|NCT02402972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270800|NCT02402972|Vitamin B Complex|vitamin b complex|mesh-ancestor
25270801|NCT02402972|Vitamins|vitamins|mesh-ancestor
25270802|NCT02402972|Micronutrients|micronutrients|mesh-ancestor
25270803|NCT02402972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25270804|NCT02402972|Antimetabolites|antimetabolites|mesh-ancestor
25270805|NCT02402972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457102|NCT00333112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457104|NCT00333112|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24457105|NCT00333112|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24457106|NCT00333112|Cholinergic Agents|cholinergic agents|mesh-ancestor
24457107|NCT00333125|Timolol|timolol|mesh-list
24457108|NCT00333125|Travoprost|travoprost|mesh-list
24457109|NCT00333125|Dorzolamide|dorzolamide|mesh-list
24692001|NCT01410370|Endostar protein|endostar protein|mesh-list
24847273|NCT02245789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24847274|NCT02245841|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24847275|NCT02245841|Hormones|hormones|mesh-ancestor
24847276|NCT02245841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25675980|NCT01791153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541321|NCT00573859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25541322|NCT00573859|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25437394|NCT04748276|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25437395|NCT04748276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25437396|NCT04748276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25437397|NCT04748276|Adrenergic Agents|adrenergic agents|mesh-ancestor
25437398|NCT04748276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25437399|NCT04748276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437400|NCT04748276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437401|NCT04748276|Sympathomimetics|sympathomimetics|mesh-ancestor
25437402|NCT04748276|Autonomic Agents|autonomic agents|mesh-ancestor
25437403|NCT04748276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437404|NCT04748276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25437405|NCT04748276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25437406|NCT04748276|Serotonin Agents|serotonin agents|mesh-ancestor
25437407|NCT04748276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25437408|NCT04748276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25437409|NCT04748341|Benzocaine|benzocaine|mesh-list
25437410|NCT04748341|Anesthetics, Local|anesthetics, local|mesh-ancestor
24792984|NCT04321551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24847277|NCT02245841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847278|NCT02245867|Antibodies|antibodies|mesh-list
24847279|NCT02245867|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24847280|NCT02245867|Immunologic Factors|immunologic factors|mesh-ancestor
24847281|NCT02245867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847282|NCT02245932|Resveratrol|resveratrol|mesh-list
24847283|NCT02245932|Antioxidants|antioxidants|mesh-ancestor
24847292|NCT02246023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270806|NCT02402868|Ketamine|ketamine|mesh-list
25270807|NCT02402868|Analgesics|analgesics|mesh-ancestor
25270808|NCT02402868|Sensory System Agents|sensory system agents|mesh-ancestor
25270813|NCT02402868|Anesthetics, General|anesthetics, general|mesh-ancestor
25437411|NCT04748341|Anesthetics|anesthetics|mesh-ancestor
25437412|NCT04748341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25437413|NCT04748341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437414|NCT04748341|Sensory System Agents|sensory system agents|mesh-ancestor
25437415|NCT04748341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437416|NCT04748419|Durvalumab|durvalumab|mesh-list
25437417|NCT04748419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25437418|NCT04748419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25437419|NCT04747678|Ivermectin|ivermectin|mesh-list
25247486|NCT03517449|Paclitaxel|paclitaxel|mesh-list
25247487|NCT03517449|Doxorubicin|doxorubicin|mesh-list
25247488|NCT03517449|Pembrolizumab|pembrolizumab|mesh-list
25247489|NCT03517449|Lenvatinib|lenvatinib|mesh-list
25247490|NCT03517449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25247491|NCT03517449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247492|NCT03517449|Tubulin Modulators|tubulin modulators|mesh-ancestor
25247493|NCT03517449|Antimitotic Agents|antimitotic agents|mesh-ancestor
25247494|NCT03517449|Mitosis Modulators|mitosis modulators|mesh-ancestor
25247496|NCT03517449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24479759|NCT00428272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479761|NCT00428311|Cyproterone Acetate|cyproterone acetate|mesh-list
24479762|NCT00428311|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24479763|NCT00428311|Estradiol|estradiol|mesh-list
24479796|NCT00428428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24942503|NCT03979976|Ramipril|ramipril|mesh-list
24847304|NCT02246049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24847305|NCT02246049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24692380|NCT01413477|Glucocorticoids|glucocorticoids|mesh-ancestor
25675992|NCT01791153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25675993|NCT01791153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25675994|NCT01791413|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25675995|NCT01791413|Medroxyprogesterone|medroxyprogesterone|mesh-list
25675996|NCT01791413|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25675997|NCT01791413|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25675998|NCT01791413|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25675999|NCT01791413|Contraceptive Agents|contraceptive agents|mesh-ancestor
24479956|NCT00429208|Cholinergic Agents|cholinergic agents|mesh-ancestor
25270826|NCT02402725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437420|NCT04747678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25437421|NCT04747678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25169024|NCT02010333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169025|NCT02010333|Sensory System Agents|sensory system agents|mesh-ancestor
25169026|NCT02010333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25169027|NCT02009579|Nintedanib|nintedanib|mesh-list
25169028|NCT02009579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169029|NCT02009579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25169030|NCT02009579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25145929|NCT02925299|Insulin|insulin|mesh-list
25146201|NCT02923583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25284630|NCT02659813|Copper|copper|mesh-list
24579160|NCT00853684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25270827|NCT02402725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270828|NCT02402725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25270829|NCT02402725|Glucocorticoids|glucocorticoids|mesh-ancestor
25270830|NCT02402725|Hormones|hormones|mesh-ancestor
25270831|NCT02402725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25270832|NCT02402725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25270833|NCT02402725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270834|NCT02402725|Protease Inhibitors|protease inhibitors|mesh-ancestor
25270835|NCT02402725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479824|NCT00428480|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24479827|NCT00428519|Antiemetics|antiemetics|mesh-ancestor
24479828|NCT00428519|Autonomic Agents|autonomic agents|mesh-ancestor
24479829|NCT00428519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24479830|NCT00428519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479831|NCT00428519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24479832|NCT00428519|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24479833|NCT00428519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24479834|NCT00428519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479835|NCT00428545|Bevacizumab|bevacizumab|mesh-list
24479836|NCT00428545|Bortezomib|bortezomib|mesh-list
24692544|NCT01415128|Rosiglitazone|rosiglitazone|mesh-list
24847310|NCT02246049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24847312|NCT02246049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270836|NCT02402725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270837|NCT02402712|Docetaxel|docetaxel|mesh-list
25270838|NCT02402712|Trastuzumab|trastuzumab|mesh-list
25270839|NCT02402712|Pertuzumab|pertuzumab|mesh-list
25147104|NCT02916381|Anesthetics|anesthetics|mesh-list
25169031|NCT02009579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169032|NCT02008344|Favipiravir|favipiravir|mesh-list
25169033|NCT02008344|Antiviral Agents|antiviral agents|mesh-ancestor
25169034|NCT02008344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25169035|NCT01999764|Retinol acetate|retinol acetate|mesh-list
25169036|NCT01999764|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25541323|NCT00573859|Adrenergic Agents|adrenergic agents|mesh-ancestor
25541324|NCT00573859|Sympathomimetics|sympathomimetics|mesh-ancestor
25541325|NCT00573859|Autonomic Agents|autonomic agents|mesh-ancestor
25541326|NCT00573859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25541327|NCT00573989|Pemetrexed|pemetrexed|mesh-list
25247553|NCT03387085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247554|NCT03387085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25247555|NCT03387085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25247556|NCT03387085|Alkylating Agents|alkylating agents|mesh-ancestor
25247557|NCT03387085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25247558|NCT03387085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25247559|NCT03387085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25247560|NCT03387085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25247561|NCT03387085|Growth Substances|growth substances|mesh-ancestor
25247562|NCT03387085|Growth Inhibitors|growth inhibitors|mesh-ancestor
25270843|NCT02402712|Mitosis Modulators|mitosis modulators|mesh-ancestor
25270848|NCT02402621|Narcotics|narcotics|mesh-ancestor
25270849|NCT02402621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24654879|NCT01251874|Alovudine|alovudine|mesh-list
24483651|NCT00444379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25676002|NCT01791413|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25676003|NCT01791413|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25676004|NCT01791413|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25676005|NCT01791413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25676006|NCT01791413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25676007|NCT01791465|Exenatide|exenatide|mesh-list
25676008|NCT01791465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25676009|NCT01791465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676010|NCT01791465|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25676011|NCT01791465|Incretins|incretins|mesh-ancestor
25676012|NCT01791465|Hormones|hormones|mesh-ancestor
25541328|NCT00573989|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25541329|NCT00573989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541330|NCT00573989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541331|NCT00573989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541332|NCT00573989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25541333|NCT00573989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25541334|NCT00573989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25541335|NCT00574067|Buprenorphine|buprenorphine|mesh-list
25247593|NCT03334318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25247594|NCT03334318|Gout Suppressants|gout suppressants|mesh-ancestor
25247595|NCT03334318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25247596|NCT03334318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25247597|NCT03334318|Antioxidants|antioxidants|mesh-ancestor
25247598|NCT03334318|Protective Agents|protective agents|mesh-ancestor
25247599|NCT03334318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247600|NCT03308825|Vaccines|vaccines|mesh-list
25247601|NCT03308825|Immunologic Factors|immunologic factors|mesh-ancestor
25247602|NCT03308825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247603|NCT03292250|Durvalumab|durvalumab|mesh-list
25247604|NCT03292250|Tremelimumab|tremelimumab|mesh-list
25247605|NCT03292250|Nintedanib|nintedanib|mesh-list
25247606|NCT03292250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25247607|NCT03292250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579251|NCT00854035|Hormones|hormones|mesh-ancestor
25247636|NCT03218085|Tenofovir|tenofovir|mesh-list
25247637|NCT03218085|Emtricitabine|emtricitabine|mesh-list
25247638|NCT03218085|Antiviral Agents|antiviral agents|mesh-ancestor
25247639|NCT03218085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25247640|NCT03218085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25247641|NCT03218085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25247642|NCT03218085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25247643|NCT03218085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247644|NCT03218085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25247646|NCT03123029|Venetoclax|venetoclax|mesh-list
24847360|NCT02246244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24847361|NCT02246244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24847362|NCT02246244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847363|NCT02246244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24847364|NCT02246244|Serotonin Agents|serotonin agents|mesh-ancestor
24847365|NCT02246244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847366|NCT02246244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24847367|NCT02246244|Antidepressive Agents|antidepressive agents|mesh-ancestor
25541336|NCT00574067|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25541337|NCT00574067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25541338|NCT00574067|Narcotics|narcotics|mesh-ancestor
25541339|NCT00574067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25541340|NCT00574067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541341|NCT00574067|Analgesics|analgesics|mesh-ancestor
25541342|NCT00574067|Sensory System Agents|sensory system agents|mesh-ancestor
25541343|NCT00574067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25541344|NCT00574067|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25541345|NCT00574119|Spironolactone|spironolactone|mesh-list
25541346|NCT00574119|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25541347|NCT00574119|Hormone Antagonists|hormone antagonists|mesh-ancestor
25541348|NCT00574119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25247674|NCT02914405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479957|NCT00429208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24479958|NCT00429208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479961|NCT00429234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24479962|NCT00429234|Antimetabolites|antimetabolites|mesh-ancestor
24479963|NCT00429234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692797|NCT01416480|Antitussive Agents|antitussive agents|mesh-ancestor
24483851|NCT00445406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483852|NCT00445406|Growth Inhibitors|growth inhibitors|mesh-ancestor
25270875|NCT02402491|Sensory System Agents|sensory system agents|mesh-ancestor
25270876|NCT02402491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25270877|NCT02402491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270878|NCT02402491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25270879|NCT02402491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25270880|NCT02402491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25270881|NCT02402491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25270882|NCT02402491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270883|NCT02402491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25270884|NCT02402491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25541349|NCT00574119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657193|NCT01584232|Insulin Glargine|insulin glargine|mesh-list
25541350|NCT00574119|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25541351|NCT00574119|Diuretics|diuretics|mesh-ancestor
25541352|NCT00574119|Natriuretic Agents|natriuretic agents|mesh-ancestor
25541353|NCT00574171|Capecitabine|capecitabine|mesh-list
25541354|NCT00574171|Lapatinib|lapatinib|mesh-list
25541355|NCT00574171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25541356|NCT00574171|Antimetabolites|antimetabolites|mesh-ancestor
25541357|NCT00574171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579393|NCT00854802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579394|NCT00854802|Antiviral Agents|antiviral agents|mesh-ancestor
25247708|NCT02807467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247711|NCT02688790|Dalbavancin|dalbavancin|mesh-list
25247712|NCT02688790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25247713|NCT02688790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25247714|NCT02617589|Nivolumab|nivolumab|mesh-list
25247715|NCT02617589|Temozolomide|temozolomide|mesh-list
25247716|NCT02617589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25247717|NCT02617589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247718|NCT02617589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25247720|NCT02617589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24483858|NCT00445497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24483859|NCT00445497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24483860|NCT00445497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24483861|NCT00445497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24483871|NCT00445510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676050|NCT01792115|Vitamins|vitamins|mesh-list
25676051|NCT01792115|Vitamin E|vitamin e|mesh-list
25676052|NCT01792115|Tocopherols|tocopherols|mesh-list
25676053|NCT01792115|Tocotrienols|tocotrienols|mesh-list
25676054|NCT01792115|alpha-Tocopherol|alpha-tocopherol|mesh-list
25676055|NCT01792115|Micronutrients|micronutrients|mesh-ancestor
25676056|NCT01792115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676057|NCT01792115|Antioxidants|antioxidants|mesh-ancestor
25676058|NCT01792115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676059|NCT01792115|Protective Agents|protective agents|mesh-ancestor
25676060|NCT01792284|Insulin|insulin|mesh-list
25676061|NCT01792284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25676062|NCT01792284|Insulin Lispro|insulin lispro|mesh-list
25676063|NCT01792284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25676064|NCT01792284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541358|NCT00574171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541359|NCT00574171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25541360|NCT00574171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541361|NCT00574197|Mycophenolic Acid|mycophenolic acid|mesh-list
25541362|NCT00574197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25541363|NCT00574197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541364|NCT00574197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25541365|NCT00574197|Antitubercular Agents|antitubercular agents|mesh-ancestor
25541366|NCT00574197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25541367|NCT00574197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25541368|NCT00574197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541369|NCT00574197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541370|NCT00574236|Doxorubicin|doxorubicin|mesh-list
25541371|NCT00574236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25541372|NCT00574236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541373|NCT00574236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25541374|NCT00574236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25541375|NCT00574236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541376|NCT00574236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847398|NCT02246816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847400|NCT02246816|Sensory System Agents|sensory system agents|mesh-ancestor
24847401|NCT02246816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24847402|NCT02246816|Antidiarrheals|antidiarrheals|mesh-ancestor
25270888|NCT02402491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25270889|NCT02402491|Purinergic Agents|purinergic agents|mesh-ancestor
25270890|NCT02402491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25270891|NCT02402465|Fluticasone|fluticasone|mesh-list
25270892|NCT02402465|Xhance|xhance|mesh-list
25270893|NCT02402465|Azelastine|azelastine|mesh-list
25270894|NCT02402465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24847429|NCT02246920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24847430|NCT02246920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847431|NCT02246920|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24847432|NCT02246920|Respiratory System Agents|respiratory system agents|mesh-ancestor
24847433|NCT02246920|Dermatologic Agents|dermatologic agents|mesh-ancestor
24847434|NCT02246920|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24635305|NCT01138384|Lapatinib|lapatinib|mesh-list
24484061|NCT00446420|Analgesics|analgesics|mesh-ancestor
24484062|NCT00446420|Sensory System Agents|sensory system agents|mesh-ancestor
24847459|NCT02247141|Antibodies|antibodies|mesh-list
25541377|NCT00574249|Adalimumab|adalimumab|mesh-list
25541378|NCT00574249|Betamethasone|betamethasone|mesh-list
25541379|NCT00574249|Calcipotriene|calcipotriene|mesh-list
25541380|NCT00574249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25541381|NCT00574249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25541382|NCT00574249|Glucocorticoids|glucocorticoids|mesh-ancestor
25541383|NCT00574249|Hormones|hormones|mesh-ancestor
25541384|NCT00574249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25541385|NCT00574249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541386|NCT00574249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25541387|NCT00574249|Respiratory System Agents|respiratory system agents|mesh-ancestor
25541388|NCT00574249|Dermatologic Agents|dermatologic agents|mesh-ancestor
25650661|NCT01506453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650662|NCT01506453|Antimanic Agents|antimanic agents|mesh-ancestor
25650663|NCT01506609|Paclitaxel|paclitaxel|mesh-list
25650664|NCT01506609|Carboplatin|carboplatin|mesh-list
25650665|NCT01506609|Temozolomide|temozolomide|mesh-list
25650666|NCT01506609|Veliparib|veliparib|mesh-list
24847488|NCT02247362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847489|NCT02247362|Agglutinins|agglutinins|mesh-ancestor
24847490|NCT02247414|Aspirin|aspirin|mesh-list
25270895|NCT02402465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25270896|NCT02402465|Autonomic Agents|autonomic agents|mesh-ancestor
25270897|NCT02402465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24479973|NCT00429247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24479974|NCT00429247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479975|NCT00429377|Tacrolimus|tacrolimus|mesh-list
24479976|NCT00429377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24847491|NCT02247414|Heparin|heparin|mesh-list
24847492|NCT02247414|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24847493|NCT02247414|Tinzaparin|tinzaparin|mesh-list
25650667|NCT01506609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25650668|NCT01506609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25650669|NCT01506609|Tubulin Modulators|tubulin modulators|mesh-ancestor
25650670|NCT01506609|Antimitotic Agents|antimitotic agents|mesh-ancestor
25650671|NCT01506609|Mitosis Modulators|mitosis modulators|mesh-ancestor
25650672|NCT01506609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650673|NCT01506609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25650674|NCT01506609|Alkylating Agents|alkylating agents|mesh-ancestor
25650675|NCT01506609|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25650676|NCT01506609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650677|NCT01506726|Salicylic Acid|salicylic acid|mesh-list
25247804|NCT02258659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25247805|NCT02258659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247806|NCT02258659|Tubulin Modulators|tubulin modulators|mesh-ancestor
25247807|NCT02258659|Antimitotic Agents|antimitotic agents|mesh-ancestor
25247808|NCT02258659|Mitosis Modulators|mitosis modulators|mesh-ancestor
25247810|NCT02258659|Antimetabolites|antimetabolites|mesh-ancestor
24847576|NCT02247687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24847577|NCT02247687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24847578|NCT02247687|Antiviral Agents|antiviral agents|mesh-ancestor
25270898|NCT02402465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270899|NCT02402465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25270900|NCT02402465|Respiratory System Agents|respiratory system agents|mesh-ancestor
25270901|NCT02402465|Dermatologic Agents|dermatologic agents|mesh-ancestor
24847579|NCT02247687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24847580|NCT02247687|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24847581|NCT02247687|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24847582|NCT02247687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24655411|NCT01256580|Autonomic Agents|autonomic agents|mesh-ancestor
24847620|NCT02248142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847621|NCT02248142|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24453441|NCT05008224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24847634|NCT02248155|Dopamine Agents|dopamine agents|mesh-ancestor
24847635|NCT02248155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24847670|NCT02248220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847671|NCT02248220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24847672|NCT02248220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25650678|NCT01506726|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
25650679|NCT01506726|Salicylates|salicylates|mesh-list
25650680|NCT01506726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25650681|NCT01506726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25650682|NCT01506726|Analgesics|analgesics|mesh-ancestor
25650683|NCT01506726|Sensory System Agents|sensory system agents|mesh-ancestor
25270904|NCT02402465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650684|NCT01506726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650685|NCT01506726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650686|NCT01506726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25650687|NCT01506726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25650688|NCT01506726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25650689|NCT01506726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650690|NCT01506726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270908|NCT02402465|Histamine Antagonists|histamine antagonists|mesh-ancestor
25270909|NCT02402465|Histamine Agents|histamine agents|mesh-ancestor
25270910|NCT02402465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24480047|NCT00429676|Autonomic Agents|autonomic agents|mesh-ancestor
24480048|NCT00429676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24480079|NCT00429806|Immunologic Factors|immunologic factors|mesh-ancestor
24847811|NCT05353673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24847813|NCT05353673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24847816|NCT05353673|Hormone Antagonists|hormone antagonists|mesh-ancestor
24847817|NCT05353543|Antidepressive Agents|antidepressive agents|mesh-list
24847818|NCT05353543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24847820|NCT05353361|Pertuzumab|pertuzumab|mesh-list
24847821|NCT05353361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24847822|NCT05353361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24847823|NCT05353361|Tubulin Modulators|tubulin modulators|mesh-ancestor
24847824|NCT05353361|Antimitotic Agents|antimitotic agents|mesh-ancestor
24847825|NCT05353361|Mitosis Modulators|mitosis modulators|mesh-ancestor
24847826|NCT05353361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847827|NCT05353361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24484823|NCT00450164|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24484824|NCT00450164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484825|NCT00450164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24484826|NCT00450164|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25270911|NCT02402400|Ticagrelor|ticagrelor|mesh-list
25270912|NCT02402400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25270913|NCT02402400|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25270914|NCT02402400|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24480080|NCT00429806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480082|NCT00429832|Diphenhydramine|diphenhydramine|mesh-list
24480083|NCT00429832|Ondansetron|ondansetron|mesh-list
24480084|NCT00429832|Antiemetics|antiemetics|mesh-ancestor
24480111|NCT00429871|Epirubicin|epirubicin|mesh-list
25650691|NCT01506726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25650692|NCT01506726|Antifungal Agents|antifungal agents|mesh-ancestor
25650693|NCT01506726|Keratolytic Agents|keratolytic agents|mesh-ancestor
25650694|NCT01506726|Dermatologic Agents|dermatologic agents|mesh-ancestor
25650695|NCT01506882|Levetiracetam|levetiracetam|mesh-list
25650696|NCT01506882|Anticonvulsants|anticonvulsants|mesh-ancestor
25541389|NCT00574275|Gemcitabine|gemcitabine|mesh-list
25541390|NCT00574275|Aflibercept|aflibercept|mesh-list
25541391|NCT00574275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25541392|NCT00574275|Antimetabolites|antimetabolites|mesh-ancestor
25541393|NCT00574275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541394|NCT00574275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541395|NCT00574275|Antiviral Agents|antiviral agents|mesh-ancestor
25541396|NCT00574275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25541397|NCT00574275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541398|NCT00574275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25541399|NCT00574275|Immunologic Factors|immunologic factors|mesh-ancestor
25541400|NCT00574275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541401|NCT00574275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25541402|NCT00574275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25541403|NCT00574275|Growth Substances|growth substances|mesh-ancestor
24485117|NCT00451672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485129|NCT00451724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24485130|NCT00451724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485132|NCT00451724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24485133|NCT00451724|Anesthetics, General|anesthetics, general|mesh-ancestor
24485134|NCT00451724|Anesthetics|anesthetics|mesh-ancestor
24847940|NCT05338983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847941|NCT05338983|Sensory System Agents|sensory system agents|mesh-ancestor
24847942|NCT05338983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24847948|NCT05335954|Norepinephrine|norepinephrine|mesh-list
24847949|NCT05335954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24847950|NCT05335954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24847951|NCT05335954|Adrenergic Agents|adrenergic agents|mesh-ancestor
24847952|NCT05335954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24847953|NCT05335954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847954|NCT05335954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847955|NCT05335954|Sympathomimetics|sympathomimetics|mesh-ancestor
24847956|NCT05335954|Autonomic Agents|autonomic agents|mesh-ancestor
24847957|NCT05335954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24847958|NCT05335954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25541404|NCT00574275|Growth Inhibitors|growth inhibitors|mesh-ancestor
25541405|NCT00574288|Dexamethasone|dexamethasone|mesh-list
25541406|NCT00574288|Methylprednisolone|methylprednisolone|mesh-list
25541407|NCT00574288|Daratumumab|daratumumab|mesh-list
25541408|NCT00574288|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25541409|NCT00574288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25541410|NCT00574288|Antiemetics|antiemetics|mesh-ancestor
25541411|NCT00574288|Autonomic Agents|autonomic agents|mesh-ancestor
25541412|NCT00574288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25541413|NCT00574288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541414|NCT00574288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25541415|NCT00574288|Glucocorticoids|glucocorticoids|mesh-ancestor
25541416|NCT00574288|Hormones|hormones|mesh-ancestor
25541417|NCT00574288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25541418|NCT00574288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25541419|NCT00574288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541420|NCT00574288|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25541421|NCT00574288|Protective Agents|protective agents|mesh-ancestor
25541422|NCT00574288|Immunologic Factors|immunologic factors|mesh-ancestor
25270949|NCT02402543|Sensory System Agents|sensory system agents|mesh-ancestor
25270950|NCT02402543|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25270951|NCT02402543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25270952|NCT02402543|Anesthetics, General|anesthetics, general|mesh-ancestor
25270953|NCT02402543|Anesthetics|anesthetics|mesh-ancestor
25270954|NCT02402543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24480211|NCT00430118|Thioguanine|thioguanine|mesh-list
24480212|NCT00430118|Vindesine|vindesine|mesh-list
24480213|NCT00430118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24485336|NCT00452595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24485337|NCT00452595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485338|NCT00452595|Antidepressive Agents|antidepressive agents|mesh-ancestor
24485339|NCT00452595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24485340|NCT00452608|Atorvastatin|atorvastatin|mesh-list
24485341|NCT00452608|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24847978|NCT05298696|Respiratory System Agents|respiratory system agents|mesh-ancestor
24847979|NCT05298696|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24847980|NCT05298696|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24693844|NCT01422616|Urapidil|urapidil|mesh-list
24847981|NCT05298696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847982|NCT05298696|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24847989|NCT05289323|Neostigmine|neostigmine|mesh-list
24848017|NCT05248633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24848018|NCT05248633|Antiemetics|antiemetics|mesh-ancestor
24656022|NCT01259362|Cocaine|cocaine|mesh-list
25541423|NCT00574340|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25541424|NCT00574340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541425|NCT00574405|Insulin|insulin|mesh-list
25541426|NCT00574405|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25541427|NCT00574405|Insulin Lispro|insulin lispro|mesh-list
25541428|NCT00574405|Insulin Aspart|insulin aspart|mesh-list
25541429|NCT00574405|Insulin, Isophane|insulin, isophane|mesh-list
25541430|NCT00574405|Isophane Insulin, Human|isophane insulin, human|mesh-list
25248038|NCT02534363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25248039|NCT02534363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25270955|NCT02402543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25270956|NCT02402543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25270957|NCT02402543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24446865|NCT00306358|Vitamin B Complex|vitamin b complex|mesh-ancestor
24848063|NCT05223582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24848064|NCT05223582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24848065|NCT05223582|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24848066|NCT05223582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24848067|NCT05223582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848068|NCT05223582|Hormone Antagonists|hormone antagonists|mesh-ancestor
24848069|NCT05223582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24637051|NCT01148446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24637053|NCT01148446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25270958|NCT02402543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270959|NCT02402543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25270960|NCT02402543|Antipyretics|antipyretics|mesh-ancestor
24480238|NCT00430118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24480297|NCT00430261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24480298|NCT00430261|Growth Substances|growth substances|mesh-ancestor
24942635|NCT03979599|Anesthetics|anesthetics|mesh-ancestor
24942636|NCT03979599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24942637|NCT03979599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24942638|NCT03979599|Anticonvulsants|anticonvulsants|mesh-ancestor
24942639|NCT03979599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25676071|NCT01792518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25676072|NCT01792518|Protease Inhibitors|protease inhibitors|mesh-ancestor
25676073|NCT01792518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676074|NCT01792518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541431|NCT00574405|Isophane insulin, beef|isophane insulin, beef|mesh-list
25541432|NCT00574405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25541433|NCT00574405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541434|NCT00574548|Vaccines|vaccines|mesh-list
25541435|NCT00574548|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25541436|NCT00574548|Immunologic Factors|immunologic factors|mesh-ancestor
25541437|NCT00574548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541438|NCT00574587|Paclitaxel|paclitaxel|mesh-list
25248082|NCT02534467|Montelukast|montelukast|mesh-list
24848074|NCT05212610|Vaccines|vaccines|mesh-list
24848075|NCT05212610|Immunologic Factors|immunologic factors|mesh-ancestor
24848076|NCT05212610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848077|NCT05197062|Aticaprant|aticaprant|mesh-list
24848078|NCT05197062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24637114|NCT01148628|Everolimus|everolimus|mesh-list
24848096|NCT05124457|Insulin Detemir|insulin detemir|mesh-list
24848097|NCT05124457|Isophane Insulin, Human|isophane insulin, human|mesh-list
24848098|NCT05124457|Insulin, Isophane|insulin, isophane|mesh-list
24848099|NCT05124457|Isophane insulin, beef|isophane insulin, beef|mesh-list
24848100|NCT05124457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25270961|NCT02402543|Anticonvulsants|anticonvulsants|mesh-ancestor
25270962|NCT02402543|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25270963|NCT02402543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25270964|NCT02402543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25270965|NCT02402543|Antimanic Agents|antimanic agents|mesh-ancestor
25270967|NCT02402348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25270968|NCT02402348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270970|NCT02402114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25270971|NCT02402179|Tryptophan|tryptophan|mesh-list
25270972|NCT02402179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25270973|NCT02402179|Antidepressive Agents|antidepressive agents|mesh-ancestor
25270974|NCT02402179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25270975|NCT02401945|Aflibercept|aflibercept|mesh-list
25270976|NCT02401945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25270977|NCT02401945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25270978|NCT02401945|Growth Substances|growth substances|mesh-ancestor
24480301|NCT00430261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24942647|NCT03979209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24848101|NCT05124457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541439|NCT00574587|Cyclophosphamide|cyclophosphamide|mesh-list
25541440|NCT00574587|Doxorubicin|doxorubicin|mesh-list
25541441|NCT00574587|Trastuzumab|trastuzumab|mesh-list
25541442|NCT00574587|Vorinostat|vorinostat|mesh-list
25541443|NCT00574587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25541444|NCT00574587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541445|NCT00574587|Tubulin Modulators|tubulin modulators|mesh-ancestor
25541446|NCT00574587|Antimitotic Agents|antimitotic agents|mesh-ancestor
25541447|NCT00574587|Mitosis Modulators|mitosis modulators|mesh-ancestor
25541448|NCT00574587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541449|NCT00574587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25541450|NCT00574587|Immunologic Factors|immunologic factors|mesh-ancestor
25541451|NCT00574587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541452|NCT00574587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25541453|NCT00574587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25248122|NCT02534623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25248123|NCT02534623|Anesthetics, General|anesthetics, general|mesh-ancestor
25270983|NCT02401971|Irinotecan|irinotecan|mesh-list
25270984|NCT02401971|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25270985|NCT02401971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24457146|NCT00333164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24848149|NCT05059977|Immunoglobulins|immunoglobulins|mesh-list
24848158|NCT05020327|Amoxicillin|amoxicillin|mesh-list
24848159|NCT05020327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24848160|NCT05020327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24637382|NCT01149980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637383|NCT01149980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24637384|NCT01149980|Antidepressive Agents|antidepressive agents|mesh-ancestor
24637486|NCT01150630|Antiviral Agents|antiviral agents|mesh-ancestor
24637487|NCT01150630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24637488|NCT01150630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676082|NCT01793285|Etanercept|etanercept|mesh-list
25541454|NCT00574587|Alkylating Agents|alkylating agents|mesh-ancestor
25541455|NCT00574587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25541456|NCT00574587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25541457|NCT00574587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25541458|NCT00574587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25541459|NCT00574587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541460|NCT00574587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25541461|NCT00574587|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25541462|NCT00574834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25248159|NCT02533908|Anesthetics|anesthetics|mesh-ancestor
24457149|NCT00333242|Respiratory System Agents|respiratory system agents|mesh-ancestor
24457150|NCT00333242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24848245|NCT04849715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24848246|NCT04849715|Immunologic Factors|immunologic factors|mesh-ancestor
24848247|NCT04849715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848248|NCT04849715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24848249|NCT04849715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25069971|NCT03422796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25069972|NCT03422705|Lisinopril|lisinopril|mesh-list
25069973|NCT03422705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24848250|NCT04849715|Alkylating Agents|alkylating agents|mesh-ancestor
24848251|NCT04849715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848253|NCT04795661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24848254|NCT04795661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24848255|NCT04792580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24848256|NCT04792580|Lifitegrast|lifitegrast|mesh-list
24848257|NCT04792580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24848258|NCT04768101|Corticosterone|corticosterone|mesh-list
24848259|NCT04768101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25541463|NCT00574834|Ramipril|ramipril|mesh-list
25541464|NCT00574834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25541465|NCT00574834|Diuretics|diuretics|mesh-ancestor
25541466|NCT00574834|Natriuretic Agents|natriuretic agents|mesh-ancestor
25541467|NCT00574834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541468|NCT00574834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25541469|NCT00574834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25541470|NCT00574834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248199|NCT02533557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25271112|NCT02401243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25270992|NCT02401971|Leprostatic Agents|leprostatic agents|mesh-ancestor
25270993|NCT02401971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25270994|NCT02401971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25270995|NCT02401971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24480320|NCT00430547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24480322|NCT00430586|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24480323|NCT00430586|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24480324|NCT00430586|Botulinum Toxins|botulinum toxins|mesh-list
24480325|NCT00430586|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24480326|NCT00430586|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24480327|NCT00430586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25676089|NCT01793285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25676090|NCT01793285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25676091|NCT01793285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25676092|NCT01793285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25676093|NCT01793285|Immunologic Factors|immunologic factors|mesh-ancestor
25676094|NCT01793688|Ampicillin|ampicillin|mesh-list
25676095|NCT01793688|Sulbactam|sulbactam|mesh-list
25676096|NCT01793688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25676097|NCT01793688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25676098|NCT01793688|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25541471|NCT00574834|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25541472|NCT00574834|Protease Inhibitors|protease inhibitors|mesh-ancestor
25541473|NCT00574834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541474|NCT00574847|Citalopram|citalopram|mesh-list
25541475|NCT00574847|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25541476|NCT00574847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25541477|NCT00574847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25541478|NCT00574847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541479|NCT00574847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25541480|NCT00574847|Serotonin Agents|serotonin agents|mesh-ancestor
25541481|NCT00574847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248237|NCT02533323|Antiviral Agents|antiviral agents|mesh-ancestor
25248238|NCT02533323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25248239|NCT02533323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248240|NCT02533323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25248241|NCT02533323|Immunologic Factors|immunologic factors|mesh-ancestor
25248242|NCT02533323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248243|NCT02533336|Abamectin|abamectin|mesh-list
24597390|NCT00949065|Antibodies|antibodies|mesh-list
24848369|NCT04553003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24848370|NCT04553003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24848382|NCT04509336|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24848383|NCT04509336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270996|NCT02401971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25270997|NCT02401971|Growth Substances|growth substances|mesh-ancestor
25270998|NCT02401971|Growth Inhibitors|growth inhibitors|mesh-ancestor
25275509|NCT02371577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25275510|NCT02371603|Pioglitazone|pioglitazone|mesh-list
25275511|NCT02371603|Trimethoprim|trimethoprim|mesh-list
25275512|NCT02371603|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25275513|NCT02371603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25275514|NCT02371603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24480388|NCT00430924|Hormone Antagonists|hormone antagonists|mesh-ancestor
24457155|NCT00333255|Nepafenac|nepafenac|mesh-list
25676099|NCT01793688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676100|NCT01793688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676101|NCT01793883|Laninamivir|laninamivir|mesh-list
25676102|NCT01793883|Zanamivir|zanamivir|mesh-list
25676103|NCT01793883|Antiviral Agents|antiviral agents|mesh-ancestor
25676104|NCT01793883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25676105|NCT01793883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541482|NCT00574847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25541483|NCT00574847|Antidepressive Agents|antidepressive agents|mesh-ancestor
25541484|NCT00574847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25541485|NCT00574873|Imatinib Mesylate|imatinib mesylate|mesh-list
25541486|NCT00574873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541487|NCT00574873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25541488|NCT00574873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24848386|NCT04509336|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24848388|NCT04509336|GABA Agents|gaba agents|mesh-ancestor
24848389|NCT04509336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24848390|NCT04509336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848391|NCT04509336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24848392|NCT04509336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24848393|NCT04509336|Parasympatholytics|parasympatholytics|mesh-ancestor
24848394|NCT04509336|Autonomic Agents|autonomic agents|mesh-ancestor
24848395|NCT04509336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25270999|NCT02401880|Empagliflozin|empagliflozin|mesh-list
25271000|NCT02401880|Linagliptin|linagliptin|mesh-list
25271001|NCT02401880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25271002|NCT02401880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271003|NCT02401880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25271004|NCT02401880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271005|NCT02401880|Incretins|incretins|mesh-ancestor
25271006|NCT02401880|Hormones|hormones|mesh-ancestor
25271007|NCT02401880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25271008|NCT02401880|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25271009|NCT02401880|Protease Inhibitors|protease inhibitors|mesh-ancestor
25271010|NCT02401880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271011|NCT02401828|Dolutegravir|dolutegravir|mesh-list
25271012|NCT02401828|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24942684|NCT03978884|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24453715|NCT04803422|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24453716|NCT04803422|Amoxicillin|amoxicillin|mesh-list
25541489|NCT00574873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541490|NCT00574912|Insulin|insulin|mesh-list
25541491|NCT00574912|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25541492|NCT00574912|Insulin Glargine|insulin glargine|mesh-list
25541493|NCT00574912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25541494|NCT00574912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541495|NCT00574951|Motesanib diphosphate|motesanib diphosphate|mesh-list
25541496|NCT00574951|Imetelstat|imetelstat|mesh-list
24453717|NCT04803422|Metronidazole|metronidazole|mesh-list
24453718|NCT04803422|Tazobactam|tazobactam|mesh-list
24453719|NCT04803422|Piperacillin|piperacillin|mesh-list
24453720|NCT04803422|Clavulanic Acids|clavulanic acids|mesh-list
24453721|NCT04803422|Clavulanic Acid|clavulanic acid|mesh-list
24453722|NCT04803422|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24453723|NCT04803422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24453724|NCT04803422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24453726|NCT04803422|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24453727|NCT04803422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486953|NCT00460707|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24486954|NCT00460707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24848454|NCT04167813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24848455|NCT04167813|Antipruritics|antipruritics|mesh-ancestor
25541497|NCT00574951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25541498|NCT00574951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541499|NCT00574951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541500|NCT00575016|Botulinum Toxins|botulinum toxins|mesh-list
25541501|NCT00575016|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25541502|NCT00575016|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25541503|NCT00575016|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25541504|NCT00575016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25541505|NCT00575016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541506|NCT00575016|Cholinergic Agents|cholinergic agents|mesh-ancestor
24694456|NCT01425619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271015|NCT02401828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271016|NCT02401828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25271017|NCT02401828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25271018|NCT02401828|Antiviral Agents|antiviral agents|mesh-ancestor
25271019|NCT02401828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25271020|NCT02401737|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25271021|NCT02401737|Antiviral Agents|antiviral agents|mesh-ancestor
25271022|NCT02401737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25271023|NCT02401477|Amoxicillin|amoxicillin|mesh-list
25271024|NCT02401477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25271025|NCT02401477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24480436|NCT00431080|Mitosis Modulators|mitosis modulators|mesh-ancestor
24480437|NCT00431080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480466|NCT00431106|Antimitotic Agents|antimitotic agents|mesh-ancestor
24480467|NCT00431106|Mitosis Modulators|mitosis modulators|mesh-ancestor
24480540|NCT00431236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24480541|NCT00431236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24480542|NCT00431236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24480543|NCT00431236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24480544|NCT00431236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24694568|NCT05386121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24694569|NCT05386121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541507|NCT00575016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25541508|NCT00575016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541509|NCT00575016|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25541510|NCT00575016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25541511|NCT00575029|Megestrol|megestrol|mesh-list
25541512|NCT00575029|Megestrol Acetate|megestrol acetate|mesh-list
25541513|NCT00575029|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25541514|NCT00575029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25437557|NCT04745260|GABA Agents|gaba agents|mesh-ancestor
25437558|NCT04745260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25437559|NCT04745260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248362|NCT02532634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25271034|NCT02401594|Anticoagulants|anticoagulants|mesh-ancestor
25271036|NCT02401594|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25271037|NCT02401334|Anti-Infective Agents|anti-infective agents|mesh-list
25271038|NCT02401334|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25271039|NCT02401425|Letrozole|letrozole|mesh-list
25271040|NCT02401425|Misoprostol|misoprostol|mesh-list
25271041|NCT02401425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25271042|NCT02401425|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25271043|NCT02401425|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25271044|NCT02401425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271211|NCT02400619|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25271045|NCT02401425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271046|NCT02401425|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25271047|NCT02401425|Hormone Antagonists|hormone antagonists|mesh-ancestor
25271048|NCT02401425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25437560|NCT04745286|Ketamine|ketamine|mesh-list
25437561|NCT04745286|Esketamine|esketamine|mesh-list
25437562|NCT04745286|Analgesics|analgesics|mesh-ancestor
25437563|NCT04745286|Sensory System Agents|sensory system agents|mesh-ancestor
25437564|NCT04745286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437565|NCT04745286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437566|NCT04745286|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25437567|NCT04745286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25437568|NCT04745286|Anesthetics, General|anesthetics, general|mesh-ancestor
25437569|NCT04745286|Anesthetics|anesthetics|mesh-ancestor
25541515|NCT00575029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25541516|NCT00575029|Contraceptive Agents|contraceptive agents|mesh-ancestor
25541517|NCT00575029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25541518|NCT00575029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541519|NCT00575029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25541520|NCT00575029|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24848521|NCT03993912|Autonomic Agents|autonomic agents|mesh-ancestor
24848522|NCT03993912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24848523|NCT03993912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638762|NCT01157975|Pioglitazone|pioglitazone|mesh-list
25271066|NCT02401269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25271067|NCT02401269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271068|NCT02401269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25271069|NCT02401269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25271070|NCT02401269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25271071|NCT02401269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25271072|NCT02401269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271073|NCT02401269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25271074|NCT02401269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24480634|NCT00431522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480636|NCT00431522|GABA Agents|gaba agents|mesh-ancestor
24480687|NCT00431678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24480688|NCT00431678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24480689|NCT00431678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24480690|NCT00431678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480691|NCT00431678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480692|NCT00431678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541521|NCT00575029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25541522|NCT00575029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541523|NCT00575029|Appetite Stimulants|appetite stimulants|mesh-ancestor
25541524|NCT00575029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25541525|NCT00575042|Fenofibrate|fenofibrate|mesh-list
25541526|NCT00575042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25541527|NCT00575042|Antimetabolites|antimetabolites|mesh-ancestor
25541528|NCT00575042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541529|NCT00575042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25541530|NCT00575094|Tigecycline|tigecycline|mesh-list
25541531|NCT00575094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25541532|NCT00575094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25541533|NCT00575094|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25541534|NCT00575094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541535|NCT00575094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541536|NCT00575367|Azithromycin|azithromycin|mesh-list
24848524|NCT03993912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24487470|NCT00463268|Vitamin D|vitamin d|mesh-list
25541537|NCT00575367|Moxifloxacin|moxifloxacin|mesh-list
25541538|NCT00575367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25541539|NCT00575367|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25541540|NCT00575367|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25541541|NCT00575367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25541542|NCT00575367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25541543|NCT00575367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25541544|NCT00575367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25541545|NCT00575367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541546|NCT00575367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541547|NCT00575367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541548|NCT00575367|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25541549|NCT00575367|Contraceptive Agents|contraceptive agents|mesh-ancestor
24597846|NCT00952094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24597847|NCT00952094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852915|NCT02264743|Contraceptive Agents|contraceptive agents|mesh-ancestor
24852916|NCT02264743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24597848|NCT00952094|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24597849|NCT00952094|Hormone Antagonists|hormone antagonists|mesh-ancestor
24597872|NCT00952432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24597890|NCT00952562|Cholecalciferol|cholecalciferol|mesh-list
25541550|NCT00575367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25541551|NCT00575367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541552|NCT00575367|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25541553|NCT00575367|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25541554|NCT00575367|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25541555|NCT00575380|Azithromycin|azithromycin|mesh-list
25541556|NCT00575380|Moxifloxacin|moxifloxacin|mesh-list
25541557|NCT00575380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25541558|NCT00575380|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25541559|NCT00575380|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25541560|NCT00575380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25541561|NCT00575380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25541562|NCT00575380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25541563|NCT00575380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25541564|NCT00575380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597934|NCT00952913|Lansoprazole|lansoprazole|mesh-list
24852918|NCT02264769|Carbetocin|carbetocin|mesh-list
25271144|NCT02400879|Narcotics|narcotics|mesh-ancestor
25541565|NCT00575380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541566|NCT00575380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541567|NCT00575380|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25541568|NCT00575380|Contraceptive Agents|contraceptive agents|mesh-ancestor
25541569|NCT00575380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25541570|NCT00575380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541571|NCT00575380|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25541572|NCT00575380|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25541573|NCT00575380|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25541574|NCT00575588|Metformin|metformin|mesh-list
25541575|NCT00575588|Saxagliptin|saxagliptin|mesh-list
25541576|NCT00575588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25541577|NCT00575588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541578|NCT00575588|Incretins|incretins|mesh-ancestor
25541579|NCT00575588|Hormones|hormones|mesh-ancestor
25541580|NCT00575588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25541581|NCT00575588|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25541582|NCT00575588|Protease Inhibitors|protease inhibitors|mesh-ancestor
25541583|NCT00575588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275525|NCT02371603|Antimalarials|antimalarials|mesh-ancestor
25275526|NCT02371603|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25275527|NCT02371603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25275528|NCT02371603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25275529|NCT02371603|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25275530|NCT02371603|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24695021|NCT04729517|Azelastine|azelastine|mesh-list
24695050|NCT04698525|Antimanic Agents|antimanic agents|mesh-ancestor
24695051|NCT04698525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24695052|NCT04698525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24695053|NCT04698525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24695054|NCT04673162|Methylprednisolone|methylprednisolone|mesh-list
24481453|NCT00434824|Testosterone|testosterone|mesh-list
24481534|NCT00435305|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24481535|NCT00435305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481536|NCT00435305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481588|NCT00435760|Respiratory System Agents|respiratory system agents|mesh-ancestor
24481589|NCT00435760|Parasympatholytics|parasympatholytics|mesh-ancestor
24942828|NCT03978234|Cholinergic Agents|cholinergic agents|mesh-ancestor
24848539|NCT03970096|Thiotepa|thiotepa|mesh-list
24487472|NCT00463268|Calcium|calcium|mesh-list
25271270|NCT02400112|Vancomycin|vancomycin|mesh-list
25271271|NCT02400112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25271272|NCT02400112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25271273|NCT02400021|Progesterone|progesterone|mesh-list
25271274|NCT02400021|Progestins|progestins|mesh-ancestor
25271275|NCT02400021|Hormones|hormones|mesh-ancestor
25271276|NCT02400021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25271277|NCT02400021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541584|NCT00575588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541585|NCT00575666|Insulin|insulin|mesh-list
25541586|NCT00575666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25541587|NCT00575666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541588|NCT00575887|Temozolomide|temozolomide|mesh-list
25541589|NCT00575887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25541590|NCT00575887|Alkylating Agents|alkylating agents|mesh-ancestor
25541591|NCT00575887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541592|NCT00575887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541593|NCT00575965|Simvastatin|simvastatin|mesh-list
24598175|NCT00954304|Loperamide|loperamide|mesh-list
25271287|NCT02400047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25271288|NCT02400047|Glucocorticoids|glucocorticoids|mesh-ancestor
25271289|NCT02400047|Hormones|hormones|mesh-ancestor
25271290|NCT02400047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25271291|NCT02400047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24481657|NCT00436241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481659|NCT00436267|Fluorouracil|fluorouracil|mesh-list
24487442|NCT00463073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487443|NCT00463086|Isoniazid|isoniazid|mesh-list
24487444|NCT00463086|Antitubercular Agents|antitubercular agents|mesh-ancestor
24487445|NCT00463086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24487462|NCT00463203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24487464|NCT00463203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487465|NCT00463203|Growth Inhibitors|growth inhibitors|mesh-ancestor
24487466|NCT00463203|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24487467|NCT00463203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24487468|NCT00463203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487469|NCT00463203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848549|NCT03970096|Alkylating Agents|alkylating agents|mesh-ancestor
24848564|NCT03970096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24848565|NCT03970096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24848566|NCT03970096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24848568|NCT03954379|Dexamethasone acetate|dexamethasone acetate|mesh-list
24848570|NCT03954379|Anesthetics|anesthetics|mesh-list
24848571|NCT03954379|Anesthetics, Local|anesthetics, local|mesh-list
25271292|NCT02400047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541594|NCT00575965|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25541595|NCT00575965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25541596|NCT00575965|Antimetabolites|antimetabolites|mesh-ancestor
25437609|NCT04744753|Calcium|calcium|mesh-list
25541597|NCT00575965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541598|NCT00575965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25541599|NCT00575965|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25541600|NCT00575965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541601|NCT00576056|Sorafenib|sorafenib|mesh-list
25271300|NCT02400047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25045531|NCT00945646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25045532|NCT00945646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25045534|NCT00945269|Aldesleukin|aldesleukin|mesh-list
25045535|NCT00945269|Interleukin-2|interleukin-2|mesh-list
25045536|NCT00945269|Denileukin diftitox|denileukin diftitox|mesh-list
25045537|NCT00945269|Immunotoxins|immunotoxins|mesh-list
25045538|NCT00945269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045539|NCT00945269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25045540|NCT00945269|Analgesics|analgesics|mesh-ancestor
25045541|NCT00945269|Sensory System Agents|sensory system agents|mesh-ancestor
25045542|NCT00945269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045543|NCT00945269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045544|NCT00945269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25045545|NCT00945269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24848581|NCT03954379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24848583|NCT03954379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24848584|NCT03954379|Protease Inhibitors|protease inhibitors|mesh-ancestor
24848592|NCT03910387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24598347|NCT00955604|Antidepressive Agents|antidepressive agents|mesh-list
24852949|NCT02264847|Clomiphene|clomiphene|mesh-list
24852950|NCT02264847|Enclomiphene|enclomiphene|mesh-list
25541602|NCT00576056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541603|NCT00576056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25541604|NCT00576056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541605|NCT00576056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541606|NCT00576199|Bevacizumab|bevacizumab|mesh-list
25541607|NCT00576199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25541608|NCT00576199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541609|NCT00576199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25271373|NCT02399397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25271374|NCT02399397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271375|NCT02399397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25271376|NCT02399397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25271377|NCT02399397|Anesthetics, General|anesthetics, general|mesh-ancestor
25541610|NCT00576199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25541611|NCT00576199|Growth Substances|growth substances|mesh-ancestor
25541612|NCT00576199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541613|NCT00576199|Growth Inhibitors|growth inhibitors|mesh-ancestor
25541614|NCT00576251|Tobramycin|tobramycin|mesh-list
25541615|NCT00576251|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
25541616|NCT00576251|Dexamethasone|dexamethasone|mesh-list
25541617|NCT00576251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25541618|NCT00576251|Antiemetics|antiemetics|mesh-ancestor
25541619|NCT00576251|Autonomic Agents|autonomic agents|mesh-ancestor
24481919|NCT00437229|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24481958|NCT00437359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051159|NCT00434850|Analgesics|analgesics|mesh-ancestor
25271426|NCT02399137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25271427|NCT02399137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25271428|NCT02399137|Tubulin Modulators|tubulin modulators|mesh-ancestor
25271429|NCT02399137|Antimitotic Agents|antimitotic agents|mesh-ancestor
25271430|NCT02399137|Mitosis Modulators|mitosis modulators|mesh-ancestor
25271431|NCT02399137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271432|NCT02399137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25271433|NCT02399137|Antimetabolites|antimetabolites|mesh-ancestor
25271434|NCT02399137|Antiviral Agents|antiviral agents|mesh-ancestor
25271435|NCT02399137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25271436|NCT02399137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271437|NCT02399137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25271438|NCT02399137|Immunologic Factors|immunologic factors|mesh-ancestor
25271439|NCT02399137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271440|NCT02398994|Methylprednisolone|methylprednisolone|mesh-list
25271441|NCT02398994|Immunoglobulins|immunoglobulins|mesh-list
25271442|NCT02398994|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25271443|NCT02398994|Antibodies|antibodies|mesh-list
25271444|NCT02398994|gamma-Globulins|gamma-globulins|mesh-list
25271445|NCT02398994|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25271446|NCT02398994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25271447|NCT02398994|Antiemetics|antiemetics|mesh-ancestor
24481959|NCT00437359|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24481960|NCT00437359|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25271448|NCT02398994|Autonomic Agents|autonomic agents|mesh-ancestor
25541620|NCT00576251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25541621|NCT00576251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541622|NCT00576251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25541623|NCT00576251|Glucocorticoids|glucocorticoids|mesh-ancestor
25541624|NCT00576251|Hormones|hormones|mesh-ancestor
25541625|NCT00576251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25541626|NCT00576251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25541627|NCT00576251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541628|NCT00576251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25271541|NCT02398474|Anesthetics|anesthetics|mesh-ancestor
25271542|NCT02398474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25271543|NCT02398474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271544|NCT02398474|Sensory System Agents|sensory system agents|mesh-ancestor
24457259|NCT00333632|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24457260|NCT00333632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24482179|NCT00438113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482180|NCT00438113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24848668|NCT03728361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24848669|NCT03728361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24848670|NCT03728361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848671|NCT03728361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24848672|NCT03728361|Alkylating Agents|alkylating agents|mesh-ancestor
24848673|NCT03715127|Psilocybin|psilocybin|mesh-list
24848687|NCT03670966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24848688|NCT03670966|Immunologic Factors|immunologic factors|mesh-ancestor
24848689|NCT03670966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848690|NCT03670966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24848691|NCT03670966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24487902|NCT00465543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24487903|NCT00465543|Analgesics|analgesics|mesh-ancestor
24848726|NCT03617328|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
24848728|NCT03617328|Immunologic Factors|immunologic factors|mesh-ancestor
24848729|NCT03617328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848730|NCT03617328|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25541629|NCT00576251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25541630|NCT00576251|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25541631|NCT00576251|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25541632|NCT00576303|Epoetin Alfa|epoetin alfa|mesh-list
25541633|NCT00576303|Hematinics|hematinics|mesh-ancestor
25541634|NCT00576316|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25541635|NCT00576316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25541636|NCT00576316|Respiratory System Agents|respiratory system agents|mesh-ancestor
25541637|NCT00576381|Dexmedetomidine|dexmedetomidine|mesh-list
25541638|NCT00576381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25541639|NCT00576381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25541640|NCT00576381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541641|NCT00576381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25541642|NCT00576381|Analgesics|analgesics|mesh-ancestor
25541643|NCT00576381|Sensory System Agents|sensory system agents|mesh-ancestor
25541644|NCT00576381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24598855|NCT05352191|Beclomethasone|beclomethasone|mesh-list
24598856|NCT05352191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24598857|NCT05352191|Glucocorticoids|glucocorticoids|mesh-ancestor
24598859|NCT05352191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24598860|NCT05352191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598861|NCT05352191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24598862|NCT05352191|Respiratory System Agents|respiratory system agents|mesh-ancestor
24482198|NCT00438139|Sensory System Agents|sensory system agents|mesh-ancestor
24482199|NCT00438139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25541645|NCT00576381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25541646|NCT00576381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25541647|NCT00576381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25541648|NCT00576381|Adrenergic Agents|adrenergic agents|mesh-ancestor
25541649|NCT00576381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25541650|NCT00576381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541651|NCT00576472|Methylphenidate|methylphenidate|mesh-list
25541652|NCT00576472|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25541653|NCT00576472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541654|NCT00576472|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25541655|NCT00576472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25541656|NCT00576472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25541657|NCT00576472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541658|NCT00576472|Dopamine Agents|dopamine agents|mesh-ancestor
25541659|NCT00576472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25541660|NCT00576576|Atorvastatin|atorvastatin|mesh-list
25541661|NCT00576576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25541662|NCT00576576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25541663|NCT00576576|Antimetabolites|antimetabolites|mesh-ancestor
25541664|NCT00576576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541665|NCT00576576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25541666|NCT00576576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25437685|NCT04744623|Glucocorticoids|glucocorticoids|mesh-ancestor
25541667|NCT00576576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271568|NCT02398136|Ketamine|ketamine|mesh-list
25541668|NCT00576628|Epoetin Alfa|epoetin alfa|mesh-list
25541669|NCT00576628|Hematinics|hematinics|mesh-ancestor
25541670|NCT00576680|Temozolomide|temozolomide|mesh-list
25541671|NCT00576680|Everolimus|everolimus|mesh-list
25541672|NCT00576680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25541673|NCT00576680|Alkylating Agents|alkylating agents|mesh-ancestor
25541674|NCT00576680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541675|NCT00576680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541676|NCT00576680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25541677|NCT00576680|Immunologic Factors|immunologic factors|mesh-ancestor
25541678|NCT00576680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541679|NCT00576732|Risperidone|risperidone|mesh-list
25541680|NCT00576732|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25541681|NCT00576732|Serotonin Agents|serotonin agents|mesh-ancestor
25541682|NCT00576732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25541683|NCT00576732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541684|NCT00576732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541685|NCT00576732|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25541686|NCT00576732|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25541687|NCT00576732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25541688|NCT00576732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25541689|NCT00576732|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25541690|NCT00576732|Dopamine Agents|dopamine agents|mesh-ancestor
25541691|NCT00576758|Rituximab|rituximab|mesh-list
25541692|NCT00576758|Obinutuzumab|obinutuzumab|mesh-list
25541693|NCT00576758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25541694|NCT00576758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599072|NCT05280457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599073|NCT05280457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24599074|NCT05280457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249125|NCT02528513|Sensory System Agents|sensory system agents|mesh-ancestor
25249126|NCT02528513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25249127|NCT02528513|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25249128|NCT02528513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25249129|NCT02528513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24848886|NCT03298893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271612|NCT02397772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25271613|NCT02397772|Tubulin Modulators|tubulin modulators|mesh-ancestor
24599165|NCT05100654|Renal Agents|renal agents|mesh-ancestor
24599182|NCT05014061|Analgesics|analgesics|mesh-ancestor
24579794|NCT00857753|Anesthetics|anesthetics|mesh-ancestor
24579795|NCT00857831|Vitamin D|vitamin d|mesh-list
24579799|NCT00857831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972084|NCT03720223|Anesthetics, Local|anesthetics, local|mesh-ancestor
24579800|NCT00857831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24579811|NCT00857909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579812|NCT00857909|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24579814|NCT00857909|Natriuretic Agents|natriuretic agents|mesh-ancestor
24579855|NCT00858325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24579856|NCT00858338|Floxuridine|floxuridine|mesh-list
24579857|NCT00858338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24579858|NCT00858338|Antimetabolites|antimetabolites|mesh-ancestor
24848973|NCT03170882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24848974|NCT03170882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848975|NCT03170882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24848976|NCT03170882|Glucocorticoids|glucocorticoids|mesh-ancestor
24848977|NCT03170882|Hormones|hormones|mesh-ancestor
24848978|NCT03170882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24848979|NCT03170882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24848980|NCT03170882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24848981|NCT03170882|Immunologic Factors|immunologic factors|mesh-ancestor
24848982|NCT03170882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24848983|NCT03170882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24848984|NCT03170882|Growth Substances|growth substances|mesh-ancestor
24848985|NCT03170882|Growth Inhibitors|growth inhibitors|mesh-ancestor
24848986|NCT03170882|Protease Inhibitors|protease inhibitors|mesh-ancestor
24848987|NCT03170882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541695|NCT00576758|Immunologic Factors|immunologic factors|mesh-ancestor
25541696|NCT00576758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541697|NCT00576758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25541698|NCT00576823|Alfuzosin|alfuzosin|mesh-list
25541699|NCT00576823|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25541700|NCT00576823|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25541701|NCT00576823|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25541702|NCT00576823|Adrenergic Agents|adrenergic agents|mesh-ancestor
25541703|NCT00576823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25541704|NCT00576823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541705|NCT00576823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541706|NCT00576823|Urological Agents|urological agents|mesh-ancestor
25541707|NCT00576901|Bevacizumab|bevacizumab|mesh-list
25541708|NCT00576901|Docetaxel|docetaxel|mesh-list
25541709|NCT00576901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25541710|NCT00576901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541711|NCT00576901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25541712|NCT00576901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25541713|NCT00576901|Growth Substances|growth substances|mesh-ancestor
25541714|NCT00576901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541715|NCT00576901|Growth Inhibitors|growth inhibitors|mesh-ancestor
25541716|NCT00576901|Tubulin Modulators|tubulin modulators|mesh-ancestor
25541717|NCT00576901|Antimitotic Agents|antimitotic agents|mesh-ancestor
24599445|NCT04577014|Mitosis Modulators|mitosis modulators|mesh-ancestor
24599446|NCT04562129|Aldesleukin|aldesleukin|mesh-list
24599447|NCT04562129|Nivolumab|nivolumab|mesh-list
25541718|NCT00576901|Mitosis Modulators|mitosis modulators|mesh-ancestor
25541719|NCT00576901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541720|NCT00577005|Levetiracetam|levetiracetam|mesh-list
25541721|NCT00577005|Anticonvulsants|anticonvulsants|mesh-ancestor
25541722|NCT00577005|Nootropic Agents|nootropic agents|mesh-ancestor
25541723|NCT00577031|Bevacizumab|bevacizumab|mesh-list
25541724|NCT00577031|Oxaliplatin|oxaliplatin|mesh-list
25541725|NCT00577031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25541726|NCT00577031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541727|NCT00577031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25541728|NCT00577031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25541729|NCT00577031|Growth Substances|growth substances|mesh-ancestor
24599521|NCT04444804|Antithrombins|antithrombins|mesh-ancestor
25541730|NCT00577031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541731|NCT00577031|Growth Inhibitors|growth inhibitors|mesh-ancestor
25541732|NCT00577096|Thalidomide|thalidomide|mesh-list
25541733|NCT00577096|Dexamethasone|dexamethasone|mesh-list
25541734|NCT00577096|Cyclophosphamide|cyclophosphamide|mesh-list
25541735|NCT00577096|Melphalan|melphalan|mesh-list
25541736|NCT00577096|Cisplatin|cisplatin|mesh-list
25541737|NCT00577096|Doxorubicin|doxorubicin|mesh-list
25541738|NCT00577096|Etoposide|etoposide|mesh-list
25541739|NCT00577096|Vincristine|vincristine|mesh-list
25541740|NCT00577096|Heparin|heparin|mesh-list
25541741|NCT00577096|Calcium heparin|calcium heparin|mesh-list
25437744|NCT04743739|Cyclosporine|cyclosporine|mesh-list
25541742|NCT00577096|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25541743|NCT00577096|Tinzaparin|tinzaparin|mesh-list
25541744|NCT00577096|Dalteparin|dalteparin|mesh-list
25437816|NCT04743063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437817|NCT04743063|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
25437818|NCT04743193|Sevoflurane|sevoflurane|mesh-list
25437819|NCT04743193|Anesthetics|anesthetics|mesh-ancestor
25437820|NCT04743193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24580002|NCT00859274|Respiratory System Agents|respiratory system agents|mesh-ancestor
24580003|NCT00859274|Glucocorticoids|glucocorticoids|mesh-ancestor
24580004|NCT00859274|Hormones|hormones|mesh-ancestor
24580005|NCT00859274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24580006|NCT00859352|Midazolam|midazolam|mesh-list
24580007|NCT00859352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24599637|NCT04119024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24599638|NCT04119024|Alkylating Agents|alkylating agents|mesh-ancestor
25075891|NCT03377400|Cisplatin|cisplatin|mesh-list
25249353|NCT02527460|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25249354|NCT02527460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25249355|NCT02527577|Ropivacaine|ropivacaine|mesh-list
25249356|NCT02527577|Anesthetics, Local|anesthetics, local|mesh-ancestor
25249357|NCT02527577|Anesthetics|anesthetics|mesh-ancestor
25249358|NCT02527577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25437821|NCT04743193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437822|NCT04743193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25437823|NCT04743193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25437824|NCT04743193|Anesthetics, General|anesthetics, general|mesh-ancestor
25437825|NCT04742504|Benralizumab|benralizumab|mesh-list
25437826|NCT04742504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25437827|NCT04742504|Respiratory System Agents|respiratory system agents|mesh-ancestor
25437828|NCT04742699|Lemborexant|lemborexant|mesh-list
25437829|NCT04742699|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25437830|NCT04742699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25437831|NCT04742699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599680|NCT04079452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599681|NCT04079452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25271823|NCT02396303|Carbetocin|carbetocin|mesh-list
25437832|NCT04742699|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25437833|NCT04742699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25437834|NCT04742699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25437835|NCT04742699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809709|NCT02035982|Donepezil|donepezil|mesh-list
25205020|NCT05225545|Iron|iron|mesh-list
25179073|NCT03755791|Sorafenib|sorafenib|mesh-list
25169037|NCT01999764|Immunologic Factors|immunologic factors|mesh-ancestor
25169038|NCT01999764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169039|NCT01999764|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25271833|NCT02396329|Plasma Substitutes|plasma substitutes|mesh-ancestor
25271834|NCT02396329|Blood Substitutes|blood substitutes|mesh-ancestor
25271835|NCT02396433|Carboplatin|carboplatin|mesh-list
25271836|NCT02396433|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25271837|NCT02396433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25271838|NCT02396433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271839|NCT02396433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271840|NCT02396030|Magnesium Sulfate|magnesium sulfate|mesh-list
25271841|NCT02396030|Analgesics|analgesics|mesh-ancestor
25271842|NCT02396030|Sensory System Agents|sensory system agents|mesh-ancestor
25271843|NCT02396030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25271844|NCT02396030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271845|NCT02396030|Anesthetics|anesthetics|mesh-ancestor
25271846|NCT02396030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25271847|NCT02396030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25271848|NCT02396030|Anticonvulsants|anticonvulsants|mesh-ancestor
25271849|NCT02396030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25271850|NCT02396030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25271851|NCT02396030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271852|NCT02396030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25271853|NCT02396030|Tocolytic Agents|tocolytic agents|mesh-ancestor
24483175|NCT00442182|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24483176|NCT00442182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483177|NCT00442182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249480|NCT02526979|Mirabegron|mirabegron|mesh-list
24849235|NCT01767129|Respiratory System Agents|respiratory system agents|mesh-ancestor
24849236|NCT01767129|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24849237|NCT01767129|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24849238|NCT01767129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24849239|NCT01767129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849240|NCT01767129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271855|NCT02396108|Paclitaxel|paclitaxel|mesh-list
25169040|NCT01999764|Protective Agents|protective agents|mesh-ancestor
25169041|NCT01999764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169042|NCT01999361|Mycophenolic Acid|mycophenolic acid|mesh-list
25169043|NCT01999361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25169044|NCT01999361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169045|NCT01999361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25169046|NCT01999361|Antitubercular Agents|antitubercular agents|mesh-ancestor
25169047|NCT01999361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25822521|NCT00004492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25822522|NCT00004492|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25822523|NCT00004492|Hormone Antagonists|hormone antagonists|mesh-ancestor
25822524|NCT00004492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25822525|NCT00004492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169048|NCT01999361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25169049|NCT01999361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271898|NCT02396043|Dermatologic Agents|dermatologic agents|mesh-ancestor
24483258|NCT00442546|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24483320|NCT00442780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24483321|NCT00442780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483354|NCT00443170|Caffeine|caffeine|mesh-list
24483355|NCT00443170|Omeprazole|omeprazole|mesh-list
24483356|NCT00443170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24483357|NCT00443170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24483358|NCT00443170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24483359|NCT00443170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271899|NCT02396043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25271901|NCT02396043|Antiviral Agents|antiviral agents|mesh-ancestor
25271902|NCT02396043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25271903|NCT02396043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25249549|NCT02525991|Loxapine|loxapine|mesh-list
25249550|NCT02525991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25249551|NCT02525991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25249552|NCT02525991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25249553|NCT02525991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249554|NCT02525991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25249555|NCT02525991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25249556|NCT02525991|Dopamine Agents|dopamine agents|mesh-ancestor
25249557|NCT02525991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25249558|NCT02525991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249596|NCT02526030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25249597|NCT02526030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249598|NCT02526030|Dopamine Agonists|dopamine agonists|mesh-ancestor
25249599|NCT02526030|Dopamine Agents|dopamine agents|mesh-ancestor
25249600|NCT02526030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25249601|NCT02526030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249604|NCT02526030|Serotonin Agents|serotonin agents|mesh-ancestor
25249639|NCT02525848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249640|NCT02525848|Antimanic Agents|antimanic agents|mesh-ancestor
25249641|NCT02525848|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25274484|NCT02377609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274485|NCT02377648|Everolimus|everolimus|mesh-list
25274486|NCT02377648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25274487|NCT02377648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25271947|NCT02395458|Clarithromycin|clarithromycin|mesh-list
25271956|NCT02395458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271958|NCT02395458|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25169050|NCT01999361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169051|NCT01998828|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
25169052|NCT01998828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25169053|NCT01998828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169054|NCT01998828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169055|NCT01998035|Azacitidine|azacitidine|mesh-list
25169056|NCT01998035|Romidepsin|romidepsin|mesh-list
24483532|NCT00443950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24943525|NCT03970044|Exenatide|exenatide|mesh-list
24849397|NCT02248571|Growth Substances|growth substances|mesh-ancestor
24849398|NCT02248571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849399|NCT02248571|Growth Inhibitors|growth inhibitors|mesh-ancestor
24849400|NCT02248571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24849401|NCT02248571|Antimetabolites|antimetabolites|mesh-ancestor
24849402|NCT02248571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849403|NCT02248571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24849404|NCT02248571|Immunologic Factors|immunologic factors|mesh-ancestor
24849405|NCT02248571|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24849406|NCT02248571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24849407|NCT02248571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849408|NCT02248571|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24849409|NCT02248571|Hormone Antagonists|hormone antagonists|mesh-ancestor
24849410|NCT02248571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24849411|NCT02248584|Ascorbic Acid|ascorbic acid|mesh-list
24849412|NCT02248584|Vitamins|vitamins|mesh-ancestor
24849413|NCT02248584|Micronutrients|micronutrients|mesh-ancestor
24849414|NCT02248584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849415|NCT02248584|Antioxidants|antioxidants|mesh-ancestor
24489491|NCT00473551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24489492|NCT00473551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24849442|NCT02248753|Metoprolol|metoprolol|mesh-list
24457386|NCT00334308|Caseins|caseins|mesh-list
25169057|NCT01998035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25169058|NCT01998035|Antimetabolites|antimetabolites|mesh-ancestor
25541745|NCT00577096|Epoetin Alfa|epoetin alfa|mesh-list
25541746|NCT00577096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25541747|NCT00577096|Immunologic Factors|immunologic factors|mesh-ancestor
24483569|NCT00444093|Antidiarrheals|antidiarrheals|mesh-list
25541748|NCT00577096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541749|NCT00577096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25541750|NCT00577096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25541751|NCT00577096|Alkylating Agents|alkylating agents|mesh-ancestor
25541752|NCT00577096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541753|NCT00577096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541754|NCT00577096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25541755|NCT00577096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25541756|NCT00577096|Antiemetics|antiemetics|mesh-ancestor
25541757|NCT00577096|Autonomic Agents|autonomic agents|mesh-ancestor
25541758|NCT00577096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25541759|NCT00577096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25541760|NCT00577096|Glucocorticoids|glucocorticoids|mesh-ancestor
25541761|NCT00577096|Hormones|hormones|mesh-ancestor
25541762|NCT00577096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25541763|NCT00577096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25541764|NCT00577096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541765|NCT00577096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25249774|NCT02524821|Metformin|metformin|mesh-list
24849469|NCT02248753|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24489743|NCT00475137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24489744|NCT00475137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25272036|NCT02394652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272037|NCT02394470|Deuterium Oxide|deuterium oxide|mesh-list
25272038|NCT02394470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272039|NCT02394470|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25272040|NCT02394470|Protective Agents|protective agents|mesh-ancestor
25272041|NCT02394470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272042|NCT02394496|Fulvestrant|fulvestrant|mesh-list
25272043|NCT02394496|Lapatinib|lapatinib|mesh-list
25272044|NCT02394496|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25272045|NCT02394496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25272046|NCT02394496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272047|NCT02394496|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25272048|NCT02394496|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25272049|NCT02394496|Hormone Antagonists|hormone antagonists|mesh-ancestor
24483748|NCT00444808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24849530|NCT02248987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24849531|NCT02248987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24849532|NCT02248987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849533|NCT02248987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24849534|NCT02249013|Paclitaxel|paclitaxel|mesh-list
24849535|NCT02249013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24849536|NCT02249013|Carboplatin|carboplatin|mesh-list
24641478|NCT01173809|Vasodilator Agents|vasodilator agents|mesh-ancestor
25272051|NCT02394496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541766|NCT00577096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25541767|NCT00577096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25541768|NCT00577096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25541769|NCT00577096|Tubulin Modulators|tubulin modulators|mesh-ancestor
25541770|NCT00577096|Antimitotic Agents|antimitotic agents|mesh-ancestor
25541771|NCT00577096|Mitosis Modulators|mitosis modulators|mesh-ancestor
25541772|NCT00577096|Anticoagulants|anticoagulants|mesh-ancestor
25541773|NCT00577096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25541774|NCT00577096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25541775|NCT00577096|Hematinics|hematinics|mesh-ancestor
25272071|NCT02394418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25272072|NCT02394418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25541776|NCT00577096|Leprostatic Agents|leprostatic agents|mesh-ancestor
25541777|NCT00577096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25541778|NCT00577096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25541779|NCT00577096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25541780|NCT00577096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25541781|NCT00577096|Growth Substances|growth substances|mesh-ancestor
25541782|NCT00577096|Growth Inhibitors|growth inhibitors|mesh-ancestor
25541783|NCT00577122|Cyclophosphamide|cyclophosphamide|mesh-list
25541784|NCT00577122|Methotrexate|methotrexate|mesh-list
25541785|NCT00577122|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25249875|NCT02523898|Metformin|metformin|mesh-list
25272106|NCT02394197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25272108|NCT02394197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25541786|NCT00577122|Medroxyprogesterone|medroxyprogesterone|mesh-list
25541787|NCT00577122|Progesterone|progesterone|mesh-list
25541788|NCT00577122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25541789|NCT00577122|Immunologic Factors|immunologic factors|mesh-ancestor
25676308|NCT01796470|Idelalisib|idelalisib|mesh-list
25541790|NCT00577122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541791|NCT00577122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25541792|NCT00577122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25541793|NCT00577122|Alkylating Agents|alkylating agents|mesh-ancestor
25541794|NCT00577122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541795|NCT00577122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541796|NCT00577122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25541797|NCT00577122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25541798|NCT00577122|Abortifacient Agents|abortifacient agents|mesh-ancestor
25541799|NCT00577122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25541800|NCT00577122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25541801|NCT00577122|Antimetabolites|antimetabolites|mesh-ancestor
25541802|NCT00577122|Dermatologic Agents|dermatologic agents|mesh-ancestor
25541803|NCT00577122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541804|NCT00577122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25249980|NCT02523755|Ropivacaine|ropivacaine|mesh-list
25249981|NCT02523755|Anesthetics, Local|anesthetics, local|mesh-ancestor
25249982|NCT02523755|Anesthetics|anesthetics|mesh-ancestor
25249983|NCT02523755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25249984|NCT02523755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249985|NCT02523755|Sensory System Agents|sensory system agents|mesh-ancestor
24698169|NCT01439243|Cholinergic Agents|cholinergic agents|mesh-ancestor
25541805|NCT00577122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25541806|NCT00577122|Progestins|progestins|mesh-ancestor
25541807|NCT00577122|Hormones|hormones|mesh-ancestor
25541808|NCT00577122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25541809|NCT00577122|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25541810|NCT00577122|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25541811|NCT00577122|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25541812|NCT00577122|Contraceptive Agents|contraceptive agents|mesh-ancestor
25541813|NCT00577122|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25541814|NCT00577122|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25541815|NCT00577122|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25541816|NCT00577122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25541817|NCT00577135|Furosemide|furosemide|mesh-list
25541818|NCT00577135|Diuretics|diuretics|mesh-list
25250027|NCT02523144|Analgesics|analgesics|mesh-ancestor
25272183|NCT02394002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25541819|NCT00577135|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
25541820|NCT00577135|Natriuretic Agents|natriuretic agents|mesh-ancestor
25541821|NCT00577135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541822|NCT00577135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25541823|NCT00577135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541824|NCT00577382|Sunitinib|sunitinib|mesh-list
25541825|NCT00577382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541826|NCT00577382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25541827|NCT00577382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25250059|NCT02522910|Tubulin Modulators|tubulin modulators|mesh-ancestor
25250060|NCT02522910|Antimitotic Agents|antimitotic agents|mesh-ancestor
25250061|NCT02522910|Mitosis Modulators|mitosis modulators|mesh-ancestor
25250062|NCT02522910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250063|NCT02522858|Atropine|atropine|mesh-list
24484910|NCT00450736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484911|NCT00450736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24484912|NCT00450736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24484913|NCT00450736|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24484914|NCT00450736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24484915|NCT00450736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484941|NCT00450840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24484942|NCT00450840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24484943|NCT00450840|Antimetabolites|antimetabolites|mesh-ancestor
25541828|NCT00577382|Growth Substances|growth substances|mesh-ancestor
25541829|NCT00577382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541830|NCT00577382|Growth Inhibitors|growth inhibitors|mesh-ancestor
25541831|NCT00577382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25541832|NCT00577382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541833|NCT00577382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541834|NCT00577408|Naltrexone|naltrexone|mesh-list
25541835|NCT00577408|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25541836|NCT00577408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25541837|NCT00577408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541838|NCT00577408|Sensory System Agents|sensory system agents|mesh-ancestor
25541839|NCT00577408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25541840|NCT00577460|Pramipexole|pramipexole|mesh-list
25541841|NCT00577460|Antioxidants|antioxidants|mesh-ancestor
24484949|NCT00450853|Antiemetics|antiemetics|mesh-ancestor
24484950|NCT00450853|Autonomic Agents|autonomic agents|mesh-ancestor
24484953|NCT00450853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24485159|NCT00451815|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
24485160|NCT00451815|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24485161|NCT00451815|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24485162|NCT00451815|Purinergic Agents|purinergic agents|mesh-ancestor
24485163|NCT00451815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24485164|NCT00451815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485165|NCT00451815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485166|NCT00451828|Simvastatin|simvastatin|mesh-list
25250161|NCT02522130|Sensory System Agents|sensory system agents|mesh-ancestor
24973893|NCT03705884|Prednisolone|prednisolone|mesh-list
25250162|NCT02522130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25250163|NCT02522130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25250173|NCT02522130|Oxytocics|oxytocics|mesh-ancestor
24485660|NCT00454402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485661|NCT00454402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485698|NCT00454519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24485739|NCT00454740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485741|NCT00454740|Urological Agents|urological agents|mesh-ancestor
24485814|NCT00455117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24485815|NCT00455117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24485816|NCT00455130|Mannitol|mannitol|mesh-list
24485817|NCT00455130|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24943794|NCT03966560|Timolol|timolol|mesh-list
24698582|NCT01441986|Respiratory System Agents|respiratory system agents|mesh-ancestor
25541842|NCT00577460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541843|NCT00577460|Protective Agents|protective agents|mesh-ancestor
25541844|NCT00577460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541845|NCT00577460|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25541846|NCT00577460|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25541847|NCT00577460|Dopamine Agonists|dopamine agonists|mesh-ancestor
25541848|NCT00577460|Dopamine Agents|dopamine agents|mesh-ancestor
25541849|NCT00577460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25541850|NCT00577473|Mesalamine|mesalamine|mesh-list
25541851|NCT00577473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25541852|NCT00577473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25541853|NCT00577473|Analgesics|analgesics|mesh-ancestor
25541854|NCT00577473|Sensory System Agents|sensory system agents|mesh-ancestor
25541855|NCT00577473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25541856|NCT00577473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541857|NCT00577473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25541858|NCT00577473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25541859|NCT00577590|Metformin|metformin|mesh-list
25541860|NCT00577590|Rosiglitazone|rosiglitazone|mesh-list
25541861|NCT00577590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25541862|NCT00577590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541863|NCT00577629|Cytarabine|cytarabine|mesh-list
25541864|NCT00577629|Cyclophosphamide|cyclophosphamide|mesh-list
25541865|NCT00577629|Rituximab|rituximab|mesh-list
25541866|NCT00577629|Doxorubicin|doxorubicin|mesh-list
25541867|NCT00577629|Etoposide|etoposide|mesh-list
25541868|NCT00577629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25541869|NCT00577629|Immunologic Factors|immunologic factors|mesh-ancestor
25541870|NCT00577629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541871|NCT00577629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25541872|NCT00577629|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25541873|NCT00577629|Alkylating Agents|alkylating agents|mesh-ancestor
25541874|NCT00577629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698801|NCT01442974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849821|NCT02250794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24849822|NCT02250794|Protease Inhibitors|protease inhibitors|mesh-ancestor
24849823|NCT02250794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849824|NCT02250794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849825|NCT02250820|Pentobarbital|pentobarbital|mesh-list
24849826|NCT02250820|Dexmedetomidine|dexmedetomidine|mesh-list
25272363|NCT02392780|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25272364|NCT02392780|Prednisolone phosphate|prednisolone phosphate|mesh-list
25272365|NCT02392780|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
25272366|NCT02392780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25272367|NCT02392780|Antiemetics|antiemetics|mesh-ancestor
25272368|NCT02392780|Autonomic Agents|autonomic agents|mesh-ancestor
25272369|NCT02392780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25272370|NCT02392780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272371|NCT02392780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25272372|NCT02392780|Glucocorticoids|glucocorticoids|mesh-ancestor
25272373|NCT02392780|Hormones|hormones|mesh-ancestor
25272374|NCT02392780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25272375|NCT02392780|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24738081|NCT01672814|Vitamins|vitamins|mesh-ancestor
25437908|NCT04740840|Vasodilator Agents|vasodilator agents|mesh-ancestor
25437909|NCT04740554|Prednisone|prednisone|mesh-list
25437910|NCT04740554|Deflazacort|deflazacort|mesh-list
25437911|NCT04740554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25437912|NCT04740554|Glucocorticoids|glucocorticoids|mesh-ancestor
25437913|NCT04740554|Hormones|hormones|mesh-ancestor
25437914|NCT04740554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25437915|NCT04740554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437916|NCT04740554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25437917|NCT04740554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24849829|NCT02250820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491393|NCT00482261|Sensory System Agents|sensory system agents|mesh-ancestor
24491394|NCT00482261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24811969|NCT02049073|Prednisolone phosphate|prednisolone phosphate|mesh-list
24811970|NCT02049073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24491466|NCT00482573|Mydriatics|mydriatics|mesh-ancestor
24491467|NCT00482573|Sympathomimetics|sympathomimetics|mesh-ancestor
24491468|NCT00482690|Nicotine|nicotine|mesh-list
24491469|NCT00482690|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24811971|NCT02049073|Antiemetics|antiemetics|mesh-ancestor
24811972|NCT02049073|Autonomic Agents|autonomic agents|mesh-ancestor
24811973|NCT02049073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24811974|NCT02049073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811975|NCT02049073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24811976|NCT02049073|Glucocorticoids|glucocorticoids|mesh-ancestor
24811977|NCT02049073|Hormones|hormones|mesh-ancestor
25272380|NCT02392780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272381|NCT02392780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486930|NCT00460642|Hormone Antagonists|hormone antagonists|mesh-ancestor
24491579|NCT00483067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812009|NCT02049255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812010|NCT02049255|Sensory System Agents|sensory system agents|mesh-ancestor
24812011|NCT02049255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437918|NCT04740554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25437919|NCT04740554|Immunologic Factors|immunologic factors|mesh-ancestor
25437920|NCT04740190|Carboplatin|carboplatin|mesh-list
25437921|NCT04740190|Talazoparib|talazoparib|mesh-list
25437922|NCT04740190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25437923|NCT04740190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25437924|NCT04740190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437925|NCT04740190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437926|NCT04740021|Carboplatin|carboplatin|mesh-list
25437927|NCT04740021|Etoposide|etoposide|mesh-list
25541875|NCT00577629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541876|NCT00577629|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25541877|NCT00577629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25541878|NCT00577629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25541879|NCT00577629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25541880|NCT00577629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25541881|NCT00577629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541882|NCT00577629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25541883|NCT00577629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25541884|NCT00577629|Antimetabolites|antimetabolites|mesh-ancestor
25541885|NCT00577629|Antiviral Agents|antiviral agents|mesh-ancestor
25541886|NCT00577629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25541887|NCT00577642|Zoledronic Acid|zoledronic acid|mesh-list
25541888|NCT00577642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25541889|NCT00577642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541890|NCT00577655|Albuterol|albuterol|mesh-list
25541891|NCT00577655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25541892|NCT00577655|Autonomic Agents|autonomic agents|mesh-ancestor
25541893|NCT00577655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25541894|NCT00577655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541895|NCT00577655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25541896|NCT00577655|Respiratory System Agents|respiratory system agents|mesh-ancestor
25541897|NCT00577655|Tocolytic Agents|tocolytic agents|mesh-ancestor
25541898|NCT00577655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25541899|NCT00577655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25541900|NCT00577655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25541901|NCT00577655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24849860|NCT02250924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24849861|NCT02250924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849862|NCT02250924|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24849863|NCT02250924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541902|NCT00577655|Adrenergic Agents|adrenergic agents|mesh-ancestor
25541903|NCT00577655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25541904|NCT00577655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541906|NCT00577707|Pemetrexed|pemetrexed|mesh-list
25541907|NCT00577707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25541908|NCT00577707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541909|NCT00577707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541910|NCT00577707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541911|NCT00577707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25541912|NCT00577707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25541913|NCT00577707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25541914|NCT00577720|Risedronic Acid|risedronic acid|mesh-list
25541915|NCT00577720|Etidronic Acid|etidronic acid|mesh-list
25541916|NCT00577720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25541917|NCT00577720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25541918|NCT00577720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541919|NCT00577720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25541920|NCT00577720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250423|NCT02520752|Anesthetics|anesthetics|mesh-ancestor
25541921|NCT00577720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25541922|NCT00577824|Exenatide|exenatide|mesh-list
25541923|NCT00577824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25541924|NCT00577824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541925|NCT00577824|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25541926|NCT00577824|Incretins|incretins|mesh-ancestor
25541927|NCT00577824|Hormones|hormones|mesh-ancestor
25541928|NCT00577824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25541929|NCT00577863|Teriparatide|teriparatide|mesh-list
25541930|NCT00577863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25541931|NCT00577863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541932|NCT00577863|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25541933|NCT00577889|Gemcitabine|gemcitabine|mesh-list
25541934|NCT00577889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25541935|NCT00577889|Antimetabolites|antimetabolites|mesh-ancestor
25541936|NCT00577889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541937|NCT00577889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541938|NCT00577889|Antiviral Agents|antiviral agents|mesh-ancestor
25541939|NCT00577889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25541940|NCT00577889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541941|NCT00577889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25541942|NCT00577889|Immunologic Factors|immunologic factors|mesh-ancestor
25541943|NCT00577889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541944|NCT00577993|Interferons|interferons|mesh-list
25541945|NCT00577993|Interferon-alpha|interferon-alpha|mesh-list
25541946|NCT00577993|Interferon alpha-2|interferon alpha-2|mesh-list
25541947|NCT00577993|Dexamethasone|dexamethasone|mesh-list
25541948|NCT00577993|Prednisone|prednisone|mesh-list
25541949|NCT00577993|Prednisolone|prednisolone|mesh-list
25541950|NCT00577993|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25541951|NCT00577993|Methylprednisolone|methylprednisolone|mesh-list
25541952|NCT00577993|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25541953|NCT00577993|Prednisolone acetate|prednisolone acetate|mesh-list
25541954|NCT00577993|Cyclophosphamide|cyclophosphamide|mesh-list
25541955|NCT00577993|Rituximab|rituximab|mesh-list
25541956|NCT00577993|Doxorubicin|doxorubicin|mesh-list
25541957|NCT00577993|Fludarabine|fludarabine|mesh-list
25541958|NCT00577993|Etoposide|etoposide|mesh-list
25541959|NCT00577993|Vincristine|vincristine|mesh-list
25541960|NCT00577993|Mitoxantrone|mitoxantrone|mesh-list
25541961|NCT00577993|Bleomycin|bleomycin|mesh-list
25541962|NCT00577993|Procarbazine|procarbazine|mesh-list
25541963|NCT00577993|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25541964|NCT00577993|Prednisolone phosphate|prednisolone phosphate|mesh-list
25541965|NCT00577993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24492134|NCT00485459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25541966|NCT00577993|Immunologic Factors|immunologic factors|mesh-ancestor
25541967|NCT00577993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25541968|NCT00577993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25541969|NCT00577993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25541970|NCT00577993|Alkylating Agents|alkylating agents|mesh-ancestor
25541971|NCT00577993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25541972|NCT00577993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25541973|NCT00577993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25541974|NCT00577993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25541975|NCT00577993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25541976|NCT00577993|Antiemetics|antiemetics|mesh-ancestor
25541977|NCT00577993|Autonomic Agents|autonomic agents|mesh-ancestor
25541978|NCT00577993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25541979|NCT00577993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25541980|NCT00577993|Glucocorticoids|glucocorticoids|mesh-ancestor
25541981|NCT00577993|Hormones|hormones|mesh-ancestor
25541982|NCT00577993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25541983|NCT00577993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25541984|NCT00577993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25541985|NCT00577993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25541986|NCT00577993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25541987|NCT00577993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25541988|NCT00577993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25541989|NCT00577993|Antiviral Agents|antiviral agents|mesh-ancestor
25541990|NCT00577993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25541991|NCT00577993|Tubulin Modulators|tubulin modulators|mesh-ancestor
25541992|NCT00577993|Antimitotic Agents|antimitotic agents|mesh-ancestor
25541993|NCT00577993|Mitosis Modulators|mitosis modulators|mesh-ancestor
25541994|NCT00577993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25541995|NCT00577993|Protective Agents|protective agents|mesh-ancestor
25541996|NCT00577993|Analgesics|analgesics|mesh-ancestor
25541997|NCT00577993|Sensory System Agents|sensory system agents|mesh-ancestor
25541998|NCT00578071|Capecitabine|capecitabine|mesh-list
25541999|NCT00578071|Oxaliplatin|oxaliplatin|mesh-list
25542000|NCT00578071|Panitumumab|panitumumab|mesh-list
25542001|NCT00578071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25542002|NCT00578071|Antimetabolites|antimetabolites|mesh-ancestor
25542003|NCT00578071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542004|NCT00578071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542005|NCT00578071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25542006|NCT00578136|Bupivacaine|bupivacaine|mesh-list
25542007|NCT00578136|Anesthetics, Local|anesthetics, local|mesh-ancestor
25542008|NCT00578136|Anesthetics|anesthetics|mesh-ancestor
25542009|NCT00578136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25542010|NCT00578136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542011|NCT00578136|Sensory System Agents|sensory system agents|mesh-ancestor
25542012|NCT00578136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25542013|NCT00578175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25542014|NCT00578175|Immunologic Factors|immunologic factors|mesh-ancestor
25542015|NCT00578175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542016|NCT00578214|Midazolam|midazolam|mesh-list
25542017|NCT00578214|Anesthetics|anesthetics|mesh-ancestor
24659849|NCT01280071|Aminophylline|aminophylline|mesh-list
25542018|NCT00578214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25542019|NCT00578214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542020|NCT00578214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25542021|NCT00578214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25542022|NCT00578214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25542023|NCT00578214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25542024|NCT00578214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25542025|NCT00578214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25542026|NCT00578214|Anesthetics, General|anesthetics, general|mesh-ancestor
25542027|NCT00578214|GABA Modulators|gaba modulators|mesh-ancestor
25542028|NCT00578214|GABA Agents|gaba agents|mesh-ancestor
25542029|NCT00578214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25542030|NCT00578214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542031|NCT00578227|Vaccines|vaccines|mesh-list
25542032|NCT00578227|Immunologic Factors|immunologic factors|mesh-ancestor
25542033|NCT00578227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542034|NCT00578279|Ethanol|ethanol|mesh-list
25542035|NCT00578279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25542036|NCT00578279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25542037|NCT00578279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25542038|NCT00578279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542039|NCT00578292|Cyclophosphamide|cyclophosphamide|mesh-list
25542040|NCT00578292|Busulfan|busulfan|mesh-list
25542041|NCT00578292|Fludarabine|fludarabine|mesh-list
25542042|NCT00578292|Alemtuzumab|alemtuzumab|mesh-list
25542043|NCT00578292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25542044|NCT00578292|Immunologic Factors|immunologic factors|mesh-ancestor
25542045|NCT00578292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542046|NCT00578292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25542047|NCT00578292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25542048|NCT00578292|Alkylating Agents|alkylating agents|mesh-ancestor
25542049|NCT00578292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542050|NCT00578292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542051|NCT00578292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25542052|NCT00578292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25542053|NCT00578305|Folic Acid|folic acid|mesh-list
25542054|NCT00578305|Methylprednisolone|methylprednisolone|mesh-list
25542055|NCT00578305|Rituximab|rituximab|mesh-list
25542056|NCT00578305|Methotrexate|methotrexate|mesh-list
25542057|NCT00578305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25542058|NCT00578305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542059|NCT00578305|Immunologic Factors|immunologic factors|mesh-ancestor
25542060|NCT00578305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542061|NCT00578305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25542062|NCT00578305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25542063|NCT00578305|Abortifacient Agents|abortifacient agents|mesh-ancestor
25542064|NCT00578305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25542065|NCT00578305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25542066|NCT00578305|Antimetabolites|antimetabolites|mesh-ancestor
25542067|NCT00578305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542068|NCT00578305|Dermatologic Agents|dermatologic agents|mesh-ancestor
25542069|NCT00578305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25542070|NCT00578305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25542071|NCT00578305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25542072|NCT00578305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25542073|NCT00578305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25542074|NCT00578305|Antiemetics|antiemetics|mesh-ancestor
25542075|NCT00578305|Autonomic Agents|autonomic agents|mesh-ancestor
25542076|NCT00578305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25542077|NCT00578305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25542078|NCT00578305|Glucocorticoids|glucocorticoids|mesh-ancestor
25542079|NCT00578305|Hormones|hormones|mesh-ancestor
25542080|NCT00578305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25542081|NCT00578305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25542082|NCT00578305|Protective Agents|protective agents|mesh-ancestor
25542083|NCT00578305|Hematinics|hematinics|mesh-ancestor
25542084|NCT00578305|Vitamin B Complex|vitamin b complex|mesh-ancestor
25542085|NCT00578305|Vitamins|vitamins|mesh-ancestor
25542086|NCT00578305|Micronutrients|micronutrients|mesh-ancestor
25542087|NCT00578331|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25542088|NCT00578331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25542089|NCT00578331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25542090|NCT00578331|Analgesics|analgesics|mesh-ancestor
25542091|NCT00578331|Sensory System Agents|sensory system agents|mesh-ancestor
25542092|NCT00578331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25542093|NCT00578331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542094|NCT00578331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25542095|NCT00578331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25542096|NCT00578331|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25542097|NCT00578331|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25542098|NCT00578331|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25542099|NCT00578331|Histamine Antagonists|histamine antagonists|mesh-ancestor
25542100|NCT00578331|Histamine Agents|histamine agents|mesh-ancestor
25542101|NCT00578331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25542102|NCT00578331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542103|NCT00578344|Cyclophosphamide|cyclophosphamide|mesh-list
25542104|NCT00578344|Busulfan|busulfan|mesh-list
25542105|NCT00578344|Alemtuzumab|alemtuzumab|mesh-list
25542106|NCT00578344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25542107|NCT00578344|Immunologic Factors|immunologic factors|mesh-ancestor
25542108|NCT00578344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542109|NCT00578344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25542110|NCT00578344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25542111|NCT00578344|Alkylating Agents|alkylating agents|mesh-ancestor
25542112|NCT00578344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438107|NCT04737889|Growth Inhibitors|growth inhibitors|mesh-ancestor
25438108|NCT04737889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25438109|NCT04737889|Alkylating Agents|alkylating agents|mesh-ancestor
25438110|NCT04737928|Latanoprost|latanoprost|mesh-list
25438111|NCT04737928|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25542113|NCT00578344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542114|NCT00578344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25542115|NCT00578344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25542116|NCT00578448|Abatacept|abatacept|mesh-list
25542117|NCT00578448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25650697|NCT01506882|Nootropic Agents|nootropic agents|mesh-ancestor
25542118|NCT00578448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542119|NCT00578448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542120|NCT00578448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25542121|NCT00578448|Immunologic Factors|immunologic factors|mesh-ancestor
25542122|NCT00578448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542123|NCT00578448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25542124|NCT00578461|Cytarabine|cytarabine|mesh-list
25542125|NCT00578461|Cyclophosphamide|cyclophosphamide|mesh-list
25542126|NCT00578461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25542127|NCT00578461|Immunologic Factors|immunologic factors|mesh-ancestor
25542128|NCT00578461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542129|NCT00578461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25542130|NCT00578461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25542131|NCT00578461|Alkylating Agents|alkylating agents|mesh-ancestor
25542132|NCT00578461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542133|NCT00578461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542134|NCT00578461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25542135|NCT00578461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25542136|NCT00578461|Antimetabolites|antimetabolites|mesh-ancestor
25542137|NCT00578461|Antiviral Agents|antiviral agents|mesh-ancestor
25542138|NCT00578461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25542139|NCT00578539|Cytarabine|cytarabine|mesh-list
25542140|NCT00578539|Cyclophosphamide|cyclophosphamide|mesh-list
25542141|NCT00578539|Alemtuzumab|alemtuzumab|mesh-list
25542142|NCT00578539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25542143|NCT00578539|Immunologic Factors|immunologic factors|mesh-ancestor
25542144|NCT00578539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542145|NCT00578539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25542146|NCT00578539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25542147|NCT00578539|Alkylating Agents|alkylating agents|mesh-ancestor
25542148|NCT00578539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542149|NCT00578539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542150|NCT00578539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25542151|NCT00578539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25542152|NCT00578539|Antimetabolites|antimetabolites|mesh-ancestor
25542153|NCT00578539|Antiviral Agents|antiviral agents|mesh-ancestor
25542154|NCT00578539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25542155|NCT00578539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25542156|NCT00578552|Gabapentin|gabapentin|mesh-list
25542157|NCT00578552|Analgesics|analgesics|mesh-ancestor
25542158|NCT00578552|Sensory System Agents|sensory system agents|mesh-ancestor
25542159|NCT00578552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25542160|NCT00578552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953810|NCT03881423|Rocuronium|rocuronium|mesh-list
25542161|NCT00578552|Anticonvulsants|anticonvulsants|mesh-ancestor
25542162|NCT00578552|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25542163|NCT00578552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25542164|NCT00578552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25542165|NCT00578552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25542166|NCT00578552|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25542167|NCT00578552|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25542168|NCT00578552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25542169|NCT00578552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542170|NCT00578552|Antimanic Agents|antimanic agents|mesh-ancestor
25542171|NCT00578565|Rituximab|rituximab|mesh-list
25542172|NCT00578565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25542173|NCT00578565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542174|NCT00578565|Immunologic Factors|immunologic factors|mesh-ancestor
25542175|NCT00578565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852132|NCT02260908|Enoxaparin|enoxaparin|mesh-list
25542176|NCT00578565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25542177|NCT00578617|Amiodarone|amiodarone|mesh-list
24589462|NCT00907504|Antiviral Agents|antiviral agents|mesh-ancestor
24604261|NCT00978172|Artesunate|artesunate|mesh-list
25542178|NCT00578617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591879|NCT00919399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25542179|NCT00578617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25542180|NCT00578617|Vasodilator Agents|vasodilator agents|mesh-ancestor
25542181|NCT00578617|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25542182|NCT00578617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25542183|NCT00578617|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25542184|NCT00578617|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25542185|NCT00578617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25542186|NCT00578617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25542187|NCT00578617|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25542188|NCT00578617|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25542189|NCT00578617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25542190|NCT00578643|Cyclosporine|cyclosporine|mesh-list
25542191|NCT00578643|Cyclophosphamide|cyclophosphamide|mesh-list
25542192|NCT00578643|Busulfan|busulfan|mesh-list
25542193|NCT00578643|Fludarabine|fludarabine|mesh-list
25542194|NCT00578643|Alemtuzumab|alemtuzumab|mesh-list
25542195|NCT00578643|Cyclosporins|cyclosporins|mesh-list
25542196|NCT00578643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25542197|NCT00578643|Immunologic Factors|immunologic factors|mesh-ancestor
25542198|NCT00578643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542199|NCT00578643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25542200|NCT00578643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25542201|NCT00578643|Alkylating Agents|alkylating agents|mesh-ancestor
25542202|NCT00578643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542203|NCT00578643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542204|NCT00578643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25542205|NCT00578643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25542206|NCT00578643|Antifungal Agents|antifungal agents|mesh-ancestor
25542207|NCT00578643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25542208|NCT00578643|Dermatologic Agents|dermatologic agents|mesh-ancestor
25542209|NCT00578643|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25542210|NCT00578643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25542211|NCT00578669|Fluoxetine|fluoxetine|mesh-list
25542212|NCT00578669|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25542213|NCT00578669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25542214|NCT00578669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25542215|NCT00578669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542216|NCT00578669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25542217|NCT00578669|Serotonin Agents|serotonin agents|mesh-ancestor
25542218|NCT00578669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542219|NCT00578669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25542220|NCT00578669|Antidepressive Agents|antidepressive agents|mesh-ancestor
25542221|NCT00578669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25542222|NCT00578669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24594004|NCT00931866|Analgesics|analgesics|mesh-ancestor
25542223|NCT00578669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25542224|NCT00578669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25542225|NCT00578734|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25542226|NCT00578734|Respiratory System Agents|respiratory system agents|mesh-ancestor
25542227|NCT00578786|Ambrisentan|ambrisentan|mesh-list
25542228|NCT00578786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25542229|NCT00578864|Cyclophosphamide|cyclophosphamide|mesh-list
25542230|NCT00578864|Cisplatin|cisplatin|mesh-list
25542231|NCT00578864|Doxorubicin|doxorubicin|mesh-list
25542232|NCT00578864|Etoposide|etoposide|mesh-list
25542233|NCT00578864|Etoposide phosphate|etoposide phosphate|mesh-list
25542234|NCT00578864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25542235|NCT00578864|Immunologic Factors|immunologic factors|mesh-ancestor
24594270|NCT00933309|Metformin|metformin|mesh-list
25542236|NCT00578864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542237|NCT00578864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25542238|NCT00578864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25542239|NCT00578864|Alkylating Agents|alkylating agents|mesh-ancestor
25542240|NCT00578864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542241|NCT00578864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542242|NCT00578864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25542243|NCT00578864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25542244|NCT00578864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25542245|NCT00578864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25542246|NCT00578864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25542247|NCT00578864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25542248|NCT00578877|Nonoxynol|nonoxynol|mesh-list
25542249|NCT00578877|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
25542250|NCT00578877|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
25542251|NCT00578877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542252|NCT00578877|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25542253|NCT00578877|Contraceptive Agents|contraceptive agents|mesh-ancestor
25542254|NCT00578877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25542255|NCT00578877|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25542256|NCT00578903|Cyclophosphamide|cyclophosphamide|mesh-list
25542257|NCT00578903|Methotrexate|methotrexate|mesh-list
25542258|NCT00578903|Alemtuzumab|alemtuzumab|mesh-list
25542259|NCT00578903|Tacrolimus|tacrolimus|mesh-list
25542260|NCT00578903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25542261|NCT00578903|Immunologic Factors|immunologic factors|mesh-ancestor
24595300|NCT00937911|Darexaban|darexaban|mesh-list
24595647|NCT00939926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25542262|NCT00578903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542263|NCT00578903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25542264|NCT00578903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25542265|NCT00578903|Alkylating Agents|alkylating agents|mesh-ancestor
25650698|NCT01506908|Nicotine|nicotine|mesh-list
25542266|NCT00578903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542267|NCT00578903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542268|NCT00578903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25542269|NCT00578903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24596311|NCT00942747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24596314|NCT00942773|Voriconazole|voriconazole|mesh-list
25542270|NCT00578903|Abortifacient Agents|abortifacient agents|mesh-ancestor
25542271|NCT00578903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25542272|NCT00578903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25542273|NCT00578903|Antimetabolites|antimetabolites|mesh-ancestor
25542274|NCT00578903|Dermatologic Agents|dermatologic agents|mesh-ancestor
25542275|NCT00578903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25010119|NCT04625803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25542276|NCT00578903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24597043|NCT00946946|Mesalamine|mesalamine|mesh-list
25542277|NCT00578903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25542278|NCT00578903|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25542279|NCT00578903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25542280|NCT00578929|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
24597276|NCT00948103|Analgesics|analgesics|mesh-ancestor
25542281|NCT00578929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25542282|NCT00578929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25542283|NCT00578929|Analgesics|analgesics|mesh-ancestor
25542284|NCT00578929|Sensory System Agents|sensory system agents|mesh-ancestor
25542285|NCT00578929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24597666|NCT00950625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25542286|NCT00578929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542287|NCT00578929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25542288|NCT00578929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25542289|NCT00578929|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25542290|NCT00578929|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24598265|NCT00954811|Hormones|hormones|mesh-ancestor
25676498|NCT01798992|Vasodilator Agents|vasodilator agents|mesh-ancestor
25542291|NCT00578929|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25542292|NCT00578929|Histamine Antagonists|histamine antagonists|mesh-ancestor
25542293|NCT00578929|Histamine Agents|histamine agents|mesh-ancestor
25542294|NCT00578929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25542295|NCT00578929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542296|NCT00578942|Alemtuzumab|alemtuzumab|mesh-list
25542297|NCT00578942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25438324|NCT04736381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25438325|NCT04736381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438326|NCT04736381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25438327|NCT04736381|Immunologic Factors|immunologic factors|mesh-ancestor
25438328|NCT04736381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438329|NCT04736381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25438330|NCT04736381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25438331|NCT04736108|Prednisolone|prednisolone|mesh-list
25438332|NCT04736108|Goserelin|goserelin|mesh-list
25438333|NCT04736108|Abiraterone Acetate|abiraterone acetate|mesh-list
25438334|NCT04736108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24600860|NCT00960921|Iron|iron|mesh-list
25438335|NCT04736108|Glucocorticoids|glucocorticoids|mesh-ancestor
25438336|NCT04736108|Hormones|hormones|mesh-ancestor
25208594|NCT01989598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25438337|NCT04736108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25438338|NCT04736108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438339|NCT04736108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25252736|NCT02505633|Autonomic Agents|autonomic agents|mesh-ancestor
25438340|NCT04736108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438341|NCT04736108|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24602580|NCT00969566|Hormones|hormones|mesh-ancestor
25438342|NCT04736108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275600|NCT02370862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25252913|NCT02504450|Dopamine Agents|dopamine agents|mesh-ancestor
25438343|NCT04736108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438344|NCT04736108|Hormone Antagonists|hormone antagonists|mesh-ancestor
24603683|NCT00974961|Bupivacaine|bupivacaine|mesh-list
25438345|NCT04736108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25542298|NCT00578942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542299|NCT00578968|Tiotropium Bromide|tiotropium bromide|mesh-list
25542300|NCT00578968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25542301|NCT00578968|Autonomic Agents|autonomic agents|mesh-ancestor
25542302|NCT00578968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24924713|NCT04156984|Golimumab|golimumab|mesh-list
25542303|NCT00578968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542304|NCT00578968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25542305|NCT00578968|Respiratory System Agents|respiratory system agents|mesh-ancestor
25542306|NCT00578968|Parasympatholytics|parasympatholytics|mesh-ancestor
25542307|NCT00578968|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25542308|NCT00578968|Cholinergic Agents|cholinergic agents|mesh-ancestor
25542309|NCT00578968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25542310|NCT00578968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542311|NCT00579098|Atorvastatin|atorvastatin|mesh-list
25542312|NCT00579098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25542313|NCT00579098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25542314|NCT00579098|Antimetabolites|antimetabolites|mesh-ancestor
25650699|NCT01506908|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25542315|NCT00579098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542316|NCT00579098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25542317|NCT00579098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25542318|NCT00579098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25542319|NCT00579111|Fludarabine|fludarabine|mesh-list
25542320|NCT00579111|Busulfan|busulfan|mesh-list
25542321|NCT00579111|Alemtuzumab|alemtuzumab|mesh-list
25542322|NCT00579111|Tacrolimus|tacrolimus|mesh-list
25542323|NCT00579111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542324|NCT00579111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542325|NCT00579111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25542326|NCT00579111|Immunologic Factors|immunologic factors|mesh-ancestor
25542327|NCT00579111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542328|NCT00579111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25542329|NCT00579111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25542330|NCT00579111|Alkylating Agents|alkylating agents|mesh-ancestor
25542331|NCT00579111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25542332|NCT00579111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25542333|NCT00579111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25650700|NCT01506908|Autonomic Agents|autonomic agents|mesh-ancestor
25650701|NCT01506908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650702|NCT01506908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650703|NCT01506908|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25650704|NCT01506908|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25650705|NCT01506908|Cholinergic Agents|cholinergic agents|mesh-ancestor
25650706|NCT01506908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25650707|NCT01506908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650708|NCT01506947|Darbepoetin alfa|darbepoetin alfa|mesh-list
25650709|NCT01506947|Hematinics|hematinics|mesh-ancestor
25650710|NCT01507051|Vitamin K|vitamin k|mesh-list
25650711|NCT01507051|Vitamin K 1|vitamin k 1|mesh-list
25650712|NCT01507051|Warfarin|warfarin|mesh-list
25650713|NCT01507051|Rivaroxaban|rivaroxaban|mesh-list
25650714|NCT01507051|Vitamins|vitamins|mesh-ancestor
25650715|NCT01507051|Micronutrients|micronutrients|mesh-ancestor
25650716|NCT01507051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650717|NCT01507051|Anticoagulants|anticoagulants|mesh-ancestor
25650718|NCT01507051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25650719|NCT01507051|Antithrombins|antithrombins|mesh-ancestor
25650720|NCT01507051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25650721|NCT01507051|Protease Inhibitors|protease inhibitors|mesh-ancestor
25650722|NCT01507051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650723|NCT01507051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650724|NCT01507051|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25650725|NCT01507051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25650726|NCT01507051|Hemostatics|hemostatics|mesh-ancestor
25650727|NCT01507051|Coagulants|coagulants|mesh-ancestor
25656870|NCT01580020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25656871|NCT01580020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25656872|NCT01580020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656873|NCT01580293|Factor VIII|factor viii|mesh-list
25656874|NCT01580293|Coagulants|coagulants|mesh-ancestor
25656875|NCT01580410|Oxaliplatin|oxaliplatin|mesh-list
25656876|NCT01580410|Mitomycins|mitomycins|mesh-list
25656877|NCT01580410|Mitomycin|mitomycin|mesh-list
25656878|NCT01580410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656879|NCT01580410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25656880|NCT01580410|Alkylating Agents|alkylating agents|mesh-ancestor
25656881|NCT01580410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656882|NCT01580410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25656883|NCT01580410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25656884|NCT01580423|Aprepitant|aprepitant|mesh-list
24605975|NCT00988403|Levan|levan|mesh-list
25656885|NCT01580423|Antiemetics|antiemetics|mesh-ancestor
25656886|NCT01580423|Autonomic Agents|autonomic agents|mesh-ancestor
25656887|NCT01580423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25656888|NCT01580423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656889|NCT01580423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25656890|NCT01580423|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25656891|NCT01580423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25656892|NCT01580423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656893|NCT01580488|Calcitriol|calcitriol|mesh-list
25656894|NCT01580488|Calcipotriene|calcipotriene|mesh-list
25656895|NCT01580488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25438378|NCT04735042|Dapagliflozin|dapagliflozin|mesh-list
25438379|NCT04735042|Empagliflozin|empagliflozin|mesh-list
25656896|NCT01580488|Dermatologic Agents|dermatologic agents|mesh-ancestor
25253499|NCT02500680|Vaccines|vaccines|mesh-list
25657194|NCT01584232|Dulaglutide|dulaglutide|mesh-list
25542334|NCT00579137|Fludarabine|fludarabine|mesh-list
25542335|NCT00579137|Alemtuzumab|alemtuzumab|mesh-list
25542336|NCT00579137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542337|NCT00579137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25542338|NCT00579280|Valproic Acid|valproic acid|mesh-list
25542339|NCT00579280|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25542340|NCT00579280|Antidepressive Agents|antidepressive agents|mesh-ancestor
25542341|NCT00579280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25542342|NCT00579280|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25542343|NCT00579280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25542344|NCT00579280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25542345|NCT00579280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542346|NCT00579280|Anticonvulsants|anticonvulsants|mesh-ancestor
25542347|NCT00579280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25542348|NCT00579280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542349|NCT00579280|GABA Agents|gaba agents|mesh-ancestor
25542350|NCT00579280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25542351|NCT00579280|Antimanic Agents|antimanic agents|mesh-ancestor
25542352|NCT00579345|Vaccines|vaccines|mesh-list
25542353|NCT00579345|Immunologic Factors|immunologic factors|mesh-ancestor
25542354|NCT00579345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542355|NCT00579501|Dexamethasone|dexamethasone|mesh-list
25542356|NCT00579501|Trabectedin|trabectedin|mesh-list
24606621|NCT00991250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606622|NCT00991250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24606623|NCT00991562|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
24606774|NCT05408221|Lenvatinib|lenvatinib|mesh-list
25542357|NCT00579501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25542358|NCT00579501|Antiemetics|antiemetics|mesh-ancestor
25542359|NCT00579501|Autonomic Agents|autonomic agents|mesh-ancestor
25542360|NCT00579501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25542361|NCT00579501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542362|NCT00579501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25542363|NCT00579501|Glucocorticoids|glucocorticoids|mesh-ancestor
25542364|NCT00579501|Hormones|hormones|mesh-ancestor
25542365|NCT00579501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25542366|NCT00579501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25542367|NCT00579501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542368|NCT00579501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25542369|NCT00579501|Alkylating Agents|alkylating agents|mesh-ancestor
25542370|NCT00579501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542371|NCT00579553|Progesterone|progesterone|mesh-list
25542372|NCT00579553|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
25542373|NCT00579553|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
25542374|NCT00579553|Progestins|progestins|mesh-ancestor
25542375|NCT00579553|Hormones|hormones|mesh-ancestor
25542376|NCT00579553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25542377|NCT00579553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542378|NCT00579553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25542379|NCT00579553|Hormone Antagonists|hormone antagonists|mesh-ancestor
25542380|NCT00579670|Ziprasidone|ziprasidone|mesh-list
25542381|NCT00579670|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25542382|NCT00579670|Serotonin Agents|serotonin agents|mesh-ancestor
25542383|NCT00579670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25542384|NCT00579670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542385|NCT00579670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542386|NCT00579670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25542387|NCT00579670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25542388|NCT00579670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25542389|NCT00579670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25542390|NCT00579670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25542391|NCT00579670|Dopamine Agents|dopamine agents|mesh-ancestor
25542392|NCT00579813|Pioglitazone|pioglitazone|mesh-list
25073961|NCT03391830|Antimetabolites|antimetabolites|mesh-ancestor
24458290|NCT00337376|Antifungal Agents|antifungal agents|mesh-ancestor
24458291|NCT00337376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24458292|NCT00337376|Immunologic Factors|immunologic factors|mesh-ancestor
24458293|NCT00337376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458295|NCT00337389|Bevacizumab|bevacizumab|mesh-list
24458296|NCT00337389|Fluorouracil|fluorouracil|mesh-list
24458297|NCT00337389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24458298|NCT00337389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458299|NCT00337389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24458300|NCT00337389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24458301|NCT00337389|Growth Substances|growth substances|mesh-ancestor
24458302|NCT00337389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631019|NCT01115543|Vitamins|vitamins|mesh-ancestor
25208778|NCT00653068|Carboplatin|carboplatin|mesh-list
25542393|NCT00579813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25542394|NCT00579813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542395|NCT00579878|Hydroxychloroquine|hydroxychloroquine|mesh-list
25542396|NCT00579878|Sulfasalazine|sulfasalazine|mesh-list
25542397|NCT00579878|Methotrexate|methotrexate|mesh-list
25542398|NCT00579878|Leflunomide|leflunomide|mesh-list
25542399|NCT00579878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25542400|NCT00579878|Abortifacient Agents|abortifacient agents|mesh-ancestor
25542401|NCT00579878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25542402|NCT00579878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542403|NCT00579878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25542404|NCT00579878|Antimetabolites|antimetabolites|mesh-ancestor
25542405|NCT00579878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542406|NCT00579878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542407|NCT00579878|Dermatologic Agents|dermatologic agents|mesh-ancestor
25542408|NCT00579878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25542409|NCT00579878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25438523|NCT05313386|Sensory System Agents|sensory system agents|mesh-ancestor
25438524|NCT05313386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25438525|NCT05313386|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25438526|NCT05313386|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25438527|NCT05313386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25438528|NCT05313386|Adrenergic Agents|adrenergic agents|mesh-ancestor
25438529|NCT05313386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25438530|NCT05313386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438531|NCT05313308|Midazolam|midazolam|mesh-list
25438532|NCT05313308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25438533|NCT05313308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25438534|NCT05313308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25438535|NCT05313308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438536|NCT05313308|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25438537|NCT05313308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25438538|NCT05313308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24450101|NCT00317785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24450103|NCT00317785|Dermatologic Agents|dermatologic agents|mesh-ancestor
24450104|NCT00317785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450105|NCT00317785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24450106|NCT00317785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25208790|NCT00653068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25208791|NCT00653068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25208792|NCT00653068|Alkylating Agents|alkylating agents|mesh-ancestor
25208793|NCT00653068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491424|NCT00482456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24491425|NCT00482456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491426|NCT00482456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24491427|NCT00482456|Analgesics|analgesics|mesh-ancestor
24625915|NCT01084369|Testosterone|testosterone|mesh-list
24631184|NCT01116310|Glycine|glycine|mesh-list
25438539|NCT05313308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25438540|NCT05313308|Anesthetics, General|anesthetics, general|mesh-ancestor
25438541|NCT05313308|Anesthetics|anesthetics|mesh-ancestor
25438542|NCT05313308|GABA Modulators|gaba modulators|mesh-ancestor
25438543|NCT05313308|GABA Agents|gaba agents|mesh-ancestor
25438544|NCT05313308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25438545|NCT05313308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542586|NCT00679458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25169059|NCT01998035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148223|NCT05311085|Cholinergic Agents|cholinergic agents|mesh-ancestor
24458264|NCT00337298|Amlodipine|amlodipine|mesh-list
24868704|NCT03393741|Paclitaxel|paclitaxel|mesh-list
25169060|NCT01998035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169061|NCT01998035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169064|NCT01994382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25169065|NCT01994382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169066|NCT01994382|Immunologic Factors|immunologic factors|mesh-ancestor
25169067|NCT01994382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169068|NCT01994382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25169069|NCT01993641|Azacitidine|azacitidine|mesh-list
25169070|NCT01993641|Decitabine|decitabine|mesh-list
25169071|NCT01993641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25169072|NCT01993641|Antimetabolites|antimetabolites|mesh-ancestor
25169073|NCT01993641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169074|NCT01993641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169075|NCT01993641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169076|NCT01989429|Vitamin D|vitamin d|mesh-list
25169077|NCT01989429|Vitamins|vitamins|mesh-ancestor
25169078|NCT01989429|Micronutrients|micronutrients|mesh-ancestor
25169079|NCT01989429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169080|NCT01989429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25169081|NCT01989325|Dexamethasone|dexamethasone|mesh-list
25169082|NCT01989325|Filanesib|filanesib|mesh-list
25169083|NCT01989325|Lenograstim|lenograstim|mesh-list
25169084|NCT01989325|Proteasome Inhibitors|proteasome inhibitors|mesh-list
25169085|NCT01989325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25542410|NCT00579878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25542411|NCT00579878|Immunologic Factors|immunologic factors|mesh-ancestor
25542412|NCT00579878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25542413|NCT00579878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25542414|NCT00579878|Antimalarials|antimalarials|mesh-ancestor
25542415|NCT00579878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25542416|NCT00579878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25542417|NCT00579878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25542418|NCT00579878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25542419|NCT00579878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25542420|NCT00579878|Analgesics|analgesics|mesh-ancestor
25542421|NCT00579878|Sensory System Agents|sensory system agents|mesh-ancestor
25542422|NCT00579878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25542423|NCT00579878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25542424|NCT00579878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24925508|NCT04149626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925509|NCT04149626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24925510|NCT04149626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24925511|NCT04149626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24451759|NCT00324727|Melphalan|melphalan|mesh-list
25542425|NCT00579982|Lamotrigine|lamotrigine|mesh-list
25542426|NCT00579982|Anticonvulsants|anticonvulsants|mesh-ancestor
25542427|NCT00579982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25542428|NCT00579982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25542429|NCT00579982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542430|NCT00579982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25542431|NCT00579982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542432|NCT00579982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25542433|NCT00579982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25542434|NCT00579982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25542435|NCT00579982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25542436|NCT00579982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25542437|NCT00580034|Alemtuzumab|alemtuzumab|mesh-list
25542438|NCT00580034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25542439|NCT00580034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542440|NCT00580047|Calcium, Dietary|calcium, dietary|mesh-list
25542441|NCT00580047|Vitamin D|vitamin d|mesh-list
25542442|NCT00580047|Zoledronic Acid|zoledronic acid|mesh-list
25542443|NCT00580047|Alendronate|alendronate|mesh-list
25542444|NCT00580047|Calcium Carbonate|calcium carbonate|mesh-list
25542445|NCT00580047|Calcium|calcium|mesh-list
25542446|NCT00580047|Vitamins|vitamins|mesh-ancestor
25542447|NCT00580047|Micronutrients|micronutrients|mesh-ancestor
25542448|NCT00580047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542449|NCT00580047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25542450|NCT00580047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25542451|NCT00580047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542452|NCT00580047|Antacids|antacids|mesh-ancestor
25542453|NCT00580047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25542454|NCT00580073|Leucovorin|leucovorin|mesh-list
25542455|NCT00580073|Fluorouracil|fluorouracil|mesh-list
25542456|NCT00580073|Oxaliplatin|oxaliplatin|mesh-list
25542457|NCT00580073|Cetuximab|cetuximab|mesh-list
25542458|NCT00580073|Antimetabolites|antimetabolites|mesh-ancestor
25542459|NCT00580073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542460|NCT00580073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25542461|NCT00580073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542462|NCT00580073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25542463|NCT00580073|Immunologic Factors|immunologic factors|mesh-ancestor
25542464|NCT00580073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542465|NCT00580073|Antidotes|antidotes|mesh-ancestor
25542466|NCT00580073|Protective Agents|protective agents|mesh-ancestor
25542467|NCT00580073|Vitamin B Complex|vitamin b complex|mesh-ancestor
25542468|NCT00580073|Vitamins|vitamins|mesh-ancestor
25542469|NCT00580073|Micronutrients|micronutrients|mesh-ancestor
25542470|NCT00580073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25542471|NCT00580151|Clonidine|clonidine|mesh-list
25542472|NCT00580151|Analgesics|analgesics|mesh-ancestor
25542473|NCT00580151|Sensory System Agents|sensory system agents|mesh-ancestor
25542474|NCT00580151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25542475|NCT00580151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542476|NCT00580151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25542477|NCT00580151|Sympatholytics|sympatholytics|mesh-ancestor
25542478|NCT00580151|Autonomic Agents|autonomic agents|mesh-ancestor
25542479|NCT00580151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25542480|NCT00580151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25542481|NCT00580151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24582604|NCT00870636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24582609|NCT00870714|Ketoconazole|ketoconazole|mesh-list
25074026|NCT03391245|Vitamins|vitamins|mesh-ancestor
25542482|NCT00580151|Adrenergic Agents|adrenergic agents|mesh-ancestor
25542483|NCT00580151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25542484|NCT00580151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542485|NCT00580229|Prednisone|prednisone|mesh-list
25542486|NCT00580229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25542487|NCT00580229|Glucocorticoids|glucocorticoids|mesh-ancestor
25542488|NCT00580229|Hormones|hormones|mesh-ancestor
25542489|NCT00580229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25542490|NCT00580229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542491|NCT00580229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25542492|NCT00580229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542493|NCT00580294|Oxymorphone|oxymorphone|mesh-list
25542494|NCT00580294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25542495|NCT00580294|Narcotics|narcotics|mesh-ancestor
25542496|NCT00580294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25542497|NCT00580294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542498|NCT00580294|Analgesics|analgesics|mesh-ancestor
25542499|NCT00580294|Sensory System Agents|sensory system agents|mesh-ancestor
25542500|NCT00580294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25542501|NCT00580294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25542502|NCT00580333|Paclitaxel|paclitaxel|mesh-list
25542503|NCT00580333|Cyclophosphamide|cyclophosphamide|mesh-list
25542504|NCT00580333|Bevacizumab|bevacizumab|mesh-list
25542505|NCT00580333|Cisplatin|cisplatin|mesh-list
25542506|NCT00580333|Doxorubicin|doxorubicin|mesh-list
25438547|NCT05312840|Cisplatin|cisplatin|mesh-list
25542507|NCT00580333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25542508|NCT00580333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542509|NCT00580333|Tubulin Modulators|tubulin modulators|mesh-ancestor
25542510|NCT00580333|Antimitotic Agents|antimitotic agents|mesh-ancestor
25542511|NCT00580333|Mitosis Modulators|mitosis modulators|mesh-ancestor
25542512|NCT00580333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542513|NCT00580333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25542514|NCT00580333|Immunologic Factors|immunologic factors|mesh-ancestor
25542515|NCT00580333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542516|NCT00580333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25542517|NCT00580333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25542518|NCT00580333|Alkylating Agents|alkylating agents|mesh-ancestor
25542519|NCT00580333|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25542520|NCT00580333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25542521|NCT00580333|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24523796|NCT05340413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25542522|NCT00580333|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25542523|NCT00580333|Growth Substances|growth substances|mesh-ancestor
25542524|NCT00580333|Growth Inhibitors|growth inhibitors|mesh-ancestor
25542525|NCT00580333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25542526|NCT00580333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25542527|NCT00580333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25542528|NCT00580333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25542529|NCT00580372|Cyclophosphamide|cyclophosphamide|mesh-list
25542530|NCT00580372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25542531|NCT00580372|Immunologic Factors|immunologic factors|mesh-ancestor
25542532|NCT00580372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542533|NCT00580372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25542534|NCT00580372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25542535|NCT00580372|Alkylating Agents|alkylating agents|mesh-ancestor
25542536|NCT00580372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542537|NCT00580372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542538|NCT00580372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25542539|NCT00580398|Varenicline|varenicline|mesh-list
25542540|NCT00580398|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25542541|NCT00580398|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25542542|NCT00580398|Cholinergic Agents|cholinergic agents|mesh-ancestor
25542543|NCT00580398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25542544|NCT00580398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542545|NCT00580398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542546|NCT00580606|Glycerol|glycerol|mesh-list
25542547|NCT00580606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25542548|NCT00580606|Protective Agents|protective agents|mesh-ancestor
25542549|NCT00580606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542550|NCT00580645|Varenicline|varenicline|mesh-list
25542551|NCT00580645|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25542552|NCT00580645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25542553|NCT00580645|Cholinergic Agents|cholinergic agents|mesh-ancestor
25542554|NCT00580645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25542555|NCT00580645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542556|NCT00580645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542557|NCT00580788|Parathyroid Hormone|parathyroid hormone|mesh-list
25542558|NCT00580788|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
25542559|NCT00580788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542560|NCT00580788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25542561|NCT00580801|Interferons|interferons|mesh-list
25542562|NCT00580801|Ribavirin|ribavirin|mesh-list
25542563|NCT00580801|Interferon-alpha|interferon-alpha|mesh-list
25542564|NCT00580801|Interferon alpha-2|interferon alpha-2|mesh-list
25542565|NCT00580801|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25542566|NCT00580801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542567|NCT00580801|Antiviral Agents|antiviral agents|mesh-ancestor
25542568|NCT00580801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25542569|NCT00580801|Antimetabolites|antimetabolites|mesh-ancestor
25542570|NCT00580801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074087|NCT03390790|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24533554|NCT00644371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24533555|NCT00644371|Immunologic Factors|immunologic factors|mesh-ancestor
24640813|NCT01170169|Omeprazole|omeprazole|mesh-list
25542571|NCT00580801|Immunologic Factors|immunologic factors|mesh-ancestor
25542572|NCT00580801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542573|NCT00580840|Certolizumab Pegol|certolizumab pegol|mesh-list
25542574|NCT00580840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25542575|NCT00580840|Immunologic Factors|immunologic factors|mesh-ancestor
25542576|NCT00580840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542577|NCT00580840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25542578|NCT00580853|Bupropion|bupropion|mesh-list
25542579|NCT00580853|Varenicline|varenicline|mesh-list
25542580|NCT00580853|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25542581|NCT00580853|Antidepressive Agents|antidepressive agents|mesh-ancestor
25542582|NCT00580853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25542583|NCT00580853|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25438628|NCT05269537|Ephedrine|ephedrine|mesh-list
25542584|NCT00580853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25542585|NCT00580853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25542586|NCT00580853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542587|NCT00580853|Dopamine Agents|dopamine agents|mesh-ancestor
25542588|NCT00580853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25542589|NCT00580853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542590|NCT00580853|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25542591|NCT00580853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25542592|NCT00580853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25542593|NCT00580853|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25542594|NCT00580853|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25542595|NCT00580853|Cholinergic Agents|cholinergic agents|mesh-ancestor
25542596|NCT00580957|Trimethaphan|trimethaphan|mesh-list
25542597|NCT00580957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25542598|NCT00580957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25542599|NCT00580957|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
25542600|NCT00580957|Autonomic Agents|autonomic agents|mesh-ancestor
25542601|NCT00580957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25542602|NCT00580957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542603|NCT00580957|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25542604|NCT00580957|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25542605|NCT00580957|Cholinergic Agents|cholinergic agents|mesh-ancestor
25542606|NCT00580957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25542607|NCT00580957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542608|NCT00580970|Lovastatin|lovastatin|mesh-list
25542609|NCT00580970|L 647318|l 647318|mesh-list
25542610|NCT00580970|Dihydromevinolin|dihydromevinolin|mesh-list
25542611|NCT00580970|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25542612|NCT00580970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25542613|NCT00580970|Antimetabolites|antimetabolites|mesh-ancestor
25542614|NCT00580970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542615|NCT00580970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25542616|NCT00580970|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25542617|NCT00580970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25542618|NCT00580983|Paclitaxel|paclitaxel|mesh-list
25542619|NCT00580983|Cisplatin|cisplatin|mesh-list
25542620|NCT00580983|Carboplatin|carboplatin|mesh-list
25542621|NCT00580983|Fluorouracil|fluorouracil|mesh-list
24455695|NCT00328718|Xhance|xhance|mesh-list
25542622|NCT00580983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25542623|NCT00580983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542624|NCT00580983|Tubulin Modulators|tubulin modulators|mesh-ancestor
25542625|NCT00580983|Antimitotic Agents|antimitotic agents|mesh-ancestor
25542626|NCT00580983|Mitosis Modulators|mitosis modulators|mesh-ancestor
25542627|NCT00580983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542628|NCT00580983|Antimetabolites|antimetabolites|mesh-ancestor
25542629|NCT00580983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25542630|NCT00580983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25542631|NCT00580983|Immunologic Factors|immunologic factors|mesh-ancestor
25542632|NCT00580983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542633|NCT00581048|Vitamin E|vitamin e|mesh-list
25542634|NCT00581048|Tocopherols|tocopherols|mesh-list
25542635|NCT00581048|alpha-Tocopherol|alpha-tocopherol|mesh-list
25542636|NCT00581048|Vitamins|vitamins|mesh-ancestor
25542637|NCT00581048|Micronutrients|micronutrients|mesh-ancestor
25542638|NCT00581048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542639|NCT00581048|Antioxidants|antioxidants|mesh-ancestor
25542640|NCT00581048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542641|NCT00581048|Protective Agents|protective agents|mesh-ancestor
25542642|NCT00581061|Solifenacin Succinate|solifenacin succinate|mesh-list
25542643|NCT00581061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25542644|NCT00581061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25542645|NCT00581061|Cholinergic Agents|cholinergic agents|mesh-ancestor
25542646|NCT00581061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25542647|NCT00581061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542648|NCT00581061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542649|NCT00581061|Urological Agents|urological agents|mesh-ancestor
25542650|NCT00581100|Etanercept|etanercept|mesh-list
25542651|NCT00581100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25542652|NCT00581100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25542653|NCT00581100|Analgesics|analgesics|mesh-ancestor
25542654|NCT00581100|Sensory System Agents|sensory system agents|mesh-ancestor
25542655|NCT00581100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25542656|NCT00581100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542657|NCT00581100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25542658|NCT00581100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25822526|NCT00004492|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25822527|NCT00004492|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25822528|NCT00004495|Folic Acid|folic acid|mesh-list
25438760|NCT04943783|Atorvastatin|atorvastatin|mesh-list
25438761|NCT04943783|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25438762|NCT04943783|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25438763|NCT04943783|Antimetabolites|antimetabolites|mesh-ancestor
25438764|NCT04943783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438765|NCT04943783|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25438766|NCT04943783|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25438767|NCT04943783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951018|NCT03909646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24951019|NCT03909646|Immunologic Factors|immunologic factors|mesh-ancestor
24827144|NCT02137616|Dopamine Agents|dopamine agents|mesh-ancestor
24805105|NCT02007603|Sultamicillin|sultamicillin|mesh-list
25148497|NCT05011214|Ketamine|ketamine|mesh-list
24827147|NCT02137616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25822529|NCT00004495|Pyridoxine|pyridoxine|mesh-list
25822530|NCT00004495|Vitamin B 12|vitamin b 12|mesh-list
25822531|NCT00004495|Hydroxocobalamin|hydroxocobalamin|mesh-list
24578491|NCT00849264|Endostar protein|endostar protein|mesh-list
25169086|NCT01989325|Antiemetics|antiemetics|mesh-ancestor
25169087|NCT01989325|Autonomic Agents|autonomic agents|mesh-ancestor
25169088|NCT01989325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25169089|NCT01989325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169090|NCT01989325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25169091|NCT01989325|Glucocorticoids|glucocorticoids|mesh-ancestor
25169092|NCT01989325|Hormones|hormones|mesh-ancestor
25169093|NCT01989325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25169094|NCT01989325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25169095|NCT01989325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169096|NCT01989325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25169097|NCT01989325|Immunologic Factors|immunologic factors|mesh-ancestor
25169098|NCT01989325|Protease Inhibitors|protease inhibitors|mesh-ancestor
25169099|NCT01989325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169100|NCT01989325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169101|NCT01989325|Antimitotic Agents|antimitotic agents|mesh-ancestor
25169102|NCT01989325|Mitosis Modulators|mitosis modulators|mesh-ancestor
25203622|NCT02713191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25203623|NCT02713191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25203624|NCT02713191|GABA Modulators|gaba modulators|mesh-ancestor
25203626|NCT02713009|Vitamin D|vitamin d|mesh-list
25203627|NCT02713009|Ergocalciferols|ergocalciferols|mesh-list
25203628|NCT02713009|Cholecalciferol|cholecalciferol|mesh-list
25203629|NCT02713009|Vitamins|vitamins|mesh-list
25203630|NCT02713009|Micronutrients|micronutrients|mesh-ancestor
25203631|NCT02713009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169103|NCT01983306|Dolcanatide|dolcanatide|mesh-list
25169104|NCT01983306|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25272588|NCT02391077|Povidone|povidone|mesh-list
25169105|NCT01983306|Enzyme Activators|enzyme activators|mesh-ancestor
25169106|NCT01983306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169107|NCT01983306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25169108|NCT01982175|Alemtuzumab|alemtuzumab|mesh-list
25169109|NCT01982175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25041647|NCT01606566|Bleomycin|bleomycin|mesh-list
25169110|NCT01982175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169111|NCT01978366|Halofuginone|halofuginone|mesh-list
25169112|NCT01978366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169113|NCT01978366|Coccidiostats|coccidiostats|mesh-ancestor
25169114|NCT01978366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25542659|NCT00581100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25542660|NCT00581100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25542661|NCT00581100|Immunologic Factors|immunologic factors|mesh-ancestor
25542662|NCT00581360|Doxorubicin|doxorubicin|mesh-list
25542663|NCT00581360|Bortezomib|bortezomib|mesh-list
25542664|NCT00581360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25542665|NCT00581360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542666|NCT00581360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25542667|NCT00581360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25542668|NCT00581360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25542669|NCT00581360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542670|NCT00581542|Moxifloxacin|moxifloxacin|mesh-list
25542671|NCT00581542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25542672|NCT00581542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25542673|NCT00581542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25542674|NCT00581542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25542675|NCT00581542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25542676|NCT00581542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542677|NCT00581542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542678|NCT00581555|Etanercept|etanercept|mesh-list
25542679|NCT00581555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25542680|NCT00581555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25542681|NCT00581555|Analgesics|analgesics|mesh-ancestor
25542682|NCT00581555|Sensory System Agents|sensory system agents|mesh-ancestor
25542683|NCT00581555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25542684|NCT00581555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542685|NCT00581555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25542686|NCT00581555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25542687|NCT00581555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25542688|NCT00581555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25542689|NCT00581555|Immunologic Factors|immunologic factors|mesh-ancestor
25542690|NCT00581776|Dexamethasone|dexamethasone|mesh-list
24582947|NCT00872651|Adrenergic Agents|adrenergic agents|mesh-ancestor
25542691|NCT00581776|Cyclophosphamide|cyclophosphamide|mesh-list
25542692|NCT00581776|Rituximab|rituximab|mesh-list
25542693|NCT00581776|Doxorubicin|doxorubicin|mesh-list
25542694|NCT00581776|Vincristine|vincristine|mesh-list
25542695|NCT00581776|Bortezomib|bortezomib|mesh-list
25542696|NCT00581776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25542697|NCT00581776|Immunologic Factors|immunologic factors|mesh-ancestor
25542698|NCT00581776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542699|NCT00581776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25542700|NCT00581776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25542701|NCT00581776|Alkylating Agents|alkylating agents|mesh-ancestor
25542702|NCT00581776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542703|NCT00581776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542704|NCT00581776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25542705|NCT00581776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25542706|NCT00581776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25542707|NCT00581776|Antiemetics|antiemetics|mesh-ancestor
25542708|NCT00581776|Autonomic Agents|autonomic agents|mesh-ancestor
25542709|NCT00581776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25542710|NCT00581776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25542711|NCT00581776|Glucocorticoids|glucocorticoids|mesh-ancestor
25542712|NCT00581776|Hormones|hormones|mesh-ancestor
25542713|NCT00581776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25542714|NCT00581776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25542715|NCT00581776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25542716|NCT00581776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25542717|NCT00581776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25542718|NCT00581776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25542719|NCT00581776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25542720|NCT00581776|Tubulin Modulators|tubulin modulators|mesh-ancestor
25542721|NCT00581776|Antimitotic Agents|antimitotic agents|mesh-ancestor
25542722|NCT00581776|Mitosis Modulators|mitosis modulators|mesh-ancestor
25542723|NCT00581828|Vitamin D|vitamin d|mesh-list
25542724|NCT00581828|Ergocalciferols|ergocalciferols|mesh-list
25542725|NCT00581828|Cholecalciferol|cholecalciferol|mesh-list
25542726|NCT00581828|Vitamins|vitamins|mesh-list
25542727|NCT00581828|Micronutrients|micronutrients|mesh-ancestor
25542728|NCT00581828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542729|NCT00581828|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25542730|NCT00581828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25542731|NCT00581867|Insulin|insulin|mesh-list
25542732|NCT00581867|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25542733|NCT00581867|Insulin Aspart|insulin aspart|mesh-list
25542734|NCT00581867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25542735|NCT00581867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542736|NCT00581893|Phenytoin|phenytoin|mesh-list
25542737|NCT00581893|Anticonvulsants|anticonvulsants|mesh-ancestor
25542738|NCT00581893|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25542739|NCT00581893|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25542740|NCT00581893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25542741|NCT00581893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542742|NCT00581893|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25542743|NCT00581893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25542744|NCT00581919|Acetylcarnitine|acetylcarnitine|mesh-list
25542745|NCT00581919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542746|NCT00581919|Vitamin B Complex|vitamin b complex|mesh-ancestor
25542747|NCT00581919|Vitamins|vitamins|mesh-ancestor
25542748|NCT00581919|Micronutrients|micronutrients|mesh-ancestor
25542749|NCT00581919|Nootropic Agents|nootropic agents|mesh-ancestor
25208847|NCT00193479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25542750|NCT00581971|Celecoxib|celecoxib|mesh-list
25542751|NCT00581971|Paclitaxel|paclitaxel|mesh-list
25542752|NCT00581971|Carboplatin|carboplatin|mesh-list
25542753|NCT00581971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25542754|NCT00581971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542755|NCT00581971|Tubulin Modulators|tubulin modulators|mesh-ancestor
25542756|NCT00581971|Antimitotic Agents|antimitotic agents|mesh-ancestor
25542757|NCT00581971|Mitosis Modulators|mitosis modulators|mesh-ancestor
25542758|NCT00581971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542759|NCT00581971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25542760|NCT00581971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25542761|NCT00581971|Analgesics|analgesics|mesh-ancestor
25542762|NCT00581971|Sensory System Agents|sensory system agents|mesh-ancestor
25542763|NCT00581971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25542764|NCT00581971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542765|NCT00581971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25542766|NCT00581971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25542767|NCT00581971|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25542768|NCT00581971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25542769|NCT00581971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25542770|NCT00582010|Nitric Oxide|nitric oxide|mesh-list
25542771|NCT00582010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25542772|NCT00582010|Autonomic Agents|autonomic agents|mesh-ancestor
25542773|NCT00582010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25542774|NCT00582010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542775|NCT00582010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25542776|NCT00582010|Respiratory System Agents|respiratory system agents|mesh-ancestor
25542777|NCT00582010|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25542778|NCT00582010|Antioxidants|antioxidants|mesh-ancestor
25542779|NCT00582010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542780|NCT00582010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25542781|NCT00582010|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25542782|NCT00582010|Vasodilator Agents|vasodilator agents|mesh-ancestor
25542783|NCT00582010|Gasotransmitters|gasotransmitters|mesh-ancestor
25542784|NCT00582010|Protective Agents|protective agents|mesh-ancestor
25542785|NCT00582075|Temozolomide|temozolomide|mesh-list
25542786|NCT00582075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25542787|NCT00582075|Alkylating Agents|alkylating agents|mesh-ancestor
25542788|NCT00582075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542789|NCT00582075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542790|NCT00582114|Atenolol|atenolol|mesh-list
25542791|NCT00582114|Lisinopril|lisinopril|mesh-list
25542792|NCT00582114|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25542793|NCT00582114|Protease Inhibitors|protease inhibitors|mesh-ancestor
25542794|NCT00582114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25542795|NCT00582114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542796|NCT00582114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25542797|NCT00582114|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25542798|NCT00582114|Protective Agents|protective agents|mesh-ancestor
25542799|NCT00582114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542800|NCT00582114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25542801|NCT00582114|Sympatholytics|sympatholytics|mesh-ancestor
25542802|NCT00582114|Autonomic Agents|autonomic agents|mesh-ancestor
25542803|NCT00582114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25542804|NCT00582114|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25542805|NCT00582114|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25542806|NCT00582114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25542807|NCT00582114|Adrenergic Agents|adrenergic agents|mesh-ancestor
25542808|NCT00582114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25542809|NCT00582166|Rituximab|rituximab|mesh-list
25542810|NCT00582166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25542811|NCT00582166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25542812|NCT00582166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542813|NCT00582166|Immunologic Factors|immunologic factors|mesh-ancestor
25542814|NCT00582166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542815|NCT00582166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25542816|NCT00582205|Paclitaxel|paclitaxel|mesh-list
25542817|NCT00582205|Cisplatin|cisplatin|mesh-list
25542818|NCT00582205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25542819|NCT00582205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542820|NCT00582205|Tubulin Modulators|tubulin modulators|mesh-ancestor
25542821|NCT00582205|Antimitotic Agents|antimitotic agents|mesh-ancestor
25542822|NCT00582205|Mitosis Modulators|mitosis modulators|mesh-ancestor
25542823|NCT00582205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542824|NCT00582309|Insulin|insulin|mesh-list
25542825|NCT00582309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25542826|NCT00582309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25438911|NCT04313972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438912|NCT04313972|Sensory System Agents|sensory system agents|mesh-ancestor
25438913|NCT04313972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25438914|NCT04302454|Leuprolide|leuprolide|mesh-list
25438915|NCT04302454|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25438916|NCT04302454|Fertility Agents|fertility agents|mesh-ancestor
25438917|NCT04302454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25438918|NCT04302454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438919|NCT04302454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25438920|NCT04302454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052916|NCT00127634|Insulin|insulin|mesh-list
24946390|NCT03939663|Misoprostol|misoprostol|mesh-list
24864560|NCT03368729|Trastuzumab|trastuzumab|mesh-list
25169115|NCT01978366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25169116|NCT01978366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25169117|NCT01978366|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25169118|NCT01978366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169119|NCT01978366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169120|NCT01978366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25169121|NCT01978366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25169122|NCT01978366|Growth Substances|growth substances|mesh-ancestor
25169123|NCT01978366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169143|NCT01972854|Micronutrients|micronutrients|mesh-ancestor
25169144|NCT01972854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169145|NCT01972854|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25169146|NCT01972854|Dermatologic Agents|dermatologic agents|mesh-ancestor
25169165|NCT01969838|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
25169166|NCT01969838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25169167|NCT01969838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169168|NCT01969838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169172|NCT01968733|Moxifloxacin|moxifloxacin|mesh-list
25169173|NCT01968733|Solithromycin|solithromycin|mesh-list
25042292|NCT01474135|Travoprost|travoprost|mesh-list
25169174|NCT01968733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25169175|NCT01968733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25169176|NCT01968733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25169177|NCT01968733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25169178|NCT01968733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25042389|NCT01455090|Ribavirin|ribavirin|mesh-list
25042431|NCT01445795|Ribavirin|ribavirin|mesh-list
25042527|NCT01423058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25061594|NCT03470077|Narcotics|narcotics|mesh-ancestor
25042769|NCT01372475|Protective Agents|protective agents|mesh-ancestor
25169179|NCT01968733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169180|NCT01968733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169181|NCT01967810|Bevacizumab|bevacizumab|mesh-list
25169182|NCT01967810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25169183|NCT01967810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169184|NCT01967810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25169185|NCT01967810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25169186|NCT01967810|Growth Substances|growth substances|mesh-ancestor
25169187|NCT01967810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169188|NCT01967810|Growth Inhibitors|growth inhibitors|mesh-ancestor
25169189|NCT01964989|Vaccines|vaccines|mesh-list
25169190|NCT01964989|Immunologic Factors|immunologic factors|mesh-ancestor
25169191|NCT01964989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169192|NCT01963208|Ganaxolone|ganaxolone|mesh-list
25169193|NCT01963208|Neurosteroids|neurosteroids|mesh-ancestor
25169194|NCT01963208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25169195|NCT01963208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169196|NCT01963208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169198|NCT01963208|GABA Agents|gaba agents|mesh-ancestor
25169199|NCT01960010|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25542827|NCT00582309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542828|NCT00582400|Arsenic Trioxide|arsenic trioxide|mesh-list
25542829|NCT00582400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542830|NCT00582426|Octreotide|octreotide|mesh-list
25542831|NCT00582426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25542832|NCT00582426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25542833|NCT00582426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542834|NCT00582491|Modafinil|modafinil|mesh-list
25542835|NCT00582491|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25542836|NCT00582491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542837|NCT00582491|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25542838|NCT00582491|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24583383|NCT00874393|Dopamine|dopamine|mesh-list
25542839|NCT00582491|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25542840|NCT00582491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542841|NCT00582556|Zoledronic Acid|zoledronic acid|mesh-list
25542843|NCT00582556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25542844|NCT00582556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542845|NCT00582556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25542846|NCT00582556|Fertility Agents|fertility agents|mesh-ancestor
25542847|NCT00582556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25542848|NCT00582556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25542849|NCT00582556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542850|NCT00582608|N-(2-aminoethyl)-5-isoquinolinesulfonamide|n-(2-aminoethyl)-5-isoquinolinesulfonamide|mesh-list
25542851|NCT00582608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25542852|NCT00582608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25542853|NCT00582608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542854|NCT00582660|Celecoxib|celecoxib|mesh-list
25542855|NCT00582660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25542856|NCT00582660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25542857|NCT00582660|Analgesics|analgesics|mesh-ancestor
25542858|NCT00582660|Sensory System Agents|sensory system agents|mesh-ancestor
25542859|NCT00582660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25542860|NCT00582660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542861|NCT00582660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25542862|NCT00582660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25542863|NCT00582660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25542864|NCT00582660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25542865|NCT00582660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25542866|NCT00582660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542867|NCT00582738|Everolimus|everolimus|mesh-list
25542868|NCT00582738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542869|NCT00582738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25542870|NCT00582738|Immunologic Factors|immunologic factors|mesh-ancestor
25542871|NCT00582738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542872|NCT00582790|Zoledronic Acid|zoledronic acid|mesh-list
25542873|NCT00582790|Interleukin-2|interleukin-2|mesh-list
25542874|NCT00582790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926129|NCT04144933|Anticonvulsants|anticonvulsants|mesh-ancestor
24450117|NCT00317798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24450118|NCT00317798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24450119|NCT00317798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450120|NCT00317798|Antifungal Agents|antifungal agents|mesh-ancestor
25542875|NCT00582790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25542876|NCT00582790|Analgesics|analgesics|mesh-ancestor
25542877|NCT00582790|Sensory System Agents|sensory system agents|mesh-ancestor
25542878|NCT00582790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25542879|NCT00582790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542880|NCT00582790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25542881|NCT00582894|Fludarabine|fludarabine|mesh-list
25542882|NCT00582894|Alemtuzumab|alemtuzumab|mesh-list
25542883|NCT00582894|Busulfan|busulfan|mesh-list
25542884|NCT00582894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542885|NCT00582894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542886|NCT00582894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25542887|NCT00582894|Immunologic Factors|immunologic factors|mesh-ancestor
25542888|NCT00582894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542889|NCT00582894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25542890|NCT00582894|Alkylating Agents|alkylating agents|mesh-ancestor
25542891|NCT00582894|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25542892|NCT00582894|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25542893|NCT00582907|Rilonacept|rilonacept|mesh-list
25542894|NCT00582907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25542895|NCT00582933|Vidarabine|vidarabine|mesh-list
25542896|NCT00582933|Fludarabine|fludarabine|mesh-list
25542897|NCT00582933|Fludarabine phosphate|fludarabine phosphate|mesh-list
25542898|NCT00582933|Melphalan|melphalan|mesh-list
25542899|NCT00582933|Busulfan|busulfan|mesh-list
25542900|NCT00582933|Lenograstim|lenograstim|mesh-list
25542901|NCT00582933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542902|NCT00582933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25542903|NCT00582933|Antimetabolites|antimetabolites|mesh-ancestor
25542904|NCT00582933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542905|NCT00582933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25542906|NCT00582933|Immunologic Factors|immunologic factors|mesh-ancestor
25542907|NCT00582933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542908|NCT00582933|Antiviral Agents|antiviral agents|mesh-ancestor
25542909|NCT00582933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25542910|NCT00582933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25542911|NCT00582933|Alkylating Agents|alkylating agents|mesh-ancestor
25542912|NCT00582933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25542913|NCT00582933|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25542914|NCT00582972|Omeprazole|omeprazole|mesh-list
25542915|NCT00582972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25542916|NCT00582972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25542917|NCT00582972|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25542918|NCT00582972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25542919|NCT00582972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542920|NCT00583011|Anesthetics|anesthetics|mesh-list
25542921|NCT00583011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25542922|NCT00583011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542923|NCT00583102|Cytarabine|cytarabine|mesh-list
25542924|NCT00583102|Lovastatin|lovastatin|mesh-list
25542925|NCT00583102|L 647318|l 647318|mesh-list
25542926|NCT00583102|Dihydromevinolin|dihydromevinolin|mesh-list
25542927|NCT00583102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25542928|NCT00583102|Antimetabolites|antimetabolites|mesh-ancestor
25542929|NCT00583102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542930|NCT00583102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542931|NCT00583102|Antiviral Agents|antiviral agents|mesh-ancestor
25542932|NCT00583102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25542933|NCT00583102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25542934|NCT00583102|Immunologic Factors|immunologic factors|mesh-ancestor
25542935|NCT00583102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542936|NCT00583102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25542937|NCT00583102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25542938|NCT00583102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25542939|NCT00583102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25542940|NCT00583102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25542941|NCT00583219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25542942|NCT00583219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25542943|NCT00583219|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
25542944|NCT00583219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25542945|NCT00583219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25542946|NCT00583219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542947|NCT00583219|Cholinergic Agents|cholinergic agents|mesh-ancestor
25542948|NCT00583219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25542949|NCT00583219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542950|NCT00583219|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25542951|NCT00583219|Protective Agents|protective agents|mesh-ancestor
25542952|NCT00583219|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25542953|NCT00583219|Antioxidants|antioxidants|mesh-ancestor
25542954|NCT00583219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25542955|NCT00583219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25542956|NCT00583362|Belimumab|belimumab|mesh-list
25542957|NCT00583362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25542958|NCT00583362|Immunologic Factors|immunologic factors|mesh-ancestor
25542959|NCT00583362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542960|NCT00583453|Celecoxib|celecoxib|mesh-list
25542961|NCT00583453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25542962|NCT00583453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25542963|NCT00583453|Analgesics|analgesics|mesh-ancestor
25542964|NCT00583453|Sensory System Agents|sensory system agents|mesh-ancestor
25542965|NCT00583453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25542966|NCT00583453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542967|NCT00583453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25542968|NCT00583453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25542969|NCT00583453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25542970|NCT00583453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25542971|NCT00583453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25542972|NCT00583453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542973|NCT00583557|Belimumab|belimumab|mesh-list
25542974|NCT00583557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25542975|NCT00583557|Immunologic Factors|immunologic factors|mesh-ancestor
25542976|NCT00583557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25542977|NCT00583622|Gemcitabine|gemcitabine|mesh-list
25542978|NCT00583622|Bevacizumab|bevacizumab|mesh-list
25542979|NCT00583622|Carboplatin|carboplatin|mesh-list
25542980|NCT00583622|Docetaxel|docetaxel|mesh-list
25542981|NCT00583622|Melphalan|melphalan|mesh-list
25542982|NCT00583622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25542983|NCT00583622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25542984|NCT00583622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25542985|NCT00583622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25542986|NCT00583622|Growth Substances|growth substances|mesh-ancestor
25542987|NCT00583622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438995|NCT04069117|Letrozole|letrozole|mesh-list
25542988|NCT00583622|Growth Inhibitors|growth inhibitors|mesh-ancestor
25542989|NCT00583622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25542990|NCT00583622|Antimetabolites|antimetabolites|mesh-ancestor
25542991|NCT00583622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25542992|NCT00583622|Antiviral Agents|antiviral agents|mesh-ancestor
25542993|NCT00583622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25542994|NCT00583622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25542995|NCT00583622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25542996|NCT00583622|Immunologic Factors|immunologic factors|mesh-ancestor
25542997|NCT00583622|Tubulin Modulators|tubulin modulators|mesh-ancestor
25542998|NCT00583622|Antimitotic Agents|antimitotic agents|mesh-ancestor
25542999|NCT00583622|Mitosis Modulators|mitosis modulators|mesh-ancestor
25543000|NCT00583622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25543001|NCT00583622|Alkylating Agents|alkylating agents|mesh-ancestor
25543002|NCT00583622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25543003|NCT00583700|Vitamin E|vitamin e|mesh-list
25543004|NCT00583700|Pentoxifylline|pentoxifylline|mesh-list
25543005|NCT00583700|Vitamins|vitamins|mesh-ancestor
25543006|NCT00583700|Micronutrients|micronutrients|mesh-ancestor
25543007|NCT00583700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543008|NCT00583700|Antioxidants|antioxidants|mesh-ancestor
25543009|NCT00583700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543010|NCT00583700|Protective Agents|protective agents|mesh-ancestor
25543011|NCT00583700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25543012|NCT00583700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543013|NCT00583700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25543014|NCT00583700|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25543015|NCT00583700|Vasodilator Agents|vasodilator agents|mesh-ancestor
25543016|NCT00583700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25543017|NCT00583947|Albuterol|albuterol|mesh-list
25543018|NCT00583947|Formoterol Fumarate|formoterol fumarate|mesh-list
25543019|NCT00583947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25543020|NCT00583947|Autonomic Agents|autonomic agents|mesh-ancestor
25543021|NCT00583947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25543022|NCT00583947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543023|NCT00583947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25439064|NCT03912818|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25439065|NCT03912818|Methotrexate|methotrexate|mesh-list
25439066|NCT03912818|Durvalumab|durvalumab|mesh-list
25439067|NCT03912818|Daunorubicin|daunorubicin|mesh-list
25439068|NCT03912818|Vinblastine|vinblastine|mesh-list
25439069|NCT03912818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439070|NCT03912818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25439071|NCT03912818|Antimetabolites|antimetabolites|mesh-ancestor
25439072|NCT03912818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439073|NCT03912818|Antiviral Agents|antiviral agents|mesh-ancestor
25439074|NCT03912818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25439075|NCT03912818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25439076|NCT03912818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25439077|NCT03912818|Immunologic Factors|immunologic factors|mesh-ancestor
25439078|NCT03912818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439079|NCT03912818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25439080|NCT03912818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25439081|NCT03912818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25439082|NCT03912818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25543024|NCT00583947|Respiratory System Agents|respiratory system agents|mesh-ancestor
25543025|NCT00583947|Tocolytic Agents|tocolytic agents|mesh-ancestor
25543026|NCT00583947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25543027|NCT00583947|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25543028|NCT00583947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25543029|NCT00583947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25543030|NCT00583947|Adrenergic Agents|adrenergic agents|mesh-ancestor
25543031|NCT00583947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25543032|NCT00583947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650728|NCT01507103|Cyclophosphamide|cyclophosphamide|mesh-list
25650729|NCT01507103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25650730|NCT01507103|Immunologic Factors|immunologic factors|mesh-ancestor
25650731|NCT01507103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650732|NCT01507103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25650733|NCT01507103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25650734|NCT01507103|Alkylating Agents|alkylating agents|mesh-ancestor
25650735|NCT01507103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650736|NCT01507103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25650737|NCT01507103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25650738|NCT01507181|Midazolam|midazolam|mesh-list
25543033|NCT00584701|Risperidone|risperidone|mesh-list
25543034|NCT00584701|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25543035|NCT00584701|Serotonin Agents|serotonin agents|mesh-ancestor
25543036|NCT00584701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25543037|NCT00584701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543038|NCT00584701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543039|NCT00584701|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25543040|NCT00584701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25543041|NCT00584701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25543042|NCT00584701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25543043|NCT00584701|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25543044|NCT00584701|Dopamine Agents|dopamine agents|mesh-ancestor
25543045|NCT00584857|Paclitaxel|paclitaxel|mesh-list
25543046|NCT00584857|Carboplatin|carboplatin|mesh-list
25543047|NCT00584857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25543048|NCT00584857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543049|NCT00584857|Tubulin Modulators|tubulin modulators|mesh-ancestor
25543050|NCT00584857|Antimitotic Agents|antimitotic agents|mesh-ancestor
25543051|NCT00584857|Mitosis Modulators|mitosis modulators|mesh-ancestor
25543052|NCT00584857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543053|NCT00584870|Naproxen|naproxen|mesh-list
25543054|NCT00584870|Tanezumab|tanezumab|mesh-list
25543055|NCT00584870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25543056|NCT00584870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25543057|NCT00584870|Analgesics|analgesics|mesh-ancestor
25543058|NCT00584870|Sensory System Agents|sensory system agents|mesh-ancestor
25543059|NCT00584870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25543060|NCT00584870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543061|NCT00584870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25543062|NCT00584870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25543063|NCT00584870|Gout Suppressants|gout suppressants|mesh-ancestor
25543064|NCT00584870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25543065|NCT00584870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543066|NCT00584870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543067|NCT00584909|Paclitaxel|paclitaxel|mesh-list
25543068|NCT00584909|Carboplatin|carboplatin|mesh-list
25543069|NCT00584909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25543070|NCT00584909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543071|NCT00584909|Tubulin Modulators|tubulin modulators|mesh-ancestor
25543072|NCT00584909|Antimitotic Agents|antimitotic agents|mesh-ancestor
25543073|NCT00584909|Mitosis Modulators|mitosis modulators|mesh-ancestor
25543074|NCT00584909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543075|NCT00584948|Memantine|memantine|mesh-list
25543076|NCT00584948|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25543077|NCT00584948|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25543078|NCT00584948|Dopamine Agents|dopamine agents|mesh-ancestor
25543079|NCT00584948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25543080|NCT00584948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543081|NCT00584948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543082|NCT00584948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25543083|NCT00584948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25543084|NCT00584987|Fluticasone|fluticasone|mesh-list
25543085|NCT00584987|Xhance|xhance|mesh-list
25543086|NCT00584987|Phenylephrine|phenylephrine|mesh-list
25543087|NCT00584987|Oxymetazoline|oxymetazoline|mesh-list
25543088|NCT00584987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25543089|NCT00584987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25543090|NCT00584987|Autonomic Agents|autonomic agents|mesh-ancestor
25543091|NCT00584987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25543092|NCT00584987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543093|NCT00584987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25543094|NCT00584987|Respiratory System Agents|respiratory system agents|mesh-ancestor
25543095|NCT00584987|Dermatologic Agents|dermatologic agents|mesh-ancestor
25543096|NCT00584987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25543097|NCT00584987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25543098|NCT00584987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25543099|NCT00584987|Adrenergic Agents|adrenergic agents|mesh-ancestor
25543100|NCT00584987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25254167|NCT02496455|Tramadol|tramadol|mesh-list
25543101|NCT00584987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543102|NCT00584987|Sympathomimetics|sympathomimetics|mesh-ancestor
25543103|NCT00584987|Nasal Decongestants|nasal decongestants|mesh-ancestor
25543104|NCT00584987|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25543105|NCT00584987|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25543106|NCT00584987|Mydriatics|mydriatics|mesh-ancestor
25543107|NCT00584987|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25543108|NCT00584987|Protective Agents|protective agents|mesh-ancestor
25543109|NCT00585013|Nitric Oxide|nitric oxide|mesh-list
25543110|NCT00585013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25543111|NCT00585013|Autonomic Agents|autonomic agents|mesh-ancestor
25543112|NCT00585013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25543113|NCT00585013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543114|NCT00585013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25543115|NCT00585013|Respiratory System Agents|respiratory system agents|mesh-ancestor
25543116|NCT00585013|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25543117|NCT00585013|Antioxidants|antioxidants|mesh-ancestor
25543118|NCT00585013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543119|NCT00585013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25543120|NCT00585013|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25543121|NCT00585013|Vasodilator Agents|vasodilator agents|mesh-ancestor
25543122|NCT00585013|Gasotransmitters|gasotransmitters|mesh-ancestor
25543123|NCT00585013|Protective Agents|protective agents|mesh-ancestor
25543124|NCT00585039|Albuterol|albuterol|mesh-list
25543125|NCT00585039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25543126|NCT00585039|Autonomic Agents|autonomic agents|mesh-ancestor
25543127|NCT00585039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25543128|NCT00585039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543129|NCT00585039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25543130|NCT00585039|Respiratory System Agents|respiratory system agents|mesh-ancestor
25543131|NCT00585039|Tocolytic Agents|tocolytic agents|mesh-ancestor
25543132|NCT00585039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25543133|NCT00585039|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25543134|NCT00585039|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25543135|NCT00585039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25543136|NCT00585039|Adrenergic Agents|adrenergic agents|mesh-ancestor
25543137|NCT00585039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25543138|NCT00585039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543139|NCT00585052|Paclitaxel|paclitaxel|mesh-list
25543140|NCT00585052|Lovastatin|lovastatin|mesh-list
25543141|NCT00585052|L 647318|l 647318|mesh-list
25254205|NCT02496182|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25254206|NCT02496182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25254207|NCT02496182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25254208|NCT02496182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25254210|NCT02496078|Asunaprevir|asunaprevir|mesh-list
25543142|NCT00585052|Dihydromevinolin|dihydromevinolin|mesh-list
25543143|NCT00585052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25543144|NCT00585052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543145|NCT00585052|Tubulin Modulators|tubulin modulators|mesh-ancestor
25543146|NCT00585052|Antimitotic Agents|antimitotic agents|mesh-ancestor
25543147|NCT00585052|Mitosis Modulators|mitosis modulators|mesh-ancestor
25543148|NCT00585052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543149|NCT00585052|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25543150|NCT00585052|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25543151|NCT00585052|Antimetabolites|antimetabolites|mesh-ancestor
25543152|NCT00585052|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25543153|NCT00585052|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25543154|NCT00585052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543155|NCT00585078|Capecitabine|capecitabine|mesh-list
25543156|NCT00585078|Oxaliplatin|oxaliplatin|mesh-list
25543157|NCT00585078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25543158|NCT00585078|Antimetabolites|antimetabolites|mesh-ancestor
25543159|NCT00585078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543160|NCT00585078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543161|NCT00585104|Simendan|simendan|mesh-list
25543162|NCT00585104|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25543163|NCT00585104|Vasodilator Agents|vasodilator agents|mesh-ancestor
25543164|NCT00585104|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25543165|NCT00585104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25543166|NCT00585104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543167|NCT00585104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543168|NCT00585104|Protective Agents|protective agents|mesh-ancestor
25543169|NCT00585104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543170|NCT00585169|Memantine|memantine|mesh-list
25543171|NCT00585169|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25543172|NCT00585169|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25543173|NCT00585169|Dopamine Agents|dopamine agents|mesh-ancestor
25543174|NCT00585169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25543175|NCT00585169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543176|NCT00585169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543177|NCT00585169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25543178|NCT00585169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25543179|NCT00585182|Enoxaparin|enoxaparin|mesh-list
25439180|NCT03633305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439181|NCT03616717|Modafinil|modafinil|mesh-list
25543180|NCT00585182|Anticoagulants|anticoagulants|mesh-ancestor
25543181|NCT00585182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25543182|NCT00585182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25543183|NCT00585182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543184|NCT00585247|Imiquimod|imiquimod|mesh-list
25543185|NCT00585247|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25543186|NCT00585247|Immunologic Factors|immunologic factors|mesh-ancestor
25543187|NCT00585247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543188|NCT00585247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543189|NCT00585247|Interferon Inducers|interferon inducers|mesh-ancestor
25543190|NCT00585312|Celecoxib|celecoxib|mesh-list
25543191|NCT00585312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25543192|NCT00585312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25543193|NCT00585312|Analgesics|analgesics|mesh-ancestor
25543194|NCT00585312|Sensory System Agents|sensory system agents|mesh-ancestor
25543195|NCT00585312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25543196|NCT00585312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543197|NCT00585312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25543198|NCT00585312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25543199|NCT00585312|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25543200|NCT00585312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25543201|NCT00585312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543202|NCT00585312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543203|NCT00585325|Lidocaine|lidocaine|mesh-list
25543204|NCT00585325|Anesthetics, Local|anesthetics, local|mesh-ancestor
25543205|NCT00585325|Anesthetics|anesthetics|mesh-ancestor
25543206|NCT00585325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25543207|NCT00585325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543208|NCT00585325|Sensory System Agents|sensory system agents|mesh-ancestor
25543209|NCT00585325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25543210|NCT00585325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25543211|NCT00585325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25543212|NCT00585325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25543213|NCT00585325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25543214|NCT00585325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543215|NCT00585351|Ranitidine|ranitidine|mesh-list
25543216|NCT00585351|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
25543217|NCT00585351|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25543218|NCT00585351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25543219|NCT00585351|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25543220|NCT00585351|Histamine Antagonists|histamine antagonists|mesh-ancestor
25543221|NCT00585351|Histamine Agents|histamine agents|mesh-ancestor
25543222|NCT00585351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25543223|NCT00585351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543224|NCT00585351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543225|NCT00585377|Bevacizumab|bevacizumab|mesh-list
25543226|NCT00585377|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25543227|NCT00585377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25543228|NCT00585377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543229|NCT00585377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25543230|NCT00585377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25543231|NCT00585377|Growth Substances|growth substances|mesh-ancestor
25543232|NCT00585377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543233|NCT00585377|Growth Inhibitors|growth inhibitors|mesh-ancestor
25543234|NCT00585377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25543235|NCT00585377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543236|NCT00585377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543237|NCT00585468|Mycophenolic Acid|mycophenolic acid|mesh-list
25543238|NCT00585468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25543239|NCT00585468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543240|NCT00585468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25543241|NCT00585468|Antitubercular Agents|antitubercular agents|mesh-ancestor
25543242|NCT00585468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25543243|NCT00585468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25543244|NCT00585468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534559|NCT00647621|Phenytoin|phenytoin|mesh-list
25543245|NCT00585468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543246|NCT00585533|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25543247|NCT00585533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543248|NCT00585533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25543249|NCT00585533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543250|NCT00585533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543251|NCT00585546|Clenbuterol|clenbuterol|mesh-list
25543252|NCT00585546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25439250|NCT03298984|Cytarabine|cytarabine|mesh-list
25543253|NCT00585546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25543254|NCT00585546|Adrenergic Agents|adrenergic agents|mesh-ancestor
25543255|NCT00585546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25543256|NCT00585546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543257|NCT00585546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543258|NCT00585546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25543259|NCT00585546|Autonomic Agents|autonomic agents|mesh-ancestor
25543260|NCT00585546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25543261|NCT00585546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25543262|NCT00585546|Respiratory System Agents|respiratory system agents|mesh-ancestor
25543263|NCT00585546|Sympathomimetics|sympathomimetics|mesh-ancestor
25543264|NCT00585637|Vitamin D|vitamin d|mesh-list
25543265|NCT00585637|Vitamins|vitamins|mesh-ancestor
25439318|NCT03175198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439319|NCT03175198|Anticoagulants|anticoagulants|mesh-ancestor
25439320|NCT03164980|Trabectedin|trabectedin|mesh-list
25439321|NCT03164980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25439322|NCT03164980|Alkylating Agents|alkylating agents|mesh-ancestor
25439323|NCT03164980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439324|NCT03164980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439325|NCT03149003|Bevacizumab|bevacizumab|mesh-list
25439326|NCT03149003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25439327|NCT03149003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439328|NCT03149003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25439329|NCT03149003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25439330|NCT03149003|Growth Substances|growth substances|mesh-ancestor
25439331|NCT03149003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439332|NCT03149003|Growth Inhibitors|growth inhibitors|mesh-ancestor
25439333|NCT03139370|Cyclophosphamide|cyclophosphamide|mesh-list
25439334|NCT03139370|Fludarabine|fludarabine|mesh-list
25439335|NCT03139370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25439336|NCT03139370|Immunologic Factors|immunologic factors|mesh-ancestor
25439337|NCT03139370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439338|NCT03139370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25439339|NCT03139370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25439340|NCT03139370|Alkylating Agents|alkylating agents|mesh-ancestor
25439341|NCT03139370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439342|NCT03139370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439343|NCT03139370|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25439344|NCT03126799|Bevacizumab|bevacizumab|mesh-list
25439345|NCT03126799|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25439346|NCT03126799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25439347|NCT03126799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543266|NCT00585637|Micronutrients|micronutrients|mesh-ancestor
25543267|NCT00585637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543268|NCT00585637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25543269|NCT00585650|Etanercept|etanercept|mesh-list
25543270|NCT00585650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25543271|NCT00585650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25543272|NCT00585650|Analgesics|analgesics|mesh-ancestor
25543273|NCT00585650|Sensory System Agents|sensory system agents|mesh-ancestor
25543274|NCT00585650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25543275|NCT00585650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543276|NCT00585650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25543277|NCT00585650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25543278|NCT00585650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25543279|NCT00585650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25543280|NCT00585650|Immunologic Factors|immunologic factors|mesh-ancestor
25543281|NCT00585689|Gemcitabine|gemcitabine|mesh-list
25543282|NCT00585689|Carboplatin|carboplatin|mesh-list
25543283|NCT00585689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25543284|NCT00585689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543285|NCT00585689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25543286|NCT00585689|Antimetabolites|antimetabolites|mesh-ancestor
25543287|NCT00585689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543288|NCT00585689|Antiviral Agents|antiviral agents|mesh-ancestor
25543289|NCT00585689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25543290|NCT00585689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543291|NCT00585689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25543292|NCT00585689|Immunologic Factors|immunologic factors|mesh-ancestor
25543293|NCT00585689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543294|NCT00585780|Prazosin|prazosin|mesh-list
25543295|NCT00585780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25650739|NCT01507181|Ketamine|ketamine|mesh-list
25543296|NCT00585780|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25543297|NCT00585780|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25543298|NCT00585780|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25543299|NCT00585780|Adrenergic Agents|adrenergic agents|mesh-ancestor
25543300|NCT00585780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25543301|NCT00585780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543302|NCT00585780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543303|NCT00585910|Methylphenidate|methylphenidate|mesh-list
25543304|NCT00585910|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25543305|NCT00585910|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25543306|NCT00585910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543307|NCT00585910|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25543308|NCT00585910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25543309|NCT00585910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25543310|NCT00585910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543311|NCT00585910|Dopamine Agents|dopamine agents|mesh-ancestor
25543312|NCT00585910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25543313|NCT00585910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25543314|NCT00585910|Adrenergic Agents|adrenergic agents|mesh-ancestor
25543315|NCT00585975|Bromfenac|bromfenac|mesh-list
25543316|NCT00585975|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25543317|NCT00585975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25543318|NCT00585975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25543319|NCT00585975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25543320|NCT00585975|Analgesics|analgesics|mesh-ancestor
25543321|NCT00585975|Sensory System Agents|sensory system agents|mesh-ancestor
25543322|NCT00585975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25543323|NCT00585975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543324|NCT00585975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25543325|NCT00585975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25543326|NCT00586066|Memantine|memantine|mesh-list
25543327|NCT00586066|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25543328|NCT00586066|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25543329|NCT00586066|Dopamine Agents|dopamine agents|mesh-ancestor
25543330|NCT00586066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25543331|NCT00586066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543332|NCT00586066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543333|NCT00586066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25543334|NCT00586066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25543335|NCT00586105|Sorafenib|sorafenib|mesh-list
25543336|NCT00586105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543337|NCT00586105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25543338|NCT00586105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543339|NCT00586105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543340|NCT00586157|Methylphenidate|methylphenidate|mesh-list
25543341|NCT00586157|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25543342|NCT00586157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543343|NCT00586157|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25543344|NCT00586157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25543345|NCT00586157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25543346|NCT00586157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543347|NCT00586157|Dopamine Agents|dopamine agents|mesh-ancestor
25543348|NCT00586157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25543349|NCT00586196|Donepezil|donepezil|mesh-list
25543350|NCT00586196|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25543351|NCT00586196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543352|NCT00586196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543353|NCT00586196|Cholinergic Agents|cholinergic agents|mesh-ancestor
25543354|NCT00586196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25543355|NCT00586196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543356|NCT00586196|Nootropic Agents|nootropic agents|mesh-ancestor
25543357|NCT00586261|Pioglitazone|pioglitazone|mesh-list
25543358|NCT00586261|Nitroglycerin|nitroglycerin|mesh-list
25543359|NCT00586261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25543360|NCT00586261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543361|NCT00586261|Vasodilator Agents|vasodilator agents|mesh-ancestor
25543362|NCT00586482|Nicotine|nicotine|mesh-list
25543363|NCT00586482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25543364|NCT00586482|Autonomic Agents|autonomic agents|mesh-ancestor
25543365|NCT00586482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25543366|NCT00586482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439358|NCT03062280|Hydrocortisone|hydrocortisone|mesh-list
25543367|NCT00586482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25543368|NCT00586482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25543369|NCT00586482|Cholinergic Agents|cholinergic agents|mesh-ancestor
25543370|NCT00586482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25543371|NCT00586482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543372|NCT00586495|Sorafenib|sorafenib|mesh-list
25543373|NCT00586495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543374|NCT00586495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25543375|NCT00586495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543376|NCT00586495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543377|NCT00586508|Bevacizumab|bevacizumab|mesh-list
25543378|NCT00586508|Anticonvulsants|anticonvulsants|mesh-list
25543379|NCT00586508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25209029|NCT02705768|Carbamazepine|carbamazepine|mesh-list
25543380|NCT00586508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543381|NCT00586508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25543382|NCT00586508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25543383|NCT00586508|Growth Substances|growth substances|mesh-ancestor
25543384|NCT00586508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543385|NCT00586508|Growth Inhibitors|growth inhibitors|mesh-ancestor
25543386|NCT00586521|Factor VIII|factor viii|mesh-list
25543387|NCT00586521|Coagulants|coagulants|mesh-ancestor
25543388|NCT00586573|Memantine|memantine|mesh-list
25543389|NCT00586573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25543390|NCT00586573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25543391|NCT00586573|Dopamine Agents|dopamine agents|mesh-ancestor
25543392|NCT00586573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25543393|NCT00586573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543394|NCT00586573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543395|NCT00586573|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25543396|NCT00586573|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25543397|NCT00586612|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25543398|NCT00586612|Immunologic Factors|immunologic factors|mesh-ancestor
25543399|NCT00586612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543400|NCT00586625|Bepotastine besilate|bepotastine besilate|mesh-list
24584870|NCT00882024|Tranilast|tranilast|mesh-list
25543401|NCT00586625|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25543402|NCT00586664|Bepotastine besilate|bepotastine besilate|mesh-list
25543403|NCT00586664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25543404|NCT00586664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25543405|NCT00586664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25543406|NCT00586690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25543407|NCT00586690|Antibodies|antibodies|mesh-list
25543408|NCT00586690|Immunoglobulins|immunoglobulins|mesh-list
25543409|NCT00586690|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25543410|NCT00586690|Immunologic Factors|immunologic factors|mesh-ancestor
25543411|NCT00586690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543412|NCT00586690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543413|NCT00586729|Mafenide|mafenide|mesh-list
25543414|NCT00586729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25543415|NCT00586729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25543416|NCT00586729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25543417|NCT00586729|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25543418|NCT00586729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543419|NCT00586729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543420|NCT00586820|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
25543421|NCT00586820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25543422|NCT00586820|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25543423|NCT00586820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543424|NCT00586846|Cisplatin|cisplatin|mesh-list
25543425|NCT00586846|Doxorubicin|doxorubicin|mesh-list
25543426|NCT00586846|Methotrexate|methotrexate|mesh-list
25254477|NCT02494895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543427|NCT00586846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543428|NCT00586846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25543429|NCT00586846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25543430|NCT00586846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24923724|NCT04167592|Benzydamine|benzydamine|mesh-list
25543431|NCT00586846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543432|NCT00586846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254734|NCT02492945|Lidocaine|lidocaine|mesh-list
25543433|NCT00586846|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25543434|NCT00586846|Abortifacient Agents|abortifacient agents|mesh-ancestor
25543435|NCT00586846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25543436|NCT00586846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543437|NCT00586846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25543438|NCT00586846|Antimetabolites|antimetabolites|mesh-ancestor
25543439|NCT00586846|Dermatologic Agents|dermatologic agents|mesh-ancestor
25439435|NCT02520011|Analgesics|analgesics|mesh-ancestor
24924806|NCT04156451|Diuretics|diuretics|mesh-ancestor
25543440|NCT00586846|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25543441|NCT00586846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25543442|NCT00586846|Immunologic Factors|immunologic factors|mesh-ancestor
25543443|NCT00586846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25543444|NCT00586846|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25543445|NCT00586898|Ketoconazole|ketoconazole|mesh-list
25543446|NCT00586898|Bicalutamide|bicalutamide|mesh-list
25543447|NCT00586898|Testosterone|testosterone|mesh-list
25543449|NCT00586898|Androgens|androgens|mesh-ancestor
25543450|NCT00586898|Hormones|hormones|mesh-ancestor
25543451|NCT00586898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25543452|NCT00586898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543453|NCT00586898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543454|NCT00586898|Antifungal Agents|antifungal agents|mesh-ancestor
25543455|NCT00586898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25543456|NCT00586898|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25543457|NCT00586898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25543458|NCT00586898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543459|NCT00586898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543460|NCT00586898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25543461|NCT00586898|Hormone Antagonists|hormone antagonists|mesh-ancestor
25543462|NCT00586898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25543463|NCT00586898|Androgen Antagonists|androgen antagonists|mesh-ancestor
25543464|NCT00587067|Floxuridine|floxuridine|mesh-list
25543465|NCT00587067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25543466|NCT00587067|Antimetabolites|antimetabolites|mesh-ancestor
25543467|NCT00587067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543468|NCT00587067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543469|NCT00587132|Secretin|secretin|mesh-list
25543470|NCT00587132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25543471|NCT00587132|Hormones|hormones|mesh-ancestor
25543472|NCT00587132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25543473|NCT00587132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543474|NCT00587288|Reslizumab|reslizumab|mesh-list
24525403|NCT03521102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25543475|NCT00587288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25543476|NCT00587288|Respiratory System Agents|respiratory system agents|mesh-ancestor
25543477|NCT00587431|Docetaxel|docetaxel|mesh-list
25543478|NCT00587431|Leuprolide|leuprolide|mesh-list
25543479|NCT00587431|Testosterone|testosterone|mesh-list
25543480|NCT00587431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543481|NCT00587431|Tubulin Modulators|tubulin modulators|mesh-ancestor
25543482|NCT00587431|Antimitotic Agents|antimitotic agents|mesh-ancestor
25543483|NCT00587431|Mitosis Modulators|mitosis modulators|mesh-ancestor
25543484|NCT00587431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927527|NCT04132557|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25543485|NCT00587431|Androgens|androgens|mesh-ancestor
25543486|NCT00587431|Hormones|hormones|mesh-ancestor
25543487|NCT00587431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25543488|NCT00587431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543489|NCT00587431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25543490|NCT00587431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25543491|NCT00587431|Fertility Agents|fertility agents|mesh-ancestor
25543492|NCT00587431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25543493|NCT00587457|Immunotoxin HA22|immunotoxin ha22|mesh-list
25543494|NCT00587457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543495|NCT00587483|Lidocaine|lidocaine|mesh-list
25543496|NCT00587483|Amiodarone|amiodarone|mesh-list
25543497|NCT00587483|Anesthetics, Local|anesthetics, local|mesh-ancestor
24927604|NCT04131582|Hormones|hormones|mesh-ancestor
25543498|NCT00587483|Anesthetics|anesthetics|mesh-ancestor
25543499|NCT00587483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24928244|NCT04124016|Grape Seed Extract|grape seed extract|mesh-list
25255600|NCT02487355|Tocolytic Agents|tocolytic agents|mesh-ancestor
25543500|NCT00587483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543501|NCT00587483|Sensory System Agents|sensory system agents|mesh-ancestor
25543502|NCT00587483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25543503|NCT00587483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25543504|NCT00587483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25543505|NCT00587483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25543506|NCT00587483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25090413|NCT03257943|Ivermectin|ivermectin|mesh-list
25011335|NCT05216419|Cholecalciferol|cholecalciferol|mesh-list
25543507|NCT00587483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543508|NCT00587483|Vasodilator Agents|vasodilator agents|mesh-ancestor
25543509|NCT00587483|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25255794|NCT02486055|Vitamins|vitamins|mesh-ancestor
25543510|NCT00587483|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25543511|NCT00587483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25543512|NCT00587483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25439496|NCT02024607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543513|NCT00587483|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25543514|NCT00587483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25543515|NCT00587483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25543516|NCT00587678|Simvastatin|simvastatin|mesh-list
25543517|NCT00587678|Ezetimibe|ezetimibe|mesh-list
25543518|NCT00587678|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25543519|NCT00587678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25543520|NCT00587678|Antimetabolites|antimetabolites|mesh-ancestor
25256022|NCT02485184|Vasodilator Agents|vasodilator agents|mesh-ancestor
25011854|NCT03424525|Trimethoprim|trimethoprim|mesh-list
25011941|NCT02947165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25011942|NCT02947165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011943|NCT02947165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011949|NCT02872025|Pembrolizumab|pembrolizumab|mesh-list
25256100|NCT02484170|Mannitol|mannitol|mesh-list
24934151|NCT04063449|Growth Substances|growth substances|mesh-ancestor
25209538|NCT02702960|Antitubercular Agents|antitubercular agents|mesh-ancestor
25543521|NCT00587678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543522|NCT00587678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25543523|NCT00587678|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25543524|NCT00587678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543525|NCT00587769|Bupropion|bupropion|mesh-list
25543526|NCT00587769|Varenicline|varenicline|mesh-list
25543527|NCT00587769|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25543528|NCT00587769|Antidepressive Agents|antidepressive agents|mesh-ancestor
25543529|NCT00587769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25543530|NCT00587769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25272632|NCT02390674|Cyclosporins|cyclosporins|mesh-list
25543531|NCT00587769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25543532|NCT00587769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25543533|NCT00587769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543534|NCT00587769|Dopamine Agents|dopamine agents|mesh-ancestor
25543535|NCT00587769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25543536|NCT00587769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543537|NCT00587769|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25543538|NCT00587769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25543539|NCT00587769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543540|NCT00587769|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25543541|NCT00587769|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25543542|NCT00587769|Cholinergic Agents|cholinergic agents|mesh-ancestor
25543543|NCT00587847|Alemtuzumab|alemtuzumab|mesh-list
25543544|NCT00587847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25543545|NCT00587847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543546|NCT05247424|Heparin|heparin|mesh-list
25543547|NCT05247424|Calcium heparin|calcium heparin|mesh-list
25256362|NCT02483078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256363|NCT02483078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25543548|NCT05247424|Anticoagulants|anticoagulants|mesh-ancestor
25543549|NCT05247424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25543550|NCT05247424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25543551|NCT05247424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543552|NCT05247385|Ticagrelor|ticagrelor|mesh-list
25543553|NCT05247385|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25543554|NCT05247385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25543555|NCT05247385|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25543556|NCT05247385|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25543557|NCT05247385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25543558|NCT05247385|Purinergic Agents|purinergic agents|mesh-ancestor
25543559|NCT05247385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25543560|NCT05247385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543561|NCT05247385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543562|NCT05247177|Dexmedetomidine|dexmedetomidine|mesh-list
25543563|NCT05247177|Ketamine|ketamine|mesh-list
25543564|NCT05247177|Anesthetics|anesthetics|mesh-list
25543565|NCT05247177|Sevoflurane|sevoflurane|mesh-list
25543566|NCT05247177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25543567|NCT05247177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209892|NCT02700711|Analgesics|analgesics|mesh-ancestor
25543568|NCT05247177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25543569|NCT05247177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25256462|NCT02482077|Sofosbuvir|sofosbuvir|mesh-list
25543570|NCT05247177|Analgesics|analgesics|mesh-ancestor
25543571|NCT05247177|Sensory System Agents|sensory system agents|mesh-ancestor
25543572|NCT05247177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25543573|NCT05247177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25543574|NCT05247177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25543575|NCT05247177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25543576|NCT05247177|Adrenergic Agents|adrenergic agents|mesh-ancestor
25543577|NCT05247177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25543578|NCT05247177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543579|NCT05247177|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25543580|NCT05247177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25543581|NCT05247177|Anesthetics, General|anesthetics, general|mesh-ancestor
25543582|NCT05247177|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25543583|NCT05247177|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25543584|NCT05247177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25439572|NCT01791816|Phenylephrine|phenylephrine|mesh-list
25543585|NCT05247177|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25543586|NCT05247151|Oxytocin|oxytocin|mesh-list
24934927|NCT04056845|Diclofenac|diclofenac|mesh-list
25543587|NCT05247151|Oxytocics|oxytocics|mesh-ancestor
25543588|NCT05247151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25543589|NCT05247151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650740|NCT01507181|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-list
24531232|NCT00634634|Sorafenib|sorafenib|mesh-list
25650741|NCT01507181|N-Methylaspartate|n-methylaspartate|mesh-list
25650742|NCT01507181|Analgesics|analgesics|mesh-ancestor
24457724|NCT00335088|Iodine|iodine|mesh-list
25650743|NCT01507181|Sensory System Agents|sensory system agents|mesh-ancestor
25650744|NCT01507181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650745|NCT01507181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650746|NCT01507181|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25650747|NCT01507181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25650748|NCT01507181|Anesthetics, General|anesthetics, general|mesh-ancestor
25650749|NCT01507181|Anesthetics|anesthetics|mesh-ancestor
25650750|NCT01507181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25256569|NCT02481453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24512969|NCT00577850|Alendronate|alendronate|mesh-list
25650751|NCT01507181|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25650752|NCT01507181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25650753|NCT01507181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650754|NCT01507181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25650755|NCT01507181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25650756|NCT01507181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25650757|NCT01507181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25650758|NCT01507181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25650759|NCT01507181|GABA Modulators|gaba modulators|mesh-ancestor
25650760|NCT01507181|GABA Agents|gaba agents|mesh-ancestor
25256595|NCT02481323|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25275013|NCT02374567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25650761|NCT01507181|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
25650762|NCT01507220|Morphine|morphine|mesh-list
25650763|NCT01507220|Bupivacaine|bupivacaine|mesh-list
25650764|NCT01507220|Anesthetics, Local|anesthetics, local|mesh-ancestor
25650765|NCT01507220|Anesthetics|anesthetics|mesh-ancestor
25650766|NCT01507220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25650767|NCT01507220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650768|NCT01507220|Sensory System Agents|sensory system agents|mesh-ancestor
25650769|NCT01507220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650770|NCT01507220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25650771|NCT01507220|Narcotics|narcotics|mesh-ancestor
25650772|NCT01507220|Analgesics|analgesics|mesh-ancestor
25650773|NCT01507246|Morphine|morphine|mesh-list
25650774|NCT01507246|Bupivacaine|bupivacaine|mesh-list
25650775|NCT01507246|Anesthetics, Local|anesthetics, local|mesh-ancestor
25256639|NCT02481076|Uncoupling Agents|uncoupling agents|mesh-ancestor
25650776|NCT01507246|Anesthetics|anesthetics|mesh-ancestor
25650777|NCT01507246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25650778|NCT01507246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650779|NCT01507246|Sensory System Agents|sensory system agents|mesh-ancestor
25650780|NCT01507246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650781|NCT01507246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25650782|NCT01507246|Narcotics|narcotics|mesh-ancestor
25650783|NCT01507246|Analgesics|analgesics|mesh-ancestor
25650784|NCT01507779|Vaccines|vaccines|mesh-list
25650785|NCT01507779|Immunologic Factors|immunologic factors|mesh-ancestor
25650786|NCT01507779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650787|NCT01507831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25650788|NCT01507831|Immunologic Factors|immunologic factors|mesh-ancestor
25650789|NCT01507831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650790|NCT01508117|Axitinib|axitinib|mesh-list
25650791|NCT01508117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25650792|NCT01508117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25650793|NCT01508117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650794|NCT01508117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650795|NCT01508325|Metoprolol|metoprolol|mesh-list
25650796|NCT01508325|Bisoprolol|bisoprolol|mesh-list
25650797|NCT01508325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25650798|NCT01508325|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25650799|NCT01508325|Sympatholytics|sympatholytics|mesh-ancestor
25650800|NCT01508325|Autonomic Agents|autonomic agents|mesh-ancestor
25650801|NCT01508325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650802|NCT01508325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650803|NCT01508325|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25650804|NCT01508325|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25650805|NCT01508325|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25650806|NCT01508325|Adrenergic Agents|adrenergic agents|mesh-ancestor
25650807|NCT01508325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25650808|NCT01508325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439645|NCT01678586|Gabapentin|gabapentin|mesh-list
25650809|NCT01508455|Fentanyl|fentanyl|mesh-list
25650810|NCT01508455|Midazolam|midazolam|mesh-list
25650811|NCT01508455|Dexmedetomidine|dexmedetomidine|mesh-list
25543590|NCT05246865|Androgens|androgens|mesh-list
25543591|NCT05246865|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25543592|NCT05246865|Hormones|hormones|mesh-ancestor
25543593|NCT05246865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25543594|NCT05246865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543595|NCT05246865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25543596|NCT05246865|Immunologic Factors|immunologic factors|mesh-ancestor
25543597|NCT05246644|Acetaminophen|acetaminophen|mesh-list
25543598|NCT05246644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25543599|NCT05246644|Analgesics|analgesics|mesh-ancestor
25543600|NCT05246644|Sensory System Agents|sensory system agents|mesh-ancestor
25543601|NCT05246644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25543602|NCT05246644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543603|NCT05246644|Antipyretics|antipyretics|mesh-ancestor
25543604|NCT05246631|Dexamethasone|dexamethasone|mesh-list
25543605|NCT05246631|Dexamethasone acetate|dexamethasone acetate|mesh-list
25543606|NCT05246631|Haloperidol|haloperidol|mesh-list
25543607|NCT05246631|Haloperidol decanoate|haloperidol decanoate|mesh-list
25543608|NCT05246631|BB 1101|bb 1101|mesh-list
25543609|NCT05246631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25543610|NCT05246631|Antiemetics|antiemetics|mesh-ancestor
25543611|NCT05246631|Autonomic Agents|autonomic agents|mesh-ancestor
25543612|NCT05246631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25543613|NCT05246631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543614|NCT05246631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25543615|NCT05246631|Glucocorticoids|glucocorticoids|mesh-ancestor
25543616|NCT05246631|Hormones|hormones|mesh-ancestor
25543617|NCT05246631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25543618|NCT05246631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25543619|NCT05246631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543620|NCT05246631|Protease Inhibitors|protease inhibitors|mesh-ancestor
25543621|NCT05246631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543622|NCT05246631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543623|NCT05246631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25543624|NCT05246631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25543625|NCT05246631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25543626|NCT05246631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24453038|NCT05354258|Anticestodal Agents|anticestodal agents|mesh-ancestor
24453039|NCT05354258|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24453040|NCT05354258|Tubulin Modulators|tubulin modulators|mesh-ancestor
24537881|NCT00656643|Sirolimus|sirolimus|mesh-list
25543627|NCT05246631|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25543628|NCT05246631|Dopamine Agents|dopamine agents|mesh-ancestor
25543629|NCT05246631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25543630|NCT05246631|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25543631|NCT05246072|Ivermectin|ivermectin|mesh-list
25543632|NCT05246072|Colchicine|colchicine|mesh-list
25543633|NCT05246072|Gout Suppressants|gout suppressants|mesh-ancestor
25543634|NCT05246072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25543635|NCT05246072|Tubulin Modulators|tubulin modulators|mesh-ancestor
25543636|NCT05246072|Antimitotic Agents|antimitotic agents|mesh-ancestor
25543637|NCT05246072|Mitosis Modulators|mitosis modulators|mesh-ancestor
25543638|NCT05246072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543639|NCT05246072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543640|NCT05246072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25543641|NCT05246072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25543642|NCT05245994|Cisplatin|cisplatin|mesh-list
25543643|NCT05245994|Carboplatin|carboplatin|mesh-list
25543644|NCT05245994|Etoposide|etoposide|mesh-list
25543645|NCT05245994|Durvalumab|durvalumab|mesh-list
25543646|NCT05245994|Olaparib|olaparib|mesh-list
25543647|NCT05245994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543648|NCT05245994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25543649|NCT05245994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25543650|NCT05245994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25543651|NCT05245994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543652|NCT05245994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543653|NCT05245994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25543654|NCT05245994|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25543655|NCT05245721|Nalbuphine|nalbuphine|mesh-list
25543656|NCT05245721|Bupivacaine|bupivacaine|mesh-list
25543657|NCT05245721|Anesthetics, Local|anesthetics, local|mesh-ancestor
25543658|NCT05245721|Anesthetics|anesthetics|mesh-ancestor
25543659|NCT05245721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25543660|NCT05245721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256699|NCT02480686|Sofosbuvir|sofosbuvir|mesh-list
25543661|NCT05245721|Sensory System Agents|sensory system agents|mesh-ancestor
25439711|NCT01156545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25543662|NCT05245721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25543663|NCT05245721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25543664|NCT05245721|Narcotics|narcotics|mesh-ancestor
25543665|NCT05245721|Analgesics|analgesics|mesh-ancestor
25543666|NCT05245708|Oxytocin|oxytocin|mesh-list
25439771|NCT04734418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439772|NCT04734418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25439773|NCT04734418|Narcotics|narcotics|mesh-ancestor
25169200|NCT01960010|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25169201|NCT01959282|Niacinamide|niacinamide|mesh-list
25169202|NCT01959282|Peficitinib|peficitinib|mesh-list
25169203|NCT01959282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169204|NCT01959282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169205|NCT01959282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25169206|NCT01959282|Immunologic Factors|immunologic factors|mesh-ancestor
25169207|NCT01959282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169208|NCT01959282|Vitamin B Complex|vitamin b complex|mesh-ancestor
25169209|NCT01959282|Vitamins|vitamins|mesh-ancestor
25169210|NCT01959282|Micronutrients|micronutrients|mesh-ancestor
25169211|NCT01956812|Gemcitabine|gemcitabine|mesh-list
25169212|NCT01956812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25169213|NCT01956812|Antimetabolites|antimetabolites|mesh-ancestor
24670440|NCT02567825|Clavulanic Acids|clavulanic acids|mesh-list
24670441|NCT02567825|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25169214|NCT01956812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169215|NCT01956812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169216|NCT01956812|Antiviral Agents|antiviral agents|mesh-ancestor
25169217|NCT01956812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25169218|NCT01956812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169219|NCT01956812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25169220|NCT01956812|Immunologic Factors|immunologic factors|mesh-ancestor
25169221|NCT01956812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169222|NCT01952990|Phenylephrine|phenylephrine|mesh-list
25169223|NCT01952990|Oxymetazoline|oxymetazoline|mesh-list
25169224|NCT01952990|Tetracaine|tetracaine|mesh-list
25169225|NCT01952990|Anesthetics, Local|anesthetics, local|mesh-ancestor
25169226|NCT01952990|Anesthetics|anesthetics|mesh-ancestor
25169227|NCT01952990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25169228|NCT01952990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169229|NCT01952990|Sensory System Agents|sensory system agents|mesh-ancestor
25169230|NCT01952990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25169231|NCT01952990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25169232|NCT01952990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25169233|NCT01952990|Adrenergic Agents|adrenergic agents|mesh-ancestor
25169234|NCT01952990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25169235|NCT01952990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769145|NCT01812928|Analgesics|analgesics|mesh-ancestor
25210350|NCT02698306|Dexamethasone|dexamethasone|mesh-list
25210351|NCT02698306|Diclofenac|diclofenac|mesh-list
25210352|NCT02698306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25210353|NCT02698306|Antiemetics|antiemetics|mesh-ancestor
25210355|NCT02698306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25210356|NCT02698306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210357|NCT02698306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25210359|NCT02698306|Hormones|hormones|mesh-ancestor
25210360|NCT02698306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24514788|NCT00592930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24514789|NCT00592930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24415611|NCT00200395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24456628|NCT00331825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24456629|NCT00331825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24538238|NCT00657943|Coagulants|coagulants|mesh-ancestor
24533343|NCT00643240|Immunologic Factors|immunologic factors|mesh-ancestor
24533344|NCT00643240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533345|NCT00643292|Amoxicillin|amoxicillin|mesh-list
24533346|NCT00643292|Azithromycin|azithromycin|mesh-list
24533347|NCT00643292|Clavulanic Acid|clavulanic acid|mesh-list
24533348|NCT00643292|Clavulanic Acids|clavulanic acids|mesh-list
24394234|NCT00132613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169236|NCT01952990|Sympathomimetics|sympathomimetics|mesh-ancestor
25169237|NCT01952990|Autonomic Agents|autonomic agents|mesh-ancestor
25169238|NCT01952990|Nasal Decongestants|nasal decongestants|mesh-ancestor
25169239|NCT01952990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25169240|NCT01952990|Respiratory System Agents|respiratory system agents|mesh-ancestor
25169241|NCT01952990|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25169242|NCT01952990|Mydriatics|mydriatics|mesh-ancestor
25169243|NCT01952990|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25169244|NCT01952990|Protective Agents|protective agents|mesh-ancestor
25044639|NCT01068704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25044756|NCT01042925|Paclitaxel|paclitaxel|mesh-list
25044798|NCT01037166|Entecavir|entecavir|mesh-list
25286968|NCT05085587|Xhance|xhance|mesh-list
25169245|NCT01941836|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
25169246|NCT01941836|Ezetimibe|ezetimibe|mesh-list
25169247|NCT01941836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25169248|NCT01941836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25169249|NCT01941836|Antimetabolites|antimetabolites|mesh-ancestor
24459117|NCT00343707|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24459118|NCT00343707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24459119|NCT00343707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24459120|NCT00343707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407859|NCT00175747|Budesonide|budesonide|mesh-list
24527658|NCT00617955|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24527659|NCT00617955|Protease Inhibitors|protease inhibitors|mesh-ancestor
24459121|NCT00343707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24459122|NCT00343707|Serotonin Agents|serotonin agents|mesh-ancestor
25822532|NCT00004495|Hematinics|hematinics|mesh-ancestor
25822533|NCT00004495|Vitamin B Complex|vitamin b complex|mesh-ancestor
25822534|NCT00004495|Vitamins|vitamins|mesh-ancestor
25822535|NCT00004495|Micronutrients|micronutrients|mesh-ancestor
25822536|NCT00004495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822537|NCT00004496|Hormones|hormones|mesh-list
24775786|NCT01854762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25044987|NCT01007721|Xhance|xhance|mesh-list
25045468|NCT00948753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24775787|NCT01854762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25543667|NCT05245708|Oxytocics|oxytocics|mesh-ancestor
25543668|NCT05245708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25543669|NCT05245708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543670|NCT05245604|Cyclosporine|cyclosporine|mesh-list
25543671|NCT05245604|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25543672|NCT05245604|Cyclosporins|cyclosporins|mesh-list
25543673|NCT05245604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543674|NCT05245604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543675|NCT05245604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25543676|NCT05245604|Immunologic Factors|immunologic factors|mesh-ancestor
25543677|NCT05245604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210367|NCT02698306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25543678|NCT05245604|Antifungal Agents|antifungal agents|mesh-ancestor
25543679|NCT05245604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25543680|NCT05245604|Dermatologic Agents|dermatologic agents|mesh-ancestor
25543681|NCT05245604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25543682|NCT05245604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25543683|NCT05245604|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25543684|NCT05245448|Tetrandrine|tetrandrine|mesh-list
25543685|NCT05245448|Antimalarials|antimalarials|mesh-ancestor
25543686|NCT05245448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25543687|NCT05245448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25543688|NCT05245448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25543689|NCT05245448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25543690|NCT05245448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543691|NCT05245448|Antiviral Agents|antiviral agents|mesh-ancestor
25543692|NCT05245448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25543693|NCT05245448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25543694|NCT05245448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543695|NCT05245448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25543696|NCT05245448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210373|NCT02698098|Narcotics|narcotics|mesh-ancestor
25543697|NCT05245448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25543698|NCT05245448|Immunologic Factors|immunologic factors|mesh-ancestor
25543699|NCT05220917|Insulin|insulin|mesh-list
25543700|NCT05220917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25543701|NCT05220917|Metformin|metformin|mesh-list
25543702|NCT05220917|Insulin Glargine|insulin glargine|mesh-list
25543703|NCT05220917|Pioglitazone|pioglitazone|mesh-list
25543704|NCT05220917|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25543705|NCT05220917|Dapagliflozin|dapagliflozin|mesh-list
25543706|NCT05220917|Liraglutide|liraglutide|mesh-list
25543707|NCT05220917|Empagliflozin|empagliflozin|mesh-list
25543708|NCT05220917|Exenatide|exenatide|mesh-list
25543709|NCT05220917|Glimepiride|glimepiride|mesh-list
25543710|NCT05220917|Linagliptin|linagliptin|mesh-list
25543711|NCT05220917|Rosiglitazone|rosiglitazone|mesh-list
25543712|NCT05220917|Canagliflozin|canagliflozin|mesh-list
25543713|NCT05220917|Saxagliptin|saxagliptin|mesh-list
25543714|NCT05220917|Alogliptin|alogliptin|mesh-list
25543715|NCT05220917|Glyburide|glyburide|mesh-list
25543716|NCT05220917|Dulaglutide|dulaglutide|mesh-list
25543717|NCT05220917|Ertugliflozin|ertugliflozin|mesh-list
25543718|NCT05220917|Lixisenatide|lixisenatide|mesh-list
25543719|NCT05220917|Glipizide|glipizide|mesh-list
25543720|NCT05220917|Xultophy|xultophy|mesh-list
25543721|NCT05220917|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25543722|NCT05220917|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25543723|NCT05220917|Simvastatin|simvastatin|mesh-list
25543724|NCT05220917|rGLP-1 protein|rglp-1 protein|mesh-list
25543725|NCT05220917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25543726|NCT05220917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543727|NCT05220917|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25543728|NCT05220917|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25543729|NCT05220917|Antimetabolites|antimetabolites|mesh-ancestor
25543730|NCT05220917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543731|NCT05220917|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25543732|NCT05220917|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25543733|NCT05220917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543734|NCT05220917|Incretins|incretins|mesh-ancestor
25543735|NCT05220917|Hormones|hormones|mesh-ancestor
25543736|NCT05220917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25543737|NCT05220917|Protease Inhibitors|protease inhibitors|mesh-ancestor
25543738|NCT05220917|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25543739|NCT05220917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25543740|NCT05220917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25543741|NCT05220917|Immunologic Factors|immunologic factors|mesh-ancestor
25543742|NCT05219877|Levofloxacin|levofloxacin|mesh-list
25439777|NCT04734353|Ticagrelor|ticagrelor|mesh-list
25543743|NCT05219877|Ofloxacin|ofloxacin|mesh-list
25543744|NCT05219877|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25543745|NCT05219877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25543746|NCT05219877|Renal Agents|renal agents|mesh-ancestor
25543747|NCT05219877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25543748|NCT05219877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25543749|NCT05219877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25543750|NCT05219877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543751|NCT05219877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543752|NCT05219877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543753|NCT05219877|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25543754|NCT05219877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25543755|NCT05204563|Imipenem|imipenem|mesh-list
24533424|NCT00643825|Temozolomide|temozolomide|mesh-list
24533425|NCT00643825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24456088|NCT00329823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24456089|NCT00329823|Immunologic Factors|immunologic factors|mesh-ancestor
24456090|NCT00329914|Progesterone|progesterone|mesh-list
24456091|NCT00329914|Progestins|progestins|mesh-ancestor
24456093|NCT00329914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25543756|NCT05204563|Relebactam|relebactam|mesh-list
25543757|NCT05204563|Cilastatin|cilastatin|mesh-list
25543758|NCT05204563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25543759|NCT05204563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25543760|NCT05204563|Protease Inhibitors|protease inhibitors|mesh-ancestor
25543761|NCT05204563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543762|NCT05204563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543763|NCT05204563|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25543764|NCT05204368|Meropenem|meropenem|mesh-list
25543765|NCT05204368|Imipenem|imipenem|mesh-list
25543766|NCT05204368|Cilastatin|cilastatin|mesh-list
25543767|NCT05204368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25543768|NCT05204368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25543769|NCT05204368|Protease Inhibitors|protease inhibitors|mesh-ancestor
25543770|NCT05204368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543771|NCT05204368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543772|NCT05194488|Botulinum Toxins|botulinum toxins|mesh-list
25543773|NCT05194488|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25543774|NCT05194488|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25543775|NCT05194488|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25543776|NCT05194488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24973539|NCT03708822|Antimitotic Agents|antimitotic agents|mesh-ancestor
24973540|NCT03708822|Mitosis Modulators|mitosis modulators|mesh-ancestor
24973541|NCT03708822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456148|NCT00330252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24456149|NCT00330278|Cefazolin|cefazolin|mesh-list
24456158|NCT00330304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25543777|NCT05194488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543778|NCT05194488|Cholinergic Agents|cholinergic agents|mesh-ancestor
25543779|NCT05194488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25543780|NCT05194488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543781|NCT05194488|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25543782|NCT05194488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25543783|NCT05175768|Niacinamide|niacinamide|mesh-list
25543784|NCT05175768|Niacin|niacin|mesh-list
25543785|NCT05175768|Nicotinic Acids|nicotinic acids|mesh-list
25543786|NCT05175768|Vitamin B Complex|vitamin b complex|mesh-ancestor
25543787|NCT05175768|Vitamins|vitamins|mesh-ancestor
25543788|NCT05175768|Micronutrients|micronutrients|mesh-ancestor
25543789|NCT05175768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543790|NCT05175768|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25543791|NCT05175768|Antimetabolites|antimetabolites|mesh-ancestor
25543792|NCT05175768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543793|NCT05175768|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25543794|NCT05175768|Vasodilator Agents|vasodilator agents|mesh-ancestor
25543795|NCT05145010|Infigratinib|infigratinib|mesh-list
25543796|NCT05145010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543797|NCT05139004|Fludarabine|fludarabine|mesh-list
25543798|NCT05139004|Fludarabine phosphate|fludarabine phosphate|mesh-list
25543799|NCT05139004|Melphalan|melphalan|mesh-list
25543800|NCT05139004|Mechlorethamine|mechlorethamine|mesh-list
25543801|NCT05139004|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25543802|NCT05139004|Basiliximab|basiliximab|mesh-list
25543803|NCT05139004|Mitogens|mitogens|mesh-list
25543804|NCT05139004|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
25543805|NCT05139004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543806|NCT05139004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25543807|NCT05139004|Antimetabolites|antimetabolites|mesh-ancestor
25543808|NCT05139004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543809|NCT05139004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25543810|NCT05139004|Immunologic Factors|immunologic factors|mesh-ancestor
25543811|NCT05139004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543812|NCT05139004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25543813|NCT05139004|Alkylating Agents|alkylating agents|mesh-ancestor
25543814|NCT05139004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25543815|NCT05139004|Mitosis Modulators|mitosis modulators|mesh-ancestor
25543816|NCT05139004|Chelating Agents|chelating agents|mesh-ancestor
25543817|NCT05139004|Sequestering Agents|sequestering agents|mesh-ancestor
25543818|NCT05121350|Epirubicin|epirubicin|mesh-list
25543819|NCT05121350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25543820|NCT05121350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543821|NCT05121350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25543822|NCT05121350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25543823|NCT05121350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543824|NCT05121350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543825|NCT05097846|Amoxicillin|amoxicillin|mesh-list
24928763|NCT04119336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25543826|NCT05097846|Doxycycline|doxycycline|mesh-list
25543827|NCT05097846|Furazolidone|furazolidone|mesh-list
25543828|NCT05097846|Esomeprazole|esomeprazole|mesh-list
25543829|NCT05097846|Bismuth|bismuth|mesh-list
25543830|NCT05097846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25543831|NCT05097846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25543832|NCT05097846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25543833|NCT05097846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25543834|NCT05097846|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25543835|NCT05097846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543836|NCT05097846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543837|NCT05097846|Antimalarials|antimalarials|mesh-ancestor
25543838|NCT05097846|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25543839|NCT05097846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25543840|NCT05097846|Antacids|antacids|mesh-ancestor
25543841|NCT05097846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25543842|NCT05097846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25543843|NCT05097846|Renal Agents|renal agents|mesh-ancestor
25543844|NCT05097846|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25543845|NCT05097846|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25543846|NCT05084222|Budesonide|budesonide|mesh-list
25017507|NCT00620464|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25017508|NCT00620464|Contraceptive Agents|contraceptive agents|mesh-ancestor
25543847|NCT05084222|Albuterol|albuterol|mesh-list
25543848|NCT05084222|Formoterol Fumarate|formoterol fumarate|mesh-list
25543849|NCT05084222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25543850|NCT05084222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25543851|NCT05084222|Autonomic Agents|autonomic agents|mesh-ancestor
25543852|NCT05084222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25543853|NCT05084222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543854|NCT05084222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25017694|NCT03704909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017695|NCT03704909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017725|NCT03704753|Sensory System Agents|sensory system agents|mesh-ancestor
25017726|NCT03704753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24580617|NCT00862472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25017773|NCT03704623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017774|NCT03704623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25017777|NCT03704506|Amoxicillin|amoxicillin|mesh-list
25543855|NCT05084222|Respiratory System Agents|respiratory system agents|mesh-ancestor
25543856|NCT05084222|Glucocorticoids|glucocorticoids|mesh-ancestor
25543857|NCT05084222|Hormones|hormones|mesh-ancestor
25543858|NCT05084222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25543859|NCT05084222|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25543860|NCT05084222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25543861|NCT05084222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25543862|NCT05084222|Adrenergic Agents|adrenergic agents|mesh-ancestor
25543863|NCT05084222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25543864|NCT05084222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543865|NCT05084222|Tocolytic Agents|tocolytic agents|mesh-ancestor
25543866|NCT05084222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25543867|NCT05069051|Belimumab|belimumab|mesh-list
25543868|NCT05069051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25543869|NCT05069051|Immunologic Factors|immunologic factors|mesh-ancestor
25543870|NCT05069051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650812|NCT01508455|Morphine|morphine|mesh-list
25650813|NCT01508455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25650814|NCT01508455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25017918|NCT03702959|Betamethasone|betamethasone|mesh-list
24798757|NCT01964846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24798759|NCT01964846|Antioxidants|antioxidants|mesh-ancestor
24537854|NCT00656552|Citalopram|citalopram|mesh-list
24537855|NCT00656552|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24537856|NCT00656552|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24537857|NCT00656552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24537858|NCT00656552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210419|NCT02697851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25210420|NCT02697851|Contraceptive Agents|contraceptive agents|mesh-ancestor
25210421|NCT02697851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25210422|NCT02697851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210423|NCT02697851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24517110|NCT00605995|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24537859|NCT00656552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24537860|NCT00656552|Serotonin Agents|serotonin agents|mesh-ancestor
24537888|NCT00656643|Immunologic Factors|immunologic factors|mesh-ancestor
24537889|NCT00656643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537892|NCT00656695|Antifungal Agents|antifungal agents|mesh-ancestor
24537894|NCT00656695|Dermatologic Agents|dermatologic agents|mesh-ancestor
24537895|NCT00656695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456749|NCT00332124|Lipotropic Agents|lipotropic agents|mesh-ancestor
25677245|NCT01808651|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25650815|NCT01508455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650816|NCT01508455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25650817|NCT01508455|Analgesics|analgesics|mesh-ancestor
25650818|NCT01508455|Sensory System Agents|sensory system agents|mesh-ancestor
25650819|NCT01508455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650820|NCT01508455|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25650821|NCT01508455|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25650822|NCT01508455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25650823|NCT01508455|Adrenergic Agents|adrenergic agents|mesh-ancestor
25650824|NCT01508455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25650825|NCT01508455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650826|NCT01508455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25650827|NCT01508455|Narcotics|narcotics|mesh-ancestor
25650828|NCT01508455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25650829|NCT01508455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25650830|NCT01508455|Anesthetics, General|anesthetics, general|mesh-ancestor
25650831|NCT01508455|Anesthetics|anesthetics|mesh-ancestor
25650832|NCT01508455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25650833|NCT01508455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25650834|NCT01508455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25650835|NCT01508455|GABA Modulators|gaba modulators|mesh-ancestor
25650836|NCT01508455|GABA Agents|gaba agents|mesh-ancestor
25650837|NCT01508676|Diclofenac|diclofenac|mesh-list
25650838|NCT01508676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25650839|NCT01508676|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25018061|NCT03702023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018062|NCT03702023|Antipyretics|antipyretics|mesh-ancestor
25018064|NCT03701984|Tramadol|tramadol|mesh-list
25018065|NCT03701984|Anesthetics, Local|anesthetics, local|mesh-ancestor
25018066|NCT03701984|Anesthetics|anesthetics|mesh-ancestor
25018067|NCT03701984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25650840|NCT01508676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25650841|NCT01508676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25650842|NCT01508676|Analgesics|analgesics|mesh-ancestor
25650843|NCT01508676|Sensory System Agents|sensory system agents|mesh-ancestor
25439964|NCT04732104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25439965|NCT04732104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439966|NCT04732104|Sensory System Agents|sensory system agents|mesh-ancestor
25439967|NCT04732104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25439968|NCT04732104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25439969|NCT04732104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25439970|NCT04732104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25439971|NCT04732104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25439972|NCT04732104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439973|NCT04732104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25439974|NCT04732104|Respiratory System Agents|respiratory system agents|mesh-ancestor
25439975|NCT04731727|Riboflavin|riboflavin|mesh-list
25439976|NCT04731727|Vitamin B Complex|vitamin b complex|mesh-ancestor
25439977|NCT04731727|Vitamins|vitamins|mesh-ancestor
25439978|NCT04731727|Micronutrients|micronutrients|mesh-ancestor
25439979|NCT04731727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439980|NCT04731727|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25439981|NCT04731727|Dermatologic Agents|dermatologic agents|mesh-ancestor
25439982|NCT04731740|Pembrolizumab|pembrolizumab|mesh-list
25439983|NCT04731740|Lenvatinib|lenvatinib|mesh-list
25439984|NCT04731740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25439985|NCT04731740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439986|NCT04731740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25439987|NCT04731740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018172|NCT03701321|BB 1101|bb 1101|mesh-list
25018173|NCT03701321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25018174|NCT03701321|Antiemetics|antiemetics|mesh-ancestor
25018175|NCT03701321|Autonomic Agents|autonomic agents|mesh-ancestor
24974664|NCT05310331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974745|NCT05303324|Growth Inhibitors|growth inhibitors|mesh-ancestor
25439988|NCT04731740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439989|NCT04731948|Vitamins|vitamins|mesh-list
25439990|NCT04731948|Folic Acid|folic acid|mesh-list
25439991|NCT04731948|Hydroxocobalamin|hydroxocobalamin|mesh-list
25439992|NCT04731948|Vitamin B 12|vitamin b 12|mesh-list
25439993|NCT04731948|Vitamin B Complex|vitamin b complex|mesh-list
25439994|NCT04731948|Micronutrients|micronutrients|mesh-ancestor
25439995|NCT04731948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439996|NCT04731948|Hematinics|hematinics|mesh-ancestor
25292060|NCT03522753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25292061|NCT03522753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776595|NCT01858623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24776596|NCT01858623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776597|NCT01858623|Diuretics|diuretics|mesh-ancestor
24776598|NCT01858623|Natriuretic Agents|natriuretic agents|mesh-ancestor
24776599|NCT01858623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543871|NCT05012371|Everolimus|everolimus|mesh-list
25543872|NCT05012371|Lenvatinib|lenvatinib|mesh-list
25543873|NCT05012371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543874|NCT05012371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25543875|NCT05012371|Immunologic Factors|immunologic factors|mesh-ancestor
25543876|NCT05012371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543877|NCT05012371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25543878|NCT05012371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543879|NCT05012371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543880|NCT04929392|Paclitaxel|paclitaxel|mesh-list
25543881|NCT04929392|Carboplatin|carboplatin|mesh-list
25543882|NCT04929392|Pembrolizumab|pembrolizumab|mesh-list
25543883|NCT04929392|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25543884|NCT04929392|Lenvatinib|lenvatinib|mesh-list
25543885|NCT04929392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25543886|NCT04929392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543887|NCT04929392|Tubulin Modulators|tubulin modulators|mesh-ancestor
25543888|NCT04929392|Antimitotic Agents|antimitotic agents|mesh-ancestor
24449658|NCT00316433|Oxaliplatin|oxaliplatin|mesh-list
24449659|NCT00316433|Irinotecan|irinotecan|mesh-list
24449660|NCT00316433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449661|NCT00316433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24449662|NCT00316433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24449663|NCT00316433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449664|NCT00316433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449669|NCT00316472|Vitamins|vitamins|mesh-ancestor
25543889|NCT04929392|Mitosis Modulators|mitosis modulators|mesh-ancestor
25543890|NCT04929392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543891|NCT04929392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25543892|NCT04929392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25543893|NCT04929392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543894|NCT04856228|Lidocaine|lidocaine|mesh-list
25543895|NCT04856228|Anesthetics, Local|anesthetics, local|mesh-ancestor
25543896|NCT04856228|Anesthetics|anesthetics|mesh-ancestor
25543897|NCT04856228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25543898|NCT04856228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543899|NCT04856228|Sensory System Agents|sensory system agents|mesh-ancestor
25543900|NCT04856228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25543901|NCT04856228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25543902|NCT04856228|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25543903|NCT04856228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25657195|NCT01584232|Biguanides|biguanides|mesh-list
25543904|NCT04856228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25543905|NCT04856228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543906|NCT04842604|Azacitidine|azacitidine|mesh-list
25543907|NCT04842604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25543908|NCT04842604|Antimetabolites|antimetabolites|mesh-ancestor
25543909|NCT04842604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543910|NCT04842604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543911|NCT04842604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543912|NCT04820023|Cetuximab|cetuximab|mesh-list
24928823|NCT04118556|Dermatologic Agents|dermatologic agents|mesh-ancestor
24945019|NCT03954964|Analgesics|analgesics|mesh-ancestor
25018244|NCT03700788|Chlorhexidine|chlorhexidine|mesh-list
25018245|NCT03700788|Calcium|calcium|mesh-list
25018251|NCT03700749|Iodine|iodine|mesh-list
25543913|NCT04820023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25543914|NCT04820023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543915|NCT04784052|Cyclophosphamide|cyclophosphamide|mesh-list
25543916|NCT04784052|Rituximab|rituximab|mesh-list
25543917|NCT04784052|Fludarabine|fludarabine|mesh-list
25543918|NCT04784052|Thymoglobulin|thymoglobulin|mesh-list
25543919|NCT04784052|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25543920|NCT04784052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25543921|NCT04784052|Immunologic Factors|immunologic factors|mesh-ancestor
25543922|NCT04784052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543923|NCT04784052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25543924|NCT04784052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25543925|NCT04784052|Alkylating Agents|alkylating agents|mesh-ancestor
25543926|NCT04784052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543927|NCT04784052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543928|NCT04784052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25543929|NCT04784052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25543930|NCT04771871|Paclitaxel|paclitaxel|mesh-list
25543931|NCT04771871|Cyclophosphamide|cyclophosphamide|mesh-list
25543932|NCT04771871|Carboplatin|carboplatin|mesh-list
25543933|NCT04771871|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25543934|NCT04771871|Epirubicin|epirubicin|mesh-list
25210445|NCT02697877|Regadenoson|regadenoson|mesh-list
25543935|NCT04771871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25543936|NCT04771871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543937|NCT04771871|Tubulin Modulators|tubulin modulators|mesh-ancestor
25543938|NCT04771871|Antimitotic Agents|antimitotic agents|mesh-ancestor
25543939|NCT04771871|Mitosis Modulators|mitosis modulators|mesh-ancestor
25543940|NCT04771871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543941|NCT04771871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25543942|NCT04771871|Immunologic Factors|immunologic factors|mesh-ancestor
25543943|NCT04771871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543944|NCT04771871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25543945|NCT04771871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25543946|NCT04771871|Alkylating Agents|alkylating agents|mesh-ancestor
25543947|NCT04771871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25543948|NCT04771871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25543949|NCT04771871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25543950|NCT04771871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25543951|NCT04771871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543952|NCT04692077|Tenofovir|tenofovir|mesh-list
25543953|NCT04692077|Emtricitabine|emtricitabine|mesh-list
25543954|NCT04692077|Cabotegravir|cabotegravir|mesh-list
25543955|NCT04692077|Antiviral Agents|antiviral agents|mesh-ancestor
25543956|NCT04692077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25543957|NCT04692077|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25543958|NCT04692077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25543959|NCT04692077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543960|NCT04692077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543961|NCT04692077|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25543962|NCT04692077|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25543963|NCT04692077|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25543964|NCT04692077|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25543965|NCT04603391|Cannabidiol|cannabidiol|mesh-list
25543966|NCT04603391|Methylphenidate|methylphenidate|mesh-list
25543967|NCT04603391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25543968|NCT04603391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543969|NCT04603391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25543970|NCT04603391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25543971|NCT04603391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25543972|NCT04603391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543973|NCT04603391|Dopamine Agents|dopamine agents|mesh-ancestor
25543974|NCT04603391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25543975|NCT04603391|Anticonvulsants|anticonvulsants|mesh-ancestor
25543976|NCT04599790|Lenvatinib|lenvatinib|mesh-list
25543977|NCT04599790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543978|NCT04599790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25543979|NCT04599790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543980|NCT04599790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543981|NCT04575857|Atorvastatin|atorvastatin|mesh-list
25543982|NCT04575857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25543983|NCT04575857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25018543|NCT03698630|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25543984|NCT04575857|Antimetabolites|antimetabolites|mesh-ancestor
25543985|NCT04575857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25543986|NCT04575857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25543987|NCT04575857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25543988|NCT04575857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25543989|NCT04561206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25543990|NCT04561206|Nivolumab|nivolumab|mesh-list
25543991|NCT04561206|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25543992|NCT04561206|Antibodies|antibodies|mesh-list
25543993|NCT04561206|Immunoglobulins|immunoglobulins|mesh-list
25543994|NCT04561206|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25543995|NCT04561206|Immunoconjugates|immunoconjugates|mesh-list
25543996|NCT04561206|Immunologic Factors|immunologic factors|mesh-ancestor
25543997|NCT04561206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25543998|NCT04561206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25543999|NCT04561206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25544000|NCT04561206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544001|NCT04545008|Acetylcysteine|acetylcysteine|mesh-list
25544002|NCT04545008|Famotidine|famotidine|mesh-list
25544003|NCT04545008|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25544004|NCT04545008|Antiviral Agents|antiviral agents|mesh-ancestor
25544005|NCT04545008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25544006|NCT04545008|Expectorants|expectorants|mesh-ancestor
25544007|NCT04545008|Respiratory System Agents|respiratory system agents|mesh-ancestor
25544008|NCT04545008|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25544009|NCT04545008|Antioxidants|antioxidants|mesh-ancestor
25544010|NCT04545008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544011|NCT04545008|Protective Agents|protective agents|mesh-ancestor
25544012|NCT04545008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544013|NCT04545008|Antidotes|antidotes|mesh-ancestor
25544014|NCT04545008|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25544015|NCT04545008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25544016|NCT04545008|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25544017|NCT04545008|Histamine Antagonists|histamine antagonists|mesh-ancestor
25544018|NCT04545008|Histamine Agents|histamine agents|mesh-ancestor
25544019|NCT04545008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25544020|NCT04527770|Dexamethasone|dexamethasone|mesh-list
25544021|NCT04527770|Midazolam|midazolam|mesh-list
25544022|NCT04527770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25544023|NCT04527770|Antiemetics|antiemetics|mesh-ancestor
25544024|NCT04527770|Autonomic Agents|autonomic agents|mesh-ancestor
25544025|NCT04527770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25544026|NCT04527770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544027|NCT04527770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25544028|NCT04527770|Glucocorticoids|glucocorticoids|mesh-ancestor
25544029|NCT04527770|Hormones|hormones|mesh-ancestor
25544030|NCT04527770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25544031|NCT04527770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25544032|NCT04527770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25544033|NCT04527770|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25018923|NCT03695705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018924|NCT03695705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018925|NCT03695705|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24582113|NCT00868153|Contraceptive Agents|contraceptive agents|mesh-ancestor
25018927|NCT03695640|Magnesium Sulfate|magnesium sulfate|mesh-list
25018928|NCT03695640|Analgesics|analgesics|mesh-ancestor
24548756|NCT00711906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25544034|NCT04527770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25544035|NCT04527770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25544036|NCT04527770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25544037|NCT04527770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25544038|NCT04527770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25544039|NCT04527770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25544040|NCT04527770|Anesthetics, General|anesthetics, general|mesh-ancestor
25544041|NCT04527770|Anesthetics|anesthetics|mesh-ancestor
25544042|NCT04527770|GABA Modulators|gaba modulators|mesh-ancestor
25544043|NCT04527770|GABA Agents|gaba agents|mesh-ancestor
25544044|NCT04527770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25544045|NCT04527770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544046|NCT04514211|Propofol|propofol|mesh-list
25544047|NCT04514211|Sevoflurane|sevoflurane|mesh-list
25544048|NCT04514211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25544049|NCT04514211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25544050|NCT04514211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544051|NCT04514211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25544052|NCT04514211|Anesthetics, General|anesthetics, general|mesh-ancestor
25544053|NCT04514211|Anesthetics|anesthetics|mesh-ancestor
25657196|NCT01584232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25544060|NCT04507204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25544061|NCT04507204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25544062|NCT04507204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544064|NCT04507204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25544065|NCT04505566|Ketorolac|ketorolac|mesh-list
25544066|NCT04505566|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25544067|NCT04505566|Lubricant Eye Drops|lubricant eye drops|mesh-list
25544068|NCT04505566|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25544069|NCT04505566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25544070|NCT04505566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25544071|NCT04505566|Analgesics|analgesics|mesh-ancestor
25019054|NCT03693885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25019055|NCT03693885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019056|NCT03693872|Dopamine|dopamine|mesh-list
25019057|NCT03693872|Apomorphine|apomorphine|mesh-list
25019058|NCT03693872|Dopamine Agonists|dopamine agonists|mesh-list
25019059|NCT03693872|Emetics|emetics|mesh-ancestor
25210485|NCT05324800|Antioxidants|antioxidants|mesh-ancestor
24550191|NCT00719602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550193|NCT00719602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24550194|NCT00719602|Antiviral Agents|antiviral agents|mesh-ancestor
24550195|NCT00719602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24516135|NCT00600639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24516136|NCT00600639|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24516137|NCT00600639|Protective Agents|protective agents|mesh-ancestor
24516138|NCT00600639|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24516139|NCT00600639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24516140|NCT00600639|Respiratory System Agents|respiratory system agents|mesh-ancestor
25677294|NCT01809106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677295|NCT01809106|Analgesics|analgesics|mesh-ancestor
25677296|NCT01809106|Sensory System Agents|sensory system agents|mesh-ancestor
25677297|NCT01809106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25677298|NCT01809106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25544072|NCT04505566|Sensory System Agents|sensory system agents|mesh-ancestor
25544073|NCT04505566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25544074|NCT04505566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544075|NCT04505566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25544076|NCT04505566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25544077|NCT04505566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25544078|NCT04505566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544079|NCT04505566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544080|NCT04504331|Tamoxifen|tamoxifen|mesh-list
25544081|NCT04504331|Infigratinib|infigratinib|mesh-list
25544082|NCT04504331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25544083|NCT04504331|Hormone Antagonists|hormone antagonists|mesh-ancestor
25544084|NCT04504331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25544085|NCT04504331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544086|NCT04504331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25019247|NCT03692416|Hormones|hormones|mesh-ancestor
25019248|NCT03692416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25019249|NCT03692416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896603|NCT04434430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25019325|NCT03691922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25019326|NCT03691922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019327|NCT03691922|Sensory System Agents|sensory system agents|mesh-ancestor
25019328|NCT03691922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25019329|NCT03691922|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25019330|NCT03691922|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25019339|NCT03691922|Mydriatics|mydriatics|mesh-ancestor
24518465|NCT04963036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24518466|NCT04963036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518467|NCT04939467|Pirfenidone|pirfenidone|mesh-list
24518468|NCT04939467|Nintedanib|nintedanib|mesh-list
24518469|NCT04939467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449712|NCT00316745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24449713|NCT00316745|Immunologic Factors|immunologic factors|mesh-ancestor
24449714|NCT00316745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677299|NCT01809106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25677300|NCT01809106|Anesthetics, General|anesthetics, general|mesh-ancestor
25677301|NCT01809106|Anesthetics|anesthetics|mesh-ancestor
25677302|NCT01809106|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25677303|NCT01809132|Zinc|zinc|mesh-list
25677304|NCT01809132|Methylprednisolone|methylprednisolone|mesh-list
25677305|NCT01809132|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25677306|NCT01809132|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25544087|NCT04504331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25544088|NCT04504331|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25544089|NCT04504331|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25544090|NCT04504331|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25544091|NCT04497298|Vaccines|vaccines|mesh-list
25544092|NCT04497298|Immunologic Factors|immunologic factors|mesh-ancestor
25544093|NCT04497298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544094|NCT04483102|Liver Extracts|liver extracts|mesh-list
25544095|NCT04483102|Hematinics|hematinics|mesh-ancestor
25544096|NCT04482244|Cannabidiol|cannabidiol|mesh-list
25544097|NCT04482244|Anticonvulsants|anticonvulsants|mesh-ancestor
25544098|NCT04459117|Acetaminophen|acetaminophen|mesh-list
25544099|NCT04459117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25544100|NCT04459117|Analgesics|analgesics|mesh-ancestor
25544101|NCT04459117|Sensory System Agents|sensory system agents|mesh-ancestor
25544102|NCT04459117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25544103|NCT04459117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544104|NCT04459117|Antipyretics|antipyretics|mesh-ancestor
25544112|NCT04417569|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25544113|NCT04417569|Estradiol|estradiol|mesh-list
25544114|NCT04417569|Progesterone|progesterone|mesh-list
25544115|NCT04417569|Hormones|hormones|mesh-ancestor
25544116|NCT04417569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25544117|NCT04417569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544118|NCT04417569|Estrogens|estrogens|mesh-ancestor
25544119|NCT04417569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25544120|NCT04417569|Progestins|progestins|mesh-ancestor
25544121|NCT04411680|Sargramostim|sargramostim|mesh-list
25544122|NCT04411680|Immunologic Factors|immunologic factors|mesh-ancestor
25544123|NCT04411680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544124|NCT04405908|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25544125|NCT04405908|Aluminum sulfate|aluminum sulfate|mesh-list
25544126|NCT04405908|1018 oligonucleotide|1018 oligonucleotide|mesh-list
25544127|NCT04405908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25544128|NCT04405908|Immunologic Factors|immunologic factors|mesh-ancestor
25440187|NCT04729491|Dutasteride|dutasteride|mesh-list
25440188|NCT04729491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25019474|NCT03691090|Mitosis Modulators|mitosis modulators|mesh-ancestor
25019475|NCT03691090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019476|NCT03691077|Ocrelizumab|ocrelizumab|mesh-list
25019477|NCT03691077|Immunologic Factors|immunologic factors|mesh-ancestor
25019478|NCT03691077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019479|NCT03691038|Pregabalin|pregabalin|mesh-list
24949383|NCT04880655|Emollients|emollients|mesh-ancestor
25210486|NCT05324800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210487|NCT05324800|Protective Agents|protective agents|mesh-ancestor
25210488|NCT05324800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210489|NCT05324774|Aflibercept|aflibercept|mesh-list
25210490|NCT05324774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25440189|NCT04729491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25440190|NCT04729491|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25440191|NCT04729491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25440192|NCT04729491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440193|NCT04729491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440194|NCT04729491|Hormone Antagonists|hormone antagonists|mesh-ancestor
25440195|NCT04729491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25440196|NCT04729491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440197|NCT04729491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25440198|NCT04729179|Cannabidiol|cannabidiol|mesh-list
25440199|NCT04729179|Anticonvulsants|anticonvulsants|mesh-ancestor
25822538|NCT00004496|alpha-MSH|alpha-msh|mesh-list
24776600|NCT01858623|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24913985|NCT04258930|Immunologic Factors|immunologic factors|mesh-ancestor
24776612|NCT01858649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24776613|NCT01858649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24776614|NCT01858649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776633|NCT01858792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24776634|NCT01858792|Immunologic Factors|immunologic factors|mesh-ancestor
24776635|NCT01858792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776637|NCT01858831|Proguanil|proguanil|mesh-list
24776638|NCT01858831|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
24776639|NCT01858831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24776640|NCT01858831|Antimalarials|antimalarials|mesh-ancestor
24776641|NCT01858831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24776642|NCT01858831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24776643|NCT01858831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776644|NCT01858831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776645|NCT01858831|Antimetabolites|antimetabolites|mesh-ancestor
24776646|NCT01858870|Lacosamide|lacosamide|mesh-list
24776647|NCT01858870|Anticonvulsants|anticonvulsants|mesh-ancestor
24516270|NCT00601302|Amlodipine|amlodipine|mesh-list
25210495|NCT05324774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25210496|NCT05324748|Methylprednisolone|methylprednisolone|mesh-list
25210497|NCT05324748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25210498|NCT05324748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25210499|NCT05324748|Prednisolone|prednisolone|mesh-list
25210500|NCT05324748|Prednisolone acetate|prednisolone acetate|mesh-list
25210501|NCT05324748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24518571|NCT04808934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518572|NCT04808934|Anticoagulants|anticoagulants|mesh-ancestor
24457779|NCT00335192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24457780|NCT00335205|Ropinirole|ropinirole|mesh-list
24518586|NCT04786275|Fentanyl|fentanyl|mesh-list
24518592|NCT04786275|Sensory System Agents|sensory system agents|mesh-ancestor
24405408|NCT00166829|Sirolimus|sirolimus|mesh-list
24456786|NCT00332293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776648|NCT01858870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24776649|NCT01858870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24776650|NCT01858870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24776651|NCT01858870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776865|NCT01860300|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24776866|NCT01860300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24776867|NCT01860300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24776868|NCT01860300|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24776869|NCT01860300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24777075|NCT01861951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24777076|NCT01861951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24777077|NCT01861951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777078|NCT01861990|Valproic Acid|valproic acid|mesh-list
24777079|NCT01861990|Anticonvulsants|anticonvulsants|mesh-ancestor
24777080|NCT01861990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24777081|NCT01861990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777082|NCT01861990|GABA Agents|gaba agents|mesh-ancestor
24777083|NCT01861990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24777084|NCT01861990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169250|NCT01941836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115289|NCT03116971|Peposertib|peposertib|mesh-list
25019771|NCT03688230|Cetuximab|cetuximab|mesh-list
25019772|NCT03688230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25019773|NCT03688230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25111420|NCT04841434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25111421|NCT04841434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25111422|NCT04841434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25111423|NCT04841434|Antimetabolites|antimetabolites|mesh-ancestor
25111424|NCT04841434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25111425|NCT04841434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25111426|NCT04841434|Dermatologic Agents|dermatologic agents|mesh-ancestor
25210502|NCT05324748|Prednisolone phosphate|prednisolone phosphate|mesh-list
25210503|NCT05324748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25210504|NCT05324748|Antiemetics|antiemetics|mesh-ancestor
25210505|NCT05324748|Autonomic Agents|autonomic agents|mesh-ancestor
25210506|NCT05324748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25115398|NCT03116555|Irinotecan|irinotecan|mesh-list
25169251|NCT01941836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25169252|NCT01941836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169253|NCT01941836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25169254|NCT01941836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169255|NCT01940991|Botulinum Toxins|botulinum toxins|mesh-list
25544129|NCT04405908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544130|NCT04405908|Antacids|antacids|mesh-ancestor
25019941|NCT03686085|Dinoprostone|dinoprostone|mesh-list
25019942|NCT03686085|Oxytocics|oxytocics|mesh-ancestor
25019943|NCT03686085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24587030|NCT00893217|Interferons|interferons|mesh-list
24587031|NCT00893217|Interferon-beta|interferon-beta|mesh-list
24587032|NCT00893217|Interferon beta-1b|interferon beta-1b|mesh-list
24587033|NCT00893217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587034|NCT00893217|Antiviral Agents|antiviral agents|mesh-ancestor
24587035|NCT00893217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24587039|NCT00893256|Risperidone|risperidone|mesh-list
24518751|NCT04372927|Etoposide phosphate|etoposide phosphate|mesh-list
24649261|NCT01219101|Enclomiphene|enclomiphene|mesh-list
25210513|NCT05324748|Protective Agents|protective agents|mesh-ancestor
25210514|NCT05324748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25210515|NCT05324748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24518753|NCT04372927|Podophyllotoxin|podophyllotoxin|mesh-list
24518815|NCT04177953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24649285|NCT01219153|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25677330|NCT01809132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25677331|NCT01809132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677332|NCT01809132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677333|NCT01809132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25677334|NCT01809132|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25677335|NCT01809132|Vasodilator Agents|vasodilator agents|mesh-ancestor
25677336|NCT01809132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25677337|NCT01809132|Antioxidants|antioxidants|mesh-ancestor
25677338|NCT01809132|Astringents|astringents|mesh-ancestor
25544131|NCT04405908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544132|NCT04405908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25544133|NCT04364984|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25544134|NCT04364984|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25544135|NCT04364984|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
25544136|NCT04364984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544137|NCT04364984|Protease Inhibitors|protease inhibitors|mesh-ancestor
25544138|NCT04363437|Colchicine|colchicine|mesh-list
25544139|NCT04363437|Gout Suppressants|gout suppressants|mesh-ancestor
25544140|NCT04363437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25544141|NCT04363437|Tubulin Modulators|tubulin modulators|mesh-ancestor
25544142|NCT04363437|Antimitotic Agents|antimitotic agents|mesh-ancestor
25544143|NCT04363437|Mitosis Modulators|mitosis modulators|mesh-ancestor
25544144|NCT04363437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544145|NCT04363437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25544147|NCT04333459|Immunologic Factors|immunologic factors|mesh-ancestor
25544148|NCT04333459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544149|NCT04331496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25544150|NCT04304274|Morphine|morphine|mesh-list
25544151|NCT04304274|Ropivacaine|ropivacaine|mesh-list
25544152|NCT04304274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25544153|NCT04304274|Narcotics|narcotics|mesh-ancestor
25544154|NCT04304274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25544155|NCT04304274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544156|NCT04304274|Analgesics|analgesics|mesh-ancestor
25544157|NCT04304274|Sensory System Agents|sensory system agents|mesh-ancestor
25544158|NCT04304274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25544159|NCT04304274|Anesthetics, Local|anesthetics, local|mesh-ancestor
25544160|NCT04304274|Anesthetics|anesthetics|mesh-ancestor
25650844|NCT01508676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650845|NCT01508676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650846|NCT01508676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25650847|NCT01508676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25650848|NCT01508676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650849|NCT01508676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650850|NCT01508702|Lesinurad|lesinurad|mesh-list
25650851|NCT01508702|Gout Suppressants|gout suppressants|mesh-ancestor
25650852|NCT01508702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25650853|NCT01508702|Uricosuric Agents|uricosuric agents|mesh-ancestor
25020112|NCT03683277|Pomalidomide|pomalidomide|mesh-list
25020113|NCT03683277|Ixazomib|ixazomib|mesh-list
25020114|NCT03683277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25020115|NCT03683277|Antiemetics|antiemetics|mesh-ancestor
25020116|NCT03683277|Autonomic Agents|autonomic agents|mesh-ancestor
24896658|NCT04434248|Amebicides|amebicides|mesh-ancestor
25020125|NCT03683277|Immunologic Factors|immunologic factors|mesh-ancestor
25020126|NCT03683277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24518819|NCT04151082|Prednisone|prednisone|mesh-list
24518820|NCT04151082|Methylprednisolone|methylprednisolone|mesh-list
24518821|NCT04151082|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25650854|NCT01508702|Renal Agents|renal agents|mesh-ancestor
25650855|NCT01508832|Lidocaine|lidocaine|mesh-list
25650856|NCT01508832|Bupivacaine|bupivacaine|mesh-list
25650857|NCT01508832|Anesthetics, Local|anesthetics, local|mesh-ancestor
25650858|NCT01508832|Anesthetics|anesthetics|mesh-ancestor
25650859|NCT01508832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25650860|NCT01508832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650861|NCT01508832|Sensory System Agents|sensory system agents|mesh-ancestor
25650862|NCT01508832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650863|NCT01508832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25650864|NCT01508832|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25650865|NCT01508832|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25650866|NCT01508832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25650867|NCT01508832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650868|NCT01508936|Reslizumab|reslizumab|mesh-list
25650869|NCT01508936|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25650870|NCT01508936|Respiratory System Agents|respiratory system agents|mesh-ancestor
25650871|NCT01509079|Vitamin D|vitamin d|mesh-list
25650872|NCT01509079|Ergocalciferols|ergocalciferols|mesh-list
25650873|NCT01509079|Cholecalciferol|cholecalciferol|mesh-list
25650874|NCT01509079|Vitamins|vitamins|mesh-list
25650875|NCT01509079|Micronutrients|micronutrients|mesh-ancestor
25650876|NCT01509079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650877|NCT01509079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25650878|NCT01509079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25650879|NCT01509105|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25650880|NCT01509105|Immunologic Factors|immunologic factors|mesh-ancestor
25650881|NCT01509105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650882|NCT01509404|Valganciclovir|valganciclovir|mesh-list
25650883|NCT01509404|Antiviral Agents|antiviral agents|mesh-ancestor
25650884|NCT01509404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25650885|NCT01509547|Varenicline|varenicline|mesh-list
25650886|NCT01509547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25650887|NCT01509547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25650888|NCT01509547|Cholinergic Agents|cholinergic agents|mesh-ancestor
25650889|NCT01509547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25650890|NCT01509547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650891|NCT01509547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650892|NCT01509586|Lobeline|lobeline|mesh-list
25650893|NCT01509586|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25650894|NCT01509586|Autonomic Agents|autonomic agents|mesh-ancestor
25020244|NCT03682029|Vitamins|vitamins|mesh-ancestor
25020245|NCT03682029|Micronutrients|micronutrients|mesh-ancestor
25020246|NCT03682029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020247|NCT03682029|Antioxidants|antioxidants|mesh-ancestor
25020248|NCT03682029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020249|NCT03682029|Protective Agents|protective agents|mesh-ancestor
25020255|NCT03681652|Azathioprine|azathioprine|mesh-list
25020256|NCT03681652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25210527|NCT05324618|Hydrocortisone|hydrocortisone|mesh-list
24518823|NCT04151082|Prednisolone|prednisolone|mesh-list
24758263|NCT01744626|Rituximab|rituximab|mesh-list
25677353|NCT01809210|Immunologic Factors|immunologic factors|mesh-ancestor
25677354|NCT01809210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677355|NCT01809210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25677356|NCT01809210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25677357|NCT01809314|Epoetin Alfa|epoetin alfa|mesh-list
25677358|NCT01809314|Hematinics|hematinics|mesh-ancestor
25677359|NCT01809327|Metformin|metformin|mesh-list
25677360|NCT01809327|Canagliflozin|canagliflozin|mesh-list
25650895|NCT01509586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650896|NCT01509586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650897|NCT01509586|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25650898|NCT01509586|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25650899|NCT01509586|Cholinergic Agents|cholinergic agents|mesh-ancestor
25650900|NCT01509586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25544161|NCT04233567|Infigratinib|infigratinib|mesh-list
25544162|NCT04233567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25544163|NCT04220684|Cytarabine|cytarabine|mesh-list
25544164|NCT04220684|Fludarabine|fludarabine|mesh-list
25020455|NCT03680339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020456|NCT03680339|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25020457|NCT03680339|Abortifacient Agents|abortifacient agents|mesh-ancestor
25020458|NCT03680339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25020459|NCT03680339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25020460|NCT03680183|Entecavir|entecavir|mesh-list
25020461|NCT03680183|Antiviral Agents|antiviral agents|mesh-ancestor
25020471|NCT03679897|Ropivacaine|ropivacaine|mesh-list
24456792|NCT00332293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451497|NCT00323947|Dopamine Agents|dopamine agents|mesh-ancestor
24451517|NCT00324012|Antimitotic Agents|antimitotic agents|mesh-ancestor
24451518|NCT00324012|Mitosis Modulators|mitosis modulators|mesh-ancestor
24451519|NCT00324012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451520|NCT00324025|Efungumab|efungumab|mesh-list
24451521|NCT00324025|Antifungal Agents|antifungal agents|mesh-ancestor
24649559|NCT01220375|Plerixafor|plerixafor|mesh-list
24451522|NCT00324025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24451523|NCT00324051|Olanzapine|olanzapine|mesh-list
24451524|NCT00324051|Antiemetics|antiemetics|mesh-ancestor
24516482|NCT00602134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516483|NCT00602134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24451530|NCT00324051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24451531|NCT00324051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24451532|NCT00324051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24451533|NCT00324051|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24451534|NCT00324051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25210532|NCT05324618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25544165|NCT04220684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25544166|NCT04220684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25544167|NCT04220684|Antimetabolites|antimetabolites|mesh-ancestor
25544168|NCT04220684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544169|NCT04220684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25544170|NCT04220684|Immunologic Factors|immunologic factors|mesh-ancestor
25544171|NCT04220684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544172|NCT04220684|Antiviral Agents|antiviral agents|mesh-ancestor
25544173|NCT04220684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25544174|NCT04159974|Durvalumab|durvalumab|mesh-list
25544175|NCT04159974|Tremelimumab|tremelimumab|mesh-list
25544176|NCT04159974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25544177|NCT04159974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25544178|NCT04157725|Clomiphene|clomiphene|mesh-list
25544179|NCT04157725|Enclomiphene|enclomiphene|mesh-list
25544180|NCT04157725|Zuclomiphene|zuclomiphene|mesh-list
25544181|NCT04157725|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25544182|NCT04157725|Hormone Antagonists|hormone antagonists|mesh-ancestor
25544183|NCT04157725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25544184|NCT04157725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544185|NCT04157725|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25544186|NCT04157725|Fertility Agents|fertility agents|mesh-ancestor
25544187|NCT04157725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25544188|NCT04157725|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25544189|NCT04157725|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25544190|NCT04142502|Dexmedetomidine|dexmedetomidine|mesh-list
25544191|NCT04142502|Propofol|propofol|mesh-list
25544192|NCT04142502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25544193|NCT04142502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25544194|NCT04142502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020549|NCT03679065|BB 1101|bb 1101|mesh-list
24669742|NCT03691376|Analgesics|analgesics|mesh-ancestor
24649902|NCT01222468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24454380|NCT03975439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24454381|NCT03975439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24454382|NCT03975439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24649924|NCT01222676|Sorafenib|sorafenib|mesh-list
25210530|NCT05324618|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25210531|NCT05324618|Tacrolimus|tacrolimus|mesh-list
25210533|NCT05324618|Immunologic Factors|immunologic factors|mesh-ancestor
25210534|NCT05324618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518829|NCT04151082|Glucocorticoids|glucocorticoids|mesh-ancestor
24518830|NCT04151082|Hormones|hormones|mesh-ancestor
24518831|NCT04151082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24518832|NCT04151082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518833|NCT04151082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24518866|NCT04117672|Antidiarrheals|antidiarrheals|mesh-ancestor
24518867|NCT04117672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24518983|NCT03710772|Rituximab|rituximab|mesh-list
24518984|NCT03710772|Doxorubicin|doxorubicin|mesh-list
24518985|NCT03710772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25544195|NCT04142502|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25544196|NCT04142502|Anesthetics, General|anesthetics, general|mesh-ancestor
25544197|NCT04142502|Anesthetics|anesthetics|mesh-ancestor
25544198|NCT04142502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25544199|NCT04142502|Analgesics|analgesics|mesh-ancestor
25544200|NCT04142502|Sensory System Agents|sensory system agents|mesh-ancestor
25544201|NCT04142502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25544202|NCT04142502|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25544203|NCT04142502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25544204|NCT04142502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25544205|NCT04142502|Adrenergic Agents|adrenergic agents|mesh-ancestor
24479021|NCT00425243|Zolpidem|zolpidem|mesh-list
25544206|NCT04142502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25544207|NCT04142502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544208|NCT04118166|Nivolumab|nivolumab|mesh-list
25544209|NCT04118166|Ipilimumab|ipilimumab|mesh-list
25544210|NCT04118166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25544211|NCT04118166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25544212|NCT04118166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25544213|NCT04118166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544214|NCT04117581|Vitamin D|vitamin d|mesh-list
25544215|NCT04117581|Cholecalciferol|cholecalciferol|mesh-list
25544216|NCT04117581|Vitamins|vitamins|mesh-ancestor
25544217|NCT04117581|Micronutrients|micronutrients|mesh-ancestor
25544218|NCT04117581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544219|NCT04117581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25544220|NCT04117581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25544221|NCT04066725|Aspirin|aspirin|mesh-list
25544222|NCT04066725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25544223|NCT04066725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25544224|NCT04066725|Analgesics|analgesics|mesh-ancestor
25021034|NCT03675555|Histamine Antagonists|histamine antagonists|mesh-ancestor
25021035|NCT03675555|Histamine Agents|histamine agents|mesh-ancestor
25021036|NCT03675555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25021037|NCT03675555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021039|NCT03675555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25544225|NCT04066725|Sensory System Agents|sensory system agents|mesh-ancestor
25544226|NCT04066725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25544227|NCT04066725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544228|NCT04066725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25544229|NCT04066725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25544230|NCT04066725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25544231|NCT04066725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25544232|NCT04066725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544233|NCT04066725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25544234|NCT04066725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25544235|NCT04066725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544236|NCT04066725|Antipyretics|antipyretics|mesh-ancestor
25544237|NCT04062032|Aspirin|aspirin|mesh-list
25544238|NCT04062032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25544239|NCT04062032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25544240|NCT04062032|Analgesics|analgesics|mesh-ancestor
25544241|NCT04062032|Sensory System Agents|sensory system agents|mesh-ancestor
25544242|NCT04062032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25544243|NCT04062032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544244|NCT04062032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25544245|NCT04062032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25544246|NCT04062032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25544247|NCT04062032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25544248|NCT04062032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544249|NCT04062032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25544250|NCT04062032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25544251|NCT04062032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544252|NCT04062032|Antipyretics|antipyretics|mesh-ancestor
25544253|NCT04055844|Decitabine|decitabine|mesh-list
25544254|NCT04055844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25544255|NCT04055844|Antimetabolites|antimetabolites|mesh-ancestor
25544256|NCT04055844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544257|NCT04055844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25544258|NCT04055844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544259|NCT04033991|Sunitinib|sunitinib|mesh-list
25544260|NCT04033991|Axitinib|axitinib|mesh-list
25544261|NCT04033991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25544262|NCT04033991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25544263|NCT04033991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25544264|NCT04033991|Growth Substances|growth substances|mesh-ancestor
25544265|NCT04033991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544266|NCT04033991|Growth Inhibitors|growth inhibitors|mesh-ancestor
25544267|NCT04033991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25544268|NCT04033991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544269|NCT04033991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544270|NCT04027361|Amphetamine|amphetamine|mesh-list
25544271|NCT04027361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25544272|NCT04027361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544273|NCT04027361|Sympathomimetics|sympathomimetics|mesh-ancestor
25544274|NCT04027361|Autonomic Agents|autonomic agents|mesh-ancestor
25544275|NCT04027361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25544276|NCT04027361|Dopamine Agents|dopamine agents|mesh-ancestor
25544277|NCT04027361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25544278|NCT04027361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516596|NCT00602524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24650268|NCT01224847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24650286|NCT01224951|Hormones|hormones|mesh-ancestor
24650322|NCT01225198|Vitamins|vitamins|mesh-list
25210578|NCT05323955|Pertuzumab|pertuzumab|mesh-list
24519274|NCT02543255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24456810|NCT00332306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24456811|NCT00332306|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24456814|NCT00332306|Antimetabolites|antimetabolites|mesh-ancestor
25544279|NCT04027361|Adrenergic Agents|adrenergic agents|mesh-ancestor
25544280|NCT04027361|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25544281|NCT04027361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25544282|NCT04027361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25544283|NCT04027361|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25544284|NCT04011839|Levobupivacaine|levobupivacaine|mesh-list
25544285|NCT04011839|Anesthetics, Local|anesthetics, local|mesh-ancestor
25544286|NCT04011839|Anesthetics|anesthetics|mesh-ancestor
25544287|NCT04011839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25544288|NCT04011839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544289|NCT04011839|Sensory System Agents|sensory system agents|mesh-ancestor
25544290|NCT04011839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25257083|NCT02478515|Ranibizumab|ranibizumab|mesh-list
24516662|NCT00602693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516663|NCT00602693|Gout Suppressants|gout suppressants|mesh-ancestor
24650325|NCT01225224|Peficitinib|peficitinib|mesh-list
24650400|NCT01225523|Immunologic Factors|immunologic factors|mesh-ancestor
24420727|NCT00216658|Narcotics|narcotics|mesh-ancestor
25210579|NCT05323955|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25210580|NCT05323955|Maytansine|maytansine|mesh-list
25210581|NCT05323955|Tucatinib|tucatinib|mesh-list
24519276|NCT02543255|Hormones|hormones|mesh-ancestor
24519277|NCT02543255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24519305|NCT02437279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519306|NCT02224144|Vitamin D|vitamin d|mesh-list
24519307|NCT02224144|Cholecalciferol|cholecalciferol|mesh-list
24519308|NCT02224144|Calcitriol|calcitriol|mesh-list
24519309|NCT02224144|Vitamins|vitamins|mesh-ancestor
24519310|NCT02224144|Micronutrients|micronutrients|mesh-ancestor
24457785|NCT00335205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24457786|NCT00335205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519569|NCT05332470|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24519570|NCT05332470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24519571|NCT05332470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24519572|NCT05332470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519573|NCT05332470|Antiviral Agents|antiviral agents|mesh-ancestor
24456816|NCT00332319|Antiemetics|antiemetics|mesh-ancestor
24456817|NCT00332319|Autonomic Agents|autonomic agents|mesh-ancestor
24456818|NCT00332319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25677395|NCT01810380|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25544291|NCT03991091|Oxytocin|oxytocin|mesh-list
25544292|NCT03991091|Oxytocics|oxytocics|mesh-ancestor
25544293|NCT03991091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25544294|NCT03991091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544295|NCT03973229|Estradiol|estradiol|mesh-list
25544296|NCT03973229|Estrogens|estrogens|mesh-ancestor
25544297|NCT03973229|Hormones|hormones|mesh-ancestor
25544298|NCT03973229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25544299|NCT03973229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544300|NCT03934840|Prednisone|prednisone|mesh-list
25544301|NCT03934840|Carboplatin|carboplatin|mesh-list
25544302|NCT03934840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25544303|NCT03934840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25544304|NCT03934840|Glucocorticoids|glucocorticoids|mesh-ancestor
25544305|NCT03934840|Hormones|hormones|mesh-ancestor
25544306|NCT03934840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25544307|NCT03934840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544308|NCT03934840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25544309|NCT03930732|Cholinergic Agents|cholinergic agents|mesh-list
25440349|NCT04728230|Dermatologic Agents|dermatologic agents|mesh-ancestor
25544310|NCT03930732|Muscarinic Antagonists|muscarinic antagonists|mesh-list
25544311|NCT03930732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25021613|NCT03669757|Betamethasone Valerate|betamethasone valerate|mesh-list
25257100|NCT02478424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257101|NCT02478424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25257102|NCT02478424|Dermatologic Agents|dermatologic agents|mesh-ancestor
25257103|NCT02478424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257104|NCT02478424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25257105|NCT02478424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25257113|NCT02478710|Vancomycin|vancomycin|mesh-list
25210582|NCT05323955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25210583|NCT05323955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25210584|NCT05323955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25210585|NCT05323955|Tubulin Modulators|tubulin modulators|mesh-ancestor
25210586|NCT05323955|Antimitotic Agents|antimitotic agents|mesh-ancestor
25210587|NCT05323955|Mitosis Modulators|mitosis modulators|mesh-ancestor
25210589|NCT05323955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25544312|NCT03930732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544313|NCT03930732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544314|NCT03930732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25544315|NCT03896659|Hydrocortisone|hydrocortisone|mesh-list
25544316|NCT03896659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25544317|NCT03793439|Prednisone|prednisone|mesh-list
25544318|NCT03793439|Tofacitinib|tofacitinib|mesh-list
25544319|NCT03793439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25544320|NCT03793439|Glucocorticoids|glucocorticoids|mesh-ancestor
25544321|NCT03793439|Hormones|hormones|mesh-ancestor
25544322|NCT03793439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25544323|NCT03793439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544324|NCT03793439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25544325|NCT03793439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25544326|NCT03793439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25544327|NCT03793439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544328|NCT03793439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544329|NCT03729401|Aspirin|aspirin|mesh-list
25544330|NCT03729401|Clopidogrel|clopidogrel|mesh-list
25544331|NCT03729401|Ticagrelor|ticagrelor|mesh-list
25544332|NCT03729401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25544333|NCT03729401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25544334|NCT03729401|Analgesics|analgesics|mesh-ancestor
25544335|NCT03729401|Sensory System Agents|sensory system agents|mesh-ancestor
25544336|NCT03729401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25544337|NCT03729401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257150|NCT02478047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25257151|NCT02478047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25257152|NCT02478047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25257153|NCT02478047|Serotonin Agents|serotonin agents|mesh-ancestor
25257154|NCT02478047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25257155|NCT02478047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257156|NCT02478047|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25257157|NCT02478242|Nafamostat|nafamostat|mesh-list
25257158|NCT02478242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25257159|NCT02478242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25272658|NCT02390739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25272660|NCT02390843|Topotecan|topotecan|mesh-list
24520466|NCT01497509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24520468|NCT01497509|Narcotics|narcotics|mesh-ancestor
24520469|NCT01497509|Analgesics|analgesics|mesh-ancestor
25117010|NCT03105466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24449863|NCT00317330|Antimetabolites|antimetabolites|mesh-ancestor
25544338|NCT03729401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25544339|NCT03729401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25544340|NCT03729401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25544341|NCT03729401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25544342|NCT03729401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544343|NCT03729401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25544344|NCT03729401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25544345|NCT03729401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25021880|NCT03667326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25021884|NCT03667326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517048|NCT00605683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24517049|NCT00605683|Emetics|emetics|mesh-ancestor
24517050|NCT00605683|Autonomic Agents|autonomic agents|mesh-ancestor
25210655|NCT05323201|Cyclophosphamide|cyclophosphamide|mesh-list
25210656|NCT05323201|Fludarabine|fludarabine|mesh-list
25210657|NCT05323201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25210658|NCT05323201|Immunologic Factors|immunologic factors|mesh-ancestor
25544346|NCT03729401|Antipyretics|antipyretics|mesh-ancestor
25544347|NCT03729401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25544348|NCT03729401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25544349|NCT03729401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25544350|NCT03729401|Purinergic Agents|purinergic agents|mesh-ancestor
25544351|NCT03729401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25544352|NCT03722966|Nicotine|nicotine|mesh-list
25544353|NCT03722966|Varenicline|varenicline|mesh-list
25544354|NCT03722966|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25544355|NCT03722966|Autonomic Agents|autonomic agents|mesh-ancestor
25544356|NCT03722966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25544357|NCT03722966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544358|NCT03722966|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25544359|NCT03722966|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25544360|NCT03722966|Cholinergic Agents|cholinergic agents|mesh-ancestor
25544361|NCT03722966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25440422|NCT04727437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440423|NCT04727320|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
25440424|NCT04727320|Antiviral Agents|antiviral agents|mesh-ancestor
25440425|NCT04727320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25440426|NCT04727320|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25440427|NCT04727320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25440428|NCT04727502|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25440429|NCT04727502|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25440430|NCT04727502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25440431|NCT04727502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25544362|NCT03722966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544363|NCT03708354|Tocotrienols|tocotrienols|mesh-list
25544364|NCT03708354|Vitamin E|vitamin e|mesh-list
25544365|NCT03708354|Tocopherols|tocopherols|mesh-list
25544366|NCT03708354|Antioxidants|antioxidants|mesh-ancestor
25544367|NCT03708354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022164|NCT03665454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25257182|NCT02478034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25275031|NCT02374567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25275032|NCT02374567|Parasympatholytics|parasympatholytics|mesh-ancestor
25275033|NCT02374567|Autonomic Agents|autonomic agents|mesh-ancestor
25544368|NCT03708354|Protective Agents|protective agents|mesh-ancestor
25544369|NCT03708354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544370|NCT03708354|Vitamins|vitamins|mesh-ancestor
25544371|NCT03708354|Micronutrients|micronutrients|mesh-ancestor
25544372|NCT03571191|Denosumab|denosumab|mesh-list
25829446|NCT00006211|Capravirine|capravirine|mesh-list
25544373|NCT03571191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25544374|NCT03571191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544375|NCT03527472|Memantine|memantine|mesh-list
25544376|NCT03527472|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25544377|NCT03527472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25544378|NCT03527472|Dopamine Agents|dopamine agents|mesh-ancestor
25544379|NCT03527472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25544380|NCT03527472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544381|NCT03527472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544382|NCT03527472|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25544383|NCT03527472|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25544384|NCT03480971|Tempol|tempol|mesh-list
25544385|NCT03480971|TEMPO|tempo|mesh-list
25544386|NCT03480971|Antioxidants|antioxidants|mesh-ancestor
25544387|NCT03480971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544388|NCT03480971|Protective Agents|protective agents|mesh-ancestor
25544389|NCT03480971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544390|NCT03480971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25544391|NCT03480971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544392|NCT03480971|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25544393|NCT03480971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25544394|NCT03433833|Digoxin|digoxin|mesh-list
25544395|NCT03433833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25544396|NCT03433833|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25544397|NCT03433833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544398|NCT03433833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544399|NCT03433833|Protective Agents|protective agents|mesh-ancestor
25544400|NCT03433833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544401|NCT03376646|Paclitaxel|paclitaxel|mesh-list
25544402|NCT03376646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25544403|NCT03376646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25544404|NCT03376646|Tubulin Modulators|tubulin modulators|mesh-ancestor
25544405|NCT03376646|Antimitotic Agents|antimitotic agents|mesh-ancestor
25544406|NCT03376646|Mitosis Modulators|mitosis modulators|mesh-ancestor
25544407|NCT03376646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544408|NCT03359811|Bupivacaine|bupivacaine|mesh-list
25544409|NCT03359811|Anesthetics, Local|anesthetics, local|mesh-list
25022378|NCT03663478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022379|NCT03663478|Sensory System Agents|sensory system agents|mesh-ancestor
25257183|NCT02477956|Vitamin D|vitamin d|mesh-list
25544410|NCT03359811|Anesthetics|anesthetics|mesh-list
25544411|NCT03359811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25544412|NCT03359811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544413|NCT03359811|Sensory System Agents|sensory system agents|mesh-ancestor
25544414|NCT03359811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25544415|NCT03297684|Aflibercept|aflibercept|mesh-list
25544416|NCT03297684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25544417|NCT03297684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25544418|NCT03297684|Growth Substances|growth substances|mesh-ancestor
25544419|NCT03297684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544420|NCT03297684|Growth Inhibitors|growth inhibitors|mesh-ancestor
25544421|NCT03297684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25544422|NCT03262662|Varenicline|varenicline|mesh-list
25022491|NCT03662269|Indomethacin|indomethacin|mesh-list
25022492|NCT03662269|Omeprazole|omeprazole|mesh-list
25210764|NCT05297903|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25210765|NCT05297903|Immunologic Factors|immunologic factors|mesh-ancestor
25210766|NCT05297903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210767|NCT05297851|Riboflavin|riboflavin|mesh-list
25210768|NCT05297851|Niacinamide|niacinamide|mesh-list
25210769|NCT05297851|Niacin|niacin|mesh-list
25210770|NCT05297851|Nicotinic Acids|nicotinic acids|mesh-list
25210771|NCT05297851|Vitamin B Complex|vitamin b complex|mesh-ancestor
25210772|NCT05297851|Vitamins|vitamins|mesh-ancestor
25210773|NCT05297851|Micronutrients|micronutrients|mesh-ancestor
25210774|NCT05297851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210775|NCT05297851|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24465791|NCT00370734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465793|NCT00370734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24465794|NCT00370734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465795|NCT00370734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24465796|NCT00370734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24465926|NCT00371111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24465927|NCT00371124|Atropine|atropine|mesh-list
24394646|NCT00133822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24517802|NCT00610077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517803|NCT00610077|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25677455|NCT01811147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25677456|NCT01811147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25677457|NCT01811147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25677458|NCT01811147|Serotonin Agents|serotonin agents|mesh-ancestor
25677459|NCT01811147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25677460|NCT01811147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25677461|NCT01811186|Oxycodone|oxycodone|mesh-list
25544423|NCT03262662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25544424|NCT03262662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25544425|NCT03262662|Cholinergic Agents|cholinergic agents|mesh-ancestor
25544426|NCT03262662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25544427|NCT03262662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544428|NCT03262662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544429|NCT03179163|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25544430|NCT03179163|Enalapril|enalapril|mesh-list
25544431|NCT03179163|Captopril|captopril|mesh-list
25544432|NCT03179163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25544433|NCT03179163|Diuretics|diuretics|mesh-ancestor
25544434|NCT03179163|Natriuretic Agents|natriuretic agents|mesh-ancestor
25544435|NCT03179163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544436|NCT03179163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25544437|NCT03179163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25544438|NCT03179163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544439|NCT03179163|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25544440|NCT03179163|Protease Inhibitors|protease inhibitors|mesh-ancestor
25022613|NCT03661515|Immunologic Factors|immunologic factors|mesh-ancestor
24452136|NCT00326131|Taxane|taxane|mesh-list
25544441|NCT03179163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544442|NCT03177122|Inositol|inositol|mesh-list
25544443|NCT03177122|Vitamin B Complex|vitamin b complex|mesh-ancestor
25544444|NCT03177122|Vitamins|vitamins|mesh-ancestor
25544445|NCT03177122|Micronutrients|micronutrients|mesh-ancestor
25544446|NCT03177122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544447|NCT03004443|Infliximab|infliximab|mesh-list
25544448|NCT03004443|Dermatologic Agents|dermatologic agents|mesh-ancestor
25544449|NCT03004443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25544450|NCT03004443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25544451|NCT02959775|Vaccines|vaccines|mesh-list
25544452|NCT02959775|Immunologic Factors|immunologic factors|mesh-ancestor
25544453|NCT02959775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544454|NCT02954406|Gemcitabine|gemcitabine|mesh-list
25544455|NCT02954406|Rituximab|rituximab|mesh-list
25544456|NCT02954406|Lenalidomide|lenalidomide|mesh-list
25544457|NCT02954406|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25544458|NCT02954406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25544459|NCT02954406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25544460|NCT02954406|Immunologic Factors|immunologic factors|mesh-ancestor
25544461|NCT02954406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544462|NCT02954406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25544463|NCT02954406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25544464|NCT02954406|Antimetabolites|antimetabolites|mesh-ancestor
25544465|NCT02954406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544466|NCT02954406|Antiviral Agents|antiviral agents|mesh-ancestor
25544467|NCT02954406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25544468|NCT02954406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544469|NCT02954406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25544470|NCT02954406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25544471|NCT02954406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25544472|NCT02954406|Growth Substances|growth substances|mesh-ancestor
25544473|NCT02954406|Growth Inhibitors|growth inhibitors|mesh-ancestor
25544474|NCT02954406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25544475|NCT02954406|Alkylating Agents|alkylating agents|mesh-ancestor
25544476|NCT02924714|Imatinib Mesylate|imatinib mesylate|mesh-list
25544477|NCT02924714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25544478|NCT02924714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25544479|NCT02924714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25210798|NCT05273632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210799|NCT05273632|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25210800|NCT05273632|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25210802|NCT05273632|Hemostatics|hemostatics|mesh-ancestor
25544480|NCT02924714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544481|NCT02910583|Venetoclax|venetoclax|mesh-list
25544482|NCT02910583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25650901|NCT01509586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650902|NCT01509586|Respiratory System Agents|respiratory system agents|mesh-ancestor
25650903|NCT01509625|Fulvestrant|fulvestrant|mesh-list
25650904|NCT01509625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25650905|NCT01509625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25650906|NCT01509625|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25650907|NCT01509625|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25650908|NCT01509625|Hormone Antagonists|hormone antagonists|mesh-ancestor
25650909|NCT01509625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25650910|NCT01509625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650911|NCT01509638|Bupivacaine|bupivacaine|mesh-list
25650912|NCT01509638|Anesthetics, Local|anesthetics, local|mesh-ancestor
25650913|NCT01509638|Anesthetics|anesthetics|mesh-ancestor
25257267|NCT02477501|Ephedrine|ephedrine|mesh-list
25650914|NCT01509638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25650915|NCT01509638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650916|NCT01509638|Sensory System Agents|sensory system agents|mesh-ancestor
25650917|NCT01509638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650918|NCT01509807|Morphine|morphine|mesh-list
25650919|NCT01509807|Bupivacaine|bupivacaine|mesh-list
25650920|NCT01509807|Anesthetics, Local|anesthetics, local|mesh-ancestor
25650921|NCT01509807|Anesthetics|anesthetics|mesh-ancestor
25650922|NCT01509807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25650923|NCT01509807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650924|NCT01509807|Sensory System Agents|sensory system agents|mesh-ancestor
25650925|NCT01509807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650926|NCT01509807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25650927|NCT01509807|Narcotics|narcotics|mesh-ancestor
25650928|NCT01509807|Analgesics|analgesics|mesh-ancestor
25650929|NCT01509846|Vaccines|vaccines|mesh-list
25650930|NCT01509846|Immunologic Factors|immunologic factors|mesh-ancestor
25257282|NCT02477488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650931|NCT01509846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650932|NCT01510145|Travoprost|travoprost|mesh-list
25650933|NCT01510145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25650934|NCT01510158|Allopurinol|allopurinol|mesh-list
25650935|NCT01510158|Lesinurad|lesinurad|mesh-list
25650936|NCT01510158|Antimetabolites|antimetabolites|mesh-ancestor
25650937|NCT01510158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650938|NCT01510158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650939|NCT01510158|Gout Suppressants|gout suppressants|mesh-ancestor
25440519|NCT04726280|Ropivacaine|ropivacaine|mesh-list
25650940|NCT01510158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25544483|NCT02829268|Dantrolene|dantrolene|mesh-list
25544484|NCT02829268|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25544485|NCT02829268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544486|NCT02829268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25544487|NCT02829268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023132|NCT03657420|Autonomic Agents|autonomic agents|mesh-ancestor
25544488|NCT02776605|Prednisone|prednisone|mesh-list
25544489|NCT02776605|Methotrexate|methotrexate|mesh-list
25544490|NCT02776605|Vincristine|vincristine|mesh-list
25544491|NCT02776605|Daunorubicin|daunorubicin|mesh-list
25544492|NCT02776605|Mercaptopurine|mercaptopurine|mesh-list
25544493|NCT02776605|Ponatinib|ponatinib|mesh-list
25544494|NCT02776605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25544495|NCT02776605|Glucocorticoids|glucocorticoids|mesh-ancestor
25544496|NCT02776605|Hormones|hormones|mesh-ancestor
25544497|NCT02776605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25257314|NCT02477397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25544498|NCT02776605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544499|NCT02776605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25544500|NCT02776605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25544501|NCT02776605|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25544502|NCT02776605|Abortifacient Agents|abortifacient agents|mesh-ancestor
25544503|NCT02776605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25544504|NCT02776605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25544505|NCT02776605|Antimetabolites|antimetabolites|mesh-ancestor
25544506|NCT02776605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257345|NCT02476955|Paclitaxel|paclitaxel|mesh-list
25544507|NCT02776605|Dermatologic Agents|dermatologic agents|mesh-ancestor
25096521|NCT03211065|Antibodies|antibodies|mesh-list
25544508|NCT02776605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544509|NCT02776605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25544510|NCT02776605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25544511|NCT02776605|Immunologic Factors|immunologic factors|mesh-ancestor
25544512|NCT02776605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25544513|NCT02776605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25544514|NCT02776605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25544515|NCT02776605|Tubulin Modulators|tubulin modulators|mesh-ancestor
25544516|NCT02776605|Antimitotic Agents|antimitotic agents|mesh-ancestor
25544517|NCT02776605|Mitosis Modulators|mitosis modulators|mesh-ancestor
25544518|NCT02776605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25544519|NCT02776605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25544520|NCT02776605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25544521|NCT02776605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25544522|NCT02664155|Vitamin K|vitamin k|mesh-list
25544523|NCT02664155|Heparin|heparin|mesh-list
25544524|NCT02664155|Rivaroxaban|rivaroxaban|mesh-list
25544525|NCT02664155|Apixaban|apixaban|mesh-list
25544526|NCT02664155|Vitamins|vitamins|mesh-ancestor
25544527|NCT02664155|Micronutrients|micronutrients|mesh-ancestor
25544528|NCT02664155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528105|NCT00619710|Meropenem|meropenem|mesh-list
25544529|NCT02664155|Anticoagulants|anticoagulants|mesh-ancestor
25544530|NCT02664155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25544531|NCT02664155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25544532|NCT02664155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544533|NCT02664155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25544534|NCT02664155|Antithrombins|antithrombins|mesh-ancestor
25544535|NCT02664155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25544536|NCT02664155|Protease Inhibitors|protease inhibitors|mesh-ancestor
25544537|NCT02664155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544538|NCT02664155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25544539|NCT02664155|Hemostatics|hemostatics|mesh-ancestor
25544540|NCT02664155|Coagulants|coagulants|mesh-ancestor
25544541|NCT02592356|Lenvatinib|lenvatinib|mesh-list
25544542|NCT02592356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25544543|NCT02592356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25544544|NCT02592356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24929129|NCT04115410|Gemcitabine|gemcitabine|mesh-list
25544545|NCT02592356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544546|NCT02506933|Vaccines|vaccines|mesh-list
25544547|NCT02506933|Immunologic Factors|immunologic factors|mesh-ancestor
25544548|NCT02506933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544549|NCT02493751|Avelumab|avelumab|mesh-list
24897225|NCT04427020|Caseins|caseins|mesh-list
25112442|NCT04098237|Pancrelipase|pancrelipase|mesh-list
25544550|NCT02493751|Axitinib|axitinib|mesh-list
24587761|NCT00896948|Antibodies|antibodies|mesh-list
25544551|NCT02493751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25544552|NCT02493751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25544553|NCT02493751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25544554|NCT02493751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544555|NCT02493751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544556|NCT02446964|Mycophenolic Acid|mycophenolic acid|mesh-list
25544557|NCT02446964|Cyclophosphamide|cyclophosphamide|mesh-list
25544558|NCT02446964|Fludarabine|fludarabine|mesh-list
25544559|NCT02446964|Fludarabine phosphate|fludarabine phosphate|mesh-list
25544560|NCT02446964|Tacrolimus|tacrolimus|mesh-list
25544561|NCT02446964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25544562|NCT02446964|Immunologic Factors|immunologic factors|mesh-ancestor
25544563|NCT02446964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544564|NCT02446964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25544565|NCT02446964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25544566|NCT02446964|Alkylating Agents|alkylating agents|mesh-ancestor
25544567|NCT02446964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544568|NCT02446964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25544569|NCT02446964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25544570|NCT02446964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25544571|NCT02446964|Antimetabolites|antimetabolites|mesh-ancestor
25544572|NCT02446964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25544573|NCT02446964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544574|NCT02446964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25544575|NCT02446964|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25544576|NCT02446964|Antitubercular Agents|antitubercular agents|mesh-ancestor
25544577|NCT02446964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25544578|NCT02446964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25211376|NCT04409834|Heparin|heparin|mesh-list
25544579|NCT02394834|Calcium, Dietary|calcium, dietary|mesh-list
25544580|NCT02394834|Leucovorin|leucovorin|mesh-list
25544581|NCT02394834|Bevacizumab|bevacizumab|mesh-list
25544582|NCT02394834|Panitumumab|panitumumab|mesh-list
25544583|NCT02394834|Oxaliplatin|oxaliplatin|mesh-list
25544584|NCT02394834|Fluorouracil|fluorouracil|mesh-list
25544585|NCT02394834|Calcium|calcium|mesh-list
25544586|NCT02394834|Levoleucovorin|levoleucovorin|mesh-list
25544587|NCT02394834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25544588|NCT02394834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25544589|NCT02394834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25544590|NCT02394834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25544591|NCT02394834|Growth Substances|growth substances|mesh-ancestor
25544592|NCT02394834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544593|NCT02394834|Growth Inhibitors|growth inhibitors|mesh-ancestor
25544594|NCT02394834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25544595|NCT02394834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25544596|NCT02394834|Antimetabolites|antimetabolites|mesh-ancestor
25544597|NCT02394834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544598|NCT02394834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25544599|NCT02394834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25544600|NCT02394834|Immunologic Factors|immunologic factors|mesh-ancestor
25544601|NCT02394834|Antidotes|antidotes|mesh-ancestor
25544602|NCT02394834|Protective Agents|protective agents|mesh-ancestor
25544603|NCT02394834|Vitamin B Complex|vitamin b complex|mesh-ancestor
25544604|NCT02394834|Vitamins|vitamins|mesh-ancestor
25544605|NCT02394834|Micronutrients|micronutrients|mesh-ancestor
25544606|NCT02394795|Calcium, Dietary|calcium, dietary|mesh-list
25544607|NCT02394795|Leucovorin|leucovorin|mesh-list
25544608|NCT02394795|Bevacizumab|bevacizumab|mesh-list
25112734|NCT03919526|Alkylating Agents|alkylating agents|mesh-ancestor
25112735|NCT03919526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544609|NCT02394795|Panitumumab|panitumumab|mesh-list
25544610|NCT02394795|Oxaliplatin|oxaliplatin|mesh-list
25544611|NCT02394795|Fluorouracil|fluorouracil|mesh-list
25544612|NCT02394795|Calcium|calcium|mesh-list
25544613|NCT02394795|Levoleucovorin|levoleucovorin|mesh-list
25544614|NCT02394795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25544615|NCT02394795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25544616|NCT02394795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25544617|NCT02394795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25544618|NCT02394795|Growth Substances|growth substances|mesh-ancestor
25544619|NCT02394795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544620|NCT02394795|Growth Inhibitors|growth inhibitors|mesh-ancestor
25544621|NCT02394795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25544622|NCT02394795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25544623|NCT02394795|Antimetabolites|antimetabolites|mesh-ancestor
25544624|NCT02394795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544625|NCT02394795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25544626|NCT02394795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25544627|NCT02394795|Immunologic Factors|immunologic factors|mesh-ancestor
25544628|NCT02394795|Antidotes|antidotes|mesh-ancestor
25544629|NCT02394795|Protective Agents|protective agents|mesh-ancestor
25544630|NCT02394795|Vitamin B Complex|vitamin b complex|mesh-ancestor
25544631|NCT02394795|Vitamins|vitamins|mesh-ancestor
25544632|NCT02394795|Micronutrients|micronutrients|mesh-ancestor
25544633|NCT02285166|Hypolipidemic Agents|hypolipidemic agents|mesh-list
25544634|NCT02285166|Antimetabolites|antimetabolites|mesh-ancestor
25544635|NCT02285166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544636|NCT02285166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25544637|NCT02202772|Gemcitabine|gemcitabine|mesh-list
25544638|NCT02202772|Cisplatin|cisplatin|mesh-list
25211612|NCT04052620|Diclofenac|diclofenac|mesh-list
25211613|NCT04052620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25211614|NCT04052620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25211615|NCT04052620|Analgesics|analgesics|mesh-ancestor
25211616|NCT04052620|Sensory System Agents|sensory system agents|mesh-ancestor
25211617|NCT04052620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25211618|NCT04052620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211619|NCT04052620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25211620|NCT04052620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25211621|NCT04052620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25211622|NCT04052620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25211624|NCT04048278|Lidocaine|lidocaine|mesh-list
25544639|NCT02202772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25544640|NCT02202772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25544641|NCT02202772|Antimetabolites|antimetabolites|mesh-ancestor
25544642|NCT02202772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544643|NCT02202772|Antiviral Agents|antiviral agents|mesh-ancestor
25544644|NCT02202772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25544645|NCT02202772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544646|NCT02202772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25544647|NCT02202772|Immunologic Factors|immunologic factors|mesh-ancestor
25544648|NCT02202772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544649|NCT02174822|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25544650|NCT02174822|Paroxetine|paroxetine|mesh-list
25440705|NCT04725422|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25440706|NCT04725422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25440707|NCT04725214|Temozolomide|temozolomide|mesh-list
25440708|NCT04725214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25440709|NCT04725214|Alkylating Agents|alkylating agents|mesh-ancestor
25440710|NCT04725214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440711|NCT04725214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440712|NCT04724486|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25440713|NCT04724486|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25440714|NCT04724486|Cetrorelix|cetrorelix|mesh-list
25440715|NCT04724486|Menotropins|menotropins|mesh-list
25440716|NCT04724486|Luteolytic Agents|luteolytic agents|mesh-ancestor
25440717|NCT04724486|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25440718|NCT04724486|Contraceptive Agents|contraceptive agents|mesh-ancestor
25440719|NCT04724486|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25440720|NCT04724486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440721|NCT04724486|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25440722|NCT04724486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25440723|NCT04724486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440724|NCT04724486|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25028272|NCT03612323|Piroxicam|piroxicam|mesh-list
25440725|NCT04724486|Fertility Agents|fertility agents|mesh-ancestor
25440726|NCT04724486|Hormone Antagonists|hormone antagonists|mesh-ancestor
25440727|NCT04724486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25440728|NCT04724473|Tretinoin|tretinoin|mesh-list
25440729|NCT04724473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440730|NCT04724473|Keratolytic Agents|keratolytic agents|mesh-ancestor
25440731|NCT04724473|Dermatologic Agents|dermatologic agents|mesh-ancestor
25440732|NCT04724538|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
25440733|NCT04724538|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25440734|NCT04724538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292934|NCT05104762|Immunologic Factors|immunologic factors|mesh-ancestor
25544651|NCT02174822|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25544652|NCT02174822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25544653|NCT02174822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25544654|NCT02174822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544655|NCT02174822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25544656|NCT02174822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544657|NCT02174822|Analgesics|analgesics|mesh-ancestor
25544658|NCT02174822|Sensory System Agents|sensory system agents|mesh-ancestor
25544659|NCT02174822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25544660|NCT02174822|Antidepressive Agents|antidepressive agents|mesh-ancestor
25544661|NCT02174822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25544662|NCT02174822|Dopamine Agents|dopamine agents|mesh-ancestor
25544663|NCT02174822|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25544664|NCT02174822|Serotonin Agents|serotonin agents|mesh-ancestor
25544665|NCT02174822|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25544666|NCT02174822|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25544667|NCT02174822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25544668|NCT02174822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544669|NCT01961063|Busulfan|busulfan|mesh-list
25544670|NCT01961063|Alkylating Agents|alkylating agents|mesh-ancestor
25544671|NCT01961063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544672|NCT01961063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25544673|NCT01961063|Immunologic Factors|immunologic factors|mesh-ancestor
24820712|NCT02101138|Antioxidants|antioxidants|mesh-ancestor
24705569|NCT01485718|Cathartics|cathartics|mesh-ancestor
25544674|NCT01961063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544675|NCT01961063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25544676|NCT01961063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25544677|NCT01961063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25544678|NCT01909245|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25544679|NCT01909245|Gastrins|gastrins|mesh-list
25544680|NCT01909245|Immunologic Factors|immunologic factors|mesh-ancestor
25544681|NCT01909245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544682|NCT01909245|Hormones|hormones|mesh-ancestor
24978993|NCT01996436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544683|NCT01909245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25544684|NCT01885689|Sirolimus|sirolimus|mesh-list
25544685|NCT01885689|Melphalan|melphalan|mesh-list
25544686|NCT01885689|Clofarabine|clofarabine|mesh-list
25544687|NCT01885689|Tacrolimus|tacrolimus|mesh-list
25544688|NCT01885689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25211828|NCT03664180|Enoxaparin|enoxaparin|mesh-list
25544689|NCT01885689|Immunologic Factors|immunologic factors|mesh-ancestor
25544690|NCT01885689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544691|NCT01885689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25544692|NCT01885689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544693|NCT01885689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544694|NCT01885689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25544695|NCT01885689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25544696|NCT01885689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25544697|NCT01885689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25544698|NCT01885689|Antifungal Agents|antifungal agents|mesh-ancestor
25544699|NCT01885689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25544700|NCT01885689|Alkylating Agents|alkylating agents|mesh-ancestor
25544701|NCT01885689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25544702|NCT01885689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25544703|NCT01885689|Antimetabolites|antimetabolites|mesh-ancestor
25544704|NCT01872260|Letrozole|letrozole|mesh-list
25544705|NCT01872260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25544706|NCT01872260|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25544707|NCT01872260|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25544708|NCT01872260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544709|NCT01872260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544710|NCT01872260|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25544711|NCT01872260|Hormone Antagonists|hormone antagonists|mesh-ancestor
25544712|NCT01872260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25544713|NCT01872260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544714|NCT01740648|Fluorouracil|fluorouracil|mesh-list
25544715|NCT01740648|Trametinib|trametinib|mesh-list
25544716|NCT01740648|Antimetabolites|antimetabolites|mesh-ancestor
25544717|NCT01740648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544718|NCT01740648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25544719|NCT01740648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25544720|NCT01740648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25544721|NCT01740648|Immunologic Factors|immunologic factors|mesh-ancestor
25544722|NCT01740648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544723|NCT01740648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25544724|NCT01740648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544725|NCT01685424|Etoricoxib|etoricoxib|mesh-list
25544726|NCT01685424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25544727|NCT01685424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25544728|NCT01685424|Analgesics|analgesics|mesh-ancestor
25544729|NCT01685424|Sensory System Agents|sensory system agents|mesh-ancestor
25544730|NCT01685424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25544731|NCT01685424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544732|NCT01685424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25544733|NCT01685424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25544734|NCT01685424|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25544735|NCT01685424|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25544736|NCT01685424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544737|NCT01685424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544738|NCT01587235|Simvastatin|simvastatin|mesh-list
25544739|NCT01587235|Ezetimibe|ezetimibe|mesh-list
25544740|NCT01587235|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
25544741|NCT01587235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25544742|NCT01587235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25544743|NCT01587235|Antimetabolites|antimetabolites|mesh-ancestor
25544744|NCT01587235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544745|NCT01587235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24410217|NCT00184886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25211889|NCT03551691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211890|NCT03548805|Mitomycins|mitomycins|mesh-list
25211891|NCT03548805|Mitomycin|mitomycin|mesh-list
25211892|NCT03548805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25211893|NCT03548805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25211894|NCT03548805|Alkylating Agents|alkylating agents|mesh-ancestor
25211895|NCT03548805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211896|NCT03548805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25211897|NCT03548805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24410220|NCT00184899|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25544746|NCT01587235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25544747|NCT01587235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544748|NCT01583322|Nintedanib|nintedanib|mesh-list
25544749|NCT01583322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25544750|NCT01583322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25544751|NCT01583322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544752|NCT01583322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544753|NCT01571128|Tenofovir|tenofovir|mesh-list
25544754|NCT01571128|Emtricitabine|emtricitabine|mesh-list
25544755|NCT01571128|Antiviral Agents|antiviral agents|mesh-ancestor
25544756|NCT01571128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25544757|NCT01571128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25544758|NCT01571128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25544759|NCT01571128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544760|NCT01571128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544761|NCT01571128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25544762|NCT01571128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25544763|NCT01429168|Etoricoxib|etoricoxib|mesh-list
25544764|NCT01429168|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25544765|NCT01429168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25544766|NCT01429168|Analgesics|analgesics|mesh-ancestor
25544767|NCT01429168|Sensory System Agents|sensory system agents|mesh-ancestor
25544768|NCT01429168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25544769|NCT01429168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544770|NCT01429168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25257775|NCT02475343|Dermatologic Agents|dermatologic agents|mesh-ancestor
25257776|NCT02475356|Levonorgestrel|levonorgestrel|mesh-list
25257777|NCT02475356|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25257790|NCT02475135|Elvitegravir|elvitegravir|mesh-list
25257791|NCT02475135|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
25257792|NCT02475135|Antiviral Agents|antiviral agents|mesh-ancestor
25257793|NCT02475135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25257794|NCT02475135|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25544771|NCT01429168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25544772|NCT01429168|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25544773|NCT01429168|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25544774|NCT01429168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544775|NCT01429168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544776|NCT01327638|Etoricoxib|etoricoxib|mesh-list
25544777|NCT01327638|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
25544778|NCT01327638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25544779|NCT01327638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25544780|NCT01327638|Analgesics|analgesics|mesh-ancestor
25544781|NCT01327638|Sensory System Agents|sensory system agents|mesh-ancestor
25544782|NCT01327638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25544783|NCT01327638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544784|NCT01327638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25544785|NCT01327638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25544786|NCT01327638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25544787|NCT01327638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257849|NCT02474654|Anesthetics|anesthetics|mesh-ancestor
25544788|NCT01327638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544789|NCT01077843|Etoricoxib|etoricoxib|mesh-list
25544790|NCT01077843|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
25544791|NCT01077843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25544792|NCT01077843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25544793|NCT01077843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25544794|NCT01077843|Analgesics|analgesics|mesh-ancestor
25212073|NCT02641873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25544795|NCT01077843|Sensory System Agents|sensory system agents|mesh-ancestor
25544796|NCT01077843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25544797|NCT01077843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544798|NCT01077843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25544799|NCT01077843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25544800|NCT01077843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544801|NCT01077843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544802|NCT00771160|Montelukast|montelukast|mesh-list
25544803|NCT00771160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25544804|NCT00771160|Respiratory System Agents|respiratory system agents|mesh-ancestor
25544805|NCT00771160|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25544806|NCT00771160|Hormone Antagonists|hormone antagonists|mesh-ancestor
25544807|NCT00771160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25544808|NCT00771160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544809|NCT00771160|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25544810|NCT00771160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24528529|NCT00621478|Lorazepam|lorazepam|mesh-list
24528530|NCT00621478|Anticonvulsants|anticonvulsants|mesh-ancestor
24929682|NCT04110028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24413300|NCT00193505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822045|NCT02109510|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24929750|NCT04109872|Growth Inhibitors|growth inhibitors|mesh-ancestor
25544811|NCT00771160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544812|NCT00756418|Theophylline|theophylline|mesh-list
25544813|NCT00756418|Montelukast|montelukast|mesh-list
25156224|NCT05093205|Estrogens|estrogens|mesh-ancestor
24658049|NCT01270165|Telbivudine|telbivudine|mesh-list
24658050|NCT01270165|Antiviral Agents|antiviral agents|mesh-ancestor
24658051|NCT01270165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24658055|NCT01270178|Entecavir|entecavir|mesh-list
25212387|NCT01614912|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25544814|NCT00756418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25544815|NCT00756418|Respiratory System Agents|respiratory system agents|mesh-ancestor
25544816|NCT00756418|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24930035|NCT04105985|Sympathomimetics|sympathomimetics|mesh-ancestor
25544817|NCT00756418|Hormone Antagonists|hormone antagonists|mesh-ancestor
24930119|NCT04105231|Serotonin Agents|serotonin agents|mesh-ancestor
25544818|NCT00756418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25544819|NCT00756418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544820|NCT00756418|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25544821|NCT00756418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25049727|NCT00576667|Hormones|hormones|mesh-ancestor
25544822|NCT00756418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034103|NCT03567629|Cetuximab|cetuximab|mesh-list
25544823|NCT00756418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25544824|NCT00756418|Autonomic Agents|autonomic agents|mesh-ancestor
25440886|NCT04721899|Vitamins|vitamins|mesh-ancestor
25440887|NCT04721899|Micronutrients|micronutrients|mesh-ancestor
25440888|NCT04721899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212597|NCT02697318|Timolol|timolol|mesh-list
25440889|NCT04721899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25440890|NCT04721964|Ferrous fumarate|ferrous fumarate|mesh-list
25440891|NCT04721964|Trace Elements|trace elements|mesh-ancestor
25440892|NCT04721964|Micronutrients|micronutrients|mesh-ancestor
25440893|NCT04721964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293138|NCT03769688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25293139|NCT03769688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25293140|NCT03769688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25293146|NCT03691311|Denosumab|denosumab|mesh-list
25293147|NCT03691311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24823542|NCT02117739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24588381|NCT00902421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25293148|NCT03691311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293149|NCT03690453|Ivermectin|ivermectin|mesh-list
25293150|NCT03690453|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25293151|NCT03690453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25169256|NCT01940991|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25169257|NCT01940991|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25169258|NCT01940991|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25169259|NCT01940991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25034699|NCT03563144|Vitamins|vitamins|mesh-ancestor
25169260|NCT01940991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169261|NCT01940991|Cholinergic Agents|cholinergic agents|mesh-ancestor
25169262|NCT01940991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25169263|NCT01940991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169264|NCT01940991|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25169265|NCT01940991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25169266|NCT01930357|Vaccines|vaccines|mesh-list
25169267|NCT01930357|Immunologic Factors|immunologic factors|mesh-ancestor
25169268|NCT01930357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169269|NCT01927198|Verinurad|verinurad|mesh-list
25169270|NCT01927198|Gout Suppressants|gout suppressants|mesh-ancestor
25169271|NCT01927198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25169272|NCT01922843|Calcitriol|calcitriol|mesh-list
24424308|NCT00228605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25169273|NCT01922843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25034921|NCT03561181|Vaccines|vaccines|mesh-list
25169274|NCT01922843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169275|NCT01922843|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25169276|NCT01922843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25169277|NCT01922843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169349|NCT01902381|Vitamins|vitamins|mesh-ancestor
25115661|NCT03114072|Adrenergic Agents|adrenergic agents|mesh-ancestor
25169281|NCT01922843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25169283|NCT01917383|Latanoprost|latanoprost|mesh-list
25169284|NCT01917383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25169285|NCT01917383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25169286|NCT01917383|Adrenergic Agents|adrenergic agents|mesh-ancestor
25169287|NCT01917383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25169288|NCT01917383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169289|NCT01917383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169290|NCT01917383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25169291|NCT01917383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25115740|NCT03113110|Empagliflozin|empagliflozin|mesh-list
25169292|NCT01917383|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25169293|NCT01917383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25169294|NCT01913158|Hydrocortisone|hydrocortisone|mesh-list
25169295|NCT01913158|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25169296|NCT01913158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25544825|NCT00756418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25544826|NCT00756418|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25544827|NCT00756418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544828|NCT00756418|Vasodilator Agents|vasodilator agents|mesh-ancestor
25544829|NCT00756418|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25544830|NCT00756418|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25544831|NCT00756418|Purinergic Agents|purinergic agents|mesh-ancestor
25544832|NCT00756418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25544833|NCT00755794|Montelukast|montelukast|mesh-list
25544834|NCT00755794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25544835|NCT00755794|Respiratory System Agents|respiratory system agents|mesh-ancestor
25544836|NCT00755794|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25544837|NCT00755794|Hormone Antagonists|hormone antagonists|mesh-ancestor
25544838|NCT00755794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25544839|NCT00755794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544840|NCT00755794|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25544841|NCT00755794|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25544842|NCT00755794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544843|NCT00700661|Montelukast|montelukast|mesh-list
24427514|NCT00238316|Letrozole|letrozole|mesh-list
25544844|NCT00700661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25544845|NCT00700661|Respiratory System Agents|respiratory system agents|mesh-ancestor
25544846|NCT00700661|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25544847|NCT00700661|Hormone Antagonists|hormone antagonists|mesh-ancestor
25544848|NCT00700661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24547564|NCT00704678|Sevelamer|sevelamer|mesh-list
25544849|NCT00700661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544850|NCT00700661|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25544851|NCT00700661|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25544852|NCT00700661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544853|NCT00653276|Cyclosporine|cyclosporine|mesh-list
25544854|NCT00653276|Ezetimibe|ezetimibe|mesh-list
25544855|NCT00653276|Cyclosporins|cyclosporins|mesh-list
25544856|NCT00653276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544857|NCT00653276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544858|NCT00653276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25544859|NCT00653276|Immunologic Factors|immunologic factors|mesh-ancestor
25544860|NCT00653276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428261|NCT00240045|Octreotide|octreotide|mesh-list
25544861|NCT00653276|Antifungal Agents|antifungal agents|mesh-ancestor
25544862|NCT00653276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25544863|NCT00653276|Dermatologic Agents|dermatologic agents|mesh-ancestor
25544864|NCT00653276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25544865|NCT00653276|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25544866|NCT00653276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25544867|NCT00653276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25544868|NCT00653276|Antimetabolites|antimetabolites|mesh-ancestor
25544869|NCT00653276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25544870|NCT00652847|Ezetimibe|ezetimibe|mesh-list
25544871|NCT00652847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25544872|NCT00652847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25544873|NCT00652847|Antimetabolites|antimetabolites|mesh-ancestor
25544874|NCT00652847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930870|NCT04095754|Analgesics|analgesics|mesh-ancestor
25544875|NCT00652847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25544876|NCT00652717|Simvastatin|simvastatin|mesh-list
24930925|NCT04095182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25544877|NCT00652717|Ezetimibe|ezetimibe|mesh-list
25544878|NCT00652717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25544879|NCT00652717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25544880|NCT00652717|Antimetabolites|antimetabolites|mesh-ancestor
25544881|NCT00652717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993868|NCT05328336|Tubulin Modulators|tubulin modulators|mesh-ancestor
25213117|NCT05141552|Dapagliflozin|dapagliflozin|mesh-list
24624994|NCT01079715|Vasodilator Agents|vasodilator agents|mesh-ancestor
24777880|NCT01867697|Levoleucovorin|levoleucovorin|mesh-list
25544882|NCT00652717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24931323|NCT04090021|Levofloxacin|levofloxacin|mesh-list
24931526|NCT04088084|Palmidrol|palmidrol|mesh-list
24717815|NCT01550146|BB 1101|bb 1101|mesh-list
25039476|NCT03824587|Calcium|calcium|mesh-list
25039974|NCT03541655|Anesthetics|anesthetics|mesh-ancestor
25544883|NCT00652717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25544884|NCT00652717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544885|NCT00652444|Simvastatin|simvastatin|mesh-list
25544886|NCT00652444|Ezetimibe|ezetimibe|mesh-list
25544887|NCT00652444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25544888|NCT00652444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25544889|NCT00652444|Antimetabolites|antimetabolites|mesh-ancestor
25544890|NCT00652444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544891|NCT00652444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25544892|NCT00652444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24931864|NCT04085419|Zoledronic Acid|zoledronic acid|mesh-list
25544893|NCT00652444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544894|NCT00652301|Simvastatin|simvastatin|mesh-list
25544895|NCT00652301|Ezetimibe|ezetimibe|mesh-list
25544896|NCT00652301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25544897|NCT00652301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25544898|NCT00652301|Antimetabolites|antimetabolites|mesh-ancestor
25544899|NCT00652301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544900|NCT00652301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25544901|NCT00652301|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25544902|NCT00652301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544903|NCT00651963|Ezetimibe|ezetimibe|mesh-list
24780509|NCT01884636|Isavuconazole|isavuconazole|mesh-list
24936114|NCT04043897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25544904|NCT00651963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25544905|NCT00651963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25544906|NCT00651963|Antimetabolites|antimetabolites|mesh-ancestor
25544907|NCT00651963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544908|NCT00651963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25544909|NCT00651560|Simvastatin|simvastatin|mesh-list
25544910|NCT00651560|Ezetimibe|ezetimibe|mesh-list
25544911|NCT00651560|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25544912|NCT00651560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25544913|NCT00651560|Antimetabolites|antimetabolites|mesh-ancestor
25544914|NCT00651560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780794|NCT01886404|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24780795|NCT01886404|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24780798|NCT01886443|Tocopherols|tocopherols|mesh-list
25544915|NCT00651560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25544916|NCT00651560|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25544918|NCT00553891|Mometasone Furoate|mometasone furoate|mesh-list
25544919|NCT00553891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25544920|NCT00553891|Dermatologic Agents|dermatologic agents|mesh-ancestor
25544921|NCT00553891|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25544922|NCT00551876|Simvastatin|simvastatin|mesh-list
25544923|NCT00551876|Ezetimibe|ezetimibe|mesh-list
25544924|NCT00551876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25544925|NCT00551876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24781102|NCT01888042|Everolimus|everolimus|mesh-list
25544926|NCT00551876|Antimetabolites|antimetabolites|mesh-ancestor
25544927|NCT00551876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544928|NCT00551876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25544929|NCT00551876|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25544930|NCT00551876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544931|NCT00551447|Simvastatin|simvastatin|mesh-list
25544932|NCT00551447|Ezetimibe|ezetimibe|mesh-list
25544933|NCT00551447|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24781169|NCT01888302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24781175|NCT01888328|Isotretinoin|isotretinoin|mesh-list
24781176|NCT01888328|Dermatologic Agents|dermatologic agents|mesh-ancestor
24781177|NCT01888341|Isotretinoin|isotretinoin|mesh-list
24799326|NCT01968460|Dopamine Agonists|dopamine agonists|mesh-ancestor
24781178|NCT01888341|Dermatologic Agents|dermatologic agents|mesh-ancestor
25544934|NCT00551447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25544935|NCT00551447|Antimetabolites|antimetabolites|mesh-ancestor
25544936|NCT00551447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902898|NCT04368585|TEMPO|tempo|mesh-list
25544937|NCT00551447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24674124|NCT01342198|Erythromycin|erythromycin|mesh-list
25544938|NCT00551447|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25544939|NCT00551447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544940|NCT00542087|Diclofenac|diclofenac|mesh-list
25544941|NCT00542087|Etoricoxib|etoricoxib|mesh-list
25544942|NCT00542087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25544943|NCT00542087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25544944|NCT00542087|Analgesics|analgesics|mesh-ancestor
25544945|NCT00542087|Sensory System Agents|sensory system agents|mesh-ancestor
25544946|NCT00542087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24621132|NCT01060774|Lidocaine|lidocaine|mesh-list
25544947|NCT00542087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544948|NCT00542087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25544949|NCT00542087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25544950|NCT00542087|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25544951|NCT00542087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24782419|NCT01895998|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25544952|NCT00542087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544953|NCT00542087|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25544954|NCT00541697|Atorvastatin|atorvastatin|mesh-list
25544955|NCT00541697|Simvastatin|simvastatin|mesh-list
25544956|NCT00541697|Ezetimibe|ezetimibe|mesh-list
25544957|NCT00541697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25544958|NCT00541697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25544959|NCT00541697|Antimetabolites|antimetabolites|mesh-ancestor
25260839|NCT02456454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544960|NCT00541697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544961|NCT00541697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24491848|NCT00484133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25544962|NCT00541697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25260957|NCT02456142|Analgesics|analgesics|mesh-ancestor
25544963|NCT00541697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544964|NCT00489346|Fluticasone|fluticasone|mesh-list
25544965|NCT00489346|Xhance|xhance|mesh-list
25544966|NCT00489346|Montelukast|montelukast|mesh-list
25544967|NCT00489346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25544968|NCT00489346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25544969|NCT00489346|Autonomic Agents|autonomic agents|mesh-ancestor
25544970|NCT00489346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24529848|NCT00628043|Epoetin Alfa|epoetin alfa|mesh-list
25544971|NCT00489346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25544972|NCT00489346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25544973|NCT00489346|Respiratory System Agents|respiratory system agents|mesh-ancestor
25544974|NCT00489346|Dermatologic Agents|dermatologic agents|mesh-ancestor
25544975|NCT00489346|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25544976|NCT00489346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544977|NCT00489346|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25544978|NCT00489346|Hormone Antagonists|hormone antagonists|mesh-ancestor
24932786|NCT04076709|Anesthetics|anesthetics|mesh-list
25544979|NCT00489346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25544980|NCT00489346|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25544981|NCT00489346|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25544982|NCT00395603|Atorvastatin|atorvastatin|mesh-list
25544983|NCT00395603|Simvastatin|simvastatin|mesh-list
25544984|NCT00395603|Ezetimibe|ezetimibe|mesh-list
25544985|NCT00395603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25544986|NCT00395603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25544987|NCT00395603|Antimetabolites|antimetabolites|mesh-ancestor
24621237|NCT01061112|Analgesics|analgesics|mesh-ancestor
25544988|NCT00395603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932856|NCT04076228|Pembrolizumab|pembrolizumab|mesh-list
25544989|NCT00395603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25544990|NCT00395603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25544991|NCT00395603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25544992|NCT00395473|Ezetimibe|ezetimibe|mesh-list
25544993|NCT00395473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25544994|NCT00395473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25544995|NCT00395473|Antimetabolites|antimetabolites|mesh-ancestor
25544996|NCT00395473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25544997|NCT00395473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25544998|NCT00393354|Etoricoxib|etoricoxib|mesh-list
25544999|NCT00393354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545000|NCT00393354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545001|NCT00393354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25545002|NCT00393354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25545003|NCT00393354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25545004|NCT00393354|Analgesics|analgesics|mesh-ancestor
25545005|NCT00393354|Sensory System Agents|sensory system agents|mesh-ancestor
25545006|NCT00393354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25545007|NCT00393354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25545008|NCT00393354|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24933014|NCT04074603|Insulin|insulin|mesh-list
24785413|NCT01914146|Insulin|insulin|mesh-list
25545009|NCT00393354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25545010|NCT00393354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545011|NCT00393211|Etoricoxib|etoricoxib|mesh-list
25545012|NCT00393211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545013|NCT00393211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785734|NCT01916252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545014|NCT00393211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25545015|NCT00393211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25545016|NCT00393211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25545017|NCT00393211|Analgesics|analgesics|mesh-ancestor
25545018|NCT00393211|Sensory System Agents|sensory system agents|mesh-ancestor
25545019|NCT00393211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24509635|NCT00561223|Iloprost|iloprost|mesh-list
25545020|NCT00393211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25545021|NCT00393211|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25545022|NCT00393211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24786238|NCT01918709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441029|NCT04720131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25441030|NCT04720131|Antimetabolites|antimetabolites|mesh-ancestor
25441031|NCT04720131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441032|NCT04720131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25441033|NCT04720131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25441034|NCT04720131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441035|NCT04720092|Rivaroxaban|rivaroxaban|mesh-list
24786399|NCT01919788|Insulin|insulin|mesh-list
25441036|NCT04720092|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25441037|NCT04720092|Antithrombins|antithrombins|mesh-ancestor
25441038|NCT04720092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25441039|NCT04720092|Protease Inhibitors|protease inhibitors|mesh-ancestor
25441040|NCT04720092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441041|NCT04720092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441042|NCT04720092|Anticoagulants|anticoagulants|mesh-ancestor
25441043|NCT04719819|Anesthetics|anesthetics|mesh-list
25441044|NCT04719819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25441045|NCT04719819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441046|NCT04719650|Zoledronic Acid|zoledronic acid|mesh-list
24787826|NCT01927640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25441047|NCT04719650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25545023|NCT00393211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545024|NCT00328523|Ezetimibe|ezetimibe|mesh-list
25545025|NCT00328523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25082299|NCT03323593|Analgesics|analgesics|mesh-ancestor
24787973|NCT01928823|Cycloserine|cycloserine|mesh-list
25545026|NCT00328523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25545027|NCT00328523|Antimetabolites|antimetabolites|mesh-ancestor
25545028|NCT00328523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545029|NCT00328523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25545030|NCT00269191|Ibuprofen|ibuprofen|mesh-list
25545031|NCT00269191|Etoricoxib|etoricoxib|mesh-list
25261781|NCT02451748|Leflunomide|leflunomide|mesh-list
25214061|NCT03577704|Tubulin Modulators|tubulin modulators|mesh-ancestor
25545032|NCT00269191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25545033|NCT00269191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25545034|NCT00269191|Analgesics|analgesics|mesh-ancestor
25545035|NCT00269191|Sensory System Agents|sensory system agents|mesh-ancestor
25545036|NCT00269191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25545037|NCT00269191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545038|NCT00269191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25545039|NCT00269191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25545040|NCT00269191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25545041|NCT00269191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545042|NCT00269191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789436|NCT01937182|Serotonin|serotonin|mesh-list
25545043|NCT00269191|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25545044|NCT00251576|Heparin|heparin|mesh-list
25545045|NCT00251576|Calcium heparin|calcium heparin|mesh-list
25545046|NCT00251576|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25545047|NCT00251576|Tinzaparin|tinzaparin|mesh-list
24543688|NCT00685009|Progestins|progestins|mesh-ancestor
25545048|NCT00251576|Dalteparin|dalteparin|mesh-list
25545049|NCT00251576|Tirofiban|tirofiban|mesh-list
25545050|NCT00251576|Simvastatin|simvastatin|mesh-list
25545051|NCT00251576|Anticoagulants|anticoagulants|mesh-ancestor
25545052|NCT00251576|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25545053|NCT00251576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25545054|NCT00251576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25157934|NCT04547907|Antimitotic Agents|antimitotic agents|mesh-ancestor
25545055|NCT00251576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25545056|NCT00251576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25545057|NCT00251576|Antimetabolites|antimetabolites|mesh-ancestor
25545058|NCT00251576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25545059|NCT00251576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25545060|NCT00251576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545061|NCT00251576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25545062|NCT00250445|Diclofenac|diclofenac|mesh-list
25545063|NCT00250445|Etoricoxib|etoricoxib|mesh-list
24790675|NCT01944189|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25545064|NCT00250445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25545065|NCT00250445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24684321|NCT01396720|Fluvoxamine|fluvoxamine|mesh-list
25262487|NCT02447835|Serotonin Agents|serotonin agents|mesh-ancestor
25545066|NCT00250445|Analgesics|analgesics|mesh-ancestor
25545067|NCT00250445|Sensory System Agents|sensory system agents|mesh-ancestor
25545068|NCT00250445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25545069|NCT00250445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275254|NCT02373280|Bismuth|bismuth|mesh-list
25545070|NCT00250445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25545071|NCT00250445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25545072|NCT00250445|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25545073|NCT00250445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545074|NCT00250445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545075|NCT00250445|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25545076|NCT00242489|Diclofenac|diclofenac|mesh-list
25545077|NCT00242489|Etoricoxib|etoricoxib|mesh-list
25545078|NCT00242489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25545079|NCT00242489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25545080|NCT00242489|Analgesics|analgesics|mesh-ancestor
25545081|NCT00242489|Sensory System Agents|sensory system agents|mesh-ancestor
25545082|NCT00242489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25545083|NCT00242489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545084|NCT00242489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25545085|NCT00242489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25545086|NCT00242489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25545087|NCT00242489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545088|NCT00242489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545089|NCT00242489|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25545090|NCT00166530|Atorvastatin|atorvastatin|mesh-list
25545091|NCT00166530|Simvastatin|simvastatin|mesh-list
25545092|NCT00166530|Ezetimibe|ezetimibe|mesh-list
25545093|NCT00166530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25545094|NCT00166530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25545095|NCT00166530|Antimetabolites|antimetabolites|mesh-ancestor
25545096|NCT00166530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545097|NCT00166530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25545098|NCT00166530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25545099|NCT00166530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545100|NCT00092833|Ezetimibe|ezetimibe|mesh-list
25545101|NCT00092833|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25545102|NCT00092833|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25545103|NCT00092833|Antimetabolites|antimetabolites|mesh-ancestor
25545104|NCT00092833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545105|NCT00092833|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25545106|NCT00092716|Atorvastatin|atorvastatin|mesh-list
25545107|NCT00092716|Ezetimibe|ezetimibe|mesh-list
25545108|NCT00092716|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25545109|NCT00092716|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25545110|NCT00092716|Antimetabolites|antimetabolites|mesh-ancestor
25545111|NCT00092716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545112|NCT00092716|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25545113|NCT00092716|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25545114|NCT00092716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545115|NCT00588094|Rituximab|rituximab|mesh-list
25545116|NCT00588094|Carboplatin|carboplatin|mesh-list
25441082|NCT04719104|Bilirubin|bilirubin|mesh-list
25441083|NCT04719104|Antioxidants|antioxidants|mesh-ancestor
25441087|NCT04718740|Vitamin K|vitamin k|mesh-list
25545118|NCT00588094|Ifosfamide|ifosfamide|mesh-list
25545119|NCT00588094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25545120|NCT00588094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545121|NCT00588094|Immunologic Factors|immunologic factors|mesh-ancestor
25545122|NCT00588094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545123|NCT00588094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25262823|NCT02445989|Contraceptive Agents|contraceptive agents|mesh-list
25545124|NCT00588094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25545125|NCT00588094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25545126|NCT00588094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25545127|NCT00588094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24792410|NCT05223075|Carticaine|carticaine|mesh-list
24829986|NCT02156570|Ribavirin|ribavirin|mesh-list
25545128|NCT00588094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545129|NCT00588094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25545130|NCT00588094|Alkylating Agents|alkylating agents|mesh-ancestor
25545131|NCT00588159|Diphenhydramine|diphenhydramine|mesh-list
25545132|NCT00588159|Promethazine|promethazine|mesh-list
25545133|NCT00588159|Gabapentin|gabapentin|mesh-list
25545134|NCT00588159|Analgesics|analgesics|mesh-ancestor
25545135|NCT00588159|Sensory System Agents|sensory system agents|mesh-ancestor
25275293|NCT02373163|Vasodilator Agents|vasodilator agents|mesh-ancestor
25545136|NCT00588159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25545137|NCT00588159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545138|NCT00588159|Anticonvulsants|anticonvulsants|mesh-ancestor
25545139|NCT00588159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25262972|NCT02445339|Naltrexone|naltrexone|mesh-list
25545140|NCT00588159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25545141|NCT00588159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25545142|NCT00588159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25263017|NCT02445066|Vitamin D|vitamin d|mesh-list
25263066|NCT02444611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25545143|NCT00588159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25545144|NCT00588159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25545145|NCT00588159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25545146|NCT00588159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545147|NCT00588159|Antimanic Agents|antimanic agents|mesh-ancestor
25545148|NCT00588159|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25545149|NCT00588159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25545150|NCT00588159|Anesthetics, Local|anesthetics, local|mesh-ancestor
25545151|NCT00588159|Anesthetics|anesthetics|mesh-ancestor
25545152|NCT00588159|Antiemetics|antiemetics|mesh-ancestor
25545153|NCT00588159|Autonomic Agents|autonomic agents|mesh-ancestor
25545154|NCT00588159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25545155|NCT00588159|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25545156|NCT00588159|Histamine Antagonists|histamine antagonists|mesh-ancestor
25545157|NCT00588159|Histamine Agents|histamine agents|mesh-ancestor
25545158|NCT00588159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25545159|NCT00588159|Antipruritics|antipruritics|mesh-ancestor
25545160|NCT00588159|Dermatologic Agents|dermatologic agents|mesh-ancestor
25545161|NCT00588237|Paclitaxel|paclitaxel|mesh-list
25545162|NCT00588237|Bevacizumab|bevacizumab|mesh-list
25545163|NCT00588237|Cisplatin|cisplatin|mesh-list
25545164|NCT00588237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25545165|NCT00588237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545166|NCT00588237|Tubulin Modulators|tubulin modulators|mesh-ancestor
25545167|NCT00588237|Antimitotic Agents|antimitotic agents|mesh-ancestor
25545168|NCT00588237|Mitosis Modulators|mitosis modulators|mesh-ancestor
25545169|NCT00588237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545170|NCT00588237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25545171|NCT00588237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25545172|NCT00588237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24685280|NCT05274139|Hormones|hormones|mesh-ancestor
25545173|NCT00588237|Growth Substances|growth substances|mesh-ancestor
25545174|NCT00588237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545175|NCT00588237|Growth Inhibitors|growth inhibitors|mesh-ancestor
25545176|NCT00588341|Temozolomide|temozolomide|mesh-list
25545177|NCT00588341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25545178|NCT00588341|Alkylating Agents|alkylating agents|mesh-ancestor
25545179|NCT00588341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545180|NCT00588341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545181|NCT00588354|Triamcinolone|triamcinolone|mesh-list
25545182|NCT00588354|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25545183|NCT00588354|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25545184|NCT00588354|Lidocaine|lidocaine|mesh-list
25545185|NCT00588354|Clonidine|clonidine|mesh-list
25545186|NCT00588354|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25441149|NCT04718402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441150|NCT04718311|Tacrolimus|tacrolimus|mesh-list
25545187|NCT00588354|Anesthetics, Local|anesthetics, local|mesh-ancestor
25545188|NCT00588354|Anesthetics|anesthetics|mesh-ancestor
25545189|NCT00588354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25545190|NCT00588354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545191|NCT00588354|Sensory System Agents|sensory system agents|mesh-ancestor
25545192|NCT00588354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25545193|NCT00588354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25545194|NCT00588354|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25545195|NCT00588354|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25545196|NCT00588354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25545197|NCT00588354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545198|NCT00588354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25275308|NCT02372903|Antiviral Agents|antiviral agents|mesh-ancestor
25545199|NCT00588354|Glucocorticoids|glucocorticoids|mesh-ancestor
25545200|NCT00588354|Hormones|hormones|mesh-ancestor
25545201|NCT00588354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25545202|NCT00588354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25545203|NCT00588354|Immunologic Factors|immunologic factors|mesh-ancestor
25545204|NCT00588354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24669839|NCT03504163|Pembrolizumab|pembrolizumab|mesh-list
25545205|NCT00588354|Analgesics|analgesics|mesh-ancestor
25545206|NCT00588354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25545207|NCT00588354|Sympatholytics|sympatholytics|mesh-ancestor
25545208|NCT00588354|Autonomic Agents|autonomic agents|mesh-ancestor
25545209|NCT00588354|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25545210|NCT00588354|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25545211|NCT00588354|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25545212|NCT00588354|Adrenergic Agents|adrenergic agents|mesh-ancestor
25545213|NCT00588354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25545214|NCT00588406|Prednisone|prednisone|mesh-list
24669840|NCT03504163|BCG Vaccine|bcg vaccine|mesh-list
24513221|NCT00579995|Antioxidants|antioxidants|mesh-ancestor
25545215|NCT00588406|Budesonide|budesonide|mesh-list
25545216|NCT00588406|Bromides|bromides|mesh-list
25545217|NCT00588406|Albuterol|albuterol|mesh-list
25545218|NCT00588406|Ipratropium|ipratropium|mesh-list
25545219|NCT00588406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25545220|NCT00588406|Glucocorticoids|glucocorticoids|mesh-ancestor
25545221|NCT00588406|Hormones|hormones|mesh-ancestor
25545222|NCT00588406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25545223|NCT00588406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545224|NCT00588406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25545225|NCT00588406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545226|NCT00588406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25545227|NCT00588406|Autonomic Agents|autonomic agents|mesh-ancestor
25545228|NCT00588406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25545229|NCT00588406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25545230|NCT00588406|Respiratory System Agents|respiratory system agents|mesh-ancestor
25545231|NCT00588406|Anticonvulsants|anticonvulsants|mesh-ancestor
25545232|NCT00588406|Tocolytic Agents|tocolytic agents|mesh-ancestor
25545233|NCT00588406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25545234|NCT00588406|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25545235|NCT00588406|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25545236|NCT00588406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25545237|NCT00588406|Adrenergic Agents|adrenergic agents|mesh-ancestor
25545238|NCT00588406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25545239|NCT00588406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545240|NCT00588406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25545241|NCT00588406|Cholinergic Agents|cholinergic agents|mesh-ancestor
25545242|NCT00588445|Gefitinib|gefitinib|mesh-list
25545243|NCT00588445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24532936|NCT00641680|Dermatologic Agents|dermatologic agents|mesh-ancestor
25545244|NCT00588445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25545245|NCT00588445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533110|NCT00642330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25545246|NCT00588445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545247|NCT00588536|Leucovorin|leucovorin|mesh-list
25545248|NCT00588536|Methotrexate|methotrexate|mesh-list
25545249|NCT00588536|Thioguanine|thioguanine|mesh-list
25545250|NCT00588536|Calcium|calcium|mesh-list
24456523|NCT00331513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545251|NCT00588536|Levoleucovorin|levoleucovorin|mesh-list
25545252|NCT00588536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24670087|NCT03300947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25545253|NCT00588536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545254|NCT00588536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25545255|NCT00588536|Abortifacient Agents|abortifacient agents|mesh-ancestor
25545256|NCT00588536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25545257|NCT00588536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25545258|NCT00588536|Antimetabolites|antimetabolites|mesh-ancestor
25545259|NCT00588536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545260|NCT00588536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545261|NCT00588536|Dermatologic Agents|dermatologic agents|mesh-ancestor
25545262|NCT00588536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545263|NCT00588536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25441205|NCT04718714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25545264|NCT00588536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25545265|NCT00588536|Immunologic Factors|immunologic factors|mesh-ancestor
25545266|NCT00588536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25545267|NCT00588536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25545268|NCT00588536|Antidotes|antidotes|mesh-ancestor
25545269|NCT00588536|Protective Agents|protective agents|mesh-ancestor
25545270|NCT00588536|Vitamin B Complex|vitamin b complex|mesh-ancestor
25545271|NCT00588536|Vitamins|vitamins|mesh-ancestor
25545272|NCT00588536|Micronutrients|micronutrients|mesh-ancestor
25545273|NCT00588640|Methadone|methadone|mesh-list
25545274|NCT00588640|D-methadone|d-methadone|mesh-list
25441280|NCT04717531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441281|NCT04717531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25441282|NCT04717531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25441283|NCT04717531|Tubulin Modulators|tubulin modulators|mesh-ancestor
25441284|NCT04717531|Antimitotic Agents|antimitotic agents|mesh-ancestor
25441285|NCT04717531|Mitosis Modulators|mitosis modulators|mesh-ancestor
25441286|NCT04717531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25441287|NCT04717531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25441288|NCT04717531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25441289|NCT04717531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25441290|NCT04717531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441291|NCT04717609|Ropivacaine|ropivacaine|mesh-list
25441292|NCT04717609|Anesthetics, Local|anesthetics, local|mesh-ancestor
25441293|NCT04717609|Anesthetics|anesthetics|mesh-ancestor
25441294|NCT04717609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25441295|NCT04717609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441296|NCT04717609|Sensory System Agents|sensory system agents|mesh-ancestor
25441297|NCT04717609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25441298|NCT04717102|Desflurane|desflurane|mesh-list
25441299|NCT04717102|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25441300|NCT04717102|Anesthetics, General|anesthetics, general|mesh-ancestor
25441301|NCT04717102|Anesthetics|anesthetics|mesh-ancestor
25441302|NCT04717102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25441303|NCT04717102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441304|NCT04717089|Anesthetics|anesthetics|mesh-list
25441305|NCT04717089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25441306|NCT04717089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441307|NCT04716894|Itraconazole|itraconazole|mesh-list
25441308|NCT04716894|Antifungal Agents|antifungal agents|mesh-ancestor
25441309|NCT04716894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24968151|NCT03753867|Acitretin|acitretin|mesh-list
25441310|NCT04716894|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25545275|NCT00588640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25545276|NCT00588640|Narcotics|narcotics|mesh-ancestor
25545277|NCT00588640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25545278|NCT00588640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545279|NCT00588640|Analgesics|analgesics|mesh-ancestor
25545280|NCT00588640|Sensory System Agents|sensory system agents|mesh-ancestor
25545281|NCT00588640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25545282|NCT00588640|Antitussive Agents|antitussive agents|mesh-ancestor
25545283|NCT00588640|Respiratory System Agents|respiratory system agents|mesh-ancestor
25545284|NCT00588640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25545285|NCT00588666|Gemcitabine|gemcitabine|mesh-list
25545286|NCT00588666|Bevacizumab|bevacizumab|mesh-list
25545287|NCT00588666|Carboplatin|carboplatin|mesh-list
25545288|NCT00588666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25545289|NCT00588666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545290|NCT00588666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25545291|NCT00588666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25545292|NCT00588666|Growth Substances|growth substances|mesh-ancestor
25545293|NCT00588666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545294|NCT00588666|Growth Inhibitors|growth inhibitors|mesh-ancestor
25545295|NCT00588666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25545296|NCT00588666|Antimetabolites|antimetabolites|mesh-ancestor
25545297|NCT00588666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545298|NCT00588666|Antiviral Agents|antiviral agents|mesh-ancestor
25545299|NCT00588666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25263926|NCT02443922|Metformin|metformin|mesh-list
25545300|NCT00588666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545301|NCT00588666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25545302|NCT00588666|Immunologic Factors|immunologic factors|mesh-ancestor
25545303|NCT00588731|Cannabidiol|cannabidiol|mesh-list
25545304|NCT00588731|Anticonvulsants|anticonvulsants|mesh-ancestor
25545305|NCT00588822|Rituximab|rituximab|mesh-list
25545306|NCT00588822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25545307|NCT00588822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545308|NCT00588822|Immunologic Factors|immunologic factors|mesh-ancestor
25545309|NCT00588822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545310|NCT00588822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25545312|NCT00588900|Cediranib|cediranib|mesh-list
25545313|NCT00588900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25545314|NCT00588900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25545315|NCT00588900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545316|NCT00588900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545317|NCT00588900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545318|NCT00588900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25545319|NCT00588952|Ketamine|ketamine|mesh-list
25545320|NCT00588952|Analgesics|analgesics|mesh-ancestor
25545321|NCT00588952|Sensory System Agents|sensory system agents|mesh-ancestor
25545322|NCT00588952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25545323|NCT00588952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545324|NCT00588952|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25264127|NCT02442466|BQ 788|bq 788|mesh-list
25545325|NCT00588952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25545326|NCT00588952|Anesthetics, General|anesthetics, general|mesh-ancestor
25545327|NCT00588952|Anesthetics|anesthetics|mesh-ancestor
25545328|NCT00588952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25545329|NCT00588952|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25545330|NCT00588952|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25264163|NCT02442063|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25264164|NCT02442063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25264165|NCT02442063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25264166|NCT02442063|Tubulin Modulators|tubulin modulators|mesh-ancestor
24691025|NCT01404767|Metoprolol|metoprolol|mesh-list
25545331|NCT00588952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25545332|NCT00588952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545333|NCT00588965|Propranolol|propranolol|mesh-list
25545334|NCT00588965|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25545335|NCT00588965|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25545336|NCT00588965|Adrenergic Agents|adrenergic agents|mesh-ancestor
25545337|NCT00588965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25545338|NCT00588965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545339|NCT00588965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545340|NCT00588965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25545341|NCT00588965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25545342|NCT00588965|Vasodilator Agents|vasodilator agents|mesh-ancestor
25264191|NCT02442128|Fentanyl|fentanyl|mesh-list
24762630|NCT01768897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24691118|NCT01405144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24498118|NCT00513253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498119|NCT00513266|Leucovorin|leucovorin|mesh-list
25545343|NCT00589056|Nelfinavir|nelfinavir|mesh-list
25545344|NCT00589056|Cisplatin|cisplatin|mesh-list
25545345|NCT00589056|Etoposide|etoposide|mesh-list
25545346|NCT00589056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545347|NCT00589056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25545348|NCT00589056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25545349|NCT00589056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25545350|NCT00589056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545351|NCT00589056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545352|NCT00589056|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25545353|NCT00589056|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25545354|NCT00589056|Protease Inhibitors|protease inhibitors|mesh-ancestor
25545355|NCT00589056|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25545356|NCT00589056|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25545357|NCT00589056|Antiviral Agents|antiviral agents|mesh-ancestor
25545358|NCT00589056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25650941|NCT01510158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25650942|NCT01510158|Antioxidants|antioxidants|mesh-ancestor
25650943|NCT01510158|Protective Agents|protective agents|mesh-ancestor
25650944|NCT01510158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650945|NCT01510158|Uricosuric Agents|uricosuric agents|mesh-ancestor
25650946|NCT01510158|Renal Agents|renal agents|mesh-ancestor
25650947|NCT01510327|Aspirin|aspirin|mesh-list
25650948|NCT01510327|Everolimus|everolimus|mesh-list
25650949|NCT01510327|Ticlopidine|ticlopidine|mesh-list
25650950|NCT01510327|Clopidogrel|clopidogrel|mesh-list
25650951|NCT01510327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25650952|NCT01510327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25650953|NCT01510327|Analgesics|analgesics|mesh-ancestor
25650954|NCT01510327|Sensory System Agents|sensory system agents|mesh-ancestor
25650955|NCT01510327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650956|NCT01510327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650957|NCT01510327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25650958|NCT01510327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25650959|NCT01510327|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25650960|NCT01510327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25650961|NCT01510327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650962|NCT01510327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25650963|NCT01510327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25650964|NCT01510327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441322|NCT04716569|Ivermectin|ivermectin|mesh-list
25545359|NCT00589290|Belinostat|belinostat|mesh-list
25545360|NCT00589290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545361|NCT00589290|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25545362|NCT00589290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545363|NCT00589290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545364|NCT00589303|Metoprolol|metoprolol|mesh-list
25545365|NCT00589303|Amiodarone|amiodarone|mesh-list
25545366|NCT00589303|Verapamil|verapamil|mesh-list
25545367|NCT00589303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25545368|NCT00589303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25545369|NCT00589303|Sympatholytics|sympatholytics|mesh-ancestor
25545370|NCT00589303|Autonomic Agents|autonomic agents|mesh-ancestor
25545371|NCT00589303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25545372|NCT00589303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545373|NCT00589303|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25545374|NCT00589303|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25545375|NCT00589303|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25545376|NCT00589303|Adrenergic Agents|adrenergic agents|mesh-ancestor
24830444|NCT02159248|Analgesics|analgesics|mesh-ancestor
25545377|NCT00589303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25545378|NCT00589303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545379|NCT00589303|Vasodilator Agents|vasodilator agents|mesh-ancestor
25545380|NCT00589303|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25545381|NCT00589303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25545382|NCT00589303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25545383|NCT00589303|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25545384|NCT00589303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25545385|NCT00589303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545386|NCT00589303|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25545387|NCT00589303|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25545388|NCT00589303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25545389|NCT00589303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25545390|NCT00589303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25545391|NCT00589329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25545392|NCT00589329|Metronidazole|metronidazole|mesh-list
25545393|NCT00589329|Erythromycin|erythromycin|mesh-list
25545394|NCT00589329|Erythromycin Estolate|erythromycin estolate|mesh-list
25545395|NCT00589329|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25545396|NCT00589329|Erythromycin stearate|erythromycin stearate|mesh-list
25545397|NCT00589329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25545398|NCT00589329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25545399|NCT00589329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25545400|NCT00589329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25545401|NCT00589329|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25545402|NCT00589329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545403|NCT00589329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545404|NCT00589472|Vorinostat|vorinostat|mesh-list
25545405|NCT00589472|Leuprolide|leuprolide|mesh-list
25545406|NCT00589472|Goserelin|goserelin|mesh-list
25545407|NCT00589472|Bicalutamide|bicalutamide|mesh-list
25545408|NCT00589472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545409|NCT00589472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25545410|NCT00589472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545411|NCT00589472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545412|NCT00589472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25545413|NCT00589472|Fertility Agents|fertility agents|mesh-ancestor
25545414|NCT00589472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25545415|NCT00589472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545416|NCT00589472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25545417|NCT00589472|Androgen Antagonists|androgen antagonists|mesh-ancestor
25545418|NCT00589472|Hormone Antagonists|hormone antagonists|mesh-ancestor
25545419|NCT00589472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25545420|NCT00589563|Sirolimus|sirolimus|mesh-list
25545421|NCT00589563|Cyclophosphamide|cyclophosphamide|mesh-list
25545422|NCT00589563|Melphalan|melphalan|mesh-list
25545423|NCT00589563|Methotrexate|methotrexate|mesh-list
25545424|NCT00589563|Fludarabine|fludarabine|mesh-list
25545425|NCT00589563|Fludarabine phosphate|fludarabine phosphate|mesh-list
25545426|NCT00589563|Etoposide|etoposide|mesh-list
25545427|NCT00589563|Tacrolimus|tacrolimus|mesh-list
25545428|NCT00589563|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25545429|NCT00589563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25545430|NCT00589563|Immunologic Factors|immunologic factors|mesh-ancestor
25545431|NCT00589563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735528|NCT01657487|Xhance|xhance|mesh-list
25545432|NCT00589563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25545433|NCT00589563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25545434|NCT00589563|Alkylating Agents|alkylating agents|mesh-ancestor
25441463|NCT04715165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441464|NCT04715165|Sensory System Agents|sensory system agents|mesh-ancestor
25441465|NCT04715165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25441466|NCT04715165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25441467|NCT04715165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25441468|NCT04715165|Analgesics|analgesics|mesh-ancestor
25441469|NCT04715165|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25441470|NCT04715165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25441471|NCT04715165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25441472|NCT04715165|Adrenergic Agents|adrenergic agents|mesh-ancestor
25441473|NCT04715165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25441474|NCT04715165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441475|NCT04715113|Sildenafil Citrate|sildenafil citrate|mesh-list
25441476|NCT04715113|Vasodilator Agents|vasodilator agents|mesh-ancestor
25441477|NCT04715113|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25441478|NCT04715113|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25441479|NCT04715113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441480|NCT04715113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441481|NCT04715113|Urological Agents|urological agents|mesh-ancestor
25441482|NCT04714827|Cyclophosphamide|cyclophosphamide|mesh-list
25441483|NCT04714827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25441484|NCT04714827|Immunologic Factors|immunologic factors|mesh-ancestor
25441485|NCT04714827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441486|NCT04714827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25441487|NCT04714827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25441488|NCT04714827|Alkylating Agents|alkylating agents|mesh-ancestor
25441489|NCT04714827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441490|NCT04714827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25441491|NCT04714827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25293866|NCT02749513|Itraconazole|itraconazole|mesh-list
25293867|NCT02749513|Antifungal Agents|antifungal agents|mesh-ancestor
24789166|NCT01935778|Capecitabine|capecitabine|mesh-list
25169297|NCT01911767|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25169298|NCT01911767|Dermatologic Agents|dermatologic agents|mesh-ancestor
25169299|NCT01911767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25169300|NCT01911767|Immunologic Factors|immunologic factors|mesh-ancestor
25169301|NCT01911767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169302|NCT01909427|Methotrexate|methotrexate|mesh-list
25169303|NCT01909427|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25169304|NCT01909427|Abortifacient Agents|abortifacient agents|mesh-ancestor
24699269|NCT01445860|Simvastatin|simvastatin|mesh-list
25169305|NCT01909427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25545435|NCT00589563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545436|NCT00589563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545437|NCT00589563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25545438|NCT00589563|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25545439|NCT00589563|Abortifacient Agents|abortifacient agents|mesh-ancestor
25545440|NCT00589563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25545441|NCT00589563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25545442|NCT00589563|Antimetabolites|antimetabolites|mesh-ancestor
25545443|NCT00589563|Dermatologic Agents|dermatologic agents|mesh-ancestor
25545444|NCT00589563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545445|NCT00589563|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25545446|NCT00589563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25545447|NCT00589563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25545448|NCT00589563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25545449|NCT00589563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25545450|NCT00589563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25545451|NCT00589563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25545452|NCT00589563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25545453|NCT00589563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25545454|NCT00589563|Antifungal Agents|antifungal agents|mesh-ancestor
25545455|NCT00589628|Infliximab|infliximab|mesh-list
25545456|NCT00589628|Dermatologic Agents|dermatologic agents|mesh-ancestor
25545457|NCT00589628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25545458|NCT00589628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25545459|NCT00589667|Gemcitabine|gemcitabine|mesh-list
25545460|NCT00589667|Pemetrexed|pemetrexed|mesh-list
25545461|NCT00589667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25545462|NCT00589667|Antimetabolites|antimetabolites|mesh-ancestor
25545463|NCT00589667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545464|NCT00589667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545465|NCT00589667|Antiviral Agents|antiviral agents|mesh-ancestor
25545466|NCT00589667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25545467|NCT00589667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545468|NCT00589667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25545469|NCT00589667|Immunologic Factors|immunologic factors|mesh-ancestor
25545470|NCT00589667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545471|NCT00589667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24969330|NCT03743883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25545472|NCT00589667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25545473|NCT00589693|Imipenem|imipenem|mesh-list
25545474|NCT00589693|Doripenem|doripenem|mesh-list
24699966|NCT01449877|Trimethoprim|trimethoprim|mesh-list
25545475|NCT00589693|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
25545476|NCT00589693|Cilastatin|cilastatin|mesh-list
25545477|NCT00589693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25545478|NCT00589693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25545479|NCT00589693|Protease Inhibitors|protease inhibitors|mesh-ancestor
25545480|NCT00589693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545481|NCT00589693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545482|NCT00589784|Sunitinib|sunitinib|mesh-list
25545483|NCT00589784|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-list
25545484|NCT00589784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545485|NCT00589784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25545486|NCT00589784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25545487|NCT00589784|Growth Substances|growth substances|mesh-ancestor
25545488|NCT00589784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545489|NCT00589784|Growth Inhibitors|growth inhibitors|mesh-ancestor
25545490|NCT00589784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25545491|NCT00589784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545492|NCT00589784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545493|NCT00589784|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25545494|NCT00589888|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25545495|NCT00589888|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25545496|NCT00589888|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25545497|NCT00589888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25545498|NCT00589914|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25545499|NCT00589914|Risperidone|risperidone|mesh-list
25545500|NCT00589914|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25545501|NCT00589914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25545502|NCT00589914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25545503|NCT00589914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545504|NCT00589914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25545505|NCT00589914|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25545506|NCT00589914|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25545507|NCT00589914|Serotonin Agents|serotonin agents|mesh-ancestor
25545508|NCT00589914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25545509|NCT00589914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545510|NCT00589914|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25545511|NCT00589914|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25545512|NCT00589914|Dopamine Agents|dopamine agents|mesh-ancestor
25545513|NCT00589979|Lidocaine|lidocaine|mesh-list
25545514|NCT00589979|Anesthetics, Local|anesthetics, local|mesh-ancestor
25545515|NCT00589979|Anesthetics|anesthetics|mesh-ancestor
25545516|NCT00589979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25545517|NCT00589979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545518|NCT00589979|Sensory System Agents|sensory system agents|mesh-ancestor
25545519|NCT00589979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25545520|NCT00589979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25545521|NCT00589979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25545522|NCT00589979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25545523|NCT00589979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25545524|NCT00589979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545525|NCT00590018|Hydrocortisone|hydrocortisone|mesh-list
25545526|NCT00590018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25545527|NCT00590031|Cisplatin|cisplatin|mesh-list
25545528|NCT00590031|Irinotecan|irinotecan|mesh-list
25545529|NCT00590031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545530|NCT00590031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24830527|NCT02159690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545531|NCT00590031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25545532|NCT00590031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545533|NCT00590031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545534|NCT00590044|Insulin|insulin|mesh-list
25545535|NCT00590044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25545536|NCT00590044|Insulin Glargine|insulin glargine|mesh-list
25545537|NCT00590044|Insulin, Isophane|insulin, isophane|mesh-list
25545538|NCT00590044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25441492|NCT04714554|Erythromycin|erythromycin|mesh-list
25545539|NCT00590044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545540|NCT00590161|Pentoxifylline|pentoxifylline|mesh-list
25545541|NCT00590161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25545542|NCT00590161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545543|NCT00590161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545544|NCT00590161|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25545545|NCT00590161|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25545546|NCT00590161|Protective Agents|protective agents|mesh-ancestor
25545547|NCT00590161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545548|NCT00590161|Vasodilator Agents|vasodilator agents|mesh-ancestor
25545549|NCT00590161|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25545550|NCT00590161|Antioxidants|antioxidants|mesh-ancestor
25214942|NCT02693769|Glycopyrrolate|glycopyrrolate|mesh-list
25214943|NCT02693769|Bromides|bromides|mesh-list
25545551|NCT00590226|Insulin|insulin|mesh-list
25545552|NCT00590226|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25545553|NCT00590226|Insulin Aspart|insulin aspart|mesh-list
25545554|NCT00590226|Insulin, Isophane|insulin, isophane|mesh-list
25545555|NCT00590226|Isophane Insulin, Human|isophane insulin, human|mesh-list
25545556|NCT00590226|Isophane insulin, beef|isophane insulin, beef|mesh-list
25545557|NCT00590226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25545558|NCT00590226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545559|NCT00590317|Ondansetron|ondansetron|mesh-list
25545560|NCT00590317|Prochlorperazine|prochlorperazine|mesh-list
25545561|NCT00590317|Antiemetics|antiemetics|mesh-ancestor
25545562|NCT00590317|Autonomic Agents|autonomic agents|mesh-ancestor
25545563|NCT00590317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25545564|NCT00590317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545565|NCT00590317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25545566|NCT00590317|Antipruritics|antipruritics|mesh-ancestor
25545567|NCT00590317|Dermatologic Agents|dermatologic agents|mesh-ancestor
25545568|NCT00590317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25545569|NCT00590317|Serotonin Agents|serotonin agents|mesh-ancestor
25545570|NCT00590317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25545571|NCT00590317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634218|NCT01132521|Urinastatin|urinastatin|mesh-list
25041949|NCT01536041|Hormone Antagonists|hormone antagonists|mesh-ancestor
24462935|NCT00358020|Thalidomide|thalidomide|mesh-list
25545572|NCT00590317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25545573|NCT00590317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25545574|NCT00590317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25545575|NCT00590317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25545576|NCT00590317|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25545577|NCT00590317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25545578|NCT00590317|Dopamine Agents|dopamine agents|mesh-ancestor
25545579|NCT00590395|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25545580|NCT00590395|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
25545581|NCT00590395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545582|NCT00590460|Fludarabine|fludarabine|mesh-list
25545583|NCT00590460|Alemtuzumab|alemtuzumab|mesh-list
25545584|NCT00590460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545585|NCT00590460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25545586|NCT00590577|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25545587|NCT00590577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25545588|NCT00590577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25545589|NCT00590577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25545590|NCT00590577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545591|NCT00590577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25545592|NCT00590577|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25545593|NCT00590577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25545594|NCT00590577|Serotonin Agents|serotonin agents|mesh-ancestor
25545595|NCT00590577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25545596|NCT00590577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545597|NCT00590577|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25545598|NCT00590577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25545599|NCT00590577|Dopamine Agents|dopamine agents|mesh-ancestor
25545600|NCT00590590|Diphenhydramine|diphenhydramine|mesh-list
24830720|NCT02160587|Chlorhexidine|chlorhexidine|mesh-list
25545601|NCT00590590|Promethazine|promethazine|mesh-list
25545602|NCT00590590|Lidocaine|lidocaine|mesh-list
25545603|NCT00590590|Anesthetics, Local|anesthetics, local|mesh-ancestor
25545604|NCT00590590|Anesthetics|anesthetics|mesh-ancestor
25545605|NCT00590590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25545606|NCT00590590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545607|NCT00590590|Sensory System Agents|sensory system agents|mesh-ancestor
25545608|NCT00590590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25545609|NCT00590590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25545610|NCT00590590|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25545611|NCT00590590|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25545612|NCT00590590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25545613|NCT00590590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545614|NCT00590590|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25545615|NCT00590590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25545616|NCT00590590|Antiemetics|antiemetics|mesh-ancestor
25545617|NCT00590590|Autonomic Agents|autonomic agents|mesh-ancestor
25545618|NCT00590590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25545619|NCT00590590|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25545620|NCT00590590|Histamine Antagonists|histamine antagonists|mesh-ancestor
25545621|NCT00590590|Histamine Agents|histamine agents|mesh-ancestor
25545622|NCT00590590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25545623|NCT00590590|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25545624|NCT00590590|Antipruritics|antipruritics|mesh-ancestor
25545625|NCT00590590|Dermatologic Agents|dermatologic agents|mesh-ancestor
25545626|NCT00590681|Bevacizumab|bevacizumab|mesh-list
25545627|NCT00590681|Temozolomide|temozolomide|mesh-list
25545628|NCT00590681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25545629|NCT00590681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545630|NCT00590681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25545631|NCT00590681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25545632|NCT00590681|Growth Substances|growth substances|mesh-ancestor
25545633|NCT00590681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545634|NCT00590681|Growth Inhibitors|growth inhibitors|mesh-ancestor
25545635|NCT00590681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25545636|NCT00590681|Alkylating Agents|alkylating agents|mesh-ancestor
25545637|NCT00590681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545638|NCT00590772|Montelukast|montelukast|mesh-list
25545639|NCT00590772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25545640|NCT00590772|Respiratory System Agents|respiratory system agents|mesh-ancestor
25545641|NCT00590772|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25545642|NCT00590772|Hormone Antagonists|hormone antagonists|mesh-ancestor
25545643|NCT00590772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25545644|NCT00590772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545645|NCT00590772|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25545646|NCT00590772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25545647|NCT00590772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545648|NCT00590824|Interleukin-2|interleukin-2|mesh-list
25545649|NCT00590824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545650|NCT00590824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25545651|NCT00590824|Analgesics|analgesics|mesh-ancestor
25545652|NCT00590824|Sensory System Agents|sensory system agents|mesh-ancestor
25545653|NCT00590824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25545654|NCT00590824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545655|NCT00590863|Dexetimide|dexetimide|mesh-list
25545656|NCT00590863|Mirtazapine|mirtazapine|mesh-list
25545657|NCT00590863|Citalopram|citalopram|mesh-list
25545658|NCT00590863|Bupropion|bupropion|mesh-list
25545659|NCT00590863|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25545660|NCT00590863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25545661|NCT00590863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25545662|NCT00590863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24628323|NCT01098084|Decitabine|decitabine|mesh-list
25545663|NCT00590863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545664|NCT00590863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25545665|NCT00590863|Serotonin Agents|serotonin agents|mesh-ancestor
25545666|NCT00590863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545667|NCT00590863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25545668|NCT00590863|Antidepressive Agents|antidepressive agents|mesh-ancestor
25545669|NCT00590863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25215253|NCT02691065|Antiviral Agents|antiviral agents|mesh-ancestor
25215254|NCT02691065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25545670|NCT00590863|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25545671|NCT00590863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25545672|NCT00590863|Parasympatholytics|parasympatholytics|mesh-ancestor
25545673|NCT00590863|Autonomic Agents|autonomic agents|mesh-ancestor
25545674|NCT00590863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25545675|NCT00590863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25545676|NCT00590863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25545677|NCT00590863|Cholinergic Agents|cholinergic agents|mesh-ancestor
25545678|NCT00590863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25545679|NCT00590863|Dopamine Agents|dopamine agents|mesh-ancestor
25545680|NCT00590863|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25545681|NCT00590863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25215296|NCT02690883|Hormones|hormones|mesh-ancestor
25545682|NCT00590863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545683|NCT00590863|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25545684|NCT00590863|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25545685|NCT00590863|Histamine Antagonists|histamine antagonists|mesh-ancestor
25545686|NCT00590863|Histamine Agents|histamine agents|mesh-ancestor
25545687|NCT00590863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25545688|NCT00590863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25545689|NCT00590863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25545690|NCT00590863|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25545691|NCT00590863|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25545692|NCT00590863|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25545693|NCT00590863|Adrenergic Agents|adrenergic agents|mesh-ancestor
25545694|NCT00590863|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25545695|NCT00590863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25545696|NCT00590863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25545697|NCT00590902|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25545698|NCT00590902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545699|NCT00590902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25545700|NCT00590902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545701|NCT00590902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545702|NCT00590967|Cisplatin|cisplatin|mesh-list
25545703|NCT00590967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545704|NCT00591006|Hydrocortisone|hydrocortisone|mesh-list
25545705|NCT00591006|Phenytoin|phenytoin|mesh-list
25545706|NCT00591006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25545707|NCT00591006|Anticonvulsants|anticonvulsants|mesh-ancestor
25545708|NCT00591006|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25545709|NCT00591006|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25545710|NCT00591006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24636736|NCT01147146|Atracurium|atracurium|mesh-list
25545711|NCT00591006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545712|NCT00591006|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25545713|NCT00591006|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25545714|NCT00591019|Modafinil|modafinil|mesh-list
25545715|NCT00591019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25545716|NCT00591019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545717|NCT00591019|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25545718|NCT00591019|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25545719|NCT00591019|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25545720|NCT00591019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545721|NCT00591123|Leucovorin|leucovorin|mesh-list
25545722|NCT00591123|Fluorouracil|fluorouracil|mesh-list
25545723|NCT00591123|Oxaliplatin|oxaliplatin|mesh-list
25545724|NCT00591123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25545725|NCT00591123|Levoleucovorin|levoleucovorin|mesh-list
25545726|NCT00591123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545727|NCT00591123|Antimetabolites|antimetabolites|mesh-ancestor
25545728|NCT00591123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545729|NCT00591123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25545730|NCT00591123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545731|NCT00591123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25545732|NCT00591123|Immunologic Factors|immunologic factors|mesh-ancestor
25545733|NCT00591123|Antidotes|antidotes|mesh-ancestor
24637015|NCT01148316|Serotonin Agents|serotonin agents|mesh-ancestor
25545734|NCT00591123|Protective Agents|protective agents|mesh-ancestor
25545735|NCT00591123|Vitamin B Complex|vitamin b complex|mesh-ancestor
25545736|NCT00591123|Vitamins|vitamins|mesh-ancestor
25545737|NCT00591123|Micronutrients|micronutrients|mesh-ancestor
25545738|NCT00591123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25545739|NCT00591123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545740|NCT00591149|Docetaxel|docetaxel|mesh-list
25545741|NCT00591149|Oxaliplatin|oxaliplatin|mesh-list
25545742|NCT00591149|Cetuximab|cetuximab|mesh-list
25545743|NCT00591149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545744|NCT00591149|Tubulin Modulators|tubulin modulators|mesh-ancestor
25545745|NCT00591149|Antimitotic Agents|antimitotic agents|mesh-ancestor
25545746|NCT00591149|Mitosis Modulators|mitosis modulators|mesh-ancestor
25545747|NCT00591149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545748|NCT00591149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25545749|NCT00591253|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25545750|NCT00591253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25545751|NCT00591253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25545752|NCT00591253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545753|NCT00591266|Amlodipine|amlodipine|mesh-list
25545754|NCT00591266|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25545755|NCT00591266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25545756|NCT00591266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25545757|NCT00591266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25545758|NCT00591266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545759|NCT00591266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25441702|NCT04713254|Metoprolol|metoprolol|mesh-list
25545760|NCT00591266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545761|NCT00591266|Vasodilator Agents|vasodilator agents|mesh-ancestor
25272837|NCT02389439|Artesunate|artesunate|mesh-list
25545762|NCT00591266|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25545763|NCT00591266|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25545764|NCT00591305|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
25545765|NCT00591305|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25545766|NCT00591305|Protective Agents|protective agents|mesh-ancestor
25545767|NCT00591305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545768|NCT00591305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545769|NCT00591370|Temozolomide|temozolomide|mesh-list
25545770|NCT00591370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25545771|NCT00591370|Alkylating Agents|alkylating agents|mesh-ancestor
25545772|NCT00591370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545773|NCT00591370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545774|NCT00591565|Acamprosate|acamprosate|mesh-list
25545775|NCT00591565|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25545776|NCT00591578|Valsartan|valsartan|mesh-list
25545777|NCT00591578|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25545778|NCT00591578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25545779|NCT00591578|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25545780|NCT00591578|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25545781|NCT00591578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545782|NCT00591630|Cytarabine|cytarabine|mesh-list
25545783|NCT00591630|Rituximab|rituximab|mesh-list
24969600|NCT03742115|Hormones|hormones|mesh-ancestor
25545784|NCT00591630|Etoposide|etoposide|mesh-list
25545785|NCT00591630|Melphalan|melphalan|mesh-list
25545786|NCT00591630|Carmustine|carmustine|mesh-list
25545787|NCT00591630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25545788|NCT00591630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545789|NCT00591630|Immunologic Factors|immunologic factors|mesh-ancestor
25545790|NCT00591630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545791|NCT00591630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25545792|NCT00591630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25545793|NCT00591630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25545794|NCT00591630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25545795|NCT00591630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545796|NCT00591630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264771|NCT02438865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25545797|NCT00591630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25545798|NCT00591630|Antimetabolites|antimetabolites|mesh-ancestor
25545799|NCT00591630|Antiviral Agents|antiviral agents|mesh-ancestor
25545800|NCT00591630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25545801|NCT00591630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25545802|NCT00591630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25545803|NCT00591630|Alkylating Agents|alkylating agents|mesh-ancestor
25545804|NCT00591630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25545805|NCT00591734|Bevacizumab|bevacizumab|mesh-list
25545806|NCT00591734|Everolimus|everolimus|mesh-list
25545807|NCT00591734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25545808|NCT00591734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545809|NCT00591734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25545810|NCT00591734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25545811|NCT00591734|Growth Substances|growth substances|mesh-ancestor
25545812|NCT00591734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545813|NCT00591734|Growth Inhibitors|growth inhibitors|mesh-ancestor
25545814|NCT00591734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25545815|NCT00591734|Immunologic Factors|immunologic factors|mesh-ancestor
25545816|NCT00591773|Chlorthalidone|chlorthalidone|mesh-list
25545817|NCT00591773|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25545818|NCT00591773|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25545819|NCT00591773|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25545820|NCT00591773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545821|NCT00591773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24767752|NCT01802970|Paclitaxel|paclitaxel|mesh-list
25545822|NCT00591773|Diuretics|diuretics|mesh-ancestor
25545823|NCT00591773|Natriuretic Agents|natriuretic agents|mesh-ancestor
25545824|NCT00591773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545825|NCT00591773|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25545826|NCT00591773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25545827|NCT00591825|Cycloserine|cycloserine|mesh-list
25545828|NCT00591825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25545829|NCT00591825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25545830|NCT00591825|Renal Agents|renal agents|mesh-ancestor
25545831|NCT00591825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25545832|NCT00591825|Antitubercular Agents|antitubercular agents|mesh-ancestor
25441760|NCT04713189|Anesthetics, General|anesthetics, general|mesh-ancestor
25155628|NCT05323552|Cholinergic Agents|cholinergic agents|mesh-ancestor
25822539|NCT00004496|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25822540|NCT00004496|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
25822541|NCT00004496|beta-Endorphin|beta-endorphin|mesh-list
25441825|NCT04712396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441826|NCT04712396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25441827|NCT04712396|Hormone Antagonists|hormone antagonists|mesh-ancestor
25441828|NCT04712396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25441829|NCT04712396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441830|NCT04712396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25441831|NCT04712266|Insulin|insulin|mesh-list
25441832|NCT04712266|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25441833|NCT04712266|Glucagon|glucagon|mesh-list
25441834|NCT04712266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25441835|NCT04712266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441836|NCT04712266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25441837|NCT04712266|Hormones|hormones|mesh-ancestor
25441838|NCT04712266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25441839|NCT04712279|Hydroxychloroquine|hydroxychloroquine|mesh-list
25441840|NCT04712279|Ivermectin|ivermectin|mesh-list
25441841|NCT04712279|Antimalarials|antimalarials|mesh-ancestor
25441842|NCT04712279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25441843|NCT04712279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25441844|NCT04712279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25441845|NCT04712279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441846|NCT04712279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441847|NCT04712279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25294314|NCT04003649|Nivolumab|nivolumab|mesh-list
25294315|NCT04003649|Ipilimumab|ipilimumab|mesh-list
25294316|NCT04003649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25294317|NCT04003649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789228|NCT01936012|Lisinopril|lisinopril|mesh-list
25294318|NCT04003649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25294319|NCT04003649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294320|NCT03943342|Venetoclax|venetoclax|mesh-list
25294321|NCT03943342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215968|NCT02687100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294322|NCT03783351|Clopidogrel|clopidogrel|mesh-list
25294323|NCT03783351|Ticagrelor|ticagrelor|mesh-list
25169306|NCT01909427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545833|NCT00591825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25545834|NCT00591825|Antimetabolites|antimetabolites|mesh-ancestor
25545835|NCT00591825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545836|NCT00591851|Paclitaxel|paclitaxel|mesh-list
25545837|NCT00591851|Cyclophosphamide|cyclophosphamide|mesh-list
25545838|NCT00591851|Doxorubicin|doxorubicin|mesh-list
25545839|NCT00591851|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25545840|NCT00591851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25545841|NCT00591851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545842|NCT00591851|Tubulin Modulators|tubulin modulators|mesh-ancestor
25545843|NCT00591851|Antimitotic Agents|antimitotic agents|mesh-ancestor
25545844|NCT00591851|Mitosis Modulators|mitosis modulators|mesh-ancestor
25216000|NCT02686619|Daclizumab|daclizumab|mesh-list
25545845|NCT00591851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545846|NCT00591851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25545847|NCT00591851|Immunologic Factors|immunologic factors|mesh-ancestor
25545848|NCT00591851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545849|NCT00591851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25545850|NCT00591851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25545851|NCT00591851|Alkylating Agents|alkylating agents|mesh-ancestor
25545852|NCT00591851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25545853|NCT00591851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25545854|NCT00591851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25545855|NCT00591851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25545856|NCT00591851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545857|NCT00592072|Decanoic acid|decanoic acid|mesh-list
25545858|NCT00592072|Antifungal Agents|antifungal agents|mesh-ancestor
25545859|NCT00592072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25545860|NCT00592124|Tenofovir|tenofovir|mesh-list
25545861|NCT00592124|Antiviral Agents|antiviral agents|mesh-ancestor
25545862|NCT00592124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25545863|NCT00592124|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25545864|NCT00592124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25545865|NCT00592124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25216116|NCT02686086|Albuterol|albuterol|mesh-list
25545866|NCT00592124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545867|NCT00592124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25545868|NCT00592124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25545869|NCT00592176|Bevacizumab|bevacizumab|mesh-list
25545870|NCT00592176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25545871|NCT00592176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545872|NCT00592176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25545873|NCT00592176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25545874|NCT00592176|Growth Substances|growth substances|mesh-ancestor
25545875|NCT00592176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545876|NCT00592176|Growth Inhibitors|growth inhibitors|mesh-ancestor
25545878|NCT00592319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25545879|NCT00592319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25545880|NCT00592319|Analgesics|analgesics|mesh-ancestor
25545881|NCT00592319|Sensory System Agents|sensory system agents|mesh-ancestor
25545882|NCT00592319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25545883|NCT00592319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545884|NCT00592319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25545885|NCT00592319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25545886|NCT00592319|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25545887|NCT00592319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25545888|NCT00592319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545889|NCT00592319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545890|NCT00592358|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25545891|NCT00592358|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25545892|NCT00592358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25545893|NCT00592358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25545894|NCT00592358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545895|NCT00592358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25545896|NCT00592358|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25545897|NCT00592358|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25545898|NCT00592358|Serotonin Agents|serotonin agents|mesh-ancestor
25545899|NCT00592358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25545900|NCT00592358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545901|NCT00592358|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25545902|NCT00592358|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25545903|NCT00592358|Dopamine Agents|dopamine agents|mesh-ancestor
25545904|NCT00592384|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25545905|NCT00592384|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25545906|NCT00592384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25545907|NCT00592384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25545908|NCT00592384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545909|NCT00592384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25216240|NCT02685618|Vasodilator Agents|vasodilator agents|mesh-ancestor
25545910|NCT00592384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545911|NCT00592384|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25545912|NCT00592384|Antidepressive Agents|antidepressive agents|mesh-ancestor
25545913|NCT00592384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25545914|NCT00592475|Conivaptan|conivaptan|mesh-list
25545915|NCT00592475|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25545916|NCT00592475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545917|NCT00592475|Natriuretic Agents|natriuretic agents|mesh-ancestor
25545918|NCT00592475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545919|NCT00592488|Acetylcarnitine|acetylcarnitine|mesh-list
25545920|NCT00592488|Vitamin B Complex|vitamin b complex|mesh-ancestor
25545921|NCT00592488|Vitamins|vitamins|mesh-ancestor
25545922|NCT00592488|Micronutrients|micronutrients|mesh-ancestor
25545923|NCT00592488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545924|NCT00592488|Nootropic Agents|nootropic agents|mesh-ancestor
25545925|NCT00592501|Cisplatin|cisplatin|mesh-list
25545926|NCT00592501|Fluorouracil|fluorouracil|mesh-list
25545927|NCT00592501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545928|NCT00592501|Antimetabolites|antimetabolites|mesh-ancestor
25545929|NCT00592501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545930|NCT00592501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25545931|NCT00592501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25545932|NCT00592501|Immunologic Factors|immunologic factors|mesh-ancestor
25545933|NCT00592501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545934|NCT00592683|Aripiprazole|aripiprazole|mesh-list
25545935|NCT00592683|Antidepressive Agents|antidepressive agents|mesh-ancestor
25545936|NCT00592683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25545937|NCT00592683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25545938|NCT00592683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25042064|NCT01516086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25545939|NCT00592683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25545940|NCT00592683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545941|NCT00592683|Dopamine Agonists|dopamine agonists|mesh-ancestor
25545942|NCT00592683|Dopamine Agents|dopamine agents|mesh-ancestor
25545943|NCT00592683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25545944|NCT00592683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545945|NCT00592683|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25545946|NCT00592683|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25545947|NCT00592683|Serotonin Agents|serotonin agents|mesh-ancestor
25545948|NCT00592683|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25545949|NCT00592683|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25545950|NCT00592683|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25545951|NCT00592683|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25545952|NCT00592839|Estrogens|estrogens|mesh-list
25545953|NCT00592839|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25545954|NCT00592839|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
25545955|NCT00592839|Estrogens, conjugated synthetic B|estrogens, conjugated synthetic b|mesh-list
25545956|NCT00592839|Hormones|hormones|mesh-ancestor
25545957|NCT00592839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25545958|NCT00592839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545959|NCT00592852|Fluoxetine|fluoxetine|mesh-list
25545960|NCT00592852|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25545961|NCT00592852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25545962|NCT00592852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25545963|NCT00592852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545964|NCT00592852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25545965|NCT00592852|Serotonin Agents|serotonin agents|mesh-ancestor
25545966|NCT00592852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545967|NCT00592852|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25545968|NCT00592852|Antidepressive Agents|antidepressive agents|mesh-ancestor
25545969|NCT00592852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25545970|NCT00592852|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25545971|NCT00592852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25545972|NCT00592852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25545973|NCT00592943|Modafinil|modafinil|mesh-list
25545974|NCT00592943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25545975|NCT00592943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545976|NCT00592943|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25545977|NCT00592943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25545978|NCT00592943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25545979|NCT00592943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545980|NCT00593112|Methylphenidate|methylphenidate|mesh-list
25545981|NCT00593112|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25545982|NCT00593112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545983|NCT00593112|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25545984|NCT00593112|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25545985|NCT00593112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25545986|NCT00593112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25545987|NCT00593112|Dopamine Agents|dopamine agents|mesh-ancestor
25545988|NCT00593112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25545989|NCT00593450|Bevacizumab|bevacizumab|mesh-list
25545990|NCT00593450|Ranibizumab|ranibizumab|mesh-list
25545991|NCT00593450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25545992|NCT00593450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25545993|NCT00593450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25545994|NCT00593450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25545995|NCT00593450|Growth Substances|growth substances|mesh-ancestor
25545996|NCT00593450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25545997|NCT00593450|Growth Inhibitors|growth inhibitors|mesh-ancestor
25545998|NCT00593489|Insulin|insulin|mesh-list
25545999|NCT00593489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25546000|NCT00593489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546001|NCT00593554|Fludarabine|fludarabine|mesh-list
25546002|NCT00593554|Thiotepa|thiotepa|mesh-list
25546003|NCT00593554|Thymoglobulin|thymoglobulin|mesh-list
25546004|NCT00593554|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25546005|NCT00593554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546006|NCT00593554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546007|NCT00593554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25546008|NCT00593554|Immunologic Factors|immunologic factors|mesh-ancestor
25546009|NCT00593554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546010|NCT00593554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25546011|NCT00593554|Alkylating Agents|alkylating agents|mesh-ancestor
25546012|NCT00593554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25546013|NCT00593606|Rotigotine|rotigotine|mesh-list
25546014|NCT00593606|Dopamine Agonists|dopamine agonists|mesh-ancestor
25546015|NCT00593606|Dopamine Agents|dopamine agents|mesh-ancestor
25546016|NCT00593606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25546017|NCT00593606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546018|NCT00593606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546019|NCT00593645|Cytarabine|cytarabine|mesh-list
25546020|NCT00593645|Clofarabine|clofarabine|mesh-list
25546021|NCT00593645|Thymoglobulin|thymoglobulin|mesh-list
25546022|NCT00593645|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25546023|NCT00593645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25546024|NCT00593645|Antimetabolites|antimetabolites|mesh-ancestor
25546025|NCT00593645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546026|NCT00593645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546027|NCT00593645|Antiviral Agents|antiviral agents|mesh-ancestor
25546028|NCT00593645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25546029|NCT00593645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25546030|NCT00593645|Immunologic Factors|immunologic factors|mesh-ancestor
25546031|NCT00593645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650965|NCT01510327|Antipyretics|antipyretics|mesh-ancestor
25650966|NCT01510327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25650967|NCT01510327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25650968|NCT01510327|Immunologic Factors|immunologic factors|mesh-ancestor
25650969|NCT01510327|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25650970|NCT01510327|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25650971|NCT01510327|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25650972|NCT01510327|Purinergic Agents|purinergic agents|mesh-ancestor
25441988|NCT04711044|Dermatologic Agents|dermatologic agents|mesh-ancestor
25441989|NCT04711044|Histamine Agonists|histamine agonists|mesh-ancestor
25441990|NCT04711044|Histamine Agents|histamine agents|mesh-ancestor
25441991|NCT04711044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25441992|NCT04711044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441993|NCT04711044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441994|NCT04710329|Ascorbic Acid|ascorbic acid|mesh-list
25441995|NCT04710329|Antioxidants|antioxidants|mesh-ancestor
25441996|NCT04710329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441997|NCT04710329|Protective Agents|protective agents|mesh-ancestor
25441998|NCT04710329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441999|NCT04710329|Vitamins|vitamins|mesh-ancestor
25442000|NCT04710329|Micronutrients|micronutrients|mesh-ancestor
25442001|NCT04710498|Atezolizumab|atezolizumab|mesh-list
25442002|NCT04710498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25442003|NCT04710017|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25442004|NCT04710017|Tranexamic Acid|tranexamic acid|mesh-list
25442005|NCT04710017|Medroxyprogesterone|medroxyprogesterone|mesh-list
25442006|NCT04710017|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25442007|NCT04710017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25442008|NCT04710017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442009|NCT04710017|Hemostatics|hemostatics|mesh-ancestor
25442010|NCT04710017|Coagulants|coagulants|mesh-ancestor
25442022|NCT04710160|Calcium|calcium|mesh-list
25650973|NCT01510327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25650974|NCT01510327|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25650975|NCT01510327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25650976|NCT01510379|Promethazine|promethazine|mesh-list
25650977|NCT01510379|Diphenhydramine|diphenhydramine|mesh-list
25650978|NCT01510379|Ondansetron|ondansetron|mesh-list
25650979|NCT01510379|Antiemetics|antiemetics|mesh-ancestor
25650980|NCT01510379|Autonomic Agents|autonomic agents|mesh-ancestor
25650981|NCT01510379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650982|NCT01510379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650983|NCT01510379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25650984|NCT01510379|Antipruritics|antipruritics|mesh-ancestor
25650985|NCT01510379|Dermatologic Agents|dermatologic agents|mesh-ancestor
25650986|NCT01510379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25650987|NCT01510379|Serotonin Agents|serotonin agents|mesh-ancestor
25650988|NCT01510379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25650989|NCT01510379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650990|NCT01510379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25650991|NCT01510379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25650992|NCT01510379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25650993|NCT01510379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25650994|NCT01510379|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25650995|NCT01510379|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25650996|NCT01510379|Histamine Antagonists|histamine antagonists|mesh-ancestor
25546032|NCT00593827|Epothilones|epothilones|mesh-list
25546033|NCT00593827|Tubulin Modulators|tubulin modulators|mesh-ancestor
25546034|NCT00593827|Antimitotic Agents|antimitotic agents|mesh-ancestor
25546035|NCT00593827|Mitosis Modulators|mitosis modulators|mesh-ancestor
25546036|NCT00593827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546037|NCT00593827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546038|NCT00593866|Gemcitabine|gemcitabine|mesh-list
25546039|NCT00593866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25546040|NCT00593866|Antimetabolites|antimetabolites|mesh-ancestor
25546041|NCT00593866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546042|NCT00593866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546043|NCT00593866|Antiviral Agents|antiviral agents|mesh-ancestor
25546044|NCT00593866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25546045|NCT00593866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25546046|NCT00593866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25679105|NCT01833832|Antidotes|antidotes|mesh-ancestor
25546047|NCT00593866|Immunologic Factors|immunologic factors|mesh-ancestor
25546048|NCT00593866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546049|NCT00593957|Dextromethorphan|dextromethorphan|mesh-list
25546050|NCT00593957|Antitussive Agents|antitussive agents|mesh-ancestor
25546051|NCT00593957|Respiratory System Agents|respiratory system agents|mesh-ancestor
25546052|NCT00593957|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25546053|NCT00593957|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25546054|NCT00593957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25546055|NCT00593957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546056|NCT00593957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546057|NCT00594165|Rotigotine|rotigotine|mesh-list
25546058|NCT00594165|Dopamine Agonists|dopamine agonists|mesh-ancestor
25546059|NCT00594165|Dopamine Agents|dopamine agents|mesh-ancestor
24831301|NCT02164773|Magnesium Sulfate|magnesium sulfate|mesh-list
25546060|NCT00594165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25546061|NCT00594165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546062|NCT00594165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546063|NCT00594204|Varenicline|varenicline|mesh-list
25546064|NCT00594204|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25546065|NCT00594204|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25546066|NCT00594204|Cholinergic Agents|cholinergic agents|mesh-ancestor
25546067|NCT00594204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25546068|NCT00594204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546069|NCT00594204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546070|NCT00594230|Panobinostat|panobinostat|mesh-list
25216883|NCT02681783|Aflibercept|aflibercept|mesh-list
25546071|NCT00594230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546072|NCT00594230|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25546073|NCT00594230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25546074|NCT00594230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546075|NCT00594256|Sodium Oxybate|sodium oxybate|mesh-list
25546076|NCT00594256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25546077|NCT00594256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25546078|NCT00594256|Anesthetics, General|anesthetics, general|mesh-ancestor
25546079|NCT00594256|Anesthetics|anesthetics|mesh-ancestor
25546080|NCT00594256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25546081|NCT00594256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546082|NCT00594308|Cyclosporine|cyclosporine|mesh-list
25546083|NCT00594308|Mycophenolic Acid|mycophenolic acid|mesh-list
25546084|NCT00594308|Cyclophosphamide|cyclophosphamide|mesh-list
25546085|NCT00594308|Fludarabine|fludarabine|mesh-list
25546086|NCT00594308|Cyclosporins|cyclosporins|mesh-list
25546087|NCT00594308|Basiliximab|basiliximab|mesh-list
25546088|NCT00594308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25546089|NCT00594308|Immunologic Factors|immunologic factors|mesh-ancestor
25546090|NCT00594308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546091|NCT00594308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25546092|NCT00594308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25216919|NCT02681471|Mannitol|mannitol|mesh-list
25546093|NCT00594308|Alkylating Agents|alkylating agents|mesh-ancestor
25546094|NCT00594308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546095|NCT00594308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546096|NCT00594308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25546097|NCT00594308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25546098|NCT00594308|Antifungal Agents|antifungal agents|mesh-ancestor
25546099|NCT00594308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25546100|NCT00594308|Dermatologic Agents|dermatologic agents|mesh-ancestor
24642551|NCT01180075|Tenofovir|tenofovir|mesh-list
25546101|NCT00594308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25546102|NCT00594308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25546103|NCT00594308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25546104|NCT00594308|Antitubercular Agents|antitubercular agents|mesh-ancestor
25546105|NCT00594308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25546106|NCT00594425|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25546107|NCT00594425|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
25546108|NCT00594425|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25546109|NCT00594425|Dermatologic Agents|dermatologic agents|mesh-ancestor
25546110|NCT00594464|Rotigotine|rotigotine|mesh-list
25546111|NCT00594464|Dopamine Agonists|dopamine agonists|mesh-ancestor
25546112|NCT00594464|Dopamine Agents|dopamine agents|mesh-ancestor
25546113|NCT00594464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25546114|NCT00594464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546115|NCT00594464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546116|NCT00594516|Tapentadol|tapentadol|mesh-list
25546117|NCT00594516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25546118|NCT00594516|Narcotics|narcotics|mesh-ancestor
25546119|NCT00594516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25546120|NCT00594516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546121|NCT00594516|Analgesics|analgesics|mesh-ancestor
25546122|NCT00594516|Sensory System Agents|sensory system agents|mesh-ancestor
25546123|NCT00594516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25546124|NCT00594516|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25546125|NCT00594516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25546126|NCT00594516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25546127|NCT00594516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546128|NCT00594516|Adrenergic Agents|adrenergic agents|mesh-ancestor
25546129|NCT00594516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25546130|NCT00594646|Tenofovir|tenofovir|mesh-list
25546131|NCT00594646|Emtricitabine|emtricitabine|mesh-list
25546132|NCT00594646|Raltegravir Potassium|raltegravir potassium|mesh-list
25546133|NCT00594646|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25546134|NCT00594646|Antiviral Agents|antiviral agents|mesh-ancestor
25546135|NCT00594646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25546136|NCT00594646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25546137|NCT00594646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25546138|NCT00594646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217032|NCT02680717|Clobetasol|clobetasol|mesh-list
25546139|NCT00594646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546140|NCT00594646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25546141|NCT00594646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25546142|NCT00594646|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25546143|NCT00594646|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25546144|NCT00594815|Leucovorin|leucovorin|mesh-list
25546145|NCT00594815|Cytarabine|cytarabine|mesh-list
25546146|NCT00594815|Rituximab|rituximab|mesh-list
25546147|NCT00594815|Methotrexate|methotrexate|mesh-list
25546148|NCT00594815|Vincristine|vincristine|mesh-list
25546149|NCT00594815|Procarbazine|procarbazine|mesh-list
25546150|NCT00594815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25546151|NCT00594815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546152|NCT00594815|Immunologic Factors|immunologic factors|mesh-ancestor
25546153|NCT00594815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546154|NCT00594815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25546155|NCT00594815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25546156|NCT00594815|Abortifacient Agents|abortifacient agents|mesh-ancestor
24969863|NCT03739294|Xhance|xhance|mesh-list
25546157|NCT00594815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25546158|NCT00594815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25546159|NCT00594815|Antimetabolites|antimetabolites|mesh-ancestor
25546160|NCT00594815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546161|NCT00594815|Dermatologic Agents|dermatologic agents|mesh-ancestor
25546162|NCT00594815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25546163|NCT00594815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25546164|NCT00594815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25546165|NCT00594815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25546166|NCT00594815|Antiviral Agents|antiviral agents|mesh-ancestor
25546167|NCT00594815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25546168|NCT00594815|Antidotes|antidotes|mesh-ancestor
25546169|NCT00594815|Protective Agents|protective agents|mesh-ancestor
25546170|NCT00594815|Vitamin B Complex|vitamin b complex|mesh-ancestor
25546171|NCT00594815|Vitamins|vitamins|mesh-ancestor
25546172|NCT00594815|Micronutrients|micronutrients|mesh-ancestor
25546173|NCT00594815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25546174|NCT00594815|Tubulin Modulators|tubulin modulators|mesh-ancestor
25546175|NCT00594815|Antimitotic Agents|antimitotic agents|mesh-ancestor
25546176|NCT00594815|Mitosis Modulators|mitosis modulators|mesh-ancestor
25546177|NCT00594854|Diclofenac|diclofenac|mesh-list
25546178|NCT00594854|Arthrotec|arthrotec|mesh-list
25546179|NCT00594854|Misoprostol|misoprostol|mesh-list
25546180|NCT00594854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25546181|NCT00594854|Abortifacient Agents|abortifacient agents|mesh-ancestor
25546182|NCT00594854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25546183|NCT00594854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546184|NCT00594854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25546185|NCT00594854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25546186|NCT00594854|Oxytocics|oxytocics|mesh-ancestor
25546187|NCT00594854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25546188|NCT00594854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25546189|NCT00594854|Analgesics|analgesics|mesh-ancestor
25546190|NCT00594854|Sensory System Agents|sensory system agents|mesh-ancestor
25546191|NCT00594854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25546192|NCT00594854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25546193|NCT00594854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25546194|NCT00594854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25546195|NCT00594854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25546196|NCT00594854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546197|NCT00594880|Interferons|interferons|mesh-list
25546198|NCT00594880|Interferon-alpha|interferon-alpha|mesh-list
25546199|NCT00594880|Interferon alpha-2|interferon alpha-2|mesh-list
25546200|NCT00594880|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25546201|NCT00594880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546202|NCT00594880|Antiviral Agents|antiviral agents|mesh-ancestor
25546203|NCT00594880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25546204|NCT00594880|Immunologic Factors|immunologic factors|mesh-ancestor
25546205|NCT00594880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546206|NCT00594906|Teriparatide|teriparatide|mesh-list
25546207|NCT00594906|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25546208|NCT00594906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546209|NCT00594906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25546210|NCT00594932|Mycophenolic Acid|mycophenolic acid|mesh-list
25546211|NCT00594932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25546212|NCT00594932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546213|NCT00594932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25546214|NCT00594932|Antitubercular Agents|antitubercular agents|mesh-ancestor
25546215|NCT00594932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25546216|NCT00594932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25546217|NCT00594932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25546218|NCT00594932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546219|NCT00594945|Clonazepam|clonazepam|mesh-list
25546220|NCT00594945|Anticonvulsants|anticonvulsants|mesh-ancestor
25546221|NCT00594945|GABA Modulators|gaba modulators|mesh-ancestor
25546222|NCT00594945|GABA Agents|gaba agents|mesh-ancestor
25546223|NCT00594945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25546224|NCT00594945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546225|NCT00594945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546226|NCT00594958|Vaccines|vaccines|mesh-list
25546227|NCT00594958|Immunologic Factors|immunologic factors|mesh-ancestor
25546228|NCT00594958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546229|NCT00595101|Latanoprost|latanoprost|mesh-list
25546230|NCT00595101|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25546231|NCT00595101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25546232|NCT00595127|Cyclophosphamide|cyclophosphamide|mesh-list
25546233|NCT00595127|Fludarabine|fludarabine|mesh-list
25546234|NCT00595127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25546235|NCT00595127|Immunologic Factors|immunologic factors|mesh-ancestor
25546236|NCT00595127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546237|NCT00595127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25546238|NCT00595127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25546239|NCT00595127|Alkylating Agents|alkylating agents|mesh-ancestor
25546240|NCT00595127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546241|NCT00595127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546242|NCT00595127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25546243|NCT00595153|Budesonide|budesonide|mesh-list
25546244|NCT00595153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25546245|NCT00595153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25546246|NCT00595153|Autonomic Agents|autonomic agents|mesh-ancestor
25546247|NCT00595153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25546248|NCT00595153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546249|NCT00595153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25546250|NCT00595153|Respiratory System Agents|respiratory system agents|mesh-ancestor
25546251|NCT00595153|Glucocorticoids|glucocorticoids|mesh-ancestor
25546252|NCT00595153|Hormones|hormones|mesh-ancestor
25546253|NCT00595153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25546254|NCT00595231|Rufinamide|rufinamide|mesh-list
25546255|NCT00595231|Anticonvulsants|anticonvulsants|mesh-ancestor
25546256|NCT00595231|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25546257|NCT00595231|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25546258|NCT00595231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25546259|NCT00595231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546260|NCT00595270|Vaccines|vaccines|mesh-list
25546261|NCT00595270|Immunologic Factors|immunologic factors|mesh-ancestor
25546262|NCT00595270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546263|NCT00595335|Methylprednisolone|methylprednisolone|mesh-list
25546264|NCT00595335|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25546265|NCT00595335|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25546266|NCT00595335|Prednisolone|prednisolone|mesh-list
25265427|NCT02433457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25546267|NCT00595335|Prednisolone acetate|prednisolone acetate|mesh-list
25546268|NCT00595335|Rituximab|rituximab|mesh-list
25546269|NCT00595335|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25546270|NCT00595335|Prednisolone phosphate|prednisolone phosphate|mesh-list
25546271|NCT00595335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25546272|NCT00595335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546273|NCT00595335|Immunologic Factors|immunologic factors|mesh-ancestor
25546274|NCT00595335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546275|NCT00595335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25546276|NCT00595335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25546277|NCT00595335|Antiemetics|antiemetics|mesh-ancestor
25546278|NCT00595335|Autonomic Agents|autonomic agents|mesh-ancestor
25546279|NCT00595335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25546280|NCT00595335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25546281|NCT00595335|Glucocorticoids|glucocorticoids|mesh-ancestor
25546282|NCT00595335|Hormones|hormones|mesh-ancestor
25442243|NCT04708353|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25442244|NCT04708353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25442245|NCT04708353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25442246|NCT04708353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25442247|NCT04708353|Antioxidants|antioxidants|mesh-ancestor
25442248|NCT04708353|Protective Agents|protective agents|mesh-ancestor
25442249|NCT04707950|Tranexamic Acid|tranexamic acid|mesh-list
25442250|NCT04707950|Oxytocin|oxytocin|mesh-list
25442251|NCT04707950|Oxytocics|oxytocics|mesh-ancestor
25442252|NCT04707950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25442253|NCT04707950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442254|NCT04707950|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25442255|NCT04707950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25442256|NCT04707950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442257|NCT04707950|Hemostatics|hemostatics|mesh-ancestor
25442258|NCT04707950|Coagulants|coagulants|mesh-ancestor
25442259|NCT04708106|Menthol|menthol|mesh-list
25442260|NCT04708106|Antipruritics|antipruritics|mesh-ancestor
25442261|NCT04708106|Dermatologic Agents|dermatologic agents|mesh-ancestor
25442262|NCT04707742|Povidone-Iodine|povidone-iodine|mesh-list
25442263|NCT04707742|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25442264|NCT04707742|Cetylpyridinium|cetylpyridinium|mesh-list
25442265|NCT04707742|Povidone|povidone|mesh-list
25442266|NCT04707742|Plasma Substitutes|plasma substitutes|mesh-ancestor
25442267|NCT04707742|Blood Substitutes|blood substitutes|mesh-ancestor
25442268|NCT04707742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24978994|NCT01996436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25546283|NCT00595335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25546284|NCT00595335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25546285|NCT00595335|Protective Agents|protective agents|mesh-ancestor
25546286|NCT00595335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25546287|NCT00595361|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25546288|NCT00595361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25546289|NCT00595361|Autonomic Agents|autonomic agents|mesh-ancestor
25442270|NCT04707560|Heparin|heparin|mesh-list
25546290|NCT00595361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25265514|NCT02433184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25083082|NCT03318159|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25546291|NCT00595361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546292|NCT00595361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25546293|NCT00595361|Respiratory System Agents|respiratory system agents|mesh-ancestor
25546294|NCT00595361|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25546295|NCT00595361|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25546296|NCT00595361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25546297|NCT00595361|Adrenergic Agents|adrenergic agents|mesh-ancestor
25083114|NCT03317912|Lidocaine|lidocaine|mesh-list
25546298|NCT00595361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25546299|NCT00595361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546300|NCT00595413|Adalimumab|adalimumab|mesh-list
25546301|NCT00595413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25546302|NCT00595413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25546303|NCT00595517|Esomeprazole|esomeprazole|mesh-list
25546304|NCT00595517|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25546305|NCT00595517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25546306|NCT00595517|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25546307|NCT00595517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25546308|NCT00595517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546309|NCT00595530|Ketamine|ketamine|mesh-list
25546310|NCT00595530|Analgesics|analgesics|mesh-ancestor
25546311|NCT00595530|Sensory System Agents|sensory system agents|mesh-ancestor
25546312|NCT00595530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25546313|NCT00595530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546314|NCT00595530|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25546315|NCT00595530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25546316|NCT00595530|Anesthetics, General|anesthetics, general|mesh-ancestor
25546317|NCT00595530|Anesthetics|anesthetics|mesh-ancestor
25546318|NCT00595530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25546319|NCT00595530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25546320|NCT00595530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24855997|NCT02282098|Colchicine|colchicine|mesh-list
25546321|NCT00595530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25546322|NCT00595530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546323|NCT00595556|Zonisamide|zonisamide|mesh-list
25546324|NCT00595556|Anticonvulsants|anticonvulsants|mesh-ancestor
25546325|NCT00595556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25546326|NCT00595556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25546327|NCT00595556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546328|NCT00595556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25546329|NCT00595556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546330|NCT00595790|Vaccines|vaccines|mesh-list
25546331|NCT00595790|Immunologic Factors|immunologic factors|mesh-ancestor
25546332|NCT00595790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546333|NCT00595868|Varenicline|varenicline|mesh-list
25546334|NCT00595868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25546335|NCT00595868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25546336|NCT00595868|Cholinergic Agents|cholinergic agents|mesh-ancestor
25546337|NCT00595868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25546338|NCT00595868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546339|NCT00595868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546340|NCT00595946|Lubiprostone|lubiprostone|mesh-list
25546341|NCT00595946|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25546342|NCT00595946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25546343|NCT00595946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546344|NCT00596167|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25546345|NCT00596167|Vancomycin|vancomycin|mesh-list
25546346|NCT00596167|Levofloxacin|levofloxacin|mesh-list
25546347|NCT00596167|Gentamicins|gentamicins|mesh-list
25546348|NCT00596167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25546349|NCT00596167|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25546350|NCT00596167|Renal Agents|renal agents|mesh-ancestor
25546351|NCT00596167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25546352|NCT00596167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25546353|NCT00596167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25546354|NCT00596167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546355|NCT00596167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546356|NCT00596167|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25546357|NCT00596167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25546358|NCT00596167|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25546359|NCT00596271|Vaccines|vaccines|mesh-list
25546360|NCT00596271|Immunologic Factors|immunologic factors|mesh-ancestor
25546361|NCT00596271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546362|NCT00596362|Bevacizumab|bevacizumab|mesh-list
25546363|NCT00596362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25546364|NCT00596362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546365|NCT00596362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25546366|NCT00596362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25546367|NCT00596362|Growth Substances|growth substances|mesh-ancestor
25265735|NCT02431988|Cyclophosphamide|cyclophosphamide|mesh-list
25265765|NCT02431975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25265767|NCT02431936|Prazosin|prazosin|mesh-list
24971003|NCT03729310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24971005|NCT03729284|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25546368|NCT00596362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546369|NCT00596362|Growth Inhibitors|growth inhibitors|mesh-ancestor
25546370|NCT00596427|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
24856555|NCT02285491|Bupivacaine|bupivacaine|mesh-list
24856556|NCT02285491|Anesthetics, Local|anesthetics, local|mesh-ancestor
24856557|NCT02285491|Anesthetics|anesthetics|mesh-ancestor
24856558|NCT02285491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25546371|NCT00596427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25546372|NCT00596427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25546373|NCT00596427|Antimetabolites|antimetabolites|mesh-ancestor
25546374|NCT00596427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546375|NCT00596427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25546376|NCT00596440|Nicotine|nicotine|mesh-list
25546377|NCT00596440|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25546378|NCT00596440|Autonomic Agents|autonomic agents|mesh-ancestor
24503813|NCT00532961|Hormones|hormones|mesh-ancestor
25546379|NCT00596440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650997|NCT01510379|Histamine Agents|histamine agents|mesh-ancestor
25442288|NCT04707209|Sirolimus|sirolimus|mesh-list
25546380|NCT00596440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546381|NCT00596440|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24971628|NCT03723395|Repaglinide|repaglinide|mesh-list
25546382|NCT00596440|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25546383|NCT00596440|Cholinergic Agents|cholinergic agents|mesh-ancestor
25546384|NCT00596440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25546385|NCT00596440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546386|NCT00596453|Ciprofloxacin|ciprofloxacin|mesh-list
25546387|NCT00596453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25546388|NCT00596453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25546389|NCT00596453|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25546390|NCT00596453|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25546391|NCT00596453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25546392|NCT00596453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045448|NCT00948961|Poly ICLC|poly iclc|mesh-list
25546393|NCT00596453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546394|NCT00596453|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25546395|NCT00596453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25546396|NCT00596466|Pregabalin|pregabalin|mesh-list
25546397|NCT00596466|Analgesics|analgesics|mesh-ancestor
25546398|NCT00596466|Sensory System Agents|sensory system agents|mesh-ancestor
25546399|NCT00596466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25546400|NCT00596466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546401|NCT00596466|Anticonvulsants|anticonvulsants|mesh-ancestor
25546402|NCT00596466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25546403|NCT00596466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25546404|NCT00596466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618215|NCT01047215|Aripiprazole|aripiprazole|mesh-list
25546405|NCT00596466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25546406|NCT00596466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25546407|NCT00596466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25546408|NCT00596466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25546409|NCT00596466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25546410|NCT00596622|Lithium Carbonate|lithium carbonate|mesh-list
25546411|NCT00596622|Antidepressive Agents|antidepressive agents|mesh-ancestor
25546412|NCT00596622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25546413|NCT00596622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25546414|NCT00596622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546415|NCT00596622|Antimanic Agents|antimanic agents|mesh-ancestor
25546416|NCT00596622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25546417|NCT00596622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25546418|NCT00596622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546419|NCT00596687|Insulin|insulin|mesh-list
25546420|NCT00596687|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25546421|NCT00596687|Insulin Glargine|insulin glargine|mesh-list
25546422|NCT00596687|Insulin glulisine|insulin glulisine|mesh-list
25546423|NCT00596687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25546424|NCT00596687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546425|NCT00596752|Alprostadil|alprostadil|mesh-list
25546426|NCT00596752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25546427|NCT00596752|Vasodilator Agents|vasodilator agents|mesh-ancestor
25546428|NCT00596752|Urological Agents|urological agents|mesh-ancestor
25546429|NCT00594386|Rotigotine|rotigotine|mesh-list
25546430|NCT00594386|Dopamine Agonists|dopamine agonists|mesh-ancestor
25546431|NCT00594386|Dopamine Agents|dopamine agents|mesh-ancestor
25546432|NCT00594386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25546433|NCT00594386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546434|NCT00594386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546435|NCT00596817|Vortioxetine|vortioxetine|mesh-list
25546436|NCT00596817|Antidepressive Agents|antidepressive agents|mesh-ancestor
25546437|NCT00596817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25546438|NCT00596817|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25546439|NCT00596817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25546440|NCT00596817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24449262|NCT00314782|Docetaxel|docetaxel|mesh-list
25546441|NCT00596817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546442|NCT00596817|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25546443|NCT00596817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25546444|NCT00596817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25546445|NCT00596817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546446|NCT00596817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25546447|NCT00596817|Serotonin Agents|serotonin agents|mesh-ancestor
25546448|NCT00596817|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25546449|NCT00596817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25546450|NCT00596817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25546451|NCT00596817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25546452|NCT00596830|Paclitaxel|paclitaxel|mesh-list
25546453|NCT00596830|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25546454|NCT00596830|Carboplatin|carboplatin|mesh-list
25546455|NCT00596830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25546456|NCT00596830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546457|NCT00596830|Tubulin Modulators|tubulin modulators|mesh-ancestor
25546458|NCT00596830|Antimitotic Agents|antimitotic agents|mesh-ancestor
25546459|NCT00596830|Mitosis Modulators|mitosis modulators|mesh-ancestor
25546460|NCT00596830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546461|NCT00597038|Dasatinib|dasatinib|mesh-list
25546462|NCT00597038|Dacarbazine|dacarbazine|mesh-list
25546463|NCT00597038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546464|NCT00597038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25546465|NCT00597038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25546466|NCT00597038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546467|NCT00597038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25546468|NCT00597038|Alkylating Agents|alkylating agents|mesh-ancestor
25546469|NCT00597116|Vinorelbine|vinorelbine|mesh-list
25546470|NCT00597116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25546471|NCT00597116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546472|NCT00597116|Tubulin Modulators|tubulin modulators|mesh-ancestor
25546473|NCT00597116|Antimitotic Agents|antimitotic agents|mesh-ancestor
25546474|NCT00597116|Mitosis Modulators|mitosis modulators|mesh-ancestor
25546475|NCT00597116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546476|NCT00597402|Bevacizumab|bevacizumab|mesh-list
25546477|NCT00597402|Irinotecan|irinotecan|mesh-list
25546478|NCT00597402|Temozolomide|temozolomide|mesh-list
25546479|NCT00597402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25546480|NCT00597402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546481|NCT00597402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25546482|NCT00597402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25546483|NCT00597402|Growth Substances|growth substances|mesh-ancestor
25546484|NCT00597402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546485|NCT00597402|Growth Inhibitors|growth inhibitors|mesh-ancestor
25546486|NCT00597402|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25546487|NCT00597402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24648106|NCT01212406|Vitamins|vitamins|mesh-ancestor
25546488|NCT00597402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25546489|NCT00597402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546490|NCT00597402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25546491|NCT00597402|Alkylating Agents|alkylating agents|mesh-ancestor
25546492|NCT00597428|Lubiprostone|lubiprostone|mesh-list
25546493|NCT00597428|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25546494|NCT00597428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25546495|NCT00597428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546496|NCT00597493|Temozolomide|temozolomide|mesh-list
25546497|NCT00597493|Sorafenib|sorafenib|mesh-list
25546498|NCT00597493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25546499|NCT00597493|Alkylating Agents|alkylating agents|mesh-ancestor
25546500|NCT00597493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546501|NCT00597493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546502|NCT00597493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25546503|NCT00597493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25546504|NCT00597506|Bevacizumab|bevacizumab|mesh-list
25546505|NCT00597506|Everolimus|everolimus|mesh-list
25546506|NCT00597506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25546507|NCT00597506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546508|NCT00597506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25546509|NCT00597506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25546510|NCT00597506|Growth Substances|growth substances|mesh-ancestor
25546511|NCT00597506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546512|NCT00597506|Growth Inhibitors|growth inhibitors|mesh-ancestor
25546513|NCT00597506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25546514|NCT00597506|Immunologic Factors|immunologic factors|mesh-ancestor
25546515|NCT00597519|Cyclophosphamide|cyclophosphamide|mesh-list
25546516|NCT00597519|Fludarabine|fludarabine|mesh-list
25546517|NCT00597519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25546518|NCT00597519|Immunologic Factors|immunologic factors|mesh-ancestor
25546519|NCT00597519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546520|NCT00597519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24856947|NCT02288078|Antiemetics|antiemetics|mesh-ancestor
25546521|NCT00597519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25546522|NCT00597519|Alkylating Agents|alkylating agents|mesh-ancestor
25546523|NCT00597519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546524|NCT00597519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546525|NCT00597519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25546526|NCT00597584|Epoetin Alfa|epoetin alfa|mesh-list
25546527|NCT00597584|Hematinics|hematinics|mesh-ancestor
25546528|NCT00597701|Lorazepam|lorazepam|mesh-list
25546529|NCT00597701|Baclofen|baclofen|mesh-list
25546530|NCT00597701|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25546531|NCT00597701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546532|NCT00597701|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25546533|NCT00597701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25546534|NCT00597701|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25546535|NCT00597701|GABA Agonists|gaba agonists|mesh-ancestor
25546536|NCT00597701|GABA Agents|gaba agents|mesh-ancestor
25546537|NCT00597701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25546538|NCT00597701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546539|NCT00597701|Anticonvulsants|anticonvulsants|mesh-ancestor
25546540|NCT00597701|Antiemetics|antiemetics|mesh-ancestor
25546541|NCT00597701|Autonomic Agents|autonomic agents|mesh-ancestor
25546542|NCT00597701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25546543|NCT00597701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25546544|NCT00597701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25546545|NCT00597701|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25546546|NCT00597701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25546547|NCT00597701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25546548|NCT00597701|GABA Modulators|gaba modulators|mesh-ancestor
25546549|NCT00597727|Glycerol|glycerol|mesh-list
25546550|NCT00597727|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25546551|NCT00597727|Protective Agents|protective agents|mesh-ancestor
25546552|NCT00597727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546553|NCT00597753|Epoetin Alfa|epoetin alfa|mesh-list
25546554|NCT00597753|Hematinics|hematinics|mesh-ancestor
25546555|NCT00597766|Triamcinolone|triamcinolone|mesh-list
25546556|NCT00597766|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25546557|NCT00597766|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25546558|NCT00597766|Lidocaine|lidocaine|mesh-list
25546559|NCT00597766|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25546560|NCT00597766|Anesthetics, Local|anesthetics, local|mesh-ancestor
25546561|NCT00597766|Anesthetics|anesthetics|mesh-ancestor
25546562|NCT00597766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25546563|NCT00597766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546564|NCT00597766|Sensory System Agents|sensory system agents|mesh-ancestor
25546565|NCT00597766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25546566|NCT00597766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25546567|NCT00597766|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25546568|NCT00597766|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25218057|NCT02673463|Diuretics|diuretics|mesh-ancestor
25546569|NCT00597766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25546570|NCT00597766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546571|NCT00597766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25546572|NCT00597766|Glucocorticoids|glucocorticoids|mesh-ancestor
25546573|NCT00597766|Hormones|hormones|mesh-ancestor
25546574|NCT00597766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25546575|NCT00597766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25546576|NCT00597766|Immunologic Factors|immunologic factors|mesh-ancestor
25546577|NCT00597766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25546578|NCT00597818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25546579|NCT00597818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25546580|NCT00597818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24973669|NCT03707808|Nivolumab|nivolumab|mesh-list
25546581|NCT00597818|Analgesics|analgesics|mesh-ancestor
25546582|NCT00597818|Sensory System Agents|sensory system agents|mesh-ancestor
25546583|NCT00597818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25546584|NCT00597818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546585|NCT00597818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25546586|NCT00597896|Pramipexole|pramipexole|mesh-list
25546587|NCT00597896|Antioxidants|antioxidants|mesh-ancestor
25546588|NCT00597896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442497|NCT04705584|Hormones|hormones|mesh-ancestor
25442498|NCT04705584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25442499|NCT04705584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25442500|NCT04705584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25442501|NCT04705454|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
25442502|NCT04705454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25546589|NCT00597896|Protective Agents|protective agents|mesh-ancestor
25546590|NCT00597896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546591|NCT00597896|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25546592|NCT00597896|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25546593|NCT00597896|Dopamine Agonists|dopamine agonists|mesh-ancestor
25546594|NCT00597896|Dopamine Agents|dopamine agents|mesh-ancestor
25546595|NCT00597896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25546596|NCT00598078|Sodium Oxybate|sodium oxybate|mesh-list
25546598|NCT00598078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25546599|NCT00598078|Anesthetics, General|anesthetics, general|mesh-ancestor
25546600|NCT00598078|Anesthetics|anesthetics|mesh-ancestor
25546601|NCT00598078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25546602|NCT00598078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546603|NCT00598273|Darbepoetin alfa|darbepoetin alfa|mesh-list
25546604|NCT00598273|Hematinics|hematinics|mesh-ancestor
25546605|NCT00598442|Darbepoetin alfa|darbepoetin alfa|mesh-list
25546606|NCT00598442|Hematinics|hematinics|mesh-ancestor
25650998|NCT01510379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25650999|NCT01510379|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25651000|NCT01510379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25651001|NCT01510379|Anesthetics, Local|anesthetics, local|mesh-ancestor
25651002|NCT01510379|Anesthetics|anesthetics|mesh-ancestor
25651003|NCT01510379|Sensory System Agents|sensory system agents|mesh-ancestor
25651004|NCT01510457|Milnacipran|milnacipran|mesh-list
25651005|NCT01510457|Levomilnacipran|levomilnacipran|mesh-list
25651006|NCT01510457|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25651007|NCT01510457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25651008|NCT01510457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25651009|NCT01510457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651010|NCT01510457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25651011|NCT01510457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651012|NCT01510457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25651013|NCT01510457|Analgesics|analgesics|mesh-ancestor
25651014|NCT01510457|Sensory System Agents|sensory system agents|mesh-ancestor
25651015|NCT01510457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25651016|NCT01510457|Antidepressive Agents|antidepressive agents|mesh-ancestor
25651017|NCT01510457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25651018|NCT01510769|Febuxostat|febuxostat|mesh-list
25651019|NCT01510769|Lesinurad|lesinurad|mesh-list
25651020|NCT01510769|Gout Suppressants|gout suppressants|mesh-ancestor
25651021|NCT01510769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25651022|NCT01510769|Uricosuric Agents|uricosuric agents|mesh-ancestor
25651023|NCT01510769|Renal Agents|renal agents|mesh-ancestor
25651024|NCT01510912|Diclofenac|diclofenac|mesh-list
25651025|NCT01510912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25651026|NCT01510912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25651027|NCT01510912|Analgesics|analgesics|mesh-ancestor
25651028|NCT01510912|Sensory System Agents|sensory system agents|mesh-ancestor
25651029|NCT01510912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24932393|NCT04080869|Antioxidants|antioxidants|mesh-ancestor
25651030|NCT01510912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651031|NCT01510912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25651032|NCT01510912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25651033|NCT01510912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25651034|NCT01510912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651035|NCT01510912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651036|NCT01511068|Sargramostim|sargramostim|mesh-list
25651037|NCT01511068|Immunologic Factors|immunologic factors|mesh-ancestor
25651038|NCT01511068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651039|NCT01511107|Amoxicillin|amoxicillin|mesh-list
25651040|NCT01511107|Clavulanic Acid|clavulanic acid|mesh-list
25651041|NCT01511107|Clavulanic Acids|clavulanic acids|mesh-list
25651042|NCT01511107|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25651043|NCT01511107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25651044|NCT01511107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25651045|NCT01511107|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25651046|NCT01511107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651047|NCT01511107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651048|NCT01511315|Ustekinumab|ustekinumab|mesh-list
25651049|NCT01511315|Dermatologic Agents|dermatologic agents|mesh-ancestor
25651050|NCT01511445|Silicon|silicon|mesh-list
25651051|NCT01511445|Trace Elements|trace elements|mesh-ancestor
25651052|NCT01511445|Micronutrients|micronutrients|mesh-ancestor
25651053|NCT01511445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651054|NCT01511536|Prednisone|prednisone|mesh-list
25651055|NCT01511536|Abiraterone Acetate|abiraterone acetate|mesh-list
25651056|NCT01511536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25651057|NCT01511536|Glucocorticoids|glucocorticoids|mesh-ancestor
25651058|NCT01511536|Hormones|hormones|mesh-ancestor
24978995|NCT01996436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651059|NCT01511536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25651060|NCT01511536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651061|NCT01511536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25651062|NCT01511536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546607|NCT00598481|Busulfan|busulfan|mesh-list
25546608|NCT00598481|Alkylating Agents|alkylating agents|mesh-ancestor
25546609|NCT00598481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546610|NCT00598481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25546611|NCT00598481|Immunologic Factors|immunologic factors|mesh-ancestor
25546612|NCT00598481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546613|NCT00598481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25218214|NCT02671708|Cyclophosphamide|cyclophosphamide|mesh-list
25546614|NCT00598481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546615|NCT00598481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25546616|NCT00598507|Sagopilone|sagopilone|mesh-list
25546617|NCT00598507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546618|NCT00598559|Acetaminophen|acetaminophen|mesh-list
25546619|NCT00598559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25546620|NCT00598559|Analgesics|analgesics|mesh-ancestor
25546621|NCT00598559|Sensory System Agents|sensory system agents|mesh-ancestor
25546622|NCT00598559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25546623|NCT00598559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546624|NCT00598559|Antipyretics|antipyretics|mesh-ancestor
25546625|NCT00598585|Sildenafil Citrate|sildenafil citrate|mesh-list
25546626|NCT00598585|Vasodilator Agents|vasodilator agents|mesh-ancestor
25546627|NCT00598585|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25546628|NCT00598585|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25546629|NCT00598585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25546630|NCT00598585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546631|NCT00598585|Urological Agents|urological agents|mesh-ancestor
25546632|NCT00598650|Donepezil|donepezil|mesh-list
25546633|NCT00598650|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25546634|NCT00598650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25546635|NCT00598650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546636|NCT00598650|Cholinergic Agents|cholinergic agents|mesh-ancestor
25546637|NCT00598650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25546638|NCT00598650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546639|NCT00598650|Nootropic Agents|nootropic agents|mesh-ancestor
25546640|NCT00598663|Insulin|insulin|mesh-list
25546641|NCT00598663|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25546642|NCT00598663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25546643|NCT00598663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546644|NCT00598702|Acetaminophen|acetaminophen|mesh-list
25546645|NCT00598702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25546646|NCT00598702|Analgesics|analgesics|mesh-ancestor
25546647|NCT00598702|Sensory System Agents|sensory system agents|mesh-ancestor
25546648|NCT00598702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25546649|NCT00598702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546650|NCT00598702|Antipyretics|antipyretics|mesh-ancestor
25546651|NCT00598806|Apaziquone|apaziquone|mesh-list
25546652|NCT00598806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546653|NCT00598832|Adapalene|adapalene|mesh-list
25546654|NCT00598832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25546655|NCT00598832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25546656|NCT00598832|Analgesics|analgesics|mesh-ancestor
25546657|NCT00598832|Sensory System Agents|sensory system agents|mesh-ancestor
25546658|NCT00598832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25546659|NCT00598832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546660|NCT00598832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25546661|NCT00598832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25546662|NCT00598832|Dermatologic Agents|dermatologic agents|mesh-ancestor
25546663|NCT00598871|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25546664|NCT00598871|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25546665|NCT00598975|Irinotecan|irinotecan|mesh-list
25546666|NCT00598975|Cetuximab|cetuximab|mesh-list
25546667|NCT00598975|Etirinotecan pegol|etirinotecan pegol|mesh-list
25546668|NCT00598975|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25546669|NCT00598975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25546670|NCT00598975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25546671|NCT00598975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546672|NCT00598975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546673|NCT00598975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25546674|NCT00598975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25546675|NCT00599053|Azithromycin|azithromycin|mesh-list
25546676|NCT00599053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25546677|NCT00599053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25546678|NCT00599196|Rotigotine|rotigotine|mesh-list
25546679|NCT00599196|Dopamine Agonists|dopamine agonists|mesh-ancestor
25546680|NCT00599196|Dopamine Agents|dopamine agents|mesh-ancestor
25546681|NCT00599196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25651063|NCT01511536|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25442615|NCT04704297|Ketorolac|ketorolac|mesh-list
25546682|NCT00599196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546683|NCT00599196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546684|NCT00599313|Sunitinib|sunitinib|mesh-list
25546685|NCT00599313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546686|NCT00599313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25546687|NCT00599313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25546688|NCT00599313|Growth Substances|growth substances|mesh-ancestor
25546689|NCT00599313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546690|NCT00599313|Growth Inhibitors|growth inhibitors|mesh-ancestor
25546691|NCT00599313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25546692|NCT00599313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25546693|NCT00599313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546694|NCT00599326|Deferasirox|deferasirox|mesh-list
25546695|NCT00599326|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25546696|NCT00599326|Chelating Agents|chelating agents|mesh-ancestor
25546697|NCT00599326|Sequestering Agents|sequestering agents|mesh-ancestor
25546698|NCT00599326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546699|NCT00599521|Adapalene|adapalene|mesh-list
25546700|NCT00599521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25546701|NCT00599521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25546702|NCT00599521|Analgesics|analgesics|mesh-ancestor
25546703|NCT00599521|Sensory System Agents|sensory system agents|mesh-ancestor
25546704|NCT00599521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25546705|NCT00599521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546706|NCT00599521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25546707|NCT00599521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25546708|NCT00599521|Dermatologic Agents|dermatologic agents|mesh-ancestor
25546709|NCT00599638|Pregabalin|pregabalin|mesh-list
25546710|NCT00599638|Analgesics|analgesics|mesh-ancestor
25546711|NCT00599638|Sensory System Agents|sensory system agents|mesh-ancestor
25546712|NCT00599638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25546713|NCT00599638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546714|NCT00599638|Anticonvulsants|anticonvulsants|mesh-ancestor
25546715|NCT00599638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25546716|NCT00599638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25546717|NCT00599638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546718|NCT00599638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25546719|NCT00599638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25546720|NCT00599638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25546721|NCT00599638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25546722|NCT00599638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25546723|NCT00599755|Gemcitabine|gemcitabine|mesh-list
25546724|NCT00599755|Cisplatin|cisplatin|mesh-list
25546725|NCT00599755|Carboplatin|carboplatin|mesh-list
25546726|NCT00599755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546727|NCT00599755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25546728|NCT00599755|Antimetabolites|antimetabolites|mesh-ancestor
25546729|NCT00599755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546730|NCT00599755|Antiviral Agents|antiviral agents|mesh-ancestor
25546731|NCT00599755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25546732|NCT00599755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25546733|NCT00599755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25546734|NCT00599755|Immunologic Factors|immunologic factors|mesh-ancestor
25546735|NCT00599755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546736|NCT00599924|Leucovorin|leucovorin|mesh-list
25546737|NCT00599924|Sunitinib|sunitinib|mesh-list
25546738|NCT00599924|Fluorouracil|fluorouracil|mesh-list
25546739|NCT00599924|Oxaliplatin|oxaliplatin|mesh-list
25546740|NCT00599924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546741|NCT00599924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25546742|NCT00599924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25546743|NCT00599924|Growth Substances|growth substances|mesh-ancestor
25546744|NCT00599924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546745|NCT00599924|Growth Inhibitors|growth inhibitors|mesh-ancestor
25546746|NCT00599924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25546747|NCT00599924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25546748|NCT00599924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546749|NCT00599924|Antimetabolites|antimetabolites|mesh-ancestor
25218470|NCT02670304|Antipyretics|antipyretics|mesh-ancestor
25546750|NCT00599924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25546751|NCT00599924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25546752|NCT00599924|Immunologic Factors|immunologic factors|mesh-ancestor
25546753|NCT00599924|Antidotes|antidotes|mesh-ancestor
25546754|NCT00599924|Protective Agents|protective agents|mesh-ancestor
25546755|NCT00599924|Vitamin B Complex|vitamin b complex|mesh-ancestor
25546756|NCT00599924|Vitamins|vitamins|mesh-ancestor
25546757|NCT00599924|Micronutrients|micronutrients|mesh-ancestor
25546758|NCT00600028|Thalidomide|thalidomide|mesh-list
25546759|NCT00600028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25546760|NCT00600028|Immunologic Factors|immunologic factors|mesh-ancestor
25546761|NCT00600028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546762|NCT00600028|Leprostatic Agents|leprostatic agents|mesh-ancestor
25546763|NCT00600028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25442738|NCT04702971|Histamine Antagonists|histamine antagonists|mesh-ancestor
25442739|NCT04702971|Histamine Agents|histamine agents|mesh-ancestor
25442740|NCT04702971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25442741|NCT04702971|Vasodilator Agents|vasodilator agents|mesh-ancestor
25442742|NCT04703088|Ondansetron|ondansetron|mesh-list
25442743|NCT04703088|Antiemetics|antiemetics|mesh-ancestor
25442744|NCT04703088|Autonomic Agents|autonomic agents|mesh-ancestor
25442745|NCT04703088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25442746|NCT04703088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442747|NCT04703088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25442748|NCT04703088|Antipruritics|antipruritics|mesh-ancestor
25442749|NCT04703088|Dermatologic Agents|dermatologic agents|mesh-ancestor
25442750|NCT04703088|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25442751|NCT04703088|Serotonin Agents|serotonin agents|mesh-ancestor
25442752|NCT04703088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25442753|NCT04703088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442754|NCT04703088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25442755|NCT04703088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25442756|NCT04703088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25442757|NCT04703088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25442758|NCT04703088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25442760|NCT04702698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25442761|NCT04702698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25442762|NCT04702698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442763|NCT04702685|Ropivacaine|ropivacaine|mesh-list
25442764|NCT04702685|Anesthetics, Local|anesthetics, local|mesh-ancestor
25442765|NCT04702685|Anesthetics|anesthetics|mesh-ancestor
25442766|NCT04702685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25442767|NCT04702685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442768|NCT04702685|Sensory System Agents|sensory system agents|mesh-ancestor
25442769|NCT04702685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25442770|NCT04702490|Empagliflozin|empagliflozin|mesh-list
25442771|NCT04702490|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25546764|NCT00600028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25546765|NCT00600028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25546766|NCT00600028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25546767|NCT00600028|Growth Substances|growth substances|mesh-ancestor
25546768|NCT00600028|Growth Inhibitors|growth inhibitors|mesh-ancestor
24462371|NCT00355927|Propofol|propofol|mesh-list
25546769|NCT00600028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546770|NCT00600067|Topiramate|topiramate|mesh-list
25546771|NCT00600067|Phentermine|phentermine|mesh-list
25546772|NCT00600067|Anticonvulsants|anticonvulsants|mesh-ancestor
25546773|NCT00600067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25546774|NCT00600067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546775|NCT00600067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25546776|NCT00600067|Appetite Depressants|appetite depressants|mesh-ancestor
25546777|NCT00600067|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25546778|NCT00600067|Sympathomimetics|sympathomimetics|mesh-ancestor
25546779|NCT00600067|Autonomic Agents|autonomic agents|mesh-ancestor
25546780|NCT00600067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25546781|NCT00600067|Adrenergic Agents|adrenergic agents|mesh-ancestor
25546782|NCT00600067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25546783|NCT00600067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546784|NCT00600119|Naloxegol|naloxegol|mesh-list
25546785|NCT00600119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25546786|NCT00600119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546787|NCT00600119|Sensory System Agents|sensory system agents|mesh-ancestor
25546788|NCT00600119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25546789|NCT00600340|Paclitaxel|paclitaxel|mesh-list
25546790|NCT00600340|Bevacizumab|bevacizumab|mesh-list
25546791|NCT00600340|Capecitabine|capecitabine|mesh-list
25546792|NCT00600340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25546793|NCT00600340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546794|NCT00600340|Tubulin Modulators|tubulin modulators|mesh-ancestor
25546795|NCT00600340|Antimitotic Agents|antimitotic agents|mesh-ancestor
25546796|NCT00600340|Mitosis Modulators|mitosis modulators|mesh-ancestor
25546797|NCT00600340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546798|NCT00600340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24462560|NCT00356954|Ascorbic Acid|ascorbic acid|mesh-list
25083590|NCT03314740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24628510|NCT01099462|Ibuprofen|ibuprofen|mesh-list
25083591|NCT03314636|Dexamethasone|dexamethasone|mesh-list
25083592|NCT03314636|Lenalidomide|lenalidomide|mesh-list
25546799|NCT00600340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25546800|NCT00600340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25546801|NCT00600340|Growth Substances|growth substances|mesh-ancestor
25546802|NCT00600340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546803|NCT00600340|Growth Inhibitors|growth inhibitors|mesh-ancestor
25546804|NCT00600340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25546805|NCT00600340|Antimetabolites|antimetabolites|mesh-ancestor
24832621|NCT02171767|Afatinib|afatinib|mesh-list
24449432|NCT00315601|Dimercaprol|dimercaprol|mesh-list
25083896|NCT03311828|Daratumumab|daratumumab|mesh-list
25679302|NCT01836198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25679303|NCT01836198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679304|NCT01836198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25218703|NCT02668497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546806|NCT00600353|Dexamethasone|dexamethasone|mesh-list
25546808|NCT00600353|Palonosetron|palonosetron|mesh-list
25546809|NCT00600353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25546810|NCT00600353|Antiemetics|antiemetics|mesh-ancestor
25546811|NCT00600353|Autonomic Agents|autonomic agents|mesh-ancestor
25546812|NCT00600353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25546813|NCT00600353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546814|NCT00600353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25546815|NCT00600353|Glucocorticoids|glucocorticoids|mesh-ancestor
25546816|NCT00600353|Hormones|hormones|mesh-ancestor
25546817|NCT00600353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25546818|NCT00600353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25546819|NCT00600353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546820|NCT00600353|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25546821|NCT00600353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25546822|NCT00600353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546823|NCT00600353|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25546824|NCT00600353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25546825|NCT00600353|Serotonin Agents|serotonin agents|mesh-ancestor
25546826|NCT00600756|Risperidone|risperidone|mesh-list
25546827|NCT00600756|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25546828|NCT00600756|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25546829|NCT00600756|Serotonin Agents|serotonin agents|mesh-ancestor
25546830|NCT00600756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24978996|NCT01996436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25546831|NCT00600756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546832|NCT00600756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546833|NCT00600756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25546834|NCT00600756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25546835|NCT00600756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25546836|NCT00600756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25546837|NCT00600756|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25546838|NCT00600756|Dopamine Agents|dopamine agents|mesh-ancestor
25546839|NCT00600756|Antidepressive Agents|antidepressive agents|mesh-ancestor
25546840|NCT00600821|Paclitaxel|paclitaxel|mesh-list
25546841|NCT00600821|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25546842|NCT00600821|Bevacizumab|bevacizumab|mesh-list
25546843|NCT00600821|Carboplatin|carboplatin|mesh-list
25546844|NCT00600821|Axitinib|axitinib|mesh-list
25546845|NCT00600821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24628923|NCT01101919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25546846|NCT00600821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546847|NCT00600821|Tubulin Modulators|tubulin modulators|mesh-ancestor
25546848|NCT00600821|Antimitotic Agents|antimitotic agents|mesh-ancestor
25546849|NCT00600821|Mitosis Modulators|mitosis modulators|mesh-ancestor
25546850|NCT00600821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546851|NCT00600821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25546852|NCT00600821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25546853|NCT00600821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25546854|NCT00600821|Growth Substances|growth substances|mesh-ancestor
25546855|NCT00600821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546856|NCT00600821|Growth Inhibitors|growth inhibitors|mesh-ancestor
25546857|NCT00600821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25546858|NCT00600821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25546859|NCT00600886|Octreotide|octreotide|mesh-list
25546860|NCT00600886|Pasireotide|pasireotide|mesh-list
25546861|NCT00600886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25546862|NCT00600886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25546863|NCT00600886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546864|NCT00600886|Hormones|hormones|mesh-ancestor
25546865|NCT00600886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25546866|NCT00600886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546867|NCT00600925|Gentamicins|gentamicins|mesh-list
25546868|NCT00600925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25546869|NCT00600925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25546870|NCT00600925|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25442775|NCT04702048|Aflibercept|aflibercept|mesh-list
25546871|NCT00600925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25546872|NCT00600925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546873|NCT00600938|Deferasirox|deferasirox|mesh-list
25546874|NCT00600938|Deferoxamine|deferoxamine|mesh-list
25546875|NCT00600938|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25546876|NCT00600938|Chelating Agents|chelating agents|mesh-ancestor
25546877|NCT00600938|Sequestering Agents|sequestering agents|mesh-ancestor
25546878|NCT00600938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546879|NCT00600938|Siderophores|siderophores|mesh-ancestor
25546880|NCT00601107|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
25546881|NCT00601107|Vitamins|vitamins|mesh-ancestor
25546882|NCT00601107|Micronutrients|micronutrients|mesh-ancestor
25546883|NCT00601107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546884|NCT00601107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25546885|NCT00601172|Dexamethasone|dexamethasone|mesh-list
25546886|NCT00601172|Ondansetron|ondansetron|mesh-list
25546887|NCT00601172|Casopitant|casopitant|mesh-list
25546888|NCT00601172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25546889|NCT00601172|Antiemetics|antiemetics|mesh-ancestor
25546890|NCT00601172|Autonomic Agents|autonomic agents|mesh-ancestor
25546891|NCT00601172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25546892|NCT00601172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546893|NCT00601172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25546894|NCT00601172|Glucocorticoids|glucocorticoids|mesh-ancestor
25546895|NCT00601172|Hormones|hormones|mesh-ancestor
25084596|NCT03305068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25266561|NCT02427334|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25546896|NCT00601172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25546897|NCT00601172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25546898|NCT00601172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546899|NCT00601172|Antipruritics|antipruritics|mesh-ancestor
25546900|NCT00601172|Dermatologic Agents|dermatologic agents|mesh-ancestor
25546901|NCT00601172|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25546902|NCT00601172|Serotonin Agents|serotonin agents|mesh-ancestor
25546903|NCT00601172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25546904|NCT00601172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546905|NCT00601172|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25546906|NCT00601172|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25546907|NCT00601172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25546908|NCT00601172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25546909|NCT00601172|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25546910|NCT00601172|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25546911|NCT00601250|Linagliptin|linagliptin|mesh-list
25546912|NCT00601250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25546913|NCT00601250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546914|NCT00601250|Incretins|incretins|mesh-ancestor
25546915|NCT00601250|Hormones|hormones|mesh-ancestor
25546916|NCT00601250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25546917|NCT00601250|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25546918|NCT00601250|Protease Inhibitors|protease inhibitors|mesh-ancestor
25546919|NCT00601250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25546920|NCT00601250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546921|NCT00601354|Orlistat|orlistat|mesh-list
25546922|NCT00601354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25546923|NCT00601354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546924|NCT00601354|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25546925|NCT00601354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25546926|NCT00601458|Naproxen|naproxen|mesh-list
25546927|NCT00601458|Pregabalin|pregabalin|mesh-list
25546928|NCT00601458|Analgesics|analgesics|mesh-ancestor
25546929|NCT00601458|Sensory System Agents|sensory system agents|mesh-ancestor
25546930|NCT00601458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25546931|NCT00601458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546932|NCT00601458|Anticonvulsants|anticonvulsants|mesh-ancestor
25546933|NCT00601458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25546934|NCT00601458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25546935|NCT00601458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546936|NCT00601458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25546937|NCT00601458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25546938|NCT00601458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25546939|NCT00601458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25546940|NCT00601458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25546941|NCT00601458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25546942|NCT00601458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25546943|NCT00601458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25084883|NCT03302390|Epinephrine|epinephrine|mesh-list
25546944|NCT00601458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25546945|NCT00601458|Gout Suppressants|gout suppressants|mesh-ancestor
25546946|NCT00601458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25546947|NCT00601458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25546948|NCT00601484|Tanezumab|tanezumab|mesh-list
25546949|NCT00601484|Analgesics|analgesics|mesh-ancestor
25546950|NCT00601484|Sensory System Agents|sensory system agents|mesh-ancestor
25546951|NCT00601484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25546952|NCT00601484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546953|NCT00601523|Pramipexole|pramipexole|mesh-list
25546954|NCT00601523|Antioxidants|antioxidants|mesh-ancestor
25546955|NCT00601523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546956|NCT00601523|Protective Agents|protective agents|mesh-ancestor
25546957|NCT00601523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546958|NCT00601523|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25546959|NCT00601523|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25546960|NCT00601523|Dopamine Agonists|dopamine agonists|mesh-ancestor
25546961|NCT00601523|Dopamine Agents|dopamine agents|mesh-ancestor
25546962|NCT00601523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25546963|NCT00601627|Gemcitabine|gemcitabine|mesh-list
25546964|NCT00601627|Fluorouracil|fluorouracil|mesh-list
25546965|NCT00601627|Capecitabine|capecitabine|mesh-list
25546966|NCT00601627|Panitumumab|panitumumab|mesh-list
25546967|NCT00601627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25546968|NCT00601627|Antimetabolites|antimetabolites|mesh-ancestor
25546969|NCT00601627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546970|NCT00601627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546971|NCT00601627|Antiviral Agents|antiviral agents|mesh-ancestor
25546972|NCT00601627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25546973|NCT00601627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085081|NCT03301233|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25546974|NCT00601627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25546975|NCT00601627|Immunologic Factors|immunologic factors|mesh-ancestor
25546976|NCT00601627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546977|NCT00601627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25546978|NCT00601640|Eflornithine|eflornithine|mesh-list
25546979|NCT00601640|Diclofenac|diclofenac|mesh-list
25546980|NCT00601640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25546981|NCT00601640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25546982|NCT00601640|Analgesics|analgesics|mesh-ancestor
25546983|NCT00601640|Sensory System Agents|sensory system agents|mesh-ancestor
25546984|NCT00601640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25546985|NCT00601640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25546986|NCT00601640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25546987|NCT00601640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25546988|NCT00601640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25546989|NCT00601640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085082|NCT03301233|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25085083|NCT03301233|Estradiol|estradiol|mesh-list
25546990|NCT00601640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25546991|NCT00601640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25546992|NCT00601640|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25546993|NCT00601640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25546994|NCT00601640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25546995|NCT00601640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25546996|NCT00601640|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
25546997|NCT00601705|Cisplatin|cisplatin|mesh-list
25546998|NCT00601705|Fluorouracil|fluorouracil|mesh-list
25218959|NCT02666365|Cefazolin|cefazolin|mesh-list
25546999|NCT00601705|Oxaliplatin|oxaliplatin|mesh-list
25547000|NCT00601705|Epirubicin|epirubicin|mesh-list
25547001|NCT00601705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25547002|NCT00601705|Antimetabolites|antimetabolites|mesh-ancestor
25547003|NCT00601705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547004|NCT00601705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25547005|NCT00601705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25547006|NCT00601705|Immunologic Factors|immunologic factors|mesh-ancestor
25547007|NCT00601705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547008|NCT00601705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25547009|NCT00601705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25085180|NCT03300960|Ganirelix|ganirelix|mesh-list
25547010|NCT00601705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25547011|NCT00601705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547012|NCT00601718|Rituximab|rituximab|mesh-list
25547013|NCT00601718|Carboplatin|carboplatin|mesh-list
25547014|NCT00601718|Etoposide|etoposide|mesh-list
25547015|NCT00601718|Etoposide phosphate|etoposide phosphate|mesh-list
25085230|NCT03300531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25547016|NCT00601718|Ifosfamide|ifosfamide|mesh-list
25547017|NCT00601718|Vorinostat|vorinostat|mesh-list
25547018|NCT00601718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25547019|NCT00601718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25442917|NCT04700475|Citric Acid|citric acid|mesh-list
25547020|NCT00601718|Immunologic Factors|immunologic factors|mesh-ancestor
25547021|NCT00601718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266657|NCT02426723|Dexamethasone|dexamethasone|mesh-list
25442968|NCT04699734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25442969|NCT04699734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442970|NCT04699734|Sensory System Agents|sensory system agents|mesh-ancestor
25442971|NCT04699734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25442972|NCT04699734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25442973|NCT04699734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25442974|NCT04699734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25085418|NCT03298516|Antimetabolites|antimetabolites|mesh-ancestor
25442975|NCT04699734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25442976|NCT04699734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442977|NCT04699721|Paclitaxel|paclitaxel|mesh-list
25442978|NCT04699721|Carboplatin|carboplatin|mesh-list
25442979|NCT04699721|Nivolumab|nivolumab|mesh-list
25442980|NCT04699721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25442981|NCT04699721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25442982|NCT04699721|Tubulin Modulators|tubulin modulators|mesh-ancestor
25085517|NCT03297463|Ipilimumab|ipilimumab|mesh-list
25442983|NCT04699721|Antimitotic Agents|antimitotic agents|mesh-ancestor
25442984|NCT04699721|Mitosis Modulators|mitosis modulators|mesh-ancestor
25442985|NCT04699721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442986|NCT04699721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25442987|NCT04699721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25295707|NCT04198623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295708|NCT04198623|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25295709|NCT04198623|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25295710|NCT04198623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295711|NCT04189510|Pancrelipase|pancrelipase|mesh-list
25295712|NCT04189510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25169307|NCT01909427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25169308|NCT01909427|Antimetabolites|antimetabolites|mesh-ancestor
25169309|NCT01909427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169310|NCT01909427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169311|NCT01909427|Dermatologic Agents|dermatologic agents|mesh-ancestor
25169312|NCT01909427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25042467|NCT01436032|Ketorolac|ketorolac|mesh-list
25085692|NCT03296098|Ulipristal acetate|ulipristal acetate|mesh-list
25169313|NCT01909427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25169314|NCT01909427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25169315|NCT01909427|Immunologic Factors|immunologic factors|mesh-ancestor
25169316|NCT01909427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25169317|NCT01909427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25169318|NCT01908738|Lidocaine|lidocaine|mesh-list
25169319|NCT01908738|Anesthetics, Local|anesthetics, local|mesh-ancestor
25169320|NCT01908738|Anesthetics|anesthetics|mesh-ancestor
25169321|NCT01908738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25169322|NCT01908738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169323|NCT01908738|Sensory System Agents|sensory system agents|mesh-ancestor
25169324|NCT01908738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25547022|NCT00601718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25547023|NCT00601718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25547024|NCT00601718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25547025|NCT00601718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25547026|NCT00601718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547027|NCT00601718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547028|NCT00601718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25547029|NCT00601718|Alkylating Agents|alkylating agents|mesh-ancestor
25547030|NCT00601718|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25547031|NCT00601796|Cyclophosphamide|cyclophosphamide|mesh-list
25547032|NCT00601796|Tretinoin|tretinoin|mesh-list
25547033|NCT00601796|Vaccines|vaccines|mesh-list
25547034|NCT00601796|Immunologic Factors|immunologic factors|mesh-ancestor
25547035|NCT00601796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547036|NCT00601796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24665904|NCT01315886|Analgesics|analgesics|mesh-ancestor
25547037|NCT00601796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25547038|NCT00601796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25547039|NCT00601796|Alkylating Agents|alkylating agents|mesh-ancestor
25547040|NCT00601796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547041|NCT00601796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25547042|NCT00601796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25547043|NCT00601796|Keratolytic Agents|keratolytic agents|mesh-ancestor
25547044|NCT00601796|Dermatologic Agents|dermatologic agents|mesh-ancestor
25547045|NCT00601835|Vaccines|vaccines|mesh-list
25547046|NCT00601835|Immunologic Factors|immunologic factors|mesh-ancestor
25547047|NCT00601835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547048|NCT00601926|Bevacizumab|bevacizumab|mesh-list
25547049|NCT00601926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25547050|NCT00601926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25547051|NCT00601926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25547052|NCT00601926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25547053|NCT00601926|Growth Substances|growth substances|mesh-ancestor
25547054|NCT00601926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547055|NCT00601926|Growth Inhibitors|growth inhibitors|mesh-ancestor
25547056|NCT00601965|Citalopram|citalopram|mesh-list
25547057|NCT00601965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25547058|NCT00601965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25547059|NCT00601965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25547060|NCT00601965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547061|NCT00601965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25547062|NCT00601965|Serotonin Agents|serotonin agents|mesh-ancestor
25547063|NCT00601965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547064|NCT00601965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25547065|NCT00601965|Antidepressive Agents|antidepressive agents|mesh-ancestor
25547066|NCT00601965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25547067|NCT00602043|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25547068|NCT00602043|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25547069|NCT00602043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547070|NCT00602225|Cytarabine|cytarabine|mesh-list
25547071|NCT00602225|Clofarabine|clofarabine|mesh-list
25547072|NCT00602225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25547073|NCT00602225|Antimetabolites|antimetabolites|mesh-ancestor
25547074|NCT00602225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547075|NCT00602225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25547076|NCT00602225|Antiviral Agents|antiviral agents|mesh-ancestor
25547077|NCT00602225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25547078|NCT00602225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25547079|NCT00602225|Immunologic Factors|immunologic factors|mesh-ancestor
25547080|NCT00602225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547081|NCT00602290|Methylphenidate|methylphenidate|mesh-list
25547082|NCT00602290|Citalopram|citalopram|mesh-list
25547083|NCT00602290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25266780|NCT02426177|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25547084|NCT00602290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547085|NCT00602290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25547086|NCT00602290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25547087|NCT00602290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25547088|NCT00602290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547089|NCT00602290|Dopamine Agents|dopamine agents|mesh-ancestor
25547090|NCT00602290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25547091|NCT00602290|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24857364|NCT02291367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24667693|NCT05323214|Dexmedetomidine|dexmedetomidine|mesh-list
25547092|NCT00602290|Serotonin Agents|serotonin agents|mesh-ancestor
25547093|NCT00602290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25547094|NCT00602290|Antidepressive Agents|antidepressive agents|mesh-ancestor
25547095|NCT00602290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25547096|NCT00602355|Sertraline|sertraline|mesh-list
25547097|NCT00602355|Antidepressive Agents|antidepressive agents|mesh-ancestor
25547098|NCT00602355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25547099|NCT00602355|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25547100|NCT00602355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25547101|NCT00602355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25547102|NCT00602355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547103|NCT00602355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25547104|NCT00602355|Serotonin Agents|serotonin agents|mesh-ancestor
25547105|NCT00602355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547106|NCT00602420|Naproxen|naproxen|mesh-list
25547107|NCT00602420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25547108|NCT00602420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25547109|NCT00602420|Analgesics|analgesics|mesh-ancestor
25547110|NCT00602420|Sensory System Agents|sensory system agents|mesh-ancestor
25547111|NCT00602420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25547112|NCT00602420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547113|NCT00602420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25547114|NCT00602420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25547115|NCT00602420|Gout Suppressants|gout suppressants|mesh-ancestor
25547116|NCT00602420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25547117|NCT00602420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547118|NCT00602420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547119|NCT00602446|Deferasirox|deferasirox|mesh-list
25547120|NCT00602446|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25547121|NCT00602446|Chelating Agents|chelating agents|mesh-ancestor
25442988|NCT04699214|Endostar protein|endostar protein|mesh-list
25547122|NCT00602446|Sequestering Agents|sequestering agents|mesh-ancestor
25547123|NCT00602446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547124|NCT00602472|Linagliptin|linagliptin|mesh-list
25547125|NCT00602472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25547126|NCT00602472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547127|NCT00602472|Incretins|incretins|mesh-ancestor
25547128|NCT00602472|Hormones|hormones|mesh-ancestor
25547129|NCT00602472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25547130|NCT00602472|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25547131|NCT00602472|Protease Inhibitors|protease inhibitors|mesh-ancestor
25547132|NCT00602472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547133|NCT00602472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547134|NCT00602537|Lithium Carbonate|lithium carbonate|mesh-list
25547135|NCT00602537|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25547136|NCT00602537|Antidepressive Agents|antidepressive agents|mesh-ancestor
25547137|NCT00602537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25547138|NCT00602537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547139|NCT00602537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547140|NCT00602537|Antimanic Agents|antimanic agents|mesh-ancestor
25547141|NCT00602537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25547142|NCT00602537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25547143|NCT00602537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547144|NCT00602537|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25547145|NCT00602537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25547146|NCT00602537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25547147|NCT00602537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24668151|NCT05070039|Immunologic Factors|immunologic factors|mesh-ancestor
25273024|NCT02387918|Hormones|hormones|mesh-ancestor
25547148|NCT00602537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25547149|NCT00602771|Etoposide|etoposide|mesh-list
25547150|NCT00602771|Etoposide phosphate|etoposide phosphate|mesh-list
25547151|NCT00602771|Tipifarnib|tipifarnib|mesh-list
25547152|NCT00602771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25547153|NCT00602771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25547154|NCT00602771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25547155|NCT00602771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25547156|NCT00602771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547157|NCT00602771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547158|NCT00602797|Paclitaxel|paclitaxel|mesh-list
25547159|NCT00602797|Vinorelbine|vinorelbine|mesh-list
25547160|NCT00602797|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25547161|NCT00602797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25547162|NCT00602797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25547163|NCT00602797|Tubulin Modulators|tubulin modulators|mesh-ancestor
25547164|NCT00602797|Antimitotic Agents|antimitotic agents|mesh-ancestor
25547165|NCT00602797|Mitosis Modulators|mitosis modulators|mesh-ancestor
25547166|NCT00602797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547167|NCT00602836|Cyclophosphamide|cyclophosphamide|mesh-list
25547168|NCT00602836|Rituximab|rituximab|mesh-list
25547169|NCT00602836|Lenalidomide|lenalidomide|mesh-list
25547170|NCT00602836|Pentostatin|pentostatin|mesh-list
25547171|NCT00602836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25547172|NCT00602836|Immunologic Factors|immunologic factors|mesh-ancestor
25547173|NCT00602836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547174|NCT00602836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25547175|NCT00602836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25547176|NCT00602836|Alkylating Agents|alkylating agents|mesh-ancestor
25547177|NCT00602836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547178|NCT00602836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25547179|NCT00602836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25547180|NCT00602836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25547181|NCT00602836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25547182|NCT00602836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25547183|NCT00602836|Growth Substances|growth substances|mesh-ancestor
25547184|NCT00602836|Growth Inhibitors|growth inhibitors|mesh-ancestor
25547185|NCT00602836|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25547186|NCT00602836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547187|NCT00602927|Varenicline|varenicline|mesh-list
25547188|NCT00602927|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25547189|NCT00602927|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25547190|NCT00602927|Cholinergic Agents|cholinergic agents|mesh-ancestor
25547191|NCT00602927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25547192|NCT00602927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547193|NCT00602927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547195|NCT00603018|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25547196|NCT00603018|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25547197|NCT00603018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25547198|NCT00603018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547199|NCT00603018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25547200|NCT00603018|Serotonin Agents|serotonin agents|mesh-ancestor
25547201|NCT00603018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547202|NCT00603018|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25547203|NCT00603018|Antidepressive Agents|antidepressive agents|mesh-ancestor
25547204|NCT00603018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25547205|NCT00603018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25547206|NCT00603018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25547207|NCT00603018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547208|NCT00603044|Fluticasone|fluticasone|mesh-list
25547209|NCT00603044|Xhance|xhance|mesh-list
25547210|NCT00603044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25547211|NCT00603044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25547212|NCT00603044|Autonomic Agents|autonomic agents|mesh-ancestor
25547213|NCT00603044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25547214|NCT00603044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547215|NCT00603044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25547216|NCT00603044|Respiratory System Agents|respiratory system agents|mesh-ancestor
25692422|NCT01999335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25547217|NCT00603044|Dermatologic Agents|dermatologic agents|mesh-ancestor
25547218|NCT00603044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25547219|NCT00603187|Acyline|acyline|mesh-list
25547220|NCT00603187|Hormone Antagonists|hormone antagonists|mesh-ancestor
25547221|NCT00603187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25547222|NCT00603187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547223|NCT00603239|Exenatide|exenatide|mesh-list
25547224|NCT00603239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25547225|NCT00603239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547226|NCT00603239|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25547227|NCT00603239|Incretins|incretins|mesh-ancestor
25547228|NCT00603239|Hormones|hormones|mesh-ancestor
25547229|NCT00603239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25547230|NCT00603265|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25547231|NCT00603265|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25547232|NCT00603265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25547233|NCT00603265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25547234|NCT00603265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547235|NCT00603265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25547236|NCT00603265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547237|NCT00603265|Analgesics|analgesics|mesh-ancestor
25547238|NCT00603265|Sensory System Agents|sensory system agents|mesh-ancestor
25219464|NCT02662647|Aclacinomycins|aclacinomycins|mesh-list
25547239|NCT00603265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25547240|NCT00603265|Antidepressive Agents|antidepressive agents|mesh-ancestor
25547241|NCT00603265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25547242|NCT00603265|Dopamine Agents|dopamine agents|mesh-ancestor
25547243|NCT00603304|Saw palmetto extract|saw palmetto extract|mesh-list
25547244|NCT00603304|Urological Agents|urological agents|mesh-ancestor
25547245|NCT00603408|Cisplatin|cisplatin|mesh-list
25547246|NCT00603408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25547247|NCT00603447|Dexamethasone|dexamethasone|mesh-list
25547248|NCT00603447|Lenalidomide|lenalidomide|mesh-list
25547249|NCT00603447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25547250|NCT00603447|Antiemetics|antiemetics|mesh-ancestor
25547251|NCT00603447|Autonomic Agents|autonomic agents|mesh-ancestor
25547252|NCT00603447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25547253|NCT00603447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547254|NCT00603447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25547255|NCT00603447|Glucocorticoids|glucocorticoids|mesh-ancestor
25547256|NCT00603447|Hormones|hormones|mesh-ancestor
25547257|NCT00603447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25547258|NCT00603447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25547259|NCT00603447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25547260|NCT00603447|Immunologic Factors|immunologic factors|mesh-ancestor
25547261|NCT00603447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25547262|NCT00603447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25547263|NCT00603447|Growth Substances|growth substances|mesh-ancestor
25443121|NCT04697641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25443122|NCT04697641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25443123|NCT04697641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25829447|NCT00006211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25443187|NCT04697511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443188|NCT04697355|Beta Carotene|beta carotene|mesh-list
25443189|NCT04697355|Naringenin|naringenin|mesh-list
25443190|NCT04697355|Carotenoids|carotenoids|mesh-list
25443191|NCT04697355|Antioxidants|antioxidants|mesh-ancestor
25443192|NCT04697355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443193|NCT04697355|Protective Agents|protective agents|mesh-ancestor
25443194|NCT04697355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443195|NCT04697355|Provitamins|provitamins|mesh-ancestor
25443196|NCT04697355|Vitamins|vitamins|mesh-ancestor
25443197|NCT04697355|Micronutrients|micronutrients|mesh-ancestor
25443198|NCT04697355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25443199|NCT04697355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25443200|NCT04697355|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25443201|NCT04697355|Hormone Antagonists|hormone antagonists|mesh-ancestor
25443202|NCT04697355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25443203|NCT04697277|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25443204|NCT04697277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25295994|NCT03234309|Hematinics|hematinics|mesh-ancestor
25295995|NCT03234309|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25295996|NCT03234309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24505159|NCT00540137|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24505160|NCT00540137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25296002|NCT03098563|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
25296004|NCT03096041|Analgesics|analgesics|mesh-list
25169325|NCT01908738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25169326|NCT01908738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25115959|NCT03111797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25115996|NCT03111511|JNJ-56136379|jnj-56136379|mesh-list
25116085|NCT03111186|Oxycodone|oxycodone|mesh-list
25169327|NCT01908738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25169328|NCT01908738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25169329|NCT01908738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169333|NCT01904409|Rifaximin|rifaximin|mesh-list
25169334|NCT01904409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25219582|NCT02662374|Antifungal Agents|antifungal agents|mesh-ancestor
25219583|NCT02662374|Ionophores|ionophores|mesh-ancestor
25169335|NCT01904409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25169336|NCT01904409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25169337|NCT01903954|Ribavirin|ribavirin|mesh-list
25169338|NCT01903954|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25169339|NCT01903954|Antimetabolites|antimetabolites|mesh-ancestor
25169340|NCT01903954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169341|NCT01903954|Antiviral Agents|antiviral agents|mesh-ancestor
25169342|NCT01903954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25169343|NCT01902381|Thioctic Acid|thioctic acid|mesh-list
25169344|NCT01902381|Antioxidants|antioxidants|mesh-ancestor
25169345|NCT01902381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169346|NCT01902381|Protective Agents|protective agents|mesh-ancestor
25169347|NCT01902381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169348|NCT01902381|Vitamin B Complex|vitamin b complex|mesh-ancestor
25547264|NCT00603447|Growth Inhibitors|growth inhibitors|mesh-ancestor
25547265|NCT00603473|Gabapentin|gabapentin|mesh-list
25547266|NCT00603473|Analgesics|analgesics|mesh-ancestor
25547267|NCT00603473|Sensory System Agents|sensory system agents|mesh-ancestor
25547268|NCT00603473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25547269|NCT00603473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547270|NCT00603473|Anticonvulsants|anticonvulsants|mesh-ancestor
25547271|NCT00603473|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25547272|NCT00603473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25547273|NCT00603473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25547274|NCT00603473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25547275|NCT00603473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25547276|NCT00603473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25547277|NCT00603473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25547278|NCT00603473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547279|NCT00603473|Antimanic Agents|antimanic agents|mesh-ancestor
25547280|NCT00603512|Tofacitinib|tofacitinib|mesh-list
25547281|NCT00603512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25547282|NCT00603512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547283|NCT00603512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547284|NCT00603525|Ofatumumab|ofatumumab|mesh-list
25547285|NCT00603525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25547286|NCT00603538|Paclitaxel|paclitaxel|mesh-list
25547287|NCT00603538|Carboplatin|carboplatin|mesh-list
25547288|NCT00603538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25547289|NCT00603538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25547290|NCT00603538|Tubulin Modulators|tubulin modulators|mesh-ancestor
25547291|NCT00603538|Antimitotic Agents|antimitotic agents|mesh-ancestor
25547292|NCT00603538|Mitosis Modulators|mitosis modulators|mesh-ancestor
25547293|NCT00603538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547294|NCT00603720|Phenylephrine|phenylephrine|mesh-list
25547295|NCT00603720|Oxymetazoline|oxymetazoline|mesh-list
25547296|NCT00603720|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
25547297|NCT00603720|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25547298|NCT00603720|Mydriatics|mydriatics|mesh-ancestor
25547299|NCT00603720|Autonomic Agents|autonomic agents|mesh-ancestor
25547300|NCT00603720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25547301|NCT00603720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547302|NCT00603720|Sympathomimetics|sympathomimetics|mesh-ancestor
25547303|NCT00603720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25547304|NCT00603720|Nasal Decongestants|nasal decongestants|mesh-ancestor
25219614|NCT02661711|Growth Substances|growth substances|mesh-ancestor
25547305|NCT00603720|Respiratory System Agents|respiratory system agents|mesh-ancestor
25547306|NCT00603720|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25547307|NCT00603720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25547308|NCT00603720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25547309|NCT00603720|Adrenergic Agents|adrenergic agents|mesh-ancestor
25547310|NCT00603720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25547311|NCT00603720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547312|NCT00603720|Protective Agents|protective agents|mesh-ancestor
25547313|NCT00603720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547315|NCT00603733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25547316|NCT00603733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25547317|NCT00603733|Analgesics|analgesics|mesh-ancestor
25547318|NCT00603733|Sensory System Agents|sensory system agents|mesh-ancestor
25547319|NCT00603733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25547320|NCT00603733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547321|NCT00603733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25547322|NCT00603733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25547323|NCT00603798|Imiquimod|imiquimod|mesh-list
25547324|NCT00603798|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25547325|NCT00603798|Immunologic Factors|immunologic factors|mesh-ancestor
25547326|NCT00603798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219680|NCT02661347|Risperidone|risperidone|mesh-list
25547327|NCT00603798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25547328|NCT00603798|Interferon Inducers|interferon inducers|mesh-ancestor
25651064|NCT01511536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651065|NCT01511536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651066|NCT01511536|Hormone Antagonists|hormone antagonists|mesh-ancestor
25651067|NCT01511536|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25651068|NCT01511640|Pregabalin|pregabalin|mesh-list
25651069|NCT01511640|Analgesics|analgesics|mesh-ancestor
25651070|NCT01511640|Sensory System Agents|sensory system agents|mesh-ancestor
25651071|NCT01511640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25651072|NCT01511640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651073|NCT01511640|Anticonvulsants|anticonvulsants|mesh-ancestor
25651074|NCT01511640|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25651075|NCT01511640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25651076|NCT01511640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651077|NCT01511640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25651078|NCT01511640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25651079|NCT01511640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25651080|NCT01511640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25651081|NCT01511640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25651082|NCT01511809|Ritonavir|ritonavir|mesh-list
25651083|NCT01511809|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25651084|NCT01511809|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24804037|NCT02000414|Daptomycin|daptomycin|mesh-list
25651085|NCT01511809|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25651086|NCT01511809|Protease Inhibitors|protease inhibitors|mesh-ancestor
25651087|NCT01511809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651088|NCT01511809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651089|NCT01511809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25651090|NCT01511809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25651091|NCT01511809|Antiviral Agents|antiviral agents|mesh-ancestor
25651092|NCT01511809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25651093|NCT01511809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25651094|NCT01511809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25651095|NCT01511939|Diclofenac|diclofenac|mesh-list
25651096|NCT01511939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25651097|NCT01511939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25547329|NCT00603915|Gemcitabine|gemcitabine|mesh-list
25547330|NCT00603915|Cisplatin|cisplatin|mesh-list
25547331|NCT00603915|Carboplatin|carboplatin|mesh-list
25547332|NCT00603915|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25547333|NCT00603915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25547334|NCT00603915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25547335|NCT00603915|Antimetabolites|antimetabolites|mesh-ancestor
25547336|NCT00603915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547337|NCT00603915|Antiviral Agents|antiviral agents|mesh-ancestor
25547338|NCT00603915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25547339|NCT00603915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547340|NCT00603915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25547341|NCT00603915|Immunologic Factors|immunologic factors|mesh-ancestor
25547342|NCT00603915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547343|NCT00603915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25547344|NCT00603941|Paclitaxel|paclitaxel|mesh-list
25547345|NCT00603941|Efatutazone|efatutazone|mesh-list
25547346|NCT00603941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25547347|NCT00603941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25547348|NCT00603941|Tubulin Modulators|tubulin modulators|mesh-ancestor
25547349|NCT00603941|Antimitotic Agents|antimitotic agents|mesh-ancestor
25547350|NCT00603941|Mitosis Modulators|mitosis modulators|mesh-ancestor
25547351|NCT00603941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547352|NCT00603980|Alprazolam|alprazolam|mesh-list
25547353|NCT00603980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25547354|NCT00603980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25547355|NCT00603980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547356|NCT00603980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25547357|NCT00603980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25547358|NCT00603980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25547359|NCT00603980|GABA Modulators|gaba modulators|mesh-ancestor
25547360|NCT00603980|GABA Agents|gaba agents|mesh-ancestor
25547361|NCT00603980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25547362|NCT00603980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547363|NCT00603993|Adalimumab|adalimumab|mesh-list
25547364|NCT00603993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25547365|NCT00603993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25547366|NCT00604019|Dopamine|dopamine|mesh-list
25547367|NCT00604019|Norepinephrine|norepinephrine|mesh-list
25547368|NCT00604019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25547369|NCT00604019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25547370|NCT00604019|Adrenergic Agents|adrenergic agents|mesh-ancestor
25547371|NCT00604019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25547372|NCT00604019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547373|NCT00604019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547374|NCT00604019|Sympathomimetics|sympathomimetics|mesh-ancestor
25086206|NCT03290963|Ketamine|ketamine|mesh-list
25547375|NCT00604019|Autonomic Agents|autonomic agents|mesh-ancestor
25547376|NCT00604019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25547377|NCT00604019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25547378|NCT00604019|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25547379|NCT00604019|Dopamine Agents|dopamine agents|mesh-ancestor
25547380|NCT00604019|Protective Agents|protective agents|mesh-ancestor
25547381|NCT00604188|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25547382|NCT00604188|Buprenorphine|buprenorphine|mesh-list
25547383|NCT00604188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25547384|NCT00604188|Narcotics|narcotics|mesh-ancestor
25547385|NCT00604188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25547386|NCT00604188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547387|NCT00604188|Analgesics|analgesics|mesh-ancestor
25547388|NCT00604188|Sensory System Agents|sensory system agents|mesh-ancestor
24429487|NCT00244153|Hormones|hormones|mesh-ancestor
25547389|NCT00604188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25547390|NCT00604188|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25547391|NCT00604214|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
25275629|NCT02370745|Incretins|incretins|mesh-list
25547392|NCT00604214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25547393|NCT00604279|Risperidone|risperidone|mesh-list
25547394|NCT00604279|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25547395|NCT00604279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25547396|NCT00604279|Serotonin Agents|serotonin agents|mesh-ancestor
25547397|NCT00604279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25547398|NCT00604279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547399|NCT00604279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547400|NCT00604279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25547401|NCT00604279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25547402|NCT00604279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25547403|NCT00604279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25547404|NCT00604279|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25219868|NCT02660502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25443337|NCT04694612|Antimetabolites|antimetabolites|mesh-ancestor
24432220|NCT00254007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25443338|NCT04694612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443339|NCT04694612|Antiviral Agents|antiviral agents|mesh-ancestor
25443340|NCT04694612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25296226|NCT01624480|Modafinil|modafinil|mesh-list
25296227|NCT01624480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25296228|NCT01624480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296229|NCT01624480|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25296230|NCT01624480|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25296231|NCT01624480|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25296232|NCT01624480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296233|NCT01475500|Dimercaprol|dimercaprol|mesh-list
25296234|NCT01475500|Chelating Agents|chelating agents|mesh-ancestor
25296235|NCT01475500|Sequestering Agents|sequestering agents|mesh-ancestor
25296236|NCT01475500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169350|NCT01902381|Micronutrients|micronutrients|mesh-ancestor
25116297|NCT03109756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25169351|NCT01897480|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25169352|NCT01897480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169353|NCT01897480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25169354|NCT01897480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169355|NCT01897480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169356|NCT01896531|Leucovorin|leucovorin|mesh-list
25169357|NCT01896531|Fluorouracil|fluorouracil|mesh-list
25169358|NCT01896531|Oxaliplatin|oxaliplatin|mesh-list
25169359|NCT01896531|Antimetabolites|antimetabolites|mesh-ancestor
25169360|NCT01896531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116372|NCT03108846|Citalopram|citalopram|mesh-list
25116581|NCT03107884|Metformin|metformin|mesh-list
25116606|NCT03107481|Acetaminophen|acetaminophen|mesh-list
25116683|NCT03107169|Vancomycin|vancomycin|mesh-list
25169361|NCT01896531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25169362|NCT01896531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169363|NCT01896531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25169364|NCT01896531|Immunologic Factors|immunologic factors|mesh-ancestor
25169365|NCT01896531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169366|NCT01896531|Antidotes|antidotes|mesh-ancestor
25219893|NCT02660177|Antipyretics|antipyretics|mesh-ancestor
25169367|NCT01896531|Protective Agents|protective agents|mesh-ancestor
25169368|NCT01896531|Vitamin B Complex|vitamin b complex|mesh-ancestor
25169369|NCT01896531|Vitamins|vitamins|mesh-ancestor
25169370|NCT01896531|Micronutrients|micronutrients|mesh-ancestor
25169371|NCT01893190|Nimodipine|nimodipine|mesh-list
25169372|NCT01893190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25169373|NCT01893190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25169374|NCT01893190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25169375|NCT01893190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169376|NCT01893190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25169377|NCT01893190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219914|NCT02660047|Incretins|incretins|mesh-ancestor
25169378|NCT01893190|Vasodilator Agents|vasodilator agents|mesh-ancestor
25169379|NCT01887886|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25169380|NCT01887886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169381|NCT01887886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25169382|NCT01887886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169383|NCT01887886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169384|NCT01877395|Vaccines|vaccines|mesh-list
25169385|NCT01877395|Immunologic Factors|immunologic factors|mesh-ancestor
25169386|NCT01877395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169387|NCT01874626|Ibuprofen|ibuprofen|mesh-list
25547405|NCT00604279|Dopamine Agents|dopamine agents|mesh-ancestor
25547406|NCT00604279|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25547407|NCT00604279|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25547408|NCT00604383|Ruboxistaurin|ruboxistaurin|mesh-list
25547409|NCT00604383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547410|NCT00604383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547411|NCT00604461|Bevacizumab|bevacizumab|mesh-list
25547412|NCT00604461|Carboplatin|carboplatin|mesh-list
25547413|NCT00604461|Pemetrexed|pemetrexed|mesh-list
25267123|NCT02424136|Antibodies|antibodies|mesh-list
25547414|NCT00604461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25547415|NCT00604461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169388|NCT01874626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25547416|NCT00604461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25547417|NCT00604461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25547418|NCT00604461|Growth Substances|growth substances|mesh-ancestor
25547419|NCT00604461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435437|NCT00266344|Gaboxadol|gaboxadol|mesh-list
25547420|NCT00604461|Growth Inhibitors|growth inhibitors|mesh-ancestor
25547421|NCT00604461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547422|NCT00604461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547423|NCT00604461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25547424|NCT00604461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25547425|NCT00604695|Tenecteplase|tenecteplase|mesh-list
25547426|NCT00604695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25547427|NCT00604695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25547428|NCT00604695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547429|NCT00604708|Vaccines|vaccines|mesh-list
25547430|NCT00604708|Immunologic Factors|immunologic factors|mesh-ancestor
25547431|NCT00604708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547432|NCT00604786|Omalizumab|omalizumab|mesh-list
25547433|NCT00604786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25547434|NCT00604786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25547435|NCT00604786|Respiratory System Agents|respiratory system agents|mesh-ancestor
25547436|NCT00604825|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25547437|NCT00604825|Estrogens|estrogens|mesh-ancestor
25547438|NCT00604825|Hormones|hormones|mesh-ancestor
25547439|NCT00604825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25547440|NCT00604825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547441|NCT00604968|Doxorubicin|doxorubicin|mesh-list
25547442|NCT00604968|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25086835|NCT03285568|Palbociclib|palbociclib|mesh-list
25086837|NCT03285568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25086838|NCT03285568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547443|NCT00604968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25547444|NCT00604968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25547445|NCT00604968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25547446|NCT00604968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25547447|NCT00604968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547448|NCT00604968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547449|NCT00605033|Buprenorphine|buprenorphine|mesh-list
24420621|NCT00216463|Mipomersen|mipomersen|mesh-list
24630952|NCT01115140|Vitamins|vitamins|mesh-ancestor
25547450|NCT00605033|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25547451|NCT00605033|Naloxone|naloxone|mesh-list
25547452|NCT00605033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25547453|NCT00605033|Narcotics|narcotics|mesh-ancestor
25547454|NCT00605033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25547455|NCT00605033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547456|NCT00605033|Analgesics|analgesics|mesh-ancestor
25547457|NCT00605033|Sensory System Agents|sensory system agents|mesh-ancestor
25267193|NCT02423915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25267194|NCT02423915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24442886|NCT00293124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442887|NCT00293124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25087075|NCT03283020|Narcotics|narcotics|mesh-ancestor
25087076|NCT03283020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25087077|NCT03283020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087078|NCT03283020|Analgesics|analgesics|mesh-ancestor
25087079|NCT03283020|Sensory System Agents|sensory system agents|mesh-ancestor
25087080|NCT03283020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267197|NCT02423915|Antiviral Agents|antiviral agents|mesh-ancestor
25220044|NCT02659085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25547458|NCT00605033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25547459|NCT00605033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25547460|NCT00605072|Metoprolol|metoprolol|mesh-list
25547461|NCT00605072|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25547462|NCT00605072|Candesartan|candesartan|mesh-list
25547463|NCT00605072|Lisinopril|lisinopril|mesh-list
25547464|NCT00605072|Nifedipine|nifedipine|mesh-list
25547465|NCT00605072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25547466|NCT00605072|Diuretics|diuretics|mesh-ancestor
25547467|NCT00605072|Natriuretic Agents|natriuretic agents|mesh-ancestor
25087199|NCT03281187|Hormones|hormones|mesh-ancestor
25087233|NCT03280511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25087234|NCT03280407|Leucovorin|leucovorin|mesh-list
25087235|NCT03280407|Capecitabine|capecitabine|mesh-list
25087236|NCT03280407|Oxaliplatin|oxaliplatin|mesh-list
25087237|NCT03280407|Levoleucovorin|levoleucovorin|mesh-list
25087238|NCT03280407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25087239|NCT03280407|Antimetabolites|antimetabolites|mesh-ancestor
25087240|NCT03280407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087241|NCT03280407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25087242|NCT03280407|Antidotes|antidotes|mesh-ancestor
25087243|NCT03280407|Protective Agents|protective agents|mesh-ancestor
24631289|NCT01116713|Autonomic Agents|autonomic agents|mesh-ancestor
24631290|NCT01116713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24631291|NCT01116713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547468|NCT00605072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547469|NCT00605072|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25547470|NCT00605072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25547471|NCT00605072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547472|NCT00605072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25547473|NCT00605072|Sympatholytics|sympatholytics|mesh-ancestor
25547474|NCT00605072|Autonomic Agents|autonomic agents|mesh-ancestor
25679471|NCT01838655|Nitisinone|nitisinone|mesh-list
25547475|NCT00605072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25547476|NCT00605072|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25547477|NCT00605072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25547478|NCT00605072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25547479|NCT00605072|Adrenergic Agents|adrenergic agents|mesh-ancestor
25547480|NCT00605072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25547481|NCT00605072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24438232|NCT00275119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25547482|NCT00605072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25547483|NCT00605072|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25547484|NCT00605072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25547485|NCT00605072|Vasodilator Agents|vasodilator agents|mesh-ancestor
25547486|NCT00605072|Tocolytic Agents|tocolytic agents|mesh-ancestor
25547487|NCT00605072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25547488|NCT00605072|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25547489|NCT00605072|Protease Inhibitors|protease inhibitors|mesh-ancestor
24631556|NCT01118871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24631557|NCT01118871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24631558|NCT01118871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24631561|NCT01118884|Promethazine|promethazine|mesh-list
25547490|NCT00605072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547491|NCT00605072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25547492|NCT00605072|Protective Agents|protective agents|mesh-ancestor
25547493|NCT00605176|Imiquimod|imiquimod|mesh-list
25547494|NCT00605176|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25547495|NCT00605176|Immunologic Factors|immunologic factors|mesh-ancestor
25547496|NCT00605176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547497|NCT00605176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25547498|NCT00605176|Interferon Inducers|interferon inducers|mesh-ancestor
25547499|NCT00605202|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25547500|NCT00605202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25547501|NCT00605202|Diuretics|diuretics|mesh-ancestor
25547502|NCT00605202|Natriuretic Agents|natriuretic agents|mesh-ancestor
25087357|NCT03279861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087359|NCT03279809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25087360|NCT03279809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25087361|NCT03279809|Analgesics|analgesics|mesh-ancestor
25087362|NCT03279809|Sensory System Agents|sensory system agents|mesh-ancestor
25547503|NCT00605202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547504|NCT00605202|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25547505|NCT00605202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25547506|NCT00605202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547507|NCT00605267|Tamoxifen|tamoxifen|mesh-list
25547508|NCT00605267|Goserelin|goserelin|mesh-list
25547509|NCT00605267|Anastrozole|anastrozole|mesh-list
25547510|NCT00605267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25547511|NCT00605267|Hormone Antagonists|hormone antagonists|mesh-ancestor
25547512|NCT00605267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25547513|NCT00605267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547514|NCT00605267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25679511|NCT01839279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672389|NCT01331902|Vitamins|vitamins|mesh-ancestor
25220105|NCT02658799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25220106|NCT02658799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25220107|NCT02658799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220109|NCT02658773|Prilocaine|prilocaine|mesh-list
25220110|NCT02658773|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25220111|NCT02658773|Anesthetics, Local|anesthetics, local|mesh-ancestor
25220112|NCT02658773|Anesthetics|anesthetics|mesh-ancestor
25220113|NCT02658773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25547515|NCT00605267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25547516|NCT00605267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25547517|NCT00605267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25547518|NCT00605267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25547519|NCT00605267|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25547520|NCT00605267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25547521|NCT00605267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547522|NCT00605267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826322|NCT02134002|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
24826325|NCT02134067|Paclitaxel|paclitaxel|mesh-list
25087392|NCT03279757|Sensory System Agents|sensory system agents|mesh-ancestor
25087479|NCT03279146|Tenofovir|tenofovir|mesh-list
24826411|NCT02134327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24826413|NCT02134327|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24440051|NCT00281567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25053005|NCT00116298|Lamivudine|lamivudine|mesh-list
25087560|NCT03278782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25087561|NCT03278782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25087562|NCT03278652|Analgesics|analgesics|mesh-list
25087563|NCT03278652|Sensory System Agents|sensory system agents|mesh-ancestor
25087564|NCT03278652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25087565|NCT03278652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832869|NCT02172352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24832870|NCT02172352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832871|NCT02172378|Tiotropium Bromide|tiotropium bromide|mesh-list
24832872|NCT02172378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24832873|NCT02172378|Autonomic Agents|autonomic agents|mesh-ancestor
25087601|NCT03278431|Piperazine citrate|piperazine citrate|mesh-list
25087602|NCT03278431|Pyrantel|pyrantel|mesh-list
25087603|NCT03278431|Pyrantel Pamoate|pyrantel pamoate|mesh-list
25220185|NCT02658721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25220186|NCT02658721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25220187|NCT02658721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25220188|NCT02658721|Respiratory System Agents|respiratory system agents|mesh-ancestor
25267316|NCT02423395|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25547523|NCT00605293|Epoetin Alfa|epoetin alfa|mesh-list
25547524|NCT00605293|Hematinics|hematinics|mesh-ancestor
25547525|NCT00605306|Mometasone Furoate|mometasone furoate|mesh-list
25547526|NCT00605306|Maleic acid|maleic acid|mesh-list
25547527|NCT00605306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547528|NCT00605306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547529|NCT00605306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25547530|NCT00605306|Dermatologic Agents|dermatologic agents|mesh-ancestor
25547531|NCT00605306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25547532|NCT00605319|Fesoterodine|fesoterodine|mesh-list
25547533|NCT00605319|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25547534|NCT00605319|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25267327|NCT02423395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25267328|NCT02423395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25220222|NCT02658188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25220223|NCT02658188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087801|NCT03276689|Antidepressive Agents|antidepressive agents|mesh-ancestor
25087802|NCT03276689|Dopamine Agents|dopamine agents|mesh-ancestor
25087803|NCT03276598|Losartan|losartan|mesh-list
25087804|NCT03276598|Amlodipine|amlodipine|mesh-list
25087805|NCT03276598|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25087806|NCT03276598|Bisoprolol|bisoprolol|mesh-list
25087807|NCT03276598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25087808|NCT03276598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25087809|NCT03276598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25087810|NCT03276598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087811|NCT03276598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25087812|NCT03276598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087823|NCT03276598|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25547535|NCT00605319|Cholinergic Agents|cholinergic agents|mesh-ancestor
25547536|NCT00605319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25547537|NCT00605319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547538|NCT00605319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547539|NCT00605319|Urological Agents|urological agents|mesh-ancestor
25547540|NCT00605345|Darbepoetin alfa|darbepoetin alfa|mesh-list
25547541|NCT00605345|Hematinics|hematinics|mesh-ancestor
25547542|NCT00605384|Tenofovir|tenofovir|mesh-list
25547543|NCT00605384|Lamivudine|lamivudine|mesh-list
25547544|NCT00605384|Entecavir|entecavir|mesh-list
25547545|NCT00605384|Adefovir|adefovir|mesh-list
25547546|NCT00605384|Antiviral Agents|antiviral agents|mesh-ancestor
25547547|NCT00605384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25547548|NCT00605384|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25547549|NCT00605384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25547550|NCT00605384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547551|NCT00605384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547552|NCT00605384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25547553|NCT00605384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25547554|NCT00605423|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
25547555|NCT00605423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25547556|NCT00605423|Glucocorticoids|glucocorticoids|mesh-ancestor
25547557|NCT00605423|Hormones|hormones|mesh-ancestor
25547558|NCT00605423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25547559|NCT00605423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547560|NCT00605475|Metformin|metformin|mesh-list
25547561|NCT00605475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25547562|NCT00605475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547563|NCT00605566|Cyclophosphamide|cyclophosphamide|mesh-list
25547564|NCT00605566|Sorafenib|sorafenib|mesh-list
25547565|NCT00605566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25547566|NCT00605566|Immunologic Factors|immunologic factors|mesh-ancestor
25547567|NCT00605566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547568|NCT00605566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25547569|NCT00605566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25443426|NCT04694105|Hormones|hormones|mesh-ancestor
25547570|NCT00605566|Alkylating Agents|alkylating agents|mesh-ancestor
25547571|NCT00605566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547572|NCT00605566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25547573|NCT00605566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25547574|NCT00605566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25547575|NCT00605566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547576|NCT00605657|Valproic Acid|valproic acid|mesh-list
25547577|NCT00605657|Anticonvulsants|anticonvulsants|mesh-ancestor
25547578|NCT00605657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547579|NCT00605657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547580|NCT00605657|GABA Agents|gaba agents|mesh-ancestor
25547581|NCT00605657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25547582|NCT00605657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547583|NCT00605657|Antimanic Agents|antimanic agents|mesh-ancestor
25547584|NCT00605657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25547585|NCT00605657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25267370|NCT02422784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25267371|NCT02422784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25087998|NCT03274817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25087999|NCT03274817|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25088001|NCT03274765|Estrogens|estrogens|mesh-ancestor
25088002|NCT03274765|Hormones|hormones|mesh-ancestor
25088003|NCT03274765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25088004|NCT03274765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088005|NCT03274700|Tamsulosin|tamsulosin|mesh-list
25088006|NCT03274700|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25088007|NCT03274700|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25088008|NCT03274700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24631712|NCT01119638|Risperidone|risperidone|mesh-list
25679546|NCT01839487|Antimetabolites|antimetabolites|mesh-ancestor
25679547|NCT01839487|Antiviral Agents|antiviral agents|mesh-ancestor
25679548|NCT01839487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25088061|NCT03274011|Apatinib|apatinib|mesh-list
25547586|NCT00605657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25547587|NCT00605696|Insulin|insulin|mesh-list
25547588|NCT00605696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25547589|NCT00605696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547590|NCT00605722|Bevacizumab|bevacizumab|mesh-list
25547591|NCT00605722|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25547592|NCT00605722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25547593|NCT00605722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443486|NCT04692623|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25443487|NCT04692623|Moxifloxacin|moxifloxacin|mesh-list
25443488|NCT04692623|Gemifloxacin|gemifloxacin|mesh-list
25443489|NCT04692623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25443490|NCT04692623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443491|NCT04692623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25443492|NCT04692623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25443493|NCT04692623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25443494|NCT04692623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25443495|NCT04692623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25443496|NCT04692623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443497|NCT04692623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443498|NCT04692558|Hyaluronic Acid|hyaluronic acid|mesh-list
25443499|NCT04692558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25443500|NCT04692558|Immunologic Factors|immunologic factors|mesh-ancestor
25443501|NCT04692558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443502|NCT04692558|Viscosupplements|viscosupplements|mesh-ancestor
25443503|NCT04692558|Protective Agents|protective agents|mesh-ancestor
25443504|NCT04692844|Propranolol|propranolol|mesh-list
25443505|NCT04692844|Primidone|primidone|mesh-list
25443506|NCT04692844|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25443507|NCT04692844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25088144|NCT03273088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24631766|NCT01120119|Calcitriol|calcitriol|mesh-list
25443508|NCT04692844|Adrenergic Agents|adrenergic agents|mesh-ancestor
25443509|NCT04692844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25443510|NCT04692844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443511|NCT04692844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547594|NCT00605722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25547595|NCT00605722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25547596|NCT00605722|Growth Substances|growth substances|mesh-ancestor
25547597|NCT00605722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547598|NCT00605722|Growth Inhibitors|growth inhibitors|mesh-ancestor
25547599|NCT00605722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25547600|NCT00605722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547601|NCT00605722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547602|NCT00605813|Sertraline|sertraline|mesh-list
25547603|NCT00605813|Antidepressive Agents|antidepressive agents|mesh-ancestor
25547604|NCT00605813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25547605|NCT00605813|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25547606|NCT00605813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25547607|NCT00605813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25547608|NCT00605813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547609|NCT00605813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25547610|NCT00605813|Serotonin Agents|serotonin agents|mesh-ancestor
25547611|NCT00605813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547612|NCT00605865|Sertraline|sertraline|mesh-list
25547613|NCT00605865|Antidepressive Agents|antidepressive agents|mesh-ancestor
25547614|NCT00605865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25547615|NCT00605865|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25547616|NCT00605865|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25088226|NCT05075265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088227|NCT05075265|Analgesics|analgesics|mesh-ancestor
25088228|NCT05075265|Sensory System Agents|sensory system agents|mesh-ancestor
25088229|NCT05075265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25088230|NCT05075265|Antitussive Agents|antitussive agents|mesh-ancestor
25088303|NCT05065775|Adrenergic Agents|adrenergic agents|mesh-ancestor
25088304|NCT05065775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25088305|NCT05065775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088306|NCT05045586|Hyaluronic Acid|hyaluronic acid|mesh-list
25088307|NCT05045586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25088308|NCT05045586|Immunologic Factors|immunologic factors|mesh-ancestor
25220407|NCT02656472|Hemostatics|hemostatics|mesh-ancestor
25547617|NCT00605865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25547618|NCT00605865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547619|NCT00605865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25547620|NCT00605865|Serotonin Agents|serotonin agents|mesh-ancestor
25547621|NCT00605865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547622|NCT00605904|Acamprosate|acamprosate|mesh-list
25547623|NCT00605904|Yohimbine|yohimbine|mesh-list
25547624|NCT00605904|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25547625|NCT00605904|Mydriatics|mydriatics|mesh-ancestor
25547626|NCT00605904|Autonomic Agents|autonomic agents|mesh-ancestor
24636888|NCT01147757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24636889|NCT01147757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636890|NCT01147757|Analgesics|analgesics|mesh-ancestor
24636891|NCT01147757|Sensory System Agents|sensory system agents|mesh-ancestor
25220430|NCT02656121|Micronutrients|micronutrients|mesh-ancestor
25220431|NCT02656121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832911|NCT02172417|Autonomic Agents|autonomic agents|mesh-ancestor
24832912|NCT02172417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25088388|NCT04733560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088389|NCT04733560|Sensory System Agents|sensory system agents|mesh-ancestor
25088390|NCT04733560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25088391|NCT04669561|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25088393|NCT04669561|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25547627|NCT00605904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25547628|NCT00605904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547629|NCT00605904|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25547630|NCT00605904|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25547631|NCT00605904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25547632|NCT00605904|Adrenergic Agents|adrenergic agents|mesh-ancestor
25547633|NCT00605904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25547634|NCT00605904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547635|NCT00605904|Urological Agents|urological agents|mesh-ancestor
25547636|NCT00605917|Sertraline|sertraline|mesh-list
25547637|NCT00605917|Antidepressive Agents|antidepressive agents|mesh-ancestor
25547638|NCT00605917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24637918|NCT01153919|Ribavirin|ribavirin|mesh-list
25220445|NCT02656342|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25220446|NCT02656342|Antitubercular Agents|antitubercular agents|mesh-ancestor
25220447|NCT02656342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25220448|NCT02656342|Antimetabolites|antimetabolites|mesh-ancestor
25220449|NCT02656342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220450|NCT02656095|Heparin|heparin|mesh-list
25220451|NCT02656095|Anticoagulants|anticoagulants|mesh-ancestor
25220452|NCT02656095|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25220453|NCT02656095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24832913|NCT02172417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832914|NCT02172417|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24832915|NCT02172417|Respiratory System Agents|respiratory system agents|mesh-ancestor
24832916|NCT02172417|Parasympatholytics|parasympatholytics|mesh-ancestor
24631934|NCT01121055|Antiemetics|antiemetics|mesh-ancestor
24631935|NCT01121055|Autonomic Agents|autonomic agents|mesh-ancestor
25547639|NCT00605917|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25547640|NCT00605917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25547641|NCT00605917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25547642|NCT00605917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547643|NCT00605917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25547644|NCT00605917|Serotonin Agents|serotonin agents|mesh-ancestor
25547645|NCT00605917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547646|NCT00606008|Sunitinib|sunitinib|mesh-list
25547647|NCT00606008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25220486|NCT02655874|Vaccines|vaccines|mesh-list
25547648|NCT00606008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25547649|NCT00606008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25547650|NCT00606008|Growth Substances|growth substances|mesh-ancestor
25547651|NCT00606008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547652|NCT00606008|Growth Inhibitors|growth inhibitors|mesh-ancestor
25547653|NCT00606008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25547654|NCT00606008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547655|NCT00606008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547656|NCT00606021|Pemetrexed|pemetrexed|mesh-list
25547657|NCT00606021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25547658|NCT00606021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547659|NCT00606021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547660|NCT00606021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25547661|NCT00606021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25547662|NCT00606034|Insulin|insulin|mesh-list
25220538|NCT02655614|Caffeine|caffeine|mesh-list
25220539|NCT02655614|Rabeprazole|rabeprazole|mesh-list
25220540|NCT02655614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25220541|NCT02655614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24832933|NCT02172430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832934|NCT02172430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25220542|NCT02655614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25547663|NCT00606034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25547664|NCT00606034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547665|NCT00606086|Interferons|interferons|mesh-list
25547666|NCT00606086|Ribavirin|ribavirin|mesh-list
25547667|NCT00606086|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25547668|NCT00606086|Interferon-alpha|interferon-alpha|mesh-list
25547669|NCT00606086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25547670|NCT00606086|Antiviral Agents|antiviral agents|mesh-ancestor
25547671|NCT00606086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25547672|NCT00606086|Antimetabolites|antimetabolites|mesh-ancestor
24589329|NCT00906867|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
24589350|NCT00907036|Alemtuzumab|alemtuzumab|mesh-list
24589351|NCT00907036|Cyclosporins|cyclosporins|mesh-list
24589352|NCT00907036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589353|NCT00907036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24589369|NCT00907114|Ketorolac|ketorolac|mesh-list
24783955|NCT01905059|Antiviral Agents|antiviral agents|mesh-ancestor
24832949|NCT02172443|Parasympatholytics|parasympatholytics|mesh-ancestor
24832951|NCT02172443|Cholinergic Agents|cholinergic agents|mesh-ancestor
25547673|NCT00606086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547674|NCT00606086|Immunologic Factors|immunologic factors|mesh-ancestor
25547675|NCT00606086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547676|NCT00606138|Ranibizumab|ranibizumab|mesh-list
25547677|NCT00606138|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25547678|NCT00606138|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25547679|NCT00606138|Growth Substances|growth substances|mesh-ancestor
25547680|NCT00606138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547681|NCT00606138|Growth Inhibitors|growth inhibitors|mesh-ancestor
25547682|NCT00606138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24832955|NCT02172456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24591041|NCT00914797|Terbutaline|terbutaline|mesh-list
24832957|NCT02172456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24832958|NCT02172456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832959|NCT02172456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25547683|NCT00606177|Aripiprazole|aripiprazole|mesh-list
25547684|NCT00606177|Antidepressive Agents|antidepressive agents|mesh-ancestor
25547685|NCT00606177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25053439|NCT00050102|Ipilimumab|ipilimumab|mesh-list
25547686|NCT00606177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25547687|NCT00606177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25547688|NCT00606177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25547689|NCT00606177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547690|NCT00606177|Dopamine Agonists|dopamine agonists|mesh-ancestor
25547691|NCT00606177|Dopamine Agents|dopamine agents|mesh-ancestor
25547692|NCT00606177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25547693|NCT00606177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547694|NCT00606177|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25547695|NCT00606177|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25011441|NCT05130788|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24805719|NCT02011841|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24444840|NCT00299286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25088606|NCT03536429|Acetazolamide|acetazolamide|mesh-list
25011468|NCT04964193|Cyproterone|cyproterone|mesh-list
25011469|NCT04964193|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
25110285|NCT05464615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25110286|NCT05464615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24631975|NCT01121276|Insulin|insulin|mesh-list
25547696|NCT00606177|Serotonin Agents|serotonin agents|mesh-ancestor
25547697|NCT00606177|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25547698|NCT00606177|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25547699|NCT00606177|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25547700|NCT00606177|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25547701|NCT00606229|Aripiprazole|aripiprazole|mesh-list
25547702|NCT00606229|Antidepressive Agents|antidepressive agents|mesh-ancestor
25547703|NCT00606229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25547704|NCT00606229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25547705|NCT00606229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25547706|NCT00606229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25547707|NCT00606229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641325|NCT01172912|Hormones|hormones|mesh-ancestor
25220684|NCT02654743|Sulforaphane|sulforaphane|mesh-list
25088683|NCT03272698|Anesthetics|anesthetics|mesh-ancestor
25088684|NCT03272698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24764376|NCT01780948|Everolimus|everolimus|mesh-list
25088685|NCT03272698|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24764441|NCT01781702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764442|NCT01781702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25547708|NCT00606229|Dopamine Agonists|dopamine agonists|mesh-ancestor
25547709|NCT00606229|Dopamine Agents|dopamine agents|mesh-ancestor
25547710|NCT00606229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25547711|NCT00606229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547712|NCT00606229|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25547713|NCT00606229|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25547714|NCT00606229|Serotonin Agents|serotonin agents|mesh-ancestor
25547715|NCT00606229|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25547716|NCT00606229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25547717|NCT00606229|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25547718|NCT00606229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25547719|NCT00606281|Aripiprazole|aripiprazole|mesh-list
25547720|NCT00606281|Antidepressive Agents|antidepressive agents|mesh-ancestor
24586138|NCT00889356|Tetracycline|tetracycline|mesh-list
24586139|NCT00889356|Ketoconazole|ketoconazole|mesh-list
24586140|NCT00889356|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24586141|NCT00889356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24586142|NCT00889356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24586143|NCT00889356|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25547721|NCT00606281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25547722|NCT00606281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25547723|NCT00606281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25547724|NCT00606281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25547725|NCT00606281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547726|NCT00606281|Dopamine Agonists|dopamine agonists|mesh-ancestor
25547727|NCT00606281|Dopamine Agents|dopamine agents|mesh-ancestor
25547728|NCT00606281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24641973|NCT01176903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25011694|NCT04369664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25011695|NCT04369664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011696|NCT04315038|Anesthetics|anesthetics|mesh-list
25011697|NCT04315038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25011698|NCT04315038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011699|NCT04304144|Dexamethasone|dexamethasone|mesh-list
25011700|NCT04304144|Cyclophosphamide|cyclophosphamide|mesh-list
24443271|NCT00294359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25273062|NCT02387567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273064|NCT02387242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25273065|NCT02387242|Antitubercular Agents|antitubercular agents|mesh-ancestor
25273066|NCT02387242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25273067|NCT02387242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25011777|NCT04083963|Alkylating Agents|alkylating agents|mesh-ancestor
25011778|NCT04083963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25011779|NCT04083963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25011780|NCT04083963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25011781|NCT04083963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25011782|NCT04083963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011786|NCT03790111|Gemcitabine|gemcitabine|mesh-list
25011787|NCT03790111|Cisplatin|cisplatin|mesh-list
25011788|NCT03790111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011798|NCT03771586|Ketamine|ketamine|mesh-list
25547729|NCT00606281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547730|NCT00606281|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25547731|NCT00606281|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25547732|NCT00606281|Serotonin Agents|serotonin agents|mesh-ancestor
25547733|NCT00606281|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25547734|NCT00606281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25547735|NCT00606281|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25547736|NCT00606281|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25088860|NCT03271164|Protective Agents|protective agents|mesh-ancestor
25088861|NCT03271255|Bevacizumab|bevacizumab|mesh-list
25088862|NCT03271255|Apatinib|apatinib|mesh-list
25088863|NCT03271255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25088864|NCT03271255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25088865|NCT03271255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25088866|NCT03271255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25088867|NCT03271255|Growth Substances|growth substances|mesh-ancestor
25088868|NCT03271255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088869|NCT03271255|Growth Inhibitors|growth inhibitors|mesh-ancestor
25088870|NCT03271255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25088871|NCT03271255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25088872|NCT03271255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088873|NCT03271073|Apatinib|apatinib|mesh-list
25088874|NCT03271073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25088875|NCT03271073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25088876|NCT03271073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25220737|NCT02654379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25220738|NCT02654093|Cholecalciferol|cholecalciferol|mesh-list
25220739|NCT02654093|Vitamin D|vitamin d|mesh-list
25547737|NCT00606307|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
25547738|NCT00606307|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25547739|NCT00606307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547740|NCT00606307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547741|NCT00606320|Aripiprazole|aripiprazole|mesh-list
25547742|NCT00606320|Antidepressive Agents|antidepressive agents|mesh-ancestor
25547743|NCT00606320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25547744|NCT00606320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25547745|NCT00606320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25547746|NCT00606320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25547747|NCT00606320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547748|NCT00606320|Dopamine Agonists|dopamine agonists|mesh-ancestor
25547749|NCT00606320|Dopamine Agents|dopamine agents|mesh-ancestor
25547750|NCT00606320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25547751|NCT00606320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547752|NCT00606320|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25547753|NCT00606320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25547754|NCT00606320|Serotonin Agents|serotonin agents|mesh-ancestor
24644145|NCT01189318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25220824|NCT02653703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25220825|NCT02653703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220826|NCT02653703|Antipruritics|antipruritics|mesh-ancestor
25220827|NCT02653703|Dermatologic Agents|dermatologic agents|mesh-ancestor
25220828|NCT02653742|Ketorolac|ketorolac|mesh-list
25220829|NCT02653742|Fentanyl|fentanyl|mesh-list
25547755|NCT00606320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25547756|NCT00606320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25547757|NCT00606320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25547758|NCT00606320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25547759|NCT00606489|Ibuprofen|ibuprofen|mesh-list
25547760|NCT00606489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25547761|NCT00606489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25547762|NCT00606489|Analgesics|analgesics|mesh-ancestor
25547763|NCT00606489|Sensory System Agents|sensory system agents|mesh-ancestor
25012012|NCT02389465|Celecoxib|celecoxib|mesh-list
25547764|NCT00606489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25443679|NCT04690647|Sensory System Agents|sensory system agents|mesh-ancestor
25443680|NCT04690751|Cenobamate|cenobamate|mesh-list
25443681|NCT04690751|Anticonvulsants|anticonvulsants|mesh-ancestor
25443682|NCT04690556|Ranibizumab|ranibizumab|mesh-list
25443683|NCT04690556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25443684|NCT04690556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25443685|NCT04690556|Growth Substances|growth substances|mesh-ancestor
25443686|NCT04690556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443687|NCT04690556|Growth Inhibitors|growth inhibitors|mesh-ancestor
24645290|NCT01197170|Bevacizumab|bevacizumab|mesh-list
25220872|NCT02653638|Sensory System Agents|sensory system agents|mesh-ancestor
25220873|NCT02653638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25220874|NCT02653638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273068|NCT02387242|Leprostatic Agents|leprostatic agents|mesh-ancestor
24467036|NCT00376051|Serotonin Agents|serotonin agents|mesh-ancestor
25053672|NCT00004897|Interferons|interferons|mesh-list
24632146|NCT01122251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24443653|NCT00295672|Vinorelbine|vinorelbine|mesh-list
24632147|NCT01122251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632148|NCT01122342|Methyltestosterone|methyltestosterone|mesh-list
24632149|NCT01122342|Testosterone|testosterone|mesh-list
25443688|NCT04690556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443689|NCT04690270|Sumatriptan|sumatriptan|mesh-list
25443690|NCT04690270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25443691|NCT04690270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25443692|NCT04690270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25443693|NCT04690270|Serotonin Agents|serotonin agents|mesh-ancestor
25443694|NCT04690270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25443695|NCT04690270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443696|NCT04690270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443697|NCT04689958|Vitamin D|vitamin d|mesh-list
25443698|NCT04689958|Vitamins|vitamins|mesh-ancestor
25443699|NCT04689958|Micronutrients|micronutrients|mesh-ancestor
25443700|NCT04689958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443701|NCT04689958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25296664|NCT03954132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296665|NCT03954132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296666|NCT03954132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25296667|NCT03929029|Nivolumab|nivolumab|mesh-list
25296668|NCT03929029|Ipilimumab|ipilimumab|mesh-list
25296669|NCT03929029|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25296670|NCT03929029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25296671|NCT03929029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296672|NCT03929029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25169389|NCT01874626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24444111|NCT00296751|Fentanyl|fentanyl|mesh-list
25089021|NCT03269604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25089022|NCT03269604|Antitubercular Agents|antitubercular agents|mesh-ancestor
25089023|NCT03269799|Ascorbic Acid|ascorbic acid|mesh-list
25089024|NCT03269799|Vitamins|vitamins|mesh-ancestor
25089025|NCT03269799|Micronutrients|micronutrients|mesh-ancestor
25089026|NCT03269799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089028|NCT03269799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089030|NCT03269591|Diclofenac|diclofenac|mesh-list
25169390|NCT01874626|Analgesics|analgesics|mesh-ancestor
25169391|NCT01874626|Sensory System Agents|sensory system agents|mesh-ancestor
24778296|NCT01870128|Hormones|hormones|mesh-ancestor
25116913|NCT03105765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25045625|NCT00934921|Antiemetics|antiemetics|mesh-ancestor
25547765|NCT00606489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547766|NCT00606489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25547767|NCT00606489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25547768|NCT00606489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25547769|NCT00606489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547770|NCT00606489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547771|NCT00606502|Vitamins|vitamins|mesh-list
25547772|NCT00606502|Folic Acid|folic acid|mesh-list
25089134|NCT03268902|Nicotinic Acids|nicotinic acids|mesh-list
25089135|NCT03268902|Azithromycin|azithromycin|mesh-list
25089136|NCT03268902|Nitazoxanide|nitazoxanide|mesh-list
25089137|NCT03268902|Vitamins|vitamins|mesh-ancestor
25220964|NCT02653014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220965|NCT02653014|Hormone Antagonists|hormone antagonists|mesh-ancestor
25547773|NCT00606502|Vitamin B 12|vitamin b 12|mesh-list
25169392|NCT01874626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25169393|NCT01874626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169394|NCT01874626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25169395|NCT01874626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25547774|NCT00606502|Hydroxocobalamin|hydroxocobalamin|mesh-list
25547775|NCT00606502|Vitamin B Complex|vitamin b complex|mesh-list
25547776|NCT00606502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25220983|NCT02652884|Betamethasone acetate|betamethasone acetate|mesh-list
25220984|NCT02652884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25220985|NCT02652884|Glucocorticoids|glucocorticoids|mesh-ancestor
25220986|NCT02652884|Hormones|hormones|mesh-ancestor
25220987|NCT02652884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25220988|NCT02652884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220989|NCT02652884|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25220990|NCT02652884|Respiratory System Agents|respiratory system agents|mesh-ancestor
25547777|NCT00606502|10-deazaaminopterin|10-deazaaminopterin|mesh-list
25547778|NCT00606502|Micronutrients|micronutrients|mesh-ancestor
25547779|NCT00606502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547780|NCT00606502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25547781|NCT00606502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25547782|NCT00606502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547783|NCT00606502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547784|NCT00606502|Hematinics|hematinics|mesh-ancestor
25547785|NCT00606502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25012252|NCT00136903|Remestemcel-l|remestemcel-l|mesh-list
24412468|NCT00191490|Docetaxel|docetaxel|mesh-list
24648951|NCT01217671|Protease Inhibitors|protease inhibitors|mesh-list
24648952|NCT01217671|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25221002|NCT02652871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25221003|NCT02652871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25221004|NCT02652871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25221005|NCT02652871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25221006|NCT02652650|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25221007|NCT02652650|Norethindrone|norethindrone|mesh-list
25221008|NCT02652650|Norethindrone Acetate|norethindrone acetate|mesh-list
25221010|NCT02652650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25547786|NCT00606580|Paromomycin|paromomycin|mesh-list
25547787|NCT00606580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25547788|NCT00606580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25547789|NCT00606580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25547790|NCT00606580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25547791|NCT00606801|Galantamine|galantamine|mesh-list
25547792|NCT00606801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25547793|NCT00606801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547794|NCT00606801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547795|NCT00606801|Cholinergic Agents|cholinergic agents|mesh-ancestor
25547796|NCT00606801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25547797|NCT00606801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547798|NCT00606801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25547799|NCT00606801|Autonomic Agents|autonomic agents|mesh-ancestor
25547800|NCT00606801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25547801|NCT00606801|Nootropic Agents|nootropic agents|mesh-ancestor
24649524|NCT01220232|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25547802|NCT00606892|Nicotine|nicotine|mesh-list
25547803|NCT00606892|Varenicline|varenicline|mesh-list
25547804|NCT00606892|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25547805|NCT00606892|Autonomic Agents|autonomic agents|mesh-ancestor
25547806|NCT00606892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25547807|NCT00606892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547808|NCT00606892|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25547809|NCT00606892|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25547810|NCT00606892|Cholinergic Agents|cholinergic agents|mesh-ancestor
24632548|NCT01124500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24632549|NCT01124500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089241|NCT03267654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25089242|NCT03267654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221039|NCT02652728|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25221040|NCT02652728|Protease Inhibitors|protease inhibitors|mesh-ancestor
25547811|NCT00606892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24650008|NCT01223131|Isophane insulin, beef|isophane insulin, beef|mesh-list
25547812|NCT00606892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547813|NCT00606905|Immunoglobulins|immunoglobulins|mesh-list
25547814|NCT00606905|gamma-Globulins|gamma-globulins|mesh-list
25547815|NCT00606905|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25547816|NCT00606905|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25547817|NCT00606905|Immunologic Factors|immunologic factors|mesh-ancestor
25547818|NCT00606905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547819|NCT00607048|Paclitaxel|paclitaxel|mesh-list
25547820|NCT00607048|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25547821|NCT00607048|Carboplatin|carboplatin|mesh-list
25547822|NCT00607048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25547823|NCT00607048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25547824|NCT00607048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25547825|NCT00607048|Tubulin Modulators|tubulin modulators|mesh-ancestor
25547826|NCT00607048|Antimitotic Agents|antimitotic agents|mesh-ancestor
25547827|NCT00607048|Mitosis Modulators|mitosis modulators|mesh-ancestor
25547828|NCT00607048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547829|NCT00607048|Immunologic Factors|immunologic factors|mesh-ancestor
25547830|NCT00607048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547831|NCT00607087|Insulin|insulin|mesh-list
25547832|NCT00607087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25547833|NCT00607087|Insulin Aspart|insulin aspart|mesh-list
25547834|NCT00607087|Insulin Lispro|insulin lispro|mesh-list
25547835|NCT00607087|Insulin glulisine|insulin glulisine|mesh-list
25547836|NCT00607087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25547837|NCT00607087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547838|NCT00607113|Bevacizumab|bevacizumab|mesh-list
25547839|NCT00607113|Everolimus|everolimus|mesh-list
25547840|NCT00607113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25547841|NCT00607113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25547842|NCT00607113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25547843|NCT00607113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25547844|NCT00607113|Growth Substances|growth substances|mesh-ancestor
24591265|NCT00915733|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24833176|NCT02172976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25547845|NCT00607113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547846|NCT00607113|Growth Inhibitors|growth inhibitors|mesh-ancestor
25547847|NCT00607113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25547848|NCT00607113|Immunologic Factors|immunologic factors|mesh-ancestor
25547849|NCT00607373|Mipomersen|mipomersen|mesh-list
25547850|NCT00607373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25547851|NCT00607373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25547852|NCT00607373|Antimetabolites|antimetabolites|mesh-ancestor
25547853|NCT00607373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547854|NCT00607373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25547855|NCT00607594|Saracatinib|saracatinib|mesh-list
25547856|NCT00607594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25547857|NCT00607594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547858|NCT00607594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547859|NCT00607672|Candesartan|candesartan|mesh-list
25547860|NCT00607672|Ramipril|ramipril|mesh-list
25547861|NCT00607672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25547862|NCT00607672|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25547863|NCT00607672|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25547864|NCT00607672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547865|NCT00607672|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25547866|NCT00607672|Protease Inhibitors|protease inhibitors|mesh-ancestor
24651039|NCT01229046|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24651064|NCT01229189|Vitamins|vitamins|mesh-ancestor
24651065|NCT01229189|Micronutrients|micronutrients|mesh-ancestor
24651066|NCT01229189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651067|NCT01229189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25089286|NCT03267316|Tubulin Modulators|tubulin modulators|mesh-ancestor
25089287|NCT03267316|Antimitotic Agents|antimitotic agents|mesh-ancestor
25089288|NCT03267316|Mitosis Modulators|mitosis modulators|mesh-ancestor
25089289|NCT03267316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089290|NCT03267316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25089291|NCT03267316|Antimetabolites|antimetabolites|mesh-ancestor
25089292|NCT03267316|Antiviral Agents|antiviral agents|mesh-ancestor
25089293|NCT03267316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25089294|NCT03267316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651740|NCT01233583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24651741|NCT01233583|Immunologic Factors|immunologic factors|mesh-ancestor
25089313|NCT03267199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089314|NCT03266965|Carbidopa|carbidopa|mesh-list
24784014|NCT01905371|Sympathomimetics|sympathomimetics|mesh-ancestor
25089315|NCT03266965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25089316|NCT03266965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25089317|NCT03266965|Dopamine Agents|dopamine agents|mesh-ancestor
25089318|NCT03266965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25089319|NCT03266965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089320|NCT03266965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012669|NCT04666454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652359|NCT01237977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652360|NCT01237977|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24652361|NCT01237977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25547867|NCT00607672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547868|NCT00607789|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25547869|NCT00607789|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25547870|NCT00607789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25547871|NCT00607789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25547872|NCT00607789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547873|NCT00607789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25012727|NCT04531176|Orlistat|orlistat|mesh-list
25221216|NCT02651610|Taxane|taxane|mesh-list
25547874|NCT00607789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547876|NCT00607789|Sensory System Agents|sensory system agents|mesh-ancestor
25547877|NCT00607789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25547878|NCT00607789|Antidepressive Agents|antidepressive agents|mesh-ancestor
25547879|NCT00607789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25547880|NCT00607789|Dopamine Agents|dopamine agents|mesh-ancestor
25547881|NCT00607919|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25547882|NCT00607919|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25547883|NCT00607919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25547884|NCT00607919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25547885|NCT00607919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547886|NCT00607919|Adrenergic Agents|adrenergic agents|mesh-ancestor
25547887|NCT00607919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25547888|NCT00607919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547889|NCT00608062|Estradiol|estradiol|mesh-list
25547890|NCT00608062|Ganirelix|ganirelix|mesh-list
25547891|NCT00608062|Estrogens|estrogens|mesh-ancestor
25547892|NCT00608062|Hormones|hormones|mesh-ancestor
25547893|NCT00608062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25547894|NCT00608062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547895|NCT00608062|Hormone Antagonists|hormone antagonists|mesh-ancestor
25547896|NCT00608205|Cisplatin|cisplatin|mesh-list
25547897|NCT00608205|Fluorouracil|fluorouracil|mesh-list
25547898|NCT00608205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25547899|NCT00608205|Antimetabolites|antimetabolites|mesh-ancestor
24633170|NCT01127490|Antidepressive Agents|antidepressive agents|mesh-ancestor
24633171|NCT01127490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24633172|NCT01127490|Dopamine Agents|dopamine agents|mesh-ancestor
25221233|NCT02651623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221234|NCT02651623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221235|NCT02651623|Antidepressive Agents|antidepressive agents|mesh-ancestor
25221236|NCT02651623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25221237|NCT02651623|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24633178|NCT01127542|Lenalidomide|lenalidomide|mesh-list
25547900|NCT00608205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547901|NCT00608205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25547902|NCT00608205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25547903|NCT00608205|Immunologic Factors|immunologic factors|mesh-ancestor
25547904|NCT00608205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547905|NCT00608244|Tacrolimus|tacrolimus|mesh-list
25547906|NCT00608244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24981361|NCT03638947|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24981362|NCT03638947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25221242|NCT02651727|Gemcitabine|gemcitabine|mesh-list
25221243|NCT02651727|Paclitaxel|paclitaxel|mesh-list
25221244|NCT02651727|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25221245|NCT02651727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25221246|NCT02651727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221247|NCT02651727|Tubulin Modulators|tubulin modulators|mesh-ancestor
25221248|NCT02651727|Antimitotic Agents|antimitotic agents|mesh-ancestor
25221249|NCT02651727|Mitosis Modulators|mitosis modulators|mesh-ancestor
24833234|NCT02173288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833235|NCT02173288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25547907|NCT00608244|Immunologic Factors|immunologic factors|mesh-ancestor
25547908|NCT00608244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547909|NCT00608244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25547910|NCT00608244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547911|NCT00608244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547912|NCT00608322|Nitric Oxide|nitric oxide|mesh-list
25547913|NCT00608322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25547914|NCT00608322|Autonomic Agents|autonomic agents|mesh-ancestor
25089472|NCT03265470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25089473|NCT03265470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25089474|NCT03265470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25089475|NCT03265470|Adrenergic Agents|adrenergic agents|mesh-ancestor
25089476|NCT03265470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25089477|NCT03265470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089478|NCT03265470|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25089479|NCT03265470|Narcotics|narcotics|mesh-ancestor
25089480|NCT03265470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25089481|NCT03265470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25089482|NCT03265470|Anesthetics, General|anesthetics, general|mesh-ancestor
25089483|NCT03265470|Anesthetics|anesthetics|mesh-ancestor
24633285|NCT01127984|Coagulants|coagulants|mesh-ancestor
24633286|NCT01128075|Interferon beta-1a|interferon beta-1a|mesh-list
24633287|NCT01128075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24633288|NCT01128075|Immunologic Factors|immunologic factors|mesh-ancestor
24633296|NCT01128101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24633297|NCT01128101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633298|NCT01128101|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24633299|NCT01128101|Diuretics|diuretics|mesh-ancestor
24633300|NCT01128101|Natriuretic Agents|natriuretic agents|mesh-ancestor
25547915|NCT00608322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25547916|NCT00608322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547917|NCT00608322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25042790|NCT01369095|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25042791|NCT01369095|Analgesics|analgesics|mesh-ancestor
25042792|NCT01369095|Sensory System Agents|sensory system agents|mesh-ancestor
25042793|NCT01369095|Dopamine Agents|dopamine agents|mesh-ancestor
25679723|NCT01842594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25013113|NCT03603184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013114|NCT03603184|Tubulin Modulators|tubulin modulators|mesh-ancestor
25013115|NCT03603184|Antimitotic Agents|antimitotic agents|mesh-ancestor
24979242|NCT05064332|Hormones|hormones|mesh-ancestor
24654509|NCT01249937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24654527|NCT01250236|Adrenergic Agents|adrenergic agents|mesh-ancestor
24654528|NCT01250236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25547918|NCT00608322|Respiratory System Agents|respiratory system agents|mesh-ancestor
25547919|NCT00608322|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25547920|NCT00608322|Antioxidants|antioxidants|mesh-ancestor
25547921|NCT00608322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547922|NCT00608322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25547923|NCT00608322|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25547924|NCT00608322|Vasodilator Agents|vasodilator agents|mesh-ancestor
25547925|NCT00608322|Gasotransmitters|gasotransmitters|mesh-ancestor
25013143|NCT03452111|Testosterone|testosterone|mesh-list
25013144|NCT03452111|Androgens|androgens|mesh-ancestor
25089541|NCT03264638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25089542|NCT03264638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089543|NCT03264638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633372|NCT01129154|Panitumumab|panitumumab|mesh-list
24633373|NCT01129154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25547926|NCT00608322|Protective Agents|protective agents|mesh-ancestor
25651098|NCT01511939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25651099|NCT01511939|Analgesics|analgesics|mesh-ancestor
25651100|NCT01511939|Sensory System Agents|sensory system agents|mesh-ancestor
25651101|NCT01511939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25651102|NCT01511939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651103|NCT01511939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25651104|NCT01511939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25651105|NCT01511939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651106|NCT01511939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787108|NCT01923818|Antipyretics|antipyretics|mesh-ancestor
24833336|NCT02173717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24633388|NCT01129271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25221368|NCT02651038|Antifungal Agents|antifungal agents|mesh-ancestor
25221369|NCT02651038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25221370|NCT02650752|Capecitabine|capecitabine|mesh-list
25221371|NCT02650752|Lapatinib|lapatinib|mesh-list
25221372|NCT02650752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25221373|NCT02650752|Antimetabolites|antimetabolites|mesh-ancestor
25221374|NCT02650752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221375|NCT02650752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221376|NCT02650752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25221377|NCT02650752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273069|NCT02387242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25221448|NCT02650479|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25221449|NCT02650479|Incretins|incretins|mesh-ancestor
25221450|NCT02650479|Hormones|hormones|mesh-ancestor
25042830|NCT01365195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467795|NCT00378755|Bortezomib|bortezomib|mesh-list
24833374|NCT02173782|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24833375|NCT02173782|Cholinergic Agents|cholinergic agents|mesh-ancestor
24833376|NCT02173795|Fenoterol|fenoterol|mesh-list
24833377|NCT02173795|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
24833378|NCT02173795|Ipratropium|ipratropium|mesh-list
24833379|NCT02173795|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24833380|NCT02173795|Autonomic Agents|autonomic agents|mesh-ancestor
24833381|NCT02173795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25054116|NCT03531918|Cytarabine|cytarabine|mesh-list
24633397|NCT01129310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24633398|NCT01129310|Antimetabolites|antimetabolites|mesh-ancestor
24633399|NCT01129310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633400|NCT01129310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586270|NCT00889850|Esomeprazole|esomeprazole|mesh-list
24833387|NCT02173795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24833390|NCT02173795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25651107|NCT01511978|Amifampridine|amifampridine|mesh-list
25651108|NCT01511978|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25651109|NCT01511978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25651110|NCT01511978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651111|NCT01511978|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25651112|NCT01511978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24416469|NCT00203138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25089611|NCT03264430|Anesthetics, Local|anesthetics, local|mesh-ancestor
25221564|NCT02649504|Mycophenolic Acid|mycophenolic acid|mesh-list
25221565|NCT02649504|Dexamethasone|dexamethasone|mesh-list
25221566|NCT02649504|Rituximab|rituximab|mesh-list
25221567|NCT02649504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25221568|NCT02649504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221569|NCT02649504|Immunologic Factors|immunologic factors|mesh-ancestor
25221577|NCT02649504|Glucocorticoids|glucocorticoids|mesh-ancestor
25054228|NCT03531047|Riboflavin|riboflavin|mesh-list
24657451|NCT01267383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657452|NCT01267383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24731216|NCT01633359|Atorvastatin|atorvastatin|mesh-list
25221616|NCT02649465|Immunologic Factors|immunologic factors|mesh-ancestor
25221617|NCT02649465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24833692|NCT02175342|Respiratory System Agents|respiratory system agents|mesh-ancestor
24833693|NCT02175342|Parasympatholytics|parasympatholytics|mesh-ancestor
24833699|NCT02175355|Telmisartan|telmisartan|mesh-list
25651113|NCT01511978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651114|NCT01512108|Liraglutide|liraglutide|mesh-list
25443835|NCT04688021|Antitubercular Agents|antitubercular agents|mesh-ancestor
25443836|NCT04688021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25443837|NCT04688151|Rituximab|rituximab|mesh-list
25443838|NCT04688151|Durvalumab|durvalumab|mesh-list
25443839|NCT04688151|Acalabrutinib|acalabrutinib|mesh-list
25443840|NCT04688151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24657790|NCT01269242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657791|NCT01269255|Cisplatin|cisplatin|mesh-list
24657792|NCT01269255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657793|NCT01269281|Sumatriptan|sumatriptan|mesh-list
24787185|NCT01923948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24787186|NCT01923948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787187|NCT01923948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24787189|NCT01923948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24833728|NCT02175394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24833730|NCT02175394|Protease Inhibitors|protease inhibitors|mesh-ancestor
25013418|NCT02845323|Nivolumab|nivolumab|mesh-list
25443841|NCT04688151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443842|NCT04688151|Immunologic Factors|immunologic factors|mesh-ancestor
25443843|NCT04688151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443844|NCT04688151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25443845|NCT04687878|Insulin|insulin|mesh-list
25443846|NCT04687878|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25443847|NCT04687878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25443848|NCT04687878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296894|NCT05084534|Midodrine|midodrine|mesh-list
25296895|NCT05084534|Sympathomimetics|sympathomimetics|mesh-ancestor
25296896|NCT05084534|Autonomic Agents|autonomic agents|mesh-ancestor
25013456|NCT02575144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25013457|NCT02575144|Antiemetics|antiemetics|mesh-ancestor
25013458|NCT02575144|Autonomic Agents|autonomic agents|mesh-ancestor
25013459|NCT02575144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658310|NCT01271166|Vitamins|vitamins|mesh-ancestor
25296897|NCT05084534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25296898|NCT05084534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296899|NCT05084534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25221692|NCT02648425|Leucovorin|leucovorin|mesh-list
24658708|NCT01273558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658710|NCT01273571|Canagliflozin|canagliflozin|mesh-list
24658711|NCT01273571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24658712|NCT01273571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658713|NCT01273571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24658714|NCT01273571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658715|NCT01273584|Metformin|metformin|mesh-list
25221710|NCT02648711|Oxaliplatin|oxaliplatin|mesh-list
25221712|NCT02648711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296900|NCT05084534|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25296901|NCT05084534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25169396|NCT01874626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25169397|NCT01874626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169398|NCT01874626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169399|NCT01873703|Azacitidine|azacitidine|mesh-list
25169400|NCT01873703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24659197|NCT01276080|Nootropic Agents|nootropic agents|mesh-ancestor
25221751|NCT02648490|Acetaminophen|acetaminophen|mesh-list
25221752|NCT02648490|Diphenhydramine|diphenhydramine|mesh-list
25221753|NCT02648490|Promethazine|promethazine|mesh-list
25221754|NCT02648490|Dexamethasone|dexamethasone|mesh-list
25221755|NCT02648490|Ondansetron|ondansetron|mesh-list
25169401|NCT01873703|Antimetabolites|antimetabolites|mesh-ancestor
25169402|NCT01873703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169403|NCT01873703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169404|NCT01873703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25221778|NCT02648490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25203632|NCT02713009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25203633|NCT02713009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25203634|NCT02713074|Povidone-Iodine|povidone-iodine|mesh-list
25203635|NCT02713074|Povidone|povidone|mesh-list
25013604|NCT02065635|Anesthetics, General|anesthetics, general|mesh-ancestor
24834190|NCT02177409|Telmisartan|telmisartan|mesh-list
24834191|NCT02177409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24834194|NCT02177409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834291|NCT02177539|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24395818|NCT00136994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24395819|NCT00136994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395820|NCT00136994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395821|NCT00136994|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24395822|NCT00136994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24395823|NCT00136994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24660379|NCT01283204|Leucovorin|leucovorin|mesh-list
25822542|NCT00004496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25822543|NCT00004496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822544|NCT00004496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25822545|NCT00004496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822546|NCT00004551|Nicotine|nicotine|mesh-list
24660667|NCT01285037|Immunologic Factors|immunologic factors|mesh-ancestor
24660668|NCT01285037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660669|NCT01285037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24660670|NCT01285141|polysaccharide-K|polysaccharide-k|mesh-list
24660711|NCT01285388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25013740|NCT05222646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273118|NCT02387086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25273119|NCT02387086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273120|NCT02387086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24660988|NCT01287494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25221951|NCT02647255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25221952|NCT02647255|Protective Agents|protective agents|mesh-ancestor
25221953|NCT02647255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25221954|NCT02647255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221955|NCT02647268|Magnesium Sulfate|magnesium sulfate|mesh-list
25221956|NCT02647268|Oxytocin|oxytocin|mesh-list
25221957|NCT02647268|Oxytocics|oxytocics|mesh-ancestor
25221958|NCT02647268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25221959|NCT02647268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221960|NCT02647268|Analgesics|analgesics|mesh-ancestor
25221961|NCT02647268|Sensory System Agents|sensory system agents|mesh-ancestor
25221962|NCT02647268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25221963|NCT02647268|Anesthetics|anesthetics|mesh-ancestor
24661367|NCT01289223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24661368|NCT01289223|Alkylating Agents|alkylating agents|mesh-ancestor
24661370|NCT01289223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221986|NCT02647047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25221987|NCT02647047|Analgesics|analgesics|mesh-ancestor
25221988|NCT02647047|Antipyretics|antipyretics|mesh-ancestor
25221989|NCT02647047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25221990|NCT02647047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25221991|NCT02647047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25822547|NCT00004551|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24982119|NCT04245436|Citalopram|citalopram|mesh-list
25822548|NCT00004551|Autonomic Agents|autonomic agents|mesh-ancestor
25822549|NCT00004551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25822550|NCT00004551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822551|NCT00004551|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25822552|NCT00004551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25822553|NCT00004551|Cholinergic Agents|cholinergic agents|mesh-ancestor
25822554|NCT00004551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25822555|NCT00004551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822556|NCT00004552|Acamprosate|acamprosate|mesh-list
25822557|NCT00004552|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25822558|NCT00004554|Naltrexone|naltrexone|mesh-list
25547927|NCT00608517|Methylprednisolone|methylprednisolone|mesh-list
25547928|NCT00608517|Cyclophosphamide|cyclophosphamide|mesh-list
25547929|NCT00608517|Fludarabine|fludarabine|mesh-list
25547930|NCT00608517|Fludarabine phosphate|fludarabine phosphate|mesh-list
25547931|NCT00608517|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25547932|NCT00608517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24661725|NCT01290471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661726|NCT01290497|Hyaluronic Acid|hyaluronic acid|mesh-list
24661727|NCT01290497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24661728|NCT01290497|Immunologic Factors|immunologic factors|mesh-ancestor
24586383|NCT00890500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547933|NCT00608517|Immunologic Factors|immunologic factors|mesh-ancestor
25547934|NCT00608517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822559|NCT00004554|Sertraline|sertraline|mesh-list
25822560|NCT00004554|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25547935|NCT00608517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25547936|NCT00608517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25547937|NCT00608517|Alkylating Agents|alkylating agents|mesh-ancestor
25547938|NCT00608517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662110|NCT01292551|Bosentan|bosentan|mesh-list
24835003|NCT02182011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24947475|NCT03928262|Respiratory System Agents|respiratory system agents|mesh-ancestor
25063004|NCT03237611|Ondansetron|ondansetron|mesh-list
25089891|NCT03262142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25222077|NCT02646735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25222078|NCT02646735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222079|NCT02646735|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25547939|NCT00608517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25547940|NCT00608517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25547941|NCT00608517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25547942|NCT00608517|Antimetabolites|antimetabolites|mesh-ancestor
25547943|NCT00608517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25547944|NCT00608517|Antiemetics|antiemetics|mesh-ancestor
25547945|NCT00608517|Autonomic Agents|autonomic agents|mesh-ancestor
25547946|NCT00608517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25547947|NCT00608517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25547948|NCT00608517|Glucocorticoids|glucocorticoids|mesh-ancestor
25547949|NCT00608517|Hormones|hormones|mesh-ancestor
25547950|NCT00608517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25547951|NCT00608517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25547952|NCT00608517|Protective Agents|protective agents|mesh-ancestor
25547953|NCT00608543|Aripiprazole|aripiprazole|mesh-list
25547954|NCT00608543|Antidepressive Agents|antidepressive agents|mesh-ancestor
25547955|NCT00608543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25547956|NCT00608543|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25547957|NCT00608543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25547958|NCT00608543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25547959|NCT00608543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25547960|NCT00608543|Dopamine Agonists|dopamine agonists|mesh-ancestor
25547961|NCT00608543|Dopamine Agents|dopamine agents|mesh-ancestor
25547962|NCT00608543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25547963|NCT00608543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396996|NCT00140530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24396997|NCT00140530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25547964|NCT00608543|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25547965|NCT00608543|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25547966|NCT00608543|Serotonin Agents|serotonin agents|mesh-ancestor
25547967|NCT00608543|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25547968|NCT00608543|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25547969|NCT00608543|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25547970|NCT00608543|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25547971|NCT00608569|Ritonavir|ritonavir|mesh-list
25547972|NCT00608569|Lopinavir|lopinavir|mesh-list
24662640|NCT01295866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25222161|NCT02646319|Antifungal Agents|antifungal agents|mesh-ancestor
25222162|NCT02646319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25222163|NCT02646319|Immunologic Factors|immunologic factors|mesh-ancestor
25222164|NCT02646319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222165|NCT02646267|Warfarin|warfarin|mesh-list
25547973|NCT00608569|Tenofovir|tenofovir|mesh-list
25547974|NCT00608569|Zidovudine|zidovudine|mesh-list
25547975|NCT00608569|Emtricitabine|emtricitabine|mesh-list
25547976|NCT00608569|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25547977|NCT00608569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25547978|NCT00608569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25547979|NCT00608569|Protease Inhibitors|protease inhibitors|mesh-ancestor
25547980|NCT00608569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547981|NCT00608569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547982|NCT00608569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25547983|NCT00608569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25222201|NCT02645747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25222202|NCT02645747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25222203|NCT02645747|Growth Substances|growth substances|mesh-ancestor
25547984|NCT00608569|Antiviral Agents|antiviral agents|mesh-ancestor
25547985|NCT00608569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25547986|NCT00608569|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25547987|NCT00608569|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25547988|NCT00608569|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25547989|NCT00608569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25547990|NCT00608569|Antimetabolites|antimetabolites|mesh-ancestor
25547991|NCT00608634|Perillyl alcohol|perillyl alcohol|mesh-list
25547992|NCT00608634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25547993|NCT00608634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25547994|NCT00608634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25547995|NCT00608842|Deoxycholic Acid|deoxycholic acid|mesh-list
25547996|NCT00608842|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25547997|NCT00608842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25547998|NCT00608868|Gefitinib|gefitinib|mesh-list
25547999|NCT00608868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548000|NCT00608868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25548001|NCT00608868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548002|NCT00608868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548003|NCT00608881|Ubiquinone|ubiquinone|mesh-list
25548004|NCT00608881|Coenzyme Q10|coenzyme q10|mesh-list
25548005|NCT00608881|Micronutrients|micronutrients|mesh-ancestor
25548006|NCT00608881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548007|NCT00608881|Vitamins|vitamins|mesh-ancestor
25548008|NCT00608894|Prednisone|prednisone|mesh-list
25548009|NCT00608894|Azathioprine|azathioprine|mesh-list
25548010|NCT00608894|Tacrolimus|tacrolimus|mesh-list
25548011|NCT00608894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25679892|NCT01844388|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25679893|NCT01844388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24665257|NCT01311141|Doripenem|doripenem|mesh-list
25222222|NCT02645734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25222223|NCT02645734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25222224|NCT02645734|Growth Substances|growth substances|mesh-ancestor
25222225|NCT02645734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222226|NCT02645734|Growth Inhibitors|growth inhibitors|mesh-ancestor
24665942|NCT01316068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24665943|NCT01316068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25222252|NCT02645565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25273149|NCT02387060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25273150|NCT02387060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25273151|NCT02387060|Narcotics|narcotics|mesh-ancestor
25273152|NCT02387060|Analgesics|analgesics|mesh-ancestor
25273153|NCT02387060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25273154|NCT02387060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25273155|NCT02387060|Anesthetics, General|anesthetics, general|mesh-ancestor
25273156|NCT02387021|Ropivacaine|ropivacaine|mesh-list
25273157|NCT02387021|Anesthetics, Local|anesthetics, local|mesh-ancestor
25273158|NCT02387021|Anesthetics|anesthetics|mesh-ancestor
25273159|NCT02387021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25273160|NCT02387021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679911|NCT01844583|Antitubercular Agents|antitubercular agents|mesh-ancestor
24666944|NCT01321671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24666945|NCT01321671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24666946|NCT01321671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24666947|NCT01321671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24666948|NCT01321671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24666949|NCT01321775|Paclitaxel|paclitaxel|mesh-list
24666950|NCT01321775|Cyclophosphamide|cyclophosphamide|mesh-list
24666951|NCT01321775|Bevacizumab|bevacizumab|mesh-list
24666952|NCT01321775|Trastuzumab|trastuzumab|mesh-list
24666954|NCT01321775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24456204|NCT00330655|Memantine|memantine|mesh-list
25679922|NCT01844687|Cannabidiol|cannabidiol|mesh-list
25014295|NCT04789499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014296|NCT04789499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25014297|NCT04789499|Respiratory System Agents|respiratory system agents|mesh-ancestor
25014298|NCT04789499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25014299|NCT04789499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548012|NCT00608894|Glucocorticoids|glucocorticoids|mesh-ancestor
25548013|NCT00608894|Hormones|hormones|mesh-ancestor
25548014|NCT00608894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25548015|NCT00608894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548016|NCT00608894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25548017|NCT00608894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548018|NCT00608894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25548019|NCT00608894|Immunologic Factors|immunologic factors|mesh-ancestor
25548020|NCT00608894|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25548021|NCT00608894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651115|NCT01512108|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25548022|NCT00608894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548023|NCT00608894|Antimetabolites|antimetabolites|mesh-ancestor
25548024|NCT00608894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25548025|NCT00608894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25548026|NCT00608907|Rifampin|rifampin|mesh-list
25548027|NCT00608907|Dexamethasone|dexamethasone|mesh-list
25548028|NCT00608907|Dexamethasone acetate|dexamethasone acetate|mesh-list
25548029|NCT00608907|Bortezomib|bortezomib|mesh-list
25548030|NCT00608907|BB 1101|bb 1101|mesh-list
25679932|NCT01844700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222396|NCT02644980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25222397|NCT02644980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25222398|NCT02644980|Anesthetics, General|anesthetics, general|mesh-ancestor
25222399|NCT02644954|Metformin|metformin|mesh-list
25222400|NCT02644954|Calcipotriene|calcipotriene|mesh-list
25222401|NCT02644954|Coal Tar|coal tar|mesh-list
25222402|NCT02644954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25548031|NCT00608907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25548032|NCT00608907|Antiemetics|antiemetics|mesh-ancestor
25548033|NCT00608907|Autonomic Agents|autonomic agents|mesh-ancestor
25548034|NCT00608907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25548035|NCT00608907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548036|NCT00608907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25548037|NCT00608907|Glucocorticoids|glucocorticoids|mesh-ancestor
25548038|NCT00608907|Hormones|hormones|mesh-ancestor
25548039|NCT00608907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25548040|NCT00608907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25548041|NCT00608907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548042|NCT00608907|Protease Inhibitors|protease inhibitors|mesh-ancestor
25548043|NCT00608907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548044|NCT00608907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548045|NCT00608907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25548046|NCT00608907|Antitubercular Agents|antitubercular agents|mesh-ancestor
25548047|NCT00608907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24398198|NCT00143728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398199|NCT00143728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222448|NCT02644863|Tubulin Modulators|tubulin modulators|mesh-ancestor
25222449|NCT02644863|Antimitotic Agents|antimitotic agents|mesh-ancestor
25222450|NCT02644863|Mitosis Modulators|mitosis modulators|mesh-ancestor
25222451|NCT02644863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222452|NCT02644629|Ketamine|ketamine|mesh-list
25222453|NCT02644629|Analgesics|analgesics|mesh-ancestor
25222454|NCT02644629|Sensory System Agents|sensory system agents|mesh-ancestor
25548048|NCT00608907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25548049|NCT00608907|Leprostatic Agents|leprostatic agents|mesh-ancestor
25548050|NCT00608907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25548051|NCT00608907|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25548052|NCT00608907|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25548053|NCT00608907|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25548054|NCT00608907|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25548055|NCT00608907|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25548056|NCT00608907|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25548057|NCT00608959|Chlorhexidine|chlorhexidine|mesh-list
25222508|NCT02644499|Hormones|hormones|mesh-ancestor
25548058|NCT00608959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25548059|NCT00608959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25548060|NCT00608959|Disinfectants|disinfectants|mesh-ancestor
25548061|NCT00608985|Zolpidem|zolpidem|mesh-list
25548062|NCT00608985|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25548063|NCT00608985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25548064|NCT00608985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25548065|NCT00608985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548066|NCT00608985|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25548067|NCT00608985|GABA Agonists|gaba agonists|mesh-ancestor
25548068|NCT00608985|GABA Agents|gaba agents|mesh-ancestor
24470216|NCT00389272|Acetaminophen|acetaminophen|mesh-list
25548069|NCT00608985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25548070|NCT00608985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548071|NCT00609128|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25548072|NCT00609128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25548073|NCT00609128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25548074|NCT00609128|Analgesics|analgesics|mesh-ancestor
25548075|NCT00609128|Sensory System Agents|sensory system agents|mesh-ancestor
25548076|NCT00609128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25548077|NCT00609128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548078|NCT00609128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25548079|NCT00609128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25548080|NCT00609128|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25548081|NCT00609128|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25548082|NCT00609128|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25548083|NCT00609128|Histamine Antagonists|histamine antagonists|mesh-ancestor
25548084|NCT00609128|Histamine Agents|histamine agents|mesh-ancestor
24534941|NCT00648310|Estrogens|estrogens|mesh-list
25548085|NCT00609128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25548086|NCT00609128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548087|NCT00609167|Dexamethasone|dexamethasone|mesh-list
25090249|NCT03259542|Itraconazole|itraconazole|mesh-list
25548088|NCT00609167|Cyclophosphamide|cyclophosphamide|mesh-list
25548089|NCT00609167|Bortezomib|bortezomib|mesh-list
25548090|NCT00609167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25548091|NCT00609167|Immunologic Factors|immunologic factors|mesh-ancestor
25548092|NCT00609167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548093|NCT00609167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25548094|NCT00609167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25443947|NCT04686643|Niacin|niacin|mesh-list
24399090|NCT00146588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24399091|NCT00146588|Immunologic Factors|immunologic factors|mesh-ancestor
25548095|NCT00609167|Alkylating Agents|alkylating agents|mesh-ancestor
25548096|NCT00609167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548097|NCT00609167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548098|NCT00609167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25548099|NCT00609167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25548100|NCT00609167|Antiemetics|antiemetics|mesh-ancestor
25548101|NCT00609167|Autonomic Agents|autonomic agents|mesh-ancestor
25548102|NCT00609167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25548103|NCT00609167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25548104|NCT00609167|Glucocorticoids|glucocorticoids|mesh-ancestor
25548105|NCT00609167|Hormones|hormones|mesh-ancestor
25548106|NCT00609167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25548107|NCT00609167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25548108|NCT00609245|Valproic Acid|valproic acid|mesh-list
25548109|NCT00609245|Anticonvulsants|anticonvulsants|mesh-ancestor
25548110|NCT00609245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548111|NCT00609245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548112|NCT00609245|GABA Agents|gaba agents|mesh-ancestor
25548113|NCT00609245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25222628|NCT02644226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25222629|NCT02644226|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25222630|NCT02644226|Anesthetics, General|anesthetics, general|mesh-ancestor
24835698|NCT02183272|Ketamine|ketamine|mesh-list
24835737|NCT02183324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25548114|NCT00609245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548115|NCT00609245|Antimanic Agents|antimanic agents|mesh-ancestor
25548116|NCT00609245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25548117|NCT00609245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25548118|NCT00609245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25548119|NCT00609336|Gemcitabine|gemcitabine|mesh-list
25273174|NCT02386735|Prednisone|prednisone|mesh-list
25548120|NCT00609336|Capecitabine|capecitabine|mesh-list
25548121|NCT00609336|Docetaxel|docetaxel|mesh-list
25548122|NCT00609336|Oxaliplatin|oxaliplatin|mesh-list
25548123|NCT00609336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25548124|NCT00609336|Antimetabolites|antimetabolites|mesh-ancestor
25548125|NCT00609336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548126|NCT00609336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548127|NCT00609336|Antiviral Agents|antiviral agents|mesh-ancestor
25548128|NCT00609336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25548129|NCT00609336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548130|NCT00609336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25548131|NCT00609336|Immunologic Factors|immunologic factors|mesh-ancestor
25548132|NCT00609336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548133|NCT00609336|Tubulin Modulators|tubulin modulators|mesh-ancestor
25548134|NCT00609336|Antimitotic Agents|antimitotic agents|mesh-ancestor
25548135|NCT00609336|Mitosis Modulators|mitosis modulators|mesh-ancestor
25548136|NCT00609362|Rosiglitazone|rosiglitazone|mesh-list
24400780|NCT00151294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25548137|NCT00609362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25548138|NCT00609362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548139|NCT00609466|Morphine|morphine|mesh-list
25548140|NCT00609466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25548141|NCT00609466|Narcotics|narcotics|mesh-ancestor
25548142|NCT00609466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25548143|NCT00609466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548144|NCT00609466|Analgesics|analgesics|mesh-ancestor
25548145|NCT00609466|Sensory System Agents|sensory system agents|mesh-ancestor
24401645|NCT00153634|Meropenem|meropenem|mesh-list
25548146|NCT00609466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25548147|NCT00609492|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25090499|NCT03257319|Morphine|morphine|mesh-list
25548148|NCT00609492|Immunologic Factors|immunologic factors|mesh-ancestor
25548149|NCT00609492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548150|NCT00609518|Folic Acid|folic acid|mesh-list
25548151|NCT00609518|Vitamin B 12|vitamin b 12|mesh-list
25548152|NCT00609518|Hydroxocobalamin|hydroxocobalamin|mesh-list
25548153|NCT00609518|Vitamin B Complex|vitamin b complex|mesh-list
25548154|NCT00609518|Dexamethasone|dexamethasone|mesh-list
25548155|NCT00609518|Dexamethasone acetate|dexamethasone acetate|mesh-list
25548156|NCT00609518|Pemetrexed|pemetrexed|mesh-list
25548157|NCT00609518|BB 1101|bb 1101|mesh-list
24934777|NCT04058522|Hormones|hormones|mesh-ancestor
25015370|NCT02516696|Glucocorticoids|glucocorticoids|mesh-ancestor
25015371|NCT02516696|Hormones|hormones|mesh-ancestor
25015372|NCT02516696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25548158|NCT00609518|Vitamins|vitamins|mesh-ancestor
25548159|NCT00609518|Micronutrients|micronutrients|mesh-ancestor
25548160|NCT00609518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548161|NCT00609518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25548162|NCT00609518|Antiemetics|antiemetics|mesh-ancestor
25548163|NCT00609518|Autonomic Agents|autonomic agents|mesh-ancestor
25548164|NCT00609518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25548165|NCT00609518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25548166|NCT00609518|Glucocorticoids|glucocorticoids|mesh-ancestor
25548167|NCT00609518|Hormones|hormones|mesh-ancestor
25548168|NCT00609518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25548169|NCT00609518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25548170|NCT00609518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548171|NCT00609518|Protease Inhibitors|protease inhibitors|mesh-ancestor
25444025|NCT04685642|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25444026|NCT04685642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444027|NCT04685642|Antipyretics|antipyretics|mesh-ancestor
25444028|NCT04685642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24835815|NCT02183415|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24402975|NCT00158873|Narcotics|narcotics|mesh-ancestor
24402976|NCT00158873|Analgesics|analgesics|mesh-ancestor
24402986|NCT00158873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402987|NCT00158873|Anticonvulsants|anticonvulsants|mesh-ancestor
24402989|NCT00158873|Autonomic Agents|autonomic agents|mesh-ancestor
24402990|NCT00158873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24402991|NCT00158886|Topotecan|topotecan|mesh-list
24402992|NCT00158886|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25444029|NCT04685642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25444030|NCT04685642|Antimetabolites|antimetabolites|mesh-ancestor
25444031|NCT04685642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25444032|NCT04685642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24507731|NCT00551733|Carboplatin|carboplatin|mesh-list
25297189|NCT03003325|Aspirin|aspirin|mesh-list
25297190|NCT03003325|Interferons|interferons|mesh-list
25297191|NCT03003325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25297192|NCT03003325|Antiviral Agents|antiviral agents|mesh-ancestor
25297193|NCT03003325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25297194|NCT03003325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25117457|NCT05164081|Clindamycin|clindamycin|mesh-list
25822561|NCT00004554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25822562|NCT00004554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822563|NCT00004554|Sensory System Agents|sensory system agents|mesh-ancestor
25822564|NCT00004554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25822565|NCT00004554|Antidepressive Agents|antidepressive agents|mesh-ancestor
25822566|NCT00004554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25822567|NCT00004554|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25822568|NCT00004554|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25822569|NCT00004554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25822570|NCT00004554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822571|NCT00004554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25822572|NCT00004554|Serotonin Agents|serotonin agents|mesh-ancestor
25822573|NCT00004564|Clopidogrel|clopidogrel|mesh-list
25123496|NCT03084250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24777383|NCT01863706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777384|NCT01863706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24777385|NCT01863706|Abortifacient Agents|abortifacient agents|mesh-ancestor
25169405|NCT01871415|Metformin|metformin|mesh-list
24403661|NCT00161239|Prednisone|prednisone|mesh-list
25169406|NCT01871415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25169407|NCT01871415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169408|NCT01870505|Letrozole|letrozole|mesh-list
25169409|NCT01870505|Exemestane|exemestane|mesh-list
24836041|NCT02184052|Meloxicam|meloxicam|mesh-list
25055222|NCT03522935|Elafin|elafin|mesh-list
25090798|NCT03253913|Antifungal Agents|antifungal agents|mesh-ancestor
25090799|NCT03253913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25090800|NCT03253913|Immunologic Factors|immunologic factors|mesh-ancestor
25090801|NCT03253913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090802|NCT03253913|Antioxidants|antioxidants|mesh-ancestor
25090803|NCT03253913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090804|NCT03253913|Protective Agents|protective agents|mesh-ancestor
25090805|NCT03253913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404008|NCT00162383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24404009|NCT00162383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25169410|NCT01870505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169411|NCT01870505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25169412|NCT01870505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25169413|NCT01870505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169414|NCT01870505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169415|NCT01870505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25169416|NCT01870505|Hormone Antagonists|hormone antagonists|mesh-ancestor
25169417|NCT01870505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25169418|NCT01870505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404356|NCT00163241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404357|NCT00163241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24404358|NCT00163241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25169419|NCT01866930|Interferons|interferons|mesh-list
25169420|NCT01866930|Ribavirin|ribavirin|mesh-list
25169421|NCT01866930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169422|NCT01866930|Antiviral Agents|antiviral agents|mesh-ancestor
25169423|NCT01866930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25169424|NCT01866930|Antimetabolites|antimetabolites|mesh-ancestor
25169425|NCT01866930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169426|NCT01862224|Methotrexate|methotrexate|mesh-list
24404821|NCT00164931|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24404822|NCT00164931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404823|NCT00164931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404824|NCT00164970|Vitamin B 12|vitamin b 12|mesh-list
24404825|NCT00164970|Hydroxocobalamin|hydroxocobalamin|mesh-list
24404826|NCT00164970|Vitamins|vitamins|mesh-ancestor
24404827|NCT00164970|Micronutrients|micronutrients|mesh-ancestor
24405519|NCT00167518|Glucocorticoids|glucocorticoids|mesh-ancestor
24405520|NCT00167518|Hormones|hormones|mesh-ancestor
24405521|NCT00167518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24405522|NCT00167518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405523|NCT00167557|Interferons|interferons|mesh-list
24405554|NCT00167648|Estrogens|estrogens|mesh-ancestor
24405555|NCT00167648|Hormones|hormones|mesh-ancestor
24405556|NCT00167648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25169427|NCT01862224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25169428|NCT01862224|Abortifacient Agents|abortifacient agents|mesh-ancestor
25169429|NCT01862224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25169430|NCT01862224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548172|NCT00609518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548173|NCT00609518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548174|NCT00609518|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25016140|NCT00395408|Respiratory System Agents|respiratory system agents|mesh-ancestor
25222939|NCT02642484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25222940|NCT02642484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25222941|NCT02642484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25222942|NCT02642484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222943|NCT02642484|Antimanic Agents|antimanic agents|mesh-ancestor
25222946|NCT02642419|Aspirin|aspirin|mesh-list
25548175|NCT00609518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25548176|NCT00609518|Hematinics|hematinics|mesh-ancestor
25548177|NCT00609609|Methylprednisolone|methylprednisolone|mesh-list
25548178|NCT00609609|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25169431|NCT01862224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25548179|NCT00609609|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25548180|NCT00609609|Prednisolone|prednisolone|mesh-list
25548181|NCT00609609|Prednisolone acetate|prednisolone acetate|mesh-list
25548182|NCT00609609|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25548183|NCT00609609|Prednisolone phosphate|prednisolone phosphate|mesh-list
25222969|NCT02642419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25222970|NCT02642419|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25222971|NCT02642419|Antithrombins|antithrombins|mesh-ancestor
24836205|NCT02184351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836206|NCT02184351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24836207|NCT02184351|Hormone Antagonists|hormone antagonists|mesh-ancestor
24836208|NCT02184351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24836209|NCT02184351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836210|NCT02184351|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25090882|NCT03253133|Oxycodone|oxycodone|mesh-list
25548184|NCT00609609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25548185|NCT00609609|Antiemetics|antiemetics|mesh-ancestor
25548186|NCT00609609|Autonomic Agents|autonomic agents|mesh-ancestor
25548187|NCT00609609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25548188|NCT00609609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548189|NCT00609609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25548190|NCT00609609|Glucocorticoids|glucocorticoids|mesh-ancestor
25548191|NCT00609609|Hormones|hormones|mesh-ancestor
24537397|NCT00654524|Goserelin|goserelin|mesh-list
24537429|NCT00654576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24406489|NCT00170573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25548192|NCT00609609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25548193|NCT00609609|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25548194|NCT00609609|Protective Agents|protective agents|mesh-ancestor
25548195|NCT00609609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25548196|NCT00609609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548197|NCT00609622|Bevacizumab|bevacizumab|mesh-list
25548198|NCT00609622|Sunitinib|sunitinib|mesh-list
25548199|NCT00609622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25548200|NCT00609622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548201|NCT00609622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24407893|NCT00175812|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24407894|NCT00175812|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24407895|NCT00175812|Purinergic Agents|purinergic agents|mesh-ancestor
24407897|NCT00175838|Hydroxyurea|hydroxyurea|mesh-list
24407900|NCT00175838|Analgesics|analgesics|mesh-ancestor
25548202|NCT00609622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25548203|NCT00609622|Growth Substances|growth substances|mesh-ancestor
25548204|NCT00609622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548205|NCT00609622|Growth Inhibitors|growth inhibitors|mesh-ancestor
25548206|NCT00609622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25548207|NCT00609622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548208|NCT00609622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548209|NCT00609674|Fluticasone|fluticasone|mesh-list
25090925|NCT03252457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25090926|NCT03252457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25090928|NCT03252457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090929|NCT03252457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25223019|NCT02642146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25548211|NCT00609674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25548212|NCT00609674|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25548213|NCT00609674|Autonomic Agents|autonomic agents|mesh-ancestor
25548214|NCT00609674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25548215|NCT00609674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548216|NCT00609674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25548217|NCT00609674|Respiratory System Agents|respiratory system agents|mesh-ancestor
24578608|NCT00849966|Celecoxib|celecoxib|mesh-list
25223035|NCT02641990|Incretins|incretins|mesh-ancestor
25223036|NCT02641990|Hormones|hormones|mesh-ancestor
25223059|NCT02641847|Doxorubicin|doxorubicin|mesh-list
25223037|NCT02641990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25223038|NCT02642003|Lenograstim|lenograstim|mesh-list
25223039|NCT02642003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25223040|NCT02642003|Immunologic Factors|immunologic factors|mesh-ancestor
25223041|NCT02642003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223042|NCT02641938|Dexmedetomidine|dexmedetomidine|mesh-list
25223043|NCT02641938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25223044|NCT02641938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25223045|NCT02641938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223046|NCT02641938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25223047|NCT02641938|Analgesics|analgesics|mesh-ancestor
25223048|NCT02641938|Sensory System Agents|sensory system agents|mesh-ancestor
25223049|NCT02641938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25548218|NCT00609674|Dermatologic Agents|dermatologic agents|mesh-ancestor
25548219|NCT00609674|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25548220|NCT00609739|Cytarabine|cytarabine|mesh-list
25548221|NCT00609739|Cyclosporine|cyclosporine|mesh-list
25548222|NCT00609739|Methylprednisolone|methylprednisolone|mesh-list
25548223|NCT00609739|Methotrexate|methotrexate|mesh-list
25548224|NCT00609739|Mitoxantrone|mitoxantrone|mesh-list
25090971|NCT03252067|Azithromycin|azithromycin|mesh-list
25090972|NCT03252067|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25090973|NCT03252067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25090974|NCT03252067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25090975|NCT03252067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25090976|NCT03252223|Hormones|hormones|mesh-list
25223091|NCT02641899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25223092|NCT02641899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25548225|NCT00609739|Tretinoin|tretinoin|mesh-list
25548226|NCT00609739|Isotretinoin|isotretinoin|mesh-list
25548227|NCT00609739|Cyclosporins|cyclosporins|mesh-list
25548228|NCT00609739|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25548229|NCT00609739|Abortifacient Agents|abortifacient agents|mesh-ancestor
25548230|NCT00609739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25548231|NCT00609739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548232|NCT00609739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25223123|NCT02641782|Tretinoin|tretinoin|mesh-list
25223124|NCT02641782|Dinutuximab|dinutuximab|mesh-list
25223125|NCT02641782|Isotretinoin|isotretinoin|mesh-list
25223126|NCT02641782|Antibodies|antibodies|mesh-list
25042999|NCT01338883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25043000|NCT01338883|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25043001|NCT01338883|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25043002|NCT01338883|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25043003|NCT01338883|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25043004|NCT01338883|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25055338|NCT03521960|Buspirone|buspirone|mesh-list
25091080|NCT03251170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25091081|NCT03251170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091082|NCT03251170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25091083|NCT03251170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25091084|NCT03251170|Anesthetics, General|anesthetics, general|mesh-ancestor
25091108|NCT03251222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25091109|NCT03251222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25091110|NCT03251222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25091111|NCT03251222|Adrenergic Agents|adrenergic agents|mesh-ancestor
24420605|NCT00216424|Capecitabine|capecitabine|mesh-list
25548233|NCT00609739|Antimetabolites|antimetabolites|mesh-ancestor
25548234|NCT00609739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548235|NCT00609739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548236|NCT00609739|Dermatologic Agents|dermatologic agents|mesh-ancestor
25548237|NCT00609739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548238|NCT00609739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25548239|NCT00609739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25548240|NCT00609739|Immunologic Factors|immunologic factors|mesh-ancestor
25548241|NCT00609739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25548242|NCT00609739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25548243|NCT00609739|Antiviral Agents|antiviral agents|mesh-ancestor
25548244|NCT00609739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25548245|NCT00609739|Antifungal Agents|antifungal agents|mesh-ancestor
25110882|NCT05329779|Pregnanolone|pregnanolone|mesh-list
25548246|NCT00609739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25548247|NCT00609739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25548248|NCT00609739|Antiemetics|antiemetics|mesh-ancestor
25548249|NCT00609739|Autonomic Agents|autonomic agents|mesh-ancestor
25548250|NCT00609739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25548251|NCT00609739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25548252|NCT00609739|Glucocorticoids|glucocorticoids|mesh-ancestor
25548253|NCT00609739|Hormones|hormones|mesh-ancestor
25548254|NCT00609739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25548255|NCT00609739|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25548256|NCT00609739|Protective Agents|protective agents|mesh-ancestor
25548257|NCT00609739|Analgesics|analgesics|mesh-ancestor
25548258|NCT00609739|Sensory System Agents|sensory system agents|mesh-ancestor
25548259|NCT00609739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25548260|NCT00609739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25548261|NCT00609739|Keratolytic Agents|keratolytic agents|mesh-ancestor
25548262|NCT00609804|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25548263|NCT00609804|Sorafenib|sorafenib|mesh-list
25548264|NCT00609804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548265|NCT00609804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25548266|NCT00609804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548267|NCT00609804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548268|NCT00609869|Rituximab|rituximab|mesh-list
25091148|NCT03250494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25091149|NCT03250494|Protease Inhibitors|protease inhibitors|mesh-ancestor
24409850|NCT00183612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24409851|NCT00183612|Serotonin Agents|serotonin agents|mesh-ancestor
24409852|NCT00183742|Docetaxel|docetaxel|mesh-list
24409853|NCT00183742|Doxorubicin|doxorubicin|mesh-list
24409882|NCT00183820|Paclitaxel|paclitaxel|mesh-list
24409883|NCT00183820|Oxaliplatin|oxaliplatin|mesh-list
25548269|NCT00609869|Lenalidomide|lenalidomide|mesh-list
25548270|NCT00609869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25548271|NCT00609869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548272|NCT00609869|Immunologic Factors|immunologic factors|mesh-ancestor
25548273|NCT00609869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548274|NCT00609869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25548275|NCT00609869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25548276|NCT00609869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25548277|NCT00609869|Growth Substances|growth substances|mesh-ancestor
25444095|NCT04684017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25444096|NCT04684017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24410108|NCT00184574|Insulin Aspart|insulin aspart|mesh-list
24410110|NCT00184574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25680136|NCT01846611|Antiemetics|antiemetics|mesh-ancestor
25091193|NCT03250338|Sensory System Agents|sensory system agents|mesh-ancestor
25091194|NCT03250338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25091195|NCT03250338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25091196|NCT03250338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25091201|NCT03250143|Cyclosporine|cyclosporine|mesh-list
25091220|NCT03250039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091221|NCT03250052|Linagliptin|linagliptin|mesh-list
25091222|NCT03250052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25091223|NCT03250052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091224|NCT03250052|Incretins|incretins|mesh-ancestor
25223294|NCT02640794|Aspirin|aspirin|mesh-list
25223307|NCT02640794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25223308|NCT02640794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25223309|NCT02640794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25223310|NCT02640794|Antipyretics|antipyretics|mesh-ancestor
25223311|NCT02640794|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24456849|NCT00332384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25223314|NCT02640794|Purinergic Agents|purinergic agents|mesh-ancestor
25223315|NCT02640794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25223316|NCT02640417|Vitamin B Complex|vitamin b complex|mesh-list
24984120|NCT04787562|Imipenem|imipenem|mesh-list
25444097|NCT04684017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444098|NCT04683458|Paclitaxel|paclitaxel|mesh-list
25444099|NCT04683458|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25444100|NCT04683458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25444101|NCT04683458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444102|NCT04683458|Tubulin Modulators|tubulin modulators|mesh-ancestor
25444103|NCT04683458|Antimitotic Agents|antimitotic agents|mesh-ancestor
25444104|NCT04683458|Mitosis Modulators|mitosis modulators|mesh-ancestor
25444105|NCT04683458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444106|NCT04683640|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
25444107|NCT04683640|GABA Agents|gaba agents|mesh-ancestor
25444108|NCT04683640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25444109|NCT04683640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444110|NCT04683640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444111|NCT04683445|Pembrolizumab|pembrolizumab|mesh-list
25444112|NCT04683445|Trastuzumab|trastuzumab|mesh-list
25444113|NCT04683445|Pertuzumab|pertuzumab|mesh-list
25444114|NCT04683445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25680143|NCT01846611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25091250|NCT03249506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25091251|NCT03249506|Glucagon|glucagon|mesh-list
25444115|NCT04683445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444116|NCT04683406|Oseltamivir|oseltamivir|mesh-list
25444117|NCT04683406|Antiviral Agents|antiviral agents|mesh-ancestor
25444118|NCT04683406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25444119|NCT04683406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444120|NCT04683406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444121|NCT04683341|Tenofovir|tenofovir|mesh-list
25444122|NCT04683341|Antiviral Agents|antiviral agents|mesh-ancestor
25444123|NCT04683341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25444124|NCT04683341|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25223369|NCT02640313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25223370|NCT02640313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25223371|NCT02640313|Nootropic Agents|nootropic agents|mesh-ancestor
25223372|NCT02640300|Clozapine|clozapine|mesh-list
25223373|NCT02640300|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25223374|NCT02640300|Serotonin Agents|serotonin agents|mesh-ancestor
25223375|NCT02640300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25223376|NCT02640300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223377|NCT02640300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223378|NCT02640300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25223379|NCT02640300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24836486|NCT02186028|Micronutrients|micronutrients|mesh-ancestor
24836487|NCT02186028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836489|NCT02186106|Cholecalciferol|cholecalciferol|mesh-list
25548278|NCT00609869|Growth Inhibitors|growth inhibitors|mesh-ancestor
25548279|NCT00609973|Ciprofloxacin|ciprofloxacin|mesh-list
25548280|NCT00609973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25548281|NCT00609973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25548282|NCT00609973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25548283|NCT00609973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25548284|NCT00609973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548285|NCT00609973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548286|NCT00609973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548287|NCT00609973|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25548288|NCT00609973|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25548289|NCT00609986|Insulin|insulin|mesh-list
25055447|NCT03521024|Lithium Carbonate|lithium carbonate|mesh-list
25223403|NCT02639767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25223404|NCT02639767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25223405|NCT02639819|Aminocaproic Acid|aminocaproic acid|mesh-list
25548290|NCT00609986|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25548291|NCT00609986|Insulin Glargine|insulin glargine|mesh-list
25548292|NCT00609986|Insulin, Isophane|insulin, isophane|mesh-list
25548293|NCT00609986|Isophane Insulin, Human|isophane insulin, human|mesh-list
25548294|NCT00609986|Isophane insulin, beef|isophane insulin, beef|mesh-list
25548295|NCT00609986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25548296|NCT00609986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548297|NCT00610155|Pregabalin|pregabalin|mesh-list
25548298|NCT00610155|Tramadol|tramadol|mesh-list
25548299|NCT00610155|Analgesics|analgesics|mesh-ancestor
25016964|NCT03697720|Analgesics|analgesics|mesh-ancestor
25223445|NCT02639533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25223446|NCT02639533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223447|NCT02639533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25223448|NCT02639533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24836530|NCT02186145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25091331|NCT03249428|Nicotine|nicotine|mesh-list
25548300|NCT00610155|Sensory System Agents|sensory system agents|mesh-ancestor
25548301|NCT00610155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25548302|NCT00610155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548303|NCT00610155|Anticonvulsants|anticonvulsants|mesh-ancestor
25548304|NCT00610155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25548305|NCT00610155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25548306|NCT00610155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016998|NCT03623373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25016999|NCT03623373|Alkylating Agents|alkylating agents|mesh-ancestor
25017000|NCT03603964|Guadecitabine|guadecitabine|mesh-list
25017001|NCT03603964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24836571|NCT02186366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836572|NCT02186457|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24836574|NCT02186457|Polymyxin B|polymyxin b|mesh-list
24836575|NCT02186457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24836576|NCT02186483|Metformin|metformin|mesh-list
24411096|NCT00187746|Antiviral Agents|antiviral agents|mesh-ancestor
24411097|NCT00187746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24411140|NCT00187993|Hormones|hormones|mesh-list
25548307|NCT00610155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25548308|NCT00610155|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25548309|NCT00610155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25548310|NCT00610155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25548311|NCT00610155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25548312|NCT00610155|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25548313|NCT00610155|Narcotics|narcotics|mesh-ancestor
25548314|NCT00610168|Vaccines|vaccines|mesh-list
25548315|NCT00610168|Immunologic Factors|immunologic factors|mesh-ancestor
25548316|NCT00610168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548317|NCT00610311|Aldesleukin|aldesleukin|mesh-list
25548318|NCT00610311|Cyclophosphamide|cyclophosphamide|mesh-list
25680160|NCT01846624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411198|NCT00188227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24411204|NCT00188227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411206|NCT00188227|Narcotics|narcotics|mesh-ancestor
25017208|NCT02275546|Hormones|hormones|mesh-ancestor
25091487|NCT03248713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25091488|NCT03248713|Contraceptive Agents|contraceptive agents|mesh-ancestor
25091489|NCT03248713|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25091490|NCT03248713|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25091491|NCT03248713|Hormone Antagonists|hormone antagonists|mesh-ancestor
24411215|NCT00188266|Antimetabolites|antimetabolites|mesh-ancestor
24411216|NCT00188266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411217|NCT00188266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25548319|NCT00610311|Fludarabine|fludarabine|mesh-list
25548320|NCT00610311|Fludarabine phosphate|fludarabine phosphate|mesh-list
25548321|NCT00610311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25548322|NCT00610311|Immunologic Factors|immunologic factors|mesh-ancestor
25548323|NCT00610311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548324|NCT00610311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25548325|NCT00610311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25548326|NCT00610311|Alkylating Agents|alkylating agents|mesh-ancestor
24451448|NCT00323791|Immunologic Factors|immunologic factors|mesh-ancestor
25548327|NCT00610311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548328|NCT00610311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548329|NCT00610311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25548330|NCT00610311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25548331|NCT00610311|Antimetabolites|antimetabolites|mesh-ancestor
25548332|NCT00610311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25548333|NCT00610311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25548334|NCT00610311|Antiviral Agents|antiviral agents|mesh-ancestor
25548335|NCT00610311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25017409|NCT01044056|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
24411248|NCT00188552|Tocotrienols|tocotrienols|mesh-list
24411249|NCT00188552|alpha-Tocopherol|alpha-tocopherol|mesh-list
24411250|NCT00188552|Pentoxifylline|pentoxifylline|mesh-list
24411252|NCT00188552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548336|NCT00610363|Rilonacept|rilonacept|mesh-list
25548337|NCT00610363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25548338|NCT00610428|Prochlorperazine|prochlorperazine|mesh-list
25548339|NCT00610428|Antiemetics|antiemetics|mesh-ancestor
25548340|NCT00610428|Autonomic Agents|autonomic agents|mesh-ancestor
25548341|NCT00610428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25548342|NCT00610428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548343|NCT00610428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25017420|NCT01044056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25017421|NCT01044056|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25091520|NCT03248791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25091521|NCT03248791|Nasal Decongestants|nasal decongestants|mesh-ancestor
25091522|NCT03248791|Respiratory System Agents|respiratory system agents|mesh-ancestor
25091523|NCT03248791|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25091524|NCT03248791|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25091525|NCT03248791|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25091526|NCT03248791|Adrenergic Agents|adrenergic agents|mesh-ancestor
25091527|NCT03248791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25091529|NCT03248791|Protective Agents|protective agents|mesh-ancestor
25548344|NCT00610428|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25548345|NCT00610428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25548346|NCT00610428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25548347|NCT00610428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25548348|NCT00610428|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25548349|NCT00610428|Dopamine Agents|dopamine agents|mesh-ancestor
25548350|NCT00610428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25548351|NCT00610428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548352|NCT00610675|Mirtazapine|mirtazapine|mesh-list
25548353|NCT00610675|Antidepressive Agents|antidepressive agents|mesh-ancestor
25548354|NCT00610675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25548355|NCT00610675|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25548356|NCT00610675|Histamine Antagonists|histamine antagonists|mesh-ancestor
25548357|NCT00610675|Histamine Agents|histamine agents|mesh-ancestor
25548358|NCT00610675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25680202|NCT01847014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680203|NCT01847014|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25223612|NCT02638506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25223613|NCT02638506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25017546|NCT00431431|Anabolic Agents|anabolic agents|mesh-ancestor
25223634|NCT02638428|Ifosfamide|ifosfamide|mesh-list
25223635|NCT02638428|Axitinib|axitinib|mesh-list
25223636|NCT02638428|Vemurafenib|vemurafenib|mesh-list
25223637|NCT02638428|Crizotinib|crizotinib|mesh-list
25223638|NCT02638428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223639|NCT02638428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25223640|NCT02638428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25223641|NCT02638428|Antimetabolites|antimetabolites|mesh-ancestor
24836771|NCT02187419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064403|NCT03460743|Vaccines|vaccines|mesh-list
24836779|NCT02187445|Respiratory System Agents|respiratory system agents|mesh-ancestor
24836780|NCT02187445|Glucocorticoids|glucocorticoids|mesh-ancestor
24836781|NCT02187445|Hormones|hormones|mesh-ancestor
24836783|NCT02187484|Telmisartan|telmisartan|mesh-list
25548359|NCT00610675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548360|NCT00610675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548361|NCT00610675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25548362|NCT00610675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25548363|NCT00610675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25548364|NCT00610675|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25548365|NCT00610675|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25017600|NCT00159796|Antiemetics|antiemetics|mesh-ancestor
25223668|NCT02638584|Rabeprazole|rabeprazole|mesh-list
25223669|NCT02638584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25223670|NCT02638584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25223671|NCT02638584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25223672|NCT02638584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548366|NCT00610675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25548367|NCT00610675|Adrenergic Agents|adrenergic agents|mesh-ancestor
25548368|NCT00610675|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25548369|NCT00610675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25548370|NCT00610675|Serotonin Agents|serotonin agents|mesh-ancestor
25548371|NCT00610675|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25548372|NCT00610688|Vitamin D|vitamin d|mesh-list
25548373|NCT00610688|Ergocalciferols|ergocalciferols|mesh-list
25548374|NCT00610688|Cholecalciferol|cholecalciferol|mesh-list
25548375|NCT00610688|Vitamins|vitamins|mesh-list
25548376|NCT00610688|Micronutrients|micronutrients|mesh-ancestor
25548377|NCT00610688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548378|NCT00610688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25548379|NCT00610688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25548380|NCT00610714|Paclitaxel|paclitaxel|mesh-list
25548381|NCT00610714|Carboplatin|carboplatin|mesh-list
25548382|NCT00610714|Saracatinib|saracatinib|mesh-list
25548383|NCT00610714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25548384|NCT00610714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548385|NCT00610714|Tubulin Modulators|tubulin modulators|mesh-ancestor
25548386|NCT00610714|Antimitotic Agents|antimitotic agents|mesh-ancestor
25548387|NCT00610714|Mitosis Modulators|mitosis modulators|mesh-ancestor
25548388|NCT00610714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680209|NCT01847131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25680210|NCT01847131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539344|NCT00663377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24443722|NCT00295893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25548389|NCT00610714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548390|NCT00610727|Prochlorperazine|prochlorperazine|mesh-list
25548391|NCT00610727|Antiemetics|antiemetics|mesh-ancestor
25548392|NCT00610727|Autonomic Agents|autonomic agents|mesh-ancestor
25548393|NCT00610727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25548394|NCT00610727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548395|NCT00610727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25548396|NCT00610727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24539360|NCT00663455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223698|NCT02638285|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25223699|NCT02638285|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25223700|NCT02638064|Surgiflo|surgiflo|mesh-list
25223701|NCT02638064|Hemostatics|hemostatics|mesh-ancestor
25223702|NCT02638064|Coagulants|coagulants|mesh-ancestor
25223703|NCT02638142|Furosemide|furosemide|mesh-list
25223704|NCT02638142|Diuretics|diuretics|mesh-ancestor
25223705|NCT02638142|Natriuretic Agents|natriuretic agents|mesh-ancestor
25223710|NCT02638116|Omeprazole|omeprazole|mesh-list
25680222|NCT01847313|Liraglutide|liraglutide|mesh-list
25680223|NCT01847313|Glucagon|glucagon|mesh-list
25680224|NCT01847313|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25017710|NCT03704831|Sensory System Agents|sensory system agents|mesh-ancestor
25017711|NCT03704831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25017712|NCT03704818|Dapagliflozin|dapagliflozin|mesh-list
25017713|NCT03704818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25548397|NCT00610727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25548398|NCT00610727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25548399|NCT00610727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25548400|NCT00610727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25548401|NCT00610727|Dopamine Agents|dopamine agents|mesh-ancestor
25548402|NCT00610727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25548403|NCT00610727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548404|NCT00610740|Gemcitabine|gemcitabine|mesh-list
25548405|NCT00610740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25548406|NCT00610740|Antimetabolites|antimetabolites|mesh-ancestor
25548407|NCT00610740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548408|NCT00610740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223747|NCT02637700|Immunoglobulins|immunoglobulins|mesh-list
25223748|NCT02637700|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25223749|NCT02637700|Antibodies|antibodies|mesh-list
25223750|NCT02637700|gamma-Globulins|gamma-globulins|mesh-list
25223751|NCT02637700|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25223752|NCT02637700|Immunologic Factors|immunologic factors|mesh-ancestor
25223826|NCT02637128|Lumefantrine|lumefantrine|mesh-list
25223753|NCT02637700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223754|NCT02637583|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25223755|NCT02637583|Immunologic Factors|immunologic factors|mesh-ancestor
25223756|NCT02637583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223757|NCT02637466|Vortioxetine|vortioxetine|mesh-list
25223758|NCT02637466|Antidepressive Agents|antidepressive agents|mesh-ancestor
25223759|NCT02637466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25223760|NCT02637466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25548409|NCT00610740|Antiviral Agents|antiviral agents|mesh-ancestor
25548410|NCT00610740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25548411|NCT00610740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548412|NCT00610740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25548413|NCT00610740|Immunologic Factors|immunologic factors|mesh-ancestor
25548414|NCT00610740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548415|NCT00610857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25548416|NCT00610857|Antibodies|antibodies|mesh-list
25548417|NCT00610857|Immunoglobulins|immunoglobulins|mesh-list
25548418|NCT00610857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25548419|NCT00610857|Immunologic Factors|immunologic factors|mesh-ancestor
25548420|NCT00610857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548421|NCT00610857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548422|NCT00610883|Cyclophosphamide|cyclophosphamide|mesh-list
25548423|NCT00610883|Methotrexate|methotrexate|mesh-list
25548424|NCT00610883|Asparaginase|asparaginase|mesh-list
25223835|NCT02637128|Antiviral Agents|antiviral agents|mesh-ancestor
25223836|NCT02637128|Schistosomicides|schistosomicides|mesh-ancestor
25223837|NCT02637128|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25223838|NCT02637128|Anthelmintics|anthelmintics|mesh-ancestor
25043089|NCT01328808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25043090|NCT01328808|Analgesics|analgesics|mesh-ancestor
25043091|NCT01328808|Sensory System Agents|sensory system agents|mesh-ancestor
25043092|NCT01328808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25043093|NCT01328808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548425|NCT00610883|Daunorubicin|daunorubicin|mesh-list
25548426|NCT00610883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25548427|NCT00610883|Immunologic Factors|immunologic factors|mesh-ancestor
25548428|NCT00610883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548429|NCT00610883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25548430|NCT00610883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25548431|NCT00610883|Alkylating Agents|alkylating agents|mesh-ancestor
25548432|NCT00610883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548433|NCT00610883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548434|NCT00610883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25548435|NCT00610883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24539559|NCT00664469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24539560|NCT00664469|Antimetabolites|antimetabolites|mesh-ancestor
24539561|NCT00664469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539562|NCT00664469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24539563|NCT00664469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24539564|NCT00664469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837060|NCT02188537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25055689|NCT03518112|Calcium, Dietary|calcium, dietary|mesh-list
25223877|NCT02636842|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25273220|NCT02386462|Propofol|propofol|mesh-list
24539624|NCT00664703|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24539625|NCT00664703|Autonomic Agents|autonomic agents|mesh-ancestor
24539626|NCT00664703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25017858|NCT03703310|Veratrum Alkaloids|veratrum alkaloids|mesh-list
24837061|NCT02188537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24837062|NCT02188537|Antiviral Agents|antiviral agents|mesh-ancestor
24837063|NCT02188537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24837064|NCT02188550|Everolimus|everolimus|mesh-list
25548436|NCT00610883|Abortifacient Agents|abortifacient agents|mesh-ancestor
25548437|NCT00610883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25548438|NCT00610883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25548439|NCT00610883|Antimetabolites|antimetabolites|mesh-ancestor
25548440|NCT00610883|Dermatologic Agents|dermatologic agents|mesh-ancestor
25548441|NCT00610883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548442|NCT00610883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25548443|NCT00610883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25548444|NCT00610883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25548445|NCT00610883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25548446|NCT00610883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25548447|NCT00610935|Peramivir|peramivir|mesh-list
25548448|NCT00610935|Antiviral Agents|antiviral agents|mesh-ancestor
25548449|NCT00610935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25548450|NCT00610935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548451|NCT00610935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548452|NCT00610987|Cefazolin|cefazolin|mesh-list
25548453|NCT00610987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25548454|NCT00610987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25548455|NCT00611026|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25548456|NCT00611026|Fesoterodine|fesoterodine|mesh-list
25548457|NCT00611026|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25444209|NCT04682795|Insulin|insulin|mesh-list
25548458|NCT00611026|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25548459|NCT00611026|Cholinergic Agents|cholinergic agents|mesh-ancestor
25548460|NCT00611026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25548461|NCT00611026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548462|NCT00611026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548463|NCT00611026|Urological Agents|urological agents|mesh-ancestor
25548464|NCT00611130|Vigabatrin|vigabatrin|mesh-list
25548465|NCT00611130|Anticonvulsants|anticonvulsants|mesh-ancestor
25548466|NCT00611130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548467|NCT00611130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548468|NCT00611130|GABA Agents|gaba agents|mesh-ancestor
25548469|NCT00611130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25548470|NCT00611130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548471|NCT00611247|Temozolomide|temozolomide|mesh-list
25548472|NCT00611247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25548473|NCT00611247|Alkylating Agents|alkylating agents|mesh-ancestor
25548474|NCT00611247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548475|NCT00611247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548476|NCT00611325|Bevacizumab|bevacizumab|mesh-list
25548477|NCT00611325|Bortezomib|bortezomib|mesh-list
25017895|NCT03703063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25091762|NCT03247218|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25091763|NCT03247218|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25091764|NCT03246919|Oxytocin|oxytocin|mesh-list
25091765|NCT03246919|Oxytocics|oxytocics|mesh-ancestor
25091771|NCT03246776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25548478|NCT00611325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25548479|NCT00611325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548480|NCT00611325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25548481|NCT00611325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25548482|NCT00611325|Growth Substances|growth substances|mesh-ancestor
25548483|NCT00611325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548484|NCT00611325|Growth Inhibitors|growth inhibitors|mesh-ancestor
25548485|NCT00611351|Mycophenolic Acid|mycophenolic acid|mesh-list
25548486|NCT00611351|Cyclophosphamide|cyclophosphamide|mesh-list
25548487|NCT00611351|Busulfan|busulfan|mesh-list
25548488|NCT00611351|Tacrolimus|tacrolimus|mesh-list
25548489|NCT00611351|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25548490|NCT00611351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25548491|NCT00611351|Immunologic Factors|immunologic factors|mesh-ancestor
25548492|NCT00611351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548493|NCT00611351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25548494|NCT00611351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25223989|NCT02635607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25223990|NCT02635607|Hormone Antagonists|hormone antagonists|mesh-ancestor
25223991|NCT02636010|Pembrolizumab|pembrolizumab|mesh-list
25223992|NCT02636010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25223993|NCT02636010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223994|NCT02635750|Donepezil|donepezil|mesh-list
25223995|NCT02635750|BI 409306|bi 409306|mesh-list
25224002|NCT02635750|Nootropic Agents|nootropic agents|mesh-ancestor
25548495|NCT00611351|Alkylating Agents|alkylating agents|mesh-ancestor
25548496|NCT00611351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548497|NCT00611351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548498|NCT00611351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25548499|NCT00611351|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25548500|NCT00611351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548501|NCT00611351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25548502|NCT00611351|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25548503|NCT00611351|Antitubercular Agents|antitubercular agents|mesh-ancestor
25548504|NCT00611351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25548505|NCT00611351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25548506|NCT00611403|Cyclosporine|cyclosporine|mesh-list
25548507|NCT00611403|Lubricant Eye Drops|lubricant eye drops|mesh-list
25548508|NCT00611403|Cyclosporins|cyclosporins|mesh-list
25548509|NCT00611403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548510|NCT00611403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091808|NCT03246555|Protease Inhibitors|protease inhibitors|mesh-ancestor
25091809|NCT03246555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091811|NCT03246620|Haloperidol|haloperidol|mesh-list
25091813|NCT03246620|Haloperidol decanoate|haloperidol decanoate|mesh-list
25091814|NCT03246620|Antiemetics|antiemetics|mesh-ancestor
25091815|NCT03246620|Autonomic Agents|autonomic agents|mesh-ancestor
25091816|NCT03246620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25224004|NCT02635867|Calcium, Dietary|calcium, dietary|mesh-list
25224005|NCT02635867|Calcium|calcium|mesh-list
25224006|NCT02635867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25224007|NCT02635867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224008|NCT02635867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25224009|NCT02635893|Cycloserine|cycloserine|mesh-list
25224012|NCT02635893|Renal Agents|renal agents|mesh-ancestor
25548511|NCT00611403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25548512|NCT00611403|Immunologic Factors|immunologic factors|mesh-ancestor
25548513|NCT00611403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548514|NCT00611403|Antifungal Agents|antifungal agents|mesh-ancestor
25548515|NCT00611403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25548516|NCT00611403|Dermatologic Agents|dermatologic agents|mesh-ancestor
25548517|NCT00611403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25548518|NCT00611403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25548519|NCT00611403|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25548520|NCT00611403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25548521|NCT00611442|Lubiprostone|lubiprostone|mesh-list
24837136|NCT02189304|Cholinergic Agents|cholinergic agents|mesh-ancestor
24837137|NCT02189343|Thalidomide|thalidomide|mesh-list
25224042|NCT02635243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25224043|NCT02635334|Montelukast|montelukast|mesh-list
25224044|NCT02635334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25224045|NCT02635334|Respiratory System Agents|respiratory system agents|mesh-ancestor
25224046|NCT02635334|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25224047|NCT02635334|Hormone Antagonists|hormone antagonists|mesh-ancestor
25224048|NCT02635334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25224049|NCT02635334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224050|NCT02635334|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25224051|NCT02635334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25224052|NCT02635334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224054|NCT02635230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25224055|NCT02635230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25224056|NCT02635230|Analgesics|analgesics|mesh-ancestor
25224057|NCT02635230|Sensory System Agents|sensory system agents|mesh-ancestor
25224058|NCT02635230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25224059|NCT02635230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224060|NCT02635230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25548522|NCT00611442|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25548523|NCT00611442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25548524|NCT00611442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548525|NCT00611455|Ofatumumab|ofatumumab|mesh-list
25548526|NCT00611455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548527|NCT00611468|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25548528|NCT00611468|Topotecan|topotecan|mesh-list
25548529|NCT00611468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548530|NCT00611468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25548531|NCT00611468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548532|NCT00611468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444357|NCT04680650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25444358|NCT04680650|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25169432|NCT01862224|Antimetabolites|antimetabolites|mesh-ancestor
25169433|NCT01862224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169434|NCT01862224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169435|NCT01862224|Dermatologic Agents|dermatologic agents|mesh-ancestor
25169436|NCT01862224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169437|NCT01862224|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25169438|NCT01862224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24540128|NCT00666692|Mitosis Modulators|mitosis modulators|mesh-ancestor
24540129|NCT00666692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540130|NCT00666692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25169439|NCT01862224|Immunologic Factors|immunologic factors|mesh-ancestor
25822574|NCT00004564|Atorvastatin|atorvastatin|mesh-list
25169440|NCT01862224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25169441|NCT01862224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25169442|NCT01861847|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25169443|NCT01861847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25169444|NCT01861847|Immunologic Factors|immunologic factors|mesh-ancestor
25169447|NCT01859962|Antimetabolites|antimetabolites|mesh-ancestor
25169448|NCT01859962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169449|NCT01859962|Antiviral Agents|antiviral agents|mesh-ancestor
25169450|NCT01859962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25118006|NCT04574479|Analgesics|analgesics|mesh-ancestor
24795735|NCT00003641|Interferons|interferons|mesh-list
25224099|NCT02635074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25091930|NCT03245970|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25091932|NCT03245996|Nebivolol|nebivolol|mesh-list
25091933|NCT03245996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25091934|NCT03245996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25091935|NCT03245996|Sympatholytics|sympatholytics|mesh-ancestor
25091936|NCT03245996|Autonomic Agents|autonomic agents|mesh-ancestor
25091937|NCT03245996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25091938|NCT03245996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169451|NCT01858883|Gemcitabine|gemcitabine|mesh-list
25822575|NCT00004564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25169452|NCT01858883|Paclitaxel|paclitaxel|mesh-list
25169453|NCT01858883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25169454|NCT01858883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169455|NCT01858883|Tubulin Modulators|tubulin modulators|mesh-ancestor
25169456|NCT01858883|Antimitotic Agents|antimitotic agents|mesh-ancestor
25169457|NCT01858883|Mitosis Modulators|mitosis modulators|mesh-ancestor
25169458|NCT01858883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161779|NCT02352558|Dexamethasone|dexamethasone|mesh-list
25018314|NCT03700229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25169459|NCT01858883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25169460|NCT01858883|Antimetabolites|antimetabolites|mesh-ancestor
25169461|NCT01858883|Antiviral Agents|antiviral agents|mesh-ancestor
25169462|NCT01858883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25169463|NCT01858883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169464|NCT01858883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25118315|NCT04245865|Antidotes|antidotes|mesh-ancestor
25118435|NCT04175470|Vitamins|vitamins|mesh-ancestor
25118499|NCT04059172|Ibuprofen|ibuprofen|mesh-list
25169465|NCT01858883|Immunologic Factors|immunologic factors|mesh-ancestor
24413006|NCT00192855|Entacapone|entacapone|mesh-list
25169466|NCT01858883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118982|NCT03177746|Tadalafil|tadalafil|mesh-list
25169467|NCT01847573|Halofuginone|halofuginone|mesh-list
24540308|NCT00667303|Antibodies|antibodies|mesh-list
25169468|NCT01847573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169469|NCT01847573|Coccidiostats|coccidiostats|mesh-ancestor
25169470|NCT01847573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25169471|NCT01847573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25119300|NCT02375295|Renal Agents|renal agents|mesh-ancestor
25169472|NCT01847573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25169473|NCT01847573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25169474|NCT01847573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169475|NCT01847573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169476|NCT01847573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25169477|NCT01847573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25169478|NCT01847573|Growth Substances|growth substances|mesh-ancestor
25169479|NCT01847573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169480|NCT01847573|Growth Inhibitors|growth inhibitors|mesh-ancestor
25169481|NCT01846481|Cocaine|cocaine|mesh-list
25169482|NCT01846481|Anesthetics, Local|anesthetics, local|mesh-ancestor
25169483|NCT01846481|Anesthetics|anesthetics|mesh-ancestor
25169484|NCT01846481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24975468|NCT03593811|Antiemetics|antiemetics|mesh-ancestor
25169485|NCT01846481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169486|NCT01846481|Sensory System Agents|sensory system agents|mesh-ancestor
25169487|NCT01846481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25169488|NCT01846481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25169489|NCT01846481|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25169490|NCT01846481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25169491|NCT01846481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25680360|NCT01849068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25169492|NCT01846481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169493|NCT01846481|Dopamine Agents|dopamine agents|mesh-ancestor
25169494|NCT01846481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25119441|NCT01731444|Phenylephrine|phenylephrine|mesh-list
25169495|NCT01836432|Leucovorin|leucovorin|mesh-list
24781094|NCT01887951|Tramadol|tramadol|mesh-list
25548533|NCT00611468|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25019103|NCT03693573|Atezolizumab|atezolizumab|mesh-list
25019194|NCT03693066|Disinfectants|disinfectants|mesh-list
25548534|NCT00611468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25548535|NCT00611533|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25548536|NCT00611533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25548537|NCT00611533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25548538|NCT00611533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25548539|NCT00611533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548540|NCT00611533|Adrenergic Agents|adrenergic agents|mesh-ancestor
25548541|NCT00611533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25548542|NCT00611533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548543|NCT00611559|PENTA|penta|mesh-list
25548544|NCT00611559|Anticoagulants|anticoagulants|mesh-ancestor
25092742|NCT03239314|Dexamethasone|dexamethasone|mesh-list
25548545|NCT00611559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25019394|NCT03691649|Timolol|timolol|mesh-list
25548546|NCT00611559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25548547|NCT00611559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548548|NCT00611715|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25548549|NCT00611715|Letrozole|letrozole|mesh-list
25548550|NCT00611715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548551|NCT00611715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25548552|NCT00611715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548553|NCT00611715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019587|NCT03690323|Antiviral Agents|antiviral agents|mesh-ancestor
25093203|NCT03236727|Analgesics|analgesics|mesh-ancestor
25548554|NCT00611715|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25548555|NCT00611715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25548556|NCT00611715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25548557|NCT00611715|Hormone Antagonists|hormone antagonists|mesh-ancestor
25548558|NCT00611715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25548559|NCT00611715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548560|NCT00611767|Thiopental|thiopental|mesh-list
25548561|NCT00611767|Anticonvulsants|anticonvulsants|mesh-ancestor
25548562|NCT00611767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25548563|NCT00611767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25548564|NCT00611767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548565|NCT00611767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25548566|NCT00611767|Anesthetics, General|anesthetics, general|mesh-ancestor
25548567|NCT00611767|Anesthetics|anesthetics|mesh-ancestor
25548568|NCT00611767|GABA Modulators|gaba modulators|mesh-ancestor
25548569|NCT00611767|GABA Agents|gaba agents|mesh-ancestor
25548570|NCT00611767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25548571|NCT00611767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548572|NCT00611806|Folic Acid|folic acid|mesh-list
25548573|NCT00611806|Vitamin B 12|vitamin b 12|mesh-list
25548574|NCT00611806|Hematinics|hematinics|mesh-ancestor
25548575|NCT00611806|Vitamin B Complex|vitamin b complex|mesh-ancestor
25548576|NCT00611806|Vitamins|vitamins|mesh-ancestor
25548577|NCT00611806|Micronutrients|micronutrients|mesh-ancestor
25094095|NCT03228628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25548578|NCT00611806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548579|NCT00611858|Fluorouracil|fluorouracil|mesh-list
25548580|NCT00611858|Cetuximab|cetuximab|mesh-list
25548581|NCT00611858|Antimetabolites|antimetabolites|mesh-ancestor
25548582|NCT00611858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548583|NCT00611858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25680471|NCT01851720|Anesthetics|anesthetics|mesh-ancestor
25548584|NCT00611858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548585|NCT00611858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25548586|NCT00611858|Immunologic Factors|immunologic factors|mesh-ancestor
25548587|NCT00611858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548588|NCT00611858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25095046|NCT03220932|Bevacizumab|bevacizumab|mesh-list
25548589|NCT00611884|Insulin|insulin|mesh-list
25548590|NCT00611884|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25548591|NCT00611884|Metformin|metformin|mesh-list
25548592|NCT00611884|Insulin Glargine|insulin glargine|mesh-list
25548593|NCT00611884|Insulin, Long-Acting|insulin, long-acting|mesh-list
25548594|NCT00611884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25548595|NCT00611884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548596|NCT00611897|Acetylcysteine|acetylcysteine|mesh-list
25548597|NCT00611897|Ketamine|ketamine|mesh-list
25095402|NCT03219645|Antipyretics|antipyretics|mesh-ancestor
25548598|NCT00611897|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25548599|NCT00611897|Analgesics|analgesics|mesh-ancestor
25548600|NCT00611897|Sensory System Agents|sensory system agents|mesh-ancestor
25548601|NCT00611897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25548602|NCT00611897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548603|NCT00611897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25548604|NCT00611897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25548605|NCT00611897|Anesthetics, General|anesthetics, general|mesh-ancestor
25548606|NCT00611897|Anesthetics|anesthetics|mesh-ancestor
25548607|NCT00611897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25548608|NCT00611897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25548609|NCT00611897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25444359|NCT04680221|Bupivacaine|bupivacaine|mesh-list
25548610|NCT00611897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25548611|NCT00611897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548612|NCT00611897|Antiviral Agents|antiviral agents|mesh-ancestor
24837568|NCT02192060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25548613|NCT00611897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25548615|NCT00611897|Respiratory System Agents|respiratory system agents|mesh-ancestor
25548616|NCT00611897|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25548617|NCT00611897|Antioxidants|antioxidants|mesh-ancestor
25548618|NCT00611897|Protective Agents|protective agents|mesh-ancestor
25548619|NCT00611897|Antidotes|antidotes|mesh-ancestor
25111536|NCT04791475|Adrenergic Agents|adrenergic agents|mesh-ancestor
25111537|NCT04791475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24707144|NCT01494363|Fluorouracil|fluorouracil|mesh-list
25111538|NCT04791475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548620|NCT00611923|Flutamide|flutamide|mesh-list
25548621|NCT00611923|Androgen Antagonists|androgen antagonists|mesh-ancestor
25548622|NCT00611923|Hormone Antagonists|hormone antagonists|mesh-ancestor
25548623|NCT00611923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25548624|NCT00611923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548625|NCT00611923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25548626|NCT00611923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548627|NCT00611975|Bupropion|bupropion|mesh-list
25548628|NCT00611975|Fluoxetine|fluoxetine|mesh-list
25548629|NCT00611975|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25224472|NCT02633384|Sorbitol|sorbitol|mesh-list
25548630|NCT00611975|Antidepressive Agents|antidepressive agents|mesh-ancestor
25548631|NCT00611975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25548632|NCT00611975|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25680555|NCT01852344|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24709100|NCT01504074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25096403|NCT03212469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548633|NCT00611975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25548634|NCT00611975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25548635|NCT00611975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548636|NCT00611975|Dopamine Agents|dopamine agents|mesh-ancestor
25548637|NCT00611975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25548638|NCT00611975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977510|NCT02987530|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24977511|NCT02987530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24977512|NCT02965690|Cimetidine|cimetidine|mesh-list
24837742|NCT02192944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24837743|NCT02192944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24837744|NCT02192944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24810462|NCT02040402|Vaccines|vaccines|mesh-list
25096690|NCT03210038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25097037|NCT03207334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548639|NCT00611975|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25097161|NCT03206658|Spironolactone|spironolactone|mesh-list
25021352|NCT03672071|Ephedrine|ephedrine|mesh-list
25097286|NCT03205033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25097287|NCT03204734|Capecitabine|capecitabine|mesh-list
25097307|NCT03204877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097308|NCT03204877|Protective Agents|protective agents|mesh-ancestor
25097309|NCT03204877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097310|NCT03204877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25548640|NCT00611975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25097501|NCT03203304|Nivolumab|nivolumab|mesh-list
25548641|NCT00611975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548642|NCT00611975|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25548643|NCT00611975|Serotonin Agents|serotonin agents|mesh-ancestor
25548644|NCT00612040|Insulin|insulin|mesh-list
25548645|NCT00612040|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25548646|NCT00612040|Insulin Glargine|insulin glargine|mesh-list
25548647|NCT00612040|Insulin Aspart|insulin aspart|mesh-list
25548648|NCT00612040|Insulin, Long-Acting|insulin, long-acting|mesh-list
25548649|NCT00612040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25097912|NCT03200613|Heparin|heparin|mesh-list
25548650|NCT00612040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548651|NCT00612066|Rosiglitazone|rosiglitazone|mesh-list
25548652|NCT00612066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25022137|NCT03665740|Protective Agents|protective agents|mesh-ancestor
25098831|NCT03195153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25098832|NCT03195153|Antimetabolites|antimetabolites|mesh-ancestor
25098833|NCT03195153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098958|NCT03194594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25098959|NCT03194594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25098960|NCT03194594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25098961|NCT03194594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25548653|NCT00612066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548654|NCT00612105|Ezogabine|ezogabine|mesh-list
25548655|NCT00612105|Anticonvulsants|anticonvulsants|mesh-ancestor
25548656|NCT00612105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25224768|NCT02631239|Dermatologic Agents|dermatologic agents|mesh-ancestor
24838025|NCT02194829|Tubulin Modulators|tubulin modulators|mesh-ancestor
24838026|NCT02194829|Antimitotic Agents|antimitotic agents|mesh-ancestor
24838027|NCT02194829|Mitosis Modulators|mitosis modulators|mesh-ancestor
25056447|NCT03512574|Analgesics|analgesics|mesh-ancestor
25548657|NCT00612105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548658|NCT00612222|Aldesleukin|aldesleukin|mesh-list
25548659|NCT00612222|Cyclophosphamide|cyclophosphamide|mesh-list
25548660|NCT00612222|Fludarabine|fludarabine|mesh-list
25548661|NCT00612222|Fludarabine phosphate|fludarabine phosphate|mesh-list
25548662|NCT00612222|Interleukin-2|interleukin-2|mesh-list
25548663|NCT00612222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25548664|NCT00612222|Immunologic Factors|immunologic factors|mesh-ancestor
25548665|NCT00612222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548666|NCT00612222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25548667|NCT00612222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25548668|NCT00612222|Alkylating Agents|alkylating agents|mesh-ancestor
24465594|NCT00370240|Sensory System Agents|sensory system agents|mesh-ancestor
25548669|NCT00612222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022717|NCT03660306|Narcotics|narcotics|mesh-ancestor
25548670|NCT00612222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587347|NCT00894569|Carboplatin|carboplatin|mesh-list
25548671|NCT00612222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24838131|NCT02195466|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25548672|NCT00612222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25548673|NCT00612222|Antimetabolites|antimetabolites|mesh-ancestor
25548674|NCT00612222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25548675|NCT00612222|Analgesics|analgesics|mesh-ancestor
25548676|NCT00612222|Sensory System Agents|sensory system agents|mesh-ancestor
25548677|NCT00612222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25548678|NCT00612222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24468525|NCT00382057|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25100798|NCT03180190|Antimalarials|antimalarials|mesh-ancestor
24469668|NCT00386672|Micronutrients|micronutrients|mesh-ancestor
25548679|NCT00612222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24470183|NCT00389090|Temozolomide|temozolomide|mesh-list
25548680|NCT00612222|Antiviral Agents|antiviral agents|mesh-ancestor
25548681|NCT00612222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25548682|NCT00612235|Lamotrigine|lamotrigine|mesh-list
24587586|NCT00895739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587587|NCT00895739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24634123|NCT01132170|Antimanic Agents|antimanic agents|mesh-ancestor
25102139|NCT03170115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25102140|NCT03170115|Analgesics|analgesics|mesh-ancestor
25102141|NCT03170115|Sensory System Agents|sensory system agents|mesh-ancestor
25102144|NCT03170115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25102205|NCT03169764|Vitamins|vitamins|mesh-ancestor
25102292|NCT03169790|Vitamins|vitamins|mesh-ancestor
25548683|NCT00612235|Carbamazepine|carbamazepine|mesh-list
25548684|NCT00612235|Levetiracetam|levetiracetam|mesh-list
25024066|NCT03649009|Thiamine|thiamine|mesh-list
25548685|NCT00612235|Anticonvulsants|anticonvulsants|mesh-ancestor
25548686|NCT00612235|Nootropic Agents|nootropic agents|mesh-ancestor
25548687|NCT00612235|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25548688|NCT00612235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25103026|NCT03164837|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
25024438|NCT03646006|Anesthetics|anesthetics|mesh-ancestor
25548689|NCT00612235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548690|NCT00612235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25103505|NCT03161041|Bevacizumab|bevacizumab|mesh-list
25548691|NCT00612235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680845|NCT01855750|Prednisone|prednisone|mesh-list
25548692|NCT00612235|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25548693|NCT00612235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25548694|NCT00612235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25548695|NCT00612235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25548696|NCT00612235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25548697|NCT00612235|Antimanic Agents|antimanic agents|mesh-ancestor
25112316|NCT04186598|Nifedipine|nifedipine|mesh-list
25548698|NCT00612235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25548699|NCT00612235|Analgesics|analgesics|mesh-ancestor
25548700|NCT00612235|Sensory System Agents|sensory system agents|mesh-ancestor
25548701|NCT00612235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25548702|NCT00612235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25548703|NCT00612235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25548705|NCT00612313|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25548706|NCT00612313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25548707|NCT00612313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25548708|NCT00612313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548709|NCT00612313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25548710|NCT00612313|Serotonin Agents|serotonin agents|mesh-ancestor
25548711|NCT00612313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548712|NCT00612313|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25104954|NCT03149783|Ropivacaine|ropivacaine|mesh-list
25548713|NCT00612313|Antidepressive Agents|antidepressive agents|mesh-ancestor
25548714|NCT00612313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25548715|NCT00612313|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25548716|NCT00612313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25548717|NCT00612313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548718|NCT00612339|Bevacizumab|bevacizumab|mesh-list
25548719|NCT00612339|Temozolomide|temozolomide|mesh-list
25548720|NCT00612339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25548721|NCT00612339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548722|NCT00612339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25548723|NCT00612339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25548724|NCT00612339|Growth Substances|growth substances|mesh-ancestor
24975038|NCT04788667|Cholinergic Agents|cholinergic agents|mesh-ancestor
24975054|NCT04776499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24975055|NCT04776499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24975056|NCT04776499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24591028|NCT00914693|Contraceptive Agents|contraceptive agents|mesh-ancestor
25026175|NCT03631602|Hormone Antagonists|hormone antagonists|mesh-ancestor
25026176|NCT03631602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25026276|NCT03630081|Meropenem|meropenem|mesh-list
25026277|NCT03630081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25026278|NCT03630081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25026284|NCT03630081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25026285|NCT03630081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25026287|NCT03630042|Pembrolizumab|pembrolizumab|mesh-list
25026288|NCT03630042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25026289|NCT03630042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25026320|NCT03629600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25026467|NCT03628430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25026468|NCT03628430|Autonomic Agents|autonomic agents|mesh-ancestor
25026471|NCT03628430|Mydriatics|mydriatics|mesh-ancestor
25225421|NCT02627456|Antimalarials|antimalarials|mesh-ancestor
24975578|NCT03476538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25225430|NCT02627469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548725|NCT00612339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548726|NCT00612339|Growth Inhibitors|growth inhibitors|mesh-ancestor
25548727|NCT00612339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25548728|NCT00612339|Alkylating Agents|alkylating agents|mesh-ancestor
25548729|NCT00612339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548730|NCT00612352|Ethanol|ethanol|mesh-list
25548731|NCT00612352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25548732|NCT00612352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24975783|NCT03008616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24975784|NCT03008616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783412|NCT01901692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24976188|NCT00360425|Moxifloxacin|moxifloxacin|mesh-list
25548733|NCT00612352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25548734|NCT00612352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548735|NCT00612430|Bevacizumab|bevacizumab|mesh-list
24976472|NCT03557242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24976473|NCT03557242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481677|NCT00436371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25548736|NCT00612430|Etoposide|etoposide|mesh-list
24977017|NCT04666688|Paclitaxel|paclitaxel|mesh-list
25548737|NCT00612430|Etoposide phosphate|etoposide phosphate|mesh-list
25548738|NCT00612430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25681010|NCT01857206|Vaccines|vaccines|mesh-list
25548739|NCT00612430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797208|NCT01954368|Sufentanil|sufentanil|mesh-list
25028483|NCT03610282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028484|NCT03610282|Dopamine Agents|dopamine agents|mesh-ancestor
25028486|NCT03610230|Iron|iron|mesh-list
25548740|NCT00612430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25548741|NCT00612430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25548742|NCT00612430|Growth Substances|growth substances|mesh-ancestor
25548743|NCT00612430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548744|NCT00612430|Growth Inhibitors|growth inhibitors|mesh-ancestor
25548745|NCT00612430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25548746|NCT00612430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25548747|NCT00612430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25548748|NCT00612430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548749|NCT00612430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548750|NCT00612508|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25548751|NCT00612508|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25548752|NCT00612508|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25548753|NCT00612508|Etonogestrel|etonogestrel|mesh-list
25548754|NCT00612508|Desogestrel|desogestrel|mesh-list
25548755|NCT00612508|NuvaRing|nuvaring|mesh-list
25548756|NCT00612508|Estradiol|estradiol|mesh-list
24416146|NCT00202176|Bromides|bromides|mesh-list
25548757|NCT00612508|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25444521|NCT04679103|Eculizumab|eculizumab|mesh-list
25444575|NCT04678076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25444576|NCT04678076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25444577|NCT04678076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25444578|NCT04678076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444579|NCT04678076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297939|NCT05114720|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25297940|NCT05114720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25297941|NCT05114720|Immunologic Factors|immunologic factors|mesh-ancestor
25297942|NCT05114720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297943|NCT05114720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25297944|NCT05114720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24416939|NCT00204542|Diclofenac|diclofenac|mesh-list
25297945|NCT05114720|Alkylating Agents|alkylating agents|mesh-ancestor
25297946|NCT05114720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297947|NCT05114720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25297948|NCT05114720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25297949|NCT05114720|Tubulin Modulators|tubulin modulators|mesh-ancestor
25169497|NCT01836432|Paclitaxel|paclitaxel|mesh-list
25169498|NCT01836432|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25169499|NCT01836432|Fluorouracil|fluorouracil|mesh-list
25169500|NCT01836432|Capecitabine|capecitabine|mesh-list
25169501|NCT01836432|Oxaliplatin|oxaliplatin|mesh-list
25169502|NCT01836432|Irinotecan|irinotecan|mesh-list
25169503|NCT01836432|Folfirinox|folfirinox|mesh-list
25169504|NCT01836432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25029007|NCT03606369|Autonomic Agents|autonomic agents|mesh-ancestor
25169505|NCT01836432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169506|NCT01836432|Tubulin Modulators|tubulin modulators|mesh-ancestor
25169507|NCT01836432|Antimitotic Agents|antimitotic agents|mesh-ancestor
25169508|NCT01836432|Mitosis Modulators|mitosis modulators|mesh-ancestor
25169509|NCT01836432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169510|NCT01836432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25169511|NCT01836432|Antimetabolites|antimetabolites|mesh-ancestor
25169512|NCT01836432|Antiviral Agents|antiviral agents|mesh-ancestor
25119817|NCT05137262|Methotrexate|methotrexate|mesh-list
25169521|NCT01836432|Protective Agents|protective agents|mesh-ancestor
25169522|NCT01836432|Vitamin B Complex|vitamin b complex|mesh-ancestor
25169523|NCT01836432|Vitamins|vitamins|mesh-ancestor
25169524|NCT01836432|Micronutrients|micronutrients|mesh-ancestor
25169534|NCT01825980|Ritonavir|ritonavir|mesh-list
24595136|NCT00936923|Furosemide|furosemide|mesh-list
25169535|NCT01825980|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25169536|NCT01825980|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25822576|NCT00004564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25822577|NCT00004564|Antimetabolites|antimetabolites|mesh-ancestor
24548155|NCT00707902|Anesthetics, Local|anesthetics, local|mesh-ancestor
24548156|NCT00707902|Anesthetics|anesthetics|mesh-ancestor
24548157|NCT00707902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24548158|NCT00707902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548159|NCT00707902|Sensory System Agents|sensory system agents|mesh-ancestor
25822578|NCT00004564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822579|NCT00004564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25822580|NCT00004564|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25822581|NCT00004564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822582|NCT00004564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24548169|NCT00707928|Nitroglycerin|nitroglycerin|mesh-list
24548170|NCT00707928|Vasodilator Agents|vasodilator agents|mesh-ancestor
24774708|NCT01847404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24548254|NCT00708591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25548758|NCT00612508|Estrogens|estrogens|mesh-ancestor
25548759|NCT00612508|Hormones|hormones|mesh-ancestor
25548760|NCT00612508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25548761|NCT00612508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548762|NCT00612508|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25225816|NCT02624505|Tocolytic Agents|tocolytic agents|mesh-ancestor
25548763|NCT00612508|Contraceptive Agents|contraceptive agents|mesh-ancestor
25548764|NCT00612508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25548765|NCT00612508|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25548766|NCT00612508|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25548767|NCT00612508|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25548768|NCT00612508|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24548255|NCT00708591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25548769|NCT00612508|Progestins|progestins|mesh-ancestor
25548770|NCT00612534|Sufentanil|sufentanil|mesh-list
25548771|NCT00612534|Dsuvia|dsuvia|mesh-list
25548772|NCT00612534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25548773|NCT00612534|Narcotics|narcotics|mesh-ancestor
25548774|NCT00612534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25548775|NCT00612534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548776|NCT00612534|Analgesics|analgesics|mesh-ancestor
25548777|NCT00612534|Sensory System Agents|sensory system agents|mesh-ancestor
25548778|NCT00612534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25548779|NCT00612534|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25548780|NCT00612534|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25548781|NCT00612534|Anesthetics, General|anesthetics, general|mesh-ancestor
25548782|NCT00612534|Anesthetics|anesthetics|mesh-ancestor
25548783|NCT00612560|Anastrozole|anastrozole|mesh-list
25548784|NCT00612560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25548785|NCT00612560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548786|NCT00612560|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25548787|NCT00612560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25548788|NCT00612560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548789|NCT00612560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548790|NCT00612560|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25548791|NCT00612560|Hormone Antagonists|hormone antagonists|mesh-ancestor
25548792|NCT00612560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25548793|NCT00612560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548794|NCT00612573|Doxycycline|doxycycline|mesh-list
25548795|NCT00612573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25548796|NCT00612573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25548797|NCT00612573|Antimalarials|antimalarials|mesh-ancestor
25548798|NCT00612573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25548799|NCT00612573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25548800|NCT00612586|Leucovorin|leucovorin|mesh-list
25548801|NCT00612586|Bevacizumab|bevacizumab|mesh-list
25548802|NCT00612586|Fluorouracil|fluorouracil|mesh-list
25548803|NCT00612586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25548804|NCT00612586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548805|NCT00612586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25548806|NCT00612586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25548807|NCT00612586|Growth Substances|growth substances|mesh-ancestor
25548808|NCT00612586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548809|NCT00612586|Growth Inhibitors|growth inhibitors|mesh-ancestor
25548810|NCT00612586|Antimetabolites|antimetabolites|mesh-ancestor
25548811|NCT00612586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548812|NCT00612586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25548813|NCT00612586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25548814|NCT00612586|Immunologic Factors|immunologic factors|mesh-ancestor
25548815|NCT00612586|Antidotes|antidotes|mesh-ancestor
25548816|NCT00612586|Protective Agents|protective agents|mesh-ancestor
25548817|NCT00612586|Vitamin B Complex|vitamin b complex|mesh-ancestor
25548818|NCT00612586|Vitamins|vitamins|mesh-ancestor
25548819|NCT00612586|Micronutrients|micronutrients|mesh-ancestor
25548820|NCT00612716|Cyclophosphamide|cyclophosphamide|mesh-list
25548821|NCT00612716|Busulfan|busulfan|mesh-list
25548822|NCT00612716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25548823|NCT00612716|Immunologic Factors|immunologic factors|mesh-ancestor
25548824|NCT00612716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548825|NCT00612716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25548826|NCT00612716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25548827|NCT00612716|Alkylating Agents|alkylating agents|mesh-ancestor
25548828|NCT00612716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548829|NCT00612716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548830|NCT00612716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25548831|NCT00612807|Tranylcypromine|tranylcypromine|mesh-list
25029692|NCT03601091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25548832|NCT00612807|Bupropion|bupropion|mesh-list
25548833|NCT00612807|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25548834|NCT00612807|Sertraline|sertraline|mesh-list
25548835|NCT00612807|Nortriptyline|nortriptyline|mesh-list
25548836|NCT00612807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25548837|NCT00612807|Antidepressive Agents|antidepressive agents|mesh-ancestor
25548838|NCT00612807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25548839|NCT00612807|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25548840|NCT00612807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25548841|NCT00612807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25548842|NCT00612807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548843|NCT00612807|Dopamine Agents|dopamine agents|mesh-ancestor
25548844|NCT00612807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25548845|NCT00612807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548846|NCT00612807|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25548847|NCT00612807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25444580|NCT04677985|Analgesics|analgesics|mesh-list
25444581|NCT04677985|Menthol|menthol|mesh-list
25548848|NCT00612807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548849|NCT00612807|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25548850|NCT00612807|Serotonin Agents|serotonin agents|mesh-ancestor
25548851|NCT00612807|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25548852|NCT00612807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25548853|NCT00612807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25548854|NCT00612807|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25548855|NCT00612807|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25548856|NCT00612807|Adrenergic Agents|adrenergic agents|mesh-ancestor
25029761|NCT03600857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25029762|NCT03600857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25029763|NCT03600857|Oxytocics|oxytocics|mesh-ancestor
25029764|NCT03600831|Docetaxel|docetaxel|mesh-list
25029765|NCT03600831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029766|NCT03600831|Tubulin Modulators|tubulin modulators|mesh-ancestor
25548857|NCT00612807|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25548858|NCT00612807|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25548859|NCT00613015|Guanfacine|guanfacine|mesh-list
25548860|NCT00613015|Modafinil|modafinil|mesh-list
25548861|NCT00613015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25548862|NCT00613015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548863|NCT00613015|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25548864|NCT00613015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25548865|NCT00613015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25548866|NCT00613015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548867|NCT00613015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25548868|NCT00613015|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25548869|NCT00613015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25548870|NCT00613015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25548871|NCT00613015|Adrenergic Agents|adrenergic agents|mesh-ancestor
25548872|NCT00613015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25548873|NCT00613028|Bevacizumab|bevacizumab|mesh-list
25548874|NCT00613028|Etoposide|etoposide|mesh-list
25548875|NCT00613028|Temozolomide|temozolomide|mesh-list
25548876|NCT00613028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25548877|NCT00613028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548878|NCT00613028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25548879|NCT00613028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25548880|NCT00613028|Growth Substances|growth substances|mesh-ancestor
25548881|NCT00613028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548882|NCT00613028|Growth Inhibitors|growth inhibitors|mesh-ancestor
25548883|NCT00613028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25548884|NCT00613028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25548885|NCT00613028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25548886|NCT00613028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548887|NCT00613028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548888|NCT00613028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25548889|NCT00613028|Alkylating Agents|alkylating agents|mesh-ancestor
25548890|NCT00613080|Leucovorin|leucovorin|mesh-list
25548891|NCT00613080|Fluorouracil|fluorouracil|mesh-list
25548892|NCT00613080|Capecitabine|capecitabine|mesh-list
25548893|NCT00613080|Oxaliplatin|oxaliplatin|mesh-list
25548894|NCT00613080|Antimetabolites|antimetabolites|mesh-ancestor
25548895|NCT00613080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548896|NCT00613080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25548897|NCT00613080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548898|NCT00613080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25548899|NCT00613080|Immunologic Factors|immunologic factors|mesh-ancestor
25548900|NCT00613080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548901|NCT00613080|Antidotes|antidotes|mesh-ancestor
25548902|NCT00613080|Protective Agents|protective agents|mesh-ancestor
25548903|NCT00613080|Vitamin B Complex|vitamin b complex|mesh-ancestor
25548904|NCT00613080|Vitamins|vitamins|mesh-ancestor
25548905|NCT00613080|Micronutrients|micronutrients|mesh-ancestor
25548906|NCT00613106|Ibuprofen|ibuprofen|mesh-list
25548907|NCT00613106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25548908|NCT00613106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25548909|NCT00613106|Analgesics|analgesics|mesh-ancestor
25548910|NCT00613106|Sensory System Agents|sensory system agents|mesh-ancestor
25029909|NCT03599726|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25029910|NCT03599726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548911|NCT00613106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25548912|NCT00613106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548913|NCT00613106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25548914|NCT00613106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25548915|NCT00613106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25548916|NCT00613106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548917|NCT00613106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548918|NCT00613171|Imatinib Mesylate|imatinib mesylate|mesh-list
25548919|NCT00613171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548920|NCT00613171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25548921|NCT00613171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548922|NCT00613171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651116|NCT01512108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651118|NCT01512108|Hormones|hormones|mesh-ancestor
25651119|NCT01512108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25651120|NCT01512160|Ibuprofen|ibuprofen|mesh-list
25651121|NCT01512160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25651122|NCT01512160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25651123|NCT01512160|Analgesics|analgesics|mesh-ancestor
25651124|NCT01512160|Sensory System Agents|sensory system agents|mesh-ancestor
25651125|NCT01512160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25651126|NCT01512160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651127|NCT01512160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25651128|NCT01512160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25651129|NCT01512160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25651130|NCT01512160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651131|NCT01512160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651132|NCT01512225|Domperidone|domperidone|mesh-list
25651133|NCT01512225|Maleic acid|maleic acid|mesh-list
25651134|NCT01512225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651135|NCT01512225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651136|NCT01512225|Antiemetics|antiemetics|mesh-ancestor
25651137|NCT01512225|Autonomic Agents|autonomic agents|mesh-ancestor
25651138|NCT01512225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25651139|NCT01512225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651140|NCT01512225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25651141|NCT01512225|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25651142|NCT01512225|Dopamine Agents|dopamine agents|mesh-ancestor
25651143|NCT01512225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25651144|NCT01512251|Vemurafenib|vemurafenib|mesh-list
25651145|NCT01512251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25651146|NCT01512251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25651147|NCT01512251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651148|NCT01512251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651149|NCT01512446|Alendronate|alendronate|mesh-list
25651150|NCT01512446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25651151|NCT01512446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651152|NCT01512745|Apatinib|apatinib|mesh-list
25651153|NCT01512745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25651154|NCT01512745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25651155|NCT01512745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651156|NCT01512745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651157|NCT01512797|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25651158|NCT01512797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25651159|NCT01512797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651160|NCT01512797|Incretins|incretins|mesh-ancestor
25651161|NCT01512797|Hormones|hormones|mesh-ancestor
25651162|NCT01512797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25651163|NCT01512797|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25651164|NCT01512797|Protease Inhibitors|protease inhibitors|mesh-ancestor
25651165|NCT01512797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651166|NCT01512797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651167|NCT01512979|Metformin|metformin|mesh-list
25651168|NCT01512979|Linagliptin|linagliptin|mesh-list
25651169|NCT01512979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25651170|NCT01512979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651171|NCT01512979|Incretins|incretins|mesh-ancestor
25651172|NCT01512979|Hormones|hormones|mesh-ancestor
25651173|NCT01512979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25651174|NCT01512979|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25651175|NCT01512979|Protease Inhibitors|protease inhibitors|mesh-ancestor
25651176|NCT01512979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651177|NCT01512979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651178|NCT01513122|Ritonavir|ritonavir|mesh-list
25651179|NCT01513122|Lopinavir|lopinavir|mesh-list
25651180|NCT01513122|Raltegravir Potassium|raltegravir potassium|mesh-list
25651181|NCT01513122|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25651182|NCT01513122|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25113237|NCT03215524|BB 1101|bb 1101|mesh-list
25225911|NCT02624310|Droxidopa|droxidopa|mesh-list
25651183|NCT01513122|Protease Inhibitors|protease inhibitors|mesh-ancestor
25651184|NCT01513122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651185|NCT01513122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651186|NCT01513122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25444715|NCT04676139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444784|NCT04675762|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25444785|NCT04675762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444786|NCT04675762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25444787|NCT04675762|Immunologic Factors|immunologic factors|mesh-ancestor
25444788|NCT04675762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444789|NCT04675528|Paclitaxel|paclitaxel|mesh-list
25444790|NCT04675528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25444791|NCT04675528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444792|NCT04675528|Tubulin Modulators|tubulin modulators|mesh-ancestor
25444793|NCT04675528|Antimitotic Agents|antimitotic agents|mesh-ancestor
25444794|NCT04675528|Mitosis Modulators|mitosis modulators|mesh-ancestor
25444795|NCT04675528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298237|NCT04987099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298238|NCT04987099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25298239|NCT04987099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25298240|NCT04987099|Nootropic Agents|nootropic agents|mesh-ancestor
25298257|NCT04965935|Dapagliflozin|dapagliflozin|mesh-list
25298258|NCT04965935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25298259|NCT04965935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298260|NCT04965935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25298261|NCT04965935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298276|NCT04804540|Vedolizumab|vedolizumab|mesh-list
25298277|NCT04804540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25298278|NCT04772209|Heparin|heparin|mesh-list
25298279|NCT04772209|Anticoagulants|anticoagulants|mesh-ancestor
25298280|NCT04772209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25298281|NCT04772209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24548256|NCT00708591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24548257|NCT00708591|Antifungal Agents|antifungal agents|mesh-ancestor
24548258|NCT00708591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25822583|NCT00004564|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25822584|NCT00004564|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25822585|NCT00004564|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25822586|NCT00004564|Purinergic Agents|purinergic agents|mesh-ancestor
25822587|NCT00004564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25822588|NCT00004564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548283|NCT00708773|Irinotecan|irinotecan|mesh-list
24548284|NCT00708773|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25225926|NCT02624440|Renal Agents|renal agents|mesh-ancestor
24548285|NCT00708773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24548286|NCT00708773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548287|NCT00708773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548288|NCT00708773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25822589|NCT00004567|Mycophenolic Acid|mycophenolic acid|mesh-list
25822590|NCT00004567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25050584|NCT00485563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25548923|NCT00613327|Oxybutynin|oxybutynin|mesh-list
25548924|NCT00613327|Parasympatholytics|parasympatholytics|mesh-ancestor
25548925|NCT00613327|Autonomic Agents|autonomic agents|mesh-ancestor
25548926|NCT00613327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25548927|NCT00613327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548928|NCT00613327|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25548929|NCT00613327|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25548930|NCT00613327|Cholinergic Agents|cholinergic agents|mesh-ancestor
25548931|NCT00613327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25548932|NCT00613327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548933|NCT00613327|Urological Agents|urological agents|mesh-ancestor
25548934|NCT00613366|Misoprostol|misoprostol|mesh-list
25548935|NCT00613366|Magnesium Oxide|magnesium oxide|mesh-list
25548936|NCT00613366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25548937|NCT00613366|Abortifacient Agents|abortifacient agents|mesh-ancestor
25548938|NCT00613366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25548939|NCT00613366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548940|NCT00613366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25548941|NCT00613366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25548942|NCT00613366|Oxytocics|oxytocics|mesh-ancestor
25548943|NCT00613366|Antacids|antacids|mesh-ancestor
25548944|NCT00613366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548945|NCT00613379|Leronlimab|leronlimab|mesh-list
25548946|NCT00613379|HIV Antibodies|hiv antibodies|mesh-list
25548947|NCT00613379|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25548948|NCT00613379|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25548949|NCT00613379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548950|NCT00613379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25548951|NCT00613379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25548952|NCT00613379|Antiviral Agents|antiviral agents|mesh-ancestor
25548953|NCT00613379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25548954|NCT00613379|Immunologic Factors|immunologic factors|mesh-ancestor
25548955|NCT00613379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548956|NCT00613509|Interferons|interferons|mesh-list
25548957|NCT00613509|Interferon-alpha|interferon-alpha|mesh-list
25548958|NCT00613509|Vaccines|vaccines|mesh-list
25548959|NCT00613509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25548960|NCT00613509|Antiviral Agents|antiviral agents|mesh-ancestor
25548961|NCT00613509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25548962|NCT00613509|Immunologic Factors|immunologic factors|mesh-ancestor
25548963|NCT00613509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548964|NCT00613574|Bromides|bromides|mesh-list
25548965|NCT00613574|Tiotropium Bromide|tiotropium bromide|mesh-list
25548966|NCT00613574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24489119|NCT00471484|Antiviral Agents|antiviral agents|mesh-ancestor
25548967|NCT00613574|Autonomic Agents|autonomic agents|mesh-ancestor
25548968|NCT00613574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25548969|NCT00613574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548970|NCT00613574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25548971|NCT00613574|Respiratory System Agents|respiratory system agents|mesh-ancestor
25548972|NCT00613574|Parasympatholytics|parasympatholytics|mesh-ancestor
25548973|NCT00613574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25548974|NCT00613574|Cholinergic Agents|cholinergic agents|mesh-ancestor
25548975|NCT00613574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25548976|NCT00613574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548977|NCT00613574|Anticonvulsants|anticonvulsants|mesh-ancestor
25548978|NCT00613626|Cisplatin|cisplatin|mesh-list
25548979|NCT00613626|Etoposide|etoposide|mesh-list
25548980|NCT00613626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489461|NCT00473460|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24489463|NCT00473486|Pemetrexed|pemetrexed|mesh-list
24489464|NCT00473486|Sorafenib|sorafenib|mesh-list
24489465|NCT00473486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225954|NCT02623816|Omeprazole|omeprazole|mesh-list
25548981|NCT00613626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25548982|NCT00613626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25548983|NCT00613626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25548984|NCT00613626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25548985|NCT00613626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548986|NCT00613821|Lidocaine|lidocaine|mesh-list
25548987|NCT00613821|Anesthetics, Local|anesthetics, local|mesh-ancestor
25548988|NCT00613821|Anesthetics|anesthetics|mesh-ancestor
25548989|NCT00613821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25548990|NCT00613821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25548991|NCT00613821|Sensory System Agents|sensory system agents|mesh-ancestor
25548992|NCT00613821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25548993|NCT00613821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25548994|NCT00613821|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25548995|NCT00613821|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25548996|NCT00613821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25548997|NCT00613821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25548998|NCT00613834|Lidocaine|lidocaine|mesh-list
25548999|NCT00613834|Anesthetics, Local|anesthetics, local|mesh-ancestor
25549000|NCT00613834|Anesthetics|anesthetics|mesh-ancestor
25549001|NCT00613834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25549002|NCT00613834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549003|NCT00613834|Sensory System Agents|sensory system agents|mesh-ancestor
25549004|NCT00613834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25549005|NCT00613834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25549006|NCT00613834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25549007|NCT00613834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25549008|NCT00613834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25549009|NCT00613834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549010|NCT00613938|Oxycodone|oxycodone|mesh-list
25549011|NCT00613938|Tapentadol|tapentadol|mesh-list
25549012|NCT00613938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25549013|NCT00613938|Narcotics|narcotics|mesh-ancestor
25549014|NCT00613938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25549015|NCT00613938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549016|NCT00613938|Analgesics|analgesics|mesh-ancestor
25549017|NCT00613938|Sensory System Agents|sensory system agents|mesh-ancestor
24489885|NCT00475813|Fluticasone|fluticasone|mesh-list
25549018|NCT00613938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25549019|NCT00613938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25549020|NCT00613938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25549021|NCT00613938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25549022|NCT00613938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549023|NCT00613938|Adrenergic Agents|adrenergic agents|mesh-ancestor
25549024|NCT00613938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25549025|NCT00613951|Insulin|insulin|mesh-list
25549026|NCT00613951|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25549027|NCT00613951|Metformin|metformin|mesh-list
25549028|NCT00613951|Insulin Aspart|insulin aspart|mesh-list
25549029|NCT00613951|Insulin, Long-Acting|insulin, long-acting|mesh-list
25549030|NCT00613951|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25549031|NCT00613951|Biphasic Insulins|biphasic insulins|mesh-list
25549032|NCT00613951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25549033|NCT00613951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549034|NCT00614055|Insulin|insulin|mesh-list
25549035|NCT00614055|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25549036|NCT00614055|Metformin|metformin|mesh-list
25549037|NCT00614055|Insulin Glargine|insulin glargine|mesh-list
25549038|NCT00614055|Insulin Aspart|insulin aspart|mesh-list
25549039|NCT00614055|Insulin, Long-Acting|insulin, long-acting|mesh-list
25549040|NCT00614055|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25549041|NCT00614055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25549042|NCT00614055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549043|NCT00614120|Metformin|metformin|mesh-list
25549044|NCT00614120|Liraglutide|liraglutide|mesh-list
25549045|NCT00614120|Glimepiride|glimepiride|mesh-list
25549046|NCT00614120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25549047|NCT00614120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549048|NCT00614120|Incretins|incretins|mesh-ancestor
25549049|NCT00614120|Hormones|hormones|mesh-ancestor
25549050|NCT00614120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25549051|NCT00614120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25549052|NCT00614120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25549053|NCT00614120|Immunologic Factors|immunologic factors|mesh-ancestor
25549054|NCT00614198|Caseins|caseins|mesh-list
25549055|NCT00614198|Chelating Agents|chelating agents|mesh-ancestor
25549056|NCT00614198|Sequestering Agents|sequestering agents|mesh-ancestor
25549057|NCT00614198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549058|NCT00614380|Amlodipine|amlodipine|mesh-list
25549059|NCT00614380|Telmisartan|telmisartan|mesh-list
25549060|NCT00614380|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
24490192|NCT00477035|Melphalan|melphalan|mesh-list
25107535|NCT03139591|Hormones|hormones|mesh-ancestor
25549061|NCT00614380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25549062|NCT00614380|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25549063|NCT00614380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25549064|NCT00614380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549065|NCT00614380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25549066|NCT00614380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549067|NCT00614380|Vasodilator Agents|vasodilator agents|mesh-ancestor
25549068|NCT00614380|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25549069|NCT00614380|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25549070|NCT00614393|Irinotecan|irinotecan|mesh-list
25549071|NCT00614393|Cetuximab|cetuximab|mesh-list
25549072|NCT00614393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25549073|NCT00614393|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25549074|NCT00614393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25549075|NCT00614393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25549076|NCT00614393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549077|NCT00614393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549078|NCT00614393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25549079|NCT00614393|Immunologic Factors|immunologic factors|mesh-ancestor
25549080|NCT00614393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549081|NCT00614406|Celecoxib|celecoxib|mesh-list
25549082|NCT00614406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25549083|NCT00614406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25549084|NCT00614406|Analgesics|analgesics|mesh-ancestor
25549085|NCT00614406|Sensory System Agents|sensory system agents|mesh-ancestor
25549086|NCT00614406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25549087|NCT00614406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549088|NCT00614406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24490774|NCT00480090|Antiviral Agents|antiviral agents|mesh-ancestor
24865551|NCT00805961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534473|NCT00647127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24534474|NCT00647127|Anesthetics, General|anesthetics, general|mesh-ancestor
24534475|NCT00647127|Anesthetics|anesthetics|mesh-ancestor
24534476|NCT00647127|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25549089|NCT00614406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25549090|NCT00614406|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25549091|NCT00614406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25549092|NCT00614406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25549093|NCT00614406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549094|NCT00614445|Pyridoxine|pyridoxine|mesh-list
25549095|NCT00614445|Vitamin B 6|vitamin b 6|mesh-list
25549096|NCT00614445|Doxylamine|doxylamine|mesh-list
25549097|NCT00614445|Doxylamine succinate|doxylamine succinate|mesh-list
25549098|NCT00614445|Vitamin B Complex|vitamin b complex|mesh-ancestor
25549099|NCT00614445|Vitamins|vitamins|mesh-ancestor
25549100|NCT00614445|Micronutrients|micronutrients|mesh-ancestor
25549101|NCT00614445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444950|NCT04673396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444952|NCT04672928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25444953|NCT04672928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444954|NCT04672928|Tubulin Modulators|tubulin modulators|mesh-ancestor
25444955|NCT04672928|Antimitotic Agents|antimitotic agents|mesh-ancestor
25444956|NCT04672928|Mitosis Modulators|mitosis modulators|mesh-ancestor
25444957|NCT04672928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298464|NCT04049786|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25298465|NCT04049786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25298466|NCT04049786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25298467|NCT04049786|Adrenergic Agents|adrenergic agents|mesh-ancestor
25298468|NCT04049786|Antioxidants|antioxidants|mesh-ancestor
25298469|NCT04049786|Protective Agents|protective agents|mesh-ancestor
25298470|NCT04049786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25298471|NCT04049786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25298472|NCT04049786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25298473|NCT04049786|Vasodilator Agents|vasodilator agents|mesh-ancestor
25298474|NCT04049786|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25298475|NCT04049786|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25298476|NCT04034238|Tofacitinib|tofacitinib|mesh-list
25298477|NCT04034238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25298478|NCT04034238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298479|NCT04034238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298480|NCT04023253|Solifenacin Succinate|solifenacin succinate|mesh-list
25298481|NCT04023253|Mirabegron|mirabegron|mesh-list
25050585|NCT00485563|Analgesics|analgesics|mesh-ancestor
25050586|NCT00485563|Sensory System Agents|sensory system agents|mesh-ancestor
25050587|NCT00485563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25050588|NCT00485563|Hematinics|hematinics|mesh-ancestor
25050589|NCT00485563|Vitamins|vitamins|mesh-ancestor
25050590|NCT00485563|Micronutrients|micronutrients|mesh-ancestor
25822591|NCT00004567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25822592|NCT00004567|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25822593|NCT00004567|Antitubercular Agents|antitubercular agents|mesh-ancestor
25822594|NCT00004567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25822595|NCT00004567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25050591|NCT00485563|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25050592|NCT00484419|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25050594|NCT00484419|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
25050595|NCT00484419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25822596|NCT00004567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822597|NCT00004567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822598|NCT00004573|Ganciclovir|ganciclovir|mesh-list
25822599|NCT00004573|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25822600|NCT00004573|Antiviral Agents|antiviral agents|mesh-ancestor
25822601|NCT00004573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25549102|NCT00614445|Antiemetics|antiemetics|mesh-ancestor
25549103|NCT00614445|Autonomic Agents|autonomic agents|mesh-ancestor
25549104|NCT00614445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25549105|NCT00614445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25549106|NCT00614445|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25549107|NCT00614445|Histamine Antagonists|histamine antagonists|mesh-ancestor
25549108|NCT00614445|Histamine Agents|histamine agents|mesh-ancestor
25549109|NCT00614445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25549110|NCT00614445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549111|NCT00614458|Raltegravir Potassium|raltegravir potassium|mesh-list
25549112|NCT00614458|Valproic Acid|valproic acid|mesh-list
25549113|NCT00614458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25549114|NCT00614458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24492151|NCT00485498|Dopamine Agents|dopamine agents|mesh-ancestor
24492152|NCT00485498|Antiemetics|antiemetics|mesh-ancestor
24492153|NCT00485498|Autonomic Agents|autonomic agents|mesh-ancestor
24534655|NCT00647777|Autonomic Agents|autonomic agents|mesh-ancestor
25225999|NCT02623673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549115|NCT00614458|Antiviral Agents|antiviral agents|mesh-ancestor
25549116|NCT00614458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25549117|NCT00614458|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25549118|NCT00614458|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25549119|NCT00614458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25549120|NCT00614458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549121|NCT00614458|Anticonvulsants|anticonvulsants|mesh-ancestor
25549122|NCT00614458|GABA Agents|gaba agents|mesh-ancestor
25549123|NCT00614458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25549124|NCT00614458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549125|NCT00614458|Antimanic Agents|antimanic agents|mesh-ancestor
25549126|NCT00614458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25549127|NCT00614458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25549128|NCT00614458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25549130|NCT00614484|Carboplatin|carboplatin|mesh-list
25549131|NCT00614484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25549132|NCT00614484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549133|NCT00614484|Tubulin Modulators|tubulin modulators|mesh-ancestor
25549134|NCT00614484|Antimitotic Agents|antimitotic agents|mesh-ancestor
25549135|NCT00614484|Mitosis Modulators|mitosis modulators|mesh-ancestor
25549136|NCT00614484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549137|NCT00614614|Vaccines|vaccines|mesh-list
25549138|NCT00614614|Immunologic Factors|immunologic factors|mesh-ancestor
25549139|NCT00614614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549140|NCT00614822|Bevacizumab|bevacizumab|mesh-list
25549141|NCT00614822|Carboplatin|carboplatin|mesh-list
25549142|NCT00614822|Pemetrexed|pemetrexed|mesh-list
25549143|NCT00614822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25549144|NCT00614822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549145|NCT00614822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25549146|NCT00614822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25549147|NCT00614822|Growth Substances|growth substances|mesh-ancestor
25549148|NCT00614822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549149|NCT00614822|Growth Inhibitors|growth inhibitors|mesh-ancestor
25549150|NCT00614822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25549151|NCT00614822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549152|NCT00614822|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25549153|NCT00614822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25549154|NCT00614874|Rosiglitazone|rosiglitazone|mesh-list
25549155|NCT00614874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25549156|NCT00614874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549157|NCT00614926|Modafinil|modafinil|mesh-list
25549158|NCT00614926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25549159|NCT00614926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549160|NCT00614926|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25549161|NCT00614926|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25549162|NCT00614926|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25549163|NCT00614926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549164|NCT00614939|Saxagliptin|saxagliptin|mesh-list
25549165|NCT00614939|Incretins|incretins|mesh-ancestor
25549166|NCT00614939|Hormones|hormones|mesh-ancestor
25549167|NCT00614939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25549168|NCT00614939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549169|NCT00614939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25549170|NCT00614939|Protease Inhibitors|protease inhibitors|mesh-ancestor
25549171|NCT00614939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25549172|NCT00614939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549173|NCT00614939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25549174|NCT00614991|Ritonavir|ritonavir|mesh-list
25549175|NCT00614991|Fosamprenavir|fosamprenavir|mesh-list
25549176|NCT00614991|Raltegravir Potassium|raltegravir potassium|mesh-list
25549177|NCT00614991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25549178|NCT00614991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25549179|NCT00614991|Protease Inhibitors|protease inhibitors|mesh-ancestor
25549180|NCT00614991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25549181|NCT00614991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549182|NCT00614991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25549183|NCT00614991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25549184|NCT00614991|Antiviral Agents|antiviral agents|mesh-ancestor
25549185|NCT00614991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25549186|NCT00614991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25549187|NCT00614991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25549188|NCT00614991|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25549189|NCT00614991|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25549190|NCT00615030|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25549191|NCT00615030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25549192|NCT00615030|Autonomic Agents|autonomic agents|mesh-ancestor
25549193|NCT00615030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25549194|NCT00615030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549195|NCT00615030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25549196|NCT00615030|Respiratory System Agents|respiratory system agents|mesh-ancestor
25549197|NCT00615030|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25226054|NCT02623062|Antacids|antacids|mesh-ancestor
24839786|NCT02206178|Analgesics|analgesics|mesh-ancestor
25549198|NCT00615030|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25549199|NCT00615030|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25549200|NCT00615030|Adrenergic Agents|adrenergic agents|mesh-ancestor
25549201|NCT00615030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25549202|NCT00615030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549203|NCT00615056|Leucovorin|leucovorin|mesh-list
25549204|NCT00615056|Bevacizumab|bevacizumab|mesh-list
25549205|NCT00615056|Fluorouracil|fluorouracil|mesh-list
25549206|NCT00615056|Oxaliplatin|oxaliplatin|mesh-list
25549207|NCT00615056|Irinotecan|irinotecan|mesh-list
25549208|NCT00615056|Axitinib|axitinib|mesh-list
25549209|NCT00615056|Levoleucovorin|levoleucovorin|mesh-list
25549210|NCT00615056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25549211|NCT00615056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549212|NCT00615056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25549213|NCT00615056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25549214|NCT00615056|Growth Substances|growth substances|mesh-ancestor
25549215|NCT00615056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549216|NCT00615056|Growth Inhibitors|growth inhibitors|mesh-ancestor
25549217|NCT00615056|Antimetabolites|antimetabolites|mesh-ancestor
25549218|NCT00615056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549219|NCT00615056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25549220|NCT00615056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25549221|NCT00615056|Immunologic Factors|immunologic factors|mesh-ancestor
25549222|NCT00615056|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25549223|NCT00615056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25549224|NCT00615056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25549225|NCT00615056|Antidotes|antidotes|mesh-ancestor
25549226|NCT00615056|Protective Agents|protective agents|mesh-ancestor
25549227|NCT00615056|Vitamin B Complex|vitamin b complex|mesh-ancestor
25549228|NCT00615056|Vitamins|vitamins|mesh-ancestor
25549229|NCT00615056|Micronutrients|micronutrients|mesh-ancestor
25549230|NCT00615056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25549231|NCT00615199|Tofacitinib|tofacitinib|mesh-list
25549232|NCT00615199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25549233|NCT00615199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493864|NCT00492687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534689|NCT00647829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534690|NCT00647829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24534691|NCT00647829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24534692|NCT00647842|Fentanyl|fentanyl|mesh-list
24534693|NCT00647842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24534699|NCT00647842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857511|NCT02292121|Mannitol|mannitol|mesh-list
24534705|NCT00647868|Androgens|androgens|mesh-ancestor
25549234|NCT00615199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549235|NCT00615290|Tipranavir|tipranavir|mesh-list
25549236|NCT00615290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25549237|NCT00615290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25549238|NCT00615290|Antiviral Agents|antiviral agents|mesh-ancestor
25549239|NCT00615290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25549240|NCT00615433|Olanzapine|olanzapine|mesh-list
25549241|NCT00615433|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25549242|NCT00615433|Antiemetics|antiemetics|mesh-ancestor
25549243|NCT00615433|Autonomic Agents|autonomic agents|mesh-ancestor
25549244|NCT00615433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25549245|NCT00615433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549246|NCT00615433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25549247|NCT00615433|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25549248|NCT00615433|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25549249|NCT00615433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25549250|NCT00615433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25549251|NCT00615433|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25549252|NCT00615433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25549253|NCT00615433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25549254|NCT00615433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549255|NCT00615433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25549256|NCT00615433|Serotonin Agents|serotonin agents|mesh-ancestor
25549257|NCT00615433|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25549258|NCT00615433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25549259|NCT00615433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25549260|NCT00615433|Adrenergic Agents|adrenergic agents|mesh-ancestor
25549261|NCT00615433|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25549262|NCT00615433|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25549263|NCT00615433|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25549264|NCT00615433|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25549265|NCT00615433|Dopamine Agents|dopamine agents|mesh-ancestor
25549266|NCT00615459|Tiotropium Bromide|tiotropium bromide|mesh-list
25549267|NCT00615459|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25549268|NCT00615459|Autonomic Agents|autonomic agents|mesh-ancestor
25549269|NCT00615459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25549270|NCT00615459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549271|NCT00615459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25549272|NCT00615459|Respiratory System Agents|respiratory system agents|mesh-ancestor
25445025|NCT04671563|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25549273|NCT00615459|Parasympatholytics|parasympatholytics|mesh-ancestor
25549274|NCT00615459|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25549275|NCT00615459|Cholinergic Agents|cholinergic agents|mesh-ancestor
25549276|NCT00615459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25445090|NCT04670809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25445091|NCT04670809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161737|NCT02483247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161738|NCT02483247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25161739|NCT02483247|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25161740|NCT02483247|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25161741|NCT02483247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25161742|NCT02483247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25161743|NCT02483247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25161744|NCT02483247|Antimetabolites|antimetabolites|mesh-ancestor
25161745|NCT02483247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25161746|NCT02483247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25161747|NCT02483247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25161748|NCT02483247|Growth Substances|growth substances|mesh-ancestor
25161749|NCT02483247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161750|NCT02483247|Growth Inhibitors|growth inhibitors|mesh-ancestor
25161751|NCT02483247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25161753|NCT02474368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161769|NCT02467361|Pembrolizumab|pembrolizumab|mesh-list
25161770|NCT02467361|Nivolumab|nivolumab|mesh-list
25161771|NCT02467361|Ipilimumab|ipilimumab|mesh-list
25161772|NCT02467361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25161773|NCT02467361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161774|NCT02467361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25161775|NCT02467361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161776|NCT02352753|Denosumab|denosumab|mesh-list
25161777|NCT02352753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25161778|NCT02352753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161785|NCT02352558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25161786|NCT02352558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161787|NCT02352558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25161788|NCT02352558|Glucocorticoids|glucocorticoids|mesh-ancestor
25161789|NCT02352558|Hormones|hormones|mesh-ancestor
25161790|NCT02352558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25161791|NCT02352558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25161792|NCT02352558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161793|NCT02352558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25161794|NCT02352558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25161795|NCT02352558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161796|NCT02324283|Propofol|propofol|mesh-list
25161797|NCT02324283|Desflurane|desflurane|mesh-list
25161798|NCT02324283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25161799|NCT02324283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25161800|NCT02324283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161801|NCT02324283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25161802|NCT02324283|Anesthetics, General|anesthetics, general|mesh-ancestor
25161803|NCT02324283|Anesthetics|anesthetics|mesh-ancestor
25161804|NCT02324283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25040624|NCT02989597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040625|NCT02989597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25040626|NCT02989597|Glucocorticoids|glucocorticoids|mesh-ancestor
25040627|NCT02989597|Hormones|hormones|mesh-ancestor
25161805|NCT02311998|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25161806|NCT02311998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25040629|NCT02989597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25161807|NCT02311998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25822602|NCT00004573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24853443|NCT02268279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25822603|NCT00004573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822604|NCT00004573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822605|NCT00004575|Miconazole|miconazole|mesh-list
24956158|NCT03856970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956159|NCT03856970|Protective Agents|protective agents|mesh-ancestor
24956160|NCT03856970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24956161|NCT03856970|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24956162|NCT03856658|Floxuridine|floxuridine|mesh-list
24956163|NCT03856658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24956164|NCT03856658|Antimetabolites|antimetabolites|mesh-ancestor
25822606|NCT00004575|Bradykinin|bradykinin|mesh-list
25549277|NCT00615459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549278|NCT00615472|Remifentanil|remifentanil|mesh-list
25549279|NCT00615472|Propofol|propofol|mesh-list
25549281|NCT00615472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25549282|NCT00615472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25549283|NCT00615472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549284|NCT00615472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25549285|NCT00615472|Anesthetics, General|anesthetics, general|mesh-ancestor
25549286|NCT00615472|Anesthetics|anesthetics|mesh-ancestor
25549287|NCT00615472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25549288|NCT00615472|Narcotics|narcotics|mesh-ancestor
25549289|NCT00615472|Analgesics|analgesics|mesh-ancestor
25549290|NCT00615472|Sensory System Agents|sensory system agents|mesh-ancestor
25549291|NCT00615472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25549292|NCT00615472|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25549293|NCT00615550|Progesterone|progesterone|mesh-list
25549294|NCT00615550|Progestins|progestins|mesh-ancestor
25549295|NCT00615550|Hormones|hormones|mesh-ancestor
25549296|NCT00615550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25549297|NCT00615550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549298|NCT00615589|Fludarabine|fludarabine|mesh-list
25549299|NCT00615589|Busulfan|busulfan|mesh-list
25549300|NCT00615589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549301|NCT00615589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549302|NCT00615589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25549303|NCT00615589|Immunologic Factors|immunologic factors|mesh-ancestor
25549304|NCT00615589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549305|NCT00615589|Alkylating Agents|alkylating agents|mesh-ancestor
25549306|NCT00615589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25549307|NCT00615589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25549308|NCT00615784|Bexarotene|bexarotene|mesh-list
25549309|NCT00615784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549310|NCT00615836|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25549311|NCT00615836|Hemostatics|hemostatics|mesh-ancestor
25549312|NCT00615836|Coagulants|coagulants|mesh-ancestor
25549313|NCT00615836|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25549314|NCT00615836|Natriuretic Agents|natriuretic agents|mesh-ancestor
25549315|NCT00615836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549316|NCT00615901|Cyclophosphamide|cyclophosphamide|mesh-list
25549317|NCT00615901|Fluorouracil|fluorouracil|mesh-list
25549318|NCT00615901|Methotrexate|methotrexate|mesh-list
25549319|NCT00615901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25549320|NCT00615901|Immunologic Factors|immunologic factors|mesh-ancestor
25549321|NCT00615901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549322|NCT00615901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25549323|NCT00615901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25549324|NCT00615901|Alkylating Agents|alkylating agents|mesh-ancestor
25549325|NCT00615901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549326|NCT00615901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549327|NCT00615901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25549328|NCT00615901|Antimetabolites|antimetabolites|mesh-ancestor
25549329|NCT00615901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25549330|NCT00615901|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25549331|NCT00615901|Abortifacient Agents|abortifacient agents|mesh-ancestor
25549332|NCT00615901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25549333|NCT00615901|Dermatologic Agents|dermatologic agents|mesh-ancestor
25549334|NCT00615901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25549335|NCT00615901|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25549336|NCT00615901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25549337|NCT00615927|Imatinib Mesylate|imatinib mesylate|mesh-list
25549338|NCT00615927|Hydroxyurea|hydroxyurea|mesh-list
25549339|NCT00615927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549340|NCT00615927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25549341|NCT00615927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25549342|NCT00615927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461224|NCT00351507|Vildagliptin|vildagliptin|mesh-list
25549343|NCT00615927|Antisickling Agents|antisickling agents|mesh-ancestor
25549344|NCT00615927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25549345|NCT00615992|Tiotropium Bromide|tiotropium bromide|mesh-list
25549346|NCT00615992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25549347|NCT00615992|Autonomic Agents|autonomic agents|mesh-ancestor
25549348|NCT00615992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25549349|NCT00615992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549350|NCT00615992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25549351|NCT00615992|Respiratory System Agents|respiratory system agents|mesh-ancestor
25549352|NCT00615992|Parasympatholytics|parasympatholytics|mesh-ancestor
25549353|NCT00615992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25549354|NCT00615992|Cholinergic Agents|cholinergic agents|mesh-ancestor
25549355|NCT00615992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25549356|NCT00615992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549357|NCT00616018|Acetaminophen|acetaminophen|mesh-list
25549358|NCT00616018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25549359|NCT00616018|Analgesics|analgesics|mesh-ancestor
25549360|NCT00616018|Sensory System Agents|sensory system agents|mesh-ancestor
25549361|NCT00616018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25549362|NCT00616018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549363|NCT00616018|Antipyretics|antipyretics|mesh-ancestor
25549364|NCT00616109|Sunitinib|sunitinib|mesh-list
25549365|NCT00616109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549366|NCT00616109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25549367|NCT00616109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25549368|NCT00616109|Growth Substances|growth substances|mesh-ancestor
25549369|NCT00616109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549370|NCT00616109|Growth Inhibitors|growth inhibitors|mesh-ancestor
25549371|NCT00616109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25549372|NCT00616109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25549373|NCT00616109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549374|NCT00616122|Cyclophosphamide|cyclophosphamide|mesh-list
25549375|NCT00616122|Methotrexate|methotrexate|mesh-list
25549376|NCT00616122|Sunitinib|sunitinib|mesh-list
25549377|NCT00616122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25549378|NCT00616122|Immunologic Factors|immunologic factors|mesh-ancestor
25549379|NCT00616122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549380|NCT00616122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25549381|NCT00616122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25549382|NCT00616122|Alkylating Agents|alkylating agents|mesh-ancestor
25549383|NCT00616122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549384|NCT00616122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549385|NCT00616122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25549386|NCT00616122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25549387|NCT00616122|Abortifacient Agents|abortifacient agents|mesh-ancestor
25549388|NCT00616122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25549389|NCT00616122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25549390|NCT00616122|Antimetabolites|antimetabolites|mesh-ancestor
25549391|NCT00616122|Dermatologic Agents|dermatologic agents|mesh-ancestor
25549392|NCT00616122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25226119|NCT02623023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24857525|NCT02292225|Obinutuzumab|obinutuzumab|mesh-list
25043425|NCT01262001|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25549393|NCT00616122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25549394|NCT00616122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25549395|NCT00616122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25549396|NCT00616122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25549397|NCT00616122|Growth Substances|growth substances|mesh-ancestor
25549398|NCT00616122|Growth Inhibitors|growth inhibitors|mesh-ancestor
25549399|NCT00616122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25549400|NCT00616239|Salicylic Acid|salicylic acid|mesh-list
25549401|NCT00616239|Salicylates|salicylates|mesh-list
25549402|NCT00616239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25549403|NCT00616239|Antifungal Agents|antifungal agents|mesh-ancestor
25549404|NCT00616239|Keratolytic Agents|keratolytic agents|mesh-ancestor
25549405|NCT00616239|Dermatologic Agents|dermatologic agents|mesh-ancestor
25549406|NCT00616239|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25549407|NCT00616239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25549408|NCT00616239|Analgesics|analgesics|mesh-ancestor
25549409|NCT00616239|Sensory System Agents|sensory system agents|mesh-ancestor
25549410|NCT00616239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25549411|NCT00616239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549412|NCT00616239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25549413|NCT00616239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25549414|NCT00616239|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25549415|NCT00616239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25549416|NCT00616239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549417|NCT00616434|Interferons|interferons|mesh-list
25549418|NCT00616434|Interferon-beta|interferon-beta|mesh-list
25549419|NCT00616434|Interferon beta-1a|interferon beta-1a|mesh-list
24495488|NCT00500422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495489|NCT00500422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24495490|NCT00500422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25549420|NCT00616434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549421|NCT00616434|Antiviral Agents|antiviral agents|mesh-ancestor
25549422|NCT00616434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25549423|NCT00616434|Immunologic Factors|immunologic factors|mesh-ancestor
25549424|NCT00616434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549425|NCT00616434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25549426|NCT00616655|Eszopiclone|eszopiclone|mesh-list
25549427|NCT00616655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25549428|NCT00616655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25549429|NCT00616655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549431|NCT00616772|Atorvastatin|atorvastatin|mesh-list
25549432|NCT00616772|Fenofibric acid|fenofibric acid|mesh-list
25549433|NCT00616772|Fenofibrate|fenofibrate|mesh-list
25549434|NCT00616772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25549435|NCT00616772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25549436|NCT00616772|Antimetabolites|antimetabolites|mesh-ancestor
25549437|NCT00616772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549438|NCT00616772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25549439|NCT00616772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25549440|NCT00616772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25549441|NCT00616772|Lipotropic Agents|lipotropic agents|mesh-ancestor
25549442|NCT00616772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25549443|NCT00616772|Nootropic Agents|nootropic agents|mesh-ancestor
25549444|NCT00616902|Ergocalciferols|ergocalciferols|mesh-list
25549445|NCT00616902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25549446|NCT00616902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549447|NCT00616902|Vitamins|vitamins|mesh-ancestor
25549448|NCT00616902|Micronutrients|micronutrients|mesh-ancestor
25549449|NCT00616902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25549450|NCT00616941|Poly ICLC|poly iclc|mesh-list
25549451|NCT00616941|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25445234|NCT04668690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25445235|NCT04668690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25445236|NCT04668690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445237|NCT04668469|Acetaminophen|acetaminophen|mesh-list
25445238|NCT04668469|Vitamins|vitamins|mesh-list
25445239|NCT04668469|Ascorbic Acid|ascorbic acid|mesh-list
25445240|NCT04668469|Zinc|zinc|mesh-list
25445241|NCT04668469|Azithromycin|azithromycin|mesh-list
25445242|NCT04668469|Hydroxychloroquine|hydroxychloroquine|mesh-list
25445243|NCT04668469|Ivermectin|ivermectin|mesh-list
25445244|NCT04668469|Lactoferrin|lactoferrin|mesh-list
25445245|NCT04668469|Fibrin fragment D|fibrin fragment d|mesh-list
25445246|NCT04668469|Micronutrients|micronutrients|mesh-ancestor
25445247|NCT04668469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445248|NCT04668469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25445249|NCT04668469|Analgesics|analgesics|mesh-ancestor
25445250|NCT04668469|Sensory System Agents|sensory system agents|mesh-ancestor
25445251|NCT04668469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25445252|NCT04668469|Antipyretics|antipyretics|mesh-ancestor
25445253|NCT04668469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25445254|NCT04668469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25445255|NCT04668469|Antimalarials|antimalarials|mesh-ancestor
24496661|NCT00505843|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24496662|NCT00505843|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24496663|NCT00505843|Dopamine Agents|dopamine agents|mesh-ancestor
24496664|NCT00505843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24496666|NCT00505843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496936|NCT00507234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497000|NCT00507793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497001|NCT00507793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839988|NCT02206802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24839989|NCT02206802|Vasodilator Agents|vasodilator agents|mesh-ancestor
24534907|NCT00648258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534908|NCT00648258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534909|NCT00648258|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24534910|NCT00648271|Metoprolol|metoprolol|mesh-list
24534911|NCT00648271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24534912|NCT00648271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25226198|NCT02622126|Bupivacaine|bupivacaine|mesh-list
25226199|NCT02622126|Anesthetics, Local|anesthetics, local|mesh-ancestor
25226200|NCT02622126|Anesthetics|anesthetics|mesh-ancestor
25226201|NCT02622126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25226202|NCT02622126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445256|NCT04668469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25445257|NCT04668469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25549452|NCT00616941|Interferon Inducers|interferon inducers|mesh-ancestor
25549453|NCT00616941|Immunologic Factors|immunologic factors|mesh-ancestor
25549454|NCT00616941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549455|NCT00616941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25549456|NCT00617058|Metformin|metformin|mesh-list
25113408|NCT02832544|Vitamin K|vitamin k|mesh-list
25549457|NCT00617058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25549458|NCT00617058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549459|NCT00617084|Everolimus|everolimus|mesh-list
25445258|NCT04668469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25445259|NCT04668469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445260|NCT04668469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25445261|NCT04668469|Trace Elements|trace elements|mesh-ancestor
25445262|NCT04668469|Antioxidants|antioxidants|mesh-ancestor
25445263|NCT04668469|Protective Agents|protective agents|mesh-ancestor
25549460|NCT00617084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549461|NCT00617084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25549462|NCT00617084|Immunologic Factors|immunologic factors|mesh-ancestor
25030910|NCT03591757|Tolcapone|tolcapone|mesh-list
25549463|NCT00617084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549464|NCT00617097|Ketorolac|ketorolac|mesh-list
25549465|NCT00617097|Lidocaine|lidocaine|mesh-list
25549466|NCT00617097|Anesthetics, Local|anesthetics, local|mesh-ancestor
25549467|NCT00617097|Anesthetics|anesthetics|mesh-ancestor
25549468|NCT00617097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25549469|NCT00617097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549470|NCT00617097|Sensory System Agents|sensory system agents|mesh-ancestor
25549471|NCT00617097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25549472|NCT00617097|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25549473|NCT00617097|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25549474|NCT00617097|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25549475|NCT00617097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25549476|NCT00617097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549477|NCT00617097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25549478|NCT00617097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25549480|NCT00617097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25549481|NCT00617097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25549482|NCT00617097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25549483|NCT00617097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25549484|NCT00617123|Vorapaxar|vorapaxar|mesh-list
25549485|NCT00617123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25549486|NCT00617188|Fulvestrant|fulvestrant|mesh-list
25549487|NCT00617188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25549488|NCT00617188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549489|NCT00617188|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25549490|NCT00617188|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25549491|NCT00617188|Hormone Antagonists|hormone antagonists|mesh-ancestor
25549492|NCT00617188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25549493|NCT00617188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549494|NCT00617201|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25549495|NCT00617201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25549496|NCT00617201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25549497|NCT00617201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25549498|NCT00617201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549499|NCT00617201|Adrenergic Agents|adrenergic agents|mesh-ancestor
25549500|NCT00617201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25549501|NCT00617201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549502|NCT00617240|Metformin|metformin|mesh-list
25549503|NCT00617240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25549504|NCT00617240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549505|NCT00617305|Ambrisentan|ambrisentan|mesh-list
25549506|NCT00617305|Sildenafil Citrate|sildenafil citrate|mesh-list
25549507|NCT00617305|Tadalafil|tadalafil|mesh-list
25549508|NCT00617305|Vasodilator Agents|vasodilator agents|mesh-ancestor
25549509|NCT00617305|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25549510|NCT00617305|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25549511|NCT00617305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25549512|NCT00617305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549513|NCT00617305|Urological Agents|urological agents|mesh-ancestor
25549514|NCT00617305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25549515|NCT00617344|Vaccines|vaccines|mesh-list
25549516|NCT00617344|Immunologic Factors|immunologic factors|mesh-ancestor
25549517|NCT00617344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549518|NCT00617396|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25549519|NCT00617396|Antidepressive Agents|antidepressive agents|mesh-ancestor
25549520|NCT00617396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25549521|NCT00617396|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25549522|NCT00617396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25549523|NCT00617396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25549524|NCT00617396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549525|NCT00617409|Paclitaxel|paclitaxel|mesh-list
25549526|NCT00617409|Tretinoin|tretinoin|mesh-list
25549527|NCT00617409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24501311|NCT00528060|Ritonavir|ritonavir|mesh-list
25549528|NCT00617409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549529|NCT00617409|Tubulin Modulators|tubulin modulators|mesh-ancestor
25549530|NCT00617409|Antimitotic Agents|antimitotic agents|mesh-ancestor
25549531|NCT00617409|Mitosis Modulators|mitosis modulators|mesh-ancestor
25549532|NCT00617409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549533|NCT00617409|Keratolytic Agents|keratolytic agents|mesh-ancestor
25549534|NCT00617409|Dermatologic Agents|dermatologic agents|mesh-ancestor
25549535|NCT00617461|Gabapentin|gabapentin|mesh-list
25549536|NCT00617461|Analgesics|analgesics|mesh-ancestor
25549537|NCT00617461|Sensory System Agents|sensory system agents|mesh-ancestor
25549538|NCT00617461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25549539|NCT00617461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549540|NCT00617461|Anticonvulsants|anticonvulsants|mesh-ancestor
25549541|NCT00617461|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25549542|NCT00617461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25549543|NCT00617461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25549544|NCT00617461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25549545|NCT00617461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25549546|NCT00617461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25549547|NCT00617461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25549548|NCT00617461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445286|NCT04667663|Dexamethasone|dexamethasone|mesh-list
25549549|NCT00617461|Antimanic Agents|antimanic agents|mesh-ancestor
25549550|NCT00617539|Irinotecan|irinotecan|mesh-list
25549551|NCT00617539|Temozolomide|temozolomide|mesh-list
25549552|NCT00617539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25549553|NCT00617539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25549554|NCT00617539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25549555|NCT00617539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549556|NCT00617539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549557|NCT00617539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25549558|NCT00617539|Alkylating Agents|alkylating agents|mesh-ancestor
25549559|NCT00617591|Dexamethasone|dexamethasone|mesh-list
25549560|NCT00617591|Doxorubicin|doxorubicin|mesh-list
25549561|NCT00617591|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25549562|NCT00617591|Lenalidomide|lenalidomide|mesh-list
25549563|NCT00617591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25549564|NCT00617591|Antiemetics|antiemetics|mesh-ancestor
25549565|NCT00617591|Autonomic Agents|autonomic agents|mesh-ancestor
25549566|NCT00617591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25549567|NCT00617591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549568|NCT00617591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25549569|NCT00617591|Glucocorticoids|glucocorticoids|mesh-ancestor
25549570|NCT00617591|Hormones|hormones|mesh-ancestor
25549571|NCT00617591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25549572|NCT00617591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25549573|NCT00617591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549574|NCT00617591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25549575|NCT00617591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25549576|NCT00617591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25549577|NCT00617591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25549578|NCT00617591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549579|NCT00617591|Immunologic Factors|immunologic factors|mesh-ancestor
25549580|NCT00617591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24451121|NCT00322075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534978|NCT00648362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24704586|NCT01479036|Antimitotic Agents|antimitotic agents|mesh-ancestor
24534982|NCT00648388|Cilostazol|cilostazol|mesh-list
25549581|NCT00617591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25549582|NCT00617591|Growth Substances|growth substances|mesh-ancestor
25549583|NCT00617591|Growth Inhibitors|growth inhibitors|mesh-ancestor
25549584|NCT00617604|Mycophenolic Acid|mycophenolic acid|mesh-list
25549585|NCT00617604|Alefacept|alefacept|mesh-list
25549586|NCT00617604|Tacrolimus|tacrolimus|mesh-list
25549587|NCT00617604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25549588|NCT00617604|Immunologic Factors|immunologic factors|mesh-ancestor
25549589|NCT00617604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549590|NCT00617604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25549591|NCT00617604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25549592|NCT00617604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549593|NCT00617604|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25549594|NCT00617604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549595|NCT00617604|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25549596|NCT00617604|Antitubercular Agents|antitubercular agents|mesh-ancestor
25549597|NCT00617604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25549598|NCT00617604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25549599|NCT00617604|Dermatologic Agents|dermatologic agents|mesh-ancestor
25549600|NCT00617669|Docetaxel|docetaxel|mesh-list
25549601|NCT00617669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549602|NCT00617669|Tubulin Modulators|tubulin modulators|mesh-ancestor
25549603|NCT00617669|Antimitotic Agents|antimitotic agents|mesh-ancestor
25549604|NCT00617669|Mitosis Modulators|mitosis modulators|mesh-ancestor
25549605|NCT00617669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549606|NCT00617734|Cetuximab|cetuximab|mesh-list
25549607|NCT00617734|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25549608|NCT00617734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25549609|NCT00617734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549610|NCT00617734|Immunologic Factors|immunologic factors|mesh-ancestor
25549611|NCT00617734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549612|NCT00617851|Vaccines|vaccines|mesh-list
25549613|NCT00617851|Immunologic Factors|immunologic factors|mesh-ancestor
25549614|NCT00617851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549615|NCT00617890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25549616|NCT00617890|Immunologic Factors|immunologic factors|mesh-ancestor
25549617|NCT00617890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549618|NCT00617903|Azelaic acid|azelaic acid|mesh-list
25681299|NCT01861002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25681300|NCT01861002|Immunologic Factors|immunologic factors|mesh-ancestor
25681301|NCT01861002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24501961|NCT00531687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549619|NCT00617903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549620|NCT00617903|Dermatologic Agents|dermatologic agents|mesh-ancestor
25549621|NCT00617929|Rituximab|rituximab|mesh-list
25549622|NCT00617929|Clofarabine|clofarabine|mesh-list
25549623|NCT00617929|Thymoglobulin|thymoglobulin|mesh-list
25445327|NCT04667819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25549624|NCT00617929|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25549625|NCT00617929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25549626|NCT00617929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549627|NCT00617929|Immunologic Factors|immunologic factors|mesh-ancestor
25549628|NCT00617929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549629|NCT00617929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25549630|NCT00617929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25549631|NCT00617929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25549632|NCT00617929|Antimetabolites|antimetabolites|mesh-ancestor
25549633|NCT00617929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549635|NCT00617942|Carboplatin|carboplatin|mesh-list
25549636|NCT00617942|Trastuzumab|trastuzumab|mesh-list
25549637|NCT00617942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25549638|NCT00617942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549639|NCT00617942|Tubulin Modulators|tubulin modulators|mesh-ancestor
25549640|NCT00617942|Antimitotic Agents|antimitotic agents|mesh-ancestor
25549641|NCT00617942|Mitosis Modulators|mitosis modulators|mesh-ancestor
25549642|NCT00617942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549643|NCT00617942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25549644|NCT00618072|Metformin|metformin|mesh-list
25549645|NCT00618072|Rosiglitazone|rosiglitazone|mesh-list
25549646|NCT00618072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25549647|NCT00618072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549648|NCT00618332|Mometasone Furoate|mometasone furoate|mesh-list
25549649|NCT00618332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25549650|NCT00618332|Dermatologic Agents|dermatologic agents|mesh-ancestor
25549651|NCT00618332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25549652|NCT00618371|Raltegravir Potassium|raltegravir potassium|mesh-list
25549653|NCT00618371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25549654|NCT00618371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25549655|NCT00618371|Antiviral Agents|antiviral agents|mesh-ancestor
25549656|NCT00618371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25549657|NCT00618371|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25549658|NCT00618371|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25445402|NCT04666805|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25445403|NCT04666805|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25681316|NCT01862250|Clonidine|clonidine|mesh-list
25445404|NCT04666805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25445405|NCT04667117|Ofatumumab|ofatumumab|mesh-list
25445406|NCT04667117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445407|NCT04666675|Upadacitinib|upadacitinib|mesh-list
25445408|NCT04666675|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25445409|NCT04666675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25445410|NCT04666675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25445411|NCT04666675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445412|NCT04666675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25445413|NCT04666623|Esketamine|esketamine|mesh-list
25445414|NCT04666623|Antidepressive Agents|antidepressive agents|mesh-ancestor
25445415|NCT04666623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25445416|NCT04666324|Simethicone|simethicone|mesh-list
25445417|NCT04666324|Antifoaming Agents|antifoaming agents|mesh-ancestor
25445418|NCT04666324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445419|NCT04666324|Emollients|emollients|mesh-ancestor
25445420|NCT04666324|Dermatologic Agents|dermatologic agents|mesh-ancestor
25445421|NCT04666168|Cyclophosphamide|cyclophosphamide|mesh-list
25445422|NCT04666168|Fludarabine|fludarabine|mesh-list
25445433|NCT04665895|Xhance|xhance|mesh-list
25549659|NCT00618371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25549660|NCT00618371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549661|NCT00618436|Phenytoin|phenytoin|mesh-list
25549662|NCT00618436|Levetiracetam|levetiracetam|mesh-list
25549663|NCT00618436|Anticonvulsants|anticonvulsants|mesh-ancestor
25549664|NCT00618436|Nootropic Agents|nootropic agents|mesh-ancestor
25549665|NCT00618436|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25549666|NCT00618436|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25549667|NCT00618436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25549668|NCT00618436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549669|NCT00618436|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25549670|NCT00618436|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25549671|NCT00618449|Azithromycin|azithromycin|mesh-list
25549672|NCT00618449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25549673|NCT00618449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25651187|NCT01513122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25651188|NCT01513122|Antiviral Agents|antiviral agents|mesh-ancestor
25651189|NCT01513122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25651190|NCT01513122|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25549674|NCT00618540|Fludarabine|fludarabine|mesh-list
25549675|NCT00618540|Fludarabine phosphate|fludarabine phosphate|mesh-list
25549676|NCT00618540|Melphalan|melphalan|mesh-list
25549677|NCT00618540|Alemtuzumab|alemtuzumab|mesh-list
25549678|NCT00618540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549679|NCT00618540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25549680|NCT00618540|Antimetabolites|antimetabolites|mesh-ancestor
24857639|NCT02293187|Vitamin D|vitamin d|mesh-list
25549681|NCT00618540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549682|NCT00618540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25549683|NCT00618540|Immunologic Factors|immunologic factors|mesh-ancestor
25549684|NCT00618540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549685|NCT00618540|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25549686|NCT00618540|Alkylating Agents|alkylating agents|mesh-ancestor
25549687|NCT00618540|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25549688|NCT00618540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25549689|NCT00618618|Deoxycholic Acid|deoxycholic acid|mesh-list
25549690|NCT00618618|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25549691|NCT00618618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25549692|NCT00618722|Deoxycholic Acid|deoxycholic acid|mesh-list
25549693|NCT00618722|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25549694|NCT00618722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25549695|NCT00618748|Olanzapine|olanzapine|mesh-list
25549696|NCT00618748|Antiemetics|antiemetics|mesh-ancestor
25549697|NCT00618748|Autonomic Agents|autonomic agents|mesh-ancestor
25549698|NCT00618748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25549699|NCT00618748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549700|NCT00618748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25549701|NCT00618748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25549702|NCT00618748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25549703|NCT00618748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25549704|NCT00618748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25549705|NCT00618748|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25549706|NCT00618748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25549707|NCT00618748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25549708|NCT00618748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549709|NCT00618748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25031151|NCT03589898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25031152|NCT03589898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25031157|NCT03589898|Antimanic Agents|antimanic agents|mesh-ancestor
25226340|NCT02621242|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25226341|NCT02621242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25549710|NCT00618748|Serotonin Agents|serotonin agents|mesh-ancestor
25549711|NCT00618774|Amlodipine|amlodipine|mesh-list
25549712|NCT00618774|Telmisartan|telmisartan|mesh-list
25549713|NCT00618774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25549714|NCT00618774|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25549715|NCT00618774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25549716|NCT00618774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549717|NCT00618774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25549718|NCT00618774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549719|NCT00618774|Vasodilator Agents|vasodilator agents|mesh-ancestor
25549720|NCT00618774|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25549721|NCT00618774|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25549722|NCT00618813|Cyclophosphamide|cyclophosphamide|mesh-list
25549723|NCT00618813|Ifosfamide|ifosfamide|mesh-list
25549724|NCT00618813|Doxorubicin|doxorubicin|mesh-list
25549725|NCT00618813|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25549726|NCT00618813|Etoposide|etoposide|mesh-list
25549727|NCT00618813|Vincristine|vincristine|mesh-list
25549728|NCT00618813|Etoposide phosphate|etoposide phosphate|mesh-list
25549729|NCT00618813|Topotecan|topotecan|mesh-list
25549730|NCT00618813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25549731|NCT00618813|Immunologic Factors|immunologic factors|mesh-ancestor
25549732|NCT00618813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549733|NCT00618813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25549734|NCT00618813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25549735|NCT00618813|Alkylating Agents|alkylating agents|mesh-ancestor
25549736|NCT00618813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031236|NCT03589040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25549737|NCT00618813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549738|NCT00618813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25549739|NCT00618813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25549740|NCT00618813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25549741|NCT00618813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25549742|NCT00618813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25549743|NCT00618813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25549744|NCT00618813|Tubulin Modulators|tubulin modulators|mesh-ancestor
25549745|NCT00618813|Antimitotic Agents|antimitotic agents|mesh-ancestor
25549746|NCT00618813|Mitosis Modulators|mitosis modulators|mesh-ancestor
25549747|NCT00618813|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25549748|NCT00618826|Gemcitabine|gemcitabine|mesh-list
25549749|NCT00618826|Paclitaxel|paclitaxel|mesh-list
25549750|NCT00618826|Bevacizumab|bevacizumab|mesh-list
25549751|NCT00618826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25549752|NCT00618826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549753|NCT00618826|Tubulin Modulators|tubulin modulators|mesh-ancestor
25549754|NCT00618826|Antimitotic Agents|antimitotic agents|mesh-ancestor
25549755|NCT00618826|Mitosis Modulators|mitosis modulators|mesh-ancestor
25549756|NCT00618826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549757|NCT00618826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25549758|NCT00618826|Antimetabolites|antimetabolites|mesh-ancestor
25549759|NCT00618826|Antiviral Agents|antiviral agents|mesh-ancestor
25549760|NCT00618826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25549761|NCT00618826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25549762|NCT00618826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25549763|NCT00618826|Immunologic Factors|immunologic factors|mesh-ancestor
25113518|NCT02723955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25113519|NCT02723955|Antimetabolites|antimetabolites|mesh-ancestor
25226384|NCT02620800|Calcium|calcium|mesh-list
25549764|NCT00618826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549765|NCT00618826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25549766|NCT00618826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25549767|NCT00618826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25549768|NCT00618826|Growth Substances|growth substances|mesh-ancestor
25549769|NCT00618826|Growth Inhibitors|growth inhibitors|mesh-ancestor
25549770|NCT00618917|Manganese|manganese|mesh-list
25549771|NCT00618917|Paclitaxel|paclitaxel|mesh-list
25549772|NCT00618917|Carboplatin|carboplatin|mesh-list
25549773|NCT00618917|Superoxide Dismutase|superoxide dismutase|mesh-list
25549774|NCT00618917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25549775|NCT00618917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549776|NCT00618917|Tubulin Modulators|tubulin modulators|mesh-ancestor
25549777|NCT00618917|Antimitotic Agents|antimitotic agents|mesh-ancestor
25549778|NCT00618917|Mitosis Modulators|mitosis modulators|mesh-ancestor
25549779|NCT00618917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549780|NCT00618917|Trace Elements|trace elements|mesh-ancestor
25549781|NCT00618917|Micronutrients|micronutrients|mesh-ancestor
25549782|NCT00618917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549783|NCT00618917|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25549784|NCT00618917|Antioxidants|antioxidants|mesh-ancestor
25549785|NCT00618917|Protective Agents|protective agents|mesh-ancestor
25549786|NCT00618956|Milnacipran|milnacipran|mesh-list
25549787|NCT00618956|Levomilnacipran|levomilnacipran|mesh-list
25549788|NCT00618956|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25549789|NCT00618956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25549790|NCT00618956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25549791|NCT00618956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549792|NCT00618956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25549793|NCT00618956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549794|NCT00618956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25549795|NCT00618956|Analgesics|analgesics|mesh-ancestor
25549796|NCT00618956|Sensory System Agents|sensory system agents|mesh-ancestor
25549797|NCT00618956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25549798|NCT00618956|Antidepressive Agents|antidepressive agents|mesh-ancestor
25549799|NCT00618956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25549800|NCT00618982|Sorafenib|sorafenib|mesh-list
25549801|NCT00618982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549802|NCT00618982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25549803|NCT00618982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25549804|NCT00618982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549805|NCT00618995|Niacin|niacin|mesh-list
25549806|NCT00618995|Niacinamide|niacinamide|mesh-list
25549807|NCT00618995|Nicotinic Acids|nicotinic acids|mesh-list
25549808|NCT00618995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25549809|NCT00618995|Antimetabolites|antimetabolites|mesh-ancestor
25549810|NCT00618995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549811|NCT00618995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25549812|NCT00618995|Vasodilator Agents|vasodilator agents|mesh-ancestor
25549813|NCT00618995|Vitamin B Complex|vitamin b complex|mesh-ancestor
25549814|NCT00618995|Vitamins|vitamins|mesh-ancestor
25549815|NCT00618995|Micronutrients|micronutrients|mesh-ancestor
25549816|NCT00618995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549817|NCT00619060|Niacin|niacin|mesh-list
25549818|NCT00619060|Nicotinic Acids|nicotinic acids|mesh-list
25549819|NCT00619060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25549820|NCT00619060|Antimetabolites|antimetabolites|mesh-ancestor
25549821|NCT00619060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549822|NCT00619060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25549823|NCT00619060|Vasodilator Agents|vasodilator agents|mesh-ancestor
25549824|NCT00619060|Vitamin B Complex|vitamin b complex|mesh-ancestor
25549825|NCT00619060|Vitamins|vitamins|mesh-ancestor
25549826|NCT00619060|Micronutrients|micronutrients|mesh-ancestor
25549827|NCT00619060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549828|NCT00619073|Aspirin|aspirin|mesh-list
25549829|NCT00619073|Clopidogrel|clopidogrel|mesh-list
25549830|NCT00619073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25549831|NCT00619073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25549832|NCT00619073|Analgesics|analgesics|mesh-ancestor
25549833|NCT00619073|Sensory System Agents|sensory system agents|mesh-ancestor
25549834|NCT00619073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25549835|NCT00619073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549836|NCT00619073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25549837|NCT00619073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25549838|NCT00619073|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25549839|NCT00619073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25549840|NCT00619073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549841|NCT00619073|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25549842|NCT00619073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25549843|NCT00619073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25549844|NCT00619073|Antipyretics|antipyretics|mesh-ancestor
25549845|NCT00619073|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25549846|NCT00619073|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25549847|NCT00619073|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25549848|NCT00619073|Purinergic Agents|purinergic agents|mesh-ancestor
25549849|NCT00619073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25549850|NCT00619099|Decitabine|decitabine|mesh-list
25549851|NCT00619099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25549852|NCT00619099|Antimetabolites|antimetabolites|mesh-ancestor
25549853|NCT00619099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549854|NCT00619099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549855|NCT00619099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25549856|NCT00619112|Temozolomide|temozolomide|mesh-list
25549857|NCT00619112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25549858|NCT00619112|Alkylating Agents|alkylating agents|mesh-ancestor
25549859|NCT00619112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549860|NCT00619112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445610|NCT04664010|Micronutrients|micronutrients|mesh-ancestor
25445611|NCT04664010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445612|NCT04664010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445613|NCT04664010|Antiviral Agents|antiviral agents|mesh-ancestor
25445614|NCT04664010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25445615|NCT04664010|Antimetabolites|antimetabolites|mesh-ancestor
25445616|NCT04664010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445617|NCT04664010|Immunologic Factors|immunologic factors|mesh-ancestor
25445618|NCT04664010|Antioxidants|antioxidants|mesh-ancestor
25445619|NCT04664010|Protective Agents|protective agents|mesh-ancestor
25445620|NCT04664127|Valacyclovir|valacyclovir|mesh-list
25445621|NCT04664127|Antiviral Agents|antiviral agents|mesh-ancestor
25445622|NCT04664127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25445623|NCT04664088|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24857660|NCT02293330|Sensory System Agents|sensory system agents|mesh-ancestor
25445624|NCT04664088|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25445625|NCT04664088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25445626|NCT04664088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25445627|NCT04664088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445628|NCT04664088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25549861|NCT00619190|Aripiprazole|aripiprazole|mesh-list
25549862|NCT00619190|Antidepressive Agents|antidepressive agents|mesh-ancestor
25549863|NCT00619190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25549864|NCT00619190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25681369|NCT01862614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25549865|NCT00619190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25549866|NCT00619190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25549867|NCT00619190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549868|NCT00619190|Dopamine Agonists|dopamine agonists|mesh-ancestor
25549869|NCT00619190|Dopamine Agents|dopamine agents|mesh-ancestor
25549870|NCT00619190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25549871|NCT00619190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549872|NCT00619190|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25549873|NCT00619190|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25549874|NCT00619190|Serotonin Agents|serotonin agents|mesh-ancestor
25549875|NCT00619190|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25549876|NCT00619190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25549877|NCT00619190|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25549878|NCT00619190|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25549879|NCT00619229|Alprostadil|alprostadil|mesh-list
25549880|NCT00619229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25549881|NCT00619229|Vasodilator Agents|vasodilator agents|mesh-ancestor
25549882|NCT00619229|Urological Agents|urological agents|mesh-ancestor
25549883|NCT00619307|Interferon beta-1a|interferon beta-1a|mesh-list
25549884|NCT00619307|Ibuprofen|ibuprofen|mesh-list
25549885|NCT00619307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25549886|NCT00619307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25549887|NCT00619307|Analgesics|analgesics|mesh-ancestor
25549888|NCT00619307|Sensory System Agents|sensory system agents|mesh-ancestor
25549889|NCT00619307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25549890|NCT00619307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549891|NCT00619307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25549892|NCT00619307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25549893|NCT00619307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25549894|NCT00619307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25549895|NCT00619307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549896|NCT00619307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25549897|NCT00619307|Immunologic Factors|immunologic factors|mesh-ancestor
25549898|NCT00619307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549899|NCT00619307|Antiviral Agents|antiviral agents|mesh-ancestor
25549900|NCT00619307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25549901|NCT00619359|Dexamethasone|dexamethasone|mesh-list
25549902|NCT00619359|Dexamethasone acetate|dexamethasone acetate|mesh-list
25549903|NCT00619359|Ondansetron|ondansetron|mesh-list
25549904|NCT00619359|Aprepitant|aprepitant|mesh-list
25549905|NCT00619359|Fosaprepitant|fosaprepitant|mesh-list
25549906|NCT00619359|BB 1101|bb 1101|mesh-list
25549907|NCT00619359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25549908|NCT00619359|Antiemetics|antiemetics|mesh-ancestor
24553634|NCT00732446|BB 1101|bb 1101|mesh-list
24535570|NCT00649376|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24535572|NCT00649376|Histamine Antagonists|histamine antagonists|mesh-ancestor
24535573|NCT00649376|Histamine Agents|histamine agents|mesh-ancestor
24857685|NCT02293525|Sensory System Agents|sensory system agents|mesh-ancestor
24857686|NCT02293525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24460188|NCT00347685|Narcotics|narcotics|mesh-ancestor
24535594|NCT00649415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535595|NCT00649415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25549909|NCT00619359|Autonomic Agents|autonomic agents|mesh-ancestor
25549910|NCT00619359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25549911|NCT00619359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549912|NCT00619359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25549913|NCT00619359|Glucocorticoids|glucocorticoids|mesh-ancestor
25549914|NCT00619359|Hormones|hormones|mesh-ancestor
25549915|NCT00619359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25549916|NCT00619359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25549917|NCT00619359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549918|NCT00619359|Protease Inhibitors|protease inhibitors|mesh-ancestor
25549919|NCT00619359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25549920|NCT00619359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549921|NCT00619359|Antipruritics|antipruritics|mesh-ancestor
25549922|NCT00619359|Dermatologic Agents|dermatologic agents|mesh-ancestor
25549923|NCT00619359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25549924|NCT00619359|Serotonin Agents|serotonin agents|mesh-ancestor
25549925|NCT00619359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25549926|NCT00619359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25549927|NCT00619359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25549928|NCT00619359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25549929|NCT00619359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25549930|NCT00619359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24503646|NCT00532519|Citalopram|citalopram|mesh-list
25226653|NCT02619578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226654|NCT02619578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25226655|NCT02619578|Anesthetics, General|anesthetics, general|mesh-ancestor
25226656|NCT02619578|Anesthetics|anesthetics|mesh-ancestor
25226657|NCT02619578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25226658|NCT02619578|Narcotics|narcotics|mesh-ancestor
25226659|NCT02619578|Analgesics|analgesics|mesh-ancestor
25549931|NCT00619359|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25549932|NCT00619476|Gabapentin|gabapentin|mesh-list
25549933|NCT00619476|Analgesics|analgesics|mesh-ancestor
25549934|NCT00619476|Sensory System Agents|sensory system agents|mesh-ancestor
25549935|NCT00619476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25549936|NCT00619476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549937|NCT00619476|Anticonvulsants|anticonvulsants|mesh-ancestor
25549938|NCT00619476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25549939|NCT00619476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25549940|NCT00619476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25549941|NCT00619476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25549942|NCT00619476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25549943|NCT00619476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25549944|NCT00619476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25549945|NCT00619476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549946|NCT00619476|Antimanic Agents|antimanic agents|mesh-ancestor
25549947|NCT00619489|Vedolizumab|vedolizumab|mesh-list
25549948|NCT00619489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25549949|NCT00619619|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25549950|NCT00619619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25549951|NCT00619619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25031874|NCT03585374|Acetaminophen|acetaminophen|mesh-list
25113570|NCT02568566|Vaccines|vaccines|mesh-list
25549952|NCT00619619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25549953|NCT00619619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445680|NCT04663269|Hormones|hormones|mesh-ancestor
25549954|NCT00619619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24504051|NCT00533923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25549955|NCT00619619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549956|NCT00619619|Antidepressive Agents|antidepressive agents|mesh-ancestor
25549957|NCT00619619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25549958|NCT00619645|Cyclosporine|cyclosporine|mesh-list
25549959|NCT00619645|Mycophenolic Acid|mycophenolic acid|mesh-list
25549960|NCT00619645|Fludarabine|fludarabine|mesh-list
25549961|NCT00619645|Fludarabine phosphate|fludarabine phosphate|mesh-list
25549963|NCT00619645|Cyclosporins|cyclosporins|mesh-list
25549964|NCT00619645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549965|NCT00619645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25549966|NCT00619645|Antimetabolites|antimetabolites|mesh-ancestor
25549967|NCT00619645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549968|NCT00619645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25549969|NCT00619645|Immunologic Factors|immunologic factors|mesh-ancestor
25549970|NCT00619645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549971|NCT00619645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25549972|NCT00619645|Antifungal Agents|antifungal agents|mesh-ancestor
25549973|NCT00619645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24841139|NCT02214381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24535787|NCT00649688|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24535788|NCT00649688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24535789|NCT00649688|Adrenergic Agents|adrenergic agents|mesh-ancestor
24535790|NCT00649688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24857707|NCT02293668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24857708|NCT02293668|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25549974|NCT00619645|Dermatologic Agents|dermatologic agents|mesh-ancestor
25549975|NCT00619645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25549976|NCT00619645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25549977|NCT00619645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25549978|NCT00619645|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25549979|NCT00619645|Antitubercular Agents|antitubercular agents|mesh-ancestor
25549980|NCT00619645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25549981|NCT00619645|Alkylating Agents|alkylating agents|mesh-ancestor
25549982|NCT00619645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25549983|NCT00619645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25549984|NCT00619684|Lenalidomide|lenalidomide|mesh-list
25549985|NCT00619684|Immunologic Factors|immunologic factors|mesh-ancestor
25549986|NCT00619684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25549987|NCT00619684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25549988|NCT00619684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25549989|NCT00619684|Growth Substances|growth substances|mesh-ancestor
25549990|NCT00619684|Growth Inhibitors|growth inhibitors|mesh-ancestor
25549991|NCT00619684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25549992|NCT00619723|Choline|choline|mesh-list
25549993|NCT00619723|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
25549994|NCT00619723|Lipotropic Agents|lipotropic agents|mesh-ancestor
25549995|NCT00619723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25549996|NCT00619723|Antimetabolites|antimetabolites|mesh-ancestor
25549997|NCT00619723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25549998|NCT00619723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25549999|NCT00619723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25550000|NCT00619723|Nootropic Agents|nootropic agents|mesh-ancestor
25550001|NCT00619801|Levocetirizine|levocetirizine|mesh-list
25550002|NCT00619801|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25550003|NCT00619801|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25550004|NCT00619801|Histamine Antagonists|histamine antagonists|mesh-ancestor
25550005|NCT00619801|Histamine Agents|histamine agents|mesh-ancestor
25550006|NCT00619801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25550007|NCT00619801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550008|NCT00619801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550009|NCT00619892|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25550010|NCT00619892|Antidepressive Agents|antidepressive agents|mesh-ancestor
25550011|NCT00619892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25550012|NCT00619892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25550013|NCT00619892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25550014|NCT00619892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25550015|NCT00619892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550016|NCT00619957|Risedronic Acid|risedronic acid|mesh-list
25550017|NCT00619957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25550018|NCT00619957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25550019|NCT00619957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550020|NCT00619957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25550021|NCT00619957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550022|NCT00619957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25550023|NCT00619970|Rifaximin|rifaximin|mesh-list
25550024|NCT00619970|Lactulose|lactulose|mesh-list
25550025|NCT00619970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25550026|NCT00619970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25550027|NCT00619970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25550028|NCT00619983|Gabapentin|gabapentin|mesh-list
25550029|NCT00619983|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25550030|NCT00619983|Donepezil|donepezil|mesh-list
25550031|NCT00619983|Analgesics|analgesics|mesh-ancestor
25550032|NCT00619983|Sensory System Agents|sensory system agents|mesh-ancestor
25550033|NCT00619983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24504816|NCT00538265|Tacrolimus|tacrolimus|mesh-list
25550034|NCT00619983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550035|NCT00619983|Anticonvulsants|anticonvulsants|mesh-ancestor
25550036|NCT00619983|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25550037|NCT00619983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25550038|NCT00619983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25550039|NCT00619983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25550040|NCT00619983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25550041|NCT00619983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25550042|NCT00619983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25550043|NCT00619983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550044|NCT00619983|Antimanic Agents|antimanic agents|mesh-ancestor
25550045|NCT00619983|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25550046|NCT00619983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25550047|NCT00619983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25550048|NCT00619983|Antidepressive Agents|antidepressive agents|mesh-ancestor
25550049|NCT00619983|Dopamine Agents|dopamine agents|mesh-ancestor
25550050|NCT00619983|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25550051|NCT00619983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550052|NCT00619983|Cholinergic Agents|cholinergic agents|mesh-ancestor
25550053|NCT00619983|Nootropic Agents|nootropic agents|mesh-ancestor
25550054|NCT00620061|Lubiprostone|lubiprostone|mesh-list
25550055|NCT00620061|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25550056|NCT00620061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25550057|NCT00620061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550058|NCT00620074|Voriconazole|voriconazole|mesh-list
25550059|NCT00620074|Anidulafungin|anidulafungin|mesh-list
25550060|NCT00620074|Antifungal Agents|antifungal agents|mesh-ancestor
25550061|NCT00620074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25550062|NCT00620074|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25550063|NCT00620074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25550064|NCT00620074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550065|NCT00620074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550066|NCT00620074|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25550067|NCT00620074|Hormone Antagonists|hormone antagonists|mesh-ancestor
25550068|NCT00620074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25550069|NCT00620074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550070|NCT00620074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25550071|NCT00620113|Vitamin D|vitamin d|mesh-list
25550072|NCT00620113|Cholecalciferol|cholecalciferol|mesh-list
25550073|NCT00620113|Calcium Carbonate|calcium carbonate|mesh-list
25550074|NCT00620113|Calcium|calcium|mesh-list
25550075|NCT00620113|Vitamins|vitamins|mesh-ancestor
25550076|NCT00620113|Micronutrients|micronutrients|mesh-ancestor
25550077|NCT00620113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550078|NCT00620113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25550079|NCT00620113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25550080|NCT00620113|Antacids|antacids|mesh-ancestor
25550081|NCT00620113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550082|NCT00620113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25550083|NCT00620191|Metformin|metformin|mesh-list
25550084|NCT00620191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25550085|NCT00620191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550086|NCT00620282|Liraglutide|liraglutide|mesh-list
25550087|NCT00620282|Glimepiride|glimepiride|mesh-list
25550088|NCT00620282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25113632|NCT02428192|Nivolumab|nivolumab|mesh-list
25550089|NCT00620282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550090|NCT00620282|Incretins|incretins|mesh-ancestor
25550091|NCT00620282|Hormones|hormones|mesh-ancestor
25550092|NCT00620282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25550093|NCT00620282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25550094|NCT00620282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25550095|NCT00620282|Immunologic Factors|immunologic factors|mesh-ancestor
25550096|NCT00620321|Cytarabine|cytarabine|mesh-list
25550097|NCT00620321|Idarubicin|idarubicin|mesh-list
25550098|NCT00620321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25550099|NCT00620321|Antimetabolites|antimetabolites|mesh-ancestor
25550100|NCT00620321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550101|NCT00620321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25550102|NCT00620321|Antiviral Agents|antiviral agents|mesh-ancestor
25550103|NCT00620321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25550104|NCT00620321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24989219|NCT04245423|Narcotics|narcotics|mesh-ancestor
25550105|NCT00620321|Immunologic Factors|immunologic factors|mesh-ancestor
25445867|NCT04661475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445868|NCT04661345|Coagulase|coagulase|mesh-list
25445869|NCT04661345|Coagulants|coagulants|mesh-ancestor
25445870|NCT04660773|Pregabalin|pregabalin|mesh-list
25445871|NCT04660773|Analgesics|analgesics|mesh-ancestor
25445872|NCT04660773|Sensory System Agents|sensory system agents|mesh-ancestor
25445873|NCT04660773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25445874|NCT04660773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445875|NCT04660773|Anticonvulsants|anticonvulsants|mesh-ancestor
25445876|NCT04660773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25445877|NCT04660773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25445878|NCT04660773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445879|NCT04660773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25445880|NCT04660773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25445881|NCT04660773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25445882|NCT04660773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25445883|NCT04660773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25445884|NCT04660916|Isotretinoin|isotretinoin|mesh-list
25445885|NCT04660916|Dermatologic Agents|dermatologic agents|mesh-ancestor
25445886|NCT04660786|Vitamin D|vitamin d|mesh-list
25445887|NCT04660786|Triamcinolone|triamcinolone|mesh-list
25445888|NCT04660786|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25445889|NCT04660786|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25445890|NCT04660786|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25445891|NCT04660786|Vitamins|vitamins|mesh-ancestor
25445892|NCT04660786|Micronutrients|micronutrients|mesh-ancestor
25445893|NCT04660786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445894|NCT04660786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25445895|NCT04660786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25445896|NCT04660786|Glucocorticoids|glucocorticoids|mesh-ancestor
25445897|NCT04660786|Hormones|hormones|mesh-ancestor
25445898|NCT04660786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25445899|NCT04660786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25445900|NCT04660786|Immunologic Factors|immunologic factors|mesh-ancestor
25445901|NCT04660786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25445902|NCT04660786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550106|NCT00620321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550107|NCT00620321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25550108|NCT00620321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25550109|NCT00620321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25550110|NCT00620321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550111|NCT00620373|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
25550112|NCT00620373|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25550113|NCT00620373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550114|NCT00620425|Sumatriptan|sumatriptan|mesh-list
25550115|NCT00620425|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25550116|NCT00620425|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25550117|NCT00620425|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25550118|NCT00620425|Serotonin Agents|serotonin agents|mesh-ancestor
25550119|NCT00620425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25550120|NCT00620425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550121|NCT00620425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550122|NCT00620542|Atorvastatin|atorvastatin|mesh-list
25550123|NCT00620542|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25550124|NCT00620542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25550125|NCT00620542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25550126|NCT00620542|Antimetabolites|antimetabolites|mesh-ancestor
25550127|NCT00620542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550128|NCT00620542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25550129|NCT00620542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25550130|NCT00620542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550131|NCT00620555|Gabapentin|gabapentin|mesh-list
25550132|NCT00620555|Analgesics|analgesics|mesh-ancestor
25550133|NCT00620555|Sensory System Agents|sensory system agents|mesh-ancestor
25550134|NCT00620555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25550135|NCT00620555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550136|NCT00620555|Anticonvulsants|anticonvulsants|mesh-ancestor
25550137|NCT00620555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25550138|NCT00620555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25550139|NCT00620555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25550140|NCT00620555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25550141|NCT00620555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25550142|NCT00620555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25550143|NCT00620555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25550144|NCT00620555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550145|NCT00620555|Antimanic Agents|antimanic agents|mesh-ancestor
25550147|NCT00620659|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25550148|NCT00620659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550149|NCT00620659|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25550150|NCT00620659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25550151|NCT00620659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25550152|NCT00620659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550153|NCT00620750|Naltrexone|naltrexone|mesh-list
25550154|NCT00620750|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25550155|NCT00620750|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25550156|NCT00620750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550157|NCT00620750|Sensory System Agents|sensory system agents|mesh-ancestor
25550158|NCT00620750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25550159|NCT00620776|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25550160|NCT00620776|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25550161|NCT00620776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25550162|NCT00620776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25550163|NCT00620776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550164|NCT00620776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25550165|NCT00620776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550166|NCT00620776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25550167|NCT00620776|Antidepressive Agents|antidepressive agents|mesh-ancestor
25550168|NCT00620776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25550169|NCT00620815|Vaccines|vaccines|mesh-list
25550170|NCT00620815|MF59 oil emulsion|mf59 oil emulsion|mesh-list
25550171|NCT00620815|Immunologic Factors|immunologic factors|mesh-ancestor
25550172|NCT00620815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550173|NCT00620815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25550174|NCT00620854|Calcitonin|calcitonin|mesh-list
25550175|NCT00620854|Salmon calcitonin|salmon calcitonin|mesh-list
25550176|NCT00620854|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
25550177|NCT00620854|Katacalcin|katacalcin|mesh-list
25550178|NCT00620854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25550179|NCT00620854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550180|NCT00620854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25550181|NCT00620854|Vasodilator Agents|vasodilator agents|mesh-ancestor
25550182|NCT00620945|Phenoxybenzamine|phenoxybenzamine|mesh-list
25550183|NCT00620945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25550184|NCT00620945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25550185|NCT00620945|Adrenergic Agents|adrenergic agents|mesh-ancestor
25550186|NCT00620945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25550187|NCT00620945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550188|NCT00620945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550189|NCT00620945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25550190|NCT00620945|Vasodilator Agents|vasodilator agents|mesh-ancestor
25550191|NCT00621023|Ascorbic Acid|ascorbic acid|mesh-list
25550192|NCT00621023|Decitabine|decitabine|mesh-list
25550193|NCT00621023|Arsenic Trioxide|arsenic trioxide|mesh-list
25550194|NCT00621023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25550195|NCT00621023|Antimetabolites|antimetabolites|mesh-ancestor
25550196|NCT00621023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550197|NCT00621023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25550198|NCT00621023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550199|NCT00621023|Antioxidants|antioxidants|mesh-ancestor
25550200|NCT00621023|Protective Agents|protective agents|mesh-ancestor
25550201|NCT00621023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550202|NCT00621023|Vitamins|vitamins|mesh-ancestor
25550203|NCT00621023|Micronutrients|micronutrients|mesh-ancestor
25550204|NCT00621049|Bevacizumab|bevacizumab|mesh-list
25550205|NCT00621049|Carboplatin|carboplatin|mesh-list
25550206|NCT00621049|Docetaxel|docetaxel|mesh-list
25550207|NCT00621049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25550208|NCT00621049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25550209|NCT00621049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25550210|NCT00621049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25550211|NCT00621049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25445903|NCT04660643|Tirzepatide|tirzepatide|mesh-list
25550212|NCT00621049|Growth Substances|growth substances|mesh-ancestor
25550213|NCT00621049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550214|NCT00621049|Growth Inhibitors|growth inhibitors|mesh-ancestor
25550215|NCT00621049|Tubulin Modulators|tubulin modulators|mesh-ancestor
25550216|NCT00621049|Antimitotic Agents|antimitotic agents|mesh-ancestor
25550217|NCT00621049|Mitosis Modulators|mitosis modulators|mesh-ancestor
25550218|NCT00621049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550219|NCT00621049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25550220|NCT00621049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550221|NCT00621140|Linagliptin|linagliptin|mesh-list
25550222|NCT00621140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25550223|NCT00621140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550224|NCT00621140|Incretins|incretins|mesh-ancestor
25550225|NCT00621140|Hormones|hormones|mesh-ancestor
25550226|NCT00621140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25550227|NCT00621140|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25550228|NCT00621140|Protease Inhibitors|protease inhibitors|mesh-ancestor
25550229|NCT00621140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550230|NCT00621140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550231|NCT00621153|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25550232|NCT00621153|Candesartan|candesartan|mesh-list
25550233|NCT00621153|Candesartan cilexetil|candesartan cilexetil|mesh-list
24536903|NCT00652860|Doxorubicin|doxorubicin|mesh-list
25550234|NCT00621153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25550235|NCT00621153|Diuretics|diuretics|mesh-ancestor
25550236|NCT00621153|Natriuretic Agents|natriuretic agents|mesh-ancestor
25550237|NCT00621153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550238|NCT00621153|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25550239|NCT00621153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25550240|NCT00621153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550241|NCT00621153|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25550242|NCT00621153|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25550243|NCT00621179|Leuprolide|leuprolide|mesh-list
25550244|NCT00621179|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25550245|NCT00621179|Fertility Agents|fertility agents|mesh-ancestor
25550246|NCT00621179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25550247|NCT00621179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550248|NCT00621179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25550249|NCT00621179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25550250|NCT00621192|Meropenem|meropenem|mesh-list
25550251|NCT00621192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25550252|NCT00621192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25550253|NCT00621244|Panobinostat|panobinostat|mesh-list
25550254|NCT00621244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25550255|NCT00621244|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25550256|NCT00621244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550257|NCT00621244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550258|NCT00621257|Vitamin D|vitamin d|mesh-list
25550259|NCT00621257|Ergocalciferols|ergocalciferols|mesh-list
25550260|NCT00621257|Cholecalciferol|cholecalciferol|mesh-list
25550261|NCT00621257|Vitamins|vitamins|mesh-list
25550262|NCT00621257|Micronutrients|micronutrients|mesh-ancestor
25550263|NCT00621257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550264|NCT00621257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25550265|NCT00621257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25550266|NCT00621309|Rifampin|rifampin|mesh-list
25550267|NCT00621309|Rifamycins|rifamycins|mesh-list
25550268|NCT00621309|Sulforaphane|sulforaphane|mesh-list
25550269|NCT00621309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25550270|NCT00621309|Antitubercular Agents|antitubercular agents|mesh-ancestor
25550271|NCT00621309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25550272|NCT00621309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25550273|NCT00621309|Leprostatic Agents|leprostatic agents|mesh-ancestor
25550274|NCT00621309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25550275|NCT00621309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550276|NCT00621309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550277|NCT00621309|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25550278|NCT00621309|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25550279|NCT00621309|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25550280|NCT00621309|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25550281|NCT00621309|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25550282|NCT00621309|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25550283|NCT00621309|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25550284|NCT00621309|Protective Agents|protective agents|mesh-ancestor
25445993|NCT04659499|Paclitaxel|paclitaxel|mesh-list
25550285|NCT00621309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550286|NCT00621309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25550287|NCT00621322|Vaccines|vaccines|mesh-list
25550288|NCT00621322|Immunologic Factors|immunologic factors|mesh-ancestor
25550289|NCT00621322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550290|NCT00621504|Clarithromycin|clarithromycin|mesh-list
25550291|NCT00621504|Ceftriaxone|ceftriaxone|mesh-list
25550292|NCT00621504|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
25550293|NCT00621504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25550294|NCT00621504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25550295|NCT00621504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25550296|NCT00621504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24629600|NCT01106547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25550297|NCT00621504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550298|NCT00621504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25550299|NCT00621504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25550300|NCT00621517|Bupropion|bupropion|mesh-list
25550301|NCT00621517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25550302|NCT00621517|Antidepressive Agents|antidepressive agents|mesh-ancestor
25550303|NCT00621517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25550304|NCT00621517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25550305|NCT00621517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25550306|NCT00621517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25550307|NCT00621517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550308|NCT00621517|Dopamine Agents|dopamine agents|mesh-ancestor
25550309|NCT00621517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25550310|NCT00621517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550311|NCT00621517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25550312|NCT00621517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25550313|NCT00621517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550314|NCT00621530|Ketorolac|ketorolac|mesh-list
25550315|NCT00621530|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25550316|NCT00621530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25550317|NCT00621530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25550318|NCT00621530|Analgesics|analgesics|mesh-ancestor
25550319|NCT00621530|Sensory System Agents|sensory system agents|mesh-ancestor
25550320|NCT00621530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25550321|NCT00621530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550322|NCT00621530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25550323|NCT00621530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25550324|NCT00621530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25550325|NCT00621530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550326|NCT00621530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550327|NCT00621543|Copper|copper|mesh-list
25550328|NCT00621543|Levonorgestrel|levonorgestrel|mesh-list
25550329|NCT00621543|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25550330|NCT00621543|Contraceptive Agents|contraceptive agents|mesh-ancestor
25550331|NCT00621543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25550332|NCT00621543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550333|NCT00621543|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25550334|NCT00621543|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24630102|NCT01109511|Oxycodone|oxycodone|mesh-list
25226964|NCT02617459|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25226965|NCT02617459|Adrenergic Agents|adrenergic agents|mesh-ancestor
25550335|NCT00621543|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25550336|NCT00621543|Trace Elements|trace elements|mesh-ancestor
25550337|NCT00621543|Micronutrients|micronutrients|mesh-ancestor
25550338|NCT00621686|Bevacizumab|bevacizumab|mesh-list
25550339|NCT00621686|Sorafenib|sorafenib|mesh-list
25550340|NCT00621686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25550341|NCT00621686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25550342|NCT00621686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25550343|NCT00621686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25550344|NCT00621686|Growth Substances|growth substances|mesh-ancestor
25550345|NCT00621686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550346|NCT00621686|Growth Inhibitors|growth inhibitors|mesh-ancestor
25550347|NCT00621686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25550348|NCT00621686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550349|NCT00621686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550350|NCT00621764|Vaccines|vaccines|mesh-list
25550351|NCT00621764|Immunologic Factors|immunologic factors|mesh-ancestor
25550352|NCT00621764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550353|NCT00621777|Varenicline|varenicline|mesh-list
25550354|NCT00621777|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25550355|NCT00621777|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25550356|NCT00621777|Cholinergic Agents|cholinergic agents|mesh-ancestor
25550357|NCT00621777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25651191|NCT01513122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24630254|NCT01110590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630321|NCT01110824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24630322|NCT01110824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25299974|NCT00584246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25299975|NCT00584246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548504|NCT00709982|Folic Acid|folic acid|mesh-list
24548505|NCT00709982|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24548506|NCT00709982|Norgestimate|norgestimate|mesh-list
24548507|NCT00709982|Estradiol|estradiol|mesh-list
24548508|NCT00709982|Estrogens|estrogens|mesh-ancestor
24548509|NCT00709982|Hormones|hormones|mesh-ancestor
24548510|NCT00709982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25822607|NCT00004575|Kininogens|kininogens|mesh-list
25822608|NCT00004575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822609|NCT00004575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822610|NCT00004575|Antifungal Agents|antifungal agents|mesh-ancestor
25822611|NCT00004575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25822612|NCT00004575|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24630400|NCT01111513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24630401|NCT01111591|Celecoxib|celecoxib|mesh-list
24630402|NCT01111591|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
24537257|NCT00654108|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24537258|NCT00654108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24537260|NCT00654108|Protective Agents|protective agents|mesh-ancestor
25822613|NCT00004575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25822614|NCT00004575|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25822615|NCT00004575|Hormone Antagonists|hormone antagonists|mesh-ancestor
25822616|NCT00004575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25822617|NCT00004575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822618|NCT00004575|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25822619|NCT00004575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25822620|NCT00004575|Vasodilator Agents|vasodilator agents|mesh-ancestor
25822621|NCT00004575|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25822622|NCT00004575|Protease Inhibitors|protease inhibitors|mesh-ancestor
24548581|NCT00710268|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24548583|NCT00710268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548584|NCT00710320|Anesthetics|anesthetics|mesh-list
24548585|NCT00710320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24548586|NCT00710320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548588|NCT00710359|Vitamin B 12|vitamin b 12|mesh-list
24548589|NCT00710359|Hydroxocobalamin|hydroxocobalamin|mesh-list
24548590|NCT00710359|Vitamin B Complex|vitamin b complex|mesh-list
24548591|NCT00710359|Micronutrients|micronutrients|mesh-ancestor
24548609|NCT00710528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24548610|NCT00710528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548611|NCT00710528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169537|NCT01825980|Protease Inhibitors|protease inhibitors|mesh-ancestor
24548636|NCT00710827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24548637|NCT00710827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548638|NCT00711074|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
24548639|NCT00711074|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24548640|NCT00711074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548642|NCT00711074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24548696|NCT00711698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24548697|NCT00711789|Angiotensin II|angiotensin ii|mesh-list
25822623|NCT00004578|Ritonavir|ritonavir|mesh-list
25822624|NCT00004578|Lopinavir|lopinavir|mesh-list
24916103|NCT04244695|Hormones|hormones|mesh-ancestor
24978140|NCT05178745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24978142|NCT05178745|Growth Substances|growth substances|mesh-ancestor
24978143|NCT05178745|Growth Inhibitors|growth inhibitors|mesh-ancestor
24978145|NCT05178511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978146|NCT05178511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24978147|NCT05178511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227010|NCT02617485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25227011|NCT02617485|Tubulin Modulators|tubulin modulators|mesh-ancestor
25227012|NCT02617485|Antimitotic Agents|antimitotic agents|mesh-ancestor
25227013|NCT02617485|Mitosis Modulators|mitosis modulators|mesh-ancestor
25227014|NCT02617121|Gabapentin|gabapentin|mesh-list
25227015|NCT02617121|Ramosetron|ramosetron|mesh-list
25227016|NCT02617121|Analgesics|analgesics|mesh-ancestor
25227017|NCT02617121|Sensory System Agents|sensory system agents|mesh-ancestor
25227018|NCT02617121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857785|NCT02294071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24857786|NCT02294071|Analgesics|analgesics|mesh-ancestor
24978148|NCT05178511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978149|NCT05177926|Tenofovir|tenofovir|mesh-list
24978150|NCT05177926|Antiviral Agents|antiviral agents|mesh-list
25822625|NCT00004578|Lamivudine|lamivudine|mesh-list
24458289|NCT00337376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24418529|NCT00209742|Leucovorin|leucovorin|mesh-list
24418530|NCT00209742|polysaccharide-K|polysaccharide-k|mesh-list
25550358|NCT00621777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550359|NCT00621777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550360|NCT00621842|Lamotrigine|lamotrigine|mesh-list
24418580|NCT00209807|Reboxetine|reboxetine|mesh-list
25550361|NCT00621842|Anticonvulsants|anticonvulsants|mesh-list
25550362|NCT00621842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25550363|NCT00621842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25550364|NCT00621842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550365|NCT00621842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25550366|NCT00621842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550367|NCT00621842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25550368|NCT00621842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25550369|NCT00621842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25550370|NCT00621842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25550371|NCT00621842|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25550372|NCT00621855|Dabigatran|dabigatran|mesh-list
25550373|NCT00621855|Antithrombins|antithrombins|mesh-ancestor
25550374|NCT00621855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25550375|NCT00621855|Protease Inhibitors|protease inhibitors|mesh-ancestor
24537898|NCT00656695|Immunologic Factors|immunologic factors|mesh-ancestor
24537899|NCT00656695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537900|NCT00656695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24537953|NCT00656864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24537954|NCT00656864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537955|NCT00656929|Vitamin D|vitamin d|mesh-list
24537956|NCT00656929|Cholecalciferol|cholecalciferol|mesh-list
24537957|NCT00656929|Vitamins|vitamins|mesh-ancestor
24537958|NCT00656929|Micronutrients|micronutrients|mesh-ancestor
24537959|NCT00656929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537960|NCT00656929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24537962|NCT00657007|Belimumab|belimumab|mesh-list
25550376|NCT00621855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550377|NCT00621855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550378|NCT00621855|Anticoagulants|anticoagulants|mesh-ancestor
25550379|NCT00621946|Dexetimide|dexetimide|mesh-list
25550380|NCT00621946|Citalopram|citalopram|mesh-list
25550381|NCT00621946|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25550382|NCT00621946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25550383|NCT00621946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25550384|NCT00621946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550385|NCT00621946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25550386|NCT00621946|Serotonin Agents|serotonin agents|mesh-ancestor
25550387|NCT00621946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550388|NCT00621946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25550389|NCT00621946|Antidepressive Agents|antidepressive agents|mesh-ancestor
25550390|NCT00621946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25550391|NCT00621946|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25550392|NCT00621946|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25550393|NCT00621946|Parasympatholytics|parasympatholytics|mesh-ancestor
25550394|NCT00621946|Autonomic Agents|autonomic agents|mesh-ancestor
24857800|NCT02294084|Incretins|incretins|mesh-ancestor
25550395|NCT00621946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25550396|NCT00621946|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25550397|NCT00621946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25550398|NCT00621946|Cholinergic Agents|cholinergic agents|mesh-ancestor
25550399|NCT00621959|Levocetirizine|levocetirizine|mesh-list
25550400|NCT00621959|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25550401|NCT00621959|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25550402|NCT00621959|Histamine Antagonists|histamine antagonists|mesh-ancestor
25550403|NCT00621959|Histamine Agents|histamine agents|mesh-ancestor
25550404|NCT00621959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25550405|NCT00621959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550406|NCT00621959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550407|NCT00621985|Dexamethasone|dexamethasone|mesh-list
25550408|NCT00621985|Hydrocortisone|hydrocortisone|mesh-list
25550409|NCT00621985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25550410|NCT00621985|Antiemetics|antiemetics|mesh-ancestor
25550411|NCT00621985|Autonomic Agents|autonomic agents|mesh-ancestor
25550412|NCT00621985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25550413|NCT00621985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550414|NCT00621985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25550415|NCT00621985|Glucocorticoids|glucocorticoids|mesh-ancestor
25550416|NCT00621985|Hormones|hormones|mesh-ancestor
25550417|NCT00621985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25550418|NCT00621985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25550419|NCT00621985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25550420|NCT00622284|Glimepiride|glimepiride|mesh-list
25550421|NCT00622284|Linagliptin|linagliptin|mesh-list
25550422|NCT00622284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25550423|NCT00622284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25550424|NCT00622284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550425|NCT00622284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25550426|NCT00622284|Immunologic Factors|immunologic factors|mesh-ancestor
25550427|NCT00622284|Incretins|incretins|mesh-ancestor
25550428|NCT00622284|Hormones|hormones|mesh-ancestor
25550429|NCT00622284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25550430|NCT00622284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25550431|NCT00622284|Protease Inhibitors|protease inhibitors|mesh-ancestor
25550432|NCT00622284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550433|NCT00622284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550434|NCT00622336|Lenalidomide|lenalidomide|mesh-list
25550435|NCT00622336|Immunologic Factors|immunologic factors|mesh-ancestor
25550436|NCT00622336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550437|NCT00622336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25550438|NCT00622336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25550439|NCT00622336|Growth Substances|growth substances|mesh-ancestor
25550440|NCT00622336|Growth Inhibitors|growth inhibitors|mesh-ancestor
25550441|NCT00622336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25550442|NCT00622388|Ofatumumab|ofatumumab|mesh-list
25550443|NCT00622388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25550444|NCT00622401|Interleukin-12|interleukin-12|mesh-list
25550445|NCT00622401|Vaccines|vaccines|mesh-list
25550446|NCT00622401|Immunologic Factors|immunologic factors|mesh-ancestor
25550447|NCT00622401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550448|NCT00622401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25550449|NCT00622401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25550450|NCT00622401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25550451|NCT00622401|Growth Substances|growth substances|mesh-ancestor
25550452|NCT00622401|Growth Inhibitors|growth inhibitors|mesh-ancestor
25550453|NCT00622401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25550454|NCT00622466|Paclitaxel|paclitaxel|mesh-list
25550455|NCT00622466|Sorafenib|sorafenib|mesh-list
25550456|NCT00622466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25550457|NCT00622466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25550458|NCT00622466|Tubulin Modulators|tubulin modulators|mesh-ancestor
25550459|NCT00622466|Antimitotic Agents|antimitotic agents|mesh-ancestor
25550460|NCT00622466|Mitosis Modulators|mitosis modulators|mesh-ancestor
25550461|NCT00622466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550462|NCT00622466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25550463|NCT00622466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550464|NCT00622505|Zoledronic Acid|zoledronic acid|mesh-list
25550465|NCT00622505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25550466|NCT00622505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651192|NCT01513122|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25651193|NCT01513122|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25651194|NCT01513317|Siltuximab|siltuximab|mesh-list
25651195|NCT01513317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25651196|NCT01513460|Glycopyrrolate|glycopyrrolate|mesh-list
25651197|NCT01513460|Tiotropium Bromide|tiotropium bromide|mesh-list
25651198|NCT01513460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25651199|NCT01513460|Autonomic Agents|autonomic agents|mesh-ancestor
25651200|NCT01513460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25651201|NCT01513460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651202|NCT01513460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25651203|NCT01513460|Respiratory System Agents|respiratory system agents|mesh-ancestor
25651204|NCT01513460|Parasympatholytics|parasympatholytics|mesh-ancestor
25651205|NCT01513460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25651206|NCT01513460|Cholinergic Agents|cholinergic agents|mesh-ancestor
25651207|NCT01513460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25651208|NCT01513460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651209|NCT01513460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25651210|NCT01513460|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25651211|NCT01513473|Insulin|insulin|mesh-list
25651212|NCT01513473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25651213|NCT01513473|Insulin Aspart|insulin aspart|mesh-list
25651214|NCT01513473|Insulin Detemir|insulin detemir|mesh-list
25651215|NCT01513473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25651216|NCT01513473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651217|NCT01513551|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25651218|NCT01513551|Immunologic Factors|immunologic factors|mesh-ancestor
25651219|NCT01513551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651220|NCT01513590|Insulin|insulin|mesh-list
25651221|NCT01513590|Insulin Aspart|insulin aspart|mesh-list
25651222|NCT01513590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25651223|NCT01513590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651224|NCT01513759|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25651225|NCT01513759|Plasminogen|plasminogen|mesh-list
25651226|NCT01513759|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25651227|NCT01513759|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25651228|NCT01513759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651229|NCT01513902|Tofacitinib|tofacitinib|mesh-list
25651230|NCT01513902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25651231|NCT01513902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651232|NCT01513902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651233|NCT01514149|Metformin|metformin|mesh-list
25651234|NCT01514149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25651235|NCT01514149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446224|NCT04656249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25446225|NCT04656249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837003|NCT02188394|Sensory System Agents|sensory system agents|mesh-ancestor
24418624|NCT00209859|Methotrexate|methotrexate|mesh-list
24418625|NCT00209859|Cyclosporins|cyclosporins|mesh-list
24418626|NCT00209859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24418627|NCT00209859|Abortifacient Agents|abortifacient agents|mesh-ancestor
24418628|NCT00209859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24418629|NCT00209859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418630|NCT00209859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24418631|NCT00209859|Antimetabolites|antimetabolites|mesh-ancestor
24418632|NCT00209859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418633|NCT00209859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978157|NCT05177926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25822626|NCT00004578|Stavudine|stavudine|mesh-list
25822627|NCT00004578|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24418679|NCT00209885|Droperidol|droperidol|mesh-list
24978172|NCT05121714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24978173|NCT05121714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978174|NCT05121714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24978175|NCT05121714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978176|NCT05121714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978177|NCT05121714|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24978178|NCT05121714|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24978179|NCT05121714|Purinergic Agents|purinergic agents|mesh-ancestor
24978203|NCT05117710|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25822628|NCT00004578|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25822629|NCT00004578|Protease Inhibitors|protease inhibitors|mesh-ancestor
25822630|NCT00004578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24418782|NCT00210132|Ropivacaine|ropivacaine|mesh-list
24418783|NCT00210132|Anesthetics, Local|anesthetics, local|mesh-ancestor
24418784|NCT00210132|Anesthetics|anesthetics|mesh-ancestor
24418785|NCT00210132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24418786|NCT00210132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418810|NCT00210210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24418811|NCT00210210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24418812|NCT00210210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418814|NCT00210301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24418815|NCT00210301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418816|NCT00210301|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24418817|NCT00210301|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24418818|NCT00210301|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24418819|NCT00210301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978204|NCT05117710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24978205|NCT05117710|Antioxidants|antioxidants|mesh-ancestor
24978206|NCT05117710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978207|NCT05117710|Protective Agents|protective agents|mesh-ancestor
24978208|NCT05117710|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25105774|NCT04930107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24783695|NCT01903278|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24978209|NCT05117710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822631|NCT00004578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418820|NCT00210314|Cytarabine|cytarabine|mesh-list
24418821|NCT00210314|Methotrexate|methotrexate|mesh-list
24418822|NCT00210314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24418823|NCT00210314|Abortifacient Agents|abortifacient agents|mesh-ancestor
24418824|NCT00210314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24418825|NCT00210314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418826|NCT00210314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24418841|NCT00210340|Rituximab|rituximab|mesh-list
24418844|NCT00210340|Immunologic Factors|immunologic factors|mesh-ancestor
24418845|NCT00210340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418846|NCT00210340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25822632|NCT00004578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25822633|NCT00004578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25822634|NCT00004578|Antiviral Agents|antiviral agents|mesh-ancestor
24418880|NCT00210444|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24418881|NCT00210444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24418882|NCT00210444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550467|NCT00622635|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25550468|NCT00622635|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25550469|NCT00622635|Autonomic Agents|autonomic agents|mesh-ancestor
25550470|NCT00622635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25550471|NCT00622635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550472|NCT00622635|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24396791|NCT00139932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24396795|NCT00139932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25227214|NCT02615938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25227215|NCT02615977|Ethanol|ethanol|mesh-list
25550473|NCT00622635|Respiratory System Agents|respiratory system agents|mesh-ancestor
25550474|NCT00622635|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25550475|NCT00622635|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25550476|NCT00622635|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25550477|NCT00622635|Adrenergic Agents|adrenergic agents|mesh-ancestor
25550478|NCT00622635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25550479|NCT00622635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550480|NCT00622700|Teriflunomide|teriflunomide|mesh-list
25550481|NCT00622700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25550482|NCT00622700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25550483|NCT00622700|Analgesics|analgesics|mesh-ancestor
25550484|NCT00622700|Sensory System Agents|sensory system agents|mesh-ancestor
25550485|NCT00622700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25550486|NCT00622700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550487|NCT00622700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25550488|NCT00622700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25550489|NCT00622700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25550490|NCT00622700|Immunologic Factors|immunologic factors|mesh-ancestor
25550491|NCT00622713|Rivastigmine|rivastigmine|mesh-list
25550492|NCT00622713|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25550493|NCT00622713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550494|NCT00622713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550495|NCT00622713|Cholinergic Agents|cholinergic agents|mesh-ancestor
25550496|NCT00622713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25550497|NCT00622713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550498|NCT00622713|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25550499|NCT00622713|Protective Agents|protective agents|mesh-ancestor
25550500|NCT00622726|Bevacizumab|bevacizumab|mesh-list
25550501|NCT00622726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25550502|NCT00622726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25550503|NCT00622726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25550504|NCT00622726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25550505|NCT00622726|Growth Substances|growth substances|mesh-ancestor
25550506|NCT00622726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550507|NCT00622726|Growth Inhibitors|growth inhibitors|mesh-ancestor
25550508|NCT00622739|Ziprasidone|ziprasidone|mesh-list
25550509|NCT00622739|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25550510|NCT00622739|Serotonin Agents|serotonin agents|mesh-ancestor
25550511|NCT00622739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25550512|NCT00622739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550513|NCT00622739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550514|NCT00622739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25550515|NCT00622739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25550516|NCT00622739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25550517|NCT00622739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25550518|NCT00622739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25550519|NCT00622739|Dopamine Agents|dopamine agents|mesh-ancestor
25550520|NCT00622869|Everolimus|everolimus|mesh-list
25550521|NCT00622869|Tacrolimus|tacrolimus|mesh-list
25550522|NCT00622869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25550523|NCT00622869|Immunologic Factors|immunologic factors|mesh-ancestor
25550524|NCT00622869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550525|NCT00622869|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25550526|NCT00622869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550527|NCT00622869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033558|NCT03572595|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24539269|NCT00662987|Amoxicillin|amoxicillin|mesh-list
25550528|NCT00622869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25550529|NCT00622895|Mycophenolic Acid|mycophenolic acid|mesh-list
25550530|NCT00622895|Fludarabine|fludarabine|mesh-list
25550531|NCT00622895|Fludarabine phosphate|fludarabine phosphate|mesh-list
25550532|NCT00622895|Tacrolimus|tacrolimus|mesh-list
25550533|NCT00622895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25550534|NCT00622895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25550535|NCT00622895|Antimetabolites|antimetabolites|mesh-ancestor
25550536|NCT00622895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550537|NCT00622895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25550538|NCT00622895|Immunologic Factors|immunologic factors|mesh-ancestor
25550539|NCT00622895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550540|NCT00622895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25550541|NCT00622895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550542|NCT00622895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25550543|NCT00622895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25550544|NCT00622895|Antitubercular Agents|antitubercular agents|mesh-ancestor
24399003|NCT00146458|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24399004|NCT00146458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399005|NCT00146471|Levetiracetam|levetiracetam|mesh-list
24399006|NCT00146471|Anticonvulsants|anticonvulsants|mesh-ancestor
24399007|NCT00146471|Nootropic Agents|nootropic agents|mesh-ancestor
24399011|NCT00146497|Budesonide|budesonide|mesh-list
24399026|NCT00146523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25227282|NCT02615782|Vasodilator Agents|vasodilator agents|mesh-ancestor
25227283|NCT02615782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25227284|NCT02615782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25227285|NCT02615782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227286|NCT02615782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227287|NCT02615782|Urological Agents|urological agents|mesh-ancestor
25227288|NCT02615782|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25227289|NCT02615782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25227290|NCT02615782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25227291|NCT02615782|Adrenergic Agents|adrenergic agents|mesh-ancestor
25227292|NCT02615782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25227293|NCT02615782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227294|NCT02615496|Aflibercept|aflibercept|mesh-list
25227295|NCT02615496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25550545|NCT00622895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25550546|NCT00622895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25550547|NCT00622908|Besifloxacin|besifloxacin|mesh-list
25550548|NCT00622908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25550549|NCT00622908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25550550|NCT00622908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25550551|NCT00622908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25550552|NCT00622908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550553|NCT00622908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550554|NCT00622908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25550556|NCT00623012|Tacrolimus|tacrolimus|mesh-list
25550557|NCT00623012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25550558|NCT00623012|Immunologic Factors|immunologic factors|mesh-ancestor
25550559|NCT00623012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550560|NCT00623012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25550561|NCT00623012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550562|NCT00623012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550563|NCT00623012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25550564|NCT00623012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25550565|NCT00623012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25550566|NCT00623012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25550567|NCT00623012|Antifungal Agents|antifungal agents|mesh-ancestor
25550568|NCT00623103|Rivastigmine|rivastigmine|mesh-list
25550569|NCT00623103|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25550570|NCT00623103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550571|NCT00623103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227322|NCT02615574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25550572|NCT00623103|Cholinergic Agents|cholinergic agents|mesh-ancestor
25550573|NCT00623103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25550574|NCT00623103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550575|NCT00623103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25550576|NCT00623103|Protective Agents|protective agents|mesh-ancestor
25550577|NCT00623181|Vaccines|vaccines|mesh-list
25550578|NCT00623181|Immunologic Factors|immunologic factors|mesh-ancestor
25550579|NCT00623181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550580|NCT00623194|Insulin|insulin|mesh-list
25550581|NCT00623194|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25550582|NCT00623194|Insulin Aspart|insulin aspart|mesh-list
25550583|NCT00623194|Insulin Detemir|insulin detemir|mesh-list
25550584|NCT00623194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25550585|NCT00623194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550586|NCT00623233|Gemcitabine|gemcitabine|mesh-list
25550587|NCT00623233|Bevacizumab|bevacizumab|mesh-list
25550588|NCT00623233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25550589|NCT00623233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25550590|NCT00623233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25550591|NCT00623233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25550592|NCT00623233|Growth Substances|growth substances|mesh-ancestor
25550593|NCT00623233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550594|NCT00623233|Growth Inhibitors|growth inhibitors|mesh-ancestor
25550595|NCT00623233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25550596|NCT00623233|Antimetabolites|antimetabolites|mesh-ancestor
24842327|NCT02220621|Viscosupplements|viscosupplements|mesh-ancestor
24842328|NCT02220621|Protective Agents|protective agents|mesh-ancestor
24842329|NCT02220634|Regadenoson|regadenoson|mesh-list
24842330|NCT02220634|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
24842331|NCT02220634|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24842337|NCT02220647|Metformin|metformin|mesh-list
25550597|NCT00623233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550598|NCT00623233|Antiviral Agents|antiviral agents|mesh-ancestor
25550599|NCT00623233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25550600|NCT00623233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550601|NCT00623233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25550602|NCT00623233|Immunologic Factors|immunologic factors|mesh-ancestor
25550603|NCT00623363|Piclozotan|piclozotan|mesh-list
25550604|NCT00623363|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25550605|NCT00623363|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25550606|NCT00623363|Serotonin Agents|serotonin agents|mesh-ancestor
25550607|NCT00623363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25550608|NCT00623363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550609|NCT00623363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550610|NCT00623428|Ribavirin|ribavirin|mesh-list
25550611|NCT00623428|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25550612|NCT00623428|Antimetabolites|antimetabolites|mesh-ancestor
25550613|NCT00623428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550614|NCT00623428|Antiviral Agents|antiviral agents|mesh-ancestor
25550615|NCT00623428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25550616|NCT00623480|Factor VIII|factor viii|mesh-list
25550617|NCT00623480|Coagulants|coagulants|mesh-ancestor
25550618|NCT00623545|Exenatide|exenatide|mesh-list
25550619|NCT00623545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25446373|NCT04654026|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25446374|NCT04654026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25446375|NCT04654026|Purinergic Agents|purinergic agents|mesh-ancestor
25446376|NCT04654026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25446377|NCT04653506|Acetaminophen|acetaminophen|mesh-list
25446378|NCT04653506|Ibuprofen|ibuprofen|mesh-list
25109811|NCT03121807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109815|NCT03121807|Antidotes|antidotes|mesh-ancestor
24402933|NCT00158834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446379|NCT04653506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24402934|NCT00158834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24402935|NCT00158834|Respiratory System Agents|respiratory system agents|mesh-ancestor
24402936|NCT00158834|Dermatologic Agents|dermatologic agents|mesh-ancestor
25446380|NCT04653506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25446381|NCT04653506|Analgesics|analgesics|mesh-ancestor
25446382|NCT04653506|Sensory System Agents|sensory system agents|mesh-ancestor
25446383|NCT04653506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446384|NCT04653506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446385|NCT04653506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25446386|NCT04653506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25446387|NCT04653506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25446388|NCT04653506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25446389|NCT04653506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446390|NCT04653506|Antipyretics|antipyretics|mesh-ancestor
25446391|NCT04653623|Tranexamic Acid|tranexamic acid|mesh-list
25446392|NCT04653623|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25446393|NCT04653623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25446394|NCT04653623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446395|NCT04653623|Hemostatics|hemostatics|mesh-ancestor
25446396|NCT04653623|Coagulants|coagulants|mesh-ancestor
25300415|NCT03843151|Antifungal Agents|antifungal agents|mesh-ancestor
25300416|NCT03843151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25300417|NCT03843151|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25300418|NCT03843151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25300419|NCT03843151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25300420|NCT03843151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300421|NCT03843151|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25300422|NCT03843151|Hormone Antagonists|hormone antagonists|mesh-ancestor
25300423|NCT03843151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25043727|NCT01220947|Ritonavir|ritonavir|mesh-list
25300424|NCT03843151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300425|NCT03843151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24418883|NCT00210444|Cholinergic Agents|cholinergic agents|mesh-ancestor
25550620|NCT00623545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550621|NCT00623545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25550622|NCT00623545|Incretins|incretins|mesh-ancestor
25550623|NCT00623545|Hormones|hormones|mesh-ancestor
24405906|NCT00168766|Methylprednisolone|methylprednisolone|mesh-list
24405907|NCT00168766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25550624|NCT00623545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25550625|NCT00623597|Ritonavir|ritonavir|mesh-list
25550626|NCT00623597|Saquinavir|saquinavir|mesh-list
25550627|NCT00623597|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25550628|NCT00623597|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25550629|NCT00623597|Protease Inhibitors|protease inhibitors|mesh-ancestor
25550630|NCT00623597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550631|NCT00623597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227551|NCT02613455|Anesthetics, Local|anesthetics, local|mesh-ancestor
25227552|NCT02613455|Anesthetics|anesthetics|mesh-ancestor
25550632|NCT00623597|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25550633|NCT00623597|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25550634|NCT00623597|Antiviral Agents|antiviral agents|mesh-ancestor
25550635|NCT00623597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25550636|NCT00623597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25550637|NCT00623597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25550638|NCT00623623|Enoxaparin|enoxaparin|mesh-list
25550639|NCT00623623|Tenecteplase|tenecteplase|mesh-list
25550640|NCT00623623|Clopidogrel|clopidogrel|mesh-list
25550641|NCT00623623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25550642|NCT00623623|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25550643|NCT00623623|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25550644|NCT00623623|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25550645|NCT00623623|Purinergic Agents|purinergic agents|mesh-ancestor
25550646|NCT00623623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25550647|NCT00623623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550648|NCT00623623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550649|NCT00623623|Anticoagulants|anticoagulants|mesh-ancestor
25550650|NCT00623623|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25550651|NCT00623623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25550652|NCT00623714|Fluticasone|fluticasone|mesh-list
25550653|NCT00623714|Xhance|xhance|mesh-list
25550654|NCT00623714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25550655|NCT00623714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25550656|NCT00623714|Autonomic Agents|autonomic agents|mesh-ancestor
25550657|NCT00623714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25550658|NCT00623714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550659|NCT00623714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25550660|NCT00623714|Respiratory System Agents|respiratory system agents|mesh-ancestor
25550661|NCT00623714|Dermatologic Agents|dermatologic agents|mesh-ancestor
25550662|NCT00623714|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25550663|NCT00623727|Factor VIII|factor viii|mesh-list
25550664|NCT00623727|Coagulants|coagulants|mesh-ancestor
25550665|NCT00623766|Dexamethasone|dexamethasone|mesh-list
25034137|NCT03567434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25550666|NCT00623766|Prednisone|prednisone|mesh-list
25550667|NCT00623766|Methylprednisolone|methylprednisolone|mesh-list
25550668|NCT00623766|Prednisolone|prednisolone|mesh-list
25550669|NCT00623766|Triamcinolone|triamcinolone|mesh-list
25550670|NCT00623766|Hydrocortisone|hydrocortisone|mesh-list
25550671|NCT00623766|Betamethasone|betamethasone|mesh-list
25550672|NCT00623766|Fludrocortisone|fludrocortisone|mesh-list
25550673|NCT00623766|Ipilimumab|ipilimumab|mesh-list
25550674|NCT00623766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25550675|NCT00623766|Antiemetics|antiemetics|mesh-ancestor
25550676|NCT00623766|Autonomic Agents|autonomic agents|mesh-ancestor
25550677|NCT00623766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25550678|NCT00623766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550679|NCT00623766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25550680|NCT00623766|Glucocorticoids|glucocorticoids|mesh-ancestor
25550681|NCT00623766|Hormones|hormones|mesh-ancestor
25550682|NCT00623766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25550683|NCT00623766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25550684|NCT00623766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25550685|NCT00623766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25550686|NCT00623766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25550687|NCT00623766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550688|NCT00623766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25550689|NCT00623766|Protective Agents|protective agents|mesh-ancestor
25550690|NCT00623766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25550691|NCT00623766|Respiratory System Agents|respiratory system agents|mesh-ancestor
25550692|NCT00623779|Aspirin|aspirin|mesh-list
25113993|NCT01552434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25113995|NCT01552434|Growth Substances|growth substances|mesh-ancestor
25550693|NCT00623779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25550694|NCT00623779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25550695|NCT00623779|Analgesics|analgesics|mesh-ancestor
25550696|NCT00623779|Sensory System Agents|sensory system agents|mesh-ancestor
25550697|NCT00623779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25550698|NCT00623779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550699|NCT00623779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25227619|NCT02613013|Sensory System Agents|sensory system agents|mesh-ancestor
25227620|NCT02613039|Contraceptive Agents|contraceptive agents|mesh-list
25227621|NCT02613039|Contraceptives, Oral|contraceptives, oral|mesh-list
25227622|NCT02613039|Estrogens|estrogens|mesh-list
25227623|NCT02613039|Progestins|progestins|mesh-list
25227624|NCT02613039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25227625|NCT02613039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227626|NCT02613039|Hormones|hormones|mesh-ancestor
25227627|NCT02613039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25227628|NCT02613039|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25227629|NCT02613026|Cyclophosphamide|cyclophosphamide|mesh-list
25227630|NCT02613026|Docetaxel|docetaxel|mesh-list
25550700|NCT00623779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25550701|NCT00623779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25550702|NCT00623779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25550703|NCT00623779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550704|NCT00623779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25550705|NCT00623779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25550706|NCT00623779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842790|NCT02223832|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24842791|NCT02223832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842792|NCT02223832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24842822|NCT02224066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24842823|NCT02224066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842824|NCT02224066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24842825|NCT02224066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24842826|NCT02224066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24842827|NCT02224066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24842828|NCT02224066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842829|NCT02224066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24543056|NCT00681772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543057|NCT00681772|Urological Agents|urological agents|mesh-ancestor
24543058|NCT00681785|Dalteparin|dalteparin|mesh-list
24543059|NCT00681785|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24995153|NCT05417893|Everolimus|everolimus|mesh-list
25550707|NCT00623779|Antipyretics|antipyretics|mesh-ancestor
25550708|NCT00623805|Bevacizumab|bevacizumab|mesh-list
25550709|NCT00623805|Capecitabine|capecitabine|mesh-list
25550710|NCT00623805|Oxaliplatin|oxaliplatin|mesh-list
25550711|NCT00623805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25550712|NCT00623805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25550713|NCT00623805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25550714|NCT00623805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25550715|NCT00623805|Growth Substances|growth substances|mesh-ancestor
25550716|NCT00623805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550717|NCT00623805|Growth Inhibitors|growth inhibitors|mesh-ancestor
25550718|NCT00623805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25550719|NCT00623805|Antimetabolites|antimetabolites|mesh-ancestor
24411737|NCT00189826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24411738|NCT00189826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411740|NCT00189839|Tacrolimus|tacrolimus|mesh-list
25227664|NCT02612480|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
25227665|NCT02612480|Clopidogrel|clopidogrel|mesh-list
25227666|NCT02612480|Ticagrelor|ticagrelor|mesh-list
25550720|NCT00623805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550721|NCT00623935|Fludarabine|fludarabine|mesh-list
25550722|NCT00623935|Busulfan|busulfan|mesh-list
25550723|NCT00623935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25550724|NCT00623935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550725|NCT00623935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25550726|NCT00623935|Immunologic Factors|immunologic factors|mesh-ancestor
25550727|NCT00623935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550728|NCT00623935|Alkylating Agents|alkylating agents|mesh-ancestor
25550729|NCT00623935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25446397|NCT04653662|Carbamide Peroxide|carbamide peroxide|mesh-list
25550730|NCT00623935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25550731|NCT00624013|Sertraline|sertraline|mesh-list
25550732|NCT00624013|Antidepressive Agents|antidepressive agents|mesh-ancestor
25550733|NCT00624013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25550734|NCT00624013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25550735|NCT00624013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25550736|NCT00624013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25550737|NCT00624013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550738|NCT00624013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25550739|NCT00624013|Serotonin Agents|serotonin agents|mesh-ancestor
25550740|NCT00624013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550741|NCT00624052|Amlodipine|amlodipine|mesh-list
25550742|NCT00624052|Telmisartan|telmisartan|mesh-list
25550743|NCT00624052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25550744|NCT00624052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25550745|NCT00624052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25550746|NCT00624052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550747|NCT00624052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25550748|NCT00624052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550749|NCT00624052|Vasodilator Agents|vasodilator agents|mesh-ancestor
25550750|NCT00624052|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25550751|NCT00624052|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25550752|NCT00624065|Carvedilol|carvedilol|mesh-list
25550753|NCT00624065|Lisinopril|lisinopril|mesh-list
25550754|NCT00624065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25550755|NCT00624065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25550756|NCT00624065|Adrenergic Agents|adrenergic agents|mesh-ancestor
25550757|NCT00624065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25227747|NCT02612298|Metoprolol|metoprolol|mesh-list
25550758|NCT00624065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550759|NCT00624065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550760|NCT00624065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25550761|NCT00624065|Antioxidants|antioxidants|mesh-ancestor
25550762|NCT00624065|Protective Agents|protective agents|mesh-ancestor
25550763|NCT00624065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25550764|NCT00624065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25550765|NCT00624065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25550766|NCT00624065|Vasodilator Agents|vasodilator agents|mesh-ancestor
25550767|NCT00624065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25550768|NCT00624065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25550769|NCT00624065|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25550770|NCT00624065|Protease Inhibitors|protease inhibitors|mesh-ancestor
25550771|NCT00624065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550772|NCT00624065|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25550773|NCT00624195|Etravirine|etravirine|mesh-list
25550774|NCT00624195|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25550775|NCT00624195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25550776|NCT00624195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25550777|NCT00624195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550778|NCT00624195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550779|NCT00624195|Antiviral Agents|antiviral agents|mesh-ancestor
25550780|NCT00624195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25550781|NCT00624377|Tiotropium Bromide|tiotropium bromide|mesh-list
25550782|NCT00624377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25550783|NCT00624377|Autonomic Agents|autonomic agents|mesh-ancestor
25550784|NCT00624377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25550785|NCT00624377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550786|NCT00624377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25550787|NCT00624377|Respiratory System Agents|respiratory system agents|mesh-ancestor
25550788|NCT00624377|Parasympatholytics|parasympatholytics|mesh-ancestor
25550789|NCT00624377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25550790|NCT00624377|Cholinergic Agents|cholinergic agents|mesh-ancestor
25550791|NCT00624377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25550792|NCT00624377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550793|NCT00624416|Prednisolone|prednisolone|mesh-list
25550794|NCT00624416|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25550795|NCT00624416|Methylprednisolone|methylprednisolone|mesh-list
25550796|NCT00624416|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25550797|NCT00624416|Prednisolone acetate|prednisolone acetate|mesh-list
25550798|NCT00624416|Cortisone|cortisone|mesh-list
25550799|NCT00624416|Isoproterenol|isoproterenol|mesh-list
25550800|NCT00624416|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25550801|NCT00624416|Prednisolone phosphate|prednisolone phosphate|mesh-list
25550802|NCT00624416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25550803|NCT00624416|Glucocorticoids|glucocorticoids|mesh-ancestor
25550804|NCT00624416|Hormones|hormones|mesh-ancestor
25446470|NCT04653337|Sympathomimetics|sympathomimetics|mesh-ancestor
25550805|NCT00624416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25550806|NCT00624416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550807|NCT00624416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25550808|NCT00624416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25550809|NCT00624416|Antiemetics|antiemetics|mesh-ancestor
25550810|NCT00624416|Autonomic Agents|autonomic agents|mesh-ancestor
24557597|NCT00753064|Prazosin|prazosin|mesh-list
25550811|NCT00624416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25550812|NCT00624416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25550813|NCT00624416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25550814|NCT00624416|Protective Agents|protective agents|mesh-ancestor
25550815|NCT00624416|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25550816|NCT00624416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25550817|NCT00624416|Adrenergic Agents|adrenergic agents|mesh-ancestor
25550818|NCT00624416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25550819|NCT00624416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550820|NCT00624416|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25550821|NCT00624416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25550822|NCT00624416|Respiratory System Agents|respiratory system agents|mesh-ancestor
25550823|NCT00624416|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25550824|NCT00624416|Sympathomimetics|sympathomimetics|mesh-ancestor
25550825|NCT00624559|Celecoxib|celecoxib|mesh-list
25550826|NCT00624559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25550827|NCT00624559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25550828|NCT00624559|Analgesics|analgesics|mesh-ancestor
25550829|NCT00624559|Sensory System Agents|sensory system agents|mesh-ancestor
25550830|NCT00624559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25550831|NCT00624559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550832|NCT00624559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25550833|NCT00624559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25550834|NCT00624559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25550835|NCT00624559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25550836|NCT00624559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550837|NCT00624559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550838|NCT00624585|Dasatinib|dasatinib|mesh-list
25550839|NCT00624585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25550840|NCT00624585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25550841|NCT00624585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550842|NCT00624585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550843|NCT00624780|Pregabalin|pregabalin|mesh-list
25550844|NCT00624780|Lorazepam|lorazepam|mesh-list
25550845|NCT00624780|Analgesics|analgesics|mesh-ancestor
25550846|NCT00624780|Sensory System Agents|sensory system agents|mesh-ancestor
25550847|NCT00624780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25550848|NCT00624780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550849|NCT00624780|Anticonvulsants|anticonvulsants|mesh-ancestor
25550850|NCT00624780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25550851|NCT00624780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25550852|NCT00624780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550853|NCT00624780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25550854|NCT00624780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25550855|NCT00624780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25550856|NCT00624780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25550857|NCT00624780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25550858|NCT00624780|Antiemetics|antiemetics|mesh-ancestor
25550859|NCT00624780|Autonomic Agents|autonomic agents|mesh-ancestor
25550860|NCT00624780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25550861|NCT00624780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25550862|NCT00624780|GABA Modulators|gaba modulators|mesh-ancestor
25550863|NCT00624780|GABA Agents|gaba agents|mesh-ancestor
25550864|NCT00624780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25550865|NCT00624819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25550866|NCT00624819|Immunologic Factors|immunologic factors|mesh-ancestor
25550867|NCT00624819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550868|NCT00624832|Omalizumab|omalizumab|mesh-list
25550869|NCT00624832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25550870|NCT00624832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25550871|NCT00624832|Respiratory System Agents|respiratory system agents|mesh-ancestor
25550872|NCT00624910|Bupivacaine|bupivacaine|mesh-list
25550873|NCT00624910|Anesthetics, Local|anesthetics, local|mesh-ancestor
25550874|NCT00624910|Anesthetics|anesthetics|mesh-ancestor
25550875|NCT00624910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25550876|NCT00624910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550877|NCT00624910|Sensory System Agents|sensory system agents|mesh-ancestor
24843248|NCT02226367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24843249|NCT02226367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843250|NCT02226367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550878|NCT00624910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25550879|NCT00624923|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
25550880|NCT00624923|Sodium Salicylate|sodium salicylate|mesh-list
25550881|NCT00624923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25550882|NCT00624923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25550883|NCT00624923|Analgesics|analgesics|mesh-ancestor
25550884|NCT00624923|Sensory System Agents|sensory system agents|mesh-ancestor
25550885|NCT00624923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446617|NCT04651556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446618|NCT04651556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25446619|NCT04651556|Analgesics|analgesics|mesh-ancestor
25446620|NCT04651556|Antipyretics|antipyretics|mesh-ancestor
25446621|NCT04651556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25446622|NCT04651556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25446623|NCT04651556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25446624|NCT04651556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25446625|NCT04651556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25446626|NCT04651556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446627|NCT04651556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25446628|NCT04651556|Anticonvulsants|anticonvulsants|mesh-ancestor
25446629|NCT04651556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25446630|NCT04651556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25446631|NCT04651556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25446632|NCT04651556|Tocolytic Agents|tocolytic agents|mesh-ancestor
25446633|NCT04651556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25446634|NCT04651049|Propranolol|propranolol|mesh-list
25446635|NCT04651049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25446636|NCT04651049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25446637|NCT04651049|Adrenergic Agents|adrenergic agents|mesh-ancestor
25446638|NCT04651049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25446639|NCT04651049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446640|NCT04651049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446641|NCT04651049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25446642|NCT04651049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25446643|NCT04651049|Vasodilator Agents|vasodilator agents|mesh-ancestor
25446644|NCT04651205|Thiamine|thiamine|mesh-list
25681750|NCT01869725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681751|NCT01869725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681752|NCT01869725|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24416555|NCT00203372|Antimitotic Agents|antimitotic agents|mesh-ancestor
24416556|NCT00203372|Mitosis Modulators|mitosis modulators|mesh-ancestor
24416557|NCT00203372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24416558|NCT00203372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24416559|NCT00203372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24416881|NCT00204347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24416882|NCT00204347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25035246|NCT03557996|Protective Agents|protective agents|mesh-ancestor
25035247|NCT03557996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227966|NCT02611466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25227967|NCT02611466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227968|NCT02611466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25227969|NCT02611466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25227970|NCT02611466|Gout Suppressants|gout suppressants|mesh-ancestor
25108132|NCT03134417|Vitamin D|vitamin d|mesh-list
25446645|NCT04651205|Vitamins|vitamins|mesh-ancestor
25446646|NCT04651205|Micronutrients|micronutrients|mesh-ancestor
25446647|NCT04651205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446648|NCT04651205|Vitamin B Complex|vitamin b complex|mesh-ancestor
25300711|NCT05127369|Fluoxetine|fluoxetine|mesh-list
25550886|NCT00624923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550887|NCT00624923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25550888|NCT00624923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25550889|NCT00624923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25550890|NCT00624923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550891|NCT00624923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550892|NCT00625131|Bupropion|bupropion|mesh-list
25550893|NCT00625131|Nicotine|nicotine|mesh-list
25550894|NCT00625131|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25550895|NCT00625131|Autonomic Agents|autonomic agents|mesh-ancestor
25550896|NCT00625131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25550897|NCT00625131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550898|NCT00625131|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25550899|NCT00625131|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25550900|NCT00625131|Cholinergic Agents|cholinergic agents|mesh-ancestor
25550901|NCT00625131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25550902|NCT00625131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550903|NCT00625131|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25550904|NCT00625131|Antidepressive Agents|antidepressive agents|mesh-ancestor
25550905|NCT00625131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25550906|NCT00625131|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25550907|NCT00625131|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25550908|NCT00625131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25227976|NCT02610920|Micronutrients|micronutrients|mesh-ancestor
25227977|NCT02610920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227978|NCT02610933|Vitamin K|vitamin k|mesh-list
25227979|NCT02610933|Vitamin K 2|vitamin k 2|mesh-list
25227981|NCT02610933|Vitamins|vitamins|mesh-ancestor
25550909|NCT00625131|Dopamine Agents|dopamine agents|mesh-ancestor
25550910|NCT00625131|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25550911|NCT00625131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25550912|NCT00625131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550913|NCT00625183|Selenium|selenium|mesh-list
25550914|NCT00625183|Capecitabine|capecitabine|mesh-list
25550915|NCT00625183|Oxaliplatin|oxaliplatin|mesh-list
25550916|NCT00625183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25550917|NCT00625183|Antimetabolites|antimetabolites|mesh-ancestor
25550918|NCT00625183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550919|NCT00625183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25550920|NCT00625183|Antioxidants|antioxidants|mesh-ancestor
25550921|NCT00625183|Protective Agents|protective agents|mesh-ancestor
25550922|NCT00625183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550923|NCT00625183|Trace Elements|trace elements|mesh-ancestor
25550924|NCT00625183|Micronutrients|micronutrients|mesh-ancestor
25550925|NCT00625404|Tenofovir|tenofovir|mesh-list
25550926|NCT00625404|Emtricitabine|emtricitabine|mesh-list
25550927|NCT00625404|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25550928|NCT00625404|Antiviral Agents|antiviral agents|mesh-ancestor
25550929|NCT00625404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25550930|NCT00625404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25550931|NCT00625404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25550932|NCT00625404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550933|NCT00625404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550934|NCT00625404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25550935|NCT00625404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25550936|NCT00625729|Aldesleukin|aldesleukin|mesh-list
25550937|NCT00625729|Cyclophosphamide|cyclophosphamide|mesh-list
25550938|NCT00625729|Rituximab|rituximab|mesh-list
25550939|NCT00625729|Fludarabine|fludarabine|mesh-list
25035493|NCT03555188|Antiemetics|antiemetics|mesh-ancestor
25550940|NCT00625729|Fludarabine phosphate|fludarabine phosphate|mesh-list
25550941|NCT00625729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25550942|NCT00625729|Immunologic Factors|immunologic factors|mesh-ancestor
25550943|NCT00625729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550944|NCT00625729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25550945|NCT00625729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25550946|NCT00625729|Alkylating Agents|alkylating agents|mesh-ancestor
25550947|NCT00625729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550948|NCT00625729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25550949|NCT00625729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25550950|NCT00625729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25550951|NCT00625729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25550952|NCT00625729|Antimetabolites|antimetabolites|mesh-ancestor
25550953|NCT00625729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25550954|NCT00625729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25550955|NCT00625729|Antiviral Agents|antiviral agents|mesh-ancestor
25550956|NCT00625729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24553046|NCT00729170|Calcium|calcium|mesh-list
25228025|NCT02610829|Antioxidants|antioxidants|mesh-ancestor
25228026|NCT02610829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228027|NCT02610829|Protective Agents|protective agents|mesh-ancestor
25228028|NCT02610686|Chloroquine|chloroquine|mesh-list
25228029|NCT02610686|Amebicides|amebicides|mesh-ancestor
25228030|NCT02610686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25228031|NCT02610686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25228032|NCT02610686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25273401|NCT02385461|Tinzaparin|tinzaparin|mesh-list
25550957|NCT00625820|Ascorbic Acid|ascorbic acid|mesh-list
25550958|NCT00625820|Vitamins|vitamins|mesh-ancestor
25550959|NCT00625820|Micronutrients|micronutrients|mesh-ancestor
25550960|NCT00625820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550961|NCT00625820|Antioxidants|antioxidants|mesh-ancestor
25550962|NCT00625820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550963|NCT00625820|Protective Agents|protective agents|mesh-ancestor
25550964|NCT00626028|Nitric Oxide|nitric oxide|mesh-list
25550965|NCT00626028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25550966|NCT00626028|Autonomic Agents|autonomic agents|mesh-ancestor
25550967|NCT00626028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25550968|NCT00626028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550969|NCT00626028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25550970|NCT00626028|Respiratory System Agents|respiratory system agents|mesh-ancestor
25550971|NCT00626028|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25550972|NCT00626028|Antioxidants|antioxidants|mesh-ancestor
25550973|NCT00626028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550974|NCT00626028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25550975|NCT00626028|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25550976|NCT00626028|Vasodilator Agents|vasodilator agents|mesh-ancestor
25550977|NCT00626028|Gasotransmitters|gasotransmitters|mesh-ancestor
25550978|NCT00626028|Protective Agents|protective agents|mesh-ancestor
25550979|NCT00626197|Mycophenolic Acid|mycophenolic acid|mesh-list
25550980|NCT00626197|Cyclophosphamide|cyclophosphamide|mesh-list
25550981|NCT00626197|Azathioprine|azathioprine|mesh-list
25550982|NCT00626197|Ocrelizumab|ocrelizumab|mesh-list
25550983|NCT00626197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25550984|NCT00626197|Immunologic Factors|immunologic factors|mesh-ancestor
25550985|NCT00626197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25550986|NCT00626197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25550987|NCT00626197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25550988|NCT00626197|Alkylating Agents|alkylating agents|mesh-ancestor
25550989|NCT00626197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25550990|NCT00626197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603034|NCT00972101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25035714|NCT03553537|Hormones|hormones|mesh-ancestor
25035715|NCT03553537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25035716|NCT03553537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25550991|NCT00626197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25550992|NCT00626197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25550993|NCT00626197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25550994|NCT00626197|Antitubercular Agents|antitubercular agents|mesh-ancestor
25550995|NCT00626197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25550996|NCT00626197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25550997|NCT00626197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25550998|NCT00626197|Antimetabolites|antimetabolites|mesh-ancestor
25550999|NCT00626197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25551001|NCT00626210|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25551002|NCT00626210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551003|NCT00626210|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25551004|NCT00626210|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25551005|NCT00626210|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25551006|NCT00626210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551007|NCT00626275|Naproxen|naproxen|mesh-list
24992423|NCT03796156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992424|NCT03796156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24992425|NCT03796156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24992426|NCT03796156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543806|NCT00685568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24543808|NCT00685568|Analgesics|analgesics|mesh-ancestor
24857982|NCT02294591|Protective Agents|protective agents|mesh-ancestor
24543848|NCT00685672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24543849|NCT00685672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25551008|NCT00626275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25551009|NCT00626275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25551010|NCT00626275|Analgesics|analgesics|mesh-ancestor
25551011|NCT00626275|Sensory System Agents|sensory system agents|mesh-ancestor
25551012|NCT00626275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25551013|NCT00626275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551014|NCT00626275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25551015|NCT00626275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25551016|NCT00626275|Gout Suppressants|gout suppressants|mesh-ancestor
25551017|NCT00626275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25551018|NCT00626275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25551019|NCT00626275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551020|NCT00626340|Fluoxetine|fluoxetine|mesh-list
25551021|NCT00626340|Estrogens|estrogens|mesh-list
24447011|NCT00307099|Meropenem|meropenem|mesh-list
25551022|NCT00626340|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25551023|NCT00626340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25551024|NCT00626340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25551025|NCT00626340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551026|NCT00626340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25551027|NCT00626340|Serotonin Agents|serotonin agents|mesh-ancestor
25446724|NCT04649723|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25446725|NCT04649723|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25446726|NCT04649645|Nicotine|nicotine|mesh-list
25446727|NCT04649645|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25446728|NCT04649645|Autonomic Agents|autonomic agents|mesh-ancestor
25446729|NCT04649645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446730|NCT04649645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446731|NCT04649645|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25446732|NCT04649645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25446733|NCT04649645|Cholinergic Agents|cholinergic agents|mesh-ancestor
25446734|NCT04649645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25446735|NCT04649645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446736|NCT04649697|Clobetasol|clobetasol|mesh-list
25446737|NCT04649697|Rebamipide|rebamipide|mesh-list
25446738|NCT04649697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25446739|NCT04649697|Glucocorticoids|glucocorticoids|mesh-ancestor
25446740|NCT04649697|Hormones|hormones|mesh-ancestor
25446741|NCT04649697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25446742|NCT04649697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446743|NCT04649697|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25446744|NCT04649697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25551028|NCT00626340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551029|NCT00626340|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25551030|NCT00626340|Antidepressive Agents|antidepressive agents|mesh-ancestor
25551031|NCT00626340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25551032|NCT00626340|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25551033|NCT00626340|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25551034|NCT00626340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25551035|NCT00626340|Hormones|hormones|mesh-ancestor
25551036|NCT00626340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25551037|NCT00626392|Aspirin|aspirin|mesh-list
25551038|NCT00626392|Niacin|niacin|mesh-list
25551039|NCT00626392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25551040|NCT00626392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25551041|NCT00626392|Analgesics|analgesics|mesh-ancestor
24797647|NCT01956981|Tocolytic Agents|tocolytic agents|mesh-ancestor
25228193|NCT02609477|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25228194|NCT02609477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25228195|NCT02609477|Purinergic Agents|purinergic agents|mesh-ancestor
25228196|NCT02609386|Zinc|zinc|mesh-list
25228197|NCT02609386|Indomethacin|indomethacin|mesh-list
25228198|NCT02609386|Cyclophosphamide|cyclophosphamide|mesh-list
25228199|NCT02609386|Omeprazole|omeprazole|mesh-list
25228200|NCT02609386|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24452618|NCT05457959|Ipilimumab|ipilimumab|mesh-list
25551042|NCT00626392|Sensory System Agents|sensory system agents|mesh-ancestor
25551043|NCT00626392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25551044|NCT00626392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551045|NCT00626392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25551046|NCT00626392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25551047|NCT00626392|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25551048|NCT00626392|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25551049|NCT00626392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551050|NCT00626392|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25551051|NCT00626392|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25551052|NCT00626392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25551053|NCT00626392|Antipyretics|antipyretics|mesh-ancestor
25551054|NCT00626392|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25551055|NCT00626392|Antimetabolites|antimetabolites|mesh-ancestor
25551056|NCT00626392|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25551057|NCT00626392|Vasodilator Agents|vasodilator agents|mesh-ancestor
25551058|NCT00626392|Vitamin B Complex|vitamin b complex|mesh-ancestor
25551059|NCT00626392|Vitamins|vitamins|mesh-ancestor
25551060|NCT00626392|Micronutrients|micronutrients|mesh-ancestor
25551061|NCT00626405|Paclitaxel|paclitaxel|mesh-list
25551062|NCT00626405|Bevacizumab|bevacizumab|mesh-list
25551063|NCT00626405|Carboplatin|carboplatin|mesh-list
25551064|NCT00626405|Temozolomide|temozolomide|mesh-list
25551065|NCT00626405|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25551066|NCT00626405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25551067|NCT00626405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551068|NCT00626405|Tubulin Modulators|tubulin modulators|mesh-ancestor
25551069|NCT00626405|Antimitotic Agents|antimitotic agents|mesh-ancestor
25551070|NCT00626405|Mitosis Modulators|mitosis modulators|mesh-ancestor
25114266|NCT01038778|Antiviral Agents|antiviral agents|mesh-ancestor
25228229|NCT02609087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25228230|NCT02609087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25228231|NCT02609087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228232|NCT02609087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25228233|NCT02609087|Anesthetics, General|anesthetics, general|mesh-ancestor
25228234|NCT02609087|Anesthetics|anesthetics|mesh-ancestor
25228235|NCT02609087|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24995730|NCT04793646|Antidotes|antidotes|mesh-ancestor
25228241|NCT02608944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25228243|NCT02608944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25551071|NCT00626405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551072|NCT00626405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25551073|NCT00626405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25551074|NCT00626405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25551075|NCT00626405|Growth Substances|growth substances|mesh-ancestor
25551076|NCT00626405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551077|NCT00626405|Growth Inhibitors|growth inhibitors|mesh-ancestor
25551078|NCT00626405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25551079|NCT00626405|Alkylating Agents|alkylating agents|mesh-ancestor
25551080|NCT00626431|Leuprolide|leuprolide|mesh-list
25551081|NCT00626431|Hormones|hormones|mesh-list
25551082|NCT00626431|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25551083|NCT00626431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25551084|NCT00626431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551085|NCT00626431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25551086|NCT00626431|Fertility Agents|fertility agents|mesh-ancestor
25551087|NCT00626431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25551088|NCT00626431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25551089|NCT00626431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25036335|NCT03548493|Analgesics|analgesics|mesh-ancestor
24606332|NCT00990028|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24843834|NCT02229760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25228256|NCT02609152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25228257|NCT02609152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551090|NCT00626522|Bromides|bromides|mesh-list
25551091|NCT00626522|Formoterol Fumarate|formoterol fumarate|mesh-list
25551092|NCT00626522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25551093|NCT00626522|Autonomic Agents|autonomic agents|mesh-ancestor
25551094|NCT00626522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25551095|NCT00626522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551096|NCT00626522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25551097|NCT00626522|Respiratory System Agents|respiratory system agents|mesh-ancestor
25551098|NCT00626522|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25551099|NCT00626522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25551100|NCT00626522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25551101|NCT00626522|Adrenergic Agents|adrenergic agents|mesh-ancestor
25551102|NCT00626522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25551103|NCT00626522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551104|NCT00626522|Anticonvulsants|anticonvulsants|mesh-ancestor
25551105|NCT00626574|Epoetin Alfa|epoetin alfa|mesh-list
25551106|NCT00626574|Hematinics|hematinics|mesh-ancestor
25551107|NCT00626626|Alemtuzumab|alemtuzumab|mesh-list
25551108|NCT00626626|Clofarabine|clofarabine|mesh-list
25551109|NCT00626626|Cyclophosphamide|cyclophosphamide|mesh-list
25551110|NCT00626626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25551111|NCT00626626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551112|NCT00626626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25551113|NCT00626626|Antimetabolites|antimetabolites|mesh-ancestor
25551114|NCT00626626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551115|NCT00626626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25551116|NCT00626626|Immunologic Factors|immunologic factors|mesh-ancestor
25551117|NCT00626626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551118|NCT00626626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25551119|NCT00626626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25551120|NCT00626626|Alkylating Agents|alkylating agents|mesh-ancestor
25551121|NCT00626626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25551122|NCT00626639|Cisplatin|cisplatin|mesh-list
25551123|NCT00626639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551124|NCT00626743|Amlodipine|amlodipine|mesh-list
25551125|NCT00626743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25551126|NCT00626743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25551127|NCT00626743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25551128|NCT00626743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551129|NCT00626743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25551130|NCT00626743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551131|NCT00626743|Vasodilator Agents|vasodilator agents|mesh-ancestor
25551132|NCT00626782|Ranibizumab|ranibizumab|mesh-list
25551133|NCT00626782|Mitomycins|mitomycins|mesh-list
25551134|NCT00626782|Mitomycin|mitomycin|mesh-list
25551135|NCT00626782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25551136|NCT00626782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25551137|NCT00626782|Growth Substances|growth substances|mesh-ancestor
25551138|NCT00626782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551139|NCT00626782|Growth Inhibitors|growth inhibitors|mesh-ancestor
25551140|NCT00626782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551141|NCT00626782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25551142|NCT00626782|Alkylating Agents|alkylating agents|mesh-ancestor
25551143|NCT00626782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551144|NCT00626782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25551145|NCT00626782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25551146|NCT00626795|Mupirocin|mupirocin|mesh-list
25551147|NCT00626795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25551148|NCT00626795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25551149|NCT00626795|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25551150|NCT00626795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25551151|NCT00626795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551152|NCT00626886|Bupivacaine|bupivacaine|mesh-list
25551153|NCT00626886|Anesthetics, Local|anesthetics, local|mesh-ancestor
25551154|NCT00626886|Anesthetics|anesthetics|mesh-ancestor
25551155|NCT00626886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25551156|NCT00626886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551157|NCT00626886|Sensory System Agents|sensory system agents|mesh-ancestor
25551158|NCT00626886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25551159|NCT00626925|Topiramate|topiramate|mesh-list
25551160|NCT00626925|Anticonvulsants|anticonvulsants|mesh-ancestor
25551161|NCT00626925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25551162|NCT00626925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551163|NCT00627016|Dexlansoprazole|dexlansoprazole|mesh-list
25551164|NCT00627016|Lansoprazole|lansoprazole|mesh-list
25551165|NCT00627016|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25551166|NCT00627016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25551167|NCT00627016|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25551168|NCT00627016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25551169|NCT00627016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551170|NCT00627042|Ramucirumab|ramucirumab|mesh-list
25551171|NCT00627042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25551172|NCT00627042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551173|NCT00627042|Immunologic Factors|immunologic factors|mesh-ancestor
25551174|NCT00627042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551175|NCT00627367|Hydromorphone|hydromorphone|mesh-list
25551176|NCT00627367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25551177|NCT00627367|Narcotics|narcotics|mesh-ancestor
25551178|NCT00627367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25551179|NCT00627367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551180|NCT00627367|Analgesics|analgesics|mesh-ancestor
25551181|NCT00627367|Sensory System Agents|sensory system agents|mesh-ancestor
25551182|NCT00627367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25551183|NCT00627393|Anti-Infective Agents|anti-infective agents|mesh-list
25551184|NCT00627393|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25551185|NCT00627393|Dexamethasone|dexamethasone|mesh-list
25551186|NCT00627393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25551187|NCT00627393|Antiemetics|antiemetics|mesh-ancestor
25551188|NCT00627393|Autonomic Agents|autonomic agents|mesh-ancestor
25551189|NCT00627393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25551190|NCT00627393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551191|NCT00627393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25551192|NCT00627393|Glucocorticoids|glucocorticoids|mesh-ancestor
25551193|NCT00627393|Hormones|hormones|mesh-ancestor
24425868|NCT00234546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24437326|NCT00273429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25036628|NCT03545373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24544194|NCT00687700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228295|NCT02608736|Valproic Acid|valproic acid|mesh-list
25551194|NCT00627393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25551195|NCT00627393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25551196|NCT00627393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551197|NCT00627406|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25551198|NCT00627406|Buserelin|buserelin|mesh-list
25551199|NCT00627406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25551200|NCT00627406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551201|NCT00627406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25551202|NCT00627406|Fertility Agents|fertility agents|mesh-ancestor
25551203|NCT00627445|Insulin|insulin|mesh-list
25551204|NCT00627445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25551205|NCT00627445|Metformin|metformin|mesh-list
25551206|NCT00627445|Insulin Aspart|insulin aspart|mesh-list
25551207|NCT00627445|Insulin, Long-Acting|insulin, long-acting|mesh-list
25551208|NCT00627445|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25551209|NCT00627445|Biphasic Insulins|biphasic insulins|mesh-list
25551210|NCT00627445|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
25551211|NCT00627445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25551212|NCT00627445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551213|NCT00627458|Vaccines|vaccines|mesh-list
25551214|NCT00627458|Immunologic Factors|immunologic factors|mesh-ancestor
25551215|NCT00627458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551216|NCT00627679|Budesonide|budesonide|mesh-list
25551217|NCT00627679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25551218|NCT00627679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25551219|NCT00627679|Autonomic Agents|autonomic agents|mesh-ancestor
25228315|NCT02608788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25228316|NCT02608788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25228317|NCT02608788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228318|NCT02608619|Choline|choline|mesh-list
25228319|NCT02608619|Lipotropic Agents|lipotropic agents|mesh-ancestor
25228320|NCT02608619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25228321|NCT02608619|Antimetabolites|antimetabolites|mesh-ancestor
25228322|NCT02608619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228323|NCT02608619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25228324|NCT02608619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25228325|NCT02608619|Nootropic Agents|nootropic agents|mesh-ancestor
25228326|NCT02608658|Immunoglobulins|immunoglobulins|mesh-list
25228327|NCT02608658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25228328|NCT02608658|Antibodies|antibodies|mesh-list
25228329|NCT02608658|Immunologic Factors|immunologic factors|mesh-ancestor
25228330|NCT02608658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228331|NCT02608606|Tacrolimus|tacrolimus|mesh-list
25228332|NCT02608606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25551220|NCT00627679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25551221|NCT00627679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551222|NCT00627679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25551223|NCT00627679|Respiratory System Agents|respiratory system agents|mesh-ancestor
25551224|NCT00627679|Glucocorticoids|glucocorticoids|mesh-ancestor
25551225|NCT00627679|Hormones|hormones|mesh-ancestor
25551226|NCT00627679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25551227|NCT00627705|Acetylcysteine|acetylcysteine|mesh-list
25551228|NCT00627705|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25551229|NCT00627705|Antiviral Agents|antiviral agents|mesh-ancestor
25551230|NCT00627705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25036902|NCT03542331|Ethiodized Oil|ethiodized oil|mesh-list
25551231|NCT00627705|Expectorants|expectorants|mesh-ancestor
25551232|NCT00627705|Respiratory System Agents|respiratory system agents|mesh-ancestor
25551233|NCT00627705|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25551234|NCT00627705|Antioxidants|antioxidants|mesh-ancestor
25551235|NCT00627705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551236|NCT00627705|Protective Agents|protective agents|mesh-ancestor
25551237|NCT00627705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551238|NCT00627705|Antidotes|antidotes|mesh-ancestor
25651236|NCT01514201|Temozolomide|temozolomide|mesh-list
25651237|NCT01514201|Veliparib|veliparib|mesh-list
25651238|NCT01514201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25651239|NCT01514201|Alkylating Agents|alkylating agents|mesh-ancestor
25651240|NCT01514201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651241|NCT01514201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25651242|NCT01514201|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25651243|NCT01514201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651244|NCT01514240|Mesalamine|mesalamine|mesh-list
25651245|NCT01514240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25651246|NCT01514240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25651247|NCT01514240|Analgesics|analgesics|mesh-ancestor
25651248|NCT01514240|Sensory System Agents|sensory system agents|mesh-ancestor
25651249|NCT01514240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25651250|NCT01514240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651251|NCT01514240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25651252|NCT01514240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25651253|NCT01514357|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24996028|NCT04397354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24996029|NCT04397354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996030|NCT04397354|Protease Inhibitors|protease inhibitors|mesh-ancestor
24447131|NCT00307606|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24447132|NCT00307606|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24447134|NCT00307606|Prednisolone acetate|prednisolone acetate|mesh-list
24447135|NCT00307606|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25651254|NCT01514357|Natriuretic Agents|natriuretic agents|mesh-ancestor
25651255|NCT01514357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651256|NCT01514370|Interferons|interferons|mesh-list
25651257|NCT01514370|Interferon-beta|interferon-beta|mesh-list
25651258|NCT01514370|Interferon beta-1a|interferon beta-1a|mesh-list
25651259|NCT01514370|Curcumin|curcumin|mesh-list
25651260|NCT01514370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25651261|NCT01514370|Antiviral Agents|antiviral agents|mesh-ancestor
25651262|NCT01514370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25651263|NCT01514370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24634396|NCT01133366|Warfarin|warfarin|mesh-list
25651264|NCT01514370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25651265|NCT01514370|Analgesics|analgesics|mesh-ancestor
25651266|NCT01514370|Sensory System Agents|sensory system agents|mesh-ancestor
24426952|NCT00236912|Metronidazole|metronidazole|mesh-list
25651267|NCT01514370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25651268|NCT01514370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651269|NCT01514370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25446992|NCT04646317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25446993|NCT04646317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25446994|NCT04646317|Adrenergic Agents|adrenergic agents|mesh-ancestor
25446995|NCT04646317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25446996|NCT04646317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446997|NCT04646161|Misoprostol|misoprostol|mesh-list
25446998|NCT04646161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25446999|NCT04646161|Abortifacient Agents|abortifacient agents|mesh-ancestor
25447000|NCT04646161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25447001|NCT04646161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447002|NCT04646161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25447003|NCT04646161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25447004|NCT04646161|Oxytocics|oxytocics|mesh-ancestor
25228443|NCT02608034|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25228444|NCT02608034|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25228445|NCT02608034|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25228446|NCT02608034|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25228447|NCT02608034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25228448|NCT02608034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25228449|NCT02608073|Capecitabine|capecitabine|mesh-list
25228450|NCT02608073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25228451|NCT02608073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25228452|NCT02608073|Antimetabolites|antimetabolites|mesh-ancestor
25228454|NCT02608060|Epoetin Alfa|epoetin alfa|mesh-list
25447005|NCT04646135|Lorazepam|lorazepam|mesh-list
25447006|NCT04646135|Anticonvulsants|anticonvulsants|mesh-ancestor
25447007|NCT04646135|Antiemetics|antiemetics|mesh-ancestor
25447008|NCT04646135|Autonomic Agents|autonomic agents|mesh-ancestor
25447009|NCT04646135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25447010|NCT04646135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447011|NCT04646135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25447012|NCT04646135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25447013|NCT04646135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25447014|NCT04646135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24428131|NCT00239551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25681926|NCT01872611|Analgesics|analgesics|mesh-ancestor
25681927|NCT01872611|Sensory System Agents|sensory system agents|mesh-ancestor
25681928|NCT01872611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25037424|NCT03537534|Sensory System Agents|sensory system agents|mesh-ancestor
25025036|NCT03640273|Histamine Agents|histamine agents|mesh-ancestor
25037425|NCT03537534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25037426|NCT03537534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25037427|NCT03537534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25037428|NCT03537534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25228489|NCT02607774|GABA Modulators|gaba modulators|mesh-ancestor
25228490|NCT02607774|GABA Agents|gaba agents|mesh-ancestor
25228491|NCT02607774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24996259|NCT03941964|Azacitidine|azacitidine|mesh-list
24996260|NCT03941964|Decitabine|decitabine|mesh-list
24844119|NCT02231320|Respiratory System Agents|respiratory system agents|mesh-ancestor
24844120|NCT02231333|Pentoxifylline|pentoxifylline|mesh-list
24844121|NCT02231333|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25447015|NCT04646135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25447016|NCT04646135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25447017|NCT04646135|GABA Modulators|gaba modulators|mesh-ancestor
25447018|NCT04646135|GABA Agents|gaba agents|mesh-ancestor
25447019|NCT04646135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25447020|NCT04646135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301157|NCT04693468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994078|NCT04930744|Isoniazid|isoniazid|mesh-list
24994154|NCT04829799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24994155|NCT04829799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24588957|NCT00904904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25228507|NCT02607540|Immunologic Factors|immunologic factors|mesh-ancestor
25228508|NCT02607540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228509|NCT02607410|Insulin|insulin|mesh-list
25228510|NCT02607410|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25228511|NCT02607410|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25228512|NCT02607410|Insulin, Isophane|insulin, isophane|mesh-list
25228513|NCT02607410|Isophane Insulin, Human|isophane insulin, human|mesh-list
25228514|NCT02607410|Isophane insulin, beef|isophane insulin, beef|mesh-list
25228515|NCT02607410|Insulin, Long-Acting|insulin, long-acting|mesh-list
25228516|NCT02607410|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25228517|NCT02607410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25228518|NCT02607410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228519|NCT02607410|Incretins|incretins|mesh-ancestor
25228520|NCT02607410|Hormones|hormones|mesh-ancestor
25301158|NCT04693468|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25301159|NCT04654312|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25301160|NCT04654312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25037735|NCT03535519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25037736|NCT03535519|Antimetabolites|antimetabolites|mesh-ancestor
25037737|NCT03535519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037738|NCT03535519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25037739|NCT03535519|Dermatologic Agents|dermatologic agents|mesh-ancestor
24428810|NCT00241241|Antiviral Agents|antiviral agents|mesh-ancestor
24844148|NCT02231372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24844150|NCT02231372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25301161|NCT04654312|Diuretics|diuretics|mesh-ancestor
25301162|NCT04654312|Natriuretic Agents|natriuretic agents|mesh-ancestor
25301163|NCT04654312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301167|NCT04635644|Morphine|morphine|mesh-list
25551239|NCT00627861|Metoprolol|metoprolol|mesh-list
24544522|NCT00689208|Miotics|miotics|mesh-ancestor
25551240|NCT00627861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25551241|NCT00627861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25551242|NCT00627861|Sympatholytics|sympatholytics|mesh-ancestor
25551243|NCT00627861|Autonomic Agents|autonomic agents|mesh-ancestor
25551244|NCT00627861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25551245|NCT00627861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978210|NCT05117710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25551246|NCT00627861|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25551247|NCT00627861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25551248|NCT00627861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25551249|NCT00627861|Adrenergic Agents|adrenergic agents|mesh-ancestor
25037871|NCT03534973|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24844203|NCT02231762|Alkylating Agents|alkylating agents|mesh-ancestor
24844204|NCT02231762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844205|NCT02231762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24844206|NCT02231788|Amlodipine|amlodipine|mesh-list
24844207|NCT02231788|Telmisartan|telmisartan|mesh-list
24756995|NCT01737086|Astringents|astringents|mesh-ancestor
24544588|NCT00689598|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24544589|NCT00689598|Diuretics|diuretics|mesh-ancestor
24544590|NCT00689598|Natriuretic Agents|natriuretic agents|mesh-ancestor
24544591|NCT00689624|Leucovorin|leucovorin|mesh-list
25228611|NCT02607072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25228612|NCT02607072|Analgesics|analgesics|mesh-ancestor
25228613|NCT02607072|Sensory System Agents|sensory system agents|mesh-ancestor
25228614|NCT02607072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25228615|NCT02607072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228616|NCT02607072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25228619|NCT02607072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25228620|NCT02607072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228621|NCT02607072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25228622|NCT02607072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25228623|NCT02607072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25228624|NCT02607072|Antipyretics|antipyretics|mesh-ancestor
25228625|NCT02607202|Gemcitabine|gemcitabine|mesh-list
25228627|NCT02607202|Carboplatin|carboplatin|mesh-list
25681970|NCT01873859|Metformin|metformin|mesh-list
25551250|NCT00627861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25551251|NCT00627861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551252|NCT00627926|Interferons|interferons|mesh-list
25551253|NCT00627926|Ribavirin|ribavirin|mesh-list
25551254|NCT00627926|Interferon-alpha|interferon-alpha|mesh-list
25551255|NCT00627926|Interferon alpha-2|interferon alpha-2|mesh-list
25551256|NCT00627926|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25551257|NCT00627926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551258|NCT00627926|Antiviral Agents|antiviral agents|mesh-ancestor
25551259|NCT00627926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25551260|NCT00627926|Antimetabolites|antimetabolites|mesh-ancestor
25551261|NCT00627926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551262|NCT00627926|Immunologic Factors|immunologic factors|mesh-ancestor
25551263|NCT00627926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551264|NCT00628108|Levocetirizine|levocetirizine|mesh-list
25551265|NCT00628108|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25551266|NCT00628108|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25551267|NCT00628108|Histamine Antagonists|histamine antagonists|mesh-ancestor
25551268|NCT00628108|Histamine Agents|histamine agents|mesh-ancestor
24432497|NCT00254930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432498|NCT00254930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24432499|NCT00254930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24432637|NCT00255554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551269|NCT00628108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25551270|NCT00628108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551271|NCT00628108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551272|NCT00628134|Calfactant|calfactant|mesh-list
25551273|NCT00628134|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
25551274|NCT00628134|Respiratory System Agents|respiratory system agents|mesh-ancestor
25551276|NCT00628251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24432970|NCT00257075|Risperidone|risperidone|mesh-list
24433014|NCT00257270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433015|NCT00257270|Anticonvulsants|anticonvulsants|mesh-ancestor
24433016|NCT00257270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24433017|NCT00257270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25038014|NCT03533387|Ibudilast|ibudilast|mesh-list
25038015|NCT03533387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25038016|NCT03533387|Autonomic Agents|autonomic agents|mesh-ancestor
25551277|NCT00628251|Olaparib|olaparib|mesh-list
25551278|NCT00628251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25551279|NCT00628251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551280|NCT00628251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25551281|NCT00628251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25551282|NCT00628251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25551283|NCT00628251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551284|NCT00628251|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25551285|NCT00628355|Lidocaine|lidocaine|mesh-list
25551286|NCT00628355|Anesthetics, Local|anesthetics, local|mesh-ancestor
25551287|NCT00628355|Anesthetics|anesthetics|mesh-ancestor
25551288|NCT00628355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25551289|NCT00628355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551290|NCT00628355|Sensory System Agents|sensory system agents|mesh-ancestor
24433273|NCT00258063|Estradiol|estradiol|mesh-list
24433274|NCT00258063|Estrogens|estrogens|mesh-ancestor
24433275|NCT00258063|Hormones|hormones|mesh-ancestor
24433276|NCT00258063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24433277|NCT00258063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433278|NCT00258063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24433279|NCT00258063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24563378|NCT00771368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273437|NCT02385422|Vasodilator Agents|vasodilator agents|mesh-ancestor
24844241|NCT02231931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844242|NCT02231931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24544645|NCT00689780|GABA Modulators|gaba modulators|mesh-ancestor
25551291|NCT00628355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25551292|NCT00628355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25551293|NCT00628355|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25551294|NCT00628355|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25551295|NCT00628355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25551296|NCT00628355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551297|NCT00628394|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25551298|NCT00628394|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25551299|NCT00628394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25551300|NCT00628394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25551301|NCT00628394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551302|NCT00628394|Adrenergic Agents|adrenergic agents|mesh-ancestor
25551303|NCT00628394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25551304|NCT00628394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551305|NCT00628498|Defibrotide|defibrotide|mesh-list
25551306|NCT00628498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25551307|NCT00628498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25551308|NCT00628498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551309|NCT00628498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25551310|NCT00628589|Loxapine|loxapine|mesh-list
25551311|NCT00628589|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25551312|NCT00628589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25551313|NCT00628589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25551314|NCT00628589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228679|NCT02606994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25228680|NCT02606994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228681|NCT02606994|Sensory System Agents|sensory system agents|mesh-ancestor
25228682|NCT02606994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25228683|NCT02606994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25228684|NCT02606994|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24844260|NCT02232035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25551315|NCT00628589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25551316|NCT00628589|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25551317|NCT00628589|Dopamine Agents|dopamine agents|mesh-ancestor
25551318|NCT00628589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25551319|NCT00628589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551320|NCT00628628|Rasburicase|rasburicase|mesh-list
25551321|NCT00628628|Gout Suppressants|gout suppressants|mesh-ancestor
25551322|NCT00628628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25551323|NCT00628758|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25551324|NCT00628758|Formoterol Fumarate|formoterol fumarate|mesh-list
25551325|NCT00628758|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25551326|NCT00628758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25551327|NCT00628758|Respiratory System Agents|respiratory system agents|mesh-ancestor
25551328|NCT00628758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25551329|NCT00628758|Autonomic Agents|autonomic agents|mesh-ancestor
25551330|NCT00628758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25551331|NCT00628758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551332|NCT00628758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25551333|NCT00628758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25551334|NCT00628758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24996716|NCT02653963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24996717|NCT02653963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544716|NCT00689845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24544718|NCT00689845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24544719|NCT00689845|Tubulin Modulators|tubulin modulators|mesh-ancestor
24544720|NCT00689845|Antimitotic Agents|antimitotic agents|mesh-ancestor
24544721|NCT00689845|Mitosis Modulators|mitosis modulators|mesh-ancestor
24544722|NCT00689858|Cilostazol|cilostazol|mesh-list
24544723|NCT00689858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25228702|NCT02606981|Antioxidants|antioxidants|mesh-ancestor
25228704|NCT02606981|Protective Agents|protective agents|mesh-ancestor
25551335|NCT00628758|Adrenergic Agents|adrenergic agents|mesh-ancestor
25551336|NCT00628758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25551337|NCT00628758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551338|NCT00628862|Formoterol Fumarate|formoterol fumarate|mesh-list
25551339|NCT00628862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25551340|NCT00628862|Autonomic Agents|autonomic agents|mesh-ancestor
25551341|NCT00628862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25551342|NCT00628862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551343|NCT00628862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25551344|NCT00628862|Respiratory System Agents|respiratory system agents|mesh-ancestor
25447021|NCT04645914|Nicotine|nicotine|mesh-list
25551345|NCT00628862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25551346|NCT00628862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25551347|NCT00628862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25551348|NCT00628862|Adrenergic Agents|adrenergic agents|mesh-ancestor
25551349|NCT00628862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25551350|NCT00628862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551351|NCT00629122|Clotrimazole|clotrimazole|mesh-list
24544724|NCT00689858|Autonomic Agents|autonomic agents|mesh-ancestor
24544725|NCT00689858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24544726|NCT00689858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544727|NCT00689858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24544728|NCT00689858|Respiratory System Agents|respiratory system agents|mesh-ancestor
24710320|NCT01509521|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24710321|NCT01509521|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24710322|NCT01509521|Adrenergic Agents|adrenergic agents|mesh-ancestor
24710323|NCT01509521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24710329|NCT01509560|Everolimus|everolimus|mesh-list
25551352|NCT00629122|Miconazole|miconazole|mesh-list
25551353|NCT00629122|Nystatin|nystatin|mesh-list
25551354|NCT00629122|Tacrolimus|tacrolimus|mesh-list
25551355|NCT00629122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25551356|NCT00629122|Immunologic Factors|immunologic factors|mesh-ancestor
25551357|NCT00629122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551358|NCT00629122|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25551359|NCT00629122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25551360|NCT00629122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551361|NCT00629122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25551362|NCT00629122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25551363|NCT00629122|Antifungal Agents|antifungal agents|mesh-ancestor
25551364|NCT00629122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25551365|NCT00629122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25551366|NCT00629122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25551367|NCT00629122|Hormone Antagonists|hormone antagonists|mesh-ancestor
25551368|NCT00629122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24996841|NCT01465334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24996842|NCT01465334|Antiemetics|antiemetics|mesh-ancestor
24996843|NCT01465334|Autonomic Agents|autonomic agents|mesh-ancestor
24844305|NCT02232308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996844|NCT01465334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24996845|NCT01465334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798188|NCT01961414|Growth Inhibitors|growth inhibitors|mesh-ancestor
24798189|NCT01961414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25059575|NCT03487133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858047|NCT02294955|Sotalol|sotalol|mesh-list
24858048|NCT02294955|Flecainide|flecainide|mesh-list
24559281|NCT05117554|Midazolam|midazolam|mesh-list
25228745|NCT02606552|Analgesics|analgesics|mesh-ancestor
25228746|NCT02606552|Sensory System Agents|sensory system agents|mesh-ancestor
25228747|NCT02606552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25228748|NCT02606552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228749|NCT02606552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25228750|NCT02606552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25228751|NCT02606552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25551369|NCT00629122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25551370|NCT00629122|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25551371|NCT00629122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25551372|NCT00629122|Ionophores|ionophores|mesh-ancestor
25551373|NCT00629122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25551374|NCT00629499|Paclitaxel|paclitaxel|mesh-list
25551375|NCT00629499|Cyclophosphamide|cyclophosphamide|mesh-list
25551376|NCT00629499|Trastuzumab|trastuzumab|mesh-list
25551377|NCT00629499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25551378|NCT00629499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551379|NCT00629499|Tubulin Modulators|tubulin modulators|mesh-ancestor
25551380|NCT00629499|Antimitotic Agents|antimitotic agents|mesh-ancestor
25551381|NCT00629499|Mitosis Modulators|mitosis modulators|mesh-ancestor
25551382|NCT00629499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551383|NCT00629499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25551384|NCT00629499|Immunologic Factors|immunologic factors|mesh-ancestor
25551385|NCT00629499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551386|NCT00629499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25551387|NCT00629499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25551388|NCT00629499|Alkylating Agents|alkylating agents|mesh-ancestor
25275878|NCT02368743|Analgesics|analgesics|mesh-ancestor
25275879|NCT02368743|Sensory System Agents|sensory system agents|mesh-ancestor
25275880|NCT02368743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275884|NCT02368665|Amlodipine|amlodipine|mesh-list
25228777|NCT02606539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24996918|NCT00655876|Antimitotic Agents|antimitotic agents|mesh-ancestor
25108203|NCT03133897|Antiemetics|antiemetics|mesh-ancestor
25551389|NCT00629499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25551390|NCT00629499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25551391|NCT00629525|Everolimus|everolimus|mesh-list
25551392|NCT00629525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551393|NCT00629525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25551394|NCT00629525|Immunologic Factors|immunologic factors|mesh-ancestor
25551395|NCT00629525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551396|NCT00629772|Infliximab|infliximab|mesh-list
25551397|NCT00629772|Dermatologic Agents|dermatologic agents|mesh-ancestor
25551398|NCT00629772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25551399|NCT00629772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25551400|NCT00630032|Cyclophosphamide|cyclophosphamide|mesh-list
25551401|NCT00630032|Docetaxel|docetaxel|mesh-list
25551402|NCT00630032|Fluorouracil|fluorouracil|mesh-list
25551403|NCT00630032|Epirubicin|epirubicin|mesh-list
25551404|NCT00630032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25551405|NCT00630032|Immunologic Factors|immunologic factors|mesh-ancestor
25551406|NCT00630032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551407|NCT00630032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25551408|NCT00630032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25551409|NCT00630032|Alkylating Agents|alkylating agents|mesh-ancestor
25551410|NCT00630032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551411|NCT00630032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551412|NCT00630032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25551413|NCT00630032|Tubulin Modulators|tubulin modulators|mesh-ancestor
25551414|NCT00630032|Antimitotic Agents|antimitotic agents|mesh-ancestor
25551415|NCT00630032|Mitosis Modulators|mitosis modulators|mesh-ancestor
25551416|NCT00630032|Antimetabolites|antimetabolites|mesh-ancestor
25551417|NCT00630032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25551418|NCT00630032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25551419|NCT00630032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25038477|NCT05092841|Cathartics|cathartics|mesh-ancestor
25038481|NCT05079217|Vaccines|vaccines|mesh-list
24844347|NCT02232386|Immunologic Factors|immunologic factors|mesh-ancestor
24844348|NCT02232386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844349|NCT02232386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24544803|NCT00690313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24544804|NCT00690313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24544805|NCT00690313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24544809|NCT00690313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24544810|NCT00690313|Contraceptive Agents|contraceptive agents|mesh-ancestor
24544811|NCT00690313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24544814|NCT00690313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25447147|NCT04643691|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25447148|NCT04643691|Diuretics|diuretics|mesh-ancestor
25447149|NCT04643691|Natriuretic Agents|natriuretic agents|mesh-ancestor
25301383|NCT04095858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301384|NCT04095858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301385|NCT04095858|Dermatologic Agents|dermatologic agents|mesh-ancestor
25301386|NCT04095858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25301387|NCT04095858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24452627|NCT05457959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452628|NCT05457959|Interferon Inducers|interferon inducers|mesh-ancestor
24452629|NCT05457959|Laxatives|laxatives|mesh-ancestor
24452635|NCT05457946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844360|NCT02232399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24844361|NCT02232516|Lenalidomide|lenalidomide|mesh-list
24844362|NCT02232516|Romidepsin|romidepsin|mesh-list
24844363|NCT02232516|Immunologic Factors|immunologic factors|mesh-ancestor
24844364|NCT02232516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997159|NCT05344495|Bupivacaine|bupivacaine|mesh-list
25301388|NCT04095858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25301389|NCT04095858|Immunologic Factors|immunologic factors|mesh-ancestor
25301390|NCT04095858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25301391|NCT04095858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25301392|NCT04095858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25301401|NCT04030000|Paclitaxel|paclitaxel|mesh-list
25301402|NCT04030000|Carboplatin|carboplatin|mesh-list
25301403|NCT04030000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25301404|NCT04030000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301405|NCT04030000|Tubulin Modulators|tubulin modulators|mesh-ancestor
25301406|NCT04030000|Antimitotic Agents|antimitotic agents|mesh-ancestor
25301407|NCT04030000|Mitosis Modulators|mitosis modulators|mesh-ancestor
25301408|NCT04030000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301409|NCT04028115|Ixazomib|ixazomib|mesh-list
25301410|NCT04028115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301411|NCT04028115|Protease Inhibitors|protease inhibitors|mesh-ancestor
25301412|NCT04028115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916141|NCT04243954|Morphine|morphine|mesh-list
24978213|NCT05035303|Epinephrine|epinephrine|mesh-list
24978214|NCT05035303|Norepinephrine|norepinephrine|mesh-list
25120442|NCT03836066|Bevacizumab|bevacizumab|mesh-list
24978215|NCT05035303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24978216|NCT05035303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24418884|NCT00210444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24418885|NCT00210444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418886|NCT00210444|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25120465|NCT03738878|Neurokinin A|neurokinin a|mesh-list
24418887|NCT00210444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24418888|NCT00210457|Lanreotide|lanreotide|mesh-list
24418889|NCT00210457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24418915|NCT00210548|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24418916|NCT00210548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24418917|NCT00210548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24418999|NCT00210782|Topiramate|topiramate|mesh-list
24419003|NCT00210782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419004|NCT00210782|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24419005|NCT00210782|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25169538|NCT01825980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25120470|NCT03738878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25120471|NCT03738878|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25120481|NCT03710460|Metformin|metformin|mesh-list
24419006|NCT00210782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24437469|NCT00273702|Respiratory System Agents|respiratory system agents|mesh-ancestor
25551420|NCT00630032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25551421|NCT00630032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25551422|NCT00630058|Interferon-alpha|interferon-alpha|mesh-list
25551423|NCT00630058|Interferon alpha-2|interferon alpha-2|mesh-list
25551424|NCT00630058|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
25551425|NCT00630058|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25551426|NCT00630058|Antiviral Agents|antiviral agents|mesh-ancestor
25551427|NCT00630058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25551428|NCT00630058|Immunologic Factors|immunologic factors|mesh-ancestor
25551429|NCT00630058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551430|NCT00630058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551431|NCT00630253|Cyclosporine|cyclosporine|mesh-list
25551432|NCT00630253|Mycophenolic Acid|mycophenolic acid|mesh-list
25551433|NCT00630253|Methylprednisolone|methylprednisolone|mesh-list
25551434|NCT00630253|Cyclophosphamide|cyclophosphamide|mesh-list
25551435|NCT00630253|Fludarabine|fludarabine|mesh-list
25551436|NCT00630253|Cyclosporins|cyclosporins|mesh-list
25551437|NCT00630253|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25551438|NCT00630253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25551439|NCT00630253|Immunologic Factors|immunologic factors|mesh-ancestor
25551440|NCT00630253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551441|NCT00630253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25551442|NCT00630253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25551443|NCT00630253|Alkylating Agents|alkylating agents|mesh-ancestor
25551444|NCT00630253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551445|NCT00630253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551446|NCT00630253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25551447|NCT00630253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25551448|NCT00630253|Antifungal Agents|antifungal agents|mesh-ancestor
25551449|NCT00630253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25551450|NCT00630253|Dermatologic Agents|dermatologic agents|mesh-ancestor
25551451|NCT00630253|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25551452|NCT00630253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25551453|NCT00630253|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25551454|NCT00630253|Antitubercular Agents|antitubercular agents|mesh-ancestor
25551455|NCT00630253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25551456|NCT00630253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25551457|NCT00630253|Antiemetics|antiemetics|mesh-ancestor
25551458|NCT00630253|Autonomic Agents|autonomic agents|mesh-ancestor
25551459|NCT00630253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25551460|NCT00630253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25551461|NCT00630253|Glucocorticoids|glucocorticoids|mesh-ancestor
25551462|NCT00630253|Hormones|hormones|mesh-ancestor
25038696|NCT04634799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25551463|NCT00630253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25551464|NCT00630253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25551465|NCT00630253|Protective Agents|protective agents|mesh-ancestor
25551466|NCT00630331|Vaccines|vaccines|mesh-list
25551467|NCT00630331|Immunologic Factors|immunologic factors|mesh-ancestor
25551468|NCT00630331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551469|NCT00630344|Everolimus|everolimus|mesh-list
25551470|NCT00630344|Bicalutamide|bicalutamide|mesh-list
25551471|NCT00630344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551472|NCT00630344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25551473|NCT00630344|Immunologic Factors|immunologic factors|mesh-ancestor
25551474|NCT00630344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551475|NCT00630344|Androgen Antagonists|androgen antagonists|mesh-ancestor
25551476|NCT00630344|Hormone Antagonists|hormone antagonists|mesh-ancestor
25551477|NCT00630344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25551478|NCT00630396|Minocycline|minocycline|mesh-list
25551479|NCT00630396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25551480|NCT00630396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25551481|NCT00630409|Gemcitabine|gemcitabine|mesh-list
25551482|NCT00630409|Doxorubicin|doxorubicin|mesh-list
25551483|NCT00630409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25551484|NCT00630409|Antimetabolites|antimetabolites|mesh-ancestor
25551485|NCT00630409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551486|NCT00630409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551487|NCT00630409|Antiviral Agents|antiviral agents|mesh-ancestor
25551488|NCT00630409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25551489|NCT00630409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25551490|NCT00630409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25551491|NCT00630409|Immunologic Factors|immunologic factors|mesh-ancestor
25551492|NCT00630409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551493|NCT00630409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25551494|NCT00630409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25551495|NCT00630409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25551496|NCT00630539|Tamoxifen|tamoxifen|mesh-list
25551497|NCT00630539|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25551498|NCT00630539|Hormone Antagonists|hormone antagonists|mesh-ancestor
25551499|NCT00630539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25551500|NCT00630539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551501|NCT00630539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25551502|NCT00630539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551503|NCT00630539|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25551504|NCT00630539|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25551505|NCT00630539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25551506|NCT00630734|Ritonavir|ritonavir|mesh-list
25551507|NCT00630734|Darunavir|darunavir|mesh-list
25551508|NCT00630734|Pravastatin|pravastatin|mesh-list
25551509|NCT00630734|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25551510|NCT00630734|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25551511|NCT00630734|Protease Inhibitors|protease inhibitors|mesh-ancestor
25551512|NCT00630734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25551513|NCT00630734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858080|NCT02295046|Calcium|calcium|mesh-list
24858081|NCT02295046|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24545026|NCT00691405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24545027|NCT00691405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545028|NCT00691405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24545029|NCT00691405|Respiratory System Agents|respiratory system agents|mesh-ancestor
25551514|NCT00630734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25551515|NCT00630734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25551516|NCT00630734|Antiviral Agents|antiviral agents|mesh-ancestor
25551517|NCT00630734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25551518|NCT00630734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25551519|NCT00630734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25551520|NCT00630734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25447217|NCT04642001|Sodium Fluoride|sodium fluoride|mesh-list
25447218|NCT04642001|Cariostatic Agents|cariostatic agents|mesh-ancestor
25447219|NCT04642001|Protective Agents|protective agents|mesh-ancestor
25447220|NCT04642001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447221|NCT04642001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25447222|NCT04642001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25447223|NCT04641780|Brexpiprazole|brexpiprazole|mesh-list
25447224|NCT04641780|Serotonin Agents|serotonin agents|mesh-ancestor
25447225|NCT04641780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25447226|NCT04641780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447227|NCT04641780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447228|NCT04641780|Dopamine Agonists|dopamine agonists|mesh-ancestor
25447229|NCT04641780|Dopamine Agents|dopamine agents|mesh-ancestor
25301544|NCT03631043|Lenalidomide|lenalidomide|mesh-list
25301545|NCT03631043|Vaccines|vaccines|mesh-list
25301546|NCT03631043|Immunologic Factors|immunologic factors|mesh-ancestor
25301547|NCT03631043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545061|NCT00691795|Sympatholytics|sympatholytics|mesh-ancestor
24545062|NCT00691795|Autonomic Agents|autonomic agents|mesh-ancestor
24545063|NCT00691795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24545067|NCT00691795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24545068|NCT00691795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545069|NCT00691873|Omalizumab|omalizumab|mesh-list
25301548|NCT03631043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25301549|NCT03631043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25301550|NCT03631043|Growth Substances|growth substances|mesh-ancestor
25301551|NCT03631043|Growth Inhibitors|growth inhibitors|mesh-ancestor
25301552|NCT03631043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419007|NCT00210782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419008|NCT00210782|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24419009|NCT00210782|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24419010|NCT00210795|Epoetin Alfa|epoetin alfa|mesh-list
24419011|NCT00210795|Hematinics|hematinics|mesh-ancestor
24844502|NCT02233023|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24844503|NCT02233023|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24844504|NCT02233023|Dopamine Agents|dopamine agents|mesh-ancestor
24844505|NCT02233023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24844506|NCT02233023|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24545086|NCT00691886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545088|NCT00691912|Doxorubicin|doxorubicin|mesh-list
24858086|NCT02295046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858088|NCT02295046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24858089|NCT02295046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24858090|NCT02295046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24419012|NCT00210808|Topiramate|topiramate|mesh-list
24419013|NCT00210808|Anticonvulsants|anticonvulsants|mesh-ancestor
24419014|NCT00210808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24419015|NCT00210808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419016|NCT00210821|Topiramate|topiramate|mesh-list
24419017|NCT00210821|Anticonvulsants|anticonvulsants|mesh-ancestor
24419018|NCT00210821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24419055|NCT00210899|Ceftazidime|ceftazidime|mesh-list
24419056|NCT00210899|Ceftobiprole|ceftobiprole|mesh-list
24419057|NCT00210899|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
24545093|NCT00691912|Antimitotic Agents|antimitotic agents|mesh-ancestor
24545094|NCT00691912|Mitosis Modulators|mitosis modulators|mesh-ancestor
24545095|NCT00691912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545096|NCT00691912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24545097|NCT00691912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24545098|NCT00691912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24545112|NCT00691951|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24545113|NCT00691951|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24858097|NCT02295124|Narcotics|narcotics|mesh-ancestor
24419058|NCT00210899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24419059|NCT00210899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24419061|NCT00210912|Anticonvulsants|anticonvulsants|mesh-ancestor
25822635|NCT00004578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24978224|NCT05035303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24978225|NCT05035303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24419174|NCT00211380|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24419176|NCT00211380|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24419188|NCT00211393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419189|NCT00211393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24419191|NCT00211406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24419192|NCT00211406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24419193|NCT00211406|Growth Substances|growth substances|mesh-ancestor
24419194|NCT00211406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419195|NCT00211406|Growth Inhibitors|growth inhibitors|mesh-ancestor
24419196|NCT00211406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551521|NCT00630734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25551522|NCT00630734|Antimetabolites|antimetabolites|mesh-ancestor
25551523|NCT00630734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25551524|NCT00630734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25551525|NCT00630786|Panitumumab|panitumumab|mesh-list
25551526|NCT00630786|Conatumumab|conatumumab|mesh-list
25551527|NCT00630786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25551528|NCT00630786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551529|NCT00630812|Mannitol|mannitol|mesh-list
24419197|NCT00211419|Triamcinolone|triamcinolone|mesh-list
25551530|NCT00630812|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25551531|NCT00630812|Diuretics|diuretics|mesh-ancestor
25551532|NCT00630812|Natriuretic Agents|natriuretic agents|mesh-ancestor
25551533|NCT00630812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551534|NCT00630825|Dulaglutide|dulaglutide|mesh-list
25551535|NCT00630825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25551536|NCT00630825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551537|NCT00630877|Aspirin|aspirin|mesh-list
25551538|NCT00630877|Niacin|niacin|mesh-list
25551539|NCT00630877|Niacinamide|niacinamide|mesh-list
25551540|NCT00630877|Nicotinic Acids|nicotinic acids|mesh-list
25551541|NCT00630877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25551542|NCT00630877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25551543|NCT00630877|Analgesics|analgesics|mesh-ancestor
25551544|NCT00630877|Sensory System Agents|sensory system agents|mesh-ancestor
25551545|NCT00630877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25551546|NCT00630877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551547|NCT00630877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25551548|NCT00630877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25551549|NCT00630877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25551550|NCT00630877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25551551|NCT00630877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551552|NCT00630877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25551553|NCT00630877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25551554|NCT00630877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25551555|NCT00630877|Antipyretics|antipyretics|mesh-ancestor
25551556|NCT00630877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25551557|NCT00630877|Antimetabolites|antimetabolites|mesh-ancestor
25551558|NCT00630877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25551559|NCT00630877|Vasodilator Agents|vasodilator agents|mesh-ancestor
25551560|NCT00630877|Vitamin B Complex|vitamin b complex|mesh-ancestor
25551561|NCT00630877|Vitamins|vitamins|mesh-ancestor
25551562|NCT00630877|Micronutrients|micronutrients|mesh-ancestor
25551563|NCT00630955|Memantine|memantine|mesh-list
25551564|NCT00630955|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25551565|NCT00630955|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25551566|NCT00630955|Dopamine Agents|dopamine agents|mesh-ancestor
25551567|NCT00630955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25276330|NCT02365727|Analgesics|analgesics|mesh-ancestor
25276331|NCT02365727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25276332|NCT02365727|Sympatholytics|sympatholytics|mesh-ancestor
25276333|NCT02365727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25276334|NCT02365805|Paclitaxel|paclitaxel|mesh-list
25276335|NCT02365805|Docetaxel|docetaxel|mesh-list
25276336|NCT02365805|Fluorouracil|fluorouracil|mesh-list
25276337|NCT02365805|Epirubicin|epirubicin|mesh-list
25276338|NCT02365805|Cyclophosphamide|cyclophosphamide|mesh-list
24545149|NCT00692120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545151|NCT00692120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24545153|NCT00692159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551568|NCT00630955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551569|NCT00630955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551570|NCT00630955|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25551571|NCT00630955|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25551572|NCT00630994|Decitabine|decitabine|mesh-list
25551573|NCT00630994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25551574|NCT00630994|Antimetabolites|antimetabolites|mesh-ancestor
25551575|NCT00630994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551576|NCT00630994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551577|NCT00630994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25551578|NCT00631007|Pioglitazone|pioglitazone|mesh-list
25551579|NCT00631007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25551580|NCT00631007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551581|NCT00631163|Deferasirox|deferasirox|mesh-list
25551582|NCT00631163|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25551583|NCT00631163|Chelating Agents|chelating agents|mesh-ancestor
25551584|NCT00631163|Sequestering Agents|sequestering agents|mesh-ancestor
25551585|NCT00631163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043905|NCT01188187|Prednisone|prednisone|mesh-list
25551586|NCT00631189|Atorvastatin|atorvastatin|mesh-list
25551587|NCT00631189|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25551588|NCT00631189|Pravastatin|pravastatin|mesh-list
25551589|NCT00631189|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25551590|NCT00631189|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25551591|NCT00631189|Antimetabolites|antimetabolites|mesh-ancestor
25551592|NCT00631189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551593|NCT00631189|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25551594|NCT00631189|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25551595|NCT00631189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25551596|NCT00631319|Hydromorphone|hydromorphone|mesh-list
25551597|NCT00631319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25551598|NCT00631319|Narcotics|narcotics|mesh-ancestor
25551599|NCT00631319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25551600|NCT00631319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551601|NCT00631319|Analgesics|analgesics|mesh-ancestor
25551602|NCT00631319|Sensory System Agents|sensory system agents|mesh-ancestor
25551603|NCT00631319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25551604|NCT00631358|Dexamethasone|dexamethasone|mesh-list
25551605|NCT00631358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25551606|NCT00631358|Antiemetics|antiemetics|mesh-ancestor
25551607|NCT00631358|Autonomic Agents|autonomic agents|mesh-ancestor
25551608|NCT00631358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25551609|NCT00631358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551610|NCT00631358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25276436|NCT02364934|Anesthetics|anesthetics|mesh-ancestor
25551611|NCT00631358|Glucocorticoids|glucocorticoids|mesh-ancestor
25551612|NCT00631358|Hormones|hormones|mesh-ancestor
25551613|NCT00631358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25551614|NCT00631358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25551615|NCT00631358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551616|NCT00631371|Interferons|interferons|mesh-list
25551617|NCT00631371|Interferon-alpha|interferon-alpha|mesh-list
25551618|NCT00631371|Sirolimus|sirolimus|mesh-list
25551620|NCT00631371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25551621|NCT00631371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551622|NCT00631371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25551623|NCT00631371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25551624|NCT00631371|Growth Substances|growth substances|mesh-ancestor
25551625|NCT00631371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551626|NCT00631371|Growth Inhibitors|growth inhibitors|mesh-ancestor
25551627|NCT00631371|Antiviral Agents|antiviral agents|mesh-ancestor
25551628|NCT00631371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25551629|NCT00631371|Immunologic Factors|immunologic factors|mesh-ancestor
25551630|NCT00631371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25551631|NCT00631371|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25551632|NCT00631371|Antifungal Agents|antifungal agents|mesh-ancestor
25551633|NCT00631371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25551634|NCT00631410|Sunitinib|sunitinib|mesh-list
25551635|NCT00631410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551636|NCT00631410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25551637|NCT00631410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25551638|NCT00631410|Growth Substances|growth substances|mesh-ancestor
25551639|NCT00631410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551640|NCT00631410|Growth Inhibitors|growth inhibitors|mesh-ancestor
25551641|NCT00631410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25551642|NCT00631410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25551643|NCT00631410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551644|NCT00631449|Raltegravir Potassium|raltegravir potassium|mesh-list
25551645|NCT00631449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25551646|NCT00631449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25551647|NCT00631449|Antiviral Agents|antiviral agents|mesh-ancestor
24545347|NCT00693108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545348|NCT00693121|Amantadine|amantadine|mesh-list
24545349|NCT00693121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24545350|NCT00693121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25682130|NCT01875848|Naloxone|naloxone|mesh-list
25551648|NCT00631449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25551649|NCT00631449|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25551650|NCT00631449|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25551651|NCT00631449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25551652|NCT00631449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551653|NCT00631475|Bosentan|bosentan|mesh-list
25551654|NCT00631475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25551655|NCT00631475|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25551656|NCT00631475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551657|NCT00631488|Metformin|metformin|mesh-list
25551658|NCT00631488|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25551659|NCT00631488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25551660|NCT00631488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551661|NCT00631488|Incretins|incretins|mesh-ancestor
25551662|NCT00631488|Hormones|hormones|mesh-ancestor
25551663|NCT00631488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25551664|NCT00631488|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25551665|NCT00631488|Protease Inhibitors|protease inhibitors|mesh-ancestor
25551666|NCT00631488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25551667|NCT00631488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551668|NCT00631566|Mupirocin|mupirocin|mesh-list
25551669|NCT00631566|Triclosan|triclosan|mesh-list
25551670|NCT00631566|Hexachlorophene|hexachlorophene|mesh-list
25551671|NCT00631566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25551672|NCT00631566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25551673|NCT00631566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25551674|NCT00631566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25551675|NCT00631566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551676|NCT00631566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25551677|NCT00631566|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25551678|NCT00631566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25551679|NCT00631566|Antimetabolites|antimetabolites|mesh-ancestor
25551680|NCT00631566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24994404|NCT04300231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229101|NCT02604615|Oxaliplatin|oxaliplatin|mesh-list
25229102|NCT02604615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25229103|NCT02604615|Antimetabolites|antimetabolites|mesh-ancestor
25229104|NCT02604615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229105|NCT02604615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25229106|NCT02604576|Bromopride|bromopride|mesh-list
25229107|NCT02604576|Metoclopramide|metoclopramide|mesh-list
25229108|NCT02604576|Simethicone|simethicone|mesh-list
25229109|NCT02604576|Antifoaming Agents|antifoaming agents|mesh-ancestor
25229110|NCT02604576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229111|NCT02604576|Emollients|emollients|mesh-ancestor
25229112|NCT02604576|Dermatologic Agents|dermatologic agents|mesh-ancestor
25229113|NCT02604576|Antiemetics|antiemetics|mesh-ancestor
24826068|NCT02132234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24826069|NCT02132234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24826070|NCT02132234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24827951|NCT02142556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25551681|NCT00631657|Mirtazapine|mirtazapine|mesh-list
25551682|NCT00631657|Antidepressive Agents|antidepressive agents|mesh-ancestor
25551683|NCT00631657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25551684|NCT00631657|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25551685|NCT00631657|Histamine Antagonists|histamine antagonists|mesh-ancestor
25551686|NCT00631657|Histamine Agents|histamine agents|mesh-ancestor
25551687|NCT00631657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25551688|NCT00631657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551689|NCT00631657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551690|NCT00631657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25551691|NCT00631657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25551692|NCT00631657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25039275|NCT03928184|Lorecivivint|lorecivivint|mesh-list
25551693|NCT00631657|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25551694|NCT00631657|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25551695|NCT00631657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25551696|NCT00631657|Adrenergic Agents|adrenergic agents|mesh-ancestor
25551697|NCT00631657|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25551698|NCT00631657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25551699|NCT00631657|Serotonin Agents|serotonin agents|mesh-ancestor
25276703|NCT02362711|Levonorgestrel|levonorgestrel|mesh-list
25682196|NCT01876381|Natriuretic Agents|natriuretic agents|mesh-ancestor
25551700|NCT00631657|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25551702|NCT00631696|Analgesics|analgesics|mesh-ancestor
25551703|NCT00631696|Sensory System Agents|sensory system agents|mesh-ancestor
25551704|NCT00631696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25551705|NCT00631696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551706|NCT00631696|Anticonvulsants|anticonvulsants|mesh-ancestor
25551707|NCT00631696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25551708|NCT00631696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24994677|NCT03534947|Imiquimod|imiquimod|mesh-list
25551709|NCT00631696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551710|NCT00631696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25551711|NCT00631696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25551712|NCT00631696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25551713|NCT00631696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25551714|NCT00631696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25551715|NCT00631748|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25551716|NCT00631748|Antidepressive Agents|antidepressive agents|mesh-ancestor
25551717|NCT00631748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25551718|NCT00631748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25551719|NCT00631748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25551720|NCT00631748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25551721|NCT00631748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551722|NCT00631917|Ramipril|ramipril|mesh-list
25551723|NCT00631917|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25551724|NCT00631917|Protease Inhibitors|protease inhibitors|mesh-ancestor
25551725|NCT00631917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25551726|NCT00631917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551727|NCT00631917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25551728|NCT00631969|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
25551729|NCT00631969|Vasodilator Agents|vasodilator agents|mesh-ancestor
25551730|NCT00631969|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25551731|NCT00631969|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25551732|NCT00631969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25551733|NCT00631969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551734|NCT00631969|Urological Agents|urological agents|mesh-ancestor
25551735|NCT00632099|Progesterone|progesterone|mesh-list
25551736|NCT00632099|Progestins|progestins|mesh-ancestor
25551737|NCT00632099|Hormones|hormones|mesh-ancestor
25551738|NCT00632099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25682212|NCT01876732|Vitamin B Complex|vitamin b complex|mesh-ancestor
25551739|NCT00632099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551740|NCT00632125|Epoetin Alfa|epoetin alfa|mesh-list
25551741|NCT00632125|Hematinics|hematinics|mesh-ancestor
25551742|NCT00632203|Temozolomide|temozolomide|mesh-list
25551743|NCT00632203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25551744|NCT00632203|Alkylating Agents|alkylating agents|mesh-ancestor
25551745|NCT00632203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551746|NCT00632203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551747|NCT00632229|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25551748|NCT00632229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25551749|NCT00632229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25551750|NCT00632229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25551751|NCT00632229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551752|NCT00632229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25551753|NCT00632229|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25551754|NCT00632229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25551755|NCT00632229|Serotonin Agents|serotonin agents|mesh-ancestor
25551756|NCT00632229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25551757|NCT00632229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551758|NCT00632229|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25551759|NCT00632229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25551760|NCT00632229|Dopamine Agents|dopamine agents|mesh-ancestor
25551761|NCT00632359|Lenalidomide|lenalidomide|mesh-list
25551762|NCT00632359|Immunologic Factors|immunologic factors|mesh-ancestor
25551763|NCT00632359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447358|NCT04639232|Probenecid|probenecid|mesh-list
25551764|NCT00632359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25551765|NCT00632359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25551766|NCT00632359|Growth Substances|growth substances|mesh-ancestor
25551767|NCT00632359|Growth Inhibitors|growth inhibitors|mesh-ancestor
25551768|NCT00632359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551769|NCT00632411|Nicotine|nicotine|mesh-list
25551770|NCT00632411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25551771|NCT00632411|Autonomic Agents|autonomic agents|mesh-ancestor
25551772|NCT00632411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25551773|NCT00632411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551774|NCT00632411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25551775|NCT00632411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25551776|NCT00632411|Cholinergic Agents|cholinergic agents|mesh-ancestor
25551777|NCT00632411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25551778|NCT00632411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460462|NCT00348452|Celecoxib|celecoxib|mesh-list
25551779|NCT00632489|Capecitabine|capecitabine|mesh-list
25551780|NCT00632489|Lapatinib|lapatinib|mesh-list
25551781|NCT00632489|Panobinostat|panobinostat|mesh-list
25551782|NCT00632489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25551783|NCT00632489|Antimetabolites|antimetabolites|mesh-ancestor
25551784|NCT00632489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551785|NCT00632489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551786|NCT00632489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25551787|NCT00632489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25551788|NCT00632489|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25551789|NCT00632541|Bevacizumab|bevacizumab|mesh-list
25551790|NCT00632541|Sorafenib|sorafenib|mesh-list
25551791|NCT00632541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25551792|NCT00632541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551793|NCT00632541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25551794|NCT00632541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25551795|NCT00632541|Growth Substances|growth substances|mesh-ancestor
25551796|NCT00632541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551797|NCT00632541|Growth Inhibitors|growth inhibitors|mesh-ancestor
25551798|NCT00632541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25551799|NCT00632541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25551800|NCT00632541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551801|NCT00632619|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
25551802|NCT00632619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551803|NCT00632632|Cycloserine|cycloserine|mesh-list
25551804|NCT00632632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25551805|NCT00632632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25551806|NCT00632632|Renal Agents|renal agents|mesh-ancestor
25551807|NCT00632632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25126037|NCT03064282|Papaverine|papaverine|mesh-list
25551808|NCT00632632|Antitubercular Agents|antitubercular agents|mesh-ancestor
25551809|NCT00632632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25551810|NCT00632632|Antimetabolites|antimetabolites|mesh-ancestor
25551811|NCT00632632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447413|NCT04639193|Natriuretic Agents|natriuretic agents|mesh-ancestor
25447414|NCT04639193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25447415|NCT04639193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25447416|NCT04638686|Lamivudine|lamivudine|mesh-list
25447417|NCT04638686|Dolutegravir|dolutegravir|mesh-list
25447418|NCT04638686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25447419|NCT04638686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25447420|NCT04638686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25447421|NCT04638686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447422|NCT04638686|Antiviral Agents|antiviral agents|mesh-ancestor
25447423|NCT04638686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25447424|NCT04638686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25447425|NCT04638686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25447426|NCT04638686|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25551812|NCT00632736|Ropinirole|ropinirole|mesh-list
25551813|NCT00632736|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25551814|NCT00632736|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25551815|NCT00632736|Dopamine Agonists|dopamine agonists|mesh-ancestor
25551816|NCT00632736|Dopamine Agents|dopamine agents|mesh-ancestor
25551817|NCT00632736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25551818|NCT00632736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551819|NCT00632736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551820|NCT00632749|Cytarabine|cytarabine|mesh-list
25551821|NCT00632749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25551822|NCT00632749|Antimetabolites|antimetabolites|mesh-ancestor
25551823|NCT00632749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551824|NCT00632749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551825|NCT00632749|Antiviral Agents|antiviral agents|mesh-ancestor
25551826|NCT00632749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25551827|NCT00632749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25551828|NCT00632749|Immunologic Factors|immunologic factors|mesh-ancestor
25551829|NCT00632749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551830|NCT00632814|Factor VIII|factor viii|mesh-list
25551831|NCT00632814|Coagulants|coagulants|mesh-ancestor
24460567|NCT00348894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24460569|NCT00348894|Adrenergic Agents|adrenergic agents|mesh-ancestor
25126073|NCT03064295|Adenosine|adenosine|mesh-list
25551832|NCT00632827|Leucovorin|leucovorin|mesh-list
25551833|NCT00632827|Gemcitabine|gemcitabine|mesh-list
25551834|NCT00632827|Cytarabine|cytarabine|mesh-list
25551835|NCT00632827|Cyclophosphamide|cyclophosphamide|mesh-list
25551836|NCT00632827|Carmustine|carmustine|mesh-list
25551837|NCT00632827|Doxorubicin|doxorubicin|mesh-list
25551838|NCT00632827|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25551839|NCT00632827|Methotrexate|methotrexate|mesh-list
25551840|NCT00632827|Etoposide|etoposide|mesh-list
25551841|NCT00632827|Vincristine|vincristine|mesh-list
25551842|NCT00632827|Vinorelbine|vinorelbine|mesh-list
25551843|NCT00632827|Denileukin diftitox|denileukin diftitox|mesh-list
25551844|NCT00632827|Lenograstim|lenograstim|mesh-list
25551845|NCT00632827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25551846|NCT00632827|Immunologic Factors|immunologic factors|mesh-ancestor
25551847|NCT00632827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551848|NCT00632827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25551849|NCT00632827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25551850|NCT00632827|Alkylating Agents|alkylating agents|mesh-ancestor
25551851|NCT00632827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551852|NCT00632827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551853|NCT00632827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25551854|NCT00632827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25551855|NCT00632827|Antimetabolites|antimetabolites|mesh-ancestor
25551856|NCT00632827|Antiviral Agents|antiviral agents|mesh-ancestor
25551857|NCT00632827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25551858|NCT00632827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25551859|NCT00632827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25551860|NCT00632827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25551861|NCT00632827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25551862|NCT00632827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25551863|NCT00632827|Abortifacient Agents|abortifacient agents|mesh-ancestor
25551864|NCT00632827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25551865|NCT00632827|Dermatologic Agents|dermatologic agents|mesh-ancestor
25551866|NCT00632827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25551867|NCT00632827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25551868|NCT00632827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25551869|NCT00632827|Antidotes|antidotes|mesh-ancestor
25551870|NCT00632827|Protective Agents|protective agents|mesh-ancestor
25551871|NCT00632827|Vitamin B Complex|vitamin b complex|mesh-ancestor
25551872|NCT00632827|Vitamins|vitamins|mesh-ancestor
25551873|NCT00632827|Micronutrients|micronutrients|mesh-ancestor
25551874|NCT00632827|Tubulin Modulators|tubulin modulators|mesh-ancestor
25551875|NCT00632827|Antimitotic Agents|antimitotic agents|mesh-ancestor
25551876|NCT00632827|Mitosis Modulators|mitosis modulators|mesh-ancestor
25551877|NCT00632827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25551878|NCT00632931|Vorinostat|vorinostat|mesh-list
25551879|NCT00632931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551880|NCT00632931|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25551881|NCT00632931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25551882|NCT00632931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551883|NCT00632970|Ritonavir|ritonavir|mesh-list
25551884|NCT00632970|Lopinavir|lopinavir|mesh-list
25551885|NCT00632970|Tenofovir|tenofovir|mesh-list
25551886|NCT00632970|Emtricitabine|emtricitabine|mesh-list
25551887|NCT00632970|Raltegravir Potassium|raltegravir potassium|mesh-list
25277115|NCT02360592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25277116|NCT02360592|Immunologic Factors|immunologic factors|mesh-ancestor
25277119|NCT02360592|Analgesics|analgesics|mesh-ancestor
25551888|NCT00632970|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25551889|NCT00632970|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25551890|NCT00632970|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25551891|NCT00632970|Protease Inhibitors|protease inhibitors|mesh-ancestor
25551892|NCT00632970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25447463|NCT04638582|Paclitaxel|paclitaxel|mesh-list
25447464|NCT04638582|Carboplatin|carboplatin|mesh-list
25447465|NCT04638582|Pembrolizumab|pembrolizumab|mesh-list
25447466|NCT04638582|Pemetrexed|pemetrexed|mesh-list
25447467|NCT04638582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25551893|NCT00632970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551894|NCT00632970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25551895|NCT00632970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25447468|NCT04638582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447477|NCT04638751|Pembrolizumab|pembrolizumab|mesh-list
25551896|NCT00632970|Antiviral Agents|antiviral agents|mesh-ancestor
25551897|NCT00632970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25551898|NCT00632970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25551899|NCT00632970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25551900|NCT00632970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25551901|NCT00632970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25551902|NCT00632970|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25551903|NCT00632970|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25551904|NCT00633074|Vaccines|vaccines|mesh-list
25551905|NCT00633074|Immunologic Factors|immunologic factors|mesh-ancestor
25551906|NCT00633074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551907|NCT00633126|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
25551908|NCT00633126|Cephalosporins|cephalosporins|mesh-list
25551909|NCT00633126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25551910|NCT00633126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25551911|NCT00633152|Linezolid|linezolid|mesh-list
25551912|NCT00633152|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
25551913|NCT00633152|Cephalosporins|cephalosporins|mesh-list
25551914|NCT00633152|Aztreonam|aztreonam|mesh-list
25551915|NCT00633152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25551916|NCT00633152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25551917|NCT00633152|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25551918|NCT00633152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25551919|NCT00633152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551920|NCT00633217|Fluticasone|fluticasone|mesh-list
25551922|NCT00633217|Norflurane|norflurane|mesh-list
25551923|NCT00633217|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25551924|NCT00633217|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25551925|NCT00633217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25551926|NCT00633217|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25551927|NCT00633217|Autonomic Agents|autonomic agents|mesh-ancestor
25551928|NCT00633217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25551929|NCT00633217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551930|NCT00633217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25551931|NCT00633217|Respiratory System Agents|respiratory system agents|mesh-ancestor
25551932|NCT00633217|Dermatologic Agents|dermatologic agents|mesh-ancestor
25551933|NCT00633217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25551934|NCT00633217|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25551935|NCT00633217|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25551936|NCT00633217|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25551937|NCT00633217|Adrenergic Agents|adrenergic agents|mesh-ancestor
25551938|NCT00633217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24550936|NCT00723268|Mitosis Modulators|mitosis modulators|mesh-ancestor
25551939|NCT00633217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551940|NCT00633217|Glucocorticoids|glucocorticoids|mesh-ancestor
25551941|NCT00633217|Hormones|hormones|mesh-ancestor
25551942|NCT00633217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25551943|NCT00633217|Sympathomimetics|sympathomimetics|mesh-ancestor
25551944|NCT00633217|Anesthetics|anesthetics|mesh-ancestor
25551945|NCT00633217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25551946|NCT00633256|Isoniazid|isoniazid|mesh-list
25551947|NCT00633256|Cycloserine|cycloserine|mesh-list
25551948|NCT00633256|Antitubercular Agents|antitubercular agents|mesh-ancestor
25551949|NCT00633256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25551950|NCT00633256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25551951|NCT00633256|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25551952|NCT00633256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25551953|NCT00633256|Antimetabolites|antimetabolites|mesh-ancestor
25551954|NCT00633256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551955|NCT00633256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25551956|NCT00633256|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25551957|NCT00633256|Renal Agents|renal agents|mesh-ancestor
25551958|NCT00633256|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25551959|NCT00633360|Drospirenone|drospirenone|mesh-list
25551960|NCT00633360|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24791975|NCT02053363|Hemostatics|hemostatics|mesh-ancestor
25551961|NCT00633360|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
25447521|NCT04636918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447522|NCT04636918|Antifungal Agents|antifungal agents|mesh-ancestor
25447523|NCT04636918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25551962|NCT00633360|Estradiol|estradiol|mesh-list
25551963|NCT00633360|Estrogens|estrogens|mesh-ancestor
25551964|NCT00633360|Hormones|hormones|mesh-ancestor
25551965|NCT00633360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25551966|NCT00633360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551967|NCT00633360|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25551968|NCT00633360|Contraceptive Agents|contraceptive agents|mesh-ancestor
25551969|NCT00633360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25551970|NCT00633360|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25551971|NCT00633360|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25551972|NCT00633360|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25551973|NCT00633360|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25551974|NCT00633360|Hormone Antagonists|hormone antagonists|mesh-ancestor
25551975|NCT00633360|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25551976|NCT00633360|Diuretics|diuretics|mesh-ancestor
25551977|NCT00633360|Natriuretic Agents|natriuretic agents|mesh-ancestor
25551978|NCT00633399|Ziprasidone|ziprasidone|mesh-list
25551979|NCT00633399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25551980|NCT00633399|Serotonin Agents|serotonin agents|mesh-ancestor
25551981|NCT00633399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25551982|NCT00633399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551983|NCT00633399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551984|NCT00633399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25551985|NCT00633399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25158274|NCT04378933|Methamphetamine|methamphetamine|mesh-list
25551986|NCT00633399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25551987|NCT00633399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25551988|NCT00633399|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25551989|NCT00633399|Dopamine Agents|dopamine agents|mesh-ancestor
25126519|NCT03061656|Melphalan|melphalan|mesh-list
25651270|NCT01514370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25651271|NCT01514370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651272|NCT01514370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651273|NCT01514370|Immunologic Factors|immunologic factors|mesh-ancestor
25651274|NCT01514370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25651275|NCT01514422|Minocycline|minocycline|mesh-list
25651276|NCT01514422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25651277|NCT01514422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25651278|NCT01514448|Everolimus|everolimus|mesh-list
25651279|NCT01514448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25651280|NCT01514448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25651281|NCT01514448|Immunologic Factors|immunologic factors|mesh-ancestor
25651282|NCT01514448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651283|NCT01514513|Permethrin|permethrin|mesh-list
25651284|NCT01514513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651285|NCT01514513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651286|NCT01514734|Timolol|timolol|mesh-list
25651287|NCT01514734|Brinzolamide|brinzolamide|mesh-list
25651288|NCT01514734|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25651289|NCT01514734|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25277460|NCT02358161|Paclitaxel|paclitaxel|mesh-list
25651290|NCT01514734|Adrenergic Agents|adrenergic agents|mesh-ancestor
24701766|NCT01460706|Edotreotide|edotreotide|mesh-list
25651291|NCT01514734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25651292|NCT01514734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651293|NCT01514734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701822|NCT01461460|Moxifloxacin|moxifloxacin|mesh-list
25126727|NCT03060018|Parasympatholytics|parasympatholytics|mesh-ancestor
25126728|NCT03060018|Autonomic Agents|autonomic agents|mesh-ancestor
25126729|NCT03060018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25126730|NCT03060018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126731|NCT03059979|Methylprednisolone|methylprednisolone|mesh-list
25126732|NCT03059979|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25126733|NCT03059979|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25126734|NCT03059979|Prednisolone|prednisolone|mesh-list
25126735|NCT03059979|Prednisolone acetate|prednisolone acetate|mesh-list
25126736|NCT03059979|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25126737|NCT03059979|Prednisolone phosphate|prednisolone phosphate|mesh-list
25126738|NCT03059979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25126739|NCT03059979|Antiemetics|antiemetics|mesh-ancestor
25126740|NCT03059979|Autonomic Agents|autonomic agents|mesh-ancestor
25126741|NCT03059979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25158445|NCT04297267|Gemcitabine|gemcitabine|mesh-list
25651294|NCT01514734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25651295|NCT01514734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25651296|NCT01514734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651297|NCT01514734|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25651298|NCT01514864|Dasatinib|dasatinib|mesh-list
25651299|NCT01514864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25126992|NCT03058354|Anesthetics|anesthetics|mesh-ancestor
24702321|NCT01465113|Vitamin D|vitamin d|mesh-list
25651300|NCT01514864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25651301|NCT01514864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651302|NCT01514864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651303|NCT01515046|Ascorbic Acid|ascorbic acid|mesh-list
25651304|NCT01515046|Gemcitabine|gemcitabine|mesh-list
25651305|NCT01515046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25651306|NCT01515046|Antimetabolites|antimetabolites|mesh-ancestor
25651307|NCT01515046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651308|NCT01515046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25651309|NCT01515046|Antiviral Agents|antiviral agents|mesh-ancestor
25651310|NCT01515046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25651311|NCT01515046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651312|NCT01515046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24702765|NCT01467531|Antiviral Agents|antiviral agents|mesh-ancestor
25651313|NCT01515046|Immunologic Factors|immunologic factors|mesh-ancestor
25651314|NCT01515046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651315|NCT01515046|Antioxidants|antioxidants|mesh-ancestor
25651316|NCT01515046|Protective Agents|protective agents|mesh-ancestor
25651317|NCT01515046|Vitamins|vitamins|mesh-ancestor
25277881|NCT02355119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277883|NCT02355119|Antiviral Agents|antiviral agents|mesh-ancestor
25651318|NCT01515046|Micronutrients|micronutrients|mesh-ancestor
25651319|NCT01515176|Ofatumumab|ofatumumab|mesh-list
25651320|NCT01515176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25651321|NCT01515176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25651322|NCT01515176|Immunologic Factors|immunologic factors|mesh-ancestor
25651323|NCT01515176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25551990|NCT00633464|Cetuximab|cetuximab|mesh-list
25551991|NCT00633464|Epothilones|epothilones|mesh-list
25551992|NCT00633464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25551993|NCT00633464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25551994|NCT00633464|Tubulin Modulators|tubulin modulators|mesh-ancestor
25551995|NCT00633464|Antimitotic Agents|antimitotic agents|mesh-ancestor
25551996|NCT00633464|Mitosis Modulators|mitosis modulators|mesh-ancestor
25551997|NCT00633464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25551998|NCT00633594|Rituximab|rituximab|mesh-list
25551999|NCT00633594|Lenalidomide|lenalidomide|mesh-list
25552000|NCT00633594|Bortezomib|bortezomib|mesh-list
25552001|NCT00633594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25552002|NCT00633594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552003|NCT00633594|Immunologic Factors|immunologic factors|mesh-ancestor
25552004|NCT00633594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552005|NCT00633594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25552006|NCT00633594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25552007|NCT00633594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25552008|NCT00633594|Growth Substances|growth substances|mesh-ancestor
25552009|NCT00633594|Growth Inhibitors|growth inhibitors|mesh-ancestor
25552010|NCT00633750|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25552011|NCT00633750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552012|NCT00633750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25552013|NCT00633750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25552014|NCT00633750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552015|NCT00633880|Droxidopa|droxidopa|mesh-list
25552016|NCT00633880|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25552017|NCT00633880|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25552018|NCT00633893|Apixaban|apixaban|mesh-list
25552019|NCT00633893|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25552020|NCT00633893|Antithrombins|antithrombins|mesh-ancestor
25552021|NCT00633893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25127503|NCT03055442|Inositol|inositol|mesh-list
25552022|NCT00633893|Protease Inhibitors|protease inhibitors|mesh-ancestor
25552023|NCT00633893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25552024|NCT00633893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552025|NCT00633893|Anticoagulants|anticoagulants|mesh-ancestor
25552026|NCT00633919|Prednisone|prednisone|mesh-list
25552027|NCT00633919|Budesonide|budesonide|mesh-list
25552028|NCT00633919|Albuterol|albuterol|mesh-list
25552029|NCT00633919|Formoterol Fumarate|formoterol fumarate|mesh-list
25552030|NCT00633919|Desloratadine|desloratadine|mesh-list
25552031|NCT00633919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25552032|NCT00633919|Glucocorticoids|glucocorticoids|mesh-ancestor
25552033|NCT00633919|Hormones|hormones|mesh-ancestor
25552034|NCT00633919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25552035|NCT00633919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552036|NCT00633919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25552037|NCT00633919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552038|NCT00633919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25552039|NCT00633919|Autonomic Agents|autonomic agents|mesh-ancestor
25552040|NCT00633919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25552041|NCT00633919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25552042|NCT00633919|Respiratory System Agents|respiratory system agents|mesh-ancestor
25552043|NCT00633919|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25552044|NCT00633919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24704125|NCT01476787|Rituximab|rituximab|mesh-list
25552045|NCT00633919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25552046|NCT00633919|Adrenergic Agents|adrenergic agents|mesh-ancestor
25447659|NCT04635553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25447660|NCT04634981|Anesthetics|anesthetics|mesh-list
25447661|NCT04634981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25447662|NCT04634981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447663|NCT04634656|Lidocaine|lidocaine|mesh-list
25447664|NCT04634656|Anesthetics, Local|anesthetics, local|mesh-ancestor
25447665|NCT04634656|Anesthetics|anesthetics|mesh-ancestor
25447668|NCT04634656|Sensory System Agents|sensory system agents|mesh-ancestor
25552047|NCT00633919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25552048|NCT00633919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613551|NCT01019655|Calcium|calcium|mesh-list
25552049|NCT00633919|Tocolytic Agents|tocolytic agents|mesh-ancestor
25552050|NCT00633919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24704669|NCT01479634|Efavirenz|efavirenz|mesh-list
25552051|NCT00633919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25552052|NCT00633919|Cholinergic Agents|cholinergic agents|mesh-ancestor
25682689|NCT05300841|Hormones|hormones|mesh-ancestor
25552053|NCT00633919|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25552054|NCT00633919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25552055|NCT00633919|Histamine Antagonists|histamine antagonists|mesh-ancestor
25552056|NCT00633919|Histamine Agents|histamine agents|mesh-ancestor
25552057|NCT00633932|Esomeprazole|esomeprazole|mesh-list
25552058|NCT00633932|Omeprazole|omeprazole|mesh-list
25552059|NCT00633932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24704833|NCT01480752|Analgesics|analgesics|mesh-ancestor
25278309|NCT02351973|Diuretics|diuretics|mesh-ancestor
25552060|NCT00633932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25552061|NCT00633932|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25552062|NCT00633932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25552063|NCT00633932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552064|NCT00633945|Lenalidomide|lenalidomide|mesh-list
25552065|NCT00633945|Immunologic Factors|immunologic factors|mesh-ancestor
25552066|NCT00633945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552067|NCT00633945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25552068|NCT00633945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25278478|NCT02351232|Liraglutide|liraglutide|mesh-list
25552069|NCT00633945|Growth Substances|growth substances|mesh-ancestor
25552070|NCT00633945|Growth Inhibitors|growth inhibitors|mesh-ancestor
25552071|NCT00633945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552072|NCT00633984|Cycloserine|cycloserine|mesh-list
25159278|NCT03918252|Ipilimumab|ipilimumab|mesh-list
25552073|NCT00633984|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25108153|NCT03134846|Cetuximab|cetuximab|mesh-list
25552074|NCT00633984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25552075|NCT00633984|Renal Agents|renal agents|mesh-ancestor
25552076|NCT00633984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25552077|NCT00633984|Antitubercular Agents|antitubercular agents|mesh-ancestor
25552078|NCT00633984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25552079|NCT00633984|Antimetabolites|antimetabolites|mesh-ancestor
25552080|NCT00633984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552081|NCT00634036|Pioglitazone|pioglitazone|mesh-list
25552082|NCT00634036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25552083|NCT00634036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552084|NCT00634049|Isavuconazole|isavuconazole|mesh-list
25159392|NCT03850379|Ofloxacin|ofloxacin|mesh-list
25552085|NCT00634049|Antifungal Agents|antifungal agents|mesh-ancestor
25552086|NCT00634049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25552087|NCT00634088|Capecitabine|capecitabine|mesh-list
25552088|NCT00634088|Lapatinib|lapatinib|mesh-list
25552089|NCT00634088|Epothilones|epothilones|mesh-list
25552090|NCT00634088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25552091|NCT00634088|Antimetabolites|antimetabolites|mesh-ancestor
25552092|NCT00634088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552093|NCT00634088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552094|NCT00634088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25552095|NCT00634088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25552096|NCT00634088|Tubulin Modulators|tubulin modulators|mesh-ancestor
25552097|NCT00634088|Antimitotic Agents|antimitotic agents|mesh-ancestor
24705276|NCT01483729|Ritonavir|ritonavir|mesh-list
25552098|NCT00634088|Mitosis Modulators|mitosis modulators|mesh-ancestor
25552099|NCT00634114|Esomeprazole|esomeprazole|mesh-list
25552100|NCT00634114|Omeprazole|omeprazole|mesh-list
25552101|NCT00634114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25278861|NCT02348905|Hormones|hormones|mesh-ancestor
25552102|NCT00634114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25552103|NCT00634114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24565390|NCT00780104|Cytarabine|cytarabine|mesh-list
25552104|NCT00634114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279016|NCT02347891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25279017|NCT02347891|Immunologic Factors|immunologic factors|mesh-ancestor
25552105|NCT00634114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552106|NCT00634179|Prednisone|prednisone|mesh-list
25552107|NCT00634179|Cyclophosphamide|cyclophosphamide|mesh-list
25552108|NCT00634179|Rituximab|rituximab|mesh-list
25552109|NCT00634179|Doxorubicin|doxorubicin|mesh-list
25552110|NCT00634179|Vincristine|vincristine|mesh-list
25552111|NCT00634179|Bortezomib|bortezomib|mesh-list
25552112|NCT00634179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25552113|NCT00634179|Immunologic Factors|immunologic factors|mesh-ancestor
25552114|NCT00634179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552115|NCT00634179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25552116|NCT00634179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25159959|NCT03421639|Leuprolide|leuprolide|mesh-list
25552117|NCT00634179|Alkylating Agents|alkylating agents|mesh-ancestor
25552118|NCT00634179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552119|NCT00634179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552120|NCT00634179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25552121|NCT00634179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25552122|NCT00634179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25552123|NCT00634179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25552124|NCT00634179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25552125|NCT00634179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25552126|NCT00634179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25552127|NCT00634179|Glucocorticoids|glucocorticoids|mesh-ancestor
25552128|NCT00634179|Hormones|hormones|mesh-ancestor
25279276|NCT02345746|Antidotes|antidotes|mesh-ancestor
25552129|NCT00634179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25552130|NCT00634179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25552131|NCT00634179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24705660|NCT01486004|Simeprevir|simeprevir|mesh-list
25279433|NCT02344862|Renal Agents|renal agents|mesh-ancestor
25552132|NCT00634179|Tubulin Modulators|tubulin modulators|mesh-ancestor
25552133|NCT00634179|Antimitotic Agents|antimitotic agents|mesh-ancestor
25552134|NCT00634179|Mitosis Modulators|mitosis modulators|mesh-ancestor
25447710|NCT04633850|Dexamethasone|dexamethasone|mesh-list
25552135|NCT00634244|Cytarabine|cytarabine|mesh-list
25552136|NCT00634244|Sirolimus|sirolimus|mesh-list
25552137|NCT00634244|Carboplatin|carboplatin|mesh-list
25552138|NCT00634244|Etoposide|etoposide|mesh-list
25552139|NCT00634244|Etoposide phosphate|etoposide phosphate|mesh-list
25552140|NCT00634244|Topotecan|topotecan|mesh-list
25552141|NCT00634244|Mitoxantrone|mitoxantrone|mesh-list
25552142|NCT00634244|Alvocidib|alvocidib|mesh-list
25279711|NCT02343419|Miotics|miotics|mesh-ancestor
25552143|NCT00634244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552144|NCT00634244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25131130|NCT03028298|Urological Agents|urological agents|mesh-ancestor
25552145|NCT00634244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25552146|NCT00634244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25552147|NCT00634244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279777|NCT02343250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25279801|NCT02342717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25552148|NCT00634244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552149|NCT00634244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25552150|NCT00634244|Antimetabolites|antimetabolites|mesh-ancestor
25552151|NCT00634244|Antiviral Agents|antiviral agents|mesh-ancestor
25552152|NCT00634244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25552153|NCT00634244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24570900|NCT00807196|Rituximab|rituximab|mesh-list
25552154|NCT00634244|Immunologic Factors|immunologic factors|mesh-ancestor
25279960|NCT02341729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25552155|NCT00634244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552156|NCT00634244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25552157|NCT00634244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25552158|NCT00634244|Antifungal Agents|antifungal agents|mesh-ancestor
25552159|NCT00634244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25552160|NCT00634244|Analgesics|analgesics|mesh-ancestor
25552161|NCT00634244|Sensory System Agents|sensory system agents|mesh-ancestor
25552162|NCT00634244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25552163|NCT00634244|Growth Inhibitors|growth inhibitors|mesh-ancestor
25552164|NCT00634244|Growth Substances|growth substances|mesh-ancestor
25552165|NCT00634244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25552166|NCT00634270|Sirolimus|sirolimus|mesh-list
25552167|NCT00634270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25280099|NCT02340988|Warfarin|warfarin|mesh-list
25552168|NCT00634270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25552169|NCT00634270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25552170|NCT00634270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552171|NCT00634270|Antifungal Agents|antifungal agents|mesh-ancestor
25552172|NCT00634270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25552173|NCT00634270|Immunologic Factors|immunologic factors|mesh-ancestor
25552174|NCT00634270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552175|NCT00634283|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25552176|NCT00634283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25552177|NCT00634283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25552178|NCT00634283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25552179|NCT00634283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552180|NCT00634283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25552181|NCT00634283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161173|NCT01808456|Vaccines|vaccines|mesh-list
25552182|NCT00634283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25280420|NCT02338544|Adapalene|adapalene|mesh-list
24961092|NCT03811418|Docetaxel|docetaxel|mesh-list
25552183|NCT00634283|Antidepressive Agents|antidepressive agents|mesh-ancestor
25552184|NCT00634283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25552185|NCT00634543|Acetaminophen|acetaminophen|mesh-list
25552186|NCT00634543|Gabapentin|gabapentin|mesh-list
25161533|NCT00334815|Cisplatin|cisplatin|mesh-list
25552187|NCT00634543|Tramadol|tramadol|mesh-list
25552188|NCT00634543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25552189|NCT00634543|Analgesics|analgesics|mesh-ancestor
25552190|NCT00634543|Sensory System Agents|sensory system agents|mesh-ancestor
25161607|NCT00042289|Ritonavir|ritonavir|mesh-list
25552191|NCT00634543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25120541|NCT03384784|Galantamine|galantamine|mesh-list
24574956|NCT00828789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25552192|NCT00634543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552193|NCT00634543|Antipyretics|antipyretics|mesh-ancestor
25552194|NCT00634543|Anticonvulsants|anticonvulsants|mesh-ancestor
25552195|NCT00634543|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25552196|NCT00634543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25552197|NCT00634543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25552198|NCT00634543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25552199|NCT00634543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25552200|NCT00634543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25133333|NCT03013361|Ropivacaine|ropivacaine|mesh-list
24530580|NCT00631085|Protective Agents|protective agents|mesh-ancestor
25552201|NCT00634543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25552202|NCT00634543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552203|NCT00634543|Antimanic Agents|antimanic agents|mesh-ancestor
25552204|NCT00634543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25552205|NCT00634543|Narcotics|narcotics|mesh-ancestor
25552206|NCT00634569|gamma-Globulins|gamma-globulins|mesh-list
25122276|NCT03095326|Zinc|zinc|mesh-list
24576972|NCT00841256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552207|NCT00634569|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25552208|NCT00634569|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25552209|NCT00634569|Immunologic Factors|immunologic factors|mesh-ancestor
25651324|NCT01515189|Ipilimumab|ipilimumab|mesh-list
25447786|NCT04632121|Vitamins|vitamins|mesh-ancestor
25447859|NCT04631315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25447860|NCT04631315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133687|NCT03011177|Hormones|hormones|mesh-ancestor
25447862|NCT04631341|Antioxidants|antioxidants|mesh-ancestor
25447863|NCT04631341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447864|NCT04631341|Protective Agents|protective agents|mesh-ancestor
25447865|NCT04631341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447866|NCT04631341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25302365|NCT03956368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25302366|NCT03933007|Fexofenadine|fexofenadine|mesh-list
25302367|NCT03933007|Colchicine|colchicine|mesh-list
25302368|NCT03933007|Midazolam|midazolam|mesh-list
25302369|NCT03933007|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25302370|NCT03933007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25302372|NCT03933007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419198|NCT00211419|Anecortave|anecortave|mesh-list
25120512|NCT03530267|Growth Substances|growth substances|mesh-ancestor
24978265|NCT04950426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24419214|NCT00211432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24419215|NCT00211432|Growth Substances|growth substances|mesh-ancestor
24419216|NCT00211432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419217|NCT00211432|Growth Inhibitors|growth inhibitors|mesh-ancestor
24419218|NCT00211432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419219|NCT00211445|Verteporfin|verteporfin|mesh-list
24419220|NCT00211445|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24419221|NCT00211445|Dermatologic Agents|dermatologic agents|mesh-ancestor
24419222|NCT00211458|Anecortave|anecortave|mesh-list
24419223|NCT00211458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25135023|NCT03003039|Rituximab|rituximab|mesh-list
24419224|NCT00211458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24419225|NCT00211458|Growth Substances|growth substances|mesh-ancestor
24419226|NCT00211458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419227|NCT00211458|Growth Inhibitors|growth inhibitors|mesh-ancestor
24419228|NCT00211458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419229|NCT00211471|Anecortave|anecortave|mesh-list
24419230|NCT00211471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24419231|NCT00211471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25281878|NCT02328495|Misoprostol|misoprostol|mesh-list
25135789|NCT02995707|Thalidomide|thalidomide|mesh-list
24978295|NCT04921722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24978296|NCT04921722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25161811|NCT02304302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25040701|NCT02933671|Anesthetics, Local|anesthetics, local|mesh-ancestor
25040702|NCT02933671|Anesthetics|anesthetics|mesh-ancestor
25040703|NCT02933671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25040704|NCT02933671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040705|NCT02933671|Sensory System Agents|sensory system agents|mesh-ancestor
25040706|NCT02933671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25282411|NCT02325986|Immunologic Factors|immunologic factors|mesh-ancestor
25130274|NCT03034850|Immunologic Factors|immunologic factors|mesh-ancestor
25040707|NCT02924389|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25040708|NCT02924389|Dolutegravir|dolutegravir|mesh-list
25040709|NCT02924389|Triumeq|triumeq|mesh-list
24420256|NCT00215423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25040711|NCT02924389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25040712|NCT02924389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25040713|NCT02924389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040714|NCT02924389|Antiviral Agents|antiviral agents|mesh-ancestor
25040715|NCT02924389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25040716|NCT02924389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25040717|NCT02924389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25040718|NCT02924389|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25040719|NCT02924389|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24707879|NCT01498718|Vaccines|vaccines|mesh-list
25040720|NCT02923531|Nivolumab|nivolumab|mesh-list
25137559|NCT02984722|Metformin|metformin|mesh-list
25552210|NCT00634569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552211|NCT00634647|Prednisone|prednisone|mesh-list
25552212|NCT00634647|Satraplatin|satraplatin|mesh-list
25552213|NCT00634647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25552214|NCT00634647|Glucocorticoids|glucocorticoids|mesh-ancestor
25552215|NCT00634647|Hormones|hormones|mesh-ancestor
25282681|NCT04026945|Lidocaine|lidocaine|mesh-list
25552216|NCT00634647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25552217|NCT00634647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552218|NCT00634647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25552219|NCT00634647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552220|NCT00634751|Capecitabine|capecitabine|mesh-list
25552221|NCT00634751|Oxaliplatin|oxaliplatin|mesh-list
25552222|NCT00634751|Sorafenib|sorafenib|mesh-list
25552223|NCT00634751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25552224|NCT00634751|Antimetabolites|antimetabolites|mesh-ancestor
25552225|NCT00634751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552226|NCT00634751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683533|NCT01794143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25552227|NCT00634751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25552228|NCT00634751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25552229|NCT00634803|Buprenorphine|buprenorphine|mesh-list
25137786|NCT02982850|Aspirin|aspirin|mesh-list
25552230|NCT00634803|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25552231|NCT00634803|Narcotics|narcotics|mesh-ancestor
24585972|NCT00888758|Sirolimus|sirolimus|mesh-list
25552232|NCT00634803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25552233|NCT00634803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552234|NCT00634803|Analgesics|analgesics|mesh-ancestor
25552235|NCT00634803|Sensory System Agents|sensory system agents|mesh-ancestor
25552236|NCT00634803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25552237|NCT00634803|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25552238|NCT00634842|Insulin|insulin|mesh-list
25552239|NCT00634842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25552240|NCT00634842|Insulin Detemir|insulin detemir|mesh-list
25552241|NCT00634842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25552242|NCT00634842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552243|NCT00634907|Warfarin|warfarin|mesh-list
25552244|NCT00634907|Anticoagulants|anticoagulants|mesh-ancestor
25137910|NCT02981719|Antiviral Agents|antiviral agents|mesh-ancestor
25552245|NCT00634920|Cyclosporine|cyclosporine|mesh-list
25552246|NCT00634920|Mycophenolic Acid|mycophenolic acid|mesh-list
25552247|NCT00634920|Prednisolone|prednisolone|mesh-list
25552248|NCT00634920|Everolimus|everolimus|mesh-list
25552249|NCT00634920|Cyclosporins|cyclosporins|mesh-list
25552250|NCT00634920|Basiliximab|basiliximab|mesh-list
25552251|NCT00634920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25552252|NCT00634920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552253|NCT00634920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25552254|NCT00634920|Immunologic Factors|immunologic factors|mesh-ancestor
25552255|NCT00634920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552256|NCT00634920|Antifungal Agents|antifungal agents|mesh-ancestor
25552257|NCT00634920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25552258|NCT00634920|Dermatologic Agents|dermatologic agents|mesh-ancestor
25552259|NCT00634920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25552260|NCT00634920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25552261|NCT00634920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552262|NCT00634920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25552263|NCT00634920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25552264|NCT00634920|Antitubercular Agents|antitubercular agents|mesh-ancestor
25552265|NCT00634920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24588495|NCT00902915|Glucocorticoids|glucocorticoids|mesh-ancestor
25552266|NCT00634920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25552267|NCT00634920|Glucocorticoids|glucocorticoids|mesh-ancestor
25552268|NCT00634920|Hormones|hormones|mesh-ancestor
25552269|NCT00634920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25552270|NCT00634920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25552271|NCT00634933|Prednisone|prednisone|mesh-list
25552272|NCT00634933|Methylprednisolone|methylprednisolone|mesh-list
25552273|NCT00634933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25552274|NCT00634933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25552275|NCT00634933|Prednisolone|prednisolone|mesh-list
25552276|NCT00634933|Prednisolone acetate|prednisolone acetate|mesh-list
25552277|NCT00634933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25552278|NCT00634933|Prednisolone phosphate|prednisolone phosphate|mesh-list
25552279|NCT00634933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25552280|NCT00634933|Glucocorticoids|glucocorticoids|mesh-ancestor
25552281|NCT00634933|Hormones|hormones|mesh-ancestor
25552282|NCT00634933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25283093|NCT05077215|Lenvatinib|lenvatinib|mesh-list
25552283|NCT00634933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552284|NCT00634933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25552285|NCT00634933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552286|NCT00634933|Antiemetics|antiemetics|mesh-ancestor
25552287|NCT00634933|Autonomic Agents|autonomic agents|mesh-ancestor
25138229|NCT02979704|Atorvastatin|atorvastatin|mesh-list
24590767|NCT00913822|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25552288|NCT00634933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25552289|NCT00634933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25552290|NCT00634933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25552291|NCT00634933|Protective Agents|protective agents|mesh-ancestor
25552292|NCT00635024|Melphalan|melphalan|mesh-list
25552293|NCT00635024|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25552294|NCT00635024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25552295|NCT00635024|Alkylating Agents|alkylating agents|mesh-ancestor
25552296|NCT00635024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552297|NCT00635024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552298|NCT00635024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25552299|NCT00635024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25552300|NCT00635024|Immunologic Factors|immunologic factors|mesh-ancestor
25447867|NCT04631484|Riboflavin|riboflavin|mesh-list
25552301|NCT00635024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552302|NCT00635050|Paclitaxel|paclitaxel|mesh-list
25552303|NCT00635050|Cyclophosphamide|cyclophosphamide|mesh-list
25552304|NCT00635050|Bevacizumab|bevacizumab|mesh-list
25552305|NCT00635050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25283294|NCT04824131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25552306|NCT00635050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552307|NCT00635050|Tubulin Modulators|tubulin modulators|mesh-ancestor
25552308|NCT00635050|Antimitotic Agents|antimitotic agents|mesh-ancestor
25552309|NCT00635050|Mitosis Modulators|mitosis modulators|mesh-ancestor
25552310|NCT00635050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552311|NCT00635050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25552312|NCT00635050|Immunologic Factors|immunologic factors|mesh-ancestor
25552313|NCT00635050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552314|NCT00635050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25552315|NCT00635050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25552316|NCT00635050|Alkylating Agents|alkylating agents|mesh-ancestor
25552317|NCT00635050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25552318|NCT00635050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25552319|NCT00635050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25552320|NCT00635050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25552321|NCT00635050|Growth Substances|growth substances|mesh-ancestor
25552322|NCT00635050|Growth Inhibitors|growth inhibitors|mesh-ancestor
25552323|NCT00635089|Reslizumab|reslizumab|mesh-list
25552324|NCT00635089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25552325|NCT00635089|Respiratory System Agents|respiratory system agents|mesh-ancestor
25552326|NCT00635102|Cycloserine|cycloserine|mesh-list
25552327|NCT00635102|Glycine|glycine|mesh-list
24592946|NCT00926614|Atorvastatin|atorvastatin|mesh-list
25552328|NCT00635102|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25552329|NCT00635102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25552330|NCT00635102|Renal Agents|renal agents|mesh-ancestor
25552331|NCT00635102|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25552332|NCT00635102|Antitubercular Agents|antitubercular agents|mesh-ancestor
25552333|NCT00635102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25552334|NCT00635102|Antimetabolites|antimetabolites|mesh-ancestor
25552335|NCT00635102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552336|NCT00635102|Glycine Agents|glycine agents|mesh-ancestor
25552337|NCT00635102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25552338|NCT00635102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552339|NCT00635154|Dexamethasone|dexamethasone|mesh-list
25552340|NCT00635154|Dexamethasone acetate|dexamethasone acetate|mesh-list
24594115|NCT00932685|Midazolam|midazolam|mesh-list
25552341|NCT00635154|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25552342|NCT00635154|BB 1101|bb 1101|mesh-list
25552343|NCT00635154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25552344|NCT00635154|Antiemetics|antiemetics|mesh-ancestor
25139794|NCT02968693|Calcium|calcium|mesh-list
25552345|NCT00635154|Autonomic Agents|autonomic agents|mesh-ancestor
24595863|NCT00940784|Aspirin|aspirin|mesh-list
25283787|NCT03815929|Estradiol|estradiol|mesh-list
25552346|NCT00635154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25552347|NCT00635154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552348|NCT00635154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25552349|NCT00635154|Glucocorticoids|glucocorticoids|mesh-ancestor
25552350|NCT00635154|Hormones|hormones|mesh-ancestor
25552351|NCT00635154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25552352|NCT00635154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25552353|NCT00635154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552354|NCT00635154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25552355|NCT00635154|Protease Inhibitors|protease inhibitors|mesh-ancestor
25552356|NCT00635154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25552357|NCT00635154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552358|NCT00635219|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25552359|NCT00635219|Vortioxetine|vortioxetine|mesh-list
25552360|NCT00635219|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25552361|NCT00635219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25552362|NCT00635219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25283903|NCT03544736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25283904|NCT03508232|Doxycycline|doxycycline|mesh-list
25283905|NCT03508232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25283906|NCT03508232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25283907|NCT03508232|Antimalarials|antimalarials|mesh-ancestor
24599433|NCT04577014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24599434|NCT04577014|Antimetabolites|antimetabolites|mesh-ancestor
25552363|NCT00635219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552364|NCT00635219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25552365|NCT00635219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552366|NCT00635219|Analgesics|analgesics|mesh-ancestor
25552367|NCT00635219|Sensory System Agents|sensory system agents|mesh-ancestor
25447926|NCT04630288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447927|NCT04630171|Anesthetics|anesthetics|mesh-list
25447928|NCT04630171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25283943|NCT03351439|Sensory System Agents|sensory system agents|mesh-ancestor
25283944|NCT03351439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25283945|NCT03351439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451784|NCT00324792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24451785|NCT00324792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463585|NCT00361517|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25138841|NCT02975141|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25138842|NCT02975141|Afatinib|afatinib|mesh-list
25138843|NCT02975141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25447929|NCT04630171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447930|NCT04629885|Oxytocin|oxytocin|mesh-list
25447934|NCT04629495|Sirolimus|sirolimus|mesh-list
25552368|NCT00635219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25552369|NCT00635219|Antidepressive Agents|antidepressive agents|mesh-ancestor
25552370|NCT00635219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25552371|NCT00635219|Dopamine Agents|dopamine agents|mesh-ancestor
25552372|NCT00635219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25552373|NCT00635219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25552374|NCT00635219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25552375|NCT00635219|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25552376|NCT00635219|Serotonin Agents|serotonin agents|mesh-ancestor
25283973|NCT03252626|Urological Agents|urological agents|mesh-ancestor
25283974|NCT03245008|Fasinumab|fasinumab|mesh-list
25283975|NCT03245008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25283976|NCT03245008|Analgesics|analgesics|mesh-ancestor
25283977|NCT03245008|Sensory System Agents|sensory system agents|mesh-ancestor
25283978|NCT03245008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25283979|NCT03245008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283992|NCT03237377|Durvalumab|durvalumab|mesh-list
25283993|NCT03237377|Tremelimumab|tremelimumab|mesh-list
25283996|NCT03236545|Estradiol|estradiol|mesh-list
25552377|NCT00635219|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25552378|NCT00635219|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25552379|NCT00635219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25552380|NCT00635219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25552381|NCT00635232|Irbesartan|irbesartan|mesh-list
25552382|NCT00635232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25552383|NCT00635232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25552384|NCT00635232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25552385|NCT00635232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552386|NCT00635349|Acetaminophen|acetaminophen|mesh-list
25552387|NCT00635349|Meloxicam|meloxicam|mesh-list
25552388|NCT00635349|Aceclofenac|aceclofenac|mesh-list
25552389|NCT00635349|Tramadol|tramadol|mesh-list
25552390|NCT00635349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25552391|NCT00635349|Analgesics|analgesics|mesh-ancestor
25552392|NCT00635349|Sensory System Agents|sensory system agents|mesh-ancestor
25552393|NCT00635349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25552394|NCT00635349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047354|NCT00821249|Glucocorticoids|glucocorticoids|mesh-ancestor
24863416|NCT05079620|Levofloxacin|levofloxacin|mesh-list
24863417|NCT05079620|Ofloxacin|ofloxacin|mesh-list
24863418|NCT05079620|Ceftriaxone|ceftriaxone|mesh-list
24863419|NCT05079620|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24863420|NCT05079620|Clavulanic Acids|clavulanic acids|mesh-list
24863421|NCT05079620|Clavulanic Acid|clavulanic acid|mesh-list
24863422|NCT05079620|Cefepime|cefepime|mesh-list
24863423|NCT05079620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25552395|NCT00635349|Antipyretics|antipyretics|mesh-ancestor
25552396|NCT00635349|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25552397|NCT00635349|Narcotics|narcotics|mesh-ancestor
25552398|NCT00635349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25552399|NCT00635349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25552400|NCT00635349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25552401|NCT00635349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25552402|NCT00635349|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25552403|NCT00635349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25552404|NCT00635349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25138931|NCT02974387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138977|NCT02974348|Lumefantrine|lumefantrine|mesh-list
25138978|NCT02974348|Piperaquine|piperaquine|mesh-list
25138979|NCT02974348|Artenimol|artenimol|mesh-list
25138980|NCT02974348|Mefloquine|mefloquine|mesh-list
25138981|NCT02974348|Quinine|quinine|mesh-list
25138982|NCT02974348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25138983|NCT02974348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25138984|NCT02974348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25138985|NCT02974348|Analgesics|analgesics|mesh-ancestor
25138986|NCT02974348|Sensory System Agents|sensory system agents|mesh-ancestor
25552405|NCT00635349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552406|NCT00635362|Levonorgestrel|levonorgestrel|mesh-list
25552407|NCT00635362|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25552408|NCT00635362|Contraceptive Agents|contraceptive agents|mesh-ancestor
25552409|NCT00635362|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25552410|NCT00635362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552411|NCT00635362|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25552412|NCT00635362|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25139058|NCT02973763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25139060|NCT02973763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139061|NCT02973724|Remifentanil|remifentanil|mesh-list
25139062|NCT02973724|Propofol|propofol|mesh-list
25139063|NCT02973724|Anesthetics|anesthetics|mesh-ancestor
25139064|NCT02973724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25139065|NCT02973724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139070|NCT02973724|Narcotics|narcotics|mesh-ancestor
25552413|NCT00635362|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25552414|NCT00635492|Insulin|insulin|mesh-list
25552415|NCT00635492|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25552416|NCT00635492|Exenatide|exenatide|mesh-list
25552417|NCT00635492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25552418|NCT00635492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552419|NCT00635492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25552420|NCT00635492|Incretins|incretins|mesh-ancestor
25552421|NCT00635492|Hormones|hormones|mesh-ancestor
25139127|NCT02973295|Silymarin|silymarin|mesh-list
25284212|NCT05080803|Bevacizumab|bevacizumab|mesh-list
25552422|NCT00635492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25552423|NCT00635570|Moxifloxacin|moxifloxacin|mesh-list
25552424|NCT00635570|NuvaRing|nuvaring|mesh-list
25552425|NCT00635570|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25552426|NCT00635570|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25552427|NCT00635570|Contraceptive Agents|contraceptive agents|mesh-ancestor
25552428|NCT00635570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25284241|NCT05055830|Antipyretics|antipyretics|mesh-ancestor
25552429|NCT00635570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552430|NCT00635570|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25552431|NCT00635570|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25552432|NCT00635570|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25552433|NCT00635570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25552434|NCT00635570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25284324|NCT04800692|Vasodilator Agents|vasodilator agents|mesh-ancestor
25552435|NCT00635570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25552436|NCT00635570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25552437|NCT00635570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25552438|NCT00635570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552439|NCT00635570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552440|NCT00635609|Doxycycline|doxycycline|mesh-list
25552441|NCT00635609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25552442|NCT00635609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25447982|NCT04628559|Ketamine|ketamine|mesh-list
25552443|NCT00635609|Antimalarials|antimalarials|mesh-ancestor
25552444|NCT00635609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25552445|NCT00635609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25552446|NCT00635648|Caspofungin|caspofungin|mesh-list
25552447|NCT00635648|Antifungal Agents|antifungal agents|mesh-ancestor
25552448|NCT00635648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25552449|NCT00635648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25552450|NCT00635648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552451|NCT00635817|Leuprolide|leuprolide|mesh-list
25552452|NCT00635817|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25552453|NCT00635817|Fertility Agents|fertility agents|mesh-ancestor
25145932|NCT02925559|Dapagliflozin|dapagliflozin|mesh-list
25552454|NCT00635817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25552455|NCT00635817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552456|NCT00635817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25552457|NCT00635817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552458|NCT00636155|Cyclophosphamide|cyclophosphamide|mesh-list
25552459|NCT00636155|Rituximab|rituximab|mesh-list
25552460|NCT00636155|Fludarabine|fludarabine|mesh-list
25552461|NCT00636155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25552462|NCT00636155|Immunologic Factors|immunologic factors|mesh-ancestor
25552463|NCT00636155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552464|NCT00636155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25552465|NCT00636155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25552466|NCT00636155|Alkylating Agents|alkylating agents|mesh-ancestor
25552467|NCT00636155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552468|NCT00636155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552469|NCT00636155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25552470|NCT00636155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25552471|NCT00636168|Ipilimumab|ipilimumab|mesh-list
25552472|NCT00636168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25552473|NCT00636168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552474|NCT00636168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25552475|NCT00636168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552476|NCT00636194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25552477|NCT00636207|Montelukast|montelukast|mesh-list
25552478|NCT00636207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25552479|NCT00636207|Respiratory System Agents|respiratory system agents|mesh-ancestor
25552480|NCT00636207|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25552481|NCT00636207|Hormone Antagonists|hormone antagonists|mesh-ancestor
25552482|NCT00636207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25552483|NCT00636207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683820|NCT01881828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25552484|NCT00636207|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25552485|NCT00636207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25552486|NCT00636207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552487|NCT00636363|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25552488|NCT00636441|Cyclophosphamide|cyclophosphamide|mesh-list
25552489|NCT00636441|Docetaxel|docetaxel|mesh-list
25552490|NCT00636441|Doxorubicin|doxorubicin|mesh-list
25552491|NCT00636441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25552492|NCT00636441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25552493|NCT00636441|Immunologic Factors|immunologic factors|mesh-ancestor
25552494|NCT00636441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552495|NCT00636441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25552496|NCT00636441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25552497|NCT00636441|Alkylating Agents|alkylating agents|mesh-ancestor
25552498|NCT00636441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552499|NCT00636441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552500|NCT00636441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25552501|NCT00636441|Tubulin Modulators|tubulin modulators|mesh-ancestor
25552502|NCT00636441|Antimitotic Agents|antimitotic agents|mesh-ancestor
25552503|NCT00636441|Mitosis Modulators|mitosis modulators|mesh-ancestor
25552504|NCT00636441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25552505|NCT00636441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25552506|NCT00636441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25552507|NCT00636441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25552508|NCT00636610|Bevacizumab|bevacizumab|mesh-list
25552509|NCT00636610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25552510|NCT00636610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866089|NCT03593252|Cefazolin|cefazolin|mesh-list
25552511|NCT00636610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25552512|NCT00636610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25552513|NCT00636610|Growth Substances|growth substances|mesh-ancestor
25552514|NCT00636610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552515|NCT00636610|Growth Inhibitors|growth inhibitors|mesh-ancestor
25552516|NCT00636636|Gabapentin|gabapentin|mesh-list
25552517|NCT00636636|Analgesics|analgesics|mesh-ancestor
25552518|NCT00636636|Sensory System Agents|sensory system agents|mesh-ancestor
25552519|NCT00636636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25552520|NCT00636636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552521|NCT00636636|Anticonvulsants|anticonvulsants|mesh-ancestor
25552522|NCT00636636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25552523|NCT00636636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25552524|NCT00636636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25552525|NCT00636636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25552526|NCT00636636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25552527|NCT00636636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25552528|NCT00636636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25552529|NCT00636636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552530|NCT00636636|Antimanic Agents|antimanic agents|mesh-ancestor
25284794|NCT05082896|Anesthetics|anesthetics|mesh-list
25552532|NCT00636649|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25552533|NCT00636649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25552534|NCT00636649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25552535|NCT00636649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284889|NCT05025735|Dapagliflozin|dapagliflozin|mesh-list
24866952|NCT03865940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25552536|NCT00636649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25552537|NCT00636649|Serotonin Agents|serotonin agents|mesh-ancestor
25552538|NCT00636649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552539|NCT00636649|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25552540|NCT00636649|Antidepressive Agents|antidepressive agents|mesh-ancestor
25552541|NCT00636649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25552542|NCT00636792|Rituximab|rituximab|mesh-list
25552543|NCT00636792|Bortezomib|bortezomib|mesh-list
25552544|NCT00636792|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25552545|NCT00636792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25552546|NCT00636792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552547|NCT00636792|Immunologic Factors|immunologic factors|mesh-ancestor
25552548|NCT00636792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552549|NCT00636792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25552550|NCT00636792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25552551|NCT00636792|Alkylating Agents|alkylating agents|mesh-ancestor
25552552|NCT00636792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552553|NCT00636805|Dexamethasone|dexamethasone|mesh-list
25552554|NCT00636805|Palonosetron|palonosetron|mesh-list
25552555|NCT00636805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25552556|NCT00636805|Antiemetics|antiemetics|mesh-ancestor
25552557|NCT00636805|Autonomic Agents|autonomic agents|mesh-ancestor
25552558|NCT00636805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25552559|NCT00636805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552560|NCT00636805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25552561|NCT00636805|Glucocorticoids|glucocorticoids|mesh-ancestor
25552562|NCT00636805|Hormones|hormones|mesh-ancestor
25552563|NCT00636805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25552564|NCT00636805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25552565|NCT00636805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552566|NCT00636805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25552567|NCT00636805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25552568|NCT00636805|Serotonin Agents|serotonin agents|mesh-ancestor
25552569|NCT00636805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25552570|NCT00636805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708784|NCT01502904|Antimetabolites|antimetabolites|mesh-ancestor
25552571|NCT00636818|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25552572|NCT00636818|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25552573|NCT00636818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25552574|NCT00636818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25552575|NCT00636818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552576|NCT00636818|Adrenergic Agents|adrenergic agents|mesh-ancestor
25552577|NCT00636818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25552578|NCT00636818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552579|NCT00637000|Buprenorphine|buprenorphine|mesh-list
25552580|NCT00637000|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25552581|NCT00637000|Naloxone|naloxone|mesh-list
25552582|NCT00637000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25552583|NCT00637000|Narcotics|narcotics|mesh-ancestor
25552584|NCT00637000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25552585|NCT00637000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552586|NCT00637000|Analgesics|analgesics|mesh-ancestor
25552587|NCT00637000|Sensory System Agents|sensory system agents|mesh-ancestor
25448097|NCT04627467|Amebicides|amebicides|mesh-ancestor
25552588|NCT00637000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25552589|NCT00637000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25552590|NCT00637195|Vaccines|vaccines|mesh-list
25552591|NCT00637195|Immunologic Factors|immunologic factors|mesh-ancestor
25552592|NCT00637195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552593|NCT00637247|Gemcitabine|gemcitabine|mesh-list
25552594|NCT00637247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25552595|NCT00637247|Antimetabolites|antimetabolites|mesh-ancestor
25552596|NCT00637247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552597|NCT00637247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552598|NCT00637247|Antiviral Agents|antiviral agents|mesh-ancestor
25552599|NCT00637247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25552600|NCT00637247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25552601|NCT00637247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25552602|NCT00637247|Immunologic Factors|immunologic factors|mesh-ancestor
25552603|NCT00637247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552604|NCT00637273|Pioglitazone|pioglitazone|mesh-list
25552605|NCT00637273|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25552606|NCT00637273|Exenatide|exenatide|mesh-list
25552607|NCT00637273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25552608|NCT00637273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552609|NCT00637273|Incretins|incretins|mesh-ancestor
25448156|NCT04626765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448157|NCT04626765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25448158|NCT04626765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25448159|NCT04626973|Ezetimibe|ezetimibe|mesh-list
25041617|NCT01616303|Paclitaxel|paclitaxel|mesh-list
25448160|NCT04626973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
25448161|NCT04626973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25448162|NCT04626973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25448163|NCT04626973|Antimetabolites|antimetabolites|mesh-ancestor
25448164|NCT04626973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448165|NCT04626973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25448166|NCT04626973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448167|NCT04626752|Cyclophosphamide|cyclophosphamide|mesh-list
25448168|NCT04626752|Fludarabine|fludarabine|mesh-list
25448169|NCT04626752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25448170|NCT04626752|Immunologic Factors|immunologic factors|mesh-ancestor
25448171|NCT04626752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448172|NCT04626752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25448173|NCT04626752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25448174|NCT04626752|Alkylating Agents|alkylating agents|mesh-ancestor
25448175|NCT04626752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448176|NCT04626752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25448177|NCT04626752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25448178|NCT04626726|Cyclophosphamide|cyclophosphamide|mesh-list
25448179|NCT04626726|Fludarabine|fludarabine|mesh-list
25448180|NCT04626726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25552610|NCT00637273|Hormones|hormones|mesh-ancestor
25041783|NCT01582347|Analgesics|analgesics|mesh-ancestor
25552611|NCT00637273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25552612|NCT00637273|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25285381|NCT05275205|Aflibercept|aflibercept|mesh-list
25552613|NCT00637273|Protease Inhibitors|protease inhibitors|mesh-ancestor
25552614|NCT00637273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25552615|NCT00637273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552616|NCT00637273|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25552617|NCT00637377|Ranibizumab|ranibizumab|mesh-list
25552618|NCT00637377|Aflibercept|aflibercept|mesh-list
25552619|NCT00637377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25552620|NCT00637377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25552621|NCT00637377|Growth Substances|growth substances|mesh-ancestor
25552622|NCT00637377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552623|NCT00637377|Growth Inhibitors|growth inhibitors|mesh-ancestor
25552624|NCT00637377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552625|NCT00637494|Mifepristone|mifepristone|mesh-list
25552626|NCT00637494|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25552627|NCT00637494|Abortifacient Agents|abortifacient agents|mesh-ancestor
25552628|NCT00637494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25552629|NCT00637494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552630|NCT00637494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25552631|NCT00637494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25552632|NCT00637494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25552633|NCT00637494|Contraceptive Agents|contraceptive agents|mesh-ancestor
25552634|NCT00637494|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25552635|NCT00637494|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25552636|NCT00637494|Hormone Antagonists|hormone antagonists|mesh-ancestor
25552637|NCT00637494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25552638|NCT00637494|Luteolytic Agents|luteolytic agents|mesh-ancestor
25552639|NCT00637494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25552640|NCT00637494|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25552641|NCT00637572|Megestrol|megestrol|mesh-list
25552642|NCT00637572|Megestrol Acetate|megestrol acetate|mesh-list
25552643|NCT00637572|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25285525|NCT05005728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25552644|NCT00637572|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25552645|NCT00637572|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25552646|NCT00637572|Contraceptive Agents|contraceptive agents|mesh-ancestor
25552647|NCT00637572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25552648|NCT00637572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552649|NCT00637572|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25552650|NCT00637572|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25552651|NCT00637572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25552652|NCT00637572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552653|NCT00637572|Appetite Stimulants|appetite stimulants|mesh-ancestor
25552654|NCT00637572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25552655|NCT00637780|Sulfasalazine|sulfasalazine|mesh-list
25552656|NCT00637780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25552657|NCT00637780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25552658|NCT00637780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25552659|NCT00637780|Analgesics|analgesics|mesh-ancestor
25552660|NCT00637780|Sensory System Agents|sensory system agents|mesh-ancestor
25552661|NCT00637780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25552662|NCT00637780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552663|NCT00637780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25552664|NCT00637780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25552665|NCT00637780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25552666|NCT00637923|Ribavirin|ribavirin|mesh-list
25552667|NCT00637923|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25552668|NCT00637923|Nitazoxanide|nitazoxanide|mesh-list
25285632|NCT04722809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25552669|NCT00637923|Antimetabolites|antimetabolites|mesh-ancestor
25552670|NCT00637923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552671|NCT00637923|Antiviral Agents|antiviral agents|mesh-ancestor
25552672|NCT00637923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25552673|NCT00637923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25552674|NCT00638027|Memantine|memantine|mesh-list
25552675|NCT00638027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25552676|NCT00638027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25552677|NCT00638027|Dopamine Agents|dopamine agents|mesh-ancestor
25552678|NCT00638027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25552679|NCT00638027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552680|NCT00638027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552681|NCT00638027|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25552682|NCT00638027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25552683|NCT00638157|Gentamicins|gentamicins|mesh-list
25552684|NCT00638157|Daptomycin|daptomycin|mesh-list
25552685|NCT00638157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25552686|NCT00638157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25552687|NCT00638157|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25552688|NCT00638157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25285710|NCT04508634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552689|NCT00638157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552690|NCT00638443|Diphenhydramine|diphenhydramine|mesh-list
25552691|NCT00638443|Promethazine|promethazine|mesh-list
25552692|NCT00638443|Pregabalin|pregabalin|mesh-list
25552693|NCT00638443|Analgesics|analgesics|mesh-ancestor
25552694|NCT00638443|Sensory System Agents|sensory system agents|mesh-ancestor
25552695|NCT00638443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25552696|NCT00638443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552697|NCT00638443|Anticonvulsants|anticonvulsants|mesh-ancestor
25552698|NCT00638443|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24869938|NCT05070650|Sensory System Agents|sensory system agents|mesh-ancestor
25552699|NCT00638443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24870033|NCT04274361|Ketamine|ketamine|mesh-list
25552700|NCT00638443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552701|NCT00638443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25552702|NCT00638443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25552703|NCT00638443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25552704|NCT00638443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25552705|NCT00638443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25042860|NCT01358695|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25552706|NCT00638443|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25552707|NCT00638443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25552708|NCT00638443|Anesthetics, Local|anesthetics, local|mesh-ancestor
25552709|NCT00638443|Anesthetics|anesthetics|mesh-ancestor
25448189|NCT04626414|Ferric maltol|ferric maltol|mesh-list
25552710|NCT00638443|Antiemetics|antiemetics|mesh-ancestor
25552711|NCT00638443|Autonomic Agents|autonomic agents|mesh-ancestor
25552712|NCT00638443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25552713|NCT00638443|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25552714|NCT00638443|Histamine Antagonists|histamine antagonists|mesh-ancestor
25552715|NCT00638443|Histamine Agents|histamine agents|mesh-ancestor
25552716|NCT00638443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25552717|NCT00638443|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25552718|NCT00638443|Antipruritics|antipruritics|mesh-ancestor
25552719|NCT00638443|Dermatologic Agents|dermatologic agents|mesh-ancestor
25552721|NCT00638456|Lansoprazole|lansoprazole|mesh-list
25552722|NCT00638456|Dexlansoprazole|dexlansoprazole|mesh-list
25552723|NCT00638456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25552724|NCT00638456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25552725|NCT00638456|Autonomic Agents|autonomic agents|mesh-ancestor
25286052|NCT03782818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25552726|NCT00638456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25552727|NCT00638456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552728|NCT00638456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25552729|NCT00638456|Respiratory System Agents|respiratory system agents|mesh-ancestor
25552730|NCT00638456|Glucocorticoids|glucocorticoids|mesh-ancestor
25552731|NCT00638456|Hormones|hormones|mesh-ancestor
25552732|NCT00638456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25552733|NCT00638456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25552734|NCT00638456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25552735|NCT00638456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25552736|NCT00638456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25552737|NCT00638456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552738|NCT00638508|Ketorolac|ketorolac|mesh-list
25552739|NCT00638508|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25552740|NCT00638508|Ropivacaine|ropivacaine|mesh-list
25552741|NCT00638508|Anesthetics, Local|anesthetics, local|mesh-ancestor
25552742|NCT00638508|Anesthetics|anesthetics|mesh-ancestor
25140616|NCT02962986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25552743|NCT00638508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25552744|NCT00638508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552745|NCT00638508|Sensory System Agents|sensory system agents|mesh-ancestor
25552746|NCT00638508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25552747|NCT00638508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25552748|NCT00638508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25552749|NCT00638508|Analgesics|analgesics|mesh-ancestor
25552750|NCT00638508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25552751|NCT00638508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25552752|NCT00638508|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25552753|NCT00638508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25286141|NCT03418922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25552754|NCT00638508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552755|NCT00638651|Imiquimod|imiquimod|mesh-list
25552756|NCT00638651|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25552757|NCT00638651|Immunologic Factors|immunologic factors|mesh-ancestor
25552758|NCT00638651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552759|NCT00638651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552760|NCT00638651|Interferon Inducers|interferon inducers|mesh-ancestor
25552761|NCT00638690|Prednisone|prednisone|mesh-list
25552762|NCT00638690|Prednisolone|prednisolone|mesh-list
25552763|NCT00638690|Abiraterone Acetate|abiraterone acetate|mesh-list
25043674|NCT01225640|Oxazolidinones|oxazolidinones|mesh-list
25043732|NCT01220947|Protease Inhibitors|protease inhibitors|mesh-ancestor
25552764|NCT00638690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25552765|NCT00638690|Glucocorticoids|glucocorticoids|mesh-ancestor
25552766|NCT00638690|Hormones|hormones|mesh-ancestor
25552767|NCT00638690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25552768|NCT00638690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141048|NCT02960035|Analgesics|analgesics|mesh-ancestor
25552769|NCT00638690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25552770|NCT00638690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552771|NCT00638690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25552772|NCT00638690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25552773|NCT00638690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552774|NCT00638690|Hormone Antagonists|hormone antagonists|mesh-ancestor
25046978|NCT00834756|Azithromycin|azithromycin|mesh-list
25552775|NCT00638690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25651325|NCT01515189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25651326|NCT01515189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25651327|NCT01515189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25651328|NCT01515189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651329|NCT01515345|Clopidogrel|clopidogrel|mesh-list
25651330|NCT01515345|Ticagrelor|ticagrelor|mesh-list
25651331|NCT01515345|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25651332|NCT01515345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25448256|NCT04625907|Alkylating Agents|alkylating agents|mesh-ancestor
25552777|NCT00638820|Alemtuzumab|alemtuzumab|mesh-list
25552778|NCT00638820|Clofarabine|clofarabine|mesh-list
25552779|NCT00638820|Alkylating Agents|alkylating agents|mesh-ancestor
25552780|NCT00638820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552781|NCT00638820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25552782|NCT00638820|Immunologic Factors|immunologic factors|mesh-ancestor
25552783|NCT00638820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552784|NCT00638820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25552785|NCT00638820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552786|NCT00638820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25044482|NCT01089790|Protease Inhibitors|protease inhibitors|mesh-ancestor
25552787|NCT00638820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25552788|NCT00638820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25552789|NCT00638820|Antimetabolites|antimetabolites|mesh-ancestor
25552790|NCT00638937|Saracatinib|saracatinib|mesh-list
25552791|NCT00638937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552792|NCT00638937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25552793|NCT00638937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552794|NCT00638963|Temozolomide|temozolomide|mesh-list
25552795|NCT00638963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25552796|NCT00638963|Alkylating Agents|alkylating agents|mesh-ancestor
25552797|NCT00638963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552798|NCT00638963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552799|NCT00638989|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25552800|NCT00638989|Immunologic Factors|immunologic factors|mesh-ancestor
25552801|NCT00638989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552802|NCT00639002|Dexamethasone|dexamethasone|mesh-list
25552803|NCT00639002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25552804|NCT00639002|Antiemetics|antiemetics|mesh-ancestor
25448327|NCT04624906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25448328|NCT04624906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25448329|NCT04624906|Immunologic Factors|immunologic factors|mesh-ancestor
25448330|NCT04624906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448331|NCT04624906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25448332|NCT04624906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25448333|NCT04624906|Alkylating Agents|alkylating agents|mesh-ancestor
25448334|NCT04624906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448335|NCT04625114|Gabexate|gabexate|mesh-list
25448336|NCT04625114|Camostat|camostat|mesh-list
25448337|NCT04625114|Protease Inhibitors|protease inhibitors|mesh-ancestor
25448338|NCT04625114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448339|NCT04625114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141370|NCT02958046|Autonomic Agents|autonomic agents|mesh-ancestor
25448340|NCT04625114|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25286886|NCT05087693|Albuterol|albuterol|mesh-list
25448341|NCT04625114|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25448342|NCT04625114|Anticoagulants|anticoagulants|mesh-ancestor
25448343|NCT04624750|Mexiletine|mexiletine|mesh-list
25448344|NCT04624750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25448345|NCT04624750|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25448346|NCT04624750|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25448347|NCT04624750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25286920|NCT05086848|Immunologic Factors|immunologic factors|mesh-ancestor
25286956|NCT05085912|Ethanol|ethanol|mesh-list
25141637|NCT02955810|Antiemetics|antiemetics|mesh-ancestor
25448348|NCT04624750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448349|NCT04624269|Hydroxychloroquine|hydroxychloroquine|mesh-list
25552805|NCT00639002|Autonomic Agents|autonomic agents|mesh-ancestor
25552806|NCT00639002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25552807|NCT00639002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552808|NCT00639002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25552809|NCT00639002|Glucocorticoids|glucocorticoids|mesh-ancestor
25552810|NCT00639002|Hormones|hormones|mesh-ancestor
25552811|NCT00639002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25552812|NCT00639002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25552813|NCT00639002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552814|NCT00639158|Choline|choline|mesh-list
25552815|NCT00639158|Atorvastatin|atorvastatin|mesh-list
25552816|NCT00639158|Ezetimibe|ezetimibe|mesh-list
25552817|NCT00639158|Fenofibric acid|fenofibric acid|mesh-list
25552818|NCT00639158|Fenofibrate|fenofibrate|mesh-list
25552819|NCT00639158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25552820|NCT00639158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25552821|NCT00639158|Antimetabolites|antimetabolites|mesh-ancestor
25552822|NCT00639158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552823|NCT00639158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25552824|NCT00639158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25552825|NCT00639158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25552826|NCT00639158|Lipotropic Agents|lipotropic agents|mesh-ancestor
25552827|NCT00639158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25552828|NCT00639158|Nootropic Agents|nootropic agents|mesh-ancestor
25552829|NCT00639223|Pravastatin|pravastatin|mesh-list
25552830|NCT00639223|Red yeast rice|red yeast rice|mesh-list
25552831|NCT00639223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25552832|NCT00639223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25552833|NCT00639223|Antimetabolites|antimetabolites|mesh-ancestor
25141936|NCT02953405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25552834|NCT00639223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552835|NCT00639223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25552836|NCT00639223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25552837|NCT00639223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25552838|NCT00639457|Pioglitazone|pioglitazone|mesh-list
25552839|NCT00639457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25552840|NCT00639457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552841|NCT00639509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25552842|NCT00639509|Immunologic Factors|immunologic factors|mesh-ancestor
25552843|NCT00639509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552844|NCT00639678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25552845|NCT00639678|Immunologic Factors|immunologic factors|mesh-ancestor
25552846|NCT00639678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552847|NCT00639717|Etanercept|etanercept|mesh-list
25552848|NCT00639717|Methoxsalen|methoxsalen|mesh-list
25552849|NCT00639717|Tacrolimus|tacrolimus|mesh-list
25552850|NCT00639717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25552851|NCT00639717|Immunologic Factors|immunologic factors|mesh-ancestor
25552852|NCT00639717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552853|NCT00639717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25552854|NCT00639717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25552855|NCT00639717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552856|NCT00639717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25552857|NCT00639717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25552858|NCT00639717|Analgesics|analgesics|mesh-ancestor
25552859|NCT00639717|Sensory System Agents|sensory system agents|mesh-ancestor
25115017|NCT03119324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25552860|NCT00639717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25552861|NCT00639717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25552862|NCT00639717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25142446|NCT02949895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25552863|NCT00639717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25552864|NCT00639717|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25552865|NCT00639717|Dermatologic Agents|dermatologic agents|mesh-ancestor
25552866|NCT00639769|Cisplatin|cisplatin|mesh-list
25552867|NCT00639769|Irinotecan|irinotecan|mesh-list
25552868|NCT00639769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552869|NCT00639769|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25552870|NCT00639769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25552871|NCT00639769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25552872|NCT00639769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552873|NCT00640016|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25552874|NCT00640016|Immunologic Factors|immunologic factors|mesh-ancestor
25142898|NCT02946632|Hormones|hormones|mesh-ancestor
25552875|NCT00640016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552876|NCT00640042|Morphine|morphine|mesh-list
25552877|NCT00640042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25552878|NCT00640042|Narcotics|narcotics|mesh-ancestor
25552879|NCT00640042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25552880|NCT00640042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552881|NCT00640042|Analgesics|analgesics|mesh-ancestor
25552882|NCT00640042|Sensory System Agents|sensory system agents|mesh-ancestor
25552883|NCT00640042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25552884|NCT00640146|Bromides|bromides|mesh-list
25552885|NCT00640146|Methylnaltrexone|methylnaltrexone|mesh-list
25552886|NCT00640146|Anticonvulsants|anticonvulsants|mesh-ancestor
25552887|NCT00640146|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25552888|NCT00640146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552889|NCT00640146|Sensory System Agents|sensory system agents|mesh-ancestor
25552890|NCT00640146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25552891|NCT00640224|Rosiglitazone|rosiglitazone|mesh-list
25552892|NCT00640224|Drospirenone|drospirenone|mesh-list
25552893|NCT00640224|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25552894|NCT00640224|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
25552895|NCT00640224|Estradiol|estradiol|mesh-list
25552896|NCT00640224|Estrogens|estrogens|mesh-ancestor
25552897|NCT00640224|Hormones|hormones|mesh-ancestor
25552898|NCT00640224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25552899|NCT00640224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552900|NCT00640224|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25552901|NCT00640224|Contraceptive Agents|contraceptive agents|mesh-ancestor
25552902|NCT00640224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25552903|NCT00640224|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25287858|NCT05089344|Hormones|hormones|mesh-list
24882996|NCT04673617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25142943|NCT02945982|Entecavir|entecavir|mesh-list
25552904|NCT00640224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25552905|NCT00640224|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25552906|NCT00640224|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25552907|NCT00640224|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25552908|NCT00640224|Hormone Antagonists|hormone antagonists|mesh-ancestor
25552909|NCT00640224|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25552910|NCT00640224|Diuretics|diuretics|mesh-ancestor
24883165|NCT04363840|Sensory System Agents|sensory system agents|mesh-ancestor
25143057|NCT02945215|Rituximab|rituximab|mesh-list
25552911|NCT00640224|Natriuretic Agents|natriuretic agents|mesh-ancestor
25552912|NCT00640289|Fibrinolysin|fibrinolysin|mesh-list
25552913|NCT00640289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25552914|NCT00640289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25552915|NCT00640289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552916|NCT00640315|Riociguat|riociguat|mesh-list
25552917|NCT00640315|Enzyme Activators|enzyme activators|mesh-ancestor
25552918|NCT00640315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552919|NCT00640328|Ofatumumab|ofatumumab|mesh-list
25552920|NCT00640328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25552921|NCT00640328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25552922|NCT00640328|Immunologic Factors|immunologic factors|mesh-ancestor
25552923|NCT00640328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552924|NCT00640393|Etanercept|etanercept|mesh-list
25552925|NCT00640393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25552926|NCT00640393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25552927|NCT00640393|Analgesics|analgesics|mesh-ancestor
25552928|NCT00640393|Sensory System Agents|sensory system agents|mesh-ancestor
25552929|NCT00640393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25552930|NCT00640393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552931|NCT00640393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25552932|NCT00640393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25552933|NCT00640393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25552934|NCT00640393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25552935|NCT00640393|Immunologic Factors|immunologic factors|mesh-ancestor
25552936|NCT00640510|Olanzapine|olanzapine|mesh-list
25552937|NCT00640510|Antiemetics|antiemetics|mesh-ancestor
25552938|NCT00640510|Autonomic Agents|autonomic agents|mesh-ancestor
25552939|NCT00640510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25552940|NCT00640510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552941|NCT00640510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25552942|NCT00640510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25552943|NCT00640510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25552944|NCT00640510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25552945|NCT00640510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25552946|NCT00640510|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25552947|NCT00640510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25552948|NCT00640510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25552949|NCT00640510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552950|NCT00640510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25552951|NCT00640510|Serotonin Agents|serotonin agents|mesh-ancestor
25552952|NCT00640562|Risperidone|risperidone|mesh-list
25552953|NCT00640562|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25552954|NCT00640562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25552955|NCT00640562|Serotonin Agents|serotonin agents|mesh-ancestor
25288099|NCT04595786|Hemostatics|hemostatics|mesh-ancestor
25288100|NCT04595786|Coagulants|coagulants|mesh-ancestor
25552956|NCT00640562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25552957|NCT00640562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552958|NCT00640562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552959|NCT00640562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25552960|NCT00640562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25552961|NCT00640562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25552962|NCT00640562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25552963|NCT00640562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25552964|NCT00640562|Dopamine Agents|dopamine agents|mesh-ancestor
25552965|NCT00640562|Antidepressive Agents|antidepressive agents|mesh-ancestor
25552966|NCT00640601|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25552967|NCT00640601|Antidepressive Agents|antidepressive agents|mesh-ancestor
25552968|NCT00640601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25552969|NCT00640601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25552970|NCT00640601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25552971|NCT00640601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25552972|NCT00640601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552973|NCT00640822|Calcitriol|calcitriol|mesh-list
25552974|NCT00640822|Hydrocortisone|hydrocortisone|mesh-list
25552975|NCT00640822|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25552976|NCT00640822|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25552977|NCT00640822|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25552978|NCT00640822|1 alpha,24-dihydroxyvitamin D3|1 alpha,24-dihydroxyvitamin d3|mesh-list
25552979|NCT00640822|Calcipotriene|calcipotriene|mesh-list
25552980|NCT00640822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25552981|NCT00640822|Dermatologic Agents|dermatologic agents|mesh-ancestor
25116044|NCT03111342|Lidocaine|lidocaine|mesh-list
25552982|NCT00640822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25552983|NCT00640822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552984|NCT00640822|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25552985|NCT00640822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25552986|NCT00640822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25552987|NCT00640822|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25552988|NCT00640822|Vitamins|vitamins|mesh-ancestor
25552989|NCT00640822|Micronutrients|micronutrients|mesh-ancestor
25552990|NCT00640822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25552991|NCT00640835|Buprenorphine|buprenorphine|mesh-list
25552992|NCT00640835|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25552993|NCT00640835|Naloxone|naloxone|mesh-list
25552994|NCT00640835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25552995|NCT00640835|Narcotics|narcotics|mesh-ancestor
25552996|NCT00640835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25552997|NCT00640835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25552998|NCT00640835|Analgesics|analgesics|mesh-ancestor
25552999|NCT00640835|Sensory System Agents|sensory system agents|mesh-ancestor
25553000|NCT00640835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25553001|NCT00640835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25553002|NCT00640926|Radezolid|radezolid|mesh-list
25553003|NCT00640926|Oxazolidinones|oxazolidinones|mesh-list
25553004|NCT00640926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25553005|NCT00640926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25553006|NCT00640926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25553007|NCT00640926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25553008|NCT00640926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092571|NCT03241017|Durvalumab|durvalumab|mesh-list
25553009|NCT00640978|Everolimus|everolimus|mesh-list
25553010|NCT00640978|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25553011|NCT00640978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25553012|NCT00640978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25553013|NCT00640978|Immunologic Factors|immunologic factors|mesh-ancestor
25553014|NCT00640978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553015|NCT00640978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25553016|NCT00640978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25553017|NCT00640978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553018|NCT00641043|Pioglitazone|pioglitazone|mesh-list
25553019|NCT00641043|Linagliptin|linagliptin|mesh-list
25553020|NCT00641043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25553021|NCT00641043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553022|NCT00641043|Incretins|incretins|mesh-ancestor
25553023|NCT00641043|Hormones|hormones|mesh-ancestor
25553024|NCT00641043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25553025|NCT00641043|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25553026|NCT00641043|Protease Inhibitors|protease inhibitors|mesh-ancestor
25553027|NCT00641043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25553028|NCT00641043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553029|NCT00641056|Insulin Glargine|insulin glargine|mesh-list
25553030|NCT00641056|Exenatide|exenatide|mesh-list
25553031|NCT00641056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25553032|NCT00641056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553033|NCT00641056|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25553034|NCT00641056|Incretins|incretins|mesh-ancestor
25553035|NCT00641056|Hormones|hormones|mesh-ancestor
25553036|NCT00641056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25553037|NCT00641147|Curcumin|curcumin|mesh-list
25553038|NCT00641147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25553039|NCT00641147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25553040|NCT00641147|Analgesics|analgesics|mesh-ancestor
25553041|NCT00641147|Sensory System Agents|sensory system agents|mesh-ancestor
25288519|NCT04710199|Maraviroc|maraviroc|mesh-list
25553042|NCT00641147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25553043|NCT00641147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553044|NCT00641147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25144059|NCT02938988|Methylene Blue|methylene blue|mesh-list
25553045|NCT00641147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25288723|NCT03593915|Azacitidine|azacitidine|mesh-list
25144467|NCT02935764|Antidotes|antidotes|mesh-ancestor
25144727|NCT02935010|Amoxicillin|amoxicillin|mesh-list
25288983|NCT05092945|Vitamins|vitamins|mesh-ancestor
25553046|NCT00641147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25553047|NCT00641147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448518|NCT04622579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25448519|NCT04622579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25448520|NCT04622579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25553048|NCT00641147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553049|NCT00641563|Midazolam|midazolam|mesh-list
25553051|NCT00641563|Remifentanil|remifentanil|mesh-list
25553052|NCT00641563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25553053|NCT00641563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25553054|NCT00641563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553055|NCT00641563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24763480|NCT01774370|Dabigatran|dabigatran|mesh-list
25553056|NCT00641563|Analgesics|analgesics|mesh-ancestor
25117290|NCT05361330|Fluoxetine|fluoxetine|mesh-list
25117416|NCT05268744|Micronutrients|micronutrients|mesh-list
25117466|NCT05164081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553057|NCT00641563|Sensory System Agents|sensory system agents|mesh-ancestor
25553058|NCT00641563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25553059|NCT00641563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25553060|NCT00641563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25553061|NCT00641563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25553062|NCT00641563|Adrenergic Agents|adrenergic agents|mesh-ancestor
25145665|NCT02928328|Antipruritics|antipruritics|mesh-ancestor
25117599|NCT05012566|Viscosupplements|viscosupplements|mesh-ancestor
25553063|NCT00641563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25553064|NCT00641563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553065|NCT00641563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25553066|NCT00641563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25553067|NCT00641563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25553068|NCT00641563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25553069|NCT00641563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25553070|NCT00641563|Anesthetics, General|anesthetics, general|mesh-ancestor
25553071|NCT00641563|Anesthetics|anesthetics|mesh-ancestor
25553072|NCT00641563|GABA Modulators|gaba modulators|mesh-ancestor
25553073|NCT00641563|GABA Agents|gaba agents|mesh-ancestor
25553074|NCT00641563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25553075|NCT00641563|Narcotics|narcotics|mesh-ancestor
25553076|NCT00641641|Tenofovir|tenofovir|mesh-list
25553077|NCT00641641|Emtricitabine|emtricitabine|mesh-list
25553078|NCT00641641|Raltegravir Potassium|raltegravir potassium|mesh-list
25145842|NCT02926248|Colchicine|colchicine|mesh-list
25553079|NCT00641641|Antiviral Agents|antiviral agents|mesh-ancestor
25553080|NCT00641641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25553081|NCT00641641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25553082|NCT00641641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25553083|NCT00641641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25289615|NCT05095259|Adrenergic Agents|adrenergic agents|mesh-ancestor
25289693|NCT04986839|Acetaminophen|acetaminophen|mesh-list
25553084|NCT00641641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463604|NCT00361621|Prednisone|prednisone|mesh-list
25553085|NCT00641641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25553086|NCT00641641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25553087|NCT00641641|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25553088|NCT00641641|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25553089|NCT00641667|Fentanyl|fentanyl|mesh-list
25553090|NCT00641667|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25553091|NCT00641667|Narcotics|narcotics|mesh-ancestor
25118189|NCT04323566|Rituximab|rituximab|mesh-list
25553092|NCT00641667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25118225|NCT04303000|Analgesics|analgesics|mesh-ancestor
25553093|NCT00641667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553094|NCT00641667|Analgesics|analgesics|mesh-ancestor
25553095|NCT00641667|Sensory System Agents|sensory system agents|mesh-ancestor
24709900|NCT01507480|Growth Substances|growth substances|mesh-ancestor
25553096|NCT00641667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25553097|NCT00641667|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25553098|NCT00641667|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25553099|NCT00641667|Anesthetics, General|anesthetics, general|mesh-ancestor
25553100|NCT00641667|Anesthetics|anesthetics|mesh-ancestor
25553101|NCT00641706|Bortezomib|bortezomib|mesh-list
25146942|NCT02918110|Oxytocics|oxytocics|mesh-ancestor
25147047|NCT02916654|Iron|iron|mesh-list
25290304|NCT05097248|Losartan|losartan|mesh-list
25553102|NCT00641706|Vorinostat|vorinostat|mesh-list
25553103|NCT00641706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290418|NCT04912791|Anesthetics|anesthetics|mesh-list
25553104|NCT00641706|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25147626|NCT02912182|Antiemetics|antiemetics|mesh-ancestor
25119215|NCT02489903|Taxane|taxane|mesh-list
25290638|NCT04389775|Glucagon|glucagon|mesh-list
25553105|NCT00641706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048018|NCT00747318|Xhance|xhance|mesh-list
25119183|NCT02620046|Vedolizumab|vedolizumab|mesh-list
25148197|NCT05311722|Narcotics|narcotics|mesh-ancestor
25048234|NCT00722917|Pioglitazone|pioglitazone|mesh-list
25148844|NCT04545866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25553106|NCT00641706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149248|NCT03686150|Vitamin D|vitamin d|mesh-list
25553107|NCT00641719|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25553108|NCT00641719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25553109|NCT00641719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25291196|NCT04956809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291197|NCT04956809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25291198|NCT04956809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048314|NCT00713401|Adrenergic Agents|adrenergic agents|mesh-ancestor
25048315|NCT00713401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25048321|NCT00712699|Adderall|adderall|mesh-list
25291238|NCT04658277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25553110|NCT00641719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25553111|NCT00641719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553112|NCT00641719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25553113|NCT00641719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119936|NCT05011812|Ritonavir|ritonavir|mesh-list
25553114|NCT00641719|Analgesics|analgesics|mesh-ancestor
24710412|NCT01510366|Vaccines|vaccines|mesh-list
25553115|NCT00641719|Sensory System Agents|sensory system agents|mesh-ancestor
24614256|NCT01023243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25553116|NCT00641719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25553117|NCT00641719|Antidepressive Agents|antidepressive agents|mesh-ancestor
25553118|NCT00641719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24711161|NCT01513772|Analgesics|analgesics|mesh-ancestor
25553119|NCT00641719|Dopamine Agents|dopamine agents|mesh-ancestor
25553120|NCT00641745|Risperidone|risperidone|mesh-list
25553121|NCT00641745|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25553122|NCT00641745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25553123|NCT00641745|Serotonin Agents|serotonin agents|mesh-ancestor
25553124|NCT00641745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25553125|NCT00641745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553126|NCT00641745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553127|NCT00641745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25553128|NCT00641745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25553129|NCT00641745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24711746|NCT01516814|Heparin|heparin|mesh-list
25553130|NCT00641745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25553131|NCT00641745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25553132|NCT00641745|Dopamine Agents|dopamine agents|mesh-ancestor
25553133|NCT00641745|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25553134|NCT00641745|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25553135|NCT00641745|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25553136|NCT00641745|Adrenergic Agents|adrenergic agents|mesh-ancestor
25553137|NCT00641745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25120657|NCT03020030|Autonomic Agents|autonomic agents|mesh-ancestor
24997931|NCT04113083|Provitamins|provitamins|mesh-ancestor
24784771|NCT01910259|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25553138|NCT00641745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25553139|NCT00641797|Diphenhydramine|diphenhydramine|mesh-list
25553140|NCT00641797|Promethazine|promethazine|mesh-list
25553141|NCT00641797|Meclizine|meclizine|mesh-list
25553142|NCT00641797|Lorazepam|lorazepam|mesh-list
25553143|NCT00641797|Ondansetron|ondansetron|mesh-list
25553144|NCT00641797|Antiemetics|antiemetics|mesh-ancestor
25553145|NCT00641797|Autonomic Agents|autonomic agents|mesh-ancestor
25553146|NCT00641797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25553147|NCT00641797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553148|NCT00641797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25553149|NCT00641797|Antipruritics|antipruritics|mesh-ancestor
24946309|NCT03940742|Tirzepatide|tirzepatide|mesh-list
25553150|NCT00641797|Dermatologic Agents|dermatologic agents|mesh-ancestor
25553151|NCT00641797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25553152|NCT00641797|Serotonin Agents|serotonin agents|mesh-ancestor
25553153|NCT00641797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25121121|NCT00072358|Molgramostim|molgramostim|mesh-list
25553154|NCT00641797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553155|NCT00641797|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24949864|NCT03439891|Sorafenib|sorafenib|mesh-list
24614696|NCT01025921|Colistin|colistin|mesh-list
25553156|NCT00641797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25553157|NCT00641797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25553158|NCT00641797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25553159|NCT00641797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25553160|NCT00641797|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25553161|NCT00641797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25553162|NCT00641797|Anesthetics, Local|anesthetics, local|mesh-ancestor
25553163|NCT00641797|Anesthetics|anesthetics|mesh-ancestor
25553164|NCT00641797|Sensory System Agents|sensory system agents|mesh-ancestor
25553165|NCT00641797|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25553166|NCT00641797|Histamine Antagonists|histamine antagonists|mesh-ancestor
25553167|NCT00641797|Histamine Agents|histamine agents|mesh-ancestor
25553168|NCT00641797|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25553169|NCT00641797|Anticonvulsants|anticonvulsants|mesh-ancestor
25553170|NCT00641797|GABA Modulators|gaba modulators|mesh-ancestor
25553171|NCT00641797|GABA Agents|gaba agents|mesh-ancestor
25553172|NCT00641862|Vitamin B 12|vitamin b 12|mesh-list
25553173|NCT00641862|Hydroxocobalamin|hydroxocobalamin|mesh-list
25553174|NCT00641862|Vitamins|vitamins|mesh-ancestor
25553175|NCT00641862|Micronutrients|micronutrients|mesh-ancestor
25553176|NCT00641862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553177|NCT00641862|Vitamin B Complex|vitamin b complex|mesh-ancestor
25553178|NCT00641862|Hematinics|hematinics|mesh-ancestor
25553179|NCT00642018|Prednisone|prednisone|mesh-list
25553180|NCT00642018|Docetaxel|docetaxel|mesh-list
25553181|NCT00642018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25553182|NCT00642018|Tubulin Modulators|tubulin modulators|mesh-ancestor
25553183|NCT00642018|Antimitotic Agents|antimitotic agents|mesh-ancestor
25553184|NCT00642018|Mitosis Modulators|mitosis modulators|mesh-ancestor
25553185|NCT00642018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553186|NCT00642018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25553187|NCT00642018|Glucocorticoids|glucocorticoids|mesh-ancestor
25553188|NCT00642018|Hormones|hormones|mesh-ancestor
25553189|NCT00642018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25553190|NCT00642018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553191|NCT00642018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25553192|NCT00642174|Clopidogrel|clopidogrel|mesh-list
25553193|NCT00642174|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25553194|NCT00642174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25553195|NCT00642174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25066573|NCT02700451|Ketorolac|ketorolac|mesh-list
25121443|NCT03102242|Atezolizumab|atezolizumab|mesh-list
25553196|NCT00642174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25553197|NCT00642174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25553198|NCT00642174|Purinergic Agents|purinergic agents|mesh-ancestor
25553199|NCT00642174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25553200|NCT00642174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072670|NCT03399955|Paromomycin|paromomycin|mesh-list
25553201|NCT00642174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553202|NCT00642278|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25553204|NCT00642278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24614997|NCT01027429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25553205|NCT00642278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553206|NCT00642278|Incretins|incretins|mesh-ancestor
25553207|NCT00642278|Hormones|hormones|mesh-ancestor
24646543|NCT01204190|Progestins|progestins|mesh-ancestor
25553208|NCT00642278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24798478|NCT01963754|Sensory System Agents|sensory system agents|mesh-ancestor
24717362|NCT01547377|Zinc|zinc|mesh-list
24615171|NCT01028287|beta-Endorphin|beta-endorphin|mesh-list
25003946|NCT02921022|Antiviral Agents|antiviral agents|mesh-ancestor
25049593|NCT00580216|Biotin|biotin|mesh-list
25553209|NCT00642278|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25553210|NCT00642278|Protease Inhibitors|protease inhibitors|mesh-ancestor
25553211|NCT00642278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25553212|NCT00642278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553213|NCT00642278|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25553214|NCT00642304|Epoetin Alfa|epoetin alfa|mesh-list
25553215|NCT00642304|Hematinics|hematinics|mesh-ancestor
25553216|NCT00642356|Levodopa|levodopa|mesh-list
25553217|NCT00642356|Carbidopa|carbidopa|mesh-list
25553218|NCT00642356|Entacapone|entacapone|mesh-list
25553219|NCT00642356|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24464353|NCT00364442|Xhance|xhance|mesh-list
25553220|NCT00642356|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25553221|NCT00642356|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25553222|NCT00642356|Dopamine Agents|dopamine agents|mesh-ancestor
25553223|NCT00642356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25553224|NCT00642356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553225|NCT00642356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553226|NCT00642356|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24850568|NCT02253550|Sofosbuvir|sofosbuvir|mesh-list
25553227|NCT00642356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25553228|NCT00642356|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25553229|NCT00642356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25553230|NCT00642356|Immunologic Factors|immunologic factors|mesh-ancestor
25553231|NCT00642356|Dopamine Agonists|dopamine agonists|mesh-ancestor
25553232|NCT00642369|Haloperidol|haloperidol|mesh-list
24672442|NCT01332201|Tacrolimus|tacrolimus|mesh-list
25553233|NCT00642369|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25553234|NCT00642369|Haloperidol decanoate|haloperidol decanoate|mesh-list
24795767|NCT01945957|Oxytocin|oxytocin|mesh-list
24983009|NCT00092586|Ezetimibe|ezetimibe|mesh-list
25685357|NCT01904149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25553235|NCT00642369|Antidepressive Agents|antidepressive agents|mesh-ancestor
25553236|NCT00642369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25553237|NCT00642369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25553238|NCT00642369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25553239|NCT00642369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25553240|NCT00642369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553241|NCT00642369|Antiemetics|antiemetics|mesh-ancestor
25553242|NCT00642369|Autonomic Agents|autonomic agents|mesh-ancestor
24985518|NCT03228186|Docetaxel|docetaxel|mesh-list
25553243|NCT00642369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24987150|NCT03554044|Letrozole|letrozole|mesh-list
25553244|NCT00642369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25553245|NCT00642369|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24990462|NCT02966301|Arsenic Trioxide|arsenic trioxide|mesh-list
24990464|NCT02966119|Aspirin|aspirin|mesh-list
24992995|NCT01881048|Celecoxib|celecoxib|mesh-list
24785893|NCT01917045|Analgesics|analgesics|mesh-ancestor
25553246|NCT00642369|Dopamine Agents|dopamine agents|mesh-ancestor
25553247|NCT00642369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25122812|NCT03090269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25553248|NCT00642369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553249|NCT00642369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25553250|NCT00642460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25553251|NCT00642460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25553252|NCT00642460|Methotrexate|methotrexate|mesh-list
25553253|NCT00642460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25553254|NCT00642460|Abortifacient Agents|abortifacient agents|mesh-ancestor
25553255|NCT00642460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25553256|NCT00642460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553257|NCT00642460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25553258|NCT00642460|Antimetabolites|antimetabolites|mesh-ancestor
25553259|NCT00642460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553260|NCT00642460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25553261|NCT00642460|Dermatologic Agents|dermatologic agents|mesh-ancestor
25553262|NCT00642460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25553263|NCT00642460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25553264|NCT00642460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25553265|NCT00642460|Immunologic Factors|immunologic factors|mesh-ancestor
25553266|NCT00642460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25553267|NCT00642460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25553268|NCT00642460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25553269|NCT00642460|Analgesics|analgesics|mesh-ancestor
25553270|NCT00642460|Sensory System Agents|sensory system agents|mesh-ancestor
25553271|NCT00642460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25553272|NCT00642473|Metronidazole|metronidazole|mesh-list
25553273|NCT00642473|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25553274|NCT00642473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25553275|NCT00642473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25553276|NCT00642473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25553277|NCT00642473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553278|NCT00642473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25553279|NCT00642473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25553280|NCT00642473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25553281|NCT00642473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25553282|NCT00642616|Insulin|insulin|mesh-list
25553283|NCT00642616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25553284|NCT00642616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553285|NCT00642668|Epoetin Alfa|epoetin alfa|mesh-list
25553286|NCT00642668|Hematinics|hematinics|mesh-ancestor
25553287|NCT00642694|Dexetimide|dexetimide|mesh-list
25553288|NCT00642694|Citalopram|citalopram|mesh-list
25553289|NCT00642694|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25553290|NCT00642694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25553291|NCT00642694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24727091|NCT01607983|Respiratory System Agents|respiratory system agents|mesh-ancestor
25553292|NCT00642694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553293|NCT00642694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25553294|NCT00642694|Serotonin Agents|serotonin agents|mesh-ancestor
25553295|NCT00642694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553296|NCT00642694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25553297|NCT00642694|Antidepressive Agents|antidepressive agents|mesh-ancestor
25553298|NCT00642694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25553299|NCT00642694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25553300|NCT00642694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25553301|NCT00642694|Parasympatholytics|parasympatholytics|mesh-ancestor
25553302|NCT00642694|Autonomic Agents|autonomic agents|mesh-ancestor
25553303|NCT00642694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25553304|NCT00642694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25553305|NCT00642694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25553306|NCT00642694|Cholinergic Agents|cholinergic agents|mesh-ancestor
25553307|NCT00642707|Leronlimab|leronlimab|mesh-list
25553308|NCT00642707|Antibodies|antibodies|mesh-list
25553309|NCT00642707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25553310|NCT00642707|Immunologic Factors|immunologic factors|mesh-ancestor
25553311|NCT00642707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553312|NCT00642707|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25553313|NCT00642707|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25553314|NCT00642707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553315|NCT00642707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25553316|NCT00642707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25553317|NCT00642707|Antiviral Agents|antiviral agents|mesh-ancestor
25553318|NCT00642707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25553319|NCT00642746|Leucovorin|leucovorin|mesh-list
25553320|NCT00642746|Fluorouracil|fluorouracil|mesh-list
25553321|NCT00642746|Oxaliplatin|oxaliplatin|mesh-list
25553322|NCT00642746|Irinotecan|irinotecan|mesh-list
25553323|NCT00642746|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25553324|NCT00642746|Antimetabolites|antimetabolites|mesh-ancestor
25553325|NCT00642746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553326|NCT00642746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25553327|NCT00642746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25553328|NCT00642746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25553329|NCT00642746|Immunologic Factors|immunologic factors|mesh-ancestor
25123188|NCT03087539|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24875245|NCT04316702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24469509|NCT00386178|Vitamins|vitamins|mesh-ancestor
24870801|NCT03837015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870802|NCT03691584|Dimercaprol|dimercaprol|mesh-list
24870803|NCT03691584|Chelating Agents|chelating agents|mesh-ancestor
25108690|NCT03130842|Anesthetics|anesthetics|mesh-ancestor
25553330|NCT00642746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448782|NCT04620590|Dapagliflozin|dapagliflozin|mesh-list
25448783|NCT04620590|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25448784|NCT04620590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448785|NCT04620590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25448786|NCT04620590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448787|NCT04620616|Menthol|menthol|mesh-list
25448788|NCT04620616|Antipruritics|antipruritics|mesh-ancestor
25448789|NCT04620616|Dermatologic Agents|dermatologic agents|mesh-ancestor
25448790|NCT04620772|Cyclophosphamide|cyclophosphamide|mesh-list
25553331|NCT00642746|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25553332|NCT00642746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25553333|NCT00642746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25553334|NCT00642746|Antidotes|antidotes|mesh-ancestor
25553335|NCT00642746|Protective Agents|protective agents|mesh-ancestor
25553336|NCT00642746|Vitamin B Complex|vitamin b complex|mesh-ancestor
25553337|NCT00642746|Vitamins|vitamins|mesh-ancestor
25553338|NCT00642746|Micronutrients|micronutrients|mesh-ancestor
25553339|NCT00642746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25553340|NCT00642759|Paclitaxel|paclitaxel|mesh-list
25553341|NCT00642759|Bevacizumab|bevacizumab|mesh-list
25553342|NCT00642759|Carboplatin|carboplatin|mesh-list
24880323|NCT03861611|Analgesics|analgesics|mesh-ancestor
25553343|NCT00642759|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25553344|NCT00642759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25553345|NCT00642759|Tubulin Modulators|tubulin modulators|mesh-ancestor
25553346|NCT00642759|Antimitotic Agents|antimitotic agents|mesh-ancestor
24732223|NCT01638377|Naltrexone|naltrexone|mesh-list
25553347|NCT00642759|Mitosis Modulators|mitosis modulators|mesh-ancestor
24956927|NCT03849183|Vasodilator Agents|vasodilator agents|mesh-ancestor
25553348|NCT00642759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733357|NCT01645423|Atorvastatin|atorvastatin|mesh-list
25553349|NCT00642759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25553350|NCT00642759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25553351|NCT00642759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25553352|NCT00642759|Growth Substances|growth substances|mesh-ancestor
24617846|NCT01045902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24652911|NCT01240928|Exemestane|exemestane|mesh-list
24963280|NCT03791918|Hormones|hormones|mesh-ancestor
25553353|NCT00642759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553354|NCT00642759|Growth Inhibitors|growth inhibitors|mesh-ancestor
25553355|NCT00642811|Aspirin|aspirin|mesh-list
25553356|NCT00642811|Clopidogrel|clopidogrel|mesh-list
25553357|NCT00642811|Ticagrelor|ticagrelor|mesh-list
25553358|NCT00642811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25553359|NCT00642811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25553360|NCT00642811|Analgesics|analgesics|mesh-ancestor
25553361|NCT00642811|Sensory System Agents|sensory system agents|mesh-ancestor
25553362|NCT00642811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25553363|NCT00642811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553364|NCT00642811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25553365|NCT00642811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25553366|NCT00642811|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25553367|NCT00642811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25553368|NCT00642811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553369|NCT00642811|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25553370|NCT00642811|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25553371|NCT00642811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25553372|NCT00642811|Antipyretics|antipyretics|mesh-ancestor
25553373|NCT00642811|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25553374|NCT00642811|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25553375|NCT00642811|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25553376|NCT00642811|Purinergic Agents|purinergic agents|mesh-ancestor
25553377|NCT00642811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25553378|NCT00642850|Epoetin Alfa|epoetin alfa|mesh-list
25553379|NCT00642850|Hematinics|hematinics|mesh-ancestor
25553380|NCT00642954|Dexamethasone|dexamethasone|mesh-list
25553381|NCT00642954|Lenalidomide|lenalidomide|mesh-list
25553382|NCT00642954|Vorinostat|vorinostat|mesh-list
25553383|NCT00642954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25553384|NCT00642954|Antiemetics|antiemetics|mesh-ancestor
25553385|NCT00642954|Autonomic Agents|autonomic agents|mesh-ancestor
25553386|NCT00642954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25553387|NCT00642954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553388|NCT00642954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25553389|NCT00642954|Glucocorticoids|glucocorticoids|mesh-ancestor
25553390|NCT00642954|Hormones|hormones|mesh-ancestor
25553391|NCT00642954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25124244|NCT03078777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25553392|NCT00642954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25553393|NCT00642954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25553394|NCT00642954|Immunologic Factors|immunologic factors|mesh-ancestor
25553395|NCT00642954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25553396|NCT00642954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25553397|NCT00642954|Growth Substances|growth substances|mesh-ancestor
25553398|NCT00642954|Growth Inhibitors|growth inhibitors|mesh-ancestor
25553399|NCT00642954|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25553400|NCT00642954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24740369|NCT01688089|Levodopa|levodopa|mesh-list
25124280|NCT03078231|Mydriatics|mydriatics|mesh-list
25553401|NCT00642954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553402|NCT00643097|Temozolomide|temozolomide|mesh-list
25553403|NCT00643097|Sargramostim|sargramostim|mesh-list
24697865|NCT01437696|Vitamin D|vitamin d|mesh-list
24741455|NCT05288738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25553404|NCT00643097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25553405|NCT00643097|Alkylating Agents|alkylating agents|mesh-ancestor
25553406|NCT00643097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553407|NCT00643097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25553408|NCT00643097|Immunologic Factors|immunologic factors|mesh-ancestor
25553409|NCT00643097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553410|NCT00643123|Allopurinol|allopurinol|mesh-list
25553411|NCT00643123|Antimetabolites|antimetabolites|mesh-ancestor
24618350|NCT01047995|Raltegravir Potassium|raltegravir potassium|mesh-list
24743183|NCT04972552|Ubiquinone|ubiquinone|mesh-list
25553412|NCT00643123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553413|NCT00643123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25553414|NCT00643123|Gout Suppressants|gout suppressants|mesh-ancestor
25553415|NCT00643123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25553416|NCT00643123|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25553417|NCT00643123|Antioxidants|antioxidants|mesh-ancestor
25553418|NCT00643123|Protective Agents|protective agents|mesh-ancestor
25553419|NCT00643123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553420|NCT00643162|Citalopram|citalopram|mesh-list
25553421|NCT00643162|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25553422|NCT00643162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25553423|NCT00643162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25553424|NCT00643162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816686|NCT02078336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24816687|NCT02078336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24512724|NCT00576329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512725|NCT00576329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25553425|NCT00643162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25553426|NCT00643162|Serotonin Agents|serotonin agents|mesh-ancestor
25553427|NCT00643162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553428|NCT00643162|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25553429|NCT00643162|Antidepressive Agents|antidepressive agents|mesh-ancestor
25553430|NCT00643162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25553431|NCT00643201|Enoxaparin|enoxaparin|mesh-list
25553432|NCT00643201|Warfarin|warfarin|mesh-list
25553433|NCT00643201|Enoxaparin sodium|enoxaparin sodium|mesh-list
25553434|NCT00643201|Apixaban|apixaban|mesh-list
25553435|NCT00643201|Anticoagulants|anticoagulants|mesh-ancestor
25553436|NCT00643201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25553437|NCT00643201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25553438|NCT00643201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745037|NCT04012177|Niacin|niacin|mesh-list
25553439|NCT00643201|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25553440|NCT00643201|Antithrombins|antithrombins|mesh-ancestor
25553441|NCT00643201|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24765938|NCT01791439|Lidocaine|lidocaine|mesh-list
25553442|NCT00643201|Protease Inhibitors|protease inhibitors|mesh-ancestor
25553443|NCT00643201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25553444|NCT00643565|Bevacizumab|bevacizumab|mesh-list
25553445|NCT00643565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24437229|NCT00273026|Dermatologic Agents|dermatologic agents|mesh-ancestor
24747649|NCT00378482|Tremelimumab|tremelimumab|mesh-list
24618692|NCT01049451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618693|NCT01049464|Magnesium Sulfate|magnesium sulfate|mesh-list
25553446|NCT00643565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25553447|NCT00643565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25553448|NCT00643565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25553449|NCT00643565|Growth Substances|growth substances|mesh-ancestor
25553450|NCT00643565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553451|NCT00643565|Growth Inhibitors|growth inhibitors|mesh-ancestor
25553452|NCT00643578|Formoterol Fumarate|formoterol fumarate|mesh-list
25553453|NCT00643578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25553454|NCT00643578|Autonomic Agents|autonomic agents|mesh-ancestor
25553455|NCT00643578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25553456|NCT00643578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553457|NCT00643578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25553458|NCT00643578|Respiratory System Agents|respiratory system agents|mesh-ancestor
25553459|NCT00643578|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25553460|NCT00643578|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24750601|NCT01699594|Autonomic Agents|autonomic agents|mesh-ancestor
25553461|NCT00643578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25553462|NCT00643578|Adrenergic Agents|adrenergic agents|mesh-ancestor
25553463|NCT00643578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24904535|NCT04355455|Citalopram|citalopram|mesh-list
25553464|NCT00643578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553465|NCT00643604|Treprostinil|treprostinil|mesh-list
25553466|NCT00643604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25553467|NCT00643760|Pregabalin|pregabalin|mesh-list
25553468|NCT00643760|Gabapentin|gabapentin|mesh-list
25553469|NCT00643760|Analgesics|analgesics|mesh-ancestor
25553470|NCT00643760|Sensory System Agents|sensory system agents|mesh-ancestor
25553471|NCT00643760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25553472|NCT00643760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553473|NCT00643760|Anticonvulsants|anticonvulsants|mesh-ancestor
25553474|NCT00643760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25553475|NCT00643760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25553476|NCT00643760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553477|NCT00643760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25553478|NCT00643760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25553479|NCT00643760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25553480|NCT00643760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25553481|NCT00643760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25553482|NCT00643760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25553483|NCT00643760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25553484|NCT00643760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25553485|NCT00643760|Antimanic Agents|antimanic agents|mesh-ancestor
25553486|NCT00643851|Metformin|metformin|mesh-list
25553487|NCT00643851|Dapagliflozin|dapagliflozin|mesh-list
25553488|NCT00643851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25553489|NCT00643851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768335|NCT01807429|Anesthetics|anesthetics|mesh-ancestor
24755570|NCT01727427|Rivaroxaban|rivaroxaban|mesh-list
24797098|NCT01953887|Tamsulosin|tamsulosin|mesh-list
25553490|NCT00643851|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25553491|NCT00643851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553492|NCT00644059|Vaccines|vaccines|mesh-list
25553493|NCT00644059|Immunologic Factors|immunologic factors|mesh-ancestor
25553494|NCT00644059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553495|NCT00644189|Clofarabine|clofarabine|mesh-list
25553496|NCT00644189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25553497|NCT00644189|Antimetabolites|antimetabolites|mesh-ancestor
25553498|NCT00644189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553499|NCT00644189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25553500|NCT00644332|Ranolazine|ranolazine|mesh-list
25553501|NCT00644332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25553502|NCT00644332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25553503|NCT00644332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553504|NCT00644358|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
25553505|NCT00644358|Antidepressive Agents|antidepressive agents|mesh-ancestor
25553506|NCT00644358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25553507|NCT00644358|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25553508|NCT00644358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25553509|NCT00644358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25553510|NCT00644358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553511|NCT00644358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25553512|NCT00644358|Serotonin Agents|serotonin agents|mesh-ancestor
25553513|NCT00644358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553514|NCT00644358|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25553515|NCT00644358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25553516|NCT00644592|Fenofibrate|fenofibrate|mesh-list
25553517|NCT00644592|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25553518|NCT00644592|Antimetabolites|antimetabolites|mesh-ancestor
25553519|NCT00644592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553520|NCT00644592|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25553521|NCT00644657|Clopidogrel|clopidogrel|mesh-list
25553522|NCT00644657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25553523|NCT00644657|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25553524|NCT00644657|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25553525|NCT00644657|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25553526|NCT00644657|Purinergic Agents|purinergic agents|mesh-ancestor
25553527|NCT00644657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25553528|NCT00644657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553529|NCT00644657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553530|NCT00644787|Fentanyl|fentanyl|mesh-list
25553531|NCT00644787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25553532|NCT00644787|Narcotics|narcotics|mesh-ancestor
25553533|NCT00644787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25553534|NCT00644787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553535|NCT00644787|Analgesics|analgesics|mesh-ancestor
25553536|NCT00644787|Sensory System Agents|sensory system agents|mesh-ancestor
25553537|NCT00644787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25553538|NCT00644787|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25553539|NCT00644787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24406172|NCT00169195|Gemcitabine|gemcitabine|mesh-list
24406409|NCT00170196|Hormones|hormones|mesh-ancestor
24891187|NCT04475029|Narcotics|narcotics|mesh-ancestor
25553540|NCT00644787|Anesthetics, General|anesthetics, general|mesh-ancestor
25553541|NCT00644787|Anesthetics|anesthetics|mesh-ancestor
25553542|NCT00644969|Varenicline|varenicline|mesh-list
25553543|NCT00644969|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24771409|NCT01827059|Bosentan|bosentan|mesh-list
24891596|NCT04469010|Iron|iron|mesh-list
24771893|NCT01830465|Bortezomib|bortezomib|mesh-list
25553544|NCT00644969|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25553545|NCT00644969|Cholinergic Agents|cholinergic agents|mesh-ancestor
25553546|NCT00644969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25010778|NCT02964507|Fulvestrant|fulvestrant|mesh-list
25553547|NCT00644969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553548|NCT00644969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700458|NCT01452607|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25010873|NCT02820857|Bevacizumab|bevacizumab|mesh-list
25651333|NCT01515345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25651334|NCT01515345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25651335|NCT01515345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25651336|NCT01515345|Purinergic Agents|purinergic agents|mesh-ancestor
25651337|NCT01515345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24777241|NCT01863173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24634193|NCT01132391|Nitroglycerin|nitroglycerin|mesh-list
24777630|NCT01865305|Insulin, Long-Acting|insulin, long-acting|mesh-list
25651338|NCT01515345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651339|NCT01515345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651340|NCT01515410|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25651341|NCT01515410|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25651342|NCT01515410|Immunologic Factors|immunologic factors|mesh-ancestor
25651343|NCT01515410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651344|NCT01515410|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25651345|NCT01515410|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25448982|NCT04618367|Lenvatinib|lenvatinib|mesh-list
25553549|NCT00645099|Olanzapine|olanzapine|mesh-list
25553550|NCT00645099|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25553551|NCT00645099|Antiemetics|antiemetics|mesh-ancestor
25553552|NCT00645099|Autonomic Agents|autonomic agents|mesh-ancestor
25553553|NCT00645099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25553554|NCT00645099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553555|NCT00645099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25553556|NCT00645099|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25065448|NCT05322265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25553557|NCT00645099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25553558|NCT00645099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25553559|NCT00645099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25553560|NCT00645099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24915721|NCT04248998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25065531|NCT05321329|Capecitabine|capecitabine|mesh-list
25553561|NCT00645099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25553562|NCT00645099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25553563|NCT00645099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553564|NCT00645099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25065625|NCT05311813|Enoxaparin|enoxaparin|mesh-list
25065858|NCT05045378|Midazolam|midazolam|mesh-list
25553565|NCT00645099|Serotonin Agents|serotonin agents|mesh-ancestor
25553566|NCT00645099|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25553567|NCT00645099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25553568|NCT00645099|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25553569|NCT00645099|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25553570|NCT00645099|Dopamine Agents|dopamine agents|mesh-ancestor
25553571|NCT00645333|Docetaxel|docetaxel|mesh-list
24628059|NCT01096420|Topiramate|topiramate|mesh-list
24916636|NCT04238884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25553572|NCT00645333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25553573|NCT00645333|Tubulin Modulators|tubulin modulators|mesh-ancestor
25553574|NCT00645333|Antimitotic Agents|antimitotic agents|mesh-ancestor
25553575|NCT00645333|Mitosis Modulators|mitosis modulators|mesh-ancestor
25553576|NCT00645333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553577|NCT00645411|Vaccines|vaccines|mesh-list
25553578|NCT00645411|Immunologic Factors|immunologic factors|mesh-ancestor
25553579|NCT00645411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553580|NCT00645450|Propranolol|propranolol|mesh-list
25553581|NCT00645450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25553582|NCT00645450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25553583|NCT00645450|Adrenergic Agents|adrenergic agents|mesh-ancestor
24586144|NCT00889356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819875|NCT02097459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819876|NCT02097459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24819877|NCT02097459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25553584|NCT00645450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25553585|NCT00645450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553586|NCT00645450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553587|NCT00645450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25553588|NCT00645450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25553589|NCT00645450|Vasodilator Agents|vasodilator agents|mesh-ancestor
25553590|NCT00645528|Insulin|insulin|mesh-list
25449055|NCT04617613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974972|NCT04862585|Paclitaxel|paclitaxel|mesh-list
25449056|NCT04617613|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25449057|NCT04617613|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25449058|NCT04617613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25084463|NCT03306745|Folic Acid|folic acid|mesh-list
25449059|NCT04617626|Azithromycin|azithromycin|mesh-list
25449060|NCT04617626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25449061|NCT04617626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25449062|NCT04617652|Magnesium Sulfate|magnesium sulfate|mesh-list
25449063|NCT04617652|Analgesics|analgesics|mesh-ancestor
25449064|NCT04617652|Sensory System Agents|sensory system agents|mesh-ancestor
25449065|NCT04617652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449066|NCT04617652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449067|NCT04617652|Anesthetics|anesthetics|mesh-ancestor
25449068|NCT04617652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25449069|NCT04617652|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25449070|NCT04617652|Anticonvulsants|anticonvulsants|mesh-ancestor
24917903|NCT04225195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25553591|NCT00645528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25553592|NCT00645528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553593|NCT00645593|Gemcitabine|gemcitabine|mesh-list
25553594|NCT00645593|Cisplatin|cisplatin|mesh-list
25553595|NCT00645593|Cetuximab|cetuximab|mesh-list
25553596|NCT00645593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25553597|NCT00645593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25553598|NCT00645593|Antimetabolites|antimetabolites|mesh-ancestor
25553599|NCT00645593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553600|NCT00645593|Antiviral Agents|antiviral agents|mesh-ancestor
25553601|NCT00645593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25553602|NCT00645593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25553603|NCT00645593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25553604|NCT00645593|Immunologic Factors|immunologic factors|mesh-ancestor
25553605|NCT00645593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553606|NCT00645593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25553607|NCT00645671|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25553608|NCT00645671|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25553609|NCT00645710|Gemcitabine|gemcitabine|mesh-list
25553610|NCT00645710|Floxuridine|floxuridine|mesh-list
25553611|NCT00645710|Antibodies|antibodies|mesh-list
25553612|NCT00645710|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25553613|NCT00645710|Immunologic Factors|immunologic factors|mesh-ancestor
24822930|NCT02114346|Atorvastatin|atorvastatin|mesh-list
25553614|NCT00645710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553615|NCT00645710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25553616|NCT00645710|Antimetabolites|antimetabolites|mesh-ancestor
25553617|NCT00645710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553618|NCT00645710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25553619|NCT00645710|Antiviral Agents|antiviral agents|mesh-ancestor
25553620|NCT00645710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25553621|NCT00645710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25553622|NCT00645710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25553623|NCT00645788|Ciprofloxacin|ciprofloxacin|mesh-list
25088698|NCT03272425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25088699|NCT03272425|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24520998|NCT05210374|Doxorubicin|doxorubicin|mesh-list
25553624|NCT00645788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25553625|NCT00645788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25553626|NCT00645788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25553627|NCT00645788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25553628|NCT00645788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25686090|NCT01914666|Analgesics|analgesics|mesh-ancestor
25553629|NCT00645788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553630|NCT00645788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25553631|NCT00645788|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25553632|NCT00645788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25553633|NCT00645840|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25553634|NCT00645840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25553635|NCT00645853|Warfarin|warfarin|mesh-list
25553636|NCT00645853|Anticoagulants|anticoagulants|mesh-ancestor
25553637|NCT00645944|Eszopiclone|eszopiclone|mesh-list
25553638|NCT00645944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25553639|NCT00645944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25553640|NCT00645944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553641|NCT00646451|Pregabalin|pregabalin|mesh-list
25553642|NCT00646451|Analgesics|analgesics|mesh-ancestor
25553643|NCT00646451|Sensory System Agents|sensory system agents|mesh-ancestor
25553644|NCT00646451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25553645|NCT00646451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553646|NCT00646451|Anticonvulsants|anticonvulsants|mesh-ancestor
25553647|NCT00646451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25553648|NCT00646451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25553649|NCT00646451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553650|NCT00646451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25553651|NCT00646451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25553652|NCT00646451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25553653|NCT00646451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25553654|NCT00646451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25553655|NCT00646581|Insulin|insulin|mesh-list
25553656|NCT00646581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25553657|NCT00646581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25553658|NCT00646581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553659|NCT00646646|Midazolam|midazolam|mesh-list
25553660|NCT00646646|Dexmedetomidine|dexmedetomidine|mesh-list
25553661|NCT00646646|Propofol|propofol|mesh-list
25553662|NCT00646646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25553663|NCT00646646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25553664|NCT00646646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553665|NCT00646646|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25553666|NCT00646646|Anesthetics, General|anesthetics, general|mesh-ancestor
25553667|NCT00646646|Anesthetics|anesthetics|mesh-ancestor
25553668|NCT00646646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25553669|NCT00646646|Analgesics|analgesics|mesh-ancestor
25553670|NCT00646646|Sensory System Agents|sensory system agents|mesh-ancestor
25553671|NCT00646646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25553672|NCT00646646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25553673|NCT00646646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25553674|NCT00646646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25553675|NCT00646646|Adrenergic Agents|adrenergic agents|mesh-ancestor
25553676|NCT00646646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25553677|NCT00646646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553678|NCT00646646|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25553679|NCT00646646|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25553680|NCT00646646|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25553681|NCT00646646|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25553682|NCT00646646|GABA Modulators|gaba modulators|mesh-ancestor
25553683|NCT00646646|GABA Agents|gaba agents|mesh-ancestor
25553684|NCT00646763|Lenograstim|lenograstim|mesh-list
25553685|NCT00646763|Sargramostim|sargramostim|mesh-list
25553686|NCT00646763|Mitogens|mitogens|mesh-list
25553687|NCT00646763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25553688|NCT00646763|Immunologic Factors|immunologic factors|mesh-ancestor
25553689|NCT00646763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553690|NCT00646763|Mitosis Modulators|mitosis modulators|mesh-ancestor
25553691|NCT00646763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553692|NCT00646776|Ritonavir|ritonavir|mesh-list
25553693|NCT00646776|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25553694|NCT00646776|Rifabutin|rifabutin|mesh-list
25553695|NCT00646776|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25553696|NCT00646776|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25553697|NCT00646776|Protease Inhibitors|protease inhibitors|mesh-ancestor
25553698|NCT00646776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25553699|NCT00646776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553700|NCT00646776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25553701|NCT00646776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25553702|NCT00646776|Antiviral Agents|antiviral agents|mesh-ancestor
25553703|NCT00646776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25553704|NCT00646776|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25553705|NCT00646776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25553706|NCT00646776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24919103|NCT04214145|Sympathomimetics|sympathomimetics|mesh-ancestor
24515882|NCT00599885|Valsartan|valsartan|mesh-list
25553707|NCT00646776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25553708|NCT00646776|Antitubercular Agents|antitubercular agents|mesh-ancestor
25553709|NCT00646906|Aspirin|aspirin|mesh-list
25553710|NCT00646906|Acetaminophen|acetaminophen|mesh-list
25553711|NCT00646906|Ibuprofen|ibuprofen|mesh-list
25553712|NCT00646906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25553713|NCT00646906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25553714|NCT00646906|Analgesics|analgesics|mesh-ancestor
25553715|NCT00646906|Sensory System Agents|sensory system agents|mesh-ancestor
25553716|NCT00646906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25553717|NCT00646906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553718|NCT00646906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25553719|NCT00646906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25553720|NCT00646906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25553721|NCT00646906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24896664|NCT04434105|Glucocorticoids|glucocorticoids|mesh-ancestor
25094920|NCT03221881|Tubulin Modulators|tubulin modulators|mesh-ancestor
25553722|NCT00646906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553723|NCT00646906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25553724|NCT00646906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25553725|NCT00646906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25553726|NCT00646906|Antipyretics|antipyretics|mesh-ancestor
25553727|NCT00646958|Linezolid|linezolid|mesh-list
25553728|NCT00646958|Radezolid|radezolid|mesh-list
25553729|NCT00646958|Oxazolidinones|oxazolidinones|mesh-list
25553730|NCT00646958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25553731|NCT00646958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25553732|NCT00646958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25553733|NCT00646958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25553734|NCT00646958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553735|NCT00647270|Adalimumab|adalimumab|mesh-list
25553736|NCT00647270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25553737|NCT00647270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25553738|NCT00647296|Pramipexole|pramipexole|mesh-list
25553739|NCT00647296|Antioxidants|antioxidants|mesh-ancestor
25553740|NCT00647296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553741|NCT00647296|Protective Agents|protective agents|mesh-ancestor
25553742|NCT00647296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553743|NCT00647296|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25553744|NCT00647296|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25553745|NCT00647296|Dopamine Agonists|dopamine agonists|mesh-ancestor
25553746|NCT00647296|Dopamine Agents|dopamine agents|mesh-ancestor
25553747|NCT00647296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25553748|NCT00647348|Simvastatin|simvastatin|mesh-list
24423063|NCT00224549|Irbesartan|irbesartan|mesh-list
25553749|NCT00647348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25553750|NCT00647348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25553751|NCT00647348|Antimetabolites|antimetabolites|mesh-ancestor
25553752|NCT00647348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553753|NCT00647348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25553754|NCT00647348|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25553755|NCT00647348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25553756|NCT00647400|Adalimumab|adalimumab|mesh-list
25553757|NCT00647400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25553758|NCT00647400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25449181|NCT04616352|Cefuroxime|cefuroxime|mesh-list
25553759|NCT00647699|Riboflavin|riboflavin|mesh-list
25553760|NCT00647699|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25553761|NCT00647699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25553762|NCT00647699|Vitamin B Complex|vitamin b complex|mesh-ancestor
25553763|NCT00647699|Vitamins|vitamins|mesh-ancestor
25553764|NCT00647699|Micronutrients|micronutrients|mesh-ancestor
25553765|NCT00647699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553766|NCT00647699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25097713|NCT03201796|Ofloxacin|ofloxacin|mesh-list
25553767|NCT00647699|Dermatologic Agents|dermatologic agents|mesh-ancestor
25553768|NCT00647998|Darbepoetin alfa|darbepoetin alfa|mesh-list
25553769|NCT00647998|Hematinics|hematinics|mesh-ancestor
25449247|NCT04615611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449248|NCT04615611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449249|NCT04615611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25067093|NCT03447093|Methimazole|methimazole|mesh-list
25449250|NCT04615611|Respiratory System Agents|respiratory system agents|mesh-ancestor
25449251|NCT04615611|Tocolytic Agents|tocolytic agents|mesh-ancestor
25449252|NCT04615611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25449253|NCT04615611|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25449254|NCT04615611|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25449255|NCT04615611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25449256|NCT04615611|Adrenergic Agents|adrenergic agents|mesh-ancestor
25449257|NCT04615611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25449258|NCT04615611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098658|NCT03196401|Durvalumab|durvalumab|mesh-list
25449259|NCT04615728|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25449260|NCT04615728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25449261|NCT04615481|Metronidazole|metronidazole|mesh-list
25449262|NCT04615481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25449263|NCT04615481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25449264|NCT04615481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25449265|NCT04615481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25449266|NCT04615403|Travoprost|travoprost|mesh-list
25449267|NCT04615403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25449268|NCT04615351|Metformin|metformin|mesh-list
25449269|NCT04615351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25449270|NCT04615351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449271|NCT04615156|Deoxyglucose|deoxyglucose|mesh-list
25449272|NCT04615156|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25449273|NCT04615156|Antimetabolites|antimetabolites|mesh-ancestor
25449274|NCT04615156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449275|NCT04615156|Antiviral Agents|antiviral agents|mesh-ancestor
25449276|NCT04615156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25449277|NCT04615156|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25553770|NCT00648037|Rituximab|rituximab|mesh-list
25553771|NCT00648037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25553772|NCT00648037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25553773|NCT00648037|Immunologic Factors|immunologic factors|mesh-ancestor
25553774|NCT00648037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553775|NCT00648037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25553776|NCT00648375|Propranolol|propranolol|mesh-list
25449278|NCT04614727|Calcium|calcium|mesh-list
25553777|NCT00648375|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25553778|NCT00648375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24897417|NCT04425642|Sympathomimetics|sympathomimetics|mesh-ancestor
25553779|NCT00648375|Adrenergic Agents|adrenergic agents|mesh-ancestor
25553780|NCT00648375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25553781|NCT00648375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553782|NCT00648375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553783|NCT00648375|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25553784|NCT00648375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25553785|NCT00648375|Vasodilator Agents|vasodilator agents|mesh-ancestor
25553786|NCT00648648|Gemcitabine|gemcitabine|mesh-list
25553787|NCT00648648|Cisplatin|cisplatin|mesh-list
25553788|NCT00648648|Carboplatin|carboplatin|mesh-list
25553789|NCT00648648|Adavosertib|adavosertib|mesh-list
25553790|NCT00648648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25553791|NCT00648648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25553792|NCT00648648|Antimetabolites|antimetabolites|mesh-ancestor
25553793|NCT00648648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553794|NCT00648648|Antiviral Agents|antiviral agents|mesh-ancestor
24920391|NCT04202952|Sofosbuvir|sofosbuvir|mesh-list
25553795|NCT00648648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25553796|NCT00648648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25553797|NCT00648648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25553798|NCT00648648|Immunologic Factors|immunologic factors|mesh-ancestor
24623971|NCT01074086|Everolimus|everolimus|mesh-list
25100907|NCT03178864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25553799|NCT00648648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553800|NCT00648908|4-Aminopyridine|4-aminopyridine|mesh-list
25553801|NCT00648908|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25553802|NCT00648908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25553803|NCT00648908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553804|NCT00649220|Memantine|memantine|mesh-list
25553805|NCT00649220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25553806|NCT00649220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25553807|NCT00649220|Dopamine Agents|dopamine agents|mesh-ancestor
25553808|NCT00649220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25553809|NCT00649220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553810|NCT00649220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553811|NCT00649220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25553812|NCT00649220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25553813|NCT00649389|Amlodipine|amlodipine|mesh-list
25553814|NCT00649389|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25553815|NCT00649389|Olmesartan|olmesartan|mesh-list
25553816|NCT00649389|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25553817|NCT00649389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25553818|NCT00649389|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25553819|NCT00649389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25553820|NCT00649389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553821|NCT00649389|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25553822|NCT00649389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553823|NCT00649389|Vasodilator Agents|vasodilator agents|mesh-ancestor
25553824|NCT00649389|Diuretics|diuretics|mesh-ancestor
25553825|NCT00649389|Natriuretic Agents|natriuretic agents|mesh-ancestor
25553826|NCT00649389|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25553827|NCT00649389|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24495843|NCT00502164|Cediranib|cediranib|mesh-list
25553828|NCT00649389|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25553829|NCT00649792|4-Aminopyridine|4-aminopyridine|mesh-list
25553830|NCT00649792|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25553831|NCT00649792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25553832|NCT00649792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553833|NCT00649961|Melatonin|melatonin|mesh-list
25553834|NCT00649961|Antioxidants|antioxidants|mesh-ancestor
25553835|NCT00649961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553836|NCT00649961|Protective Agents|protective agents|mesh-ancestor
25040289|NCT03198728|Testosterone|testosterone|mesh-list
25553837|NCT00649961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553838|NCT00649961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25553839|NCT00650078|Prednisone|prednisone|mesh-list
25553840|NCT00650078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25553841|NCT00650078|Glucocorticoids|glucocorticoids|mesh-ancestor
25553842|NCT00650078|Hormones|hormones|mesh-ancestor
25553843|NCT00650078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25553844|NCT00650078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686347|NCT01919190|Bupivacaine|bupivacaine|mesh-list
25553845|NCT00650078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24607490|NCT04469842|Prednisone|prednisone|mesh-list
25553846|NCT00650078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25553847|NCT00650091|Acetylcysteine|acetylcysteine|mesh-list
24853526|NCT02268773|Dipyridamole|dipyridamole|mesh-list
25553848|NCT00650091|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25553849|NCT00650091|Antiviral Agents|antiviral agents|mesh-ancestor
25553850|NCT00650091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24607843|NCT03331484|Ticagrelor|ticagrelor|mesh-list
25553851|NCT00650091|Expectorants|expectorants|mesh-ancestor
25553852|NCT00650091|Respiratory System Agents|respiratory system agents|mesh-ancestor
25553853|NCT00650091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25553854|NCT00650091|Antioxidants|antioxidants|mesh-ancestor
25553855|NCT00650091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553856|NCT00650091|Protective Agents|protective agents|mesh-ancestor
25553857|NCT00650091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553858|NCT00650091|Antidotes|antidotes|mesh-ancestor
25553859|NCT00650104|Ropinirole|ropinirole|mesh-list
25553860|NCT00650104|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25102220|NCT03169738|Avelumab|avelumab|mesh-list
25553861|NCT00650104|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25553862|NCT00650104|Dopamine Agonists|dopamine agonists|mesh-ancestor
25553863|NCT00650104|Dopamine Agents|dopamine agents|mesh-ancestor
25553864|NCT00650104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25553865|NCT00650104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553866|NCT00650104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553867|NCT00650546|Exenatide|exenatide|mesh-list
24899710|NCT04401007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899711|NCT04401007|Sensory System Agents|sensory system agents|mesh-ancestor
25553868|NCT00650546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25553869|NCT00650546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553870|NCT00650546|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25553871|NCT00650546|Incretins|incretins|mesh-ancestor
25553872|NCT00650546|Hormones|hormones|mesh-ancestor
25553873|NCT00650546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25553874|NCT00650806|Canagliflozin|canagliflozin|mesh-list
25553875|NCT00650806|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25553876|NCT00650806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553877|NCT00650806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25553878|NCT00650806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553879|NCT00650845|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
25553880|NCT00650845|Chelating Agents|chelating agents|mesh-ancestor
25553881|NCT00650845|Sequestering Agents|sequestering agents|mesh-ancestor
25553882|NCT00650845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553883|NCT00650858|Plasminogen|plasminogen|mesh-list
25241883|NCT05196308|Cholinergic Agents|cholinergic agents|mesh-ancestor
25553884|NCT00650858|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24851455|NCT02256813|Hemostatics|hemostatics|mesh-ancestor
25553885|NCT00650858|Fibrinolytic Agents|fibrinolytic agents|mesh-list
25553886|NCT00650858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25553887|NCT00650858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553888|NCT00651040|Prednisone|prednisone|mesh-list
25553889|NCT00651040|Prednisolone|prednisolone|mesh-list
25553890|NCT00651040|Methotrexate|methotrexate|mesh-list
25553891|NCT00651040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25553892|NCT00651040|Glucocorticoids|glucocorticoids|mesh-ancestor
25553893|NCT00651040|Hormones|hormones|mesh-ancestor
25553894|NCT00651040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25553895|NCT00651040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553896|NCT00651040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25553897|NCT00651040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25553898|NCT00651040|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25553899|NCT00651040|Abortifacient Agents|abortifacient agents|mesh-ancestor
25553900|NCT00651040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25553901|NCT00651040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25553902|NCT00651040|Antimetabolites|antimetabolites|mesh-ancestor
25553903|NCT00651040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553904|NCT00651040|Dermatologic Agents|dermatologic agents|mesh-ancestor
25553905|NCT00651040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25553906|NCT00651040|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25553907|NCT00651040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25553908|NCT00651040|Immunologic Factors|immunologic factors|mesh-ancestor
25553909|NCT00651040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25553910|NCT00651040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25553911|NCT00651118|Fluticasone|fluticasone|mesh-list
25553912|NCT00651118|Xhance|xhance|mesh-list
25553913|NCT00651118|Azelastine|azelastine|mesh-list
25553914|NCT00651118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25553915|NCT00651118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25553916|NCT00651118|Autonomic Agents|autonomic agents|mesh-ancestor
25553917|NCT00651118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25553918|NCT00651118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553919|NCT00651118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25553920|NCT00651118|Respiratory System Agents|respiratory system agents|mesh-ancestor
25553921|NCT00651118|Dermatologic Agents|dermatologic agents|mesh-ancestor
25553922|NCT00651118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25553923|NCT00651118|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25553924|NCT00651118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25553925|NCT00651118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553926|NCT00651118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25553927|NCT00651118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25553928|NCT00651118|Histamine Antagonists|histamine antagonists|mesh-ancestor
25553929|NCT00651118|Histamine Agents|histamine agents|mesh-ancestor
25553930|NCT00651118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25553931|NCT00651183|Pramipexole|pramipexole|mesh-list
25553932|NCT00651183|Antioxidants|antioxidants|mesh-ancestor
25553933|NCT00651183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553934|NCT00651183|Protective Agents|protective agents|mesh-ancestor
25553935|NCT00651183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553936|NCT00651183|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25553937|NCT00651183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25553938|NCT00651183|Dopamine Agonists|dopamine agonists|mesh-ancestor
25553939|NCT00651183|Dopamine Agents|dopamine agents|mesh-ancestor
25553940|NCT00651183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25553941|NCT00651261|Cytarabine|cytarabine|mesh-list
25553942|NCT00651261|Dexamethasone|dexamethasone|mesh-list
25553943|NCT00651261|Dexamethasone acetate|dexamethasone acetate|mesh-list
25553944|NCT00651261|Daunorubicin|daunorubicin|mesh-list
25553945|NCT00651261|Midostaurin|midostaurin|mesh-list
25553946|NCT00651261|BB 1101|bb 1101|mesh-list
25553947|NCT00651261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25553948|NCT00651261|Antiemetics|antiemetics|mesh-ancestor
25553949|NCT00651261|Autonomic Agents|autonomic agents|mesh-ancestor
25651346|NCT01515410|Dopamine Agonists|dopamine agonists|mesh-ancestor
25553950|NCT00651261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25553951|NCT00651261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553952|NCT00651261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25553953|NCT00651261|Glucocorticoids|glucocorticoids|mesh-ancestor
25553954|NCT00651261|Hormones|hormones|mesh-ancestor
25553955|NCT00651261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25553956|NCT00651261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25553957|NCT00651261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25553958|NCT00651261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25553959|NCT00651261|Antimetabolites|antimetabolites|mesh-ancestor
25553960|NCT00651261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553961|NCT00651261|Antiviral Agents|antiviral agents|mesh-ancestor
25553962|NCT00651261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25553963|NCT00651261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25553964|NCT00651261|Immunologic Factors|immunologic factors|mesh-ancestor
25553965|NCT00651261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24673974|NCT01341353|Amiodarone|amiodarone|mesh-list
25553966|NCT00651261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25553967|NCT00651261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24419329|NCT00211744|Anticonvulsants|anticonvulsants|mesh-ancestor
25553968|NCT00651261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25553969|NCT00651261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25553970|NCT00651261|Protease Inhibitors|protease inhibitors|mesh-ancestor
25553971|NCT00651313|Lidocaine|lidocaine|mesh-list
25553972|NCT00651313|Anesthetics, Local|anesthetics, local|mesh-ancestor
25553973|NCT00651313|Anesthetics|anesthetics|mesh-ancestor
24674862|NCT04216134|Sequestering Agents|sequestering agents|mesh-ancestor
25553974|NCT00651313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25553975|NCT00651313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553976|NCT00651313|Sensory System Agents|sensory system agents|mesh-ancestor
24427082|NCT00237341|Analgesics|analgesics|mesh-ancestor
25553977|NCT00651313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25553978|NCT00651313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25553979|NCT00651313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25553980|NCT00651313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25553981|NCT00651313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24675578|NCT01344174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25553982|NCT00651313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25553983|NCT00651482|Bevacizumab|bevacizumab|mesh-list
25553984|NCT00651482|Everolimus|everolimus|mesh-list
25553985|NCT00651482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25553986|NCT00651482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25553987|NCT00651482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25553988|NCT00651482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25553989|NCT00651482|Growth Substances|growth substances|mesh-ancestor
24432392|NCT00254709|Antifungal Agents|antifungal agents|mesh-ancestor
25553990|NCT00651482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25553991|NCT00651482|Growth Inhibitors|growth inhibitors|mesh-ancestor
25553992|NCT00651482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25553993|NCT00651482|Immunologic Factors|immunologic factors|mesh-ancestor
25553994|NCT00651755|Prednisone|prednisone|mesh-list
25553995|NCT00651755|Cyclophosphamide|cyclophosphamide|mesh-list
25553996|NCT00651755|Rituximab|rituximab|mesh-list
25553997|NCT00651755|Doxorubicin|doxorubicin|mesh-list
25553998|NCT00651755|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25553999|NCT00651755|Vincristine|vincristine|mesh-list
25554000|NCT00651755|Ondansetron|ondansetron|mesh-list
25554001|NCT00651755|Aprepitant|aprepitant|mesh-list
25554002|NCT00651755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25554003|NCT00651755|Immunologic Factors|immunologic factors|mesh-ancestor
25554004|NCT00651755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554005|NCT00651755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25554006|NCT00651755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24433848|NCT00260260|Oxycodone|oxycodone|mesh-list
25554007|NCT00651755|Alkylating Agents|alkylating agents|mesh-ancestor
25554008|NCT00651755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554009|NCT00651755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25554010|NCT00651755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25554011|NCT00651755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25554012|NCT00651755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25554013|NCT00651755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25554014|NCT00651755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25554015|NCT00651755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554016|NCT00651755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25554017|NCT00651755|Glucocorticoids|glucocorticoids|mesh-ancestor
25554018|NCT00651755|Hormones|hormones|mesh-ancestor
25554019|NCT00651755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25554020|NCT00651755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25554021|NCT00651755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25554022|NCT00651755|Tubulin Modulators|tubulin modulators|mesh-ancestor
25554023|NCT00651755|Antimitotic Agents|antimitotic agents|mesh-ancestor
25554024|NCT00651755|Mitosis Modulators|mitosis modulators|mesh-ancestor
25554025|NCT00651755|Antiemetics|antiemetics|mesh-ancestor
25554026|NCT00651755|Autonomic Agents|autonomic agents|mesh-ancestor
25554027|NCT00651755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25554028|NCT00651755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25554029|NCT00651755|Antipruritics|antipruritics|mesh-ancestor
25554030|NCT00651755|Dermatologic Agents|dermatologic agents|mesh-ancestor
25554031|NCT00651755|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25554032|NCT00651755|Serotonin Agents|serotonin agents|mesh-ancestor
25554033|NCT00651755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25554034|NCT00651755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25554035|NCT00651755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25554036|NCT00651755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25554037|NCT00651755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25554038|NCT00651755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25449467|NCT04612803|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25449468|NCT04612803|Histamine Agents|histamine agents|mesh-ancestor
25449469|NCT04612803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25449470|NCT04612803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449471|NCT04612803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449472|NCT04612556|Vaccines|vaccines|mesh-list
25449473|NCT04612556|Immunologic Factors|immunologic factors|mesh-ancestor
25449474|NCT04612556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449475|NCT04612582|Thalidomide|thalidomide|mesh-list
25449476|NCT04612582|Cyclophosphamide|cyclophosphamide|mesh-list
25449477|NCT04612582|Bortezomib|bortezomib|mesh-list
25449478|NCT04612582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25449479|NCT04612582|Immunologic Factors|immunologic factors|mesh-ancestor
25449480|NCT04612582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449481|NCT04612582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25449482|NCT04612582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25449483|NCT04612582|Alkylating Agents|alkylating agents|mesh-ancestor
25449484|NCT04612582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449485|NCT04612582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449486|NCT04612582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25449487|NCT04612582|Leprostatic Agents|leprostatic agents|mesh-ancestor
25449488|NCT04612582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25449489|NCT04612582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25449490|NCT04612582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24854199|NCT02272647|Estradiol|estradiol|mesh-list
25449491|NCT04612582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25449492|NCT04612582|Growth Substances|growth substances|mesh-ancestor
25449493|NCT04612582|Growth Inhibitors|growth inhibitors|mesh-ancestor
25449494|NCT04612530|Nivolumab|nivolumab|mesh-list
25449495|NCT04612530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25449496|NCT04612530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242549|NCT04360473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25554039|NCT00651755|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25554040|NCT00651937|Melphalan|melphalan|mesh-list
25554041|NCT00651937|Lenograstim|lenograstim|mesh-list
25007522|NCT03342196|Melphalan|melphalan|mesh-list
25554042|NCT00651937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25554043|NCT00651937|Alkylating Agents|alkylating agents|mesh-ancestor
25554044|NCT00651937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554045|NCT00651937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25554046|NCT00651937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25554047|NCT00651937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25554048|NCT00651937|Immunologic Factors|immunologic factors|mesh-ancestor
25554049|NCT00651937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554050|NCT00651937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25554051|NCT00652028|Fentanyl|fentanyl|mesh-list
25554052|NCT00652028|Midazolam|midazolam|mesh-list
25554053|NCT00652028|Dexmedetomidine|dexmedetomidine|mesh-list
25554054|NCT00652028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25554055|NCT00652028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25554056|NCT00652028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554057|NCT00652028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25554058|NCT00652028|Analgesics|analgesics|mesh-ancestor
25554059|NCT00652028|Sensory System Agents|sensory system agents|mesh-ancestor
25554060|NCT00652028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24442248|NCT00290628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25554061|NCT00652028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25554062|NCT00652028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25554063|NCT00652028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25554064|NCT00652028|Adrenergic Agents|adrenergic agents|mesh-ancestor
25554065|NCT00652028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25554066|NCT00652028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554067|NCT00652028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25554068|NCT00652028|Narcotics|narcotics|mesh-ancestor
25554069|NCT00652028|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25554070|NCT00652028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25554071|NCT00652028|Anesthetics, General|anesthetics, general|mesh-ancestor
25554072|NCT00652028|Anesthetics|anesthetics|mesh-ancestor
25554073|NCT00652028|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25554074|NCT00652028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25554075|NCT00652028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25554076|NCT00652028|GABA Modulators|gaba modulators|mesh-ancestor
25554077|NCT00652028|GABA Agents|gaba agents|mesh-ancestor
25554078|NCT00652093|Acetaminophen|acetaminophen|mesh-list
25554079|NCT00652093|Oxymorphone|oxymorphone|mesh-list
25554080|NCT00652093|Acetaminophen, dextropropoxyphene, drug combination|acetaminophen, dextropropoxyphene, drug combination|mesh-list
25554081|NCT00652093|Dextropropoxyphene|dextropropoxyphene|mesh-list
25554082|NCT00652093|Levopropoxyphene|levopropoxyphene|mesh-list
25554083|NCT00652093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25554084|NCT00652093|Analgesics|analgesics|mesh-ancestor
25554085|NCT00652093|Sensory System Agents|sensory system agents|mesh-ancestor
25554086|NCT00652093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25554087|NCT00652093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554088|NCT00652093|Antipyretics|antipyretics|mesh-ancestor
25554089|NCT00652093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25554090|NCT00652093|Narcotics|narcotics|mesh-ancestor
25554091|NCT00652093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25554092|NCT00652093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25554093|NCT00652093|Antitussive Agents|antitussive agents|mesh-ancestor
25554094|NCT00652093|Respiratory System Agents|respiratory system agents|mesh-ancestor
25554095|NCT00652145|Mesalamine|mesalamine|mesh-list
25554096|NCT00652145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25554097|NCT00652145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25554098|NCT00652145|Analgesics|analgesics|mesh-ancestor
25554099|NCT00652145|Sensory System Agents|sensory system agents|mesh-ancestor
25554100|NCT00652145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25554101|NCT00652145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554102|NCT00652145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25554103|NCT00652145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25554104|NCT00652314|Thrombin|thrombin|mesh-list
25554105|NCT00652314|Hemostatics|hemostatics|mesh-ancestor
25554106|NCT00652314|Coagulants|coagulants|mesh-ancestor
25554107|NCT00652340|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25554108|NCT00652340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25554109|NCT00652340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25554110|NCT00652340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554111|NCT00652340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554112|NCT00652366|Gemcitabine|gemcitabine|mesh-list
25554113|NCT00652366|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25554114|NCT00652366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25554115|NCT00652366|Antimetabolites|antimetabolites|mesh-ancestor
25554116|NCT00652366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554117|NCT00652366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25554118|NCT00652366|Antiviral Agents|antiviral agents|mesh-ancestor
25554119|NCT00652366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25554120|NCT00652366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554121|NCT00652366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25554122|NCT00652366|Immunologic Factors|immunologic factors|mesh-ancestor
25554123|NCT00652366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554124|NCT00652366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25554125|NCT00652626|Azacitidine|azacitidine|mesh-list
25554126|NCT00652626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25554127|NCT00652626|Antimetabolites|antimetabolites|mesh-ancestor
25554128|NCT00652626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554129|NCT00652626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25554130|NCT00652626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554131|NCT00652834|Mycophenolic Acid|mycophenolic acid|mesh-list
25554132|NCT00652834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25554133|NCT00652834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25554134|NCT00652834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25554135|NCT00652834|Antitubercular Agents|antitubercular agents|mesh-ancestor
25554136|NCT00652834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25554137|NCT00652834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25554138|NCT00652834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554139|NCT00652834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554140|NCT00652899|Vidarabine|vidarabine|mesh-list
25554141|NCT00652899|Aldesleukin|aldesleukin|mesh-list
25554142|NCT00652899|Cyclophosphamide|cyclophosphamide|mesh-list
25554143|NCT00652899|Fludarabine|fludarabine|mesh-list
25554144|NCT00652899|Fludarabine phosphate|fludarabine phosphate|mesh-list
25554145|NCT00652899|Interleukin-2|interleukin-2|mesh-list
25449510|NCT04612257|Insulin|insulin|mesh-list
25554146|NCT00652899|Allopurinol|allopurinol|mesh-list
25554147|NCT00652899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25554148|NCT00652899|Immunologic Factors|immunologic factors|mesh-ancestor
25554149|NCT00652899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554150|NCT00652899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25554151|NCT00652899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25554152|NCT00652899|Alkylating Agents|alkylating agents|mesh-ancestor
25554153|NCT00652899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554154|NCT00652899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25554155|NCT00652899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25554156|NCT00652899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25554157|NCT00652899|Antimetabolites|antimetabolites|mesh-ancestor
25554158|NCT00652899|Antiviral Agents|antiviral agents|mesh-ancestor
25554159|NCT00652899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25554160|NCT00652899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25554161|NCT00652899|Analgesics|analgesics|mesh-ancestor
25554162|NCT00652899|Sensory System Agents|sensory system agents|mesh-ancestor
25554163|NCT00652899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25554164|NCT00652899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25554165|NCT00652899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25554166|NCT00652899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554167|NCT00652899|Gout Suppressants|gout suppressants|mesh-ancestor
25554168|NCT00652899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25554169|NCT00652899|Antioxidants|antioxidants|mesh-ancestor
25554170|NCT00652899|Protective Agents|protective agents|mesh-ancestor
25554171|NCT00652951|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25554172|NCT00652951|Immunologic Factors|immunologic factors|mesh-ancestor
25554173|NCT00652951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554174|NCT00653159|Copper|copper|mesh-list
25554175|NCT00653159|Levonorgestrel|levonorgestrel|mesh-list
25554176|NCT00653159|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25554177|NCT00653159|Contraceptive Agents|contraceptive agents|mesh-ancestor
25554178|NCT00653159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25554179|NCT00653159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554180|NCT00653159|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25554181|NCT00653159|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25554182|NCT00653159|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25554183|NCT00653159|Trace Elements|trace elements|mesh-ancestor
25554184|NCT00653159|Micronutrients|micronutrients|mesh-ancestor
25554185|NCT00653224|Levocetirizine|levocetirizine|mesh-list
25554186|NCT00653224|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25554187|NCT00653224|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25554188|NCT00653224|Histamine Antagonists|histamine antagonists|mesh-ancestor
25554189|NCT00653224|Histamine Agents|histamine agents|mesh-ancestor
25554190|NCT00653224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25554191|NCT00653224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554192|NCT00653224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554193|NCT00653328|Doxorubicin|doxorubicin|mesh-list
25554194|NCT00653328|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25554195|NCT00653328|Atrasentan|atrasentan|mesh-list
25554196|NCT00653328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25554197|NCT00653328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25554198|NCT00653328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25554199|NCT00653328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24796719|NCT01951729|Atropine|atropine|mesh-list
25554200|NCT00653328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554201|NCT00653328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554202|NCT00653328|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25554203|NCT00653328|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25554204|NCT00653432|Hyaluronic Acid|hyaluronic acid|mesh-list
25554205|NCT00653432|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25554206|NCT00653432|Immunologic Factors|immunologic factors|mesh-ancestor
25554207|NCT00653432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554208|NCT00653432|Viscosupplements|viscosupplements|mesh-ancestor
25554209|NCT00653432|Protective Agents|protective agents|mesh-ancestor
25554210|NCT00653861|Lidocaine|lidocaine|mesh-list
25554211|NCT00653861|Anesthetics, Local|anesthetics, local|mesh-ancestor
25554212|NCT00653861|Anesthetics|anesthetics|mesh-ancestor
25554213|NCT00653861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25554214|NCT00653861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554215|NCT00653861|Sensory System Agents|sensory system agents|mesh-ancestor
25554216|NCT00653861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25554217|NCT00653861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25554218|NCT00653861|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25554219|NCT00653861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25554220|NCT00653861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25554221|NCT00653861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554222|NCT00653939|Paclitaxel|paclitaxel|mesh-list
25554223|NCT00653939|Fosbretabulin|fosbretabulin|mesh-list
25554224|NCT00653939|Combretastatin|combretastatin|mesh-list
25554225|NCT00653939|Bevacizumab|bevacizumab|mesh-list
25554226|NCT00653939|Carboplatin|carboplatin|mesh-list
25554227|NCT00653939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25554228|NCT00653939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25554229|NCT00653939|Tubulin Modulators|tubulin modulators|mesh-ancestor
25554230|NCT00653939|Antimitotic Agents|antimitotic agents|mesh-ancestor
25554231|NCT00653939|Mitosis Modulators|mitosis modulators|mesh-ancestor
25554232|NCT00653939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554233|NCT00653939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25554234|NCT00653939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25554235|NCT00653939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25554236|NCT00653939|Growth Substances|growth substances|mesh-ancestor
25554237|NCT00653939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554238|NCT00653939|Growth Inhibitors|growth inhibitors|mesh-ancestor
25554239|NCT00654030|Vaccines|vaccines|mesh-list
25554240|NCT00654030|Immunologic Factors|immunologic factors|mesh-ancestor
25554241|NCT00654030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554242|NCT00654069|Niacin|niacin|mesh-list
25554243|NCT00654069|Niacinamide|niacinamide|mesh-list
25449663|NCT04610567|Immunologic Factors|immunologic factors|mesh-ancestor
25449664|NCT04610567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25449665|NCT04610567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25449666|NCT04610541|Remdesivir|remdesivir|mesh-list
25449667|NCT04610541|Antimetabolites|antimetabolites|mesh-ancestor
25449668|NCT04610541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449669|NCT04610541|Antiviral Agents|antiviral agents|mesh-ancestor
25449670|NCT04610541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25449671|NCT04610320|Daratumumab|daratumumab|mesh-list
25449672|NCT04610320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449673|NCT04610164|Tranexamic Acid|tranexamic acid|mesh-list
25449674|NCT04610164|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25449675|NCT04610164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25449676|NCT04610164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449677|NCT04610164|Hemostatics|hemostatics|mesh-ancestor
25449678|NCT04610164|Coagulants|coagulants|mesh-ancestor
25449679|NCT04610307|Anesthetics|anesthetics|mesh-list
25449680|NCT04610307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25449681|NCT04610307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449682|NCT04610502|Immunoglobulins|immunoglobulins|mesh-list
25449683|NCT04610502|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25449684|NCT04610502|Antibodies|antibodies|mesh-list
25449685|NCT04610502|Immunologic Factors|immunologic factors|mesh-ancestor
25449686|NCT04610502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449687|NCT04610398|Dexamethasone|dexamethasone|mesh-list
25449688|NCT04610398|Dexamethasone acetate|dexamethasone acetate|mesh-list
25449690|NCT04610398|Antiemetics|antiemetics|mesh-ancestor
25554244|NCT00654069|Nicotinic Acids|nicotinic acids|mesh-list
25554245|NCT00654069|Oxycodone|oxycodone|mesh-list
25554246|NCT00654069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25554247|NCT00654069|Narcotics|narcotics|mesh-ancestor
25554248|NCT00654069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25554249|NCT00654069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554250|NCT00654069|Analgesics|analgesics|mesh-ancestor
25554251|NCT00654069|Sensory System Agents|sensory system agents|mesh-ancestor
25554252|NCT00654069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25554253|NCT00654069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25554254|NCT00654069|Antimetabolites|antimetabolites|mesh-ancestor
25554255|NCT00654069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554256|NCT00654069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25554257|NCT00654069|Vasodilator Agents|vasodilator agents|mesh-ancestor
25554258|NCT00654069|Vitamin B Complex|vitamin b complex|mesh-ancestor
25554259|NCT00654069|Vitamins|vitamins|mesh-ancestor
25554260|NCT00654069|Micronutrients|micronutrients|mesh-ancestor
25554261|NCT00654147|Ritonavir|ritonavir|mesh-list
25554262|NCT00654147|Lopinavir|lopinavir|mesh-list
25554263|NCT00654147|Tenofovir|tenofovir|mesh-list
25554264|NCT00654147|Emtricitabine|emtricitabine|mesh-list
25554265|NCT00654147|Raltegravir Potassium|raltegravir potassium|mesh-list
25554266|NCT00654147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25554267|NCT00654147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25554268|NCT00654147|Protease Inhibitors|protease inhibitors|mesh-ancestor
25554269|NCT00654147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554270|NCT00654147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554271|NCT00654147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25554272|NCT00654147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25554273|NCT00654147|Antiviral Agents|antiviral agents|mesh-ancestor
25554274|NCT00654147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25554275|NCT00654147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25554276|NCT00654147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25554277|NCT00654147|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25554278|NCT00654147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25554279|NCT00654147|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25554280|NCT00654147|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25554281|NCT00654186|Lenalidomide|lenalidomide|mesh-list
25554282|NCT00654186|Immunologic Factors|immunologic factors|mesh-ancestor
25554283|NCT00654186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554284|NCT00654186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25554285|NCT00654186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25554286|NCT00654186|Growth Substances|growth substances|mesh-ancestor
25554287|NCT00654186|Growth Inhibitors|growth inhibitors|mesh-ancestor
25554288|NCT00654186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25554290|NCT00654238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25554291|NCT00654238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25554292|NCT00654238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554293|NCT00654238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554294|NCT00654329|Fentanyl|fentanyl|mesh-list
25554295|NCT00654329|Dexmedetomidine|dexmedetomidine|mesh-list
25554296|NCT00654329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25554297|NCT00654329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25554298|NCT00654329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554299|NCT00654329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25554300|NCT00654329|Analgesics|analgesics|mesh-ancestor
25554301|NCT00654329|Sensory System Agents|sensory system agents|mesh-ancestor
25554302|NCT00654329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25554303|NCT00654329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25554304|NCT00654329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25554305|NCT00654329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25554306|NCT00654329|Adrenergic Agents|adrenergic agents|mesh-ancestor
25554307|NCT00654329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25554308|NCT00654329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554309|NCT00654329|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25554310|NCT00654329|Narcotics|narcotics|mesh-ancestor
25554311|NCT00654329|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25554312|NCT00654329|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25554313|NCT00654329|Anesthetics, General|anesthetics, general|mesh-ancestor
25554314|NCT00654329|Anesthetics|anesthetics|mesh-ancestor
25554315|NCT00654355|Tacrolimus|tacrolimus|mesh-list
25554316|NCT00654355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25554317|NCT00654355|Immunologic Factors|immunologic factors|mesh-ancestor
25554318|NCT00654355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554319|NCT00654355|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25554320|NCT00654355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554321|NCT00654355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651347|NCT01515410|Dopamine Agents|dopamine agents|mesh-ancestor
25651348|NCT01515410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25651349|NCT01515410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651350|NCT01515423|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25651351|NCT01515423|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25651352|NCT01515423|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25651353|NCT01515423|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25651354|NCT01515540|Lidocaine|lidocaine|mesh-list
25651355|NCT01515540|Anesthetics, Local|anesthetics, local|mesh-ancestor
25651356|NCT01515540|Anesthetics|anesthetics|mesh-ancestor
25651357|NCT01515540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25651358|NCT01515540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651359|NCT01515540|Sensory System Agents|sensory system agents|mesh-ancestor
25651360|NCT01515540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25651361|NCT01515540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25651362|NCT01515540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25651363|NCT01515540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25651364|NCT01515540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25651365|NCT01515540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651366|NCT01515566|Fentanyl|fentanyl|mesh-list
25651367|NCT01515566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25651368|NCT01515566|Narcotics|narcotics|mesh-ancestor
25651369|NCT01515566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25554322|NCT00654368|Etanercept|etanercept|mesh-list
25554323|NCT00654368|Methotrexate|methotrexate|mesh-list
25554324|NCT00654368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25554325|NCT00654368|Abortifacient Agents|abortifacient agents|mesh-ancestor
25554326|NCT00654368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25554327|NCT00654368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554328|NCT00654368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25554329|NCT00654368|Antimetabolites|antimetabolites|mesh-ancestor
25554330|NCT00654368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554331|NCT00654368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25554332|NCT00654368|Dermatologic Agents|dermatologic agents|mesh-ancestor
25554333|NCT00654368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554334|NCT00654368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25554335|NCT00654368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25554336|NCT00654368|Immunologic Factors|immunologic factors|mesh-ancestor
25554337|NCT00654368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25554338|NCT00654368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25554339|NCT00654368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25554340|NCT00654368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25554341|NCT00654368|Analgesics|analgesics|mesh-ancestor
25554342|NCT00654368|Sensory System Agents|sensory system agents|mesh-ancestor
25554343|NCT00654368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25554344|NCT00654368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25554345|NCT00654368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25554346|NCT00654381|Inositol|inositol|mesh-list
25554347|NCT00654381|Linagliptin|linagliptin|mesh-list
25554348|NCT00654381|Voglibose|voglibose|mesh-list
25554349|NCT00654381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25554350|NCT00654381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554351|NCT00654381|Incretins|incretins|mesh-ancestor
25554352|NCT00654381|Hormones|hormones|mesh-ancestor
25554353|NCT00654381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25554354|NCT00654381|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25554355|NCT00654381|Protease Inhibitors|protease inhibitors|mesh-ancestor
25554356|NCT00654381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554357|NCT00654381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554358|NCT00654381|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25554359|NCT00654381|Vitamin B Complex|vitamin b complex|mesh-ancestor
25554360|NCT00654381|Vitamins|vitamins|mesh-ancestor
25554361|NCT00654381|Micronutrients|micronutrients|mesh-ancestor
25554362|NCT00654420|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25554363|NCT00654420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25554364|NCT00654420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25554365|NCT00654420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554366|NCT00654420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554367|NCT00654498|Pramipexole|pramipexole|mesh-list
25554368|NCT00654498|Antioxidants|antioxidants|mesh-ancestor
25554369|NCT00654498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554370|NCT00654498|Protective Agents|protective agents|mesh-ancestor
25554371|NCT00654498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554372|NCT00654498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25554373|NCT00654498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25554374|NCT00654498|Dopamine Agonists|dopamine agonists|mesh-ancestor
25554375|NCT00654498|Dopamine Agents|dopamine agents|mesh-ancestor
25554376|NCT00654498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25554377|NCT00654511|Fentanyl|fentanyl|mesh-list
25554378|NCT00654511|Dexmedetomidine|dexmedetomidine|mesh-list
25554379|NCT00654511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25554380|NCT00654511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25554381|NCT00654511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554382|NCT00654511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25554383|NCT00654511|Analgesics|analgesics|mesh-ancestor
25554384|NCT00654511|Sensory System Agents|sensory system agents|mesh-ancestor
25554385|NCT00654511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25554386|NCT00654511|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25554387|NCT00654511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25554388|NCT00654511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25554389|NCT00654511|Adrenergic Agents|adrenergic agents|mesh-ancestor
25554390|NCT00654511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25554391|NCT00654511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554392|NCT00654511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25554393|NCT00654511|Narcotics|narcotics|mesh-ancestor
25554394|NCT00654511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25554395|NCT00654511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25449786|NCT04609033|Morphine|morphine|mesh-list
25554396|NCT00654511|Anesthetics, General|anesthetics, general|mesh-ancestor
25554397|NCT00654511|Anesthetics|anesthetics|mesh-ancestor
25554398|NCT00654732|Rituximab|rituximab|mesh-list
25554399|NCT00654732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25554400|NCT00654732|Doxorubicin|doxorubicin|mesh-list
25554401|NCT00654732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25554402|NCT00654732|Dacarbazine|dacarbazine|mesh-list
25554403|NCT00654732|Bleomycin|bleomycin|mesh-list
25554404|NCT00654732|Vinblastine|vinblastine|mesh-list
25554405|NCT00654732|Antibodies|antibodies|mesh-list
25554406|NCT00654732|Immunoglobulins|immunoglobulins|mesh-list
25554407|NCT00654732|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25554408|NCT00654732|Imidazole|imidazole|mesh-list
25554409|NCT00654732|Immunologic Factors|immunologic factors|mesh-ancestor
25554410|NCT00654732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554411|NCT00654732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25554412|NCT00654732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25554413|NCT00654732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25554414|NCT00654732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25554415|NCT00654732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25554416|NCT00654732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554417|NCT00654732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554418|NCT00654732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25554419|NCT00654732|Alkylating Agents|alkylating agents|mesh-ancestor
25554420|NCT00654732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25554421|NCT00654732|Tubulin Modulators|tubulin modulators|mesh-ancestor
25554422|NCT00654732|Antimitotic Agents|antimitotic agents|mesh-ancestor
25554423|NCT00654732|Mitosis Modulators|mitosis modulators|mesh-ancestor
25554424|NCT00654745|Amlodipine|amlodipine|mesh-list
25554425|NCT00654745|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25554426|NCT00654745|Olmesartan|olmesartan|mesh-list
25554427|NCT00654745|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25554428|NCT00654745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25007858|NCT02611232|Liraglutide|liraglutide|mesh-list
25554429|NCT00654745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25554430|NCT00654745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25554431|NCT00654745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554432|NCT00654745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25554433|NCT00654745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554434|NCT00654745|Vasodilator Agents|vasodilator agents|mesh-ancestor
25554435|NCT00654745|Diuretics|diuretics|mesh-ancestor
25554436|NCT00654745|Natriuretic Agents|natriuretic agents|mesh-ancestor
25554437|NCT00654745|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25554438|NCT00654745|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25554439|NCT00654745|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25554440|NCT00654784|Idebenone|idebenone|mesh-list
25554441|NCT00654784|Antioxidants|antioxidants|mesh-ancestor
25554442|NCT00654784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554443|NCT00654784|Protective Agents|protective agents|mesh-ancestor
25554444|NCT00654784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554445|NCT00654836|Bevacizumab|bevacizumab|mesh-list
25554446|NCT00654836|Carboplatin|carboplatin|mesh-list
25554447|NCT00654836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25554448|NCT00654836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25554449|NCT00654836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25554450|NCT00654836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25554451|NCT00654836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25554452|NCT00654836|Growth Substances|growth substances|mesh-ancestor
25554453|NCT00654836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554454|NCT00654836|Growth Inhibitors|growth inhibitors|mesh-ancestor
25554455|NCT00654901|Vaccines|vaccines|mesh-list
25554456|NCT00654901|Immunologic Factors|immunologic factors|mesh-ancestor
25554457|NCT00654901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554458|NCT00654927|4-Aminopyridine|4-aminopyridine|mesh-list
25554459|NCT00654927|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25554460|NCT00654927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25554461|NCT00654927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554462|NCT00654940|Pregabalin|pregabalin|mesh-list
25554463|NCT00654940|Analgesics|analgesics|mesh-ancestor
25554464|NCT00654940|Sensory System Agents|sensory system agents|mesh-ancestor
25554465|NCT00654940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25554466|NCT00654940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554467|NCT00654940|Anticonvulsants|anticonvulsants|mesh-ancestor
25554468|NCT00654940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25554469|NCT00654940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25651370|NCT01515566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449853|NCT04608006|Narcotics|narcotics|mesh-ancestor
25449914|NCT04607447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25449915|NCT04607447|Antimetabolites|antimetabolites|mesh-ancestor
25449916|NCT04607447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449917|NCT04607447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25449918|NCT04607447|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25449919|NCT04607447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25242804|NCT05360030|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25449920|NCT04607525|Dexmedetomidine|dexmedetomidine|mesh-list
25449921|NCT04607525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25449922|NCT04607525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25449923|NCT04607525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449924|NCT04607525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25449925|NCT04607525|Analgesics|analgesics|mesh-ancestor
25449926|NCT04607525|Sensory System Agents|sensory system agents|mesh-ancestor
25449927|NCT04607525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449928|NCT04607525|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25449929|NCT04607525|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25449930|NCT04607525|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25449931|NCT04607525|Adrenergic Agents|adrenergic agents|mesh-ancestor
25449932|NCT04607525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25449933|NCT04607525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304918|NCT05304845|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25304919|NCT05304845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304920|NCT05304845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25304921|NCT05304845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25304922|NCT05304845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25304923|NCT05304845|Antipyretics|antipyretics|mesh-ancestor
25304940|NCT05304598|Dexmedetomidine|dexmedetomidine|mesh-list
25304941|NCT05304598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24554017|NCT00733811|Chelating Agents|chelating agents|mesh-ancestor
25304942|NCT05304598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25304943|NCT05304598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304944|NCT05304598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24555313|NCT00741169|Rifampin|rifampin|mesh-list
25040721|NCT02923531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24854821|NCT02275806|Camptothecin|camptothecin|mesh-list
24682553|NCT01386710|Bevacizumab|bevacizumab|mesh-list
24556132|NCT00745069|Adrenergic Agents|adrenergic agents|mesh-ancestor
25040722|NCT02923531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25040723|NCT02923531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25040724|NCT02923531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161813|NCT02304302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25161814|NCT02304302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161815|NCT02304302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554470|NCT00654940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554471|NCT00654940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25554472|NCT00654940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25554473|NCT00654940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25554474|NCT00654940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25554475|NCT00654940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25554476|NCT00654953|Gabapentin|gabapentin|mesh-list
25554477|NCT00654953|Sertraline|sertraline|mesh-list
25554478|NCT00654953|Analgesics|analgesics|mesh-ancestor
25554479|NCT00654953|Sensory System Agents|sensory system agents|mesh-ancestor
25554480|NCT00654953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25554481|NCT00654953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554482|NCT00654953|Anticonvulsants|anticonvulsants|mesh-ancestor
25554483|NCT00654953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25554484|NCT00654953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25554485|NCT00654953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25554486|NCT00654953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25554487|NCT00654953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25554488|NCT00654953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25554489|NCT00654953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25554490|NCT00654953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554491|NCT00654953|Antimanic Agents|antimanic agents|mesh-ancestor
25554492|NCT00654953|Antidepressive Agents|antidepressive agents|mesh-ancestor
25554493|NCT00654953|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25554494|NCT00654953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25554495|NCT00654953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25554496|NCT00654953|Serotonin Agents|serotonin agents|mesh-ancestor
25554497|NCT00655083|MEN 11420|men 11420|mesh-list
25554498|NCT00655083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25554499|NCT00655083|Autonomic Agents|autonomic agents|mesh-ancestor
25554500|NCT00655083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25554501|NCT00655083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683715|NCT01393756|Lenalidomide|lenalidomide|mesh-list
25554502|NCT00655083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25554503|NCT00655083|Respiratory System Agents|respiratory system agents|mesh-ancestor
25554505|NCT00655473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24562043|NCT00764374|Z 338|z 338|mesh-list
25554506|NCT00655473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25554507|NCT00655473|Antimetabolites|antimetabolites|mesh-ancestor
25554508|NCT00655473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554509|NCT00655473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25554510|NCT00655486|Lacosamide|lacosamide|mesh-list
25554511|NCT00655486|Anticonvulsants|anticonvulsants|mesh-ancestor
25554512|NCT00655486|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25554513|NCT00655486|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25554514|NCT00655486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25554515|NCT00655486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554516|NCT00655499|Irinotecan|irinotecan|mesh-list
25554517|NCT00655499|Panitumumab|panitumumab|mesh-list
25554518|NCT00655499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25554519|NCT00655499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25554520|NCT00655499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554521|NCT00655499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554522|NCT00655499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25554523|NCT00655499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25554524|NCT00655538|Dalcetrapib|dalcetrapib|mesh-list
24791599|NCT03785691|Ondansetron|ondansetron|mesh-list
25554525|NCT00655538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25554526|NCT00655538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25554527|NCT00655538|Antimetabolites|antimetabolites|mesh-ancestor
25554528|NCT00655538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563926|NCT00774462|Rituximab|rituximab|mesh-list
25554529|NCT00655538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25554530|NCT00655551|Lacosamide|lacosamide|mesh-list
25554531|NCT00655551|Anticonvulsants|anticonvulsants|mesh-ancestor
25554532|NCT00655551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25554533|NCT00655551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25554534|NCT00655551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25554535|NCT00655551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554536|NCT00655564|Alefacept|alefacept|mesh-list
25554537|NCT00655564|Dermatologic Agents|dermatologic agents|mesh-ancestor
25554538|NCT00655564|Immunologic Factors|immunologic factors|mesh-ancestor
25554539|NCT00655564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554540|NCT00655629|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
25554541|NCT00655629|Vasodilator Agents|vasodilator agents|mesh-ancestor
25554542|NCT00655629|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25554543|NCT00655629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25554544|NCT00655629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554545|NCT00655629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554546|NCT00655629|Urological Agents|urological agents|mesh-ancestor
25554547|NCT00655642|Promethazine|promethazine|mesh-list
25554548|NCT00655642|Diphenhydramine|diphenhydramine|mesh-list
25554549|NCT00655642|Ondansetron|ondansetron|mesh-list
25554550|NCT00655642|Metoclopramide|metoclopramide|mesh-list
25554551|NCT00655642|Antiemetics|antiemetics|mesh-ancestor
24688487|NCT03038802|Vaccines|vaccines|mesh-list
25554552|NCT00655642|Autonomic Agents|autonomic agents|mesh-ancestor
25554553|NCT00655642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24688753|NCT02711826|Antitubercular Agents|antitubercular agents|mesh-ancestor
24689150|NCT02293109|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25554554|NCT00655642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691050|NCT01404806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25554555|NCT00655642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24565974|NCT00783653|Sunitinib|sunitinib|mesh-list
25554556|NCT00655642|Antipruritics|antipruritics|mesh-ancestor
25554557|NCT00655642|Dermatologic Agents|dermatologic agents|mesh-ancestor
25554558|NCT00655642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25554559|NCT00655642|Serotonin Agents|serotonin agents|mesh-ancestor
25554560|NCT00655642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25554561|NCT00655642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554562|NCT00655642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25554563|NCT00655642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25554564|NCT00655642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25554565|NCT00655642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25554566|NCT00655642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25554567|NCT00655642|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25554568|NCT00655642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25554569|NCT00655642|Dopamine Agents|dopamine agents|mesh-ancestor
25554570|NCT00655642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25554571|NCT00655642|Histamine Antagonists|histamine antagonists|mesh-ancestor
25554572|NCT00655642|Histamine Agents|histamine agents|mesh-ancestor
25554573|NCT00655642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25274159|NCT02380131|Trastuzumab|trastuzumab|mesh-list
25554574|NCT00655642|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25554575|NCT00655642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25554576|NCT00655642|Anesthetics, Local|anesthetics, local|mesh-ancestor
25554577|NCT00655642|Anesthetics|anesthetics|mesh-ancestor
25243605|NCT05276284|Immunologic Factors|immunologic factors|mesh-ancestor
25554578|NCT00655642|Sensory System Agents|sensory system agents|mesh-ancestor
25554579|NCT00655668|Lenalidomide|lenalidomide|mesh-list
25554580|NCT00655668|Immunologic Factors|immunologic factors|mesh-ancestor
25554581|NCT00655668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554582|NCT00655668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25554583|NCT00655668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25554584|NCT00655668|Growth Substances|growth substances|mesh-ancestor
25554585|NCT00655668|Growth Inhibitors|growth inhibitors|mesh-ancestor
25554586|NCT00655668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25554587|NCT00655746|Dasatinib|dasatinib|mesh-list
25554588|NCT00655746|Omeprazole|omeprazole|mesh-list
25554589|NCT00655746|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25554590|NCT00655746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25554591|NCT00655746|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25554592|NCT00655746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554593|NCT00655746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554594|NCT00655746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25554595|NCT00655746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25554596|NCT00655811|Capsaicin|capsaicin|mesh-list
25554597|NCT00655811|Antipruritics|antipruritics|mesh-ancestor
25554598|NCT00655811|Dermatologic Agents|dermatologic agents|mesh-ancestor
25554599|NCT00655811|Sensory System Agents|sensory system agents|mesh-ancestor
25554600|NCT00655811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25554601|NCT00655811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554602|NCT00655850|Gemcitabine|gemcitabine|mesh-list
25554603|NCT00655850|Paclitaxel|paclitaxel|mesh-list
25274178|NCT02380118|Anesthetics|anesthetics|mesh-ancestor
25554604|NCT00655850|Bevacizumab|bevacizumab|mesh-list
25554605|NCT00655850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24566745|NCT00787553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635623|NCT01140438|Hormones|hormones|mesh-ancestor
25554606|NCT00655850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25554607|NCT00655850|Tubulin Modulators|tubulin modulators|mesh-ancestor
25554608|NCT00655850|Antimitotic Agents|antimitotic agents|mesh-ancestor
25554609|NCT00655850|Mitosis Modulators|mitosis modulators|mesh-ancestor
25554610|NCT00655850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554611|NCT00655850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25554612|NCT00655850|Antimetabolites|antimetabolites|mesh-ancestor
25554613|NCT00655850|Antiviral Agents|antiviral agents|mesh-ancestor
25554614|NCT00655850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25554615|NCT00655850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554616|NCT00655850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25554617|NCT00655850|Immunologic Factors|immunologic factors|mesh-ancestor
25554618|NCT00655850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554619|NCT00655850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25554620|NCT00655850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25554621|NCT00655850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25244468|NCT04730362|Propofol|propofol|mesh-list
25554622|NCT00655850|Growth Substances|growth substances|mesh-ancestor
25554623|NCT00655850|Growth Inhibitors|growth inhibitors|mesh-ancestor
25554624|NCT00655863|Pioglitazone|pioglitazone|mesh-list
25554625|NCT00655863|Alogliptin|alogliptin|mesh-list
25554626|NCT00655863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25554627|NCT00655863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554628|NCT00655863|Incretins|incretins|mesh-ancestor
25554629|NCT00655863|Hormones|hormones|mesh-ancestor
25554630|NCT00655863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25554631|NCT00655863|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25554632|NCT00655863|Protease Inhibitors|protease inhibitors|mesh-ancestor
25554633|NCT00655863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554634|NCT00655863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554635|NCT00655928|Acetylcysteine|acetylcysteine|mesh-list
25554636|NCT00655928|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25554637|NCT00655928|Antiviral Agents|antiviral agents|mesh-ancestor
25554638|NCT00655928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25554639|NCT00655928|Expectorants|expectorants|mesh-ancestor
25554640|NCT00655928|Respiratory System Agents|respiratory system agents|mesh-ancestor
25554641|NCT00655928|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25554642|NCT00655928|Antioxidants|antioxidants|mesh-ancestor
25554643|NCT00655928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554644|NCT00655928|Protective Agents|protective agents|mesh-ancestor
25554645|NCT00655928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554646|NCT00655928|Antidotes|antidotes|mesh-ancestor
25554647|NCT00655980|Folic Acid|folic acid|mesh-list
25554648|NCT00655980|Vitamin B 12|vitamin b 12|mesh-list
25554649|NCT00655980|Hydroxocobalamin|hydroxocobalamin|mesh-list
25554650|NCT00655980|Nitrous Oxide|nitrous oxide|mesh-list
25554651|NCT00655980|Vitamins|vitamins|mesh-ancestor
25554652|NCT00655980|Micronutrients|micronutrients|mesh-ancestor
25554653|NCT00655980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450058|NCT04604938|Losartan|losartan|mesh-list
25245092|NCT04271917|Antipyretics|antipyretics|mesh-ancestor
25450059|NCT04604938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25450060|NCT04604938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25450061|NCT04604938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25450062|NCT04604938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25450063|NCT04604938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567557|NCT00791531|Dermatologic Agents|dermatologic agents|mesh-ancestor
25161816|NCT02304302|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25161817|NCT02304302|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25161819|NCT02269670|Everolimus|everolimus|mesh-list
25161820|NCT02269670|Letrozole|letrozole|mesh-list
25161821|NCT02269670|Fulvestrant|fulvestrant|mesh-list
25161822|NCT02269670|Anastrozole|anastrozole|mesh-list
25161823|NCT02269670|Megestrol|megestrol|mesh-list
25161824|NCT02269670|Megestrol Acetate|megestrol acetate|mesh-list
25161825|NCT02269670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161826|NCT02269670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161827|NCT02269670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25161828|NCT02269670|Immunologic Factors|immunologic factors|mesh-ancestor
25161829|NCT02269670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161830|NCT02269670|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25161831|NCT02269670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25161832|NCT02269670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25161833|NCT02269670|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25161834|NCT02269670|Hormone Antagonists|hormone antagonists|mesh-ancestor
25161835|NCT02269670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25161836|NCT02269670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25161837|NCT02269670|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25161838|NCT02269670|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25161839|NCT02269670|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25161840|NCT02269670|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25161841|NCT02269670|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25161842|NCT02269670|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25161843|NCT02269670|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25161844|NCT02269670|Contraceptive Agents|contraceptive agents|mesh-ancestor
25161845|NCT02269670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25161846|NCT02269670|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24978297|NCT04921722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24646333|NCT01203254|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
24695876|NCT01426100|Telmisartan|telmisartan|mesh-list
24978303|NCT04745845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24978304|NCT04745845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24660869|NCT01286766|Cisplatin|cisplatin|mesh-list
24419294|NCT00211653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419295|NCT00211653|Protective Agents|protective agents|mesh-ancestor
24590466|NCT00912678|Tacrolimus|tacrolimus|mesh-list
24419296|NCT00211653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419297|NCT00211653|Antidotes|antidotes|mesh-ancestor
24978323|NCT04740294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24590510|NCT00912938|Zoledronic Acid|zoledronic acid|mesh-list
24978324|NCT04740294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665503|NCT01312714|Vitamins|vitamins|mesh-ancestor
24665719|NCT01314300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24978325|NCT04740294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24978326|NCT04740294|Tocolytic Agents|tocolytic agents|mesh-ancestor
24978327|NCT04740294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24978328|NCT04728646|Dexamethasone|dexamethasone|mesh-list
25120650|NCT03020030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25120651|NCT03020030|Alkylating Agents|alkylating agents|mesh-ancestor
25120656|NCT03020030|Antiemetics|antiemetics|mesh-ancestor
24978329|NCT04728646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24978330|NCT04728646|Antiemetics|antiemetics|mesh-ancestor
24568490|NCT00796211|Nortriptyline|nortriptyline|mesh-list
24978331|NCT04728646|Autonomic Agents|autonomic agents|mesh-ancestor
24978334|NCT04728646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24978335|NCT04728646|Glucocorticoids|glucocorticoids|mesh-ancestor
24494164|NCT00494156|Aspirin|aspirin|mesh-list
24978336|NCT04728646|Hormones|hormones|mesh-ancestor
24774709|NCT01847404|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24419298|NCT00211679|Botulinum Toxins|botulinum toxins|mesh-list
24419299|NCT00211679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24419300|NCT00211679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25246256|NCT03158064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419301|NCT00211679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24419302|NCT00211679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24568822|NCT00797745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24591355|NCT00916045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25120662|NCT03020030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25120663|NCT03020030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25554654|NCT00655980|Hematinics|hematinics|mesh-ancestor
25246383|NCT03002389|Fluticasone|fluticasone|mesh-list
25554655|NCT00655980|Vitamin B Complex|vitamin b complex|mesh-ancestor
25554656|NCT00655980|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25554657|NCT00655980|Anesthetics, General|anesthetics, general|mesh-ancestor
24791921|NCT02553460|Vitamins|vitamins|mesh-ancestor
25554658|NCT00655980|Anesthetics|anesthetics|mesh-ancestor
25554659|NCT00655980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25554660|NCT00655980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25554661|NCT00655980|Analgesics|analgesics|mesh-ancestor
25554662|NCT00655980|Sensory System Agents|sensory system agents|mesh-ancestor
25554663|NCT00655980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25554664|NCT00656019|Vitamin D|vitamin d|mesh-list
25554665|NCT00656019|Calcipotriene|calcipotriene|mesh-list
25554666|NCT00656019|Vitamins|vitamins|mesh-ancestor
25554667|NCT00656019|Micronutrients|micronutrients|mesh-ancestor
24569707|NCT00801528|Anesthetics|anesthetics|mesh-ancestor
25554668|NCT00656019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554669|NCT00656019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25554670|NCT00656019|Dermatologic Agents|dermatologic agents|mesh-ancestor
25554671|NCT00656058|Montelukast|montelukast|mesh-list
25554672|NCT00656058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25554673|NCT00656058|Respiratory System Agents|respiratory system agents|mesh-ancestor
25554674|NCT00656058|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25554675|NCT00656058|Hormone Antagonists|hormone antagonists|mesh-ancestor
25554676|NCT00656058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25554677|NCT00656058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591813|NCT00919243|Prednisone|prednisone|mesh-list
24592059|NCT00920153|Bleomycin|bleomycin|mesh-list
25554678|NCT00656058|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25554679|NCT00656058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25554680|NCT00656058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554681|NCT00656084|Gemcitabine|gemcitabine|mesh-list
25554682|NCT00656084|Rituximab|rituximab|mesh-list
25554683|NCT00656084|Mitoxantrone|mitoxantrone|mesh-list
25554684|NCT00656084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25554685|NCT00656084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25554686|NCT00656084|Immunologic Factors|immunologic factors|mesh-ancestor
24501301|NCT00528008|Chlorhexidine|chlorhexidine|mesh-list
25554687|NCT00656084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246691|NCT02420717|Vitamins|vitamins|mesh-ancestor
25246704|NCT02408068|Antiemetics|antiemetics|mesh-ancestor
25554688|NCT00656084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25246753|NCT02294032|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25554689|NCT00656084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25554690|NCT00656084|Antimetabolites|antimetabolites|mesh-ancestor
25554691|NCT00656084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554692|NCT00656084|Antiviral Agents|antiviral agents|mesh-ancestor
25554693|NCT00656084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25554694|NCT00656084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25686729|NCT01923896|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25246812|NCT02107937|Mitosis Modulators|mitosis modulators|mesh-ancestor
25246814|NCT02095184|Letrozole|letrozole|mesh-list
25554695|NCT00656084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25554696|NCT00656084|Analgesics|analgesics|mesh-ancestor
25554697|NCT00656084|Sensory System Agents|sensory system agents|mesh-ancestor
25554698|NCT00656084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25554699|NCT00656084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25554700|NCT00656084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25554701|NCT00656136|Afatinib|afatinib|mesh-list
25554702|NCT00656136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25554703|NCT00656136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25554704|NCT00656136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554705|NCT00656136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554706|NCT00656175|Raltegravir Potassium|raltegravir potassium|mesh-list
25554707|NCT00656175|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25554708|NCT00656175|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25554709|NCT00656175|Antiviral Agents|antiviral agents|mesh-ancestor
25554710|NCT00656175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571882|NCT00812123|Hormones|hormones|mesh-ancestor
25554711|NCT00656175|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25554712|NCT00656175|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25554713|NCT00656175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554714|NCT00656175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554715|NCT00656201|Progesterone|progesterone|mesh-list
25554716|NCT00656201|Progestins|progestins|mesh-ancestor
25554717|NCT00656201|Hormones|hormones|mesh-ancestor
25554718|NCT00656201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25554719|NCT00656201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554720|NCT00656292|Simvastatin|simvastatin|mesh-list
25554721|NCT00656292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25554722|NCT00656292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25554723|NCT00656292|Antimetabolites|antimetabolites|mesh-ancestor
24702615|NCT01466855|Topotecan|topotecan|mesh-list
24594217|NCT00933179|Progestins|progestins|mesh-ancestor
25554724|NCT00656292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554725|NCT00656292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25554726|NCT00656292|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25554727|NCT00656292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554728|NCT00656448|Epoetin Alfa|epoetin alfa|mesh-list
25554729|NCT00656448|Hematinics|hematinics|mesh-ancestor
25554730|NCT00656487|Rimonabant|rimonabant|mesh-list
25554731|NCT00656487|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25554732|NCT00656487|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
25554733|NCT00656487|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25554734|NCT00656487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25554735|NCT00656487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554736|NCT00656487|Hormones|hormones|mesh-ancestor
25554737|NCT00656487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25554738|NCT00656487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554739|NCT00656513|Pilocarpine|pilocarpine|mesh-list
25554740|NCT00656513|Miotics|miotics|mesh-ancestor
24585485|NCT00885820|Prednisone|prednisone|mesh-list
25554741|NCT00656513|Autonomic Agents|autonomic agents|mesh-ancestor
24594513|NCT00934232|Busulfan|busulfan|mesh-list
24940553|NCT04000386|Protective Agents|protective agents|mesh-ancestor
25554742|NCT00656513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25554743|NCT00656513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554744|NCT00656513|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25554745|NCT00656513|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24594582|NCT00934687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24594686|NCT00935194|Oseltamivir|oseltamivir|mesh-list
25554746|NCT00656513|Cholinergic Agents|cholinergic agents|mesh-ancestor
25554747|NCT00656513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25554748|NCT00656513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554749|NCT00656617|Cytarabine|cytarabine|mesh-list
25554750|NCT00656617|Vorinostat|vorinostat|mesh-list
25554751|NCT00656617|Idarubicin|idarubicin|mesh-list
25554752|NCT00656617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25554753|NCT00656617|Antimetabolites|antimetabolites|mesh-ancestor
25554754|NCT00656617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554755|NCT00656617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25554756|NCT00656617|Antiviral Agents|antiviral agents|mesh-ancestor
25554757|NCT00656617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24705408|NCT01485068|Paclitaxel|paclitaxel|mesh-list
24576502|NCT00838968|Interferon-alpha|interferon-alpha|mesh-list
25554758|NCT00656617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25554759|NCT00656617|Immunologic Factors|immunologic factors|mesh-ancestor
25554760|NCT00656617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792825|NCT04605614|Copper|copper|mesh-list
25554761|NCT00656617|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24969748|NCT03740373|Hormones|hormones|mesh-ancestor
25554762|NCT00656617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554763|NCT00656617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25554764|NCT00656617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25554765|NCT00656617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24706891|NCT01492920|Vitamins|vitamins|mesh-ancestor
25247539|NCT03387085|Paclitaxel|paclitaxel|mesh-list
25554766|NCT00656630|Naltrexone|naltrexone|mesh-list
24595920|NCT00940953|Azelastine|azelastine|mesh-list
25554767|NCT00656630|Acamprosate|acamprosate|mesh-list
24708196|NCT01500577|Analgesics|analgesics|mesh-ancestor
25554768|NCT00656630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25554769|NCT00656630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24579515|NCT00855699|Acamprosate|acamprosate|mesh-list
25554770|NCT00656630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554771|NCT00656630|Sensory System Agents|sensory system agents|mesh-ancestor
25554772|NCT00656630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25554773|NCT00656656|Dexamethasone|dexamethasone|mesh-list
25554774|NCT00656656|Rituximab|rituximab|mesh-list
24597335|NCT00948727|Cyclosporins|cyclosporins|mesh-list
25554775|NCT00656656|Azathioprine|azathioprine|mesh-list
24711811|NCT01517022|Cholinergic Agents|cholinergic agents|mesh-ancestor
24712057|NCT01518231|Anticoagulants|anticoagulants|mesh-ancestor
24712195|NCT01519076|Keratolytic Agents|keratolytic agents|mesh-ancestor
24765751|NCT01790464|Lidocaine|lidocaine|mesh-list
25554776|NCT00656656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25554777|NCT00656656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248537|NCT02531854|Pemetrexed|pemetrexed|mesh-list
24614716|NCT01026116|Cyclophosphamide|cyclophosphamide|mesh-list
24714250|NCT01529541|Hormones|hormones|mesh-ancestor
25554778|NCT00656656|Immunologic Factors|immunologic factors|mesh-ancestor
25554779|NCT00656656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554780|NCT00656656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24598719|NCT00957385|Growth Substances|growth substances|mesh-ancestor
25554781|NCT00656656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25554782|NCT00656656|Antiemetics|antiemetics|mesh-ancestor
25554783|NCT00656656|Autonomic Agents|autonomic agents|mesh-ancestor
25554784|NCT00656656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24715459|NCT01536600|Insulin Aspart|insulin aspart|mesh-list
25554785|NCT00656656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25554786|NCT00656656|Glucocorticoids|glucocorticoids|mesh-ancestor
24599398|NCT04591431|Nivolumab|nivolumab|mesh-list
24599536|NCT04413799|Lidocaine|lidocaine|mesh-list
24716605|NCT01542710|Timolol|timolol|mesh-list
25554787|NCT00656656|Hormones|hormones|mesh-ancestor
25249537|NCT02526303|Nadroparin|nadroparin|mesh-list
24854848|NCT02275962|Rifampin|rifampin|mesh-list
24423009|NCT00224419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554788|NCT00656656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25554789|NCT00656656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25554790|NCT00656656|Antimetabolites|antimetabolites|mesh-ancestor
24423011|NCT00224445|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24853137|NCT02266030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25554791|NCT00656656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718832|NCT01557335|Antipyretics|antipyretics|mesh-ancestor
24601291|NCT00963729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24601333|NCT00963976|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24601709|NCT00965653|Vitamins|vitamins|mesh-ancestor
24720209|NCT01567072|Ibuprofen|ibuprofen|mesh-list
24720490|NCT01568749|Acetaminophen|acetaminophen|mesh-list
25554792|NCT00656656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25250690|NCT02518789|Anesthetics|anesthetics|mesh-ancestor
24721591|NCT01575717|Vitamin D|vitamin d|mesh-list
25554793|NCT00656656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25554794|NCT00656669|Paclitaxel|paclitaxel|mesh-list
25554795|NCT00656669|Cyclophosphamide|cyclophosphamide|mesh-list
25554796|NCT00656669|Doxorubicin|doxorubicin|mesh-list
25554797|NCT00656669|Sunitinib|sunitinib|mesh-list
25554798|NCT00656669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25554799|NCT00656669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25554800|NCT00656669|Tubulin Modulators|tubulin modulators|mesh-ancestor
25554801|NCT00656669|Antimitotic Agents|antimitotic agents|mesh-ancestor
24671179|NCT01324180|Vincristine|vincristine|mesh-list
24605687|NCT00986765|Antipyretics|antipyretics|mesh-ancestor
25554802|NCT00656669|Mitosis Modulators|mitosis modulators|mesh-ancestor
24615798|NCT01031927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615799|NCT01031966|Thymalfasin|thymalfasin|mesh-list
25554803|NCT00656669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554804|NCT00656669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25554805|NCT00656669|Immunologic Factors|immunologic factors|mesh-ancestor
25450138|NCT04604028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450139|NCT04604028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25450140|NCT04604028|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25450141|NCT04604028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25450142|NCT04604028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25554806|NCT00656669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554807|NCT00656669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25554808|NCT00656669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25554809|NCT00656669|Alkylating Agents|alkylating agents|mesh-ancestor
25554810|NCT00656669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25554811|NCT00656669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25554812|NCT00656669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25554813|NCT00656669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25554814|NCT00656669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554815|NCT00656669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25554816|NCT00656669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25554817|NCT00656669|Growth Substances|growth substances|mesh-ancestor
25554818|NCT00656669|Growth Inhibitors|growth inhibitors|mesh-ancestor
25554819|NCT00656669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25554820|NCT00656799|Bromides|bromides|mesh-list
25554821|NCT00656799|Rocuronium|rocuronium|mesh-list
25554822|NCT00656799|Anticonvulsants|anticonvulsants|mesh-ancestor
25554823|NCT00656799|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25554824|NCT00656799|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25554825|NCT00656799|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25554826|NCT00656799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25554827|NCT00656799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554828|NCT00656851|Pioglitazone|pioglitazone|mesh-list
25554829|NCT00656851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25554830|NCT00656851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554831|NCT00656968|Esomeprazole|esomeprazole|mesh-list
25554832|NCT00656968|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25554833|NCT00656968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25554834|NCT00656968|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25554835|NCT00656968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554836|NCT00656968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554837|NCT00657020|Nicotine|nicotine|mesh-list
25554838|NCT00657020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25554839|NCT00657020|Autonomic Agents|autonomic agents|mesh-ancestor
25554840|NCT00657020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25554841|NCT00657020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554842|NCT00657020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25251519|NCT02513004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084434|NCT03307148|Antimetabolites|antimetabolites|mesh-ancestor
25251521|NCT02513147|Lopinavir|lopinavir|mesh-list
25554843|NCT00657020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25554844|NCT00657020|Cholinergic Agents|cholinergic agents|mesh-ancestor
25554845|NCT00657020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25554846|NCT00657020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554847|NCT00657046|Droxidopa|droxidopa|mesh-list
25554848|NCT00657046|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25554849|NCT00657046|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25554850|NCT00657150|Enoxaparin|enoxaparin|mesh-list
25554851|NCT00657150|Dabigatran|dabigatran|mesh-list
25554852|NCT00657150|Anticoagulants|anticoagulants|mesh-ancestor
25554853|NCT00657150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25554854|NCT00657150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25554855|NCT00657150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554856|NCT00657150|Antithrombins|antithrombins|mesh-ancestor
25554857|NCT00657150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25554858|NCT00657150|Protease Inhibitors|protease inhibitors|mesh-ancestor
25554859|NCT00657150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554860|NCT00657267|Temozolomide|temozolomide|mesh-list
25554861|NCT00657267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25554862|NCT00657267|Alkylating Agents|alkylating agents|mesh-ancestor
25554863|NCT00657267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554864|NCT00657267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25554865|NCT00657280|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25554866|NCT00657280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25554867|NCT00657280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045273|NCT00978016|Baclofen|baclofen|mesh-list
25554868|NCT00657280|Incretins|incretins|mesh-ancestor
25554869|NCT00657280|Hormones|hormones|mesh-ancestor
25554870|NCT00657280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25554871|NCT00657280|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25554872|NCT00657280|Protease Inhibitors|protease inhibitors|mesh-ancestor
25554873|NCT00657280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554874|NCT00657280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554875|NCT00657358|Lidocaine|lidocaine|mesh-list
25554876|NCT00657358|Anesthetics, Local|anesthetics, local|mesh-ancestor
25554877|NCT00657358|Anesthetics|anesthetics|mesh-ancestor
25554878|NCT00657358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25554879|NCT00657358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554880|NCT00657358|Sensory System Agents|sensory system agents|mesh-ancestor
25450268|NCT04602273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25450269|NCT04602273|Antimetabolites|antimetabolites|mesh-ancestor
25450270|NCT04602273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450271|NCT04602273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25450272|NCT04602273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25450273|NCT04602247|Fesoterodine|fesoterodine|mesh-list
25450274|NCT04602247|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25450275|NCT04602247|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25450276|NCT04602247|Cholinergic Agents|cholinergic agents|mesh-ancestor
25450277|NCT04602247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25450278|NCT04602247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251616|NCT02512055|Atropine|atropine|mesh-list
25450279|NCT04602247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450280|NCT04602247|Urological Agents|urological agents|mesh-ancestor
25305438|NCT05229055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25305439|NCT05229055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25305440|NCT05229055|Anesthetics, General|anesthetics, general|mesh-ancestor
25305441|NCT05229055|Anesthetics|anesthetics|mesh-ancestor
25305442|NCT05229055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25305443|NCT05229055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25305444|NCT05229055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25305445|NCT05229055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25305447|NCT05219825|Psychotropic Drugs|psychotropic drugs|mesh-list
25120664|NCT03020030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25120672|NCT03020030|Antimetabolites|antimetabolites|mesh-ancestor
24419303|NCT00211679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419304|NCT00211679|Cholinergic Agents|cholinergic agents|mesh-ancestor
24978353|NCT04594408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24419354|NCT00211939|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24419355|NCT00211939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419356|NCT00211939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24419357|NCT00211939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24419358|NCT00211939|Antimetabolites|antimetabolites|mesh-ancestor
24419360|NCT00211939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24419379|NCT00211978|Calcium acetate|calcium acetate|mesh-list
24419458|NCT00212108|Analgesics|analgesics|mesh-ancestor
24419459|NCT00212108|Sensory System Agents|sensory system agents|mesh-ancestor
24419460|NCT00212108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24419461|NCT00212108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120677|NCT03020030|Antiviral Agents|antiviral agents|mesh-ancestor
24419462|NCT00212108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24419518|NCT00212342|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24419519|NCT00212342|Norethindrone|norethindrone|mesh-list
24419520|NCT00212342|Norethindrone Acetate|norethindrone acetate|mesh-list
24724434|NCT01593124|Imiquimod|imiquimod|mesh-list
24419521|NCT00212342|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24419522|NCT00212342|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24419523|NCT00212342|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24419583|NCT00212680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24419585|NCT00212810|Anticonvulsants|anticonvulsants|mesh-ancestor
24419624|NCT00213109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554881|NCT00657358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25554882|NCT00657358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25554883|NCT00657358|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25554884|NCT00657358|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25554885|NCT00657358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25554886|NCT00657358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554887|NCT00657618|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
25554888|NCT00657618|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25554889|NCT00657618|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25554890|NCT00657618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25554891|NCT00657618|Schistosomicides|schistosomicides|mesh-ancestor
25554892|NCT00657618|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25554893|NCT00657618|Anthelmintics|anthelmintics|mesh-ancestor
25554894|NCT00657709|Vaccines|vaccines|mesh-list
25554895|NCT00657709|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25554896|NCT00657709|Immunologic Factors|immunologic factors|mesh-ancestor
25554897|NCT00657709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554898|NCT00657917|Gentamicins|gentamicins|mesh-list
25554899|NCT00657917|Paromomycin|paromomycin|mesh-list
25554900|NCT00657917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25554901|NCT00657917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25554902|NCT00657917|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25554903|NCT00657917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554904|NCT00657917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554905|NCT00657917|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25554906|NCT00657917|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25554907|NCT00658021|Exenatide|exenatide|mesh-list
25554908|NCT00658021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25554909|NCT00658021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554910|NCT00658021|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25554911|NCT00658021|Incretins|incretins|mesh-ancestor
25554912|NCT00658021|Hormones|hormones|mesh-ancestor
25554913|NCT00658021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25554914|NCT00658112|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25554915|NCT00658112|Dermatologic Agents|dermatologic agents|mesh-ancestor
25554916|NCT00658320|Cyclosporine|cyclosporine|mesh-list
25554917|NCT00658320|Mycophenolic Acid|mycophenolic acid|mesh-list
25554918|NCT00658320|Everolimus|everolimus|mesh-list
25554919|NCT00658320|Cyclosporins|cyclosporins|mesh-list
25554920|NCT00658320|Basiliximab|basiliximab|mesh-list
25554921|NCT00658320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554922|NCT00658320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554923|NCT00658320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25554924|NCT00658320|Immunologic Factors|immunologic factors|mesh-ancestor
25554925|NCT00658320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554926|NCT00658320|Antifungal Agents|antifungal agents|mesh-ancestor
25554927|NCT00658320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25554928|NCT00658320|Dermatologic Agents|dermatologic agents|mesh-ancestor
25554929|NCT00658320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25554930|NCT00658320|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25554931|NCT00658320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25554932|NCT00658320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24965284|NCT03777956|Lacosamide|lacosamide|mesh-list
25554933|NCT00658320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25554934|NCT00658320|Antitubercular Agents|antitubercular agents|mesh-ancestor
25554935|NCT00658320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25554936|NCT00658333|Mycophenolic Acid|mycophenolic acid|mesh-list
25554937|NCT00658333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25554938|NCT00658333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25554939|NCT00658333|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25554940|NCT00658333|Antitubercular Agents|antitubercular agents|mesh-ancestor
25554941|NCT00658333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25554942|NCT00658333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25554943|NCT00658333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554944|NCT00658333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554945|NCT00658359|Cyclosporine|cyclosporine|mesh-list
25554946|NCT00658359|Cyclosporins|cyclosporins|mesh-list
25554947|NCT00658359|Tofacitinib|tofacitinib|mesh-list
25554948|NCT00658359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554949|NCT00658359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554950|NCT00658359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25554951|NCT00658359|Immunologic Factors|immunologic factors|mesh-ancestor
25554952|NCT00658359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554953|NCT00658359|Antifungal Agents|antifungal agents|mesh-ancestor
25554954|NCT00658359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25554955|NCT00658359|Dermatologic Agents|dermatologic agents|mesh-ancestor
25554956|NCT00658359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25554957|NCT00658359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25554958|NCT00658359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25554959|NCT00658411|Deferoxamine|deferoxamine|mesh-list
25554960|NCT00658411|Siderophores|siderophores|mesh-ancestor
25554961|NCT00658411|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25554962|NCT00658411|Chelating Agents|chelating agents|mesh-ancestor
25554963|NCT00658411|Sequestering Agents|sequestering agents|mesh-ancestor
25554964|NCT00658411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554965|NCT00658515|Dalcetrapib|dalcetrapib|mesh-list
25554966|NCT00658515|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25554967|NCT00658515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25554968|NCT00658515|Antimetabolites|antimetabolites|mesh-ancestor
25554969|NCT00658515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554970|NCT00658515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25554971|NCT00658528|Esomeprazole|esomeprazole|mesh-list
25554972|NCT00658528|Rabeprazole|rabeprazole|mesh-list
25554973|NCT00658528|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25554974|NCT00658528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25554975|NCT00658528|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25554976|NCT00658528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25554977|NCT00658528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554978|NCT00658541|Zolpidem|zolpidem|mesh-list
25651371|NCT01515566|Analgesics|analgesics|mesh-ancestor
25450281|NCT04602026|Coal Tar|coal tar|mesh-list
25554979|NCT00658541|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25554980|NCT00658541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24725050|NCT01596166|Ketorolac|ketorolac|mesh-list
25155418|NCT05374564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25554981|NCT00658541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25554982|NCT00658541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554983|NCT00658541|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25554984|NCT00658541|GABA Agonists|gaba agonists|mesh-ancestor
25554985|NCT00658541|GABA Agents|gaba agents|mesh-ancestor
25554986|NCT00658541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25554987|NCT00658541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25554988|NCT00658567|Pimavanserin|pimavanserin|mesh-list
25554989|NCT00658567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25554990|NCT00658567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25554991|NCT00658567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25554992|NCT00658567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25554993|NCT00658567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25554994|NCT00658567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25554995|NCT00658567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25554996|NCT00658567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25554997|NCT00658567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25554998|NCT00658567|Serotonin Agents|serotonin agents|mesh-ancestor
25554999|NCT00658567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25555000|NCT00658567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555001|NCT00658606|Alefacept|alefacept|mesh-list
25555002|NCT00658606|Dermatologic Agents|dermatologic agents|mesh-ancestor
25555003|NCT00658606|Immunologic Factors|immunologic factors|mesh-ancestor
25555004|NCT00658606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555005|NCT00658619|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25555006|NCT00658619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25555007|NCT00658619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25555008|NCT00658619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25555009|NCT00658619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25555010|NCT00658619|Adrenergic Agents|adrenergic agents|mesh-ancestor
25555011|NCT00658619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25555012|NCT00658619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085049|NCT03301454|Paclitaxel|paclitaxel|mesh-list
25555013|NCT00658619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555014|NCT00658632|Esomeprazole|esomeprazole|mesh-list
25555015|NCT00658632|Rabeprazole|rabeprazole|mesh-list
25555016|NCT00658632|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25555017|NCT00658632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25555018|NCT00658632|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25555019|NCT00658632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555020|NCT00658632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555021|NCT00658658|Panitumumab|panitumumab|mesh-list
25555022|NCT00658658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25555023|NCT00658658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555024|NCT00658684|Fesoterodine|fesoterodine|mesh-list
25555025|NCT00658684|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25555026|NCT00658684|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25555027|NCT00658684|Cholinergic Agents|cholinergic agents|mesh-ancestor
25555028|NCT00658684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25555029|NCT00658684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555030|NCT00658684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555031|NCT00658684|Urological Agents|urological agents|mesh-ancestor
25555032|NCT00658697|Bevacizumab|bevacizumab|mesh-list
25555033|NCT00658697|Docetaxel|docetaxel|mesh-list
25555034|NCT00658697|Bicalutamide|bicalutamide|mesh-list
25555035|NCT00658697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25555036|NCT00658697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555037|NCT00658697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25555038|NCT00658697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25555039|NCT00658697|Growth Substances|growth substances|mesh-ancestor
25555040|NCT00658697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555041|NCT00658697|Growth Inhibitors|growth inhibitors|mesh-ancestor
25555042|NCT00658697|Tubulin Modulators|tubulin modulators|mesh-ancestor
25555043|NCT00658697|Antimitotic Agents|antimitotic agents|mesh-ancestor
25555044|NCT00658697|Mitosis Modulators|mitosis modulators|mesh-ancestor
25555045|NCT00658697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555046|NCT00658697|Androgen Antagonists|androgen antagonists|mesh-ancestor
25555047|NCT00658697|Hormone Antagonists|hormone antagonists|mesh-ancestor
25555048|NCT00658697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25555049|NCT00658736|Triamcinolone|triamcinolone|mesh-list
25555050|NCT00658736|Bupivacaine|bupivacaine|mesh-list
25555051|NCT00658736|Anesthetics, Local|anesthetics, local|mesh-ancestor
25555052|NCT00658736|Anesthetics|anesthetics|mesh-ancestor
25555053|NCT00658736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25555054|NCT00658736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555055|NCT00658736|Sensory System Agents|sensory system agents|mesh-ancestor
25555056|NCT00658736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25555057|NCT00658736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25555058|NCT00658736|Glucocorticoids|glucocorticoids|mesh-ancestor
25555059|NCT00658736|Hormones|hormones|mesh-ancestor
25555060|NCT00658736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25555061|NCT00658775|Esomeprazole|esomeprazole|mesh-list
25555062|NCT00658775|Rabeprazole|rabeprazole|mesh-list
25555063|NCT00658775|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25555064|NCT00658775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25555065|NCT00658775|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25555066|NCT00658775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555067|NCT00658775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555068|NCT00659165|Insulin|insulin|mesh-list
25555069|NCT00659165|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25555070|NCT00659165|Insulin Glargine|insulin glargine|mesh-list
25555071|NCT00659165|Insulin Detemir|insulin detemir|mesh-list
25555072|NCT00659165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25555073|NCT00659165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555074|NCT00659230|Dopamine|dopamine|mesh-list
25555075|NCT00659230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25555076|NCT00659230|Sympathomimetics|sympathomimetics|mesh-ancestor
25555077|NCT00659230|Autonomic Agents|autonomic agents|mesh-ancestor
25555078|NCT00659230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25555079|NCT00659230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555080|NCT00659230|Dopamine Agents|dopamine agents|mesh-ancestor
25555081|NCT00659230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25555082|NCT00659230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555083|NCT00659230|Protective Agents|protective agents|mesh-ancestor
25555084|NCT00659269|Vitamins|vitamins|mesh-list
25555085|NCT00659269|Vitamin B 12|vitamin b 12|mesh-list
25555086|NCT00659269|Hydroxocobalamin|hydroxocobalamin|mesh-list
25555087|NCT00659269|Vitamin B 6|vitamin b 6|mesh-list
25555088|NCT00659269|Pyridoxal|pyridoxal|mesh-list
25555089|NCT00659269|Pyridoxine|pyridoxine|mesh-list
25555090|NCT00659269|Vitamin B Complex|vitamin b complex|mesh-list
25555091|NCT00659269|Vincristine|vincristine|mesh-list
25555092|NCT00659269|Vinorelbine|vinorelbine|mesh-list
25555093|NCT00659269|Docetaxel|docetaxel|mesh-list
25555094|NCT00659269|Cisplatin|cisplatin|mesh-list
25555095|NCT00659269|Oxaliplatin|oxaliplatin|mesh-list
25555096|NCT00659269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25555097|NCT00659269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555098|NCT00659269|Tubulin Modulators|tubulin modulators|mesh-ancestor
25555099|NCT00659269|Antimitotic Agents|antimitotic agents|mesh-ancestor
25555100|NCT00659269|Mitosis Modulators|mitosis modulators|mesh-ancestor
25555101|NCT00659269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555102|NCT00659269|Micronutrients|micronutrients|mesh-ancestor
25555103|NCT00659269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555104|NCT00659269|Hematinics|hematinics|mesh-ancestor
25555105|NCT00659295|Insulin Detemir|insulin detemir|mesh-list
25555106|NCT00659295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25555107|NCT00659295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555108|NCT00659360|Saracatinib|saracatinib|mesh-list
25555109|NCT00659360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555110|NCT00659360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555111|NCT00659360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555112|NCT00659373|Tamoxifen|tamoxifen|mesh-list
25555113|NCT00659373|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25555114|NCT00659373|Exemestane|exemestane|mesh-list
25555115|NCT00659373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25555116|NCT00659373|Hormone Antagonists|hormone antagonists|mesh-ancestor
25555117|NCT00659373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25555118|NCT00659373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555119|NCT00659373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25555120|NCT00659373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555121|NCT00659373|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25555122|NCT00659373|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25555123|NCT00659373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25555124|NCT00659373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25555125|NCT00659373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25555126|NCT00659373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555127|NCT00659373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863061|NCT03635788|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25555128|NCT00659373|Luteolytic Agents|luteolytic agents|mesh-ancestor
25555129|NCT00659373|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25555130|NCT00659373|Contraceptive Agents|contraceptive agents|mesh-ancestor
25555131|NCT00659373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25555132|NCT00659373|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25651372|NCT01515566|Sensory System Agents|sensory system agents|mesh-ancestor
25651373|NCT01515566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25651374|NCT01515566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25651375|NCT01515566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25651376|NCT01515566|Anesthetics, General|anesthetics, general|mesh-ancestor
25651377|NCT01515566|Anesthetics|anesthetics|mesh-ancestor
25651378|NCT01515657|Aspirin|aspirin|mesh-list
25651379|NCT01515657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25651380|NCT01515657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25651381|NCT01515657|Analgesics|analgesics|mesh-ancestor
25651382|NCT01515657|Sensory System Agents|sensory system agents|mesh-ancestor
25651383|NCT01515657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25651384|NCT01515657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651385|NCT01515657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25651386|NCT01515657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25651387|NCT01515657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25651388|NCT01515657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25651389|NCT01515657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651390|NCT01515657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25651391|NCT01515657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25651392|NCT01515657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651393|NCT01515657|Antipyretics|antipyretics|mesh-ancestor
25651394|NCT01515865|Midodrine|midodrine|mesh-list
25651395|NCT01515865|Sympathomimetics|sympathomimetics|mesh-ancestor
25651396|NCT01515865|Autonomic Agents|autonomic agents|mesh-ancestor
25651397|NCT01515865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25651398|NCT01515865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651399|NCT01515865|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25651400|NCT01515865|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25651401|NCT01515865|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25651402|NCT01515865|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25651403|NCT01515865|Adrenergic Agents|adrenergic agents|mesh-ancestor
25651404|NCT01515865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25651405|NCT01515865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651406|NCT01515891|Opicapone|opicapone|mesh-list
25651407|NCT01515891|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25651408|NCT01515891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651409|NCT01515891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651410|NCT01515891|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25651411|NCT01515891|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25651412|NCT01515995|Magnesium Sulfate|magnesium sulfate|mesh-list
25651413|NCT01515995|Analgesics|analgesics|mesh-ancestor
25651414|NCT01515995|Sensory System Agents|sensory system agents|mesh-ancestor
25651415|NCT01515995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25651416|NCT01515995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651417|NCT01515995|Anesthetics|anesthetics|mesh-ancestor
25651418|NCT01515995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25651419|NCT01515995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25651420|NCT01515995|Anticonvulsants|anticonvulsants|mesh-ancestor
25651421|NCT01515995|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25651422|NCT01515995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25651423|NCT01515995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651424|NCT01515995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25651425|NCT01515995|Tocolytic Agents|tocolytic agents|mesh-ancestor
25651426|NCT01515995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25651427|NCT01516008|Tapentadol|tapentadol|mesh-list
25651428|NCT01516008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25651429|NCT01516008|Narcotics|narcotics|mesh-ancestor
25651430|NCT01516008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25651431|NCT01516008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651432|NCT01516008|Analgesics|analgesics|mesh-ancestor
25251976|NCT02509429|Insulin Aspart|insulin aspart|mesh-list
25651433|NCT01516008|Sensory System Agents|sensory system agents|mesh-ancestor
25651434|NCT01516008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25651435|NCT01516008|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25651436|NCT01516008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25651437|NCT01516008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25651438|NCT01516008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651439|NCT01516008|Adrenergic Agents|adrenergic agents|mesh-ancestor
25651440|NCT01516008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25450491|NCT04600089|Ketamine|ketamine|mesh-list
25450551|NCT04599894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25450552|NCT04599894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25450553|NCT04599894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450554|NCT04599894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25450555|NCT04599894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25450556|NCT04599894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25450557|NCT04599894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25450558|NCT04599894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25305811|NCT04895280|Hormones|hormones|mesh-ancestor
25305812|NCT04895280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25305813|NCT04895280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25305814|NCT04895280|Immunologic Factors|immunologic factors|mesh-ancestor
25305815|NCT04895280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978364|NCT04594408|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24978365|NCT04594408|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24978366|NCT04594408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24978367|NCT04594408|Hemostatics|hemostatics|mesh-ancestor
24978368|NCT04594408|Coagulants|coagulants|mesh-ancestor
24978369|NCT04580134|Risperidone|risperidone|mesh-list
24978370|NCT04580134|Clozapine|clozapine|mesh-list
24978371|NCT04580134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24978372|NCT04580134|Serotonin Agents|serotonin agents|mesh-ancestor
24978373|NCT04580134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24978374|NCT04580134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978375|NCT04580134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978376|NCT04580134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24978377|NCT04580134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24978378|NCT04580134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24978379|NCT04580134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24978380|NCT04580134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24978381|NCT04580134|Dopamine Agents|dopamine agents|mesh-ancestor
24978382|NCT04580134|GABA Antagonists|gaba antagonists|mesh-ancestor
24978383|NCT04580134|GABA Agents|gaba agents|mesh-ancestor
24419731|NCT00213564|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25105776|NCT04930107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105777|NCT04930107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25105778|NCT04930107|Hormone Antagonists|hormone antagonists|mesh-ancestor
25105779|NCT04930107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25105780|NCT04930107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473053|NCT00401648|Brivaracetam|brivaracetam|mesh-list
24978403|NCT04545424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24978404|NCT04545424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25822636|NCT00004578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25252076|NCT02509195|Antiviral Agents|antiviral agents|mesh-ancestor
24419625|NCT00213109|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24419626|NCT00213122|Miglitol|miglitol|mesh-list
24419648|NCT00213226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419649|NCT00213226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24419650|NCT00213226|Glucocorticoids|glucocorticoids|mesh-ancestor
24419651|NCT00213226|Hormones|hormones|mesh-ancestor
24419652|NCT00213226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24419653|NCT00213226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24419654|NCT00213226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419655|NCT00213252|Prednisolone|prednisolone|mesh-list
24419657|NCT00213252|Methylprednisolone|methylprednisolone|mesh-list
24978415|NCT04522284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978416|NCT04522284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978417|NCT04507555|Antidepressive Agents|antidepressive agents|mesh-list
24923451|NCT04170270|Omeprazole|omeprazole|mesh-list
25252615|NCT02506140|Analgesics|analgesics|mesh-ancestor
24978418|NCT04507555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24978453|NCT04409795|Protease Inhibitors|protease inhibitors|mesh-ancestor
25555133|NCT00659425|Immunotoxin HA22|immunotoxin ha22|mesh-list
25252715|NCT02505633|Lidocaine|lidocaine|mesh-list
25252767|NCT02505516|Metformin|metformin|mesh-list
24728185|NCT01614431|Antiviral Agents|antiviral agents|mesh-ancestor
25555134|NCT00659425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555135|NCT00659438|Bicalutamide|bicalutamide|mesh-list
25555136|NCT00659438|Androgen Antagonists|androgen antagonists|mesh-ancestor
25555137|NCT00659438|Hormone Antagonists|hormone antagonists|mesh-ancestor
24793218|NCT03747042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25253039|NCT02504177|Anticoagulants|anticoagulants|mesh-list
25555138|NCT00659438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25253068|NCT02504125|Hemostatics|hemostatics|mesh-ancestor
25555139|NCT00659438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253124|NCT02503904|Mydriatics|mydriatics|mesh-ancestor
25555140|NCT00659438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555141|NCT00659490|Naproxen|naproxen|mesh-list
25555142|NCT00659490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25555143|NCT00659490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25555144|NCT00659490|Analgesics|analgesics|mesh-ancestor
25555145|NCT00659490|Sensory System Agents|sensory system agents|mesh-ancestor
24523260|NCT02336750|Histamine Agents|histamine agents|mesh-ancestor
25253457|NCT02500784|Formoterol Fumarate|formoterol fumarate|mesh-list
25555146|NCT00659490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25555147|NCT00659490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555148|NCT00659490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25555149|NCT00659490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25555150|NCT00659490|Gout Suppressants|gout suppressants|mesh-ancestor
25555151|NCT00659490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25555152|NCT00659490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25253705|NCT02499445|Sufentanil|sufentanil|mesh-list
25253744|NCT02499341|Ketamine|ketamine|mesh-list
24731710|NCT01636141|Dapansutrile|dapansutrile|mesh-list
25253820|NCT02498535|Antioxidants|antioxidants|mesh-ancestor
25253842|NCT02498301|Rifaximin|rifaximin|mesh-list
24617079|NCT01040702|Dopamine Agents|dopamine agents|mesh-ancestor
24617135|NCT01041183|Ramosetron|ramosetron|mesh-list
24732599|NCT01640535|Histamine Agents|histamine agents|mesh-ancestor
24617229|NCT01041729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555153|NCT00659490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555154|NCT00659529|Sildenafil Citrate|sildenafil citrate|mesh-list
25555155|NCT00659529|Vasodilator Agents|vasodilator agents|mesh-ancestor
25555156|NCT00659529|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25555157|NCT00659529|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25254287|NCT02495662|Hormones|hormones|mesh-ancestor
24617356|NCT01042704|Analgesics|analgesics|mesh-ancestor
25555158|NCT00659529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733722|NCT01648127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25555159|NCT00659529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584852|NCT00881816|Paclitaxel|paclitaxel|mesh-list
25555160|NCT00659529|Urological Agents|urological agents|mesh-ancestor
25254633|NCT02493504|Heparin|heparin|mesh-list
25555162|NCT00659581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24524783|NCT04369742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24735173|NCT01655875|Antiviral Agents|antiviral agents|mesh-ancestor
24617632|NCT01044342|Donepezil|donepezil|mesh-list
25555163|NCT00659581|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25555164|NCT00659581|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25555165|NCT00659581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555166|NCT00659633|Lidocaine|lidocaine|mesh-list
25555167|NCT00659633|Anesthetics, Local|anesthetics, local|mesh-ancestor
25555168|NCT00659633|Anesthetics|anesthetics|mesh-ancestor
25555169|NCT00659633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25555170|NCT00659633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555171|NCT00659633|Sensory System Agents|sensory system agents|mesh-ancestor
25555172|NCT00659633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25555173|NCT00659633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25555174|NCT00659633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24942682|NCT03978884|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24942683|NCT03978884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24617669|NCT01044810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24927287|NCT04134078|Antioxidants|antioxidants|mesh-ancestor
25051129|NCT00436683|Sevelamer|sevelamer|mesh-list
25255235|NCT02489487|Ritonavir|ritonavir|mesh-list
25555175|NCT00659633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25555176|NCT00659633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24736495|NCT01662622|Sevoflurane|sevoflurane|mesh-list
24736544|NCT01662869|Antidotes|antidotes|mesh-ancestor
25555177|NCT00659633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555178|NCT00659737|Scopolamine|scopolamine|mesh-list
25555179|NCT00659737|Aprepitant|aprepitant|mesh-list
25555180|NCT00659737|Fosaprepitant|fosaprepitant|mesh-list
25255539|NCT02487719|Teferrol|teferrol|mesh-list
25555181|NCT00659737|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25555182|NCT00659737|Antiemetics|antiemetics|mesh-ancestor
24736938|NCT01665742|Antioxidants|antioxidants|mesh-ancestor
25555183|NCT00659737|Autonomic Agents|autonomic agents|mesh-ancestor
25555184|NCT00659737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24800598|NCT01976780|Mefloquine|mefloquine|mesh-list
25255665|NCT02486926|Thiopental|thiopental|mesh-list
25555185|NCT00659737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555186|NCT00659737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25555187|NCT00659737|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24927945|NCT04127721|Busulfan|busulfan|mesh-list
24526420|NCT00611650|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24943506|NCT03970213|Tranexamic Acid|tranexamic acid|mesh-list
24737468|NCT01669044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24928160|NCT04124822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24752641|NCT01711463|Xhance|xhance|mesh-list
25256075|NCT02484248|Antipruritics|antipruritics|mesh-ancestor
24738189|NCT01673997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24526971|NCT00613964|Diuretics|diuretics|mesh-list
24738709|NCT01676987|Glucocorticoids|glucocorticoids|mesh-ancestor
25256307|NCT02483169|Antipyretics|antipyretics|mesh-ancestor
24928497|NCT04121416|Sufentanil|sufentanil|mesh-list
25012599|NCT04724252|Gabapentin|gabapentin|mesh-list
25012710|NCT04546126|Antiemetics|antiemetics|mesh-ancestor
25013201|NCT03353922|Tolperisone|tolperisone|mesh-list
25013243|NCT03188705|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24740470|NCT01688583|Fentanyl|fentanyl|mesh-list
25555188|NCT00659737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25555189|NCT00659737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555190|NCT00659737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25555191|NCT00659737|Mydriatics|mydriatics|mesh-ancestor
25555192|NCT00659737|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25555193|NCT00659737|Cholinergic Agents|cholinergic agents|mesh-ancestor
25555194|NCT00659737|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25555195|NCT00659737|Parasympatholytics|parasympatholytics|mesh-ancestor
25555196|NCT00659815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25555197|NCT00659945|Ondansetron|ondansetron|mesh-list
25555198|NCT00659945|Aprepitant|aprepitant|mesh-list
25555199|NCT00659945|Antiemetics|antiemetics|mesh-ancestor
25555200|NCT00659945|Autonomic Agents|autonomic agents|mesh-ancestor
25555201|NCT00659945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24586454|NCT00890708|Hormone Antagonists|hormone antagonists|mesh-ancestor
24742283|NCT05288062|Lenalidomide|lenalidomide|mesh-list
25555202|NCT00659945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555203|NCT00659945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24618371|NCT01048034|Hematinics|hematinics|mesh-ancestor
25555204|NCT00659945|Antipruritics|antipruritics|mesh-ancestor
25555205|NCT00659945|Dermatologic Agents|dermatologic agents|mesh-ancestor
25555206|NCT00659945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25555207|NCT00659945|Serotonin Agents|serotonin agents|mesh-ancestor
25555208|NCT00659945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25555209|NCT00659945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743823|NCT04602078|Atezolizumab|atezolizumab|mesh-list
25555210|NCT00659945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25555211|NCT00659945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25555212|NCT00659945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25555213|NCT00659945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25555214|NCT00659945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24744744|NCT04159818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555215|NCT00659945|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25555216|NCT00659984|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24443575|NCT00295464|Betamethasone|betamethasone|mesh-list
25016883|NCT03882918|Gaboxadol|gaboxadol|mesh-list
25555217|NCT00659984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555218|NCT00659984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25450559|NCT04599712|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
25555219|NCT00659984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555220|NCT00659984|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25555221|NCT00660010|Leuprolide|leuprolide|mesh-list
25555222|NCT00660010|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25555223|NCT00660010|Fertility Agents|fertility agents|mesh-ancestor
25555224|NCT00660010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25555225|NCT00660010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555226|NCT00660010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25555227|NCT00660010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555228|NCT00660023|Epoetin Alfa|epoetin alfa|mesh-list
25555229|NCT00660023|Hematinics|hematinics|mesh-ancestor
25450619|NCT04598061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25450620|NCT04598061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450621|NCT04598061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24745832|NCT03573115|Adapalene|adapalene|mesh-list
25450622|NCT04598061|Analgesics|analgesics|mesh-ancestor
25450623|NCT04598061|Sensory System Agents|sensory system agents|mesh-ancestor
25450624|NCT04598061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018206|NCT03701087|Vitamin D|vitamin d|mesh-list
25450625|NCT04598061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25687576|NCT01933984|Autonomic Agents|autonomic agents|mesh-ancestor
25450626|NCT04598061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25450627|NCT04598061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25450628|NCT04598061|Adrenergic Agents|adrenergic agents|mesh-ancestor
25687590|NCT01933984|Tocolytic Agents|tocolytic agents|mesh-ancestor
25450629|NCT04598061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25450630|NCT04598061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450631|NCT04597762|Cyclosporine|cyclosporine|mesh-list
25450632|NCT04597762|Hydrocortisone|hydrocortisone|mesh-list
25450633|NCT04597762|Cyclosporins|cyclosporins|mesh-list
25450634|NCT04597762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25450635|NCT04597762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450636|NCT04597762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25450637|NCT04597762|Immunologic Factors|immunologic factors|mesh-ancestor
25450638|NCT04597762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450639|NCT04597762|Antifungal Agents|antifungal agents|mesh-ancestor
25450640|NCT04597762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25450641|NCT04597762|Dermatologic Agents|dermatologic agents|mesh-ancestor
25450642|NCT04597762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25687629|NCT01934894|Lapatinib|lapatinib|mesh-list
25450643|NCT04597762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25450644|NCT04597762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25450645|NCT04597931|Zoledronic Acid|zoledronic acid|mesh-list
25687650|NCT01935700|Gout Suppressants|gout suppressants|mesh-ancestor
24746721|NCT04100096|Serotonin Agents|serotonin agents|mesh-ancestor
24746927|NCT02679144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450646|NCT04597931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25450647|NCT04597931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411733|NCT00189826|Tacrolimus|tacrolimus|mesh-list
25450648|NCT04597775|Hydroxychloroquine|hydroxychloroquine|mesh-list
25450649|NCT04597775|Antimalarials|antimalarials|mesh-ancestor
25450650|NCT04597775|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25555230|NCT00660075|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24857396|NCT02291536|Analgesics|analgesics|mesh-ancestor
25555231|NCT00660075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25555232|NCT00660075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555233|NCT00660075|Incretins|incretins|mesh-ancestor
25555234|NCT00660075|Hormones|hormones|mesh-ancestor
25555235|NCT00660075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25555236|NCT00660075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25555237|NCT00660075|Protease Inhibitors|protease inhibitors|mesh-ancestor
25555238|NCT00660075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555239|NCT00660075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555240|NCT00660179|Macitentan|macitentan|mesh-list
25555241|NCT00660179|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25555242|NCT00660179|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25555243|NCT00660179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555244|NCT00660179|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25555245|NCT00660309|Irbesartan|irbesartan|mesh-list
25555246|NCT00660309|Captopril|captopril|mesh-list
24748184|NCT02821754|Durvalumab|durvalumab|mesh-list
25555247|NCT00660309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25555248|NCT00660309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25555249|NCT00660309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25022122|NCT03665753|Ketorolac|ketorolac|mesh-list
24748721|NCT02204241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25257204|NCT02477852|Antitubercular Agents|antitubercular agents|mesh-ancestor
25555250|NCT00660309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555251|NCT00660309|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25555252|NCT00660309|Protease Inhibitors|protease inhibitors|mesh-ancestor
25555253|NCT00660309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555254|NCT00660387|Levodopa|levodopa|mesh-list
25555255|NCT00660387|Carbidopa|carbidopa|mesh-list
25687876|NCT01938625|Simeprevir|simeprevir|mesh-list
25555256|NCT00660387|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25023703|NCT03652428|Paclitaxel|paclitaxel|mesh-list
25555257|NCT00660387|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25555258|NCT00660387|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25555259|NCT00660387|Dopamine Agents|dopamine agents|mesh-ancestor
25555260|NCT00660387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25555261|NCT00660387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555262|NCT00660387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587596|NCT00895739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25024499|NCT03645109|Cholecalciferol|cholecalciferol|mesh-list
24751176|NCT01702649|Biapenem|biapenem|mesh-list
25555263|NCT00660387|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25025456|NCT03636971|Mannitol|mannitol|mesh-list
25555264|NCT00660387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555265|NCT00660387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24751392|NCT01703910|Sorafenib|sorafenib|mesh-list
25555266|NCT00660387|Immunologic Factors|immunologic factors|mesh-ancestor
25555267|NCT00660387|Dopamine Agonists|dopamine agonists|mesh-ancestor
24751481|NCT01704508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25555269|NCT00660400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25555270|NCT00660400|Antimetabolites|antimetabolites|mesh-ancestor
25026762|NCT03625167|Petrolatum|petrolatum|mesh-list
25555271|NCT00660400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595625|NCT00939848|Cisplatin|cisplatin|mesh-list
25555272|NCT00660400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555273|NCT00660400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555274|NCT00660504|Cisplatin|cisplatin|mesh-list
25555275|NCT00660504|Etoposide|etoposide|mesh-list
25555276|NCT00660504|Amrubicin|amrubicin|mesh-list
25555277|NCT00660504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555278|NCT00660504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24752598|NCT01711125|GABA Agonists|gaba agonists|mesh-ancestor
25555279|NCT00660504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25555280|NCT00660504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25555281|NCT00660504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555282|NCT00660504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555283|NCT00660517|Fluticasone|fluticasone|mesh-list
25555284|NCT00660517|Xhance|xhance|mesh-list
25555285|NCT00660517|Azelastine|azelastine|mesh-list
24799285|NCT01968044|Hormones|hormones|mesh-ancestor
25555286|NCT00660517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25555287|NCT00660517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25555288|NCT00660517|Autonomic Agents|autonomic agents|mesh-ancestor
24929469|NCT04112498|Nivolumab|nivolumab|mesh-list
24929581|NCT04110665|Antipyretics|antipyretics|mesh-ancestor
25555289|NCT00660517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24753432|NCT01715363|Leucovorin|leucovorin|mesh-list
25555290|NCT00660517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555291|NCT00660517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24753835|NCT01718054|Chloroquine|chloroquine|mesh-list
24604031|NCT00976963|Fosfomycin|fosfomycin|mesh-list
24929881|NCT04107480|Autonomic Agents|autonomic agents|mesh-ancestor
24754126|NCT01719185|Sympathomimetics|sympathomimetics|mesh-ancestor
25555292|NCT00660517|Respiratory System Agents|respiratory system agents|mesh-ancestor
25555293|NCT00660517|Dermatologic Agents|dermatologic agents|mesh-ancestor
25555294|NCT00660517|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25555295|NCT00660517|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25555296|NCT00660517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25033116|NCT03576378|Analgesics|analgesics|mesh-ancestor
25555297|NCT00660517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555298|NCT00660517|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25033374|NCT03573986|Bevacizumab|bevacizumab|mesh-list
24528745|NCT00622570|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25555299|NCT00660517|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25258406|NCT02471950|Isoflurane|isoflurane|mesh-list
24857899|NCT02294357|Dexamethasone|dexamethasone|mesh-list
25034203|NCT03566576|Docetaxel|docetaxel|mesh-list
25555300|NCT00660517|Histamine Antagonists|histamine antagonists|mesh-ancestor
25555301|NCT00660517|Histamine Agents|histamine agents|mesh-ancestor
25555302|NCT00660517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24754855|NCT01723371|Carvedilol|carvedilol|mesh-list
25555303|NCT00660543|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25555304|NCT00660543|Hematinics|hematinics|mesh-ancestor
24755445|NCT01726582|Capecitabine|capecitabine|mesh-list
24755446|NCT01726582|Oxaliplatin|oxaliplatin|mesh-list
25555305|NCT00660543|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24755878|NCT01729806|Rituximab|rituximab|mesh-list
24991973|NCT04703101|Vitamins|vitamins|mesh-ancestor
24588791|NCT00904306|Chromium|chromium|mesh-list
25555306|NCT00660543|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25555307|NCT00660660|Esomeprazole|esomeprazole|mesh-list
25555308|NCT00660660|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25555309|NCT00660660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25555310|NCT00660660|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25555311|NCT00660660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555312|NCT00660660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555313|NCT00660699|Gemcitabine|gemcitabine|mesh-list
25555314|NCT00660699|Docetaxel|docetaxel|mesh-list
25258958|NCT02467023|Lidocaine|lidocaine|mesh-list
25555315|NCT00660699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25555316|NCT00660699|Antimetabolites|antimetabolites|mesh-ancestor
25555317|NCT00660699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555318|NCT00660699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555319|NCT00660699|Antiviral Agents|antiviral agents|mesh-ancestor
25555320|NCT00660699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25555321|NCT00660699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555322|NCT00660699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25555323|NCT00660699|Immunologic Factors|immunologic factors|mesh-ancestor
25555324|NCT00660699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731252|NCT01633658|Vitamin D|vitamin d|mesh-list
25555325|NCT00660699|Tubulin Modulators|tubulin modulators|mesh-ancestor
25555326|NCT00660699|Antimitotic Agents|antimitotic agents|mesh-ancestor
25555327|NCT00660699|Mitosis Modulators|mitosis modulators|mesh-ancestor
25555328|NCT00660816|Docetaxel|docetaxel|mesh-list
25555329|NCT00660816|Pemetrexed|pemetrexed|mesh-list
25555330|NCT00660816|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25555331|NCT00660816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555332|NCT00660816|Tubulin Modulators|tubulin modulators|mesh-ancestor
25555333|NCT00660816|Antimitotic Agents|antimitotic agents|mesh-ancestor
25555334|NCT00660816|Mitosis Modulators|mitosis modulators|mesh-ancestor
25555335|NCT00660816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038276|NCT05261971|Etodolac|etodolac|mesh-list
25555336|NCT00660816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555337|NCT00660816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25555338|NCT00660816|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25555339|NCT00660816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25555340|NCT00660829|Azelastine|azelastine|mesh-list
25555341|NCT00660829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25555342|NCT00660829|Autonomic Agents|autonomic agents|mesh-ancestor
25555343|NCT00660829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25555344|NCT00660829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555345|NCT00660829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25259383|NCT02464722|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25555346|NCT00660829|Respiratory System Agents|respiratory system agents|mesh-ancestor
25555347|NCT00660829|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25555348|NCT00660829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038515|NCT05042791|Capecitabine|capecitabine|mesh-list
25259564|NCT02463812|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25555349|NCT00660829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555350|NCT00660829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25555351|NCT00660829|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25555352|NCT00660829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25555353|NCT00660829|Histamine Antagonists|histamine antagonists|mesh-ancestor
25555354|NCT00660829|Histamine Agents|histamine agents|mesh-ancestor
25555355|NCT00660829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25555356|NCT00660907|Metformin|metformin|mesh-list
25555357|NCT00660907|Dapagliflozin|dapagliflozin|mesh-list
25555358|NCT00660907|Glipizide|glipizide|mesh-list
25038793|NCT04521335|Disulfiram|disulfiram|mesh-list
25555359|NCT00660907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25555360|NCT00660907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039242|NCT03948646|Bromides|bromides|mesh-list
25555361|NCT00660907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25555362|NCT00660907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555363|NCT00660985|Adapalene|adapalene|mesh-list
25039781|NCT03660878|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25555364|NCT00660985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25555365|NCT00660985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25555366|NCT00660985|Analgesics|analgesics|mesh-ancestor
25259902|NCT02461888|Antiemetics|antiemetics|mesh-ancestor
25555367|NCT00660985|Sensory System Agents|sensory system agents|mesh-ancestor
24398391|NCT00144287|Tipranavir|tipranavir|mesh-list
24945880|NCT03945344|Tiotropium Bromide|tiotropium bromide|mesh-list
25555368|NCT00660985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25555369|NCT00660985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555370|NCT00660985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25555371|NCT00660985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25555372|NCT00660985|Dermatologic Agents|dermatologic agents|mesh-ancestor
25260019|NCT02461043|Paclitaxel|paclitaxel|mesh-list
25555373|NCT00661089|Botulinum Toxins|botulinum toxins|mesh-list
25555374|NCT00661089|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25555375|NCT00661089|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25555376|NCT00661089|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25555377|NCT00661089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25260097|NCT02460419|Antimetabolites|antimetabolites|mesh-ancestor
24608147|NCT02096588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555378|NCT00661089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555379|NCT00661089|Cholinergic Agents|cholinergic agents|mesh-ancestor
25555380|NCT00661089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25555381|NCT00661089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555382|NCT00661089|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25555383|NCT00661089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25555384|NCT00661141|Ethanol|ethanol|mesh-list
25555385|NCT00661141|Fomepizole|fomepizole|mesh-list
25555386|NCT00661141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25555387|NCT00661141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25555388|NCT00661141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25555389|NCT00661141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555390|NCT00661141|Antidotes|antidotes|mesh-ancestor
25555391|NCT00661141|Protective Agents|protective agents|mesh-ancestor
25555392|NCT00661141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408075|NCT00176475|Rituximab|rituximab|mesh-list
25555393|NCT00661141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555394|NCT00661193|Paclitaxel|paclitaxel|mesh-list
25555395|NCT00661193|Carboplatin|carboplatin|mesh-list
25555396|NCT00661193|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25555397|NCT00661193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25555398|NCT00661193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555399|NCT00661193|Tubulin Modulators|tubulin modulators|mesh-ancestor
25555400|NCT00661193|Antimitotic Agents|antimitotic agents|mesh-ancestor
25555401|NCT00661193|Mitosis Modulators|mitosis modulators|mesh-ancestor
24409307|NCT00181727|GABA Agents|gaba agents|mesh-ancestor
24409996|NCT00184015|Bevacizumab|bevacizumab|mesh-list
24756503|NCT01733836|Metformin|metformin|mesh-list
25555402|NCT00661193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555403|NCT00661193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25555404|NCT00661193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555405|NCT00661362|Metformin|metformin|mesh-list
25555406|NCT00661362|Saxagliptin|saxagliptin|mesh-list
25555407|NCT00661362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25450716|NCT04595916|Antimetabolites|antimetabolites|mesh-ancestor
25450781|NCT04595591|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24853858|NCT02270749|Vitamins|vitamins|mesh-ancestor
25450783|NCT04595409|Ustekinumab|ustekinumab|mesh-list
25450784|NCT04595409|Dermatologic Agents|dermatologic agents|mesh-ancestor
25306195|NCT04460352|Leucovorin|leucovorin|mesh-list
25306196|NCT04460352|Paclitaxel|paclitaxel|mesh-list
25306197|NCT04460352|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25306198|NCT04460352|Carboplatin|carboplatin|mesh-list
25306199|NCT04460352|Fluorouracil|fluorouracil|mesh-list
25306200|NCT04460352|Oxaliplatin|oxaliplatin|mesh-list
25306201|NCT04460352|Calcium|calcium|mesh-list
25306202|NCT04460352|Levoleucovorin|levoleucovorin|mesh-list
24788476|NCT01931592|Gentamicins|gentamicins|mesh-list
25306203|NCT04460352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24978454|NCT04409795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978455|NCT04409795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978456|NCT04367740|Antibodies|antibodies|mesh-list
24978457|NCT04367740|Immunoglobulin G|immunoglobulin g|mesh-list
24978458|NCT04367740|Immunologic Factors|immunologic factors|mesh-ancestor
24978459|NCT04367740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978460|NCT04297605|Paclitaxel|paclitaxel|mesh-list
24978461|NCT04297605|Pembrolizumab|pembrolizumab|mesh-list
24978462|NCT04297605|Pemetrexed|pemetrexed|mesh-list
24414971|NCT00199017|Prednisolone|prednisolone|mesh-list
24978463|NCT04297605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24978464|NCT04297605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978465|NCT04297605|Tubulin Modulators|tubulin modulators|mesh-ancestor
24978466|NCT04297605|Antimitotic Agents|antimitotic agents|mesh-ancestor
24932365|NCT04080349|Oxytocics|oxytocics|mesh-ancestor
24419693|NCT00213278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419695|NCT00213291|Hematinics|hematinics|mesh-ancestor
24419715|NCT00213538|Antimetabolites|antimetabolites|mesh-ancestor
24419716|NCT00213538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795376|NCT02900560|Azacitidine|azacitidine|mesh-list
24795378|NCT02900560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24795379|NCT02900560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795380|NCT02900560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24795382|NCT02900560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795383|NCT02900560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795385|NCT02877550|Obinutuzumab|obinutuzumab|mesh-list
25120788|NCT02639650|Vincristine|vincristine|mesh-list
25120789|NCT02639650|Cyclophosphamide|cyclophosphamide|mesh-list
25260771|NCT02456844|Antidotes|antidotes|mesh-ancestor
24795386|NCT02877550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795387|NCT02877550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24419726|NCT00213551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419727|NCT00213551|Protective Agents|protective agents|mesh-ancestor
24419728|NCT00213551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419729|NCT00213564|Methotrexate|methotrexate|mesh-list
24419733|NCT00213564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24419734|NCT00213564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419735|NCT00213564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24419736|NCT00213564|Antimetabolites|antimetabolites|mesh-ancestor
24419738|NCT00213564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419739|NCT00213564|Dermatologic Agents|dermatologic agents|mesh-ancestor
24419740|NCT00213564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978495|NCT04183101|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24978496|NCT04183101|Protease Inhibitors|protease inhibitors|mesh-ancestor
24978497|NCT04183101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24677730|NCT01358045|Vitamins|vitamins|mesh-ancestor
24978498|NCT04183101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529764|NCT00627731|Hormones|hormones|mesh-ancestor
24678383|NCT01361542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24978518|NCT04078568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24978519|NCT04078568|Analgesics|analgesics|mesh-ancestor
24978520|NCT04078568|Sensory System Agents|sensory system agents|mesh-ancestor
24978521|NCT04078568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24431055|NCT00250172|Rolipram|rolipram|mesh-list
24978522|NCT04078568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978523|NCT04078568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24978524|NCT04078568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24978525|NCT04078568|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25555408|NCT00661362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555409|NCT00661362|Incretins|incretins|mesh-ancestor
25555410|NCT00661362|Hormones|hormones|mesh-ancestor
25555411|NCT00661362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25555412|NCT00661362|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25555413|NCT00661362|Protease Inhibitors|protease inhibitors|mesh-ancestor
25555414|NCT00661362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432468|NCT00254865|Norelgestromin|norelgestromin|mesh-list
25555415|NCT00661362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555416|NCT00661388|Epoetin Alfa|epoetin alfa|mesh-list
25555417|NCT00661388|Hematinics|hematinics|mesh-ancestor
25555418|NCT00661427|Cetuximab|cetuximab|mesh-list
25555419|NCT00661427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25555420|NCT00661427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555421|NCT00661453|Valproic Acid|valproic acid|mesh-list
25555422|NCT00661453|Anticonvulsants|anticonvulsants|mesh-ancestor
25555423|NCT00661453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555424|NCT00661453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555425|NCT00661453|GABA Agents|gaba agents|mesh-ancestor
25555426|NCT00661453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24932843|NCT04076098|Minocycline|minocycline|mesh-list
24681271|NCT01379196|Azithromycin|azithromycin|mesh-list
25688214|NCT01942993|Vemurafenib|vemurafenib|mesh-list
25555427|NCT00661453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555428|NCT00661453|Antimanic Agents|antimanic agents|mesh-ancestor
25555429|NCT00661453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24530002|NCT00628719|Amphotericin B|amphotericin b|mesh-list
25555430|NCT00661453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25555431|NCT00661453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25555432|NCT00661479|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25555433|NCT00661479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24439570|NCT00279448|Tamoxifen|tamoxifen|mesh-list
25555434|NCT00661479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25555435|NCT00661479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25555436|NCT00661479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25555437|NCT00661479|Adrenergic Agents|adrenergic agents|mesh-ancestor
25555438|NCT00661479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25555439|NCT00661479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555440|NCT00661479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555441|NCT00661492|Cetuximab|cetuximab|mesh-list
25555442|NCT00661492|Mitoxantrone|mitoxantrone|mesh-list
25555443|NCT00661492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25555444|NCT00661492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555445|NCT00661492|Analgesics|analgesics|mesh-ancestor
25555446|NCT00661492|Sensory System Agents|sensory system agents|mesh-ancestor
25555447|NCT00661492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25555448|NCT00661492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555449|NCT00661492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25555450|NCT00661492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24933550|NCT04069208|Cytarabine|cytarabine|mesh-list
25555451|NCT00661492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933739|NCT04067856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25555452|NCT00661492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555453|NCT00661505|Epoetin Alfa|epoetin alfa|mesh-list
25555454|NCT00661505|Hematinics|hematinics|mesh-ancestor
25555455|NCT00661531|Anastrozole|anastrozole|mesh-list
25555456|NCT00661531|Estradiol|estradiol|mesh-list
25555457|NCT00661531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25555458|NCT00661531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555459|NCT00661531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25555460|NCT00661531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25555461|NCT00661531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555462|NCT00661531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555463|NCT00661531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25555464|NCT00661531|Hormone Antagonists|hormone antagonists|mesh-ancestor
25555465|NCT00661531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25555466|NCT00661531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555467|NCT00661531|Estrogens|estrogens|mesh-ancestor
25555468|NCT00661531|Hormones|hormones|mesh-ancestor
25555469|NCT00661544|Ascorbic Acid|ascorbic acid|mesh-list
25555470|NCT00661544|Melphalan|melphalan|mesh-list
25555471|NCT00661544|Arsenic Trioxide|arsenic trioxide|mesh-list
25555472|NCT00661544|Vitamins|vitamins|mesh-ancestor
25555473|NCT00661544|Micronutrients|micronutrients|mesh-ancestor
25555474|NCT00661544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555475|NCT00661544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25555476|NCT00661544|Alkylating Agents|alkylating agents|mesh-ancestor
25555477|NCT00661544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555478|NCT00661544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555479|NCT00661544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25555480|NCT00661544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25555481|NCT00661544|Immunologic Factors|immunologic factors|mesh-ancestor
25555482|NCT00661544|Antioxidants|antioxidants|mesh-ancestor
25555483|NCT00661544|Protective Agents|protective agents|mesh-ancestor
25555484|NCT00661583|Ranibizumab|ranibizumab|mesh-list
25555485|NCT00661583|Mitomycins|mitomycins|mesh-list
25555486|NCT00661583|Mitomycin|mitomycin|mesh-list
25555487|NCT00661583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25261695|NCT02452255|Adrenergic Agents|adrenergic agents|mesh-ancestor
25555488|NCT00661583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25555489|NCT00661583|Growth Substances|growth substances|mesh-ancestor
25555490|NCT00661583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555491|NCT00661583|Growth Inhibitors|growth inhibitors|mesh-ancestor
25555492|NCT00661583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555493|NCT00661583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25555494|NCT00661583|Alkylating Agents|alkylating agents|mesh-ancestor
25555495|NCT00661583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555496|NCT00661583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25555497|NCT00661583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555498|NCT00661622|Molgramostim|molgramostim|mesh-list
25555499|NCT00661622|Sargramostim|sargramostim|mesh-list
25555500|NCT00661622|Immunologic Factors|immunologic factors|mesh-ancestor
25555501|NCT00661622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555502|NCT00661622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555503|NCT00661661|Tofacitinib|tofacitinib|mesh-list
25555504|NCT00661661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25555505|NCT00661661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555506|NCT00661661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555507|NCT00661674|Palonosetron|palonosetron|mesh-list
25555508|NCT00661674|Hydroxyzine|hydroxyzine|mesh-list
25555509|NCT00661674|Antiemetics|antiemetics|mesh-ancestor
25555510|NCT00661674|Autonomic Agents|autonomic agents|mesh-ancestor
25555511|NCT00661674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25555512|NCT00661674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555513|NCT00661674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25555514|NCT00661674|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24626142|NCT01085721|Ephedrine|ephedrine|mesh-list
25555515|NCT00661674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25555516|NCT00661674|Serotonin Agents|serotonin agents|mesh-ancestor
25555517|NCT00661674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25555518|NCT00661674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555519|NCT00661674|Antipruritics|antipruritics|mesh-ancestor
25555520|NCT00661674|Dermatologic Agents|dermatologic agents|mesh-ancestor
25555521|NCT00661674|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25555522|NCT00661674|Histamine Antagonists|histamine antagonists|mesh-ancestor
25555523|NCT00661674|Histamine Agents|histamine agents|mesh-ancestor
25555524|NCT00661713|Vaccines|vaccines|mesh-list
25555525|NCT00661713|Immunologic Factors|immunologic factors|mesh-ancestor
25555526|NCT00661713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555527|NCT00661726|Decitabine|decitabine|mesh-list
25555528|NCT00661726|Azacitidine|azacitidine|mesh-list
25555529|NCT00661726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25555530|NCT00661726|Antimetabolites|antimetabolites|mesh-ancestor
25555531|NCT00661726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555532|NCT00661726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555533|NCT00661726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443285|NCT00294385|Antimetabolites|antimetabolites|mesh-ancestor
24443286|NCT00294385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261825|NCT02451605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25261826|NCT02451605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261827|NCT02451605|Sensory System Agents|sensory system agents|mesh-ancestor
25261828|NCT02451605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25261829|NCT02451579|Cetirizine|cetirizine|mesh-list
25555534|NCT00661778|Bevacizumab|bevacizumab|mesh-list
25555535|NCT00661778|Cisplatin|cisplatin|mesh-list
25555536|NCT00661778|Docetaxel|docetaxel|mesh-list
25555537|NCT00661778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25555538|NCT00661778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555539|NCT00661778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25555540|NCT00661778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25555541|NCT00661778|Growth Substances|growth substances|mesh-ancestor
25555542|NCT00661778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555543|NCT00661778|Growth Inhibitors|growth inhibitors|mesh-ancestor
25555544|NCT00661778|Tubulin Modulators|tubulin modulators|mesh-ancestor
25555545|NCT00661778|Antimitotic Agents|antimitotic agents|mesh-ancestor
25555546|NCT00661778|Mitosis Modulators|mitosis modulators|mesh-ancestor
24934383|NCT04062006|Sensory System Agents|sensory system agents|mesh-ancestor
25261965|NCT02450682|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25555547|NCT00661778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555548|NCT00661830|Gemcitabine|gemcitabine|mesh-list
25555549|NCT00661830|Sorafenib|sorafenib|mesh-list
25555550|NCT00661830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25555551|NCT00661830|Antimetabolites|antimetabolites|mesh-ancestor
25555552|NCT00661830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555553|NCT00661830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555554|NCT00661830|Antiviral Agents|antiviral agents|mesh-ancestor
25555555|NCT00661830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24934692|NCT04059679|Aspirin|aspirin|mesh-list
25555556|NCT00661830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555557|NCT00661830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25262195|NCT02449265|Prednisone|prednisone|mesh-list
24552456|NCT03068624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25555558|NCT00661830|Immunologic Factors|immunologic factors|mesh-ancestor
24935162|NCT04054024|Analgesics|analgesics|mesh-ancestor
24531171|NCT00634348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24531172|NCT00634361|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
24668508|NCT04889547|Dexamethasone|dexamethasone|mesh-list
24554127|NCT00734383|Anesthetics, General|anesthetics, general|mesh-ancestor
24554128|NCT00734383|Anesthetics|anesthetics|mesh-ancestor
24554129|NCT00734448|Inositol|inositol|mesh-list
25275262|NCT02373280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555559|NCT00661830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555560|NCT00661830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25555561|NCT00661895|Metoprolol|metoprolol|mesh-list
25555562|NCT00661895|Atenolol|atenolol|mesh-list
24554794|NCT00738192|Analgesics|analgesics|mesh-ancestor
25555563|NCT00661895|Amlodipine|amlodipine|mesh-list
25555564|NCT00661895|Valsartan|valsartan|mesh-list
25555565|NCT00661895|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25555566|NCT00661895|Clonidine|clonidine|mesh-list
25555567|NCT00661895|Lisinopril|lisinopril|mesh-list
25555568|NCT00661895|Doxazosin|doxazosin|mesh-list
25555569|NCT00661895|Hydralazine|hydralazine|mesh-list
25555570|NCT00661895|Nifedipine|nifedipine|mesh-list
25555571|NCT00661895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25262839|NCT02446002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25555572|NCT00661895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25450861|NCT04593446|Cathartics|cathartics|mesh-ancestor
25555573|NCT00661895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25555574|NCT00661895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556653|NCT00748644|Rituximab|rituximab|mesh-list
24640374|NCT01167803|Desflurane|desflurane|mesh-list
25555575|NCT00661895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25555576|NCT00661895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555577|NCT00661895|Vasodilator Agents|vasodilator agents|mesh-ancestor
25263011|NCT02445391|Carboplatin|carboplatin|mesh-list
25555578|NCT00661895|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24557177|NCT00751556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25688472|NCT01945866|Antiemetics|antiemetics|mesh-ancestor
24812691|NCT02054078|Growth Inhibitors|growth inhibitors|mesh-ancestor
24812692|NCT02054143|Sevoflurane|sevoflurane|mesh-list
25555579|NCT00661895|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25555580|NCT00661895|Diuretics|diuretics|mesh-ancestor
25555581|NCT00661895|Natriuretic Agents|natriuretic agents|mesh-ancestor
25555582|NCT00661895|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25555583|NCT00661895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25555584|NCT00661895|Sympatholytics|sympatholytics|mesh-ancestor
25555585|NCT00661895|Autonomic Agents|autonomic agents|mesh-ancestor
25555586|NCT00661895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24532645|NCT00640705|Diclofenac|diclofenac|mesh-list
25555587|NCT00661895|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25555588|NCT00661895|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25555589|NCT00661895|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25555590|NCT00661895|Adrenergic Agents|adrenergic agents|mesh-ancestor
25555591|NCT00661895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25555592|NCT00661895|Analgesics|analgesics|mesh-ancestor
25555593|NCT00661895|Sensory System Agents|sensory system agents|mesh-ancestor
25555594|NCT00661895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25555595|NCT00661895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25555596|NCT00661895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25555597|NCT00661895|Tocolytic Agents|tocolytic agents|mesh-ancestor
25555598|NCT00661895|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25263496|NCT01453179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25555599|NCT00661895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25555600|NCT00661895|Protease Inhibitors|protease inhibitors|mesh-ancestor
25555601|NCT00661895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555602|NCT00661895|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25555603|NCT00661895|Protective Agents|protective agents|mesh-ancestor
24687529|NCT03932318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555604|NCT00661895|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25555605|NCT00661895|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25555606|NCT00661960|Efavirenz|efavirenz|mesh-list
25555607|NCT00661960|Raltegravir Potassium|raltegravir potassium|mesh-list
25555608|NCT00661960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25555609|NCT00661960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25555610|NCT00661960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555611|NCT00661960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555612|NCT00661960|Antiviral Agents|antiviral agents|mesh-ancestor
25555613|NCT00661960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25555614|NCT00661960|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25555615|NCT00661960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25555616|NCT00661960|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25555617|NCT00661960|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25555618|NCT00661960|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25555619|NCT00661960|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25555620|NCT00661960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25555621|NCT00661960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25555622|NCT00661960|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25555623|NCT00661960|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24948190|NCT03921671|Carboplatin|carboplatin|mesh-list
25555624|NCT00661999|Darbepoetin alfa|darbepoetin alfa|mesh-list
25555625|NCT00661999|Ferric gluconate|ferric gluconate|mesh-list
25555626|NCT00661999|Hematinics|hematinics|mesh-ancestor
25555627|NCT00662012|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
25555628|NCT00662012|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25555629|NCT00662012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25555630|NCT00662012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25555631|NCT00662012|Schistosomicides|schistosomicides|mesh-ancestor
25555632|NCT00662012|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25555633|NCT00662012|Anthelmintics|anthelmintics|mesh-ancestor
25555634|NCT00662025|Capecitabine|capecitabine|mesh-list
25555635|NCT00662025|Sunitinib|sunitinib|mesh-list
25555636|NCT00662025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25555637|NCT00662025|Antimetabolites|antimetabolites|mesh-ancestor
25555638|NCT00662025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555639|NCT00662025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555640|NCT00662025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25555641|NCT00662025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25555642|NCT00662025|Growth Substances|growth substances|mesh-ancestor
25555643|NCT00662025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555644|NCT00662025|Growth Inhibitors|growth inhibitors|mesh-ancestor
25555645|NCT00662025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25555646|NCT00662025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555647|NCT00662038|Pirfenidone|pirfenidone|mesh-list
24558748|NCT05435378|Vitamin B Complex|vitamin b complex|mesh-list
24558749|NCT05435378|Micronutrients|micronutrients|mesh-ancestor
25555648|NCT00662038|Analgesics|analgesics|mesh-ancestor
25555649|NCT00662038|Sensory System Agents|sensory system agents|mesh-ancestor
25555650|NCT00662038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25555651|NCT00662038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555652|NCT00662038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25555653|NCT00662038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25555654|NCT00662038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25692630|NCT02003365|FX006|fx006|mesh-list
25555655|NCT00662038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25555656|NCT00662038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555657|NCT00662129|Gemcitabine|gemcitabine|mesh-list
25555658|NCT00662129|Paclitaxel|paclitaxel|mesh-list
25555659|NCT00662129|Bevacizumab|bevacizumab|mesh-list
25555660|NCT00662129|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25555661|NCT00662129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25555662|NCT00662129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555663|NCT00662129|Tubulin Modulators|tubulin modulators|mesh-ancestor
25555664|NCT00662129|Antimitotic Agents|antimitotic agents|mesh-ancestor
25555665|NCT00662129|Mitosis Modulators|mitosis modulators|mesh-ancestor
25555666|NCT00662129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555667|NCT00662129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25555668|NCT00662129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25555669|NCT00662129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25555670|NCT00662129|Growth Substances|growth substances|mesh-ancestor
25555671|NCT00662129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558999|NCT05343156|Dexamethasone|dexamethasone|mesh-list
25555672|NCT00662129|Growth Inhibitors|growth inhibitors|mesh-ancestor
25555673|NCT00662129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25555674|NCT00662129|Antimetabolites|antimetabolites|mesh-ancestor
25555675|NCT00662129|Antiviral Agents|antiviral agents|mesh-ancestor
25555676|NCT00662129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25555677|NCT00662129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555678|NCT00662129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25555679|NCT00662129|Immunologic Factors|immunologic factors|mesh-ancestor
25555680|NCT00662155|Zolpidem|zolpidem|mesh-list
25555681|NCT00662155|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25555682|NCT00662155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25555683|NCT00662155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25555684|NCT00662155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555685|NCT00662155|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25555686|NCT00662155|GABA Agonists|gaba agonists|mesh-ancestor
25555687|NCT00662155|GABA Agents|gaba agents|mesh-ancestor
25555688|NCT00662155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25555689|NCT00662155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555690|NCT00662259|Alprazolam|alprazolam|mesh-list
25555691|NCT00662259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25555692|NCT00662259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25555693|NCT00662259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555694|NCT00662259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25555695|NCT00662259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25555696|NCT00662259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25555697|NCT00662259|GABA Modulators|gaba modulators|mesh-ancestor
25555698|NCT00662259|GABA Agents|gaba agents|mesh-ancestor
25555699|NCT00662259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25555700|NCT00662259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555701|NCT00662298|Prednisolone|prednisolone|mesh-list
25555702|NCT00662298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25555703|NCT00662298|Glucocorticoids|glucocorticoids|mesh-ancestor
25555704|NCT00662298|Hormones|hormones|mesh-ancestor
25555705|NCT00662298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25555706|NCT00662298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555707|NCT00662298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25555708|NCT00662298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555709|NCT00662311|Paclitaxel|paclitaxel|mesh-list
25555710|NCT00662311|Vorinostat|vorinostat|mesh-list
25555711|NCT00662311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25555712|NCT00662311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555713|NCT00662311|Tubulin Modulators|tubulin modulators|mesh-ancestor
25555714|NCT00662311|Antimitotic Agents|antimitotic agents|mesh-ancestor
25555715|NCT00662311|Mitosis Modulators|mitosis modulators|mesh-ancestor
25555716|NCT00662311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555717|NCT00662311|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25555718|NCT00662311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25450986|NCT04592081|Dexamethasone|dexamethasone|mesh-list
25555719|NCT00662363|Lubiprostone|lubiprostone|mesh-list
25651441|NCT01516268|Sufentanil|sufentanil|mesh-list
25555720|NCT00662363|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25555721|NCT00662363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25555722|NCT00662363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555723|NCT00662532|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25555725|NCT00662532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25555726|NCT00662545|Tenofovir|tenofovir|mesh-list
25555727|NCT00662545|Lamivudine|lamivudine|mesh-list
25555728|NCT00662545|Emtricitabine|emtricitabine|mesh-list
25555729|NCT00662545|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25555730|NCT00662545|Entecavir|entecavir|mesh-list
25555731|NCT00662545|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25555732|NCT00662545|Antiviral Agents|antiviral agents|mesh-ancestor
24559998|NCT03873883|Pembrolizumab|pembrolizumab|mesh-list
24559999|NCT03873883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25555733|NCT00662545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25555734|NCT00662545|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25555735|NCT00662545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25555736|NCT00662545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555737|NCT00662545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555738|NCT00662545|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25555739|NCT00662558|Celecoxib|celecoxib|mesh-list
25555740|NCT00662558|Tramadol|tramadol|mesh-list
25555741|NCT00662558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25555742|NCT00662558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25555743|NCT00662558|Analgesics|analgesics|mesh-ancestor
25555744|NCT00662558|Sensory System Agents|sensory system agents|mesh-ancestor
25555745|NCT00662558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25555746|NCT00662558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555747|NCT00662558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25555748|NCT00662558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25555749|NCT00662558|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25555750|NCT00662558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25555751|NCT00662558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555752|NCT00662558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555753|NCT00662558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25555754|NCT00662558|Narcotics|narcotics|mesh-ancestor
25555755|NCT00662558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24948309|NCT03920644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25555756|NCT00662649|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25555757|NCT00662649|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25555758|NCT00662649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555759|NCT00662649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25555760|NCT00662649|Immunologic Factors|immunologic factors|mesh-ancestor
25555761|NCT00662649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555762|NCT00662675|Pancrelipase|pancrelipase|mesh-list
25555763|NCT00662675|Pancreatin|pancreatin|mesh-list
25555764|NCT00662675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25688624|NCT01948830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478263|NCT00421967|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24478264|NCT00421980|Etanercept|etanercept|mesh-list
25555765|NCT00662818|Acetaminophen|acetaminophen|mesh-list
25555766|NCT00662818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25555767|NCT00662818|Analgesics|analgesics|mesh-ancestor
25555768|NCT00662818|Sensory System Agents|sensory system agents|mesh-ancestor
25555769|NCT00662818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25555770|NCT00662818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555771|NCT00662818|Antipyretics|antipyretics|mesh-ancestor
25555772|NCT00662831|Dalteparin|dalteparin|mesh-list
25555773|NCT00662831|Tinzaparin|tinzaparin|mesh-list
25555774|NCT00662831|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25555775|NCT00662831|Anticoagulants|anticoagulants|mesh-ancestor
24560860|NCT01302834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25555776|NCT00662831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25555777|NCT00662831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25555778|NCT00662831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555779|NCT00662857|Insulin|insulin|mesh-list
25555780|NCT00662857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25555781|NCT00662857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25555782|NCT00662857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555783|NCT00662909|Mirabegron|mirabegron|mesh-list
25555784|NCT00662909|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25555785|NCT00662909|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25555786|NCT00662909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24561463|NCT00760695|Hormones|hormones|mesh-ancestor
25275333|NCT02372656|Metformin|metformin|mesh-list
25275334|NCT02372656|Simvastatin|simvastatin|mesh-list
25275335|NCT02372656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25275336|NCT02372656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275337|NCT02372656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25275338|NCT02372656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25555787|NCT00662909|Adrenergic Agents|adrenergic agents|mesh-ancestor
25555788|NCT00662909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25555789|NCT00662909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555790|NCT00662909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555791|NCT00662909|Urological Agents|urological agents|mesh-ancestor
25555792|NCT00663039|Oxytocin|oxytocin|mesh-list
25555793|NCT00663039|Oxytocics|oxytocics|mesh-ancestor
25451060|NCT04591444|Fluorides, Topical|fluorides, topical|mesh-list
25555794|NCT00663039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24561658|NCT00762060|Sensory System Agents|sensory system agents|mesh-ancestor
25264076|NCT02442648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25264077|NCT02442648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25264078|NCT02442648|Immunologic Factors|immunologic factors|mesh-ancestor
25275339|NCT02372656|Antimetabolites|antimetabolites|mesh-ancestor
25045437|NCT00953420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045438|NCT00953420|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25045439|NCT00953420|Immunologic Factors|immunologic factors|mesh-ancestor
25045440|NCT00950885|Melatonin|melatonin|mesh-list
25045441|NCT00950885|Antioxidants|antioxidants|mesh-ancestor
24998419|NCT02881957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690554|NCT01402336|Fertility Agents|fertility agents|mesh-ancestor
24690555|NCT01402336|Hormone Antagonists|hormone antagonists|mesh-ancestor
24690556|NCT01402479|Ramipril|ramipril|mesh-list
24690557|NCT01402479|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24690558|NCT01402479|Protease Inhibitors|protease inhibitors|mesh-ancestor
24690559|NCT01402479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555795|NCT00663039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555796|NCT00663117|Naltrexone|naltrexone|mesh-list
25555797|NCT00663117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25555798|NCT00663117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25555799|NCT00663117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555800|NCT00663117|Sensory System Agents|sensory system agents|mesh-ancestor
25555801|NCT00663117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25555802|NCT00663169|Dexamethasone|dexamethasone|mesh-list
25555803|NCT00663169|Dexamethasone acetate|dexamethasone acetate|mesh-list
25555804|NCT00663169|BB 1101|bb 1101|mesh-list
25555805|NCT00663169|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25555806|NCT00663169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25555807|NCT00663169|Antiemetics|antiemetics|mesh-ancestor
25555808|NCT00663169|Autonomic Agents|autonomic agents|mesh-ancestor
24561763|NCT00762736|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25264100|NCT02442362|Immunologic Factors|immunologic factors|mesh-ancestor
24767183|NCT01799109|Analgesics|analgesics|mesh-ancestor
25264109|NCT02442739|Anesthetics, General|anesthetics, general|mesh-ancestor
25264110|NCT02442739|Anesthetics|anesthetics|mesh-ancestor
25264111|NCT02442739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25264112|NCT02442739|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25555809|NCT00663169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25555810|NCT00663169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555811|NCT00663169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25555812|NCT00663169|Glucocorticoids|glucocorticoids|mesh-ancestor
25555813|NCT00663169|Hormones|hormones|mesh-ancestor
25555814|NCT00663169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25555815|NCT00663169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25555816|NCT00663169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555817|NCT00663169|Protease Inhibitors|protease inhibitors|mesh-ancestor
25555818|NCT00663169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555819|NCT00663169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555820|NCT00663169|Immunologic Factors|immunologic factors|mesh-ancestor
25555821|NCT00663234|Atorvastatin|atorvastatin|mesh-list
25688669|NCT01949116|Immunologic Factors|immunologic factors|mesh-ancestor
25688670|NCT01949116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25688671|NCT01949116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24561836|NCT00763165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24561837|NCT00763165|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25051646|NCT00391209|Insulin|insulin|mesh-list
25264146|NCT02442440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25264147|NCT02442440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24611996|NCT01011621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24690595|NCT01402674|Sympathomimetics|sympathomimetics|mesh-ancestor
25555822|NCT00663234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25555823|NCT00663234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25555824|NCT00663234|Antimetabolites|antimetabolites|mesh-ancestor
25555825|NCT00663234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555826|NCT00663234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25555827|NCT00663234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25555828|NCT00663234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555829|NCT00663260|Dapagliflozin|dapagliflozin|mesh-list
25264150|NCT02442440|Autonomic Agents|autonomic agents|mesh-ancestor
25264151|NCT02442440|Vasodilator Agents|vasodilator agents|mesh-ancestor
25264152|NCT02442440|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25264153|NCT02442440|Antioxidants|antioxidants|mesh-ancestor
25264154|NCT02442440|Protective Agents|protective agents|mesh-ancestor
24691026|NCT01404767|Esmolol|esmolol|mesh-list
24691436|NCT01406535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691437|NCT01406535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691438|NCT01406535|Urological Agents|urological agents|mesh-ancestor
25555830|NCT00663260|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25555831|NCT00663260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555832|NCT00663260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25555833|NCT00663260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555834|NCT00663403|Daptomycin|daptomycin|mesh-list
25555835|NCT00663403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25555836|NCT00663403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25555837|NCT00663702|Abatacept|abatacept|mesh-list
24562099|NCT00764582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562100|NCT00764582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562105|NCT00764595|Imatinib Mesylate|imatinib mesylate|mesh-list
24855312|NCT02278861|Protective Agents|protective agents|mesh-ancestor
24519568|NCT05332470|Lamivudine|lamivudine|mesh-list
24691881|NCT01409499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691882|NCT01409499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24691883|NCT01409499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691884|NCT01409499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691885|NCT01409603|Naproxen|naproxen|mesh-list
24691886|NCT01409603|Darexaban|darexaban|mesh-list
24691889|NCT01409603|Analgesics|analgesics|mesh-ancestor
24691896|NCT01409603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24691897|NCT01409603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691949|NCT01409694|Dopamine Agents|dopamine agents|mesh-ancestor
24691950|NCT01409694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24691954|NCT01409733|Doxorubicin|doxorubicin|mesh-list
25555838|NCT00663702|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25555839|NCT00663702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555840|NCT00663702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555841|NCT00663702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25555842|NCT00663702|Immunologic Factors|immunologic factors|mesh-ancestor
25555843|NCT00663702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555844|NCT00663702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25555845|NCT00663793|Methyltestosterone|methyltestosterone|mesh-list
25555846|NCT00663793|Finasteride|finasteride|mesh-list
25555847|NCT00663793|Testosterone|testosterone|mesh-list
25555848|NCT00663793|Testosterone undecanoate|testosterone undecanoate|mesh-list
25555849|NCT00663793|Testosterone enanthate|testosterone enanthate|mesh-list
24562390|NCT00766337|Sirolimus|sirolimus|mesh-list
25555850|NCT00663793|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25555851|NCT00663793|Acyline|acyline|mesh-list
25555852|NCT00663793|Androgens|androgens|mesh-ancestor
25555853|NCT00663793|Hormones|hormones|mesh-ancestor
25555854|NCT00663793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25555855|NCT00663793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555856|NCT00663793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25555857|NCT00663793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555858|NCT00663793|Anabolic Agents|anabolic agents|mesh-ancestor
24693544|NCT01421069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25555859|NCT00663793|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25555860|NCT00663793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25555861|NCT00663793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555862|NCT00663793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555863|NCT00663793|Hormone Antagonists|hormone antagonists|mesh-ancestor
25555864|NCT00663793|Urological Agents|urological agents|mesh-ancestor
25555865|NCT00663858|Cetrorelix|cetrorelix|mesh-list
25555866|NCT00663858|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25451126|NCT04590612|Serotonin Agents|serotonin agents|mesh-ancestor
25555867|NCT00663858|Fertility Agents|fertility agents|mesh-ancestor
25451197|NCT04589819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25451198|NCT04589819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451199|NCT04589819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25306719|NCT05430230|Naproxen|naproxen|mesh-list
25306720|NCT05430230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
24699076|NCT01444807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822637|NCT00004578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25306721|NCT05430230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25306722|NCT05430230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25306723|NCT05430230|Analgesics|analgesics|mesh-ancestor
25306724|NCT05430230|Sensory System Agents|sensory system agents|mesh-ancestor
25306725|NCT05430230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25306726|NCT05430230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306727|NCT05430230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25306728|NCT05430230|Gout Suppressants|gout suppressants|mesh-ancestor
25306729|NCT05430230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25306730|NCT05430230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978526|NCT04078568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24978530|NCT04078568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978531|NCT04078568|Antipyretics|antipyretics|mesh-ancestor
25161848|NCT02269670|Appetite Stimulants|appetite stimulants|mesh-ancestor
24419814|NCT00214110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24419815|NCT00214110|Hormone Antagonists|hormone antagonists|mesh-ancestor
24699799|NCT01449123|Diuretics|diuretics|mesh-ancestor
24699800|NCT01449123|Natriuretic Agents|natriuretic agents|mesh-ancestor
24419816|NCT00214110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24419817|NCT00214110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419818|NCT00214110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24700095|NCT01450514|Pipamperone|pipamperone|mesh-list
24419819|NCT00214110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419820|NCT00214110|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24700557|NCT01453192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24419821|NCT00214110|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24613187|NCT01017640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633859|NCT01131429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419822|NCT00214110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24633980|NCT01131767|Autonomic Agents|autonomic agents|mesh-ancestor
24419824|NCT00214214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24419825|NCT00214214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419826|NCT00214240|Immunoglobulins|immunoglobulins|mesh-list
24419827|NCT00214240|Antibodies|antibodies|mesh-list
24419828|NCT00214240|gamma-Globulins|gamma-globulins|mesh-list
24419829|NCT00214240|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24419830|NCT00214240|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24419831|NCT00214240|Immunologic Factors|immunologic factors|mesh-ancestor
24978534|NCT04078568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24978535|NCT04078568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24978536|NCT04078568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978537|NCT04078568|Immunologic Factors|immunologic factors|mesh-ancestor
24978538|NCT03985371|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24978539|NCT03985371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24978540|NCT03979365|Tacrolimus|tacrolimus|mesh-list
24978541|NCT03979365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24978542|NCT03979365|Immunologic Factors|immunologic factors|mesh-ancestor
24978543|NCT03979365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566077|NCT00784316|Vasodilator Agents|vasodilator agents|mesh-ancestor
24419865|NCT00214318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419866|NCT00214318|Antioxidants|antioxidants|mesh-ancestor
24419867|NCT00214318|Protective Agents|protective agents|mesh-ancestor
24419868|NCT00214318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24419869|NCT00214318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24419870|NCT00214318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24419880|NCT00214318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24419881|NCT00214318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24419882|NCT00214318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25555868|NCT00663858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25555869|NCT00663858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555870|NCT00663858|Hormone Antagonists|hormone antagonists|mesh-ancestor
24635638|NCT01140529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25555871|NCT00663858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25555872|NCT00663962|Pregabalin|pregabalin|mesh-list
25555873|NCT00663962|Analgesics|analgesics|mesh-ancestor
25555874|NCT00663962|Sensory System Agents|sensory system agents|mesh-ancestor
25555875|NCT00663962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25555876|NCT00663962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555877|NCT00663962|Anticonvulsants|anticonvulsants|mesh-ancestor
25555878|NCT00663962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25555879|NCT00663962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25555880|NCT00663962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555881|NCT00663962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25555882|NCT00663962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25555883|NCT00663962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25555884|NCT00663962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25555885|NCT00663962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25651442|NCT01516268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25651443|NCT01516268|Narcotics|narcotics|mesh-ancestor
25651444|NCT01516268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25651445|NCT01516268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948532|NCT03918616|Dopamine Agents|dopamine agents|mesh-ancestor
24635894|NCT01141855|Varenicline|varenicline|mesh-list
25651446|NCT01516268|Analgesics|analgesics|mesh-ancestor
25651447|NCT01516268|Sensory System Agents|sensory system agents|mesh-ancestor
25651448|NCT01516268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25651449|NCT01516268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25651450|NCT01516268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25651451|NCT01516268|Anesthetics, General|anesthetics, general|mesh-ancestor
25651452|NCT01516268|Anesthetics|anesthetics|mesh-ancestor
25651453|NCT01516424|Risperidone|risperidone|mesh-list
25651454|NCT01516424|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25651455|NCT01516424|Serotonin Agents|serotonin agents|mesh-ancestor
25651456|NCT01516424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25651457|NCT01516424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651458|NCT01516424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651459|NCT01516424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25651460|NCT01516424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25651461|NCT01516424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25651462|NCT01516424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25651463|NCT01516424|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25651464|NCT01516424|Dopamine Agents|dopamine agents|mesh-ancestor
25651465|NCT01516684|Lidocaine|lidocaine|mesh-list
25651466|NCT01516684|Fentanyl|fentanyl|mesh-list
25651467|NCT01516684|Anesthetics, Local|anesthetics, local|mesh-list
25651468|NCT01516684|Prilocaine|prilocaine|mesh-list
25651469|NCT01516684|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25651470|NCT01516684|Propofol|propofol|mesh-list
25651471|NCT01516684|Anesthetics|anesthetics|mesh-list
25651472|NCT01516684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25651473|NCT01516684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567831|NCT00793052|Dexamethasone|dexamethasone|mesh-list
24529577|NCT00626769|Genistein|genistein|mesh-list
25651474|NCT01516684|Sensory System Agents|sensory system agents|mesh-ancestor
25651475|NCT01516684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25651476|NCT01516684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25651477|NCT01516684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25651478|NCT01516684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25651479|NCT01516684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25651480|NCT01516684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651481|NCT01516684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25651482|NCT01516684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25651483|NCT01516684|Anesthetics, General|anesthetics, general|mesh-ancestor
25651484|NCT01516684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25651485|NCT01516684|Narcotics|narcotics|mesh-ancestor
25651486|NCT01516684|Analgesics|analgesics|mesh-ancestor
25651487|NCT01516684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25651488|NCT01516684|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25651489|NCT01516749|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25651490|NCT01516749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25651491|NCT01516892|Botulinum Toxins|botulinum toxins|mesh-list
25651492|NCT01516892|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25651493|NCT01516892|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25651494|NCT01516892|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25651495|NCT01516892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24636671|NCT01146626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651496|NCT01516892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651497|NCT01516892|Cholinergic Agents|cholinergic agents|mesh-ancestor
25651498|NCT01516892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25651499|NCT01516892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651500|NCT01516892|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25651501|NCT01516892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25651502|NCT01516957|Brodalumab|brodalumab|mesh-list
25651503|NCT01516957|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25651504|NCT01516957|Dermatologic Agents|dermatologic agents|mesh-ancestor
25651505|NCT01516957|Immunologic Factors|immunologic factors|mesh-ancestor
25651506|NCT01516957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651507|NCT01516970|Ritonavir|ritonavir|mesh-list
25651508|NCT01516970|Lopinavir|lopinavir|mesh-list
25651509|NCT01516970|Darunavir|darunavir|mesh-list
25651510|NCT01516970|Zidovudine|zidovudine|mesh-list
25651511|NCT01516970|Efavirenz|efavirenz|mesh-list
25651512|NCT01516970|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25451200|NCT04589728|Venetoclax|venetoclax|mesh-list
25651513|NCT01516970|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25651514|NCT01516970|Protease Inhibitors|protease inhibitors|mesh-ancestor
25555886|NCT00664105|Carboplatin|carboplatin|mesh-list
25555887|NCT00664105|Docetaxel|docetaxel|mesh-list
25555888|NCT00664105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555889|NCT00664105|Tubulin Modulators|tubulin modulators|mesh-ancestor
25555890|NCT00664105|Antimitotic Agents|antimitotic agents|mesh-ancestor
25555891|NCT00664105|Mitosis Modulators|mitosis modulators|mesh-ancestor
25555892|NCT00664105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555893|NCT00664209|Amoxicillin|amoxicillin|mesh-list
25555894|NCT00664209|Omeprazole|omeprazole|mesh-list
25555895|NCT00664209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25555896|NCT00664209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25555897|NCT00664209|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25555898|NCT00664209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25555899|NCT00664209|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25555900|NCT00664209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456082|NCT00329823|Sensory System Agents|sensory system agents|mesh-ancestor
24456085|NCT00329823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25555901|NCT00664209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555902|NCT00664430|Calcitriol|calcitriol|mesh-list
25555903|NCT00664430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25555904|NCT00664430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555905|NCT00664430|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25555906|NCT00664430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25555907|NCT00664430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555908|NCT00664430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25555909|NCT00664430|Vitamins|vitamins|mesh-ancestor
25555910|NCT00664430|Micronutrients|micronutrients|mesh-ancestor
25555911|NCT00664430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25555912|NCT00664521|Rituximab|rituximab|mesh-list
24570331|NCT00804401|Analgesics|analgesics|mesh-ancestor
24456126|NCT00330148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555913|NCT00664521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25555914|NCT00664521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25555915|NCT00664521|Immunologic Factors|immunologic factors|mesh-ancestor
25555916|NCT00664521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555917|NCT00664521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25555918|NCT00664534|Insulin|insulin|mesh-list
25555919|NCT00664534|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25555920|NCT00664534|Insulin Glargine|insulin glargine|mesh-list
25555921|NCT00664534|Insulin Lispro|insulin lispro|mesh-list
25555922|NCT00664534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25555923|NCT00664534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555924|NCT00664560|Celecoxib|celecoxib|mesh-list
25555925|NCT00664560|Antacids|antacids|mesh-list
25264743|NCT02438657|Lidocaine|lidocaine|mesh-list
25555926|NCT00664560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25555927|NCT00664560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25555928|NCT00664560|Analgesics|analgesics|mesh-ancestor
25555929|NCT00664560|Sensory System Agents|sensory system agents|mesh-ancestor
25555930|NCT00664560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25555931|NCT00664560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555932|NCT00664560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25555933|NCT00664560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25555934|NCT00664560|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25555935|NCT00664560|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25555936|NCT00664560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555937|NCT00664560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555938|NCT00664560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25555939|NCT00664755|Nicotine|nicotine|mesh-list
25555940|NCT00664755|Varenicline|varenicline|mesh-list
25555941|NCT00664755|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25555942|NCT00664755|Autonomic Agents|autonomic agents|mesh-ancestor
25555943|NCT00664755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24855495|NCT02279914|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24637435|NCT01150318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25555944|NCT00664755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555945|NCT00664755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25555946|NCT00664755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25555947|NCT00664755|Cholinergic Agents|cholinergic agents|mesh-ancestor
25555948|NCT00664755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25555949|NCT00664755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555950|NCT00664859|Atorvastatin|atorvastatin|mesh-list
25555951|NCT00664859|Fenofibrate|fenofibrate|mesh-list
25555952|NCT00664859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24637816|NCT01153217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25555953|NCT00664859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25555954|NCT00664859|Antimetabolites|antimetabolites|mesh-ancestor
25555955|NCT00664859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555956|NCT00664859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25555957|NCT00664859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25555958|NCT00664859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555959|NCT00665002|Sargramostim|sargramostim|mesh-list
25451277|NCT04588935|Bisoprolol|bisoprolol|mesh-list
25555960|NCT00665002|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25555961|NCT00665002|Immunologic Factors|immunologic factors|mesh-ancestor
25555962|NCT00665002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555963|NCT00665002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25555964|NCT00665353|Pioglitazone|pioglitazone|mesh-list
25555965|NCT00665353|Ribavirin|ribavirin|mesh-list
25555966|NCT00665353|Antimetabolites|antimetabolites|mesh-ancestor
25555967|NCT00665353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555968|NCT00665353|Antiviral Agents|antiviral agents|mesh-ancestor
25555969|NCT00665353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25555970|NCT00665353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25555971|NCT00665353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555972|NCT00665366|Valproic Acid|valproic acid|mesh-list
25555973|NCT00665366|Aripiprazole|aripiprazole|mesh-list
25555974|NCT00665366|Antidepressive Agents|antidepressive agents|mesh-ancestor
25555975|NCT00665366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25555976|NCT00665366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24637898|NCT01153828|Fusidic Acid|fusidic acid|mesh-list
24637899|NCT01153828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24637900|NCT01153828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24637934|NCT01154348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24638049|NCT01154738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24638050|NCT01154738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638051|NCT01154738|Sensory System Agents|sensory system agents|mesh-ancestor
24638052|NCT01154738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24638053|NCT01154738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24638054|NCT01154738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24638055|NCT01154738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24638056|NCT01154738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25555977|NCT00665366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25555978|NCT00665366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25555979|NCT00665366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25555980|NCT00665366|Dopamine Agonists|dopamine agonists|mesh-ancestor
25555981|NCT00665366|Dopamine Agents|dopamine agents|mesh-ancestor
25555982|NCT00665366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25555983|NCT00665366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25555984|NCT00665366|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25264853|NCT02438072|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25555985|NCT00665366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25555986|NCT00665366|Serotonin Agents|serotonin agents|mesh-ancestor
25555987|NCT00665366|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25555988|NCT00665366|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25555989|NCT00665366|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25555990|NCT00665366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25555991|NCT00665366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25555992|NCT00665366|Antimanic Agents|antimanic agents|mesh-ancestor
25555993|NCT00665366|Anticonvulsants|anticonvulsants|mesh-ancestor
25555994|NCT00665366|GABA Agents|gaba agents|mesh-ancestor
25555995|NCT00665392|Cisplatin|cisplatin|mesh-list
25555996|NCT00665392|Docetaxel|docetaxel|mesh-list
24638183|NCT01155115|Vasodilator Agents|vasodilator agents|mesh-ancestor
25555997|NCT00665392|Fluorouracil|fluorouracil|mesh-list
25555998|NCT00665392|Cetuximab|cetuximab|mesh-list
25555999|NCT00665392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25556000|NCT00665392|Tubulin Modulators|tubulin modulators|mesh-ancestor
25556001|NCT00665392|Antimitotic Agents|antimitotic agents|mesh-ancestor
25556002|NCT00665392|Mitosis Modulators|mitosis modulators|mesh-ancestor
25556003|NCT00665392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556004|NCT00665392|Antimetabolites|antimetabolites|mesh-ancestor
25556005|NCT00665392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25556006|NCT00665392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25556007|NCT00665392|Immunologic Factors|immunologic factors|mesh-ancestor
25556008|NCT00665392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556009|NCT00665392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25556010|NCT00665431|Celecoxib|celecoxib|mesh-list
25556011|NCT00665431|Antacids|antacids|mesh-list
25556012|NCT00665431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25556013|NCT00665431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25556014|NCT00665431|Analgesics|analgesics|mesh-ancestor
25556015|NCT00665431|Sensory System Agents|sensory system agents|mesh-ancestor
25556016|NCT00665431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24573073|NCT00817739|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25556017|NCT00665431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556018|NCT00665431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25556019|NCT00665431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25556020|NCT00665431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25556021|NCT00665431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25556022|NCT00665431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556023|NCT00665431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556024|NCT00665431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25556025|NCT00665457|Celecoxib|celecoxib|mesh-list
25556026|NCT00665457|Cyclophosphamide|cyclophosphamide|mesh-list
25556027|NCT00665457|Docetaxel|docetaxel|mesh-list
25556028|NCT00665457|Doxorubicin|doxorubicin|mesh-list
25556029|NCT00665457|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25556030|NCT00665457|Capecitabine|capecitabine|mesh-list
25556031|NCT00665457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25556032|NCT00665457|Immunologic Factors|immunologic factors|mesh-ancestor
25451326|NCT04588441|Purinergic Agents|purinergic agents|mesh-ancestor
25556033|NCT00665457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556034|NCT00665457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25556035|NCT00665457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25556036|NCT00665457|Alkylating Agents|alkylating agents|mesh-ancestor
24639133|NCT01160315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24639134|NCT01160315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639136|NCT01160315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25556037|NCT00665457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556038|NCT00665457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25556039|NCT00665457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25556040|NCT00665457|Tubulin Modulators|tubulin modulators|mesh-ancestor
25556041|NCT00665457|Antimitotic Agents|antimitotic agents|mesh-ancestor
25556042|NCT00665457|Mitosis Modulators|mitosis modulators|mesh-ancestor
25556043|NCT00665457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25556044|NCT00665457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25556045|NCT00665457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25556046|NCT00665457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24964365|NCT03783754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25556047|NCT00665457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25556048|NCT00665457|Antimetabolites|antimetabolites|mesh-ancestor
25556049|NCT00665457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25556050|NCT00665457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25556052|NCT00665457|Sensory System Agents|sensory system agents|mesh-ancestor
25556053|NCT00665457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25556054|NCT00665457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25556055|NCT00665457|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25556056|NCT00665457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25556057|NCT00665470|Aldesleukin|aldesleukin|mesh-list
24948978|NCT05400902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24948979|NCT05400902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24948980|NCT05400902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948981|NCT05400889|Tofacitinib|tofacitinib|mesh-list
24630494|NCT01111942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24630495|NCT01111942|Immunologic Factors|immunologic factors|mesh-ancestor
25556058|NCT00665470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25556059|NCT00665470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25556060|NCT00665470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25556061|NCT00665470|Antiviral Agents|antiviral agents|mesh-ancestor
25451393|NCT04587843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451394|NCT04587843|Dopamine Agents|dopamine agents|mesh-ancestor
25451395|NCT04587843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25451396|NCT04587843|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25451397|NCT04587843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25451398|NCT04587843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451399|NCT04587843|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25451400|NCT04587778|Ketamine|ketamine|mesh-list
25451401|NCT04587778|Esketamine|esketamine|mesh-list
25451402|NCT04587778|Analgesics|analgesics|mesh-ancestor
25451403|NCT04587778|Sensory System Agents|sensory system agents|mesh-ancestor
25451404|NCT04587778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451405|NCT04587778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451406|NCT04587778|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25451407|NCT04587778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25451408|NCT04587778|Anesthetics, General|anesthetics, general|mesh-ancestor
25451409|NCT04587778|Anesthetics|anesthetics|mesh-ancestor
24949311|NCT04982146|Expectorants|expectorants|mesh-ancestor
24949313|NCT04982146|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25451410|NCT04587778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25451411|NCT04587778|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25451412|NCT04587778|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24640215|NCT01166815|Astringents|astringents|mesh-ancestor
25451413|NCT04587778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25451414|NCT04587778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451415|NCT04587778|Antidepressive Agents|antidepressive agents|mesh-ancestor
25451416|NCT04587778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25451417|NCT04587505|Morphine|morphine|mesh-list
25556062|NCT00665470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25556063|NCT00665561|Maraviroc|maraviroc|mesh-list
25556064|NCT00665561|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25556065|NCT00665561|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25556066|NCT00665561|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25556067|NCT00665561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556068|NCT00665561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25556069|NCT00665561|Antiviral Agents|antiviral agents|mesh-ancestor
25556070|NCT00665561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25556071|NCT00665561|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25556072|NCT00665652|Lenalidomide|lenalidomide|mesh-list
25556073|NCT00665652|Immunologic Factors|immunologic factors|mesh-ancestor
25556074|NCT00665652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556075|NCT00665652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25556076|NCT00665652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25556077|NCT00665652|Growth Substances|growth substances|mesh-ancestor
25556078|NCT00665652|Growth Inhibitors|growth inhibitors|mesh-ancestor
25556079|NCT00665652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24949625|NCT04006288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25556080|NCT00665847|Etravirine|etravirine|mesh-list
25556081|NCT00665847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25556082|NCT00665847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25556083|NCT00665847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556084|NCT00665847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556085|NCT00665847|Antiviral Agents|antiviral agents|mesh-ancestor
25556086|NCT00665847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25556087|NCT00666029|Atorvastatin|atorvastatin|mesh-list
25556088|NCT00666029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25556089|NCT00666029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25556090|NCT00666029|Antimetabolites|antimetabolites|mesh-ancestor
25556091|NCT00666029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556092|NCT00666029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25556093|NCT00666029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25556094|NCT00666029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556095|NCT00666198|Sildenafil Citrate|sildenafil citrate|mesh-list
25556096|NCT00666198|Vasodilator Agents|vasodilator agents|mesh-ancestor
24804002|NCT02000336|Hormones|hormones|mesh-ancestor
25556097|NCT00666198|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25556098|NCT00666198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25556099|NCT00666198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556100|NCT00666198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556101|NCT00666198|Urological Agents|urological agents|mesh-ancestor
25556102|NCT00666224|Glatiramer Acetate|glatiramer acetate|mesh-list
25556103|NCT00666224|(T,G)-A-L|(t,g)-a-l|mesh-list
25556104|NCT00666224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25556105|NCT00666224|Immunologic Factors|immunologic factors|mesh-ancestor
25556106|NCT00666224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556107|NCT00666224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25556108|NCT00666224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25556109|NCT00666263|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25556110|NCT00666263|Immunoglobulins|immunoglobulins|mesh-list
25556111|NCT00666263|Antibodies|antibodies|mesh-list
25556112|NCT00666263|gamma-Globulins|gamma-globulins|mesh-list
25556113|NCT00666263|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25556114|NCT00666263|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25556115|NCT00666263|Immunologic Factors|immunologic factors|mesh-ancestor
25556116|NCT00666263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556117|NCT00666276|Linezolid|linezolid|mesh-list
25556118|NCT00666276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25556119|NCT00666276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25556120|NCT00666276|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25556121|NCT00666276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556122|NCT00666276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556123|NCT00666328|Clevidipine|clevidipine|mesh-list
25556124|NCT00666328|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25556125|NCT00666328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24576571|NCT00839345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25556126|NCT00666328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556127|NCT00666328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25556128|NCT00666328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556129|NCT00666406|Factor VIII|factor viii|mesh-list
25556130|NCT00666406|Coagulants|coagulants|mesh-ancestor
25556131|NCT00666458|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25556132|NCT00666458|Saxagliptin|saxagliptin|mesh-list
25556133|NCT00666458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25556134|NCT00666458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556135|NCT00666458|Incretins|incretins|mesh-ancestor
25556136|NCT00666458|Hormones|hormones|mesh-ancestor
25556137|NCT00666458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25556138|NCT00666458|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25556139|NCT00666458|Protease Inhibitors|protease inhibitors|mesh-ancestor
25556140|NCT00666458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642215|NCT01178203|Gout Suppressants|gout suppressants|mesh-ancestor
25556141|NCT00666458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556142|NCT00666536|Amlodipine|amlodipine|mesh-list
25556143|NCT00666536|Valsartan|valsartan|mesh-list
25556144|NCT00666536|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
25556145|NCT00666536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25556146|NCT00666536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25556147|NCT00666536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25556148|NCT00666536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556149|NCT00666536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25556150|NCT00666536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556151|NCT00666536|Vasodilator Agents|vasodilator agents|mesh-ancestor
25556152|NCT00666536|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25556153|NCT00666536|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25556154|NCT00666562|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24626207|NCT01085981|Vitamins|vitamins|mesh-ancestor
24576635|NCT00839488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576636|NCT00839488|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24642657|NCT01180426|Tosedostat|tosedostat|mesh-list
24642664|NCT01180569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24642668|NCT01180621|Vaccines|vaccines|mesh-list
25556155|NCT00666562|Antioxidants|antioxidants|mesh-ancestor
25556156|NCT00666562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556157|NCT00666562|Protective Agents|protective agents|mesh-ancestor
25556158|NCT00666562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556159|NCT00666562|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25556160|NCT00666562|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25556161|NCT00666562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25556162|NCT00666562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25556163|NCT00666588|Cytarabine|cytarabine|mesh-list
25556164|NCT00666588|Etoposide|etoposide|mesh-list
25556165|NCT00666588|Idarubicin|idarubicin|mesh-list
25556166|NCT00666588|Bortezomib|bortezomib|mesh-list
24965898|NCT03773367|Fluorouracil|fluorouracil|mesh-list
25556167|NCT00666588|Etoposide phosphate|etoposide phosphate|mesh-list
25556168|NCT00666588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25556169|NCT00666588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25556170|NCT00666588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25556171|NCT00666588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25556172|NCT00666588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556173|NCT00666588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556174|NCT00666588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25556175|NCT00666588|Antimetabolites|antimetabolites|mesh-ancestor
25556176|NCT00666588|Antiviral Agents|antiviral agents|mesh-ancestor
25556177|NCT00666588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25556178|NCT00666588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25556179|NCT00666588|Immunologic Factors|immunologic factors|mesh-ancestor
25556180|NCT00666588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556181|NCT00666588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25556182|NCT00666666|Acetic Acid|acetic acid|mesh-list
25556183|NCT00666666|Bicalutamide|bicalutamide|mesh-list
25556184|NCT00666666|Gossypol acetic acid|gossypol acetic acid|mesh-list
25556185|NCT00666666|Gossypol|gossypol|mesh-list
25556186|NCT00666666|Hormones|hormones|mesh-list
25556187|NCT00666666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25556188|NCT00666666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556189|NCT00666666|Androgen Antagonists|androgen antagonists|mesh-ancestor
25556190|NCT00666666|Hormone Antagonists|hormone antagonists|mesh-ancestor
25556191|NCT00666666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25556192|NCT00666666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24515629|NCT00598533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417636|NCT00206986|Clonidine|clonidine|mesh-list
25556193|NCT00666666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25556194|NCT00666666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25556195|NCT00666666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25556196|NCT00666666|Contraceptive Agents|contraceptive agents|mesh-ancestor
25556197|NCT00666666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25556198|NCT00666666|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
25556199|NCT00666666|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
25556200|NCT00666666|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25556201|NCT00666679|Mometasone Furoate|mometasone furoate|mesh-list
25556202|NCT00666679|Montelukast|montelukast|mesh-list
25556203|NCT00666679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25556204|NCT00666679|Respiratory System Agents|respiratory system agents|mesh-ancestor
25556205|NCT00666679|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25556206|NCT00666679|Hormone Antagonists|hormone antagonists|mesh-ancestor
25556207|NCT00666679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25556208|NCT00666679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576905|NCT00840918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25556209|NCT00666679|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25556210|NCT00666679|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25556211|NCT00666679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556212|NCT00666679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25556213|NCT00666679|Dermatologic Agents|dermatologic agents|mesh-ancestor
25556214|NCT00666679|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25556215|NCT00666705|Raltegravir Potassium|raltegravir potassium|mesh-list
25556216|NCT00666705|Maraviroc|maraviroc|mesh-list
25556217|NCT00666705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25556218|NCT00666705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25556219|NCT00666705|Antiviral Agents|antiviral agents|mesh-ancestor
25556220|NCT00666705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25556221|NCT00666705|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25556222|NCT00666705|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25556223|NCT00666705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951030|NCT03908944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25556224|NCT00666705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556225|NCT00666705|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25556226|NCT00666705|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25556227|NCT00666705|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25556228|NCT00666718|Insulin|insulin|mesh-list
25556229|NCT00666718|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25556230|NCT00666718|Insulin Glargine|insulin glargine|mesh-list
25556231|NCT00666718|Insulin Lispro|insulin lispro|mesh-list
25556232|NCT00666718|Protamines|protamines|mesh-list
25556233|NCT00666718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25556234|NCT00666718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556235|NCT00666718|Heparin Antagonists|heparin antagonists|mesh-ancestor
25556236|NCT00666718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556237|NCT00666718|Coagulants|coagulants|mesh-ancestor
25050397|NCT00508989|Niacin|niacin|mesh-list
24643229|NCT01184638|Sevoflurane|sevoflurane|mesh-list
25556238|NCT00666757|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25556240|NCT00666757|Fluoxetine|fluoxetine|mesh-list
25556241|NCT00666757|Paroxetine|paroxetine|mesh-list
25556242|NCT00666757|Citalopram|citalopram|mesh-list
25556243|NCT00666757|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25556244|NCT00666757|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25556245|NCT00666757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25556246|NCT00666757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556247|NCT00666757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25556248|NCT00666757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556249|NCT00666757|Analgesics|analgesics|mesh-ancestor
25556250|NCT00666757|Sensory System Agents|sensory system agents|mesh-ancestor
25556251|NCT00666757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25556252|NCT00666757|Antidepressive Agents|antidepressive agents|mesh-ancestor
25556253|NCT00666757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25556254|NCT00666757|Dopamine Agents|dopamine agents|mesh-ancestor
25556255|NCT00666757|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25556256|NCT00666757|Serotonin Agents|serotonin agents|mesh-ancestor
25556257|NCT00666757|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25556258|NCT00666757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25556259|NCT00666757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25556260|NCT00666757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556261|NCT00666835|Epoetin Alfa|epoetin alfa|mesh-list
25556262|NCT00666835|Hematinics|hematinics|mesh-ancestor
25556263|NCT00666848|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25556264|NCT00666848|Enalapril|enalapril|mesh-list
25556265|NCT00666848|Enalaprilat|enalaprilat|mesh-list
25556266|NCT00666848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25556267|NCT00666848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556268|NCT00666848|Incretins|incretins|mesh-ancestor
25556269|NCT00666848|Hormones|hormones|mesh-ancestor
25556270|NCT00666848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25556271|NCT00666848|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25556272|NCT00666848|Protease Inhibitors|protease inhibitors|mesh-ancestor
25556273|NCT00666848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556274|NCT00666848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556275|NCT00666848|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25556276|NCT00666848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25556277|NCT00666965|Rotigotine|rotigotine|mesh-list
25556278|NCT00666965|Dopamine Agonists|dopamine agonists|mesh-ancestor
25556279|NCT00666965|Dopamine Agents|dopamine agents|mesh-ancestor
25556280|NCT00666965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25556281|NCT00666965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643818|NCT01187537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643819|NCT01187537|Sensory System Agents|sensory system agents|mesh-ancestor
24643820|NCT01187537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24643821|NCT01187589|Albuterol|albuterol|mesh-list
24643822|NCT01187589|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24643823|NCT01187589|Autonomic Agents|autonomic agents|mesh-ancestor
24643864|NCT01187862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643866|NCT01187862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25556282|NCT00666965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556283|NCT00666978|Bupropion|bupropion|mesh-list
25556284|NCT00666978|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25556285|NCT00666978|Antidepressive Agents|antidepressive agents|mesh-ancestor
25556286|NCT00666978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25556287|NCT00666978|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25556288|NCT00666978|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25556289|NCT00666978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25556290|NCT00666978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556291|NCT00666978|Dopamine Agents|dopamine agents|mesh-ancestor
25556292|NCT00666978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25556293|NCT00666978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556294|NCT00666978|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25556295|NCT00666978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25556296|NCT00666978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556297|NCT00667004|Ecabet|ecabet|mesh-list
25556298|NCT00667004|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25556299|NCT00667004|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25556300|NCT00667004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25556301|NCT00667004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25556302|NCT00667004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25556303|NCT00667004|Protease Inhibitors|protease inhibitors|mesh-ancestor
24644135|NCT01189253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24644136|NCT01189253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24644137|NCT01189253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855950|NCT02281968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24855951|NCT02281968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693083|NCT01418157|Acetazolamide|acetazolamide|mesh-list
25556304|NCT00667004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556305|NCT00667004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451568|NCT04585490|Paclitaxel|paclitaxel|mesh-list
25556306|NCT00667004|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25556307|NCT00667004|Protective Agents|protective agents|mesh-ancestor
25556308|NCT00667004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556309|NCT00667004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25556310|NCT00667095|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25556311|NCT00667095|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
25556312|NCT00667095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25556313|NCT00667095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25556314|NCT00667095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556315|NCT00667095|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25556316|NCT00667095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24449635|NCT00316407|Paclitaxel|paclitaxel|mesh-list
25556317|NCT00667095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556318|NCT00667095|Cholinergic Agents|cholinergic agents|mesh-ancestor
25556319|NCT00667095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25556320|NCT00667095|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25556321|NCT00667095|Protective Agents|protective agents|mesh-ancestor
25556322|NCT00667095|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25556323|NCT00667095|Antioxidants|antioxidants|mesh-ancestor
25556324|NCT00667225|Cantharidin|cantharidin|mesh-list
25556325|NCT00667225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556326|NCT00667225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556327|NCT00667277|Bevacizumab|bevacizumab|mesh-list
25556328|NCT00667277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25556329|NCT00667277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25556330|NCT00667277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25556331|NCT00667277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25556332|NCT00667277|Growth Substances|growth substances|mesh-ancestor
25556333|NCT00667277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556334|NCT00667277|Growth Inhibitors|growth inhibitors|mesh-ancestor
25556335|NCT00667342|Bevacizumab|bevacizumab|mesh-list
25556336|NCT00667342|Cisplatin|cisplatin|mesh-list
25556337|NCT00667342|Doxorubicin|doxorubicin|mesh-list
25556338|NCT00667342|Methotrexate|methotrexate|mesh-list
25556339|NCT00667342|Etoposide|etoposide|mesh-list
25556340|NCT00667342|Ifosfamide|ifosfamide|mesh-list
25556341|NCT00667342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25556342|NCT00667342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25556343|NCT00667342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25556344|NCT00667342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25265554|NCT02433041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556345|NCT00667342|Growth Substances|growth substances|mesh-ancestor
25556346|NCT00667342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556347|NCT00667342|Growth Inhibitors|growth inhibitors|mesh-ancestor
25556348|NCT00667342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25556349|NCT00667342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25556350|NCT00667342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25556351|NCT00667342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556352|NCT00667342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556353|NCT00667342|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25556354|NCT00667342|Abortifacient Agents|abortifacient agents|mesh-ancestor
25556355|NCT00667342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25556356|NCT00667342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25556357|NCT00667342|Antimetabolites|antimetabolites|mesh-ancestor
25556358|NCT00667342|Dermatologic Agents|dermatologic agents|mesh-ancestor
25556359|NCT00667342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25556360|NCT00667342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25556361|NCT00667342|Immunologic Factors|immunologic factors|mesh-ancestor
25556362|NCT00667342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25556363|NCT00667342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25556364|NCT00667342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25556365|NCT00667342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25556366|NCT00667342|Alkylating Agents|alkylating agents|mesh-ancestor
25556367|NCT00667355|Adalimumab|adalimumab|mesh-list
25556368|NCT00667355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25556369|NCT00667355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25556370|NCT00667368|Metronidazole|metronidazole|mesh-list
25556371|NCT00667368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25556372|NCT00667368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25556373|NCT00667368|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24645827|NCT01200121|Bevacizumab|bevacizumab|mesh-list
25265584|NCT02432976|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25556374|NCT00667368|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25556375|NCT00667394|Bevacizumab|bevacizumab|mesh-list
25556376|NCT00667394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25556377|NCT00667394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25556378|NCT00667394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25556379|NCT00667394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25556380|NCT00667394|Growth Substances|growth substances|mesh-ancestor
25451690|NCT04584580|Heparin|heparin|mesh-list
25451691|NCT04584580|Enoxaparin|enoxaparin|mesh-list
25451692|NCT04584580|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24856087|NCT02282774|Anesthetics|anesthetics|mesh-ancestor
24856088|NCT02282774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24856089|NCT02282774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265609|NCT02432781|Insulin|insulin|mesh-list
25451693|NCT04584580|Tinzaparin|tinzaparin|mesh-list
25451694|NCT04584580|Dalteparin|dalteparin|mesh-list
25451695|NCT04584580|Anticoagulants|anticoagulants|mesh-ancestor
25451696|NCT04584580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25451697|NCT04584580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25451698|NCT04584580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307372|NCT04283604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307373|NCT04283604|Dopamine Agents|dopamine agents|mesh-ancestor
25307374|NCT04283604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25307375|NCT04266938|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25307376|NCT04266938|Antiviral Agents|antiviral agents|mesh-ancestor
25265629|NCT02432612|Analgesics|analgesics|mesh-ancestor
25265630|NCT02432612|Sensory System Agents|sensory system agents|mesh-ancestor
25265631|NCT02432612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25265632|NCT02432612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265633|NCT02432677|Remifentanil|remifentanil|mesh-list
25265634|NCT02432677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25265635|NCT02432677|Narcotics|narcotics|mesh-ancestor
24646075|NCT01201902|Vaccines|vaccines|mesh-list
25307377|NCT04266938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25307378|NCT04231331|Ertugliflozin|ertugliflozin|mesh-list
25307379|NCT04231331|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24896211|NCT01117441|Cytarabine|cytarabine|mesh-list
25307380|NCT04231331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307381|NCT04231331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25307382|NCT04231331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307383|NCT04214834|Morphine|morphine|mesh-list
25307384|NCT04214834|Methadone|methadone|mesh-list
25307385|NCT04214834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25307386|NCT04214834|Narcotics|narcotics|mesh-ancestor
25307394|NCT04198506|Tacrolimus|tacrolimus|mesh-list
24419883|NCT00214331|Azithromycin|azithromycin|mesh-list
24419884|NCT00214331|Ciprofloxacin|ciprofloxacin|mesh-list
24419885|NCT00214331|Gentamicins|gentamicins|mesh-list
24419886|NCT00214331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24419887|NCT00214331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24419888|NCT00214331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24419889|NCT00214331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24419891|NCT00214331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822638|NCT00004578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25822639|NCT00004578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25822640|NCT00004578|Antimetabolites|antimetabolites|mesh-ancestor
25822641|NCT00004580|Ritonavir|ritonavir|mesh-list
24978553|NCT03948035|Autonomic Agents|autonomic agents|mesh-ancestor
24978554|NCT03948035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24978555|NCT03948035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978556|NCT03948035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24978557|NCT03948035|Glucocorticoids|glucocorticoids|mesh-ancestor
24978559|NCT03948035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24978560|NCT03948035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24978561|NCT03948035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161849|NCT02269670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24419911|NCT00214435|Antiviral Agents|antiviral agents|mesh-ancestor
24419912|NCT00214435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24419913|NCT00214552|Rabeprazole|rabeprazole|mesh-list
24419914|NCT00214552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25556381|NCT00667394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556382|NCT00667394|Growth Inhibitors|growth inhibitors|mesh-ancestor
25556383|NCT00667420|Oxaliplatin|oxaliplatin|mesh-list
25556384|NCT00667420|Epirubicin|epirubicin|mesh-list
25556385|NCT00667420|Panitumumab|panitumumab|mesh-list
25556386|NCT00667420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25556387|NCT00667420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556388|NCT00667420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25556389|NCT00667420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25556390|NCT00667420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25556391|NCT00667420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275397|NCT02372461|Amoxicillin|amoxicillin|mesh-list
24856387|NCT02284048|Ticagrelor|ticagrelor|mesh-list
25556392|NCT00667420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25556393|NCT00667446|Leuprolide|leuprolide|mesh-list
25556394|NCT00667446|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25556395|NCT00667446|Fertility Agents|fertility agents|mesh-ancestor
25556396|NCT00667446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25556397|NCT00667446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556398|NCT00667446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25556399|NCT00667446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25556400|NCT00667576|Maxacalcitol|maxacalcitol|mesh-list
25556401|NCT00667576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25556402|NCT00667576|Dermatologic Agents|dermatologic agents|mesh-ancestor
24646536|NCT01204190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25556403|NCT00667576|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25556404|NCT00667576|Protective Agents|protective agents|mesh-ancestor
25556405|NCT00667576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556406|NCT00667589|Fluocinonide|fluocinonide|mesh-list
25556407|NCT00667589|Tazarotene|tazarotene|mesh-list
25556408|NCT00667589|Emollients|emollients|mesh-list
25556409|NCT00667589|Dermatologic Agents|dermatologic agents|mesh-ancestor
25556410|NCT00667589|Keratolytic Agents|keratolytic agents|mesh-ancestor
25556411|NCT00667589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25556412|NCT00667589|Glucocorticoids|glucocorticoids|mesh-ancestor
25556413|NCT00667589|Hormones|hormones|mesh-ancestor
25556414|NCT00667589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25556415|NCT00667589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556416|NCT00667589|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25556417|NCT00667615|Prednisone|prednisone|mesh-list
25556418|NCT00667615|Cyclophosphamide|cyclophosphamide|mesh-list
25556419|NCT00667615|Rituximab|rituximab|mesh-list
25556420|NCT00667615|Etoposide|etoposide|mesh-list
25556421|NCT00667615|Vorinostat|vorinostat|mesh-list
25556422|NCT00667615|Lenograstim|lenograstim|mesh-list
25556423|NCT00667615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25556424|NCT00667615|Immunologic Factors|immunologic factors|mesh-ancestor
25556425|NCT00667615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556426|NCT00667615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25556427|NCT00667615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25556428|NCT00667615|Alkylating Agents|alkylating agents|mesh-ancestor
25556429|NCT00667615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556430|NCT00667615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25556431|NCT00667615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25556432|NCT00667615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25556433|NCT00667615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25556434|NCT00667615|Glucocorticoids|glucocorticoids|mesh-ancestor
25556435|NCT00667615|Hormones|hormones|mesh-ancestor
25556436|NCT00667615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25556437|NCT00667615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25556438|NCT00667615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25556439|NCT00667615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25556440|NCT00667615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25556441|NCT00667615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556442|NCT00667615|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25556443|NCT00667615|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25556444|NCT00667719|Amlodipine|amlodipine|mesh-list
25556445|NCT00667719|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24646727|NCT01205022|Calcium, Dietary|calcium, dietary|mesh-list
25556446|NCT00667719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25556447|NCT00667719|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25556448|NCT00667719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25556449|NCT00667719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556450|NCT00667719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25556451|NCT00667719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556452|NCT00667719|Vasodilator Agents|vasodilator agents|mesh-ancestor
25556453|NCT00667719|Diuretics|diuretics|mesh-ancestor
25556454|NCT00667719|Natriuretic Agents|natriuretic agents|mesh-ancestor
25556455|NCT00667719|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25556456|NCT00667732|Exenatide|exenatide|mesh-list
25556457|NCT00667732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25556458|NCT00667732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556459|NCT00667732|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25556460|NCT00667732|Incretins|incretins|mesh-ancestor
25556461|NCT00667732|Hormones|hormones|mesh-ancestor
25556462|NCT00667732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25556463|NCT00667745|Lithium Carbonate|lithium carbonate|mesh-list
25556464|NCT00667745|Antidepressive Agents|antidepressive agents|mesh-ancestor
25556465|NCT00667745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25556466|NCT00667745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556467|NCT00667745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556468|NCT00667745|Antimanic Agents|antimanic agents|mesh-ancestor
25556469|NCT00667745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25556470|NCT00667745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25556471|NCT00667745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556472|NCT00667862|Panobinostat|panobinostat|mesh-list
25556473|NCT00667862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25556474|NCT00667862|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25556475|NCT00667862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556476|NCT00667862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556477|NCT00667875|Naltrexone|naltrexone|mesh-list
25556478|NCT00667875|Aripiprazole|aripiprazole|mesh-list
25556479|NCT00667875|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25556480|NCT00667875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25451699|NCT04584749|Lidocaine|lidocaine|mesh-list
25556481|NCT00667875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556482|NCT00667875|Sensory System Agents|sensory system agents|mesh-ancestor
25556483|NCT00667875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25556484|NCT00667875|Antidepressive Agents|antidepressive agents|mesh-ancestor
25556485|NCT00667875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25556486|NCT00667875|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25556487|NCT00667875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25556488|NCT00667875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25556489|NCT00667875|Dopamine Agonists|dopamine agonists|mesh-ancestor
25556490|NCT00667875|Dopamine Agents|dopamine agents|mesh-ancestor
25556491|NCT00667875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25556492|NCT00667875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556493|NCT00667875|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25556494|NCT00667875|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25556495|NCT00667875|Serotonin Agents|serotonin agents|mesh-ancestor
25556496|NCT00667875|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25556497|NCT00667875|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25556498|NCT00667875|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25556499|NCT00667875|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25556500|NCT00667992|Budesonide|budesonide|mesh-list
25556501|NCT00667992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25556502|NCT00667992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25556503|NCT00667992|Autonomic Agents|autonomic agents|mesh-ancestor
25556504|NCT00667992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25556505|NCT00667992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556506|NCT00667992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25556507|NCT00667992|Respiratory System Agents|respiratory system agents|mesh-ancestor
25556508|NCT00667992|Glucocorticoids|glucocorticoids|mesh-ancestor
25556509|NCT00667992|Hormones|hormones|mesh-ancestor
25556510|NCT00667992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25556511|NCT00668148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25556512|NCT00668148|Immunologic Factors|immunologic factors|mesh-ancestor
25556513|NCT00668148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556514|NCT00668200|Vitamin D|vitamin d|mesh-list
25556515|NCT00668200|Zoledronic Acid|zoledronic acid|mesh-list
25556516|NCT00668200|Calcium|calcium|mesh-list
25556517|NCT00668200|Vitamins|vitamins|mesh-ancestor
25556518|NCT00668200|Micronutrients|micronutrients|mesh-ancestor
25556519|NCT00668200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556520|NCT00668200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25556521|NCT00668200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25556522|NCT00668317|Omeprazole|omeprazole|mesh-list
25556523|NCT00668317|Ranitidine|ranitidine|mesh-list
25556524|NCT00668317|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
25556525|NCT00668317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24863122|NCT03065244|Infliximab|infliximab|mesh-list
25265873|NCT02431013|Cilostazol|cilostazol|mesh-list
25556526|NCT00668317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25556527|NCT00668317|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25556528|NCT00668317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556529|NCT00668317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856725|NCT02286609|Deflazacort|deflazacort|mesh-list
25556530|NCT00668317|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25556531|NCT00668317|Histamine Antagonists|histamine antagonists|mesh-ancestor
25556532|NCT00668317|Histamine Agents|histamine agents|mesh-ancestor
25556533|NCT00668317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25556534|NCT00668317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556535|NCT00668395|Efavirenz|efavirenz|mesh-list
25556536|NCT00668395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25556537|NCT00668395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25556538|NCT00668395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265918|NCT02430896|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25265924|NCT02430896|Dopamine Agents|dopamine agents|mesh-ancestor
25556539|NCT00668395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556540|NCT00668395|Antiviral Agents|antiviral agents|mesh-ancestor
25556541|NCT00668395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25556542|NCT00668395|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25556543|NCT00668395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25556544|NCT00668395|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25556545|NCT00668395|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25556546|NCT00668395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25556547|NCT00668395|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25556548|NCT00668434|Prednisone|prednisone|mesh-list
25556549|NCT00668434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25556550|NCT00668434|Glucocorticoids|glucocorticoids|mesh-ancestor
25556551|NCT00668434|Hormones|hormones|mesh-ancestor
25556552|NCT00668434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25556553|NCT00668434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556554|NCT00668434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25556555|NCT00668434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25556556|NCT00668525|Dexetimide|dexetimide|mesh-list
25556557|NCT00668525|Citalopram|citalopram|mesh-list
25556558|NCT00668525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25556559|NCT00668525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25556560|NCT00668525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25688992|NCT01953328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25275412|NCT02372604|Cetirizine|cetirizine|mesh-list
25556561|NCT00668525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556562|NCT00668525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25556563|NCT00668525|Serotonin Agents|serotonin agents|mesh-ancestor
25556564|NCT00668525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556565|NCT00668525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25556566|NCT00668525|Antidepressive Agents|antidepressive agents|mesh-ancestor
25556567|NCT00668525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25556568|NCT00668525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25556569|NCT00668525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25556570|NCT00668525|Parasympatholytics|parasympatholytics|mesh-ancestor
25556571|NCT00668525|Autonomic Agents|autonomic agents|mesh-ancestor
25556572|NCT00668525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25052706|NCT00215852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556573|NCT00668525|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25556574|NCT00668525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25556575|NCT00668525|Cholinergic Agents|cholinergic agents|mesh-ancestor
25556576|NCT00668564|Cyclophosphamide|cyclophosphamide|mesh-list
25556577|NCT00668564|Busulfan|busulfan|mesh-list
25556578|NCT00668564|Alemtuzumab|alemtuzumab|mesh-list
25556579|NCT00668564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25556580|NCT00668564|Immunologic Factors|immunologic factors|mesh-ancestor
25556581|NCT00668564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052791|NCT00141284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24647855|NCT01211158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24647856|NCT01211158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24647857|NCT01211158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24647858|NCT01211158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24647859|NCT01211158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24407264|NCT00173888|Antimitotic Agents|antimitotic agents|mesh-ancestor
25556582|NCT00668564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25556583|NCT00668564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25556584|NCT00668564|Alkylating Agents|alkylating agents|mesh-ancestor
25556585|NCT00668564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556586|NCT00668564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25556587|NCT00668564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25556588|NCT00668564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25556589|NCT00668707|Melatonin|melatonin|mesh-list
25556590|NCT00668707|Antioxidants|antioxidants|mesh-ancestor
24863936|NCT02922985|Antipyretics|antipyretics|mesh-ancestor
25266040|NCT02429973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24648194|NCT01212913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24648364|NCT01213849|Xhance|xhance|mesh-list
25556591|NCT00668707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556592|NCT00668707|Protective Agents|protective agents|mesh-ancestor
25556593|NCT00668707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556594|NCT00668707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25556595|NCT00668746|Minocycline|minocycline|mesh-list
25556596|NCT00668746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25556597|NCT00668746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25556598|NCT00668811|Sunitinib|sunitinib|mesh-list
25556599|NCT00668811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25556600|NCT00668811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25556601|NCT00668811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25556602|NCT00668811|Growth Substances|growth substances|mesh-ancestor
24856900|NCT02287389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556603|NCT00668811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556604|NCT00668811|Growth Inhibitors|growth inhibitors|mesh-ancestor
25556605|NCT00668811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25556606|NCT00668811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556607|NCT00668811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556608|NCT00668863|Leucovorin|leucovorin|mesh-list
25556609|NCT00668863|Fluorouracil|fluorouracil|mesh-list
25556610|NCT00668863|Irinotecan|irinotecan|mesh-list
25556611|NCT00668863|Sunitinib|sunitinib|mesh-list
25556612|NCT00668863|Levoleucovorin|levoleucovorin|mesh-list
25556613|NCT00668863|Antimetabolites|antimetabolites|mesh-ancestor
25556614|NCT00668863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556615|NCT00668863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25556616|NCT00668863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25556617|NCT00668863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25556618|NCT00668863|Immunologic Factors|immunologic factors|mesh-ancestor
25556619|NCT00668863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556620|NCT00668863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25556621|NCT00668863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25556622|NCT00668863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556623|NCT00668863|Antidotes|antidotes|mesh-ancestor
25689006|NCT01953692|Pembrolizumab|pembrolizumab|mesh-list
25556624|NCT00668863|Protective Agents|protective agents|mesh-ancestor
25556625|NCT00668863|Vitamin B Complex|vitamin b complex|mesh-ancestor
25556626|NCT00668863|Vitamins|vitamins|mesh-ancestor
25556627|NCT00668863|Micronutrients|micronutrients|mesh-ancestor
25556628|NCT00668863|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25451871|NCT04582084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451872|NCT04582084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451873|NCT04582084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25451874|NCT04582084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25689017|NCT01953783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864387|NCT04715230|Haloperidol decanoate|haloperidol decanoate|mesh-list
24864388|NCT04715230|Antiemetics|antiemetics|mesh-ancestor
25451875|NCT04582084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25451876|NCT04582084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25451877|NCT04582084|Immunologic Factors|immunologic factors|mesh-ancestor
25307683|NCT03553836|Pembrolizumab|pembrolizumab|mesh-list
25307684|NCT03553836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25307685|NCT03553836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307707|NCT03465592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25307708|NCT03465592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307709|NCT03465592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25307710|NCT03465592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307711|NCT03433313|Trastuzumab|trastuzumab|mesh-list
24544398|NCT00688896|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24544399|NCT00688896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24864510|NCT03686306|Sildenafil Citrate|sildenafil citrate|mesh-list
25266161|NCT02429596|Antimanic Agents|antimanic agents|mesh-ancestor
25266162|NCT02429596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25266163|NCT02429596|Analgesics|analgesics|mesh-ancestor
25266164|NCT02429596|Sensory System Agents|sensory system agents|mesh-ancestor
25266165|NCT02429596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25266166|NCT02429596|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25266168|NCT02429219|Ethanol|ethanol|mesh-list
25307712|NCT03433313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25307713|NCT03433313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307728|NCT03283150|Dexmedetomidine|dexmedetomidine|mesh-list
25307729|NCT03283150|Remifentanil|remifentanil|mesh-list
24419915|NCT00214552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24419916|NCT00214552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24419917|NCT00214552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689033|NCT01954121|Carbamazepine|carbamazepine|mesh-list
24419931|NCT00214604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419932|NCT00214604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24419933|NCT00214604|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24978578|NCT03861078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24978579|NCT03861078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978580|NCT03861078|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24857037|NCT02288923|Analgesics|analgesics|mesh-ancestor
24978581|NCT03861078|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24978582|NCT03861078|Cholinergic Agents|cholinergic agents|mesh-ancestor
24978583|NCT03861078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24978584|NCT03861078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120934|NCT01506986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25120935|NCT01506986|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25120936|NCT01506986|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25120937|NCT01506986|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25120938|NCT01506986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048495|NCT00694135|Autonomic Agents|autonomic agents|mesh-ancestor
24978587|NCT03849443|Vitamins|vitamins|mesh-ancestor
25689056|NCT01954927|Sensory System Agents|sensory system agents|mesh-ancestor
24978588|NCT03849443|Micronutrients|micronutrients|mesh-ancestor
24978589|NCT03849443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649554|NCT01220362|Narcotics|narcotics|mesh-ancestor
24978590|NCT03849443|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24783717|NCT01903421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24783718|NCT01903421|Narcotics|narcotics|mesh-ancestor
24783719|NCT01903421|Analgesics|analgesics|mesh-ancestor
24783720|NCT01903421|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24783721|NCT01903421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24783722|NCT01903421|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24419934|NCT00214604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419935|NCT00214617|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24419936|NCT00214617|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24419937|NCT00214617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25105789|NCT04862949|Bevacizumab|bevacizumab|mesh-list
25556629|NCT00668863|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25556630|NCT00668863|Growth Substances|growth substances|mesh-ancestor
25556631|NCT00668863|Growth Inhibitors|growth inhibitors|mesh-ancestor
25556632|NCT00668863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24649772|NCT01221883|Antiemetics|antiemetics|mesh-ancestor
25556633|NCT00668902|Pantoprazole|pantoprazole|mesh-list
25556634|NCT00668902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25556635|NCT00668902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25556636|NCT00668902|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25556637|NCT00668902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556638|NCT00668902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556639|NCT00669019|Saracatinib|saracatinib|mesh-list
24814088|NCT02062255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556640|NCT00669019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25556641|NCT00669019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556642|NCT00669019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556643|NCT00669032|Hyaluronic Acid|hyaluronic acid|mesh-list
25556644|NCT00669032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25556645|NCT00669032|Immunologic Factors|immunologic factors|mesh-ancestor
25556646|NCT00669032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556647|NCT00669032|Viscosupplements|viscosupplements|mesh-ancestor
25556648|NCT00669032|Protective Agents|protective agents|mesh-ancestor
25556649|NCT00669110|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25689069|NCT01955382|Artesunate|artesunate|mesh-list
25053538|NCT00005918|Antiviral Agents|antiviral agents|mesh-ancestor
25556650|NCT00669110|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25556651|NCT00669110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25556652|NCT00669110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25556653|NCT00669110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556654|NCT00669110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25556655|NCT00669110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556656|NCT00669110|Antidepressive Agents|antidepressive agents|mesh-ancestor
25556657|NCT00669110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25556658|NCT00669162|Docetaxel|docetaxel|mesh-list
25556659|NCT00669162|Leuprolide|leuprolide|mesh-list
25556660|NCT00669162|Goserelin|goserelin|mesh-list
25556661|NCT00669162|Bicalutamide|bicalutamide|mesh-list
25556662|NCT00669162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25556663|NCT00669162|Tubulin Modulators|tubulin modulators|mesh-ancestor
25556664|NCT00669162|Antimitotic Agents|antimitotic agents|mesh-ancestor
25556665|NCT00669162|Mitosis Modulators|mitosis modulators|mesh-ancestor
24952335|NCT03894839|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24952336|NCT03894839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24952337|NCT03894839|Disinfectants|disinfectants|mesh-ancestor
24952338|NCT03894839|Dermatologic Agents|dermatologic agents|mesh-ancestor
24952339|NCT03894826|Vorinostat|vorinostat|mesh-list
24952340|NCT03894826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266273|NCT02428751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25556666|NCT00669162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556667|NCT00669162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25556668|NCT00669162|Fertility Agents|fertility agents|mesh-ancestor
25556669|NCT00669162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25556670|NCT00669162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053730|NCT00004231|Prednisone|prednisone|mesh-list
25556671|NCT00669162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25556672|NCT00669162|Androgen Antagonists|androgen antagonists|mesh-ancestor
25556673|NCT00669162|Hormone Antagonists|hormone antagonists|mesh-ancestor
25556674|NCT00669162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25556675|NCT00669240|Varenicline|varenicline|mesh-list
25556676|NCT00669240|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25556677|NCT00669240|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25556678|NCT00669240|Cholinergic Agents|cholinergic agents|mesh-ancestor
25556679|NCT00669240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25556680|NCT00669240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556681|NCT00669240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556682|NCT00669279|Atenolol|atenolol|mesh-list
25556683|NCT00669279|Carvedilol|carvedilol|mesh-list
24865617|NCT05151796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24865618|NCT05151796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25689103|NCT01955629|Growth Substances|growth substances|mesh-ancestor
24865619|NCT05151796|Analgesics|analgesics|mesh-ancestor
24939362|NCT04010942|Clomiphene|clomiphene|mesh-list
24459719|NCT00346099|Antimetabolites|antimetabolites|mesh-ancestor
25556684|NCT00669279|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25556685|NCT00669279|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25556686|NCT00669279|Adrenergic Agents|adrenergic agents|mesh-ancestor
25556687|NCT00669279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25556688|NCT00669279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556689|NCT00669279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556690|NCT00669279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25556691|NCT00669279|Antioxidants|antioxidants|mesh-ancestor
25556692|NCT00669279|Protective Agents|protective agents|mesh-ancestor
25556693|NCT00669279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25556694|NCT00669279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25556695|NCT00669279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25556696|NCT00669279|Vasodilator Agents|vasodilator agents|mesh-ancestor
25689107|NCT01955707|Immunologic Factors|immunologic factors|mesh-ancestor
25689108|NCT01955707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652497|NCT01238705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24652498|NCT01238705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24652499|NCT01238705|Sympatholytics|sympatholytics|mesh-ancestor
25556697|NCT00669279|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25556698|NCT00669279|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25556699|NCT00669279|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25556700|NCT00669279|Sympatholytics|sympatholytics|mesh-ancestor
25556701|NCT00669279|Autonomic Agents|autonomic agents|mesh-ancestor
25556702|NCT00669279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25556703|NCT00669279|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25556704|NCT00669318|Rituximab|rituximab|mesh-list
25556705|NCT00669318|Alemtuzumab|alemtuzumab|mesh-list
24652770|NCT01240096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24652771|NCT01240096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24652772|NCT01240096|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24652773|NCT01240096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24652774|NCT01240096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24652775|NCT01240096|Adrenergic Agents|adrenergic agents|mesh-ancestor
24652899|NCT01240850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25556706|NCT00669318|Pentostatin|pentostatin|mesh-list
25556707|NCT00669318|Sargramostim|sargramostim|mesh-list
25556708|NCT00669318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25556709|NCT00669318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25556710|NCT00669318|Immunologic Factors|immunologic factors|mesh-ancestor
25556711|NCT00669318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556712|NCT00669318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25556713|NCT00669318|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25556714|NCT00669318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556715|NCT00669318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556716|NCT00669331|Mannitol|mannitol|mesh-list
25556717|NCT00669331|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25556718|NCT00669331|Diuretics|diuretics|mesh-ancestor
25556719|NCT00669331|Natriuretic Agents|natriuretic agents|mesh-ancestor
25556720|NCT00669331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556721|NCT00669383|Betamethasone|betamethasone|mesh-list
24808279|NCT02026219|Clopidogrel|clopidogrel|mesh-list
24865851|NCT04750759|Niclosamide|niclosamide|mesh-list
25556722|NCT00669383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25556723|NCT00669383|Glucocorticoids|glucocorticoids|mesh-ancestor
25556724|NCT00669383|Hormones|hormones|mesh-ancestor
25556725|NCT00669383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25556726|NCT00669383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556727|NCT00669383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25556728|NCT00669383|Respiratory System Agents|respiratory system agents|mesh-ancestor
25556729|NCT00669396|Copper|copper|mesh-list
25556730|NCT00669396|Levonorgestrel|levonorgestrel|mesh-list
25556731|NCT00669396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25556732|NCT00669396|Contraceptive Agents|contraceptive agents|mesh-ancestor
25556733|NCT00669396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25556734|NCT00669396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556735|NCT00669396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25556736|NCT00669396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25556737|NCT00669396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25556738|NCT00669396|Trace Elements|trace elements|mesh-ancestor
25556739|NCT00669396|Micronutrients|micronutrients|mesh-ancestor
25651515|NCT01516970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651516|NCT01516970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651517|NCT01516970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25651518|NCT01516970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25651519|NCT01516970|Antiviral Agents|antiviral agents|mesh-ancestor
25651520|NCT01516970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25651521|NCT01516970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25651522|NCT01516970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25651523|NCT01516970|Antimetabolites|antimetabolites|mesh-ancestor
25651524|NCT01516970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25651525|NCT01516970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25651526|NCT01516970|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25651527|NCT01516970|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25651528|NCT01516970|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25651529|NCT01516970|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25651530|NCT01516970|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25651531|NCT01517074|Sirolimus|sirolimus|mesh-list
25651532|NCT01517074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25651533|NCT01517074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25651534|NCT01517074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25651535|NCT01517074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25651536|NCT01517074|Antifungal Agents|antifungal agents|mesh-ancestor
25651537|NCT01517074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25651538|NCT01517074|Immunologic Factors|immunologic factors|mesh-ancestor
25651539|NCT01517074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651540|NCT01517295|Hydrocodone|hydrocodone|mesh-list
25651541|NCT01517295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25651542|NCT01517295|Narcotics|narcotics|mesh-ancestor
25651543|NCT01517295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25651544|NCT01517295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866017|NCT03948867|Antisickling Agents|antisickling agents|mesh-ancestor
25651545|NCT01517295|Analgesics|analgesics|mesh-ancestor
25651546|NCT01517295|Sensory System Agents|sensory system agents|mesh-ancestor
25651547|NCT01517295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25651548|NCT01517295|Antitussive Agents|antitussive agents|mesh-ancestor
25451946|NCT04581265|Tubulin Modulators|tubulin modulators|mesh-ancestor
25451947|NCT04581265|Antimitotic Agents|antimitotic agents|mesh-ancestor
25451948|NCT04581265|Mitosis Modulators|mitosis modulators|mesh-ancestor
25451949|NCT04581265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689164|NCT01957644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451950|NCT04581265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25451951|NCT04581265|Alkylating Agents|alkylating agents|mesh-ancestor
25451952|NCT04580797|PF-06700841|pf-06700841|mesh-list
25451953|NCT04580797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25451954|NCT04580797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451955|NCT04580797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451956|NCT04580355|Amoxicillin|amoxicillin|mesh-list
25451957|NCT04580355|Metronidazole|metronidazole|mesh-list
25651549|NCT01517295|Respiratory System Agents|respiratory system agents|mesh-ancestor
25651550|NCT01517373|Glimepiride|glimepiride|mesh-list
25651551|NCT01517373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25651552|NCT01517373|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25651553|NCT01517373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651554|NCT01517373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25651555|NCT01517373|Immunologic Factors|immunologic factors|mesh-ancestor
25651556|NCT01517412|Metformin|metformin|mesh-list
25651557|NCT01517412|Lixisenatide|lixisenatide|mesh-list
25651558|NCT01517412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25651559|NCT01517412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556740|NCT00669409|Tanezumab|tanezumab|mesh-list
25556741|NCT00669409|Analgesics|analgesics|mesh-ancestor
25689165|NCT01957644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25689166|NCT01957644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689167|NCT01957709|Interferons|interferons|mesh-list
25556742|NCT00669409|Sensory System Agents|sensory system agents|mesh-ancestor
25556743|NCT00669409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25556744|NCT00669409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556745|NCT00669578|Pomalidomide|pomalidomide|mesh-list
25556746|NCT00669578|Immunologic Factors|immunologic factors|mesh-ancestor
25556747|NCT00669578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556748|NCT00669578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25054573|NCT03529149|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25054576|NCT03529097|Dipyrone|dipyrone|mesh-list
24656031|NCT01259362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24656033|NCT01259362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556749|NCT00669578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25556750|NCT00669578|Growth Substances|growth substances|mesh-ancestor
25556751|NCT00669578|Growth Inhibitors|growth inhibitors|mesh-ancestor
25556752|NCT00669578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25556753|NCT00669617|Fluticasone|fluticasone|mesh-list
25556754|NCT00669617|Xhance|xhance|mesh-list
25556755|NCT00669617|Albuterol|albuterol|mesh-list
25556756|NCT00669617|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25556757|NCT00669617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25556758|NCT00669617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25556759|NCT00669617|Autonomic Agents|autonomic agents|mesh-ancestor
25556760|NCT00669617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25556761|NCT00669617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556762|NCT00669617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25556763|NCT00669617|Respiratory System Agents|respiratory system agents|mesh-ancestor
25556764|NCT00669617|Dermatologic Agents|dermatologic agents|mesh-ancestor
25556765|NCT00669617|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25556766|NCT00669617|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25556767|NCT00669617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25556768|NCT00669617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25556769|NCT00669617|Adrenergic Agents|adrenergic agents|mesh-ancestor
25556770|NCT00669617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25556771|NCT00669617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808996|NCT02030483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24808997|NCT02030483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808998|NCT02030483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656433|NCT01261689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24656434|NCT01261689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24697543|NCT01435343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24449720|NCT00316745|Vitamin B Complex|vitamin b complex|mesh-ancestor
24449719|NCT00316745|Protective Agents|protective agents|mesh-ancestor
24919574|NCT04209933|Potassium Citrate|potassium citrate|mesh-list
25266414|NCT02428439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266415|NCT02428439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25266416|NCT02428439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25266417|NCT02428439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25266418|NCT02428439|Anticonvulsants|anticonvulsants|mesh-ancestor
25266419|NCT02428439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25266420|NCT02428439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25556772|NCT00669617|Tocolytic Agents|tocolytic agents|mesh-ancestor
25556773|NCT00669617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25556774|NCT00669864|Metformin|metformin|mesh-list
25556775|NCT00669864|Insulin Aspart|insulin aspart|mesh-list
25556776|NCT00669864|Biphasic Insulins|biphasic insulins|mesh-list
25556777|NCT00669864|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
25556778|NCT00669864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25556779|NCT00669864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556780|NCT00669877|Cytarabine|cytarabine|mesh-list
25556781|NCT00669877|Dexamethasone|dexamethasone|mesh-list
25556782|NCT00669877|Cyclophosphamide|cyclophosphamide|mesh-list
25556783|NCT00669877|Rituximab|rituximab|mesh-list
25556784|NCT00669877|Doxorubicin|doxorubicin|mesh-list
24866728|NCT05033808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24866729|NCT05033808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24866730|NCT05033808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25266423|NCT02428439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25266424|NCT02428439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25266426|NCT02428374|Ticagrelor|ticagrelor|mesh-list
25266427|NCT02428374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25266428|NCT02428374|Simvastatin|simvastatin|mesh-list
25266429|NCT02428374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25266430|NCT02428374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25266431|NCT02428374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25266432|NCT02428374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25266433|NCT02428374|Purinergic Agents|purinergic agents|mesh-ancestor
25266434|NCT02428374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25556785|NCT00669877|Methotrexate|methotrexate|mesh-list
25556786|NCT00669877|Vincristine|vincristine|mesh-list
25556787|NCT00669877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25556788|NCT00669877|Immunologic Factors|immunologic factors|mesh-ancestor
25556789|NCT00669877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556790|NCT00669877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25556791|NCT00669877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25556792|NCT00669877|Alkylating Agents|alkylating agents|mesh-ancestor
25054842|NCT03527134|Sensory System Agents|sensory system agents|mesh-ancestor
25054843|NCT03527134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24569762|NCT00801866|Growth Substances|growth substances|mesh-ancestor
24569763|NCT00801866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266456|NCT02428257|Sensory System Agents|sensory system agents|mesh-ancestor
25266459|NCT02428257|Sympathomimetics|sympathomimetics|mesh-ancestor
25556793|NCT00669877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556794|NCT00669877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25556795|NCT00669877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25556796|NCT00669877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25556797|NCT00669877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25556798|NCT00669877|Antiemetics|antiemetics|mesh-ancestor
25556799|NCT00669877|Autonomic Agents|autonomic agents|mesh-ancestor
25054904|NCT03526224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25054905|NCT03526224|Immunologic Factors|immunologic factors|mesh-ancestor
25054906|NCT03526224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054907|NCT03526224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25556800|NCT00669877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25556801|NCT00669877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25556802|NCT00669877|Glucocorticoids|glucocorticoids|mesh-ancestor
25556803|NCT00669877|Hormones|hormones|mesh-ancestor
25556804|NCT00669877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25556805|NCT00669877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25556806|NCT00669877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25556807|NCT00669877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25556808|NCT00669877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25556809|NCT00669877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657389|NCT01267084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24657390|NCT01267084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657391|NCT01267084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24697762|NCT01437189|Sertraline|sertraline|mesh-list
25556810|NCT00669877|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25556811|NCT00669877|Abortifacient Agents|abortifacient agents|mesh-ancestor
25556812|NCT00669877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25556813|NCT00669877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25556814|NCT00669877|Antimetabolites|antimetabolites|mesh-ancestor
25452001|NCT04579731|Lactitol|lactitol|mesh-list
25556815|NCT00669877|Dermatologic Agents|dermatologic agents|mesh-ancestor
25556816|NCT00669877|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25055006|NCT03525652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055011|NCT03525561|Acetazolamide|acetazolamide|mesh-list
24867576|NCT03842696|Alkylating Agents|alkylating agents|mesh-ancestor
25055016|NCT03525561|Diuretics|diuretics|mesh-ancestor
25055017|NCT03525561|Natriuretic Agents|natriuretic agents|mesh-ancestor
25055018|NCT03525561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055019|NCT03525522|Betamethasone|betamethasone|mesh-list
25055020|NCT03525522|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25055021|NCT03525522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25266494|NCT02428062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24657582|NCT01268384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657585|NCT01268384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24657586|NCT01268384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657622|NCT01268670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556817|NCT00669877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25556818|NCT00669877|Antiviral Agents|antiviral agents|mesh-ancestor
25556819|NCT00669877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25556820|NCT00669877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25556821|NCT00669877|Tubulin Modulators|tubulin modulators|mesh-ancestor
25556822|NCT00669877|Antimitotic Agents|antimitotic agents|mesh-ancestor
25556823|NCT00669877|Mitosis Modulators|mitosis modulators|mesh-ancestor
25556824|NCT00669955|Amoxicillin|amoxicillin|mesh-list
24547799|NCT00705770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547800|NCT00705770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24814412|NCT02064491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814413|NCT02064491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24814451|NCT02064556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24814452|NCT02064556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24690062|NCT01398670|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24867814|NCT05155592|Adalimumab|adalimumab|mesh-list
25266500|NCT02428062|Autonomic Agents|autonomic agents|mesh-ancestor
25266501|NCT02428062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25266502|NCT02428062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25266503|NCT02428062|Respiratory System Agents|respiratory system agents|mesh-ancestor
25266504|NCT02428062|Mydriatics|mydriatics|mesh-ancestor
24658084|NCT01270412|Mitogens|mitogens|mesh-list
25556825|NCT00669955|Metronidazole|metronidazole|mesh-list
25556826|NCT00669955|Clarithromycin|clarithromycin|mesh-list
25556827|NCT00669955|Tetracycline|tetracycline|mesh-list
25556828|NCT00669955|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
25556829|NCT00669955|Omeprazole|omeprazole|mesh-list
25556830|NCT00669955|Bismuth|bismuth|mesh-list
25556831|NCT00669955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25556832|NCT00669955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25556833|NCT00669955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24548221|NCT00708357|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
25556834|NCT00669955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25556835|NCT00669955|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25556836|NCT00669955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25556837|NCT00669955|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25556838|NCT00669955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556839|NCT00669955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556840|NCT00669955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25556841|NCT00669955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25556842|NCT00669955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25556843|NCT00669955|Antacids|antacids|mesh-ancestor
25556844|NCT00670007|Protease Inhibitors|protease inhibitors|mesh-list
25556845|NCT00670007|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
24548396|NCT00709332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25556846|NCT00670007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556847|NCT00670007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556848|NCT00670007|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25556849|NCT00670007|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25556850|NCT00670046|Valproic Acid|valproic acid|mesh-list
25556851|NCT00670046|Anticonvulsants|anticonvulsants|mesh-ancestor
25556852|NCT00670046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556853|NCT00670046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556854|NCT00670046|GABA Agents|gaba agents|mesh-ancestor
25556855|NCT00670046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25556856|NCT00670046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556857|NCT00670046|Antimanic Agents|antimanic agents|mesh-ancestor
25556858|NCT00670046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25556859|NCT00670046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24658509|NCT01272128|Immunologic Factors|immunologic factors|mesh-ancestor
24658510|NCT01272128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556860|NCT00670046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25556861|NCT00670202|Fasudil|fasudil|mesh-list
25556862|NCT00670202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25556863|NCT00670202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25556864|NCT00670202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556865|NCT00670202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25556866|NCT00670202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556867|NCT00670202|Vasodilator Agents|vasodilator agents|mesh-ancestor
25556868|NCT00670202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24868863|NCT00328653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556869|NCT00670202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556870|NCT00670228|Insulin|insulin|mesh-list
25556871|NCT00670228|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25556872|NCT00670228|Insulin Glargine|insulin glargine|mesh-list
25556873|NCT00670228|Insulin glulisine|insulin glulisine|mesh-list
25556874|NCT00670228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25556875|NCT00670228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556876|NCT00670241|Betamethasone|betamethasone|mesh-list
25556877|NCT00670241|1 alpha,24-dihydroxyvitamin D3|1 alpha,24-dihydroxyvitamin d3|mesh-list
25556878|NCT00670241|Calcipotriene|calcipotriene|mesh-list
25556879|NCT00670241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25556880|NCT00670241|Glucocorticoids|glucocorticoids|mesh-ancestor
25556881|NCT00670241|Hormones|hormones|mesh-ancestor
25556882|NCT00670241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25556883|NCT00670241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556884|NCT00670241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25556885|NCT00670241|Respiratory System Agents|respiratory system agents|mesh-ancestor
25556886|NCT00670241|Dermatologic Agents|dermatologic agents|mesh-ancestor
25556887|NCT00670267|Nadolol|nadolol|mesh-list
25556888|NCT00670267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25556889|NCT00670267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25556890|NCT00670267|Adrenergic Agents|adrenergic agents|mesh-ancestor
25452121|NCT04577417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452122|NCT04577417|Dopamine Agents|dopamine agents|mesh-ancestor
25452123|NCT04577417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25452124|NCT04577417|Sympathomimetics|sympathomimetics|mesh-ancestor
25452125|NCT04577417|Autonomic Agents|autonomic agents|mesh-ancestor
25452126|NCT04577417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24659136|NCT01275885|Cholecalciferol|cholecalciferol|mesh-list
24659161|NCT01275937|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24659162|NCT01275937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24659163|NCT01275937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452127|NCT04577417|Adrenergic Agents|adrenergic agents|mesh-ancestor
25452128|NCT04577417|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25452129|NCT04577027|Travoprost|travoprost|mesh-list
25452130|NCT04577027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25105790|NCT04862949|Atezolizumab|atezolizumab|mesh-list
25105791|NCT04862949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25105792|NCT04862949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105793|NCT04862949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25105794|NCT04862949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25105795|NCT04862949|Growth Substances|growth substances|mesh-ancestor
25120952|NCT01295944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120953|NCT01295944|Growth Inhibitors|growth inhibitors|mesh-ancestor
25120954|NCT01285557|Cisplatin|cisplatin|mesh-list
24869486|NCT03365635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869488|NCT03365635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24869489|NCT03287050|Pembrolizumab|pembrolizumab|mesh-list
25120955|NCT01285557|Fluorouracil|fluorouracil|mesh-list
25120956|NCT01285557|Tegafur|tegafur|mesh-list
25105796|NCT04862949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105797|NCT04862949|Growth Inhibitors|growth inhibitors|mesh-ancestor
25105799|NCT04861064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25105800|NCT04861064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25105801|NCT04861064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25105803|NCT04861064|Antifungal Agents|antifungal agents|mesh-ancestor
25105804|NCT04861064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25105805|NCT04861064|Immunologic Factors|immunologic factors|mesh-ancestor
25105806|NCT04861064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822642|NCT00004580|Lopinavir|lopinavir|mesh-list
25822643|NCT00004580|Nevirapine|nevirapine|mesh-list
24419938|NCT00214617|Antimetabolites|antimetabolites|mesh-ancestor
25120980|NCT01228331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25120981|NCT01228331|Immunologic Factors|immunologic factors|mesh-ancestor
25120982|NCT01228331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809600|NCT02035020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25120983|NCT01228331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25120990|NCT01228331|Antiemetics|antiemetics|mesh-ancestor
24419939|NCT00214617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419940|NCT00214617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24419941|NCT00214617|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24419942|NCT00214617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419944|NCT00214630|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24419945|NCT00214630|Calcium|calcium|mesh-list
24419946|NCT00214630|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24495838|NCT00502138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495846|NCT00502164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055506|NCT03520543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055507|NCT03520543|Mydriatics|mydriatics|mesh-ancestor
25055585|NCT03519633|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24419947|NCT00214630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419948|NCT00214630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24419949|NCT00214630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25105814|NCT04860635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25105815|NCT04860635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25105816|NCT04860635|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25161850|NCT02240407|Acetaminophen|acetaminophen|mesh-list
25105830|NCT04850495|Rituximab|rituximab|mesh-list
25055723|NCT03518112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25055724|NCT03518112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25055747|NCT03518112|Vitamins|vitamins|mesh-ancestor
25055748|NCT03518112|Micronutrients|micronutrients|mesh-ancestor
25055749|NCT03518112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25055750|NCT03518112|Tubulin Modulators|tubulin modulators|mesh-ancestor
24857264|NCT02290431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24857265|NCT02290431|Antiemetics|antiemetics|mesh-ancestor
24857266|NCT02290431|Autonomic Agents|autonomic agents|mesh-ancestor
25105831|NCT04850495|Doxorubicin|doxorubicin|mesh-list
25105832|NCT04850495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25105833|NCT04850495|Vincristine|vincristine|mesh-list
25105834|NCT04850495|Zanubrutinib|zanubrutinib|mesh-list
25105835|NCT04850495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25822644|NCT00004580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25822645|NCT00004580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25822646|NCT00004580|Protease Inhibitors|protease inhibitors|mesh-ancestor
24419974|NCT00214721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24419975|NCT00214825|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24419977|NCT00214825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24419978|NCT00214825|Diuretics|diuretics|mesh-ancestor
24419979|NCT00214825|Natriuretic Agents|natriuretic agents|mesh-ancestor
25556891|NCT00670267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25556892|NCT00670267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556893|NCT00670267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556894|NCT00670267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25556895|NCT00670267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24870749|NCT04017442|Narcotics|narcotics|mesh-ancestor
25556896|NCT00670267|Sympatholytics|sympatholytics|mesh-ancestor
25556897|NCT00670267|Autonomic Agents|autonomic agents|mesh-ancestor
25556898|NCT00670267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25556899|NCT00670306|Cetrorelix|cetrorelix|mesh-list
25556900|NCT00670306|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25822647|NCT00004580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556901|NCT00670306|Fertility Agents|fertility agents|mesh-ancestor
25556902|NCT00670306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25556903|NCT00670306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556904|NCT00670306|Hormone Antagonists|hormone antagonists|mesh-ancestor
25556905|NCT00670306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25556906|NCT00670449|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24871193|NCT04578600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25556907|NCT00670449|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25556908|NCT00670449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661654|NCT01290276|Methylphenidate|methylphenidate|mesh-list
25556909|NCT00670449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25556910|NCT00670449|Immunologic Factors|immunologic factors|mesh-ancestor
25556911|NCT00670449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556912|NCT00670748|Aldesleukin|aldesleukin|mesh-list
25556913|NCT00670748|Cyclophosphamide|cyclophosphamide|mesh-list
25556914|NCT00670748|Fludarabine|fludarabine|mesh-list
25556915|NCT00670748|Fludarabine phosphate|fludarabine phosphate|mesh-list
25556916|NCT00670748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25556917|NCT00670748|Immunologic Factors|immunologic factors|mesh-ancestor
25556918|NCT00670748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556919|NCT00670748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25556920|NCT00670748|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25556921|NCT00670748|Alkylating Agents|alkylating agents|mesh-ancestor
24662133|NCT01292720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662134|NCT01292720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24666674|NCT01320436|Analgesics|analgesics|mesh-ancestor
25556922|NCT00670748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556923|NCT00670748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25556924|NCT00670748|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25556925|NCT00670748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25556926|NCT00670748|Antimetabolites|antimetabolites|mesh-ancestor
25556927|NCT00670748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25556928|NCT00670748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25556929|NCT00670748|Antiviral Agents|antiviral agents|mesh-ancestor
25556930|NCT00670748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25556931|NCT00670774|Eculizumab|eculizumab|mesh-list
25556932|NCT00670774|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24871780|NCT04527289|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25556933|NCT00670774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25556934|NCT00670774|Immunologic Factors|immunologic factors|mesh-ancestor
25556935|NCT00670774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556936|NCT00670800|Metformin|metformin|mesh-list
25556937|NCT00670800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25556938|NCT00670800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556939|NCT00670930|Omalizumab|omalizumab|mesh-list
25556940|NCT00670930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24872017|NCT05400603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24872018|NCT05400603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25556941|NCT00670930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25556942|NCT00670930|Respiratory System Agents|respiratory system agents|mesh-ancestor
25556943|NCT00670956|Betamethasone|betamethasone|mesh-list
25556944|NCT00670956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25556945|NCT00670956|Glucocorticoids|glucocorticoids|mesh-ancestor
25556946|NCT00670956|Hormones|hormones|mesh-ancestor
25556947|NCT00670956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25556948|NCT00670956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662770|NCT01296555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24662771|NCT01296555|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24662772|NCT01296555|Hormone Antagonists|hormone antagonists|mesh-ancestor
24662773|NCT01296555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24662776|NCT01296802|Fenfluramine|fenfluramine|mesh-list
24872358|NCT05396209|Autonomic Agents|autonomic agents|mesh-ancestor
24872359|NCT05396209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24872360|NCT05396209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872361|NCT05396209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24872362|NCT05396209|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24663105|NCT01298310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24663142|NCT01298466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689355|NCT01959672|Calcium, Dietary|calcium, dietary|mesh-list
24872534|NCT05325580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24872535|NCT05325580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24872536|NCT05325580|Anticonvulsants|anticonvulsants|mesh-ancestor
24872537|NCT05325580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24872541|NCT05325580|Tocolytic Agents|tocolytic agents|mesh-ancestor
24872719|NCT05238844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24872720|NCT05238844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24872721|NCT05232734|Caffeine|caffeine|mesh-list
24872722|NCT05232734|Caffeine citrate|caffeine citrate|mesh-list
24872723|NCT05232734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872724|NCT05232734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24872725|NCT05232734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872726|NCT05232734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24872853|NCT05439772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24872854|NCT05439772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872855|NCT05439772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24872856|NCT05439772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24872869|NCT05439577|Hormones|hormones|mesh-ancestor
24815055|NCT02068170|Haloperidol decanoate|haloperidol decanoate|mesh-list
24872905|NCT05439408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872914|NCT05439213|Epinephrine|epinephrine|mesh-list
24872915|NCT05439213|Racepinephrine|racepinephrine|mesh-list
24872916|NCT05439213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24872917|NCT05439213|Epinephryl borate|epinephryl borate|mesh-list
24872918|NCT05439213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24664839|NCT01309009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24664840|NCT01309009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664841|NCT01309009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24664843|NCT01309022|Mycophenolic Acid|mycophenolic acid|mesh-list
25056145|NCT03515200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25056146|NCT03515200|Antiviral Agents|antiviral agents|mesh-ancestor
25056147|NCT03515200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25556949|NCT00670956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25556950|NCT00670956|Respiratory System Agents|respiratory system agents|mesh-ancestor
25556951|NCT00670982|Bevacizumab|bevacizumab|mesh-list
25556952|NCT00670982|Trastuzumab|trastuzumab|mesh-list
25556953|NCT00670982|Vinorelbine|vinorelbine|mesh-list
25556954|NCT00670982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25556955|NCT00670982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25556956|NCT00670982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24815134|NCT02068287|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24815135|NCT02068287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24815136|NCT02068287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25556957|NCT00670982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25556958|NCT00670982|Growth Substances|growth substances|mesh-ancestor
25556959|NCT00670982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556960|NCT00670982|Growth Inhibitors|growth inhibitors|mesh-ancestor
25556961|NCT00670982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25556962|NCT00670982|Tubulin Modulators|tubulin modulators|mesh-ancestor
25556963|NCT00670982|Antimitotic Agents|antimitotic agents|mesh-ancestor
25556964|NCT00670982|Mitosis Modulators|mitosis modulators|mesh-ancestor
25556965|NCT00670982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25556966|NCT00671034|Cytarabine|cytarabine|mesh-list
25056189|NCT03514810|Serotonin Agents|serotonin agents|mesh-ancestor
24665887|NCT01315496|Immunologic Factors|immunologic factors|mesh-ancestor
25556967|NCT00671034|Dexamethasone|dexamethasone|mesh-list
25556968|NCT00671034|Dexamethasone acetate|dexamethasone acetate|mesh-list
25556969|NCT00671034|Prednisone|prednisone|mesh-list
25556970|NCT00671034|Cortisone|cortisone|mesh-list
25556971|NCT00671034|Cyclophosphamide|cyclophosphamide|mesh-list
25556972|NCT00671034|Doxorubicin|doxorubicin|mesh-list
25556973|NCT00671034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25452131|NCT04577040|Tadalafil|tadalafil|mesh-list
25556974|NCT00671034|Methotrexate|methotrexate|mesh-list
25556975|NCT00671034|Vincristine|vincristine|mesh-list
25556976|NCT00671034|Daunorubicin|daunorubicin|mesh-list
25556977|NCT00671034|Asparaginase|asparaginase|mesh-list
25556978|NCT00671034|Mercaptopurine|mercaptopurine|mesh-list
25556979|NCT00671034|Pegaspargase|pegaspargase|mesh-list
25556980|NCT00671034|Thioguanine|thioguanine|mesh-list
25556981|NCT00671034|BB 1101|bb 1101|mesh-list
25556982|NCT00671034|2-Aminopurine|2-aminopurine|mesh-list
25556983|NCT00671034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25556984|NCT00671034|Immunologic Factors|immunologic factors|mesh-ancestor
25556985|NCT00671034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25556986|NCT00671034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25556987|NCT00671034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25556988|NCT00671034|Alkylating Agents|alkylating agents|mesh-ancestor
25556989|NCT00671034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056204|NCT03514771|Dermatologic Agents|dermatologic agents|mesh-ancestor
25556990|NCT00671034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25556991|NCT00671034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25556992|NCT00671034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25556993|NCT00671034|Antiemetics|antiemetics|mesh-ancestor
25556994|NCT00671034|Autonomic Agents|autonomic agents|mesh-ancestor
25556995|NCT00671034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25556996|NCT00671034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25556997|NCT00671034|Glucocorticoids|glucocorticoids|mesh-ancestor
25556998|NCT00671034|Hormones|hormones|mesh-ancestor
25556999|NCT00671034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25557000|NCT00671034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25557001|NCT00671034|Protease Inhibitors|protease inhibitors|mesh-ancestor
25557002|NCT00671034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557003|NCT00671034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25557004|NCT00671034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25689450|NCT01960296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25056258|NCT03514108|Hydralazine|hydralazine|mesh-list
25266764|NCT02426229|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24666482|NCT01319448|Sulfadoxine|sulfadoxine|mesh-list
24666517|NCT01319682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24666518|NCT01319682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24666519|NCT01319682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24666520|NCT01319682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24666521|NCT01319682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666522|NCT01319695|Hormones|hormones|mesh-list
24857360|NCT02291367|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24857361|NCT02291367|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24857362|NCT02291367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24666523|NCT01319695|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25557005|NCT00671034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25557006|NCT00671034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25557007|NCT00671034|Abortifacient Agents|abortifacient agents|mesh-ancestor
25557008|NCT00671034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25557009|NCT00671034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25557010|NCT00671034|Antimetabolites|antimetabolites|mesh-ancestor
25557011|NCT00671034|Dermatologic Agents|dermatologic agents|mesh-ancestor
25557012|NCT00671034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25557013|NCT00671034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25557014|NCT00671034|Antiviral Agents|antiviral agents|mesh-ancestor
25557015|NCT00671034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25557016|NCT00671034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25557017|NCT00671034|Tubulin Modulators|tubulin modulators|mesh-ancestor
25557018|NCT00671034|Antimitotic Agents|antimitotic agents|mesh-ancestor
24874025|NCT04949828|Pancrelipase|pancrelipase|mesh-list
24874026|NCT04949828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25689460|NCT01960387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25689471|NCT01960413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689472|NCT01960413|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25689473|NCT01960413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25056301|NCT03513601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056302|NCT03513601|Immunologic Factors|immunologic factors|mesh-ancestor
25056303|NCT03513601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056304|NCT03513601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25056305|NCT03513575|Chlorhexidine|chlorhexidine|mesh-list
25056312|NCT03513549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25557019|NCT00671034|Mitosis Modulators|mitosis modulators|mesh-ancestor
25557020|NCT00671060|Misoprostol|misoprostol|mesh-list
25557021|NCT00671060|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25557022|NCT00671060|Abortifacient Agents|abortifacient agents|mesh-ancestor
25557023|NCT00671060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25557024|NCT00671060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557025|NCT00671060|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25557026|NCT00671060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25557027|NCT00671060|Oxytocics|oxytocics|mesh-ancestor
25557028|NCT00671437|Cetuximab|cetuximab|mesh-list
25557029|NCT00671437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25557030|NCT00671437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25557031|NCT00671502|Carisoprodol|carisoprodol|mesh-list
25557032|NCT00671502|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25557033|NCT00671502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557034|NCT00671502|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25557035|NCT00671502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25557036|NCT00671515|Pioglitazone|pioglitazone|mesh-list
25557037|NCT00671515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25557038|NCT00671515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557039|NCT00671658|Cytarabine|cytarabine|mesh-list
25557040|NCT00671658|Dexamethasone|dexamethasone|mesh-list
25557041|NCT00671658|Methylprednisolone|methylprednisolone|mesh-list
25557042|NCT00671658|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25056363|NCT03513276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25056364|NCT03513276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25056365|NCT03513276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25056366|NCT03513276|Adrenergic Agents|adrenergic agents|mesh-ancestor
24815228|NCT02069080|Plerixafor|plerixafor|mesh-list
24815257|NCT02069197|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24815258|NCT02069197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24815259|NCT02069288|Fludrocortisone|fludrocortisone|mesh-list
24815260|NCT02069288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24667914|NCT05247619|Paclitaxel|paclitaxel|mesh-list
24667915|NCT05247619|Bevacizumab|bevacizumab|mesh-list
24667916|NCT05247619|Carboplatin|carboplatin|mesh-list
25266803|NCT02426164|Anesthetics|anesthetics|mesh-ancestor
25266804|NCT02426164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25266809|NCT02426164|Narcotics|narcotics|mesh-ancestor
25557043|NCT00671658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25557044|NCT00671658|Prednisolone|prednisolone|mesh-list
25557045|NCT00671658|Prednisolone acetate|prednisolone acetate|mesh-list
25557046|NCT00671658|Cyclophosphamide|cyclophosphamide|mesh-list
25557047|NCT00671658|Rituximab|rituximab|mesh-list
25557048|NCT00671658|Doxorubicin|doxorubicin|mesh-list
25557049|NCT00671658|Methotrexate|methotrexate|mesh-list
25452200|NCT04576143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25557050|NCT00671658|Vincristine|vincristine|mesh-list
25557051|NCT00671658|Asparaginase|asparaginase|mesh-list
25557052|NCT00671658|Pegaspargase|pegaspargase|mesh-list
25557053|NCT00671658|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25557054|NCT00671658|Prednisolone phosphate|prednisolone phosphate|mesh-list
25557055|NCT00671658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25557056|NCT00671658|Immunologic Factors|immunologic factors|mesh-ancestor
25557057|NCT00671658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557058|NCT00671658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25557059|NCT00671658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25557060|NCT00671658|Alkylating Agents|alkylating agents|mesh-ancestor
25557061|NCT00671658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557062|NCT00671658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25557063|NCT00671658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25557064|NCT00671658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25557065|NCT00671658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25557066|NCT00671658|Antiemetics|antiemetics|mesh-ancestor
25557067|NCT00671658|Autonomic Agents|autonomic agents|mesh-ancestor
25557068|NCT00671658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25557069|NCT00671658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25557070|NCT00671658|Glucocorticoids|glucocorticoids|mesh-ancestor
25557071|NCT00671658|Hormones|hormones|mesh-ancestor
25557072|NCT00671658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24874955|NCT04492033|Paclitaxel|paclitaxel|mesh-list
24874967|NCT04491032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24874969|NCT04488978|Amlodipine|amlodipine|mesh-list
25557073|NCT00671658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25557074|NCT00671658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25557075|NCT00671658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25557076|NCT00671658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25557077|NCT00671658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557078|NCT00671658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25557079|NCT00671658|Abortifacient Agents|abortifacient agents|mesh-ancestor
25557080|NCT00671658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25557081|NCT00671658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25557082|NCT00671658|Antimetabolites|antimetabolites|mesh-ancestor
25557083|NCT00671658|Dermatologic Agents|dermatologic agents|mesh-ancestor
25557084|NCT00671658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25557085|NCT00671658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25557086|NCT00671658|Antiviral Agents|antiviral agents|mesh-ancestor
25557087|NCT00671658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25557088|NCT00671658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25557089|NCT00671658|Tubulin Modulators|tubulin modulators|mesh-ancestor
25557090|NCT00671658|Antimitotic Agents|antimitotic agents|mesh-ancestor
25557091|NCT00671658|Mitosis Modulators|mitosis modulators|mesh-ancestor
25557092|NCT00671658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25557093|NCT00671658|Protective Agents|protective agents|mesh-ancestor
25557094|NCT00671788|Dasatinib|dasatinib|mesh-list
25557095|NCT00671788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25557096|NCT00671788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25557097|NCT00671788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557098|NCT00671788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557099|NCT00671853|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25557100|NCT00671853|Antidepressive Agents|antidepressive agents|mesh-ancestor
25557101|NCT00671853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25056432|NCT03512834|Mitosis Modulators|mitosis modulators|mesh-ancestor
25056435|NCT03512821|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25557102|NCT00671853|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25557103|NCT00671853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25557104|NCT00671853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25557105|NCT00671853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557106|NCT00671879|Carisoprodol|carisoprodol|mesh-list
25557107|NCT00671879|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25557108|NCT00671879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557109|NCT00671879|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25557110|NCT00671879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25557111|NCT00671931|Dexmedetomidine|dexmedetomidine|mesh-list
25557112|NCT00671931|Propofol|propofol|mesh-list
25557113|NCT00671931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25557114|NCT00671931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25557115|NCT00671931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557116|NCT00671931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25557117|NCT00671931|Anesthetics, General|anesthetics, general|mesh-ancestor
25557118|NCT00671931|Anesthetics|anesthetics|mesh-ancestor
25557119|NCT00671931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25557120|NCT00671931|Analgesics|analgesics|mesh-ancestor
25557121|NCT00671931|Sensory System Agents|sensory system agents|mesh-ancestor
25557122|NCT00671931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25557123|NCT00671931|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25557124|NCT00671931|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25557125|NCT00671931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25557126|NCT00671931|Adrenergic Agents|adrenergic agents|mesh-ancestor
25557127|NCT00671931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25557128|NCT00671931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557129|NCT00671970|Bevacizumab|bevacizumab|mesh-list
25557130|NCT00671970|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25557131|NCT00671970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25557132|NCT00671970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25557133|NCT00671970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25557134|NCT00671970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25557135|NCT00671970|Growth Substances|growth substances|mesh-ancestor
25557136|NCT00671970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557137|NCT00671970|Growth Inhibitors|growth inhibitors|mesh-ancestor
25557138|NCT00671970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25557139|NCT00671970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557140|NCT00671970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557141|NCT00672100|Ropivacaine|ropivacaine|mesh-list
25557142|NCT00672100|Anesthetics, Local|anesthetics, local|mesh-ancestor
25557143|NCT00672100|Anesthetics|anesthetics|mesh-ancestor
25557144|NCT00672100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25557145|NCT00672100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557146|NCT00672100|Sensory System Agents|sensory system agents|mesh-ancestor
25557147|NCT00672100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25557148|NCT00672139|Bromides|bromides|mesh-list
25557149|NCT00672139|Methylnaltrexone|methylnaltrexone|mesh-list
25557150|NCT00672139|Anticonvulsants|anticonvulsants|mesh-ancestor
25557151|NCT00672139|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25557152|NCT00672139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557153|NCT00672139|Sensory System Agents|sensory system agents|mesh-ancestor
25557154|NCT00672139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24875702|NCT03907475|Antimitotic Agents|antimitotic agents|mesh-ancestor
25557155|NCT00672204|Sirolimus|sirolimus|mesh-list
25557156|NCT00672204|Thymoglobulin|thymoglobulin|mesh-list
25557157|NCT00672204|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25557158|NCT00672204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25557159|NCT00672204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25557160|NCT00672204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25557161|NCT00672204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25557162|NCT00672204|Antifungal Agents|antifungal agents|mesh-ancestor
25557163|NCT00672204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25557164|NCT00672204|Immunologic Factors|immunologic factors|mesh-ancestor
25557165|NCT00672204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557166|NCT00672243|Sirolimus|sirolimus|mesh-list
25557167|NCT00672243|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25557168|NCT00672243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25557169|NCT00672243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25557170|NCT00672243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557171|NCT00672243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557172|NCT00672243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25557173|NCT00672243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25557174|NCT00672243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25557175|NCT00672243|Antifungal Agents|antifungal agents|mesh-ancestor
25557176|NCT00672243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25557177|NCT00672243|Immunologic Factors|immunologic factors|mesh-ancestor
25557178|NCT00672243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557179|NCT00672438|Alfentanil|alfentanil|mesh-list
25557180|NCT00672438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25557181|NCT00672438|Narcotics|narcotics|mesh-ancestor
25557182|NCT00672438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25557183|NCT00672438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557184|NCT00672438|Analgesics|analgesics|mesh-ancestor
25557185|NCT00672438|Sensory System Agents|sensory system agents|mesh-ancestor
25557186|NCT00672438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25557187|NCT00672438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25557188|NCT00672438|Anesthetics, General|anesthetics, general|mesh-ancestor
25557189|NCT00672438|Anesthetics|anesthetics|mesh-ancestor
25557190|NCT00672477|Methylnaltrexone|methylnaltrexone|mesh-list
25557191|NCT00672477|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25557192|NCT00672477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557193|NCT00672477|Sensory System Agents|sensory system agents|mesh-ancestor
25557194|NCT00672477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25557195|NCT00672490|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25557196|NCT00672490|Antidepressive Agents|antidepressive agents|mesh-ancestor
25557197|NCT00672490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25557198|NCT00672490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25557199|NCT00672490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25557200|NCT00672490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25557201|NCT00672490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557202|NCT00672594|Sunitinib|sunitinib|mesh-list
25452389|NCT04574791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25452390|NCT04574791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452391|NCT04574791|Anticonvulsants|anticonvulsants|mesh-ancestor
25452392|NCT04574791|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25452393|NCT04574791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25452394|NCT04574791|Parasympatholytics|parasympatholytics|mesh-ancestor
25452395|NCT04574791|Autonomic Agents|autonomic agents|mesh-ancestor
25452396|NCT04574791|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25452397|NCT04574791|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25452398|NCT04574791|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25452399|NCT04574791|Adrenergic Agents|adrenergic agents|mesh-ancestor
25452400|NCT04574791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25452401|NCT04574791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308434|NCT03750786|Micronutrients|micronutrients|mesh-ancestor
25308435|NCT03748966|Calcitriol|calcitriol|mesh-list
25308436|NCT03748966|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
25308437|NCT03748966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25308438|NCT03748966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701092|NCT01456624|Megestrol Acetate|megestrol acetate|mesh-list
25308439|NCT03748966|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25308440|NCT03748966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25308443|NCT03748966|Vitamins|vitamins|mesh-ancestor
24419980|NCT00214825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419981|NCT00214825|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24419982|NCT00214825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25822648|NCT00004580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822649|NCT00004580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24420018|NCT00214955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420019|NCT00214955|Analgesics|analgesics|mesh-ancestor
24420020|NCT00214955|Sensory System Agents|sensory system agents|mesh-ancestor
24420021|NCT00214955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24420022|NCT00214955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24420023|NCT00214955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24420024|NCT00214955|Anesthetics, General|anesthetics, general|mesh-ancestor
24420025|NCT00214955|Anesthetics|anesthetics|mesh-ancestor
24420027|NCT00214981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24420028|NCT00214981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420029|NCT00214981|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24420030|NCT00214981|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24420031|NCT00214981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25822650|NCT00004580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24978619|NCT03557749|Chelating Agents|chelating agents|mesh-ancestor
24978620|NCT03557749|Sequestering Agents|sequestering agents|mesh-ancestor
24815398|NCT02070120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815399|NCT02070120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24857384|NCT02291471|T0001|t0001|mesh-list
24978621|NCT03557749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978622|NCT03532555|Zinc|zinc|mesh-list
24978623|NCT03532555|Trace Elements|trace elements|mesh-ancestor
24978624|NCT03532555|Micronutrients|micronutrients|mesh-ancestor
24978625|NCT03532555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978626|NCT03511599|Cycloserine|cycloserine|mesh-list
25040730|NCT02918019|Antiviral Agents|antiviral agents|mesh-ancestor
25040731|NCT02918019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25557203|NCT00672594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25557204|NCT00672594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25557205|NCT00672594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25557206|NCT00672594|Growth Substances|growth substances|mesh-ancestor
25557207|NCT00672594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557208|NCT00672594|Growth Inhibitors|growth inhibitors|mesh-ancestor
25557209|NCT00672594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25557210|NCT00672594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557211|NCT00672594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557212|NCT00672620|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25557213|NCT00672620|Vortioxetine|vortioxetine|mesh-list
24611250|NCT01008020|Protective Agents|protective agents|mesh-ancestor
24611251|NCT01008020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611252|NCT01008020|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24623386|NCT01071174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25557214|NCT00672620|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25557215|NCT00672620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25557216|NCT00672620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25557217|NCT00672620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557218|NCT00672620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25557219|NCT00672620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557220|NCT00672620|Analgesics|analgesics|mesh-ancestor
25557221|NCT00672620|Sensory System Agents|sensory system agents|mesh-ancestor
25557222|NCT00672620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25557223|NCT00672620|Antidepressive Agents|antidepressive agents|mesh-ancestor
25557224|NCT00672620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25557225|NCT00672620|Dopamine Agents|dopamine agents|mesh-ancestor
25557226|NCT00672620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25557227|NCT00672620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25557228|NCT00672620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25557229|NCT00672620|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25557230|NCT00672620|Serotonin Agents|serotonin agents|mesh-ancestor
25557231|NCT00672620|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25557232|NCT00672620|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25557233|NCT00672620|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24877019|NCT03023631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24877021|NCT02998645|Cyclosporins|cyclosporins|mesh-list
24877022|NCT02998645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25056573|NCT03511560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557234|NCT00672620|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25557235|NCT00672646|Naproxen|naproxen|mesh-list
25557236|NCT00672646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25557237|NCT00672646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25557238|NCT00672646|Analgesics|analgesics|mesh-ancestor
25557239|NCT00672646|Sensory System Agents|sensory system agents|mesh-ancestor
25557240|NCT00672646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25557241|NCT00672646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557242|NCT00672646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25557243|NCT00672646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25557244|NCT00672646|Gout Suppressants|gout suppressants|mesh-ancestor
25557245|NCT00672646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25557246|NCT00672646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557247|NCT00672646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557248|NCT00672737|Remifentanil|remifentanil|mesh-list
25557249|NCT00672737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25557250|NCT00672737|Narcotics|narcotics|mesh-ancestor
25557251|NCT00672737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25557252|NCT00672737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557253|NCT00672737|Analgesics|analgesics|mesh-ancestor
25557254|NCT00672737|Sensory System Agents|sensory system agents|mesh-ancestor
25557255|NCT00672737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25557256|NCT00672841|Antifungal Agents|antifungal agents|mesh-list
25557257|NCT00672841|Clotrimazole|clotrimazole|mesh-list
25557258|NCT00672841|Miconazole|miconazole|mesh-list
25557259|NCT00672841|Anidulafungin|anidulafungin|mesh-list
25557260|NCT00672841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25557261|NCT00672841|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25557262|NCT00672841|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25557263|NCT00672841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25557264|NCT00672841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557265|NCT00672841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557266|NCT00672841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25557267|NCT00672841|Hormone Antagonists|hormone antagonists|mesh-ancestor
25557268|NCT00672841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25557269|NCT00672841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557270|NCT00672841|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25557271|NCT00672841|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25557272|NCT00672854|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25557273|NCT00672854|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25557274|NCT00672854|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25557275|NCT00672854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25557276|NCT00672932|Raltegravir Potassium|raltegravir potassium|mesh-list
25557277|NCT00672932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25557278|NCT00672932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25557279|NCT00672932|Antiviral Agents|antiviral agents|mesh-ancestor
25557280|NCT00672932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25557281|NCT00672932|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25557282|NCT00672932|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25557283|NCT00672932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557284|NCT00672932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557285|NCT00672958|Vortioxetine|vortioxetine|mesh-list
25557286|NCT00672958|Antidepressive Agents|antidepressive agents|mesh-ancestor
25557287|NCT00672958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25557288|NCT00672958|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25557289|NCT00672958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25557290|NCT00672958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25557291|NCT00672958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557292|NCT00672958|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25557293|NCT00672958|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25557294|NCT00672958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25651560|NCT01517893|Simvastatin|simvastatin|mesh-list
25557295|NCT00672958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557296|NCT00672958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25557298|NCT00672958|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25557299|NCT00672958|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25557300|NCT00672958|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25557301|NCT00672958|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25557302|NCT00672984|Moxifloxacin|moxifloxacin|mesh-list
25557303|NCT00672984|Guanfacine|guanfacine|mesh-list
25557304|NCT00672984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25557305|NCT00672984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25557306|NCT00672984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25557307|NCT00672984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25557308|NCT00672984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557309|NCT00672984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557310|NCT00672984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25557311|NCT00672984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557312|NCT00672984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24600311|NCT01026220|Ifosfamide|ifosfamide|mesh-list
25689666|NCT01963481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25557313|NCT00672984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25557314|NCT00672984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25557315|NCT00672984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25557316|NCT00672984|Adrenergic Agents|adrenergic agents|mesh-ancestor
24940158|NCT04003350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24922654|NCT04177641|Antioxidants|antioxidants|mesh-list
25557317|NCT00672984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25557318|NCT00673049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25557319|NCT00673049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25557320|NCT00673049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25557321|NCT00673049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557322|NCT00673049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557323|NCT00673075|Carvedilol|carvedilol|mesh-list
25557324|NCT00673075|Nebivolol|nebivolol|mesh-list
25557325|NCT00673075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25557326|NCT00673075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25557327|NCT00673075|Adrenergic Agents|adrenergic agents|mesh-ancestor
25557328|NCT00673075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25557329|NCT00673075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557330|NCT00673075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557331|NCT00673075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25557332|NCT00673075|Antioxidants|antioxidants|mesh-ancestor
25557333|NCT00673075|Protective Agents|protective agents|mesh-ancestor
25557334|NCT00673075|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25557335|NCT00673075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25557336|NCT00673075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25557337|NCT00673075|Vasodilator Agents|vasodilator agents|mesh-ancestor
25557338|NCT00673075|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25557339|NCT00673075|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25557340|NCT00673075|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25557341|NCT00673075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25557342|NCT00673075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25557343|NCT00673127|Ketoconazole|ketoconazole|mesh-list
25557344|NCT00673127|Hydrocortisone|hydrocortisone|mesh-list
25557345|NCT00673127|Dutasteride|dutasteride|mesh-list
25557346|NCT00673127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25557347|NCT00673127|Antifungal Agents|antifungal agents|mesh-ancestor
25557348|NCT00673127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25557349|NCT00673127|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25557350|NCT00673127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25557351|NCT00673127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557352|NCT00673127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557353|NCT00673127|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25557354|NCT00673127|Hormone Antagonists|hormone antagonists|mesh-ancestor
25557355|NCT00673127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25557356|NCT00673127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557357|NCT00673127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25452470|NCT04572685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25452471|NCT04572685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25452472|NCT04572685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452473|NCT04572685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25557358|NCT00673127|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25557359|NCT00673153|Vorinostat|vorinostat|mesh-list
25557360|NCT00673153|Gemtuzumab|gemtuzumab|mesh-list
25557361|NCT00673153|Calicheamicins|calicheamicins|mesh-list
25557362|NCT00673153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25557363|NCT00673153|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25557364|NCT00673153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557365|NCT00673153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557366|NCT00673153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25557367|NCT00673153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25557369|NCT00673231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25557370|NCT00673231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557371|NCT00673231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25557372|NCT00673231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557373|NCT00673244|Furosemide|furosemide|mesh-list
25557374|NCT00673244|Diuretics|diuretics|mesh-ancestor
25557375|NCT00673244|Natriuretic Agents|natriuretic agents|mesh-ancestor
25557376|NCT00673244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557377|NCT00673244|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25557378|NCT00673244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25557379|NCT00673244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557380|NCT00673387|Pramlintide|pramlintide|mesh-list
25557381|NCT00673387|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
25557382|NCT00673387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25557383|NCT00673387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557384|NCT00673387|Appetite Depressants|appetite depressants|mesh-ancestor
25557385|NCT00673387|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25557386|NCT00673387|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
25557387|NCT00673387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557388|NCT00673439|PENTA|penta|mesh-list
24952608|NCT03892525|Atezolizumab|atezolizumab|mesh-list
25557389|NCT00673439|Warfarin|warfarin|mesh-list
25557390|NCT00673439|Fondaparinux|fondaparinux|mesh-list
25557391|NCT00673439|Anticoagulants|anticoagulants|mesh-ancestor
25557392|NCT00673439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25557393|NCT00673439|Antithrombins|antithrombins|mesh-ancestor
25557394|NCT00673439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25557395|NCT00673439|Protease Inhibitors|protease inhibitors|mesh-ancestor
25557396|NCT00673439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557397|NCT00673439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557398|NCT00673439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24878371|NCT01861314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24878372|NCT01861314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24815667|NCT02071537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25266982|NCT02425462|Hormone Antagonists|hormone antagonists|mesh-ancestor
25557399|NCT00673439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25557400|NCT00673452|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25557401|NCT00673452|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25557402|NCT00673452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25557403|NCT00673452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25557404|NCT00673452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557405|NCT00673452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25557406|NCT00673452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557407|NCT00673452|Analgesics|analgesics|mesh-ancestor
25557408|NCT00673452|Sensory System Agents|sensory system agents|mesh-ancestor
25557409|NCT00673452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25557410|NCT00673452|Antidepressive Agents|antidepressive agents|mesh-ancestor
25557411|NCT00673452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25557412|NCT00673452|Dopamine Agents|dopamine agents|mesh-ancestor
25557413|NCT00673465|Metformin|metformin|mesh-list
25557414|NCT00673465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25557415|NCT00673465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557416|NCT00673673|Bevacizumab|bevacizumab|mesh-list
25557417|NCT00673673|Fluorouracil|fluorouracil|mesh-list
25557418|NCT00673673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25557419|NCT00673673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25557420|NCT00673673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25557421|NCT00673673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25557422|NCT00673673|Growth Substances|growth substances|mesh-ancestor
25557423|NCT00673673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557424|NCT00673673|Growth Inhibitors|growth inhibitors|mesh-ancestor
25557425|NCT00673673|Antimetabolites|antimetabolites|mesh-ancestor
25557426|NCT00673673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557427|NCT00673673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25557428|NCT00673673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25557429|NCT00673673|Immunologic Factors|immunologic factors|mesh-ancestor
25557430|NCT00673712|Analgesics, Opioid|analgesics, opioid|mesh-list
25557431|NCT00673712|Narcotics|narcotics|mesh-ancestor
25557432|NCT00673712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25557433|NCT00673712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557434|NCT00673712|Analgesics|analgesics|mesh-ancestor
25557435|NCT00673712|Sensory System Agents|sensory system agents|mesh-ancestor
25050540|NCT00486512|Aspirin|aspirin|mesh-list
25689700|NCT01964326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25557436|NCT00673712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25557437|NCT00673738|Docetaxel|docetaxel|mesh-list
25557438|NCT00673738|Cetuximab|cetuximab|mesh-list
25557439|NCT00673738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25557440|NCT00673738|Tubulin Modulators|tubulin modulators|mesh-ancestor
25557441|NCT00673738|Antimitotic Agents|antimitotic agents|mesh-ancestor
25557442|NCT00673738|Mitosis Modulators|mitosis modulators|mesh-ancestor
25557443|NCT00673738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557444|NCT00673738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25557445|NCT00673764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25557446|NCT00673764|Lubricant Eye Drops|lubricant eye drops|mesh-list
25557447|NCT00673764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25557448|NCT00673790|Losartan|losartan|mesh-list
25557449|NCT00673790|Lisinopril|lisinopril|mesh-list
25557450|NCT00673790|Nebivolol|nebivolol|mesh-list
25557451|NCT00673790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25557452|NCT00673790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25557453|NCT00673790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25557454|NCT00673790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25557455|NCT00673790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557456|NCT00673790|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25557457|NCT00673790|Protease Inhibitors|protease inhibitors|mesh-ancestor
25557458|NCT00673790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557459|NCT00673790|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25557460|NCT00673790|Protective Agents|protective agents|mesh-ancestor
25557461|NCT00673790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557462|NCT00673790|Vasodilator Agents|vasodilator agents|mesh-ancestor
25557463|NCT00673790|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25557464|NCT00673790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25557465|NCT00673790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25557466|NCT00673790|Adrenergic Agents|adrenergic agents|mesh-ancestor
25557467|NCT00673790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25557468|NCT00673816|Sunitinib|sunitinib|mesh-list
25557469|NCT00673816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25557470|NCT00673816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25557471|NCT00673816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25557472|NCT00673816|Growth Substances|growth substances|mesh-ancestor
25557473|NCT00673816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557474|NCT00673816|Growth Inhibitors|growth inhibitors|mesh-ancestor
25557475|NCT00673816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25557476|NCT00673816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557477|NCT00673816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557478|NCT00673855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25557479|NCT00673855|Lubricant Eye Drops|lubricant eye drops|mesh-list
25557480|NCT00673855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25557481|NCT00673881|Choline|choline|mesh-list
25557482|NCT00673881|Fenofibrate|fenofibrate|mesh-list
25557483|NCT00673881|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24878792|NCT00828854|Entinostat|entinostat|mesh-list
25557484|NCT00673881|Antimetabolites|antimetabolites|mesh-ancestor
25557485|NCT00673881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557486|NCT00673881|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25557487|NCT00673881|Lipotropic Agents|lipotropic agents|mesh-ancestor
25557488|NCT00673881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25557489|NCT00673881|Nootropic Agents|nootropic agents|mesh-ancestor
25557490|NCT00673894|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25557491|NCT00673894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25557492|NCT00673894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557493|NCT00673894|Incretins|incretins|mesh-ancestor
25557494|NCT00673894|Hormones|hormones|mesh-ancestor
25557495|NCT00673894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25557496|NCT00673894|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25557497|NCT00673894|Protease Inhibitors|protease inhibitors|mesh-ancestor
25557498|NCT00673894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557499|NCT00673894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557500|NCT00673920|Methotrexate|methotrexate|mesh-list
25557501|NCT00673920|Ocrelizumab|ocrelizumab|mesh-list
25557502|NCT00673920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25557503|NCT00673920|Abortifacient Agents|abortifacient agents|mesh-ancestor
25557504|NCT00673920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25557505|NCT00673920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557506|NCT00673920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25557507|NCT00673920|Antimetabolites|antimetabolites|mesh-ancestor
25557508|NCT00673920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822651|NCT00004580|Antiviral Agents|antiviral agents|mesh-ancestor
25557509|NCT00673920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25557510|NCT00673920|Dermatologic Agents|dermatologic agents|mesh-ancestor
25557511|NCT00673920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557512|NCT00673920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25557513|NCT00673920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25557514|NCT00673920|Immunologic Factors|immunologic factors|mesh-ancestor
25557515|NCT00673920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25557516|NCT00673920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25557517|NCT00673933|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25557518|NCT00673933|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
25557519|NCT00673933|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25557520|NCT00673933|Dermatologic Agents|dermatologic agents|mesh-ancestor
25557521|NCT00673959|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25557522|NCT00673959|Lubricant Eye Drops|lubricant eye drops|mesh-list
25557523|NCT00673959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25557524|NCT00674115|Omeprazole|omeprazole|mesh-list
25557525|NCT00674115|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
25557526|NCT00674115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25557527|NCT00674115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25557528|NCT00674115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25557529|NCT00674115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557530|NCT00674115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557531|NCT00674154|Vitamin D|vitamin d|mesh-list
25557532|NCT00674154|Cholecalciferol|cholecalciferol|mesh-list
25557533|NCT00674154|Vitamins|vitamins|mesh-ancestor
25557534|NCT00674154|Micronutrients|micronutrients|mesh-ancestor
25557535|NCT00674154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557536|NCT00674154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25557537|NCT00674154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25557538|NCT00674206|Gemcitabine|gemcitabine|mesh-list
25557539|NCT00674206|Oxaliplatin|oxaliplatin|mesh-list
25557540|NCT00674206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25557541|NCT00674206|Antimetabolites|antimetabolites|mesh-ancestor
25557542|NCT00674206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557543|NCT00674206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25557544|NCT00674206|Antiviral Agents|antiviral agents|mesh-ancestor
25557545|NCT00674206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25557546|NCT00674206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557547|NCT00674206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25557548|NCT00674206|Immunologic Factors|immunologic factors|mesh-ancestor
25557549|NCT00674206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557550|NCT00674219|Memantine|memantine|mesh-list
25557551|NCT00674219|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25557552|NCT00674219|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25557553|NCT00674219|Dopamine Agents|dopamine agents|mesh-ancestor
25557554|NCT00674219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25557555|NCT00674219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557556|NCT00674219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557557|NCT00674219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25557558|NCT00674219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25557559|NCT00674323|Ranibizumab|ranibizumab|mesh-list
25557560|NCT00674323|Verteporfin|verteporfin|mesh-list
25557561|NCT00674323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25557562|NCT00674323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25557563|NCT00674323|Growth Substances|growth substances|mesh-ancestor
25557564|NCT00674323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557565|NCT00674323|Growth Inhibitors|growth inhibitors|mesh-ancestor
25557566|NCT00674323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25557567|NCT00674323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25557568|NCT00674323|Dermatologic Agents|dermatologic agents|mesh-ancestor
25056708|NCT03510208|Immunologic Factors|immunologic factors|mesh-ancestor
25056709|NCT03510208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879009|NCT05171374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24879010|NCT05171374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815702|NCT02071615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25651561|NCT01517893|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25651562|NCT01517893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25651563|NCT01517893|Antimetabolites|antimetabolites|mesh-ancestor
25651564|NCT01517893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651565|NCT01517893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25651566|NCT01517893|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25651567|NCT01517893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651568|NCT01517984|Mycophenolic Acid|mycophenolic acid|mesh-list
25651569|NCT01517984|Prednisone|prednisone|mesh-list
25651570|NCT01517984|Tacrolimus|tacrolimus|mesh-list
25651571|NCT01517984|Thymoglobulin|thymoglobulin|mesh-list
25651572|NCT01517984|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25651573|NCT01517984|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25651574|NCT01517984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
25651575|NCT01517984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25651576|NCT01517984|Glucocorticoids|glucocorticoids|mesh-ancestor
25557569|NCT00674362|Certolizumab Pegol|certolizumab pegol|mesh-list
25557570|NCT00674362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25557571|NCT00674362|Immunologic Factors|immunologic factors|mesh-ancestor
25557572|NCT00674362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557573|NCT00674362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25557574|NCT00674570|Cycloserine|cycloserine|mesh-list
25557575|NCT00674570|Hydrocortisone|hydrocortisone|mesh-list
25557576|NCT00674570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25557577|NCT00674570|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25557578|NCT00674570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25557579|NCT00674570|Renal Agents|renal agents|mesh-ancestor
24428975|NCT00242164|Dialysis Solutions|dialysis solutions|mesh-list
25557580|NCT00674570|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25557581|NCT00674570|Antitubercular Agents|antitubercular agents|mesh-ancestor
25557582|NCT00674570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25557583|NCT00674570|Antimetabolites|antimetabolites|mesh-ancestor
25557584|NCT00674570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557585|NCT00674583|Vaccines|vaccines|mesh-list
25557586|NCT00674583|Immunologic Factors|immunologic factors|mesh-ancestor
25557587|NCT00674583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557588|NCT00674609|Nabiximols|nabiximols|mesh-list
25557589|NCT00674609|Analgesics|analgesics|mesh-ancestor
25557590|NCT00674609|Sensory System Agents|sensory system agents|mesh-ancestor
25557591|NCT00674609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25452747|NCT04570150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25452748|NCT04570306|Belimumab|belimumab|mesh-list
25452749|NCT04570306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25452750|NCT04570306|Immunologic Factors|immunologic factors|mesh-ancestor
25452751|NCT04570306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452752|NCT04570033|Parathyroid Hormone|parathyroid hormone|mesh-list
25452753|NCT04570033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25452754|NCT04570033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452755|NCT04569838|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25452756|NCT04569838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25452757|NCT04569838|Alkylating Agents|alkylating agents|mesh-ancestor
25452758|NCT04569838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452759|NCT04569838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25452760|NCT04569916|Irinotecan|irinotecan|mesh-list
25452761|NCT04569916|Apatinib|apatinib|mesh-list
25452762|NCT04569916|Antibodies|antibodies|mesh-list
25452763|NCT04569916|Immunologic Factors|immunologic factors|mesh-ancestor
25452764|NCT04569916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452765|NCT04569916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25452766|NCT04569916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25452767|NCT04569916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452768|NCT04569916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452769|NCT04569916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25452770|NCT04569916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25452771|NCT04569890|Hydroxychloroquine|hydroxychloroquine|mesh-list
25557592|NCT00674609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557593|NCT00674661|Riboflavin|riboflavin|mesh-list
25557594|NCT00674661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24880520|NCT03608358|Protease Inhibitors|protease inhibitors|mesh-ancestor
25557595|NCT00674661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25557596|NCT00674661|Vitamin B Complex|vitamin b complex|mesh-ancestor
25557597|NCT00674661|Vitamins|vitamins|mesh-ancestor
25557598|NCT00674661|Micronutrients|micronutrients|mesh-ancestor
24880913|NCT03179904|Letrozole|letrozole|mesh-list
25557599|NCT00674661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557600|NCT00674661|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25557601|NCT00674661|Dermatologic Agents|dermatologic agents|mesh-ancestor
25557602|NCT00674700|Immunologic Factors|immunologic factors|mesh-list
25557603|NCT00674700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557604|NCT00674739|Imiquimod|imiquimod|mesh-list
25557605|NCT00674739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25557606|NCT00674739|Immunologic Factors|immunologic factors|mesh-ancestor
25557607|NCT00674739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557608|NCT00674739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25557609|NCT00674739|Interferon Inducers|interferon inducers|mesh-ancestor
25557610|NCT00674765|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25557611|NCT00674765|Antidepressive Agents|antidepressive agents|mesh-ancestor
25557612|NCT00674765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25557613|NCT00674765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25557614|NCT00674765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25557615|NCT00674765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25557616|NCT00674765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557617|NCT00674973|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25557618|NCT00674973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25651577|NCT01517984|Hormones|hormones|mesh-ancestor
25557619|NCT00674973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25557620|NCT00674973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557621|NCT00674973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557623|NCT00675025|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25557624|NCT00675025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431877|NCT00253162|Serotonin Agents|serotonin agents|mesh-ancestor
24431878|NCT00253162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431879|NCT00253162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431880|NCT00253162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431881|NCT00253162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24431882|NCT00253162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25557625|NCT00675025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557626|NCT00675025|Cholinergic Agents|cholinergic agents|mesh-ancestor
25557627|NCT00675025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25557628|NCT00675025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557629|NCT00675025|Nootropic Agents|nootropic agents|mesh-ancestor
25557630|NCT00675259|Paclitaxel|paclitaxel|mesh-list
25557631|NCT00675259|Bevacizumab|bevacizumab|mesh-list
25557632|NCT00675259|Carboplatin|carboplatin|mesh-list
25557633|NCT00675259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25557634|NCT00675259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25557635|NCT00675259|Tubulin Modulators|tubulin modulators|mesh-ancestor
25557636|NCT00675259|Antimitotic Agents|antimitotic agents|mesh-ancestor
25557637|NCT00675259|Mitosis Modulators|mitosis modulators|mesh-ancestor
25557638|NCT00675259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557639|NCT00675259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25557640|NCT00675259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25557641|NCT00675259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25557642|NCT00675259|Growth Substances|growth substances|mesh-ancestor
25267092|NCT02424461|Renal Agents|renal agents|mesh-ancestor
25267093|NCT02424461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24432916|NCT00256932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25557643|NCT00675259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557644|NCT00675259|Growth Inhibitors|growth inhibitors|mesh-ancestor
25557645|NCT00675428|Natalizumab|natalizumab|mesh-list
25557646|NCT00675428|Immunologic Factors|immunologic factors|mesh-ancestor
25557647|NCT00675428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557648|NCT00675441|Lenalidomide|lenalidomide|mesh-list
25557649|NCT00675441|Immunologic Factors|immunologic factors|mesh-ancestor
25557650|NCT00675441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557651|NCT00675441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24825321|NCT02128191|Ibuprofen|ibuprofen|mesh-list
25557652|NCT00675441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25557653|NCT00675441|Growth Substances|growth substances|mesh-ancestor
25557654|NCT00675441|Growth Inhibitors|growth inhibitors|mesh-ancestor
25557655|NCT00675441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25557656|NCT00675506|Hormones|hormones|mesh-list
25557657|NCT00675506|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
25557658|NCT00675506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25557659|NCT00675506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267119|NCT02424435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267120|NCT02424136|Nitric Oxide|nitric oxide|mesh-list
25267121|NCT02424136|Immunoglobulins|immunoglobulins|mesh-list
24434825|NCT00263796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467196|NCT00376519|Cyclosporine|cyclosporine|mesh-list
25557660|NCT00675584|Budesonide|budesonide|mesh-list
25557661|NCT00675584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25557662|NCT00675584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25557663|NCT00675584|Autonomic Agents|autonomic agents|mesh-ancestor
25557664|NCT00675584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25557665|NCT00675584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557666|NCT00675584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25557667|NCT00675584|Respiratory System Agents|respiratory system agents|mesh-ancestor
25557668|NCT00675584|Glucocorticoids|glucocorticoids|mesh-ancestor
25557669|NCT00675584|Hormones|hormones|mesh-ancestor
25557670|NCT00675584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25557671|NCT00675597|Bevacizumab|bevacizumab|mesh-list
25557672|NCT00675597|Docetaxel|docetaxel|mesh-list
25557673|NCT00675597|Vinorelbine|vinorelbine|mesh-list
25557674|NCT00675597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25557675|NCT00675597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25557676|NCT00675597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25267125|NCT02424136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267126|NCT02424136|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25557677|NCT00675597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25557678|NCT00675597|Growth Substances|growth substances|mesh-ancestor
25557679|NCT00675597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557680|NCT00675597|Growth Inhibitors|growth inhibitors|mesh-ancestor
25557681|NCT00675597|Tubulin Modulators|tubulin modulators|mesh-ancestor
25557682|NCT00675597|Antimitotic Agents|antimitotic agents|mesh-ancestor
25557683|NCT00675597|Mitosis Modulators|mitosis modulators|mesh-ancestor
25557684|NCT00675597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882183|NCT02735707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24435507|NCT00266591|Topiramate|topiramate|mesh-list
25557685|NCT00675597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25557686|NCT00675792|Bromides|bromides|mesh-list
25557687|NCT00675792|Rocuronium|rocuronium|mesh-list
25557688|NCT00675792|Neostigmine|neostigmine|mesh-list
25557689|NCT00675792|Anticonvulsants|anticonvulsants|mesh-ancestor
25557690|NCT00675792|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25557691|NCT00675792|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25557692|NCT00675792|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25557693|NCT00675792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25557694|NCT00675792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557695|NCT00675792|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25557697|NCT00675792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557698|NCT00675792|Cholinergic Agents|cholinergic agents|mesh-ancestor
25557699|NCT00675792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25557700|NCT00675792|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25557701|NCT00675792|Autonomic Agents|autonomic agents|mesh-ancestor
25557702|NCT00675909|Midazolam|midazolam|mesh-list
25557703|NCT00675909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25557704|NCT00675909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25557705|NCT00675909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25557706|NCT00675909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557707|NCT00675909|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25557708|NCT00675909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25557709|NCT00675909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25557710|NCT00675909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25557711|NCT00675909|Anesthetics, General|anesthetics, general|mesh-ancestor
25557712|NCT00675909|Anesthetics|anesthetics|mesh-ancestor
24825601|NCT02129257|Fluorouracil|fluorouracil|mesh-list
24825602|NCT02129257|Irinotecan|irinotecan|mesh-list
24825603|NCT02129257|Aflibercept|aflibercept|mesh-list
25557713|NCT00675909|GABA Modulators|gaba modulators|mesh-ancestor
25557714|NCT00675909|GABA Agents|gaba agents|mesh-ancestor
25557715|NCT00675909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25557716|NCT00675909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557717|NCT00675922|Silver Nitrate|silver nitrate|mesh-list
25557718|NCT00675922|Mafenide|mafenide|mesh-list
25557719|NCT00675922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25557720|NCT00675922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25557721|NCT00675922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25557722|NCT00675922|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25557723|NCT00675922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557724|NCT00675922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557725|NCT00675948|Nabiximols|nabiximols|mesh-list
25689848|NCT01965535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25689849|NCT01965756|Metformin|metformin|mesh-list
25689850|NCT01965756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25689851|NCT01965756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689852|NCT01965834|Fenofibrate|fenofibrate|mesh-list
25689853|NCT01965834|Fenofibric acid|fenofibric acid|mesh-list
25689854|NCT01965834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25557726|NCT00675948|Analgesics|analgesics|mesh-ancestor
25557727|NCT00675948|Sensory System Agents|sensory system agents|mesh-ancestor
25557728|NCT00675948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25557729|NCT00675948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557730|NCT00675987|Losartan|losartan|mesh-list
25557731|NCT00675987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25557732|NCT00675987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25557733|NCT00675987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25557734|NCT00675987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25557735|NCT00675987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557736|NCT00676091|Vaccines|vaccines|mesh-list
25557737|NCT00676091|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25557738|NCT00676091|Immunologic Factors|immunologic factors|mesh-ancestor
25689857|NCT01965834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25689858|NCT01965834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24816188|NCT02074878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816189|NCT02074891|Tenofovir|tenofovir|mesh-list
24816190|NCT02074891|Antiviral Agents|antiviral agents|mesh-ancestor
24816191|NCT02074891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25267184|NCT02423915|Fludarabine phosphate|fludarabine phosphate|mesh-list
25267166|NCT02423954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25267167|NCT02423954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25557739|NCT00676091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557740|NCT00676130|Trimethoprim|trimethoprim|mesh-list
25557741|NCT00676130|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25557742|NCT00676130|Sulfamethoxazole|sulfamethoxazole|mesh-list
25557743|NCT00676130|Cephalexin|cephalexin|mesh-list
25557744|NCT00676130|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25557745|NCT00676130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25557746|NCT00676130|Renal Agents|renal agents|mesh-ancestor
25557747|NCT00676130|Antimalarials|antimalarials|mesh-ancestor
25557748|NCT00676130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25689859|NCT01966003|Paclitaxel|paclitaxel|mesh-list
25689860|NCT01966003|Bevacizumab|bevacizumab|mesh-list
24393455|NCT00130091|Analgesics|analgesics|mesh-ancestor
24883071|NCT04588818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057318|NCT03506178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25057319|NCT03506178|Nasal Decongestants|nasal decongestants|mesh-ancestor
25557749|NCT00676130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25557750|NCT00676130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25557751|NCT00676130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557752|NCT00676130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557753|NCT00676130|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25557754|NCT00676130|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25557755|NCT00676130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25557756|NCT00676130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24507577|NCT00551005|Analgesics|analgesics|mesh-ancestor
24883313|NCT03991403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440110|NCT00281788|Paclitaxel|paclitaxel|mesh-list
25557757|NCT00676195|Acetylcysteine|acetylcysteine|mesh-list
25557758|NCT00676195|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25557759|NCT00676195|Antiviral Agents|antiviral agents|mesh-ancestor
25557760|NCT00676195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25557761|NCT00676195|Expectorants|expectorants|mesh-ancestor
25557762|NCT00676195|Respiratory System Agents|respiratory system agents|mesh-ancestor
25557763|NCT00676195|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25557764|NCT00676195|Antioxidants|antioxidants|mesh-ancestor
25557765|NCT00676195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557766|NCT00676195|Protective Agents|protective agents|mesh-ancestor
25452921|NCT04568161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25452922|NCT04568161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25452923|NCT04568018|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25452924|NCT04568018|Respiratory System Agents|respiratory system agents|mesh-ancestor
25452925|NCT04567576|Antirheumatic Agents|antirheumatic agents|mesh-list
25452926|NCT04567433|Hydrocortisone|hydrocortisone|mesh-list
25452927|NCT04567433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25452928|NCT04567290|Ticagrelor|ticagrelor|mesh-list
25452929|NCT04567290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25452930|NCT04567290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25452931|NCT04567290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25452932|NCT04567290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25452933|NCT04567290|Purinergic Agents|purinergic agents|mesh-ancestor
25452934|NCT04567290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25452935|NCT04567290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452936|NCT04567290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452937|NCT04566952|Olaparib|olaparib|mesh-list
25452938|NCT04566952|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25452939|NCT04566952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452940|NCT04566952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452941|NCT04566952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309096|NCT02487108|Respiratory System Agents|respiratory system agents|mesh-ancestor
25309097|NCT02487108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25309098|NCT02487108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25309099|NCT02487108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24883381|NCT03926624|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24883382|NCT03926624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25309100|NCT02455557|Temozolomide|temozolomide|mesh-list
25309101|NCT02455557|Sargramostim|sargramostim|mesh-list
25309102|NCT02455557|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25309103|NCT02455557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25309111|NCT02455141|Carboplatin|carboplatin|mesh-list
25040732|NCT02917629|Pioglitazone|pioglitazone|mesh-list
25040733|NCT02917629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25040734|NCT02917629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040735|NCT02913612|Timolol|timolol|mesh-list
25040736|NCT02913612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25040737|NCT02913612|Maleic acid|maleic acid|mesh-list
25040738|NCT02913612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25040739|NCT02913612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25040740|NCT02913612|Adrenergic Agents|adrenergic agents|mesh-ancestor
25040741|NCT02913612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25040742|NCT02913612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040743|NCT02913612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040744|NCT02913612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25557767|NCT00676195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557768|NCT00676195|Antidotes|antidotes|mesh-ancestor
25557769|NCT00676338|Metformin|metformin|mesh-list
25557770|NCT00676338|Pioglitazone|pioglitazone|mesh-list
25557771|NCT00676338|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25557772|NCT00676338|Exenatide|exenatide|mesh-list
25557773|NCT00676338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25557774|NCT00676338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557775|NCT00676338|Incretins|incretins|mesh-ancestor
25557776|NCT00676338|Hormones|hormones|mesh-ancestor
25557777|NCT00676338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25557778|NCT00676338|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25557779|NCT00676338|Protease Inhibitors|protease inhibitors|mesh-ancestor
25557780|NCT00676338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557781|NCT00676338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557782|NCT00676338|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25557783|NCT00676364|Lidocaine|lidocaine|mesh-list
25557784|NCT00676364|Anesthetics, Local|anesthetics, local|mesh-list
25557785|NCT00676364|Anesthetics|anesthetics|mesh-list
25557786|NCT00676364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25557787|NCT00676364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557788|NCT00676364|Sensory System Agents|sensory system agents|mesh-ancestor
25557789|NCT00676364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25557790|NCT00676364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25557791|NCT00676364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25557792|NCT00676364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25557793|NCT00676364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25557794|NCT00676364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557795|NCT00676403|Pregabalin|pregabalin|mesh-list
25557796|NCT00676403|Analgesics|analgesics|mesh-ancestor
25557797|NCT00676403|Sensory System Agents|sensory system agents|mesh-ancestor
25557798|NCT00676403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25557799|NCT00676403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557800|NCT00676403|Anticonvulsants|anticonvulsants|mesh-ancestor
25057442|NCT03505008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267195|NCT02423915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25267198|NCT02423915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24705114|NCT01482156|Everolimus|everolimus|mesh-list
24443079|NCT00293631|Piroxicam|piroxicam|mesh-list
24825941|NCT02131012|Analgesics|analgesics|mesh-ancestor
24825942|NCT02131012|Sensory System Agents|sensory system agents|mesh-ancestor
24609337|NCT00996099|Insulin|insulin|mesh-list
25267199|NCT02423915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25267200|NCT02423915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25267206|NCT02424045|Carboplatin|carboplatin|mesh-list
25557801|NCT00676403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25557802|NCT00676403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25557803|NCT00676403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557804|NCT00676403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25557805|NCT00676403|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25557806|NCT00676403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25557807|NCT00676403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25557808|NCT00676403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25557809|NCT00676520|Everolimus|everolimus|mesh-list
25557810|NCT00676520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25557811|NCT00676520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25557812|NCT00676520|Immunologic Factors|immunologic factors|mesh-ancestor
25557813|NCT00676520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557814|NCT00676585|Hydrocortisone|hydrocortisone|mesh-list
25557815|NCT00676585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25557816|NCT00676650|Prednisone|prednisone|mesh-list
25557817|NCT00676650|Sunitinib|sunitinib|mesh-list
25557818|NCT00676650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25557819|NCT00676650|Glucocorticoids|glucocorticoids|mesh-ancestor
25557820|NCT00676650|Hormones|hormones|mesh-ancestor
25557821|NCT00676650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25557822|NCT00676650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557823|NCT00676650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24883543|NCT05238064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24883544|NCT05238064|Alkylating Agents|alkylating agents|mesh-ancestor
25267207|NCT02424045|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25267208|NCT02424045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25267209|NCT02424045|Antiemetics|antiemetics|mesh-ancestor
25267210|NCT02424045|Autonomic Agents|autonomic agents|mesh-ancestor
25267211|NCT02424045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267212|NCT02424045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443153|NCT00293787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24443166|NCT00293800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24443167|NCT00293826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24443168|NCT00293826|Immunologic Factors|immunologic factors|mesh-ancestor
25557824|NCT00676650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25557825|NCT00676650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25557826|NCT00676650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25557827|NCT00676650|Growth Substances|growth substances|mesh-ancestor
25557828|NCT00676650|Growth Inhibitors|growth inhibitors|mesh-ancestor
25557829|NCT00676650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25557830|NCT00676650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557831|NCT00676650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557832|NCT00676676|Testosterone|testosterone|mesh-list
25557833|NCT00676676|Androgens|androgens|mesh-ancestor
25557834|NCT00676676|Hormones|hormones|mesh-ancestor
25557835|NCT00676676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25557836|NCT00676676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557837|NCT00676806|Cyclophosphamide|cyclophosphamide|mesh-list
25557838|NCT00676806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25557839|NCT00676806|Immunologic Factors|immunologic factors|mesh-ancestor
25557840|NCT00676806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952745|NCT03892421|Autonomic Agents|autonomic agents|mesh-ancestor
24952746|NCT03892421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24952747|NCT03892421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24952748|NCT03892421|Glucocorticoids|glucocorticoids|mesh-ancestor
24811764|NCT02048293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883611|NCT05237323|Mycophenolic Acid|mycophenolic acid|mesh-list
24883612|NCT05237323|Azathioprine|azathioprine|mesh-list
24883613|NCT05237323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24883614|NCT05237323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24443207|NCT00293969|Analgesics|analgesics|mesh-ancestor
25557841|NCT00676806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25557842|NCT00676806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25557843|NCT00676806|Alkylating Agents|alkylating agents|mesh-ancestor
25557844|NCT00676806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557845|NCT00676806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25557846|NCT00676806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25557847|NCT00676897|Simvastatin|simvastatin|mesh-list
25557848|NCT00676897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25557849|NCT00676897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25557850|NCT00676897|Antimetabolites|antimetabolites|mesh-ancestor
25557851|NCT00676897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557852|NCT00676897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25557853|NCT00676897|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25557854|NCT00676897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557855|NCT00677092|Imatinib Mesylate|imatinib mesylate|mesh-list
25557856|NCT00677092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25557857|NCT00677092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25557858|NCT00677092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557859|NCT00677092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557860|NCT00677352|Sertraline|sertraline|mesh-list
25557861|NCT00677352|Paroxetine|paroxetine|mesh-list
25557862|NCT00677352|Antidepressive Agents|antidepressive agents|mesh-ancestor
25557863|NCT00677352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25557864|NCT00677352|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25557865|NCT00677352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25557866|NCT00677352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25557867|NCT00677352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557868|NCT00677352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25557869|NCT00677352|Serotonin Agents|serotonin agents|mesh-ancestor
25557870|NCT00677352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557871|NCT00677352|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25557872|NCT00677352|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25557873|NCT00677352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25557874|NCT00677352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557875|NCT00677365|Levofloxacin|levofloxacin|mesh-list
25557876|NCT00677365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25557877|NCT00677365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24671814|NCT01328015|Oxybutynin|oxybutynin|mesh-list
25557878|NCT00677365|Renal Agents|renal agents|mesh-ancestor
25557879|NCT00677365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25557880|NCT00677365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25557881|NCT00677365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25557882|NCT00677365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557883|NCT00677365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557884|NCT00677365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25557885|NCT00677365|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25557886|NCT00677365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25557887|NCT00677534|Vitamin D|vitamin d|mesh-list
25557888|NCT00677534|Cholecalciferol|cholecalciferol|mesh-list
25557889|NCT00677534|Ergocalciferols|ergocalciferols|mesh-list
25557890|NCT00677534|Vitamins|vitamins|mesh-ancestor
25557891|NCT00677534|Micronutrients|micronutrients|mesh-ancestor
25557892|NCT00677534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557893|NCT00677534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25557894|NCT00677534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25557895|NCT00677833|Azithromycin|azithromycin|mesh-list
25557896|NCT00677833|Chloroquine|chloroquine|mesh-list
25557897|NCT00677833|Lumefantrine|lumefantrine|mesh-list
25557898|NCT00677833|Artemether|artemether|mesh-list
25557899|NCT00677833|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25557900|NCT00677833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25557901|NCT00677833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25557902|NCT00677833|Amebicides|amebicides|mesh-ancestor
25557903|NCT00677833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25557904|NCT00677833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25557905|NCT00677833|Antimalarials|antimalarials|mesh-ancestor
25557906|NCT00677833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25557907|NCT00677924|Zalutumumab|zalutumumab|mesh-list
25557908|NCT00677924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25557909|NCT00677924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25557910|NCT00678015|Masoprocol|masoprocol|mesh-list
25557911|NCT00678015|Antioxidants|antioxidants|mesh-ancestor
25557912|NCT00678015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557913|NCT00678015|Protective Agents|protective agents|mesh-ancestor
25689910|NCT01967173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25689911|NCT01967173|Autonomic Agents|autonomic agents|mesh-ancestor
25689912|NCT01967173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25689913|NCT01967173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610450|NCT01002157|Vitamin K|vitamin k|mesh-list
25267261|NCT02423759|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25267262|NCT02423694|Dexetimide|dexetimide|mesh-list
25267263|NCT02423694|Citalopram|citalopram|mesh-list
25267264|NCT02423694|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25557914|NCT00678015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557915|NCT00678015|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25557916|NCT00678015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557917|NCT00678015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25557918|NCT00678015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25557919|NCT00678015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25557920|NCT00678015|Analgesics|analgesics|mesh-ancestor
25557921|NCT00678015|Sensory System Agents|sensory system agents|mesh-ancestor
25557922|NCT00678015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25557923|NCT00678015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25557924|NCT00678015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25557925|NCT00678080|Metformin|metformin|mesh-list
25557926|NCT00678080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25557927|NCT00678080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557928|NCT00678210|Tofacitinib|tofacitinib|mesh-list
25557929|NCT00678210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25557930|NCT00678210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557931|NCT00678210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557932|NCT00678301|Vaccines|vaccines|mesh-list
25557933|NCT00678301|Immunologic Factors|immunologic factors|mesh-ancestor
25557934|NCT00678301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557935|NCT00678379|Lidocaine|lidocaine|mesh-list
25557936|NCT00678379|Clonidine|clonidine|mesh-list
25557937|NCT00678379|Bupivacaine|bupivacaine|mesh-list
25557938|NCT00678379|Anesthetics, Local|anesthetics, local|mesh-ancestor
25267267|NCT02423694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557939|NCT00678379|Anesthetics|anesthetics|mesh-ancestor
25557940|NCT00678379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25557941|NCT00678379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557942|NCT00678379|Sensory System Agents|sensory system agents|mesh-ancestor
25557943|NCT00678379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25557944|NCT00678379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25557945|NCT00678379|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25453066|NCT04564456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25453067|NCT04564456|Respiratory System Agents|respiratory system agents|mesh-ancestor
25453068|NCT04564456|Dermatologic Agents|dermatologic agents|mesh-ancestor
25453069|NCT04564456|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25453070|NCT04564456|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25453071|NCT04564456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25453072|NCT04564456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25453073|NCT04564456|Adrenergic Agents|adrenergic agents|mesh-ancestor
25453074|NCT04564456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25453075|NCT04564456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453076|NCT04564456|Glucocorticoids|glucocorticoids|mesh-ancestor
25453078|NCT04564456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25453079|NCT04564456|Sympathomimetics|sympathomimetics|mesh-ancestor
25453080|NCT04564430|Clonidine|clonidine|mesh-list
25453081|NCT04564430|Analgesics|analgesics|mesh-ancestor
25453082|NCT04564430|Sensory System Agents|sensory system agents|mesh-ancestor
25453083|NCT04564430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25453084|NCT04564430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453085|NCT04564430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25453086|NCT04564430|Sympatholytics|sympatholytics|mesh-ancestor
25453087|NCT04564430|Autonomic Agents|autonomic agents|mesh-ancestor
25453088|NCT04564430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25453089|NCT04564430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25689919|NCT01967173|Sympathomimetics|sympathomimetics|mesh-ancestor
24826427|NCT02134366|Lorazepam|lorazepam|mesh-list
25453090|NCT04564430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25453091|NCT04564430|Adrenergic Agents|adrenergic agents|mesh-ancestor
25453092|NCT04564430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25453093|NCT04564430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040745|NCT02913612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25040746|NCT02913612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25040747|NCT02907359|Guadecitabine|guadecitabine|mesh-list
24997345|NCT05133687|Bupivacaine|bupivacaine|mesh-list
24997420|NCT04964622|Ibuprofen|ibuprofen|mesh-list
24997421|NCT04964622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24997422|NCT04964622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24997423|NCT04964622|Analgesics|analgesics|mesh-ancestor
24997424|NCT04964622|Sensory System Agents|sensory system agents|mesh-ancestor
24997425|NCT04964622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24997426|NCT04964622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997427|NCT04964622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24997428|NCT04964622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25822652|NCT00004580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24420056|NCT00215046|Vinblastine|vinblastine|mesh-list
25161859|NCT02240407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161860|NCT02240407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25161861|NCT02240407|Anesthetics, Local|anesthetics, local|mesh-ancestor
25161862|NCT02240407|Anesthetics|anesthetics|mesh-ancestor
25121079|NCT00583778|Ipratropium|ipratropium|mesh-list
25557946|NCT00678379|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25557947|NCT00678379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25557948|NCT00678379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557949|NCT00678379|Analgesics|analgesics|mesh-ancestor
25557950|NCT00678379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25557951|NCT00678379|Sympatholytics|sympatholytics|mesh-ancestor
25557952|NCT00678379|Autonomic Agents|autonomic agents|mesh-ancestor
25557953|NCT00678379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25557954|NCT00678379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25557955|NCT00678379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25557956|NCT00678379|Adrenergic Agents|adrenergic agents|mesh-ancestor
25557957|NCT00678379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25557958|NCT00678392|Sorafenib|sorafenib|mesh-list
25557959|NCT00678392|Axitinib|axitinib|mesh-list
25557960|NCT00678392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25557961|NCT00678392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25557962|NCT00678392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557963|NCT00678392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557964|NCT00678418|Naltrexone|naltrexone|mesh-list
25557965|NCT00678418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25557966|NCT00678418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25557967|NCT00678418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557968|NCT00678418|Sensory System Agents|sensory system agents|mesh-ancestor
25557969|NCT00678418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25557970|NCT00678470|Alefacept|alefacept|mesh-list
25557971|NCT00678470|Dermatologic Agents|dermatologic agents|mesh-ancestor
25057683|NCT03503136|Antimetabolites|antimetabolites|mesh-ancestor
25267298|NCT02423642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25267299|NCT02423603|Paclitaxel|paclitaxel|mesh-list
25267300|NCT02423603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25557972|NCT00678470|Immunologic Factors|immunologic factors|mesh-ancestor
25557973|NCT00678470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557974|NCT00678535|Cisplatin|cisplatin|mesh-list
25557975|NCT00678535|Capecitabine|capecitabine|mesh-list
25557976|NCT00678535|Cetuximab|cetuximab|mesh-list
25557977|NCT00678535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25557978|NCT00678535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25557979|NCT00678535|Antimetabolites|antimetabolites|mesh-ancestor
25557980|NCT00678535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557981|NCT00678535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25557982|NCT00678561|Tofacitinib|tofacitinib|mesh-list
25557983|NCT00678561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25557984|NCT00678561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25557985|NCT00678561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557986|NCT00678652|Vaccines|vaccines|mesh-list
25557987|NCT00678652|Immunologic Factors|immunologic factors|mesh-ancestor
25557988|NCT00678652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557989|NCT00678691|Modafinil|modafinil|mesh-list
25557990|NCT00678691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25557991|NCT00678691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25557992|NCT00678691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25557993|NCT00678691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25557994|NCT00678691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25557995|NCT00678691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25557996|NCT00678795|Nabiximols|nabiximols|mesh-list
25557997|NCT00678795|Analgesics|analgesics|mesh-ancestor
25557998|NCT00678795|Sensory System Agents|sensory system agents|mesh-ancestor
25557999|NCT00678795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25558000|NCT00678795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558001|NCT00678834|Tocopherols|tocopherols|mesh-list
25558002|NCT00678834|Vitamin E|vitamin e|mesh-list
25558003|NCT00678834|Tocotrienols|tocotrienols|mesh-list
25267306|NCT02423824|Liraglutide|liraglutide|mesh-list
25267307|NCT02423824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25267308|NCT02423824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267309|NCT02423824|Incretins|incretins|mesh-ancestor
25267310|NCT02423824|Hormones|hormones|mesh-ancestor
25267311|NCT02423824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25267312|NCT02423395|Orphenadrine|orphenadrine|mesh-list
25267313|NCT02423395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267314|NCT02423395|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25267315|NCT02423395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24516752|NCT00603109|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
25050598|NCT00484419|Hormones|hormones|mesh-ancestor
25558004|NCT00678834|alpha-Tocopherol|alpha-tocopherol|mesh-list
25558005|NCT00678834|Antioxidants|antioxidants|mesh-ancestor
25558006|NCT00678834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558007|NCT00678834|Protective Agents|protective agents|mesh-ancestor
25558008|NCT00678834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558009|NCT00678834|Vitamins|vitamins|mesh-ancestor
25558010|NCT00678834|Micronutrients|micronutrients|mesh-ancestor
25558011|NCT00678886|Muromonab-CD3|muromonab-cd3|mesh-list
25558012|NCT00678886|Immunologic Factors|immunologic factors|mesh-ancestor
25558013|NCT00678886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558014|NCT00678886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25558015|NCT00679029|Gemcitabine|gemcitabine|mesh-list
25558016|NCT00679029|Cyclophosphamide|cyclophosphamide|mesh-list
25558017|NCT00679029|Bevacizumab|bevacizumab|mesh-list
25558018|NCT00679029|Doxorubicin|doxorubicin|mesh-list
25558019|NCT00679029|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25558020|NCT00679029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25558021|NCT00679029|Antibodies|antibodies|mesh-list
25558022|NCT00679029|Immunoglobulins|immunoglobulins|mesh-list
25558023|NCT00679029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25558024|NCT00679029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25558025|NCT00679029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558026|NCT00679029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25558027|NCT00679029|Immunologic Factors|immunologic factors|mesh-ancestor
25558028|NCT00679029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558029|NCT00679029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25558030|NCT00679029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25558031|NCT00679029|Alkylating Agents|alkylating agents|mesh-ancestor
25558032|NCT00679029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25689926|NCT01967225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25267323|NCT02423395|Cholinergic Agents|cholinergic agents|mesh-ancestor
25558033|NCT00679029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25558034|NCT00679029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25558035|NCT00679029|Growth Substances|growth substances|mesh-ancestor
25558036|NCT00679029|Growth Inhibitors|growth inhibitors|mesh-ancestor
25558037|NCT00679029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25558038|NCT00679029|Antimetabolites|antimetabolites|mesh-ancestor
25558039|NCT00679029|Antiviral Agents|antiviral agents|mesh-ancestor
25558040|NCT00679029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25558041|NCT00679029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25558042|NCT00679029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25558043|NCT00679029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25558044|NCT00679029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25558045|NCT00679211|Trastuzumab|trastuzumab|mesh-list
25558046|NCT00679211|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25558047|NCT00679211|Maytansine|maytansine|mesh-list
25558048|NCT00679211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25558049|NCT00679211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25558050|NCT00679211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25558051|NCT00679211|Tubulin Modulators|tubulin modulators|mesh-ancestor
25558052|NCT00679211|Antimitotic Agents|antimitotic agents|mesh-ancestor
25558053|NCT00679211|Mitosis Modulators|mitosis modulators|mesh-ancestor
25558054|NCT00679211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558055|NCT00679289|Interferons|interferons|mesh-list
25558056|NCT00679289|Ecromeximab|ecromeximab|mesh-list
25558057|NCT00679289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25558058|NCT00679289|Antiviral Agents|antiviral agents|mesh-ancestor
25558059|NCT00679289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25558060|NCT00679289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25558061|NCT00679302|Trimethoprim|trimethoprim|mesh-list
25558062|NCT00679302|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25558063|NCT00679302|Sulfamethoxazole|sulfamethoxazole|mesh-list
25558064|NCT00679302|Simethicone|simethicone|mesh-list
25558065|NCT00679302|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25558066|NCT00679302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25558067|NCT00679302|Renal Agents|renal agents|mesh-ancestor
25558068|NCT00679302|Antimalarials|antimalarials|mesh-ancestor
25558069|NCT00679302|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25558070|NCT00679302|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25558071|NCT00679302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25558072|NCT00679302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25558073|NCT00679302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558074|NCT00679302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25558075|NCT00679302|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25558076|NCT00679302|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25558077|NCT00679302|Antifoaming Agents|antifoaming agents|mesh-ancestor
25558078|NCT00679302|Emollients|emollients|mesh-ancestor
25558079|NCT00679302|Dermatologic Agents|dermatologic agents|mesh-ancestor
25558080|NCT00679302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25558081|NCT00679341|Docetaxel|docetaxel|mesh-list
24745628|NCT03673826|Dexamethasone|dexamethasone|mesh-list
24410189|NCT00184847|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24745651|NCT03662919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24745652|NCT03662685|Coal Tar|coal tar|mesh-list
25050611|NCT00483977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25558082|NCT00679341|Trastuzumab|trastuzumab|mesh-list
25558083|NCT00679341|Maytansine|maytansine|mesh-list
25558084|NCT00679341|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25558085|NCT00679341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25558086|NCT00679341|Tubulin Modulators|tubulin modulators|mesh-ancestor
25558087|NCT00679341|Antimitotic Agents|antimitotic agents|mesh-ancestor
25558088|NCT00679341|Mitosis Modulators|mitosis modulators|mesh-ancestor
25558089|NCT00679341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558090|NCT00679341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25558091|NCT00679341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25558092|NCT00679367|Dexamethasone|dexamethasone|mesh-list
25558093|NCT00679367|Lenalidomide|lenalidomide|mesh-list
25558094|NCT00679367|Melphalan|melphalan|mesh-list
25558095|NCT00679367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25558096|NCT00679367|Antiemetics|antiemetics|mesh-ancestor
25558097|NCT00679367|Autonomic Agents|autonomic agents|mesh-ancestor
25558098|NCT00679367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25558099|NCT00679367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558100|NCT00679367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25558101|NCT00679367|Glucocorticoids|glucocorticoids|mesh-ancestor
25558102|NCT00679367|Hormones|hormones|mesh-ancestor
25558103|NCT00679367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25558104|NCT00679367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25558105|NCT00679367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25558106|NCT00679367|Immunologic Factors|immunologic factors|mesh-ancestor
25558107|NCT00679367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25558108|NCT00679367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25558109|NCT00679367|Growth Substances|growth substances|mesh-ancestor
25558110|NCT00679367|Growth Inhibitors|growth inhibitors|mesh-ancestor
25558111|NCT00679367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25558112|NCT00679367|Alkylating Agents|alkylating agents|mesh-ancestor
25558113|NCT00679367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675559|NCT01344083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24443758|NCT00295945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24443759|NCT00295945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24443760|NCT00295945|Narcotics|narcotics|mesh-ancestor
24443761|NCT00295945|Analgesics|analgesics|mesh-ancestor
24443762|NCT00295945|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25267345|NCT02423239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25267346|NCT02423239|Antimetabolites|antimetabolites|mesh-ancestor
25267347|NCT02423239|Antiviral Agents|antiviral agents|mesh-ancestor
24805459|NCT02009449|Vitamins|vitamins|mesh-ancestor
25267348|NCT02423239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25267349|NCT02423239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25267350|NCT02423239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25267351|NCT02423239|Immunologic Factors|immunologic factors|mesh-ancestor
25267352|NCT02423239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267353|NCT02423239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25267354|NCT02423239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25267355|NCT02423239|Antiemetics|antiemetics|mesh-ancestor
25267356|NCT02423239|Autonomic Agents|autonomic agents|mesh-ancestor
25558114|NCT00679367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25558115|NCT00679367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25558116|NCT00679380|Budesonide|budesonide|mesh-list
25558117|NCT00679380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25558118|NCT00679380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25558119|NCT00679380|Autonomic Agents|autonomic agents|mesh-ancestor
25558120|NCT00679380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25558121|NCT00679380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558122|NCT00679380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25558123|NCT00679380|Respiratory System Agents|respiratory system agents|mesh-ancestor
25558124|NCT00679380|Glucocorticoids|glucocorticoids|mesh-ancestor
25558125|NCT00679380|Hormones|hormones|mesh-ancestor
25453244|NCT04561921|Sensory System Agents|sensory system agents|mesh-ancestor
25453245|NCT04561921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25453246|NCT04561921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453247|NCT04561921|Anesthetics|anesthetics|mesh-ancestor
25558126|NCT00679380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25558127|NCT00679432|Budesonide|budesonide|mesh-list
24883965|NCT03987919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883966|NCT03987919|Incretins|incretins|mesh-ancestor
25453248|NCT04561921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25453249|NCT04561921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25453250|NCT04561921|Anticonvulsants|anticonvulsants|mesh-ancestor
25453251|NCT04561921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25453252|NCT04561921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25453253|NCT04561921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453254|NCT04561921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25453255|NCT04561921|Tocolytic Agents|tocolytic agents|mesh-ancestor
25453256|NCT04561921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25453257|NCT04561921|Anesthetics, Local|anesthetics, local|mesh-ancestor
25453258|NCT04561921|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25309533|NCT04968158|Acetaminophen|acetaminophen|mesh-list
25309534|NCT04968158|Etoricoxib|etoricoxib|mesh-list
25309535|NCT04968158|Tramadol|tramadol|mesh-list
25267377|NCT02422901|Ascorbic Acid|ascorbic acid|mesh-list
25309536|NCT04968158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25309537|NCT04968158|Analgesics|analgesics|mesh-ancestor
25309538|NCT04968158|Sensory System Agents|sensory system agents|mesh-ancestor
25309539|NCT04968158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25309540|NCT04968158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309541|NCT04968158|Antipyretics|antipyretics|mesh-ancestor
25309542|NCT04968158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25309543|NCT04968158|Narcotics|narcotics|mesh-ancestor
25309544|NCT04968158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25309545|NCT04968158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25309546|NCT04968158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25309547|NCT04968158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25309548|NCT04968158|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25309549|NCT04968158|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25309550|NCT04968158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25309551|NCT04968158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558128|NCT00679432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25558129|NCT00679432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25558130|NCT00679432|Autonomic Agents|autonomic agents|mesh-ancestor
25558131|NCT00679432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25558132|NCT00679432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558133|NCT00679432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25558134|NCT00679432|Respiratory System Agents|respiratory system agents|mesh-ancestor
25558135|NCT00679432|Glucocorticoids|glucocorticoids|mesh-ancestor
24819993|NCT02098460|Probucol|probucol|mesh-list
24634590|NCT01134224|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25558136|NCT00679432|Hormones|hormones|mesh-ancestor
25558137|NCT00679432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25651578|NCT01517984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25651579|NCT01517984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689964|NCT01967576|Axitinib|axitinib|mesh-list
25651580|NCT01517984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25651581|NCT01517984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25651582|NCT01517984|Immunologic Factors|immunologic factors|mesh-ancestor
25651583|NCT01517984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651584|NCT01517984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651585|NCT01517984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25651586|NCT01517984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25651587|NCT01517984|Antitubercular Agents|antitubercular agents|mesh-ancestor
25651588|NCT01517984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25651589|NCT01517984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25651590|NCT01518153|Vidarabine|vidarabine|mesh-list
25651591|NCT01518153|Methotrexate|methotrexate|mesh-list
25651592|NCT01518153|Fludarabine phosphate|fludarabine phosphate|mesh-list
25651593|NCT01518153|Fludarabine|fludarabine|mesh-list
25651594|NCT01518153|Melphalan|melphalan|mesh-list
25651595|NCT01518153|Alemtuzumab|alemtuzumab|mesh-list
25651596|NCT01518153|Tacrolimus|tacrolimus|mesh-list
25651597|NCT01518153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25651598|NCT01518153|Abortifacient Agents|abortifacient agents|mesh-ancestor
25651599|NCT01518153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25651600|NCT01518153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651601|NCT01518153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25651602|NCT01518153|Antimetabolites|antimetabolites|mesh-ancestor
25558138|NCT00679627|Galantamine|galantamine|mesh-list
25558139|NCT00679627|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25558140|NCT00679627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25558141|NCT00679627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558142|NCT00679627|Cholinergic Agents|cholinergic agents|mesh-ancestor
24635913|NCT01141881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636301|NCT01144676|Dapivirine|dapivirine|mesh-list
25558143|NCT00679627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24636712|NCT01147016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25558144|NCT00679627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558145|NCT00679627|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25558146|NCT00679627|Autonomic Agents|autonomic agents|mesh-ancestor
25558147|NCT00679627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25558148|NCT00679627|Nootropic Agents|nootropic agents|mesh-ancestor
25558149|NCT00679939|Metformin|metformin|mesh-list
25558150|NCT00679939|Rosiglitazone|rosiglitazone|mesh-list
25558151|NCT00679939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25558152|NCT00679939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558153|NCT00680017|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25558154|NCT00680017|Fenofibric acid|fenofibric acid|mesh-list
25011239|NCT00659646|Renal Agents|renal agents|mesh-ancestor
25558155|NCT00680017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25558156|NCT00680017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25558157|NCT00680017|Antimetabolites|antimetabolites|mesh-ancestor
25558158|NCT00680017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558159|NCT00680017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25558160|NCT00680017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25558161|NCT00680017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25558162|NCT00680043|Epoetin Alfa|epoetin alfa|mesh-list
25558163|NCT00680043|Hematinics|hematinics|mesh-ancestor
25558164|NCT00680056|Formoterol Fumarate|formoterol fumarate|mesh-list
25558165|NCT00680056|Tiotropium Bromide|tiotropium bromide|mesh-list
25558166|NCT00680056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25558167|NCT00680056|Autonomic Agents|autonomic agents|mesh-ancestor
25558168|NCT00680056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24506216|NCT00544349|Levoleucovorin|levoleucovorin|mesh-list
25558169|NCT00680056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558170|NCT00680056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25558171|NCT00680056|Respiratory System Agents|respiratory system agents|mesh-ancestor
24639703|NCT01163994|Doxycycline|doxycycline|mesh-list
25011434|NCT05189145|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25558172|NCT00680056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25558173|NCT00680056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25558174|NCT00680056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25558175|NCT00680056|Adrenergic Agents|adrenergic agents|mesh-ancestor
25558176|NCT00680056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25558177|NCT00680056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558178|NCT00680056|Parasympatholytics|parasympatholytics|mesh-ancestor
25058373|NCT03497702|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25558179|NCT00680056|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25558180|NCT00680056|Cholinergic Agents|cholinergic agents|mesh-ancestor
25558181|NCT00680121|Benphothiamine|benphothiamine|mesh-list
25558182|NCT00680121|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25558183|NCT00680121|Immunologic Factors|immunologic factors|mesh-ancestor
25558184|NCT00680121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558185|NCT00680121|Chelating Agents|chelating agents|mesh-ancestor
25558186|NCT00680121|Sequestering Agents|sequestering agents|mesh-ancestor
25558187|NCT00680121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558188|NCT00680186|Warfarin|warfarin|mesh-list
25558189|NCT00680186|Dabigatran|dabigatran|mesh-list
25558190|NCT00680186|Anticoagulants|anticoagulants|mesh-ancestor
25558191|NCT00680186|Antithrombins|antithrombins|mesh-ancestor
25558192|NCT00680186|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25558193|NCT00680186|Protease Inhibitors|protease inhibitors|mesh-ancestor
25558194|NCT00680186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25558195|NCT00680186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558196|NCT00680225|Ranibizumab|ranibizumab|mesh-list
25011882|NCT03206463|Hormones|hormones|mesh-ancestor
24978689|NCT03223883|Curcumin|curcumin|mesh-list
24643608|NCT01186159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24643609|NCT01186172|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24643615|NCT01186185|Fludrocortisone|fludrocortisone|mesh-list
25558197|NCT00680225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25558198|NCT00680225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25558199|NCT00680225|Growth Substances|growth substances|mesh-ancestor
25558200|NCT00680225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558201|NCT00680225|Growth Inhibitors|growth inhibitors|mesh-ancestor
25558202|NCT00680225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25558203|NCT00680407|Silymarin|silymarin|mesh-list
25558204|NCT00680407|Antioxidants|antioxidants|mesh-ancestor
24644076|NCT01188824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25558205|NCT00680407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558206|NCT00680407|Protective Agents|protective agents|mesh-ancestor
25558207|NCT00680407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558208|NCT00680459|Ethanol|ethanol|mesh-list
25558209|NCT00680459|Heparin|heparin|mesh-list
25558210|NCT00680459|Anticoagulants|anticoagulants|mesh-list
25558211|NCT00680459|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24645257|NCT01197014|Amlodipine|amlodipine|mesh-list
25558212|NCT00680459|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25558213|NCT00680459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645919|NCT01200693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24508743|NCT00556699|Rituximab|rituximab|mesh-list
25558214|NCT00680459|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25558215|NCT00680459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25558216|NCT00680459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25558217|NCT00680459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558218|NCT00680628|Enoxaparin|enoxaparin|mesh-list
25558219|NCT00680628|Tenecteplase|tenecteplase|mesh-list
25558220|NCT00680628|Enoxaparin sodium|enoxaparin sodium|mesh-list
25558221|NCT00680628|Anticoagulants|anticoagulants|mesh-ancestor
25558222|NCT00680628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25558223|NCT00680628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25558224|NCT00680628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558225|NCT00680706|Thiamine|thiamine|mesh-list
25558226|NCT00680706|Vitamins|vitamins|mesh-ancestor
25012195|NCT01180374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012196|NCT01180374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25558227|NCT00680706|Micronutrients|micronutrients|mesh-ancestor
25558228|NCT00680706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558229|NCT00680706|Vitamin B Complex|vitamin b complex|mesh-ancestor
25558230|NCT00680745|Metformin|metformin|mesh-list
25558231|NCT00680745|Pioglitazone|pioglitazone|mesh-list
25558232|NCT00680745|Dapagliflozin|dapagliflozin|mesh-list
25558233|NCT00680745|Glimepiride|glimepiride|mesh-list
25558234|NCT00680745|Rosiglitazone|rosiglitazone|mesh-list
25558235|NCT00680745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25558236|NCT00680745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558237|NCT00680745|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25558238|NCT00680745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558239|NCT00680745|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25558240|NCT00680745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25558241|NCT00680745|Immunologic Factors|immunologic factors|mesh-ancestor
25558242|NCT00680797|Testosterone|testosterone|mesh-list
25558243|NCT00680797|Estrogens|estrogens|mesh-list
25558244|NCT00680797|Androgens|androgens|mesh-ancestor
25558245|NCT00680797|Hormones|hormones|mesh-ancestor
25558246|NCT00680797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25558247|NCT00680797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558248|NCT00680823|Ropivacaine|ropivacaine|mesh-list
25558249|NCT00680823|Anesthetics, Local|anesthetics, local|mesh-ancestor
25558250|NCT00680823|Anesthetics|anesthetics|mesh-ancestor
24510628|NCT00565188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25558251|NCT00680823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25558252|NCT00680823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558253|NCT00680823|Sensory System Agents|sensory system agents|mesh-ancestor
25558254|NCT00680823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25558255|NCT00680836|Rifaximin|rifaximin|mesh-list
25558256|NCT00680836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25558257|NCT00680836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25558258|NCT00680836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25558259|NCT00680914|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25558260|NCT00680914|Immunologic Factors|immunologic factors|mesh-ancestor
25558261|NCT00680914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558262|NCT00680953|Denosumab|denosumab|mesh-list
25558263|NCT00680953|Alendronate|alendronate|mesh-list
25558264|NCT00680953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25558265|NCT00680953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558266|NCT00681109|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25558267|NCT00681109|Lubricant Eye Drops|lubricant eye drops|mesh-list
24510629|NCT00565188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510631|NCT00565214|Vitamin E|vitamin e|mesh-list
25558268|NCT00681109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25558269|NCT00681109|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25558270|NCT00681109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25558271|NCT00681187|Lanreotide|lanreotide|mesh-list
25558272|NCT00681187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25558273|NCT00681265|Glycerol|glycerol|mesh-list
25558274|NCT00681265|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25558275|NCT00681265|Protective Agents|protective agents|mesh-ancestor
25558276|NCT00681265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558277|NCT00681538|Nabiximols|nabiximols|mesh-list
25558278|NCT00681538|Analgesics|analgesics|mesh-ancestor
25558279|NCT00681538|Sensory System Agents|sensory system agents|mesh-ancestor
25558280|NCT00681538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25558281|NCT00681538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558282|NCT00681590|Vitamin D|vitamin d|mesh-list
25558283|NCT00681590|Ergocalciferols|ergocalciferols|mesh-list
25558284|NCT00681590|Cholecalciferol|cholecalciferol|mesh-list
25558285|NCT00681590|Vitamins|vitamins|mesh-list
25558286|NCT00681590|Micronutrients|micronutrients|mesh-ancestor
25558287|NCT00681590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558288|NCT00681590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25558289|NCT00681590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25558290|NCT00681668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25558291|NCT00681668|Antidepressive Agents|antidepressive agents|mesh-ancestor
25558293|NCT00681668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25558294|NCT00681668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25558295|NCT00681668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25558296|NCT00681668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558297|NCT00681824|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25558298|NCT00681824|Thrombin|thrombin|mesh-list
25558299|NCT00681824|Aprotinin|aprotinin|mesh-list
25558300|NCT00681824|Hemostatics|hemostatics|mesh-ancestor
25558301|NCT00681824|Coagulants|coagulants|mesh-ancestor
25558302|NCT00681824|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25558303|NCT00681824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25558304|NCT00681824|Protease Inhibitors|protease inhibitors|mesh-ancestor
25558305|NCT00681824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25558306|NCT00681824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558307|NCT00681863|Pramipexole|pramipexole|mesh-list
24822927|NCT02114333|Vaccines|vaccines|mesh-list
25558308|NCT00681863|Antioxidants|antioxidants|mesh-ancestor
25558309|NCT00681863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558310|NCT00681863|Protective Agents|protective agents|mesh-ancestor
25558311|NCT00681863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558312|NCT00681863|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25558313|NCT00681863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25558314|NCT00681863|Dopamine Agonists|dopamine agonists|mesh-ancestor
25558315|NCT00681863|Dopamine Agents|dopamine agents|mesh-ancestor
25558316|NCT00681863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25558317|NCT00681889|Ranibizumab|ranibizumab|mesh-list
25558318|NCT00681889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25558319|NCT00681889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25558320|NCT00681889|Growth Substances|growth substances|mesh-ancestor
25558321|NCT00681889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558322|NCT00681889|Growth Inhibitors|growth inhibitors|mesh-ancestor
25558323|NCT00681889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25558324|NCT00682357|Methylprednisolone|methylprednisolone|mesh-list
25558325|NCT00682357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25558326|NCT00682357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25558327|NCT00682357|Prednisolone|prednisolone|mesh-list
25558328|NCT00682357|Prednisolone acetate|prednisolone acetate|mesh-list
25558329|NCT00682357|Lidocaine|lidocaine|mesh-list
25558330|NCT00682357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25060592|NCT03478423|Oxycodone|oxycodone|mesh-list
25558331|NCT00682357|Prednisolone phosphate|prednisolone phosphate|mesh-list
25558332|NCT00682357|Anesthetics, Local|anesthetics, local|mesh-ancestor
25558333|NCT00682357|Anesthetics|anesthetics|mesh-ancestor
25558334|NCT00682357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24655465|NCT01256866|Midazolam|midazolam|mesh-list
25558335|NCT00682357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558336|NCT00682357|Sensory System Agents|sensory system agents|mesh-ancestor
25558337|NCT00682357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25558338|NCT00682357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25558339|NCT00682357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25558340|NCT00682357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25558341|NCT00682357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25558342|NCT00682357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558343|NCT00682357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25558344|NCT00682357|Antiemetics|antiemetics|mesh-ancestor
25558345|NCT00682357|Autonomic Agents|autonomic agents|mesh-ancestor
24655743|NCT01257828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24655744|NCT01257828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24655745|NCT01257828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25558346|NCT00682357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25558347|NCT00682357|Glucocorticoids|glucocorticoids|mesh-ancestor
25558348|NCT00682357|Hormones|hormones|mesh-ancestor
25558349|NCT00682357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25558350|NCT00682357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25558351|NCT00682357|Protective Agents|protective agents|mesh-ancestor
25558352|NCT00682357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25558353|NCT00682357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25558354|NCT00682435|Hydromorphone|hydromorphone|mesh-list
25558355|NCT00682435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25558356|NCT00682435|Narcotics|narcotics|mesh-ancestor
25558357|NCT00682435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25558358|NCT00682435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558359|NCT00682435|Analgesics|analgesics|mesh-ancestor
25558360|NCT00682435|Sensory System Agents|sensory system agents|mesh-ancestor
25558361|NCT00682435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25558362|NCT00682448|Metformin|metformin|mesh-list
25558363|NCT00682448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25558364|NCT00682448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512502|NCT00575419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24512503|NCT00575419|Expectorants|expectorants|mesh-ancestor
24512504|NCT00575419|Respiratory System Agents|respiratory system agents|mesh-ancestor
24512505|NCT00575419|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24512506|NCT00575419|Antioxidants|antioxidants|mesh-ancestor
24656640|NCT01263171|Oxaliplatin|oxaliplatin|mesh-list
24656641|NCT01263171|Calcium|calcium|mesh-list
24656697|NCT01263574|Ethanol|ethanol|mesh-list
24586281|NCT00890110|Immunologic Factors|immunologic factors|mesh-ancestor
25110457|NCT05463367|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25558365|NCT00682539|Triamcinolone|triamcinolone|mesh-list
25558366|NCT00682539|Bevacizumab|bevacizumab|mesh-list
25558367|NCT00682539|Ranibizumab|ranibizumab|mesh-list
25558368|NCT00682539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25558369|NCT00682539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25558370|NCT00682539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25558371|NCT00682539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25558372|NCT00682539|Growth Substances|growth substances|mesh-ancestor
25013258|NCT03173456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25013259|NCT03173456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558373|NCT00682539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558374|NCT00682539|Growth Inhibitors|growth inhibitors|mesh-ancestor
25558375|NCT00682539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25558376|NCT00682539|Glucocorticoids|glucocorticoids|mesh-ancestor
25558377|NCT00682539|Hormones|hormones|mesh-ancestor
25558378|NCT00682539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25558379|NCT00682461|Nicotine|nicotine|mesh-list
25558380|NCT00682461|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25558381|NCT00682461|Autonomic Agents|autonomic agents|mesh-ancestor
25558382|NCT00682461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25558383|NCT00682461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887780|NCT04512404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
24887781|NCT04512404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24657348|NCT01266785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24657349|NCT01266811|Dexamethasone|dexamethasone|mesh-list
24657350|NCT01266811|Dexamethasone acetate|dexamethasone acetate|mesh-list
24657351|NCT01266811|Bortezomib|bortezomib|mesh-list
25558384|NCT00682461|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25558385|NCT00682461|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25558386|NCT00682461|Cholinergic Agents|cholinergic agents|mesh-ancestor
25558387|NCT00682461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25558388|NCT00682461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558389|NCT00682643|Fluticasone|fluticasone|mesh-list
25558390|NCT00682643|Xhance|xhance|mesh-list
25558391|NCT00682643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25558392|NCT00682643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25558393|NCT00682643|Autonomic Agents|autonomic agents|mesh-ancestor
25558394|NCT00682643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060832|NCT03476044|Selenium|selenium|mesh-list
24953027|NCT03889288|Sensory System Agents|sensory system agents|mesh-ancestor
24658044|NCT01270152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658045|NCT01270152|Protective Agents|protective agents|mesh-ancestor
24658046|NCT01270152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658124|NCT01270490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24888651|NCT04501809|Misoprostol|misoprostol|mesh-list
24888652|NCT04501809|Oxytocin|oxytocin|mesh-list
25013488|NCT02542956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013489|NCT02542956|Sensory System Agents|sensory system agents|mesh-ancestor
25013490|NCT02542956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25013492|NCT02471144|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25013493|NCT02471144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25013494|NCT02471144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24889130|NCT04497012|Trace Elements|trace elements|mesh-ancestor
24659040|NCT01275443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24659045|NCT01275521|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24659046|NCT01275521|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24659047|NCT01275521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24659089|NCT01275599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24659090|NCT01275599|Narcotics|narcotics|mesh-ancestor
24659091|NCT01275599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24659093|NCT01275599|Analgesics|analgesics|mesh-ancestor
25558395|NCT00682643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558396|NCT00682643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25558397|NCT00682643|Respiratory System Agents|respiratory system agents|mesh-ancestor
25558398|NCT00682643|Dermatologic Agents|dermatologic agents|mesh-ancestor
25558399|NCT00682643|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25558400|NCT00682734|Diphenhydramine|diphenhydramine|mesh-list
25558401|NCT00682734|Promethazine|promethazine|mesh-list
25558402|NCT00682734|Metoclopramide|metoclopramide|mesh-list
25558403|NCT00682734|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25558404|NCT00682734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25558405|NCT00682734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24659605|NCT01278784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25558406|NCT00682734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558407|NCT00682734|Anesthetics, Local|anesthetics, local|mesh-ancestor
25558408|NCT00682734|Anesthetics|anesthetics|mesh-ancestor
25558409|NCT00682734|Sensory System Agents|sensory system agents|mesh-ancestor
25558410|NCT00682734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25558411|NCT00682734|Antiemetics|antiemetics|mesh-ancestor
25558412|NCT00682734|Autonomic Agents|autonomic agents|mesh-ancestor
25558413|NCT00682734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25558414|NCT00682734|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25558415|NCT00682734|Histamine Antagonists|histamine antagonists|mesh-ancestor
25453468|NCT04559308|Metformin|metformin|mesh-list
25453469|NCT04559308|Paclitaxel|paclitaxel|mesh-list
25453470|NCT04559308|Cyclophosphamide|cyclophosphamide|mesh-list
25453471|NCT04559308|Doxorubicin|doxorubicin|mesh-list
25453472|NCT04559308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25453473|NCT04559308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453474|NCT04559308|Tubulin Modulators|tubulin modulators|mesh-ancestor
25453475|NCT04559308|Antimitotic Agents|antimitotic agents|mesh-ancestor
25453476|NCT04559308|Mitosis Modulators|mitosis modulators|mesh-ancestor
25453477|NCT04559308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453478|NCT04559308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25453479|NCT04559308|Immunologic Factors|immunologic factors|mesh-ancestor
25558416|NCT00682734|Histamine Agents|histamine agents|mesh-ancestor
25558417|NCT00682734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25558418|NCT00682734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558419|NCT00682734|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25558420|NCT00682734|Antipruritics|antipruritics|mesh-ancestor
25558421|NCT00682734|Dermatologic Agents|dermatologic agents|mesh-ancestor
25558422|NCT00682734|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25558423|NCT00682734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25558424|NCT00682734|Dopamine Agents|dopamine agents|mesh-ancestor
25558425|NCT00682786|Fluorouracil|fluorouracil|mesh-list
25453480|NCT04559308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453481|NCT04559308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25558426|NCT00682786|Irinotecan|irinotecan|mesh-list
25558427|NCT00682786|Antimetabolites|antimetabolites|mesh-ancestor
25558428|NCT00682786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558429|NCT00682786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25558430|NCT00682786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25558431|NCT00682786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25558432|NCT00682786|Immunologic Factors|immunologic factors|mesh-ancestor
25061341|NCT03472144|Levofloxacin|levofloxacin|mesh-list
25061342|NCT03472144|Ofloxacin|ofloxacin|mesh-list
25558433|NCT00682786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558434|NCT00682786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25558435|NCT00682786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25558436|NCT00682786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25558437|NCT00682890|Metformin|metformin|mesh-list
25558438|NCT00682890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25558439|NCT00682890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558440|NCT00682929|Dronabinol|dronabinol|mesh-list
25558441|NCT00682929|Hallucinogens|hallucinogens|mesh-ancestor
25558442|NCT00682929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558443|NCT00682929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25558444|NCT00682929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25558445|NCT00682929|Analgesics|analgesics|mesh-ancestor
25558446|NCT00682929|Sensory System Agents|sensory system agents|mesh-ancestor
25558447|NCT00682929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25558448|NCT00682929|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25558449|NCT00682929|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25061632|NCT03469544|Immunologic Factors|immunologic factors|mesh-ancestor
25558450|NCT00682929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25558451|NCT00682929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558452|NCT00682929|Hormones|hormones|mesh-ancestor
25558453|NCT00682929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25558454|NCT00683046|Fludarabine|fludarabine|mesh-list
25558455|NCT00683046|Melphalan|melphalan|mesh-list
25558456|NCT00683046|Alemtuzumab|alemtuzumab|mesh-list
25558457|NCT00683046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25558458|NCT00683046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558459|NCT00683046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24661493|NCT01289756|Clarithromycin|clarithromycin|mesh-list
24891453|NCT04470531|Renal Agents|renal agents|mesh-ancestor
24891454|NCT04470531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24891455|NCT04470531|Antimalarials|antimalarials|mesh-ancestor
24891456|NCT04470531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24891457|NCT04470531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25558460|NCT00683046|Immunologic Factors|immunologic factors|mesh-ancestor
25558461|NCT00683046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558462|NCT00683046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25558463|NCT00683046|Alkylating Agents|alkylating agents|mesh-ancestor
25558464|NCT00683046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25558465|NCT00683046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25558466|NCT00683163|Ibandronic Acid|ibandronic acid|mesh-list
25558467|NCT00683163|Parathyroid Hormone|parathyroid hormone|mesh-list
25558468|NCT00683163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25558469|NCT00683163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893005|NCT04455711|Narcotics|narcotics|mesh-ancestor
24662297|NCT01293838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25558470|NCT00683163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25558471|NCT00683332|Tigecycline|tigecycline|mesh-list
25558472|NCT00683332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25558473|NCT00683332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25558474|NCT00683332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25558475|NCT00683332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25558476|NCT00683332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558477|NCT00683384|Etanercept|etanercept|mesh-list
25558478|NCT00683384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24893627|NCT04447209|Sensory System Agents|sensory system agents|mesh-ancestor
24893628|NCT04447209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24893629|NCT04447209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893630|NCT04447209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24893631|NCT04447209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24893633|NCT04447443|Antidiarrheals|antidiarrheals|mesh-list
24893634|NCT04447443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24893644|NCT04447560|Bupivacaine|bupivacaine|mesh-list
25558479|NCT00683384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25558480|NCT00683384|Analgesics|analgesics|mesh-ancestor
25558481|NCT00683384|Sensory System Agents|sensory system agents|mesh-ancestor
25558482|NCT00683384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25558483|NCT00683384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558484|NCT00683384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25558485|NCT00683384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25558486|NCT00683384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25558487|NCT00683384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25558488|NCT00683384|Immunologic Factors|immunologic factors|mesh-ancestor
25558489|NCT00683410|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25558490|NCT00683410|Immunologic Factors|immunologic factors|mesh-ancestor
25014058|NCT05095311|Immunologic Factors|immunologic factors|mesh-ancestor
25558491|NCT00683410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558492|NCT00683475|Prednisone|prednisone|mesh-list
25558493|NCT00683475|Mitoxantrone|mitoxantrone|mesh-list
25558494|NCT00683475|Ramucirumab|ramucirumab|mesh-list
25558495|NCT00683475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25558496|NCT00683475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25558497|NCT00683475|Glucocorticoids|glucocorticoids|mesh-ancestor
25558498|NCT00683475|Hormones|hormones|mesh-ancestor
24663194|NCT01299181|Antimetabolites|antimetabolites|mesh-ancestor
24663195|NCT01299181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663196|NCT01299181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25558499|NCT00683475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25558500|NCT00683475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558501|NCT00683475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25558502|NCT00683475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453520|NCT04559074|Amlodipine|amlodipine|mesh-list
25558503|NCT00683475|Analgesics|analgesics|mesh-ancestor
25558504|NCT00683475|Sensory System Agents|sensory system agents|mesh-ancestor
25558505|NCT00683475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25558506|NCT00683475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25558507|NCT00683475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25558508|NCT00683475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25558509|NCT00683475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558510|NCT00683475|Immunologic Factors|immunologic factors|mesh-ancestor
24513843|NCT00585559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24664530|NCT01307488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24664751|NCT01308528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664754|NCT01308541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24664755|NCT01308541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25558511|NCT00683592|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
25558512|NCT00683592|Antidepressive Agents|antidepressive agents|mesh-ancestor
25558513|NCT00683592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25558514|NCT00683592|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25558515|NCT00683592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25558516|NCT00683592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25558517|NCT00683592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558518|NCT00683592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25558519|NCT00683592|Serotonin Agents|serotonin agents|mesh-ancestor
25558520|NCT00683592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558521|NCT00683592|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25558522|NCT00683592|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25558523|NCT00683618|Atorvastatin|atorvastatin|mesh-list
25558524|NCT00683618|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25558525|NCT00683618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25558526|NCT00683618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24514333|NCT00589927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24514334|NCT00589927|Autonomic Agents|autonomic agents|mesh-ancestor
24514335|NCT00589927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24514336|NCT00589927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514337|NCT00589927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25558527|NCT00683618|Antimetabolites|antimetabolites|mesh-ancestor
25558528|NCT00683618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558529|NCT00683618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25558530|NCT00683618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25558531|NCT00683618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25558533|NCT00683644|Zinc Sulfate|zinc sulfate|mesh-list
25558534|NCT00683644|Trace Elements|trace elements|mesh-ancestor
25558535|NCT00683644|Micronutrients|micronutrients|mesh-ancestor
25558536|NCT00683644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558537|NCT00683644|Astringents|astringents|mesh-ancestor
25558538|NCT00683644|Dermatologic Agents|dermatologic agents|mesh-ancestor
25558539|NCT00683657|Saxagliptin|saxagliptin|mesh-list
25558540|NCT00683657|Incretins|incretins|mesh-ancestor
25558541|NCT00683657|Hormones|hormones|mesh-ancestor
25558542|NCT00683657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25690321|NCT01971593|Natriuretic Agents|natriuretic agents|mesh-ancestor
24514399|NCT00590174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24895052|NCT05191875|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24895053|NCT05191875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25558543|NCT00683657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558544|NCT00683657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25558545|NCT00683657|Protease Inhibitors|protease inhibitors|mesh-ancestor
25558546|NCT00683657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25558547|NCT00683657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558548|NCT00683657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25558549|NCT00683774|Diazoxide|diazoxide|mesh-list
25558550|NCT00683774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25558551|NCT00683774|Vasodilator Agents|vasodilator agents|mesh-ancestor
25558552|NCT00683800|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25558553|NCT00683800|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25558554|NCT00683800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25558555|NCT00683800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25558556|NCT00683800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558557|NCT00683800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25453585|NCT04557878|Mitosis Modulators|mitosis modulators|mesh-ancestor
25453586|NCT04557878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453587|NCT04557943|Hyaluronic Acid|hyaluronic acid|mesh-list
25453588|NCT04557943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25453589|NCT04557943|Immunologic Factors|immunologic factors|mesh-ancestor
25453590|NCT04557943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453591|NCT04557943|Viscosupplements|viscosupplements|mesh-ancestor
25453592|NCT04557943|Protective Agents|protective agents|mesh-ancestor
25453593|NCT04557475|Aspirin|aspirin|mesh-list
25453594|NCT04557475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25453595|NCT04557475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25453596|NCT04557475|Analgesics|analgesics|mesh-ancestor
25453597|NCT04557475|Sensory System Agents|sensory system agents|mesh-ancestor
25453598|NCT04557475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25453599|NCT04557475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453600|NCT04557475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25453601|NCT04557475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25558558|NCT00683800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558559|NCT00683800|Antidepressive Agents|antidepressive agents|mesh-ancestor
25558560|NCT00683800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25558561|NCT00683852|Aripiprazole|aripiprazole|mesh-list
25558562|NCT00683852|Antidepressive Agents|antidepressive agents|mesh-ancestor
25558563|NCT00683852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25558564|NCT00683852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25558565|NCT00683852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25558566|NCT00683852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25558567|NCT00683852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558568|NCT00683852|Dopamine Agonists|dopamine agonists|mesh-ancestor
25558569|NCT00683852|Dopamine Agents|dopamine agents|mesh-ancestor
25558570|NCT00683852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25558571|NCT00683852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558572|NCT00683852|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25558573|NCT00683852|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25558574|NCT00683852|Serotonin Agents|serotonin agents|mesh-ancestor
24420151|NCT00215280|Ivermectin|ivermectin|mesh-list
25453635|NCT04557163|Itraconazole|itraconazole|mesh-list
25453636|NCT04557163|Antifungal Agents|antifungal agents|mesh-ancestor
25453637|NCT04557163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25453638|NCT04557163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25453639|NCT04557163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25453640|NCT04557163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453641|NCT04557163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453642|NCT04557163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25453643|NCT04557163|Hormone Antagonists|hormone antagonists|mesh-ancestor
25453644|NCT04557163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25453645|NCT04557163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453646|NCT04557163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25453647|NCT04557137|Somatostatin|somatostatin|mesh-list
25453648|NCT04557137|Hormones|hormones|mesh-ancestor
25453649|NCT04557137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25453650|NCT04557137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453651|NCT04557202|Tamsulosin|tamsulosin|mesh-list
25453652|NCT04557202|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25453653|NCT04557202|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25453654|NCT04557202|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25453655|NCT04557202|Adrenergic Agents|adrenergic agents|mesh-ancestor
25453656|NCT04557202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25453657|NCT04557202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453658|NCT04557202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453659|NCT04557202|Urological Agents|urological agents|mesh-ancestor
25453660|NCT04557020|Gemcitabine|gemcitabine|mesh-list
25453661|NCT04557020|Cisplatin|cisplatin|mesh-list
25558575|NCT00683852|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25558576|NCT00683852|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25558577|NCT00683852|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25558578|NCT00683852|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25558579|NCT00683878|Pioglitazone|pioglitazone|mesh-list
25558580|NCT00683878|Dapagliflozin|dapagliflozin|mesh-list
25558581|NCT00683878|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
25558582|NCT00683878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25558583|NCT00683878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558584|NCT00683878|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25558585|NCT00683878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558586|NCT00683904|Carboplatin|carboplatin|mesh-list
25558587|NCT00683904|Epothilones|epothilones|mesh-list
25558588|NCT00683904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25558589|NCT00683904|Tubulin Modulators|tubulin modulators|mesh-ancestor
25558590|NCT00683904|Antimitotic Agents|antimitotic agents|mesh-ancestor
25558591|NCT00683904|Mitosis Modulators|mitosis modulators|mesh-ancestor
25558592|NCT00683904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558593|NCT00683930|Mycophenolic Acid|mycophenolic acid|mesh-list
25558594|NCT00683930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25558595|NCT00683930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25558596|NCT00683930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25558597|NCT00683930|Antitubercular Agents|antitubercular agents|mesh-ancestor
25558598|NCT00683930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25558599|NCT00683930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25558600|NCT00683930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25558601|NCT00683930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558602|NCT00684073|Buprenorphine|buprenorphine|mesh-list
25558603|NCT00684073|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25558604|NCT00684073|Naloxone|naloxone|mesh-list
25558605|NCT00684073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25558606|NCT00684073|Narcotics|narcotics|mesh-ancestor
25558607|NCT00684073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25558608|NCT00684073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558609|NCT00684073|Analgesics|analgesics|mesh-ancestor
25558610|NCT00684073|Sensory System Agents|sensory system agents|mesh-ancestor
25558611|NCT00684073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25558612|NCT00684073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25558613|NCT00684177|Retapamulin|retapamulin|mesh-list
25558614|NCT00684177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25558615|NCT00684177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25558616|NCT00684203|Aspirin|aspirin|mesh-list
25558617|NCT00684203|Clopidogrel|clopidogrel|mesh-list
25558618|NCT00684203|Vorapaxar|vorapaxar|mesh-list
25558619|NCT00684203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25558620|NCT00684203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25558621|NCT00684203|Analgesics|analgesics|mesh-ancestor
25558622|NCT00684203|Sensory System Agents|sensory system agents|mesh-ancestor
25558623|NCT00684203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25558624|NCT00684203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558625|NCT00684203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25558626|NCT00684203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25558627|NCT00684203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25558628|NCT00684203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25558629|NCT00684203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558630|NCT00684203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25558631|NCT00684203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25558632|NCT00684203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25558633|NCT00684203|Antipyretics|antipyretics|mesh-ancestor
25558634|NCT00684203|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25558635|NCT00684203|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25558636|NCT00684203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25558637|NCT00684203|Purinergic Agents|purinergic agents|mesh-ancestor
25558638|NCT00684203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25558639|NCT00684242|Lenalidomide|lenalidomide|mesh-list
25558640|NCT00684242|Immunologic Factors|immunologic factors|mesh-ancestor
25558641|NCT00684242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558642|NCT00684242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25558643|NCT00684242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25558644|NCT00684242|Growth Substances|growth substances|mesh-ancestor
25558645|NCT00684242|Growth Inhibitors|growth inhibitors|mesh-ancestor
25558646|NCT00684242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25558647|NCT00684307|Vitamin K|vitamin k|mesh-list
25558648|NCT00684307|Warfarin|warfarin|mesh-list
25558649|NCT00684307|Vitamins|vitamins|mesh-ancestor
25558650|NCT00684307|Micronutrients|micronutrients|mesh-ancestor
25558651|NCT00684307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558652|NCT00684307|Anticoagulants|anticoagulants|mesh-ancestor
25558653|NCT00684307|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25558654|NCT00684307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25558655|NCT00684307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558656|NCT00684307|Hemostatics|hemostatics|mesh-ancestor
25558657|NCT00684307|Coagulants|coagulants|mesh-ancestor
25558658|NCT00684411|Imatinib Mesylate|imatinib mesylate|mesh-list
25558659|NCT00684411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25558660|NCT00684411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25558661|NCT00684411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25558662|NCT00684411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558663|NCT00684515|Aspirin|aspirin|mesh-list
25558664|NCT00684515|Vorapaxar|vorapaxar|mesh-list
24895596|NCT03820466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24895658|NCT03643367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24895659|NCT03643367|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24895660|NCT03632044|Ropivacaine|ropivacaine|mesh-list
24895661|NCT03632044|Anesthetics, Local|anesthetics, local|mesh-ancestor
24515122|NCT00594633|Cholinergic Agents|cholinergic agents|mesh-ancestor
24515123|NCT00594633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24515125|NCT00594633|Nootropic Agents|nootropic agents|mesh-ancestor
25558665|NCT00684515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25558666|NCT00684515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25558667|NCT00684515|Analgesics|analgesics|mesh-ancestor
25558668|NCT00684515|Sensory System Agents|sensory system agents|mesh-ancestor
25558669|NCT00684515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25558670|NCT00684515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558671|NCT00684515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25558672|NCT00684515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25558673|NCT00684515|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25558674|NCT00684515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25558675|NCT00684515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453682|NCT04556760|Hormones|hormones|mesh-ancestor
25558676|NCT00684515|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25558677|NCT00684515|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25558678|NCT00684515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25558679|NCT00684515|Antipyretics|antipyretics|mesh-ancestor
25558680|NCT00684554|Buprenorphine|buprenorphine|mesh-list
25558681|NCT00684554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25558682|NCT00684554|Narcotics|narcotics|mesh-ancestor
25558683|NCT00684554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25558684|NCT00684554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558685|NCT00684554|Analgesics|analgesics|mesh-ancestor
25558686|NCT00684554|Sensory System Agents|sensory system agents|mesh-ancestor
25558687|NCT00684554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25558688|NCT00684554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25558689|NCT00684567|Temozolomide|temozolomide|mesh-list
25558690|NCT00684567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25558691|NCT00684567|Alkylating Agents|alkylating agents|mesh-ancestor
25558692|NCT00684567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558693|NCT00684567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25558694|NCT00684645|Sunitinib|sunitinib|mesh-list
25558695|NCT00684645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25558696|NCT00684645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25558697|NCT00684645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25558698|NCT00684645|Growth Substances|growth substances|mesh-ancestor
25558699|NCT00684645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558700|NCT00684645|Growth Inhibitors|growth inhibitors|mesh-ancestor
25558701|NCT00684645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25558702|NCT00684645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25558703|NCT00684645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558704|NCT00684723|Lovastatin|lovastatin|mesh-list
25062506|NCT04502589|Disulfiram|disulfiram|mesh-list
25558705|NCT00684723|L 647318|l 647318|mesh-list
25558706|NCT00684723|Dihydromevinolin|dihydromevinolin|mesh-list
25558707|NCT00684723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25558708|NCT00684723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25558709|NCT00684723|Antimetabolites|antimetabolites|mesh-ancestor
25558710|NCT00684723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558711|NCT00684723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25558712|NCT00684723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25558713|NCT00684723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25558714|NCT00684762|Cilostazol|cilostazol|mesh-list
25558715|NCT00684762|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25558716|NCT00684762|Autonomic Agents|autonomic agents|mesh-ancestor
25558717|NCT00684762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25558718|NCT00684762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558719|NCT00684762|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25558720|NCT00684762|Respiratory System Agents|respiratory system agents|mesh-ancestor
25558721|NCT00684762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25558722|NCT00684762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25558723|NCT00684762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558724|NCT00684762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25558725|NCT00684762|Vasodilator Agents|vasodilator agents|mesh-ancestor
25558726|NCT00684762|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25558727|NCT00684762|Protective Agents|protective agents|mesh-ancestor
25558728|NCT00684762|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25558729|NCT00684762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25558730|NCT00684762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25558731|NCT00684775|Naltrexone|naltrexone|mesh-list
25558732|NCT00684775|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25558733|NCT00684775|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25558734|NCT00684775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558735|NCT00684775|Sensory System Agents|sensory system agents|mesh-ancestor
25558736|NCT00684775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25651603|NCT01518153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651604|NCT01518153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25651605|NCT01518153|Dermatologic Agents|dermatologic agents|mesh-ancestor
24534058|NCT00645918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25651606|NCT01518153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651607|NCT01518153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25651608|NCT01518153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25651609|NCT01518153|Immunologic Factors|immunologic factors|mesh-ancestor
25651610|NCT01518153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25651611|NCT01518153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25651612|NCT01518153|Antiviral Agents|antiviral agents|mesh-ancestor
25651613|NCT01518153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25651614|NCT01518153|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25651615|NCT01518153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25651616|NCT01518153|Alkylating Agents|alkylating agents|mesh-ancestor
25651617|NCT01518153|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25558737|NCT00684814|Zolpidem|zolpidem|mesh-list
25558738|NCT00684814|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25558739|NCT00684814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25558740|NCT00684814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25558741|NCT00684814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558742|NCT00684814|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25558743|NCT00684814|GABA Agonists|gaba agonists|mesh-ancestor
25558744|NCT00684814|GABA Agents|gaba agents|mesh-ancestor
25558745|NCT00684814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25558746|NCT00684814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558747|NCT00684983|Capecitabine|capecitabine|mesh-list
25558748|NCT00684983|Lapatinib|lapatinib|mesh-list
25558749|NCT00684983|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25558750|NCT00684983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25558751|NCT00684983|Antimetabolites|antimetabolites|mesh-ancestor
25558752|NCT00684983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558753|NCT00684983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25558754|NCT00684983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25558755|NCT00684983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25558756|NCT00684983|Immunologic Factors|immunologic factors|mesh-ancestor
25558757|NCT00684983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558758|NCT00684996|Bevacizumab|bevacizumab|mesh-list
25558759|NCT00684996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25558760|NCT00684996|Antibodies|antibodies|mesh-list
25558761|NCT00684996|Immunoglobulins|immunoglobulins|mesh-list
25558762|NCT00684996|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25558763|NCT00684996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25558764|NCT00684996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25558765|NCT00684996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25558766|NCT00684996|Growth Substances|growth substances|mesh-ancestor
25558767|NCT00684996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558768|NCT00684996|Growth Inhibitors|growth inhibitors|mesh-ancestor
25558769|NCT00684996|Immunologic Factors|immunologic factors|mesh-ancestor
25558770|NCT00685139|Zonisamide|zonisamide|mesh-list
25558771|NCT00685139|Anticonvulsants|anticonvulsants|mesh-ancestor
25558772|NCT00685139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25558773|NCT00685139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25558774|NCT00685139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817374|NCT02083276|Renal Agents|renal agents|mesh-ancestor
25558775|NCT00685139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25558776|NCT00685139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558777|NCT00685165|Primidone|primidone|mesh-list
25558778|NCT00685165|Anticonvulsants|anticonvulsants|mesh-ancestor
25558779|NCT00685165|GABA Modulators|gaba modulators|mesh-ancestor
25558780|NCT00685165|GABA Agents|gaba agents|mesh-ancestor
25558781|NCT00685165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25558782|NCT00685165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558783|NCT00685165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558784|NCT00685178|Topiramate|topiramate|mesh-list
25558785|NCT00685178|Anticonvulsants|anticonvulsants|mesh-ancestor
25558786|NCT00685178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25558787|NCT00685178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558788|NCT00685295|Fentanyl|fentanyl|mesh-list
25558789|NCT00685295|Oxycodone|oxycodone|mesh-list
25558790|NCT00685295|Lansoprazole|lansoprazole|mesh-list
25453814|NCT04554979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25453815|NCT04554979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25453816|NCT04554979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453817|NCT04554979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453818|NCT04554979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25453819|NCT04554654|Progesterone|progesterone|mesh-list
25453820|NCT04554654|Progestins|progestins|mesh-ancestor
25453821|NCT04554654|Hormones|hormones|mesh-ancestor
25453822|NCT04554654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25453823|NCT04554654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558791|NCT00685295|Dexlansoprazole|dexlansoprazole|mesh-list
25558792|NCT00685295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25558793|NCT00685295|Narcotics|narcotics|mesh-ancestor
25558794|NCT00685295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25558795|NCT00685295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558796|NCT00685295|Analgesics|analgesics|mesh-ancestor
25558797|NCT00685295|Sensory System Agents|sensory system agents|mesh-ancestor
25558798|NCT00685295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25558799|NCT00685295|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25558800|NCT00685295|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25558801|NCT00685295|Anesthetics, General|anesthetics, general|mesh-ancestor
25558802|NCT00685295|Anesthetics|anesthetics|mesh-ancestor
25558803|NCT00685295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25558804|NCT00685295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25558805|NCT00685295|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25558806|NCT00685295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25558807|NCT00685295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558808|NCT00685334|Olanzapine|olanzapine|mesh-list
25558809|NCT00685334|Aripiprazole|aripiprazole|mesh-list
25558810|NCT00685334|Antiemetics|antiemetics|mesh-ancestor
25558811|NCT00685334|Autonomic Agents|autonomic agents|mesh-ancestor
25558812|NCT00685334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25558813|NCT00685334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558814|NCT00685334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25558815|NCT00685334|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25558816|NCT00685334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25558817|NCT00685334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25558818|NCT00685334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25558819|NCT00685334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25558820|NCT00685334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25558821|NCT00685334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25558822|NCT00685334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558823|NCT00685334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25558824|NCT00685334|Serotonin Agents|serotonin agents|mesh-ancestor
25558825|NCT00685334|Antidepressive Agents|antidepressive agents|mesh-ancestor
25558826|NCT00685334|Dopamine Agonists|dopamine agonists|mesh-ancestor
25558827|NCT00685334|Dopamine Agents|dopamine agents|mesh-ancestor
25558828|NCT00685334|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25558829|NCT00685334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25558830|NCT00685334|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25558831|NCT00685334|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25558832|NCT00685334|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25558833|NCT00685334|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25558834|NCT00685399|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25558835|NCT00685399|Immunologic Factors|immunologic factors|mesh-ancestor
25558836|NCT00685399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558837|NCT00685685|Lovastatin|lovastatin|mesh-list
25558838|NCT00685685|L 647318|l 647318|mesh-list
25558839|NCT00685685|Dihydromevinolin|dihydromevinolin|mesh-list
25558840|NCT00685685|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25558841|NCT00685685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25558842|NCT00685685|Antimetabolites|antimetabolites|mesh-ancestor
25558843|NCT00685685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558844|NCT00685685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25558845|NCT00685685|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25558846|NCT00685685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25558847|NCT00685763|Gemcitabine|gemcitabine|mesh-list
25558848|NCT00685763|Capecitabine|capecitabine|mesh-list
25558849|NCT00685763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25558850|NCT00685763|Antimetabolites|antimetabolites|mesh-ancestor
25558851|NCT00685763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558852|NCT00685763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25558853|NCT00685763|Antiviral Agents|antiviral agents|mesh-ancestor
25558854|NCT00685763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25558855|NCT00685763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25558856|NCT00685763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25558857|NCT00685763|Immunologic Factors|immunologic factors|mesh-ancestor
25558858|NCT00685763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558859|NCT00685802|Cilostazol|cilostazol|mesh-list
25558860|NCT00685802|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25558861|NCT00685802|Autonomic Agents|autonomic agents|mesh-ancestor
25558862|NCT00685802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25558863|NCT00685802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558864|NCT00685802|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25558865|NCT00685802|Respiratory System Agents|respiratory system agents|mesh-ancestor
25558866|NCT00685802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25558867|NCT00685802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25558868|NCT00685802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558869|NCT00685802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25558870|NCT00685802|Vasodilator Agents|vasodilator agents|mesh-ancestor
25558871|NCT00685802|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25558872|NCT00685802|Protective Agents|protective agents|mesh-ancestor
25558873|NCT00685802|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25558874|NCT00685802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25558875|NCT00685802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25558876|NCT00685945|Isosorbide|isosorbide|mesh-list
25558878|NCT00685945|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25558879|NCT00685945|Sildenafil Citrate|sildenafil citrate|mesh-list
25558880|NCT00685945|Bradykinin|bradykinin|mesh-list
25558881|NCT00685945|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
25558882|NCT00685945|Kininogens|kininogens|mesh-list
25558883|NCT00685945|Vasodilator Agents|vasodilator agents|mesh-ancestor
25558884|NCT00685945|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25558885|NCT00685945|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25558886|NCT00685945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25558887|NCT00685945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558888|NCT00685945|Urological Agents|urological agents|mesh-ancestor
25558889|NCT00685945|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25558890|NCT00685945|Diuretics|diuretics|mesh-ancestor
25558891|NCT00685945|Natriuretic Agents|natriuretic agents|mesh-ancestor
25558892|NCT00685945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558893|NCT00685945|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25558894|NCT00685945|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25558895|NCT00685945|Protease Inhibitors|protease inhibitors|mesh-ancestor
25558896|NCT00686127|Lidocaine|lidocaine|mesh-list
25558897|NCT00686127|Anesthetics, Local|anesthetics, local|mesh-ancestor
25558898|NCT00686127|Anesthetics|anesthetics|mesh-ancestor
25558899|NCT00686127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25558900|NCT00686127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453934|NCT04552977|Alkylating Agents|alkylating agents|mesh-ancestor
25453935|NCT04552977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453936|NCT04552977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453937|NCT04552951|Vitamin D|vitamin d|mesh-list
25453938|NCT04552951|Cholecalciferol|cholecalciferol|mesh-list
25453939|NCT04552951|Vitamins|vitamins|mesh-ancestor
25453940|NCT04552951|Micronutrients|micronutrients|mesh-ancestor
25453941|NCT04552951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453942|NCT04552951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25453943|NCT04552951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25453944|NCT04552808|Yimitasvir|yimitasvir|mesh-list
25453945|NCT04552808|Antiviral Agents|antiviral agents|mesh-ancestor
25453946|NCT04552808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25453947|NCT04552483|Nitazoxanide|nitazoxanide|mesh-list
25453948|NCT04552483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25453949|NCT04552483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25453950|NCT04552444|Biapenem|biapenem|mesh-list
25453951|NCT04552444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25453952|NCT04552613|Carboplatin|carboplatin|mesh-list
25453953|NCT04552613|Pemetrexed|pemetrexed|mesh-list
25453954|NCT04552613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453955|NCT04552613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453956|NCT04552613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453957|NCT04552613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25453958|NCT04552613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25558901|NCT00686127|Sensory System Agents|sensory system agents|mesh-ancestor
25453959|NCT04552405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25453961|NCT04552431|Tamsulosin|tamsulosin|mesh-list
25558902|NCT00686127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25558903|NCT00686127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25558904|NCT00686127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25558905|NCT00686127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25558906|NCT00686127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25558907|NCT00686127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558908|NCT00686166|Capecitabine|capecitabine|mesh-list
25558909|NCT00686166|Oxaliplatin|oxaliplatin|mesh-list
25558910|NCT00686166|Cetuximab|cetuximab|mesh-list
25558911|NCT00686166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25558912|NCT00686166|Antimetabolites|antimetabolites|mesh-ancestor
25558913|NCT00686166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558914|NCT00686166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25558915|NCT00686166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25558916|NCT00686231|Lidocaine|lidocaine|mesh-list
25558917|NCT00686231|Nitroglycerin|nitroglycerin|mesh-list
25558918|NCT00686231|Anesthetics, Local|anesthetics, local|mesh-ancestor
25558919|NCT00686231|Anesthetics|anesthetics|mesh-ancestor
25558920|NCT00686231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25558921|NCT00686231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558922|NCT00686231|Sensory System Agents|sensory system agents|mesh-ancestor
25558923|NCT00686231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25558924|NCT00686231|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25558925|NCT00686231|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25558926|NCT00686231|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25558927|NCT00686231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25558928|NCT00686231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558929|NCT00686231|Vasodilator Agents|vasodilator agents|mesh-ancestor
25558930|NCT00686335|Prednisone|prednisone|mesh-list
25558931|NCT00686335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25558932|NCT00686335|Glucocorticoids|glucocorticoids|mesh-ancestor
25558933|NCT00686335|Hormones|hormones|mesh-ancestor
25558934|NCT00686335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25558935|NCT00686335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558936|NCT00686335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25558937|NCT00686335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25558938|NCT00686517|Interferons|interferons|mesh-list
25558939|NCT00686517|Ribavirin|ribavirin|mesh-list
25558940|NCT00686517|Interferon-alpha|interferon-alpha|mesh-list
25558941|NCT00686517|Interferon alpha-2|interferon alpha-2|mesh-list
25558942|NCT00686517|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25558943|NCT00686517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25558944|NCT00686517|Antiviral Agents|antiviral agents|mesh-ancestor
25558945|NCT00686517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25558946|NCT00686517|Antimetabolites|antimetabolites|mesh-ancestor
24534977|NCT00648362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25558947|NCT00686517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558948|NCT00686517|Immunologic Factors|immunologic factors|mesh-ancestor
25558949|NCT00686517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558950|NCT00686543|Posaconazole|posaconazole|mesh-list
25558951|NCT00686543|Antifungal Agents|antifungal agents|mesh-ancestor
25558952|NCT00686543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25558953|NCT00686543|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25558954|NCT00686543|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25558955|NCT00686543|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25558956|NCT00686543|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25558957|NCT00686543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25558958|NCT00686543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25558959|NCT00686543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558960|NCT00686543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25558961|NCT00686543|Hormone Antagonists|hormone antagonists|mesh-ancestor
25558962|NCT00686543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25558963|NCT00686543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558964|NCT00686595|Infliximab|infliximab|mesh-list
25558965|NCT00686595|Dermatologic Agents|dermatologic agents|mesh-ancestor
25558966|NCT00686595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25558967|NCT00686595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25558968|NCT00686634|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25558969|NCT00686634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25558970|NCT00686634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558971|NCT00686634|Incretins|incretins|mesh-ancestor
25558972|NCT00686634|Hormones|hormones|mesh-ancestor
25558973|NCT00686634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25558974|NCT00686634|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25558975|NCT00686634|Protease Inhibitors|protease inhibitors|mesh-ancestor
25558976|NCT00686634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25558977|NCT00686634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558978|NCT00686686|Infliximab|infliximab|mesh-list
25558979|NCT00686686|Dermatologic Agents|dermatologic agents|mesh-ancestor
25558980|NCT00686686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25558981|NCT00686686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25558982|NCT00686712|Insulin|insulin|mesh-list
25558983|NCT00686712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25558984|NCT00686712|Insulin Glargine|insulin glargine|mesh-list
25558985|NCT00686712|Insulin, Isophane|insulin, isophane|mesh-list
25558986|NCT00686712|Isophane Insulin, Human|isophane insulin, human|mesh-list
25558987|NCT00686712|Isophane insulin, beef|isophane insulin, beef|mesh-list
25558988|NCT00686712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25558989|NCT00686712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25558990|NCT00686725|Temozolomide|temozolomide|mesh-list
25558991|NCT00686725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25558992|NCT00686725|Alkylating Agents|alkylating agents|mesh-ancestor
25558993|NCT00686725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25558994|NCT00686725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25558995|NCT00686777|Interferons|interferons|mesh-list
25558996|NCT00686777|Ribavirin|ribavirin|mesh-list
25558997|NCT00686777|Interferon-alpha|interferon-alpha|mesh-list
25558998|NCT00686777|Interferon alpha-2|interferon alpha-2|mesh-list
25558999|NCT00686777|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25559000|NCT00686777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559001|NCT00686777|Antiviral Agents|antiviral agents|mesh-ancestor
25559002|NCT00686777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25559003|NCT00686777|Antimetabolites|antimetabolites|mesh-ancestor
25559004|NCT00686777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559005|NCT00686777|Immunologic Factors|immunologic factors|mesh-ancestor
25559006|NCT00686777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559007|NCT00686790|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25559008|NCT00686790|Interferon-alpha|interferon-alpha|mesh-list
25559009|NCT00686790|Antiviral Agents|antiviral agents|mesh-ancestor
25559010|NCT00686790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25559011|NCT00686790|Immunologic Factors|immunologic factors|mesh-ancestor
25559012|NCT00686790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559013|NCT00686829|Maleic acid|maleic acid|mesh-list
25559014|NCT00686829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559015|NCT00686829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559016|NCT00686855|Dexamethasone|dexamethasone|mesh-list
25559017|NCT00686855|Tacrolimus|tacrolimus|mesh-list
25559018|NCT00686855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25559019|NCT00686855|Antiemetics|antiemetics|mesh-ancestor
25559020|NCT00686855|Autonomic Agents|autonomic agents|mesh-ancestor
25559021|NCT00686855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25559022|NCT00686855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559023|NCT00686855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25559024|NCT00686855|Glucocorticoids|glucocorticoids|mesh-ancestor
25559025|NCT00686855|Hormones|hormones|mesh-ancestor
25559026|NCT00686855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25559027|NCT00686855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25559028|NCT00686855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559029|NCT00686855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25559030|NCT00686855|Immunologic Factors|immunologic factors|mesh-ancestor
25559031|NCT00686855|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25559032|NCT00686855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559033|NCT00686855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559034|NCT00686881|Interferons|interferons|mesh-list
25559035|NCT00686881|Interferon-alpha|interferon-alpha|mesh-list
25559036|NCT00686881|Interferon alpha-2|interferon alpha-2|mesh-list
25559037|NCT00686881|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25559038|NCT00686881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559039|NCT00686881|Antiviral Agents|antiviral agents|mesh-ancestor
25559040|NCT00686881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25559041|NCT00686881|Immunologic Factors|immunologic factors|mesh-ancestor
25559042|NCT00686881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559043|NCT00686894|Infliximab|infliximab|mesh-list
25559044|NCT00686894|Dermatologic Agents|dermatologic agents|mesh-ancestor
25559045|NCT00686894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25559046|NCT00686894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25559047|NCT00686920|Rifaximin|rifaximin|mesh-list
25559048|NCT00686920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25559049|NCT00686920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25559050|NCT00686920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25559051|NCT00686959|Paclitaxel|paclitaxel|mesh-list
25559052|NCT00686959|Etoposide|etoposide|mesh-list
25559053|NCT00686959|Vinorelbine|vinorelbine|mesh-list
25559054|NCT00686959|Cisplatin|cisplatin|mesh-list
25559055|NCT00686959|Carboplatin|carboplatin|mesh-list
25559056|NCT00686959|Pemetrexed|pemetrexed|mesh-list
25559057|NCT00686959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25559058|NCT00686959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559059|NCT00686959|Tubulin Modulators|tubulin modulators|mesh-ancestor
25559060|NCT00686959|Antimitotic Agents|antimitotic agents|mesh-ancestor
25559061|NCT00686959|Mitosis Modulators|mitosis modulators|mesh-ancestor
25559062|NCT00686959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559063|NCT00686959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25559064|NCT00686959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25559065|NCT00686959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559066|NCT00686959|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25014743|NCT03926299|Clobetasol|clobetasol|mesh-list
25559067|NCT00686959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25559068|NCT00686998|Olanzapine|olanzapine|mesh-list
25559069|NCT00686998|Antiemetics|antiemetics|mesh-ancestor
25559070|NCT00686998|Autonomic Agents|autonomic agents|mesh-ancestor
25559071|NCT00686998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25559072|NCT00686998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559073|NCT00686998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25559074|NCT00686998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25559075|NCT00686998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25559076|NCT00686998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25559077|NCT00686998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25559078|NCT00686998|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25559079|NCT00686998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25559080|NCT00686998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25559081|NCT00686998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559082|NCT00686998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25559083|NCT00686998|Serotonin Agents|serotonin agents|mesh-ancestor
25559084|NCT00687076|Aspirin|aspirin|mesh-list
25559085|NCT00687076|Niacin|niacin|mesh-list
25559086|NCT00687076|Nicotinic Acids|nicotinic acids|mesh-list
25559087|NCT00687076|Clopidogrel|clopidogrel|mesh-list
25559088|NCT00687076|Ezetimibe|ezetimibe|mesh-list
25559089|NCT00687076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25559090|NCT00687076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25559091|NCT00687076|Analgesics|analgesics|mesh-ancestor
25559092|NCT00687076|Sensory System Agents|sensory system agents|mesh-ancestor
25559093|NCT00687076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25559094|NCT00687076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559095|NCT00687076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25559096|NCT00687076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25559097|NCT00687076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25559098|NCT00687076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25559099|NCT00687076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559100|NCT00687076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25559101|NCT00687076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25559102|NCT00687076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559103|NCT00687076|Antipyretics|antipyretics|mesh-ancestor
25559104|NCT00687076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25559105|NCT00687076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25559106|NCT00687076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25559107|NCT00687076|Purinergic Agents|purinergic agents|mesh-ancestor
25559108|NCT00687076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25559109|NCT00687076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25559110|NCT00687076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25559111|NCT00687076|Antimetabolites|antimetabolites|mesh-ancestor
25559112|NCT00687076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25559113|NCT00687076|Vasodilator Agents|vasodilator agents|mesh-ancestor
24535418|NCT00649116|Metoprolol|metoprolol|mesh-list
25559114|NCT00687076|Vitamin B Complex|vitamin b complex|mesh-ancestor
25559115|NCT00687076|Vitamins|vitamins|mesh-ancestor
25559116|NCT00687076|Micronutrients|micronutrients|mesh-ancestor
25559117|NCT00687102|Tamoxifen|tamoxifen|mesh-list
25559118|NCT00687102|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25559119|NCT00687102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25559120|NCT00687102|Hormone Antagonists|hormone antagonists|mesh-ancestor
25559121|NCT00687102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25559122|NCT00687102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559123|NCT00687102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25559124|NCT00687102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559125|NCT00687102|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25559126|NCT00687102|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25559127|NCT00687102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25559128|NCT00687167|Zonisamide|zonisamide|mesh-list
25559129|NCT00687167|Anticonvulsants|anticonvulsants|mesh-ancestor
25559130|NCT00687167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25559131|NCT00687167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25559132|NCT00687167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559133|NCT00687167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25559134|NCT00687167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559135|NCT00687193|Tofacitinib|tofacitinib|mesh-list
25559136|NCT00687193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25559137|NCT00687193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559138|NCT00687193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559139|NCT00687219|Ribavirin|ribavirin|mesh-list
25559140|NCT00687219|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25559141|NCT00687219|Antimetabolites|antimetabolites|mesh-ancestor
25559142|NCT00687219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559143|NCT00687219|Antiviral Agents|antiviral agents|mesh-ancestor
25454110|NCT04550702|Mirabegron|mirabegron|mesh-list
25454111|NCT04550702|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25454112|NCT04550702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25454113|NCT04550702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25454114|NCT04550702|Adrenergic Agents|adrenergic agents|mesh-ancestor
25559144|NCT00687219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25559145|NCT00687271|Atorvastatin|atorvastatin|mesh-list
25559146|NCT00687271|Calcium|calcium|mesh-list
25559147|NCT00687271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25559148|NCT00687271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559149|NCT00687271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25559150|NCT00687271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25559151|NCT00687271|Antimetabolites|antimetabolites|mesh-ancestor
25559152|NCT00687271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559153|NCT00687271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25559154|NCT00687271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25559155|NCT00687271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559156|NCT00687297|Carboplatin|carboplatin|mesh-list
25559157|NCT00687297|Docetaxel|docetaxel|mesh-list
25559158|NCT00687297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559159|NCT00687297|Tubulin Modulators|tubulin modulators|mesh-ancestor
25559160|NCT00687297|Antimitotic Agents|antimitotic agents|mesh-ancestor
25559161|NCT00687297|Mitosis Modulators|mitosis modulators|mesh-ancestor
25559162|NCT00687297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559163|NCT00687323|Temozolomide|temozolomide|mesh-list
25559164|NCT00687323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25559165|NCT00687323|Alkylating Agents|alkylating agents|mesh-ancestor
25559166|NCT00687323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559167|NCT00687323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559168|NCT00687362|Infliximab|infliximab|mesh-list
25559169|NCT00687362|Dermatologic Agents|dermatologic agents|mesh-ancestor
25559170|NCT00687362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25559171|NCT00687362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25559172|NCT00687401|Infliximab|infliximab|mesh-list
25559173|NCT00687401|Dermatologic Agents|dermatologic agents|mesh-ancestor
25559174|NCT00687401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25559175|NCT00687401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25559176|NCT00687440|Docetaxel|docetaxel|mesh-list
25559177|NCT00687440|Doxorubicin|doxorubicin|mesh-list
25559178|NCT00687440|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25559179|NCT00687440|Trastuzumab|trastuzumab|mesh-list
25559180|NCT00687440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559181|NCT00687440|Tubulin Modulators|tubulin modulators|mesh-ancestor
25559182|NCT00687440|Antimitotic Agents|antimitotic agents|mesh-ancestor
25559183|NCT00687440|Mitosis Modulators|mitosis modulators|mesh-ancestor
25559184|NCT00687440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559185|NCT00687440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25559186|NCT00687440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25559187|NCT00687440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25559188|NCT00687440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559189|NCT00687440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25559190|NCT00687453|Insulin Glargine|insulin glargine|mesh-list
25559191|NCT00687453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25559192|NCT00687453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559193|NCT00687544|Ribavirin|ribavirin|mesh-list
25559194|NCT00687544|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25559195|NCT00687544|Antimetabolites|antimetabolites|mesh-ancestor
25559196|NCT00687544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559197|NCT00687544|Antiviral Agents|antiviral agents|mesh-ancestor
25559198|NCT00687544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25559199|NCT00687609|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25559200|NCT00687609|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25559201|NCT00687609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25559202|NCT00687609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25559203|NCT00687609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559204|NCT00687609|Adrenergic Agents|adrenergic agents|mesh-ancestor
25559205|NCT00687609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25559206|NCT00687609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559207|NCT00687674|Dexamethasone|dexamethasone|mesh-list
25559208|NCT00687674|Lenalidomide|lenalidomide|mesh-list
25559209|NCT00687674|Sorafenib|sorafenib|mesh-list
25559210|NCT00687674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25559211|NCT00687674|Antiemetics|antiemetics|mesh-ancestor
25559212|NCT00687674|Autonomic Agents|autonomic agents|mesh-ancestor
25559213|NCT00687674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25559214|NCT00687674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559215|NCT00687674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25559216|NCT00687674|Glucocorticoids|glucocorticoids|mesh-ancestor
25559217|NCT00687674|Hormones|hormones|mesh-ancestor
25559218|NCT00687674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25559219|NCT00687674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25559220|NCT00687674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559221|NCT00687674|Immunologic Factors|immunologic factors|mesh-ancestor
25559222|NCT00687674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25559223|NCT00687674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25559224|NCT00687674|Growth Substances|growth substances|mesh-ancestor
25559225|NCT00687674|Growth Inhibitors|growth inhibitors|mesh-ancestor
25559226|NCT00687674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25559227|NCT00687674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559228|NCT00687674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559229|NCT00687713|Bupropion|bupropion|mesh-list
25559230|NCT00687713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25559231|NCT00687713|Antidepressive Agents|antidepressive agents|mesh-ancestor
25559232|NCT00687713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25559233|NCT00687713|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25559234|NCT00687713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25559235|NCT00687713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25559236|NCT00687713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559237|NCT00687713|Dopamine Agents|dopamine agents|mesh-ancestor
25559238|NCT00687713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25559239|NCT00687713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559240|NCT00687713|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25559241|NCT00687713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25559242|NCT00687713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559243|NCT00687739|Leuprolide|leuprolide|mesh-list
25559244|NCT00687739|Estradiol|estradiol|mesh-list
25559245|NCT00687739|Estrogens|estrogens|mesh-ancestor
25559246|NCT00687739|Hormones|hormones|mesh-ancestor
25559247|NCT00687739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25559248|NCT00687739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559249|NCT00687739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25559250|NCT00687739|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25559251|NCT00687739|Fertility Agents|fertility agents|mesh-ancestor
25559252|NCT00687739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25559253|NCT00687739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559254|NCT00687804|Ranibizumab|ranibizumab|mesh-list
25559255|NCT00687804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25559256|NCT00687804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25559257|NCT00687804|Growth Substances|growth substances|mesh-ancestor
25559258|NCT00687804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559259|NCT00687804|Growth Inhibitors|growth inhibitors|mesh-ancestor
24566924|NCT00788580|Sirolimus|sirolimus|mesh-list
25559260|NCT00687804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559261|NCT00687908|Adapalene|adapalene|mesh-list
25559262|NCT00687908|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25559263|NCT00687908|Dermatologic Agents|dermatologic agents|mesh-ancestor
25559264|NCT00687908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25559265|NCT00687908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25559266|NCT00687908|Analgesics|analgesics|mesh-ancestor
25559267|NCT00687908|Sensory System Agents|sensory system agents|mesh-ancestor
25559268|NCT00687908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25559269|NCT00687908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559270|NCT00687908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25559271|NCT00687908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25559272|NCT00687973|Atenolol|atenolol|mesh-list
25559273|NCT00687973|Amlodipine|amlodipine|mesh-list
25559274|NCT00687973|Valsartan|valsartan|mesh-list
25559275|NCT00687973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25559276|NCT00687973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25559277|NCT00687973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25559278|NCT00687973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559279|NCT00687973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25559280|NCT00687973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559281|NCT00687973|Vasodilator Agents|vasodilator agents|mesh-ancestor
25559282|NCT00687973|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25559283|NCT00687973|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25559284|NCT00687973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25559285|NCT00687973|Sympatholytics|sympatholytics|mesh-ancestor
25559286|NCT00687973|Autonomic Agents|autonomic agents|mesh-ancestor
25559287|NCT00687973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25559288|NCT00687973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25559289|NCT00687973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25559290|NCT00687973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25559291|NCT00687973|Adrenergic Agents|adrenergic agents|mesh-ancestor
25559292|NCT00687973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25559293|NCT00688064|Doxycycline|doxycycline|mesh-list
25559294|NCT00688064|Adapalene|adapalene|mesh-list
25559295|NCT00688064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25454332|NCT04546802|Grazoprevir|grazoprevir|mesh-list
25454333|NCT04546802|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25454334|NCT04546802|Antiviral Agents|antiviral agents|mesh-ancestor
25454335|NCT04546802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25454336|NCT04546815|Daptomycin|daptomycin|mesh-list
25454337|NCT04546815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25454338|NCT04546815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25454339|NCT04547088|Apatinib|apatinib|mesh-list
25454340|NCT04547088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25454341|NCT04547088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25454342|NCT04547088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454343|NCT04547088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454344|NCT04547179|Erenumab|erenumab|mesh-list
25454345|NCT04547179|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25454346|NCT04547179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454347|NCT04547179|Analgesics|analgesics|mesh-ancestor
25454348|NCT04547179|Sensory System Agents|sensory system agents|mesh-ancestor
25454349|NCT04547179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25454350|NCT04547179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161863|NCT02240407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25161864|NCT02240407|Sensory System Agents|sensory system agents|mesh-ancestor
25161865|NCT02240407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25161866|NCT02240407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25161867|NCT02240407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25161868|NCT02240407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25161869|NCT02240407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25161870|NCT02240407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161871|NCT02240407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25161872|NCT02240407|Analgesics|analgesics|mesh-ancestor
25161873|NCT02240407|Antipyretics|antipyretics|mesh-ancestor
25161874|NCT02240407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25161875|NCT02240407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25161876|NCT02240407|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25161877|NCT02240407|Antifungal Agents|antifungal agents|mesh-ancestor
25161878|NCT02240407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25161879|NCT02240407|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25161880|NCT02240407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25161881|NCT02240407|Antiemetics|antiemetics|mesh-ancestor
25161882|NCT02240407|Autonomic Agents|autonomic agents|mesh-ancestor
25161883|NCT02240407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25161884|NCT02240407|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25161885|NCT02240407|Histamine Antagonists|histamine antagonists|mesh-ancestor
24420060|NCT00215046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420061|NCT00215046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24916493|NCT04239794|Propofol|propofol|mesh-list
24978677|NCT03432741|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24978679|NCT03410706|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24420084|NCT00215163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420086|NCT00215163|Serotonin Agents|serotonin agents|mesh-ancestor
24420087|NCT00215163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420088|NCT00215163|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24420091|NCT00215163|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24420092|NCT00215163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24420094|NCT00215176|Modafinil|modafinil|mesh-list
25559296|NCT00688064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25559297|NCT00688064|Antimalarials|antimalarials|mesh-ancestor
25559298|NCT00688064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25559299|NCT00688064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25559300|NCT00688064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25559301|NCT00688064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25559302|NCT00688064|Analgesics|analgesics|mesh-ancestor
25559303|NCT00688064|Sensory System Agents|sensory system agents|mesh-ancestor
25559304|NCT00688064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25559305|NCT00688064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559306|NCT00688064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25559307|NCT00688064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25559308|NCT00688064|Dermatologic Agents|dermatologic agents|mesh-ancestor
25559309|NCT00688103|Etanercept|etanercept|mesh-list
25559310|NCT00688103|Methotrexate|methotrexate|mesh-list
25559311|NCT00688103|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25559312|NCT00688103|Abortifacient Agents|abortifacient agents|mesh-ancestor
25559313|NCT00688103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25559314|NCT00688103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559315|NCT00688103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25559316|NCT00688103|Antimetabolites|antimetabolites|mesh-ancestor
25559317|NCT00688103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559318|NCT00688103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559319|NCT00688103|Dermatologic Agents|dermatologic agents|mesh-ancestor
25559320|NCT00688103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559321|NCT00688103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25559322|NCT00688103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25559323|NCT00688103|Immunologic Factors|immunologic factors|mesh-ancestor
25559324|NCT00688103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25559325|NCT00688103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25559326|NCT00688103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25559327|NCT00688103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25559328|NCT00688103|Analgesics|analgesics|mesh-ancestor
25559329|NCT00688103|Sensory System Agents|sensory system agents|mesh-ancestor
25559330|NCT00688103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25559331|NCT00688103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25559332|NCT00688103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25559333|NCT00688324|Acamprosate|acamprosate|mesh-list
25559334|NCT00688324|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25559335|NCT00688545|Celecoxib|celecoxib|mesh-list
25559336|NCT00688545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25559337|NCT00688545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25559338|NCT00688545|Analgesics|analgesics|mesh-ancestor
25690424|NCT01973231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25559339|NCT00688545|Sensory System Agents|sensory system agents|mesh-ancestor
25559340|NCT00688545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25559341|NCT00688545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559342|NCT00688545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25559343|NCT00688545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25559344|NCT00688545|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25559345|NCT00688545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25559346|NCT00688545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559347|NCT00688545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559348|NCT00688597|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
25559349|NCT00688597|Antiviral Agents|antiviral agents|mesh-ancestor
25559350|NCT00688597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25559351|NCT00688597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559352|NCT00688597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559353|NCT00688623|Everolimus|everolimus|mesh-list
25559354|NCT00688623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559355|NCT00688623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25559356|NCT00688623|Immunologic Factors|immunologic factors|mesh-ancestor
25559357|NCT00688623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559358|NCT00688636|Infliximab|infliximab|mesh-list
25559359|NCT00688636|Dermatologic Agents|dermatologic agents|mesh-ancestor
25559360|NCT00688636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25559361|NCT00688636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25559362|NCT00688688|Mirabegron|mirabegron|mesh-list
25559363|NCT00688688|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25559364|NCT00688688|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25559365|NCT00688688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25559366|NCT00688688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25559367|NCT00688688|Adrenergic Agents|adrenergic agents|mesh-ancestor
24972128|NCT03720041|Hormones|hormones|mesh-ancestor
25559368|NCT00688688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25559369|NCT00688688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559370|NCT00688688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559371|NCT00688688|Urological Agents|urological agents|mesh-ancestor
25559372|NCT00688688|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25559373|NCT00688688|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25559374|NCT00688688|Cholinergic Agents|cholinergic agents|mesh-ancestor
25559375|NCT00688701|Lixisenatide|lixisenatide|mesh-list
25559376|NCT00688701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25559377|NCT00688701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559378|NCT00688740|Cyclophosphamide|cyclophosphamide|mesh-list
25559379|NCT00688740|Docetaxel|docetaxel|mesh-list
25559380|NCT00688740|Doxorubicin|doxorubicin|mesh-list
25559381|NCT00688740|Fluorouracil|fluorouracil|mesh-list
25559382|NCT00688740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25559383|NCT00688740|Immunologic Factors|immunologic factors|mesh-ancestor
25559384|NCT00688740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559385|NCT00688740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25559386|NCT00688740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25559387|NCT00688740|Alkylating Agents|alkylating agents|mesh-ancestor
25559388|NCT00688740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559389|NCT00688740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559390|NCT00688740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25559391|NCT00688740|Tubulin Modulators|tubulin modulators|mesh-ancestor
25559392|NCT00688740|Antimitotic Agents|antimitotic agents|mesh-ancestor
25559393|NCT00688740|Mitosis Modulators|mitosis modulators|mesh-ancestor
25559394|NCT00688740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25559395|NCT00688740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25559396|NCT00688740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25559397|NCT00688740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559398|NCT00688740|Antimetabolites|antimetabolites|mesh-ancestor
25559399|NCT00688740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25559401|NCT00688753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559402|NCT00688753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25559403|NCT00688753|Immunologic Factors|immunologic factors|mesh-ancestor
25559404|NCT00688753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559405|NCT00688870|Vaccines|vaccines|mesh-list
25559406|NCT00688870|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25559407|NCT00688870|Immunologic Factors|immunologic factors|mesh-ancestor
25559408|NCT00688870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559409|NCT00688909|Letrozole|letrozole|mesh-list
25559410|NCT00688909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559411|NCT00688909|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25015627|NCT01350934|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25559412|NCT00688909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25559413|NCT00688909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559414|NCT00688909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559415|NCT00688909|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25559416|NCT00688909|Hormone Antagonists|hormone antagonists|mesh-ancestor
25559417|NCT00688909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25559418|NCT00688909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559419|NCT00689026|Lubiprostone|lubiprostone|mesh-list
25559420|NCT00689026|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25559421|NCT00689026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25559422|NCT00689026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559423|NCT00689078|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25559424|NCT00689078|Prednisolone|prednisolone|mesh-list
25559425|NCT00689078|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25559426|NCT00689078|Methylprednisolone|methylprednisolone|mesh-list
25559427|NCT00689078|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25559428|NCT00689078|Prednisolone acetate|prednisolone acetate|mesh-list
25559429|NCT00689078|Lubricant Eye Drops|lubricant eye drops|mesh-list
25559430|NCT00689078|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25559431|NCT00689078|Prednisolone phosphate|prednisolone phosphate|mesh-list
25559432|NCT00689078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25559433|NCT00689078|Glucocorticoids|glucocorticoids|mesh-ancestor
25559434|NCT00689078|Hormones|hormones|mesh-ancestor
25559435|NCT00689078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25559436|NCT00689078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559437|NCT00689078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25559438|NCT00689078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559439|NCT00689078|Antiemetics|antiemetics|mesh-ancestor
25559440|NCT00689078|Autonomic Agents|autonomic agents|mesh-ancestor
25559441|NCT00689078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25559442|NCT00689078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25559443|NCT00689078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25559444|NCT00689078|Protective Agents|protective agents|mesh-ancestor
25559445|NCT00689078|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25559446|NCT00689078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25559447|NCT00689078|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25559448|NCT00689104|Mirabegron|mirabegron|mesh-list
25559449|NCT00689104|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25559450|NCT00689104|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25559451|NCT00689104|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25559452|NCT00689104|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25559453|NCT00689104|Adrenergic Agents|adrenergic agents|mesh-ancestor
25559454|NCT00689104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25559455|NCT00689104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559456|NCT00689104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559457|NCT00689104|Urological Agents|urological agents|mesh-ancestor
25559458|NCT00689104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25559459|NCT00689104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25559460|NCT00689104|Cholinergic Agents|cholinergic agents|mesh-ancestor
25559461|NCT00689117|Clindamycin|clindamycin|mesh-list
25559462|NCT00689117|Clindamycin palmitate|clindamycin palmitate|mesh-list
25559463|NCT00689117|Clindamycin phosphate|clindamycin phosphate|mesh-list
25559464|NCT00689117|Tretinoin|tretinoin|mesh-list
25559465|NCT00689117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25559466|NCT00689117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25559467|NCT00689117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25559468|NCT00689117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559469|NCT00689117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559470|NCT00689117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559471|NCT00689117|Keratolytic Agents|keratolytic agents|mesh-ancestor
25559472|NCT00689117|Dermatologic Agents|dermatologic agents|mesh-ancestor
25559473|NCT00689221|Temozolomide|temozolomide|mesh-list
25559474|NCT00689221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25559475|NCT00689221|Alkylating Agents|alkylating agents|mesh-ancestor
25559476|NCT00689221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559477|NCT00689221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25651618|NCT01518153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25651619|NCT01518192|Doxycycline|doxycycline|mesh-list
25651620|NCT01518192|Cefuroxime|cefuroxime|mesh-list
25651621|NCT01518192|Cefuroxime axetil|cefuroxime axetil|mesh-list
25651622|NCT01518192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25651623|NCT01518192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25651624|NCT01518192|Antimalarials|antimalarials|mesh-ancestor
25651625|NCT01518192|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25651626|NCT01518192|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25651627|NCT01518244|Timolol|timolol|mesh-list
25651628|NCT01518244|Brinzolamide|brinzolamide|mesh-list
25651629|NCT01518244|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25651630|NCT01518244|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25651631|NCT01518244|Adrenergic Agents|adrenergic agents|mesh-ancestor
25651632|NCT01518244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25651633|NCT01518244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651634|NCT01518244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651635|NCT01518244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25651636|NCT01518244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25651637|NCT01518244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651638|NCT01518244|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25651639|NCT01518257|Botulinum Toxins|botulinum toxins|mesh-list
25651640|NCT01518257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25651641|NCT01518257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25651642|NCT01518257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25651643|NCT01518257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25651644|NCT01518257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651645|NCT01518257|Cholinergic Agents|cholinergic agents|mesh-ancestor
25651646|NCT01518257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25651647|NCT01518257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651648|NCT01518257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25651649|NCT01518257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25651650|NCT01518309|Pimavanserin|pimavanserin|mesh-list
25651651|NCT01518309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25651652|NCT01518309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25651653|NCT01518309|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25651654|NCT01518309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25651655|NCT01518309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25651656|NCT01518309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651657|NCT01518309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25651658|NCT01518309|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25651659|NCT01518309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25651660|NCT01518309|Serotonin Agents|serotonin agents|mesh-ancestor
25651661|NCT01518309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25651662|NCT01518309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651663|NCT01518699|Moxifloxacin|moxifloxacin|mesh-list
25063130|NCT03112044|Sofosbuvir|sofosbuvir|mesh-list
25651664|NCT01518699|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25651665|NCT01518699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25651666|NCT01518699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25651667|NCT01518699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25651668|NCT01518699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25651669|NCT01518699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651670|NCT01518699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651671|NCT01518699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25651672|NCT01518699|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25651673|NCT01518699|Contraceptive Agents|contraceptive agents|mesh-ancestor
25651674|NCT01518699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25651675|NCT01518699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651676|NCT01518699|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25454503|NCT04545450|Methyltestosterone|methyltestosterone|mesh-list
25454578|NCT04544683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454579|NCT04544306|Anti-Infective Agents|anti-infective agents|mesh-list
25454580|NCT04544306|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25454581|NCT04544228|Ketamine|ketamine|mesh-list
25454582|NCT04544228|Bupivacaine|bupivacaine|mesh-list
25454583|NCT04544228|Neostigmine|neostigmine|mesh-list
25454584|NCT04544228|Anesthetics, Local|anesthetics, local|mesh-ancestor
25454585|NCT04544228|Anesthetics|anesthetics|mesh-ancestor
25454586|NCT04544228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25454587|NCT04544228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454588|NCT04544228|Sensory System Agents|sensory system agents|mesh-ancestor
25454589|NCT04544228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25454590|NCT04544228|Analgesics|analgesics|mesh-ancestor
25454591|NCT04544228|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25454592|NCT04544228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25454593|NCT04544228|Anesthetics, General|anesthetics, general|mesh-ancestor
25454594|NCT04544228|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25454595|NCT04544228|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25454596|NCT04544228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25454597|NCT04544228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454598|NCT04544228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25454599|NCT04544228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454600|NCT04544228|Cholinergic Agents|cholinergic agents|mesh-ancestor
25454601|NCT04544228|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25454602|NCT04544228|Autonomic Agents|autonomic agents|mesh-ancestor
25311160|NCT04095845|Nootropic Agents|nootropic agents|mesh-ancestor
24420095|NCT00215176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24420096|NCT00215176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420097|NCT00215176|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24420098|NCT00215176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24837791|NCT02193334|Mitogens|mitogens|mesh-list
24420116|NCT00215228|Antidepressive Agents|antidepressive agents|mesh-ancestor
24420117|NCT00215228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24420118|NCT00215228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24420119|NCT00215228|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24420121|NCT00215228|Sensory System Agents|sensory system agents|mesh-ancestor
24420122|NCT00215228|Dopamine Agents|dopamine agents|mesh-ancestor
25822653|NCT00004580|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25822654|NCT00004580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25822655|NCT00004580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24420136|NCT00215241|Antidepressive Agents|antidepressive agents|mesh-ancestor
24420137|NCT00215241|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25822656|NCT00004580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25822657|NCT00004580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25822658|NCT00004580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25822659|NCT00004581|Ritonavir|ritonavir|mesh-list
25822660|NCT00004581|Lopinavir|lopinavir|mesh-list
25161886|NCT02240407|Histamine Agents|histamine agents|mesh-ancestor
25559478|NCT00689338|Fluconazole|fluconazole|mesh-list
25559479|NCT00689338|Voriconazole|voriconazole|mesh-list
25559480|NCT00689338|Anidulafungin|anidulafungin|mesh-list
25559481|NCT00689338|Antifungal Agents|antifungal agents|mesh-ancestor
25559482|NCT00689338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25559483|NCT00689338|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25559484|NCT00689338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25559485|NCT00689338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559486|NCT00689338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559487|NCT00689338|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25559488|NCT00689338|Hormone Antagonists|hormone antagonists|mesh-ancestor
25559489|NCT00689338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25559490|NCT00689338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559491|NCT00689338|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25559492|NCT00689338|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25559493|NCT00689338|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25559494|NCT00689351|Vaccines|vaccines|mesh-list
25559495|NCT00689351|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25559496|NCT00689351|Immunologic Factors|immunologic factors|mesh-ancestor
25559497|NCT00689351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559498|NCT00689390|Ribavirin|ribavirin|mesh-list
25559499|NCT00689390|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25559500|NCT00689390|Antimetabolites|antimetabolites|mesh-ancestor
25559501|NCT00689390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559502|NCT00689390|Antiviral Agents|antiviral agents|mesh-ancestor
25559503|NCT00689390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25559504|NCT00689572|Ondansetron|ondansetron|mesh-list
25559505|NCT00689572|Antiemetics|antiemetics|mesh-ancestor
25559506|NCT00689572|Autonomic Agents|autonomic agents|mesh-ancestor
25559507|NCT00689572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25559508|NCT00689572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559509|NCT00689572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25559510|NCT00689572|Antipruritics|antipruritics|mesh-ancestor
25559511|NCT00689572|Dermatologic Agents|dermatologic agents|mesh-ancestor
25559512|NCT00689572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25559513|NCT00689572|Serotonin Agents|serotonin agents|mesh-ancestor
25559514|NCT00689572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25559515|NCT00689572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559516|NCT00689572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25559517|NCT00689572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25559518|NCT00689572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25559519|NCT00689572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25559520|NCT00689572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25559521|NCT00689611|Bupropion|bupropion|mesh-list
25559522|NCT00689611|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25559523|NCT00689611|Antidepressive Agents|antidepressive agents|mesh-ancestor
25559524|NCT00689611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25559525|NCT00689611|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25559526|NCT00689611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25559527|NCT00689611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25559528|NCT00689611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559529|NCT00689611|Dopamine Agents|dopamine agents|mesh-ancestor
25559530|NCT00689611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25559531|NCT00689611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559532|NCT00689611|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25559533|NCT00689611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25559534|NCT00689611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559535|NCT00689793|Iron|iron|mesh-list
25559536|NCT00689793|Trace Elements|trace elements|mesh-ancestor
25559537|NCT00689793|Micronutrients|micronutrients|mesh-ancestor
25559538|NCT00689793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559539|NCT00689936|Thalidomide|thalidomide|mesh-list
25559540|NCT00689936|Dexamethasone|dexamethasone|mesh-list
25559541|NCT00689936|Dexamethasone acetate|dexamethasone acetate|mesh-list
25559542|NCT00689936|Prednisone|prednisone|mesh-list
25559543|NCT00689936|Lenalidomide|lenalidomide|mesh-list
25559544|NCT00689936|Melphalan|melphalan|mesh-list
25559545|NCT00689936|BB 1101|bb 1101|mesh-list
25559546|NCT00689936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25559547|NCT00689936|Antiemetics|antiemetics|mesh-ancestor
25559548|NCT00689936|Autonomic Agents|autonomic agents|mesh-ancestor
25559549|NCT00689936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25559550|NCT00689936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559551|NCT00689936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25559552|NCT00689936|Glucocorticoids|glucocorticoids|mesh-ancestor
25559553|NCT00689936|Hormones|hormones|mesh-ancestor
25559554|NCT00689936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25559555|NCT00689936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25559556|NCT00689936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559557|NCT00689936|Protease Inhibitors|protease inhibitors|mesh-ancestor
25559558|NCT00689936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559559|NCT00689936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559560|NCT00689936|Immunologic Factors|immunologic factors|mesh-ancestor
25559561|NCT00689936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25559562|NCT00689936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25559563|NCT00689936|Growth Substances|growth substances|mesh-ancestor
25559564|NCT00689936|Growth Inhibitors|growth inhibitors|mesh-ancestor
25559565|NCT00689936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25559566|NCT00689936|Alkylating Agents|alkylating agents|mesh-ancestor
25559567|NCT00689936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25559568|NCT00689936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25559569|NCT00689936|Leprostatic Agents|leprostatic agents|mesh-ancestor
25559570|NCT00689936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25559571|NCT00689936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25559572|NCT00690235|Pramlintide|pramlintide|mesh-list
25559573|NCT00690235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25559574|NCT00690235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559575|NCT00690378|Imipenem|imipenem|mesh-list
25559576|NCT00690378|Ceftazidime|ceftazidime|mesh-list
25559577|NCT00690378|Avibactam|avibactam|mesh-list
25559578|NCT00690378|Cilastatin|cilastatin|mesh-list
25559579|NCT00690378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25559580|NCT00690378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25559581|NCT00690378|Protease Inhibitors|protease inhibitors|mesh-ancestor
25559582|NCT00690378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559583|NCT00690378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559584|NCT00690378|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25559586|NCT00690430|Pasireotide|pasireotide|mesh-list
25559587|NCT00690430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25559588|NCT00690430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25559589|NCT00690430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559590|NCT00690430|Hormones|hormones|mesh-ancestor
25559591|NCT00690430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25559592|NCT00690430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559593|NCT00690443|Atorvastatin|atorvastatin|mesh-list
25559594|NCT00690443|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25559595|NCT00690443|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25559596|NCT00690443|Antimetabolites|antimetabolites|mesh-ancestor
25559597|NCT00690443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559598|NCT00690443|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25559599|NCT00690443|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25559600|NCT00690443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559601|NCT00690495|Propofol|propofol|mesh-list
25559602|NCT00690495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25559603|NCT00690495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25559604|NCT00690495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559605|NCT00690495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25559606|NCT00690495|Anesthetics, General|anesthetics, general|mesh-ancestor
24578436|NCT00849082|Goserelin|goserelin|mesh-list
25559607|NCT00690495|Anesthetics|anesthetics|mesh-ancestor
25559608|NCT00690573|Adalimumab|adalimumab|mesh-list
25559609|NCT00690573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25559610|NCT00690573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25559611|NCT00690612|Candesartan|candesartan|mesh-list
25559612|NCT00690612|Candesartan cilexetil|candesartan cilexetil|mesh-list
25559613|NCT00690612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25559614|NCT00690612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25559615|NCT00690612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25559616|NCT00690612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559617|NCT00690794|Travoprost|travoprost|mesh-list
25559618|NCT00690794|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25559619|NCT00690794|Latanoprost|latanoprost|mesh-list
25559620|NCT00690794|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25559621|NCT00690794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25559622|NCT00690820|Pancrelipase|pancrelipase|mesh-list
25559623|NCT00690820|Pancreatin|pancreatin|mesh-list
25559624|NCT00690820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25559625|NCT00690833|Desonide|desonide|mesh-list
25559626|NCT00690833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25559627|NCT00690898|Lanreotide|lanreotide|mesh-list
25559628|NCT00690898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559629|NCT00690924|Calcitriol|calcitriol|mesh-list
25559630|NCT00690924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25559631|NCT00690924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559632|NCT00690924|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25559633|NCT00690924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25559634|NCT00690924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559635|NCT00690924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25559636|NCT00690924|Vitamins|vitamins|mesh-ancestor
25559637|NCT00690924|Micronutrients|micronutrients|mesh-ancestor
25559638|NCT00690924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25559639|NCT00691002|Calcitriol|calcitriol|mesh-list
25559640|NCT00691002|Hydrocortisone|hydrocortisone|mesh-list
25559641|NCT00691002|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25559642|NCT00691002|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25559643|NCT00691002|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25559644|NCT00691002|Calcipotriene|calcipotriene|mesh-list
24537507|NCT00655018|Vitamins|vitamins|mesh-ancestor
25559645|NCT00691002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25559646|NCT00691002|Dermatologic Agents|dermatologic agents|mesh-ancestor
25559647|NCT00691002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25559648|NCT00691002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559649|NCT00691002|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25559650|NCT00691002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25559651|NCT00691002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559652|NCT00691002|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25559653|NCT00691002|Vitamins|vitamins|mesh-ancestor
25559654|NCT00691002|Micronutrients|micronutrients|mesh-ancestor
25559655|NCT00691002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25559656|NCT00691015|Cytarabine|cytarabine|mesh-list
25559657|NCT00691015|Cyclophosphamide|cyclophosphamide|mesh-list
25559658|NCT00691015|Melphalan|melphalan|mesh-list
25559659|NCT00691015|Busulfan|busulfan|mesh-list
25559660|NCT00691015|Carmustine|carmustine|mesh-list
25559661|NCT00691015|Rituximab|rituximab|mesh-list
25559662|NCT00691015|Fludarabine|fludarabine|mesh-list
25559663|NCT00691015|Fludarabine phosphate|fludarabine phosphate|mesh-list
25559664|NCT00691015|Etoposide|etoposide|mesh-list
25559665|NCT00691015|Thymoglobulin|thymoglobulin|mesh-list
25559666|NCT00691015|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25559667|NCT00691015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25559668|NCT00691015|Immunologic Factors|immunologic factors|mesh-ancestor
25559669|NCT00691015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559670|NCT00691015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25559671|NCT00691015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25559672|NCT00691015|Alkylating Agents|alkylating agents|mesh-ancestor
25559673|NCT00691015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559674|NCT00691015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559675|NCT00691015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25559676|NCT00691015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25559677|NCT00691015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25559678|NCT00691015|Antimetabolites|antimetabolites|mesh-ancestor
25559679|NCT00691015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25559680|NCT00691015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25559681|NCT00691015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25559682|NCT00691015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559683|NCT00691015|Antiviral Agents|antiviral agents|mesh-ancestor
25559684|NCT00691015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25559685|NCT00691028|Infliximab|infliximab|mesh-list
25559686|NCT00691028|Dermatologic Agents|dermatologic agents|mesh-ancestor
25559687|NCT00691028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25559688|NCT00691028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25559689|NCT00691054|Paclitaxel|paclitaxel|mesh-list
25559690|NCT00691054|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25559691|NCT00691054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25559692|NCT00691054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559693|NCT00691054|Tubulin Modulators|tubulin modulators|mesh-ancestor
25559694|NCT00691054|Antimitotic Agents|antimitotic agents|mesh-ancestor
25559695|NCT00691054|Mitosis Modulators|mitosis modulators|mesh-ancestor
25559696|NCT00691054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559697|NCT00691093|Fesoterodine|fesoterodine|mesh-list
25559698|NCT00691093|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25559699|NCT00691093|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25559700|NCT00691093|Cholinergic Agents|cholinergic agents|mesh-ancestor
25559701|NCT00691093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25559702|NCT00691093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559703|NCT00691093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559704|NCT00691093|Urological Agents|urological agents|mesh-ancestor
25559705|NCT00691132|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
25559706|NCT00691132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559707|NCT00691132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559708|NCT00691132|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25559709|NCT00691132|Protective Agents|protective agents|mesh-ancestor
25559710|NCT00691132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559711|NCT00691132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559712|NCT00691197|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25559713|NCT00691197|Glycerol|glycerol|mesh-list
25110851|NCT05336266|Ketorolac|ketorolac|mesh-list
25559714|NCT00691197|Laxatives|laxatives|mesh-ancestor
25559715|NCT00691197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25559716|NCT00691197|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25559717|NCT00691197|Protective Agents|protective agents|mesh-ancestor
25559718|NCT00691197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559719|NCT00691210|Niacinamide|niacinamide|mesh-list
25559720|NCT00691210|Niacin|niacin|mesh-list
25454745|NCT04542733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454746|NCT04542733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25454747|NCT04542473|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25454748|NCT04542473|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25454750|NCT04542226|Bromides|bromides|mesh-list
25559721|NCT00691210|Nicotinic Acids|nicotinic acids|mesh-list
25559722|NCT00691210|Etoposide|etoposide|mesh-list
25559723|NCT00691210|Vorinostat|vorinostat|mesh-list
25559724|NCT00691210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25559725|NCT00691210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559726|NCT00691210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25559727|NCT00691210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25559728|NCT00691210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559729|NCT00691210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559730|NCT00691210|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25559731|NCT00691210|Vitamin B Complex|vitamin b complex|mesh-ancestor
25559733|NCT00691210|Micronutrients|micronutrients|mesh-ancestor
25559734|NCT00691210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559735|NCT00691210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25559736|NCT00691210|Antimetabolites|antimetabolites|mesh-ancestor
25559737|NCT00691210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25559738|NCT00691210|Vasodilator Agents|vasodilator agents|mesh-ancestor
25559739|NCT00691301|Cisplatin|cisplatin|mesh-list
25559740|NCT00691301|Pemetrexed|pemetrexed|mesh-list
25559741|NCT00691301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559742|NCT00691301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559743|NCT00691301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559744|NCT00691301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25559745|NCT00691301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25559746|NCT00691483|Varenicline|varenicline|mesh-list
25559747|NCT00691483|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25559748|NCT00691483|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25559749|NCT00691483|Cholinergic Agents|cholinergic agents|mesh-ancestor
25559750|NCT00691483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25559751|NCT00691483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559752|NCT00691483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559753|NCT00691600|Trimethoprim|trimethoprim|mesh-list
25559754|NCT00691600|Sulfamethoxazole|sulfamethoxazole|mesh-list
25559755|NCT00691600|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25559756|NCT00691600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25559757|NCT00691600|Renal Agents|renal agents|mesh-ancestor
25559758|NCT00691600|Antimalarials|antimalarials|mesh-ancestor
25559759|NCT00691600|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25559760|NCT00691600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25559761|NCT00691600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25559762|NCT00691600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559763|NCT00691600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559764|NCT00691600|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25559765|NCT00691600|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25559766|NCT00691600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25559767|NCT00691665|Fluticasone|fluticasone|mesh-list
25559768|NCT00691665|Xhance|xhance|mesh-list
25559769|NCT00691665|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25559770|NCT00691665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25559771|NCT00691665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25559772|NCT00691665|Autonomic Agents|autonomic agents|mesh-ancestor
25559773|NCT00691665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25559774|NCT00691665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559775|NCT00691665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25559776|NCT00691665|Respiratory System Agents|respiratory system agents|mesh-ancestor
25559777|NCT00691665|Dermatologic Agents|dermatologic agents|mesh-ancestor
25559778|NCT00691665|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25559779|NCT00691665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25559780|NCT00691665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25559781|NCT00691665|Analgesics|analgesics|mesh-ancestor
25559782|NCT00691665|Sensory System Agents|sensory system agents|mesh-ancestor
25559783|NCT00691665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25559784|NCT00691665|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25559785|NCT00691665|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25559786|NCT00691665|Histamine Antagonists|histamine antagonists|mesh-ancestor
25559787|NCT00691665|Histamine Agents|histamine agents|mesh-ancestor
25559788|NCT00691665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25559789|NCT00691665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559790|NCT00691704|Aspirin|aspirin|mesh-list
25559791|NCT00691704|Prednisone|prednisone|mesh-list
25559792|NCT00691704|Lenalidomide|lenalidomide|mesh-list
25559793|NCT00691704|Bortezomib|bortezomib|mesh-list
25559794|NCT00691704|Melphalan|melphalan|mesh-list
25559795|NCT00691704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25559796|NCT00691704|Glucocorticoids|glucocorticoids|mesh-ancestor
25559797|NCT00691704|Hormones|hormones|mesh-ancestor
25559798|NCT00691704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25559799|NCT00691704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559800|NCT00691704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25559801|NCT00691704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559802|NCT00691704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25559803|NCT00691704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25559804|NCT00691704|Analgesics|analgesics|mesh-ancestor
25559805|NCT00691704|Sensory System Agents|sensory system agents|mesh-ancestor
25559806|NCT00691704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25559807|NCT00691704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25559808|NCT00691704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25559809|NCT00691704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25559810|NCT00691704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559811|NCT00691704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25559812|NCT00691704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25559813|NCT00691704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559814|NCT00691704|Antipyretics|antipyretics|mesh-ancestor
25559815|NCT00691704|Immunologic Factors|immunologic factors|mesh-ancestor
25559816|NCT00691704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25559817|NCT00691704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25559818|NCT00691704|Growth Substances|growth substances|mesh-ancestor
25559819|NCT00691704|Growth Inhibitors|growth inhibitors|mesh-ancestor
25559820|NCT00691704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25559821|NCT00691704|Alkylating Agents|alkylating agents|mesh-ancestor
25559822|NCT00691704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25559823|NCT00691704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25559824|NCT00691938|Decitabine|decitabine|mesh-list
25559825|NCT00691938|Panobinostat|panobinostat|mesh-list
25559826|NCT00691938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25559827|NCT00691938|Antimetabolites|antimetabolites|mesh-ancestor
25559828|NCT00691938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559829|NCT00691938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559830|NCT00691938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559831|NCT00691938|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25559832|NCT00692185|Olanzapine|olanzapine|mesh-list
25559833|NCT00692185|Antiemetics|antiemetics|mesh-ancestor
25559834|NCT00692185|Autonomic Agents|autonomic agents|mesh-ancestor
25559835|NCT00692185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25559836|NCT00692185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559837|NCT00692185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25559838|NCT00692185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25559839|NCT00692185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25559840|NCT00692185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25559841|NCT00692185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25559842|NCT00692185|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25559843|NCT00692185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25559844|NCT00692185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25559845|NCT00692185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559846|NCT00692185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25559847|NCT00692185|Serotonin Agents|serotonin agents|mesh-ancestor
25559848|NCT00692237|Sildenafil Citrate|sildenafil citrate|mesh-list
25559849|NCT00692237|Vasodilator Agents|vasodilator agents|mesh-ancestor
25559850|NCT00692237|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25559851|NCT00692237|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25559852|NCT00692237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559853|NCT00692237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559854|NCT00692237|Urological Agents|urological agents|mesh-ancestor
25559855|NCT00692341|Axitinib|axitinib|mesh-list
25559856|NCT00692341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25690557|NCT01975246|Amlodipine|amlodipine|mesh-list
25559857|NCT00692341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25559858|NCT00692341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559859|NCT00692341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559860|NCT00692770|Sorafenib|sorafenib|mesh-list
25559861|NCT00692770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559862|NCT00692770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25559863|NCT00692770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559864|NCT00692770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559865|NCT00692978|Fluticasone|fluticasone|mesh-list
25559866|NCT00692978|Xhance|xhance|mesh-list
25559867|NCT00692978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25559868|NCT00692978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25559869|NCT00692978|Autonomic Agents|autonomic agents|mesh-ancestor
25559870|NCT00692978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25559871|NCT00692978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559872|NCT00692978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25559873|NCT00692978|Respiratory System Agents|respiratory system agents|mesh-ancestor
25559874|NCT00692978|Dermatologic Agents|dermatologic agents|mesh-ancestor
25559875|NCT00692978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25559876|NCT00693160|Ketorolac|ketorolac|mesh-list
25559877|NCT00693160|Remifentanil|remifentanil|mesh-list
25559878|NCT00693160|Capsaicin|capsaicin|mesh-list
25559879|NCT00693160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25559880|NCT00693160|Narcotics|narcotics|mesh-ancestor
25559881|NCT00693160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25559882|NCT00693160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559883|NCT00693160|Analgesics|analgesics|mesh-ancestor
25690567|NCT01975246|Vasodilator Agents|vasodilator agents|mesh-ancestor
25559884|NCT00693160|Sensory System Agents|sensory system agents|mesh-ancestor
25559885|NCT00693160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25559886|NCT00693160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25559887|NCT00693160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25559888|NCT00693160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25559889|NCT00693160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25559890|NCT00693160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25559891|NCT00693160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559892|NCT00693160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559893|NCT00693160|Antipruritics|antipruritics|mesh-ancestor
25559894|NCT00693160|Dermatologic Agents|dermatologic agents|mesh-ancestor
25559895|NCT00693225|Omeprazole|omeprazole|mesh-list
25559896|NCT00693225|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
25559897|NCT00693225|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25559898|NCT00693225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25559899|NCT00693225|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25559900|NCT00693225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559901|NCT00693225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559902|NCT00693420|Bimatoprost|bimatoprost|mesh-list
25559903|NCT00693420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25559904|NCT00693420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25559905|NCT00693472|Propranolol|propranolol|mesh-list
25559906|NCT00693472|Haloperidol|haloperidol|mesh-list
25559907|NCT00693472|Haloperidol decanoate|haloperidol decanoate|mesh-list
25559908|NCT00693472|Cholinergic Antagonists|cholinergic antagonists|mesh-list
25559909|NCT00693472|Antiemetics|antiemetics|mesh-ancestor
24586738|NCT00892073|Metformin|metformin|mesh-list
25559910|NCT00693472|Autonomic Agents|autonomic agents|mesh-ancestor
25559911|NCT00693472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25559912|NCT00693472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559913|NCT00693472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25559914|NCT00693472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25559915|NCT00693472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25559916|NCT00693472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25559917|NCT00693472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25559918|NCT00693472|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25559919|NCT00693472|Dopamine Agents|dopamine agents|mesh-ancestor
25559920|NCT00693472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25559921|NCT00693472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559922|NCT00693472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25559923|NCT00693472|Cholinergic Agents|cholinergic agents|mesh-ancestor
25559924|NCT00693472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25559925|NCT00693472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25559926|NCT00693472|Adrenergic Agents|adrenergic agents|mesh-ancestor
25559927|NCT00693472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25559928|NCT00693472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25559929|NCT00693472|Vasodilator Agents|vasodilator agents|mesh-ancestor
25559930|NCT00693485|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25559931|NCT00693485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25559932|NCT00693485|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25559933|NCT00693485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25559934|NCT00693485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25559935|NCT00693485|Adrenergic Agents|adrenergic agents|mesh-ancestor
25559936|NCT00693485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25559937|NCT00693485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559938|NCT00693485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559939|NCT00693693|Hydrocortisone|hydrocortisone|mesh-list
25559940|NCT00693693|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25559941|NCT00693693|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25559942|NCT00693693|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25559943|NCT00693693|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
25559944|NCT00693693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25559945|NCT00693693|Dermatologic Agents|dermatologic agents|mesh-ancestor
25559946|NCT00693719|Irinotecan|irinotecan|mesh-list
25559947|NCT00693719|Etoposide|etoposide|mesh-list
25559948|NCT00693719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25559949|NCT00693719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25559950|NCT00693719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651677|NCT01518699|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25559951|NCT00693719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559952|NCT00693719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559953|NCT00693719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25559954|NCT00693719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25559956|NCT00693992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559957|NCT00693992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25559958|NCT00693992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24433727|NCT00259792|Budesonide|budesonide|mesh-list
25559959|NCT00693992|Growth Substances|growth substances|mesh-ancestor
25559960|NCT00693992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559961|NCT00693992|Growth Inhibitors|growth inhibitors|mesh-ancestor
25559962|NCT00693992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25559963|NCT00693992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559964|NCT00693992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559965|NCT00694096|Sunitinib|sunitinib|mesh-list
25559966|NCT00694096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25559967|NCT00694096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25559968|NCT00694096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25559969|NCT00694096|Growth Substances|growth substances|mesh-ancestor
25559970|NCT00694096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559971|NCT00694096|Growth Inhibitors|growth inhibitors|mesh-ancestor
25559972|NCT00694096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25559973|NCT00694096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25559974|NCT00694096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559975|NCT00694109|Mipomersen|mipomersen|mesh-list
25559976|NCT00694109|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25559977|NCT00694109|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25559978|NCT00694109|Antimetabolites|antimetabolites|mesh-ancestor
25559979|NCT00694109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559980|NCT00694109|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25559981|NCT00694122|Insulin Glargine|insulin glargine|mesh-list
25559982|NCT00694122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25559983|NCT00694122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559984|NCT00694304|Vortioxetine|vortioxetine|mesh-list
25559985|NCT00694304|Antidepressive Agents|antidepressive agents|mesh-ancestor
25559986|NCT00694304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25559987|NCT00694304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25559988|NCT00694304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25559989|NCT00694304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25559990|NCT00694304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25559991|NCT00694304|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25559992|NCT00694304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25559993|NCT00694304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25559994|NCT00694304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25559995|NCT00694304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25559996|NCT00694304|Serotonin Agents|serotonin agents|mesh-ancestor
25559997|NCT00694304|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25559998|NCT00694304|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25559999|NCT00694304|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25560000|NCT00694304|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25560001|NCT00694551|Poly I-C|poly i-c|mesh-list
25560002|NCT00694551|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25560003|NCT00694551|Vaccines|vaccines|mesh-list
25560004|NCT00694551|Poly ICLC|poly iclc|mesh-list
25560005|NCT00694551|Immunologic Factors|immunologic factors|mesh-ancestor
25560006|NCT00694551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560007|NCT00694551|Interferon Inducers|interferon inducers|mesh-ancestor
25560008|NCT00694551|Laxatives|laxatives|mesh-ancestor
25560009|NCT00694551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25560010|NCT00694551|Antiviral Agents|antiviral agents|mesh-ancestor
25560011|NCT00694551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25560012|NCT00694603|Cetuximab|cetuximab|mesh-list
25560013|NCT00694603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25560014|NCT00694603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560015|NCT00694707|Risperidone|risperidone|mesh-list
25560016|NCT00694707|Cariprazine|cariprazine|mesh-list
25560017|NCT00694707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25560018|NCT00694707|Serotonin Agents|serotonin agents|mesh-ancestor
25560019|NCT00694707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25560020|NCT00694707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560021|NCT00694707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560022|NCT00694707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25560023|NCT00694707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25455020|NCT04539054|Caffeine|caffeine|mesh-list
25560024|NCT00694707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25560025|NCT00694707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25560026|NCT00694707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25560027|NCT00694707|Dopamine Agents|dopamine agents|mesh-ancestor
25560029|NCT00695019|Interferon-alpha|interferon-alpha|mesh-list
25560030|NCT00695019|Interferon alpha-2|interferon alpha-2|mesh-list
25560031|NCT00695019|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
25560032|NCT00695019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560033|NCT00695019|Antiviral Agents|antiviral agents|mesh-ancestor
25560034|NCT00695019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25560035|NCT00695019|Immunologic Factors|immunologic factors|mesh-ancestor
25560036|NCT00695019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560037|NCT00695097|Rituximab|rituximab|mesh-list
25560038|NCT00695097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25560039|NCT00695097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560040|NCT00695097|Immunologic Factors|immunologic factors|mesh-ancestor
25560041|NCT00695097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560042|NCT00695097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25560043|NCT00695110|Methyltestosterone|methyltestosterone|mesh-list
25560044|NCT00695110|Testosterone|testosterone|mesh-list
25560045|NCT00695110|Testosterone undecanoate|testosterone undecanoate|mesh-list
25560046|NCT00695110|Testosterone enanthate|testosterone enanthate|mesh-list
25560047|NCT00695110|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25560048|NCT00695110|Androgens|androgens|mesh-ancestor
25560049|NCT00695110|Hormones|hormones|mesh-ancestor
25560050|NCT00695110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25560051|NCT00695110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560052|NCT00695110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25560053|NCT00695110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560054|NCT00695110|Anabolic Agents|anabolic agents|mesh-ancestor
25560055|NCT00695136|Donepezil|donepezil|mesh-list
25560056|NCT00695136|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25560057|NCT00695136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25560058|NCT00695136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560059|NCT00695136|Cholinergic Agents|cholinergic agents|mesh-ancestor
25560060|NCT00695136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25560061|NCT00695136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560062|NCT00695136|Nootropic Agents|nootropic agents|mesh-ancestor
25560063|NCT00695188|Methotrexate|methotrexate|mesh-list
25560064|NCT00695188|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25560065|NCT00695188|Abortifacient Agents|abortifacient agents|mesh-ancestor
25560066|NCT00695188|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25560067|NCT00695188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560068|NCT00695188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25560069|NCT00695188|Antimetabolites|antimetabolites|mesh-ancestor
25560070|NCT00695188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560071|NCT00695188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560072|NCT00695188|Dermatologic Agents|dermatologic agents|mesh-ancestor
25560073|NCT00695188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25560074|NCT00695188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25560075|NCT00695188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25560076|NCT00695188|Immunologic Factors|immunologic factors|mesh-ancestor
25560077|NCT00695188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25455092|NCT04537780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455093|NCT04537780|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25455094|NCT04537780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25455095|NCT04537780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455096|NCT04537767|Esmolol|esmolol|mesh-list
25455097|NCT04537767|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25455098|NCT04537767|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25455099|NCT04537767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25455100|NCT04537767|Adrenergic Agents|adrenergic agents|mesh-ancestor
25560078|NCT00695188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25560079|NCT00695292|Carboplatin|carboplatin|mesh-list
25560080|NCT00695292|Irinotecan|irinotecan|mesh-list
25560081|NCT00695292|Sunitinib|sunitinib|mesh-list
25560082|NCT00695292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063626|NCT03467178|Mitosis Modulators|mitosis modulators|mesh-ancestor
25560083|NCT00695292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25560084|NCT00695292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25560085|NCT00695292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25560086|NCT00695292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560087|NCT00695292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25560088|NCT00695292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25560089|NCT00695292|Growth Substances|growth substances|mesh-ancestor
25560090|NCT00695292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560091|NCT00695292|Growth Inhibitors|growth inhibitors|mesh-ancestor
25560092|NCT00695292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25560093|NCT00695318|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
25560094|NCT00695318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25560095|NCT00695318|Glucocorticoids|glucocorticoids|mesh-ancestor
25560096|NCT00695318|Hormones|hormones|mesh-ancestor
24817938|NCT02086032|Estrogens|estrogens|mesh-list
25560097|NCT00695318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25560098|NCT00695318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560099|NCT00695396|Epoetin Alfa|epoetin alfa|mesh-list
25560100|NCT00695396|Hematinics|hematinics|mesh-ancestor
25560101|NCT00695409|Cytarabine|cytarabine|mesh-list
25560102|NCT00695409|Rituximab|rituximab|mesh-list
25560103|NCT00695409|Etoposide|etoposide|mesh-list
25560104|NCT00695409|Etoposide phosphate|etoposide phosphate|mesh-list
25560105|NCT00695409|Melphalan|melphalan|mesh-list
25560106|NCT00695409|Carmustine|carmustine|mesh-list
25560107|NCT00695409|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25560108|NCT00695409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25560109|NCT00695409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560110|NCT00695409|Immunologic Factors|immunologic factors|mesh-ancestor
25560111|NCT00695409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560112|NCT00695409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25560113|NCT00695409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25560114|NCT00695409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25560115|NCT00695409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25560116|NCT00695409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25560117|NCT00695409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560118|NCT00695409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25560119|NCT00695409|Antimetabolites|antimetabolites|mesh-ancestor
25560120|NCT00695409|Antiviral Agents|antiviral agents|mesh-ancestor
25560121|NCT00695409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25560122|NCT00695409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25560123|NCT00695409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25560124|NCT00695409|Alkylating Agents|alkylating agents|mesh-ancestor
25560125|NCT00695409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25560126|NCT00695435|Tobramycin|tobramycin|mesh-list
25560127|NCT00695435|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
25560128|NCT00695435|Dexamethasone|dexamethasone|mesh-list
25560129|NCT00695435|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25560130|NCT00695435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25560131|NCT00695435|Antiemetics|antiemetics|mesh-ancestor
25560132|NCT00695435|Autonomic Agents|autonomic agents|mesh-ancestor
25560133|NCT00695435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25560134|NCT00695435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560135|NCT00695435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25560136|NCT00695435|Glucocorticoids|glucocorticoids|mesh-ancestor
25560137|NCT00695435|Hormones|hormones|mesh-ancestor
25560138|NCT00695435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25560139|NCT00695435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25560140|NCT00695435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560141|NCT00695435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25560142|NCT00695435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25560143|NCT00695435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25560144|NCT00695500|Varenicline|varenicline|mesh-list
25560145|NCT00695500|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25560146|NCT00695500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25560147|NCT00695500|Cholinergic Agents|cholinergic agents|mesh-ancestor
25560148|NCT00695500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25560149|NCT00695500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560150|NCT00695500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560151|NCT00695565|Clonidine|clonidine|mesh-list
25560152|NCT00695565|Analgesics|analgesics|mesh-ancestor
25560153|NCT00695565|Sensory System Agents|sensory system agents|mesh-ancestor
25560154|NCT00695565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25560155|NCT00695565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560156|NCT00695565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25560157|NCT00695565|Sympatholytics|sympatholytics|mesh-ancestor
25560158|NCT00695565|Autonomic Agents|autonomic agents|mesh-ancestor
25560159|NCT00695565|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25560160|NCT00695565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25560161|NCT00695565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25560162|NCT00695565|Adrenergic Agents|adrenergic agents|mesh-ancestor
25560163|NCT00695565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25560164|NCT00695565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560165|NCT00695578|Bacitracin|bacitracin|mesh-list
25560166|NCT00695578|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25560167|NCT00695578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25560168|NCT00695578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25560169|NCT00695786|Rituximab|rituximab|mesh-list
25560170|NCT00695786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25560171|NCT00695786|Lenalidomide|lenalidomide|mesh-list
25560172|NCT00695786|Antibodies|antibodies|mesh-list
25560173|NCT00695786|Immunoglobulins|immunoglobulins|mesh-list
25560174|NCT00695786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25560175|NCT00695786|Immunologic Factors|immunologic factors|mesh-ancestor
25560176|NCT00695786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560177|NCT00695786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560178|NCT00695786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25560179|NCT00695786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25560180|NCT00695786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25560181|NCT00695786|Growth Substances|growth substances|mesh-ancestor
25560182|NCT00695786|Growth Inhibitors|growth inhibitors|mesh-ancestor
25560183|NCT00695864|Ondansetron|ondansetron|mesh-list
25560184|NCT00695864|Antiemetics|antiemetics|mesh-ancestor
25560185|NCT00695864|Autonomic Agents|autonomic agents|mesh-ancestor
25560186|NCT00695864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25560187|NCT00695864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560188|NCT00695864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25560189|NCT00695864|Antipruritics|antipruritics|mesh-ancestor
25560190|NCT00695864|Dermatologic Agents|dermatologic agents|mesh-ancestor
25560191|NCT00695864|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25560192|NCT00695864|Serotonin Agents|serotonin agents|mesh-ancestor
25560193|NCT00695864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25560194|NCT00695864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560195|NCT00695864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25560196|NCT00695864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25560197|NCT00695864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25560198|NCT00695864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25560199|NCT00695864|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25560200|NCT00695903|Vancomycin|vancomycin|mesh-list
25560201|NCT00695903|Daptomycin|daptomycin|mesh-list
25560202|NCT00695903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25560203|NCT00695903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25560204|NCT00695955|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25560205|NCT00695955|Chlorthalidone|chlorthalidone|mesh-list
25560206|NCT00695955|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25560207|NCT00695955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25560208|NCT00695955|Diuretics|diuretics|mesh-ancestor
25560209|NCT00695955|Natriuretic Agents|natriuretic agents|mesh-ancestor
25560210|NCT00695955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560211|NCT00695955|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25560212|NCT00695955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25560213|NCT00695955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560214|NCT00695955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25560215|NCT00695955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25651678|NCT01518699|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25651679|NCT01518946|Midodrine|midodrine|mesh-list
25651680|NCT01518946|Sympathomimetics|sympathomimetics|mesh-ancestor
25651681|NCT01518946|Autonomic Agents|autonomic agents|mesh-ancestor
25651682|NCT01518946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25651683|NCT01518946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651684|NCT01518946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25651685|NCT01518946|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25651686|NCT01518946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25651687|NCT01518946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25651688|NCT01518946|Adrenergic Agents|adrenergic agents|mesh-ancestor
25651689|NCT01518946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25651690|NCT01518946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651691|NCT01518972|Prazosin|prazosin|mesh-list
25651692|NCT01518972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25651693|NCT01518972|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25651694|NCT01518972|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25651695|NCT01518972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25651696|NCT01518972|Adrenergic Agents|adrenergic agents|mesh-ancestor
25651697|NCT01518972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25651698|NCT01518972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651699|NCT01518972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651700|NCT01519063|Naltrexone|naltrexone|mesh-list
25651701|NCT01519063|Memantine|memantine|mesh-list
25455211|NCT04536662|Glucocorticoids|glucocorticoids|mesh-ancestor
25560216|NCT00696020|Bromides|bromides|mesh-list
25560217|NCT00696020|Tiotropium Bromide|tiotropium bromide|mesh-list
25560218|NCT00696020|Olodaterol|olodaterol|mesh-list
25560219|NCT00696020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25560220|NCT00696020|Autonomic Agents|autonomic agents|mesh-ancestor
25560221|NCT00696020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25560222|NCT00696020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560223|NCT00696020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25560224|NCT00696020|Respiratory System Agents|respiratory system agents|mesh-ancestor
25560225|NCT00696020|Parasympatholytics|parasympatholytics|mesh-ancestor
25560226|NCT00696020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25560227|NCT00696020|Cholinergic Agents|cholinergic agents|mesh-ancestor
25560228|NCT00696020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25560229|NCT00696020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560230|NCT00696020|Anticonvulsants|anticonvulsants|mesh-ancestor
25560231|NCT00696072|Letrozole|letrozole|mesh-list
25560232|NCT00696072|Dasatinib|dasatinib|mesh-list
25560233|NCT00696072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560234|NCT00696072|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25560235|NCT00696072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25560236|NCT00696072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25560237|NCT00696072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981947|NCT00493961|Hormones|hormones|mesh-list
25560238|NCT00696072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25560239|NCT00696072|Hormone Antagonists|hormone antagonists|mesh-ancestor
25560240|NCT00696072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25560241|NCT00696072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560242|NCT00696072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25560243|NCT00696137|Fentanyl|fentanyl|mesh-list
25560244|NCT00696137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25560245|NCT00696137|Narcotics|narcotics|mesh-ancestor
25560246|NCT00696137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25560247|NCT00696137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560248|NCT00696137|Analgesics|analgesics|mesh-ancestor
25560249|NCT00696137|Sensory System Agents|sensory system agents|mesh-ancestor
25560250|NCT00696137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25560251|NCT00696137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25560252|NCT00696137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25560253|NCT00696137|Anesthetics, General|anesthetics, general|mesh-ancestor
25560254|NCT00696137|Anesthetics|anesthetics|mesh-ancestor
25560255|NCT00696241|Olmesartan|olmesartan|mesh-list
25560256|NCT00696241|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25560257|NCT00696241|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25560258|NCT00696241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25560259|NCT00696241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25560260|NCT00696241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25560261|NCT00696241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560262|NCT00696293|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25560263|NCT00696293|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25560264|NCT00696293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25560265|NCT00696293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25560266|NCT00696293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560267|NCT00696293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25560268|NCT00696293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560269|NCT00696293|Analgesics|analgesics|mesh-ancestor
25560270|NCT00696293|Sensory System Agents|sensory system agents|mesh-ancestor
25560271|NCT00696293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24539457|NCT00663949|Captopril|captopril|mesh-list
25560272|NCT00696293|Antidepressive Agents|antidepressive agents|mesh-ancestor
25560273|NCT00696293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25560274|NCT00696293|Dopamine Agents|dopamine agents|mesh-ancestor
25560275|NCT00696384|Chlorthalidone|chlorthalidone|mesh-list
25560276|NCT00696384|Antihypertensive Agents|antihypertensive agents|mesh-list
25560277|NCT00696384|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25560278|NCT00696384|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25560279|NCT00696384|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25560280|NCT00696384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560281|NCT00696384|Diuretics|diuretics|mesh-ancestor
25560282|NCT00696384|Natriuretic Agents|natriuretic agents|mesh-ancestor
25560283|NCT00696384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560284|NCT00696384|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25560285|NCT00696384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25560286|NCT00696410|Zinc|zinc|mesh-list
25560287|NCT00696410|Trace Elements|trace elements|mesh-ancestor
25560288|NCT00696410|Micronutrients|micronutrients|mesh-ancestor
25455279|NCT04536181|Prednisone|prednisone|mesh-list
25312043|NCT05061147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312044|NCT05060822|Pirfenidone|pirfenidone|mesh-list
25312045|NCT05060822|Analgesics|analgesics|mesh-ancestor
25312046|NCT05060822|Sensory System Agents|sensory system agents|mesh-ancestor
25312052|NCT05060822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25121158|NCT03104855|Calcifediol|calcifediol|mesh-list
25161887|NCT02240407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24997430|NCT04964622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822661|NCT00004581|Nevirapine|nevirapine|mesh-list
25822662|NCT00004581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25822663|NCT00004581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24420138|NCT00215241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24420139|NCT00215241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24420140|NCT00215254|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24420141|NCT00215254|Antidepressive Agents|antidepressive agents|mesh-ancestor
24420142|NCT00215254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25822664|NCT00004581|Protease Inhibitors|protease inhibitors|mesh-ancestor
24420240|NCT00215410|Respiratory System Agents|respiratory system agents|mesh-ancestor
24978709|NCT03125642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25121179|NCT03104634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420257|NCT00215423|Adrenergic Agents|adrenergic agents|mesh-ancestor
24420258|NCT00215423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25063910|NCT03464734|Pembrolizumab|pembrolizumab|mesh-list
24420259|NCT00215423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420260|NCT00215436|Formoterol Fumarate|formoterol fumarate|mesh-list
24420261|NCT00215436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24420262|NCT00215436|Autonomic Agents|autonomic agents|mesh-ancestor
24420263|NCT00215436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24420264|NCT00215436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420265|NCT00215436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24420266|NCT00215436|Respiratory System Agents|respiratory system agents|mesh-ancestor
24420267|NCT00215436|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24420268|NCT00215436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24420269|NCT00215436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24420270|NCT00215436|Adrenergic Agents|adrenergic agents|mesh-ancestor
24420271|NCT00215436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24420272|NCT00215436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420273|NCT00215449|Formoterol Fumarate|formoterol fumarate|mesh-list
24420274|NCT00215449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24420275|NCT00215449|Autonomic Agents|autonomic agents|mesh-ancestor
24420282|NCT00215449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24420283|NCT00215449|Adrenergic Agents|adrenergic agents|mesh-ancestor
24420284|NCT00215449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24420285|NCT00215449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420287|NCT00215462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24420288|NCT00215462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121198|NCT03104309|Levonorgestrel|levonorgestrel|mesh-list
24420289|NCT00215462|Tubulin Modulators|tubulin modulators|mesh-ancestor
24420290|NCT00215462|Antimitotic Agents|antimitotic agents|mesh-ancestor
24420291|NCT00215462|Mitosis Modulators|mitosis modulators|mesh-ancestor
24420292|NCT00215462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420293|NCT00215501|Fluorouracil|fluorouracil|mesh-list
24420294|NCT00215501|Capecitabine|capecitabine|mesh-list
24420295|NCT00215501|Irinotecan|irinotecan|mesh-list
24420296|NCT00215501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25822665|NCT00004581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420309|NCT00215514|Antimetabolites|antimetabolites|mesh-ancestor
24420310|NCT00215514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420311|NCT00215514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24978719|NCT03125642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24420344|NCT00215631|Urological Agents|urological agents|mesh-ancestor
24420346|NCT00215709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420347|NCT00215709|Tubulin Modulators|tubulin modulators|mesh-ancestor
24420348|NCT00215709|Antimitotic Agents|antimitotic agents|mesh-ancestor
24420349|NCT00215709|Mitosis Modulators|mitosis modulators|mesh-ancestor
24420350|NCT00215709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420351|NCT00215722|Cetuximab|cetuximab|mesh-list
24420352|NCT00215722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25560289|NCT00696410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560290|NCT00696436|Valsartan|valsartan|mesh-list
25560291|NCT00696436|Olmesartan|olmesartan|mesh-list
24539504|NCT00664170|Docetaxel|docetaxel|mesh-list
25560292|NCT00696436|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25560293|NCT00696436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25560294|NCT00696436|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25560295|NCT00696436|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25560296|NCT00696436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560297|NCT00696449|Adapalene|adapalene|mesh-list
25560298|NCT00696449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25560299|NCT00696449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25560300|NCT00696449|Analgesics|analgesics|mesh-ancestor
25560301|NCT00696449|Sensory System Agents|sensory system agents|mesh-ancestor
25560302|NCT00696449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25560303|NCT00696449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560304|NCT00696449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25560305|NCT00696449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25560306|NCT00696449|Dermatologic Agents|dermatologic agents|mesh-ancestor
25560307|NCT00696488|Fluorouracil|fluorouracil|mesh-list
25560308|NCT00696488|Antimetabolites|antimetabolites|mesh-ancestor
25560309|NCT00696488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560310|NCT00696488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25560311|NCT00696488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560312|NCT00696488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25560313|NCT00696488|Immunologic Factors|immunologic factors|mesh-ancestor
25560314|NCT00696488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560315|NCT00696618|Plasma-lyte 148|plasma-lyte 148|mesh-list
24518854|NCT04133948|Nivolumab|nivolumab|mesh-list
25560316|NCT00696618|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25560317|NCT00696618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25560318|NCT00696657|Liraglutide|liraglutide|mesh-list
25560319|NCT00696657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25560320|NCT00696657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560321|NCT00696657|Incretins|incretins|mesh-ancestor
25560322|NCT00696657|Hormones|hormones|mesh-ancestor
25560323|NCT00696657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25560324|NCT00696696|Gemcitabine|gemcitabine|mesh-list
25560325|NCT00696696|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25560326|NCT00696696|Sorafenib|sorafenib|mesh-list
25560327|NCT00696696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25560328|NCT00696696|Antimetabolites|antimetabolites|mesh-ancestor
25560329|NCT00696696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560330|NCT00696696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560331|NCT00696696|Antiviral Agents|antiviral agents|mesh-ancestor
25560332|NCT00696696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25560333|NCT00696696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25560334|NCT00696696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24901215|NCT04387565|Vanadium|vanadium|mesh-list
25560335|NCT00696696|Immunologic Factors|immunologic factors|mesh-ancestor
25560336|NCT00696696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560337|NCT00696696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25560338|NCT00696761|Alfuzosin|alfuzosin|mesh-list
25560339|NCT00696761|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25560340|NCT00696761|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25560341|NCT00696761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25560342|NCT00696761|Adrenergic Agents|adrenergic agents|mesh-ancestor
25560343|NCT00696761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25560344|NCT00696761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560345|NCT00696761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560346|NCT00696761|Urological Agents|urological agents|mesh-ancestor
25560347|NCT00696774|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25560348|NCT00696774|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25560349|NCT00696774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25560350|NCT00696774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25560351|NCT00696774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560352|NCT00696774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25560353|NCT00696774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560354|NCT00696774|Analgesics|analgesics|mesh-ancestor
25560355|NCT00696774|Sensory System Agents|sensory system agents|mesh-ancestor
25560356|NCT00696774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25560357|NCT00696774|Antidepressive Agents|antidepressive agents|mesh-ancestor
25560358|NCT00696774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25560359|NCT00696774|Dopamine Agents|dopamine agents|mesh-ancestor
25560360|NCT00696787|Pregabalin|pregabalin|mesh-list
25560361|NCT00696787|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25560362|NCT00696787|Analgesics|analgesics|mesh-ancestor
25560363|NCT00696787|Sensory System Agents|sensory system agents|mesh-ancestor
25560364|NCT00696787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25560365|NCT00696787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560366|NCT00696787|Anticonvulsants|anticonvulsants|mesh-ancestor
25560367|NCT00696787|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25560368|NCT00696787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25560369|NCT00696787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560370|NCT00696787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25560371|NCT00696787|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25560372|NCT00696787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25560373|NCT00696787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25560374|NCT00696787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25560375|NCT00696787|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25560376|NCT00696787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25560377|NCT00696787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25560378|NCT00696787|Antidepressive Agents|antidepressive agents|mesh-ancestor
25560379|NCT00697073|Idebenone|idebenone|mesh-list
25560380|NCT00697073|Antioxidants|antioxidants|mesh-ancestor
25560381|NCT00697073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560382|NCT00697073|Protective Agents|protective agents|mesh-ancestor
25560383|NCT00697073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560384|NCT00697112|Sirolimus|sirolimus|mesh-list
25560385|NCT00697112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25560386|NCT00697112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25560387|NCT00697112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25560388|NCT00697112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560389|NCT00697112|Antifungal Agents|antifungal agents|mesh-ancestor
25560390|NCT00697112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25560391|NCT00697112|Immunologic Factors|immunologic factors|mesh-ancestor
25560392|NCT00697112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560393|NCT00697203|Pravastatin|pravastatin|mesh-list
25560394|NCT00697203|Dalcetrapib|dalcetrapib|mesh-list
25560395|NCT00697203|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25560396|NCT00697203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25560397|NCT00697203|Antimetabolites|antimetabolites|mesh-ancestor
25560398|NCT00697203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560399|NCT00697203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25560400|NCT00697203|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25560401|NCT00697203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25560402|NCT00697463|Teriparatide|teriparatide|mesh-list
25560403|NCT00697463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25560404|NCT00697463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560405|NCT00697463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25560406|NCT00697541|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25560407|NCT00697541|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25560408|NCT00697541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25560409|NCT00697541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25560410|NCT00697541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25560411|NCT00697541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25560412|NCT00697541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25560413|NCT00697541|Adrenergic Agents|adrenergic agents|mesh-ancestor
25560414|NCT00697541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25560415|NCT00697541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560416|NCT00697541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560417|NCT00697593|Antibodies|antibodies|mesh-list
25560418|NCT00697593|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25560419|NCT00697593|Immunologic Factors|immunologic factors|mesh-ancestor
25560420|NCT00697593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560421|NCT00697619|Zoledronic Acid|zoledronic acid|mesh-list
25560422|NCT00697619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25560423|NCT00697619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560424|NCT00697788|Dexmedetomidine|dexmedetomidine|mesh-list
25560425|NCT00697788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25560426|NCT00697788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25560427|NCT00697788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560428|NCT00697788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25560429|NCT00697788|Analgesics|analgesics|mesh-ancestor
25560430|NCT00697788|Sensory System Agents|sensory system agents|mesh-ancestor
25560431|NCT00697788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24478122|NCT00421512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25560432|NCT00697788|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25560433|NCT00697788|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25560434|NCT00697788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25560435|NCT00697788|Adrenergic Agents|adrenergic agents|mesh-ancestor
25560436|NCT00697788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25560437|NCT00697788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560438|NCT00698035|Methyltestosterone|methyltestosterone|mesh-list
25560439|NCT00698035|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25560440|NCT00698035|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25560441|NCT00698035|Testosterone|testosterone|mesh-list
25560442|NCT00698035|Testosterone undecanoate|testosterone undecanoate|mesh-list
25560443|NCT00698035|Testosterone enanthate|testosterone enanthate|mesh-list
25560444|NCT00698035|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25560445|NCT00698035|Estradiol|estradiol|mesh-list
25560446|NCT00698035|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25560447|NCT00698035|Androgens|androgens|mesh-ancestor
25560448|NCT00698035|Hormones|hormones|mesh-ancestor
25560449|NCT00698035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25560450|NCT00698035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560451|NCT00698035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25560452|NCT00698035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560453|NCT00698035|Anabolic Agents|anabolic agents|mesh-ancestor
25560454|NCT00698035|Estrogens|estrogens|mesh-ancestor
25560455|NCT00698035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25560456|NCT00698035|Contraceptive Agents|contraceptive agents|mesh-ancestor
25560457|NCT00698035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25560458|NCT00698035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25560459|NCT00698204|Celecoxib|celecoxib|mesh-list
25560460|NCT00698204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25560461|NCT00698204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25560462|NCT00698204|Analgesics|analgesics|mesh-ancestor
25560463|NCT00698204|Sensory System Agents|sensory system agents|mesh-ancestor
25560464|NCT00698204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25560465|NCT00698204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560466|NCT00698204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25560467|NCT00698204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25560468|NCT00698204|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25560469|NCT00698204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25560470|NCT00698204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25560471|NCT00698204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560472|NCT00698451|Bevacizumab|bevacizumab|mesh-list
25560473|NCT00698451|Carboplatin|carboplatin|mesh-list
25560474|NCT00698451|Doxorubicin|doxorubicin|mesh-list
25560475|NCT00698451|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25560476|NCT00698451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25560477|NCT00698451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560478|NCT00698451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25560479|NCT00698451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25560480|NCT00698451|Growth Substances|growth substances|mesh-ancestor
25560481|NCT00698451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560482|NCT00698451|Growth Inhibitors|growth inhibitors|mesh-ancestor
25560483|NCT00698451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25560484|NCT00698451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25560485|NCT00698451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25560486|NCT00698451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25560487|NCT00698451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560488|NCT00698516|Bevacizumab|bevacizumab|mesh-list
25560489|NCT00698516|Topotecan|topotecan|mesh-list
25560490|NCT00698516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25560491|NCT00698516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560492|NCT00698516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25560493|NCT00698516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25560494|NCT00698516|Growth Substances|growth substances|mesh-ancestor
25560495|NCT00698516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560496|NCT00698516|Growth Inhibitors|growth inhibitors|mesh-ancestor
25560497|NCT00698516|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25560498|NCT00698516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25560499|NCT00698516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25560500|NCT00698516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560501|NCT00698581|Brivaracetam|brivaracetam|mesh-list
25560502|NCT00698581|Anticonvulsants|anticonvulsants|mesh-ancestor
25560503|NCT00698646|Valsartan|valsartan|mesh-list
25560504|NCT00698646|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25560505|NCT00698646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25560506|NCT00698646|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25560507|NCT00698646|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25560508|NCT00698646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560509|NCT00698646|Diuretics|diuretics|mesh-ancestor
25560510|NCT00698646|Natriuretic Agents|natriuretic agents|mesh-ancestor
25560511|NCT00698646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560512|NCT00698646|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25560513|NCT00698646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25560514|NCT00698685|Alemtuzumab|alemtuzumab|mesh-list
25560515|NCT00698685|Pentostatin|pentostatin|mesh-list
25560516|NCT00698685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25560517|NCT00698685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560518|NCT00698685|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25560519|NCT00698685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25560520|NCT00698685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560521|NCT00698841|Cetuximab|cetuximab|mesh-list
25560522|NCT00698841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25560523|NCT00698841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560524|NCT00698932|Saxagliptin|saxagliptin|mesh-list
25560525|NCT00698932|Incretins|incretins|mesh-ancestor
25560526|NCT00698932|Hormones|hormones|mesh-ancestor
25560527|NCT00698932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25560528|NCT00698932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560529|NCT00698932|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25560530|NCT00698932|Protease Inhibitors|protease inhibitors|mesh-ancestor
25560531|NCT00698932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25560532|NCT00698932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560533|NCT00698932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25560534|NCT00699010|Oxycodone|oxycodone|mesh-list
25560535|NCT00699010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25560536|NCT00699010|Narcotics|narcotics|mesh-ancestor
25560537|NCT00699010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25560538|NCT00699010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560539|NCT00699010|Analgesics|analgesics|mesh-ancestor
25560540|NCT00699010|Sensory System Agents|sensory system agents|mesh-ancestor
25560541|NCT00699010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25560542|NCT00699153|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25560543|NCT00699153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25560544|NCT00699192|Amlodipine|amlodipine|mesh-list
25560545|NCT00699192|Valsartan|valsartan|mesh-list
25560546|NCT00699192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25560547|NCT00699192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25560548|NCT00699192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25560549|NCT00699192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560550|NCT00699192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25560551|NCT00699192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560552|NCT00699192|Vasodilator Agents|vasodilator agents|mesh-ancestor
25560553|NCT00699192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24902436|NCT04374006|Hormone Antagonists|hormone antagonists|mesh-ancestor
25560554|NCT00699192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25560555|NCT00699283|Brivaracetam|brivaracetam|mesh-list
25560556|NCT00699283|Anticonvulsants|anticonvulsants|mesh-ancestor
25560557|NCT00699335|Fentanyl|fentanyl|mesh-list
25560558|NCT00699335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25560559|NCT00699335|Narcotics|narcotics|mesh-ancestor
25560560|NCT00699335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25560561|NCT00699335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560562|NCT00699335|Analgesics|analgesics|mesh-ancestor
25560563|NCT00699335|Sensory System Agents|sensory system agents|mesh-ancestor
25560564|NCT00699335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25560565|NCT00699335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25560566|NCT00699335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25560567|NCT00699335|Anesthetics, General|anesthetics, general|mesh-ancestor
25560568|NCT00699335|Anesthetics|anesthetics|mesh-ancestor
25560569|NCT00699348|Epoetin Alfa|epoetin alfa|mesh-list
25560570|NCT00699348|Hematinics|hematinics|mesh-ancestor
25560571|NCT00699374|Sorafenib|sorafenib|mesh-list
25560572|NCT00699374|Sunitinib|sunitinib|mesh-list
25560573|NCT00699374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560574|NCT00699374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25560575|NCT00699374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25560576|NCT00699374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560577|NCT00699374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25560578|NCT00699374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25560579|NCT00699374|Growth Substances|growth substances|mesh-ancestor
25560580|NCT00699374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560581|NCT00699374|Growth Inhibitors|growth inhibitors|mesh-ancestor
25560582|NCT00699491|Sirolimus|sirolimus|mesh-list
25560583|NCT00699491|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25560584|NCT00699491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25560585|NCT00699491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25560586|NCT00699491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25560587|NCT00699491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560588|NCT00699491|Antifungal Agents|antifungal agents|mesh-ancestor
25560589|NCT00699491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25560590|NCT00699491|Immunologic Factors|immunologic factors|mesh-ancestor
25560591|NCT00699491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560592|NCT00699556|Nicotine|nicotine|mesh-list
25560593|NCT00699556|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25560594|NCT00699556|Autonomic Agents|autonomic agents|mesh-ancestor
25560595|NCT00699556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25560596|NCT00699556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560597|NCT00699556|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25560598|NCT00699556|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25560599|NCT00699556|Cholinergic Agents|cholinergic agents|mesh-ancestor
25560600|NCT00699556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25560601|NCT00699556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560602|NCT00699608|Zopiclone|zopiclone|mesh-list
25560603|NCT00699608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25560604|NCT00699608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25560605|NCT00699608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560606|NCT00699751|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25560607|NCT00699751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560608|NCT00699803|Prednisone|prednisone|mesh-list
25560609|NCT00699803|Prednisolone acetate|prednisolone acetate|mesh-list
25560610|NCT00699803|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25560611|NCT00699803|Methylprednisolone|methylprednisolone|mesh-list
25560612|NCT00699803|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25560613|NCT00699803|Prednisolone|prednisolone|mesh-list
25560614|NCT00699803|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25560615|NCT00699803|Prednisolone phosphate|prednisolone phosphate|mesh-list
25560616|NCT00699803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25560617|NCT00699803|Glucocorticoids|glucocorticoids|mesh-ancestor
25560618|NCT00699803|Hormones|hormones|mesh-ancestor
25560619|NCT00699803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25560620|NCT00699803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560621|NCT00699803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25560622|NCT00699803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560623|NCT00699803|Antiemetics|antiemetics|mesh-ancestor
25560624|NCT00699803|Autonomic Agents|autonomic agents|mesh-ancestor
25560625|NCT00699803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25455615|NCT04532684|Dopamine Agents|dopamine agents|mesh-ancestor
25455616|NCT04532736|Mometasone Furoate|mometasone furoate|mesh-list
25455617|NCT04532736|Methylprednisolone|methylprednisolone|mesh-list
25455618|NCT04532736|Methotrexate|methotrexate|mesh-list
25455619|NCT04532736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25455620|NCT04532736|Abortifacient Agents|abortifacient agents|mesh-ancestor
25455621|NCT04532736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25455622|NCT04532736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455623|NCT04532736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25455624|NCT04532736|Antimetabolites|antimetabolites|mesh-ancestor
25455625|NCT04532736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455626|NCT04532736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25455627|NCT04532736|Dermatologic Agents|dermatologic agents|mesh-ancestor
25455628|NCT04532736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25455629|NCT04532736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25455630|NCT04532736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25455631|NCT04532736|Immunologic Factors|immunologic factors|mesh-ancestor
25455632|NCT04532736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25018740|NCT03697265|Anesthetics|anesthetics|mesh-ancestor
25455633|NCT04532736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25455635|NCT04532736|Antiemetics|antiemetics|mesh-ancestor
25560626|NCT00699803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25560627|NCT00699803|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25560628|NCT00699803|Protective Agents|protective agents|mesh-ancestor
25560629|NCT00699907|Flutamide|flutamide|mesh-list
25560630|NCT00699907|Androgen Antagonists|androgen antagonists|mesh-ancestor
25560631|NCT00699907|Hormone Antagonists|hormone antagonists|mesh-ancestor
25560632|NCT00699907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25560633|NCT00699907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560634|NCT00699907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25560635|NCT00699907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560636|NCT00699998|Aspirin|aspirin|mesh-list
25560637|NCT00699998|Clopidogrel|clopidogrel|mesh-list
25560638|NCT00699998|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25560639|NCT00699998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25560640|NCT00699998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25560641|NCT00699998|Analgesics|analgesics|mesh-ancestor
25560642|NCT00699998|Sensory System Agents|sensory system agents|mesh-ancestor
25560643|NCT00699998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25560644|NCT00699998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560645|NCT00699998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25560646|NCT00699998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25560647|NCT00699998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25560648|NCT00699998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25560649|NCT00699998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560650|NCT00699998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25560651|NCT00699998|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25560652|NCT00699998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25560653|NCT00699998|Antipyretics|antipyretics|mesh-ancestor
25560654|NCT00699998|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25560655|NCT00699998|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25560656|NCT00699998|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25560657|NCT00699998|Purinergic Agents|purinergic agents|mesh-ancestor
25560658|NCT00699998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25560659|NCT00700011|Clofarabine|clofarabine|mesh-list
25560660|NCT00700011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25560661|NCT00700011|Antimetabolites|antimetabolites|mesh-ancestor
25560662|NCT00700011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560663|NCT00700011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560664|NCT00700102|Bevacizumab|bevacizumab|mesh-list
25560665|NCT00700102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24442861|NCT00293085|Docetaxel|docetaxel|mesh-list
25560666|NCT00700102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560667|NCT00700102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25560668|NCT00700102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25560669|NCT00700102|Growth Substances|growth substances|mesh-ancestor
25560670|NCT00700102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560671|NCT00700102|Growth Inhibitors|growth inhibitors|mesh-ancestor
25560672|NCT00700115|Ritonavir|ritonavir|mesh-list
25560673|NCT00700115|Lopinavir|lopinavir|mesh-list
25560674|NCT00700115|Raltegravir Potassium|raltegravir potassium|mesh-list
25560675|NCT00700115|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25560676|NCT00700115|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25560677|NCT00700115|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25560678|NCT00700115|Protease Inhibitors|protease inhibitors|mesh-ancestor
25560679|NCT00700115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25560680|NCT00700115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560681|NCT00700115|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25560682|NCT00700115|Antiviral Agents|antiviral agents|mesh-ancestor
25560683|NCT00700115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25560684|NCT00700115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25560685|NCT00700115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25560686|NCT00700115|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25560687|NCT00700115|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25560688|NCT00700180|Bevacizumab|bevacizumab|mesh-list
25560689|NCT00700180|Carboplatin|carboplatin|mesh-list
25560690|NCT00700180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25560691|NCT00700180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560692|NCT00700180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25560693|NCT00700180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25560694|NCT00700180|Growth Substances|growth substances|mesh-ancestor
25560695|NCT00700180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560696|NCT00700180|Growth Inhibitors|growth inhibitors|mesh-ancestor
25560697|NCT00700271|Amlodipine|amlodipine|mesh-list
25560698|NCT00700271|Valsartan|valsartan|mesh-list
25560699|NCT00700271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25560700|NCT00700271|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25560701|NCT00700271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25560702|NCT00700271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560703|NCT00700271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25560704|NCT00700271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560705|NCT00700271|Vasodilator Agents|vasodilator agents|mesh-ancestor
25560706|NCT00700271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25560707|NCT00700271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25560708|NCT00700336|Cisplatin|cisplatin|mesh-list
25560709|NCT00700336|Pemetrexed|pemetrexed|mesh-list
25560710|NCT00700336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560711|NCT00700336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25560712|NCT00700336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560713|NCT00700336|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25560714|NCT00700336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25560715|NCT00700401|Ribavirin|ribavirin|mesh-list
25560716|NCT00700401|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25560717|NCT00700401|Antimetabolites|antimetabolites|mesh-ancestor
24904314|NCT04356508|Nivolumab|nivolumab|mesh-list
25560718|NCT00700401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560719|NCT00700401|Antiviral Agents|antiviral agents|mesh-ancestor
25560720|NCT00700401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25560721|NCT00700427|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25560722|NCT00700427|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25560723|NCT00700427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25560724|NCT00700427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25560725|NCT00700427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560726|NCT00700427|Adrenergic Agents|adrenergic agents|mesh-ancestor
25560727|NCT00700427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25560728|NCT00700427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560729|NCT00700440|Cetuximab|cetuximab|mesh-list
25560730|NCT00700440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24904546|NCT04355026|Hydroxychloroquine|hydroxychloroquine|mesh-list
25560731|NCT00700440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560732|NCT00700570|Bevacizumab|bevacizumab|mesh-list
25560733|NCT00700570|Capecitabine|capecitabine|mesh-list
25560734|NCT00700570|Oxaliplatin|oxaliplatin|mesh-list
25560735|NCT00700570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25560736|NCT00700570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560737|NCT00700570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25560738|NCT00700570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25560739|NCT00700570|Growth Substances|growth substances|mesh-ancestor
25560740|NCT00700570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560741|NCT00700570|Growth Inhibitors|growth inhibitors|mesh-ancestor
25560742|NCT00700570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25560743|NCT00700570|Antimetabolites|antimetabolites|mesh-ancestor
25560744|NCT00700570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560745|NCT00700622|Insulin|insulin|mesh-list
25560746|NCT00700622|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25560747|NCT00700622|Insulin Glargine|insulin glargine|mesh-list
24976202|NCT00346125|Ifosfamide|ifosfamide|mesh-list
25560748|NCT00700622|Insulin Lispro|insulin lispro|mesh-list
25560749|NCT00700622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25560750|NCT00700622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560751|NCT00700817|Metformin|metformin|mesh-list
25560752|NCT00700817|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25560753|NCT00700817|Liraglutide|liraglutide|mesh-list
25560754|NCT00700817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25560755|NCT00700817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560756|NCT00700817|Incretins|incretins|mesh-ancestor
25560757|NCT00700817|Hormones|hormones|mesh-ancestor
25560758|NCT00700817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25560759|NCT00700817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25560760|NCT00700817|Protease Inhibitors|protease inhibitors|mesh-ancestor
25560761|NCT00700817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25560762|NCT00700817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560763|NCT00700999|Paroxetine|paroxetine|mesh-list
25560764|NCT00700999|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25560765|NCT00700999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25560766|NCT00700999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25560767|NCT00700999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560768|NCT00700999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25560769|NCT00700999|Serotonin Agents|serotonin agents|mesh-ancestor
25560770|NCT00700999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560771|NCT00700999|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25560772|NCT00700999|Antidepressive Agents|antidepressive agents|mesh-ancestor
25560773|NCT00700999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25560774|NCT00700999|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25019982|NCT03685032|Dexamethasone|dexamethasone|mesh-list
25020007|NCT03684993|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25560775|NCT00700999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25560776|NCT00700999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25560777|NCT00701090|Metformin|metformin|mesh-list
25560778|NCT00701090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25560779|NCT00701090|Glimepiride|glimepiride|mesh-list
25560780|NCT00701090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25560781|NCT00701090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560782|NCT00701090|Incretins|incretins|mesh-ancestor
25560783|NCT00701090|Hormones|hormones|mesh-ancestor
25560784|NCT00701090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25560785|NCT00701090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25560786|NCT00701090|Protease Inhibitors|protease inhibitors|mesh-ancestor
25560787|NCT00701090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25560788|NCT00701090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560789|NCT00701090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25560790|NCT00701090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25560791|NCT00701090|Immunologic Factors|immunologic factors|mesh-ancestor
25455725|NCT04531748|Hormone Antagonists|hormone antagonists|mesh-ancestor
25560792|NCT00701129|Rituximab|rituximab|mesh-list
25560793|NCT00701129|Methotrexate|methotrexate|mesh-list
25560794|NCT00701129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25560795|NCT00701129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560796|NCT00701129|Immunologic Factors|immunologic factors|mesh-ancestor
25560797|NCT00701129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560798|NCT00701129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25560799|NCT00701129|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25560800|NCT00701129|Abortifacient Agents|abortifacient agents|mesh-ancestor
25560801|NCT00701129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25560802|NCT00701129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25560803|NCT00701129|Antimetabolites|antimetabolites|mesh-ancestor
25560804|NCT00701129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560805|NCT00701129|Dermatologic Agents|dermatologic agents|mesh-ancestor
25560806|NCT00701129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25560807|NCT00701129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25560808|NCT00701129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25560809|NCT00701129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25560810|NCT00701311|Apremilast|apremilast|mesh-list
25560811|NCT00701311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25560812|NCT00701311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25560813|NCT00701311|Analgesics|analgesics|mesh-ancestor
25560814|NCT00701311|Sensory System Agents|sensory system agents|mesh-ancestor
25560815|NCT00701311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25560816|NCT00701311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560817|NCT00701311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25560818|NCT00701311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25560819|NCT00701311|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25560820|NCT00701311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25560821|NCT00701311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25560822|NCT00701311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560823|NCT00701363|Lanreotide|lanreotide|mesh-list
25560824|NCT00701363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560825|NCT00701376|Liver Extracts|liver extracts|mesh-list
25560826|NCT00701376|Hematinics|hematinics|mesh-ancestor
25560827|NCT00701389|Sumatriptan|sumatriptan|mesh-list
25560828|NCT00701389|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25560829|NCT00701389|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25560830|NCT00701389|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25560831|NCT00701389|Serotonin Agents|serotonin agents|mesh-ancestor
25560832|NCT00701389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25560833|NCT00701389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560834|NCT00701389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651702|NCT01519063|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25651703|NCT01519063|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25651704|NCT01519063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651705|NCT01519063|Sensory System Agents|sensory system agents|mesh-ancestor
25651706|NCT01519063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25651707|NCT01519063|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25651708|NCT01519063|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25651709|NCT01519063|Dopamine Agents|dopamine agents|mesh-ancestor
25651710|NCT01519063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25651711|NCT01519063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651712|NCT01519063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25651713|NCT01519063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25651714|NCT01519089|Tofacitinib|tofacitinib|mesh-list
25651715|NCT01519089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25651716|NCT01519089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651717|NCT01519089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651718|NCT01519167|Fentanyl|fentanyl|mesh-list
25651719|NCT01519167|Midazolam|midazolam|mesh-list
25651720|NCT01519167|Dexmedetomidine|dexmedetomidine|mesh-list
25651721|NCT01519167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25651722|NCT01519167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25651723|NCT01519167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651724|NCT01519167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25651725|NCT01519167|Analgesics|analgesics|mesh-ancestor
24864752|NCT02686346|Ifosfamide|ifosfamide|mesh-list
25651726|NCT01519167|Sensory System Agents|sensory system agents|mesh-ancestor
25651727|NCT01519167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25651728|NCT01519167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25651729|NCT01519167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25651730|NCT01519167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25455799|NCT04531072|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25560835|NCT00701558|Gemcitabine|gemcitabine|mesh-list
25560836|NCT00701558|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25560837|NCT00701558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25560838|NCT00701558|Antimetabolites|antimetabolites|mesh-ancestor
25560839|NCT00701558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560840|NCT00701558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560841|NCT00701558|Antiviral Agents|antiviral agents|mesh-ancestor
25560842|NCT00701558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25560843|NCT00701558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25560844|NCT00701558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25560845|NCT00701558|Immunologic Factors|immunologic factors|mesh-ancestor
25560846|NCT00701558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560847|NCT00701558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25560848|NCT00701636|Daptomycin|daptomycin|mesh-list
25560849|NCT00701636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25455854|NCT04530500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25455855|NCT04530500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455856|NCT04530578|Heparin|heparin|mesh-list
25455857|NCT04530578|Calcium heparin|calcium heparin|mesh-list
25455858|NCT04530578|Enoxaparin|enoxaparin|mesh-list
25455859|NCT04530578|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25455860|NCT04530578|Tinzaparin|tinzaparin|mesh-list
25455861|NCT04530578|Dalteparin|dalteparin|mesh-list
25455862|NCT04530578|Anticoagulants|anticoagulants|mesh-ancestor
25455863|NCT04530578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25455864|NCT04530578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25455865|NCT04530578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455866|NCT04530422|Azithromycin|azithromycin|mesh-list
25455867|NCT04530422|Hydroxychloroquine|hydroxychloroquine|mesh-list
25455868|NCT04530422|Sofosbuvir|sofosbuvir|mesh-list
25455869|NCT04530422|Oseltamivir|oseltamivir|mesh-list
25455870|NCT04530422|Ledipasvir|ledipasvir|mesh-list
25455871|NCT04530422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25455872|NCT04530422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25455873|NCT04530422|Antimalarials|antimalarials|mesh-ancestor
25455874|NCT04530422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25455875|NCT04530422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25455876|NCT04530422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25455877|NCT04530422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455878|NCT04530422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25455879|NCT04530422|Antiviral Agents|antiviral agents|mesh-ancestor
25455880|NCT04530617|Camostat|camostat|mesh-list
25455881|NCT04530617|Protease Inhibitors|protease inhibitors|mesh-ancestor
25455882|NCT04530617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25455883|NCT04530617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455884|NCT04530617|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25560850|NCT00701636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25455885|NCT04530617|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25560851|NCT00701662|Immunoglobulins|immunoglobulins|mesh-list
25560852|NCT00701662|Immunologic Factors|immunologic factors|mesh-ancestor
25560853|NCT00701662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560854|NCT00701675|Sertraline|sertraline|mesh-list
25560855|NCT00701675|Antidepressive Agents|antidepressive agents|mesh-ancestor
25560856|NCT00701675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24905497|NCT04347031|Mefloquine|mefloquine|mesh-list
24905534|NCT04346797|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24905535|NCT04346797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24905536|NCT04346797|Immunologic Factors|immunologic factors|mesh-ancestor
24905591|NCT04346277|Antibodies|antibodies|mesh-list
25560857|NCT00701675|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25560858|NCT00701675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25560859|NCT00701675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25560860|NCT00701675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560861|NCT00701675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25560862|NCT00701675|Serotonin Agents|serotonin agents|mesh-ancestor
25560863|NCT00701675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560864|NCT00701714|Epoetin Alfa|epoetin alfa|mesh-list
25560865|NCT00701714|Hematinics|hematinics|mesh-ancestor
25560866|NCT00701727|Ezetimibe|ezetimibe|mesh-list
25560867|NCT00701727|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25560868|NCT00701727|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25560869|NCT00701727|Antimetabolites|antimetabolites|mesh-ancestor
25560870|NCT00701727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560871|NCT00701727|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25560872|NCT00701779|Tamsulosin|tamsulosin|mesh-list
25560873|NCT00701779|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25560874|NCT00701779|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25560875|NCT00701779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25560876|NCT00701779|Adrenergic Agents|adrenergic agents|mesh-ancestor
25560877|NCT00701779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24542246|NCT00677755|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25651731|NCT01519167|Adrenergic Agents|adrenergic agents|mesh-ancestor
25560878|NCT00701779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560879|NCT00701779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560881|NCT00701896|Nicotine|nicotine|mesh-list
25560882|NCT00701896|Varenicline|varenicline|mesh-list
25560883|NCT00701896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25560884|NCT00701896|Autonomic Agents|autonomic agents|mesh-ancestor
25560885|NCT00701896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25560886|NCT00701896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560887|NCT00701896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25560888|NCT00701896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25560889|NCT00701896|Cholinergic Agents|cholinergic agents|mesh-ancestor
25560890|NCT00701896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25560891|NCT00701896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560892|NCT00701935|Exenatide|exenatide|mesh-list
25560893|NCT00701935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25560894|NCT00701935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560895|NCT00701935|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25560896|NCT00701935|Incretins|incretins|mesh-ancestor
25560897|NCT00701935|Hormones|hormones|mesh-ancestor
25560898|NCT00701935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25560899|NCT00702052|Everolimus|everolimus|mesh-list
25560900|NCT00702052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560901|NCT00702052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25560902|NCT00702052|Immunologic Factors|immunologic factors|mesh-ancestor
25560903|NCT00702052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560904|NCT00702221|Vaccines|vaccines|mesh-list
25560905|NCT00702221|Immunologic Factors|immunologic factors|mesh-ancestor
25560906|NCT00702221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560907|NCT00702299|Paclitaxel|paclitaxel|mesh-list
25560908|NCT00702299|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25560909|NCT00702299|Cisplatin|cisplatin|mesh-list
25560910|NCT00702299|Pemetrexed|pemetrexed|mesh-list
25560911|NCT00702299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25560912|NCT00702299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560913|NCT00702299|Tubulin Modulators|tubulin modulators|mesh-ancestor
25560914|NCT00702299|Antimitotic Agents|antimitotic agents|mesh-ancestor
25560915|NCT00702299|Mitosis Modulators|mitosis modulators|mesh-ancestor
25560916|NCT00702299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560917|NCT00702299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25560918|NCT00702299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25560919|NCT00702299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25560920|NCT00702325|Budesonide|budesonide|mesh-list
25560921|NCT00702325|Formoterol Fumarate|formoterol fumarate|mesh-list
25560922|NCT00702325|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25560923|NCT00702325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25560924|NCT00702325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25560925|NCT00702325|Autonomic Agents|autonomic agents|mesh-ancestor
25560926|NCT00702325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25560927|NCT00702325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560928|NCT00702325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25560929|NCT00702325|Respiratory System Agents|respiratory system agents|mesh-ancestor
25560930|NCT00702325|Glucocorticoids|glucocorticoids|mesh-ancestor
25560931|NCT00702325|Hormones|hormones|mesh-ancestor
25560932|NCT00702325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25560933|NCT00702325|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25560934|NCT00702325|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25560935|NCT00702325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25560936|NCT00702325|Adrenergic Agents|adrenergic agents|mesh-ancestor
25560937|NCT00702325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25560938|NCT00702325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560939|NCT00702364|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25560940|NCT00702364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25560941|NCT00702364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25560942|NCT00702364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25560943|NCT00702364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560944|NCT00702364|Adrenergic Agents|adrenergic agents|mesh-ancestor
25560945|NCT00702364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25560946|NCT00702364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560947|NCT00702403|Imatinib Mesylate|imatinib mesylate|mesh-list
25560948|NCT00702403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560949|NCT00702403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25560950|NCT00702403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25560951|NCT00702403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560952|NCT00702468|Nabiximols|nabiximols|mesh-list
25560953|NCT00702468|Analgesics|analgesics|mesh-ancestor
25560954|NCT00702468|Sensory System Agents|sensory system agents|mesh-ancestor
25560955|NCT00702468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25560956|NCT00702468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560957|NCT00702507|Miconazole|miconazole|mesh-list
25560958|NCT00702507|Clotrimazole|clotrimazole|mesh-list
25560959|NCT00702507|Antifungal Agents|antifungal agents|mesh-ancestor
25560960|NCT00702507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25560961|NCT00702507|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25560962|NCT00702507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25560963|NCT00702507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25560964|NCT00702507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560965|NCT00702507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25560966|NCT00702507|Hormone Antagonists|hormone antagonists|mesh-ancestor
25560967|NCT00702507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25560968|NCT00702507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560969|NCT00702507|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25560970|NCT00702507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25560971|NCT00702507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25560972|NCT00702650|Testosterone|testosterone|mesh-list
25560973|NCT00702650|Androgens|androgens|mesh-ancestor
25560974|NCT00702650|Hormones|hormones|mesh-ancestor
25560975|NCT00702650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25560976|NCT00702650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560977|NCT00702689|Imatinib Mesylate|imatinib mesylate|mesh-list
25560978|NCT00702689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25560979|NCT00702689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25560980|NCT00702689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25560981|NCT00702689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560982|NCT00702754|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
25560983|NCT00702754|Botulinum Toxins|botulinum toxins|mesh-list
25560984|NCT00702754|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25560985|NCT00702754|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25560986|NCT00702754|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25560987|NCT00702754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25560988|NCT00702754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25560989|NCT00702754|Cholinergic Agents|cholinergic agents|mesh-ancestor
25560990|NCT00702754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25560991|NCT00702754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25560992|NCT00702754|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25560993|NCT00702754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25560994|NCT00702754|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25560995|NCT00702780|Citalopram|citalopram|mesh-list
25560996|NCT00702780|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25560997|NCT00702780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25560998|NCT00702780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25560999|NCT00702780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561000|NCT00702780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25561001|NCT00702780|Serotonin Agents|serotonin agents|mesh-ancestor
25561002|NCT00702780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561003|NCT00702780|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25561004|NCT00702780|Antidepressive Agents|antidepressive agents|mesh-ancestor
25561005|NCT00702780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25561006|NCT00702884|Sunitinib|sunitinib|mesh-list
25561007|NCT00702884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25561008|NCT00702884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25561009|NCT00702884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25561010|NCT00702884|Growth Substances|growth substances|mesh-ancestor
25561011|NCT00702884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561012|NCT00702884|Growth Inhibitors|growth inhibitors|mesh-ancestor
25561013|NCT00702884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25561014|NCT00702884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25561015|NCT00702884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561016|NCT00702923|Tremelimumab|tremelimumab|mesh-list
25561017|NCT00702923|Bicalutamide|bicalutamide|mesh-list
25561018|NCT00702923|Ipilimumab|ipilimumab|mesh-list
25561019|NCT00702923|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25561020|NCT00702923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25561021|NCT00702923|Immunologic Factors|immunologic factors|mesh-ancestor
25561022|NCT00702923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561023|NCT00702923|Androgen Antagonists|androgen antagonists|mesh-ancestor
25561024|NCT00702923|Hormone Antagonists|hormone antagonists|mesh-ancestor
25561025|NCT00702923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25561026|NCT00702923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25561027|NCT00702923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25561028|NCT00702923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561029|NCT00702949|Pregabalin|pregabalin|mesh-list
25561030|NCT00702949|Analgesics|analgesics|mesh-ancestor
25561031|NCT00702949|Sensory System Agents|sensory system agents|mesh-ancestor
25561032|NCT00702949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25561033|NCT00702949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561034|NCT00702949|Anticonvulsants|anticonvulsants|mesh-ancestor
25561035|NCT00702949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25561036|NCT00702949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25561037|NCT00702949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561038|NCT00702949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25561039|NCT00702949|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25561040|NCT00702949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25561041|NCT00702949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25561042|NCT00702949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25561043|NCT00703118|Ribavirin|ribavirin|mesh-list
25561044|NCT00703118|Interferon alpha-2|interferon alpha-2|mesh-list
25561045|NCT00703118|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25561046|NCT00703118|Antimetabolites|antimetabolites|mesh-ancestor
25561047|NCT00703118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545691|NCT00694408|Antiemetics|antiemetics|mesh-ancestor
25561048|NCT00703118|Antiviral Agents|antiviral agents|mesh-ancestor
25561049|NCT00703118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25561050|NCT00703118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25561051|NCT00703261|Atorvastatin|atorvastatin|mesh-list
25561052|NCT00703261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25561053|NCT00703261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25561054|NCT00703261|Antimetabolites|antimetabolites|mesh-ancestor
25561055|NCT00703261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561056|NCT00703261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25561057|NCT00703261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25561058|NCT00703261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25561059|NCT00703508|Metformin|metformin|mesh-list
25561060|NCT00703508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25561061|NCT00703508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561062|NCT00703664|Bortezomib|bortezomib|mesh-list
25561063|NCT00703664|Vorinostat|vorinostat|mesh-list
25561064|NCT00703664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25561065|NCT00703664|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25561066|NCT00703664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25561067|NCT00703664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561068|NCT00703677|Lithium Carbonate|lithium carbonate|mesh-list
25064413|NCT03460678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24545971|NCT00696111|Leuprolide|leuprolide|mesh-list
25561069|NCT00703677|Antidepressive Agents|antidepressive agents|mesh-ancestor
25561070|NCT00703677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25561071|NCT00703677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25561072|NCT00703677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561073|NCT00703677|Antimanic Agents|antimanic agents|mesh-ancestor
25561074|NCT00703677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25561075|NCT00703677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25561076|NCT00703677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561077|NCT00703781|Bromfenac|bromfenac|mesh-list
25561078|NCT00703781|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25561079|NCT00703781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25561080|NCT00703781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25561081|NCT00703781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25561082|NCT00703781|Analgesics|analgesics|mesh-ancestor
25561083|NCT00703781|Sensory System Agents|sensory system agents|mesh-ancestor
25561084|NCT00703781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25561085|NCT00703781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561086|NCT00703781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25561087|NCT00703781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25561088|NCT00703820|Cytarabine|cytarabine|mesh-list
25561089|NCT00703820|Etoposide|etoposide|mesh-list
25561090|NCT00703820|Daunorubicin|daunorubicin|mesh-list
25561091|NCT00703820|Clofarabine|clofarabine|mesh-list
25561092|NCT00703820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25561093|NCT00703820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25561094|NCT00703820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25561095|NCT00703820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25456049|NCT04528797|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25561096|NCT00703820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25561097|NCT00703820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561098|NCT00703820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25561099|NCT00703820|Antimetabolites|antimetabolites|mesh-ancestor
25561100|NCT00703820|Antiviral Agents|antiviral agents|mesh-ancestor
25561101|NCT00703820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25561102|NCT00703820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25561103|NCT00703820|Immunologic Factors|immunologic factors|mesh-ancestor
25561104|NCT00703820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561105|NCT00703820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25561106|NCT00703846|Ketoconazole|ketoconazole|mesh-list
25561107|NCT00703846|Antifungal Agents|antifungal agents|mesh-ancestor
25456109|NCT04528095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25456110|NCT04528095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25456111|NCT04528095|GABA Antagonists|gaba antagonists|mesh-ancestor
25456112|NCT04528095|GABA Agents|gaba agents|mesh-ancestor
25456113|NCT04528095|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25456114|NCT04528095|Dopamine Agents|dopamine agents|mesh-ancestor
25456115|NCT04528095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25456116|NCT04528095|Antidepressive Agents|antidepressive agents|mesh-ancestor
25456117|NCT04528056|Sulfasalazine|sulfasalazine|mesh-list
25456118|NCT04528056|Ambrisentan|ambrisentan|mesh-list
25456119|NCT04528056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456120|NCT04528056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25456121|NCT04528056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25456122|NCT04528056|Analgesics|analgesics|mesh-ancestor
25456123|NCT04528056|Sensory System Agents|sensory system agents|mesh-ancestor
25456124|NCT04528056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25456125|NCT04528056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456126|NCT04528056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25456127|NCT04528056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25456128|NCT04528056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25456129|NCT04528056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25456130|NCT04528004|Niacinamide|niacinamide|mesh-list
25456131|NCT04528004|Niacin|niacin|mesh-list
25456132|NCT04528004|Nicotinic Acids|nicotinic acids|mesh-list
25456133|NCT04528004|Vitamin B Complex|vitamin b complex|mesh-ancestor
25456134|NCT04528004|Vitamins|vitamins|mesh-ancestor
25456135|NCT04528004|Micronutrients|micronutrients|mesh-ancestor
25456136|NCT04528004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456137|NCT04528004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25456138|NCT04528004|Antimetabolites|antimetabolites|mesh-ancestor
25456139|NCT04528004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456140|NCT04528004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25561108|NCT00703846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25561109|NCT00703846|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25561110|NCT00703846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25561111|NCT00703846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25561112|NCT00703846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561113|NCT00703846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25561114|NCT00703846|Hormone Antagonists|hormone antagonists|mesh-ancestor
25561115|NCT00703846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25561116|NCT00703846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561117|NCT00703846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25561118|NCT00703924|Paromomycin|paromomycin|mesh-list
25561119|NCT00703924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25561120|NCT00703924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25561121|NCT00703924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25561122|NCT00703924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25561123|NCT00703976|Bevacizumab|bevacizumab|mesh-list
25561124|NCT00703976|Cetuximab|cetuximab|mesh-list
25561125|NCT00703976|Pemetrexed|pemetrexed|mesh-list
25561126|NCT00703976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25561127|NCT00703976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25561128|NCT00703976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25561129|NCT00703976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25561130|NCT00703976|Growth Substances|growth substances|mesh-ancestor
25561131|NCT00703976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561132|NCT00703976|Growth Inhibitors|growth inhibitors|mesh-ancestor
25561133|NCT00703976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25561134|NCT00703976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561135|NCT00703976|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25561136|NCT00703976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25561137|NCT00704028|Dextrans|dextrans|mesh-list
25561138|NCT00704028|Iron-Dextran Complex|iron-dextran complex|mesh-list
24548945|NCT00712686|Aripiprazole|aripiprazole|mesh-list
25561139|NCT00704028|Anticoagulants|anticoagulants|mesh-ancestor
25561140|NCT00704028|Plasma Substitutes|plasma substitutes|mesh-ancestor
25561141|NCT00704028|Blood Substitutes|blood substitutes|mesh-ancestor
25561142|NCT00704028|Hematinics|hematinics|mesh-ancestor
25561143|NCT00704132|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25561144|NCT00704132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25561145|NCT00704132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561146|NCT00704132|Incretins|incretins|mesh-ancestor
25561147|NCT00704132|Hormones|hormones|mesh-ancestor
25561148|NCT00704132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25561149|NCT00704132|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25561150|NCT00704132|Protease Inhibitors|protease inhibitors|mesh-ancestor
25561151|NCT00704132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25561152|NCT00704132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561153|NCT00704184|Interferons|interferons|mesh-list
25561154|NCT00704184|Ribavirin|ribavirin|mesh-list
25561155|NCT00704184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25561156|NCT00704184|Antiviral Agents|antiviral agents|mesh-ancestor
25561157|NCT00704184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25561158|NCT00704184|Antimetabolites|antimetabolites|mesh-ancestor
25561159|NCT00704184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561160|NCT00704262|Hydrocortisone|hydrocortisone|mesh-list
25561161|NCT00704262|Calcipotriene|calcipotriene|mesh-list
25561162|NCT00704262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25561163|NCT00704262|Dermatologic Agents|dermatologic agents|mesh-ancestor
25561164|NCT00704353|Ferric gluconate|ferric gluconate|mesh-list
25561165|NCT00704353|Iron-Dextran Complex|iron-dextran complex|mesh-list
25561166|NCT00704353|Hematinics|hematinics|mesh-ancestor
25561167|NCT00704379|Sertraline|sertraline|mesh-list
25561168|NCT00704379|Antidepressive Agents|antidepressive agents|mesh-ancestor
25561169|NCT00704379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25561170|NCT00704379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25561171|NCT00704379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25561172|NCT00704379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25561173|NCT00704379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561174|NCT00704379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25561175|NCT00704379|Serotonin Agents|serotonin agents|mesh-ancestor
25561176|NCT00704379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561177|NCT00704405|Interferons|interferons|mesh-list
25561178|NCT00704405|Ribavirin|ribavirin|mesh-list
25561179|NCT00704405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25561180|NCT00704405|Antiviral Agents|antiviral agents|mesh-ancestor
25561181|NCT00704405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24906382|NCT04341038|Protective Agents|protective agents|mesh-ancestor
25561182|NCT00704405|Antimetabolites|antimetabolites|mesh-ancestor
25561183|NCT00704405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561184|NCT00704418|Bromfenac|bromfenac|mesh-list
25561185|NCT00704418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25561186|NCT00704418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25561187|NCT00704418|Analgesics|analgesics|mesh-ancestor
25561188|NCT00704418|Sensory System Agents|sensory system agents|mesh-ancestor
25561189|NCT00704418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25561190|NCT00704418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690959|NCT01980589|Antiemetics|antiemetics|mesh-ancestor
25690960|NCT01980589|Autonomic Agents|autonomic agents|mesh-ancestor
25690961|NCT01980589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25690962|NCT01980589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24906559|NCT04339348|Lidocaine|lidocaine|mesh-list
24906560|NCT04339348|Prilocaine|prilocaine|mesh-list
24906562|NCT04339348|Misoprostol|misoprostol|mesh-list
24906573|NCT04339348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906579|NCT04339348|Oxytocics|oxytocics|mesh-ancestor
25020710|NCT03678116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020711|NCT03678116|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25020712|NCT03678116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25020713|NCT03678116|Purinergic Agents|purinergic agents|mesh-ancestor
25020714|NCT03678116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25020715|NCT03678090|Plasminogen|plasminogen|mesh-list
25020716|NCT03678090|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25020717|NCT03678090|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25020718|NCT03678090|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25020719|NCT03678090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020720|NCT03678038|Triamcinolone|triamcinolone|mesh-list
25020721|NCT03678038|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25020722|NCT03678038|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25020723|NCT03678038|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25020724|NCT03678038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25020739|NCT03678012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25020740|NCT03677895|Hyaluronic Acid|hyaluronic acid|mesh-list
25020772|NCT03677323|Analgesics|analgesics|mesh-ancestor
25690963|NCT01980589|Glucocorticoids|glucocorticoids|mesh-ancestor
25690964|NCT01980589|Hormones|hormones|mesh-ancestor
25690965|NCT01980589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25690966|NCT01980589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25690967|NCT01980654|Rituximab|rituximab|mesh-list
25561191|NCT00704418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25561192|NCT00704418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25561193|NCT00704522|Ribavirin|ribavirin|mesh-list
25561194|NCT00704522|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25561195|NCT00704522|Antimetabolites|antimetabolites|mesh-ancestor
25561196|NCT00704522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561197|NCT00704522|Antiviral Agents|antiviral agents|mesh-ancestor
25561198|NCT00704522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25561199|NCT00704717|Ribavirin|ribavirin|mesh-list
25561200|NCT00704717|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25020741|NCT03677895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25020742|NCT03677895|Immunologic Factors|immunologic factors|mesh-ancestor
25020743|NCT03677895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020744|NCT03677895|Viscosupplements|viscosupplements|mesh-ancestor
25020745|NCT03677895|Protective Agents|protective agents|mesh-ancestor
25020746|NCT03677492|Cytochalasin D|cytochalasin d|mesh-list
25020747|NCT03677492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25020748|NCT03677492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25020749|NCT03677492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020750|NCT03677466|Tenecteplase|tenecteplase|mesh-list
25020751|NCT03677466|Streptokinase|streptokinase|mesh-list
25020752|NCT03677466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25020753|NCT03677466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25020754|NCT03677466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020755|NCT03677336|Progesterone|progesterone|mesh-list
25020756|NCT03677336|Dydrogesterone|dydrogesterone|mesh-list
25020757|NCT03677336|Progestins|progestins|mesh-ancestor
25020758|NCT03677336|Hormones|hormones|mesh-ancestor
25020759|NCT03677336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25020760|NCT03677336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020761|NCT03677323|Sufentanil|sufentanil|mesh-list
25020762|NCT03677323|Droperidol|droperidol|mesh-list
25020763|NCT03677323|Propofol|propofol|mesh-list
25020769|NCT03677323|Anesthetics|anesthetics|mesh-ancestor
25561201|NCT00704717|Interferon-alpha|interferon-alpha|mesh-list
25561202|NCT00704717|Antimetabolites|antimetabolites|mesh-ancestor
25561203|NCT00704717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561204|NCT00704717|Antiviral Agents|antiviral agents|mesh-ancestor
25561205|NCT00704717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25561206|NCT00704717|Immunologic Factors|immunologic factors|mesh-ancestor
25561207|NCT00704717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561208|NCT00704808|Temozolomide|temozolomide|mesh-list
25561209|NCT00704808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25561210|NCT00704808|Alkylating Agents|alkylating agents|mesh-ancestor
25561211|NCT00704808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561212|NCT00704808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25020801|NCT03676985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25020803|NCT03676985|Immunoglobulins|immunoglobulins|mesh-list
25020805|NCT03676985|Immunologic Factors|immunologic factors|mesh-ancestor
25020806|NCT03676985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020807|NCT03676985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25020808|NCT03676959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25020809|NCT03676959|Antibodies|antibodies|mesh-list
25020810|NCT03676959|Immunoglobulins|immunoglobulins|mesh-list
25020811|NCT03676959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25020812|NCT03676959|Immunologic Factors|immunologic factors|mesh-ancestor
25020813|NCT03676959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020814|NCT03676959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25020815|NCT03676946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25020816|NCT03676946|Antibodies|antibodies|mesh-list
25020817|NCT03676946|Immunoglobulins|immunoglobulins|mesh-list
25020818|NCT03676946|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25020819|NCT03676946|Immunologic Factors|immunologic factors|mesh-ancestor
25020820|NCT03676946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020821|NCT03676946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25020822|NCT03676933|Hydrocortisone|hydrocortisone|mesh-list
25020823|NCT03676933|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
25020824|NCT03676933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25020825|NCT03676933|Dermatologic Agents|dermatologic agents|mesh-ancestor
25111529|NCT04791475|Sensory System Agents|sensory system agents|mesh-ancestor
25111530|NCT04791475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25111531|NCT04791475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25111532|NCT04791475|Analgesics|analgesics|mesh-ancestor
25111533|NCT04791475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25020930|NCT03676140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24983769|NCT05163561|Immunologic Factors|immunologic factors|mesh-ancestor
24983770|NCT05163561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561213|NCT00704847|Calcitonin|calcitonin|mesh-list
25561214|NCT00704847|Salmon calcitonin|salmon calcitonin|mesh-list
25561215|NCT00704847|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
25561216|NCT00704847|Katacalcin|katacalcin|mesh-list
25561217|NCT00704847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25561218|NCT00704847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561219|NCT00704847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25561220|NCT00704847|Vasodilator Agents|vasodilator agents|mesh-ancestor
25561221|NCT00704912|Orlistat|orlistat|mesh-list
25561222|NCT00704912|Contraceptive Agents|contraceptive agents|mesh-list
25561223|NCT00704912|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
25561224|NCT00704912|Contraceptives, Oral|contraceptives, oral|mesh-list
25561225|NCT00704912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25561226|NCT00704912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561227|NCT00704912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25561228|NCT00704912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25561229|NCT00704912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561230|NCT00704912|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25561231|NCT00704912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25561232|NCT00704912|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25561233|NCT00704912|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25561234|NCT00704912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25561235|NCT00704912|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
25561236|NCT00704912|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25561237|NCT00704938|Aldesleukin|aldesleukin|mesh-list
25561238|NCT00704938|Cyclophosphamide|cyclophosphamide|mesh-list
25690970|NCT01980654|Immunologic Factors|immunologic factors|mesh-ancestor
25690971|NCT01980654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690972|NCT01980654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24906817|NCT04336891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24906818|NCT04336891|Anabolic Agents|anabolic agents|mesh-ancestor
24906820|NCT04336904|Antiviral Agents|antiviral agents|mesh-ancestor
25111534|NCT04791475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25111535|NCT04791475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24447958|NCT00309920|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24447959|NCT00309920|Fluorouracil|fluorouracil|mesh-list
24447960|NCT00309920|Epirubicin|epirubicin|mesh-list
24447961|NCT00309920|Darbepoetin alfa|darbepoetin alfa|mesh-list
24447962|NCT00309920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24447963|NCT00309920|Immunologic Factors|immunologic factors|mesh-ancestor
24447965|NCT00309920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25020828|NCT03676764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25020830|NCT03676621|Oxytocin|oxytocin|mesh-list
25020831|NCT03676621|Oxytocics|oxytocics|mesh-ancestor
25020835|NCT03676621|Abortifacient Agents|abortifacient agents|mesh-ancestor
25561239|NCT00704938|Fludarabine|fludarabine|mesh-list
25561240|NCT00704938|Fludarabine phosphate|fludarabine phosphate|mesh-list
25561241|NCT00704938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25561242|NCT00704938|Immunologic Factors|immunologic factors|mesh-ancestor
25561243|NCT00704938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561244|NCT00704938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25561245|NCT00704938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25561246|NCT00704938|Alkylating Agents|alkylating agents|mesh-ancestor
25561247|NCT00704938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561248|NCT00704938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25561249|NCT00704938|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25561250|NCT00704938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25561251|NCT00704938|Antimetabolites|antimetabolites|mesh-ancestor
25561252|NCT00704938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24613954|NCT01021735|Sensory System Agents|sensory system agents|mesh-ancestor
24613955|NCT01021735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24613956|NCT01021735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25020850|NCT03676504|Cyclophosphamide|cyclophosphamide|mesh-list
25020851|NCT03676504|Fludarabine|fludarabine|mesh-list
25020852|NCT03676504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25020853|NCT03676504|Immunologic Factors|immunologic factors|mesh-ancestor
25020854|NCT03676504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784638|NCT01909752|Cyclophosphamide|cyclophosphamide|mesh-list
25020859|NCT03676504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25020860|NCT03676504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25020861|NCT03676413|Fluticasone|fluticasone|mesh-list
25020880|NCT03676413|Glucocorticoids|glucocorticoids|mesh-ancestor
25020881|NCT03676413|Hormones|hormones|mesh-ancestor
25020882|NCT03676413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25020883|NCT03676413|Sympathomimetics|sympathomimetics|mesh-ancestor
25020884|NCT03676374|Prucalopride|prucalopride|mesh-list
25020885|NCT03676374|Laxatives|laxatives|mesh-ancestor
25561253|NCT00704938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25561254|NCT00704938|Antiviral Agents|antiviral agents|mesh-ancestor
25561255|NCT00704938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25561256|NCT00704964|Ribavirin|ribavirin|mesh-list
25561257|NCT00704964|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25561258|NCT00704964|Interferon-alpha|interferon-alpha|mesh-list
25561259|NCT00704964|Antimetabolites|antimetabolites|mesh-ancestor
25561260|NCT00704964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561261|NCT00704964|Antiviral Agents|antiviral agents|mesh-ancestor
25561262|NCT00704964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25561263|NCT00704964|Immunologic Factors|immunologic factors|mesh-ancestor
25561264|NCT00704964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561265|NCT00705003|Melatonin|melatonin|mesh-list
25561266|NCT00705003|Buspirone|buspirone|mesh-list
25561267|NCT00705003|Antioxidants|antioxidants|mesh-ancestor
25561268|NCT00705003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561269|NCT00705003|Protective Agents|protective agents|mesh-ancestor
25561270|NCT00705003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561271|NCT00705003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25561272|NCT00705003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25561273|NCT00705003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25561274|NCT00705003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24906985|NCT04334928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24482394|NCT00438841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24482395|NCT00438841|Glucocorticoids|glucocorticoids|mesh-ancestor
24482396|NCT00438841|Hormones|hormones|mesh-ancestor
24906986|NCT04334928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24708187|NCT01500577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24454542|NCT03897868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24454543|NCT03897868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25690981|NCT01980706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25690982|NCT01980706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690983|NCT01980888|Rituximab|rituximab|mesh-list
25690984|NCT01980888|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25690985|NCT01980888|Idelalisib|idelalisib|mesh-list
25690986|NCT01980888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25690987|NCT01980888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25690988|NCT01980888|Immunologic Factors|immunologic factors|mesh-ancestor
25690989|NCT01980888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561275|NCT00705003|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25561276|NCT00705003|Serotonin Agents|serotonin agents|mesh-ancestor
25561277|NCT00705003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25561278|NCT00705016|Cisplatin|cisplatin|mesh-list
25561279|NCT00705016|Fluorouracil|fluorouracil|mesh-list
25561280|NCT00705016|Cetuximab|cetuximab|mesh-list
25561281|NCT00705016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25561282|NCT00705016|Antimetabolites|antimetabolites|mesh-ancestor
25561283|NCT00705016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561284|NCT00705016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25561285|NCT00705016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25561286|NCT00705016|Immunologic Factors|immunologic factors|mesh-ancestor
25561287|NCT00705016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456220|NCT05139238|Labetalol|labetalol|mesh-list
25456279|NCT05126121|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25456280|NCT05126121|Alkylating Agents|alkylating agents|mesh-ancestor
25456281|NCT05126121|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25456282|NCT05126121|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25456283|NCT05126121|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25064470|NCT03459911|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25064471|NCT03459911|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25064472|NCT03459911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064473|NCT03459833|Hyaluronic Acid|hyaluronic acid|mesh-list
25064474|NCT03459833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25064475|NCT03459833|Immunologic Factors|immunologic factors|mesh-ancestor
24949114|NCT05255666|Irinotecan|irinotecan|mesh-list
24454569|NCT03878524|Nivolumab|nivolumab|mesh-list
24454572|NCT03878524|Bortezomib|bortezomib|mesh-list
24454573|NCT03878524|Sorafenib|sorafenib|mesh-list
24454574|NCT03878524|Ipilimumab|ipilimumab|mesh-list
24454583|NCT03878524|Vorinostat|vorinostat|mesh-list
24454584|NCT03878524|Pertuzumab|pertuzumab|mesh-list
24454585|NCT03878524|Trametinib|trametinib|mesh-list
24454586|NCT03878524|Retinol palmitate|retinol palmitate|mesh-list
24454587|NCT03878524|Tretinoin|tretinoin|mesh-list
24454588|NCT03878524|Bicalutamide|bicalutamide|mesh-list
25020898|NCT03676361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020899|NCT03676335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25020900|NCT03676335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25020901|NCT03676296|Puerarin|puerarin|mesh-list
25020902|NCT03676296|Vasodilator Agents|vasodilator agents|mesh-ancestor
25021349|NCT03672149|Cefazolin|cefazolin|mesh-list
25690990|NCT01980888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25690991|NCT01980888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25690992|NCT01980888|Alkylating Agents|alkylating agents|mesh-ancestor
25690993|NCT01980888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690994|NCT01980888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25690995|NCT01981473|Infliximab|infliximab|mesh-list
25690996|NCT01981473|Dermatologic Agents|dermatologic agents|mesh-ancestor
25456284|NCT05126121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25456285|NCT05126121|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25456286|NCT05108688|Sumatriptan|sumatriptan|mesh-list
25456287|NCT05108688|Mirtazapine|mirtazapine|mesh-list
25456288|NCT05108688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25456289|NCT05108688|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25456290|NCT05108688|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25456291|NCT05108688|Serotonin Agents|serotonin agents|mesh-ancestor
25456292|NCT05108688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25456293|NCT05108688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456294|NCT05108688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456295|NCT05108688|Antidepressive Agents|antidepressive agents|mesh-ancestor
25456296|NCT05108688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25456297|NCT05108688|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25456298|NCT05108688|Histamine Antagonists|histamine antagonists|mesh-ancestor
25456299|NCT05108688|Histamine Agents|histamine agents|mesh-ancestor
25456300|NCT05108688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25456301|NCT05108688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25456302|NCT05108688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25456303|NCT05108688|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25456304|NCT05108688|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25456305|NCT05108688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25456306|NCT05108688|Adrenergic Agents|adrenergic agents|mesh-ancestor
25456307|NCT05108688|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25456308|NCT05108688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24511019|NCT00567034|Naltrexone|naltrexone|mesh-list
24826929|NCT02136875|Xhance|xhance|mesh-list
25020911|NCT03676140|Azithromycin|azithromycin|mesh-list
25020912|NCT03676140|Ivermectin|ivermectin|mesh-list
25020913|NCT03676140|Albendazole|albendazole|mesh-list
25020914|NCT03676140|Diethylcarbamazine|diethylcarbamazine|mesh-list
25020915|NCT03676140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25020916|NCT03676140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25020926|NCT03676140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25020927|NCT03676140|Filaricides|filaricides|mesh-ancestor
25020928|NCT03676140|Antinematodal Agents|antinematodal agents|mesh-ancestor
25020929|NCT03676140|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25020934|NCT03676114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25020935|NCT03676114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020936|NCT03676114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25020937|NCT03676114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25020938|NCT03676114|Anesthetics, General|anesthetics, general|mesh-ancestor
25020939|NCT03676114|Anesthetics|anesthetics|mesh-ancestor
25020940|NCT03676114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25020941|NCT03676114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25690998|NCT01981473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25690999|NCT01981616|Vedolizumab|vedolizumab|mesh-list
25691000|NCT01981616|Vaccines|vaccines|mesh-list
25456309|NCT05108688|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25161888|NCT02240407|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24420357|NCT00215748|Autonomic Agents|autonomic agents|mesh-ancestor
25121255|NCT03103685|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24420358|NCT00215748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24420359|NCT00215748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420360|NCT00215748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24420361|NCT00215748|Glucocorticoids|glucocorticoids|mesh-ancestor
24420363|NCT00215748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24420364|NCT00215748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24420379|NCT00215826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561288|NCT00705016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25561289|NCT00705107|Ribavirin|ribavirin|mesh-list
25561290|NCT00705107|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25561291|NCT00705107|Interferon-alpha|interferon-alpha|mesh-list
25561292|NCT00705107|Antimetabolites|antimetabolites|mesh-ancestor
25561293|NCT00705107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561294|NCT00705107|Antiviral Agents|antiviral agents|mesh-ancestor
25561295|NCT00705107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25561296|NCT00705107|Immunologic Factors|immunologic factors|mesh-ancestor
25561297|NCT00705107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561298|NCT00705133|Treprostinil|treprostinil|mesh-list
25561299|NCT00705133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25561300|NCT00705159|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25561301|NCT00705159|Tobramycin|tobramycin|mesh-list
25561302|NCT00705159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25561303|NCT00705159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25561304|NCT00705159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25561305|NCT00705224|Interferons|interferons|mesh-list
25561306|NCT00705224|Ribavirin|ribavirin|mesh-list
25561307|NCT00705224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24907147|NCT04332276|Dopamine|dopamine|mesh-list
25020943|NCT03676114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25020944|NCT03676114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020945|NCT03676088|Mitogens|mitogens|mesh-list
25020946|NCT03676088|Mitosis Modulators|mitosis modulators|mesh-ancestor
25020947|NCT03676088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020948|NCT03676049|Cannabidiol|cannabidiol|mesh-list
25020949|NCT03676049|Anticonvulsants|anticonvulsants|mesh-ancestor
25020950|NCT03676036|Mometasone Furoate|mometasone furoate|mesh-list
25020951|NCT03676036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25561308|NCT00705224|Antiviral Agents|antiviral agents|mesh-ancestor
25561309|NCT00705224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25561310|NCT00705224|Antimetabolites|antimetabolites|mesh-ancestor
25561311|NCT00705224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561312|NCT00705250|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25561313|NCT00705250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25561314|NCT00705250|Alkylating Agents|alkylating agents|mesh-ancestor
25561315|NCT00705250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561316|NCT00705250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25561317|NCT00705263|Ribavirin|ribavirin|mesh-list
25561318|NCT00705263|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25561319|NCT00705263|Antimetabolites|antimetabolites|mesh-ancestor
25561320|NCT00705263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561321|NCT00705263|Antiviral Agents|antiviral agents|mesh-ancestor
25561322|NCT00705263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25561324|NCT00705289|Dermatologic Agents|dermatologic agents|mesh-ancestor
25561325|NCT00705289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25561326|NCT00705289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25561327|NCT00705341|Fluticasone|fluticasone|mesh-list
25561328|NCT00705341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25561329|NCT00705341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25561330|NCT00705341|Autonomic Agents|autonomic agents|mesh-ancestor
25561331|NCT00705341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953322|NCT03886441|Respiratory System Agents|respiratory system agents|mesh-ancestor
24826939|NCT02136875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24826940|NCT02136875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24907199|NCT04331743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907201|NCT04331730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24907202|NCT04331730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24448293|NCT00311051|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24448294|NCT00311051|Hormone Antagonists|hormone antagonists|mesh-ancestor
24448295|NCT00311051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24448296|NCT00311051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709235|NCT01504659|Ketamine|ketamine|mesh-list
25020991|NCT03675815|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25020992|NCT03675815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25020995|NCT03675802|Misoprostol|misoprostol|mesh-list
25020996|NCT03675802|Dinoprostone|dinoprostone|mesh-list
25561332|NCT00705341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561333|NCT00705341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25561334|NCT00705341|Respiratory System Agents|respiratory system agents|mesh-ancestor
25561335|NCT00705341|Dermatologic Agents|dermatologic agents|mesh-ancestor
25561336|NCT00705341|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25561337|NCT00705367|Abatacept|abatacept|mesh-list
25561338|NCT00705367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25561339|NCT00705367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561340|NCT00705367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25561341|NCT00705367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25561342|NCT00705367|Immunologic Factors|immunologic factors|mesh-ancestor
25561343|NCT00705367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561344|NCT00705367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25561345|NCT00705406|Peramivir|peramivir|mesh-list
24709519|NCT01506037|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24877045|NCT02974621|Antibodies|antibodies|mesh-list
24788685|NCT01932580|Antimetabolites|antimetabolites|mesh-ancestor
24788686|NCT01932580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24788687|NCT01932580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24788688|NCT01932580|Immunologic Factors|immunologic factors|mesh-ancestor
25561346|NCT00705406|Antiviral Agents|antiviral agents|mesh-ancestor
25561347|NCT00705406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25561348|NCT00705406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25561349|NCT00705406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561350|NCT00705432|Ribavirin|ribavirin|mesh-list
25561351|NCT00705432|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25561352|NCT00705432|Antimetabolites|antimetabolites|mesh-ancestor
25561353|NCT00705432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561354|NCT00705432|Antiviral Agents|antiviral agents|mesh-ancestor
25561355|NCT00705432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25561356|NCT00705484|Infliximab|infliximab|mesh-list
25561357|NCT00705484|Dermatologic Agents|dermatologic agents|mesh-ancestor
25561358|NCT00705484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25561359|NCT00705484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25561360|NCT00705523|Varenicline|varenicline|mesh-list
25561361|NCT00705523|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25561362|NCT00705523|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25691020|NCT01981772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691021|NCT01981772|Sensory System Agents|sensory system agents|mesh-ancestor
25021086|NCT03674671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25021087|NCT03674671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25021088|NCT03674671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25021089|NCT03674671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021090|NCT03674658|Propafenone|propafenone|mesh-list
25021091|NCT03674658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25021092|NCT03674658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25021093|NCT03674658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25021094|NCT03674658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25021095|NCT03674658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021096|NCT03674606|Aspirin|aspirin|mesh-list
25021097|NCT03674606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25021098|NCT03674606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25021099|NCT03674606|Analgesics|analgesics|mesh-ancestor
25021100|NCT03674606|Sensory System Agents|sensory system agents|mesh-ancestor
25021147|NCT03674385|Clomiphene|clomiphene|mesh-list
25021106|NCT03674606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25021107|NCT03674606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021108|NCT03674606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25021109|NCT03674606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25021110|NCT03674606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709997|NCT01507974|Cephalexin|cephalexin|mesh-list
25561363|NCT00705523|Cholinergic Agents|cholinergic agents|mesh-ancestor
25561364|NCT00705523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25561365|NCT00705523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561366|NCT00705523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561367|NCT00705536|Insulin|insulin|mesh-list
25561368|NCT00705536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25561369|NCT00705536|Insulin Lispro|insulin lispro|mesh-list
25561370|NCT00705536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25561371|NCT00705536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561372|NCT00705575|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25561373|NCT00705575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25561374|NCT00705575|Diuretics|diuretics|mesh-ancestor
25561375|NCT00705575|Natriuretic Agents|natriuretic agents|mesh-ancestor
25561376|NCT00705575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561377|NCT00705575|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24517435|NCT00607958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517436|NCT00607958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691023|NCT01981772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25691024|NCT01981772|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25021119|NCT03674541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25021120|NCT03674541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021121|NCT03674411|Mycophenolic Acid|mycophenolic acid|mesh-list
25021122|NCT03674411|Cyclophosphamide|cyclophosphamide|mesh-list
25021123|NCT03674411|Melphalan|melphalan|mesh-list
25021124|NCT03674411|Busulfan|busulfan|mesh-list
25021125|NCT03674411|Fludarabine|fludarabine|mesh-list
25021126|NCT03674411|Tacrolimus|tacrolimus|mesh-list
25021127|NCT03674411|Lenograstim|lenograstim|mesh-list
25021128|NCT03674411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25021129|NCT03674411|Immunologic Factors|immunologic factors|mesh-ancestor
25021130|NCT03674411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021131|NCT03674411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25021132|NCT03674411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25021133|NCT03674411|Alkylating Agents|alkylating agents|mesh-ancestor
25021146|NCT03674385|Metformin|metformin|mesh-list
25561378|NCT00705575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25561379|NCT00705575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561380|NCT00705614|Infliximab|infliximab|mesh-list
25561381|NCT00705614|Dermatologic Agents|dermatologic agents|mesh-ancestor
25561382|NCT00705614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25561383|NCT00705614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25561384|NCT00705666|Ribavirin|ribavirin|mesh-list
25561385|NCT00705666|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25561386|NCT00705666|Antimetabolites|antimetabolites|mesh-ancestor
25561387|NCT00705666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561388|NCT00705666|Antiviral Agents|antiviral agents|mesh-ancestor
25561389|NCT00705666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25561390|NCT00705679|Tenofovir|tenofovir|mesh-list
25561391|NCT00705679|Emtricitabine|emtricitabine|mesh-list
25561392|NCT00705679|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25561393|NCT00705679|Antiviral Agents|antiviral agents|mesh-ancestor
25561394|NCT00705679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456316|NCT04459871|Thrombin|thrombin|mesh-list
25561395|NCT00705679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25561396|NCT00705679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25561397|NCT00705679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25561398|NCT00705679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561399|NCT00705679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25561400|NCT00705679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25561401|NCT00705757|Bimatoprost|bimatoprost|mesh-list
25561402|NCT00705757|Travoprost|travoprost|mesh-list
25561403|NCT00705757|Latanoprost|latanoprost|mesh-list
25561404|NCT00705757|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25561405|NCT00705757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25561406|NCT00705757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25561407|NCT00705783|Aripiprazole|aripiprazole|mesh-list
25561408|NCT00705783|Antidepressive Agents|antidepressive agents|mesh-ancestor
25561409|NCT00705783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25561410|NCT00705783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25561411|NCT00705783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25561412|NCT00705783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25561413|NCT00705783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561414|NCT00705783|Dopamine Agonists|dopamine agonists|mesh-ancestor
25561415|NCT00705783|Dopamine Agents|dopamine agents|mesh-ancestor
25561416|NCT00705783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25561417|NCT00705783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907522|NCT04329611|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24907539|NCT04329650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24907540|NCT04329650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907541|NCT04329650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24907543|NCT04329650|Hormones|hormones|mesh-ancestor
24907545|NCT04329650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25021232|NCT03674073|Immunologic Factors|immunologic factors|mesh-ancestor
25021233|NCT03674073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561418|NCT00705783|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25561419|NCT00705783|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25561420|NCT00705783|Serotonin Agents|serotonin agents|mesh-ancestor
25561421|NCT00705783|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25561422|NCT00705783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25561423|NCT00705783|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25561424|NCT00705783|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25561425|NCT00705874|Leucovorin|leucovorin|mesh-list
25561426|NCT00705874|Gemcitabine|gemcitabine|mesh-list
25561427|NCT00705874|Bevacizumab|bevacizumab|mesh-list
25561428|NCT00705874|Sunitinib|sunitinib|mesh-list
25561429|NCT00705874|Cisplatin|cisplatin|mesh-list
25561430|NCT00705874|Docetaxel|docetaxel|mesh-list
25561431|NCT00705874|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25561432|NCT00705874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25561433|NCT00705874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25561434|NCT00705874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25561435|NCT00705874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25561436|NCT00705874|Growth Substances|growth substances|mesh-ancestor
25561437|NCT00705874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561438|NCT00705874|Growth Inhibitors|growth inhibitors|mesh-ancestor
25561439|NCT00705874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25561440|NCT00705874|Antimetabolites|antimetabolites|mesh-ancestor
25561441|NCT00705874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482861|NCT00440804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24482862|NCT00440804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064514|NCT03459404|Anesthetics, General|anesthetics, general|mesh-ancestor
25021281|NCT03673384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25021282|NCT03673384|Respiratory System Agents|respiratory system agents|mesh-ancestor
25021283|NCT03673384|Dermatologic Agents|dermatologic agents|mesh-ancestor
25021284|NCT03673384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25021285|NCT03673384|Histamine Agonists|histamine agonists|mesh-ancestor
25021286|NCT03673384|Histamine Agents|histamine agents|mesh-ancestor
25021287|NCT03673384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25021288|NCT03673384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021289|NCT03673332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24977776|NCT02145403|Immunologic Factors|immunologic factors|mesh-ancestor
25021292|NCT03673280|Morphine|morphine|mesh-list
25561442|NCT00705874|Antiviral Agents|antiviral agents|mesh-ancestor
25561443|NCT00705874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25561444|NCT00705874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25561445|NCT00705874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25561446|NCT00705874|Immunologic Factors|immunologic factors|mesh-ancestor
25561447|NCT00705874|Tubulin Modulators|tubulin modulators|mesh-ancestor
25561448|NCT00705874|Antimitotic Agents|antimitotic agents|mesh-ancestor
25561449|NCT00705874|Mitosis Modulators|mitosis modulators|mesh-ancestor
25561450|NCT00705874|Antidotes|antidotes|mesh-ancestor
25561451|NCT00705874|Protective Agents|protective agents|mesh-ancestor
25561452|NCT00705874|Vitamin B Complex|vitamin b complex|mesh-ancestor
25561453|NCT00705874|Vitamins|vitamins|mesh-ancestor
25561454|NCT00705874|Micronutrients|micronutrients|mesh-ancestor
24710495|NCT01510977|Cathartics|cathartics|mesh-ancestor
24710588|NCT01511198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24710589|NCT01511198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710590|NCT01511198|Incretins|incretins|mesh-ancestor
25021310|NCT03673163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25021311|NCT03673163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021312|NCT03673137|Gemcitabine|gemcitabine|mesh-list
25021313|NCT03673137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25021314|NCT03673137|Antimetabolites|antimetabolites|mesh-ancestor
25021315|NCT03673137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561455|NCT00705874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25561456|NCT00706004|Lubiprostone|lubiprostone|mesh-list
25561457|NCT00706004|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25561458|NCT00706004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25561459|NCT00706004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561460|NCT00706030|Vinorelbine|vinorelbine|mesh-list
25561461|NCT00706030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25561462|NCT00706030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25021375|NCT03671941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25021376|NCT03671941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24584997|NCT00882609|Cariostatic Agents|cariostatic agents|mesh-ancestor
25021393|NCT03671759|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25021395|NCT03671759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25021396|NCT03671746|Ketorolac|ketorolac|mesh-list
25021397|NCT03671746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25021398|NCT03671746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25021399|NCT03671746|Analgesics|analgesics|mesh-ancestor
25021400|NCT03671746|Sensory System Agents|sensory system agents|mesh-ancestor
25021401|NCT03671746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25021402|NCT03671746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021403|NCT03671746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25021404|NCT03671746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25021405|NCT03671746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25021406|NCT03671746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984059|NCT04840641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24393911|NCT00131261|Glucocorticoids|glucocorticoids|mesh-ancestor
24393989|NCT00131521|Acetylcysteine|acetylcysteine|mesh-list
25021407|NCT03671746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021409|NCT03671733|Exenatide|exenatide|mesh-list
25021410|NCT03671733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25021776|NCT03668470|Dulaglutide|dulaglutide|mesh-list
25021412|NCT03671733|Incretins|incretins|mesh-ancestor
25561463|NCT00706030|Tubulin Modulators|tubulin modulators|mesh-ancestor
25561464|NCT00706030|Antimitotic Agents|antimitotic agents|mesh-ancestor
25561465|NCT00706030|Mitosis Modulators|mitosis modulators|mesh-ancestor
25561466|NCT00706030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561467|NCT00706121|Vitamins|vitamins|mesh-list
25561468|NCT00706121|Vitamin E|vitamin e|mesh-list
25561469|NCT00706121|Tocopherols|tocopherols|mesh-list
25561470|NCT00706121|Tocotrienols|tocotrienols|mesh-list
25561471|NCT00706121|alpha-Tocopherol|alpha-tocopherol|mesh-list
25561472|NCT00706121|Selenium|selenium|mesh-list
25561473|NCT00706121|Micronutrients|micronutrients|mesh-ancestor
25561474|NCT00706121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021428|NCT03671655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25021429|NCT03671655|Tubulin Modulators|tubulin modulators|mesh-ancestor
25021430|NCT03671655|Antimitotic Agents|antimitotic agents|mesh-ancestor
25021431|NCT03671655|Mitosis Modulators|mitosis modulators|mesh-ancestor
24978035|NCT00102648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978036|NCT00102648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978037|NCT00038675|Imatinib Mesylate|imatinib mesylate|mesh-list
24978038|NCT00038675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978039|NCT00038675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24978040|NCT00038675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587111|NCT00893490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25561475|NCT00706121|Antioxidants|antioxidants|mesh-ancestor
25561476|NCT00706121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561477|NCT00706121|Protective Agents|protective agents|mesh-ancestor
25561478|NCT00706121|Trace Elements|trace elements|mesh-ancestor
25561479|NCT00706264|Silicon|silicon|mesh-list
25561480|NCT00706264|Trace Elements|trace elements|mesh-ancestor
25561481|NCT00706264|Micronutrients|micronutrients|mesh-ancestor
25561482|NCT00706264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651732|NCT01519167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25651733|NCT01519167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651734|NCT01519167|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25651735|NCT01519167|Narcotics|narcotics|mesh-ancestor
25651736|NCT01519167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25021462|NCT03671174|Analgesics|analgesics|mesh-ancestor
25021463|NCT03671174|Sensory System Agents|sensory system agents|mesh-ancestor
25021464|NCT03671174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25021465|NCT03671174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25021466|NCT03671174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25021467|NCT03671174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25021468|NCT03671174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021494|NCT03671070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25021495|NCT03671070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25021496|NCT03671070|Autonomic Agents|autonomic agents|mesh-ancestor
25021497|NCT03671070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25021498|NCT03671070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25021499|NCT03671070|Respiratory System Agents|respiratory system agents|mesh-ancestor
25021500|NCT03671070|Mydriatics|mydriatics|mesh-ancestor
25021501|NCT03671070|Sympathomimetics|sympathomimetics|mesh-ancestor
25021502|NCT03671070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25021503|NCT03671057|Midazolam|midazolam|mesh-list
25021504|NCT03671057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25021505|NCT03671057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25021506|NCT03671057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25021507|NCT03671057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021508|NCT03671057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25651737|NCT01519167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25651738|NCT01519167|Anesthetics, General|anesthetics, general|mesh-ancestor
25651739|NCT01519167|Anesthetics|anesthetics|mesh-ancestor
25651740|NCT01519167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25651741|NCT01519167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25651742|NCT01519167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25651743|NCT01519167|GABA Modulators|gaba modulators|mesh-ancestor
25651744|NCT01519167|GABA Agents|gaba agents|mesh-ancestor
25651745|NCT01519245|Tranexamic Acid|tranexamic acid|mesh-list
25651746|NCT01519245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25651747|NCT01519245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25021651|NCT03669484|Analgesics|analgesics|mesh-ancestor
25021652|NCT03669484|Sensory System Agents|sensory system agents|mesh-ancestor
25021653|NCT03669484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24756249|NCT01731795|BB 1101|bb 1101|mesh-list
25021654|NCT03669484|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25021655|NCT03669484|Anticonvulsants|anticonvulsants|mesh-ancestor
25021656|NCT03669484|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25021657|NCT03669484|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25021658|NCT03669484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25021659|NCT03669445|Dexamethasone|dexamethasone|mesh-list
25021660|NCT03669445|Lenalidomide|lenalidomide|mesh-list
25021661|NCT03669445|Daratumumab|daratumumab|mesh-list
25021662|NCT03669445|Ixazomib|ixazomib|mesh-list
25021663|NCT03669445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25651748|NCT01519245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651749|NCT01519245|Hemostatics|hemostatics|mesh-ancestor
25651750|NCT01519245|Coagulants|coagulants|mesh-ancestor
25651751|NCT01519271|Rivastigmine|rivastigmine|mesh-list
25651752|NCT01519271|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25651753|NCT01519271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651754|NCT01519271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651755|NCT01519271|Cholinergic Agents|cholinergic agents|mesh-ancestor
25691072|NCT01982240|Plecanatide|plecanatide|mesh-list
25691073|NCT01982240|Cathartics|cathartics|mesh-ancestor
25021832|NCT03667937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24978428|NCT04423237|Deferasirox|deferasirox|mesh-list
24978429|NCT04423237|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24978430|NCT04423237|Chelating Agents|chelating agents|mesh-ancestor
24978431|NCT04423237|Sequestering Agents|sequestering agents|mesh-ancestor
24978432|NCT04423237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021842|NCT03667677|Amlodipine|amlodipine|mesh-list
25021843|NCT03667677|Tandospirone|tandospirone|mesh-list
25021844|NCT03667677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25021845|NCT03667677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25021846|NCT03667677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24711912|NCT01517568|Hormones|hormones|mesh-ancestor
24908501|NCT04319900|Favipiravir|favipiravir|mesh-list
25021918|NCT03667131|Enalaprilat|enalaprilat|mesh-list
25021919|NCT03667131|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25021920|NCT03667131|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25021921|NCT03667131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021922|NCT03667131|Protease Inhibitors|protease inhibitors|mesh-ancestor
25021923|NCT03667131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25021924|NCT03667066|Clopidogrel|clopidogrel|mesh-list
25021925|NCT03667066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25021926|NCT03667066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24712413|NCT01520389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712446|NCT01520467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24712447|NCT01520467|Hormone Antagonists|hormone antagonists|mesh-ancestor
25022136|NCT03665740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022063|NCT03666299|Anesthetics, Local|anesthetics, local|mesh-ancestor
25022064|NCT03666299|Anesthetics|anesthetics|mesh-ancestor
24908727|NCT04316936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908728|NCT04316936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24908729|NCT04316936|Glucocorticoids|glucocorticoids|mesh-ancestor
25022239|NCT03664869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25651756|NCT01519271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25651757|NCT01519271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651758|NCT01519271|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25651759|NCT01519271|Protective Agents|protective agents|mesh-ancestor
25651760|NCT01519284|Levodopa|levodopa|mesh-list
25651761|NCT01519284|Carbidopa|carbidopa|mesh-list
25651762|NCT01519284|Opicapone|opicapone|mesh-list
25651763|NCT01519284|Entacapone|entacapone|mesh-list
25651764|NCT01519284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25651765|NCT01519284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24908896|NCT04315454|Levobupivacaine|levobupivacaine|mesh-list
25022359|NCT03664037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25022360|NCT03663751|Decitabine|decitabine|mesh-list
24463619|NCT00361621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24499293|NCT00518635|Insulin|insulin|mesh-list
25022366|NCT03663673|Decanoic acid|decanoic acid|mesh-list
25022367|NCT03663673|Antifungal Agents|antifungal agents|mesh-ancestor
25022368|NCT03663673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25022383|NCT03663465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25022384|NCT03663465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022385|NCT03663465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25022387|NCT03663114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25022388|NCT03663114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25022389|NCT03663114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984631|NCT04296942|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24713406|NCT01526005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24713407|NCT01526005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713408|NCT01526070|Aflibercept|aflibercept|mesh-list
24713409|NCT01526070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24713410|NCT01526070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24713411|NCT01526070|Growth Substances|growth substances|mesh-ancestor
25691077|NCT01982240|Enzyme Activators|enzyme activators|mesh-ancestor
25691078|NCT01982240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691079|NCT01982331|Vaccines|vaccines|mesh-list
25691080|NCT01982331|Immunologic Factors|immunologic factors|mesh-ancestor
25691081|NCT01982331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691082|NCT01982435|Ranibizumab|ranibizumab|mesh-list
25691083|NCT01982435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25691084|NCT01982435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25651766|NCT01519284|Dopamine Agents|dopamine agents|mesh-ancestor
25651767|NCT01519284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25651768|NCT01519284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651769|NCT01519284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651770|NCT01519284|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25651771|NCT01519284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651772|NCT01519284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25651773|NCT01519323|Vemurafenib|vemurafenib|mesh-list
25651774|NCT01519323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25651775|NCT01519323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25651776|NCT01519323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651777|NCT01519323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827066|NCT02137265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24827067|NCT02137265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827069|NCT02137265|Fertility Agents|fertility agents|mesh-ancestor
24827070|NCT02137265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25691085|NCT01982435|Growth Substances|growth substances|mesh-ancestor
24713440|NCT01526122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25022392|NCT03662984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25651778|NCT01519518|Heparin|heparin|mesh-list
25651779|NCT01519518|Calcium heparin|calcium heparin|mesh-list
25651780|NCT01519518|Bivalirudin|bivalirudin|mesh-list
25651781|NCT01519518|Anticoagulants|anticoagulants|mesh-ancestor
25651782|NCT01519518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25651783|NCT01519518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25651784|NCT01519518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651785|NCT01519518|Antithrombins|antithrombins|mesh-ancestor
25651786|NCT01519518|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25651787|NCT01519518|Protease Inhibitors|protease inhibitors|mesh-ancestor
25651788|NCT01519518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691093|NCT01982539|Sensory System Agents|sensory system agents|mesh-ancestor
24908941|NCT04314739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908942|NCT04314739|Protective Agents|protective agents|mesh-ancestor
24908943|NCT04314739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022427|NCT03662711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25022428|NCT03662711|Respiratory System Agents|respiratory system agents|mesh-ancestor
25022429|NCT03662620|Amlodipine|amlodipine|mesh-list
25022430|NCT03662620|Telmisartan|telmisartan|mesh-list
25022431|NCT03662620|Chlorthalidone|chlorthalidone|mesh-list
25022449|NCT03662568|Protease Inhibitors|protease inhibitors|mesh-ancestor
25022450|NCT03662568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978970|NCT02031250|Carboplatin|carboplatin|mesh-list
25022451|NCT03662568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463846|NCT00362531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24463847|NCT00362531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463848|NCT00362531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24463849|NCT00362531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463850|NCT00362531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24463851|NCT00362531|Immunologic Factors|immunologic factors|mesh-ancestor
24463852|NCT00362531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25022452|NCT03662568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25651789|NCT01519635|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25651790|NCT01519635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25651791|NCT01519635|Diuretics|diuretics|mesh-ancestor
25651792|NCT01519635|Natriuretic Agents|natriuretic agents|mesh-ancestor
25651793|NCT01519635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651794|NCT01519635|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25651795|NCT01519635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25651796|NCT01519635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064634|NCT03458208|Metformin|metformin|mesh-list
25064635|NCT03458208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25064636|NCT03458208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064637|NCT03458143|Ketamine|ketamine|mesh-list
25064638|NCT03458143|Remifentanil|remifentanil|mesh-list
25064639|NCT03458143|Analgesics|analgesics|mesh-ancestor
25022457|NCT03662568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25022458|NCT03662568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25022459|NCT03662568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25022464|NCT03662516|Estradiol|estradiol|mesh-list
25651797|NCT01519674|Insulin|insulin|mesh-list
25456506|NCT02995694|Estradiol|estradiol|mesh-list
25456507|NCT02995694|Estrogens|estrogens|mesh-ancestor
25456508|NCT02995694|Hormones|hormones|mesh-ancestor
25456509|NCT02995694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25456510|NCT02995694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313523|NCT05035147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25313524|NCT05035147|Tubulin Modulators|tubulin modulators|mesh-ancestor
25313525|NCT05035147|Antimitotic Agents|antimitotic agents|mesh-ancestor
25313526|NCT05035147|Mitosis Modulators|mitosis modulators|mesh-ancestor
25313527|NCT05035147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313528|NCT05035147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24909126|NCT04312347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24909127|NCT04312243|Nitric Oxide|nitric oxide|mesh-list
24714215|NCT01529320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24714216|NCT01529320|Glucocorticoids|glucocorticoids|mesh-ancestor
24714218|NCT01529320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24714219|NCT01529320|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24463962|NCT00362869|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24463963|NCT00362869|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24463967|NCT00362895|Dexamethasone acetate|dexamethasone acetate|mesh-list
24463969|NCT00362895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24463970|NCT00362895|Antiemetics|antiemetics|mesh-ancestor
24463971|NCT00362895|Autonomic Agents|autonomic agents|mesh-ancestor
24463973|NCT00362895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463974|NCT00362895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24420381|NCT00215839|Antimetabolites|antimetabolites|mesh-ancestor
24420382|NCT00215839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420383|NCT00215839|Antiviral Agents|antiviral agents|mesh-ancestor
25121269|NCT03103555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121270|NCT03103555|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25121271|NCT03103412|Tofacitinib|tofacitinib|mesh-list
24420384|NCT00215839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24420385|NCT00215865|Ribavirin|ribavirin|mesh-list
24909226|NCT04311697|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24909227|NCT04311697|Adrenergic Agents|adrenergic agents|mesh-ancestor
24464089|NCT00363337|Antidepressive Agents|antidepressive agents|mesh-ancestor
24464090|NCT00363337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24464091|NCT00363337|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24464092|NCT00363337|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24587237|NCT00893854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24587238|NCT00893880|Nitric Oxide|nitric oxide|mesh-list
24587239|NCT00893880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24587240|NCT00893880|Autonomic Agents|autonomic agents|mesh-ancestor
24587254|NCT00893906|Immunologic Factors|immunologic factors|mesh-ancestor
24587255|NCT00893906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587256|NCT00893919|Mycophenolic Acid|mycophenolic acid|mesh-list
24587257|NCT00893919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24587269|NCT00893958|Antitubercular Agents|antitubercular agents|mesh-ancestor
24587270|NCT00893958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24984747|NCT04120766|Micronutrients|micronutrients|mesh-ancestor
24984748|NCT04120766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464093|NCT00363337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24464094|NCT00363337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464111|NCT00363350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24587271|NCT00893958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25691120|NCT01982682|Mycophenolic Acid|mycophenolic acid|mesh-list
25691121|NCT01982682|Cyclophosphamide|cyclophosphamide|mesh-list
25691122|NCT01982682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25691123|NCT01982682|Immunologic Factors|immunologic factors|mesh-ancestor
25691124|NCT01982682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691125|NCT01982682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25691126|NCT01982682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24420386|NCT00215865|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24420402|NCT00215956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420403|NCT00215956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420404|NCT00215982|Capecitabine|capecitabine|mesh-list
24420405|NCT00215982|Oxaliplatin|oxaliplatin|mesh-list
24420406|NCT00215982|Irinotecan|irinotecan|mesh-list
24420407|NCT00215982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24420408|NCT00215982|Antimetabolites|antimetabolites|mesh-ancestor
24587272|NCT00893958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587273|NCT00893958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587274|NCT00894010|Carbamazepine|carbamazepine|mesh-list
24587275|NCT00894010|Levetiracetam|levetiracetam|mesh-list
24587276|NCT00894010|Anticonvulsants|anticonvulsants|mesh-ancestor
24587277|NCT00894010|Nootropic Agents|nootropic agents|mesh-ancestor
24587278|NCT00894010|Antimanic Agents|antimanic agents|mesh-ancestor
24587279|NCT00894010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24587280|NCT00894010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24587281|NCT00894010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587282|NCT00894010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24587283|NCT00894010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24587284|NCT00894010|Analgesics|analgesics|mesh-ancestor
24587285|NCT00894010|Sensory System Agents|sensory system agents|mesh-ancestor
24587286|NCT00894010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25022478|NCT03662425|Oxytocin|oxytocin|mesh-list
25022479|NCT03662425|Oxytocics|oxytocics|mesh-ancestor
25022480|NCT03662425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24452692|NCT05457829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24452693|NCT05457829|Alkylating Agents|alkylating agents|mesh-ancestor
24452694|NCT05457751|Rocuronium|rocuronium|mesh-list
24464287|NCT00364026|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25022483|NCT03662412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25121282|NCT03103568|Sympatholytics|sympatholytics|mesh-ancestor
25121283|NCT03103568|Autonomic Agents|autonomic agents|mesh-ancestor
25121284|NCT03103568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25121289|NCT03103568|Adrenergic Agents|adrenergic agents|mesh-ancestor
24420409|NCT00215982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420410|NCT00215982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420412|NCT00215982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24420489|NCT00216164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420525|NCT00216190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24420526|NCT00216190|Anesthetics, General|anesthetics, general|mesh-ancestor
24420527|NCT00216190|Anesthetics|anesthetics|mesh-ancestor
24909399|NCT04309708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24909400|NCT04309708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909427|NCT04308954|GABA Agents|gaba agents|mesh-ancestor
24869436|NCT03769376|Salvin|salvin|mesh-list
24869473|NCT03423355|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24909428|NCT04308954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24909430|NCT04309058|Vitamin D|vitamin d|mesh-list
25022563|NCT03661775|Analgesics|analgesics|mesh-ancestor
24464288|NCT00364026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452741|NCT05455944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464347|NCT00364429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24464348|NCT00364429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24464349|NCT00364429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24464350|NCT00364429|GABA Modulators|gaba modulators|mesh-ancestor
24464351|NCT00364429|GABA Agents|gaba agents|mesh-ancestor
24464373|NCT00364481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24464374|NCT00364481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25022566|NCT03661775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022567|NCT03661775|Anesthetics|anesthetics|mesh-ancestor
25022568|NCT03661775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24420528|NCT00216190|GABA Modulators|gaba modulators|mesh-ancestor
24420529|NCT00216190|GABA Agents|gaba agents|mesh-ancestor
24420530|NCT00216216|Pemetrexed|pemetrexed|mesh-list
24420531|NCT00216216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420532|NCT00216216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774711|NCT01847417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24795428|NCT02758847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25829448|NCT00006211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24420563|NCT00216346|Amphotericin B|amphotericin b|mesh-list
24905386|NCT04347733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24420564|NCT00216346|Paromomycin|paromomycin|mesh-list
24420565|NCT00216346|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24420619|NCT00216450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691135|NCT01982682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24909579|NCT04307290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909580|NCT04307147|Capecitabine|capecitabine|mesh-list
24909581|NCT04307147|Vinorelbine|vinorelbine|mesh-list
25691136|NCT01982682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691137|NCT01982695|Losartan|losartan|mesh-list
24979208|NCT05140694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25161889|NCT02240407|Antipruritics|antipruritics|mesh-ancestor
25041655|NCT01604889|Ipilimumab|ipilimumab|mesh-list
24420620|NCT00216450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420622|NCT00216463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24420623|NCT00216463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24420624|NCT00216463|Antimetabolites|antimetabolites|mesh-ancestor
25121315|NCT03103646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25121316|NCT03103204|Chlorhexidine|chlorhexidine|mesh-list
24420625|NCT00216463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420626|NCT00216463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25022637|NCT03661463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25022638|NCT03661463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25022639|NCT03661463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022643|NCT03661463|Antipyretics|antipyretics|mesh-ancestor
25022646|NCT03661385|Autonomic Agents|autonomic agents|mesh-ancestor
25022647|NCT03661385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25022648|NCT03661385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795429|NCT02758847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795430|NCT02758847|Tubulin Modulators|tubulin modulators|mesh-ancestor
24795431|NCT02758847|Antimitotic Agents|antimitotic agents|mesh-ancestor
25561483|NCT00706381|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25561484|NCT00706381|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25561485|NCT00706381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25561486|NCT00706433|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24818962|NCT02092363|Paclitaxel|paclitaxel|mesh-list
25561487|NCT00706433|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25561488|NCT00706433|Dermatologic Agents|dermatologic agents|mesh-ancestor
24795432|NCT02758847|Mitosis Modulators|mitosis modulators|mesh-ancestor
25561489|NCT00706446|Fluticasone|fluticasone|mesh-list
25561490|NCT00706446|Xhance|xhance|mesh-list
25561491|NCT00706446|Budesonide|budesonide|mesh-list
25561492|NCT00706446|Bromides|bromides|mesh-list
25561493|NCT00706446|Formoterol Fumarate|formoterol fumarate|mesh-list
25561494|NCT00706446|Tiotropium Bromide|tiotropium bromide|mesh-list
25561495|NCT00706446|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25561496|NCT00706446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25561497|NCT00706446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25561498|NCT00706446|Autonomic Agents|autonomic agents|mesh-ancestor
25561499|NCT00706446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25561500|NCT00706446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561501|NCT00706446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25561502|NCT00706446|Respiratory System Agents|respiratory system agents|mesh-ancestor
25561503|NCT00706446|Dermatologic Agents|dermatologic agents|mesh-ancestor
25561504|NCT00706446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25561505|NCT00706446|Glucocorticoids|glucocorticoids|mesh-ancestor
25561506|NCT00706446|Hormones|hormones|mesh-ancestor
25561507|NCT00706446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25561508|NCT00706446|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25561509|NCT00706446|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25561510|NCT00706446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25561511|NCT00706446|Adrenergic Agents|adrenergic agents|mesh-ancestor
25561512|NCT00706446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25561513|NCT00706446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561514|NCT00706446|Parasympatholytics|parasympatholytics|mesh-ancestor
25561515|NCT00706446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25561516|NCT00706446|Cholinergic Agents|cholinergic agents|mesh-ancestor
25561517|NCT00706446|Anticonvulsants|anticonvulsants|mesh-ancestor
25561518|NCT00706550|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25561519|NCT00706550|Immunologic Factors|immunologic factors|mesh-ancestor
25561520|NCT00706550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561521|NCT00706589|Aripiprazole|aripiprazole|mesh-list
25561522|NCT00706589|Antidepressive Agents|antidepressive agents|mesh-ancestor
25561523|NCT00706589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25691144|NCT01982695|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25561524|NCT00706589|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25561525|NCT00706589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25561526|NCT00706589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25561527|NCT00706589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561528|NCT00706589|Dopamine Agonists|dopamine agonists|mesh-ancestor
25561529|NCT00706589|Dopamine Agents|dopamine agents|mesh-ancestor
25561530|NCT00706589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25561531|NCT00706589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561532|NCT00706589|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25561533|NCT00706589|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25561534|NCT00706589|Serotonin Agents|serotonin agents|mesh-ancestor
25561535|NCT00706589|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25561536|NCT00706589|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25561537|NCT00706589|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25561538|NCT00706589|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24909990|NCT04303598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909991|NCT04303598|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25022992|NCT03658330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25561539|NCT00706628|Nintedanib|nintedanib|mesh-list
25561540|NCT00706628|Afatinib|afatinib|mesh-list
25561541|NCT00706628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25561542|NCT00706628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25561543|NCT00706628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25561544|NCT00706628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561545|NCT00706641|Dasatinib|dasatinib|mesh-list
25561546|NCT00706641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587395|NCT00894673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587396|NCT00894712|Sulforaphane|sulforaphane|mesh-list
24587397|NCT00894712|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24587398|NCT00894712|Protective Agents|protective agents|mesh-ancestor
25023034|NCT03658057|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25561547|NCT00706641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25561548|NCT00706641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25561549|NCT00706641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561550|NCT00706654|Aripiprazole|aripiprazole|mesh-list
25561551|NCT00706654|Antidepressive Agents|antidepressive agents|mesh-ancestor
25561552|NCT00706654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25561553|NCT00706654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25561554|NCT00706654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24870350|NCT01471444|Thymoglobulin|thymoglobulin|mesh-list
24446766|NCT00305825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24870395|NCT05162456|Immunologic Factors|immunologic factors|mesh-ancestor
24870396|NCT05162456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910130|NCT04301882|Interferons|interferons|mesh-list
24468166|NCT00380263|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
24468167|NCT00380263|Growth Substances|growth substances|mesh-ancestor
24468230|NCT00380614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468231|NCT00380614|Antiviral Agents|antiviral agents|mesh-ancestor
24468323|NCT00381030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24468324|NCT00381030|Vasodilator Agents|vasodilator agents|mesh-ancestor
24468372|NCT00381199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468373|NCT00381199|Adrenergic Agents|adrenergic agents|mesh-ancestor
24468374|NCT00381199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25561555|NCT00706654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25561556|NCT00706654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561557|NCT00706654|Dopamine Agonists|dopamine agonists|mesh-ancestor
25561558|NCT00706654|Dopamine Agents|dopamine agents|mesh-ancestor
25561559|NCT00706654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25456511|NCT02698865|Hyaluronic Acid|hyaluronic acid|mesh-list
25456512|NCT02698865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25456513|NCT02698865|Immunologic Factors|immunologic factors|mesh-ancestor
25561560|NCT00706654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456514|NCT02698865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456515|NCT02698865|Viscosupplements|viscosupplements|mesh-ancestor
25456516|NCT02698865|Protective Agents|protective agents|mesh-ancestor
25064755|NCT03457025|Antiviral Agents|antiviral agents|mesh-list
25456517|NCT02257567|Rituximab|rituximab|mesh-list
25561561|NCT00706654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25561562|NCT00706654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25456581|NCT04512118|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25456582|NCT04512118|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25456583|NCT04512118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456584|NCT04497519|Hydroxychloroquine|hydroxychloroquine|mesh-list
25456585|NCT04497519|Antimalarials|antimalarials|mesh-ancestor
25456586|NCT04497519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25456587|NCT04497519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25456588|NCT04497519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456589|NCT04497519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24827201|NCT02137759|Belinostat|belinostat|mesh-list
24910411|NCT04298372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023204|NCT03656666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25023205|NCT03656666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25023206|NCT03656666|Analgesics|analgesics|mesh-ancestor
25023207|NCT03656666|Sensory System Agents|sensory system agents|mesh-ancestor
25456590|NCT04497519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456591|NCT04497519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25313663|NCT05032118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25313664|NCT05032118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313665|NCT05032118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25313666|NCT05032118|Anesthetics, General|anesthetics, general|mesh-ancestor
24978754|NCT02995252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24469666|NCT00386672|Vitamins|vitamins|mesh-list
24469667|NCT00386672|Calcium|calcium|mesh-list
24469670|NCT00386672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24469671|NCT00386672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24469672|NCT00386685|Trastuzumab|trastuzumab|mesh-list
24469673|NCT00386685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24469674|NCT00386685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469675|NCT00386750|Lumefantrine|lumefantrine|mesh-list
24469676|NCT00386750|Artemether|artemether|mesh-list
24469722|NCT00386841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469728|NCT00386841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24446820|NCT00306137|Aprotinin|aprotinin|mesh-list
24446821|NCT00306137|Hemostatics|hemostatics|mesh-ancestor
24446822|NCT00306137|Coagulants|coagulants|mesh-ancestor
25023243|NCT03656588|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25023244|NCT03656588|Cadexomer iodine|cadexomer iodine|mesh-list
25023245|NCT03656588|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25023246|NCT03656588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25023247|NCT03656588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25023248|NCT03656588|Disinfectants|disinfectants|mesh-ancestor
25023249|NCT03656588|Dermatologic Agents|dermatologic agents|mesh-ancestor
25023250|NCT03656588|Trace Elements|trace elements|mesh-ancestor
25023251|NCT03656588|Micronutrients|micronutrients|mesh-ancestor
25023252|NCT03656588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469758|NCT00386997|Antifungal Agents|antifungal agents|mesh-ancestor
24469845|NCT00387556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24978756|NCT02995252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978757|NCT02995252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24978758|NCT02995252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24978759|NCT02995252|Hematinics|hematinics|mesh-ancestor
24978762|NCT02991144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24978763|NCT02991144|Glucocorticoids|glucocorticoids|mesh-ancestor
25822666|NCT00004581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420627|NCT00216489|Rabeprazole|rabeprazole|mesh-list
24420628|NCT00216489|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25121325|NCT03103399|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-list
25121326|NCT03103399|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24420629|NCT00216489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24420630|NCT00216489|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24420631|NCT00216489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420632|NCT00216489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420633|NCT00216502|Galantamine|galantamine|mesh-list
24420634|NCT00216502|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24420635|NCT00216502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420637|NCT00216502|Cholinergic Agents|cholinergic agents|mesh-ancestor
24420643|NCT00216502|Nootropic Agents|nootropic agents|mesh-ancestor
24420644|NCT00216515|Galantamine|galantamine|mesh-list
24420645|NCT00216515|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24420646|NCT00216515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420647|NCT00216515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420648|NCT00216515|Cholinergic Agents|cholinergic agents|mesh-ancestor
24978764|NCT02991144|Hormones|hormones|mesh-ancestor
24978765|NCT02991144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25121350|NCT03103152|Aspirin|aspirin|mesh-list
24978766|NCT02991144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978767|NCT02991144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24978768|NCT02991144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978769|NCT02918500|Nicotine|nicotine|mesh-list
24978770|NCT02918500|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24978771|NCT02918500|Autonomic Agents|autonomic agents|mesh-ancestor
24978772|NCT02918500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24978773|NCT02918500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978774|NCT02918500|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24978775|NCT02918500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24470200|NCT00389129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24470201|NCT00389129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470202|NCT00389129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24470221|NCT00389272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24470222|NCT00389272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470223|NCT00389272|Antipyretics|antipyretics|mesh-ancestor
24470224|NCT00389272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24470225|NCT00389272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24470226|NCT00389272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24470227|NCT00389272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24470228|NCT00389272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24470229|NCT00389272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587533|NCT00895544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023431|NCT03654703|Alkylating Agents|alkylating agents|mesh-ancestor
25023432|NCT03654703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023434|NCT03654703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25023436|NCT03654612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023437|NCT03654612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24470279|NCT00389428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470280|NCT00389428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24470285|NCT00389506|Fludarabine|fludarabine|mesh-list
24978776|NCT02918500|Cholinergic Agents|cholinergic agents|mesh-ancestor
24978777|NCT02918500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25105850|NCT04850495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24420733|NCT00216658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25561563|NCT00706654|Serotonin Agents|serotonin agents|mesh-ancestor
25561564|NCT00706654|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25561565|NCT00706654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25561566|NCT00706654|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25561567|NCT00706654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25561568|NCT00706706|Sunitinib|sunitinib|mesh-list
25561569|NCT00706706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910580|NCT04296370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24910581|NCT04296370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910582|NCT04296383|Azithromycin|azithromycin|mesh-list
24910583|NCT04296383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24910584|NCT04296383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24873514|NCT05181124|Meloxicam|meloxicam|mesh-list
24733567|NCT01647165|Dexamethasone|dexamethasone|mesh-list
24470757|NCT00391638|Tenofovir|tenofovir|mesh-list
25561570|NCT00706706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25561571|NCT00706706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25561572|NCT00706706|Growth Substances|growth substances|mesh-ancestor
25561573|NCT00706706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561574|NCT00706706|Growth Inhibitors|growth inhibitors|mesh-ancestor
25561575|NCT00706706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25561576|NCT00706706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25561577|NCT00706706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456607|NCT04477382|Tretinoin|tretinoin|mesh-list
25456608|NCT04477382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456609|NCT04477382|Keratolytic Agents|keratolytic agents|mesh-ancestor
25456610|NCT04477382|Dermatologic Agents|dermatologic agents|mesh-ancestor
25313729|NCT05030545|Natriuretic Agents|natriuretic agents|mesh-ancestor
25313730|NCT05030545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25313731|NCT05030545|Hormones|hormones|mesh-ancestor
25313732|NCT05030493|Bevacizumab|bevacizumab|mesh-list
25313733|NCT05030493|Panitumumab|panitumumab|mesh-list
25313734|NCT05030493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24420734|NCT00216658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24420735|NCT00216658|Anesthetics, General|anesthetics, general|mesh-ancestor
24420737|NCT00216684|Fentanyl|fentanyl|mesh-list
24420738|NCT00216684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24420739|NCT00216684|Narcotics|narcotics|mesh-ancestor
24420740|NCT00216684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24420741|NCT00216684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420742|NCT00216684|Analgesics|analgesics|mesh-ancestor
24420743|NCT00216684|Sensory System Agents|sensory system agents|mesh-ancestor
24978778|NCT02918500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978779|NCT02903381|Dexamethasone|dexamethasone|mesh-list
24978780|NCT02903381|Nivolumab|nivolumab|mesh-list
24978781|NCT02903381|Lenalidomide|lenalidomide|mesh-list
25161890|NCT02240407|Dermatologic Agents|dermatologic agents|mesh-ancestor
24420782|NCT00216775|Antimetabolites|antimetabolites|mesh-ancestor
25822667|NCT00004581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25064888|NCT03455426|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25064889|NCT03455426|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25064890|NCT03455426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25064891|NCT03455426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822668|NCT00004581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24420801|NCT00216827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24420802|NCT00216827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420803|NCT00216827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24420804|NCT00216827|Respiratory System Agents|respiratory system agents|mesh-ancestor
24420805|NCT00216827|Dermatologic Agents|dermatologic agents|mesh-ancestor
24420807|NCT00216840|Betamethasone Valerate|betamethasone valerate|mesh-list
25023609|NCT03652870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25023610|NCT03652870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25023611|NCT03652870|Parasympatholytics|parasympatholytics|mesh-ancestor
25023612|NCT03652870|Autonomic Agents|autonomic agents|mesh-ancestor
25023639|NCT03652753|Respiratory System Agents|respiratory system agents|mesh-ancestor
25023640|NCT03652753|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25023641|NCT03652753|Antioxidants|antioxidants|mesh-ancestor
25023642|NCT03652753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023643|NCT03652753|Protective Agents|protective agents|mesh-ancestor
25023644|NCT03652753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023645|NCT03652753|Antidotes|antidotes|mesh-ancestor
25023646|NCT03652714|Anesthetics|anesthetics|mesh-list
25023647|NCT03652714|Anesthetics, Local|anesthetics, local|mesh-list
25023648|NCT03652714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25023649|NCT03652714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023650|NCT03652714|Sensory System Agents|sensory system agents|mesh-ancestor
25023651|NCT03652714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023652|NCT03652571|Nortriptyline|nortriptyline|mesh-list
25106956|NCT03143491|Antimitotic Agents|antimitotic agents|mesh-ancestor
25023654|NCT03652571|Antidepressive Agents|antidepressive agents|mesh-ancestor
25023656|NCT03652571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25023657|NCT03652571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25023658|NCT03652571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24588093|NCT00900887|Ketorolac|ketorolac|mesh-list
25023696|NCT03652467|Chelating Agents|chelating agents|mesh-ancestor
25023697|NCT03652467|Sequestering Agents|sequestering agents|mesh-ancestor
25023714|NCT03652428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25023715|NCT03652428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25023716|NCT03652428|Immunologic Factors|immunologic factors|mesh-ancestor
25023717|NCT03652428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023718|NCT03652415|Lubricant Eye Drops|lubricant eye drops|mesh-list
25023719|NCT03652415|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24420808|NCT00216840|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24420809|NCT00216840|Betamethasone benzoate|betamethasone benzoate|mesh-list
24420810|NCT00216840|Calcipotriene|calcipotriene|mesh-list
25561578|NCT00706719|Enclomiphene|enclomiphene|mesh-list
25561579|NCT00706719|Clomiphene|clomiphene|mesh-list
25561580|NCT00706719|Zuclomiphene|zuclomiphene|mesh-list
25561581|NCT00706719|Testosterone|testosterone|mesh-list
25561582|NCT00706719|Androgens|androgens|mesh-ancestor
25561583|NCT00706719|Hormones|hormones|mesh-ancestor
24420811|NCT00216840|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24420812|NCT00216840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25561584|NCT00706719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25023720|NCT03652415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25023721|NCT03652376|Benralizumab|benralizumab|mesh-list
25023722|NCT03652376|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25023723|NCT03652376|Respiratory System Agents|respiratory system agents|mesh-ancestor
24471609|NCT00396214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24471610|NCT00396214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561585|NCT00706719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561586|NCT00706719|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25561587|NCT00706719|Hormone Antagonists|hormone antagonists|mesh-ancestor
25561588|NCT00706719|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25561589|NCT00706719|Fertility Agents|fertility agents|mesh-ancestor
25561590|NCT00706719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25561591|NCT00706719|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25561592|NCT00706719|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25561593|NCT00706810|Hydroxyurea|hydroxyurea|mesh-list
25561594|NCT00706810|Verapamil|verapamil|mesh-list
25561595|NCT00706810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25561596|NCT00706810|Antisickling Agents|antisickling agents|mesh-ancestor
25561597|NCT00706810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485343|NCT00452608|Antimetabolites|antimetabolites|mesh-ancestor
24485344|NCT00452608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485345|NCT00452608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25064944|NCT03455075|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25561598|NCT00706810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561599|NCT00706810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25561600|NCT00706810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25561601|NCT00706810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25822669|NCT00004581|Antiviral Agents|antiviral agents|mesh-ancestor
25822670|NCT00004581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25822671|NCT00004581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25456611|NCT04455776|Propofol|propofol|mesh-list
25106959|NCT03143244|Ketorolac|ketorolac|mesh-list
24471896|NCT00397384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24471897|NCT00397384|Antibodies|antibodies|mesh-list
24471898|NCT00397384|Immunoglobulins|immunoglobulins|mesh-list
24471899|NCT00397384|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24471900|NCT00397384|Immunologic Factors|immunologic factors|mesh-ancestor
24471901|NCT00397384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471902|NCT00397384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24471903|NCT00397384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24471904|NCT00397384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24471926|NCT00397501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24471927|NCT00397501|Antimetabolites|antimetabolites|mesh-ancestor
24472020|NCT00397761|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24472021|NCT00397761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24472022|NCT00397761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472023|NCT00397761|Tubulin Modulators|tubulin modulators|mesh-ancestor
24472024|NCT00397761|Antimitotic Agents|antimitotic agents|mesh-ancestor
24472025|NCT00397761|Mitosis Modulators|mitosis modulators|mesh-ancestor
24472026|NCT00397761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472028|NCT00397761|Antimetabolites|antimetabolites|mesh-ancestor
24827349|NCT02138409|Fentanyl|fentanyl|mesh-list
25023872|NCT03650738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023873|NCT03650738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25023874|NCT03650738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25023875|NCT03650608|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25023876|NCT03650608|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25023877|NCT03650582|Glucagon|glucagon|mesh-list
25023879|NCT03650582|Hormones|hormones|mesh-ancestor
24472362|NCT00399022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472363|NCT00399022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24472364|NCT00399022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472365|NCT00399022|Analgesics|analgesics|mesh-ancestor
24472366|NCT00399022|Sensory System Agents|sensory system agents|mesh-ancestor
25024107|NCT03648697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25024108|NCT03648697|Alkylating Agents|alkylating agents|mesh-ancestor
25024109|NCT03648697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024110|NCT03648697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25024111|NCT03648697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25024113|NCT03648684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25024114|NCT03648684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024115|NCT03648684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24472557|NCT00399633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472558|NCT00399659|Tegaserod|tegaserod|mesh-list
24472559|NCT00399659|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24472560|NCT00399659|Serotonin Agents|serotonin agents|mesh-ancestor
24980980|NCT04648969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24980981|NCT04648969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980982|NCT04641351|Triamcinolone|triamcinolone|mesh-list
24980983|NCT04641351|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25456612|NCT04455776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25456613|NCT04455776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25456614|NCT04455776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456615|NCT04455776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25456616|NCT04455776|Anesthetics, General|anesthetics, general|mesh-ancestor
25456617|NCT04455776|Anesthetics|anesthetics|mesh-ancestor
25313804|NCT05029063|Anticoagulants|anticoagulants|mesh-ancestor
25313805|NCT05028907|Tocopherols|tocopherols|mesh-list
25313806|NCT05028907|Vitamin E|vitamin e|mesh-list
24472916|NCT00401128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25313807|NCT05028907|alpha-Tocopherol|alpha-tocopherol|mesh-list
25313808|NCT05028907|Chloramphenicol|chloramphenicol|mesh-list
25313809|NCT05028907|Dexamethasone|dexamethasone|mesh-list
25313810|NCT05028907|Dexamethasone acetate|dexamethasone acetate|mesh-list
25313811|NCT05028907|Tetrahydrozoline|tetrahydrozoline|mesh-list
25313812|NCT05028907|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25313813|NCT05028907|Hyaluronic Acid|hyaluronic acid|mesh-list
25313814|NCT05028907|BB 1101|bb 1101|mesh-list
25313815|NCT05028907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24910836|NCT04293549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910837|NCT04293549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24910838|NCT04293419|Durvalumab|durvalumab|mesh-list
25313816|NCT05028907|Antiemetics|antiemetics|mesh-ancestor
25313817|NCT05028907|Autonomic Agents|autonomic agents|mesh-ancestor
25313818|NCT05028907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024583|NCT03644576|Immunologic Factors|immunologic factors|mesh-ancestor
25313819|NCT05028907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313820|NCT05028907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25313821|NCT05028907|Glucocorticoids|glucocorticoids|mesh-ancestor
25822672|NCT00004581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25313822|NCT05028907|Hormones|hormones|mesh-ancestor
24420896|NCT00217191|Analgesics|analgesics|mesh-ancestor
24420897|NCT00217191|Sensory System Agents|sensory system agents|mesh-ancestor
24420898|NCT00217191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24420899|NCT00217191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420900|NCT00217191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24420901|NCT00217191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24420902|NCT00217191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24420903|NCT00217191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420904|NCT00217191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420968|NCT00217386|Immunologic Factors|immunologic factors|mesh-ancestor
24420969|NCT00217412|Vorinostat|vorinostat|mesh-list
24420970|NCT00217412|Isotretinoin|isotretinoin|mesh-list
24420973|NCT00217412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420977|NCT00217451|Clindamycin palmitate|clindamycin palmitate|mesh-list
24420978|NCT00217451|Clindamycin phosphate|clindamycin phosphate|mesh-list
24420980|NCT00217451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24420981|NCT00217451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24978799|NCT02903381|Growth Substances|growth substances|mesh-ancestor
25024914|NCT03641209|Acetaminophen|acetaminophen|mesh-list
24978800|NCT02903381|Growth Inhibitors|growth inhibitors|mesh-ancestor
24978801|NCT02866279|Contraceptive Agents|contraceptive agents|mesh-list
24978802|NCT02866279|Etonogestrel|etonogestrel|mesh-list
24978803|NCT02866279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25561602|NCT00706810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25561603|NCT00706810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25561604|NCT00706810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561605|NCT00706810|Vasodilator Agents|vasodilator agents|mesh-ancestor
25561606|NCT00706836|Pregabalin|pregabalin|mesh-list
25561607|NCT00706836|Analgesics|analgesics|mesh-ancestor
25561608|NCT00706836|Sensory System Agents|sensory system agents|mesh-ancestor
25561609|NCT00706836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25561610|NCT00706836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561611|NCT00706836|Anticonvulsants|anticonvulsants|mesh-ancestor
25561612|NCT00706836|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25561613|NCT00706836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24911529|NCT04287205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561614|NCT00706836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561615|NCT00706836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25561616|NCT00706836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25561617|NCT00706836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25561618|NCT00706836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25561619|NCT00706836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25561620|NCT00706849|Mipomersen|mipomersen|mesh-list
25561621|NCT00706849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25561622|NCT00706849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25561623|NCT00706849|Antimetabolites|antimetabolites|mesh-ancestor
25561624|NCT00706849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561625|NCT00706849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25456618|NCT04446793|Bevacizumab|bevacizumab|mesh-list
25456619|NCT04446793|Onvansertib|onvansertib|mesh-list
25456620|NCT04446793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25456621|NCT04446793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456622|NCT04446793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25456623|NCT04446793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24519933|NCT04413279|Hormones|hormones|mesh-ancestor
24587716|NCT00896519|Hormones|hormones|mesh-ancestor
24587717|NCT00896519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25456624|NCT04446793|Growth Substances|growth substances|mesh-ancestor
25456625|NCT04446793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456626|NCT04446793|Growth Inhibitors|growth inhibitors|mesh-ancestor
25456627|NCT04446793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25456628|NCT04446793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25456629|NCT04446793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456630|NCT04445415|Antibodies|antibodies|mesh-list
25456631|NCT04445415|Immunologic Factors|immunologic factors|mesh-ancestor
25456632|NCT04445415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456633|NCT04433026|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25456634|NCT04433026|Natriuretic Agents|natriuretic agents|mesh-ancestor
25456635|NCT04433026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025591|NCT03635827|Xenon|xenon|mesh-list
25313878|NCT05028049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25313879|NCT05028049|Narcotics|narcotics|mesh-ancestor
25313880|NCT05028049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24978804|NCT02866279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978805|NCT02866279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24978806|NCT02866279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24978807|NCT02774265|Aspirin|aspirin|mesh-list
24978808|NCT02774265|Heparin|heparin|mesh-list
24978809|NCT02774265|Enoxaparin|enoxaparin|mesh-list
24978810|NCT02774265|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24421035|NCT00217516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421036|NCT00217516|Trace Elements|trace elements|mesh-ancestor
24421037|NCT00217516|Micronutrients|micronutrients|mesh-ancestor
24421038|NCT00217529|Carboplatin|carboplatin|mesh-list
24421039|NCT00217529|Docetaxel|docetaxel|mesh-list
24421040|NCT00217529|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24421041|NCT00217529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421042|NCT00217529|Tubulin Modulators|tubulin modulators|mesh-ancestor
24421043|NCT00217529|Antimitotic Agents|antimitotic agents|mesh-ancestor
24421044|NCT00217529|Mitosis Modulators|mitosis modulators|mesh-ancestor
24421045|NCT00217529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911855|NCT04283331|Sensory System Agents|sensory system agents|mesh-ancestor
24911856|NCT04283331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24421047|NCT00217529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25065239|NCT03451695|Morphine|morphine|mesh-list
25822673|NCT00004581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24421074|NCT00217555|Immunologic Factors|immunologic factors|mesh-ancestor
24421076|NCT00217555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24421087|NCT00217607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421088|NCT00217607|Tubulin Modulators|tubulin modulators|mesh-ancestor
24421089|NCT00217607|Antimitotic Agents|antimitotic agents|mesh-ancestor
24421090|NCT00217607|Mitosis Modulators|mitosis modulators|mesh-ancestor
24421091|NCT00217607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421093|NCT00217646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421094|NCT00217646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24421095|NCT00217646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421096|NCT00217646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421097|NCT00217659|Anastrozole|anastrozole|mesh-list
24421191|NCT00218101|Sensory System Agents|sensory system agents|mesh-ancestor
25561626|NCT00706914|Formoterol Fumarate|formoterol fumarate|mesh-list
24912147|NCT04279379|Decitabine|decitabine|mesh-list
25561627|NCT00706914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25561628|NCT00706914|Autonomic Agents|autonomic agents|mesh-ancestor
25561629|NCT00706914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25561630|NCT00706914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561631|NCT00706914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25561632|NCT00706914|Respiratory System Agents|respiratory system agents|mesh-ancestor
25561633|NCT00706914|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25561634|NCT00706914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25561635|NCT00706914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25561636|NCT00706914|Adrenergic Agents|adrenergic agents|mesh-ancestor
25561637|NCT00706914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25561638|NCT00706914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561639|NCT00706966|Dutasteride|dutasteride|mesh-list
25561640|NCT00706966|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25561641|NCT00706966|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25561642|NCT00706966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25561643|NCT00706966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561644|NCT00706966|Hormone Antagonists|hormone antagonists|mesh-ancestor
25651798|NCT01519674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25456636|NCT04407572|Vitamin D|vitamin d|mesh-list
25456637|NCT04407572|Vitamins|vitamins|mesh-list
25456638|NCT04407572|Vitamin B 12|vitamin b 12|mesh-list
25456639|NCT04407572|Hydroxocobalamin|hydroxocobalamin|mesh-list
25456640|NCT04407572|Micronutrients|micronutrients|mesh-ancestor
25456641|NCT04407572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456642|NCT04407572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25456643|NCT04407572|Vitamin B Complex|vitamin b complex|mesh-ancestor
25456644|NCT04407572|Hematinics|hematinics|mesh-ancestor
24421192|NCT00218101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24421193|NCT00218101|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24421195|NCT00218114|Anticonvulsants|anticonvulsants|mesh-ancestor
24421196|NCT00218114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421197|NCT00218114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421199|NCT00218114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24421200|NCT00218114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421201|NCT00218114|Antimanic Agents|antimanic agents|mesh-ancestor
24421202|NCT00218114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24421203|NCT00218114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24421204|NCT00218114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24421205|NCT00218127|Methadyl Acetate|methadyl acetate|mesh-list
24912438|NCT04275388|Interferons|interferons|mesh-list
25822674|NCT00004581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24421215|NCT00218140|Autonomic Agents|autonomic agents|mesh-ancestor
24421216|NCT00218140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24421217|NCT00218140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421218|NCT00218140|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24421219|NCT00218140|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24421220|NCT00218140|Cholinergic Agents|cholinergic agents|mesh-ancestor
24421221|NCT00218140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24421222|NCT00218140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421257|NCT00218205|Sensory System Agents|sensory system agents|mesh-ancestor
24421258|NCT00218205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24421259|NCT00218205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822675|NCT00004581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25121462|NCT03101800|Allopurinol|allopurinol|mesh-list
24421260|NCT00218205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24421261|NCT00218205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24421262|NCT00218205|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24421263|NCT00218205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24421264|NCT00218205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421265|NCT00218205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421266|NCT00218205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24421267|NCT00218205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421268|NCT00218205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24421269|NCT00218205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24421270|NCT00218205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24421271|NCT00218205|Alkylating Agents|alkylating agents|mesh-ancestor
24421272|NCT00218205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24421333|NCT00218322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24421334|NCT00218322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421336|NCT00218348|Dextroamphetamine|dextroamphetamine|mesh-list
24421337|NCT00218348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24421338|NCT00218348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421339|NCT00218348|Sympathomimetics|sympathomimetics|mesh-ancestor
24421340|NCT00218348|Autonomic Agents|autonomic agents|mesh-ancestor
24421341|NCT00218348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24421342|NCT00218348|Dopamine Agents|dopamine agents|mesh-ancestor
24421343|NCT00218348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24978824|NCT02774265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24978825|NCT02774265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24978826|NCT02774265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978827|NCT02774265|Antipyretics|antipyretics|mesh-ancestor
24978828|NCT02774265|Anticoagulants|anticoagulants|mesh-ancestor
24978829|NCT02736617|Obinutuzumab|obinutuzumab|mesh-list
24978830|NCT02736617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24978831|NCT02736617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161891|NCT02231723|Leucovorin|leucovorin|mesh-list
25561645|NCT00706966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25561646|NCT00706966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561647|NCT00706979|Nicotine|nicotine|mesh-list
25561648|NCT00706979|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25561649|NCT00706979|Autonomic Agents|autonomic agents|mesh-ancestor
25561650|NCT00706979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25561651|NCT00706979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456645|NCT04405284|Disinfectants|disinfectants|mesh-list
25456646|NCT04405284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456647|NCT04397302|Valsartan|valsartan|mesh-list
25456648|NCT04397302|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25456649|NCT04397302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25456650|NCT04397302|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25456651|NCT04397302|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25456652|NCT04397302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456653|NCT04396587|Sufentanil|sufentanil|mesh-list
25456654|NCT04396587|Oxycodone|oxycodone|mesh-list
25456655|NCT04396587|Hydromorphone|hydromorphone|mesh-list
25456656|NCT04396587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25456657|NCT04396587|Narcotics|narcotics|mesh-ancestor
25456658|NCT04396587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25456659|NCT04396587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456660|NCT04396587|Analgesics|analgesics|mesh-ancestor
25456661|NCT04396587|Sensory System Agents|sensory system agents|mesh-ancestor
25456662|NCT04396587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25456663|NCT04396587|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25456664|NCT04396587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25456665|NCT04396587|Anesthetics, General|anesthetics, general|mesh-ancestor
25456666|NCT04396587|Anesthetics|anesthetics|mesh-ancestor
25456667|NCT04390802|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25456668|NCT04390802|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25456669|NCT04390802|Dermatologic Agents|dermatologic agents|mesh-ancestor
25456670|NCT04389294|Antibodies|antibodies|mesh-list
25456671|NCT04389294|Immunologic Factors|immunologic factors|mesh-ancestor
25456672|NCT04389294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161892|NCT02231723|Gemcitabine|gemcitabine|mesh-list
24421364|NCT00218374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24421365|NCT00218374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24421366|NCT00218374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24421367|NCT00218374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24421368|NCT00218374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24421369|NCT00218374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24421370|NCT00218374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24421371|NCT00218374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861281|NCT02316535|Capecitabine|capecitabine|mesh-list
24421372|NCT00218374|Antimanic Agents|antimanic agents|mesh-ancestor
24421373|NCT00218413|Vaccines|vaccines|mesh-list
24421374|NCT00218413|Immunologic Factors|immunologic factors|mesh-ancestor
24421375|NCT00218413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421376|NCT00218504|Dronabinol|dronabinol|mesh-list
24421377|NCT00218504|Hallucinogens|hallucinogens|mesh-ancestor
25121568|NCT03101137|Dexamethasone|dexamethasone|mesh-list
24913036|NCT04268888|Nivolumab|nivolumab|mesh-list
25822676|NCT00004581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24421419|NCT00218608|Disulfiram|disulfiram|mesh-list
24421420|NCT00218608|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24978884|NCT02525029|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24421422|NCT00218608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25561652|NCT00706979|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25561653|NCT00706979|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25561654|NCT00706979|Cholinergic Agents|cholinergic agents|mesh-ancestor
25561655|NCT00706979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25561656|NCT00706979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561657|NCT00706992|Aldesleukin|aldesleukin|mesh-list
25561658|NCT00706992|Vaccines|vaccines|mesh-list
25561659|NCT00706992|Freund's Adjuvant|freund's adjuvant|mesh-list
24587860|NCT00897871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25561660|NCT00706992|Immunologic Factors|immunologic factors|mesh-ancestor
25561661|NCT00706992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561662|NCT00706992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25561663|NCT00706992|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25561664|NCT00706992|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25561665|NCT00706992|Antiviral Agents|antiviral agents|mesh-ancestor
25561666|NCT00706992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25561667|NCT00706992|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25561668|NCT00707031|Metformin|metformin|mesh-list
25561669|NCT00707031|Exenatide|exenatide|mesh-list
25561670|NCT00707031|Lixisenatide|lixisenatide|mesh-list
25561671|NCT00707031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25561672|NCT00707031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561673|NCT00707031|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25561674|NCT00707031|Incretins|incretins|mesh-ancestor
25561675|NCT00707031|Hormones|hormones|mesh-ancestor
24913516|NCT04263844|Analgesics|analgesics|mesh-ancestor
25561676|NCT00707031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25561677|NCT00707057|Ibuprofen|ibuprofen|mesh-list
25561678|NCT00707057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25561679|NCT00707057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25456674|NCT04381091|Antioxidants|antioxidants|mesh-ancestor
24478930|NCT00425009|Metformin|metformin|mesh-list
25456675|NCT04381091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456676|NCT04381091|Protective Agents|protective agents|mesh-ancestor
25456677|NCT04381091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456678|NCT04377295|Ranibizumab|ranibizumab|mesh-list
25456679|NCT04377295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25456680|NCT04377295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25456681|NCT04377295|Growth Substances|growth substances|mesh-ancestor
24819399|NCT02095366|Sufentanil|sufentanil|mesh-list
25456682|NCT04377295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456683|NCT04377295|Growth Inhibitors|growth inhibitors|mesh-ancestor
25456684|NCT04377295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456685|NCT04374123|Antibodies|antibodies|mesh-list
25456686|NCT04374123|Immunoglobulin M|immunoglobulin m|mesh-list
25456687|NCT04374123|Immunologic Factors|immunologic factors|mesh-ancestor
25456688|NCT04374123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421423|NCT00218608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421424|NCT00218621|Buprenorphine|buprenorphine|mesh-list
24421425|NCT00218621|Methadone|methadone|mesh-list
24978843|NCT02695992|Adrenergic Agents|adrenergic agents|mesh-ancestor
24978844|NCT02695992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24978845|NCT02695992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450986|NCT00321230|Micronutrients|micronutrients|mesh-ancestor
24978846|NCT02695992|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24978847|NCT02695992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24978848|NCT02695992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24978849|NCT02695992|Vasodilator Agents|vasodilator agents|mesh-ancestor
24978850|NCT02667418|Vancomycin|vancomycin|mesh-list
24978851|NCT02667418|Fidaxomicin|fidaxomicin|mesh-list
24978852|NCT02667418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24978853|NCT02667418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24978854|NCT02652468|Mycophenolic Acid|mycophenolic acid|mesh-list
24421462|NCT00219232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121582|NCT03101137|Anesthetics|anesthetics|mesh-ancestor
24421463|NCT00219232|Cholinergic Agents|cholinergic agents|mesh-ancestor
24421464|NCT00219232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24421465|NCT00219232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421466|NCT00219232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24421467|NCT00219232|Protective Agents|protective agents|mesh-ancestor
24421468|NCT00219245|Rivastigmine|rivastigmine|mesh-list
24421469|NCT00219245|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24421470|NCT00219245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480854|NCT00432406|Etanercept|etanercept|mesh-list
24421471|NCT00219245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421472|NCT00219245|Cholinergic Agents|cholinergic agents|mesh-ancestor
24421473|NCT00219245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24421481|NCT00219271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24421482|NCT00219271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421484|NCT00219310|Antiviral Agents|antiviral agents|mesh-ancestor
24421485|NCT00219310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24421486|NCT00219310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24421487|NCT00219310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421488|NCT00219310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421490|NCT00219323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24421491|NCT00219323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24421492|NCT00219323|Respiratory System Agents|respiratory system agents|mesh-ancestor
25161893|NCT02231723|Paclitaxel|paclitaxel|mesh-list
25121603|NCT03100994|Bupivacaine|bupivacaine|mesh-list
24421666|NCT00219869|Cholinergic Agents|cholinergic agents|mesh-ancestor
24997431|NCT04964622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997435|NCT04899193|Hormones|hormones|mesh-ancestor
25561680|NCT00707057|Analgesics|analgesics|mesh-ancestor
25561681|NCT00707057|Sensory System Agents|sensory system agents|mesh-ancestor
25561682|NCT00707057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25561683|NCT00707057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561684|NCT00707057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25561685|NCT00707057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25561686|NCT00707057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25561687|NCT00707057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25561688|NCT00707057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561689|NCT00707174|Imiquimod|imiquimod|mesh-list
25561690|NCT00707174|Tazarotene|tazarotene|mesh-list
25561691|NCT00707174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25561692|NCT00707174|Immunologic Factors|immunologic factors|mesh-ancestor
25561693|NCT00707174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561694|NCT00707174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456691|NCT04367688|Antiviral Agents|antiviral agents|mesh-ancestor
25456692|NCT04367688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456693|NCT04367688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25456694|NCT04367688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25456695|NCT04367688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25456696|NCT04367688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456697|NCT04367688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25456698|NCT04367688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25456699|NCT04366830|Remestemcel-l|remestemcel-l|mesh-list
25456700|NCT04366830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25456701|NCT04366830|Antiviral Agents|antiviral agents|mesh-ancestor
25456702|NCT04366830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456703|NCT04365725|Remdesivir|remdesivir|mesh-list
24985082|NCT03694002|Ramucirumab|ramucirumab|mesh-list
25456704|NCT04365725|Antimetabolites|antimetabolites|mesh-ancestor
25456705|NCT04365725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456706|NCT04365725|Antiviral Agents|antiviral agents|mesh-ancestor
25456707|NCT04365725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25314163|NCT05024344|Hormones|hormones|mesh-ancestor
25161894|NCT02231723|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25161895|NCT02231723|Fluorouracil|fluorouracil|mesh-list
25161896|NCT02231723|Oxaliplatin|oxaliplatin|mesh-list
25161897|NCT02231723|Irinotecan|irinotecan|mesh-list
25161898|NCT02231723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25161899|NCT02231723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161900|NCT02231723|Tubulin Modulators|tubulin modulators|mesh-ancestor
25161901|NCT02231723|Antimitotic Agents|antimitotic agents|mesh-ancestor
25161902|NCT02231723|Mitosis Modulators|mitosis modulators|mesh-ancestor
25161903|NCT02231723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161904|NCT02231723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25161905|NCT02231723|Antimetabolites|antimetabolites|mesh-ancestor
25161906|NCT02231723|Antiviral Agents|antiviral agents|mesh-ancestor
25161907|NCT02231723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25161908|NCT02231723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25161909|NCT02231723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25161910|NCT02231723|Immunologic Factors|immunologic factors|mesh-ancestor
25161911|NCT02231723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161912|NCT02231723|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25161913|NCT02231723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25161914|NCT02231723|Antidotes|antidotes|mesh-ancestor
25161915|NCT02231723|Protective Agents|protective agents|mesh-ancestor
25161916|NCT02231723|Vitamin B Complex|vitamin b complex|mesh-ancestor
25161917|NCT02231723|Vitamins|vitamins|mesh-ancestor
25161918|NCT02231723|Micronutrients|micronutrients|mesh-ancestor
25161929|NCT01964495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25161930|NCT01964495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25161931|NCT01964495|Antitubercular Agents|antitubercular agents|mesh-ancestor
25161933|NCT01860976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25161934|NCT01860976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161935|NCT01860976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161936|NCT01860976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25161937|NCT01860976|Immunologic Factors|immunologic factors|mesh-ancestor
25161938|NCT01860976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161939|NCT01860976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25161940|NCT01761266|Sorafenib|sorafenib|mesh-list
25561695|NCT00707174|Interferon Inducers|interferon inducers|mesh-ancestor
25561696|NCT00707174|Dermatologic Agents|dermatologic agents|mesh-ancestor
25561697|NCT00707174|Keratolytic Agents|keratolytic agents|mesh-ancestor
25561698|NCT00707239|Imipenem|imipenem|mesh-list
25561699|NCT00707239|Tigecycline|tigecycline|mesh-list
25561700|NCT00707239|Cilastatin|cilastatin|mesh-list
25561701|NCT00707239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25561702|NCT00707239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25561703|NCT00707239|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25561704|NCT00707239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25561705|NCT00707239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561706|NCT00707239|Protease Inhibitors|protease inhibitors|mesh-ancestor
25561707|NCT00707486|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
25561708|NCT00707486|Hemostatics|hemostatics|mesh-ancestor
25561709|NCT00707486|Coagulants|coagulants|mesh-ancestor
25561710|NCT00707655|Zalutumumab|zalutumumab|mesh-list
25561711|NCT00707655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25561712|NCT00707655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25561713|NCT00707746|Mipomersen|mipomersen|mesh-list
25561714|NCT00707746|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25456708|NCT04350021|Cyclophosphamide|cyclophosphamide|mesh-list
25456709|NCT04350021|Capecitabine|capecitabine|mesh-list
25456710|NCT04350021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25456711|NCT04350021|Immunologic Factors|immunologic factors|mesh-ancestor
25456712|NCT04350021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456713|NCT04350021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25456714|NCT04350021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25028282|NCT03612323|Analgesics|analgesics|mesh-ancestor
25028295|NCT03612180|Metoprolol|metoprolol|mesh-list
25456715|NCT04350021|Alkylating Agents|alkylating agents|mesh-ancestor
25456716|NCT04350021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456717|NCT04350021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456718|NCT04350021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25456719|NCT04350021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25456720|NCT04350021|Antimetabolites|antimetabolites|mesh-ancestor
25456721|NCT04348448|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25456722|NCT04348448|Immunologic Factors|immunologic factors|mesh-ancestor
25456723|NCT04348448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456724|NCT04334837|Copper|copper|mesh-list
25456725|NCT04334837|Trace Elements|trace elements|mesh-ancestor
25456726|NCT04334837|Micronutrients|micronutrients|mesh-ancestor
25456727|NCT04334837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161941|NCT01761266|Lenvatinib|lenvatinib|mesh-list
25161942|NCT01761266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161943|NCT01761266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25028422|NCT03610893|Dexamethasone|dexamethasone|mesh-list
25161944|NCT01761266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25161945|NCT01761266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161946|NCT01550289|Vaccines|vaccines|mesh-list
25161947|NCT01550289|Immunologic Factors|immunologic factors|mesh-ancestor
25161948|NCT01550289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161949|NCT01325441|Paclitaxel|paclitaxel|mesh-list
25161950|NCT01325441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24600922|NCT00961194|Ketamine|ketamine|mesh-list
25161951|NCT01325441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161952|NCT01325441|Tubulin Modulators|tubulin modulators|mesh-ancestor
25161953|NCT01325441|Antimitotic Agents|antimitotic agents|mesh-ancestor
25161954|NCT01325441|Mitosis Modulators|mitosis modulators|mesh-ancestor
24997436|NCT04899193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25161955|NCT01325441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161956|NCT01101438|Metformin|metformin|mesh-list
25161957|NCT01101438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25161958|NCT01101438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161959|NCT01074190|Fentanyl|fentanyl|mesh-list
25161960|NCT01074190|Bupivacaine|bupivacaine|mesh-list
25161961|NCT01074190|Anesthetics, Local|anesthetics, local|mesh-ancestor
25161962|NCT01074190|Anesthetics|anesthetics|mesh-ancestor
24978871|NCT02652468|Antimetabolites|antimetabolites|mesh-ancestor
24978872|NCT02652468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24978873|NCT02652468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978874|NCT02652468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24978875|NCT02652468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24978876|NCT02652468|Antitubercular Agents|antitubercular agents|mesh-ancestor
25822677|NCT00004582|Ritonavir|ritonavir|mesh-list
24421636|NCT00219778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24843228|NCT02226328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421638|NCT00219778|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24421664|NCT00219869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421665|NCT00219869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978882|NCT02579265|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25561715|NCT00707746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25561716|NCT00707746|Antimetabolites|antimetabolites|mesh-ancestor
25561717|NCT00707746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561718|NCT00707746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25561719|NCT00707759|Mycophenolic Acid|mycophenolic acid|mesh-list
25561720|NCT00707759|Prednisone|prednisone|mesh-list
25561721|NCT00707759|Prednisolone|prednisolone|mesh-list
25561722|NCT00707759|Tacrolimus|tacrolimus|mesh-list
25561723|NCT00707759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25561724|NCT00707759|Glucocorticoids|glucocorticoids|mesh-ancestor
25561725|NCT00707759|Hormones|hormones|mesh-ancestor
25561726|NCT00707759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25561727|NCT00707759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561728|NCT00707759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25561729|NCT00707759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25561730|NCT00707759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25561731|NCT00707759|Immunologic Factors|immunologic factors|mesh-ancestor
25561732|NCT00707759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25561733|NCT00707759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651799|NCT01519674|Metformin|metformin|mesh-list
25822678|NCT00004582|Lopinavir|lopinavir|mesh-list
25456728|NCT04327752|Dermatologic Agents|dermatologic agents|mesh-list
25456729|NCT04326023|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25456730|NCT04326023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25456731|NCT04326023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456732|NCT04326023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456733|NCT04321733|Amoxicillin|amoxicillin|mesh-list
24486486|NCT00458250|Busulfan|busulfan|mesh-list
25456734|NCT04321733|Clavulanic Acid|clavulanic acid|mesh-list
25456735|NCT04321733|Clavulanic Acids|clavulanic acids|mesh-list
25456736|NCT04321733|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25456737|NCT04321733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25456738|NCT04321733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456739|NCT04321733|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25456740|NCT04321733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25456741|NCT04321733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456742|NCT04319341|Autoantibodies|autoantibodies|mesh-list
25456743|NCT04319341|Immunologic Factors|immunologic factors|mesh-ancestor
25456744|NCT04319341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24874460|NCT04750616|Micronutrients|micronutrients|mesh-ancestor
25456745|NCT04318405|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25456746|NCT04318405|Hematinics|hematinics|mesh-ancestor
25456747|NCT04314336|Coal Tar|coal tar|mesh-list
25692698|NCT02004093|Paclitaxel|paclitaxel|mesh-list
25456748|NCT04314336|Keratolytic Agents|keratolytic agents|mesh-ancestor
25456749|NCT04314336|Dermatologic Agents|dermatologic agents|mesh-ancestor
25456750|NCT04312555|Alprostadil|alprostadil|mesh-list
25456751|NCT04312555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25456752|NCT04312555|Vasodilator Agents|vasodilator agents|mesh-ancestor
25456753|NCT04312555|Urological Agents|urological agents|mesh-ancestor
25314294|NCT05021887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314295|NCT05021887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25314296|NCT05021887|Respiratory System Agents|respiratory system agents|mesh-ancestor
25314297|NCT05021887|Dermatologic Agents|dermatologic agents|mesh-ancestor
25029056|NCT03605940|Methoxsalen|methoxsalen|mesh-list
25113108|NCT03511625|Prednisolone|prednisolone|mesh-list
25314298|NCT05021887|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24978883|NCT02579265|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24421927|NCT00220623|Antidepressive Agents|antidepressive agents|mesh-list
25822679|NCT00004582|Efavirenz|efavirenz|mesh-list
25822680|NCT00004582|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25822681|NCT00004582|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25029378|NCT03602898|Busulfan|busulfan|mesh-list
25161963|NCT01074190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25042055|NCT01516086|Xhance|xhance|mesh-list
24421936|NCT00220649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421937|NCT00220649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029656|NCT03601533|Phenol|phenol|mesh-list
24872588|NCT05309460|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24872589|NCT05309460|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25029674|NCT03601091|Midazolam|midazolam|mesh-list
24421938|NCT00220649|Antiviral Agents|antiviral agents|mesh-ancestor
24421939|NCT00220649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24421940|NCT00220649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25561734|NCT00707759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561735|NCT00707759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25561736|NCT00707759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25561737|NCT00707759|Antitubercular Agents|antitubercular agents|mesh-ancestor
25561738|NCT00707759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24421941|NCT00220649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24421973|NCT00220831|Vitamin E|vitamin e|mesh-list
25561739|NCT00707759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25561740|NCT00707863|Citalopram|citalopram|mesh-list
25561741|NCT00707863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25561742|NCT00707863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25561743|NCT00707863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25561744|NCT00707863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561745|NCT00707863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25561746|NCT00707863|Serotonin Agents|serotonin agents|mesh-ancestor
25561747|NCT00707863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561748|NCT00707863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25561749|NCT00707863|Antidepressive Agents|antidepressive agents|mesh-ancestor
25561750|NCT00707863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25561751|NCT00707967|Vaccines|vaccines|mesh-list
25561752|NCT00707967|Immunologic Factors|immunologic factors|mesh-ancestor
25561753|NCT00707967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561754|NCT00707980|Vortioxetine|vortioxetine|mesh-list
25561755|NCT00707980|Antidepressive Agents|antidepressive agents|mesh-ancestor
25561756|NCT00707980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25561757|NCT00707980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25561758|NCT00707980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25561759|NCT00707980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25561760|NCT00707980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561761|NCT00707980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25651800|NCT01519674|Insulin Aspart|insulin aspart|mesh-list
25456754|NCT04310631|Ranibizumab|ranibizumab|mesh-list
25456755|NCT04310631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25456756|NCT04310631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25456757|NCT04310631|Growth Substances|growth substances|mesh-ancestor
25456758|NCT04310631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456759|NCT04310631|Growth Inhibitors|growth inhibitors|mesh-ancestor
25456760|NCT04310631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456761|NCT04302012|Mydriatics|mydriatics|mesh-list
25456762|NCT04302012|Autonomic Agents|autonomic agents|mesh-ancestor
25456763|NCT04302012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25456764|NCT04302012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456765|NCT04296253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25456766|NCT04296253|Mitogens|mitogens|mesh-list
25456767|NCT04296253|Mitosis Modulators|mitosis modulators|mesh-ancestor
25456768|NCT04296253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456769|NCT04288713|Eculizumab|eculizumab|mesh-list
25456770|NCT04288713|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25456771|NCT04288713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25456772|NCT04288713|Immunologic Factors|immunologic factors|mesh-ancestor
25456773|NCT04288713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314372|NCT05021276|Basiliximab|basiliximab|mesh-list
25314373|NCT05021276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25314374|NCT05021276|Immunologic Factors|immunologic factors|mesh-ancestor
25314375|NCT05021276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314376|NCT05021250|Ethiodized Oil|ethiodized oil|mesh-list
25314377|NCT05021250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616002|NCT01033461|Calcium|calcium|mesh-list
25314378|NCT05020964|Trastuzumab|trastuzumab|mesh-list
25314379|NCT05020964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25314380|NCT05020964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314381|NCT05020704|Empagliflozin|empagliflozin|mesh-list
25314382|NCT05020704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25314401|NCT05020210|Sivelestat|sivelestat|mesh-list
24421974|NCT00220831|Vitamins|vitamins|mesh-ancestor
24421975|NCT00220831|Micronutrients|micronutrients|mesh-ancestor
24887819|NCT04511975|Antimetabolites|antimetabolites|mesh-ancestor
24421976|NCT00220831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421977|NCT00220831|Antioxidants|antioxidants|mesh-ancestor
24888250|NCT04508231|Hormones|hormones|mesh-list
24700174|NCT01451086|Vaccines|vaccines|mesh-list
24889480|NCT04493073|Mitomycins|mitomycins|mesh-list
24421978|NCT00220831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421979|NCT00220831|Protective Agents|protective agents|mesh-ancestor
24421980|NCT00220844|Amitriptyline|amitriptyline|mesh-list
24421981|NCT00220844|Desipramine|desipramine|mesh-list
24421982|NCT00220844|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25561762|NCT00707980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25561763|NCT00707980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25561764|NCT00707980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561765|NCT00707980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25561766|NCT00707980|Serotonin Agents|serotonin agents|mesh-ancestor
25561767|NCT00707980|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25561768|NCT00707980|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25561769|NCT00707980|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24893724|NCT04446715|Sufentanil|sufentanil|mesh-list
25561770|NCT00707980|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25561771|NCT00707993|Alogliptin|alogliptin|mesh-list
25561772|NCT00707993|Glipizide|glipizide|mesh-list
25561773|NCT00707993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24421983|NCT00220844|Antidepressive Agents|antidepressive agents|mesh-ancestor
24494234|NCT00494468|GABA Agents|gaba agents|mesh-ancestor
24916770|NCT04237246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473542|NCT00403286|Xhance|xhance|mesh-list
25561774|NCT00707993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561775|NCT00707993|Incretins|incretins|mesh-ancestor
25561776|NCT00707993|Hormones|hormones|mesh-ancestor
25561777|NCT00707993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25561778|NCT00707993|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25561779|NCT00707993|Protease Inhibitors|protease inhibitors|mesh-ancestor
25561780|NCT00707993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25561781|NCT00707993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561782|NCT00708071|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25561783|NCT00708071|Thrombin|thrombin|mesh-list
25561784|NCT00708071|Aprotinin|aprotinin|mesh-list
25561785|NCT00708071|Hemostatics|hemostatics|mesh-ancestor
25561786|NCT00708071|Coagulants|coagulants|mesh-ancestor
25561787|NCT00708071|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25561788|NCT00708071|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25107259|NCT03140982|Propofol|propofol|mesh-list
25561789|NCT00708071|Protease Inhibitors|protease inhibitors|mesh-ancestor
25561790|NCT00708071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25561791|NCT00708071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561792|NCT00708097|Fluorides|fluorides|mesh-list
25456774|NCT04286230|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25456775|NCT04286230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25456776|NCT04286230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456777|NCT04286230|Antitubercular Agents|antitubercular agents|mesh-ancestor
25456778|NCT04267601|Anagliptin|anagliptin|mesh-list
25456779|NCT04267601|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25456780|NCT04267601|Protease Inhibitors|protease inhibitors|mesh-ancestor
25456781|NCT04267601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25456782|NCT04267601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456783|NCT04267601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25456784|NCT04267601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314433|NCT05019690|Antimitotic Agents|antimitotic agents|mesh-ancestor
25314434|NCT05019690|Mitosis Modulators|mitosis modulators|mesh-ancestor
25314439|NCT05019417|Glycerol|glycerol|mesh-list
24422043|NCT00221052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24422044|NCT00221052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24422045|NCT00221052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24422046|NCT00221052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422047|NCT00221052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422049|NCT00221156|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24422050|NCT00221156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422051|NCT00221156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422052|NCT00221156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24422053|NCT00221156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422054|NCT00221260|Anesthetics|anesthetics|mesh-list
24422057|NCT00221286|Interferons|interferons|mesh-list
24422058|NCT00221286|Tenofovir|tenofovir|mesh-list
24422059|NCT00221286|Interferon-alpha|interferon-alpha|mesh-list
24422060|NCT00221286|Interferon alpha-2|interferon alpha-2|mesh-list
24422061|NCT00221286|Emtricitabine|emtricitabine|mesh-list
24422062|NCT00221286|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24422063|NCT00221286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24422064|NCT00221286|Antiviral Agents|antiviral agents|mesh-ancestor
24422095|NCT00221416|Antidepressive Agents|antidepressive agents|mesh-ancestor
24422096|NCT00221416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24422097|NCT00221416|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24422098|NCT00221416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24422099|NCT00221416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24422100|NCT00221416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822682|NCT00004582|Protease Inhibitors|protease inhibitors|mesh-ancestor
24978919|NCT02398825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978921|NCT02393248|Docetaxel|docetaxel|mesh-list
24978922|NCT02393248|Pembrolizumab|pembrolizumab|mesh-list
25822683|NCT00004582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422102|NCT00221416|Dopamine Agents|dopamine agents|mesh-ancestor
24422103|NCT00221416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25105870|NCT04824274|Morphine|morphine|mesh-list
24422107|NCT00221416|Serotonin Agents|serotonin agents|mesh-ancestor
24422108|NCT00221416|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24422109|NCT00221416|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24422110|NCT00221416|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24422111|NCT00221416|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24422112|NCT00221429|Valproic Acid|valproic acid|mesh-list
24422113|NCT00221429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24422114|NCT00221429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25031033|NCT03590912|Levocetirizine|levocetirizine|mesh-list
24422124|NCT00221442|Anticonvulsants|anticonvulsants|mesh-ancestor
24422125|NCT00221442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24902958|NCT04368507|Monoclonal antibody YYB-101|monoclonal antibody yyb-101|mesh-list
25161964|NCT01074190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422126|NCT00221442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24838829|NCT02200640|Losartan|losartan|mesh-list
24422197|NCT00221611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24422198|NCT00221611|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24422199|NCT00221611|GABA Agonists|gaba agonists|mesh-ancestor
25561793|NCT00708097|Cariostatic Agents|cariostatic agents|mesh-ancestor
25561794|NCT00708097|Protective Agents|protective agents|mesh-ancestor
25561795|NCT00708097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561796|NCT00708110|Dolutegravir|dolutegravir|mesh-list
25561797|NCT00708110|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25561798|NCT00708110|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25561799|NCT00708110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25561800|NCT00708110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561801|NCT00708110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25561802|NCT00708110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25561803|NCT00708110|Antiviral Agents|antiviral agents|mesh-ancestor
25561804|NCT00708110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25561805|NCT00708123|Listerine|listerine|mesh-list
25561806|NCT00708123|Fluorides|fluorides|mesh-list
25456785|NCT04264884|Daratumumab|daratumumab|mesh-list
25456786|NCT04264884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456787|NCT04261231|Anesthetics|anesthetics|mesh-list
25456788|NCT04261231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25456789|NCT04261231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456790|NCT04260139|Metronidazole|metronidazole|mesh-list
25456791|NCT04260139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456792|NCT04260139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25456793|NCT04260139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25456794|NCT04260139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25456795|NCT04256265|Risdiplam|risdiplam|mesh-list
25456796|NCT04256265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25456797|NCT04256265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25456798|NCT04256265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456799|NCT04253119|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25456800|NCT04253119|Antiviral Agents|antiviral agents|mesh-ancestor
25456801|NCT04253119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456802|NCT04240509|Tenofovir|tenofovir|mesh-list
25456803|NCT04240509|Emtricitabine|emtricitabine|mesh-list
25456804|NCT04240509|Antiviral Agents|antiviral agents|mesh-ancestor
25456805|NCT04240509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456806|NCT04240509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25456807|NCT04240509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25456808|NCT04240509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25456809|NCT04240509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456810|NCT04240509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25456811|NCT04240509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25314500|NCT05018364|Epoetin Alfa|epoetin alfa|mesh-list
24422200|NCT00221611|GABA Agents|gaba agents|mesh-ancestor
24422201|NCT00221611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25691875|NCT01991548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422202|NCT00221611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422204|NCT00221624|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24422205|NCT00221624|Amantadine|amantadine|mesh-list
24422206|NCT00221624|Antimetabolites|antimetabolites|mesh-ancestor
24422207|NCT00221624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422208|NCT00221624|Antiviral Agents|antiviral agents|mesh-ancestor
24422209|NCT00221624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24422212|NCT00221624|Dopamine Agents|dopamine agents|mesh-ancestor
25822684|NCT00004582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822685|NCT00004582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25822686|NCT00004582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25822687|NCT00004582|Antiviral Agents|antiviral agents|mesh-ancestor
25822688|NCT00004582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25822689|NCT00004582|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25822690|NCT00004582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25121841|NCT03098823|Glucocorticoids|glucocorticoids|mesh-ancestor
24422237|NCT00221689|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24422238|NCT00221689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561807|NCT00708123|Sodium Fluoride|sodium fluoride|mesh-list
25561808|NCT00708123|Cariostatic Agents|cariostatic agents|mesh-ancestor
25561809|NCT00708123|Protective Agents|protective agents|mesh-ancestor
25561810|NCT00708123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561811|NCT00708123|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25561812|NCT00708123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25561813|NCT00708162|Raltegravir Potassium|raltegravir potassium|mesh-list
25561814|NCT00708162|Elvitegravir|elvitegravir|mesh-list
25561815|NCT00708162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25561816|NCT00708162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25561817|NCT00708162|Antiviral Agents|antiviral agents|mesh-ancestor
25561818|NCT00708162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25561819|NCT00708162|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25561820|NCT00708162|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25561821|NCT00708162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25561822|NCT00708162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561823|NCT00708175|Pioglitazone|pioglitazone|mesh-list
25561824|NCT00708175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24503245|NCT02384850|Leucovorin|leucovorin|mesh-list
25561825|NCT00708175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561826|NCT00708201|Alvimopan|alvimopan|mesh-list
25561827|NCT00708201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25561828|NCT00708214|Letrozole|letrozole|mesh-list
25561829|NCT00708214|Afatinib|afatinib|mesh-list
25031785|NCT03585829|Prednisolone|prednisolone|mesh-list
25561830|NCT00708214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25561831|NCT00708214|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25561832|NCT00708214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25561833|NCT00708214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651801|NCT01519674|Insulin, Long-Acting|insulin, long-acting|mesh-list
25561834|NCT00708214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561835|NCT00708214|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25561836|NCT00708214|Hormone Antagonists|hormone antagonists|mesh-ancestor
25561837|NCT00708214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25561838|NCT00708214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561839|NCT00708214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25561840|NCT00708305|Listerine|listerine|mesh-list
25561841|NCT00708305|Fluorides|fluorides|mesh-list
25561842|NCT00708305|Sodium Fluoride|sodium fluoride|mesh-list
25561843|NCT00708305|Cariostatic Agents|cariostatic agents|mesh-ancestor
25561844|NCT00708305|Protective Agents|protective agents|mesh-ancestor
25561845|NCT00708305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561846|NCT00708305|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25561847|NCT00708305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25561848|NCT00708422|Travoprost|travoprost|mesh-list
25561849|NCT00708422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25561850|NCT00708422|Latanoprost|latanoprost|mesh-list
25561851|NCT00708422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25561852|NCT00708422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25561853|NCT00708435|Protein C|protein c|mesh-list
25561854|NCT00708435|Protein S|protein s|mesh-list
25561855|NCT00708435|Anticoagulants|anticoagulants|mesh-ancestor
25561856|NCT00708435|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25561857|NCT00708435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25561858|NCT00708435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561859|NCT00708500|Interferons|interferons|mesh-list
25561860|NCT00708500|Ribavirin|ribavirin|mesh-list
25561861|NCT00708500|Interferon-alpha|interferon-alpha|mesh-list
25561862|NCT00708500|Interferon alpha-2|interferon alpha-2|mesh-list
25561863|NCT00708500|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25561864|NCT00708500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25561865|NCT00708500|Antiviral Agents|antiviral agents|mesh-ancestor
25561866|NCT00708500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456812|NCT04238741|Anesthetics|anesthetics|mesh-list
25456813|NCT04238741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25456814|NCT04238741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456815|NCT04230707|Melatonin|melatonin|mesh-list
25456816|NCT04230707|Antioxidants|antioxidants|mesh-ancestor
25692702|NCT02004093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456817|NCT04230707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456818|NCT04230707|Protective Agents|protective agents|mesh-ancestor
25456819|NCT04230707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456820|NCT04230707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25456821|NCT04221568|Fentanyl|fentanyl|mesh-list
25456822|NCT04221568|Bupivacaine|bupivacaine|mesh-list
25456823|NCT04221568|Levobupivacaine|levobupivacaine|mesh-list
25456824|NCT04221568|Anesthetics, Local|anesthetics, local|mesh-ancestor
25456825|NCT04221568|Anesthetics|anesthetics|mesh-ancestor
25456826|NCT04221568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25456827|NCT04221568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456828|NCT04221568|Sensory System Agents|sensory system agents|mesh-ancestor
25456829|NCT04221568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25456830|NCT04221568|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25456831|NCT04221568|Narcotics|narcotics|mesh-ancestor
25561867|NCT00708500|Antimetabolites|antimetabolites|mesh-ancestor
25561868|NCT00708500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561869|NCT00708500|Immunologic Factors|immunologic factors|mesh-ancestor
25561870|NCT00708500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561871|NCT00708526|Anesthetics|anesthetics|mesh-list
25561872|NCT00708526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25561873|NCT00708526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561874|NCT00708552|Donepezil|donepezil|mesh-list
25561875|NCT00708552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25561876|NCT00708552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25561877|NCT00708552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561878|NCT00708552|Cholinergic Agents|cholinergic agents|mesh-ancestor
25456832|NCT04221568|Analgesics|analgesics|mesh-ancestor
25456833|NCT04221568|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25561879|NCT00708552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25561880|NCT00708552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561881|NCT00708552|Nootropic Agents|nootropic agents|mesh-ancestor
25561882|NCT00708682|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25561883|NCT00708682|Immunologic Factors|immunologic factors|mesh-ancestor
25561884|NCT00708682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561885|NCT00708708|Etanercept|etanercept|mesh-list
25561886|NCT00708708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25561887|NCT00708708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25456855|NCT04204928|Pralsetinib|pralsetinib|mesh-list
25456856|NCT04204928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456857|NCT04195009|Anesthetics|anesthetics|mesh-list
25456858|NCT04195009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25456859|NCT04195009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456860|NCT04187248|Asparaginase|asparaginase|mesh-list
25456861|NCT04187248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24422239|NCT00221689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24422240|NCT00221689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24422241|NCT00221689|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24422242|NCT00221689|GABA Agonists|gaba agonists|mesh-ancestor
24422243|NCT00221689|GABA Agents|gaba agents|mesh-ancestor
24422244|NCT00221689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25032245|NCT03582878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24422245|NCT00221689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422278|NCT00221962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24422279|NCT00221962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24422280|NCT00221962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24422281|NCT00221962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25121873|NCT03098680|Mydriatics|mydriatics|mesh-ancestor
24422282|NCT00221962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032916|NCT03577158|Insulin|insulin|mesh-list
24422283|NCT00221962|Dopamine Agonists|dopamine agonists|mesh-ancestor
24422284|NCT00221962|Dopamine Agents|dopamine agents|mesh-ancestor
24422285|NCT00221962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24422286|NCT00221962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161965|NCT01074190|Sensory System Agents|sensory system agents|mesh-ancestor
24422311|NCT00222053|Thalidomide|thalidomide|mesh-list
24422312|NCT00222053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24422313|NCT00222053|Immunologic Factors|immunologic factors|mesh-ancestor
24954491|NCT03876587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24954492|NCT03876587|Tubulin Modulators|tubulin modulators|mesh-ancestor
24954493|NCT03876587|Antimitotic Agents|antimitotic agents|mesh-ancestor
25076361|NCT03373708|Tamoxifen|tamoxifen|mesh-list
24989778|NCT04820205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24422314|NCT00222053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105860|NCT04850495|Mitosis Modulators|mitosis modulators|mesh-ancestor
25105861|NCT04850495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24989782|NCT04776408|Nitric Oxide|nitric oxide|mesh-list
25105863|NCT04844905|Piperaquine|piperaquine|mesh-list
25105865|NCT04844905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25105866|NCT04844905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25076513|NCT03372473|Loratadine|loratadine|mesh-list
25105867|NCT04844905|Antimalarials|antimalarials|mesh-ancestor
25105868|NCT04844905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25105869|NCT04824274|Fentanyl|fentanyl|mesh-list
25105873|NCT04824274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25105874|NCT04824274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105876|NCT04824274|Sensory System Agents|sensory system agents|mesh-ancestor
25105877|NCT04824274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25105878|NCT04824274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25105879|NCT04824274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24422370|NCT00222235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24631515|NCT01118598|Vitamins|vitamins|mesh-ancestor
24422371|NCT00222235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422372|NCT00222261|Aspirin|aspirin|mesh-list
24422373|NCT00222261|Clopidogrel|clopidogrel|mesh-list
25033260|NCT03574909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24422374|NCT00222261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24422375|NCT00222261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24422376|NCT00222261|Analgesics|analgesics|mesh-ancestor
24422377|NCT00222261|Sensory System Agents|sensory system agents|mesh-ancestor
24422378|NCT00222261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24422379|NCT00222261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422380|NCT00222261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24422381|NCT00222261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24422382|NCT00222261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24422383|NCT00222261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25105886|NCT04771923|Racepinephrine|racepinephrine|mesh-list
25105887|NCT04771923|Tranexamic Acid|tranexamic acid|mesh-list
25105888|NCT04771923|Epinephryl borate|epinephryl borate|mesh-list
25105889|NCT04771923|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25105890|NCT04771923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25105891|NCT04771923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105892|NCT04771923|Hemostatics|hemostatics|mesh-ancestor
25105893|NCT04771923|Coagulants|coagulants|mesh-ancestor
25105894|NCT04771923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25105895|NCT04771923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25105896|NCT04771923|Adrenergic Agents|adrenergic agents|mesh-ancestor
25822691|NCT00004582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25561888|NCT00708708|Analgesics|analgesics|mesh-ancestor
25561889|NCT00708708|Sensory System Agents|sensory system agents|mesh-ancestor
25561890|NCT00708708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25561891|NCT00708708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396189|NCT00138060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25561892|NCT00708708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25561893|NCT00708708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25456862|NCT04179266|Ketamine|ketamine|mesh-list
25456863|NCT04179266|Analgesics|analgesics|mesh-ancestor
25456864|NCT04179266|Sensory System Agents|sensory system agents|mesh-ancestor
24397342|NCT00141375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397344|NCT00141375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25456865|NCT04179266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25456866|NCT04179266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456867|NCT04179266|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25456868|NCT04179266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25456869|NCT04179266|Anesthetics, General|anesthetics, general|mesh-ancestor
25456870|NCT04179266|Anesthetics|anesthetics|mesh-ancestor
24399443|NCT00147784|Antiviral Agents|antiviral agents|mesh-ancestor
25456871|NCT04179266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25456872|NCT04179266|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25456873|NCT04179266|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25456874|NCT04179266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25456875|NCT04179266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076924|NCT03369795|Antimetabolites|antimetabolites|mesh-ancestor
25456876|NCT04171128|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25456877|NCT04171128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456878|NCT04163224|Imidacloprid|imidacloprid|mesh-list
24402078|NCT00154739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24402079|NCT00154739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24402080|NCT00154778|Leucovorin|leucovorin|mesh-list
24402081|NCT00154778|Antidotes|antidotes|mesh-ancestor
25077135|NCT03367182|Growth Inhibitors|growth inhibitors|mesh-ancestor
25077136|NCT03367182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25033926|NCT03570112|Velpatasvir|velpatasvir|mesh-list
25033927|NCT03570112|Antiviral Agents|antiviral agents|mesh-ancestor
25077166|NCT03366974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077167|NCT03366974|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25033981|NCT03569540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24404166|NCT00162669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24404167|NCT00162669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24404252|NCT00162877|Esomeprazole|esomeprazole|mesh-list
24442591|NCT00291759|Tamoxifen|tamoxifen|mesh-list
24442592|NCT00291759|Anastrozole|anastrozole|mesh-list
24404488|NCT00163592|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24404489|NCT00163592|Hemostatics|hemostatics|mesh-ancestor
24404490|NCT00163592|Coagulants|coagulants|mesh-ancestor
24404491|NCT00163605|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25456879|NCT04163224|Cholinergic Agents|cholinergic agents|mesh-ancestor
25456880|NCT04163224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25456881|NCT04163224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456882|NCT04163224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314721|NCT05015595|Memantine|memantine|mesh-list
24422411|NCT00222469|Antimetabolites|antimetabolites|mesh-ancestor
24422412|NCT00222469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990826|NCT04005209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24990827|NCT04005209|Anesthetics, General|anesthetics, general|mesh-ancestor
24990828|NCT04005209|Anesthetics|anesthetics|mesh-ancestor
24990829|NCT04005209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24990830|NCT04005209|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24990831|NCT04005209|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24422413|NCT00222469|Antiviral Agents|antiviral agents|mesh-ancestor
24422414|NCT00222469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24422415|NCT00222469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422416|NCT00222469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25161966|NCT01074190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25105902|NCT04771923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25105903|NCT04771923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25105904|NCT04771923|Respiratory System Agents|respiratory system agents|mesh-ancestor
25105906|NCT04771923|Sympathomimetics|sympathomimetics|mesh-ancestor
25034071|NCT03567941|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25034072|NCT03567941|Narcotics|narcotics|mesh-ancestor
25034073|NCT03567941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25034074|NCT03567941|Antitussive Agents|antitussive agents|mesh-ancestor
25034075|NCT03567941|Respiratory System Agents|respiratory system agents|mesh-ancestor
25034076|NCT03567928|Propofol|propofol|mesh-list
25034077|NCT03567928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25034078|NCT03567928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25105907|NCT04771923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25105908|NCT04762459|Pemetrexed|pemetrexed|mesh-list
25105909|NCT04762459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105910|NCT04762459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25105911|NCT04762459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105912|NCT04762459|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25105913|NCT04762459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25121946|NCT03098160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25121948|NCT03098199|Menotropins|menotropins|mesh-list
24505875|NCT00543023|Calcitonin|calcitonin|mesh-list
24410269|NCT00184977|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24410270|NCT00184977|Autonomic Agents|autonomic agents|mesh-ancestor
24410271|NCT00184977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24410272|NCT00184977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410273|NCT00184977|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24410275|NCT00184977|Dermatologic Agents|dermatologic agents|mesh-ancestor
24410314|NCT00185094|Losartan|losartan|mesh-list
24410315|NCT00185094|Atenolol|atenolol|mesh-list
24410316|NCT00185094|Olmesartan|olmesartan|mesh-list
24410317|NCT00185094|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24410318|NCT00185094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24410319|NCT00185094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24410320|NCT00185094|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24410321|NCT00185094|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24410323|NCT00185094|Sympatholytics|sympatholytics|mesh-ancestor
24410489|NCT00185510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25105914|NCT04754230|Tranexamic Acid|tranexamic acid|mesh-list
25105915|NCT04754230|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25105916|NCT04754230|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24422447|NCT00222495|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24422448|NCT00222495|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24422449|NCT00222495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24422450|NCT00222495|Antidepressive Agents|antidepressive agents|mesh-ancestor
24422451|NCT00222521|Insulin Glargine|insulin glargine|mesh-list
24422452|NCT00222521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25561894|NCT00708708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25114005|NCT01552434|Anticonvulsants|anticonvulsants|mesh-ancestor
24411032|NCT00187447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24411033|NCT00187447|Gout Suppressants|gout suppressants|mesh-ancestor
24411034|NCT00187447|Tocolytic Agents|tocolytic agents|mesh-ancestor
24411084|NCT00187707|Anticonvulsants|anticonvulsants|mesh-ancestor
24411085|NCT00187707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24411086|NCT00187707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24411087|NCT00187707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24411088|NCT00187707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25077404|NCT03365115|Narcotics|narcotics|mesh-ancestor
25561895|NCT00708708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25561896|NCT00708708|Immunologic Factors|immunologic factors|mesh-ancestor
25561897|NCT00708721|Clofarabine|clofarabine|mesh-list
25561898|NCT00708721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25561899|NCT00708721|Antimetabolites|antimetabolites|mesh-ancestor
25561900|NCT00708721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561901|NCT00708721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25561902|NCT00708942|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25561903|NCT00708942|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25034577|NCT03563664|Danazol|danazol|mesh-list
25561904|NCT00708942|Dermatologic Agents|dermatologic agents|mesh-ancestor
25561905|NCT00709059|Ribavirin|ribavirin|mesh-list
25561906|NCT00709059|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24414828|NCT00198978|Idarubicin|idarubicin|mesh-list
25077534|NCT03363984|Anesthetics|anesthetics|mesh-ancestor
24511626|NCT00569920|BB 1101|bb 1101|mesh-list
25561907|NCT00709059|Interferon-alpha|interferon-alpha|mesh-list
25561908|NCT00709059|Antimetabolites|antimetabolites|mesh-ancestor
25561909|NCT00709059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561910|NCT00709059|Antiviral Agents|antiviral agents|mesh-ancestor
25561911|NCT00709059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25561912|NCT00709059|Immunologic Factors|immunologic factors|mesh-ancestor
25561913|NCT00709059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561914|NCT00709098|Iloprost|iloprost|mesh-list
24454836|NCT03474029|Rifampin|rifampin|mesh-list
25561915|NCT00709098|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25561916|NCT00709098|Vasodilator Agents|vasodilator agents|mesh-ancestor
25561917|NCT00709111|Maraviroc|maraviroc|mesh-list
25561918|NCT00709111|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25561919|NCT00709111|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25561920|NCT00709111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561921|NCT00709111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25561922|NCT00709111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25561923|NCT00709111|Antiviral Agents|antiviral agents|mesh-ancestor
25561924|NCT00709111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25561925|NCT00709111|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25561926|NCT00709202|Betahistine|betahistine|mesh-list
25456883|NCT04152941|Olaparib|olaparib|mesh-list
25456884|NCT04152941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25456885|NCT04152941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25456886|NCT04152941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456887|NCT04152941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456888|NCT04138641|Cangrelor|cangrelor|mesh-list
25456889|NCT04138641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25456890|NCT04138641|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25456891|NCT04138641|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24425165|NCT00232115|Analgesics|analgesics|mesh-ancestor
25036148|NCT03549819|Cannabidiol|cannabidiol|mesh-list
25036524|NCT03547024|Purinergic Agents|purinergic agents|mesh-ancestor
24993244|NCT05198947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036733|NCT03544073|Fertility Agents|fertility agents|mesh-ancestor
25036734|NCT03544073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25036735|NCT03544073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036736|NCT03544073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25036864|NCT03542552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25036865|NCT03542552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456892|NCT04138641|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25456893|NCT04138641|Purinergic Agents|purinergic agents|mesh-ancestor
25456894|NCT04138641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25456895|NCT04138641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456896|NCT04138641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456897|NCT04135092|Aldesleukin|aldesleukin|mesh-list
25456898|NCT04135092|Cyclophosphamide|cyclophosphamide|mesh-list
25456899|NCT04135092|Pembrolizumab|pembrolizumab|mesh-list
25456900|NCT04135092|Fludarabine|fludarabine|mesh-list
25456901|NCT04135092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25456902|NCT04135092|Immunologic Factors|immunologic factors|mesh-ancestor
25037369|NCT03537898|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25456903|NCT04135092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456904|NCT04135092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25456905|NCT04135092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25037509|NCT03536806|Canrenone|canrenone|mesh-list
25456906|NCT04135092|Alkylating Agents|alkylating agents|mesh-ancestor
25456907|NCT04135092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428817|NCT00241254|Prednisolone|prednisolone|mesh-list
25456908|NCT04135092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456909|NCT04135092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25456910|NCT04135092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25456911|NCT04135092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25456912|NCT04135092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25456913|NCT04135092|Antiviral Agents|antiviral agents|mesh-ancestor
25314796|NCT05014711|Fentanyl|fentanyl|mesh-list
25561927|NCT00709202|Vasodilator Agents|vasodilator agents|mesh-ancestor
25561928|NCT00709202|Histamine Agonists|histamine agonists|mesh-ancestor
25561929|NCT00709202|Histamine Agents|histamine agents|mesh-ancestor
25561930|NCT00709202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25561931|NCT00709202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884187|NCT02744742|Busulfan|busulfan|mesh-list
25561932|NCT00709202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561933|NCT00709228|Ribavirin|ribavirin|mesh-list
25275767|NCT02369406|Antimetabolites|antimetabolites|mesh-ancestor
24435529|NCT00266643|Dopamine Agents|dopamine agents|mesh-ancestor
25561934|NCT00709228|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25561935|NCT00709228|Antimetabolites|antimetabolites|mesh-ancestor
25275944|NCT02368054|Racepinephrine|racepinephrine|mesh-list
25275945|NCT02368054|Bupivacaine|bupivacaine|mesh-list
25276041|NCT02367755|Anticonvulsants|anticonvulsants|mesh-ancestor
25561936|NCT00709228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561937|NCT00709228|Antiviral Agents|antiviral agents|mesh-ancestor
25692141|NCT01994993|Tazobactam|tazobactam|mesh-list
25561938|NCT00709228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25561939|NCT00709592|Mycophenolic Acid|mycophenolic acid|mesh-list
24455158|NCT02567409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24455159|NCT02567409|Antimetabolites|antimetabolites|mesh-ancestor
25038835|NCT04465760|Immunoglobulins|immunoglobulins|mesh-list
25038836|NCT04465760|Immunologic Factors|immunologic factors|mesh-ancestor
25038837|NCT04465760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561940|NCT00709592|Tacrolimus|tacrolimus|mesh-list
25561941|NCT00709592|Thymoglobulin|thymoglobulin|mesh-list
25561942|NCT00709592|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25561943|NCT00709592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25561944|NCT00709592|Immunologic Factors|immunologic factors|mesh-ancestor
25561945|NCT00709592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561946|NCT00709592|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25561947|NCT00709592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25561948|NCT00709592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561949|NCT00709592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25561950|NCT00709592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25561951|NCT00709592|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25561952|NCT00709592|Antitubercular Agents|antitubercular agents|mesh-ancestor
25561953|NCT00709592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25561954|NCT00709592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25561955|NCT00709618|Vinorelbine|vinorelbine|mesh-list
25561956|NCT00709618|Lapatinib|lapatinib|mesh-list
25561957|NCT00709618|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25561958|NCT00709618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25561959|NCT00709618|Tubulin Modulators|tubulin modulators|mesh-ancestor
25561960|NCT00709618|Antimitotic Agents|antimitotic agents|mesh-ancestor
25456915|NCT04132882|Sodium thiosulfate|sodium thiosulfate|mesh-list
25456916|NCT04132882|Antidotes|antidotes|mesh-ancestor
25456917|NCT04132882|Protective Agents|protective agents|mesh-ancestor
25038891|NCT04379518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038892|NCT04378114|Acetaminophen|acetaminophen|mesh-list
25038893|NCT04378114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25038894|NCT04378114|Analgesics|analgesics|mesh-ancestor
25456918|NCT04132882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456919|NCT04132882|Antioxidants|antioxidants|mesh-ancestor
25456920|NCT04132882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456921|NCT04132882|Antitubercular Agents|antitubercular agents|mesh-ancestor
25456922|NCT04132882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25456923|NCT04132882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456924|NCT04132882|Chelating Agents|chelating agents|mesh-ancestor
25456925|NCT04132882|Sequestering Agents|sequestering agents|mesh-ancestor
25456926|NCT04130776|Kallikreins|kallikreins|mesh-list
25456927|NCT04130776|Coagulants|coagulants|mesh-ancestor
25456928|NCT04130776|Fertility Agents, Male|fertility agents, male|mesh-ancestor
25456929|NCT04130776|Fertility Agents|fertility agents|mesh-ancestor
25456930|NCT04130776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25456931|NCT04130776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456932|NCT04124562|Nitrous Oxide|nitrous oxide|mesh-list
25456933|NCT04124562|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25456934|NCT04124562|Anesthetics, General|anesthetics, general|mesh-ancestor
25456935|NCT04124562|Anesthetics|anesthetics|mesh-ancestor
25456936|NCT04124562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25456937|NCT04124562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456938|NCT04124562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25456939|NCT04124562|Analgesics|analgesics|mesh-ancestor
25456940|NCT04124562|Sensory System Agents|sensory system agents|mesh-ancestor
25456941|NCT04124562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25456942|NCT04124133|Hyaluronic Acid|hyaluronic acid|mesh-list
25456943|NCT04124133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25456944|NCT04124133|Immunologic Factors|immunologic factors|mesh-ancestor
25456945|NCT04124133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456946|NCT04124133|Viscosupplements|viscosupplements|mesh-ancestor
25456947|NCT04124133|Protective Agents|protective agents|mesh-ancestor
25456948|NCT04114500|Estradiol|estradiol|mesh-list
25456949|NCT04114500|Progesterone|progesterone|mesh-list
25456950|NCT04114500|Estrogens|estrogens|mesh-ancestor
25456951|NCT04114500|Hormones|hormones|mesh-ancestor
25456952|NCT04114500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25456954|NCT04114500|Progestins|progestins|mesh-ancestor
25561961|NCT00709618|Mitosis Modulators|mitosis modulators|mesh-ancestor
25561962|NCT00709618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561963|NCT00709618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24995770|NCT04780581|Glucocorticoids|glucocorticoids|mesh-ancestor
25561964|NCT00709618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25561965|NCT00709696|Varenicline|varenicline|mesh-list
25561966|NCT00709696|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25561967|NCT00709696|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25561968|NCT00709696|Cholinergic Agents|cholinergic agents|mesh-ancestor
25561969|NCT00709696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25561970|NCT00709696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561971|NCT00709696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561972|NCT00709722|Gusperimus|gusperimus|mesh-list
25561973|NCT00709722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25561974|NCT00709722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25561975|NCT00709722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25561976|NCT00709722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561977|NCT00709722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25561978|NCT00709722|Immunologic Factors|immunologic factors|mesh-ancestor
25561979|NCT00709722|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25561980|NCT00709722|Protective Agents|protective agents|mesh-ancestor
25561981|NCT00709735|Propranolol|propranolol|mesh-list
25561982|NCT00709735|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25561983|NCT00709735|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25561984|NCT00709735|Adrenergic Agents|adrenergic agents|mesh-ancestor
25561985|NCT00709735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25561986|NCT00709735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561987|NCT00709735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25561988|NCT00709735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25561989|NCT00709735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25561990|NCT00709735|Vasodilator Agents|vasodilator agents|mesh-ancestor
25561991|NCT00709761|Paclitaxel|paclitaxel|mesh-list
25561992|NCT00709761|Lapatinib|lapatinib|mesh-list
25561993|NCT00709761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25561994|NCT00709761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25561995|NCT00709761|Tubulin Modulators|tubulin modulators|mesh-ancestor
25456956|NCT04112277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25276438|NCT02364934|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25456958|NCT04112277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25456959|NCT04112277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456960|NCT04112277|Analgesics|analgesics|mesh-ancestor
25456961|NCT04112277|Sensory System Agents|sensory system agents|mesh-ancestor
25456962|NCT04112277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25456963|NCT04102319|Hepcidins|hepcidins|mesh-list
24955239|NCT03866681|Anticoagulants|anticoagulants|mesh-ancestor
25276461|NCT02365012|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25276462|NCT02365012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25276463|NCT02365012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25456964|NCT04102319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456965|NCT04095494|Nitrous Oxide|nitrous oxide|mesh-list
25456966|NCT04095494|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25456967|NCT04095494|Anesthetics, General|anesthetics, general|mesh-ancestor
25456968|NCT04095494|Anesthetics|anesthetics|mesh-ancestor
25456969|NCT04095494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25456970|NCT04095494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456971|NCT04095494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25456972|NCT04095494|Analgesics|analgesics|mesh-ancestor
25456973|NCT04095494|Sensory System Agents|sensory system agents|mesh-ancestor
25456974|NCT04095494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25314938|NCT05013034|Immunologic Factors|immunologic factors|mesh-ancestor
24422453|NCT00222521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422454|NCT00222534|Acetazolamide|acetazolamide|mesh-list
24422455|NCT00222534|Anticonvulsants|anticonvulsants|mesh-ancestor
24422456|NCT00222534|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24422457|NCT00222534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422458|NCT00222534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422459|NCT00222534|Diuretics|diuretics|mesh-ancestor
24422460|NCT00222534|Natriuretic Agents|natriuretic agents|mesh-ancestor
24422461|NCT00222534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422524|NCT00222794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422525|NCT00222820|Citalopram|citalopram|mesh-list
24422526|NCT00222820|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24422527|NCT00222820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24422528|NCT00222820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24978954|NCT02307656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24978955|NCT02307656|Antiviral Agents|antiviral agents|mesh-ancestor
24978956|NCT02307656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24978957|NCT02307656|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24978958|NCT02307656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24978959|NCT02216838|Botulinum Toxins|botulinum toxins|mesh-list
24978960|NCT02216838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24978961|NCT02216838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24978962|NCT02216838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24978963|NCT02216838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24978964|NCT02216838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978965|NCT02216838|Cholinergic Agents|cholinergic agents|mesh-ancestor
24422607|NCT00223054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24422608|NCT00223054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24422609|NCT00223054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24422610|NCT00223054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24422611|NCT00223210|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24422612|NCT00223210|Antidepressive Agents|antidepressive agents|mesh-ancestor
25561996|NCT00709761|Antimitotic Agents|antimitotic agents|mesh-ancestor
24422613|NCT00223210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25561997|NCT00709761|Mitosis Modulators|mitosis modulators|mesh-ancestor
25561998|NCT00709761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25561999|NCT00709761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25562000|NCT00709761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562001|NCT00709826|Gemcitabine|gemcitabine|mesh-list
25562002|NCT00709826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25562003|NCT00709826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25562004|NCT00709826|Antimetabolites|antimetabolites|mesh-ancestor
25562005|NCT00709826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562006|NCT00709826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562007|NCT00709826|Antiviral Agents|antiviral agents|mesh-ancestor
25562008|NCT00709826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25562009|NCT00709826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562010|NCT00709826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25562011|NCT00709826|Immunologic Factors|immunologic factors|mesh-ancestor
25562012|NCT00709826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562013|NCT00709826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25562014|NCT00709956|Iloprost|iloprost|mesh-list
25822692|NCT00004582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25822693|NCT00004582|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25456975|NCT04064476|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25456976|NCT04064476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25456977|NCT04064476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25456978|NCT04064476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25456979|NCT04064476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456980|NCT04064476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25456981|NCT04064476|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25456982|NCT04064476|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25456983|NCT04064476|Serotonin Agents|serotonin agents|mesh-ancestor
25456984|NCT04064476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25456985|NCT04064476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456986|NCT04064476|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25456987|NCT04064476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25456988|NCT04064476|Dopamine Agents|dopamine agents|mesh-ancestor
25315011|NCT05011669|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25315012|NCT05011669|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25315013|NCT05011669|Dopamine Agents|dopamine agents|mesh-ancestor
24422614|NCT00223210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24422615|NCT00223210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24422616|NCT00223210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24422617|NCT00223210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422618|NCT00223223|Levetiracetam|levetiracetam|mesh-list
24422619|NCT00223223|Anticonvulsants|anticonvulsants|mesh-ancestor
24422655|NCT00223418|Antidepressive Agents|antidepressive agents|mesh-ancestor
24422738|NCT00223691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24422739|NCT00223691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422742|NCT00223691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24422743|NCT00223691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422744|NCT00223691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422745|NCT00223691|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24422746|NCT00223691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24422747|NCT00223691|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24422748|NCT00223691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24422749|NCT00223691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24422750|NCT00223691|Dopamine Agents|dopamine agents|mesh-ancestor
24422751|NCT00223691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24422752|NCT00223691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24422753|NCT00223691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24422755|NCT00223691|Purinergic Agents|purinergic agents|mesh-ancestor
24422767|NCT00223691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24422768|NCT00223691|Anesthetics, Local|anesthetics, local|mesh-ancestor
24422770|NCT00223691|Antiemetics|antiemetics|mesh-ancestor
24422771|NCT00223691|Autonomic Agents|autonomic agents|mesh-ancestor
24422780|NCT00223691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24422791|NCT00223691|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24422792|NCT00223691|Protective Agents|protective agents|mesh-ancestor
24422793|NCT00223691|Sympathomimetics|sympathomimetics|mesh-ancestor
24422794|NCT00223691|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24422795|NCT00223691|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24422796|NCT00223691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24422797|NCT00223691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24422798|NCT00223691|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25562015|NCT00709956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25562016|NCT00709956|Vasodilator Agents|vasodilator agents|mesh-ancestor
25562017|NCT00709995|Sunitinib|sunitinib|mesh-list
25562018|NCT00709995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562019|NCT00709995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25562020|NCT00709995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25562021|NCT00709995|Growth Substances|growth substances|mesh-ancestor
25562022|NCT00709995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562023|NCT00709995|Growth Inhibitors|growth inhibitors|mesh-ancestor
25562024|NCT00709995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25562025|NCT00709995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562026|NCT00709995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562027|NCT00710021|Vitamin D|vitamin d|mesh-list
25562028|NCT00710021|Ergocalciferols|ergocalciferols|mesh-list
25562029|NCT00710021|Cholecalciferol|cholecalciferol|mesh-list
25562030|NCT00710021|Vitamins|vitamins|mesh-list
25562031|NCT00710021|Micronutrients|micronutrients|mesh-ancestor
25562032|NCT00710021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562033|NCT00710021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25822694|NCT00004582|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25456989|NCT04045171|Tacrolimus|tacrolimus|mesh-list
25456990|NCT04045171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25456991|NCT04045171|Immunologic Factors|immunologic factors|mesh-ancestor
25456992|NCT04045171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456993|NCT04045171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25456994|NCT04045171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25456995|NCT04045171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315081|NCT05009953|Leucovorin|leucovorin|mesh-list
25315082|NCT05009953|Fluorouracil|fluorouracil|mesh-list
25315083|NCT05009953|Irinotecan|irinotecan|mesh-list
25315084|NCT05009953|Antimetabolites|antimetabolites|mesh-ancestor
25315085|NCT05009953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829449|NCT00006211|Protease Inhibitors|protease inhibitors|mesh-ancestor
25108568|NCT03131973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25108569|NCT03131973|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25108570|NCT03131973|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25108571|NCT03131973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25108572|NCT03131973|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25108573|NCT03131973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25315086|NCT05009953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25315087|NCT05009953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315088|NCT05009953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25315089|NCT05009953|Immunologic Factors|immunologic factors|mesh-ancestor
25315090|NCT05009953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315091|NCT05009953|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25315092|NCT05009953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25315093|NCT05009953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422799|NCT00223691|Immunologic Factors|immunologic factors|mesh-ancestor
24422800|NCT00223691|Dopamine Agonists|dopamine agonists|mesh-ancestor
24422863|NCT00223717|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24422865|NCT00223717|Diuretics|diuretics|mesh-ancestor
24422866|NCT00223717|Natriuretic Agents|natriuretic agents|mesh-ancestor
24422867|NCT00223717|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24422868|NCT00223717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24978974|NCT02015351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978975|NCT02015351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24978976|NCT02015351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24978977|NCT02015351|Growth Substances|growth substances|mesh-ancestor
24978978|NCT02015351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978979|NCT02015351|Growth Inhibitors|growth inhibitors|mesh-ancestor
24978981|NCT02013167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978982|NCT02004522|Ofatumumab|ofatumumab|mesh-list
24978983|NCT02004522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24422869|NCT00223717|Sympatholytics|sympatholytics|mesh-ancestor
24422870|NCT00223717|Autonomic Agents|autonomic agents|mesh-ancestor
25562034|NCT00710021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25562035|NCT00710034|Nicotine|nicotine|mesh-list
25562036|NCT00710034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25562037|NCT00710034|Autonomic Agents|autonomic agents|mesh-ancestor
25562038|NCT00710034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25562039|NCT00710034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562040|NCT00710034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25562041|NCT00710034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25562042|NCT00710034|Cholinergic Agents|cholinergic agents|mesh-ancestor
25562043|NCT00710034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25562044|NCT00710034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562045|NCT00710385|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25562046|NCT00710385|Buprenorphine|buprenorphine|mesh-list
25562047|NCT00710385|Heroin|heroin|mesh-list
25562048|NCT00710385|Naloxone|naloxone|mesh-list
25562049|NCT00710385|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25562050|NCT00710385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562051|NCT00710385|Sensory System Agents|sensory system agents|mesh-ancestor
25562052|NCT00710385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25562053|NCT00710385|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25562054|NCT00710385|Narcotics|narcotics|mesh-ancestor
25562055|NCT00710385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25562056|NCT00710385|Analgesics|analgesics|mesh-ancestor
25562057|NCT00710424|Nabiximols|nabiximols|mesh-list
25562058|NCT00710424|Analgesics|analgesics|mesh-ancestor
25562059|NCT00710424|Sensory System Agents|sensory system agents|mesh-ancestor
25562060|NCT00710424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25562061|NCT00710424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562062|NCT00710554|Nabiximols|nabiximols|mesh-list
25456996|NCT03998774|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
25456997|NCT03998774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25456998|NCT03998774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25456999|NCT03998774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457000|NCT03998774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25457002|NCT03994419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25457003|NCT03994419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457004|NCT03988179|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
25457005|NCT03988179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457006|NCT03988179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457007|NCT03988179|Cholinergic Agents|cholinergic agents|mesh-ancestor
25457008|NCT03988179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25457009|NCT03988179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457010|NCT03979625|Heparin|heparin|mesh-list
25457011|NCT03979625|Antibodies|antibodies|mesh-list
25457012|NCT03979625|Immunologic Factors|immunologic factors|mesh-ancestor
25457013|NCT03979625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457014|NCT03979625|Anticoagulants|anticoagulants|mesh-ancestor
25457015|NCT03979625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25457016|NCT03979625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25457017|NCT03979625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315147|NCT05008861|Antibodies|antibodies|mesh-list
24422871|NCT00223717|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24422872|NCT00223717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24422873|NCT00223717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24422874|NCT00223717|Adrenergic Agents|adrenergic agents|mesh-ancestor
24422875|NCT00223717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24422876|NCT00223717|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25692189|NCT01995201|Dermatologic Agents|dermatologic agents|mesh-ancestor
24422877|NCT00223717|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24422878|NCT00223717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24422880|NCT00223717|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24422936|NCT00224094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422938|NCT00224146|Parasympatholytics|parasympatholytics|mesh-ancestor
24422939|NCT00224146|Autonomic Agents|autonomic agents|mesh-ancestor
24422940|NCT00224146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24422941|NCT00224146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422942|NCT00224146|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24422943|NCT00224146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24422944|NCT00224146|Cholinergic Agents|cholinergic agents|mesh-ancestor
24422990|NCT00224393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24422991|NCT00224393|Analgesics|analgesics|mesh-ancestor
24422992|NCT00224393|Sensory System Agents|sensory system agents|mesh-ancestor
25039370|NCT03879408|Narcotics|narcotics|mesh-ancestor
24422993|NCT00224393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24422994|NCT00224393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422995|NCT00224393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25040787|NCT02829814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040788|NCT02829814|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25040789|NCT02829814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25040790|NCT02829814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25040791|NCT02829814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25562063|NCT00710554|Analgesics|analgesics|mesh-ancestor
25562064|NCT00710554|Sensory System Agents|sensory system agents|mesh-ancestor
25562065|NCT00710554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25562066|NCT00710554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562067|NCT00710606|NuvaRing|nuvaring|mesh-list
25562068|NCT00710606|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25562069|NCT00710606|Desogestrel|desogestrel|mesh-list
25562070|NCT00710606|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25562071|NCT00710606|Contraceptive Agents|contraceptive agents|mesh-ancestor
25276728|NCT02362529|Minocycline|minocycline|mesh-list
24393374|NCT00129870|Oxaliplatin|oxaliplatin|mesh-list
25562072|NCT00710606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25562073|NCT00710606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562074|NCT00710606|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25562075|NCT00710606|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25562076|NCT00710606|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25562077|NCT00710606|Estrogens|estrogens|mesh-ancestor
25562078|NCT00710606|Hormones|hormones|mesh-ancestor
24994674|NCT03625323|Pembrolizumab|pembrolizumab|mesh-list
25562079|NCT00710606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25562080|NCT00710606|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25562081|NCT00710606|Progestins|progestins|mesh-ancestor
25562082|NCT00710684|Donepezil|donepezil|mesh-list
25562083|NCT00710684|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25562084|NCT00710684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457018|NCT03977142|Chrysarobin|chrysarobin|mesh-list
25457019|NCT03977142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25457020|NCT03977142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25457021|NCT03977142|Analgesics|analgesics|mesh-ancestor
25457022|NCT03977142|Sensory System Agents|sensory system agents|mesh-ancestor
25457023|NCT03977142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25457024|NCT03977142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457025|NCT03977142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25457026|NCT03977142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25457027|NCT03974464|Arginine Vasopressin|arginine vasopressin|mesh-list
25457028|NCT03974464|Hemostatics|hemostatics|mesh-ancestor
25457029|NCT03974464|Coagulants|coagulants|mesh-ancestor
25457030|NCT03974464|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25457031|NCT03974464|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25457032|NCT03974464|Natriuretic Agents|natriuretic agents|mesh-ancestor
25457033|NCT03974464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457034|NCT03970265|Meropenem|meropenem|mesh-list
25457035|NCT03970265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25457036|NCT03970265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25457037|NCT03967483|Indomethacin|indomethacin|mesh-list
25457038|NCT03967483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25457039|NCT03967483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25457040|NCT03967483|Analgesics|analgesics|mesh-ancestor
25457041|NCT03967483|Sensory System Agents|sensory system agents|mesh-ancestor
25457042|NCT03967483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25457043|NCT03967483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457044|NCT03967483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25457045|NCT03967483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25457046|NCT03967483|Gout Suppressants|gout suppressants|mesh-ancestor
25457047|NCT03967483|Tocolytic Agents|tocolytic agents|mesh-ancestor
25457048|NCT03967483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25457049|NCT03967483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25457050|NCT03967483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457051|NCT03967483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315219|NCT05008237|Mitosis Modulators|mitosis modulators|mesh-ancestor
25315221|NCT05008250|Metoprolol|metoprolol|mesh-list
25315240|NCT05007587|Leucovorin|leucovorin|mesh-list
25040793|NCT02822508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25040794|NCT02820714|Laxatives|laxatives|mesh-list
25161967|NCT01074190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25161968|NCT01074190|Narcotics|narcotics|mesh-ancestor
25562085|NCT00710684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562086|NCT00710684|Cholinergic Agents|cholinergic agents|mesh-ancestor
25562087|NCT00710684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25562088|NCT00710684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562089|NCT00710684|Nootropic Agents|nootropic agents|mesh-ancestor
25562090|NCT00710762|Nintedanib|nintedanib|mesh-list
25562091|NCT00710762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562092|NCT00710762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25562093|NCT00710762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562094|NCT00710762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651802|NCT01519674|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25651803|NCT01519674|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25651804|NCT01519674|Biphasic Insulins|biphasic insulins|mesh-list
25651805|NCT01519674|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
25651806|NCT01519674|Insulin, Isophane|insulin, isophane|mesh-list
25651807|NCT01519674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25651808|NCT01519674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651809|NCT01519674|Incretins|incretins|mesh-ancestor
25651810|NCT01519674|Hormones|hormones|mesh-ancestor
25651811|NCT01519674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25651812|NCT01519674|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25651813|NCT01519674|Protease Inhibitors|protease inhibitors|mesh-ancestor
25651814|NCT01519674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651815|NCT01519674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651816|NCT01519700|Lenograstim|lenograstim|mesh-list
24393636|NCT00130546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393637|NCT00130546|Tubulin Modulators|tubulin modulators|mesh-ancestor
24437393|NCT00273507|Mitosis Modulators|mitosis modulators|mesh-ancestor
25277008|NCT02360956|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25277009|NCT02360956|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25277010|NCT02360956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861435|NCT02317679|Bosentan|bosentan|mesh-list
25651817|NCT01519700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25651818|NCT01519700|Immunologic Factors|immunologic factors|mesh-ancestor
25651819|NCT01519700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651820|NCT01519765|Misoprostol|misoprostol|mesh-list
25651821|NCT01519765|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25651822|NCT01519765|Abortifacient Agents|abortifacient agents|mesh-ancestor
25651823|NCT01519765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25829450|NCT00006211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457052|NCT03947632|Chrysarobin|chrysarobin|mesh-list
25457053|NCT03947632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25457054|NCT03947632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25457055|NCT03947632|Analgesics|analgesics|mesh-ancestor
25457056|NCT03947632|Sensory System Agents|sensory system agents|mesh-ancestor
25457057|NCT03947632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25457058|NCT03947632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457059|NCT03947632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25457060|NCT03947632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25457061|NCT03947099|Ketamine|ketamine|mesh-list
25457062|NCT03947099|Analgesics|analgesics|mesh-ancestor
25457063|NCT03947099|Sensory System Agents|sensory system agents|mesh-ancestor
25457064|NCT03947099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25457065|NCT03947099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457066|NCT03947099|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25457067|NCT03947099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25457068|NCT03947099|Anesthetics, General|anesthetics, general|mesh-ancestor
25457069|NCT03947099|Anesthetics|anesthetics|mesh-ancestor
25457070|NCT03947099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25457071|NCT03947099|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25457072|NCT03947099|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25457073|NCT03947099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25457074|NCT03947099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161969|NCT01074190|Analgesics|analgesics|mesh-ancestor
25277094|NCT02360618|Antimetabolites|antimetabolites|mesh-ancestor
25277021|NCT02360826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25161970|NCT01074190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25161971|NCT01074190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25161972|NCT01074190|Anesthetics, General|anesthetics, general|mesh-ancestor
25161973|NCT00875524|Vaccines|vaccines|mesh-list
25161974|NCT00875524|Immunologic Factors|immunologic factors|mesh-ancestor
25161975|NCT00875524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161976|NCT00842530|Vaccines|vaccines|mesh-list
25161977|NCT00842530|Immunologic Factors|immunologic factors|mesh-ancestor
25161978|NCT00842530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161979|NCT00788151|Vaccines|vaccines|mesh-list
25161980|NCT00788151|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25161981|NCT00788151|Immunologic Factors|immunologic factors|mesh-ancestor
25161982|NCT00788151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161983|NCT00539591|Interferons|interferons|mesh-list
25161984|NCT00539591|Interferon-alpha|interferon-alpha|mesh-list
25161985|NCT00539591|Interferon alpha-2|interferon alpha-2|mesh-list
25277088|NCT02360618|Metformin|metformin|mesh-list
25161986|NCT00539591|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25161987|NCT00539591|Temozolomide|temozolomide|mesh-list
25161988|NCT00539591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161989|NCT00539591|Antiviral Agents|antiviral agents|mesh-ancestor
25161990|NCT00539591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25161991|NCT00539591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25161992|NCT00539591|Alkylating Agents|alkylating agents|mesh-ancestor
25161993|NCT00539591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161994|NCT00539591|Immunologic Factors|immunologic factors|mesh-ancestor
25161995|NCT00539591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161996|NCT02909088|Ecopipam|ecopipam|mesh-list
25161997|NCT02909088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25562095|NCT00711009|Ritonavir|ritonavir|mesh-list
25562096|NCT00711009|Lopinavir|lopinavir|mesh-list
25562097|NCT00711009|Tenofovir|tenofovir|mesh-list
25562098|NCT00711009|Emtricitabine|emtricitabine|mesh-list
25562099|NCT00711009|Raltegravir Potassium|raltegravir potassium|mesh-list
25562100|NCT00711009|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25562101|NCT00711009|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25562102|NCT00711009|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25562103|NCT00711009|Protease Inhibitors|protease inhibitors|mesh-ancestor
25562104|NCT00711009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562105|NCT00711009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562106|NCT00711009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25562107|NCT00711009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25562108|NCT00711009|Antiviral Agents|antiviral agents|mesh-ancestor
25562109|NCT00711009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25562110|NCT00711009|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25562111|NCT00711009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25562112|NCT00711009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25562113|NCT00711009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25562114|NCT00711009|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25562115|NCT00711009|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25562116|NCT00711191|Antibodies|antibodies|mesh-list
25562117|NCT00711191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25562118|NCT00711191|Immunologic Factors|immunologic factors|mesh-ancestor
25562119|NCT00711191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562120|NCT00711243|Docetaxel|docetaxel|mesh-list
25562121|NCT00711243|Fluorouracil|fluorouracil|mesh-list
25562122|NCT00711243|Oxaliplatin|oxaliplatin|mesh-list
25457075|NCT03930017|Vaccines|vaccines|mesh-list
25457076|NCT03930017|Immunologic Factors|immunologic factors|mesh-ancestor
25457077|NCT03930017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457078|NCT03920566|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25457079|NCT03920566|Dalteparin|dalteparin|mesh-list
25457080|NCT03920566|Anticoagulants|anticoagulants|mesh-ancestor
25457081|NCT03920566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25457082|NCT03920566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25457083|NCT03920566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315371|NCT05006664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315372|NCT05006664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25315373|NCT05006664|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25315374|NCT05006664|Alkylating Agents|alkylating agents|mesh-ancestor
25315375|NCT05006664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562123|NCT00711243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562124|NCT00711243|Tubulin Modulators|tubulin modulators|mesh-ancestor
25315376|NCT05006664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315377|NCT05006664|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25315378|NCT05006664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25315379|NCT05006664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25315380|NCT05006664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25315381|NCT05006664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25315382|NCT05006664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25315383|NCT05006664|Glucocorticoids|glucocorticoids|mesh-ancestor
25315384|NCT05006664|Hormones|hormones|mesh-ancestor
25315385|NCT05006664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25315386|NCT05006664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25315387|NCT05006664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25315388|NCT05006664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25315389|NCT05006287|Warfarin|warfarin|mesh-list
25315390|NCT05006287|Rivaroxaban|rivaroxaban|mesh-list
25315391|NCT05006287|Dabigatran|dabigatran|mesh-list
25315392|NCT05006287|Apixaban|apixaban|mesh-list
25315393|NCT05006287|Edoxaban|edoxaban|mesh-list
25315394|NCT05006287|Anticoagulants|anticoagulants|mesh-list
25315395|NCT05006287|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25562125|NCT00711243|Antimitotic Agents|antimitotic agents|mesh-ancestor
25562126|NCT00711243|Mitosis Modulators|mitosis modulators|mesh-ancestor
25562127|NCT00711243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562128|NCT00711243|Antimetabolites|antimetabolites|mesh-ancestor
25562129|NCT00711243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25562130|NCT00711243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25562131|NCT00711243|Immunologic Factors|immunologic factors|mesh-ancestor
25562132|NCT00711243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562133|NCT00711347|Hyaluronic Acid|hyaluronic acid|mesh-list
25562134|NCT00711347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25562135|NCT00711347|Immunologic Factors|immunologic factors|mesh-ancestor
25562136|NCT00711347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562137|NCT00711347|Viscosupplements|viscosupplements|mesh-ancestor
25562138|NCT00711347|Protective Agents|protective agents|mesh-ancestor
25562139|NCT00711412|Capecitabine|capecitabine|mesh-list
25562140|NCT00711412|Oxaliplatin|oxaliplatin|mesh-list
25562141|NCT00711412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25562142|NCT00711412|Antimetabolites|antimetabolites|mesh-ancestor
25562143|NCT00711412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562144|NCT00711412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562145|NCT00711464|Modafinil|modafinil|mesh-list
25562146|NCT00711464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25562147|NCT00711464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562148|NCT00711464|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25562149|NCT00711464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25562150|NCT00711464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25562151|NCT00711464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562152|NCT00711477|Naltrexone|naltrexone|mesh-list
25562153|NCT00711477|Bupropion|bupropion|mesh-list
25562154|NCT00711477|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25562155|NCT00711477|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25562156|NCT00711477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562157|NCT00711477|Sensory System Agents|sensory system agents|mesh-ancestor
25562158|NCT00711477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25562159|NCT00711477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25562160|NCT00711477|Antidepressive Agents|antidepressive agents|mesh-ancestor
25562161|NCT00711477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25562162|NCT00711477|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25562163|NCT00711477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25562164|NCT00711477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25562165|NCT00711477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562166|NCT00711477|Dopamine Agents|dopamine agents|mesh-ancestor
25562167|NCT00711477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25562168|NCT00711477|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25562169|NCT00711477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25562170|NCT00711477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562171|NCT00711490|Sirolimus|sirolimus|mesh-list
25562172|NCT00711490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25562173|NCT00711490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25562174|NCT00711490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25562175|NCT00711490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457084|NCT03914170|Cetuximab|cetuximab|mesh-list
25457085|NCT03914170|Folfirinox|folfirinox|mesh-list
25457086|NCT03914170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25457087|NCT03914170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457088|NCT03910985|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
25457089|NCT03910985|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25457090|NCT03910985|Autonomic Agents|autonomic agents|mesh-ancestor
25457091|NCT03910985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25457092|NCT03910985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457093|NCT03910985|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25457094|NCT03910985|Respiratory System Agents|respiratory system agents|mesh-ancestor
25457095|NCT03907605|Hormones|hormones|mesh-list
25457096|NCT03907605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25457097|NCT03907605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457098|NCT03903406|Dexamethasone|dexamethasone|mesh-list
25457099|NCT03903406|Lenalidomide|lenalidomide|mesh-list
25457100|NCT03903406|Ixazomib|ixazomib|mesh-list
25457101|NCT03903406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25457102|NCT03903406|Antiemetics|antiemetics|mesh-ancestor
25457103|NCT03903406|Autonomic Agents|autonomic agents|mesh-ancestor
25457104|NCT03903406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25457105|NCT03903406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995124|NCT05417997|Enoxaparin|enoxaparin|mesh-list
25457106|NCT03903406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25457107|NCT03903406|Glucocorticoids|glucocorticoids|mesh-ancestor
25457108|NCT03903406|Hormones|hormones|mesh-ancestor
25277527|NCT02357849|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25277528|NCT02357849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25277529|NCT02357849|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25277530|NCT02357849|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25277531|NCT02357849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25277532|NCT02357849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25117307|NCT05338866|Capecitabine|capecitabine|mesh-list
24626577|NCT01087879|Norelgestromin|norelgestromin|mesh-list
24956053|NCT03857854|Pirfenidone|pirfenidone|mesh-list
25277727|NCT02356445|Infliximab|infliximab|mesh-list
25457109|NCT03903406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25457110|NCT03903406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25457111|NCT03903406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457112|NCT03903406|Immunologic Factors|immunologic factors|mesh-ancestor
25562176|NCT00711490|Antifungal Agents|antifungal agents|mesh-ancestor
25692233|NCT01996332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24956430|NCT03854383|Natriuretic Agents|natriuretic agents|mesh-ancestor
24956532|NCT03853525|Petrolatum|petrolatum|mesh-list
24956533|NCT03853525|Emollients|emollients|mesh-ancestor
25562177|NCT00711490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25562178|NCT00711490|Immunologic Factors|immunologic factors|mesh-ancestor
25562179|NCT00711490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562180|NCT00711516|Modafinil|modafinil|mesh-list
24956595|NCT03853096|Cefazolin|cefazolin|mesh-list
25562181|NCT00711516|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25562182|NCT00711516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562183|NCT00711516|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25562184|NCT00711516|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25562185|NCT00711516|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25562186|NCT00711516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562187|NCT00711529|Gabapentin|gabapentin|mesh-list
25562188|NCT00711529|Analgesics|analgesics|mesh-ancestor
25278054|NCT02354053|Antiviral Agents|antiviral agents|mesh-ancestor
25692266|NCT01997333|Capecitabine|capecitabine|mesh-list
25562189|NCT00711529|Sensory System Agents|sensory system agents|mesh-ancestor
25562190|NCT00711529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25562191|NCT00711529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562192|NCT00711529|Anticonvulsants|anticonvulsants|mesh-ancestor
25562193|NCT00711529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25562194|NCT00711529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24798083|NCT01960426|Adalimumab|adalimumab|mesh-list
25562195|NCT00711529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25562196|NCT00711529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25562197|NCT00711529|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25562198|NCT00711529|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25562199|NCT00711529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25562200|NCT00711529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562201|NCT00711529|Antimanic Agents|antimanic agents|mesh-ancestor
25457131|NCT03894696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25457132|NCT03881917|Cystatins|cystatins|mesh-list
25457133|NCT03881917|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25457134|NCT03881917|Protease Inhibitors|protease inhibitors|mesh-ancestor
25457135|NCT03881917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457136|NCT03881917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315523|NCT05004753|Antiemetics|antiemetics|mesh-ancestor
25161998|NCT02909088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25161999|NCT02909088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25162000|NCT02909088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162001|NCT02909088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25162002|NCT02909088|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25162003|NCT02909088|Dopamine Agents|dopamine agents|mesh-ancestor
24957291|NCT03845348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25278331|NCT02352155|Mydriatics|mydriatics|mesh-ancestor
25162004|NCT02909088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25162005|NCT02909088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162006|NCT02909049|Midazolam|midazolam|mesh-list
25162007|NCT02909049|Ketamine|ketamine|mesh-list
25162008|NCT02909049|Mepivacaine|mepivacaine|mesh-list
25162009|NCT02909049|Analgesics|analgesics|mesh-ancestor
25162010|NCT02909049|Sensory System Agents|sensory system agents|mesh-ancestor
25162011|NCT02909049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25278420|NCT02351687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25278421|NCT02351687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25278422|NCT02351687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25278423|NCT02351687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162012|NCT02909049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162013|NCT02909049|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25278424|NCT02351687|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25162014|NCT02909049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25162015|NCT02909049|Anesthetics, General|anesthetics, general|mesh-ancestor
25162016|NCT02909049|Anesthetics|anesthetics|mesh-ancestor
25162017|NCT02909049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25162018|NCT02909049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25162019|NCT02909049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25162020|NCT02909049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25162021|NCT02909049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162022|NCT02909049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25162023|NCT02909049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24463319|NCT00359905|Urological Agents|urological agents|mesh-ancestor
24463320|NCT00359970|Azithromycin|azithromycin|mesh-list
24463321|NCT00359970|Loperamide|loperamide|mesh-list
25278688|NCT02350218|Alprostadil|alprostadil|mesh-list
25162024|NCT02909049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25162025|NCT02909049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25162026|NCT02909049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25162027|NCT02909049|GABA Modulators|gaba modulators|mesh-ancestor
25162028|NCT02909049|GABA Agents|gaba agents|mesh-ancestor
24529678|NCT00627536|Mitogens|mitogens|mesh-list
25162029|NCT02909049|Anesthetics, Local|anesthetics, local|mesh-ancestor
25162030|NCT02908581|Folic Acid|folic acid|mesh-list
25162031|NCT02908581|Vitamin B Complex|vitamin b complex|mesh-list
25162032|NCT02908581|Hematinics|hematinics|mesh-ancestor
25162033|NCT02908581|Vitamins|vitamins|mesh-ancestor
25162034|NCT02908581|Micronutrients|micronutrients|mesh-ancestor
25162035|NCT02908581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422997|NCT00224393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24422998|NCT00224393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24423001|NCT00224419|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24423002|NCT00224419|Autonomic Agents|autonomic agents|mesh-ancestor
24705431|NCT01485185|Donepezil|donepezil|mesh-list
24996381|NCT03639558|Anesthetics|anesthetics|mesh-ancestor
25279088|NCT02346682|Clonazepam|clonazepam|mesh-list
25279099|NCT02346682|Anticonvulsants|anticonvulsants|mesh-ancestor
24959585|NCT03823846|Parecoxib|parecoxib|mesh-list
24423012|NCT00224445|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24423013|NCT00224445|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24584684|NCT00881296|Antimetabolites|antimetabolites|mesh-ancestor
25279540|NCT02344732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24423014|NCT00224445|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24423015|NCT00224445|Protease Inhibitors|protease inhibitors|mesh-ancestor
24423016|NCT00224445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423017|NCT00224445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562202|NCT00711594|Afatinib|afatinib|mesh-list
25562203|NCT00711594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562204|NCT00711594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25562205|NCT00711594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562206|NCT00711594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562207|NCT00711646|Nabiximols|nabiximols|mesh-list
25562208|NCT00711646|Analgesics|analgesics|mesh-ancestor
25457138|NCT03851965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25279814|NCT02342587|Lapatinib|lapatinib|mesh-list
25160595|NCT02781519|Dronabinol|dronabinol|mesh-list
25160687|NCT02623439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160688|NCT02623439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25160689|NCT02623439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25160690|NCT02623439|Alkylating Agents|alkylating agents|mesh-ancestor
25279949|NCT02341794|Antimetabolites|antimetabolites|mesh-ancestor
25457139|NCT03851965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25280054|NCT02341105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280055|NCT02341105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25280056|NCT02341105|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25280057|NCT02341105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25280058|NCT02341105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280062|NCT02341079|Bupivacaine|bupivacaine|mesh-list
25606095|NCT01064414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25280220|NCT02339753|Carboplatin|carboplatin|mesh-list
25161066|NCT02102113|Dronabinol|dronabinol|mesh-list
24786974|NCT01922921|Trastuzumab|trastuzumab|mesh-list
24463801|NCT00362271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24463802|NCT00362271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25280639|NCT02336633|Antioxidants|antioxidants|mesh-ancestor
25078687|NCT03354312|Lidocaine|lidocaine|mesh-list
25078688|NCT03354312|Epinephrine|epinephrine|mesh-list
25078689|NCT03354312|Racepinephrine|racepinephrine|mesh-list
25078690|NCT03354312|Carticaine|carticaine|mesh-list
25280817|NCT02335398|Methadone|methadone|mesh-list
25457140|NCT03851965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457141|NCT03839511|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25457142|NCT03839511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457143|NCT05278897|Hyaluronic Acid|hyaluronic acid|mesh-list
25457144|NCT05278897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25457145|NCT05278897|Immunologic Factors|immunologic factors|mesh-ancestor
25457146|NCT05278897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457147|NCT05278897|Viscosupplements|viscosupplements|mesh-ancestor
25457148|NCT05278897|Protective Agents|protective agents|mesh-ancestor
25457149|NCT05278884|Anesthetics|anesthetics|mesh-list
25457150|NCT05278884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25457151|NCT05278884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315606|NCT05003752|Goserelin|goserelin|mesh-list
24423033|NCT00224458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24423034|NCT00224458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24423035|NCT00224458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25121320|NCT03103399|Levodopa|levodopa|mesh-list
24423036|NCT00224458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25281147|NCT02333188|Antidotes|antidotes|mesh-ancestor
24423037|NCT00224458|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24423038|NCT00224458|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25281171|NCT02333123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24423039|NCT00224458|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25281237|NCT02332603|Hormones|hormones|mesh-ancestor
24963313|NCT03791827|Rituximab|rituximab|mesh-list
24423040|NCT00224458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25123915|NCT03080766|Decitabine|decitabine|mesh-list
24423041|NCT00224458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24423043|NCT00224471|Immunologic Factors|immunologic factors|mesh-ancestor
24423044|NCT00224471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423045|NCT00224510|Lamotrigine|lamotrigine|mesh-list
24423046|NCT00224510|Anticonvulsants|anticonvulsants|mesh-ancestor
24978997|NCT01957332|Trastuzumab|trastuzumab|mesh-list
24978998|NCT01957332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24978999|NCT01957332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979000|NCT01860456|Imatinib Mesylate|imatinib mesylate|mesh-list
24979001|NCT01860456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25122265|NCT03095378|Tetracycline|tetracycline|mesh-list
25122267|NCT03095378|Citric Acid|citric acid|mesh-list
24979002|NCT01860456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24979003|NCT01860456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24979004|NCT01860456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979005|NCT01807182|Aldesleukin|aldesleukin|mesh-list
24979006|NCT01807182|Cyclophosphamide|cyclophosphamide|mesh-list
24979007|NCT01807182|Fludarabine|fludarabine|mesh-list
24979008|NCT01807182|Fludarabine phosphate|fludarabine phosphate|mesh-list
24423105|NCT00224679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423106|NCT00224679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25202825|NCT02718521|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24423107|NCT00224679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24423121|NCT00224692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24423123|NCT00224692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423124|NCT00224809|Aspirin|aspirin|mesh-list
24423162|NCT00224822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423164|NCT00224822|Dopamine Agents|dopamine agents|mesh-ancestor
24423165|NCT00224822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24979010|NCT01807182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24979011|NCT01807182|Immunologic Factors|immunologic factors|mesh-ancestor
24979012|NCT01807182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979013|NCT01807182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24979014|NCT01807182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25562209|NCT00711646|Sensory System Agents|sensory system agents|mesh-ancestor
25562210|NCT00711646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25562211|NCT00711646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562212|NCT00711802|Daptomycin|daptomycin|mesh-list
25562213|NCT00711802|Cloxacillin|cloxacillin|mesh-list
25562214|NCT00711802|Oxacillin|oxacillin|mesh-list
25562215|NCT00711802|Nafcillin|nafcillin|mesh-list
25562216|NCT00711802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25562217|NCT00711802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25562218|NCT00711828|Dexamethasone|dexamethasone|mesh-list
25562219|NCT00711828|Cyclophosphamide|cyclophosphamide|mesh-list
25562220|NCT00711828|Rituximab|rituximab|mesh-list
25562221|NCT00711828|Bortezomib|bortezomib|mesh-list
25562222|NCT00711828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25562223|NCT00711828|Immunologic Factors|immunologic factors|mesh-ancestor
25562224|NCT00711828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562225|NCT00711828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25562226|NCT00711828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25562227|NCT00711828|Alkylating Agents|alkylating agents|mesh-ancestor
25562228|NCT00711828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562229|NCT00711828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562230|NCT00711828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25562231|NCT00711828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25562232|NCT00711828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25562233|NCT00711828|Antiemetics|antiemetics|mesh-ancestor
25562234|NCT00711828|Autonomic Agents|autonomic agents|mesh-ancestor
25562235|NCT00711828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25562236|NCT00711828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25562237|NCT00711828|Glucocorticoids|glucocorticoids|mesh-ancestor
25562238|NCT00711828|Hormones|hormones|mesh-ancestor
25562239|NCT00711828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25562240|NCT00711828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25562241|NCT00711880|Nabiximols|nabiximols|mesh-list
25562242|NCT00711880|Analgesics|analgesics|mesh-ancestor
25562243|NCT00711880|Sensory System Agents|sensory system agents|mesh-ancestor
25281694|NCT02330120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25562244|NCT00711880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25562245|NCT00711880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562246|NCT00711958|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25562247|NCT00712010|Caseins|caseins|mesh-list
25562248|NCT00712010|Chelating Agents|chelating agents|mesh-ancestor
25562249|NCT00712010|Sequestering Agents|sequestering agents|mesh-ancestor
25562250|NCT00712010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562251|NCT00712244|Hyaluronic Acid|hyaluronic acid|mesh-list
25562252|NCT00712244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25562253|NCT00712244|Immunologic Factors|immunologic factors|mesh-ancestor
25562254|NCT00712244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562255|NCT00712244|Viscosupplements|viscosupplements|mesh-ancestor
25562256|NCT00712244|Protective Agents|protective agents|mesh-ancestor
25562257|NCT00712270|Risperidone|risperidone|mesh-list
25562258|NCT00712270|Aripiprazole|aripiprazole|mesh-list
25562259|NCT00712270|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25562260|NCT00712270|Serotonin Agents|serotonin agents|mesh-ancestor
25562261|NCT00712270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25562262|NCT00712270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562263|NCT00712270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562264|NCT00712270|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25562265|NCT00712270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25562266|NCT00712270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25562267|NCT00712270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25562268|NCT00712270|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25562269|NCT00712270|Dopamine Agents|dopamine agents|mesh-ancestor
25562270|NCT00712270|Antidepressive Agents|antidepressive agents|mesh-ancestor
25562271|NCT00712270|Dopamine Agonists|dopamine agonists|mesh-ancestor
25562272|NCT00712270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25562273|NCT00712270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25562274|NCT00712270|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25562275|NCT00712270|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25562276|NCT00712335|Fluticasone|fluticasone|mesh-list
25562277|NCT00712335|Xhance|xhance|mesh-list
25562278|NCT00712335|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25562279|NCT00712335|Montelukast|montelukast|mesh-list
25562280|NCT00712335|Leukotriene Antagonists|leukotriene antagonists|mesh-list
25562281|NCT00712335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25562282|NCT00712335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25562283|NCT00712335|Autonomic Agents|autonomic agents|mesh-ancestor
25562284|NCT00712335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25562285|NCT00712335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562286|NCT00712335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25562287|NCT00712335|Respiratory System Agents|respiratory system agents|mesh-ancestor
25562288|NCT00712335|Dermatologic Agents|dermatologic agents|mesh-ancestor
25562289|NCT00712335|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25562290|NCT00712335|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25562291|NCT00712335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25562292|NCT00712335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25562293|NCT00712335|Adrenergic Agents|adrenergic agents|mesh-ancestor
25562294|NCT00712335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25562295|NCT00712335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562296|NCT00712335|Hormone Antagonists|hormone antagonists|mesh-ancestor
25562297|NCT00712335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25562298|NCT00712335|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25562299|NCT00712335|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25562300|NCT00712530|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25562301|NCT00712530|Antiviral Agents|antiviral agents|mesh-ancestor
25562302|NCT00712530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25562303|NCT00712543|Lactulose|lactulose|mesh-list
25562304|NCT00712543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25562305|NCT00712673|Metformin|metformin|mesh-list
25562306|NCT00712673|Lixisenatide|lixisenatide|mesh-list
25562307|NCT00712673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25562308|NCT00712673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562309|NCT00712712|Acetaminophen|acetaminophen|mesh-list
25562310|NCT00712712|Morphine|morphine|mesh-list
25562311|NCT00712712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25562312|NCT00712712|Narcotics|narcotics|mesh-ancestor
25562313|NCT00712712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25562314|NCT00712712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562315|NCT00712712|Analgesics|analgesics|mesh-ancestor
25562316|NCT00712712|Sensory System Agents|sensory system agents|mesh-ancestor
25562317|NCT00712712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25562318|NCT00712712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25562319|NCT00712712|Antipyretics|antipyretics|mesh-ancestor
25562320|NCT00712920|Azelastine|azelastine|mesh-list
25562321|NCT00712920|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25562322|NCT00712920|Autonomic Agents|autonomic agents|mesh-ancestor
25562323|NCT00712920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25562324|NCT00712920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562325|NCT00712920|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25562326|NCT00712920|Respiratory System Agents|respiratory system agents|mesh-ancestor
25562327|NCT00712920|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25562328|NCT00712920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562329|NCT00712920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562330|NCT00712920|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25562331|NCT00712920|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25562332|NCT00712920|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25562333|NCT00712920|Histamine Antagonists|histamine antagonists|mesh-ancestor
25562334|NCT00712920|Histamine Agents|histamine agents|mesh-ancestor
25562335|NCT00712920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25562336|NCT00712985|Zoledronic Acid|zoledronic acid|mesh-list
25562337|NCT00712985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25562338|NCT00712985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562339|NCT00713219|Docetaxel|docetaxel|mesh-list
25562340|NCT00713219|Cetuximab|cetuximab|mesh-list
25562341|NCT00713219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562342|NCT00713219|Tubulin Modulators|tubulin modulators|mesh-ancestor
25562343|NCT00713219|Antimitotic Agents|antimitotic agents|mesh-ancestor
25562344|NCT00713219|Mitosis Modulators|mitosis modulators|mesh-ancestor
25562345|NCT00713219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281916|NCT02328079|Prednisolone phosphate|prednisolone phosphate|mesh-list
25562346|NCT00713219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25562347|NCT00713284|Sirolimus|sirolimus|mesh-list
25562348|NCT00713284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25562349|NCT00713284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24965210|NCT03778567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25562350|NCT00713284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25562351|NCT00713284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562352|NCT00713284|Antifungal Agents|antifungal agents|mesh-ancestor
25562353|NCT00713284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25562354|NCT00713284|Immunologic Factors|immunologic factors|mesh-ancestor
25562355|NCT00713284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562356|NCT00713310|Mesalamine|mesalamine|mesh-list
25562357|NCT00713310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25562358|NCT00713310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24965351|NCT03777423|Cobalt|cobalt|mesh-list
25562359|NCT00713310|Analgesics|analgesics|mesh-ancestor
25562360|NCT00713310|Sensory System Agents|sensory system agents|mesh-ancestor
25562361|NCT00713310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25562362|NCT00713310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562363|NCT00713310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25562364|NCT00713310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25562365|NCT00713323|Nabiximols|nabiximols|mesh-list
25562366|NCT00713323|Analgesics|analgesics|mesh-ancestor
25562367|NCT00713323|Sensory System Agents|sensory system agents|mesh-ancestor
25562368|NCT00713323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25562369|NCT00713323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562370|NCT00713479|Varenicline|varenicline|mesh-list
25562371|NCT00713479|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25562372|NCT00713479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25562373|NCT00713479|Cholinergic Agents|cholinergic agents|mesh-ancestor
25562374|NCT00713479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25562375|NCT00713479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562376|NCT00713479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457303|NCT05173493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25457304|NCT05173493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24791482|NCT04294160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457305|NCT05173493|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25457306|NCT05168618|Atezolizumab|atezolizumab|mesh-list
25457307|NCT05168618|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25457308|NCT05168618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25692914|NCT02006160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282087|NCT02327923|Ondansetron|ondansetron|mesh-list
25282088|NCT02327923|Bupivacaine|bupivacaine|mesh-list
25282089|NCT02327923|Propofol|propofol|mesh-list
25282090|NCT02327923|Neostigmine|neostigmine|mesh-list
25457309|NCT05168618|Immunologic Factors|immunologic factors|mesh-ancestor
25457310|NCT05168618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315826|NCT05001074|Immunologic Factors|immunologic factors|mesh-ancestor
25315827|NCT05001074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979015|NCT01807182|Alkylating Agents|alkylating agents|mesh-ancestor
24979016|NCT01807182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979017|NCT01807182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979018|NCT01807182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24979019|NCT01807182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24916898|NCT04236258|Enalapril|enalapril|mesh-list
25282091|NCT02327923|Vecuronium Bromide|vecuronium bromide|mesh-list
24979021|NCT01807182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24979022|NCT01807182|Analgesics|analgesics|mesh-ancestor
24979023|NCT01807182|Sensory System Agents|sensory system agents|mesh-ancestor
24979024|NCT01807182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24979025|NCT01807182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24979026|NCT01807182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24979027|NCT01807182|Antiviral Agents|antiviral agents|mesh-ancestor
24979028|NCT01807182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24979029|NCT01765140|Amifampridine|amifampridine|mesh-list
24979030|NCT01765140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24979031|NCT01765140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24979032|NCT01765140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979033|NCT01765140|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24979034|NCT01765140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24979035|NCT01765140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979036|NCT01761890|Dasatinib|dasatinib|mesh-list
24979037|NCT01761890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24423188|NCT00225043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24423189|NCT00225043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122360|NCT03094663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24979044|NCT01688076|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24979045|NCT01688076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24979046|NCT01688076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979047|NCT01688076|Cholinergic Agents|cholinergic agents|mesh-ancestor
24979048|NCT01688076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24979049|NCT01688076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979050|NCT01688076|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24979051|NCT01688076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24979052|NCT01556776|Lenalidomide|lenalidomide|mesh-list
24979053|NCT01556776|Immunologic Factors|immunologic factors|mesh-ancestor
24979054|NCT01556776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979055|NCT01556776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25127787|NCT03053284|Hormones|hormones|mesh-ancestor
24979056|NCT01556776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24979057|NCT01556776|Growth Substances|growth substances|mesh-ancestor
24979058|NCT01556776|Growth Inhibitors|growth inhibitors|mesh-ancestor
24979060|NCT01519960|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24979061|NCT01519960|Interferon-alpha|interferon-alpha|mesh-list
24979062|NCT01519960|Antiviral Agents|antiviral agents|mesh-ancestor
24979063|NCT01519960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24979064|NCT01519960|Immunologic Factors|immunologic factors|mesh-ancestor
24979065|NCT01519960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979066|NCT01186640|Vidarabine|vidarabine|mesh-list
24979067|NCT01186640|Cyclophosphamide|cyclophosphamide|mesh-list
24979068|NCT01186640|Fludarabine|fludarabine|mesh-list
24979069|NCT01186640|Fludarabine phosphate|fludarabine phosphate|mesh-list
24979070|NCT01186640|Mitoxantrone|mitoxantrone|mesh-list
24979071|NCT01186640|Alemtuzumab|alemtuzumab|mesh-list
24979072|NCT01186640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24423224|NCT00225160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562377|NCT00713544|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
25562378|NCT00713544|Etanercept|etanercept|mesh-list
25562379|NCT00713544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25562380|NCT00713544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25562381|NCT00713544|Analgesics|analgesics|mesh-ancestor
25562382|NCT00713544|Sensory System Agents|sensory system agents|mesh-ancestor
25562383|NCT00713544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25562384|NCT00713544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562385|NCT00713544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25562386|NCT00713544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25562387|NCT00713544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25562388|NCT00713544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24707130|NCT01494311|Lidocaine|lidocaine|mesh-list
25562389|NCT00713544|Immunologic Factors|immunologic factors|mesh-ancestor
25562390|NCT00713544|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25562391|NCT00713544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562392|NCT00713544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25562393|NCT00713544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25562394|NCT00713544|Antiviral Agents|antiviral agents|mesh-ancestor
25562395|NCT00713544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25562396|NCT00713583|Levodopa|levodopa|mesh-list
25562397|NCT00713583|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25562398|NCT00713583|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24966592|NCT03766893|Naltrexone|naltrexone|mesh-list
25562399|NCT00713583|Dopamine Agents|dopamine agents|mesh-ancestor
25562400|NCT00713583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25562401|NCT00713583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562402|NCT00713583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562403|NCT00713609|Clindamycin|clindamycin|mesh-list
25562404|NCT00713609|Clindamycin palmitate|clindamycin palmitate|mesh-list
25562405|NCT00713609|Clindamycin phosphate|clindamycin phosphate|mesh-list
25562406|NCT00713609|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25562407|NCT00713609|Tazarotene|tazarotene|mesh-list
25562408|NCT00713609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25562409|NCT00713609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25562410|NCT00713609|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25562411|NCT00713609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562412|NCT00713609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562413|NCT00713609|Dermatologic Agents|dermatologic agents|mesh-ancestor
25562414|NCT00713609|Keratolytic Agents|keratolytic agents|mesh-ancestor
25562415|NCT00713817|Nabiximols|nabiximols|mesh-list
25562416|NCT00713817|Analgesics|analgesics|mesh-ancestor
25562417|NCT00713817|Sensory System Agents|sensory system agents|mesh-ancestor
25562418|NCT00713817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25562419|NCT00713817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562420|NCT00713830|Metformin|metformin|mesh-list
25562421|NCT00713830|Lixisenatide|lixisenatide|mesh-list
25562422|NCT00713830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25562423|NCT00713830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562424|NCT00714233|Metformin|metformin|mesh-list
25562425|NCT00714233|Contraceptive Agents|contraceptive agents|mesh-list
25562426|NCT00714233|Contraceptives, Oral|contraceptives, oral|mesh-list
25562427|NCT00714233|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
25562428|NCT00714233|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25562429|NCT00714233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25562430|NCT00714233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562431|NCT00714233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25562432|NCT00714233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25562433|NCT00714259|Fludarabine|fludarabine|mesh-list
25562434|NCT00714259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562435|NCT00714285|Vaccines|vaccines|mesh-list
25562436|NCT00714285|Immunologic Factors|immunologic factors|mesh-ancestor
25562437|NCT00714285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562438|NCT00714493|Infliximab|infliximab|mesh-list
25562439|NCT00714493|Dermatologic Agents|dermatologic agents|mesh-ancestor
25562440|NCT00714493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25562441|NCT00714493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25562442|NCT00714688|Methylphenidate|methylphenidate|mesh-list
25562443|NCT00714688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25562444|NCT00714688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562445|NCT00714688|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25562446|NCT00714688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25562447|NCT00714688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25562448|NCT00714688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562449|NCT00714688|Dopamine Agents|dopamine agents|mesh-ancestor
25562450|NCT00714688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25562451|NCT00714714|Adapalene|adapalene|mesh-list
25562452|NCT00714714|Tretinoin|tretinoin|mesh-list
25562453|NCT00714714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25562454|NCT00714714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25562455|NCT00714714|Analgesics|analgesics|mesh-ancestor
25562456|NCT00714714|Sensory System Agents|sensory system agents|mesh-ancestor
25562457|NCT00714714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25562458|NCT00714714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562459|NCT00714714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25562460|NCT00714714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25562461|NCT00714714|Dermatologic Agents|dermatologic agents|mesh-ancestor
25562462|NCT00714714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562463|NCT00714714|Keratolytic Agents|keratolytic agents|mesh-ancestor
25562464|NCT00715117|Naltrexone|naltrexone|mesh-list
25562465|NCT00715117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25562466|NCT00715117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25562467|NCT00715117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562468|NCT00715117|Sensory System Agents|sensory system agents|mesh-ancestor
25562469|NCT00715117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25562470|NCT00715208|Prednisone|prednisone|mesh-list
25562471|NCT00715208|Cyclophosphamide|cyclophosphamide|mesh-list
25562472|NCT00715208|Rituximab|rituximab|mesh-list
25562473|NCT00715208|Doxorubicin|doxorubicin|mesh-list
25562474|NCT00715208|Bortezomib|bortezomib|mesh-list
25562475|NCT00715208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25562476|NCT00715208|Immunologic Factors|immunologic factors|mesh-ancestor
25562477|NCT00715208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562478|NCT00715208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25562479|NCT00715208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25562480|NCT00715208|Alkylating Agents|alkylating agents|mesh-ancestor
24707743|NCT01497535|Insulin|insulin|mesh-list
25562481|NCT00715208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562482|NCT00715208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562483|NCT00715208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25562484|NCT00715208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25562485|NCT00715208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25562486|NCT00715208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25562487|NCT00715208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25562488|NCT00715208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562489|NCT00715208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25562490|NCT00715208|Glucocorticoids|glucocorticoids|mesh-ancestor
25562491|NCT00715208|Hormones|hormones|mesh-ancestor
25562492|NCT00715208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25562493|NCT00715208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25562494|NCT00715403|Nintedanib|nintedanib|mesh-list
25562495|NCT00715403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562496|NCT00715403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25562497|NCT00715403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562498|NCT00715403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562499|NCT00715429|Vitamin D|vitamin d|mesh-list
25562500|NCT00715429|Ergocalciferols|ergocalciferols|mesh-list
25562501|NCT00715429|Vitamins|vitamins|mesh-ancestor
25562502|NCT00715429|Micronutrients|micronutrients|mesh-ancestor
25562503|NCT00715429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562504|NCT00715429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25562505|NCT00715429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25562506|NCT00715520|Levodopa|levodopa|mesh-list
25562507|NCT00715520|Carbidopa|carbidopa|mesh-list
25562508|NCT00715520|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25562509|NCT00715520|Methylphenidate|methylphenidate|mesh-list
25562510|NCT00715520|Amphetamine|amphetamine|mesh-list
25562511|NCT00715520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25562512|NCT00715520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562513|NCT00715520|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25562514|NCT00715520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25562515|NCT00715520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25562516|NCT00715520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708359|NCT01501136|Mesna|mesna|mesh-list
24796919|NCT01953172|Tocotrienols|tocotrienols|mesh-list
25562517|NCT00715520|Dopamine Agents|dopamine agents|mesh-ancestor
25562518|NCT00715520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25562519|NCT00715520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25562520|NCT00715520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25562521|NCT00715520|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25562522|NCT00715520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562523|NCT00715520|Sympathomimetics|sympathomimetics|mesh-ancestor
25562524|NCT00715520|Autonomic Agents|autonomic agents|mesh-ancestor
25562525|NCT00715520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25282709|NCT03978767|Ibuprofen|ibuprofen|mesh-list
25562526|NCT00715520|Adrenergic Agents|adrenergic agents|mesh-ancestor
25562527|NCT00715520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25562528|NCT00715520|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25562529|NCT00715520|Immunologic Factors|immunologic factors|mesh-ancestor
25562530|NCT00715520|Dopamine Agonists|dopamine agonists|mesh-ancestor
25562531|NCT00715559|Cysteamine|cysteamine|mesh-list
25562532|NCT00715559|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
25562533|NCT00715559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562534|NCT00715624|Metformin|metformin|mesh-list
25562535|NCT00715624|Lixisenatide|lixisenatide|mesh-list
25562536|NCT00715624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25562537|NCT00715624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562538|NCT00715676|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
25562540|NCT00715676|Micronutrients|micronutrients|mesh-ancestor
25562541|NCT00715676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562542|NCT00715676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25562543|NCT00715793|Temozolomide|temozolomide|mesh-list
25562544|NCT00715793|Decitabine|decitabine|mesh-list
25562545|NCT00715793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25562546|NCT00715793|Alkylating Agents|alkylating agents|mesh-ancestor
25562547|NCT00715793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562548|NCT00715793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562549|NCT00715793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25562550|NCT00715793|Antimetabolites|antimetabolites|mesh-ancestor
25562551|NCT00715793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562552|NCT00715884|Sirolimus|sirolimus|mesh-list
25562553|NCT00715884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25562554|NCT00715884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25562555|NCT00715884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25562556|NCT00715884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562557|NCT00715884|Antifungal Agents|antifungal agents|mesh-ancestor
25562558|NCT00715884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25457463|NCT05324891|Sensory System Agents|sensory system agents|mesh-ancestor
25457464|NCT05324891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25457465|NCT05324891|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25457466|NCT05324891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25457467|NCT05324891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25457468|NCT05324891|Adrenergic Agents|adrenergic agents|mesh-ancestor
25457469|NCT05324891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25457470|NCT05324891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457471|NCT05324891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25457472|NCT05324891|Narcotics|narcotics|mesh-ancestor
25457473|NCT05324891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25457474|NCT05324891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25457475|NCT05324891|Anesthetics, General|anesthetics, general|mesh-ancestor
25457476|NCT05324891|Anesthetics|anesthetics|mesh-ancestor
25457477|NCT05323058|Benzydamine|benzydamine|mesh-list
25457478|NCT05323058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25457479|NCT05317403|Cytarabine|cytarabine|mesh-list
25457480|NCT05317403|Fludarabine|fludarabine|mesh-list
25457481|NCT05317403|Venetoclax|venetoclax|mesh-list
25457482|NCT05317403|Vorinostat|vorinostat|mesh-list
25457483|NCT05317403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457484|NCT05317403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25457485|NCT05317403|Antimetabolites|antimetabolites|mesh-ancestor
25457486|NCT05317403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457487|NCT05317403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25457488|NCT05317403|Immunologic Factors|immunologic factors|mesh-ancestor
25562559|NCT00715884|Immunologic Factors|immunologic factors|mesh-ancestor
25562560|NCT00715884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562561|NCT00715910|Vaccines|vaccines|mesh-list
25562562|NCT00715910|Immunologic Factors|immunologic factors|mesh-ancestor
25562563|NCT00715910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651824|NCT01519765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457489|NCT05317403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651825|NCT01519765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25651826|NCT01519765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25651827|NCT01519765|Oxytocics|oxytocics|mesh-ancestor
25651828|NCT01519778|Tedizolid|tedizolid|mesh-list
25651829|NCT01519778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25651830|NCT01519778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25651831|NCT01519791|Methotrexate|methotrexate|mesh-list
25651832|NCT01519791|Certolizumab Pegol|certolizumab pegol|mesh-list
25651833|NCT01519791|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25651834|NCT01519791|Abortifacient Agents|abortifacient agents|mesh-ancestor
25651835|NCT01519791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25651836|NCT01519791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651837|NCT01519791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25651838|NCT01519791|Antimetabolites|antimetabolites|mesh-ancestor
25651839|NCT01519791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651840|NCT01519791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25651841|NCT01519791|Dermatologic Agents|dermatologic agents|mesh-ancestor
25651842|NCT01519791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651843|NCT01519791|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25651844|NCT01519791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25562564|NCT00716079|Metoprolol|metoprolol|mesh-list
25562565|NCT00716079|Clonidine|clonidine|mesh-list
25562566|NCT00716079|Hydralazine|hydralazine|mesh-list
25562567|NCT00716079|Labetalol|labetalol|mesh-list
25562568|NCT00716079|Nicardipine|nicardipine|mesh-list
25562569|NCT00716079|Phentolamine|phentolamine|mesh-list
25562570|NCT00716079|Urapidil|urapidil|mesh-list
25562571|NCT00716079|Enalaprilat|enalaprilat|mesh-list
25562572|NCT00716079|Esmolol|esmolol|mesh-list
25562573|NCT00716079|Glycerol|glycerol|mesh-list
25562574|NCT00716079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25562575|NCT00716079|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25562576|NCT00716079|Sympatholytics|sympatholytics|mesh-ancestor
25562577|NCT00716079|Autonomic Agents|autonomic agents|mesh-ancestor
25562578|NCT00716079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25562579|NCT00716079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562580|NCT00716079|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25562581|NCT00716079|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25562582|NCT00716079|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25562583|NCT00716079|Adrenergic Agents|adrenergic agents|mesh-ancestor
25562584|NCT00716079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25562585|NCT00716079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562586|NCT00716079|Analgesics|analgesics|mesh-ancestor
25562587|NCT00716079|Sensory System Agents|sensory system agents|mesh-ancestor
25562588|NCT00716079|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25562589|NCT00716079|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25562590|NCT00716079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25562591|NCT00716079|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25562592|NCT00716079|Protective Agents|protective agents|mesh-ancestor
25562593|NCT00716079|Vasodilator Agents|vasodilator agents|mesh-ancestor
25562594|NCT00716079|Sympathomimetics|sympathomimetics|mesh-ancestor
25562595|NCT00716079|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25562596|NCT00716079|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25562597|NCT00716079|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25562598|NCT00716079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25562599|NCT00716079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25562600|NCT00716079|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25024713|NCT03643276|Blinatumomab|blinatumomab|mesh-list
25562601|NCT00716079|Serotonin Agents|serotonin agents|mesh-ancestor
25562602|NCT00716079|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25562603|NCT00716079|Protease Inhibitors|protease inhibitors|mesh-ancestor
25562604|NCT00716079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562605|NCT00716092|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25562606|NCT00716092|Linagliptin|linagliptin|mesh-list
25562607|NCT00716092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25562608|NCT00716092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562609|NCT00716092|Incretins|incretins|mesh-ancestor
25562610|NCT00716092|Hormones|hormones|mesh-ancestor
25562611|NCT00716092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25562612|NCT00716092|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25562613|NCT00716092|Protease Inhibitors|protease inhibitors|mesh-ancestor
25562614|NCT00716092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562615|NCT00716092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562616|NCT00716144|R 115866|r 115866|mesh-list
25562617|NCT00716144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25562618|NCT00716144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562619|NCT00716144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562620|NCT00716274|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25562621|NCT00716274|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25562622|NCT00716274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25562623|NCT00716274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25606096|NCT01064414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562624|NCT00716274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562625|NCT00716274|Adrenergic Agents|adrenergic agents|mesh-ancestor
25562626|NCT00716274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25562627|NCT00716274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562628|NCT00716417|Afatinib|afatinib|mesh-list
25562629|NCT00716417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562630|NCT00716417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25562631|NCT00716417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562632|NCT00716417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562633|NCT00716456|Cetuximab|cetuximab|mesh-list
25562634|NCT00716456|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25562635|NCT00716456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25562636|NCT00716456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562637|NCT00716456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25457519|NCT05140941|Sofosbuvir|sofosbuvir|mesh-list
25562638|NCT00716456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606097|NCT01064622|Gemcitabine|gemcitabine|mesh-list
25562639|NCT00716456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562640|NCT00716586|Dorzolamide|dorzolamide|mesh-list
25562641|NCT00716586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25562642|NCT00716586|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25562643|NCT00716586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562644|NCT00716586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562645|NCT00716625|Sunitinib|sunitinib|mesh-list
25562646|NCT00716625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562647|NCT00716625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25562648|NCT00716625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25562649|NCT00716625|Growth Substances|growth substances|mesh-ancestor
25562650|NCT00716625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562651|NCT00716625|Growth Inhibitors|growth inhibitors|mesh-ancestor
25562652|NCT00716625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24470583|NCT00390793|Cortisone|cortisone|mesh-list
25562653|NCT00716625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562654|NCT00716625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562655|NCT00716742|Bimatoprost|bimatoprost|mesh-list
25562656|NCT00716742|Travoprost|travoprost|mesh-list
25562657|NCT00716742|Latanoprost|latanoprost|mesh-list
25562658|NCT00716742|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25562659|NCT00716742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25562660|NCT00716742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25562661|NCT00716820|Sunitinib|sunitinib|mesh-list
25562662|NCT00716820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562663|NCT00716820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25562664|NCT00716820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25562665|NCT00716820|Growth Substances|growth substances|mesh-ancestor
25562666|NCT00716820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562667|NCT00716820|Growth Inhibitors|growth inhibitors|mesh-ancestor
25562668|NCT00716820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25562669|NCT00716820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562670|NCT00716820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562671|NCT00716859|Timolol|timolol|mesh-list
25562672|NCT00716859|Latanoprost|latanoprost|mesh-list
25562673|NCT00716859|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25562674|NCT00716859|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25562675|NCT00716859|Adrenergic Agents|adrenergic agents|mesh-ancestor
25562676|NCT00716859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25046088|NCT00880217|Dopamine Agents|dopamine agents|mesh-ancestor
25562677|NCT00716859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562678|NCT00716859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562679|NCT00716859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25562680|NCT00716859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25562681|NCT00716859|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25562682|NCT00716859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25562683|NCT00716963|Fluticasone|fluticasone|mesh-list
25562684|NCT00716963|Xhance|xhance|mesh-list
25562685|NCT00716963|Budesonide|budesonide|mesh-list
25562686|NCT00716963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25562687|NCT00716963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25562688|NCT00716963|Autonomic Agents|autonomic agents|mesh-ancestor
25562689|NCT00716963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25562690|NCT00716963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562691|NCT00716963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25562692|NCT00716963|Respiratory System Agents|respiratory system agents|mesh-ancestor
25562693|NCT00716963|Dermatologic Agents|dermatologic agents|mesh-ancestor
25562694|NCT00716963|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25562695|NCT00716963|Glucocorticoids|glucocorticoids|mesh-ancestor
25562696|NCT00716963|Hormones|hormones|mesh-ancestor
25562697|NCT00716963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25562698|NCT00716976|Sodium thiosulfate|sodium thiosulfate|mesh-list
25562699|NCT00716976|Antidotes|antidotes|mesh-ancestor
25562700|NCT00716976|Protective Agents|protective agents|mesh-ancestor
25562701|NCT00716976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562702|NCT00716976|Antioxidants|antioxidants|mesh-ancestor
25283542|NCT04192955|Analgesics|analgesics|mesh-ancestor
25283596|NCT04149964|Acetaminophen|acetaminophen|mesh-list
25562703|NCT00716976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562704|NCT00716976|Antitubercular Agents|antitubercular agents|mesh-ancestor
25562705|NCT00716976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25562706|NCT00716976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25562707|NCT00716976|Chelating Agents|chelating agents|mesh-ancestor
25562708|NCT00716976|Sequestering Agents|sequestering agents|mesh-ancestor
25562709|NCT00717054|Scopolamine|scopolamine|mesh-list
25562710|NCT00717054|Aprepitant|aprepitant|mesh-list
25140582|NCT02963103|Tacrolimus|tacrolimus|mesh-list
25562711|NCT00717054|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25562712|NCT00717054|Antiemetics|antiemetics|mesh-ancestor
25457585|NCT04498923|Glucocorticoids|glucocorticoids|mesh-ancestor
25562713|NCT00717054|Autonomic Agents|autonomic agents|mesh-ancestor
25562714|NCT00717054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25562715|NCT00717054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141125|NCT02959606|Sarpogrelate|sarpogrelate|mesh-list
25606098|NCT01064622|Hydrocortisone|hydrocortisone|mesh-list
25606099|NCT01064622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25562716|NCT00717054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25562717|NCT00717054|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25562718|NCT00717054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25562719|NCT00717054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562720|NCT00717054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25562721|NCT00717054|Mydriatics|mydriatics|mesh-ancestor
25562722|NCT00717054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25562723|NCT00717054|Cholinergic Agents|cholinergic agents|mesh-ancestor
25562724|NCT00717054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25562725|NCT00717054|Parasympatholytics|parasympatholytics|mesh-ancestor
25562726|NCT00717067|Ritonavir|ritonavir|mesh-list
25562727|NCT00717067|Saquinavir|saquinavir|mesh-list
25562728|NCT00717067|Maraviroc|maraviroc|mesh-list
25562729|NCT00717067|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25562730|NCT00717067|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25562731|NCT00717067|Protease Inhibitors|protease inhibitors|mesh-ancestor
25562732|NCT00717067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562733|NCT00717067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562734|NCT00717067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25562735|NCT00717067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25562736|NCT00717067|Antiviral Agents|antiviral agents|mesh-ancestor
25562737|NCT00717067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25562738|NCT00717067|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25562739|NCT00717067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25562740|NCT00717067|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25562741|NCT00717067|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25562742|NCT00717067|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25283893|NCT03544736|Paclitaxel|paclitaxel|mesh-list
25562743|NCT00717093|Varenicline|varenicline|mesh-list
25562744|NCT00717093|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25562745|NCT00717093|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25562746|NCT00717093|Cholinergic Agents|cholinergic agents|mesh-ancestor
25562747|NCT00717093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25562748|NCT00717093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562749|NCT00717093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562750|NCT00717197|Capecitabine|capecitabine|mesh-list
25562751|NCT00717197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25562752|NCT00717197|Antimetabolites|antimetabolites|mesh-ancestor
25562753|NCT00717197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562754|NCT00717197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562755|NCT00717236|Certolizumab Pegol|certolizumab pegol|mesh-list
25562756|NCT00717236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25562757|NCT00717236|Immunologic Factors|immunologic factors|mesh-ancestor
25562758|NCT00717236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562759|NCT00717236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25562760|NCT00717288|Insulin Detemir|insulin detemir|mesh-list
25562761|NCT00717288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25562762|NCT00717288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562763|NCT00717314|Mycophenolic Acid|mycophenolic acid|mesh-list
25562764|NCT00717314|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25562765|NCT00717314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562766|NCT00717314|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25562767|NCT00717314|Antitubercular Agents|antitubercular agents|mesh-ancestor
25562768|NCT00717314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25562769|NCT00717314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25562770|NCT00717314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562771|NCT00717314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562772|NCT00717366|Epoetin Alfa|epoetin alfa|mesh-list
25562773|NCT00717366|Hematinics|hematinics|mesh-ancestor
25562774|NCT00717405|Bevacizumab|bevacizumab|mesh-list
25562775|NCT00717405|Trastuzumab|trastuzumab|mesh-list
25562776|NCT00717405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25562777|NCT00717405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562778|NCT00717405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25562779|NCT00717405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25562780|NCT00717405|Growth Substances|growth substances|mesh-ancestor
25562781|NCT00717405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562782|NCT00717405|Growth Inhibitors|growth inhibitors|mesh-ancestor
25562783|NCT00717418|Cyclosporine|cyclosporine|mesh-list
25562784|NCT00717418|Lubricant Eye Drops|lubricant eye drops|mesh-list
25562785|NCT00717418|Cyclosporins|cyclosporins|mesh-list
25562786|NCT00717418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651845|NCT01519791|Immunologic Factors|immunologic factors|mesh-ancestor
25457650|NCT04410965|Teriflunomide|teriflunomide|mesh-list
25562787|NCT00717418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562788|NCT00717418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25562789|NCT00717418|Immunologic Factors|immunologic factors|mesh-ancestor
25562790|NCT00717418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457720|NCT04155424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25457721|NCT04155424|Immunologic Factors|immunologic factors|mesh-ancestor
25457722|NCT04155424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457723|NCT04133792|Simvastatin|simvastatin|mesh-list
25457724|NCT04133792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25457725|NCT04133792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25457726|NCT04133792|Antimetabolites|antimetabolites|mesh-ancestor
25457727|NCT04133792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457728|NCT04133792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25457729|NCT04133792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25457730|NCT04133792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457731|NCT04099849|Zinc|zinc|mesh-list
25457732|NCT04099849|Trace Elements|trace elements|mesh-ancestor
25457733|NCT04099849|Micronutrients|micronutrients|mesh-ancestor
25457734|NCT04099849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457735|NCT04095442|Benzocaine|benzocaine|mesh-list
25457736|NCT04095442|Anesthetics, Local|anesthetics, local|mesh-ancestor
25457737|NCT04095442|Anesthetics|anesthetics|mesh-ancestor
25457738|NCT04095442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25457739|NCT04095442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457740|NCT04095442|Sensory System Agents|sensory system agents|mesh-ancestor
25457741|NCT04095442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25316336|NCT04994119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316340|NCT04993222|Amphotericin B|amphotericin b|mesh-list
25316341|NCT04993222|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25316342|NCT04993222|Amebicides|amebicides|mesh-ancestor
25316343|NCT04993222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25316344|NCT04993222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25316345|NCT04993222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25316346|NCT04993222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25316347|NCT04993222|Antifungal Agents|antifungal agents|mesh-ancestor
25316348|NCT04993014|Trastuzumab|trastuzumab|mesh-list
25316349|NCT04993014|Pertuzumab|pertuzumab|mesh-list
25316350|NCT04993014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25316351|NCT04993014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25316352|NCT04993040|Paclitaxel|paclitaxel|mesh-list
25562791|NCT00717418|Antifungal Agents|antifungal agents|mesh-ancestor
25562792|NCT00717418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25562793|NCT00717418|Dermatologic Agents|dermatologic agents|mesh-ancestor
25562794|NCT00717418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25562795|NCT00717418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25562796|NCT00717418|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25562797|NCT00717418|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25562798|NCT00717522|Pomalidomide|pomalidomide|mesh-list
25562799|NCT00717522|Immunologic Factors|immunologic factors|mesh-ancestor
25562800|NCT00717522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562801|NCT00717522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25562802|NCT00717522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25562803|NCT00717522|Growth Substances|growth substances|mesh-ancestor
25562804|NCT00717522|Growth Inhibitors|growth inhibitors|mesh-ancestor
25562805|NCT00717522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562806|NCT00717574|Nitrous Oxide|nitrous oxide|mesh-list
25562807|NCT00717574|Propofol|propofol|mesh-list
25562808|NCT00717574|Sevoflurane|sevoflurane|mesh-list
25562809|NCT00717574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25562810|NCT00717574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25562811|NCT00717574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562812|NCT00717574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25562813|NCT00717574|Anesthetics, General|anesthetics, general|mesh-ancestor
25562814|NCT00717574|Anesthetics|anesthetics|mesh-ancestor
25562815|NCT00717574|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25562816|NCT00717574|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25562817|NCT00717574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25562818|NCT00717574|Analgesics|analgesics|mesh-ancestor
25562819|NCT00717574|Sensory System Agents|sensory system agents|mesh-ancestor
25562820|NCT00717574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25562821|NCT00717626|Factor VIII|factor viii|mesh-list
25562822|NCT00717626|Coagulants|coagulants|mesh-ancestor
25562823|NCT00717756|Lenalidomide|lenalidomide|mesh-list
25562824|NCT00717756|Immunologic Factors|immunologic factors|mesh-ancestor
25562825|NCT00717756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562826|NCT00717756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25562827|NCT00717756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24965514|NCT03776279|Analgesics|analgesics|mesh-ancestor
25562828|NCT00717756|Growth Substances|growth substances|mesh-ancestor
25562829|NCT00717756|Growth Inhibitors|growth inhibitors|mesh-ancestor
25562830|NCT00717756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562831|NCT00717860|Caspofungin|caspofungin|mesh-list
25562832|NCT00717860|Micafungin|micafungin|mesh-list
25562833|NCT00717860|Antifungal Agents|antifungal agents|mesh-ancestor
25562834|NCT00717860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25562835|NCT00717860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562836|NCT00717860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562837|NCT00718081|Sufentanil|sufentanil|mesh-list
25562838|NCT00718081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25562839|NCT00718081|Narcotics|narcotics|mesh-ancestor
25562840|NCT00718081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25562841|NCT00718081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562842|NCT00718081|Analgesics|analgesics|mesh-ancestor
25562843|NCT00718081|Sensory System Agents|sensory system agents|mesh-ancestor
25562844|NCT00718081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25562845|NCT00718081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25562846|NCT00718081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25562847|NCT00718081|Anesthetics, General|anesthetics, general|mesh-ancestor
25562848|NCT00718081|Anesthetics|anesthetics|mesh-ancestor
25562849|NCT00718315|Erythromycin|erythromycin|mesh-list
25562850|NCT00718315|Erythromycin Estolate|erythromycin estolate|mesh-list
25562851|NCT00718315|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25562852|NCT00718315|Erythromycin stearate|erythromycin stearate|mesh-list
25562853|NCT00718315|Fusidic Acid|fusidic acid|mesh-list
25562854|NCT00718315|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25562855|NCT00718315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562856|NCT00718315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25562857|NCT00718315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562858|NCT00718315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562859|NCT00718315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25562860|NCT00718315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25562861|NCT00718315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25562862|NCT00718315|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25562863|NCT00718328|Simvastatin|simvastatin|mesh-list
25562864|NCT00718328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25562865|NCT00718328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25562866|NCT00718328|Antimetabolites|antimetabolites|mesh-ancestor
25562867|NCT00718328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562868|NCT00718328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25562869|NCT00718328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25562870|NCT00718328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562871|NCT00718523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25562872|NCT00718523|Immunologic Factors|immunologic factors|mesh-ancestor
25562873|NCT00718523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562874|NCT00718549|Cyclophosphamide|cyclophosphamide|mesh-list
25562875|NCT00718549|Rituximab|rituximab|mesh-list
25562876|NCT00718549|Cladribine|cladribine|mesh-list
25562877|NCT00718549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25562878|NCT00718549|Immunologic Factors|immunologic factors|mesh-ancestor
25562879|NCT00718549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562880|NCT00718549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25562881|NCT00718549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25562882|NCT00718549|Alkylating Agents|alkylating agents|mesh-ancestor
25562883|NCT00718549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562884|NCT00718549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562885|NCT00718549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25562886|NCT00718549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25562887|NCT00718718|Methotrexate|methotrexate|mesh-list
25562888|NCT00718718|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25562889|NCT00718718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25562890|NCT00718718|Abortifacient Agents|abortifacient agents|mesh-ancestor
25562891|NCT00718718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25562892|NCT00718718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562893|NCT00718718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25562894|NCT00718718|Antimetabolites|antimetabolites|mesh-ancestor
25562895|NCT00718718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562896|NCT00718718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562897|NCT00718718|Dermatologic Agents|dermatologic agents|mesh-ancestor
25562898|NCT00718718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562899|NCT00718718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25562900|NCT00718718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25562901|NCT00718718|Immunologic Factors|immunologic factors|mesh-ancestor
25562902|NCT00718718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25562903|NCT00718718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25562904|NCT00718770|Bexarotene|bexarotene|mesh-list
25562905|NCT00718770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562906|NCT00718809|Saracatinib|saracatinib|mesh-list
25562907|NCT00718809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562908|NCT00718809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562909|NCT00718809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562910|NCT00718861|Zoledronic Acid|zoledronic acid|mesh-list
25146185|NCT02923687|Ketorolac|ketorolac|mesh-list
25562911|NCT00718861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25562912|NCT00718861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562913|NCT00718887|Entecavir|entecavir|mesh-list
25562914|NCT00718887|Adefovir|adefovir|mesh-list
25562915|NCT00718887|Antiviral Agents|antiviral agents|mesh-ancestor
25562916|NCT00718887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25562917|NCT00718887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25562918|NCT00718887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25562919|NCT00718887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562920|NCT00718887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562921|NCT00719043|Vaccines|vaccines|mesh-list
25562922|NCT00719043|Immunologic Factors|immunologic factors|mesh-ancestor
25562923|NCT00719043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562924|NCT00719134|Rizatriptan|rizatriptan|mesh-list
25562925|NCT00719134|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25562926|NCT00719134|Serotonin Agents|serotonin agents|mesh-ancestor
24760349|NCT01757587|Metformin|metformin|mesh-list
25606100|NCT01064622|Antimetabolites|antimetabolites|mesh-ancestor
25606101|NCT01064622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544469|NCT00689169|Cytarabine|cytarabine|mesh-list
25562927|NCT00719134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25284657|NCT05084456|Antimitotic Agents|antimitotic agents|mesh-ancestor
25562928|NCT00719134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562929|NCT00719134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562930|NCT00719160|Esomeprazole|esomeprazole|mesh-list
25562931|NCT00719160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25562932|NCT00719160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25562933|NCT00719160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25562934|NCT00719160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562935|NCT00719160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562936|NCT00719186|Letrozole|letrozole|mesh-list
25562937|NCT00719186|Clomiphene|clomiphene|mesh-list
25562938|NCT00719186|Enclomiphene|enclomiphene|mesh-list
25562939|NCT00719186|Zuclomiphene|zuclomiphene|mesh-list
25562940|NCT00719186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562941|NCT00719186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562942|NCT00719186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25562943|NCT00719186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25562944|NCT00719186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562945|NCT00719186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25562946|NCT00719186|Hormone Antagonists|hormone antagonists|mesh-ancestor
25562947|NCT00719186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25562948|NCT00719186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562949|NCT00719186|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25562950|NCT00719186|Fertility Agents|fertility agents|mesh-ancestor
25562951|NCT00719186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25562952|NCT00719186|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25562953|NCT00719186|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25562954|NCT00719264|Interferons|interferons|mesh-list
25562955|NCT00719264|Interferon-alpha|interferon-alpha|mesh-list
25562956|NCT00719264|Interferon alpha-2|interferon alpha-2|mesh-list
25562957|NCT00719264|Bevacizumab|bevacizumab|mesh-list
25562958|NCT00719264|Everolimus|everolimus|mesh-list
25562959|NCT00719264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25562960|NCT00719264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562961|NCT00719264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25562962|NCT00719264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25562963|NCT00719264|Growth Substances|growth substances|mesh-ancestor
25562964|NCT00719264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562965|NCT00719264|Growth Inhibitors|growth inhibitors|mesh-ancestor
25562966|NCT00719264|Antiviral Agents|antiviral agents|mesh-ancestor
25562967|NCT00719264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25148226|NCT05310929|Labetalol|labetalol|mesh-list
25562968|NCT00719264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25562969|NCT00719264|Immunologic Factors|immunologic factors|mesh-ancestor
25562970|NCT00719329|Chlorhexidine|chlorhexidine|mesh-list
25148403|NCT05124067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562971|NCT00719329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25562972|NCT00719329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25562973|NCT00719329|Disinfectants|disinfectants|mesh-ancestor
25562974|NCT00719472|Antipyretics|antipyretics|mesh-list
25562975|NCT00719472|Prednisone|prednisone|mesh-list
25457803|NCT03860428|Acetaminophen|acetaminophen|mesh-list
25562976|NCT00719472|Cyclophosphamide|cyclophosphamide|mesh-list
25562977|NCT00719472|Rituximab|rituximab|mesh-list
25562978|NCT00719472|Doxorubicin|doxorubicin|mesh-list
25562979|NCT00719472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25562980|NCT00719472|Vincristine|vincristine|mesh-list
25562981|NCT00719472|Analgesics|analgesics|mesh-list
25562982|NCT00719472|Histamine Antagonists|histamine antagonists|mesh-list
25562983|NCT00719472|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25562984|NCT00719472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25562985|NCT00719472|Immunologic Factors|immunologic factors|mesh-ancestor
25149100|NCT04105270|Carboplatin|carboplatin|mesh-list
25562986|NCT00719472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25562987|NCT00719472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25562988|NCT00719472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25562989|NCT00719472|Alkylating Agents|alkylating agents|mesh-ancestor
25562990|NCT00719472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25562991|NCT00719472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25562992|NCT00719472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25562993|NCT00719472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25562994|NCT00719472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25562995|NCT00719472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25562996|NCT00719472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25562997|NCT00719472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25562998|NCT00719472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25562999|NCT00719472|Glucocorticoids|glucocorticoids|mesh-ancestor
25563000|NCT00719472|Hormones|hormones|mesh-ancestor
25563001|NCT00719472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25563002|NCT00719472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25563003|NCT00719472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25563004|NCT00719472|Tubulin Modulators|tubulin modulators|mesh-ancestor
25563005|NCT00719472|Antimitotic Agents|antimitotic agents|mesh-ancestor
25563006|NCT00719472|Mitosis Modulators|mitosis modulators|mesh-ancestor
24761020|NCT01760655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24761022|NCT01760694|Oxaliplatin|oxaliplatin|mesh-list
24761023|NCT01760694|Irinotecan|irinotecan|mesh-list
24761024|NCT01760694|Folfirinox|folfirinox|mesh-list
24761025|NCT01760694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761026|NCT01760694|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25040815|NCT02813447|Antidepressive Agents|antidepressive agents|mesh-ancestor
24708749|NCT01502774|Cyclosporins|cyclosporins|mesh-list
24708750|NCT01502774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708751|NCT01502774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708752|NCT01502774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24708753|NCT01502774|Immunologic Factors|immunologic factors|mesh-ancestor
24708771|NCT01502904|Sirolimus|sirolimus|mesh-list
25563007|NCT00719472|Sensory System Agents|sensory system agents|mesh-ancestor
25563008|NCT00719472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25285138|NCT05392452|Insulin|insulin|mesh-list
25042076|NCT01515007|Ciprofloxacin|ciprofloxacin|mesh-list
25563009|NCT00719472|Histamine Agents|histamine agents|mesh-ancestor
25563010|NCT00719472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25043549|NCT01242930|Vitamins|vitamins|mesh-ancestor
25563011|NCT00719537|Aspirin|aspirin|mesh-list
25563012|NCT00719537|Progesterone|progesterone|mesh-list
24620238|NCT01056042|Gestodene|gestodene|mesh-list
25043874|NCT01192035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25563013|NCT00719537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25563014|NCT00719537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25563015|NCT00719537|Analgesics|analgesics|mesh-ancestor
25563016|NCT00719537|Sensory System Agents|sensory system agents|mesh-ancestor
25044659|NCT01065012|Udenafil|udenafil|mesh-list
24480505|NCT00431197|Ketoconazole|ketoconazole|mesh-list
24778181|NCT01869803|Gemtuzumab|gemtuzumab|mesh-list
24763797|NCT01777100|Sufentanil|sufentanil|mesh-list
25287130|NCT05013242|Goserelin|goserelin|mesh-list
25563017|NCT00719537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25287614|NCT03541850|Antioxidants|antioxidants|mesh-ancestor
25287711|NCT02864004|Dopamine Agonists|dopamine agonists|mesh-ancestor
24765109|NCT01786018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25115554|NCT03115255|Ranibizumab|ranibizumab|mesh-list
25563018|NCT00719537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288085|NCT04691986|Nicotinic Acids|nicotinic acids|mesh-list
25563019|NCT00719537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25563020|NCT00719537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25563021|NCT00719537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25115903|NCT03112382|Antioxidants|antioxidants|mesh-ancestor
25115975|NCT03111810|Hormones|hormones|mesh-ancestor
25563022|NCT00719537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25563023|NCT00719537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708993|NCT01503658|Purinergic Agents|purinergic agents|mesh-ancestor
25288406|NCT05090592|Atropine|atropine|mesh-list
24767255|NCT01799486|Adefovir|adefovir|mesh-list
24585408|NCT00885443|Anesthetics|anesthetics|mesh-ancestor
24627241|NCT01091376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25080450|NCT03338426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25563024|NCT00719537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25563025|NCT00719537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25116468|NCT03108300|Doxorubicin|doxorubicin|mesh-list
25563026|NCT00719537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25563027|NCT00719537|Antipyretics|antipyretics|mesh-ancestor
25563028|NCT00719537|Progestins|progestins|mesh-ancestor
25563029|NCT00719537|Hormones|hormones|mesh-ancestor
25563030|NCT00719537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25563031|NCT00719706|Acetylcarnitine|acetylcarnitine|mesh-list
25563032|NCT00719706|Vitamin B Complex|vitamin b complex|mesh-ancestor
25563033|NCT00719706|Vitamins|vitamins|mesh-ancestor
25563034|NCT00719706|Micronutrients|micronutrients|mesh-ancestor
24620399|NCT01056874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24767908|NCT01804335|Trifarotene|trifarotene|mesh-list
25563035|NCT00719706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563036|NCT00719706|Nootropic Agents|nootropic agents|mesh-ancestor
24768274|NCT01807078|Ezetimibe|ezetimibe|mesh-list
25563037|NCT00719810|Tigecycline|tigecycline|mesh-list
25563038|NCT00719810|Fluoroquinolones|fluoroquinolones|mesh-list
25563039|NCT00719810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25563040|NCT00719810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25563041|NCT00719810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25563042|NCT00719810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606102|NCT01064622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25117348|NCT05314127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25117349|NCT05314127|Immunologic Factors|immunologic factors|mesh-ancestor
25117350|NCT05314127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289298|NCT03854032|Nivolumab|nivolumab|mesh-list
25606103|NCT01064622|Antiviral Agents|antiviral agents|mesh-ancestor
24769248|NCT01813513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563043|NCT00719810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563044|NCT00719810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25563045|NCT00719849|Cyclosporine|cyclosporine|mesh-list
25563046|NCT00719849|Mycophenolic Acid|mycophenolic acid|mesh-list
25563047|NCT00719849|Cyclophosphamide|cyclophosphamide|mesh-list
25563048|NCT00719849|Fludarabine|fludarabine|mesh-list
25563049|NCT00719849|Fludarabine phosphate|fludarabine phosphate|mesh-list
25563050|NCT00719849|Cyclosporins|cyclosporins|mesh-list
25563051|NCT00719849|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25563052|NCT00719849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25563053|NCT00719849|Immunologic Factors|immunologic factors|mesh-ancestor
25563054|NCT00719849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563055|NCT00719849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25563056|NCT00719849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25563057|NCT00719849|Alkylating Agents|alkylating agents|mesh-ancestor
25563058|NCT00719849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563059|NCT00719849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771170|NCT01825031|Tubulin Modulators|tubulin modulators|mesh-ancestor
25118856|NCT03576716|Calcifediol|calcifediol|mesh-list
24966998|NCT03763669|Vitamins|vitamins|mesh-ancestor
24404075|NCT00162487|Albuterol|albuterol|mesh-list
24772006|NCT01830946|Caseins|caseins|mesh-list
24967090|NCT03762928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25291088|NCT05099614|Naloxone|naloxone|mesh-list
25563060|NCT00719849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25120245|NCT04323956|Glucocorticoids|glucocorticoids|mesh-ancestor
25563061|NCT00719849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25563062|NCT00719849|Antimetabolites|antimetabolites|mesh-ancestor
25563063|NCT00719849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25563064|NCT00719849|Antifungal Agents|antifungal agents|mesh-ancestor
25563065|NCT00719849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25563066|NCT00719849|Dermatologic Agents|dermatologic agents|mesh-ancestor
25563067|NCT00719849|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25563068|NCT00719849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25563069|NCT00719849|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25563070|NCT00719849|Antitubercular Agents|antitubercular agents|mesh-ancestor
25563071|NCT00719849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25563073|NCT00719862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25563074|NCT00719862|Autonomic Agents|autonomic agents|mesh-ancestor
25563075|NCT00719862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25120549|NCT03384784|Autonomic Agents|autonomic agents|mesh-ancestor
25563076|NCT00719862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563077|NCT00719862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25563078|NCT00719862|Respiratory System Agents|respiratory system agents|mesh-ancestor
25563079|NCT00719862|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25563080|NCT00719862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25563081|NCT00719862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563082|NCT00719862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25563083|NCT00719862|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25563084|NCT00719862|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25563085|NCT00719862|Histamine Antagonists|histamine antagonists|mesh-ancestor
25563086|NCT00719862|Histamine Agents|histamine agents|mesh-ancestor
25563087|NCT00719862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25563088|NCT00719901|Bortezomib|bortezomib|mesh-list
25563089|NCT00719901|Obatoclax|obatoclax|mesh-list
25563090|NCT00719901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796944|NCT01953419|Pemetrexed|pemetrexed|mesh-list
25563091|NCT00719901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25563092|NCT00719901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563093|NCT00720057|Naproxen|naproxen|mesh-list
25563094|NCT00720057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25563095|NCT00720057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25563096|NCT00720057|Analgesics|analgesics|mesh-ancestor
25563097|NCT00720057|Sensory System Agents|sensory system agents|mesh-ancestor
25563098|NCT00720057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25563099|NCT00720057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563100|NCT00720057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24773686|NCT01841320|Analgesics|analgesics|mesh-ancestor
25563101|NCT00720057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25563102|NCT00720057|Gout Suppressants|gout suppressants|mesh-ancestor
25563103|NCT00720057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25563104|NCT00720057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25563105|NCT00720057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563106|NCT00720096|Doxorubicin|doxorubicin|mesh-list
25457938|NCT03125811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25457939|NCT03125811|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25457940|NCT02989857|Ivosidenib|ivosidenib|mesh-list
25457941|NCT02989857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457942|NCT02989857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457943|NCT02989857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457944|NCT02983799|Olaparib|olaparib|mesh-list
24712316|NCT01519726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457945|NCT02983799|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25457946|NCT02983799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24712408|NCT01520389|Irinotecan|irinotecan|mesh-list
25457947|NCT02983799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457948|NCT02983799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25563107|NCT00720096|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25563108|NCT00720096|Topotecan|topotecan|mesh-list
25563109|NCT00720096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25563110|NCT00720096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25563111|NCT00720096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25563112|NCT00720096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25563113|NCT00720096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774013|NCT01843296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25563114|NCT00720096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563115|NCT00720096|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25563116|NCT00720109|Calcium, Dietary|calcium, dietary|mesh-list
25563117|NCT00720109|Leucovorin|leucovorin|mesh-list
25563118|NCT00720109|Folic Acid|folic acid|mesh-list
25563119|NCT00720109|Cytarabine|cytarabine|mesh-list
25563120|NCT00720109|Dexamethasone|dexamethasone|mesh-list
25563121|NCT00720109|Dexamethasone acetate|dexamethasone acetate|mesh-list
25563122|NCT00720109|Prednisone|prednisone|mesh-list
25563123|NCT00720109|Methylprednisolone|methylprednisolone|mesh-list
25563124|NCT00720109|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25563125|NCT00720109|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25563126|NCT00720109|Prednisolone|prednisolone|mesh-list
25563127|NCT00720109|Prednisolone acetate|prednisolone acetate|mesh-list
25563128|NCT00720109|Hydrocortisone|hydrocortisone|mesh-list
25563129|NCT00720109|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24712583|NCT01521572|Tocolytic Agents|tocolytic agents|mesh-ancestor
25563130|NCT00720109|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25563131|NCT00720109|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25563132|NCT00720109|Cortisone|cortisone|mesh-list
25563133|NCT00720109|Cyclophosphamide|cyclophosphamide|mesh-list
25563134|NCT00720109|Ifosfamide|ifosfamide|mesh-list
25563135|NCT00720109|Isophosphamide mustard|isophosphamide mustard|mesh-list
25563136|NCT00720109|Methotrexate|methotrexate|mesh-list
25563137|NCT00720109|Etoposide|etoposide|mesh-list
25563138|NCT00720109|Vincristine|vincristine|mesh-list
25563139|NCT00720109|Etoposide phosphate|etoposide phosphate|mesh-list
25563140|NCT00720109|Daunorubicin|daunorubicin|mesh-list
25563141|NCT00720109|Dasatinib|dasatinib|mesh-list
25563142|NCT00720109|Asparaginase|asparaginase|mesh-list
25563143|NCT00720109|Mercaptopurine|mercaptopurine|mesh-list
25563144|NCT00720109|Podophyllotoxin|podophyllotoxin|mesh-list
25563145|NCT00720109|Pegaspargase|pegaspargase|mesh-list
25563146|NCT00720109|Lenograstim|lenograstim|mesh-list
25563147|NCT00720109|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25563148|NCT00720109|Prednisolone phosphate|prednisolone phosphate|mesh-list
25563149|NCT00720109|BB 1101|bb 1101|mesh-list
25563150|NCT00720109|Calcium|calcium|mesh-list
25563151|NCT00720109|Levoleucovorin|levoleucovorin|mesh-list
25563152|NCT00720109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25563153|NCT00720109|Immunologic Factors|immunologic factors|mesh-ancestor
25563154|NCT00720109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563155|NCT00720109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25563156|NCT00720109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25563157|NCT00720109|Alkylating Agents|alkylating agents|mesh-ancestor
25563158|NCT00720109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563159|NCT00720109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24920873|NCT04196998|Tenofovir|tenofovir|mesh-list
25563160|NCT00720109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25563161|NCT00720109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25563162|NCT00720109|Antiemetics|antiemetics|mesh-ancestor
25563163|NCT00720109|Autonomic Agents|autonomic agents|mesh-ancestor
25563164|NCT00720109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25563165|NCT00720109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25563166|NCT00720109|Glucocorticoids|glucocorticoids|mesh-ancestor
25563167|NCT00720109|Hormones|hormones|mesh-ancestor
25563168|NCT00720109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25563169|NCT00720109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25563170|NCT00720109|Protease Inhibitors|protease inhibitors|mesh-ancestor
25563171|NCT00720109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25563172|NCT00720109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25563173|NCT00720109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25563174|NCT00720109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25563175|NCT00720109|Abortifacient Agents|abortifacient agents|mesh-ancestor
25563176|NCT00720109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25563177|NCT00720109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25563178|NCT00720109|Antimetabolites|antimetabolites|mesh-ancestor
25563179|NCT00720109|Dermatologic Agents|dermatologic agents|mesh-ancestor
25563180|NCT00720109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25563181|NCT00720109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25563182|NCT00720109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24716051|NCT01539655|Omeprazole|omeprazole|mesh-list
24921996|NCT04184921|Antipyretics|antipyretics|mesh-ancestor
24615054|NCT01027546|Coagulants|coagulants|mesh-ancestor
25563183|NCT00720109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24623555|NCT01072175|Trametinib|trametinib|mesh-list
24497712|NCT00511576|Docetaxel|docetaxel|mesh-list
25563184|NCT00720109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25563185|NCT00720109|Antiviral Agents|antiviral agents|mesh-ancestor
25563186|NCT00720109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24716820|NCT01544140|Midazolam|midazolam|mesh-list
25563187|NCT00720109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25563188|NCT00720109|Antidotes|antidotes|mesh-ancestor
25563189|NCT00720109|Protective Agents|protective agents|mesh-ancestor
25563190|NCT00720109|Vitamin B Complex|vitamin b complex|mesh-ancestor
25563191|NCT00720109|Vitamins|vitamins|mesh-ancestor
25563192|NCT00720109|Micronutrients|micronutrients|mesh-ancestor
25563193|NCT00720109|Tubulin Modulators|tubulin modulators|mesh-ancestor
25563194|NCT00720109|Antimitotic Agents|antimitotic agents|mesh-ancestor
25563195|NCT00720109|Mitosis Modulators|mitosis modulators|mesh-ancestor
25563196|NCT00720109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25563197|NCT00720109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25563198|NCT00720109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25563199|NCT00720109|Hematinics|hematinics|mesh-ancestor
25563200|NCT00720109|Keratolytic Agents|keratolytic agents|mesh-ancestor
25563201|NCT00720122|Insulin|insulin|mesh-list
25563202|NCT00720122|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25563203|NCT00720122|Mitogens|mitogens|mesh-list
25563204|NCT00720122|Mecasermin|mecasermin|mesh-list
25563205|NCT00720122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25563206|NCT00720122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563207|NCT00720122|Mitosis Modulators|mitosis modulators|mesh-ancestor
25563208|NCT00720122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563209|NCT00720122|Growth Substances|growth substances|mesh-ancestor
25563210|NCT00720226|Losartan|losartan|mesh-list
25563211|NCT00720226|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25563212|NCT00720226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25563213|NCT00720226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24718948|NCT01558167|Immunologic Factors|immunologic factors|mesh-ancestor
24603907|NCT00976092|Anticoagulants|anticoagulants|mesh-ancestor
25563214|NCT00720226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25563215|NCT00720226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563216|NCT00720278|Azelastine|azelastine|mesh-list
25563217|NCT00720278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24719514|NCT01562197|Axitinib|axitinib|mesh-list
25563218|NCT00720278|Autonomic Agents|autonomic agents|mesh-ancestor
25563219|NCT00720278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24606011|NCT00988663|Memantine|memantine|mesh-list
24607173|NCT05072093|Tenofovir|tenofovir|mesh-list
25563220|NCT00720278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563221|NCT00720278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24720382|NCT01568125|Hormones|hormones|mesh-ancestor
25563222|NCT00720278|Respiratory System Agents|respiratory system agents|mesh-ancestor
25563223|NCT00720278|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25563224|NCT00720278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25563225|NCT00720278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563226|NCT00720278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25563227|NCT00720278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25563228|NCT00720278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25563229|NCT00720278|Histamine Antagonists|histamine antagonists|mesh-ancestor
25563230|NCT00720278|Histamine Agents|histamine agents|mesh-ancestor
25563231|NCT00720278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25563232|NCT00720330|Lidocaine|lidocaine|mesh-list
25563233|NCT00720330|Ketamine|ketamine|mesh-list
24509135|NCT00558818|Clevudine|clevudine|mesh-list
25563234|NCT00720330|Ropivacaine|ropivacaine|mesh-list
25563235|NCT00720330|Anesthetics, Local|anesthetics, local|mesh-ancestor
25563236|NCT00720330|Anesthetics|anesthetics|mesh-ancestor
25563237|NCT00720330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25563238|NCT00720330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563239|NCT00720330|Sensory System Agents|sensory system agents|mesh-ancestor
25563240|NCT00720330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25563241|NCT00720330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25563242|NCT00720330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25563243|NCT00720330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25563244|NCT00720330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25606104|NCT01064622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25563245|NCT00720330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563246|NCT00720330|Analgesics|analgesics|mesh-ancestor
25563247|NCT00720330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25563248|NCT00720330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25563249|NCT00720330|Anesthetics, General|anesthetics, general|mesh-ancestor
25563250|NCT00720330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25563251|NCT00720330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25563252|NCT00720330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25563253|NCT00720356|Bevacizumab|bevacizumab|mesh-list
25563254|NCT00720356|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25563255|NCT00720356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24682167|NCT01384578|Vitamin E|vitamin e|mesh-list
24722900|NCT01583439|Ritonavir|ritonavir|mesh-list
25563256|NCT00720356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25563257|NCT00720356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25563258|NCT00720356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25563259|NCT00720356|Growth Substances|growth substances|mesh-ancestor
25606105|NCT01064622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611624|NCT01010139|Analgesics|analgesics|mesh-ancestor
25563260|NCT00720356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563261|NCT00720356|Growth Inhibitors|growth inhibitors|mesh-ancestor
25563262|NCT00720356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25563263|NCT00720356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25563264|NCT00720356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563265|NCT00720369|Ubiquinone|ubiquinone|mesh-list
25563266|NCT00720369|Coenzyme Q10|coenzyme q10|mesh-list
25563267|NCT00720369|Micronutrients|micronutrients|mesh-ancestor
25563268|NCT00720369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563269|NCT00720369|Vitamins|vitamins|mesh-ancestor
25458079|NCT01791478|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25563270|NCT00720382|Mometasone Furoate|mometasone furoate|mesh-list
25563272|NCT00720382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25563273|NCT00720382|Dermatologic Agents|dermatologic agents|mesh-ancestor
24687636|NCT03858621|Fentanyl|fentanyl|mesh-list
25563274|NCT00720382|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25563275|NCT00720382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25563276|NCT00720382|Autonomic Agents|autonomic agents|mesh-ancestor
25563277|NCT00720382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25563278|NCT00720382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563279|NCT00720382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25563280|NCT00720382|Respiratory System Agents|respiratory system agents|mesh-ancestor
25563281|NCT00720382|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25563282|NCT00720382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25563283|NCT00720382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563284|NCT00720382|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25563285|NCT00720382|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25563286|NCT00720382|Histamine Antagonists|histamine antagonists|mesh-ancestor
25563287|NCT00720382|Histamine Agents|histamine agents|mesh-ancestor
25563288|NCT00720382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25563289|NCT00720473|Lamotrigine|lamotrigine|mesh-list
25563290|NCT00720473|Anticonvulsants|anticonvulsants|mesh-ancestor
25563291|NCT00720473|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25563292|NCT00720473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25563293|NCT00720473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563294|NCT00720473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25563295|NCT00720473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069085|NCT03429127|Plasma-lyte 148|plasma-lyte 148|mesh-list
25563296|NCT00720473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25563297|NCT00720473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25563298|NCT00720473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25563299|NCT00720473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25563300|NCT00720473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25563301|NCT00720499|Bromides|bromides|mesh-list
25563302|NCT00720499|Tiotropium Bromide|tiotropium bromide|mesh-list
25563303|NCT00720499|Olodaterol|olodaterol|mesh-list
25563304|NCT00720499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25563305|NCT00720499|Autonomic Agents|autonomic agents|mesh-ancestor
25563306|NCT00720499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25563307|NCT00720499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123099|NCT03088176|Trametinib|trametinib|mesh-list
25563308|NCT00720499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25563309|NCT00720499|Respiratory System Agents|respiratory system agents|mesh-ancestor
25563310|NCT00720499|Parasympatholytics|parasympatholytics|mesh-ancestor
25563311|NCT00720499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25563312|NCT00720499|Cholinergic Agents|cholinergic agents|mesh-ancestor
25563313|NCT00720499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25563314|NCT00720499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563315|NCT00720499|Anticonvulsants|anticonvulsants|mesh-ancestor
25563316|NCT00720629|Methotrexate|methotrexate|mesh-list
25563317|NCT00720629|Tacrolimus|tacrolimus|mesh-list
25563318|NCT00720629|Thymoglobulin|thymoglobulin|mesh-list
25563319|NCT00720629|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25563320|NCT00720629|Visilizumab|visilizumab|mesh-list
25563321|NCT00720629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25563322|NCT00720629|Abortifacient Agents|abortifacient agents|mesh-ancestor
25563323|NCT00720629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25563324|NCT00720629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069373|NCT03426969|Lenograstim|lenograstim|mesh-list
25563325|NCT00720629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25563326|NCT00720629|Antimetabolites|antimetabolites|mesh-ancestor
25563327|NCT00720629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563328|NCT00720629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25563329|NCT00720629|Dermatologic Agents|dermatologic agents|mesh-ancestor
25563330|NCT00720629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25563331|NCT00720629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25563332|NCT00720629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25563333|NCT00720629|Immunologic Factors|immunologic factors|mesh-ancestor
25563334|NCT00720629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25563335|NCT00720629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25563336|NCT00720629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25563337|NCT00720759|Cycloserine|cycloserine|mesh-list
25563338|NCT00720759|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25563339|NCT00720759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25563340|NCT00720759|Renal Agents|renal agents|mesh-ancestor
25563341|NCT00720759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25563342|NCT00720759|Antitubercular Agents|antitubercular agents|mesh-ancestor
25563343|NCT00720759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25458151|NCT01068249|Everolimus|everolimus|mesh-list
25563344|NCT00720759|Antimetabolites|antimetabolites|mesh-ancestor
25563345|NCT00720759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563346|NCT00720798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25563347|NCT00720798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25563348|NCT00720798|Antirheumatic Agents|antirheumatic agents|mesh-list
25563349|NCT00720798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25563350|NCT00720798|Analgesics|analgesics|mesh-ancestor
25563351|NCT00720798|Sensory System Agents|sensory system agents|mesh-ancestor
25563352|NCT00720798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25563353|NCT00720798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563354|NCT00720876|Rituximab|rituximab|mesh-list
25563355|NCT00720876|Vorinostat|vorinostat|mesh-list
25563356|NCT00720876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25563357|NCT00720876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25563358|NCT00720876|Immunologic Factors|immunologic factors|mesh-ancestor
25563359|NCT00720876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563360|NCT00720876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25563361|NCT00720876|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25563362|NCT00720876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25563363|NCT00720876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563364|NCT00720941|Sunitinib|sunitinib|mesh-list
25563365|NCT00720941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25563366|NCT00720941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25563367|NCT00720941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25563368|NCT00720941|Growth Substances|growth substances|mesh-ancestor
25563369|NCT00720941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563370|NCT00720941|Growth Inhibitors|growth inhibitors|mesh-ancestor
25563371|NCT00720941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25563372|NCT00720941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25563373|NCT00720941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563374|NCT00721110|Lidocaine|lidocaine|mesh-list
25563375|NCT00721110|Ketamine|ketamine|mesh-list
25563376|NCT00721110|Anesthetics, Local|anesthetics, local|mesh-ancestor
25563377|NCT00721110|Anesthetics|anesthetics|mesh-ancestor
25563378|NCT00721110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25563379|NCT00721110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731677|NCT01636037|Levodopa|levodopa|mesh-list
24693441|NCT01420471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123589|NCT03083704|Anticoagulants|anticoagulants|mesh-ancestor
25563380|NCT00721110|Sensory System Agents|sensory system agents|mesh-ancestor
25563381|NCT00721110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25563382|NCT00721110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25563383|NCT00721110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24733268|NCT01644825|Paclitaxel|paclitaxel|mesh-list
25693655|NCT02017535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25693665|NCT02017899|Immunologic Factors|immunologic factors|mesh-ancestor
25563384|NCT00721110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25563385|NCT00721110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25563386|NCT00721110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563387|NCT00721110|Analgesics|analgesics|mesh-ancestor
25563388|NCT00721110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24695182|NCT04246762|Vitamin K|vitamin k|mesh-list
25563389|NCT00721110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25563390|NCT00721110|Anesthetics, General|anesthetics, general|mesh-ancestor
25563391|NCT00721110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25563392|NCT00721110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25563393|NCT00721110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25563394|NCT00721136|Heparin|heparin|mesh-list
25563395|NCT00721136|Warfarin|warfarin|mesh-list
25563396|NCT00721136|Anticoagulants|anticoagulants|mesh-ancestor
25563397|NCT00721136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25563398|NCT00721136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25563399|NCT00721136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651846|NCT01519791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25651847|NCT01519791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25651848|NCT01519817|Vaccines|vaccines|mesh-list
25651849|NCT01519817|Immunologic Factors|immunologic factors|mesh-ancestor
24617843|NCT01045902|Ampicillin|ampicillin|mesh-list
25651850|NCT01519817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651851|NCT01519882|Rotigotine|rotigotine|mesh-list
25651852|NCT01519882|Dopamine Agonists|dopamine agonists|mesh-ancestor
25651853|NCT01519882|Dopamine Agents|dopamine agents|mesh-ancestor
25651854|NCT01519882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24738253|NCT01674413|Adalimumab|adalimumab|mesh-list
25606106|NCT01064622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25651855|NCT01519882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651856|NCT01519882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651857|NCT01519921|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25651858|NCT01519921|Antiviral Agents|antiviral agents|mesh-ancestor
25651859|NCT01519921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25656897|NCT01580488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25656898|NCT01580488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656899|NCT01580488|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25458214|NCT00268476|Estrogens|estrogens|mesh-ancestor
25563400|NCT00721162|Ramucirumab|ramucirumab|mesh-list
25563401|NCT00721162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25563402|NCT00721188|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25563403|NCT00721188|Hematinics|hematinics|mesh-ancestor
25563404|NCT00721214|Azacitidine|azacitidine|mesh-list
25563405|NCT00721214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25563406|NCT00721214|Antimetabolites|antimetabolites|mesh-ancestor
25563407|NCT00721214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563408|NCT00721214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25563409|NCT00721214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25563410|NCT00721279|Pramipexole|pramipexole|mesh-list
25124088|NCT03079388|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24739692|NCT01683552|Prednisone|prednisone|mesh-list
25563411|NCT00721279|Antioxidants|antioxidants|mesh-ancestor
25606107|NCT01064622|Immunologic Factors|immunologic factors|mesh-ancestor
25563412|NCT00721279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563413|NCT00721279|Protective Agents|protective agents|mesh-ancestor
25563414|NCT00721279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563415|NCT00721279|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25563416|NCT00721279|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25563417|NCT00721279|Dopamine Agonists|dopamine agonists|mesh-ancestor
25563418|NCT00721279|Dopamine Agents|dopamine agents|mesh-ancestor
24699008|NCT01444248|Metformin|metformin|mesh-list
25563419|NCT00721279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25563420|NCT00721396|Vaccines|vaccines|mesh-list
25606108|NCT01064622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613016|NCT01016249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24613018|NCT01016509|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25563421|NCT00721396|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25563422|NCT00721396|Immunologic Factors|immunologic factors|mesh-ancestor
25563423|NCT00721396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563424|NCT00721409|Letrozole|letrozole|mesh-list
25563425|NCT00721409|Palbociclib|palbociclib|mesh-list
25070828|NCT03415763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25070829|NCT03415763|Antimetabolites|antimetabolites|mesh-ancestor
25070832|NCT03415763|Antidotes|antidotes|mesh-ancestor
25563426|NCT00721409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25563427|NCT00721409|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25563428|NCT00721409|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25563429|NCT00721409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25563430|NCT00721409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124379|NCT03077217|Rifaximin|rifaximin|mesh-list
24741297|NCT01693302|Insulin|insulin|mesh-list
25563431|NCT00721409|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25563432|NCT00721409|Hormone Antagonists|hormone antagonists|mesh-ancestor
25071190|NCT03412500|Vancomycin|vancomycin|mesh-list
25563433|NCT00721409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25563434|NCT00721409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741659|NCT05290857|Hemostatics|hemostatics|mesh-list
25563435|NCT00721409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25563436|NCT00721513|Cisplatin|cisplatin|mesh-list
25563437|NCT00721513|Docetaxel|docetaxel|mesh-list
25563438|NCT00721513|Fluorouracil|fluorouracil|mesh-list
25563439|NCT00721513|Cetuximab|cetuximab|mesh-list
25563440|NCT00721513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25563441|NCT00721513|Tubulin Modulators|tubulin modulators|mesh-ancestor
24547263|NCT00703300|Bortezomib|bortezomib|mesh-list
24742174|NCT05296564|Aldesleukin|aldesleukin|mesh-list
24742186|NCT05296564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24742187|NCT05296564|Analgesics|analgesics|mesh-ancestor
24742188|NCT05296564|Sensory System Agents|sensory system agents|mesh-ancestor
24742189|NCT05296564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24742190|NCT05296564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25563442|NCT00721513|Antimitotic Agents|antimitotic agents|mesh-ancestor
25563443|NCT00721513|Mitosis Modulators|mitosis modulators|mesh-ancestor
25563444|NCT00721513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563445|NCT00721513|Antimetabolites|antimetabolites|mesh-ancestor
24743713|NCT04655144|Autonomic Agents|autonomic agents|mesh-ancestor
24743716|NCT04655144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25563446|NCT00721513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25563447|NCT00721513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25563448|NCT00721513|Immunologic Factors|immunologic factors|mesh-ancestor
25124681|NCT03073408|Propofol|propofol|mesh-list
25563449|NCT00721513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563450|NCT00721513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25563451|NCT00721578|Voriconazole|voriconazole|mesh-list
25563452|NCT00721578|Antifungal Agents|antifungal agents|mesh-ancestor
25563453|NCT00721578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25563454|NCT00721578|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24957658|NCT03842800|Ketamine|ketamine|mesh-list
25563455|NCT00721578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25563456|NCT00721578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24789748|NCT01938911|Oxytocics|oxytocics|mesh-ancestor
25606109|NCT01064622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25606110|NCT01064687|Metformin|metformin|mesh-list
25606111|NCT01064687|Pioglitazone|pioglitazone|mesh-list
25072680|NCT03399903|Mesalamine|mesalamine|mesh-list
25563457|NCT00721578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563458|NCT00721578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25563459|NCT00721578|Hormone Antagonists|hormone antagonists|mesh-ancestor
25563460|NCT00721578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25563461|NCT00721578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563462|NCT00721578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25563463|NCT00721617|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25563464|NCT00721617|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25563465|NCT00721617|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25563466|NCT00721617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25072903|NCT03398837|Sensory System Agents|sensory system agents|mesh-ancestor
25072904|NCT03398837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24634397|NCT01133366|Mipomersen|mipomersen|mesh-list
25458287|NCT04903353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25458288|NCT04903353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25458289|NCT04903353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25458290|NCT04903353|Dopamine Agents|dopamine agents|mesh-ancestor
25563467|NCT00721630|Capecitabine|capecitabine|mesh-list
25563468|NCT00721630|Lapatinib|lapatinib|mesh-list
25606113|NCT01064687|Dulaglutide|dulaglutide|mesh-list
25563469|NCT00721630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25563470|NCT00721630|Antimetabolites|antimetabolites|mesh-ancestor
25563471|NCT00721630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563472|NCT00721630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25563473|NCT00721630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25563474|NCT00721630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25563475|NCT00721955|Loxapine|loxapine|mesh-list
25563476|NCT00721955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25563477|NCT00721955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25563478|NCT00721955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25563479|NCT00721955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563480|NCT00721955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25563481|NCT00721955|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25563482|NCT00721955|Dopamine Agents|dopamine agents|mesh-ancestor
25563483|NCT00721955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25563484|NCT00721955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563485|NCT00722072|Sorafenib|sorafenib|mesh-list
25563486|NCT00722072|Fulvestrant|fulvestrant|mesh-list
25563487|NCT00722072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25563488|NCT00722072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25563489|NCT00722072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25563490|NCT00722072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563491|NCT00722072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25563492|NCT00722072|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25563493|NCT00722072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25563494|NCT00722072|Hormone Antagonists|hormone antagonists|mesh-ancestor
25563495|NCT00722072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25563496|NCT00722072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563497|NCT00722137|Prednisone|prednisone|mesh-list
25563498|NCT00722137|Cyclophosphamide|cyclophosphamide|mesh-list
25563499|NCT00722137|Rituximab|rituximab|mesh-list
25563500|NCT00722137|Doxorubicin|doxorubicin|mesh-list
24421926|NCT00220584|Nootropic Agents|nootropic agents|mesh-ancestor
24757331|NCT01739218|Paclitaxel|paclitaxel|mesh-list
25563501|NCT00722137|Vincristine|vincristine|mesh-list
25563502|NCT00722137|Bortezomib|bortezomib|mesh-list
25563503|NCT00722137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25563504|NCT00722137|Immunologic Factors|immunologic factors|mesh-ancestor
25563505|NCT00722137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563506|NCT00722137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25563507|NCT00722137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25563508|NCT00722137|Alkylating Agents|alkylating agents|mesh-ancestor
25563509|NCT00722137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563510|NCT00722137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25563511|NCT00722137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25563512|NCT00722137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25563513|NCT00722137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25563514|NCT00722137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25563515|NCT00722137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25563516|NCT00722137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25563517|NCT00722137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25563518|NCT00722137|Glucocorticoids|glucocorticoids|mesh-ancestor
25563519|NCT00722137|Hormones|hormones|mesh-ancestor
25563520|NCT00722137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25563521|NCT00722137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25563522|NCT00722137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25563523|NCT00722137|Tubulin Modulators|tubulin modulators|mesh-ancestor
25563524|NCT00722137|Antimitotic Agents|antimitotic agents|mesh-ancestor
25563525|NCT00722137|Mitosis Modulators|mitosis modulators|mesh-ancestor
25563526|NCT00722371|Metformin|metformin|mesh-list
25563527|NCT00722371|Pioglitazone|pioglitazone|mesh-list
25563528|NCT00722371|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25563529|NCT00722371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25563530|NCT00722371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563531|NCT00722371|Incretins|incretins|mesh-ancestor
25563532|NCT00722371|Hormones|hormones|mesh-ancestor
25563533|NCT00722371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25563534|NCT00722371|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25563535|NCT00722371|Protease Inhibitors|protease inhibitors|mesh-ancestor
25563536|NCT00722371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25563537|NCT00722371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563538|NCT00722436|Tranexamic Acid|tranexamic acid|mesh-list
25563539|NCT00722436|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25563540|NCT00722436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25606114|NCT01064687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24758597|NCT01746992|Immunologic Factors|immunologic factors|mesh-ancestor
25563541|NCT00722436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563542|NCT00722436|Hemostatics|hemostatics|mesh-ancestor
25458350|NCT04693715|RNS60|rns60|mesh-list
25563543|NCT00722436|Coagulants|coagulants|mesh-ancestor
25563544|NCT00722553|Vitamins|vitamins|mesh-list
25563545|NCT00722553|Folic Acid|folic acid|mesh-list
25563546|NCT00722553|Vitamin B 12|vitamin b 12|mesh-list
25563547|NCT00722553|Hydroxocobalamin|hydroxocobalamin|mesh-list
25563548|NCT00722553|Vitamin B Complex|vitamin b complex|mesh-list
25563549|NCT00722553|10-deazaaminopterin|10-deazaaminopterin|mesh-list
25563550|NCT00722553|Aminopterin|aminopterin|mesh-list
25563551|NCT00722553|Micronutrients|micronutrients|mesh-ancestor
25563552|NCT00722553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563553|NCT00722553|Hematinics|hematinics|mesh-ancestor
25563554|NCT00722553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25563555|NCT00722553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25563556|NCT00722553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563557|NCT00722553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25563558|NCT00722566|Bortezomib|bortezomib|mesh-list
25563559|NCT00722566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25563560|NCT00722722|Bortezomib|bortezomib|mesh-list
25563561|NCT00722722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25563562|NCT00722761|Drospirenone|drospirenone|mesh-list
25563563|NCT00722761|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25563564|NCT00722761|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
25563565|NCT00722761|Estradiol|estradiol|mesh-list
25563566|NCT00722761|Estrogens|estrogens|mesh-ancestor
25563567|NCT00722761|Hormones|hormones|mesh-ancestor
25563568|NCT00722761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25563569|NCT00722761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563570|NCT00722761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25563571|NCT00722761|Contraceptive Agents|contraceptive agents|mesh-ancestor
25563572|NCT00722761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25563573|NCT00722761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25563574|NCT00722761|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25563575|NCT00722761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25563576|NCT00722761|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25563577|NCT00722761|Hormone Antagonists|hormone antagonists|mesh-ancestor
25563578|NCT00722761|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25563579|NCT00722761|Diuretics|diuretics|mesh-ancestor
25563580|NCT00722761|Natriuretic Agents|natriuretic agents|mesh-ancestor
25563581|NCT00722800|Drospirenone|drospirenone|mesh-list
25563582|NCT00722800|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25563583|NCT00722800|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
25563584|NCT00722800|Estradiol|estradiol|mesh-list
25563585|NCT00722800|Estrogens|estrogens|mesh-ancestor
25563586|NCT00722800|Hormones|hormones|mesh-ancestor
25563587|NCT00722800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24459774|NCT00346359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25563588|NCT00722800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563589|NCT00722800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25563590|NCT00722800|Contraceptive Agents|contraceptive agents|mesh-ancestor
25563591|NCT00722800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25563592|NCT00722800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25563593|NCT00722800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25563594|NCT00722800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25563595|NCT00722800|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25563596|NCT00722800|Hormone Antagonists|hormone antagonists|mesh-ancestor
24394406|NCT00133237|Mitosis Modulators|mitosis modulators|mesh-ancestor
24394407|NCT00133237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563597|NCT00722800|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25563598|NCT00722800|Diuretics|diuretics|mesh-ancestor
25125402|NCT03069027|Autonomic Agents|autonomic agents|mesh-ancestor
25563599|NCT00722800|Natriuretic Agents|natriuretic agents|mesh-ancestor
25563600|NCT00722865|Bevacizumab|bevacizumab|mesh-list
24400579|NCT00150891|Mycophenolic Acid|mycophenolic acid|mesh-list
25563601|NCT00722865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25563602|NCT00722865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25563603|NCT00722865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25563604|NCT00722865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25563605|NCT00722865|Growth Substances|growth substances|mesh-ancestor
25563606|NCT00722865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563607|NCT00722865|Growth Inhibitors|growth inhibitors|mesh-ancestor
25563608|NCT00723021|Zileuton|zileuton|mesh-list
25563609|NCT00723021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25563610|NCT00723021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25563611|NCT00723021|Analgesics|analgesics|mesh-ancestor
25563612|NCT00723021|Sensory System Agents|sensory system agents|mesh-ancestor
25563613|NCT00723021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25563614|NCT00723021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563615|NCT00723021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25563616|NCT00723021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25563617|NCT00723021|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25563618|NCT00723021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25458408|NCT04401579|Remdesivir|remdesivir|mesh-list
25458480|NCT04080427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25458481|NCT04070157|Lofexidine|lofexidine|mesh-list
25458482|NCT04070157|Clonidine|clonidine|mesh-list
25458483|NCT04070157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25125554|NCT03067883|Ritonavir|ritonavir|mesh-list
25458484|NCT04070157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25458485|NCT04070157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458486|NCT04070157|Sensory System Agents|sensory system agents|mesh-ancestor
25458487|NCT04070157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25458488|NCT04070157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25458489|NCT04070157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25458490|NCT04070157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25458491|NCT04070157|Adrenergic Agents|adrenergic agents|mesh-ancestor
25458492|NCT04070157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25458493|NCT04070157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458494|NCT04070157|Analgesics|analgesics|mesh-ancestor
25458495|NCT04070157|Sympatholytics|sympatholytics|mesh-ancestor
25458496|NCT04070157|Autonomic Agents|autonomic agents|mesh-ancestor
25458497|NCT03973333|Atezolizumab|atezolizumab|mesh-list
25458498|NCT03973333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25317225|NCT04981327|Apixaban|apixaban|mesh-list
25317226|NCT04981327|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24979077|NCT01186640|Alkylating Agents|alkylating agents|mesh-ancestor
25010701|NCT03296553|Valganciclovir|valganciclovir|mesh-list
25074539|NCT03387592|Leucovorin|leucovorin|mesh-list
24699567|NCT01447654|Losartan|losartan|mesh-list
24979078|NCT01186640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979079|NCT01186640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979080|NCT01186640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24979081|NCT01186640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24979082|NCT01186640|Antimetabolites|antimetabolites|mesh-ancestor
24979083|NCT01186640|Antiviral Agents|antiviral agents|mesh-ancestor
24979084|NCT01186640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24979085|NCT01186640|Analgesics|analgesics|mesh-ancestor
24979086|NCT01186640|Sensory System Agents|sensory system agents|mesh-ancestor
24998459|NCT02691793|Sunitinib|sunitinib|mesh-list
24979087|NCT01186640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25822695|NCT00004582|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24998999|NCT05393713|Antibodies|antibodies|mesh-list
25822696|NCT00004582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24423225|NCT00225160|Nootropic Agents|nootropic agents|mesh-ancestor
24423226|NCT00225173|Gemcitabine|gemcitabine|mesh-list
24423228|NCT00225173|Cyclophosphamide|cyclophosphamide|mesh-list
24423229|NCT00225173|Doxorubicin|doxorubicin|mesh-list
24423242|NCT00225173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423302|NCT00225355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24423303|NCT00225355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423304|NCT00225381|Anesthetics|anesthetics|mesh-list
25122411|NCT03094507|Cobicistat|cobicistat|mesh-list
25122412|NCT03094507|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25122413|NCT03094507|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24423305|NCT00225381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24423306|NCT00225381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423307|NCT00225433|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24423308|NCT00225433|Ganirelix|ganirelix|mesh-list
24423309|NCT00225433|Hormones|hormones|mesh-ancestor
24423310|NCT00225433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25822697|NCT00004582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25822698|NCT00004583|Ritonavir|ritonavir|mesh-list
25563619|NCT00723021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563620|NCT00723021|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24979088|NCT01186640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24798353|NCT01963039|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24914990|NCT05252117|Carticaine|carticaine|mesh-list
24979089|NCT01186640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25563621|NCT00723021|Hormone Antagonists|hormone antagonists|mesh-ancestor
25563622|NCT00723021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25563623|NCT00723099|Cyclosporine|cyclosporine|mesh-list
25563624|NCT00723099|Mycophenolic Acid|mycophenolic acid|mesh-list
25563625|NCT00723099|Cyclophosphamide|cyclophosphamide|mesh-list
25563626|NCT00723099|Fludarabine|fludarabine|mesh-list
24937584|NCT04027517|Darbepoetin alfa|darbepoetin alfa|mesh-list
25563627|NCT00723099|Fludarabine phosphate|fludarabine phosphate|mesh-list
25563628|NCT00723099|Cyclosporins|cyclosporins|mesh-list
25563629|NCT00723099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25563630|NCT00723099|Immunologic Factors|immunologic factors|mesh-ancestor
25563631|NCT00723099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563632|NCT00723099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25563633|NCT00723099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25563634|NCT00723099|Alkylating Agents|alkylating agents|mesh-ancestor
25563635|NCT00723099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563636|NCT00723099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25563637|NCT00723099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25563638|NCT00723099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25563639|NCT00723099|Antimetabolites|antimetabolites|mesh-ancestor
25563640|NCT00723099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25563641|NCT00723099|Antifungal Agents|antifungal agents|mesh-ancestor
25563642|NCT00723099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25563643|NCT00723099|Dermatologic Agents|dermatologic agents|mesh-ancestor
25563644|NCT00723099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25563645|NCT00723099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25563646|NCT00723099|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25563647|NCT00723099|Antitubercular Agents|antitubercular agents|mesh-ancestor
25563648|NCT00723099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25563650|NCT00723125|Bevacizumab|bevacizumab|mesh-list
25563651|NCT00723125|Carboplatin|carboplatin|mesh-list
25563652|NCT00723125|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25563653|NCT00723125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25563654|NCT00723125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25563655|NCT00723125|Tubulin Modulators|tubulin modulators|mesh-ancestor
25563656|NCT00723125|Antimitotic Agents|antimitotic agents|mesh-ancestor
25563657|NCT00723125|Mitosis Modulators|mitosis modulators|mesh-ancestor
24999787|NCT03246529|Immunologic Factors|immunologic factors|mesh-ancestor
24999788|NCT03246529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999792|NCT03188796|Vitamin D|vitamin d|mesh-list
24999793|NCT03188796|Cholecalciferol|cholecalciferol|mesh-list
25563658|NCT00723125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563659|NCT00723125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25563660|NCT00723125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25563661|NCT00723125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25563662|NCT00723125|Growth Substances|growth substances|mesh-ancestor
25563663|NCT00723125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563664|NCT00723125|Growth Inhibitors|growth inhibitors|mesh-ancestor
25563665|NCT00723177|Ibudilast|ibudilast|mesh-list
25563666|NCT00723177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25563667|NCT00723177|Autonomic Agents|autonomic agents|mesh-ancestor
25563668|NCT00723177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25563669|NCT00723177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563670|NCT00723177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25563671|NCT00723177|Respiratory System Agents|respiratory system agents|mesh-ancestor
25563672|NCT00723177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25048842|NCT00662597|Paclitaxel|paclitaxel|mesh-list
25563673|NCT00723177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25563674|NCT00723177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563675|NCT00723177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25563676|NCT00723177|Vasodilator Agents|vasodilator agents|mesh-ancestor
25563677|NCT00723190|Clonidine|clonidine|mesh-list
25563678|NCT00723190|Analgesics|analgesics|mesh-ancestor
25563679|NCT00723190|Sensory System Agents|sensory system agents|mesh-ancestor
25563680|NCT00723190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25563681|NCT00723190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563682|NCT00723190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25563683|NCT00723190|Sympatholytics|sympatholytics|mesh-ancestor
25563684|NCT00723190|Autonomic Agents|autonomic agents|mesh-ancestor
25563685|NCT00723190|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25563686|NCT00723190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25563687|NCT00723190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25563688|NCT00723190|Adrenergic Agents|adrenergic agents|mesh-ancestor
25563689|NCT00723190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25563690|NCT00723190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563691|NCT00723203|Panobinostat|panobinostat|mesh-list
25563692|NCT00723203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25563693|NCT00723203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25563694|NCT00723203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25563695|NCT00723203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563696|NCT00723229|Acyclovir|acyclovir|mesh-list
25563697|NCT00723229|Antiviral Agents|antiviral agents|mesh-ancestor
25563698|NCT00723229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25563699|NCT00723255|Sirolimus|sirolimus|mesh-list
25563700|NCT00723255|Bevacizumab|bevacizumab|mesh-list
25563701|NCT00723255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25563702|NCT00723255|Antibodies|antibodies|mesh-list
25563703|NCT00723255|Immunoglobulins|immunoglobulins|mesh-list
25563704|NCT00723255|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25563705|NCT00723255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25563706|NCT00723255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25563707|NCT00723255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25563708|NCT00723255|Growth Substances|growth substances|mesh-ancestor
25563709|NCT00723255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563710|NCT00723255|Growth Inhibitors|growth inhibitors|mesh-ancestor
25563711|NCT00723255|Immunologic Factors|immunologic factors|mesh-ancestor
25563712|NCT00723255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25563713|NCT00723255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25563714|NCT00723255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25563715|NCT00723255|Antifungal Agents|antifungal agents|mesh-ancestor
25563716|NCT00723255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25563717|NCT00723398|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25563718|NCT00723398|Pitavastatin|pitavastatin|mesh-list
25563719|NCT00723398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25563720|NCT00723398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25563721|NCT00723398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25563722|NCT00723398|Antimetabolites|antimetabolites|mesh-ancestor
25563723|NCT00723398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563724|NCT00723398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25563725|NCT00723398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25563726|NCT00723398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25563727|NCT00723398|Hormone Antagonists|hormone antagonists|mesh-ancestor
25563728|NCT00723398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25563729|NCT00723398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563730|NCT00723398|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25563731|NCT00723398|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25563732|NCT00723398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25563733|NCT00723450|Lamotrigine|lamotrigine|mesh-list
25563734|NCT00723450|Anticonvulsants|anticonvulsants|mesh-ancestor
25563735|NCT00723450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25049004|NCT00647231|Sensory System Agents|sensory system agents|mesh-ancestor
25049007|NCT00647231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25563736|NCT00723450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25563737|NCT00723450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563738|NCT00723450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25563739|NCT00723450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563740|NCT00723450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25563741|NCT00723450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25563742|NCT00723450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25563743|NCT00723450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25563744|NCT00723450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25563745|NCT00723528|Ustekinumab|ustekinumab|mesh-list
25563746|NCT00723528|Dermatologic Agents|dermatologic agents|mesh-ancestor
25563747|NCT00723554|Iloprost|iloprost|mesh-list
25563748|NCT00723554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25563749|NCT00723554|Vasodilator Agents|vasodilator agents|mesh-ancestor
25563750|NCT00723580|Risperidone|risperidone|mesh-list
25563751|NCT00723580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25563752|NCT00723580|Serotonin Agents|serotonin agents|mesh-ancestor
25563753|NCT00723580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25563754|NCT00723580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563755|NCT00723580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563756|NCT00723580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25563757|NCT00723580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25563758|NCT00723580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25563759|NCT00723580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25563760|NCT00723580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25563761|NCT00723580|Dopamine Agents|dopamine agents|mesh-ancestor
25563762|NCT00723606|Haloperidol|haloperidol|mesh-list
25563763|NCT00723606|Haloperidol decanoate|haloperidol decanoate|mesh-list
25563764|NCT00723606|Ziprasidone|ziprasidone|mesh-list
25563765|NCT00723606|Antiemetics|antiemetics|mesh-ancestor
25563766|NCT00723606|Autonomic Agents|autonomic agents|mesh-ancestor
24826104|NCT02132403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25001440|NCT05302271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25001441|NCT05302271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065868|NCT05045378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25065869|NCT05045378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25065870|NCT05045378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25563767|NCT00723606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25563768|NCT00723606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065896|NCT04966481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25563769|NCT00723606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25563770|NCT00723606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25563771|NCT00723606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25563772|NCT00723606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25563773|NCT00723606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25563774|NCT00723606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25563775|NCT00723606|Dopamine Agents|dopamine agents|mesh-ancestor
25563776|NCT00723606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25001745|NCT05132660|Levodopa|levodopa|mesh-list
25001746|NCT05132660|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25563777|NCT00723606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563778|NCT00723606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25563779|NCT00723606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25563780|NCT00723606|Serotonin Agents|serotonin agents|mesh-ancestor
25563781|NCT00723632|Ribavirin|ribavirin|mesh-list
25563782|NCT00723632|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25563783|NCT00723632|Antimetabolites|antimetabolites|mesh-ancestor
25563784|NCT00723632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563785|NCT00723632|Antiviral Agents|antiviral agents|mesh-ancestor
24393914|NCT00131261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25563786|NCT00723632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25563787|NCT00723697|Buprenorphine|buprenorphine|mesh-list
25563788|NCT00723697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25563789|NCT00723697|Narcotics|narcotics|mesh-ancestor
25563790|NCT00723697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24916372|NCT04241523|Lenvatinib|lenvatinib|mesh-list
25563791|NCT00723697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563792|NCT00723697|Analgesics|analgesics|mesh-ancestor
25563793|NCT00723697|Sensory System Agents|sensory system agents|mesh-ancestor
25563794|NCT00723697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25563795|NCT00723697|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25563796|NCT00723710|Interferons|interferons|mesh-list
25563797|NCT00723710|Interferon-alpha|interferon-alpha|mesh-list
25563798|NCT00723710|Interferon alpha-2|interferon alpha-2|mesh-list
25563799|NCT00723710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25563800|NCT00723710|Antiviral Agents|antiviral agents|mesh-ancestor
25563801|NCT00723710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25563802|NCT00723710|Immunologic Factors|immunologic factors|mesh-ancestor
25563803|NCT00723710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563804|NCT00723749|Buprenorphine|buprenorphine|mesh-list
25563805|NCT00723749|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25563806|NCT00723749|Naloxone|naloxone|mesh-list
25563807|NCT00723749|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25563808|NCT00723749|Narcotics|narcotics|mesh-ancestor
25002519|NCT04573946|Vitamin D|vitamin d|mesh-list
25563809|NCT00723749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25563810|NCT00723749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563811|NCT00723749|Analgesics|analgesics|mesh-ancestor
25563812|NCT00723749|Sensory System Agents|sensory system agents|mesh-ancestor
25563813|NCT00723749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25563814|NCT00723749|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25563815|NCT00723801|Losartan|losartan|mesh-list
25563816|NCT00723801|Atenolol|atenolol|mesh-list
25563817|NCT00723801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24520522|NCT05337969|Vildagliptin|vildagliptin|mesh-list
25563818|NCT00723801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25563819|NCT00723801|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25563820|NCT00723801|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25563821|NCT00723801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563822|NCT00723801|Sympatholytics|sympatholytics|mesh-ancestor
25563823|NCT00723801|Autonomic Agents|autonomic agents|mesh-ancestor
25563824|NCT00723801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25563825|NCT00723801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563826|NCT00723801|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25563827|NCT00723801|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25563828|NCT00723801|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24916936|NCT04235426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25563829|NCT00723801|Adrenergic Agents|adrenergic agents|mesh-ancestor
25563830|NCT00723801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24916938|NCT04235426|Analgesics|analgesics|mesh-ancestor
25563831|NCT00723827|Temozolomide|temozolomide|mesh-list
25563832|NCT00723827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25563833|NCT00723827|Alkylating Agents|alkylating agents|mesh-ancestor
25563834|NCT00723827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563835|NCT00723827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25563836|NCT00723892|Ribavirin|ribavirin|mesh-list
25563837|NCT00723892|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25563838|NCT00723892|Interferon-alpha|interferon-alpha|mesh-list
25563839|NCT00723892|Antimetabolites|antimetabolites|mesh-ancestor
25563840|NCT00723892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563841|NCT00723892|Antiviral Agents|antiviral agents|mesh-ancestor
25563842|NCT00723892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25563843|NCT00723892|Immunologic Factors|immunologic factors|mesh-ancestor
25563844|NCT00723892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563845|NCT00723931|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25563846|NCT00723931|Antiviral Agents|antiviral agents|mesh-ancestor
25563847|NCT00723931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25563848|NCT00723957|Paclitaxel|paclitaxel|mesh-list
25563849|NCT00723957|Carboplatin|carboplatin|mesh-list
25563850|NCT00723957|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25563851|NCT00723957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25563852|NCT00723957|Tubulin Modulators|tubulin modulators|mesh-ancestor
25563853|NCT00723957|Antimitotic Agents|antimitotic agents|mesh-ancestor
25563854|NCT00723957|Mitosis Modulators|mitosis modulators|mesh-ancestor
25563855|NCT00723957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563856|NCT00724009|Clofarabine|clofarabine|mesh-list
25563857|NCT00724009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25563858|NCT00724009|Antimetabolites|antimetabolites|mesh-ancestor
25563859|NCT00724009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563860|NCT00724009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25563861|NCT00724061|Interferons|interferons|mesh-list
25563862|NCT00724061|Interferon-alpha|interferon-alpha|mesh-list
25563863|NCT00724061|Interferon alpha-2|interferon alpha-2|mesh-list
25563864|NCT00724061|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25563865|NCT00724061|Furocoumarins|furocoumarins|mesh-list
25563866|NCT00724061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25563867|NCT00724061|Antiviral Agents|antiviral agents|mesh-ancestor
25563868|NCT00724061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25563869|NCT00724061|Immunologic Factors|immunologic factors|mesh-ancestor
25563870|NCT00724061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563871|NCT00724061|Dermatologic Agents|dermatologic agents|mesh-ancestor
25563872|NCT00724061|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25563873|NCT00724126|Rifaximin|rifaximin|mesh-list
25563874|NCT00724126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25563875|NCT00724126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25563876|NCT00724126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25563877|NCT00724243|Infliximab|infliximab|mesh-list
25563878|NCT00724243|Dermatologic Agents|dermatologic agents|mesh-ancestor
25563879|NCT00724243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25563880|NCT00724243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25563881|NCT00724373|Ribavirin|ribavirin|mesh-list
25563882|NCT00724373|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25563883|NCT00724373|Antimetabolites|antimetabolites|mesh-ancestor
25563884|NCT00724373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563885|NCT00724373|Antiviral Agents|antiviral agents|mesh-ancestor
25563886|NCT00724373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25563887|NCT00724451|Ribavirin|ribavirin|mesh-list
25563888|NCT00724451|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25563889|NCT00724451|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25563890|NCT00724451|Antimetabolites|antimetabolites|mesh-ancestor
25563891|NCT00724451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563892|NCT00724451|Antiviral Agents|antiviral agents|mesh-ancestor
25563893|NCT00724451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25563894|NCT00724464|Interferons|interferons|mesh-list
25563895|NCT00724464|Ribavirin|ribavirin|mesh-list
25563896|NCT00724464|Interferon-alpha|interferon-alpha|mesh-list
25563897|NCT00724464|Interferon alpha-2|interferon alpha-2|mesh-list
25563898|NCT00724464|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25563899|NCT00724464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647795|NCT01210755|Rivaroxaban|rivaroxaban|mesh-list
25563900|NCT00724464|Antiviral Agents|antiviral agents|mesh-ancestor
25563901|NCT00724464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24647796|NCT01210755|Dabigatran|dabigatran|mesh-list
25563902|NCT00724464|Antimetabolites|antimetabolites|mesh-ancestor
25563903|NCT00724464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563904|NCT00724464|Immunologic Factors|immunologic factors|mesh-ancestor
25563905|NCT00724464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563906|NCT00724568|Dexamethasone|dexamethasone|mesh-list
25563907|NCT00724568|Lenalidomide|lenalidomide|mesh-list
25563908|NCT00724568|Bortezomib|bortezomib|mesh-list
25563909|NCT00724568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25563910|NCT00724568|Antiemetics|antiemetics|mesh-ancestor
25563911|NCT00724568|Autonomic Agents|autonomic agents|mesh-ancestor
25563912|NCT00724568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25563913|NCT00724568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563914|NCT00724568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25563915|NCT00724568|Glucocorticoids|glucocorticoids|mesh-ancestor
25563916|NCT00724568|Hormones|hormones|mesh-ancestor
25563917|NCT00724568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25563918|NCT00724568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25563919|NCT00724568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25563920|NCT00724568|Immunologic Factors|immunologic factors|mesh-ancestor
25563921|NCT00724568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25563922|NCT00724568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25563923|NCT00724568|Growth Substances|growth substances|mesh-ancestor
25563924|NCT00724568|Growth Inhibitors|growth inhibitors|mesh-ancestor
25563925|NCT00724594|Acetylcysteine|acetylcysteine|mesh-list
25563926|NCT00724594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25563927|NCT00724594|Antiviral Agents|antiviral agents|mesh-ancestor
25563928|NCT00724594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25563929|NCT00724594|Expectorants|expectorants|mesh-ancestor
25563930|NCT00724594|Respiratory System Agents|respiratory system agents|mesh-ancestor
25563931|NCT00724594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25563932|NCT00724594|Antioxidants|antioxidants|mesh-ancestor
25563933|NCT00724594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563934|NCT00724594|Protective Agents|protective agents|mesh-ancestor
25563935|NCT00724594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563936|NCT00724594|Antidotes|antidotes|mesh-ancestor
25563937|NCT00724711|Tenofovir|tenofovir|mesh-list
25563938|NCT00724711|Lamivudine|lamivudine|mesh-list
25563939|NCT00724711|Emtricitabine|emtricitabine|mesh-list
25563940|NCT00724711|Abacavir|abacavir|mesh-list
25563941|NCT00724711|Antiviral Agents|antiviral agents|mesh-ancestor
25563942|NCT00724711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25563943|NCT00724711|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25563944|NCT00724711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25563945|NCT00724711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25563946|NCT00724711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563947|NCT00724711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25563948|NCT00724711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25563949|NCT00724815|Sumatriptan|sumatriptan|mesh-list
25563950|NCT00724815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25563951|NCT00724815|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25563952|NCT00724815|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25563953|NCT00724815|Serotonin Agents|serotonin agents|mesh-ancestor
25563954|NCT00724815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25563955|NCT00724815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563956|NCT00724815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563957|NCT00724854|Ribavirin|ribavirin|mesh-list
25563958|NCT00724854|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25563959|NCT00724854|Interferon-alpha|interferon-alpha|mesh-list
25563960|NCT00724854|Antimetabolites|antimetabolites|mesh-ancestor
25563961|NCT00724854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563962|NCT00724854|Antiviral Agents|antiviral agents|mesh-ancestor
25563963|NCT00724854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25563964|NCT00724854|Immunologic Factors|immunologic factors|mesh-ancestor
25563965|NCT00724854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563966|NCT00724867|Belimumab|belimumab|mesh-list
25563967|NCT00724867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25563968|NCT00724867|Immunologic Factors|immunologic factors|mesh-ancestor
25694337|NCT02029417|Antimetabolites|antimetabolites|mesh-ancestor
25563969|NCT00724867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563970|NCT00724893|Interferons|interferons|mesh-list
25563971|NCT00724893|Ribavirin|ribavirin|mesh-list
25563972|NCT00724893|Interferon-alpha|interferon-alpha|mesh-list
25563973|NCT00724893|Interferon alpha-2|interferon alpha-2|mesh-list
25563974|NCT00724893|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25563975|NCT00724893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25563976|NCT00724893|Antiviral Agents|antiviral agents|mesh-ancestor
25563977|NCT00724893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25563978|NCT00724893|Antimetabolites|antimetabolites|mesh-ancestor
25563979|NCT00724893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25563980|NCT00724893|Immunologic Factors|immunologic factors|mesh-ancestor
25563981|NCT00724893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563982|NCT00724932|Atropine|atropine|mesh-list
25563983|NCT00724932|Bromides|bromides|mesh-list
25563984|NCT00724932|Rocuronium|rocuronium|mesh-list
25563985|NCT00724932|Neostigmine|neostigmine|mesh-list
25563986|NCT00724932|Anticonvulsants|anticonvulsants|mesh-ancestor
25563987|NCT00724932|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25563988|NCT00724932|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25563989|NCT00724932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25563990|NCT00724932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25004168|NCT02591953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25563991|NCT00724932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25563992|NCT00724932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25563993|NCT00724932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25563994|NCT00724932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25563995|NCT00724932|Autonomic Agents|autonomic agents|mesh-ancestor
25563996|NCT00724932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25563997|NCT00724932|Respiratory System Agents|respiratory system agents|mesh-ancestor
25563998|NCT00724932|Mydriatics|mydriatics|mesh-ancestor
25563999|NCT00724932|Parasympatholytics|parasympatholytics|mesh-ancestor
25564000|NCT00724932|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25004170|NCT02569489|Paclitaxel|paclitaxel|mesh-list
24648513|NCT01215136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564001|NCT00724932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25564002|NCT00724932|Cholinergic Agents|cholinergic agents|mesh-ancestor
25564003|NCT00724932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25564004|NCT00724932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564005|NCT00724932|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25564006|NCT00724932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564007|NCT00724932|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25564008|NCT00724958|Infliximab|infliximab|mesh-list
25564009|NCT00724958|Dermatologic Agents|dermatologic agents|mesh-ancestor
25564010|NCT00724958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25564011|NCT00724958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25564012|NCT00724971|Rituximab|rituximab|mesh-list
25564013|NCT00724971|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
24819935|NCT02097953|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25564014|NCT00724971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25564015|NCT00724971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564016|NCT00724971|Immunologic Factors|immunologic factors|mesh-ancestor
25564017|NCT00724971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564018|NCT00724971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25458841|NCT02892123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25458842|NCT02673333|Pembrolizumab|pembrolizumab|mesh-list
25458843|NCT02673333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25458844|NCT02673333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458845|NCT02639702|Clozapine|clozapine|mesh-list
25458846|NCT02639702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25458847|NCT02639702|Serotonin Agents|serotonin agents|mesh-ancestor
25458848|NCT02639702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25458849|NCT02639702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458850|NCT02639702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458851|NCT02639702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25458852|NCT02639702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24918245|NCT04221555|Immunologic Factors|immunologic factors|mesh-ancestor
25458853|NCT02639702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25458854|NCT02639702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25458855|NCT02639702|GABA Antagonists|gaba antagonists|mesh-ancestor
25458856|NCT02639702|GABA Agents|gaba agents|mesh-ancestor
24979090|NCT01186640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24979091|NCT01186640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24979094|NCT00688376|Donepezil|donepezil|mesh-list
24979095|NCT00688376|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24979096|NCT00688376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24979102|NCT00492349|Varenicline|varenicline|mesh-list
24979103|NCT00492349|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24979104|NCT00492349|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24979105|NCT00492349|Cholinergic Agents|cholinergic agents|mesh-ancestor
24979106|NCT00492349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24979107|NCT00492349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979296|NCT04812951|Cyclosporins|cyclosporins|mesh-list
24979110|NCT00003102|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24979111|NCT00003102|Immunologic Factors|immunologic factors|mesh-ancestor
24839691|NCT02205892|Lupeol|lupeol|mesh-list
25122457|NCT03093909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979114|NCT05181852|Analgesics|analgesics|mesh-ancestor
24979115|NCT05181852|Sensory System Agents|sensory system agents|mesh-ancestor
24979116|NCT05181852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24979117|NCT05181852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979118|NCT05181852|Anticonvulsants|anticonvulsants|mesh-ancestor
24979119|NCT05181852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24979120|NCT05181852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24979121|NCT05181852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979122|NCT05181852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24979123|NCT05181852|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24979124|NCT05181852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24979125|NCT05181852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24979126|NCT05181852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25162036|NCT02908789|Anti-Infective Agents|anti-infective agents|mesh-list
24423330|NCT00225511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24423485|NCT00226096|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24918397|NCT04220073|Antibodies|antibodies|mesh-list
24423486|NCT00226096|Vasodilator Agents|vasodilator agents|mesh-ancestor
24423487|NCT00226096|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24423488|NCT00226096|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24423489|NCT00226096|Protective Agents|protective agents|mesh-ancestor
25122511|NCT03093389|Resveratrol|resveratrol|mesh-list
24423490|NCT00226096|Sympathomimetics|sympathomimetics|mesh-ancestor
24423491|NCT00226096|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24423492|NCT00226096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24423493|NCT00226096|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24423494|NCT00226096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24423574|NCT00226356|Lipotropic Agents|lipotropic agents|mesh-ancestor
24423575|NCT00226356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25564019|NCT00724971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25564020|NCT00724984|Abexinostat|abexinostat|mesh-list
25564021|NCT00724984|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25564022|NCT00724984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564023|NCT00724984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564024|NCT00725010|Temozolomide|temozolomide|mesh-list
25564025|NCT00725010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25564026|NCT00725010|Alkylating Agents|alkylating agents|mesh-ancestor
25564027|NCT00725010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564028|NCT00725010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564029|NCT00725205|Ribavirin|ribavirin|mesh-list
25564030|NCT00725205|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25564031|NCT00725205|Interferon-alpha|interferon-alpha|mesh-list
25564032|NCT00725205|Antimetabolites|antimetabolites|mesh-ancestor
25564033|NCT00725205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564034|NCT00725205|Antiviral Agents|antiviral agents|mesh-ancestor
25564035|NCT00725205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25564036|NCT00725205|Immunologic Factors|immunologic factors|mesh-ancestor
25564037|NCT00725205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564038|NCT00725270|Mifepristone|mifepristone|mesh-list
25564039|NCT00725270|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25564040|NCT00725270|Abortifacient Agents|abortifacient agents|mesh-ancestor
25564041|NCT00725270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25564042|NCT00725270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564043|NCT00725270|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25564044|NCT00725270|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25564045|NCT00725270|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25564046|NCT00725270|Contraceptive Agents|contraceptive agents|mesh-ancestor
25564047|NCT00725270|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25564048|NCT00725270|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25564049|NCT00725270|Hormone Antagonists|hormone antagonists|mesh-ancestor
25564050|NCT00725270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25564051|NCT00725270|Luteolytic Agents|luteolytic agents|mesh-ancestor
25564052|NCT00725270|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25564053|NCT00725270|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25564054|NCT00725296|Infliximab|infliximab|mesh-list
25564055|NCT00725296|Dermatologic Agents|dermatologic agents|mesh-ancestor
25564056|NCT00725296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25564057|NCT00725296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24918472|NCT04219358|Protective Agents|protective agents|mesh-ancestor
25564058|NCT00725322|Botulinum Toxins|botulinum toxins|mesh-list
25564059|NCT00725322|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25564060|NCT00725322|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25564061|NCT00725322|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25564062|NCT00725322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25564063|NCT00725322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564064|NCT00725322|Cholinergic Agents|cholinergic agents|mesh-ancestor
25564065|NCT00725322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25564066|NCT00725322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564067|NCT00725322|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25564068|NCT00725322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25564069|NCT00725361|Ambrisentan|ambrisentan|mesh-list
25564070|NCT00725361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25651860|NCT01519947|Epoetin Alfa|epoetin alfa|mesh-list
25651861|NCT01519947|Hematinics|hematinics|mesh-ancestor
25651862|NCT01520207|Mannitol|mannitol|mesh-list
25651863|NCT01520207|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25651864|NCT01520207|Diuretics|diuretics|mesh-ancestor
25651865|NCT01520207|Natriuretic Agents|natriuretic agents|mesh-ancestor
25651866|NCT01520207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651867|NCT01520363|Dextromethorphan|dextromethorphan|mesh-list
25651868|NCT01520363|Antitussive Agents|antitussive agents|mesh-ancestor
25651869|NCT01520363|Respiratory System Agents|respiratory system agents|mesh-ancestor
25651870|NCT01520363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25651871|NCT01520363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25651872|NCT01520363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25651873|NCT01520363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651874|NCT01520363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651875|NCT01520402|Warfarin|warfarin|mesh-list
25651876|NCT01520402|Anticoagulants|anticoagulants|mesh-list
25651877|NCT01520454|Heparin|heparin|mesh-list
25651878|NCT01520454|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25651879|NCT01520454|Anticoagulants|anticoagulants|mesh-ancestor
25651880|NCT01520454|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25651881|NCT01520454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25651882|NCT01520454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651883|NCT01520454|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25651884|NCT01520454|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25651885|NCT01520454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25651886|NCT01520519|Rituximab|rituximab|mesh-list
25651887|NCT01520519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25651888|NCT01520519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25651889|NCT01520519|Immunologic Factors|immunologic factors|mesh-ancestor
25651890|NCT01520519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651891|NCT01520519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25651892|NCT01520688|Fluticasone|fluticasone|mesh-list
25651893|NCT01520688|Xhance|xhance|mesh-list
25651894|NCT01520688|Budesonide|budesonide|mesh-list
25651895|NCT01520688|Beclomethasone|beclomethasone|mesh-list
25651896|NCT01520688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25651897|NCT01520688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25458857|NCT02596997|Brincidofovir|brincidofovir|mesh-list
25564071|NCT00725452|Infliximab|infliximab|mesh-list
25564072|NCT00725452|Dermatologic Agents|dermatologic agents|mesh-ancestor
25564073|NCT00725452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25564074|NCT00725452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25564075|NCT00725504|Lidocaine|lidocaine|mesh-list
25564076|NCT00725504|Anesthetics, Local|anesthetics, local|mesh-ancestor
25564077|NCT00725504|Anesthetics|anesthetics|mesh-ancestor
25564078|NCT00725504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25564079|NCT00725504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564080|NCT00725504|Sensory System Agents|sensory system agents|mesh-ancestor
24918766|NCT04216628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24918767|NCT04216628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066938|NCT03449056|Autonomic Agents|autonomic agents|mesh-ancestor
25066939|NCT03449056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24826507|NCT02134717|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25066940|NCT03449056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066941|NCT03449056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25066942|NCT03449056|Respiratory System Agents|respiratory system agents|mesh-ancestor
25066943|NCT03449056|Tocolytic Agents|tocolytic agents|mesh-ancestor
25564081|NCT00725504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25564082|NCT00725504|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25564083|NCT00725504|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25564084|NCT00725504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25564085|NCT00725504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25564086|NCT00725504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564087|NCT00725543|Infliximab|infliximab|mesh-list
25564088|NCT00725543|Dermatologic Agents|dermatologic agents|mesh-ancestor
24918861|NCT04215731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25564089|NCT00725543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25564090|NCT00725543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25564091|NCT00725608|Buprenorphine|buprenorphine|mesh-list
25564092|NCT00725608|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25564093|NCT00725608|Naloxone|naloxone|mesh-list
25564094|NCT00725608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25564095|NCT00725608|Narcotics|narcotics|mesh-ancestor
25564096|NCT00725608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25564097|NCT00725608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564098|NCT00725608|Analgesics|analgesics|mesh-ancestor
25564099|NCT00725608|Sensory System Agents|sensory system agents|mesh-ancestor
24919027|NCT04214808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564100|NCT00725608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25564101|NCT00725608|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25564102|NCT00725621|Infliximab|infliximab|mesh-list
25564103|NCT00725621|Dermatologic Agents|dermatologic agents|mesh-ancestor
25564104|NCT00725621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25564105|NCT00725621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25564106|NCT00725751|Interferons|interferons|mesh-list
25564107|NCT00725751|Ribavirin|ribavirin|mesh-list
25564108|NCT00725751|Interferon-alpha|interferon-alpha|mesh-list
25564109|NCT00725751|Interferon alpha-2|interferon alpha-2|mesh-list
25564110|NCT00725751|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25564111|NCT00725751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564112|NCT00725751|Antiviral Agents|antiviral agents|mesh-ancestor
25564113|NCT00725751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25564114|NCT00725751|Antimetabolites|antimetabolites|mesh-ancestor
25564115|NCT00725751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564116|NCT00725751|Immunologic Factors|immunologic factors|mesh-ancestor
24652879|NCT01240850|Prednisone|prednisone|mesh-list
25564117|NCT00725751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564118|NCT00725842|Ribavirin|ribavirin|mesh-list
25564119|NCT00725842|Interferon alpha-2|interferon alpha-2|mesh-list
25564120|NCT00725842|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25564121|NCT00725842|Antimetabolites|antimetabolites|mesh-ancestor
25564122|NCT00725842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564123|NCT00725842|Antiviral Agents|antiviral agents|mesh-ancestor
25564124|NCT00725842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25564125|NCT00725842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564126|NCT00725920|Topiramate|topiramate|mesh-list
25564127|NCT00725920|Anticonvulsants|anticonvulsants|mesh-ancestor
25564128|NCT00725920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25564129|NCT00725920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564130|NCT00726375|Etanercept|etanercept|mesh-list
25564131|NCT00726375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25564132|NCT00726375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25564133|NCT00726375|Analgesics|analgesics|mesh-ancestor
25067002|NCT03448549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067003|NCT03448549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564134|NCT00726375|Sensory System Agents|sensory system agents|mesh-ancestor
25564135|NCT00726375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25564136|NCT00726375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564137|NCT00726375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25564138|NCT00726375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25564139|NCT00726375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25564140|NCT00726375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25564141|NCT00726375|Immunologic Factors|immunologic factors|mesh-ancestor
25564142|NCT00726388|Diclofenac|diclofenac|mesh-list
25564143|NCT00726388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25564144|NCT00726388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25564145|NCT00726388|Analgesics|analgesics|mesh-ancestor
25564146|NCT00726388|Sensory System Agents|sensory system agents|mesh-ancestor
25564147|NCT00726388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25651898|NCT01520688|Autonomic Agents|autonomic agents|mesh-ancestor
25564148|NCT00726388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564149|NCT00726388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25564150|NCT00726388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25564151|NCT00726388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25067041|NCT03447873|Antiviral Agents|antiviral agents|mesh-ancestor
25564152|NCT00726388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564153|NCT00726388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564155|NCT00726414|Antimalarials|antimalarials|mesh-ancestor
25564156|NCT00726414|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25564157|NCT00726414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25564158|NCT00726414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25564159|NCT00726414|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24654865|NCT01251848|Ritonavir|ritonavir|mesh-list
25564160|NCT00726414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564161|NCT00726414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25564162|NCT00726414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25564163|NCT00726414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25564164|NCT00726414|Analgesics|analgesics|mesh-ancestor
25564165|NCT00726414|Sensory System Agents|sensory system agents|mesh-ancestor
25564166|NCT00726557|Interferons|interferons|mesh-list
25564167|NCT00726557|Ribavirin|ribavirin|mesh-list
25564168|NCT00726557|Interferon-alpha|interferon-alpha|mesh-list
24946544|NCT03938259|Anesthetics|anesthetics|mesh-ancestor
24919808|NCT04208516|Ropivacaine|ropivacaine|mesh-list
25564169|NCT00726557|Interferon alpha-2|interferon alpha-2|mesh-list
25564170|NCT00726557|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25564171|NCT00726557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564172|NCT00726557|Antiviral Agents|antiviral agents|mesh-ancestor
25564173|NCT00726557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25564174|NCT00726557|Antimetabolites|antimetabolites|mesh-ancestor
25564175|NCT00726557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564176|NCT00726557|Immunologic Factors|immunologic factors|mesh-ancestor
25564177|NCT00726557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564178|NCT00726609|Posaconazole|posaconazole|mesh-list
25564179|NCT00726609|Antifungal Agents|antifungal agents|mesh-ancestor
25067100|NCT03447093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564180|NCT00726609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25564181|NCT00726609|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25564182|NCT00726609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25564183|NCT00726609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25564184|NCT00726609|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25564185|NCT00726609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25564186|NCT00726609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564187|NCT00726609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655995|NCT01259193|Sorafenib|sorafenib|mesh-list
25564188|NCT00726609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25564189|NCT00726609|Hormone Antagonists|hormone antagonists|mesh-ancestor
25564190|NCT00726609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25564191|NCT00726609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564192|NCT00726713|Vitamin B 12|vitamin b 12|mesh-list
25564193|NCT00726713|Vitamin B Complex|vitamin b complex|mesh-ancestor
25564194|NCT00726713|Vitamins|vitamins|mesh-ancestor
25564195|NCT00726713|Micronutrients|micronutrients|mesh-ancestor
25564196|NCT00726713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564197|NCT00726739|Aldesleukin|aldesleukin|mesh-list
25564198|NCT00726739|Interleukin-2|interleukin-2|mesh-list
25564199|NCT00726739|Vaccines|vaccines|mesh-list
25564200|NCT00726739|Immunologic Factors|immunologic factors|mesh-ancestor
25564201|NCT00726739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564202|NCT00726739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564203|NCT00726739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25564204|NCT00726739|Analgesics|analgesics|mesh-ancestor
24826986|NCT02137083|Docetaxel|docetaxel|mesh-list
25564205|NCT00726739|Sensory System Agents|sensory system agents|mesh-ancestor
25564206|NCT00726739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25564207|NCT00726739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25564208|NCT00726739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25564209|NCT00726739|Antiviral Agents|antiviral agents|mesh-ancestor
25564210|NCT00726739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25564211|NCT00726752|Axitinib|axitinib|mesh-list
25564212|NCT00726752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564213|NCT00726752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25564214|NCT00726752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564215|NCT00726752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564216|NCT00726895|Quinine|quinine|mesh-list
25564217|NCT00726895|Antimalarials|antimalarials|mesh-ancestor
25564218|NCT00726895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25564219|NCT00726895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25564220|NCT00726895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25564221|NCT00726895|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25564222|NCT00726895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459002|NCT05282771|Tazarotene|tazarotene|mesh-list
25459062|NCT05281861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459063|NCT05281861|Antimanic Agents|antimanic agents|mesh-ancestor
25459064|NCT05281861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24656648|NCT01263171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459065|NCT05281861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25459066|NCT05281861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459067|NCT05281419|Triamcinolone|triamcinolone|mesh-list
25459068|NCT05281419|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25459069|NCT05281419|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25459070|NCT05281419|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25459071|NCT05281419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25459072|NCT05281419|Glucocorticoids|glucocorticoids|mesh-ancestor
25459073|NCT05281419|Hormones|hormones|mesh-ancestor
25459074|NCT05281419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25067195|NCT03445897|Miltefosine|miltefosine|mesh-list
25459075|NCT05281419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459076|NCT05281419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25459077|NCT05281419|Immunologic Factors|immunologic factors|mesh-ancestor
25459078|NCT05281419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459079|NCT05281419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459080|NCT05281406|Cisplatin|cisplatin|mesh-list
25459081|NCT05281406|Carboplatin|carboplatin|mesh-list
25459082|NCT05281406|Pemetrexed|pemetrexed|mesh-list
25459083|NCT05281406|Osimertinib|osimertinib|mesh-list
24799173|NCT01967524|Sensory System Agents|sensory system agents|mesh-ancestor
25459084|NCT05281406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459085|NCT05281406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459086|NCT05281406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459087|NCT05281406|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25459088|NCT05281406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25459089|NCT05281406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24423576|NCT00226356|Antimetabolites|antimetabolites|mesh-ancestor
24518720|NCT04450329|Aflibercept|aflibercept|mesh-list
24423577|NCT00226356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423578|NCT00226356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24423579|NCT00226382|Interferons|interferons|mesh-list
24423580|NCT00226382|Interferon-alpha|interferon-alpha|mesh-list
24423581|NCT00226382|Interferon alpha-2|interferon alpha-2|mesh-list
24423582|NCT00226382|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24423583|NCT00226382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24423584|NCT00226382|Antiviral Agents|antiviral agents|mesh-ancestor
24423585|NCT00226382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24423586|NCT00226382|Immunologic Factors|immunologic factors|mesh-ancestor
24423587|NCT00226382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979129|NCT05181592|Luspatercept|luspatercept|mesh-list
24979130|NCT05181592|Hematinics|hematinics|mesh-ancestor
25103479|NCT03161574|Irinotecan|irinotecan|mesh-list
24979131|NCT05181514|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24979132|NCT05181514|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24979133|NCT05181514|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24979134|NCT05181514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24979135|NCT05181150|Glucagon|glucagon|mesh-list
25564223|NCT00726895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25564224|NCT00726895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25564225|NCT00726895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25564226|NCT00726895|Analgesics|analgesics|mesh-ancestor
25564227|NCT00726895|Sensory System Agents|sensory system agents|mesh-ancestor
25564228|NCT00726986|Cisplatin|cisplatin|mesh-list
25564229|NCT00726986|Etoposide|etoposide|mesh-list
25564230|NCT00726986|Sorafenib|sorafenib|mesh-list
25564231|NCT00726986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564232|NCT00726986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24906070|NCT04343144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484763|NCT00449839|Insulin|insulin|mesh-list
25564233|NCT00726986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24608867|NCT00994097|Antiviral Agents|antiviral agents|mesh-ancestor
24853699|NCT02269540|Antidotes|antidotes|mesh-ancestor
25564234|NCT00726986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25564235|NCT00726986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564236|NCT00726986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564237|NCT00726986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25564238|NCT00726999|Morphine|morphine|mesh-list
25564239|NCT00726999|Gabapentin|gabapentin|mesh-list
25564240|NCT00726999|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25564241|NCT00726999|Narcotics|narcotics|mesh-ancestor
25564242|NCT00726999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25564243|NCT00726999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564244|NCT00726999|Analgesics|analgesics|mesh-ancestor
25564245|NCT00726999|Sensory System Agents|sensory system agents|mesh-ancestor
25564246|NCT00726999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24827682|NCT02140814|Niacin|niacin|mesh-list
25564247|NCT00726999|Anticonvulsants|anticonvulsants|mesh-ancestor
25564248|NCT00726999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25564249|NCT00726999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25564250|NCT00726999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25822699|NCT00004583|Lopinavir|lopinavir|mesh-list
25564251|NCT00726999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25564252|NCT00726999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25564253|NCT00726999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25564254|NCT00726999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564255|NCT00726999|Antimanic Agents|antimanic agents|mesh-ancestor
24819137|NCT02093598|Sirolimus|sirolimus|mesh-list
25564256|NCT00727064|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25564257|NCT00727064|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25564258|NCT00727064|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24637583|NCT01151696|Histamine Agents|histamine agents|mesh-ancestor
25564259|NCT00727064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25564260|NCT00727064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25564261|NCT00727064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970370|NCT03733652|Interferons|interferons|mesh-list
25564262|NCT00727064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24458428|NCT00337792|Anticonvulsants|anticonvulsants|mesh-ancestor
25564263|NCT00727064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564264|NCT00727064|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25564265|NCT00727064|Antidepressive Agents|antidepressive agents|mesh-ancestor
25564266|NCT00727064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25564267|NCT00727194|Eculizumab|eculizumab|mesh-list
25564268|NCT00727194|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24675241|NCT02489448|Durvalumab|durvalumab|mesh-list
25564269|NCT00727194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25564270|NCT00727194|Immunologic Factors|immunologic factors|mesh-ancestor
25564271|NCT00727194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564272|NCT00727246|Choline|choline|mesh-list
25564273|NCT00727246|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
24976293|NCT04192370|Cannabidiol|cannabidiol|mesh-list
25564274|NCT00727246|Lipotropic Agents|lipotropic agents|mesh-ancestor
25564275|NCT00727246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25564276|NCT00727246|Antimetabolites|antimetabolites|mesh-ancestor
25564277|NCT00727246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564278|NCT00727246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25564279|NCT00727246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25564280|NCT00727246|Nootropic Agents|nootropic agents|mesh-ancestor
24976708|NCT05274984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25564281|NCT00727259|Ribavirin|ribavirin|mesh-list
25564282|NCT00727259|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24977009|NCT04671966|Hormones|hormones|mesh-ancestor
25564283|NCT00727259|Antimetabolites|antimetabolites|mesh-ancestor
25564284|NCT00727259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564285|NCT00727259|Antiviral Agents|antiviral agents|mesh-ancestor
25564286|NCT00727259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25564287|NCT00727272|Quinine|quinine|mesh-list
25564288|NCT00727272|Antimalarials|antimalarials|mesh-ancestor
25564289|NCT00727272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25564290|NCT00727272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25564291|NCT00727272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25564292|NCT00727272|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25564293|NCT00727272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564294|NCT00727272|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25564295|NCT00727272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25564296|NCT00727272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25564297|NCT00727272|Analgesics|analgesics|mesh-ancestor
25564298|NCT00727272|Sensory System Agents|sensory system agents|mesh-ancestor
25564299|NCT00727298|Infliximab|infliximab|mesh-list
25564300|NCT00727298|Dermatologic Agents|dermatologic agents|mesh-ancestor
25564301|NCT00727298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25564302|NCT00727298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25564303|NCT00727311|Ribavirin|ribavirin|mesh-list
25564304|NCT00727311|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25564305|NCT00727311|Interferon-alpha|interferon-alpha|mesh-list
25564306|NCT00727311|Antimetabolites|antimetabolites|mesh-ancestor
25564307|NCT00727311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564308|NCT00727311|Antiviral Agents|antiviral agents|mesh-ancestor
25564309|NCT00727311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25564310|NCT00727311|Immunologic Factors|immunologic factors|mesh-ancestor
24472872|NCT00400855|Fluticasone|fluticasone|mesh-list
24534347|NCT00646750|Rituximab|rituximab|mesh-list
24677899|NCT01359059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25564311|NCT00727311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564312|NCT00727415|Cyclophosphamide|cyclophosphamide|mesh-list
25564313|NCT00727415|Fludarabine|fludarabine|mesh-list
25564314|NCT00727415|Fludarabine phosphate|fludarabine phosphate|mesh-list
25564315|NCT00727415|Lenalidomide|lenalidomide|mesh-list
25564316|NCT00727415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25564317|NCT00727415|Immunologic Factors|immunologic factors|mesh-ancestor
24678203|NCT01360151|Growth Substances|growth substances|mesh-ancestor
25564318|NCT00727415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564319|NCT00727415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25564320|NCT00727415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25564321|NCT00727415|Alkylating Agents|alkylating agents|mesh-ancestor
25564322|NCT00727415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564323|NCT00727415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564324|NCT00727415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25822700|NCT00004583|Nelfinavir|nelfinavir|mesh-list
25564325|NCT00727415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25564326|NCT00727415|Antimetabolites|antimetabolites|mesh-ancestor
25564327|NCT00727415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25564328|NCT00727415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25564329|NCT00727415|Growth Substances|growth substances|mesh-ancestor
25564330|NCT00727415|Growth Inhibitors|growth inhibitors|mesh-ancestor
25564331|NCT00727441|Cyclophosphamide|cyclophosphamide|mesh-list
25564332|NCT00727441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25564333|NCT00727441|Immunologic Factors|immunologic factors|mesh-ancestor
25564334|NCT00727441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564335|NCT00727441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24915504|NCT01822288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24678934|NCT01365221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25564336|NCT00727441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25564337|NCT00727441|Alkylating Agents|alkylating agents|mesh-ancestor
25564338|NCT00727441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564339|NCT00727441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564340|NCT00727441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25564341|NCT00727506|Afatinib|afatinib|mesh-list
25564342|NCT00727506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564343|NCT00727506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25564344|NCT00727506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564345|NCT00727506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564346|NCT00727532|Sorafenib|sorafenib|mesh-list
25564347|NCT00727532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564348|NCT00727532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25564349|NCT00727532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564350|NCT00727532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564351|NCT00727597|Efavirenz|efavirenz|mesh-list
25564352|NCT00727597|Fosamprenavir|fosamprenavir|mesh-list
25564353|NCT00727597|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25564354|NCT00727597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25564355|NCT00727597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680321|NCT01374126|Anthelmintics|anthelmintics|mesh-ancestor
25564356|NCT00727597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564357|NCT00727597|Antiviral Agents|antiviral agents|mesh-ancestor
25564358|NCT00727597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24819807|NCT02097329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25564359|NCT00727597|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24447143|NCT00307606|Glucocorticoids|glucocorticoids|mesh-ancestor
24916717|NCT04237987|Analgesics|analgesics|mesh-ancestor
25564360|NCT00727597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25564361|NCT00727597|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25564362|NCT00727597|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25564363|NCT00727597|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24614185|NCT01022749|Vaccines|vaccines|mesh-list
25564364|NCT00727597|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25564365|NCT00727597|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25564366|NCT00727597|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25564367|NCT00727597|Protease Inhibitors|protease inhibitors|mesh-ancestor
25564368|NCT00727597|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25564369|NCT00727597|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25564370|NCT00727636|Vaccines|vaccines|mesh-list
25564371|NCT00727636|Immunologic Factors|immunologic factors|mesh-ancestor
24916864|NCT04236310|Trastuzumab|trastuzumab|mesh-list
25564372|NCT00727636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564373|NCT00727649|Loperamide|loperamide|mesh-list
25564374|NCT00727649|Antidiarrheals|antidiarrheals|mesh-list
25564375|NCT00727649|Psyllium|psyllium|mesh-list
25564376|NCT00727649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25564377|NCT00727649|Cathartics|cathartics|mesh-ancestor
25564378|NCT00727740|Indomethacin|indomethacin|mesh-list
25564379|NCT00727740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24746990|NCT02333292|Sofosbuvir|sofosbuvir|mesh-list
25564380|NCT00727740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25564381|NCT00727740|Analgesics|analgesics|mesh-ancestor
25709350|NCT02265510|Antimitotic Agents|antimitotic agents|mesh-ancestor
25564382|NCT00727740|Sensory System Agents|sensory system agents|mesh-ancestor
25564383|NCT00727740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25564384|NCT00727740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467222|NCT00376584|Niacin|niacin|mesh-list
24858361|NCT02296671|Leucovorin|leucovorin|mesh-list
25564385|NCT00727740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25564386|NCT00727740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25564387|NCT00727740|Gout Suppressants|gout suppressants|mesh-ancestor
25564388|NCT00727740|Tocolytic Agents|tocolytic agents|mesh-ancestor
25564389|NCT00727740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25564390|NCT00727740|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24683301|NCT01391156|Minoxidil|minoxidil|mesh-list
25564391|NCT00727740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683414|NCT01392144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25564392|NCT00727740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564393|NCT00727844|Linezolid|linezolid|mesh-list
25564394|NCT00727844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24461470|NCT00352430|Nitric Oxide|nitric oxide|mesh-list
24684268|NCT01396304|Calcium|calcium|mesh-list
25564395|NCT00727844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25564396|NCT00727844|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25564397|NCT00727844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564398|NCT00727844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564399|NCT00727857|Metformin|metformin|mesh-list
24684988|NCT03107611|Tacrolimus|tacrolimus|mesh-list
25694847|NCT02037295|Vancomycin|vancomycin|mesh-list
25564400|NCT00727857|Pioglitazone|pioglitazone|mesh-list
25564401|NCT00727857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25564402|NCT00727857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564403|NCT00727961|Doxorubicin|doxorubicin|mesh-list
25564404|NCT00727961|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24686130|NCT05045313|Probenecid|probenecid|mesh-list
25564405|NCT00727961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25564406|NCT00727961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564407|NCT00727961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25564408|NCT00727961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25564409|NCT00727961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606115|NCT01064687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564410|NCT00727961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564411|NCT00728481|Budesonide|budesonide|mesh-list
25564412|NCT00728481|Esomeprazole|esomeprazole|mesh-list
24918158|NCT04222920|Adalimumab|adalimumab|mesh-list
25564413|NCT00728481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25564414|NCT00728481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25564415|NCT00728481|Autonomic Agents|autonomic agents|mesh-ancestor
25564416|NCT00728481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24689509|NCT01226732|Antimetabolites|antimetabolites|mesh-ancestor
25564417|NCT00728481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564418|NCT00728481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24691011|NCT01404715|Metformin|metformin|mesh-list
25564419|NCT00728481|Respiratory System Agents|respiratory system agents|mesh-ancestor
25564420|NCT00728481|Glucocorticoids|glucocorticoids|mesh-ancestor
24691975|NCT01410201|BB 1101|bb 1101|mesh-list
25564421|NCT00728481|Hormones|hormones|mesh-ancestor
25564422|NCT00728481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25564423|NCT00728481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25564424|NCT00728481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25564425|NCT00728481|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25564426|NCT00728481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564427|NCT00728481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564428|NCT00728494|Ribavirin|ribavirin|mesh-list
25564429|NCT00728494|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25564430|NCT00728494|Interferon-alpha|interferon-alpha|mesh-list
25564431|NCT00728494|Antimetabolites|antimetabolites|mesh-ancestor
24693500|NCT01420900|Tacrine|tacrine|mesh-list
25606116|NCT01064687|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25606117|NCT01064687|Incretins|incretins|mesh-ancestor
25606118|NCT01064687|Hormones|hormones|mesh-ancestor
25606119|NCT01064687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25606120|NCT01064830|Cyclosporine|cyclosporine|mesh-list
25606121|NCT01064830|Cyclosporins|cyclosporins|mesh-list
24494522|NCT00495547|Hematinics|hematinics|mesh-ancestor
24698975|NCT01444118|Vaccines|vaccines|mesh-list
24699577|NCT01447797|Antimetabolites|antimetabolites|mesh-ancestor
24699579|NCT01447797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25564432|NCT00728494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564433|NCT00728494|Antiviral Agents|antiviral agents|mesh-ancestor
25564434|NCT00728494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25564435|NCT00728494|Immunologic Factors|immunologic factors|mesh-ancestor
25564436|NCT00728494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564437|NCT00728507|Moxifloxacin|moxifloxacin|mesh-list
25564438|NCT00728507|Rifampin|rifampin|mesh-list
25564439|NCT00728507|Isoniazid|isoniazid|mesh-list
25564440|NCT00728507|Pyrazinamide|pyrazinamide|mesh-list
25564441|NCT00728507|Ethambutol|ethambutol|mesh-list
25564442|NCT00728507|Rifapentine|rifapentine|mesh-list
25564443|NCT00728507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25564444|NCT00728507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25564445|NCT00728507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25606122|NCT01064830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564446|NCT00728507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25564447|NCT00728507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564448|NCT00728507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564449|NCT00728507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564450|NCT00728507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24635346|NCT01138605|Ritonavir|ritonavir|mesh-list
25564451|NCT00728507|Antitubercular Agents|antitubercular agents|mesh-ancestor
25564452|NCT00728507|Leprostatic Agents|leprostatic agents|mesh-ancestor
25564453|NCT00728507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25564454|NCT00728507|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25564455|NCT00728507|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25564456|NCT00728507|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25564457|NCT00728507|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25564458|NCT00728507|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25564459|NCT00728507|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25564460|NCT00728507|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24635828|NCT01141439|Beclomethasone|beclomethasone|mesh-list
24611878|NCT01011114|Cinacalcet|cinacalcet|mesh-list
24636237|NCT01144091|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24636238|NCT01144091|Protective Agents|protective agents|mesh-ancestor
24636239|NCT01144091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636240|NCT01144091|Vasodilator Agents|vasodilator agents|mesh-ancestor
25564461|NCT00728507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25564462|NCT00728507|Antimetabolites|antimetabolites|mesh-ancestor
25564463|NCT00728507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25564464|NCT00728910|Niacin|niacin|mesh-list
25564465|NCT00728910|Atorvastatin|atorvastatin|mesh-list
25564466|NCT00728910|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25564467|NCT00728910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25564468|NCT00728910|Antimetabolites|antimetabolites|mesh-ancestor
25564469|NCT00728910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564470|NCT00728910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25564471|NCT00728910|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25564472|NCT00728910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564473|NCT00728910|Vasodilator Agents|vasodilator agents|mesh-ancestor
25459234|NCT05280197|Bupivacaine|bupivacaine|mesh-list
25564474|NCT00728910|Vitamin B Complex|vitamin b complex|mesh-ancestor
25564475|NCT00728910|Vitamins|vitamins|mesh-ancestor
25564476|NCT00728910|Micronutrients|micronutrients|mesh-ancestor
25564477|NCT00728910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564478|NCT00728949|Tamoxifen|tamoxifen|mesh-list
25564479|NCT00728949|Letrozole|letrozole|mesh-list
25564480|NCT00728949|Fulvestrant|fulvestrant|mesh-list
25564481|NCT00728949|Anastrozole|anastrozole|mesh-list
25564482|NCT00728949|Exemestane|exemestane|mesh-list
25564483|NCT00728949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24636242|NCT01144091|Antioxidants|antioxidants|mesh-ancestor
25564484|NCT00728949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564485|NCT00728949|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25564486|NCT00728949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25564487|NCT00728949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564488|NCT00728949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564489|NCT00728949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25564490|NCT00728949|Hormone Antagonists|hormone antagonists|mesh-ancestor
25564491|NCT00728949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25564492|NCT00728949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564493|NCT00728949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25564494|NCT00728949|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25564495|NCT00728949|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25564496|NCT00728949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25564497|NCT00728949|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25564498|NCT00728949|Immunologic Factors|immunologic factors|mesh-ancestor
25564499|NCT00728988|Atorvastatin|atorvastatin|mesh-list
24637659|NCT01152203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637660|NCT01152203|Growth Inhibitors|growth inhibitors|mesh-ancestor
25564500|NCT00728988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25564501|NCT00728988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25564502|NCT00728988|Antimetabolites|antimetabolites|mesh-ancestor
24637661|NCT01152203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25564503|NCT00728988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564504|NCT00728988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25564505|NCT00728988|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25564506|NCT00728988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564507|NCT00729157|Deoxyglucose|deoxyglucose|mesh-list
25564508|NCT00729157|Aflibercept|aflibercept|mesh-list
25564509|NCT00729157|Endothelial Growth Factors|endothelial growth factors|mesh-list
25564510|NCT00729157|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25564511|NCT00729157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25564512|NCT00729157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25564513|NCT00729157|Growth Substances|growth substances|mesh-ancestor
25564514|NCT00729157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564515|NCT00729157|Growth Inhibitors|growth inhibitors|mesh-ancestor
25564516|NCT00729157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564517|NCT00729157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564518|NCT00729157|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25564519|NCT00729157|Antimetabolites|antimetabolites|mesh-ancestor
25564520|NCT00729157|Antiviral Agents|antiviral agents|mesh-ancestor
25564521|NCT00729157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25564522|NCT00729183|Calcium, Dietary|calcium, dietary|mesh-list
25564523|NCT00729183|Vitamin D|vitamin d|mesh-list
25564524|NCT00729183|Cholecalciferol|cholecalciferol|mesh-list
25564525|NCT00729183|Calcium Carbonate|calcium carbonate|mesh-list
25564526|NCT00729183|Calcium|calcium|mesh-list
25564527|NCT00729183|Vitamins|vitamins|mesh-ancestor
25564528|NCT00729183|Micronutrients|micronutrients|mesh-ancestor
25564529|NCT00729183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564530|NCT00729183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25564531|NCT00729183|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25564532|NCT00729183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564533|NCT00729183|Antacids|antacids|mesh-ancestor
25564534|NCT00729183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25564535|NCT00729326|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25564536|NCT00729326|Exenatide|exenatide|mesh-list
25564537|NCT00729326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25564538|NCT00729326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564539|NCT00729326|Incretins|incretins|mesh-ancestor
25564540|NCT00729326|Hormones|hormones|mesh-ancestor
25694923|NCT02038179|Antioxidants|antioxidants|mesh-ancestor
25564541|NCT00729326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25564542|NCT00729326|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25564543|NCT00729326|Protease Inhibitors|protease inhibitors|mesh-ancestor
25564544|NCT00729326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564545|NCT00729326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564546|NCT00729326|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25564547|NCT00729482|Everolimus|everolimus|mesh-list
25564548|NCT00729482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564549|NCT00729482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25822701|NCT00004583|Lamivudine|lamivudine|mesh-list
25459387|NCT05254808|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25459388|NCT05254808|Renal Agents|renal agents|mesh-ancestor
25459389|NCT05250596|Colchicine|colchicine|mesh-list
25459390|NCT05250596|Atorvastatin|atorvastatin|mesh-list
25459391|NCT05250596|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25459392|NCT05250596|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25459393|NCT05250596|Antimetabolites|antimetabolites|mesh-ancestor
25459394|NCT05250596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459395|NCT05250596|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25459396|NCT05250596|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25459397|NCT05250596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459398|NCT05250596|Gout Suppressants|gout suppressants|mesh-ancestor
25459399|NCT05250596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25459400|NCT05250596|Tubulin Modulators|tubulin modulators|mesh-ancestor
24855718|NCT02280694|Immunologic Factors|immunologic factors|mesh-ancestor
25459401|NCT05250596|Antimitotic Agents|antimitotic agents|mesh-ancestor
25459402|NCT05250596|Mitosis Modulators|mitosis modulators|mesh-ancestor
25459403|NCT05250596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25822702|NCT00004583|Stavudine|stavudine|mesh-list
25318284|NCT04967196|Ipilimumab|ipilimumab|mesh-list
25318285|NCT04967196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25318286|NCT04967196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318287|NCT04967196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24641446|NCT01173627|Narcotics|narcotics|mesh-ancestor
24641732|NCT01174953|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24641733|NCT01174953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24641775|NCT01175291|Leucovorin|leucovorin|mesh-list
25318288|NCT04967196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318289|NCT04967157|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
25318290|NCT04967157|Nootropic Agents|nootropic agents|mesh-ancestor
25318304|NCT04966845|Carbon Monoxide|carbon monoxide|mesh-list
25318305|NCT04966845|Antimetabolites|antimetabolites|mesh-ancestor
24724221|NCT01591889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24642512|NCT01179828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25318306|NCT04966845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318307|NCT04966845|Gasotransmitters|gasotransmitters|mesh-ancestor
25318346|NCT04965545|Copper|copper|mesh-list
24581178|NCT00864604|Analgesics|analgesics|mesh-ancestor
24979136|NCT05181150|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24979137|NCT05181150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24979138|NCT05181150|Hormones|hormones|mesh-ancestor
24979139|NCT05181150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24979140|NCT05181150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979141|NCT05181150|Incretins|incretins|mesh-ancestor
25822703|NCT00004583|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24423809|NCT00226915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24979147|NCT05181033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979148|NCT05181033|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24979149|NCT05181033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24979150|NCT05181033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24979151|NCT05181033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642660|NCT01180569|Lenalidomide|lenalidomide|mesh-list
24483004|NCT00441415|Adapalene|adapalene|mesh-list
24643422|NCT01185574|Vitamins|vitamins|mesh-ancestor
24643423|NCT01185574|Micronutrients|micronutrients|mesh-ancestor
24643424|NCT01185574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643425|NCT01185574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24855939|NCT02281929|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24855940|NCT02281968|Naproxen|naproxen|mesh-list
24855941|NCT02281968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24423824|NCT00226980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25564550|NCT00729482|Immunologic Factors|immunologic factors|mesh-ancestor
25564551|NCT00729482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564552|NCT00729586|Tamoxifen|tamoxifen|mesh-list
25564553|NCT00729586|Sirolimus|sirolimus|mesh-list
25564554|NCT00729586|Megestrol|megestrol|mesh-list
25564555|NCT00729586|Megestrol Acetate|megestrol acetate|mesh-list
25564556|NCT00729586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25564557|NCT00729586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25564558|NCT00729586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25564559|NCT00729586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855942|NCT02281968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25564560|NCT00729586|Antifungal Agents|antifungal agents|mesh-ancestor
25564561|NCT00729586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25564562|NCT00729586|Immunologic Factors|immunologic factors|mesh-ancestor
25564563|NCT00729586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564564|NCT00729586|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25564565|NCT00729586|Hormone Antagonists|hormone antagonists|mesh-ancestor
25564566|NCT00729586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24921488|NCT04190745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25564567|NCT00729586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25564568|NCT00729586|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25564569|NCT00729586|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25564570|NCT00729586|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24693258|NCT01419262|Vitamin D|vitamin d|mesh-list
24644470|NCT01191203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24644471|NCT01191203|Medroxyprogesterone|medroxyprogesterone|mesh-list
24644472|NCT01191203|Trace Elements|trace elements|mesh-ancestor
24644473|NCT01191203|Micronutrients|micronutrients|mesh-ancestor
24644474|NCT01191203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564571|NCT00729586|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25564572|NCT00729586|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25564573|NCT00729586|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25564574|NCT00729586|Contraceptive Agents|contraceptive agents|mesh-ancestor
25564575|NCT00729586|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25564576|NCT00729586|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24644475|NCT01191203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25564577|NCT00729586|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25564578|NCT00729586|Appetite Stimulants|appetite stimulants|mesh-ancestor
25564579|NCT00729586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25564581|NCT00729612|Carboplatin|carboplatin|mesh-list
25564582|NCT00729612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25564583|NCT00729612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25564584|NCT00729612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564585|NCT00729612|Tubulin Modulators|tubulin modulators|mesh-ancestor
25564586|NCT00729612|Antimitotic Agents|antimitotic agents|mesh-ancestor
25564587|NCT00729612|Mitosis Modulators|mitosis modulators|mesh-ancestor
25564588|NCT00729612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564589|NCT00729690|Pregabalin|pregabalin|mesh-list
25564590|NCT00729690|Analgesics|analgesics|mesh-ancestor
25564591|NCT00729690|Sensory System Agents|sensory system agents|mesh-ancestor
24623113|NCT01070225|Vasodilator Agents|vasodilator agents|mesh-ancestor
25564592|NCT00729690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25564593|NCT00729690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564594|NCT00729690|Anticonvulsants|anticonvulsants|mesh-ancestor
25564595|NCT00729690|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25564596|NCT00729690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25564597|NCT00729690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564598|NCT00729690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25564599|NCT00729690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25564600|NCT00729690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25564601|NCT00729690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25564602|NCT00729690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25564603|NCT00729807|Pentamidine|pentamidine|mesh-list
25564604|NCT00729807|Antifungal Agents|antifungal agents|mesh-ancestor
25564605|NCT00729807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25564606|NCT00729807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25564607|NCT00729807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25564608|NCT00729807|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25564609|NCT00729833|Sunitinib|sunitinib|mesh-list
25564610|NCT00729833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564611|NCT00729833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25564612|NCT00729833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25564613|NCT00729833|Growth Substances|growth substances|mesh-ancestor
25564614|NCT00729833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564615|NCT00729833|Growth Inhibitors|growth inhibitors|mesh-ancestor
25564616|NCT00729833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25564617|NCT00729833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564618|NCT00729833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564619|NCT00729846|Bevacizumab|bevacizumab|mesh-list
25564620|NCT00729846|Verteporfin|verteporfin|mesh-list
25564621|NCT00729846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25564622|NCT00729846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564623|NCT00729846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25564624|NCT00729846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24654198|NCT01248195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24654199|NCT01248195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24654200|NCT01248195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24654257|NCT01248338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24654258|NCT01248338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659352|NCT01277016|Alkylating Agents|alkylating agents|mesh-ancestor
25564625|NCT00729846|Growth Substances|growth substances|mesh-ancestor
25564626|NCT00729846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564627|NCT00729846|Growth Inhibitors|growth inhibitors|mesh-ancestor
25564628|NCT00729846|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25564629|NCT00729846|Dermatologic Agents|dermatologic agents|mesh-ancestor
25564630|NCT00729859|Methyltestosterone|methyltestosterone|mesh-list
25564631|NCT00729859|Anastrozole|anastrozole|mesh-list
25564632|NCT00729859|Testosterone|testosterone|mesh-list
24659428|NCT01277627|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25564633|NCT00729859|Testosterone undecanoate|testosterone undecanoate|mesh-list
25564634|NCT00729859|Testosterone enanthate|testosterone enanthate|mesh-list
25564635|NCT00729859|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25564636|NCT00729859|Acyline|acyline|mesh-list
25564637|NCT00729859|Androgens|androgens|mesh-ancestor
25564638|NCT00729859|Hormones|hormones|mesh-ancestor
25564639|NCT00729859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25564640|NCT00729859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564641|NCT00729859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25564642|NCT00729859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564643|NCT00729859|Anabolic Agents|anabolic agents|mesh-ancestor
25564644|NCT00729859|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25564645|NCT00729859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25564646|NCT00729859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564647|NCT00729859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564648|NCT00729859|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25564649|NCT00729859|Hormone Antagonists|hormone antagonists|mesh-ancestor
25564650|NCT00729924|Raltegravir Potassium|raltegravir potassium|mesh-list
24624115|NCT01074853|Adrenergic Agents|adrenergic agents|mesh-ancestor
24662803|NCT01297010|Dexamethasone acetate|dexamethasone acetate|mesh-list
24662804|NCT01297010|BB 1101|bb 1101|mesh-list
24662805|NCT01297010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24662807|NCT01297010|Autonomic Agents|autonomic agents|mesh-ancestor
24662808|NCT01297010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25564651|NCT00729924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25459404|NCT05249634|Testosterone|testosterone|mesh-list
25564652|NCT00729924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25564654|NCT00729924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25564655|NCT00729924|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25564656|NCT00729924|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25564657|NCT00729924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564658|NCT00729924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662809|NCT01297010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662810|NCT01297010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24662811|NCT01297010|Glucocorticoids|glucocorticoids|mesh-ancestor
25564659|NCT00729937|Clindamycin|clindamycin|mesh-list
25564660|NCT00729937|Clindamycin palmitate|clindamycin palmitate|mesh-list
25564661|NCT00729937|Clindamycin phosphate|clindamycin phosphate|mesh-list
25564662|NCT00729937|Cephalexin|cephalexin|mesh-list
25564663|NCT00729937|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25564664|NCT00729937|Trimethoprim|trimethoprim|mesh-list
25564665|NCT00729937|Sulfamethoxazole|sulfamethoxazole|mesh-list
25564666|NCT00729937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25564667|NCT00729937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24663341|NCT01300637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663342|NCT01300676|Estradiol|estradiol|mesh-list
24663343|NCT01300676|Dydrogesterone|dydrogesterone|mesh-list
24663344|NCT01300676|Estrogens|estrogens|mesh-ancestor
25564668|NCT00729937|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25564669|NCT00729937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564670|NCT00729937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564671|NCT00729937|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25564672|NCT00729937|Renal Agents|renal agents|mesh-ancestor
25564673|NCT00729937|Antimalarials|antimalarials|mesh-ancestor
25564674|NCT00729937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25564675|NCT00729937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25564676|NCT00729937|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25564677|NCT00729937|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25564678|NCT00729937|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25564679|NCT00729937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25564680|NCT00730015|Linaclotide|linaclotide|mesh-list
25564681|NCT00730015|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25564682|NCT00730015|Enzyme Activators|enzyme activators|mesh-ancestor
25564683|NCT00730015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564684|NCT00730015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25564685|NCT00730028|Clindamycin|clindamycin|mesh-list
25564686|NCT00730028|Clindamycin palmitate|clindamycin palmitate|mesh-list
25564687|NCT00730028|Clindamycin phosphate|clindamycin phosphate|mesh-list
25564688|NCT00730028|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24664954|NCT01309477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24664955|NCT01309477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564689|NCT00730028|Trimethoprim|trimethoprim|mesh-list
25564690|NCT00730028|Sulfamethoxazole|sulfamethoxazole|mesh-list
25564691|NCT00730028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25564692|NCT00730028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25564693|NCT00730028|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25564694|NCT00730028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564695|NCT00730028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564696|NCT00730028|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25564697|NCT00730028|Renal Agents|renal agents|mesh-ancestor
25564698|NCT00730028|Antimalarials|antimalarials|mesh-ancestor
25564699|NCT00730028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25564700|NCT00730028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25564701|NCT00730028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25564702|NCT00730028|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25564703|NCT00730028|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25564704|NCT00730028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24665332|NCT01311778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24665333|NCT01311778|Narcotics|narcotics|mesh-ancestor
24665334|NCT01311778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24665335|NCT01311778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665496|NCT01312441|Micronutrients|micronutrients|mesh-ancestor
24665955|NCT01316081|Protective Agents|protective agents|mesh-ancestor
25564705|NCT00730158|Irinotecan|irinotecan|mesh-list
25564706|NCT00730158|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25564707|NCT00730158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25564708|NCT00730158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564709|NCT00730158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564710|NCT00730158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564711|NCT00730171|Linaclotide|linaclotide|mesh-list
25564712|NCT00730171|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25564713|NCT00730171|Enzyme Activators|enzyme activators|mesh-ancestor
25564714|NCT00730171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564715|NCT00730171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25564716|NCT00730275|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25564717|NCT00730275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25564718|NCT00730275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564719|NCT00730275|Incretins|incretins|mesh-ancestor
25564720|NCT00730275|Hormones|hormones|mesh-ancestor
25564721|NCT00730275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25564722|NCT00730275|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25564723|NCT00730275|Protease Inhibitors|protease inhibitors|mesh-ancestor
25564724|NCT00730275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564725|NCT00730275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651899|NCT01520688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25651900|NCT01520688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651901|NCT01520688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25651902|NCT01520688|Respiratory System Agents|respiratory system agents|mesh-ancestor
25651903|NCT01520688|Dermatologic Agents|dermatologic agents|mesh-ancestor
25651904|NCT01520688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25651905|NCT01520688|Glucocorticoids|glucocorticoids|mesh-ancestor
25651906|NCT01520688|Hormones|hormones|mesh-ancestor
25651907|NCT01520688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25651908|NCT01520727|Opicapone|opicapone|mesh-list
25651909|NCT01520727|Entacapone|entacapone|mesh-list
25651910|NCT01520727|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25651911|NCT01520727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651912|NCT01520727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651913|NCT01520727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25651914|NCT01520727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25651915|NCT01520922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25651916|NCT01520922|Ofatumumab|ofatumumab|mesh-list
25651917|NCT01520922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25651918|NCT01520922|Alkylating Agents|alkylating agents|mesh-ancestor
25651919|NCT01520922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651920|NCT01520922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25651921|NCT01520987|Opicapone|opicapone|mesh-list
25651922|NCT01520987|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25651923|NCT01520987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651924|NCT01520987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651925|NCT01520987|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25651926|NCT01520987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25651927|NCT01521117|Donepezil|donepezil|mesh-list
25651928|NCT01521117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25651929|NCT01521117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651930|NCT01521117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651931|NCT01521117|Cholinergic Agents|cholinergic agents|mesh-ancestor
25651932|NCT01521117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25651933|NCT01521117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651934|NCT01521117|Nootropic Agents|nootropic agents|mesh-ancestor
25651935|NCT01521260|Chlorhexidine|chlorhexidine|mesh-list
25651936|NCT01521260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25651937|NCT01521260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25651938|NCT01521260|Disinfectants|disinfectants|mesh-ancestor
25651939|NCT01521364|Clarithromycin|clarithromycin|mesh-list
25651940|NCT01521364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25651941|NCT01521364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25651942|NCT01521364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25651943|NCT01521364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651944|NCT01521364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651945|NCT01521364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25651946|NCT01521364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25651947|NCT01521546|Eplerenone|eplerenone|mesh-list
25651948|NCT01521546|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25651949|NCT01521546|Hormone Antagonists|hormone antagonists|mesh-ancestor
25651950|NCT01521546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25651951|NCT01521546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651952|NCT01521546|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25651953|NCT01521546|Diuretics|diuretics|mesh-ancestor
25651954|NCT01521546|Natriuretic Agents|natriuretic agents|mesh-ancestor
25651955|NCT01521546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25651956|NCT01521559|Aflibercept|aflibercept|mesh-list
25651957|NCT01521559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25651958|NCT01521559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25651959|NCT01521559|Growth Substances|growth substances|mesh-ancestor
25651960|NCT01521559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651961|NCT01521559|Growth Inhibitors|growth inhibitors|mesh-ancestor
25651962|NCT01521559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25651963|NCT01521897|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25651964|NCT01521897|Immunologic Factors|immunologic factors|mesh-ancestor
25651965|NCT01521897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651966|NCT01521923|Methotrexate|methotrexate|mesh-list
25651967|NCT01521923|Certolizumab Pegol|certolizumab pegol|mesh-list
25651968|NCT01521923|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25651969|NCT01521923|Abortifacient Agents|abortifacient agents|mesh-ancestor
25459522|NCT05193968|Tocolytic Agents|tocolytic agents|mesh-ancestor
25564726|NCT00730353|Paclitaxel|paclitaxel|mesh-list
25564727|NCT00730353|Sunitinib|sunitinib|mesh-list
25564728|NCT00730353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25564729|NCT00730353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564730|NCT00730353|Tubulin Modulators|tubulin modulators|mesh-ancestor
25564731|NCT00730353|Antimitotic Agents|antimitotic agents|mesh-ancestor
25564732|NCT00730353|Mitosis Modulators|mitosis modulators|mesh-ancestor
25564733|NCT00730353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564734|NCT00730353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25564735|NCT00730353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25564736|NCT00730353|Growth Substances|growth substances|mesh-ancestor
25564737|NCT00730353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564738|NCT00730353|Growth Inhibitors|growth inhibitors|mesh-ancestor
25564739|NCT00730353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25564740|NCT00730353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564741|NCT00730405|Albaconazole|albaconazole|mesh-list
25564742|NCT00730405|Antifungal Agents|antifungal agents|mesh-ancestor
25564743|NCT00730405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25564744|NCT00730483|Doxorubicin|doxorubicin|mesh-list
25564745|NCT00730483|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25564746|NCT00730483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24458356|NCT00337558|Solifenacin Succinate|solifenacin succinate|mesh-list
25564747|NCT00730483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564748|NCT00730483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25564749|NCT00730483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25564750|NCT00730483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564751|NCT00730483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564752|NCT00730522|Vigabatrin|vigabatrin|mesh-list
25564753|NCT00730522|Anticonvulsants|anticonvulsants|mesh-ancestor
25564754|NCT00730522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564755|NCT00730522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564756|NCT00730522|GABA Agents|gaba agents|mesh-ancestor
25564757|NCT00730522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25564758|NCT00730522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564759|NCT00730691|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25564760|NCT00730691|Vortioxetine|vortioxetine|mesh-list
25564761|NCT00730691|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25564762|NCT00730691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25564763|NCT00730691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25564764|NCT00730691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564765|NCT00730691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25564766|NCT00730691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564767|NCT00730691|Analgesics|analgesics|mesh-ancestor
25564768|NCT00730691|Sensory System Agents|sensory system agents|mesh-ancestor
25564769|NCT00730691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25564770|NCT00730691|Antidepressive Agents|antidepressive agents|mesh-ancestor
25564771|NCT00730691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25564772|NCT00730691|Dopamine Agents|dopamine agents|mesh-ancestor
25564773|NCT00730691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25564774|NCT00730691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25564775|NCT00730691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25564776|NCT00730691|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25564777|NCT00730691|Serotonin Agents|serotonin agents|mesh-ancestor
25564778|NCT00730691|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25564779|NCT00730691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25564780|NCT00730691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25564781|NCT00730691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25564782|NCT00730756|Fluticasone|fluticasone|mesh-list
25564783|NCT00730756|Xhance|xhance|mesh-list
25564784|NCT00730756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25564785|NCT00730756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25564786|NCT00730756|Autonomic Agents|autonomic agents|mesh-ancestor
25564787|NCT00730756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25564788|NCT00730756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564789|NCT00730756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25564790|NCT00730756|Respiratory System Agents|respiratory system agents|mesh-ancestor
25564791|NCT00730756|Dermatologic Agents|dermatologic agents|mesh-ancestor
25564792|NCT00730756|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25564793|NCT00730847|Vaccines|vaccines|mesh-list
25564794|NCT00730847|Immunologic Factors|immunologic factors|mesh-ancestor
25564795|NCT00730847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564796|NCT00730912|Loratadine|loratadine|mesh-list
25564797|NCT00730912|Antipruritics|antipruritics|mesh-ancestor
25564798|NCT00730912|Dermatologic Agents|dermatologic agents|mesh-ancestor
25564799|NCT00730912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25564800|NCT00730912|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25459670|NCT05114941|Immunologic Factors|immunologic factors|mesh-ancestor
25459671|NCT05114941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459672|NCT05102591|Ketorolac|ketorolac|mesh-list
25459673|NCT05102591|Metoclopramide|metoclopramide|mesh-list
25459674|NCT05102591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25459675|NCT05102591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25459676|NCT05102591|Analgesics|analgesics|mesh-ancestor
25459677|NCT05102591|Sensory System Agents|sensory system agents|mesh-ancestor
24441094|NCT00286117|Tamoxifen|tamoxifen|mesh-list
25459678|NCT05102591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25459679|NCT05102591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459680|NCT05102591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25459681|NCT05102591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25459682|NCT05102591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25459683|NCT05102591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459684|NCT05102591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459685|NCT05102591|Antiemetics|antiemetics|mesh-ancestor
25459686|NCT05102591|Autonomic Agents|autonomic agents|mesh-ancestor
25459687|NCT05102591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25459688|NCT05102591|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25459689|NCT05102591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25459690|NCT05102591|Dopamine Agents|dopamine agents|mesh-ancestor
25459691|NCT05102591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25459692|NCT05088252|Propofol|propofol|mesh-list
25459693|NCT05088252|Desflurane|desflurane|mesh-list
25459694|NCT05088252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25459695|NCT05088252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25459696|NCT05088252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459697|NCT05088252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25459698|NCT05088252|Anesthetics, General|anesthetics, general|mesh-ancestor
25459699|NCT05088252|Anesthetics|anesthetics|mesh-ancestor
25459700|NCT05088252|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25122549|NCT03092986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423826|NCT00226980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423827|NCT00226980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24423828|NCT00226980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24423829|NCT00226980|Immunologic Factors|immunologic factors|mesh-ancestor
24423830|NCT00226980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162037|NCT02908789|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24423835|NCT00226980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24423836|NCT00226980|Growth Substances|growth substances|mesh-ancestor
24423847|NCT00227110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24423848|NCT00227110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423849|NCT00227123|Risperidone|risperidone|mesh-list
24423850|NCT00227123|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24979167|NCT05180461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25564801|NCT00730912|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25564802|NCT00730912|Histamine Antagonists|histamine antagonists|mesh-ancestor
25564803|NCT00730912|Histamine Agents|histamine agents|mesh-ancestor
25564804|NCT00730912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25564805|NCT00730912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564806|NCT00730912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564807|NCT00730925|Paclitaxel|paclitaxel|mesh-list
25564808|NCT00730925|Afatinib|afatinib|mesh-list
25564809|NCT00730925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25564810|NCT00730925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564811|NCT00730925|Tubulin Modulators|tubulin modulators|mesh-ancestor
25564812|NCT00730925|Antimitotic Agents|antimitotic agents|mesh-ancestor
25564813|NCT00730925|Mitosis Modulators|mitosis modulators|mesh-ancestor
25564814|NCT00730925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564815|NCT00730925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25564816|NCT00730925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564817|NCT00731042|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25564818|NCT00731042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25564819|NCT00731042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25564820|NCT00731042|Dermatologic Agents|dermatologic agents|mesh-ancestor
25564821|NCT00731055|Varenicline|varenicline|mesh-list
25564822|NCT00731055|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25564823|NCT00731055|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25564824|NCT00731055|Cholinergic Agents|cholinergic agents|mesh-ancestor
25564825|NCT00731055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25564826|NCT00731055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564827|NCT00731055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564828|NCT00731120|Vortioxetine|vortioxetine|mesh-list
25564829|NCT00731120|Antidepressive Agents|antidepressive agents|mesh-ancestor
25564830|NCT00731120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25564831|NCT00731120|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25564832|NCT00731120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25564833|NCT00731120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25564834|NCT00731120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564835|NCT00731120|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25564836|NCT00731120|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25564837|NCT00731120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25564838|NCT00731120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564839|NCT00731120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25564840|NCT00731120|Serotonin Agents|serotonin agents|mesh-ancestor
25564841|NCT00731120|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25564842|NCT00731120|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25564843|NCT00731120|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25564844|NCT00731120|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25564845|NCT00731133|Disulfiram|disulfiram|mesh-list
25564846|NCT00731133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25564847|NCT00731133|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25564848|NCT00731133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564849|NCT00731133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564850|NCT00731198|Drotaverin|drotaverin|mesh-list
25564851|NCT00731198|Scopolamine|scopolamine|mesh-list
25564852|NCT00731198|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25564853|NCT00731198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25564854|NCT00731198|Antiemetics|antiemetics|mesh-ancestor
25564855|NCT00731198|Autonomic Agents|autonomic agents|mesh-ancestor
25564856|NCT00731198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25564857|NCT00731198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564858|NCT00731198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25564859|NCT00731198|Mydriatics|mydriatics|mesh-ancestor
25564860|NCT00731198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25564861|NCT00731198|Cholinergic Agents|cholinergic agents|mesh-ancestor
25564862|NCT00731198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25564863|NCT00731198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564864|NCT00731198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25564865|NCT00731198|Parasympatholytics|parasympatholytics|mesh-ancestor
25564866|NCT00731198|Analgesics|analgesics|mesh-ancestor
25564867|NCT00731198|Sensory System Agents|sensory system agents|mesh-ancestor
25564868|NCT00731198|Vasodilator Agents|vasodilator agents|mesh-ancestor
25564869|NCT00731549|Aripiprazole|aripiprazole|mesh-list
25564870|NCT00731549|Antidepressive Agents|antidepressive agents|mesh-ancestor
25564871|NCT00731549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25564872|NCT00731549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25564873|NCT00731549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25564874|NCT00731549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25564875|NCT00731549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564876|NCT00731549|Dopamine Agonists|dopamine agonists|mesh-ancestor
25564877|NCT00731549|Dopamine Agents|dopamine agents|mesh-ancestor
25564878|NCT00731549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25564879|NCT00731549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564880|NCT00731549|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25564881|NCT00731549|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25564882|NCT00731549|Serotonin Agents|serotonin agents|mesh-ancestor
25564883|NCT00731549|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25564884|NCT00731549|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25564885|NCT00731549|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25564886|NCT00731549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25564887|NCT00731588|Biotin|biotin|mesh-list
25564888|NCT00731588|Vitamin B Complex|vitamin b complex|mesh-ancestor
25564889|NCT00731588|Vitamins|vitamins|mesh-ancestor
25564890|NCT00731588|Micronutrients|micronutrients|mesh-ancestor
25564891|NCT00731588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564892|NCT00731679|Rifaximin|rifaximin|mesh-list
25564893|NCT00731679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25564894|NCT00731679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25564895|NCT00731679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25564896|NCT00731692|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25564897|NCT00731692|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25564898|NCT00731692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564899|NCT00731692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25564900|NCT00731692|Immunologic Factors|immunologic factors|mesh-ancestor
25564901|NCT00731692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564902|NCT00731783|Chlorhexidine|chlorhexidine|mesh-list
25564903|NCT00731783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25564904|NCT00731783|Mupirocin|mupirocin|mesh-list
25564905|NCT00731783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25564906|NCT00731783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25564907|NCT00731783|Disinfectants|disinfectants|mesh-ancestor
25564908|NCT00731783|Dermatologic Agents|dermatologic agents|mesh-ancestor
25564909|NCT00731783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25564910|NCT00731783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25564911|NCT00731783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564912|NCT00731783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564913|NCT00731874|Tacrolimus|tacrolimus|mesh-list
25564914|NCT00731874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25564915|NCT00731874|Immunologic Factors|immunologic factors|mesh-ancestor
25564916|NCT00731874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564917|NCT00731874|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25564918|NCT00731874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564919|NCT00731874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564920|NCT00732069|Valsartan|valsartan|mesh-list
25564921|NCT00732069|Ramipril|ramipril|mesh-list
25564922|NCT00732069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25564923|NCT00732069|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25564924|NCT00732069|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25564925|NCT00732069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564926|NCT00732069|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25564927|NCT00732069|Protease Inhibitors|protease inhibitors|mesh-ancestor
25564928|NCT00732069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564929|NCT00732225|Hyaluronic Acid|hyaluronic acid|mesh-list
25564930|NCT00732225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25564931|NCT00732225|Immunologic Factors|immunologic factors|mesh-ancestor
25564932|NCT00732225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564933|NCT00732225|Viscosupplements|viscosupplements|mesh-ancestor
25564934|NCT00732225|Protective Agents|protective agents|mesh-ancestor
25564935|NCT00732238|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25564936|NCT00732238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25564937|NCT00732251|Allopurinol|allopurinol|mesh-list
25564938|NCT00732251|Antimetabolites|antimetabolites|mesh-ancestor
25564939|NCT00732251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564940|NCT00732251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564941|NCT00732251|Gout Suppressants|gout suppressants|mesh-ancestor
25564942|NCT00732251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25564943|NCT00732251|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25564944|NCT00732251|Antioxidants|antioxidants|mesh-ancestor
25564945|NCT00732251|Protective Agents|protective agents|mesh-ancestor
25564946|NCT00732251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564947|NCT00732303|Pemetrexed|pemetrexed|mesh-list
25564948|NCT00732303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564949|NCT00732303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564950|NCT00732303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564951|NCT00732303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25564952|NCT00732303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25564953|NCT00732498|Cytarabine|cytarabine|mesh-list
25564954|NCT00732498|Methylprednisolone|methylprednisolone|mesh-list
25564955|NCT00732498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25564956|NCT00732498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25564957|NCT00732498|Prednisolone|prednisolone|mesh-list
25564958|NCT00732498|Prednisolone acetate|prednisolone acetate|mesh-list
25564959|NCT00732498|Rituximab|rituximab|mesh-list
25564960|NCT00732498|Etoposide|etoposide|mesh-list
25564961|NCT00732498|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25564962|NCT00732498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25564963|NCT00732498|Prednisolone phosphate|prednisolone phosphate|mesh-list
25564964|NCT00732498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25564965|NCT00732498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25564966|NCT00732498|Immunologic Factors|immunologic factors|mesh-ancestor
25564967|NCT00732498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564968|NCT00732498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25564969|NCT00732498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25564970|NCT00732498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25564971|NCT00732498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25564972|NCT00732498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25564973|NCT00732498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564974|NCT00732498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25564975|NCT00732498|Antimetabolites|antimetabolites|mesh-ancestor
25564976|NCT00732498|Antiviral Agents|antiviral agents|mesh-ancestor
25564977|NCT00732498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25564978|NCT00732498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25564979|NCT00732498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25564980|NCT00732498|Antiemetics|antiemetics|mesh-ancestor
25564981|NCT00732498|Autonomic Agents|autonomic agents|mesh-ancestor
25564982|NCT00732498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25564983|NCT00732498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25564984|NCT00732498|Glucocorticoids|glucocorticoids|mesh-ancestor
25564986|NCT00732498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25564987|NCT00732498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25564988|NCT00732498|Protective Agents|protective agents|mesh-ancestor
25564989|NCT00732498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25564990|NCT00732654|Immunologic Factors|immunologic factors|mesh-list
25564991|NCT00732654|Caseins|caseins|mesh-list
25564992|NCT00732654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25564993|NCT00732654|Chelating Agents|chelating agents|mesh-ancestor
25564994|NCT00732654|Sequestering Agents|sequestering agents|mesh-ancestor
25564995|NCT00732654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25564996|NCT00732758|Vitamin D|vitamin d|mesh-list
25564997|NCT00732758|Cholecalciferol|cholecalciferol|mesh-list
25564998|NCT00732758|Vitamins|vitamins|mesh-ancestor
25564999|NCT00732758|Micronutrients|micronutrients|mesh-ancestor
25565000|NCT00732758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565001|NCT00732758|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25565002|NCT00732758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25565003|NCT00732875|Methotrexate|methotrexate|mesh-list
25565004|NCT00732875|Infliximab|infliximab|mesh-list
25565005|NCT00732875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25565006|NCT00732875|Abortifacient Agents|abortifacient agents|mesh-ancestor
25565007|NCT00732875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25565008|NCT00732875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565009|NCT00732875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25565010|NCT00732875|Antimetabolites|antimetabolites|mesh-ancestor
25565011|NCT00732875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831006|NCT02162485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24542846|NCT00680511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24450314|NCT00318669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565012|NCT00732875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565013|NCT00732875|Dermatologic Agents|dermatologic agents|mesh-ancestor
25565014|NCT00732875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565015|NCT00732875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25565016|NCT00732875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25565017|NCT00732875|Immunologic Factors|immunologic factors|mesh-ancestor
25565018|NCT00732875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25565019|NCT00732875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25565020|NCT00732875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25565021|NCT00732901|Citalopram|citalopram|mesh-list
25565022|NCT00732901|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25565023|NCT00732901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25565024|NCT00732901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25565025|NCT00732901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565026|NCT00732901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25565027|NCT00732901|Serotonin Agents|serotonin agents|mesh-ancestor
25565028|NCT00732901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565029|NCT00732901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25565030|NCT00732901|Antidepressive Agents|antidepressive agents|mesh-ancestor
25565031|NCT00732901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25565032|NCT00732940|Belimumab|belimumab|mesh-list
25565033|NCT00732940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25565034|NCT00732940|Immunologic Factors|immunologic factors|mesh-ancestor
25565035|NCT00732940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565036|NCT00732992|Pemetrexed|pemetrexed|mesh-list
25565037|NCT00732992|Sunitinib|sunitinib|mesh-list
25565038|NCT00732992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565039|NCT00732992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565040|NCT00732992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565041|NCT00732992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25565042|NCT00732992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25565043|NCT00732992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25565044|NCT00732992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25565045|NCT00732992|Growth Substances|growth substances|mesh-ancestor
25565046|NCT00732992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565047|NCT00732992|Growth Inhibitors|growth inhibitors|mesh-ancestor
25565048|NCT00732992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25565049|NCT00733096|Methylprednisolone|methylprednisolone|mesh-list
25565050|NCT00733096|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25565051|NCT00733096|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25459843|NCT04910711|Dolutegravir|dolutegravir|mesh-list
25565052|NCT00733096|Prednisolone|prednisolone|mesh-list
25565053|NCT00733096|Prednisolone acetate|prednisolone acetate|mesh-list
25565054|NCT00733096|Etanercept|etanercept|mesh-list
25565055|NCT00733096|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25565056|NCT00733096|Prednisolone phosphate|prednisolone phosphate|mesh-list
25565057|NCT00733096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25565058|NCT00733096|Antiemetics|antiemetics|mesh-ancestor
25565059|NCT00733096|Autonomic Agents|autonomic agents|mesh-ancestor
25565060|NCT00733096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25565061|NCT00733096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565062|NCT00733096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25565063|NCT00733096|Glucocorticoids|glucocorticoids|mesh-ancestor
25459904|NCT04846348|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25459905|NCT04846348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25459906|NCT04846348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25459907|NCT04846348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459908|NCT04846348|Anesthetics, Local|anesthetics, local|mesh-ancestor
25459909|NCT04846348|Anesthetics|anesthetics|mesh-ancestor
25459910|NCT04846348|Sensory System Agents|sensory system agents|mesh-ancestor
25459911|NCT04846348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25459912|NCT04846348|Antiemetics|antiemetics|mesh-ancestor
25459913|NCT04846348|Autonomic Agents|autonomic agents|mesh-ancestor
25459914|NCT04846348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24449102|NCT00314379|Vitamins|vitamins|mesh-ancestor
24449103|NCT00314379|Micronutrients|micronutrients|mesh-ancestor
24449104|NCT00314379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695052|NCT02040298|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25459915|NCT04846348|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25459916|NCT04846348|Histamine Antagonists|histamine antagonists|mesh-ancestor
25459917|NCT04846348|Histamine Agents|histamine agents|mesh-ancestor
25459918|NCT04846348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25459919|NCT04846348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459920|NCT04846348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25459921|NCT04846348|Antipruritics|antipruritics|mesh-ancestor
25459922|NCT04846348|Dermatologic Agents|dermatologic agents|mesh-ancestor
25459923|NCT04846348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25459924|NCT04846348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25459925|NCT04846348|Analgesics|analgesics|mesh-ancestor
25459926|NCT04846348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25459927|NCT04846348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25459928|NCT04846348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25459929|NCT04846348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459930|NCT04846348|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
25459931|NCT04846348|Immunologic Factors|immunologic factors|mesh-ancestor
25459932|NCT04846348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25459933|NCT04846348|Respiratory System Agents|respiratory system agents|mesh-ancestor
25459934|NCT04840472|Panitumumab|panitumumab|mesh-list
25318910|NCT04954560|Losartan|losartan|mesh-list
25565064|NCT00733096|Hormones|hormones|mesh-ancestor
25565065|NCT00733096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25565066|NCT00733096|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25565067|NCT00733096|Protective Agents|protective agents|mesh-ancestor
25565068|NCT00733096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25565069|NCT00733096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565070|NCT00733096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25565071|NCT00733096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25565072|NCT00733096|Analgesics|analgesics|mesh-ancestor
25565073|NCT00733096|Sensory System Agents|sensory system agents|mesh-ancestor
25565074|NCT00733096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25565075|NCT00733096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25565076|NCT00733096|Immunologic Factors|immunologic factors|mesh-ancestor
25565077|NCT00733226|Broncho-Vaxom|broncho-vaxom|mesh-list
25565078|NCT00733226|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25565079|NCT00733226|Immunologic Factors|immunologic factors|mesh-ancestor
25565080|NCT00733226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565081|NCT00733278|Copper|copper|mesh-list
25565082|NCT00733278|Contraceptive Agents|contraceptive agents|mesh-list
25565083|NCT00733278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25565084|NCT00733278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565085|NCT00733278|Trace Elements|trace elements|mesh-ancestor
25565086|NCT00733278|Micronutrients|micronutrients|mesh-ancestor
25565087|NCT00733291|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25565088|NCT00733356|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25565089|NCT00733356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25565090|NCT00733356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565091|NCT00733356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25565092|NCT00733356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25565093|NCT00733356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25565094|NCT00733356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565096|NCT00733356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25565097|NCT00733408|Paclitaxel|paclitaxel|mesh-list
25565098|NCT00733408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25565099|NCT00733408|Bevacizumab|bevacizumab|mesh-list
25565100|NCT00733408|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25565101|NCT00733408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25565102|NCT00733408|Antibodies|antibodies|mesh-list
25565103|NCT00733408|Immunoglobulins|immunoglobulins|mesh-list
25565104|NCT00733408|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25565105|NCT00733408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25565106|NCT00733408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565107|NCT00733408|Tubulin Modulators|tubulin modulators|mesh-ancestor
24831026|NCT02162537|Bevacizumab|bevacizumab|mesh-list
25565108|NCT00733408|Antimitotic Agents|antimitotic agents|mesh-ancestor
25565109|NCT00733408|Mitosis Modulators|mitosis modulators|mesh-ancestor
25565110|NCT00733408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565111|NCT00733408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25565112|NCT00733408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25565113|NCT00733408|Growth Substances|growth substances|mesh-ancestor
25565114|NCT00733408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565115|NCT00733408|Growth Inhibitors|growth inhibitors|mesh-ancestor
25565116|NCT00733408|Immunologic Factors|immunologic factors|mesh-ancestor
25565117|NCT00733408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25565118|NCT00733408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565119|NCT00733421|Etoricoxib|etoricoxib|mesh-list
25565120|NCT00733421|Tramadol|tramadol|mesh-list
25565121|NCT00733421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25565122|NCT00733421|Narcotics|narcotics|mesh-ancestor
25565123|NCT00733421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25565124|NCT00733421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565125|NCT00733421|Analgesics|analgesics|mesh-ancestor
25565126|NCT00733421|Sensory System Agents|sensory system agents|mesh-ancestor
25565127|NCT00733421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25565128|NCT00733421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25565129|NCT00733421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25565130|NCT00733421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25565131|NCT00733421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25565132|NCT00733421|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25565133|NCT00733421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25565134|NCT00733421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565135|NCT00733421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565136|NCT00733746|Gemcitabine|gemcitabine|mesh-list
25565137|NCT00733746|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25565138|NCT00733746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25565139|NCT00733746|Antimetabolites|antimetabolites|mesh-ancestor
25565140|NCT00733746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565141|NCT00733746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565142|NCT00733746|Antiviral Agents|antiviral agents|mesh-ancestor
25565143|NCT00733746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25565144|NCT00733746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565145|NCT00733746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25565146|NCT00733746|Immunologic Factors|immunologic factors|mesh-ancestor
25565147|NCT00733746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565148|NCT00733746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25565149|NCT00733824|Plerixafor|plerixafor|mesh-list
25565150|NCT00733824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25565151|NCT00733824|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25565152|NCT00733824|Antiviral Agents|antiviral agents|mesh-ancestor
25565153|NCT00733824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25565154|NCT00733902|Tanezumab|tanezumab|mesh-list
25565155|NCT00733902|Analgesics|analgesics|mesh-ancestor
25565156|NCT00733902|Sensory System Agents|sensory system agents|mesh-ancestor
25565157|NCT00733902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25565158|NCT00733902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565159|NCT00733993|Caffeine|caffeine|mesh-list
25565160|NCT00733993|Amphetamine|amphetamine|mesh-list
25565161|NCT00733993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25565162|NCT00733993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565163|NCT00733993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25565164|NCT00733993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565165|NCT00733993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565166|NCT00733993|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25565167|NCT00733993|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25459937|NCT04823091|Cyclophosphamide|cyclophosphamide|mesh-list
25565168|NCT00733993|Purinergic Agents|purinergic agents|mesh-ancestor
25565169|NCT00733993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25565170|NCT00733993|Sympathomimetics|sympathomimetics|mesh-ancestor
25565171|NCT00733993|Autonomic Agents|autonomic agents|mesh-ancestor
25565172|NCT00733993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25565173|NCT00733993|Dopamine Agents|dopamine agents|mesh-ancestor
25565174|NCT00733993|Adrenergic Agents|adrenergic agents|mesh-ancestor
25565175|NCT00733993|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25565176|NCT00733993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25565177|NCT00733993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25565178|NCT00733993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25565179|NCT00734032|Darapladib|darapladib|mesh-list
25039759|NCT03676751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25565180|NCT00734032|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
25565181|NCT00734032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565182|NCT00734032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565183|NCT00734071|Vortioxetine|vortioxetine|mesh-list
25565184|NCT00734071|Antidepressive Agents|antidepressive agents|mesh-ancestor
25565185|NCT00734071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25565186|NCT00734071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25565187|NCT00734071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25565188|NCT00734071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25565189|NCT00734071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565190|NCT00734071|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25565191|NCT00734071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25565192|NCT00734071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25565193|NCT00734071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565194|NCT00734071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25565195|NCT00734071|Serotonin Agents|serotonin agents|mesh-ancestor
25565196|NCT00734071|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25565197|NCT00734071|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25565198|NCT00734071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25565199|NCT00734071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25565200|NCT00734097|Esomeprazole|esomeprazole|mesh-list
25565201|NCT00734097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25565202|NCT00734097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25565203|NCT00734097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25565204|NCT00734097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565205|NCT00734097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565206|NCT00734149|Prednisone|prednisone|mesh-list
25565207|NCT00734149|Bortezomib|bortezomib|mesh-list
25565208|NCT00734149|Melphalan|melphalan|mesh-list
25565209|NCT00734149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25565210|NCT00734149|Glucocorticoids|glucocorticoids|mesh-ancestor
25565211|NCT00734149|Hormones|hormones|mesh-ancestor
25565212|NCT00734149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25565213|NCT00734149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565214|NCT00734149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25565215|NCT00734149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565216|NCT00734149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25565217|NCT00734149|Alkylating Agents|alkylating agents|mesh-ancestor
25565218|NCT00734149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565219|NCT00734149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25565220|NCT00734149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25565221|NCT00734149|Immunologic Factors|immunologic factors|mesh-ancestor
25565222|NCT00734162|Tenofovir|tenofovir|mesh-list
25565223|NCT00734162|Antiviral Agents|antiviral agents|mesh-ancestor
25565224|NCT00734162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25565225|NCT00734162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25565226|NCT00734162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25565227|NCT00734162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565228|NCT00734162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565229|NCT00734162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25565230|NCT00734162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25565231|NCT00734344|Tenofovir|tenofovir|mesh-list
25565232|NCT00734344|Efavirenz|efavirenz|mesh-list
25565233|NCT00734344|Raltegravir Potassium|raltegravir potassium|mesh-list
24534279|NCT00646607|Antidotes|antidotes|mesh-ancestor
24802345|NCT01989676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25565234|NCT00734344|Antiviral Agents|antiviral agents|mesh-ancestor
25565235|NCT00734344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25565236|NCT00734344|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25565237|NCT00734344|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25565238|NCT00734344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565239|NCT00734344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460008|NCT04753879|Gemcitabine|gemcitabine|mesh-list
25565240|NCT00734344|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25565241|NCT00734344|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25565242|NCT00734344|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25565243|NCT00734344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25565244|NCT00734344|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25565245|NCT00734344|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25565246|NCT00734344|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25565247|NCT00734344|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25565248|NCT00734344|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25565249|NCT00734344|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25565250|NCT00734474|Metformin|metformin|mesh-list
25565251|NCT00734474|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25565252|NCT00734474|Dulaglutide|dulaglutide|mesh-list
25565253|NCT00734474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25565254|NCT00734474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565255|NCT00734474|Incretins|incretins|mesh-ancestor
25565256|NCT00734474|Hormones|hormones|mesh-ancestor
25565257|NCT00734474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25565258|NCT00734474|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25565259|NCT00734474|Protease Inhibitors|protease inhibitors|mesh-ancestor
25565260|NCT00734474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565261|NCT00734474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565262|NCT00734500|Anidulafungin|anidulafungin|mesh-list
25565263|NCT00734500|Antifungal Agents|antifungal agents|mesh-ancestor
25565264|NCT00734500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25565265|NCT00734539|Fluconazole|fluconazole|mesh-list
25565266|NCT00734539|Antifungal Agents|antifungal agents|mesh-ancestor
25565267|NCT00734539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25565268|NCT00734539|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25565269|NCT00734539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25565270|NCT00734539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565271|NCT00734539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565272|NCT00734539|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25565273|NCT00734539|Hormone Antagonists|hormone antagonists|mesh-ancestor
25565274|NCT00734539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24802346|NCT01989676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24802347|NCT01989676|Tubulin Modulators|tubulin modulators|mesh-ancestor
24802348|NCT01989676|Antimitotic Agents|antimitotic agents|mesh-ancestor
24802349|NCT01989676|Mitosis Modulators|mitosis modulators|mesh-ancestor
24802391|NCT01989884|IDN 5109|idn 5109|mesh-list
25565275|NCT00734539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565276|NCT00734539|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25565277|NCT00734539|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25565278|NCT00734578|Guanfacine|guanfacine|mesh-list
25565279|NCT00734578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25565280|NCT00734578|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25565281|NCT00734578|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25565282|NCT00734578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25565283|NCT00734578|Adrenergic Agents|adrenergic agents|mesh-ancestor
25565284|NCT00734578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25565285|NCT00734578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565286|NCT00734578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565287|NCT00734604|Sildenafil Citrate|sildenafil citrate|mesh-list
25565288|NCT00734604|Tadalafil|tadalafil|mesh-list
25565289|NCT00734604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565290|NCT00734604|Vasodilator Agents|vasodilator agents|mesh-ancestor
25565291|NCT00734604|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25565292|NCT00734604|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25565293|NCT00734604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565294|NCT00734604|Urological Agents|urological agents|mesh-ancestor
25565295|NCT00734617|Nicotine|nicotine|mesh-list
25565296|NCT00734617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25565297|NCT00734617|Autonomic Agents|autonomic agents|mesh-ancestor
25565298|NCT00734617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25565299|NCT00734617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565300|NCT00734617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25565301|NCT00734617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25565302|NCT00734617|Cholinergic Agents|cholinergic agents|mesh-ancestor
25565303|NCT00734617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25565304|NCT00734617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565305|NCT00734630|Losartan|losartan|mesh-list
25565306|NCT00734630|Lisinopril|lisinopril|mesh-list
25565307|NCT00734630|Nebivolol|nebivolol|mesh-list
25565308|NCT00734630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25565309|NCT00734630|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25565310|NCT00734630|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25565311|NCT00734630|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25565312|NCT00734630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460075|NCT04701281|Antimetabolites|antimetabolites|mesh-ancestor
25460138|NCT04633564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25460139|NCT04633564|Growth Substances|growth substances|mesh-ancestor
25460140|NCT04633564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460141|NCT04633564|Growth Inhibitors|growth inhibitors|mesh-ancestor
25319193|NCT04950049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25319194|NCT04950049|Glucocorticoids|glucocorticoids|mesh-ancestor
25319195|NCT04950049|Hormones|hormones|mesh-ancestor
25319196|NCT04950049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25319199|NCT04950049|Protease Inhibitors|protease inhibitors|mesh-ancestor
24979168|NCT05173298|Bevacizumab|bevacizumab|mesh-list
24979169|NCT05173298|Atezolizumab|atezolizumab|mesh-list
24979170|NCT05173298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24979171|NCT05173298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979172|NCT05173298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24979173|NCT05173298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24979174|NCT05173298|Growth Substances|growth substances|mesh-ancestor
24795455|NCT02581943|Tubulin Modulators|tubulin modulators|mesh-ancestor
24979175|NCT05173298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979205|NCT05140694|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
24423862|NCT00227123|Antidepressive Agents|antidepressive agents|mesh-ancestor
24423879|NCT00227292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423880|NCT00227292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24423881|NCT00227292|Serotonin Agents|serotonin agents|mesh-ancestor
24423882|NCT00227292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423883|NCT00227292|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24423884|NCT00227292|Antidepressive Agents|antidepressive agents|mesh-ancestor
24423885|NCT00227292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24423931|NCT00227448|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24423932|NCT00227448|Nasal Decongestants|nasal decongestants|mesh-ancestor
24423933|NCT00227448|Respiratory System Agents|respiratory system agents|mesh-ancestor
24423934|NCT00227448|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24423935|NCT00227448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25122602|NCT03092466|Sensory System Agents|sensory system agents|mesh-ancestor
25122603|NCT03092466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25122604|NCT03092076|Ticagrelor|ticagrelor|mesh-list
24423936|NCT00227448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24424030|NCT00227682|Micronutrients|micronutrients|mesh-ancestor
24424031|NCT00227695|Rituximab|rituximab|mesh-list
24979297|NCT04812951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24979226|NCT05116774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24979228|NCT05116774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979234|NCT05089123|Vaccines|vaccines|mesh-list
24979235|NCT05089123|Immunologic Factors|immunologic factors|mesh-ancestor
24621216|NCT01061060|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25122627|NCT03091894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24621217|NCT01061060|Vasodilator Agents|vasodilator agents|mesh-ancestor
24621218|NCT01061060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24621222|NCT01061112|Flurbiprofen|flurbiprofen|mesh-list
24621223|NCT01061112|Antifungal Agents|antifungal agents|mesh-ancestor
25105953|NCT04718415|Paclitaxel|paclitaxel|mesh-list
25105954|NCT04718415|Carboplatin|carboplatin|mesh-list
25105955|NCT04718415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25105956|NCT04718415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105957|NCT04718415|Tubulin Modulators|tubulin modulators|mesh-ancestor
25105958|NCT04718415|Antimitotic Agents|antimitotic agents|mesh-ancestor
25105959|NCT04718415|Mitosis Modulators|mitosis modulators|mesh-ancestor
25105960|NCT04718415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105961|NCT04718025|Aspirin|aspirin|mesh-list
25105962|NCT04718025|Ticagrelor|ticagrelor|mesh-list
24840040|NCT02207335|Gemcitabine|gemcitabine|mesh-list
25122645|NCT03091712|Insulin|insulin|mesh-list
24424195|NCT00228254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424196|NCT00228267|Propofol|propofol|mesh-list
24424197|NCT00228267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24424198|NCT00228267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24424199|NCT00228267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105970|NCT04718025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25565313|NCT00734630|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25565314|NCT00734630|Protease Inhibitors|protease inhibitors|mesh-ancestor
25565315|NCT00734630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565316|NCT00734630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25565317|NCT00734630|Protective Agents|protective agents|mesh-ancestor
25565318|NCT00734630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565319|NCT00734630|Vasodilator Agents|vasodilator agents|mesh-ancestor
25565320|NCT00734630|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25565321|NCT00734630|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25565322|NCT00734630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24450380|NCT00318955|Dexmedetomidine|dexmedetomidine|mesh-list
24450381|NCT00318955|Propofol|propofol|mesh-list
24450382|NCT00318955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24450383|NCT00318955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24450384|NCT00318955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450386|NCT00318955|Anesthetics, General|anesthetics, general|mesh-ancestor
24450388|NCT00318955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24450389|NCT00318955|Analgesics|analgesics|mesh-ancestor
24450390|NCT00318955|Sensory System Agents|sensory system agents|mesh-ancestor
24450391|NCT00318955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25565323|NCT00734630|Adrenergic Agents|adrenergic agents|mesh-ancestor
25565324|NCT00734630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25565325|NCT00734656|Ethanol|ethanol|mesh-list
25565326|NCT00734656|Dutasteride|dutasteride|mesh-list
25565327|NCT00734656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25565328|NCT00734656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25565329|NCT00734656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25565330|NCT00734656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565331|NCT00734656|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25565332|NCT00734656|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25565333|NCT00734656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565334|NCT00734656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565335|NCT00734656|Hormone Antagonists|hormone antagonists|mesh-ancestor
25565336|NCT00734656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25565337|NCT00734851|Docetaxel|docetaxel|mesh-list
25565338|NCT00734851|Sunitinib|sunitinib|mesh-list
25565339|NCT00734851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565340|NCT00734851|Tubulin Modulators|tubulin modulators|mesh-ancestor
25565341|NCT00734851|Antimitotic Agents|antimitotic agents|mesh-ancestor
25565342|NCT00734851|Mitosis Modulators|mitosis modulators|mesh-ancestor
25565343|NCT00734851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565344|NCT00734851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25565345|NCT00734851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25565346|NCT00734851|Growth Substances|growth substances|mesh-ancestor
25565347|NCT00734851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565348|NCT00734851|Growth Inhibitors|growth inhibitors|mesh-ancestor
25565349|NCT00734851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25565350|NCT00734851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565351|NCT00734929|Dexamethasone|dexamethasone|mesh-list
25565352|NCT00734929|Dexamethasone acetate|dexamethasone acetate|mesh-list
25565353|NCT00734929|Ondansetron|ondansetron|mesh-list
25565354|NCT00734929|Aprepitant|aprepitant|mesh-list
25565355|NCT00734929|BB 1101|bb 1101|mesh-list
25565356|NCT00734929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25565357|NCT00734929|Antiemetics|antiemetics|mesh-ancestor
25565358|NCT00734929|Autonomic Agents|autonomic agents|mesh-ancestor
25565359|NCT00734929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25565360|NCT00734929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565361|NCT00734929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25565362|NCT00734929|Glucocorticoids|glucocorticoids|mesh-ancestor
25565363|NCT00734929|Hormones|hormones|mesh-ancestor
25565364|NCT00734929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25565365|NCT00734929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25565366|NCT00734929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565367|NCT00734929|Protease Inhibitors|protease inhibitors|mesh-ancestor
25565368|NCT00734929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565369|NCT00734929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565370|NCT00734929|Antipruritics|antipruritics|mesh-ancestor
25565371|NCT00734929|Dermatologic Agents|dermatologic agents|mesh-ancestor
25565372|NCT00734929|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25565373|NCT00734929|Serotonin Agents|serotonin agents|mesh-ancestor
25565374|NCT00734929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25565375|NCT00734929|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25565376|NCT00734929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25565377|NCT00734929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25565378|NCT00734929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25565379|NCT00734929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25565380|NCT00734929|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25565381|NCT00734968|Nitrofurantoin|nitrofurantoin|mesh-list
25565382|NCT00734968|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25565383|NCT00734968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24451562|NCT00324298|Bleomycin|bleomycin|mesh-list
25040613|NCT02990806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25565384|NCT00734968|Renal Agents|renal agents|mesh-ancestor
25565385|NCT00734968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25565386|NCT00734994|Mitomycins|mitomycins|mesh-list
25565387|NCT00734994|Mitomycin|mitomycin|mesh-list
25565388|NCT00734994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25565389|NCT00734994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565390|NCT00734994|Alkylating Agents|alkylating agents|mesh-ancestor
25565391|NCT00734994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565392|NCT00734994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25565393|NCT00734994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565394|NCT00735072|Maraviroc|maraviroc|mesh-list
25565395|NCT00735072|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25565396|NCT00735072|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25460142|NCT04602845|Flurbiprofen|flurbiprofen|mesh-list
25565397|NCT00735072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565399|NCT00735072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25565400|NCT00735072|Antiviral Agents|antiviral agents|mesh-ancestor
25565401|NCT00735072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25565402|NCT00735072|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25565403|NCT00735306|Bevacizumab|bevacizumab|mesh-list
25565404|NCT00735306|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25565405|NCT00735306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25565406|NCT00735306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565407|NCT00735306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25565408|NCT00735306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25565409|NCT00735306|Growth Substances|growth substances|mesh-ancestor
25565410|NCT00735306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565411|NCT00735306|Growth Inhibitors|growth inhibitors|mesh-ancestor
25565412|NCT00735306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25565413|NCT00735306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565414|NCT00735306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565415|NCT00735371|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25565416|NCT00735371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25565417|NCT00735371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565418|NCT00735371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25565419|NCT00735371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25565420|NCT00735371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25565421|NCT00735371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565422|NCT00735371|Dopamine Agents|dopamine agents|mesh-ancestor
25565423|NCT00735371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25651970|NCT01521923|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25651971|NCT01521923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651972|NCT01521923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25651973|NCT01521923|Antimetabolites|antimetabolites|mesh-ancestor
25651974|NCT01521923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651975|NCT01521923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25651976|NCT01521923|Dermatologic Agents|dermatologic agents|mesh-ancestor
25651977|NCT01521923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25651978|NCT01521923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25651979|NCT01521923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25651980|NCT01521923|Immunologic Factors|immunologic factors|mesh-ancestor
25651981|NCT01521923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25651982|NCT01521923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25651983|NCT01522235|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25651984|NCT01522235|gamma-Globulins|gamma-globulins|mesh-list
25651985|NCT01522235|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25651986|NCT01522235|Immunologic Factors|immunologic factors|mesh-ancestor
25651987|NCT01522235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651988|NCT01522404|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25651989|NCT01522404|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25651990|NCT01522404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25651991|NCT01522404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25651992|NCT01522404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25651993|NCT01522404|Adrenergic Agents|adrenergic agents|mesh-ancestor
25651994|NCT01522404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25651995|NCT01522404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25651996|NCT01522417|Tirofiban|tirofiban|mesh-list
25651997|NCT01522417|Eptifibatide|eptifibatide|mesh-list
25651998|NCT01522417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25651999|NCT01522417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25652000|NCT01522417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652001|NCT01522417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25652002|NCT01522443|Prednisone|prednisone|mesh-list
25652003|NCT01522443|Mitoxantrone|mitoxantrone|mesh-list
25652004|NCT01522443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25652005|NCT01522443|Glucocorticoids|glucocorticoids|mesh-ancestor
25652006|NCT01522443|Hormones|hormones|mesh-ancestor
25652007|NCT01522443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25652008|NCT01522443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652009|NCT01522443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25652010|NCT01522443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652011|NCT01522443|Analgesics|analgesics|mesh-ancestor
25652012|NCT01522443|Sensory System Agents|sensory system agents|mesh-ancestor
25652013|NCT01522443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25565424|NCT00735436|Bevacizumab|bevacizumab|mesh-list
25565425|NCT00735436|Irinotecan|irinotecan|mesh-list
25565426|NCT00735436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25565427|NCT00735436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565428|NCT00735436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25565429|NCT00735436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25565430|NCT00735436|Growth Substances|growth substances|mesh-ancestor
25565431|NCT00735436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565432|NCT00735436|Growth Inhibitors|growth inhibitors|mesh-ancestor
25565433|NCT00735436|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25565434|NCT00735436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25565435|NCT00735436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565436|NCT00735436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565437|NCT00735449|Timolol|timolol|mesh-list
25565438|NCT00735449|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25565439|NCT00735449|Latanoprost|latanoprost|mesh-list
25565440|NCT00735449|Maleic acid|maleic acid|mesh-list
25565441|NCT00735449|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25565442|NCT00735449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25565443|NCT00735449|Adrenergic Agents|adrenergic agents|mesh-ancestor
25565444|NCT00735449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25565445|NCT00735449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565446|NCT00735449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565447|NCT00735449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25565448|NCT00735449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25565449|NCT00735449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565450|NCT00735449|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25565451|NCT00735449|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25565452|NCT00735449|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25565453|NCT00735449|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25565454|NCT00735449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25565455|NCT00735462|Imiquimod|imiquimod|mesh-list
25565456|NCT00735462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25565457|NCT00735462|Immunologic Factors|immunologic factors|mesh-ancestor
25565458|NCT00735462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565459|NCT00735462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565460|NCT00735462|Interferon Inducers|interferon inducers|mesh-ancestor
25565461|NCT00735475|Vaccines|vaccines|mesh-list
25565462|NCT00735475|Immunologic Factors|immunologic factors|mesh-ancestor
25565463|NCT00735475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565464|NCT00735644|Vaccines|vaccines|mesh-list
24802457|NCT01990144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602893|NCT00971607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24637142|NCT01149005|Insulin|insulin|mesh-list
25565465|NCT00735644|Immunologic Factors|immunologic factors|mesh-ancestor
25565466|NCT00735644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565467|NCT00735670|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25565468|NCT00735670|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25565469|NCT00735670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25565470|NCT00735670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25565471|NCT00735670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565472|NCT00735670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25565473|NCT00735670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565474|NCT00735670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25565475|NCT00735670|Antidepressive Agents|antidepressive agents|mesh-ancestor
25565476|NCT00735670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25565477|NCT00735696|Paclitaxel|paclitaxel|mesh-list
25565478|NCT00735696|Carboplatin|carboplatin|mesh-list
25565479|NCT00735696|Ramucirumab|ramucirumab|mesh-list
25565480|NCT00735696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25565481|NCT00735696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565482|NCT00735696|Tubulin Modulators|tubulin modulators|mesh-ancestor
25565483|NCT00735696|Antimitotic Agents|antimitotic agents|mesh-ancestor
25565484|NCT00735696|Mitosis Modulators|mitosis modulators|mesh-ancestor
25565485|NCT00735696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565486|NCT00735709|Vortioxetine|vortioxetine|mesh-list
25565487|NCT00735709|Antidepressive Agents|antidepressive agents|mesh-ancestor
25565488|NCT00735709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25565489|NCT00735709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25565490|NCT00735709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25565491|NCT00735709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25565492|NCT00735709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565493|NCT00735709|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25565494|NCT00735709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25565495|NCT00735709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25652014|NCT01522443|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25565496|NCT00735709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565497|NCT00735709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25565498|NCT00735709|Serotonin Agents|serotonin agents|mesh-ancestor
25565499|NCT00735709|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25565500|NCT00735709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25565501|NCT00735709|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25565502|NCT00735709|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25565504|NCT00735787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25565505|NCT00735787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25565506|NCT00735826|Vorinostat|vorinostat|mesh-list
25565507|NCT00735826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450233|NCT00318175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565508|NCT00735826|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25565509|NCT00735826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565510|NCT00735826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565511|NCT00735878|Carboplatin|carboplatin|mesh-list
25565512|NCT00735878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565513|NCT00735904|Gemcitabine|gemcitabine|mesh-list
25565514|NCT00735904|Cisplatin|cisplatin|mesh-list
25565515|NCT00735904|Axitinib|axitinib|mesh-list
25565516|NCT00735904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565517|NCT00735904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25565518|NCT00735904|Antimetabolites|antimetabolites|mesh-ancestor
25565519|NCT00735904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565520|NCT00735904|Antiviral Agents|antiviral agents|mesh-ancestor
25565521|NCT00735904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25565522|NCT00735904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565523|NCT00735904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25565524|NCT00735904|Immunologic Factors|immunologic factors|mesh-ancestor
25565525|NCT00735904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565526|NCT00735904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25565527|NCT00735917|Saracatinib|saracatinib|mesh-list
25565528|NCT00735917|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25565529|NCT00735917|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25565530|NCT00735917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565531|NCT00735917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565532|NCT00735917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565533|NCT00735969|Ribavirin|ribavirin|mesh-list
25565534|NCT00735969|Antimetabolites|antimetabolites|mesh-ancestor
25565535|NCT00735969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565536|NCT00735969|Antiviral Agents|antiviral agents|mesh-ancestor
25565537|NCT00735969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25565538|NCT00736073|Aprepitant|aprepitant|mesh-list
25565539|NCT00736073|Antiemetics|antiemetics|mesh-ancestor
25565540|NCT00736073|Autonomic Agents|autonomic agents|mesh-ancestor
25565541|NCT00736073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25565542|NCT00736073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565543|NCT00736073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25565544|NCT00736073|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25565545|NCT00736073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25565546|NCT00736073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565547|NCT00736099|Pioglitazone|pioglitazone|mesh-list
25565548|NCT00736099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24548877|NCT00712491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24548878|NCT00712491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24548880|NCT00712491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565549|NCT00736099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565550|NCT00736190|Tenofovir|tenofovir|mesh-list
25565551|NCT00736190|Antiviral Agents|antiviral agents|mesh-ancestor
25565552|NCT00736190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25565553|NCT00736190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25565554|NCT00736190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25565555|NCT00736190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565556|NCT00736190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565557|NCT00736190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25565558|NCT00736190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25565559|NCT00736229|Exenatide|exenatide|mesh-list
25565560|NCT00736229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25565561|NCT00736229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565562|NCT00736229|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25565563|NCT00736229|Incretins|incretins|mesh-ancestor
25565564|NCT00736229|Hormones|hormones|mesh-ancestor
25565565|NCT00736229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25565566|NCT00736242|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25565567|NCT00736242|Interferon alpha-2|interferon alpha-2|mesh-list
25565568|NCT00736242|Antiviral Agents|antiviral agents|mesh-ancestor
25565569|NCT00736242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25565570|NCT00736242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565571|NCT00736255|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25565572|NCT00736255|Dextroamphetamine|dextroamphetamine|mesh-list
25565573|NCT00736255|Nicotine|nicotine|mesh-list
25565574|NCT00736255|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25565575|NCT00736255|Autonomic Agents|autonomic agents|mesh-ancestor
25565576|NCT00736255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25565577|NCT00736255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565578|NCT00736255|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25565579|NCT00736255|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25565580|NCT00736255|Cholinergic Agents|cholinergic agents|mesh-ancestor
25565581|NCT00736255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25565582|NCT00736255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565583|NCT00736255|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25565584|NCT00736255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25565585|NCT00736255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25565586|NCT00736255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25565587|NCT00736255|Dopamine Agents|dopamine agents|mesh-ancestor
25565588|NCT00736333|Doxorubicin|doxorubicin|mesh-list
25565589|NCT00736333|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25565590|NCT00736333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25565591|NCT00736333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565592|NCT00736333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25565593|NCT00736333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25565594|NCT00736333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565595|NCT00736333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565596|NCT00736450|Prednisone|prednisone|mesh-list
25565597|NCT00736450|Cyclophosphamide|cyclophosphamide|mesh-list
25565598|NCT00736450|Rituximab|rituximab|mesh-list
25565599|NCT00736450|Doxorubicin|doxorubicin|mesh-list
25565600|NCT00736450|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25565601|NCT00736450|Vincristine|vincristine|mesh-list
25565602|NCT00736450|Oblimersen|oblimersen|mesh-list
25565603|NCT00736450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25565604|NCT00736450|Immunologic Factors|immunologic factors|mesh-ancestor
25565605|NCT00736450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565606|NCT00736450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25565607|NCT00736450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25565608|NCT00736450|Alkylating Agents|alkylating agents|mesh-ancestor
25565609|NCT00736450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565610|NCT00736450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565611|NCT00736450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25565612|NCT00736450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25565613|NCT00736450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25565614|NCT00736450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25565615|NCT00736450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25565616|NCT00736450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565617|NCT00736450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24831213|NCT02164110|Vaccines|vaccines|mesh-list
25565618|NCT00736450|Glucocorticoids|glucocorticoids|mesh-ancestor
25565619|NCT00736450|Hormones|hormones|mesh-ancestor
25565620|NCT00736450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25565621|NCT00736450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25565622|NCT00736450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25565623|NCT00736450|Tubulin Modulators|tubulin modulators|mesh-ancestor
25565624|NCT00736450|Antimitotic Agents|antimitotic agents|mesh-ancestor
25565625|NCT00736450|Mitosis Modulators|mitosis modulators|mesh-ancestor
25565626|NCT00736476|Vaccines|vaccines|mesh-list
25565627|NCT00736476|Immunologic Factors|immunologic factors|mesh-ancestor
25565628|NCT00736476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565629|NCT00736489|Formoterol Fumarate|formoterol fumarate|mesh-list
25565630|NCT00736489|AZD-3199|azd-3199|mesh-list
25565631|NCT00736489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25565632|NCT00736489|Autonomic Agents|autonomic agents|mesh-ancestor
25565633|NCT00736489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25565634|NCT00736489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565635|NCT00736489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25565636|NCT00736489|Respiratory System Agents|respiratory system agents|mesh-ancestor
25565637|NCT00736489|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25565638|NCT00736489|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25565639|NCT00736489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25565640|NCT00736489|Adrenergic Agents|adrenergic agents|mesh-ancestor
25565641|NCT00736489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25565642|NCT00736489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565643|NCT00736632|Vitamin D|vitamin d|mesh-list
25565644|NCT00736632|Ergocalciferols|ergocalciferols|mesh-list
25460404|NCT04429321|Nivolumab|nivolumab|mesh-list
25460467|NCT04345666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25460468|NCT04345666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460469|NCT04345666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25460470|NCT04345666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460471|NCT04345666|Anabolic Agents|anabolic agents|mesh-ancestor
25319639|NCT04945694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25105971|NCT04718025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25122671|NCT03091569|Hemostatics|hemostatics|mesh-ancestor
25105972|NCT04718025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25105973|NCT04718025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105974|NCT04718025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25105975|NCT04718025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25105976|NCT04718025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25105977|NCT04718025|Antipyretics|antipyretics|mesh-ancestor
25105978|NCT04718025|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25105979|NCT04718025|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25105980|NCT04718025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25105981|NCT04718025|Purinergic Agents|purinergic agents|mesh-ancestor
24979238|NCT05064332|Contraceptive Agents|contraceptive agents|mesh-list
24979239|NCT05064332|Contraceptives, Oral|contraceptives, oral|mesh-list
24979240|NCT05064332|Estradiol|estradiol|mesh-list
24979241|NCT05064332|Estrogens|estrogens|mesh-ancestor
24424200|NCT00228267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24424221|NCT00228358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424222|NCT00228358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24424223|NCT00228358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24424224|NCT00228358|Alkylating Agents|alkylating agents|mesh-ancestor
24424225|NCT00228358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424407|NCT00229216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24424408|NCT00229216|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
24424409|NCT00229216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24424410|NCT00229216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24424411|NCT00229242|Diuretics|diuretics|mesh-list
24424412|NCT00229242|Natriuretic Agents|natriuretic agents|mesh-ancestor
24424413|NCT00229242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424414|NCT00229333|Citalopram|citalopram|mesh-list
24424415|NCT00229333|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24424416|NCT00229333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24424417|NCT00229333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24424418|NCT00229333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169539|NCT01825980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979243|NCT05064332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24979244|NCT05064332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979245|NCT05064332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25040852|NCT02804282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040854|NCT02804035|Diuretics|diuretics|mesh-ancestor
25040855|NCT02804035|Natriuretic Agents|natriuretic agents|mesh-ancestor
24603924|NCT00976131|Ubiquinone|ubiquinone|mesh-list
25169540|NCT01825980|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25122736|NCT03090971|Analgesics|analgesics|mesh-ancestor
25040856|NCT02804035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040857|NCT02804035|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25040858|NCT02804035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25040859|NCT02804035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040860|NCT02802813|Piperaquine|piperaquine|mesh-list
25040861|NCT02802813|Primaquine|primaquine|mesh-list
25040862|NCT02802813|Artenimol|artenimol|mesh-list
25040863|NCT02802813|Artemisinins|artemisinins|mesh-list
25040864|NCT02802813|Antimalarials|antimalarials|mesh-ancestor
25040865|NCT02802813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25040866|NCT02802813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25040867|NCT02802813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25040868|NCT02796170|Dapagliflozin|dapagliflozin|mesh-list
25122740|NCT03090971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25040869|NCT02796170|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25040870|NCT02796170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040871|NCT02796170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24549519|NCT00715780|Insulin|insulin|mesh-list
25565645|NCT00736632|Cholecalciferol|cholecalciferol|mesh-list
25565646|NCT00736632|Vitamins|vitamins|mesh-list
25565647|NCT00736632|Micronutrients|micronutrients|mesh-ancestor
25565648|NCT00736632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565649|NCT00736632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25565650|NCT00736632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25565651|NCT00736645|Selenium|selenium|mesh-list
25565652|NCT00736645|Finasteride|finasteride|mesh-list
25565653|NCT00736645|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25565654|NCT00736645|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25565655|NCT00736645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565656|NCT00736645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565657|NCT00736645|Hormone Antagonists|hormone antagonists|mesh-ancestor
25565658|NCT00736645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25565659|NCT00736645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565660|NCT00736645|Urological Agents|urological agents|mesh-ancestor
25565661|NCT00736645|Antioxidants|antioxidants|mesh-ancestor
25565662|NCT00736645|Protective Agents|protective agents|mesh-ancestor
25565663|NCT00736645|Trace Elements|trace elements|mesh-ancestor
25565664|NCT00736645|Micronutrients|micronutrients|mesh-ancestor
25565665|NCT00736853|Acetaminophen|acetaminophen|mesh-list
25565666|NCT00736853|Tramadol|tramadol|mesh-list
25565667|NCT00736853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25565668|NCT00736853|Analgesics|analgesics|mesh-ancestor
25565669|NCT00736853|Sensory System Agents|sensory system agents|mesh-ancestor
25565670|NCT00736853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25565671|NCT00736853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565672|NCT00736853|Antipyretics|antipyretics|mesh-ancestor
25565673|NCT00736853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25565674|NCT00736853|Narcotics|narcotics|mesh-ancestor
25565675|NCT00736853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25565676|NCT00736879|Dapagliflozin|dapagliflozin|mesh-list
25565677|NCT00736879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25565678|NCT00736879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565679|NCT00736879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25565680|NCT00736879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565681|NCT00736944|Cisplatin|cisplatin|mesh-list
25565682|NCT00736944|Cetuximab|cetuximab|mesh-list
25565683|NCT00736944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25565684|NCT00736944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565685|NCT00736944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25565686|NCT00736957|Acetaminophen|acetaminophen|mesh-list
25565687|NCT00736957|Tramadol|tramadol|mesh-list
25565688|NCT00736957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25565689|NCT00736957|Analgesics|analgesics|mesh-ancestor
25565690|NCT00736957|Sensory System Agents|sensory system agents|mesh-ancestor
25565691|NCT00736957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25565692|NCT00736957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565693|NCT00736957|Antipyretics|antipyretics|mesh-ancestor
25565694|NCT00736957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25565695|NCT00736957|Narcotics|narcotics|mesh-ancestor
25565696|NCT00736957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25565697|NCT00736996|Pioglitazone|pioglitazone|mesh-list
25565698|NCT00736996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25565699|NCT00736996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565700|NCT00737048|Acetaminophen|acetaminophen|mesh-list
25565701|NCT00737048|Tramadol|tramadol|mesh-list
25565702|NCT00737048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25565703|NCT00737048|Analgesics|analgesics|mesh-ancestor
25565704|NCT00737048|Sensory System Agents|sensory system agents|mesh-ancestor
25565705|NCT00737048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25565706|NCT00737048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565707|NCT00737048|Antipyretics|antipyretics|mesh-ancestor
25565708|NCT00737048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25565709|NCT00737048|Narcotics|narcotics|mesh-ancestor
25565710|NCT00737048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25565711|NCT00737100|Bromides|bromides|mesh-list
25565712|NCT00737100|Tiotropium Bromide|tiotropium bromide|mesh-list
25565713|NCT00737100|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25565714|NCT00737100|Autonomic Agents|autonomic agents|mesh-ancestor
25565715|NCT00737100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25565716|NCT00737100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565717|NCT00737100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25565718|NCT00737100|Respiratory System Agents|respiratory system agents|mesh-ancestor
25565719|NCT00737100|Parasympatholytics|parasympatholytics|mesh-ancestor
25565720|NCT00737100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25565721|NCT00737100|Cholinergic Agents|cholinergic agents|mesh-ancestor
25565722|NCT00737100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25565723|NCT00737100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460472|NCT04338529|Cholecalciferol|cholecalciferol|mesh-list
25565724|NCT00737100|Anticonvulsants|anticonvulsants|mesh-ancestor
25565725|NCT00737178|Copper|copper|mesh-list
25565726|NCT00737178|Trace Elements|trace elements|mesh-ancestor
25565727|NCT00737178|Micronutrients|micronutrients|mesh-ancestor
25565728|NCT00737178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565729|NCT00737204|Modafinil|modafinil|mesh-list
25565730|NCT00737204|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25565731|NCT00737204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565732|NCT00737204|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25565733|NCT00737204|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25565734|NCT00737204|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25565735|NCT00737204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565736|NCT00737243|Paclitaxel|paclitaxel|mesh-list
25565737|NCT00737243|Bevacizumab|bevacizumab|mesh-list
25565738|NCT00737243|Carboplatin|carboplatin|mesh-list
25565739|NCT00737243|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25565740|NCT00737243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25565741|NCT00737243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565742|NCT00737243|Tubulin Modulators|tubulin modulators|mesh-ancestor
25565743|NCT00737243|Antimitotic Agents|antimitotic agents|mesh-ancestor
25565744|NCT00737243|Mitosis Modulators|mitosis modulators|mesh-ancestor
24549750|NCT00717470|Basiliximab|basiliximab|mesh-list
24452680|NCT05457829|Temozolomide|temozolomide|mesh-list
25565745|NCT00737243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565746|NCT00737243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25565747|NCT00737243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25565748|NCT00737243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25565749|NCT00737243|Growth Substances|growth substances|mesh-ancestor
25565750|NCT00737243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565751|NCT00737243|Growth Inhibitors|growth inhibitors|mesh-ancestor
25565752|NCT00737243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25565753|NCT00737243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565754|NCT00737438|Bevacizumab|bevacizumab|mesh-list
25565755|NCT00737438|Cisplatin|cisplatin|mesh-list
25565756|NCT00737438|Docetaxel|docetaxel|mesh-list
25565757|NCT00737438|Capecitabine|capecitabine|mesh-list
25565758|NCT00737438|Irinotecan|irinotecan|mesh-list
25565759|NCT00737438|Epirubicin|epirubicin|mesh-list
25565760|NCT00737438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25565761|NCT00737438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565762|NCT00737438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25565763|NCT00737438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25565764|NCT00737438|Growth Substances|growth substances|mesh-ancestor
25565765|NCT00737438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565766|NCT00737438|Growth Inhibitors|growth inhibitors|mesh-ancestor
25565767|NCT00737438|Tubulin Modulators|tubulin modulators|mesh-ancestor
25565768|NCT00737438|Antimitotic Agents|antimitotic agents|mesh-ancestor
25565769|NCT00737438|Mitosis Modulators|mitosis modulators|mesh-ancestor
25565770|NCT00737438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565771|NCT00737438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25565772|NCT00737438|Antimetabolites|antimetabolites|mesh-ancestor
25565773|NCT00737438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25565774|NCT00737438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25565775|NCT00737438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565776|NCT00737438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25565777|NCT00737438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25565778|NCT00737464|Epoetin Alfa|epoetin alfa|mesh-list
25565779|NCT00737464|Hematinics|hematinics|mesh-ancestor
25565780|NCT00737477|Epoetin Alfa|epoetin alfa|mesh-list
25565781|NCT00737477|Hematinics|hematinics|mesh-ancestor
25565782|NCT00737529|Lenalidomide|lenalidomide|mesh-list
25565783|NCT00737529|Immunologic Factors|immunologic factors|mesh-ancestor
25565784|NCT00737529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565785|NCT00737529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25565786|NCT00737529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25565787|NCT00737529|Growth Substances|growth substances|mesh-ancestor
25565788|NCT00737529|Growth Inhibitors|growth inhibitors|mesh-ancestor
25565789|NCT00737529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565790|NCT00737568|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25565791|NCT00737568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25565792|NCT00737568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25565793|NCT00737568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565794|NCT00737568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565795|NCT00737568|Antiviral Agents|antiviral agents|mesh-ancestor
25565796|NCT00737568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25565797|NCT00737568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25565798|NCT00737568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25565799|NCT00737711|Epoetin Alfa|epoetin alfa|mesh-list
25565800|NCT00737711|Hematinics|hematinics|mesh-ancestor
25460542|NCT04300985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25565801|NCT00737737|Morphine|morphine|mesh-list
25565802|NCT00737737|Oxycodone|oxycodone|mesh-list
25565803|NCT00737737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25565804|NCT00737737|Narcotics|narcotics|mesh-ancestor
25565805|NCT00737737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25565806|NCT00737737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565807|NCT00737737|Analgesics|analgesics|mesh-ancestor
25565808|NCT00737737|Sensory System Agents|sensory system agents|mesh-ancestor
25565809|NCT00737737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25565810|NCT00737893|Epoetin Alfa|epoetin alfa|mesh-list
25565811|NCT00737893|Hematinics|hematinics|mesh-ancestor
25565812|NCT00738023|Rosiglitazone|rosiglitazone|mesh-list
25565813|NCT00738023|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25565814|NCT00738023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25565815|NCT00738023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565816|NCT00738023|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25565817|NCT00738023|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25565818|NCT00738023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25565819|NCT00738049|Darusentan|darusentan|mesh-list
25565820|NCT00738049|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25565821|NCT00738049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565822|NCT00738062|Droxidopa|droxidopa|mesh-list
25565823|NCT00738062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25565824|NCT00738062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25565825|NCT00738361|Paclitaxel|paclitaxel|mesh-list
25565826|NCT00738361|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25565827|NCT00738361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25565828|NCT00738361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565829|NCT00738361|Tubulin Modulators|tubulin modulators|mesh-ancestor
25565830|NCT00738361|Antimitotic Agents|antimitotic agents|mesh-ancestor
25565831|NCT00738361|Mitosis Modulators|mitosis modulators|mesh-ancestor
25565832|NCT00738361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565833|NCT00738374|Rituximab|rituximab|mesh-list
25565834|NCT00738374|Chlorambucil|chlorambucil|mesh-list
25565835|NCT00738374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25565836|NCT00738374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565837|NCT00738374|Immunologic Factors|immunologic factors|mesh-ancestor
25565838|NCT00738374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565839|NCT00738374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25565840|NCT00738374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25565841|NCT00738374|Alkylating Agents|alkylating agents|mesh-ancestor
25565842|NCT00738374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565843|NCT00738400|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
25565844|NCT00738400|Vasodilator Agents|vasodilator agents|mesh-ancestor
25565845|NCT00738400|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25565846|NCT00738400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25565847|NCT00738400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565848|NCT00738400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565849|NCT00738400|Urological Agents|urological agents|mesh-ancestor
25565850|NCT00738530|Interferons|interferons|mesh-list
25565851|NCT00738530|Interferon-alpha|interferon-alpha|mesh-list
25565852|NCT00738530|Interferon alpha-2|interferon alpha-2|mesh-list
25565853|NCT00738530|Bevacizumab|bevacizumab|mesh-list
25565854|NCT00738530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25565855|NCT00738530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565856|NCT00738530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25565857|NCT00738530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24465086|NCT00367874|Sensory System Agents|sensory system agents|mesh-ancestor
24492159|NCT00485511|Hydroxyurea|hydroxyurea|mesh-list
24550298|NCT00720148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940288|NCT04002349|Respiratory System Agents|respiratory system agents|mesh-ancestor
24589654|NCT00908362|Xhance|xhance|mesh-list
25565858|NCT00738530|Growth Substances|growth substances|mesh-ancestor
25565859|NCT00738530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565860|NCT00738530|Growth Inhibitors|growth inhibitors|mesh-ancestor
25565861|NCT00738530|Antiviral Agents|antiviral agents|mesh-ancestor
25565862|NCT00738530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25565863|NCT00738530|Immunologic Factors|immunologic factors|mesh-ancestor
25565864|NCT00738543|Povidone-Iodine|povidone-iodine|mesh-list
25565865|NCT00738543|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25565866|NCT00738543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25565867|NCT00738699|Paclitaxel|paclitaxel|mesh-list
25565868|NCT00738699|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25565869|NCT00738699|Farletuzumab|farletuzumab|mesh-list
25565870|NCT00738699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25565871|NCT00738699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565872|NCT00738699|Tubulin Modulators|tubulin modulators|mesh-ancestor
25565873|NCT00738699|Antimitotic Agents|antimitotic agents|mesh-ancestor
25565874|NCT00738699|Mitosis Modulators|mitosis modulators|mesh-ancestor
25565875|NCT00738699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565876|NCT00738881|Pemetrexed|pemetrexed|mesh-list
25565877|NCT00738881|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25565879|NCT00738881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565880|NCT00738881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565881|NCT00738881|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25565882|NCT00738881|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25565883|NCT00738881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25565884|NCT00738894|Aspirin|aspirin|mesh-list
25565885|NCT00738894|Dipyridamole|dipyridamole|mesh-list
25565886|NCT00738894|Clopidogrel|clopidogrel|mesh-list
25565887|NCT00738894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24940289|NCT04002349|Glucocorticoids|glucocorticoids|mesh-ancestor
24940290|NCT04002349|Hormones|hormones|mesh-ancestor
24940291|NCT04002349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24940292|NCT04002349|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24940293|NCT04002349|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24940294|NCT04002349|Histamine Antagonists|histamine antagonists|mesh-ancestor
24940295|NCT04002349|Histamine Agents|histamine agents|mesh-ancestor
24940296|NCT04002349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24940297|NCT04002349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695098|NCT02040766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25695099|NCT02040779|Beclomethasone|beclomethasone|mesh-list
25695100|NCT02040779|Albuterol|albuterol|mesh-list
25565888|NCT00738894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25565889|NCT00738894|Analgesics|analgesics|mesh-ancestor
25565890|NCT00738894|Sensory System Agents|sensory system agents|mesh-ancestor
25565891|NCT00738894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25565892|NCT00738894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565893|NCT00738894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25565894|NCT00738894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25565895|NCT00738894|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25565896|NCT00738894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25565897|NCT00738894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565898|NCT00738894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25565899|NCT00738894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25565900|NCT00738894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565901|NCT00738894|Antipyretics|antipyretics|mesh-ancestor
25565902|NCT00738894|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24831812|NCT02169154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24940327|NCT04002141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24940328|NCT04002141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24940329|NCT04002141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940330|NCT04002141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24940331|NCT04002141|Hormone Antagonists|hormone antagonists|mesh-ancestor
24940332|NCT04002141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25075948|NCT03377101|Hormone Antagonists|hormone antagonists|mesh-ancestor
25565903|NCT00738894|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25565904|NCT00738894|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25565905|NCT00738894|Purinergic Agents|purinergic agents|mesh-ancestor
25565906|NCT00738894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25565907|NCT00738894|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25565908|NCT00738894|Vasodilator Agents|vasodilator agents|mesh-ancestor
25565909|NCT00739297|Montelukast|montelukast|mesh-list
25565910|NCT00739297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25565911|NCT00739297|Respiratory System Agents|respiratory system agents|mesh-ancestor
25565912|NCT00739297|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25565913|NCT00739297|Hormone Antagonists|hormone antagonists|mesh-ancestor
25565914|NCT00739297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25565915|NCT00739297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565916|NCT00739297|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25565917|NCT00739297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25565918|NCT00739297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565919|NCT00739596|Amlodipine|amlodipine|mesh-list
25565920|NCT00739596|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25565921|NCT00739596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25565922|NCT00739596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25565923|NCT00739596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25565924|NCT00739596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565925|NCT00739596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25565926|NCT00739596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565927|NCT00739596|Vasodilator Agents|vasodilator agents|mesh-ancestor
25565928|NCT00739596|Diuretics|diuretics|mesh-ancestor
25565929|NCT00739596|Natriuretic Agents|natriuretic agents|mesh-ancestor
25565930|NCT00739596|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25565931|NCT00739648|Levofloxacin|levofloxacin|mesh-list
25565932|NCT00739648|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25565933|NCT00739648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25565934|NCT00739648|Renal Agents|renal agents|mesh-ancestor
25565935|NCT00739648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25565936|NCT00739648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25565937|NCT00739648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25565938|NCT00739648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565939|NCT00739648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565940|NCT00739648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565941|NCT00739648|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25565942|NCT00739648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25565943|NCT00739934|Voriconazole|voriconazole|mesh-list
25565944|NCT00739934|Antifungal Agents|antifungal agents|mesh-ancestor
25565945|NCT00739934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25565946|NCT00739934|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25565947|NCT00739934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25565948|NCT00739934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565949|NCT00739934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565950|NCT00739934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24940333|NCT04002141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609694|NCT00997880|Calcium|calcium|mesh-list
24450010|NCT00317577|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24450011|NCT00317577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24450012|NCT00317629|Meglumine Antimoniate|meglumine antimoniate|mesh-list
24533325|NCT00643136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24533326|NCT00643136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24436940|NCT00272207|Autonomic Agents|autonomic agents|mesh-ancestor
25565951|NCT00739934|Hormone Antagonists|hormone antagonists|mesh-ancestor
25565952|NCT00739934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25565953|NCT00739934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565954|NCT00739934|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25565955|NCT00739960|Abatacept|abatacept|mesh-list
25565956|NCT00739960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25565957|NCT00739960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565958|NCT00739960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25565959|NCT00739960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25565960|NCT00739960|Immunologic Factors|immunologic factors|mesh-ancestor
25565961|NCT00739960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565962|NCT00739960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25565963|NCT00739973|Amlodipine|amlodipine|mesh-list
25565964|NCT00739973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25565965|NCT00739973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25565966|NCT00739973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25565967|NCT00739973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565968|NCT00739973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25565969|NCT00739973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565970|NCT00739973|Vasodilator Agents|vasodilator agents|mesh-ancestor
25565971|NCT00739999|Atorvastatin|atorvastatin|mesh-list
25565972|NCT00739999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25565973|NCT00739999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25565974|NCT00739999|Antimetabolites|antimetabolites|mesh-ancestor
25565975|NCT00739999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565976|NCT00739999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25565977|NCT00739999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25565978|NCT00739999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565979|NCT00740051|Glimepiride|glimepiride|mesh-list
25565980|NCT00740051|Linagliptin|linagliptin|mesh-list
25565981|NCT00740051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25565982|NCT00740051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25565983|NCT00740051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565984|NCT00740051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25565985|NCT00740051|Immunologic Factors|immunologic factors|mesh-ancestor
25565986|NCT00740051|Incretins|incretins|mesh-ancestor
25565987|NCT00740051|Hormones|hormones|mesh-ancestor
25565988|NCT00740051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25565989|NCT00740051|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25565990|NCT00740051|Protease Inhibitors|protease inhibitors|mesh-ancestor
25565991|NCT00740051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25565992|NCT00740051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25565993|NCT00740129|Zoledronic Acid|zoledronic acid|mesh-list
25565994|NCT00740129|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25565995|NCT00740129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25565996|NCT00740636|Temozolomide|temozolomide|mesh-list
25565997|NCT00740636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25565998|NCT00740636|Alkylating Agents|alkylating agents|mesh-ancestor
25565999|NCT00740636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803125|NCT01994733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24533349|NCT00643292|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25566000|NCT00740636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25566001|NCT00740714|Vitamins|vitamins|mesh-list
25566002|NCT00740714|Vitamin E|vitamin e|mesh-list
25566003|NCT00740714|Tocopherols|tocopherols|mesh-list
25566004|NCT00740714|Tocotrienols|tocotrienols|mesh-list
25566005|NCT00740714|alpha-Tocopherol|alpha-tocopherol|mesh-list
25566006|NCT00740714|Coenzyme Q10|coenzyme q10|mesh-list
25566007|NCT00740714|Ubiquinone|ubiquinone|mesh-list
25566008|NCT00740714|Micronutrients|micronutrients|mesh-ancestor
25566009|NCT00740714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566010|NCT00740714|Antioxidants|antioxidants|mesh-ancestor
25566011|NCT00740714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566012|NCT00740714|Protective Agents|protective agents|mesh-ancestor
25566013|NCT00740779|Silodosin|silodosin|mesh-list
25566014|NCT00740779|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25566015|NCT00740779|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25566016|NCT00740779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25566017|NCT00740779|Adrenergic Agents|adrenergic agents|mesh-ancestor
25566018|NCT00740779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25566019|NCT00740779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566020|NCT00740779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460744|NCT04117932|Ustekinumab|ustekinumab|mesh-list
25460815|NCT04080947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25460816|NCT04080947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460817|NCT04064931|Niacin|niacin|mesh-list
25460818|NCT04064931|Vitamins|vitamins|mesh-ancestor
25460819|NCT04064931|Micronutrients|micronutrients|mesh-ancestor
25460820|NCT04064931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460821|NCT04064931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25460822|NCT04064931|Antimetabolites|antimetabolites|mesh-ancestor
25460823|NCT04064931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460824|NCT04064931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25460825|NCT04064931|Vasodilator Agents|vasodilator agents|mesh-ancestor
25460826|NCT04064931|Vitamin B Complex|vitamin b complex|mesh-ancestor
25320070|NCT04940689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25320071|NCT04940689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25320072|NCT04940689|Analgesics|analgesics|mesh-ancestor
25320073|NCT04940689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25320074|NCT04940689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25320075|NCT04940689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25320076|NCT04940689|Adrenergic Agents|adrenergic agents|mesh-ancestor
25320077|NCT04940689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25320078|NCT04940689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25320079|NCT04940689|Narcotics|narcotics|mesh-ancestor
25320080|NCT04940845|Denosumab|denosumab|mesh-list
25320081|NCT04940845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25320082|NCT04940845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320083|NCT04940871|Favipiravir|favipiravir|mesh-list
25320084|NCT04940871|Antiviral Agents|antiviral agents|mesh-ancestor
25320085|NCT04940871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25320086|NCT04940546|Bevacizumab|bevacizumab|mesh-list
25040872|NCT02796170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040873|NCT02784288|Paclitaxel|paclitaxel|mesh-list
25040874|NCT02784288|Carboplatin|carboplatin|mesh-list
25040875|NCT02784288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25040876|NCT02784288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25040877|NCT02784288|Tubulin Modulators|tubulin modulators|mesh-ancestor
25040878|NCT02784288|Antimitotic Agents|antimitotic agents|mesh-ancestor
25040879|NCT02784288|Mitosis Modulators|mitosis modulators|mesh-ancestor
25040880|NCT02784288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040881|NCT02784002|Fidaxomicin|fidaxomicin|mesh-list
25162038|NCT02908711|Ropivacaine|ropivacaine|mesh-list
25162039|NCT02908711|Anesthetics, Local|anesthetics, local|mesh-ancestor
25162040|NCT02908711|Anesthetics|anesthetics|mesh-ancestor
25162041|NCT02908711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25162042|NCT02908711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162043|NCT02908711|Sensory System Agents|sensory system agents|mesh-ancestor
25162044|NCT02908711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25566021|NCT00740779|Urological Agents|urological agents|mesh-ancestor
25566022|NCT00740792|Fluticasone|fluticasone|mesh-list
25566023|NCT00740792|Xhance|xhance|mesh-list
25566024|NCT00740792|Azelastine|azelastine|mesh-list
25566025|NCT00740792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25566026|NCT00740792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25566027|NCT00740792|Autonomic Agents|autonomic agents|mesh-ancestor
25566028|NCT00740792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25566029|NCT00740792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832132|NCT02170740|Anticoagulants|anticoagulants|mesh-ancestor
25566030|NCT00740792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25566031|NCT00740792|Respiratory System Agents|respiratory system agents|mesh-ancestor
25566032|NCT00740792|Dermatologic Agents|dermatologic agents|mesh-ancestor
25566033|NCT00740792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25566034|NCT00740792|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25566035|NCT00740792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25566036|NCT00740792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566037|NCT00740792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24702409|NCT01465828|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24702414|NCT01465867|Selenium|selenium|mesh-list
25162045|NCT02908763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25162046|NCT02908763|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25566038|NCT00740792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24804221|NCT02001584|GABA Agonists|gaba agonists|mesh-ancestor
25566039|NCT00740792|Histamine Antagonists|histamine antagonists|mesh-ancestor
25566040|NCT00740792|Histamine Agents|histamine agents|mesh-ancestor
25566041|NCT00740792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25566042|NCT00740831|Leuprolide|leuprolide|mesh-list
25566043|NCT00740831|Ulipristal acetate|ulipristal acetate|mesh-list
25566044|NCT00740831|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25566045|NCT00740831|Fertility Agents|fertility agents|mesh-ancestor
25566046|NCT00740831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25566047|NCT00740831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566048|NCT00740831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25566049|NCT00740831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25566050|NCT00740831|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25566051|NCT00740831|Contraceptive Agents|contraceptive agents|mesh-ancestor
25566052|NCT00740831|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25566053|NCT00740857|Ibuprofen|ibuprofen|mesh-list
25566054|NCT00740857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25566055|NCT00740857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25566056|NCT00740857|Analgesics|analgesics|mesh-ancestor
25566057|NCT00740857|Sensory System Agents|sensory system agents|mesh-ancestor
25566058|NCT00740857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25566059|NCT00740857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566060|NCT00740857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25566061|NCT00740857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24703408|NCT01471678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25566062|NCT00740857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25566063|NCT00740857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25566064|NCT00740857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652015|NCT01522443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25652016|NCT01522443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652017|NCT01522443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652018|NCT01522651|Dronedarone|dronedarone|mesh-list
25652019|NCT01522651|Ranolazine|ranolazine|mesh-list
25652020|NCT01522651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25652021|NCT01522651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25652022|NCT01522651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613547|NCT01019642|Vitamins|vitamins|mesh-ancestor
24617794|NCT01045837|Prednisolone|prednisolone|mesh-list
24805172|NCT02007928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25652023|NCT01522651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25652024|NCT01522950|Atenolol|atenolol|mesh-list
25652025|NCT01522950|Nebivolol|nebivolol|mesh-list
25652026|NCT01522950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25652027|NCT01522950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25652028|NCT01522950|Sympatholytics|sympatholytics|mesh-ancestor
25652029|NCT01522950|Autonomic Agents|autonomic agents|mesh-ancestor
25652030|NCT01522950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25652031|NCT01522950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652032|NCT01522950|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25652033|NCT01522950|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25652034|NCT01522950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25652035|NCT01522950|Adrenergic Agents|adrenergic agents|mesh-ancestor
25652036|NCT01522950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25652037|NCT01522950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652038|NCT01522950|Vasodilator Agents|vasodilator agents|mesh-ancestor
25652039|NCT01522950|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25652040|NCT01522950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25652041|NCT01522950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25652042|NCT01522963|Nicotine|nicotine|mesh-list
25652043|NCT01522963|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24704738|NCT01479933|Vitamin D|vitamin d|mesh-list
25652044|NCT01522963|Autonomic Agents|autonomic agents|mesh-ancestor
25652045|NCT01522963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25652046|NCT01522963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652047|NCT01522963|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25652048|NCT01522963|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25652049|NCT01522963|Cholinergic Agents|cholinergic agents|mesh-ancestor
25695154|NCT02042443|Leucovorin|leucovorin|mesh-list
25652050|NCT01522963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25652051|NCT01522963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652052|NCT01523275|Mitomycins|mitomycins|mesh-list
25652053|NCT01523275|Mitomycin|mitomycin|mesh-list
24469935|NCT00388076|Paclitaxel|paclitaxel|mesh-list
25652054|NCT01523275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25652055|NCT01523275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652056|NCT01523275|Alkylating Agents|alkylating agents|mesh-ancestor
25652057|NCT01523275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652058|NCT01523275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25652059|NCT01523275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652060|NCT01523301|Rotigotine|rotigotine|mesh-list
25652061|NCT01523301|Dopamine Agonists|dopamine agonists|mesh-ancestor
25652062|NCT01523301|Dopamine Agents|dopamine agents|mesh-ancestor
25652063|NCT01523301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25652064|NCT01523301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652065|NCT01523301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652066|NCT01523366|Clopidogrel|clopidogrel|mesh-list
25652067|NCT01523366|Ticagrelor|ticagrelor|mesh-list
25652068|NCT01523366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25652069|NCT01523366|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25652070|NCT01523366|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25652071|NCT01523366|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25652072|NCT01523366|Purinergic Agents|purinergic agents|mesh-ancestor
25566065|NCT00741013|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
25566066|NCT00741013|Protein C|protein c|mesh-list
25566067|NCT00741013|Lovastatin|lovastatin|mesh-list
25566068|NCT00741013|L 647318|l 647318|mesh-list
25566069|NCT00741013|Dihydromevinolin|dihydromevinolin|mesh-list
25566070|NCT00741013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25566071|NCT00741013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25566072|NCT00741013|Antimetabolites|antimetabolites|mesh-ancestor
24706134|NCT01488773|Montelukast|montelukast|mesh-list
25566073|NCT00741013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566074|NCT00741013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25566075|NCT00741013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25566076|NCT00741013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25566077|NCT00741013|Anticoagulants|anticoagulants|mesh-ancestor
25566078|NCT00741013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25566079|NCT00741013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25566080|NCT00741013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25566081|NCT00741026|Olanzapine|olanzapine|mesh-list
25566082|NCT00741026|Antiemetics|antiemetics|mesh-ancestor
25566083|NCT00741026|Autonomic Agents|autonomic agents|mesh-ancestor
24956806|NCT03850886|Niacin|niacin|mesh-list
24673520|NCT01338675|Busulfan|busulfan|mesh-list
25566084|NCT00741026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25566085|NCT00741026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566086|NCT00741026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25566087|NCT00741026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25566088|NCT00741026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24707256|NCT01495026|Tamsulosin|tamsulosin|mesh-list
25566089|NCT00741026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25566090|NCT00741026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24674726|NCT04721132|Atezolizumab|atezolizumab|mesh-list
25566091|NCT00741026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25566092|NCT00741026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24610691|NCT01004497|Hormones|hormones|mesh-ancestor
25566093|NCT00741026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25566094|NCT00741026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566095|NCT00741026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24613897|NCT01021566|Methadone|methadone|mesh-list
25566096|NCT00741026|Serotonin Agents|serotonin agents|mesh-ancestor
25566097|NCT00741039|Vaccines|vaccines|mesh-list
25566098|NCT00741039|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24708642|NCT01501890|Algestone|algestone|mesh-list
25566099|NCT00741039|Immunologic Factors|immunologic factors|mesh-ancestor
25566100|NCT00741039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566101|NCT00741104|Infliximab|infliximab|mesh-list
25566102|NCT00741104|Dermatologic Agents|dermatologic agents|mesh-ancestor
24906041|NCT04343001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24709794|NCT01507077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24709796|NCT01507077|Growth Substances|growth substances|mesh-ancestor
24679297|NCT01367678|Disinfectants|disinfectants|mesh-ancestor
24710222|NCT01508949|Incretins|incretins|mesh-ancestor
25566103|NCT00741104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25566104|NCT00741104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25566105|NCT00741156|Enalaprilat|enalaprilat|mesh-list
25566106|NCT00741156|Enalapril|enalapril|mesh-list
25566107|NCT00741156|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25566108|NCT00741156|Protease Inhibitors|protease inhibitors|mesh-ancestor
25566109|NCT00741156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907926|NCT04326725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24710792|NCT01511822|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24710793|NCT01511822|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24710838|NCT01511887|Analgesics|analgesics|mesh-ancestor
24710839|NCT01511887|Sensory System Agents|sensory system agents|mesh-ancestor
24710840|NCT01511887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24710841|NCT01511887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710889|NCT01512173|Propranolol|propranolol|mesh-list
24680959|NCT01377259|Anesthetics|anesthetics|mesh-list
24680977|NCT01377324|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24680978|NCT01377324|Estrogens|estrogens|mesh-ancestor
24956943|NCT03848611|Vorolanib|vorolanib|mesh-list
24908401|NCT04320706|Oxytocics|oxytocics|mesh-ancestor
25109211|NCT03126721|GABA Agents|gaba agents|mesh-ancestor
24682043|NCT01383538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566110|NCT00741156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566111|NCT00741156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25566112|NCT00741260|Capecitabine|capecitabine|mesh-list
25566113|NCT00741260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25566114|NCT00741260|Antimetabolites|antimetabolites|mesh-ancestor
24645355|NCT01198054|Lenalidomide|lenalidomide|mesh-list
24682952|NCT01389414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24712500|NCT01520896|Naloxegol|naloxegol|mesh-list
25566115|NCT00741260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566116|NCT00741260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684903|NCT03336983|Zoledronic Acid|zoledronic acid|mesh-list
25566117|NCT00741286|Aspirin|aspirin|mesh-list
25566118|NCT00741286|Cilostazol|cilostazol|mesh-list
25566119|NCT00741286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24713746|NCT01527422|Prednisone|prednisone|mesh-list
24713951|NCT01528371|Midazolam|midazolam|mesh-list
24686774|NCT04583501|Respiratory System Agents|respiratory system agents|mesh-ancestor
24686775|NCT04580381|Natalizumab|natalizumab|mesh-list
24686776|NCT04580381|Immunologic Factors|immunologic factors|mesh-ancestor
24686777|NCT04580381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686778|NCT04579848|Folic Acid|folic acid|mesh-list
24686806|NCT04564612|Itraconazole|itraconazole|mesh-list
24686807|NCT04564612|Rabeprazole|rabeprazole|mesh-list
24686808|NCT04564612|Antifungal Agents|antifungal agents|mesh-ancestor
24686809|NCT04564612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25566120|NCT00741286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25566121|NCT00741286|Analgesics|analgesics|mesh-ancestor
25566122|NCT00741286|Sensory System Agents|sensory system agents|mesh-ancestor
24687738|NCT03758170|Glucocorticoids|glucocorticoids|mesh-ancestor
25566123|NCT00741286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25566124|NCT00741286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566125|NCT00741286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25566126|NCT00741286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25566127|NCT00741286|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24689359|NCT01622998|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25566128|NCT00741286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24689919|NCT01398072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690536|NCT01402297|Antioxidants|antioxidants|mesh-ancestor
24612036|NCT01011699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24941518|NCT03990038|Sensory System Agents|sensory system agents|mesh-ancestor
24835084|NCT02182232|Mitosis Modulators|mitosis modulators|mesh-ancestor
24412446|NCT00191438|Docetaxel|docetaxel|mesh-list
24923370|NCT04170751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693082|NCT01418144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24693084|NCT01418157|Anticonvulsants|anticonvulsants|mesh-ancestor
25566129|NCT00741286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787509|NCT01925729|Phenylephrine|phenylephrine|mesh-list
25566130|NCT00741286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25695440|NCT02046369|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24957736|NCT03842020|Amiodarone|amiodarone|mesh-list
25566131|NCT00741286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25566132|NCT00741286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25566133|NCT00741286|Antipyretics|antipyretics|mesh-ancestor
25566134|NCT00741286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25566135|NCT00741286|Autonomic Agents|autonomic agents|mesh-ancestor
24719067|NCT01558960|Melphalan|melphalan|mesh-list
24456841|NCT00332384|Adrenergic Agents|adrenergic agents|mesh-ancestor
24456842|NCT00332384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24719277|NCT01560390|Ketamine|ketamine|mesh-list
24719278|NCT01560390|Analgesics|analgesics|mesh-ancestor
24719279|NCT01560390|Sensory System Agents|sensory system agents|mesh-ancestor
24719280|NCT01560390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24719303|NCT01560481|Metformin|metformin|mesh-list
24719304|NCT01560481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24719305|NCT01560481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566136|NCT00741286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24456957|NCT00332774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25566137|NCT00741286|Respiratory System Agents|respiratory system agents|mesh-ancestor
25566138|NCT00741286|Vasodilator Agents|vasodilator agents|mesh-ancestor
25566139|NCT00741286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25460903|NCT03873311|Cytarabine|cytarabine|mesh-list
25566140|NCT00741286|Protective Agents|protective agents|mesh-ancestor
24481250|NCT00433927|Levoleucovorin|levoleucovorin|mesh-list
25566141|NCT00741286|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24749458|NCT01093196|Growth Substances|growth substances|mesh-ancestor
25566142|NCT00741286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25566144|NCT00741338|Azathioprine|azathioprine|mesh-list
25566145|NCT00741338|Cyclosporins|cyclosporins|mesh-list
25566146|NCT00741338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25566147|NCT00741338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566148|NCT00741338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25566149|NCT00741338|Immunologic Factors|immunologic factors|mesh-ancestor
25566150|NCT00741338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566151|NCT00741338|Antifungal Agents|antifungal agents|mesh-ancestor
24510761|NCT00565539|Interferons|interferons|mesh-list
24720739|NCT01570569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720740|NCT01570569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24720741|NCT01570569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24720745|NCT01570569|Anesthetics|anesthetics|mesh-ancestor
24695448|NCT03512405|Pembrolizumab|pembrolizumab|mesh-list
24941833|NCT03987152|Sirolimus|sirolimus|mesh-list
24518702|NCT04524130|Anesthetics, General|anesthetics, general|mesh-ancestor
25566152|NCT00741338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25566153|NCT00741338|Dermatologic Agents|dermatologic agents|mesh-ancestor
24695556|NCT02926833|Fludarabine|fludarabine|mesh-list
24721458|NCT01574313|Niacin|niacin|mesh-list
25566154|NCT00741338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24524246|NCT05091905|Ropivacaine|ropivacaine|mesh-list
24524939|NCT04188873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24526123|NCT01192698|Antiviral Agents|antiviral agents|mesh-ancestor
25566155|NCT00741338|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25566156|NCT00741338|Antimetabolites|antimetabolites|mesh-ancestor
25566157|NCT00741338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25566158|NCT00741338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25566159|NCT00741455|Cyclosporine|cyclosporine|mesh-list
25566160|NCT00741455|Cyclophosphamide|cyclophosphamide|mesh-list
24721927|NCT01577992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722052|NCT01578343|Antiviral Agents|antiviral agents|mesh-ancestor
25566161|NCT00741455|Methotrexate|methotrexate|mesh-list
25566162|NCT00741455|Fludarabine|fludarabine|mesh-list
25566163|NCT00741455|Cyclosporins|cyclosporins|mesh-list
25566164|NCT00741455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25566165|NCT00741455|Immunologic Factors|immunologic factors|mesh-ancestor
25566166|NCT00741455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566167|NCT00741455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25460980|NCT03756961|Anesthetics, Local|anesthetics, local|mesh-ancestor
25460981|NCT03756961|Anesthetics|anesthetics|mesh-ancestor
25460982|NCT03756961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25460983|NCT03756961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460984|NCT03756961|Sensory System Agents|sensory system agents|mesh-ancestor
25460985|NCT03756961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25460986|NCT03756961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24707102|NCT01494155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460987|NCT03756961|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25460988|NCT03756961|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25460989|NCT03756961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25460990|NCT03756961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460991|NCT03756961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25460992|NCT03756961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25460993|NCT03756961|Anesthetics, General|anesthetics, general|mesh-ancestor
25460994|NCT03756961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25460995|NCT03756961|Analgesics|analgesics|mesh-ancestor
25460996|NCT03756961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25460997|NCT03756961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25460998|NCT03756961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25460999|NCT03756961|Adrenergic Agents|adrenergic agents|mesh-ancestor
25461000|NCT03756961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25461001|NCT03756961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25461002|NCT03756961|Narcotics|narcotics|mesh-ancestor
25566168|NCT00741455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25566169|NCT00741455|Alkylating Agents|alkylating agents|mesh-ancestor
25566170|NCT00741455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566171|NCT00741455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25566172|NCT00741455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25566173|NCT00741455|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25566174|NCT00741455|Abortifacient Agents|abortifacient agents|mesh-ancestor
25566175|NCT00741455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25566176|NCT00741455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25566177|NCT00741455|Antimetabolites|antimetabolites|mesh-ancestor
25566178|NCT00741455|Dermatologic Agents|dermatologic agents|mesh-ancestor
25566179|NCT00741455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25566180|NCT00741455|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25566181|NCT00741455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24722876|NCT01583114|Perindopril|perindopril|mesh-list
25566182|NCT00741455|Antifungal Agents|antifungal agents|mesh-ancestor
25566183|NCT00741455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25566184|NCT00741455|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25566185|NCT00741468|Tolbutamide|tolbutamide|mesh-list
25566186|NCT00741468|Midazolam|midazolam|mesh-list
25566187|NCT00741468|Dextromethorphan|dextromethorphan|mesh-list
25566188|NCT00741468|Caffeine|caffeine|mesh-list
25566189|NCT00741468|Omeprazole|omeprazole|mesh-list
24724228|NCT01591902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566190|NCT00741468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25566191|NCT00741468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25566192|NCT00741468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24724593|NCT01593644|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24724594|NCT01593644|Purinergic Agonists|purinergic agonists|mesh-ancestor
24724595|NCT01593644|Purinergic Agents|purinergic agents|mesh-ancestor
24724596|NCT01593644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24724597|NCT01593644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724598|NCT01593644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24724599|NCT01593644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724600|NCT01593644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24724602|NCT01593774|Antioxidants|antioxidants|mesh-ancestor
24724603|NCT01593774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724604|NCT01593774|Protective Agents|protective agents|mesh-ancestor
24724605|NCT01593774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566193|NCT00741468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566194|NCT00741468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25566195|NCT00741468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25566196|NCT00741468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24942080|NCT03984409|Diuretics|diuretics|mesh-ancestor
24442399|NCT00290901|Celecoxib|celecoxib|mesh-list
24736463|NCT01662401|Anesthetics|anesthetics|mesh-ancestor
25006892|NCT04549376|Povidone|povidone|mesh-list
24745927|NCT03518242|Alkylating Agents|alkylating agents|mesh-ancestor
25566197|NCT00741468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25566198|NCT00741468|Anesthetics, General|anesthetics, general|mesh-ancestor
25566199|NCT00741468|Anesthetics|anesthetics|mesh-ancestor
25566200|NCT00741468|GABA Modulators|gaba modulators|mesh-ancestor
25566201|NCT00741468|GABA Agents|gaba agents|mesh-ancestor
25566202|NCT00741468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25566203|NCT00741468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566204|NCT00741468|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25566205|NCT00741468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25566206|NCT00741468|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25566207|NCT00741468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25566208|NCT00741468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25566209|NCT00741468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25566210|NCT00741468|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25566211|NCT00741468|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25566212|NCT00741468|Purinergic Agents|purinergic agents|mesh-ancestor
25566213|NCT00741468|Antitussive Agents|antitussive agents|mesh-ancestor
25566214|NCT00741468|Respiratory System Agents|respiratory system agents|mesh-ancestor
25566215|NCT00741468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25566216|NCT00741468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25566217|NCT00741468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25566218|NCT00741598|Galantamine|galantamine|mesh-list
25566219|NCT00741598|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25566220|NCT00741598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24727122|NCT01608139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25566221|NCT00741598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566222|NCT00741598|Cholinergic Agents|cholinergic agents|mesh-ancestor
25566223|NCT00741598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24757169|NCT01738178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25566224|NCT00741598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566225|NCT00741598|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25566226|NCT00741598|Autonomic Agents|autonomic agents|mesh-ancestor
25566227|NCT00741598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25566228|NCT00741598|Nootropic Agents|nootropic agents|mesh-ancestor
25566229|NCT00741611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
25566230|NCT00741819|Treprostinil|treprostinil|mesh-list
25566231|NCT00741819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24727402|NCT01609647|Clopidogrel|clopidogrel|mesh-list
25566232|NCT00741858|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25566233|NCT00741858|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25566234|NCT00741858|Estradiol|estradiol|mesh-list
25566235|NCT00741858|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25566236|NCT00741858|Estrogens|estrogens|mesh-ancestor
25566237|NCT00741858|Hormones|hormones|mesh-ancestor
25566238|NCT00741858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25566239|NCT00741858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566240|NCT00741858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25566241|NCT00741858|Contraceptive Agents|contraceptive agents|mesh-ancestor
25566242|NCT00741858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25566243|NCT00741858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25566244|NCT00742027|Panobinostat|panobinostat|mesh-list
25566245|NCT00742027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25566246|NCT00742027|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25566247|NCT00742027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25566248|NCT00742027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566249|NCT00742079|Cycloserine|cycloserine|mesh-list
25566250|NCT00742079|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25566251|NCT00742079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25566252|NCT00742079|Renal Agents|renal agents|mesh-ancestor
25566253|NCT00742079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25566254|NCT00742079|Antitubercular Agents|antitubercular agents|mesh-ancestor
25566255|NCT00742079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25566256|NCT00742079|Antimetabolites|antimetabolites|mesh-ancestor
25566257|NCT00742079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566258|NCT00742183|Silver Sulfadiazine|silver sulfadiazine|mesh-list
25566259|NCT00742183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25566260|NCT00742183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25566261|NCT00742235|Vitamin D|vitamin d|mesh-list
25566262|NCT00742235|Ergocalciferols|ergocalciferols|mesh-list
25566263|NCT00742235|Vitamins|vitamins|mesh-ancestor
25566264|NCT00742235|Micronutrients|micronutrients|mesh-ancestor
25566265|NCT00742235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566266|NCT00742235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25566267|NCT00742235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25566268|NCT00742313|Hemostatics|hemostatics|mesh-list
25566269|NCT00742313|Coagulants|coagulants|mesh-ancestor
25566270|NCT00742326|Pioglitazone|pioglitazone|mesh-list
25566271|NCT00742326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25566272|NCT00742326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566273|NCT00742469|Rifaximin|rifaximin|mesh-list
24727820|NCT01612975|Naproxen|naproxen|mesh-list
25566274|NCT00742469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25566275|NCT00742469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25566276|NCT00742469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25566277|NCT00742508|Carvedilol|carvedilol|mesh-list
25566278|NCT00742508|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25566279|NCT00742508|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25566280|NCT00742508|Adrenergic Agents|adrenergic agents|mesh-ancestor
25566281|NCT00742508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25566282|NCT00742508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566283|NCT00742508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566284|NCT00742508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25566285|NCT00742508|Antioxidants|antioxidants|mesh-ancestor
25566286|NCT00742508|Protective Agents|protective agents|mesh-ancestor
25566287|NCT00742508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25566288|NCT00742508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25566289|NCT00742508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25566290|NCT00742508|Vasodilator Agents|vasodilator agents|mesh-ancestor
25566291|NCT00742508|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25566292|NCT00742508|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25566293|NCT00742560|Dexamethasone|dexamethasone|mesh-list
25566294|NCT00742560|Dexamethasone acetate|dexamethasone acetate|mesh-list
25566295|NCT00742560|Lenalidomide|lenalidomide|mesh-list
25566296|NCT00742560|Elotuzumab|elotuzumab|mesh-list
25566297|NCT00742560|BB 1101|bb 1101|mesh-list
25566298|NCT00742560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25566299|NCT00742560|Antiemetics|antiemetics|mesh-ancestor
25566300|NCT00742560|Autonomic Agents|autonomic agents|mesh-ancestor
24727888|NCT01613170|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24727891|NCT01613170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566301|NCT00742560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25566302|NCT00742560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566303|NCT00742560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25566304|NCT00742560|Glucocorticoids|glucocorticoids|mesh-ancestor
25566305|NCT00742560|Hormones|hormones|mesh-ancestor
25566306|NCT00742560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25566307|NCT00742560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25566308|NCT00742560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25566309|NCT00742560|Protease Inhibitors|protease inhibitors|mesh-ancestor
25566310|NCT00742560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25566311|NCT00742560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566312|NCT00742560|Immunologic Factors|immunologic factors|mesh-ancestor
25566313|NCT00742560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25566314|NCT00742560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25566315|NCT00742560|Growth Substances|growth substances|mesh-ancestor
25566316|NCT00742560|Growth Inhibitors|growth inhibitors|mesh-ancestor
25566317|NCT00742573|Antidepressive Agents|antidepressive agents|mesh-list
25566318|NCT00742573|Bupropion|bupropion|mesh-list
25566319|NCT00742573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25566320|NCT00742573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25007358|NCT03647488|Docetaxel|docetaxel|mesh-list
25566321|NCT00742573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25566322|NCT00742573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566323|NCT00742573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25566324|NCT00742573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566325|NCT00742573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25566326|NCT00742573|Dopamine Agents|dopamine agents|mesh-ancestor
25566327|NCT00742573|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25566328|NCT00742573|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25566329|NCT00742573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25566330|NCT00742573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25566331|NCT00742625|Cytarabine|cytarabine|mesh-list
25566332|NCT00742625|Bortezomib|bortezomib|mesh-list
25566333|NCT00742625|Daunorubicin|daunorubicin|mesh-list
25566334|NCT00742625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25566335|NCT00742625|Antimetabolites|antimetabolites|mesh-ancestor
25566336|NCT00742625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566337|NCT00742625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25566338|NCT00742625|Antiviral Agents|antiviral agents|mesh-ancestor
25566339|NCT00742625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25566340|NCT00742625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25566341|NCT00742625|Immunologic Factors|immunologic factors|mesh-ancestor
25566342|NCT00742625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566343|NCT00742625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25566344|NCT00742625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25566345|NCT00742625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25566346|NCT00742625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25566347|NCT00742781|Vitamin D|vitamin d|mesh-list
25566348|NCT00742781|Cholecalciferol|cholecalciferol|mesh-list
25566349|NCT00742781|Vitamins|vitamins|mesh-ancestor
25566350|NCT00742781|Micronutrients|micronutrients|mesh-ancestor
25566351|NCT00742781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566352|NCT00742781|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24728408|NCT01616069|Simendan|simendan|mesh-list
25566353|NCT00742781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25566354|NCT00742859|Warfarin|warfarin|mesh-list
25566355|NCT00742859|Acenocoumarol|acenocoumarol|mesh-list
25566356|NCT00742859|Betrixaban|betrixaban|mesh-list
25566357|NCT00742859|Anticoagulants|anticoagulants|mesh-ancestor
25566358|NCT00742859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25566359|NCT00742859|Antithrombins|antithrombins|mesh-ancestor
25566360|NCT00742859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25566361|NCT00742859|Protease Inhibitors|protease inhibitors|mesh-ancestor
25566362|NCT00742859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25566363|NCT00742859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566364|NCT00742872|Mosapride|mosapride|mesh-list
25566365|NCT00742872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566366|NCT00742872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25566367|NCT00742872|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25566368|NCT00742872|Serotonin Agents|serotonin agents|mesh-ancestor
25566369|NCT00742872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25566370|NCT00742872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566371|NCT00742924|Zoledronic Acid|zoledronic acid|mesh-list
25566372|NCT00742924|Leucovorin|leucovorin|mesh-list
25566373|NCT00742924|Cisplatin|cisplatin|mesh-list
25566374|NCT00742924|Doxorubicin|doxorubicin|mesh-list
25566375|NCT00742924|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25566376|NCT00742924|Methotrexate|methotrexate|mesh-list
25566377|NCT00742924|Etoposide|etoposide|mesh-list
25566378|NCT00742924|Ifosfamide|ifosfamide|mesh-list
25566379|NCT00742924|Isophosphamide mustard|isophosphamide mustard|mesh-list
25566380|NCT00742924|Dexrazoxane|dexrazoxane|mesh-list
25566381|NCT00742924|Razoxane|razoxane|mesh-list
25566382|NCT00742924|Imidazole|imidazole|mesh-list
25566383|NCT00742924|Lenograstim|lenograstim|mesh-list
25566384|NCT00742924|Levoleucovorin|levoleucovorin|mesh-list
25566385|NCT00742924|Mesna|mesna|mesh-list
25566386|NCT00742924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25566387|NCT00742924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25566388|NCT00742924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25566389|NCT00742924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25566390|NCT00742924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25566391|NCT00742924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566392|NCT00742924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566393|NCT00742924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25566394|NCT00742924|Abortifacient Agents|abortifacient agents|mesh-ancestor
25566395|NCT00742924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25566396|NCT00742924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25566397|NCT00742924|Antimetabolites|antimetabolites|mesh-ancestor
25566398|NCT00742924|Dermatologic Agents|dermatologic agents|mesh-ancestor
25566399|NCT00742924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25566400|NCT00742924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25566401|NCT00742924|Immunologic Factors|immunologic factors|mesh-ancestor
25566402|NCT00742924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25566403|NCT00742924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25566404|NCT00742924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25566405|NCT00742924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25566406|NCT00742924|Antidotes|antidotes|mesh-ancestor
25566407|NCT00742924|Protective Agents|protective agents|mesh-ancestor
25566408|NCT00742924|Vitamin B Complex|vitamin b complex|mesh-ancestor
25566409|NCT00742924|Vitamins|vitamins|mesh-ancestor
25566410|NCT00742924|Micronutrients|micronutrients|mesh-ancestor
25566411|NCT00742924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25566412|NCT00742924|Alkylating Agents|alkylating agents|mesh-ancestor
25566413|NCT00742924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25566414|NCT00742924|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25566415|NCT00742924|Antimitotic Agents|antimitotic agents|mesh-ancestor
25566416|NCT00742924|Mitosis Modulators|mitosis modulators|mesh-ancestor
25566417|NCT00743093|Acetaminophen|acetaminophen|mesh-list
25566418|NCT00743093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25566419|NCT00743093|Analgesics|analgesics|mesh-ancestor
25566420|NCT00743093|Sensory System Agents|sensory system agents|mesh-ancestor
25461189|NCT03417544|Pertuzumab|pertuzumab|mesh-list
25566421|NCT00743093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25566422|NCT00743093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566423|NCT00743093|Antipyretics|antipyretics|mesh-ancestor
25566424|NCT00743106|Fenoldopam|fenoldopam|mesh-list
25566425|NCT00743106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25566426|NCT00743106|Vasodilator Agents|vasodilator agents|mesh-ancestor
25566427|NCT00743106|Dopamine Agonists|dopamine agonists|mesh-ancestor
25566428|NCT00743106|Dopamine Agents|dopamine agents|mesh-ancestor
25566429|NCT00743106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25566430|NCT00743106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566431|NCT00743106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566432|NCT00743119|Dronabinol|dronabinol|mesh-list
25566433|NCT00743119|Hallucinogens|hallucinogens|mesh-ancestor
24729051|NCT01619566|Analgesics|analgesics|mesh-ancestor
25566434|NCT00743119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566435|NCT00743119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25566436|NCT00743119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25566437|NCT00743119|Analgesics|analgesics|mesh-ancestor
25566438|NCT00743119|Sensory System Agents|sensory system agents|mesh-ancestor
25566439|NCT00743119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25566440|NCT00743119|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24567691|NCT00792181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25566441|NCT00743119|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25566442|NCT00743119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25566443|NCT00743119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566444|NCT00743119|Hormones|hormones|mesh-ancestor
25566445|NCT00743119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25566446|NCT00743145|Naltrexone|naltrexone|mesh-list
25566447|NCT00743145|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24729430|NCT01621620|Yohimbine|yohimbine|mesh-list
25566448|NCT00743145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25566449|NCT00743145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566450|NCT00743145|Sensory System Agents|sensory system agents|mesh-ancestor
25566451|NCT00743145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25566452|NCT00743288|Melphalan|melphalan|mesh-list
25566453|NCT00743288|Panobinostat|panobinostat|mesh-list
25566454|NCT00743288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25566455|NCT00743288|Alkylating Agents|alkylating agents|mesh-ancestor
25566456|NCT00743288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566457|NCT00743288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25566458|NCT00743288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25566459|NCT00743288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25566460|NCT00743288|Immunologic Factors|immunologic factors|mesh-ancestor
25566461|NCT00743288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566462|NCT00743288|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25566463|NCT00743288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25566464|NCT00743340|Emtricitabine|emtricitabine|mesh-list
25566465|NCT00743340|Antiviral Agents|antiviral agents|mesh-ancestor
25566466|NCT00743340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25566467|NCT00743340|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25566468|NCT00743340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25566469|NCT00743340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25566470|NCT00743340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566471|NCT00743340|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25566472|NCT00743340|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25566473|NCT00743366|Riboflavin|riboflavin|mesh-list
25566474|NCT00743366|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25695874|NCT02054754|Analgesics|analgesics|mesh-ancestor
25695875|NCT02054754|Sensory System Agents|sensory system agents|mesh-ancestor
25695876|NCT02054754|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25566475|NCT00743366|Antidepressive Agents|antidepressive agents|mesh-ancestor
25566476|NCT00743366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25566477|NCT00743366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25566478|NCT00743366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25566479|NCT00743366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25566480|NCT00743366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566481|NCT00743366|Vitamin B Complex|vitamin b complex|mesh-ancestor
25566482|NCT00743366|Vitamins|vitamins|mesh-ancestor
25566483|NCT00743366|Micronutrients|micronutrients|mesh-ancestor
25566484|NCT00743366|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25566485|NCT00743366|Dermatologic Agents|dermatologic agents|mesh-ancestor
25566486|NCT00743431|Doxorubicin|doxorubicin|mesh-list
25566487|NCT00743431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25566488|NCT00743431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25566489|NCT00743431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25566490|NCT00743431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25566491|NCT00743431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729660|NCT01623024|Vitamins|vitamins|mesh-ancestor
24729661|NCT01623024|Micronutrients|micronutrients|mesh-ancestor
24729662|NCT01623024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729663|NCT01623024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24729671|NCT01623102|Growth Substances|growth substances|mesh-ancestor
24729672|NCT01623102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729758|NCT01623713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25566492|NCT00743431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566493|NCT00743444|Lesogaberan|lesogaberan|mesh-list
25566494|NCT00743444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25461306|NCT03283605|Durvalumab|durvalumab|mesh-list
25461307|NCT03283605|Tremelimumab|tremelimumab|mesh-list
24844912|NCT02235246|Anticonvulsants|anticonvulsants|mesh-ancestor
25461308|NCT03283605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25461309|NCT03283605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461310|NCT03266783|Rivaroxaban|rivaroxaban|mesh-list
25461311|NCT03266783|Apixaban|apixaban|mesh-list
25461312|NCT03266783|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25461313|NCT03266783|Antithrombins|antithrombins|mesh-ancestor
25461314|NCT03266783|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25461315|NCT03266783|Protease Inhibitors|protease inhibitors|mesh-ancestor
25461316|NCT03266783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461317|NCT03266783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551808|NCT04956627|Phenytoin|phenytoin|mesh-list
25461318|NCT03266783|Anticoagulants|anticoagulants|mesh-ancestor
25320658|NCT04933292|Antiemetics|antiemetics|mesh-ancestor
25162047|NCT02908763|Antiviral Agents|antiviral agents|mesh-ancestor
25202832|NCT02718521|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25202833|NCT02718521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558499|NCT00757523|Analgesics|analgesics|mesh-ancestor
24558966|NCT05382338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24558967|NCT05382338|Immunologic Factors|immunologic factors|mesh-ancestor
24559006|NCT05343156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25202835|NCT02718482|Docetaxel|docetaxel|mesh-list
25202836|NCT02718482|Ifosfamide|ifosfamide|mesh-list
25202837|NCT02718482|Isophosphamide mustard|isophosphamide mustard|mesh-list
25202838|NCT02718482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25202839|NCT02718482|Antimetabolites|antimetabolites|mesh-ancestor
25202840|NCT02718482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202841|NCT02718482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25202842|NCT02718482|Antiviral Agents|antiviral agents|mesh-ancestor
25202843|NCT02718482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25202844|NCT02718482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202845|NCT02718482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25202846|NCT02718482|Immunologic Factors|immunologic factors|mesh-ancestor
25202847|NCT02718482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202848|NCT02718482|Tubulin Modulators|tubulin modulators|mesh-ancestor
25202849|NCT02718482|Antimitotic Agents|antimitotic agents|mesh-ancestor
25202850|NCT02718482|Mitosis Modulators|mitosis modulators|mesh-ancestor
25202851|NCT02718482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25202852|NCT02718482|Alkylating Agents|alkylating agents|mesh-ancestor
25202853|NCT02718599|Terlipressin|terlipressin|mesh-list
25202854|NCT02718599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25202855|NCT02718599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25202856|NCT02718261|Pantoprazole|pantoprazole|mesh-list
25202857|NCT02718261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24979255|NCT04966325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24979256|NCT04966325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24979257|NCT04966325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24979258|NCT04966325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424482|NCT00229515|Protective Agents|protective agents|mesh-ancestor
24979268|NCT04936984|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
24979269|NCT04936984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24979270|NCT04936984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979271|NCT04936984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24979273|NCT04855526|Hallucinogens|hallucinogens|mesh-ancestor
24979274|NCT04855526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979275|NCT04855526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24979276|NCT04855526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24979277|NCT04855526|Analgesics|analgesics|mesh-ancestor
24732885|NCT01642030|Analgesics|analgesics|mesh-ancestor
24979278|NCT04855526|Sensory System Agents|sensory system agents|mesh-ancestor
24979279|NCT04855526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24979280|NCT04855526|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24979281|NCT04855526|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24840171|NCT02208427|Isoniazid|isoniazid|mesh-list
25822704|NCT00004583|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24424496|NCT00229528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24424498|NCT00229567|Ketamine|ketamine|mesh-list
24424523|NCT00229593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24424524|NCT00229593|Contraceptive Agents|contraceptive agents|mesh-ancestor
25566495|NCT00743444|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25566496|NCT00743444|GABA Agonists|gaba agonists|mesh-ancestor
25566497|NCT00743444|GABA Agents|gaba agents|mesh-ancestor
25566498|NCT00743444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25566499|NCT00743444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566500|NCT00743444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566501|NCT00743509|Sirolimus|sirolimus|mesh-list
25566502|NCT00743509|Cyclophosphamide|cyclophosphamide|mesh-list
25566503|NCT00743509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25566504|NCT00743509|Immunologic Factors|immunologic factors|mesh-ancestor
25566505|NCT00743509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566506|NCT00743509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24617239|NCT01041872|Anesthetics|anesthetics|mesh-ancestor
24584527|NCT00880815|Antimetabolites|antimetabolites|mesh-ancestor
25566507|NCT00743509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25566508|NCT00743509|Alkylating Agents|alkylating agents|mesh-ancestor
25566509|NCT00743509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566510|NCT00743509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25566511|NCT00743509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25566512|NCT00743509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25566513|NCT00743509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25566514|NCT00743509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25566515|NCT00743509|Antifungal Agents|antifungal agents|mesh-ancestor
25566516|NCT00743574|Vitamin D|vitamin d|mesh-list
25566517|NCT00743574|Ergocalciferols|ergocalciferols|mesh-list
25566518|NCT00743574|Cholecalciferol|cholecalciferol|mesh-list
25566519|NCT00743574|Vitamins|vitamins|mesh-list
25566520|NCT00743574|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25566521|NCT00743574|Medroxyprogesterone|medroxyprogesterone|mesh-list
25566522|NCT00743574|Calcium|calcium|mesh-list
25566523|NCT00743574|Micronutrients|micronutrients|mesh-ancestor
25566524|NCT00743574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566525|NCT00743574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25566526|NCT00743574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25566527|NCT00743574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25566528|NCT00743574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25566529|NCT00743574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25566530|NCT00743574|Contraceptive Agents|contraceptive agents|mesh-ancestor
25566531|NCT00743574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25566532|NCT00743574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25566533|NCT00743574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25566534|NCT00743574|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25566535|NCT00743574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25566536|NCT00743574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25566537|NCT00743652|Vaccines|vaccines|mesh-list
24570953|NCT00807521|Dexamethasone|dexamethasone|mesh-list
25566538|NCT00743652|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25566539|NCT00743652|Immunologic Factors|immunologic factors|mesh-ancestor
25566540|NCT00743652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566541|NCT00743717|Cobalt|cobalt|mesh-list
25566542|NCT00743717|Trace Elements|trace elements|mesh-ancestor
25566543|NCT00743717|Micronutrients|micronutrients|mesh-ancestor
25566544|NCT00743717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566545|NCT00743730|Morphine|morphine|mesh-list
25566546|NCT00743730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25566547|NCT00743730|Narcotics|narcotics|mesh-ancestor
24734473|NCT01652339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25566548|NCT00743730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25566549|NCT00743730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566550|NCT00743730|Analgesics|analgesics|mesh-ancestor
25566551|NCT00743730|Sensory System Agents|sensory system agents|mesh-ancestor
25566552|NCT00743730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25566553|NCT00744042|Immunoglobulin G|immunoglobulin g|mesh-list
25566554|NCT00744042|Immunologic Factors|immunologic factors|mesh-ancestor
25566555|NCT00744042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566556|NCT00744055|Prazosin|prazosin|mesh-list
25566557|NCT00744055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25566558|NCT00744055|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25566559|NCT00744055|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25566560|NCT00744055|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25566561|NCT00744055|Adrenergic Agents|adrenergic agents|mesh-ancestor
25566562|NCT00744055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25566563|NCT00744055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566564|NCT00744055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566565|NCT00744211|Sitaxsentan|sitaxsentan|mesh-list
25566566|NCT00744211|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25566567|NCT00744211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566568|NCT00744237|Metoprolol|metoprolol|mesh-list
25566569|NCT00744237|Nebivolol|nebivolol|mesh-list
25566570|NCT00744237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25566571|NCT00744237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25566572|NCT00744237|Sympatholytics|sympatholytics|mesh-ancestor
25566573|NCT00744237|Autonomic Agents|autonomic agents|mesh-ancestor
25566574|NCT00744237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25566575|NCT00744237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566576|NCT00744237|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25566577|NCT00744237|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25566578|NCT00744237|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25566579|NCT00744237|Adrenergic Agents|adrenergic agents|mesh-ancestor
25566580|NCT00744237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25461319|NCT03217097|Oxaliplatin|oxaliplatin|mesh-list
25566581|NCT00744237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566582|NCT00744237|Vasodilator Agents|vasodilator agents|mesh-ancestor
25566583|NCT00744237|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25566584|NCT00744237|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25566585|NCT00744237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25566586|NCT00744263|Vaccines|vaccines|mesh-list
25566587|NCT00744263|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25566588|NCT00744263|Immunologic Factors|immunologic factors|mesh-ancestor
25566589|NCT00744263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566590|NCT00744328|Sertraline|sertraline|mesh-list
25566591|NCT00744328|Estradiol|estradiol|mesh-list
25566592|NCT00744328|Estrogens|estrogens|mesh-ancestor
25566593|NCT00744328|Hormones|hormones|mesh-ancestor
25566594|NCT00744328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25566595|NCT00744328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566596|NCT00744328|Antidepressive Agents|antidepressive agents|mesh-ancestor
25566597|NCT00744328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25566598|NCT00744328|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25566599|NCT00744328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25566600|NCT00744328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25566601|NCT00744328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566602|NCT00744328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25566603|NCT00744328|Serotonin Agents|serotonin agents|mesh-ancestor
25566604|NCT00744380|Midazolam|midazolam|mesh-list
25566605|NCT00744380|Dexmedetomidine|dexmedetomidine|mesh-list
25566606|NCT00744380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25566607|NCT00744380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25566608|NCT00744380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566609|NCT00744380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25566610|NCT00744380|Analgesics|analgesics|mesh-ancestor
25566611|NCT00744380|Sensory System Agents|sensory system agents|mesh-ancestor
25566612|NCT00744380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25566613|NCT00744380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25566614|NCT00744380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25566615|NCT00744380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25566616|NCT00744380|Adrenergic Agents|adrenergic agents|mesh-ancestor
25566617|NCT00744380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25566618|NCT00744380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566619|NCT00744380|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25566620|NCT00744380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25566621|NCT00744380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25566622|NCT00744380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25566623|NCT00744380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25566624|NCT00744380|Anesthetics, General|anesthetics, general|mesh-ancestor
25566625|NCT00744380|Anesthetics|anesthetics|mesh-ancestor
25566626|NCT00744380|GABA Modulators|gaba modulators|mesh-ancestor
25566627|NCT00744380|GABA Agents|gaba agents|mesh-ancestor
25566628|NCT00744471|Tanezumab|tanezumab|mesh-list
25566629|NCT00744471|Analgesics|analgesics|mesh-ancestor
25566630|NCT00744471|Sensory System Agents|sensory system agents|mesh-ancestor
25566631|NCT00744471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24576411|NCT00838357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25566632|NCT00744471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566633|NCT00744497|Prednisone|prednisone|mesh-list
25566634|NCT00744497|Docetaxel|docetaxel|mesh-list
25566635|NCT00744497|Dasatinib|dasatinib|mesh-list
25566636|NCT00744497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25566637|NCT00744497|Tubulin Modulators|tubulin modulators|mesh-ancestor
25566638|NCT00744497|Antimitotic Agents|antimitotic agents|mesh-ancestor
25566639|NCT00744497|Mitosis Modulators|mitosis modulators|mesh-ancestor
25566640|NCT00744497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566641|NCT00744497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25566642|NCT00744497|Glucocorticoids|glucocorticoids|mesh-ancestor
25566643|NCT00744497|Hormones|hormones|mesh-ancestor
24735421|NCT01657058|Antiemetics|antiemetics|mesh-ancestor
25566644|NCT00744497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25566645|NCT00744497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566646|NCT00744497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25566647|NCT00744497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25566648|NCT00744497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25566649|NCT00744627|Vortioxetine|vortioxetine|mesh-list
25566650|NCT00744627|Antidepressive Agents|antidepressive agents|mesh-ancestor
25566651|NCT00744627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25566652|NCT00744627|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25566653|NCT00744627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25566654|NCT00744627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25566655|NCT00744627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566656|NCT00744627|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25566657|NCT00744627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25566658|NCT00744627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25566659|NCT00744627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566660|NCT00744627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25566661|NCT00744627|Serotonin Agents|serotonin agents|mesh-ancestor
25566662|NCT00744627|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25566663|NCT00744627|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25566664|NCT00744627|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24577459|NCT00844207|Analgesics|analgesics|mesh-ancestor
25566665|NCT00744627|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25566666|NCT00744653|Bleomycin|bleomycin|mesh-list
25566667|NCT00744653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25566668|NCT00744653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25566669|NCT00744692|Fludarabine|fludarabine|mesh-list
25566670|NCT00744692|Melphalan|melphalan|mesh-list
25566671|NCT00744692|Thiotepa|thiotepa|mesh-list
25566672|NCT00744692|Hydroxyurea|hydroxyurea|mesh-list
25566673|NCT00744692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25566674|NCT00744692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566675|NCT00744692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25566676|NCT00744692|Immunologic Factors|immunologic factors|mesh-ancestor
24578629|NCT00850005|Antibodies|antibodies|mesh-list
25566677|NCT00744692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566678|NCT00744692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25566679|NCT00744692|Alkylating Agents|alkylating agents|mesh-ancestor
25566680|NCT00744692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25566681|NCT00744692|Antisickling Agents|antisickling agents|mesh-ancestor
25566682|NCT00744692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25566683|NCT00744692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25566684|NCT00744757|Decitabine|decitabine|mesh-list
25566685|NCT00744757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25566686|NCT00744757|Antimetabolites|antimetabolites|mesh-ancestor
25566687|NCT00744757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566688|NCT00744757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942990|NCT03975270|Paclitaxel|paclitaxel|mesh-list
25566689|NCT00744757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25566690|NCT00744848|Epinephrine|epinephrine|mesh-list
25566691|NCT00744848|Bupivacaine|bupivacaine|mesh-list
25566692|NCT00744848|Anesthetics, Local|anesthetics, local|mesh-ancestor
25566693|NCT00744848|Anesthetics|anesthetics|mesh-ancestor
25566694|NCT00744848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25566695|NCT00744848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566696|NCT00744848|Sensory System Agents|sensory system agents|mesh-ancestor
25566697|NCT00744848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25566698|NCT00744848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25566699|NCT00744848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25566700|NCT00744848|Adrenergic Agents|adrenergic agents|mesh-ancestor
25566701|NCT00744848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25566702|NCT00744848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566703|NCT00744848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25566704|NCT00744848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25566705|NCT00744848|Autonomic Agents|autonomic agents|mesh-ancestor
25566706|NCT00744848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25566707|NCT00744848|Respiratory System Agents|respiratory system agents|mesh-ancestor
25566708|NCT00744848|Mydriatics|mydriatics|mesh-ancestor
25566709|NCT00744848|Sympathomimetics|sympathomimetics|mesh-ancestor
25566710|NCT00744848|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24581577|NCT00865501|Diuretics|diuretics|mesh-ancestor
25566711|NCT00744965|Glyburide|glyburide|mesh-list
25566712|NCT00744965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25566713|NCT00744965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566714|NCT00744978|Varenicline|varenicline|mesh-list
25566715|NCT00744978|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25566716|NCT00744978|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25566717|NCT00744978|Cholinergic Agents|cholinergic agents|mesh-ancestor
25566718|NCT00744978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581926|NCT00866684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25566719|NCT00744978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566720|NCT00744978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566721|NCT00745095|Neostigmine|neostigmine|mesh-list
25566722|NCT00745095|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25566723|NCT00745095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25566724|NCT00745095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566725|NCT00745095|Cholinergic Agents|cholinergic agents|mesh-ancestor
25566726|NCT00745095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25461464|NCT02856113|Hormones|hormones|mesh-ancestor
25566727|NCT00745095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566728|NCT00745095|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25566729|NCT00745095|Autonomic Agents|autonomic agents|mesh-ancestor
25566730|NCT00745095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25566731|NCT00745290|Bupivacaine|bupivacaine|mesh-list
25566732|NCT00745290|Anesthetics, Local|anesthetics, local|mesh-ancestor
25566733|NCT00745290|Anesthetics|anesthetics|mesh-ancestor
24582588|NCT00870532|Tubulin Modulators|tubulin modulators|mesh-ancestor
24582589|NCT00870532|Antimitotic Agents|antimitotic agents|mesh-ancestor
24582590|NCT00870532|Mitosis Modulators|mitosis modulators|mesh-ancestor
24582592|NCT00870558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582593|NCT00870571|Amlodipine|amlodipine|mesh-list
24582594|NCT00870571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24582595|NCT00870571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24580538|NCT00862108|Dopamine Agents|dopamine agents|mesh-ancestor
24582626|NCT00870779|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24737118|NCT01666756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737119|NCT01666769|Micafungin|micafungin|mesh-list
24737276|NCT01668043|UB-421|ub-421|mesh-list
25566734|NCT00745290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25566735|NCT00745290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566736|NCT00745290|Sensory System Agents|sensory system agents|mesh-ancestor
25566737|NCT00745290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25566738|NCT00745368|Raltegravir Potassium|raltegravir potassium|mesh-list
24737303|NCT01668121|Budesonide|budesonide|mesh-list
25566739|NCT00745368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25566740|NCT00745368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25566741|NCT00745368|Antiviral Agents|antiviral agents|mesh-ancestor
25566742|NCT00745368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25566743|NCT00745368|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25566744|NCT00745368|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25566745|NCT00745368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25566746|NCT00745368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566747|NCT00745498|Bevacizumab|bevacizumab|mesh-list
25566748|NCT00745498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25566749|NCT00745498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25566750|NCT00745498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25566751|NCT00745498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25566752|NCT00745498|Growth Substances|growth substances|mesh-ancestor
25566753|NCT00745498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737621|NCT01670071|Risperidone|risperidone|mesh-list
24737697|NCT01670149|Rifaximin|rifaximin|mesh-list
24738554|NCT01675999|Oxaliplatin|oxaliplatin|mesh-list
24737771|NCT01670552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25566754|NCT00745498|Growth Inhibitors|growth inhibitors|mesh-ancestor
25566755|NCT00745823|Raltegravir Potassium|raltegravir potassium|mesh-list
25566756|NCT00745823|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25566757|NCT00745823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25566758|NCT00745823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25566759|NCT00745823|Antiviral Agents|antiviral agents|mesh-ancestor
25566760|NCT00745823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25566761|NCT00745823|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25566762|NCT00745823|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25566763|NCT00745823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25566764|NCT00745823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566765|NCT00745823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25566766|NCT00745823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25566767|NCT00745849|Esomeprazole|esomeprazole|mesh-list
25566768|NCT00745849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25566769|NCT00745849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25566770|NCT00745849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25566771|NCT00745849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24738042|NCT01672476|Valsartan|valsartan|mesh-list
25566772|NCT00745849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566773|NCT00745875|Pemetrexed|pemetrexed|mesh-list
25566774|NCT00745875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25566775|NCT00745875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25566776|NCT00745875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566777|NCT00745875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24738517|NCT01675947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25566778|NCT00745875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25566779|NCT00745901|Drospirenone|drospirenone|mesh-list
24633307|NCT01128257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566780|NCT00745901|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25566781|NCT00745901|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25566782|NCT00745901|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25566783|NCT00745901|Norgestimate|norgestimate|mesh-list
25566784|NCT00745901|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
25566785|NCT00745901|Estradiol|estradiol|mesh-list
25566786|NCT00745901|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25566787|NCT00745901|Estrogens|estrogens|mesh-ancestor
25566788|NCT00745901|Hormones|hormones|mesh-ancestor
25566789|NCT00745901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25566790|NCT00745901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566791|NCT00745901|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25566792|NCT00745901|Contraceptive Agents|contraceptive agents|mesh-ancestor
24585670|NCT00886574|Autonomic Agents|autonomic agents|mesh-ancestor
25566793|NCT00745901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25566794|NCT00745901|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25566795|NCT00745901|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25566796|NCT00745901|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24696804|NCT01431326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25566797|NCT00745901|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25566798|NCT00745901|Hormone Antagonists|hormone antagonists|mesh-ancestor
25566799|NCT00745901|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25566800|NCT00745901|Diuretics|diuretics|mesh-ancestor
25566801|NCT00745901|Natriuretic Agents|natriuretic agents|mesh-ancestor
25566802|NCT00745901|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25566803|NCT00746252|Risperidone|risperidone|mesh-list
25566804|NCT00746252|Aripiprazole|aripiprazole|mesh-list
25566805|NCT00746252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25566806|NCT00746252|Serotonin Agents|serotonin agents|mesh-ancestor
25566807|NCT00746252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25566808|NCT00746252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566809|NCT00746252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566810|NCT00746252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25566811|NCT00746252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25566812|NCT00746252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25566813|NCT00746252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25566814|NCT00746252|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25566815|NCT00746252|Dopamine Agents|dopamine agents|mesh-ancestor
25566816|NCT00746252|Antidepressive Agents|antidepressive agents|mesh-ancestor
25566817|NCT00746252|Dopamine Agonists|dopamine agonists|mesh-ancestor
25566818|NCT00746252|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25566819|NCT00746252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25566820|NCT00746252|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25566821|NCT00746252|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25652073|NCT01523366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25652074|NCT01523366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652075|NCT01523366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652076|NCT01523392|Clopidogrel|clopidogrel|mesh-list
25652077|NCT01523392|Ticagrelor|ticagrelor|mesh-list
25652078|NCT01523392|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25652079|NCT01523392|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25652080|NCT01523392|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25652081|NCT01523392|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25652082|NCT01523392|Purinergic Agents|purinergic agents|mesh-ancestor
25652083|NCT01523392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25652084|NCT01523392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697493|NCT01435213|Atipamezole|atipamezole|mesh-list
24739763|NCT01684059|Astringents|astringents|mesh-ancestor
25652085|NCT01523392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652086|NCT01523457|Folfirinox|folfirinox|mesh-list
25652087|NCT01523457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652088|NCT01523496|Vitamin D|vitamin d|mesh-list
25652089|NCT01523496|Ergocalciferols|ergocalciferols|mesh-list
25652090|NCT01523496|Cholecalciferol|cholecalciferol|mesh-list
25652091|NCT01523496|Calcifediol|calcifediol|mesh-list
25652092|NCT01523496|Vitamins|vitamins|mesh-list
25652093|NCT01523496|Micronutrients|micronutrients|mesh-ancestor
25652094|NCT01523496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652095|NCT01523496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24740170|NCT01686659|Analgesics|analgesics|mesh-ancestor
25652096|NCT01523496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25652097|NCT01523587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25652098|NCT01523587|Afatinib|afatinib|mesh-list
25652099|NCT01523587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652100|NCT01523587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25652101|NCT01523587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24740612|NCT01689259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652102|NCT01523587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652103|NCT01523821|Protease Inhibitors|protease inhibitors|mesh-list
24740791|NCT01690325|Docetaxel|docetaxel|mesh-list
25652104|NCT01523821|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25652105|NCT01523821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652106|NCT01523821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652107|NCT01523821|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25652108|NCT01523821|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25652109|NCT01523834|Panobinostat|panobinostat|mesh-list
25652110|NCT01523834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652111|NCT01523834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25652112|NCT01523834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652113|NCT01523834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652114|NCT01523886|Rocuronium|rocuronium|mesh-list
25652115|NCT01523886|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25652116|NCT01523886|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25652117|NCT01523886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25652118|NCT01523886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25652119|NCT01523886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652120|NCT01524133|Sertraline|sertraline|mesh-list
25652121|NCT01524133|Antidepressive Agents|antidepressive agents|mesh-ancestor
25652122|NCT01524133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25652123|NCT01524133|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25652124|NCT01524133|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25652125|NCT01524133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25652126|NCT01524133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566822|NCT00746330|Mometasone Furoate|mometasone furoate|mesh-list
25566823|NCT00746330|Formoterol Fumarate|formoterol fumarate|mesh-list
25566824|NCT00746330|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25566825|NCT00746330|Autonomic Agents|autonomic agents|mesh-ancestor
25566826|NCT00746330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25566827|NCT00746330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566828|NCT00746330|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25566829|NCT00746330|Respiratory System Agents|respiratory system agents|mesh-ancestor
25566830|NCT00746330|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25566831|NCT00746330|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25566832|NCT00746330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25566833|NCT00746330|Adrenergic Agents|adrenergic agents|mesh-ancestor
25566834|NCT00746330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25566835|NCT00746330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566836|NCT00746330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25566837|NCT00746330|Dermatologic Agents|dermatologic agents|mesh-ancestor
25566838|NCT00746330|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25566839|NCT00746395|Lubiprostone|lubiprostone|mesh-list
24609973|NCT00999271|Incretins|incretins|mesh-list
25566840|NCT00746395|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25566841|NCT00746395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25566842|NCT00746395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566843|NCT00746421|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25566844|NCT00746421|Antidepressive Agents|antidepressive agents|mesh-ancestor
25566845|NCT00746421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25566846|NCT00746421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25566847|NCT00746421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25566848|NCT00746421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25566849|NCT00746421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566850|NCT00746512|Prednisone|prednisone|mesh-list
25566851|NCT00746512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25566852|NCT00746512|Glucocorticoids|glucocorticoids|mesh-ancestor
25566853|NCT00746512|Hormones|hormones|mesh-ancestor
25696304|NCT02059239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25606123|NCT01064830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566854|NCT00746512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25566855|NCT00746512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566856|NCT00746512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25566857|NCT00746512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25566858|NCT00746551|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25566859|NCT00746551|Hematinics|hematinics|mesh-ancestor
25566860|NCT00746733|Amphetamine|amphetamine|mesh-list
25566861|NCT00746733|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25566862|NCT00746733|Adderall|adderall|mesh-list
25566863|NCT00746733|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25566864|NCT00746733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566865|NCT00746733|Sympathomimetics|sympathomimetics|mesh-ancestor
25566866|NCT00746733|Autonomic Agents|autonomic agents|mesh-ancestor
25566867|NCT00746733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25566868|NCT00746733|Dopamine Agents|dopamine agents|mesh-ancestor
24743399|NCT04843631|Ustekinumab|ustekinumab|mesh-list
25566869|NCT00746733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25566870|NCT00746733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566871|NCT00746733|Adrenergic Agents|adrenergic agents|mesh-ancestor
25566872|NCT00746733|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25566873|NCT00746733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25566874|NCT00746733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25566875|NCT00746733|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25566876|NCT00746785|Olanzapine|olanzapine|mesh-list
25566877|NCT00746785|Antiemetics|antiemetics|mesh-ancestor
25566878|NCT00746785|Autonomic Agents|autonomic agents|mesh-ancestor
24857280|NCT02290470|Paclitaxel|paclitaxel|mesh-list
25566879|NCT00746785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25566880|NCT00746785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566881|NCT00746785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25566882|NCT00746785|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25566883|NCT00746785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24658326|NCT01271179|Purinergic Agents|purinergic agents|mesh-ancestor
25566884|NCT00746785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25566885|NCT00746785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25566886|NCT00746785|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25566887|NCT00746785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25566888|NCT00746785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25566889|NCT00746785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566890|NCT00746785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25566891|NCT00746785|Serotonin Agents|serotonin agents|mesh-ancestor
25566892|NCT00746798|Vaccines|vaccines|mesh-list
25566893|NCT00746798|Immunologic Factors|immunologic factors|mesh-ancestor
25566894|NCT00746798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658612|NCT01273090|Imetelstat|imetelstat|mesh-list
25461727|NCT02356705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25461728|NCT02356705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25321155|NCT04922996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25321157|NCT04922996|Hemostatics|hemostatics|mesh-ancestor
24424525|NCT00229593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24424526|NCT00229593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24424528|NCT00229632|Antioxidants|antioxidants|mesh-ancestor
24424529|NCT00229632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424530|NCT00229632|Protective Agents|protective agents|mesh-ancestor
24979287|NCT04842552|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24979288|NCT04842552|Vasodilator Agents|vasodilator agents|mesh-ancestor
24979294|NCT04812951|Cyclosporine|cyclosporine|mesh-list
24979295|NCT04812951|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25822705|NCT00004583|Protease Inhibitors|protease inhibitors|mesh-ancestor
25822706|NCT00004583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450213|NCT00317993|Antimetabolites|antimetabolites|mesh-ancestor
25822707|NCT00004583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822708|NCT00004583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24424531|NCT00229632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424532|NCT00229645|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24840223|NCT02208596|Pentazocine|pentazocine|mesh-list
24979304|NCT04812951|Dermatologic Agents|dermatologic agents|mesh-ancestor
24979305|NCT04812951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24979306|NCT04812951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24840265|NCT02208882|Midazolam|midazolam|mesh-list
24424898|NCT00231218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424899|NCT00231218|Protective Agents|protective agents|mesh-ancestor
24424900|NCT00231218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24424902|NCT00231244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24424903|NCT00231244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24424985|NCT00231556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424987|NCT00231569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24424988|NCT00231569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24425108|NCT00232011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24425109|NCT00232011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425111|NCT00232024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24425112|NCT00232024|Serotonin Agents|serotonin agents|mesh-ancestor
24425113|NCT00232024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24425114|NCT00232024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425115|NCT00232024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425116|NCT00232037|Tegaserod|tegaserod|mesh-list
24425117|NCT00232037|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24425118|NCT00232037|Serotonin Agents|serotonin agents|mesh-ancestor
24425119|NCT00232037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24425120|NCT00232037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425121|NCT00232037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425122|NCT00232050|Omalizumab|omalizumab|mesh-list
24425123|NCT00232050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24425124|NCT00232050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24425125|NCT00232050|Respiratory System Agents|respiratory system agents|mesh-ancestor
24425126|NCT00232063|Cyclosporine|cyclosporine|mesh-list
25822709|NCT00004583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24425129|NCT00232063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425709|NCT00234091|Antiviral Agents|antiviral agents|mesh-ancestor
24425710|NCT00234091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24425711|NCT00234091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24425712|NCT00234091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24425722|NCT00234117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24425723|NCT00234117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24426054|NCT00234975|Antiviral Agents|antiviral agents|mesh-ancestor
24426055|NCT00234975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24426056|NCT00234975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24426057|NCT00234975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24426058|NCT00234988|Sibutramine|sibutramine|mesh-list
24426059|NCT00234988|Antidepressive Agents|antidepressive agents|mesh-ancestor
24426060|NCT00234988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24426061|NCT00234988|Appetite Depressants|appetite depressants|mesh-ancestor
24426062|NCT00234988|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24426064|NCT00235001|Trandolapril|trandolapril|mesh-list
24426065|NCT00235001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25566895|NCT00746863|Bupivacaine|bupivacaine|mesh-list
25566896|NCT00746863|Anesthetics, Local|anesthetics, local|mesh-ancestor
25566897|NCT00746863|Anesthetics|anesthetics|mesh-ancestor
25566898|NCT00746863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25822710|NCT00004583|Antiviral Agents|antiviral agents|mesh-ancestor
25566899|NCT00746863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566901|NCT00746863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25566902|NCT00746889|Triamcinolone|triamcinolone|mesh-list
25566903|NCT00746889|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25566904|NCT00746889|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25566905|NCT00746889|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25566906|NCT00746889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25566907|NCT00746889|Glucocorticoids|glucocorticoids|mesh-ancestor
25566908|NCT00746889|Hormones|hormones|mesh-ancestor
25566909|NCT00746889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25566910|NCT00746889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566911|NCT00746889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25566912|NCT00746889|Immunologic Factors|immunologic factors|mesh-ancestor
25566913|NCT00746889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25566914|NCT00746889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566915|NCT00746941|Mefloquine|mefloquine|mesh-list
25566916|NCT00746941|Antimalarials|antimalarials|mesh-ancestor
25566917|NCT00746941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25566918|NCT00746941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25566919|NCT00746941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25566920|NCT00746954|Acetazolamide|acetazolamide|mesh-list
25566921|NCT00746954|Buspirone|buspirone|mesh-list
25566922|NCT00746954|Anticonvulsants|anticonvulsants|mesh-ancestor
25566923|NCT00746954|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25566924|NCT00746954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25566925|NCT00746954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566926|NCT00746954|Diuretics|diuretics|mesh-ancestor
25566927|NCT00746954|Natriuretic Agents|natriuretic agents|mesh-ancestor
25566928|NCT00746954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566929|NCT00746954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25566930|NCT00746954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25566931|NCT00746954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25566932|NCT00746954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25566933|NCT00746954|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25566934|NCT00746954|Serotonin Agents|serotonin agents|mesh-ancestor
25566935|NCT00746954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25566936|NCT00747006|Insulin Lispro|insulin lispro|mesh-list
25566937|NCT00747006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25566938|NCT00747006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566939|NCT00747149|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25566940|NCT00747149|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25566941|NCT00747149|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25566942|NCT00747149|Antimetabolites|antimetabolites|mesh-ancestor
25566943|NCT00747149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566944|NCT00747149|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25566945|NCT00747149|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25566946|NCT00747149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25566947|NCT00747214|Prednisolone|prednisolone|mesh-list
25566948|NCT00747214|Antirheumatic Agents|antirheumatic agents|mesh-list
25566949|NCT00747214|Dipyridamole|dipyridamole|mesh-list
25566950|NCT00747214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25566951|NCT00747214|Glucocorticoids|glucocorticoids|mesh-ancestor
25566952|NCT00747214|Hormones|hormones|mesh-ancestor
25566953|NCT00747214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25566954|NCT00747214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566955|NCT00747214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25566956|NCT00747214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25566957|NCT00747214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25566958|NCT00747214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25566959|NCT00747214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566960|NCT00747214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25566961|NCT00747214|Vasodilator Agents|vasodilator agents|mesh-ancestor
25566962|NCT00747344|Ustekinumab|ustekinumab|mesh-list
25566963|NCT00747344|Dermatologic Agents|dermatologic agents|mesh-ancestor
25566964|NCT00747617|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25566965|NCT00747617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25566966|NCT00747617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566967|NCT00747643|Varenicline|varenicline|mesh-list
25566968|NCT00747643|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25566969|NCT00747643|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25566970|NCT00747643|Cholinergic Agents|cholinergic agents|mesh-ancestor
25566971|NCT00747643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25566972|NCT00747643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566973|NCT00747643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566974|NCT00748072|Vasopressins|vasopressins|mesh-list
25566975|NCT00748072|Hemostatics|hemostatics|mesh-ancestor
25566976|NCT00748072|Coagulants|coagulants|mesh-ancestor
25566977|NCT00748072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25566978|NCT00748072|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25566979|NCT00748072|Natriuretic Agents|natriuretic agents|mesh-ancestor
25566980|NCT00748072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566981|NCT00748098|Gabapentin|gabapentin|mesh-list
25566982|NCT00748098|Analgesics|analgesics|mesh-ancestor
25566983|NCT00748098|Sensory System Agents|sensory system agents|mesh-ancestor
25566984|NCT00748098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25566985|NCT00748098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25566986|NCT00748098|Anticonvulsants|anticonvulsants|mesh-ancestor
25566987|NCT00748098|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25566988|NCT00748098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25566989|NCT00748098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25566990|NCT00748098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25566991|NCT00748098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25566992|NCT00748098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25566993|NCT00748098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25566994|NCT00748098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25566995|NCT00748098|Antimanic Agents|antimanic agents|mesh-ancestor
25566996|NCT00748189|Ofatumumab|ofatumumab|mesh-list
25566997|NCT00748189|Chlorambucil|chlorambucil|mesh-list
25566998|NCT00748189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25566999|NCT00748189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25567000|NCT00748189|Alkylating Agents|alkylating agents|mesh-ancestor
25567001|NCT00748189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567002|NCT00748215|Antidiarrheals|antidiarrheals|mesh-list
25567003|NCT00748215|Loperamide|loperamide|mesh-list
25567004|NCT00748215|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
25567005|NCT00748215|Calcium|calcium|mesh-list
25567006|NCT00748215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25567007|NCT00748215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535238|NCT00648830|Clarithromycin|clarithromycin|mesh-list
25567008|NCT00748215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25567009|NCT00748553|Paclitaxel|paclitaxel|mesh-list
25567010|NCT00748553|Azacitidine|azacitidine|mesh-list
25567011|NCT00748553|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25567012|NCT00748553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25567013|NCT00748553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25567014|NCT00748553|Tubulin Modulators|tubulin modulators|mesh-ancestor
25567015|NCT00748553|Antimitotic Agents|antimitotic agents|mesh-ancestor
25567016|NCT00748553|Mitosis Modulators|mitosis modulators|mesh-ancestor
25567017|NCT00748553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567018|NCT00748553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25567019|NCT00748553|Antimetabolites|antimetabolites|mesh-ancestor
25567020|NCT00748553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567021|NCT00748566|Ziprasidone|ziprasidone|mesh-list
25567022|NCT00748566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25567023|NCT00748566|Serotonin Agents|serotonin agents|mesh-ancestor
25567024|NCT00748566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25567025|NCT00748566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567026|NCT00748566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567027|NCT00748566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25567028|NCT00748566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25567029|NCT00748566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25567030|NCT00748566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25567031|NCT00748566|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25567032|NCT00748566|Dopamine Agents|dopamine agents|mesh-ancestor
25567033|NCT00748657|Bevacizumab|bevacizumab|mesh-list
25567034|NCT00748657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25567035|NCT00748657|Endothelial Growth Factors|endothelial growth factors|mesh-list
25567036|NCT00748657|Antibodies|antibodies|mesh-list
25567037|NCT00748657|Immunoglobulins|immunoglobulins|mesh-list
25567038|NCT00748657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25567039|NCT00748657|Immunoglobulin G|immunoglobulin g|mesh-list
24618541|NCT01048983|Curcumin|curcumin|mesh-list
25567040|NCT00748657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25567041|NCT00748657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25567042|NCT00748657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25567043|NCT00748657|Growth Substances|growth substances|mesh-ancestor
25567044|NCT00748657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567045|NCT00748657|Growth Inhibitors|growth inhibitors|mesh-ancestor
25567046|NCT00748657|Immunologic Factors|immunologic factors|mesh-ancestor
25567047|NCT00748709|Afatinib|afatinib|mesh-list
25461799|NCT01837277|Antiviral Agents|antiviral agents|mesh-ancestor
25567048|NCT00748709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25567050|NCT00748709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567051|NCT00748709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567052|NCT00748826|Infliximab|infliximab|mesh-list
25567053|NCT00748826|Dermatologic Agents|dermatologic agents|mesh-ancestor
25567054|NCT00748826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25567055|NCT00748826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25567056|NCT00748865|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25567057|NCT00748865|Lubricant Eye Drops|lubricant eye drops|mesh-list
25567058|NCT00748865|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25567059|NCT00749125|Citalopram|citalopram|mesh-list
25567060|NCT00749125|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24745637|NCT03673826|Hormones|hormones|mesh-ancestor
25567061|NCT00749125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25567062|NCT00749125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25567063|NCT00749125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567064|NCT00749125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25567065|NCT00749125|Serotonin Agents|serotonin agents|mesh-ancestor
25567066|NCT00749125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745752|NCT03596385|Metoprolol|metoprolol|mesh-list
25567067|NCT00749125|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25567068|NCT00749125|Antidepressive Agents|antidepressive agents|mesh-ancestor
25567069|NCT00749125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25567070|NCT00749190|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25567071|NCT00749190|Empagliflozin|empagliflozin|mesh-list
25567072|NCT00749190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25567073|NCT00749190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567074|NCT00749190|Incretins|incretins|mesh-ancestor
25567075|NCT00749190|Hormones|hormones|mesh-ancestor
25567076|NCT00749190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25567077|NCT00749190|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25567078|NCT00749190|Protease Inhibitors|protease inhibitors|mesh-ancestor
25567079|NCT00749190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567080|NCT00749190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567081|NCT00749190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25567082|NCT00749203|Midazolam|midazolam|mesh-list
25567083|NCT00749203|Ketamine|ketamine|mesh-list
25567084|NCT00749203|Analgesics|analgesics|mesh-ancestor
25567085|NCT00749203|Sensory System Agents|sensory system agents|mesh-ancestor
25567086|NCT00749203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25567087|NCT00749203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567088|NCT00749203|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24659807|NCT01279811|Dopamine Agents|dopamine agents|mesh-ancestor
25567089|NCT00749203|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25567090|NCT00749203|Anesthetics, General|anesthetics, general|mesh-ancestor
25567091|NCT00749203|Anesthetics|anesthetics|mesh-ancestor
25567092|NCT00749203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25567093|NCT00749203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25567094|NCT00749203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25567095|NCT00749203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25567096|NCT00749203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567097|NCT00749203|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25567098|NCT00749203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25567099|NCT00749203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25567100|NCT00749203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25567101|NCT00749203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25567102|NCT00749203|GABA Modulators|gaba modulators|mesh-ancestor
25567103|NCT00749203|GABA Agents|gaba agents|mesh-ancestor
25567104|NCT00749398|Infliximab|infliximab|mesh-list
25567105|NCT00749398|Dermatologic Agents|dermatologic agents|mesh-ancestor
25567106|NCT00749398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25567107|NCT00749398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25567108|NCT00749463|Nicotine|nicotine|mesh-list
25567109|NCT00749463|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25567110|NCT00749463|Autonomic Agents|autonomic agents|mesh-ancestor
25567111|NCT00749463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25567112|NCT00749463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567113|NCT00749463|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25567114|NCT00749463|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25567115|NCT00749463|Cholinergic Agents|cholinergic agents|mesh-ancestor
25567116|NCT00749463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25567117|NCT00749463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567118|NCT00749515|Deferasirox|deferasirox|mesh-list
25567119|NCT00749515|Deferoxamine|deferoxamine|mesh-list
24746215|NCT03236311|Purinergic Agents|purinergic agents|mesh-ancestor
24746216|NCT03236311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25567120|NCT00749515|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25567121|NCT00749515|Chelating Agents|chelating agents|mesh-ancestor
25567122|NCT00749515|Sequestering Agents|sequestering agents|mesh-ancestor
25567123|NCT00749515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567125|NCT00749580|Raltegravir Potassium|raltegravir potassium|mesh-list
25567126|NCT00749580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25567127|NCT00749580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25567128|NCT00749580|Antiviral Agents|antiviral agents|mesh-ancestor
25567129|NCT00749580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25567130|NCT00749580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25567131|NCT00749580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25567132|NCT00749580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567133|NCT00749580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567134|NCT00749684|Interferons|interferons|mesh-list
25567135|NCT00749684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25567136|NCT00749684|Antiviral Agents|antiviral agents|mesh-ancestor
24746334|NCT05437575|Sensory System Agents|sensory system agents|mesh-ancestor
25567137|NCT00749684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25567138|NCT00749749|Bupivacaine|bupivacaine|mesh-list
25567139|NCT00749749|Anesthetics, Local|anesthetics, local|mesh-ancestor
25567140|NCT00749749|Anesthetics|anesthetics|mesh-ancestor
25567141|NCT00749749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25567142|NCT00749749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567143|NCT00749749|Sensory System Agents|sensory system agents|mesh-ancestor
25567144|NCT00749749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25567145|NCT00749892|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25567146|NCT00749892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746677|NCT04511416|Metformin|metformin|mesh-list
25567147|NCT00749892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25567148|NCT00749892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567149|NCT00749892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567150|NCT00749944|Varenicline|varenicline|mesh-list
25567151|NCT00749944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25567152|NCT00749944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25567153|NCT00749944|Cholinergic Agents|cholinergic agents|mesh-ancestor
25567154|NCT00749944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25567155|NCT00749944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567156|NCT00749944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567157|NCT00750061|Lithium Carbonate|lithium carbonate|mesh-list
25567158|NCT00750061|Antidepressive Agents|antidepressive agents|mesh-ancestor
25567159|NCT00750061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25567160|NCT00750061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567161|NCT00750061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567162|NCT00750061|Antimanic Agents|antimanic agents|mesh-ancestor
25567163|NCT00750061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25567164|NCT00750061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25567165|NCT00750061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567166|NCT00750308|Ramipril|ramipril|mesh-list
25567167|NCT00750308|Tadalafil|tadalafil|mesh-list
25567168|NCT00750308|Vasodilator Agents|vasodilator agents|mesh-ancestor
24944217|NCT03962803|Vaccines|vaccines|mesh-list
25567169|NCT00750308|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25567170|NCT00750308|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25567171|NCT00750308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567172|NCT00750308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567173|NCT00750308|Urological Agents|urological agents|mesh-ancestor
25567174|NCT00750308|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25567175|NCT00750308|Protease Inhibitors|protease inhibitors|mesh-ancestor
25567176|NCT00750308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25567177|NCT00750737|Amphotericin B|amphotericin b|mesh-list
25567178|NCT00750737|Posaconazole|posaconazole|mesh-list
25567179|NCT00750737|Amebicides|amebicides|mesh-ancestor
25567180|NCT00750737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25567181|NCT00750737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25567182|NCT00750737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25567183|NCT00750737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25567184|NCT00750737|Antifungal Agents|antifungal agents|mesh-ancestor
25567185|NCT00750737|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25567186|NCT00750737|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25567187|NCT00750737|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25567188|NCT00750737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567189|NCT00750737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567190|NCT00750737|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25567191|NCT00750737|Hormone Antagonists|hormone antagonists|mesh-ancestor
25567192|NCT00750737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25567193|NCT00750737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567194|NCT00750815|Dexamethasone|dexamethasone|mesh-list
25567195|NCT00750815|Cyclophosphamide|cyclophosphamide|mesh-list
25567196|NCT00750815|Doxorubicin|doxorubicin|mesh-list
25567197|NCT00750815|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25567198|NCT00750815|Bortezomib|bortezomib|mesh-list
25567199|NCT00750815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25567200|NCT00750815|Immunologic Factors|immunologic factors|mesh-ancestor
25567201|NCT00750815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567202|NCT00750815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25567203|NCT00750815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25567204|NCT00750815|Alkylating Agents|alkylating agents|mesh-ancestor
25567205|NCT00750815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567206|NCT00750815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25567207|NCT00750815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25567208|NCT00750815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25567209|NCT00750815|Antiemetics|antiemetics|mesh-ancestor
25567210|NCT00750815|Autonomic Agents|autonomic agents|mesh-ancestor
25567211|NCT00750815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25567212|NCT00750815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25567213|NCT00750815|Glucocorticoids|glucocorticoids|mesh-ancestor
25567214|NCT00750815|Hormones|hormones|mesh-ancestor
25567215|NCT00750815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25567216|NCT00750815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25567217|NCT00750815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25567218|NCT00750815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25567219|NCT00750815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25567220|NCT00750815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567221|NCT00750867|Immunoglobulins|immunoglobulins|mesh-list
25567222|NCT00750867|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25567223|NCT00750867|Antibodies|antibodies|mesh-list
25567224|NCT00750867|gamma-Globulins|gamma-globulins|mesh-list
25567225|NCT00750867|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25567226|NCT00750867|Immunologic Factors|immunologic factors|mesh-ancestor
25567227|NCT00750867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567228|NCT00750919|Mirtazapine|mirtazapine|mesh-list
25567229|NCT00750919|Antidepressive Agents|antidepressive agents|mesh-ancestor
25567230|NCT00750919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25567231|NCT00750919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25567232|NCT00750919|Histamine Antagonists|histamine antagonists|mesh-ancestor
25567233|NCT00750919|Histamine Agents|histamine agents|mesh-ancestor
25567234|NCT00750919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25567235|NCT00750919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567236|NCT00750919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567237|NCT00750919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25567238|NCT00750919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25567239|NCT00750919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25567240|NCT00750919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25567241|NCT00750919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25567242|NCT00750919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25567243|NCT00750919|Adrenergic Agents|adrenergic agents|mesh-ancestor
25567244|NCT00750919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25567245|NCT00750919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25567246|NCT00750919|Serotonin Agents|serotonin agents|mesh-ancestor
25567247|NCT00750919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25567248|NCT00751023|Modafinil|modafinil|mesh-list
25567249|NCT00751023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25567250|NCT00751023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567251|NCT00751023|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25567252|NCT00751023|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25567253|NCT00751023|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25567254|NCT00751023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567255|NCT00751036|Imatinib Mesylate|imatinib mesylate|mesh-list
25567256|NCT00751036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25567257|NCT00751036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25567258|NCT00751036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567259|NCT00751036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567260|NCT00751101|Nicotine|nicotine|mesh-list
25567261|NCT00751101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25567262|NCT00751101|Autonomic Agents|autonomic agents|mesh-ancestor
25462007|NCT00142584|Metoprolol|metoprolol|mesh-list
25462008|NCT00142584|Nebivolol|nebivolol|mesh-list
25462009|NCT00142584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25462010|NCT00142584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25462011|NCT00142584|Sympatholytics|sympatholytics|mesh-ancestor
25462012|NCT00142584|Autonomic Agents|autonomic agents|mesh-ancestor
25462016|NCT00142584|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25567263|NCT00751101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25567264|NCT00751101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567265|NCT00751101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25567266|NCT00751101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25567267|NCT00751101|Cholinergic Agents|cholinergic agents|mesh-ancestor
25567268|NCT00751101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25567269|NCT00751101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567270|NCT00751114|Metformin|metformin|mesh-list
25567271|NCT00751114|Insulin Glargine|insulin glargine|mesh-list
25567272|NCT00751114|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25567273|NCT00751114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25567274|NCT00751114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567275|NCT00751114|Incretins|incretins|mesh-ancestor
25567276|NCT00751114|Hormones|hormones|mesh-ancestor
25567277|NCT00751114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25567278|NCT00751114|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25567279|NCT00751114|Protease Inhibitors|protease inhibitors|mesh-ancestor
25567280|NCT00751114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567281|NCT00751114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567282|NCT00751179|Bromides|bromides|mesh-list
25567283|NCT00751179|Rocuronium|rocuronium|mesh-list
25567284|NCT00751179|Succinylcholine|succinylcholine|mesh-list
25567285|NCT00751179|Anticonvulsants|anticonvulsants|mesh-ancestor
25567286|NCT00751179|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25567287|NCT00751179|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25567288|NCT00751179|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25567289|NCT00751179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25567290|NCT00751179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567291|NCT00751179|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
25567292|NCT00751296|Lenalidomide|lenalidomide|mesh-list
25567293|NCT00751296|Immunologic Factors|immunologic factors|mesh-ancestor
25567294|NCT00751296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567295|NCT00751296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25567296|NCT00751296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25567297|NCT00751296|Growth Substances|growth substances|mesh-ancestor
25567298|NCT00751296|Growth Inhibitors|growth inhibitors|mesh-ancestor
25567299|NCT00751296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25567300|NCT00751400|Naproxen|naproxen|mesh-list
25567301|NCT00751400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25567302|NCT00751400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25567303|NCT00751400|Analgesics|analgesics|mesh-ancestor
25567304|NCT00751400|Sensory System Agents|sensory system agents|mesh-ancestor
25567305|NCT00751400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25567306|NCT00751400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567307|NCT00751400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25567308|NCT00751400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25567309|NCT00751400|Gout Suppressants|gout suppressants|mesh-ancestor
24710055|NCT01508195|Metformin|metformin|mesh-list
25567310|NCT00751400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25567311|NCT00751400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567312|NCT00751400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567313|NCT00751530|Raltegravir Potassium|raltegravir potassium|mesh-list
25567314|NCT00751530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25567315|NCT00751530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25567316|NCT00751530|Antiviral Agents|antiviral agents|mesh-ancestor
25567317|NCT00751530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25567318|NCT00751530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25567319|NCT00751530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25567320|NCT00751530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567321|NCT00751530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567322|NCT00751777|Vaccines|vaccines|mesh-list
25567323|NCT00751777|Immunologic Factors|immunologic factors|mesh-ancestor
24749460|NCT01054248|Artesunate|artesunate|mesh-list
24534526|NCT00647491|Adalimumab|adalimumab|mesh-list
25567324|NCT00751777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567325|NCT00751790|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25567326|NCT00751790|Luteolytic Agents|luteolytic agents|mesh-ancestor
25567327|NCT00751790|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25567328|NCT00751790|Contraceptive Agents|contraceptive agents|mesh-ancestor
25567329|NCT00751790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25567330|NCT00751790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567331|NCT00751790|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25567332|NCT00751790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25567333|NCT00751790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25567334|NCT00751881|Teriflunomide|teriflunomide|mesh-list
25567335|NCT00751881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25567336|NCT00751881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25567337|NCT00751881|Analgesics|analgesics|mesh-ancestor
25567338|NCT00751881|Sensory System Agents|sensory system agents|mesh-ancestor
25567339|NCT00751881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25567340|NCT00751881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567341|NCT00751881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25567342|NCT00751881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25567343|NCT00751881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25567344|NCT00751881|Immunologic Factors|immunologic factors|mesh-ancestor
25652127|NCT01524133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25652128|NCT01524133|Serotonin Agents|serotonin agents|mesh-ancestor
25652129|NCT01524133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652130|NCT01524198|Budesonide|budesonide|mesh-list
25652131|NCT01524198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25652132|NCT01524198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25652133|NCT01524198|Autonomic Agents|autonomic agents|mesh-ancestor
25652134|NCT01524198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25652135|NCT01524198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652136|NCT01524198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25652137|NCT01524198|Respiratory System Agents|respiratory system agents|mesh-ancestor
25652138|NCT01524198|Glucocorticoids|glucocorticoids|mesh-ancestor
25652139|NCT01524198|Hormones|hormones|mesh-ancestor
25652140|NCT01524198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25652141|NCT01524289|Anacetrapib|anacetrapib|mesh-list
25652142|NCT01524289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25652143|NCT01524289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25652144|NCT01524289|Antimetabolites|antimetabolites|mesh-ancestor
25652145|NCT01524289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652146|NCT01524289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25652147|NCT01524302|Levofloxacin|levofloxacin|mesh-list
25652148|NCT01524302|Ofloxacin|ofloxacin|mesh-list
25652149|NCT01524302|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
25652150|NCT01524302|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25652151|NCT01524302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25652152|NCT01524302|Renal Agents|renal agents|mesh-ancestor
25652153|NCT01524302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25652154|NCT01524302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25652155|NCT01524302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25652156|NCT01524302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652157|NCT01524302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652158|NCT01524302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652159|NCT01524302|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25652160|NCT01524302|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25652161|NCT01524627|Varenicline|varenicline|mesh-list
25652162|NCT01524627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25652163|NCT01524627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25652164|NCT01524627|Cholinergic Agents|cholinergic agents|mesh-ancestor
24848090|NCT05147233|Hormones|hormones|mesh-ancestor
25652165|NCT01524627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25652166|NCT01524627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652167|NCT01524627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652168|NCT01524679|Interferons|interferons|mesh-list
25652169|NCT01524679|Interferon-alpha|interferon-alpha|mesh-list
25652170|NCT01524679|Interferon alpha-2|interferon alpha-2|mesh-list
25652171|NCT01524679|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25652172|NCT01524679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652173|NCT01524679|Antiviral Agents|antiviral agents|mesh-ancestor
25652174|NCT01524679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25652175|NCT01524679|Immunologic Factors|immunologic factors|mesh-ancestor
25652176|NCT01524679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652177|NCT01524770|Dulaglutide|dulaglutide|mesh-list
25652178|NCT01524770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25652179|NCT01524770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652180|NCT01524783|Everolimus|everolimus|mesh-list
25652181|NCT01524783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652182|NCT01524783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25652183|NCT01524783|Immunologic Factors|immunologic factors|mesh-ancestor
25652184|NCT01524783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652185|NCT01524796|Pregabalin|pregabalin|mesh-list
25652186|NCT01524796|Analgesics|analgesics|mesh-ancestor
25652187|NCT01524796|Sensory System Agents|sensory system agents|mesh-ancestor
25652188|NCT01524796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25652189|NCT01524796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652190|NCT01524796|Anticonvulsants|anticonvulsants|mesh-ancestor
25652191|NCT01524796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25652192|NCT01524796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25652193|NCT01524796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652194|NCT01524796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25652195|NCT01524796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25567345|NCT00752102|Calcitriol|calcitriol|mesh-list
25567346|NCT00752102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25567347|NCT00752102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567348|NCT00752102|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25567349|NCT00752102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25567350|NCT00752102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567351|NCT00752102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25567352|NCT00752102|Vitamins|vitamins|mesh-ancestor
25567353|NCT00752102|Micronutrients|micronutrients|mesh-ancestor
25567354|NCT00752102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25567355|NCT00752206|Saracatinib|saracatinib|mesh-list
25567356|NCT00752206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25567357|NCT00752206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567358|NCT00752206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567359|NCT00752219|Metronidazole|metronidazole|mesh-list
25567360|NCT00752219|Meropenem|meropenem|mesh-list
25567361|NCT00752219|Ceftazidime|ceftazidime|mesh-list
25567362|NCT00752219|Avibactam|avibactam|mesh-list
25567363|NCT00752219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25567364|NCT00752219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25567365|NCT00752219|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25567366|NCT00752219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25567367|NCT00752219|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25567368|NCT00752219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567369|NCT00752219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567370|NCT00752232|Saponin QA-21V1|saponin qa-21v1|mesh-list
25567371|NCT00752232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25567372|NCT00752232|Immunologic Factors|immunologic factors|mesh-ancestor
25567373|NCT00752232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567374|NCT00752557|Calcium, Dietary|calcium, dietary|mesh-list
25567375|NCT00752557|Vitamin D|vitamin d|mesh-list
25567376|NCT00752557|Ergocalciferols|ergocalciferols|mesh-list
25567377|NCT00752557|Cholecalciferol|cholecalciferol|mesh-list
25567378|NCT00752557|Diphosphonates|diphosphonates|mesh-list
25567379|NCT00752557|Vitamins|vitamins|mesh-list
25567380|NCT00752557|Calcium|calcium|mesh-list
25567381|NCT00752557|Micronutrients|micronutrients|mesh-ancestor
25567382|NCT00752557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567383|NCT00752557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25567384|NCT00752557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25567385|NCT00752622|Infliximab|infliximab|mesh-list
25567386|NCT00752622|Dermatologic Agents|dermatologic agents|mesh-ancestor
25567387|NCT00752622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25567388|NCT00752622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25462228|NCT05252884|Calcium Carbonate|calcium carbonate|mesh-list
25462229|NCT05252884|Calcium|calcium|mesh-list
25462230|NCT05252884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25462231|NCT05252884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462232|NCT05252884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25462233|NCT05252884|Antacids|antacids|mesh-ancestor
25462234|NCT05252884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462235|NCT05252884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25462236|NCT05252884|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25462237|NCT05252884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25462238|NCT05252884|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24750406|NCT01698203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24750410|NCT01698476|Vitamin D|vitamin d|mesh-list
24594053|NCT00932100|Tinzaparin|tinzaparin|mesh-list
25462239|NCT05252884|Vitamins|vitamins|mesh-ancestor
25462240|NCT05252884|Micronutrients|micronutrients|mesh-ancestor
25462241|NCT05233163|Empagliflozin|empagliflozin|mesh-list
25462242|NCT05233163|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25567389|NCT00752726|Orlistat|orlistat|mesh-list
25567390|NCT00752726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567391|NCT00752726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567392|NCT00752726|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25567393|NCT00752726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25567394|NCT00752856|Ritonavir|ritonavir|mesh-list
25567395|NCT00752856|Lopinavir|lopinavir|mesh-list
25567396|NCT00752856|Tenofovir|tenofovir|mesh-list
25567397|NCT00752856|Emtricitabine|emtricitabine|mesh-list
25567398|NCT00752856|Raltegravir Potassium|raltegravir potassium|mesh-list
24944417|NCT03960801|Remifentanil|remifentanil|mesh-list
25567399|NCT00752856|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25567400|NCT00752856|Efavirenz|efavirenz|mesh-list
25567401|NCT00752856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25567402|NCT00752856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25567403|NCT00752856|Protease Inhibitors|protease inhibitors|mesh-ancestor
25567404|NCT00752856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567405|NCT00752856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567406|NCT00752856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25567407|NCT00752856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24663435|NCT01301222|Octreotide|octreotide|mesh-list
25696418|NCT02061397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24663470|NCT01301612|Cisplatin|cisplatin|mesh-list
25567408|NCT00752856|Antiviral Agents|antiviral agents|mesh-ancestor
25567409|NCT00752856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25567410|NCT00752856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25567411|NCT00752856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25567412|NCT00752856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25567413|NCT00752856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25567414|NCT00752856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25567415|NCT00752856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25567416|NCT00752856|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25567417|NCT00752856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25567418|NCT00752856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25567419|NCT00752856|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25567420|NCT00752856|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25567422|NCT00752973|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25567423|NCT00752973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567424|NCT00752973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567425|NCT00752973|Cholinergic Agents|cholinergic agents|mesh-ancestor
25567426|NCT00752973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25567427|NCT00752973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567428|NCT00753012|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25567429|NCT00753012|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25567430|NCT00753012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567431|NCT00753012|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25567432|NCT00753012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25567433|NCT00753012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25567434|NCT00753012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567435|NCT00753012|Dopamine Agents|dopamine agents|mesh-ancestor
25567436|NCT00753012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25567437|NCT00753142|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25567438|NCT00753142|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25567439|NCT00753142|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25567440|NCT00753142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25567441|NCT00753220|Cyclophosphamide|cyclophosphamide|mesh-list
25567442|NCT00753220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25567443|NCT00753220|Immunologic Factors|immunologic factors|mesh-ancestor
25567444|NCT00753220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567445|NCT00753220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25567446|NCT00753220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25567447|NCT00753220|Alkylating Agents|alkylating agents|mesh-ancestor
25567448|NCT00753220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567449|NCT00753220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25567450|NCT00753220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25567451|NCT00753337|Cobalt|cobalt|mesh-list
25567452|NCT00753337|Trace Elements|trace elements|mesh-ancestor
25567453|NCT00753337|Micronutrients|micronutrients|mesh-ancestor
25567454|NCT00753337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567455|NCT00753454|Certolizumab Pegol|certolizumab pegol|mesh-list
24751389|NCT01703910|Pemetrexed|pemetrexed|mesh-list
25567456|NCT00753454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25567457|NCT00753454|Immunologic Factors|immunologic factors|mesh-ancestor
25567458|NCT00753454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567459|NCT00753454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25567460|NCT00753506|Artemisinins|artemisinins|mesh-list
25567461|NCT00753506|Artemisinin|artemisinin|mesh-list
25567462|NCT00753506|Antimalarials|antimalarials|mesh-ancestor
25567463|NCT00753506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25567464|NCT00753506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24619113|NCT01050842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567465|NCT00753506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25567466|NCT00753636|Isradipine|isradipine|mesh-list
25567467|NCT00753636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25567468|NCT00753636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25567469|NCT00753636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25567470|NCT00753636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567471|NCT00753636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25567472|NCT00753636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567473|NCT00753636|Vasodilator Agents|vasodilator agents|mesh-ancestor
24664351|NCT01306318|Anticonvulsants|anticonvulsants|mesh-ancestor
25567474|NCT00753675|Gemcitabine|gemcitabine|mesh-list
25567475|NCT00753675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25567476|NCT00753675|Antimetabolites|antimetabolites|mesh-ancestor
25567477|NCT00753675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567478|NCT00753675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25567479|NCT00753675|Antiviral Agents|antiviral agents|mesh-ancestor
25567480|NCT00753675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25567481|NCT00753675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567482|NCT00753675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25567483|NCT00753675|Immunologic Factors|immunologic factors|mesh-ancestor
25567484|NCT00753675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567485|NCT00753714|Gemcitabine|gemcitabine|mesh-list
25567486|NCT00753714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25567487|NCT00753714|Antimetabolites|antimetabolites|mesh-ancestor
25567488|NCT00753714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567489|NCT00753714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25567490|NCT00753714|Antiviral Agents|antiviral agents|mesh-ancestor
25567491|NCT00753714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25567492|NCT00753714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567493|NCT00753714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25567494|NCT00753714|Immunologic Factors|immunologic factors|mesh-ancestor
25567495|NCT00753714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567497|NCT00753896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25567498|NCT00753896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567499|NCT00753896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25567500|NCT00753896|Incretins|incretins|mesh-ancestor
25567501|NCT00753896|Hormones|hormones|mesh-ancestor
24664375|NCT01306461|Adrenergic Agents|adrenergic agents|mesh-ancestor
25567502|NCT00753896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25567503|NCT00753935|Aspirin|aspirin|mesh-list
25567504|NCT00753935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25567505|NCT00753935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25567506|NCT00753935|Analgesics|analgesics|mesh-ancestor
25567507|NCT00753935|Sensory System Agents|sensory system agents|mesh-ancestor
25567508|NCT00753935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25567509|NCT00753935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567510|NCT00753935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25567511|NCT00753935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25567512|NCT00753935|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25567513|NCT00753935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25567514|NCT00753935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567515|NCT00753935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25567516|NCT00753935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25567517|NCT00753935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567518|NCT00753935|Antipyretics|antipyretics|mesh-ancestor
25567519|NCT00754065|Moxifloxacin|moxifloxacin|mesh-list
25567520|NCT00754065|Dienogest|dienogest|mesh-list
25567521|NCT00754065|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25567522|NCT00754065|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25567523|NCT00754065|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25567524|NCT00754065|Estradiol|estradiol|mesh-list
25567525|NCT00754065|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25567526|NCT00754065|Estrogens|estrogens|mesh-ancestor
25567527|NCT00754065|Hormones|hormones|mesh-ancestor
25567528|NCT00754065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25567529|NCT00754065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567530|NCT00754065|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25567531|NCT00754065|Contraceptive Agents|contraceptive agents|mesh-ancestor
25567532|NCT00754065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25567533|NCT00754065|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25567534|NCT00754065|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25567535|NCT00754065|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25567536|NCT00754065|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25567537|NCT00754065|Hormone Antagonists|hormone antagonists|mesh-ancestor
25567538|NCT00754065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25567539|NCT00754065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25567540|NCT00754065|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25567541|NCT00754065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25567542|NCT00754065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25567543|NCT00754065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25567544|NCT00754065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25567545|NCT00754065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567546|NCT00754065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567547|NCT00754247|Vitamin E|vitamin e|mesh-list
25567548|NCT00754247|Hydrocortisone|hydrocortisone|mesh-list
25567549|NCT00754247|Vitamins|vitamins|mesh-ancestor
25567550|NCT00754247|Micronutrients|micronutrients|mesh-ancestor
25567551|NCT00754247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567552|NCT00754247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25567553|NCT00754247|Antioxidants|antioxidants|mesh-ancestor
25567554|NCT00754247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567555|NCT00754247|Protective Agents|protective agents|mesh-ancestor
25567556|NCT00754325|Dasatinib|dasatinib|mesh-list
25567557|NCT00754325|Fulvestrant|fulvestrant|mesh-list
25567558|NCT00754325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25567559|NCT00754325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25567560|NCT00754325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567561|NCT00754325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664642|NCT01308086|Vitamins|vitamins|mesh-ancestor
25567562|NCT00754325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25567563|NCT00754325|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25567564|NCT00754325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25567565|NCT00754325|Hormone Antagonists|hormone antagonists|mesh-ancestor
25567566|NCT00754325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25567567|NCT00754325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567568|NCT00754338|Dipivefrin|dipivefrin|mesh-list
25567569|NCT00754338|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25567570|NCT00754338|Adrenergic Agents|adrenergic agents|mesh-ancestor
25567571|NCT00754338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25567572|NCT00754338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567573|NCT00754338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567574|NCT00754390|Calcium, Dietary|calcium, dietary|mesh-list
25567575|NCT00754390|Calcium|calcium|mesh-list
25567576|NCT00754390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25567577|NCT00754390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664700|NCT01308255|Autonomic Agents|autonomic agents|mesh-ancestor
25567578|NCT00754390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25567579|NCT00754442|Teriparatide|teriparatide|mesh-list
25567580|NCT00754442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25567581|NCT00754442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567582|NCT00754442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25567583|NCT00754494|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25567584|NCT00754494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25567585|NCT00754494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25567586|NCT00754494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567587|NCT00754494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567588|NCT00754546|Formoterol Fumarate|formoterol fumarate|mesh-list
25567589|NCT00754546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25567590|NCT00754546|Autonomic Agents|autonomic agents|mesh-ancestor
25567591|NCT00754546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25567592|NCT00754546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567593|NCT00754546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25567594|NCT00754546|Respiratory System Agents|respiratory system agents|mesh-ancestor
25567595|NCT00754546|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25567596|NCT00754546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25567597|NCT00754546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25567598|NCT00754546|Adrenergic Agents|adrenergic agents|mesh-ancestor
25567599|NCT00754546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25567600|NCT00754546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567601|NCT00754572|Methotrexate|methotrexate|mesh-list
25567602|NCT00754572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25567603|NCT00754572|Abortifacient Agents|abortifacient agents|mesh-ancestor
25567604|NCT00754572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25567605|NCT00754572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567606|NCT00754572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25567607|NCT00754572|Antimetabolites|antimetabolites|mesh-ancestor
25567608|NCT00754572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567609|NCT00754572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25567610|NCT00754572|Dermatologic Agents|dermatologic agents|mesh-ancestor
25567611|NCT00754572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567612|NCT00754572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25567613|NCT00754572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25567614|NCT00754572|Immunologic Factors|immunologic factors|mesh-ancestor
25567615|NCT00754572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25567616|NCT00754572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25567617|NCT00754624|Insulin|insulin|mesh-list
25567618|NCT00754624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25567619|NCT00754624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567620|NCT00754650|Bevacizumab|bevacizumab|mesh-list
25567621|NCT00754650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25567622|NCT00754650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462405|NCT04933721|Berotralstat|berotralstat|mesh-list
25567623|NCT00754650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25567624|NCT00754650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25567625|NCT00754650|Growth Substances|growth substances|mesh-ancestor
25567626|NCT00754650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567627|NCT00754650|Growth Inhibitors|growth inhibitors|mesh-ancestor
25567628|NCT00754845|Letrozole|letrozole|mesh-list
25567629|NCT00754845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25567630|NCT00754845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25567631|NCT00754845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25567632|NCT00754845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567633|NCT00754845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752461|NCT01710540|Metformin|metformin|mesh-list
25567634|NCT00754845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25567635|NCT00754845|Hormone Antagonists|hormone antagonists|mesh-ancestor
25567636|NCT00754845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25567637|NCT00754845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567638|NCT00754923|Sorafenib|sorafenib|mesh-list
25567639|NCT00754923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25567640|NCT00754923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25567641|NCT00754923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567642|NCT00754923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567643|NCT00754936|Citalopram|citalopram|mesh-list
25567644|NCT00754936|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25567645|NCT00754936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25567646|NCT00754936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25567647|NCT00754936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567648|NCT00754936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25567649|NCT00754936|Serotonin Agents|serotonin agents|mesh-ancestor
25567650|NCT00754936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567651|NCT00754936|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25567652|NCT00754936|Antidepressive Agents|antidepressive agents|mesh-ancestor
25567653|NCT00754936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25567654|NCT00755040|Cyclosporine|cyclosporine|mesh-list
25567655|NCT00755040|Cyclosporins|cyclosporins|mesh-list
25567656|NCT00755040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567657|NCT00755040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567658|NCT00755040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25567659|NCT00755040|Immunologic Factors|immunologic factors|mesh-ancestor
25567660|NCT00755040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567661|NCT00755040|Antifungal Agents|antifungal agents|mesh-ancestor
25567662|NCT00755040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25567663|NCT00755040|Dermatologic Agents|dermatologic agents|mesh-ancestor
25567664|NCT00755040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24752754|NCT01711827|Isavuconazole|isavuconazole|mesh-list
25567665|NCT00755040|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25567666|NCT00755079|Adrenergic Agents|adrenergic agents|mesh-list
25567667|NCT00755079|Adrenergic Agonists|adrenergic agonists|mesh-list
25567668|NCT00755079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25567669|NCT00755079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567670|NCT00755079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567671|NCT00755183|Methyltestosterone|methyltestosterone|mesh-list
25567672|NCT00755183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25567673|NCT00755183|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25567674|NCT00755183|Testosterone|testosterone|mesh-list
25567675|NCT00755183|Testosterone undecanoate|testosterone undecanoate|mesh-list
25567676|NCT00755183|Testosterone enanthate|testosterone enanthate|mesh-list
25567677|NCT00755183|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25567678|NCT00755183|Androgens|androgens|mesh-ancestor
25567679|NCT00755183|Hormones|hormones|mesh-ancestor
25606124|NCT01064830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25567680|NCT00755183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25567681|NCT00755183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567682|NCT00755183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25567683|NCT00755183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25567684|NCT00755183|Anabolic Agents|anabolic agents|mesh-ancestor
25567685|NCT00755274|Vaccines|vaccines|mesh-list
25567686|NCT00755274|Immunologic Factors|immunologic factors|mesh-ancestor
24752941|NCT01712893|Goserelin|goserelin|mesh-list
25567687|NCT00755274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567688|NCT00755417|Gabapentin|gabapentin|mesh-list
25567689|NCT00755417|Analgesics|analgesics|mesh-ancestor
25567690|NCT00755417|Sensory System Agents|sensory system agents|mesh-ancestor
25567691|NCT00755417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25567692|NCT00755417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567693|NCT00755417|Anticonvulsants|anticonvulsants|mesh-ancestor
25567694|NCT00755417|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25567695|NCT00755417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25567696|NCT00755417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25462551|NCT04090190|Autonomic Agents|autonomic agents|mesh-ancestor
25462552|NCT04090190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25462553|NCT03954782|Nintedanib|nintedanib|mesh-list
25462554|NCT03954782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462555|NCT03954782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25462556|NCT03954782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25462557|NCT03954782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462558|NCT03899428|Sorafenib|sorafenib|mesh-list
25462559|NCT03899428|Durvalumab|durvalumab|mesh-list
25462560|NCT03899428|Lenvatinib|lenvatinib|mesh-list
25462561|NCT03899428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462562|NCT03899428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25462563|NCT03899428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25462564|NCT03899428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462565|NCT03899428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25322091|NCT04912167|Valsartan|valsartan|mesh-list
25322092|NCT04912167|Enalapril|enalapril|mesh-list
25322093|NCT04912167|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25322094|NCT04912167|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25322095|NCT04912167|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25322096|NCT04912167|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25322097|NCT04912167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322098|NCT04912167|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25322099|NCT04912167|Protease Inhibitors|protease inhibitors|mesh-ancestor
25322100|NCT04912167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322101|NCT04912271|Dexamethasone|dexamethasone|mesh-list
25322102|NCT04912271|Aprepitant|aprepitant|mesh-list
25322103|NCT04912271|Fosaprepitant|fosaprepitant|mesh-list
25322104|NCT04912271|Palonosetron|palonosetron|mesh-list
25322105|NCT04912271|Granisetron|granisetron|mesh-list
25322106|NCT04912271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25322107|NCT04912271|Antiemetics|antiemetics|mesh-ancestor
25322108|NCT04912271|Autonomic Agents|autonomic agents|mesh-ancestor
25322109|NCT04912271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24753254|NCT01714401|Respiratory System Agents|respiratory system agents|mesh-ancestor
24753255|NCT01714401|Tocolytic Agents|tocolytic agents|mesh-ancestor
24753256|NCT01714401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25322110|NCT04912271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322111|NCT04912271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25322112|NCT04912271|Glucocorticoids|glucocorticoids|mesh-ancestor
25567697|NCT00755417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25567698|NCT00755417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25567699|NCT00755417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25567700|NCT00755417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25567701|NCT00755417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567702|NCT00755417|Antimanic Agents|antimanic agents|mesh-ancestor
25567703|NCT00755716|Topiramate|topiramate|mesh-list
25567704|NCT00755716|Nicotine|nicotine|mesh-list
25567705|NCT00755716|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25567706|NCT00755716|Autonomic Agents|autonomic agents|mesh-ancestor
25567707|NCT00755716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25567708|NCT00755716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567709|NCT00755716|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25567710|NCT00755716|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25567711|NCT00755716|Cholinergic Agents|cholinergic agents|mesh-ancestor
25567712|NCT00755716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25567713|NCT00755716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567714|NCT00755716|Anticonvulsants|anticonvulsants|mesh-ancestor
25567715|NCT00755716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25567716|NCT00755755|Iron|iron|mesh-list
25567717|NCT00755755|Ulipristal acetate|ulipristal acetate|mesh-list
25567718|NCT00755755|Trace Elements|trace elements|mesh-ancestor
25567719|NCT00755755|Micronutrients|micronutrients|mesh-ancestor
25322113|NCT04912271|Hormones|hormones|mesh-ancestor
25567720|NCT00755755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567721|NCT00755755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25567722|NCT00755755|Contraceptive Agents|contraceptive agents|mesh-ancestor
25567723|NCT00755755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25567724|NCT00755755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25567725|NCT00755807|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25567726|NCT00755807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25567727|NCT00755807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25567728|NCT00755807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25606125|NCT01064830|Immunologic Factors|immunologic factors|mesh-ancestor
25567729|NCT00755807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567730|NCT00755807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25567731|NCT00755807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567732|NCT00755807|Analgesics|analgesics|mesh-ancestor
25567733|NCT00755807|Sensory System Agents|sensory system agents|mesh-ancestor
25567734|NCT00755807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25567735|NCT00755807|Antidepressive Agents|antidepressive agents|mesh-ancestor
25567736|NCT00755807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25567737|NCT00755807|Dopamine Agents|dopamine agents|mesh-ancestor
25567738|NCT00755846|Alogliptin|alogliptin|mesh-list
25567739|NCT00755846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25567740|NCT00755846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567741|NCT00755846|Incretins|incretins|mesh-ancestor
25567742|NCT00755846|Hormones|hormones|mesh-ancestor
25567743|NCT00755846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25567744|NCT00755846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25567745|NCT00755846|Protease Inhibitors|protease inhibitors|mesh-ancestor
25567746|NCT00755846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567747|NCT00755846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567748|NCT00755911|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
25567749|NCT00755911|Hemostatics|hemostatics|mesh-ancestor
25567750|NCT00755911|Coagulants|coagulants|mesh-ancestor
25567751|NCT00756093|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25567752|NCT00756093|Lubricant Eye Drops|lubricant eye drops|mesh-list
25567753|NCT00756093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25567754|NCT00756106|Temozolomide|temozolomide|mesh-list
25567755|NCT00756106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25567756|NCT00756106|Alkylating Agents|alkylating agents|mesh-ancestor
25567757|NCT00756106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567758|NCT00756106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25567759|NCT00756236|Metoprolol|metoprolol|mesh-list
25567760|NCT00756236|Esmolol|esmolol|mesh-list
25567761|NCT00756236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25567762|NCT00756236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25567763|NCT00756236|Sympatholytics|sympatholytics|mesh-ancestor
25567764|NCT00756236|Autonomic Agents|autonomic agents|mesh-ancestor
25567765|NCT00756236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25567766|NCT00756236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567767|NCT00756236|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25567768|NCT00756236|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25567769|NCT00756236|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24753433|NCT01715363|Folic Acid|folic acid|mesh-list
25567770|NCT00756236|Adrenergic Agents|adrenergic agents|mesh-ancestor
25567771|NCT00756236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25567772|NCT00756236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567773|NCT00756275|Nicotine|nicotine|mesh-list
25567774|NCT00756275|Varenicline|varenicline|mesh-list
25567775|NCT00756275|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25567776|NCT00756275|Autonomic Agents|autonomic agents|mesh-ancestor
25567777|NCT00756275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25567778|NCT00756275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567779|NCT00756275|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25567780|NCT00756275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25567781|NCT00756275|Cholinergic Agents|cholinergic agents|mesh-ancestor
25567782|NCT00756275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25567783|NCT00756275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567784|NCT00756314|Contraceptive Agents|contraceptive agents|mesh-list
25567785|NCT00756314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25567786|NCT00756314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567787|NCT00756444|Cisplatin|cisplatin|mesh-list
25567788|NCT00756444|Panitumumab|panitumumab|mesh-list
25567789|NCT00756444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25567790|NCT00756444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25567791|NCT00756470|Paclitaxel|paclitaxel|mesh-list
25567792|NCT00756470|Cyclophosphamide|cyclophosphamide|mesh-list
25567793|NCT00756470|Fluorouracil|fluorouracil|mesh-list
25567794|NCT00756470|Epirubicin|epirubicin|mesh-list
25567795|NCT00756470|Lapatinib|lapatinib|mesh-list
25567796|NCT00756470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25567797|NCT00756470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25567798|NCT00756470|Tubulin Modulators|tubulin modulators|mesh-ancestor
25567799|NCT00756470|Antimitotic Agents|antimitotic agents|mesh-ancestor
25567800|NCT00756470|Mitosis Modulators|mitosis modulators|mesh-ancestor
25567801|NCT00756470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567802|NCT00756470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25567803|NCT00756470|Immunologic Factors|immunologic factors|mesh-ancestor
25567804|NCT00756470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567805|NCT00756470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25567806|NCT00756470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25567807|NCT00756470|Alkylating Agents|alkylating agents|mesh-ancestor
25462566|NCT03885713|Adalimumab|adalimumab|mesh-list
25567809|NCT00756470|Antimetabolites|antimetabolites|mesh-ancestor
25567810|NCT00756470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25567811|NCT00756470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25567812|NCT00756470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25567813|NCT00756470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25567814|NCT00756470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567815|NCT00756470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25567816|NCT00756548|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25567817|NCT00756548|Laxatives|laxatives|mesh-ancestor
25567818|NCT00756548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25567819|NCT00756600|Anesthetics|anesthetics|mesh-list
25567820|NCT00756600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25567821|NCT00756600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567822|NCT00756678|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25567823|NCT00756678|Lubricant Eye Drops|lubricant eye drops|mesh-list
25567824|NCT00756678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25567825|NCT00756730|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25567826|NCT00756730|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25567827|NCT00756730|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25567828|NCT00756730|Protease Inhibitors|protease inhibitors|mesh-ancestor
25567829|NCT00756730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567830|NCT00756730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567831|NCT00756730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25567832|NCT00756730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25567833|NCT00756730|Antiviral Agents|antiviral agents|mesh-ancestor
25567834|NCT00756730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25567835|NCT00756886|Atorvastatin|atorvastatin|mesh-list
25567836|NCT00756886|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25567837|NCT00756886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25567838|NCT00756886|Antimetabolites|antimetabolites|mesh-ancestor
25567839|NCT00756886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567840|NCT00756886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25567841|NCT00756886|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25567842|NCT00756886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567843|NCT00756964|Rasburicase|rasburicase|mesh-list
25567844|NCT00756964|Gout Suppressants|gout suppressants|mesh-ancestor
25567845|NCT00756964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25567846|NCT00756977|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25567847|NCT00756977|Laxatives|laxatives|mesh-ancestor
25567848|NCT00756977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25567849|NCT00757172|Cisplatin|cisplatin|mesh-list
25567850|NCT00757172|Docetaxel|docetaxel|mesh-list
25567851|NCT00757172|Panitumumab|panitumumab|mesh-list
25567852|NCT00757172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25567853|NCT00757172|Tubulin Modulators|tubulin modulators|mesh-ancestor
25567854|NCT00757172|Antimitotic Agents|antimitotic agents|mesh-ancestor
25567855|NCT00757172|Mitosis Modulators|mitosis modulators|mesh-ancestor
25567856|NCT00757172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567857|NCT00757172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25567858|NCT00757237|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25567859|NCT00757237|Tobramycin|tobramycin|mesh-list
25567860|NCT00757237|Aztreonam|aztreonam|mesh-list
25567861|NCT00757237|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25567862|NCT00757237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25567863|NCT00757237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25567864|NCT00757237|Antitubercular Agents|antitubercular agents|mesh-ancestor
25652196|NCT01524796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25652197|NCT01524796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25652198|NCT01524796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25652199|NCT01524887|Immunoglobulins|immunoglobulins|mesh-list
25652200|NCT01524887|Antibodies|antibodies|mesh-list
25652201|NCT01524887|gamma-Globulins|gamma-globulins|mesh-list
25652202|NCT01524887|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25652203|NCT01524887|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25652204|NCT01524887|Immunologic Factors|immunologic factors|mesh-ancestor
25652205|NCT01524887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753795|NCT01717846|Abatacept|abatacept|mesh-list
25652206|NCT01524913|Hyaluronic Acid|hyaluronic acid|mesh-list
25652207|NCT01524913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25652208|NCT01524913|Immunologic Factors|immunologic factors|mesh-ancestor
25652209|NCT01524913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652210|NCT01524913|Viscosupplements|viscosupplements|mesh-ancestor
25652211|NCT01524913|Protective Agents|protective agents|mesh-ancestor
25652212|NCT01524978|Cetuximab|cetuximab|mesh-list
25652213|NCT01524978|Vemurafenib|vemurafenib|mesh-list
25652214|NCT01524978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25652215|NCT01524978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25567865|NCT00757588|Insulin|insulin|mesh-list
25567866|NCT00757588|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25567867|NCT00757588|Saxagliptin|saxagliptin|mesh-list
25567868|NCT00757588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25567869|NCT00757588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567870|NCT00757588|Incretins|incretins|mesh-ancestor
25567871|NCT00757588|Hormones|hormones|mesh-ancestor
25567872|NCT00757588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25567873|NCT00757588|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25567874|NCT00757588|Protease Inhibitors|protease inhibitors|mesh-ancestor
25567875|NCT00757588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567876|NCT00757588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567877|NCT00757705|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25567878|NCT00757705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25567879|NCT00757705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25567880|NCT00757705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25567881|NCT00757705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567882|NCT00757705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25567883|NCT00757705|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25567884|NCT00757705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25567885|NCT00757705|Serotonin Agents|serotonin agents|mesh-ancestor
25567886|NCT00757705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25567887|NCT00757705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567888|NCT00757705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25567889|NCT00757705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25567890|NCT00757705|Dopamine Agents|dopamine agents|mesh-ancestor
25567891|NCT00757783|Ritonavir|ritonavir|mesh-list
25567892|NCT00757783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25567893|NCT00757783|Darunavir|darunavir|mesh-list
25567894|NCT00757783|Tenofovir|tenofovir|mesh-list
25567895|NCT00757783|Emtricitabine|emtricitabine|mesh-list
25567896|NCT00757783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25567897|NCT00757783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25567898|NCT00757783|Protease Inhibitors|protease inhibitors|mesh-ancestor
25567899|NCT00757783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567900|NCT00757783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567901|NCT00757783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25567902|NCT00757783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24666198|NCT01318005|Norinyl|norinyl|mesh-list
25567903|NCT00757783|Antiviral Agents|antiviral agents|mesh-ancestor
25567904|NCT00757783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25567905|NCT00757783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25567906|NCT00757783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25567907|NCT00757783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25567908|NCT00757783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25567909|NCT00757822|Dronabinol|dronabinol|mesh-list
25567910|NCT00757822|Ondansetron|ondansetron|mesh-list
25567911|NCT00757822|Antiemetics|antiemetics|mesh-ancestor
25567912|NCT00757822|Autonomic Agents|autonomic agents|mesh-ancestor
24666307|NCT01318369|GABA Modulators|gaba modulators|mesh-ancestor
25567913|NCT00757822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25567914|NCT00757822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567915|NCT00757822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25567916|NCT00757822|Antipruritics|antipruritics|mesh-ancestor
25567917|NCT00757822|Dermatologic Agents|dermatologic agents|mesh-ancestor
25567918|NCT00757822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25567919|NCT00757822|Serotonin Agents|serotonin agents|mesh-ancestor
25567920|NCT00757822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25567921|NCT00757822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567922|NCT00757822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25567923|NCT00757822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25567924|NCT00757822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25567925|NCT00757822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25567926|NCT00757822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25567927|NCT00757822|Hallucinogens|hallucinogens|mesh-ancestor
25567928|NCT00757822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25567929|NCT00757822|Analgesics|analgesics|mesh-ancestor
25567930|NCT00757822|Sensory System Agents|sensory system agents|mesh-ancestor
25567931|NCT00757822|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25567932|NCT00757822|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25567933|NCT00757822|Hormones|hormones|mesh-ancestor
25567934|NCT00757822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25567935|NCT00758043|Ribavirin|ribavirin|mesh-list
25567936|NCT00758043|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25567937|NCT00758043|Antimetabolites|antimetabolites|mesh-ancestor
25567938|NCT00758043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567939|NCT00758043|Antiviral Agents|antiviral agents|mesh-ancestor
24952246|NCT03896217|Simvastatin|simvastatin|mesh-list
25462788|NCT01904136|Mechlorethamine|mechlorethamine|mesh-list
25462789|NCT01904136|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25462790|NCT01904136|Fludarabine|fludarabine|mesh-list
25462792|NCT01904136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25462793|NCT01904136|Immunologic Factors|immunologic factors|mesh-ancestor
25462794|NCT01904136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462795|NCT01904136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25462796|NCT01904136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25462797|NCT01904136|Alkylating Agents|alkylating agents|mesh-ancestor
24666545|NCT01319825|Sensory System Agents|sensory system agents|mesh-ancestor
24666546|NCT01319825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24666547|NCT01319825|Antidepressive Agents|antidepressive agents|mesh-ancestor
25462798|NCT01904136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462799|NCT01904136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462800|NCT01904136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25462801|NCT01904136|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25462802|NCT01904136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25462803|NCT01904136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25462804|NCT01904136|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25462805|NCT01904136|Antitubercular Agents|antitubercular agents|mesh-ancestor
25462806|NCT01904136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25462807|NCT01904136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25322355|NCT04908566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322356|NCT04908813|Capecitabine|capecitabine|mesh-list
25322357|NCT04908813|Oxaliplatin|oxaliplatin|mesh-list
25322358|NCT04908813|Trastuzumab|trastuzumab|mesh-list
25322359|NCT04908813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25322360|NCT04908813|Antimetabolites|antimetabolites|mesh-ancestor
25322364|NCT04908345|Fentanyl|fentanyl|mesh-list
24979350|NCT04707625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979351|NCT04696146|Complement C1s|complement c1s|mesh-list
24979352|NCT04696146|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
24979353|NCT04696146|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
24979354|NCT04696146|Immunologic Factors|immunologic factors|mesh-ancestor
24979355|NCT04696146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979356|NCT04696146|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24979357|NCT04696146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24979358|NCT04663464|Abaloparatide|abaloparatide|mesh-list
24795456|NCT02581943|Antimitotic Agents|antimitotic agents|mesh-ancestor
24588752|NCT00904176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24795457|NCT02581943|Mitosis Modulators|mitosis modulators|mesh-ancestor
24795458|NCT02581943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822711|NCT00004583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24426066|NCT00235001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24426067|NCT00235001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24426068|NCT00235001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426110|NCT00235053|Sympathomimetics|sympathomimetics|mesh-ancestor
24426112|NCT00235079|Gout Suppressants|gout suppressants|mesh-ancestor
24426113|NCT00235079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24426114|NCT00235079|Tubulin Modulators|tubulin modulators|mesh-ancestor
24426115|NCT00235079|Antimitotic Agents|antimitotic agents|mesh-ancestor
24426116|NCT00235079|Mitosis Modulators|mitosis modulators|mesh-ancestor
25567940|NCT00758043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25567941|NCT00758069|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25567942|NCT00758069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25567943|NCT00758069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567944|NCT00758069|Incretins|incretins|mesh-ancestor
25567945|NCT00758069|Hormones|hormones|mesh-ancestor
25567946|NCT00758069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25567947|NCT00758069|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25567948|NCT00758069|Protease Inhibitors|protease inhibitors|mesh-ancestor
25567949|NCT00758069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567950|NCT00758069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567951|NCT00758160|Methylphenidate|methylphenidate|mesh-list
25567952|NCT00758160|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25567953|NCT00758160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567954|NCT00758160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25567955|NCT00758160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25567956|NCT00758160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25567957|NCT00758160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567958|NCT00758160|Dopamine Agents|dopamine agents|mesh-ancestor
25567959|NCT00758160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25567960|NCT00758264|Vaccines|vaccines|mesh-list
25567961|NCT00758264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25567962|NCT00758264|Immunologic Factors|immunologic factors|mesh-ancestor
25567963|NCT00758264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567965|NCT00758342|Brinzolamide|brinzolamide|mesh-list
25567966|NCT00758342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25567967|NCT00758342|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25567968|NCT00758342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25567969|NCT00758342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567970|NCT00758394|Listerine|listerine|mesh-list
25567971|NCT00758394|Triclosan|triclosan|mesh-list
25567972|NCT00758394|Fluorides|fluorides|mesh-list
25567973|NCT00758394|Sodium Fluoride|sodium fluoride|mesh-list
25567974|NCT00758394|Fluorophosphate|fluorophosphate|mesh-list
25567975|NCT00758394|Cariostatic Agents|cariostatic agents|mesh-ancestor
25567976|NCT00758394|Protective Agents|protective agents|mesh-ancestor
25567977|NCT00758394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567978|NCT00758394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25567979|NCT00758394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25567980|NCT00758394|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25567981|NCT00758394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25567982|NCT00758394|Antimetabolites|antimetabolites|mesh-ancestor
25567983|NCT00758394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567984|NCT00758394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25567985|NCT00758420|Polidocanol|polidocanol|mesh-list
25567986|NCT00758420|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25567987|NCT00758420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25567988|NCT00758498|Modafinil|modafinil|mesh-list
25567989|NCT00758498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25567990|NCT00758498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25567991|NCT00758498|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25567992|NCT00758498|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25567993|NCT00758498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24542145|NCT00677248|Ezetimibe|ezetimibe|mesh-list
25567994|NCT00758498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25567995|NCT00758524|Eplerenone|eplerenone|mesh-list
25567996|NCT00758524|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25567997|NCT00758524|Hormone Antagonists|hormone antagonists|mesh-ancestor
25567998|NCT00758524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25567999|NCT00758524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568000|NCT00758524|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25568001|NCT00758524|Diuretics|diuretics|mesh-ancestor
25568002|NCT00758524|Natriuretic Agents|natriuretic agents|mesh-ancestor
25568003|NCT00758524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25568004|NCT00758602|Mycophenolic Acid|mycophenolic acid|mesh-list
25568005|NCT00758602|Tacrolimus|tacrolimus|mesh-list
25568006|NCT00758602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25568007|NCT00758602|Immunologic Factors|immunologic factors|mesh-ancestor
25568008|NCT00758602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568009|NCT00758602|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25568010|NCT00758602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568011|NCT00758602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568012|NCT00758602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25568013|NCT00758602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25568014|NCT00758602|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25568015|NCT00758602|Antitubercular Agents|antitubercular agents|mesh-ancestor
25568016|NCT00758602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25568017|NCT00758602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25568018|NCT00758667|Mesna|mesna|mesh-list
25568019|NCT00758667|Protective Agents|protective agents|mesh-ancestor
25568020|NCT00758667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568021|NCT00758784|Bromfenac|bromfenac|mesh-list
25568022|NCT00758784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25568023|NCT00758784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25568024|NCT00758784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25568025|NCT00758784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25568026|NCT00758784|Analgesics|analgesics|mesh-ancestor
25568027|NCT00758784|Sensory System Agents|sensory system agents|mesh-ancestor
25568028|NCT00758784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25568029|NCT00758784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568030|NCT00758784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25568031|NCT00758784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25568032|NCT00758836|Acetaminophen|acetaminophen|mesh-list
25568033|NCT00758836|Ibuprofen|ibuprofen|mesh-list
25568034|NCT00758836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25568035|NCT00758836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25568036|NCT00758836|Analgesics|analgesics|mesh-ancestor
25568037|NCT00758836|Sensory System Agents|sensory system agents|mesh-ancestor
25462884|NCT00161044|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25462885|NCT00161044|Autonomic Agents|autonomic agents|mesh-ancestor
25462886|NCT00161044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25462887|NCT00161044|Nootropic Agents|nootropic agents|mesh-ancestor
25462888|NCT03833323|Treprostinil|treprostinil|mesh-list
25462889|NCT03833323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25462890|NCT03829579|Esketamine|esketamine|mesh-list
25462891|NCT03829579|Antidepressive Agents|antidepressive agents|mesh-ancestor
25462892|NCT03829579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25462893|NCT03828162|Anticoagulants|anticoagulants|mesh-list
25462894|NCT03819413|Antibodies|antibodies|mesh-list
25462895|NCT03819413|Immunoglobulins|immunoglobulins|mesh-list
25462896|NCT03819413|Immunologic Factors|immunologic factors|mesh-ancestor
25462897|NCT03819413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462898|NCT03819452|Vitamin D|vitamin d|mesh-list
25462899|NCT03819452|Vitamins|vitamins|mesh-ancestor
25462900|NCT03819452|Micronutrients|micronutrients|mesh-ancestor
25462901|NCT03819452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462902|NCT03819452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24426125|NCT00235092|Mitosis Modulators|mitosis modulators|mesh-ancestor
24426126|NCT00235092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426127|NCT00235092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24667318|NCT05459649|Dermatologic Agents|dermatologic agents|mesh-ancestor
24426128|NCT00235092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24426185|NCT00235235|Antiviral Agents|antiviral agents|mesh-ancestor
24426186|NCT00235235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24426187|NCT00235235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24426188|NCT00235235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24426196|NCT00235248|Warfarin|warfarin|mesh-list
24426278|NCT00235508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426280|NCT00235521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24426281|NCT00235521|Vasodilator Agents|vasodilator agents|mesh-ancestor
24426282|NCT00235560|Sirolimus|sirolimus|mesh-list
24426283|NCT00235560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24936061|NCT04044651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24936062|NCT04044703|Vancomycin|vancomycin|mesh-list
24936063|NCT04044703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24936064|NCT04044703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24944945|NCT03956134|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24426284|NCT00235560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24426285|NCT00235560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24426286|NCT00235560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24426287|NCT00235560|Antifungal Agents|antifungal agents|mesh-ancestor
24426288|NCT00235560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24426289|NCT00235560|Immunologic Factors|immunologic factors|mesh-ancestor
24426290|NCT00235560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426291|NCT00235651|Amphotericin B|amphotericin b|mesh-list
24426292|NCT00235651|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24426293|NCT00235651|Amebicides|amebicides|mesh-ancestor
24426294|NCT00235651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24426301|NCT00235729|Lofexidine|lofexidine|mesh-list
24426381|NCT00235911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426382|NCT00235937|Anastrozole|anastrozole|mesh-list
24426383|NCT00235937|Goserelin|goserelin|mesh-list
25045711|NCT00924833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795459|NCT02581943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24795461|NCT02518009|Androgens|androgens|mesh-list
24795462|NCT02518009|Hormones|hormones|mesh-ancestor
24426384|NCT00235937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24426385|NCT00235937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24426386|NCT00235937|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24426387|NCT00235937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24426388|NCT00235937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25162049|NCT02908698|Prednisone|prednisone|mesh-list
24426389|NCT00235937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409247|NCT00181597|Trilostane|trilostane|mesh-list
25696595|NCT02062905|Hormones|hormones|mesh-ancestor
25696602|NCT02063035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696603|NCT02063035|Hemostatics|hemostatics|mesh-ancestor
25696604|NCT02063035|Coagulants|coagulants|mesh-ancestor
25696605|NCT02063217|Sodium Oxybate|sodium oxybate|mesh-list
24667556|NCT05384496|Nivolumab|nivolumab|mesh-list
24426391|NCT00235937|Hormone Antagonists|hormone antagonists|mesh-ancestor
24426406|NCT00235950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25568038|NCT00758836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25568039|NCT00758836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568040|NCT00758836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25568041|NCT00758836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25568042|NCT00758836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25568043|NCT00758836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568044|NCT00758836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568045|NCT00758836|Antipyretics|antipyretics|mesh-ancestor
25568046|NCT00759031|Listerine|listerine|mesh-list
25568047|NCT00759031|Triclosan|triclosan|mesh-list
25568048|NCT00759031|Fluorides|fluorides|mesh-list
25568049|NCT00759031|Sodium Fluoride|sodium fluoride|mesh-list
25568050|NCT00759031|Fluorophosphate|fluorophosphate|mesh-list
25568051|NCT00759031|Cariostatic Agents|cariostatic agents|mesh-ancestor
25568052|NCT00759031|Protective Agents|protective agents|mesh-ancestor
25568053|NCT00759031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568054|NCT00759031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25462903|NCT03815422|Anesthetics|anesthetics|mesh-list
25462904|NCT03815422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25462905|NCT03815422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812026|NCT02049294|Omalizumab|omalizumab|mesh-list
25462906|NCT03811366|Prednisone|prednisone|mesh-list
25462907|NCT03811366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25462908|NCT03811366|Glucocorticoids|glucocorticoids|mesh-ancestor
25462909|NCT03811366|Hormones|hormones|mesh-ancestor
25462910|NCT03811366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25462911|NCT03811366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462912|NCT03811366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25462913|NCT03811366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462914|NCT03806543|Vancomycin|vancomycin|mesh-list
24668447|NCT04918147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25462915|NCT03806543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25462916|NCT03806543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25462917|NCT03804099|Aflibercept|aflibercept|mesh-list
25462918|NCT03804099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25462919|NCT03804099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25462920|NCT03804099|Growth Substances|growth substances|mesh-ancestor
25462921|NCT03804099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462922|NCT03804099|Growth Inhibitors|growth inhibitors|mesh-ancestor
25462923|NCT03804099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462924|NCT03797547|Aflibercept|aflibercept|mesh-list
25462925|NCT03797547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25462926|NCT03797547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25462927|NCT03797547|Growth Substances|growth substances|mesh-ancestor
25462928|NCT03797547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462929|NCT03797547|Growth Inhibitors|growth inhibitors|mesh-ancestor
25462930|NCT03797547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24426407|NCT00235950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24426408|NCT00235950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24426409|NCT00235950|Purinergic Agents|purinergic agents|mesh-ancestor
24426410|NCT00235950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24426411|NCT00235950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426412|NCT00235963|Simvastatin|simvastatin|mesh-list
24426415|NCT00235963|Antimetabolites|antimetabolites|mesh-ancestor
24426416|NCT00235963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426417|NCT00235963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24426418|NCT00235963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24426419|NCT00235963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24426420|NCT00236002|Alendronate|alendronate|mesh-list
24426421|NCT00236002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24426603|NCT00236379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24426605|NCT00236379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24426606|NCT00236379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426607|NCT00236379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426608|NCT00236379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25568055|NCT00759031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25568056|NCT00759031|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25568057|NCT00759031|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25568058|NCT00759031|Antimetabolites|antimetabolites|mesh-ancestor
25568059|NCT00759031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568060|NCT00759031|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25568061|NCT00759109|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25568062|NCT00759109|Antiviral Agents|antiviral agents|mesh-ancestor
25568063|NCT00759109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25568064|NCT00759148|Moxifloxacin|moxifloxacin|mesh-list
25568065|NCT00759148|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25568066|NCT00759148|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25568067|NCT00759148|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25568068|NCT00759148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25568069|NCT00759148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25568070|NCT00759148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25568071|NCT00759148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25568072|NCT00759148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568073|NCT00759148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568074|NCT00759148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25568075|NCT00759148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25568076|NCT00759148|Contraceptive Agents|contraceptive agents|mesh-ancestor
25568077|NCT00759148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25568078|NCT00759148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568079|NCT00759148|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25568080|NCT00759148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25822712|NCT00004583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25462931|NCT03793400|Bevacizumab|bevacizumab|mesh-list
25462932|NCT03793400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25462933|NCT03793400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462934|NCT03793400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25462935|NCT03793400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25462936|NCT03793400|Growth Substances|growth substances|mesh-ancestor
25462937|NCT03793400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462938|NCT03793400|Growth Inhibitors|growth inhibitors|mesh-ancestor
25462939|NCT03792334|Anesthetics|anesthetics|mesh-list
25462940|NCT03792334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25462941|NCT03792334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462942|NCT03789968|Tenofovir|tenofovir|mesh-list
25462943|NCT03789968|Emtricitabine|emtricitabine|mesh-list
25462944|NCT03789968|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25462945|NCT03789968|Antiviral Agents|antiviral agents|mesh-ancestor
25462946|NCT03789968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25462947|NCT03789968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25462948|NCT03789968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25462949|NCT03789968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25462950|NCT03789968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462951|NCT03789968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25462952|NCT03789968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25322648|NCT04905563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696687|NCT02065245|Penicillins|penicillins|mesh-list
25322649|NCT04905563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25322650|NCT04905563|Narcotics|narcotics|mesh-ancestor
25322651|NCT04905563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24756060|NCT01731067|Histamine Agents|histamine agents|mesh-ancestor
25322652|NCT04905563|Antitussive Agents|antitussive agents|mesh-ancestor
25322653|NCT04905563|Respiratory System Agents|respiratory system agents|mesh-ancestor
24575778|NCT00834379|Pravastatin|pravastatin|mesh-list
25078404|NCT03356769|Aspirin|aspirin|mesh-list
25322667|NCT04905108|Riboflavin|riboflavin|mesh-list
25322668|NCT04905108|Vitamin B Complex|vitamin b complex|mesh-ancestor
25322669|NCT04905108|Vitamins|vitamins|mesh-ancestor
25322670|NCT04905108|Micronutrients|micronutrients|mesh-ancestor
25322672|NCT04905108|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24426609|NCT00236379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25122930|NCT03088709|Mycophenolic Acid|mycophenolic acid|mesh-list
24426610|NCT00236379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25568081|NCT00759148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25568082|NCT00759187|Chlorhexidine|chlorhexidine|mesh-list
25568083|NCT00759187|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25568084|NCT00759187|Triclosan|triclosan|mesh-list
25568085|NCT00759187|Fluorides|fluorides|mesh-list
25568086|NCT00759187|Sodium Fluoride|sodium fluoride|mesh-list
25568087|NCT00759187|Fluorophosphate|fluorophosphate|mesh-list
25568088|NCT00759187|Cariostatic Agents|cariostatic agents|mesh-ancestor
25568089|NCT00759187|Protective Agents|protective agents|mesh-ancestor
25568090|NCT00759187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756061|NCT01731067|Analgesics|analgesics|mesh-ancestor
24756062|NCT01731067|Sensory System Agents|sensory system agents|mesh-ancestor
24756063|NCT01731067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24945097|NCT03953677|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24945098|NCT03953677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24945099|NCT03953677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24756068|NCT01731067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24756070|NCT01731132|Levonorgestrel|levonorgestrel|mesh-list
25568091|NCT00759187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25568092|NCT00759187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25568093|NCT00759187|Disinfectants|disinfectants|mesh-ancestor
25568094|NCT00759187|Dermatologic Agents|dermatologic agents|mesh-ancestor
24756415|NCT01733108|Glyburide|glyburide|mesh-list
25568095|NCT00759187|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25568096|NCT00759187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25568097|NCT00759187|Antimetabolites|antimetabolites|mesh-ancestor
25568098|NCT00759187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756454|NCT01733485|Aspirin|aspirin|mesh-list
25568099|NCT00759187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25568100|NCT00759330|Flurbiprofen|flurbiprofen|mesh-list
25568101|NCT00759330|Analgesics|analgesics|mesh-ancestor
25568102|NCT00759330|Sensory System Agents|sensory system agents|mesh-ancestor
25568103|NCT00759330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25568104|NCT00759330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568105|NCT00759330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25568106|NCT00759330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25568107|NCT00759330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25568108|NCT00759330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25568109|NCT00759330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25568110|NCT00759330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568111|NCT00759330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568112|NCT00759356|Morphine|morphine|mesh-list
25568113|NCT00759356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25568114|NCT00759356|Narcotics|narcotics|mesh-ancestor
25568115|NCT00759356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25568116|NCT00759356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462954|NCT03768115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25462955|NCT03767712|Antibodies|antibodies|mesh-list
25462956|NCT03767712|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
25462957|NCT03767712|Immunologic Factors|immunologic factors|mesh-ancestor
25462958|NCT03767712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462959|NCT03763370|Immunoconjugates|immunoconjugates|mesh-list
25462960|NCT03763370|Immunologic Factors|immunologic factors|mesh-ancestor
25462961|NCT03763370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462962|NCT03760562|Glucocorticoids|glucocorticoids|mesh-list
25462963|NCT03760562|Hormones|hormones|mesh-ancestor
25462964|NCT03760562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25462965|NCT03760562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426611|NCT00236379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24426612|NCT00236379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24426613|NCT00236379|Dopamine Agents|dopamine agents|mesh-ancestor
24426614|NCT00236379|Antiemetics|antiemetics|mesh-ancestor
24426615|NCT00236379|Autonomic Agents|autonomic agents|mesh-ancestor
24426616|NCT00236379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24795463|NCT02518009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24795464|NCT02518009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795465|NCT02512718|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24426655|NCT00236444|Dopamine Agents|dopamine agents|mesh-ancestor
24426656|NCT00236457|Risperidone|risperidone|mesh-list
24426657|NCT00236457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24426658|NCT00236457|Serotonin Agents|serotonin agents|mesh-ancestor
24426659|NCT00236457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24426710|NCT00236522|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24426711|NCT00236522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24426713|NCT00236535|Tramadol|tramadol|mesh-list
24426714|NCT00236535|Hydrocodone|hydrocodone|mesh-list
24426715|NCT00236535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24426727|NCT00236548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24426728|NCT00236548|Serotonin Agents|serotonin agents|mesh-ancestor
24426729|NCT00236548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24426730|NCT00236548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426731|NCT00236548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426766|NCT00236587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426767|NCT00236587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426769|NCT00236587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24426770|NCT00236587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24756742|NCT01735370|Sensory System Agents|sensory system agents|mesh-ancestor
24756749|NCT01735370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24426771|NCT00236587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24426772|NCT00236587|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24426773|NCT00236587|Dopamine Agents|dopamine agents|mesh-ancestor
24426775|NCT00236600|Anticonvulsants|anticonvulsants|mesh-ancestor
24426776|NCT00236600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24426777|NCT00236600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426778|NCT00236613|Topiramate|topiramate|mesh-list
24426779|NCT00236613|Anticonvulsants|anticonvulsants|mesh-ancestor
24426780|NCT00236613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24426781|NCT00236613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426782|NCT00236626|Topiramate|topiramate|mesh-list
24426826|NCT00236717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24426827|NCT00236717|Antimanic Agents|antimanic agents|mesh-ancestor
24426828|NCT00236717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24426955|NCT00236912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24426956|NCT00236912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24426957|NCT00236912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24426958|NCT00236912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24426959|NCT00236912|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24426961|NCT00236912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24426962|NCT00236912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25568117|NCT00759356|Analgesics|analgesics|mesh-ancestor
25568118|NCT00759356|Sensory System Agents|sensory system agents|mesh-ancestor
25568119|NCT00759356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24757343|NCT01739218|Growth Substances|growth substances|mesh-ancestor
25568120|NCT00759408|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
25568121|NCT00759408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25568122|NCT00759408|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25568123|NCT00759408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568124|NCT00759473|Cycloserine|cycloserine|mesh-list
25568125|NCT00759473|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25568126|NCT00759473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25568127|NCT00759473|Renal Agents|renal agents|mesh-ancestor
25568128|NCT00759473|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25462967|NCT03751397|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25462968|NCT03751397|Protease Inhibitors|protease inhibitors|mesh-ancestor
25462969|NCT03751397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25462970|NCT03751397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462971|NCT03748095|Tazobactam|tazobactam|mesh-list
25462972|NCT03748095|Piperacillin|piperacillin|mesh-list
25462973|NCT03748095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25462974|NCT03748095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25462975|NCT03748095|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25462976|NCT03748095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25462977|NCT03748095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462978|NCT03744546|Tilavonemab|tilavonemab|mesh-list
25462979|NCT03744546|Nootropic Agents|nootropic agents|mesh-ancestor
25462980|NCT03738683|Tazobactam|tazobactam|mesh-list
25462981|NCT03738683|Piperacillin|piperacillin|mesh-list
25462982|NCT03738683|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25462983|NCT03738683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25462984|NCT03738683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25462985|NCT03738683|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25462986|NCT03738683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25462987|NCT03738683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462988|NCT03738553|Trastuzumab|trastuzumab|mesh-list
25462989|NCT03738553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25462990|NCT03738553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322792|NCT04903054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322793|NCT04903054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25322794|NCT04903054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322795|NCT04903054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25322796|NCT04903054|Immunologic Factors|immunologic factors|mesh-ancestor
25322797|NCT04903054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25322798|NCT04903054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322805|NCT04903054|Antiemetics|antiemetics|mesh-ancestor
25822713|NCT00004583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24427163|NCT00237575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427164|NCT00237575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24427166|NCT00237575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427167|NCT00237575|Antiviral Agents|antiviral agents|mesh-ancestor
24427168|NCT00237575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24979361|NCT04663464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568129|NCT00759473|Antitubercular Agents|antitubercular agents|mesh-ancestor
25568130|NCT00759473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25568131|NCT00759473|Antimetabolites|antimetabolites|mesh-ancestor
25568132|NCT00759473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568133|NCT00759525|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
25568134|NCT00759525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25568135|NCT00759564|Lactams|lactams|mesh-list
25568136|NCT00759564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25568137|NCT00759564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25568138|NCT00759603|Rituximab|rituximab|mesh-list
25568139|NCT00759603|Lenalidomide|lenalidomide|mesh-list
25568140|NCT00759603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25568141|NCT00759603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25568142|NCT00759603|Immunologic Factors|immunologic factors|mesh-ancestor
25568143|NCT00759603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568144|NCT00759603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25568145|NCT00759603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25568146|NCT00759603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25568147|NCT00759603|Growth Substances|growth substances|mesh-ancestor
25568148|NCT00759603|Growth Inhibitors|growth inhibitors|mesh-ancestor
25568149|NCT00759642|Lapatinib|lapatinib|mesh-list
25568150|NCT00759642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25696723|NCT02065622|Adalimumab|adalimumab|mesh-list
25568151|NCT00759642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25568152|NCT00759642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568153|NCT00759642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568154|NCT00759681|Thrombin|thrombin|mesh-list
25568155|NCT00759681|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
25568156|NCT00759681|Hemostatics|hemostatics|mesh-ancestor
25568157|NCT00759681|Coagulants|coagulants|mesh-ancestor
25568158|NCT00759707|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
25568159|NCT00759707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568160|NCT00759707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568161|NCT00759759|Morphine|morphine|mesh-list
25568162|NCT00759759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25568164|NCT00759759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25568165|NCT00759759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568166|NCT00759759|Analgesics|analgesics|mesh-ancestor
25568167|NCT00759759|Sensory System Agents|sensory system agents|mesh-ancestor
25568168|NCT00759759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25568169|NCT00759772|Teriparatide|teriparatide|mesh-list
25568170|NCT00759772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25568171|NCT00759772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568172|NCT00759772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25568173|NCT00759785|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25568174|NCT00759785|Immunologic Factors|immunologic factors|mesh-ancestor
25568175|NCT00759785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568176|NCT00759798|Cyclophosphamide|cyclophosphamide|mesh-list
25568177|NCT00759798|Rituximab|rituximab|mesh-list
25568178|NCT00759798|Fludarabine|fludarabine|mesh-list
25568179|NCT00759798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25568180|NCT00759798|Immunologic Factors|immunologic factors|mesh-ancestor
25568181|NCT00759798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568182|NCT00759798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25568183|NCT00759798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25568184|NCT00759798|Alkylating Agents|alkylating agents|mesh-ancestor
25568185|NCT00759798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568186|NCT00759798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25568187|NCT00759798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25568188|NCT00759798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25568189|NCT00759811|Methotrexate|methotrexate|mesh-list
25568190|NCT00759811|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25568191|NCT00759811|Abortifacient Agents|abortifacient agents|mesh-ancestor
25568192|NCT00759811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25568193|NCT00759811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568194|NCT00759811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25568195|NCT00759811|Antimetabolites|antimetabolites|mesh-ancestor
25568196|NCT00759811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568197|NCT00759811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25568198|NCT00759811|Dermatologic Agents|dermatologic agents|mesh-ancestor
25568199|NCT00759811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568200|NCT00759811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25568201|NCT00759811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25568202|NCT00759811|Immunologic Factors|immunologic factors|mesh-ancestor
25568203|NCT00759811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25568204|NCT00759811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25568205|NCT00759902|Morphine|morphine|mesh-list
25568206|NCT00759902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25568207|NCT00759902|Narcotics|narcotics|mesh-ancestor
25568208|NCT00759902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25568209|NCT00759902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568210|NCT00759902|Analgesics|analgesics|mesh-ancestor
25568211|NCT00759902|Sensory System Agents|sensory system agents|mesh-ancestor
25568212|NCT00759902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25568213|NCT00759915|Morphine|morphine|mesh-list
25568214|NCT00759915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25568215|NCT00759915|Narcotics|narcotics|mesh-ancestor
25568216|NCT00759915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25568217|NCT00759915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568218|NCT00759915|Analgesics|analgesics|mesh-ancestor
25568219|NCT00759915|Sensory System Agents|sensory system agents|mesh-ancestor
25568220|NCT00759915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24757781|NCT01742429|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25568221|NCT00759941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25568222|NCT00759941|Latanoprost|latanoprost|mesh-list
25568223|NCT00759941|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25568224|NCT00759941|Brinzolamide|brinzolamide|mesh-list
25568225|NCT00759941|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25568226|NCT00759941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568227|NCT00759941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568228|NCT00759954|Morphine|morphine|mesh-list
25568229|NCT00759954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25568230|NCT00759954|Narcotics|narcotics|mesh-ancestor
25568231|NCT00759954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25568232|NCT00759954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568233|NCT00759954|Analgesics|analgesics|mesh-ancestor
25568234|NCT00759954|Sensory System Agents|sensory system agents|mesh-ancestor
25568235|NCT00759954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25568236|NCT00760006|Ampicillin|ampicillin|mesh-list
25568237|NCT00760006|Sulbactam|sulbactam|mesh-list
25463064|NCT05089175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25463065|NCT05089175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25463066|NCT05089175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25463067|NCT05089175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24757829|NCT01742663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24757830|NCT01742663|Analgesics|analgesics|mesh-ancestor
24945186|NCT03953287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945187|NCT03953287|Antipyretics|antipyretics|mesh-ancestor
24757831|NCT01742663|Sensory System Agents|sensory system agents|mesh-ancestor
25463068|NCT05089175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463069|NCT05089175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25463070|NCT05089175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25463071|NCT05089175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25463072|NCT05089175|Antipyretics|antipyretics|mesh-ancestor
24979362|NCT04663464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24979364|NCT04639466|Immunologic Factors|immunologic factors|mesh-ancestor
24979365|NCT04639466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979366|NCT04624945|Thromboplastin|thromboplastin|mesh-list
24979367|NCT04624945|Hemostatics|hemostatics|mesh-ancestor
24979368|NCT04624945|Coagulants|coagulants|mesh-ancestor
24824928|NCT02126293|Zinc|zinc|mesh-list
25822714|NCT00004583|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24427435|NCT00238173|Antitubercular Agents|antitubercular agents|mesh-ancestor
24427436|NCT00238173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24427437|NCT00238173|Chelating Agents|chelating agents|mesh-ancestor
24427456|NCT00238212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24427457|NCT00238212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427458|NCT00238212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427459|NCT00238225|Calcitriol|calcitriol|mesh-list
24427460|NCT00238225|Ketoconazole|ketoconazole|mesh-list
24427461|NCT00238225|Dexamethasone|dexamethasone|mesh-list
24427462|NCT00238225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25822715|NCT00004583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24427490|NCT00238251|Gefitinib|gefitinib|mesh-list
24427492|NCT00238251|Alkylating Agents|alkylating agents|mesh-ancestor
24427493|NCT00238251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427494|NCT00238251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427495|NCT00238251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24427496|NCT00238251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24979380|NCT04596657|Micronutrients|micronutrients|mesh-ancestor
24979381|NCT04596657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979382|NCT04596657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24427501|NCT00238277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427502|NCT00238290|Trastuzumab|trastuzumab|mesh-list
24427504|NCT00238290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24427505|NCT00238290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427506|NCT00238290|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24758030|NCT01743365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427507|NCT00238290|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24427508|NCT00238290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427509|NCT00238290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840910|NCT02213159|Analgesics|analgesics|mesh-ancestor
24427589|NCT00238394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427590|NCT00238394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24427591|NCT00238407|Docetaxel|docetaxel|mesh-list
24427625|NCT00238641|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
24427626|NCT00238641|Botulinum Toxins|botulinum toxins|mesh-list
24427639|NCT00238667|Heparin|heparin|mesh-list
24427640|NCT00238667|Calcium heparin|calcium heparin|mesh-list
24758277|NCT01744873|Bisoprolol|bisoprolol|mesh-list
24427641|NCT00238667|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24427642|NCT00238667|Dalteparin|dalteparin|mesh-list
25822716|NCT00004583|Antimetabolites|antimetabolites|mesh-ancestor
25822717|NCT00004585|Lamivudine|lamivudine|mesh-list
25822718|NCT00004585|Zidovudine|zidovudine|mesh-list
25822719|NCT00004585|Efavirenz|efavirenz|mesh-list
24841070|NCT02213913|Rituximab|rituximab|mesh-list
24427885|NCT00239174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24427886|NCT00239174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979392|NCT04540380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979393|NCT04540380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979394|NCT04540380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24979395|NCT04540380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24979396|NCT04523129|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25568238|NCT00760006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25568239|NCT00760006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25568240|NCT00760006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25568241|NCT00760006|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25568242|NCT00760006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758389|NCT01745614|Nimesulide|nimesulide|mesh-list
25568243|NCT00760006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568244|NCT00760019|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
25568245|NCT00760019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25822720|NCT00004585|Abacavir|abacavir|mesh-list
25568246|NCT00760019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25568247|NCT00760019|Analgesics|analgesics|mesh-ancestor
25568248|NCT00760019|Sensory System Agents|sensory system agents|mesh-ancestor
25568249|NCT00760019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25568250|NCT00760019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568251|NCT00760019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25568252|NCT00760019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25568253|NCT00760084|Decitabine|decitabine|mesh-list
25568254|NCT00760084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25568255|NCT00760084|Antimetabolites|antimetabolites|mesh-ancestor
25568256|NCT00760084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568257|NCT00760084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25568258|NCT00760084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568259|NCT00760214|Ramipril|ramipril|mesh-list
25568260|NCT00760214|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25568261|NCT00760214|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25568262|NCT00760214|Protease Inhibitors|protease inhibitors|mesh-ancestor
25568263|NCT00760214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606126|NCT01064830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051331|NCT00415623|Amlodipine|amlodipine|mesh-list
24936913|NCT04034836|Parecoxib|parecoxib|mesh-list
25568264|NCT00760214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568265|NCT00760214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25568266|NCT00760214|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25568267|NCT00760214|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25568268|NCT00760266|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25568269|NCT00760266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25568270|NCT00760266|Diuretics|diuretics|mesh-ancestor
25568271|NCT00760266|Natriuretic Agents|natriuretic agents|mesh-ancestor
25568272|NCT00760266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568273|NCT00760266|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25568274|NCT00760266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25568275|NCT00760266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568276|NCT00760435|Infliximab|infliximab|mesh-list
25568277|NCT00760435|Dermatologic Agents|dermatologic agents|mesh-ancestor
25568278|NCT00760435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25568279|NCT00760435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25568280|NCT00760474|Pregabalin|pregabalin|mesh-list
25568281|NCT00760474|Analgesics|analgesics|mesh-ancestor
24620010|NCT01055249|Ibuprofen|ibuprofen|mesh-list
25568282|NCT00760474|Sensory System Agents|sensory system agents|mesh-ancestor
25568283|NCT00760474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25568284|NCT00760474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568285|NCT00760474|Anticonvulsants|anticonvulsants|mesh-ancestor
25568286|NCT00760474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25568287|NCT00760474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25568288|NCT00760474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568289|NCT00760474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25568290|NCT00760474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25568291|NCT00760474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25568292|NCT00760474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25568293|NCT00760474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25568294|NCT00760578|Pioglitazone|pioglitazone|mesh-list
25568295|NCT00760578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25568296|NCT00760578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568297|NCT00760669|Methotrexate|methotrexate|mesh-list
25568298|NCT00760669|Infliximab|infliximab|mesh-list
25568299|NCT00760669|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25568300|NCT00760669|Abortifacient Agents|abortifacient agents|mesh-ancestor
25568301|NCT00760669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25568302|NCT00760669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568303|NCT00760669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25568304|NCT00760669|Antimetabolites|antimetabolites|mesh-ancestor
25568305|NCT00760669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568306|NCT00760669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25568307|NCT00760669|Dermatologic Agents|dermatologic agents|mesh-ancestor
25568308|NCT00760669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568309|NCT00760669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25568310|NCT00760669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25568311|NCT00760669|Immunologic Factors|immunologic factors|mesh-ancestor
25568312|NCT00760669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25568313|NCT00760669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25568314|NCT00760669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25568315|NCT00760747|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25568316|NCT00760747|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25568317|NCT00760747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25568318|NCT00760747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25568319|NCT00760747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568320|NCT00760747|Adrenergic Agents|adrenergic agents|mesh-ancestor
25568321|NCT00760747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25568322|NCT00760747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568323|NCT00760838|Azithromycin|azithromycin|mesh-list
25568324|NCT00760838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25568325|NCT00760838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25568326|NCT00760877|Imatinib Mesylate|imatinib mesylate|mesh-list
25568327|NCT00760877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25568328|NCT00760877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25568329|NCT00760877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568330|NCT00760877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568331|NCT00760929|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25568332|NCT00760929|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25568333|NCT00760929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25568334|NCT00760929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25568335|NCT00760929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568336|NCT00760929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568337|NCT00760929|Immunologic Factors|immunologic factors|mesh-ancestor
25606127|NCT01064830|Antifungal Agents|antifungal agents|mesh-ancestor
25568338|NCT00760929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568339|NCT00761085|Morphine|morphine|mesh-list
25568340|NCT00761085|Methadone|methadone|mesh-list
25568341|NCT00761085|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25568342|NCT00761085|Narcotics|narcotics|mesh-ancestor
25568343|NCT00761085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25568344|NCT00761085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568345|NCT00761085|Analgesics|analgesics|mesh-ancestor
25568346|NCT00761085|Sensory System Agents|sensory system agents|mesh-ancestor
25568347|NCT00761085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25568348|NCT00761085|Antitussive Agents|antitussive agents|mesh-ancestor
25568349|NCT00761085|Respiratory System Agents|respiratory system agents|mesh-ancestor
25568350|NCT00761137|Tropicamide|tropicamide|mesh-list
25568351|NCT00761137|Mydriatics|mydriatics|mesh-ancestor
25568352|NCT00761137|Autonomic Agents|autonomic agents|mesh-ancestor
25568353|NCT00761137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25568354|NCT00761137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568355|NCT00761137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25568356|NCT00761137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25568357|NCT00761137|Cholinergic Agents|cholinergic agents|mesh-ancestor
25568358|NCT00761137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25568359|NCT00761137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568360|NCT00761150|Acetaminophen|acetaminophen|mesh-list
25568361|NCT00761150|Hydrocodone|hydrocodone|mesh-list
25568362|NCT00761150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25568363|NCT00761150|Analgesics|analgesics|mesh-ancestor
25568364|NCT00761150|Sensory System Agents|sensory system agents|mesh-ancestor
25568365|NCT00761150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25568366|NCT00761150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568367|NCT00761150|Antipyretics|antipyretics|mesh-ancestor
25568368|NCT00761150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25568369|NCT00761150|Narcotics|narcotics|mesh-ancestor
25568370|NCT00761150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25568371|NCT00761150|Antitussive Agents|antitussive agents|mesh-ancestor
25568372|NCT00761150|Respiratory System Agents|respiratory system agents|mesh-ancestor
25568373|NCT00761189|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25568374|NCT00761189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25568375|NCT00761189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25568376|NCT00761189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25568377|NCT00761189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568378|NCT00761189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25568379|NCT00761189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25568380|NCT00761189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25568381|NCT00761189|Serotonin Agents|serotonin agents|mesh-ancestor
25568382|NCT00761189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25568383|NCT00761189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568384|NCT00761189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25568385|NCT00761189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25568386|NCT00761189|Dopamine Agents|dopamine agents|mesh-ancestor
25568387|NCT00761202|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25568388|NCT00761202|Hyaluronic Acid|hyaluronic acid|mesh-list
25568389|NCT00761202|Glycerol|glycerol|mesh-list
25568390|NCT00761202|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25568391|NCT00761202|Immunologic Factors|immunologic factors|mesh-ancestor
25568392|NCT00761202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568393|NCT00761202|Viscosupplements|viscosupplements|mesh-ancestor
25568394|NCT00761202|Protective Agents|protective agents|mesh-ancestor
25568395|NCT00761202|Laxatives|laxatives|mesh-ancestor
25568396|NCT00761202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25568397|NCT00761202|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25568398|NCT00761215|Tedizolid phosphate|tedizolid phosphate|mesh-list
25568399|NCT00761215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25568400|NCT00761215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25568401|NCT00761267|Fluconazole|fluconazole|mesh-list
25568402|NCT00761267|Anidulafungin|anidulafungin|mesh-list
25568403|NCT00761267|Antifungal Agents|antifungal agents|mesh-ancestor
25568404|NCT00761267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25568405|NCT00761267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25568406|NCT00761267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25568407|NCT00761267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568408|NCT00761267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568409|NCT00761267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25568410|NCT00761267|Hormone Antagonists|hormone antagonists|mesh-ancestor
25568411|NCT00761267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25568412|NCT00761267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568413|NCT00761267|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25568414|NCT00761267|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25568415|NCT00761280|Temozolomide|temozolomide|mesh-list
25568416|NCT00761280|Carmustine|carmustine|mesh-list
25568417|NCT00761280|Lomustine|lomustine|mesh-list
25568418|NCT00761280|Trabedersen|trabedersen|mesh-list
25568419|NCT00761280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24945383|NCT03950830|Disulfiram|disulfiram|mesh-list
25568420|NCT00761280|Alkylating Agents|alkylating agents|mesh-ancestor
25568421|NCT00761280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568422|NCT00761280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25568423|NCT00761306|Vortioxetine|vortioxetine|mesh-list
25568424|NCT00761306|Antidepressive Agents|antidepressive agents|mesh-ancestor
25568425|NCT00761306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25568426|NCT00761306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25568427|NCT00761306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25568428|NCT00761306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25568429|NCT00761306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568430|NCT00761306|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25568431|NCT00761306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25568432|NCT00761306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25568433|NCT00761306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568434|NCT00761306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25568435|NCT00761306|Serotonin Agents|serotonin agents|mesh-ancestor
25568436|NCT00761306|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25568437|NCT00761306|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25568438|NCT00761306|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25568439|NCT00761306|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25568440|NCT00761319|Travoprost|travoprost|mesh-list
25568441|NCT00761319|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25568442|NCT00761319|Latanoprost|latanoprost|mesh-list
25568443|NCT00761319|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25568444|NCT00761319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25568445|NCT00761345|Gemcitabine|gemcitabine|mesh-list
25568446|NCT00761345|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25568447|NCT00761345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25568448|NCT00761345|Antimetabolites|antimetabolites|mesh-ancestor
25568449|NCT00761345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568450|NCT00761345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25568451|NCT00761345|Antiviral Agents|antiviral agents|mesh-ancestor
25568452|NCT00761345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25568453|NCT00761345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568454|NCT00761345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25568455|NCT00761345|Immunologic Factors|immunologic factors|mesh-ancestor
25568456|NCT00761345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568457|NCT00761345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25568458|NCT00761462|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25568459|NCT00761462|Ciprofloxacin|ciprofloxacin|mesh-list
25568460|NCT00761462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25568461|NCT00761462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25568462|NCT00761462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25568463|NCT00761462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568464|NCT00761462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568465|NCT00761462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25568466|NCT00761462|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25463229|NCT04558190|Ubiquinone|ubiquinone|mesh-list
25568467|NCT00761462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25568468|NCT00761514|Adalimumab|adalimumab|mesh-list
25568469|NCT00761514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25568470|NCT00761514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25568471|NCT00761579|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25568472|NCT00761579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25568473|NCT00761579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25568474|NCT00761579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25568475|NCT00761579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568476|NCT00761579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25568477|NCT00761579|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25568478|NCT00761579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25568479|NCT00761579|Serotonin Agents|serotonin agents|mesh-ancestor
25568480|NCT00761579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25568481|NCT00761579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568482|NCT00761579|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25568483|NCT00761579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25568484|NCT00761579|Dopamine Agents|dopamine agents|mesh-ancestor
25568485|NCT00761592|Botulinum Toxins|botulinum toxins|mesh-list
25568486|NCT00761592|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25568487|NCT00761592|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25568488|NCT00761592|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25568489|NCT00761592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25568490|NCT00761592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568491|NCT00761592|Cholinergic Agents|cholinergic agents|mesh-ancestor
25568492|NCT00761592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25568493|NCT00761592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568494|NCT00761592|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25568495|NCT00761592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25568496|NCT00761605|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25568497|NCT00761605|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25568498|NCT00761605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25568499|NCT00761605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25568500|NCT00761605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568501|NCT00761605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24424497|NCT00229567|Lidocaine|lidocaine|mesh-list
25568502|NCT00761605|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25696827|NCT02066792|Cycloserine|cycloserine|mesh-list
25568503|NCT00761605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25568504|NCT00761605|Serotonin Agents|serotonin agents|mesh-ancestor
25568505|NCT00761605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25568506|NCT00761605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568507|NCT00761605|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25568508|NCT00761605|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25568509|NCT00761605|Dopamine Agents|dopamine agents|mesh-ancestor
25652216|NCT01524978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25652217|NCT01524978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652218|NCT01524978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652219|NCT01525082|Bevacizumab|bevacizumab|mesh-list
24395319|NCT00135746|Nicotine|nicotine|mesh-list
25652220|NCT01525082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25652221|NCT01525082|Capecitabine|capecitabine|mesh-list
25652222|NCT01525082|Temozolomide|temozolomide|mesh-list
25652223|NCT01525082|Antibodies|antibodies|mesh-list
25652224|NCT01525082|Immunoglobulins|immunoglobulins|mesh-list
25652225|NCT01525082|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25652226|NCT01525082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652227|NCT01525082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25652228|NCT01525082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25652229|NCT01525082|Growth Substances|growth substances|mesh-ancestor
25652230|NCT01525082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652231|NCT01525082|Growth Inhibitors|growth inhibitors|mesh-ancestor
25652232|NCT01525082|Immunologic Factors|immunologic factors|mesh-ancestor
25696833|NCT02066792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25652233|NCT01525082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25652234|NCT01525082|Antimetabolites|antimetabolites|mesh-ancestor
25652235|NCT01525082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652236|NCT01525082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25652237|NCT01525082|Alkylating Agents|alkylating agents|mesh-ancestor
25652238|NCT01525173|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25652239|NCT01525173|Bimatoprost|bimatoprost|mesh-list
25652240|NCT01525173|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25652241|NCT01525173|Latanoprost|latanoprost|mesh-list
25652242|NCT01525173|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25652243|NCT01525173|Lubricant Eye Drops|lubricant eye drops|mesh-list
25652244|NCT01525173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25652245|NCT01525173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25652246|NCT01525173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25463366|NCT04078737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463367|NCT04078737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25463368|NCT04078737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25463370|NCT04078737|Antipyretics|antipyretics|mesh-ancestor
25463371|NCT04078737|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25463372|NCT04078737|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24937878|NCT04024813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25463373|NCT04078737|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25463374|NCT04078737|Purinergic Agents|purinergic agents|mesh-ancestor
25463375|NCT04078737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25463376|NCT04058197|Deferoxamine|deferoxamine|mesh-list
25463377|NCT04058197|Siderophores|siderophores|mesh-ancestor
25463378|NCT04058197|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25463379|NCT04058197|Chelating Agents|chelating agents|mesh-ancestor
25463380|NCT04058197|Sequestering Agents|sequestering agents|mesh-ancestor
25463381|NCT04058197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323328|NCT04898101|Acalabrutinib|acalabrutinib|mesh-list
25323329|NCT04898101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323330|NCT04898556|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25323331|NCT04898556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25323332|NCT04898556|Immunologic Factors|immunologic factors|mesh-ancestor
25323333|NCT04898556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323334|NCT04898023|Ascorbic Acid|ascorbic acid|mesh-list
25323335|NCT04898023|Antioxidants|antioxidants|mesh-ancestor
25323339|NCT04898023|Vitamins|vitamins|mesh-ancestor
24979397|NCT04523129|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24979398|NCT04499131|Progesterone|progesterone|mesh-list
24427919|NCT00239278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946225|NCT03942029|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25822721|NCT00004585|Dideoxynucleosides|dideoxynucleosides|mesh-list
24427947|NCT00239369|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24427948|NCT00239369|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24427949|NCT00239369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427950|NCT00239369|Diuretics|diuretics|mesh-ancestor
24427951|NCT00239369|Natriuretic Agents|natriuretic agents|mesh-ancestor
24427952|NCT00239369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427953|NCT00239369|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24427954|NCT00239369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24428009|NCT00239421|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24428010|NCT00239421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24979415|NCT04454424|Midazolam|midazolam|mesh-list
24979416|NCT04454424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24979417|NCT04454424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24979418|NCT04454424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24428044|NCT00239447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123177|NCT03087669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24428046|NCT00239460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24783847|NCT01904487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24783848|NCT01904487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25568510|NCT00761631|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25568511|NCT00761631|Immunologic Factors|immunologic factors|mesh-ancestor
25568512|NCT00761631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568513|NCT00761735|Ribavirin|ribavirin|mesh-list
24404202|NCT00162734|Ribavirin|ribavirin|mesh-list
25568514|NCT00761735|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25568515|NCT00761735|Antimetabolites|antimetabolites|mesh-ancestor
24451119|NCT00322075|Insulin Glargine|insulin glargine|mesh-list
25568516|NCT00761735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568517|NCT00761735|Antiviral Agents|antiviral agents|mesh-ancestor
25568518|NCT00761735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25568519|NCT00761774|Brivaracetam|brivaracetam|mesh-list
25568520|NCT00761774|Anticonvulsants|anticonvulsants|mesh-ancestor
25568521|NCT00761891|Aspirin|aspirin|mesh-list
25568522|NCT00761891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25568523|NCT00761891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25568524|NCT00761891|Analgesics|analgesics|mesh-ancestor
25568525|NCT00761891|Sensory System Agents|sensory system agents|mesh-ancestor
25568526|NCT00761891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25568527|NCT00761891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568528|NCT00761891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25568529|NCT00761891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25568530|NCT00761891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25568531|NCT00761891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25568532|NCT00761891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652247|NCT01525173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25568533|NCT00761891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25568534|NCT00761891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25568535|NCT00761891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568536|NCT00761891|Antipyretics|antipyretics|mesh-ancestor
25568537|NCT00761930|Listerine|listerine|mesh-list
25568538|NCT00761930|Triclosan|triclosan|mesh-list
25568539|NCT00761930|Fluorides|fluorides|mesh-list
25568540|NCT00761930|Sodium Fluoride|sodium fluoride|mesh-list
25568541|NCT00761930|Cariostatic Agents|cariostatic agents|mesh-ancestor
24946448|NCT03940001|Paclitaxel|paclitaxel|mesh-list
25568542|NCT00761930|Protective Agents|protective agents|mesh-ancestor
25568543|NCT00761930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568544|NCT00761930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25568545|NCT00761930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25568546|NCT00761930|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25568547|NCT00761930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25568548|NCT00761930|Antimetabolites|antimetabolites|mesh-ancestor
25568549|NCT00761930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568550|NCT00761930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25568551|NCT00762034|Paclitaxel|paclitaxel|mesh-list
25568552|NCT00762034|Bevacizumab|bevacizumab|mesh-list
25568553|NCT00762034|Carboplatin|carboplatin|mesh-list
25568554|NCT00762034|Pemetrexed|pemetrexed|mesh-list
25568555|NCT00762034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24938209|NCT04021017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25568556|NCT00762034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25568557|NCT00762034|Tubulin Modulators|tubulin modulators|mesh-ancestor
25568558|NCT00762034|Antimitotic Agents|antimitotic agents|mesh-ancestor
25568559|NCT00762034|Mitosis Modulators|mitosis modulators|mesh-ancestor
25568560|NCT00762034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568561|NCT00762034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25568562|NCT00762034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25568563|NCT00762034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25568564|NCT00762034|Growth Substances|growth substances|mesh-ancestor
24411372|NCT00188864|Glucocorticoids|glucocorticoids|mesh-ancestor
25568565|NCT00762034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568566|NCT00762034|Growth Inhibitors|growth inhibitors|mesh-ancestor
25568567|NCT00762034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568568|NCT00762034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25568569|NCT00762034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25568570|NCT00762073|Budesonide|budesonide|mesh-list
25568571|NCT00762073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25568572|NCT00762073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25568573|NCT00762073|Autonomic Agents|autonomic agents|mesh-ancestor
25568574|NCT00762073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25568575|NCT00762073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568576|NCT00762073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25568577|NCT00762073|Respiratory System Agents|respiratory system agents|mesh-ancestor
25568578|NCT00762073|Glucocorticoids|glucocorticoids|mesh-ancestor
25568579|NCT00762073|Hormones|hormones|mesh-ancestor
25568580|NCT00762073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24946672|NCT03936140|Iloprost|iloprost|mesh-list
25568581|NCT00762164|Simvastatin|simvastatin|mesh-list
25568582|NCT00762164|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
25568583|NCT00762164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25568584|NCT00762164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25568585|NCT00762164|Antimetabolites|antimetabolites|mesh-ancestor
25568586|NCT00762164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568587|NCT00762164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25568588|NCT00762164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25568589|NCT00762164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568590|NCT00762177|Triclosan|triclosan|mesh-list
25568591|NCT00762177|Fluorides|fluorides|mesh-list
25568592|NCT00762177|Tin Fluorides|tin fluorides|mesh-list
25568593|NCT00762177|Cariostatic Agents|cariostatic agents|mesh-ancestor
25568594|NCT00762177|Protective Agents|protective agents|mesh-ancestor
25568595|NCT00762177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568596|NCT00762177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25568597|NCT00762177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25568598|NCT00762177|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25568599|NCT00762177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25568600|NCT00762177|Antimetabolites|antimetabolites|mesh-ancestor
25568601|NCT00762177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568602|NCT00762177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24459958|NCT00346957|Anecortave|anecortave|mesh-list
25568603|NCT00762229|Ezetimibe|ezetimibe|mesh-list
25568604|NCT00762229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25568605|NCT00762229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25568606|NCT00762229|Antimetabolites|antimetabolites|mesh-ancestor
25568607|NCT00762229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652248|NCT01525173|Adrenergic Agents|adrenergic agents|mesh-ancestor
25568608|NCT00762229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25568609|NCT00762320|Ritonavir|ritonavir|mesh-list
25568610|NCT00762320|Lopinavir|lopinavir|mesh-list
25568611|NCT00762320|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25568612|NCT00762320|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25568613|NCT00762320|Protease Inhibitors|protease inhibitors|mesh-ancestor
25568614|NCT00762320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568615|NCT00762320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568616|NCT00762320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25568617|NCT00762320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25568618|NCT00762320|Antiviral Agents|antiviral agents|mesh-ancestor
25568619|NCT00762320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25568620|NCT00762320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25568621|NCT00762320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25568622|NCT00762359|Lansoprazole|lansoprazole|mesh-list
25568623|NCT00762359|Dexlansoprazole|dexlansoprazole|mesh-list
25568624|NCT00762359|Gefarnate|gefarnate|mesh-list
25568625|NCT00762359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25051462|NCT00402428|Antiviral Agents|antiviral agents|mesh-ancestor
24413118|NCT00193141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25568626|NCT00762359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25568627|NCT00762359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25568628|NCT00762359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568629|NCT00762359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568630|NCT00762372|Nitrous Oxide|nitrous oxide|mesh-list
25568631|NCT00762372|Sevoflurane|sevoflurane|mesh-list
25568632|NCT00762372|Desflurane|desflurane|mesh-list
25568633|NCT00762372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25568634|NCT00762372|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24413468|NCT00193973|Idarubicin|idarubicin|mesh-list
25568635|NCT00762372|Anesthetics, General|anesthetics, general|mesh-ancestor
25568636|NCT00762372|Anesthetics|anesthetics|mesh-ancestor
25568637|NCT00762372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25568638|NCT00762372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414520|NCT00197886|Sympathomimetics|sympathomimetics|mesh-ancestor
25568639|NCT00762372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25568640|NCT00762372|Analgesics|analgesics|mesh-ancestor
25568641|NCT00762372|Sensory System Agents|sensory system agents|mesh-ancestor
25568642|NCT00762372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25568643|NCT00762450|Triclosan|triclosan|mesh-list
25568644|NCT00762450|Fluorides|fluorides|mesh-list
25568645|NCT00762450|Cariostatic Agents|cariostatic agents|mesh-ancestor
25568646|NCT00762450|Protective Agents|protective agents|mesh-ancestor
25568647|NCT00762450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568648|NCT00762450|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24946905|NCT03933865|Narcotics|narcotics|mesh-ancestor
25568649|NCT00762450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25568650|NCT00762450|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25568651|NCT00762450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25568652|NCT00762450|Antimetabolites|antimetabolites|mesh-ancestor
24418993|NCT00210769|Serotonin Agents|serotonin agents|mesh-ancestor
25568653|NCT00762450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568654|NCT00762450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25568655|NCT00762463|Celecoxib|celecoxib|mesh-list
25568656|NCT00762463|Diclofenac|diclofenac|mesh-list
25696932|NCT02069041|Fluorouracil|fluorouracil|mesh-list
25568657|NCT00762463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25568658|NCT00762463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25568659|NCT00762463|Analgesics|analgesics|mesh-ancestor
25568660|NCT00762463|Sensory System Agents|sensory system agents|mesh-ancestor
25568661|NCT00762463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25568662|NCT00762463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568663|NCT00762463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25568664|NCT00762463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25568665|NCT00762463|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25568666|NCT00762463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25568667|NCT00762463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568668|NCT00762463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568669|NCT00762515|Triclosan|triclosan|mesh-list
25568670|NCT00762515|Fluorides|fluorides|mesh-list
25568671|NCT00762515|Cariostatic Agents|cariostatic agents|mesh-ancestor
25568672|NCT00762515|Protective Agents|protective agents|mesh-ancestor
25568673|NCT00762515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568674|NCT00762515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25568675|NCT00762515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25568676|NCT00762515|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25568677|NCT00762515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25568678|NCT00762515|Antimetabolites|antimetabolites|mesh-ancestor
25568679|NCT00762515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463458|NCT03471624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568680|NCT00762515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25568681|NCT00762528|Triclosan|triclosan|mesh-list
25568682|NCT00762528|Fluorides|fluorides|mesh-list
25568683|NCT00762528|Fluorophosphate|fluorophosphate|mesh-list
25568685|NCT00762528|Protective Agents|protective agents|mesh-ancestor
24536310|NCT00650637|Antacids|antacids|mesh-ancestor
24424437|NCT00229424|Famotidine|famotidine|mesh-list
25568686|NCT00762528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460143|NCT00347503|Ketorolac|ketorolac|mesh-list
25568687|NCT00762528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25568688|NCT00762528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25568689|NCT00762528|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25568690|NCT00762528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25568691|NCT00762528|Antimetabolites|antimetabolites|mesh-ancestor
25568692|NCT00762528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568693|NCT00762528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25568694|NCT00762619|Triclosan|triclosan|mesh-list
25568695|NCT00762619|Fluorides|fluorides|mesh-list
25568696|NCT00762619|Cariostatic Agents|cariostatic agents|mesh-ancestor
25568697|NCT00762619|Protective Agents|protective agents|mesh-ancestor
25568698|NCT00762619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568699|NCT00762619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25568700|NCT00762619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25568701|NCT00762619|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25568702|NCT00762619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25568703|NCT00762619|Antimetabolites|antimetabolites|mesh-ancestor
24425797|NCT00234390|Glucocorticoids|glucocorticoids|mesh-ancestor
25568704|NCT00762619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568705|NCT00762619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25568706|NCT00762645|Travoprost|travoprost|mesh-list
25568707|NCT00762645|Pilocarpine|pilocarpine|mesh-list
25568708|NCT00762645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25568709|NCT00762645|Miotics|miotics|mesh-ancestor
25568710|NCT00762645|Autonomic Agents|autonomic agents|mesh-ancestor
25568711|NCT00762645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25568712|NCT00762645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568713|NCT00762645|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25568714|NCT00762645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24426134|NCT00235105|Adalimumab|adalimumab|mesh-list
25568715|NCT00762645|Cholinergic Agents|cholinergic agents|mesh-ancestor
25568716|NCT00762645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24426970|NCT00236964|Epoetin Alfa|epoetin alfa|mesh-list
25568717|NCT00762645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568718|NCT00762710|Prazosin|prazosin|mesh-list
25568719|NCT00762710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25568720|NCT00762710|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25568721|NCT00762710|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25696965|NCT02069093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568722|NCT00762710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25568723|NCT00762710|Adrenergic Agents|adrenergic agents|mesh-ancestor
25568724|NCT00762710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25568725|NCT00762710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568726|NCT00762710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568727|NCT00762762|Triclosan|triclosan|mesh-list
24430814|NCT00249366|Anticonvulsants|anticonvulsants|mesh-ancestor
25568728|NCT00762762|Fluorides|fluorides|mesh-list
25568729|NCT00762762|Cariostatic Agents|cariostatic agents|mesh-ancestor
25568730|NCT00762762|Protective Agents|protective agents|mesh-ancestor
25568731|NCT00762762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568732|NCT00762762|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24938955|NCT04014244|Glucocorticoids|glucocorticoids|mesh-ancestor
25568733|NCT00762762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24432470|NCT00254865|Estradiol|estradiol|mesh-list
25568734|NCT00762762|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24460287|NCT00348023|Timolol|timolol|mesh-list
25568735|NCT00762762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24433896|NCT00260390|Hormones|hormones|mesh-ancestor
25568736|NCT00762762|Antimetabolites|antimetabolites|mesh-ancestor
25568737|NCT00762762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568738|NCT00762762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25568739|NCT00762853|Triclosan|triclosan|mesh-list
25568740|NCT00762853|Fluorides|fluorides|mesh-list
25568741|NCT00762853|Cariostatic Agents|cariostatic agents|mesh-ancestor
25568742|NCT00762853|Protective Agents|protective agents|mesh-ancestor
25568743|NCT00762853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568744|NCT00762853|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25568745|NCT00762853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25050469|NCT00495131|Interferons|interferons|mesh-list
25568746|NCT00762853|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25568747|NCT00762853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25568748|NCT00762853|Antimetabolites|antimetabolites|mesh-ancestor
25568749|NCT00762853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568750|NCT00762853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25568751|NCT00762892|Tenofovir|tenofovir|mesh-list
25568752|NCT00762892|Emtricitabine|emtricitabine|mesh-list
25568753|NCT00762892|Raltegravir Potassium|raltegravir potassium|mesh-list
25568754|NCT00762892|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25568755|NCT00762892|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25568756|NCT00762892|Antiviral Agents|antiviral agents|mesh-ancestor
25568757|NCT00762892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25568758|NCT00762892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25568759|NCT00762892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25568760|NCT00762892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568761|NCT00762892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568762|NCT00762892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25568763|NCT00762892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25568764|NCT00762892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25568765|NCT00762892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25568766|NCT00762892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25568767|NCT00762892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25568768|NCT00762892|Protease Inhibitors|protease inhibitors|mesh-ancestor
25568769|NCT00763035|Dobutamine|dobutamine|mesh-list
25568770|NCT00763035|Regadenoson|regadenoson|mesh-list
25568771|NCT00763035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25568772|NCT00763035|Sympathomimetics|sympathomimetics|mesh-ancestor
25568773|NCT00763035|Autonomic Agents|autonomic agents|mesh-ancestor
25568774|NCT00763035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25568775|NCT00763035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568776|NCT00763035|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25568777|NCT00763035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25568778|NCT00763035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25568779|NCT00763035|Adrenergic Agents|adrenergic agents|mesh-ancestor
25568780|NCT00763035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25568781|NCT00763035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568782|NCT00763035|Protective Agents|protective agents|mesh-ancestor
25568783|NCT00763035|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25568784|NCT00763035|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25568785|NCT00763035|Purinergic Agonists|purinergic agonists|mesh-ancestor
25568786|NCT00763035|Purinergic Agents|purinergic agents|mesh-ancestor
25568787|NCT00763048|Triclosan|triclosan|mesh-list
25568788|NCT00763048|Fluorides|fluorides|mesh-list
25568789|NCT00763048|Cariostatic Agents|cariostatic agents|mesh-ancestor
25568790|NCT00763048|Protective Agents|protective agents|mesh-ancestor
25568791|NCT00763048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568792|NCT00763048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25568793|NCT00763048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25568794|NCT00763048|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25568795|NCT00763048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25568796|NCT00763048|Antimetabolites|antimetabolites|mesh-ancestor
25568797|NCT00763048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568798|NCT00763048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25568799|NCT00763061|Timolol|timolol|mesh-list
25568800|NCT00763061|Travoprost|travoprost|mesh-list
25568801|NCT00763061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25568802|NCT00763061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25568803|NCT00763061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25568804|NCT00763061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25568805|NCT00763061|Adrenergic Agents|adrenergic agents|mesh-ancestor
25568806|NCT00763061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25568807|NCT00763061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568808|NCT00763061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568809|NCT00763061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25568810|NCT00763061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25568811|NCT00763139|Pioglitazone|pioglitazone|mesh-list
25568812|NCT00763139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25568813|NCT00763139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568814|NCT00763256|Triclosan|triclosan|mesh-list
25568815|NCT00763256|Fluorides|fluorides|mesh-list
25568816|NCT00763256|Cariostatic Agents|cariostatic agents|mesh-ancestor
25568817|NCT00763256|Protective Agents|protective agents|mesh-ancestor
25568818|NCT00763256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568819|NCT00763256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25568820|NCT00763256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25568821|NCT00763256|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25568822|NCT00763256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25568823|NCT00763256|Antimetabolites|antimetabolites|mesh-ancestor
25568824|NCT00763256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568825|NCT00763256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25568826|NCT00763269|Silicon|silicon|mesh-list
25568827|NCT00763269|Triclosan|triclosan|mesh-list
25568828|NCT00763269|Fluorides|fluorides|mesh-list
25568829|NCT00763269|Cariostatic Agents|cariostatic agents|mesh-ancestor
25568830|NCT00763269|Protective Agents|protective agents|mesh-ancestor
25568831|NCT00763269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568832|NCT00763269|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25568833|NCT00763269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25568834|NCT00763269|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25568835|NCT00763269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25568836|NCT00763269|Antimetabolites|antimetabolites|mesh-ancestor
25568837|NCT00763269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568838|NCT00763269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25568839|NCT00763269|Trace Elements|trace elements|mesh-ancestor
25568840|NCT00763269|Micronutrients|micronutrients|mesh-ancestor
25568841|NCT00763321|Acetaminophen|acetaminophen|mesh-list
25568842|NCT00763321|Hydrocodone|hydrocodone|mesh-list
25568843|NCT00763321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25568844|NCT00763321|Analgesics|analgesics|mesh-ancestor
25568845|NCT00763321|Sensory System Agents|sensory system agents|mesh-ancestor
25568846|NCT00763321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25568847|NCT00763321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568848|NCT00763321|Antipyretics|antipyretics|mesh-ancestor
25568849|NCT00763321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25568850|NCT00763321|Narcotics|narcotics|mesh-ancestor
25568851|NCT00763321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25568852|NCT00763321|Antitussive Agents|antitussive agents|mesh-ancestor
25568853|NCT00763321|Respiratory System Agents|respiratory system agents|mesh-ancestor
25568854|NCT00763360|Hyaluronic Acid|hyaluronic acid|mesh-list
25568855|NCT00763360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25568856|NCT00763360|Immunologic Factors|immunologic factors|mesh-ancestor
25568857|NCT00763360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568858|NCT00763360|Viscosupplements|viscosupplements|mesh-ancestor
25568859|NCT00763360|Protective Agents|protective agents|mesh-ancestor
25568860|NCT00763412|Repaglinide|repaglinide|mesh-list
25568861|NCT00763412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25568862|NCT00763412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568863|NCT00763451|Metformin|metformin|mesh-list
25568864|NCT00763451|Lixisenatide|lixisenatide|mesh-list
25568865|NCT00763451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24955337|NCT03865680|Fluorides|fluorides|mesh-list
24440166|NCT00281931|Fludarabine|fludarabine|mesh-list
24440167|NCT00281931|Fludarabine phosphate|fludarabine phosphate|mesh-list
24440168|NCT00281931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24440169|NCT00281931|Immunologic Factors|immunologic factors|mesh-ancestor
24440170|NCT00281931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440171|NCT00281931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24440172|NCT00281931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24440325|NCT00282386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450082|NCT00317785|Cyclosporine|cyclosporine|mesh-list
24440213|NCT00281983|Cyclosporins|cyclosporins|mesh-list
24440214|NCT00281983|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25568866|NCT00763451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568867|NCT00763490|Mycophenolic Acid|mycophenolic acid|mesh-list
25568868|NCT00763490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25568869|NCT00763490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25568870|NCT00763490|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25568871|NCT00763490|Antitubercular Agents|antitubercular agents|mesh-ancestor
25568872|NCT00763490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25568873|NCT00763490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25697049|NCT02070692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24593256|NCT00927615|Abciximab|abciximab|mesh-list
24440280|NCT00282139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25568874|NCT00763490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568875|NCT00763490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568876|NCT00763815|Metformin|metformin|mesh-list
25568877|NCT00763815|Pioglitazone|pioglitazone|mesh-list
25463653|NCT02427724|Prilocaine|prilocaine|mesh-list
25463654|NCT02427724|Anesthetics, Local|anesthetics, local|mesh-list
25463655|NCT02427724|Anesthetics|anesthetics|mesh-list
25463656|NCT02427724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25463657|NCT02427724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463658|NCT02427724|Sensory System Agents|sensory system agents|mesh-ancestor
25463659|NCT02427724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25463660|NCT02427724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24440879|NCT00285155|Dopamine Agents|dopamine agents|mesh-ancestor
25463661|NCT02427724|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25463662|NCT02427724|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25463663|NCT02427724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25463664|NCT02427724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463665|NCT02393794|Cisplatin|cisplatin|mesh-list
25463666|NCT02393794|Nivolumab|nivolumab|mesh-list
25463667|NCT02393794|Romidepsin|romidepsin|mesh-list
25463675|NCT02043847|Melphalan|melphalan|mesh-list
25568878|NCT00763815|Lixisenatide|lixisenatide|mesh-list
25568879|NCT00763815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25568880|NCT00763815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568881|NCT00763867|Sildenafil Citrate|sildenafil citrate|mesh-list
25568882|NCT00763867|Vasodilator Agents|vasodilator agents|mesh-ancestor
25568883|NCT00763867|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25568884|NCT00763867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25568885|NCT00763867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568886|NCT00763867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506030|NCT00543829|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24442384|NCT00290836|Aprotinin|aprotinin|mesh-list
25568887|NCT00763867|Urological Agents|urological agents|mesh-ancestor
25568888|NCT00763958|Buprenorphine|buprenorphine|mesh-list
25568889|NCT00763958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25568890|NCT00763958|Narcotics|narcotics|mesh-ancestor
25568891|NCT00763958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25568892|NCT00763958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568893|NCT00763958|Analgesics|analgesics|mesh-ancestor
25568894|NCT00763958|Sensory System Agents|sensory system agents|mesh-ancestor
25568895|NCT00763958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25568896|NCT00763958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25568897|NCT00763971|Methylphenidate|methylphenidate|mesh-list
25568898|NCT00763971|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25568899|NCT00763971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25568900|NCT00763971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568901|NCT00763971|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25568902|NCT00763971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25568903|NCT00763971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25568904|NCT00763971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568905|NCT00763971|Dopamine Agents|dopamine agents|mesh-ancestor
25568906|NCT00763971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25568907|NCT00764309|Dasatinib|dasatinib|mesh-list
25568908|NCT00764309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25568909|NCT00764309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25568910|NCT00764309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568911|NCT00764309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568912|NCT00764322|Tamoxifen|tamoxifen|mesh-list
25568913|NCT00764322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25568914|NCT00764322|Hormone Antagonists|hormone antagonists|mesh-ancestor
25568915|NCT00764322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25568916|NCT00764322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568917|NCT00764322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25568918|NCT00764322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25568919|NCT00764322|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25568920|NCT00764322|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25568921|NCT00764322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25568922|NCT00764361|Doxycycline|doxycycline|mesh-list
25568923|NCT00764361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25568924|NCT00764361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25568925|NCT00764361|Antimalarials|antimalarials|mesh-ancestor
25568926|NCT00764361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25568927|NCT00764361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25568928|NCT00764465|Ritonavir|ritonavir|mesh-list
25568929|NCT00764465|Fosamprenavir|fosamprenavir|mesh-list
25568930|NCT00764465|Maraviroc|maraviroc|mesh-list
25568931|NCT00764465|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25568932|NCT00764465|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25568933|NCT00764465|Protease Inhibitors|protease inhibitors|mesh-ancestor
25568934|NCT00764465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568935|NCT00764465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568936|NCT00764465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25568937|NCT00764465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25568938|NCT00764465|Antiviral Agents|antiviral agents|mesh-ancestor
25568939|NCT00764465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25568940|NCT00764465|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25568941|NCT00764465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25568942|NCT00764465|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25568943|NCT00764465|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25568944|NCT00764465|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25568945|NCT00764517|Rituximab|rituximab|mesh-list
25568946|NCT00764517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25568947|NCT00764517|Vorinostat|vorinostat|mesh-list
25568948|NCT00764517|Cladribine|cladribine|mesh-list
25568949|NCT00764517|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
25568950|NCT00764517|Antibodies|antibodies|mesh-list
25568951|NCT00764517|Immunoglobulins|immunoglobulins|mesh-list
25568952|NCT00764517|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25568953|NCT00764517|Immunologic Factors|immunologic factors|mesh-ancestor
25568954|NCT00764517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568955|NCT00764517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25568956|NCT00764517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25568957|NCT00764517|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25568958|NCT00764517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25568959|NCT00764517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568960|NCT00764517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25568961|NCT00764517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25568962|NCT00764517|Antimetabolites|antimetabolites|mesh-ancestor
25568963|NCT00764738|Ranibizumab|ranibizumab|mesh-list
25568964|NCT00764738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25568965|NCT00764738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25568966|NCT00764738|Growth Substances|growth substances|mesh-ancestor
25568967|NCT00764738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568968|NCT00764738|Growth Inhibitors|growth inhibitors|mesh-ancestor
25568969|NCT00764738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25568970|NCT00764751|Calcipotriene|calcipotriene|mesh-list
25568971|NCT00764751|Dermatologic Agents|dermatologic agents|mesh-ancestor
25568972|NCT00764868|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25568973|NCT00764868|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25568974|NCT00764868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568975|NCT00764868|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25568976|NCT00764868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25568977|NCT00764868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25568978|NCT00764868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25568979|NCT00764868|Dopamine Agents|dopamine agents|mesh-ancestor
25568980|NCT00764868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25568981|NCT00764881|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25568982|NCT00764881|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
25568983|NCT00764881|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25568984|NCT00764881|Contraceptive Agents|contraceptive agents|mesh-ancestor
25568985|NCT00764881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25568986|NCT00764881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25568987|NCT00764881|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25568988|NCT00764881|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25568989|NCT00764881|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25568990|NCT00764881|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25568991|NCT00764881|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25568992|NCT00764881|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
25568993|NCT00764881|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25568994|NCT00764881|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25568995|NCT00764946|Raltegravir Potassium|raltegravir potassium|mesh-list
25568996|NCT00764946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25568997|NCT00764946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25568998|NCT00764946|Antiviral Agents|antiviral agents|mesh-ancestor
24947588|NCT03927118|BB 1101|bb 1101|mesh-list
25568999|NCT00764946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25569000|NCT00764946|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25569001|NCT00764946|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25569002|NCT00764946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569003|NCT00764946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569004|NCT00765063|Dalteparin|dalteparin|mesh-list
25569005|NCT00765063|Anticoagulants|anticoagulants|mesh-ancestor
25569006|NCT00765063|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25569007|NCT00765063|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25569008|NCT00765063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569009|NCT00765102|Bortezomib|bortezomib|mesh-list
25569010|NCT00765102|Romidepsin|romidepsin|mesh-list
25569011|NCT00765102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25569012|NCT00765102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25569013|NCT00765128|Ketorolac|ketorolac|mesh-list
25569014|NCT00765128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25569015|NCT00765128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25569016|NCT00765128|Analgesics|analgesics|mesh-ancestor
25569017|NCT00765128|Sensory System Agents|sensory system agents|mesh-ancestor
25569018|NCT00765128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25569019|NCT00765128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569020|NCT00765128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25569021|NCT00765128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25569022|NCT00765128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25569023|NCT00765128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569024|NCT00765128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569025|NCT00765206|Omeprazole|omeprazole|mesh-list
25569026|NCT00765206|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
25569027|NCT00765206|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25569028|NCT00765206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25569029|NCT00765206|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25569030|NCT00765206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569031|NCT00765206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569032|NCT00765232|Ketorolac|ketorolac|mesh-list
25569033|NCT00765232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25569034|NCT00765232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25569035|NCT00765232|Analgesics|analgesics|mesh-ancestor
25569036|NCT00765232|Sensory System Agents|sensory system agents|mesh-ancestor
25569037|NCT00765232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25569038|NCT00765232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569039|NCT00765232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25569040|NCT00765232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25569041|NCT00765232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25569042|NCT00765232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569043|NCT00765232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569044|NCT00765245|Rituximab|rituximab|mesh-list
25569045|NCT00765245|Lenalidomide|lenalidomide|mesh-list
25569046|NCT00765245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25569047|NCT00765245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25569048|NCT00765245|Immunologic Factors|immunologic factors|mesh-ancestor
25569049|NCT00765245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569050|NCT00765245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25569051|NCT00765245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25569052|NCT00765245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25569053|NCT00765245|Growth Substances|growth substances|mesh-ancestor
25569054|NCT00765245|Growth Inhibitors|growth inhibitors|mesh-ancestor
25569055|NCT00765336|Minocycline|minocycline|mesh-list
25569056|NCT00765336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25569057|NCT00765336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25569058|NCT00765375|Botulinum Toxins|botulinum toxins|mesh-list
25569059|NCT00765375|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25569060|NCT00765375|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25569061|NCT00765375|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25569062|NCT00765375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25569063|NCT00765375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569064|NCT00765375|Cholinergic Agents|cholinergic agents|mesh-ancestor
25569065|NCT00765375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25569066|NCT00765375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569067|NCT00765375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25569068|NCT00765375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25569069|NCT00765648|Labetalol|labetalol|mesh-list
25569070|NCT00765648|Nicardipine|nicardipine|mesh-list
25569071|NCT00765648|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25569072|NCT00765648|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25569073|NCT00765648|Adrenergic Agents|adrenergic agents|mesh-ancestor
25569074|NCT00765648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25569075|NCT00765648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569076|NCT00765648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569077|NCT00765648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25569078|NCT00765648|Sympathomimetics|sympathomimetics|mesh-ancestor
25569079|NCT00765648|Autonomic Agents|autonomic agents|mesh-ancestor
25569080|NCT00765648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25569081|NCT00765648|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25569082|NCT00765648|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25569083|NCT00765648|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25569084|NCT00765648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25569085|NCT00765648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25569086|NCT00765648|Vasodilator Agents|vasodilator agents|mesh-ancestor
25569087|NCT00765661|Tacrolimus|tacrolimus|mesh-list
24559518|NCT04741438|Nivolumab|nivolumab|mesh-list
25569088|NCT00765661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25569089|NCT00765661|Immunologic Factors|immunologic factors|mesh-ancestor
25569090|NCT00765661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569091|NCT00765661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25569092|NCT00765661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569093|NCT00765661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569094|NCT00765674|Amlodipine|amlodipine|mesh-list
25569095|NCT00765674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25569096|NCT00765674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25569097|NCT00765674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25569098|NCT00765674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25569099|NCT00765674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569100|NCT00765674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25569101|NCT00765674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569102|NCT00765674|Vasodilator Agents|vasodilator agents|mesh-ancestor
25569103|NCT00765674|Diuretics|diuretics|mesh-ancestor
25569104|NCT00765674|Natriuretic Agents|natriuretic agents|mesh-ancestor
25569105|NCT00765674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25569106|NCT00765726|Factor VIII|factor viii|mesh-list
25569107|NCT00765726|Coagulants|coagulants|mesh-ancestor
25569108|NCT00765817|Exenatide|exenatide|mesh-list
25569109|NCT00765817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25569110|NCT00765817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569111|NCT00765817|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25569112|NCT00765817|Incretins|incretins|mesh-ancestor
25569113|NCT00765817|Hormones|hormones|mesh-ancestor
25569114|NCT00765817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25569115|NCT00765856|Oxymorphone|oxymorphone|mesh-list
25569116|NCT00765856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25569117|NCT00765856|Narcotics|narcotics|mesh-ancestor
25569118|NCT00765856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25569119|NCT00765856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569120|NCT00765856|Analgesics|analgesics|mesh-ancestor
25569121|NCT00765856|Sensory System Agents|sensory system agents|mesh-ancestor
25569122|NCT00765856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25569123|NCT00765856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25569124|NCT00765882|Linaclotide|linaclotide|mesh-list
25569125|NCT00765882|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25569126|NCT00765882|Enzyme Activators|enzyme activators|mesh-ancestor
25569127|NCT00765882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569128|NCT00765882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25569129|NCT00765895|Nortriptyline|nortriptyline|mesh-list
25569130|NCT00765895|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25569131|NCT00765895|Antidepressive Agents|antidepressive agents|mesh-ancestor
25569132|NCT00765895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24437817|NCT00274534|Parasympatholytics|parasympatholytics|mesh-ancestor
25569133|NCT00765895|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25569134|NCT00765895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25569135|NCT00765895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25569136|NCT00765895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569137|NCT00765895|Adrenergic Agents|adrenergic agents|mesh-ancestor
25569138|NCT00765895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25569139|NCT00765895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569140|NCT00765947|Amlodipine|amlodipine|mesh-list
25569141|NCT00765947|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25569142|NCT00765947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25569143|NCT00765947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25569144|NCT00765947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25569145|NCT00765947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569146|NCT00765947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25569147|NCT00765947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569148|NCT00765947|Vasodilator Agents|vasodilator agents|mesh-ancestor
25569149|NCT00765947|Diuretics|diuretics|mesh-ancestor
25569150|NCT00765947|Natriuretic Agents|natriuretic agents|mesh-ancestor
25569151|NCT00765947|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25569152|NCT00765999|Linaclotide|linaclotide|mesh-list
25569153|NCT00765999|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25569154|NCT00765999|Enzyme Activators|enzyme activators|mesh-ancestor
25569155|NCT00765999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569156|NCT00765999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25569157|NCT00766038|Hormones|hormones|mesh-list
25569158|NCT00766038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25569159|NCT00766038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569160|NCT00766116|Azacitidine|azacitidine|mesh-list
25569161|NCT00766116|Gemtuzumab|gemtuzumab|mesh-list
25569162|NCT00766116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25569163|NCT00766116|Antimetabolites|antimetabolites|mesh-ancestor
25569164|NCT00766116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569165|NCT00766116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25569166|NCT00766116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569167|NCT00766116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25569168|NCT00766142|Leucovorin|leucovorin|mesh-list
25569169|NCT00766142|Fluorouracil|fluorouracil|mesh-list
25569170|NCT00766142|Oxaliplatin|oxaliplatin|mesh-list
25569171|NCT00766142|Cetuximab|cetuximab|mesh-list
25569172|NCT00766142|Calcium|calcium|mesh-list
25569173|NCT00766142|Levoleucovorin|levoleucovorin|mesh-list
25569174|NCT00766142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25569175|NCT00766142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569176|NCT00766142|Antimetabolites|antimetabolites|mesh-ancestor
25569177|NCT00766142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569178|NCT00766142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25569179|NCT00766142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25569180|NCT00766142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25569181|NCT00766142|Immunologic Factors|immunologic factors|mesh-ancestor
25569182|NCT00766142|Antidotes|antidotes|mesh-ancestor
25569183|NCT00766142|Protective Agents|protective agents|mesh-ancestor
25569184|NCT00766142|Vitamin B Complex|vitamin b complex|mesh-ancestor
25569185|NCT00766142|Vitamins|vitamins|mesh-ancestor
25569186|NCT00766142|Micronutrients|micronutrients|mesh-ancestor
25569187|NCT00766142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25569188|NCT00766363|Rivastigmine|rivastigmine|mesh-list
25569190|NCT00766363|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25569191|NCT00766363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569192|NCT00766363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569193|NCT00766363|Cholinergic Agents|cholinergic agents|mesh-ancestor
25569194|NCT00766363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25569195|NCT00766363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569196|NCT00766363|Nootropic Agents|nootropic agents|mesh-ancestor
25569197|NCT00766363|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25569198|NCT00766363|Protective Agents|protective agents|mesh-ancestor
25569199|NCT00766467|Modafinil|modafinil|mesh-list
25569200|NCT00766467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25569201|NCT00766467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569202|NCT00766467|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25569203|NCT00766467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25569204|NCT00766467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25569205|NCT00766467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569206|NCT00766506|Fentanyl|fentanyl|mesh-list
25569207|NCT00766506|Morphine|morphine|mesh-list
25569208|NCT00766506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25569209|NCT00766506|Narcotics|narcotics|mesh-ancestor
25569210|NCT00766506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25569211|NCT00766506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569212|NCT00766506|Analgesics|analgesics|mesh-ancestor
25569213|NCT00766506|Sensory System Agents|sensory system agents|mesh-ancestor
25569214|NCT00766506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25569215|NCT00766506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25569216|NCT00766506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25569217|NCT00766506|Anesthetics, General|anesthetics, general|mesh-ancestor
25569218|NCT00766506|Anesthetics|anesthetics|mesh-ancestor
25569219|NCT00766532|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25569220|NCT00766532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25569221|NCT00766532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569222|NCT00766532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569223|NCT00766532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25569224|NCT00766532|Hormone Antagonists|hormone antagonists|mesh-ancestor
25569225|NCT00766532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25569226|NCT00766532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569227|NCT00766649|Sirolimus|sirolimus|mesh-list
25569228|NCT00766649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25569229|NCT00766649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25569230|NCT00766649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25569231|NCT00766649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25569232|NCT00766649|Antifungal Agents|antifungal agents|mesh-ancestor
25569233|NCT00766649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25569234|NCT00766649|Immunologic Factors|immunologic factors|mesh-ancestor
25569235|NCT00766649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569236|NCT00766675|Acetaminophen|acetaminophen|mesh-list
25569237|NCT00766675|Tramadol|tramadol|mesh-list
25569238|NCT00766675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25569239|NCT00766675|Analgesics|analgesics|mesh-ancestor
25569240|NCT00766675|Sensory System Agents|sensory system agents|mesh-ancestor
25569241|NCT00766675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25569242|NCT00766675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569243|NCT00766675|Antipyretics|antipyretics|mesh-ancestor
25569244|NCT00766675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25569245|NCT00766675|Narcotics|narcotics|mesh-ancestor
25569246|NCT00766675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25569247|NCT00766753|Vaccines|vaccines|mesh-list
25569248|NCT00766753|Immunologic Factors|immunologic factors|mesh-ancestor
25569249|NCT00766753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569250|NCT00766831|Hydromorphone|hydromorphone|mesh-list
25569251|NCT00766831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25569252|NCT00766831|Narcotics|narcotics|mesh-ancestor
25569253|NCT00766831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25569254|NCT00766831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569255|NCT00766831|Analgesics|analgesics|mesh-ancestor
25569256|NCT00766831|Sensory System Agents|sensory system agents|mesh-ancestor
25569257|NCT00766831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25569258|NCT00767000|Metformin|metformin|mesh-list
25569259|NCT00767000|Insulin Glargine|insulin glargine|mesh-list
25569260|NCT00767000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25569261|NCT00767000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569262|NCT00767039|Poractant alfa|poractant alfa|mesh-list
25569263|NCT00767039|Beractant|beractant|mesh-list
25569264|NCT00767039|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
25569265|NCT00767039|Respiratory System Agents|respiratory system agents|mesh-ancestor
25569266|NCT00767325|Methotrexate|methotrexate|mesh-list
25569267|NCT00767325|Abatacept|abatacept|mesh-list
25569268|NCT00767325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25569269|NCT00767325|Abortifacient Agents|abortifacient agents|mesh-ancestor
25569270|NCT00767325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25569271|NCT00767325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569272|NCT00767325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25569273|NCT00767325|Antimetabolites|antimetabolites|mesh-ancestor
25606128|NCT01064830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24443461|NCT00295035|Curcumin|curcumin|mesh-list
25569274|NCT00767325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569275|NCT00767325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25569276|NCT00767325|Dermatologic Agents|dermatologic agents|mesh-ancestor
25569277|NCT00767325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569278|NCT00767325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25569279|NCT00767325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25569280|NCT00767325|Immunologic Factors|immunologic factors|mesh-ancestor
25569281|NCT00767325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25569282|NCT00767325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25569283|NCT00767325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25569284|NCT00767364|Vaccines|vaccines|mesh-list
25569285|NCT00767364|Immunologic Factors|immunologic factors|mesh-ancestor
25569286|NCT00767364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569287|NCT00767507|Cangrelor|cangrelor|mesh-list
25569288|NCT00767507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25569289|NCT00767507|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25569290|NCT00767507|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25569291|NCT00767507|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25569292|NCT00767507|Purinergic Agents|purinergic agents|mesh-ancestor
25569293|NCT00767507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25569294|NCT00767507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569295|NCT00767507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569296|NCT00767520|Dasatinib|dasatinib|mesh-list
25569297|NCT00767520|Exemestane|exemestane|mesh-list
25569298|NCT00767520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25569299|NCT00767520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25569300|NCT00767520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569301|NCT00767520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569302|NCT00767520|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25569303|NCT00767520|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25569304|NCT00767520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25569305|NCT00767520|Hormone Antagonists|hormone antagonists|mesh-ancestor
25569306|NCT00767520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25569307|NCT00767520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569308|NCT00767572|Atorvastatin|atorvastatin|mesh-list
25569309|NCT00767572|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25569310|NCT00767572|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25569311|NCT00767572|Antimetabolites|antimetabolites|mesh-ancestor
25569312|NCT00767572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569313|NCT00767572|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25569314|NCT00767572|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25569315|NCT00767572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569316|NCT00767624|Antidepressive Agents|antidepressive agents|mesh-list
25569317|NCT00767624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25569318|NCT00767767|Thiopental|thiopental|mesh-list
25569319|NCT00767767|Propofol|propofol|mesh-list
25569320|NCT00767767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25569321|NCT00767767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25569322|NCT00767767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569323|NCT00767767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25569324|NCT00767767|Anesthetics, General|anesthetics, general|mesh-ancestor
25569325|NCT00767767|Anesthetics|anesthetics|mesh-ancestor
25569326|NCT00767767|Anticonvulsants|anticonvulsants|mesh-ancestor
25569327|NCT00767767|GABA Modulators|gaba modulators|mesh-ancestor
25569328|NCT00767767|GABA Agents|gaba agents|mesh-ancestor
25569329|NCT00767767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25569330|NCT00767767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569331|NCT00767806|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25569332|NCT00767806|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24801721|NCT01985373|Antibodies|antibodies|mesh-list
25569333|NCT00767806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25569334|NCT00767806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25569335|NCT00767806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569336|NCT00767806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25464069|NCT00001262|Trace Elements|trace elements|mesh-ancestor
25569337|NCT00767806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569338|NCT00767806|Analgesics|analgesics|mesh-ancestor
25569339|NCT00767806|Sensory System Agents|sensory system agents|mesh-ancestor
25569340|NCT00767806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25569341|NCT00767806|Antidepressive Agents|antidepressive agents|mesh-ancestor
25569342|NCT00767806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25569343|NCT00767806|Dopamine Agents|dopamine agents|mesh-ancestor
25569344|NCT00767819|Everolimus|everolimus|mesh-list
25569345|NCT00767819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25569346|NCT00767819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25569347|NCT00767819|Immunologic Factors|immunologic factors|mesh-ancestor
25569348|NCT00767819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569349|NCT00768053|Etanercept|etanercept|mesh-list
25569350|NCT00768053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25569351|NCT00768053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25569352|NCT00768053|Analgesics|analgesics|mesh-ancestor
25569353|NCT00768053|Sensory System Agents|sensory system agents|mesh-ancestor
25569354|NCT00768053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25569355|NCT00768053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569356|NCT00768053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25569357|NCT00768053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25569358|NCT00768053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25569359|NCT00768053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25569360|NCT00768053|Immunologic Factors|immunologic factors|mesh-ancestor
25569361|NCT00768079|Benralizumab|benralizumab|mesh-list
25569362|NCT00768079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25569363|NCT00768079|Respiratory System Agents|respiratory system agents|mesh-ancestor
25569364|NCT00768118|Curcumin|curcumin|mesh-list
25569365|NCT00768118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25569366|NCT00768118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25569367|NCT00768118|Analgesics|analgesics|mesh-ancestor
25569368|NCT00768118|Sensory System Agents|sensory system agents|mesh-ancestor
25569369|NCT00768118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25569370|NCT00768118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569371|NCT00768118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25569372|NCT00768118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25697128|NCT02072096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25697129|NCT02072096|Immunologic Factors|immunologic factors|mesh-ancestor
25569373|NCT00768118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25569374|NCT00768118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569375|NCT00768118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569376|NCT00768144|Sunitinib|sunitinib|mesh-list
25569377|NCT00768144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25569378|NCT00768144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25569379|NCT00768144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25569380|NCT00768144|Growth Substances|growth substances|mesh-ancestor
25569381|NCT00768144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569382|NCT00768144|Growth Inhibitors|growth inhibitors|mesh-ancestor
25569383|NCT00768144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25569384|NCT00768144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569385|NCT00768144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569386|NCT00768222|Triclosan|triclosan|mesh-list
25569387|NCT00768222|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25569388|NCT00768222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25569389|NCT00768222|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25569390|NCT00768222|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25569391|NCT00768222|Antimetabolites|antimetabolites|mesh-ancestor
25569392|NCT00768222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569393|NCT00768222|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25569394|NCT00768261|Memantine|memantine|mesh-list
25569395|NCT00768261|Donepezil|donepezil|mesh-list
25569396|NCT00768261|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25569397|NCT00768261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569398|NCT00768261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569399|NCT00768261|Cholinergic Agents|cholinergic agents|mesh-ancestor
25569400|NCT00768261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25569401|NCT00768261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569402|NCT00768261|Nootropic Agents|nootropic agents|mesh-ancestor
25569403|NCT00768261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25569404|NCT00768261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25569405|NCT00768261|Dopamine Agents|dopamine agents|mesh-ancestor
25569406|NCT00768261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25569407|NCT00768261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25569408|NCT00768300|Ambrisentan|ambrisentan|mesh-list
25569409|NCT00768300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25569410|NCT00768430|Midazolam|midazolam|mesh-list
25464154|NCT00001656|GABA Agents|gaba agents|mesh-ancestor
25569411|NCT00768430|Ketamine|ketamine|mesh-list
25569412|NCT00768430|Analgesics|analgesics|mesh-ancestor
25569413|NCT00768430|Sensory System Agents|sensory system agents|mesh-ancestor
25569414|NCT00768430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25569415|NCT00768430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569416|NCT00768430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25569417|NCT00768430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25569418|NCT00768430|Anesthetics, General|anesthetics, general|mesh-ancestor
25569419|NCT00768430|Anesthetics|anesthetics|mesh-ancestor
25569420|NCT00768430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25569421|NCT00768430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25569422|NCT00768430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25569423|NCT00768430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25569424|NCT00768430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569425|NCT00768430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25569426|NCT00768430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25569427|NCT00768430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25569428|NCT00768430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25569429|NCT00768430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25569430|NCT00768430|GABA Modulators|gaba modulators|mesh-ancestor
25569431|NCT00768430|GABA Agents|gaba agents|mesh-ancestor
25569432|NCT00768469|Paclitaxel|paclitaxel|mesh-list
25569433|NCT00768469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25569434|NCT00768469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25569435|NCT00768469|Tubulin Modulators|tubulin modulators|mesh-ancestor
25569436|NCT00768469|Antimitotic Agents|antimitotic agents|mesh-ancestor
25569437|NCT00768469|Mitosis Modulators|mitosis modulators|mesh-ancestor
25569438|NCT00768469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569439|NCT00768521|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25569440|NCT00768521|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25569441|NCT00768521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25569442|NCT00768521|Cholinergic Agents|cholinergic agents|mesh-ancestor
25569443|NCT00768521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25569444|NCT00768521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569445|NCT00768521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569446|NCT00768521|Urological Agents|urological agents|mesh-ancestor
25569447|NCT00768560|Nifedipine|nifedipine|mesh-list
25569448|NCT00768560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25569449|NCT00768560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25569450|NCT00768560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569451|NCT00768560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25569452|NCT00768560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569453|NCT00768560|Vasodilator Agents|vasodilator agents|mesh-ancestor
25569454|NCT00768560|Tocolytic Agents|tocolytic agents|mesh-ancestor
25569455|NCT00768560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25569456|NCT00768599|Econazole|econazole|mesh-list
25569457|NCT00768599|Antifungal Agents|antifungal agents|mesh-ancestor
25569458|NCT00768599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25569459|NCT00768599|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25569460|NCT00768599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25569461|NCT00768599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569462|NCT00768599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569463|NCT00768599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25569464|NCT00768599|Hormone Antagonists|hormone antagonists|mesh-ancestor
25569465|NCT00768599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25569466|NCT00768599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569467|NCT00768651|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25569468|NCT00768651|Pantoprazole|pantoprazole|mesh-list
25569469|NCT00768651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25569470|NCT00768651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569471|NCT00768651|Incretins|incretins|mesh-ancestor
25569472|NCT00768651|Hormones|hormones|mesh-ancestor
25569473|NCT00768651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25569474|NCT00768651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25569475|NCT00768651|Protease Inhibitors|protease inhibitors|mesh-ancestor
25569476|NCT00768651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569477|NCT00768651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569478|NCT00768651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25569479|NCT00768651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25569480|NCT00768651|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25569481|NCT00768716|Acetaminophen|acetaminophen|mesh-list
25569482|NCT00768716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25569483|NCT00768716|Analgesics|analgesics|mesh-ancestor
25569484|NCT00768716|Sensory System Agents|sensory system agents|mesh-ancestor
25569485|NCT00768716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25569486|NCT00768716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569487|NCT00768716|Antipyretics|antipyretics|mesh-ancestor
25569489|NCT00768755|Axitinib|axitinib|mesh-list
25569490|NCT00768755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25569491|NCT00768755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569492|NCT00768755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569493|NCT00768755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25569494|NCT00768755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25569495|NCT00768755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25569496|NCT00768989|Ritonavir|ritonavir|mesh-list
25569497|NCT00768989|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25569498|NCT00768989|Tenofovir|tenofovir|mesh-list
25569499|NCT00768989|Emtricitabine|emtricitabine|mesh-list
25569500|NCT00768989|Raltegravir Potassium|raltegravir potassium|mesh-list
25697155|NCT02072226|Antipyretics|antipyretics|mesh-ancestor
25569501|NCT00768989|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25569502|NCT00768989|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25569503|NCT00768989|Protease Inhibitors|protease inhibitors|mesh-ancestor
25569504|NCT00768989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569505|NCT00768989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569506|NCT00768989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25569507|NCT00768989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25569508|NCT00768989|Antiviral Agents|antiviral agents|mesh-ancestor
25569509|NCT00768989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25569510|NCT00768989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25569511|NCT00768989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25569512|NCT00768989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25569513|NCT00768989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25569514|NCT00768989|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25569515|NCT00768989|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25569516|NCT00769067|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25569517|NCT00769067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25569518|NCT00769067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25569519|NCT00769067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569520|NCT00769067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569521|NCT00769132|Niacin|niacin|mesh-list
25569522|NCT00769132|Niacinamide|niacinamide|mesh-list
25569523|NCT00769132|Nicotinic Acids|nicotinic acids|mesh-list
25569524|NCT00769132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25569525|NCT00769132|Antimetabolites|antimetabolites|mesh-ancestor
25569526|NCT00769132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569527|NCT00769132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25569528|NCT00769132|Vasodilator Agents|vasodilator agents|mesh-ancestor
25569529|NCT00769132|Vitamin B Complex|vitamin b complex|mesh-ancestor
25569530|NCT00769132|Vitamins|vitamins|mesh-ancestor
25569531|NCT00769132|Micronutrients|micronutrients|mesh-ancestor
25569532|NCT00769132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569533|NCT00769184|Clobetasol|clobetasol|mesh-list
25569534|NCT00769184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25569535|NCT00769184|Glucocorticoids|glucocorticoids|mesh-ancestor
25569536|NCT00769184|Hormones|hormones|mesh-ancestor
25569537|NCT00769184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25569538|NCT00769184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569539|NCT00769314|Acyclovir|acyclovir|mesh-list
25569540|NCT00769314|Antiviral Agents|antiviral agents|mesh-ancestor
25569541|NCT00769314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25569542|NCT00769392|Lidocaine|lidocaine|mesh-list
25569543|NCT00769392|Tetracaine|tetracaine|mesh-list
25569544|NCT00769392|Proxymetacaine|proxymetacaine|mesh-list
25569545|NCT00769392|Anesthetics, Local|anesthetics, local|mesh-ancestor
25569546|NCT00769392|Anesthetics|anesthetics|mesh-ancestor
25569547|NCT00769392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25569548|NCT00769392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569549|NCT00769392|Sensory System Agents|sensory system agents|mesh-ancestor
25569550|NCT00769392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25569551|NCT00769392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25569552|NCT00769392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25569553|NCT00769392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25569554|NCT00769392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25569555|NCT00769392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569556|NCT00769483|Gemcitabine|gemcitabine|mesh-list
25569557|NCT00769483|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25464273|NCT00002597|Fertility Agents|fertility agents|mesh-ancestor
25569558|NCT00769483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25569559|NCT00769483|Antimetabolites|antimetabolites|mesh-ancestor
25569560|NCT00769483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569561|NCT00769483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25569562|NCT00769483|Antiviral Agents|antiviral agents|mesh-ancestor
25569563|NCT00769483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25569564|NCT00769483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569565|NCT00769483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25569566|NCT00769483|Immunologic Factors|immunologic factors|mesh-ancestor
25569567|NCT00769483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569568|NCT00769483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25569569|NCT00769561|Salicylic Acid|salicylic acid|mesh-list
25569570|NCT00769561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25569571|NCT00769561|Antifungal Agents|antifungal agents|mesh-ancestor
25569572|NCT00769561|Keratolytic Agents|keratolytic agents|mesh-ancestor
25569573|NCT00769561|Dermatologic Agents|dermatologic agents|mesh-ancestor
25569574|NCT00769600|Itraconazole|itraconazole|mesh-list
25569575|NCT00769600|Pemetrexed|pemetrexed|mesh-list
25569576|NCT00769600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25569577|NCT00769600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569578|NCT00769600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569579|NCT00769600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25569580|NCT00769600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25569581|NCT00769600|Antifungal Agents|antifungal agents|mesh-ancestor
25569582|NCT00769600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25569583|NCT00769600|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25569584|NCT00769600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25569585|NCT00769600|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25569586|NCT00769600|Hormone Antagonists|hormone antagonists|mesh-ancestor
25606129|NCT01064830|Dermatologic Agents|dermatologic agents|mesh-ancestor
24947670|NCT03927079|Dimercaprol|dimercaprol|mesh-list
25569587|NCT00769600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25569588|NCT00769600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569589|NCT00769600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25569590|NCT00769704|Molgramostim|molgramostim|mesh-list
25569591|NCT00769704|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25569592|NCT00769704|Sargramostim|sargramostim|mesh-list
25569593|NCT00769704|Immunologic Factors|immunologic factors|mesh-ancestor
25569594|NCT00769704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569595|NCT00769704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25569596|NCT00769704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25569597|NCT00769886|Ketotifen|ketotifen|mesh-list
25569598|NCT00769886|Naphazoline|naphazoline|mesh-list
25569599|NCT00769886|Antipruritics|antipruritics|mesh-ancestor
24461478|NCT00352430|Antioxidants|antioxidants|mesh-ancestor
24550875|NCT00723060|Citalopram|citalopram|mesh-list
24551820|NCT04956627|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25569600|NCT00769886|Dermatologic Agents|dermatologic agents|mesh-ancestor
25569601|NCT00769886|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25569602|NCT00769886|Histamine Antagonists|histamine antagonists|mesh-ancestor
25569603|NCT00769886|Histamine Agents|histamine agents|mesh-ancestor
25569604|NCT00769886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25569605|NCT00769886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569606|NCT00769886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569607|NCT00769886|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25569608|NCT00769886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25569609|NCT00769886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25697181|NCT02072824|Anticonvulsants|anticonvulsants|mesh-ancestor
25569610|NCT00769886|Adrenergic Agents|adrenergic agents|mesh-ancestor
25569611|NCT00769886|Nasal Decongestants|nasal decongestants|mesh-ancestor
25569612|NCT00769886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25569613|NCT00769886|Respiratory System Agents|respiratory system agents|mesh-ancestor
25569614|NCT00770029|Botulinum Toxins|botulinum toxins|mesh-list
25569615|NCT00770029|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25569616|NCT00770029|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25569617|NCT00770029|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25569618|NCT00770029|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25569619|NCT00770029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25569620|NCT00770029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569621|NCT00770029|Cholinergic Agents|cholinergic agents|mesh-ancestor
25569622|NCT00770029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25569623|NCT00770029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569624|NCT00770029|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25569625|NCT00770029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25569626|NCT00770120|Everolimus|everolimus|mesh-list
25569627|NCT00770120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25569628|NCT00770120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25569629|NCT00770120|Immunologic Factors|immunologic factors|mesh-ancestor
25569630|NCT00770120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569631|NCT00770133|Ketotifen|ketotifen|mesh-list
25569632|NCT00770133|Naphazoline|naphazoline|mesh-list
25569633|NCT00770133|Antipruritics|antipruritics|mesh-ancestor
24553834|NCT00733031|Antimetabolites|antimetabolites|mesh-ancestor
25569634|NCT00770133|Dermatologic Agents|dermatologic agents|mesh-ancestor
25569635|NCT00770133|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25569636|NCT00770133|Histamine Antagonists|histamine antagonists|mesh-ancestor
24801905|NCT01986283|Oxycodone|oxycodone|mesh-list
25569637|NCT00770133|Histamine Agents|histamine agents|mesh-ancestor
25569638|NCT00770133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25569639|NCT00770133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569640|NCT00770133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569641|NCT00770133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25569642|NCT00770133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25569643|NCT00770133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25569644|NCT00770133|Adrenergic Agents|adrenergic agents|mesh-ancestor
25569645|NCT00770133|Nasal Decongestants|nasal decongestants|mesh-ancestor
25569646|NCT00770133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25569647|NCT00770133|Respiratory System Agents|respiratory system agents|mesh-ancestor
25569648|NCT00770146|Mipomersen|mipomersen|mesh-list
25569649|NCT00770146|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24947930|NCT03925155|Iodine|iodine|mesh-list
25569650|NCT00770146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25569651|NCT00770146|Antimetabolites|antimetabolites|mesh-ancestor
25569652|NCT00770146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569653|NCT00770146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25569654|NCT00770211|Botulinum Toxins|botulinum toxins|mesh-list
25569655|NCT00770211|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25569656|NCT00770211|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25569657|NCT00770211|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25569658|NCT00770211|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25569659|NCT00770211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25569660|NCT00770211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569661|NCT00770211|Cholinergic Agents|cholinergic agents|mesh-ancestor
25569662|NCT00770211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25569663|NCT00770211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569664|NCT00770211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25569665|NCT00770211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25569666|NCT00770224|Prednisone|prednisone|mesh-list
25569667|NCT00770224|Cyclophosphamide|cyclophosphamide|mesh-list
25569668|NCT00770224|Rituximab|rituximab|mesh-list
25569669|NCT00770224|Doxorubicin|doxorubicin|mesh-list
25569670|NCT00770224|Vincristine|vincristine|mesh-list
25569671|NCT00770224|Tositumomab I-131|tositumomab i-131|mesh-list
25569672|NCT00770224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25569673|NCT00770224|Immunologic Factors|immunologic factors|mesh-ancestor
25569674|NCT00770224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569675|NCT00770224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25569676|NCT00770224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25569677|NCT00770224|Alkylating Agents|alkylating agents|mesh-ancestor
25569678|NCT00770224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697226|NCT02073487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25697227|NCT02073487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25569679|NCT00770224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25569680|NCT00770224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25569681|NCT00770224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25569682|NCT00770224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25569683|NCT00770224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25569684|NCT00770224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25569685|NCT00770224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569686|NCT00770224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25569687|NCT00770224|Glucocorticoids|glucocorticoids|mesh-ancestor
25569688|NCT00770224|Hormones|hormones|mesh-ancestor
25569689|NCT00770224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25569690|NCT00770224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25569691|NCT00770224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24543528|NCT00684112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24556626|NCT00748423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25569692|NCT00770224|Tubulin Modulators|tubulin modulators|mesh-ancestor
25569693|NCT00770224|Antimitotic Agents|antimitotic agents|mesh-ancestor
25569694|NCT00770224|Mitosis Modulators|mitosis modulators|mesh-ancestor
25569695|NCT00770328|Pentoxifylline|pentoxifylline|mesh-list
25569696|NCT00770328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25569697|NCT00770328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569698|NCT00770328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569699|NCT00770328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25569700|NCT00770328|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25569701|NCT00770328|Protective Agents|protective agents|mesh-ancestor
25569702|NCT00770328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569703|NCT00770328|Vasodilator Agents|vasodilator agents|mesh-ancestor
25569704|NCT00770328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25697236|NCT02073682|Tinzaparin|tinzaparin|mesh-list
24556896|NCT00750217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24556897|NCT00750217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569705|NCT00770328|Antioxidants|antioxidants|mesh-ancestor
25464401|NCT05384821|Tretinoin|tretinoin|mesh-list
25464474|NCT05384210|Antidepressive Agents|antidepressive agents|mesh-ancestor
25324595|NCT04882163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25324596|NCT04882163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25324597|NCT04882163|Growth Substances|growth substances|mesh-ancestor
25324598|NCT04882163|Growth Inhibitors|growth inhibitors|mesh-ancestor
24783850|NCT01904500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24783851|NCT01904500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783852|NCT01904539|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
25822722|NCT00004585|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
24783853|NCT01904539|Cathartics|cathartics|mesh-ancestor
24783854|NCT01904539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24783855|NCT01904591|Vitamin E|vitamin e|mesh-list
24783856|NCT01904591|Selenium|selenium|mesh-list
24783857|NCT01904591|Vitamins|vitamins|mesh-ancestor
24783858|NCT01904591|Micronutrients|micronutrients|mesh-ancestor
24557080|NCT00751205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24557081|NCT00751205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557085|NCT00751205|Autonomic Agents|autonomic agents|mesh-ancestor
24783859|NCT01904591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783860|NCT01904591|Antioxidants|antioxidants|mesh-ancestor
24783861|NCT01904591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783862|NCT01904591|Protective Agents|protective agents|mesh-ancestor
24783863|NCT01904591|Trace Elements|trace elements|mesh-ancestor
24783864|NCT01904643|Cytarabine|cytarabine|mesh-list
24783865|NCT01904643|Etoposide|etoposide|mesh-list
24783866|NCT01904643|Mitoxantrone|mitoxantrone|mesh-list
24783867|NCT01904643|Lenalidomide|lenalidomide|mesh-list
24783868|NCT01904643|Etoposide phosphate|etoposide phosphate|mesh-list
24428274|NCT00240045|Adrenergic Agents|adrenergic agents|mesh-ancestor
24428275|NCT00240045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24428276|NCT00240045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428277|NCT00240058|Phenylephrine|phenylephrine|mesh-list
24428278|NCT00240058|Oxymetazoline|oxymetazoline|mesh-list
24428279|NCT00240058|Nitric Oxide|nitric oxide|mesh-list
25123231|NCT03086720|Eusol|eusol|mesh-list
25050530|NCT00488267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24517447|NCT00607971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557219|NCT00751829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24557220|NCT00751829|Diuretics|diuretics|mesh-ancestor
24428280|NCT00240058|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24428281|NCT00240058|Mydriatics|mydriatics|mesh-ancestor
24428350|NCT00240279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24428351|NCT00240279|Antimetabolites|antimetabolites|mesh-ancestor
24428352|NCT00240279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428353|NCT00240279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24428354|NCT00240279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24428355|NCT00240279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25040897|NCT02762929|Anesthetics, Local|anesthetics, local|mesh-ancestor
25040898|NCT02762929|Anesthetics|anesthetics|mesh-ancestor
25040899|NCT02762929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25040900|NCT02762929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040901|NCT02762929|Sensory System Agents|sensory system agents|mesh-ancestor
25040902|NCT02762929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25040903|NCT02744833|Enoxaparin|enoxaparin|mesh-list
25040904|NCT02744833|Enoxaparin sodium|enoxaparin sodium|mesh-list
25040905|NCT02744833|Anticoagulants|anticoagulants|mesh-ancestor
24544274|NCT00688272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25040906|NCT02744833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25040907|NCT02744833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25040908|NCT02744833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040909|NCT02741791|Bupropion|bupropion|mesh-list
25040916|NCT02741791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040917|NCT02741791|Dopamine Agents|dopamine agents|mesh-ancestor
25040918|NCT02741791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25040919|NCT02741791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557523|NCT00752869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24948132|NCT03922815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24948133|NCT03922815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24948134|NCT03922919|Ceftriaxone|ceftriaxone|mesh-list
24948135|NCT03922919|Cefotaxime|cefotaxime|mesh-list
25040920|NCT02741791|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25040921|NCT02741791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25040922|NCT02741791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25040923|NCT02736968|Auranofin|auranofin|mesh-list
25040924|NCT02736968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24428356|NCT00240292|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24428366|NCT00240305|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24428367|NCT00240305|Antimetabolites|antimetabolites|mesh-ancestor
24428368|NCT00240305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428369|NCT00240305|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24428372|NCT00240318|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24428420|NCT00240435|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24428421|NCT00240435|Cholinergic Agents|cholinergic agents|mesh-ancestor
25569706|NCT00770341|Vancomycin|vancomycin|mesh-list
25569707|NCT00770341|Daptomycin|daptomycin|mesh-list
25569708|NCT00770341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25569709|NCT00770341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24428422|NCT00240435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24437470|NCT00273702|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24544832|NCT00690534|Insulin|insulin|mesh-list
25569710|NCT00770367|Pioglitazone|pioglitazone|mesh-list
25569711|NCT00770367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25569712|NCT00770367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569713|NCT00770432|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25569714|NCT00770432|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25569715|NCT00770432|Laxatives|laxatives|mesh-ancestor
25569716|NCT00770432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25569717|NCT00770484|Propranolol|propranolol|mesh-list
25569718|NCT00770484|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25569719|NCT00770484|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25569720|NCT00770484|Adrenergic Agents|adrenergic agents|mesh-ancestor
25569721|NCT00770484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25569722|NCT00770484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569723|NCT00770484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569724|NCT00770484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25569725|NCT00770484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25569726|NCT00770484|Vasodilator Agents|vasodilator agents|mesh-ancestor
25569727|NCT00770510|Zolpidem|zolpidem|mesh-list
25569728|NCT00770510|Eszopiclone|eszopiclone|mesh-list
25569729|NCT00770510|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25569730|NCT00770510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25569731|NCT00770510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25569732|NCT00770510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569733|NCT00770510|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25569734|NCT00770510|GABA Agonists|gaba agonists|mesh-ancestor
25569735|NCT00770510|GABA Agents|gaba agents|mesh-ancestor
25569736|NCT00770510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25569737|NCT00770510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569738|NCT00770562|Dexamethasone|dexamethasone|mesh-list
25569739|NCT00770562|Rituximab|rituximab|mesh-list
25569740|NCT00770562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25569741|NCT00770562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25569742|NCT00770562|Immunologic Factors|immunologic factors|mesh-ancestor
25569743|NCT00770562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569744|NCT00770562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25569745|NCT00770562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25569746|NCT00770562|Antiemetics|antiemetics|mesh-ancestor
25569747|NCT00770562|Autonomic Agents|autonomic agents|mesh-ancestor
25569748|NCT00770562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25569749|NCT00770562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25569750|NCT00770562|Glucocorticoids|glucocorticoids|mesh-ancestor
25569751|NCT00770562|Hormones|hormones|mesh-ancestor
25569752|NCT00770562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25569753|NCT00770562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25569754|NCT00770588|Gefitinib|gefitinib|mesh-list
25569755|NCT00770588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25569756|NCT00770588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25569757|NCT00770588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569758|NCT00770588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569759|NCT00770653|Metformin|metformin|mesh-list
25569760|NCT00770653|Pioglitazone|pioglitazone|mesh-list
25569761|NCT00770653|Glimepiride|glimepiride|mesh-list
25569762|NCT00770653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25569763|NCT00770653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939780|NCT04006847|Dasatinib|dasatinib|mesh-list
25569764|NCT00770653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25569765|NCT00770653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25569766|NCT00770653|Immunologic Factors|immunologic factors|mesh-ancestor
25569767|NCT00770679|Atorvastatin|atorvastatin|mesh-list
25569768|NCT00770679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25569769|NCT00770679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25569770|NCT00770679|Antimetabolites|antimetabolites|mesh-ancestor
25569771|NCT00770679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558284|NCT00755963|Contraceptive Agents|contraceptive agents|mesh-ancestor
24558285|NCT00755963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24558286|NCT00755963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24456861|NCT00332436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24455023|NCT03011268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24455024|NCT03011268|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24558287|NCT00755963|Progestins|progestins|mesh-ancestor
24558288|NCT00755976|Sulindac|sulindac|mesh-list
25569772|NCT00770679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25569773|NCT00770679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25569774|NCT00770679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569775|NCT00770692|Eszopiclone|eszopiclone|mesh-list
25569776|NCT00770692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25569777|NCT00770692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25569778|NCT00770692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569779|NCT00770757|Pomalidomide|pomalidomide|mesh-list
25569780|NCT00770757|Immunologic Factors|immunologic factors|mesh-ancestor
25569781|NCT00770757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558406|NCT00757029|Dopamine Agents|dopamine agents|mesh-ancestor
25569782|NCT00770757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25569783|NCT00770757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25569784|NCT00770757|Growth Substances|growth substances|mesh-ancestor
25569785|NCT00770757|Growth Inhibitors|growth inhibitors|mesh-ancestor
25569786|NCT00770757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25569787|NCT00770770|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
25569788|NCT00770770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25569789|NCT00770770|Glucocorticoids|glucocorticoids|mesh-ancestor
25569790|NCT00770770|Hormones|hormones|mesh-ancestor
25569791|NCT00770770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25569792|NCT00770770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569793|NCT00770861|Nebivolol|nebivolol|mesh-list
25569794|NCT00770861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25569795|NCT00770861|Vasodilator Agents|vasodilator agents|mesh-ancestor
25569796|NCT00770861|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25569797|NCT00770861|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25569798|NCT00770861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25569799|NCT00770861|Adrenergic Agents|adrenergic agents|mesh-ancestor
25569800|NCT00770861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25569801|NCT00770861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569802|NCT00770861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569803|NCT00770874|Cisplatin|cisplatin|mesh-list
25569804|NCT00770874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25569805|NCT00770913|Rabeprazole|rabeprazole|mesh-list
25569806|NCT00770913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25569807|NCT00770913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25569808|NCT00770913|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25569809|NCT00770913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569810|NCT00770913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569811|NCT00771030|Brodalumab|brodalumab|mesh-list
25569812|NCT00771030|Dermatologic Agents|dermatologic agents|mesh-ancestor
25652249|NCT01525173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25652250|NCT01525173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652251|NCT01525173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652252|NCT01525225|Metformin|metformin|mesh-list
25652253|NCT01525225|Saxagliptin|saxagliptin|mesh-list
25652254|NCT01525225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25652255|NCT01525225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652256|NCT01525225|Incretins|incretins|mesh-ancestor
25652257|NCT01525225|Hormones|hormones|mesh-ancestor
25652258|NCT01525225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25652259|NCT01525225|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25652260|NCT01525225|Protease Inhibitors|protease inhibitors|mesh-ancestor
25652261|NCT01525225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652262|NCT01525225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652263|NCT01525238|Dapagliflozin|dapagliflozin|mesh-list
25652264|NCT01525238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25652265|NCT01525238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652266|NCT01525238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25652267|NCT01525238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652268|NCT01525407|Atorvastatin|atorvastatin|mesh-list
25652269|NCT01525407|Calcium|calcium|mesh-list
25652270|NCT01525407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25652271|NCT01525407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652272|NCT01525407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25652273|NCT01525407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25652274|NCT01525407|Antimetabolites|antimetabolites|mesh-ancestor
25652275|NCT01525407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652276|NCT01525407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25652277|NCT01525407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25652278|NCT01525407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652279|NCT01525550|Sunitinib|sunitinib|mesh-list
25652280|NCT01525550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652281|NCT01525550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25652282|NCT01525550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25652283|NCT01525550|Growth Substances|growth substances|mesh-ancestor
25652284|NCT01525550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652285|NCT01525550|Growth Inhibitors|growth inhibitors|mesh-ancestor
25652286|NCT01525550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25652287|NCT01525550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652288|NCT01525550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652289|NCT01525602|Paclitaxel|paclitaxel|mesh-list
25652290|NCT01525602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25652291|NCT01525602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652292|NCT01525602|Tubulin Modulators|tubulin modulators|mesh-ancestor
25652293|NCT01525602|Antimitotic Agents|antimitotic agents|mesh-ancestor
25652294|NCT01525602|Mitosis Modulators|mitosis modulators|mesh-ancestor
25652295|NCT01525602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569813|NCT00771056|Hydroxychloroquine|hydroxychloroquine|mesh-list
25569814|NCT00771056|Antimalarials|antimalarials|mesh-ancestor
25569815|NCT00771056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25569816|NCT00771056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25569817|NCT00771056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25569818|NCT00771056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569819|NCT00771056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569820|NCT00771056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25569821|NCT00771472|Vorinostat|vorinostat|mesh-list
25569822|NCT00771472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25569823|NCT00771472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25569824|NCT00771472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569825|NCT00771472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569826|NCT00771667|Ustekinumab|ustekinumab|mesh-list
25464621|NCT05294588|Vaccines|vaccines|mesh-list
25464622|NCT05294588|Immunologic Factors|immunologic factors|mesh-ancestor
25464623|NCT05294588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464624|NCT05294588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25464625|NCT05294588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25464626|NCT05294588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25464627|NCT05294588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25464628|NCT05294588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464629|NCT05294588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464630|NCT05294588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464631|NCT05294588|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25464632|NCT05294588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25464633|NCT05269615|Valsartan|valsartan|mesh-list
25464634|NCT05269615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25464635|NCT05269615|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25464636|NCT05269615|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25464637|NCT05269615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464638|NCT05262244|Bevacizumab|bevacizumab|mesh-list
25464639|NCT05262244|Vedolizumab|vedolizumab|mesh-list
25464640|NCT05262244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25464641|NCT05262244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464642|NCT05262244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25464643|NCT05262244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25464644|NCT05262244|Growth Substances|growth substances|mesh-ancestor
25464645|NCT05262244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464646|NCT05262244|Growth Inhibitors|growth inhibitors|mesh-ancestor
25464647|NCT05262244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25464648|NCT05231460|Narcotics|narcotics|mesh-list
25464649|NCT05231460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25464650|NCT05231460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569827|NCT00771667|Dermatologic Agents|dermatologic agents|mesh-ancestor
25569828|NCT00771745|Thymoglobulin|thymoglobulin|mesh-list
25569829|NCT00771745|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25569830|NCT00771745|Immunologic Factors|immunologic factors|mesh-ancestor
25569831|NCT00771745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569832|NCT00771745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25569833|NCT00771758|Oxycodone|oxycodone|mesh-list
25569834|NCT00771758|Tapentadol|tapentadol|mesh-list
25569835|NCT00771758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25569836|NCT00771758|Narcotics|narcotics|mesh-ancestor
25569837|NCT00771758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25569838|NCT00771758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569839|NCT00771758|Analgesics|analgesics|mesh-ancestor
25569840|NCT00771758|Sensory System Agents|sensory system agents|mesh-ancestor
25569841|NCT00771758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25569842|NCT00771758|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25569843|NCT00771758|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25569844|NCT00771758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25569845|NCT00771758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569846|NCT00771758|Adrenergic Agents|adrenergic agents|mesh-ancestor
25569847|NCT00771758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25569848|NCT00771810|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
25569849|NCT00771810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25569850|NCT00771810|Vasodilator Agents|vasodilator agents|mesh-ancestor
25569851|NCT00771875|Acetaminophen|acetaminophen|mesh-list
25569852|NCT00771875|Diphenhydramine|diphenhydramine|mesh-list
25569853|NCT00771875|Methylprednisolone|methylprednisolone|mesh-list
25569854|NCT00771875|Rituximab|rituximab|mesh-list
25569855|NCT00771875|Bortezomib|bortezomib|mesh-list
25569856|NCT00771875|Thymoglobulin|thymoglobulin|mesh-list
25569857|NCT00771875|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25569858|NCT00771875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25569859|NCT00771875|Histamine Antagonists|histamine antagonists|mesh-list
25569860|NCT00771875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25569861|NCT00771875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25569862|NCT00771875|Immunologic Factors|immunologic factors|mesh-ancestor
25569863|NCT00771875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569864|NCT00771875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25569865|NCT00771875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25569866|NCT00771875|Analgesics|analgesics|mesh-ancestor
25569867|NCT00771875|Sensory System Agents|sensory system agents|mesh-ancestor
25569868|NCT00771875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25569869|NCT00771875|Antipyretics|antipyretics|mesh-ancestor
25569870|NCT00771875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25569871|NCT00771875|Antiemetics|antiemetics|mesh-ancestor
25569872|NCT00771875|Autonomic Agents|autonomic agents|mesh-ancestor
25569873|NCT00771875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25569874|NCT00771875|Glucocorticoids|glucocorticoids|mesh-ancestor
25569875|NCT00771875|Hormones|hormones|mesh-ancestor
25606130|NCT01064830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25569876|NCT00771875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25569877|NCT00771875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25569878|NCT00771875|Protective Agents|protective agents|mesh-ancestor
25569879|NCT00771875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25569880|NCT00771875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25569881|NCT00771875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25569882|NCT00771875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25569883|NCT00771875|Anesthetics, Local|anesthetics, local|mesh-ancestor
25569884|NCT00771875|Anesthetics|anesthetics|mesh-ancestor
25569885|NCT00771875|Histamine Agents|histamine agents|mesh-ancestor
25569886|NCT00771875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25569887|NCT00771875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569888|NCT00771875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25569889|NCT00771901|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
25569890|NCT00771901|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25569891|NCT00771901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25569892|NCT00771901|Antiviral Agents|antiviral agents|mesh-ancestor
25569893|NCT00771901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25569894|NCT00771901|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25569895|NCT00771901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25569896|NCT00771914|Aspirin|aspirin|mesh-list
25569897|NCT00771914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25569898|NCT00771914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25569899|NCT00771914|Analgesics|analgesics|mesh-ancestor
25569900|NCT00771914|Sensory System Agents|sensory system agents|mesh-ancestor
25569901|NCT00771914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25569902|NCT00771914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569903|NCT00771914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25569904|NCT00771914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25569905|NCT00771914|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25569906|NCT00771914|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25569907|NCT00771914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569908|NCT00771914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25569909|NCT00771914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25569910|NCT00771914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569911|NCT00771914|Antipyretics|antipyretics|mesh-ancestor
25569912|NCT00771927|Lacosamide|lacosamide|mesh-list
25569913|NCT00771927|Anticonvulsants|anticonvulsants|mesh-ancestor
25569914|NCT00771927|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25569915|NCT00771927|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24625656|NCT01082796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625657|NCT01082809|Sunitinib|sunitinib|mesh-list
25569916|NCT00771927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25569917|NCT00771927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569918|NCT00771953|Docetaxel|docetaxel|mesh-list
25569919|NCT00771953|Pemetrexed|pemetrexed|mesh-list
25569920|NCT00771953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25569921|NCT00771953|Tubulin Modulators|tubulin modulators|mesh-ancestor
25569922|NCT00771953|Antimitotic Agents|antimitotic agents|mesh-ancestor
25569923|NCT00771953|Mitosis Modulators|mitosis modulators|mesh-ancestor
25569924|NCT00771953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569925|NCT00771953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051616|NCT00393068|Bevacizumab|bevacizumab|mesh-list
25569926|NCT00771953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25569927|NCT00771953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25569928|NCT00772005|Modafinil|modafinil|mesh-list
25569929|NCT00772005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25569930|NCT00772005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569931|NCT00772005|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25569932|NCT00772005|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25569933|NCT00772005|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25569934|NCT00772005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569935|NCT00772031|Topiramate|topiramate|mesh-list
25569936|NCT00772031|Propranolol|propranolol|mesh-list
25569937|NCT00772031|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25569938|NCT00772031|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25569939|NCT00772031|Adrenergic Agents|adrenergic agents|mesh-ancestor
25569940|NCT00772031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24561649|NCT00761904|Diuretics|diuretics|mesh-ancestor
25569941|NCT00772031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569942|NCT00772031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569943|NCT00772031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25569944|NCT00772031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25569945|NCT00772031|Vasodilator Agents|vasodilator agents|mesh-ancestor
25569946|NCT00772031|Anticonvulsants|anticonvulsants|mesh-ancestor
25569947|NCT00772031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25569948|NCT00772070|Vaccines|vaccines|mesh-list
25569949|NCT00772070|Immunologic Factors|immunologic factors|mesh-ancestor
25569950|NCT00772070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569951|NCT00772109|Vaccines|vaccines|mesh-list
25569952|NCT00772109|Immunologic Factors|immunologic factors|mesh-ancestor
25569953|NCT00772109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569954|NCT00772148|Tacrolimus|tacrolimus|mesh-list
25569955|NCT00772148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25569956|NCT00772148|Immunologic Factors|immunologic factors|mesh-ancestor
25569957|NCT00772148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569958|NCT00772148|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25569959|NCT00772148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569960|NCT00772148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569961|NCT00772304|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25569962|NCT00772304|Azelastine|azelastine|mesh-list
25569963|NCT00772304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25569964|NCT00772304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25569965|NCT00772304|Analgesics|analgesics|mesh-ancestor
25569966|NCT00772304|Sensory System Agents|sensory system agents|mesh-ancestor
25569967|NCT00772304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25569968|NCT00772304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532863|NCT00641433|Sulfadiazine|sulfadiazine|mesh-list
25569969|NCT00772304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25569970|NCT00772304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25569971|NCT00772304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25569972|NCT00772304|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25569973|NCT00772304|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25569974|NCT00772304|Histamine Antagonists|histamine antagonists|mesh-ancestor
25569975|NCT00772304|Histamine Agents|histamine agents|mesh-ancestor
25569976|NCT00772304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25569977|NCT00772304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25569978|NCT00772304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25569979|NCT00772304|Autonomic Agents|autonomic agents|mesh-ancestor
25569980|NCT00772304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25569981|NCT00772304|Respiratory System Agents|respiratory system agents|mesh-ancestor
25569982|NCT00772304|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25569983|NCT00772304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25569984|NCT00772447|Vancomycin|vancomycin|mesh-list
25569985|NCT00772447|Daptomycin|daptomycin|mesh-list
25569986|NCT00772447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25569987|NCT00772447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25569988|NCT00772538|Tiotropium Bromide|tiotropium bromide|mesh-list
25569989|NCT00772538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25569990|NCT00772538|Autonomic Agents|autonomic agents|mesh-ancestor
25569991|NCT00772538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25569992|NCT00772538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25569993|NCT00772538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25569994|NCT00772538|Respiratory System Agents|respiratory system agents|mesh-ancestor
25569995|NCT00772538|Parasympatholytics|parasympatholytics|mesh-ancestor
25569996|NCT00772538|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25569997|NCT00772538|Cholinergic Agents|cholinergic agents|mesh-ancestor
25569998|NCT00772538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24562086|NCT00764556|Insulin|insulin|mesh-list
25569999|NCT00772538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570000|NCT00772577|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25570001|NCT00772577|Ramipril|ramipril|mesh-list
25570002|NCT00772577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25570003|NCT00772577|Diuretics|diuretics|mesh-ancestor
25570004|NCT00772577|Natriuretic Agents|natriuretic agents|mesh-ancestor
25570005|NCT00772577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464716|NCT04940338|Bromfenac|bromfenac|mesh-list
25570006|NCT00772577|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25570007|NCT00772577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25570008|NCT00772577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570009|NCT00772577|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25570010|NCT00772577|Protease Inhibitors|protease inhibitors|mesh-ancestor
25570011|NCT00772577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570012|NCT00772590|Raltegravir Potassium|raltegravir potassium|mesh-list
25570013|NCT00772590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25570014|NCT00772590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25570015|NCT00772590|Antiviral Agents|antiviral agents|mesh-ancestor
25570016|NCT00772590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25570017|NCT00772590|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25570018|NCT00772590|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25570019|NCT00772590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24940045|NCT04004234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570020|NCT00772590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570021|NCT00772603|Oxcarbazepine|oxcarbazepine|mesh-list
25570022|NCT00772603|Anticonvulsants|anticonvulsants|mesh-ancestor
25570023|NCT00772603|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25570024|NCT00772603|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25570025|NCT00772603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25570026|NCT00772603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570027|NCT00772603|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25570028|NCT00772603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25570029|NCT00772668|Prednisone|prednisone|mesh-list
25570030|NCT00772668|Cyclophosphamide|cyclophosphamide|mesh-list
25570031|NCT00772668|Rituximab|rituximab|mesh-list
25570032|NCT00772668|Bortezomib|bortezomib|mesh-list
25570033|NCT00772668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25570034|NCT00772668|Immunologic Factors|immunologic factors|mesh-ancestor
25570035|NCT00772668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570036|NCT00772668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25570037|NCT00772668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25570038|NCT00772668|Alkylating Agents|alkylating agents|mesh-ancestor
25570039|NCT00772668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570040|NCT00772668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570041|NCT00772668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24547967|NCT00707070|Acitretin|acitretin|mesh-list
25570042|NCT00772668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25570043|NCT00772668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25570044|NCT00772668|Glucocorticoids|glucocorticoids|mesh-ancestor
25570045|NCT00772668|Hormones|hormones|mesh-ancestor
25570046|NCT00772668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25570047|NCT00772668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25570048|NCT00772772|Vitamin D|vitamin d|mesh-list
25570049|NCT00772772|Ergocalciferols|ergocalciferols|mesh-list
25570050|NCT00772772|Cholecalciferol|cholecalciferol|mesh-list
25570051|NCT00772772|Vitamins|vitamins|mesh-list
25570052|NCT00772772|Micronutrients|micronutrients|mesh-ancestor
25570053|NCT00772772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570054|NCT00772772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25570055|NCT00772772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25570056|NCT00772915|Dexamethasone|dexamethasone|mesh-list
25570057|NCT00772915|Lenalidomide|lenalidomide|mesh-list
25570058|NCT00772915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25570059|NCT00772915|Antiemetics|antiemetics|mesh-ancestor
25570060|NCT00772915|Autonomic Agents|autonomic agents|mesh-ancestor
25570061|NCT00772915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25570062|NCT00772915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570063|NCT00772915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25570064|NCT00772915|Glucocorticoids|glucocorticoids|mesh-ancestor
25570065|NCT00772915|Hormones|hormones|mesh-ancestor
25570066|NCT00772915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25570067|NCT00772915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25570068|NCT00772915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570069|NCT00772915|Immunologic Factors|immunologic factors|mesh-ancestor
25570070|NCT00772915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25570071|NCT00772915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25570072|NCT00772915|Growth Substances|growth substances|mesh-ancestor
25570073|NCT00772915|Growth Inhibitors|growth inhibitors|mesh-ancestor
25570074|NCT00772928|Vaccines|vaccines|mesh-list
25570075|NCT00772928|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25570076|NCT00772928|Immunologic Factors|immunologic factors|mesh-ancestor
25570077|NCT00772928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570078|NCT00772941|Varenicline|varenicline|mesh-list
25570079|NCT00772941|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24562613|NCT00767286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570080|NCT00772941|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25570081|NCT00772941|Cholinergic Agents|cholinergic agents|mesh-ancestor
25570082|NCT00772941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25570083|NCT00772941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570084|NCT00772941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570085|NCT00772954|Vaccines|vaccines|mesh-list
25570086|NCT00772954|Immunologic Factors|immunologic factors|mesh-ancestor
25570087|NCT00772954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570088|NCT00772967|Naproxen|naproxen|mesh-list
25570089|NCT00772967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25570090|NCT00772967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25570091|NCT00772967|Analgesics|analgesics|mesh-ancestor
25570092|NCT00772967|Sensory System Agents|sensory system agents|mesh-ancestor
25570093|NCT00772967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25570094|NCT00772967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570095|NCT00772967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25570096|NCT00772967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25570097|NCT00772967|Gout Suppressants|gout suppressants|mesh-ancestor
25570098|NCT00772967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25570099|NCT00772967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570100|NCT00772967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570101|NCT00773097|Poly ICLC|poly iclc|mesh-list
25570102|NCT00773097|Interferon Inducers|interferon inducers|mesh-ancestor
25570103|NCT00773097|Immunologic Factors|immunologic factors|mesh-ancestor
25570104|NCT00773097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570105|NCT00773136|Bimatoprost|bimatoprost|mesh-list
25570106|NCT00773136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25570107|NCT00773253|Botulinum Toxins|botulinum toxins|mesh-list
24562675|NCT00767689|Micronutrients|micronutrients|mesh-ancestor
24562678|NCT00767715|Haloperidol|haloperidol|mesh-list
25570108|NCT00773253|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25570109|NCT00773253|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25570110|NCT00773253|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25570111|NCT00773253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25570112|NCT00773253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570113|NCT00773253|Cholinergic Agents|cholinergic agents|mesh-ancestor
25570114|NCT00773253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25570115|NCT00773253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570116|NCT00773253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25570117|NCT00773253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25570118|NCT00773292|Cyclosporine|cyclosporine|mesh-list
25570119|NCT00773292|Cyclosporins|cyclosporins|mesh-list
25570120|NCT00773292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570121|NCT00773292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570122|NCT00773292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25570123|NCT00773292|Immunologic Factors|immunologic factors|mesh-ancestor
25570124|NCT00773292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570125|NCT00773292|Antifungal Agents|antifungal agents|mesh-ancestor
25570126|NCT00773292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25570127|NCT00773292|Dermatologic Agents|dermatologic agents|mesh-ancestor
25570128|NCT00773292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25570129|NCT00773292|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25570130|NCT00773383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25570131|NCT00773383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570132|NCT00773383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25570133|NCT00773383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570134|NCT00773383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570135|NCT00773422|Naltrexone|naltrexone|mesh-list
25570136|NCT00773422|Varenicline|varenicline|mesh-list
25570137|NCT00773422|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25570138|NCT00773422|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25570139|NCT00773422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570140|NCT00773422|Sensory System Agents|sensory system agents|mesh-ancestor
25570141|NCT00773422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25570142|NCT00773422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25570143|NCT00773422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25570144|NCT00773422|Cholinergic Agents|cholinergic agents|mesh-ancestor
25570145|NCT00773422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25570146|NCT00773422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570147|NCT00773474|Lonafarnib|lonafarnib|mesh-list
25570148|NCT00773474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570149|NCT00773474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570150|NCT00773513|Epoetin Alfa|epoetin alfa|mesh-list
25570151|NCT00773513|Darbepoetin alfa|darbepoetin alfa|mesh-list
25570152|NCT00773513|Hematinics|hematinics|mesh-ancestor
25570153|NCT00773734|Thalidomide|thalidomide|mesh-list
25570154|NCT00773734|Apremilast|apremilast|mesh-list
25570155|NCT00773734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25570156|NCT00773734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25570157|NCT00773734|Analgesics|analgesics|mesh-ancestor
24562781|NCT00768183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25570158|NCT00773734|Sensory System Agents|sensory system agents|mesh-ancestor
25570159|NCT00773734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25570160|NCT00773734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570161|NCT00773734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25570162|NCT00773734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25570163|NCT00773734|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25570164|NCT00773734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25570165|NCT00773734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570166|NCT00773734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570167|NCT00773734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25570168|NCT00773734|Immunologic Factors|immunologic factors|mesh-ancestor
25570169|NCT00773734|Leprostatic Agents|leprostatic agents|mesh-ancestor
25570170|NCT00773734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25570171|NCT00773734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25570172|NCT00773734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25570173|NCT00773734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25570174|NCT00773734|Growth Substances|growth substances|mesh-ancestor
25570175|NCT00773734|Growth Inhibitors|growth inhibitors|mesh-ancestor
25570176|NCT00773734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570177|NCT00773747|Bortezomib|bortezomib|mesh-list
25570178|NCT00773747|Vorinostat|vorinostat|mesh-list
25570179|NCT00773747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570180|NCT00773747|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25570181|NCT00773747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570182|NCT00773747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570183|NCT00773786|Formoterol Fumarate|formoterol fumarate|mesh-list
25570184|NCT00773786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25570185|NCT00773786|Autonomic Agents|autonomic agents|mesh-ancestor
25570186|NCT00773786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25570187|NCT00773786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570188|NCT00773786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25570189|NCT00773786|Respiratory System Agents|respiratory system agents|mesh-ancestor
25570190|NCT00773786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25570191|NCT00773786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25570192|NCT00773786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25570193|NCT00773786|Adrenergic Agents|adrenergic agents|mesh-ancestor
25570194|NCT00773786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25570195|NCT00773786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570196|NCT00773838|Dexamethasone|dexamethasone|mesh-list
25570197|NCT00773838|Bortezomib|bortezomib|mesh-list
25570198|NCT00773838|Vorinostat|vorinostat|mesh-list
25570199|NCT00773838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25570200|NCT00773838|Antiemetics|antiemetics|mesh-ancestor
25570201|NCT00773838|Autonomic Agents|autonomic agents|mesh-ancestor
25570202|NCT00773838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25570203|NCT00773838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570204|NCT00773838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25570205|NCT00773838|Glucocorticoids|glucocorticoids|mesh-ancestor
25570206|NCT00773838|Hormones|hormones|mesh-ancestor
25570207|NCT00773838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25570208|NCT00773838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25570209|NCT00773838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570210|NCT00773838|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25570211|NCT00773838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570212|NCT00773838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570213|NCT00773955|Acetic Acid|acetic acid|mesh-list
25570214|NCT00773955|Retinol acetate|retinol acetate|mesh-list
25570215|NCT00773955|Gossypol acetic acid|gossypol acetic acid|mesh-list
25570216|NCT00773955|Gossypol|gossypol|mesh-list
24836882|NCT02187822|Taxane|taxane|mesh-list
25570217|NCT00773955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25570218|NCT00773955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25570219|NCT00773955|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25570220|NCT00773955|Immunologic Factors|immunologic factors|mesh-ancestor
25570221|NCT00773955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570222|NCT00773955|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25570223|NCT00773955|Protective Agents|protective agents|mesh-ancestor
25570224|NCT00773955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570225|NCT00773955|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25570226|NCT00773955|Contraceptive Agents|contraceptive agents|mesh-ancestor
25570227|NCT00773955|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25570228|NCT00773955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25464960|NCT04116541|Trametinib|trametinib|mesh-list
25464961|NCT04116541|Dabrafenib|dabrafenib|mesh-list
25464962|NCT04116541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464963|NCT04116541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25464964|NCT04116541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464965|NCT04116541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428423|NCT00240435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428425|NCT00240448|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25162050|NCT02908698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25162051|NCT02908698|Glucocorticoids|glucocorticoids|mesh-ancestor
25162052|NCT02908698|Hormones|hormones|mesh-ancestor
25162053|NCT02908698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25162054|NCT02908698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162055|NCT02908698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25162056|NCT02908698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162057|NCT02908438|Hormones|hormones|mesh-list
25123287|NCT03086291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25162058|NCT02908438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25162059|NCT02908438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162060|NCT02908412|Bupivacaine|bupivacaine|mesh-list
25162061|NCT02908412|Anesthetics, Local|anesthetics, local|mesh-ancestor
25162062|NCT02908412|Anesthetics|anesthetics|mesh-ancestor
25162063|NCT02908412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25162064|NCT02908412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162065|NCT02908412|Sensory System Agents|sensory system agents|mesh-ancestor
25162066|NCT02908412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25162067|NCT02908191|Tenofovir|tenofovir|mesh-list
25162068|NCT02908191|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25162069|NCT02908191|Entecavir|entecavir|mesh-list
25162070|NCT02908191|Antiviral Agents|antiviral agents|mesh-ancestor
25162071|NCT02908191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25162072|NCT02908191|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24563275|NCT00770744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25162073|NCT02908191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25162074|NCT02908191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25162075|NCT02908191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162076|NCT02908191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25162077|NCT02908191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24428489|NCT00240617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24428490|NCT00240630|Naproxen|naproxen|mesh-list
24428491|NCT00240630|Sumatriptan|sumatriptan|mesh-list
24428492|NCT00240630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24841277|NCT02215148|Tolvaptan|tolvaptan|mesh-list
24428539|NCT00240695|Galantamine|galantamine|mesh-list
24428565|NCT00240721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428566|NCT00240734|Epoetin Alfa|epoetin alfa|mesh-list
24428567|NCT00240734|Hematinics|hematinics|mesh-ancestor
25697355|NCT02076243|Paclitaxel|paclitaxel|mesh-list
25697356|NCT02076243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24563490|NCT00772057|Propranolol|propranolol|mesh-list
24563500|NCT00772122|Lenograstim|lenograstim|mesh-list
24563640|NCT00772681|Docetaxel|docetaxel|mesh-list
24428568|NCT00240747|Quinupristin-dalfopristin|quinupristin-dalfopristin|mesh-list
24428569|NCT00240747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24428570|NCT00240747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24428583|NCT00240773|Acetaminophen|acetaminophen|mesh-list
24428584|NCT00240773|Naproxen|naproxen|mesh-list
24428585|NCT00240773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24428685|NCT00240942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428686|NCT00240942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428687|NCT00240942|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24428688|NCT00240942|Hormone Antagonists|hormone antagonists|mesh-ancestor
24428689|NCT00240942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24428690|NCT00240942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428744|NCT00241098|Valsartan|valsartan|mesh-list
24428745|NCT00241098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24428746|NCT00241098|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24428747|NCT00241098|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24428748|NCT00241098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428749|NCT00241111|Zoledronic Acid|zoledronic acid|mesh-list
24428750|NCT00241111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24428751|NCT00241111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428752|NCT00241124|Valsartan|valsartan|mesh-list
24428753|NCT00241124|Lisinopril|lisinopril|mesh-list
24428799|NCT00241215|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25570229|NCT00773955|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25570230|NCT00773955|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
25570231|NCT00773955|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
25570232|NCT00773968|Epoetin Alfa|epoetin alfa|mesh-list
25570233|NCT00773968|Hematinics|hematinics|mesh-ancestor
25570234|NCT00774046|Cytarabine|cytarabine|mesh-list
25570235|NCT00774046|Etoposide|etoposide|mesh-list
25570236|NCT00774046|Mitoxantrone|mitoxantrone|mesh-list
25570237|NCT00774046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25570238|NCT00774046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570239|NCT00774046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25570240|NCT00774046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25570241|NCT00774046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570242|NCT00774046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570243|NCT00774046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25570244|NCT00774046|Antimetabolites|antimetabolites|mesh-ancestor
25570245|NCT00774046|Antiviral Agents|antiviral agents|mesh-ancestor
25570246|NCT00774046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25570247|NCT00774046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25570248|NCT00774046|Immunologic Factors|immunologic factors|mesh-ancestor
25570249|NCT00774046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570250|NCT00774046|Analgesics|analgesics|mesh-ancestor
25570251|NCT00774046|Sensory System Agents|sensory system agents|mesh-ancestor
25570252|NCT00774046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25570253|NCT00774202|Prednisone|prednisone|mesh-list
25570254|NCT00774202|Cyclophosphamide|cyclophosphamide|mesh-list
25570255|NCT00774202|Rituximab|rituximab|mesh-list
25570256|NCT00774202|Vincristine|vincristine|mesh-list
25570257|NCT00774202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25570258|NCT00774202|Immunologic Factors|immunologic factors|mesh-ancestor
25570259|NCT00774202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570260|NCT00774202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25570261|NCT00774202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25570262|NCT00774202|Alkylating Agents|alkylating agents|mesh-ancestor
25570263|NCT00774202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570264|NCT00774202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570265|NCT00774202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25697376|NCT02076919|Acrizanib|acrizanib|mesh-list
25570266|NCT00774202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25570267|NCT00774202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25570268|NCT00774202|Glucocorticoids|glucocorticoids|mesh-ancestor
25570269|NCT00774202|Hormones|hormones|mesh-ancestor
25570270|NCT00774202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25570271|NCT00774202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24567232|NCT00790179|Ropivacaine|ropivacaine|mesh-list
25570272|NCT00774202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25570273|NCT00774202|Tubulin Modulators|tubulin modulators|mesh-ancestor
25570274|NCT00774202|Antimitotic Agents|antimitotic agents|mesh-ancestor
25570275|NCT00774202|Mitosis Modulators|mitosis modulators|mesh-ancestor
25570276|NCT00774267|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25570277|NCT00774267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25570278|NCT00774267|Hormone Antagonists|hormone antagonists|mesh-ancestor
25570279|NCT00774267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25570280|NCT00774267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570281|NCT00774267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25570282|NCT00774267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25570283|NCT00774267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25570284|NCT00774787|Imiquimod|imiquimod|mesh-list
25570285|NCT00774787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25570286|NCT00774787|Immunologic Factors|immunologic factors|mesh-ancestor
24567599|NCT00791739|Trazodone|trazodone|mesh-list
25570287|NCT00774787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570288|NCT00774787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570289|NCT00774787|Interferon Inducers|interferon inducers|mesh-ancestor
25570290|NCT00774800|Insulin|insulin|mesh-list
25570291|NCT00774800|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25570292|NCT00774800|Insulin Lispro|insulin lispro|mesh-list
25570293|NCT00774800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25570294|NCT00774800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570295|NCT00774852|Prednisone|prednisone|mesh-list
25570296|NCT00774852|Cyclophosphamide|cyclophosphamide|mesh-list
25697409|NCT02078102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25570297|NCT00774852|Abatacept|abatacept|mesh-list
25570298|NCT00774852|Azathioprine|azathioprine|mesh-list
25570299|NCT00774852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25570300|NCT00774852|Immunologic Factors|immunologic factors|mesh-ancestor
25570301|NCT00774852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570302|NCT00774852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25570303|NCT00774852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25570304|NCT00774852|Alkylating Agents|alkylating agents|mesh-ancestor
25570305|NCT00774852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570306|NCT00774852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570307|NCT00774852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25570308|NCT00774852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25570309|NCT00774852|Glucocorticoids|glucocorticoids|mesh-ancestor
25570310|NCT00774852|Hormones|hormones|mesh-ancestor
25570311|NCT00774852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25570312|NCT00774852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25570313|NCT00774852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25570314|NCT00774852|Antimetabolites|antimetabolites|mesh-ancestor
24568098|NCT00794638|Rituximab|rituximab|mesh-list
25570315|NCT00774852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25570316|NCT00774930|Lanreotide|lanreotide|mesh-list
25570317|NCT00774930|Somatostatin|somatostatin|mesh-list
25570318|NCT00774930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570319|NCT00774930|Hormones|hormones|mesh-ancestor
25570320|NCT00774930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25570321|NCT00774930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570322|NCT00775138|Amikacin|amikacin|mesh-list
25570323|NCT00775138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25570324|NCT00775138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25570325|NCT00775203|Trazodone|trazodone|mesh-list
25570326|NCT00775203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25570327|NCT00775203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25570328|NCT00775203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24568859|NCT00797810|Antiemetics|antiemetics|mesh-ancestor
25570329|NCT00775203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570330|NCT00775203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25570331|NCT00775203|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25570332|NCT00775203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24569519|NCT00800917|Sirolimus|sirolimus|mesh-list
25570333|NCT00775203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25570334|NCT00775203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570335|NCT00775203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25570336|NCT00775203|Serotonin Agents|serotonin agents|mesh-ancestor
25570337|NCT00775203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25570338|NCT00775203|Antidepressive Agents|antidepressive agents|mesh-ancestor
25570339|NCT00775229|Naltrexone|naltrexone|mesh-list
25570340|NCT00775229|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25570341|NCT00775229|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25570342|NCT00775229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570343|NCT00775229|Sensory System Agents|sensory system agents|mesh-ancestor
25570344|NCT00775229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25570345|NCT00775268|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25570346|NCT00775268|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25570347|NCT00775268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570348|NCT00775411|Dexamethasone|dexamethasone|mesh-list
25570349|NCT00775411|Ranibizumab|ranibizumab|mesh-list
25570350|NCT00775411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25570351|NCT00775411|Antiemetics|antiemetics|mesh-ancestor
25570352|NCT00775411|Autonomic Agents|autonomic agents|mesh-ancestor
25570353|NCT00775411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25570354|NCT00775411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570355|NCT00775411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25570356|NCT00775411|Glucocorticoids|glucocorticoids|mesh-ancestor
25570357|NCT00775411|Hormones|hormones|mesh-ancestor
25570358|NCT00775411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24423618|NCT00226447|Lamivudine|lamivudine|mesh-list
25570359|NCT00775411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25570360|NCT00775411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570361|NCT00775411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25570362|NCT00775411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25570363|NCT00775411|Growth Substances|growth substances|mesh-ancestor
25570364|NCT00775411|Growth Inhibitors|growth inhibitors|mesh-ancestor
25570365|NCT00775437|Adalimumab|adalimumab|mesh-list
25570366|NCT00775437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25570367|NCT00775437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25570368|NCT00775450|Vaccines|vaccines|mesh-list
25570369|NCT00775450|Immunologic Factors|immunologic factors|mesh-ancestor
25570370|NCT00775450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570371|NCT00775463|Treprostinil|treprostinil|mesh-list
25570372|NCT00775463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25570373|NCT00775528|Pancrelipase|pancrelipase|mesh-list
25570374|NCT00775528|Pancreatin|pancreatin|mesh-list
25570375|NCT00775528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25570376|NCT00775593|Sirolimus|sirolimus|mesh-list
25570377|NCT00775593|Clofarabine|clofarabine|mesh-list
25570378|NCT00775593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25570379|NCT00775593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25570380|NCT00775593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25570381|NCT00775593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24571998|NCT00812578|Vitamin D|vitamin d|mesh-list
25570382|NCT00775593|Antifungal Agents|antifungal agents|mesh-ancestor
25570383|NCT00775593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25570384|NCT00775593|Immunologic Factors|immunologic factors|mesh-ancestor
25652296|NCT01525615|Tiotropium Bromide|tiotropium bromide|mesh-list
25570385|NCT00775593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570386|NCT00775593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25570387|NCT00775593|Antimetabolites|antimetabolites|mesh-ancestor
25570388|NCT00775593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570389|NCT00775606|Ritonavir|ritonavir|mesh-list
25570390|NCT00775606|Lopinavir|lopinavir|mesh-list
25570391|NCT00775606|Efavirenz|efavirenz|mesh-list
25570392|NCT00775606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25570393|NCT00775606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25570394|NCT00775606|Protease Inhibitors|protease inhibitors|mesh-ancestor
25570395|NCT00775606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570396|NCT00775606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572918|NCT00817245|Omeprazole|omeprazole|mesh-list
25570397|NCT00775606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25570398|NCT00775606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25570399|NCT00775606|Antiviral Agents|antiviral agents|mesh-ancestor
25570400|NCT00775606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24427918|NCT00239278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25570401|NCT00775606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25570402|NCT00775606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25570403|NCT00775606|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25570404|NCT00775606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25570405|NCT00775606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25570406|NCT00775606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25570407|NCT00775606|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25570408|NCT00775606|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25570409|NCT00775606|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25570410|NCT00775645|Acetylcarnitine|acetylcarnitine|mesh-list
25570411|NCT00775645|Vitamin B Complex|vitamin b complex|mesh-ancestor
25570412|NCT00775645|Vitamins|vitamins|mesh-ancestor
25570413|NCT00775645|Micronutrients|micronutrients|mesh-ancestor
25570414|NCT00775645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570415|NCT00775645|Nootropic Agents|nootropic agents|mesh-ancestor
25570416|NCT00775658|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25606131|NCT01064830|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25570417|NCT00775658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25570418|NCT00775658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25570419|NCT00775658|Analgesics|analgesics|mesh-ancestor
25570420|NCT00775658|Sensory System Agents|sensory system agents|mesh-ancestor
25570421|NCT00775658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25570422|NCT00775658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570423|NCT00775658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25570424|NCT00775658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25570425|NCT00775658|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25606132|NCT01064856|Adalimumab|adalimumab|mesh-list
25697492|NCT02078882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570426|NCT00775658|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25570427|NCT00775658|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25570428|NCT00775658|Histamine Antagonists|histamine antagonists|mesh-ancestor
25570429|NCT00775658|Histamine Agents|histamine agents|mesh-ancestor
25570430|NCT00775658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25570431|NCT00775658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570432|NCT00775671|Metoprolol|metoprolol|mesh-list
25570433|NCT00775671|Nebivolol|nebivolol|mesh-list
25570434|NCT00775671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25570435|NCT00775671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25570436|NCT00775671|Sympatholytics|sympatholytics|mesh-ancestor
25570437|NCT00775671|Autonomic Agents|autonomic agents|mesh-ancestor
25570438|NCT00775671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25570439|NCT00775671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570440|NCT00775671|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25570441|NCT00775671|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25570442|NCT00775671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25570443|NCT00775671|Adrenergic Agents|adrenergic agents|mesh-ancestor
24433603|NCT00259181|Chlorhexidine|chlorhexidine|mesh-list
24434105|NCT00261508|Risperidone|risperidone|mesh-list
25570444|NCT00775671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25570445|NCT00775671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570446|NCT00775671|Vasodilator Agents|vasodilator agents|mesh-ancestor
25570447|NCT00775671|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25570448|NCT00775671|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25570449|NCT00775671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25570450|NCT00775931|Cyclophosphamide|cyclophosphamide|mesh-list
25570451|NCT00775931|Busulfan|busulfan|mesh-list
24950079|NCT02655692|Ketamine|ketamine|mesh-list
25570452|NCT00775931|Fludarabine|fludarabine|mesh-list
25570453|NCT00775931|Fludarabine phosphate|fludarabine phosphate|mesh-list
25570454|NCT00775931|Alemtuzumab|alemtuzumab|mesh-list
25570455|NCT00775931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25570456|NCT00775931|Immunologic Factors|immunologic factors|mesh-ancestor
25570457|NCT00775931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570458|NCT00775931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25570459|NCT00775931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25570460|NCT00775931|Alkylating Agents|alkylating agents|mesh-ancestor
25570461|NCT00775931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570462|NCT00775931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570463|NCT00775931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25570464|NCT00775931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25570465|NCT00775931|Antimetabolites|antimetabolites|mesh-ancestor
25570466|NCT00775931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25570467|NCT00775944|Nicotine|nicotine|mesh-list
25570468|NCT00775944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25570469|NCT00775944|Autonomic Agents|autonomic agents|mesh-ancestor
25570470|NCT00775944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25570471|NCT00775944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570472|NCT00775944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25570473|NCT00775944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25570474|NCT00775944|Cholinergic Agents|cholinergic agents|mesh-ancestor
25570475|NCT00775944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25570476|NCT00775944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570477|NCT00776009|Methylphenidate|methylphenidate|mesh-list
25570478|NCT00776009|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
25570479|NCT00776009|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25570480|NCT00776009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570481|NCT00776009|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25570482|NCT00776009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25570483|NCT00776009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25570484|NCT00776009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570485|NCT00776009|Dopamine Agents|dopamine agents|mesh-ancestor
25570486|NCT00776009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25570487|NCT00776230|Vaccines|vaccines|mesh-list
25570488|NCT00776230|Immunologic Factors|immunologic factors|mesh-ancestor
25570489|NCT00776230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570490|NCT00776594|Bevacizumab|bevacizumab|mesh-list
25570491|NCT00776594|Bicalutamide|bicalutamide|mesh-list
25570492|NCT00776594|Androgens|androgens|mesh-list
25570493|NCT00776594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25570494|NCT00776594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570495|NCT00776594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25570496|NCT00776594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25570497|NCT00776594|Growth Substances|growth substances|mesh-ancestor
25570498|NCT00776594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570499|NCT00776594|Growth Inhibitors|growth inhibitors|mesh-ancestor
25570500|NCT00776594|Androgen Antagonists|androgen antagonists|mesh-ancestor
25570501|NCT00776594|Hormone Antagonists|hormone antagonists|mesh-ancestor
25570502|NCT00776594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25570503|NCT00776594|Hormones|hormones|mesh-ancestor
25570504|NCT00776659|Exemestane|exemestane|mesh-list
25570505|NCT00776659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570506|NCT00776659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25570507|NCT00776659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25570508|NCT00776659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570509|NCT00776659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570510|NCT00776659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25570511|NCT00776659|Hormone Antagonists|hormone antagonists|mesh-ancestor
25606133|NCT01064856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25570512|NCT00776659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25570513|NCT00776659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652297|NCT01525615|Olodaterol|olodaterol|mesh-list
25652298|NCT01525615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25652299|NCT01525615|Autonomic Agents|autonomic agents|mesh-ancestor
25652300|NCT01525615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25652301|NCT01525615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652302|NCT01525615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25652303|NCT01525615|Respiratory System Agents|respiratory system agents|mesh-ancestor
25652304|NCT01525615|Parasympatholytics|parasympatholytics|mesh-ancestor
25652305|NCT01525615|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25652306|NCT01525615|Cholinergic Agents|cholinergic agents|mesh-ancestor
25652307|NCT01525615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25652308|NCT01525615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652309|NCT01525628|Tolbutamide|tolbutamide|mesh-list
25652310|NCT01525628|Interferons|interferons|mesh-list
25652311|NCT01525628|Tenofovir|tenofovir|mesh-list
25652312|NCT01525628|Ribavirin|ribavirin|mesh-list
25652313|NCT01525628|Midazolam|midazolam|mesh-list
25652314|NCT01525628|Caffeine|caffeine|mesh-list
25570514|NCT00776919|Clindamycin|clindamycin|mesh-list
25570515|NCT00776919|Clindamycin palmitate|clindamycin palmitate|mesh-list
25570516|NCT00776919|Clindamycin phosphate|clindamycin phosphate|mesh-list
25570517|NCT00776919|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25570518|NCT00776919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25570519|NCT00776919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25570520|NCT00776919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25570521|NCT00776919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570522|NCT00776919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570523|NCT00776919|Dermatologic Agents|dermatologic agents|mesh-ancestor
25570524|NCT00776984|Tiotropium Bromide|tiotropium bromide|mesh-list
25570525|NCT00776984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25570526|NCT00776984|Autonomic Agents|autonomic agents|mesh-ancestor
25570527|NCT00776984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25570528|NCT00776984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570529|NCT00776984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25570530|NCT00776984|Respiratory System Agents|respiratory system agents|mesh-ancestor
25570531|NCT00776984|Parasympatholytics|parasympatholytics|mesh-ancestor
25570532|NCT00776984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25570533|NCT00776984|Cholinergic Agents|cholinergic agents|mesh-ancestor
25570534|NCT00776984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25606134|NCT01064856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25570535|NCT00776984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570536|NCT00777023|Gabapentin|gabapentin|mesh-list
25570537|NCT00777023|Analgesics|analgesics|mesh-ancestor
25570538|NCT00777023|Sensory System Agents|sensory system agents|mesh-ancestor
25570539|NCT00777023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25570540|NCT00777023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570541|NCT00777023|Anticonvulsants|anticonvulsants|mesh-ancestor
25570542|NCT00777023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25570543|NCT00777023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25570544|NCT00777023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25570545|NCT00777023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25570546|NCT00777023|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25570547|NCT00777023|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25570548|NCT00777023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25570549|NCT00777023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570550|NCT00777023|Antimanic Agents|antimanic agents|mesh-ancestor
25570551|NCT00777049|Panobinostat|panobinostat|mesh-list
25570552|NCT00777049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570553|NCT00777049|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25570554|NCT00777049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570555|NCT00777049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570556|NCT00777062|Naltrexone|naltrexone|mesh-list
25570557|NCT00777062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25570558|NCT00777062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25570559|NCT00777062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570560|NCT00777062|Sensory System Agents|sensory system agents|mesh-ancestor
25570561|NCT00777062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25570562|NCT00777101|Capecitabine|capecitabine|mesh-list
25570563|NCT00777101|Lapatinib|lapatinib|mesh-list
25570564|NCT00777101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25570565|NCT00777101|Antimetabolites|antimetabolites|mesh-ancestor
25570566|NCT00777101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570567|NCT00777101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570568|NCT00777101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25570569|NCT00777101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570570|NCT00777153|Cediranib|cediranib|mesh-list
25570571|NCT00777153|Lomustine|lomustine|mesh-list
25570572|NCT00777153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570573|NCT00777153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25570574|NCT00777153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570575|NCT00777153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577642|NCT00845351|Bexarotene|bexarotene|mesh-list
25570576|NCT00777153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25570577|NCT00777153|Alkylating Agents|alkylating agents|mesh-ancestor
25570578|NCT00777296|Amikacin|amikacin|mesh-list
25570579|NCT00777296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25570580|NCT00777296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25570581|NCT00777335|Panobinostat|panobinostat|mesh-list
24980338|NCT05353829|Antimetabolites|antimetabolites|mesh-ancestor
25570582|NCT00777335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570583|NCT00777335|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25570584|NCT00777335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570585|NCT00777335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570586|NCT00777556|Levonorgestrel|levonorgestrel|mesh-list
25570587|NCT00777556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25570588|NCT00777556|Contraceptive Agents|contraceptive agents|mesh-ancestor
25570589|NCT00777556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25570590|NCT00777556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570591|NCT00777556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25570592|NCT00777556|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25570593|NCT00777556|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25570594|NCT00777608|Donepezil|donepezil|mesh-list
25570595|NCT00777608|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25570596|NCT00777608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570597|NCT00777608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570598|NCT00777608|Cholinergic Agents|cholinergic agents|mesh-ancestor
25570599|NCT00777608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25570600|NCT00777608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570601|NCT00777608|Nootropic Agents|nootropic agents|mesh-ancestor
25570602|NCT00777803|Botulinum Toxins|botulinum toxins|mesh-list
25570603|NCT00777803|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24980519|NCT05199324|Cefazolin|cefazolin|mesh-list
24579537|NCT00855972|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24580284|NCT00861276|Nicotine|nicotine|mesh-list
25570604|NCT00777803|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25570605|NCT00777803|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25570606|NCT00777803|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25570607|NCT00777803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25570608|NCT00777803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570609|NCT00777803|Cholinergic Agents|cholinergic agents|mesh-ancestor
25570610|NCT00777803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25570611|NCT00777803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570612|NCT00777803|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25570613|NCT00777803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25570614|NCT00777829|Zolpidem|zolpidem|mesh-list
25570615|NCT00777829|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25570616|NCT00777829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25570617|NCT00777829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25570618|NCT00777829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570619|NCT00777829|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25570620|NCT00777829|GABA Agonists|gaba agonists|mesh-ancestor
25570621|NCT00777829|GABA Agents|gaba agents|mesh-ancestor
25570622|NCT00777829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25570623|NCT00777829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570624|NCT00777855|Rifampin|rifampin|mesh-list
25570625|NCT00777855|Warfarin|warfarin|mesh-list
25570626|NCT00777855|Anticoagulants|anticoagulants|mesh-ancestor
25570627|NCT00777855|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25570628|NCT00777855|Antitubercular Agents|antitubercular agents|mesh-ancestor
25570629|NCT00777855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25465261|NCT03246906|Cyclosporins|cyclosporins|mesh-list
25465262|NCT03246906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25465263|NCT03246906|Immunologic Factors|immunologic factors|mesh-ancestor
25465264|NCT03246906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465265|NCT03246906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25465266|NCT03246906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25465267|NCT03246906|Alkylating Agents|alkylating agents|mesh-ancestor
25465268|NCT03246906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951428|NCT03904745|Atosiban|atosiban|mesh-list
25465269|NCT03246906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465270|NCT03246906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25465271|NCT03246906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25465272|NCT03246906|Antifungal Agents|antifungal agents|mesh-ancestor
25465273|NCT03246906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25465274|NCT03246906|Dermatologic Agents|dermatologic agents|mesh-ancestor
25465275|NCT03246906|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25465276|NCT03246906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25570630|NCT00777855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25570631|NCT00777855|Leprostatic Agents|leprostatic agents|mesh-ancestor
25570632|NCT00777855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25570633|NCT00777855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570634|NCT00777855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570635|NCT00777855|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25570636|NCT00777855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25570637|NCT00777855|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25570638|NCT00777855|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25606135|NCT01064882|Bimatoprost|bimatoprost|mesh-list
25570639|NCT00777855|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25570640|NCT00777855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25570641|NCT00777920|Ambrisentan|ambrisentan|mesh-list
25570642|NCT00777920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25570643|NCT00777946|Amlodipine|amlodipine|mesh-list
25570644|NCT00777946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25570645|NCT00777946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25570646|NCT00777946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25570647|NCT00777946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570648|NCT00777946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25570649|NCT00777946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570650|NCT00777946|Vasodilator Agents|vasodilator agents|mesh-ancestor
25570651|NCT00778102|Leucovorin|leucovorin|mesh-list
25570652|NCT00778102|Bevacizumab|bevacizumab|mesh-list
25570653|NCT00778102|Oxaliplatin|oxaliplatin|mesh-list
25570654|NCT00778102|Irinotecan|irinotecan|mesh-list
25570655|NCT00778102|Fluorouracil|fluorouracil|mesh-list
25570656|NCT00778102|Levoleucovorin|levoleucovorin|mesh-list
25570657|NCT00778102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25570658|NCT00778102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570659|NCT00778102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25570660|NCT00778102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25570661|NCT00778102|Growth Substances|growth substances|mesh-ancestor
25570662|NCT00778102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570663|NCT00778102|Growth Inhibitors|growth inhibitors|mesh-ancestor
25570664|NCT00778102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25570665|NCT00778102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25570666|NCT00778102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570667|NCT00778102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570668|NCT00778102|Antidotes|antidotes|mesh-ancestor
25570669|NCT00778102|Protective Agents|protective agents|mesh-ancestor
25570670|NCT00778102|Vitamin B Complex|vitamin b complex|mesh-ancestor
25570671|NCT00778102|Vitamins|vitamins|mesh-ancestor
25570672|NCT00778102|Micronutrients|micronutrients|mesh-ancestor
25570673|NCT00778102|Antimetabolites|antimetabolites|mesh-ancestor
25570674|NCT00778102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25570675|NCT00778102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25570676|NCT00778102|Immunologic Factors|immunologic factors|mesh-ancestor
25570677|NCT00778167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25570678|NCT00778167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25570679|NCT00778167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795640|NCT01097746|Paclitaxel|paclitaxel|mesh-list
25570680|NCT00778167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25570681|NCT00778167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570682|NCT00778167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570683|NCT00778167|Immunologic Factors|immunologic factors|mesh-ancestor
25570684|NCT00778167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570685|NCT00778310|Methylphenidate|methylphenidate|mesh-list
25570686|NCT00778310|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25570687|NCT00778310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570688|NCT00778310|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25570689|NCT00778310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25570690|NCT00778310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25570691|NCT00778310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570692|NCT00778310|Dopamine Agents|dopamine agents|mesh-ancestor
25570693|NCT00778310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25570694|NCT00778375|Cytarabine|cytarabine|mesh-list
25570695|NCT00778375|Decitabine|decitabine|mesh-list
25570696|NCT00778375|Clofarabine|clofarabine|mesh-list
25697802|NCT02082912|Antimetabolites|antimetabolites|mesh-ancestor
25570697|NCT00778375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25570698|NCT00778375|Antimetabolites|antimetabolites|mesh-ancestor
25570699|NCT00778375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570700|NCT00778375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570701|NCT00778375|Antiviral Agents|antiviral agents|mesh-ancestor
25570702|NCT00778375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25570703|NCT00778375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25570704|NCT00778375|Immunologic Factors|immunologic factors|mesh-ancestor
24444791|NCT00299091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24473503|NCT00403065|Autonomic Agents|autonomic agents|mesh-ancestor
24473504|NCT00403065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24473505|NCT00403065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473506|NCT00403065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25570705|NCT00778375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570706|NCT00778375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570707|NCT00778622|Metformin|metformin|mesh-list
25570708|NCT00778622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25570709|NCT00778622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570710|NCT00778817|Mitotane|mitotane|mesh-list
25570711|NCT00778817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25570712|NCT00778817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570713|NCT00778830|Cetuximab|cetuximab|mesh-list
25570714|NCT00778830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25570715|NCT00778830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570716|NCT00778869|Infliximab|infliximab|mesh-list
25570717|NCT00778869|Dermatologic Agents|dermatologic agents|mesh-ancestor
25570718|NCT00778869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25570719|NCT00778869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25570720|NCT00778921|Amlodipine|amlodipine|mesh-list
25570721|NCT00778921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25570722|NCT00778921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25570723|NCT00778921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25570724|NCT00778921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570725|NCT00778921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25570726|NCT00778921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570727|NCT00778921|Vasodilator Agents|vasodilator agents|mesh-ancestor
25570728|NCT00779142|Methotrexate|methotrexate|mesh-list
25570729|NCT00779142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25570730|NCT00779142|Abortifacient Agents|abortifacient agents|mesh-ancestor
25570731|NCT00779142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25570732|NCT00779142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570733|NCT00779142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25570734|NCT00779142|Antimetabolites|antimetabolites|mesh-ancestor
25570735|NCT00779142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570736|NCT00779142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570737|NCT00779142|Dermatologic Agents|dermatologic agents|mesh-ancestor
25570738|NCT00779142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570739|NCT00779142|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24459500|NCT00344851|Metformin|metformin|mesh-list
24981886|NCT01156220|Furosemide|furosemide|mesh-list
24981887|NCT01156220|Diuretics|diuretics|mesh-ancestor
25570740|NCT00779142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25570741|NCT00779142|Immunologic Factors|immunologic factors|mesh-ancestor
25570742|NCT00779142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25570743|NCT00779142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25570744|NCT00779246|Chlorhexidine|chlorhexidine|mesh-list
25570745|NCT00779246|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24981888|NCT01156220|Natriuretic Agents|natriuretic agents|mesh-ancestor
25570746|NCT00779246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25570747|NCT00779246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25570748|NCT00779246|Disinfectants|disinfectants|mesh-ancestor
25570749|NCT00779246|Dermatologic Agents|dermatologic agents|mesh-ancestor
25570750|NCT00779259|Quinine|quinine|mesh-list
25570751|NCT00779259|Theophylline|theophylline|mesh-list
25570752|NCT00779259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25570753|NCT00779259|Autonomic Agents|autonomic agents|mesh-ancestor
25570754|NCT00779259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25570755|NCT00779259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570756|NCT00779259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24594375|NCT00933582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25570757|NCT00779259|Respiratory System Agents|respiratory system agents|mesh-ancestor
25570758|NCT00779259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25570759|NCT00779259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570760|NCT00779259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570761|NCT00779259|Vasodilator Agents|vasodilator agents|mesh-ancestor
25570762|NCT00779259|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25570763|NCT00779259|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25570764|NCT00779259|Purinergic Agents|purinergic agents|mesh-ancestor
25570765|NCT00779259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25570766|NCT00779259|Antimalarials|antimalarials|mesh-ancestor
25570767|NCT00779259|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25570768|NCT00779259|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25570769|NCT00779259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25570770|NCT00779259|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25570771|NCT00779259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25570772|NCT00779259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25570773|NCT00779259|Analgesics|analgesics|mesh-ancestor
25570774|NCT00779259|Sensory System Agents|sensory system agents|mesh-ancestor
25570775|NCT00779285|Doxorubicin|doxorubicin|mesh-list
25570776|NCT00779285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25570777|NCT00779285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25570778|NCT00779285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570779|NCT00779285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25570780|NCT00779285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25570781|NCT00779285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570782|NCT00779285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570783|NCT00779311|Bevacizumab|bevacizumab|mesh-list
25570784|NCT00779311|Sorafenib|sorafenib|mesh-list
25570785|NCT00779311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25570786|NCT00779311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570787|NCT00779311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25570788|NCT00779311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25570789|NCT00779311|Growth Substances|growth substances|mesh-ancestor
25570790|NCT00779311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570791|NCT00779311|Growth Inhibitors|growth inhibitors|mesh-ancestor
25570792|NCT00779311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25465373|NCT02925195|Micronutrients|micronutrients|mesh-ancestor
25570793|NCT00779311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570794|NCT00779311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599464|NCT04534023|Antioxidants|antioxidants|mesh-ancestor
24599831|NCT03581240|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24599892|NCT03284502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24599893|NCT03284502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599894|NCT03282799|Etonogestrel|etonogestrel|mesh-list
24599962|NCT02942095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24599963|NCT02942095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24599964|NCT02942095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599965|NCT02942095|Protease Inhibitors|protease inhibitors|mesh-ancestor
24599966|NCT02940522|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
24599967|NCT02940522|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
24600204|NCT01696734|Antiemetics|antiemetics|mesh-ancestor
24600209|NCT01696734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24600210|NCT01696734|Dopamine Agents|dopamine agents|mesh-ancestor
24600211|NCT01696734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24600212|NCT01696734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600271|NCT01529593|Sirolimus|sirolimus|mesh-list
24600272|NCT01529593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24600273|NCT01529593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600274|NCT01529593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24600275|NCT01529593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24600276|NCT01529593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24600277|NCT01529593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570796|NCT00779467|Bupivacaine|bupivacaine|mesh-list
25570797|NCT00779467|Neostigmine|neostigmine|mesh-list
25570798|NCT00779467|Anesthetics, Local|anesthetics, local|mesh-ancestor
25570799|NCT00779467|Anesthetics|anesthetics|mesh-ancestor
25570800|NCT00779467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25570801|NCT00779467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570802|NCT00779467|Sensory System Agents|sensory system agents|mesh-ancestor
24982167|NCT03837860|Analgesics|analgesics|mesh-ancestor
24982168|NCT03837860|Sensory System Agents|sensory system agents|mesh-ancestor
24863131|NCT03065244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24626368|NCT01086956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24626369|NCT01086956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24626370|NCT01086956|Anesthetics, General|anesthetics, general|mesh-ancestor
24626371|NCT01086982|Octreotide|octreotide|mesh-list
24626372|NCT01086982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24626373|NCT01086982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24626374|NCT01086982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626375|NCT01087008|Zoledronic Acid|zoledronic acid|mesh-list
24806211|NCT02014506|Alkylating Agents|alkylating agents|mesh-ancestor
24806213|NCT02014506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863216|NCT02681302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863217|NCT02681302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24863219|NCT02590094|Bevacizumab|bevacizumab|mesh-list
24863220|NCT02590094|Aflibercept|aflibercept|mesh-list
24863221|NCT02590094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24863222|NCT02590094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967245|NCT03761004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24967246|NCT03761004|Dopamine Agents|dopamine agents|mesh-ancestor
24967247|NCT03761004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24952159|NCT03896893|Dermatologic Agents|dermatologic agents|mesh-ancestor
25697897|NCT02083861|Respiratory System Agents|respiratory system agents|mesh-ancestor
25697898|NCT02083926|Ketamine|ketamine|mesh-list
25570803|NCT00779467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25570804|NCT00779467|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25570805|NCT00779467|Narcotics|narcotics|mesh-ancestor
25570806|NCT00779467|Analgesics|analgesics|mesh-ancestor
25570807|NCT00779467|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25570808|NCT00779467|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25570809|NCT00779467|Anesthetics, General|anesthetics, general|mesh-ancestor
25570810|NCT00779467|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25570811|NCT00779467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450813|NCT00320658|Immunologic Factors|immunologic factors|mesh-ancestor
24863266|NCT02136069|Immunologic Factors|immunologic factors|mesh-ancestor
24863267|NCT02136069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863268|NCT02096874|Bevacizumab|bevacizumab|mesh-list
24614027|NCT01022125|Antiviral Agents|antiviral agents|mesh-ancestor
24863269|NCT02096874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24863270|NCT02096874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863271|NCT02096874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24863272|NCT02096874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24863273|NCT02096874|Growth Substances|growth substances|mesh-ancestor
24863274|NCT02096874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863275|NCT02096874|Growth Inhibitors|growth inhibitors|mesh-ancestor
24863277|NCT02086552|Immunologic Factors|immunologic factors|mesh-ancestor
24863425|NCT05079620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24863426|NCT05079620|Renal Agents|renal agents|mesh-ancestor
24863427|NCT05079620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24863428|NCT05079620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24863435|NCT05043805|Dextromethorphan|dextromethorphan|mesh-list
24863483|NCT04834362|Insulin Aspart|insulin aspart|mesh-list
24543251|NCT00682656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24863485|NCT04834362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863486|NCT04826354|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25570812|NCT00779467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570813|NCT00779467|Cholinergic Agents|cholinergic agents|mesh-ancestor
25570814|NCT00779467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25570815|NCT00779467|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25570816|NCT00779467|Autonomic Agents|autonomic agents|mesh-ancestor
25570817|NCT00779506|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25570818|NCT00779506|Antidepressive Agents|antidepressive agents|mesh-ancestor
25570819|NCT00779506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25570820|NCT00779506|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25570821|NCT00779506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25570822|NCT00779506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25570823|NCT00779506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570824|NCT00779558|Heparin|heparin|mesh-list
25570825|NCT00779558|Calcium heparin|calcium heparin|mesh-list
25570826|NCT00779558|Anticoagulants|anticoagulants|mesh-ancestor
25570827|NCT00779558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25570828|NCT00779558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25570829|NCT00779558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570830|NCT00779584|Gemcitabine|gemcitabine|mesh-list
25570831|NCT00779584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25570832|NCT00779584|Antimetabolites|antimetabolites|mesh-ancestor
25570833|NCT00779584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570834|NCT00779584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570835|NCT00779584|Antiviral Agents|antiviral agents|mesh-ancestor
25570836|NCT00779584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25570837|NCT00779584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570838|NCT00779584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25570839|NCT00779584|Immunologic Factors|immunologic factors|mesh-ancestor
25052836|NCT00135382|Antiviral Agents|antiviral agents|mesh-ancestor
25052837|NCT00135382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24586892|NCT00892489|Serotonin Agents|serotonin agents|mesh-ancestor
25570840|NCT00779584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570841|NCT00779675|Infliximab|infliximab|mesh-list
25570842|NCT00779675|Dermatologic Agents|dermatologic agents|mesh-ancestor
25570843|NCT00779675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25570844|NCT00779675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25570845|NCT00779701|Insulin|insulin|mesh-list
25570846|NCT00779701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25570847|NCT00779701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570848|NCT00779909|Vitamin D|vitamin d|mesh-list
25570849|NCT00779909|Cholecalciferol|cholecalciferol|mesh-list
25570850|NCT00779909|Vitamins|vitamins|mesh-ancestor
25570851|NCT00779909|Micronutrients|micronutrients|mesh-ancestor
25570852|NCT00779909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570853|NCT00779909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25570854|NCT00779909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25570855|NCT00780026|Insulin|insulin|mesh-list
25570856|NCT00780026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25570857|NCT00780026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570858|NCT00780143|Cytarabine|cytarabine|mesh-list
25570859|NCT00780143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25570860|NCT00780143|Antimetabolites|antimetabolites|mesh-ancestor
25606136|NCT01064882|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25570861|NCT00780143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570862|NCT00780143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570863|NCT00780143|Antiviral Agents|antiviral agents|mesh-ancestor
25570864|NCT00780143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25570865|NCT00780143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25570866|NCT00780143|Immunologic Factors|immunologic factors|mesh-ancestor
25570867|NCT00780143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570868|NCT00780208|Methylphenidate|methylphenidate|mesh-list
25465425|NCT02256696|Rifampin|rifampin|mesh-list
25606137|NCT01064882|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25570869|NCT00780208|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25570870|NCT00780208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570871|NCT00780208|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25570872|NCT00780208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25570873|NCT00780208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25570874|NCT00780208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570876|NCT00780208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25570877|NCT00780234|Pioglitazone|pioglitazone|mesh-list
25570878|NCT00780234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25570879|NCT00780234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570880|NCT00780273|Cimetidine|cimetidine|mesh-list
25570881|NCT00780273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25570882|NCT00780273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25570883|NCT00780273|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25570884|NCT00780273|Histamine Antagonists|histamine antagonists|mesh-ancestor
25570885|NCT00780273|Histamine Agents|histamine agents|mesh-ancestor
25570886|NCT00780273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25570887|NCT00780273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570888|NCT00780273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570889|NCT00780273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25570890|NCT00780273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25570891|NCT00780273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570892|NCT00780416|Ribavirin|ribavirin|mesh-list
25570893|NCT00780416|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25570894|NCT00780416|Interferon-alpha|interferon-alpha|mesh-list
25570895|NCT00780416|Antimetabolites|antimetabolites|mesh-ancestor
25570896|NCT00780416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570897|NCT00780416|Antiviral Agents|antiviral agents|mesh-ancestor
25570898|NCT00780416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25570899|NCT00780416|Immunologic Factors|immunologic factors|mesh-ancestor
25570900|NCT00780416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570901|NCT00780442|Cycloserine|cycloserine|mesh-list
25570902|NCT00780442|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25570903|NCT00780442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25570904|NCT00780442|Renal Agents|renal agents|mesh-ancestor
25570905|NCT00780442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25570906|NCT00780442|Antitubercular Agents|antitubercular agents|mesh-ancestor
25570907|NCT00780442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25570908|NCT00780442|Antimetabolites|antimetabolites|mesh-ancestor
25570909|NCT00780442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570910|NCT00780494|Bevacizumab|bevacizumab|mesh-list
25570911|NCT00780494|Carboplatin|carboplatin|mesh-list
25570912|NCT00780494|Capecitabine|capecitabine|mesh-list
25570913|NCT00780494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25570914|NCT00780494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570915|NCT00780494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25570916|NCT00780494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25570917|NCT00780494|Growth Substances|growth substances|mesh-ancestor
25570918|NCT00780494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570919|NCT00780494|Growth Inhibitors|growth inhibitors|mesh-ancestor
25570920|NCT00780494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25570921|NCT00780494|Antimetabolites|antimetabolites|mesh-ancestor
25570922|NCT00780494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570923|NCT00780676|Dasatinib|dasatinib|mesh-list
25570924|NCT00780676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25570925|NCT00780676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25570926|NCT00780676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570927|NCT00780676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570928|NCT00780715|Metformin|metformin|mesh-list
25053914|NCT00002479|Tretinoin|tretinoin|mesh-list
25570929|NCT00780715|Pioglitazone|pioglitazone|mesh-list
25570930|NCT00780715|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25570931|NCT00780715|Gliclazide|gliclazide|mesh-list
25570932|NCT00780715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25570933|NCT00780715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570934|NCT00780715|Incretins|incretins|mesh-ancestor
25570935|NCT00780715|Hormones|hormones|mesh-ancestor
25570936|NCT00780715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25570937|NCT00780715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25570938|NCT00780715|Protease Inhibitors|protease inhibitors|mesh-ancestor
25570939|NCT00780715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570940|NCT00780715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106587|NCT02245672|Xhance|xhance|mesh-list
25570941|NCT00780910|Ribavirin|ribavirin|mesh-list
25570942|NCT00780910|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25570943|NCT00780910|Antimetabolites|antimetabolites|mesh-ancestor
24983284|NCT01453946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25570944|NCT00780910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570945|NCT00780910|Antiviral Agents|antiviral agents|mesh-ancestor
25570946|NCT00780910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25570947|NCT00780962|Acetylcysteine|acetylcysteine|mesh-list
25570948|NCT00780962|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25570949|NCT00780962|Antiviral Agents|antiviral agents|mesh-ancestor
25570950|NCT00780962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25570951|NCT00780962|Expectorants|expectorants|mesh-ancestor
25570952|NCT00780962|Respiratory System Agents|respiratory system agents|mesh-ancestor
25570953|NCT00780962|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25570954|NCT00780962|Antioxidants|antioxidants|mesh-ancestor
25606138|NCT01064882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25570955|NCT00780962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570956|NCT00780962|Protective Agents|protective agents|mesh-ancestor
25570957|NCT00780962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570958|NCT00780962|Antidotes|antidotes|mesh-ancestor
25570960|NCT00781274|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25570961|NCT00781274|Antimetabolites|antimetabolites|mesh-ancestor
25570962|NCT00781274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570963|NCT00781274|Antiviral Agents|antiviral agents|mesh-ancestor
25570964|NCT00781274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25570965|NCT00781326|Nimodipine|nimodipine|mesh-list
25570966|NCT00781326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25570967|NCT00781326|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25606139|NCT01064947|Retapamulin|retapamulin|mesh-list
25570968|NCT00781326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25606140|NCT01064947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25570969|NCT00781326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570970|NCT00781326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25570971|NCT00781326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570972|NCT00781326|Vasodilator Agents|vasodilator agents|mesh-ancestor
25570973|NCT00781391|Warfarin|warfarin|mesh-list
25570974|NCT00781391|Edoxaban|edoxaban|mesh-list
25570975|NCT00781391|Anticoagulants|anticoagulants|mesh-ancestor
25570976|NCT00781391|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25570977|NCT00781391|Antithrombins|antithrombins|mesh-ancestor
25570978|NCT00781391|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25570979|NCT00781391|Protease Inhibitors|protease inhibitors|mesh-ancestor
25570980|NCT00781391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570981|NCT00781391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570982|NCT00781456|Contraceptive Agents|contraceptive agents|mesh-list
25570983|NCT00781456|Levonorgestrel|levonorgestrel|mesh-list
25570984|NCT00781456|Contraceptives, Oral|contraceptives, oral|mesh-list
25570985|NCT00781456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25570986|NCT00781456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25570987|NCT00781456|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25570988|NCT00781456|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25570989|NCT00781456|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25570990|NCT00781508|Sildenafil Citrate|sildenafil citrate|mesh-list
25570991|NCT00781508|Vasodilator Agents|vasodilator agents|mesh-ancestor
25570992|NCT00781508|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25570993|NCT00781508|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25570994|NCT00781508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25570995|NCT00781508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25570996|NCT00781508|Urological Agents|urological agents|mesh-ancestor
25570997|NCT00781599|Varenicline|varenicline|mesh-list
25570998|NCT00781599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25570999|NCT00781599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25571000|NCT00781599|Cholinergic Agents|cholinergic agents|mesh-ancestor
25571001|NCT00781599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25571002|NCT00781599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571003|NCT00781599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571004|NCT00781768|Ondansetron|ondansetron|mesh-list
25571005|NCT00781768|Aprepitant|aprepitant|mesh-list
25571006|NCT00781768|Antiemetics|antiemetics|mesh-ancestor
25571007|NCT00781768|Autonomic Agents|autonomic agents|mesh-ancestor
25571008|NCT00781768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25571009|NCT00781768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571010|NCT00781768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25571011|NCT00781768|Antipruritics|antipruritics|mesh-ancestor
25571012|NCT00781768|Dermatologic Agents|dermatologic agents|mesh-ancestor
25571013|NCT00781768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25571014|NCT00781768|Serotonin Agents|serotonin agents|mesh-ancestor
25571015|NCT00781768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25571016|NCT00781768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571018|NCT00781768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25571019|NCT00781768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25571020|NCT00781768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25571021|NCT00781768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25571022|NCT00781768|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25571023|NCT00781859|Plasminogen|plasminogen|mesh-list
25571024|NCT00781859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25571025|NCT00781859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25571026|NCT00781859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571027|NCT00781885|Beraprost|beraprost|mesh-list
25571028|NCT00781885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25571029|NCT00781885|Vasodilator Agents|vasodilator agents|mesh-ancestor
25571030|NCT00781898|Naltrexone|naltrexone|mesh-list
25571031|NCT00781898|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25571032|NCT00781898|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25571033|NCT00781898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571034|NCT00781898|Sensory System Agents|sensory system agents|mesh-ancestor
25571035|NCT00781898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25571036|NCT00781911|Octreotide|octreotide|mesh-list
25571037|NCT00781911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25571038|NCT00781911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25571039|NCT00781911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571040|NCT00781937|Liraglutide|liraglutide|mesh-list
25571041|NCT00781937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25465620|NCT05234840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465621|NCT05234619|Ketorolac|ketorolac|mesh-list
25465622|NCT05234619|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25465623|NCT05234619|Lidocaine|lidocaine|mesh-list
25465624|NCT05234619|Anesthetics, Local|anesthetics, local|mesh-ancestor
25465625|NCT05234619|Anesthetics|anesthetics|mesh-ancestor
25465626|NCT05234619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25465627|NCT05234619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465628|NCT05234619|Sensory System Agents|sensory system agents|mesh-ancestor
25465629|NCT05234619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25465630|NCT05234619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25465631|NCT05234619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25465632|NCT05234619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25465633|NCT05234619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24869189|NCT04345861|Azithromycin|azithromycin|mesh-list
25465634|NCT05234619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465635|NCT05234619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25465636|NCT05234619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25465637|NCT05234619|Analgesics|analgesics|mesh-ancestor
25465638|NCT05234619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25465639|NCT05234619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25465640|NCT05234619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25465641|NCT05234619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25571042|NCT00781937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571043|NCT00781937|Incretins|incretins|mesh-ancestor
25571044|NCT00781937|Hormones|hormones|mesh-ancestor
25571045|NCT00781937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25571046|NCT00782067|Midostaurin|midostaurin|mesh-list
25571047|NCT00782067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571048|NCT00782067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25571049|NCT00782067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25571050|NCT00782067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571051|NCT00782210|Olodaterol|olodaterol|mesh-list
25571052|NCT00782210|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25571053|NCT00782210|Autonomic Agents|autonomic agents|mesh-ancestor
25571054|NCT00782210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25571055|NCT00782210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571056|NCT00782210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25571057|NCT00782210|Respiratory System Agents|respiratory system agents|mesh-ancestor
25571058|NCT00782275|Sirolimus|sirolimus|mesh-list
25571059|NCT00782275|Bevacizumab|bevacizumab|mesh-list
25571060|NCT00782275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25571061|NCT00782275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571062|NCT00782275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25571063|NCT00782275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25571064|NCT00782275|Growth Substances|growth substances|mesh-ancestor
25571065|NCT00782275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571066|NCT00782275|Growth Inhibitors|growth inhibitors|mesh-ancestor
25571067|NCT00782275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25698128|NCT02087748|Analgesics|analgesics|mesh-ancestor
25571069|NCT00782275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25571070|NCT00782275|Antifungal Agents|antifungal agents|mesh-ancestor
25571071|NCT00782275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25571072|NCT00782275|Immunologic Factors|immunologic factors|mesh-ancestor
25571073|NCT00782340|Droxidopa|droxidopa|mesh-list
25571074|NCT00782340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25571075|NCT00782340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25571076|NCT00782379|Mycophenolic Acid|mycophenolic acid|mesh-list
25571077|NCT00782379|Cyclophosphamide|cyclophosphamide|mesh-list
25571078|NCT00782379|Busulfan|busulfan|mesh-list
25571079|NCT00782379|Fludarabine|fludarabine|mesh-list
25571080|NCT00782379|Fludarabine phosphate|fludarabine phosphate|mesh-list
25571081|NCT00782379|Tacrolimus|tacrolimus|mesh-list
25571082|NCT00782379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25571083|NCT00782379|Immunologic Factors|immunologic factors|mesh-ancestor
25571084|NCT00782379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571085|NCT00782379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25571086|NCT00782379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25571087|NCT00782379|Alkylating Agents|alkylating agents|mesh-ancestor
25571088|NCT00782379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571089|NCT00782379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571090|NCT00782379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25571091|NCT00782379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25571092|NCT00782379|Antimetabolites|antimetabolites|mesh-ancestor
25571093|NCT00782379|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25571094|NCT00782379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25571095|NCT00782379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24984972|NCT03829007|Durvalumab|durvalumab|mesh-list
25571096|NCT00782379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25571097|NCT00782379|Antitubercular Agents|antitubercular agents|mesh-ancestor
25571098|NCT00782379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25571099|NCT00782379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25571100|NCT00782418|Exenatide|exenatide|mesh-list
25571101|NCT00782418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25571102|NCT00782418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571103|NCT00782418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25571104|NCT00782418|Incretins|incretins|mesh-ancestor
25571105|NCT00782418|Hormones|hormones|mesh-ancestor
25571106|NCT00782418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25571107|NCT00782509|Olodaterol|olodaterol|mesh-list
25571108|NCT00782509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25571109|NCT00782509|Autonomic Agents|autonomic agents|mesh-ancestor
25571110|NCT00782509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25571111|NCT00782509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571112|NCT00782509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25571113|NCT00782509|Respiratory System Agents|respiratory system agents|mesh-ancestor
25571114|NCT00782626|Everolimus|everolimus|mesh-list
25571115|NCT00782626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571116|NCT00782626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25571117|NCT00782626|Immunologic Factors|immunologic factors|mesh-ancestor
25106934|NCT03143452|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25571118|NCT00782626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652315|NCT01525628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652316|NCT01525628|Antiviral Agents|antiviral agents|mesh-ancestor
25652317|NCT01525628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25652318|NCT01525628|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25652319|NCT01525628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25652320|NCT01525628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25652321|NCT01525628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652322|NCT01525628|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25698228|NCT02090075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25056098|NCT03515382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056099|NCT03515382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25652323|NCT01525628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25652324|NCT01525628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25652325|NCT01525628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25652326|NCT01525628|Anesthetics, General|anesthetics, general|mesh-ancestor
25652327|NCT01525628|Anesthetics|anesthetics|mesh-ancestor
25652328|NCT01525628|GABA Modulators|gaba modulators|mesh-ancestor
25652329|NCT01525628|GABA Agents|gaba agents|mesh-ancestor
25652330|NCT01525628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25652331|NCT01525628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652332|NCT01525628|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25652333|NCT01525628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25652334|NCT01525628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652335|NCT01525628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25652336|NCT01525628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25652337|NCT01525628|Antimetabolites|antimetabolites|mesh-ancestor
25652338|NCT01525628|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25571120|NCT00782717|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25571121|NCT00782717|Methylprednisolone|methylprednisolone|mesh-list
25571122|NCT00782717|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25571123|NCT00782717|Prednisolone acetate|prednisolone acetate|mesh-list
25571124|NCT00782717|Nepafenac|nepafenac|mesh-list
25698236|NCT02090374|Interferon Inducers|interferon inducers|mesh-ancestor
25571125|NCT00782717|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25571126|NCT00782717|Prednisolone phosphate|prednisolone phosphate|mesh-list
25571127|NCT00782717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25571128|NCT00782717|Glucocorticoids|glucocorticoids|mesh-ancestor
25571129|NCT00782717|Hormones|hormones|mesh-ancestor
25571130|NCT00782717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25571131|NCT00782717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571132|NCT00782717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25571133|NCT00782717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571134|NCT00782717|Antiemetics|antiemetics|mesh-ancestor
25571135|NCT00782717|Autonomic Agents|autonomic agents|mesh-ancestor
24985287|NCT03514121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24985289|NCT03513770|Ketorolac|ketorolac|mesh-list
25571136|NCT00782717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25571137|NCT00782717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25571138|NCT00782717|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25571139|NCT00782717|Protective Agents|protective agents|mesh-ancestor
25571140|NCT00782717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25571141|NCT00782717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25571142|NCT00782717|Analgesics|analgesics|mesh-ancestor
25571143|NCT00782717|Sensory System Agents|sensory system agents|mesh-ancestor
25571144|NCT00782717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25571145|NCT00782756|Bevacizumab|bevacizumab|mesh-list
25571146|NCT00782756|Temozolomide|temozolomide|mesh-list
25571147|NCT00782756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25571148|NCT00782756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571149|NCT00782756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25571150|NCT00782756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25571151|NCT00782756|Growth Substances|growth substances|mesh-ancestor
25571152|NCT00782756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571153|NCT00782756|Growth Inhibitors|growth inhibitors|mesh-ancestor
25571154|NCT00782756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25571155|NCT00782756|Alkylating Agents|alkylating agents|mesh-ancestor
25571156|NCT00782756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571157|NCT00782795|Pioglitazone|pioglitazone|mesh-list
25571158|NCT00782795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25571159|NCT00782795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571160|NCT00782821|Rituximab|rituximab|mesh-list
25571161|NCT00782821|Bortezomib|bortezomib|mesh-list
25571162|NCT00782821|Thymoglobulin|thymoglobulin|mesh-list
25571163|NCT00782821|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25571164|NCT00782821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25571165|NCT00782821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571166|NCT00782821|Immunologic Factors|immunologic factors|mesh-ancestor
25571167|NCT00782821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571168|NCT00782821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25571169|NCT00782821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25571170|NCT00783094|Tadalafil|tadalafil|mesh-list
25571171|NCT00783094|Vasodilator Agents|vasodilator agents|mesh-ancestor
25571172|NCT00783094|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25571173|NCT00783094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25571174|NCT00783094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25571175|NCT00783094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571176|NCT00783094|Urological Agents|urological agents|mesh-ancestor
25571177|NCT00783289|Benralizumab|benralizumab|mesh-list
25571178|NCT00783289|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25571179|NCT00783289|Respiratory System Agents|respiratory system agents|mesh-ancestor
25571180|NCT00783432|Azelastine|azelastine|mesh-list
25571181|NCT00783432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25571182|NCT00783432|Autonomic Agents|autonomic agents|mesh-ancestor
25571183|NCT00783432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25571184|NCT00783432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571185|NCT00783432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25465718|NCT05233202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465719|NCT05233202|Protective Agents|protective agents|mesh-ancestor
25465720|NCT05233202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465721|NCT05233124|Aspirin|aspirin|mesh-list
25465722|NCT05233124|Rivaroxaban|rivaroxaban|mesh-list
25465778|NCT05230797|Zinc|zinc|mesh-list
25571186|NCT00783432|Respiratory System Agents|respiratory system agents|mesh-ancestor
25571187|NCT00783432|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25571188|NCT00783432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25571189|NCT00783432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571190|NCT00783432|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25571191|NCT00783432|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25571192|NCT00783432|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25571193|NCT00783432|Histamine Antagonists|histamine antagonists|mesh-ancestor
25571194|NCT00783432|Histamine Agents|histamine agents|mesh-ancestor
25571195|NCT00783432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25571197|NCT00783614|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25571198|NCT00783614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25571199|NCT00783614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25571200|NCT00783614|Analgesics|analgesics|mesh-ancestor
25571201|NCT00783614|Sensory System Agents|sensory system agents|mesh-ancestor
25571202|NCT00783614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25571203|NCT00783614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571204|NCT00783614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25571205|NCT00783614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25571206|NCT00783614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25571207|NCT00783614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25571208|NCT00783614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571209|NCT00783614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25571210|NCT00783614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25571211|NCT00783614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25571212|NCT00783614|Antipyretics|antipyretics|mesh-ancestor
25571213|NCT00783614|Antiviral Agents|antiviral agents|mesh-ancestor
25571214|NCT00783614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25571215|NCT00783692|Vedolizumab|vedolizumab|mesh-list
25571216|NCT00783692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25571217|NCT00783705|Inositol|inositol|mesh-list
25571218|NCT00783705|Vitamin B Complex|vitamin b complex|mesh-ancestor
25571219|NCT00783705|Vitamins|vitamins|mesh-ancestor
25571220|NCT00783705|Micronutrients|micronutrients|mesh-ancestor
25571221|NCT00783705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571222|NCT00783718|Vedolizumab|vedolizumab|mesh-list
25571223|NCT00783718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25571224|NCT00783796|Everolimus|everolimus|mesh-list
25571225|NCT00783796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571226|NCT00783796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25571227|NCT00783796|Immunologic Factors|immunologic factors|mesh-ancestor
25571228|NCT00783796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571229|NCT00783835|Methylphenidate|methylphenidate|mesh-list
25571230|NCT00783835|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25571231|NCT00783835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571232|NCT00783835|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25571233|NCT00783835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25571234|NCT00783835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25571235|NCT00783835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571236|NCT00783835|Dopamine Agents|dopamine agents|mesh-ancestor
25571237|NCT00783835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25571238|NCT00783965|Tazarotene|tazarotene|mesh-list
25571239|NCT00783965|Dermatologic Agents|dermatologic agents|mesh-ancestor
25571240|NCT00783965|Keratolytic Agents|keratolytic agents|mesh-ancestor
25571241|NCT00784134|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25571242|NCT00784134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25571243|NCT00784134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25571244|NCT00784134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571245|NCT00784147|Ibalizumab|ibalizumab|mesh-list
25571246|NCT00784147|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25571247|NCT00784147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25571248|NCT00784147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25571249|NCT00784147|Antiviral Agents|antiviral agents|mesh-ancestor
25571250|NCT00784147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25571251|NCT00784147|Immunologic Factors|immunologic factors|mesh-ancestor
25056250|NCT03514342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25571252|NCT00784147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571253|NCT00784225|Vitamins|vitamins|mesh-list
25571254|NCT00784225|Vitamin E|vitamin e|mesh-list
25571255|NCT00784225|Tocopherols|tocopherols|mesh-list
25571256|NCT00784225|Tocotrienols|tocotrienols|mesh-list
25571257|NCT00784225|alpha-Tocopherol|alpha-tocopherol|mesh-list
25571258|NCT00784225|Selenium|selenium|mesh-list
25571259|NCT00784225|Micronutrients|micronutrients|mesh-ancestor
25571260|NCT00784225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571261|NCT00784225|Antioxidants|antioxidants|mesh-ancestor
25571262|NCT00784225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571263|NCT00784225|Protective Agents|protective agents|mesh-ancestor
25571264|NCT00784225|Trace Elements|trace elements|mesh-ancestor
25465791|NCT05230654|Aprepitant|aprepitant|mesh-list
25056441|NCT03512574|Pregabalin|pregabalin|mesh-list
25571265|NCT00784238|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25571266|NCT00784238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25571267|NCT00784238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25571268|NCT00784238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25571269|NCT00784238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571270|NCT00784238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25571271|NCT00784238|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25571272|NCT00784238|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25571273|NCT00784238|Serotonin Agents|serotonin agents|mesh-ancestor
25571274|NCT00784238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25571275|NCT00784238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571276|NCT00784238|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25571277|NCT00784238|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24611249|NCT01008020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623404|NCT01071291|Vitamin B Complex|vitamin b complex|mesh-ancestor
25571278|NCT00784238|Dopamine Agents|dopamine agents|mesh-ancestor
25571280|NCT00784277|Tapentadol|tapentadol|mesh-list
25571281|NCT00784277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25571282|NCT00784277|Narcotics|narcotics|mesh-ancestor
25571283|NCT00784277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25571284|NCT00784277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571285|NCT00784277|Analgesics|analgesics|mesh-ancestor
25571286|NCT00784277|Sensory System Agents|sensory system agents|mesh-ancestor
25571287|NCT00784277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25571288|NCT00784277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25698281|NCT02091739|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25698282|NCT02091739|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25698283|NCT02091739|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25698284|NCT02091739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25056602|NCT03511183|Bevacizumab|bevacizumab|mesh-list
25571289|NCT00784277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25571290|NCT00784277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25571291|NCT00784277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571292|NCT00784277|Adrenergic Agents|adrenergic agents|mesh-ancestor
25571293|NCT00784277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25571294|NCT00784303|Lenvatinib|lenvatinib|mesh-list
25571295|NCT00784303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571296|NCT00784303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25571297|NCT00784303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25571298|NCT00784303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465863|NCT05075876|Antiemetics|antiemetics|mesh-ancestor
25465864|NCT05075876|Autonomic Agents|autonomic agents|mesh-ancestor
25465865|NCT05075876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25465866|NCT05075876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465867|NCT05075876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25465868|NCT05075876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25465869|NCT05075876|Serotonin Agents|serotonin agents|mesh-ancestor
25465870|NCT05075876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25465871|NCT05075876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465872|NCT05045170|Dexmedetomidine|dexmedetomidine|mesh-list
25465873|NCT05045170|Propofol|propofol|mesh-list
25465874|NCT05045170|Anesthetics|anesthetics|mesh-ancestor
25465875|NCT05045170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25465876|NCT05045170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24878554|NCT01430572|Everolimus|everolimus|mesh-list
25465877|NCT05045170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25465878|NCT05045170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25465879|NCT05045170|Anesthetics, General|anesthetics, general|mesh-ancestor
25465880|NCT05045170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25465881|NCT05045170|Analgesics|analgesics|mesh-ancestor
25571299|NCT00784368|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25571300|NCT00784459|Abatacept|abatacept|mesh-list
25571301|NCT00784459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25571302|NCT00784459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465882|NCT05045170|Sensory System Agents|sensory system agents|mesh-ancestor
25571303|NCT00784459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571304|NCT00784459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25571305|NCT00784459|Immunologic Factors|immunologic factors|mesh-ancestor
25571306|NCT00784459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571307|NCT00784459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25571308|NCT00784524|Aldesleukin|aldesleukin|mesh-list
25571309|NCT00784524|Interleukin-2|interleukin-2|mesh-list
25571310|NCT00784524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571311|NCT00784524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25571312|NCT00784524|Analgesics|analgesics|mesh-ancestor
25571313|NCT00784524|Sensory System Agents|sensory system agents|mesh-ancestor
25571314|NCT00784524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25571315|NCT00784524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571316|NCT00784524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25571317|NCT00784524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25571318|NCT00784524|Antiviral Agents|antiviral agents|mesh-ancestor
25571319|NCT00784524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25571320|NCT00784550|Fluticasone|fluticasone|mesh-list
25571321|NCT00784550|Xhance|xhance|mesh-list
24879003|NCT05174845|Vitamins|vitamins|mesh-ancestor
25571322|NCT00784550|Bromides|bromides|mesh-list
25571323|NCT00784550|Tiotropium Bromide|tiotropium bromide|mesh-list
25571324|NCT00784550|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25571325|NCT00784550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25571326|NCT00784550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25571327|NCT00784550|Autonomic Agents|autonomic agents|mesh-ancestor
25571328|NCT00784550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25571329|NCT00784550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571330|NCT00784550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25571331|NCT00784550|Respiratory System Agents|respiratory system agents|mesh-ancestor
25571332|NCT00784550|Dermatologic Agents|dermatologic agents|mesh-ancestor
25571333|NCT00784550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25571334|NCT00784550|Parasympatholytics|parasympatholytics|mesh-ancestor
25571335|NCT00784550|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25571336|NCT00784550|Cholinergic Agents|cholinergic agents|mesh-ancestor
25571337|NCT00784550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25571338|NCT00784550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571339|NCT00784550|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25571340|NCT00784550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25571341|NCT00784550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25056739|NCT03509831|Irsogladine|irsogladine|mesh-list
25571342|NCT00784550|Adrenergic Agents|adrenergic agents|mesh-ancestor
25571343|NCT00784550|Anticonvulsants|anticonvulsants|mesh-ancestor
25571344|NCT00784654|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25571345|NCT00784654|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25571346|NCT00784654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571347|NCT00784654|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25571348|NCT00784654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25571349|NCT00784654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24879540|NCT04673786|Ustekinumab|ustekinumab|mesh-list
24879543|NCT04670068|Fludarabine|fludarabine|mesh-list
25571350|NCT00784654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571351|NCT00784654|Dopamine Agents|dopamine agents|mesh-ancestor
25571352|NCT00784654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25571353|NCT00784693|Tanezumab|tanezumab|mesh-list
25571354|NCT00784693|Analgesics|analgesics|mesh-ancestor
25571355|NCT00784693|Sensory System Agents|sensory system agents|mesh-ancestor
24509684|NCT00561613|Contraceptive Agents|contraceptive agents|mesh-ancestor
25571356|NCT00784693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25571357|NCT00784693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571358|NCT00784719|Cyclosporine|cyclosporine|mesh-list
25571359|NCT00784719|Cyclosporins|cyclosporins|mesh-list
25571360|NCT00784719|Tofacitinib|tofacitinib|mesh-list
25571361|NCT00784719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25571362|NCT00784719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571363|NCT00784719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25571364|NCT00784719|Immunologic Factors|immunologic factors|mesh-ancestor
25571365|NCT00784719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571366|NCT00784719|Antifungal Agents|antifungal agents|mesh-ancestor
25571367|NCT00784719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25571368|NCT00784719|Dermatologic Agents|dermatologic agents|mesh-ancestor
25571369|NCT00784719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25571370|NCT00784719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24881035|NCT03109795|Analgesics|analgesics|mesh-ancestor
25571371|NCT00784719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25571372|NCT00784784|Zanamivir|zanamivir|mesh-list
25571373|NCT00784784|Antiviral Agents|antiviral agents|mesh-ancestor
25571374|NCT00784784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25571375|NCT00784784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25571376|NCT00784784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881384|NCT02564263|Paclitaxel|paclitaxel|mesh-list
25571377|NCT00784810|Acetaminophen|acetaminophen|mesh-list
25571378|NCT00784810|Oxycodone|oxycodone|mesh-list
25571379|NCT00784810|Codeine|codeine|mesh-list
25571380|NCT00784810|Naloxone|naloxone|mesh-list
25571381|NCT00784810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25571382|NCT00784810|Analgesics|analgesics|mesh-ancestor
24952679|NCT03892512|Adrenergic Agents|adrenergic agents|mesh-ancestor
25571383|NCT00784810|Sensory System Agents|sensory system agents|mesh-ancestor
25571384|NCT00784810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25571385|NCT00784810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571386|NCT00784810|Antipyretics|antipyretics|mesh-ancestor
25571387|NCT00784810|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25571388|NCT00784810|Narcotics|narcotics|mesh-ancestor
25571389|NCT00784810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25571390|NCT00784810|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25571391|NCT00784810|Antitussive Agents|antitussive agents|mesh-ancestor
25571392|NCT00784810|Respiratory System Agents|respiratory system agents|mesh-ancestor
25571393|NCT00784836|Interferons|interferons|mesh-list
25571394|NCT00784836|Interferon-beta|interferon-beta|mesh-list
25571395|NCT00784836|Interferon beta-1a|interferon beta-1a|mesh-list
25571396|NCT00784836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571397|NCT00784836|Antiviral Agents|antiviral agents|mesh-ancestor
25571398|NCT00784836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25571399|NCT00784836|Immunologic Factors|immunologic factors|mesh-ancestor
25571400|NCT00784836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571401|NCT00784836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25571402|NCT00784849|Methylene Blue|methylene blue|mesh-list
25571403|NCT00784849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25571404|NCT00784849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571406|NCT00784875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25571407|NCT00784875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25571408|NCT00784875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25571409|NCT00784875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571410|NCT00784875|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25571411|NCT00784875|GABA Agonists|gaba agonists|mesh-ancestor
25571412|NCT00784875|GABA Agents|gaba agents|mesh-ancestor
25571413|NCT00784875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25571414|NCT00784875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571415|NCT00784927|Dexamethasone|dexamethasone|mesh-list
25571416|NCT00784927|Cyclophosphamide|cyclophosphamide|mesh-list
25571417|NCT00784927|Rituximab|rituximab|mesh-list
25571418|NCT00784927|Lenalidomide|lenalidomide|mesh-list
25571419|NCT00784927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25571420|NCT00784927|Immunologic Factors|immunologic factors|mesh-ancestor
25571421|NCT00784927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571422|NCT00784927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25571423|NCT00784927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25571424|NCT00784927|Alkylating Agents|alkylating agents|mesh-ancestor
25571425|NCT00784927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571426|NCT00784927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571427|NCT00784927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25571428|NCT00784927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25571429|NCT00784927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25571430|NCT00784927|Antiemetics|antiemetics|mesh-ancestor
25571431|NCT00784927|Autonomic Agents|autonomic agents|mesh-ancestor
25571432|NCT00784927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25571433|NCT00784927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25571434|NCT00784927|Glucocorticoids|glucocorticoids|mesh-ancestor
25571435|NCT00784927|Hormones|hormones|mesh-ancestor
25571436|NCT00784927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25571437|NCT00784927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25571438|NCT00784927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25571439|NCT00784927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25571440|NCT00784927|Growth Substances|growth substances|mesh-ancestor
25571441|NCT00784927|Growth Inhibitors|growth inhibitors|mesh-ancestor
25571442|NCT00784979|Immunoglobulins|immunoglobulins|mesh-list
25571443|NCT00784979|Immunologic Factors|immunologic factors|mesh-ancestor
25571444|NCT00784979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571445|NCT00785213|Rosiglitazone|rosiglitazone|mesh-list
25571446|NCT00785213|Quinine|quinine|mesh-list
25571447|NCT00785213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25571448|NCT00785213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571449|NCT00785213|Antimalarials|antimalarials|mesh-ancestor
25571450|NCT00785213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25571451|NCT00785213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25571452|NCT00785213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25571453|NCT00785213|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25571454|NCT00785213|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25571455|NCT00785213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25571456|NCT00785213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25571457|NCT00785213|Analgesics|analgesics|mesh-ancestor
25571458|NCT00785213|Sensory System Agents|sensory system agents|mesh-ancestor
25571459|NCT00785486|Quinine|quinine|mesh-list
25571460|NCT00785486|Midazolam|midazolam|mesh-list
25571461|NCT00785486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25571462|NCT00785486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25571463|NCT00785486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25571464|NCT00785486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571465|NCT00785486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25571466|NCT00785486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25571467|NCT00785486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25571468|NCT00785486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25571469|NCT00785486|Anesthetics, General|anesthetics, general|mesh-ancestor
25571470|NCT00785486|Anesthetics|anesthetics|mesh-ancestor
25571471|NCT00785486|GABA Modulators|gaba modulators|mesh-ancestor
25571472|NCT00785486|GABA Agents|gaba agents|mesh-ancestor
25571473|NCT00785486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25571474|NCT00785486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571475|NCT00785486|Antimalarials|antimalarials|mesh-ancestor
25571476|NCT00785486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25571477|NCT00785486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25571478|NCT00785486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25571479|NCT00785486|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25571480|NCT00785486|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25571481|NCT00785486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25571482|NCT00785486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25571483|NCT00785486|Analgesics|analgesics|mesh-ancestor
25571484|NCT00785486|Sensory System Agents|sensory system agents|mesh-ancestor
25571486|NCT00785512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25571487|NCT00785512|Vasodilator Agents|vasodilator agents|mesh-ancestor
25571488|NCT00785512|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25571489|NCT00785512|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25571490|NCT00785512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25571491|NCT00785512|Adrenergic Agents|adrenergic agents|mesh-ancestor
25571492|NCT00785512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25571493|NCT00785512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571494|NCT00785512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571495|NCT00785538|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25571496|NCT00785538|Immunologic Factors|immunologic factors|mesh-ancestor
25571497|NCT00785538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571498|NCT00785577|Pregabalin|pregabalin|mesh-list
25571499|NCT00785577|Analgesics|analgesics|mesh-ancestor
25571500|NCT00785577|Sensory System Agents|sensory system agents|mesh-ancestor
25571501|NCT00785577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25571502|NCT00785577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571503|NCT00785577|Anticonvulsants|anticonvulsants|mesh-ancestor
25571504|NCT00785577|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25571505|NCT00785577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25571506|NCT00785577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571507|NCT00785577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25571508|NCT00785577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25571509|NCT00785577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25571510|NCT00785577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25571511|NCT00785577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25571512|NCT00785629|Calcium|calcium|mesh-list
25571513|NCT00785629|Sevelamer|sevelamer|mesh-list
25571514|NCT00785629|Calcium acetate|calcium acetate|mesh-list
25571515|NCT00785629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25571516|NCT00785629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571517|NCT00785629|Chelating Agents|chelating agents|mesh-ancestor
25571518|NCT00785629|Sequestering Agents|sequestering agents|mesh-ancestor
25571519|NCT00785629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571520|NCT00785772|Gabapentin|gabapentin|mesh-list
25571521|NCT00785772|Analgesics|analgesics|mesh-ancestor
25571522|NCT00785772|Sensory System Agents|sensory system agents|mesh-ancestor
25571523|NCT00785772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25571524|NCT00785772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571525|NCT00785772|Anticonvulsants|anticonvulsants|mesh-ancestor
25571526|NCT00785772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25571527|NCT00785772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25571528|NCT00785772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25571529|NCT00785772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25571530|NCT00785772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25571531|NCT00785772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25571532|NCT00785772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25571533|NCT00785772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571534|NCT00785772|Antimanic Agents|antimanic agents|mesh-ancestor
25571535|NCT00785785|Imatinib Mesylate|imatinib mesylate|mesh-list
25571536|NCT00785785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571537|NCT00785785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25571538|NCT00785785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25571539|NCT00785785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571540|NCT00785980|Ciprofloxacin|ciprofloxacin|mesh-list
25571541|NCT00785980|Quinine|quinine|mesh-list
25571542|NCT00785980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25571543|NCT00785980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25571544|NCT00785980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25466038|NCT05369819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25466106|NCT05369091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466107|NCT05369091|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25466108|NCT05369091|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25466110|NCT05369052|Linezolid|linezolid|mesh-list
25466111|NCT05369052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25466112|NCT05369052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25466113|NCT05369052|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25466114|NCT05369052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466115|NCT05369052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466116|NCT05369039|Prednisolone|prednisolone|mesh-list
25466117|NCT05369039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25466118|NCT05369039|Glucocorticoids|glucocorticoids|mesh-ancestor
25466119|NCT05369039|Hormones|hormones|mesh-ancestor
25466120|NCT05369039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25466121|NCT05369039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466122|NCT05369039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25466123|NCT05369039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466124|NCT05366283|Sargramostim|sargramostim|mesh-list
25466125|NCT05366283|Immunologic Factors|immunologic factors|mesh-ancestor
25466126|NCT05366283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466127|NCT05364996|Dimercaprol|dimercaprol|mesh-list
25466128|NCT05364996|Chelating Agents|chelating agents|mesh-ancestor
25466129|NCT05364996|Sequestering Agents|sequestering agents|mesh-ancestor
25466130|NCT05364996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326742|NCT04868773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25326743|NCT04868175|Timolol|timolol|mesh-list
25326744|NCT04868175|Travoprost|travoprost|mesh-list
25326745|NCT04868175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25326746|NCT04868175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24428800|NCT00241215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24428866|NCT00241371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24428868|NCT00241423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24428869|NCT00241423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428870|NCT00241423|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24428871|NCT00241423|Incretins|incretins|mesh-ancestor
24428872|NCT00241423|Hormones|hormones|mesh-ancestor
24841462|NCT02216058|Sirolimus|sirolimus|mesh-list
24429003|NCT00242203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24429004|NCT00242203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24429005|NCT00242203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25105988|NCT04688203|Magnesium Sulfate|magnesium sulfate|mesh-list
24429006|NCT00242203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24429007|NCT00242203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429008|NCT00242268|Simvastatin|simvastatin|mesh-list
25571545|NCT00785980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25571546|NCT00785980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25571547|NCT00785980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571548|NCT00785980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571549|NCT00785980|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25571550|NCT00785980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25571551|NCT00785980|Antimalarials|antimalarials|mesh-ancestor
25571552|NCT00785980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25571553|NCT00785980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24883761|NCT04874480|Antimetabolites|antimetabolites|mesh-ancestor
25571554|NCT00785980|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25571555|NCT00785980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571556|NCT00785980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25571557|NCT00785980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25571558|NCT00785980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25571559|NCT00785980|Analgesics|analgesics|mesh-ancestor
25571560|NCT00785980|Sensory System Agents|sensory system agents|mesh-ancestor
25571561|NCT00786019|Vitamins|vitamins|mesh-list
25571562|NCT00786019|Ascorbic Acid|ascorbic acid|mesh-list
25571563|NCT00786019|Micronutrients|micronutrients|mesh-ancestor
25571564|NCT00786019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571565|NCT00786019|Antioxidants|antioxidants|mesh-ancestor
25571566|NCT00786019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571567|NCT00786019|Protective Agents|protective agents|mesh-ancestor
25571568|NCT00786188|Paroxetine|paroxetine|mesh-list
25571569|NCT00786188|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25571570|NCT00786188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25571571|NCT00786188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25571572|NCT00786188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571573|NCT00786188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25571574|NCT00786188|Serotonin Agents|serotonin agents|mesh-ancestor
25571575|NCT00786188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571576|NCT00786188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25571577|NCT00786188|Antidepressive Agents|antidepressive agents|mesh-ancestor
25571578|NCT00786188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25571579|NCT00786188|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25571580|NCT00786188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25571581|NCT00786188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25571582|NCT00786422|Rivaroxaban|rivaroxaban|mesh-list
25571583|NCT00786422|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25571584|NCT00786422|Antithrombins|antithrombins|mesh-ancestor
25571585|NCT00786422|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25571586|NCT00786422|Protease Inhibitors|protease inhibitors|mesh-ancestor
24514148|NCT00588302|Moexipril|moexipril|mesh-list
25571587|NCT00786422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25571588|NCT00786422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571589|NCT00786422|Anticoagulants|anticoagulants|mesh-ancestor
25571590|NCT00786474|Dalteparin|dalteparin|mesh-list
25571591|NCT00786474|Tinzaparin|tinzaparin|mesh-list
25571592|NCT00786474|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25571593|NCT00786474|Anticoagulants|anticoagulants|mesh-ancestor
25571594|NCT00786474|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25571595|NCT00786474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25571596|NCT00786474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571597|NCT00786487|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25571598|NCT00786487|Glycerol|glycerol|mesh-list
25571599|NCT00786487|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25571600|NCT00786487|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25571601|NCT00786487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25571602|NCT00786487|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25571603|NCT00786487|Protective Agents|protective agents|mesh-ancestor
25571604|NCT00786487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571605|NCT00786643|Leucovorin|leucovorin|mesh-list
25571606|NCT00786643|Interferons|interferons|mesh-list
25571607|NCT00786643|Interferon-gamma|interferon-gamma|mesh-list
25571608|NCT00786643|Bevacizumab|bevacizumab|mesh-list
25057896|NCT03500874|Vitamins|vitamins|mesh-ancestor
25571609|NCT00786643|Fluorouracil|fluorouracil|mesh-list
25571610|NCT00786643|Levoleucovorin|levoleucovorin|mesh-list
25571611|NCT00786643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25571612|NCT00786643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571613|NCT00786643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25571614|NCT00786643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25571615|NCT00786643|Growth Substances|growth substances|mesh-ancestor
25571616|NCT00786643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571617|NCT00786643|Growth Inhibitors|growth inhibitors|mesh-ancestor
25571618|NCT00786643|Antimetabolites|antimetabolites|mesh-ancestor
25571619|NCT00786643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571620|NCT00786643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25571621|NCT00786643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25571622|NCT00786643|Immunologic Factors|immunologic factors|mesh-ancestor
25571623|NCT00786643|Antiviral Agents|antiviral agents|mesh-ancestor
25571624|NCT00786643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25571625|NCT00786643|Antidotes|antidotes|mesh-ancestor
25571626|NCT00786643|Protective Agents|protective agents|mesh-ancestor
25571627|NCT00786643|Vitamin B Complex|vitamin b complex|mesh-ancestor
25571628|NCT00786643|Vitamins|vitamins|mesh-ancestor
25571629|NCT00786643|Micronutrients|micronutrients|mesh-ancestor
25571630|NCT00786825|Somatostatin|somatostatin|mesh-list
25571631|NCT00786825|Hormones|hormones|mesh-ancestor
24883978|NCT03861039|Incretins|incretins|mesh-ancestor
25571632|NCT00786825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25571633|NCT00786825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571634|NCT00786838|Trabectedin|trabectedin|mesh-list
25571635|NCT00786838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25571636|NCT00786838|Alkylating Agents|alkylating agents|mesh-ancestor
25571637|NCT00786838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571638|NCT00786838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571639|NCT00786916|Lidocaine|lidocaine|mesh-list
25571640|NCT00786916|Anesthetics, Local|anesthetics, local|mesh-ancestor
25571641|NCT00786916|Anesthetics|anesthetics|mesh-ancestor
25571642|NCT00786916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25571643|NCT00786916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466131|NCT05363514|Naltrexone|naltrexone|mesh-list
25571644|NCT00786916|Sensory System Agents|sensory system agents|mesh-ancestor
25571645|NCT00786916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25571646|NCT00786916|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25571647|NCT00786916|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25571648|NCT00786916|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25571649|NCT00786916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25571650|NCT00786916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571651|NCT00786994|Petrolatum|petrolatum|mesh-list
25571652|NCT00786994|Emollients|emollients|mesh-ancestor
25571653|NCT00786994|Dermatologic Agents|dermatologic agents|mesh-ancestor
25571654|NCT00787150|Warfarin|warfarin|mesh-list
25571655|NCT00787150|Apixaban|apixaban|mesh-list
25571656|NCT00787150|Anticoagulants|anticoagulants|mesh-ancestor
25571657|NCT00787150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25571658|NCT00787150|Antithrombins|antithrombins|mesh-ancestor
25571659|NCT00787150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25571660|NCT00787150|Protease Inhibitors|protease inhibitors|mesh-ancestor
25571661|NCT00787150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25571662|NCT00787150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571663|NCT00787254|Lansoprazole|lansoprazole|mesh-list
25571664|NCT00787254|Dexlansoprazole|dexlansoprazole|mesh-list
25571665|NCT00787254|Gefarnate|gefarnate|mesh-list
25571666|NCT00787254|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25571667|NCT00787254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25571668|NCT00787254|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25571669|NCT00787254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25571670|NCT00787254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571671|NCT00787267|Dasatinib|dasatinib|mesh-list
25571672|NCT00787267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571673|NCT00787267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25571674|NCT00787267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25571675|NCT00787267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571676|NCT00787332|Desirudin|desirudin|mesh-list
25571677|NCT00787332|Argatroban|argatroban|mesh-list
25571678|NCT00787332|Antithrombins|antithrombins|mesh-ancestor
25571679|NCT00787332|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25571680|NCT00787332|Protease Inhibitors|protease inhibitors|mesh-ancestor
25571681|NCT00787332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25571682|NCT00787332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571683|NCT00787332|Anticoagulants|anticoagulants|mesh-ancestor
25571684|NCT00787332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25571685|NCT00787332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25571686|NCT00787332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25571687|NCT00787527|Prednisone|prednisone|mesh-list
25571688|NCT00787527|Cyclophosphamide|cyclophosphamide|mesh-list
25571689|NCT00787527|Doxorubicin|doxorubicin|mesh-list
25571690|NCT00787527|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25571691|NCT00787527|Vincristine|vincristine|mesh-list
25571692|NCT00787527|Vorinostat|vorinostat|mesh-list
25571693|NCT00787527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25571694|NCT00787527|Immunologic Factors|immunologic factors|mesh-ancestor
25571695|NCT00787527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571696|NCT00787527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25571697|NCT00787527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25571698|NCT00787527|Alkylating Agents|alkylating agents|mesh-ancestor
25571699|NCT00787527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571700|NCT00787527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571701|NCT00787527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25571702|NCT00787527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25571703|NCT00787527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25571704|NCT00787527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25571705|NCT00787527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25571706|NCT00787527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25571707|NCT00787527|Glucocorticoids|glucocorticoids|mesh-ancestor
25571708|NCT00787527|Hormones|hormones|mesh-ancestor
25571709|NCT00787527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25571710|NCT00787527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25571711|NCT00787527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25571712|NCT00787527|Tubulin Modulators|tubulin modulators|mesh-ancestor
25571713|NCT00787527|Antimitotic Agents|antimitotic agents|mesh-ancestor
25571714|NCT00787527|Mitosis Modulators|mitosis modulators|mesh-ancestor
25571715|NCT00787527|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25571716|NCT00787566|Granisetron|granisetron|mesh-list
25571717|NCT00787566|Antiemetics|antiemetics|mesh-ancestor
25571718|NCT00787566|Autonomic Agents|autonomic agents|mesh-ancestor
25571719|NCT00787566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25571720|NCT00787566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571721|NCT00787566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25571722|NCT00787566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25571723|NCT00787566|Serotonin Agents|serotonin agents|mesh-ancestor
25571724|NCT00787566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25571725|NCT00787566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571726|NCT00787605|Amlodipine|amlodipine|mesh-list
25571727|NCT00787605|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25571728|NCT00787605|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25571729|NCT00787605|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25571730|NCT00787605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25571731|NCT00787605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571732|NCT00787605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25571733|NCT00787605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571734|NCT00787605|Vasodilator Agents|vasodilator agents|mesh-ancestor
25571735|NCT00787605|Diuretics|diuretics|mesh-ancestor
25571736|NCT00787605|Natriuretic Agents|natriuretic agents|mesh-ancestor
25571737|NCT00787605|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25571738|NCT00787644|Pioglitazone|pioglitazone|mesh-list
25571739|NCT00787644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25571740|NCT00787644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571741|NCT00787722|Methylprednisolone|methylprednisolone|mesh-list
25571742|NCT00787722|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25571743|NCT00787722|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25571744|NCT00787722|Prednisolone|prednisolone|mesh-list
25571745|NCT00787722|Prednisolone acetate|prednisolone acetate|mesh-list
25571746|NCT00787722|Cyclophosphamide|cyclophosphamide|mesh-list
25571747|NCT00787722|Rituximab|rituximab|mesh-list
25571748|NCT00787722|Thymoglobulin|thymoglobulin|mesh-list
25571749|NCT00787722|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25571750|NCT00787722|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25571751|NCT00787722|Prednisolone phosphate|prednisolone phosphate|mesh-list
25571752|NCT00787722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25571753|NCT00787722|Immunologic Factors|immunologic factors|mesh-ancestor
25571754|NCT00787722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571755|NCT00787722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25571756|NCT00787722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25571757|NCT00787722|Alkylating Agents|alkylating agents|mesh-ancestor
25571758|NCT00787722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571759|NCT00787722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571760|NCT00787722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25571761|NCT00787722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25571762|NCT00787722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25571763|NCT00787722|Antiemetics|antiemetics|mesh-ancestor
25571764|NCT00787722|Autonomic Agents|autonomic agents|mesh-ancestor
25571765|NCT00787722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25571766|NCT00787722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25571767|NCT00787722|Glucocorticoids|glucocorticoids|mesh-ancestor
25571768|NCT00787722|Hormones|hormones|mesh-ancestor
25571769|NCT00787722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25571770|NCT00787722|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25571771|NCT00787722|Protective Agents|protective agents|mesh-ancestor
25571772|NCT00787722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25571773|NCT00787761|Cyclophosphamide|cyclophosphamide|mesh-list
25571774|NCT00787761|Busulfan|busulfan|mesh-list
25571775|NCT00787761|Methotrexate|methotrexate|mesh-list
25571776|NCT00787761|Fludarabine|fludarabine|mesh-list
25571777|NCT00787761|Fludarabine phosphate|fludarabine phosphate|mesh-list
25571778|NCT00787761|Tacrolimus|tacrolimus|mesh-list
25571779|NCT00787761|Thymoglobulin|thymoglobulin|mesh-list
25571780|NCT00787761|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25466274|NCT04726618|Anesthetics|anesthetics|mesh-ancestor
25466275|NCT04726618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25466276|NCT04726618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466277|NCT04697693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25466278|NCT04697693|Citalopram|citalopram|mesh-list
25466279|NCT04697693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25466280|NCT04697693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25466281|NCT04697693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25466283|NCT04697693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25571781|NCT00787761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25571782|NCT00787761|Immunologic Factors|immunologic factors|mesh-ancestor
24516160|NCT00600769|Clarithromycin|clarithromycin|mesh-list
25571783|NCT00787761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571784|NCT00787761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25571785|NCT00787761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25571786|NCT00787761|Alkylating Agents|alkylating agents|mesh-ancestor
25606141|NCT01064947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25571787|NCT00787761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571788|NCT00787761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571789|NCT00787761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25571790|NCT00787761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25058148|NCT03499106|Itraconazole|itraconazole|mesh-list
25571791|NCT00787761|Abortifacient Agents|abortifacient agents|mesh-ancestor
25571792|NCT00787761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25571793|NCT00787761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25571794|NCT00787761|Antimetabolites|antimetabolites|mesh-ancestor
25571795|NCT00787761|Dermatologic Agents|dermatologic agents|mesh-ancestor
25571796|NCT00787761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606142|NCT01065350|Ketamine|ketamine|mesh-list
25571797|NCT00787761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25571798|NCT00787761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25571799|NCT00787761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25571800|NCT00787787|Capecitabine|capecitabine|mesh-list
25571801|NCT00787787|Sunitinib|sunitinib|mesh-list
25571802|NCT00787787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25571803|NCT00787787|Antimetabolites|antimetabolites|mesh-ancestor
25571804|NCT00787787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571805|NCT00787787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571806|NCT00787787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25571807|NCT00787787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25571808|NCT00787787|Growth Substances|growth substances|mesh-ancestor
25571809|NCT00787787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571810|NCT00787787|Growth Inhibitors|growth inhibitors|mesh-ancestor
25571811|NCT00787787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25571812|NCT00787787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25571813|NCT00787852|Paclitaxel|paclitaxel|mesh-list
25571814|NCT00787852|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25571815|NCT00787852|Dasatinib|dasatinib|mesh-list
25571816|NCT00787852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25571817|NCT00787852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571818|NCT00787852|Tubulin Modulators|tubulin modulators|mesh-ancestor
25571819|NCT00787852|Antimitotic Agents|antimitotic agents|mesh-ancestor
25571820|NCT00787852|Mitosis Modulators|mitosis modulators|mesh-ancestor
25571821|NCT00787852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571822|NCT00787852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25571823|NCT00787852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25571824|NCT00787891|Rabeprazole|rabeprazole|mesh-list
25571825|NCT00787891|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25571826|NCT00787891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25571827|NCT00787891|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25571828|NCT00787891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25571829|NCT00787891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571830|NCT00787930|Valproic Acid|valproic acid|mesh-list
25571831|NCT00787930|Anticonvulsants|anticonvulsants|mesh-ancestor
25571832|NCT00787930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25571833|NCT00787930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571834|NCT00787930|GABA Agents|gaba agents|mesh-ancestor
25571835|NCT00787930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24507747|NCT00551850|MP 412|mp 412|mesh-list
25571836|NCT00787930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571837|NCT00787930|Antimanic Agents|antimanic agents|mesh-ancestor
25571838|NCT00787930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25571839|NCT00787930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25571840|NCT00787930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25571841|NCT00787943|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25571842|NCT00787943|Dermatologic Agents|dermatologic agents|mesh-ancestor
25571843|NCT00788008|Propofol|propofol|mesh-list
25571844|NCT00788008|Isoflurane|isoflurane|mesh-list
25571845|NCT00788008|Anesthetics|anesthetics|mesh-ancestor
25571846|NCT00788008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25571847|NCT00788008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571848|NCT00788008|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25571849|NCT00788008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25571850|NCT00788008|Anesthetics, General|anesthetics, general|mesh-ancestor
25571851|NCT00788008|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25571852|NCT00788255|Oxytocin|oxytocin|mesh-list
25571853|NCT00788255|Oxytocics|oxytocics|mesh-ancestor
25571854|NCT00788255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25571855|NCT00788255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571856|NCT00788372|Fentanyl|fentanyl|mesh-list
25571857|NCT00788372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25571858|NCT00788372|Narcotics|narcotics|mesh-ancestor
25571859|NCT00788372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25571860|NCT00788372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571861|NCT00788372|Analgesics|analgesics|mesh-ancestor
25571862|NCT00788372|Sensory System Agents|sensory system agents|mesh-ancestor
25571863|NCT00788372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25571864|NCT00788372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25571865|NCT00788372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25571866|NCT00788372|Anesthetics, General|anesthetics, general|mesh-ancestor
25571867|NCT00788372|Anesthetics|anesthetics|mesh-ancestor
25571869|NCT00788593|Pancrelipase|pancrelipase|mesh-list
25571870|NCT00788593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25652339|NCT01525628|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25652340|NCT01525628|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25652341|NCT01525628|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25652342|NCT01525628|Purinergic Agents|purinergic agents|mesh-ancestor
25652343|NCT01525628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24989103|NCT04635631|Talazoparib|talazoparib|mesh-list
24989118|NCT04559139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989119|NCT04559139|Antiviral Agents|antiviral agents|mesh-ancestor
24989120|NCT04559139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24989121|NCT04559139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652344|NCT01525641|Pramipexole|pramipexole|mesh-list
25652345|NCT01525641|Antioxidants|antioxidants|mesh-ancestor
25652346|NCT01525641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652347|NCT01525641|Protective Agents|protective agents|mesh-ancestor
25652348|NCT01525641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652349|NCT01525641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25652350|NCT01525641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24520889|NCT05246007|Analgesics|analgesics|mesh-ancestor
25059479|NCT03487770|Dopamine Agonists|dopamine agonists|mesh-ancestor
25652351|NCT01525641|Dopamine Agonists|dopamine agonists|mesh-ancestor
25652352|NCT01525641|Dopamine Agents|dopamine agents|mesh-ancestor
25652353|NCT01525641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25652354|NCT01525875|Magnesium Oxide|magnesium oxide|mesh-list
25652355|NCT01525875|Antacids|antacids|mesh-ancestor
25652356|NCT01525875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652357|NCT01525875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25652358|NCT01526057|Rituximab|rituximab|mesh-list
25652359|NCT01526057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25652360|NCT01526057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652361|NCT01526057|Immunologic Factors|immunologic factors|mesh-ancestor
25652362|NCT01526057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652363|NCT01526057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25606143|NCT01065350|Propofol|propofol|mesh-list
25656900|NCT01580488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25656901|NCT01580488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656902|NCT01580488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25656903|NCT01580488|Vitamins|vitamins|mesh-ancestor
25656904|NCT01580488|Micronutrients|micronutrients|mesh-ancestor
25656905|NCT01580488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25656906|NCT01580592|Omalizumab|omalizumab|mesh-list
25656907|NCT01580592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24822099|NCT02109861|Dexamethasone|dexamethasone|mesh-list
25656908|NCT01580592|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25656909|NCT01580592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25656910|NCT01580592|Respiratory System Agents|respiratory system agents|mesh-ancestor
25656911|NCT01580592|Immunologic Factors|immunologic factors|mesh-ancestor
25656912|NCT01580592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656913|NCT01580618|Tenecteplase|tenecteplase|mesh-list
25656914|NCT01580618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25656915|NCT01580618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25656916|NCT01580618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656917|NCT01580670|Infliximab|infliximab|mesh-list
25656918|NCT01580670|Dermatologic Agents|dermatologic agents|mesh-ancestor
25656919|NCT01580670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25656920|NCT01580670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25656921|NCT01580969|Minocycline|minocycline|mesh-list
25656922|NCT01580969|Bevacizumab|bevacizumab|mesh-list
25656923|NCT01580969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25656924|NCT01580969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656925|NCT01580969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25656926|NCT01580969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25656927|NCT01580969|Growth Substances|growth substances|mesh-ancestor
25656928|NCT01580969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656929|NCT01580969|Growth Inhibitors|growth inhibitors|mesh-ancestor
25656930|NCT01580969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25656931|NCT01580969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25656932|NCT01580995|Valacyclovir|valacyclovir|mesh-list
25656933|NCT01580995|Antiviral Agents|antiviral agents|mesh-ancestor
25656934|NCT01580995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25656935|NCT01581281|Topiramate|topiramate|mesh-list
25656936|NCT01581281|Amitriptyline|amitriptyline|mesh-list
25656937|NCT01581281|Anticonvulsants|anticonvulsants|mesh-ancestor
25656938|NCT01581281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25656939|NCT01581281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656940|NCT01581281|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25656941|NCT01581281|Antidepressive Agents|antidepressive agents|mesh-ancestor
25656942|NCT01581281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25656943|NCT01581281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25656944|NCT01581281|Analgesics|analgesics|mesh-ancestor
25656945|NCT01581281|Sensory System Agents|sensory system agents|mesh-ancestor
25656946|NCT01581281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060075|NCT03482960|Anesthetics|anesthetics|mesh-ancestor
25466402|NCT04294459|Histamine Agents|histamine agents|mesh-ancestor
25656947|NCT01581281|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25571871|NCT00788892|Cytarabine|cytarabine|mesh-list
25571872|NCT00788892|Daunorubicin|daunorubicin|mesh-list
25571873|NCT00788892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25571874|NCT00788892|Antimetabolites|antimetabolites|mesh-ancestor
24990896|NCT03728179|Analgesics|analgesics|mesh-ancestor
25571875|NCT00788892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571876|NCT00788892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571877|NCT00788892|Antiviral Agents|antiviral agents|mesh-ancestor
25571878|NCT00788892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25571879|NCT00788892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25571880|NCT00788892|Immunologic Factors|immunologic factors|mesh-ancestor
25571881|NCT00788892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571882|NCT00788892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25571883|NCT00788892|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24990978|NCT03417999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060361|NCT03480321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060362|NCT03480321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24464896|NCT00367250|Trastuzumab|trastuzumab|mesh-list
24511240|NCT00567957|Remifentanil|remifentanil|mesh-list
25571884|NCT00788892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25571885|NCT00788892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25571886|NCT00788957|Panitumumab|panitumumab|mesh-list
25571887|NCT00788957|Rilotumumab|rilotumumab|mesh-list
25571888|NCT00788957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25571889|NCT00788957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571890|NCT00789035|Metformin|metformin|mesh-list
25571891|NCT00789035|Empagliflozin|empagliflozin|mesh-list
25571892|NCT00789035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25571893|NCT00789035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571894|NCT00789035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25571895|NCT00789035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571896|NCT00789074|Varenicline|varenicline|mesh-list
25571897|NCT00789074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25571898|NCT00789074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25571899|NCT00789074|Cholinergic Agents|cholinergic agents|mesh-ancestor
25571900|NCT00789074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25571901|NCT00789074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571902|NCT00789074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571903|NCT00789113|Lamotrigine|lamotrigine|mesh-list
25571904|NCT00789113|Anticonvulsants|anticonvulsants|mesh-ancestor
25571905|NCT00789113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25571906|NCT00789113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25571907|NCT00789113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571908|NCT00789113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25571909|NCT00789113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571910|NCT00789113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25571911|NCT00789113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25571912|NCT00789113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25571913|NCT00789113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25571914|NCT00789113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25571915|NCT00789191|Metformin|metformin|mesh-list
25571916|NCT00789191|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25571917|NCT00789191|Insulin Detemir|insulin detemir|mesh-list
25571918|NCT00789191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25571919|NCT00789191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571920|NCT00789191|Incretins|incretins|mesh-ancestor
25571921|NCT00789191|Hormones|hormones|mesh-ancestor
25571922|NCT00789191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25571923|NCT00789191|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25571924|NCT00789191|Protease Inhibitors|protease inhibitors|mesh-ancestor
25571925|NCT00789191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25571926|NCT00789191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571927|NCT00789256|Bortezomib|bortezomib|mesh-list
25571928|NCT00789256|Melphalan|melphalan|mesh-list
25571929|NCT00789256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24991527|NCT05143073|Ethanol|ethanol|mesh-list
25060595|NCT03478423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25571930|NCT00789256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25571931|NCT00789256|Alkylating Agents|alkylating agents|mesh-ancestor
25571932|NCT00789256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571933|NCT00789256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25571934|NCT00789256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25571935|NCT00789256|Immunologic Factors|immunologic factors|mesh-ancestor
25571936|NCT00789256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571937|NCT00789321|Amlodipine|amlodipine|mesh-list
25571938|NCT00789321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25571939|NCT00789321|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25571940|NCT00789321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25571941|NCT00789321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571942|NCT00789321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25571943|NCT00789321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571944|NCT00789321|Vasodilator Agents|vasodilator agents|mesh-ancestor
25571945|NCT00789360|Loxapine|loxapine|mesh-list
25571946|NCT00789360|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25571947|NCT00789360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25571948|NCT00789360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25571949|NCT00789360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571950|NCT00789360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25571951|NCT00789360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25571952|NCT00789360|Dopamine Agents|dopamine agents|mesh-ancestor
25571953|NCT00789360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25606144|NCT01065350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25571954|NCT00789360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571955|NCT00789373|Cisplatin|cisplatin|mesh-list
25571956|NCT00789373|Pemetrexed|pemetrexed|mesh-list
25571957|NCT00789373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571958|NCT00789373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25571959|NCT00789373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571960|NCT00789373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25698724|NCT02097056|Nootropic Agents|nootropic agents|mesh-ancestor
25571961|NCT00789373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25571962|NCT00789477|Aflibercept|aflibercept|mesh-list
25571963|NCT00789477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25571964|NCT00789477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25571965|NCT00789477|Growth Substances|growth substances|mesh-ancestor
25571966|NCT00789477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571967|NCT00789477|Growth Inhibitors|growth inhibitors|mesh-ancestor
25571968|NCT00789477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571969|NCT00789555|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25571970|NCT00789555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24953026|NCT03889288|Analgesics|analgesics|mesh-list
25571971|NCT00789555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25571972|NCT00789555|Analgesics|analgesics|mesh-ancestor
25571973|NCT00789555|Sensory System Agents|sensory system agents|mesh-ancestor
25571974|NCT00789555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25571975|NCT00789555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571976|NCT00789555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25571977|NCT00789555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25571978|NCT00789555|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25571979|NCT00789555|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25571980|NCT00789555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24512978|NCT00577967|Analgesics|analgesics|mesh-ancestor
25571981|NCT00789555|Histamine Antagonists|histamine antagonists|mesh-ancestor
25571982|NCT00789555|Histamine Agents|histamine agents|mesh-ancestor
25571983|NCT00789555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25571984|NCT00789555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571985|NCT00789581|Paclitaxel|paclitaxel|mesh-list
25571986|NCT00789581|Cyclophosphamide|cyclophosphamide|mesh-list
25571987|NCT00789581|Doxorubicin|doxorubicin|mesh-list
25061163|NCT03473314|Nitric Oxide|nitric oxide|mesh-list
25571988|NCT00789581|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25571989|NCT00789581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25571990|NCT00789581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25571991|NCT00789581|Tubulin Modulators|tubulin modulators|mesh-ancestor
25571992|NCT00789581|Antimitotic Agents|antimitotic agents|mesh-ancestor
25571993|NCT00789581|Mitosis Modulators|mitosis modulators|mesh-ancestor
25571994|NCT00789581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25571995|NCT00789581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25571996|NCT00789581|Immunologic Factors|immunologic factors|mesh-ancestor
25571997|NCT00789581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25571998|NCT00789581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25571999|NCT00789581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25572000|NCT00789581|Alkylating Agents|alkylating agents|mesh-ancestor
25572001|NCT00789581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25572002|NCT00789581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25572003|NCT00789581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25572004|NCT00789581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25572005|NCT00789581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572006|NCT00789672|Levodopa|levodopa|mesh-list
25572007|NCT00789672|Carbidopa|carbidopa|mesh-list
24513125|NCT00578825|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25572008|NCT00789672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25572009|NCT00789672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25572010|NCT00789672|Dopamine Agents|dopamine agents|mesh-ancestor
25572011|NCT00789672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25061483|NCT03470961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25572012|NCT00789672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572013|NCT00789672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572014|NCT00789672|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25572015|NCT00789672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572016|NCT00789685|Interferons|interferons|mesh-list
25572017|NCT00789685|Interferon-beta|interferon-beta|mesh-list
25652364|NCT01526148|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25466626|NCT03628391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25466627|NCT03628391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596015|NCT00941174|Leucovorin|leucovorin|mesh-list
25466628|NCT03628391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25466630|NCT03617666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25466631|NCT03617666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466632|NCT03602261|Calcifediol|calcifediol|mesh-list
25466633|NCT03602261|Vitamins|vitamins|mesh-ancestor
25466634|NCT03602261|Micronutrients|micronutrients|mesh-ancestor
25466635|NCT03602261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466636|NCT03602261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25327320|NCT04860167|Sensory System Agents|sensory system agents|mesh-ancestor
25327321|NCT04860167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25327322|NCT04860167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24429009|NCT00242268|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25123404|NCT03085563|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24429068|NCT00242463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429069|NCT00242463|Anabolic Agents|anabolic agents|mesh-ancestor
24429070|NCT00242463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24429071|NCT00242528|Zoledronic Acid|zoledronic acid|mesh-list
24429072|NCT00242528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24429073|NCT00242528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429075|NCT00242541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24429076|NCT00242541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24429123|NCT00242775|Formoterol Fumarate|formoterol fumarate|mesh-list
24429361|NCT00243737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24429362|NCT00243737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24429363|NCT00243737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24429364|NCT00243737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429365|NCT00243737|Antiviral Agents|antiviral agents|mesh-ancestor
24429366|NCT00243737|Schistosomicides|schistosomicides|mesh-ancestor
24429367|NCT00243737|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24429368|NCT00243737|Anthelmintics|anthelmintics|mesh-ancestor
24429369|NCT00243750|Methotrexate|methotrexate|mesh-list
24824167|NCT02122055|Propofol|propofol|mesh-list
24429382|NCT00243750|Immunologic Factors|immunologic factors|mesh-ancestor
24429425|NCT00243893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24429426|NCT00243893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24429427|NCT00243893|Antimalarials|antimalarials|mesh-ancestor
24429428|NCT00243893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24429429|NCT00243893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25123430|NCT03085394|Coagulants|coagulants|mesh-ancestor
25123431|NCT03085186|Crizotinib|crizotinib|mesh-list
25123432|NCT03085186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123433|NCT03085186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25123434|NCT03085186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123436|NCT03084952|Meglumine Antimoniate|meglumine antimoniate|mesh-list
24429430|NCT00243945|Rotigotine|rotigotine|mesh-list
24890642|NCT04481789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24429431|NCT00243945|Dopamine Agonists|dopamine agonists|mesh-ancestor
24429432|NCT00243945|Dopamine Agents|dopamine agents|mesh-ancestor
24429433|NCT00243945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24429436|NCT00243984|Topiramate|topiramate|mesh-list
24429496|NCT00244166|Prednisolone|prednisolone|mesh-list
24429497|NCT00244166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24429498|NCT00244166|Glucocorticoids|glucocorticoids|mesh-ancestor
24429499|NCT00244166|Hormones|hormones|mesh-ancestor
24429500|NCT00244166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25105989|NCT04688203|Labetalol|labetalol|mesh-list
25105990|NCT04688203|Analgesics|analgesics|mesh-ancestor
25105991|NCT04688203|Sensory System Agents|sensory system agents|mesh-ancestor
25105992|NCT04688203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25105993|NCT04688203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572018|NCT00789685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572019|NCT00789685|Antiviral Agents|antiviral agents|mesh-ancestor
25572020|NCT00789685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25105994|NCT04688203|Anesthetics|anesthetics|mesh-ancestor
24429563|NCT00244361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572021|NCT00789685|Immunologic Factors|immunologic factors|mesh-ancestor
24992771|NCT02891811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25572022|NCT00789685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572023|NCT00789698|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25572024|NCT00789698|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25572025|NCT00789698|Antidepressive Agents|antidepressive agents|mesh-ancestor
25572026|NCT00789698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25572027|NCT00789698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25572028|NCT00789698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25572029|NCT00789698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25572030|NCT00789698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652365|NCT01526148|Lithium Carbonate|lithium carbonate|mesh-list
25572031|NCT00789698|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25572032|NCT00789698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25572033|NCT00789698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25572034|NCT00789698|Adrenergic Agents|adrenergic agents|mesh-ancestor
25572035|NCT00789698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24470071|NCT00388700|Antidotes|antidotes|mesh-ancestor
25572036|NCT00789698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572037|NCT00789698|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25572038|NCT00789698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25572039|NCT00789698|Serotonin Agents|serotonin agents|mesh-ancestor
25572040|NCT00789698|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25572041|NCT00789698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25572042|NCT00789698|Dopamine Agents|dopamine agents|mesh-ancestor
24817090|NCT02080858|Ticagrelor|ticagrelor|mesh-list
25606145|NCT01065350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25606146|NCT01065350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572043|NCT00789724|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25572044|NCT00789724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25572045|NCT00789737|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
25572046|NCT00789737|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25572047|NCT00789737|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25572048|NCT00789737|Antimetabolites|antimetabolites|mesh-ancestor
25572049|NCT00789737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572050|NCT00789737|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25572051|NCT00789750|Pioglitazone|pioglitazone|mesh-list
25572052|NCT00789750|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
25572053|NCT00789750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25698835|NCT02097849|Dermatologic Agents|dermatologic agents|mesh-ancestor
25572054|NCT00789750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572055|NCT00789750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25572056|NCT00789750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25572057|NCT00789750|Antimetabolites|antimetabolites|mesh-ancestor
25572058|NCT00789750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572059|NCT00789750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25572060|NCT00789776|Mycophenolic Acid|mycophenolic acid|mesh-list
25572061|NCT00789776|Cyclophosphamide|cyclophosphamide|mesh-list
25572062|NCT00789776|Fludarabine|fludarabine|mesh-list
25572063|NCT00789776|Fludarabine phosphate|fludarabine phosphate|mesh-list
25572064|NCT00789776|Tacrolimus|tacrolimus|mesh-list
25572065|NCT00789776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25572066|NCT00789776|Immunologic Factors|immunologic factors|mesh-ancestor
25572067|NCT00789776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572068|NCT00789776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25572069|NCT00789776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25572070|NCT00789776|Alkylating Agents|alkylating agents|mesh-ancestor
25572071|NCT00789776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572072|NCT00789776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572073|NCT00789776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25572074|NCT00789776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25572075|NCT00789776|Antimetabolites|antimetabolites|mesh-ancestor
25572076|NCT00789776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25572077|NCT00789776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572078|NCT00789776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25572079|NCT00789776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25572080|NCT00789776|Antitubercular Agents|antitubercular agents|mesh-ancestor
25572081|NCT00789776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25572082|NCT00789776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25572083|NCT00789802|Naproxen|naproxen|mesh-list
25572084|NCT00789802|Estradiol|estradiol|mesh-list
25572085|NCT00789802|Estrogens|estrogens|mesh-ancestor
25572086|NCT00789802|Hormones|hormones|mesh-ancestor
25572087|NCT00789802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25572088|NCT00789802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572089|NCT00789802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25572090|NCT00789802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25572091|NCT00789802|Analgesics|analgesics|mesh-ancestor
25572092|NCT00789802|Sensory System Agents|sensory system agents|mesh-ancestor
25572093|NCT00789802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25572094|NCT00789802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25572095|NCT00789802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25572096|NCT00789802|Gout Suppressants|gout suppressants|mesh-ancestor
25572097|NCT00789802|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25572098|NCT00789802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572099|NCT00789802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572100|NCT00789815|Midazolam|midazolam|mesh-list
25572101|NCT00789815|Propofol|propofol|mesh-list
25572102|NCT00789815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25572103|NCT00789815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25572104|NCT00789815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572105|NCT00789815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25572106|NCT00789815|Anesthetics, General|anesthetics, general|mesh-ancestor
25572107|NCT00789815|Anesthetics|anesthetics|mesh-ancestor
25572108|NCT00789815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25572109|NCT00789815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25572110|NCT00789815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25572111|NCT00789815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25572112|NCT00789815|GABA Modulators|gaba modulators|mesh-ancestor
25572113|NCT00789815|GABA Agents|gaba agents|mesh-ancestor
25572114|NCT00789815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25572115|NCT00789815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572116|NCT00789828|Everolimus|everolimus|mesh-list
25572117|NCT00789828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572118|NCT00789828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25572119|NCT00789828|Immunologic Factors|immunologic factors|mesh-ancestor
25572120|NCT00789828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572121|NCT00789854|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25572122|NCT00789854|Lithium Carbonate|lithium carbonate|mesh-list
25572123|NCT00789854|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25572124|NCT00789854|Antidepressive Agents|antidepressive agents|mesh-ancestor
25572125|NCT00789854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25572126|NCT00789854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25572127|NCT00789854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25572128|NCT00789854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25572129|NCT00789854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572130|NCT00789854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572131|NCT00789854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572132|NCT00789854|Antimanic Agents|antimanic agents|mesh-ancestor
25572133|NCT00789854|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25572134|NCT00789854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25572135|NCT00789854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25572136|NCT00789854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25572137|NCT00789854|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25572138|NCT00789880|Vitamin D|vitamin d|mesh-list
25572139|NCT00789880|Ergocalciferols|ergocalciferols|mesh-list
25572140|NCT00789880|Cholecalciferol|cholecalciferol|mesh-list
25572141|NCT00789880|Vitamins|vitamins|mesh-list
25572142|NCT00789880|Micronutrients|micronutrients|mesh-ancestor
25572143|NCT00789880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572144|NCT00789880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25572145|NCT00789880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25572146|NCT00789958|Gemcitabine|gemcitabine|mesh-list
25572147|NCT00789958|Capecitabine|capecitabine|mesh-list
25572148|NCT00789958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25572149|NCT00789958|Antimetabolites|antimetabolites|mesh-ancestor
25572150|NCT00789958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572151|NCT00789958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572152|NCT00789958|Antiviral Agents|antiviral agents|mesh-ancestor
25572153|NCT00789958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25572154|NCT00789958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572155|NCT00789958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25572156|NCT00789958|Immunologic Factors|immunologic factors|mesh-ancestor
25572157|NCT00789958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572158|NCT00789997|Levofloxacin|levofloxacin|mesh-list
25572159|NCT00789997|Ofloxacin|ofloxacin|mesh-list
25572160|NCT00789997|Prednisone|prednisone|mesh-list
25572161|NCT00789997|Etanercept|etanercept|mesh-list
25572162|NCT00789997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25572163|NCT00789997|Glucocorticoids|glucocorticoids|mesh-ancestor
25572164|NCT00789997|Hormones|hormones|mesh-ancestor
25572165|NCT00789997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25572166|NCT00789997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572167|NCT00789997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25572168|NCT00789997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572169|NCT00789997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25572170|NCT00789997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25572171|NCT00789997|Analgesics|analgesics|mesh-ancestor
25572172|NCT00789997|Sensory System Agents|sensory system agents|mesh-ancestor
25572173|NCT00789997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25572174|NCT00789997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25698915|NCT02099084|Teduglutide|teduglutide|mesh-list
25572175|NCT00789997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25572176|NCT00789997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25572177|NCT00789997|Immunologic Factors|immunologic factors|mesh-ancestor
25572178|NCT00789997|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25572179|NCT00789997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25572180|NCT00789997|Renal Agents|renal agents|mesh-ancestor
25572181|NCT00789997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25572182|NCT00789997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25572183|NCT00789997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25572184|NCT00789997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572185|NCT00789997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572186|NCT00789997|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25572187|NCT00789997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25572188|NCT00790023|Ciclesonide|ciclesonide|mesh-list
25572189|NCT00790023|Glucocorticoids|glucocorticoids|mesh-ancestor
25572190|NCT00790023|Hormones|hormones|mesh-ancestor
25572191|NCT00790023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25572192|NCT00790023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572193|NCT00790023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25572194|NCT00790036|Everolimus|everolimus|mesh-list
25572195|NCT00790036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572196|NCT00790036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25572197|NCT00790036|Immunologic Factors|immunologic factors|mesh-ancestor
25572198|NCT00790036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572199|NCT00790062|Oxytocin|oxytocin|mesh-list
25572200|NCT00790062|Oxytocics|oxytocics|mesh-ancestor
25572201|NCT00790062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25572202|NCT00790062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572203|NCT00790192|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25572204|NCT00790192|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25572205|NCT00790192|Antidepressive Agents|antidepressive agents|mesh-ancestor
25572206|NCT00790192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25572207|NCT00790192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25572208|NCT00790192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25572209|NCT00790192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25572210|NCT00790192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572211|NCT00790192|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25572212|NCT00790192|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25572213|NCT00790192|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25572214|NCT00790192|Adrenergic Agents|adrenergic agents|mesh-ancestor
25572215|NCT00790192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25572216|NCT00790192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515546|NCT00598169|Hormones|hormones|mesh-ancestor
25572217|NCT00790192|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25572218|NCT00790192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25572219|NCT00790192|Serotonin Agents|serotonin agents|mesh-ancestor
25572220|NCT00790192|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25572221|NCT00790192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25572222|NCT00790192|Dopamine Agents|dopamine agents|mesh-ancestor
25572223|NCT00790205|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25572224|NCT00790205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25572225|NCT00790205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572226|NCT00790205|Incretins|incretins|mesh-ancestor
25572227|NCT00790205|Hormones|hormones|mesh-ancestor
25572228|NCT00790205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25572229|NCT00790205|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25572230|NCT00790205|Protease Inhibitors|protease inhibitors|mesh-ancestor
25572231|NCT00790205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572232|NCT00790205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572233|NCT00790270|Ibuprofen|ibuprofen|mesh-list
25572234|NCT00790270|Amitriptyline|amitriptyline|mesh-list
25572235|NCT00790270|Cyclobenzaprine|cyclobenzaprine|mesh-list
25572236|NCT00790270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25572237|NCT00790270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25572238|NCT00790270|Analgesics|analgesics|mesh-ancestor
25572239|NCT00790270|Sensory System Agents|sensory system agents|mesh-ancestor
25572240|NCT00790270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25572241|NCT00790270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572242|NCT00790270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25572243|NCT00790270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25572244|NCT00790270|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25572245|NCT00790270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572246|NCT00790270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572247|NCT00790270|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25572248|NCT00790270|Antidepressive Agents|antidepressive agents|mesh-ancestor
25572249|NCT00790270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25572250|NCT00790270|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25466778|NCT02138955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25466779|NCT02138955|Analgesics|analgesics|mesh-ancestor
25466780|NCT02138955|Sensory System Agents|sensory system agents|mesh-ancestor
25466846|NCT01849783|Growth Substances|growth substances|mesh-ancestor
25466847|NCT01849783|Growth Inhibitors|growth inhibitors|mesh-ancestor
25466849|NCT01744912|Immunologic Factors|immunologic factors|mesh-ancestor
25466850|NCT01744912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466851|NCT01744912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25466852|NCT01744912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25466853|NCT01744912|Growth Substances|growth substances|mesh-ancestor
25466854|NCT01744912|Growth Inhibitors|growth inhibitors|mesh-ancestor
25466855|NCT01744912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466856|NCT01505465|Melatonin|melatonin|mesh-list
25466857|NCT01505465|Antioxidants|antioxidants|mesh-ancestor
25466858|NCT01505465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466859|NCT01505465|Protective Agents|protective agents|mesh-ancestor
25466860|NCT01505465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466861|NCT01505465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25466862|NCT00676663|Exemestane|exemestane|mesh-list
25466863|NCT00676663|Entinostat|entinostat|mesh-list
25466864|NCT00676663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466865|NCT00676663|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25466866|NCT00676663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25466867|NCT00676663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466868|NCT00676663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466869|NCT00676663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25466870|NCT00676663|Hormone Antagonists|hormone antagonists|mesh-ancestor
25466871|NCT00676663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25466872|NCT00676663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466873|NCT00676663|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25466874|NCT00555555|Factor VIII|factor viii|mesh-list
25466875|NCT00555555|Coagulants|coagulants|mesh-ancestor
25327611|NCT04856137|Paclitaxel|paclitaxel|mesh-list
24429564|NCT00244361|Immunologic Factors|immunologic factors|mesh-ancestor
24429565|NCT00244361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429566|NCT00244361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24429567|NCT00244426|Aspirin|aspirin|mesh-list
24429570|NCT00244426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24429571|NCT00244426|Analgesics|analgesics|mesh-ancestor
25162078|NCT02908295|Misoprostol|misoprostol|mesh-list
24429572|NCT00244426|Sensory System Agents|sensory system agents|mesh-ancestor
24429584|NCT00244439|Permethrin|permethrin|mesh-list
25123456|NCT03084809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123457|NCT03084809|Vitamin B Complex|vitamin b complex|mesh-ancestor
24429631|NCT00244556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24429632|NCT00244556|Antimetabolites|antimetabolites|mesh-ancestor
24429633|NCT00244556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572251|NCT00790270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25572252|NCT00790270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25572253|NCT00790270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25572254|NCT00790270|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25572255|NCT00790270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25572256|NCT00790270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25572257|NCT00790270|Adrenergic Agents|adrenergic agents|mesh-ancestor
25572258|NCT00790270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25572259|NCT00790296|Hormones|hormones|mesh-list
25572260|NCT00790296|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
25572261|NCT00790296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25572262|NCT00790296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572263|NCT00790335|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25572264|NCT00790335|Plasminogen|plasminogen|mesh-list
25572265|NCT00790335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25572266|NCT00790335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25572267|NCT00790335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572268|NCT00790400|Everolimus|everolimus|mesh-list
25572269|NCT00790400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572270|NCT00790400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25572271|NCT00790400|Immunologic Factors|immunologic factors|mesh-ancestor
25572272|NCT00790400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572273|NCT00790569|Nicotine|nicotine|mesh-list
25572274|NCT00790569|Varenicline|varenicline|mesh-list
25572275|NCT00790569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25572276|NCT00790569|Autonomic Agents|autonomic agents|mesh-ancestor
25572277|NCT00790569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25572278|NCT00790569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572279|NCT00790569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25572280|NCT00790569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25572281|NCT00790569|Cholinergic Agents|cholinergic agents|mesh-ancestor
25572282|NCT00790569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25572283|NCT00790569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572284|NCT00790582|Lithium Carbonate|lithium carbonate|mesh-list
25572285|NCT00790582|Antidepressive Agents|antidepressive agents|mesh-ancestor
25572286|NCT00790582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25572287|NCT00790582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572288|NCT00790582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572289|NCT00790582|Antimanic Agents|antimanic agents|mesh-ancestor
25572290|NCT00790582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25572291|NCT00790582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25572292|NCT00790582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572293|NCT00790647|Bortezomib|bortezomib|mesh-list
25572294|NCT00790647|Melphalan|melphalan|mesh-list
25572295|NCT00790647|Immunologic Factors|immunologic factors|mesh-ancestor
25572296|NCT00790647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572297|NCT00790647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572298|NCT00790647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25572299|NCT00790647|Alkylating Agents|alkylating agents|mesh-ancestor
25572300|NCT00790647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572301|NCT00790647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25572302|NCT00790647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25572303|NCT00790842|Aspirin|aspirin|mesh-list
25572304|NCT00790842|Dexamethasone|dexamethasone|mesh-list
25572305|NCT00790842|Lenalidomide|lenalidomide|mesh-list
25572306|NCT00790842|Heparin|heparin|mesh-list
24515808|NCT00599287|Protective Agents|protective agents|mesh-ancestor
25572307|NCT00790842|Calcium heparin|calcium heparin|mesh-list
25572308|NCT00790842|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25572309|NCT00790842|Tinzaparin|tinzaparin|mesh-list
25572310|NCT00790842|Dalteparin|dalteparin|mesh-list
25572311|NCT00790842|Anticoagulants|anticoagulants|mesh-list
25572312|NCT00790842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25572313|NCT00790842|Antiemetics|antiemetics|mesh-ancestor
25572314|NCT00790842|Autonomic Agents|autonomic agents|mesh-ancestor
25572315|NCT00790842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25572316|NCT00790842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572317|NCT00790842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25572318|NCT00790842|Glucocorticoids|glucocorticoids|mesh-ancestor
25572319|NCT00790842|Hormones|hormones|mesh-ancestor
25572320|NCT00790842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25572321|NCT00790842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25572322|NCT00790842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572323|NCT00790842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25572324|NCT00790842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25572325|NCT00790842|Analgesics|analgesics|mesh-ancestor
25572326|NCT00790842|Sensory System Agents|sensory system agents|mesh-ancestor
25572327|NCT00790842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25572328|NCT00790842|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25572329|NCT00790842|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25572330|NCT00790842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572331|NCT00790842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25572332|NCT00790842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25572333|NCT00790842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572334|NCT00790842|Antipyretics|antipyretics|mesh-ancestor
25572335|NCT00790842|Immunologic Factors|immunologic factors|mesh-ancestor
25572336|NCT00790842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25572337|NCT00790842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25572338|NCT00790842|Growth Substances|growth substances|mesh-ancestor
25572339|NCT00790842|Growth Inhibitors|growth inhibitors|mesh-ancestor
25572340|NCT00790855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25572341|NCT00790855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25572342|NCT00790855|Alkylating Agents|alkylating agents|mesh-ancestor
25572343|NCT00790855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572344|NCT00790855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572345|NCT00790868|Cycloserine|cycloserine|mesh-list
25572346|NCT00790868|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25572347|NCT00790868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25572348|NCT00790868|Renal Agents|renal agents|mesh-ancestor
25572349|NCT00790868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25572350|NCT00790868|Antitubercular Agents|antitubercular agents|mesh-ancestor
25572351|NCT00790868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25572352|NCT00790868|Antimetabolites|antimetabolites|mesh-ancestor
25572353|NCT00790868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572354|NCT00790907|Heparin|heparin|mesh-list
25572355|NCT00790907|PENTA|penta|mesh-list
25572356|NCT00790907|Fondaparinux|fondaparinux|mesh-list
25572357|NCT00790907|Anticoagulants|anticoagulants|mesh-ancestor
25572358|NCT00790907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25572359|NCT00790907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25572360|NCT00790907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572361|NCT00790907|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25572362|NCT00790907|Antithrombins|antithrombins|mesh-ancestor
25572363|NCT00790907|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25572364|NCT00790907|Protease Inhibitors|protease inhibitors|mesh-ancestor
25572365|NCT00790907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572366|NCT00791037|Cyclophosphamide|cyclophosphamide|mesh-list
25572367|NCT00791037|Sargramostim|sargramostim|mesh-list
25572368|NCT00791037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25572369|NCT00791037|Immunologic Factors|immunologic factors|mesh-ancestor
25572370|NCT00791037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572371|NCT00791037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25572372|NCT00791037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25572373|NCT00791037|Alkylating Agents|alkylating agents|mesh-ancestor
25572374|NCT00791037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572375|NCT00791037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572376|NCT00791037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25572377|NCT00791219|Itraconazole|itraconazole|mesh-list
25572378|NCT00791219|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
25572379|NCT00791219|Antifungal Agents|antifungal agents|mesh-ancestor
25572380|NCT00791219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25572381|NCT00791219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25572382|NCT00791219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25572383|NCT00791219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572384|NCT00791219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572385|NCT00791219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25572386|NCT00791219|Hormone Antagonists|hormone antagonists|mesh-ancestor
25572387|NCT00791219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25572388|NCT00791219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572389|NCT00791219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25572390|NCT00791258|Amlodipine|amlodipine|mesh-list
25572391|NCT00791258|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25572392|NCT00791258|Olmesartan|olmesartan|mesh-list
25572393|NCT00791258|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25572394|NCT00791258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25572395|NCT00791258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25572396|NCT00791258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25572397|NCT00791258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572398|NCT00791258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25572399|NCT00791258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933025|NCT04074551|Losartan|losartan|mesh-list
24515874|NCT00599820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24515875|NCT00599820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24515876|NCT00599820|Growth Substances|growth substances|mesh-ancestor
24515877|NCT00599820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515885|NCT00599885|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24515886|NCT00599885|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24515887|NCT00599885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572400|NCT00791258|Vasodilator Agents|vasodilator agents|mesh-ancestor
25572401|NCT00791258|Diuretics|diuretics|mesh-ancestor
25572402|NCT00791258|Natriuretic Agents|natriuretic agents|mesh-ancestor
25572403|NCT00791258|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25572404|NCT00791258|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25572405|NCT00791258|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25572406|NCT00791323|Ketorolac|ketorolac|mesh-list
25572407|NCT00791323|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25572408|NCT00791323|Lubricant Eye Drops|lubricant eye drops|mesh-list
25572409|NCT00791323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25572410|NCT00791323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25572411|NCT00791323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25572412|NCT00791323|Analgesics|analgesics|mesh-ancestor
25572413|NCT00791323|Sensory System Agents|sensory system agents|mesh-ancestor
25572414|NCT00791323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25572415|NCT00791323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572416|NCT00791323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25572417|NCT00791323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25572418|NCT00791323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25572419|NCT00791323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572420|NCT00791323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572421|NCT00791479|Dulaglutide|dulaglutide|mesh-list
25572422|NCT00791479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25572423|NCT00791479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572424|NCT00791557|Infliximab|infliximab|mesh-list
25572425|NCT00791557|Dermatologic Agents|dermatologic agents|mesh-ancestor
25572426|NCT00791557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25572427|NCT00791557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25572428|NCT00791648|Atorvastatin|atorvastatin|mesh-list
25466940|NCT04714710|Diuretics|diuretics|mesh-ancestor
25572429|NCT00791648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25572430|NCT00791648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25572431|NCT00791648|Antimetabolites|antimetabolites|mesh-ancestor
25572432|NCT00791648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572433|NCT00791648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25572434|NCT00791648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25572435|NCT00791648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572436|NCT00791700|Maraviroc|maraviroc|mesh-list
25572437|NCT00791700|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25572438|NCT00791700|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25572439|NCT00791700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572440|NCT00791700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25572441|NCT00791700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25572442|NCT00791700|Antiviral Agents|antiviral agents|mesh-ancestor
25572443|NCT00791700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25572444|NCT00791700|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25572445|NCT00791765|Etanercept|etanercept|mesh-list
25699014|NCT02100644|Anticonvulsants|anticonvulsants|mesh-ancestor
25572446|NCT00791765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25572447|NCT00791765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25572448|NCT00791765|Analgesics|analgesics|mesh-ancestor
25572449|NCT00791765|Sensory System Agents|sensory system agents|mesh-ancestor
25572450|NCT00791765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25572451|NCT00791765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572452|NCT00791765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25572453|NCT00791765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25572454|NCT00791765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25572455|NCT00791765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25572456|NCT00791765|Immunologic Factors|immunologic factors|mesh-ancestor
25572457|NCT00791778|Sorafenib|sorafenib|mesh-list
25572458|NCT00791778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572459|NCT00791778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25572460|NCT00791778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572461|NCT00791778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572462|NCT00791921|Certolizumab Pegol|certolizumab pegol|mesh-list
25572463|NCT00791921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25572464|NCT00791921|Immunologic Factors|immunologic factors|mesh-ancestor
24995308|NCT05285566|Lidocaine|lidocaine|mesh-list
25572465|NCT00791921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572466|NCT00791921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25572467|NCT00791973|Fluticasone|fluticasone|mesh-list
25572468|NCT00791973|Xhance|xhance|mesh-list
25572469|NCT00791973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25572470|NCT00791973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25572471|NCT00791973|Autonomic Agents|autonomic agents|mesh-ancestor
25572472|NCT00791973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25572473|NCT00791973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572474|NCT00791973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25572475|NCT00791973|Respiratory System Agents|respiratory system agents|mesh-ancestor
25572476|NCT00791973|Dermatologic Agents|dermatologic agents|mesh-ancestor
25572477|NCT00791973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25572478|NCT00791999|Certolizumab Pegol|certolizumab pegol|mesh-list
25572479|NCT00791999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25572480|NCT00791999|Immunologic Factors|immunologic factors|mesh-ancestor
25572481|NCT00791999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572482|NCT00791999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25572483|NCT00792077|Lenalidomide|lenalidomide|mesh-list
25572484|NCT00792077|Immunologic Factors|immunologic factors|mesh-ancestor
25572485|NCT00792077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572486|NCT00792077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25572487|NCT00792077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25572488|NCT00792077|Growth Substances|growth substances|mesh-ancestor
25572489|NCT00792077|Growth Inhibitors|growth inhibitors|mesh-ancestor
25572490|NCT00792077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572491|NCT00792142|Thalidomide|thalidomide|mesh-list
25572492|NCT00792142|Dexamethasone|dexamethasone|mesh-list
25572493|NCT00792142|Bortezomib|bortezomib|mesh-list
25572494|NCT00792142|Melphalan|melphalan|mesh-list
25572495|NCT00792142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25572496|NCT00792142|Antiemetics|antiemetics|mesh-ancestor
25572497|NCT00792142|Autonomic Agents|autonomic agents|mesh-ancestor
25572498|NCT00792142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25572499|NCT00792142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572500|NCT00792142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25572501|NCT00792142|Glucocorticoids|glucocorticoids|mesh-ancestor
25572502|NCT00792142|Hormones|hormones|mesh-ancestor
25572503|NCT00792142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25572504|NCT00792142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25572505|NCT00792142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572506|NCT00792142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25572507|NCT00792142|Alkylating Agents|alkylating agents|mesh-ancestor
25572508|NCT00792142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572509|NCT00792142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25572510|NCT00792142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25572511|NCT00792142|Immunologic Factors|immunologic factors|mesh-ancestor
25572512|NCT00792142|Leprostatic Agents|leprostatic agents|mesh-ancestor
24516149|NCT00600691|Finasteride|finasteride|mesh-list
25572513|NCT00792142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25572514|NCT00792142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25572515|NCT00792142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25572516|NCT00792142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25572517|NCT00792142|Growth Substances|growth substances|mesh-ancestor
25572518|NCT00792142|Growth Inhibitors|growth inhibitors|mesh-ancestor
25572520|NCT00792298|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25572521|NCT00792298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25572522|NCT00792298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25572523|NCT00792298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572524|NCT00792298|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25572525|NCT00792298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25572526|NCT00792298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572527|NCT00792467|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25572528|NCT00792467|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
25572529|NCT00792467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572530|NCT00792467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572531|NCT00792571|Epoprostenol|epoprostenol|mesh-list
25572532|NCT00792571|Beraprost|beraprost|mesh-list
25572533|NCT00792571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25572534|NCT00792571|Vasodilator Agents|vasodilator agents|mesh-ancestor
25572535|NCT00792571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25572536|NCT00792636|Naproxen|naproxen|mesh-list
25572537|NCT00792636|Sumatriptan|sumatriptan|mesh-list
25572538|NCT00792636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25572539|NCT00792636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25572540|NCT00792636|Analgesics|analgesics|mesh-ancestor
25572541|NCT00792636|Sensory System Agents|sensory system agents|mesh-ancestor
25572542|NCT00792636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24995451|NCT05166096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25572543|NCT00792636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572544|NCT00792636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25572545|NCT00792636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25572546|NCT00792636|Gout Suppressants|gout suppressants|mesh-ancestor
25572547|NCT00792636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25572548|NCT00792636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572549|NCT00792636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572550|NCT00792636|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25572551|NCT00792636|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25572552|NCT00792636|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25572553|NCT00792636|Serotonin Agents|serotonin agents|mesh-ancestor
25572554|NCT00792636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25572555|NCT00792701|Gemcitabine|gemcitabine|mesh-list
25572556|NCT00792701|Cisplatin|cisplatin|mesh-list
25572557|NCT00792701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572558|NCT00792701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25572559|NCT00792701|Antimetabolites|antimetabolites|mesh-ancestor
25572560|NCT00792701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572561|NCT00792701|Antiviral Agents|antiviral agents|mesh-ancestor
25572562|NCT00792701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25572563|NCT00792701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572564|NCT00792701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25572565|NCT00792701|Immunologic Factors|immunologic factors|mesh-ancestor
25572566|NCT00792701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572567|NCT00792909|Vaccines|vaccines|mesh-list
25572568|NCT00792909|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25572569|NCT00792909|Immunologic Factors|immunologic factors|mesh-ancestor
25572570|NCT00792909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572571|NCT00792922|Azithromycin|azithromycin|mesh-list
25572572|NCT00792922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25572573|NCT00792922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25572574|NCT00792935|Metformin|metformin|mesh-list
25572575|NCT00792935|Glimepiride|glimepiride|mesh-list
25572576|NCT00792935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25572577|NCT00792935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572578|NCT00792935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25572579|NCT00792935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25572580|NCT00792935|Immunologic Factors|immunologic factors|mesh-ancestor
25652366|NCT01526148|Antidepressive Agents|antidepressive agents|mesh-ancestor
25652367|NCT01526148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25652368|NCT01526148|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25652369|NCT01526148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25652370|NCT01526148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25652371|NCT01526148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652372|NCT01526148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652373|NCT01526148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652375|NCT01526213|Fexofenadine|fexofenadine|mesh-list
25652376|NCT01526213|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25652377|NCT01526213|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25652378|NCT01526213|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25652379|NCT01526213|Histamine Antagonists|histamine antagonists|mesh-ancestor
25652380|NCT01526213|Histamine Agents|histamine agents|mesh-ancestor
25652381|NCT01526213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25652382|NCT01526213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652383|NCT01526213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652384|NCT01526356|Sirolimus|sirolimus|mesh-list
25652385|NCT01526356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25652386|NCT01526356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25652387|NCT01526356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25652388|NCT01526356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652389|NCT01526356|Antifungal Agents|antifungal agents|mesh-ancestor
25652390|NCT01526356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25652391|NCT01526356|Immunologic Factors|immunologic factors|mesh-ancestor
25652392|NCT01526356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652393|NCT01526538|Cycloserine|cycloserine|mesh-list
25652394|NCT01526538|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25652395|NCT01526538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25652396|NCT01526538|Renal Agents|renal agents|mesh-ancestor
25652397|NCT01526538|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25652398|NCT01526538|Antitubercular Agents|antitubercular agents|mesh-ancestor
25652399|NCT01526538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25652400|NCT01526538|Antimetabolites|antimetabolites|mesh-ancestor
25699089|NCT02101021|Paclitaxel|paclitaxel|mesh-list
25652401|NCT01526538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652402|NCT01526551|Vaccines|vaccines|mesh-list
25652403|NCT01526551|Immunologic Factors|immunologic factors|mesh-ancestor
25652404|NCT01526551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652405|NCT01526577|Ticagrelor|ticagrelor|mesh-list
25652406|NCT01526577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25652407|NCT01526577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25652408|NCT01526577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25652409|NCT01526577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25652410|NCT01526577|Purinergic Agents|purinergic agents|mesh-ancestor
25652411|NCT01526577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25652412|NCT01526577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063043|NCT03229408|Analgesics|analgesics|mesh-ancestor
24516447|NCT00601159|Immunologic Factors|immunologic factors|mesh-ancestor
25652413|NCT01526577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652414|NCT01526733|Insulin|insulin|mesh-list
25652415|NCT01526733|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25652416|NCT01526733|Insulin Aspart|insulin aspart|mesh-list
25652417|NCT01526733|Insulin Lispro|insulin lispro|mesh-list
25652418|NCT01526733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25652419|NCT01526733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652420|NCT01527045|Calcium, Dietary|calcium, dietary|mesh-list
25652421|NCT01527045|Cyclosporine|cyclosporine|mesh-list
25652422|NCT01527045|Mycophenolic Acid|mycophenolic acid|mesh-list
25652423|NCT01527045|Fludarabine|fludarabine|mesh-list
25652424|NCT01527045|Fludarabine phosphate|fludarabine phosphate|mesh-list
25652425|NCT01527045|Atorvastatin|atorvastatin|mesh-list
25652426|NCT01527045|Calcium|calcium|mesh-list
25652427|NCT01527045|Cyclosporins|cyclosporins|mesh-list
25652428|NCT01527045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25652429|NCT01527045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652430|NCT01527045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25652431|NCT01527045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652432|NCT01527045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25652433|NCT01527045|Antimetabolites|antimetabolites|mesh-ancestor
25652434|NCT01527045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652435|NCT01527045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25652436|NCT01527045|Immunologic Factors|immunologic factors|mesh-ancestor
25652437|NCT01527045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652438|NCT01527045|Antifungal Agents|antifungal agents|mesh-ancestor
25572581|NCT00793546|Exemestane|exemestane|mesh-list
25572582|NCT00793546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572583|NCT00793546|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25572584|NCT00793546|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25572585|NCT00793546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572586|NCT00793546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572587|NCT00793546|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25572588|NCT00793546|Hormone Antagonists|hormone antagonists|mesh-ancestor
25572589|NCT00793546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25572590|NCT00793546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572591|NCT00793572|Cyclosporine|cyclosporine|mesh-list
25572592|NCT00793572|Mycophenolic Acid|mycophenolic acid|mesh-list
25572593|NCT00793572|Fludarabine|fludarabine|mesh-list
25572594|NCT00793572|Fludarabine phosphate|fludarabine phosphate|mesh-list
25572595|NCT00793572|Bortezomib|bortezomib|mesh-list
25572596|NCT00793572|Melphalan|melphalan|mesh-list
25572597|NCT00793572|Mechlorethamine|mechlorethamine|mesh-list
25572598|NCT00793572|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25572599|NCT00793572|Cyclosporins|cyclosporins|mesh-list
25572600|NCT00793572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572601|NCT00793572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25572602|NCT00793572|Antimetabolites|antimetabolites|mesh-ancestor
25572603|NCT00793572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572604|NCT00793572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25572605|NCT00793572|Immunologic Factors|immunologic factors|mesh-ancestor
25572606|NCT00793572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572607|NCT00793572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572608|NCT00793572|Antifungal Agents|antifungal agents|mesh-ancestor
25572609|NCT00793572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25572610|NCT00793572|Dermatologic Agents|dermatologic agents|mesh-ancestor
25572611|NCT00793572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25572612|NCT00793572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25572613|NCT00793572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25572614|NCT00793572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25572615|NCT00793572|Antitubercular Agents|antitubercular agents|mesh-ancestor
25572616|NCT00793572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25572617|NCT00793572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25572618|NCT00793572|Alkylating Agents|alkylating agents|mesh-ancestor
25572619|NCT00793572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25572620|NCT00793585|Allopurinol|allopurinol|mesh-list
25572621|NCT00793585|Antimetabolites|antimetabolites|mesh-ancestor
25572622|NCT00793585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572623|NCT00793585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572624|NCT00793585|Gout Suppressants|gout suppressants|mesh-ancestor
25572625|NCT00793585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25572626|NCT00793585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25572627|NCT00793585|Antioxidants|antioxidants|mesh-ancestor
25572628|NCT00793585|Protective Agents|protective agents|mesh-ancestor
25572629|NCT00793585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572630|NCT00793598|Brincidofovir|brincidofovir|mesh-list
25572631|NCT00793598|Antiviral Agents|antiviral agents|mesh-ancestor
25572632|NCT00793598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25572633|NCT00793624|Formoterol Fumarate|formoterol fumarate|mesh-list
25572634|NCT00793624|Olodaterol|olodaterol|mesh-list
25572635|NCT00793624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25572636|NCT00793624|Autonomic Agents|autonomic agents|mesh-ancestor
25572637|NCT00793624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25572638|NCT00793624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572639|NCT00793624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25572640|NCT00793624|Respiratory System Agents|respiratory system agents|mesh-ancestor
25572641|NCT00793624|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25572642|NCT00793624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25572643|NCT00793624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25572644|NCT00793624|Adrenergic Agents|adrenergic agents|mesh-ancestor
25572645|NCT00793624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25572646|NCT00793624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572647|NCT00793650|Bortezomib|bortezomib|mesh-list
25572648|NCT00793650|Melphalan|melphalan|mesh-list
24786121|NCT01918124|Paclitaxel|paclitaxel|mesh-list
25572649|NCT00793650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572650|NCT00793650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25572651|NCT00793650|Alkylating Agents|alkylating agents|mesh-ancestor
25572652|NCT00793650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572653|NCT00793650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25572654|NCT00793650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25572655|NCT00793650|Immunologic Factors|immunologic factors|mesh-ancestor
25572656|NCT00793650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467300|NCT04203927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467301|NCT04183712|Gemcitabine|gemcitabine|mesh-list
25467302|NCT04183712|Oxaliplatin|oxaliplatin|mesh-list
25467303|NCT04183712|Afatinib|afatinib|mesh-list
25467304|NCT04183712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25467305|NCT04183712|Antimetabolites|antimetabolites|mesh-ancestor
25467306|NCT04183712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467307|NCT04183712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467308|NCT04183712|Antiviral Agents|antiviral agents|mesh-ancestor
25467309|NCT04183712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25467310|NCT04183712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467311|NCT04183712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25467312|NCT04183712|Immunologic Factors|immunologic factors|mesh-ancestor
25467313|NCT04183712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467314|NCT04183712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25467315|NCT04171167|Fluticasone|fluticasone|mesh-list
25467316|NCT04171167|Xhance|xhance|mesh-list
25467317|NCT04171167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25467318|NCT04171167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25467319|NCT04171167|Autonomic Agents|autonomic agents|mesh-ancestor
25467320|NCT04171167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25467321|NCT04171167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467322|NCT04171167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25467323|NCT04171167|Respiratory System Agents|respiratory system agents|mesh-ancestor
25467324|NCT04171167|Dermatologic Agents|dermatologic agents|mesh-ancestor
25467325|NCT04171167|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25467326|NCT04134000|Atezolizumab|atezolizumab|mesh-list
25467327|NCT04134000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429652|NCT00244608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24429653|NCT00244608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24429654|NCT00244608|Autonomic Agents|autonomic agents|mesh-ancestor
24429655|NCT00244608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24429710|NCT00244920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24429722|NCT00244946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24429723|NCT00244946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429724|NCT00244946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24429725|NCT00244946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24429726|NCT00244946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429727|NCT00244946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429728|NCT00244946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24429729|NCT00244946|Antimetabolites|antimetabolites|mesh-ancestor
24429730|NCT00244946|Antiviral Agents|antiviral agents|mesh-ancestor
24429731|NCT00244946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24429732|NCT00244946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24429733|NCT00244946|Immunologic Factors|immunologic factors|mesh-ancestor
24429734|NCT00244946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429735|NCT00244946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24429736|NCT00244946|Alkylating Agents|alkylating agents|mesh-ancestor
25572657|NCT00793780|Naltrexone|naltrexone|mesh-list
25572658|NCT00793780|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25572659|NCT00793780|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25572660|NCT00793780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572661|NCT00793780|Sensory System Agents|sensory system agents|mesh-ancestor
25572662|NCT00793780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25572663|NCT00793819|Silodosin|silodosin|mesh-list
25572664|NCT00793819|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25572665|NCT00793819|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25572666|NCT00793819|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25572667|NCT00793819|Adrenergic Agents|adrenergic agents|mesh-ancestor
25572668|NCT00793819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25572669|NCT00793819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572670|NCT00793819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572671|NCT00793819|Urological Agents|urological agents|mesh-ancestor
25572672|NCT00793871|Sunitinib|sunitinib|mesh-list
25572673|NCT00793871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572674|NCT00793871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25572675|NCT00793871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25572676|NCT00793871|Growth Substances|growth substances|mesh-ancestor
25572677|NCT00793871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572678|NCT00793871|Growth Inhibitors|growth inhibitors|mesh-ancestor
25572679|NCT00793871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25572680|NCT00793871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572681|NCT00793871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572682|NCT00793910|Gabapentin|gabapentin|mesh-list
25572683|NCT00793910|Analgesics|analgesics|mesh-ancestor
25572684|NCT00793910|Sensory System Agents|sensory system agents|mesh-ancestor
25572685|NCT00793910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25572686|NCT00793910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572687|NCT00793910|Anticonvulsants|anticonvulsants|mesh-ancestor
25572688|NCT00793910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25572689|NCT00793910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25572690|NCT00793910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25572691|NCT00793910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25572692|NCT00793910|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25572693|NCT00793910|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25572694|NCT00793910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25572695|NCT00793910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572696|NCT00793910|Antimanic Agents|antimanic agents|mesh-ancestor
25572697|NCT00794040|Methylphenidate|methylphenidate|mesh-list
25572698|NCT00794040|Citalopram|citalopram|mesh-list
25572699|NCT00794040|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25572700|NCT00794040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572701|NCT00794040|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25572702|NCT00794040|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25572703|NCT00794040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25572704|NCT00794040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572705|NCT00794040|Dopamine Agents|dopamine agents|mesh-ancestor
25572706|NCT00794040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24934390|NCT04061512|Dexamethasone|dexamethasone|mesh-list
25572707|NCT00794040|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25572708|NCT00794040|Serotonin Agents|serotonin agents|mesh-ancestor
25572709|NCT00794040|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25572710|NCT00794040|Antidepressive Agents|antidepressive agents|mesh-ancestor
25572711|NCT00794040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25572712|NCT00794144|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25572713|NCT00794144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25572714|NCT00794144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25572715|NCT00794144|Analgesics|analgesics|mesh-ancestor
25572716|NCT00794144|Sensory System Agents|sensory system agents|mesh-ancestor
25572717|NCT00794144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25572718|NCT00794144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572719|NCT00794144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25572720|NCT00794144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25572721|NCT00794144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25572722|NCT00794144|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25572723|NCT00794144|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25572724|NCT00794144|Histamine Antagonists|histamine antagonists|mesh-ancestor
25572725|NCT00794144|Histamine Agents|histamine agents|mesh-ancestor
25572726|NCT00794144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25572727|NCT00794144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572728|NCT00794196|Antidepressive Agents|antidepressive agents|mesh-list
25572729|NCT00794196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25572730|NCT00794313|Topiramate|topiramate|mesh-list
25572731|NCT00794313|Amantadine|amantadine|mesh-list
25572732|NCT00794313|Anticonvulsants|anticonvulsants|mesh-ancestor
25572733|NCT00794313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25572734|NCT00794313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572735|NCT00794313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25572736|NCT00794313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25572737|NCT00794313|Antiviral Agents|antiviral agents|mesh-ancestor
25572738|NCT00794313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25572739|NCT00794313|Dopamine Agents|dopamine agents|mesh-ancestor
25572740|NCT00794313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25572741|NCT00794313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572742|NCT00794313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25572743|NCT00794313|Analgesics|analgesics|mesh-ancestor
25572744|NCT00794313|Sensory System Agents|sensory system agents|mesh-ancestor
25572745|NCT00794313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25572746|NCT00794339|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25572747|NCT00794339|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25572748|NCT00794339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572749|NCT00794365|Varenicline|varenicline|mesh-list
25572750|NCT00794365|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25572751|NCT00794365|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25572752|NCT00794365|Cholinergic Agents|cholinergic agents|mesh-ancestor
25572753|NCT00794365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25572754|NCT00794365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572755|NCT00794365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572756|NCT00794417|Cisplatin|cisplatin|mesh-list
25572757|NCT00794417|Pemetrexed|pemetrexed|mesh-list
25572758|NCT00794417|Aflibercept|aflibercept|mesh-list
25572759|NCT00794417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572760|NCT00794417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572761|NCT00794417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572762|NCT00794417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25572763|NCT00794417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25572764|NCT00794417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25572765|NCT00794417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25572766|NCT00794417|Growth Substances|growth substances|mesh-ancestor
25572767|NCT00794417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572768|NCT00794417|Growth Inhibitors|growth inhibitors|mesh-ancestor
25572769|NCT00794547|Calcitriol|calcitriol|mesh-list
25572770|NCT00794547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24996943|NCT05420948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25572771|NCT00794547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572772|NCT00794547|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25572773|NCT00794547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25572774|NCT00794547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572775|NCT00794547|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25572776|NCT00794547|Vitamins|vitamins|mesh-ancestor
25572777|NCT00794547|Micronutrients|micronutrients|mesh-ancestor
25572778|NCT00794547|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25572779|NCT00794573|Varenicline|varenicline|mesh-list
25572780|NCT00794573|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25572781|NCT00794573|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25572782|NCT00794573|Cholinergic Agents|cholinergic agents|mesh-ancestor
25572783|NCT00794573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25572784|NCT00794573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572785|NCT00794573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572786|NCT00794664|Mipomersen|mipomersen|mesh-list
25572787|NCT00794664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25572788|NCT00794664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25572789|NCT00794664|Antimetabolites|antimetabolites|mesh-ancestor
25572790|NCT00794664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572791|NCT00794664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25572792|NCT00794820|Vidarabine|vidarabine|mesh-list
25572793|NCT00794820|Cyclophosphamide|cyclophosphamide|mesh-list
25572794|NCT00794820|Rituximab|rituximab|mesh-list
25572795|NCT00794820|Fludarabine|fludarabine|mesh-list
25572796|NCT00794820|Fludarabine phosphate|fludarabine phosphate|mesh-list
25572797|NCT00794820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25572798|NCT00794820|Immunologic Factors|immunologic factors|mesh-ancestor
25572799|NCT00794820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572800|NCT00794820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24997104|NCT05411991|Chlorthalidone|chlorthalidone|mesh-list
25572801|NCT00794820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25572802|NCT00794820|Alkylating Agents|alkylating agents|mesh-ancestor
25572803|NCT00794820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572804|NCT00794820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572805|NCT00794820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25572806|NCT00794820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25572807|NCT00794820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25572808|NCT00794820|Antimetabolites|antimetabolites|mesh-ancestor
25572809|NCT00794820|Antiviral Agents|antiviral agents|mesh-ancestor
25572810|NCT00794820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25572811|NCT00794950|Sunitinib|sunitinib|mesh-list
25572812|NCT00794950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572813|NCT00794950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25572814|NCT00794950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25572815|NCT00794950|Growth Substances|growth substances|mesh-ancestor
25572816|NCT00794950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572817|NCT00794950|Growth Inhibitors|growth inhibitors|mesh-ancestor
25572818|NCT00794950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25572819|NCT00794950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606147|NCT01065350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25572820|NCT00794950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572821|NCT00794963|Metformin|metformin|mesh-list
25572822|NCT00794963|Orlistat|orlistat|mesh-list
25572823|NCT00794963|Irbesartan|irbesartan|mesh-list
25572824|NCT00794963|Fenofibrate|fenofibrate|mesh-list
25572825|NCT00794963|Pravastatin|pravastatin|mesh-list
25572826|NCT00794963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25572827|NCT00794963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572828|NCT00794963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25572829|NCT00794963|Antimetabolites|antimetabolites|mesh-ancestor
24475781|NCT00411372|Xhance|xhance|mesh-list
25572830|NCT00794963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572831|NCT00794963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25572832|NCT00794963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25606148|NCT01065350|Anesthetics, General|anesthetics, general|mesh-ancestor
25572833|NCT00794963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25572834|NCT00794963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572835|NCT00794963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25572836|NCT00794963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25572837|NCT00794963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25572838|NCT00794963|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25572839|NCT00795002|Cytarabine|cytarabine|mesh-list
25572840|NCT00795002|Mitoxantrone|mitoxantrone|mesh-list
25572841|NCT00795002|Alvocidib|alvocidib|mesh-list
25572842|NCT00795002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25572843|NCT00795002|Antimetabolites|antimetabolites|mesh-ancestor
25572844|NCT00795002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572845|NCT00795002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572846|NCT00795002|Antiviral Agents|antiviral agents|mesh-ancestor
25572847|NCT00795002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25572848|NCT00795002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25572849|NCT00795002|Immunologic Factors|immunologic factors|mesh-ancestor
25572850|NCT00795002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572851|NCT00795002|Analgesics|analgesics|mesh-ancestor
25572852|NCT00795002|Sensory System Agents|sensory system agents|mesh-ancestor
25572853|NCT00795002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25572854|NCT00795002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25572855|NCT00795002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25572856|NCT00795002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572857|NCT00795002|Growth Inhibitors|growth inhibitors|mesh-ancestor
25572858|NCT00795002|Growth Substances|growth substances|mesh-ancestor
25572859|NCT00795002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25572860|NCT00795132|Cyclosporine|cyclosporine|mesh-list
25572861|NCT00795132|Mycophenolic Acid|mycophenolic acid|mesh-list
25572862|NCT00795132|Fludarabine|fludarabine|mesh-list
25572863|NCT00795132|Busulfan|busulfan|mesh-list
25572864|NCT00795132|Cyclosporins|cyclosporins|mesh-list
25572865|NCT00795132|Thymoglobulin|thymoglobulin|mesh-list
25572866|NCT00795132|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25572867|NCT00795132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572868|NCT00795132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572869|NCT00795132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25572870|NCT00795132|Immunologic Factors|immunologic factors|mesh-ancestor
25572871|NCT00795132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572872|NCT00795132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572873|NCT00795132|Antifungal Agents|antifungal agents|mesh-ancestor
25572874|NCT00795132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25572875|NCT00795132|Dermatologic Agents|dermatologic agents|mesh-ancestor
25572876|NCT00795132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25572877|NCT00795132|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25572878|NCT00795132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25572879|NCT00795132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25572880|NCT00795132|Antitubercular Agents|antitubercular agents|mesh-ancestor
25572881|NCT00795132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25572882|NCT00795132|Alkylating Agents|alkylating agents|mesh-ancestor
25572883|NCT00795132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25572884|NCT00795132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25572885|NCT00795145|Moxifloxacin|moxifloxacin|mesh-list
25572886|NCT00795145|Linezolid|linezolid|mesh-list
25572887|NCT00795145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25572888|NCT00795145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24476082|NCT00412802|Enoxaparin|enoxaparin|mesh-list
25572889|NCT00795145|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25572890|NCT00795145|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25572891|NCT00795145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572892|NCT00795145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572893|NCT00795145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572894|NCT00795145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25572895|NCT00795210|Hormones|hormones|mesh-list
25572896|NCT00795210|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
25572897|NCT00795210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25572898|NCT00795210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572899|NCT00795275|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25572900|NCT00795275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25572901|NCT00795275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572902|NCT00795275|Incretins|incretins|mesh-ancestor
25572903|NCT00795275|Hormones|hormones|mesh-ancestor
25572904|NCT00795275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25572905|NCT00795275|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25572906|NCT00795275|Protease Inhibitors|protease inhibitors|mesh-ancestor
25572907|NCT00795275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572908|NCT00795275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572910|NCT00795288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25572911|NCT00795288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25572912|NCT00795288|Antimetabolites|antimetabolites|mesh-ancestor
25572913|NCT00795288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572914|NCT00795288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25572915|NCT00795288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25572916|NCT00795288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572917|NCT00795340|Paclitaxel|paclitaxel|mesh-list
25572918|NCT00795340|Carboplatin|carboplatin|mesh-list
25572919|NCT00795340|Cediranib|cediranib|mesh-list
25572920|NCT00795340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25572921|NCT00795340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572922|NCT00795340|Tubulin Modulators|tubulin modulators|mesh-ancestor
25572923|NCT00795340|Antimitotic Agents|antimitotic agents|mesh-ancestor
25572924|NCT00795340|Mitosis Modulators|mitosis modulators|mesh-ancestor
25572925|NCT00795340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572926|NCT00795340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572927|NCT00795340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25572928|NCT00795366|Vasopressins|vasopressins|mesh-list
25572929|NCT00795366|Arginine Vasopressin|arginine vasopressin|mesh-list
25572930|NCT00795366|Hemostatics|hemostatics|mesh-ancestor
25572931|NCT00795366|Coagulants|coagulants|mesh-ancestor
25572932|NCT00795366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25572933|NCT00795366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25572934|NCT00795366|Natriuretic Agents|natriuretic agents|mesh-ancestor
25572935|NCT00795366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572936|NCT00795509|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25572937|NCT00795509|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25572938|NCT00795509|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25572939|NCT00795509|Cholinergic Agents|cholinergic agents|mesh-ancestor
25572940|NCT00795509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25572941|NCT00795509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572942|NCT00795509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572943|NCT00795509|Urological Agents|urological agents|mesh-ancestor
25572944|NCT00795600|Insulin|insulin|mesh-list
24948089|NCT03923231|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25572945|NCT00795600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25572946|NCT00795600|Insulin Detemir|insulin detemir|mesh-list
25572947|NCT00795600|Isophane Insulin, Human|isophane insulin, human|mesh-list
25572948|NCT00795600|Insulin, Isophane|insulin, isophane|mesh-list
25572949|NCT00795600|Isophane insulin, beef|isophane insulin, beef|mesh-list
25572950|NCT00795600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25572951|NCT00795600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572952|NCT00795639|Sitaxsentan|sitaxsentan|mesh-list
25606149|NCT01065350|Anesthetics|anesthetics|mesh-ancestor
24817974|NCT02086227|Hormones|hormones|mesh-ancestor
25572953|NCT00795639|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25572954|NCT00795639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572955|NCT00795769|Ondansetron|ondansetron|mesh-list
25572956|NCT00795769|Antiemetics|antiemetics|mesh-ancestor
25572957|NCT00795769|Autonomic Agents|autonomic agents|mesh-ancestor
25572958|NCT00795769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25572959|NCT00795769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572960|NCT00795769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25572961|NCT00795769|Antipruritics|antipruritics|mesh-ancestor
25572962|NCT00795769|Dermatologic Agents|dermatologic agents|mesh-ancestor
25572963|NCT00795769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25572964|NCT00795769|Serotonin Agents|serotonin agents|mesh-ancestor
25467539|NCT03745144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25467540|NCT03745144|Contraceptive Agents|contraceptive agents|mesh-ancestor
25467541|NCT03745144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25467542|NCT03745144|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25467543|NCT03745144|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25467544|NCT03745144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25467545|NCT03745144|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25572965|NCT00795769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25606150|NCT01065350|Analgesics|analgesics|mesh-ancestor
24900794|NCT04391361|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25572966|NCT00795769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572967|NCT00795769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25572968|NCT00795769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25572969|NCT00795769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24900985|NCT04389554|Hemostatics|hemostatics|mesh-ancestor
25572970|NCT00795769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25572971|NCT00795769|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25572972|NCT00795886|Sirolimus|sirolimus|mesh-list
25572973|NCT00795886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25572974|NCT00795886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25572975|NCT00795886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25572976|NCT00795886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572977|NCT00795886|Antifungal Agents|antifungal agents|mesh-ancestor
25572978|NCT00795886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25572979|NCT00795886|Immunologic Factors|immunologic factors|mesh-ancestor
25572980|NCT00795886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25572981|NCT00796003|Decitabine|decitabine|mesh-list
25572982|NCT00796003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25572983|NCT00796003|Antimetabolites|antimetabolites|mesh-ancestor
24518807|NCT04177953|Nivolumab|nivolumab|mesh-list
25572984|NCT00796003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572985|NCT00796003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572986|NCT00796003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572987|NCT00796120|Doxorubicin|doxorubicin|mesh-list
25572988|NCT00796120|Ifosfamide|ifosfamide|mesh-list
25572989|NCT00796120|Trabectedin|trabectedin|mesh-list
25572990|NCT00796120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25572991|NCT00796120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25572992|NCT00796120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25572993|NCT00796120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24826474|NCT02134457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24901205|NCT04387604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901208|NCT04387539|Sofosbuvir|sofosbuvir|mesh-list
25572994|NCT00796120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25572995|NCT00796120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572996|NCT00796120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25572997|NCT00796120|Alkylating Agents|alkylating agents|mesh-ancestor
25572998|NCT00796224|Azithromycin|azithromycin|mesh-list
24826502|NCT02134717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25572999|NCT00796224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25573000|NCT00796224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25573001|NCT00796302|Risperidone|risperidone|mesh-list
25573002|NCT00796302|Methylphenidate|methylphenidate|mesh-list
25573003|NCT00796302|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25573004|NCT00796302|Serotonin Agents|serotonin agents|mesh-ancestor
25573005|NCT00796302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25573006|NCT00796302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573007|NCT00796302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573008|NCT00796302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25573009|NCT00796302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25573010|NCT00796302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25699328|NCT02105454|Grazoprevir|grazoprevir|mesh-list
25699329|NCT02105454|Antimetabolites|antimetabolites|mesh-ancestor
25573011|NCT00796302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25573012|NCT00796302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25573013|NCT00796302|Dopamine Agents|dopamine agents|mesh-ancestor
25573014|NCT00796302|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25573015|NCT00796302|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25573016|NCT00796302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25573017|NCT00796302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25573018|NCT00796315|Doxylamine|doxylamine|mesh-list
25573019|NCT00796315|Doxylamine succinate|doxylamine succinate|mesh-list
25573020|NCT00796315|Antiemetics|antiemetics|mesh-ancestor
25573021|NCT00796315|Autonomic Agents|autonomic agents|mesh-ancestor
25573022|NCT00796315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25573023|NCT00796315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573024|NCT00796315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25699353|NCT02105974|Xhance|xhance|mesh-list
25573025|NCT00796315|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25573026|NCT00796315|Histamine Antagonists|histamine antagonists|mesh-ancestor
25573027|NCT00796315|Histamine Agents|histamine agents|mesh-ancestor
25573028|NCT00796315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25573029|NCT00796315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573030|NCT00796328|Phenylephrine|phenylephrine|mesh-list
25573031|NCT00796328|Oxymetazoline|oxymetazoline|mesh-list
25573032|NCT00796328|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25573033|NCT00796328|Mydriatics|mydriatics|mesh-ancestor
25573034|NCT00796328|Autonomic Agents|autonomic agents|mesh-ancestor
24901989|NCT04379310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901990|NCT04379310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24901992|NCT04378972|Cholecalciferol|cholecalciferol|mesh-list
24901998|NCT04378972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24901999|NCT04378972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24902006|NCT04378972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24902007|NCT04378972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24902008|NCT04378972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902010|NCT04378972|Anticonvulsants|anticonvulsants|mesh-ancestor
25573035|NCT00796328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25573036|NCT00796328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573037|NCT00796328|Sympathomimetics|sympathomimetics|mesh-ancestor
25573038|NCT00796328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25573039|NCT00796328|Nasal Decongestants|nasal decongestants|mesh-ancestor
25573040|NCT00796328|Respiratory System Agents|respiratory system agents|mesh-ancestor
25573041|NCT00796328|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24902140|NCT04376970|Fluorometholone|fluorometholone|mesh-list
24902141|NCT04376970|Cyclosporine|cyclosporine|mesh-list
24902142|NCT04376970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25064093|NCT03463252|Progestins|progestins|mesh-ancestor
25064095|NCT03463252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25573042|NCT00796328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25573043|NCT00796328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25573044|NCT00796328|Adrenergic Agents|adrenergic agents|mesh-ancestor
25573045|NCT00796328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25573046|NCT00796328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573047|NCT00796328|Protective Agents|protective agents|mesh-ancestor
25064121|NCT03463083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25573048|NCT00796419|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
25573049|NCT00796419|Plasma Substitutes|plasma substitutes|mesh-ancestor
24903161|NCT04365686|Anesthetics|anesthetics|mesh-ancestor
25573050|NCT00796419|Blood Substitutes|blood substitutes|mesh-ancestor
25573051|NCT00796549|Afatinib|afatinib|mesh-list
25573052|NCT00796549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573053|NCT00796549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25573054|NCT00796549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573055|NCT00796549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573056|NCT00796562|Cyclophosphamide|cyclophosphamide|mesh-list
24903663|NCT04361708|Vitamins|vitamins|mesh-ancestor
25573057|NCT00796562|Busulfan|busulfan|mesh-list
25573058|NCT00796562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25573059|NCT00796562|Immunologic Factors|immunologic factors|mesh-ancestor
25573060|NCT00796562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573061|NCT00796562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25573062|NCT00796562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25573063|NCT00796562|Alkylating Agents|alkylating agents|mesh-ancestor
25573064|NCT00796562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573065|NCT00796562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573066|NCT00796562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25573067|NCT00796614|Tamsulosin|tamsulosin|mesh-list
25573068|NCT00796614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25573069|NCT00796614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25573070|NCT00796614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25573071|NCT00796614|Adrenergic Agents|adrenergic agents|mesh-ancestor
25573072|NCT00796614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24904277|NCT04357002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904278|NCT04357002|Hemostatics|hemostatics|mesh-ancestor
25064203|NCT03462212|Rucaparib|rucaparib|mesh-list
25606151|NCT01065350|Sensory System Agents|sensory system agents|mesh-ancestor
25606152|NCT01065350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25606153|NCT01065350|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25606154|NCT01065350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25606155|NCT01065350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24904588|NCT04355039|Hormones|hormones|mesh-ancestor
25573073|NCT00796614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573074|NCT00796614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573075|NCT00796614|Urological Agents|urological agents|mesh-ancestor
25573076|NCT00796653|Formoterol Fumarate|formoterol fumarate|mesh-list
25573077|NCT00796653|Olodaterol|olodaterol|mesh-list
25573078|NCT00796653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25573079|NCT00796653|Autonomic Agents|autonomic agents|mesh-ancestor
25573080|NCT00796653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25573081|NCT00796653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573082|NCT00796653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25573083|NCT00796653|Respiratory System Agents|respiratory system agents|mesh-ancestor
25573084|NCT00796653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25573085|NCT00796653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25573086|NCT00796653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25573087|NCT00796653|Adrenergic Agents|adrenergic agents|mesh-ancestor
25573088|NCT00796653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24904843|NCT04352621|Sensory System Agents|sensory system agents|mesh-ancestor
24904844|NCT04352621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24904845|NCT04352621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904846|NCT04352621|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24904862|NCT04352400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25064263|NCT03461627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25573089|NCT00796653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573090|NCT00796666|Sildenafil Citrate|sildenafil citrate|mesh-list
25573091|NCT00796666|Sitaxsentan|sitaxsentan|mesh-list
25573092|NCT00796666|Vasodilator Agents|vasodilator agents|mesh-ancestor
25573093|NCT00796666|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25573094|NCT00796666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25573095|NCT00796666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573096|NCT00796666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573097|NCT00796666|Urological Agents|urological agents|mesh-ancestor
25064275|NCT03461575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064276|NCT03461575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24623617|NCT01072812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24623618|NCT01072812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623619|NCT01072812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573098|NCT00796666|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25573099|NCT00796705|Adalimumab|adalimumab|mesh-list
25573100|NCT00796705|Etanercept|etanercept|mesh-list
25573101|NCT00796705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25573102|NCT00796705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25573103|NCT00796705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25573104|NCT00796705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25573105|NCT00796705|Analgesics|analgesics|mesh-ancestor
25573106|NCT00796705|Sensory System Agents|sensory system agents|mesh-ancestor
25573107|NCT00796705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25573108|NCT00796705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905193|NCT04350086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24905194|NCT04350086|Analgesics|analgesics|mesh-ancestor
24905195|NCT04350086|Sensory System Agents|sensory system agents|mesh-ancestor
24905196|NCT04350086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25064290|NCT03461328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25064291|NCT03461328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25064292|NCT03461328|Anticonvulsants|anticonvulsants|mesh-ancestor
25064293|NCT03461328|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24905197|NCT04350086|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24905198|NCT04350086|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24905208|NCT04350281|Interferons|interferons|mesh-list
25573109|NCT00796705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25573110|NCT00796705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25573111|NCT00796705|Immunologic Factors|immunologic factors|mesh-ancestor
25573112|NCT00796718|Capecitabine|capecitabine|mesh-list
25573113|NCT00796718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25573114|NCT00796718|Antimetabolites|antimetabolites|mesh-ancestor
25573115|NCT00796718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573116|NCT00796718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905281|NCT04349410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24905282|NCT04349410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24905283|NCT04349410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24905284|NCT04349410|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24905285|NCT04349410|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24905286|NCT04349410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24905287|NCT04349410|Antimetabolites|antimetabolites|mesh-ancestor
24905288|NCT04349241|Favipiravir|favipiravir|mesh-list
25573117|NCT00796744|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
25573118|NCT00796744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25573119|NCT00796744|Vasodilator Agents|vasodilator agents|mesh-ancestor
25573120|NCT00796757|Interferons|interferons|mesh-list
25573121|NCT00796757|Interferon-alpha|interferon-alpha|mesh-list
25573122|NCT00796757|Interferon alpha-2|interferon alpha-2|mesh-list
25573123|NCT00796757|Bevacizumab|bevacizumab|mesh-list
25573124|NCT00796757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25573125|NCT00796757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573126|NCT00796757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24905340|NCT04348474|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24905341|NCT04348474|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24905342|NCT04348474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905343|NCT04348474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064307|NCT03461185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25064308|NCT03461081|Amlodipine|amlodipine|mesh-list
25064309|NCT03461081|Telmisartan|telmisartan|mesh-list
25064310|NCT03461081|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
25064311|NCT03461081|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
25064312|NCT03461081|Atorvastatin|atorvastatin|mesh-list
25064313|NCT03461081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25573127|NCT00796757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25573128|NCT00796757|Growth Substances|growth substances|mesh-ancestor
25573129|NCT00796757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573130|NCT00796757|Growth Inhibitors|growth inhibitors|mesh-ancestor
25573131|NCT00796757|Antiviral Agents|antiviral agents|mesh-ancestor
25573132|NCT00796757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25573133|NCT00796757|Immunologic Factors|immunologic factors|mesh-ancestor
25573135|NCT00796822|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25573136|NCT00796822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573137|NCT00796822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573138|NCT00796822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24537055|NCT00653380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24459645|NCT00345696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573139|NCT00796822|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25573140|NCT00796822|Protective Agents|protective agents|mesh-ancestor
25573141|NCT00796822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573142|NCT00796822|Vasodilator Agents|vasodilator agents|mesh-ancestor
25573143|NCT00796822|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25573144|NCT00796822|Antioxidants|antioxidants|mesh-ancestor
25573145|NCT00796926|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25573146|NCT00796926|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25573147|NCT00796978|Trastuzumab|trastuzumab|mesh-list
24905599|NCT04345926|Propofol|propofol|mesh-list
24905600|NCT04345926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24905601|NCT04345926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24905602|NCT04345926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905603|NCT04345926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24905604|NCT04345926|Anesthetics, General|anesthetics, general|mesh-ancestor
24905605|NCT04345926|Anesthetics|anesthetics|mesh-ancestor
24905606|NCT04346030|Triamcinolone|triamcinolone|mesh-list
24905607|NCT04346030|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24905608|NCT04346030|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24905609|NCT04346030|Lidocaine|lidocaine|mesh-list
24905610|NCT04346030|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24905611|NCT04346030|Anesthetics, Local|anesthetics, local|mesh-ancestor
24905612|NCT04346030|Anesthetics|anesthetics|mesh-ancestor
24905619|NCT04346030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24905620|NCT04346030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24905621|NCT04346030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905622|NCT04346030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24905623|NCT04346030|Glucocorticoids|glucocorticoids|mesh-ancestor
24905624|NCT04346030|Hormones|hormones|mesh-ancestor
24905625|NCT04346030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24905626|NCT04346030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24905627|NCT04346030|Immunologic Factors|immunologic factors|mesh-ancestor
24905628|NCT04346030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905629|NCT04346095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
24728565|NCT01617057|Tiludronic acid|tiludronic acid|mesh-list
24905630|NCT04346095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24905632|NCT04346017|Complement System Proteins|complement system proteins|mesh-list
24905633|NCT04346017|Immunologic Factors|immunologic factors|mesh-ancestor
25573148|NCT00796978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25573149|NCT00796978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573150|NCT00796991|Paclitaxel|paclitaxel|mesh-list
25573151|NCT00796991|Carboplatin|carboplatin|mesh-list
25573152|NCT00796991|Ipilimumab|ipilimumab|mesh-list
25573153|NCT00796991|Dacarbazine|dacarbazine|mesh-list
25573154|NCT00796991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25573155|NCT00796991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573156|NCT00796991|Tubulin Modulators|tubulin modulators|mesh-ancestor
25573157|NCT00796991|Antimitotic Agents|antimitotic agents|mesh-ancestor
25573158|NCT00796991|Mitosis Modulators|mitosis modulators|mesh-ancestor
25573159|NCT00796991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905745|NCT04344951|Chloroquine|chloroquine|mesh-list
25064365|NCT03460860|Antioxidants|antioxidants|mesh-ancestor
25064366|NCT03460860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826833|NCT02136329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905659|NCT04345432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24905660|NCT04345432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24905661|NCT04345432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24905662|NCT04345432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24905663|NCT04345432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24905664|NCT04345432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24905665|NCT04345432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905666|NCT04345432|Antimanic Agents|antimanic agents|mesh-ancestor
24905667|NCT04345692|Hydroxychloroquine|hydroxychloroquine|mesh-list
24905668|NCT04345692|Antimalarials|antimalarials|mesh-ancestor
24905669|NCT04345692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24905672|NCT04345692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905673|NCT04345692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856472|NCT02284529|Leucovorin|leucovorin|mesh-list
24657217|NCT01266213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905674|NCT04345692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24905675|NCT04345445|Methylprednisolone|methylprednisolone|mesh-list
24905676|NCT04345445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24905677|NCT04345445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24905678|NCT04345445|Prednisolone|prednisolone|mesh-list
24905679|NCT04345445|Prednisolone acetate|prednisolone acetate|mesh-list
24905680|NCT04345445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24905681|NCT04345445|Prednisolone phosphate|prednisolone phosphate|mesh-list
25573160|NCT00796991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24905714|NCT04345458|Etanercept|etanercept|mesh-list
25573161|NCT00796991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25573162|NCT00796991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25573163|NCT00796991|Alkylating Agents|alkylating agents|mesh-ancestor
25573164|NCT00797108|Amoxicillin|amoxicillin|mesh-list
25573165|NCT00797108|Ceftriaxone|ceftriaxone|mesh-list
25573166|NCT00797108|Clavulanic Acid|clavulanic acid|mesh-list
25573167|NCT00797108|Clavulanic Acids|clavulanic acids|mesh-list
25573168|NCT00797108|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25573169|NCT00797108|Lactams|lactams|mesh-list
25573170|NCT00797108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25573171|NCT00797108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25573172|NCT00797108|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25573173|NCT00797108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573174|NCT00797108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573175|NCT00797225|Leuprolide|leuprolide|mesh-list
25573176|NCT00797225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25573177|NCT00797225|Fertility Agents|fertility agents|mesh-ancestor
25573178|NCT00797225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25573179|NCT00797225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573180|NCT00797225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25573181|NCT00797225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573182|NCT00797277|Lorazepam|lorazepam|mesh-list
25573183|NCT00797277|Haloperidol|haloperidol|mesh-list
25573184|NCT00797277|Olanzapine|olanzapine|mesh-list
25573185|NCT00797277|Haloperidol decanoate|haloperidol decanoate|mesh-list
25573186|NCT00797277|Antiemetics|antiemetics|mesh-ancestor
24905867|NCT04344756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905868|NCT04344782|Bevacizumab|bevacizumab|mesh-list
24905869|NCT04344782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24905870|NCT04344782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905871|NCT04344782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24905872|NCT04344782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24905873|NCT04344782|Growth Substances|growth substances|mesh-ancestor
24818571|NCT02089438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818572|NCT02089438|Incretins|incretins|mesh-ancestor
24818573|NCT02089438|Hormones|hormones|mesh-ancestor
24818574|NCT02089438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24818575|NCT02089438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24818576|NCT02089438|Protease Inhibitors|protease inhibitors|mesh-ancestor
25573187|NCT00797277|Autonomic Agents|autonomic agents|mesh-ancestor
25573188|NCT00797277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25573189|NCT00797277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573190|NCT00797277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25573191|NCT00797277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25573192|NCT00797277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25573193|NCT00797277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25573194|NCT00797277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25573195|NCT00797277|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25573196|NCT00797277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25573197|NCT00797277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25573198|NCT00797277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467757|NCT03223155|Nivolumab|nivolumab|mesh-list
25573199|NCT00797277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25573200|NCT00797277|Serotonin Agents|serotonin agents|mesh-ancestor
25064397|NCT03460808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25064399|NCT03460782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25064402|NCT03460782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948961|NCT05401019|Antioxidants|antioxidants|mesh-ancestor
24826853|NCT02136589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573201|NCT00797277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25573202|NCT00797277|Dopamine Agents|dopamine agents|mesh-ancestor
25573203|NCT00797277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25573204|NCT00797277|Anticonvulsants|anticonvulsants|mesh-ancestor
25573205|NCT00797277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25573206|NCT00797277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25573207|NCT00797277|GABA Modulators|gaba modulators|mesh-ancestor
25573208|NCT00797277|GABA Agents|gaba agents|mesh-ancestor
25573209|NCT00797316|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25573210|NCT00797316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25573211|NCT00797316|Diuretics|diuretics|mesh-ancestor
25573212|NCT00797316|Natriuretic Agents|natriuretic agents|mesh-ancestor
25573213|NCT00797316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905921|NCT04344041|Vitamin D|vitamin d|mesh-list
25573214|NCT00797316|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25573215|NCT00797316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25573216|NCT00797316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573217|NCT00797459|Hyaluronic Acid|hyaluronic acid|mesh-list
25573218|NCT00797459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25573219|NCT00797459|Immunologic Factors|immunologic factors|mesh-ancestor
25573220|NCT00797459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573221|NCT00797459|Viscosupplements|viscosupplements|mesh-ancestor
25573222|NCT00797459|Protective Agents|protective agents|mesh-ancestor
25573223|NCT00797797|Milnacipran|milnacipran|mesh-list
25573224|NCT00797797|Levomilnacipran|levomilnacipran|mesh-list
25573225|NCT00797797|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25573226|NCT00797797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25573227|NCT00797797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25573228|NCT00797797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573229|NCT00797797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25573230|NCT00797797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573231|NCT00797797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25573232|NCT00797797|Analgesics|analgesics|mesh-ancestor
25573233|NCT00797797|Sensory System Agents|sensory system agents|mesh-ancestor
25573234|NCT00797797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25573235|NCT00797797|Antidepressive Agents|antidepressive agents|mesh-ancestor
25573236|NCT00797797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25573237|NCT00797823|Insulin|insulin|mesh-list
25573238|NCT00797823|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25573239|NCT00797823|Glucagon|glucagon|mesh-list
25573240|NCT00797823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25573241|NCT00797823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573242|NCT00797823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25573243|NCT00797823|Hormones|hormones|mesh-ancestor
25573244|NCT00797823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25573245|NCT00797862|Amlodipine|amlodipine|mesh-list
25573246|NCT00797862|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25573247|NCT00797862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25573248|NCT00797862|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25573249|NCT00797862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25606156|NCT01065350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24444920|NCT00299676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573250|NCT00797862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573251|NCT00797862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25573252|NCT00797862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573253|NCT00797862|Vasodilator Agents|vasodilator agents|mesh-ancestor
25573254|NCT00797862|Diuretics|diuretics|mesh-ancestor
25573255|NCT00797862|Natriuretic Agents|natriuretic agents|mesh-ancestor
25573256|NCT00797862|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25573257|NCT00797966|Citalopram|citalopram|mesh-list
25573258|NCT00797966|Fluoxetine|fluoxetine|mesh-list
25573259|NCT00797966|Paroxetine|paroxetine|mesh-list
25573260|NCT00797966|Sertraline|sertraline|mesh-list
25573261|NCT00797966|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25573262|NCT00797966|Brexpiprazole|brexpiprazole|mesh-list
25573263|NCT00797966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25573264|NCT00797966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25573265|NCT00797966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25573266|NCT00797966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573267|NCT00797966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25573268|NCT00797966|Serotonin Agents|serotonin agents|mesh-ancestor
25573269|NCT00797966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573270|NCT00797966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25573271|NCT00797966|Antidepressive Agents|antidepressive agents|mesh-ancestor
25573272|NCT00797966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25573273|NCT00797966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25573274|NCT00797966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25573275|NCT00797966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573276|NCT00797966|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25573277|NCT00797966|Dopamine Agonists|dopamine agonists|mesh-ancestor
25573279|NCT00798018|Lidocaine|lidocaine|mesh-list
25573280|NCT00798018|Tetracaine|tetracaine|mesh-list
25573281|NCT00798018|Anesthetics, Local|anesthetics, local|mesh-ancestor
25573282|NCT00798018|Anesthetics|anesthetics|mesh-ancestor
25573283|NCT00798018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25573284|NCT00798018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573285|NCT00798018|Sensory System Agents|sensory system agents|mesh-ancestor
25573286|NCT00798018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25573287|NCT00798018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25573288|NCT00798018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25573289|NCT00798018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25573290|NCT00798018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25573291|NCT00798018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573292|NCT00798135|Itraconazole|itraconazole|mesh-list
25573293|NCT00798135|Antifungal Agents|antifungal agents|mesh-ancestor
25573294|NCT00798135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25573295|NCT00798135|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25573296|NCT00798135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25573297|NCT00798135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573298|NCT00798135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573299|NCT00798135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25573300|NCT00798135|Hormone Antagonists|hormone antagonists|mesh-ancestor
25573301|NCT00798135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25573302|NCT00798135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573303|NCT00798135|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25573304|NCT00798161|Metformin|metformin|mesh-list
25573305|NCT00798161|Linagliptin|linagliptin|mesh-list
25573306|NCT00798161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25573307|NCT00798161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573308|NCT00798161|Incretins|incretins|mesh-ancestor
25573309|NCT00798161|Hormones|hormones|mesh-ancestor
25573310|NCT00798161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25573311|NCT00798161|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25573312|NCT00798161|Protease Inhibitors|protease inhibitors|mesh-ancestor
25573313|NCT00798161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573314|NCT00798161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573315|NCT00798304|Vaccines|vaccines|mesh-list
25573316|NCT00798304|Immunologic Factors|immunologic factors|mesh-ancestor
25573317|NCT00798304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573318|NCT00798317|Plasminogen|plasminogen|mesh-list
25573319|NCT00798317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25573320|NCT00798317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25573321|NCT00798317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573322|NCT00798369|Triamcinolone|triamcinolone|mesh-list
25573323|NCT00798369|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25573324|NCT00798369|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25573325|NCT00798369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25573326|NCT00798369|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25573327|NCT00798369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25573328|NCT00798369|Glucocorticoids|glucocorticoids|mesh-ancestor
25573329|NCT00798369|Hormones|hormones|mesh-ancestor
25573330|NCT00798369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25573331|NCT00798369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573332|NCT00798369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25573333|NCT00798369|Immunologic Factors|immunologic factors|mesh-ancestor
25573334|NCT00798369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573335|NCT00798369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573336|NCT00798434|Fesoterodine|fesoterodine|mesh-list
25573337|NCT00798434|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24906882|NCT04336228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24906885|NCT04336228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25573338|NCT00798434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25573339|NCT00798434|Cholinergic Agents|cholinergic agents|mesh-ancestor
25573340|NCT00798434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25573341|NCT00798434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573342|NCT00798434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573343|NCT00798434|Urological Agents|urological agents|mesh-ancestor
25467889|NCT03059173|Vitamin B Complex|vitamin b complex|mesh-ancestor
25573345|NCT00798577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25573346|NCT00798603|Bevacizumab|bevacizumab|mesh-list
25573347|NCT00798603|Carboplatin|carboplatin|mesh-list
25573348|NCT00798603|Pemetrexed|pemetrexed|mesh-list
25573349|NCT00798603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25573350|NCT00798603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573351|NCT00798603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25573352|NCT00798603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25573353|NCT00798603|Growth Substances|growth substances|mesh-ancestor
25573354|NCT00798603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573355|NCT00798603|Growth Inhibitors|growth inhibitors|mesh-ancestor
25573356|NCT00798603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573357|NCT00798603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573358|NCT00798603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25573359|NCT00798603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25573360|NCT00798655|Cisplatin|cisplatin|mesh-list
25573361|NCT00798655|Panitumumab|panitumumab|mesh-list
25573362|NCT00798655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573363|NCT00798655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25652439|NCT01527045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25652440|NCT01527045|Dermatologic Agents|dermatologic agents|mesh-ancestor
25652441|NCT01527045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25652442|NCT01527045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25652443|NCT01527045|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25652444|NCT01527045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25652445|NCT01527045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25652446|NCT01527045|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25652447|NCT01527045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25467943|NCT02921555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467944|NCT02921555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25467945|NCT02921555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467946|NCT02921555|Antiemetics|antiemetics|mesh-ancestor
25467947|NCT02921555|Autonomic Agents|autonomic agents|mesh-ancestor
25467948|NCT02921555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25467949|NCT02921555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25467950|NCT02921555|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25467951|NCT02921555|Protective Agents|protective agents|mesh-ancestor
25467952|NCT02899078|Nivolumab|nivolumab|mesh-list
25467953|NCT02899078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25467954|NCT02899078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467955|NCT02899078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24867463|NCT04372017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467956|NCT02899078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467957|NCT02895373|Alprostadil|alprostadil|mesh-list
25467958|NCT02895373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25467959|NCT02895373|Vasodilator Agents|vasodilator agents|mesh-ancestor
25467960|NCT02895373|Urological Agents|urological agents|mesh-ancestor
25467961|NCT02861417|Vidarabine|vidarabine|mesh-list
25467962|NCT02861417|Mycophenolic Acid|mycophenolic acid|mesh-list
25467963|NCT02861417|Cyclophosphamide|cyclophosphamide|mesh-list
25467964|NCT02861417|Busulfan|busulfan|mesh-list
25467965|NCT02861417|Thiotepa|thiotepa|mesh-list
25467966|NCT02861417|Fludarabine|fludarabine|mesh-list
25652448|NCT01527045|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25652449|NCT01527045|Antitubercular Agents|antitubercular agents|mesh-ancestor
25652450|NCT01527045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25652451|NCT01527110|Zanamivir|zanamivir|mesh-list
25652452|NCT01527110|Antiviral Agents|antiviral agents|mesh-ancestor
25652453|NCT01527110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25652454|NCT01527110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652455|NCT01527110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652456|NCT01527357|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25652457|NCT01527357|Fibrin Foam|fibrin foam|mesh-list
25652458|NCT01527357|Hemostatics|hemostatics|mesh-ancestor
25652459|NCT01527357|Coagulants|coagulants|mesh-ancestor
25652460|NCT01527383|Vaccines|vaccines|mesh-list
25652461|NCT01527383|Immunologic Factors|immunologic factors|mesh-ancestor
25652462|NCT01527383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652463|NCT01527487|Cyclophosphamide|cyclophosphamide|mesh-list
25652464|NCT01527487|Docetaxel|docetaxel|mesh-list
25652465|NCT01527487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25652466|NCT01527487|Immunologic Factors|immunologic factors|mesh-ancestor
25652467|NCT01527487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652468|NCT01527487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25652469|NCT01527487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25652470|NCT01527487|Alkylating Agents|alkylating agents|mesh-ancestor
25573365|NCT00798694|Latanoprost|latanoprost|mesh-list
25573366|NCT00798694|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25573367|NCT00798694|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25573368|NCT00798694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25573369|NCT00798707|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25573370|NCT00798707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25573371|NCT00798707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25573372|NCT00798707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25573373|NCT00798707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573374|NCT00798707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25573375|NCT00798707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573376|NCT00798707|Antidepressive Agents|antidepressive agents|mesh-ancestor
25573377|NCT00798707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25573378|NCT00798720|Bortezomib|bortezomib|mesh-list
25573379|NCT00798720|Vorinostat|vorinostat|mesh-list
25573380|NCT00798720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573381|NCT00798720|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25573382|NCT00798720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573383|NCT00798720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573384|NCT00798759|Travoprost|travoprost|mesh-list
25573385|NCT00798759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25573386|NCT00798759|Latanoprost|latanoprost|mesh-list
25573387|NCT00798759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25573388|NCT00798759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25573389|NCT00798889|Sunitinib|sunitinib|mesh-list
25573390|NCT00798889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573391|NCT00798889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25573392|NCT00798889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25573393|NCT00798889|Growth Substances|growth substances|mesh-ancestor
25573394|NCT00798889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573395|NCT00798889|Growth Inhibitors|growth inhibitors|mesh-ancestor
25573396|NCT00798889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25573397|NCT00798889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573398|NCT00798889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573399|NCT00798967|Teduglutide|teduglutide|mesh-list
25573400|NCT00798967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25573401|NCT00798967|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25573402|NCT00798967|Protective Agents|protective agents|mesh-ancestor
25573403|NCT00798967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573404|NCT00799227|Dexamethasone|dexamethasone|mesh-list
25573405|NCT00799227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25573406|NCT00799227|Antiemetics|antiemetics|mesh-ancestor
25573407|NCT00799227|Autonomic Agents|autonomic agents|mesh-ancestor
25573408|NCT00799227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25573409|NCT00799227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573410|NCT00799227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25573411|NCT00799227|Glucocorticoids|glucocorticoids|mesh-ancestor
25573412|NCT00799227|Hormones|hormones|mesh-ancestor
25573413|NCT00799227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25573414|NCT00799227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25573415|NCT00799227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573416|NCT00799383|Vitamin D|vitamin d|mesh-list
25573417|NCT00799383|Calcium|calcium|mesh-list
25573418|NCT00799383|Vitamins|vitamins|mesh-ancestor
25573419|NCT00799383|Micronutrients|micronutrients|mesh-ancestor
25573420|NCT00799383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573421|NCT00799383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25573422|NCT00799383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25573423|NCT00799409|Methylphenidate|methylphenidate|mesh-list
25573424|NCT00799409|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25573425|NCT00799409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573426|NCT00799409|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24523458|NCT00467142|Growth Inhibitors|growth inhibitors|mesh-ancestor
25573427|NCT00799409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25573428|NCT00799409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25573429|NCT00799409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573430|NCT00799409|Dopamine Agents|dopamine agents|mesh-ancestor
25573431|NCT00799409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25573432|NCT00799435|Exenatide|exenatide|mesh-list
25573433|NCT00799435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25573434|NCT00799435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573435|NCT00799435|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25573436|NCT00799435|Incretins|incretins|mesh-ancestor
25573437|NCT00799435|Hormones|hormones|mesh-ancestor
25573438|NCT00799435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25573439|NCT00799487|Methylphenidate|methylphenidate|mesh-list
25573440|NCT00799487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25573441|NCT00799487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573442|NCT00799487|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25573443|NCT00799487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25573444|NCT00799487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25573445|NCT00799487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573446|NCT00799487|Dopamine Agents|dopamine agents|mesh-ancestor
25573447|NCT00799487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25573448|NCT00799578|Cysteamine|cysteamine|mesh-list
25573449|NCT00799578|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
25573450|NCT00799578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573451|NCT00799604|Clevidipine|clevidipine|mesh-list
25573452|NCT00799604|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25573453|NCT00799604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25573454|NCT00799604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573455|NCT00799604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25573456|NCT00799604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573457|NCT00799617|Methyltestosterone|methyltestosterone|mesh-list
25573458|NCT00799617|Testosterone|testosterone|mesh-list
25573459|NCT00799617|Testosterone undecanoate|testosterone undecanoate|mesh-list
25573460|NCT00799617|Testosterone enanthate|testosterone enanthate|mesh-list
25573461|NCT00799617|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25573462|NCT00799617|Androgens|androgens|mesh-ancestor
25573463|NCT00799617|Hormones|hormones|mesh-ancestor
25573464|NCT00799617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25573465|NCT00799617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573466|NCT00799617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25573467|NCT00799617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573468|NCT00799617|Anabolic Agents|anabolic agents|mesh-ancestor
25573469|NCT00799643|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
25573470|NCT00799643|Sodium Salicylate|sodium salicylate|mesh-list
25573471|NCT00799643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25573472|NCT00799643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25573473|NCT00799643|Analgesics|analgesics|mesh-ancestor
25573474|NCT00799643|Sensory System Agents|sensory system agents|mesh-ancestor
25573475|NCT00799643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25573476|NCT00799643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908129|NCT04323761|Remdesivir|remdesivir|mesh-list
25573477|NCT00799643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25573478|NCT00799643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25573479|NCT00799643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25573480|NCT00799643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573481|NCT00799643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573482|NCT00799708|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25573483|NCT00799708|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25573484|NCT00799708|Estradiol|estradiol|mesh-list
25573485|NCT00799708|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25573486|NCT00799708|Estrogens|estrogens|mesh-ancestor
25573487|NCT00799708|Hormones|hormones|mesh-ancestor
25573488|NCT00799708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25573489|NCT00799708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573490|NCT00799708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25573491|NCT00799708|Contraceptive Agents|contraceptive agents|mesh-ancestor
25573492|NCT00799708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25573493|NCT00799708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25573494|NCT00799812|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25573495|NCT00799812|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25573496|NCT00799812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25573497|NCT00799812|Dermatologic Agents|dermatologic agents|mesh-ancestor
25573498|NCT00799903|Darapladib|darapladib|mesh-list
25573499|NCT00799903|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
25573500|NCT00799903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573501|NCT00799903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573502|NCT00800202|Paclitaxel|paclitaxel|mesh-list
25573503|NCT00800202|Bevacizumab|bevacizumab|mesh-list
25573504|NCT00800202|Carboplatin|carboplatin|mesh-list
25573505|NCT00800202|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25573506|NCT00800202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25573507|NCT00800202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573508|NCT00800202|Tubulin Modulators|tubulin modulators|mesh-ancestor
25573509|NCT00800202|Antimitotic Agents|antimitotic agents|mesh-ancestor
25468053|NCT02728050|Cladribine|cladribine|mesh-list
25573510|NCT00800202|Mitosis Modulators|mitosis modulators|mesh-ancestor
25699473|NCT02106884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25573511|NCT00800202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573512|NCT00800202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25573513|NCT00800202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25573514|NCT00800202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25573515|NCT00800202|Growth Substances|growth substances|mesh-ancestor
25573516|NCT00800202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573517|NCT00800202|Growth Inhibitors|growth inhibitors|mesh-ancestor
25573518|NCT00800202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25573519|NCT00800202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573520|NCT00800345|Topotecan|topotecan|mesh-list
25573521|NCT00800345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25573522|NCT00800345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25573523|NCT00800345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573524|NCT00800345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573525|NCT00800345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573526|NCT00800436|Trastuzumab|trastuzumab|mesh-list
25573527|NCT00800436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25573528|NCT00800436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573529|NCT00800540|Timolol|timolol|mesh-list
25573530|NCT00800540|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25573531|NCT00800540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25573532|NCT00800540|Brinzolamide|brinzolamide|mesh-list
25573533|NCT00800540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25573534|NCT00800540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25573535|NCT00800540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25573536|NCT00800540|Adrenergic Agents|adrenergic agents|mesh-ancestor
25573537|NCT00800540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25573538|NCT00800540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573539|NCT00800540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573540|NCT00800540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25573541|NCT00800540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25573542|NCT00800540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25573543|NCT00800540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25573544|NCT00800540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25573545|NCT00800540|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25573546|NCT00800540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573547|NCT00800683|Linagliptin|linagliptin|mesh-list
25573548|NCT00800683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25573549|NCT00800683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573550|NCT00800683|Incretins|incretins|mesh-ancestor
25573551|NCT00800683|Hormones|hormones|mesh-ancestor
25573552|NCT00800683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25573553|NCT00800683|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25573554|NCT00800683|Protease Inhibitors|protease inhibitors|mesh-ancestor
25573555|NCT00800683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573556|NCT00800683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573557|NCT00800735|Interferons|interferons|mesh-list
25573558|NCT00800735|Ribavirin|ribavirin|mesh-list
25573559|NCT00800735|Interferon-alpha|interferon-alpha|mesh-list
25573560|NCT00800735|Interferon alpha-2|interferon alpha-2|mesh-list
25573561|NCT00800735|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25573562|NCT00800735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573563|NCT00800735|Antiviral Agents|antiviral agents|mesh-ancestor
25573564|NCT00800735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25573565|NCT00800735|Antimetabolites|antimetabolites|mesh-ancestor
25573566|NCT00800735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573567|NCT00800735|Immunologic Factors|immunologic factors|mesh-ancestor
25573568|NCT00800735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573569|NCT00800839|Vidarabine|vidarabine|mesh-list
25573570|NCT00800839|Cyclophosphamide|cyclophosphamide|mesh-list
25573571|NCT00800839|Busulfan|busulfan|mesh-list
25573572|NCT00800839|Fludarabine|fludarabine|mesh-list
25573573|NCT00800839|Fludarabine phosphate|fludarabine phosphate|mesh-list
25573574|NCT00800839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25573575|NCT00800839|Immunologic Factors|immunologic factors|mesh-ancestor
25573576|NCT00800839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573577|NCT00800839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25573578|NCT00800839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25573579|NCT00800839|Alkylating Agents|alkylating agents|mesh-ancestor
25573580|NCT00800839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573581|NCT00800839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573582|NCT00800839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25573583|NCT00800839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25573584|NCT00800839|Antimetabolites|antimetabolites|mesh-ancestor
25573585|NCT00800839|Antiviral Agents|antiviral agents|mesh-ancestor
25573586|NCT00800839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25573587|NCT00800982|Etanercept|etanercept|mesh-list
25573588|NCT00800982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25573589|NCT00800982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25573590|NCT00800982|Analgesics|analgesics|mesh-ancestor
25573591|NCT00800982|Sensory System Agents|sensory system agents|mesh-ancestor
25573592|NCT00800982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25573593|NCT00800982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573594|NCT00800982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25573595|NCT00800982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25573596|NCT00800982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25573597|NCT00800982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25573598|NCT00800982|Immunologic Factors|immunologic factors|mesh-ancestor
25573599|NCT00801099|Amoxicillin|amoxicillin|mesh-list
24814604|NCT02065752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827056|NCT02137239|Autonomic Agents|autonomic agents|mesh-ancestor
24827057|NCT02137239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24827058|NCT02137239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25573600|NCT00801099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25573601|NCT00801099|Clavulanic Acids|clavulanic acids|mesh-list
25573602|NCT00801099|Clavulanic Acid|clavulanic acid|mesh-list
25573603|NCT00801099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25573604|NCT00801099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25573605|NCT00801099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25573606|NCT00801099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573607|NCT00801099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573608|NCT00801138|Dexamethasone|dexamethasone|mesh-list
25573609|NCT00801138|Bupivacaine|bupivacaine|mesh-list
25573610|NCT00801138|Ropivacaine|ropivacaine|mesh-list
25573611|NCT00801138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25573612|NCT00801138|Antiemetics|antiemetics|mesh-ancestor
25573613|NCT00801138|Autonomic Agents|autonomic agents|mesh-ancestor
25573614|NCT00801138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25573615|NCT00801138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573616|NCT00801138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25573617|NCT00801138|Glucocorticoids|glucocorticoids|mesh-ancestor
25573618|NCT00801138|Hormones|hormones|mesh-ancestor
25573619|NCT00801138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25573620|NCT00801138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25573621|NCT00801138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573622|NCT00801138|Anesthetics, Local|anesthetics, local|mesh-ancestor
25573623|NCT00801138|Anesthetics|anesthetics|mesh-ancestor
25573624|NCT00801138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25573625|NCT00801138|Sensory System Agents|sensory system agents|mesh-ancestor
25573626|NCT00801229|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25573627|NCT00801229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25573628|NCT00801229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573629|NCT00801229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25573630|NCT00801229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25573631|NCT00801229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25573632|NCT00801229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573633|NCT00801229|Dopamine Agents|dopamine agents|mesh-ancestor
25573634|NCT00801229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25573635|NCT00801398|Oxymorphone|oxymorphone|mesh-list
25573636|NCT00801398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25573637|NCT00801398|Narcotics|narcotics|mesh-ancestor
25573638|NCT00801398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25573639|NCT00801398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573640|NCT00801398|Analgesics|analgesics|mesh-ancestor
25573641|NCT00801398|Sensory System Agents|sensory system agents|mesh-ancestor
25573642|NCT00801398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25573643|NCT00801398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25573644|NCT00801632|Prednisone|prednisone|mesh-list
25573645|NCT00801632|Methylprednisolone|methylprednisolone|mesh-list
25573646|NCT00801632|Cyclophosphamide|cyclophosphamide|mesh-list
25573647|NCT00801632|Rituximab|rituximab|mesh-list
25573648|NCT00801632|Tacrolimus|tacrolimus|mesh-list
25573649|NCT00801632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25573650|NCT00801632|Immunologic Factors|immunologic factors|mesh-ancestor
25573651|NCT00801632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573652|NCT00801632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25573653|NCT00801632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25573654|NCT00801632|Alkylating Agents|alkylating agents|mesh-ancestor
24909489|NCT04308343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573655|NCT00801632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573656|NCT00801632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573657|NCT00801632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25573658|NCT00801632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25573659|NCT00801632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25573660|NCT00801632|Glucocorticoids|glucocorticoids|mesh-ancestor
25573661|NCT00801632|Hormones|hormones|mesh-ancestor
25573662|NCT00801632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25573663|NCT00801632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25573664|NCT00801632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25573665|NCT00801632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573666|NCT00801632|Antiemetics|antiemetics|mesh-ancestor
25573667|NCT00801632|Autonomic Agents|autonomic agents|mesh-ancestor
25573668|NCT00801632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25573669|NCT00801632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25573670|NCT00801632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25573671|NCT00801632|Protective Agents|protective agents|mesh-ancestor
24827129|NCT02137525|Anesthetics|anesthetics|mesh-ancestor
25573672|NCT00801684|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25573673|NCT00801684|Formoterol Fumarate|formoterol fumarate|mesh-list
25573674|NCT00801684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25573675|NCT00801684|Autonomic Agents|autonomic agents|mesh-ancestor
25573676|NCT00801684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25573677|NCT00801684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573678|NCT00801684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25573679|NCT00801684|Respiratory System Agents|respiratory system agents|mesh-ancestor
25573680|NCT00801684|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25573681|NCT00801684|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25573682|NCT00801684|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25573683|NCT00801684|Adrenergic Agents|adrenergic agents|mesh-ancestor
25573684|NCT00801684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24531323|NCT00635076|Alprazolam|alprazolam|mesh-list
25573685|NCT00801684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573686|NCT00801684|Luteolytic Agents|luteolytic agents|mesh-ancestor
25573687|NCT00801684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25573688|NCT00801684|Contraceptive Agents|contraceptive agents|mesh-ancestor
25573689|NCT00801684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25573690|NCT00801684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25573691|NCT00801684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25573692|NCT00801684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573693|NCT00801723|Budesonide|budesonide|mesh-list
25573694|NCT00801723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25573695|NCT00801723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25573696|NCT00801723|Autonomic Agents|autonomic agents|mesh-ancestor
25573697|NCT00801723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25573698|NCT00801723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573699|NCT00801723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25573700|NCT00801723|Respiratory System Agents|respiratory system agents|mesh-ancestor
25573701|NCT00801723|Glucocorticoids|glucocorticoids|mesh-ancestor
25573702|NCT00801723|Hormones|hormones|mesh-ancestor
25573703|NCT00801723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25573704|NCT00801801|Docetaxel|docetaxel|mesh-list
25573705|NCT00801801|Sorafenib|sorafenib|mesh-list
25573706|NCT00801801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573707|NCT00801801|Tubulin Modulators|tubulin modulators|mesh-ancestor
25573708|NCT00801801|Antimitotic Agents|antimitotic agents|mesh-ancestor
25573709|NCT00801801|Mitosis Modulators|mitosis modulators|mesh-ancestor
25573710|NCT00801801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909870|NCT04304261|Metformin|metformin|mesh-list
25573711|NCT00801801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25573712|NCT00801801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573713|NCT00801827|Fallypride|fallypride|mesh-list
25573714|NCT00801827|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25573715|NCT00801827|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25573716|NCT00801827|Dopamine Agents|dopamine agents|mesh-ancestor
25573717|NCT00801827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25573718|NCT00801827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573719|NCT00801827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573720|NCT00802074|Ritonavir|ritonavir|mesh-list
25573721|NCT00802074|Fosamprenavir|fosamprenavir|mesh-list
25573722|NCT00802074|Raltegravir Potassium|raltegravir potassium|mesh-list
25573723|NCT00802074|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25573724|NCT00802074|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25573725|NCT00802074|Protease Inhibitors|protease inhibitors|mesh-ancestor
25573726|NCT00802074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573727|NCT00802074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573728|NCT00802074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25573729|NCT00802074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25573730|NCT00802074|Antiviral Agents|antiviral agents|mesh-ancestor
25573731|NCT00802074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25573732|NCT00802074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25064742|NCT03457233|Menotropins|menotropins|mesh-list
25573733|NCT00802074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25573734|NCT00802074|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25573735|NCT00802074|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25573737|NCT00802100|Benztropine|benztropine|mesh-list
25573738|NCT00802100|Olanzapine|olanzapine|mesh-list
25573739|NCT00802100|Aripiprazole|aripiprazole|mesh-list
25573740|NCT00802100|Perphenazine|perphenazine|mesh-list
25573741|NCT00802100|Simvastatin|simvastatin|mesh-list
25573742|NCT00802100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25573743|NCT00802100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573744|NCT00802100|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25573745|NCT00802100|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25573746|NCT00802100|Antimetabolites|antimetabolites|mesh-ancestor
25573747|NCT00802100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573748|NCT00802100|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25573749|NCT00802100|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25573750|NCT00802100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573751|NCT00802100|Antiemetics|antiemetics|mesh-ancestor
25573752|NCT00802100|Autonomic Agents|autonomic agents|mesh-ancestor
24484865|NCT00450307|Sargramostim|sargramostim|mesh-list
25573753|NCT00802100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25573754|NCT00802100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25573755|NCT00802100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25573756|NCT00802100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25573757|NCT00802100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25573758|NCT00802100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25573759|NCT00802100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25573760|NCT00802100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25573761|NCT00802100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25573762|NCT00802100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25573763|NCT00802100|Serotonin Agents|serotonin agents|mesh-ancestor
25573764|NCT00802100|Antidepressive Agents|antidepressive agents|mesh-ancestor
25573765|NCT00802100|Dopamine Agonists|dopamine agonists|mesh-ancestor
25573766|NCT00802100|Dopamine Agents|dopamine agents|mesh-ancestor
25573767|NCT00802100|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25573768|NCT00802100|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25573769|NCT00802100|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25573770|NCT00802100|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25573771|NCT00802100|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25573772|NCT00802100|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25573773|NCT00802100|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25573774|NCT00802100|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25573775|NCT00802100|Parasympatholytics|parasympatholytics|mesh-ancestor
25573776|NCT00802100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25573777|NCT00802100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25573778|NCT00802100|Cholinergic Agents|cholinergic agents|mesh-ancestor
25573779|NCT00802100|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25573780|NCT00802113|Fludarabine|fludarabine|mesh-list
25573781|NCT00802113|Busulfan|busulfan|mesh-list
25573782|NCT00802113|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25573783|NCT00802113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573784|NCT00802113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573785|NCT00802113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25573786|NCT00802113|Immunologic Factors|immunologic factors|mesh-ancestor
25573787|NCT00802113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573788|NCT00802113|Alkylating Agents|alkylating agents|mesh-ancestor
25573789|NCT00802113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25573790|NCT00802113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25573791|NCT00802360|Menotropins|menotropins|mesh-list
25573792|NCT00802360|Progesterone|progesterone|mesh-list
25573793|NCT00802360|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25573794|NCT00802360|Ganirelix|ganirelix|mesh-list
25573795|NCT00802360|Progestins|progestins|mesh-ancestor
25573796|NCT00802360|Hormones|hormones|mesh-ancestor
25573797|NCT00802360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25573798|NCT00802360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573799|NCT00802360|Hormone Antagonists|hormone antagonists|mesh-ancestor
25573800|NCT00802360|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25573801|NCT00802360|Fertility Agents|fertility agents|mesh-ancestor
25573802|NCT00802360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25573803|NCT00802412|Topiramate|topiramate|mesh-list
25573804|NCT00802412|Anticonvulsants|anticonvulsants|mesh-ancestor
25573805|NCT00802412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25573806|NCT00802412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573807|NCT00802529|Gentamicins|gentamicins|mesh-list
25573808|NCT00802529|Methylprednisolone|methylprednisolone|mesh-list
25573809|NCT00802529|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25573810|NCT00802529|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25573811|NCT00802529|Prednisolone|prednisolone|mesh-list
25573812|NCT00802529|Prednisolone acetate|prednisolone acetate|mesh-list
25573813|NCT00802529|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25573814|NCT00802529|Prednisolone phosphate|prednisolone phosphate|mesh-list
25573815|NCT00802529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25573816|NCT00802529|Antiemetics|antiemetics|mesh-ancestor
25573817|NCT00802529|Autonomic Agents|autonomic agents|mesh-ancestor
25573818|NCT00802529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25573819|NCT00802529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573820|NCT00802529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25573821|NCT00802529|Glucocorticoids|glucocorticoids|mesh-ancestor
25573822|NCT00802529|Hormones|hormones|mesh-ancestor
25573823|NCT00802529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24949396|NCT04814940|Fertility Agents|fertility agents|mesh-ancestor
24733457|NCT01646437|Aspirin|aspirin|mesh-list
25573824|NCT00802529|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25573825|NCT00802529|Protective Agents|protective agents|mesh-ancestor
25573826|NCT00802529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25573827|NCT00802529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573828|NCT00802529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25573829|NCT00802529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25573830|NCT00802529|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25573831|NCT00802529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573832|NCT00802529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573833|NCT00802672|Ciclopirox|ciclopirox|mesh-list
25573834|NCT00802672|Antifungal Agents|antifungal agents|mesh-ancestor
25573835|NCT00802672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25573836|NCT00802685|Ibuprofen|ibuprofen|mesh-list
25573837|NCT00802685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25573838|NCT00802685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25573839|NCT00802685|Analgesics|analgesics|mesh-ancestor
25573840|NCT00802685|Sensory System Agents|sensory system agents|mesh-ancestor
25573841|NCT00802685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25573842|NCT00802685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573843|NCT00802685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25573844|NCT00802685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25573845|NCT00802685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25573846|NCT00802685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573847|NCT00802685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573848|NCT00802737|Ofatumumab|ofatumumab|mesh-list
25573849|NCT00802737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573850|NCT00802841|Imatinib Mesylate|imatinib mesylate|mesh-list
25573851|NCT00802841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573852|NCT00802841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25573853|NCT00802841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573854|NCT00802841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573855|NCT00802880|Dacarbazine|dacarbazine|mesh-list
25573856|NCT00802880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25573857|NCT00802880|Alkylating Agents|alkylating agents|mesh-ancestor
25573858|NCT00802880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573859|NCT00802880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573860|NCT00802919|Varenicline|varenicline|mesh-list
25573861|NCT00802919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25573862|NCT00802919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25573863|NCT00802919|Cholinergic Agents|cholinergic agents|mesh-ancestor
25573864|NCT00802919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25573865|NCT00802919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573866|NCT00802919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573867|NCT00802945|Etirinotecan pegol|etirinotecan pegol|mesh-list
25573868|NCT00802945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573869|NCT00802945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25573870|NCT00802945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25573871|NCT00802945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573872|NCT00802945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573873|NCT00803010|Sirolimus|sirolimus|mesh-list
25573874|NCT00803010|Methotrexate|methotrexate|mesh-list
25573875|NCT00803010|Tacrolimus|tacrolimus|mesh-list
25573876|NCT00803010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25573877|NCT00803010|Abortifacient Agents|abortifacient agents|mesh-ancestor
25573878|NCT00803010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25573879|NCT00803010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468390|NCT01893320|Decitabine|decitabine|mesh-list
25573880|NCT00803010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25573881|NCT00803010|Antimetabolites|antimetabolites|mesh-ancestor
25573882|NCT00803010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573883|NCT00803010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573884|NCT00803010|Dermatologic Agents|dermatologic agents|mesh-ancestor
25573885|NCT00803010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573886|NCT00803010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25573887|NCT00803010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25573888|NCT00803010|Immunologic Factors|immunologic factors|mesh-ancestor
25573889|NCT00803010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25573890|NCT00803010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25573891|NCT00803010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25573892|NCT00803010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25573893|NCT00803010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25573894|NCT00803010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25573895|NCT00803010|Antifungal Agents|antifungal agents|mesh-ancestor
25573897|NCT00803023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25573898|NCT00803023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25573899|NCT00803023|Anesthetics, General|anesthetics, general|mesh-ancestor
25573900|NCT00803023|Anesthetics|anesthetics|mesh-ancestor
25573901|NCT00803023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25573902|NCT00803023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573903|NCT00803049|Teriflunomide|teriflunomide|mesh-list
25573904|NCT00803049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25573905|NCT00803049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25573906|NCT00803049|Analgesics|analgesics|mesh-ancestor
25573907|NCT00803049|Sensory System Agents|sensory system agents|mesh-ancestor
25573908|NCT00803049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25573909|NCT00803049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573910|NCT00803049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25573911|NCT00803049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25573912|NCT00803049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25573913|NCT00803049|Immunologic Factors|immunologic factors|mesh-ancestor
25573914|NCT00803062|Paclitaxel|paclitaxel|mesh-list
25573915|NCT00803062|Bevacizumab|bevacizumab|mesh-list
25573916|NCT00803062|Cisplatin|cisplatin|mesh-list
25573917|NCT00803062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25573918|NCT00803062|Topotecan|topotecan|mesh-list
25573919|NCT00803062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25573920|NCT00803062|Endothelial Growth Factors|endothelial growth factors|mesh-list
25573921|NCT00803062|Antibodies|antibodies|mesh-list
25573922|NCT00803062|Immunoglobulins|immunoglobulins|mesh-list
25573923|NCT00803062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25573924|NCT00803062|Immunoglobulin G|immunoglobulin g|mesh-list
25573925|NCT00803062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25573926|NCT00803062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25573927|NCT00803062|Tubulin Modulators|tubulin modulators|mesh-ancestor
25573928|NCT00803062|Antimitotic Agents|antimitotic agents|mesh-ancestor
25573929|NCT00803062|Mitosis Modulators|mitosis modulators|mesh-ancestor
25573930|NCT00803062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573931|NCT00803062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25573932|NCT00803062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25573933|NCT00803062|Growth Substances|growth substances|mesh-ancestor
25573934|NCT00803062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573935|NCT00803062|Growth Inhibitors|growth inhibitors|mesh-ancestor
25573936|NCT00803062|Immunologic Factors|immunologic factors|mesh-ancestor
25573937|NCT00803062|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24910528|NCT04296578|Prednisone|prednisone|mesh-list
24862551|NCT05142865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24813503|NCT02058706|Hormone Antagonists|hormone antagonists|mesh-ancestor
24813506|NCT02058823|Amlodipine|amlodipine|mesh-list
25573938|NCT00803062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25573939|NCT00803062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573940|NCT00803101|Protein C|protein c|mesh-list
25573941|NCT00803101|Protein S|protein s|mesh-list
25573942|NCT00803101|Anticoagulants|anticoagulants|mesh-ancestor
25573943|NCT00803101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25573944|NCT00803101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25573945|NCT00803101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573946|NCT00803361|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25573947|NCT00803361|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25573948|NCT00803361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25573949|NCT00803361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25573950|NCT00803361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573951|NCT00803361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25573952|NCT00803361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573953|NCT00803361|Analgesics|analgesics|mesh-ancestor
25468430|NCT01709318|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25468433|NCT01709318|Estradiol|estradiol|mesh-list
25573954|NCT00803361|Sensory System Agents|sensory system agents|mesh-ancestor
25573955|NCT00803361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25573956|NCT00803361|Antidepressive Agents|antidepressive agents|mesh-ancestor
25573957|NCT00803361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25573958|NCT00803361|Dopamine Agents|dopamine agents|mesh-ancestor
25573959|NCT00803400|Alprazolam|alprazolam|mesh-list
25573960|NCT00803400|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25573961|NCT00803400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25573962|NCT00803400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573963|NCT00803400|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25573964|NCT00803400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25573965|NCT00803400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25573966|NCT00803400|GABA Modulators|gaba modulators|mesh-ancestor
25573967|NCT00803400|GABA Agents|gaba agents|mesh-ancestor
25573968|NCT00803400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25573969|NCT00803400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573970|NCT00803452|Azithromycin|azithromycin|mesh-list
25573971|NCT00803452|Doxycycline|doxycycline|mesh-list
25573972|NCT00803452|Minocycline|minocycline|mesh-list
25573973|NCT00803452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25573974|NCT00803452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25573975|NCT00803452|Antimalarials|antimalarials|mesh-ancestor
25573976|NCT00803452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25573977|NCT00803452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25573978|NCT00803543|Valacyclovir|valacyclovir|mesh-list
25573979|NCT00803543|Antiviral Agents|antiviral agents|mesh-ancestor
25573980|NCT00803543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25573981|NCT00803569|Sargramostim|sargramostim|mesh-list
25573982|NCT00803569|Immunologic Factors|immunologic factors|mesh-ancestor
25573983|NCT00803569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25573984|NCT00803595|Oseltamivir|oseltamivir|mesh-list
25573985|NCT00803595|Antiviral Agents|antiviral agents|mesh-ancestor
25573986|NCT00803595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25573987|NCT00803595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25573988|NCT00803595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25573989|NCT00803634|Antihypertensive Agents|antihypertensive agents|mesh-list
25573990|NCT00803634|Diltiazem|diltiazem|mesh-list
25573991|NCT00803634|Nitroprusside|nitroprusside|mesh-list
24862585|NCT05042466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25573992|NCT00803634|Nicardipine|nicardipine|mesh-list
25573993|NCT00803634|Clevidipine|clevidipine|mesh-list
25573994|NCT00803634|Isosorbide|isosorbide|mesh-list
25573995|NCT00803634|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25573996|NCT00803634|Nitroglycerin|nitroglycerin|mesh-list
25573997|NCT00803634|Vasodilator Agents|vasodilator agents|mesh-ancestor
25573998|NCT00803634|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25573999|NCT00803634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25574000|NCT00803634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574001|NCT00803634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25574002|NCT00803634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574003|NCT00803634|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25574004|NCT00803634|Diuretics|diuretics|mesh-ancestor
25574005|NCT00803634|Natriuretic Agents|natriuretic agents|mesh-ancestor
25574006|NCT00803634|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25574007|NCT00803647|Leucovorin|leucovorin|mesh-list
25574008|NCT00803647|Fluorouracil|fluorouracil|mesh-list
25574009|NCT00803647|Oxaliplatin|oxaliplatin|mesh-list
25574010|NCT00803647|Cetuximab|cetuximab|mesh-list
25574011|NCT00803647|Antimetabolites|antimetabolites|mesh-ancestor
25574012|NCT00803647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574013|NCT00803647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25574014|NCT00803647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25574015|NCT00803647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25574016|NCT00803647|Immunologic Factors|immunologic factors|mesh-ancestor
25574017|NCT00803647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574018|NCT00803647|Antidotes|antidotes|mesh-ancestor
25574019|NCT00803647|Protective Agents|protective agents|mesh-ancestor
25574020|NCT00803647|Vitamin B Complex|vitamin b complex|mesh-ancestor
25574021|NCT00803647|Vitamins|vitamins|mesh-ancestor
25574022|NCT00803647|Micronutrients|micronutrients|mesh-ancestor
25574023|NCT00803647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25574024|NCT00803686|Salmon calcitonin|salmon calcitonin|mesh-list
25574025|NCT00803686|Calcitonin|calcitonin|mesh-list
25574026|NCT00803686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25574027|NCT00803686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468487|NCT01617187|Olanzapine|olanzapine|mesh-list
25574028|NCT00803686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25574029|NCT00803712|Vitamin D|vitamin d|mesh-list
25574030|NCT00803712|Ergocalciferols|ergocalciferols|mesh-list
25574031|NCT00803712|Cholecalciferol|cholecalciferol|mesh-list
25574032|NCT00803712|Vitamins|vitamins|mesh-list
25574033|NCT00803712|Cinacalcet|cinacalcet|mesh-list
24862672|NCT04722952|Cytarabine|cytarabine|mesh-list
25574034|NCT00803712|Micronutrients|micronutrients|mesh-ancestor
25574035|NCT00803712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574036|NCT00803712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25574037|NCT00803712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25574038|NCT00803712|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25574039|NCT00803712|Hormone Antagonists|hormone antagonists|mesh-ancestor
25574040|NCT00803712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25574041|NCT00803738|Terconazole|terconazole|mesh-list
25574042|NCT00803738|Antifungal Agents|antifungal agents|mesh-ancestor
25574043|NCT00803738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25574044|NCT00804141|Bromides|bromides|mesh-list
25574045|NCT00804141|Methylnaltrexone|methylnaltrexone|mesh-list
25574046|NCT00804141|Anticonvulsants|anticonvulsants|mesh-ancestor
25574047|NCT00804141|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25574048|NCT00804141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574049|NCT00804141|Sensory System Agents|sensory system agents|mesh-ancestor
25574050|NCT00804141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25574051|NCT00804193|Ciclopirox|ciclopirox|mesh-list
25574052|NCT00804193|Antifungal Agents|antifungal agents|mesh-ancestor
25574053|NCT00804193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25574054|NCT00804609|Lidocaine|lidocaine|mesh-list
25574055|NCT00804609|Morphine|morphine|mesh-list
25574056|NCT00804609|Anesthetics|anesthetics|mesh-list
25574057|NCT00804609|Anesthetics, Local|anesthetics, local|mesh-ancestor
25574058|NCT00804609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25574059|NCT00804609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574060|NCT00804609|Sensory System Agents|sensory system agents|mesh-ancestor
25574061|NCT00804609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25574062|NCT00804609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25574063|NCT00804609|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25574064|NCT00804609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25574065|NCT00804609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25574066|NCT00804609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574067|NCT00804609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25574068|NCT00804609|Narcotics|narcotics|mesh-ancestor
25574069|NCT00804609|Analgesics|analgesics|mesh-ancestor
25574070|NCT00804648|Timolol|timolol|mesh-list
25574071|NCT00804648|Maleic acid|maleic acid|mesh-list
25574072|NCT00804648|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25574073|NCT00804648|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25574074|NCT00804648|Adrenergic Agents|adrenergic agents|mesh-ancestor
25574075|NCT00804648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25574076|NCT00804648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574077|NCT00804648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574078|NCT00804648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25574079|NCT00804648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25574080|NCT00804648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574081|NCT00804687|Pseudoephedrine|pseudoephedrine|mesh-list
25574082|NCT00804687|Ephedrine|ephedrine|mesh-list
25574083|NCT00804687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25574084|NCT00804687|Autonomic Agents|autonomic agents|mesh-ancestor
25574085|NCT00804687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25574086|NCT00804687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574087|NCT00804687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25574088|NCT00804687|Respiratory System Agents|respiratory system agents|mesh-ancestor
25574089|NCT00804687|Nasal Decongestants|nasal decongestants|mesh-ancestor
25574090|NCT00804687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25574091|NCT00804687|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25574092|NCT00804687|Sympathomimetics|sympathomimetics|mesh-ancestor
25574093|NCT00804687|Adrenergic Agents|adrenergic agents|mesh-ancestor
25574094|NCT00804687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25574095|NCT00804687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574096|NCT00804843|Niacin|niacin|mesh-list
25574097|NCT00804843|Atorvastatin|atorvastatin|mesh-list
25574098|NCT00804843|Simvastatin|simvastatin|mesh-list
25574099|NCT00804843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25574100|NCT00804843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25574101|NCT00804843|Antimetabolites|antimetabolites|mesh-ancestor
25574102|NCT00804843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574103|NCT00804843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25468547|NCT01490190|Contraceptive Agents|contraceptive agents|mesh-ancestor
25468551|NCT01490190|Estrogens|estrogens|mesh-ancestor
25574104|NCT00804843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25574105|NCT00804843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574106|NCT00804843|Vasodilator Agents|vasodilator agents|mesh-ancestor
25574107|NCT00804843|Vitamin B Complex|vitamin b complex|mesh-ancestor
25574108|NCT00804843|Vitamins|vitamins|mesh-ancestor
25574109|NCT00804843|Micronutrients|micronutrients|mesh-ancestor
25574110|NCT00804843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574111|NCT00804908|Temozolomide|temozolomide|mesh-list
25574112|NCT00804908|Veliparib|veliparib|mesh-list
25574113|NCT00804908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25574114|NCT00804908|Alkylating Agents|alkylating agents|mesh-ancestor
25574115|NCT00804908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574116|NCT00804908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25574117|NCT00804908|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25574118|NCT00804908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652471|NCT01527487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652472|NCT01527487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652473|NCT01527487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25652474|NCT01527487|Tubulin Modulators|tubulin modulators|mesh-ancestor
25652475|NCT01527487|Antimitotic Agents|antimitotic agents|mesh-ancestor
25652476|NCT01527487|Mitosis Modulators|mitosis modulators|mesh-ancestor
25652477|NCT01527513|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
24910699|NCT04295161|Hormone Antagonists|hormone antagonists|mesh-ancestor
25652478|NCT01527513|Anticonvulsants|anticonvulsants|mesh-ancestor
25652479|NCT01527513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25652480|NCT01527513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25652481|NCT01527513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25652482|NCT01527513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652483|NCT01527682|Dorzolamide|dorzolamide|mesh-list
25652484|NCT01527682|Latanoprost|latanoprost|mesh-list
25652485|NCT01527682|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25652486|NCT01527682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25652487|NCT01527682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25652488|NCT01527682|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25652489|NCT01527682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652490|NCT01527682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652491|NCT01528254|Metformin|metformin|mesh-list
25652492|NCT01528254|Vildagliptin|vildagliptin|mesh-list
25652493|NCT01528254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25652494|NCT01528254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652495|NCT01528254|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25652496|NCT01528254|Protease Inhibitors|protease inhibitors|mesh-ancestor
25652497|NCT01528254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652498|NCT01528254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652499|NCT01528345|Fulvestrant|fulvestrant|mesh-list
25652500|NCT01528345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25652501|NCT01528345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652502|NCT01528345|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25652503|NCT01528345|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25652504|NCT01528345|Hormone Antagonists|hormone antagonists|mesh-ancestor
25652505|NCT01528345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25652506|NCT01528345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652507|NCT01528592|Levodopa|levodopa|mesh-list
25652508|NCT01528592|Carbidopa|carbidopa|mesh-list
25652509|NCT01528592|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25652510|NCT01528592|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25652511|NCT01528592|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25652512|NCT01528592|Dopamine Agents|dopamine agents|mesh-ancestor
25652513|NCT01528592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25652514|NCT01528592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652515|NCT01528592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652516|NCT01528592|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25652517|NCT01528592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652518|NCT01528592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25652519|NCT01528592|Immunologic Factors|immunologic factors|mesh-ancestor
25652520|NCT01528592|Dopamine Agonists|dopamine agonists|mesh-ancestor
25652521|NCT01528709|Atorvastatin|atorvastatin|mesh-list
25652522|NCT01528709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25652523|NCT01528709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25652524|NCT01528709|Antimetabolites|antimetabolites|mesh-ancestor
25652525|NCT01528709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652526|NCT01528709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25652527|NCT01528709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25652528|NCT01528709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652529|NCT01528735|Ribavirin|ribavirin|mesh-list
25652530|NCT01528735|Antimetabolites|antimetabolites|mesh-ancestor
25656948|NCT01581281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25574119|NCT00804973|Sumatriptan|sumatriptan|mesh-list
25574120|NCT00804973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25574121|NCT00804973|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25574122|NCT00804973|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25574123|NCT00804973|Serotonin Agents|serotonin agents|mesh-ancestor
25574124|NCT00804973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25574125|NCT00804973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574126|NCT00804973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574127|NCT00804999|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25574128|NCT00804999|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25574129|NCT00804999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25574130|NCT00805142|Tapentadol|tapentadol|mesh-list
25574131|NCT00805142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25574132|NCT00805142|Narcotics|narcotics|mesh-ancestor
25574133|NCT00805142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25574134|NCT00805142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574135|NCT00805142|Analgesics|analgesics|mesh-ancestor
25574136|NCT00805142|Sensory System Agents|sensory system agents|mesh-ancestor
25574137|NCT00805142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25574138|NCT00805142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25574139|NCT00805142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25574140|NCT00805142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25574141|NCT00805142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574142|NCT00805142|Adrenergic Agents|adrenergic agents|mesh-ancestor
25574143|NCT00805142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25574144|NCT00805194|Docetaxel|docetaxel|mesh-list
25574145|NCT00805194|Nintedanib|nintedanib|mesh-list
25574146|NCT00805194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25574147|NCT00805194|Tubulin Modulators|tubulin modulators|mesh-ancestor
25574148|NCT00805194|Antimitotic Agents|antimitotic agents|mesh-ancestor
25574149|NCT00805194|Mitosis Modulators|mitosis modulators|mesh-ancestor
25574150|NCT00805194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574151|NCT00805194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25574152|NCT00805194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574153|NCT00805207|Estradiol|estradiol|mesh-list
25574154|NCT00805207|Estrogens|estrogens|mesh-list
25574155|NCT00805207|Testosterone|testosterone|mesh-list
25574156|NCT00805207|Progesterone|progesterone|mesh-list
25574157|NCT00805207|Glucocorticoids|glucocorticoids|mesh-list
25574158|NCT00805207|Hormones|hormones|mesh-ancestor
25574159|NCT00805207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25574160|NCT00805207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574161|NCT00805207|Androgens|androgens|mesh-ancestor
25574162|NCT00805207|Progestins|progestins|mesh-ancestor
25574163|NCT00805285|Budesonide|budesonide|mesh-list
25574164|NCT00805285|Hydrocortisone|hydrocortisone|mesh-list
25574165|NCT00805285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25574166|NCT00805285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25574167|NCT00805285|Autonomic Agents|autonomic agents|mesh-ancestor
25574168|NCT00805285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25574169|NCT00805285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574170|NCT00805285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25574171|NCT00805285|Respiratory System Agents|respiratory system agents|mesh-ancestor
25574172|NCT00805285|Glucocorticoids|glucocorticoids|mesh-ancestor
25574173|NCT00805285|Hormones|hormones|mesh-ancestor
25574174|NCT00805285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25574175|NCT00805493|Riluzole|riluzole|mesh-list
25574176|NCT00805493|Anticonvulsants|anticonvulsants|mesh-ancestor
25574177|NCT00805493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25574178|NCT00805493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25574179|NCT00805493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25574180|NCT00805493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574181|NCT00805493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574182|NCT00805493|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25574183|NCT00805493|Protective Agents|protective agents|mesh-ancestor
25574184|NCT00805545|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25574185|NCT00805545|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25574186|NCT00805545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25574187|NCT00805545|Antitubercular Agents|antitubercular agents|mesh-ancestor
25574188|NCT00805675|Tenofovir|tenofovir|mesh-list
25574189|NCT00805675|Telbivudine|telbivudine|mesh-list
25574190|NCT00805675|Antiviral Agents|antiviral agents|mesh-ancestor
25574191|NCT00805675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25574192|NCT00805675|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25574193|NCT00805675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25468679|NCT01208207|Naproxen|naproxen|mesh-list
25574194|NCT00805675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574195|NCT00805675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574196|NCT00805675|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25574197|NCT00805675|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25574198|NCT00805740|Caspofungin|caspofungin|mesh-list
25574199|NCT00805740|Anidulafungin|anidulafungin|mesh-list
25574200|NCT00805740|Antifungal Agents|antifungal agents|mesh-ancestor
25574201|NCT00805740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25574202|NCT00805740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574203|NCT00805740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574204|NCT00805766|Infliximab|infliximab|mesh-list
25574205|NCT00805766|Dermatologic Agents|dermatologic agents|mesh-ancestor
25574206|NCT00805766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25574207|NCT00805766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25574208|NCT00805792|Donepezil|donepezil|mesh-list
25574209|NCT00805792|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25574210|NCT00805792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574211|NCT00805792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574212|NCT00805792|Cholinergic Agents|cholinergic agents|mesh-ancestor
25574213|NCT00805792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24734149|NCT01650740|Analgesics|analgesics|mesh-ancestor
25574214|NCT00805792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574215|NCT00805792|Nootropic Agents|nootropic agents|mesh-ancestor
25574216|NCT00805935|Leuprolide|leuprolide|mesh-list
25574217|NCT00805935|Menotropins|menotropins|mesh-list
25574218|NCT00805935|Progesterone|progesterone|mesh-list
25574219|NCT00805935|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25574220|NCT00805935|Progestins|progestins|mesh-ancestor
25574221|NCT00805935|Hormones|hormones|mesh-ancestor
25574222|NCT00805935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25574223|NCT00805935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574224|NCT00805935|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25574225|NCT00805935|Fertility Agents|fertility agents|mesh-ancestor
25574226|NCT00805935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25574227|NCT00805935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25574228|NCT00805935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25574229|NCT00806026|Pregabalin|pregabalin|mesh-list
25574230|NCT00806026|Pramipexole|pramipexole|mesh-list
25574231|NCT00806026|Analgesics|analgesics|mesh-ancestor
25574232|NCT00806026|Sensory System Agents|sensory system agents|mesh-ancestor
25574233|NCT00806026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25574234|NCT00806026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574235|NCT00806026|Anticonvulsants|anticonvulsants|mesh-ancestor
25574236|NCT00806026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25574237|NCT00806026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25574238|NCT00806026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574239|NCT00806026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25574240|NCT00806026|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24827439|NCT02139098|GABA Agents|gaba agents|mesh-ancestor
25574241|NCT00806026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25574242|NCT00806026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25574243|NCT00806026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25574244|NCT00806026|Antioxidants|antioxidants|mesh-ancestor
25574245|NCT00806026|Protective Agents|protective agents|mesh-ancestor
25574246|NCT00806026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25574247|NCT00806026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25574248|NCT00806026|Dopamine Agonists|dopamine agonists|mesh-ancestor
25574249|NCT00806026|Dopamine Agents|dopamine agents|mesh-ancestor
25574250|NCT00806026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25574251|NCT00806078|Quinine|quinine|mesh-list
25574252|NCT00806078|Antimalarials|antimalarials|mesh-ancestor
25574253|NCT00806078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25574254|NCT00806078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25574255|NCT00806078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25574256|NCT00806078|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25574257|NCT00806078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574258|NCT00806078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25574259|NCT00806078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25574260|NCT00806078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25574261|NCT00806078|Analgesics|analgesics|mesh-ancestor
25574262|NCT00806078|Sensory System Agents|sensory system agents|mesh-ancestor
25574263|NCT00806156|Etirinotecan pegol|etirinotecan pegol|mesh-list
25574264|NCT00806156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25574265|NCT00806156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25574266|NCT00806156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25574267|NCT00806156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476579|NCT00415792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574268|NCT00806156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574269|NCT00806195|Vaccines|vaccines|mesh-list
25574270|NCT00806195|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25574271|NCT00806195|Immunologic Factors|immunologic factors|mesh-ancestor
25574272|NCT00806195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574274|NCT00806221|Dermatologic Agents|dermatologic agents|mesh-ancestor
25574275|NCT00806234|Metformin|metformin|mesh-list
25574276|NCT00806234|Olanzapine|olanzapine|mesh-list
25574277|NCT00806234|Risperidone|risperidone|mesh-list
25574278|NCT00806234|Aripiprazole|aripiprazole|mesh-list
25574279|NCT00806234|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25574280|NCT00806234|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25574281|NCT00806234|Ziprasidone|ziprasidone|mesh-list
25574282|NCT00806234|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25574283|NCT00806234|Asenapine|asenapine|mesh-list
25574284|NCT00806234|Iloperidone|iloperidone|mesh-list
25574285|NCT00806234|Perphenazine|perphenazine|mesh-list
25574286|NCT00806234|Fluoxetine|fluoxetine|mesh-list
25574287|NCT00806234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25574288|NCT00806234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574289|NCT00806234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25574290|NCT00806234|Serotonin Agents|serotonin agents|mesh-ancestor
25574291|NCT00806234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25574292|NCT00806234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574293|NCT00806234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25574294|NCT00806234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25574295|NCT00806234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25574296|NCT00806234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25574297|NCT00806234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25574298|NCT00806234|Dopamine Agents|dopamine agents|mesh-ancestor
25574299|NCT00806234|Antiemetics|antiemetics|mesh-ancestor
25574300|NCT00806234|Autonomic Agents|autonomic agents|mesh-ancestor
25574301|NCT00806234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25574302|NCT00806234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25574303|NCT00806234|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25574304|NCT00806234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25574305|NCT00806234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25574306|NCT00806234|Antidepressive Agents|antidepressive agents|mesh-ancestor
25574307|NCT00806234|Dopamine Agonists|dopamine agonists|mesh-ancestor
25574308|NCT00806234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25574309|NCT00806234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25574310|NCT00806234|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25574311|NCT00806234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25574312|NCT00806234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25574313|NCT00806234|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25574314|NCT00806234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25574315|NCT00806234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574316|NCT00806234|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25574317|NCT00806234|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25574318|NCT00806234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25574319|NCT00806234|Adrenergic Agents|adrenergic agents|mesh-ancestor
25574320|NCT00806260|Ethanol|ethanol|mesh-list
25574321|NCT00806260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25574322|NCT00806260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25574323|NCT00806260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25574324|NCT00806260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574325|NCT00806286|Paclitaxel|paclitaxel|mesh-list
25574326|NCT00806286|Carboplatin|carboplatin|mesh-list
25574327|NCT00806286|Efatutazone|efatutazone|mesh-list
25574328|NCT00806286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25574329|NCT00806286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25574330|NCT00806286|Tubulin Modulators|tubulin modulators|mesh-ancestor
25574331|NCT00806286|Antimitotic Agents|antimitotic agents|mesh-ancestor
25065217|NCT03452306|Metformin|metformin|mesh-list
25574332|NCT00806286|Mitosis Modulators|mitosis modulators|mesh-ancestor
24911913|NCT04283162|Calcium Dobesilate|calcium dobesilate|mesh-list
25574333|NCT00806286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574334|NCT00806351|Caspofungin|caspofungin|mesh-list
25574335|NCT00806351|Anidulafungin|anidulafungin|mesh-list
24912262|NCT04277884|Firibastat|firibastat|mesh-list
25574336|NCT00806351|Antifungal Agents|antifungal agents|mesh-ancestor
25574337|NCT00806351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25574338|NCT00806351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574339|NCT00806351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574340|NCT00806442|Borage oil|borage oil|mesh-list
25574341|NCT00806442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25574342|NCT00806494|Fesoterodine|fesoterodine|mesh-list
25574343|NCT00806494|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25574344|NCT00806494|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25574345|NCT00806494|Cholinergic Agents|cholinergic agents|mesh-ancestor
25574346|NCT00806494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24478891|NCT00424853|Antiviral Agents|antiviral agents|mesh-ancestor
25574347|NCT00806494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574348|NCT00806494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574349|NCT00806494|Urological Agents|urological agents|mesh-ancestor
25574350|NCT00806598|Cyclosporine|cyclosporine|mesh-list
25574351|NCT00806598|Methylprednisolone|methylprednisolone|mesh-list
25574352|NCT00806598|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25574353|NCT00806598|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25574354|NCT00806598|Prednisolone|prednisolone|mesh-list
25574355|NCT00806598|Prednisolone acetate|prednisolone acetate|mesh-list
25574356|NCT00806598|Cyclosporins|cyclosporins|mesh-list
25574357|NCT00806598|Thymoglobulin|thymoglobulin|mesh-list
25574358|NCT00806598|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25574359|NCT00806598|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25574360|NCT00806598|Prednisolone phosphate|prednisolone phosphate|mesh-list
25574361|NCT00806598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574362|NCT00806598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574363|NCT00806598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25574364|NCT00806598|Immunologic Factors|immunologic factors|mesh-ancestor
25574365|NCT00806598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574366|NCT00806598|Antifungal Agents|antifungal agents|mesh-ancestor
25574367|NCT00806598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25574368|NCT00806598|Dermatologic Agents|dermatologic agents|mesh-ancestor
25574369|NCT00806598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25574370|NCT00806598|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25574371|NCT00806598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25574372|NCT00806598|Antiemetics|antiemetics|mesh-ancestor
25574373|NCT00806598|Autonomic Agents|autonomic agents|mesh-ancestor
25574374|NCT00806598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25574375|NCT00806598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25574376|NCT00806598|Glucocorticoids|glucocorticoids|mesh-ancestor
25574377|NCT00806598|Hormones|hormones|mesh-ancestor
25574378|NCT00806598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25574379|NCT00806598|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25574380|NCT00806598|Protective Agents|protective agents|mesh-ancestor
25574381|NCT00806598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25574382|NCT00806598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25574383|NCT00806624|Warfarin|warfarin|mesh-list
25574384|NCT00806624|Edoxaban|edoxaban|mesh-list
25574385|NCT00806624|Anticoagulants|anticoagulants|mesh-ancestor
25574386|NCT00806624|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25574387|NCT00806624|Antithrombins|antithrombins|mesh-ancestor
25574388|NCT00806624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25574389|NCT00806624|Protease Inhibitors|protease inhibitors|mesh-ancestor
25574390|NCT00806624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574391|NCT00806624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574392|NCT00806819|Folic Acid|folic acid|mesh-list
25574393|NCT00806819|Vitamin B Complex|vitamin b complex|mesh-list
25574394|NCT00806819|Hydroxocobalamin|hydroxocobalamin|mesh-list
25574395|NCT00806819|Vitamin B 12|vitamin b 12|mesh-list
25574396|NCT00806819|Dexamethasone|dexamethasone|mesh-list
25574397|NCT00806819|Dexamethasone acetate|dexamethasone acetate|mesh-list
25574398|NCT00806819|Pemetrexed|pemetrexed|mesh-list
25574399|NCT00806819|Nintedanib|nintedanib|mesh-list
25574400|NCT00806819|BB 1101|bb 1101|mesh-list
25574401|NCT00806819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25574402|NCT00806819|Antiemetics|antiemetics|mesh-ancestor
25574403|NCT00806819|Autonomic Agents|autonomic agents|mesh-ancestor
25574404|NCT00806819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25574405|NCT00806819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574406|NCT00806819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25574407|NCT00806819|Glucocorticoids|glucocorticoids|mesh-ancestor
25574408|NCT00806819|Hormones|hormones|mesh-ancestor
25574409|NCT00806819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25574410|NCT00806819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25574411|NCT00806819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25574412|NCT00806819|Protease Inhibitors|protease inhibitors|mesh-ancestor
25574413|NCT00806819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574414|NCT00806819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574415|NCT00806819|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24913545|NCT04263402|Prednisolone acetate|prednisolone acetate|mesh-list
24913546|NCT04263402|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24913547|NCT04263402|Prednisolone phosphate|prednisolone phosphate|mesh-list
24913548|NCT04263402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24913549|NCT04263402|Antiemetics|antiemetics|mesh-ancestor
24913550|NCT04263402|Autonomic Agents|autonomic agents|mesh-ancestor
24913551|NCT04263402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24913553|NCT04263402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25574416|NCT00806819|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25574417|NCT00806819|Hematinics|hematinics|mesh-ancestor
25574418|NCT00806819|Vitamins|vitamins|mesh-ancestor
25574419|NCT00806819|Micronutrients|micronutrients|mesh-ancestor
25574420|NCT00806819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25468859|NCT00788710|Analgesics|analgesics|mesh-ancestor
25574421|NCT00807014|Adapalene|adapalene|mesh-list
25656949|NCT01581281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25574422|NCT00807014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25574423|NCT00807014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25574424|NCT00807014|Analgesics|analgesics|mesh-ancestor
25574425|NCT00807014|Sensory System Agents|sensory system agents|mesh-ancestor
25574426|NCT00807014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25574427|NCT00807014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574428|NCT00807014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25574429|NCT00807014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25574430|NCT00807014|Dermatologic Agents|dermatologic agents|mesh-ancestor
25574431|NCT00807092|Insulin|insulin|mesh-list
25574432|NCT00807092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25574433|NCT00807092|Metformin|metformin|mesh-list
25574434|NCT00807092|Insulin Aspart|insulin aspart|mesh-list
25574435|NCT00807092|Biphasic Insulins|biphasic insulins|mesh-list
25574436|NCT00807092|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24914005|NCT04258475|Calcium|calcium|mesh-list
25574437|NCT00807092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24914162|NCT04257461|Oxaliplatin|oxaliplatin|mesh-list
25574438|NCT00807092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574439|NCT00807144|Tacrolimus|tacrolimus|mesh-list
25574440|NCT00807144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25574441|NCT00807144|Immunologic Factors|immunologic factors|mesh-ancestor
25574442|NCT00807144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914304|NCT04256057|Tocolytic Agents|tocolytic agents|mesh-ancestor
25574443|NCT00807144|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25574444|NCT00807144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574445|NCT00807144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574446|NCT00807209|Fentanyl|fentanyl|mesh-list
25574447|NCT00807209|Bupivacaine|bupivacaine|mesh-list
25574448|NCT00807209|Anesthetics, Local|anesthetics, local|mesh-ancestor
25574449|NCT00807209|Anesthetics|anesthetics|mesh-ancestor
25574450|NCT00807209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25574451|NCT00807209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574452|NCT00807209|Sensory System Agents|sensory system agents|mesh-ancestor
25574453|NCT00807209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25574454|NCT00807209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25574455|NCT00807209|Narcotics|narcotics|mesh-ancestor
25574456|NCT00807209|Analgesics|analgesics|mesh-ancestor
25574457|NCT00807209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25574458|NCT00807209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25574459|NCT00807209|Anesthetics, General|anesthetics, general|mesh-ancestor
25574460|NCT00807235|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25574461|NCT00807235|Respiratory System Agents|respiratory system agents|mesh-ancestor
25574462|NCT00807248|Gaboxadol|gaboxadol|mesh-list
25574463|NCT00807248|Dexetimide|dexetimide|mesh-list
25574464|NCT00807248|Citalopram|citalopram|mesh-list
25574465|NCT00807248|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25574466|NCT00807248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25574467|NCT00807248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25574468|NCT00807248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574469|NCT00807248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25574470|NCT00807248|Serotonin Agents|serotonin agents|mesh-ancestor
25574471|NCT00807248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574472|NCT00807248|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25574473|NCT00807248|Antidepressive Agents|antidepressive agents|mesh-ancestor
25574474|NCT00807248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25574475|NCT00807248|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25574476|NCT00807248|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25574477|NCT00807248|Parasympatholytics|parasympatholytics|mesh-ancestor
25574478|NCT00807248|Autonomic Agents|autonomic agents|mesh-ancestor
25065364|NCT03451110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574479|NCT00807248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25574480|NCT00807248|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25574481|NCT00807248|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25574482|NCT00807248|Cholinergic Agents|cholinergic agents|mesh-ancestor
25574483|NCT00807248|Analgesics|analgesics|mesh-ancestor
25574484|NCT00807248|Sensory System Agents|sensory system agents|mesh-ancestor
25574485|NCT00807248|Anticonvulsants|anticonvulsants|mesh-ancestor
25574486|NCT00807248|GABA Agonists|gaba agonists|mesh-ancestor
25574487|NCT00807248|GABA Agents|gaba agents|mesh-ancestor
25574488|NCT00807573|Paclitaxel|paclitaxel|mesh-list
25574489|NCT00807573|Bevacizumab|bevacizumab|mesh-list
25574490|NCT00807573|Pemetrexed|pemetrexed|mesh-list
25574491|NCT00807573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25574492|NCT00807573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25574493|NCT00807573|Tubulin Modulators|tubulin modulators|mesh-ancestor
25574494|NCT00807573|Antimitotic Agents|antimitotic agents|mesh-ancestor
25468919|NCT00761527|Histamine Agents|histamine agents|mesh-ancestor
25574495|NCT00807573|Mitosis Modulators|mitosis modulators|mesh-ancestor
25574496|NCT00807573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574497|NCT00807573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25574498|NCT00807573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25574499|NCT00807573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25574500|NCT00807573|Growth Substances|growth substances|mesh-ancestor
25574501|NCT00807573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574502|NCT00807573|Growth Inhibitors|growth inhibitors|mesh-ancestor
25574503|NCT00807573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574504|NCT00807573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25574505|NCT00807573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25574506|NCT00807586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25574507|NCT00807586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25574508|NCT00807586|Methylprednisolone|methylprednisolone|mesh-list
25574509|NCT00807586|Prednisolone|prednisolone|mesh-list
25574510|NCT00807586|Prednisolone acetate|prednisolone acetate|mesh-list
25574511|NCT00807586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25574512|NCT00807586|Prednisolone phosphate|prednisolone phosphate|mesh-list
25574513|NCT00807586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25574514|NCT00807586|Glucocorticoids|glucocorticoids|mesh-ancestor
25574515|NCT00807586|Hormones|hormones|mesh-ancestor
25574516|NCT00807586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25574517|NCT00807586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574518|NCT00807586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25574519|NCT00807586|Protective Agents|protective agents|mesh-ancestor
25574520|NCT00807586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25574521|NCT00807586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25574522|NCT00807586|Antiemetics|antiemetics|mesh-ancestor
25574523|NCT00807586|Autonomic Agents|autonomic agents|mesh-ancestor
25574524|NCT00807586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25574525|NCT00807586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25574526|NCT00807599|Dexamethasone|dexamethasone|mesh-list
25574527|NCT00807599|Dexamethasone acetate|dexamethasone acetate|mesh-list
24819512|NCT02095834|Ichthammol|ichthammol|mesh-list
25574528|NCT00807599|Lenalidomide|lenalidomide|mesh-list
25574529|NCT00807599|Melphalan|melphalan|mesh-list
25574530|NCT00807599|BB 1101|bb 1101|mesh-list
25574531|NCT00807599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25574532|NCT00807599|Antiemetics|antiemetics|mesh-ancestor
25574533|NCT00807599|Autonomic Agents|autonomic agents|mesh-ancestor
25574534|NCT00807599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25574535|NCT00807599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574536|NCT00807599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25574537|NCT00807599|Glucocorticoids|glucocorticoids|mesh-ancestor
25574538|NCT00807599|Hormones|hormones|mesh-ancestor
24914673|NCT04252963|Streptokinase|streptokinase|mesh-list
25574539|NCT00807599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25574540|NCT00807599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25574541|NCT00807599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25574542|NCT00807599|Protease Inhibitors|protease inhibitors|mesh-ancestor
25574543|NCT00807599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574544|NCT00807599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574545|NCT00807599|Immunologic Factors|immunologic factors|mesh-ancestor
25574546|NCT00807599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25574547|NCT00807599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25574548|NCT00807599|Growth Substances|growth substances|mesh-ancestor
25574549|NCT00807599|Growth Inhibitors|growth inhibitors|mesh-ancestor
25574550|NCT00807599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25574551|NCT00807599|Alkylating Agents|alkylating agents|mesh-ancestor
25574552|NCT00807599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25574553|NCT00807599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25574554|NCT00807742|Nicotine|nicotine|mesh-list
25574555|NCT00807742|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25574556|NCT00807742|Autonomic Agents|autonomic agents|mesh-ancestor
25574557|NCT00807742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25574558|NCT00807742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574559|NCT00807742|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25574560|NCT00807742|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24831388|NCT02165046|Procaterol|procaterol|mesh-list
25574561|NCT00807742|Cholinergic Agents|cholinergic agents|mesh-ancestor
25574562|NCT00807742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25574563|NCT00807742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574564|NCT00807768|Paclitaxel|paclitaxel|mesh-list
25574565|NCT00807768|Carboplatin|carboplatin|mesh-list
25574566|NCT00807768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25574567|NCT00807768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25574568|NCT00807768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25574569|NCT00807768|Tubulin Modulators|tubulin modulators|mesh-ancestor
25574570|NCT00807768|Antimitotic Agents|antimitotic agents|mesh-ancestor
25574571|NCT00807768|Mitosis Modulators|mitosis modulators|mesh-ancestor
25574572|NCT00807768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574573|NCT00807846|Celecoxib|celecoxib|mesh-list
25574575|NCT00807846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25574576|NCT00807846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25574577|NCT00807846|Analgesics|analgesics|mesh-ancestor
25574578|NCT00807846|Sensory System Agents|sensory system agents|mesh-ancestor
25574579|NCT00807846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25574580|NCT00807846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574581|NCT00807846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25574582|NCT00807846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25574583|NCT00807846|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25699738|NCT02111798|Dopamine Agents|dopamine agents|mesh-ancestor
25574584|NCT00807846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25574585|NCT00807846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574586|NCT00807846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574587|NCT00807846|Gout Suppressants|gout suppressants|mesh-ancestor
25574588|NCT00807937|Lorazepam|lorazepam|mesh-list
25574589|NCT00807937|Anticonvulsants|anticonvulsants|mesh-ancestor
25574590|NCT00807937|Antiemetics|antiemetics|mesh-ancestor
25574591|NCT00807937|Autonomic Agents|autonomic agents|mesh-ancestor
25574592|NCT00807937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25574593|NCT00807937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574594|NCT00807937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25574595|NCT00807937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25574596|NCT00807937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25574597|NCT00807937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24840991|NCT02213588|Antioxidants|antioxidants|mesh-list
25574598|NCT00807937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25574599|NCT00807937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25574600|NCT00807937|GABA Modulators|gaba modulators|mesh-ancestor
25574601|NCT00807937|GABA Agents|gaba agents|mesh-ancestor
25574602|NCT00807937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25574603|NCT00807937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574604|NCT00807989|Lamotrigine|lamotrigine|mesh-list
25574605|NCT00807989|Carbamazepine|carbamazepine|mesh-list
25574606|NCT00807989|Valproic Acid|valproic acid|mesh-list
25574607|NCT00807989|Anticonvulsants|anticonvulsants|mesh-ancestor
25574608|NCT00807989|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25574609|NCT00807989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25574610|NCT00807989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574611|NCT00807989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25574612|NCT00807989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574613|NCT00807989|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25574614|NCT00807989|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25574615|NCT00807989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25574616|NCT00807989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25574617|NCT00807989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25574618|NCT00807989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574619|NCT00807989|GABA Agents|gaba agents|mesh-ancestor
25574620|NCT00807989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25574621|NCT00807989|Antimanic Agents|antimanic agents|mesh-ancestor
25574622|NCT00807989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25574623|NCT00807989|Analgesics|analgesics|mesh-ancestor
25574624|NCT00807989|Sensory System Agents|sensory system agents|mesh-ancestor
24486159|NCT00456586|Istradefylline|istradefylline|mesh-list
25574625|NCT00807989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25574626|NCT00807989|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25574627|NCT00807989|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25574628|NCT00808015|Varenicline|varenicline|mesh-list
25574629|NCT00808015|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25574630|NCT00808015|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25574631|NCT00808015|Cholinergic Agents|cholinergic agents|mesh-ancestor
25574632|NCT00808015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25574633|NCT00808015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574634|NCT00808015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574635|NCT00808028|Vaccines|vaccines|mesh-list
25574636|NCT00808028|Immunologic Factors|immunologic factors|mesh-ancestor
25574637|NCT00808028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574638|NCT00808067|Dabigatran|dabigatran|mesh-list
25574639|NCT00808067|Antithrombins|antithrombins|mesh-ancestor
25574640|NCT00808067|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25574641|NCT00808067|Protease Inhibitors|protease inhibitors|mesh-ancestor
25574642|NCT00808067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574643|NCT00808067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574644|NCT00808067|Anticoagulants|anticoagulants|mesh-ancestor
25574645|NCT00808132|Bazedoxifene|bazedoxifene|mesh-list
25574646|NCT00808132|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25574647|NCT00808132|Medroxyprogesterone|medroxyprogesterone|mesh-list
25574648|NCT00808132|Estrogens|estrogens|mesh-list
25574649|NCT00808132|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25574650|NCT00808132|Hormones|hormones|mesh-ancestor
24843378|NCT02227056|Dopamine Agents|dopamine agents|mesh-ancestor
25574651|NCT00808132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25574652|NCT00808132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574653|NCT00808132|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25574654|NCT00808132|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25574655|NCT00808132|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25574656|NCT00808132|Contraceptive Agents|contraceptive agents|mesh-ancestor
25574657|NCT00808132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25574658|NCT00808132|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25574659|NCT00808132|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25574660|NCT00808132|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25574661|NCT00808132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25574662|NCT00808132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25574663|NCT00808132|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25574664|NCT00808132|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24844626|NCT02233556|Memantine|memantine|mesh-list
25574665|NCT00808132|Hormone Antagonists|hormone antagonists|mesh-ancestor
25574666|NCT00808132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25574667|NCT00808210|Methylprednisolone|methylprednisolone|mesh-list
25574668|NCT00808210|Methotrexate|methotrexate|mesh-list
25574669|NCT00808210|Infliximab|infliximab|mesh-list
25574670|NCT00808210|Ocrelizumab|ocrelizumab|mesh-list
25574671|NCT00808210|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25574672|NCT00808210|Abortifacient Agents|abortifacient agents|mesh-ancestor
25574673|NCT00808210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25574674|NCT00808210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574675|NCT00808210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25574676|NCT00808210|Antimetabolites|antimetabolites|mesh-ancestor
25574677|NCT00808210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574678|NCT00808210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25574679|NCT00808210|Dermatologic Agents|dermatologic agents|mesh-ancestor
25574680|NCT00808210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574681|NCT00808210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25574682|NCT00808210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25574683|NCT00808210|Immunologic Factors|immunologic factors|mesh-ancestor
25574684|NCT00808210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25574685|NCT00808210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25574686|NCT00808210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25574687|NCT00808210|Antiemetics|antiemetics|mesh-ancestor
25574688|NCT00808210|Autonomic Agents|autonomic agents|mesh-ancestor
25574689|NCT00808210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25574690|NCT00808210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25574691|NCT00808210|Glucocorticoids|glucocorticoids|mesh-ancestor
25574692|NCT00808210|Hormones|hormones|mesh-ancestor
25574693|NCT00808210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25574694|NCT00808210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25574695|NCT00808210|Protective Agents|protective agents|mesh-ancestor
25574696|NCT00808405|Acyclovir|acyclovir|mesh-list
25574697|NCT00808405|Antiviral Agents|antiviral agents|mesh-ancestor
25574698|NCT00808405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25574699|NCT00808444|Vaccines|vaccines|mesh-list
25574700|NCT00808444|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25574701|NCT00808444|Immunologic Factors|immunologic factors|mesh-ancestor
25574702|NCT00808444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574703|NCT00808470|Ascorbic Acid|ascorbic acid|mesh-list
25574704|NCT00808470|Beta Carotene|beta carotene|mesh-list
25574705|NCT00808470|Carotenoids|carotenoids|mesh-list
25574706|NCT00808470|Vitamins|vitamins|mesh-ancestor
25574707|NCT00808470|Micronutrients|micronutrients|mesh-ancestor
25574708|NCT00808470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574709|NCT00808470|Antioxidants|antioxidants|mesh-ancestor
25574710|NCT00808470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574711|NCT00808470|Protective Agents|protective agents|mesh-ancestor
25574712|NCT00808470|Provitamins|provitamins|mesh-ancestor
25574713|NCT00808509|Adalimumab|adalimumab|mesh-list
25574714|NCT00808509|Methotrexate|methotrexate|mesh-list
25574715|NCT00808509|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25574716|NCT00808509|Abortifacient Agents|abortifacient agents|mesh-ancestor
25574717|NCT00808509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25574718|NCT00808509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574719|NCT00808509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25574720|NCT00808509|Antimetabolites|antimetabolites|mesh-ancestor
25574721|NCT00808509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574722|NCT00808509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469119|NCT00447603|Losartan|losartan|mesh-list
25574723|NCT00808509|Dermatologic Agents|dermatologic agents|mesh-ancestor
25574724|NCT00808509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574725|NCT00808509|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25574726|NCT00808509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25574727|NCT00808509|Immunologic Factors|immunologic factors|mesh-ancestor
25574728|NCT00808509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25574729|NCT00808509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25574730|NCT00808509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25574731|NCT00808639|Cisplatin|cisplatin|mesh-list
25574732|NCT00808639|Doxorubicin|doxorubicin|mesh-list
25574733|NCT00808639|Methotrexate|methotrexate|mesh-list
25574734|NCT00808639|Vinblastine|vinblastine|mesh-list
25574735|NCT00808639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25574736|NCT00808639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25574737|NCT00808639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25574738|NCT00808639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25574739|NCT00808639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574740|NCT00808639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574741|NCT00808639|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25574742|NCT00808639|Abortifacient Agents|abortifacient agents|mesh-ancestor
25574743|NCT00808639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25574744|NCT00808639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574745|NCT00808639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25574746|NCT00808639|Antimetabolites|antimetabolites|mesh-ancestor
25574747|NCT00808639|Dermatologic Agents|dermatologic agents|mesh-ancestor
25574748|NCT00808639|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25574749|NCT00808639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25574750|NCT00808639|Immunologic Factors|immunologic factors|mesh-ancestor
25574751|NCT00808639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25574752|NCT00808639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25574753|NCT00808639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25574754|NCT00808639|Tubulin Modulators|tubulin modulators|mesh-ancestor
25574755|NCT00808639|Antimitotic Agents|antimitotic agents|mesh-ancestor
25574756|NCT00808639|Mitosis Modulators|mitosis modulators|mesh-ancestor
25574757|NCT00808665|Dexmedetomidine|dexmedetomidine|mesh-list
25574758|NCT00808665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25574759|NCT00808665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25574760|NCT00808665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574761|NCT00808665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25574762|NCT00808665|Analgesics|analgesics|mesh-ancestor
25574763|NCT00808665|Sensory System Agents|sensory system agents|mesh-ancestor
25574764|NCT00808665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25574765|NCT00808665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25574766|NCT00808665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25574767|NCT00808665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25574768|NCT00808665|Adrenergic Agents|adrenergic agents|mesh-ancestor
25574769|NCT00808665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24868039|NCT04013555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574770|NCT00808665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574771|NCT00809055|Caffeine|caffeine|mesh-list
25574772|NCT00809055|Caffeine citrate|caffeine citrate|mesh-list
25574773|NCT00809055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574774|NCT00809055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25574775|NCT00809055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574776|NCT00809055|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25574777|NCT00809055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574778|NCT00809055|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25574779|NCT00809055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25574780|NCT00809055|Purinergic Agents|purinergic agents|mesh-ancestor
25574781|NCT00809055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25574782|NCT00809094|Acetylcysteine|acetylcysteine|mesh-list
24885608|NCT05030272|Nicotine|nicotine|mesh-list
24870688|NCT04510311|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
25574783|NCT00809094|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25574784|NCT00809094|Antiviral Agents|antiviral agents|mesh-ancestor
25574785|NCT00809094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25574786|NCT00809094|Expectorants|expectorants|mesh-ancestor
25574787|NCT00809094|Respiratory System Agents|respiratory system agents|mesh-ancestor
25574788|NCT00809094|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25574789|NCT00809094|Antioxidants|antioxidants|mesh-ancestor
25574790|NCT00809094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574791|NCT00809094|Protective Agents|protective agents|mesh-ancestor
25574792|NCT00809094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574793|NCT00809094|Antidotes|antidotes|mesh-ancestor
25574794|NCT00809133|Paclitaxel|paclitaxel|mesh-list
24493096|NCT00489528|Hormones|hormones|mesh-list
24876525|NCT03463876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875737|NCT03896269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574795|NCT00809133|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25574796|NCT00809133|Bevacizumab|bevacizumab|mesh-list
25574797|NCT00809133|Carboplatin|carboplatin|mesh-list
25574798|NCT00809133|Afatinib|afatinib|mesh-list
25574799|NCT00809133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25574800|NCT00809133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25574801|NCT00809133|Tubulin Modulators|tubulin modulators|mesh-ancestor
24887193|NCT04519385|Hormones|hormones|mesh-ancestor
24887762|NCT04513184|Hormones|hormones|mesh-ancestor
25574802|NCT00809133|Antimitotic Agents|antimitotic agents|mesh-ancestor
25574803|NCT00809133|Mitosis Modulators|mitosis modulators|mesh-ancestor
25574804|NCT00809133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574805|NCT00809133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25574806|NCT00809133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24889837|NCT04489121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25574807|NCT00809133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25574808|NCT00809133|Growth Substances|growth substances|mesh-ancestor
25574809|NCT00809133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574810|NCT00809133|Growth Inhibitors|growth inhibitors|mesh-ancestor
25574811|NCT00809133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25574812|NCT00809133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574813|NCT00809185|Everolimus|everolimus|mesh-list
25574814|NCT00809185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25574815|NCT00809185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25574816|NCT00809185|Immunologic Factors|immunologic factors|mesh-ancestor
25574817|NCT00809185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574818|NCT00809276|Cyclophosphamide|cyclophosphamide|mesh-list
25574819|NCT00809276|Busulfan|busulfan|mesh-list
25574820|NCT00809276|Fludarabine|fludarabine|mesh-list
25574821|NCT00809276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25574822|NCT00809276|Immunologic Factors|immunologic factors|mesh-ancestor
25574823|NCT00809276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574824|NCT00809276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25574825|NCT00809276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25574826|NCT00809276|Alkylating Agents|alkylating agents|mesh-ancestor
25574827|NCT00809276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574828|NCT00809276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25574829|NCT00809276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25574830|NCT00809328|Azithromycin|azithromycin|mesh-list
25574831|NCT00809328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25574832|NCT00809328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25574833|NCT00809354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25574834|NCT00809354|Tanezumab|tanezumab|mesh-list
25574835|NCT00809354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25574836|NCT00809354|Analgesics|analgesics|mesh-ancestor
25574837|NCT00809354|Sensory System Agents|sensory system agents|mesh-ancestor
25574838|NCT00809354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25574839|NCT00809354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574840|NCT00809354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25574841|NCT00809354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25574842|NCT00809757|Albuterol|albuterol|mesh-list
25574843|NCT00809757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25574844|NCT00809757|Autonomic Agents|autonomic agents|mesh-ancestor
25574845|NCT00809757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25574846|NCT00809757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574847|NCT00809757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25574848|NCT00809757|Respiratory System Agents|respiratory system agents|mesh-ancestor
25574849|NCT00809757|Tocolytic Agents|tocolytic agents|mesh-ancestor
25574850|NCT00809757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25574851|NCT00809757|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25574852|NCT00809757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25574853|NCT00809757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25574854|NCT00809757|Adrenergic Agents|adrenergic agents|mesh-ancestor
25574855|NCT00809757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25108859|NCT03129594|Incretins|incretins|mesh-ancestor
25574856|NCT00809757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574857|NCT00809783|Tanezumab|tanezumab|mesh-list
25574858|NCT00809783|Analgesics|analgesics|mesh-ancestor
25574859|NCT00809783|Sensory System Agents|sensory system agents|mesh-ancestor
25574860|NCT00809783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25574861|NCT00809783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574862|NCT00809809|Zinc|zinc|mesh-list
25574863|NCT00809809|Trace Elements|trace elements|mesh-ancestor
25574864|NCT00809809|Micronutrients|micronutrients|mesh-ancestor
25574865|NCT00809809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574866|NCT00809835|Galantamine|galantamine|mesh-list
25574867|NCT00809835|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25574868|NCT00809835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574869|NCT00809835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574870|NCT00809835|Cholinergic Agents|cholinergic agents|mesh-ancestor
25574871|NCT00809835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25574872|NCT00809835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574873|NCT00809835|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25574874|NCT00809835|Autonomic Agents|autonomic agents|mesh-ancestor
24900156|NCT04397328|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25574875|NCT00809835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25574876|NCT00809835|Nootropic Agents|nootropic agents|mesh-ancestor
25574877|NCT00809848|Bimatoprost|bimatoprost|mesh-list
25574878|NCT00809848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24880184|NCT03986996|Amoxicillin|amoxicillin|mesh-list
25574879|NCT00809848|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24891509|NCT04470076|Afatinib|afatinib|mesh-list
25574880|NCT00809848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25574881|NCT00809926|Valsartan|valsartan|mesh-list
25574882|NCT00809926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25574883|NCT00809926|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25574884|NCT00809926|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25574885|NCT00809926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574886|NCT00809965|Rivaroxaban|rivaroxaban|mesh-list
25574887|NCT00809965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25574888|NCT00809965|Antithrombins|antithrombins|mesh-ancestor
24902647|NCT04371601|Antiviral Agents|antiviral agents|mesh-ancestor
25574889|NCT00809965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25574890|NCT00809965|Protease Inhibitors|protease inhibitors|mesh-ancestor
25574891|NCT00809965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574892|NCT00809965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574893|NCT00809965|Anticoagulants|anticoagulants|mesh-ancestor
25652531|NCT01528735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652532|NCT01528735|Antiviral Agents|antiviral agents|mesh-ancestor
25652533|NCT01528735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25652534|NCT01528787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25652535|NCT01528787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25652536|NCT01528891|Dexmedetomidine|dexmedetomidine|mesh-list
25652537|NCT01528891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25652538|NCT01528891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25652539|NCT01528891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652540|NCT01528891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25652541|NCT01528891|Analgesics|analgesics|mesh-ancestor
25652542|NCT01528891|Sensory System Agents|sensory system agents|mesh-ancestor
25652543|NCT01528891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25652544|NCT01528891|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25652545|NCT01528891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25652546|NCT01528891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25652547|NCT01528891|Adrenergic Agents|adrenergic agents|mesh-ancestor
25652548|NCT01528891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25652549|NCT01528891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652550|NCT01528969|Sorbitol|sorbitol|mesh-list
25652551|NCT01528969|Cathartics|cathartics|mesh-ancestor
25652552|NCT01528969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25652553|NCT01529060|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25652554|NCT01529060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652555|NCT01529112|Lenvatinib|lenvatinib|mesh-list
25652556|NCT01529112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652557|NCT01529112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25652558|NCT01529112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25109022|NCT03127371|Anesthetics, General|anesthetics, general|mesh-ancestor
25652559|NCT01529112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652560|NCT01529203|Botulinum Toxins|botulinum toxins|mesh-list
24504993|NCT00538889|Citalopram|citalopram|mesh-list
25652561|NCT01529203|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25652562|NCT01529203|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25652563|NCT01529203|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25652564|NCT01529203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25652565|NCT01529203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652566|NCT01529203|Cholinergic Agents|cholinergic agents|mesh-ancestor
25652567|NCT01529203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25652568|NCT01529203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652569|NCT01529203|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25652570|NCT01529203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25652571|NCT01529268|Cysteamine|cysteamine|mesh-list
25652572|NCT01529268|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
25652573|NCT01529268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652574|NCT01529346|Ibuprofen|ibuprofen|mesh-list
25652575|NCT01529346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25652576|NCT01529346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25652577|NCT01529346|Analgesics|analgesics|mesh-ancestor
25652578|NCT01529346|Sensory System Agents|sensory system agents|mesh-ancestor
25652579|NCT01529346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25652580|NCT01529346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652581|NCT01529346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25652582|NCT01529346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25652583|NCT01529346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25469410|NCT00003389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25469411|NCT00003389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25469412|NCT00003389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25469413|NCT00003389|Tubulin Modulators|tubulin modulators|mesh-ancestor
25469414|NCT00003389|Antimitotic Agents|antimitotic agents|mesh-ancestor
25469415|NCT00003389|Mitosis Modulators|mitosis modulators|mesh-ancestor
25469416|NCT00003389|Keratolytic Agents|keratolytic agents|mesh-ancestor
25469417|NCT00003389|Dermatologic Agents|dermatologic agents|mesh-ancestor
25330465|NCT04821843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330466|NCT04821843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25016574|NCT05041426|Letermovir|letermovir|mesh-list
24482467|NCT00439166|Rifampin|rifampin|mesh-list
25330476|NCT04821583|Hydrocortisone|hydrocortisone|mesh-list
25330477|NCT04821583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25330478|NCT04821765|Paclitaxel|paclitaxel|mesh-list
25330479|NCT04821765|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25330480|NCT04821765|Antibodies|antibodies|mesh-list
25330481|NCT04821765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24429737|NCT00244946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24429738|NCT00244959|Anastrozole|anastrozole|mesh-list
24429739|NCT00244959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24429754|NCT00244972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429756|NCT00244998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24429757|NCT00244998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429758|NCT00244998|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24429759|NCT00244998|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24429760|NCT00244998|Hormone Antagonists|hormone antagonists|mesh-ancestor
25109034|NCT03127631|Aspirin|aspirin|mesh-list
24979569|NCT03823989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429761|NCT00244998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25105998|NCT04688203|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25105999|NCT04688203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25106000|NCT04688203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429829|NCT00245141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429830|NCT00245141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24429832|NCT00245154|Carboplatin|carboplatin|mesh-list
24429833|NCT00245154|Cediranib|cediranib|mesh-list
24429834|NCT00245154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24429835|NCT00245154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429836|NCT00245154|Tubulin Modulators|tubulin modulators|mesh-ancestor
24429837|NCT00245154|Antimitotic Agents|antimitotic agents|mesh-ancestor
24429838|NCT00245154|Mitosis Modulators|mitosis modulators|mesh-ancestor
24429839|NCT00245154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429840|NCT00245154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429841|NCT00245154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24429842|NCT00245206|Olanzapine|olanzapine|mesh-list
24429843|NCT00245206|Risperidone|risperidone|mesh-list
24429844|NCT00245206|Aripiprazole|aripiprazole|mesh-list
24429845|NCT00245206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24429890|NCT00245375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429891|NCT00245375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24429892|NCT00245375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24429893|NCT00245375|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24429894|NCT00245375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429895|NCT00245375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429897|NCT00245401|Sirolimus|sirolimus|mesh-list
25574894|NCT00810069|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25574895|NCT00810069|Citalopram|citalopram|mesh-list
25574896|NCT00810069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25574897|NCT00810069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25574898|NCT00810069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25574899|NCT00810069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574900|NCT00810069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25574901|NCT00810069|Serotonin Agents|serotonin agents|mesh-ancestor
25574902|NCT00810069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574903|NCT00810069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25574904|NCT00810069|Antidepressive Agents|antidepressive agents|mesh-ancestor
25574905|NCT00810069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25574906|NCT00810069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25574907|NCT00810069|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25574908|NCT00810069|Analgesics|analgesics|mesh-ancestor
25574909|NCT00810069|Sensory System Agents|sensory system agents|mesh-ancestor
25574910|NCT00810069|Dopamine Agents|dopamine agents|mesh-ancestor
25574911|NCT00810108|Ritonavir|ritonavir|mesh-list
25574912|NCT00810108|Lopinavir|lopinavir|mesh-list
25574913|NCT00810108|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25574914|NCT00810108|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25574915|NCT00810108|Protease Inhibitors|protease inhibitors|mesh-ancestor
25574916|NCT00810108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574917|NCT00810108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574918|NCT00810108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25574919|NCT00810108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25574920|NCT00810108|Antiviral Agents|antiviral agents|mesh-ancestor
25574921|NCT00810108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25574922|NCT00810108|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25574923|NCT00810108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25574924|NCT00810199|Methotrexate|methotrexate|mesh-list
25574925|NCT00810199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25574926|NCT00810199|Abortifacient Agents|abortifacient agents|mesh-ancestor
25574927|NCT00810199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25574928|NCT00810199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574929|NCT00810199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25574930|NCT00810199|Antimetabolites|antimetabolites|mesh-ancestor
25574931|NCT00810199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574932|NCT00810199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25574933|NCT00810199|Dermatologic Agents|dermatologic agents|mesh-ancestor
25574934|NCT00810199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574935|NCT00810199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25574936|NCT00810199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25574937|NCT00810199|Immunologic Factors|immunologic factors|mesh-ancestor
25574938|NCT00810199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25574939|NCT00810199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25574940|NCT00810303|Efavirenz|efavirenz|mesh-list
25574941|NCT00810303|Ezetimibe|ezetimibe|mesh-list
25574942|NCT00810303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25574943|NCT00810303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25574944|NCT00810303|Antimetabolites|antimetabolites|mesh-ancestor
25574945|NCT00810303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574946|NCT00810303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25574947|NCT00810303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25574948|NCT00810303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25574949|NCT00810303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574950|NCT00810303|Antiviral Agents|antiviral agents|mesh-ancestor
25574951|NCT00810303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25574952|NCT00810303|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25574953|NCT00810303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25574954|NCT00810303|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25574955|NCT00810303|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25574956|NCT00810303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25574957|NCT00810303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25574958|NCT00810394|Sorafenib|sorafenib|mesh-list
25574959|NCT00810394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25574960|NCT00810394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25574961|NCT00810394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574962|NCT00810394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574963|NCT00810407|Rifabutin|rifabutin|mesh-list
25574964|NCT00810407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25574965|NCT00810407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25574966|NCT00810407|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25574967|NCT00810407|Antitubercular Agents|antitubercular agents|mesh-ancestor
25574968|NCT00810576|Bortezomib|bortezomib|mesh-list
25574969|NCT00810576|Vorinostat|vorinostat|mesh-list
25574970|NCT00810576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25574971|NCT00810576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25574972|NCT00810576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574973|NCT00810576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574974|NCT00810602|Vorinostat|vorinostat|mesh-list
25574975|NCT00810602|Tacrolimus|tacrolimus|mesh-list
25574976|NCT00810602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25574977|NCT00810602|Immunologic Factors|immunologic factors|mesh-ancestor
25574978|NCT00810602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574979|NCT00810602|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25574980|NCT00810602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574981|NCT00810602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574982|NCT00810602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25574983|NCT00810602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25574984|NCT00810693|Riociguat|riociguat|mesh-list
25574985|NCT00810693|Enzyme Activators|enzyme activators|mesh-ancestor
25574986|NCT00810693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574987|NCT00810719|Gemcitabine|gemcitabine|mesh-list
24471638|NCT00396396|Expectorants|expectorants|mesh-ancestor
25574988|NCT00810719|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25574989|NCT00810719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25574990|NCT00810719|Antimetabolites|antimetabolites|mesh-ancestor
25574991|NCT00810719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25574992|NCT00810719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25574993|NCT00810719|Antiviral Agents|antiviral agents|mesh-ancestor
25574994|NCT00810719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25574995|NCT00810719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25574996|NCT00810719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25574997|NCT00810719|Immunologic Factors|immunologic factors|mesh-ancestor
25574998|NCT00810719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25574999|NCT00810719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25575000|NCT00810797|Exemestane|exemestane|mesh-list
24727395|NCT01609517|Bupivacaine|bupivacaine|mesh-list
25575001|NCT00810797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25575002|NCT00810797|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25575003|NCT00810797|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25575004|NCT00810797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575005|NCT00810797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575006|NCT00810797|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25575007|NCT00810797|Hormone Antagonists|hormone antagonists|mesh-ancestor
25575008|NCT00810797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25109067|NCT03127137|Anesthetics|anesthetics|mesh-ancestor
25575009|NCT00810797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575010|NCT00811018|Sitaxsentan|sitaxsentan|mesh-list
25575011|NCT00811018|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25575012|NCT00811018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575013|NCT00811057|Indomethacin|indomethacin|mesh-list
25575014|NCT00811057|Magnesium Sulfate|magnesium sulfate|mesh-list
25575015|NCT00811057|Nifedipine|nifedipine|mesh-list
25575016|NCT00811057|Analgesics|analgesics|mesh-ancestor
25575017|NCT00811057|Sensory System Agents|sensory system agents|mesh-ancestor
25575018|NCT00811057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25575019|NCT00811057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575020|NCT00811057|Anesthetics|anesthetics|mesh-ancestor
25575021|NCT00811057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25575022|NCT00811057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25575023|NCT00811057|Anticonvulsants|anticonvulsants|mesh-ancestor
25575024|NCT00811057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25575025|NCT00811057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25575026|NCT00811057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575027|NCT00811057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25575028|NCT00811057|Tocolytic Agents|tocolytic agents|mesh-ancestor
25575029|NCT00811057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25575030|NCT00811057|Vasodilator Agents|vasodilator agents|mesh-ancestor
25575031|NCT00811057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25575032|NCT00811057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25575033|NCT00811057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25575034|NCT00811057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25575035|NCT00811057|Gout Suppressants|gout suppressants|mesh-ancestor
25575036|NCT00811057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25575037|NCT00811057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575038|NCT00811135|Bevacizumab|bevacizumab|mesh-list
25575039|NCT00811135|Trastuzumab|trastuzumab|mesh-list
25575040|NCT00811135|Capecitabine|capecitabine|mesh-list
25575041|NCT00811135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25575042|NCT00811135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25575043|NCT00811135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25575044|NCT00811135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25575045|NCT00811135|Growth Substances|growth substances|mesh-ancestor
25575046|NCT00811135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575047|NCT00811135|Growth Inhibitors|growth inhibitors|mesh-ancestor
25575048|NCT00811135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25575049|NCT00811135|Antimetabolites|antimetabolites|mesh-ancestor
25575050|NCT00811135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575051|NCT00811174|gamma-Globulins|gamma-globulins|mesh-list
25575052|NCT00811174|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25575053|NCT00811174|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25575054|NCT00811174|Immunologic Factors|immunologic factors|mesh-ancestor
25575055|NCT00811174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905557|NCT04346407|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24905558|NCT04346407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24905559|NCT04346407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905560|NCT04346407|Hormones|hormones|mesh-ancestor
24881812|NCT01239797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881813|NCT01239797|Immunologic Factors|immunologic factors|mesh-ancestor
24905563|NCT04346589|Immunoglobulins|immunoglobulins|mesh-list
24905564|NCT04346589|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24905640|NCT04345848|Heparin|heparin|mesh-list
25575056|NCT00811187|Lidocaine|lidocaine|mesh-list
25575057|NCT00811187|Anesthetics, Local|anesthetics, local|mesh-ancestor
25575058|NCT00811187|Anesthetics|anesthetics|mesh-ancestor
25575059|NCT00811187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25575060|NCT00811187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575061|NCT00811187|Sensory System Agents|sensory system agents|mesh-ancestor
25575062|NCT00811187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25575063|NCT00811187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25575064|NCT00811187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25575065|NCT00811187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25575066|NCT00811187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25575067|NCT00811187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575068|NCT00811252|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25575069|NCT00811252|Vortioxetine|vortioxetine|mesh-list
25575070|NCT00811252|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24817363|NCT02083068|Vaccines|vaccines|mesh-list
24626495|NCT01087580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626496|NCT01087580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24626497|NCT01087593|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24626500|NCT01087593|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24626502|NCT01087593|Hormones|hormones|mesh-ancestor
24881981|NCT00006455|Methotrexate|methotrexate|mesh-list
24881982|NCT00006455|Etoposide|etoposide|mesh-list
24626518|NCT01087632|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24626519|NCT01087632|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24626520|NCT01087632|Antimetabolites|antimetabolites|mesh-ancestor
24954382|NCT03877120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954383|NCT03877120|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24954384|NCT03877120|Anticonvulsants|anticonvulsants|mesh-ancestor
24954385|NCT03877120|Antiemetics|antiemetics|mesh-ancestor
24954399|NCT03877003|Lipotropic Agents|lipotropic agents|mesh-ancestor
24954400|NCT03877003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24954401|NCT03877003|Antimetabolites|antimetabolites|mesh-ancestor
24954402|NCT03877003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954403|NCT03877003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24882009|NCT00006455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24882010|NCT00006455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24882011|NCT00006455|Antimetabolites|antimetabolites|mesh-ancestor
24882012|NCT00006455|Dermatologic Agents|dermatologic agents|mesh-ancestor
24882013|NCT00006455|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24882014|NCT00006455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24882015|NCT00006455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24882021|NCT00006455|Vitamins|vitamins|mesh-ancestor
25076064|NCT03376139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25076065|NCT03376139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575071|NCT00811252|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25575072|NCT00811252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25575073|NCT00811252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575074|NCT00811252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25575075|NCT00811252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575076|NCT00811252|Analgesics|analgesics|mesh-ancestor
25575077|NCT00811252|Sensory System Agents|sensory system agents|mesh-ancestor
25575078|NCT00811252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25575079|NCT00811252|Antidepressive Agents|antidepressive agents|mesh-ancestor
24397667|NCT00142233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397668|NCT00142233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397669|NCT00142246|Amodiaquine|amodiaquine|mesh-list
24397670|NCT00142246|Antimalarials|antimalarials|mesh-ancestor
24397674|NCT00142324|Donepezil|donepezil|mesh-list
25076145|NCT03375593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076146|NCT03375593|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25076147|NCT03375593|Narcotics|narcotics|mesh-ancestor
25076148|NCT03375593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25076149|NCT03375593|Antitussive Agents|antitussive agents|mesh-ancestor
25076150|NCT03375593|Respiratory System Agents|respiratory system agents|mesh-ancestor
25076151|NCT03375580|Metformin|metformin|mesh-list
25076152|NCT03375580|Simvastatin|simvastatin|mesh-list
25076153|NCT03375580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24882104|NCT02735707|Aspirin|aspirin|mesh-list
24817459|NCT02084043|Amikacin|amikacin|mesh-list
25076169|NCT03375515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076170|NCT03375463|Tirzepatide|tirzepatide|mesh-list
25076171|NCT03375463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25076172|NCT03375463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076173|NCT03375463|Incretins|incretins|mesh-ancestor
25076174|NCT03375463|Hormones|hormones|mesh-ancestor
25076175|NCT03375463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25076176|NCT03375424|Vedolizumab|vedolizumab|mesh-list
25076244|NCT03374540|Antithrombins|antithrombins|mesh-ancestor
25575080|NCT00811252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25575081|NCT00811252|Dopamine Agents|dopamine agents|mesh-ancestor
25575082|NCT00811252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25575083|NCT00811252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25575084|NCT00811252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25575085|NCT00811252|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25575086|NCT00811252|Serotonin Agents|serotonin agents|mesh-ancestor
25575087|NCT00811252|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25575088|NCT00811252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25575089|NCT00811252|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25575090|NCT00811252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25575091|NCT00811395|Interferons|interferons|mesh-list
25076253|NCT03374540|Coagulants|coagulants|mesh-ancestor
25076254|NCT03374514|Dexamethasone|dexamethasone|mesh-list
25076255|NCT03374514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25076256|NCT03374514|Antiemetics|antiemetics|mesh-ancestor
25076257|NCT03374514|Autonomic Agents|autonomic agents|mesh-ancestor
25076258|NCT03374514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076259|NCT03374514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076260|NCT03374514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25076261|NCT03374514|Glucocorticoids|glucocorticoids|mesh-ancestor
25076262|NCT03374514|Hormones|hormones|mesh-ancestor
25076263|NCT03374514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25076264|NCT03374514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25076265|NCT03374514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25076267|NCT03374501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25076268|NCT03374501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076269|NCT03374345|Juzentaihoto|juzentaihoto|mesh-list
25076270|NCT03374345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25076272|NCT03374345|Mitosis Modulators|mitosis modulators|mesh-ancestor
25076273|NCT03374345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076274|NCT03374306|Atropine|atropine|mesh-list
25575092|NCT00811395|Interferon-beta|interferon-beta|mesh-list
25575093|NCT00811395|Teriflunomide|teriflunomide|mesh-list
25575094|NCT00811395|Glatiramer Acetate|glatiramer acetate|mesh-list
25575095|NCT00811395|Interferon beta-1b|interferon beta-1b|mesh-list
25575096|NCT00811395|(T,G)-A-L|(t,g)-a-l|mesh-list
25575097|NCT00811395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25575098|NCT00811395|Antiviral Agents|antiviral agents|mesh-ancestor
25575099|NCT00811395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25575100|NCT00811395|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25575101|NCT00811395|Immunologic Factors|immunologic factors|mesh-ancestor
25575102|NCT00811395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575103|NCT00811395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25575104|NCT00811395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25575105|NCT00811395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24398924|NCT00146146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515813|NCT00599534|Montelukast|montelukast|mesh-list
25076289|NCT03374306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25076290|NCT03374306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076291|NCT03374306|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25076292|NCT03374306|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25076294|NCT03374293|Immunologic Factors|immunologic factors|mesh-ancestor
25076315|NCT03374007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25076316|NCT03374007|Immunologic Factors|immunologic factors|mesh-ancestor
24447916|NCT00309881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24515832|NCT00599573|Antiemetics|antiemetics|mesh-ancestor
24896607|NCT04434430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896608|NCT04434430|Antimanic Agents|antimanic agents|mesh-ancestor
25699903|NCT02115256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25699904|NCT02115256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699905|NCT02115282|Exemestane|exemestane|mesh-list
25699906|NCT02115282|Goserelin|goserelin|mesh-list
25699907|NCT02115282|Entinostat|entinostat|mesh-list
25699908|NCT02115282|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25699909|NCT02115282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25699910|NCT02115282|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25575106|NCT00811395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25575107|NCT00811395|Analgesics|analgesics|mesh-ancestor
25575108|NCT00811395|Sensory System Agents|sensory system agents|mesh-ancestor
25575109|NCT00811395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25575110|NCT00811395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25575111|NCT00811434|Lactulose|lactulose|mesh-list
25575112|NCT00811434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25575113|NCT00811473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25575114|NCT00811473|Antidepressive Agents|antidepressive agents|mesh-ancestor
25575115|NCT00811473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25575116|NCT00811473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25575117|NCT00811473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24399283|NCT00147355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25076427|NCT03373305|Growth Inhibitors|growth inhibitors|mesh-ancestor
25076349|NCT03373825|Fentanyl|fentanyl|mesh-list
25076350|NCT03373825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25076351|NCT03373825|Narcotics|narcotics|mesh-ancestor
25076352|NCT03373825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25076353|NCT03373825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076354|NCT03373825|Analgesics|analgesics|mesh-ancestor
25076355|NCT03373825|Sensory System Agents|sensory system agents|mesh-ancestor
25076356|NCT03373825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076357|NCT03373825|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25076358|NCT03373825|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25076359|NCT03373825|Anesthetics, General|anesthetics, general|mesh-ancestor
25076360|NCT03373825|Anesthetics|anesthetics|mesh-ancestor
24954408|NCT03876899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24954409|NCT03876899|Analgesics|analgesics|mesh-ancestor
24954410|NCT03876899|Sensory System Agents|sensory system agents|mesh-ancestor
24954411|NCT03876899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24954412|NCT03876899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575118|NCT00811473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25575119|NCT00811473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575120|NCT00811564|Timolol|timolol|mesh-list
25575121|NCT00811564|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25575122|NCT00811564|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25575123|NCT00811564|Latanoprost|latanoprost|mesh-list
25575124|NCT00811564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25575125|NCT00811564|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24811420|NCT02046590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24954457|NCT03876886|Alkylating Agents|alkylating agents|mesh-ancestor
25575126|NCT00811564|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25575127|NCT00811564|Adrenergic Agents|adrenergic agents|mesh-ancestor
25575128|NCT00811564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25575129|NCT00811564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575130|NCT00811564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575131|NCT00811564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25575132|NCT00811564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25575133|NCT00811564|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25575134|NCT00811564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24400435|NCT00150553|Sensory System Agents|sensory system agents|mesh-ancestor
24400436|NCT00150553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24516183|NCT00600873|Antioxidants|antioxidants|mesh-ancestor
24516185|NCT00600873|Protective Agents|protective agents|mesh-ancestor
25076443|NCT03373227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076444|NCT03373227|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25076445|NCT03373227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25076446|NCT03373227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076448|NCT03373149|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25076449|NCT03373149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25076450|NCT03373149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076451|NCT03372850|Esomeprazole|esomeprazole|mesh-list
25076452|NCT03372850|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25076453|NCT03372850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25076474|NCT03372785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076475|NCT03372785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25076476|NCT03372785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25076477|NCT03372785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25575135|NCT00811564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25575136|NCT00811642|Posaconazole|posaconazole|mesh-list
25575137|NCT00811642|Antifungal Agents|antifungal agents|mesh-ancestor
25575138|NCT00811642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25575139|NCT00811642|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25575140|NCT00811642|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25575141|NCT00811642|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25575142|NCT00811642|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25076503|NCT03372681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25076512|NCT03372486|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25076514|NCT03372473|Montelukast|montelukast|mesh-list
25076515|NCT03372473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25076516|NCT03372473|Respiratory System Agents|respiratory system agents|mesh-ancestor
25076517|NCT03372473|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25076518|NCT03372473|Hormone Antagonists|hormone antagonists|mesh-ancestor
25076519|NCT03372473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25076520|NCT03372473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076521|NCT03372473|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25076537|NCT03372447|Vitamins|vitamins|mesh-ancestor
25575143|NCT00811642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25575144|NCT00811642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575145|NCT00811642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575146|NCT00811642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25575147|NCT00811642|Hormone Antagonists|hormone antagonists|mesh-ancestor
25575148|NCT00811642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25575149|NCT00811642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575150|NCT00811720|Nalmefene|nalmefene|mesh-list
24400876|NCT00151541|Dapsone|dapsone|mesh-list
25076568|NCT03372122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25076569|NCT03372122|Disinfectants|disinfectants|mesh-ancestor
25076570|NCT03372122|Dermatologic Agents|dermatologic agents|mesh-ancestor
25076571|NCT03372109|Calcium|calcium|mesh-list
25076572|NCT03372109|Turmeric extract|turmeric extract|mesh-list
25076573|NCT03372109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25076574|NCT03372109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076575|NCT03372109|Antioxidants|antioxidants|mesh-ancestor
25076577|NCT03372109|Protective Agents|protective agents|mesh-ancestor
25575151|NCT00811720|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25575152|NCT00811720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575153|NCT00811720|Sensory System Agents|sensory system agents|mesh-ancestor
25575154|NCT00811720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25575155|NCT00811733|Ofatumumab|ofatumumab|mesh-list
25575156|NCT00811733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25575157|NCT00811850|Timolol|timolol|mesh-list
25575158|NCT00811850|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25575159|NCT00811850|Dorzolamide|dorzolamide|mesh-list
25575160|NCT00811850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25575161|NCT00811850|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25575162|NCT00811850|Maleic acid|maleic acid|mesh-list
25575163|NCT00811850|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24954516|NCT03876574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24954517|NCT03876574|Immunologic Factors|immunologic factors|mesh-ancestor
24954518|NCT03876041|Dexamethasone|dexamethasone|mesh-list
24954519|NCT03876041|Dexamethasone acetate|dexamethasone acetate|mesh-list
24954520|NCT03876041|Methylprednisolone|methylprednisolone|mesh-list
24954521|NCT03876041|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24954522|NCT03876041|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24954526|NCT03876041|Autonomic Agents|autonomic agents|mesh-ancestor
24954527|NCT03876041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24954528|NCT03876041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954529|NCT03876041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24954530|NCT03876041|Glucocorticoids|glucocorticoids|mesh-ancestor
24954531|NCT03876041|Hormones|hormones|mesh-ancestor
25575164|NCT00811850|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25575165|NCT00811850|Adrenergic Agents|adrenergic agents|mesh-ancestor
25575166|NCT00811850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25575167|NCT00811850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575168|NCT00811850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575169|NCT00811850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25575170|NCT00811850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25575171|NCT00811850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575172|NCT00811850|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25575173|NCT00811850|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25575174|NCT00811850|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25575175|NCT00811850|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25575176|NCT00811928|Fluconazole|fluconazole|mesh-list
25076629|NCT03371797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25076630|NCT03371784|Hydrocortisone|hydrocortisone|mesh-list
25076631|NCT03371784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25076632|NCT03371589|Dexamethasone|dexamethasone|mesh-list
25076633|NCT03371589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25076634|NCT03371589|Antiemetics|antiemetics|mesh-ancestor
25076635|NCT03371589|Autonomic Agents|autonomic agents|mesh-ancestor
25076636|NCT03371589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076637|NCT03371589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076638|NCT03371589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25076639|NCT03371589|Glucocorticoids|glucocorticoids|mesh-ancestor
25076640|NCT03371589|Hormones|hormones|mesh-ancestor
25076641|NCT03371589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25076642|NCT03371589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25076643|NCT03371589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25076644|NCT03371563|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24882634|NCT05167175|Glucocorticoids|glucocorticoids|mesh-ancestor
24882635|NCT05167175|Hormones|hormones|mesh-ancestor
25575177|NCT00811928|Posaconazole|posaconazole|mesh-list
25575178|NCT00811928|Antifungal Agents|antifungal agents|mesh-ancestor
25575179|NCT00811928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25575180|NCT00811928|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25575181|NCT00811928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25575182|NCT00811928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575183|NCT00811928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575184|NCT00811928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25575185|NCT00811928|Hormone Antagonists|hormone antagonists|mesh-ancestor
25575186|NCT00811928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25575187|NCT00811928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575188|NCT00811928|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25575189|NCT00811928|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25575190|NCT00811928|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25575191|NCT00811928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25575192|NCT00811928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25575193|NCT00811941|Nalmefene|nalmefene|mesh-list
25575194|NCT00811941|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25575195|NCT00811941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575196|NCT00811941|Sensory System Agents|sensory system agents|mesh-ancestor
25575197|NCT00811941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25575198|NCT00811954|Ritonavir|ritonavir|mesh-list
25575199|NCT00811954|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25575200|NCT00811954|Darunavir|darunavir|mesh-list
25575201|NCT00811954|Tenofovir|tenofovir|mesh-list
25575202|NCT00811954|Emtricitabine|emtricitabine|mesh-list
25575203|NCT00811954|Raltegravir Potassium|raltegravir potassium|mesh-list
25575204|NCT00811954|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25575205|NCT00811954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25469642|NCT00004031|Cyclophosphamide|cyclophosphamide|mesh-list
25575206|NCT00811954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25575207|NCT00811954|Protease Inhibitors|protease inhibitors|mesh-ancestor
24401543|NCT00153192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25076647|NCT03371550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25076648|NCT03371550|Tubulin Modulators|tubulin modulators|mesh-ancestor
25076649|NCT03371550|Antimitotic Agents|antimitotic agents|mesh-ancestor
25076650|NCT03371550|Mitosis Modulators|mitosis modulators|mesh-ancestor
25076651|NCT03371550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076652|NCT03371498|Methylprednisolone|methylprednisolone|mesh-list
25076653|NCT03371498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24882648|NCT05167123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447948|NCT00309894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24447949|NCT00309894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817644|NCT02084732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817646|NCT02084784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817650|NCT02084875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516628|NCT00602615|Diuretics|diuretics|mesh-ancestor
25575208|NCT00811954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575209|NCT00811954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575210|NCT00811954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25575211|NCT00811954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25575212|NCT00811954|Antiviral Agents|antiviral agents|mesh-ancestor
25575213|NCT00811954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25575214|NCT00811954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25575215|NCT00811954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25575216|NCT00811954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25575217|NCT00811954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25575218|NCT00811954|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25575219|NCT00811954|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25575220|NCT00812253|Insulin|insulin|mesh-list
25575221|NCT00812253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25575222|NCT00812253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25575223|NCT00812253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575224|NCT00812331|Simeprevir|simeprevir|mesh-list
25575225|NCT00812331|Antiviral Agents|antiviral agents|mesh-ancestor
25575226|NCT00812331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25575227|NCT00812331|Protease Inhibitors|protease inhibitors|mesh-ancestor
25575228|NCT00812331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575229|NCT00812331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575230|NCT00812461|Nalmefene|nalmefene|mesh-list
25575231|NCT00812461|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25575232|NCT00812461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575233|NCT00812461|Sensory System Agents|sensory system agents|mesh-ancestor
25575234|NCT00812461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25575235|NCT00812487|Insulin|insulin|mesh-list
25575236|NCT00812487|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25575237|NCT00812487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25575238|NCT00812487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575239|NCT00812565|gamma-Globulins|gamma-globulins|mesh-list
24401857|NCT00154141|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24401858|NCT00154141|Hemostatics|hemostatics|mesh-ancestor
24401859|NCT00154141|Coagulants|coagulants|mesh-ancestor
25076680|NCT03371342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25076681|NCT03371186|Contraceptive Agents|contraceptive agents|mesh-list
25076682|NCT03371186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25076683|NCT03371186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076684|NCT03371173|Ferric maltol|ferric maltol|mesh-list
25076685|NCT03371173|Hematinics|hematinics|mesh-ancestor
25575240|NCT00812565|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25575241|NCT00812565|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25575242|NCT00812565|Immunologic Factors|immunologic factors|mesh-ancestor
25575243|NCT00812565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575244|NCT00812604|Analgesics|analgesics|mesh-list
25575245|NCT00812604|Petrolatum|petrolatum|mesh-list
25575246|NCT00812604|Sensory System Agents|sensory system agents|mesh-ancestor
25575247|NCT00812604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25575248|NCT00812604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575249|NCT00812604|Emollients|emollients|mesh-ancestor
25575250|NCT00812604|Dermatologic Agents|dermatologic agents|mesh-ancestor
25575251|NCT00812812|Paroxetine|paroxetine|mesh-list
25575252|NCT00812812|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25575253|NCT00812812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25575254|NCT00812812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25575255|NCT00812812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575256|NCT00812812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25575257|NCT00812812|Serotonin Agents|serotonin agents|mesh-ancestor
25575258|NCT00812812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575259|NCT00812812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25575260|NCT00812812|Antidepressive Agents|antidepressive agents|mesh-ancestor
25076714|NCT03370848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25076715|NCT03370848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25076716|NCT03370848|Analgesics|analgesics|mesh-ancestor
25076717|NCT03370848|Sensory System Agents|sensory system agents|mesh-ancestor
25076718|NCT03370848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076719|NCT03370848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076720|NCT03370848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25076721|NCT03370848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25076722|NCT03370848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25076723|NCT03370848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24882700|NCT05111912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25076724|NCT03370848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076725|NCT03370848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25076726|NCT03370848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25076727|NCT03370848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575261|NCT00812812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25575262|NCT00812812|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25575263|NCT00812812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25575264|NCT00812812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575265|NCT00812838|Botulinum Toxins|botulinum toxins|mesh-list
25575266|NCT00812838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25575267|NCT00812838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25575268|NCT00812838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25575269|NCT00812838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25575270|NCT00812838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575271|NCT00812838|Cholinergic Agents|cholinergic agents|mesh-ancestor
25575272|NCT00812838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25575273|NCT00812838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575274|NCT00812838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25575275|NCT00812838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25575276|NCT00812877|Calcium|calcium|mesh-list
25575277|NCT00812877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25575278|NCT00812877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575279|NCT00812955|Simvastatin|simvastatin|mesh-list
25575280|NCT00812955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25575281|NCT00812955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25575282|NCT00812955|Antimetabolites|antimetabolites|mesh-ancestor
25575283|NCT00812955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575284|NCT00812955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25575285|NCT00812955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25575286|NCT00812955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575287|NCT00812968|Lenalidomide|lenalidomide|mesh-list
25575288|NCT00812968|Immunologic Factors|immunologic factors|mesh-ancestor
25575289|NCT00812968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575290|NCT00812968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24447968|NCT00309920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076752|NCT03370835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24962810|NCT03794843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962811|NCT03794843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24962812|NCT03794843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962814|NCT03794505|Methylprednisolone|methylprednisolone|mesh-list
24962815|NCT03794505|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24962816|NCT03794505|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24962817|NCT03794505|Prednisolone|prednisolone|mesh-list
24962818|NCT03794505|Prednisolone acetate|prednisolone acetate|mesh-list
24962819|NCT03794505|Lidocaine|lidocaine|mesh-list
24962820|NCT03794505|Ropivacaine|ropivacaine|mesh-list
24962821|NCT03794505|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24962822|NCT03794505|Prednisolone phosphate|prednisolone phosphate|mesh-list
24882736|NCT05031078|Lidocaine|lidocaine|mesh-list
25575291|NCT00812968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25575292|NCT00812968|Growth Substances|growth substances|mesh-ancestor
25575293|NCT00812968|Growth Inhibitors|growth inhibitors|mesh-ancestor
25575294|NCT00812968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25575295|NCT00813111|Epinephrine|epinephrine|mesh-list
25575296|NCT00813111|Bupivacaine|bupivacaine|mesh-list
25575297|NCT00813111|Anesthetics, Local|anesthetics, local|mesh-ancestor
25575298|NCT00813111|Anesthetics|anesthetics|mesh-ancestor
25575299|NCT00813111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25575300|NCT00813111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575301|NCT00813111|Sensory System Agents|sensory system agents|mesh-ancestor
25575302|NCT00813111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25575303|NCT00813111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25575304|NCT00813111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25575305|NCT00813111|Adrenergic Agents|adrenergic agents|mesh-ancestor
25575306|NCT00813111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25575307|NCT00813111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575308|NCT00813111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25575309|NCT00813111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25575310|NCT00813111|Autonomic Agents|autonomic agents|mesh-ancestor
25575311|NCT00813111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25575312|NCT00813111|Respiratory System Agents|respiratory system agents|mesh-ancestor
25575313|NCT00813111|Mydriatics|mydriatics|mesh-ancestor
25575314|NCT00813111|Sympathomimetics|sympathomimetics|mesh-ancestor
25575315|NCT00813111|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25575316|NCT00813124|Vidarabine|vidarabine|mesh-list
25575317|NCT00813124|Fludarabine|fludarabine|mesh-list
25575318|NCT00813124|Fludarabine phosphate|fludarabine phosphate|mesh-list
25575319|NCT00813124|Azacitidine|azacitidine|mesh-list
25575320|NCT00813124|Busulfan|busulfan|mesh-list
25575321|NCT00813124|Thymoglobulin|thymoglobulin|mesh-list
25575322|NCT00813124|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25575323|NCT00813124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25575324|NCT00813124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25575325|NCT00813124|Antimetabolites|antimetabolites|mesh-ancestor
25575326|NCT00813124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076775|NCT03370705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25076776|NCT03370705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25076777|NCT03370705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076778|NCT03370705|Analgesics|analgesics|mesh-ancestor
24474450|NCT00406042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24897337|NCT04426097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897338|NCT04425993|Indomethacin|indomethacin|mesh-list
24897339|NCT04425993|Isosorbide|isosorbide|mesh-list
25076779|NCT03370705|Sensory System Agents|sensory system agents|mesh-ancestor
25076786|NCT03370627|Antibodies|antibodies|mesh-list
25076787|NCT03370627|Immunologic Factors|immunologic factors|mesh-ancestor
25076788|NCT03370627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076790|NCT03370601|Azathioprine|azathioprine|mesh-list
25575327|NCT00813124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25575328|NCT00813124|Immunologic Factors|immunologic factors|mesh-ancestor
25575329|NCT00813124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575330|NCT00813124|Antiviral Agents|antiviral agents|mesh-ancestor
25575331|NCT00813124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25575332|NCT00813124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575333|NCT00813124|Alkylating Agents|alkylating agents|mesh-ancestor
25575334|NCT00813124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25575335|NCT00813124|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25575336|NCT00813150|Dexamethasone|dexamethasone|mesh-list
25076791|NCT03370601|Infliximab|infliximab|mesh-list
25076792|NCT03370601|Dermatologic Agents|dermatologic agents|mesh-ancestor
25076793|NCT03370601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25076794|NCT03370601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25076795|NCT03370601|Antimetabolites|antimetabolites|mesh-ancestor
25076796|NCT03370601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076797|NCT03370601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25076798|NCT03370601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25076799|NCT03370601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25076800|NCT03370601|Immunologic Factors|immunologic factors|mesh-ancestor
25076801|NCT03370601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076802|NCT03370601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25076803|NCT03370601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25076804|NCT03370588|Dexmedetomidine|dexmedetomidine|mesh-list
25076805|NCT03370588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25076806|NCT03370588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25076807|NCT03370588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076808|NCT03370588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25076809|NCT03370588|Analgesics|analgesics|mesh-ancestor
25076810|NCT03370588|Sensory System Agents|sensory system agents|mesh-ancestor
25076811|NCT03370588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076812|NCT03370588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25076813|NCT03370588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25076814|NCT03370588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25076815|NCT03370588|Adrenergic Agents|adrenergic agents|mesh-ancestor
25575337|NCT00813150|Cyclophosphamide|cyclophosphamide|mesh-list
25575338|NCT00813150|Bortezomib|bortezomib|mesh-list
25575339|NCT00813150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25575340|NCT00813150|Immunologic Factors|immunologic factors|mesh-ancestor
25575341|NCT00813150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575342|NCT00813150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25575343|NCT00813150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25575344|NCT00813150|Alkylating Agents|alkylating agents|mesh-ancestor
25575345|NCT00813150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575346|NCT00813150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25575347|NCT00813150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25575348|NCT00813150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25575349|NCT00813150|Antiemetics|antiemetics|mesh-ancestor
25575350|NCT00813150|Autonomic Agents|autonomic agents|mesh-ancestor
25575351|NCT00813150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25575352|NCT00813150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25469801|NCT00004228|Antiemetics|antiemetics|mesh-ancestor
25575353|NCT00813150|Glucocorticoids|glucocorticoids|mesh-ancestor
25575354|NCT00813150|Hormones|hormones|mesh-ancestor
25652584|NCT01529346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25076833|NCT03370406|Imiquimod|imiquimod|mesh-list
25076852|NCT03370367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25076853|NCT03370367|Keratolytic Agents|keratolytic agents|mesh-ancestor
25076854|NCT03370367|Dermatologic Agents|dermatologic agents|mesh-ancestor
25076855|NCT03370328|Peppermint oil|peppermint oil|mesh-list
25076856|NCT03370328|Antiemetics|antiemetics|mesh-ancestor
25076857|NCT03370328|Autonomic Agents|autonomic agents|mesh-ancestor
25076858|NCT03370328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076859|NCT03370328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076860|NCT03370328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25076861|NCT03370328|Parasympatholytics|parasympatholytics|mesh-ancestor
24882825|NCT04933682|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24882826|NCT04933682|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24882827|NCT04933682|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25076868|NCT03370159|Thioctic Acid|thioctic acid|mesh-list
25076870|NCT03370159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25076871|NCT03370159|Tubulin Modulators|tubulin modulators|mesh-ancestor
24882850|NCT04928521|Bupivacaine|bupivacaine|mesh-list
25076879|NCT03370159|Vitamins|vitamins|mesh-ancestor
25575355|NCT00813150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25575356|NCT00813150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25575357|NCT00813293|Sorafenib|sorafenib|mesh-list
25575358|NCT00813293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25575359|NCT00813293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25575360|NCT00813293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575361|NCT00813293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954552|NCT03875872|Propofol|propofol|mesh-list
24954553|NCT03875872|Anesthetics|anesthetics|mesh-list
24954554|NCT03875872|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
24954555|NCT03875872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24954556|NCT03875872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24474607|NCT00406887|Glucocorticoids|glucocorticoids|mesh-ancestor
24954557|NCT03875872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780300|NCT01883323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24780301|NCT01883323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24780302|NCT01883323|Alkylating Agents|alkylating agents|mesh-ancestor
24780303|NCT01883323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780304|NCT01883323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24780305|NCT01883323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24780306|NCT01883323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24780307|NCT01883323|Analgesics|analgesics|mesh-ancestor
24780308|NCT01883323|Sensory System Agents|sensory system agents|mesh-ancestor
24780309|NCT01883323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24780310|NCT01883323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24780311|NCT01883323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24780312|NCT01883323|Antiviral Agents|antiviral agents|mesh-ancestor
24780313|NCT01883323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24626521|NCT01087632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626522|NCT01087632|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24626523|NCT01087632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25575362|NCT00813488|Fentanyl|fentanyl|mesh-list
25575363|NCT00813488|Oxycodone|oxycodone|mesh-list
25575364|NCT00813488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25575365|NCT00813488|Narcotics|narcotics|mesh-ancestor
25575366|NCT00813488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25575367|NCT00813488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575368|NCT00813488|Analgesics|analgesics|mesh-ancestor
25575369|NCT00813488|Sensory System Agents|sensory system agents|mesh-ancestor
25575370|NCT00813488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25575371|NCT00813488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25575372|NCT00813488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25575373|NCT00813488|Anesthetics, General|anesthetics, general|mesh-ancestor
25575374|NCT00813488|Anesthetics|anesthetics|mesh-ancestor
25575375|NCT00813592|Pasireotide|pasireotide|mesh-list
25575376|NCT00813592|Hormones|hormones|mesh-ancestor
25575377|NCT00813592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25575378|NCT00813592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575379|NCT00813709|Interferon beta-1a|interferon beta-1a|mesh-list
25575380|NCT00813709|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25575381|NCT00813709|Immunologic Factors|immunologic factors|mesh-ancestor
25575382|NCT00813709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575383|NCT00813709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25575384|NCT00813709|Antiviral Agents|antiviral agents|mesh-ancestor
25575385|NCT00813709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25575386|NCT00813748|Omalizumab|omalizumab|mesh-list
25575387|NCT00813748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25575388|NCT00813748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25575389|NCT00813748|Respiratory System Agents|respiratory system agents|mesh-ancestor
25575390|NCT00813761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25575391|NCT00813800|Varenicline|varenicline|mesh-list
25575392|NCT00813800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25575393|NCT00813800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25575394|NCT00813800|Cholinergic Agents|cholinergic agents|mesh-ancestor
24626524|NCT01087632|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24962983|NCT03794180|Plonmarlimab|plonmarlimab|mesh-list
25076881|NCT03369990|Botulinum Toxins|botulinum toxins|mesh-list
25076882|NCT03369990|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25076883|NCT03369990|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25076889|NCT03369990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076890|NCT03369990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25076891|NCT03369990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076892|NCT03369964|Atezolizumab|atezolizumab|mesh-list
25076893|NCT03369964|Obinutuzumab|obinutuzumab|mesh-list
25575395|NCT00813800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25575396|NCT00813800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575397|NCT00813800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575398|NCT00813917|Varenicline|varenicline|mesh-list
25575399|NCT00813917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25575400|NCT00813917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25575401|NCT00813917|Cholinergic Agents|cholinergic agents|mesh-ancestor
25575402|NCT00813917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25575403|NCT00813917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076931|NCT03369795|Immunologic Factors|immunologic factors|mesh-ancestor
25076932|NCT03369795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25076934|NCT03369782|Rocuronium|rocuronium|mesh-list
25575404|NCT00813917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575405|NCT00813943|Temozolomide|temozolomide|mesh-list
25575406|NCT00813943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25575407|NCT00813943|Alkylating Agents|alkylating agents|mesh-ancestor
25575408|NCT00813943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575409|NCT00813943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25575410|NCT00813995|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25575411|NCT00813995|Metformin|metformin|mesh-list
25575412|NCT00813995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25575413|NCT00813995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575414|NCT00813995|Incretins|incretins|mesh-ancestor
25575415|NCT00813995|Hormones|hormones|mesh-ancestor
25575416|NCT00813995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25575417|NCT00813995|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25575418|NCT00813995|Protease Inhibitors|protease inhibitors|mesh-ancestor
25575419|NCT00813995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575420|NCT00813995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575421|NCT00814138|Methotrexate|methotrexate|mesh-list
25575422|NCT00814138|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25575423|NCT00814138|Abortifacient Agents|abortifacient agents|mesh-ancestor
25575424|NCT00814138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24404137|NCT00162643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404138|NCT00162643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897844|NCT04421300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24897845|NCT04421300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25077032|NCT03368391|Sensory System Agents|sensory system agents|mesh-ancestor
25077033|NCT03368391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25077034|NCT03368391|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25077035|NCT03368391|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25077036|NCT03368391|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25077037|NCT03368391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25077038|NCT03368391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077039|NCT03368391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25077043|NCT03368391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25077044|NCT03368391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25575425|NCT00814138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575426|NCT00814138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25575427|NCT00814138|Antimetabolites|antimetabolites|mesh-ancestor
25575428|NCT00814138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575429|NCT00814138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25575430|NCT00814138|Dermatologic Agents|dermatologic agents|mesh-ancestor
25575431|NCT00814138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575432|NCT00814138|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24404272|NCT00162955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24404273|NCT00162955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24404274|NCT00162955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077070|NCT03368131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25077071|NCT03368131|Antimetabolites|antimetabolites|mesh-ancestor
25077072|NCT03368131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077073|NCT03368131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25077074|NCT03368131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25575433|NCT00814138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25575434|NCT00814138|Immunologic Factors|immunologic factors|mesh-ancestor
25575435|NCT00814138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25575436|NCT00814138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25575437|NCT00814164|Daunorubicin|daunorubicin|mesh-list
25575438|NCT00814164|Clofarabine|clofarabine|mesh-list
25575439|NCT00814164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25575440|NCT00814164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25575441|NCT00814164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25699972|NCT02116309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25699973|NCT02116309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25699974|NCT02116309|Analgesics|analgesics|mesh-ancestor
24516988|NCT00605137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24898078|NCT04418154|Cyclophosphamide|cyclophosphamide|mesh-list
25077138|NCT03367182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25077139|NCT03367182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25077140|NCT03367182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25077141|NCT03367143|Carboplatin|carboplatin|mesh-list
25077143|NCT03367143|Lenalidomide|lenalidomide|mesh-list
25077144|NCT03367143|Ifosfamide|ifosfamide|mesh-list
25077145|NCT03367143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25077146|NCT03367143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25077147|NCT03367143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25077148|NCT03367143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25077149|NCT03367143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25077150|NCT03367143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077151|NCT03367143|Immunologic Factors|immunologic factors|mesh-ancestor
25077152|NCT03367143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077153|NCT03367143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25077157|NCT03367143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25077158|NCT03367143|Alkylating Agents|alkylating agents|mesh-ancestor
25077161|NCT03366974|Clarithromycin|clarithromycin|mesh-list
25077162|NCT03366974|Midazolam|midazolam|mesh-list
25077163|NCT03366974|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25077164|NCT03366974|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24898171|NCT04417452|Adrenergic Agents|adrenergic agents|mesh-list
25077165|NCT03366974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25699975|NCT02116309|Sensory System Agents|sensory system agents|mesh-ancestor
25699976|NCT02116309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25699977|NCT02116309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25699978|NCT02116309|Gout Suppressants|gout suppressants|mesh-ancestor
25575442|NCT00814164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25575443|NCT00814164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575444|NCT00814164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575445|NCT00814164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25575446|NCT00814164|Antimetabolites|antimetabolites|mesh-ancestor
25575447|NCT00814177|Warfarin|warfarin|mesh-list
25575448|NCT00814177|Anticoagulants|anticoagulants|mesh-ancestor
25575449|NCT00814255|Adalimumab|adalimumab|mesh-list
25575450|NCT00814255|Losartan|losartan|mesh-list
25575451|NCT00814255|Lisinopril|lisinopril|mesh-list
25575452|NCT00814255|Atorvastatin|atorvastatin|mesh-list
25575453|NCT00814255|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25575454|NCT00814255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25575455|NCT00814255|Antimetabolites|antimetabolites|mesh-ancestor
24898172|NCT04417452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25077169|NCT03366974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25077170|NCT03366974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25077171|NCT03366974|Anesthetics, General|anesthetics, general|mesh-ancestor
25077172|NCT03366974|Anesthetics|anesthetics|mesh-ancestor
25077173|NCT03366974|GABA Modulators|gaba modulators|mesh-ancestor
25077174|NCT03366974|GABA Agents|gaba agents|mesh-ancestor
25077175|NCT03366974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25077176|NCT03366974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077177|NCT03366974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25077178|NCT03366974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25077179|NCT03366974|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25077180|NCT03366974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25077181|NCT03366974|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25077182|NCT03366974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25077183|NCT03366883|Paclitaxel|paclitaxel|mesh-list
25077184|NCT03366883|Cisplatin|cisplatin|mesh-list
25077185|NCT03366883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25077186|NCT03366883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25575456|NCT00814255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575457|NCT00814255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25575458|NCT00814255|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25575459|NCT00814255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575460|NCT00814255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25575461|NCT00814255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25575462|NCT00814255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25575463|NCT00814255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25575464|NCT00814255|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25575465|NCT00814255|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25575466|NCT00814255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25575467|NCT00814255|Protease Inhibitors|protease inhibitors|mesh-ancestor
25575468|NCT00814255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24954559|NCT03875872|Anesthetics, General|anesthetics, general|mesh-ancestor
24954565|NCT03875274|Morphine|morphine|mesh-list
24954566|NCT03875274|Ropivacaine|ropivacaine|mesh-list
24954567|NCT03875274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24954568|NCT03875274|Narcotics|narcotics|mesh-ancestor
25077209|NCT03366597|Sevoflurane|sevoflurane|mesh-list
25077210|NCT03366597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25077211|NCT03366597|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25077213|NCT03366597|Anesthetics|anesthetics|mesh-ancestor
25077214|NCT03366597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25077215|NCT03366597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077216|NCT03366584|Vitamin D|vitamin d|mesh-list
25077217|NCT03366584|Cholecalciferol|cholecalciferol|mesh-list
25077218|NCT03366584|Beta Carotene|beta carotene|mesh-list
25077219|NCT03366584|Zinc|zinc|mesh-list
25077220|NCT03366584|Dexamethasone|dexamethasone|mesh-list
25077223|NCT03366584|Vitamins|vitamins|mesh-ancestor
25077224|NCT03366584|Micronutrients|micronutrients|mesh-ancestor
25077225|NCT03366584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077226|NCT03366584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25077227|NCT03366584|Antiemetics|antiemetics|mesh-ancestor
24448061|NCT00310128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24448062|NCT00310128|Antiemetics|antiemetics|mesh-ancestor
24448063|NCT00310128|Autonomic Agents|autonomic agents|mesh-ancestor
25575469|NCT00814255|Protective Agents|protective agents|mesh-ancestor
25575470|NCT00814255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575471|NCT00814307|Tofacitinib|tofacitinib|mesh-list
25575472|NCT00814307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25575473|NCT00814307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575474|NCT00814307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575475|NCT00814320|Immunoglobulins|immunoglobulins|mesh-list
25575476|NCT00814320|Antibodies|antibodies|mesh-list
25575477|NCT00814320|gamma-Globulins|gamma-globulins|mesh-list
25575478|NCT00814320|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25575479|NCT00814320|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25575480|NCT00814320|Immunoglobulin G|immunoglobulin g|mesh-list
25575481|NCT00814320|Immunologic Factors|immunologic factors|mesh-ancestor
25575482|NCT00814320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575483|NCT00814502|Zolpidem|zolpidem|mesh-list
25575484|NCT00814502|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25575485|NCT00814502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25575486|NCT00814502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25575487|NCT00814502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575488|NCT00814502|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25575489|NCT00814502|GABA Agonists|gaba agonists|mesh-ancestor
25575490|NCT00814502|GABA Agents|gaba agents|mesh-ancestor
25575491|NCT00814502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25575492|NCT00814502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575493|NCT00814580|Oxycodone|oxycodone|mesh-list
25575494|NCT00814580|Tapentadol|tapentadol|mesh-list
25575495|NCT00814580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25575496|NCT00814580|Narcotics|narcotics|mesh-ancestor
25575497|NCT00814580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25575498|NCT00814580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575499|NCT00814580|Analgesics|analgesics|mesh-ancestor
25575500|NCT00814580|Sensory System Agents|sensory system agents|mesh-ancestor
25575501|NCT00814580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25575502|NCT00814580|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24404442|NCT00163449|Glucocorticoids|glucocorticoids|mesh-ancestor
25575503|NCT00814580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25575504|NCT00814580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25575505|NCT00814580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575506|NCT00814580|Adrenergic Agents|adrenergic agents|mesh-ancestor
25575507|NCT00814580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25575509|NCT00814632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25575510|NCT00814632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25575511|NCT00814632|Analgesics|analgesics|mesh-ancestor
24454565|NCT03878524|Pembrolizumab|pembrolizumab|mesh-list
24454566|NCT03878524|Fluorouracil|fluorouracil|mesh-list
24454567|NCT03878524|Capecitabine|capecitabine|mesh-list
25077270|NCT03366246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25077271|NCT03366246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077272|NCT03366246|Sensory System Agents|sensory system agents|mesh-ancestor
25077273|NCT03366246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25077274|NCT03366246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25077295|NCT03365999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077296|NCT03365999|Hemostatics|hemostatics|mesh-ancestor
25077297|NCT03365999|Coagulants|coagulants|mesh-ancestor
25077298|NCT03365869|Sirolimus|sirolimus|mesh-list
24883220|NCT04297293|Serotonin Agents|serotonin agents|mesh-ancestor
25077299|NCT03365869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25077300|NCT03365869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25077301|NCT03365869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25077302|NCT03365869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25077303|NCT03365869|Antifungal Agents|antifungal agents|mesh-ancestor
25077304|NCT03365869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25077305|NCT03365869|Immunologic Factors|immunologic factors|mesh-ancestor
25077306|NCT03365869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077307|NCT03365817|Fentanyl|fentanyl|mesh-list
25077308|NCT03365817|Morphine|morphine|mesh-list
25077309|NCT03365817|Oxycodone|oxycodone|mesh-list
25077313|NCT03365817|Narcotics|narcotics|mesh-ancestor
25077314|NCT03365817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25077315|NCT03365817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077316|NCT03365817|Analgesics|analgesics|mesh-ancestor
25077317|NCT03365817|Sensory System Agents|sensory system agents|mesh-ancestor
25077318|NCT03365817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25077319|NCT03365817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25077322|NCT03365817|Anesthetics|anesthetics|mesh-ancestor
25575512|NCT00814632|Sensory System Agents|sensory system agents|mesh-ancestor
25575513|NCT00814632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25575514|NCT00814632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575515|NCT00814632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25575516|NCT00814632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25575517|NCT00814632|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25575518|NCT00814632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25575519|NCT00814632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575520|NCT00814632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575521|NCT00814658|Nimodipine|nimodipine|mesh-list
25575522|NCT00814658|Galantamine|galantamine|mesh-list
25575523|NCT00814658|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25575524|NCT00814658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575525|NCT00814658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575526|NCT00814658|Cholinergic Agents|cholinergic agents|mesh-ancestor
25575527|NCT00814658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25575528|NCT00814658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077326|NCT03365765|Oxaliplatin|oxaliplatin|mesh-list
25077327|NCT03365765|Apatinib|apatinib|mesh-list
25077328|NCT03365765|Antimetabolites|antimetabolites|mesh-ancestor
24883262|NCT04167761|Ertugliflozin|ertugliflozin|mesh-list
24883263|NCT04167761|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25077361|NCT03365466|Analgesics|analgesics|mesh-ancestor
25077329|NCT03365765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077330|NCT03365765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25077331|NCT03365765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25077332|NCT03365765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25077333|NCT03365765|Immunologic Factors|immunologic factors|mesh-ancestor
25077334|NCT03365765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077335|NCT03365765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25077336|NCT03365765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25077337|NCT03365726|Dobutamine|dobutamine|mesh-list
25077338|NCT03365726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25077339|NCT03365726|Sympathomimetics|sympathomimetics|mesh-ancestor
25077340|NCT03365726|Autonomic Agents|autonomic agents|mesh-ancestor
25077341|NCT03365726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25077342|NCT03365726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077343|NCT03365726|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25077344|NCT03365726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25077345|NCT03365726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25077346|NCT03365726|Adrenergic Agents|adrenergic agents|mesh-ancestor
25077347|NCT03365726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25575529|NCT00814658|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25575530|NCT00814658|Autonomic Agents|autonomic agents|mesh-ancestor
25575531|NCT00814658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25575532|NCT00814658|Nootropic Agents|nootropic agents|mesh-ancestor
25575533|NCT00814658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25575534|NCT00814658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25575535|NCT00814658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25575536|NCT00814658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25575537|NCT00814658|Vasodilator Agents|vasodilator agents|mesh-ancestor
25652585|NCT01529346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652586|NCT01529502|Nitric Oxide|nitric oxide|mesh-list
25652587|NCT01529502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25077356|NCT03365466|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25077357|NCT03365466|Tinzaparin|tinzaparin|mesh-list
25077358|NCT03365466|Dalteparin|dalteparin|mesh-list
25077359|NCT03365466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25077360|NCT03365466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25077362|NCT03365466|Sensory System Agents|sensory system agents|mesh-ancestor
25077363|NCT03365466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25077364|NCT03365466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077365|NCT03365466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25077366|NCT03365466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25077367|NCT03365466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25077368|NCT03365466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25077369|NCT03365466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077370|NCT03365466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25077376|NCT03365388|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25652588|NCT01529502|Autonomic Agents|autonomic agents|mesh-ancestor
25652589|NCT01529502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25652590|NCT01529502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652591|NCT01529502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25652592|NCT01529502|Respiratory System Agents|respiratory system agents|mesh-ancestor
25652593|NCT01529502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25652594|NCT01529502|Antioxidants|antioxidants|mesh-ancestor
25652595|NCT01529502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652596|NCT01529502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25077394|NCT03365141|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25077395|NCT03365141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25077396|NCT03365141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077397|NCT03365141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25077398|NCT03365141|Glucocorticoids|glucocorticoids|mesh-ancestor
25077399|NCT03365141|Hormones|hormones|mesh-ancestor
25077400|NCT03365141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25077401|NCT03365115|Fentanyl|fentanyl|mesh-list
25077402|NCT03365115|Morphine|morphine|mesh-list
25077403|NCT03365115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24454617|NCT03878524|Micronutrients|micronutrients|mesh-ancestor
24454618|NCT03878524|Immunologic Factors|immunologic factors|mesh-ancestor
24476198|NCT00413439|Isavuconazole|isavuconazole|mesh-list
24454619|NCT03878524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24454620|NCT03878524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24454621|NCT03878524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24454633|NCT03878524|Antifungal Agents|antifungal agents|mesh-ancestor
24789389|NCT01936961|Antibodies|antibodies|mesh-list
25652597|NCT01529502|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25652598|NCT01529502|Vasodilator Agents|vasodilator agents|mesh-ancestor
25652599|NCT01529502|Gasotransmitters|gasotransmitters|mesh-ancestor
25652600|NCT01529502|Protective Agents|protective agents|mesh-ancestor
25652601|NCT01529515|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25652602|NCT01529515|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25652603|NCT01529515|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25652604|NCT01529515|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25652605|NCT01529632|Glycopyrrolate|glycopyrrolate|mesh-list
25652606|NCT01529632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25652607|NCT01529632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25652608|NCT01529632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25652609|NCT01529632|Cholinergic Agents|cholinergic agents|mesh-ancestor
25652610|NCT01529632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25652611|NCT01529632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652612|NCT01529632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652613|NCT01529645|Vaccines|vaccines|mesh-list
25652614|NCT01529645|Immunologic Factors|immunologic factors|mesh-ancestor
25652615|NCT01529645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652616|NCT01529749|Raltegravir Potassium|raltegravir potassium|mesh-list
25652617|NCT01529749|Losartan|losartan|mesh-list
25652618|NCT01529749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25652619|NCT01529749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25077438|NCT03364764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24954581|NCT03874832|Dihydroergotamine|dihydroergotamine|mesh-list
24518200|NCT05330273|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24518201|NCT05330273|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24518202|NCT05330273|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24518223|NCT05330065|Growth Substances|growth substances|mesh-ancestor
24518224|NCT05330065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077443|NCT03364764|Immunologic Factors|immunologic factors|mesh-ancestor
25077444|NCT03364764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963502|NCT03790228|Carboplatin|carboplatin|mesh-list
24954569|NCT03875274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24954570|NCT03875274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954571|NCT03875274|Analgesics|analgesics|mesh-ancestor
25652620|NCT01529749|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25652621|NCT01529749|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25652622|NCT01529749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652623|NCT01529749|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25575538|NCT00814671|Rifampin|rifampin|mesh-list
25575539|NCT00814671|Rifapentine|rifapentine|mesh-list
25575540|NCT00814671|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25575541|NCT00814671|Antitubercular Agents|antitubercular agents|mesh-ancestor
25575542|NCT00814671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25575543|NCT00814671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25575544|NCT00814671|Leprostatic Agents|leprostatic agents|mesh-ancestor
25575545|NCT00814671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25575546|NCT00814671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899527|NCT04403321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899528|NCT04403321|Antifungal Agents|antifungal agents|mesh-ancestor
24899529|NCT04403321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24899530|NCT04403321|Dermatologic Agents|dermatologic agents|mesh-ancestor
24899531|NCT04403321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24954572|NCT03875274|Sensory System Agents|sensory system agents|mesh-ancestor
24954573|NCT03875274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24954574|NCT03875274|Anesthetics, Local|anesthetics, local|mesh-ancestor
24954575|NCT03875274|Anesthetics|anesthetics|mesh-ancestor
24954576|NCT03874975|Vitamin D|vitamin d|mesh-list
24954577|NCT03874975|Vitamins|vitamins|mesh-ancestor
24954578|NCT03874975|Micronutrients|micronutrients|mesh-ancestor
24954579|NCT03874975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954580|NCT03874975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24954582|NCT03874832|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24954583|NCT03874832|Dopamine Agonists|dopamine agonists|mesh-ancestor
25575547|NCT00814671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575548|NCT00814671|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25575549|NCT00814671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25575550|NCT00814671|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25575551|NCT00814671|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25575552|NCT00814671|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25575553|NCT00814671|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25575554|NCT00814710|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24540470|NCT00668044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24540471|NCT00668057|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24540472|NCT00668057|Vasodilator Agents|vasodilator agents|mesh-ancestor
24404992|NCT00165230|Immunologic Factors|immunologic factors|mesh-ancestor
24404993|NCT00165230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404994|NCT00165230|Leprostatic Agents|leprostatic agents|mesh-ancestor
24404997|NCT00165230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24899593|NCT04402320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722466|NCT01580865|Mycophenolic Acid|mycophenolic acid|mesh-list
24899596|NCT04402359|Avibactam|avibactam|mesh-list
24954586|NCT03874832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954587|NCT03874832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954588|NCT03874832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24954590|NCT03874832|Sensory System Agents|sensory system agents|mesh-ancestor
24954591|NCT03874832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24954592|NCT03874884|Olaparib|olaparib|mesh-list
24954593|NCT03874884|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24954594|NCT03874884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24954595|NCT03874884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575555|NCT00814710|Immunologic Factors|immunologic factors|mesh-ancestor
25575556|NCT00814710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575557|NCT00814788|Everolimus|everolimus|mesh-list
25575558|NCT00814788|Bicalutamide|bicalutamide|mesh-list
25575559|NCT00814788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25575560|NCT00814788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25575561|NCT00814788|Immunologic Factors|immunologic factors|mesh-ancestor
25575562|NCT00814788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575563|NCT00814788|Androgen Antagonists|androgen antagonists|mesh-ancestor
25575564|NCT00814788|Hormone Antagonists|hormone antagonists|mesh-ancestor
25575565|NCT00814788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25575566|NCT00814801|Galantamine|galantamine|mesh-list
25575567|NCT00814801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25575568|NCT00814801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24954614|NCT03874585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954616|NCT03874364|Anesthetics, Local|anesthetics, local|mesh-ancestor
24954617|NCT03874364|Anesthetics|anesthetics|mesh-ancestor
24963577|NCT03789890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25077445|NCT03364569|Tranexamic Acid|tranexamic acid|mesh-list
25077446|NCT03364569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25077447|NCT03364569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25077448|NCT03364569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077449|NCT03364569|Hemostatics|hemostatics|mesh-ancestor
24817904|NCT02086019|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24817907|NCT02086019|Analgesics|analgesics|mesh-ancestor
25077461|NCT03364530|Immunologic Factors|immunologic factors|mesh-ancestor
25077462|NCT03364530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077463|NCT03364348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25077464|NCT03364348|Trastuzumab|trastuzumab|mesh-list
25077465|NCT03364348|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25077467|NCT03364348|Antibodies|antibodies|mesh-list
25077468|NCT03364348|Immunoglobulins|immunoglobulins|mesh-list
24454716|NCT03769532|Pembrolizumab|pembrolizumab|mesh-list
24454717|NCT03769532|Azacitidine|azacitidine|mesh-list
24454718|NCT03769532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24454719|NCT03769532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24454720|NCT03769532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24454721|NCT03769532|Antimetabolites|antimetabolites|mesh-ancestor
24454722|NCT03769532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24454723|NCT03769532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24454724|NCT03769311|Cetuximab|cetuximab|mesh-list
24405137|NCT00165555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811614|NCT02047422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24454725|NCT03769311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25077470|NCT03364348|Immunoconjugates|immunoconjugates|mesh-list
25077471|NCT03364348|Immunoglobulin G|immunoglobulin g|mesh-list
25077472|NCT03364348|Immunologic Factors|immunologic factors|mesh-ancestor
25077473|NCT03364348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077474|NCT03364348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25575569|NCT00814801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575570|NCT00814801|Cholinergic Agents|cholinergic agents|mesh-ancestor
25575571|NCT00814801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25575572|NCT00814801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575573|NCT00814801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25575574|NCT00814801|Autonomic Agents|autonomic agents|mesh-ancestor
25575575|NCT00814801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25575576|NCT00814801|Nootropic Agents|nootropic agents|mesh-ancestor
25575577|NCT00814879|Raltegravir Potassium|raltegravir potassium|mesh-list
25575578|NCT00814879|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25575579|NCT00814879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25575580|NCT00814879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25575581|NCT00814879|Antiviral Agents|antiviral agents|mesh-ancestor
25575582|NCT00814879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25575583|NCT00814879|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25575584|NCT00814879|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25575585|NCT00814879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575586|NCT00814879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575587|NCT00814879|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25575588|NCT00814879|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25575589|NCT00814879|Protease Inhibitors|protease inhibitors|mesh-ancestor
25575590|NCT00815295|Cetuximab|cetuximab|mesh-list
25575591|NCT00815295|Sorafenib|sorafenib|mesh-list
25575592|NCT00815295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25575593|NCT00815295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25575594|NCT00815295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25575595|NCT00815295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575596|NCT00815295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575597|NCT00815308|Paclitaxel|paclitaxel|mesh-list
25575598|NCT00815308|Cisplatin|cisplatin|mesh-list
25575599|NCT00815308|Cetuximab|cetuximab|mesh-list
25077506|NCT03364075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25077507|NCT03364075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077508|NCT03364075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24900532|NCT04393025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25077509|NCT03364075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077510|NCT03364075|Analgesics|analgesics|mesh-ancestor
25077511|NCT03364075|Sensory System Agents|sensory system agents|mesh-ancestor
24818035|NCT02086656|Antimetabolites|antimetabolites|mesh-ancestor
25575600|NCT00815308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25575601|NCT00815308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25575602|NCT00815308|Tubulin Modulators|tubulin modulators|mesh-ancestor
25470089|NCT00006101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25470090|NCT00006101|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
25470091|NCT00006101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470092|NCT00006101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540609|NCT00668616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24540610|NCT00668616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24540611|NCT00668616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24540612|NCT00668616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25077512|NCT03364075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25077513|NCT03364075|Antidepressive Agents|antidepressive agents|mesh-ancestor
25077514|NCT03364075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25077515|NCT03364075|Dopamine Agents|dopamine agents|mesh-ancestor
25077516|NCT03364075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25077517|NCT03364075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25077518|NCT03364075|Adrenergic Agents|adrenergic agents|mesh-ancestor
25077519|NCT03364075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25077520|NCT03364075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25077521|NCT03364075|Vasodilator Agents|vasodilator agents|mesh-ancestor
25077524|NCT03363984|Midazolam|midazolam|mesh-list
24883490|NCT05239390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883491|NCT05239390|Hormones|hormones|mesh-ancestor
24518674|NCT04559906|Anesthetics|anesthetics|mesh-ancestor
25077525|NCT03363984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25077526|NCT03363984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24901084|NCT04388774|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24901085|NCT04388774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24901086|NCT04388774|Anesthetics, General|anesthetics, general|mesh-ancestor
24901106|NCT04388904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25699998|NCT02116530|Olanzapine|olanzapine|mesh-list
25699999|NCT02116530|Aprepitant|aprepitant|mesh-list
25700000|NCT02116530|Fosaprepitant|fosaprepitant|mesh-list
25700001|NCT02116530|Palonosetron|palonosetron|mesh-list
25700002|NCT02116530|Granisetron|granisetron|mesh-list
25700003|NCT02116530|Antiemetics|antiemetics|mesh-list
25575603|NCT00815308|Antimitotic Agents|antimitotic agents|mesh-ancestor
25575604|NCT00815308|Mitosis Modulators|mitosis modulators|mesh-ancestor
25575605|NCT00815308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575606|NCT00815308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25575607|NCT00815347|Bosentan|bosentan|mesh-list
25575608|NCT00815347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25575609|NCT00815347|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25575610|NCT00815347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575611|NCT00815360|Triamcinolone|triamcinolone|mesh-list
25575612|NCT00815360|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25575613|NCT00815360|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25575614|NCT00815360|Ranibizumab|ranibizumab|mesh-list
25575615|NCT00815360|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25575616|NCT00815360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25575617|NCT00815360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25575618|NCT00815360|Growth Substances|growth substances|mesh-ancestor
25575619|NCT00815360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575620|NCT00815360|Growth Inhibitors|growth inhibitors|mesh-ancestor
25575621|NCT00815360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25575622|NCT00815360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25575623|NCT00815360|Glucocorticoids|glucocorticoids|mesh-ancestor
25575624|NCT00815360|Hormones|hormones|mesh-ancestor
25575625|NCT00815360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25575626|NCT00815360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25575627|NCT00815360|Immunologic Factors|immunologic factors|mesh-ancestor
25575628|NCT00815360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575629|NCT00815360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575630|NCT00815516|Amphotericin B|amphotericin b|mesh-list
25575631|NCT00815516|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25575632|NCT00815516|Micafungin|micafungin|mesh-list
25575633|NCT00815516|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
25575634|NCT00815516|Deoxycholic Acid|deoxycholic acid|mesh-list
24901107|NCT04388904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24454813|NCT03535350|Temozolomide|temozolomide|mesh-list
25077538|NCT03363984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077539|NCT03363867|Bevacizumab|bevacizumab|mesh-list
25077540|NCT03363867|Atezolizumab|atezolizumab|mesh-list
25077541|NCT03363867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25077542|NCT03363867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25077544|NCT03363867|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25077545|NCT03363867|Growth Substances|growth substances|mesh-ancestor
25077546|NCT03363867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077547|NCT03363867|Growth Inhibitors|growth inhibitors|mesh-ancestor
25077549|NCT03363841|Antifungal Agents|antifungal agents|mesh-ancestor
25077550|NCT03363841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25077551|NCT03363815|Vitamin K|vitamin k|mesh-list
25077553|NCT03363815|Nintedanib|nintedanib|mesh-list
25077554|NCT03363815|Digoxin|digoxin|mesh-list
25077555|NCT03363815|Midazolam|midazolam|mesh-list
25575635|NCT00815516|Amebicides|amebicides|mesh-ancestor
25575636|NCT00815516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25575637|NCT00815516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25575638|NCT00815516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25575639|NCT00815516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25575640|NCT00815516|Antifungal Agents|antifungal agents|mesh-ancestor
25575641|NCT00815516|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25575642|NCT00815516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25575643|NCT00815659|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25575644|NCT00815659|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25575645|NCT00815659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25575646|NCT00815659|Antimetabolites|antimetabolites|mesh-ancestor
25575647|NCT00815659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575648|NCT00815659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25575649|NCT00815659|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25575650|NCT00815659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575651|NCT00815919|Prednisone|prednisone|mesh-list
25575652|NCT00815919|Bortezomib|bortezomib|mesh-list
24454837|NCT03474029|Rifapentine|rifapentine|mesh-list
24454838|NCT03474029|Isoniazid|isoniazid|mesh-list
25077575|NCT03363815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077576|NCT03363815|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25077577|NCT03363815|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25077578|NCT03363815|Antimetabolites|antimetabolites|mesh-ancestor
25077579|NCT03363815|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25077580|NCT03363815|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25077581|NCT03363815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25077582|NCT03363815|Anticoagulants|anticoagulants|mesh-ancestor
25077583|NCT03363815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25077584|NCT03363815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24519058|NCT03594552|Baclofen|baclofen|mesh-list
25077585|NCT03363815|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25077586|NCT03363815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25077587|NCT03363815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24901444|NCT04385407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901445|NCT04384744|Hormones|hormones|mesh-list
24901446|NCT04384744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24901448|NCT04384783|Hormones|hormones|mesh-list
25077588|NCT03363815|Protective Agents|protective agents|mesh-ancestor
25077589|NCT03363815|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25575653|NCT00815919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25575654|NCT00815919|Glucocorticoids|glucocorticoids|mesh-ancestor
25575655|NCT00815919|Hormones|hormones|mesh-ancestor
25575656|NCT00815919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25575657|NCT00815919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575658|NCT00815919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25575659|NCT00815919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25575660|NCT00816023|Ecallantide|ecallantide|mesh-list
25077590|NCT03363815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25077591|NCT03363815|Hemostatics|hemostatics|mesh-ancestor
25077592|NCT03363815|Coagulants|coagulants|mesh-ancestor
25077593|NCT03363815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25077594|NCT03363815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25077607|NCT03363659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25077608|NCT03363477|Enoxaparin|enoxaparin|mesh-list
24901477|NCT04384458|Hydroxychloroquine|hydroxychloroquine|mesh-list
24448144|NCT00310505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24448145|NCT00310505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24448146|NCT00310505|Antifungal Agents|antifungal agents|mesh-ancestor
25077609|NCT03363477|Enoxaparin sodium|enoxaparin sodium|mesh-list
25077610|NCT03363477|Anticoagulants|anticoagulants|mesh-ancestor
25077611|NCT03363477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25077612|NCT03363477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25077613|NCT03363477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077614|NCT03363451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25077615|NCT03363451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25077616|NCT03363425|Lidocaine|lidocaine|mesh-list
25077617|NCT03363425|Dexmedetomidine|dexmedetomidine|mesh-list
25077618|NCT03363425|Anesthetics, Local|anesthetics, local|mesh-ancestor
25077619|NCT03363425|Anesthetics|anesthetics|mesh-ancestor
25077620|NCT03363425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25077621|NCT03363425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077622|NCT03363425|Sensory System Agents|sensory system agents|mesh-ancestor
25077623|NCT03363425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25077624|NCT03363425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25077625|NCT03363425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25575661|NCT00816023|Analgesics|analgesics|mesh-ancestor
25575662|NCT00816023|Sensory System Agents|sensory system agents|mesh-ancestor
25575663|NCT00816023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25575664|NCT00816023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575665|NCT00816023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25575666|NCT00816023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25575667|NCT00816023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25575668|NCT00816023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25575669|NCT00816101|Anti-Infective Agents|anti-infective agents|mesh-list
25575670|NCT00816101|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25575671|NCT00816166|Aspirin|aspirin|mesh-list
25575672|NCT00816166|Clopidogrel|clopidogrel|mesh-list
25575673|NCT00816166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25575674|NCT00816166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25575675|NCT00816166|Analgesics|analgesics|mesh-ancestor
25575676|NCT00816166|Sensory System Agents|sensory system agents|mesh-ancestor
25575677|NCT00816166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25575678|NCT00816166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575679|NCT00816166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25575680|NCT00816166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25575681|NCT00816166|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25575682|NCT00816166|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25575683|NCT00816166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575684|NCT00816166|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25575685|NCT00816166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25575686|NCT00816166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575687|NCT00816166|Antipyretics|antipyretics|mesh-ancestor
25575688|NCT00816166|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24405702|NCT00167960|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24405703|NCT00167960|Lactams|lactams|mesh-list
24405704|NCT00167960|beta-Lactams|beta-lactams|mesh-list
25077647|NCT03363204|Antifungal Agents|antifungal agents|mesh-ancestor
25077648|NCT03363204|Keratolytic Agents|keratolytic agents|mesh-ancestor
25077649|NCT03363204|Dermatologic Agents|dermatologic agents|mesh-ancestor
25077650|NCT03363191|Fluticasone|fluticasone|mesh-list
25077651|NCT03363191|Xhance|xhance|mesh-list
25077652|NCT03363191|Albuterol|albuterol|mesh-list
25077653|NCT03363191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25077654|NCT03363191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25077655|NCT03363191|Autonomic Agents|autonomic agents|mesh-ancestor
25077656|NCT03363191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25077657|NCT03363191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077658|NCT03363191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25575689|NCT00816166|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25575690|NCT00816166|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25575691|NCT00816166|Purinergic Agents|purinergic agents|mesh-ancestor
25575692|NCT00816166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25575693|NCT00816556|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25575694|NCT00816556|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25575695|NCT00816556|Estradiol|estradiol|mesh-list
25575696|NCT00816556|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25575697|NCT00816556|Estrogens|estrogens|mesh-ancestor
25575698|NCT00816556|Hormones|hormones|mesh-ancestor
25575699|NCT00816556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25575700|NCT00816556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575701|NCT00816556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25575702|NCT00816556|Contraceptive Agents|contraceptive agents|mesh-ancestor
25575703|NCT00816556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25575704|NCT00816556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25575705|NCT00816595|Cyclophosphamide|cyclophosphamide|mesh-list
25575706|NCT00816595|Bevacizumab|bevacizumab|mesh-list
25575707|NCT00816595|Rituximab|rituximab|mesh-list
25575708|NCT00816595|Pentostatin|pentostatin|mesh-list
25575709|NCT00816595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25575710|NCT00816595|Immunologic Factors|immunologic factors|mesh-ancestor
24448288|NCT00311038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25077701|NCT03362814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25077702|NCT03362814|Protease Inhibitors|protease inhibitors|mesh-ancestor
25077703|NCT03362814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24883669|NCT05214183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25077704|NCT03362814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077705|NCT03362814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25077706|NCT03362814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25077707|NCT03362814|Antiviral Agents|antiviral agents|mesh-ancestor
25077708|NCT03362814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24859498|NCT02303899|Gemcitabine|gemcitabine|mesh-list
25077709|NCT03362814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25077710|NCT03362814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25077711|NCT03362814|Antimetabolites|antimetabolites|mesh-ancestor
24883675|NCT05181527|Dextromethorphan|dextromethorphan|mesh-list
25575711|NCT00816595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575712|NCT00816595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25575713|NCT00816595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25575714|NCT00816595|Alkylating Agents|alkylating agents|mesh-ancestor
25575715|NCT00816595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575716|NCT00816595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25575717|NCT00816595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25575718|NCT00816595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24811815|NCT02048423|Anesthetics, General|anesthetics, general|mesh-ancestor
25077712|NCT03362814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25077713|NCT03362788|Vitamin K|vitamin k|mesh-list
25077714|NCT03362788|Anticoagulants|anticoagulants|mesh-list
25077715|NCT03362788|Vitamins|vitamins|mesh-ancestor
25077716|NCT03362788|Micronutrients|micronutrients|mesh-ancestor
25077717|NCT03362788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077718|NCT03362788|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25077721|NCT03362788|Hemostatics|hemostatics|mesh-ancestor
25575719|NCT00816595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25575720|NCT00816595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25575721|NCT00816595|Growth Substances|growth substances|mesh-ancestor
25575722|NCT00816595|Growth Inhibitors|growth inhibitors|mesh-ancestor
25575723|NCT00816595|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25575724|NCT00816595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575725|NCT00816751|Lidocaine|lidocaine|mesh-list
25575726|NCT00816751|Vasopressins|vasopressins|mesh-list
25575727|NCT00816751|Arginine Vasopressin|arginine vasopressin|mesh-list
25575728|NCT00816751|Anesthetics, Local|anesthetics, local|mesh-ancestor
25575729|NCT00816751|Anesthetics|anesthetics|mesh-ancestor
25575730|NCT00816751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25575731|NCT00816751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575732|NCT00816751|Sensory System Agents|sensory system agents|mesh-ancestor
25575733|NCT00816751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25077792|NCT03362073|Anesthetics, General|anesthetics, general|mesh-ancestor
25077793|NCT03362073|Anesthetics|anesthetics|mesh-ancestor
25077794|NCT03362073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25077799|NCT03362060|Pembrolizumab|pembrolizumab|mesh-list
24954624|NCT03874364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24954625|NCT03874364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24954626|NCT03874364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954628|NCT03874273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24954629|NCT03874273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25077802|NCT03362047|Macitentan|macitentan|mesh-list
25077803|NCT03362047|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25077804|NCT03362047|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25077805|NCT03362047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077806|NCT03362047|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25077807|NCT03362008|Varenicline|varenicline|mesh-list
25077808|NCT03362008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25077814|NCT03361878|Metformin|metformin|mesh-list
24818225|NCT02087527|Autonomic Agents|autonomic agents|mesh-ancestor
24818226|NCT02087527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24902415|NCT04374071|Glucocorticoids|glucocorticoids|mesh-ancestor
24406065|NCT00169065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24406066|NCT00169065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24448397|NCT00311636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24902532|NCT04372264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25575734|NCT00816751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25575735|NCT00816751|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25575736|NCT00816751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25575737|NCT00816751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25575738|NCT00816751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575739|NCT00816751|Hemostatics|hemostatics|mesh-ancestor
25575740|NCT00816751|Coagulants|coagulants|mesh-ancestor
24902533|NCT04372264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24902534|NCT04372264|Analgesics|analgesics|mesh-ancestor
24902535|NCT04372264|Sensory System Agents|sensory system agents|mesh-ancestor
24902536|NCT04372264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24902561|NCT04371874|Aspirin|aspirin|mesh-list
24448398|NCT00311636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24448399|NCT00311636|Abortifacient Agents|abortifacient agents|mesh-ancestor
24448400|NCT00311636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24448401|NCT00311636|Dermatologic Agents|dermatologic agents|mesh-ancestor
24448403|NCT00311636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24954630|NCT03874273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25077837|NCT03361709|Dexamethasone|dexamethasone|mesh-list
25077838|NCT03361709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25077839|NCT03361709|Antiemetics|antiemetics|mesh-ancestor
25077840|NCT03361709|Autonomic Agents|autonomic agents|mesh-ancestor
24902575|NCT04371874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902576|NCT04371874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24902675|NCT04371224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902676|NCT04371224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25077848|NCT03361709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24883791|NCT04770012|Clopidogrel|clopidogrel|mesh-list
24454941|NCT03161353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25575741|NCT00816751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25575742|NCT00816751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25575743|NCT00816751|Natriuretic Agents|natriuretic agents|mesh-ancestor
25575744|NCT00816829|Fenofibrate|fenofibrate|mesh-list
25575745|NCT00816829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25575746|NCT00816829|Antimetabolites|antimetabolites|mesh-ancestor
25575747|NCT00816829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575748|NCT00816829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25575749|NCT00816907|Metformin|metformin|mesh-list
25575750|NCT00816907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25575751|NCT00816907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575752|NCT00817063|Alitretinoin|alitretinoin|mesh-list
25575753|NCT00817063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25575754|NCT00817063|Dermatologic Agents|dermatologic agents|mesh-ancestor
25575755|NCT00817089|Naltrexone|naltrexone|mesh-list
25575756|NCT00817089|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25575757|NCT00817089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24811942|NCT02048943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24552018|NCT04254627|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24902777|NCT04370431|Edaravone|edaravone|mesh-list
25077859|NCT03361397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25077860|NCT03361397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25077861|NCT03361397|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25077862|NCT03361397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25077863|NCT03361397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25077864|NCT03361397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077865|NCT03361319|Paclitaxel|paclitaxel|mesh-list
25077866|NCT03361319|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25077867|NCT03361319|Nintedanib|nintedanib|mesh-list
25077868|NCT03361319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24883814|NCT04760626|Insulin Glargine|insulin glargine|mesh-list
25077873|NCT03361319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077874|NCT03361319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25077875|NCT03361319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25077876|NCT03361280|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25077877|NCT03361280|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25077878|NCT03361280|Adrenergic Agents|adrenergic agents|mesh-ancestor
25077879|NCT03361280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25077880|NCT03361280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575758|NCT00817089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575759|NCT00817089|Sensory System Agents|sensory system agents|mesh-ancestor
25575760|NCT00817089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25575762|NCT00817206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25575763|NCT00817206|Immunologic Factors|immunologic factors|mesh-ancestor
25575764|NCT00817206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575765|NCT00817206|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25575766|NCT00817206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575767|NCT00817206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575768|NCT00817219|Betamethasone|betamethasone|mesh-list
25575769|NCT00817219|Betamethasone Valerate|betamethasone valerate|mesh-list
25575770|NCT00817219|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25575771|NCT00817219|Betamethasone benzoate|betamethasone benzoate|mesh-list
25575772|NCT00817219|Calcipotriene|calcipotriene|mesh-list
25575773|NCT00817219|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25575774|NCT00817219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25575775|NCT00817219|Glucocorticoids|glucocorticoids|mesh-ancestor
25575776|NCT00817219|Hormones|hormones|mesh-ancestor
25575777|NCT00817219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25077921|NCT03360760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077922|NCT03360760|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25077924|NCT03360760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25077925|NCT03360760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077926|NCT03360760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25077927|NCT03360760|Antimetabolites|antimetabolites|mesh-ancestor
25077928|NCT03360760|Dermatologic Agents|dermatologic agents|mesh-ancestor
25077929|NCT03360760|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25077930|NCT03360760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25077931|NCT03360760|Immunologic Factors|immunologic factors|mesh-ancestor
25077932|NCT03360760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25077933|NCT03360760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25077934|NCT03360760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25077935|NCT03360760|Alkylating Agents|alkylating agents|mesh-ancestor
25077936|NCT03360734|Cetuximab|cetuximab|mesh-list
25077937|NCT03360734|Panitumumab|panitumumab|mesh-list
24903297|NCT04364945|Anesthetics, General|anesthetics, general|mesh-ancestor
25077949|NCT03360682|Antiviral Agents|antiviral agents|mesh-ancestor
25077950|NCT03360682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25077951|NCT03360682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25077952|NCT03360682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25077953|NCT03360682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24883893|NCT04567992|Bupivacaine|bupivacaine|mesh-list
25575778|NCT00817219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575779|NCT00817219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25575780|NCT00817219|Respiratory System Agents|respiratory system agents|mesh-ancestor
25575781|NCT00817219|Dermatologic Agents|dermatologic agents|mesh-ancestor
25575782|NCT00817479|Dexamethasone|dexamethasone|mesh-list
25575783|NCT00817479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25575784|NCT00817479|Antiemetics|antiemetics|mesh-ancestor
25575785|NCT00817479|Autonomic Agents|autonomic agents|mesh-ancestor
25575786|NCT00817479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25575787|NCT00817479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575788|NCT00817479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25575789|NCT00817479|Glucocorticoids|glucocorticoids|mesh-ancestor
25575790|NCT00817479|Hormones|hormones|mesh-ancestor
25575791|NCT00817479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25575792|NCT00817479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25575793|NCT00817479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25575794|NCT00817531|Dasatinib|dasatinib|mesh-list
25575795|NCT00817531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700045|NCT02116608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25700046|NCT02116608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25700047|NCT02116608|Dermatologic Agents|dermatologic agents|mesh-ancestor
25700048|NCT02116660|Ritonavir|ritonavir|mesh-list
24406328|NCT00169728|Vaccines|vaccines|mesh-list
25077954|NCT03360682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077955|NCT03360682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25077956|NCT03360682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25077961|NCT03360279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25077962|NCT03360279|Tubulin Modulators|tubulin modulators|mesh-ancestor
25077963|NCT03360279|Antimitotic Agents|antimitotic agents|mesh-ancestor
25077964|NCT03360279|Mitosis Modulators|mitosis modulators|mesh-ancestor
25077965|NCT03360279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077966|NCT03360266|Listerine|listerine|mesh-list
25077967|NCT03360266|Fluorides|fluorides|mesh-list
25077968|NCT03360266|Sodium Fluoride|sodium fluoride|mesh-list
25077969|NCT03360266|Fluorides, Topical|fluorides, topical|mesh-list
25077970|NCT03360266|Cariostatic Agents|cariostatic agents|mesh-ancestor
24883913|NCT04501211|Granisetron|granisetron|mesh-list
25077973|NCT03360266|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25077974|NCT03360266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25077975|NCT03360123|Midazolam|midazolam|mesh-list
25077976|NCT03360123|Triazolam|triazolam|mesh-list
25077977|NCT03360123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25077978|NCT03360123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24904109|NCT04358627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24904110|NCT04358627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24904111|NCT04358627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575796|NCT00817531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25575797|NCT00817531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575798|NCT00817531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575799|NCT00817635|Eplerenone|eplerenone|mesh-list
25575800|NCT00817635|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25575801|NCT00817635|Hormone Antagonists|hormone antagonists|mesh-ancestor
25575802|NCT00817635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25575803|NCT00817635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575804|NCT00817635|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25575805|NCT00817635|Diuretics|diuretics|mesh-ancestor
25470295|NCT05345808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24406425|NCT00170209|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24904144|NCT04358367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904145|NCT04358367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24904146|NCT04358367|Analgesics|analgesics|mesh-ancestor
24904147|NCT04358367|Sensory System Agents|sensory system agents|mesh-ancestor
24904225|NCT04358016|Terlipressin|terlipressin|mesh-list
24904226|NCT04358016|Somatostatin|somatostatin|mesh-list
24904227|NCT04358016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24904228|NCT04358016|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24904230|NCT04358016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24904232|NCT04357522|Vaccines|vaccines|mesh-list
25077979|NCT03360123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25077980|NCT03360123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077982|NCT03360123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25077983|NCT03360123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25077984|NCT03360123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25077985|NCT03360123|Anesthetics, General|anesthetics, general|mesh-ancestor
25077986|NCT03360123|Anesthetics|anesthetics|mesh-ancestor
25077987|NCT03360123|GABA Modulators|gaba modulators|mesh-ancestor
25077988|NCT03360123|GABA Agents|gaba agents|mesh-ancestor
24883928|NCT04435808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904598|NCT04354805|Antiemetics|antiemetics|mesh-ancestor
25700050|NCT02116660|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25700051|NCT02116660|Darunavir|darunavir|mesh-list
25700052|NCT02116660|Tenofovir|tenofovir|mesh-list
25700053|NCT02116660|Lamivudine|lamivudine|mesh-list
25700054|NCT02116660|Emtricitabine|emtricitabine|mesh-list
25700055|NCT02116660|Raltegravir Potassium|raltegravir potassium|mesh-list
25700056|NCT02116660|Nevirapine|nevirapine|mesh-list
25700057|NCT02116660|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25700058|NCT02116660|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25470296|NCT05345808|Immunologic Factors|immunologic factors|mesh-ancestor
25470297|NCT05345808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470298|NCT05345808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470299|NCT05345639|Ropivacaine|ropivacaine|mesh-list
25470300|NCT05345639|Anesthetics|anesthetics|mesh-ancestor
25470301|NCT05345639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25470302|NCT05345639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470303|NCT05345639|Anesthetics, Local|anesthetics, local|mesh-ancestor
25470304|NCT05345639|Sensory System Agents|sensory system agents|mesh-ancestor
24562910|NCT00768859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24562911|NCT00768911|Temozolomide|temozolomide|mesh-list
24563213|NCT00770666|Bupropion|bupropion|mesh-list
24563355|NCT00771303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25077998|NCT03359967|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25077999|NCT03359967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25078000|NCT03359967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078001|NCT03359876|Warfarin|warfarin|mesh-list
25078002|NCT03359876|Rivaroxaban|rivaroxaban|mesh-list
25078003|NCT03359876|Anticoagulants|anticoagulants|mesh-ancestor
25078004|NCT03359876|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25078005|NCT03359876|Antithrombins|antithrombins|mesh-ancestor
25078024|NCT03359837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078025|NCT03359798|Narcotics|narcotics|mesh-list
25078026|NCT03359798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25078027|NCT03359798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700059|NCT02116660|Protease Inhibitors|protease inhibitors|mesh-ancestor
25700060|NCT02116660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700061|NCT02116660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700062|NCT02116660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25700063|NCT02116660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25700064|NCT02116660|Antiviral Agents|antiviral agents|mesh-ancestor
25700065|NCT02116660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25700066|NCT02116660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25470305|NCT05345639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25470306|NCT05345574|Dexmedetomidine|dexmedetomidine|mesh-list
25575806|NCT00817635|Natriuretic Agents|natriuretic agents|mesh-ancestor
25575807|NCT00817635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25470307|NCT05345574|Remifentanil|remifentanil|mesh-list
25470331|NCT05334056|Cocaine|cocaine|mesh-list
25575808|NCT00817843|Simvastatin|simvastatin|mesh-list
25575809|NCT00817843|Ezetimibe|ezetimibe|mesh-list
25575810|NCT00817843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25575811|NCT00817843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25575812|NCT00817843|Antimetabolites|antimetabolites|mesh-ancestor
25575813|NCT00817843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575814|NCT00817843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25575815|NCT00817843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24406597|NCT00170872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25078028|NCT03359798|Analgesics|analgesics|mesh-ancestor
25078029|NCT03359798|Sensory System Agents|sensory system agents|mesh-ancestor
25078030|NCT03359798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078031|NCT03359746|Grazoprevir|grazoprevir|mesh-list
25078032|NCT03359746|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25078033|NCT03359746|Antiviral Agents|antiviral agents|mesh-ancestor
25078034|NCT03359746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25078035|NCT03359694|Docetaxel|docetaxel|mesh-list
25078036|NCT03359694|Doxorubicin|doxorubicin|mesh-list
24883975|NCT03861039|Tirzepatide|tirzepatide|mesh-list
24505115|NCT00539968|Lonafarnib|lonafarnib|mesh-list
25078037|NCT03359694|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25078038|NCT03359694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25078039|NCT03359694|Tubulin Modulators|tubulin modulators|mesh-ancestor
24905246|NCT04349228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24905247|NCT04349410|Interferons|interferons|mesh-list
24905248|NCT04349410|Interferon-alpha|interferon-alpha|mesh-list
24905249|NCT04349410|Interferon alpha-2|interferon alpha-2|mesh-list
25078040|NCT03359694|Antimitotic Agents|antimitotic agents|mesh-ancestor
25078041|NCT03359694|Mitosis Modulators|mitosis modulators|mesh-ancestor
25078042|NCT03359694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706379|NCT01489917|Heparin|heparin|mesh-list
25078063|NCT03359655|Antiemetics|antiemetics|mesh-ancestor
25078064|NCT03359655|Autonomic Agents|autonomic agents|mesh-ancestor
25078065|NCT03359655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25700067|NCT02116660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25078066|NCT03359655|Mydriatics|mydriatics|mesh-ancestor
25078067|NCT03359655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25078068|NCT03359655|Cholinergic Agents|cholinergic agents|mesh-ancestor
25078069|NCT03359655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25078070|NCT03359655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575816|NCT00817843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575817|NCT00817999|Clopidogrel|clopidogrel|mesh-list
25575818|NCT00817999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25575819|NCT00817999|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25575820|NCT00817999|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25575821|NCT00817999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25575822|NCT00817999|Purinergic Agents|purinergic agents|mesh-ancestor
25575823|NCT00817999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25575824|NCT00817999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575825|NCT00817999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575826|NCT00818168|Infliximab|infliximab|mesh-list
25575827|NCT00818168|Dermatologic Agents|dermatologic agents|mesh-ancestor
25575828|NCT00818168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25575829|NCT00818168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25575830|NCT00818259|Dexamethasone|dexamethasone|mesh-list
25078071|NCT03359655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25078072|NCT03359655|Parasympatholytics|parasympatholytics|mesh-ancestor
25078073|NCT03359525|Tranexamic Acid|tranexamic acid|mesh-list
25078074|NCT03359525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25078075|NCT03359525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25078076|NCT03359525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078077|NCT03359525|Hemostatics|hemostatics|mesh-ancestor
25078078|NCT03359525|Coagulants|coagulants|mesh-ancestor
25078079|NCT03359499|Trimebutine|trimebutine|mesh-list
25078080|NCT03359499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25078081|NCT03359499|Parasympatholytics|parasympatholytics|mesh-ancestor
25078082|NCT03359499|Autonomic Agents|autonomic agents|mesh-ancestor
25078083|NCT03359499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078084|NCT03359499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954631|NCT03874273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954633|NCT03874130|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24954634|NCT03874130|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24954635|NCT03874130|Antiemetics|antiemetics|mesh-ancestor
24954636|NCT03874130|Autonomic Agents|autonomic agents|mesh-ancestor
24954637|NCT03874130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24954638|NCT03874130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954639|NCT03874130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24954640|NCT03874130|Mydriatics|mydriatics|mesh-ancestor
24954647|NCT03874260|Fenofibrate|fenofibrate|mesh-list
25575831|NCT00818259|Ondansetron|ondansetron|mesh-list
25575832|NCT00818259|Aprepitant|aprepitant|mesh-list
25575833|NCT00818259|Fosaprepitant|fosaprepitant|mesh-list
25575834|NCT00818259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25575835|NCT00818259|Antiemetics|antiemetics|mesh-ancestor
25575836|NCT00818259|Autonomic Agents|autonomic agents|mesh-ancestor
25575837|NCT00818259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25575838|NCT00818259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575839|NCT00818259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25575840|NCT00818259|Glucocorticoids|glucocorticoids|mesh-ancestor
25575841|NCT00818259|Hormones|hormones|mesh-ancestor
25575842|NCT00818259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25575843|NCT00818259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25575844|NCT00818259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25575845|NCT00818259|Antipruritics|antipruritics|mesh-ancestor
25575846|NCT00818259|Dermatologic Agents|dermatologic agents|mesh-ancestor
25575847|NCT00818259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25575848|NCT00818259|Serotonin Agents|serotonin agents|mesh-ancestor
25575849|NCT00818259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25575850|NCT00818259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575851|NCT00818259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25575852|NCT00818259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25575853|NCT00818259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25575854|NCT00818259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25078086|NCT03359291|Macitentan|macitentan|mesh-list
25078087|NCT03359291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25078088|NCT03359291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25078089|NCT03359291|Antimetabolites|antimetabolites|mesh-ancestor
25078090|NCT03359291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078091|NCT03359291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25078092|NCT03359291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25078093|NCT03359291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078094|NCT03359291|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25078095|NCT03359291|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25078096|NCT03359291|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25078097|NCT03359161|Furosemide|furosemide|mesh-list
25078098|NCT03359161|Diuretics|diuretics|mesh-ancestor
25575855|NCT00818259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25575856|NCT00818259|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25575857|NCT00818272|Infliximab|infliximab|mesh-list
25575858|NCT00818272|Dermatologic Agents|dermatologic agents|mesh-ancestor
25575859|NCT00818272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25575860|NCT00818272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25575861|NCT00818324|Rebamipide|rebamipide|mesh-list
25575862|NCT00818324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25575863|NCT00818324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25575864|NCT00818324|Antioxidants|antioxidants|mesh-ancestor
25575865|NCT00818324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575866|NCT00818324|Protective Agents|protective agents|mesh-ancestor
25575867|NCT00818324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575868|NCT00818324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575869|NCT00818337|Aspirin|aspirin|mesh-list
25575870|NCT00818337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25575871|NCT00818337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25575872|NCT00818337|Analgesics|analgesics|mesh-ancestor
25575873|NCT00818337|Sensory System Agents|sensory system agents|mesh-ancestor
25575874|NCT00818337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25575875|NCT00818337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575876|NCT00818337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25575877|NCT00818337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25575878|NCT00818337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25575879|NCT00818337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25575880|NCT00818337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575881|NCT00818337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25575882|NCT00818337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25700068|NCT02116660|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24407123|NCT00171912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700069|NCT02116660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24954664|NCT03874156|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24954665|NCT03874156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24954668|NCT03873974|Immunologic Factors|immunologic factors|mesh-ancestor
24954669|NCT03873974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954671|NCT03873298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24954672|NCT03873298|Autonomic Agents|autonomic agents|mesh-ancestor
24954673|NCT03873298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24954674|NCT03873298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954675|NCT03873298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24954676|NCT03873298|Respiratory System Agents|respiratory system agents|mesh-ancestor
25700070|NCT02116660|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25700071|NCT02116660|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25700072|NCT02116660|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25700073|NCT02116660|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25700074|NCT02116777|Temozolomide|temozolomide|mesh-list
25700075|NCT02116777|Talazoparib|talazoparib|mesh-list
25700076|NCT02116777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25575883|NCT00818337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575884|NCT00818337|Antipyretics|antipyretics|mesh-ancestor
25575885|NCT00818363|Bupivacaine|bupivacaine|mesh-list
25575886|NCT00818363|Anesthetics, Local|anesthetics, local|mesh-ancestor
25575887|NCT00818363|Anesthetics|anesthetics|mesh-ancestor
25575888|NCT00818363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25575889|NCT00818363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575890|NCT00818363|Sensory System Agents|sensory system agents|mesh-ancestor
25575891|NCT00818363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25575892|NCT00818389|Riluzole|riluzole|mesh-list
25575893|NCT00818389|Lithium Carbonate|lithium carbonate|mesh-list
25575894|NCT00818389|Antidepressive Agents|antidepressive agents|mesh-ancestor
25575895|NCT00818389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25575896|NCT00818389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575897|NCT00818389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575898|NCT00818389|Antimanic Agents|antimanic agents|mesh-ancestor
25575899|NCT00818389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24407332|NCT00174317|Diclofenac|diclofenac|mesh-list
24954677|NCT03873298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24954685|NCT03873740|Vaccines|vaccines|mesh-list
24954686|NCT03873740|Immunologic Factors|immunologic factors|mesh-ancestor
24954687|NCT03873740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954688|NCT03873025|Pembrolizumab|pembrolizumab|mesh-list
24954689|NCT03873025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24954690|NCT03873025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24954691|NCT03872661|Bevacizumab|bevacizumab|mesh-list
24954692|NCT03872661|Carboplatin|carboplatin|mesh-list
24954693|NCT03872661|Pemetrexed|pemetrexed|mesh-list
24954694|NCT03872661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24954695|NCT03872661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25575900|NCT00818389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25575901|NCT00818389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575902|NCT00818389|Anticonvulsants|anticonvulsants|mesh-ancestor
25575903|NCT00818389|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25575904|NCT00818389|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25575905|NCT00818389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25575906|NCT00818389|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25575907|NCT00818389|Protective Agents|protective agents|mesh-ancestor
25575908|NCT00818454|Albuterol|albuterol|mesh-list
25575909|NCT00818454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25575910|NCT00818454|Autonomic Agents|autonomic agents|mesh-ancestor
25575911|NCT00818454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25575912|NCT00818454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575913|NCT00818454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25575914|NCT00818454|Respiratory System Agents|respiratory system agents|mesh-ancestor
25575915|NCT00818454|Tocolytic Agents|tocolytic agents|mesh-ancestor
25575916|NCT00818454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25575917|NCT00818454|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25575918|NCT00818454|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25575919|NCT00818454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25575920|NCT00818454|Adrenergic Agents|adrenergic agents|mesh-ancestor
25575921|NCT00818454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25575922|NCT00818454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575923|NCT00818519|Drospirenone|drospirenone|mesh-list
25575924|NCT00818519|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25575925|NCT00818519|Hormone Antagonists|hormone antagonists|mesh-ancestor
25575926|NCT00818519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25575927|NCT00818519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575928|NCT00818519|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25700085|NCT02116803|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25700086|NCT02116803|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24954724|NCT03872570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24954725|NCT03872570|Mydriatics|mydriatics|mesh-ancestor
24954726|NCT03872570|Autonomic Agents|autonomic agents|mesh-ancestor
24954727|NCT03872570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24907166|NCT04332393|Metformin|metformin|mesh-list
24907330|NCT04331197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24907331|NCT04331197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907332|NCT04331197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24907333|NCT04331197|Fertility Agents|fertility agents|mesh-ancestor
24907334|NCT04331197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24907336|NCT04331197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25700087|NCT02116803|Hormone Antagonists|hormone antagonists|mesh-ancestor
25700088|NCT02116803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25575929|NCT00818519|Diuretics|diuretics|mesh-ancestor
25575930|NCT00818519|Natriuretic Agents|natriuretic agents|mesh-ancestor
25575931|NCT00818649|Bortezomib|bortezomib|mesh-list
25575932|NCT00818649|Vorinostat|vorinostat|mesh-list
25575933|NCT00818649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25575934|NCT00818649|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25575935|NCT00818649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575936|NCT00818649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575937|NCT00818662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25575938|NCT00818662|Immunoglobulins|immunoglobulins|mesh-list
25575939|NCT00818662|Antibodies|antibodies|mesh-list
25575940|NCT00818662|gamma-Globulins|gamma-globulins|mesh-list
25575941|NCT00818662|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25575942|NCT00818662|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25575943|NCT00818662|Immunoglobulin G|immunoglobulin g|mesh-list
25575944|NCT00818662|Immunologic Factors|immunologic factors|mesh-ancestor
25575945|NCT00818662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575946|NCT00818753|Heparin|heparin|mesh-list
25575947|NCT00818753|Calcium heparin|calcium heparin|mesh-list
25575948|NCT00818753|Dabigatran|dabigatran|mesh-list
25575949|NCT00818753|Anticoagulants|anticoagulants|mesh-ancestor
25575950|NCT00818753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25575951|NCT00818753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25575952|NCT00818753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575953|NCT00818753|Antithrombins|antithrombins|mesh-ancestor
25575954|NCT00818753|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25575955|NCT00818753|Protease Inhibitors|protease inhibitors|mesh-ancestor
25575956|NCT00818753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25575957|NCT00818766|Vancomycin|vancomycin|mesh-list
25575958|NCT00818766|Cefazolin|cefazolin|mesh-list
25575959|NCT00818766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25575960|NCT00818766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25575961|NCT00818779|Amlodipine|amlodipine|mesh-list
25575962|NCT00818779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25575963|NCT00818779|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25575964|NCT00818779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25575965|NCT00818779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575966|NCT00818779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25575967|NCT00818779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575968|NCT00818779|Vasodilator Agents|vasodilator agents|mesh-ancestor
25575969|NCT00818805|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25575970|NCT00818805|Tranilast|tranilast|mesh-list
24407623|NCT00174876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24907418|NCT04330300|Losartan|losartan|mesh-list
25575971|NCT00818805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25575972|NCT00818805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25575973|NCT00818805|Analgesics|analgesics|mesh-ancestor
25575974|NCT00818805|Sensory System Agents|sensory system agents|mesh-ancestor
25575975|NCT00818805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25575976|NCT00818805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575977|NCT00818805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25575978|NCT00818805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25575979|NCT00818805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25575980|NCT00818805|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25575981|NCT00818805|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25575982|NCT00818805|Histamine Antagonists|histamine antagonists|mesh-ancestor
25575983|NCT00818805|Histamine Agents|histamine agents|mesh-ancestor
25575984|NCT00818805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25575985|NCT00818805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25575986|NCT00818805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25575987|NCT00818805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25575988|NCT00818805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25575989|NCT00818805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25575990|NCT00818883|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25575991|NCT00818883|Chlorthalidone|chlorthalidone|mesh-list
25575992|NCT00818883|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25575993|NCT00818883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25575994|NCT00818883|Diuretics|diuretics|mesh-ancestor
25575995|NCT00818883|Natriuretic Agents|natriuretic agents|mesh-ancestor
25575996|NCT00818883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25575997|NCT00818883|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25575998|NCT00818883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25575999|NCT00818883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576000|NCT00818883|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25576001|NCT00818883|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25576002|NCT00818961|Cyclophosphamide|cyclophosphamide|mesh-list
25576003|NCT00818961|Busulfan|busulfan|mesh-list
25576004|NCT00818961|Rituximab|rituximab|mesh-list
25576005|NCT00818961|Methotrexate|methotrexate|mesh-list
25576006|NCT00818961|Fludarabine|fludarabine|mesh-list
25576007|NCT00818961|Fludarabine phosphate|fludarabine phosphate|mesh-list
25576008|NCT00818961|Alemtuzumab|alemtuzumab|mesh-list
25576009|NCT00818961|Tacrolimus|tacrolimus|mesh-list
25576010|NCT00818961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24954743|NCT03872505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24954744|NCT03872505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24954745|NCT03872505|Tubulin Modulators|tubulin modulators|mesh-ancestor
24505117|NCT00539968|Tubulin Modulators|tubulin modulators|mesh-ancestor
24907653|NCT04329000|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24907654|NCT04329000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907655|NCT04329000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448669|NCT00312546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25576011|NCT00818961|Immunologic Factors|immunologic factors|mesh-ancestor
25576012|NCT00818961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576013|NCT00818961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25576014|NCT00818961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25576015|NCT00818961|Alkylating Agents|alkylating agents|mesh-ancestor
25576016|NCT00818961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576017|NCT00818961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576018|NCT00818961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25576019|NCT00818961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25576020|NCT00818961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25576021|NCT00818961|Abortifacient Agents|abortifacient agents|mesh-ancestor
25576022|NCT00818961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25576023|NCT00818961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25576024|NCT00818961|Antimetabolites|antimetabolites|mesh-ancestor
25576025|NCT00818961|Dermatologic Agents|dermatologic agents|mesh-ancestor
25576026|NCT00818961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576027|NCT00818961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25576028|NCT00818961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25576029|NCT00818961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25576030|NCT00819013|Vaccines|vaccines|mesh-list
25576031|NCT00819013|Immunologic Factors|immunologic factors|mesh-ancestor
25576032|NCT00819013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576033|NCT00819039|Ondansetron|ondansetron|mesh-list
25576034|NCT00819039|Aprepitant|aprepitant|mesh-list
25576035|NCT00819039|Antiemetics|antiemetics|mesh-ancestor
25576036|NCT00819039|Autonomic Agents|autonomic agents|mesh-ancestor
25576037|NCT00819039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25576038|NCT00819039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576039|NCT00819039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25576040|NCT00819039|Antipruritics|antipruritics|mesh-ancestor
25576041|NCT00819039|Dermatologic Agents|dermatologic agents|mesh-ancestor
25470502|NCT04110145|Linaclotide|linaclotide|mesh-list
25470571|NCT03884556|Immunologic Factors|immunologic factors|mesh-ancestor
25470572|NCT03884556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470573|NCT03884556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25470574|NCT03859869|Pancrelipase|pancrelipase|mesh-list
25470575|NCT03859869|Pancreatin|pancreatin|mesh-list
25470576|NCT03859869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25470577|NCT03836105|Cemiplimab|cemiplimab|mesh-list
25470578|NCT03836105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25470579|NCT03836105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429898|NCT00245401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24954768|NCT03873532|Capecitabine|capecitabine|mesh-list
24954769|NCT03873532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24954770|NCT03873532|Antimetabolites|antimetabolites|mesh-ancestor
24954771|NCT03873532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954772|NCT03873532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24954773|NCT03872232|Telmisartan|telmisartan|mesh-list
24954774|NCT03872232|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24954775|NCT03872232|Ezetimibe|ezetimibe|mesh-list
24954781|NCT03872232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25078140|NCT03359018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25078141|NCT03359018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429899|NCT00245401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24429900|NCT00245401|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25822723|NCT00004585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24430009|NCT00245791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24430010|NCT00245791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24430011|NCT00245791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430012|NCT00245791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430014|NCT00245791|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24430015|NCT00245791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24430016|NCT00245895|Darbepoetin alfa|darbepoetin alfa|mesh-list
24430017|NCT00245895|Hematinics|hematinics|mesh-ancestor
24430197|NCT00246389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430332|NCT00247130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430335|NCT00247169|Hormones|hormones|mesh-ancestor
24430336|NCT00247169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24430337|NCT00247169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430338|NCT00247208|Paclitaxel|paclitaxel|mesh-list
24430339|NCT00247208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24430340|NCT00247208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24430341|NCT00247208|Tubulin Modulators|tubulin modulators|mesh-ancestor
24430342|NCT00247208|Antimitotic Agents|antimitotic agents|mesh-ancestor
24430343|NCT00247208|Mitosis Modulators|mitosis modulators|mesh-ancestor
24430344|NCT00247208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430345|NCT00247247|Entacapone|entacapone|mesh-list
24430346|NCT00247247|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24430347|NCT00247247|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24430348|NCT00247247|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24430875|NCT00249509|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24430876|NCT00249509|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24430877|NCT00249509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24430878|NCT00249509|Serotonin Agents|serotonin agents|mesh-ancestor
24430879|NCT00249574|Buprenorphine|buprenorphine|mesh-list
24430880|NCT00249574|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
24430882|NCT00249574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24430883|NCT00249574|Narcotics|narcotics|mesh-ancestor
24430884|NCT00249574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24430885|NCT00249574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430897|NCT00249587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24430898|NCT00249587|Antitussive Agents|antitussive agents|mesh-ancestor
24430899|NCT00249587|Respiratory System Agents|respiratory system agents|mesh-ancestor
24430900|NCT00249691|Topiramate|topiramate|mesh-list
24430901|NCT00249691|Anticonvulsants|anticonvulsants|mesh-ancestor
24430902|NCT00249691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24979670|NCT03032510|Ofloxacin|ofloxacin|mesh-list
24430938|NCT00249847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24430939|NCT00249847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430940|NCT00249847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430941|NCT00249847|Serotonin Agents|serotonin agents|mesh-ancestor
24430942|NCT00249847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24430943|NCT00249847|Antidepressive Agents|antidepressive agents|mesh-ancestor
24430944|NCT00249847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24979499|NCT04133623|Sensory System Agents|sensory system agents|mesh-ancestor
25576042|NCT00819039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25576043|NCT00819039|Serotonin Agents|serotonin agents|mesh-ancestor
24954798|NCT03872011|Hydrocortisone|hydrocortisone|mesh-list
24954799|NCT03872011|Micronutrients|micronutrients|mesh-ancestor
25576044|NCT00819039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25576045|NCT00819039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576046|NCT00819039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25576047|NCT00819039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25576048|NCT00819039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25576049|NCT00819039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25576050|NCT00819039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25576051|NCT00819039|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25700089|NCT02116803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954823|NCT03871803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954824|NCT03871517|Aspirin|aspirin|mesh-list
24954825|NCT03871517|Indobufen|indobufen|mesh-list
24954826|NCT03871517|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24954827|NCT03871517|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24954828|NCT03871517|Analgesics|analgesics|mesh-ancestor
24954829|NCT03871517|Sensory System Agents|sensory system agents|mesh-ancestor
24954830|NCT03871517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24954831|NCT03871517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954832|NCT03871517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24954840|NCT03871517|Antipyretics|antipyretics|mesh-ancestor
25576052|NCT00819052|Nevirapine|nevirapine|mesh-list
25576053|NCT00819052|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25576054|NCT00819052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25576055|NCT00819052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576056|NCT00819052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576057|NCT00819052|Antiviral Agents|antiviral agents|mesh-ancestor
25576058|NCT00819052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25576059|NCT00819052|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25576060|NCT00819052|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25576061|NCT00819052|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25576062|NCT00819052|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25576063|NCT00819091|Linagliptin|linagliptin|mesh-list
25576064|NCT00819091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25576065|NCT00819091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576066|NCT00819091|Incretins|incretins|mesh-ancestor
25576067|NCT00819091|Hormones|hormones|mesh-ancestor
25576068|NCT00819091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25576069|NCT00819091|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25576070|NCT00819091|Protease Inhibitors|protease inhibitors|mesh-ancestor
25576071|NCT00819091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576072|NCT00819091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576073|NCT00819234|Pramlintide|pramlintide|mesh-list
25576074|NCT00819234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25576075|NCT00819234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576076|NCT00819390|Chloroquine|chloroquine|mesh-list
24954869|NCT03871478|Sensory System Agents|sensory system agents|mesh-ancestor
24954870|NCT03871478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24954872|NCT03871478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24954873|NCT03871478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24954874|NCT03871478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24954875|NCT03871478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954876|NCT03871062|Anesthetics|anesthetics|mesh-list
24954877|NCT03871062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24954878|NCT03871062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954879|NCT03871114|Triamcinolone|triamcinolone|mesh-list
24954880|NCT03871114|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24954881|NCT03871114|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24954883|NCT03871114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24954884|NCT03871114|Glucocorticoids|glucocorticoids|mesh-ancestor
24954885|NCT03871114|Hormones|hormones|mesh-ancestor
24954886|NCT03871114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24484242|NCT00447304|Moxifloxacin|moxifloxacin|mesh-list
24954887|NCT03871114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954902|NCT03870828|Dimercaprol|dimercaprol|mesh-list
24954903|NCT03870828|Chelating Agents|chelating agents|mesh-ancestor
24954904|NCT03870828|Sequestering Agents|sequestering agents|mesh-ancestor
25576077|NCT00819390|Amebicides|amebicides|mesh-ancestor
25576078|NCT00819390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25576079|NCT00819390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25576080|NCT00819390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25576081|NCT00819390|Antimalarials|antimalarials|mesh-ancestor
25576082|NCT00819390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25576083|NCT00819403|Simvastatin|simvastatin|mesh-list
25576084|NCT00819403|Ezetimibe|ezetimibe|mesh-list
25576085|NCT00819403|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
25576086|NCT00819403|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25576087|NCT00819403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25576088|NCT00819403|Antimetabolites|antimetabolites|mesh-ancestor
25576089|NCT00819403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576090|NCT00819403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25576091|NCT00819403|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25576092|NCT00819403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576093|NCT00819507|Fluocinonide|fluocinonide|mesh-list
25576094|NCT00819507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25576095|NCT00819507|Glucocorticoids|glucocorticoids|mesh-ancestor
25576096|NCT00819507|Hormones|hormones|mesh-ancestor
25576097|NCT00819507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25576098|NCT00819507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576099|NCT00819507|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25576100|NCT00819585|Colchicine|colchicine|mesh-list
25576101|NCT00819585|Allopurinol|allopurinol|mesh-list
25576102|NCT00819585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25576103|NCT00819585|Gout Suppressants|gout suppressants|mesh-ancestor
25576104|NCT00819585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25576105|NCT00819585|Tubulin Modulators|tubulin modulators|mesh-ancestor
25576106|NCT00819585|Antimitotic Agents|antimitotic agents|mesh-ancestor
25576107|NCT00819585|Mitosis Modulators|mitosis modulators|mesh-ancestor
25576108|NCT00819585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576109|NCT00819585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576110|NCT00819585|Antimetabolites|antimetabolites|mesh-ancestor
25576111|NCT00819585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576112|NCT00819585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25576113|NCT00819585|Antioxidants|antioxidants|mesh-ancestor
25576114|NCT00819585|Protective Agents|protective agents|mesh-ancestor
25576115|NCT00819585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408738|NCT00179244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24408739|NCT00179244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408743|NCT00179257|Sertraline|sertraline|mesh-list
24954915|NCT03870581|Warfarin|warfarin|mesh-list
24954916|NCT03870581|Anticoagulants|anticoagulants|mesh-ancestor
24954917|NCT03870711|Lidocaine|lidocaine|mesh-list
24954918|NCT03870711|Anesthetics, Local|anesthetics, local|mesh-ancestor
24954919|NCT03870711|Anesthetics|anesthetics|mesh-ancestor
24954923|NCT03870711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24954924|NCT03870711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24954925|NCT03870711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24954926|NCT03870711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24954927|NCT03870711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24954928|NCT03870711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954929|NCT03870646|Hyaluronic Acid|hyaluronic acid|mesh-list
25700097|NCT02116972|Immunologic Factors|immunologic factors|mesh-ancestor
25700098|NCT02117024|Gemcitabine|gemcitabine|mesh-list
25700099|NCT02117024|Paclitaxel|paclitaxel|mesh-list
24448743|NCT00312988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25576116|NCT00819585|Immunologic Factors|immunologic factors|mesh-ancestor
25576117|NCT00819637|Albuterol|albuterol|mesh-list
25576118|NCT00819637|Formoterol Fumarate|formoterol fumarate|mesh-list
25576119|NCT00819637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25576120|NCT00819637|Autonomic Agents|autonomic agents|mesh-ancestor
25576121|NCT00819637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25576122|NCT00819637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576123|NCT00819637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25576124|NCT00819637|Respiratory System Agents|respiratory system agents|mesh-ancestor
25576125|NCT00819637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25576126|NCT00819637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25576127|NCT00819637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25576128|NCT00819637|Adrenergic Agents|adrenergic agents|mesh-ancestor
25576129|NCT00819637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25576130|NCT00819637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576131|NCT00819637|Tocolytic Agents|tocolytic agents|mesh-ancestor
25576132|NCT00819637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25576133|NCT00819741|Metformin|metformin|mesh-list
25576134|NCT00819741|Repaglinide|repaglinide|mesh-list
25576135|NCT00819741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25576136|NCT00819741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576137|NCT00819767|Valsartan|valsartan|mesh-list
25576138|NCT00819767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25576139|NCT00819767|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25576140|NCT00819767|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25576141|NCT00819767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576142|NCT00819910|Rosiglitazone|rosiglitazone|mesh-list
25576143|NCT00819910|Fenofibrate|fenofibrate|mesh-list
25576144|NCT00819910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24860516|NCT02310347|Hormones|hormones|mesh-ancestor
24954930|NCT03870646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24954931|NCT03870646|Immunologic Factors|immunologic factors|mesh-ancestor
24954932|NCT03870646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954933|NCT03870646|Viscosupplements|viscosupplements|mesh-ancestor
24954934|NCT03870646|Protective Agents|protective agents|mesh-ancestor
24954935|NCT03870503|Misoprostol|misoprostol|mesh-list
24954936|NCT03870503|Oxytocin|oxytocin|mesh-list
24954937|NCT03870503|Carbetocin|carbetocin|mesh-list
24954938|NCT03870503|Oxytocics|oxytocics|mesh-ancestor
24954939|NCT03870503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24954940|NCT03870503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954941|NCT03870503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24954942|NCT03870503|Abortifacient Agents|abortifacient agents|mesh-ancestor
25576145|NCT00819910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576146|NCT00819910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24455105|NCT02850016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455115|NCT02846545|Golimumab|golimumab|mesh-list
25576147|NCT00819910|Antimetabolites|antimetabolites|mesh-ancestor
24819003|NCT02092506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24954990|NCT03869931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24954992|NCT03869762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25576148|NCT00819910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576149|NCT00819910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25576150|NCT00820170|Paclitaxel|paclitaxel|mesh-list
25576151|NCT00820170|Dasatinib|dasatinib|mesh-list
25576152|NCT00820170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25576153|NCT00820170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576154|NCT00820170|Tubulin Modulators|tubulin modulators|mesh-ancestor
25576155|NCT00820170|Antimitotic Agents|antimitotic agents|mesh-ancestor
25576156|NCT00820170|Mitosis Modulators|mitosis modulators|mesh-ancestor
25576157|NCT00820170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576158|NCT00820170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25576159|NCT00820170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576160|NCT00820222|Capecitabine|capecitabine|mesh-list
25576161|NCT00820222|Trastuzumab|trastuzumab|mesh-list
25576162|NCT00820222|Lapatinib|lapatinib|mesh-list
25576163|NCT00820222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25576164|NCT00820222|Antimetabolites|antimetabolites|mesh-ancestor
25576165|NCT00820222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576166|NCT00820222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576167|NCT00820222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24954993|NCT03869762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954994|NCT03869736|Nitrous Oxide|nitrous oxide|mesh-list
24954995|NCT03869736|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24954996|NCT03869736|Anesthetics, General|anesthetics, general|mesh-ancestor
25700107|NCT02117024|Tubulin Modulators|tubulin modulators|mesh-ancestor
25700108|NCT02117024|Antimitotic Agents|antimitotic agents|mesh-ancestor
25700109|NCT02117024|Mitosis Modulators|mitosis modulators|mesh-ancestor
25700110|NCT02117024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700111|NCT02117024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25700112|NCT02117024|Immunologic Factors|immunologic factors|mesh-ancestor
25700113|NCT02117024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700114|NCT02117024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25700115|NCT02117024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25576168|NCT00820222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25576169|NCT00820222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576170|NCT00820248|Cisplatin|cisplatin|mesh-list
25576171|NCT00820248|Panitumumab|panitumumab|mesh-list
25576172|NCT00820248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576173|NCT00820248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25576174|NCT00820534|Penciclovir|penciclovir|mesh-list
25576175|NCT00820534|Antiviral Agents|antiviral agents|mesh-ancestor
25576176|NCT00820534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25576177|NCT00820573|Metformin|metformin|mesh-list
25576178|NCT00820573|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25576179|NCT00820573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25576180|NCT00820573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576181|NCT00820573|Incretins|incretins|mesh-ancestor
25576182|NCT00820573|Hormones|hormones|mesh-ancestor
25576183|NCT00820573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25576184|NCT00820573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25576185|NCT00820573|Protease Inhibitors|protease inhibitors|mesh-ancestor
25576186|NCT00820573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576187|NCT00820573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576188|NCT00820612|Indomethacin|indomethacin|mesh-list
25576189|NCT00820612|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25576190|NCT00820612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25576191|NCT00820612|Analgesics|analgesics|mesh-ancestor
25576192|NCT00820612|Sensory System Agents|sensory system agents|mesh-ancestor
25576193|NCT00820612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24910393|NCT04298684|Metformin|metformin|mesh-list
24954998|NCT03869736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24954999|NCT03869736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955000|NCT03869736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24955001|NCT03869736|Analgesics|analgesics|mesh-ancestor
24955002|NCT03869736|Sensory System Agents|sensory system agents|mesh-ancestor
24955003|NCT03869736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955004|NCT03869528|Lidocaine|lidocaine|mesh-list
24955005|NCT03869528|Anesthetics, Local|anesthetics, local|mesh-ancestor
24955006|NCT03869528|Anesthetics|anesthetics|mesh-ancestor
24955007|NCT03869528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24955008|NCT03869528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955009|NCT03869528|Sensory System Agents|sensory system agents|mesh-ancestor
24955010|NCT03869528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955011|NCT03869528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25576194|NCT00820612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576195|NCT00820612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25576196|NCT00820612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25576197|NCT00820612|Gout Suppressants|gout suppressants|mesh-ancestor
25576198|NCT00820612|Tocolytic Agents|tocolytic agents|mesh-ancestor
25576199|NCT00820612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25576200|NCT00820612|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25576201|NCT00820612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576202|NCT00820612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652624|NCT01529749|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25652625|NCT01529749|Antiviral Agents|antiviral agents|mesh-ancestor
25652626|NCT01529749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25652627|NCT01529749|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25652628|NCT01529749|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25652629|NCT01529749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652630|NCT01529827|Mycophenolic Acid|mycophenolic acid|mesh-list
25652631|NCT01529827|Methotrexate|methotrexate|mesh-list
25652632|NCT01529827|Fludarabine phosphate|fludarabine phosphate|mesh-list
25652633|NCT01529827|Fludarabine|fludarabine|mesh-list
25652634|NCT01529827|Melphalan|melphalan|mesh-list
25652635|NCT01529827|Tacrolimus|tacrolimus|mesh-list
25652636|NCT01529827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25652637|NCT01529827|Abortifacient Agents|abortifacient agents|mesh-ancestor
25652638|NCT01529827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25652639|NCT01529827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652640|NCT01529827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24910646|NCT04296149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24910647|NCT04296149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24780832|NCT01886534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780833|NCT01886560|Doxycycline|doxycycline|mesh-list
24780834|NCT01886560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24780835|NCT01886560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24780836|NCT01886560|Antimalarials|antimalarials|mesh-ancestor
24780837|NCT01886560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24780838|NCT01886560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24780839|NCT01886573|Azacitidine|azacitidine|mesh-list
24780840|NCT01886573|Entinostat|entinostat|mesh-list
24485325|NCT00452582|Vasodilator Agents|vasodilator agents|mesh-ancestor
24910691|NCT04295629|Anesthetics|anesthetics|mesh-list
24910692|NCT04295629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24910693|NCT04295629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910853|NCT04292990|Fentanyl|fentanyl|mesh-list
25652641|NCT01529827|Antimetabolites|antimetabolites|mesh-ancestor
25652642|NCT01529827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652643|NCT01529827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652644|NCT01529827|Dermatologic Agents|dermatologic agents|mesh-ancestor
25652645|NCT01529827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652646|NCT01529827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25652647|NCT01529827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25652648|NCT01529827|Immunologic Factors|immunologic factors|mesh-ancestor
25652649|NCT01529827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25652650|NCT01529827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25652651|NCT01529827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25652652|NCT01529827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25652653|NCT01529827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25652654|NCT01529827|Antitubercular Agents|antitubercular agents|mesh-ancestor
25652655|NCT01529827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25652656|NCT01529827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25652657|NCT01529827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25652658|NCT01529827|Alkylating Agents|alkylating agents|mesh-ancestor
25652659|NCT01529827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25652660|NCT01530178|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25652661|NCT01530178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25652662|NCT01530178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652663|NCT01530178|Incretins|incretins|mesh-ancestor
25652664|NCT01530178|Hormones|hormones|mesh-ancestor
25652665|NCT01530178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25652666|NCT01530178|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25652667|NCT01530178|Protease Inhibitors|protease inhibitors|mesh-ancestor
25652668|NCT01530178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24910790|NCT04294329|Bupivacaine|bupivacaine|mesh-list
24955014|NCT03869528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24955015|NCT03869528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955017|NCT03869281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24955018|NCT03869398|Calcitriol|calcitriol|mesh-list
24955019|NCT03869398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24955020|NCT03869398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955021|NCT03869398|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24955022|NCT03869398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24860632|NCT02311569|Urological Agents|urological agents|mesh-ancestor
24819138|NCT02093598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25652669|NCT01530178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652670|NCT01530243|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25652671|NCT01530243|Terazosin|terazosin|mesh-list
25652672|NCT01530243|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25652673|NCT01530243|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25652674|NCT01530243|Cholinergic Agents|cholinergic agents|mesh-ancestor
25652675|NCT01530243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25652676|NCT01530243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652677|NCT01530243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652678|NCT01530243|Urological Agents|urological agents|mesh-ancestor
25652679|NCT01530243|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25652680|NCT01530243|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25652681|NCT01530243|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25652682|NCT01530243|Adrenergic Agents|adrenergic agents|mesh-ancestor
25652683|NCT01530334|Gefitinib|gefitinib|mesh-list
25652684|NCT01530334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652685|NCT01530334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25652686|NCT01530334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652687|NCT01530334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652688|NCT01530399|Tranexamic Acid|tranexamic acid|mesh-list
25652689|NCT01530399|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25652690|NCT01530399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25652691|NCT01530399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652692|NCT01530399|Hemostatics|hemostatics|mesh-ancestor
25652693|NCT01530399|Coagulants|coagulants|mesh-ancestor
25652694|NCT01530464|Ambrisentan|ambrisentan|mesh-list
25470739|NCT03265405|Hormones|hormones|mesh-ancestor
25652695|NCT01530464|Aminophylline|aminophylline|mesh-list
25652696|NCT01530464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25576203|NCT00820664|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25576204|NCT00820664|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25576205|NCT00820664|Estradiol|estradiol|mesh-list
25576206|NCT00820664|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25576207|NCT00820664|Estrogens|estrogens|mesh-ancestor
25576208|NCT00820664|Hormones|hormones|mesh-ancestor
25576209|NCT00820664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25576210|NCT00820664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576211|NCT00820664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25576212|NCT00820664|Contraceptive Agents|contraceptive agents|mesh-ancestor
25576213|NCT00820664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24955047|NCT03868852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24955048|NCT03868852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24955049|NCT03868852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955051|NCT03869073|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24955052|NCT03869073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24448921|NCT00313547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24448922|NCT00313547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24448923|NCT00313547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448924|NCT00313547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25576214|NCT00820664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25576215|NCT00820755|Cetuximab|cetuximab|mesh-list
25576216|NCT00820755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25576217|NCT00820755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576218|NCT00820872|Carboplatin|carboplatin|mesh-list
25576219|NCT00820872|Docetaxel|docetaxel|mesh-list
25576220|NCT00820872|Trastuzumab|trastuzumab|mesh-list
25576221|NCT00820872|Lapatinib|lapatinib|mesh-list
25576222|NCT00820872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576223|NCT00820872|Tubulin Modulators|tubulin modulators|mesh-ancestor
25576224|NCT00820872|Antimitotic Agents|antimitotic agents|mesh-ancestor
25576225|NCT00820872|Mitosis Modulators|mitosis modulators|mesh-ancestor
25576226|NCT00820872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576227|NCT00820872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25576228|NCT00820872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25576229|NCT00820872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576230|NCT00820898|Gemcitabine|gemcitabine|mesh-list
25576231|NCT00820898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25576232|NCT00820898|Antimetabolites|antimetabolites|mesh-ancestor
25576233|NCT00820898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576234|NCT00820898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576235|NCT00820898|Antiviral Agents|antiviral agents|mesh-ancestor
25576236|NCT00820898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25576237|NCT00820898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576238|NCT00820898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25576239|NCT00820898|Immunologic Factors|immunologic factors|mesh-ancestor
25576240|NCT00820898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576241|NCT00821093|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25576242|NCT00821093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24955083|NCT03868124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24955084|NCT03868124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24955085|NCT03868137|Ibuprofen|ibuprofen|mesh-list
24955086|NCT03868137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24911285|NCT04289675|Interferons|interferons|mesh-list
24911286|NCT04289675|Interferon-beta|interferon-beta|mesh-list
24911287|NCT04289675|Teriflunomide|teriflunomide|mesh-list
24911288|NCT04289675|Dimethyl Fumarate|dimethyl fumarate|mesh-list
24955087|NCT03868137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24955088|NCT03868137|Analgesics|analgesics|mesh-ancestor
24955089|NCT03868137|Sensory System Agents|sensory system agents|mesh-ancestor
24955090|NCT03868137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078142|NCT03359018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078143|NCT03359005|Vincristine|vincristine|mesh-list
25078144|NCT03359005|Temozolomide|temozolomide|mesh-list
25078145|NCT03359005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25078146|NCT03359005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25078147|NCT03359005|Tubulin Modulators|tubulin modulators|mesh-ancestor
25078148|NCT03359005|Antimitotic Agents|antimitotic agents|mesh-ancestor
25078149|NCT03359005|Mitosis Modulators|mitosis modulators|mesh-ancestor
25078150|NCT03359005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078151|NCT03359005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25078152|NCT03359005|Alkylating Agents|alkylating agents|mesh-ancestor
25576243|NCT00821093|Autonomic Agents|autonomic agents|mesh-ancestor
25576244|NCT00821093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25576245|NCT00821093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576246|NCT00821093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25576247|NCT00821093|Respiratory System Agents|respiratory system agents|mesh-ancestor
25576248|NCT00821093|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25576249|NCT00821093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25576250|NCT00821093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25576251|NCT00821093|Adrenergic Agents|adrenergic agents|mesh-ancestor
25576252|NCT00821093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25576253|NCT00821093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576254|NCT00821184|Solifenacin Succinate|solifenacin succinate|mesh-list
25576255|NCT00821184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25576256|NCT00821184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25576257|NCT00821184|Cholinergic Agents|cholinergic agents|mesh-ancestor
25576258|NCT00821184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25576259|NCT00821184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576260|NCT00821184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576261|NCT00821184|Urological Agents|urological agents|mesh-ancestor
25576262|NCT05237115|Amoxicillin|amoxicillin|mesh-list
25576263|NCT05237115|Clarithromycin|clarithromycin|mesh-list
25576264|NCT05237115|Esomeprazole|esomeprazole|mesh-list
25576265|NCT05237115|Bismuth|bismuth|mesh-list
25576266|NCT05237115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25576267|NCT05237115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25576268|NCT05237115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25576269|NCT05237115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25576270|NCT05237115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25576271|NCT05237115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576272|NCT05237115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576273|NCT05237115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25576274|NCT05237115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25576275|NCT05237115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25576276|NCT05237115|Antacids|antacids|mesh-ancestor
25576277|NCT05236998|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25576278|NCT05236998|Dapagliflozin|dapagliflozin|mesh-list
25576279|NCT05236998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25576280|NCT05236998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576281|NCT05236998|Incretins|incretins|mesh-ancestor
25576282|NCT05236998|Hormones|hormones|mesh-ancestor
25576283|NCT05236998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25078153|NCT03358953|Nicotine|nicotine|mesh-list
25078154|NCT03358953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25576284|NCT05236998|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25576285|NCT05236998|Protease Inhibitors|protease inhibitors|mesh-ancestor
25576286|NCT05236998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576287|NCT05236998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576288|NCT05236998|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25576289|NCT05236972|Capecitabine|capecitabine|mesh-list
25576290|NCT05236972|Oxaliplatin|oxaliplatin|mesh-list
25576291|NCT05236972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25576292|NCT05236972|Antimetabolites|antimetabolites|mesh-ancestor
25576293|NCT05236972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576294|NCT05236972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576295|NCT05236907|Midazolam|midazolam|mesh-list
25576296|NCT05236907|Melatonin|melatonin|mesh-list
25576297|NCT05236907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25576298|NCT05236907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25576299|NCT05236907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25576300|NCT05236907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576301|NCT05236907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25576302|NCT05236907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25576303|NCT05236907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25576304|NCT05236907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25576305|NCT05236907|Anesthetics, General|anesthetics, general|mesh-ancestor
25576306|NCT05236907|Anesthetics|anesthetics|mesh-ancestor
25576307|NCT05236907|GABA Modulators|gaba modulators|mesh-ancestor
25576308|NCT05236907|GABA Agents|gaba agents|mesh-ancestor
25576309|NCT05236907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25576310|NCT05236907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576311|NCT05236907|Antioxidants|antioxidants|mesh-ancestor
25576312|NCT05236907|Protective Agents|protective agents|mesh-ancestor
25576313|NCT05236842|Sulthiame|sulthiame|mesh-list
25576314|NCT05236842|Anticonvulsants|anticonvulsants|mesh-ancestor
25576315|NCT05236777|Natalizumab|natalizumab|mesh-list
25576316|NCT05236777|Immunologic Factors|immunologic factors|mesh-ancestor
25576317|NCT05236777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576318|NCT05236634|Tadalafil|tadalafil|mesh-list
25576319|NCT05236634|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
24955100|NCT03868111|Narcotics|narcotics|mesh-ancestor
24955101|NCT03868111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24955102|NCT03868111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955103|NCT03868111|Analgesics|analgesics|mesh-ancestor
24955104|NCT03868111|Sensory System Agents|sensory system agents|mesh-ancestor
24912037|NCT04281745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24912118|NCT04279938|Rituximab|rituximab|mesh-list
24955116|NCT03868202|Progestins|progestins|mesh-ancestor
24884511|NCT00418834|Ezetimibe|ezetimibe|mesh-list
25576320|NCT05236634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
25576321|NCT05236634|Vasodilator Agents|vasodilator agents|mesh-ancestor
25576322|NCT05236634|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25576323|NCT05236634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576324|NCT05236634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576325|NCT05236634|Urological Agents|urological agents|mesh-ancestor
25576326|NCT05236634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25576327|NCT05236634|Adrenergic Agents|adrenergic agents|mesh-ancestor
25576328|NCT05236634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25576329|NCT05236634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576330|NCT05236621|Dexamethasone|dexamethasone|mesh-list
25576331|NCT05236621|Pomalidomide|pomalidomide|mesh-list
25576332|NCT05236621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25576333|NCT05236621|Antiemetics|antiemetics|mesh-ancestor
25576334|NCT05236621|Autonomic Agents|autonomic agents|mesh-ancestor
25576335|NCT05236621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25576336|NCT05236621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576337|NCT05236621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25576338|NCT05236621|Glucocorticoids|glucocorticoids|mesh-ancestor
25576339|NCT05236621|Hormones|hormones|mesh-ancestor
25576340|NCT05236621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25576341|NCT05236621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25576342|NCT05236621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576343|NCT05236621|Immunologic Factors|immunologic factors|mesh-ancestor
25576344|NCT05236621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25700133|NCT02117479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700134|NCT02117479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412527|NCT00191555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412528|NCT00191555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24912159|NCT04279106|Protective Agents|protective agents|mesh-ancestor
24912160|NCT04279106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912243|NCT04278495|Losartan|losartan|mesh-list
24455151|NCT02645149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455152|NCT02628067|Pembrolizumab|pembrolizumab|mesh-list
25576345|NCT05236621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25576346|NCT05236621|Growth Substances|growth substances|mesh-ancestor
25576347|NCT05236621|Growth Inhibitors|growth inhibitors|mesh-ancestor
25576348|NCT05236569|Tranexamic Acid|tranexamic acid|mesh-list
25576349|NCT05236569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25576350|NCT05236569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25576351|NCT05236569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576352|NCT05236569|Hemostatics|hemostatics|mesh-ancestor
25576360|NCT05236166|Anticonvulsants|anticonvulsants|mesh-list
25576362|NCT05235256|Lidocaine|lidocaine|mesh-list
25576363|NCT05235256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25576364|NCT05235256|Antiemetics|antiemetics|mesh-ancestor
25576365|NCT05235256|Autonomic Agents|autonomic agents|mesh-ancestor
25576366|NCT05235256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25576367|NCT05235256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576368|NCT05235256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25576369|NCT05235256|Glucocorticoids|glucocorticoids|mesh-ancestor
25576370|NCT05235256|Hormones|hormones|mesh-ancestor
25576371|NCT05235256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25576372|NCT05235256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25576373|NCT05235256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576374|NCT05235256|Anesthetics, Local|anesthetics, local|mesh-ancestor
25576375|NCT05235256|Anesthetics|anesthetics|mesh-ancestor
25576376|NCT05235256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25576377|NCT05235256|Sensory System Agents|sensory system agents|mesh-ancestor
25576378|NCT05235256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25576379|NCT05235256|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25576380|NCT05235256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25576381|NCT05235256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412920|NCT00192660|Enfuvirtide|enfuvirtide|mesh-list
24519997|NCT04286529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520025|NCT04029116|Fluconazole|fluconazole|mesh-list
24912502|NCT04274933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24912503|NCT04274933|Antimetabolites|antimetabolites|mesh-ancestor
24912608|NCT04273581|Thalidomide|thalidomide|mesh-list
24912609|NCT04273581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24912610|NCT04273581|Immunologic Factors|immunologic factors|mesh-ancestor
24912611|NCT04273581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912612|NCT04273581|Leprostatic Agents|leprostatic agents|mesh-ancestor
24912619|NCT04273581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912676|NCT04273282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24912677|NCT04273282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24912678|NCT04273282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912696|NCT04273191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912697|NCT04273191|GABA Modulators|gaba modulators|mesh-ancestor
24912698|NCT04273191|GABA Agents|gaba agents|mesh-ancestor
24912699|NCT04273100|Lenvatinib|lenvatinib|mesh-list
24912700|NCT04273100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912701|NCT04273100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24955159|NCT03867695|Anesthetics|anesthetics|mesh-ancestor
25576382|NCT05235256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576383|NCT05235191|Methadone|methadone|mesh-list
25576384|NCT05235191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25576385|NCT05235191|Narcotics|narcotics|mesh-ancestor
25576386|NCT05235191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25576387|NCT05235191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576388|NCT05235191|Analgesics|analgesics|mesh-ancestor
25576389|NCT05235191|Sensory System Agents|sensory system agents|mesh-ancestor
25576390|NCT05235191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25576391|NCT05235191|Antitussive Agents|antitussive agents|mesh-ancestor
25576392|NCT05235191|Respiratory System Agents|respiratory system agents|mesh-ancestor
25576393|NCT05214196|Povidone-Iodine|povidone-iodine|mesh-list
25576394|NCT05214196|Povidone|povidone|mesh-list
25576395|NCT05214196|Plasma Substitutes|plasma substitutes|mesh-ancestor
25576396|NCT05214196|Blood Substitutes|blood substitutes|mesh-ancestor
25576397|NCT05214196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25576398|NCT05214196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25576399|NCT05209620|Pemetrexed|pemetrexed|mesh-list
25576400|NCT05209620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576401|NCT05209620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576402|NCT05209620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576403|NCT05209620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25576404|NCT05209620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25576405|NCT05206812|Durvalumab|durvalumab|mesh-list
24822092|NCT02109783|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24822093|NCT02109783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24822094|NCT02109783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576406|NCT05206812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25576407|NCT05206812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652697|NCT01530464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25652698|NCT01530464|Autonomic Agents|autonomic agents|mesh-ancestor
25652699|NCT01530464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25652700|NCT01530464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652701|NCT01530464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25652702|NCT01530464|Respiratory System Agents|respiratory system agents|mesh-ancestor
25652703|NCT01530464|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25652704|NCT01530464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25652705|NCT01530464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652706|NCT01530464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652707|NCT01530464|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25652708|NCT01530464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25470970|NCT02106572|Viscum album peptide|viscum album peptide|mesh-list
25470971|NCT02106572|Mitomycins|mitomycins|mesh-list
25470972|NCT02106572|Mitomycin|mitomycin|mesh-list
25470973|NCT02106572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25470974|NCT02106572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470975|NCT02106572|Alkylating Agents|alkylating agents|mesh-ancestor
25470976|NCT02106572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470977|NCT02106572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25470978|NCT02106572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470979|NCT02106572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25470980|NCT02106572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25470981|NCT02106572|Antiviral Agents|antiviral agents|mesh-ancestor
25470982|NCT02106572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25470983|NCT01960530|Dexamethasone|dexamethasone|mesh-list
25470984|NCT01960530|Hydrocortisone|hydrocortisone|mesh-list
25470985|NCT01960530|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25470986|NCT01960530|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25470987|NCT01960530|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25470988|NCT01960530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25470989|NCT01960530|Antiemetics|antiemetics|mesh-ancestor
25470990|NCT01960530|Autonomic Agents|autonomic agents|mesh-ancestor
25470991|NCT01960530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24413751|NCT00195104|Antimetabolites|antimetabolites|mesh-ancestor
24955196|NCT03867240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24955197|NCT03867240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24955198|NCT03867240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24955199|NCT03867240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24955200|NCT03867240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24955201|NCT03867240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24955202|NCT03867240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24955203|NCT03867240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955204|NCT03867240|Antimanic Agents|antimanic agents|mesh-ancestor
24955205|NCT03866980|Carboplatin|carboplatin|mesh-list
24955207|NCT03866980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24955208|NCT03866980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24955209|NCT03866980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470992|NCT01960530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470993|NCT01960530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25470994|NCT01960530|Glucocorticoids|glucocorticoids|mesh-ancestor
25470995|NCT01960530|Hormones|hormones|mesh-ancestor
25470996|NCT01960530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25470997|NCT01960530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25470998|NCT01960530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332251|NCT04798703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332252|NCT04798703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25332253|NCT04798703|Immunologic Factors|immunologic factors|mesh-ancestor
24979500|NCT04133623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24979501|NCT04133623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431037|NCT00250081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431038|NCT00250081|Cholinergic Agents|cholinergic agents|mesh-ancestor
24431041|NCT00250094|Topotecan|topotecan|mesh-list
24431078|NCT00250237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24431080|NCT00250237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24431194|NCT00250744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24431195|NCT00250744|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24431196|NCT00250796|Interferons|interferons|mesh-list
25576415|NCT05177198|Clindamycin|clindamycin|mesh-list
25700149|NCT02117687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25700150|NCT02117687|Immunologic Factors|immunologic factors|mesh-ancestor
24414419|NCT00197548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822332|NCT02111044|Octreotide|octreotide|mesh-list
24955220|NCT03866928|Stiripentol|stiripentol|mesh-list
24955221|NCT03866928|Anticonvulsants|anticonvulsants|mesh-ancestor
24955222|NCT03866746|Aflibercept|aflibercept|mesh-list
24955223|NCT03866746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24955224|NCT03866746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24955225|NCT03866746|Growth Substances|growth substances|mesh-ancestor
24955226|NCT03866746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955227|NCT03866746|Growth Inhibitors|growth inhibitors|mesh-ancestor
25700151|NCT02117687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700152|NCT02117687|Viscosupplements|viscosupplements|mesh-ancestor
25700153|NCT02117687|Protective Agents|protective agents|mesh-ancestor
25700154|NCT02117687|Laxatives|laxatives|mesh-ancestor
25700155|NCT02117687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25700156|NCT02117687|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25576416|NCT05177198|Clindamycin palmitate|clindamycin palmitate|mesh-list
25576417|NCT05177198|Clindamycin phosphate|clindamycin phosphate|mesh-list
25576418|NCT05177198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25576419|NCT05177198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25576420|NCT05177198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25576421|NCT05177198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576422|NCT05177198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576423|NCT05131152|Cyclosporine|cyclosporine|mesh-list
25576424|NCT05131152|Cyclosporins|cyclosporins|mesh-list
25576425|NCT05131152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576426|NCT05131152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576427|NCT05131152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25576428|NCT05131152|Immunologic Factors|immunologic factors|mesh-ancestor
25576429|NCT05131152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576430|NCT05131152|Antifungal Agents|antifungal agents|mesh-ancestor
25576431|NCT05131152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25576432|NCT05131152|Dermatologic Agents|dermatologic agents|mesh-ancestor
25576433|NCT05131152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25576434|NCT05131152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25576435|NCT05125029|Botulinum Toxins|botulinum toxins|mesh-list
25576436|NCT05125029|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25576437|NCT05125029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25576438|NCT05125029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576439|NCT05125029|Cholinergic Agents|cholinergic agents|mesh-ancestor
25576440|NCT05125029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25576441|NCT05125029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576442|NCT05124704|Ropivacaine|ropivacaine|mesh-list
25576443|NCT05124704|Anesthetics, Local|anesthetics, local|mesh-ancestor
25576444|NCT05124704|Anesthetics|anesthetics|mesh-ancestor
25576445|NCT05124704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25576446|NCT05124704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576447|NCT05124704|Sensory System Agents|sensory system agents|mesh-ancestor
25576448|NCT05124704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25576449|NCT05120505|Metformin|metformin|mesh-list
25576450|NCT05120505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25576451|NCT05120505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576452|NCT05003089|Prednisolone|prednisolone|mesh-list
25576453|NCT05003089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25576454|NCT05003089|Glucocorticoids|glucocorticoids|mesh-ancestor
24414936|NCT00199004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24449407|NCT00315523|Histamine Agents|histamine agents|mesh-ancestor
24955231|NCT03866681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24955232|NCT03866681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24955235|NCT03866681|Antifungal Agents|antifungal agents|mesh-ancestor
24955238|NCT03866681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449427|NCT00315549|Telithromycin|telithromycin|mesh-list
24955240|NCT03866629|Lifitegrast|lifitegrast|mesh-list
24955241|NCT03866629|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24955242|NCT03866629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24955243|NCT03866733|Narcotics|narcotics|mesh-list
24955244|NCT03866733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24955245|NCT03866733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576455|NCT05003089|Hormones|hormones|mesh-ancestor
25576456|NCT05003089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25576457|NCT05003089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576458|NCT05003089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25576459|NCT05003089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576460|NCT05000450|Cyclophosphamide|cyclophosphamide|mesh-list
25576461|NCT05000450|Fludarabine|fludarabine|mesh-list
25576462|NCT05000450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25576463|NCT05000450|Immunologic Factors|immunologic factors|mesh-ancestor
25576464|NCT05000450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576465|NCT05000450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25576466|NCT05000450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25576467|NCT05000450|Alkylating Agents|alkylating agents|mesh-ancestor
25576468|NCT05000450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576469|NCT05000450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576470|NCT05000450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25576471|NCT04994431|Tamsulosin|tamsulosin|mesh-list
25576472|NCT04994431|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25576473|NCT04994431|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25576474|NCT04994431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25576475|NCT04994431|Adrenergic Agents|adrenergic agents|mesh-ancestor
25576476|NCT04994431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25576477|NCT04994431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576478|NCT04994431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576479|NCT04994431|Urological Agents|urological agents|mesh-ancestor
25576480|NCT04964947|Tobramycin|tobramycin|mesh-list
25576481|NCT04964947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25576482|NCT04964947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25576483|NCT04918407|Empagliflozin|empagliflozin|mesh-list
25576484|NCT04918407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25576485|NCT04918407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576486|NCT04918407|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25576487|NCT04918407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576488|NCT04900116|Bupivacaine|bupivacaine|mesh-list
25576489|NCT04900116|Anesthetics, Local|anesthetics, local|mesh-ancestor
25576490|NCT04900116|Anesthetics|anesthetics|mesh-ancestor
25576491|NCT04900116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25576492|NCT04900116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576493|NCT04900116|Sensory System Agents|sensory system agents|mesh-ancestor
25576494|NCT04900116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25576495|NCT04894123|Trifluridine|trifluridine|mesh-list
25576496|NCT04894123|Oxaliplatin|oxaliplatin|mesh-list
25576497|NCT04894123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576498|NCT04894123|Antimetabolites|antimetabolites|mesh-ancestor
25576499|NCT04894123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576500|NCT04894123|Antiviral Agents|antiviral agents|mesh-ancestor
25576501|NCT04894123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25576502|NCT04857684|Bevacizumab|bevacizumab|mesh-list
25576503|NCT04857684|Atezolizumab|atezolizumab|mesh-list
25576504|NCT04857684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25576505|NCT04857684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576506|NCT04857684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25576507|NCT04857684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25576508|NCT04857684|Growth Substances|growth substances|mesh-ancestor
25576509|NCT04857684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576510|NCT04857684|Growth Inhibitors|growth inhibitors|mesh-ancestor
25576511|NCT04760275|Fluoxetine|fluoxetine|mesh-list
25576512|NCT04760275|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25576513|NCT04760275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25576514|NCT04760275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25576515|NCT04760275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576516|NCT04760275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25576517|NCT04760275|Serotonin Agents|serotonin agents|mesh-ancestor
25576518|NCT04760275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576519|NCT04760275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25576520|NCT04760275|Antidepressive Agents|antidepressive agents|mesh-ancestor
25576521|NCT04760275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25576522|NCT04760275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25576523|NCT04760275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25576524|NCT04760275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576525|NCT04742283|Timolol|timolol|mesh-list
25576526|NCT04742283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25576527|NCT04742283|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25576528|NCT04742283|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25576529|NCT04742283|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25576530|NCT04742283|Adrenergic Agents|adrenergic agents|mesh-ancestor
25576531|NCT04742283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25576532|NCT04742283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576533|NCT04742283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576534|NCT04742283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25576535|NCT04742283|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25576536|NCT04729725|Cemiplimab|cemiplimab|mesh-list
25576537|NCT04729725|Antibodies|antibodies|mesh-list
25576538|NCT04729725|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25576539|NCT04729725|Immunologic Factors|immunologic factors|mesh-ancestor
25576540|NCT04729725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576541|NCT04729725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25576542|NCT04729725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576543|NCT04703335|Anti-Infective Agents|anti-infective agents|mesh-list
25576544|NCT04703335|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25576545|NCT04694976|Vitamin D|vitamin d|mesh-list
25576546|NCT04694976|Vitamins|vitamins|mesh-ancestor
25576547|NCT04694976|Micronutrients|micronutrients|mesh-ancestor
25576548|NCT04694976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576549|NCT04694976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25576550|NCT04661280|Donepezil|donepezil|mesh-list
25576551|NCT04661280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25576552|NCT04661280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576553|NCT04661280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576554|NCT04661280|Cholinergic Agents|cholinergic agents|mesh-ancestor
25576555|NCT04661280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25576556|NCT04661280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576557|NCT04661280|Nootropic Agents|nootropic agents|mesh-ancestor
25576558|NCT04645550|Aspirin|aspirin|mesh-list
25576559|NCT04645550|Heparin|heparin|mesh-list
25576560|NCT04645550|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25576561|NCT04645550|Tinzaparin|tinzaparin|mesh-list
25576562|NCT04645550|Dalteparin|dalteparin|mesh-list
25576563|NCT04645550|Dipyridamole|dipyridamole|mesh-list
25700165|NCT02118337|Nivolumab|nivolumab|mesh-list
24416859|NCT00204308|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24955318|NCT03865550|Anesthetics, General|anesthetics, general|mesh-ancestor
24955319|NCT03865550|Anesthetics|anesthetics|mesh-ancestor
24884631|NCT00092989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24884632|NCT00092989|Respiratory System Agents|respiratory system agents|mesh-ancestor
24508157|NCT00554424|Lidocaine|lidocaine|mesh-list
24884645|NCT00092144|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24884646|NCT00092144|Hormone Antagonists|hormone antagonists|mesh-ancestor
24884648|NCT00092144|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24819432|NCT02095509|Enoxaparin|enoxaparin|mesh-list
24955355|NCT03865511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24955356|NCT03865511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24955357|NCT03865511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781132|NCT01888224|Dermatologic Agents|dermatologic agents|mesh-ancestor
24781133|NCT01888250|Lamotrigine|lamotrigine|mesh-list
24781134|NCT01888250|Anticonvulsants|anticonvulsants|mesh-ancestor
24781135|NCT01888250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24781136|NCT01888250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25576564|NCT04645550|Warfarin|warfarin|mesh-list
25576565|NCT04645550|Apixaban|apixaban|mesh-list
25576566|NCT04645550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25576567|NCT04645550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25576568|NCT04645550|Analgesics|analgesics|mesh-ancestor
25576569|NCT04645550|Sensory System Agents|sensory system agents|mesh-ancestor
25576570|NCT04645550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25576571|NCT04645550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576572|NCT04645550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25576573|NCT04645550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25576574|NCT04645550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25576575|NCT04645550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25576576|NCT04645550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576577|NCT04645550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24417617|NCT00206947|Dopamine Agents|dopamine agents|mesh-ancestor
24417619|NCT00206960|Clopenthixol|clopenthixol|mesh-list
24417620|NCT00206960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24417621|NCT00206960|Serotonin Agents|serotonin agents|mesh-ancestor
25078191|NCT03358524|Tocopherols|tocopherols|mesh-list
25078192|NCT03358524|Tocotrienols|tocotrienols|mesh-list
24884671|NCT03753074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078193|NCT03358524|alpha-Tocopherol|alpha-tocopherol|mesh-list
25078194|NCT03358524|Micronutrients|micronutrients|mesh-ancestor
25078195|NCT03358524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078196|NCT03358524|Antioxidants|antioxidants|mesh-ancestor
25078197|NCT03358524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078198|NCT03358524|Protective Agents|protective agents|mesh-ancestor
25078199|NCT03358433|Antidepressive Agents|antidepressive agents|mesh-list
25078200|NCT03358433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25078201|NCT03358277|Methylphenidate|methylphenidate|mesh-list
25078202|NCT03358277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914804|NCT04251962|Fentanyl|fentanyl|mesh-list
24393150|NCT00128934|Levonorgestrel|levonorgestrel|mesh-list
24393151|NCT00128934|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24393152|NCT00128934|Estradiol|estradiol|mesh-list
24393153|NCT00128934|Estrogens|estrogens|mesh-ancestor
24393154|NCT00128934|Hormones|hormones|mesh-ancestor
24393176|NCT00129038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24393177|NCT00129038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25700170|NCT02118337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700171|NCT02118597|Interferons|interferons|mesh-list
25700172|NCT02118597|Ribavirin|ribavirin|mesh-list
25576578|NCT04645550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25576579|NCT04645550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576580|NCT04645550|Antipyretics|antipyretics|mesh-ancestor
25576581|NCT04645550|Anticoagulants|anticoagulants|mesh-ancestor
25576582|NCT04645550|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25576583|NCT04645550|Antithrombins|antithrombins|mesh-ancestor
25576584|NCT04645550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25576585|NCT04645550|Protease Inhibitors|protease inhibitors|mesh-ancestor
25576586|NCT04645550|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25576587|NCT04645550|Vasodilator Agents|vasodilator agents|mesh-ancestor
25576588|NCT04634071|Bupropion|bupropion|mesh-list
25576589|NCT04634071|Nicotine|nicotine|mesh-list
25576590|NCT04634071|Varenicline|varenicline|mesh-list
24418187|NCT00208819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24418189|NCT00208819|Anticonvulsants|anticonvulsants|mesh-ancestor
24955366|NCT03865160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955367|NCT03865160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955368|NCT03865160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24393194|NCT00129090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24393195|NCT00129090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393196|NCT00129090|Immunologic Factors|immunologic factors|mesh-ancestor
24393197|NCT00129090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393221|NCT00129168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24955369|NCT03865160|Respiratory System Agents|respiratory system agents|mesh-ancestor
24955371|NCT03865160|Parasympatholytics|parasympatholytics|mesh-ancestor
24955372|NCT03865160|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24955379|NCT03865004|Morphine|morphine|mesh-list
25576591|NCT04634071|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25576592|NCT04634071|Autonomic Agents|autonomic agents|mesh-ancestor
25576593|NCT04634071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25471088|NCT00006184|Hormones|hormones|mesh-ancestor
25576594|NCT04634071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576595|NCT04634071|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25576597|NCT04634071|Cholinergic Agents|cholinergic agents|mesh-ancestor
25576598|NCT04634071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25576599|NCT04634071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955386|NCT03865004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955387|NCT03865004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24955388|NCT03865004|Antipyretics|antipyretics|mesh-ancestor
24955390|NCT03865004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24393240|NCT00129181|Dopamine Agonists|dopamine agonists|mesh-ancestor
24393241|NCT00129181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24393242|NCT00129181|Immunologic Factors|immunologic factors|mesh-ancestor
24393243|NCT00129207|Bortezomib|bortezomib|mesh-list
24393244|NCT00129207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393245|NCT00129233|Amlodipine|amlodipine|mesh-list
24393246|NCT00129233|Valsartan|valsartan|mesh-list
24393247|NCT00129233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24393248|NCT00129233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24451945|NCT00325390|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24451946|NCT00325390|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24451947|NCT00325390|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24393250|NCT00129233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393255|NCT00129233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24393257|NCT00129298|Anticonvulsants|anticonvulsants|mesh-ancestor
24393258|NCT00129298|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
24955397|NCT03865147|Acetaminophen|acetaminophen|mesh-list
24955398|NCT03865147|Cetrimonium|cetrimonium|mesh-list
24955400|NCT03865147|Lidocaine|lidocaine|mesh-list
24955401|NCT03865147|Epinephrine|epinephrine|mesh-list
24955402|NCT03865147|Racepinephrine|racepinephrine|mesh-list
24955403|NCT03865147|Bupivacaine|bupivacaine|mesh-list
24955404|NCT03865147|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24955405|NCT03865147|Epinephryl borate|epinephryl borate|mesh-list
25576600|NCT04634071|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25576601|NCT04634071|Antidepressive Agents|antidepressive agents|mesh-ancestor
25576602|NCT04634071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25576603|NCT04634071|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25576604|NCT04634071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25576605|NCT04634071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25576606|NCT04634071|Dopamine Agents|dopamine agents|mesh-ancestor
25576607|NCT04634071|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25576608|NCT04634071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24420387|NCT00215865|Antimetabolites|antimetabolites|mesh-ancestor
24420388|NCT00215865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420389|NCT00215865|Antiviral Agents|antiviral agents|mesh-ancestor
24420390|NCT00215865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24420391|NCT00215891|Interferons|interferons|mesh-list
24955425|NCT03865147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24955426|NCT03865147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24955427|NCT03865147|Adrenergic Agents|adrenergic agents|mesh-ancestor
24955428|NCT03865147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24955429|NCT03865147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24955430|NCT03865147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24955431|NCT03865147|Autonomic Agents|autonomic agents|mesh-ancestor
24884745|NCT03636451|Anesthetics, Local|anesthetics, local|mesh-ancestor
24393288|NCT00129506|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24393289|NCT00129506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955454|NCT03864783|Curcumin|curcumin|mesh-list
25576609|NCT04634071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576610|NCT04608201|Nicotine|nicotine|mesh-list
25576611|NCT04608201|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25576612|NCT04608201|Autonomic Agents|autonomic agents|mesh-ancestor
25576613|NCT04608201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25576614|NCT04608201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576615|NCT04608201|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25576616|NCT04608201|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24393333|NCT00129805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24393334|NCT00129805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24393335|NCT00129805|Analgesics|analgesics|mesh-ancestor
24393336|NCT00129805|Sensory System Agents|sensory system agents|mesh-ancestor
24393337|NCT00129805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24393338|NCT00129805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393339|NCT00129805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24393340|NCT00129805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24955455|NCT03864783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25576617|NCT04608201|Cholinergic Agents|cholinergic agents|mesh-ancestor
25576618|NCT04608201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25576619|NCT04608201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576620|NCT04603248|Nivolumab|nivolumab|mesh-list
25576621|NCT04603248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25576622|NCT04603248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576623|NCT04603248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25576624|NCT04603248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576625|NCT04591925|Insulin|insulin|mesh-list
25576626|NCT04591925|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25576627|NCT04591925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25576628|NCT04591925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652709|NCT01530464|Purinergic Agents|purinergic agents|mesh-ancestor
25700192|NCT02118831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24421123|NCT00217711|Oxaliplatin|oxaliplatin|mesh-list
24421124|NCT00217711|Irinotecan|irinotecan|mesh-list
24421125|NCT00217711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24421131|NCT00217711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421132|NCT00217789|Dimercaprol|dimercaprol|mesh-list
24421133|NCT00217789|Chelating Agents|chelating agents|mesh-ancestor
24421134|NCT00217789|Sequestering Agents|sequestering agents|mesh-ancestor
24421144|NCT00217815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24421145|NCT00217828|Citalopram|citalopram|mesh-list
24916624|NCT04238832|Nicotine|nicotine|mesh-list
24491446|NCT00482521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24491447|NCT00482521|Growth Substances|growth substances|mesh-ancestor
24916685|NCT04238169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24955487|NCT03864250|Tacrolimus|tacrolimus|mesh-list
24955490|NCT03864250|Hormones|hormones|mesh-ancestor
25652710|NCT01530464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25652711|NCT01530464|Protective Agents|protective agents|mesh-ancestor
25652712|NCT01531153|Galantamine|galantamine|mesh-list
25652713|NCT01531153|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25652714|NCT01531153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652715|NCT01531153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652716|NCT01531153|Cholinergic Agents|cholinergic agents|mesh-ancestor
25652717|NCT01531153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25652718|NCT01531153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652719|NCT01531153|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25652720|NCT01531153|Autonomic Agents|autonomic agents|mesh-ancestor
25652721|NCT01531153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25652722|NCT01531153|Nootropic Agents|nootropic agents|mesh-ancestor
24393433|NCT00130026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24393434|NCT00130026|Purinergic Agents|purinergic agents|mesh-ancestor
24393435|NCT00130026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24393436|NCT00130065|Folic Acid|folic acid|mesh-list
24393444|NCT00130065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393446|NCT00130065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24393447|NCT00130065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24393448|NCT00130065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24393449|NCT00130065|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24955512|NCT03864588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955514|NCT03864575|Nivolumab|nivolumab|mesh-list
24955515|NCT03864575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24955516|NCT03864575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24955517|NCT03864575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24955518|NCT03864575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955519|NCT03864575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24955520|NCT03864575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24955522|NCT03864575|Sensory System Agents|sensory system agents|mesh-ancestor
25652723|NCT01531205|Leuprolide|leuprolide|mesh-list
25652724|NCT01531205|Goserelin|goserelin|mesh-list
25652725|NCT01531205|Bicalutamide|bicalutamide|mesh-list
25652726|NCT01531205|Androgens|androgens|mesh-list
25652727|NCT01531205|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25652728|NCT01531205|Fertility Agents|fertility agents|mesh-ancestor
25652729|NCT01531205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25652730|NCT01531205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652731|NCT01531205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25652732|NCT01531205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652733|NCT01531205|Androgen Antagonists|androgen antagonists|mesh-ancestor
25652734|NCT01531205|Hormone Antagonists|hormone antagonists|mesh-ancestor
25652735|NCT01531205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25652736|NCT01531205|Hormones|hormones|mesh-ancestor
25652737|NCT01531439|Naloxone|naloxone|mesh-list
25652738|NCT01531439|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25652739|NCT01531439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652740|NCT01531439|Sensory System Agents|sensory system agents|mesh-ancestor
25652741|NCT01531439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25652742|NCT01531673|Ivacaftor|ivacaftor|mesh-list
25652743|NCT01531673|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25652744|NCT01531673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25652745|NCT01531673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652746|NCT01531803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25652747|NCT01531959|Midodrine|midodrine|mesh-list
25652748|NCT01531959|Sympathomimetics|sympathomimetics|mesh-ancestor
25652749|NCT01531959|Autonomic Agents|autonomic agents|mesh-ancestor
25576629|NCT04565730|Anesthetics|anesthetics|mesh-list
25576630|NCT04565730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25576631|NCT04565730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576632|NCT04537156|Vaccines|vaccines|mesh-list
25576633|NCT04537156|Immunologic Factors|immunologic factors|mesh-ancestor
25576634|NCT04537156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576635|NCT04501718|Etoposide|etoposide|mesh-list
25576636|NCT04501718|Temozolomide|temozolomide|mesh-list
25576637|NCT04501718|Apatinib|apatinib|mesh-list
24422034|NCT00221039|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25576638|NCT04501718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25576639|NCT04501718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576640|NCT04501718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25576641|NCT04501718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25576642|NCT04501718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576643|NCT04501718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576644|NCT04501718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25576645|NCT04501718|Alkylating Agents|alkylating agents|mesh-ancestor
25576646|NCT04501718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25576647|NCT04501705|Apatinib|apatinib|mesh-list
25576648|NCT04501705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24422474|NCT00222547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24422493|NCT00222573|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24422494|NCT00222573|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24917289|NCT04231448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24955718|NCT03862287|Bupivacaine|bupivacaine|mesh-list
24393615|NCT00130481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24393616|NCT00130481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24455221|NCT02329080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24455222|NCT02329080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24455223|NCT02329080|Alkylating Agents|alkylating agents|mesh-ancestor
24955606|NCT03863392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24955613|NCT03863626|Natriuretic Agents|natriuretic agents|mesh-ancestor
24955614|NCT03863626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955615|NCT03863626|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24955616|NCT03863626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24955617|NCT03863626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955618|NCT03863613|Progesterone|progesterone|mesh-list
24955619|NCT03863613|Progestins|progestins|mesh-ancestor
24955620|NCT03863613|Hormones|hormones|mesh-ancestor
24393634|NCT00130546|Paclitaxel|paclitaxel|mesh-list
25576649|NCT04501705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25576650|NCT04501705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576651|NCT04501705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576652|NCT04410406|Ivermectin|ivermectin|mesh-list
25576653|NCT04410406|Albendazole|albendazole|mesh-list
25576654|NCT04410406|Moxidectin|moxidectin|mesh-list
25576655|NCT04410406|Diethylcarbamazine|diethylcarbamazine|mesh-list
25576656|NCT04410406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576657|NCT04410406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25576658|NCT04410406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24823590|NCT02118051|Ganirelix|ganirelix|mesh-list
24393670|NCT00130676|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24393671|NCT00130676|Abortifacient Agents|abortifacient agents|mesh-ancestor
24955621|NCT03863613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24955622|NCT03863613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955623|NCT03863366|Prucalopride|prucalopride|mesh-list
24955630|NCT03863366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955631|NCT03863366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955632|NCT03863249|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24955633|NCT03863249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24621050|NCT01060501|Immunologic Factors|immunologic factors|mesh-ancestor
24621051|NCT01060501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955634|NCT03863223|Docetaxel|docetaxel|mesh-list
24955635|NCT03863223|Trastuzumab|trastuzumab|mesh-list
24955636|NCT03863223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576659|NCT04410406|Anthelmintics|anthelmintics|mesh-ancestor
25576660|NCT04410406|Anticestodal Agents|anticestodal agents|mesh-ancestor
25576661|NCT04410406|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25576662|NCT04410406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25576663|NCT04410406|Tubulin Modulators|tubulin modulators|mesh-ancestor
25576664|NCT04410406|Antimitotic Agents|antimitotic agents|mesh-ancestor
25576665|NCT04410406|Mitosis Modulators|mitosis modulators|mesh-ancestor
25576666|NCT04410406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576667|NCT04410406|Antinematodal Agents|antinematodal agents|mesh-ancestor
25576668|NCT04410406|Filaricides|filaricides|mesh-ancestor
25576669|NCT04410406|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25576670|NCT04410406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24955663|NCT03862456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24884913|NCT03267433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393722|NCT00130858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393724|NCT00130871|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24393725|NCT00130871|Vasodilator Agents|vasodilator agents|mesh-ancestor
24955664|NCT03862456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24955665|NCT03862586|Acetylcysteine|acetylcysteine|mesh-list
24955666|NCT03862586|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24955667|NCT03862586|Antiviral Agents|antiviral agents|mesh-ancestor
24955668|NCT03862586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24955669|NCT03862586|Expectorants|expectorants|mesh-ancestor
24955670|NCT03862586|Respiratory System Agents|respiratory system agents|mesh-ancestor
24955672|NCT03862586|Antioxidants|antioxidants|mesh-ancestor
24955673|NCT03862586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955674|NCT03862586|Protective Agents|protective agents|mesh-ancestor
24955675|NCT03862586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955676|NCT03862586|Antidotes|antidotes|mesh-ancestor
24955677|NCT03862651|Cangrelor|cangrelor|mesh-list
24955678|NCT03862651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24955679|NCT03862651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24955680|NCT03862651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24955681|NCT03862651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24393726|NCT00130871|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24393727|NCT00130871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24393728|NCT00130871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24393729|NCT00130871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955685|NCT03862651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918059|NCT04224246|Anesthetics, General|anesthetics, general|mesh-ancestor
25576671|NCT04342975|Niacinamide|niacinamide|mesh-list
25576672|NCT04342975|Niacin|niacin|mesh-list
25576673|NCT04342975|Nicotinic Acids|nicotinic acids|mesh-list
25576674|NCT04342975|Vitamin B Complex|vitamin b complex|mesh-ancestor
25576675|NCT04342975|Vitamins|vitamins|mesh-ancestor
25576676|NCT04342975|Micronutrients|micronutrients|mesh-ancestor
25576677|NCT04342975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576678|NCT04342975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25576679|NCT04342975|Antimetabolites|antimetabolites|mesh-ancestor
24955687|NCT03862612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24955688|NCT03862612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955689|NCT03862404|Epinephrine|epinephrine|mesh-list
24955690|NCT03862404|Bupivacaine|bupivacaine|mesh-list
24955691|NCT03862404|Anesthetics, Local|anesthetics, local|mesh-ancestor
24393796|NCT00131027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955694|NCT03862404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576680|NCT04342975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576681|NCT04342975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25576682|NCT04342975|Vasodilator Agents|vasodilator agents|mesh-ancestor
25576683|NCT04294069|Azithromycin|azithromycin|mesh-list
25576684|NCT04294069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25576685|NCT04294069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25576686|NCT04290689|Botulinum Toxins|botulinum toxins|mesh-list
24626560|NCT01087840|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24626561|NCT01087840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24626562|NCT01087840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626565|NCT01087840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24626566|NCT01087840|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24626567|NCT01087840|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24626569|NCT01087866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24626570|NCT01087866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626571|NCT01087879|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24626572|NCT01087879|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24955708|NCT03862404|Sympathomimetics|sympathomimetics|mesh-ancestor
24955709|NCT03862404|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24393829|NCT00131040|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24393830|NCT00131040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24393831|NCT00131040|Protease Inhibitors|protease inhibitors|mesh-ancestor
24393838|NCT00131053|Cyclophosphamide|cyclophosphamide|mesh-list
24393840|NCT00131053|Vincristine|vincristine|mesh-list
24393841|NCT00131053|Asparaginase|asparaginase|mesh-list
24393842|NCT00131053|Mercaptopurine|mercaptopurine|mesh-list
24955711|NCT03862391|Antiemetics|antiemetics|mesh-list
24955712|NCT03862391|Sensory System Agents|sensory system agents|mesh-ancestor
24955713|NCT03862391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955714|NCT03862391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955715|NCT03862391|Autonomic Agents|autonomic agents|mesh-ancestor
24955716|NCT03862391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24955717|NCT03862287|Lidocaine|lidocaine|mesh-list
24955719|NCT03862287|Anesthetics, Local|anesthetics, local|mesh-ancestor
24955720|NCT03862287|Anesthetics|anesthetics|mesh-ancestor
24955721|NCT03862287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24955722|NCT03862287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955723|NCT03862287|Sensory System Agents|sensory system agents|mesh-ancestor
24955724|NCT03862287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25576687|NCT04290689|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25576688|NCT04290689|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25576689|NCT04290689|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25576690|NCT04290689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25576691|NCT04290689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576692|NCT04290689|Cholinergic Agents|cholinergic agents|mesh-ancestor
25576693|NCT04290689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25576694|NCT04290689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576695|NCT04290689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25576696|NCT04290689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24423905|NCT00227357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24423906|NCT00227357|Antitussive Agents|antitussive agents|mesh-ancestor
24393852|NCT00131053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24918828|NCT04216186|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24955760|NCT03861598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955761|NCT03861598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955762|NCT03861598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24955763|NCT03861598|Antioxidants|antioxidants|mesh-ancestor
24885041|NCT02857426|Nivolumab|nivolumab|mesh-list
24918836|NCT04216186|Vitamins|vitamins|mesh-ancestor
24393853|NCT00131053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24393855|NCT00131053|Autonomic Agents|autonomic agents|mesh-ancestor
24393856|NCT00131053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24393857|NCT00131053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24393858|NCT00131053|Glucocorticoids|glucocorticoids|mesh-ancestor
24393859|NCT00131053|Hormones|hormones|mesh-ancestor
24955765|NCT03861598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24955766|NCT03861598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24955767|NCT03861598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24393867|NCT00131053|Dermatologic Agents|dermatologic agents|mesh-ancestor
25700235|NCT02119650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700236|NCT02119650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25700237|NCT02119650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25700238|NCT02119663|Capecitabine|capecitabine|mesh-list
25700239|NCT02119663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25700240|NCT02119663|Antimetabolites|antimetabolites|mesh-ancestor
25700241|NCT02119663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576697|NCT04267978|Irinotecan|irinotecan|mesh-list
25576698|NCT04267978|Temozolomide|temozolomide|mesh-list
25576699|NCT04267978|Endostatins|endostatins|mesh-list
25576700|NCT04267978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25576701|NCT04267978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25576702|NCT04267978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576703|NCT04267978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576704|NCT04267978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576705|NCT04267978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25576706|NCT04267978|Alkylating Agents|alkylating agents|mesh-ancestor
25576707|NCT04267978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25576708|NCT04267978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24393881|NCT00131144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24393882|NCT00131144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24393883|NCT00131144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24955781|NCT03861403|Alkylating Agents|alkylating agents|mesh-ancestor
24955782|NCT03861403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955783|NCT03861403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24955784|NCT03861403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24955785|NCT03861403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24955786|NCT03861416|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24393893|NCT00131235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24393894|NCT00131235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24393895|NCT00131235|Antimalarials|antimalarials|mesh-ancestor
24393896|NCT00131235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24393897|NCT00131235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24393899|NCT00131235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24393900|NCT00131235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393901|NCT00131235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24393902|NCT00131235|Renal Agents|renal agents|mesh-ancestor
24393903|NCT00131261|Dexamethasone|dexamethasone|mesh-list
24393904|NCT00131261|Belinostat|belinostat|mesh-list
24393905|NCT00131261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24393906|NCT00131261|Antiemetics|antiemetics|mesh-ancestor
24393907|NCT00131261|Autonomic Agents|autonomic agents|mesh-ancestor
24393908|NCT00131261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25576709|NCT04267978|Growth Substances|growth substances|mesh-ancestor
25576710|NCT04267978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576711|NCT04267978|Growth Inhibitors|growth inhibitors|mesh-ancestor
25576712|NCT04173494|Danazol|danazol|mesh-list
25576713|NCT04173494|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
25576714|NCT04173494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25576715|NCT04173494|Hormone Antagonists|hormone antagonists|mesh-ancestor
25606157|NCT01065350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955817|NCT03860831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24955818|NCT03860831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24955819|NCT03860831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24955820|NCT03860831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24955821|NCT03860831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955822|NCT03860831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24955823|NCT03860831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24955824|NCT03860831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24955825|NCT03860831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24393984|NCT00131495|Testosterone|testosterone|mesh-list
24393952|NCT00131339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393953|NCT00131391|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
24393955|NCT00131391|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24393956|NCT00131391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24955826|NCT03860831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24955827|NCT03860831|GABA Modulators|gaba modulators|mesh-ancestor
24955828|NCT03860831|GABA Agents|gaba agents|mesh-ancestor
24955829|NCT03860662|Baclofen|baclofen|mesh-list
24393957|NCT00131391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393958|NCT00131391|Hormones|hormones|mesh-ancestor
24393959|NCT00131391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24393960|NCT00131391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393962|NCT00131404|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24393963|NCT00131404|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25576716|NCT04173494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25576717|NCT04173494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576718|NCT04173494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25576719|NCT04173494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576720|NCT04173494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576721|NCT04155164|Metformin|metformin|mesh-list
25576722|NCT04155164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25576723|NCT04155164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576724|NCT04138316|Candesartan|candesartan|mesh-list
25576725|NCT04138316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24955838|NCT03860662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955839|NCT03860636|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24955840|NCT03860636|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24955841|NCT03860636|Estradiol|estradiol|mesh-list
24955842|NCT03860636|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24955843|NCT03860636|Progesterone|progesterone|mesh-list
24955844|NCT03860636|Estrogens|estrogens|mesh-ancestor
24955845|NCT03860636|Hormones|hormones|mesh-ancestor
24955846|NCT03860636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24955847|NCT03860636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955848|NCT03860636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25576726|NCT04138316|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25576727|NCT04138316|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25576728|NCT04138316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576729|NCT04134663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25576730|NCT04134663|Oxytocin|oxytocin|mesh-list
25576731|NCT04134663|Oxytocics|oxytocics|mesh-ancestor
25576732|NCT04134663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25576733|NCT04134663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576734|NCT04095221|Irinotecan|irinotecan|mesh-list
25576735|NCT04095221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24394013|NCT00131703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24394015|NCT00131716|Pyrimethamine|pyrimethamine|mesh-list
24394016|NCT00131716|Sulfadoxine|sulfadoxine|mesh-list
24394017|NCT00131716|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24394018|NCT00131716|Antimalarials|antimalarials|mesh-ancestor
24394019|NCT00131716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24394020|NCT00131716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24394021|NCT00131716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24394022|NCT00131716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24394023|NCT00131716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394026|NCT00131716|Renal Agents|renal agents|mesh-ancestor
24394054|NCT00131963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24394055|NCT00131963|Tubulin Modulators|tubulin modulators|mesh-ancestor
24394056|NCT00131963|Antimitotic Agents|antimitotic agents|mesh-ancestor
25078232|NCT03358017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25078234|NCT03358017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25078235|NCT03358017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394057|NCT00131963|Mitosis Modulators|mitosis modulators|mesh-ancestor
24394058|NCT00131963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576736|NCT04095221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25576737|NCT04095221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576738|NCT04095221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576739|NCT04095221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576740|NCT04037683|Misoprostol|misoprostol|mesh-list
25576741|NCT04037683|Oxytocin|oxytocin|mesh-list
25576742|NCT04037683|Oxytocics|oxytocics|mesh-ancestor
25576743|NCT04037683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25078242|NCT03358004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25078243|NCT03358004|Tubulin Modulators|tubulin modulators|mesh-ancestor
25078244|NCT03358004|Antimitotic Agents|antimitotic agents|mesh-ancestor
25078245|NCT03358004|Mitosis Modulators|mitosis modulators|mesh-ancestor
25078247|NCT03357900|Propofol|propofol|mesh-list
25078248|NCT03357900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25576744|NCT04037683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576745|NCT04037683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25576746|NCT04037683|Abortifacient Agents|abortifacient agents|mesh-ancestor
25576747|NCT04037683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25576748|NCT04037683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25576749|NCT03958474|Remifentanil|remifentanil|mesh-list
25576750|NCT03958474|Oxycodone|oxycodone|mesh-list
25576751|NCT03958474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25576752|NCT03958474|Narcotics|narcotics|mesh-ancestor
25576753|NCT03958474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25576754|NCT03958474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576755|NCT03958474|Analgesics|analgesics|mesh-ancestor
25576756|NCT03958474|Sensory System Agents|sensory system agents|mesh-ancestor
24426738|NCT00236561|Topiramate|topiramate|mesh-list
24426739|NCT00236561|Propranolol|propranolol|mesh-list
24955906|NCT03860077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955907|NCT03860077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955908|NCT03860077|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24955909|NCT03860077|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24955910|NCT03860077|Cholinergic Agents|cholinergic agents|mesh-ancestor
24955911|NCT03860077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24955912|NCT03860077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955913|NCT03859921|Dydrogesterone|dydrogesterone|mesh-list
24955914|NCT03859921|Progestins|progestins|mesh-ancestor
24573603|NCT00821028|Tubulin Modulators|tubulin modulators|mesh-ancestor
24573604|NCT00821028|Antimitotic Agents|antimitotic agents|mesh-ancestor
24955916|NCT03859921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24955917|NCT03859921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955918|NCT03859856|Hormones|hormones|mesh-list
25606158|NCT01065506|Nicotine|nicotine|mesh-list
25606159|NCT01065506|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25606160|NCT01065506|Autonomic Agents|autonomic agents|mesh-ancestor
25606161|NCT01065506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25606162|NCT01065506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606163|NCT01065506|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25606164|NCT01065506|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25606165|NCT01065506|Cholinergic Agents|cholinergic agents|mesh-ancestor
24427047|NCT00237237|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24427048|NCT00237237|Protease Inhibitors|protease inhibitors|mesh-ancestor
24427050|NCT00237237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955989|NCT03859219|Immunologic Factors|immunologic factors|mesh-ancestor
24955990|NCT03859219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955991|NCT03858972|Capecitabine|capecitabine|mesh-list
24955992|NCT03858972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24955993|NCT03858972|Antimetabolites|antimetabolites|mesh-ancestor
24955994|NCT03858972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955995|NCT03858972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24781777|NCT01891812|Anesthetics, General|anesthetics, general|mesh-ancestor
24781778|NCT01891812|Anesthetics|anesthetics|mesh-ancestor
24781779|NCT01891812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24781780|NCT01891812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576757|NCT03958474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25576758|NCT03936270|Letrozole|letrozole|mesh-list
25576759|NCT03936270|Palbociclib|palbociclib|mesh-list
25576760|NCT03936270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576761|NCT03936270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25576762|NCT03936270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25576763|NCT03936270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576764|NCT03936270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576765|NCT03936270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25576766|NCT03936270|Hormone Antagonists|hormone antagonists|mesh-ancestor
25576767|NCT03936270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24626588|NCT01087879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24626589|NCT01087879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24626599|NCT01087983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24626600|NCT01087983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626601|NCT01087983|Antifungal Agents|antifungal agents|mesh-ancestor
24626602|NCT01087983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24626603|NCT01087983|Immunologic Factors|immunologic factors|mesh-ancestor
24462873|NCT00357721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462874|NCT00357721|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24462875|NCT00357721|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24462876|NCT00357721|Antiviral Agents|antiviral agents|mesh-ancestor
24462877|NCT00357721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24462878|NCT00357747|Docetaxel|docetaxel|mesh-list
24462879|NCT00357747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626604|NCT01087983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24626605|NCT01087983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626606|NCT01087983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626622|NCT01088022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24626623|NCT01088022|Antiemetics|antiemetics|mesh-ancestor
24626624|NCT01088022|Autonomic Agents|autonomic agents|mesh-ancestor
24626625|NCT01088022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24645432|NCT01198236|Itraconazole|itraconazole|mesh-list
24645578|NCT01198665|Hormones|hormones|mesh-ancestor
24956012|NCT03858465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24956014|NCT03858465|Adrenergic Agents|adrenergic agents|mesh-ancestor
24885345|NCT00038727|Metformin|metformin|mesh-list
24462886|NCT00357773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24411876|NCT00190307|Aspirin|aspirin|mesh-list
24956050|NCT03858062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24956051|NCT03858062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956052|NCT03858062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24956054|NCT03857854|Analgesics|analgesics|mesh-ancestor
25576768|NCT03936270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576769|NCT03936270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25576770|NCT03918850|Buprenorphine|buprenorphine|mesh-list
25576771|NCT03918850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25576772|NCT03918850|Narcotics|narcotics|mesh-ancestor
25576773|NCT03918850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25576774|NCT03918850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576775|NCT03918850|Analgesics|analgesics|mesh-ancestor
25576776|NCT03918850|Sensory System Agents|sensory system agents|mesh-ancestor
25576777|NCT03918850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24427567|NCT00238368|Glucocorticoids|glucocorticoids|mesh-ancestor
24956056|NCT03857854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24621957|NCT01064986|Sympathomimetics|sympathomimetics|mesh-ancestor
24956057|NCT03857854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956058|NCT03857854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24956059|NCT03857854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24956075|NCT03857711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24956076|NCT03857711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956077|NCT03857711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24956078|NCT03857711|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24956079|NCT03857711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24956080|NCT03857711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542114|NCT00676936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24956081|NCT03857711|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24956082|NCT03857711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24956083|NCT03857711|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24956085|NCT03857763|Apatinib|apatinib|mesh-list
24956086|NCT03857763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24956087|NCT03857763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24956088|NCT03857763|Tubulin Modulators|tubulin modulators|mesh-ancestor
24885421|NCT05172934|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24885433|NCT05172570|Gabapentin|gabapentin|mesh-list
25576778|NCT03918850|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25576779|NCT03911739|Buprenorphine|buprenorphine|mesh-list
25576780|NCT03911739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25576781|NCT03911739|Narcotics|narcotics|mesh-ancestor
25576782|NCT03911739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25576783|NCT03911739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576784|NCT03911739|Analgesics|analgesics|mesh-ancestor
25576785|NCT03911739|Sensory System Agents|sensory system agents|mesh-ancestor
25576786|NCT03911739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25576787|NCT03911739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25576788|NCT03911466|Buprenorphine|buprenorphine|mesh-list
24824552|NCT02124005|Sensory System Agents|sensory system agents|mesh-ancestor
24824628|NCT02124330|Bentonite|bentonite|mesh-list
24462957|NCT00358176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24462958|NCT00358176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411947|NCT00190502|Antibodies|antibodies|mesh-list
24462959|NCT00358176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24956102|NCT03857581|Antiemetics|antiemetics|mesh-ancestor
24462969|NCT00358228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462972|NCT00358228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956136|NCT03856866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24956137|NCT03856866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24956138|NCT03856866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956139|NCT03856866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24956141|NCT03856970|Digoxin|digoxin|mesh-list
24956142|NCT03856970|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24956143|NCT03856970|Norethindrone|norethindrone|mesh-list
24956144|NCT03856970|Estradiol|estradiol|mesh-list
24956146|NCT03856970|Hormones|hormones|mesh-ancestor
25576789|NCT03911466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25576790|NCT03911466|Narcotics|narcotics|mesh-ancestor
25576791|NCT03911466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25576792|NCT03911466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576793|NCT03911466|Analgesics|analgesics|mesh-ancestor
25576794|NCT03911466|Sensory System Agents|sensory system agents|mesh-ancestor
25576795|NCT03911466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25576796|NCT03911466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24956236|NCT03856112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25078290|NCT03357757|Avelumab|avelumab|mesh-list
25576797|NCT03857321|Insulin|insulin|mesh-list
25576798|NCT03857321|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25576799|NCT03857321|Insulin, Isophane|insulin, isophane|mesh-list
25576800|NCT03857321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25576801|NCT03857321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576802|NCT03846219|Calcium, Dietary|calcium, dietary|mesh-list
25576803|NCT03846219|Calcium|calcium|mesh-list
25576804|NCT03846219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25576805|NCT03846219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956321|NCT03855332|Urological Agents|urological agents|mesh-ancestor
25078321|NCT03357718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24956383|NCT03854812|Magnesium Sulfate|magnesium sulfate|mesh-list
24956385|NCT03854812|Propofol|propofol|mesh-list
24956386|NCT03854812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24956387|NCT03854812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24956388|NCT03854812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956389|NCT03854812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24956390|NCT03854812|Anesthetics, General|anesthetics, general|mesh-ancestor
24956391|NCT03854812|Anesthetics|anesthetics|mesh-ancestor
25576806|NCT03846219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25576807|NCT03839446|Etoposide|etoposide|mesh-list
25576808|NCT03839446|Mitoxantrone|mitoxantrone|mesh-list
25576809|NCT03839446|Gemtuzumab|gemtuzumab|mesh-list
25576810|NCT03839446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25576811|NCT03839446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576812|NCT03839446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25576813|NCT03839446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24956488|NCT03854175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956489|NCT03854175|Estrogens|estrogens|mesh-ancestor
24956490|NCT03854175|Hormones|hormones|mesh-ancestor
24621148|NCT01060787|Hormones|hormones|mesh-ancestor
25576814|NCT03839446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576815|NCT03839446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576816|NCT03839446|Analgesics|analgesics|mesh-ancestor
25576817|NCT03839446|Sensory System Agents|sensory system agents|mesh-ancestor
25576818|NCT03839446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25576819|NCT03839446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576820|NCT03839446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25576821|NCT03781986|Carboplatin|carboplatin|mesh-list
25576822|NCT03781986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576823|NCT03763656|Hydroxyurea|hydroxyurea|mesh-list
25700265|NCT02120157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700266|NCT02120157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25700267|NCT02120157|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25700268|NCT02120157|Antitubercular Agents|antitubercular agents|mesh-ancestor
25700269|NCT02120157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25700270|NCT02120157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24956605|NCT03852979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956607|NCT03852914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24956608|NCT03852914|Immunologic Factors|immunologic factors|mesh-ancestor
24956609|NCT03852914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956610|NCT03852914|Viscosupplements|viscosupplements|mesh-ancestor
24956611|NCT03852914|Protective Agents|protective agents|mesh-ancestor
25576824|NCT03763656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576825|NCT03763656|Antisickling Agents|antisickling agents|mesh-ancestor
25576826|NCT03763656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576827|NCT03763656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576828|NCT03763656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25576829|NCT03713645|Tacrolimus|tacrolimus|mesh-list
25576830|NCT03713645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25576831|NCT03713645|Immunologic Factors|immunologic factors|mesh-ancestor
24452226|NCT00326456|Doxorubicin|doxorubicin|mesh-list
25576832|NCT03713645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576833|NCT03713645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25576834|NCT03713645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576835|NCT03713645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576836|NCT03690869|Cemiplimab|cemiplimab|mesh-list
25576837|NCT03690869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25576838|NCT03690869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576839|NCT03641001|Micronutrients|micronutrients|mesh-list
25576840|NCT03641001|Trace Elements|trace elements|mesh-list
25576841|NCT03641001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576842|NCT03608696|Buprenorphine|buprenorphine|mesh-list
25576843|NCT03608696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25576844|NCT03608696|Narcotics|narcotics|mesh-ancestor
25576845|NCT03608696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25576846|NCT03608696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576847|NCT03608696|Analgesics|analgesics|mesh-ancestor
25576848|NCT03608696|Sensory System Agents|sensory system agents|mesh-ancestor
25576849|NCT03608696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25576850|NCT03608696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25576851|NCT03541486|Gemcitabine|gemcitabine|mesh-list
25576852|NCT03541486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576853|NCT03541486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25576854|NCT03541486|Antimetabolites|antimetabolites|mesh-ancestor
25471359|NCT00014222|Immunologic Factors|immunologic factors|mesh-ancestor
25576855|NCT03541486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576856|NCT03541486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576857|NCT03541486|Antiviral Agents|antiviral agents|mesh-ancestor
25576858|NCT03541486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25576859|NCT03541486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576860|NCT03541486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25576861|NCT03541486|Immunologic Factors|immunologic factors|mesh-ancestor
25576863|NCT03500731|Alemtuzumab|alemtuzumab|mesh-list
25576864|NCT03500731|Fludarabine|fludarabine|mesh-list
25576865|NCT03500731|Thiotepa|thiotepa|mesh-list
25576866|NCT03500731|Hydroxyurea|hydroxyurea|mesh-list
25576867|NCT03500731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25576868|NCT03500731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24956919|NCT03849729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956920|NCT03849404|Adalimumab|adalimumab|mesh-list
24956986|NCT03848780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956987|NCT03848234|Estradiol|estradiol|mesh-list
24956988|NCT03848234|Estrogens|estrogens|mesh-ancestor
24956989|NCT03848234|Hormones|hormones|mesh-ancestor
24956990|NCT03848234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24956991|NCT03848234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956992|NCT03848104|Cefoxitin|cefoxitin|mesh-list
24956993|NCT03848104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24956994|NCT03848104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24956995|NCT03848065|Vaccines|vaccines|mesh-list
24956996|NCT03848065|Immunologic Factors|immunologic factors|mesh-ancestor
24957017|NCT03847792|Autonomic Agents|autonomic agents|mesh-ancestor
25576869|NCT03500731|Immunologic Factors|immunologic factors|mesh-ancestor
25576870|NCT03500731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576871|NCT03500731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25576872|NCT03500731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576873|NCT03500731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25576874|NCT03500731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25576875|NCT03500731|Alkylating Agents|alkylating agents|mesh-ancestor
25576876|NCT03500731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25576877|NCT03500731|Antisickling Agents|antisickling agents|mesh-ancestor
25576878|NCT03500731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576879|NCT03500731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25576880|NCT03493178|Acetylcysteine|acetylcysteine|mesh-list
24652329|NCT01237808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627323|NCT01091818|Anesthetics, General|anesthetics, general|mesh-ancestor
24463044|NCT00358384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463046|NCT00358384|Respiratory System Agents|respiratory system agents|mesh-ancestor
24463047|NCT00358384|Dermatologic Agents|dermatologic agents|mesh-ancestor
24463048|NCT00358410|Casopitant|casopitant|mesh-list
24463049|NCT00358410|Antiemetics|antiemetics|mesh-ancestor
24463050|NCT00358410|Autonomic Agents|autonomic agents|mesh-ancestor
24463051|NCT00358410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24463052|NCT00358410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463053|NCT00358410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24957039|NCT03847571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24957040|NCT03847571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957041|NCT03847571|Diuretics|diuretics|mesh-ancestor
24957042|NCT03847571|Natriuretic Agents|natriuretic agents|mesh-ancestor
24957044|NCT03847922|Lidocaine|lidocaine|mesh-list
24463054|NCT00358410|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24957081|NCT03847623|Curcumin|curcumin|mesh-list
24957082|NCT03847623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24957083|NCT03847623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24957084|NCT03847623|Analgesics|analgesics|mesh-ancestor
24957085|NCT03847623|Sensory System Agents|sensory system agents|mesh-ancestor
24957086|NCT03847623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25576881|NCT03493178|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25576882|NCT03493178|Glycine|glycine|mesh-list
25576883|NCT03493178|Antiviral Agents|antiviral agents|mesh-ancestor
25576884|NCT03493178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25576885|NCT03493178|Expectorants|expectorants|mesh-ancestor
25576886|NCT03493178|Respiratory System Agents|respiratory system agents|mesh-ancestor
25576887|NCT03493178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25576888|NCT03493178|Antioxidants|antioxidants|mesh-ancestor
25576889|NCT03493178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463088|NCT00358618|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24463089|NCT00358618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24463090|NCT00358618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463091|NCT00358618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24782873|NCT01898676|Valproic Acid|valproic acid|mesh-list
24782875|NCT01898676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24782876|NCT01898676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782877|NCT01898676|GABA Agents|gaba agents|mesh-ancestor
24782878|NCT01898676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24782879|NCT01898676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782880|NCT01898676|Antimanic Agents|antimanic agents|mesh-ancestor
24957103|NCT03847207|Hormones|hormones|mesh-ancestor
24886238|NCT02432378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463098|NCT00358683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24463099|NCT00358696|Tenofovir|tenofovir|mesh-list
24463100|NCT00358696|Antiviral Agents|antiviral agents|mesh-ancestor
24957107|NCT03847246|Antiviral Agents|antiviral agents|mesh-ancestor
25576890|NCT03493178|Protective Agents|protective agents|mesh-ancestor
25576891|NCT03493178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576892|NCT03493178|Antidotes|antidotes|mesh-ancestor
25576893|NCT03493178|Glycine Agents|glycine agents|mesh-ancestor
25576894|NCT03493178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25576895|NCT03414112|Oxytocin|oxytocin|mesh-list
25576896|NCT03414112|Oxytocics|oxytocics|mesh-ancestor
25576897|NCT03414112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25576898|NCT03414112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652750|NCT01531959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25652751|NCT01531959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463152|NCT00359125|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24463153|NCT00359125|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24463155|NCT00359151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24463156|NCT00359151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24463157|NCT00359151|Analgesics|analgesics|mesh-ancestor
24602568|NCT00969462|Doxorubicin|doxorubicin|mesh-list
24463158|NCT00359151|Sensory System Agents|sensory system agents|mesh-ancestor
25078349|NCT03357133|Tirofiban|tirofiban|mesh-list
24463166|NCT00359151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463168|NCT00359164|Verteporfin|verteporfin|mesh-list
24463169|NCT00359164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24463170|NCT00359164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463171|NCT00359164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24463172|NCT00359164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24463173|NCT00359164|Growth Substances|growth substances|mesh-ancestor
24463174|NCT00359164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463175|NCT00359164|Growth Inhibitors|growth inhibitors|mesh-ancestor
24463176|NCT00359164|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24463178|NCT00359177|Casopitant|casopitant|mesh-list
24463179|NCT00359177|Antiemetics|antiemetics|mesh-ancestor
24463180|NCT00359177|Autonomic Agents|autonomic agents|mesh-ancestor
25078381|NCT03356899|Anesthetics|anesthetics|mesh-list
24463193|NCT00359229|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24957128|NCT03847272|Dermatologic Agents|dermatologic agents|mesh-ancestor
24886356|NCT04526951|Tenecteplase|tenecteplase|mesh-list
24886357|NCT04526951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24886358|NCT04526951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24886359|NCT04526951|Analgesics|analgesics|mesh-ancestor
24886360|NCT04526951|Sensory System Agents|sensory system agents|mesh-ancestor
24886361|NCT04526951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24886362|NCT04526951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465103|NCT00367913|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25652752|NCT01531959|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25652753|NCT01531959|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25652754|NCT01531959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25652755|NCT01531959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25652756|NCT01531959|Adrenergic Agents|adrenergic agents|mesh-ancestor
25652757|NCT01531959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25652758|NCT01531959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652759|NCT01531998|Dexamethasone|dexamethasone|mesh-list
25652760|NCT01531998|Lenalidomide|lenalidomide|mesh-list
25652761|NCT01531998|Bortezomib|bortezomib|mesh-list
25652762|NCT01531998|Siltuximab|siltuximab|mesh-list
25652763|NCT01531998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25652764|NCT01531998|Antiemetics|antiemetics|mesh-ancestor
25652765|NCT01531998|Autonomic Agents|autonomic agents|mesh-ancestor
25652766|NCT01531998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25652767|NCT01531998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652768|NCT01531998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25652769|NCT01531998|Glucocorticoids|glucocorticoids|mesh-ancestor
25652770|NCT01531998|Hormones|hormones|mesh-ancestor
25606166|NCT01065506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24957392|NCT03844854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24957393|NCT03844854|Antifungal Agents|antifungal agents|mesh-ancestor
24957394|NCT03844854|Keratolytic Agents|keratolytic agents|mesh-ancestor
24957395|NCT03844854|Dermatologic Agents|dermatologic agents|mesh-ancestor
24957396|NCT03844581|Propiverine|propiverine|mesh-list
24957397|NCT03844581|Parasympatholytics|parasympatholytics|mesh-ancestor
24957398|NCT03844581|Autonomic Agents|autonomic agents|mesh-ancestor
24957399|NCT03844581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24957400|NCT03844581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957401|NCT03844581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24886566|NCT04525274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957421|NCT03844451|Bupivacaine|bupivacaine|mesh-list
25652771|NCT01531998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25652772|NCT01531998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25652773|NCT01531998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652774|NCT01531998|Immunologic Factors|immunologic factors|mesh-ancestor
25652775|NCT01531998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25652776|NCT01531998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25652777|NCT01531998|Growth Substances|growth substances|mesh-ancestor
25652778|NCT01531998|Growth Inhibitors|growth inhibitors|mesh-ancestor
24957460|NCT03844776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957461|NCT03844620|Trifluridine|trifluridine|mesh-list
24957462|NCT03844620|Antimetabolites|antimetabolites|mesh-ancestor
25078407|NCT03356769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25078408|NCT03356769|Analgesics|analgesics|mesh-ancestor
25078409|NCT03356769|Sensory System Agents|sensory system agents|mesh-ancestor
25078410|NCT03356769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078411|NCT03356769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078412|NCT03356769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24957490|NCT03844763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24957491|NCT03844763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24957492|NCT03844139|Glycerol|glycerol|mesh-list
24957494|NCT03844139|Protective Agents|protective agents|mesh-ancestor
24957495|NCT03844139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957511|NCT03844217|Tryptophan|tryptophan|mesh-list
24957512|NCT03844217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24957513|NCT03844217|Antidepressive Agents|antidepressive agents|mesh-ancestor
24957514|NCT03844217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24957515|NCT03844360|Anti-Infective Agents|anti-infective agents|mesh-list
24957516|NCT03844360|Bortezomib|bortezomib|mesh-list
24957517|NCT03844360|Imatinib Mesylate|imatinib mesylate|mesh-list
24957518|NCT03844360|Dasatinib|dasatinib|mesh-list
24957519|NCT03844360|Pegaspargase|pegaspargase|mesh-list
24957520|NCT03844360|Lenograstim|lenograstim|mesh-list
24957521|NCT03844360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24957522|NCT03844360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24957523|NCT03844360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24957524|NCT03844360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652779|NCT01532089|Bevacizumab|bevacizumab|mesh-list
25652780|NCT01532089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25652781|NCT01532089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25576900|NCT03410030|Gemcitabine|gemcitabine|mesh-list
25576901|NCT03410030|Paclitaxel|paclitaxel|mesh-list
25576902|NCT03410030|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25576903|NCT03410030|Cisplatin|cisplatin|mesh-list
25576904|NCT03410030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25576905|NCT03410030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576906|NCT03410030|Tubulin Modulators|tubulin modulators|mesh-ancestor
25576907|NCT03410030|Antimitotic Agents|antimitotic agents|mesh-ancestor
25576908|NCT03410030|Mitosis Modulators|mitosis modulators|mesh-ancestor
25576909|NCT03410030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576910|NCT03410030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25576911|NCT03410030|Antimetabolites|antimetabolites|mesh-ancestor
25576912|NCT03410030|Antiviral Agents|antiviral agents|mesh-ancestor
24957562|NCT03843879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24957564|NCT03843879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24957565|NCT03843879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957566|NCT03843736|Drospirenone|drospirenone|mesh-list
24957567|NCT03843736|Contraceptive Agents|contraceptive agents|mesh-list
24957568|NCT03843736|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24957569|NCT03843736|Contraceptives, Oral|contraceptives, oral|mesh-list
24957593|NCT03843541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957595|NCT03843541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957596|NCT03843541|Antidotes|antidotes|mesh-ancestor
24957605|NCT03843281|Acetaminophen|acetaminophen|mesh-list
24957606|NCT03843281|Morphine|morphine|mesh-list
24957607|NCT03843281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24957608|NCT03843281|Narcotics|narcotics|mesh-ancestor
24957609|NCT03843281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24957610|NCT03843281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957611|NCT03843281|Analgesics|analgesics|mesh-ancestor
24957612|NCT03843281|Sensory System Agents|sensory system agents|mesh-ancestor
24957613|NCT03843281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24783826|NCT01904253|Topotecan|topotecan|mesh-list
24783468|NCT01902160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783470|NCT01902160|Antifungal Agents|antifungal agents|mesh-ancestor
24957661|NCT03842800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24957662|NCT03842800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957663|NCT03842800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24957664|NCT03842800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24604741|NCT00981513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604742|NCT00981591|Iloprost|iloprost|mesh-list
24604743|NCT00981591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24957714|NCT03842423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957715|NCT03842254|Epoetin Alfa|epoetin alfa|mesh-list
24957716|NCT03842254|Hematinics|hematinics|mesh-ancestor
24957717|NCT03842046|Phenylephrine|phenylephrine|mesh-list
24957718|NCT03842046|Oxymetazoline|oxymetazoline|mesh-list
24957719|NCT03842046|Norepinephrine|norepinephrine|mesh-list
24783522|NCT01902498|Aspirin|aspirin|mesh-list
25576913|NCT03410030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25576914|NCT03410030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576915|NCT03410030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25576916|NCT03410030|Immunologic Factors|immunologic factors|mesh-ancestor
25576917|NCT03410030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576918|NCT03410030|Antioxidants|antioxidants|mesh-ancestor
25576919|NCT03410030|Protective Agents|protective agents|mesh-ancestor
24914190|NCT04257656|Remdesivir|remdesivir|mesh-list
25078425|NCT03356600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081573|NCT03328728|Hylan|hylan|mesh-list
24463317|NCT00359905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463318|NCT00359905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957989|NCT03839433|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24957990|NCT03838926|Trichostatin A|trichostatin a|mesh-list
24957991|NCT03838926|Antifungal Agents|antifungal agents|mesh-ancestor
24957992|NCT03838926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24957993|NCT03838926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24957994|NCT03838926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576920|NCT03410030|Vitamins|vitamins|mesh-ancestor
25576921|NCT03410030|Micronutrients|micronutrients|mesh-ancestor
25576922|NCT03386240|Triclosan|triclosan|mesh-list
25576923|NCT03386240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25576924|NCT03386240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25576925|NCT03386240|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25576926|NCT03386240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25576927|NCT03386240|Antimetabolites|antimetabolites|mesh-ancestor
25576928|NCT03386240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576929|NCT03386240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25576930|NCT03240861|Aldesleukin|aldesleukin|mesh-list
25576931|NCT03240861|Plerixafor|plerixafor|mesh-list
25576932|NCT03240861|Fludarabine|fludarabine|mesh-list
25576933|NCT03240861|Busulfan|busulfan|mesh-list
25576934|NCT03240861|Interleukin-2|interleukin-2|mesh-list
25576935|NCT03240861|Lenograstim|lenograstim|mesh-list
25576936|NCT03240861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576937|NCT03240861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576938|NCT03240861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25576939|NCT03240861|Immunologic Factors|immunologic factors|mesh-ancestor
25576940|NCT03240861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778259|NCT01870115|Vitamin D|vitamin d|mesh-list
24958701|NCT03830385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24958702|NCT03830385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24958703|NCT03830086|Midazolam|midazolam|mesh-list
24958704|NCT03830086|Sufentanil|sufentanil|mesh-list
24958705|NCT03830086|Bupivacaine|bupivacaine|mesh-list
24958706|NCT03830086|Propofol|propofol|mesh-list
24958707|NCT03830086|Sevoflurane|sevoflurane|mesh-list
24958708|NCT03830086|Rocuronium|rocuronium|mesh-list
24958709|NCT03830086|Anesthetics, Local|anesthetics, local|mesh-ancestor
24958710|NCT03830086|Anesthetics|anesthetics|mesh-ancestor
24958711|NCT03830086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24958712|NCT03830086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958751|NCT03829696|Abortifacient Agents|abortifacient agents|mesh-ancestor
24958752|NCT03829696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24958753|NCT03829696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958754|NCT03829696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24958755|NCT03829696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24958756|NCT03829696|Oxytocics|oxytocics|mesh-ancestor
24958757|NCT03829696|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24958758|NCT03829696|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24958759|NCT03829696|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24958760|NCT03829696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24958831|NCT03829566|Alkylating Agents|alkylating agents|mesh-ancestor
24958832|NCT03829566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958833|NCT03829566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24958834|NCT03829566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24958835|NCT03829566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24958836|NCT03829566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24958837|NCT03829566|Antiemetics|antiemetics|mesh-ancestor
25576941|NCT03240861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25576942|NCT03240861|Alkylating Agents|alkylating agents|mesh-ancestor
25576943|NCT03240861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25576944|NCT03240861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25576945|NCT03240861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25576946|NCT03240861|Analgesics|analgesics|mesh-ancestor
25576947|NCT03240861|Sensory System Agents|sensory system agents|mesh-ancestor
25576948|NCT03240861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25576949|NCT03240861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25576950|NCT03240861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25576951|NCT03240861|Antiviral Agents|antiviral agents|mesh-ancestor
25576952|NCT03240861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25576953|NCT03088930|Crizotinib|crizotinib|mesh-list
25576954|NCT03088930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25576955|NCT03088930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25576956|NCT03088930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576957|NCT03088930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576958|NCT02955511|Pyrithione zinc|pyrithione zinc|mesh-list
25576959|NCT02955511|Keratolytic Agents|keratolytic agents|mesh-ancestor
25576960|NCT02955511|Dermatologic Agents|dermatologic agents|mesh-ancestor
25576961|NCT02845596|Cyclosporine|cyclosporine|mesh-list
25576962|NCT02845596|Cyclophosphamide|cyclophosphamide|mesh-list
25576963|NCT02845596|Methotrexate|methotrexate|mesh-list
25576964|NCT02845596|Fludarabine|fludarabine|mesh-list
25576965|NCT02845596|Cyclosporins|cyclosporins|mesh-list
25576966|NCT02845596|Thymoglobulin|thymoglobulin|mesh-list
25576967|NCT02845596|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25576968|NCT02845596|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25576969|NCT02845596|Immunologic Factors|immunologic factors|mesh-ancestor
25576970|NCT02845596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25576971|NCT02845596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25576972|NCT02845596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25576973|NCT02845596|Alkylating Agents|alkylating agents|mesh-ancestor
25576974|NCT02845596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25576975|NCT02845596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25078508|NCT03355716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078509|NCT03355716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25078510|NCT03355716|Narcotics|narcotics|mesh-ancestor
25078511|NCT03355716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25078512|NCT03355638|Pyranoprofen|pyranoprofen|mesh-list
25078513|NCT03355638|Aflibercept|aflibercept|mesh-list
25078514|NCT03355638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25078515|NCT03355638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25078516|NCT03355638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25078517|NCT03355638|Growth Substances|growth substances|mesh-ancestor
25078518|NCT03355638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078519|NCT03355638|Growth Inhibitors|growth inhibitors|mesh-ancestor
25078520|NCT03355638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25078521|NCT03355638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24609093|NCT00994981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24463429|NCT00360815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463430|NCT00360854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24463431|NCT00360854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463432|NCT00360854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24488421|NCT00468429|Growth Inhibitors|growth inhibitors|mesh-ancestor
24780611|NCT01885338|Acetylcysteine|acetylcysteine|mesh-list
25576976|NCT02845596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24959698|NCT03823248|Vitamins|vitamins|mesh-ancestor
24489144|NCT00471549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24489146|NCT00471549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24489306|NCT00472173|Calcium|calcium|mesh-list
24489387|NCT00472953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959812|NCT03822065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24959813|NCT03822065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959815|NCT03822065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25576977|NCT02845596|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25576978|NCT02845596|Abortifacient Agents|abortifacient agents|mesh-ancestor
25576979|NCT02845596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25576980|NCT02845596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25576981|NCT02845596|Antimetabolites|antimetabolites|mesh-ancestor
25576982|NCT02845596|Dermatologic Agents|dermatologic agents|mesh-ancestor
25576983|NCT02845596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25576984|NCT02845596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24785900|NCT01917058|Abatacept|abatacept|mesh-list
24671460|NCT01325987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671461|NCT01325987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24671462|NCT01325987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24671463|NCT01326000|Cetuximab|cetuximab|mesh-list
24671464|NCT01326000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24671466|NCT01326039|Bupivacaine|bupivacaine|mesh-list
24671476|NCT01326078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671477|NCT01326078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24671478|NCT01326078|Anesthetics, General|anesthetics, general|mesh-ancestor
24671479|NCT01326078|Anesthetics|anesthetics|mesh-ancestor
24671480|NCT01326117|Tadalafil|tadalafil|mesh-list
24671583|NCT01326611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671584|NCT01326611|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24959884|NCT03821480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24959885|NCT03821480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24959886|NCT03821480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24959887|NCT03821480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959889|NCT03821480|Hormone Antagonists|hormone antagonists|mesh-ancestor
24959890|NCT03821480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24959891|NCT03821480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959892|NCT03821480|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24888973|NCT04499209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888974|NCT04499209|Anticonvulsants|anticonvulsants|mesh-ancestor
24888975|NCT04499209|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24888976|NCT04499209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24888977|NCT04499209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888979|NCT04499209|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25576985|NCT02845596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25576986|NCT02845596|Antifungal Agents|antifungal agents|mesh-ancestor
25576987|NCT02845596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25576988|NCT02845596|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25576989|NCT02812615|Micronutrients|micronutrients|mesh-list
25576990|NCT02812615|Trace Elements|trace elements|mesh-list
25576991|NCT02812615|Albendazole|albendazole|mesh-list
25576992|NCT02812615|Pyrantel|pyrantel|mesh-list
25576993|NCT02812615|Pyrantel Pamoate|pyrantel pamoate|mesh-list
25576994|NCT02812615|Anthelmintics|anthelmintics|mesh-ancestor
25576995|NCT02812615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24959893|NCT03821480|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24959894|NCT03821415|Estradiol|estradiol|mesh-list
25576996|NCT02812615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25576997|NCT02812615|Anticestodal Agents|anticestodal agents|mesh-ancestor
25576998|NCT02812615|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25576999|NCT02812615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25577000|NCT02812615|Tubulin Modulators|tubulin modulators|mesh-ancestor
25577001|NCT02812615|Antimitotic Agents|antimitotic agents|mesh-ancestor
25577002|NCT02812615|Mitosis Modulators|mitosis modulators|mesh-ancestor
25577003|NCT02812615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577004|NCT02812615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577005|NCT02812615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577006|NCT02812615|Antinematodal Agents|antinematodal agents|mesh-ancestor
25577007|NCT02812615|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
25577008|NCT02812615|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25577009|NCT02812615|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25577010|NCT02812615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25577011|NCT02807883|Blinatumomab|blinatumomab|mesh-list
24781590|NCT01890863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24781591|NCT01890863|Respiratory System Agents|respiratory system agents|mesh-ancestor
24781592|NCT01890863|Dermatologic Agents|dermatologic agents|mesh-ancestor
24959951|NCT03820518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24785975|NCT01917331|Cholinergic Agents|cholinergic agents|mesh-ancestor
24621107|NCT01060696|Antiemetics|antiemetics|mesh-ancestor
24621108|NCT01060696|Autonomic Agents|autonomic agents|mesh-ancestor
24621111|NCT01060696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24959973|NCT03820193|Hydrocodone|hydrocodone|mesh-list
24959974|NCT03820193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25577012|NCT02807883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577013|NCT02807363|Leuprolide|leuprolide|mesh-list
25577014|NCT02807363|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25577015|NCT02807363|Fertility Agents|fertility agents|mesh-ancestor
25577016|NCT02807363|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25577017|NCT02807363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577018|NCT02807363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25577019|NCT02807363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577020|NCT02756403|Azithromycin|azithromycin|mesh-list
25577021|NCT02756403|Metronidazole|metronidazole|mesh-list
25577022|NCT02756403|Doxycycline|doxycycline|mesh-list
25577023|NCT02756403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25577024|NCT02756403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25577025|NCT02756403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25577026|NCT02756403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25577027|NCT02756403|Antimalarials|antimalarials|mesh-ancestor
25577028|NCT02739035|Dexamethasone|dexamethasone|mesh-list
25577029|NCT02739035|Celecoxib|celecoxib|mesh-list
25577030|NCT02739035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24781850|NCT01892384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960104|NCT03819101|Atorvastatin|atorvastatin|mesh-list
24960105|NCT03819101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24960106|NCT03819101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24960107|NCT03819101|Antimetabolites|antimetabolites|mesh-ancestor
24960108|NCT03819101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960109|NCT03819101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24960111|NCT03819101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577031|NCT02739035|Antiemetics|antiemetics|mesh-ancestor
25577032|NCT02739035|Autonomic Agents|autonomic agents|mesh-ancestor
25577033|NCT02739035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25577034|NCT02739035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577035|NCT02739035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25577036|NCT02739035|Glucocorticoids|glucocorticoids|mesh-ancestor
25577037|NCT02739035|Hormones|hormones|mesh-ancestor
25577038|NCT02739035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24960143|NCT03819010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960144|NCT03819010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24960145|NCT03818997|Paclitaxel|paclitaxel|mesh-list
24960147|NCT03818997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24960148|NCT03818997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24960149|NCT03818997|Tubulin Modulators|tubulin modulators|mesh-ancestor
24960150|NCT03818997|Antimitotic Agents|antimitotic agents|mesh-ancestor
24960151|NCT03818997|Mitosis Modulators|mitosis modulators|mesh-ancestor
24960152|NCT03818997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960153|NCT03818945|Listerine|listerine|mesh-list
24960154|NCT03818945|Fluorides|fluorides|mesh-list
24960155|NCT03818945|Sodium Fluoride|sodium fluoride|mesh-list
24960156|NCT03818945|Fluorides, Topical|fluorides, topical|mesh-list
24960157|NCT03818945|Cariostatic Agents|cariostatic agents|mesh-ancestor
24960158|NCT03818945|Protective Agents|protective agents|mesh-ancestor
24960162|NCT03818932|Acetaminophen|acetaminophen|mesh-list
24960163|NCT03818932|Celecoxib|celecoxib|mesh-list
25577039|NCT02739035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25577040|NCT02739035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490547|NCT00478907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25700355|NCT02121041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782312|NCT01895296|Pasireotide|pasireotide|mesh-list
24889376|NCT04494399|Antiviral Agents|antiviral agents|mesh-ancestor
24673377|NCT01337440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452387|NCT00327353|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24960352|NCT03818321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24960353|NCT03818321|Renal Agents|renal agents|mesh-ancestor
24960354|NCT03818321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24960356|NCT03817541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24960357|NCT03817541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24960358|NCT03817541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960359|NCT03817541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24960360|NCT03817541|Anesthetics, General|anesthetics, general|mesh-ancestor
24491302|NCT00481975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491303|NCT00481975|Hormones|hormones|mesh-ancestor
24442423|NCT00290914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25082107|NCT03324776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782563|NCT01896609|Ribavirin|ribavirin|mesh-list
24889584|NCT04491786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24889585|NCT04491786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24960522|NCT03816072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25577041|NCT02739035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25577042|NCT02739035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25577043|NCT02739035|Analgesics|analgesics|mesh-ancestor
25577044|NCT02739035|Sensory System Agents|sensory system agents|mesh-ancestor
25577045|NCT02739035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25577046|NCT02739035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25577047|NCT02739035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25577048|NCT02739035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577049|NCT02739035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577050|NCT02710851|Vaccines|vaccines|mesh-list
25577051|NCT02710851|Immunologic Factors|immunologic factors|mesh-ancestor
25577052|NCT02710851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577053|NCT02682888|Oxytocin|oxytocin|mesh-list
25577054|NCT02682888|Oxytocics|oxytocics|mesh-ancestor
25577055|NCT02682888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25700360|NCT02121041|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25700361|NCT02121041|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24889657|NCT04491357|Calcium, Dietary|calcium, dietary|mesh-list
24889658|NCT04491357|Calcium|calcium|mesh-list
24889659|NCT04491357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24889660|NCT04491357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889661|NCT04491357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24960603|NCT03815448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24960604|NCT03815344|Misoprostol|misoprostol|mesh-list
24960605|NCT03815344|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24960606|NCT03815344|Abortifacient Agents|abortifacient agents|mesh-ancestor
24960607|NCT03815344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24960608|NCT03815344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960610|NCT03815344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24960611|NCT03815344|Oxytocics|oxytocics|mesh-ancestor
24960612|NCT03815305|Petrolatum|petrolatum|mesh-list
24960613|NCT03815305|Emollients|emollients|mesh-ancestor
24960614|NCT03815305|Dermatologic Agents|dermatologic agents|mesh-ancestor
24960615|NCT03815435|Anesthetics|anesthetics|mesh-list
25577056|NCT02682888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577057|NCT02669186|Fentanyl|fentanyl|mesh-list
25577058|NCT02669186|Bupivacaine|bupivacaine|mesh-list
25577059|NCT02669186|Anesthetics, Local|anesthetics, local|mesh-ancestor
25577060|NCT02669186|Anesthetics|anesthetics|mesh-ancestor
25577061|NCT02669186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25577062|NCT02669186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577063|NCT02669186|Sensory System Agents|sensory system agents|mesh-ancestor
24574872|NCT00828230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24574873|NCT00828230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24574874|NCT00828230|Autonomic Agents|autonomic agents|mesh-ancestor
24960691|NCT03814707|Immunologic Factors|immunologic factors|mesh-ancestor
24960692|NCT03814707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960693|NCT03814707|Viscosupplements|viscosupplements|mesh-ancestor
24960694|NCT03814707|Protective Agents|protective agents|mesh-ancestor
24786632|NCT01921010|Vitamin B Complex|vitamin b complex|mesh-ancestor
24960697|NCT03814447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24960698|NCT03814447|Immunologic Factors|immunologic factors|mesh-ancestor
24960699|NCT03814447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623920|NCT01073995|Anesthetics|anesthetics|mesh-ancestor
24960910|NCT03813316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960911|NCT03813316|Incretins|incretins|mesh-ancestor
24960912|NCT03813316|Hormones|hormones|mesh-ancestor
24960913|NCT03813316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24960914|NCT03813316|Protease Inhibitors|protease inhibitors|mesh-ancestor
24960915|NCT03813316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24960916|NCT03813316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960917|NCT03813303|Fentanyl|fentanyl|mesh-list
24960918|NCT03813303|Midazolam|midazolam|mesh-list
24960919|NCT03813303|Propofol|propofol|mesh-list
24960925|NCT03813303|Anesthetics|anesthetics|mesh-ancestor
25577064|NCT02669186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25577065|NCT02669186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25577066|NCT02669186|Narcotics|narcotics|mesh-ancestor
25577067|NCT02669186|Analgesics|analgesics|mesh-ancestor
25577068|NCT02669186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25577069|NCT02669186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25577070|NCT02669186|Anesthetics, General|anesthetics, general|mesh-ancestor
25577071|NCT02665117|Chlorthalidone|chlorthalidone|mesh-list
25577072|NCT02665117|Magnesium citrate|magnesium citrate|mesh-list
24492230|NCT00485771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24960990|NCT03813030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24960991|NCT03813030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24960992|NCT03813030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24960993|NCT03813030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960995|NCT03812783|Folfirinox|folfirinox|mesh-list
24960996|NCT03812783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24960997|NCT03812783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24960998|NCT03812783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24961000|NCT03812796|Avelumab|avelumab|mesh-list
24786964|NCT01922817|Hormones|hormones|mesh-ancestor
24784158|NCT01906671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24784159|NCT01906671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492444|NCT00486343|Hormone Antagonists|hormone antagonists|mesh-ancestor
24961011|NCT03812731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24961043|NCT03812770|Fluorouracil|fluorouracil|mesh-list
24961044|NCT03812770|Oxaliplatin|oxaliplatin|mesh-list
24961045|NCT03812770|Sorafenib|sorafenib|mesh-list
24961046|NCT03812770|Antimetabolites|antimetabolites|mesh-ancestor
24961047|NCT03812770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961049|NCT03812770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24785014|NCT01911494|Autonomic Agents|autonomic agents|mesh-ancestor
24785015|NCT01911494|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24961105|NCT03811509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24961106|NCT03811509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961107|NCT03810872|Paclitaxel|paclitaxel|mesh-list
24961108|NCT03810872|Afatinib|afatinib|mesh-list
24961110|NCT03810872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24961112|NCT03810872|Antimitotic Agents|antimitotic agents|mesh-ancestor
24961113|NCT03810872|Mitosis Modulators|mitosis modulators|mesh-ancestor
24961114|NCT03810872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785493|NCT01914744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24785494|NCT01914744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24785495|NCT01914744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785542|NCT01914965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24785543|NCT01915069|Cilostazol|cilostazol|mesh-list
24785544|NCT01915069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24785545|NCT01915069|Autonomic Agents|autonomic agents|mesh-ancestor
24785546|NCT01915069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24785560|NCT01915082|Azithromycin|azithromycin|mesh-list
24785584|NCT01915264|Metformin|metformin|mesh-list
24675784|NCT01345279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463748|NCT00361998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24463749|NCT00361998|Renal Agents|renal agents|mesh-ancestor
24463750|NCT00361998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24463751|NCT00362037|Irbesartan|irbesartan|mesh-list
24463752|NCT00362037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24463753|NCT00362037|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24961219|NCT03809702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25577073|NCT02665117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577074|NCT02665117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25577075|NCT02665117|Diuretics|diuretics|mesh-ancestor
25577076|NCT02665117|Natriuretic Agents|natriuretic agents|mesh-ancestor
25577077|NCT02665117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577078|NCT02665117|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25577079|NCT02665117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25577080|NCT02665117|Cathartics|cathartics|mesh-ancestor
25577081|NCT02665117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25577082|NCT02646839|Biotin|biotin|mesh-list
25577083|NCT02646839|Vitamin B Complex|vitamin b complex|mesh-ancestor
25577084|NCT02646839|Vitamins|vitamins|mesh-ancestor
24786348|NCT01919294|Testosterone|testosterone|mesh-list
24786349|NCT01919294|Testosterone undecanoate|testosterone undecanoate|mesh-list
24786350|NCT01919294|Testosterone enanthate|testosterone enanthate|mesh-list
24817065|NCT02080728|Ropivacaine|ropivacaine|mesh-list
24961272|NCT03809312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24961274|NCT03809312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961275|NCT03809312|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24890263|NCT04484844|Listerine|listerine|mesh-list
24675879|NCT01345981|Anesthetics, Local|anesthetics, local|mesh-ancestor
24675880|NCT01345981|Anesthetics|anesthetics|mesh-ancestor
24675881|NCT01345981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24675882|NCT01345981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675883|NCT01345981|Sensory System Agents|sensory system agents|mesh-ancestor
24675884|NCT01345981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24675885|NCT01345981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24675886|NCT01345981|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24675887|NCT01345981|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24675888|NCT01345981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24463797|NCT00362271|Aripiprazole|aripiprazole|mesh-list
24463800|NCT00362271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24961334|NCT03809325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961335|NCT03809325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961377|NCT03809221|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24961378|NCT03809221|Hormones|hormones|mesh-list
24961379|NCT03809221|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24961380|NCT03809221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25577085|NCT02646839|Micronutrients|micronutrients|mesh-ancestor
25577086|NCT02646839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577087|NCT02641236|Vancomycin|vancomycin|mesh-list
25577088|NCT02641236|Polymyxins|polymyxins|mesh-list
25577089|NCT02641236|Polymyxin B|polymyxin b|mesh-list
25577090|NCT02641236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25577091|NCT02641236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25577092|NCT02487797|Oxytocin|oxytocin|mesh-list
25577093|NCT02487797|Oxytocics|oxytocics|mesh-ancestor
25577094|NCT02487797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24961512|NCT03807882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961513|NCT03807882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961514|NCT03807882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24961515|NCT03807882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24961516|NCT03807882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961517|NCT03807882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24961518|NCT03807882|GABA Antagonists|gaba antagonists|mesh-ancestor
24961519|NCT03807882|GABA Agents|gaba agents|mesh-ancestor
24961520|NCT03807297|Dexmedetomidine|dexmedetomidine|mesh-list
24961521|NCT03807297|Nitrous Oxide|nitrous oxide|mesh-list
24961522|NCT03807297|Propofol|propofol|mesh-list
24961523|NCT03807297|Sevoflurane|sevoflurane|mesh-list
24961533|NCT03807297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961534|NCT03807297|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24788236|NCT01930396|Tinzaparin|tinzaparin|mesh-list
24788237|NCT01930396|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24788238|NCT01930396|Dalteparin|dalteparin|mesh-list
24627971|NCT01095900|Botulinum Toxins|botulinum toxins|mesh-list
24627972|NCT01095900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24788377|NCT01931085|Triclabendazole|triclabendazole|mesh-list
24961656|NCT03806062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961657|NCT03806062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24961658|NCT03806062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24961659|NCT03806062|Dopamine Agents|dopamine agents|mesh-ancestor
24961660|NCT03806062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24961661|NCT03806062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961663|NCT03806036|Clomiphene|clomiphene|mesh-list
24961664|NCT03806036|Enclomiphene|enclomiphene|mesh-list
25577095|NCT02487797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577096|NCT02348762|Acetylcysteine|acetylcysteine|mesh-list
24677655|NCT01357603|Insulin Glargine|insulin glargine|mesh-list
24961857|NCT03805035|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24961858|NCT03804866|Doxorubicin|doxorubicin|mesh-list
24961859|NCT03804866|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24961860|NCT03804866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24961861|NCT03804866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24961862|NCT03804866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24961863|NCT03804866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24961864|NCT03804866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24790816|NCT01945476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790817|NCT01945476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24790818|NCT01945476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24790819|NCT01945476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24790820|NCT01945476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24790821|NCT01945476|Anesthetics, General|anesthetics, general|mesh-ancestor
24790822|NCT01945476|Anesthetics|anesthetics|mesh-ancestor
24790823|NCT01945476|GABA Modulators|gaba modulators|mesh-ancestor
25577097|NCT02348762|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25577098|NCT02348762|Glycine|glycine|mesh-list
25577099|NCT02348762|Antiviral Agents|antiviral agents|mesh-ancestor
25577100|NCT02348762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25577101|NCT02348762|Expectorants|expectorants|mesh-ancestor
25577102|NCT02348762|Respiratory System Agents|respiratory system agents|mesh-ancestor
25577103|NCT02348762|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25577104|NCT02348762|Antioxidants|antioxidants|mesh-ancestor
24791223|NCT04946396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24584152|NCT00878748|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24584153|NCT00878748|Antidepressive Agents|antidepressive agents|mesh-ancestor
24584154|NCT00878748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24791332|NCT04773392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24962078|NCT03802838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962079|NCT03802838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24962080|NCT03802838|Antidepressive Agents|antidepressive agents|mesh-ancestor
24962081|NCT03802773|Cyclophosphamide|cyclophosphamide|mesh-list
24962082|NCT03802773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24962083|NCT03802773|Immunologic Factors|immunologic factors|mesh-ancestor
24962084|NCT03802773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962085|NCT03802773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24962086|NCT03802773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25577105|NCT02348762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577106|NCT02348762|Protective Agents|protective agents|mesh-ancestor
24924672|NCT04157959|Febuxostat|febuxostat|mesh-list
24493646|NCT00491855|Growth Substances|growth substances|mesh-ancestor
24493647|NCT00491855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493648|NCT00491855|Growth Inhibitors|growth inhibitors|mesh-ancestor
24493649|NCT00491868|Epoetin Alfa|epoetin alfa|mesh-list
24493795|NCT00492466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493796|NCT00492466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24626848|NCT01088893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626849|NCT01088893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24626850|NCT01088893|Immunologic Factors|immunologic factors|mesh-ancestor
24626851|NCT01088893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626852|NCT01088906|Pemetrexed|pemetrexed|mesh-list
24626853|NCT01088906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626854|NCT01088906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626855|NCT01088906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626856|NCT01088906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24626857|NCT01088906|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25577107|NCT02348762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577108|NCT02348762|Antidotes|antidotes|mesh-ancestor
25577109|NCT02348762|Glycine Agents|glycine agents|mesh-ancestor
25577110|NCT02348762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25577111|NCT02348359|Ranibizumab|ranibizumab|mesh-list
25577112|NCT02348359|Aflibercept|aflibercept|mesh-list
25577113|NCT02348359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577114|NCT02348359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25577115|NCT02348359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25577116|NCT02348359|Growth Substances|growth substances|mesh-ancestor
25577117|NCT02348359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577118|NCT02348359|Growth Inhibitors|growth inhibitors|mesh-ancestor
25577119|NCT02252432|Ketamine|ketamine|mesh-list
25577120|NCT02252432|Methadone|methadone|mesh-list
25577121|NCT02252432|Analgesics|analgesics|mesh-ancestor
25577122|NCT02252432|Sensory System Agents|sensory system agents|mesh-ancestor
25577123|NCT02252432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25577124|NCT02252432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792857|NCT04493333|Cathartics|cathartics|mesh-ancestor
24585930|NCT00888186|Dopamine Agents|dopamine agents|mesh-ancestor
24493895|NCT00492778|Cisplatin|cisplatin|mesh-list
24803830|NCT01998698|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24804046|NCT02000674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804047|NCT02000674|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
24804048|NCT02000700|Canagliflozin|canagliflozin|mesh-list
25082636|NCT03321318|Bazedoxifene|bazedoxifene|mesh-list
25082637|NCT03321318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25577125|NCT02252432|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25577126|NCT02252432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25577127|NCT02252432|Anesthetics, General|anesthetics, general|mesh-ancestor
25577128|NCT02252432|Anesthetics|anesthetics|mesh-ancestor
25577129|NCT02252432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25577130|NCT02252432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25577131|NCT02252432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25577132|NCT02252432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24793139|NCT04073303|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24494846|NCT00497237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24494847|NCT00497237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494884|NCT00497458|Testosterone|testosterone|mesh-list
25577133|NCT02252432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577134|NCT02252432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25577135|NCT02252432|Narcotics|narcotics|mesh-ancestor
25577136|NCT02252432|Antitussive Agents|antitussive agents|mesh-ancestor
25577137|NCT02252432|Respiratory System Agents|respiratory system agents|mesh-ancestor
25577138|NCT02224872|Mycophenolic Acid|mycophenolic acid|mesh-list
25577139|NCT02224872|Cyclophosphamide|cyclophosphamide|mesh-list
25577140|NCT02224872|Fludarabine|fludarabine|mesh-list
25577141|NCT02224872|Tacrolimus|tacrolimus|mesh-list
25577142|NCT02224872|Thymoglobulin|thymoglobulin|mesh-list
25577143|NCT02224872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25577144|NCT02224872|Immunologic Factors|immunologic factors|mesh-ancestor
25577145|NCT02224872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577146|NCT02224872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25577147|NCT02224872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25577148|NCT02224872|Alkylating Agents|alkylating agents|mesh-ancestor
25577149|NCT02224872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577150|NCT02224872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577151|NCT02224872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24628178|NCT01096940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24628179|NCT01096940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24628180|NCT01096940|Antimetabolites|antimetabolites|mesh-ancestor
25577152|NCT02224872|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25577153|NCT02224872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577154|NCT02224872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25577155|NCT02224872|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25577156|NCT02224872|Antitubercular Agents|antitubercular agents|mesh-ancestor
25577157|NCT02224872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25577158|NCT02224872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25577159|NCT02187224|Progesterone|progesterone|mesh-list
25577160|NCT02187224|Progestins|progestins|mesh-ancestor
25577161|NCT02187224|Hormones|hormones|mesh-ancestor
25577162|NCT02187224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25577163|NCT02187224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577164|NCT01995669|Lenalidomide|lenalidomide|mesh-list
25577165|NCT01995669|Obinutuzumab|obinutuzumab|mesh-list
25577166|NCT01995669|Immunologic Factors|immunologic factors|mesh-ancestor
25577167|NCT01995669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577168|NCT01995669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25577169|NCT01995669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25577170|NCT01995669|Growth Substances|growth substances|mesh-ancestor
24962788|NCT03795311|Bevacizumab|bevacizumab|mesh-list
25577171|NCT01995669|Growth Inhibitors|growth inhibitors|mesh-ancestor
24968267|NCT03752398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962980|NCT03794167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24962981|NCT03794167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24962982|NCT03794167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078801|NCT03353857|Hormone Antagonists|hormone antagonists|mesh-ancestor
25577172|NCT01995669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577173|NCT01995669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25577174|NCT01968109|Nivolumab|nivolumab|mesh-list
25577175|NCT01968109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25577176|NCT01968109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577177|NCT01968109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25577178|NCT01968109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577179|NCT01935336|Ponatinib|ponatinib|mesh-list
25577180|NCT01935336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577181|NCT01935336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25577182|NCT01935336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577183|NCT01935336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577184|NCT01905436|Ivermectin|ivermectin|mesh-list
25577185|NCT01905436|Albendazole|albendazole|mesh-list
25577186|NCT01905436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25577187|NCT01905436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25082850|NCT03319563|Respiratory System Agents|respiratory system agents|mesh-ancestor
25577188|NCT01905436|Anthelmintics|anthelmintics|mesh-ancestor
25577189|NCT01905436|Anticestodal Agents|anticestodal agents|mesh-ancestor
25577190|NCT01905436|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25577191|NCT01905436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25577192|NCT01905436|Tubulin Modulators|tubulin modulators|mesh-ancestor
25577193|NCT01905436|Antimitotic Agents|antimitotic agents|mesh-ancestor
25577194|NCT01905436|Mitosis Modulators|mitosis modulators|mesh-ancestor
25577195|NCT01905436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577196|NCT01905436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24963374|NCT03791424|Midazolam|midazolam|mesh-list
25577197|NCT01733693|Buprenorphine|buprenorphine|mesh-list
24969179|NCT03745157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24969180|NCT03745157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969218|NCT03744988|Hormones|hormones|mesh-ancestor
24963737|NCT03788889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24963738|NCT03788889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963739|NCT03788889|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24963740|NCT03788889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24963741|NCT03788889|Anesthetics, General|anesthetics, general|mesh-ancestor
24963742|NCT03788889|Anesthetics|anesthetics|mesh-ancestor
24892770|NCT04458948|Azithromycin|azithromycin|mesh-list
25577198|NCT01733693|Methadone|methadone|mesh-list
25577199|NCT01733693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25577200|NCT01733693|Narcotics|narcotics|mesh-ancestor
25577201|NCT01733693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25577202|NCT01733693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577203|NCT01733693|Analgesics|analgesics|mesh-ancestor
25577204|NCT01733693|Sensory System Agents|sensory system agents|mesh-ancestor
25577205|NCT01733693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25577206|NCT01733693|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25577207|NCT01733693|Antitussive Agents|antitussive agents|mesh-ancestor
24969396|NCT03743285|Insulin Lispro|insulin lispro|mesh-list
24789718|NCT01938729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24963839|NCT03788538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24892912|NCT04456985|Vitamins|vitamins|mesh-ancestor
24963865|NCT03788317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24628327|NCT01098084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24628328|NCT01098084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25082981|NCT03318757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25082982|NCT03318757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969609|NCT03741933|Apremilast|apremilast|mesh-list
24963979|NCT03787017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963980|NCT03786757|Rivaroxaban|rivaroxaban|mesh-list
25577208|NCT01733693|Respiratory System Agents|respiratory system agents|mesh-ancestor
25577209|NCT01712490|Doxorubicin|doxorubicin|mesh-list
25577210|NCT01712490|Bleomycin|bleomycin|mesh-list
25577211|NCT01712490|Dacarbazine|dacarbazine|mesh-list
25577212|NCT01712490|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25577213|NCT01712490|Vinblastine|vinblastine|mesh-list
25577214|NCT01712490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25577215|NCT01712490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577216|NCT01712490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25577217|NCT01712490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25577218|NCT01712490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577219|NCT01712490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577220|NCT01712490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25577221|NCT01712490|Alkylating Agents|alkylating agents|mesh-ancestor
25577222|NCT01712490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25577223|NCT01712490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25577224|NCT01712490|Tubulin Modulators|tubulin modulators|mesh-ancestor
25577225|NCT01712490|Antimitotic Agents|antimitotic agents|mesh-ancestor
25577226|NCT01712490|Mitosis Modulators|mitosis modulators|mesh-ancestor
25577227|NCT01499160|Everolimus|everolimus|mesh-list
25577228|NCT01499160|Letrozole|letrozole|mesh-list
25577229|NCT01499160|Lapatinib|lapatinib|mesh-list
25083069|NCT03318211|Anesthetics|anesthetics|mesh-ancestor
24964479|NCT03783065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25577230|NCT01499160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577231|NCT01499160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25577232|NCT01499160|Immunologic Factors|immunologic factors|mesh-ancestor
25078963|NCT03351842|Pemetrexed|pemetrexed|mesh-list
25700549|NCT02123966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700550|NCT02124044|Asunaprevir|asunaprevir|mesh-list
24970709|NCT03731403|Cariostatic Agents|cariostatic agents|mesh-ancestor
24970710|NCT03731403|Protective Agents|protective agents|mesh-ancestor
24970711|NCT03731403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970712|NCT03731286|Caffeine|caffeine|mesh-list
25577233|NCT01499160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577234|NCT01499160|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25577235|NCT01499160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25577236|NCT01499160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577237|NCT01499160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577238|NCT01499160|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25577239|NCT01499160|Hormone Antagonists|hormone antagonists|mesh-ancestor
25577240|NCT01499160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24627048|NCT01090206|Micronutrients|micronutrients|mesh-ancestor
24627049|NCT01090206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627050|NCT01090206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24627051|NCT01090206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24627052|NCT01090466|Gemcitabine|gemcitabine|mesh-list
24627053|NCT01090466|Sirolimus|sirolimus|mesh-list
24627054|NCT01090466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24627055|NCT01090466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24627056|NCT01090466|Antimetabolites|antimetabolites|mesh-ancestor
25577241|NCT01499160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25577242|NCT01256086|Formoterol Fumarate|formoterol fumarate|mesh-list
25577243|NCT01256086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25700567|NCT02124564|Lacosamide|lacosamide|mesh-list
25577244|NCT01256086|Autonomic Agents|autonomic agents|mesh-ancestor
25577245|NCT01256086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25577246|NCT01256086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577247|NCT01256086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25577248|NCT01256086|Respiratory System Agents|respiratory system agents|mesh-ancestor
25577249|NCT01256086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25577250|NCT01256086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25577251|NCT01256086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25577252|NCT01256086|Adrenergic Agents|adrenergic agents|mesh-ancestor
25577253|NCT01256086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25577254|NCT01256086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577255|NCT01149850|Bevacizumab|bevacizumab|mesh-list
25577256|NCT01149850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25700580|NCT02124707|Mitosis Modulators|mitosis modulators|mesh-ancestor
25700581|NCT02124707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700582|NCT02124707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25700583|NCT02124746|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
25700584|NCT02124746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24971086|NCT03728829|Tubulin Modulators|tubulin modulators|mesh-ancestor
25577257|NCT01149850|Temozolomide|temozolomide|mesh-list
25577258|NCT01149850|Antibodies|antibodies|mesh-list
25577259|NCT01149850|Immunoglobulins|immunoglobulins|mesh-list
25577260|NCT01149850|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25577261|NCT01149850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577262|NCT01149850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25577263|NCT01149850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25577264|NCT01149850|Growth Substances|growth substances|mesh-ancestor
25577265|NCT01149850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577266|NCT01149850|Growth Inhibitors|growth inhibitors|mesh-ancestor
25079048|NCT03351062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25079049|NCT03351062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894441|NCT04440280|Antiviral Agents|antiviral agents|mesh-ancestor
24452728|NCT05457361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24452729|NCT05457361|Antimetabolites|antimetabolites|mesh-ancestor
25577267|NCT01149850|Immunologic Factors|immunologic factors|mesh-ancestor
25577268|NCT01149850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25577269|NCT01149850|Alkylating Agents|alkylating agents|mesh-ancestor
25577270|NCT01149850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577271|NCT01090089|Dexamethasone|dexamethasone|mesh-list
25577272|NCT01090089|Dexamethasone acetate|dexamethasone acetate|mesh-list
25577273|NCT01090089|Lenalidomide|lenalidomide|mesh-list
25577274|NCT01090089|BB 1101|bb 1101|mesh-list
25577275|NCT01090089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25577276|NCT01090089|Antiemetics|antiemetics|mesh-ancestor
25577277|NCT01090089|Autonomic Agents|autonomic agents|mesh-ancestor
25577278|NCT01090089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24971274|NCT03726788|Botulinum Toxins|botulinum toxins|mesh-list
24971275|NCT03726788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24971276|NCT03726788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24971277|NCT03726788|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24971278|NCT03726788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24894479|NCT04440267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24808635|NCT02028494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688891|NCT02578368|Leucovorin|leucovorin|mesh-list
24464330|NCT00364429|Lorazepam|lorazepam|mesh-list
24464331|NCT00364429|Risperidone|risperidone|mesh-list
24464332|NCT00364429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24965307|NCT03777930|Thalidomide|thalidomide|mesh-list
24965308|NCT03777930|Megestrol|megestrol|mesh-list
24965309|NCT03777930|Megestrol Acetate|megestrol acetate|mesh-list
24965310|NCT03777930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24965311|NCT03777930|Immunologic Factors|immunologic factors|mesh-ancestor
24965312|NCT03777930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965313|NCT03777930|Leprostatic Agents|leprostatic agents|mesh-ancestor
24965314|NCT03777930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24965315|NCT03777930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24464333|NCT00364429|Serotonin Agents|serotonin agents|mesh-ancestor
24464334|NCT00364429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24464335|NCT00364429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464346|NCT00364429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25700594|NCT02124772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25700595|NCT02124772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700596|NCT02124772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700597|NCT02124798|Belimumab|belimumab|mesh-list
25700598|NCT02124798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25700599|NCT02124798|Immunologic Factors|immunologic factors|mesh-ancestor
25700600|NCT02124798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700601|NCT02124811|Minocycline|minocycline|mesh-list
25577279|NCT01090089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577280|NCT01090089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25577281|NCT01090089|Glucocorticoids|glucocorticoids|mesh-ancestor
25577282|NCT01090089|Hormones|hormones|mesh-ancestor
25577283|NCT01090089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25577284|NCT01090089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25577285|NCT01090089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577286|NCT01090089|Protease Inhibitors|protease inhibitors|mesh-ancestor
25577287|NCT01090089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577288|NCT01090089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577289|NCT01090089|Immunologic Factors|immunologic factors|mesh-ancestor
25577290|NCT01090089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25577291|NCT01090089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25577292|NCT01090089|Growth Substances|growth substances|mesh-ancestor
25577293|NCT01090089|Growth Inhibitors|growth inhibitors|mesh-ancestor
24909356|NCT04310176|GABA Agents|gaba agents|mesh-ancestor
24965624|NCT03775746|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24965625|NCT03775746|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24965640|NCT03775928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624864|NCT01079078|Antipyretics|antipyretics|mesh-ancestor
24965645|NCT03775538|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24965648|NCT03775538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24965649|NCT03775538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965651|NCT03775538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24965702|NCT03775395|Sorafenib|sorafenib|mesh-list
25577295|NCT01061151|Lopinavir|lopinavir|mesh-list
25577296|NCT01061151|Tenofovir|tenofovir|mesh-list
25577297|NCT01061151|Lamivudine|lamivudine|mesh-list
25577298|NCT01061151|Zidovudine|zidovudine|mesh-list
25577299|NCT01061151|Emtricitabine|emtricitabine|mesh-list
25577300|NCT01061151|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25577301|NCT01061151|Nevirapine|nevirapine|mesh-list
25577302|NCT01061151|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25577303|NCT01061151|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25577304|NCT01061151|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25577305|NCT01061151|Protease Inhibitors|protease inhibitors|mesh-ancestor
25577306|NCT01061151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577307|NCT01061151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577308|NCT01061151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25577309|NCT01061151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25577310|NCT01061151|Antiviral Agents|antiviral agents|mesh-ancestor
25577311|NCT01061151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25577312|NCT01061151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25577313|NCT01061151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25083299|NCT03316963|Cholinergic Agents|cholinergic agents|mesh-ancestor
25577314|NCT01061151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25577315|NCT01061151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25577316|NCT01061151|Antimetabolites|antimetabolites|mesh-ancestor
24971676|NCT03723395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25577317|NCT01061151|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25577318|NCT01061151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25577319|NCT00981058|Gemcitabine|gemcitabine|mesh-list
25577320|NCT00981058|Cisplatin|cisplatin|mesh-list
25577321|NCT00981058|Necitumumab|necitumumab|mesh-list
25577322|NCT00981058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577323|NCT00981058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25577324|NCT00981058|Antimetabolites|antimetabolites|mesh-ancestor
25577325|NCT00981058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971827|NCT03722290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24971828|NCT03722290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971861|NCT03721874|Dapagliflozin|dapagliflozin|mesh-list
24971862|NCT03721874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24971863|NCT03721874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577326|NCT00981058|Antiviral Agents|antiviral agents|mesh-ancestor
25577327|NCT00981058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25577328|NCT00981058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577329|NCT00981058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25577330|NCT00981058|Immunologic Factors|immunologic factors|mesh-ancestor
25577331|NCT00981058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577332|NCT00981058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25577333|NCT00885495|Ritonavir|ritonavir|mesh-list
25577334|NCT00885495|Darunavir|darunavir|mesh-list
25577335|NCT00885495|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25577336|NCT00885495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24971985|NCT03721081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24971986|NCT03721081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24971987|NCT03721081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24971988|NCT03721081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971989|NCT03720899|Nicotine|nicotine|mesh-list
24971990|NCT03720899|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25577337|NCT00885495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25577338|NCT00885495|Protease Inhibitors|protease inhibitors|mesh-ancestor
25577339|NCT00885495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577340|NCT00885495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577341|NCT00885495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25577342|NCT00885495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25577343|NCT00885495|Antiviral Agents|antiviral agents|mesh-ancestor
25577344|NCT00885495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25577345|NCT00885495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25577346|NCT00885495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25577347|NCT00885495|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25577348|NCT00885495|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25577349|NCT00885495|Antimetabolites|antimetabolites|mesh-ancestor
25577350|NCT00885495|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24627249|NCT01091493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24464879|NCT00367211|Naproxen|naproxen|mesh-list
24464918|NCT00367302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24464919|NCT00367302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464920|NCT00367302|Analgesics|analgesics|mesh-ancestor
24627250|NCT01091493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24627252|NCT01091493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627253|NCT01091493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24627255|NCT01091571|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25577351|NCT00885495|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25577352|NCT00692939|Cyclophosphamide|cyclophosphamide|mesh-list
25577353|NCT00692939|Melphalan|melphalan|mesh-list
25577354|NCT00692939|Thiotepa|thiotepa|mesh-list
25577355|NCT00692939|Rituximab|rituximab|mesh-list
25577356|NCT00692939|Alemtuzumab|alemtuzumab|mesh-list
25577357|NCT00692939|Thymoglobulin|thymoglobulin|mesh-list
25577358|NCT00692939|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25471834|NCT00026208|Hormones|hormones|mesh-ancestor
25577359|NCT00692939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25577360|NCT00692939|Immunologic Factors|immunologic factors|mesh-ancestor
25577361|NCT00692939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577362|NCT00692939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25577363|NCT00692939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25577364|NCT00692939|Alkylating Agents|alkylating agents|mesh-ancestor
25577365|NCT00692939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577366|NCT00692939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577367|NCT00692939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25577368|NCT00692939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25700674|NCT02127372|Cisplatin|cisplatin|mesh-list
25700675|NCT02127372|Docetaxel|docetaxel|mesh-list
25700676|NCT02127372|Imatinib Mesylate|imatinib mesylate|mesh-list
24504143|NCT00534287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504195|NCT00534573|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24972349|NCT03718624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24972350|NCT03718624|Tubulin Modulators|tubulin modulators|mesh-ancestor
24972351|NCT03718624|Antimitotic Agents|antimitotic agents|mesh-ancestor
24972352|NCT03718624|Mitosis Modulators|mitosis modulators|mesh-ancestor
24972354|NCT03718624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25652782|NCT01532089|Endothelial Growth Factors|endothelial growth factors|mesh-list
25652784|NCT01532089|Immunoglobulins|immunoglobulins|mesh-list
25652785|NCT01532089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25652786|NCT01532089|Immunoglobulin G|immunoglobulin g|mesh-list
25652787|NCT01532089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652788|NCT01532089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25652789|NCT01532089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25652790|NCT01532089|Growth Substances|growth substances|mesh-ancestor
24472344|NCT00398905|Anticoagulants|anticoagulants|mesh-ancestor
24966621|NCT03766867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24966622|NCT03766854|Insulin|insulin|mesh-list
24966623|NCT03766854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24966624|NCT03766854|Insulin Glargine|insulin glargine|mesh-list
24966625|NCT03766854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24966626|NCT03766854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966641|NCT03766724|Dapagliflozin|dapagliflozin|mesh-list
24966642|NCT03766724|Empagliflozin|empagliflozin|mesh-list
24966643|NCT03766724|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24966644|NCT03766724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966645|NCT03766724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24966653|NCT03766607|Antimitotic Agents|antimitotic agents|mesh-ancestor
24966654|NCT03766607|Mitosis Modulators|mitosis modulators|mesh-ancestor
24966655|NCT03766607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966656|NCT03766607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24966658|NCT03766594|Sildenafil Citrate|sildenafil citrate|mesh-list
24966659|NCT03766594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966660|NCT03766594|Vasodilator Agents|vasodilator agents|mesh-ancestor
24966661|NCT03766594|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24465697|NCT00370591|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24966662|NCT03766594|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24966663|NCT03766594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652791|NCT01532089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652792|NCT01532089|Growth Inhibitors|growth inhibitors|mesh-ancestor
25652793|NCT01532089|Immunologic Factors|immunologic factors|mesh-ancestor
25652794|NCT01532089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25652795|NCT01532089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652796|NCT01532089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652797|NCT01532128|Opicapone|opicapone|mesh-list
25652798|NCT01532128|Rasagiline|rasagiline|mesh-list
25652799|NCT01532128|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25652800|NCT01532128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504288|NCT00534898|Bexarotene|bexarotene|mesh-list
24604277|NCT00978211|Hormones|hormones|mesh-ancestor
24966690|NCT03766269|Hallucinogens|hallucinogens|mesh-ancestor
24966691|NCT03766269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966692|NCT03766269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24966693|NCT03766269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24966694|NCT03766269|Analgesics|analgesics|mesh-ancestor
24966695|NCT03766269|Sensory System Agents|sensory system agents|mesh-ancestor
24966696|NCT03766269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24966697|NCT03766269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24966698|NCT03766269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24966699|NCT03766269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24966700|NCT03766269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966701|NCT03766269|Hormones|hormones|mesh-ancestor
24966702|NCT03766269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24966703|NCT03766178|Nimotuzumab|nimotuzumab|mesh-list
24966704|NCT03766178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24966705|NCT03766178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24966706|NCT03766074|Vitamin D|vitamin d|mesh-list
24966707|NCT03766074|Vitamins|vitamins|mesh-ancestor
24966708|NCT03766074|Micronutrients|micronutrients|mesh-ancestor
24623598|NCT01072695|Ribavirin|ribavirin|mesh-list
24465035|NCT00367614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966709|NCT03766074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966710|NCT03766074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24966824|NCT03764605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966825|NCT03764605|Natriuretic Agents|natriuretic agents|mesh-ancestor
24966826|NCT03764553|Leucovorin|leucovorin|mesh-list
24966827|NCT03764553|Carboplatin|carboplatin|mesh-list
24966828|NCT03764553|Fluorouracil|fluorouracil|mesh-list
24966829|NCT03764553|Capecitabine|capecitabine|mesh-list
24966830|NCT03764553|Oxaliplatin|oxaliplatin|mesh-list
24966831|NCT03764553|Irinotecan|irinotecan|mesh-list
24966832|NCT03764553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24966833|NCT03764553|Antimetabolites|antimetabolites|mesh-ancestor
24966834|NCT03764553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966835|NCT03764553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24966836|NCT03764553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25079195|NCT03349606|Autonomic Agents|autonomic agents|mesh-ancestor
24966837|NCT03764553|Immunologic Factors|immunologic factors|mesh-ancestor
25652801|NCT01532128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652802|NCT01532128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25652803|NCT01532128|Protective Agents|protective agents|mesh-ancestor
25652804|NCT01532128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652805|NCT01532128|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25652806|NCT01532128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25652807|NCT01532128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25652808|NCT01532141|Opicapone|opicapone|mesh-list
25652809|NCT01532141|Rasagiline|rasagiline|mesh-list
24972867|NCT03714594|Incretins|incretins|mesh-ancestor
24465307|NCT00368862|Antidepressive Agents|antidepressive agents|mesh-ancestor
24465308|NCT00368862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24465309|NCT00368862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24465310|NCT00368862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24465311|NCT00368862|Dopamine Agents|dopamine agents|mesh-ancestor
24465312|NCT00368862|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24465313|NCT00368862|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24465314|NCT00368901|Darbepoetin alfa|darbepoetin alfa|mesh-list
24465319|NCT00368914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24966908|NCT03764267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966909|NCT03764267|Sensory System Agents|sensory system agents|mesh-ancestor
24966910|NCT03764267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24966911|NCT03764267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24966912|NCT03764267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24966913|NCT03764267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24966915|NCT03764267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966916|NCT03764267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24966917|NCT03764267|Narcotics|narcotics|mesh-ancestor
24966918|NCT03764267|Analgesics|analgesics|mesh-ancestor
24966919|NCT03764241|Vitamin K|vitamin k|mesh-list
24966920|NCT03764241|Rivaroxaban|rivaroxaban|mesh-list
24966921|NCT03764241|Vitamins|vitamins|mesh-ancestor
24966922|NCT03764241|Micronutrients|micronutrients|mesh-ancestor
24966923|NCT03764241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966935|NCT03764202|Sufentanil|sufentanil|mesh-list
24966936|NCT03764202|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24966937|NCT03764202|Narcotics|narcotics|mesh-ancestor
24966938|NCT03764202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24966939|NCT03764202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966940|NCT03764202|Analgesics|analgesics|mesh-ancestor
24966975|NCT03763760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972954|NCT03713762|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24972955|NCT03713762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24972956|NCT03713762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972957|NCT03713762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24972958|NCT03713762|Narcotics|narcotics|mesh-ancestor
24972959|NCT03713762|Analgesics|analgesics|mesh-ancestor
24972960|NCT03713762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24972961|NCT03713762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24794552|NCT04998279|Lenograstim|lenograstim|mesh-list
24794553|NCT04998279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24967063|NCT03763084|Antipyretics|antipyretics|mesh-ancestor
24587820|NCT00897312|Interferons|interferons|mesh-list
25652810|NCT01532141|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25652811|NCT01532141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652812|NCT01532141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652813|NCT01532141|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25652814|NCT01532141|Protective Agents|protective agents|mesh-ancestor
25652815|NCT01532141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652816|NCT01532141|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25652817|NCT01532141|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24465873|NCT00370968|Dermatologic Agents|dermatologic agents|mesh-ancestor
25652818|NCT01532141|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25652819|NCT01532349|Cholecalciferol|cholecalciferol|mesh-list
25652820|NCT01532349|Vitamin D|vitamin d|mesh-list
25652821|NCT01532349|Vitamins|vitamins|mesh-ancestor
25652822|NCT01532349|Micronutrients|micronutrients|mesh-ancestor
25652823|NCT01532349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652824|NCT01532349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25652825|NCT01532349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24973604|NCT03708458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24973605|NCT03708458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24794592|NCT04910386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25652826|NCT01532414|Enclomiphene|enclomiphene|mesh-list
25652827|NCT01532414|Clomiphene|clomiphene|mesh-list
25652828|NCT01532414|Zuclomiphene|zuclomiphene|mesh-list
25652829|NCT01532414|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25652830|NCT01532414|Hormone Antagonists|hormone antagonists|mesh-ancestor
25652831|NCT01532414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25652832|NCT01532414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652833|NCT01532414|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25652834|NCT01532414|Fertility Agents|fertility agents|mesh-ancestor
25652835|NCT01532414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25652836|NCT01532414|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25652837|NCT01532414|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25652838|NCT01532648|Budesonide|budesonide|mesh-list
25652839|NCT01532648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25652840|NCT01532648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25652841|NCT01532648|Autonomic Agents|autonomic agents|mesh-ancestor
25652842|NCT01532648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25652843|NCT01532648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652844|NCT01532648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25471904|NCT00027846|Cyclophosphamide|cyclophosphamide|mesh-list
25577369|NCT00388921|Vitamin A|vitamin a|mesh-list
25577370|NCT00388921|Vitamins|vitamins|mesh-ancestor
25471977|NCT00029107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471978|NCT00029107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24697759|NCT01437046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24973710|NCT03707652|Niacin|niacin|mesh-list
24697760|NCT01437046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697784|NCT01437293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697785|NCT01437293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431197|NCT00250796|Interferon-alpha|interferon-alpha|mesh-list
24431198|NCT00250796|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
24979507|NCT04064411|Abaloparatide|abaloparatide|mesh-list
24431379|NCT00251524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431381|NCT00251524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431382|NCT00251524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694774|NCT05316220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24466402|NCT00373464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466403|NCT00373464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24466414|NCT00373503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24466415|NCT00373503|Analgesics|analgesics|mesh-ancestor
24466416|NCT00373503|Sensory System Agents|sensory system agents|mesh-ancestor
24466417|NCT00373503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24466420|NCT00373503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24466421|NCT00373503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466422|NCT00373503|Hormones|hormones|mesh-ancestor
24466423|NCT00373503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24466424|NCT00373503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24466425|NCT00373503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24466426|NCT00373503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24431383|NCT00251524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24431438|NCT00251706|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24431663|NCT00252668|Abortifacient Agents|abortifacient agents|mesh-ancestor
25822724|NCT00004585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25822725|NCT00004585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822726|NCT00004585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431893|NCT00253188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973960|NCT05177601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973961|NCT05177588|Metformin|metformin|mesh-list
24973962|NCT05177588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24973963|NCT05177588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973973|NCT05177406|Erenumab|erenumab|mesh-list
24759398|NCT01751074|Darapladib|darapladib|mesh-list
24973979|NCT05177406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431894|NCT00253188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432121|NCT00253578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432123|NCT00253591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432124|NCT00253591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24432125|NCT00253591|Tubulin Modulators|tubulin modulators|mesh-ancestor
24432126|NCT00253591|Antimitotic Agents|antimitotic agents|mesh-ancestor
24432127|NCT00253591|Mitosis Modulators|mitosis modulators|mesh-ancestor
24979538|NCT03907826|Antibodies, Blocking|antibodies, blocking|mesh-list
24979539|NCT03907826|Immunologic Factors|immunologic factors|mesh-ancestor
24979540|NCT03907826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979541|NCT03905889|Sunitinib|sunitinib|mesh-list
24979542|NCT03905889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979543|NCT03905889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24841935|NCT02219152|Tranexamic Acid|tranexamic acid|mesh-list
24432629|NCT00255541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432631|NCT00255554|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24432632|NCT00255554|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24794695|NCT04776850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24432633|NCT00255554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24432634|NCT00255554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432635|NCT00255554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24432636|NCT00255554|Serotonin Agents|serotonin agents|mesh-ancestor
24432679|NCT00255658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24432680|NCT00255658|Immunologic Factors|immunologic factors|mesh-ancestor
24432681|NCT00255658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432683|NCT00255710|Cyclophosphamide|cyclophosphamide|mesh-list
24432684|NCT00255710|Fludarabine|fludarabine|mesh-list
24432685|NCT00255710|Fludarabine phosphate|fludarabine phosphate|mesh-list
24432686|NCT00255710|Tacrolimus|tacrolimus|mesh-list
24432700|NCT00255710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24432701|NCT00255710|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24979568|NCT03823989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24432803|NCT00256256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974485|NCT04602507|Ivermectin|ivermectin|mesh-list
24432858|NCT00256542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24432859|NCT00256542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432860|NCT00256542|Sensory System Agents|sensory system agents|mesh-ancestor
24432861|NCT00256542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24432862|NCT00256542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24432863|NCT00256542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24433055|NCT00257426|Octreotide|octreotide|mesh-list
24433056|NCT00257426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24433057|NCT00257426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24433168|NCT00257751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24437471|NCT00273702|Antioxidants|antioxidants|mesh-ancestor
25577371|NCT00388921|Micronutrients|micronutrients|mesh-ancestor
25577372|NCT00388921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577373|NCT00142285|Zinc Sulfate|zinc sulfate|mesh-list
25577374|NCT00142285|Astringents|astringents|mesh-ancestor
25577375|NCT00142285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577376|NCT00142285|Dermatologic Agents|dermatologic agents|mesh-ancestor
25577377|NCT00142272|Ciprofloxacin|ciprofloxacin|mesh-list
25577378|NCT00142272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25577379|NCT00142272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25577380|NCT00142272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25577381|NCT00142272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25577382|NCT00142272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577383|NCT00142272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577384|NCT00142272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577385|NCT00142272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25577386|NCT00142272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25700811|NCT02129426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25700812|NCT02129426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25700813|NCT02129426|Adrenergic Agents|adrenergic agents|mesh-ancestor
25700814|NCT02129426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25700815|NCT02129426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700816|NCT02129426|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24462366|NCT00355862|Antimetabolites|antimetabolites|mesh-ancestor
24462367|NCT00355862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24462369|NCT00355901|Immunologic Factors|immunologic factors|mesh-ancestor
24794820|NCT04435795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24794821|NCT04435795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806582|NCT02016547|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24806583|NCT02016547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806814|NCT02018263|Anesthetics|anesthetics|mesh-ancestor
25577387|NCT00084799|Antibodies|antibodies|mesh-list
25577388|NCT00084799|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25577389|NCT00084799|Immunologic Factors|immunologic factors|mesh-ancestor
25577390|NCT00084799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577391|NCT00821327|Gemcitabine|gemcitabine|mesh-list
25577392|NCT00821327|Cisplatin|cisplatin|mesh-list
25577393|NCT00821327|Sunitinib|sunitinib|mesh-list
25577394|NCT00821327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577395|NCT00821327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25577396|NCT00821327|Antimetabolites|antimetabolites|mesh-ancestor
25079364|NCT03348423|Anesthetics, General|anesthetics, general|mesh-ancestor
25079365|NCT03348423|Anesthetics|anesthetics|mesh-ancestor
25079366|NCT03348371|Ethanol|ethanol|mesh-list
25079367|NCT03348371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25079368|NCT03348371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25079369|NCT03348371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25079370|NCT03348371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079371|NCT03348267|Caseins|caseins|mesh-list
25079372|NCT03348267|Chelating Agents|chelating agents|mesh-ancestor
25079373|NCT03348267|Sequestering Agents|sequestering agents|mesh-ancestor
25079374|NCT03348267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807130|NCT02019875|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24467903|NCT00379028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467904|NCT00379041|Prednisone|prednisone|mesh-list
24467905|NCT00379041|Doxorubicin|doxorubicin|mesh-list
24467906|NCT00379041|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24468747|NCT00383045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24468748|NCT00383045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577397|NCT00821327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577398|NCT00821327|Antiviral Agents|antiviral agents|mesh-ancestor
25577399|NCT00821327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25577400|NCT00821327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577401|NCT00821327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25577402|NCT00821327|Immunologic Factors|immunologic factors|mesh-ancestor
25577403|NCT00821327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577404|NCT00821327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25577405|NCT00821327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25577406|NCT00821327|Growth Substances|growth substances|mesh-ancestor
25577407|NCT00821327|Growth Inhibitors|growth inhibitors|mesh-ancestor
25577408|NCT00821327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25577409|NCT00821509|Disinfectants|disinfectants|mesh-list
25577410|NCT00821509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25577411|NCT00821795|Insulin|insulin|mesh-list
25577412|NCT00821795|Insulin Aspart|insulin aspart|mesh-list
25577413|NCT00821795|Protamines|protamines|mesh-list
25577414|NCT00821795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25577415|NCT00821795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577416|NCT00821795|Heparin Antagonists|heparin antagonists|mesh-ancestor
25083889|NCT03311945|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25083890|NCT03311906|Hyaluronic Acid|hyaluronic acid|mesh-list
25083891|NCT03311906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25577417|NCT00821795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577418|NCT00821795|Coagulants|coagulants|mesh-ancestor
25577419|NCT00821821|Edaravone|edaravone|mesh-list
25577420|NCT00821821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25577421|NCT00821821|Antioxidants|antioxidants|mesh-ancestor
25577422|NCT00821821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577423|NCT00821821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25577424|NCT00821821|Protective Agents|protective agents|mesh-ancestor
25577425|NCT00821821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577426|NCT00821886|Carboplatin|carboplatin|mesh-list
25577427|NCT00821886|Trastuzumab|trastuzumab|mesh-list
25577428|NCT00821886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577429|NCT00821886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25577430|NCT00821951|Vorinostat|vorinostat|mesh-list
25577431|NCT00821951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577432|NCT00821951|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25577433|NCT00821951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25079425|NCT03347890|Liraglutide|liraglutide|mesh-list
24471337|NCT00394537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24811663|NCT02047552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24811665|NCT02047565|Edoxaban|edoxaban|mesh-list
24811666|NCT02047565|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24811667|NCT02047565|Antithrombins|antithrombins|mesh-ancestor
24811668|NCT02047565|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24811669|NCT02047565|Protease Inhibitors|protease inhibitors|mesh-ancestor
24811670|NCT02047565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811671|NCT02047565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811672|NCT02047565|Anticoagulants|anticoagulants|mesh-ancestor
24811673|NCT02047578|Busulfan|busulfan|mesh-list
24811674|NCT02047578|Alkylating Agents|alkylating agents|mesh-ancestor
25577434|NCT00821951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577435|NCT00821964|Paclitaxel|paclitaxel|mesh-list
25577436|NCT00821964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25577437|NCT00821964|Imiquimod|imiquimod|mesh-list
25577438|NCT00821964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25577439|NCT00821964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577440|NCT00821964|Tubulin Modulators|tubulin modulators|mesh-ancestor
25577441|NCT00821964|Antimitotic Agents|antimitotic agents|mesh-ancestor
25577442|NCT00821964|Mitosis Modulators|mitosis modulators|mesh-ancestor
25577443|NCT00821964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577444|NCT00821964|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25577445|NCT00821964|Immunologic Factors|immunologic factors|mesh-ancestor
25577446|NCT00821964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577447|NCT00821964|Interferon Inducers|interferon inducers|mesh-ancestor
24446830|NCT00306150|Coagulants|coagulants|mesh-ancestor
24446831|NCT00306150|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24446832|NCT00306150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24612591|NCT01014520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612592|NCT01014520|Antimanic Agents|antimanic agents|mesh-ancestor
24612594|NCT01014520|Antidepressive Agents|antidepressive agents|mesh-ancestor
24446833|NCT00306150|Protease Inhibitors|protease inhibitors|mesh-ancestor
24446834|NCT00306150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446835|NCT00306150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446836|NCT00306176|Rosiglitazone|rosiglitazone|mesh-list
24812434|NCT02052167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24628589|NCT01100060|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24628590|NCT01100060|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24628591|NCT01100060|Antimalarials|antimalarials|mesh-ancestor
24896799|NCT04432714|Glucocorticoids|glucocorticoids|mesh-ancestor
24628620|NCT01100164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628621|NCT01100177|Sunitinib|sunitinib|mesh-list
24965384|NCT03777761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24965385|NCT03777761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24965386|NCT03777761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24472043|NCT00397800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24472045|NCT00397800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472046|NCT00397800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24472049|NCT00397800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472050|NCT00397800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577448|NCT00822107|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25577449|NCT00822107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25577450|NCT00822107|Diuretics|diuretics|mesh-ancestor
25577451|NCT00822107|Natriuretic Agents|natriuretic agents|mesh-ancestor
25577452|NCT00822107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577453|NCT00822107|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25577454|NCT00822107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25822727|NCT00004585|Antiviral Agents|antiviral agents|mesh-ancestor
24629136|NCT01103388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965394|NCT03777488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24965395|NCT03777488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965424|NCT03777254|RC28-E protein|rc28-e protein|mesh-list
24965425|NCT03777254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24965426|NCT03777254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24965427|NCT03777254|Growth Substances|growth substances|mesh-ancestor
24965428|NCT03777254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965429|NCT03777254|Growth Inhibitors|growth inhibitors|mesh-ancestor
24965430|NCT03777254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965433|NCT03777280|Trace Elements|trace elements|mesh-ancestor
24965434|NCT03777280|Micronutrients|micronutrients|mesh-ancestor
24965435|NCT03777280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965436|NCT03777163|Vaccines|vaccines|mesh-list
24696130|NCT01427400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696131|NCT01427400|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24696132|NCT01427400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24965437|NCT03777163|Immunologic Factors|immunologic factors|mesh-ancestor
24965438|NCT03777163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965439|NCT03777033|Calcium|calcium|mesh-list
24965440|NCT03777033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24772960|NCT01837043|Cyclosporins|cyclosporins|mesh-list
24628622|NCT01100177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24628623|NCT01100177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24628624|NCT01100177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24628625|NCT01100177|Growth Substances|growth substances|mesh-ancestor
24628626|NCT01100177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628627|NCT01100177|Growth Inhibitors|growth inhibitors|mesh-ancestor
24628633|NCT01100203|Hormone Antagonists|hormone antagonists|mesh-ancestor
25577455|NCT00822107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577456|NCT00822172|Cilostazol|cilostazol|mesh-list
25577457|NCT00822172|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25577458|NCT00822172|Autonomic Agents|autonomic agents|mesh-ancestor
25577459|NCT00822172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25577460|NCT00822172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577461|NCT00822172|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25577462|NCT00822172|Respiratory System Agents|respiratory system agents|mesh-ancestor
25577463|NCT00822172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25577464|NCT00822172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24629257|NCT01103830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629261|NCT01103830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628637|NCT01100203|Diuretics|diuretics|mesh-ancestor
25577465|NCT00822172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577466|NCT00822172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25577467|NCT00822172|Vasodilator Agents|vasodilator agents|mesh-ancestor
25577468|NCT00822172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25577469|NCT00822172|Protective Agents|protective agents|mesh-ancestor
25577470|NCT00822172|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25577471|NCT00822172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25577472|NCT00822172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577473|NCT00822237|Vaccines|vaccines|mesh-list
25577474|NCT00822237|Immunologic Factors|immunologic factors|mesh-ancestor
25577475|NCT00822237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577476|NCT00822354|Tadalafil|tadalafil|mesh-list
25577477|NCT00822354|Vasodilator Agents|vasodilator agents|mesh-ancestor
25577478|NCT00822354|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25577479|NCT00822354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25577480|NCT00822354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577481|NCT00822354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577482|NCT00822354|Urological Agents|urological agents|mesh-ancestor
25577483|NCT00822523|Botulinum Toxins|botulinum toxins|mesh-list
25577484|NCT00822523|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24629572|NCT01106235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629573|NCT01106235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24629574|NCT01106235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24629575|NCT01106235|Analgesics|analgesics|mesh-ancestor
24629576|NCT01106235|Sensory System Agents|sensory system agents|mesh-ancestor
24629768|NCT01107782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24815466|NCT02070458|Mitoxantrone|mitoxantrone|mesh-list
24815467|NCT02070458|Etoposide phosphate|etoposide phosphate|mesh-list
24815469|NCT02070458|Glycine|glycine|mesh-list
24815470|NCT02070458|Proteasome Inhibitors|proteasome inhibitors|mesh-list
24815471|NCT02070458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24815472|NCT02070458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815473|NCT02070458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24472828|NCT00400725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815474|NCT02070458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25577485|NCT00822523|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25577486|NCT00822523|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25577487|NCT00822523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25577488|NCT00822523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577489|NCT00822523|Cholinergic Agents|cholinergic agents|mesh-ancestor
25577490|NCT00822523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25577491|NCT00822523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577492|NCT00822523|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25577493|NCT00822523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25577494|NCT00822692|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25577495|NCT00822692|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25577496|NCT00822692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25577497|NCT00822692|Renal Agents|renal agents|mesh-ancestor
25577498|NCT00822692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25577499|NCT00822692|Antimalarials|antimalarials|mesh-ancestor
25577500|NCT00822692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25577501|NCT00822692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25577502|NCT00822770|Vidarabine|vidarabine|mesh-list
25577503|NCT00822770|Plerixafor|plerixafor|mesh-list
25577504|NCT00822770|Fludarabine|fludarabine|mesh-list
25577505|NCT00822770|Fludarabine phosphate|fludarabine phosphate|mesh-list
25577506|NCT00822770|Busulfan|busulfan|mesh-list
25577507|NCT00822770|Thymoglobulin|thymoglobulin|mesh-list
25577508|NCT00822770|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25577509|NCT00822770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577510|NCT00822770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25577511|NCT00822770|Antimetabolites|antimetabolites|mesh-ancestor
25577512|NCT00822770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577513|NCT00822770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25577514|NCT00822770|Immunologic Factors|immunologic factors|mesh-ancestor
25577515|NCT00822770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577516|NCT00822770|Antiviral Agents|antiviral agents|mesh-ancestor
25577517|NCT00822770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25577518|NCT00822770|Alkylating Agents|alkylating agents|mesh-ancestor
25577519|NCT00822770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25577520|NCT00822770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25577521|NCT00822770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25577522|NCT00822770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25577523|NCT00822900|Progesterone|progesterone|mesh-list
25577524|NCT00822900|Progestins|progestins|mesh-ancestor
25577525|NCT00822900|Hormones|hormones|mesh-ancestor
25577526|NCT00822900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25577527|NCT00822900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577528|NCT00822926|Botulinum Toxins|botulinum toxins|mesh-list
25577529|NCT00822926|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25577530|NCT00822926|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25577531|NCT00822926|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25577532|NCT00822926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25577533|NCT00822926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577534|NCT00822926|Cholinergic Agents|cholinergic agents|mesh-ancestor
25577535|NCT00822926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25577536|NCT00822926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577537|NCT00822926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25577538|NCT00822926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25577539|NCT00823043|Timolol|timolol|mesh-list
25577540|NCT00823043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25577541|NCT00823043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25577542|NCT00823043|Adrenergic Agents|adrenergic agents|mesh-ancestor
25577543|NCT00823043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25577544|NCT00823043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631070|NCT01116050|Misoprostol|misoprostol|mesh-list
25577545|NCT00823043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577546|NCT00823043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25577547|NCT00823043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25577548|NCT00823082|Antithrombins|antithrombins|mesh-list
25577549|NCT00823082|Antithrombin III|antithrombin iii|mesh-list
25577550|NCT00823082|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25577551|NCT00823082|Protease Inhibitors|protease inhibitors|mesh-ancestor
25577552|NCT00823082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577553|NCT00823082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577554|NCT00823082|Anticoagulants|anticoagulants|mesh-ancestor
25577555|NCT00823212|Aspirin|aspirin|mesh-list
25577556|NCT00823212|Ticlopidine|ticlopidine|mesh-list
25577557|NCT00823212|Clopidogrel|clopidogrel|mesh-list
25577558|NCT00823212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25577559|NCT00823212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25577560|NCT00823212|Analgesics|analgesics|mesh-ancestor
25577561|NCT00823212|Sensory System Agents|sensory system agents|mesh-ancestor
25577562|NCT00823212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25577563|NCT00823212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577564|NCT00823212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25577565|NCT00823212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25577566|NCT00823212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25577567|NCT00823212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25577568|NCT00823212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577569|NCT00823212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25577570|NCT00823212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25577571|NCT00823212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577572|NCT00823212|Antipyretics|antipyretics|mesh-ancestor
25577573|NCT00823212|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25577574|NCT00823212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24698344|NCT01440621|Vitamins|vitamins|mesh-ancestor
25577575|NCT00823212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25577576|NCT00823212|Purinergic Agents|purinergic agents|mesh-ancestor
25577577|NCT00823212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25089042|NCT03269591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25577578|NCT00823212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25577579|NCT00823212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25577580|NCT00823264|Charcoal|charcoal|mesh-list
25577581|NCT00823264|Antidotes|antidotes|mesh-ancestor
25577582|NCT00823264|Protective Agents|protective agents|mesh-ancestor
25577583|NCT00823264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577584|NCT00823303|Calcitriol|calcitriol|mesh-list
25577585|NCT00823303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25577586|NCT00823303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577587|NCT00823303|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25577588|NCT00823303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25577589|NCT00823303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577590|NCT00823303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25577591|NCT00823303|Vitamins|vitamins|mesh-ancestor
25577592|NCT00823303|Micronutrients|micronutrients|mesh-ancestor
25577593|NCT00823303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25577594|NCT00823459|Everolimus|everolimus|mesh-list
25577595|NCT00823459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577596|NCT00823459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25577597|NCT00823459|Immunologic Factors|immunologic factors|mesh-ancestor
25577598|NCT00823459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577599|NCT00823472|Ganirelix|ganirelix|mesh-list
25577600|NCT00823472|Hormone Antagonists|hormone antagonists|mesh-ancestor
25577601|NCT00823472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25577602|NCT00823472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577603|NCT00823719|Ofatumumab|ofatumumab|mesh-list
25577604|NCT00823719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25089730|NCT03263520|Nandrolone Decanoate|nandrolone decanoate|mesh-list
24760119|NCT01756443|Bupivacaine|bupivacaine|mesh-list
24760120|NCT01756443|Epinephryl borate|epinephryl borate|mesh-list
25079595|NCT03346681|Antioxidants|antioxidants|mesh-ancestor
24760121|NCT01756443|Anesthetics, Local|anesthetics, local|mesh-ancestor
24760122|NCT01756443|Anesthetics|anesthetics|mesh-ancestor
24699883|NCT01449448|Ketorolac|ketorolac|mesh-list
24760123|NCT01756443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24760124|NCT01756443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760126|NCT01756443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25577605|NCT00823719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577606|NCT00823719|Immunologic Factors|immunologic factors|mesh-ancestor
25577607|NCT00823719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577608|NCT00823797|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25577609|NCT00823797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25577610|NCT00823797|Alkylating Agents|alkylating agents|mesh-ancestor
25577611|NCT00823797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577612|NCT00823797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577613|NCT00823823|Calpastatin|calpastatin|mesh-list
24760385|NCT01757769|Urological Agents|urological agents|mesh-ancestor
24760386|NCT01757795|Otaplimastat|otaplimastat|mesh-list
24760387|NCT01757795|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24760388|NCT01757795|Protective Agents|protective agents|mesh-ancestor
24760389|NCT01757795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760390|NCT01757808|Ranolazine|ranolazine|mesh-list
24760396|NCT01757860|Micronutrients|micronutrients|mesh-ancestor
24760397|NCT01757860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760398|NCT01757860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24760399|NCT01757899|Methylprednisolone|methylprednisolone|mesh-list
24760400|NCT01757899|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24760401|NCT01757899|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24760402|NCT01757899|Prednisolone|prednisolone|mesh-list
24760403|NCT01757899|Prednisolone acetate|prednisolone acetate|mesh-list
24760404|NCT01757899|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24760405|NCT01757899|Prednisolone phosphate|prednisolone phosphate|mesh-list
24760406|NCT01757899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24760407|NCT01757899|Antiemetics|antiemetics|mesh-ancestor
24760408|NCT01757899|Autonomic Agents|autonomic agents|mesh-ancestor
24760409|NCT01757899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24760410|NCT01757899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760411|NCT01757899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24502008|NCT00531986|Protease Inhibitors|protease inhibitors|mesh-ancestor
24451656|NCT00324467|Dermatologic Agents|dermatologic agents|mesh-ancestor
24760412|NCT01757899|Glucocorticoids|glucocorticoids|mesh-ancestor
25079597|NCT03346681|Protective Agents|protective agents|mesh-ancestor
24965583|NCT03775902|Nicorandil|nicorandil|mesh-list
25577614|NCT00823823|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25577615|NCT00823823|Protease Inhibitors|protease inhibitors|mesh-ancestor
25577616|NCT00823823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577617|NCT00823823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577618|NCT00823836|Ropinirole|ropinirole|mesh-list
25577619|NCT00823836|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25577620|NCT00823836|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25577621|NCT00823836|Dopamine Agonists|dopamine agonists|mesh-ancestor
25577622|NCT00823836|Dopamine Agents|dopamine agents|mesh-ancestor
25577623|NCT00823836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25577624|NCT00823836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090331|NCT03258749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25090332|NCT03258749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079612|NCT03346629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079617|NCT03346629|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25079618|NCT03346629|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25079619|NCT03346629|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25079620|NCT03346629|Contraceptive Agents|contraceptive agents|mesh-ancestor
25079621|NCT03346629|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25079622|NCT03346629|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25079623|NCT03346629|Hormone Antagonists|hormone antagonists|mesh-ancestor
25577625|NCT00823836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577626|NCT00823901|Clindamycin|clindamycin|mesh-list
25577627|NCT00823901|Clindamycin palmitate|clindamycin palmitate|mesh-list
25577628|NCT00823901|Clindamycin phosphate|clindamycin phosphate|mesh-list
25577629|NCT00823901|Tretinoin|tretinoin|mesh-list
25577630|NCT00823901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25577631|NCT00823901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25577632|NCT00823901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25577633|NCT00823901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577634|NCT00823901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577635|NCT00823901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760435|NCT01758094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760436|NCT01758107|Cyclosporine|cyclosporine|mesh-list
24760437|NCT01758107|Cyclosporins|cyclosporins|mesh-list
24760438|NCT01758107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760439|NCT01758107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760440|NCT01758107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24760441|NCT01758107|Immunologic Factors|immunologic factors|mesh-ancestor
24760442|NCT01758107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760443|NCT01758107|Antifungal Agents|antifungal agents|mesh-ancestor
24760448|NCT01758120|Prednisone|prednisone|mesh-list
25577636|NCT00823901|Keratolytic Agents|keratolytic agents|mesh-ancestor
25577637|NCT00823901|Dermatologic Agents|dermatologic agents|mesh-ancestor
25577638|NCT00823966|Delavirdine|delavirdine|mesh-list
25577639|NCT00823966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25577640|NCT00823966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25577641|NCT00823966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577642|NCT00823966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577643|NCT00823966|Antiviral Agents|antiviral agents|mesh-ancestor
25577644|NCT00823966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25577645|NCT00823966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25577646|NCT00823966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25577647|NCT00823979|Etravirine|etravirine|mesh-list
24475171|NCT00409253|Adrenergic Agents|adrenergic agents|mesh-ancestor
25577648|NCT00823979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25577649|NCT00823979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25577650|NCT00823979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577651|NCT00823979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577652|NCT00823979|Antiviral Agents|antiviral agents|mesh-ancestor
25577653|NCT00823979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25577654|NCT00824044|Citalopram|citalopram|mesh-list
25577655|NCT00824044|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25577656|NCT00824044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25577657|NCT00824044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25577658|NCT00824044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577659|NCT00824044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25577660|NCT00824044|Serotonin Agents|serotonin agents|mesh-ancestor
25577661|NCT00824044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577662|NCT00824044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25577663|NCT00824044|Antidepressive Agents|antidepressive agents|mesh-ancestor
25577664|NCT00824044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25577665|NCT00824070|Moxifloxacin|moxifloxacin|mesh-list
25577666|NCT00824070|Gatifloxacin|gatifloxacin|mesh-list
25577667|NCT00824070|Besifloxacin|besifloxacin|mesh-list
25577668|NCT00824070|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25577669|NCT00824070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25577670|NCT00824070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25577671|NCT00824070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25577672|NCT00824070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25577673|NCT00824070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577674|NCT00824070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577675|NCT00824070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577676|NCT00824070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25577677|NCT00824070|Contraceptive Agents|contraceptive agents|mesh-ancestor
25577678|NCT00824070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25577679|NCT00824070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577680|NCT00824070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25577681|NCT00824070|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25577682|NCT00824070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25577683|NCT00824070|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25577684|NCT00824070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25577685|NCT00824291|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25577686|NCT00824291|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25577687|NCT00824291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25577688|NCT00824291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25091721|NCT03247400|Atorvastatin|atorvastatin|mesh-list
25577689|NCT00824291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577690|NCT00824291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25577691|NCT00824291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577692|NCT00824291|Antidepressive Agents|antidepressive agents|mesh-ancestor
25577693|NCT00824291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25577695|NCT00824382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25577696|NCT00824382|Autonomic Agents|autonomic agents|mesh-ancestor
25577697|NCT00824382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25577698|NCT00824382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577699|NCT00824382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24476708|NCT00416273|Bortezomib|bortezomib|mesh-list
25577700|NCT00824382|Respiratory System Agents|respiratory system agents|mesh-ancestor
25577701|NCT00824408|Pemetrexed|pemetrexed|mesh-list
25577702|NCT00824408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577703|NCT00824408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577704|NCT00824408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577705|NCT00824408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25577706|NCT00824408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25577707|NCT00824460|Iron|iron|mesh-list
25577708|NCT00824460|Sevelamer|sevelamer|mesh-list
25577709|NCT00824460|Trace Elements|trace elements|mesh-ancestor
25577710|NCT00824460|Micronutrients|micronutrients|mesh-ancestor
25577711|NCT00824460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577712|NCT00824460|Chelating Agents|chelating agents|mesh-ancestor
25577713|NCT00824460|Sequestering Agents|sequestering agents|mesh-ancestor
25577714|NCT00824460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577715|NCT00824473|Azelastine|azelastine|mesh-list
25577716|NCT00824473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25577717|NCT00824473|Autonomic Agents|autonomic agents|mesh-ancestor
25577718|NCT00824473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25577719|NCT00824473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577720|NCT00824473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25577721|NCT00824473|Respiratory System Agents|respiratory system agents|mesh-ancestor
25577722|NCT00824473|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25577723|NCT00824473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577724|NCT00824473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577725|NCT00824473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25577726|NCT00824473|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25577727|NCT00824473|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25577728|NCT00824473|Histamine Antagonists|histamine antagonists|mesh-ancestor
25577729|NCT00824473|Histamine Agents|histamine agents|mesh-ancestor
25092222|NCT03243500|Lidocaine|lidocaine|mesh-list
25577730|NCT00824473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25577731|NCT00824538|Sunitinib|sunitinib|mesh-list
25577732|NCT00824538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577733|NCT00824538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25577734|NCT00824538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25577735|NCT00824538|Growth Substances|growth substances|mesh-ancestor
25577736|NCT00824538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577737|NCT00824538|Growth Inhibitors|growth inhibitors|mesh-ancestor
25092984|NCT03237533|Doxycycline|doxycycline|mesh-list
24761603|NCT01763463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24478800|NCT00424580|Histamine Antagonists|histamine antagonists|mesh-ancestor
25577738|NCT00824538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25577739|NCT00824538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577740|NCT00824538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577741|NCT00824564|Tranexamic Acid|tranexamic acid|mesh-list
25577742|NCT00824564|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25577743|NCT00824564|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25577744|NCT00824564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577745|NCT00824564|Hemostatics|hemostatics|mesh-ancestor
25577746|NCT00824564|Coagulants|coagulants|mesh-ancestor
25094459|NCT03225937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094460|NCT03225937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094462|NCT03225937|Tubulin Modulators|tubulin modulators|mesh-ancestor
25094483|NCT03225924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577747|NCT00824616|Insulin|insulin|mesh-list
25577748|NCT00824616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25577749|NCT00824616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095410|NCT03218969|Ecopipam|ecopipam|mesh-list
25095469|NCT03218631|Oxandrolone|oxandrolone|mesh-list
25577750|NCT00824733|Trastuzumab|trastuzumab|mesh-list
25577751|NCT00824733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25577752|NCT00824733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577754|NCT00824746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577755|NCT00824746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25577756|NCT00824746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577757|NCT00824746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577758|NCT00824824|Timolol|timolol|mesh-list
25577759|NCT00824824|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25577760|NCT00824824|Dorzolamide|dorzolamide|mesh-list
25577761|NCT00824824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24762121|NCT01766258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24762122|NCT01766258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505052|NCT00539409|Insulin|insulin|mesh-list
25577762|NCT00824824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25577763|NCT00824824|Adrenergic Agents|adrenergic agents|mesh-ancestor
25577764|NCT00824824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25577765|NCT00824824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577766|NCT00824824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577767|NCT00824824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25577768|NCT00824824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25577769|NCT00824824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25577770|NCT00824824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25577771|NCT00824824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25577772|NCT00824824|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25577773|NCT00824824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577774|NCT00824850|Vaccines|vaccines|mesh-list
25577775|NCT00824850|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25577776|NCT00824850|Immunologic Factors|immunologic factors|mesh-ancestor
25577777|NCT00824850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577778|NCT00824993|Ibandronic Acid|ibandronic acid|mesh-list
25577779|NCT00824993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577780|NCT00824993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25577781|NCT00825162|Vaccines|vaccines|mesh-list
25577782|NCT00825162|Immunologic Factors|immunologic factors|mesh-ancestor
25577783|NCT00825162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577784|NCT00825266|Pioglitazone|pioglitazone|mesh-list
25577785|NCT00825266|Bosentan|bosentan|mesh-list
25096872|NCT03208712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25096914|NCT03208465|Incretins|incretins|mesh-ancestor
25577786|NCT00825266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25577787|NCT00825266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577788|NCT00825266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25577789|NCT00825266|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25577790|NCT00825266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577791|NCT00825305|Vaccines|vaccines|mesh-list
25577792|NCT00825305|Immunologic Factors|immunologic factors|mesh-ancestor
24620169|NCT01055756|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24620170|NCT01055756|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24620171|NCT01055756|Histamine Antagonists|histamine antagonists|mesh-ancestor
24620173|NCT01055756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24620174|NCT01055756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620175|NCT01055756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620176|NCT01055756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24620177|NCT01055756|Autonomic Agents|autonomic agents|mesh-ancestor
24620178|NCT01055756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24620184|NCT01055756|Sympathomimetics|sympathomimetics|mesh-ancestor
25577793|NCT00825305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577794|NCT00825344|Etanercept|etanercept|mesh-list
25577795|NCT00825344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25577796|NCT00825344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25577797|NCT00825344|Analgesics|analgesics|mesh-ancestor
25577798|NCT00825344|Sensory System Agents|sensory system agents|mesh-ancestor
25577799|NCT00825344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25577800|NCT00825344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762683|NCT01769079|Diuretics|diuretics|mesh-ancestor
24762743|NCT01769651|Methadone|methadone|mesh-list
25577801|NCT00825344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25577802|NCT00825344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25577803|NCT00825344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25577804|NCT00825344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25577805|NCT00825344|Immunologic Factors|immunologic factors|mesh-ancestor
25577806|NCT00825370|Hydromorphone|hydromorphone|mesh-list
25577807|NCT00825370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25577808|NCT00825370|Narcotics|narcotics|mesh-ancestor
25577809|NCT00825370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25079937|NCT03343873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25079938|NCT03343873|Anesthetics, General|anesthetics, general|mesh-ancestor
25079939|NCT03343873|Anesthetics|anesthetics|mesh-ancestor
25577810|NCT00825370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577811|NCT00825370|Analgesics|analgesics|mesh-ancestor
25097964|NCT03200015|Metformin|metformin|mesh-list
25577812|NCT00825370|Sensory System Agents|sensory system agents|mesh-ancestor
24763075|NCT01771198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577813|NCT00825370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25577814|NCT00825500|Loxapine|loxapine|mesh-list
25577815|NCT00825500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25577816|NCT00825500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25577817|NCT00825500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25577818|NCT00825500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577819|NCT00825500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25080022|NCT03343002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080023|NCT03343002|Analgesics|analgesics|mesh-ancestor
25080024|NCT03343002|Sensory System Agents|sensory system agents|mesh-ancestor
25080025|NCT03343002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25080026|NCT03343002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25080027|NCT03343002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25080028|NCT03343002|Anesthetics, General|anesthetics, general|mesh-ancestor
25080029|NCT03343002|Anesthetics|anesthetics|mesh-ancestor
24620244|NCT01056042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24620245|NCT01056042|Contraceptive Agents|contraceptive agents|mesh-ancestor
24620246|NCT01056042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24620247|NCT01056042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24620248|NCT01056042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24644719|NCT01192724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620249|NCT01056042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25577820|NCT00825500|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25577821|NCT00825500|Dopamine Agents|dopamine agents|mesh-ancestor
25472337|NCT00038610|Dermatologic Agents|dermatologic agents|mesh-ancestor
25577822|NCT00825500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25577823|NCT00825500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577825|NCT00825565|Dermatologic Agents|dermatologic agents|mesh-ancestor
25577826|NCT00825630|Esomeprazole|esomeprazole|mesh-list
25577827|NCT00825630|Pantoprazole|pantoprazole|mesh-list
25577828|NCT00825630|Lansoprazole|lansoprazole|mesh-list
25577829|NCT00825630|Dexlansoprazole|dexlansoprazole|mesh-list
25577830|NCT00825630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25099224|NCT03192969|Abatacept|abatacept|mesh-list
25577831|NCT00825630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25577832|NCT00825630|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25577833|NCT00825630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577834|NCT00825630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577835|NCT00825734|Sorafenib|sorafenib|mesh-list
25577836|NCT00825734|Epothilones|epothilones|mesh-list
25577837|NCT00825734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577838|NCT00825734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25577839|NCT00825734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100494|NCT03182504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25100498|NCT03182218|Heparin|heparin|mesh-list
25100499|NCT03182218|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25100500|NCT03182218|Tinzaparin|tinzaparin|mesh-list
25100501|NCT03182218|Dalteparin|dalteparin|mesh-list
25100502|NCT03182218|Anticoagulants|anticoagulants|mesh-list
24645674|NCT01199328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25577840|NCT00825734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577841|NCT00825734|Tubulin Modulators|tubulin modulators|mesh-ancestor
25577842|NCT00825734|Antimitotic Agents|antimitotic agents|mesh-ancestor
25577843|NCT00825734|Mitosis Modulators|mitosis modulators|mesh-ancestor
25577844|NCT00825786|Ropivacaine|ropivacaine|mesh-list
25577845|NCT00825786|Mepivacaine|mepivacaine|mesh-list
25577846|NCT00825786|Anesthetics, Local|anesthetics, local|mesh-ancestor
25577847|NCT00825786|Anesthetics|anesthetics|mesh-ancestor
25577848|NCT00825786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25577849|NCT00825786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577850|NCT00825786|Sensory System Agents|sensory system agents|mesh-ancestor
25577851|NCT00825786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25577852|NCT00825812|Atropine|atropine|mesh-list
25577853|NCT00825812|Neostigmine|neostigmine|mesh-list
25577854|NCT00825812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25577855|NCT00825812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25577856|NCT00825812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25577857|NCT00825812|Autonomic Agents|autonomic agents|mesh-ancestor
25577858|NCT00825812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25577859|NCT00825812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577860|NCT00825812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25577861|NCT00825812|Respiratory System Agents|respiratory system agents|mesh-ancestor
25577862|NCT00825812|Mydriatics|mydriatics|mesh-ancestor
25577863|NCT00825812|Parasympatholytics|parasympatholytics|mesh-ancestor
25577864|NCT00825812|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25577865|NCT00825812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25577866|NCT00825812|Cholinergic Agents|cholinergic agents|mesh-ancestor
25577867|NCT00825812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25577868|NCT00825812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577869|NCT00825812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24763890|NCT01778075|Tramadol|tramadol|mesh-list
25577870|NCT00825812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577871|NCT00825812|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25577872|NCT00825825|Citalopram|citalopram|mesh-list
25577873|NCT00825825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25577874|NCT00825825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25577875|NCT00825825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25577876|NCT00825825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577877|NCT00825825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25104796|NCT03151096|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25104797|NCT03151096|Dermatologic Agents|dermatologic agents|mesh-ancestor
25104799|NCT03151005|Liraglutide|liraglutide|mesh-list
25104800|NCT03151005|Exenatide|exenatide|mesh-list
25577878|NCT00825825|Serotonin Agents|serotonin agents|mesh-ancestor
25577879|NCT00825825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577880|NCT00825825|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25577881|NCT00825825|Antidepressive Agents|antidepressive agents|mesh-ancestor
25577882|NCT00825825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25652845|NCT01532648|Respiratory System Agents|respiratory system agents|mesh-ancestor
25652846|NCT01532648|Glucocorticoids|glucocorticoids|mesh-ancestor
25652847|NCT01532648|Hormones|hormones|mesh-ancestor
25652848|NCT01532648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25652849|NCT01532687|Gemcitabine|gemcitabine|mesh-list
25652850|NCT01532687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25652851|NCT01532687|Antimetabolites|antimetabolites|mesh-ancestor
25652852|NCT01532687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652853|NCT01532687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652854|NCT01532687|Antiviral Agents|antiviral agents|mesh-ancestor
25652855|NCT01532687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25652856|NCT01532687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652857|NCT01532687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25652858|NCT01532687|Immunologic Factors|immunologic factors|mesh-ancestor
25577883|NCT00826111|Eszopiclone|eszopiclone|mesh-list
25577884|NCT00826111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25577885|NCT00826111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25577886|NCT00826111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975767|NCT03013998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24481009|NCT00433121|Olanzapine|olanzapine|mesh-list
25577887|NCT00826228|Teriparatide|teriparatide|mesh-list
25577888|NCT00826228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25577889|NCT00826228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577890|NCT00826228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25577891|NCT00826241|Temozolomide|temozolomide|mesh-list
25577893|NCT00826241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25577894|NCT00826241|Alkylating Agents|alkylating agents|mesh-ancestor
25577895|NCT00826241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577896|NCT00826241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577897|NCT00826241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25577898|NCT00826241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577899|NCT00826267|Trastuzumab|trastuzumab|mesh-list
25577900|NCT00826267|Lapatinib|lapatinib|mesh-list
25577901|NCT00826267|Afatinib|afatinib|mesh-list
24976144|NCT01220531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24976145|NCT01220531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24976146|NCT01220531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976147|NCT01220531|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24976148|NCT01220531|Antitubercular Agents|antitubercular agents|mesh-ancestor
24976194|NCT00360425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764070|NCT01779362|Insulin Glargine|insulin glargine|mesh-list
25577902|NCT00826267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25577903|NCT00826267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577904|NCT00826267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25577905|NCT00826267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24415352|NCT00199277|Hematinics|hematinics|mesh-ancestor
25577906|NCT00826267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577907|NCT00826280|Caffeine|caffeine|mesh-list
25577908|NCT00826280|Regadenoson|regadenoson|mesh-list
25577909|NCT00826280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25577910|NCT00826280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577911|NCT00826280|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25577912|NCT00826280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764614|NCT01782950|Rifampin|rifampin|mesh-list
24977986|NCT01127256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24764780|NCT01784250|Adrenergic Agents|adrenergic agents|mesh-ancestor
25577913|NCT00826280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577914|NCT00826280|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25577915|NCT00826280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25577916|NCT00826280|Purinergic Agents|purinergic agents|mesh-ancestor
25577917|NCT00826280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25577918|NCT00826280|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25577919|NCT00826280|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24764909|NCT01785030|Nitrous Oxide|nitrous oxide|mesh-list
25577920|NCT00826280|Purinergic Agonists|purinergic agonists|mesh-ancestor
25577921|NCT00826449|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25577922|NCT00826449|Dasatinib|dasatinib|mesh-list
25577923|NCT00826449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577924|NCT00826449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25577925|NCT00826449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25577926|NCT00826449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577927|NCT00826514|Tanezumab|tanezumab|mesh-list
25577928|NCT00826514|Analgesics|analgesics|mesh-ancestor
25577929|NCT00826514|Sensory System Agents|sensory system agents|mesh-ancestor
25577930|NCT00826514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25577931|NCT00826514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577932|NCT00826540|Bevacizumab|bevacizumab|mesh-list
25577933|NCT00826540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25577934|NCT00826540|Sorafenib|sorafenib|mesh-list
24765009|NCT01785589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556855|NCT00750048|Analgesics|analgesics|mesh-ancestor
24765011|NCT01785641|Ciprofloxacin|ciprofloxacin|mesh-list
24765012|NCT01785641|Gentamicins|gentamicins|mesh-list
25577935|NCT00826540|Antibodies|antibodies|mesh-list
25577936|NCT00826540|Immunoglobulins|immunoglobulins|mesh-list
25577937|NCT00826540|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25577938|NCT00826540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24765070|NCT01785979|Chloroquine|chloroquine|mesh-list
25577939|NCT00826540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25577940|NCT00826540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25577941|NCT00826540|Growth Substances|growth substances|mesh-ancestor
25577942|NCT00826540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577943|NCT00826540|Growth Inhibitors|growth inhibitors|mesh-ancestor
25577944|NCT00826540|Immunologic Factors|immunologic factors|mesh-ancestor
25577945|NCT00826540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25577946|NCT00826540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966260|NCT03770013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24966261|NCT03770013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25577947|NCT00826540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577948|NCT00826618|Ranibizumab|ranibizumab|mesh-list
25577949|NCT00826618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25577950|NCT00826618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25577951|NCT00826618|Growth Substances|growth substances|mesh-ancestor
24765856|NCT01790997|Antipyretics|antipyretics|mesh-ancestor
24766013|NCT01792037|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25577952|NCT00826618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472493|NCT00039377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25472494|NCT00039377|Alkylating Agents|alkylating agents|mesh-ancestor
25472495|NCT00039377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577953|NCT00826618|Growth Inhibitors|growth inhibitors|mesh-ancestor
25577954|NCT00826618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577955|NCT00826748|Beclomethasone|beclomethasone|mesh-list
25577956|NCT00826748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25577957|NCT00826748|Glucocorticoids|glucocorticoids|mesh-ancestor
24766351|NCT01794247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24766352|NCT01794247|Tocolytic Agents|tocolytic agents|mesh-ancestor
24766353|NCT01794247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24766354|NCT01794273|Phenylephrine|phenylephrine|mesh-list
24766355|NCT01794273|Oxymetazoline|oxymetazoline|mesh-list
24766376|NCT01794351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577958|NCT00826748|Hormones|hormones|mesh-ancestor
25577959|NCT00826748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25577960|NCT00826748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577961|NCT00826748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25577962|NCT00826748|Respiratory System Agents|respiratory system agents|mesh-ancestor
25577963|NCT00826800|Bevacizumab|bevacizumab|mesh-list
25577964|NCT00826800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25577965|NCT00826800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25577966|NCT00826800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25577967|NCT00826800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24857711|NCT02293668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857712|NCT02293668|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24766476|NCT01795131|Hydroxocobalamin|hydroxocobalamin|mesh-list
24766477|NCT01795131|Vitamins|vitamins|mesh-ancestor
25577968|NCT00826800|Growth Substances|growth substances|mesh-ancestor
25577969|NCT00826800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577970|NCT00826800|Growth Inhibitors|growth inhibitors|mesh-ancestor
25577971|NCT00826943|Cetirizine|cetirizine|mesh-list
25577972|NCT00826943|Levocetirizine|levocetirizine|mesh-list
25577973|NCT00826943|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25577974|NCT00826943|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25577975|NCT00826943|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25577976|NCT00826943|Histamine Antagonists|histamine antagonists|mesh-ancestor
25577977|NCT00826943|Histamine Agents|histamine agents|mesh-ancestor
25577978|NCT00826943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25577979|NCT00826943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577980|NCT00826943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577981|NCT00827073|Lidocaine|lidocaine|mesh-list
24766598|NCT01795664|Xhance|xhance|mesh-list
25577982|NCT00827073|Tetracaine|tetracaine|mesh-list
25577983|NCT00827073|Anesthetics, Local|anesthetics, local|mesh-ancestor
25577984|NCT00827073|Anesthetics|anesthetics|mesh-ancestor
25577985|NCT00827073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25577986|NCT00827073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25577987|NCT00827073|Sensory System Agents|sensory system agents|mesh-ancestor
25577988|NCT00827073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25577989|NCT00827073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25577990|NCT00827073|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24766806|NCT01796808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24766807|NCT01796808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24766808|NCT01796808|Autonomic Agents|autonomic agents|mesh-ancestor
24766809|NCT01796808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24766810|NCT01796808|Respiratory System Agents|respiratory system agents|mesh-ancestor
24766811|NCT01796808|Mydriatics|mydriatics|mesh-ancestor
24766812|NCT01796808|Sympathomimetics|sympathomimetics|mesh-ancestor
24766813|NCT01796808|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24766814|NCT01796899|Brivaracetam|brivaracetam|mesh-list
24766815|NCT01796899|Anticonvulsants|anticonvulsants|mesh-ancestor
24766816|NCT01796938|Lacosamide|lacosamide|mesh-list
24766817|NCT01796938|Anticonvulsants|anticonvulsants|mesh-ancestor
24766818|NCT01796938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25577991|NCT00827073|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25577992|NCT00827073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25577993|NCT00827073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25577994|NCT00827099|Mycophenolic Acid|mycophenolic acid|mesh-list
25577995|NCT00827099|Fludarabine|fludarabine|mesh-list
25577996|NCT00827099|Fludarabine phosphate|fludarabine phosphate|mesh-list
25577997|NCT00827099|Melphalan|melphalan|mesh-list
25577998|NCT00827099|Tacrolimus|tacrolimus|mesh-list
25577999|NCT00827099|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24766911|NCT01797848|Ribavirin|ribavirin|mesh-list
25578000|NCT00827099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25578001|NCT00827099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25578002|NCT00827099|Antimetabolites|antimetabolites|mesh-ancestor
25578003|NCT00827099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578004|NCT00827099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24767021|NCT01798277|Sympatholytics|sympatholytics|mesh-ancestor
24767182|NCT01799109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767184|NCT01799109|Sensory System Agents|sensory system agents|mesh-ancestor
25578005|NCT00827099|Immunologic Factors|immunologic factors|mesh-ancestor
25578006|NCT00827099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578007|NCT00827099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25578008|NCT00827099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578009|NCT00827099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25578010|NCT00827099|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25578011|NCT00827099|Antitubercular Agents|antitubercular agents|mesh-ancestor
25578012|NCT00827099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24767319|NCT01800019|Autonomic Agents|autonomic agents|mesh-ancestor
24767320|NCT01800019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24767321|NCT01800019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767322|NCT01800019|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24767323|NCT01800019|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24767324|NCT01800019|Cholinergic Agents|cholinergic agents|mesh-ancestor
24767325|NCT01800019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24767326|NCT01800019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767327|NCT01800097|Modafinil|modafinil|mesh-list
24767328|NCT01800097|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24767329|NCT01800097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767330|NCT01800097|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24767331|NCT01800097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24767332|NCT01800097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24767333|NCT01800097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767334|NCT01800227|Metformin|metformin|mesh-list
25578013|NCT00827099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25578014|NCT00827099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25578015|NCT00827099|Alkylating Agents|alkylating agents|mesh-ancestor
25578016|NCT00827099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25578017|NCT00827112|Ritonavir|ritonavir|mesh-list
25578018|NCT00827112|Lopinavir|lopinavir|mesh-list
25578019|NCT00827112|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25578020|NCT00827112|Darunavir|darunavir|mesh-list
25578021|NCT00827112|Tenofovir|tenofovir|mesh-list
25578022|NCT00827112|Emtricitabine|emtricitabine|mesh-list
25578023|NCT00827112|Maraviroc|maraviroc|mesh-list
25578024|NCT00827112|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25578025|NCT00827112|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25578026|NCT00827112|Protease Inhibitors|protease inhibitors|mesh-ancestor
24558385|NCT00757016|Triamcinolone|triamcinolone|mesh-list
25578027|NCT00827112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578028|NCT00827112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578029|NCT00827112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25578030|NCT00827112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25578031|NCT00827112|Antiviral Agents|antiviral agents|mesh-ancestor
25578032|NCT00827112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25578033|NCT00827112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25578034|NCT00827112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25578035|NCT00827112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25578036|NCT00827112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25578037|NCT00827112|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25578038|NCT00827112|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25578039|NCT00827112|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25578040|NCT00827242|Tadalafil|tadalafil|mesh-list
25578041|NCT00827242|Vasodilator Agents|vasodilator agents|mesh-ancestor
25578042|NCT00827242|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25578043|NCT00827242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25578044|NCT00827242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578045|NCT00827242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578046|NCT00827242|Urological Agents|urological agents|mesh-ancestor
25578047|NCT00827255|Cyclosporine|cyclosporine|mesh-list
24543167|NCT00682149|Micronutrients|micronutrients|mesh-ancestor
25578048|NCT00827255|Cyclosporins|cyclosporins|mesh-list
25578049|NCT00827255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578050|NCT00827255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578051|NCT00827255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25578052|NCT00827255|Immunologic Factors|immunologic factors|mesh-ancestor
25578053|NCT00827255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578054|NCT00827255|Antifungal Agents|antifungal agents|mesh-ancestor
25578055|NCT00827255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25578056|NCT00827255|Dermatologic Agents|dermatologic agents|mesh-ancestor
25578057|NCT00827255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25578058|NCT00827255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25578059|NCT00827359|Everolimus|everolimus|mesh-list
25578060|NCT00827359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25578061|NCT00827359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25578062|NCT00827359|Immunologic Factors|immunologic factors|mesh-ancestor
24544105|NCT00687245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544106|NCT00687245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544108|NCT00687258|Vitamins|vitamins|mesh-ancestor
24544109|NCT00687258|Micronutrients|micronutrients|mesh-ancestor
24544110|NCT00687258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768201|NCT01806324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24768202|NCT01806324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25578063|NCT00827359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578064|NCT00827541|Tigecycline|tigecycline|mesh-list
25578065|NCT00827541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25578066|NCT00827541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25578067|NCT00827541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25578068|NCT00827541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544551|NCT00689520|Dalteparin|dalteparin|mesh-list
25578069|NCT00827541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578070|NCT00827606|Atorvastatin|atorvastatin|mesh-list
25578071|NCT00827606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25578072|NCT00827606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25578073|NCT00827606|Antimetabolites|antimetabolites|mesh-ancestor
25578074|NCT00827606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578075|NCT00827606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25578076|NCT00827606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24768342|NCT01807429|Narcotics|narcotics|mesh-ancestor
25578077|NCT00827606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578078|NCT00827775|Carvedilol|carvedilol|mesh-list
24768421|NCT01807962|Anesthetics, Local|anesthetics, local|mesh-ancestor
25578079|NCT00827775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25578080|NCT00827775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25578081|NCT00827775|Adrenergic Agents|adrenergic agents|mesh-ancestor
25578082|NCT00827775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25578083|NCT00827775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578084|NCT00827775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578085|NCT00827775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25578086|NCT00827775|Antioxidants|antioxidants|mesh-ancestor
25578087|NCT00827775|Protective Agents|protective agents|mesh-ancestor
25578088|NCT00827775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25578089|NCT00827775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25578090|NCT00827775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25578091|NCT00827775|Vasodilator Agents|vasodilator agents|mesh-ancestor
25578092|NCT00827775|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25578093|NCT00827775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25578094|NCT00827918|Olanzapine|olanzapine|mesh-list
24858335|NCT02296398|Romidepsin|romidepsin|mesh-list
24460810|NCT00349557|Androgen Antagonists|androgen antagonists|mesh-ancestor
25578095|NCT00827918|Antiemetics|antiemetics|mesh-ancestor
25578096|NCT00827918|Autonomic Agents|autonomic agents|mesh-ancestor
24768846|NCT01810887|Antiviral Agents|antiviral agents|mesh-ancestor
25578097|NCT00827918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24769019|NCT01812135|Vaccines|vaccines|mesh-list
25578098|NCT00827918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578099|NCT00827918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25578100|NCT00827918|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25578101|NCT00827918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25472628|NCT00041080|Immunologic Factors|immunologic factors|mesh-ancestor
25578102|NCT00827918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25578103|NCT00827918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25578104|NCT00827918|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25578105|NCT00827918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25578106|NCT00827918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25578107|NCT00827918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578108|NCT00827918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25578109|NCT00827918|Serotonin Agents|serotonin agents|mesh-ancestor
25578110|NCT00827931|Tranexamic Acid|tranexamic acid|mesh-list
25578111|NCT00827931|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25578112|NCT00827931|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25578113|NCT00827931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401172|NCT00152308|Sirolimus|sirolimus|mesh-list
25578114|NCT00827931|Hemostatics|hemostatics|mesh-ancestor
25578115|NCT00827931|Coagulants|coagulants|mesh-ancestor
25578116|NCT00827983|Progesterone|progesterone|mesh-list
25578117|NCT00827983|Progestins|progestins|mesh-ancestor
25578118|NCT00827983|Hormones|hormones|mesh-ancestor
25578119|NCT00827983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25578120|NCT00827983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578121|NCT00828009|Paclitaxel|paclitaxel|mesh-list
25578122|NCT00828009|Cyclophosphamide|cyclophosphamide|mesh-list
25578123|NCT00828009|Bevacizumab|bevacizumab|mesh-list
25578124|NCT00828009|Carboplatin|carboplatin|mesh-list
25578125|NCT00828009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25578126|NCT00828009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25578127|NCT00828009|Tubulin Modulators|tubulin modulators|mesh-ancestor
24661697|NCT01290406|Dactolisib|dactolisib|mesh-list
24451860|NCT00325000|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24451861|NCT00325000|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24620458|NCT01057212|Bevacizumab|bevacizumab|mesh-list
24620459|NCT01057212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24620481|NCT01057264|Growth Inhibitors|growth inhibitors|mesh-ancestor
24620482|NCT01057264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24620483|NCT01057264|Antimetabolites|antimetabolites|mesh-ancestor
24620484|NCT01057264|Antiviral Agents|antiviral agents|mesh-ancestor
24451863|NCT00325000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451864|NCT00325000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24451865|NCT00325000|Serotonin Agents|serotonin agents|mesh-ancestor
24451866|NCT00325000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080734|NCT03335956|Pioglitazone|pioglitazone|mesh-list
25080735|NCT03335956|Prednisone|prednisone|mesh-list
25080736|NCT03335956|Cortisone|cortisone|mesh-list
25080737|NCT03335956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25080738|NCT03335956|Glucocorticoids|glucocorticoids|mesh-ancestor
25080739|NCT03335956|Hormones|hormones|mesh-ancestor
25080740|NCT03335956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25080741|NCT03335956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080742|NCT03335956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24769415|NCT01814163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769416|NCT01814163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24769417|NCT01814163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24769418|NCT01814163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24769419|NCT01814163|Growth Substances|growth substances|mesh-ancestor
24769420|NCT01814163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769421|NCT01814163|Growth Inhibitors|growth inhibitors|mesh-ancestor
24769422|NCT01814189|Promethazine|promethazine|mesh-list
25578128|NCT00828009|Antimitotic Agents|antimitotic agents|mesh-ancestor
25578129|NCT00828009|Mitosis Modulators|mitosis modulators|mesh-ancestor
25578130|NCT00828009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578131|NCT00828009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25578132|NCT00828009|Immunologic Factors|immunologic factors|mesh-ancestor
25578133|NCT00828009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578134|NCT00828009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25578135|NCT00828009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25578136|NCT00828009|Alkylating Agents|alkylating agents|mesh-ancestor
24769423|NCT01814189|Diphenhydramine|diphenhydramine|mesh-list
24769424|NCT01814189|Sumatriptan|sumatriptan|mesh-list
24769425|NCT01814189|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24769426|NCT01814189|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24769428|NCT01814189|Serotonin Agents|serotonin agents|mesh-ancestor
24769429|NCT01814189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24769433|NCT01814189|Dermatologic Agents|dermatologic agents|mesh-ancestor
24769434|NCT01814189|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24769435|NCT01814189|Histamine Antagonists|histamine antagonists|mesh-ancestor
24769436|NCT01814189|Histamine Agents|histamine agents|mesh-ancestor
24769437|NCT01814189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24769438|NCT01814189|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24769439|NCT01814189|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24769440|NCT01814189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24769442|NCT01814189|Anesthetics|anesthetics|mesh-ancestor
24769443|NCT01814189|Sensory System Agents|sensory system agents|mesh-ancestor
24769444|NCT01814189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25578137|NCT00828009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25578138|NCT00828009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25578139|NCT00828009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25578140|NCT00828009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25578141|NCT00828009|Growth Substances|growth substances|mesh-ancestor
25578142|NCT00828009|Growth Inhibitors|growth inhibitors|mesh-ancestor
25578143|NCT00828061|Prednisone|prednisone|mesh-list
25578144|NCT00828061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25578145|NCT00828061|Glucocorticoids|glucocorticoids|mesh-ancestor
25578146|NCT00828061|Hormones|hormones|mesh-ancestor
25578147|NCT00828061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25578148|NCT00828061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578149|NCT00828061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25578150|NCT00828061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25578151|NCT00828074|Sorafenib|sorafenib|mesh-list
25578152|NCT00828074|Vinorelbine|vinorelbine|mesh-list
25578153|NCT00828074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25578154|NCT00828074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25578155|NCT00828074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578156|NCT00828074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578157|NCT00828074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25578158|NCT00828074|Tubulin Modulators|tubulin modulators|mesh-ancestor
25578159|NCT00828074|Antimitotic Agents|antimitotic agents|mesh-ancestor
25578160|NCT00828074|Mitosis Modulators|mitosis modulators|mesh-ancestor
25578161|NCT00828113|Varenicline|varenicline|mesh-list
24769783|NCT01816191|Diltiazem|diltiazem|mesh-list
25578162|NCT00828113|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25578163|NCT00828113|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25578164|NCT00828113|Cholinergic Agents|cholinergic agents|mesh-ancestor
25578165|NCT00828113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25578166|NCT00828113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578167|NCT00828113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578168|NCT00828139|Aflibercept|aflibercept|mesh-list
25578169|NCT00828139|Topotecan|topotecan|mesh-list
25578170|NCT00828139|Endothelial Growth Factors|endothelial growth factors|mesh-list
25578171|NCT00828139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24770007|NCT01817348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25578172|NCT00828139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25578173|NCT00828139|Growth Substances|growth substances|mesh-ancestor
25578174|NCT00828139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472704|NCT00041132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25578175|NCT00828139|Growth Inhibitors|growth inhibitors|mesh-ancestor
25578176|NCT00828139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25578177|NCT00828139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25578178|NCT00828139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24770134|NCT01818713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24770135|NCT01818713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24770136|NCT01818713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24770137|NCT01818713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770138|NCT01818713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770139|NCT01818843|Carbon Monoxide|carbon monoxide|mesh-list
24770145|NCT01818856|Ritonavir|ritonavir|mesh-list
24549699|NCT00717145|Risedronic Acid|risedronic acid|mesh-list
25578179|NCT00828139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578180|NCT00828139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578181|NCT00828191|Progesterone|progesterone|mesh-list
25578182|NCT00828191|Progestins|progestins|mesh-ancestor
25578183|NCT00828191|Hormones|hormones|mesh-ancestor
25578184|NCT00828191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25578185|NCT00828191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578186|NCT00828204|Interferons|interferons|mesh-list
25578187|NCT00828204|Interferon-beta|interferon-beta|mesh-list
25578188|NCT00828204|Interferon beta-1a|interferon beta-1a|mesh-list
25578189|NCT00828204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25578190|NCT00828204|Antiviral Agents|antiviral agents|mesh-ancestor
25578191|NCT00828204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25578192|NCT00828204|Immunologic Factors|immunologic factors|mesh-ancestor
25578193|NCT00828204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578194|NCT00828204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25578195|NCT00828295|Palonosetron|palonosetron|mesh-list
25578196|NCT00828295|Antiemetics|antiemetics|mesh-ancestor
25578197|NCT00828295|Autonomic Agents|autonomic agents|mesh-ancestor
25578198|NCT00828295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25578199|NCT00828295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550398|NCT00720512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550405|NCT00720512|Antimetabolites|antimetabolites|mesh-ancestor
24770665|NCT01821612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770666|NCT01821612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24770667|NCT01821612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24770668|NCT01821612|Antidotes|antidotes|mesh-ancestor
24770669|NCT01821612|Protective Agents|protective agents|mesh-ancestor
24770670|NCT01821612|Vitamin B Complex|vitamin b complex|mesh-ancestor
24770671|NCT01821612|Vitamins|vitamins|mesh-ancestor
24770672|NCT01821612|Micronutrients|micronutrients|mesh-ancestor
24770673|NCT01821664|Heparin|heparin|mesh-list
24770674|NCT01821664|Anticoagulants|anticoagulants|mesh-ancestor
25578200|NCT00828295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25578201|NCT00828295|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25578202|NCT00828295|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25578203|NCT00828295|Serotonin Agents|serotonin agents|mesh-ancestor
25578204|NCT00828295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25578205|NCT00828295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578206|NCT00828347|Alfacalcidol|alfacalcidol|mesh-list
25578207|NCT00828347|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
25578208|NCT00828347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25578209|NCT00828347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578210|NCT00828347|Vitamins|vitamins|mesh-ancestor
25578211|NCT00828347|Micronutrients|micronutrients|mesh-ancestor
25578212|NCT00828412|Desonide|desonide|mesh-list
25578213|NCT00828412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24770733|NCT01822028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24607410|NCT04665037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770735|NCT01822080|Dienogest|dienogest|mesh-list
24770736|NCT01822080|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24770737|NCT01822080|Contraceptive Agents|contraceptive agents|mesh-ancestor
24770738|NCT01822080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24770739|NCT01822080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770740|NCT01822080|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24402576|NCT00157872|Analgesics|analgesics|mesh-ancestor
24770780|NCT01822405|Vasodilator Agents|vasodilator agents|mesh-ancestor
24770781|NCT01822405|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24770782|NCT01822405|Antioxidants|antioxidants|mesh-ancestor
24770783|NCT01822405|Vitamins|vitamins|mesh-ancestor
24770784|NCT01822405|Micronutrients|micronutrients|mesh-ancestor
24770785|NCT01822418|S 20098|s 20098|mesh-list
24770786|NCT01822418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24770787|NCT01822418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24770788|NCT01822418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578214|NCT00828464|Clobetasol|clobetasol|mesh-list
25578215|NCT00828464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25701308|NCT02137785|Dermatologic Agents|dermatologic agents|mesh-ancestor
25701309|NCT02137837|Everolimus|everolimus|mesh-list
25578216|NCT00828464|Glucocorticoids|glucocorticoids|mesh-ancestor
25578217|NCT00828464|Hormones|hormones|mesh-ancestor
25578218|NCT00828464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25578219|NCT00828464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578220|NCT00828542|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25578221|NCT00828542|Medroxyprogesterone|medroxyprogesterone|mesh-list
25578222|NCT00828542|Desogestrel|desogestrel|mesh-list
25578223|NCT00828542|Etonogestrel|etonogestrel|mesh-list
25578224|NCT00828542|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25578225|NCT00828542|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24770872|NCT01822860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770873|NCT01822860|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24770874|NCT01822860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24770963|NCT01823744|Trace Elements|trace elements|mesh-list
24770964|NCT01823744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578226|NCT00828542|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25578227|NCT00828542|Contraceptive Agents|contraceptive agents|mesh-ancestor
25578228|NCT00828542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25578229|NCT00828542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578230|NCT00828542|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25578231|NCT00828542|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25578232|NCT00828542|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25578233|NCT00828542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24770965|NCT01823770|Rotigotine|rotigotine|mesh-list
24770974|NCT01823809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24770975|NCT01823809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770977|NCT01823809|Vasodilator Agents|vasodilator agents|mesh-ancestor
24770978|NCT01823809|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24770979|NCT01823809|Purinergic Agonists|purinergic agonists|mesh-ancestor
24770980|NCT01823809|Purinergic Agents|purinergic agents|mesh-ancestor
24770981|NCT01823809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24771067|NCT01824433|Serotonin Agents|serotonin agents|mesh-ancestor
24770982|NCT01823809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771009|NCT01824225|Aflibercept|aflibercept|mesh-list
25578234|NCT00828542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25578235|NCT00828542|Progestins|progestins|mesh-ancestor
25578236|NCT00828542|Hormones|hormones|mesh-ancestor
25578237|NCT00828542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25578238|NCT00828568|Imiquimod|imiquimod|mesh-list
25578239|NCT00828568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25578240|NCT00828568|Immunologic Factors|immunologic factors|mesh-ancestor
25578241|NCT00828568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801513|NCT01983800|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24801514|NCT01983800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24801515|NCT01983800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24771056|NCT01824420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24771057|NCT01824420|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25578242|NCT00828568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25578243|NCT00828568|Interferon Inducers|interferon inducers|mesh-ancestor
25578244|NCT00828672|Bevacizumab|bevacizumab|mesh-list
25578245|NCT00828672|Capecitabine|capecitabine|mesh-list
25578246|NCT00828672|Oxaliplatin|oxaliplatin|mesh-list
25578247|NCT00828672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25578248|NCT00828672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25578249|NCT00828672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25578250|NCT00828672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25578251|NCT00828672|Growth Substances|growth substances|mesh-ancestor
25578252|NCT00828672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771257|NCT01825603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578253|NCT00828672|Growth Inhibitors|growth inhibitors|mesh-ancestor
25578254|NCT00828672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25578255|NCT00828672|Antimetabolites|antimetabolites|mesh-ancestor
25578256|NCT00828672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578257|NCT00828841|Gemcitabine|gemcitabine|mesh-list
25578258|NCT00828841|Paclitaxel|paclitaxel|mesh-list
25578259|NCT00828841|Cisplatin|cisplatin|mesh-list
25578260|NCT00828841|Carboplatin|carboplatin|mesh-list
25578261|NCT00828841|Cetuximab|cetuximab|mesh-list
24447884|NCT00309816|Sildenafil Citrate|sildenafil citrate|mesh-list
24447888|NCT00309816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24447889|NCT00309816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578262|NCT00828841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25578263|NCT00828841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25578264|NCT00828841|Tubulin Modulators|tubulin modulators|mesh-ancestor
25578265|NCT00828841|Antimitotic Agents|antimitotic agents|mesh-ancestor
25578266|NCT00828841|Mitosis Modulators|mitosis modulators|mesh-ancestor
24771502|NCT01827540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25578267|NCT00828841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578268|NCT00828841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25578269|NCT00828841|Antimetabolites|antimetabolites|mesh-ancestor
25578270|NCT00828841|Antiviral Agents|antiviral agents|mesh-ancestor
25578271|NCT00828841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25578272|NCT00828841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578273|NCT00828841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25578274|NCT00828841|Immunologic Factors|immunologic factors|mesh-ancestor
24562959|NCT00769158|Sensory System Agents|sensory system agents|mesh-ancestor
25578275|NCT00828841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578276|NCT00828841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25578277|NCT00828984|Laxatives|laxatives|mesh-list
25578278|NCT00828984|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25578279|NCT00828984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25578280|NCT00829010|Vaccines|vaccines|mesh-list
25578281|NCT00829010|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25578282|NCT00829010|Immunologic Factors|immunologic factors|mesh-ancestor
25578283|NCT00829010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578284|NCT00829049|Adapalene|adapalene|mesh-list
25578285|NCT00829049|Tazarotene|tazarotene|mesh-list
25578286|NCT00829049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25578287|NCT00829049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25578288|NCT00829049|Analgesics|analgesics|mesh-ancestor
25578289|NCT00829049|Sensory System Agents|sensory system agents|mesh-ancestor
24771968|NCT01830777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578290|NCT00829049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25578291|NCT00829049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578292|NCT00829049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25578293|NCT00829049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25578294|NCT00829049|Dermatologic Agents|dermatologic agents|mesh-ancestor
25578295|NCT00829049|Keratolytic Agents|keratolytic agents|mesh-ancestor
25578296|NCT00829166|Capecitabine|capecitabine|mesh-list
25578297|NCT00829166|Trastuzumab|trastuzumab|mesh-list
25578298|NCT00829166|Lapatinib|lapatinib|mesh-list
25578299|NCT00829166|Maytansine|maytansine|mesh-list
25578300|NCT00829166|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25578301|NCT00829166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25578302|NCT00829166|Antimetabolites|antimetabolites|mesh-ancestor
25578303|NCT00829166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578304|NCT00829166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25578305|NCT00829166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25578306|NCT00829166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25578307|NCT00829166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578308|NCT00829166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25578309|NCT00829166|Tubulin Modulators|tubulin modulators|mesh-ancestor
25578310|NCT00829166|Antimitotic Agents|antimitotic agents|mesh-ancestor
25578311|NCT00829166|Mitosis Modulators|mitosis modulators|mesh-ancestor
25578312|NCT00829179|Omalizumab|omalizumab|mesh-list
25578313|NCT00829179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25578314|NCT00829179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25578315|NCT00829179|Respiratory System Agents|respiratory system agents|mesh-ancestor
25578316|NCT00829244|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25578317|NCT00829244|Hormones|hormones|mesh-ancestor
25578318|NCT00829244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24772266|NCT01832662|Purinergic Agents|purinergic agents|mesh-ancestor
24772352|NCT01833299|Sorafenib|sorafenib|mesh-list
25578319|NCT00829244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578320|NCT00829283|Orlistat|orlistat|mesh-list
25578321|NCT00829283|Sibutramine|sibutramine|mesh-list
25578322|NCT00829283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772595|NCT01834547|Dopamine Agents|dopamine agents|mesh-ancestor
25578323|NCT00829283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578324|NCT00829283|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25578325|NCT00829283|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25578326|NCT00829283|Antidepressive Agents|antidepressive agents|mesh-ancestor
25472850|NCT00044005|Serotonin Agents|serotonin agents|mesh-ancestor
25578327|NCT00829283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25578328|NCT00829283|Appetite Depressants|appetite depressants|mesh-ancestor
25578329|NCT00829296|Metoprolol|metoprolol|mesh-list
24772819|NCT01836016|Tocolytic Agents|tocolytic agents|mesh-ancestor
25578330|NCT00829296|Nebivolol|nebivolol|mesh-list
25578331|NCT00829296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25578332|NCT00829296|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25578333|NCT00829296|Sympatholytics|sympatholytics|mesh-ancestor
25578334|NCT00829296|Autonomic Agents|autonomic agents|mesh-ancestor
25578335|NCT00829296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25578336|NCT00829296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578337|NCT00829296|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25578338|NCT00829296|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25578339|NCT00829296|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25578340|NCT00829296|Adrenergic Agents|adrenergic agents|mesh-ancestor
25578341|NCT00829296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25578342|NCT00829296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578343|NCT00829296|Vasodilator Agents|vasodilator agents|mesh-ancestor
24620712|NCT01058408|Cisplatin|cisplatin|mesh-list
25578344|NCT00829296|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25578345|NCT00829296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25578346|NCT00829296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25578347|NCT00829439|Levodopa|levodopa|mesh-list
25578348|NCT00829439|Carbidopa|carbidopa|mesh-list
25578349|NCT00829439|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25578350|NCT00829439|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25578351|NCT00829439|Dopamine Agents|dopamine agents|mesh-ancestor
25578352|NCT00829439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24773382|NCT01839253|Protease Inhibitors|protease inhibitors|mesh-ancestor
25578353|NCT00829439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578354|NCT00829439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578355|NCT00829439|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25578356|NCT00829439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578357|NCT00829738|Pantoprazole|pantoprazole|mesh-list
25578358|NCT00829738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25578359|NCT00829738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24773496|NCT01839955|Quinacrine|quinacrine|mesh-list
25578360|NCT00829738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25578361|NCT00829738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578362|NCT00829738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578363|NCT00829829|Rilonacept|rilonacept|mesh-list
25578364|NCT00829829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25578365|NCT00829933|Warfarin|warfarin|mesh-list
25578366|NCT00829933|Edoxaban|edoxaban|mesh-list
25578367|NCT00829933|Anticoagulants|anticoagulants|mesh-ancestor
25578368|NCT00829933|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25578369|NCT00829933|Antithrombins|antithrombins|mesh-ancestor
24773653|NCT01841242|Chlorhexidine|chlorhexidine|mesh-list
25578370|NCT00829933|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25578371|NCT00829933|Protease Inhibitors|protease inhibitors|mesh-ancestor
25578372|NCT00829933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578373|NCT00829933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578374|NCT00830063|Naproxen|naproxen|mesh-list
25578375|NCT00830063|Tanezumab|tanezumab|mesh-list
24773776|NCT01841827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773777|NCT01841996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24773778|NCT01842074|Bortezomib|bortezomib|mesh-list
25578376|NCT00830063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25578377|NCT00830063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25578378|NCT00830063|Analgesics|analgesics|mesh-ancestor
24774003|NCT01843296|Anesthetics, Local|anesthetics, local|mesh-ancestor
24774004|NCT01843296|Anesthetics|anesthetics|mesh-ancestor
25578379|NCT00830063|Sensory System Agents|sensory system agents|mesh-ancestor
25578380|NCT00830063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25578381|NCT00830063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578382|NCT00830063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25578383|NCT00830063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25578384|NCT00830063|Gout Suppressants|gout suppressants|mesh-ancestor
25578385|NCT00830063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25578386|NCT00830063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578387|NCT00830063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578388|NCT00830076|Metformin|metformin|mesh-list
25578389|NCT00830076|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25578390|NCT00830076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25578391|NCT00830076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578392|NCT00830076|Incretins|incretins|mesh-ancestor
25578393|NCT00830076|Hormones|hormones|mesh-ancestor
25578394|NCT00830076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25578395|NCT00830076|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25578396|NCT00830076|Protease Inhibitors|protease inhibitors|mesh-ancestor
25578397|NCT00830076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774222|NCT01844622|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25578398|NCT00830076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578399|NCT00830115|Pantoprazole|pantoprazole|mesh-list
25578400|NCT00830115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25578401|NCT00830115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25578402|NCT00830115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25578403|NCT00830115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578404|NCT00830115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578406|NCT00830128|Analgesics|analgesics|mesh-ancestor
25578407|NCT00830128|Sensory System Agents|sensory system agents|mesh-ancestor
25578408|NCT00830128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25578409|NCT00830128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578410|NCT00830128|Anticonvulsants|anticonvulsants|mesh-ancestor
25578411|NCT00830128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25578412|NCT00830128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25067520|NCT03443492|Vitamins|vitamins|mesh-ancestor
25578413|NCT00830128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578414|NCT00830128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25578415|NCT00830128|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25578416|NCT00830128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25578417|NCT00830128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25578418|NCT00830128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25578419|NCT00830167|Pregabalin|pregabalin|mesh-list
25578420|NCT00830167|Analgesics|analgesics|mesh-ancestor
25578421|NCT00830167|Sensory System Agents|sensory system agents|mesh-ancestor
25578422|NCT00830167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24921241|NCT04193059|Paclitaxel|paclitaxel|mesh-list
24921338|NCT04192253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25578423|NCT00830167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578424|NCT00830167|Anticonvulsants|anticonvulsants|mesh-ancestor
25578425|NCT00830167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25578426|NCT00830167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25578427|NCT00830167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578428|NCT00830167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25578429|NCT00830167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25578430|NCT00830167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25578431|NCT00830167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25578432|NCT00830167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25578433|NCT00830362|Propranolol|propranolol|mesh-list
25578434|NCT00830362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24522740|NCT03365752|Anesthetics, Local|anesthetics, local|mesh-ancestor
25578435|NCT00830362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25578436|NCT00830362|Adrenergic Agents|adrenergic agents|mesh-ancestor
24953118|NCT03888664|Antiviral Agents|antiviral agents|mesh-ancestor
24953119|NCT03888664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24953120|NCT03888729|Velpatasvir|velpatasvir|mesh-list
24953121|NCT03888729|Antiviral Agents|antiviral agents|mesh-ancestor
24953122|NCT03888729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24953123|NCT03888534|Ixazomib|ixazomib|mesh-list
24953488|NCT03884530|Aspirin|aspirin|mesh-list
25578437|NCT00830362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24921844|NCT04186299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25578438|NCT00830362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578439|NCT00830362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578440|NCT00830362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25578441|NCT00830362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25578442|NCT00830362|Vasodilator Agents|vasodilator agents|mesh-ancestor
25578443|NCT00830375|Memantine|memantine|mesh-list
25578444|NCT00830375|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25578445|NCT00830375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25578446|NCT00830375|Dopamine Agents|dopamine agents|mesh-ancestor
25578447|NCT00830375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25578448|NCT00830375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578449|NCT00830375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068039|NCT03437057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24623961|NCT01074073|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24623963|NCT01074073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24624127|NCT01074892|Levonorgestrel|levonorgestrel|mesh-list
24922306|NCT04181749|Aspirin|aspirin|mesh-list
25578450|NCT00830375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25578451|NCT00830375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25578452|NCT00830388|Ketoconazole|ketoconazole|mesh-list
25578453|NCT00830388|Antifungal Agents|antifungal agents|mesh-ancestor
25578454|NCT00830388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25578455|NCT00830388|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25578456|NCT00830388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25578457|NCT00830388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578458|NCT00830388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578459|NCT00830388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25578460|NCT00830388|Hormone Antagonists|hormone antagonists|mesh-ancestor
25578461|NCT00830388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25578462|NCT00830388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578463|NCT00830388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25578464|NCT00830765|Progesterone|progesterone|mesh-list
25578465|NCT00830765|Progestins|progestins|mesh-ancestor
25578466|NCT00830765|Hormones|hormones|mesh-ancestor
25578467|NCT00830765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25578468|NCT00830765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578469|NCT00830804|Ritonavir|ritonavir|mesh-list
25578470|NCT00830804|Darunavir|darunavir|mesh-list
25578471|NCT00830804|Raltegravir Potassium|raltegravir potassium|mesh-list
25472997|NCT00045435|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25472998|NCT00045435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25578472|NCT00830804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25578473|NCT00830804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25578475|NCT00830804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25068241|NCT03435094|Alendronate|alendronate|mesh-list
25578476|NCT00830804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578477|NCT00830804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24605513|NCT00985647|Antiviral Agents|antiviral agents|mesh-ancestor
25578478|NCT00830804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25578479|NCT00830804|Antiviral Agents|antiviral agents|mesh-ancestor
25578480|NCT00830804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25578481|NCT00830804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25578482|NCT00830804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25578483|NCT00830804|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25578484|NCT00830804|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25578485|NCT00830869|Ixazomib|ixazomib|mesh-list
25578486|NCT00830869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25578487|NCT00830869|Protease Inhibitors|protease inhibitors|mesh-ancestor
25578488|NCT00830869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24465610|NCT00370266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25578489|NCT00830869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578490|NCT00830960|Clopidogrel|clopidogrel|mesh-list
25578491|NCT00830960|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25578492|NCT00830960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25578493|NCT00830960|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25578494|NCT00830960|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25578495|NCT00830960|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25578496|NCT00830960|Purinergic Agents|purinergic agents|mesh-ancestor
25578497|NCT00830960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25701446|NCT02139982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578498|NCT00830960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578499|NCT00830960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578500|NCT00831129|Rosiglitazone|rosiglitazone|mesh-list
25578501|NCT00831129|Simvastatin|simvastatin|mesh-list
24672851|NCT01333982|Gentamicins|gentamicins|mesh-list
25578502|NCT00831129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24803366|NCT01996150|Eusol|eusol|mesh-list
25578503|NCT00831129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25578504|NCT00831129|Antimetabolites|antimetabolites|mesh-ancestor
24673641|NCT01339468|Tacrolimus|tacrolimus|mesh-list
25578505|NCT00831129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578506|NCT00831129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25578507|NCT00831129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25578508|NCT00831129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578509|NCT00831129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25578510|NCT00831129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578511|NCT00831181|Leucovorin|leucovorin|mesh-list
25578512|NCT00831181|Fluorouracil|fluorouracil|mesh-list
25578513|NCT00831181|Oxaliplatin|oxaliplatin|mesh-list
25578514|NCT00831181|Antimetabolites|antimetabolites|mesh-ancestor
25578515|NCT00831181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578516|NCT00831181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25578517|NCT00831181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24539815|NCT00665717|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25578518|NCT00831181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25578519|NCT00831181|Immunologic Factors|immunologic factors|mesh-ancestor
24680666|NCT01375816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25578520|NCT00831181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578521|NCT00831181|Antidotes|antidotes|mesh-ancestor
25578522|NCT00831181|Protective Agents|protective agents|mesh-ancestor
25578523|NCT00831181|Vitamin B Complex|vitamin b complex|mesh-ancestor
25578524|NCT00831181|Vitamins|vitamins|mesh-ancestor
25578525|NCT00831181|Micronutrients|micronutrients|mesh-ancestor
25578526|NCT00831233|Goserelin|goserelin|mesh-list
25578527|NCT00831233|Bicalutamide|bicalutamide|mesh-list
25578528|NCT00831233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24684454|NCT05268562|Anesthetics|anesthetics|mesh-ancestor
25578529|NCT00831233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25578530|NCT00831233|Androgen Antagonists|androgen antagonists|mesh-ancestor
25578531|NCT00831233|Hormone Antagonists|hormone antagonists|mesh-ancestor
24685015|NCT03089866|GABA Agents|gaba agents|mesh-ancestor
25578532|NCT00831233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25578533|NCT00831233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578534|NCT00831272|Naltrexone|naltrexone|mesh-list
25578535|NCT00831272|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24641103|NCT01171885|Ropivacaine|ropivacaine|mesh-list
25578536|NCT00831272|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25578537|NCT00831272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578538|NCT00831272|Sensory System Agents|sensory system agents|mesh-ancestor
25578539|NCT00831272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25578540|NCT00831311|Vaccines|vaccines|mesh-list
25578541|NCT00831311|Immunologic Factors|immunologic factors|mesh-ancestor
24468585|NCT00382343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24468587|NCT00382343|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25578542|NCT00831311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578543|NCT00831415|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25578544|NCT00831415|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25473052|NCT00046228|Reteplase|reteplase|mesh-list
25578545|NCT00831415|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25578546|NCT00831415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25578547|NCT00831415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578548|NCT00831415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25578549|NCT00831415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578550|NCT00831415|Antidepressive Agents|antidepressive agents|mesh-ancestor
25578551|NCT00831415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25652859|NCT01532687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652860|NCT01532700|Ofatumumab|ofatumumab|mesh-list
25652861|NCT01532700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652862|NCT01532908|Sofosbuvir|sofosbuvir|mesh-list
25652863|NCT01532908|Antiviral Agents|antiviral agents|mesh-ancestor
25652864|NCT01532908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25652865|NCT01533077|Levodopa|levodopa|mesh-list
25652866|NCT01533077|Carbidopa|carbidopa|mesh-list
25652867|NCT01533077|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25652868|NCT01533077|Opicapone|opicapone|mesh-list
25652869|NCT01533077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25652870|NCT01533077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25652871|NCT01533077|Dopamine Agents|dopamine agents|mesh-ancestor
25652872|NCT01533077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25069263|NCT03427502|Epinephrine|epinephrine|mesh-list
24690118|NCT01399450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25652873|NCT01533077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652874|NCT01533077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652875|NCT01533077|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25652876|NCT01533077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652877|NCT01533077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25652878|NCT01533077|Immunologic Factors|immunologic factors|mesh-ancestor
25652879|NCT01533077|Dopamine Agonists|dopamine agonists|mesh-ancestor
25652880|NCT01533077|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25652881|NCT01533116|Levodopa|levodopa|mesh-list
25652882|NCT01533116|Carbidopa|carbidopa|mesh-list
25652883|NCT01533116|Opicapone|opicapone|mesh-list
25652884|NCT01533116|Benserazide|benserazide|mesh-list
25652885|NCT01533116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25652886|NCT01533116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25652887|NCT01533116|Dopamine Agents|dopamine agents|mesh-ancestor
25652888|NCT01533116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25652889|NCT01533116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652890|NCT01533116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652891|NCT01533116|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25652892|NCT01533116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652893|NCT01533116|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25652894|NCT01533181|Topotecan|topotecan|mesh-list
25652895|NCT01533181|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25652896|NCT01533181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25652897|NCT01533181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652898|NCT01533181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652899|NCT01533181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652900|NCT01533207|Gemcitabine|gemcitabine|mesh-list
25652901|NCT01533207|Docetaxel|docetaxel|mesh-list
24691174|NCT01405326|Adalimumab|adalimumab|mesh-list
25652902|NCT01533207|Doxorubicin|doxorubicin|mesh-list
25652903|NCT01533207|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25652904|NCT01533207|Lenograstim|lenograstim|mesh-list
25652905|NCT01533207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25652906|NCT01533207|Antimetabolites|antimetabolites|mesh-ancestor
25701556|NCT02141620|Cocaine|cocaine|mesh-list
25652907|NCT01533207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652908|NCT01533207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652909|NCT01533207|Antiviral Agents|antiviral agents|mesh-ancestor
24693220|NCT01418742|Doxycycline|doxycycline|mesh-list
25652910|NCT01533207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25652911|NCT01533207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693846|NCT01422616|Enalapril|enalapril|mesh-list
25652912|NCT01533207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25652913|NCT01533207|Immunologic Factors|immunologic factors|mesh-ancestor
25652914|NCT01533207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652915|NCT01533207|Tubulin Modulators|tubulin modulators|mesh-ancestor
25652916|NCT01533207|Antimitotic Agents|antimitotic agents|mesh-ancestor
25652917|NCT01533207|Mitosis Modulators|mitosis modulators|mesh-ancestor
25652918|NCT01533207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25652919|NCT01533207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24818715|NCT02090439|Silodosin|silodosin|mesh-list
25652920|NCT01533207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25652921|NCT01533207|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25656950|NCT01581281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656951|NCT01581281|Adrenergic Agents|adrenergic agents|mesh-ancestor
25656952|NCT01581281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25656953|NCT01581307|Leucovorin|leucovorin|mesh-list
25656954|NCT01581307|Folic Acid|folic acid|mesh-list
25656955|NCT01581307|Fluorouracil|fluorouracil|mesh-list
25578553|NCT00831441|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25578554|NCT00831441|Antithrombins|antithrombins|mesh-ancestor
25578555|NCT00831441|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25578556|NCT00831441|Protease Inhibitors|protease inhibitors|mesh-ancestor
25578557|NCT00831441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578558|NCT00831441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578559|NCT00831441|Anticoagulants|anticoagulants|mesh-ancestor
25578560|NCT00831480|Everolimus|everolimus|mesh-list
25578561|NCT00831480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25578562|NCT00831480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25578563|NCT00831480|Immunologic Factors|immunologic factors|mesh-ancestor
25578564|NCT00831480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473205|NCT00048165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25473206|NCT00048165|Glucocorticoids|glucocorticoids|mesh-ancestor
25473207|NCT00048165|Hormones|hormones|mesh-ancestor
25473208|NCT00048165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25473209|NCT00048165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25473210|NCT00048165|Protective Agents|protective agents|mesh-ancestor
25473211|NCT00048347|Interferon beta-1a|interferon beta-1a|mesh-list
24612425|NCT01013909|Antifungal Agents|antifungal agents|mesh-ancestor
25473212|NCT00048347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25473213|NCT00048347|Immunologic Factors|immunologic factors|mesh-ancestor
25473214|NCT00048347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473215|NCT00048347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473216|NCT00048347|Antiviral Agents|antiviral agents|mesh-ancestor
25473217|NCT00048347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25473218|NCT00048542|Adalimumab|adalimumab|mesh-list
25473219|NCT00048542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25473220|NCT00048542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25473221|NCT00048568|Methotrexate|methotrexate|mesh-list
25473222|NCT00048568|Abatacept|abatacept|mesh-list
25473223|NCT00048568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25473224|NCT00048568|Abortifacient Agents|abortifacient agents|mesh-ancestor
25473225|NCT00048568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25473226|NCT00048568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473227|NCT00048568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25473228|NCT00048568|Antimetabolites|antimetabolites|mesh-ancestor
25473229|NCT00048568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473230|NCT00048568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473231|NCT00048568|Dermatologic Agents|dermatologic agents|mesh-ancestor
25473232|NCT00048568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473233|NCT00048568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25473234|NCT00048568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25473235|NCT00048568|Immunologic Factors|immunologic factors|mesh-ancestor
25473239|NCT00048581|Abatacept|abatacept|mesh-list
25578565|NCT00831493|Vorinostat|vorinostat|mesh-list
25578566|NCT00831493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109223|NCT03126695|Ticagrelor|ticagrelor|mesh-list
25578567|NCT00831493|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25578568|NCT00831493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578569|NCT00831493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578570|NCT00831675|Vaccines|vaccines|mesh-list
25578571|NCT00831675|Immunologic Factors|immunologic factors|mesh-ancestor
25578572|NCT00831675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578573|NCT00831701|Tamsulosin|tamsulosin|mesh-list
25578574|NCT00831701|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25701616|NCT02141854|Xhance|xhance|mesh-list
25578575|NCT00831701|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25578576|NCT00831701|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25578577|NCT00831701|Adrenergic Agents|adrenergic agents|mesh-ancestor
25578578|NCT00831701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25578579|NCT00831701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578580|NCT00831701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578581|NCT00831701|Urological Agents|urological agents|mesh-ancestor
25578582|NCT00831766|Cytarabine|cytarabine|mesh-list
25578583|NCT00831766|Lenalidomide|lenalidomide|mesh-list
25578584|NCT00831766|Idarubicin|idarubicin|mesh-list
25578585|NCT00831766|Antineoplastic Agents|antineoplastic agents|mesh-list
25578586|NCT00831766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25578587|NCT00831766|Antimetabolites|antimetabolites|mesh-ancestor
25578588|NCT00831766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578589|NCT00831766|Antiviral Agents|antiviral agents|mesh-ancestor
25578590|NCT00831766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25578591|NCT00831766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24698511|NCT01441531|Gabapentin|gabapentin|mesh-list
24484296|NCT00447577|Tobramycin|tobramycin|mesh-list
25578592|NCT00831766|Immunologic Factors|immunologic factors|mesh-ancestor
25578593|NCT00831766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578594|NCT00831766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25578595|NCT00831766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25578596|NCT00831766|Growth Substances|growth substances|mesh-ancestor
25578597|NCT00831766|Growth Inhibitors|growth inhibitors|mesh-ancestor
25701656|NCT02142712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25578598|NCT00831766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25578599|NCT00831766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25578600|NCT00831766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24700089|NCT01450462|Cholecalciferol|cholecalciferol|mesh-list
25578601|NCT00831766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578602|NCT00831779|Dapagliflozin|dapagliflozin|mesh-list
25071183|NCT03412513|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25578603|NCT00831779|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24700354|NCT01451918|Protective Agents|protective agents|mesh-ancestor
25578604|NCT00831779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578605|NCT00831779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25578606|NCT00831779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578607|NCT00831844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25578608|NCT00831844|Immunologic Factors|immunologic factors|mesh-ancestor
25578609|NCT00831844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578610|NCT00831987|Vaccines|vaccines|mesh-list
25578611|NCT00831987|Immunologic Factors|immunologic factors|mesh-ancestor
25578612|NCT00831987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578613|NCT00832000|Mexiletine|mexiletine|mesh-list
25578614|NCT00832000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25578615|NCT00832000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25578616|NCT00832000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25578617|NCT00832000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24700357|NCT01451918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24929484|NCT04111822|Hemostatics|hemostatics|mesh-ancestor
25578618|NCT00832000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578619|NCT00832117|Cisplatin|cisplatin|mesh-list
25578620|NCT00832117|Epothilones|epothilones|mesh-list
25578621|NCT00832117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25578622|NCT00832117|Tubulin Modulators|tubulin modulators|mesh-ancestor
25578623|NCT00832117|Antimitotic Agents|antimitotic agents|mesh-ancestor
25578624|NCT00832117|Mitosis Modulators|mitosis modulators|mesh-ancestor
25578625|NCT00832117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578626|NCT00832338|Dexamethasone|dexamethasone|mesh-list
25578627|NCT00832338|Docetaxel|docetaxel|mesh-list
25578628|NCT00832338|Cyclophosphamide|cyclophosphamide|mesh-list
25578629|NCT00832338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25578630|NCT00832338|Antiemetics|antiemetics|mesh-ancestor
25578631|NCT00832338|Autonomic Agents|autonomic agents|mesh-ancestor
25578632|NCT00832338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25578633|NCT00832338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578634|NCT00832338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25578635|NCT00832338|Glucocorticoids|glucocorticoids|mesh-ancestor
25578636|NCT00832338|Hormones|hormones|mesh-ancestor
25578637|NCT00832338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25578638|NCT00832338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25578639|NCT00832338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25578640|NCT00832338|Tubulin Modulators|tubulin modulators|mesh-ancestor
25578641|NCT00832338|Antimitotic Agents|antimitotic agents|mesh-ancestor
25578642|NCT00832338|Mitosis Modulators|mitosis modulators|mesh-ancestor
25578643|NCT00832338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578644|NCT00832338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25578645|NCT00832338|Immunologic Factors|immunologic factors|mesh-ancestor
25578646|NCT00832338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25578647|NCT00832338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25578648|NCT00832338|Alkylating Agents|alkylating agents|mesh-ancestor
25578649|NCT00832338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25578650|NCT00832377|Timolol|timolol|mesh-list
25578651|NCT00832377|Dorzolamide|dorzolamide|mesh-list
25578652|NCT00832377|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25578653|NCT00832377|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25578654|NCT00832377|Adrenergic Agents|adrenergic agents|mesh-ancestor
25578655|NCT00832377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25578656|NCT00832377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578657|NCT00832377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578658|NCT00832377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25578659|NCT00832377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25578660|NCT00832377|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25578661|NCT00832377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578662|NCT00832390|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25578663|NCT00832390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25578664|NCT00832390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578665|NCT00832390|Incretins|incretins|mesh-ancestor
25578666|NCT00832390|Hormones|hormones|mesh-ancestor
25606167|NCT01065506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578667|NCT00832390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25578668|NCT00832390|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25578669|NCT00832390|Protease Inhibitors|protease inhibitors|mesh-ancestor
25578670|NCT00832390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578671|NCT00832390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578672|NCT00832416|Tramadol|tramadol|mesh-list
25578673|NCT00832416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25578674|NCT00832416|Narcotics|narcotics|mesh-ancestor
25578675|NCT00832416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25578676|NCT00832416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578677|NCT00832416|Analgesics|analgesics|mesh-ancestor
25578678|NCT00832416|Sensory System Agents|sensory system agents|mesh-ancestor
25578679|NCT00832416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25578680|NCT00832585|Alefacept|alefacept|mesh-list
25578681|NCT00832585|Dermatologic Agents|dermatologic agents|mesh-ancestor
25578682|NCT00832585|Immunologic Factors|immunologic factors|mesh-ancestor
25578683|NCT00832585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578684|NCT00832637|Gemcitabine|gemcitabine|mesh-list
25578685|NCT00832637|Cisplatin|cisplatin|mesh-list
25578686|NCT00832637|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25578687|NCT00832637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25578688|NCT00832637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25578689|NCT00832637|Antimetabolites|antimetabolites|mesh-ancestor
25578690|NCT00832637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578691|NCT00832637|Antiviral Agents|antiviral agents|mesh-ancestor
25578692|NCT00832637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25578693|NCT00832637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578694|NCT00832637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25578695|NCT00832637|Immunologic Factors|immunologic factors|mesh-ancestor
25578696|NCT00832637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578697|NCT00832637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25578698|NCT00832650|Solifenacin Succinate|solifenacin succinate|mesh-list
25578699|NCT00832650|Fesoterodine|fesoterodine|mesh-list
25578700|NCT00832650|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25578701|NCT00832650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25578702|NCT00832650|Cholinergic Agents|cholinergic agents|mesh-ancestor
25578703|NCT00832650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25578704|NCT00832650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606168|NCT01065558|Ecopipam|ecopipam|mesh-list
25005108|NCT04856176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005109|NCT04856176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25578705|NCT00832650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578706|NCT00832650|Urological Agents|urological agents|mesh-ancestor
25578707|NCT00832819|Paclitaxel|paclitaxel|mesh-list
25578708|NCT00832819|Carboplatin|carboplatin|mesh-list
25578709|NCT00832819|Lenvatinib|lenvatinib|mesh-list
25578710|NCT00832819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25578711|NCT00832819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25578712|NCT00832819|Tubulin Modulators|tubulin modulators|mesh-ancestor
25578713|NCT00832819|Antimitotic Agents|antimitotic agents|mesh-ancestor
24513474|NCT00582582|Vitamin D|vitamin d|mesh-list
24635835|NCT01141439|Respiratory System Agents|respiratory system agents|mesh-ancestor
24635836|NCT01141439|Dermatologic Agents|dermatologic agents|mesh-ancestor
24635837|NCT01141439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24635840|NCT01141439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24635841|NCT01141452|Fluticasone|fluticasone|mesh-list
24635842|NCT01141452|Xhance|xhance|mesh-list
24635843|NCT01141452|Beclomethasone|beclomethasone|mesh-list
25073406|NCT03395093|Fentanyl|fentanyl|mesh-list
25578714|NCT00832819|Mitosis Modulators|mitosis modulators|mesh-ancestor
25578715|NCT00832819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578716|NCT00832819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25578717|NCT00832819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578718|NCT00832871|Mifepristone|mifepristone|mesh-list
25578719|NCT00832871|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25578720|NCT00832871|Abortifacient Agents|abortifacient agents|mesh-ancestor
25578721|NCT00832871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25578722|NCT00832871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606169|NCT01065558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25578723|NCT00832871|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25578724|NCT00832871|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25578725|NCT00832871|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25578726|NCT00832871|Contraceptive Agents|contraceptive agents|mesh-ancestor
25578727|NCT00832871|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25578728|NCT00832871|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25578729|NCT00832871|Hormone Antagonists|hormone antagonists|mesh-ancestor
25578730|NCT00832871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25578731|NCT00832871|Luteolytic Agents|luteolytic agents|mesh-ancestor
25578732|NCT00832871|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25578733|NCT00832871|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25578734|NCT00833027|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25578735|NCT00833027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25073614|NCT03394001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25578736|NCT00833027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578737|NCT00833027|Incretins|incretins|mesh-ancestor
25578738|NCT00833027|Hormones|hormones|mesh-ancestor
25578739|NCT00833027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25578740|NCT00833027|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25578741|NCT00833027|Protease Inhibitors|protease inhibitors|mesh-ancestor
25578742|NCT00833027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473320|NCT00049036|Prednisone|prednisone|mesh-list
25578743|NCT00833027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578745|NCT00833040|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25578746|NCT00833040|Narcotics|narcotics|mesh-ancestor
25578747|NCT00833040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25578748|NCT00833040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578749|NCT00833040|Analgesics|analgesics|mesh-ancestor
25578750|NCT00833040|Sensory System Agents|sensory system agents|mesh-ancestor
25578751|NCT00833040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25578752|NCT00833040|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25578753|NCT00833040|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25578754|NCT00833040|Anesthetics, General|anesthetics, general|mesh-ancestor
25578755|NCT00833040|Anesthetics|anesthetics|mesh-ancestor
25578756|NCT00833053|Methotrexate|methotrexate|mesh-list
25578757|NCT00833053|Infliximab|infliximab|mesh-list
24639506|NCT01162031|Bortezomib|bortezomib|mesh-list
25578758|NCT00833053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25578759|NCT00833053|Abortifacient Agents|abortifacient agents|mesh-ancestor
25578760|NCT00833053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25578761|NCT00833053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578762|NCT00833053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25578763|NCT00833053|Antimetabolites|antimetabolites|mesh-ancestor
25578764|NCT00833053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578765|NCT00833053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25578766|NCT00833053|Dermatologic Agents|dermatologic agents|mesh-ancestor
25578767|NCT00833053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578768|NCT00833053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25578769|NCT00833053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25578770|NCT00833053|Immunologic Factors|immunologic factors|mesh-ancestor
24640377|NCT01167803|Anesthetics|anesthetics|mesh-ancestor
24954118|NCT03879382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24954119|NCT03879382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24954120|NCT03879382|Alkylating Agents|alkylating agents|mesh-ancestor
24954121|NCT03879382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578771|NCT00833053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25578772|NCT00833053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25578773|NCT00833053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25578774|NCT00833248|Goserelin|goserelin|mesh-list
25578775|NCT00833248|Bicalutamide|bicalutamide|mesh-list
25578776|NCT00833248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25701786|NCT02145026|Epoetin Alfa|epoetin alfa|mesh-list
25578777|NCT00833248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25578778|NCT00833248|Androgen Antagonists|androgen antagonists|mesh-ancestor
25578779|NCT00833248|Hormone Antagonists|hormone antagonists|mesh-ancestor
25578780|NCT00833248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25578781|NCT00833248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578782|NCT00833261|Paclitaxel|paclitaxel|mesh-list
25578783|NCT00833261|Cisplatin|cisplatin|mesh-list
25578784|NCT00833261|Cetuximab|cetuximab|mesh-list
25578785|NCT00833261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25578786|NCT00833261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25578787|NCT00833261|Tubulin Modulators|tubulin modulators|mesh-ancestor
25578788|NCT00833261|Antimitotic Agents|antimitotic agents|mesh-ancestor
25578789|NCT00833261|Mitosis Modulators|mitosis modulators|mesh-ancestor
25578790|NCT00833261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578791|NCT00833261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25578792|NCT00833365|Ibuprofen|ibuprofen|mesh-list
24640903|NCT01170507|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25578793|NCT00833365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25578794|NCT00833365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25578795|NCT00833365|Analgesics|analgesics|mesh-ancestor
25578796|NCT00833365|Sensory System Agents|sensory system agents|mesh-ancestor
25578797|NCT00833365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25578798|NCT00833365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578799|NCT00833365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24716586|NCT01542489|Insulin Aspart|insulin aspart|mesh-list
24716587|NCT01542489|Insulin Detemir|insulin detemir|mesh-list
24716588|NCT01542489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24717503|NCT01548209|Adrenergic Agents|adrenergic agents|mesh-ancestor
25578800|NCT00833365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25578801|NCT00833365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25578802|NCT00833365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578803|NCT00833365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578804|NCT00833443|Bupropion|bupropion|mesh-list
25074223|NCT03389776|Anesthetics|anesthetics|mesh-list
25074275|NCT03389412|Coagulants|coagulants|mesh-ancestor
25074276|NCT03389412|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25578805|NCT00833443|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25578806|NCT00833443|Antidepressive Agents|antidepressive agents|mesh-ancestor
25578807|NCT00833443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25578808|NCT00833443|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25578809|NCT00833443|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25578810|NCT00833443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25578811|NCT00833443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578812|NCT00833443|Dopamine Agents|dopamine agents|mesh-ancestor
25578813|NCT00833443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25578814|NCT00833443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578815|NCT00833443|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25606170|NCT01065558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25578816|NCT00833443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25578817|NCT00833443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578818|NCT00833469|Citalopram|citalopram|mesh-list
25578819|NCT00833469|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25578820|NCT00833469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25578821|NCT00833469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25578822|NCT00833469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578823|NCT00833469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25578824|NCT00833469|Serotonin Agents|serotonin agents|mesh-ancestor
25578825|NCT00833469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578826|NCT00833469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25578827|NCT00833469|Antidepressive Agents|antidepressive agents|mesh-ancestor
25074545|NCT03387592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437076|NCT00272610|Vitamins|vitamins|mesh-ancestor
25578828|NCT00833469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25578829|NCT00833482|Ritonavir|ritonavir|mesh-list
25578830|NCT00833482|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25578831|NCT00833482|Voriconazole|voriconazole|mesh-list
25578832|NCT00833482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25578833|NCT00833482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25578834|NCT00833482|Protease Inhibitors|protease inhibitors|mesh-ancestor
24724499|NCT01593319|Ropivacaine|ropivacaine|mesh-list
25578835|NCT00833482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578836|NCT00833482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578837|NCT00833482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25578838|NCT00833482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25578839|NCT00833482|Antiviral Agents|antiviral agents|mesh-ancestor
25578840|NCT00833482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25578841|NCT00833482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25075356|NCT03381664|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25578842|NCT00833482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25578843|NCT00833482|Antifungal Agents|antifungal agents|mesh-ancestor
24728834|NCT01618539|Anesthetics|anesthetics|mesh-ancestor
25578844|NCT00833482|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25578845|NCT00833482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25075851|NCT03377608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25578846|NCT00833482|Hormone Antagonists|hormone antagonists|mesh-ancestor
25578847|NCT00833482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25578848|NCT00833482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578849|NCT00833547|Eszopiclone|eszopiclone|mesh-list
25578850|NCT00833547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25578851|NCT00833547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25578852|NCT00833547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578853|NCT00833560|Dexamethasone|dexamethasone|mesh-list
24729813|NCT01624051|Cisplatin|cisplatin|mesh-list
25578854|NCT00833560|Cyclophosphamide|cyclophosphamide|mesh-list
25578855|NCT00833560|Bortezomib|bortezomib|mesh-list
25578856|NCT00833560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25578857|NCT00833560|Immunologic Factors|immunologic factors|mesh-ancestor
25578858|NCT00833560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578859|NCT00833560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25578860|NCT00833560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25578861|NCT00833560|Alkylating Agents|alkylating agents|mesh-ancestor
25578862|NCT00833560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578863|NCT00833560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25578864|NCT00833560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25578865|NCT00833560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25578866|NCT00833560|Antiemetics|antiemetics|mesh-ancestor
25578867|NCT00833560|Autonomic Agents|autonomic agents|mesh-ancestor
25578868|NCT00833560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25578869|NCT00833560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25578870|NCT00833560|Glucocorticoids|glucocorticoids|mesh-ancestor
25578871|NCT00833560|Hormones|hormones|mesh-ancestor
25578872|NCT00833560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25578873|NCT00833560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25578874|NCT00833638|Tadalafil|tadalafil|mesh-list
25578875|NCT00833638|Vasodilator Agents|vasodilator agents|mesh-ancestor
24798356|NCT01963182|Irinotecan|irinotecan|mesh-list
24798357|NCT01963182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24798358|NCT01963182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24798359|NCT01963182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24798361|NCT01963182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25578876|NCT00833638|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25578877|NCT00833638|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25578878|NCT00833638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578879|NCT00833638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578880|NCT00833638|Urological Agents|urological agents|mesh-ancestor
25578881|NCT00833703|Clopidogrel|clopidogrel|mesh-list
25578882|NCT00833703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25578883|NCT00833703|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25578884|NCT00833703|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25578885|NCT00833703|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25578886|NCT00833703|Purinergic Agents|purinergic agents|mesh-ancestor
24999772|NCT03354728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999774|NCT03341936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24999775|NCT03341936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999776|NCT03341936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24944371|NCT03961048|Ropivacaine|ropivacaine|mesh-list
25048829|NCT00662740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24999777|NCT03341936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999785|NCT03246529|Lenograstim|lenograstim|mesh-list
24999786|NCT03246529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24999795|NCT03188796|Micronutrients|micronutrients|mesh-ancestor
24999796|NCT03188796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578887|NCT00833703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25656956|NCT01581307|Oxaliplatin|oxaliplatin|mesh-list
25578888|NCT00833703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578889|NCT00833703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578891|NCT00833755|Analgesics|analgesics|mesh-ancestor
25578892|NCT00833755|Sensory System Agents|sensory system agents|mesh-ancestor
25578893|NCT00833755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25578894|NCT00833755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578895|NCT00833755|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25578896|NCT00833755|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25578897|NCT00833755|Anesthetics, General|anesthetics, general|mesh-ancestor
25578898|NCT00833755|Anesthetics|anesthetics|mesh-ancestor
25578899|NCT00833755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25578900|NCT00833755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25578901|NCT00833755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24999922|NCT02727803|Antibodies|antibodies|mesh-list
24999936|NCT02696993|Nivolumab|nivolumab|mesh-list
24841143|NCT02214381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578902|NCT00833755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25578903|NCT00833755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578904|NCT00833794|Tramadol|tramadol|mesh-list
25578905|NCT00833794|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25578906|NCT00833794|Narcotics|narcotics|mesh-ancestor
25578907|NCT00833794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25578908|NCT00833794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578909|NCT00833794|Analgesics|analgesics|mesh-ancestor
25578910|NCT00833794|Sensory System Agents|sensory system agents|mesh-ancestor
25578911|NCT00833794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25578912|NCT00833833|Aspirin|aspirin|mesh-list
25578913|NCT00833833|Dexamethasone|dexamethasone|mesh-list
25578914|NCT00833833|Dexamethasone acetate|dexamethasone acetate|mesh-list
25578915|NCT00833833|Pomalidomide|pomalidomide|mesh-list
25578916|NCT00833833|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25578917|NCT00833833|BB 1101|bb 1101|mesh-list
24938056|NCT04022811|Protective Agents|protective agents|mesh-ancestor
24938057|NCT04022811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24938058|NCT04022811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24938059|NCT04022811|Analgesics|analgesics|mesh-ancestor
24938060|NCT04022811|Sensory System Agents|sensory system agents|mesh-ancestor
25048880|NCT00658762|Paroxetine|paroxetine|mesh-list
25578918|NCT00833833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25578919|NCT00833833|Antiemetics|antiemetics|mesh-ancestor
25578920|NCT00833833|Autonomic Agents|autonomic agents|mesh-ancestor
25578921|NCT00833833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25578922|NCT00833833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578923|NCT00833833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25578924|NCT00833833|Glucocorticoids|glucocorticoids|mesh-ancestor
25578925|NCT00833833|Hormones|hormones|mesh-ancestor
25578926|NCT00833833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25578927|NCT00833833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25578928|NCT00833833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25578929|NCT00833833|Protease Inhibitors|protease inhibitors|mesh-ancestor
25578930|NCT00833833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578931|NCT00833833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578932|NCT00833833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25578933|NCT00833833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25578934|NCT00833833|Analgesics|analgesics|mesh-ancestor
24733801|NCT01648608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733802|NCT01648608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24733803|NCT01648608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24733804|NCT01648608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733805|NCT01648608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733806|NCT01648608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24733807|NCT01648608|Hormone Antagonists|hormone antagonists|mesh-ancestor
25578935|NCT00833833|Sensory System Agents|sensory system agents|mesh-ancestor
25578936|NCT00833833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25578937|NCT00833833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25578938|NCT00833833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25578939|NCT00833833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25578940|NCT00833833|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25578941|NCT00833833|Antipyretics|antipyretics|mesh-ancestor
25578942|NCT00833833|Immunologic Factors|immunologic factors|mesh-ancestor
25578943|NCT00833833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24734136|NCT01650727|Rituximab|rituximab|mesh-list
24734137|NCT01650727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24734138|NCT01650727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24734139|NCT01650727|Immunologic Factors|immunologic factors|mesh-ancestor
24734140|NCT01650727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578944|NCT00833833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25578945|NCT00833833|Growth Substances|growth substances|mesh-ancestor
25578946|NCT00833833|Growth Inhibitors|growth inhibitors|mesh-ancestor
25578947|NCT00833911|Tramadol|tramadol|mesh-list
25578948|NCT00833911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25578949|NCT00833911|Narcotics|narcotics|mesh-ancestor
25578950|NCT00833911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25578951|NCT00833911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578952|NCT00833911|Analgesics|analgesics|mesh-ancestor
24735272|NCT01656057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24735273|NCT01656070|Vitamin D|vitamin d|mesh-list
24735274|NCT01656070|Cholecalciferol|cholecalciferol|mesh-list
25048953|NCT00656357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25048954|NCT00656357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578953|NCT00833911|Sensory System Agents|sensory system agents|mesh-ancestor
25578954|NCT00833911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25578955|NCT00834080|Naltrexone|naltrexone|mesh-list
25578956|NCT00834080|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25578957|NCT00834080|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25578958|NCT00834080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578959|NCT00834080|Sensory System Agents|sensory system agents|mesh-ancestor
25578960|NCT00834080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25578961|NCT00834171|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25578962|NCT00834171|Tobramycin|tobramycin|mesh-list
25578963|NCT00834171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25578964|NCT00834171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25578965|NCT00834171|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25578966|NCT00834210|Nicotinic Acids|nicotinic acids|mesh-list
25578967|NCT00834210|Dapsone|dapsone|mesh-list
25578968|NCT00834210|Tazarotene|tazarotene|mesh-list
25578969|NCT00834210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25578970|NCT00834210|Antimalarials|antimalarials|mesh-ancestor
25578971|NCT00834210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25701852|NCT02146430|Sensory System Agents|sensory system agents|mesh-ancestor
24644508|NCT01191450|Chlorthalidone|chlorthalidone|mesh-list
25578972|NCT00834210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25578973|NCT00834210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25578974|NCT00834210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25578975|NCT00834210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25578976|NCT00834210|Leprostatic Agents|leprostatic agents|mesh-ancestor
25578977|NCT00834210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25578978|NCT00834210|Dermatologic Agents|dermatologic agents|mesh-ancestor
25578979|NCT00834210|Keratolytic Agents|keratolytic agents|mesh-ancestor
24737856|NCT01670890|Alkylating Agents|alkylating agents|mesh-ancestor
24737895|NCT01671709|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24737926|NCT01671787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24738112|NCT01673204|Vitamins|vitamins|mesh-ancestor
24651105|NCT01229579|Zinc Sulfate|zinc sulfate|mesh-list
24738133|NCT01673308|Lenalidomide|lenalidomide|mesh-list
24738134|NCT01673308|Immunologic Factors|immunologic factors|mesh-ancestor
24738135|NCT01673308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738136|NCT01673308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24738137|NCT01673308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24738138|NCT01673308|Growth Substances|growth substances|mesh-ancestor
24738246|NCT01674270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738247|NCT01674270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25049077|NCT00637052|Antimitotic Agents|antimitotic agents|mesh-ancestor
24644665|NCT01192308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24644666|NCT01192308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25578980|NCT00834210|Vitamin B Complex|vitamin b complex|mesh-ancestor
25578981|NCT00834210|Vitamins|vitamins|mesh-ancestor
25578982|NCT00834210|Micronutrients|micronutrients|mesh-ancestor
25578983|NCT00834210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578984|NCT00834288|Tramadol|tramadol|mesh-list
25578985|NCT00834288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25578986|NCT00834288|Narcotics|narcotics|mesh-ancestor
25578987|NCT00834288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25578988|NCT00834288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25578989|NCT00834288|Analgesics|analgesics|mesh-ancestor
25578990|NCT00834288|Sensory System Agents|sensory system agents|mesh-ancestor
25578991|NCT00834288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25578992|NCT00834366|Tramadol|tramadol|mesh-list
25578993|NCT00834366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25578994|NCT00834366|Narcotics|narcotics|mesh-ancestor
25578995|NCT00834366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25578996|NCT00834366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740538|NCT01688947|Anticonvulsants|anticonvulsants|mesh-ancestor
24740539|NCT01688947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25049076|NCT00637052|Filanesib|filanesib|mesh-list
25578997|NCT00834366|Analgesics|analgesics|mesh-ancestor
25578998|NCT00834366|Sensory System Agents|sensory system agents|mesh-ancestor
25578999|NCT00834366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25579000|NCT00834652|Metformin|metformin|mesh-list
25579001|NCT00834652|Sertraline|sertraline|mesh-list
25579002|NCT00834652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25579003|NCT00834652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579004|NCT00834652|Antidepressive Agents|antidepressive agents|mesh-ancestor
25579005|NCT00834652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25579006|NCT00834652|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25579007|NCT00834652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25701880|NCT02147158|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24618469|NCT01048398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24618470|NCT01048398|Analgesics|analgesics|mesh-ancestor
25701881|NCT02147158|Contraceptive Agents|contraceptive agents|mesh-ancestor
24408334|NCT00177398|Insulin|insulin|mesh-list
24743863|NCT04584684|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25579008|NCT00834652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25579009|NCT00834652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579010|NCT00834652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25579011|NCT00834652|Serotonin Agents|serotonin agents|mesh-ancestor
24452050|NCT00325858|Tramadol|tramadol|mesh-list
24746789|NCT03537014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24746790|NCT03537014|Serotonin Agents|serotonin agents|mesh-ancestor
25701899|NCT02147561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701900|NCT02147561|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25701901|NCT02147561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25701902|NCT02147587|Tofacitinib|tofacitinib|mesh-list
24746820|NCT03435640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24746821|NCT03435640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25002278|NCT04752384|Analgesics|analgesics|mesh-ancestor
25701910|NCT02147691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25007020|NCT04358133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25007021|NCT04358133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007022|NCT04358133|Analgesics|analgesics|mesh-ancestor
25007023|NCT04358133|Sensory System Agents|sensory system agents|mesh-ancestor
25007024|NCT04358133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24645253|NCT01197001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24645273|NCT01197040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24645274|NCT01197040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645275|NCT01197040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25579012|NCT00834678|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25579013|NCT00834678|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25579014|NCT00834678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579015|NCT00834678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25579016|NCT00834678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579017|NCT00834678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579018|NCT00834678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25579019|NCT00834678|Alkylating Agents|alkylating agents|mesh-ancestor
25579020|NCT00834808|Tramadol|tramadol|mesh-list
24750256|NCT01697293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25007032|NCT04332211|Pseudoephedrine|pseudoephedrine|mesh-list
24750454|NCT01698645|Fentanyl|fentanyl|mesh-list
24940069|NCT04003844|Aspirin|aspirin|mesh-list
24940070|NCT04003844|Immunoglobulins|immunoglobulins|mesh-list
24940072|NCT04003844|Antibodies|antibodies|mesh-list
25579021|NCT00834808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25579022|NCT00834808|Narcotics|narcotics|mesh-ancestor
25579023|NCT00834808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25579024|NCT00834808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579025|NCT00834808|Analgesics|analgesics|mesh-ancestor
25579026|NCT00834808|Sensory System Agents|sensory system agents|mesh-ancestor
25579027|NCT00834808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25579028|NCT00834834|Fluoxetine|fluoxetine|mesh-list
25579029|NCT00834834|Citalopram|citalopram|mesh-list
25579030|NCT00834834|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24751510|NCT01704638|Antidepressive Agents|antidepressive agents|mesh-ancestor
24751511|NCT01704638|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24434990|NCT00264654|Paroxetine|paroxetine|mesh-list
24645861|NCT01200264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24645864|NCT01200472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24645865|NCT01200472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24645866|NCT01200472|Analgesics|analgesics|mesh-ancestor
25579031|NCT00834834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25579032|NCT00834834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25579033|NCT00834834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579034|NCT00834834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25579035|NCT00834834|Serotonin Agents|serotonin agents|mesh-ancestor
25579036|NCT00834834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579037|NCT00834834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25579038|NCT00834834|Antidepressive Agents|antidepressive agents|mesh-ancestor
25579039|NCT00834834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25579040|NCT00834834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24753823|NCT01717963|Buprenorphine|buprenorphine|mesh-list
24753861|NCT01718236|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24753862|NCT01718236|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24418523|NCT00209729|Docetaxel|docetaxel|mesh-list
24753989|NCT01718626|Tubulin Modulators|tubulin modulators|mesh-ancestor
24754200|NCT01719614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24754201|NCT01719614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24754202|NCT01719614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24754203|NCT01719627|Maraviroc|maraviroc|mesh-list
24754204|NCT01719627|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25579041|NCT00834834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25579042|NCT00834834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579043|NCT00834886|Melatonin|melatonin|mesh-list
25579044|NCT00834886|Antioxidants|antioxidants|mesh-ancestor
25579045|NCT00834886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579046|NCT00834886|Protective Agents|protective agents|mesh-ancestor
25579047|NCT00834886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579048|NCT00834886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25579049|NCT00834899|Eptifibatide|eptifibatide|mesh-list
25579050|NCT00834899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25579051|NCT00834912|Tramadol|tramadol|mesh-list
25579052|NCT00834912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25579053|NCT00834912|Narcotics|narcotics|mesh-ancestor
25579054|NCT00834912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25579055|NCT00834912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579056|NCT00834912|Analgesics|analgesics|mesh-ancestor
25579057|NCT00834912|Sensory System Agents|sensory system agents|mesh-ancestor
25579058|NCT00834912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25579059|NCT00835120|Pioglitazone|pioglitazone|mesh-list
25579060|NCT00835120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25579061|NCT00835120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646433|NCT01203709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24646465|NCT01204086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24646466|NCT01204086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579062|NCT00835159|Rivastigmine|rivastigmine|mesh-list
25579063|NCT00835159|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25579064|NCT00835159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579065|NCT00835159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579066|NCT00835159|Cholinergic Agents|cholinergic agents|mesh-ancestor
25579067|NCT00835159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25579068|NCT00835159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579069|NCT00835159|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25579070|NCT00835159|Protective Agents|protective agents|mesh-ancestor
25579071|NCT00835185|Leucovorin|leucovorin|mesh-list
25579072|NCT00835185|Folic Acid|folic acid|mesh-list
25579073|NCT00835185|Oxaliplatin|oxaliplatin|mesh-list
25579074|NCT00835185|Necitumumab|necitumumab|mesh-list
24395325|NCT00135746|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25579075|NCT00835185|Levoleucovorin|levoleucovorin|mesh-list
25579076|NCT00835185|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25579077|NCT00835185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579078|NCT00835185|Antidotes|antidotes|mesh-ancestor
25579079|NCT00835185|Protective Agents|protective agents|mesh-ancestor
25579080|NCT00835185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579081|NCT00835185|Vitamin B Complex|vitamin b complex|mesh-ancestor
25579082|NCT00835185|Vitamins|vitamins|mesh-ancestor
25579083|NCT00835185|Micronutrients|micronutrients|mesh-ancestor
25579084|NCT00835185|Hematinics|hematinics|mesh-ancestor
25579085|NCT00835185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25579086|NCT00835185|Immunologic Factors|immunologic factors|mesh-ancestor
25579087|NCT00835198|Dapsone|dapsone|mesh-list
25579088|NCT00835198|Tretinoin|tretinoin|mesh-list
24463030|NCT00358358|Sympathomimetics|sympathomimetics|mesh-ancestor
24647232|NCT01207128|Micafungin|micafungin|mesh-list
24647233|NCT01207128|Antifungal Agents|antifungal agents|mesh-ancestor
25049345|NCT00616330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25003417|NCT03703375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25003418|NCT03703375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25003419|NCT03703375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25003420|NCT03703375|Immunologic Factors|immunologic factors|mesh-ancestor
25003421|NCT03703375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25003422|NCT03703375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25003424|NCT03703271|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25003425|NCT03703271|Abortifacient Agents|abortifacient agents|mesh-ancestor
25003426|NCT03703271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25003427|NCT03703271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25003459|NCT03657264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25003460|NCT03657264|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25003461|NCT03657264|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25003462|NCT03657264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579089|NCT00835198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579090|NCT00835198|Keratolytic Agents|keratolytic agents|mesh-ancestor
25579091|NCT00835198|Dermatologic Agents|dermatologic agents|mesh-ancestor
25579092|NCT00835198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25579093|NCT00835198|Antimalarials|antimalarials|mesh-ancestor
25579094|NCT00835198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25579095|NCT00835198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25579096|NCT00835198|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25579097|NCT00835198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579098|NCT00835198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579099|NCT00835198|Leprostatic Agents|leprostatic agents|mesh-ancestor
25049378|NCT00612742|Testosterone|testosterone|mesh-list
25049386|NCT00612170|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25049387|NCT00612170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25049388|NCT00612170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24647578|NCT01209455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24647579|NCT01209455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647580|NCT01209455|Antipruritics|antipruritics|mesh-ancestor
24647581|NCT01209455|Dermatologic Agents|dermatologic agents|mesh-ancestor
24647582|NCT01209455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24647583|NCT01209455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24647586|NCT01209533|Vasodilator Agents|vasodilator agents|mesh-ancestor
25003649|NCT03173560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25003700|NCT03120624|Iodine|iodine|mesh-list
25579100|NCT00835198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25579101|NCT00835224|Midodrine|midodrine|mesh-list
25579102|NCT00835224|Sympathomimetics|sympathomimetics|mesh-ancestor
25579103|NCT00835224|Autonomic Agents|autonomic agents|mesh-ancestor
25579104|NCT00835224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25579105|NCT00835224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579106|NCT00835224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25579107|NCT00835224|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25579108|NCT00835224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25579109|NCT00835224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25579110|NCT00835224|Adrenergic Agents|adrenergic agents|mesh-ancestor
25579111|NCT00835224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25579112|NCT00835224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579113|NCT00835510|Butenafine|butenafine|mesh-list
24647834|NCT01211002|Growth Inhibitors|growth inhibitors|mesh-ancestor
24647867|NCT01211210|Oxaliplatin|oxaliplatin|mesh-list
25579114|NCT00835510|Clotrimazole|clotrimazole|mesh-list
25579115|NCT00835510|Antifungal Agents|antifungal agents|mesh-ancestor
25579116|NCT00835510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25579117|NCT00835510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25579118|NCT00835510|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24798727|NCT01964781|Sensory System Agents|sensory system agents|mesh-ancestor
25579119|NCT00835510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25579120|NCT00835510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579121|NCT00835510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579122|NCT00835510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25579123|NCT00835510|Hormone Antagonists|hormone antagonists|mesh-ancestor
25579124|NCT00835510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25579125|NCT00835510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798769|NCT01965041|Aflibercept|aflibercept|mesh-list
24798772|NCT01965041|Growth Substances|growth substances|mesh-ancestor
25579126|NCT00835731|Vitamin B 12|vitamin b 12|mesh-list
25579127|NCT00835731|Hydroxocobalamin|hydroxocobalamin|mesh-list
25579128|NCT00835731|Misoprostol|misoprostol|mesh-list
25579129|NCT00835731|Vitamins|vitamins|mesh-ancestor
25579130|NCT00835731|Micronutrients|micronutrients|mesh-ancestor
25579131|NCT00835731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579132|NCT00835731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25579133|NCT00835731|Abortifacient Agents|abortifacient agents|mesh-ancestor
25579134|NCT00835731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24431512|NCT00251966|Esomeprazole|esomeprazole|mesh-list
25579135|NCT00835731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25579136|NCT00835731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25579137|NCT00835731|Oxytocics|oxytocics|mesh-ancestor
25579138|NCT00835731|Vitamin B Complex|vitamin b complex|mesh-ancestor
25579139|NCT00835731|Hematinics|hematinics|mesh-ancestor
25579140|NCT00835770|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25579141|NCT00835770|Dermatologic Agents|dermatologic agents|mesh-ancestor
25579142|NCT00835770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25579143|NCT00835770|Immunologic Factors|immunologic factors|mesh-ancestor
25579144|NCT00835770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579145|NCT00835861|Insulin|insulin|mesh-list
25579146|NCT00835861|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25579147|NCT00835861|Metformin|metformin|mesh-list
25579148|NCT00835861|Insulin, Isophane|insulin, isophane|mesh-list
25579149|NCT00835861|Isophane Insulin, Human|isophane insulin, human|mesh-list
25579150|NCT00835861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25701964|NCT02149173|Cariostatic Agents|cariostatic agents|mesh-ancestor
25579151|NCT00835861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579152|NCT00835900|Varenicline|varenicline|mesh-list
25579153|NCT00835900|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25579154|NCT00835900|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25579155|NCT00835900|Cholinergic Agents|cholinergic agents|mesh-ancestor
25579156|NCT00835900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25579157|NCT00835900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579158|NCT00835900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579159|NCT00835926|Vaccines|vaccines|mesh-list
25579160|NCT00835926|Immunologic Factors|immunologic factors|mesh-ancestor
25579161|NCT00835926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579162|NCT00835978|Axitinib|axitinib|mesh-list
25579163|NCT00835978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579164|NCT00835978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25579165|NCT00835978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579166|NCT00835978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579167|NCT00836277|Irinotecan|irinotecan|mesh-list
25579168|NCT00836277|Panitumumab|panitumumab|mesh-list
25579169|NCT00836277|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25579170|NCT00836277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25579171|NCT00836277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579172|NCT00836277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701971|NCT02149199|Terbutaline|terbutaline|mesh-list
24649327|NCT01219400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579173|NCT00836277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579174|NCT00836277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25579175|NCT00836407|Ipilimumab|ipilimumab|mesh-list
25579176|NCT00836407|Vaccines|vaccines|mesh-list
25579177|NCT00836407|Immunologic Factors|immunologic factors|mesh-ancestor
25579178|NCT00836407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579179|NCT00836407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25579180|NCT00836407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579181|NCT00836407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25579182|NCT00836407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579183|NCT00836641|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25579184|NCT00836641|Immunologic Factors|immunologic factors|mesh-ancestor
25579185|NCT00836641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652922|NCT01533259|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25652923|NCT01533259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24650495|NCT01225913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24650496|NCT01225913|Adrenergic Agents|adrenergic agents|mesh-ancestor
24650497|NCT01225913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24650498|NCT01225913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650499|NCT01225913|Sympathomimetics|sympathomimetics|mesh-ancestor
24650501|NCT01226017|Oxytocics|oxytocics|mesh-ancestor
24650502|NCT01226017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25652924|NCT01533259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25652925|NCT01533259|Antiviral Agents|antiviral agents|mesh-ancestor
25473754|NCT00053989|Glucocorticoids|glucocorticoids|mesh-ancestor
25579186|NCT00836693|Tadalafil|tadalafil|mesh-list
25579187|NCT00836693|Vasodilator Agents|vasodilator agents|mesh-ancestor
25579188|NCT00836693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25579189|NCT00836693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25579190|NCT00836693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579191|NCT00836693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579192|NCT00836693|Urological Agents|urological agents|mesh-ancestor
25579193|NCT00836875|Voriconazole|voriconazole|mesh-list
25579194|NCT00836875|Antifungal Agents|antifungal agents|mesh-ancestor
25579195|NCT00836875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25579196|NCT00836875|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25579197|NCT00836875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25579198|NCT00836875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579199|NCT00836875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579200|NCT00836875|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25579201|NCT00836875|Hormone Antagonists|hormone antagonists|mesh-ancestor
25579202|NCT00836875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25579203|NCT00836875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579204|NCT00836875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25579205|NCT00836888|Nivolumab|nivolumab|mesh-list
24790965|NCT05409339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579206|NCT00836888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25579207|NCT00836888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579208|NCT00836888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25579209|NCT00836888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579210|NCT00836927|Sirolimus|sirolimus|mesh-list
25579211|NCT00836927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25579212|NCT00836927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25701997|NCT02149303|Dabigatran|dabigatran|mesh-list
25579213|NCT00836927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25579214|NCT00836927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556120|NCT00745069|Tapentadol|tapentadol|mesh-list
24556121|NCT00745069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24556122|NCT00745069|Narcotics|narcotics|mesh-ancestor
24556125|NCT00745069|Analgesics|analgesics|mesh-ancestor
24651755|NCT01233635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651757|NCT01233752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24651758|NCT01233752|Narcotics|narcotics|mesh-ancestor
24651759|NCT01233752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24651760|NCT01233752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651761|NCT01233752|Analgesics|analgesics|mesh-ancestor
24556589|NCT00748345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651921|NCT01234506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24651922|NCT01234597|Insulin|insulin|mesh-list
24651923|NCT01234597|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24651924|NCT01234597|Insulin Glargine|insulin glargine|mesh-list
24651925|NCT01234597|Insulin glulisine|insulin glulisine|mesh-list
25579215|NCT00836927|Antifungal Agents|antifungal agents|mesh-ancestor
25579216|NCT00836927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25579217|NCT00836927|Immunologic Factors|immunologic factors|mesh-ancestor
25579218|NCT00836927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579219|NCT00837031|Gemcitabine|gemcitabine|mesh-list
25579220|NCT00837031|Lenalidomide|lenalidomide|mesh-list
24560045|NCT03719131|Ipilimumab|ipilimumab|mesh-list
24560048|NCT03719131|Immunologic Factors|immunologic factors|mesh-ancestor
24652609|NCT01239173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652610|NCT01239173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25579221|NCT00837031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25579222|NCT00837031|Antimetabolites|antimetabolites|mesh-ancestor
25579223|NCT00837031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579224|NCT00837031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579225|NCT00837031|Antiviral Agents|antiviral agents|mesh-ancestor
25702045|NCT02150499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25702046|NCT02150499|Adrenergic Agents|adrenergic agents|mesh-ancestor
25702047|NCT02150499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25702048|NCT02150499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579226|NCT00837031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25579227|NCT00837031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579228|NCT00837031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25579229|NCT00837031|Immunologic Factors|immunologic factors|mesh-ancestor
25579230|NCT00837031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579231|NCT00837031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25579232|NCT00837031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25109875|NCT03121690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25579233|NCT00837031|Growth Substances|growth substances|mesh-ancestor
25579234|NCT00837031|Growth Inhibitors|growth inhibitors|mesh-ancestor
25579235|NCT00837148|Sorafenib|sorafenib|mesh-list
25579236|NCT00837148|Dacarbazine|dacarbazine|mesh-list
25579237|NCT00837148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579238|NCT00837148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25579239|NCT00837148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579240|NCT00837148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702061|NCT02150759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25702062|NCT02150759|Adrenergic Agents|adrenergic agents|mesh-ancestor
24564216|NCT00775619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25702063|NCT02150759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25579241|NCT00837148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25579242|NCT00837148|Alkylating Agents|alkylating agents|mesh-ancestor
25579243|NCT00837200|Doxorubicin|doxorubicin|mesh-list
25579244|NCT00837200|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25579245|NCT00837200|Asparaginase|asparaginase|mesh-list
25579246|NCT00837200|Pegaspargase|pegaspargase|mesh-list
25579247|NCT00837200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25579248|NCT00837200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579249|NCT00837200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25579250|NCT00837200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25579251|NCT00837200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579252|NCT00837200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579253|NCT00837213|Doxycycline|doxycycline|mesh-list
25579254|NCT00837213|Clindamycin|clindamycin|mesh-list
25579255|NCT00837213|Clindamycin palmitate|clindamycin palmitate|mesh-list
25579256|NCT00837213|Clindamycin phosphate|clindamycin phosphate|mesh-list
24653783|NCT01245803|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24653784|NCT01245803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653787|NCT01245816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653788|NCT01245816|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24945500|NCT03950271|Trastuzumab|trastuzumab|mesh-list
24945501|NCT03950271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24945502|NCT03950271|Antimetabolites|antimetabolites|mesh-ancestor
24464888|NCT00367211|Analgesics|analgesics|mesh-ancestor
25579257|NCT00837213|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25579258|NCT00837213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25579259|NCT00837213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25579260|NCT00837213|Antimalarials|antimalarials|mesh-ancestor
25579261|NCT00837213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25579262|NCT00837213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25579263|NCT00837213|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25579264|NCT00837213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579265|NCT00837213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579266|NCT00837213|Dermatologic Agents|dermatologic agents|mesh-ancestor
25579267|NCT00837252|Finasteride|finasteride|mesh-list
25579268|NCT00837252|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25579269|NCT00837252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25579270|NCT00837252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579271|NCT00837252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579272|NCT00837252|Hormone Antagonists|hormone antagonists|mesh-ancestor
25579273|NCT00837252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25579274|NCT00837252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579275|NCT00837252|Urological Agents|urological agents|mesh-ancestor
25579276|NCT00837330|Ranibizumab|ranibizumab|mesh-list
25579277|NCT00837330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24946279|NCT03941795|Axitinib|axitinib|mesh-list
25579278|NCT00837330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25579279|NCT00837330|Growth Substances|growth substances|mesh-ancestor
25579280|NCT00837330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579281|NCT00837330|Growth Inhibitors|growth inhibitors|mesh-ancestor
25579282|NCT00837330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579283|NCT00837434|Adalimumab|adalimumab|mesh-list
25579284|NCT00837434|Etanercept|etanercept|mesh-list
25579285|NCT00837434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25579286|NCT00837434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25579287|NCT00837434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24566683|NCT00787410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566684|NCT00787436|Thalidomide|thalidomide|mesh-list
24654868|NCT01251848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25579288|NCT00837434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25579289|NCT00837434|Analgesics|analgesics|mesh-ancestor
25579290|NCT00837434|Sensory System Agents|sensory system agents|mesh-ancestor
25579291|NCT00837434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25579292|NCT00837434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579293|NCT00837434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25579294|NCT00837434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25579295|NCT00837434|Immunologic Factors|immunologic factors|mesh-ancestor
25579296|NCT00837512|Insulin|insulin|mesh-list
25579297|NCT00837512|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25579298|NCT00837512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25579299|NCT00837512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579300|NCT00837577|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25579301|NCT00837577|Voglibose|voglibose|mesh-list
25579302|NCT00837577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25579303|NCT00837577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579304|NCT00837577|Incretins|incretins|mesh-ancestor
25579305|NCT00837577|Hormones|hormones|mesh-ancestor
25606171|NCT01065558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24946543|NCT03938259|Anesthetics, General|anesthetics, general|mesh-ancestor
25579306|NCT00837577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25579307|NCT00837577|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24655838|NCT01258322|Pioglitazone|pioglitazone|mesh-list
25579308|NCT00837577|Protease Inhibitors|protease inhibitors|mesh-ancestor
25579309|NCT00837577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579310|NCT00837577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579311|NCT00837577|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25579312|NCT00837590|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
25579313|NCT00837590|Sodium Salicylate|sodium salicylate|mesh-list
25579314|NCT00837590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25579315|NCT00837590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25579316|NCT00837590|Analgesics|analgesics|mesh-ancestor
25579317|NCT00837590|Sensory System Agents|sensory system agents|mesh-ancestor
24847144|NCT02245269|Antiviral Agents|antiviral agents|mesh-ancestor
25579318|NCT00837590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25579319|NCT00837590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579320|NCT00837590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25579321|NCT00837590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25579322|NCT00837590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25579323|NCT00837590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579324|NCT00837590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579325|NCT00837616|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25579326|NCT00837616|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25579327|NCT00837616|Estradiol|estradiol|mesh-list
25579328|NCT00837616|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25579329|NCT00837616|Estrogens|estrogens|mesh-ancestor
25579330|NCT00837616|Hormones|hormones|mesh-ancestor
25579331|NCT00837616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25579332|NCT00837616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473910|NCT00054756|Hormones|hormones|mesh-list
25579333|NCT00837616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25579334|NCT00837616|Contraceptive Agents|contraceptive agents|mesh-ancestor
25579335|NCT00837616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25579336|NCT00837616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25579337|NCT00837759|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25579338|NCT00837759|Lansoprazole|lansoprazole|mesh-list
25579339|NCT00837759|Dexlansoprazole|dexlansoprazole|mesh-list
25579340|NCT00837759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25579341|NCT00837759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579342|NCT00837759|Incretins|incretins|mesh-ancestor
25579343|NCT00837759|Hormones|hormones|mesh-ancestor
25579344|NCT00837759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25579345|NCT00837759|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25579346|NCT00837759|Protease Inhibitors|protease inhibitors|mesh-ancestor
25579347|NCT00837759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579348|NCT00837759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579349|NCT00837759|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25579350|NCT00837759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25579351|NCT00837759|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25579352|NCT00837876|Sorafenib|sorafenib|mesh-list
25579353|NCT00837876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579354|NCT00837876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25579355|NCT00837876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579356|NCT00837876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579357|NCT00837902|Atenolol|atenolol|mesh-list
25579358|NCT00837902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25579359|NCT00837902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25579360|NCT00837902|Sympatholytics|sympatholytics|mesh-ancestor
25579361|NCT00837902|Autonomic Agents|autonomic agents|mesh-ancestor
25579362|NCT00837902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25579363|NCT00837902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579364|NCT00837902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25579365|NCT00837902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25579366|NCT00837902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24571673|NCT00811291|Calcium, Dietary|calcium, dietary|mesh-list
24656983|NCT01264874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24656984|NCT01265004|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24656985|NCT01265004|Hemostatics|hemostatics|mesh-ancestor
24656986|NCT01265004|Coagulants|coagulants|mesh-ancestor
24656987|NCT01265017|Hydrocortisone|hydrocortisone|mesh-list
24466899|NCT00375557|GABA Agents|gaba agents|mesh-ancestor
25579367|NCT00837902|Adrenergic Agents|adrenergic agents|mesh-ancestor
25579368|NCT00837902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25579369|NCT00837902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579370|NCT00837967|Terbutaline|terbutaline|mesh-list
25606172|NCT01065558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606173|NCT01065558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25606174|NCT01065558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25606175|NCT01065558|Dopamine Agents|dopamine agents|mesh-ancestor
25606176|NCT01065558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25606177|NCT01065558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606178|NCT01065766|Metformin|metformin|mesh-list
25606179|NCT01065766|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25606180|NCT01065766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24467077|NCT00376129|Alefacept|alefacept|mesh-list
25579371|NCT00837967|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25579372|NCT00837967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25579373|NCT00837967|Respiratory System Agents|respiratory system agents|mesh-ancestor
24572689|NCT00816283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579374|NCT00837967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25579375|NCT00837967|Autonomic Agents|autonomic agents|mesh-ancestor
25579376|NCT00837967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25579377|NCT00837967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579378|NCT00837967|Sympathomimetics|sympathomimetics|mesh-ancestor
25579379|NCT00837967|Tocolytic Agents|tocolytic agents|mesh-ancestor
25579380|NCT00837967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25579381|NCT00837967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25579382|NCT00837967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25579383|NCT00837967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25102949|NCT03165396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25102950|NCT03165396|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25102951|NCT03165253|Amoxicillin|amoxicillin|mesh-list
25102952|NCT03165253|Clarithromycin|clarithromycin|mesh-list
25102953|NCT03165253|Omeprazole|omeprazole|mesh-list
25102972|NCT03165123|Glucocorticoids|glucocorticoids|mesh-ancestor
25102974|NCT03165123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25102975|NCT03165123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25102976|NCT03165123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102977|NCT03165123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25102978|NCT03165123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25102979|NCT03165240|Eplerenone|eplerenone|mesh-list
25102981|NCT03165240|Hormone Antagonists|hormone antagonists|mesh-ancestor
24573054|NCT00817687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24573055|NCT00817687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573056|NCT00817687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579384|NCT00837967|Adrenergic Agents|adrenergic agents|mesh-ancestor
25579385|NCT00837967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25579386|NCT00837967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579387|NCT00838162|Ritonavir|ritonavir|mesh-list
25579388|NCT00838162|TMC-310911|tmc-310911|mesh-list
24467492|NCT00377923|Hormones|hormones|mesh-ancestor
25579389|NCT00838162|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25579390|NCT00838162|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25579391|NCT00838162|Protease Inhibitors|protease inhibitors|mesh-ancestor
25579392|NCT00838162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573340|NCT00819468|Protective Agents|protective agents|mesh-ancestor
24573522|NCT00820547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25606181|NCT01065766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606182|NCT01065766|Incretins|incretins|mesh-ancestor
24903501|NCT04363255|Cisplatin|cisplatin|mesh-list
25579393|NCT00838162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579394|NCT00838162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25579395|NCT00838162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25579396|NCT00838162|Antiviral Agents|antiviral agents|mesh-ancestor
25579397|NCT00838162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25579398|NCT00838162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25579399|NCT00838162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25702162|NCT02151643|Iron|iron|mesh-list
25579400|NCT00838201|Denosumab|denosumab|mesh-list
25579401|NCT00838201|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25579402|NCT00838201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579403|NCT00838435|Verapamil|verapamil|mesh-list
25579404|NCT00838435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25579405|NCT00838435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25656957|NCT01581307|Levoleucovorin|levoleucovorin|mesh-list
25579406|NCT00838435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25579407|NCT00838435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606183|NCT01065766|Hormones|hormones|mesh-ancestor
25702179|NCT02151682|Adrenergic Agents|adrenergic agents|mesh-ancestor
25104433|NCT03152955|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24908686|NCT04317872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24519593|NCT05332106|Dienogest|dienogest|mesh-list
25009945|NCT04827979|Abatacept|abatacept|mesh-list
25579408|NCT00838435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25579409|NCT00838435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910933|NCT04292808|Methoxyflurane|methoxyflurane|mesh-list
25579410|NCT00838435|Vasodilator Agents|vasodilator agents|mesh-ancestor
25579411|NCT00838513|Eculizumab|eculizumab|mesh-list
24582960|NCT00872716|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25579412|NCT00838513|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25579413|NCT00838513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25579414|NCT00838513|Immunologic Factors|immunologic factors|mesh-ancestor
25579415|NCT00838513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579416|NCT00838539|Sirolimus|sirolimus|mesh-list
25579417|NCT00838539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25579418|NCT00838539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25579419|NCT00838539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25579420|NCT00838539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579421|NCT00838539|Antifungal Agents|antifungal agents|mesh-ancestor
25579422|NCT00838539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25579423|NCT00838539|Immunologic Factors|immunologic factors|mesh-ancestor
25579424|NCT00838539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579425|NCT00838578|Irinotecan|irinotecan|mesh-list
25011061|NCT02184741|Immunologic Factors|immunologic factors|mesh-ancestor
25579426|NCT00838578|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25579427|NCT00838578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25579428|NCT00838578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579429|NCT00838578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012054|NCT02335060|Antidotes|antidotes|mesh-ancestor
25579430|NCT00838578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579431|NCT00838682|Omeprazole|omeprazole|mesh-list
25579432|NCT00838682|Rabeprazole|rabeprazole|mesh-list
25579433|NCT00838682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25579434|NCT00838682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25579435|NCT00838682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25579436|NCT00838682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24913806|NCT04260711|Sensory System Agents|sensory system agents|mesh-ancestor
24976428|NCT03610438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24976429|NCT03608865|Durvalumab|durvalumab|mesh-list
24976430|NCT03608865|Tremelimumab|tremelimumab|mesh-list
24976431|NCT03608865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24976432|NCT03608865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976433|NCT03602235|Ascorbic Acid|ascorbic acid|mesh-list
24976434|NCT03602235|Melphalan|melphalan|mesh-list
24976435|NCT03602235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24976436|NCT03602235|Alkylating Agents|alkylating agents|mesh-ancestor
25579437|NCT00838682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579438|NCT00838695|Phenylephrine|phenylephrine|mesh-list
25579439|NCT00838695|Oxymetazoline|oxymetazoline|mesh-list
25579440|NCT00838695|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25579441|NCT00838695|Mydriatics|mydriatics|mesh-ancestor
25579442|NCT00838695|Autonomic Agents|autonomic agents|mesh-ancestor
25579443|NCT00838695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25579444|NCT00838695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702240|NCT02152137|Antimitotic Agents|antimitotic agents|mesh-ancestor
25702241|NCT02152137|Mitosis Modulators|mitosis modulators|mesh-ancestor
25013326|NCT03006068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25013625|NCT01694069|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25013626|NCT01694069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25013628|NCT01446016|Paclitaxel|paclitaxel|mesh-list
24976734|NCT05274672|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24976737|NCT05255471|Olaparib|olaparib|mesh-list
25579445|NCT00838695|Sympathomimetics|sympathomimetics|mesh-ancestor
25579446|NCT00838695|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25579447|NCT00838695|Nasal Decongestants|nasal decongestants|mesh-ancestor
25579448|NCT00838695|Respiratory System Agents|respiratory system agents|mesh-ancestor
25579449|NCT00838695|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25579450|NCT00838695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25579451|NCT00838695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25579452|NCT00838695|Adrenergic Agents|adrenergic agents|mesh-ancestor
25579453|NCT00838695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25579454|NCT00838695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579455|NCT00838695|Protective Agents|protective agents|mesh-ancestor
25579456|NCT00838903|Metformin|metformin|mesh-list
25579457|NCT00838903|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25579458|NCT00838903|Glimepiride|glimepiride|mesh-list
25579459|NCT00838903|rGLP-1 protein|rglp-1 protein|mesh-list
25579460|NCT00838903|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25579461|NCT00838903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25702266|NCT02152345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25014162|NCT04963816|Antiemetics|antiemetics|mesh-ancestor
24914455|NCT04254822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24914456|NCT04254822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914457|NCT04254822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914458|NCT04254822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24914459|NCT04254822|Antioxidants|antioxidants|mesh-ancestor
24914463|NCT04254822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25579462|NCT00838903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579463|NCT00838903|Incretins|incretins|mesh-ancestor
25579464|NCT00838903|Hormones|hormones|mesh-ancestor
25579465|NCT00838903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25579466|NCT00838903|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25579467|NCT00838903|Protease Inhibitors|protease inhibitors|mesh-ancestor
25579468|NCT00838903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579469|NCT00838903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579470|NCT00838903|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25579471|NCT00838903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24472571|NCT00399685|Efavirenz|efavirenz|mesh-list
25579472|NCT00838903|Immunologic Factors|immunologic factors|mesh-ancestor
25579473|NCT00838916|Insulin Glargine|insulin glargine|mesh-list
25579474|NCT00838916|rGLP-1 protein|rglp-1 protein|mesh-list
25579475|NCT00838916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25579476|NCT00838916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579477|NCT00838916|Incretins|incretins|mesh-ancestor
25579478|NCT00838916|Hormones|hormones|mesh-ancestor
25579479|NCT00838916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25579480|NCT00838929|Vorinostat|vorinostat|mesh-list
25474060|NCT00057681|GABA Agents|gaba agents|mesh-ancestor
25579481|NCT00838929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579482|NCT00838929|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25579483|NCT00838929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579484|NCT00838929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579485|NCT00839072|Trazodone|trazodone|mesh-list
25579486|NCT00839072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25579487|NCT00839072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25579488|NCT00839072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25579489|NCT00839072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015117|NCT03126968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25015118|NCT03126968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24977835|NCT01973452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579490|NCT00839072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25579491|NCT00839072|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25579492|NCT00839072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25579493|NCT00839072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25579494|NCT00839072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579495|NCT00839072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25579496|NCT00839072|Serotonin Agents|serotonin agents|mesh-ancestor
25579497|NCT00839072|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25579498|NCT00839072|Antidepressive Agents|antidepressive agents|mesh-ancestor
25579499|NCT00839254|Vaccines|vaccines|mesh-list
25579500|NCT00839254|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25579501|NCT00839254|Immunologic Factors|immunologic factors|mesh-ancestor
25579502|NCT00839254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579503|NCT00839306|Rabeprazole|rabeprazole|mesh-list
25579504|NCT00839306|Ranitidine|ranitidine|mesh-list
25579505|NCT00839306|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
25579506|NCT00839306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25579507|NCT00839306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25579508|NCT00839306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25579509|NCT00839306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579510|NCT00839306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579511|NCT00839306|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25579512|NCT00839306|Histamine Antagonists|histamine antagonists|mesh-ancestor
25579513|NCT00839306|Histamine Agents|histamine agents|mesh-ancestor
25579514|NCT00839306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25579515|NCT00839306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579516|NCT00839319|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25579517|NCT00839319|Testosterone|testosterone|mesh-list
25579518|NCT00839319|Acyline|acyline|mesh-list
25579519|NCT00839319|Androgens|androgens|mesh-ancestor
25579520|NCT00839319|Hormones|hormones|mesh-ancestor
25579521|NCT00839319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25579522|NCT00839319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579523|NCT00839319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25579524|NCT00839319|Hormone Antagonists|hormone antagonists|mesh-ancestor
25579525|NCT00839332|Gemcitabine|gemcitabine|mesh-list
25579526|NCT00839332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25579527|NCT00839332|Antimetabolites|antimetabolites|mesh-ancestor
25579528|NCT00839332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579529|NCT00839332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579530|NCT00839332|Antiviral Agents|antiviral agents|mesh-ancestor
25579531|NCT00839332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25579532|NCT00839332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25015196|NCT02980666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015197|NCT02962102|Calcitriol|calcitriol|mesh-list
25015198|NCT02962102|Calcifediol|calcifediol|mesh-list
24914595|NCT04254081|Analgesics|analgesics|mesh-ancestor
25579533|NCT00839332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25579534|NCT00839332|Immunologic Factors|immunologic factors|mesh-ancestor
25579535|NCT00839332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579536|NCT00839423|Vortioxetine|vortioxetine|mesh-list
25579537|NCT00839423|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25579538|NCT00839423|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25579539|NCT00839423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25579540|NCT00839423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25015389|NCT02511106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25015390|NCT02511106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25015398|NCT02476058|Promethazine|promethazine|mesh-list
24914691|NCT04252885|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24914692|NCT04252885|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24914693|NCT04252885|Protease Inhibitors|protease inhibitors|mesh-ancestor
24914694|NCT04252885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701772|NCT01460836|Tobramycin|tobramycin|mesh-list
25579541|NCT00839423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579542|NCT00839423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25579543|NCT00839423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579544|NCT00839423|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25579545|NCT00839423|Antidepressive Agents|antidepressive agents|mesh-ancestor
25579546|NCT00839423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25579547|NCT00839423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25579548|NCT00839423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25579549|NCT00839423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25579550|NCT00839423|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25579551|NCT00839423|Serotonin Agents|serotonin agents|mesh-ancestor
25579552|NCT00839423|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25579553|NCT00839423|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25579554|NCT00839423|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25579555|NCT00839423|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25579556|NCT00839527|Metformin|metformin|mesh-list
25579557|NCT00839527|Pioglitazone|pioglitazone|mesh-list
25579558|NCT00839527|Glimepiride|glimepiride|mesh-list
25579559|NCT00839527|rGLP-1 protein|rglp-1 protein|mesh-list
25579560|NCT00839527|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25579561|NCT00839527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25015876|NCT00745108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015877|NCT00745108|Androgen Antagonists|androgen antagonists|mesh-ancestor
24914845|NCT04251845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24534086|NCT00646009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24534087|NCT00646009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24534109|NCT00646061|Cholinergic Agents|cholinergic agents|mesh-ancestor
24472735|NCT00400374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24472754|NCT00400387|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24472755|NCT00400387|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24472756|NCT00400387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472758|NCT00400387|Micronutrients|micronutrients|mesh-ancestor
24472759|NCT00400387|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24472760|NCT00400387|Dermatologic Agents|dermatologic agents|mesh-ancestor
24472761|NCT00400387|Antioxidants|antioxidants|mesh-ancestor
24472762|NCT00400387|Protective Agents|protective agents|mesh-ancestor
24472763|NCT00400387|Hematinics|hematinics|mesh-ancestor
24857420|NCT02291562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24857422|NCT02291666|Midazolam|midazolam|mesh-list
24857423|NCT02291666|Dextromethorphan|dextromethorphan|mesh-list
24857424|NCT02291666|Caffeine|caffeine|mesh-list
25579562|NCT00839527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579563|NCT00839527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25579564|NCT00839527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25579565|NCT00839527|Immunologic Factors|immunologic factors|mesh-ancestor
25579566|NCT00839527|Incretins|incretins|mesh-ancestor
25579567|NCT00839527|Hormones|hormones|mesh-ancestor
25579568|NCT00839527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25579569|NCT00839540|Caspofungin|caspofungin|mesh-list
25579570|NCT00839540|Micafungin|micafungin|mesh-list
25579571|NCT00839540|Antifungal Agents|antifungal agents|mesh-ancestor
25579572|NCT00839540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25579573|NCT00839540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579574|NCT00839540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579575|NCT00839800|Terbutaline|terbutaline|mesh-list
25579576|NCT00839800|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25579577|NCT00839800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25579578|NCT00839800|Respiratory System Agents|respiratory system agents|mesh-ancestor
25579579|NCT00839800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25579580|NCT00839800|Autonomic Agents|autonomic agents|mesh-ancestor
25579581|NCT00839800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25579582|NCT00839800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579583|NCT00839800|Sympathomimetics|sympathomimetics|mesh-ancestor
25579584|NCT00839800|Tocolytic Agents|tocolytic agents|mesh-ancestor
25579585|NCT00839800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25579586|NCT00839800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25579587|NCT00839800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25579588|NCT00839800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24409434|NCT00181987|Dopamine Agents|dopamine agents|mesh-ancestor
24409435|NCT00181987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24409436|NCT00182013|Olanzapine|olanzapine|mesh-list
24857432|NCT02291666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24857433|NCT02291666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24857434|NCT02291666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24857435|NCT02291666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24857442|NCT02291666|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24857443|NCT02291666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24857444|NCT02291666|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24857445|NCT02291666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534216|NCT00646516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24534217|NCT00646516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24534218|NCT00646516|Adrenergic Agents|adrenergic agents|mesh-ancestor
24534219|NCT00646516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24971174|NCT03727646|Niacinamide|niacinamide|mesh-list
24914846|NCT04251832|Sodium thiosulfate|sodium thiosulfate|mesh-list
24914847|NCT04251832|Antidotes|antidotes|mesh-ancestor
24914848|NCT04251832|Protective Agents|protective agents|mesh-ancestor
24914863|NCT04251169|Paclitaxel|paclitaxel|mesh-list
24914927|NCT05253066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24914928|NCT05253066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914929|NCT05253066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25579589|NCT00839800|Adrenergic Agents|adrenergic agents|mesh-ancestor
25579590|NCT00839800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25579591|NCT00839800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579592|NCT00839852|Cariprazine|cariprazine|mesh-list
25579593|NCT00839852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25579594|NCT00839852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25579595|NCT00839852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25579596|NCT00839852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579597|NCT00839852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25579598|NCT00839956|Bortezomib|bortezomib|mesh-list
25579599|NCT00839956|Vorinostat|vorinostat|mesh-list
25579600|NCT00839956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579601|NCT00839956|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25579602|NCT00839956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579603|NCT00839956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579604|NCT00839982|Cytarabine|cytarabine|mesh-list
25579605|NCT00839982|Clofarabine|clofarabine|mesh-list
25579606|NCT00839982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25579607|NCT00839982|Antimetabolites|antimetabolites|mesh-ancestor
25579608|NCT00839982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579609|NCT00839982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579610|NCT00839982|Antiviral Agents|antiviral agents|mesh-ancestor
25579611|NCT00839982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25579612|NCT00839982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25579613|NCT00839982|Immunologic Factors|immunologic factors|mesh-ancestor
25579614|NCT00839982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579615|NCT00840294|Ciprofloxacin|ciprofloxacin|mesh-list
25579616|NCT00840294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25579617|NCT00840294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25579618|NCT00840294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25579619|NCT00840294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25579620|NCT00840294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579621|NCT00840294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579622|NCT00840294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579623|NCT00840294|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25579624|NCT00840294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25579625|NCT00840450|Paclitaxel|paclitaxel|mesh-list
25579626|NCT00840450|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25579627|NCT00840450|Imatinib Mesylate|imatinib mesylate|mesh-list
25579628|NCT00840450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25579629|NCT00840450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579630|NCT00840450|Tubulin Modulators|tubulin modulators|mesh-ancestor
25579631|NCT00840450|Antimitotic Agents|antimitotic agents|mesh-ancestor
25579632|NCT00840450|Mitosis Modulators|mitosis modulators|mesh-ancestor
25579633|NCT00840450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579634|NCT00840450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25579635|NCT00840450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579636|NCT00840463|Ambrisentan|ambrisentan|mesh-list
25579637|NCT00840463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25579638|NCT00840996|Lidocaine|lidocaine|mesh-list
25579639|NCT00840996|Anesthetics, Local|anesthetics, local|mesh-ancestor
25579640|NCT00840996|Anesthetics|anesthetics|mesh-ancestor
25579641|NCT00840996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25579642|NCT00840996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579643|NCT00840996|Sensory System Agents|sensory system agents|mesh-ancestor
25579644|NCT00840996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25579645|NCT00840996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25579646|NCT00840996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25579647|NCT00840996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25017722|NCT03704753|Anesthetics|anesthetics|mesh-ancestor
24472922|NCT00401167|Memantine|memantine|mesh-list
25579648|NCT00840996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25579649|NCT00840996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579650|NCT00841087|Insulin|insulin|mesh-list
25579651|NCT00841087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25579652|NCT00841087|Insulin Aspart|insulin aspart|mesh-list
25579653|NCT00841087|Insulin Detemir|insulin detemir|mesh-list
25579654|NCT00841087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25579655|NCT00841087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579656|NCT00841204|Sulindac|sulindac|mesh-list
25579657|NCT00841204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25579658|NCT00841204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25579659|NCT00841204|Analgesics|analgesics|mesh-ancestor
25579660|NCT00841204|Sensory System Agents|sensory system agents|mesh-ancestor
25579661|NCT00841204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25579662|NCT00841204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579663|NCT00841204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25579664|NCT00841204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25579665|NCT00841204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579666|NCT00841204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25579667|NCT00841204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579668|NCT00841204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579669|NCT00841555|Temozolomide|temozolomide|mesh-list
25579670|NCT00841555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25579671|NCT00841555|Alkylating Agents|alkylating agents|mesh-ancestor
25579672|NCT00841555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579673|NCT00841555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579674|NCT00841568|Tolvaptan|tolvaptan|mesh-list
25579675|NCT00841568|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25579676|NCT00841568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579677|NCT00841568|Natriuretic Agents|natriuretic agents|mesh-ancestor
25579678|NCT00841568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579679|NCT00841672|Amlodipine|amlodipine|mesh-list
25579680|NCT00841672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25579681|NCT00841672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24534461|NCT00647101|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24534462|NCT00647101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24534494|NCT00647192|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24534495|NCT00647192|Hormone Antagonists|hormone antagonists|mesh-ancestor
25579682|NCT00841672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25579683|NCT00841672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579684|NCT00841672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25579685|NCT00841672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579686|NCT00841672|Vasodilator Agents|vasodilator agents|mesh-ancestor
25579687|NCT00841763|Vaccines|vaccines|mesh-list
25579688|NCT00841763|Immunologic Factors|immunologic factors|mesh-ancestor
25579689|NCT00841763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579690|NCT00841828|Cyclophosphamide|cyclophosphamide|mesh-list
25579691|NCT00841828|Docetaxel|docetaxel|mesh-list
25579692|NCT00841828|Trastuzumab|trastuzumab|mesh-list
25579693|NCT00841828|Epirubicin|epirubicin|mesh-list
25579694|NCT00841828|Lapatinib|lapatinib|mesh-list
25579695|NCT00841828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25579696|NCT00841828|Immunologic Factors|immunologic factors|mesh-ancestor
25579697|NCT00841828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579698|NCT00841828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25579699|NCT00841828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25579700|NCT00841828|Alkylating Agents|alkylating agents|mesh-ancestor
25656958|NCT01581307|Antimetabolites|antimetabolites|mesh-ancestor
25579701|NCT00841828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579702|NCT00841828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579703|NCT00841828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24703692|NCT01473303|Leucovorin|leucovorin|mesh-list
24451041|NCT00321516|Dopamine Agonists|dopamine agonists|mesh-ancestor
25579704|NCT00841828|Tubulin Modulators|tubulin modulators|mesh-ancestor
25579705|NCT00841828|Antimitotic Agents|antimitotic agents|mesh-ancestor
25579706|NCT00841828|Mitosis Modulators|mitosis modulators|mesh-ancestor
25474346|NCT00059332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25474347|NCT00059332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25474348|NCT00059332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474349|NCT00059332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25474350|NCT00059332|Tocolytic Agents|tocolytic agents|mesh-ancestor
25474351|NCT00059332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25474352|NCT00059475|polysaccharide-K|polysaccharide-k|mesh-list
25474353|NCT00059475|Interleukin-2|interleukin-2|mesh-list
25474354|NCT00059475|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25474355|NCT00059475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474356|NCT00059475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25474357|NCT00059475|Analgesics|analgesics|mesh-ancestor
25474358|NCT00059475|Sensory System Agents|sensory system agents|mesh-ancestor
25474359|NCT00059475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25474360|NCT00059475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474361|NCT00059475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25474362|NCT00059475|Immunologic Factors|immunologic factors|mesh-ancestor
25474363|NCT00059475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25474364|NCT00059475|Antiviral Agents|antiviral agents|mesh-ancestor
25474365|NCT00059475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25474366|NCT00059475|Interferon Inducers|interferon inducers|mesh-ancestor
25474367|NCT00059475|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25474368|NCT00059475|Protective Agents|protective agents|mesh-ancestor
25474369|NCT00059787|Paclitaxel|paclitaxel|mesh-list
25474370|NCT00059787|Carboplatin|carboplatin|mesh-list
25474371|NCT00059787|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25474372|NCT00059787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25474373|NCT00059787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474374|NCT00059787|Tubulin Modulators|tubulin modulators|mesh-ancestor
25474375|NCT00059787|Antimitotic Agents|antimitotic agents|mesh-ancestor
25474376|NCT00059787|Mitosis Modulators|mitosis modulators|mesh-ancestor
25474377|NCT00059787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474378|NCT00059787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25474379|NCT00059787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579707|NCT00841828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25579708|NCT00841828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25579709|NCT00841828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25579710|NCT00841828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25579711|NCT00841828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579712|NCT00841828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25579713|NCT00841971|Fluconazole|fluconazole|mesh-list
25579714|NCT00841971|Anidulafungin|anidulafungin|mesh-list
25579715|NCT00841971|Antifungal Agents|antifungal agents|mesh-ancestor
25579716|NCT00841971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25579717|NCT00841971|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25579718|NCT00841971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25579719|NCT00841971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579720|NCT00841971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579721|NCT00841971|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25579722|NCT00841971|Hormone Antagonists|hormone antagonists|mesh-ancestor
25579723|NCT00841971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25579724|NCT00841971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579725|NCT00841971|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25579726|NCT00841971|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25579727|NCT00842023|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25579728|NCT00842023|Nitroglycerin|nitroglycerin|mesh-list
25579729|NCT00842023|Vasodilator Agents|vasodilator agents|mesh-ancestor
25579730|NCT00842023|Natriuretic Agents|natriuretic agents|mesh-ancestor
25579731|NCT00842023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579732|NCT00842075|Pramlintide|pramlintide|mesh-list
25579733|NCT00842075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25579734|NCT00842075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579735|NCT00842153|Clobetasol|clobetasol|mesh-list
25579736|NCT00842153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25579737|NCT00842153|Glucocorticoids|glucocorticoids|mesh-ancestor
25579738|NCT00842153|Hormones|hormones|mesh-ancestor
25652926|NCT01533259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25579739|NCT00842153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25579740|NCT00842153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579741|NCT00842244|Cisplatin|cisplatin|mesh-list
25579742|NCT00842244|Capecitabine|capecitabine|mesh-list
25579743|NCT00842244|Axitinib|axitinib|mesh-list
25579744|NCT00842244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579745|NCT00842244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25579746|NCT00842244|Antimetabolites|antimetabolites|mesh-ancestor
25579747|NCT00842244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579748|NCT00842244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25579749|NCT00842244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579750|NCT00842257|Panitumumab|panitumumab|mesh-list
25579751|NCT00842257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25579752|NCT00842257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579753|NCT00842309|Cycloserine|cycloserine|mesh-list
25579754|NCT00842309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25579755|NCT00842309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25579756|NCT00842309|Renal Agents|renal agents|mesh-ancestor
25579757|NCT00842309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25579758|NCT00842309|Antitubercular Agents|antitubercular agents|mesh-ancestor
25579759|NCT00842309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25579760|NCT00842309|Antimetabolites|antimetabolites|mesh-ancestor
25579761|NCT00842309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579762|NCT00842348|Lanreotide|lanreotide|mesh-list
25579763|NCT00842348|Somatostatin|somatostatin|mesh-list
25579764|NCT00842348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579765|NCT00842348|Hormones|hormones|mesh-ancestor
25579766|NCT00842348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25579767|NCT00842348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579768|NCT00842361|Insulin|insulin|mesh-list
25579769|NCT00842361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25579770|NCT00842361|Insulin Aspart|insulin aspart|mesh-list
25579771|NCT00842361|Insulin, Long-Acting|insulin, long-acting|mesh-list
25579772|NCT00842361|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25579773|NCT00842361|Biphasic Insulins|biphasic insulins|mesh-list
25579774|NCT00842361|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
25579775|NCT00842361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25579776|NCT00842361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579777|NCT00842608|Haloperidol|haloperidol|mesh-list
25579778|NCT00842608|Haloperidol decanoate|haloperidol decanoate|mesh-list
25579779|NCT00842608|Cholinergic Antagonists|cholinergic antagonists|mesh-list
25579780|NCT00842608|Antiemetics|antiemetics|mesh-ancestor
25579781|NCT00842608|Autonomic Agents|autonomic agents|mesh-ancestor
25579782|NCT00842608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25579783|NCT00842608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579784|NCT00842608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25579785|NCT00842608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25579786|NCT00842608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25579787|NCT00842608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25579788|NCT00842608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25579789|NCT00842608|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25579790|NCT00842608|Dopamine Agents|dopamine agents|mesh-ancestor
25579791|NCT00842608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25579792|NCT00842608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579793|NCT00842608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25022862|NCT03658746|Levofloxacin|levofloxacin|mesh-list
25579794|NCT00842608|Cholinergic Agents|cholinergic agents|mesh-ancestor
25652927|NCT01533428|Capsaicin|capsaicin|mesh-list
25652928|NCT01533428|Antipruritics|antipruritics|mesh-ancestor
25652929|NCT01533428|Dermatologic Agents|dermatologic agents|mesh-ancestor
25652930|NCT01533428|Sensory System Agents|sensory system agents|mesh-ancestor
25652931|NCT01533428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25652932|NCT01533428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652933|NCT01533493|Memantine|memantine|mesh-list
25652934|NCT01533493|Methylphenidate|methylphenidate|mesh-list
25652935|NCT01533493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25652936|NCT01533493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652937|NCT01533493|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25652938|NCT01533493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25652939|NCT01533493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25652940|NCT01533493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652941|NCT01533493|Dopamine Agents|dopamine agents|mesh-ancestor
25652942|NCT01533493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25652943|NCT01533493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25652944|NCT01533493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25579795|NCT00842712|Gemcitabine|gemcitabine|mesh-list
25579796|NCT00842712|Cisplatin|cisplatin|mesh-list
25579797|NCT00842712|Cetuximab|cetuximab|mesh-list
25579798|NCT00842712|Vinorelbine|vinorelbine|mesh-list
25579799|NCT00842712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579800|NCT00842712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25579801|NCT00842712|Antimetabolites|antimetabolites|mesh-ancestor
25579802|NCT00842712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579803|NCT00842712|Antiviral Agents|antiviral agents|mesh-ancestor
25579804|NCT00842712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25579805|NCT00842712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579806|NCT00842712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25579807|NCT00842712|Immunologic Factors|immunologic factors|mesh-ancestor
25579808|NCT00842712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579809|NCT00842712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25579810|NCT00842712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25579811|NCT00842712|Tubulin Modulators|tubulin modulators|mesh-ancestor
25579812|NCT00842712|Antimitotic Agents|antimitotic agents|mesh-ancestor
25579813|NCT00842712|Mitosis Modulators|mitosis modulators|mesh-ancestor
25579814|NCT00842751|Finasteride|finasteride|mesh-list
25579815|NCT00842751|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25579816|NCT00842751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25579817|NCT00842751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579818|NCT00842751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579819|NCT00842751|Hormone Antagonists|hormone antagonists|mesh-ancestor
25579820|NCT00842751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25579821|NCT00842751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579822|NCT00842751|Urological Agents|urological agents|mesh-ancestor
25579823|NCT00842829|Fentanyl|fentanyl|mesh-list
25579824|NCT00842829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25579825|NCT00842829|Narcotics|narcotics|mesh-ancestor
25579826|NCT00842829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25579827|NCT00842829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579828|NCT00842829|Analgesics|analgesics|mesh-ancestor
25579829|NCT00842829|Sensory System Agents|sensory system agents|mesh-ancestor
25579830|NCT00842829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25579831|NCT00842829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25579832|NCT00842829|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25579833|NCT00842829|Anesthetics, General|anesthetics, general|mesh-ancestor
25579834|NCT00842829|Anesthetics|anesthetics|mesh-ancestor
25579835|NCT00842985|Dronabinol|dronabinol|mesh-list
25579836|NCT00842985|Modafinil|modafinil|mesh-list
25579837|NCT00842985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25579838|NCT00842985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579839|NCT00842985|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25579840|NCT00842985|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25579841|NCT00842985|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25579842|NCT00842985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579843|NCT00842985|Hallucinogens|hallucinogens|mesh-ancestor
25579844|NCT00842985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25579845|NCT00842985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25579846|NCT00842985|Analgesics|analgesics|mesh-ancestor
25579847|NCT00842985|Sensory System Agents|sensory system agents|mesh-ancestor
25579848|NCT00842985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25579849|NCT00842985|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25579850|NCT00842985|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25579851|NCT00842985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25579852|NCT00842985|Hormones|hormones|mesh-ancestor
25579853|NCT00842985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25579854|NCT00843024|Naproxen|naproxen|mesh-list
25579855|NCT00843024|Sumatriptan|sumatriptan|mesh-list
25579856|NCT00843024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25579857|NCT00843024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25579858|NCT00843024|Analgesics|analgesics|mesh-ancestor
25579859|NCT00843024|Sensory System Agents|sensory system agents|mesh-ancestor
25579860|NCT00843024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25579861|NCT00843024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579862|NCT00843024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25579863|NCT00843024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25579864|NCT00843024|Gout Suppressants|gout suppressants|mesh-ancestor
25579865|NCT00843024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25579866|NCT00843024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579867|NCT00843024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579868|NCT00843024|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24542884|NCT00680680|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25579869|NCT00843024|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25579870|NCT00843024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25579871|NCT00843024|Serotonin Agents|serotonin agents|mesh-ancestor
25579872|NCT00843024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25579873|NCT00843115|Donepezil|donepezil|mesh-list
25579874|NCT00843115|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25579875|NCT00843115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579876|NCT00843115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579877|NCT00843115|Cholinergic Agents|cholinergic agents|mesh-ancestor
25579878|NCT00843115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25579879|NCT00843115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579880|NCT00843115|Nootropic Agents|nootropic agents|mesh-ancestor
25579881|NCT00843193|Fluticasone|fluticasone|mesh-list
25579882|NCT00843193|Xhance|xhance|mesh-list
25579883|NCT00843193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25579884|NCT00843193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25579885|NCT00843193|Autonomic Agents|autonomic agents|mesh-ancestor
25579886|NCT00843193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25579887|NCT00843193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579888|NCT00843193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25579889|NCT00843193|Respiratory System Agents|respiratory system agents|mesh-ancestor
25579890|NCT00843193|Dermatologic Agents|dermatologic agents|mesh-ancestor
25579891|NCT00843193|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25579892|NCT00843284|Pregabalin|pregabalin|mesh-list
25579893|NCT00843284|Analgesics|analgesics|mesh-ancestor
25579894|NCT00843284|Sensory System Agents|sensory system agents|mesh-ancestor
25579895|NCT00843284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25579896|NCT00843284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579897|NCT00843284|Anticonvulsants|anticonvulsants|mesh-ancestor
25579898|NCT00843284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25579899|NCT00843284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25579900|NCT00843284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579901|NCT00843284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25579902|NCT00843284|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25579903|NCT00843284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25579904|NCT00843284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25579905|NCT00843284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25579906|NCT00843492|PENTA|penta|mesh-list
25579907|NCT00843492|Nadroparin|nadroparin|mesh-list
25579908|NCT00843492|Fondaparinux|fondaparinux|mesh-list
25579909|NCT00843492|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25579910|NCT00843492|Antithrombins|antithrombins|mesh-ancestor
25579911|NCT00843492|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25579912|NCT00843492|Protease Inhibitors|protease inhibitors|mesh-ancestor
25579913|NCT00843492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579914|NCT00843492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579915|NCT00843492|Anticoagulants|anticoagulants|mesh-ancestor
25579916|NCT00843492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25579917|NCT00843492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25579918|NCT00843531|Everolimus|everolimus|mesh-list
25579919|NCT00843531|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25579920|NCT00843531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579921|NCT00843531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25579922|NCT00843531|Immunologic Factors|immunologic factors|mesh-ancestor
25579923|NCT00843531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579924|NCT00843531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25579925|NCT00843531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579926|NCT00843531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579927|NCT00843635|Tadalafil|tadalafil|mesh-list
25579928|NCT00843635|Vasodilator Agents|vasodilator agents|mesh-ancestor
25579929|NCT00843635|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25579930|NCT00843635|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25579931|NCT00843635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579932|NCT00843635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579933|NCT00843635|Urological Agents|urological agents|mesh-ancestor
25579934|NCT00843713|Raltegravir Potassium|raltegravir potassium|mesh-list
25579935|NCT00843713|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25579936|NCT00843713|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25579937|NCT00843713|Antiviral Agents|antiviral agents|mesh-ancestor
25579938|NCT00843713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25579939|NCT00843713|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25579940|NCT00843713|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25579941|NCT00843713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474522|NCT00061373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25025374|NCT03637790|Rifampin|rifampin|mesh-list
25474523|NCT00061373|Analgesics|analgesics|mesh-ancestor
25474535|NCT00061373|Antipyretics|antipyretics|mesh-ancestor
25579942|NCT00843713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579943|NCT00843778|Certolizumab Pegol|certolizumab pegol|mesh-list
25579944|NCT00843778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25579945|NCT00843778|Immunologic Factors|immunologic factors|mesh-ancestor
25579946|NCT00843778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579947|NCT00843778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25579948|NCT00843856|Mycophenolic Acid|mycophenolic acid|mesh-list
25579949|NCT00843856|Tacrolimus|tacrolimus|mesh-list
25579950|NCT00843856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25579951|NCT00843856|Immunologic Factors|immunologic factors|mesh-ancestor
25579952|NCT00843856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579953|NCT00843856|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25579954|NCT00843856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25579955|NCT00843856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579956|NCT00843856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25579957|NCT00843856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579958|NCT00843856|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25579959|NCT00843856|Antitubercular Agents|antitubercular agents|mesh-ancestor
25579960|NCT00843856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25579961|NCT00843856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25579962|NCT00844090|Methylphenidate|methylphenidate|mesh-list
25579963|NCT00844090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25579964|NCT00844090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579965|NCT00844090|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25579966|NCT00844090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25579967|NCT00844090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25579968|NCT00844090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579969|NCT00844090|Dopamine Agents|dopamine agents|mesh-ancestor
25579970|NCT00844090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25579971|NCT00844194|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25579972|NCT00844194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25579973|NCT00844194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25579974|NCT00844194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25579975|NCT00844194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579976|NCT00844194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25579977|NCT00844194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579978|NCT00844194|Analgesics|analgesics|mesh-ancestor
25579979|NCT00844194|Sensory System Agents|sensory system agents|mesh-ancestor
25579980|NCT00844194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25579981|NCT00844194|Antidepressive Agents|antidepressive agents|mesh-ancestor
25579982|NCT00844194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25579983|NCT00844194|Dopamine Agents|dopamine agents|mesh-ancestor
25579984|NCT00844298|Cytarabine|cytarabine|mesh-list
25579985|NCT00844298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25579986|NCT00844298|Antimetabolites|antimetabolites|mesh-ancestor
25579987|NCT00844298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579988|NCT00844298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25579989|NCT00844298|Antiviral Agents|antiviral agents|mesh-ancestor
25579990|NCT00844298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25579991|NCT00844298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25579992|NCT00844298|Immunologic Factors|immunologic factors|mesh-ancestor
25579993|NCT00844298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25579994|NCT00844376|Atorvastatin|atorvastatin|mesh-list
25579995|NCT00844376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25579996|NCT00844376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25579997|NCT00844376|Antimetabolites|antimetabolites|mesh-ancestor
25579998|NCT00844376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25579999|NCT00844376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25580000|NCT00844376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25580001|NCT00844376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580002|NCT00844415|Dabigatran|dabigatran|mesh-list
25580003|NCT00844415|Antithrombins|antithrombins|mesh-ancestor
25580004|NCT00844415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25580005|NCT00844415|Protease Inhibitors|protease inhibitors|mesh-ancestor
25580006|NCT00844415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580007|NCT00844415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580008|NCT00844415|Anticoagulants|anticoagulants|mesh-ancestor
25580009|NCT00844428|Eculizumab|eculizumab|mesh-list
25580010|NCT00844428|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25474592|NCT00062010|Mitosis Modulators|mitosis modulators|mesh-ancestor
25474593|NCT00062010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474594|NCT00062010|Antiviral Agents|antiviral agents|mesh-ancestor
25580011|NCT00844428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25580012|NCT00844428|Immunologic Factors|immunologic factors|mesh-ancestor
25580013|NCT00844428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580014|NCT00844519|Maraviroc|maraviroc|mesh-list
25580015|NCT00844519|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25580016|NCT00844519|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25580017|NCT00844519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819819|NCT02097342|Voglibose|voglibose|mesh-list
25580018|NCT00844519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25580019|NCT00844519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25580020|NCT00844519|Antiviral Agents|antiviral agents|mesh-ancestor
25580021|NCT00844519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25580022|NCT00844519|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25580023|NCT00844545|Eculizumab|eculizumab|mesh-list
25580024|NCT00844545|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25580025|NCT00844545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25580026|NCT00844545|Immunologic Factors|immunologic factors|mesh-ancestor
25580027|NCT00844545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580028|NCT00844649|Gemcitabine|gemcitabine|mesh-list
25580029|NCT00844649|Paclitaxel|paclitaxel|mesh-list
25580030|NCT00844649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25580031|NCT00844649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25580032|NCT00844649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25580033|NCT00844649|Tubulin Modulators|tubulin modulators|mesh-ancestor
25580034|NCT00844649|Antimitotic Agents|antimitotic agents|mesh-ancestor
25580035|NCT00844649|Mitosis Modulators|mitosis modulators|mesh-ancestor
25580036|NCT00844649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580037|NCT00844649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25580038|NCT00844649|Antimetabolites|antimetabolites|mesh-ancestor
25580039|NCT00844649|Antiviral Agents|antiviral agents|mesh-ancestor
25580040|NCT00844649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25580041|NCT00844649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580042|NCT00844649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25580043|NCT00844649|Immunologic Factors|immunologic factors|mesh-ancestor
25580044|NCT00844649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580045|NCT00844714|Rituximab|rituximab|mesh-list
25580046|NCT00844714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25580047|NCT00844714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25580048|NCT00844714|Immunologic Factors|immunologic factors|mesh-ancestor
25580049|NCT00844714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580050|NCT00844714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25580051|NCT00844753|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25580052|NCT00844753|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25580053|NCT00844753|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25580054|NCT00844753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25580055|NCT00844753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580056|NCT00844753|Adrenergic Agents|adrenergic agents|mesh-ancestor
25580057|NCT00844753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25580058|NCT00844753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580059|NCT00844805|Naproxen|naproxen|mesh-list
25580060|NCT00844805|Infliximab|infliximab|mesh-list
25580061|NCT00844805|Dermatologic Agents|dermatologic agents|mesh-ancestor
25580062|NCT00844805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25580063|NCT00844805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25580064|NCT00844805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25580065|NCT00844805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25580066|NCT00844805|Analgesics|analgesics|mesh-ancestor
25580067|NCT00844805|Sensory System Agents|sensory system agents|mesh-ancestor
25580068|NCT00844805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25580069|NCT00844805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580070|NCT00844805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25580071|NCT00844805|Gout Suppressants|gout suppressants|mesh-ancestor
25580072|NCT00844805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25580073|NCT00844805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580074|NCT00844805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580075|NCT00844831|Lubiprostone|lubiprostone|mesh-list
25580076|NCT00844831|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25580077|NCT00844831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25580078|NCT00844831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580079|NCT00844844|Eculizumab|eculizumab|mesh-list
25580080|NCT00844844|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25580081|NCT00844844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25580082|NCT00844844|Immunologic Factors|immunologic factors|mesh-ancestor
25580083|NCT00844844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580084|NCT00844857|Olanzapine|olanzapine|mesh-list
25580086|NCT00844857|Antiemetics|antiemetics|mesh-ancestor
25580087|NCT00844857|Autonomic Agents|autonomic agents|mesh-ancestor
25580088|NCT00844857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25580089|NCT00844857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580090|NCT00844857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25580091|NCT00844857|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25580092|NCT00844857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25580093|NCT00844857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25580094|NCT00844857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24446579|NCT00305396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25580095|NCT00844857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25580096|NCT00844857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25580097|NCT00844857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25580098|NCT00844857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580099|NCT00844857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25580100|NCT00844857|Serotonin Agents|serotonin agents|mesh-ancestor
25580101|NCT00844857|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25580102|NCT00844857|Antidepressive Agents|antidepressive agents|mesh-ancestor
25580103|NCT00844857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25580104|NCT00844857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25580105|NCT00844857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580106|NCT00844883|Sorafenib|sorafenib|mesh-list
25580107|NCT00844883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25580108|NCT00844883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25580109|NCT00844883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580110|NCT00844883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580111|NCT00844896|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
25580112|NCT00844896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580113|NCT00844896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580114|NCT00845000|Levodopa|levodopa|mesh-list
25580115|NCT00845000|Carbidopa|carbidopa|mesh-list
25580116|NCT00845000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25580117|NCT00845000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25580118|NCT00845000|Dopamine Agents|dopamine agents|mesh-ancestor
25580119|NCT00845000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25580120|NCT00845000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580121|NCT00845000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580122|NCT00845000|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25580123|NCT00845000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580124|NCT00845039|Irinotecan|irinotecan|mesh-list
25580125|NCT00845039|Cetuximab|cetuximab|mesh-list
25580126|NCT00845039|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25580127|NCT00845039|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25580128|NCT00845039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25580129|NCT00845039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580130|NCT00845039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580131|NCT00845039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25580132|NCT00845039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25580133|NCT00845039|Immunologic Factors|immunologic factors|mesh-ancestor
25580134|NCT00845039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580135|NCT00845065|Ribavirin|ribavirin|mesh-list
25580136|NCT00845065|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25580137|NCT00845065|Antimetabolites|antimetabolites|mesh-ancestor
25580138|NCT00845065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580139|NCT00845065|Antiviral Agents|antiviral agents|mesh-ancestor
25580140|NCT00845065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25580141|NCT00845130|Vitamins|vitamins|mesh-list
25580142|NCT00845130|Ascorbic Acid|ascorbic acid|mesh-list
25580143|NCT00845130|Micronutrients|micronutrients|mesh-ancestor
25580144|NCT00845130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580145|NCT00845130|Antioxidants|antioxidants|mesh-ancestor
25580146|NCT00845130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580147|NCT00845130|Protective Agents|protective agents|mesh-ancestor
25580148|NCT00845182|Pioglitazone|pioglitazone|mesh-list
25580149|NCT00845182|Exenatide|exenatide|mesh-list
25580150|NCT00845182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25580151|NCT00845182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580152|NCT00845182|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25580153|NCT00845182|Incretins|incretins|mesh-ancestor
25580154|NCT00845182|Hormones|hormones|mesh-ancestor
25580155|NCT00845182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25580156|NCT00845195|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25580157|NCT00845195|Azelastine|azelastine|mesh-list
25580158|NCT00845195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25027105|NCT03622502|Dexmedetomidine|dexmedetomidine|mesh-list
25580159|NCT00845195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25580160|NCT00845195|Analgesics|analgesics|mesh-ancestor
25580161|NCT00845195|Sensory System Agents|sensory system agents|mesh-ancestor
25580162|NCT00845195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25580163|NCT00845195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580164|NCT00845195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24984154|NCT04762836|Renal Agents|renal agents|mesh-ancestor
25580165|NCT00845195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25580166|NCT00845195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25580167|NCT00845195|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25580168|NCT00845195|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25580169|NCT00845195|Histamine Antagonists|histamine antagonists|mesh-ancestor
25580170|NCT00845195|Histamine Agents|histamine agents|mesh-ancestor
25580171|NCT00845195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25580172|NCT00845195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580173|NCT00845195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25580174|NCT00845195|Autonomic Agents|autonomic agents|mesh-ancestor
25580175|NCT00845195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25580176|NCT00845195|Respiratory System Agents|respiratory system agents|mesh-ancestor
25580177|NCT00845195|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25580178|NCT00845195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580179|NCT00845429|Vaccines|vaccines|mesh-list
25580180|NCT00845429|Immunologic Factors|immunologic factors|mesh-ancestor
25580181|NCT00845429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580182|NCT00845481|Calcitriol|calcitriol|mesh-list
25580183|NCT00845481|Betamethasone|betamethasone|mesh-list
25580184|NCT00845481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25580185|NCT00845481|Glucocorticoids|glucocorticoids|mesh-ancestor
25580186|NCT00845481|Hormones|hormones|mesh-ancestor
25580187|NCT00845481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25580188|NCT00845481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580189|NCT00845481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25580190|NCT00845481|Respiratory System Agents|respiratory system agents|mesh-ancestor
25580191|NCT00845481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25580192|NCT00845481|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25580193|NCT00845481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25580194|NCT00845481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580195|NCT00845481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25580196|NCT00845481|Vitamins|vitamins|mesh-ancestor
25580197|NCT00845481|Micronutrients|micronutrients|mesh-ancestor
25580198|NCT00845481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25580199|NCT00845507|Exenatide|exenatide|mesh-list
25580200|NCT00845507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25580201|NCT00845507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580202|NCT00845507|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25580203|NCT00845507|Incretins|incretins|mesh-ancestor
25580204|NCT00845507|Hormones|hormones|mesh-ancestor
25580205|NCT00845507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25580206|NCT00845650|Immunoglobulins|immunoglobulins|mesh-list
25580207|NCT00845650|gamma-Globulins|gamma-globulins|mesh-list
25580208|NCT00845650|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25580209|NCT00845650|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25580210|NCT00845650|Immunologic Factors|immunologic factors|mesh-ancestor
25027678|NCT03618082|Desflurane|desflurane|mesh-list
25580211|NCT00845650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580212|NCT00845663|Certolizumab Pegol|certolizumab pegol|mesh-list
25580213|NCT00845663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25580214|NCT00845663|Immunologic Factors|immunologic factors|mesh-ancestor
25580215|NCT00845663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580216|NCT00845663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25580217|NCT00845676|Interferons|interferons|mesh-list
25580218|NCT00845676|Ribavirin|ribavirin|mesh-list
25580219|NCT00845676|Interferon-alpha|interferon-alpha|mesh-list
25580220|NCT00845676|Interferon alpha-2|interferon alpha-2|mesh-list
25580221|NCT00845676|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25580222|NCT00845676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25580223|NCT00845676|Antiviral Agents|antiviral agents|mesh-ancestor
25580224|NCT00845676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25580225|NCT00845676|Antimetabolites|antimetabolites|mesh-ancestor
25580226|NCT00845676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580227|NCT00845676|Immunologic Factors|immunologic factors|mesh-ancestor
25580228|NCT00845676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580229|NCT00845728|Tiotropium Bromide|tiotropium bromide|mesh-list
25580230|NCT00845728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25580231|NCT00845728|Autonomic Agents|autonomic agents|mesh-ancestor
25580232|NCT00845728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25580233|NCT00845728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580234|NCT00845728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25580235|NCT00845728|Respiratory System Agents|respiratory system agents|mesh-ancestor
25580237|NCT00845728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25580238|NCT00845728|Cholinergic Agents|cholinergic agents|mesh-ancestor
25580239|NCT00845728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25580240|NCT00845728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580241|NCT00845832|Rituximab|rituximab|mesh-list
25580242|NCT00845832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25580243|NCT00845832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25580244|NCT00845832|Immunologic Factors|immunologic factors|mesh-ancestor
25580245|NCT00845832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580246|NCT00845832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25580247|NCT00845858|Metoclopramide|metoclopramide|mesh-list
25580248|NCT00845858|Antiemetics|antiemetics|mesh-ancestor
25580249|NCT00845858|Autonomic Agents|autonomic agents|mesh-ancestor
25580250|NCT00845858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25580251|NCT00845858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580252|NCT00845858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25580253|NCT00845858|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25580254|NCT00845858|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25580255|NCT00845858|Dopamine Agents|dopamine agents|mesh-ancestor
25580256|NCT00845858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25580257|NCT00845858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580258|NCT00845871|Deferasirox|deferasirox|mesh-list
25580259|NCT00845871|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25580260|NCT00845871|Chelating Agents|chelating agents|mesh-ancestor
25580261|NCT00845871|Sequestering Agents|sequestering agents|mesh-ancestor
25580262|NCT00845871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580263|NCT00845897|Botulinum Toxins|botulinum toxins|mesh-list
25580264|NCT00845897|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25580265|NCT00845897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25580266|NCT00845897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580267|NCT00845897|Cholinergic Agents|cholinergic agents|mesh-ancestor
25580268|NCT00845897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25580269|NCT00845897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580270|NCT00846027|Gemcitabine|gemcitabine|mesh-list
25580271|NCT00846027|Paclitaxel|paclitaxel|mesh-list
25580272|NCT00846027|Bevacizumab|bevacizumab|mesh-list
25580273|NCT00846027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25580274|NCT00846027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25580275|NCT00846027|Tubulin Modulators|tubulin modulators|mesh-ancestor
25580276|NCT00846027|Antimitotic Agents|antimitotic agents|mesh-ancestor
25580277|NCT00846027|Mitosis Modulators|mitosis modulators|mesh-ancestor
25580278|NCT00846027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580279|NCT00846027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25580280|NCT00846027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25580281|NCT00846027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25580282|NCT00846027|Growth Substances|growth substances|mesh-ancestor
25580283|NCT00846027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580284|NCT00846027|Growth Inhibitors|growth inhibitors|mesh-ancestor
25580285|NCT00846027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25580286|NCT00846027|Antimetabolites|antimetabolites|mesh-ancestor
25580287|NCT00846027|Antiviral Agents|antiviral agents|mesh-ancestor
25580288|NCT00846027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25580289|NCT00846027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580290|NCT00846027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25580291|NCT00846027|Immunologic Factors|immunologic factors|mesh-ancestor
25580292|NCT00846040|Fallypride|fallypride|mesh-list
25580293|NCT00846040|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25580294|NCT00846040|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25580295|NCT00846040|Dopamine Agents|dopamine agents|mesh-ancestor
25580296|NCT00846040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25580297|NCT00846040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580298|NCT00846040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580299|NCT00846365|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25580300|NCT00846365|Olmesartan|olmesartan|mesh-list
25580301|NCT00846365|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25580302|NCT00846365|Chlorthalidone|chlorthalidone|mesh-list
25580303|NCT00846365|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25580304|NCT00846365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25580305|NCT00846365|Diuretics|diuretics|mesh-ancestor
25580306|NCT00846365|Natriuretic Agents|natriuretic agents|mesh-ancestor
25580307|NCT00846365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580308|NCT00846365|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25580309|NCT00846365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25580310|NCT00846365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580311|NCT00846365|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25580312|NCT00846365|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25580313|NCT00846482|Oxaliplatin|oxaliplatin|mesh-list
25580314|NCT00846482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25580315|NCT00846495|Topiramate|topiramate|mesh-list
25580316|NCT00846495|Frovatriptan|frovatriptan|mesh-list
25580317|NCT00846495|Anticonvulsants|anticonvulsants|mesh-ancestor
25580318|NCT00846495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25580319|NCT00846495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580320|NCT00846495|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25580321|NCT00846495|Serotonin Agents|serotonin agents|mesh-ancestor
25580322|NCT00846495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25580323|NCT00846495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580324|NCT00846521|Acarbose|acarbose|mesh-list
25580325|NCT00846521|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25580326|NCT00846521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580327|NCT00846521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580328|NCT00846521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25580329|NCT00846521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580330|NCT00846586|Tiotropium Bromide|tiotropium bromide|mesh-list
25580331|NCT00846586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25580332|NCT00846586|Autonomic Agents|autonomic agents|mesh-ancestor
25580333|NCT00846586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25580334|NCT00846586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580335|NCT00846586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25580336|NCT00846586|Respiratory System Agents|respiratory system agents|mesh-ancestor
25580337|NCT00846586|Parasympatholytics|parasympatholytics|mesh-ancestor
25580338|NCT00846586|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25580339|NCT00846586|Cholinergic Agents|cholinergic agents|mesh-ancestor
25580340|NCT00846586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25580341|NCT00846586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580342|NCT00846651|Phenylephrine|phenylephrine|mesh-list
25580343|NCT00846651|Oxymetazoline|oxymetazoline|mesh-list
25580344|NCT00846651|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25580345|NCT00846651|Mydriatics|mydriatics|mesh-ancestor
25580346|NCT00846651|Autonomic Agents|autonomic agents|mesh-ancestor
25580347|NCT00846651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25580348|NCT00846651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580349|NCT00846651|Sympathomimetics|sympathomimetics|mesh-ancestor
25580350|NCT00846651|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25580351|NCT00846651|Nasal Decongestants|nasal decongestants|mesh-ancestor
25580352|NCT00846651|Respiratory System Agents|respiratory system agents|mesh-ancestor
25580353|NCT00846651|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25580354|NCT00846651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25580355|NCT00846651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25580356|NCT00846651|Adrenergic Agents|adrenergic agents|mesh-ancestor
25580357|NCT00846651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25580358|NCT00846651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580359|NCT00846651|Protective Agents|protective agents|mesh-ancestor
25580360|NCT00846768|Olodaterol|olodaterol|mesh-list
25580361|NCT00846768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25580362|NCT00846768|Autonomic Agents|autonomic agents|mesh-ancestor
25580363|NCT00846768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25580364|NCT00846768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580365|NCT00846768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25580366|NCT00846768|Respiratory System Agents|respiratory system agents|mesh-ancestor
25580367|NCT00847015|Gemcitabine|gemcitabine|mesh-list
25580368|NCT00847015|Cisplatin|cisplatin|mesh-list
25580369|NCT00847015|Sunitinib|sunitinib|mesh-list
25580370|NCT00847015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25580371|NCT00847015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25580372|NCT00847015|Antimetabolites|antimetabolites|mesh-ancestor
25702496|NCT02155322|Interferon alpha-2|interferon alpha-2|mesh-list
25580373|NCT00847015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580374|NCT00847015|Antiviral Agents|antiviral agents|mesh-ancestor
25580375|NCT00847015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25580376|NCT00847015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580377|NCT00847015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25580378|NCT00847015|Immunologic Factors|immunologic factors|mesh-ancestor
25580379|NCT00847015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580380|NCT00847015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25580381|NCT00847015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25474957|NCT00065507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25580382|NCT00847015|Growth Substances|growth substances|mesh-ancestor
25580383|NCT00847015|Growth Inhibitors|growth inhibitors|mesh-ancestor
25580384|NCT00847015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25580385|NCT00847145|Vaccines|vaccines|mesh-list
25580386|NCT00847145|Immunologic Factors|immunologic factors|mesh-ancestor
25580387|NCT00847145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580388|NCT00847171|Cyclophosphamide|cyclophosphamide|mesh-list
25580389|NCT00847171|Trastuzumab|trastuzumab|mesh-list
25580390|NCT00847171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25580391|NCT00847171|Immunologic Factors|immunologic factors|mesh-ancestor
25580392|NCT00847171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580393|NCT00847171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25580394|NCT00847171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25580395|NCT00847171|Alkylating Agents|alkylating agents|mesh-ancestor
25580396|NCT00847171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580397|NCT00847171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25580398|NCT00847171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25580399|NCT00847171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25580400|NCT00847210|Dexlansoprazole|dexlansoprazole|mesh-list
25580401|NCT00847210|Lansoprazole|lansoprazole|mesh-list
25580402|NCT00847210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25580403|NCT00847210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25580404|NCT00847210|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25580405|NCT00847210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580406|NCT00847210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580407|NCT00847587|Contraceptive Agents|contraceptive agents|mesh-list
25580408|NCT00847587|Etonogestrel|etonogestrel|mesh-list
25580409|NCT00847587|Desogestrel|desogestrel|mesh-list
25580410|NCT00847587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25580411|NCT00847587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580412|NCT00847587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25580413|NCT00847587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25580414|NCT00847587|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25580415|NCT00847587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25580416|NCT00847587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25580417|NCT00847587|Progestins|progestins|mesh-ancestor
25580418|NCT00847587|Hormones|hormones|mesh-ancestor
25580419|NCT00847587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25580420|NCT00847613|Tofacitinib|tofacitinib|mesh-list
25580421|NCT00847613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25580422|NCT00847613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580423|NCT00847613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580424|NCT00847626|Chlorthalidone|chlorthalidone|mesh-list
25580425|NCT00847626|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25580426|NCT00847626|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25580427|NCT00847626|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25580428|NCT00847626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580429|NCT00847626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25580430|NCT00847626|Diuretics|diuretics|mesh-ancestor
25580431|NCT00847626|Natriuretic Agents|natriuretic agents|mesh-ancestor
25580432|NCT00847626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580433|NCT00847626|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25580434|NCT00847626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25580435|NCT00847808|Dexlansoprazole|dexlansoprazole|mesh-list
25580436|NCT00847808|Lansoprazole|lansoprazole|mesh-list
25580437|NCT00847808|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25580438|NCT00847808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25580439|NCT00847808|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25580440|NCT00847808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474963|NCT00408252|Growth Substances|growth substances|mesh-ancestor
25580441|NCT00847808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652945|NCT01533493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25652946|NCT01533493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25652947|NCT01533597|Tamsulosin|tamsulosin|mesh-list
25652948|NCT01533597|Solifenacin Succinate|solifenacin succinate|mesh-list
25652949|NCT01533597|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25652950|NCT01533597|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25652951|NCT01533597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25652952|NCT01533597|Adrenergic Agents|adrenergic agents|mesh-ancestor
25652953|NCT01533597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25652954|NCT01533597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652955|NCT01533597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652956|NCT01533597|Urological Agents|urological agents|mesh-ancestor
25652957|NCT01533597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25580442|NCT00847886|Methotrexate|methotrexate|mesh-list
25580443|NCT00847886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25580444|NCT00847886|Abortifacient Agents|abortifacient agents|mesh-ancestor
25580445|NCT00847886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25580446|NCT00847886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580447|NCT00847886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25580448|NCT00847886|Antimetabolites|antimetabolites|mesh-ancestor
25580449|NCT00847886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580450|NCT00847886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25580451|NCT00847886|Dermatologic Agents|dermatologic agents|mesh-ancestor
25580452|NCT00847886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580453|NCT00847886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25580454|NCT00847886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25580455|NCT00847886|Immunologic Factors|immunologic factors|mesh-ancestor
25580456|NCT00847886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25580457|NCT00847886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25580458|NCT00847912|Fluorouracil|fluorouracil|mesh-list
25580459|NCT00847912|Antimetabolites|antimetabolites|mesh-ancestor
24712791|NCT01522872|BB 1101|bb 1101|mesh-list
25580460|NCT00847912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580461|NCT00847912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25580462|NCT00847912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25580463|NCT00847912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25580464|NCT00847912|Immunologic Factors|immunologic factors|mesh-ancestor
25580465|NCT00847912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580466|NCT00847938|Neostigmine|neostigmine|mesh-list
25580467|NCT00847938|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25580468|NCT00847938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580469|NCT00847938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580470|NCT00847938|Cholinergic Agents|cholinergic agents|mesh-ancestor
25580471|NCT00847938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25580472|NCT00847938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580473|NCT00847938|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25580474|NCT00847938|Autonomic Agents|autonomic agents|mesh-ancestor
25580475|NCT00847938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25580476|NCT00848016|Acetic Acid|acetic acid|mesh-list
25580477|NCT00848016|Retinol acetate|retinol acetate|mesh-list
25580478|NCT00848016|Gossypol acetic acid|gossypol acetic acid|mesh-list
25580479|NCT00848016|Gossypol|gossypol|mesh-list
25580480|NCT00848016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25580481|NCT00848016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25580482|NCT00848016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25580483|NCT00848016|Immunologic Factors|immunologic factors|mesh-ancestor
25580484|NCT00848016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580485|NCT00848016|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25580486|NCT00848016|Protective Agents|protective agents|mesh-ancestor
25580487|NCT00848016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25580488|NCT00848016|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25580489|NCT00848016|Contraceptive Agents|contraceptive agents|mesh-ancestor
25580490|NCT00848016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25580491|NCT00848016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25580492|NCT00848016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25580493|NCT00848016|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
25580494|NCT00848016|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
25580495|NCT00848081|Tadalafil|tadalafil|mesh-list
25580496|NCT00848081|Vasodilator Agents|vasodilator agents|mesh-ancestor
25580497|NCT00848081|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25580498|NCT00848081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25580499|NCT00848081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580500|NCT00848081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580501|NCT00848081|Urological Agents|urological agents|mesh-ancestor
25580502|NCT00848107|Treprostinil|treprostinil|mesh-list
25580503|NCT00848107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25580504|NCT00848250|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25580505|NCT00848250|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25580506|NCT00848250|Protease Inhibitors|protease inhibitors|mesh-ancestor
25580507|NCT00848250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580508|NCT00848354|Etanercept|etanercept|mesh-list
25580509|NCT00848354|Methotrexate|methotrexate|mesh-list
25580510|NCT00848354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25580511|NCT00848354|Abortifacient Agents|abortifacient agents|mesh-ancestor
25580512|NCT00848354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25580513|NCT00848354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580514|NCT00848354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25580515|NCT00848354|Antimetabolites|antimetabolites|mesh-ancestor
25580516|NCT00848354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580517|NCT00848354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25580518|NCT00848354|Dermatologic Agents|dermatologic agents|mesh-ancestor
25580519|NCT00848354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036014|NCT03551171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580520|NCT00848354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25580521|NCT00848354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25580522|NCT00848354|Immunologic Factors|immunologic factors|mesh-ancestor
25580523|NCT00848354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25580524|NCT00848354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25580525|NCT00848354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25580526|NCT00848354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25580527|NCT00848354|Analgesics|analgesics|mesh-ancestor
25580528|NCT00848354|Sensory System Agents|sensory system agents|mesh-ancestor
25580529|NCT00848354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25580530|NCT00848354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25580531|NCT00848354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25580533|NCT00848393|Dexmedetomidine|dexmedetomidine|mesh-list
25580534|NCT00848393|Citric Acid|citric acid|mesh-list
25580535|NCT00848393|Sodium Citrate|sodium citrate|mesh-list
25580536|NCT00848393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25580537|NCT00848393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25580538|NCT00848393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580539|NCT00848393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25580540|NCT00848393|Analgesics|analgesics|mesh-ancestor
25580541|NCT00848393|Sensory System Agents|sensory system agents|mesh-ancestor
25580542|NCT00848393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25580543|NCT00848393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25036211|NCT03549611|Analgesics|analgesics|mesh-ancestor
25580544|NCT00848393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25580545|NCT00848393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25580546|NCT00848393|Adrenergic Agents|adrenergic agents|mesh-ancestor
25580547|NCT00848393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25580548|NCT00848393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580549|NCT00848393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25580550|NCT00848393|Narcotics|narcotics|mesh-ancestor
25580551|NCT00848393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25580552|NCT00848393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25580553|NCT00848393|Anesthetics, General|anesthetics, general|mesh-ancestor
25580554|NCT00848393|Anesthetics|anesthetics|mesh-ancestor
25580555|NCT00848393|Anticoagulants|anticoagulants|mesh-ancestor
25580556|NCT00848393|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25580557|NCT00848393|Chelating Agents|chelating agents|mesh-ancestor
25580558|NCT00848393|Sequestering Agents|sequestering agents|mesh-ancestor
25580559|NCT00848497|Methyltestosterone|methyltestosterone|mesh-list
25580560|NCT00848497|Sildenafil Citrate|sildenafil citrate|mesh-list
25580561|NCT00848497|Testosterone|testosterone|mesh-list
25580562|NCT00848497|Testosterone undecanoate|testosterone undecanoate|mesh-list
25580563|NCT00848497|Testosterone enanthate|testosterone enanthate|mesh-list
25580564|NCT00848497|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25580565|NCT00848497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580566|NCT00848497|Androgens|androgens|mesh-ancestor
25580567|NCT00848497|Hormones|hormones|mesh-ancestor
25580568|NCT00848497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25580569|NCT00848497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036936|NCT03542149|Vitamins|vitamins|mesh-ancestor
25580570|NCT00848497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25580571|NCT00848497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25580572|NCT00848497|Anabolic Agents|anabolic agents|mesh-ancestor
25580573|NCT00848497|Vasodilator Agents|vasodilator agents|mesh-ancestor
25580574|NCT00848497|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25580575|NCT00848497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25580576|NCT00848497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580577|NCT00848497|Urological Agents|urological agents|mesh-ancestor
25580578|NCT00848536|Travoprost|travoprost|mesh-list
25580579|NCT00848536|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25580580|NCT00848536|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25580581|NCT00848536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25580582|NCT00848549|Carbamazepine|carbamazepine|mesh-list
25580583|NCT00848549|Zonisamide|zonisamide|mesh-list
25580584|NCT00848549|Anticonvulsants|anticonvulsants|mesh-ancestor
25580585|NCT00848549|Antimanic Agents|antimanic agents|mesh-ancestor
25580586|NCT00848549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25580587|NCT00848549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25580588|NCT00848549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580589|NCT00848549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25580590|NCT00848549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25580591|NCT00848549|Analgesics|analgesics|mesh-ancestor
25580592|NCT00848549|Sensory System Agents|sensory system agents|mesh-ancestor
25580593|NCT00848549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25580594|NCT00848549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25580595|NCT00848549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25580596|NCT00848549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580597|NCT00848549|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25580598|NCT00848549|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25580599|NCT00848549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25580600|NCT00848549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25580601|NCT00848718|Paclitaxel|paclitaxel|mesh-list
25580602|NCT00848718|Docetaxel|docetaxel|mesh-list
25580603|NCT00848718|Carboplatin|carboplatin|mesh-list
25580604|NCT00848718|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25580605|NCT00848718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25580606|NCT00848718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25580607|NCT00848718|Tubulin Modulators|tubulin modulators|mesh-ancestor
25580608|NCT00848718|Antimitotic Agents|antimitotic agents|mesh-ancestor
25580609|NCT00848718|Mitosis Modulators|mitosis modulators|mesh-ancestor
25580610|NCT00848718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580611|NCT00848718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25580612|NCT00848718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580613|NCT00848783|Cisplatin|cisplatin|mesh-list
25580614|NCT00848783|Capecitabine|capecitabine|mesh-list
25580615|NCT00848783|Irinotecan|irinotecan|mesh-list
25580616|NCT00848783|Floxuridine|floxuridine|mesh-list
25580617|NCT00848783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25580618|NCT00848783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25580619|NCT00848783|Antimetabolites|antimetabolites|mesh-ancestor
25580620|NCT00848783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580621|NCT00848783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25580622|NCT00848783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25580623|NCT00848783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580624|NCT00848926|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25580625|NCT00848926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25580626|NCT00848926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25580627|NCT00848965|Fluticasone|fluticasone|mesh-list
25580628|NCT00848965|Xhance|xhance|mesh-list
25580629|NCT00848965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25580630|NCT00848965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25580631|NCT00848965|Autonomic Agents|autonomic agents|mesh-ancestor
25580632|NCT00848965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25580633|NCT00848965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580634|NCT00848965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25580635|NCT00848965|Respiratory System Agents|respiratory system agents|mesh-ancestor
25580636|NCT00848965|Dermatologic Agents|dermatologic agents|mesh-ancestor
25580637|NCT00848965|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25580638|NCT00849017|rGLP-1 protein|rglp-1 protein|mesh-list
25580639|NCT00849017|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25580640|NCT00849017|Incretins|incretins|mesh-ancestor
25580641|NCT00849017|Hormones|hormones|mesh-ancestor
25580642|NCT00849017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25580643|NCT00849017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580644|NCT00849056|rGLP-1 protein|rglp-1 protein|mesh-list
25580645|NCT00849056|Incretins|incretins|mesh-ancestor
25580646|NCT00849056|Hormones|hormones|mesh-ancestor
25580647|NCT00849056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25580648|NCT00849056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580649|NCT00849121|Vaccines|vaccines|mesh-list
25580650|NCT00849121|Immunologic Factors|immunologic factors|mesh-ancestor
25580651|NCT00849121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580652|NCT00849186|Sunitinib|sunitinib|mesh-list
25580653|NCT00849186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25580654|NCT00849186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25580655|NCT00849186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25580656|NCT00849186|Growth Substances|growth substances|mesh-ancestor
25580657|NCT00849186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580658|NCT00849186|Growth Inhibitors|growth inhibitors|mesh-ancestor
25580659|NCT00849186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25580660|NCT00849186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580661|NCT00849186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580662|NCT00849251|Dexamethasone|dexamethasone|mesh-list
25580663|NCT00849251|Cyclophosphamide|cyclophosphamide|mesh-list
25475243|NCT00068380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580664|NCT00849251|Doxorubicin|doxorubicin|mesh-list
25580665|NCT00849251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25580666|NCT00849251|Bortezomib|bortezomib|mesh-list
25580667|NCT00849251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25580668|NCT00849251|Immunologic Factors|immunologic factors|mesh-ancestor
25580669|NCT00849251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580670|NCT00849251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25580671|NCT00849251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25580672|NCT00849251|Alkylating Agents|alkylating agents|mesh-ancestor
25580673|NCT00849251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580674|NCT00849251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25580675|NCT00849251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25580676|NCT00849251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25580678|NCT00849251|Autonomic Agents|autonomic agents|mesh-ancestor
25580679|NCT00849251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25580680|NCT00849251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25580681|NCT00849251|Glucocorticoids|glucocorticoids|mesh-ancestor
25580682|NCT00849251|Hormones|hormones|mesh-ancestor
25580683|NCT00849251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25580684|NCT00849251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25580685|NCT00849251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25580686|NCT00849251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25580687|NCT00849251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25580688|NCT00849251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580689|NCT00849472|Paclitaxel|paclitaxel|mesh-list
25580690|NCT00849472|Cyclophosphamide|cyclophosphamide|mesh-list
25580691|NCT00849472|Doxorubicin|doxorubicin|mesh-list
25580692|NCT00849472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25580693|NCT00849472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25580694|NCT00849472|Tubulin Modulators|tubulin modulators|mesh-ancestor
25580695|NCT00849472|Antimitotic Agents|antimitotic agents|mesh-ancestor
25580696|NCT00849472|Mitosis Modulators|mitosis modulators|mesh-ancestor
25580697|NCT00849472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580698|NCT00849472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25580699|NCT00849472|Immunologic Factors|immunologic factors|mesh-ancestor
25580700|NCT00849472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580701|NCT00849472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25580702|NCT00849472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25580703|NCT00849472|Alkylating Agents|alkylating agents|mesh-ancestor
25580704|NCT00849472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25580705|NCT00849472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25580706|NCT00849472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25580707|NCT00849472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25580708|NCT00849472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580709|NCT00849680|Vaccines|vaccines|mesh-list
25580710|NCT00849680|Immunologic Factors|immunologic factors|mesh-ancestor
25580711|NCT00849680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580712|NCT00849693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25580713|NCT00849693|Fluoxetine|fluoxetine|mesh-list
25580714|NCT00849693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25580715|NCT00849693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25580716|NCT00849693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25580717|NCT00849693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580718|NCT00849693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25580719|NCT00849693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580720|NCT00849693|Analgesics|analgesics|mesh-ancestor
25580721|NCT00849693|Sensory System Agents|sensory system agents|mesh-ancestor
25580722|NCT00849693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25580723|NCT00849693|Antidepressive Agents|antidepressive agents|mesh-ancestor
25580724|NCT00849693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25580725|NCT00849693|Dopamine Agents|dopamine agents|mesh-ancestor
25580726|NCT00849693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25580727|NCT00849693|Serotonin Agents|serotonin agents|mesh-ancestor
25580728|NCT00849693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25580729|NCT00849693|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25580730|NCT00849693|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25580731|NCT00849693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580732|NCT00849810|Metoprolol|metoprolol|mesh-list
25580733|NCT00849810|Nebivolol|nebivolol|mesh-list
25580734|NCT00849810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25580735|NCT00849810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25580736|NCT00849810|Sympatholytics|sympatholytics|mesh-ancestor
25580737|NCT00849810|Autonomic Agents|autonomic agents|mesh-ancestor
25580738|NCT00849810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25580739|NCT00849810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580740|NCT00849810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25580741|NCT00849810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25475386|NCT00069095|Micronutrients|micronutrients|mesh-ancestor
25475387|NCT00069108|Leucovorin|leucovorin|mesh-list
25475388|NCT00069108|Capecitabine|capecitabine|mesh-list
25475389|NCT00069108|Oxaliplatin|oxaliplatin|mesh-list
25475390|NCT00069108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25475391|NCT00069108|Antimetabolites|antimetabolites|mesh-ancestor
25475392|NCT00069108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475393|NCT00069108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475394|NCT00069108|Antidotes|antidotes|mesh-ancestor
25475395|NCT00069108|Protective Agents|protective agents|mesh-ancestor
25475396|NCT00069108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475397|NCT00069108|Vitamin B Complex|vitamin b complex|mesh-ancestor
25475398|NCT00069108|Vitamins|vitamins|mesh-ancestor
25475399|NCT00069108|Micronutrients|micronutrients|mesh-ancestor
25475400|NCT00069121|Leucovorin|leucovorin|mesh-list
25475401|NCT00069121|Fluorouracil|fluorouracil|mesh-list
25475402|NCT00069121|Capecitabine|capecitabine|mesh-list
25475403|NCT00069121|Oxaliplatin|oxaliplatin|mesh-list
25475404|NCT00069121|Antimetabolites|antimetabolites|mesh-ancestor
25475405|NCT00069121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475406|NCT00069121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25475407|NCT00069121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475408|NCT00069121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25475409|NCT00069121|Immunologic Factors|immunologic factors|mesh-ancestor
25475410|NCT00069121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475411|NCT00069121|Antidotes|antidotes|mesh-ancestor
25475412|NCT00069121|Protective Agents|protective agents|mesh-ancestor
25475413|NCT00069121|Vitamin B Complex|vitamin b complex|mesh-ancestor
25475414|NCT00069121|Vitamins|vitamins|mesh-ancestor
25475415|NCT00069121|Micronutrients|micronutrients|mesh-ancestor
25475416|NCT00069160|Docetaxel|docetaxel|mesh-list
25475417|NCT00069160|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
25475418|NCT00069160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475419|NCT00069160|Tubulin Modulators|tubulin modulators|mesh-ancestor
25475420|NCT00069160|Antimitotic Agents|antimitotic agents|mesh-ancestor
25475421|NCT00069160|Mitosis Modulators|mitosis modulators|mesh-ancestor
25475422|NCT00069160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475423|NCT00069160|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25580742|NCT00849810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25580743|NCT00849810|Adrenergic Agents|adrenergic agents|mesh-ancestor
25580744|NCT00849810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25580745|NCT00849810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580746|NCT00849810|Vasodilator Agents|vasodilator agents|mesh-ancestor
25580747|NCT00849810|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25580748|NCT00849810|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25580749|NCT00849810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25580750|NCT00849875|Dacarbazine|dacarbazine|mesh-list
25580751|NCT00849875|Imidazole|imidazole|mesh-list
25580752|NCT00849875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25580753|NCT00849875|Alkylating Agents|alkylating agents|mesh-ancestor
25580754|NCT00849875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580755|NCT00849875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25580756|NCT00849875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580757|NCT00849901|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25580758|NCT00849901|Fluoxetine|fluoxetine|mesh-list
25580759|NCT00849901|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25580760|NCT00849901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25580761|NCT00849901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25580762|NCT00849901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580763|NCT00849901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25580764|NCT00849901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580765|NCT00849901|Analgesics|analgesics|mesh-ancestor
25580766|NCT00849901|Sensory System Agents|sensory system agents|mesh-ancestor
24801353|NCT01982929|Autonomic Agents|autonomic agents|mesh-ancestor
25580767|NCT00849901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25580768|NCT00849901|Antidepressive Agents|antidepressive agents|mesh-ancestor
25580769|NCT00849901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25580770|NCT00849901|Dopamine Agents|dopamine agents|mesh-ancestor
25580771|NCT00849901|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25580772|NCT00849901|Serotonin Agents|serotonin agents|mesh-ancestor
25580773|NCT00849901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25580774|NCT00849901|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25580775|NCT00849901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25580776|NCT00849901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580777|NCT00850096|Insulin|insulin|mesh-list
25580778|NCT00850096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25580779|NCT00850096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580780|NCT00850343|Certolizumab Pegol|certolizumab pegol|mesh-list
25580781|NCT00850343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25580782|NCT00850343|Immunologic Factors|immunologic factors|mesh-ancestor
25580783|NCT00850343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580784|NCT00850343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25580785|NCT00850395|Maraviroc|maraviroc|mesh-list
25580786|NCT00850395|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25580787|NCT00850395|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25580788|NCT00850395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580789|NCT00850395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25580790|NCT00850395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25580791|NCT00850395|Antiviral Agents|antiviral agents|mesh-ancestor
25580792|NCT00850395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25580793|NCT00850395|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25580794|NCT00850460|Atorvastatin|atorvastatin|mesh-list
25580795|NCT00850460|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25580796|NCT00850460|Simvastatin|simvastatin|mesh-list
25580797|NCT00850460|Pravastatin|pravastatin|mesh-list
25580798|NCT00850460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25580799|NCT00850460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25580800|NCT00850460|Antimetabolites|antimetabolites|mesh-ancestor
24974503|NCT04552197|Tofacitinib|tofacitinib|mesh-list
24503978|NCT00533611|Niacin|niacin|mesh-list
25580801|NCT00850460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580802|NCT00850460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25580803|NCT00850460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25580804|NCT00850460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580805|NCT00850499|Rituximab|rituximab|mesh-list
25580806|NCT00850499|Fludarabine|fludarabine|mesh-list
25580807|NCT00850499|Bortezomib|bortezomib|mesh-list
25580808|NCT00850499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25580809|NCT00850499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25580810|NCT00850499|Immunologic Factors|immunologic factors|mesh-ancestor
25580811|NCT00850499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580812|NCT00850499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25580813|NCT00850564|Hormones|hormones|mesh-list
25580814|NCT00850564|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
25580815|NCT00850564|Tesamorelin|tesamorelin|mesh-list
25580816|NCT00850564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25580817|NCT00850564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580818|NCT00850564|Growth Substances|growth substances|mesh-ancestor
25580819|NCT00850889|Lidocaine|lidocaine|mesh-list
25580820|NCT00850889|Hyaluronic Acid|hyaluronic acid|mesh-list
25580821|NCT00850889|Anesthetics, Local|anesthetics, local|mesh-ancestor
25580822|NCT00850889|Anesthetics|anesthetics|mesh-ancestor
25580823|NCT00850889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25580824|NCT00850889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580825|NCT00850889|Sensory System Agents|sensory system agents|mesh-ancestor
25580826|NCT00850889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25580827|NCT00850889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25580828|NCT00850889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25580829|NCT00850889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25580830|NCT00850889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25580831|NCT00850889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580832|NCT00850889|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25580833|NCT00850889|Immunologic Factors|immunologic factors|mesh-ancestor
25580834|NCT00850889|Viscosupplements|viscosupplements|mesh-ancestor
25580835|NCT00850889|Protective Agents|protective agents|mesh-ancestor
25580836|NCT00850993|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
25580837|NCT00850993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580838|NCT00850993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580839|NCT00851084|Leucovorin|leucovorin|mesh-list
25580840|NCT00851084|Folic Acid|folic acid|mesh-list
25580841|NCT00851084|Oxaliplatin|oxaliplatin|mesh-list
25580842|NCT00851084|Aflibercept|aflibercept|mesh-list
25580843|NCT00851084|Levoleucovorin|levoleucovorin|mesh-list
25580844|NCT00851084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25580845|NCT00851084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25580846|NCT00851084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25580847|NCT00851084|Growth Substances|growth substances|mesh-ancestor
25580848|NCT00851084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580849|NCT00851084|Growth Inhibitors|growth inhibitors|mesh-ancestor
25475426|NCT00069784|Insulin|insulin|mesh-list
25580850|NCT00851084|Antidotes|antidotes|mesh-ancestor
25580851|NCT00851084|Protective Agents|protective agents|mesh-ancestor
25580852|NCT00851084|Vitamin B Complex|vitamin b complex|mesh-ancestor
25580853|NCT00851084|Vitamins|vitamins|mesh-ancestor
25580854|NCT00851084|Micronutrients|micronutrients|mesh-ancestor
25580855|NCT00851084|Hematinics|hematinics|mesh-ancestor
25580856|NCT00851318|Methotrexate|methotrexate|mesh-list
25580857|NCT00851318|Certolizumab Pegol|certolizumab pegol|mesh-list
25580858|NCT00851318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25580859|NCT00851318|Abortifacient Agents|abortifacient agents|mesh-ancestor
25580860|NCT00851318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25580861|NCT00851318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672757|NCT01333514|Insulin Aspart|insulin aspart|mesh-list
24742235|NCT05296005|Vitamins|vitamins|mesh-ancestor
25580862|NCT00851318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25580863|NCT00851318|Antimetabolites|antimetabolites|mesh-ancestor
25580864|NCT00851318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580865|NCT00851318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25580866|NCT00851318|Dermatologic Agents|dermatologic agents|mesh-ancestor
25580867|NCT00851318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580868|NCT00851318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25580869|NCT00851318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25580870|NCT00851318|Immunologic Factors|immunologic factors|mesh-ancestor
25580871|NCT00851318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24673805|NCT01340456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24673806|NCT01340456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673807|NCT01340456|Leprostatic Agents|leprostatic agents|mesh-ancestor
24673837|NCT01340599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673838|NCT01340599|Protective Agents|protective agents|mesh-ancestor
24794819|NCT04435795|Hormones|hormones|mesh-ancestor
24550200|NCT00719602|Antimetabolites|antimetabolites|mesh-ancestor
25580872|NCT00851318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25580873|NCT00851357|Nicotine|nicotine|mesh-list
25580874|NCT00851357|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25580875|NCT00851357|Autonomic Agents|autonomic agents|mesh-ancestor
25580876|NCT00851357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25580877|NCT00851357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580878|NCT00851357|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25580879|NCT00851357|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25580880|NCT00851357|Cholinergic Agents|cholinergic agents|mesh-ancestor
25580881|NCT00851357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25580882|NCT00851357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580883|NCT00851409|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
24674466|NCT05198128|Calcium|calcium|mesh-list
24674477|NCT05164549|Buprenorphine|buprenorphine|mesh-list
24674479|NCT05164549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24674480|NCT05164549|Narcotics|narcotics|mesh-ancestor
24674481|NCT05164549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24801414|NCT01983462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24801415|NCT01983462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24474695|NCT00407017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24801430|NCT01983514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801431|NCT01983527|Methylprednisolone|methylprednisolone|mesh-list
24595643|NCT00939926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801432|NCT01983527|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24801433|NCT01983527|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24801434|NCT01983527|Prednisolone|prednisolone|mesh-list
24794838|NCT04350593|Dapagliflozin|dapagliflozin|mesh-list
25083331|NCT03316599|Antimetabolites|antimetabolites|mesh-ancestor
25702677|NCT02158520|Immunologic Factors|immunologic factors|mesh-ancestor
25702678|NCT02158520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25702679|NCT02158533|Naltrexone|naltrexone|mesh-list
25702680|NCT02158533|Buprenorphine|buprenorphine|mesh-list
25702681|NCT02158533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25702682|NCT02158533|Narcotics|narcotics|mesh-ancestor
25702683|NCT02158533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25702684|NCT02158533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702685|NCT02158533|Analgesics|analgesics|mesh-ancestor
25702686|NCT02158533|Sensory System Agents|sensory system agents|mesh-ancestor
25580884|NCT00851409|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25580885|NCT00851409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25580886|NCT00851409|Immunologic Factors|immunologic factors|mesh-ancestor
25580887|NCT00851409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580888|NCT00851630|Lamivudine|lamivudine|mesh-list
25580889|NCT00851630|Zidovudine|zidovudine|mesh-list
25580890|NCT00851630|Abacavir|abacavir|mesh-list
25580891|NCT00851630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25580892|NCT00851630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24674918|NCT03875690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24801455|NCT01983657|Molgramostim|molgramostim|mesh-list
24801456|NCT01983657|Sargramostim|sargramostim|mesh-list
24801457|NCT01983657|Immunologic Factors|immunologic factors|mesh-ancestor
24718333|NCT01553981|Tadalafil|tadalafil|mesh-list
24494521|NCT00495547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478738|NCT00424203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24801458|NCT01983657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801459|NCT01983657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24801461|NCT01983722|Anticonvulsants|anticonvulsants|mesh-ancestor
24801462|NCT01983735|Niacin|niacin|mesh-list
24494446|NCT00495287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919472|NCT04211805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24919474|NCT04211805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24919476|NCT04211805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702687|NCT02158533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25702688|NCT02158533|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25702689|NCT02158533|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25702690|NCT02158572|Contraceptive Agents|contraceptive agents|mesh-list
25702691|NCT02158572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25702692|NCT02158572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702693|NCT02158806|Aspirin|aspirin|mesh-list
25702694|NCT02158806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25580893|NCT00851630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580894|NCT00851630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580895|NCT00851630|Antiviral Agents|antiviral agents|mesh-ancestor
25580896|NCT00851630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25580897|NCT00851630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25580898|NCT00851630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25580899|NCT00851630|Antimetabolites|antimetabolites|mesh-ancestor
25580900|NCT00851721|Factor VIII|factor viii|mesh-list
25580901|NCT00851721|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
25580902|NCT00851721|Coagulants|coagulants|mesh-ancestor
25580903|NCT00851799|Ritonavir|ritonavir|mesh-list
25580904|NCT00851799|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25580905|NCT00851799|Darunavir|darunavir|mesh-list
25580906|NCT00851799|Tenofovir|tenofovir|mesh-list
25580907|NCT00851799|Emtricitabine|emtricitabine|mesh-list
25580908|NCT00851799|Raltegravir Potassium|raltegravir potassium|mesh-list
25580909|NCT00851799|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25580910|NCT00851799|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24478765|NCT00424281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24919477|NCT04211805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24919478|NCT04211805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24919479|NCT04211558|Ozanimod|ozanimod|mesh-list
24919482|NCT04211558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24494520|NCT00495547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919520|NCT04211012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556096|NCT00745004|Antiemetics|antiemetics|mesh-ancestor
24556097|NCT00745004|Autonomic Agents|autonomic agents|mesh-ancestor
24919634|NCT04209426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919636|NCT04209426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24919637|NCT04209426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919638|NCT04209426|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24919639|NCT04209426|Autonomic Agents|autonomic agents|mesh-ancestor
24395923|NCT00137202|Anesthetics|anesthetics|mesh-ancestor
24801494|NCT01983761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24801495|NCT01983761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24801496|NCT01983761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25580911|NCT00851799|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25580912|NCT00851799|Protease Inhibitors|protease inhibitors|mesh-ancestor
25580913|NCT00851799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580914|NCT00851799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580915|NCT00851799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25580916|NCT00851799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25580917|NCT00851799|Antiviral Agents|antiviral agents|mesh-ancestor
25580918|NCT00851799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24801497|NCT01983761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24801498|NCT01983761|Antitubercular Agents|antitubercular agents|mesh-ancestor
24479087|NCT00425516|Docetaxel|docetaxel|mesh-list
24718841|NCT01557374|Abatacept|abatacept|mesh-list
24801525|NCT01983943|Protective Agents|protective agents|mesh-ancestor
24801526|NCT01983943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718925|NCT01557985|Anesthetics|anesthetics|mesh-ancestor
24479167|NCT00425841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24479168|NCT00425841|Antimetabolites|antimetabolites|mesh-ancestor
25580919|NCT00851799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25580920|NCT00851799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25580921|NCT00851799|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25580922|NCT00851799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25580923|NCT00851799|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25580924|NCT00851799|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25580925|NCT00851877|Paclitaxel|paclitaxel|mesh-list
25580926|NCT00851877|Cisplatin|cisplatin|mesh-list
25580927|NCT00851877|Cetuximab|cetuximab|mesh-list
25580928|NCT00851877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25580929|NCT00851877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25580930|NCT00851877|Tubulin Modulators|tubulin modulators|mesh-ancestor
25580931|NCT00851877|Antimitotic Agents|antimitotic agents|mesh-ancestor
24677544|NCT01356732|Anesthetics|anesthetics|mesh-ancestor
24854251|NCT02272738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24479170|NCT00425841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479181|NCT00425906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479182|NCT00425906|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24479183|NCT00425906|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24479184|NCT00425906|Cholinergic Agents|cholinergic agents|mesh-ancestor
24479185|NCT00425906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24479187|NCT00425932|Rituximab|rituximab|mesh-list
24479238|NCT00426023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24479239|NCT00426049|Everolimus|everolimus|mesh-list
24479240|NCT00426049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479241|NCT00426049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24801586|NCT01984099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24719375|NCT01561014|Antimetabolites|antimetabolites|mesh-ancestor
25702695|NCT02158806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25702696|NCT02158806|Analgesics|analgesics|mesh-ancestor
25702697|NCT02158806|Sensory System Agents|sensory system agents|mesh-ancestor
25580932|NCT00851877|Mitosis Modulators|mitosis modulators|mesh-ancestor
25580933|NCT00851877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580934|NCT00851877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25580935|NCT00851890|Interferons|interferons|mesh-list
25580936|NCT00851890|Ribavirin|ribavirin|mesh-list
25580937|NCT00851890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25580938|NCT00851890|Antiviral Agents|antiviral agents|mesh-ancestor
25580939|NCT00851890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25580940|NCT00851890|Antimetabolites|antimetabolites|mesh-ancestor
25580941|NCT00851890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580942|NCT00851903|Metformin|metformin|mesh-list
25580943|NCT00851903|Insulin Glargine|insulin glargine|mesh-list
25580944|NCT00851903|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25580945|NCT00851903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25580946|NCT00851903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580947|NCT00851903|Incretins|incretins|mesh-ancestor
25580948|NCT00851903|Hormones|hormones|mesh-ancestor
25580949|NCT00851903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25580950|NCT00851903|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25580951|NCT00851903|Protease Inhibitors|protease inhibitors|mesh-ancestor
25580952|NCT00851903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580953|NCT00851903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580954|NCT00852202|Cariprazine|cariprazine|mesh-list
25580955|NCT00852202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25580956|NCT00852202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25580957|NCT00852202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25580958|NCT00852202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580959|NCT00852202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25580960|NCT00852397|Apixaban|apixaban|mesh-list
25580961|NCT00852397|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24801608|NCT01984372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24801609|NCT01984372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801610|NCT01984463|Fentanyl|fentanyl|mesh-list
24801611|NCT01984463|Morphine|morphine|mesh-list
24801612|NCT01984463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24801613|NCT01984463|Narcotics|narcotics|mesh-ancestor
24801614|NCT01984463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24801615|NCT01984463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801616|NCT01984463|Analgesics|analgesics|mesh-ancestor
25083460|NCT03315520|Cytarabine|cytarabine|mesh-list
24919777|NCT04208581|Glucocorticoids|glucocorticoids|mesh-ancestor
24919778|NCT04208581|Hormones|hormones|mesh-ancestor
24919779|NCT04208581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24919813|NCT04208516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580962|NCT00852397|Antithrombins|antithrombins|mesh-ancestor
25580963|NCT00852397|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25580964|NCT00852397|Protease Inhibitors|protease inhibitors|mesh-ancestor
25580965|NCT00852397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580966|NCT00852397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580967|NCT00852397|Anticoagulants|anticoagulants|mesh-ancestor
25580968|NCT00852540|Linezolid|linezolid|mesh-list
25580969|NCT00852540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25580970|NCT00852540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25580971|NCT00852540|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25580972|NCT00852540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25580973|NCT00852540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580974|NCT00852631|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25580975|NCT00852631|Antidepressive Agents|antidepressive agents|mesh-ancestor
25580976|NCT00852631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25580977|NCT00852631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25580978|NCT00852631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25580979|NCT00852631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25580980|NCT00852631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580981|NCT00852644|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25580982|NCT00852644|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25580983|NCT00852644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25580984|NCT00852761|Clobetasol|clobetasol|mesh-list
25580985|NCT00852761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25580986|NCT00852761|Glucocorticoids|glucocorticoids|mesh-ancestor
25580987|NCT00852761|Hormones|hormones|mesh-ancestor
25580988|NCT00852761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25580989|NCT00852761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580990|NCT00852917|Tramadol|tramadol|mesh-list
25580991|NCT00852917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25580992|NCT00852917|Narcotics|narcotics|mesh-ancestor
25580993|NCT00852917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25580994|NCT00852917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25580995|NCT00852917|Analgesics|analgesics|mesh-ancestor
25580996|NCT00852917|Sensory System Agents|sensory system agents|mesh-ancestor
25580997|NCT00852917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25580998|NCT00852969|Niacin|niacin|mesh-list
25580999|NCT00852969|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25581000|NCT00852969|Antimetabolites|antimetabolites|mesh-ancestor
25581001|NCT00852969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581002|NCT00852969|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25581003|NCT00852969|Vasodilator Agents|vasodilator agents|mesh-ancestor
25581004|NCT00852969|Vitamin B Complex|vitamin b complex|mesh-ancestor
24521550|NCT04690322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521553|NCT04661930|Antimetabolites|antimetabolites|mesh-ancestor
24521554|NCT04661930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521555|NCT04661930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24521556|NCT04657003|Tirzepatide|tirzepatide|mesh-list
24521557|NCT04657003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24623834|NCT01073761|Ritonavir|ritonavir|mesh-list
24623835|NCT01073761|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24623836|NCT01073761|Darunavir|darunavir|mesh-list
24919909|NCT04207723|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24919910|NCT04207723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24919911|NCT04207723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24919912|NCT04207723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919913|NCT04207723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24495023|NCT00498108|Rotigotine|rotigotine|mesh-list
25581005|NCT00852969|Vitamins|vitamins|mesh-ancestor
25581006|NCT00852969|Micronutrients|micronutrients|mesh-ancestor
25581007|NCT00852969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581008|NCT00853021|Aldesleukin|aldesleukin|mesh-list
25581009|NCT00853021|Bevacizumab|bevacizumab|mesh-list
25581010|NCT00853021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25581011|NCT00853021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581012|NCT00853021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25581013|NCT00853021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25581014|NCT00853021|Growth Substances|growth substances|mesh-ancestor
25581015|NCT00853021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479579|NCT00427388|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24479580|NCT00427388|Prednisolone|prednisolone|mesh-list
24479581|NCT00427388|Prednisolone acetate|prednisolone acetate|mesh-list
24479582|NCT00427388|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24479583|NCT00427388|Prednisolone phosphate|prednisolone phosphate|mesh-list
24479588|NCT00427388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479608|NCT00427466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479609|NCT00427466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479610|NCT00427466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479611|NCT00427466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24719926|NCT01565018|Rotigotine|rotigotine|mesh-list
24919916|NCT04207723|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24919918|NCT04207723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24919919|NCT04207723|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24919920|NCT04207723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24919921|NCT04207723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24919922|NCT04207125|Psychotropic Drugs|psychotropic drugs|mesh-list
24919923|NCT04207112|Moxifloxacin|moxifloxacin|mesh-list
24919924|NCT04207112|Linezolid|linezolid|mesh-list
25702698|NCT02158806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24919925|NCT04207112|Bedaquiline|bedaquiline|mesh-list
24919926|NCT04207112|Clofazimine|clofazimine|mesh-list
24623854|NCT01073800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25702699|NCT02158806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702700|NCT02158806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25702701|NCT02158806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25702702|NCT02158806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25702703|NCT02158806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25702704|NCT02158806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581016|NCT00853021|Growth Inhibitors|growth inhibitors|mesh-ancestor
25581017|NCT00853021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25581018|NCT00853021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25581019|NCT00853021|Antiviral Agents|antiviral agents|mesh-ancestor
25581020|NCT00853021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25581021|NCT00853047|Octreotide|octreotide|mesh-list
25581022|NCT00853047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25581023|NCT00853047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25581024|NCT00853047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581025|NCT00853073|Bevacizumab|bevacizumab|mesh-list
25581026|NCT00853073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25581027|NCT00853073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581028|NCT00853073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25581029|NCT00853073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25581030|NCT00853073|Growth Substances|growth substances|mesh-ancestor
25581031|NCT00853073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581032|NCT00853073|Growth Inhibitors|growth inhibitors|mesh-ancestor
25581033|NCT00853099|Adalimumab|adalimumab|mesh-list
25581034|NCT00853099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25581035|NCT00853099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25581036|NCT00853112|Sildenafil Citrate|sildenafil citrate|mesh-list
25581037|NCT00853112|Vasodilator Agents|vasodilator agents|mesh-ancestor
25581038|NCT00853112|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25581039|NCT00853112|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25581040|NCT00853112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581041|NCT00853112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581042|NCT00853112|Urological Agents|urological agents|mesh-ancestor
25581043|NCT00853125|Sunitinib|sunitinib|mesh-list
25581044|NCT00853125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581045|NCT00853125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25581046|NCT00853125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25581047|NCT00853125|Growth Substances|growth substances|mesh-ancestor
24919927|NCT04207112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24521603|NCT04637594|Nivolumab|nivolumab|mesh-list
24521622|NCT04637529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521624|NCT04635605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24521625|NCT04635605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521628|NCT04629534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24919936|NCT04207112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24919937|NCT04207112|Leprostatic Agents|leprostatic agents|mesh-ancestor
24919939|NCT04207021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24521741|NCT04553536|Antidepressive Agents|antidepressive agents|mesh-ancestor
24493923|NCT00493116|Interferons|interferons|mesh-list
24495319|NCT00499525|Mitosis Modulators|mitosis modulators|mesh-ancestor
24801638|NCT01984606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25083654|NCT03314025|Tamsulosin|tamsulosin|mesh-list
24495320|NCT00499525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495321|NCT00499525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24495322|NCT00499525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495323|NCT00499577|Vaccines|vaccines|mesh-list
24720093|NCT01566422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25581048|NCT00853125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581049|NCT00853125|Growth Inhibitors|growth inhibitors|mesh-ancestor
25581050|NCT00853125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25581051|NCT00853125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581052|NCT00853125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581053|NCT00853242|Sevelamer|sevelamer|mesh-list
25581054|NCT00853242|Chelating Agents|chelating agents|mesh-ancestor
25581055|NCT00853242|Sequestering Agents|sequestering agents|mesh-ancestor
25581056|NCT00853242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581057|NCT00853333|Midazolam|midazolam|mesh-list
25581058|NCT00853333|Dexmedetomidine|dexmedetomidine|mesh-list
25581059|NCT00853333|Propofol|propofol|mesh-list
25581060|NCT00853333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25581061|NCT00853333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25581062|NCT00853333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581063|NCT00853333|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25581064|NCT00853333|Anesthetics, General|anesthetics, general|mesh-ancestor
25581065|NCT00853333|Anesthetics|anesthetics|mesh-ancestor
25581066|NCT00853333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25581067|NCT00853333|Analgesics|analgesics|mesh-ancestor
25581068|NCT00853333|Sensory System Agents|sensory system agents|mesh-ancestor
25581069|NCT00853333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25581070|NCT00853333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25581071|NCT00853333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25581072|NCT00853333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25581073|NCT00853333|Adrenergic Agents|adrenergic agents|mesh-ancestor
25581074|NCT00853333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25581075|NCT00853333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581076|NCT00853333|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25581077|NCT00853333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25581078|NCT00853333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24720203|NCT01566942|Irinotecan|irinotecan|mesh-list
24495324|NCT00499577|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24622338|NCT01066676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24479904|NCT00428818|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24479919|NCT00428896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479920|NCT00428896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24479921|NCT00428896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622339|NCT01066676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24622340|NCT01066676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859005|NCT02301000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24447918|NCT00309881|Alkylating Agents|alkylating agents|mesh-ancestor
24447938|NCT00309894|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24447940|NCT00309894|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24397115|NCT00140803|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24447941|NCT00309894|Sargramostim|sargramostim|mesh-list
24447942|NCT00309894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24447943|NCT00309894|Immunologic Factors|immunologic factors|mesh-ancestor
24720330|NCT01567670|Naloxone|naloxone|mesh-list
24479922|NCT00428896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479923|NCT00428909|Acetaminophen|acetaminophen|mesh-list
25581079|NCT00853333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25581080|NCT00853333|GABA Modulators|gaba modulators|mesh-ancestor
25581081|NCT00853333|GABA Agents|gaba agents|mesh-ancestor
25581082|NCT00853372|Sunitinib|sunitinib|mesh-list
25581083|NCT00853372|Trebananib|trebananib|mesh-list
25581084|NCT00853372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
25581085|NCT00853372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581086|NCT00853372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25581087|NCT00853372|Growth Substances|growth substances|mesh-ancestor
25581088|NCT00853372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581089|NCT00853372|Growth Inhibitors|growth inhibitors|mesh-ancestor
25581090|NCT00853372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25581091|NCT00853372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581092|NCT00853372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652958|NCT01533597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25652959|NCT01533597|Cholinergic Agents|cholinergic agents|mesh-ancestor
25652960|NCT01533688|Bisacodyl|bisacodyl|mesh-list
25652961|NCT01533688|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25652962|NCT01533688|Cathartics|cathartics|mesh-ancestor
25652963|NCT01533688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25652964|NCT01533688|Laxatives|laxatives|mesh-ancestor
25652965|NCT01533922|Tiotropium Bromide|tiotropium bromide|mesh-list
25652966|NCT01533922|Olodaterol|olodaterol|mesh-list
25652967|NCT01533922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25652968|NCT01533922|Autonomic Agents|autonomic agents|mesh-ancestor
25652969|NCT01533922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25652970|NCT01533922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652971|NCT01533922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25652972|NCT01533922|Respiratory System Agents|respiratory system agents|mesh-ancestor
25652973|NCT01533922|Parasympatholytics|parasympatholytics|mesh-ancestor
25652974|NCT01533922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25652975|NCT01533922|Cholinergic Agents|cholinergic agents|mesh-ancestor
25652976|NCT01533922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25652977|NCT01533922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652978|NCT01533935|Tiotropium Bromide|tiotropium bromide|mesh-list
25652979|NCT01533935|Olodaterol|olodaterol|mesh-list
25652980|NCT01533935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24622347|NCT01066689|Immunologic Factors|immunologic factors|mesh-ancestor
24859006|NCT02301000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24479953|NCT00429208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479959|NCT00429234|Gemcitabine|gemcitabine|mesh-list
24479990|NCT00429468|Acetaminophen|acetaminophen|mesh-list
24479991|NCT00429468|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
24479992|NCT00429468|Hydrocodone|hydrocodone|mesh-list
24479993|NCT00429468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24479994|NCT00429468|Analgesics|analgesics|mesh-ancestor
24720657|NCT01569919|Antiemetics|antiemetics|mesh-ancestor
25652981|NCT01533935|Autonomic Agents|autonomic agents|mesh-ancestor
25652982|NCT01533935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25652983|NCT01533935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25652984|NCT01533935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25652985|NCT01533935|Respiratory System Agents|respiratory system agents|mesh-ancestor
25652986|NCT01533935|Parasympatholytics|parasympatholytics|mesh-ancestor
25652987|NCT01533935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25652988|NCT01533935|Cholinergic Agents|cholinergic agents|mesh-ancestor
25652989|NCT01533935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25652990|NCT01533935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652991|NCT01533948|Axitinib|axitinib|mesh-list
25652992|NCT01533948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25652993|NCT01533948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25652994|NCT01533948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25652995|NCT01533948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652996|NCT01534013|Insulin|insulin|mesh-list
25652997|NCT01534013|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25652998|NCT01534013|Pancrelipase|pancrelipase|mesh-list
24611368|NCT01009021|Diclofenac|diclofenac|mesh-list
24447967|NCT00309920|Alkylating Agents|alkylating agents|mesh-ancestor
24615486|NCT01030016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24622414|NCT01066884|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24622415|NCT01066884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622416|NCT01066884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24622417|NCT01066884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622418|NCT01066884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622419|NCT01066962|Ritonavir|ritonavir|mesh-list
24622420|NCT01066962|Darunavir|darunavir|mesh-list
24622421|NCT01066962|Tenofovir|tenofovir|mesh-list
24622422|NCT01066962|Emtricitabine|emtricitabine|mesh-list
24622423|NCT01066962|Raltegravir Potassium|raltegravir potassium|mesh-list
24801649|NCT01984827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24801650|NCT01984827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24801651|NCT01984827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24801652|NCT01984827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24801653|NCT01984827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25652999|NCT01534013|Pancreatin|pancreatin|mesh-list
25653000|NCT01534013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25653001|NCT01534013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653002|NCT01534013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25653003|NCT01534078|Doxorubicin|doxorubicin|mesh-list
25653004|NCT01534078|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25653005|NCT01534078|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25653006|NCT01534078|Dacarbazine|dacarbazine|mesh-list
25653007|NCT01534078|Vinblastine|vinblastine|mesh-list
25653008|NCT01534078|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24480276|NCT00430196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24480358|NCT00430794|Diuretics|diuretics|mesh-ancestor
24801669|NCT01984931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24801670|NCT01984931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24721246|NCT01572649|Lixisenatide|lixisenatide|mesh-list
24801677|NCT01984931|Emollients|emollients|mesh-ancestor
24801678|NCT01984931|Dermatologic Agents|dermatologic agents|mesh-ancestor
24801679|NCT01984931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24801680|NCT01984931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25084029|NCT03310372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480405|NCT00431028|Triamcinolone|triamcinolone|mesh-list
25084030|NCT03310372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25084031|NCT03310333|Dinoprostone|dinoprostone|mesh-list
25084032|NCT03310333|Oxytocics|oxytocics|mesh-ancestor
25084033|NCT03310333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25084034|NCT03310333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084035|NCT03310242|Vitamin D|vitamin d|mesh-list
25084036|NCT03310242|Vitamins|vitamins|mesh-ancestor
25653009|NCT01534078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25653010|NCT01534078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25653011|NCT01534078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25653012|NCT01534078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653013|NCT01534078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653014|NCT01534078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25653015|NCT01534078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25653016|NCT01534078|Alkylating Agents|alkylating agents|mesh-ancestor
25653017|NCT01534078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25475737|NCT00073073|Antacids|antacids|mesh-ancestor
25653018|NCT01534078|Tubulin Modulators|tubulin modulators|mesh-ancestor
25653019|NCT01534078|Antimitotic Agents|antimitotic agents|mesh-ancestor
25581093|NCT00853385|Adalimumab|adalimumab|mesh-list
25581094|NCT00853385|Tofacitinib|tofacitinib|mesh-list
25581095|NCT00853385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25581096|NCT00853385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25581097|NCT00853385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25581098|NCT00853385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581099|NCT00853385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581100|NCT00853580|Lovastatin|lovastatin|mesh-list
25702709|NCT02158936|Azacitidine|azacitidine|mesh-list
25702710|NCT02158936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24448030|NCT00310089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24448031|NCT00310089|Tubulin Modulators|tubulin modulators|mesh-ancestor
24721672|NCT01576315|Itraconazole|itraconazole|mesh-list
24721733|NCT01576692|Antibodies|antibodies|mesh-list
24721784|NCT01577017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615554|NCT01030328|Fenofibrate|fenofibrate|mesh-list
25702711|NCT02158936|Antimetabolites|antimetabolites|mesh-ancestor
25702712|NCT02158936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702713|NCT02158936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25702714|NCT02158936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812679|NCT02054052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24812680|NCT02054052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24812681|NCT02054052|Growth Substances|growth substances|mesh-ancestor
24812682|NCT02054052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812683|NCT02054052|Growth Inhibitors|growth inhibitors|mesh-ancestor
24812684|NCT02054078|Bevacizumab|bevacizumab|mesh-list
24812685|NCT02054078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24801703|NCT01985152|Choline|choline|mesh-list
25581101|NCT00853580|L 647318|l 647318|mesh-list
25581102|NCT00853580|Dihydromevinolin|dihydromevinolin|mesh-list
25581103|NCT00853580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25581104|NCT00853580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25581105|NCT00853580|Antimetabolites|antimetabolites|mesh-ancestor
25581106|NCT00853580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581107|NCT00853580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25581108|NCT00853580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25581109|NCT00853580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581110|NCT00853658|Enalapril|enalapril|mesh-list
25581111|NCT00853658|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25581112|NCT00853658|Protease Inhibitors|protease inhibitors|mesh-ancestor
25581113|NCT00853658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581114|NCT00853658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581115|NCT00853658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25581116|NCT00853671|Adenosine|adenosine|mesh-list
25581117|NCT00853671|Analgesics|analgesics|mesh-ancestor
25581118|NCT00853671|Sensory System Agents|sensory system agents|mesh-ancestor
24685819|NCT05173142|Mitosis Modulators|mitosis modulators|mesh-ancestor
24685820|NCT05168735|Ketamine|ketamine|mesh-list
24685821|NCT05168735|Analgesics|analgesics|mesh-ancestor
24685839|NCT05166746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24685907|NCT05142267|Oxycodone|oxycodone|mesh-list
24454535|NCT03901469|Talazoparib|talazoparib|mesh-list
24454536|NCT03901469|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24920322|NCT04203368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24920323|NCT04203368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920324|NCT04203368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24920325|NCT04203368|Vasodilator Agents|vasodilator agents|mesh-ancestor
24444723|NCT00299013|Prednisolone|prednisolone|mesh-list
24480995|NCT00433069|Antimetabolites|antimetabolites|mesh-ancestor
24522007|NCT04377932|Cyclophosphamide|cyclophosphamide|mesh-list
24522008|NCT04377932|Fludarabine|fludarabine|mesh-list
24522009|NCT04377932|Fludarabine phosphate|fludarabine phosphate|mesh-list
24522010|NCT04377932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24522011|NCT04377932|Immunologic Factors|immunologic factors|mesh-ancestor
24495653|NCT00501410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25581119|NCT00853671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25581120|NCT00853671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581121|NCT00853671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25581122|NCT00853671|Vasodilator Agents|vasodilator agents|mesh-ancestor
25581123|NCT00853671|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25581124|NCT00853671|Purinergic Agonists|purinergic agonists|mesh-ancestor
25581125|NCT00853671|Purinergic Agents|purinergic agents|mesh-ancestor
25581126|NCT00853671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25702730|NCT02159352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702731|NCT02159352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25702732|NCT02159352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25702733|NCT02159352|Antiviral Agents|antiviral agents|mesh-ancestor
25702734|NCT02159352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24611665|NCT01010243|Hormones|hormones|mesh-ancestor
24801709|NCT01985152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24801710|NCT01985152|Antimetabolites|antimetabolites|mesh-ancestor
24522120|NCT04275661|Anesthetics, Local|anesthetics, local|mesh-ancestor
24522121|NCT04256317|Azacitidine|azacitidine|mesh-list
24522122|NCT04256317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24522123|NCT04256317|Antimetabolites|antimetabolites|mesh-ancestor
24920552|NCT04201769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522124|NCT04256317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722142|NCT01578629|Antipyretics|antipyretics|mesh-ancestor
24454575|NCT03878524|Durvalumab|durvalumab|mesh-list
24454576|NCT03878524|Sunitinib|sunitinib|mesh-list
24454577|NCT03878524|Daunorubicin|daunorubicin|mesh-list
24454578|NCT03878524|Dasatinib|dasatinib|mesh-list
24454579|NCT03878524|Venetoclax|venetoclax|mesh-list
25702735|NCT02159352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25702736|NCT02159352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25702737|NCT02159365|Dexamethasone|dexamethasone|mesh-list
25702738|NCT02159365|Lenalidomide|lenalidomide|mesh-list
24454580|NCT03878524|Olaparib|olaparib|mesh-list
24454581|NCT03878524|Lenvatinib|lenvatinib|mesh-list
24454582|NCT03878524|Palbociclib|palbociclib|mesh-list
24454622|NCT03878524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24454623|NCT03878524|Antimetabolites|antimetabolites|mesh-ancestor
24801715|NCT01985256|Antifungal Agents|antifungal agents|mesh-ancestor
24855115|NCT02277587|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24855116|NCT02277587|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24855118|NCT02277587|Glucocorticoids|glucocorticoids|mesh-list
24686781|NCT04579848|Abortifacient Agents|abortifacient agents|mesh-ancestor
24686782|NCT04579848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24686783|NCT04579848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686784|NCT04579848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24722173|NCT01578889|Vaccines|vaccines|mesh-list
25581127|NCT00853671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581128|NCT00853723|Teriparatide|teriparatide|mesh-list
25581129|NCT00853723|Hormones|hormones|mesh-list
25581130|NCT00853723|Parathyroid Hormone|parathyroid hormone|mesh-list
25581131|NCT00853723|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
25581132|NCT00853723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25581133|NCT00853723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581134|NCT00853723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25581135|NCT00853723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25581136|NCT00853749|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25581137|NCT00853749|Immunologic Factors|immunologic factors|mesh-ancestor
25702748|NCT02159365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24687036|NCT04399746|Cholecalciferol|cholecalciferol|mesh-list
24687037|NCT04399746|Vitamin D|vitamin d|mesh-list
24687038|NCT04399746|Azithromycin|azithromycin|mesh-list
24687039|NCT04399746|Ivermectin|ivermectin|mesh-list
24687040|NCT04399746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24687042|NCT04399746|Vitamins|vitamins|mesh-ancestor
24687096|NCT04389177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24687097|NCT04389177|Tubulin Modulators|tubulin modulators|mesh-ancestor
24687098|NCT04389177|Antimitotic Agents|antimitotic agents|mesh-ancestor
24801731|NCT01985477|Dexamethasone|dexamethasone|mesh-list
24801732|NCT01985477|Lenalidomide|lenalidomide|mesh-list
24801733|NCT01985477|Tretinoin|tretinoin|mesh-list
24801734|NCT01985477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24801735|NCT01985477|Antiemetics|antiemetics|mesh-ancestor
24801736|NCT01985477|Autonomic Agents|autonomic agents|mesh-ancestor
24801737|NCT01985477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24801738|NCT01985477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801739|NCT01985477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24687476|NCT03967925|Immunologic Factors|immunologic factors|mesh-ancestor
24687477|NCT03967925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687478|NCT03967925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24687479|NCT03967925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24687480|NCT03967925|Glucocorticoids|glucocorticoids|mesh-ancestor
24855148|NCT02277717|Trastuzumab|trastuzumab|mesh-list
24855149|NCT02277717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24855150|NCT02277717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25039931|NCT03588884|Calcifediol|calcifediol|mesh-list
24920557|NCT04201769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920558|NCT04201561|Selenious Acid|selenious acid|mesh-list
24920559|NCT04201561|Sodium Selenite|sodium selenite|mesh-list
24522290|NCT04004078|Antifungal Agents|antifungal agents|mesh-list
25581138|NCT00853749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581139|NCT00853840|Maraviroc|maraviroc|mesh-list
25581140|NCT00853840|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
25581141|NCT00853840|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25581142|NCT00853840|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25581143|NCT00853840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581144|NCT00853840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25581145|NCT00853840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25581146|NCT00853840|Antiviral Agents|antiviral agents|mesh-ancestor
25581147|NCT00853840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25581148|NCT00853840|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25581149|NCT00853840|Vasodilator Agents|vasodilator agents|mesh-ancestor
25581150|NCT00853840|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25581151|NCT00853840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25581152|NCT00853840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24688333|NCT03110107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688334|NCT03110107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24688335|NCT03110107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688336|NCT03092011|Clonidine|clonidine|mesh-list
24688337|NCT03092011|Morphine|morphine|mesh-list
24688338|NCT03092011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24688355|NCT03091660|Vaccines|vaccines|mesh-list
24688357|NCT03091660|Immunologic Factors|immunologic factors|mesh-ancestor
24688358|NCT03091660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581153|NCT00853840|Urological Agents|urological agents|mesh-ancestor
25581154|NCT00853905|Triamcinolone|triamcinolone|mesh-list
25581155|NCT00853905|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25581156|NCT00853905|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25581157|NCT00853905|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25581158|NCT00853905|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25581159|NCT00853905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25581160|NCT00853905|Glucocorticoids|glucocorticoids|mesh-ancestor
25581161|NCT00853905|Hormones|hormones|mesh-ancestor
25581162|NCT00853905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25581163|NCT00853905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581164|NCT00853905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25581165|NCT00853905|Immunologic Factors|immunologic factors|mesh-ancestor
25702790|NCT02159807|Bupivacaine|bupivacaine|mesh-list
25702791|NCT02159807|Anesthetics, Local|anesthetics, local|mesh-ancestor
25702792|NCT02159807|Anesthetics|anesthetics|mesh-ancestor
24689100|NCT02299999|Capecitabine|capecitabine|mesh-list
24689101|NCT02299999|Methotrexate|methotrexate|mesh-list
25475801|NCT00073983|Docetaxel|docetaxel|mesh-list
25581166|NCT00853905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581167|NCT00853905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581168|NCT00853957|Amlodipine|amlodipine|mesh-list
25581169|NCT00853957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25581170|NCT00853957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25581171|NCT00853957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25581172|NCT00853957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690437|NCT01401933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690511|NCT01402193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24690512|NCT01402193|Hormone Antagonists|hormone antagonists|mesh-ancestor
24690514|NCT01402193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722966|NCT01583660|Narcotics|narcotics|mesh-ancestor
24920733|NCT04198467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24920734|NCT04198467|Immunologic Factors|immunologic factors|mesh-ancestor
24920735|NCT04198467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920736|NCT04198467|Viscosupplements|viscosupplements|mesh-ancestor
24920737|NCT04198467|Protective Agents|protective agents|mesh-ancestor
24920738|NCT04198129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24448130|NCT00310349|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24448131|NCT00310349|Immunologic Factors|immunologic factors|mesh-ancestor
24448132|NCT00310349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448133|NCT00310388|Ezogabine|ezogabine|mesh-list
24448134|NCT00310388|Anticonvulsants|anticonvulsants|mesh-ancestor
24448135|NCT00310388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24481976|NCT00437385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481977|NCT00437385|Antimanic Agents|antimanic agents|mesh-ancestor
24448136|NCT00310388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801794|NCT01985750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24801795|NCT01985750|Antimetabolites|antimetabolites|mesh-ancestor
24801796|NCT01985750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921255|NCT04193059|Immunologic Factors|immunologic factors|mesh-ancestor
25702797|NCT02159807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25702798|NCT02159807|Narcotics|narcotics|mesh-ancestor
25702799|NCT02159807|Analgesics|analgesics|mesh-ancestor
25702800|NCT02159807|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25581173|NCT00853957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25581174|NCT00853957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581175|NCT00853957|Vasodilator Agents|vasodilator agents|mesh-ancestor
25581176|NCT00853970|Bromfenac|bromfenac|mesh-list
25581177|NCT00853970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25581178|NCT00853970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25581179|NCT00853970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24693430|NCT01420471|Triamcinolone|triamcinolone|mesh-list
24482046|NCT00437762|Botulinum Toxins|botulinum toxins|mesh-list
24801800|NCT01985789|Desloratadine|desloratadine|mesh-list
24801803|NCT01985789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24790262|NCT01941888|Propofol|propofol|mesh-list
24920739|NCT04198129|Amoxicillin|amoxicillin|mesh-list
24920740|NCT04198129|Clindamycin|clindamycin|mesh-list
24920741|NCT04198129|Clindamycin palmitate|clindamycin palmitate|mesh-list
24723401|NCT01587313|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24482146|NCT00438048|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24454844|NCT03474029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24454845|NCT03474029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24454846|NCT03474029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24454847|NCT03474029|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24454848|NCT03474029|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24454849|NCT03474029|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24454850|NCT03474029|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24454851|NCT03474029|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24454852|NCT03474029|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25702801|NCT02159807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25581180|NCT00853970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25581181|NCT00853970|Analgesics|analgesics|mesh-ancestor
25581182|NCT00853970|Sensory System Agents|sensory system agents|mesh-ancestor
25581183|NCT00853970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25581184|NCT00853970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581185|NCT00853970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25581186|NCT00853970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25581187|NCT00854061|Prednisone|prednisone|mesh-list
25581188|NCT00854061|Prednisolone acetate|prednisolone acetate|mesh-list
25581189|NCT00854061|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25581190|NCT00854061|Methylprednisolone|methylprednisolone|mesh-list
24801807|NCT01985789|Sensory System Agents|sensory system agents|mesh-ancestor
24801808|NCT01985789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24801809|NCT01985789|Antiemetics|antiemetics|mesh-ancestor
24448147|NCT00310505|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24448148|NCT00310505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24723597|NCT01588522|Calcitriol|calcitriol|mesh-list
24801813|NCT01985789|Histamine Antagonists|histamine antagonists|mesh-ancestor
24801814|NCT01985789|Histamine Agents|histamine agents|mesh-ancestor
24801815|NCT01985789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24801816|NCT01985789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920759|NCT04198233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920760|NCT04198233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24920772|NCT04198233|GABA Agents|gaba agents|mesh-ancestor
24482304|NCT00438568|Insulin|insulin|mesh-list
24920773|NCT04198233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25702802|NCT02159807|Anesthetics, General|anesthetics, general|mesh-ancestor
25581191|NCT00854061|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25581192|NCT00854061|Prednisolone|prednisolone|mesh-list
25581193|NCT00854061|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25581194|NCT00854061|Prednisolone phosphate|prednisolone phosphate|mesh-list
25581195|NCT00854061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25581196|NCT00854061|Glucocorticoids|glucocorticoids|mesh-ancestor
25581197|NCT00854061|Hormones|hormones|mesh-ancestor
25581198|NCT00854061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25581199|NCT00854061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581200|NCT00854061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25581201|NCT00854061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581202|NCT00854061|Antiemetics|antiemetics|mesh-ancestor
25581203|NCT00854061|Autonomic Agents|autonomic agents|mesh-ancestor
25581204|NCT00854061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25581205|NCT00854061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24920774|NCT04198233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920775|NCT04197817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24920776|NCT04197817|Antibodies|antibodies|mesh-list
24920777|NCT04197817|Immunoglobulins|immunoglobulins|mesh-list
24920778|NCT04197817|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24920779|NCT04197817|Immunologic Factors|immunologic factors|mesh-ancestor
24920780|NCT04197817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920781|NCT04197817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24920782|NCT04197752|Anesthetics|anesthetics|mesh-list
24920783|NCT04197752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24920784|NCT04197752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522395|NCT03893175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24522396|NCT03893175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24522397|NCT03893175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494579|NCT00495872|Anticonvulsants|anticonvulsants|mesh-ancestor
25581206|NCT00854061|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25581207|NCT00854061|Protective Agents|protective agents|mesh-ancestor
25581208|NCT00854100|Cariprazine|cariprazine|mesh-list
25581209|NCT00854100|Antidepressive Agents|antidepressive agents|mesh-list
25581210|NCT00854100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25581211|NCT00854100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25581212|NCT00854100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25581213|NCT00854100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24621255|NCT01061216|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24621256|NCT01061216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24621257|NCT01061216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621258|NCT01061268|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24621259|NCT01061268|Lubricant Eye Drops|lubricant eye drops|mesh-list
24621260|NCT01061268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24621262|NCT01061320|Vitamin E|vitamin e|mesh-list
24621263|NCT01061320|Tocotrienols|tocotrienols|mesh-list
24920915|NCT04196608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24920916|NCT04196608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24920917|NCT04196608|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24920918|NCT04196608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24494753|NCT00496704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522566|NCT03651011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522567|NCT03651011|Growth Inhibitors|growth inhibitors|mesh-ancestor
24522568|NCT03651011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522569|NCT03641326|Sunitinib|sunitinib|mesh-list
24522570|NCT03641326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522571|NCT03641326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24522572|NCT03641326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24482710|NCT00440258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25581214|NCT00854100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581215|NCT00854113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25581216|NCT00854113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581217|NCT00854113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25581218|NCT00854113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581219|NCT00854308|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25581220|NCT00854308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581221|NCT00854308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25581222|NCT00854308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581223|NCT00854308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581224|NCT00854360|Beclomethasone|beclomethasone|mesh-list
25581225|NCT00854360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25581226|NCT00854360|Glucocorticoids|glucocorticoids|mesh-ancestor
25581227|NCT00854360|Hormones|hormones|mesh-ancestor
25581228|NCT00854360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25581229|NCT00854360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581230|NCT00854360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25581231|NCT00854360|Respiratory System Agents|respiratory system agents|mesh-ancestor
25581232|NCT00854373|Hormones|hormones|mesh-list
25581233|NCT00854373|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25581234|NCT00854373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25581235|NCT00854373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581236|NCT00854581|Interferons|interferons|mesh-list
25581237|NCT00854581|Interferon-alpha|interferon-alpha|mesh-list
25581238|NCT00854581|Interferon alpha-2|interferon alpha-2|mesh-list
25581239|NCT00854581|Zidovudine|zidovudine|mesh-list
25581240|NCT00854581|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25581241|NCT00854581|Valproic Acid|valproic acid|mesh-list
24448203|NCT00310765|Anticonvulsants|anticonvulsants|mesh-ancestor
24448204|NCT00310765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24482711|NCT00440258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482712|NCT00440258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482713|NCT00440284|Insulin|insulin|mesh-list
24482714|NCT00440284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24482715|NCT00440284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482716|NCT00440323|Zolpidem|zolpidem|mesh-list
24482717|NCT00440323|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24448208|NCT00310765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24801839|NCT01985841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24801841|NCT01985841|Antimitotic Agents|antimitotic agents|mesh-ancestor
24801842|NCT01985841|Mitosis Modulators|mitosis modulators|mesh-ancestor
24801843|NCT01985841|Antimetabolites|antimetabolites|mesh-ancestor
25581242|NCT00854581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581243|NCT00854581|Antiviral Agents|antiviral agents|mesh-ancestor
25581244|NCT00854581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25581245|NCT00854581|Immunologic Factors|immunologic factors|mesh-ancestor
25581246|NCT00854581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581247|NCT00854581|Antimetabolites|antimetabolites|mesh-ancestor
25581248|NCT00854581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581249|NCT00854581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25581250|NCT00854581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25581251|NCT00854581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581252|NCT00854581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25581253|NCT00854581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25581254|NCT00854581|Anticonvulsants|anticonvulsants|mesh-ancestor
24635087|NCT01136863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24522578|NCT03641326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522579|NCT03637062|Progesterone|progesterone|mesh-list
24522580|NCT03637062|Progestins|progestins|mesh-ancestor
24522581|NCT03637062|Hormones|hormones|mesh-ancestor
24494849|NCT00497237|Hormones|hormones|mesh-ancestor
24921168|NCT04193852|Hormones|hormones|mesh-ancestor
24621948|NCT01064986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621949|NCT01064986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621950|NCT01064986|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24621951|NCT01064986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24621952|NCT01064986|Autonomic Agents|autonomic agents|mesh-ancestor
24621953|NCT01064986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24621954|NCT01064986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24621955|NCT01064986|Respiratory System Agents|respiratory system agents|mesh-ancestor
24621956|NCT01064986|Mydriatics|mydriatics|mesh-ancestor
24921224|NCT04193293|Pembrolizumab|pembrolizumab|mesh-list
24921225|NCT04193293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25581255|NCT00854581|GABA Agents|gaba agents|mesh-ancestor
25581256|NCT00854581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25581257|NCT00854581|Antimanic Agents|antimanic agents|mesh-ancestor
25581258|NCT00854581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25581259|NCT00854581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25581260|NCT00854581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25581261|NCT00854620|Sorafenib|sorafenib|mesh-list
25581262|NCT00854620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581263|NCT00854620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25581264|NCT00854620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581265|NCT00854620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581266|NCT00854724|Puerarin|puerarin|mesh-list
25581267|NCT00854724|Vasodilator Agents|vasodilator agents|mesh-ancestor
25581268|NCT00855010|Pioglitazone|pioglitazone|mesh-list
25581269|NCT00855010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25581270|NCT00855010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581271|NCT00855062|Minocycline|minocycline|mesh-list
24801865|NCT01986036|Calcium|calcium|mesh-list
24801866|NCT01986036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24801867|NCT01986036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801869|NCT01986049|Anesthetics, Local|anesthetics, local|mesh-ancestor
24801870|NCT01986049|Anesthetics|anesthetics|mesh-ancestor
24921400|NCT04191694|Dermatologic Agents|dermatologic agents|mesh-ancestor
24921401|NCT04191694|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24482926|NCT00440960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24482927|NCT00440960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24482928|NCT00440960|Narcotics|narcotics|mesh-ancestor
24482929|NCT00440960|Analgesics|analgesics|mesh-ancestor
24482930|NCT00440973|Bevacizumab|bevacizumab|mesh-list
24482931|NCT00440973|Interleukin-2|interleukin-2|mesh-list
24482932|NCT00440973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24921402|NCT04191694|Serotonin Agents|serotonin agents|mesh-ancestor
24921403|NCT04191694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24921404|NCT04191694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921405|NCT04191694|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25581272|NCT00855062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25581273|NCT00855062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25581274|NCT00855166|Metformin|metformin|mesh-list
25581275|NCT00855166|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25581276|NCT00855166|Dapagliflozin|dapagliflozin|mesh-list
25581277|NCT00855166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25581278|NCT00855166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581279|NCT00855166|Incretins|incretins|mesh-ancestor
25581280|NCT00855166|Hormones|hormones|mesh-ancestor
25581281|NCT00855166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25581282|NCT00855166|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25581283|NCT00855166|Protease Inhibitors|protease inhibitors|mesh-ancestor
25581284|NCT00855166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581285|NCT00855166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581286|NCT00855166|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25581287|NCT00855218|Sorafenib|sorafenib|mesh-list
25581288|NCT00855218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581289|NCT00855218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25581290|NCT00855218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581291|NCT00855218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581292|NCT00855309|Acyclovir|acyclovir|mesh-list
25581293|NCT00855309|Antiviral Agents|antiviral agents|mesh-ancestor
25581294|NCT00855309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25581295|NCT00855335|Ritonavir|ritonavir|mesh-list
25581296|NCT00855335|Darunavir|darunavir|mesh-list
25581297|NCT00855335|Cobicistat|cobicistat|mesh-list
25581298|NCT00855335|Rilpivirine|rilpivirine|mesh-list
25581299|NCT00855335|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
25581300|NCT00855335|Etravirine|etravirine|mesh-list
24483111|NCT00441909|UC-781|uc-781|mesh-list
24921486|NCT04190745|Paclitaxel|paclitaxel|mesh-list
24921487|NCT04190745|Apatinib|apatinib|mesh-list
24921493|NCT04190745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921494|NCT04190745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24921495|NCT04190745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921496|NCT04190173|Prucalopride|prucalopride|mesh-list
24921497|NCT04190173|Laxatives|laxatives|mesh-ancestor
24921604|NCT04189666|Antioxidants|antioxidants|mesh-ancestor
24921605|NCT04189666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921700|NCT04188184|Coagulants|coagulants|mesh-ancestor
25581301|NCT00855335|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25581302|NCT00855335|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25581303|NCT00855335|Protease Inhibitors|protease inhibitors|mesh-ancestor
25581304|NCT00855335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581305|NCT00855335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581306|NCT00855335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25581307|NCT00855335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25581308|NCT00855335|Antiviral Agents|antiviral agents|mesh-ancestor
25581309|NCT00855335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25581310|NCT00855335|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25581311|NCT00855335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25581312|NCT00855335|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25581313|NCT00855335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25581314|NCT00855413|Ritonavir|ritonavir|mesh-list
25581315|NCT00855413|Darunavir|darunavir|mesh-list
25581316|NCT00855413|Etravirine|etravirine|mesh-list
25581317|NCT00855413|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25581318|NCT00855413|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25581319|NCT00855413|Protease Inhibitors|protease inhibitors|mesh-ancestor
25581320|NCT00855413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581321|NCT00855413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581322|NCT00855413|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25581323|NCT00855413|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25581324|NCT00855413|Antiviral Agents|antiviral agents|mesh-ancestor
25581325|NCT00855413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25581326|NCT00855413|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25581327|NCT00855413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25581328|NCT00855413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25581329|NCT00855413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24637183|NCT01149174|Mitomycins|mitomycins|mesh-list
24724543|NCT01593410|Immunologic Factors|immunologic factors|mesh-ancestor
24724601|NCT01593774|Melatonin|melatonin|mesh-list
24801906|NCT01986283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24801907|NCT01986283|Narcotics|narcotics|mesh-ancestor
24801910|NCT01986283|Analgesics|analgesics|mesh-ancestor
24801911|NCT01986283|Sensory System Agents|sensory system agents|mesh-ancestor
24801912|NCT01986283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24801914|NCT01986309|Anesthetics, Local|anesthetics, local|mesh-ancestor
24801915|NCT01986309|Anesthetics|anesthetics|mesh-ancestor
25581330|NCT00855439|Exenatide|exenatide|mesh-list
25581331|NCT00855439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25581332|NCT00855439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581333|NCT00855439|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25581334|NCT00855439|Incretins|incretins|mesh-ancestor
25581335|NCT00855439|Hormones|hormones|mesh-ancestor
25581336|NCT00855439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25581337|NCT00855465|Riociguat|riociguat|mesh-list
25581338|NCT00855465|Enzyme Activators|enzyme activators|mesh-ancestor
25581339|NCT00855465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801916|NCT01986309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24801917|NCT01986309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801918|NCT01986309|Sensory System Agents|sensory system agents|mesh-ancestor
24801919|NCT01986309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24801920|NCT01986309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24921741|NCT04187469|Pyrazinamide|pyrazinamide|mesh-list
24921742|NCT04187469|Ethambutol|ethambutol|mesh-list
24921743|NCT04187469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24921744|NCT04187469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24921745|NCT04187469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24921746|NCT04187469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24921747|NCT04187469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921748|NCT04187469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921749|NCT04187469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921916|NCT04185233|Nitrous Oxide|nitrous oxide|mesh-list
25581340|NCT00855582|Tadalafil|tadalafil|mesh-list
25581341|NCT00855582|Vasodilator Agents|vasodilator agents|mesh-ancestor
25581342|NCT00855582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25581343|NCT00855582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25581344|NCT00855582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581345|NCT00855582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581346|NCT00855582|Urological Agents|urological agents|mesh-ancestor
25581347|NCT00855595|Metronidazole|metronidazole|mesh-list
25581348|NCT00855595|Doxycycline|doxycycline|mesh-list
25581349|NCT00855595|Azelaic acid|azelaic acid|mesh-list
25581350|NCT00855595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25581351|NCT00855595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25581352|NCT00855595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25581353|NCT00855595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25581354|NCT00855595|Antimalarials|antimalarials|mesh-ancestor
25581355|NCT00855595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581356|NCT00855595|Dermatologic Agents|dermatologic agents|mesh-ancestor
25581357|NCT00855738|Topiramate|topiramate|mesh-list
25581358|NCT00855738|Pregabalin|pregabalin|mesh-list
25581359|NCT00855738|Lamotrigine|lamotrigine|mesh-list
25581360|NCT00855738|Zonisamide|zonisamide|mesh-list
25581361|NCT00855738|Gabapentin|gabapentin|mesh-list
25581362|NCT00855738|Levetiracetam|levetiracetam|mesh-list
25581363|NCT00855738|Tiagabine|tiagabine|mesh-list
25581364|NCT00855738|Analgesics|analgesics|mesh-ancestor
25581365|NCT00855738|Sensory System Agents|sensory system agents|mesh-ancestor
25581366|NCT00855738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25581367|NCT00855738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581368|NCT00855738|Anticonvulsants|anticonvulsants|mesh-ancestor
24801982|NCT01986608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563899|NCT00774280|Alkylating Agents|alkylating agents|mesh-ancestor
24563901|NCT00774280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448379|NCT00311636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24448380|NCT00311636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448381|NCT00311636|Tubulin Modulators|tubulin modulators|mesh-ancestor
24448382|NCT00311636|Antimitotic Agents|antimitotic agents|mesh-ancestor
24448383|NCT00311636|Mitosis Modulators|mitosis modulators|mesh-ancestor
24448384|NCT00311636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448385|NCT00311636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24448386|NCT00311636|Immunologic Factors|immunologic factors|mesh-ancestor
24448387|NCT00311636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448388|NCT00311636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24448389|NCT00311636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24448390|NCT00311636|Alkylating Agents|alkylating agents|mesh-ancestor
24448391|NCT00311636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24448392|NCT00311636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24448393|NCT00311636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24615963|NCT01033279|Warfarin|warfarin|mesh-list
25581369|NCT00855738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25581370|NCT00855738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25581371|NCT00855738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581372|NCT00855738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25581373|NCT00855738|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25581374|NCT00855738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25581375|NCT00855738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25581376|NCT00855738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25581377|NCT00855738|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25581378|NCT00855738|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25581379|NCT00855738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25581380|NCT00855738|Antimanic Agents|antimanic agents|mesh-ancestor
25581381|NCT00855738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25581382|NCT00855738|Nootropic Agents|nootropic agents|mesh-ancestor
25581383|NCT00855738|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25581384|NCT00855738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25581385|NCT00855738|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
25581386|NCT00855738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25581387|NCT00855738|GABA Agents|gaba agents|mesh-ancestor
25581388|NCT00855894|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25581389|NCT00855894|Pertuzumab|pertuzumab|mesh-list
25581390|NCT00855894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581391|NCT00855894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25581392|NCT00855894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581393|NCT00855894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581394|NCT00855894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24638990|NCT01159418|Paclitaxel|paclitaxel|mesh-list
24564080|NCT00775073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24564081|NCT00775073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24622455|NCT01067053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622456|NCT01067066|Temozolomide|temozolomide|mesh-list
24622457|NCT01067066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24622458|NCT01067066|Alkylating Agents|alkylating agents|mesh-ancestor
24622459|NCT01067066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622460|NCT01067066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24564124|NCT00775164|Pioglitazone|pioglitazone|mesh-list
24647987|NCT01211795|Analgesics|analgesics|mesh-ancestor
24483970|NCT00446017|Respiratory System Agents|respiratory system agents|mesh-ancestor
24483971|NCT00446017|Mydriatics|mydriatics|mesh-ancestor
24446851|NCT00306267|Hematinics|hematinics|mesh-ancestor
24446852|NCT00306319|Moxifloxacin|moxifloxacin|mesh-list
24446853|NCT00306319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24446854|NCT00306319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24483984|NCT00446043|Dermatologic Agents|dermatologic agents|mesh-ancestor
24483985|NCT00446043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24483986|NCT00446043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25581396|NCT00855920|Rilonacept|rilonacept|mesh-list
25581397|NCT00855920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25581398|NCT00855920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25581399|NCT00855920|Analgesics|analgesics|mesh-ancestor
25581400|NCT00855920|Sensory System Agents|sensory system agents|mesh-ancestor
25581401|NCT00855920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25581402|NCT00855920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581403|NCT00855920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25581404|NCT00855920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25581405|NCT00855920|Gout Suppressants|gout suppressants|mesh-ancestor
25581406|NCT00855920|Tocolytic Agents|tocolytic agents|mesh-ancestor
25581407|NCT00855920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24622474|NCT01067235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24622475|NCT01067235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622476|NCT01067235|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24564319|NCT00775879|Anesthetics, General|anesthetics, general|mesh-ancestor
24426398|NCT00235950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25085506|NCT03297502|Sensory System Agents|sensory system agents|mesh-ancestor
24622485|NCT01067274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622486|NCT01067274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622487|NCT01067274|Antiviral Agents|antiviral agents|mesh-ancestor
24622488|NCT01067274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24622489|NCT01067274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24454977|NCT03089606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25085507|NCT03297502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24522847|NCT03103750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522848|NCT03103750|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24522849|NCT03103750|Vitamins|vitamins|mesh-ancestor
24922152|NCT04183296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922153|NCT04183296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24922154|NCT04183296|Anesthetics, General|anesthetics, general|mesh-ancestor
25581408|NCT00855920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25581409|NCT00855920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581410|NCT00855920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581411|NCT00855933|Cetylpyridinium|cetylpyridinium|mesh-list
25581412|NCT00855933|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25581413|NCT00855933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25581414|NCT00855959|Budesonide|budesonide|mesh-list
25581415|NCT00855959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25581416|NCT00855959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25581417|NCT00855959|Autonomic Agents|autonomic agents|mesh-ancestor
25581418|NCT00855959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25581419|NCT00855959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581420|NCT00855959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25581421|NCT00855959|Respiratory System Agents|respiratory system agents|mesh-ancestor
25581422|NCT00855959|Glucocorticoids|glucocorticoids|mesh-ancestor
25581423|NCT00855959|Hormones|hormones|mesh-ancestor
25581424|NCT00855959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25581425|NCT00856024|Ribavirin|ribavirin|mesh-list
25581426|NCT00856024|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25581427|NCT00856024|Antimetabolites|antimetabolites|mesh-ancestor
25581428|NCT00856024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581429|NCT00856024|Antiviral Agents|antiviral agents|mesh-ancestor
25581430|NCT00856024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25581431|NCT00856050|Letrozole|letrozole|mesh-list
25581432|NCT00856050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581433|NCT00856050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25581434|NCT00856050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25581435|NCT00856050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640827|NCT01170260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24922155|NCT04183296|Anesthetics|anesthetics|mesh-ancestor
24922156|NCT04183296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24522858|NCT03103750|Adrenergic Agents|adrenergic agents|mesh-ancestor
24522859|NCT03103750|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24522860|NCT03103750|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24522861|NCT03103750|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25581436|NCT00856050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581437|NCT00856050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25581438|NCT00856050|Hormone Antagonists|hormone antagonists|mesh-ancestor
25581439|NCT00856050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25581440|NCT00856050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581441|NCT00856180|Cyclophosphamide|cyclophosphamide|mesh-list
25581442|NCT00856180|Bevacizumab|bevacizumab|mesh-list
25581443|NCT00856180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25581444|NCT00856180|Immunologic Factors|immunologic factors|mesh-ancestor
24641491|NCT01173926|Insulin|insulin|mesh-list
24454981|NCT03031483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24454982|NCT03031483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24454983|NCT03031483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24454991|NCT03031483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24454992|NCT03031483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25581445|NCT00856180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581446|NCT00856180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25581447|NCT00856180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25581448|NCT00856180|Alkylating Agents|alkylating agents|mesh-ancestor
25581449|NCT00856180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581450|NCT00856180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581451|NCT00856180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25581452|NCT00856180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25581453|NCT00856180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25581454|NCT00856180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25581455|NCT00856180|Growth Substances|growth substances|mesh-ancestor
25581456|NCT00856180|Growth Inhibitors|growth inhibitors|mesh-ancestor
25581457|NCT00856193|Glycopyrrolate|glycopyrrolate|mesh-list
25581458|NCT00856193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25581459|NCT00856193|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25581460|NCT00856193|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25581461|NCT00856193|Cholinergic Agents|cholinergic agents|mesh-ancestor
25581462|NCT00856193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25581463|NCT00856193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581464|NCT00856193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581465|NCT00856206|Rilonacept|rilonacept|mesh-list
25581466|NCT00856206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25581467|NCT00856245|Rituximab|rituximab|mesh-list
25581468|NCT00856245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25581469|NCT00856245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581470|NCT00856245|Immunologic Factors|immunologic factors|mesh-ancestor
25581471|NCT00856245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448509|NCT00312039|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24922617|NCT04178148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24922625|NCT04178200|Sensory System Agents|sensory system agents|mesh-ancestor
24922633|NCT04178057|Antibodies|antibodies|mesh-list
24922648|NCT04177875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24922649|NCT04177875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922650|NCT04177875|Tubulin Modulators|tubulin modulators|mesh-ancestor
24922660|NCT04178109|Tramadol|tramadol|mesh-list
25581472|NCT00856245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25581473|NCT00856284|Metformin|metformin|mesh-list
25581474|NCT00856284|Alogliptin|alogliptin|mesh-list
25581475|NCT00856284|Glipizide|glipizide|mesh-list
25581476|NCT00856284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25581477|NCT00856284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581478|NCT00856284|Incretins|incretins|mesh-ancestor
25581479|NCT00856284|Hormones|hormones|mesh-ancestor
25581480|NCT00856284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25581481|NCT00856284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25581482|NCT00856284|Protease Inhibitors|protease inhibitors|mesh-ancestor
25581483|NCT00856284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581484|NCT00856284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581485|NCT00856297|Vaccines|vaccines|mesh-list
25581486|NCT00856297|Immunologic Factors|immunologic factors|mesh-ancestor
25581487|NCT00856297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581488|NCT00856323|Tenofovir|tenofovir|mesh-list
25581489|NCT00856323|Emtricitabine|emtricitabine|mesh-list
25581490|NCT00856323|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25581491|NCT00856323|Antiviral Agents|antiviral agents|mesh-ancestor
25581492|NCT00856323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25581493|NCT00856323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25581494|NCT00856323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25581495|NCT00856323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581496|NCT00856323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581497|NCT00856323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25581498|NCT00856323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25581499|NCT00856375|Irinotecan|irinotecan|mesh-list
25581500|NCT00856375|Etirinotecan pegol|etirinotecan pegol|mesh-list
25581501|NCT00856375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25581502|NCT00856375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25581503|NCT00856375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581504|NCT00856375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498202|NCT00513513|Antiviral Agents|antiviral agents|mesh-ancestor
24498203|NCT00513513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24498204|NCT00513513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24624116|NCT01074853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24624117|NCT01074853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746346|NCT05437575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25581505|NCT00856375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581506|NCT00856375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25581507|NCT00856388|Fludarabine|fludarabine|mesh-list
25581508|NCT00856388|Fludarabine phosphate|fludarabine phosphate|mesh-list
25581509|NCT00856388|Melphalan|melphalan|mesh-list
25581510|NCT00856388|Thymoglobulin|thymoglobulin|mesh-list
25581511|NCT00856388|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25581512|NCT00856388|Immunoglobulins|immunoglobulins|mesh-list
25581513|NCT00856388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581514|NCT00856388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25581515|NCT00856388|Antimetabolites|antimetabolites|mesh-ancestor
25581516|NCT00856388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581517|NCT00856388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25581518|NCT00856388|Immunologic Factors|immunologic factors|mesh-ancestor
24855910|NCT02281721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24624150|NCT01074905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24624151|NCT01074905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922909|NCT04175002|Progestins|progestins|mesh-ancestor
24922910|NCT04175002|Hormones|hormones|mesh-ancestor
24922911|NCT04175002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24922912|NCT04175002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922913|NCT04174872|Midazolam|midazolam|mesh-list
24922914|NCT04174872|Dexmedetomidine|dexmedetomidine|mesh-list
24922915|NCT04174872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24922916|NCT04174872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24922917|NCT04174872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922918|NCT04174872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24922919|NCT04174872|Analgesics|analgesics|mesh-ancestor
24600335|NCT01026220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24600336|NCT01026220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25581519|NCT00856388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581520|NCT00856388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25581521|NCT00856388|Alkylating Agents|alkylating agents|mesh-ancestor
25581522|NCT00856388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25581523|NCT00856414|Botulinum Toxins|botulinum toxins|mesh-list
25581524|NCT00856414|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25581525|NCT00856414|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25581526|NCT00856414|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25581527|NCT00856414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25581528|NCT00856414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581529|NCT00856414|Cholinergic Agents|cholinergic agents|mesh-ancestor
24448733|NCT00312871|Hematinics|hematinics|mesh-ancestor
24600668|NCT00959881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484976|NCT00450957|Protective Agents|protective agents|mesh-ancestor
24485135|NCT00451724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24600670|NCT00959933|Ribavirin|ribavirin|mesh-list
24600671|NCT00959933|Antimetabolites|antimetabolites|mesh-ancestor
24600672|NCT00959933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600673|NCT00959933|Antiviral Agents|antiviral agents|mesh-ancestor
24636405|NCT01145326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24636406|NCT01145326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636407|NCT01145326|Sensory System Agents|sensory system agents|mesh-ancestor
24636408|NCT01145326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24600771|NCT00960492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24600772|NCT00960492|Alkylating Agents|alkylating agents|mesh-ancestor
24600773|NCT00960492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600774|NCT00960492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600777|NCT00960518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24600778|NCT00960518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24600779|NCT00960518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24600780|NCT00960518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600782|NCT00960544|Capecitabine|capecitabine|mesh-list
25581530|NCT00856414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25581531|NCT00856414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581532|NCT00856414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25581533|NCT00856414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25581534|NCT00856492|Paclitaxel|paclitaxel|mesh-list
25581535|NCT00856492|Cyclophosphamide|cyclophosphamide|mesh-list
25581536|NCT00856492|Bevacizumab|bevacizumab|mesh-list
25581537|NCT00856492|Doxorubicin|doxorubicin|mesh-list
25581538|NCT00856492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25581539|NCT00856492|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25581540|NCT00856492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25581541|NCT00856492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581542|NCT00856492|Tubulin Modulators|tubulin modulators|mesh-ancestor
25581543|NCT00856492|Antimitotic Agents|antimitotic agents|mesh-ancestor
25581544|NCT00856492|Mitosis Modulators|mitosis modulators|mesh-ancestor
25581545|NCT00856492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581546|NCT00856492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25581547|NCT00856492|Immunologic Factors|immunologic factors|mesh-ancestor
25581548|NCT00856492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581549|NCT00856492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25581550|NCT00856492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25581551|NCT00856492|Alkylating Agents|alkylating agents|mesh-ancestor
25581552|NCT00856492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24600794|NCT00960635|Vitamin D|vitamin d|mesh-list
24600795|NCT00960635|Cholecalciferol|cholecalciferol|mesh-list
24600796|NCT00960635|Calcitriol|calcitriol|mesh-list
24600797|NCT00960635|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
24802061|NCT01986998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24802063|NCT01987076|Clobetasol|clobetasol|mesh-list
24726321|NCT01602861|Diuretics|diuretics|mesh-ancestor
24485506|NCT00453323|Mitosis Modulators|mitosis modulators|mesh-ancestor
24485511|NCT00453375|Antioxidants|antioxidants|mesh-ancestor
24485512|NCT00453375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485545|NCT00453635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485550|NCT00453635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24485551|NCT00453635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24485552|NCT00453648|Vitamin A|vitamin a|mesh-list
24485553|NCT00453648|Retinol palmitate|retinol palmitate|mesh-list
24485554|NCT00453648|Antioxidants|antioxidants|mesh-ancestor
24485555|NCT00453648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802081|NCT01987154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581553|NCT00856492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25581554|NCT00856492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25581555|NCT00856492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25581556|NCT00856492|Growth Substances|growth substances|mesh-ancestor
25581557|NCT00856492|Growth Inhibitors|growth inhibitors|mesh-ancestor
25581558|NCT00856492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25581559|NCT00856492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25581560|NCT00856492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25581561|NCT00856492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581562|NCT00856544|Tofacitinib|tofacitinib|mesh-list
24645791|NCT01199900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24485606|NCT00453908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24485607|NCT00453908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726800|NCT01605994|Antacids|antacids|mesh-list
24802104|NCT01987297|Keratolytic Agents|keratolytic agents|mesh-ancestor
24802105|NCT01987297|Dermatologic Agents|dermatologic agents|mesh-ancestor
24802107|NCT01987310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24802108|NCT01987310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24802109|NCT01987310|Antimetabolites|antimetabolites|mesh-ancestor
24726885|NCT01606540|Ibuprofen|ibuprofen|mesh-list
24600844|NCT00960830|Histamine Antagonists|histamine antagonists|mesh-ancestor
24600846|NCT00960830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24600847|NCT00960830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600848|NCT00960830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600849|NCT00960830|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24600935|NCT00961194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600937|NCT00961324|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24600938|NCT00961324|Insulin Glargine|insulin glargine|mesh-list
24600939|NCT00961324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24600940|NCT00961324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600985|NCT00961480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600987|NCT00961753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24636490|NCT01145846|Antimetabolites|antimetabolites|mesh-ancestor
24636491|NCT01145846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636492|NCT01145846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24636493|NCT01145846|Antiviral Agents|antiviral agents|mesh-ancestor
24636494|NCT01145846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24636495|NCT01145846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24636496|NCT01145846|Immunologic Factors|immunologic factors|mesh-ancestor
25581563|NCT00856544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25581564|NCT00856544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581565|NCT00856544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581566|NCT00856583|Risperidone|risperidone|mesh-list
25581567|NCT00856583|Sertindole|sertindole|mesh-list
25581568|NCT00856583|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25581569|NCT00856583|Serotonin Agents|serotonin agents|mesh-ancestor
25581570|NCT00856583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25581571|NCT00856583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581572|NCT00856583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581573|NCT00856583|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25581574|NCT00856583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25581575|NCT00856583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25581576|NCT00856583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25581577|NCT00856583|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25581578|NCT00856583|Dopamine Agents|dopamine agents|mesh-ancestor
24856055|NCT02282371|Cetuximab|cetuximab|mesh-list
24856056|NCT02282371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24856057|NCT02282371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24856058|NCT02282384|Oseltamivir|oseltamivir|mesh-list
24856060|NCT02282384|Antiviral Agents|antiviral agents|mesh-ancestor
24856061|NCT02282384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24856062|NCT02282384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856063|NCT02282384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645965|NCT01201005|Hematinics|hematinics|mesh-ancestor
24645966|NCT01201005|Vitamin B Complex|vitamin b complex|mesh-ancestor
24645968|NCT01201005|Micronutrients|micronutrients|mesh-ancestor
24802112|NCT01987310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24802113|NCT01987310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449009|NCT00313898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24449010|NCT00313898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449011|NCT00313898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449012|NCT00313898|Urological Agents|urological agents|mesh-ancestor
24449013|NCT00313924|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24449015|NCT00313924|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24449016|NCT00313924|Cholinergic Agents|cholinergic agents|mesh-ancestor
25581579|NCT00856609|Exenatide|exenatide|mesh-list
25581580|NCT00856609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25581581|NCT00856609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581582|NCT00856609|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25581583|NCT00856609|Incretins|incretins|mesh-ancestor
25581584|NCT00856609|Hormones|hormones|mesh-ancestor
25581585|NCT00856609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25581586|NCT00856635|Glatiramer Acetate|glatiramer acetate|mesh-list
25581587|NCT00856635|(T,G)-A-L|(t,g)-a-l|mesh-list
25581588|NCT00856635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25581589|NCT00856635|Immunologic Factors|immunologic factors|mesh-ancestor
25581590|NCT00856635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581591|NCT00856635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25581592|NCT00856635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25581593|NCT00856661|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
24727206|NCT01608464|Fluorouracil|fluorouracil|mesh-list
24616352|NCT01036659|Ecallantide|ecallantide|mesh-list
24636497|NCT01145846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601082|NCT00962637|Enclomiphene|enclomiphene|mesh-list
24601083|NCT00962637|Clomiphene|clomiphene|mesh-list
24601084|NCT00962637|Zuclomiphene|zuclomiphene|mesh-list
24601085|NCT00962637|Testosterone|testosterone|mesh-list
24601086|NCT00962637|Anticoagulants|anticoagulants|mesh-ancestor
24601087|NCT00962637|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24601088|NCT00962637|Chelating Agents|chelating agents|mesh-ancestor
24601136|NCT00962936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24601137|NCT00962975|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24601138|NCT00962975|Antiviral Agents|antiviral agents|mesh-ancestor
24601139|NCT00962975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24601141|NCT00963001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24601142|NCT00963027|Treprostinil|treprostinil|mesh-list
24601143|NCT00963027|Esomeprazole|esomeprazole|mesh-list
24601145|NCT00963027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24601146|NCT00963027|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24601147|NCT00963027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601148|NCT00963027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601150|NCT00963040|Oxytocin|oxytocin|mesh-list
24601152|NCT00963040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24601153|NCT00963040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601154|NCT00963131|Antioxidants|antioxidants|mesh-list
24601155|NCT00963131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485882|NCT00455286|Hormones|hormones|mesh-ancestor
24601156|NCT00963131|Protective Agents|protective agents|mesh-ancestor
24601157|NCT00963131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581594|NCT00856661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25581595|NCT00856661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25581596|NCT00856661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581597|NCT00856726|Parathyroid Hormone|parathyroid hormone|mesh-list
25581598|NCT00856726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25581599|NCT00856726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581600|NCT00856791|ON 01910|on 01910|mesh-list
25581601|NCT00856791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581602|NCT00856791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25581603|NCT00856791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581604|NCT00856791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581605|NCT00856830|Carboplatin|carboplatin|mesh-list
25581606|NCT00856830|Irinotecan|irinotecan|mesh-list
25581607|NCT00856830|Etoposide|etoposide|mesh-list
25581608|NCT00856830|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25581609|NCT00856830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581610|NCT00856830|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25581611|NCT00856830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25581612|NCT00856830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581613|NCT00856830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581614|NCT00856830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25476248|NCT00076024|Docetaxel|docetaxel|mesh-list
24802133|NCT01987739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24802134|NCT01987739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802135|NCT01987739|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24802136|NCT01987739|GABA Agonists|gaba agonists|mesh-ancestor
24802137|NCT01987739|GABA Agents|gaba agents|mesh-ancestor
24802138|NCT01987739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24802139|NCT01987739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727396|NCT01609517|Anesthetics|anesthetics|mesh-list
24432693|NCT00255710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432694|NCT00255710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460277|NCT00347984|Lubricant Eye Drops|lubricant eye drops|mesh-list
25086100|NCT03292315|Exenatide|exenatide|mesh-list
24802142|NCT01987804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24802143|NCT01987804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485886|NCT00455286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24485942|NCT00455507|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24601320|NCT00963976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24601321|NCT00963976|Protease Inhibitors|protease inhibitors|mesh-ancestor
24601322|NCT00963976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601323|NCT00963976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601324|NCT00963976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24601325|NCT00963976|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25581615|NCT00856830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25581616|NCT00856830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25581617|NCT00856830|Alkylating Agents|alkylating agents|mesh-ancestor
25581618|NCT00856843|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25581619|NCT00856843|Laxatives|laxatives|mesh-ancestor
25581620|NCT00856843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25581621|NCT00856856|Everolimus|everolimus|mesh-list
25581622|NCT00856856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581623|NCT00856856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25581624|NCT00856856|Immunologic Factors|immunologic factors|mesh-ancestor
25581625|NCT00856856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581626|NCT00856973|Eszopiclone|eszopiclone|mesh-list
25581627|NCT00856973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25581628|NCT00856973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24601379|NCT00964106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24601380|NCT00964106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24601381|NCT00964106|Anesthetics, General|anesthetics, general|mesh-ancestor
24601382|NCT00964106|Anesthetics|anesthetics|mesh-ancestor
24601383|NCT00964106|GABA Modulators|gaba modulators|mesh-ancestor
24601384|NCT00964106|GABA Agents|gaba agents|mesh-ancestor
24601427|NCT00964106|Analgesics|analgesics|mesh-ancestor
24601428|NCT00964106|Sensory System Agents|sensory system agents|mesh-ancestor
24455160|NCT02567409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455161|NCT02567409|Antiviral Agents|antiviral agents|mesh-ancestor
25581629|NCT00856973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581630|NCT00856986|Metformin|metformin|mesh-list
25581631|NCT00856986|Liraglutide|liraglutide|mesh-list
25581632|NCT00856986|Insulin Detemir|insulin detemir|mesh-list
25581633|NCT00856986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25581634|NCT00856986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581635|NCT00856986|Incretins|incretins|mesh-ancestor
25581636|NCT00856986|Hormones|hormones|mesh-ancestor
25581637|NCT00856986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25581638|NCT00857220|Eszopiclone|eszopiclone|mesh-list
25581639|NCT00857220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25581640|NCT00857220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24802202|NCT01988610|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24802203|NCT01988610|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24567227|NCT00790114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24727771|NCT01612728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24601440|NCT00964171|Antiviral Agents|antiviral agents|mesh-ancestor
24601441|NCT00964171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24601442|NCT00964171|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24601443|NCT00964171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24601454|NCT00964262|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24601455|NCT00964262|Incretins|incretins|mesh-ancestor
24601457|NCT00964262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24601458|NCT00964275|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24601467|NCT00964288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24601468|NCT00964288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25581641|NCT00857220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581642|NCT00857233|Memantine|memantine|mesh-list
25581643|NCT00857233|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25581644|NCT00857233|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25581645|NCT00857233|Dopamine Agents|dopamine agents|mesh-ancestor
25581646|NCT00857233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25581647|NCT00857233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581648|NCT00857233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581649|NCT00857233|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24393275|NCT00129363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24802236|NCT01989000|Imidazole|imidazole|mesh-list
24393516|NCT00130195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24728114|NCT01614223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24393600|NCT00130455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393601|NCT00130455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24393602|NCT00130455|Antidepressive Agents|antidepressive agents|mesh-ancestor
24393603|NCT00130455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24393604|NCT00130468|Hyaluronic Acid|hyaluronic acid|mesh-list
24393605|NCT00130468|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24393699|NCT00130767|Hormone Antagonists|hormone antagonists|mesh-ancestor
24601525|NCT00964574|Insulin glulisine|insulin glulisine|mesh-list
24802253|NCT01989052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24802254|NCT01989052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25086443|NCT03289390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25581650|NCT00857233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25581651|NCT00857246|Cisplatin|cisplatin|mesh-list
25581652|NCT00857246|Irinotecan|irinotecan|mesh-list
25581653|NCT00857246|Cetuximab|cetuximab|mesh-list
25581654|NCT00857246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581655|NCT00857246|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25581656|NCT00857246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25581657|NCT00857246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856658|NCT02285985|Saxagliptin|saxagliptin|mesh-list
24393926|NCT00131300|Protective Agents|protective agents|mesh-ancestor
24393927|NCT00131300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393928|NCT00131313|Cyclophosphamide|cyclophosphamide|mesh-list
24393930|NCT00131313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24393931|NCT00131313|Immunologic Factors|immunologic factors|mesh-ancestor
24393932|NCT00131313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581658|NCT00857246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581659|NCT00857246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25581660|NCT00857259|Everolimus|everolimus|mesh-list
25581661|NCT00857259|Ranibizumab|ranibizumab|mesh-list
25581662|NCT00857259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581663|NCT00857259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25581664|NCT00857259|Immunologic Factors|immunologic factors|mesh-ancestor
25581665|NCT00857259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452042|NCT00325806|Protease Inhibitors|protease inhibitors|mesh-ancestor
24452043|NCT00325806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24452044|NCT00325806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452045|NCT00325806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24486776|NCT00460083|Analgesics|analgesics|mesh-ancestor
24486907|NCT00460512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394079|NCT00132054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394080|NCT00132054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394081|NCT00132054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24394083|NCT00132067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24394084|NCT00132067|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24394085|NCT00132067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394086|NCT00132067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596627|NCT00944502|Hormones|hormones|mesh-ancestor
24601655|NCT00965289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24601656|NCT00965315|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24601657|NCT00965315|Fenofibrate|fenofibrate|mesh-list
24601658|NCT00965315|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24601659|NCT00965315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24601810|NCT00966056|Mitomycins|mitomycins|mesh-list
25581666|NCT00857259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25581667|NCT00857259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25581668|NCT00857259|Growth Substances|growth substances|mesh-ancestor
25581669|NCT00857259|Growth Inhibitors|growth inhibitors|mesh-ancestor
25581670|NCT00857272|Bisacodyl|bisacodyl|mesh-list
25581671|NCT00857272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25581672|NCT00857272|Cathartics|cathartics|mesh-ancestor
25581673|NCT00857272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25581674|NCT00857272|Laxatives|laxatives|mesh-ancestor
25581675|NCT00857311|Vaccines|vaccines|mesh-list
25581676|NCT00857311|Immunologic Factors|immunologic factors|mesh-ancestor
25581677|NCT00857311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581678|NCT00857389|Cyclophosphamide|cyclophosphamide|mesh-list
25581679|NCT00857389|Busulfan|busulfan|mesh-list
25581680|NCT00857389|Thiotepa|thiotepa|mesh-list
25702844|NCT02160288|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25702845|NCT02160288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24394116|NCT00132158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24455232|NCT02244125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24455233|NCT02244125|Alkylating Agents|alkylating agents|mesh-ancestor
24452153|NCT00326235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24452154|NCT00326235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452171|NCT00326300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452172|NCT00326300|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24601825|NCT00966082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24601844|NCT00966160|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24601845|NCT00966160|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24601846|NCT00966160|Protease Inhibitors|protease inhibitors|mesh-ancestor
24601847|NCT00966160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601848|NCT00966160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601850|NCT00966160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24601851|NCT00966160|Antiviral Agents|antiviral agents|mesh-ancestor
24601852|NCT00966160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24601853|NCT00966160|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24601854|NCT00966160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24601855|NCT00966160|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25581681|NCT00857389|Methotrexate|methotrexate|mesh-list
25581682|NCT00857389|Clofarabine|clofarabine|mesh-list
25581683|NCT00857389|Tacrolimus|tacrolimus|mesh-list
25581684|NCT00857389|Thymoglobulin|thymoglobulin|mesh-list
25581685|NCT00857389|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25581686|NCT00857389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25581687|NCT00857389|Immunologic Factors|immunologic factors|mesh-ancestor
25581688|NCT00857389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581689|NCT00857389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25581690|NCT00857389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25581691|NCT00857389|Alkylating Agents|alkylating agents|mesh-ancestor
25476321|NCT00076752|Antimetabolites|antimetabolites|mesh-ancestor
24856860|NCT02287246|Anesthetics|anesthetics|mesh-ancestor
24856861|NCT02287246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24856862|NCT02287246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856863|NCT02287246|Sensory System Agents|sensory system agents|mesh-ancestor
24452212|NCT00326404|Estrogens|estrogens|mesh-ancestor
25653020|NCT01534078|Mitosis Modulators|mitosis modulators|mesh-ancestor
25581692|NCT00857389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581693|NCT00857389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581694|NCT00857389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25581695|NCT00857389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25581696|NCT00857389|Abortifacient Agents|abortifacient agents|mesh-ancestor
25581697|NCT00857389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25581698|NCT00857389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25581699|NCT00857389|Antimetabolites|antimetabolites|mesh-ancestor
25581700|NCT00857389|Dermatologic Agents|dermatologic agents|mesh-ancestor
25581701|NCT00857389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581702|NCT00857389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24856950|NCT02288078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856951|NCT02288078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24856952|NCT02288078|Glucocorticoids|glucocorticoids|mesh-ancestor
24463159|NCT00359151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25086673|NCT03287336|Hemostatics|hemostatics|mesh-ancestor
24601862|NCT00966160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24601863|NCT00966199|Antihypertensive Agents|antihypertensive agents|mesh-list
24601864|NCT00966251|Pidilizumab|pidilizumab|mesh-list
24601865|NCT00966251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25581703|NCT00857389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25581704|NCT00857389|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25581705|NCT00857454|Testosterone|testosterone|mesh-list
25581706|NCT00857454|Androgens|androgens|mesh-ancestor
25581707|NCT00857454|Hormones|hormones|mesh-ancestor
25581708|NCT00857454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25581709|NCT00857454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581710|NCT00857545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
24601959|NCT00966745|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24498979|NCT00517062|Hormones|hormones|mesh-list
25581711|NCT00857545|Immunologic Factors|immunologic factors|mesh-ancestor
25581712|NCT00857545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581713|NCT00857584|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25581714|NCT00857584|Sertraline|sertraline|mesh-list
25581715|NCT00857584|Antidepressive Agents|antidepressive agents|mesh-ancestor
25581716|NCT00857584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25581717|NCT00857584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25581718|NCT00857584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24602213|NCT00967642|Insulin|insulin|mesh-list
24649007|NCT01218217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24463316|NCT00359905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24463322|NCT00359970|Antidiarrheals|antidiarrheals|mesh-list
24602368|NCT00968565|Anticoagulants|anticoagulants|mesh-ancestor
24602369|NCT00968565|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24602370|NCT00968565|Chelating Agents|chelating agents|mesh-ancestor
24602371|NCT00968565|Sequestering Agents|sequestering agents|mesh-ancestor
24602372|NCT00968565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581719|NCT00857584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25581720|NCT00857584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476396|NCT00077649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476397|NCT00077649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476398|NCT00077675|Vancomycin|vancomycin|mesh-list
25476399|NCT00077675|Penicillins|penicillins|mesh-list
25476400|NCT00077675|Telavancin|telavancin|mesh-list
25476401|NCT00077675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25476402|NCT00077675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25476403|NCT00077766|Darbepoetin alfa|darbepoetin alfa|mesh-list
25476404|NCT00077766|Hematinics|hematinics|mesh-ancestor
24649676|NCT01221129|Zinc|zinc|mesh-list
24602564|NCT00969449|Gout Suppressants|gout suppressants|mesh-ancestor
24602565|NCT00969449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24602566|NCT00969449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24602651|NCT00969982|Contraceptive Agents|contraceptive agents|mesh-ancestor
24602653|NCT00969982|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25476405|NCT00077857|Docetaxel|docetaxel|mesh-list
25476406|NCT00077857|Capecitabine|capecitabine|mesh-list
25476407|NCT00077857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476408|NCT00077857|Tubulin Modulators|tubulin modulators|mesh-ancestor
25476409|NCT00077857|Antimitotic Agents|antimitotic agents|mesh-ancestor
25476410|NCT00077857|Mitosis Modulators|mitosis modulators|mesh-ancestor
25476411|NCT00077857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476412|NCT00077857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25476413|NCT00077857|Antimetabolites|antimetabolites|mesh-ancestor
25476414|NCT00077974|Sunitinib|sunitinib|mesh-list
25476415|NCT00077974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476416|NCT00077974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25476417|NCT00077974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24650072|NCT01223729|Vitamins|vitamins|mesh-ancestor
24602730|NCT00970879|Mefloquine|mefloquine|mesh-list
24602732|NCT00970879|Antimalarials|antimalarials|mesh-ancestor
25476418|NCT00077974|Growth Substances|growth substances|mesh-ancestor
25581721|NCT00857584|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25581722|NCT00857584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25581723|NCT00857584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25581724|NCT00857584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581725|NCT00857584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25581726|NCT00857584|Serotonin Agents|serotonin agents|mesh-ancestor
24463408|NCT00360750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729480|NCT01621763|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24802429|NCT01990079|Cholinergic Agents|cholinergic agents|mesh-ancestor
24802430|NCT01990079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24729569|NCT01622439|Immunologic Factors|immunologic factors|mesh-ancestor
24569445|NCT00800553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24463573|NCT00361452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24602894|NCT00971607|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24602895|NCT00971607|Anesthetics, General|anesthetics, general|mesh-ancestor
24602896|NCT00971607|Anesthetics|anesthetics|mesh-ancestor
24602897|NCT00971607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24602898|NCT00971607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602899|NCT00971659|Insulin|insulin|mesh-list
24602900|NCT00971659|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24602901|NCT00971659|Metformin|metformin|mesh-list
24602902|NCT00971659|Insulin Glargine|insulin glargine|mesh-list
24602904|NCT00971659|Exenatide|exenatide|mesh-list
24602946|NCT00971763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24602974|NCT00971815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24602975|NCT00971815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602976|NCT00971815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24602977|NCT00971815|Serotonin Agents|serotonin agents|mesh-ancestor
24602978|NCT00971815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602979|NCT00971815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24397158|NCT00140933|Diclofenac|diclofenac|mesh-list
24602982|NCT00971815|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24602983|NCT00971815|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24602984|NCT00971815|Parasympatholytics|parasympatholytics|mesh-ancestor
25581727|NCT00857649|Memantine|memantine|mesh-list
25581728|NCT00857649|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25581729|NCT00857649|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25581730|NCT00857649|Dopamine Agents|dopamine agents|mesh-ancestor
25581731|NCT00857649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25581732|NCT00857649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581733|NCT00857649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581734|NCT00857649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25581735|NCT00857649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25653021|NCT01534182|Interferons|interferons|mesh-list
25653022|NCT01534182|Interferon-beta|interferon-beta|mesh-list
25653023|NCT01534182|Glatiramer Acetate|glatiramer acetate|mesh-list
25653024|NCT01534182|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25702868|NCT02160730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24602985|NCT00971815|Autonomic Agents|autonomic agents|mesh-ancestor
24602986|NCT00971815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24602987|NCT00971815|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24602988|NCT00971815|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24602989|NCT00971815|Cholinergic Agents|cholinergic agents|mesh-ancestor
24602990|NCT00971893|Methylprednisolone|methylprednisolone|mesh-list
24602991|NCT00971893|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24441136|NCT00286143|Anesthetics|anesthetics|mesh-ancestor
25086907|NCT03284645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24602992|NCT00971893|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24602993|NCT00971893|Prednisolone|prednisolone|mesh-list
24602994|NCT00971893|Prednisolone acetate|prednisolone acetate|mesh-list
24602995|NCT00971893|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24602996|NCT00971893|Prednisolone phosphate|prednisolone phosphate|mesh-list
24602997|NCT00971893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24602998|NCT00971893|Antiemetics|antiemetics|mesh-ancestor
24602999|NCT00971893|Autonomic Agents|autonomic agents|mesh-ancestor
24603002|NCT00971893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24603039|NCT00972101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24603040|NCT00972101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25653025|NCT01534182|(T,G)-A-L|(t,g)-a-l|mesh-list
25653026|NCT01534182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25653027|NCT01534182|Antiviral Agents|antiviral agents|mesh-ancestor
25653028|NCT01534182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25581736|NCT00857714|Lapatinib|lapatinib|mesh-list
25581737|NCT00857714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581738|NCT00857714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25581739|NCT00857714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581740|NCT00857714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581741|NCT00857727|Dexmedetomidine|dexmedetomidine|mesh-list
25581742|NCT00857727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24603128|NCT00972569|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24603129|NCT00972569|Natriuretic Agents|natriuretic agents|mesh-ancestor
24603130|NCT00972569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603131|NCT00972660|Cyclosporine|cyclosporine|mesh-list
24603132|NCT00972660|Mycophenolic Acid|mycophenolic acid|mesh-list
24603134|NCT00972660|Cyclosporins|cyclosporins|mesh-list
24603136|NCT00972660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25581743|NCT00857727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25581744|NCT00857727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581745|NCT00857727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25581746|NCT00857727|Analgesics|analgesics|mesh-ancestor
25581747|NCT00857727|Sensory System Agents|sensory system agents|mesh-ancestor
25581748|NCT00857727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25581749|NCT00857727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24603376|NCT00973505|Anastrozole|anastrozole|mesh-list
24603377|NCT00973505|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24463736|NCT00361959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24463737|NCT00361959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24463738|NCT00361959|Adrenergic Agents|adrenergic agents|mesh-ancestor
24463739|NCT00361959|Anticonvulsants|anticonvulsants|mesh-ancestor
24730118|NCT01626222|Everolimus|everolimus|mesh-list
24463760|NCT00362089|Hallucinogens|hallucinogens|mesh-ancestor
24463761|NCT00362089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463762|NCT00362089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24463763|NCT00362089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24463764|NCT00362089|Analgesics|analgesics|mesh-ancestor
24463765|NCT00362089|Sensory System Agents|sensory system agents|mesh-ancestor
24802484|NCT01990404|Sensory System Agents|sensory system agents|mesh-ancestor
24802485|NCT01990404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24802486|NCT01990443|Reslizumab|reslizumab|mesh-list
24730143|NCT01626443|Hematinics|hematinics|mesh-ancestor
24603379|NCT00973505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24603382|NCT00973505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24655657|NCT01257516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24488895|NCT00470483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24730387|NCT01627678|Antacids|antacids|mesh-ancestor
24603426|NCT00973713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24603428|NCT00973713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603429|NCT00973778|Capecitabine|capecitabine|mesh-list
24603430|NCT00973778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24603431|NCT00973778|Antimetabolites|antimetabolites|mesh-ancestor
24603432|NCT00973778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581750|NCT00857727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25581751|NCT00857727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25581752|NCT00857727|Adrenergic Agents|adrenergic agents|mesh-ancestor
25581753|NCT00857727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25581754|NCT00857727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581755|NCT00857766|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25581756|NCT00857766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25581757|NCT00857766|Autonomic Agents|autonomic agents|mesh-ancestor
25581758|NCT00857766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25581759|NCT00857766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463933|NCT00362765|Fenofibrate|fenofibrate|mesh-list
24463942|NCT00362778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463943|NCT00362804|Tetrabenazine|tetrabenazine|mesh-list
24463944|NCT00362804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24570554|NCT00805298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25087099|NCT03282825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603740|NCT00975325|Mydriatics|mydriatics|mesh-ancestor
24603741|NCT00975325|Autonomic Agents|autonomic agents|mesh-ancestor
24603742|NCT00975325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24603743|NCT00975325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603744|NCT00975325|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24603745|NCT00975325|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24603746|NCT00975325|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24603747|NCT00975325|Adrenergic Agents|adrenergic agents|mesh-ancestor
24603748|NCT00975325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24603749|NCT00975325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603750|NCT00975325|Urological Agents|urological agents|mesh-ancestor
24603751|NCT00975351|Tetrahydrofolates|tetrahydrofolates|mesh-list
24603783|NCT00975663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24603785|NCT00975663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603787|NCT00975728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603788|NCT00975728|Protective Agents|protective agents|mesh-ancestor
24603789|NCT00975728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603790|NCT00975741|Mometasone Furoate|mometasone furoate|mesh-list
24603791|NCT00975741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24603792|NCT00975741|Dermatologic Agents|dermatologic agents|mesh-ancestor
24603793|NCT00975741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24603794|NCT00975754|Budesonide|budesonide|mesh-list
24603795|NCT00975754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25581760|NCT00857766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25581761|NCT00857766|Respiratory System Agents|respiratory system agents|mesh-ancestor
25581762|NCT00857766|Glucocorticoids|glucocorticoids|mesh-ancestor
25581763|NCT00857766|Hormones|hormones|mesh-ancestor
25581764|NCT00857766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25581765|NCT00857766|Sympathomimetics|sympathomimetics|mesh-ancestor
25581766|NCT00857792|Regadenoson|regadenoson|mesh-list
25581767|NCT00857792|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
24659080|NCT01275547|Antidepressive Agents|antidepressive agents|mesh-ancestor
24659081|NCT01275560|Metronidazole|metronidazole|mesh-list
24659082|NCT01275560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24659083|NCT01275560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24464001|NCT00362934|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24464002|NCT00362934|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24464003|NCT00362934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464005|NCT00362947|Anticoagulants|anticoagulants|mesh-ancestor
24464006|NCT00362947|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24442006|NCT00289419|Autonomic Agents|autonomic agents|mesh-ancestor
24464007|NCT00362947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24464008|NCT00362947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464009|NCT00362960|Losartan|losartan|mesh-list
24464016|NCT00362960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464017|NCT00362973|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24464018|NCT00362973|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24730682|NCT01629628|Adalimumab|adalimumab|mesh-list
25581768|NCT00857792|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25581769|NCT00857792|Purinergic Agonists|purinergic agonists|mesh-ancestor
25581770|NCT00857792|Purinergic Agents|purinergic agents|mesh-ancestor
25581771|NCT00857792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25581772|NCT00857792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581773|NCT00857792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581774|NCT00857818|Risperidone|risperidone|mesh-list
25581775|NCT00857818|Aripiprazole|aripiprazole|mesh-list
25581776|NCT00857818|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24464096|NCT00363337|Dopamine Agents|dopamine agents|mesh-ancestor
24464097|NCT00363337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24464098|NCT00363337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464099|NCT00363337|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24464100|NCT00363337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24464101|NCT00363337|Serotonin Agents|serotonin agents|mesh-ancestor
24464102|NCT00363337|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24464103|NCT00363337|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24464104|NCT00363337|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24464105|NCT00363337|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24464106|NCT00363350|Rituximab|rituximab|mesh-list
24464107|NCT00363350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24489834|NCT00475553|NuvaRing|nuvaring|mesh-list
24489835|NCT00475553|Estradiol|estradiol|mesh-list
24464108|NCT00363350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24464109|NCT00363350|Immunologic Factors|immunologic factors|mesh-ancestor
25087194|NCT03281187|Testosterone|testosterone|mesh-list
24603882|NCT00975988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24603883|NCT00975988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671144|NCT01324063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671145|NCT01324063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581777|NCT00857818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25581778|NCT00857818|Serotonin Agents|serotonin agents|mesh-ancestor
25581779|NCT00857818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25581780|NCT00857818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581781|NCT00857818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581782|NCT00857818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25581783|NCT00857818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25581784|NCT00857818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24603943|NCT00976261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603994|NCT00976690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24603996|NCT00976755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603997|NCT00976755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24603998|NCT00976755|Immunologic Factors|immunologic factors|mesh-ancestor
24603999|NCT00976755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604000|NCT00976768|Fluorouracil|fluorouracil|mesh-list
24604001|NCT00976768|Oxaliplatin|oxaliplatin|mesh-list
24604002|NCT00976768|Antimetabolites|antimetabolites|mesh-ancestor
24464168|NCT00363584|Antimetabolites|antimetabolites|mesh-ancestor
25581785|NCT00857818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25581786|NCT00857818|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25581787|NCT00857818|Dopamine Agents|dopamine agents|mesh-ancestor
25581788|NCT00857818|Antidepressive Agents|antidepressive agents|mesh-ancestor
25581789|NCT00857818|Dopamine Agonists|dopamine agonists|mesh-ancestor
25581790|NCT00857818|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25581791|NCT00857818|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25581792|NCT00857818|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25581793|NCT00857818|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25581794|NCT00857896|Fesoterodine|fesoterodine|mesh-list
24631512|NCT01118598|Niacin|niacin|mesh-list
24604102|NCT00977223|Aprepitant|aprepitant|mesh-list
24604103|NCT00977223|Fosaprepitant|fosaprepitant|mesh-list
24604104|NCT00977223|Antiemetics|antiemetics|mesh-ancestor
24604105|NCT00977223|Autonomic Agents|autonomic agents|mesh-ancestor
24604106|NCT00977223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24604112|NCT00977249|Varenicline|varenicline|mesh-list
24490255|NCT00477282|Topotecan|topotecan|mesh-list
25581795|NCT00857896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25581796|NCT00857896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25581797|NCT00857896|Cholinergic Agents|cholinergic agents|mesh-ancestor
25581798|NCT00857896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25581799|NCT00857896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581800|NCT00857896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581801|NCT00857896|Urological Agents|urological agents|mesh-ancestor
25581802|NCT00857948|Ivermectin|ivermectin|mesh-list
25581803|NCT00857948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25581804|NCT00857948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24604553|NCT00980187|Natriuretic Agents|natriuretic agents|mesh-ancestor
24636795|NCT01147354|Micronutrients|micronutrients|mesh-ancestor
24604554|NCT00980187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604555|NCT00980187|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24604556|NCT00980187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24604557|NCT00980187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604558|NCT00980213|Sunitinib|sunitinib|mesh-list
24604571|NCT00980239|Irinotecan|irinotecan|mesh-list
24604572|NCT00980239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24604573|NCT00980239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24452677|NCT05457829|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24452678|NCT05457829|Irinotecan|irinotecan|mesh-list
24452679|NCT05457829|Vincristine|vincristine|mesh-list
24596985|NCT00946686|Immunologic Factors|immunologic factors|mesh-ancestor
24596986|NCT00946686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596988|NCT00946725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24474698|NCT00407017|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24452740|NCT05455944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24464293|NCT00364052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24464294|NCT00364052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25581805|NCT00857961|Testosterone|testosterone|mesh-list
25581806|NCT00857961|Androgens|androgens|mesh-ancestor
25581807|NCT00857961|Hormones|hormones|mesh-ancestor
25653029|NCT01534182|Immunologic Factors|immunologic factors|mesh-ancestor
25476448|NCT00078338|Interferons|interferons|mesh-list
25581808|NCT00857961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25581809|NCT00857961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581811|NCT00858013|Nateglinide|nateglinide|mesh-list
25581812|NCT00858013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24604586|NCT00980304|Immunologic Factors|immunologic factors|mesh-ancestor
24622504|NCT01067365|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24622505|NCT01067365|Chelating Agents|chelating agents|mesh-ancestor
24622506|NCT01067365|Sequestering Agents|sequestering agents|mesh-ancestor
24622507|NCT01067365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802569|NCT01990937|Anesthetics, General|anesthetics, general|mesh-ancestor
24802570|NCT01990937|Anesthetics|anesthetics|mesh-ancestor
24802571|NCT01990937|GABA Modulators|gaba modulators|mesh-ancestor
24474699|NCT00407043|Loteprednol Etabonate|loteprednol etabonate|mesh-list
24802827|NCT01992653|Prednisolone|prednisolone|mesh-list
24464504|NCT00365222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464506|NCT00365287|Cyclosporine|cyclosporine|mesh-list
24464507|NCT00365287|Mycophenolic Acid|mycophenolic acid|mesh-list
24464508|NCT00365287|Cyclophosphamide|cyclophosphamide|mesh-list
24464509|NCT00365287|Fludarabine|fludarabine|mesh-list
24464510|NCT00365287|Fludarabine phosphate|fludarabine phosphate|mesh-list
24464565|NCT00365339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24464566|NCT00365339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24464567|NCT00365339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24464732|NCT00366262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24464733|NCT00366262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464734|NCT00366262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464780|NCT00366834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24464979|NCT00367471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24464980|NCT00367471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24464981|NCT00367471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464982|NCT00367497|Cytarabine|cytarabine|mesh-list
24802588|NCT01991119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24732048|NCT01637636|Rifampin|rifampin|mesh-list
24802636|NCT01991288|Anesthetics|anesthetics|mesh-ancestor
24802637|NCT01991288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25581813|NCT00858013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25581814|NCT00858013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581815|NCT00858013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25581816|NCT00858013|Immunologic Factors|immunologic factors|mesh-ancestor
25581817|NCT00858117|Rituximab|rituximab|mesh-list
25581818|NCT00858117|Alemtuzumab|alemtuzumab|mesh-list
25581819|NCT00858117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25581820|NCT00858117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581821|NCT00858117|Immunologic Factors|immunologic factors|mesh-ancestor
25581822|NCT00858117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581823|NCT00858117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25581824|NCT00858234|Bortezomib|bortezomib|mesh-list
25581825|NCT00858234|Vorinostat|vorinostat|mesh-list
25581826|NCT00858234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581827|NCT00858234|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24665678|NCT01314066|Growth Substances|growth substances|mesh-ancestor
24465081|NCT00367874|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24465082|NCT00367874|Narcotics|narcotics|mesh-ancestor
24465083|NCT00367874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24474700|NCT00407043|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24465085|NCT00367874|Analgesics|analgesics|mesh-ancestor
24465087|NCT00367874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24465088|NCT00367874|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24465089|NCT00367874|Anticonvulsants|anticonvulsants|mesh-ancestor
24465090|NCT00367874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617048|NCT01040455|Lansoprazole|lansoprazole|mesh-list
24802651|NCT01991288|Mydriatics|mydriatics|mesh-ancestor
24802652|NCT01991288|Sympathomimetics|sympathomimetics|mesh-ancestor
24802653|NCT01991288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24802654|NCT01991327|Enclomiphene|enclomiphene|mesh-list
24802656|NCT01991327|Zuclomiphene|zuclomiphene|mesh-list
24802657|NCT01991327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24802658|NCT01991327|Hormone Antagonists|hormone antagonists|mesh-ancestor
24465133|NCT00367965|Eszopiclone|eszopiclone|mesh-list
25581828|NCT00858234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581829|NCT00858234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581830|NCT00858247|Vitamin D|vitamin d|mesh-list
25581831|NCT00858247|Cholecalciferol|cholecalciferol|mesh-list
25581832|NCT00858247|Vitamins|vitamins|mesh-ancestor
25581833|NCT00858247|Micronutrients|micronutrients|mesh-ancestor
25581834|NCT00858247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581835|NCT00858247|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25581836|NCT00858247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25087837|NCT03276325|Nalbuphine|nalbuphine|mesh-list
25581837|NCT00858364|Darbepoetin alfa|darbepoetin alfa|mesh-list
25581838|NCT00858364|Hematinics|hematinics|mesh-ancestor
25581839|NCT00858403|Dasatinib|dasatinib|mesh-list
25581840|NCT00858403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581841|NCT00858403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25581842|NCT00858403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581843|NCT00858403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581844|NCT00858468|Vaccines|vaccines|mesh-list
25581845|NCT00858468|Immunologic Factors|immunologic factors|mesh-ancestor
25581846|NCT00858468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581847|NCT00858637|Bile Acids and Salts|bile acids and salts|mesh-list
25581848|NCT00858637|Simvastatin|simvastatin|mesh-list
24668156|NCT05069896|Analgesics|analgesics|mesh-ancestor
24465341|NCT00369044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24465342|NCT00369044|Glucocorticoids|glucocorticoids|mesh-ancestor
25581849|NCT00858637|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25581850|NCT00858637|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25581851|NCT00858637|Antimetabolites|antimetabolites|mesh-ancestor
25581852|NCT00858637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581853|NCT00858637|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25581854|NCT00858637|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25581855|NCT00858637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581856|NCT00858637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25581857|NCT00858689|Minocycline|minocycline|mesh-list
25581858|NCT00858689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25581859|NCT00858689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25581860|NCT00858780|Etanercept|etanercept|mesh-list
25581861|NCT00858780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25581862|NCT00858780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25581863|NCT00858780|Analgesics|analgesics|mesh-ancestor
25581864|NCT00858780|Sensory System Agents|sensory system agents|mesh-ancestor
25581865|NCT00858780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25581866|NCT00858780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581867|NCT00858780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25581868|NCT00858780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24803189|NCT01995019|Prednisolone|prednisolone|mesh-list
24604886|NCT00981955|Purinergic Agents|purinergic agents|mesh-ancestor
25581869|NCT00858780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25581870|NCT00858780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25581871|NCT00858780|Immunologic Factors|immunologic factors|mesh-ancestor
25581872|NCT00858832|Methylergonovine|methylergonovine|mesh-list
25581873|NCT00858832|Oxytocics|oxytocics|mesh-ancestor
24605200|NCT00983788|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25581874|NCT00858832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25581875|NCT00858832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581876|NCT00858845|Clonidine|clonidine|mesh-list
25581877|NCT00858845|Analgesics|analgesics|mesh-ancestor
25581878|NCT00858845|Sensory System Agents|sensory system agents|mesh-ancestor
24803756|NCT01998347|Fluorouracil|fluorouracil|mesh-list
25581879|NCT00858845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25581880|NCT00858845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476546|NCT00078715|Yohimbine|yohimbine|mesh-list
25581881|NCT00858845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25581882|NCT00858845|Sympatholytics|sympatholytics|mesh-ancestor
25581884|NCT00858845|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25581885|NCT00858845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25581886|NCT00858845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25581887|NCT00858845|Adrenergic Agents|adrenergic agents|mesh-ancestor
25581888|NCT00858845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25581889|NCT00858845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581890|NCT00858858|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25581891|NCT00858858|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24430995|NCT00249964|Paclitaxel|paclitaxel|mesh-list
25581892|NCT00858858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25581893|NCT00858962|Raltegravir Potassium|raltegravir potassium|mesh-list
25581894|NCT00858962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25581895|NCT00858962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25581896|NCT00858962|Antiviral Agents|antiviral agents|mesh-ancestor
25581897|NCT00858962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25581898|NCT00858962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25581899|NCT00858962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25581900|NCT00858962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24804951|NCT02006043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804952|NCT02006173|Lidocaine|lidocaine|mesh-list
24804953|NCT02006173|Anesthetics, Local|anesthetics, local|mesh-ancestor
24804954|NCT02006173|Anesthetics|anesthetics|mesh-ancestor
24804955|NCT02006173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24804970|NCT02006277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24804973|NCT02006277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466786|NCT00374894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466787|NCT00374894|Chelating Agents|chelating agents|mesh-ancestor
24466811|NCT00375076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24805000|NCT02006589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805002|NCT02006602|Candesartan cilexetil|candesartan cilexetil|mesh-list
24805003|NCT02006602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25581901|NCT00858962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581902|NCT00858988|Rifaximin|rifaximin|mesh-list
25581903|NCT00858988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25581904|NCT00858988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25581905|NCT00858988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25581906|NCT00859027|Risedronic Acid|risedronic acid|mesh-list
25581907|NCT00859027|Etidronic Acid|etidronic acid|mesh-list
25581908|NCT00859027|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25581909|NCT00859027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24467107|NCT00376285|Antimetabolites|antimetabolites|mesh-ancestor
24467108|NCT00376285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467109|NCT00376285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24467110|NCT00376311|Calcitonin|calcitonin|mesh-list
24605906|NCT00987844|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24605907|NCT00987844|Serotonin Agents|serotonin agents|mesh-ancestor
24605908|NCT00987844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24605909|NCT00987844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606048|NCT00988728|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24606049|NCT00988728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24499968|NCT00521859|Antimetabolites|antimetabolites|mesh-ancestor
24671245|NCT01324492|Immunologic Factors|immunologic factors|mesh-ancestor
24671246|NCT01324492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671247|NCT01324544|Buprenorphine|buprenorphine|mesh-list
25581910|NCT00859027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581911|NCT00859027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25581912|NCT00859027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581913|NCT00859027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25581914|NCT00859040|Pasireotide|pasireotide|mesh-list
25581915|NCT00859040|Hormones|hormones|mesh-ancestor
25581916|NCT00859040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25581917|NCT00859040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581918|NCT00859131|Thymoglobulin|thymoglobulin|mesh-list
25581919|NCT00859131|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25581920|NCT00859131|Daclizumab|daclizumab|mesh-list
25581921|NCT00859131|Immunologic Factors|immunologic factors|mesh-ancestor
25581922|NCT00859131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581923|NCT00859131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25581924|NCT00859222|Bevacizumab|bevacizumab|mesh-list
25581925|NCT00859222|Panobinostat|panobinostat|mesh-list
25581926|NCT00859222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24432363|NCT00254618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24432364|NCT00254618|Analgesics|analgesics|mesh-ancestor
24432774|NCT00256100|PENTA|penta|mesh-list
25581927|NCT00859222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581928|NCT00859222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25581929|NCT00859222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25581930|NCT00859222|Growth Substances|growth substances|mesh-ancestor
25581931|NCT00859222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581932|NCT00859222|Growth Inhibitors|growth inhibitors|mesh-ancestor
25581933|NCT00859222|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25581934|NCT00859222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581935|NCT00859222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581936|NCT00859313|Sufentanil|sufentanil|mesh-list
25581937|NCT00859313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25581938|NCT00859313|Narcotics|narcotics|mesh-ancestor
25581939|NCT00859313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25581940|NCT00859313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581941|NCT00859313|Analgesics|analgesics|mesh-ancestor
25581942|NCT00859313|Sensory System Agents|sensory system agents|mesh-ancestor
25581943|NCT00859313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25581944|NCT00859313|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25581945|NCT00859313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25581946|NCT00859313|Anesthetics, General|anesthetics, general|mesh-ancestor
25581947|NCT00859313|Anesthetics|anesthetics|mesh-ancestor
25581948|NCT00859339|Gemcitabine|gemcitabine|mesh-list
25581949|NCT00859339|Cisplatin|cisplatin|mesh-list
25581950|NCT00859339|Sunitinib|sunitinib|mesh-list
25581951|NCT00859339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581952|NCT00859339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25581953|NCT00859339|Antimetabolites|antimetabolites|mesh-ancestor
25581954|NCT00859339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581955|NCT00859339|Antiviral Agents|antiviral agents|mesh-ancestor
25581956|NCT00859339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25476600|NCT00078897|Selenium|selenium|mesh-list
25581958|NCT00859339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25581959|NCT00859339|Immunologic Factors|immunologic factors|mesh-ancestor
24607233|NCT04951206|Hormones|hormones|mesh-ancestor
24467785|NCT00378716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24502324|NCT05273671|Dexmedetomidine|dexmedetomidine|mesh-list
24467830|NCT00378872|Coagulants|coagulants|mesh-ancestor
24467831|NCT00378911|Sunitinib|sunitinib|mesh-list
24467974|NCT00379418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24607234|NCT04951206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24607235|NCT04951206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607236|NCT04946006|Oxytocin|oxytocin|mesh-list
24607286|NCT04849455|Ropivacaine|ropivacaine|mesh-list
24607287|NCT04849455|Anesthetics, Local|anesthetics, local|mesh-list
24434169|NCT00261599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25581960|NCT00859339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581961|NCT00859339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25581962|NCT00859339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25581963|NCT00859339|Growth Substances|growth substances|mesh-ancestor
25581964|NCT00859339|Growth Inhibitors|growth inhibitors|mesh-ancestor
25581965|NCT00859339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25581966|NCT00859456|Sunitinib|sunitinib|mesh-list
25581967|NCT00859456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581968|NCT00859456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25581969|NCT00859456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25581970|NCT00859456|Growth Substances|growth substances|mesh-ancestor
25581971|NCT00859456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581972|NCT00859456|Growth Inhibitors|growth inhibitors|mesh-ancestor
25581973|NCT00859456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25581974|NCT00859456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24607793|NCT03646474|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25089164|NCT03268278|Sensory System Agents|sensory system agents|mesh-ancestor
25581975|NCT00859456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581976|NCT00859469|Gemcitabine|gemcitabine|mesh-list
25581977|NCT00859469|Oxaliplatin|oxaliplatin|mesh-list
25581978|NCT00859469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25581979|NCT00859469|Antimetabolites|antimetabolites|mesh-ancestor
25581980|NCT00859469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581981|NCT00859469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581982|NCT00859469|Antiviral Agents|antiviral agents|mesh-ancestor
24434932|NCT00264355|Dermatologic Agents|dermatologic agents|mesh-ancestor
25581983|NCT00859469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25581984|NCT00859469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581985|NCT00859469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25581986|NCT00859469|Immunologic Factors|immunologic factors|mesh-ancestor
25581987|NCT00859469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25581988|NCT00859495|Cisplatin|cisplatin|mesh-list
25581989|NCT00859495|Doxorubicin|doxorubicin|mesh-list
25581990|NCT00859495|Pemetrexed|pemetrexed|mesh-list
25581991|NCT00859495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25581992|NCT00859495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25581993|NCT00859495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24470105|NCT00388856|Ascorbic Acid|ascorbic acid|mesh-list
24470106|NCT00388856|Vitamins|vitamins|mesh-ancestor
24608358|NCT00992030|Rituximab|rituximab|mesh-list
25581994|NCT00859495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25581995|NCT00859495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25581996|NCT00859495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25581997|NCT00859495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25581998|NCT00859495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25581999|NCT00859508|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25582000|NCT00859508|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25582001|NCT00859508|Estradiol|estradiol|mesh-list
25582002|NCT00859508|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25582003|NCT00859508|Estrogens|estrogens|mesh-ancestor
25582004|NCT00859508|Hormones|hormones|mesh-ancestor
24608715|NCT00993135|Abortifacient Agents|abortifacient agents|mesh-ancestor
24503218|NCT02665143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608716|NCT00993135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24608719|NCT00993135|Antimetabolites|antimetabolites|mesh-ancestor
24470841|NCT00392106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24470842|NCT00392106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24470843|NCT00392106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24470844|NCT00392106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24470845|NCT00392106|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24470846|NCT00392158|Anesthetics|anesthetics|mesh-list
24470847|NCT00392158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25582005|NCT00859508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25582006|NCT00859508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582007|NCT00859508|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25582008|NCT00859508|Contraceptive Agents|contraceptive agents|mesh-ancestor
25582009|NCT00859508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25582010|NCT00859508|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25582011|NCT00859573|Modafinil|modafinil|mesh-list
25582012|NCT00859573|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25582013|NCT00859573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582014|NCT00859573|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25582015|NCT00859573|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25582016|NCT00859573|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25582017|NCT00859573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582018|NCT00859651|Vitamin D|vitamin d|mesh-list
25582019|NCT00859651|Cholecalciferol|cholecalciferol|mesh-list
25582020|NCT00859651|Vitamins|vitamins|mesh-ancestor
25582021|NCT00859651|Micronutrients|micronutrients|mesh-ancestor
25582022|NCT00859651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582023|NCT00859651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25582024|NCT00859651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25582025|NCT00859833|Adenosine|adenosine|mesh-list
25582026|NCT00859833|Regadenoson|regadenoson|mesh-list
25582027|NCT00859833|Analgesics|analgesics|mesh-ancestor
25582028|NCT00859833|Sensory System Agents|sensory system agents|mesh-ancestor
24472115|NCT00398385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472116|NCT00398385|Antiviral Agents|antiviral agents|mesh-ancestor
24805515|NCT02009787|Micronutrients|micronutrients|mesh-ancestor
24805516|NCT02009787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805517|NCT02009787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24805518|NCT02009787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24805519|NCT02009943|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24805520|NCT02009943|Hematinics|hematinics|mesh-ancestor
24805521|NCT02010164|Coenzyme Q10|coenzyme q10|mesh-list
24805522|NCT02010164|Ubiquinone|ubiquinone|mesh-list
24805523|NCT02010164|Vitamins|vitamins|mesh-ancestor
25582029|NCT00859833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25582030|NCT00859833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582031|NCT00859833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25582032|NCT00859833|Vasodilator Agents|vasodilator agents|mesh-ancestor
25582033|NCT00859833|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25582034|NCT00859833|Purinergic Agonists|purinergic agonists|mesh-ancestor
25582035|NCT00859833|Purinergic Agents|purinergic agents|mesh-ancestor
25582036|NCT00859833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25582037|NCT00859833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582038|NCT00859833|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25582039|NCT00859898|Metformin|metformin|mesh-list
25582040|NCT00859898|Dapagliflozin|dapagliflozin|mesh-list
25582041|NCT00859898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25582042|NCT00859898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582043|NCT00859898|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25582044|NCT00859898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582045|NCT00859937|Dasatinib|dasatinib|mesh-list
24438588|NCT00276315|Botulinum Toxins|botulinum toxins|mesh-list
24438589|NCT00276315|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24673526|NCT01338675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24673527|NCT01338675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472470|NCT00399256|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25582046|NCT00859937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582047|NCT00859937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25582048|NCT00859937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582049|NCT00859937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582050|NCT00860015|Gemcitabine|gemcitabine|mesh-list
25582051|NCT00860015|Pemetrexed|pemetrexed|mesh-list
25582052|NCT00860015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25582053|NCT00860015|Antimetabolites|antimetabolites|mesh-ancestor
24439172|NCT00277758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439173|NCT00277758|Antiviral Agents|antiviral agents|mesh-ancestor
24439174|NCT00277758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25702954|NCT02161562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702955|NCT02161575|Ranibizumab|ranibizumab|mesh-list
25582054|NCT00860015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582055|NCT00860015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582056|NCT00860015|Antiviral Agents|antiviral agents|mesh-ancestor
24673859|NCT01340846|Dabrafenib|dabrafenib|mesh-list
25582057|NCT00860015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25582058|NCT00860015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582059|NCT00860015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25582060|NCT00860015|Immunologic Factors|immunologic factors|mesh-ancestor
25582061|NCT00860015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582062|NCT00860015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25582063|NCT00860015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25582064|NCT00860028|Varenicline|varenicline|mesh-list
24473710|NCT00403910|Canrenone|canrenone|mesh-list
25582065|NCT00860028|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25582066|NCT00860028|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24674837|NCT04326933|Imatinib Mesylate|imatinib mesylate|mesh-list
25582067|NCT00860028|Cholinergic Agents|cholinergic agents|mesh-ancestor
24675352|NCT00496834|Carvedilol|carvedilol|mesh-list
25582068|NCT00860028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25582069|NCT00860028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582070|NCT00860028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582071|NCT00860171|Iodine|iodine|mesh-list
25582072|NCT00860171|Cadexomer iodine|cadexomer iodine|mesh-list
25582073|NCT00860171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25582074|NCT00860171|Antibodies|antibodies|mesh-list
25582075|NCT00860171|Immunoglobulins|immunoglobulins|mesh-list
25582076|NCT00860171|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25582077|NCT00860171|Immunologic Factors|immunologic factors|mesh-ancestor
24676903|NCT01353209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582078|NCT00860171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582079|NCT00860171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442956|NCT00293358|Etoposide|etoposide|mesh-list
25582080|NCT00860171|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25582081|NCT00860171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25582082|NCT00860171|Trace Elements|trace elements|mesh-ancestor
25582083|NCT00860171|Micronutrients|micronutrients|mesh-ancestor
25582084|NCT00860262|Amlodipine|amlodipine|mesh-list
25582085|NCT00860262|Telmisartan|telmisartan|mesh-list
25582086|NCT00860262|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
25582087|NCT00860262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25582088|NCT00860262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25582089|NCT00860262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25582090|NCT00860262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582091|NCT00860262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25582092|NCT00860262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582093|NCT00860262|Vasodilator Agents|vasodilator agents|mesh-ancestor
25582094|NCT00860262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25582095|NCT00860262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25582096|NCT00860379|Selenium|selenium|mesh-list
25582097|NCT00860379|Antioxidants|antioxidants|mesh-ancestor
25582098|NCT00860379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582099|NCT00860379|Protective Agents|protective agents|mesh-ancestor
25582100|NCT00860379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906018|NCT04343170|Vitamins|vitamins|mesh-ancestor
25582101|NCT00860379|Trace Elements|trace elements|mesh-ancestor
25582102|NCT00860379|Micronutrients|micronutrients|mesh-ancestor
25582103|NCT00860405|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
25582104|NCT00860405|Plasma Substitutes|plasma substitutes|mesh-ancestor
25582106|NCT00860457|Rituximab|rituximab|mesh-list
25582107|NCT00860457|Fludarabine|fludarabine|mesh-list
25582108|NCT00860457|Lenalidomide|lenalidomide|mesh-list
25582109|NCT00860457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25582110|NCT00860457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582111|NCT00860457|Immunologic Factors|immunologic factors|mesh-ancestor
25582112|NCT00860457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582113|NCT00860457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25582114|NCT00860457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25582115|NCT00860457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25582116|NCT00860457|Growth Substances|growth substances|mesh-ancestor
25582117|NCT00860457|Growth Inhibitors|growth inhibitors|mesh-ancestor
25582118|NCT00860470|Iron|iron|mesh-list
25582119|NCT00860470|Trace Elements|trace elements|mesh-list
25582120|NCT00860470|Folic Acid|folic acid|mesh-list
25582121|NCT00860470|Micronutrients|micronutrients|mesh-list
25582122|NCT00860470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582123|NCT00860470|Hematinics|hematinics|mesh-ancestor
25582124|NCT00860470|Vitamin B Complex|vitamin b complex|mesh-ancestor
25582125|NCT00860470|Vitamins|vitamins|mesh-ancestor
25582126|NCT00860574|Methotrexate|methotrexate|mesh-list
25582127|NCT00860574|Fludarabine phosphate|fludarabine phosphate|mesh-list
25582128|NCT00860574|Fludarabine|fludarabine|mesh-list
25582129|NCT00860574|Treosulfan|treosulfan|mesh-list
25582130|NCT00860574|Tacrolimus|tacrolimus|mesh-list
25582131|NCT00860574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25582132|NCT00860574|Abortifacient Agents|abortifacient agents|mesh-ancestor
24680437|NCT01374737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25582133|NCT00860574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25582134|NCT00860574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582135|NCT00860574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25582136|NCT00860574|Antimetabolites|antimetabolites|mesh-ancestor
25582137|NCT00860574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582138|NCT00860574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582139|NCT00860574|Dermatologic Agents|dermatologic agents|mesh-ancestor
25582140|NCT00860574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582141|NCT00860574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25582142|NCT00860574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25582143|NCT00860574|Immunologic Factors|immunologic factors|mesh-ancestor
25582144|NCT00860574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25582145|NCT00860574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25582146|NCT00860574|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25582147|NCT00860574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25582148|NCT00860574|Alkylating Agents|alkylating agents|mesh-ancestor
25582149|NCT00860743|Antioxidants|antioxidants|mesh-list
25582150|NCT00860743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582151|NCT00860743|Protective Agents|protective agents|mesh-ancestor
25582152|NCT00860743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582153|NCT00860847|Ubiquinone|ubiquinone|mesh-list
25582154|NCT00860847|Coenzyme Q10|coenzyme q10|mesh-list
25582155|NCT00860847|Micronutrients|micronutrients|mesh-ancestor
25582156|NCT00860847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582157|NCT00860847|Vitamins|vitamins|mesh-ancestor
25582158|NCT00860938|Budesonide|budesonide|mesh-list
25582159|NCT00860938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25582160|NCT00860938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25582161|NCT00860938|Autonomic Agents|autonomic agents|mesh-ancestor
25582162|NCT00860938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25582163|NCT00860938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582164|NCT00860938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25582165|NCT00860938|Respiratory System Agents|respiratory system agents|mesh-ancestor
24682852|NCT01388660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682853|NCT01388660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582166|NCT00860938|Glucocorticoids|glucocorticoids|mesh-ancestor
25582167|NCT00860938|Hormones|hormones|mesh-ancestor
25582168|NCT00860938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25582169|NCT00861341|Aspirin|aspirin|mesh-list
25582170|NCT00861341|Pioglitazone|pioglitazone|mesh-list
25582171|NCT00861341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25582172|NCT00861341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25582173|NCT00861341|Analgesics|analgesics|mesh-ancestor
25582174|NCT00861341|Sensory System Agents|sensory system agents|mesh-ancestor
25582175|NCT00861341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25582176|NCT00861341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582177|NCT00861341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25582178|NCT00861341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25582179|NCT00861341|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25582180|NCT00861341|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25582181|NCT00861341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582182|NCT00861341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25582183|NCT00861341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25582184|NCT00861341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582186|NCT00861341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24911847|NCT04283487|Levan|levan|mesh-list
25582187|NCT00861380|Vaccines|vaccines|mesh-list
25582188|NCT00861380|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25582189|NCT00861380|Immunologic Factors|immunologic factors|mesh-ancestor
25582190|NCT00861380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582191|NCT00861471|Docetaxel|docetaxel|mesh-list
25582192|NCT00861471|Imatinib Mesylate|imatinib mesylate|mesh-list
25582193|NCT00861471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582194|NCT00861471|Tubulin Modulators|tubulin modulators|mesh-ancestor
25582195|NCT00861471|Antimitotic Agents|antimitotic agents|mesh-ancestor
25582196|NCT00861471|Mitosis Modulators|mitosis modulators|mesh-ancestor
25582197|NCT00861471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826669|NCT02135627|Epinephrine|epinephrine|mesh-list
25703105|NCT02163447|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25703106|NCT02163447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582198|NCT00861471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25582199|NCT00861471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582200|NCT00861614|Ipilimumab|ipilimumab|mesh-list
25582201|NCT00861614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25582202|NCT00861614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582203|NCT00861614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25703111|NCT02163759|Etrolizumab|etrolizumab|mesh-list
24914065|NCT04258163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25582204|NCT00861614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582205|NCT00861692|Argatroban|argatroban|mesh-list
25582206|NCT00861692|Antithrombins|antithrombins|mesh-ancestor
25582207|NCT00861692|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24611842|NCT01011010|Mitomycin|mitomycin|mesh-list
24688935|NCT02551991|Leucovorin|leucovorin|mesh-list
25582208|NCT00861692|Protease Inhibitors|protease inhibitors|mesh-ancestor
25582209|NCT00861692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582210|NCT00861692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582211|NCT00861692|Anticoagulants|anticoagulants|mesh-ancestor
25582212|NCT00861692|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25582213|NCT00861744|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25582214|NCT00861744|Immunologic Factors|immunologic factors|mesh-ancestor
25582215|NCT00861744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582216|NCT00861757|Tadalafil|tadalafil|mesh-list
25582217|NCT00861757|Tamsulosin|tamsulosin|mesh-list
25582218|NCT00861757|Vasodilator Agents|vasodilator agents|mesh-ancestor
24489903|NCT00475826|Ezetimibe|ezetimibe|mesh-list
25582219|NCT00861757|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25582220|NCT00861757|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25582221|NCT00861757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582222|NCT00861757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582223|NCT00861757|Urological Agents|urological agents|mesh-ancestor
25582224|NCT00861757|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25582225|NCT00861757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25582226|NCT00861757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25582227|NCT00861757|Adrenergic Agents|adrenergic agents|mesh-ancestor
25582228|NCT00861757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25582229|NCT00861757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582230|NCT00862082|Sorafenib|sorafenib|mesh-list
25582231|NCT00862082|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25582232|NCT00862082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582233|NCT00862082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25582234|NCT00862082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582235|NCT00862082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582236|NCT00862082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25582237|NCT00862082|Alkylating Agents|alkylating agents|mesh-ancestor
25582238|NCT00862121|Mesalamine|mesalamine|mesh-list
25582239|NCT00862121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25582240|NCT00862121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25582241|NCT00862121|Analgesics|analgesics|mesh-ancestor
25582242|NCT00862121|Sensory System Agents|sensory system agents|mesh-ancestor
25582243|NCT00862121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25582244|NCT00862121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582245|NCT00862121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25582246|NCT00862121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25582247|NCT00862134|Docetaxel|docetaxel|mesh-list
25582248|NCT00862134|Lenograstim|lenograstim|mesh-list
25582249|NCT00862134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582250|NCT00862134|Tubulin Modulators|tubulin modulators|mesh-ancestor
25582251|NCT00862134|Antimitotic Agents|antimitotic agents|mesh-ancestor
25582252|NCT00862134|Mitosis Modulators|mitosis modulators|mesh-ancestor
25582253|NCT00862134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582254|NCT00862134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25582255|NCT00862134|Immunologic Factors|immunologic factors|mesh-ancestor
25582256|NCT00862134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582258|NCT00862563|Zonisamide|zonisamide|mesh-list
25582259|NCT00862563|Levetiracetam|levetiracetam|mesh-list
25582260|NCT00862563|Anticonvulsants|anticonvulsants|mesh-ancestor
25582261|NCT00862563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25582262|NCT00862563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582263|NCT00862563|Nootropic Agents|nootropic agents|mesh-ancestor
25582264|NCT00862563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25582265|NCT00862563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25582266|NCT00862563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582267|NCT00862563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25582268|NCT00862641|Regadenoson|regadenoson|mesh-list
25582269|NCT00862641|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25582270|NCT00862641|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25582271|NCT00862641|Purinergic Agonists|purinergic agonists|mesh-ancestor
25582272|NCT00862641|Purinergic Agents|purinergic agents|mesh-ancestor
25582273|NCT00862641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25582274|NCT00862641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582275|NCT00862641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582276|NCT00862654|Ketoconazole|ketoconazole|mesh-list
25582277|NCT00862654|Clobetasol|clobetasol|mesh-list
25582278|NCT00862654|Antifungal Agents|antifungal agents|mesh-ancestor
25582279|NCT00862654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25582280|NCT00862654|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25582281|NCT00862654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25582282|NCT00862654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24827884|NCT02142140|Adderall|adderall|mesh-list
25582283|NCT00862654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582284|NCT00862654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25582285|NCT00862654|Hormone Antagonists|hormone antagonists|mesh-ancestor
25582286|NCT00862654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25582287|NCT00862654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828026|NCT02142829|Bupivacaine|bupivacaine|mesh-list
25703214|NCT02164916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25703215|NCT02164916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24694550|NCT05386186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24694594|NCT05385887|Metronidazole|metronidazole|mesh-list
25582288|NCT00862654|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25582289|NCT00862654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25582290|NCT00862654|Glucocorticoids|glucocorticoids|mesh-ancestor
25582291|NCT00862654|Hormones|hormones|mesh-ancestor
25582292|NCT00862719|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25582293|NCT00862719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25582294|NCT00862719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582295|NCT00862719|Incretins|incretins|mesh-ancestor
25582296|NCT00862719|Hormones|hormones|mesh-ancestor
25109625|NCT03122756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24670610|NCT02201108|Analgesics|analgesics|mesh-ancestor
24514132|NCT00588016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24670741|NCT01998971|Growth Inhibitors|growth inhibitors|mesh-ancestor
24670742|NCT01998971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24670876|NCT01457781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24670877|NCT01457781|Respiratory System Agents|respiratory system agents|mesh-ancestor
24791004|NCT05406895|Lidocaine|lidocaine|mesh-list
24791005|NCT05406895|Epinephrine|epinephrine|mesh-list
24670878|NCT01457781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24670879|NCT01457781|Antioxidants|antioxidants|mesh-ancestor
25582297|NCT00862719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25582298|NCT00862719|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25582299|NCT00862719|Protease Inhibitors|protease inhibitors|mesh-ancestor
25582300|NCT00862719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582301|NCT00862719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582302|NCT00862745|Fesoterodine|fesoterodine|mesh-list
25582303|NCT00862745|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25582304|NCT00862745|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25582305|NCT00862745|Cholinergic Agents|cholinergic agents|mesh-ancestor
25582306|NCT00862745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25582307|NCT00862745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582308|NCT00862745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582309|NCT00862745|Urological Agents|urological agents|mesh-ancestor
25582310|NCT00862784|Leucovorin|leucovorin|mesh-list
25582311|NCT00862784|Folic Acid|folic acid|mesh-list
25582312|NCT00862784|Oxaliplatin|oxaliplatin|mesh-list
25582313|NCT00862784|Fluorouracil|fluorouracil|mesh-list
25582314|NCT00862784|Ramucirumab|ramucirumab|mesh-list
25582315|NCT00862784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25582316|NCT00862784|Levoleucovorin|levoleucovorin|mesh-list
25582317|NCT00862784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582318|NCT00862784|Antimetabolites|antimetabolites|mesh-ancestor
24470917|NCT00392457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25582319|NCT00862784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582320|NCT00862784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25582321|NCT00862784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25582322|NCT00862784|Immunologic Factors|immunologic factors|mesh-ancestor
25582323|NCT00862784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582324|NCT00862784|Antidotes|antidotes|mesh-ancestor
25582325|NCT00862784|Protective Agents|protective agents|mesh-ancestor
25582326|NCT00862784|Vitamin B Complex|vitamin b complex|mesh-ancestor
25582327|NCT00862784|Vitamins|vitamins|mesh-ancestor
25582328|NCT00862784|Micronutrients|micronutrients|mesh-ancestor
25582329|NCT00862784|Hematinics|hematinics|mesh-ancestor
25582330|NCT00862810|Vaccines|vaccines|mesh-list
25582331|NCT00862810|Immunologic Factors|immunologic factors|mesh-ancestor
25582332|NCT00862810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582333|NCT00862823|Tenofovir|tenofovir|mesh-list
25582334|NCT00862823|Emtricitabine|emtricitabine|mesh-list
25582335|NCT00862823|Efavirenz|efavirenz|mesh-list
25582336|NCT00862823|Antiviral Agents|antiviral agents|mesh-ancestor
24491198|NCT00481572|Sympathomimetics|sympathomimetics|mesh-ancestor
25582337|NCT00862823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25582338|NCT00862823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25582339|NCT00862823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25582340|NCT00862823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582341|NCT00862823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582342|NCT00862823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25582343|NCT00862823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25582344|NCT00862823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25582345|NCT00862823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25582346|NCT00862823|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25582347|NCT00862823|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25582348|NCT00862823|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25582349|NCT00862823|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25582350|NCT00862849|Insulin|insulin|mesh-list
25582351|NCT00862849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25582352|NCT00862849|Insulin Lispro|insulin lispro|mesh-list
25582353|NCT00862849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24612483|NCT01014221|Glucocorticoids|glucocorticoids|mesh-ancestor
25582354|NCT00862849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653030|NCT01534182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653031|NCT01534182|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25653032|NCT01534182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653033|NCT01534182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25653034|NCT01534182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25653035|NCT01534182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25653036|NCT01534195|Prednisolone|prednisolone|mesh-list
25653037|NCT01534195|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25653038|NCT01534195|Methylprednisolone|methylprednisolone|mesh-list
24510494|NCT00564655|Mydriatics|mydriatics|mesh-ancestor
25653039|NCT01534195|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25653040|NCT01534195|Prednisolone acetate|prednisolone acetate|mesh-list
25653041|NCT01534195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25653042|NCT01534195|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25653043|NCT01534195|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25653044|NCT01534195|Prednisolone phosphate|prednisolone phosphate|mesh-list
25653045|NCT01534195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25653046|NCT01534195|Glucocorticoids|glucocorticoids|mesh-ancestor
25653047|NCT01534195|Hormones|hormones|mesh-ancestor
25653048|NCT01534195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25653049|NCT01534195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653050|NCT01534195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25653051|NCT01534195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25653052|NCT01534195|Antiemetics|antiemetics|mesh-ancestor
25653053|NCT01534195|Autonomic Agents|autonomic agents|mesh-ancestor
25653054|NCT01534195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653055|NCT01534195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25653056|NCT01534195|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25653057|NCT01534195|Protective Agents|protective agents|mesh-ancestor
25653058|NCT01534208|Enclomiphene|enclomiphene|mesh-list
25653059|NCT01534208|Clomiphene|clomiphene|mesh-list
25653060|NCT01534208|Zuclomiphene|zuclomiphene|mesh-list
25653061|NCT01534208|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25653062|NCT01534208|Hormone Antagonists|hormone antagonists|mesh-ancestor
25653063|NCT01534208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25653064|NCT01534208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703254|NCT02164929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25653065|NCT01534208|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25653066|NCT01534208|Fertility Agents|fertility agents|mesh-ancestor
25653067|NCT01534208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25653068|NCT01534208|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25653069|NCT01534208|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25653070|NCT01534260|Bortezomib|bortezomib|mesh-list
25653071|NCT01534260|Sorafenib|sorafenib|mesh-list
25653072|NCT01534260|Vorinostat|vorinostat|mesh-list
25653073|NCT01534260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25653074|NCT01534260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25653075|NCT01534260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653076|NCT01534260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653077|NCT01534260|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25653078|NCT01534351|Tamsulosin|tamsulosin|mesh-list
25653079|NCT01534351|Finasteride|finasteride|mesh-list
25477044|NCT00083551|Vincristine|vincristine|mesh-list
25582355|NCT00862940|Memantine|memantine|mesh-list
25582356|NCT00862940|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25582357|NCT00862940|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25582358|NCT00862940|Dopamine Agents|dopamine agents|mesh-ancestor
25582359|NCT00862940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25582360|NCT00862940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582361|NCT00862940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582362|NCT00862940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25582363|NCT00862940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25582364|NCT00862979|Cyclosporine|cyclosporine|mesh-list
25582365|NCT00862979|Mycophenolic Acid|mycophenolic acid|mesh-list
25582366|NCT00862979|Everolimus|everolimus|mesh-list
25582367|NCT00862979|Tacrolimus|tacrolimus|mesh-list
25582368|NCT00862979|Cyclosporins|cyclosporins|mesh-list
25582369|NCT00862979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25582370|NCT00862979|Immunologic Factors|immunologic factors|mesh-ancestor
25582371|NCT00862979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582372|NCT00862979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25582373|NCT00862979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709268|NCT01504828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582374|NCT00862979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582375|NCT00862979|Antifungal Agents|antifungal agents|mesh-ancestor
25582376|NCT00862979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25582377|NCT00862979|Dermatologic Agents|dermatologic agents|mesh-ancestor
25582378|NCT00862979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25582379|NCT00862979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582380|NCT00862979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25582381|NCT00862979|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25582382|NCT00862979|Antitubercular Agents|antitubercular agents|mesh-ancestor
25582383|NCT00862979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25582384|NCT00862992|Cariprazine|cariprazine|mesh-list
24709647|NCT01506557|Vitamin D|vitamin d|mesh-list
25582385|NCT00862992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25582386|NCT00862992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25582387|NCT00862992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25582388|NCT00862992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582389|NCT00862992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25582390|NCT00863057|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25582391|NCT00863057|Methadone|methadone|mesh-list
25582392|NCT00863057|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25582393|NCT00863057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25582394|NCT00863057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25582395|NCT00863057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582396|NCT00863057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25582397|NCT00863057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582398|NCT00863057|Analgesics|analgesics|mesh-ancestor
25582399|NCT00863057|Sensory System Agents|sensory system agents|mesh-ancestor
25582400|NCT00863057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25582401|NCT00863057|Antidepressive Agents|antidepressive agents|mesh-ancestor
25582402|NCT00863057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24829570|NCT02153125|Diuretics|diuretics|mesh-ancestor
25582403|NCT00863057|Dopamine Agents|dopamine agents|mesh-ancestor
25582404|NCT00863057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25582405|NCT00863057|Narcotics|narcotics|mesh-ancestor
24715313|NCT01535781|Hemostatics|hemostatics|mesh-ancestor
25582406|NCT00863057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25582407|NCT00863057|Antitussive Agents|antitussive agents|mesh-ancestor
25582408|NCT00863057|Respiratory System Agents|respiratory system agents|mesh-ancestor
25582409|NCT00863109|Ribavirin|ribavirin|mesh-list
25582410|NCT00863109|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25582411|NCT00863109|Antimetabolites|antimetabolites|mesh-ancestor
24717848|NCT01550354|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25582412|NCT00863109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582413|NCT00863109|Antiviral Agents|antiviral agents|mesh-ancestor
25582414|NCT00863109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25582415|NCT00863122|Lapatinib|lapatinib|mesh-list
25582416|NCT00863122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582417|NCT00863122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25582418|NCT00863122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582419|NCT00863122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582420|NCT00863265|Ezetimibe|ezetimibe|mesh-list
25582421|NCT00863265|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25582422|NCT00863265|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25582423|NCT00863265|Antimetabolites|antimetabolites|mesh-ancestor
25582424|NCT00863265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582425|NCT00863265|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25582426|NCT00863304|Naproxen|naproxen|mesh-list
25582427|NCT00863304|Tanezumab|tanezumab|mesh-list
25582428|NCT00863304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25582429|NCT00863304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25582430|NCT00863304|Analgesics|analgesics|mesh-ancestor
25582431|NCT00863304|Sensory System Agents|sensory system agents|mesh-ancestor
25582432|NCT00863304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25703323|NCT02166476|Piperacillin|piperacillin|mesh-list
25582433|NCT00863304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582434|NCT00863304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25582435|NCT00863304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25582436|NCT00863304|Gout Suppressants|gout suppressants|mesh-ancestor
24789511|NCT01937611|Anesthetics|anesthetics|mesh-ancestor
25582437|NCT00863304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25582438|NCT00863304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582439|NCT00863304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582440|NCT00863317|Montelukast|montelukast|mesh-list
25582441|NCT00863317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25582442|NCT00863317|Respiratory System Agents|respiratory system agents|mesh-ancestor
25582443|NCT00863317|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24730536|NCT01628731|Diuretics|diuretics|mesh-ancestor
24734647|NCT01653015|Vaccines|vaccines|mesh-list
25582444|NCT00863317|Hormone Antagonists|hormone antagonists|mesh-ancestor
25582445|NCT00863317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24740500|NCT01688648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25582446|NCT00863317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582447|NCT00863317|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25582448|NCT00863317|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24426265|NCT00235313|Nicotine|nicotine|mesh-list
25582449|NCT00863317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006854|NCT04603846|Antibodies|antibodies|mesh-list
25582450|NCT00863356|Hemostatics|hemostatics|mesh-list
25582452|NCT00863356|Coagulants|coagulants|mesh-ancestor
25582453|NCT00863356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25582454|NCT00863356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25582455|NCT00863356|Antimetabolites|antimetabolites|mesh-ancestor
24832028|NCT02170415|Pregabalin|pregabalin|mesh-list
25582456|NCT00863356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582457|NCT00863356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25582458|NCT00863356|Chelating Agents|chelating agents|mesh-ancestor
25582459|NCT00863356|Sequestering Agents|sequestering agents|mesh-ancestor
25582460|NCT00863434|Cytarabine|cytarabine|mesh-list
25582461|NCT00863434|Clofarabine|clofarabine|mesh-list
25582462|NCT00863434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25582463|NCT00863434|Antimetabolites|antimetabolites|mesh-ancestor
25582464|NCT00863434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582465|NCT00863434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582466|NCT00863434|Antiviral Agents|antiviral agents|mesh-ancestor
25582467|NCT00863434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25582468|NCT00863434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25582469|NCT00863434|Immunologic Factors|immunologic factors|mesh-ancestor
25582470|NCT00863434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582471|NCT00863551|Trospium chloride|trospium chloride|mesh-list
25582472|NCT00863551|Parasympatholytics|parasympatholytics|mesh-ancestor
25582473|NCT00863551|Autonomic Agents|autonomic agents|mesh-ancestor
24753284|NCT01714427|Autonomic Agents|autonomic agents|mesh-ancestor
25582474|NCT00863551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25582475|NCT00863551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582476|NCT00863551|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25582477|NCT00863551|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25582478|NCT00863551|Cholinergic Agents|cholinergic agents|mesh-ancestor
25582479|NCT00863551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25582480|NCT00863551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582481|NCT00863551|Urological Agents|urological agents|mesh-ancestor
25582482|NCT00863655|Everolimus|everolimus|mesh-list
25582483|NCT00863655|Exemestane|exemestane|mesh-list
25582484|NCT00863655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582485|NCT00863655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25582486|NCT00863655|Immunologic Factors|immunologic factors|mesh-ancestor
24449506|NCT00315874|Buprenorphine|buprenorphine|mesh-list
25582487|NCT00863655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582488|NCT00863655|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25582489|NCT00863655|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25582490|NCT00863655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582491|NCT00863655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582492|NCT00863655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25582493|NCT00863655|Hormone Antagonists|hormone antagonists|mesh-ancestor
25582494|NCT00863655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25582495|NCT00863681|Riociguat|riociguat|mesh-list
25582496|NCT00863681|Enzyme Activators|enzyme activators|mesh-ancestor
25582497|NCT00863681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703387|NCT02167451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24758223|NCT01744379|Lesinurad|lesinurad|mesh-list
24758360|NCT01745575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24758361|NCT01745575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758362|NCT01745575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25582498|NCT00863707|Regadenoson|regadenoson|mesh-list
25582499|NCT00863707|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25582500|NCT00863707|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25582501|NCT00863707|Purinergic Agonists|purinergic agonists|mesh-ancestor
25582502|NCT00863707|Purinergic Agents|purinergic agents|mesh-ancestor
25582503|NCT00863707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25582504|NCT00863707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582505|NCT00863707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582507|NCT00863746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582508|NCT00863746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25582509|NCT00863746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451948|NCT00325390|Purinergic Agents|purinergic agents|mesh-ancestor
24450867|NCT00320736|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24450868|NCT00320736|Autonomic Agents|autonomic agents|mesh-ancestor
25582510|NCT00863746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582511|NCT00863772|Tanezumab|tanezumab|mesh-list
25582512|NCT00863772|Analgesics|analgesics|mesh-ancestor
25582513|NCT00863772|Sensory System Agents|sensory system agents|mesh-ancestor
25582514|NCT00863772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25582515|NCT00863772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582516|NCT00863798|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25582517|NCT00863798|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25582518|NCT00863798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25582519|NCT00863798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25582520|NCT00863798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582521|NCT00863798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25582522|NCT00863798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582523|NCT00863798|Antidepressive Agents|antidepressive agents|mesh-ancestor
25582524|NCT00863798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25582525|NCT00864032|Sorafenib|sorafenib|mesh-list
25582526|NCT00864032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582527|NCT00864032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25582528|NCT00864032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582529|NCT00864032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582530|NCT00864097|Diclofenac|diclofenac|mesh-list
25582531|NCT00864097|Tanezumab|tanezumab|mesh-list
25582532|NCT00864097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25582533|NCT00864097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25582534|NCT00864097|Analgesics|analgesics|mesh-ancestor
25582535|NCT00864097|Sensory System Agents|sensory system agents|mesh-ancestor
24791664|NCT03619850|Hematinics|hematinics|mesh-ancestor
25582536|NCT00864097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25582537|NCT00864097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582538|NCT00864097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25582539|NCT00864097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25582540|NCT00864097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24397542|NCT00141830|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24397543|NCT00141830|Abortifacient Agents|abortifacient agents|mesh-ancestor
24397544|NCT00141830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25582541|NCT00864097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582542|NCT00864097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582543|NCT00864123|Cycloserine|cycloserine|mesh-list
25582544|NCT00864123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25582545|NCT00864123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25582546|NCT00864123|Renal Agents|renal agents|mesh-ancestor
25582547|NCT00864123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25582548|NCT00864123|Antitubercular Agents|antitubercular agents|mesh-ancestor
25582549|NCT00864123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25582550|NCT00864123|Antimetabolites|antimetabolites|mesh-ancestor
25582551|NCT00864123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582552|NCT00864253|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25582553|NCT00864253|Dacarbazine|dacarbazine|mesh-list
25582554|NCT00864253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582555|NCT00864253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25582556|NCT00864253|Alkylating Agents|alkylating agents|mesh-ancestor
25582557|NCT00864253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582558|NCT00864383|Moxifloxacin|moxifloxacin|mesh-list
25582559|NCT00864383|Rifampin|rifampin|mesh-list
25582560|NCT00864383|Isoniazid|isoniazid|mesh-list
25582561|NCT00864383|Pyrazinamide|pyrazinamide|mesh-list
25582562|NCT00864383|Ethambutol|ethambutol|mesh-list
25582563|NCT00864383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25582564|NCT00864383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25582565|NCT00864383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25582566|NCT00864383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25582567|NCT00864383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582568|NCT00864383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582569|NCT00864383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582570|NCT00864383|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25582571|NCT00864383|Antitubercular Agents|antitubercular agents|mesh-ancestor
25582572|NCT00864383|Leprostatic Agents|leprostatic agents|mesh-ancestor
25582573|NCT00864383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25582574|NCT00864383|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25582575|NCT00864383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25582576|NCT00864383|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25582577|NCT00864383|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25582578|NCT00864383|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25582579|NCT00864383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25582580|NCT00864383|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24426394|NCT00235950|Clopidogrel|clopidogrel|mesh-list
25582581|NCT00864383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25582582|NCT00864383|Antimetabolites|antimetabolites|mesh-ancestor
25582583|NCT00864383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25582585|NCT00864513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582586|NCT00864513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582587|NCT00864513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582588|NCT00864513|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25582589|NCT00864513|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25582590|NCT00864539|Vitamin D|vitamin d|mesh-list
25582591|NCT00864539|Calcium|calcium|mesh-list
25582592|NCT00864539|Vitamins|vitamins|mesh-ancestor
25582593|NCT00864539|Micronutrients|micronutrients|mesh-ancestor
25582594|NCT00864539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582595|NCT00864539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25582596|NCT00864539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25582597|NCT00864682|Lidocaine|lidocaine|mesh-list
25582598|NCT00864682|Propofol|propofol|mesh-list
25582599|NCT00864682|Anesthetics, Local|anesthetics, local|mesh-ancestor
25582600|NCT00864682|Anesthetics|anesthetics|mesh-ancestor
25582601|NCT00864682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25097365|NCT03204565|Hyaluronic Acid|hyaluronic acid|mesh-list
25582602|NCT00864682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582603|NCT00864682|Sensory System Agents|sensory system agents|mesh-ancestor
25582604|NCT00864682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25582605|NCT00864682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25582606|NCT00864682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25582607|NCT00864682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25582608|NCT00864682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25582609|NCT00864682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582610|NCT00864682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25582611|NCT00864682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25582612|NCT00864682|Anesthetics, General|anesthetics, general|mesh-ancestor
25582613|NCT00864721|Sunitinib|sunitinib|mesh-list
25582614|NCT00864721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582615|NCT00864721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25582616|NCT00864721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25582617|NCT00864721|Growth Substances|growth substances|mesh-ancestor
25582618|NCT00864721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582619|NCT00864721|Growth Inhibitors|growth inhibitors|mesh-ancestor
25582620|NCT00864721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25582621|NCT00864721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582622|NCT00864721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582623|NCT00864916|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25582624|NCT00864916|Pentoxifylline|pentoxifylline|mesh-list
25582625|NCT00864916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25582626|NCT00864916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582627|NCT00864916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582628|NCT00864916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25582629|NCT00864916|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25582630|NCT00864916|Protective Agents|protective agents|mesh-ancestor
25582631|NCT00864916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582632|NCT00864916|Vasodilator Agents|vasodilator agents|mesh-ancestor
25582633|NCT00864916|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25582634|NCT00864916|Antioxidants|antioxidants|mesh-ancestor
25582635|NCT00864916|Antiviral Agents|antiviral agents|mesh-ancestor
25582636|NCT00864916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25582637|NCT00865020|Telmisartan|telmisartan|mesh-list
25582638|NCT00865020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25582639|NCT00865020|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25582640|NCT00865020|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25582641|NCT00865020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582642|NCT00865098|Cetuximab|cetuximab|mesh-list
25582643|NCT00865098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25582644|NCT00865098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582645|NCT00865124|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25582646|NCT00865124|Spironolactone|spironolactone|mesh-list
25477322|NCT00085423|Antiviral Agents|antiviral agents|mesh-ancestor
25582647|NCT00865124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25582648|NCT00865124|Diuretics|diuretics|mesh-ancestor
25582649|NCT00865124|Natriuretic Agents|natriuretic agents|mesh-ancestor
25582650|NCT00865124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582651|NCT00865124|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25582652|NCT00865124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24443016|NCT00293475|Methotrexate|methotrexate|mesh-list
25582653|NCT00865124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582654|NCT00865124|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25582655|NCT00865124|Hormone Antagonists|hormone antagonists|mesh-ancestor
25582656|NCT00865124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25582657|NCT00865124|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25582658|NCT00865189|Leucovorin|leucovorin|mesh-list
25582659|NCT00865189|Folic Acid|folic acid|mesh-list
25582660|NCT00865189|Bevacizumab|bevacizumab|mesh-list
25582661|NCT00865189|Fluorouracil|fluorouracil|mesh-list
25582662|NCT00865189|Oxaliplatin|oxaliplatin|mesh-list
25582663|NCT00865189|Levoleucovorin|levoleucovorin|mesh-list
25582664|NCT00865189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25582665|NCT00865189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582666|NCT00865189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25582667|NCT00865189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25582668|NCT00865189|Growth Substances|growth substances|mesh-ancestor
25582669|NCT00865189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582670|NCT00865189|Growth Inhibitors|growth inhibitors|mesh-ancestor
25582671|NCT00865189|Antimetabolites|antimetabolites|mesh-ancestor
25582672|NCT00865189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582673|NCT00865189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25582674|NCT00865189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25582675|NCT00865189|Immunologic Factors|immunologic factors|mesh-ancestor
25582676|NCT00865189|Antidotes|antidotes|mesh-ancestor
25582677|NCT00865189|Protective Agents|protective agents|mesh-ancestor
25582678|NCT00865189|Vitamin B Complex|vitamin b complex|mesh-ancestor
25582679|NCT00865189|Vitamins|vitamins|mesh-ancestor
25582680|NCT00865189|Micronutrients|micronutrients|mesh-ancestor
25582681|NCT00865189|Hematinics|hematinics|mesh-ancestor
25582682|NCT00865202|Tryptophan|tryptophan|mesh-list
25582683|NCT00865202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25582684|NCT00865202|Antidepressive Agents|antidepressive agents|mesh-ancestor
25582685|NCT00865202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25582686|NCT00865280|Moxifloxacin|moxifloxacin|mesh-list
25582687|NCT00865280|Linezolid|linezolid|mesh-list
25582688|NCT00865280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25582689|NCT00865280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25582690|NCT00865280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25582691|NCT00865280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25582692|NCT00865280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582693|NCT00865280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582694|NCT00865280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582695|NCT00865280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25582696|NCT00865566|Vaccines|vaccines|mesh-list
25582697|NCT00865566|Immunologic Factors|immunologic factors|mesh-ancestor
25582698|NCT00865566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582699|NCT00865709|Leucovorin|leucovorin|mesh-list
25582700|NCT00865709|Oxaliplatin|oxaliplatin|mesh-list
25582701|NCT00865709|Fluorouracil|fluorouracil|mesh-list
25582702|NCT00865709|Sorafenib|sorafenib|mesh-list
25582703|NCT00865709|Levoleucovorin|levoleucovorin|mesh-list
25582704|NCT00865709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582705|NCT00865709|Antidotes|antidotes|mesh-ancestor
25582706|NCT00865709|Protective Agents|protective agents|mesh-ancestor
25582707|NCT00865709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582708|NCT00865709|Vitamin B Complex|vitamin b complex|mesh-ancestor
25582709|NCT00865709|Vitamins|vitamins|mesh-ancestor
25582710|NCT00865709|Micronutrients|micronutrients|mesh-ancestor
25582711|NCT00865709|Antimetabolites|antimetabolites|mesh-ancestor
25582712|NCT00865709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582713|NCT00865709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25582714|NCT00865709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25582715|NCT00865709|Immunologic Factors|immunologic factors|mesh-ancestor
25582716|NCT00865709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25582717|NCT00865709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582718|NCT00865969|Belinostat|belinostat|mesh-list
25582719|NCT00865969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582720|NCT00865969|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25582721|NCT00865969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582722|NCT00865969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582723|NCT00866034|Cetrorelix|cetrorelix|mesh-list
25582724|NCT00866034|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25582726|NCT00866034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25582727|NCT00866034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582728|NCT00866034|Hormone Antagonists|hormone antagonists|mesh-ancestor
25582729|NCT00866034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25582730|NCT00866047|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25582731|NCT00866047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25582732|NCT00866047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582733|NCT00866281|Midostaurin|midostaurin|mesh-list
25582734|NCT00866281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582735|NCT00866281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25582736|NCT00866281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582737|NCT00866281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582738|NCT00866294|Paroxetine|paroxetine|mesh-list
25582739|NCT00866294|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25582740|NCT00866294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25582741|NCT00866294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25582742|NCT00866294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582743|NCT00866294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25582744|NCT00866294|Serotonin Agents|serotonin agents|mesh-ancestor
25582745|NCT00866294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582746|NCT00866294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25582747|NCT00866294|Antidepressive Agents|antidepressive agents|mesh-ancestor
25582748|NCT00866294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25582749|NCT00866294|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25477459|NCT00086346|Antifungal Agents|antifungal agents|mesh-ancestor
25477460|NCT00086346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25477461|NCT00086346|Dermatologic Agents|dermatologic agents|mesh-ancestor
25477462|NCT00086346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25477463|NCT00086346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25477464|NCT00086346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25477465|NCT00086346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477466|NCT00086385|Bupropion|bupropion|mesh-list
25477467|NCT00086385|Nicotine|nicotine|mesh-list
25477468|NCT00086385|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25477469|NCT00086385|Autonomic Agents|autonomic agents|mesh-ancestor
25477470|NCT00086385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25477471|NCT00086385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477472|NCT00086385|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25477473|NCT00086385|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25477474|NCT00086385|Cholinergic Agents|cholinergic agents|mesh-ancestor
25477475|NCT00086385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25477476|NCT00086385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477477|NCT00086385|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25477478|NCT00086385|Antidepressive Agents|antidepressive agents|mesh-ancestor
25477479|NCT00086385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25477480|NCT00086385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25477481|NCT00086385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25477482|NCT00086385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25582750|NCT00866294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25582751|NCT00866294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582752|NCT00866307|Cytarabine|cytarabine|mesh-list
25582753|NCT00866307|Dexamethasone|dexamethasone|mesh-list
25582754|NCT00866307|Dexamethasone acetate|dexamethasone acetate|mesh-list
25582755|NCT00866307|Prednisone|prednisone|mesh-list
25582756|NCT00866307|Cortisone|cortisone|mesh-list
25582757|NCT00866307|Cyclophosphamide|cyclophosphamide|mesh-list
25582758|NCT00866307|Doxorubicin|doxorubicin|mesh-list
25582759|NCT00866307|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25582760|NCT00866307|Methotrexate|methotrexate|mesh-list
25582761|NCT00866307|Vincristine|vincristine|mesh-list
25582762|NCT00866307|Daunorubicin|daunorubicin|mesh-list
25582763|NCT00866307|Asparaginase|asparaginase|mesh-list
25582764|NCT00866307|Mercaptopurine|mercaptopurine|mesh-list
25582765|NCT00866307|Pegaspargase|pegaspargase|mesh-list
25582766|NCT00866307|Thioguanine|thioguanine|mesh-list
25582767|NCT00866307|BB 1101|bb 1101|mesh-list
25582768|NCT00866307|2-Aminopurine|2-aminopurine|mesh-list
25582769|NCT00866307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25582770|NCT00866307|Immunologic Factors|immunologic factors|mesh-ancestor
25582771|NCT00866307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582772|NCT00866307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25582773|NCT00866307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25582774|NCT00866307|Alkylating Agents|alkylating agents|mesh-ancestor
25582775|NCT00866307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582776|NCT00866307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582777|NCT00866307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25582778|NCT00866307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25582779|NCT00866307|Antiemetics|antiemetics|mesh-ancestor
25582780|NCT00866307|Autonomic Agents|autonomic agents|mesh-ancestor
25582781|NCT00866307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25582782|NCT00866307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25582783|NCT00866307|Glucocorticoids|glucocorticoids|mesh-ancestor
25582784|NCT00866307|Hormones|hormones|mesh-ancestor
25582785|NCT00866307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25582786|NCT00866307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25582787|NCT00866307|Protease Inhibitors|protease inhibitors|mesh-ancestor
25582788|NCT00866307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582789|NCT00866307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25582790|NCT00866307|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25582791|NCT00866307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25582792|NCT00866307|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25582793|NCT00866307|Abortifacient Agents|abortifacient agents|mesh-ancestor
25582794|NCT00866307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25582795|NCT00866307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25582796|NCT00866307|Antimetabolites|antimetabolites|mesh-ancestor
25582797|NCT00866307|Dermatologic Agents|dermatologic agents|mesh-ancestor
25582798|NCT00866307|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25582799|NCT00866307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25582800|NCT00866307|Antiviral Agents|antiviral agents|mesh-ancestor
25582801|NCT00866307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25582802|NCT00866307|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25582803|NCT00866307|Tubulin Modulators|tubulin modulators|mesh-ancestor
25582804|NCT00866307|Antimitotic Agents|antimitotic agents|mesh-ancestor
25582805|NCT00866307|Mitosis Modulators|mitosis modulators|mesh-ancestor
25582806|NCT00866320|Sorafenib|sorafenib|mesh-list
25582807|NCT00866320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582808|NCT00866320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25582809|NCT00866320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582810|NCT00866320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582811|NCT00866333|Entinostat|entinostat|mesh-list
25582812|NCT00866333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582813|NCT00866333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25582814|NCT00866333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582815|NCT00866333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582816|NCT00866359|Apremilast|apremilast|mesh-list
25582817|NCT00866359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25582818|NCT00866359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25582819|NCT00866359|Analgesics|analgesics|mesh-ancestor
25582820|NCT00866359|Sensory System Agents|sensory system agents|mesh-ancestor
25582821|NCT00866359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25582822|NCT00866359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582823|NCT00866359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25582824|NCT00866359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25582825|NCT00866359|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25582826|NCT00866359|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25582827|NCT00866359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582828|NCT00866359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582829|NCT00866619|Vaccines|vaccines|mesh-list
25582830|NCT00866619|Immunologic Factors|immunologic factors|mesh-ancestor
25582831|NCT00866619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582832|NCT00866658|Lixisenatide|lixisenatide|mesh-list
25582833|NCT00866658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25582834|NCT00866658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582835|NCT00866723|Bevacizumab|bevacizumab|mesh-list
25582836|NCT00866723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25582837|NCT00866723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582838|NCT00866723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25582839|NCT00866723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25582840|NCT00866723|Growth Substances|growth substances|mesh-ancestor
25582841|NCT00866723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582842|NCT00866723|Growth Inhibitors|growth inhibitors|mesh-ancestor
25582843|NCT00866749|Cytarabine|cytarabine|mesh-list
25582844|NCT00866749|Cyclophosphamide|cyclophosphamide|mesh-list
25582845|NCT00866749|Doxorubicin|doxorubicin|mesh-list
25582846|NCT00866749|Methotrexate|methotrexate|mesh-list
25582847|NCT00866749|Vincristine|vincristine|mesh-list
25582848|NCT00866749|Daunorubicin|daunorubicin|mesh-list
25582849|NCT00866749|Asparaginase|asparaginase|mesh-list
25582850|NCT00866749|Mercaptopurine|mercaptopurine|mesh-list
25582851|NCT00866749|Thioguanine|thioguanine|mesh-list
25582852|NCT00866749|Pegaspargase|pegaspargase|mesh-list
25582853|NCT00866749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25582854|NCT00866749|Immunologic Factors|immunologic factors|mesh-ancestor
25582855|NCT00866749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582856|NCT00866749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25582857|NCT00866749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25582858|NCT00866749|Alkylating Agents|alkylating agents|mesh-ancestor
25582859|NCT00866749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582860|NCT00866749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582861|NCT00866749|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25582862|NCT00866749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25582863|NCT00866749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25582864|NCT00866749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25582865|NCT00866749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582866|NCT00866749|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25582867|NCT00866749|Abortifacient Agents|abortifacient agents|mesh-ancestor
25582868|NCT00866749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25582869|NCT00866749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25582870|NCT00866749|Antimetabolites|antimetabolites|mesh-ancestor
25582871|NCT00866749|Dermatologic Agents|dermatologic agents|mesh-ancestor
25582872|NCT00866749|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25582873|NCT00866749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25582874|NCT00866749|Antiviral Agents|antiviral agents|mesh-ancestor
25582875|NCT00866749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25582876|NCT00866749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25582877|NCT00866749|Tubulin Modulators|tubulin modulators|mesh-ancestor
25582878|NCT00866749|Antimitotic Agents|antimitotic agents|mesh-ancestor
25582879|NCT00866749|Mitosis Modulators|mitosis modulators|mesh-ancestor
25582880|NCT00866775|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25582881|NCT00866775|Anticonvulsants|anticonvulsants|mesh-ancestor
25582882|NCT00866775|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25582883|NCT00866775|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25582884|NCT00866775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25582885|NCT00866775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582886|NCT00866788|Omalizumab|omalizumab|mesh-list
25582887|NCT00866788|Diphenhydramine|diphenhydramine|mesh-list
25582888|NCT00866788|Promethazine|promethazine|mesh-list
25582889|NCT00866788|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25582890|NCT00866788|Histamine Antagonists|histamine antagonists|mesh-list
25582891|NCT00866788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25582892|NCT00866788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25582893|NCT00866788|Respiratory System Agents|respiratory system agents|mesh-ancestor
25582894|NCT00866788|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25582895|NCT00866788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25582896|NCT00866788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25582897|NCT00866788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582898|NCT00866788|Anesthetics, Local|anesthetics, local|mesh-ancestor
25582899|NCT00866788|Anesthetics|anesthetics|mesh-ancestor
25582900|NCT00866788|Sensory System Agents|sensory system agents|mesh-ancestor
25582901|NCT00866788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25582902|NCT00866788|Antiemetics|antiemetics|mesh-ancestor
25582903|NCT00866788|Autonomic Agents|autonomic agents|mesh-ancestor
25582904|NCT00866788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25582905|NCT00866788|Histamine Agents|histamine agents|mesh-ancestor
25582906|NCT00866788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25582907|NCT00866788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582908|NCT00866788|Antipruritics|antipruritics|mesh-ancestor
25582909|NCT00866788|Dermatologic Agents|dermatologic agents|mesh-ancestor
25582910|NCT00866879|Sirolimus|sirolimus|mesh-list
25582911|NCT00866879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25582912|NCT00866879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25582913|NCT00866879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25582914|NCT00866879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582915|NCT00866879|Antifungal Agents|antifungal agents|mesh-ancestor
25582916|NCT00866879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25582917|NCT00866879|Immunologic Factors|immunologic factors|mesh-ancestor
25582918|NCT00866879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582919|NCT00866905|Cyclophosphamide|cyclophosphamide|mesh-list
25582920|NCT00866905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25582921|NCT00866905|Immunologic Factors|immunologic factors|mesh-ancestor
25582922|NCT00866905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582923|NCT00866905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25582924|NCT00866905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25582925|NCT00866905|Alkylating Agents|alkylating agents|mesh-ancestor
25582926|NCT00866905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582927|NCT00866905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582928|NCT00866905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25582929|NCT00867009|Cisplatin|cisplatin|mesh-list
25582930|NCT00867009|Pemetrexed|pemetrexed|mesh-list
25582931|NCT00867009|Cetuximab|cetuximab|mesh-list
25582932|NCT00867009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582933|NCT00867009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582934|NCT00867009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582935|NCT00867009|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25582936|NCT00867009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25582937|NCT00867009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25582938|NCT00867035|Chlorhexidine|chlorhexidine|mesh-list
25582939|NCT00867035|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25582940|NCT00867035|Chlorine dioxide|chlorine dioxide|mesh-list
25582941|NCT00867035|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25582942|NCT00867035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25582943|NCT00867035|Disinfectants|disinfectants|mesh-ancestor
25582944|NCT00867035|Dermatologic Agents|dermatologic agents|mesh-ancestor
25582945|NCT00867035|Dental Disinfectants|dental disinfectants|mesh-ancestor
25582946|NCT00867087|Rituximab|rituximab|mesh-list
25582947|NCT00867087|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25582948|NCT00867087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25582949|NCT00867087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582950|NCT00867087|Immunologic Factors|immunologic factors|mesh-ancestor
25582951|NCT00867087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582952|NCT00867087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25582953|NCT00867087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25582954|NCT00867113|Imatinib Mesylate|imatinib mesylate|mesh-list
25582955|NCT00867113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582956|NCT00867113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25582957|NCT00867113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582958|NCT00867113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582959|NCT00867139|Oseltamivir|oseltamivir|mesh-list
25582960|NCT00867139|Ribavirin|ribavirin|mesh-list
25582961|NCT00867139|Zanamivir|zanamivir|mesh-list
25582962|NCT00867139|Amantadine|amantadine|mesh-list
25582963|NCT00867139|Thiazole-4-carboxamide adenine dinucleotide|thiazole-4-carboxamide adenine dinucleotide|mesh-list
25582964|NCT00867139|Antiviral Agents|antiviral agents|mesh-ancestor
25582965|NCT00867139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25582966|NCT00867139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582967|NCT00867139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582968|NCT00867139|Antimetabolites|antimetabolites|mesh-ancestor
25582969|NCT00867139|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24551913|NCT04620291|UB-421|ub-421|mesh-list
25582970|NCT00867139|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25582971|NCT00867139|Dopamine Agents|dopamine agents|mesh-ancestor
25008034|NCT02339740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25703511|NCT02168803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24836002|NCT02183779|Fluconazole|fluconazole|mesh-list
25582972|NCT00867139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25582973|NCT00867139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582974|NCT00867139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25582975|NCT00867139|Analgesics|analgesics|mesh-ancestor
25582976|NCT00867139|Sensory System Agents|sensory system agents|mesh-ancestor
25582977|NCT00867139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25582978|NCT00867217|Vitamin D|vitamin d|mesh-list
25582979|NCT00867217|Ergocalciferols|ergocalciferols|mesh-list
25582980|NCT00867217|Cholecalciferol|cholecalciferol|mesh-list
25582981|NCT00867217|Vitamins|vitamins|mesh-list
25582982|NCT00867217|Letrozole|letrozole|mesh-list
25582983|NCT00867217|Micronutrients|micronutrients|mesh-ancestor
25582984|NCT00867217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582985|NCT00867217|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25582986|NCT00867217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25582987|NCT00867217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25582988|NCT00867217|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24554712|NCT00737724|Antimetabolites|antimetabolites|mesh-ancestor
24555561|NCT00742066|Irbesartan|irbesartan|mesh-list
25582989|NCT00867217|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25582990|NCT00867217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25582991|NCT00867217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25582992|NCT00867217|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25582993|NCT00867217|Hormone Antagonists|hormone antagonists|mesh-ancestor
25582994|NCT00867217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25582995|NCT00867308|Lenalidomide|lenalidomide|mesh-list
24557170|NCT00751556|Analgesics|analgesics|mesh-ancestor
25582996|NCT00867308|Immunologic Factors|immunologic factors|mesh-ancestor
25582997|NCT00867308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25582998|NCT00867308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25582999|NCT00867308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25583000|NCT00867308|Growth Substances|growth substances|mesh-ancestor
25583001|NCT00867308|Growth Inhibitors|growth inhibitors|mesh-ancestor
25583002|NCT00867308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583003|NCT00867334|Imatinib Mesylate|imatinib mesylate|mesh-list
25583004|NCT00867334|Panitumumab|panitumumab|mesh-list
25583005|NCT00867334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583006|NCT00867334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25583007|NCT00867334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583008|NCT00867334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558963|NCT05382338|Cyclophosphamide|cyclophosphamide|mesh-list
24558965|NCT05382338|Vincristine|vincristine|mesh-list
24559037|NCT05319730|Antimitotic Agents|antimitotic agents|mesh-ancestor
25583009|NCT00867334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25583010|NCT00867360|Mifepristone|mifepristone|mesh-list
25583011|NCT00867360|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25583012|NCT00867360|Abortifacient Agents|abortifacient agents|mesh-ancestor
25583013|NCT00867360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25583014|NCT00867360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583015|NCT00867360|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25583016|NCT00867360|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24559168|NCT05230901|Diuretics|diuretics|mesh-ancestor
24559469|NCT04767061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25583017|NCT00867360|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25583018|NCT00867360|Contraceptive Agents|contraceptive agents|mesh-ancestor
25583019|NCT00867360|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25583020|NCT00867360|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25583021|NCT00867360|Hormone Antagonists|hormone antagonists|mesh-ancestor
25583022|NCT00867360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25583023|NCT00867360|Luteolytic Agents|luteolytic agents|mesh-ancestor
25583024|NCT00867360|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25583025|NCT00867360|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25583026|NCT00867451|Melatonin|melatonin|mesh-list
25583027|NCT00867451|Antioxidants|antioxidants|mesh-ancestor
25583028|NCT00867451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583029|NCT00867451|Protective Agents|protective agents|mesh-ancestor
25583030|NCT00867451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583031|NCT00867451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25583032|NCT00867490|Amlodipine|amlodipine|mesh-list
25583033|NCT00867490|Candesartan|candesartan|mesh-list
25583034|NCT00867490|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25583035|NCT00867490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25583036|NCT00867490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25583037|NCT00867490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25583038|NCT00867490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583039|NCT00867490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25583040|NCT00867490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583041|NCT00867490|Vasodilator Agents|vasodilator agents|mesh-ancestor
24566026|NCT00783926|Hemagglutinins|hemagglutinins|mesh-list
25583042|NCT00867490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25583043|NCT00867490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25583044|NCT00867490|Diuretics|diuretics|mesh-ancestor
25583045|NCT00867490|Natriuretic Agents|natriuretic agents|mesh-ancestor
25583046|NCT00867490|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25583047|NCT00867503|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24472757|NCT00400387|Vitamins|vitamins|mesh-ancestor
24564663|NCT00777439|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24564664|NCT00777439|Dopamine Agents|dopamine agents|mesh-ancestor
24564665|NCT00777439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24564666|NCT00777478|Sunitinib|sunitinib|mesh-list
25583048|NCT00867503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25583049|NCT00867503|Alkylating Agents|alkylating agents|mesh-ancestor
25583050|NCT00867503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583051|NCT00867503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583052|NCT00867529|Rituximab|rituximab|mesh-list
25583053|NCT00867529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25583054|NCT00867529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583055|NCT00867529|Immunologic Factors|immunologic factors|mesh-ancestor
25583056|NCT00867529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583057|NCT00867529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25583058|NCT00867659|Cetrorelix|cetrorelix|mesh-list
25583059|NCT00867659|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25583060|NCT00867659|Fertility Agents|fertility agents|mesh-ancestor
25583061|NCT00867659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25583062|NCT00867659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583063|NCT00867659|Hormone Antagonists|hormone antagonists|mesh-ancestor
25583064|NCT00867659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25583065|NCT00867789|Trimethoprim|trimethoprim|mesh-list
24565121|NCT00778765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25583066|NCT00867789|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25583067|NCT00867789|Sulfamethoxazole|sulfamethoxazole|mesh-list
25583068|NCT00867789|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24568255|NCT00795444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25583069|NCT00867789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25583070|NCT00867789|Renal Agents|renal agents|mesh-ancestor
25583071|NCT00867789|Antimalarials|antimalarials|mesh-ancestor
25583072|NCT00867789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25583073|NCT00867789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25583074|NCT00867789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25583075|NCT00867789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583076|NCT00867789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583077|NCT00867789|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25583078|NCT00867789|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25583079|NCT00867789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25583080|NCT00867789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25583082|NCT00867932|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25583083|NCT00867932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25583084|NCT00867932|Immunologic Factors|immunologic factors|mesh-ancestor
24570805|NCT00806767|Busulfan|busulfan|mesh-list
24840885|NCT02213081|Ulipristal acetate|ulipristal acetate|mesh-list
24841176|NCT02214602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24841177|NCT02214602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841262|NCT02215057|Anesthetics, Local|anesthetics, local|mesh-ancestor
24571854|NCT00811993|Growth Substances|growth substances|mesh-ancestor
24571855|NCT00811993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571872|NCT00812019|Immunologic Factors|immunologic factors|mesh-ancestor
24571873|NCT00812019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571898|NCT00812123|Antitubercular Agents|antitubercular agents|mesh-ancestor
24571899|NCT00812123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24571901|NCT00812175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24571902|NCT00812175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24571903|NCT00812175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571904|NCT00812175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571905|NCT00812214|Eszopiclone|eszopiclone|mesh-list
24571906|NCT00812214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25583085|NCT00867932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583086|NCT00868140|Pioglitazone|pioglitazone|mesh-list
25583087|NCT00868140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25583088|NCT00868140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583089|NCT00868166|Riluzole|riluzole|mesh-list
24572096|NCT00813072|Docetaxel|docetaxel|mesh-list
25583090|NCT00868166|Anticonvulsants|anticonvulsants|mesh-ancestor
25583091|NCT00868166|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25583092|NCT00868166|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25009401|NCT01383109|Pyronaridine|pyronaridine|mesh-list
25583093|NCT00868166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25583094|NCT00868166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583095|NCT00868166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583096|NCT00868166|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25583097|NCT00868166|Protective Agents|protective agents|mesh-ancestor
25583098|NCT00868192|Bevacizumab|bevacizumab|mesh-list
25583099|NCT00868192|Pemetrexed|pemetrexed|mesh-list
25583100|NCT00868192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25583101|NCT00868192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583102|NCT00868192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25583103|NCT00868192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25583104|NCT00868192|Growth Substances|growth substances|mesh-ancestor
25583105|NCT00868192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583106|NCT00868192|Growth Inhibitors|growth inhibitors|mesh-ancestor
25583107|NCT00868192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583108|NCT00868192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583109|NCT00868192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25583110|NCT00868192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25583111|NCT00868231|Bromides|bromides|mesh-list
25583112|NCT00868231|Tiotropium Bromide|tiotropium bromide|mesh-list
25583113|NCT00868231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25583114|NCT00868231|Autonomic Agents|autonomic agents|mesh-ancestor
25583115|NCT00868231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25583116|NCT00868231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583117|NCT00868231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25583118|NCT00868231|Respiratory System Agents|respiratory system agents|mesh-ancestor
25583119|NCT00868231|Parasympatholytics|parasympatholytics|mesh-ancestor
25583120|NCT00868231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25583121|NCT00868231|Cholinergic Agents|cholinergic agents|mesh-ancestor
25583122|NCT00868231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25583123|NCT00868231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583124|NCT00868231|Anticonvulsants|anticonvulsants|mesh-ancestor
25583125|NCT00868296|Pantoprazole|pantoprazole|mesh-list
25583126|NCT00868296|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25583127|NCT00868296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24844084|NCT02231281|Ritonavir|ritonavir|mesh-list
25583128|NCT00868296|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25583129|NCT00868296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583130|NCT00868296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583131|NCT00868309|Antivenins|antivenins|mesh-list
25583132|NCT00868309|Immunologic Factors|immunologic factors|mesh-ancestor
25583133|NCT00868309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583134|NCT00868348|Ketorolac|ketorolac|mesh-list
24578171|NCT00847119|Capecitabine|capecitabine|mesh-list
25583135|NCT00868348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25583136|NCT00868348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25583137|NCT00868348|Analgesics|analgesics|mesh-ancestor
25009899|NCT05058872|Estradiol|estradiol|mesh-list
25583138|NCT00868348|Sensory System Agents|sensory system agents|mesh-ancestor
25583139|NCT00868348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25583140|NCT00868348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583141|NCT00868348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25583142|NCT00868348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25583143|NCT00868348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25583144|NCT00868348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583145|NCT00868348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583146|NCT00868374|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25583147|NCT00868374|Antidepressive Agents|antidepressive agents|mesh-ancestor
25583148|NCT00868374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25583149|NCT00868374|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25583150|NCT00868374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25583151|NCT00868374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25583152|NCT00868374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583153|NCT00868452|Valproic Acid|valproic acid|mesh-list
25583154|NCT00868452|Lithium Carbonate|lithium carbonate|mesh-list
25583155|NCT00868452|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25583156|NCT00868452|Antidepressive Agents|antidepressive agents|mesh-ancestor
25583157|NCT00868452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25583158|NCT00868452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24846608|NCT02243241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25583159|NCT00868452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583160|NCT00868452|Antimanic Agents|antimanic agents|mesh-ancestor
25583161|NCT00868452|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25583162|NCT00868452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25583163|NCT00868452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583164|NCT00868452|Anticonvulsants|anticonvulsants|mesh-ancestor
25583165|NCT00868452|GABA Agents|gaba agents|mesh-ancestor
25583166|NCT00868452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24580541|NCT00862264|Norflurane|norflurane|mesh-list
25583167|NCT00868452|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24795061|NCT03783013|Lycopene|lycopene|mesh-list
24580769|NCT00863499|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25583168|NCT00868452|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25583169|NCT00868452|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25583170|NCT00868452|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25583171|NCT00868452|Adrenergic Agents|adrenergic agents|mesh-ancestor
25583172|NCT00868452|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25583173|NCT00868452|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25583174|NCT00868452|Serotonin Agents|serotonin agents|mesh-ancestor
24580770|NCT00863499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580908|NCT00864006|Antimanic Agents|antimanic agents|mesh-ancestor
25583175|NCT00868452|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25583176|NCT00868452|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25583177|NCT00868452|Dopamine Agents|dopamine agents|mesh-ancestor
24581466|NCT00865241|Metformin|metformin|mesh-list
24793223|NCT03747042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583178|NCT00868608|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25583179|NCT00868608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25583180|NCT00868608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583181|NCT00868608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25583182|NCT00868699|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25583183|NCT00868699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25583184|NCT00868699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25583185|NCT00868699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25583186|NCT00868699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581877|NCT00866593|Dexetimide|dexetimide|mesh-list
25583187|NCT00868699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25583188|NCT00868699|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25583189|NCT00868699|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25583190|NCT00868699|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25703691|NCT02169505|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25583191|NCT00868699|Adrenergic Agents|adrenergic agents|mesh-ancestor
25583192|NCT00868699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25583193|NCT00868699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583194|NCT00868699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25583195|NCT00868699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25583196|NCT00868699|Serotonin Agents|serotonin agents|mesh-ancestor
25583197|NCT00868699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25583198|NCT00868699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24847169|NCT02245438|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25583199|NCT00868699|Dopamine Agents|dopamine agents|mesh-ancestor
25653080|NCT01534351|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25653081|NCT01534351|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25653082|NCT01534351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25653083|NCT01534351|Adrenergic Agents|adrenergic agents|mesh-ancestor
25653084|NCT01534351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25653085|NCT01534351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653086|NCT01534351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653087|NCT01534351|Urological Agents|urological agents|mesh-ancestor
25653088|NCT01534351|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25653089|NCT01534351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25653090|NCT01534351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653091|NCT01534351|Hormone Antagonists|hormone antagonists|mesh-ancestor
24582893|NCT00872417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653092|NCT01534351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25653093|NCT01534416|Bupivacaine|bupivacaine|mesh-list
25653094|NCT01534416|Anesthetics, Local|anesthetics, local|mesh-ancestor
25653095|NCT01534416|Anesthetics|anesthetics|mesh-ancestor
25653096|NCT01534416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25653097|NCT01534416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583200|NCT00868790|Metformin|metformin|mesh-list
25583201|NCT00868790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25583202|NCT00868790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583203|NCT00868959|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25583204|NCT00868959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24847529|NCT02247518|Tadalafil|tadalafil|mesh-list
25583205|NCT00868959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25583206|NCT00868959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25583207|NCT00868959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583208|NCT00868959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24484623|NCT00449449|Anesthetics|anesthetics|mesh-ancestor
25583209|NCT00868959|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25583210|NCT00868959|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25583211|NCT00868959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25583212|NCT00868959|Adrenergic Agents|adrenergic agents|mesh-ancestor
25583213|NCT00868959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25583214|NCT00868959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637294|NCT01149746|Tamsulosin|tamsulosin|mesh-list
24633003|NCT01126697|Micronutrients|micronutrients|mesh-ancestor
24633004|NCT01126697|Vitamins|vitamins|mesh-ancestor
24583516|NCT00874978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24583517|NCT00874978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25583215|NCT00868959|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25583216|NCT00868959|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24583523|NCT00875030|Artesunate|artesunate|mesh-list
25583217|NCT00868959|Serotonin Agents|serotonin agents|mesh-ancestor
24583642|NCT00875927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25583218|NCT00868959|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25583219|NCT00868959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25583220|NCT00868959|Dopamine Agents|dopamine agents|mesh-ancestor
25583221|NCT00869050|Capecitabine|capecitabine|mesh-list
25583222|NCT00869050|Temozolomide|temozolomide|mesh-list
25583223|NCT00869050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25583224|NCT00869050|Antimetabolites|antimetabolites|mesh-ancestor
24583643|NCT00875966|Azithromycin|azithromycin|mesh-list
25583225|NCT00869050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583226|NCT00869050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583227|NCT00869050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25583228|NCT00869050|Alkylating Agents|alkylating agents|mesh-ancestor
25583229|NCT00869089|Apremilast|apremilast|mesh-list
25583230|NCT00869089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25583231|NCT00869089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25583232|NCT00869089|Analgesics|analgesics|mesh-ancestor
24583738|NCT00876616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24583739|NCT00876616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24583740|NCT00876616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24583741|NCT00876616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25010401|NCT04181476|Protective Agents|protective agents|mesh-ancestor
25583233|NCT00869089|Sensory System Agents|sensory system agents|mesh-ancestor
25583234|NCT00869089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25583235|NCT00869089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583236|NCT00869089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25583237|NCT00869089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25583238|NCT00869089|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25583239|NCT00869089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25583240|NCT00869089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488057|NCT00466401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24584218|NCT00879021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25583241|NCT00869089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583242|NCT00869141|Timolol|timolol|mesh-list
25583243|NCT00869141|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25583244|NCT00869141|Dorzolamide|dorzolamide|mesh-list
25583245|NCT00869141|Brinzolamide|brinzolamide|mesh-list
25583246|NCT00869141|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25583247|NCT00869141|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25583248|NCT00869141|Adrenergic Agents|adrenergic agents|mesh-ancestor
24584373|NCT00880178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849254|NCT01767129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24489035|NCT00471094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24793624|NCT02910414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793625|NCT02897063|Midodrine|midodrine|mesh-list
24793626|NCT02897063|Droxidopa|droxidopa|mesh-list
24793627|NCT02897063|Sympathomimetics|sympathomimetics|mesh-ancestor
24793628|NCT02897063|Autonomic Agents|autonomic agents|mesh-ancestor
24793629|NCT02897063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24793630|NCT02897063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583249|NCT00869141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25583250|NCT00869141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583251|NCT00869141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583252|NCT00869141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25583253|NCT00869141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25583254|NCT00869141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25583255|NCT00869141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24584692|NCT00881387|Gemcitabine|gemcitabine|mesh-list
25583256|NCT00869141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25583257|NCT00869141|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25583258|NCT00869141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583259|NCT00869206|Zoledronic Acid|zoledronic acid|mesh-list
25583260|NCT00869206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25583261|NCT00869206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583262|NCT00869323|Rituximab|rituximab|mesh-list
25583263|NCT00869323|Bortezomib|bortezomib|mesh-list
25583264|NCT00869323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25583265|NCT00869323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583266|NCT00869323|Immunologic Factors|immunologic factors|mesh-ancestor
25583267|NCT00869323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583268|NCT00869323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25583269|NCT00869401|Temozolomide|temozolomide|mesh-list
25583270|NCT00869401|Dasatinib|dasatinib|mesh-list
25583271|NCT00869401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25583272|NCT00869401|Alkylating Agents|alkylating agents|mesh-ancestor
24584991|NCT00882531|Isotretinoin|isotretinoin|mesh-list
25583273|NCT00869401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583274|NCT00869401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583275|NCT00869401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25583276|NCT00869401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583278|NCT00869440|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25583279|NCT00869440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24585474|NCT00885781|SMOFlipid|smoflipid|mesh-list
24849856|NCT02250859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24696727|NCT01431326|Piperacillin|piperacillin|mesh-list
24696728|NCT01431326|Tobramycin|tobramycin|mesh-list
25583280|NCT00869440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25583281|NCT00869440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583282|NCT00869440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25583283|NCT00869440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25583284|NCT00869440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25583285|NCT00869440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25583286|NCT00869440|Anesthetics, General|anesthetics, general|mesh-ancestor
25583287|NCT00869440|Anesthetics|anesthetics|mesh-ancestor
25583288|NCT00869440|GABA Modulators|gaba modulators|mesh-ancestor
25583289|NCT00869440|GABA Agents|gaba agents|mesh-ancestor
25583290|NCT00869440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25583291|NCT00869440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583292|NCT00869518|Trimethoprim|trimethoprim|mesh-list
25583293|NCT00869518|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24696729|NCT01431326|Amikacin|amikacin|mesh-list
25583294|NCT00869518|Sulfamethoxazole|sulfamethoxazole|mesh-list
25583295|NCT00869518|Rifabutin|rifabutin|mesh-list
25583296|NCT00869518|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25583297|NCT00869518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25583298|NCT00869518|Renal Agents|renal agents|mesh-ancestor
25583299|NCT00869518|Antimalarials|antimalarials|mesh-ancestor
25583300|NCT00869518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25583301|NCT00869518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25583302|NCT00869518|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25583303|NCT00869518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583304|NCT00869518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583305|NCT00869518|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25583306|NCT00869518|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25583307|NCT00869518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25583308|NCT00869518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25583309|NCT00869518|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25583310|NCT00869518|Antitubercular Agents|antitubercular agents|mesh-ancestor
25583311|NCT00869557|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25583312|NCT00869557|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25583313|NCT00869557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24454176|NCT04326257|Nivolumab|nivolumab|mesh-list
25583314|NCT00869557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25583315|NCT00869557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583316|NCT00869557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583317|NCT00869557|Antiviral Agents|antiviral agents|mesh-ancestor
25583318|NCT00869557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25583319|NCT00869557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25583320|NCT00869557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25583321|NCT00869622|Vitamin D|vitamin d|mesh-list
25583322|NCT00869622|Risedronic Acid|risedronic acid|mesh-list
25583323|NCT00869622|Calcium|calcium|mesh-list
25583324|NCT00869622|Vitamins|vitamins|mesh-ancestor
25583325|NCT00869622|Micronutrients|micronutrients|mesh-ancestor
25583326|NCT00869622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583327|NCT00869622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24696800|NCT01431326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24696801|NCT01431326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24696802|NCT01431326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24696803|NCT01431326|Dopamine Agents|dopamine agents|mesh-ancestor
24697491|NCT01435213|Ketamine|ketamine|mesh-list
24696807|NCT01431326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24696819|NCT01431326|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24696821|NCT01431326|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24696827|NCT01431326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25583328|NCT00869622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25583329|NCT00869622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25583330|NCT00869622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25583331|NCT00869622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583332|NCT00869778|Vaccines|vaccines|mesh-list
25583333|NCT00869778|Immunologic Factors|immunologic factors|mesh-ancestor
25583334|NCT00869778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583335|NCT00869791|Levodopa|levodopa|mesh-list
25583336|NCT00869791|Carbidopa|carbidopa|mesh-list
25583337|NCT00869791|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25583338|NCT00869791|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24448845|NCT00313261|Antiviral Agents|antiviral agents|mesh-ancestor
25583339|NCT00869791|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25583340|NCT00869791|Dopamine Agents|dopamine agents|mesh-ancestor
25583341|NCT00869791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25583342|NCT00869791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583343|NCT00869791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583344|NCT00869791|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25583345|NCT00869791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583347|NCT00869791|Immunologic Factors|immunologic factors|mesh-ancestor
25583348|NCT00869791|Dopamine Agonists|dopamine agonists|mesh-ancestor
25583349|NCT00869960|Ritonavir|ritonavir|mesh-list
25703794|NCT02170662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24697579|NCT01435707|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25583350|NCT00869960|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25583351|NCT00869960|Tenofovir|tenofovir|mesh-list
25583352|NCT00869960|Emtricitabine|emtricitabine|mesh-list
25583353|NCT00869960|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25583354|NCT00869960|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25583355|NCT00869960|Protease Inhibitors|protease inhibitors|mesh-ancestor
25583356|NCT00869960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583357|NCT00869960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583358|NCT00869960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25583359|NCT00869960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25583360|NCT00869960|Antiviral Agents|antiviral agents|mesh-ancestor
25583361|NCT00869960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25583362|NCT00869960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25583363|NCT00869960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25583364|NCT00869960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25583365|NCT00869960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25583366|NCT00869999|Rituximab|rituximab|mesh-list
25583367|NCT00869999|Everolimus|everolimus|mesh-list
25583368|NCT00869999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25583369|NCT00869999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583370|NCT00869999|Immunologic Factors|immunologic factors|mesh-ancestor
25583371|NCT00869999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583372|NCT00869999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25583373|NCT00869999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25583374|NCT00870103|Moxifloxacin|moxifloxacin|mesh-list
25583375|NCT00870103|Dexamethasone|dexamethasone|mesh-list
25583376|NCT00870103|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25583377|NCT00870103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25583378|NCT00870103|Antiemetics|antiemetics|mesh-ancestor
25583379|NCT00870103|Autonomic Agents|autonomic agents|mesh-ancestor
25583380|NCT00870103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25583381|NCT00870103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583382|NCT00870103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25583383|NCT00870103|Glucocorticoids|glucocorticoids|mesh-ancestor
25583384|NCT00870103|Hormones|hormones|mesh-ancestor
25583385|NCT00870103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25583386|NCT00870103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25583387|NCT00870103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583388|NCT00870103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25583389|NCT00870103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25583390|NCT00870103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25583391|NCT00870103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25583392|NCT00870103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583393|NCT00870103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583394|NCT00870103|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25583395|NCT00870194|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25583396|NCT00870194|Exenatide|exenatide|mesh-list
25583397|NCT00870194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25583398|NCT00870194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493397|NCT00490854|Insulin|insulin|mesh-list
24657251|NCT01266486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657252|NCT01266499|Colistin|colistin|mesh-list
25583399|NCT00870194|Incretins|incretins|mesh-ancestor
25583400|NCT00870194|Hormones|hormones|mesh-ancestor
25583401|NCT00870194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25583402|NCT00870194|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25583403|NCT00870194|Protease Inhibitors|protease inhibitors|mesh-ancestor
25583404|NCT00870194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583405|NCT00870194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583406|NCT00870194|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25583407|NCT00870363|Efavirenz|efavirenz|mesh-list
25583408|NCT00870363|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
25583409|NCT00870363|Raltegravir Potassium|raltegravir potassium|mesh-list
25583410|NCT00870363|Maraviroc|maraviroc|mesh-list
25583411|NCT00870363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25583412|NCT00870363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583413|NCT00870363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583414|NCT00870363|Antiviral Agents|antiviral agents|mesh-ancestor
25583415|NCT00870363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25583416|NCT00870363|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25583417|NCT00870363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25478093|NCT00089843|Androgens|androgens|mesh-ancestor
25583418|NCT00870363|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25583419|NCT00870363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25583420|NCT00870363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25583421|NCT00870363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25583422|NCT00870363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25583423|NCT00870363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25583424|NCT00870363|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25583425|NCT00870363|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24657295|NCT01266694|Mitosis Modulators|mitosis modulators|mesh-ancestor
24657296|NCT01266694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583426|NCT00870363|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25583427|NCT00870363|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25583428|NCT00870363|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25583429|NCT00870467|Adalimumab|adalimumab|mesh-list
25583430|NCT00870467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25583431|NCT00870467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25583432|NCT00870584|Omalizumab|omalizumab|mesh-list
25583433|NCT00870584|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25583434|NCT00870584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25583435|NCT00870584|Respiratory System Agents|respiratory system agents|mesh-ancestor
25583436|NCT00870727|Aripiprazole|aripiprazole|mesh-list
25583437|NCT00870727|Antidepressive Agents|antidepressive agents|mesh-ancestor
25583438|NCT00870727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25583439|NCT00870727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25583440|NCT00870727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25583441|NCT00870727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25583442|NCT00870727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583443|NCT00870727|Dopamine Agonists|dopamine agonists|mesh-ancestor
25583444|NCT00870727|Dopamine Agents|dopamine agents|mesh-ancestor
25583445|NCT00870727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25583446|NCT00870727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583447|NCT00870727|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25583448|NCT00870727|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25583449|NCT00870727|Serotonin Agents|serotonin agents|mesh-ancestor
25583450|NCT00870727|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25583451|NCT00870727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25583452|NCT00870727|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25583453|NCT00870727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25583454|NCT00870740|Daclizumab|daclizumab|mesh-list
25583455|NCT00870740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25583456|NCT00870740|Immunologic Factors|immunologic factors|mesh-ancestor
25583457|NCT00870740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583458|NCT00870870|Gemcitabine|gemcitabine|mesh-list
25703804|NCT02171195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25703805|NCT02171195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25703806|NCT02171195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24494903|NCT00497497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24494904|NCT00497497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494905|NCT00497497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25583459|NCT00870870|Cisplatin|cisplatin|mesh-list
25583460|NCT00870870|Carboplatin|carboplatin|mesh-list
25583461|NCT00870870|Cetuximab|cetuximab|mesh-list
25583462|NCT00870870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25583463|NCT00870870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583464|NCT00870870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25583465|NCT00870870|Antimetabolites|antimetabolites|mesh-ancestor
25583466|NCT00870870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583467|NCT00870870|Antiviral Agents|antiviral agents|mesh-ancestor
25583468|NCT00870870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25583469|NCT00870870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583470|NCT00870870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25583471|NCT00870870|Immunologic Factors|immunologic factors|mesh-ancestor
25583472|NCT00870870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583473|NCT00870870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25583474|NCT00870896|Tiotropium Bromide|tiotropium bromide|mesh-list
25583475|NCT00870896|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25583476|NCT00870896|Autonomic Agents|autonomic agents|mesh-ancestor
24851491|NCT02256943|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25583477|NCT00870896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25583478|NCT00870896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583479|NCT00870896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25583480|NCT00870896|Respiratory System Agents|respiratory system agents|mesh-ancestor
25583481|NCT00870896|Parasympatholytics|parasympatholytics|mesh-ancestor
25583482|NCT00870896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25583483|NCT00870896|Cholinergic Agents|cholinergic agents|mesh-ancestor
25583484|NCT00870896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25583485|NCT00870896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583486|NCT00871000|Pentetic Acid|pentetic acid|mesh-list
25583487|NCT00871000|Antidotes|antidotes|mesh-ancestor
25583488|NCT00871000|Protective Agents|protective agents|mesh-ancestor
25583489|NCT00871000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583490|NCT00871000|Chelating Agents|chelating agents|mesh-ancestor
25583491|NCT00871000|Sequestering Agents|sequestering agents|mesh-ancestor
25583492|NCT00871000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583493|NCT00871000|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25583494|NCT00871169|Oxaliplatin|oxaliplatin|mesh-list
25583495|NCT00871169|Irinotecan|irinotecan|mesh-list
25583496|NCT00871169|Cetuximab|cetuximab|mesh-list
25583497|NCT00871169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583498|NCT00871169|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25583499|NCT00871169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25583500|NCT00871169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583501|NCT00871169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583502|NCT00871169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25583503|NCT00871234|Etravirine|etravirine|mesh-list
25583504|NCT00871234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25583505|NCT00871234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25703825|NCT02171611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703826|NCT02171611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583506|NCT00871234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583507|NCT00871234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583508|NCT00871234|Antiviral Agents|antiviral agents|mesh-ancestor
25583509|NCT00871234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25583510|NCT00871260|Regadenoson|regadenoson|mesh-list
25583511|NCT00871260|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25583512|NCT00871260|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25583513|NCT00871260|Purinergic Agonists|purinergic agonists|mesh-ancestor
25583514|NCT00871260|Purinergic Agents|purinergic agents|mesh-ancestor
25583515|NCT00871260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25583516|NCT00871260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583517|NCT00871260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583518|NCT00871338|Vaccines|vaccines|mesh-list
25583519|NCT00871338|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25583520|NCT00871338|Immunologic Factors|immunologic factors|mesh-ancestor
25583521|NCT00871338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583522|NCT00871403|Cisplatin|cisplatin|mesh-list
25583523|NCT00871403|Pemetrexed|pemetrexed|mesh-list
25583524|NCT00871403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583525|NCT00871403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583526|NCT00871403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583527|NCT00871403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25583528|NCT00871403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25583529|NCT00871494|Azithromycin|azithromycin|mesh-list
25583530|NCT00871494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25583531|NCT00871494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25583532|NCT00871624|Dexmedetomidine|dexmedetomidine|mesh-list
25583533|NCT00871624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25583534|NCT00871624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25583535|NCT00871624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703833|NCT02172040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444864|NCT00299455|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24799236|NCT01967979|Hormone Antagonists|hormone antagonists|mesh-ancestor
24593102|NCT00926900|Cycloserine|cycloserine|mesh-list
25583536|NCT00871624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25583537|NCT00871624|Analgesics|analgesics|mesh-ancestor
25583538|NCT00871624|Sensory System Agents|sensory system agents|mesh-ancestor
25583539|NCT00871624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25583540|NCT00871624|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25583541|NCT00871624|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25583542|NCT00871624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25583543|NCT00871624|Adrenergic Agents|adrenergic agents|mesh-ancestor
25583544|NCT00871624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25583545|NCT00871624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583546|NCT00871689|Vidarabine|vidarabine|mesh-list
25583547|NCT00871689|Aldesleukin|aldesleukin|mesh-list
25583548|NCT00871689|Cyclophosphamide|cyclophosphamide|mesh-list
25583549|NCT00871689|Fludarabine|fludarabine|mesh-list
25583550|NCT00871689|Fludarabine phosphate|fludarabine phosphate|mesh-list
25583551|NCT00871689|Interleukin-2|interleukin-2|mesh-list
25583552|NCT00871689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25583553|NCT00871689|Immunologic Factors|immunologic factors|mesh-ancestor
25583554|NCT00871689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583555|NCT00871689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25583556|NCT00871689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25583557|NCT00871689|Alkylating Agents|alkylating agents|mesh-ancestor
25583558|NCT00871689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583559|NCT00871689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583560|NCT00871689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25583561|NCT00871689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25583562|NCT00871689|Antimetabolites|antimetabolites|mesh-ancestor
25583563|NCT00871689|Antiviral Agents|antiviral agents|mesh-ancestor
25583564|NCT00871689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25583565|NCT00871689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25583566|NCT00871689|Analgesics|analgesics|mesh-ancestor
25583567|NCT00871689|Sensory System Agents|sensory system agents|mesh-ancestor
24948760|NCT03917394|Hematinics|hematinics|mesh-ancestor
25583568|NCT00871689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25478304|NCT00092417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478305|NCT00093041|Zalutumumab|zalutumumab|mesh-list
24948769|NCT05402865|Denosumab|denosumab|mesh-list
25478306|NCT00093041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25478307|NCT00093041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718026|NCT01551511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24433169|NCT00257751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123734|NCT03081923|Durvalumab|durvalumab|mesh-list
24433171|NCT00257790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24433172|NCT00257790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24433173|NCT00257803|Oxytocin|oxytocin|mesh-list
24433174|NCT00257803|Oxytocics|oxytocics|mesh-ancestor
24433175|NCT00257803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24433176|NCT00257803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433177|NCT00257816|Topotecan|topotecan|mesh-list
24433178|NCT00257816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433179|NCT00257816|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24433180|NCT00257816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24433196|NCT00257855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433232|NCT00257959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24433233|NCT00257972|Aripiprazole|aripiprazole|mesh-list
24433234|NCT00257972|Antidepressive Agents|antidepressive agents|mesh-ancestor
24433235|NCT00257972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24433236|NCT00257972|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24433237|NCT00257972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24433238|NCT00257972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24433239|NCT00257972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433240|NCT00257972|Dopamine Agonists|dopamine agonists|mesh-ancestor
24433241|NCT00257972|Dopamine Agents|dopamine agents|mesh-ancestor
24433242|NCT00257972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24433243|NCT00257972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433244|NCT00257972|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24433245|NCT00257972|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24433246|NCT00257972|Serotonin Agents|serotonin agents|mesh-ancestor
24433247|NCT00257972|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24433248|NCT00257972|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24657976|NCT01269788|Fluoxetine|fluoxetine|mesh-list
24433249|NCT00257972|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24433250|NCT00257972|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24433251|NCT00258050|Lapatinib|lapatinib|mesh-list
24433252|NCT00258050|Midazolam|midazolam|mesh-list
24433253|NCT00258050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24433254|NCT00258050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24433281|NCT00258063|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24433282|NCT00258063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24433283|NCT00258076|Contraceptive Agents|contraceptive agents|mesh-list
25123767|NCT03081702|Itraconazole|itraconazole|mesh-list
24979594|NCT03727971|Omalizumab|omalizumab|mesh-list
24979595|NCT03727971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24979596|NCT03727971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24979597|NCT03727971|Respiratory System Agents|respiratory system agents|mesh-ancestor
25583569|NCT00871689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25583570|NCT00871689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25583571|NCT00871728|Itraconazole|itraconazole|mesh-list
25583572|NCT00871728|Antifungal Agents|antifungal agents|mesh-ancestor
25583573|NCT00871728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25583574|NCT00871728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25583575|NCT00871728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25583576|NCT00871728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583577|NCT00871728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583578|NCT00871728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25583579|NCT00871728|Hormone Antagonists|hormone antagonists|mesh-ancestor
25583580|NCT00871728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25583581|NCT00871728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583582|NCT00871728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25583584|NCT00871780|Immunologic Factors|immunologic factors|mesh-ancestor
25583585|NCT00871780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658109|NCT01270438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658111|NCT01270438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24658112|NCT01270438|Immunologic Factors|immunologic factors|mesh-ancestor
25583586|NCT00871858|Fulvestrant|fulvestrant|mesh-list
25583587|NCT00871858|Anastrozole|anastrozole|mesh-list
25583588|NCT00871858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25583589|NCT00871858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583590|NCT00871858|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25583591|NCT00871858|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25583592|NCT00871858|Hormone Antagonists|hormone antagonists|mesh-ancestor
25583593|NCT00871858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25583594|NCT00871858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583595|NCT00871858|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25583596|NCT00871858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25583597|NCT00871858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583598|NCT00871858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583599|NCT00871871|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25583600|NCT00871871|Isosorbide|isosorbide|mesh-list
25583601|NCT00871871|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25583602|NCT00871871|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25583603|NCT00871871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25583604|NCT00871871|Diuretics|diuretics|mesh-ancestor
25583605|NCT00871871|Natriuretic Agents|natriuretic agents|mesh-ancestor
25583606|NCT00871871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703864|NCT02172755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583607|NCT00871871|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25583608|NCT00871871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25583609|NCT00871871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583610|NCT00871871|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25583611|NCT00871871|Vasodilator Agents|vasodilator agents|mesh-ancestor
25583612|NCT00871871|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25583613|NCT00871923|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25583614|NCT00871923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583615|NCT00871923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25583616|NCT00871923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583617|NCT00871923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583618|NCT00872027|Citalopram|citalopram|mesh-list
25583619|NCT00872027|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25583620|NCT00872027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25583621|NCT00872027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25583622|NCT00872027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583623|NCT00872027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25583624|NCT00872027|Serotonin Agents|serotonin agents|mesh-ancestor
25583625|NCT00872027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583626|NCT00872027|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25583627|NCT00872027|Antidepressive Agents|antidepressive agents|mesh-ancestor
25583628|NCT00872027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25583629|NCT00872170|Sildenafil Citrate|sildenafil citrate|mesh-list
25583630|NCT00872170|Vasodilator Agents|vasodilator agents|mesh-ancestor
25583631|NCT00872170|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25583632|NCT00872170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25583633|NCT00872170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583634|NCT00872170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583635|NCT00872170|Urological Agents|urological agents|mesh-ancestor
25583636|NCT00872534|Aspirin|aspirin|mesh-list
25583637|NCT00872534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25583638|NCT00872534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25583639|NCT00872534|Analgesics|analgesics|mesh-ancestor
25583640|NCT00872534|Sensory System Agents|sensory system agents|mesh-ancestor
25583641|NCT00872534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25583642|NCT00872534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583643|NCT00872534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25583644|NCT00872534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25583645|NCT00872534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25583646|NCT00872534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25583647|NCT00872534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583648|NCT00872534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25583649|NCT00872534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25583650|NCT00872534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583651|NCT00872534|Antipyretics|antipyretics|mesh-ancestor
25583652|NCT00872599|Fenofibrate|fenofibrate|mesh-list
25583653|NCT00872599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25583654|NCT00872599|Antimetabolites|antimetabolites|mesh-ancestor
25583655|NCT00872599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583656|NCT00872599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25583657|NCT00872729|Cysteamine|cysteamine|mesh-list
25583658|NCT00872729|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
25583659|NCT00872729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583660|NCT00872898|Memantine|memantine|mesh-list
25583661|NCT00872898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25583662|NCT00872898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25583663|NCT00872898|Dopamine Agents|dopamine agents|mesh-ancestor
25583664|NCT00872898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25583665|NCT00872898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583666|NCT00872898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583667|NCT00872898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25583668|NCT00872898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25583669|NCT00872989|Docetaxel|docetaxel|mesh-list
25583670|NCT00872989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583671|NCT00872989|Tubulin Modulators|tubulin modulators|mesh-ancestor
25583672|NCT00872989|Antimitotic Agents|antimitotic agents|mesh-ancestor
25583673|NCT00872989|Mitosis Modulators|mitosis modulators|mesh-ancestor
25583674|NCT00872989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583675|NCT00873041|Deferasirox|deferasirox|mesh-list
25583676|NCT00873041|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25583677|NCT00873041|Chelating Agents|chelating agents|mesh-ancestor
25583678|NCT00873041|Sequestering Agents|sequestering agents|mesh-ancestor
25583679|NCT00873041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583680|NCT00873093|Leucovorin|leucovorin|mesh-list
25583681|NCT00873093|Cytarabine|cytarabine|mesh-list
25583682|NCT00873093|Prednisone|prednisone|mesh-list
25583683|NCT00873093|Hydrocortisone|hydrocortisone|mesh-list
25583684|NCT00873093|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25583685|NCT00873093|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25583686|NCT00873093|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25583687|NCT00873093|Cyclophosphamide|cyclophosphamide|mesh-list
25583688|NCT00873093|Doxorubicin|doxorubicin|mesh-list
25583689|NCT00873093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25583690|NCT00873093|Methotrexate|methotrexate|mesh-list
25583691|NCT00873093|Etoposide|etoposide|mesh-list
25583692|NCT00873093|Vincristine|vincristine|mesh-list
25583693|NCT00873093|Bortezomib|bortezomib|mesh-list
25583694|NCT00873093|Asparaginase|asparaginase|mesh-list
25583695|NCT00873093|Pegaspargase|pegaspargase|mesh-list
25583696|NCT00873093|Etoposide phosphate|etoposide phosphate|mesh-list
25583697|NCT00873093|Levoleucovorin|levoleucovorin|mesh-list
25583698|NCT00873093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25583699|NCT00873093|Immunologic Factors|immunologic factors|mesh-ancestor
25583700|NCT00873093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583701|NCT00873093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25583702|NCT00873093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25583703|NCT00873093|Alkylating Agents|alkylating agents|mesh-ancestor
25583704|NCT00873093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583705|NCT00873093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583706|NCT00873093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25583707|NCT00873093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25583708|NCT00873093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25583709|NCT00873093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25583710|NCT00873093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703883|NCT02173769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24594752|NCT00935415|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24594753|NCT00935415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25049711|NCT00577148|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
25049712|NCT00577148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25049713|NCT00577148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25049715|NCT00577148|Hormones|hormones|mesh-ancestor
25049721|NCT00576667|Rimonabant|rimonabant|mesh-list
25583711|NCT00873093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25583712|NCT00873093|Glucocorticoids|glucocorticoids|mesh-ancestor
25583713|NCT00873093|Hormones|hormones|mesh-ancestor
25583714|NCT00873093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25583715|NCT00873093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25583716|NCT00873093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25583717|NCT00873093|Abortifacient Agents|abortifacient agents|mesh-ancestor
25583718|NCT00873093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25583719|NCT00873093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25583720|NCT00873093|Antimetabolites|antimetabolites|mesh-ancestor
25583721|NCT00873093|Dermatologic Agents|dermatologic agents|mesh-ancestor
25583722|NCT00873093|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24503090|NCT03288545|Gemcitabine|gemcitabine|mesh-list
24595519|NCT00939328|Rituximab|rituximab|mesh-list
24659139|NCT01275885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659142|NCT01275885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24659143|NCT01275911|Remifentanil|remifentanil|mesh-list
24659144|NCT01275911|Esmolol|esmolol|mesh-list
25583723|NCT00873093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25583724|NCT00873093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25583725|NCT00873093|Antiviral Agents|antiviral agents|mesh-ancestor
25583726|NCT00873093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25583727|NCT00873093|Antidotes|antidotes|mesh-ancestor
25583728|NCT00873093|Protective Agents|protective agents|mesh-ancestor
25583729|NCT00873093|Vitamin B Complex|vitamin b complex|mesh-ancestor
25583730|NCT00873093|Vitamins|vitamins|mesh-ancestor
25583731|NCT00873093|Micronutrients|micronutrients|mesh-ancestor
25583732|NCT00873093|Tubulin Modulators|tubulin modulators|mesh-ancestor
25583733|NCT00873093|Antimitotic Agents|antimitotic agents|mesh-ancestor
25583734|NCT00873093|Mitosis Modulators|mitosis modulators|mesh-ancestor
25583735|NCT00873119|Paclitaxel|paclitaxel|mesh-list
25583736|NCT00873119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25583737|NCT00873119|Carboplatin|carboplatin|mesh-list
25583738|NCT00873119|Belinostat|belinostat|mesh-list
25583739|NCT00873119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25583740|NCT00873119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583741|NCT00873119|Tubulin Modulators|tubulin modulators|mesh-ancestor
25583742|NCT00873119|Antimitotic Agents|antimitotic agents|mesh-ancestor
25583743|NCT00873119|Mitosis Modulators|mitosis modulators|mesh-ancestor
25583744|NCT00873119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583745|NCT00873119|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25583746|NCT00873119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583747|NCT00873327|Tazobactam|tazobactam|mesh-list
25583748|NCT00873327|Piperacillin|piperacillin|mesh-list
25583749|NCT00873327|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25583750|NCT00873327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25583751|NCT00873327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25583752|NCT00873327|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25583753|NCT00873327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583754|NCT00873327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583755|NCT00873730|Etanercept|etanercept|mesh-list
25049739|NCT00576342|Adrenergic Agents|adrenergic agents|mesh-ancestor
25583756|NCT00873730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25583757|NCT00873730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25583758|NCT00873730|Analgesics|analgesics|mesh-ancestor
25583759|NCT00873730|Sensory System Agents|sensory system agents|mesh-ancestor
25583760|NCT00873730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25583761|NCT00873730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583762|NCT00873730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25583763|NCT00873730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25583764|NCT00873730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24598348|NCT00955604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25583765|NCT00873730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25583766|NCT00873730|Immunologic Factors|immunologic factors|mesh-ancestor
25583767|NCT00873860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25583768|NCT00873860|Immunologic Factors|immunologic factors|mesh-ancestor
25583769|NCT00873860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583770|NCT00874120|Phenylephrine|phenylephrine|mesh-list
25583771|NCT00874120|Oxymetazoline|oxymetazoline|mesh-list
25583772|NCT00874120|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25583773|NCT00874120|Mydriatics|mydriatics|mesh-ancestor
25583774|NCT00874120|Autonomic Agents|autonomic agents|mesh-ancestor
25583775|NCT00874120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25583776|NCT00874120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583777|NCT00874120|Sympathomimetics|sympathomimetics|mesh-ancestor
25583778|NCT00874120|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25583779|NCT00874120|Nasal Decongestants|nasal decongestants|mesh-ancestor
25583780|NCT00874120|Respiratory System Agents|respiratory system agents|mesh-ancestor
25583781|NCT00874120|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25583782|NCT00874120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25583783|NCT00874120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24599256|NCT04919369|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24599789|NCT03908437|Buprenorphine|buprenorphine|mesh-list
25583784|NCT00874120|Adrenergic Agents|adrenergic agents|mesh-ancestor
25583785|NCT00874120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25583786|NCT00874120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583787|NCT00874120|Protective Agents|protective agents|mesh-ancestor
25583788|NCT00874237|Moxifloxacin|moxifloxacin|mesh-list
25583789|NCT00874237|Loxapine|loxapine|mesh-list
25583790|NCT00874237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25583791|NCT00874237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25583792|NCT00874237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25583793|NCT00874237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25583794|NCT00874237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583795|NCT00874237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583796|NCT00874237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583797|NCT00874237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659530|NCT01278264|Anesthetics|anesthetics|mesh-ancestor
24799309|NCT01968239|Growth Substances|growth substances|mesh-ancestor
24799310|NCT01968239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583798|NCT00874237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25583799|NCT00874237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25583800|NCT00874237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25583801|NCT00874237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25583802|NCT00874237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25583803|NCT00874237|Dopamine Agents|dopamine agents|mesh-ancestor
25583804|NCT00874237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25583805|NCT00874432|Lisinopril|lisinopril|mesh-list
25583806|NCT00874432|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25478462|NCT00094497|Cisplatin|cisplatin|mesh-list
25583807|NCT00874432|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25583808|NCT00874432|Protease Inhibitors|protease inhibitors|mesh-ancestor
25583809|NCT00874432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583810|NCT00874432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24659645|NCT01279096|Analgesics|analgesics|mesh-ancestor
25583811|NCT00874432|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25583812|NCT00874432|Protective Agents|protective agents|mesh-ancestor
25583813|NCT00874432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583814|NCT00874614|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
25583815|NCT00874614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583816|NCT00874614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583817|NCT00874614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583818|NCT00874614|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25583819|NCT00874731|Sirolimus|sirolimus|mesh-list
25583820|NCT00874731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25583821|NCT00874731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25583822|NCT00874731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25583823|NCT00874731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583824|NCT00874731|Antifungal Agents|antifungal agents|mesh-ancestor
25583825|NCT00874731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25583826|NCT00874731|Immunologic Factors|immunologic factors|mesh-ancestor
25583827|NCT00874731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583828|NCT00874770|Ribavirin|ribavirin|mesh-list
25583829|NCT00874770|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25583830|NCT00874770|Antimetabolites|antimetabolites|mesh-ancestor
25583831|NCT00874770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583832|NCT00874770|Antiviral Agents|antiviral agents|mesh-ancestor
25583833|NCT00874770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25583834|NCT00874848|Paclitaxel|paclitaxel|mesh-list
25583835|NCT00874848|Carboplatin|carboplatin|mesh-list
25583836|NCT00874848|Cetuximab|cetuximab|mesh-list
25583837|NCT00874848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25583838|NCT00874848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24659971|NCT01281163|Lapatinib|lapatinib|mesh-list
25583839|NCT00874848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583840|NCT00874848|Tubulin Modulators|tubulin modulators|mesh-ancestor
25583841|NCT00874848|Antimitotic Agents|antimitotic agents|mesh-ancestor
25583842|NCT00874848|Mitosis Modulators|mitosis modulators|mesh-ancestor
25583843|NCT00874848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583844|NCT00874848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25653098|NCT01534416|Sensory System Agents|sensory system agents|mesh-ancestor
25653099|NCT01534416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653100|NCT01534520|Lidocaine|lidocaine|mesh-list
25653101|NCT01534520|Anesthetics, Local|anesthetics, local|mesh-ancestor
25653102|NCT01534520|Anesthetics|anesthetics|mesh-ancestor
25653103|NCT01534520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25703942|NCT02174523|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25653104|NCT01534520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653105|NCT01534520|Sensory System Agents|sensory system agents|mesh-ancestor
25653106|NCT01534520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653107|NCT01534520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25653108|NCT01534520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25653109|NCT01534520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25653110|NCT01534520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25653111|NCT01534520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653112|NCT01534637|Gemcitabine|gemcitabine|mesh-list
25653113|NCT01534637|Fluorouracil|fluorouracil|mesh-list
25653114|NCT01534637|Capecitabine|capecitabine|mesh-list
25653115|NCT01534637|Aprepitant|aprepitant|mesh-list
25653116|NCT01534637|Antiemetics|antiemetics|mesh-list
25653117|NCT01534637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25653118|NCT01534637|Antimetabolites|antimetabolites|mesh-ancestor
25653119|NCT01534637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653120|NCT01534637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25653121|NCT01534637|Antiviral Agents|antiviral agents|mesh-ancestor
25653122|NCT01534637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25653123|NCT01534637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653124|NCT01534637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25653125|NCT01534637|Immunologic Factors|immunologic factors|mesh-ancestor
25653126|NCT01534637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653127|NCT01534637|Autonomic Agents|autonomic agents|mesh-ancestor
25653128|NCT01534637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653129|NCT01534637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25653130|NCT01534637|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25653131|NCT01534637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25653132|NCT01534897|Dabrafenib|dabrafenib|mesh-list
25478525|NCT00094861|Tubulin Modulators|tubulin modulators|mesh-ancestor
25653133|NCT01534897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583845|NCT00874887|Moxifloxacin|moxifloxacin|mesh-list
25583846|NCT00874887|Gatifloxacin|gatifloxacin|mesh-list
25583847|NCT00874887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25583848|NCT00874887|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25583849|NCT00874887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25583850|NCT00874887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25583851|NCT00874887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25583852|NCT00874887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25583853|NCT00874887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583854|NCT00874887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583855|NCT00874887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583856|NCT00875017|Sevelamer|sevelamer|mesh-list
25583857|NCT00875017|Chelating Agents|chelating agents|mesh-ancestor
24660047|NCT01281657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25583858|NCT00875017|Sequestering Agents|sequestering agents|mesh-ancestor
25583859|NCT00875017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583860|NCT00875056|Vorinostat|vorinostat|mesh-list
25583861|NCT00875056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583862|NCT00875056|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25583863|NCT00875056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583864|NCT00875056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583865|NCT00875212|Calcium|calcium|mesh-list
25583866|NCT00875212|Fluorides|fluorides|mesh-list
25583867|NCT00875212|Sodium Fluoride|sodium fluoride|mesh-list
25583868|NCT00875212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25583869|NCT00875212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583870|NCT00875212|Cariostatic Agents|cariostatic agents|mesh-ancestor
25583871|NCT00875212|Protective Agents|protective agents|mesh-ancestor
25583872|NCT00875277|Betamethasone|betamethasone|mesh-list
25583873|NCT00875277|Betamethasone Valerate|betamethasone valerate|mesh-list
25583874|NCT00875277|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25583875|NCT00875277|Betamethasone benzoate|betamethasone benzoate|mesh-list
25583876|NCT00875277|Calcipotriene|calcipotriene|mesh-list
25583877|NCT00875277|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25583878|NCT00875277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25583879|NCT00875277|Glucocorticoids|glucocorticoids|mesh-ancestor
25583880|NCT00875277|Hormones|hormones|mesh-ancestor
25583881|NCT00875277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25583882|NCT00875277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583883|NCT00875277|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25583884|NCT00875277|Respiratory System Agents|respiratory system agents|mesh-ancestor
25583885|NCT00875277|Dermatologic Agents|dermatologic agents|mesh-ancestor
24799438|NCT01969032|Doxorubicin|doxorubicin|mesh-list
24799444|NCT01969032|Tubulin Modulators|tubulin modulators|mesh-ancestor
24799445|NCT01969032|Antimitotic Agents|antimitotic agents|mesh-ancestor
24799446|NCT01969032|Mitosis Modulators|mitosis modulators|mesh-ancestor
25583886|NCT00875433|Afatinib|afatinib|mesh-list
25583887|NCT00875433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583888|NCT00875433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25583889|NCT00875433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583890|NCT00875433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583891|NCT00875550|Fentanyl|fentanyl|mesh-list
25583892|NCT00875550|Midazolam|midazolam|mesh-list
25583893|NCT00875550|Dexmedetomidine|dexmedetomidine|mesh-list
25583894|NCT00875550|Morphine|morphine|mesh-list
25583895|NCT00875550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25583896|NCT00875550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25583897|NCT00875550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583898|NCT00875550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25583899|NCT00875550|Analgesics|analgesics|mesh-ancestor
25583900|NCT00875550|Sensory System Agents|sensory system agents|mesh-ancestor
25583901|NCT00875550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25583902|NCT00875550|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25583903|NCT00875550|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25583904|NCT00875550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25583905|NCT00875550|Adrenergic Agents|adrenergic agents|mesh-ancestor
25583906|NCT00875550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25583907|NCT00875550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583908|NCT00875550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25583909|NCT00875550|Narcotics|narcotics|mesh-ancestor
25583910|NCT00875550|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25583911|NCT00875550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25583912|NCT00875550|Anesthetics, General|anesthetics, general|mesh-ancestor
25583913|NCT00875550|Anesthetics|anesthetics|mesh-ancestor
25583914|NCT00875550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25583915|NCT00875550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25583916|NCT00875550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25583917|NCT00875550|GABA Modulators|gaba modulators|mesh-ancestor
25583918|NCT00875550|GABA Agents|gaba agents|mesh-ancestor
25583919|NCT00875615|Cisplatin|cisplatin|mesh-list
25583920|NCT00875615|Carboplatin|carboplatin|mesh-list
25583921|NCT00875615|Sorafenib|sorafenib|mesh-list
25583922|NCT00875615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583923|NCT00875615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25583924|NCT00875615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583925|NCT00875615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583926|NCT00875667|Fludarabine|fludarabine|mesh-list
25583927|NCT00875667|Fludarabine phosphate|fludarabine phosphate|mesh-list
25583928|NCT00875667|Lenalidomide|lenalidomide|mesh-list
25583929|NCT00875667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583930|NCT00875667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25583931|NCT00875667|Antimetabolites|antimetabolites|mesh-ancestor
25583932|NCT00875667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583933|NCT00875667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25583934|NCT00875667|Immunologic Factors|immunologic factors|mesh-ancestor
25583935|NCT00875667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606382|NCT00990223|Eplerenone|eplerenone|mesh-list
25583936|NCT00875667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25583937|NCT00875667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25583938|NCT00875667|Growth Substances|growth substances|mesh-ancestor
25583939|NCT00875667|Growth Inhibitors|growth inhibitors|mesh-ancestor
25583940|NCT00875836|Buspirone|buspirone|mesh-list
25583941|NCT00875836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25583942|NCT00875836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25583943|NCT00875836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25583944|NCT00875836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583945|NCT00875836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25583946|NCT00875836|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25583947|NCT00875836|Serotonin Agents|serotonin agents|mesh-ancestor
25583948|NCT00875836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25583949|NCT00875836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583950|NCT00875979|Trastuzumab|trastuzumab|mesh-list
25583951|NCT00875979|Pertuzumab|pertuzumab|mesh-list
25583952|NCT00875979|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25583953|NCT00875979|Maytansine|maytansine|mesh-list
25583954|NCT00875979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25583955|NCT00875979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25583956|NCT00875979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25583957|NCT00875979|Tubulin Modulators|tubulin modulators|mesh-ancestor
25583958|NCT00875979|Antimitotic Agents|antimitotic agents|mesh-ancestor
25583959|NCT00875979|Mitosis Modulators|mitosis modulators|mesh-ancestor
25583960|NCT00875979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583961|NCT00876187|Naproxen|naproxen|mesh-list
25583962|NCT00876187|Tanezumab|tanezumab|mesh-list
25583963|NCT00876187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25583964|NCT00876187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25583965|NCT00876187|Analgesics|analgesics|mesh-ancestor
25583966|NCT00876187|Sensory System Agents|sensory system agents|mesh-ancestor
25583967|NCT00876187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25583968|NCT00876187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583969|NCT00876187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25583970|NCT00876187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25583971|NCT00876187|Gout Suppressants|gout suppressants|mesh-ancestor
25583972|NCT00876187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25583973|NCT00876187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583974|NCT00876187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583975|NCT00876200|Minoxidil|minoxidil|mesh-list
25583976|NCT00876200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25583977|NCT00876200|Vasodilator Agents|vasodilator agents|mesh-ancestor
25583978|NCT00876343|Aripiprazole|aripiprazole|mesh-list
25583979|NCT00876343|Antidepressive Agents|antidepressive agents|mesh-ancestor
25583980|NCT00876343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25583981|NCT00876343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25583982|NCT00876343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25583983|NCT00876343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25583984|NCT00876343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25583985|NCT00876343|Dopamine Agonists|dopamine agonists|mesh-ancestor
25583986|NCT00876343|Dopamine Agents|dopamine agents|mesh-ancestor
24449341|NCT00315016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25583987|NCT00876343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25583988|NCT00876343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25583989|NCT00876343|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25583990|NCT00876343|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25583991|NCT00876343|Serotonin Agents|serotonin agents|mesh-ancestor
25583992|NCT00876343|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25583993|NCT00876343|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25583994|NCT00876343|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25583995|NCT00876343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25583996|NCT00876395|Paclitaxel|paclitaxel|mesh-list
25583997|NCT00876395|Trastuzumab|trastuzumab|mesh-list
24660300|NCT01282632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25583998|NCT00876395|Everolimus|everolimus|mesh-list
25583999|NCT00876395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25584000|NCT00876395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584001|NCT00876395|Tubulin Modulators|tubulin modulators|mesh-ancestor
25584002|NCT00876395|Antimitotic Agents|antimitotic agents|mesh-ancestor
25584003|NCT00876395|Mitosis Modulators|mitosis modulators|mesh-ancestor
25584004|NCT00876395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584005|NCT00876395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25584006|NCT00876395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25584007|NCT00876395|Immunologic Factors|immunologic factors|mesh-ancestor
25584008|NCT00876395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584009|NCT00876447|Botulinum Toxins|botulinum toxins|mesh-list
25584010|NCT00876447|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25584011|NCT00876447|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25584012|NCT00876447|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25584013|NCT00876447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25584014|NCT00876447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584015|NCT00876447|Cholinergic Agents|cholinergic agents|mesh-ancestor
25584016|NCT00876447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25584017|NCT00876447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584018|NCT00876447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24799578|NCT01969682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24799579|NCT01969682|Leprostatic Agents|leprostatic agents|mesh-ancestor
24799582|NCT01969682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584019|NCT00876447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25584020|NCT00876460|Docetaxel|docetaxel|mesh-list
25584021|NCT00876460|Nintedanib|nintedanib|mesh-list
25584022|NCT00876460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584023|NCT00876460|Tubulin Modulators|tubulin modulators|mesh-ancestor
25584024|NCT00876460|Antimitotic Agents|antimitotic agents|mesh-ancestor
25584025|NCT00876460|Mitosis Modulators|mitosis modulators|mesh-ancestor
25584026|NCT00876460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584027|NCT00876460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25584028|NCT00876460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584029|NCT00876694|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25584030|NCT00876694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25584031|NCT00876694|Autonomic Agents|autonomic agents|mesh-ancestor
25584032|NCT00876694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25584033|NCT00876694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584034|NCT00876694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25584035|NCT00876694|Respiratory System Agents|respiratory system agents|mesh-ancestor
25584036|NCT00876694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25584037|NCT00876694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25584038|NCT00876694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25584039|NCT00876694|Adrenergic Agents|adrenergic agents|mesh-ancestor
25584040|NCT00876694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25584041|NCT00876694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584042|NCT00876915|Dalteparin|dalteparin|mesh-list
25584043|NCT00876915|Tinzaparin|tinzaparin|mesh-list
25584044|NCT00876915|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25584045|NCT00876915|Anticoagulants|anticoagulants|mesh-ancestor
25584046|NCT00876915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25584047|NCT00876915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25584048|NCT00876915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584049|NCT00876928|Vitamin D|vitamin d|mesh-list
25584050|NCT00876928|Vitamins|vitamins|mesh-ancestor
24660629|NCT01284868|Adrenergic Agents|adrenergic agents|mesh-ancestor
24799736|NCT01970904|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25584051|NCT00876928|Micronutrients|micronutrients|mesh-ancestor
25584052|NCT00876928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584053|NCT00876928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25584054|NCT00876993|Bevacizumab|bevacizumab|mesh-list
25584055|NCT00876993|Irinotecan|irinotecan|mesh-list
25584056|NCT00876993|Temozolomide|temozolomide|mesh-list
25584057|NCT00876993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25584058|NCT00876993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584059|NCT00876993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25584060|NCT00876993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25584061|NCT00876993|Growth Substances|growth substances|mesh-ancestor
25584062|NCT00876993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584063|NCT00876993|Growth Inhibitors|growth inhibitors|mesh-ancestor
25584064|NCT00876993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25584065|NCT00876993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25584066|NCT00876993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584067|NCT00876993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584068|NCT00876993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25584069|NCT00876993|Alkylating Agents|alkylating agents|mesh-ancestor
25478736|NCT00096135|Hormones|hormones|mesh-ancestor
25584070|NCT00877006|Prednisone|prednisone|mesh-list
25584071|NCT00877006|Cyclophosphamide|cyclophosphamide|mesh-list
25584072|NCT00877006|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25584073|NCT00877006|Rituximab|rituximab|mesh-list
25584074|NCT00877006|Doxorubicin|doxorubicin|mesh-list
25584075|NCT00877006|Vincristine|vincristine|mesh-list
25584076|NCT00877006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25584077|NCT00877006|Immunologic Factors|immunologic factors|mesh-ancestor
25584078|NCT00877006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584079|NCT00877006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25584080|NCT00877006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25584081|NCT00877006|Alkylating Agents|alkylating agents|mesh-ancestor
25584082|NCT00877006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584083|NCT00877006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584084|NCT00877006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25584085|NCT00877006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25584086|NCT00877006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25584087|NCT00877006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25584088|NCT00877006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25584089|NCT00877006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584090|NCT00877006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25584091|NCT00877006|Glucocorticoids|glucocorticoids|mesh-ancestor
25584092|NCT00877006|Hormones|hormones|mesh-ancestor
24799759|NCT01971190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24799760|NCT01971190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24799761|NCT01971190|Growth Substances|growth substances|mesh-ancestor
24799762|NCT01971190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799763|NCT01971190|Growth Inhibitors|growth inhibitors|mesh-ancestor
24799764|NCT01971190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799765|NCT01971242|Exenatide|exenatide|mesh-list
24799766|NCT01971242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24661119|NCT01287962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661120|NCT01287962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661121|NCT01288092|Dactolisib|dactolisib|mesh-list
24661122|NCT01288092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584093|NCT00877006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25584094|NCT00877006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25584095|NCT00877006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25584096|NCT00877006|Tubulin Modulators|tubulin modulators|mesh-ancestor
25584097|NCT00877006|Antimitotic Agents|antimitotic agents|mesh-ancestor
25584098|NCT00877006|Mitosis Modulators|mitosis modulators|mesh-ancestor
25584099|NCT00877370|Ertapenem|ertapenem|mesh-list
25584100|NCT00877370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25584101|NCT00877370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25584102|NCT00877383|Tiotropium Bromide|tiotropium bromide|mesh-list
24799779|NCT01971268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799780|NCT01971268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584103|NCT00877383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25584104|NCT00877383|Autonomic Agents|autonomic agents|mesh-ancestor
25584105|NCT00877383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25584106|NCT00877383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584107|NCT00877383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25584108|NCT00877383|Respiratory System Agents|respiratory system agents|mesh-ancestor
25584109|NCT00877383|Parasympatholytics|parasympatholytics|mesh-ancestor
25584110|NCT00877383|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25584111|NCT00877383|Cholinergic Agents|cholinergic agents|mesh-ancestor
25584112|NCT00877383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25584113|NCT00877383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584114|NCT00877487|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25584115|NCT00877487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25584116|NCT00877487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584117|NCT00877487|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25584118|NCT00877487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25584119|NCT00877487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24499795|NCT00521157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24499796|NCT00521157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924149|NCT04162535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24924150|NCT04162535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24924151|NCT04162535|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24924152|NCT04162535|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24799808|NCT01971411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24799809|NCT01971411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24661413|NCT01289327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24661431|NCT01289483|Anesthetics, General|anesthetics, general|mesh-ancestor
24661432|NCT01289483|Anesthetics|anesthetics|mesh-ancestor
24661433|NCT01289496|Interferons|interferons|mesh-list
25584120|NCT00877487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584121|NCT00877487|Dopamine Agents|dopamine agents|mesh-ancestor
25584122|NCT00877487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25584123|NCT00877604|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
25584124|NCT00877604|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25584125|NCT00877604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25584126|NCT00877604|Antiviral Agents|antiviral agents|mesh-ancestor
25584127|NCT00877604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25584128|NCT00877773|Sirolimus|sirolimus|mesh-list
25584129|NCT00877773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25584130|NCT00877773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25584131|NCT00877773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25584132|NCT00877773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584133|NCT00877773|Antifungal Agents|antifungal agents|mesh-ancestor
25584134|NCT00877773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25584135|NCT00877773|Immunologic Factors|immunologic factors|mesh-ancestor
25049824|NCT00562497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25049826|NCT00562497|Autonomic Agents|autonomic agents|mesh-ancestor
25049827|NCT00562497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25049828|NCT00562497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25049829|NCT00562497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25049830|NCT00562497|Protective Agents|protective agents|mesh-ancestor
25049831|NCT00562497|Antiviral Agents|antiviral agents|mesh-ancestor
25049832|NCT00562497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25049833|NCT00561743|Dexamethasone|dexamethasone|mesh-list
25584136|NCT00877773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584137|NCT00877890|Exenatide|exenatide|mesh-list
25584138|NCT00877890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25584139|NCT00877890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584140|NCT00877890|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25584141|NCT00877890|Incretins|incretins|mesh-ancestor
25584142|NCT00877890|Hormones|hormones|mesh-ancestor
25584143|NCT00877890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25584144|NCT00877929|Amlodipine|amlodipine|mesh-list
25584145|NCT00877929|Telmisartan|telmisartan|mesh-list
25584146|NCT00877929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24924703|NCT04157257|Tenofovir|tenofovir|mesh-list
24924704|NCT04157257|Entecavir|entecavir|mesh-list
24924705|NCT04157257|Antiviral Agents|antiviral agents|mesh-ancestor
24500370|NCT00524004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661565|NCT01289938|Dermatologic Agents|dermatologic agents|mesh-ancestor
24661566|NCT01289938|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24661567|NCT01289938|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24661568|NCT01289938|Dopamine Agents|dopamine agents|mesh-ancestor
24661569|NCT01289951|Raltegravir Potassium|raltegravir potassium|mesh-list
24661570|NCT01289951|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24661572|NCT01289951|Antiviral Agents|antiviral agents|mesh-ancestor
24661591|NCT01290120|Doxorubicin|doxorubicin|mesh-list
24661592|NCT01290120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24951087|NCT03908528|Vitamins|vitamins|mesh-ancestor
25584147|NCT00877929|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25584148|NCT00877929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25584149|NCT00877929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584150|NCT00877929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25584151|NCT00877929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584152|NCT00877929|Vasodilator Agents|vasodilator agents|mesh-ancestor
24624324|NCT01075711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584153|NCT00877929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25584154|NCT00877929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25584155|NCT00878072|Famciclovir|famciclovir|mesh-list
25584156|NCT00878072|Antiviral Agents|antiviral agents|mesh-ancestor
25584157|NCT00878072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25584158|NCT00878072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25584159|NCT00878072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584160|NCT00878072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584161|NCT00878215|Liver Extracts|liver extracts|mesh-list
25704003|NCT02175225|Sequestering Agents|sequestering agents|mesh-ancestor
24500813|NCT00525759|Antimitotic Agents|antimitotic agents|mesh-ancestor
24925180|NCT04152694|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
24925181|NCT04152694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24925182|NCT04152694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24925183|NCT04152681|Apatinib|apatinib|mesh-list
24925184|NCT04152681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24925185|NCT04152681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24925186|NCT04152681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925187|NCT04152681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661867|NCT01291433|Tocotrienols|tocotrienols|mesh-list
24661868|NCT01291433|alpha-Tocopherol|alpha-tocopherol|mesh-list
25584162|NCT00878215|Hematinics|hematinics|mesh-ancestor
25584163|NCT00878228|Ondansetron|ondansetron|mesh-list
25584164|NCT00878228|Antiemetics|antiemetics|mesh-ancestor
25584165|NCT00878228|Autonomic Agents|autonomic agents|mesh-ancestor
25584166|NCT00878228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25584167|NCT00878228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584168|NCT00878228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25584169|NCT00878228|Antipruritics|antipruritics|mesh-ancestor
25584170|NCT00878228|Dermatologic Agents|dermatologic agents|mesh-ancestor
25584171|NCT00878228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25584172|NCT00878228|Serotonin Agents|serotonin agents|mesh-ancestor
24501139|NCT00527033|Mirabegron|mirabegron|mesh-list
24523723|NCT05340803|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25584173|NCT00878228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25584174|NCT00878228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584175|NCT00878228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25584176|NCT00878228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25584177|NCT00878228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25584178|NCT00878228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25584179|NCT00878228|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25584180|NCT00878436|Bicalutamide|bicalutamide|mesh-list
25584181|NCT00878436|Panobinostat|panobinostat|mesh-list
24925836|NCT04147208|Ritonavir|ritonavir|mesh-list
24799880|NCT01971658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24662063|NCT01292174|Immunologic Factors|immunologic factors|mesh-ancestor
24662064|NCT01292174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662066|NCT01292213|Chelating Agents|chelating agents|mesh-ancestor
24662067|NCT01292213|Sequestering Agents|sequestering agents|mesh-ancestor
24662068|NCT01292213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662069|NCT01292343|Listerine|listerine|mesh-list
24662070|NCT01292343|Triclosan|triclosan|mesh-list
24662096|NCT01292460|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24662097|NCT01292460|Adrenergic Agents|adrenergic agents|mesh-ancestor
24662145|NCT01292993|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24662146|NCT01292993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662147|NCT01293058|Naloxone|naloxone|mesh-list
24662148|NCT01293058|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25584182|NCT00878436|Androgen Antagonists|androgen antagonists|mesh-ancestor
25584183|NCT00878436|Hormone Antagonists|hormone antagonists|mesh-ancestor
25584184|NCT00878436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25584185|NCT00878436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584186|NCT00878436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584187|NCT00878436|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25584188|NCT00878436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584189|NCT00878436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524046|NCT05314660|Fluorides|fluorides|mesh-list
24848082|NCT05147233|Dexamethasone|dexamethasone|mesh-list
24848083|NCT05147233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24524084|NCT05282277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24524085|NCT05282277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24622234|NCT01066247|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24662377|NCT01294293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24662379|NCT01294410|Immunoglobulins|immunoglobulins|mesh-list
24662380|NCT01294410|Immunologic Factors|immunologic factors|mesh-ancestor
24662381|NCT01294410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662497|NCT01295099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662503|NCT01295099|Hormones|hormones|mesh-ancestor
25584190|NCT00878553|Zaleplon|zaleplon|mesh-list
25584191|NCT00878553|Anticonvulsants|anticonvulsants|mesh-ancestor
25584192|NCT00878553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25584193|NCT00878553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25584194|NCT00878553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584195|NCT00878553|GABA Modulators|gaba modulators|mesh-ancestor
25584196|NCT00878553|GABA Agents|gaba agents|mesh-ancestor
25584197|NCT00878553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24926782|NCT04138836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24926784|NCT04138719|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24926785|NCT04138719|Carboplatin|carboplatin|mesh-list
24662635|NCT01295866|Autonomic Agents|autonomic agents|mesh-ancestor
24662636|NCT01295866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24662637|NCT01295866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622250|NCT01066377|Sulfalene|sulfalene|mesh-list
25584198|NCT00878553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584199|NCT00878722|Idarubicin|idarubicin|mesh-list
25584200|NCT00878722|Belinostat|belinostat|mesh-list
25584201|NCT00878722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25584202|NCT00878722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584203|NCT00878722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25584204|NCT00878722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25584205|NCT00878722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584206|NCT00878722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584207|NCT00878722|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24624470|NCT01076478|Protective Agents|protective agents|mesh-ancestor
24662682|NCT01296256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24662683|NCT01296256|Alkylating Agents|alkylating agents|mesh-ancestor
24662684|NCT01296256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662685|NCT01296256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662707|NCT01296438|Insulin|insulin|mesh-list
24848222|NCT04876066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24799940|NCT01972230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24799941|NCT01972230|Narcotics|narcotics|mesh-ancestor
24799942|NCT01972230|Analgesics|analgesics|mesh-ancestor
24799943|NCT01972230|Sensory System Agents|sensory system agents|mesh-ancestor
24799944|NCT01972230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24799945|NCT01972230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24799946|NCT01972230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24799947|NCT01972269|Lidocaine|lidocaine|mesh-list
24799948|NCT01972269|Fentanyl|fentanyl|mesh-list
24799949|NCT01972269|Bupivacaine|bupivacaine|mesh-list
24799950|NCT01972269|Anesthetics, Local|anesthetics, local|mesh-ancestor
24799951|NCT01972269|Anesthetics|anesthetics|mesh-ancestor
24799952|NCT01972269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24799953|NCT01972269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584208|NCT00878800|Doxorubicin|doxorubicin|mesh-list
25584209|NCT00878800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25584210|NCT00878800|Belinostat|belinostat|mesh-list
25584211|NCT00878800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25584212|NCT00878800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584213|NCT00878800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25584214|NCT00878800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25584215|NCT00878800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525697|NCT02869217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478878|NCT00096447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478879|NCT00096460|Cyclophosphamide|cyclophosphamide|mesh-list
25584216|NCT00878800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584217|NCT00878800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25584218|NCT00878826|Enoxaparin|enoxaparin|mesh-list
25584219|NCT00878826|Anticoagulants|anticoagulants|mesh-ancestor
25584220|NCT00878826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25584221|NCT00878826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25584222|NCT00878826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584223|NCT00878995|Methyltestosterone|methyltestosterone|mesh-list
25584224|NCT00878995|Testosterone|testosterone|mesh-list
25584225|NCT00878995|Testosterone undecanoate|testosterone undecanoate|mesh-list
25584226|NCT00878995|Testosterone enanthate|testosterone enanthate|mesh-list
25584227|NCT00878995|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25584228|NCT00878995|Androgens|androgens|mesh-ancestor
25584229|NCT00878995|Hormones|hormones|mesh-ancestor
25584230|NCT00878995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25584231|NCT00878995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584232|NCT00878995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25584233|NCT00878995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584234|NCT00878995|Anabolic Agents|anabolic agents|mesh-ancestor
24663090|NCT01298284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24663091|NCT01298284|Vasodilator Agents|vasodilator agents|mesh-ancestor
24663093|NCT01298297|Buprenorphine|buprenorphine|mesh-list
24663129|NCT01298401|Antimetabolites|antimetabolites|mesh-ancestor
24663137|NCT01298401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663138|NCT01298466|Pregabalin|pregabalin|mesh-list
24663139|NCT01298466|Analgesics|analgesics|mesh-ancestor
24663140|NCT01298466|Sensory System Agents|sensory system agents|mesh-ancestor
24663162|NCT01298713|Tamoxifen|tamoxifen|mesh-list
25584235|NCT00879034|Zoledronic Acid|zoledronic acid|mesh-list
25584236|NCT00879034|Pravastatin|pravastatin|mesh-list
25584237|NCT00879034|Lonafarnib|lonafarnib|mesh-list
24928131|NCT04125706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25584238|NCT00879034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25584239|NCT00879034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584240|NCT00879034|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25584241|NCT00879034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25584242|NCT00879034|Antimetabolites|antimetabolites|mesh-ancestor
25584243|NCT00879034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584244|NCT00879034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25584245|NCT00879034|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25584246|NCT00879034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584247|NCT00879060|Spironolactone|spironolactone|mesh-list
25584248|NCT00879060|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25584249|NCT00879060|Hormone Antagonists|hormone antagonists|mesh-ancestor
25584250|NCT00879060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25584251|NCT00879060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584252|NCT00879060|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25584253|NCT00879060|Diuretics|diuretics|mesh-ancestor
25584254|NCT00879060|Natriuretic Agents|natriuretic agents|mesh-ancestor
24455816|NCT00329134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663399|NCT01300962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24663400|NCT01300962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24663401|NCT01300962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663402|NCT01300988|Aprepitant|aprepitant|mesh-list
24663403|NCT01300988|Fosaprepitant|fosaprepitant|mesh-list
24663404|NCT01300988|Antiemetics|antiemetics|mesh-ancestor
24800043|NCT01973010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24800045|NCT01973010|Analgesics|analgesics|mesh-ancestor
24800055|NCT01973101|Cisplatin|cisplatin|mesh-list
25584255|NCT00879190|Gentamicins|gentamicins|mesh-list
25584256|NCT00879190|Ampicillin|ampicillin|mesh-list
25584257|NCT00879190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25584258|NCT00879190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25584259|NCT00879190|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25584260|NCT00879190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584261|NCT00879190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584262|NCT00879229|Ambrisentan|ambrisentan|mesh-list
25584263|NCT00879229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25584264|NCT00879333|Everolimus|everolimus|mesh-list
25584265|NCT00879333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584266|NCT00879333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25584267|NCT00879333|Immunologic Factors|immunologic factors|mesh-ancestor
25584268|NCT00879333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584269|NCT00879359|Paclitaxel|paclitaxel|mesh-list
25584270|NCT00879359|Bevacizumab|bevacizumab|mesh-list
25584271|NCT00879359|Carboplatin|carboplatin|mesh-list
25584272|NCT00879359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24929181|NCT04115111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24929182|NCT04115111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929183|NCT04115163|Gemcitabine|gemcitabine|mesh-list
24663457|NCT01301586|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24663458|NCT01301586|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24663459|NCT01301599|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
24663460|NCT01301599|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
24663461|NCT01301599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24663547|NCT01302158|Glimepiride|glimepiride|mesh-list
25584273|NCT00879359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584274|NCT00879359|Tubulin Modulators|tubulin modulators|mesh-ancestor
25584275|NCT00879359|Antimitotic Agents|antimitotic agents|mesh-ancestor
25584276|NCT00879359|Mitosis Modulators|mitosis modulators|mesh-ancestor
25584277|NCT00879359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584278|NCT00879359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25584279|NCT00879359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25584280|NCT00879359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25584281|NCT00879359|Growth Substances|growth substances|mesh-ancestor
24930002|NCT04106726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24930003|NCT04106843|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
24528607|NCT00621907|Anesthetics|anesthetics|mesh-ancestor
24800076|NCT01973309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584282|NCT00879359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584283|NCT00879359|Growth Inhibitors|growth inhibitors|mesh-ancestor
25584284|NCT00879398|Fesoterodine|fesoterodine|mesh-list
25584285|NCT00879398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25584286|NCT00879398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25584287|NCT00879398|Cholinergic Agents|cholinergic agents|mesh-ancestor
25584288|NCT00879398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24930958|NCT04095013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24930959|NCT04095013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24930960|NCT04095013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24930961|NCT04095013|Analgesics|analgesics|mesh-ancestor
24930962|NCT04095013|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24930963|NCT04095013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24930964|NCT04095013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24930965|NCT04095013|Adrenergic Agents|adrenergic agents|mesh-ancestor
25584289|NCT00879398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584290|NCT00879398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584291|NCT00879398|Urological Agents|urological agents|mesh-ancestor
25584293|NCT00879411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25584294|NCT00879411|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25584295|NCT00879411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25584296|NCT00879411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584297|NCT00879437|Bevacizumab|bevacizumab|mesh-list
25584298|NCT00879437|Valproic Acid|valproic acid|mesh-list
25584299|NCT00879437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24625054|NCT01080352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625055|NCT01080352|Protective Agents|protective agents|mesh-ancestor
24625056|NCT01080417|Mycophenolic Acid|mycophenolic acid|mesh-list
24931357|NCT04089813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931379|NCT04089605|BB 1101|bb 1101|mesh-list
24507709|NCT00551564|Rosiglitazone|rosiglitazone|mesh-list
24529337|NCT00625495|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24663681|NCT01303055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24663682|NCT01303055|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24663683|NCT01303055|Protease Inhibitors|protease inhibitors|mesh-ancestor
24663746|NCT01303549|Amebicides|amebicides|mesh-ancestor
25584300|NCT00879437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584301|NCT00879437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25584302|NCT00879437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25584303|NCT00879437|Growth Substances|growth substances|mesh-ancestor
24800109|NCT01973660|Tamoxifen|tamoxifen|mesh-list
25584304|NCT00879437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584305|NCT00879437|Growth Inhibitors|growth inhibitors|mesh-ancestor
25584306|NCT00879437|Anticonvulsants|anticonvulsants|mesh-ancestor
25584307|NCT00879437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584308|NCT00879437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584309|NCT00879437|GABA Agents|gaba agents|mesh-ancestor
25584310|NCT00879437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25584311|NCT00879437|Antimanic Agents|antimanic agents|mesh-ancestor
25584312|NCT00879437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25584313|NCT00879437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25584314|NCT00879437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25584315|NCT00879658|Siponimod|siponimod|mesh-list
25584316|NCT00879658|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25704102|NCT02176031|Protective Agents|protective agents|mesh-ancestor
24625249|NCT01081223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625250|NCT01081353|Aspirin|aspirin|mesh-list
24625251|NCT01081353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24625252|NCT01081353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24625253|NCT01081353|Analgesics|analgesics|mesh-ancestor
25584317|NCT00879658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584318|NCT00879658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25584319|NCT00879658|Immunologic Factors|immunologic factors|mesh-ancestor
25584320|NCT00879658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584321|NCT00879710|Simvastatin|simvastatin|mesh-list
25584322|NCT00879710|Ezetimibe|ezetimibe|mesh-list
25584323|NCT00879710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25584324|NCT00879710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25584325|NCT00879710|Antimetabolites|antimetabolites|mesh-ancestor
24664158|NCT01305551|Incretins|incretins|mesh-ancestor
24664159|NCT01305551|Hormones|hormones|mesh-ancestor
24664160|NCT01305551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24664161|NCT01305551|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24664162|NCT01305551|Protease Inhibitors|protease inhibitors|mesh-ancestor
24664186|NCT01305707|Fluoxetine|fluoxetine|mesh-list
25584326|NCT00879710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584327|NCT00879710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25584328|NCT00879710|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25584329|NCT00879710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584330|NCT00879775|Sodium Benzoate|sodium benzoate|mesh-list
25584331|NCT00879775|Caffeine|caffeine|mesh-list
25584332|NCT00879775|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25584333|NCT00879775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933425|NCT04070794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933524|NCT04069845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933525|NCT04069858|Entecavir|entecavir|mesh-list
24933526|NCT04069858|Antiviral Agents|antiviral agents|mesh-ancestor
25584334|NCT00879775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25584335|NCT00879775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584336|NCT00879775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584337|NCT00879775|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25584338|NCT00879775|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25584339|NCT00879775|Purinergic Agents|purinergic agents|mesh-ancestor
25584340|NCT00879775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25584341|NCT00879775|Antifungal Agents|antifungal agents|mesh-ancestor
25584342|NCT00879775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25584343|NCT00879814|Vaccines|vaccines|mesh-list
25584344|NCT00879814|Immunologic Factors|immunologic factors|mesh-ancestor
24625308|NCT01081561|Dermatologic Agents|dermatologic agents|mesh-ancestor
24625309|NCT01081600|Trastuzumab|trastuzumab|mesh-list
24625310|NCT01081600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24800283|NCT01974518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24800284|NCT01974622|Verteporfin|verteporfin|mesh-list
24664499|NCT01307215|Ropivacaine|ropivacaine|mesh-list
24664500|NCT01307215|Anesthetics, Local|anesthetics, local|mesh-ancestor
24664501|NCT01307215|Anesthetics|anesthetics|mesh-ancestor
25584345|NCT00879814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584346|NCT00879879|Losartan|losartan|mesh-list
25584347|NCT00879879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25584348|NCT00879879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25584349|NCT00879879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25584350|NCT00879879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25584351|NCT00879879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584352|NCT00879970|Vitamin D|vitamin d|mesh-list
25584353|NCT00879970|Pioglitazone|pioglitazone|mesh-list
25584354|NCT00879970|Rosiglitazone|rosiglitazone|mesh-list
24934080|NCT04064073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800309|NCT01974934|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24800312|NCT01974934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049982|NCT00552708|Adrenergic Agents|adrenergic agents|mesh-ancestor
25049983|NCT00552708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24452494|NCT05458492|Sirolimus|sirolimus|mesh-list
25584355|NCT00879970|Vitamins|vitamins|mesh-ancestor
25584356|NCT00879970|Micronutrients|micronutrients|mesh-ancestor
25584357|NCT00879970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584358|NCT00879970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25584359|NCT00879970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25584360|NCT00879996|Buprenorphine|buprenorphine|mesh-list
25584361|NCT00879996|Methadone|methadone|mesh-list
25584362|NCT00879996|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25584363|NCT00879996|Naloxone|naloxone|mesh-list
24530585|NCT00631124|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24848753|NCT03529110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24848754|NCT03529110|Tubulin Modulators|tubulin modulators|mesh-ancestor
24848755|NCT03529110|Antimitotic Agents|antimitotic agents|mesh-ancestor
24664585|NCT01307839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24664586|NCT01307839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951641|NCT03902782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25584365|NCT00879996|Narcotics|narcotics|mesh-ancestor
25584366|NCT00879996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25584367|NCT00879996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584368|NCT00879996|Analgesics|analgesics|mesh-ancestor
25584369|NCT00879996|Sensory System Agents|sensory system agents|mesh-ancestor
25584370|NCT00879996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25584371|NCT00879996|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25584372|NCT00879996|Antitussive Agents|antitussive agents|mesh-ancestor
25584373|NCT00879996|Respiratory System Agents|respiratory system agents|mesh-ancestor
25584374|NCT00880009|Letrozole|letrozole|mesh-list
25584375|NCT00880009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584376|NCT00880009|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25584377|NCT00880009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25584378|NCT00880009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584379|NCT00880009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584380|NCT00880009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25584381|NCT00880009|Hormone Antagonists|hormone antagonists|mesh-ancestor
24759643|NCT01753349|Cholinergic Agents|cholinergic agents|mesh-ancestor
24759644|NCT01753349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24759645|NCT01753349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664682|NCT01308255|Micronutrients|micronutrients|mesh-ancestor
24664683|NCT01308255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664684|NCT01308255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24664699|NCT01308255|Antiemetics|antiemetics|mesh-ancestor
24664702|NCT01308255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24759647|NCT01753349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24759648|NCT01753375|Vitamin D|vitamin d|mesh-list
24759649|NCT01753375|Cholecalciferol|cholecalciferol|mesh-list
24759650|NCT01753375|Vitamins|vitamins|mesh-ancestor
24951724|NCT03901768|Hormones|hormones|mesh-ancestor
24759651|NCT01753375|Micronutrients|micronutrients|mesh-ancestor
24759652|NCT01753375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759653|NCT01753375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24759654|NCT01753375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24759655|NCT01753453|Plerixafor|plerixafor|mesh-list
24759656|NCT01753453|Lenograstim|lenograstim|mesh-list
24759657|NCT01753453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24759658|NCT01753453|Immunologic Factors|immunologic factors|mesh-ancestor
24759659|NCT01753453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584382|NCT00880009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25584383|NCT00880009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584384|NCT00880100|Pancrelipase|pancrelipase|mesh-list
25584385|NCT00880100|Pancreatin|pancreatin|mesh-list
25584386|NCT00880100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25584387|NCT00880191|Dexamethasone|dexamethasone|mesh-list
25584388|NCT00880191|Gabapentin|gabapentin|mesh-list
25584389|NCT00880191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25584390|NCT00880191|Antiemetics|antiemetics|mesh-ancestor
25584391|NCT00880191|Autonomic Agents|autonomic agents|mesh-ancestor
24664714|NCT01308268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24664715|NCT01308268|Anthelmintics|anthelmintics|mesh-ancestor
24664716|NCT01308268|Anticestodal Agents|anticestodal agents|mesh-ancestor
24664717|NCT01308268|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24664718|NCT01308268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24625480|NCT01082263|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24625481|NCT01082263|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24625482|NCT01082263|Dopamine Agents|dopamine agents|mesh-ancestor
24625483|NCT01082276|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
24625484|NCT01082276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24935280|NCT04052659|Antimetabolites|antimetabolites|mesh-ancestor
24935220|NCT04053621|Metformin|metformin|mesh-list
24935221|NCT04053621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24935222|NCT04053621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935223|NCT04053621|Vitamin B Complex|vitamin b complex|mesh-ancestor
24935224|NCT04053621|Vitamins|vitamins|mesh-ancestor
24935225|NCT04053621|Micronutrients|micronutrients|mesh-ancestor
24935226|NCT04053543|CXA-10|cxa-10|mesh-list
24935227|NCT04053543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24935228|NCT04053400|Ketamine|ketamine|mesh-list
24935229|NCT04053400|Analgesics|analgesics|mesh-ancestor
25584392|NCT00880191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25584393|NCT00880191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584394|NCT00880191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25584395|NCT00880191|Glucocorticoids|glucocorticoids|mesh-ancestor
25584396|NCT00880191|Hormones|hormones|mesh-ancestor
25584397|NCT00880191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25584398|NCT00880191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25584399|NCT00880191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584400|NCT00880191|Analgesics|analgesics|mesh-ancestor
25584401|NCT00880191|Sensory System Agents|sensory system agents|mesh-ancestor
24935275|NCT04053205|Antimitotic Agents|antimitotic agents|mesh-ancestor
24935276|NCT04053205|Mitosis Modulators|mitosis modulators|mesh-ancestor
24935277|NCT04053205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935278|NCT04052659|Azacitidine|azacitidine|mesh-list
24935289|NCT04052269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935290|NCT04052269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935291|NCT04052269|Urological Agents|urological agents|mesh-ancestor
24935293|NCT04052178|Antipruritics|antipruritics|mesh-ancestor
24935294|NCT04052178|Dermatologic Agents|dermatologic agents|mesh-ancestor
24935295|NCT04052178|Sensory System Agents|sensory system agents|mesh-ancestor
24848932|NCT03257163|Capecitabine|capecitabine|mesh-list
24848933|NCT03257163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24848934|NCT03257163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24848935|NCT03257163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24848936|NCT03257163|Antimetabolites|antimetabolites|mesh-ancestor
24848938|NCT03249714|Ofatumumab|ofatumumab|mesh-list
25584402|NCT00880191|Anticonvulsants|anticonvulsants|mesh-ancestor
25584403|NCT00880191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25584404|NCT00880191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25584405|NCT00880191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25584406|NCT00880191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25584407|NCT00880191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25584408|NCT00880191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25584409|NCT00880191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25584410|NCT00880191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584411|NCT00880191|Antimanic Agents|antimanic agents|mesh-ancestor
25584412|NCT00880269|Panobinostat|panobinostat|mesh-list
25584413|NCT00880269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584414|NCT00880269|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25584415|NCT00880269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584416|NCT00880269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584417|NCT00880334|Docetaxel|docetaxel|mesh-list
24935204|NCT04054128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24935206|NCT04053985|Lenvatinib|lenvatinib|mesh-list
25584418|NCT00880334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584419|NCT00880334|Tubulin Modulators|tubulin modulators|mesh-ancestor
25584420|NCT00880334|Antimitotic Agents|antimitotic agents|mesh-ancestor
25584421|NCT00880334|Mitosis Modulators|mitosis modulators|mesh-ancestor
25584422|NCT00880334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584423|NCT00880360|Denileukin diftitox|denileukin diftitox|mesh-list
25584424|NCT00880360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584425|NCT00880607|Morphine|morphine|mesh-list
25584426|NCT00880607|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24668586|NCT04823364|Neurotransmitter Agents|neurotransmitter agents|mesh-list
24668587|NCT04823364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704151|NCT02176421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25704152|NCT02176421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050013|NCT00547651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25050014|NCT00547651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050015|NCT00547651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664812|NCT01308723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664822|NCT01308944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24664823|NCT01308944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24664824|NCT01308944|Vasodilator Agents|vasodilator agents|mesh-ancestor
24664825|NCT01308983|Amiloride|amiloride|mesh-list
24664826|NCT01308983|Diuretics|diuretics|mesh-ancestor
24664827|NCT01308983|Natriuretic Agents|natriuretic agents|mesh-ancestor
24664828|NCT01308983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664829|NCT01308983|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24664830|NCT01308983|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24664831|NCT01308983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24664832|NCT01308983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664833|NCT01308983|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24668870|NCT04543968|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
25584427|NCT00880607|Narcotics|narcotics|mesh-ancestor
25584428|NCT00880607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25584429|NCT00880607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584430|NCT00880607|Analgesics|analgesics|mesh-ancestor
25584431|NCT00880607|Sensory System Agents|sensory system agents|mesh-ancestor
25584432|NCT00880607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653134|NCT01534897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25653135|NCT01534897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24668871|NCT04543968|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
24668872|NCT04543968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24668873|NCT04543968|Antioxidants|antioxidants|mesh-ancestor
24668874|NCT04543968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24668875|NCT04543968|Protective Agents|protective agents|mesh-ancestor
25050019|NCT00546793|Veltuzumab|veltuzumab|mesh-list
25653136|NCT01534897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653137|NCT01534962|Ranolazine|ranolazine|mesh-list
25479099|NCT00098306|Antiviral Agents|antiviral agents|mesh-ancestor
25479102|NCT00098371|Alvocidib|alvocidib|mesh-list
25584433|NCT00880620|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25584434|NCT00880620|Carbidopa|carbidopa|mesh-list
25584435|NCT00880620|Levodopa|levodopa|mesh-list
25584436|NCT00880620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25584437|NCT00880620|Immunologic Factors|immunologic factors|mesh-ancestor
24664935|NCT01309438|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24664940|NCT01309438|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25050036|NCT00544466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25050037|NCT00544466|Antimetabolites|antimetabolites|mesh-ancestor
25050038|NCT00544466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935379|NCT04051047|Gemcitabine|gemcitabine|mesh-list
24935380|NCT04051047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24935381|NCT04051047|Antimetabolites|antimetabolites|mesh-ancestor
24935382|NCT04051047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935383|NCT04051047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584438|NCT00880620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584439|NCT00880620|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25584440|NCT00880620|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25584441|NCT00880620|Dopamine Agonists|dopamine agonists|mesh-ancestor
25584442|NCT00880620|Dopamine Agents|dopamine agents|mesh-ancestor
25584443|NCT00880620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25584444|NCT00880620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584445|NCT00880620|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25584446|NCT00880620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935411|NCT04050592|Estrogens|estrogens|mesh-ancestor
24669374|NCT04058717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584447|NCT00880685|Memantine|memantine|mesh-list
25584448|NCT00880685|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25584449|NCT00880685|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25584450|NCT00880685|Dopamine Agents|dopamine agents|mesh-ancestor
25584451|NCT00880685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25584452|NCT00880685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584453|NCT00880685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584454|NCT00880685|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25584455|NCT00880685|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25584456|NCT00880763|Interferons|interferons|mesh-list
25584457|NCT00880763|Ribavirin|ribavirin|mesh-list
25584458|NCT00880763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584459|NCT00880763|Antiviral Agents|antiviral agents|mesh-ancestor
25584460|NCT00880763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25584461|NCT00880763|Antimetabolites|antimetabolites|mesh-ancestor
25584462|NCT00880763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584463|NCT00880906|Fluticasone|fluticasone|mesh-list
25584464|NCT00880906|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25584465|NCT00880906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25584466|NCT00880906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25584467|NCT00880906|Autonomic Agents|autonomic agents|mesh-ancestor
25584468|NCT00880906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25584469|NCT00880906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584470|NCT00880906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25584471|NCT00880906|Respiratory System Agents|respiratory system agents|mesh-ancestor
24532226|NCT00638729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24532242|NCT00638729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24532243|NCT00638729|Adrenergic Agents|adrenergic agents|mesh-ancestor
24532244|NCT00638742|Latanoprost|latanoprost|mesh-list
24532245|NCT00638742|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24532270|NCT00638833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935512|NCT04049409|Trastuzumab|trastuzumab|mesh-list
25584472|NCT00880906|Dermatologic Agents|dermatologic agents|mesh-ancestor
25584473|NCT00880906|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25584474|NCT00880906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584475|NCT00880906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584476|NCT00880919|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25584477|NCT00880919|Antidepressive Agents|antidepressive agents|mesh-ancestor
25584478|NCT00880919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25584479|NCT00880919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25584480|NCT00880919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25584481|NCT00880919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25584482|NCT00880919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584483|NCT00880997|Doxazosin|doxazosin|mesh-list
24532603|NCT00640575|Immunologic Factors|immunologic factors|mesh-ancestor
24532604|NCT00640575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532606|NCT00640588|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
24532607|NCT00640588|Telbivudine|telbivudine|mesh-list
24665376|NCT01311960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665377|NCT01311960|Growth Inhibitors|growth inhibitors|mesh-ancestor
24665378|NCT01311960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24665380|NCT01312012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24665383|NCT01312064|Tacrolimus|tacrolimus|mesh-list
24935548|NCT04049201|Midazolam|midazolam|mesh-list
24935549|NCT04049201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24935550|NCT04049201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24935551|NCT04049201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24935552|NCT04049201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935553|NCT04049201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24935554|NCT04049201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24935555|NCT04049201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24935556|NCT04049201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24935557|NCT04049201|Anesthetics, General|anesthetics, general|mesh-ancestor
24935558|NCT04049201|Anesthetics|anesthetics|mesh-ancestor
24935559|NCT04049201|GABA Modulators|gaba modulators|mesh-ancestor
24935560|NCT04049201|GABA Agents|gaba agents|mesh-ancestor
24665393|NCT01312064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532914|NCT00641654|Interferons|interferons|mesh-list
24532915|NCT00641654|Ribavirin|ribavirin|mesh-list
24532916|NCT00641654|Interferon-alpha|interferon-alpha|mesh-list
24532917|NCT00641654|Interferon alpha-2|interferon alpha-2|mesh-list
24532918|NCT00641654|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24532919|NCT00641654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24532920|NCT00641654|Antiviral Agents|antiviral agents|mesh-ancestor
24532921|NCT00641654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24532922|NCT00641654|Antimetabolites|antimetabolites|mesh-ancestor
24532923|NCT00641654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532924|NCT00641654|Immunologic Factors|immunologic factors|mesh-ancestor
24532927|NCT00641680|Xhance|xhance|mesh-list
24665437|NCT01312350|Docetaxel|docetaxel|mesh-list
25584484|NCT00880997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25584485|NCT00880997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25584486|NCT00880997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25584487|NCT00880997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25584488|NCT00880997|Adrenergic Agents|adrenergic agents|mesh-ancestor
25584489|NCT00880997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25584490|NCT00880997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584491|NCT00880997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584492|NCT00881504|Bevacizumab|bevacizumab|mesh-list
24533121|NCT00642395|Bortezomib|bortezomib|mesh-list
25584493|NCT00881504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25584494|NCT00881504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584495|NCT00881504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25584496|NCT00881504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25584497|NCT00881504|Growth Substances|growth substances|mesh-ancestor
25584498|NCT00881504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584499|NCT00881504|Growth Inhibitors|growth inhibitors|mesh-ancestor
25584500|NCT00881530|Metformin|metformin|mesh-list
25584501|NCT00881530|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25584502|NCT00881530|Empagliflozin|empagliflozin|mesh-list
25584503|NCT00881530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25584504|NCT00881530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665540|NCT01313377|Antiviral Agents|antiviral agents|mesh-ancestor
24665541|NCT01313377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24849302|NCT01309191|Vasodilator Agents|vasodilator agents|mesh-ancestor
25050061|NCT00544115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24665542|NCT01313377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24665556|NCT01313403|Antidepressive Agents|antidepressive agents|mesh-list
24665558|NCT01313429|Celecoxib|celecoxib|mesh-list
24665569|NCT01313429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24665570|NCT01313429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24665571|NCT01313429|Analgesics|analgesics|mesh-ancestor
24665572|NCT01313429|Sensory System Agents|sensory system agents|mesh-ancestor
24665573|NCT01313429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24665574|NCT01313429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24665575|NCT01313429|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24665576|NCT01313429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24452718|NCT05457530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24665596|NCT01313585|Hormones|hormones|mesh-ancestor
24670585|NCT02274155|Immunologic Factors|immunologic factors|mesh-ancestor
24670586|NCT02274155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584505|NCT00881530|Incretins|incretins|mesh-ancestor
25584506|NCT00881530|Hormones|hormones|mesh-ancestor
25479174|NCT00098774|Antidotes|antidotes|mesh-ancestor
25584507|NCT00881530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25584508|NCT00881530|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25584509|NCT00881530|Protease Inhibitors|protease inhibitors|mesh-ancestor
25584510|NCT00881530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584511|NCT00881530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584512|NCT00881530|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25584513|NCT00881569|Efatutazone|efatutazone|mesh-list
25584514|NCT00881569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584515|NCT00881621|Capecitabine|capecitabine|mesh-list
25584516|NCT00881621|Lapatinib|lapatinib|mesh-list
24456586|NCT00331786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24456587|NCT00331786|Analgesics|analgesics|mesh-ancestor
24456588|NCT00331786|Sensory System Agents|sensory system agents|mesh-ancestor
24670715|NCT01998971|Diphenhydramine|diphenhydramine|mesh-list
24670716|NCT01998971|Promethazine|promethazine|mesh-list
24670717|NCT01998971|Thalidomide|thalidomide|mesh-list
24670718|NCT01998971|Dexamethasone|dexamethasone|mesh-list
24670719|NCT01998971|Prednisone|prednisone|mesh-list
24670720|NCT01998971|Lenalidomide|lenalidomide|mesh-list
24665597|NCT01313585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24665598|NCT01313611|Rituximab|rituximab|mesh-list
24665599|NCT01313611|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24665600|NCT01313611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24665601|NCT01313611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665603|NCT01313611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665604|NCT01313611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24453995|NCT04575233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050076|NCT00544115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25050077|NCT00544115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24665639|NCT01313819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24665641|NCT01313819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665642|NCT01313819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584517|NCT00881621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25584518|NCT00881621|Antimetabolites|antimetabolites|mesh-ancestor
25584519|NCT00881621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584520|NCT00881621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584521|NCT00881621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25584522|NCT00881621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584523|NCT00881751|Bevacizumab|bevacizumab|mesh-list
25584524|NCT00881751|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25584525|NCT00881751|Sorafenib|sorafenib|mesh-list
25704259|NCT02178696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25050080|NCT00544115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25050081|NCT00544115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25050082|NCT00544115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25050083|NCT00544115|Antitubercular Agents|antitubercular agents|mesh-ancestor
25050084|NCT00544115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25584526|NCT00881751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25584527|NCT00881751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584528|NCT00881751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25584529|NCT00881751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25584530|NCT00881751|Growth Substances|growth substances|mesh-ancestor
25584531|NCT00881751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584532|NCT00881751|Growth Inhibitors|growth inhibitors|mesh-ancestor
25584533|NCT00881751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25584534|NCT00881751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584535|NCT00881751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584536|NCT00881894|Rotigotine|rotigotine|mesh-list
25584537|NCT00881894|Dopamine Agonists|dopamine agonists|mesh-ancestor
25584538|NCT00881894|Dopamine Agents|dopamine agents|mesh-ancestor
24665739|NCT01314352|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24665740|NCT01314352|Histamine Antagonists|histamine antagonists|mesh-ancestor
24665741|NCT01314352|Histamine Agents|histamine agents|mesh-ancestor
24665742|NCT01314482|Minocycline|minocycline|mesh-list
24665743|NCT01314482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24665744|NCT01314482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24665745|NCT01314495|Abatacept|abatacept|mesh-list
24665746|NCT01314495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24665747|NCT01314495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665833|NCT01314976|Metronidazole|metronidazole|mesh-list
24665748|NCT01314495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665749|NCT01314495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24665750|NCT01314495|Immunologic Factors|immunologic factors|mesh-ancestor
24665751|NCT01314495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665752|NCT01314495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24665753|NCT01314508|Mecasermin|mecasermin|mesh-list
24665754|NCT01314508|Growth Substances|growth substances|mesh-ancestor
24665755|NCT01314508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665756|NCT01314586|Secoisolariciresinol|secoisolariciresinol|mesh-list
24665757|NCT01314586|Phytoestrogens|phytoestrogens|mesh-ancestor
24665758|NCT01314586|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24665760|NCT01314586|Hormones|hormones|mesh-ancestor
24665777|NCT01314833|Cyclophosphamide|cyclophosphamide|mesh-list
24935654|NCT04048226|Analgesics|analgesics|mesh-ancestor
25584539|NCT00881894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25584540|NCT00881894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584541|NCT00881894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584542|NCT00882102|Decitabine|decitabine|mesh-list
25584543|NCT00882102|Gemtuzumab|gemtuzumab|mesh-list
25584544|NCT00882102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25584545|NCT00882102|Antimetabolites|antimetabolites|mesh-ancestor
24455501|NCT00327587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24665794|NCT01314833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24665795|NCT01314833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24665796|NCT01314833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24665797|NCT01314833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24665798|NCT01314833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24665799|NCT01314859|Nifedipine|nifedipine|mesh-list
24665800|NCT01314859|Atosiban|atosiban|mesh-list
24665801|NCT01314859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24665802|NCT01314859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24665804|NCT01314859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25584546|NCT00882102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584547|NCT00882102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584548|NCT00882102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584549|NCT00882102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25584550|NCT00882115|Sulforaphane|sulforaphane|mesh-list
25584551|NCT00882115|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25584552|NCT00882115|Protective Agents|protective agents|mesh-ancestor
25584553|NCT00882115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584554|NCT00882115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584555|NCT00882206|Cytarabine|cytarabine|mesh-list
25584556|NCT00882206|Prednisone|prednisone|mesh-list
25584557|NCT00882206|Doxorubicin|doxorubicin|mesh-list
25584558|NCT00882206|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25584559|NCT00882206|Methotrexate|methotrexate|mesh-list
25584560|NCT00882206|Vincristine|vincristine|mesh-list
25584561|NCT00882206|Imatinib Mesylate|imatinib mesylate|mesh-list
25584562|NCT00882206|Decitabine|decitabine|mesh-list
25584563|NCT00882206|Asparaginase|asparaginase|mesh-list
25584564|NCT00882206|Vorinostat|vorinostat|mesh-list
25584565|NCT00882206|Pegaspargase|pegaspargase|mesh-list
25584566|NCT00882206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25584567|NCT00882206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584568|NCT00882206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25584569|NCT00882206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25584570|NCT00882206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584571|NCT00882206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584572|NCT00882206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24935736|NCT04047940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24935737|NCT04047940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935738|NCT04047940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24935739|NCT04047940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25584573|NCT00882206|Glucocorticoids|glucocorticoids|mesh-ancestor
25584574|NCT00882206|Hormones|hormones|mesh-ancestor
25584575|NCT00882206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25584576|NCT00882206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584577|NCT00882206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25584578|NCT00882206|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25584579|NCT00882206|Abortifacient Agents|abortifacient agents|mesh-ancestor
25584580|NCT00882206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25584581|NCT00882206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25584582|NCT00882206|Antimetabolites|antimetabolites|mesh-ancestor
25584583|NCT00882206|Dermatologic Agents|dermatologic agents|mesh-ancestor
25584584|NCT00882206|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25479325|NCT00099268|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25479326|NCT00099268|Immunologic Factors|immunologic factors|mesh-ancestor
25479327|NCT00099268|Dopamine Agonists|dopamine agonists|mesh-ancestor
25479328|NCT00099268|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24445458|NCT00301587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25040926|NCT02736149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25040927|NCT02736149|Immunologic Factors|immunologic factors|mesh-ancestor
24433479|NCT00258596|Sirolimus|sirolimus|mesh-list
25040958|NCT02733432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25040959|NCT02733432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25040960|NCT02733432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040961|NCT02733432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25162079|NCT02908295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25162080|NCT02908295|Abortifacient Agents|abortifacient agents|mesh-ancestor
25162081|NCT02908295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24935784|NCT04047680|Grazoprevir|grazoprevir|mesh-list
24935785|NCT04047680|Ledipasvir|ledipasvir|mesh-list
24935786|NCT04047680|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25162082|NCT02908295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162083|NCT02908295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25162084|NCT02908295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25162085|NCT02908295|Oxytocics|oxytocics|mesh-ancestor
25162086|NCT02908165|Sorafenib|sorafenib|mesh-list
25162087|NCT02908165|Chlorotrianisene|chlorotrianisene|mesh-list
25162088|NCT02908165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162089|NCT02908165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25162090|NCT02908165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666191|NCT01317992|Respiratory System Agents|respiratory system agents|mesh-ancestor
24666192|NCT01317992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24666199|NCT01318005|Contraceptives, Oral|contraceptives, oral|mesh-list
24666200|NCT01318005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24666201|NCT01318005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162091|NCT02908165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162092|NCT02908165|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25162093|NCT02908165|Estrogens|estrogens|mesh-ancestor
25162094|NCT02908165|Hormones|hormones|mesh-ancestor
25162095|NCT02908165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25162096|NCT02908165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162097|NCT02908165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25162098|NCT02908282|Povidone|povidone|mesh-list
25162099|NCT02908282|Plasma Substitutes|plasma substitutes|mesh-ancestor
25162100|NCT02908282|Blood Substitutes|blood substitutes|mesh-ancestor
25162101|NCT02908152|Curcumin|curcumin|mesh-list
25162102|NCT02908152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25162103|NCT02908152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25162104|NCT02908152|Analgesics|analgesics|mesh-ancestor
25162105|NCT02908152|Sensory System Agents|sensory system agents|mesh-ancestor
25162106|NCT02908152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25162107|NCT02908152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162108|NCT02908152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25162109|NCT02908152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24666323|NCT01318590|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25162110|NCT02908152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162111|NCT02908152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25162112|NCT02908152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162113|NCT02908126|Oxytocin|oxytocin|mesh-list
25162114|NCT02908126|Oxytocics|oxytocics|mesh-ancestor
25162115|NCT02908126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24433342|NCT00258232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24433343|NCT00258232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24433344|NCT00258232|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24433345|NCT00258232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24449694|NCT00316563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24666407|NCT01319188|Growth Substances|growth substances|mesh-ancestor
24433346|NCT00258245|Aspirin|aspirin|mesh-list
24433347|NCT00258245|Vitamins|vitamins|mesh-list
24433348|NCT00258245|Ascorbic Acid|ascorbic acid|mesh-list
24433349|NCT00258245|Thalidomide|thalidomide|mesh-list
24979624|NCT03455439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24979625|NCT03455439|Antithrombins|antithrombins|mesh-ancestor
24979626|NCT03455439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24666535|NCT01319825|Milnacipran|milnacipran|mesh-list
24979627|NCT03455439|Protease Inhibitors|protease inhibitors|mesh-ancestor
24979628|NCT03455439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24979629|NCT03455439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979630|NCT03455439|Anticoagulants|anticoagulants|mesh-ancestor
24979631|NCT03386214|Pevonedistat|pevonedistat|mesh-list
25584585|NCT00882206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25584586|NCT00882206|Immunologic Factors|immunologic factors|mesh-ancestor
25584587|NCT00882206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24666773|NCT01320982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24666784|NCT01321021|Losartan|losartan|mesh-list
24666785|NCT01321021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24666786|NCT01321021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24666787|NCT01321021|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24453168|NCT05238831|Trastuzumab|trastuzumab|mesh-list
24666788|NCT01321021|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24666789|NCT01321021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666790|NCT01321021|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24666791|NCT01321021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24666792|NCT01321021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24666793|NCT01321021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666794|NCT01321021|Anesthetics, Local|anesthetics, local|mesh-ancestor
24935931|NCT04046029|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24935932|NCT04046029|Protease Inhibitors|protease inhibitors|mesh-ancestor
24935933|NCT04046029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584588|NCT00882206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25584589|NCT00882206|Antiviral Agents|antiviral agents|mesh-ancestor
24979632|NCT03386214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584590|NCT00882206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25584591|NCT00882206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25584592|NCT00882206|Tubulin Modulators|tubulin modulators|mesh-ancestor
25584593|NCT00882206|Antimitotic Agents|antimitotic agents|mesh-ancestor
25584594|NCT00882206|Mitosis Modulators|mitosis modulators|mesh-ancestor
25584595|NCT00882206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24516039|NCT00600405|Oxycodone|oxycodone|mesh-list
24666852|NCT01321138|Sensory System Agents|sensory system agents|mesh-ancestor
24666853|NCT01321138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24666855|NCT01321255|Ramipril|ramipril|mesh-list
24666856|NCT01321255|Simvastatin|simvastatin|mesh-list
25584596|NCT00882206|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25584597|NCT00882362|Aripiprazole|aripiprazole|mesh-list
25584598|NCT00882362|Antidepressive Agents|antidepressive agents|mesh-ancestor
25584599|NCT00882362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25584600|NCT00882362|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25584601|NCT00882362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25584602|NCT00882362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25584603|NCT00882362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584604|NCT00882362|Dopamine Agonists|dopamine agonists|mesh-ancestor
25584605|NCT00882362|Dopamine Agents|dopamine agents|mesh-ancestor
25584606|NCT00882362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24935962|NCT04046133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584607|NCT00882362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584608|NCT00882362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25584609|NCT00882362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25584610|NCT00882362|Serotonin Agents|serotonin agents|mesh-ancestor
25584611|NCT00882362|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25584612|NCT00882362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25584613|NCT00882362|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25584614|NCT00882362|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25584615|NCT00882518|Chlorpromazine|chlorpromazine|mesh-list
25584616|NCT00882518|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25584617|NCT00882518|Antidepressive Agents|antidepressive agents|mesh-ancestor
25584618|NCT00882518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25584619|NCT00882518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25584620|NCT00882518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24666965|NCT01321775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24666966|NCT01321775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24666967|NCT01321775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25584621|NCT00882518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25584622|NCT00882518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584623|NCT00882518|Antiemetics|antiemetics|mesh-ancestor
25584624|NCT00882518|Autonomic Agents|autonomic agents|mesh-ancestor
25584625|NCT00882518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25584626|NCT00882518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25584627|NCT00882518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25584628|NCT00882518|Dopamine Agents|dopamine agents|mesh-ancestor
25584629|NCT00882518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24667051|NCT01321957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24667052|NCT01321957|Antimetabolites|antimetabolites|mesh-ancestor
24667053|NCT01321957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24667054|NCT01321957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24667057|NCT01322061|Vitamins|vitamins|mesh-ancestor
24667058|NCT01322061|Micronutrients|micronutrients|mesh-ancestor
24667063|NCT01322100|Bleomycin|bleomycin|mesh-list
24667064|NCT01322100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24667076|NCT01322139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24667077|NCT01322139|Contraceptive Agents|contraceptive agents|mesh-ancestor
24667078|NCT01322139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24667079|NCT01322139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584630|NCT00882518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584631|NCT00882557|Daptomycin|daptomycin|mesh-list
24667080|NCT01322139|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24667081|NCT01322139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24667082|NCT01322139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25584632|NCT00882557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25584633|NCT00882557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25584634|NCT00882583|Cisplatin|cisplatin|mesh-list
25584635|NCT00882583|Cetuximab|cetuximab|mesh-list
25584636|NCT00882583|Dasatinib|dasatinib|mesh-list
25584637|NCT00882583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584638|NCT00882583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25584639|NCT00882583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25584640|NCT00882583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584641|NCT00882583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584642|NCT00882687|Lifitegrast|lifitegrast|mesh-list
25584643|NCT00882687|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25584644|NCT00882687|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24667098|NCT01322191|Morphine|morphine|mesh-list
24667132|NCT01322438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24936010|NCT04045522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584645|NCT00882713|Epoetin Alfa|epoetin alfa|mesh-list
25584646|NCT00882713|Hematinics|hematinics|mesh-ancestor
25584647|NCT00882908|Ribavirin|ribavirin|mesh-list
25584648|NCT00882908|Simeprevir|simeprevir|mesh-list
25584649|NCT00882908|Antimetabolites|antimetabolites|mesh-ancestor
25584650|NCT00882908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584651|NCT00882908|Antiviral Agents|antiviral agents|mesh-ancestor
25584652|NCT00882908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25584653|NCT00882908|Protease Inhibitors|protease inhibitors|mesh-ancestor
25584654|NCT00882908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584655|NCT00883051|Lasmiditan|lasmiditan|mesh-list
25584656|NCT00883051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25584657|NCT00883051|Serotonin Agents|serotonin agents|mesh-ancestor
25479329|NCT00099359|Lamivudine|lamivudine|mesh-list
25479330|NCT00099359|Zidovudine|zidovudine|mesh-list
25479331|NCT00099359|Nevirapine|nevirapine|mesh-list
25479332|NCT00099359|Nelfinavir|nelfinavir|mesh-list
25584658|NCT00883051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25584659|NCT00883051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584660|NCT00883051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584661|NCT00883090|Fibrinolysin|fibrinolysin|mesh-list
25479333|NCT00099359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24936011|NCT04046185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24936013|NCT04046185|Progestins|progestins|mesh-ancestor
24936014|NCT04046185|Hormones|hormones|mesh-ancestor
24936015|NCT04046185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24936017|NCT04046185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936022|NCT04046159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25479337|NCT00099359|Antiviral Agents|antiviral agents|mesh-ancestor
25584662|NCT00883090|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25584663|NCT00883090|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25584664|NCT00883090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584666|NCT00883103|Anesthetics, Local|anesthetics, local|mesh-ancestor
25584667|NCT00883103|Anesthetics|anesthetics|mesh-ancestor
25584668|NCT00883103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25584669|NCT00883103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584670|NCT00883103|Sensory System Agents|sensory system agents|mesh-ancestor
25584671|NCT00883103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24936032|NCT04045431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936033|NCT04045093|Warfarin|warfarin|mesh-list
25584672|NCT00883103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25584673|NCT00883103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25584674|NCT00883103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24936034|NCT04045093|Dabigatran|dabigatran|mesh-list
24667275|NCT05459857|Antipruritics|antipruritics|mesh-ancestor
24667276|NCT05459857|Dermatologic Agents|dermatologic agents|mesh-ancestor
24456177|NCT00330395|Caspofungin|caspofungin|mesh-list
24667308|NCT05459649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24667309|NCT05459649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584675|NCT00883103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25584676|NCT00883103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584677|NCT00883116|Paclitaxel|paclitaxel|mesh-list
25584678|NCT00883116|Doxorubicin|doxorubicin|mesh-list
25584679|NCT00883116|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25584680|NCT00883116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25584681|NCT00883116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584682|NCT00883116|Tubulin Modulators|tubulin modulators|mesh-ancestor
25584683|NCT00883116|Antimitotic Agents|antimitotic agents|mesh-ancestor
25584684|NCT00883116|Mitosis Modulators|mitosis modulators|mesh-ancestor
25584685|NCT00883116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584686|NCT00883116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24625494|NCT01082276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625495|NCT01082276|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24952483|NCT03893695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952484|NCT03893734|Methadone|methadone|mesh-list
24952485|NCT03893734|Hydromorphone|hydromorphone|mesh-list
24952486|NCT03893734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24952487|NCT03893734|Narcotics|narcotics|mesh-ancestor
24952488|NCT03893734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24952489|NCT03893734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952490|NCT03893734|Analgesics|analgesics|mesh-ancestor
24952491|NCT03893734|Sensory System Agents|sensory system agents|mesh-ancestor
24849831|NCT02250820|Analgesics|analgesics|mesh-ancestor
24667561|NCT05384496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24667562|NCT05384496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24667563|NCT05384496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25050160|NCT00535366|Autonomic Agents|autonomic agents|mesh-ancestor
25584687|NCT00883116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25584688|NCT00883116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25584689|NCT00883116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584690|NCT00883129|Mycophenolic Acid|mycophenolic acid|mesh-list
25584691|NCT00883129|Cyclophosphamide|cyclophosphamide|mesh-list
25584692|NCT00883129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25584693|NCT00883129|Immunologic Factors|immunologic factors|mesh-ancestor
25584694|NCT00883129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704341|NCT02180100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24667842|NCT05274633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667858|NCT05266586|Ezetimibe|ezetimibe|mesh-list
24667868|NCT05261516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667869|NCT05261516|Anesthetics|anesthetics|mesh-ancestor
24667873|NCT05261516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25584695|NCT00883129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25584696|NCT00883129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25584697|NCT00883129|Alkylating Agents|alkylating agents|mesh-ancestor
25584698|NCT00883129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584699|NCT00883129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584700|NCT00883129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25584701|NCT00883129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25584702|NCT00883129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25584703|NCT00883129|Antitubercular Agents|antitubercular agents|mesh-ancestor
25584704|NCT00883129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25584705|NCT00883129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25584706|NCT00883129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584707|NCT00883168|Fluticasone|fluticasone|mesh-list
25584708|NCT00883168|Xhance|xhance|mesh-list
25584709|NCT00883168|Azelastine|azelastine|mesh-list
25584710|NCT00883168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25584711|NCT00883168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25584712|NCT00883168|Autonomic Agents|autonomic agents|mesh-ancestor
25584713|NCT00883168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25584714|NCT00883168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584715|NCT00883168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24812028|NCT02049294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24849859|NCT02250924|Caffeine|caffeine|mesh-list
24812029|NCT02049294|Respiratory System Agents|respiratory system agents|mesh-ancestor
24812030|NCT02049320|Remifentanil|remifentanil|mesh-list
24936071|NCT04044430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24936072|NCT04044430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24936073|NCT04044430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25075929|NCT03377257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24668118|NCT05084378|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24668119|NCT05084378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24668120|NCT05084378|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24668122|NCT05084378|Plasma Substitutes|plasma substitutes|mesh-ancestor
24668123|NCT05084378|Blood Substitutes|blood substitutes|mesh-ancestor
24453433|NCT05008224|Doxorubicin|doxorubicin|mesh-list
24453434|NCT05008224|Pembrolizumab|pembrolizumab|mesh-list
24453435|NCT05008224|Etoposide|etoposide|mesh-list
24453436|NCT05008224|Etoposide phosphate|etoposide phosphate|mesh-list
24453437|NCT05008224|Vincristine|vincristine|mesh-list
24668161|NCT05069896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25584716|NCT00883168|Respiratory System Agents|respiratory system agents|mesh-ancestor
25584717|NCT00883168|Dermatologic Agents|dermatologic agents|mesh-ancestor
25584718|NCT00883168|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25584719|NCT00883168|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25584720|NCT00883168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584721|NCT00883168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584722|NCT00883168|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25584723|NCT00883168|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25584724|NCT00883168|Histamine Antagonists|histamine antagonists|mesh-ancestor
25584725|NCT00883168|Histamine Agents|histamine agents|mesh-ancestor
25584726|NCT00883168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25584727|NCT00883233|Adapalene|adapalene|mesh-list
25584728|NCT00883233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25584729|NCT00883233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25584730|NCT00883233|Analgesics|analgesics|mesh-ancestor
25584731|NCT00883233|Sensory System Agents|sensory system agents|mesh-ancestor
25584732|NCT00883233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25479396|NCT00100048|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25479397|NCT00100048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25584733|NCT00883233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584734|NCT00883233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25584735|NCT00883233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25584736|NCT00883233|Dermatologic Agents|dermatologic agents|mesh-ancestor
25584737|NCT00883337|Interferons|interferons|mesh-list
25704348|NCT02180165|Posaconazole|posaconazole|mesh-list
25704349|NCT02180165|Antifungal Agents|antifungal agents|mesh-ancestor
24936116|NCT04043858|Midodrine|midodrine|mesh-list
25584738|NCT00883337|Interferon-beta|interferon-beta|mesh-list
25584739|NCT00883337|Interferon beta-1a|interferon beta-1a|mesh-list
25584740|NCT00883337|Teriflunomide|teriflunomide|mesh-list
25584741|NCT00883337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584742|NCT00883337|Antiviral Agents|antiviral agents|mesh-ancestor
25584743|NCT00883337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25584744|NCT00883337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25584745|NCT00883337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25584746|NCT00883337|Analgesics|analgesics|mesh-ancestor
25584747|NCT00883337|Sensory System Agents|sensory system agents|mesh-ancestor
25584748|NCT00883337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25584749|NCT00883337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584750|NCT00883337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25584751|NCT00883337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25584752|NCT00883337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25584753|NCT00883337|Immunologic Factors|immunologic factors|mesh-ancestor
25584754|NCT00883337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25584755|NCT00883415|Darbepoetin alfa|darbepoetin alfa|mesh-list
25584756|NCT00883415|Hematinics|hematinics|mesh-ancestor
25584757|NCT00883493|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25584758|NCT00883493|Lithium Carbonate|lithium carbonate|mesh-list
25584759|NCT00883493|Antidepressive Agents|antidepressive agents|mesh-ancestor
25584760|NCT00883493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25584761|NCT00883493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25584762|NCT00883493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25584763|NCT00883493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25584764|NCT00883493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584765|NCT00883493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584766|NCT00883493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584767|NCT00883493|Antimanic Agents|antimanic agents|mesh-ancestor
24936153|NCT04043676|Ponatinib|ponatinib|mesh-list
24849905|NCT02251041|Immunologic Factors|immunologic factors|mesh-ancestor
24849907|NCT02251119|Tipranavir|tipranavir|mesh-list
24849908|NCT02251119|Loperamide|loperamide|mesh-list
24849909|NCT02251119|Antidiarrheals|antidiarrheals|mesh-list
24849910|NCT02251119|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24849911|NCT02251119|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24849912|NCT02251119|Protease Inhibitors|protease inhibitors|mesh-ancestor
24444434|NCT00297960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25584768|NCT00883558|Insulin|insulin|mesh-list
25584769|NCT00883558|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25584770|NCT00883558|Insulin Glargine|insulin glargine|mesh-list
25584771|NCT00883558|Insulin Lispro|insulin lispro|mesh-list
25584772|NCT00883558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25584773|NCT00883558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584774|NCT00883675|Carboplatin|carboplatin|mesh-list
25584775|NCT00883675|Docetaxel|docetaxel|mesh-list
25584776|NCT00883675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584777|NCT00883675|Tubulin Modulators|tubulin modulators|mesh-ancestor
25584778|NCT00883675|Antimitotic Agents|antimitotic agents|mesh-ancestor
25584779|NCT00883675|Mitosis Modulators|mitosis modulators|mesh-ancestor
25584780|NCT00883675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584781|NCT00883688|Bevacizumab|bevacizumab|mesh-list
25584782|NCT00883688|Lapatinib|lapatinib|mesh-list
25584783|NCT00883688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25584784|NCT00883688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584785|NCT00883688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25584786|NCT00883688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25584787|NCT00883688|Growth Substances|growth substances|mesh-ancestor
25584788|NCT00883688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584789|NCT00883688|Growth Inhibitors|growth inhibitors|mesh-ancestor
25584790|NCT00883688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25584791|NCT00883688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533539|NCT00644319|Narcotics|narcotics|mesh-ancestor
24533540|NCT00644319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24533541|NCT00644319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533542|NCT00644319|Analgesics|analgesics|mesh-ancestor
24533543|NCT00644319|Sensory System Agents|sensory system agents|mesh-ancestor
24533544|NCT00644319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24533545|NCT00644319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25075931|NCT03377218|Iodine|iodine|mesh-list
25584792|NCT00883688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584793|NCT00883740|Pregabalin|pregabalin|mesh-list
25584794|NCT00883740|Analgesics|analgesics|mesh-ancestor
25584795|NCT00883740|Sensory System Agents|sensory system agents|mesh-ancestor
25584796|NCT00883740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25584797|NCT00883740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584798|NCT00883740|Anticonvulsants|anticonvulsants|mesh-ancestor
25584799|NCT00883740|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25584800|NCT00883740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25584801|NCT00883740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584802|NCT00883740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25584803|NCT00883740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25584804|NCT00883740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25584805|NCT00883740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25584806|NCT00883740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25584807|NCT00883779|Gemcitabine|gemcitabine|mesh-list
25584808|NCT00883779|Cisplatin|cisplatin|mesh-list
25479465|NCT00100815|Growth Inhibitors|growth inhibitors|mesh-ancestor
25584809|NCT00883779|Carboplatin|carboplatin|mesh-list
25584810|NCT00883779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25584811|NCT00883779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584812|NCT00883779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25584813|NCT00883779|Antimetabolites|antimetabolites|mesh-ancestor
25584814|NCT00883779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584815|NCT00883779|Antiviral Agents|antiviral agents|mesh-ancestor
25584816|NCT00883779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25584817|NCT00883779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584818|NCT00883779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25584819|NCT00883779|Immunologic Factors|immunologic factors|mesh-ancestor
25584820|NCT00883779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584821|NCT00883779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25584822|NCT00884039|Hydrocortisone|hydrocortisone|mesh-list
25584823|NCT00884039|Anecortave|anecortave|mesh-list
25584824|NCT00884039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25584825|NCT00884039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25584826|NCT00884039|Growth Substances|growth substances|mesh-ancestor
25584827|NCT00884039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584828|NCT00884039|Growth Inhibitors|growth inhibitors|mesh-ancestor
25584829|NCT00884039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584830|NCT00884039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25584831|NCT00884052|Levetiracetam|levetiracetam|mesh-list
25584832|NCT00884052|Anticonvulsants|anticonvulsants|mesh-ancestor
25584833|NCT00884052|Nootropic Agents|nootropic agents|mesh-ancestor
25584834|NCT00884117|Oseltamivir|oseltamivir|mesh-list
25584835|NCT00884117|Antiviral Agents|antiviral agents|mesh-ancestor
24830566|NCT02160080|Interferons|interferons|mesh-list
24533594|NCT00644553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533595|NCT00644553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533596|NCT00644553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24936211|NCT04043494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24936212|NCT04043494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24936213|NCT04043494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24830579|NCT02160132|Prednisolone|prednisolone|mesh-list
24533607|NCT00644618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24533608|NCT00644618|Antimetabolites|antimetabolites|mesh-ancestor
24533609|NCT00644618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533611|NCT00644618|Antiviral Agents|antiviral agents|mesh-ancestor
24936220|NCT04043494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24936221|NCT04043494|Antimetabolites|antimetabolites|mesh-ancestor
24936222|NCT04043494|Dermatologic Agents|dermatologic agents|mesh-ancestor
24936225|NCT04043494|Antiviral Agents|antiviral agents|mesh-ancestor
25584836|NCT00884117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25584837|NCT00884117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584838|NCT00884117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584839|NCT00884221|Menotropins|menotropins|mesh-list
25584840|NCT00884221|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25584841|NCT00884221|Fertility Agents|fertility agents|mesh-ancestor
25584842|NCT00884221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25584843|NCT00884221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584844|NCT00884273|Goserelin|goserelin|mesh-list
25584845|NCT00884273|Bicalutamide|bicalutamide|mesh-list
25584846|NCT00884273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25584847|NCT00884273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584848|NCT00884273|Androgen Antagonists|androgen antagonists|mesh-ancestor
25584849|NCT00884273|Hormone Antagonists|hormone antagonists|mesh-ancestor
25584850|NCT00884273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25584851|NCT00884273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584852|NCT00884325|Levocetirizine|levocetirizine|mesh-list
25584853|NCT00884325|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25584854|NCT00884325|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25584855|NCT00884325|Histamine Antagonists|histamine antagonists|mesh-ancestor
25584856|NCT00884325|Histamine Agents|histamine agents|mesh-ancestor
25584857|NCT00884325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25584858|NCT00884325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584859|NCT00884325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584860|NCT00884377|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
25584861|NCT00884377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25584862|NCT00884377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25584863|NCT00884377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25584864|NCT00884377|Schistosomicides|schistosomicides|mesh-ancestor
25584865|NCT00884377|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25584866|NCT00884377|Anthelmintics|anthelmintics|mesh-ancestor
25584867|NCT00884390|Factor VIII|factor viii|mesh-list
25584868|NCT00884390|Coagulants|coagulants|mesh-ancestor
25584869|NCT00884585|Cyclosporine|cyclosporine|mesh-list
25584870|NCT00884585|Cyclosporins|cyclosporins|mesh-list
25584871|NCT00884585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584872|NCT00884585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584873|NCT00884585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25584874|NCT00884585|Immunologic Factors|immunologic factors|mesh-ancestor
25584875|NCT00884585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584876|NCT00884585|Antifungal Agents|antifungal agents|mesh-ancestor
25584877|NCT00884585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25584878|NCT00884585|Dermatologic Agents|dermatologic agents|mesh-ancestor
25584879|NCT00884585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25584880|NCT00884585|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25584881|NCT00884650|Analgesics|analgesics|mesh-list
24533613|NCT00644618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584882|NCT00884650|Sensory System Agents|sensory system agents|mesh-ancestor
25479543|NCT00101283|Gemcitabine|gemcitabine|mesh-list
25584883|NCT00884650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25584884|NCT00884650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584885|NCT00884741|Bevacizumab|bevacizumab|mesh-list
25584886|NCT00884741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25584887|NCT00884741|Temozolomide|temozolomide|mesh-list
25584888|NCT00884741|Endothelial Growth Factors|endothelial growth factors|mesh-list
25584889|NCT00884741|Antibodies|antibodies|mesh-list
25584890|NCT00884741|Immunoglobulins|immunoglobulins|mesh-list
25584891|NCT00884741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25584892|NCT00884741|Immunoglobulin G|immunoglobulin g|mesh-list
25584893|NCT00884741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584894|NCT00884741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25584895|NCT00884741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25584896|NCT00884741|Growth Substances|growth substances|mesh-ancestor
25584897|NCT00884741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584898|NCT00884741|Growth Inhibitors|growth inhibitors|mesh-ancestor
25584899|NCT00884741|Immunologic Factors|immunologic factors|mesh-ancestor
25584900|NCT00884741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25584901|NCT00884741|Alkylating Agents|alkylating agents|mesh-ancestor
25584902|NCT00884741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584903|NCT00884793|Ritonavir|ritonavir|mesh-list
25584904|NCT00884793|Lopinavir|lopinavir|mesh-list
25584905|NCT00884793|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25584906|NCT00884793|Fosamprenavir|fosamprenavir|mesh-list
25584907|NCT00884793|Raltegravir Potassium|raltegravir potassium|mesh-list
25584908|NCT00884793|Efavirenz|efavirenz|mesh-list
25584909|NCT00884793|Etravirine|etravirine|mesh-list
25584910|NCT00884793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25584911|NCT00884793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25584912|NCT00884793|Protease Inhibitors|protease inhibitors|mesh-ancestor
25584913|NCT00884793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584914|NCT00884793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584915|NCT00884793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25584916|NCT00884793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25584917|NCT00884793|Antiviral Agents|antiviral agents|mesh-ancestor
25584918|NCT00884793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25584919|NCT00884793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25584920|NCT00884793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25704389|NCT02180672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25704390|NCT02180672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24936229|NCT04043494|Antimitotic Agents|antimitotic agents|mesh-ancestor
24936230|NCT04043494|Mitosis Modulators|mitosis modulators|mesh-ancestor
24936231|NCT04043741|Sulfamethazine|sulfamethazine|mesh-list
24778443|NCT01870895|Autonomic Agents|autonomic agents|mesh-ancestor
24936232|NCT04043741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24936233|NCT04043325|Antibodies|antibodies|mesh-list
24936234|NCT04043325|Immunologic Factors|immunologic factors|mesh-ancestor
24936236|NCT04042948|Acetaminophen|acetaminophen|mesh-list
25584921|NCT00884793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25584922|NCT00884793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25584923|NCT00884793|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25584924|NCT00884793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25584925|NCT00884793|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25584926|NCT00884793|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25584927|NCT00884793|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25584928|NCT00884793|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25584929|NCT00884793|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25584930|NCT00884832|Clonidine|clonidine|mesh-list
25584931|NCT00884832|Analgesics|analgesics|mesh-ancestor
25584932|NCT00884832|Sensory System Agents|sensory system agents|mesh-ancestor
25584933|NCT00884832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25584934|NCT00884832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584935|NCT00884832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25584936|NCT00884832|Sympatholytics|sympatholytics|mesh-ancestor
25584937|NCT00884832|Autonomic Agents|autonomic agents|mesh-ancestor
25584938|NCT00884832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25584939|NCT00884832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25584940|NCT00884832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25584941|NCT00884832|Adrenergic Agents|adrenergic agents|mesh-ancestor
25584942|NCT00884832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25584943|NCT00884832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584944|NCT00884897|Oxytocin|oxytocin|mesh-list
25584945|NCT00884897|Oxytocics|oxytocics|mesh-ancestor
25584946|NCT00884897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25584947|NCT00884897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584948|NCT00885079|Rebamipide|rebamipide|mesh-list
25584949|NCT00885079|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25584950|NCT00885079|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25584951|NCT00885079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25584952|NCT00885079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25584953|NCT00885079|Antioxidants|antioxidants|mesh-ancestor
25584954|NCT00885079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584955|NCT00885079|Protective Agents|protective agents|mesh-ancestor
24936249|NCT04043195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936250|NCT04042974|Dinoprostone|dinoprostone|mesh-list
24936251|NCT04042974|Oxytocics|oxytocics|mesh-ancestor
24533702|NCT00644891|Cefdinir|cefdinir|mesh-list
24936253|NCT04042974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936254|NCT04043065|Anti-Infective Agents|anti-infective agents|mesh-list
24936255|NCT04043065|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24936256|NCT04042805|Lenvatinib|lenvatinib|mesh-list
24936257|NCT04042805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24936258|NCT04042805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24936259|NCT04042805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24936261|NCT04042506|Nivolumab|nivolumab|mesh-list
24936302|NCT04041934|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24936303|NCT04041934|Antidepressive Agents|antidepressive agents|mesh-ancestor
24936306|NCT04042051|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24936307|NCT04042051|Maytansine|maytansine|mesh-list
24936308|NCT04042051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24936309|NCT04042051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25584956|NCT00885079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584957|NCT00885079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584958|NCT00885092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25584959|NCT00885105|Vaccines|vaccines|mesh-list
25584960|NCT00885105|Immunologic Factors|immunologic factors|mesh-ancestor
25584961|NCT00885105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584962|NCT00885118|Empagliflozin|empagliflozin|mesh-list
25584963|NCT00885118|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25584964|NCT00885118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584965|NCT00885118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25584966|NCT00885118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584967|NCT00885170|Vitamin D|vitamin d|mesh-list
25584968|NCT00885170|Cholecalciferol|cholecalciferol|mesh-list
25584969|NCT00885170|Calcium|calcium|mesh-list
24936320|NCT04041856|Povidone|povidone|mesh-list
25584970|NCT00885170|Vitamins|vitamins|mesh-ancestor
25584971|NCT00885170|Micronutrients|micronutrients|mesh-ancestor
25584972|NCT00885170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584973|NCT00885170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25584974|NCT00885170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25584975|NCT00885352|Metformin|metformin|mesh-list
25584976|NCT00885352|Pioglitazone|pioglitazone|mesh-list
25584977|NCT00885352|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25584978|NCT00885352|Glipizide|glipizide|mesh-list
25584979|NCT00885352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25584980|NCT00885352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584981|NCT00885352|Incretins|incretins|mesh-ancestor
25584982|NCT00885352|Hormones|hormones|mesh-ancestor
25584983|NCT00885352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25584984|NCT00885352|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25584985|NCT00885352|Protease Inhibitors|protease inhibitors|mesh-ancestor
25584986|NCT00885352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25584987|NCT00885352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25584988|NCT00885365|Tobramycin|tobramycin|mesh-list
25584989|NCT00885365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25584990|NCT00885365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25584991|NCT00885378|Metformin|metformin|mesh-list
25584992|NCT00885378|Saxagliptin|saxagliptin|mesh-list
25584993|NCT00885378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25584994|NCT00885378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25584995|NCT00885378|Incretins|incretins|mesh-ancestor
25584996|NCT00885378|Hormones|hormones|mesh-ancestor
25584997|NCT00885378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25584998|NCT00885378|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25584999|NCT00885378|Protease Inhibitors|protease inhibitors|mesh-ancestor
25585000|NCT00885378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585001|NCT00885378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585002|NCT00885482|Ritonavir|ritonavir|mesh-list
25585003|NCT00885482|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25585004|NCT00885482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25585005|NCT00885482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25585006|NCT00885482|Protease Inhibitors|protease inhibitors|mesh-ancestor
25585007|NCT00885482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585008|NCT00885482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585009|NCT00885482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25585010|NCT00885482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25585011|NCT00885482|Antiviral Agents|antiviral agents|mesh-ancestor
25585012|NCT00885482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24936321|NCT04041856|Plasma Substitutes|plasma substitutes|mesh-ancestor
25704398|NCT02180828|Fluconazole|fluconazole|mesh-list
25704399|NCT02180828|Clotrimazole|clotrimazole|mesh-list
25704400|NCT02180828|Miconazole|miconazole|mesh-list
25704401|NCT02180828|Antifungal Agents|antifungal agents|mesh-ancestor
25704402|NCT02180828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25704403|NCT02180828|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25704404|NCT02180828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25704405|NCT02180828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585013|NCT00885482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25585014|NCT00885482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25585015|NCT00885534|Cisplatin|cisplatin|mesh-list
25585016|NCT00885534|Temozolomide|temozolomide|mesh-list
25585017|NCT00885534|Vinblastine|vinblastine|mesh-list
25585018|NCT00885534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585019|NCT00885534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25585020|NCT00885534|Alkylating Agents|alkylating agents|mesh-ancestor
25585021|NCT00885534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585022|NCT00885534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25585023|NCT00885534|Tubulin Modulators|tubulin modulators|mesh-ancestor
25585024|NCT00885534|Antimitotic Agents|antimitotic agents|mesh-ancestor
25585025|NCT00885534|Mitosis Modulators|mitosis modulators|mesh-ancestor
25585026|NCT00885638|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25585027|NCT00885638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25585028|NCT00885638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585029|NCT00885638|Incretins|incretins|mesh-ancestor
25585030|NCT00885638|Hormones|hormones|mesh-ancestor
25585031|NCT00885638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25585032|NCT00885638|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25585033|NCT00885638|Protease Inhibitors|protease inhibitors|mesh-ancestor
25585034|NCT00885638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585035|NCT00885638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585036|NCT00885703|Fluconazole|fluconazole|mesh-list
25585037|NCT00885703|Amphotericin B|amphotericin b|mesh-list
25585038|NCT00885703|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25585039|NCT00885703|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
25585040|NCT00885703|Deoxycholic Acid|deoxycholic acid|mesh-list
25585041|NCT00885703|Antifungal Agents|antifungal agents|mesh-ancestor
24936326|NCT04042142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24936328|NCT04042142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24936329|NCT04042142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760892|NCT01760252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760893|NCT01760252|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24760894|NCT01760252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24760895|NCT01760252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760896|NCT01760278|Cetrorelix|cetrorelix|mesh-list
24760897|NCT01760278|Hormones|hormones|mesh-list
24760898|NCT01760278|Progesterone|progesterone|mesh-list
24760899|NCT01760278|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24760900|NCT01760278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24760901|NCT01760278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760902|NCT01760278|Progestins|progestins|mesh-ancestor
24760904|NCT01760278|Fertility Agents|fertility agents|mesh-ancestor
24760905|NCT01760278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25050179|NCT00534027|Conatumumab|conatumumab|mesh-list
25585042|NCT00885703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25585043|NCT00885703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25585044|NCT00885703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25585045|NCT00885703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585046|NCT00885703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585047|NCT00885703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25585048|NCT00885703|Hormone Antagonists|hormone antagonists|mesh-ancestor
25585049|NCT00885703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25585050|NCT00885703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585051|NCT00885703|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25585052|NCT00885703|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25585053|NCT00885703|Amebicides|amebicides|mesh-ancestor
25585054|NCT00885703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25585055|NCT00885703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25585056|NCT00885703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25585057|NCT00885703|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25585058|NCT00885703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25585059|NCT00885742|Fibrinolysin|fibrinolysin|mesh-list
25585060|NCT00885742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25585061|NCT00885742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25585062|NCT00885742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585063|NCT00885755|Capecitabine|capecitabine|mesh-list
25585064|NCT00885755|Trastuzumab|trastuzumab|mesh-list
25585065|NCT00885755|Taxane|taxane|mesh-list
25585066|NCT00885755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25585067|NCT00885755|Antimetabolites|antimetabolites|mesh-ancestor
25585068|NCT00885755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585069|NCT00885755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24936331|NCT04041843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24936332|NCT04041843|Antithrombins|antithrombins|mesh-ancestor
24936333|NCT04041843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24936334|NCT04041843|Protease Inhibitors|protease inhibitors|mesh-ancestor
24936335|NCT04041843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24936336|NCT04041843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936337|NCT04041843|Anticoagulants|anticoagulants|mesh-ancestor
24936339|NCT04041492|Cholecalciferol|cholecalciferol|mesh-list
24936340|NCT04041492|Vitamins|vitamins|mesh-ancestor
24936341|NCT04041492|Micronutrients|micronutrients|mesh-ancestor
24936342|NCT04041492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936343|NCT04041492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25075933|NCT03377218|Cadexomer iodine|cadexomer iodine|mesh-list
24850066|NCT02251509|Antioxidants|antioxidants|mesh-ancestor
24533762|NCT00645073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24533763|NCT00645086|Clarithromycin|clarithromycin|mesh-list
24533764|NCT00645086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24533765|NCT00645086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24533766|NCT00645086|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24936344|NCT04041492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25585070|NCT00885755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25585071|NCT00886236|Gabapentin|gabapentin|mesh-list
25585072|NCT00886236|Analgesics|analgesics|mesh-ancestor
25585073|NCT00886236|Sensory System Agents|sensory system agents|mesh-ancestor
25585074|NCT00886236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25585075|NCT00886236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585076|NCT00886236|Anticonvulsants|anticonvulsants|mesh-ancestor
25585077|NCT00886236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25585078|NCT00886236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25585079|NCT00886236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25585080|NCT00886236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25585081|NCT00886236|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25585082|NCT00886236|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25585083|NCT00886236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25585084|NCT00886236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585085|NCT00886236|Antimanic Agents|antimanic agents|mesh-ancestor
25585086|NCT00886262|Vasopressins|vasopressins|mesh-list
25585087|NCT00886262|Arginine Vasopressin|arginine vasopressin|mesh-list
25585088|NCT00886262|Hemostatics|hemostatics|mesh-ancestor
25585089|NCT00886262|Coagulants|coagulants|mesh-ancestor
25585090|NCT00886262|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25585091|NCT00886262|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25585092|NCT00886262|Natriuretic Agents|natriuretic agents|mesh-ancestor
25585093|NCT00886262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585094|NCT00886379|Vitamin D|vitamin d|mesh-list
25585095|NCT00886379|Ergocalciferols|ergocalciferols|mesh-list
25585096|NCT00886379|Cholecalciferol|cholecalciferol|mesh-list
25585097|NCT00886379|Vitamins|vitamins|mesh-list
25585098|NCT00886379|Micronutrients|micronutrients|mesh-ancestor
25585099|NCT00886379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585100|NCT00886379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25585101|NCT00886379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25653138|NCT01534962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25653139|NCT01534962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25653140|NCT01534962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653141|NCT01535001|Acetaminophen|acetaminophen|mesh-list
25653142|NCT01535001|Pantoprazole|pantoprazole|mesh-list
24453992|NCT04575233|Anesthetics, Local|anesthetics, local|mesh-ancestor
24453993|NCT04575233|Anesthetics|anesthetics|mesh-ancestor
24453994|NCT04575233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24936362|NCT04041362|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24936363|NCT04041362|UB-421|ub-421|mesh-list
24936365|NCT04041362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24936366|NCT04041349|Mitogens|mitogens|mesh-list
25653143|NCT01535001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25585102|NCT00886613|Vaccines|vaccines|mesh-list
25585103|NCT00886613|Immunologic Factors|immunologic factors|mesh-ancestor
25585104|NCT00886613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585105|NCT00886626|Exenatide|exenatide|mesh-list
25585106|NCT00886626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25585107|NCT00886626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585108|NCT00886626|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25585109|NCT00886626|Incretins|incretins|mesh-ancestor
25585110|NCT00886626|Hormones|hormones|mesh-ancestor
25585111|NCT00886626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25585112|NCT00886743|Oprelvekin|oprelvekin|mesh-list
25585113|NCT00886743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585114|NCT00886795|Abatacept|abatacept|mesh-list
25585115|NCT00886795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25585116|NCT00886795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585117|NCT00886795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585118|NCT00886795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25585119|NCT00886795|Immunologic Factors|immunologic factors|mesh-ancestor
25585120|NCT00886795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585121|NCT00886795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25585122|NCT00886834|Misoprostol|misoprostol|mesh-list
24936383|NCT04041167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936384|NCT04041167|Protective Agents|protective agents|mesh-ancestor
24936385|NCT04041167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936386|NCT04041167|Vitamin B Complex|vitamin b complex|mesh-ancestor
24936388|NCT04041167|Micronutrients|micronutrients|mesh-ancestor
24936389|NCT04041128|Olaparib|olaparib|mesh-list
24936390|NCT04041128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24644720|NCT01192724|Antipyretics|antipyretics|mesh-ancestor
24936393|NCT04041128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585123|NCT00886834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25585124|NCT00886834|Abortifacient Agents|abortifacient agents|mesh-ancestor
25585125|NCT00886834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25585126|NCT00886834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585127|NCT00886834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25585128|NCT00886834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25585129|NCT00886834|Oxytocics|oxytocics|mesh-ancestor
25585130|NCT00887068|Azacitidine|azacitidine|mesh-list
25585131|NCT00887068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25585132|NCT00887068|Antimetabolites|antimetabolites|mesh-ancestor
25585133|NCT00887068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585134|NCT00887068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585135|NCT00887068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585136|NCT00887159|Cisplatin|cisplatin|mesh-list
25585137|NCT00887159|Etoposide|etoposide|mesh-list
25585138|NCT00887159|Etoposide phosphate|etoposide phosphate|mesh-list
25585139|NCT00887159|Podophyllotoxin|podophyllotoxin|mesh-list
24533803|NCT00645203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24936422|NCT04040465|Sensory System Agents|sensory system agents|mesh-ancestor
24936423|NCT04040465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24936424|NCT04040465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936425|NCT04040465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25585140|NCT00887159|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25585141|NCT00887159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585142|NCT00887159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25585143|NCT00887159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25585144|NCT00887159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25585145|NCT00887159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585146|NCT00887159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585147|NCT00887159|Keratolytic Agents|keratolytic agents|mesh-ancestor
25585148|NCT00887159|Dermatologic Agents|dermatologic agents|mesh-ancestor
25585149|NCT00887159|Tubulin Modulators|tubulin modulators|mesh-ancestor
25585150|NCT00887159|Antimitotic Agents|antimitotic agents|mesh-ancestor
25585151|NCT00887159|Mitosis Modulators|mitosis modulators|mesh-ancestor
25585152|NCT00887159|Immunologic Factors|immunologic factors|mesh-ancestor
25704422|NCT02181075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24936486|NCT04040023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585153|NCT00887159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585154|NCT00887198|Prednisone|prednisone|mesh-list
25585155|NCT00887198|Abiraterone Acetate|abiraterone acetate|mesh-list
25585156|NCT00887198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25585157|NCT00887198|Glucocorticoids|glucocorticoids|mesh-ancestor
25585158|NCT00887198|Hormones|hormones|mesh-ancestor
25585159|NCT00887198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25585160|NCT00887198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585161|NCT00887198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25585162|NCT00887198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585163|NCT00887198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25585164|NCT00887198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585165|NCT00887198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585166|NCT00887198|Hormone Antagonists|hormone antagonists|mesh-ancestor
25585167|NCT00887198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25585168|NCT00887224|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25585169|NCT00887224|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25585170|NCT00887224|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25585171|NCT00887224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25585172|NCT00887224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585173|NCT00887224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25585174|NCT00887224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585175|NCT00887224|Antidepressive Agents|antidepressive agents|mesh-ancestor
25585176|NCT00887224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25585177|NCT00887354|Vitamin D|vitamin d|mesh-list
25585178|NCT00887354|Teriparatide|teriparatide|mesh-list
25585179|NCT00887354|Risedronic Acid|risedronic acid|mesh-list
25585180|NCT00887354|Calcium|calcium|mesh-list
25585181|NCT00887354|Vitamins|vitamins|mesh-ancestor
25585182|NCT00887354|Micronutrients|micronutrients|mesh-ancestor
25585183|NCT00887354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704423|NCT02181075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704424|NCT02181075|Hematinics|hematinics|mesh-ancestor
24850225|NCT02252341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850226|NCT02252341|Antidotes|antidotes|mesh-ancestor
24850227|NCT02252367|Tadalafil|tadalafil|mesh-list
24850234|NCT02252419|Acetaminophen|acetaminophen|mesh-list
24533830|NCT00645255|Antidepressive Agents|antidepressive agents|mesh-ancestor
24533831|NCT00645255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24533843|NCT00645281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24533844|NCT00645281|Cholinergic Agents|cholinergic agents|mesh-ancestor
24533845|NCT00645281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050218|NCT00531622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25050220|NCT00529503|Dacetuzumab|dacetuzumab|mesh-list
25050225|NCT00529503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050226|NCT00529503|Immunologic Factors|immunologic factors|mesh-ancestor
25050227|NCT00529503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952856|NCT03891472|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24952857|NCT03891472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25585184|NCT00887354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25585185|NCT00887354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25585186|NCT00887354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25585187|NCT00887354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25585188|NCT00887354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585189|NCT00887432|Vitamin D|vitamin d|mesh-list
25585190|NCT00887432|Cholecalciferol|cholecalciferol|mesh-list
25585191|NCT00887432|Vitamins|vitamins|mesh-ancestor
25585192|NCT00887432|Micronutrients|micronutrients|mesh-ancestor
25585193|NCT00887432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585194|NCT00887432|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25585195|NCT00887432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25585196|NCT00887458|Itraconazole|itraconazole|mesh-list
25585197|NCT00887458|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
25585198|NCT00887458|Antifungal Agents|antifungal agents|mesh-ancestor
25585199|NCT00887458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25585200|NCT00887458|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25585201|NCT00887458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25585202|NCT00887458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585203|NCT00887458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585204|NCT00887458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25585205|NCT00887458|Hormone Antagonists|hormone antagonists|mesh-ancestor
25585206|NCT00887458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25585207|NCT00887458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471249|NCT00394186|Solabegron|solabegron|mesh-list
25585208|NCT00887458|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25585209|NCT00887484|Clindamycin|clindamycin|mesh-list
25585210|NCT00887484|Clindamycin palmitate|clindamycin palmitate|mesh-list
25585211|NCT00887484|Clindamycin phosphate|clindamycin phosphate|mesh-list
25585212|NCT00887484|Adapalene|adapalene|mesh-list
25585213|NCT00887484|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25585214|NCT00887484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25585215|NCT00887484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25585216|NCT00887484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25585217|NCT00887484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585218|NCT00887484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585219|NCT00887484|Dermatologic Agents|dermatologic agents|mesh-ancestor
25585220|NCT00887484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25585221|NCT00887484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25585222|NCT00887484|Analgesics|analgesics|mesh-ancestor
25585223|NCT00887484|Sensory System Agents|sensory system agents|mesh-ancestor
25585224|NCT00887484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25585225|NCT00887484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585226|NCT00887484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25585227|NCT00887484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25585228|NCT00887510|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25585229|NCT00887510|Trandolapril|trandolapril|mesh-list
25585230|NCT00887510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25585231|NCT00887510|Diuretics|diuretics|mesh-ancestor
25585232|NCT00887510|Natriuretic Agents|natriuretic agents|mesh-ancestor
25585233|NCT00887510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585234|NCT00887510|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25585235|NCT00887510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25585236|NCT00887510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585237|NCT00887510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25585238|NCT00887510|Protease Inhibitors|protease inhibitors|mesh-ancestor
25585239|NCT00887510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585240|NCT00887549|Cisplatin|cisplatin|mesh-list
25585241|NCT00887549|Pemetrexed|pemetrexed|mesh-list
25585242|NCT00887549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24936530|NCT04039126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24936531|NCT04039126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24936532|NCT04039126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585243|NCT00887549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585244|NCT00887549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585245|NCT00887549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25585246|NCT00887549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25585247|NCT00887562|Ubiquinone|ubiquinone|mesh-list
25585248|NCT00887562|Idebenone|idebenone|mesh-list
25479899|NCT00104247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25585249|NCT00887562|Antioxidants|antioxidants|mesh-ancestor
25585250|NCT00887562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585251|NCT00887562|Protective Agents|protective agents|mesh-ancestor
25585252|NCT00887562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585253|NCT00887562|Micronutrients|micronutrients|mesh-ancestor
25585255|NCT00887575|Carboplatin|carboplatin|mesh-list
25585256|NCT00887575|Sunitinib|sunitinib|mesh-list
25585257|NCT00887575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25585258|NCT00887575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585259|NCT00887575|Tubulin Modulators|tubulin modulators|mesh-ancestor
25585260|NCT00887575|Antimitotic Agents|antimitotic agents|mesh-ancestor
25585261|NCT00887575|Mitosis Modulators|mitosis modulators|mesh-ancestor
25585262|NCT00887575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585263|NCT00887575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25585264|NCT00887575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25585265|NCT00887575|Growth Substances|growth substances|mesh-ancestor
25585266|NCT00887575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585267|NCT00887575|Growth Inhibitors|growth inhibitors|mesh-ancestor
25585268|NCT00887575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25585269|NCT00887575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585270|NCT00887588|Valsartan|valsartan|mesh-list
25585271|NCT00887588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25585272|NCT00887588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24444562|NCT00298506|Tacrolimus|tacrolimus|mesh-list
25585273|NCT00887588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25585274|NCT00887588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25585275|NCT00887588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585276|NCT00887640|Diphenhydramine|diphenhydramine|mesh-list
25585277|NCT00887640|Promethazine|promethazine|mesh-list
25585278|NCT00887640|Sirolimus|sirolimus|mesh-list
25585279|NCT00887640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25585280|NCT00887640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25585281|NCT00887640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25585282|NCT00887640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585283|NCT00887640|Antifungal Agents|antifungal agents|mesh-ancestor
25585284|NCT00887640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25585285|NCT00887640|Immunologic Factors|immunologic factors|mesh-ancestor
25585286|NCT00887640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585287|NCT00887640|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25585288|NCT00887640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25585289|NCT00887640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25585290|NCT00887640|Anesthetics, Local|anesthetics, local|mesh-ancestor
25585291|NCT00887640|Anesthetics|anesthetics|mesh-ancestor
25585292|NCT00887640|Sensory System Agents|sensory system agents|mesh-ancestor
25585293|NCT00887640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25585294|NCT00887640|Antiemetics|antiemetics|mesh-ancestor
25585295|NCT00887640|Autonomic Agents|autonomic agents|mesh-ancestor
25585296|NCT00887640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25585297|NCT00887640|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25585298|NCT00887640|Histamine Antagonists|histamine antagonists|mesh-ancestor
25585299|NCT00887640|Histamine Agents|histamine agents|mesh-ancestor
25585300|NCT00887640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25585301|NCT00887640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585302|NCT00887640|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25585303|NCT00887640|Antipruritics|antipruritics|mesh-ancestor
25585304|NCT00887640|Dermatologic Agents|dermatologic agents|mesh-ancestor
25585305|NCT00887653|Raltegravir Potassium|raltegravir potassium|mesh-list
25585306|NCT00887653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25585307|NCT00887653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25585308|NCT00887653|Antiviral Agents|antiviral agents|mesh-ancestor
25585309|NCT00887653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25585310|NCT00887653|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25585311|NCT00887653|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25585312|NCT00887653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444724|NCT00299013|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24850324|NCT02252692|Enalapril|enalapril|mesh-list
25585313|NCT00887653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585314|NCT00887679|Citalopram|citalopram|mesh-list
25585315|NCT00887679|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25585316|NCT00887679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25585317|NCT00887679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25585318|NCT00887679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585319|NCT00887679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25585320|NCT00887679|Serotonin Agents|serotonin agents|mesh-ancestor
25585321|NCT00887679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585322|NCT00887679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25585323|NCT00887679|Antidepressive Agents|antidepressive agents|mesh-ancestor
25585324|NCT00887679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25585325|NCT00887809|Gemcitabine|gemcitabine|mesh-list
25585326|NCT00887809|Bevacizumab|bevacizumab|mesh-list
25585327|NCT00887809|Docetaxel|docetaxel|mesh-list
25585328|NCT00887809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25585329|NCT00887809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585330|NCT00887809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25585331|NCT00887809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25585332|NCT00887809|Growth Substances|growth substances|mesh-ancestor
25585333|NCT00887809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585334|NCT00887809|Growth Inhibitors|growth inhibitors|mesh-ancestor
25585335|NCT00887809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25585336|NCT00887809|Antimetabolites|antimetabolites|mesh-ancestor
25585337|NCT00887809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585338|NCT00887809|Antiviral Agents|antiviral agents|mesh-ancestor
25585339|NCT00887809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25585340|NCT00887809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585341|NCT00887809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25585342|NCT00887809|Immunologic Factors|immunologic factors|mesh-ancestor
25585343|NCT00887809|Tubulin Modulators|tubulin modulators|mesh-ancestor
25585344|NCT00887809|Antimitotic Agents|antimitotic agents|mesh-ancestor
25585345|NCT00887809|Mitosis Modulators|mitosis modulators|mesh-ancestor
25585346|NCT00887822|Bevacizumab|bevacizumab|mesh-list
25585347|NCT00887822|Cisplatin|cisplatin|mesh-list
25585348|NCT00887822|Capecitabine|capecitabine|mesh-list
25585349|NCT00887822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25585350|NCT00887822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585351|NCT00887822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25585352|NCT00887822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25585353|NCT00887822|Growth Substances|growth substances|mesh-ancestor
25585354|NCT00887822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585355|NCT00887822|Growth Inhibitors|growth inhibitors|mesh-ancestor
25585356|NCT00887822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25585357|NCT00887822|Antimetabolites|antimetabolites|mesh-ancestor
25585358|NCT00887822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585359|NCT00887965|Denosumab|denosumab|mesh-list
25585360|NCT00887965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25585361|NCT00887965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585362|NCT00887978|Treprostinil|treprostinil|mesh-list
25585363|NCT00887978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25585364|NCT00888238|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25585365|NCT00888238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25585366|NCT00888238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585367|NCT00888238|Incretins|incretins|mesh-ancestor
25585368|NCT00888238|Hormones|hormones|mesh-ancestor
25585369|NCT00888238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25585370|NCT00888238|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25585371|NCT00888238|Protease Inhibitors|protease inhibitors|mesh-ancestor
25585372|NCT00888238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585373|NCT00888238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585374|NCT00888329|Aprepitant|aprepitant|mesh-list
25585375|NCT00888329|Antiemetics|antiemetics|mesh-ancestor
25585376|NCT00888329|Autonomic Agents|autonomic agents|mesh-ancestor
25585377|NCT00888329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25585378|NCT00888329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585379|NCT00888329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25585380|NCT00888329|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25585381|NCT00888329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25585382|NCT00888329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585383|NCT00888381|Vaccines|vaccines|mesh-list
25585384|NCT00888381|Immunologic Factors|immunologic factors|mesh-ancestor
25585385|NCT00888381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585386|NCT00888459|Nicotine|nicotine|mesh-list
25585387|NCT00888459|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25585388|NCT00888459|Autonomic Agents|autonomic agents|mesh-ancestor
25585389|NCT00888459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25585390|NCT00888459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585391|NCT00888459|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25585392|NCT00888459|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25585393|NCT00888459|Cholinergic Agents|cholinergic agents|mesh-ancestor
25585394|NCT00888459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25585395|NCT00888459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585396|NCT00888511|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25480041|NCT00105066|Metformin|metformin|mesh-list
25585397|NCT00888511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585398|NCT00888511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25585399|NCT00888511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585400|NCT00888511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585401|NCT00888615|Paclitaxel|paclitaxel|mesh-list
25585402|NCT00888615|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25585403|NCT00888615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25585404|NCT00888615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585405|NCT00888615|Tubulin Modulators|tubulin modulators|mesh-ancestor
25585406|NCT00888615|Antimitotic Agents|antimitotic agents|mesh-ancestor
25585407|NCT00888615|Mitosis Modulators|mitosis modulators|mesh-ancestor
25585408|NCT00888615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585409|NCT00888628|Etanercept|etanercept|mesh-list
25585410|NCT00888628|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25585411|NCT00888628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25585412|NCT00888628|Analgesics|analgesics|mesh-ancestor
25585413|NCT00888628|Sensory System Agents|sensory system agents|mesh-ancestor
25585414|NCT00888628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25585415|NCT00888628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585416|NCT00888628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25585417|NCT00888628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25585418|NCT00888628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25585419|NCT00888628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25585420|NCT00888628|Immunologic Factors|immunologic factors|mesh-ancestor
25585421|NCT00888654|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
25585422|NCT00888654|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25585423|NCT00888654|Protective Agents|protective agents|mesh-ancestor
25585424|NCT00888654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585425|NCT00888654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585426|NCT00888927|Mogamulizumab|mogamulizumab|mesh-list
25585427|NCT00888927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585428|NCT00888940|Ecallantide|ecallantide|mesh-list
25585429|NCT00888940|Tranexamic Acid|tranexamic acid|mesh-list
25585430|NCT00888940|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25585431|NCT00888940|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25585432|NCT00888940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585433|NCT00888940|Hemostatics|hemostatics|mesh-ancestor
25585434|NCT00888940|Coagulants|coagulants|mesh-ancestor
25585435|NCT00888940|Analgesics|analgesics|mesh-ancestor
25585436|NCT00888940|Sensory System Agents|sensory system agents|mesh-ancestor
25585437|NCT00888940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25585438|NCT00888940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585439|NCT00888940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25585440|NCT00888940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25585441|NCT00888940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25585442|NCT00888940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25585443|NCT00888979|Nicotine|nicotine|mesh-list
25585444|NCT00888979|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25585445|NCT00888979|Autonomic Agents|autonomic agents|mesh-ancestor
25585446|NCT00888979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25585447|NCT00888979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585448|NCT00888979|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25585449|NCT00888979|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25585450|NCT00888979|Cholinergic Agents|cholinergic agents|mesh-ancestor
25585451|NCT00888979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25585452|NCT00888979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585453|NCT00889187|Capecitabine|capecitabine|mesh-list
25585454|NCT00889187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25585455|NCT00889187|Antimetabolites|antimetabolites|mesh-ancestor
25585456|NCT00889187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585457|NCT00889187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585458|NCT00889200|Eszopiclone|eszopiclone|mesh-list
25585459|NCT00889200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25585460|NCT00889200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25585461|NCT00889200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585462|NCT00889226|Atorvastatin|atorvastatin|mesh-list
25585463|NCT00889226|Pitavastatin|pitavastatin|mesh-list
25585464|NCT00889226|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25585465|NCT00889226|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25585466|NCT00889226|Antimetabolites|antimetabolites|mesh-ancestor
25480109|NCT00105235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480111|NCT00105235|Antifungal Agents|antifungal agents|mesh-ancestor
25585467|NCT00889226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585468|NCT00889226|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25653144|NCT01535001|Analgesics|analgesics|mesh-ancestor
25585469|NCT00889226|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25585470|NCT00889226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585471|NCT00889252|Ketotifen|ketotifen|mesh-list
25585472|NCT00889252|Antipruritics|antipruritics|mesh-ancestor
25585473|NCT00889252|Dermatologic Agents|dermatologic agents|mesh-ancestor
25585474|NCT00889252|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25585475|NCT00889252|Histamine Antagonists|histamine antagonists|mesh-ancestor
25585476|NCT00889252|Histamine Agents|histamine agents|mesh-ancestor
25585477|NCT00889252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25585478|NCT00889252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936723|NCT04036721|Prednisone|prednisone|mesh-list
25585479|NCT00889252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585480|NCT00889252|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25585481|NCT00889330|Alcaftadine|alcaftadine|mesh-list
25585482|NCT00889330|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25585483|NCT00889330|Histamine Antagonists|histamine antagonists|mesh-ancestor
25585484|NCT00889330|Histamine Agents|histamine agents|mesh-ancestor
25585485|NCT00889330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25585486|NCT00889330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585487|NCT00889330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585488|NCT00889603|Donepezil|donepezil|mesh-list
25585489|NCT00889603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25585490|NCT00889603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585491|NCT00889603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585492|NCT00889603|Cholinergic Agents|cholinergic agents|mesh-ancestor
25585493|NCT00889603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25585494|NCT00889603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585495|NCT00889603|Nootropic Agents|nootropic agents|mesh-ancestor
25585496|NCT00889720|Varenicline|varenicline|mesh-list
25585497|NCT00889720|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25585498|NCT00889720|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25585499|NCT00889720|Cholinergic Agents|cholinergic agents|mesh-ancestor
25585500|NCT00889720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25585501|NCT00889720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585502|NCT00889720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585503|NCT00889915|Methylphenidate|methylphenidate|mesh-list
25585504|NCT00889915|Amphetamine|amphetamine|mesh-list
25585505|NCT00889915|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25585506|NCT00889915|Adderall|adderall|mesh-list
24489341|NCT00472472|Paclitaxel|paclitaxel|mesh-list
25585507|NCT00889915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25585508|NCT00889915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585509|NCT00889915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25585510|NCT00889915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25585511|NCT00889915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25585512|NCT00889915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585513|NCT00889915|Dopamine Agents|dopamine agents|mesh-ancestor
25585514|NCT00889915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25585515|NCT00889915|Sympathomimetics|sympathomimetics|mesh-ancestor
25585516|NCT00889915|Autonomic Agents|autonomic agents|mesh-ancestor
25585517|NCT00889915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25585518|NCT00889915|Adrenergic Agents|adrenergic agents|mesh-ancestor
25585519|NCT00889915|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25585520|NCT00890084|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25585521|NCT00890084|Telmisartan|telmisartan|mesh-list
25585522|NCT00890084|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
25585523|NCT00890084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25585524|NCT00890084|Diuretics|diuretics|mesh-ancestor
25585525|NCT00890084|Natriuretic Agents|natriuretic agents|mesh-ancestor
25585526|NCT00890084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585527|NCT00890084|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25480180|NCT00106028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25480181|NCT00106028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480182|NCT00106028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25480183|NCT00106106|Acamprosate|acamprosate|mesh-list
25480184|NCT00106106|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25480185|NCT00106184|Rituximab|rituximab|mesh-list
25480186|NCT00106184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24936895|NCT04035070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25585528|NCT00890084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25585529|NCT00890084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585530|NCT00890084|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25585531|NCT00890084|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25585532|NCT00890097|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25585533|NCT00890097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25585534|NCT00890162|Omalizumab|omalizumab|mesh-list
25585536|NCT00890162|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25585537|NCT00890162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25585538|NCT00890162|Adrenergic Agents|adrenergic agents|mesh-ancestor
25585539|NCT00890162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25585540|NCT00890162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585541|NCT00890162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585542|NCT00890162|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25585543|NCT00890162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25585544|NCT00890162|Autonomic Agents|autonomic agents|mesh-ancestor
25585545|NCT00890162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25585546|NCT00890162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25585547|NCT00890162|Respiratory System Agents|respiratory system agents|mesh-ancestor
25585548|NCT00890162|Mydriatics|mydriatics|mesh-ancestor
25585549|NCT00890162|Sympathomimetics|sympathomimetics|mesh-ancestor
25585550|NCT00890162|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25585551|NCT00890162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25585552|NCT00890396|Hydroxyurea|hydroxyurea|mesh-list
25585553|NCT00890396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585554|NCT00890396|Antisickling Agents|antisickling agents|mesh-ancestor
25585555|NCT00890396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585556|NCT00890396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585557|NCT00890396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25585558|NCT00890552|Dexamethasone|dexamethasone|mesh-list
25585559|NCT00890552|Dexamethasone acetate|dexamethasone acetate|mesh-list
25585560|NCT00890552|Lenalidomide|lenalidomide|mesh-list
25585561|NCT00890552|Melphalan|melphalan|mesh-list
25585562|NCT00890552|BB 1101|bb 1101|mesh-list
25585563|NCT00890552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25585564|NCT00890552|Antiemetics|antiemetics|mesh-ancestor
25585565|NCT00890552|Autonomic Agents|autonomic agents|mesh-ancestor
25585566|NCT00890552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25585567|NCT00890552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585568|NCT00890552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25585569|NCT00890552|Glucocorticoids|glucocorticoids|mesh-ancestor
25585570|NCT00890552|Hormones|hormones|mesh-ancestor
25585571|NCT00890552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25585572|NCT00890552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25585573|NCT00890552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585574|NCT00890552|Protease Inhibitors|protease inhibitors|mesh-ancestor
25585575|NCT00890552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585576|NCT00890552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585577|NCT00890552|Immunologic Factors|immunologic factors|mesh-ancestor
25585578|NCT00890552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25585579|NCT00890552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25585580|NCT00890552|Growth Substances|growth substances|mesh-ancestor
25585581|NCT00890552|Growth Inhibitors|growth inhibitors|mesh-ancestor
25585582|NCT00890552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25585583|NCT00890552|Alkylating Agents|alkylating agents|mesh-ancestor
25585584|NCT00890552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25585585|NCT00890552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25585586|NCT00890617|Prednisone|prednisone|mesh-list
25585587|NCT00890617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24850818|NCT02254018|Antimitotic Agents|antimitotic agents|mesh-ancestor
25585588|NCT00890617|Glucocorticoids|glucocorticoids|mesh-ancestor
25585589|NCT00890617|Hormones|hormones|mesh-ancestor
24850819|NCT02254018|Mitosis Modulators|mitosis modulators|mesh-ancestor
25585590|NCT00890617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25585591|NCT00890617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585592|NCT00890617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25585593|NCT00890617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585594|NCT00890656|Dexamethasone|dexamethasone|mesh-list
25585595|NCT00890656|Cyclophosphamide|cyclophosphamide|mesh-list
25585596|NCT00890656|Doxorubicin|doxorubicin|mesh-list
25585597|NCT00890656|Methotrexate|methotrexate|mesh-list
25585598|NCT00890656|Vincristine|vincristine|mesh-list
25585599|NCT00890656|Asparaginase|asparaginase|mesh-list
25585600|NCT00890656|Pegaspargase|pegaspargase|mesh-list
25585601|NCT00890656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25585602|NCT00890656|Immunologic Factors|immunologic factors|mesh-ancestor
25585603|NCT00890656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585604|NCT00890656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25585605|NCT00890656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25585606|NCT00890656|Alkylating Agents|alkylating agents|mesh-ancestor
25585607|NCT00890656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480246|NCT00107120|Citalopram|citalopram|mesh-list
25585608|NCT00890656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585609|NCT00890656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25585610|NCT00890656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25585612|NCT00890656|Autonomic Agents|autonomic agents|mesh-ancestor
25585613|NCT00890656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25585614|NCT00890656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25585615|NCT00890656|Glucocorticoids|glucocorticoids|mesh-ancestor
25585616|NCT00890656|Hormones|hormones|mesh-ancestor
25585617|NCT00890656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24850822|NCT02254031|Maytansine|maytansine|mesh-list
25585618|NCT00890656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25585619|NCT00890656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585620|NCT00890656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25585621|NCT00890656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25585622|NCT00890656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25585623|NCT00890656|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25585624|NCT00890656|Abortifacient Agents|abortifacient agents|mesh-ancestor
25585625|NCT00890656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25585626|NCT00890656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25585627|NCT00890656|Antimetabolites|antimetabolites|mesh-ancestor
25585628|NCT00890656|Dermatologic Agents|dermatologic agents|mesh-ancestor
25585629|NCT00890656|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25585630|NCT00890656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25585631|NCT00890656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25585632|NCT00890656|Tubulin Modulators|tubulin modulators|mesh-ancestor
25585633|NCT00890656|Antimitotic Agents|antimitotic agents|mesh-ancestor
25585634|NCT00890656|Mitosis Modulators|mitosis modulators|mesh-ancestor
25585635|NCT00890825|Docetaxel|docetaxel|mesh-list
25585636|NCT00890825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585637|NCT00890825|Tubulin Modulators|tubulin modulators|mesh-ancestor
25585638|NCT00890825|Antimitotic Agents|antimitotic agents|mesh-ancestor
25585639|NCT00890825|Mitosis Modulators|mitosis modulators|mesh-ancestor
25585640|NCT00890825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585641|NCT00890929|Lenalidomide|lenalidomide|mesh-list
25585642|NCT00890929|Azacitidine|azacitidine|mesh-list
25585643|NCT00890929|Immunologic Factors|immunologic factors|mesh-ancestor
25585644|NCT00890929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585645|NCT00890929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25585646|NCT00890929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25585647|NCT00890929|Growth Substances|growth substances|mesh-ancestor
25585648|NCT00890929|Growth Inhibitors|growth inhibitors|mesh-ancestor
25585649|NCT00890929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585650|NCT00890929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25585651|NCT00890929|Antimetabolites|antimetabolites|mesh-ancestor
25585652|NCT00890929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585653|NCT00890929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585654|NCT00890981|Denosumab|denosumab|mesh-list
25585655|NCT00890981|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25585656|NCT00890981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585657|NCT00891176|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25585658|NCT00891176|Immunologic Factors|immunologic factors|mesh-ancestor
25585659|NCT00891176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585660|NCT00891202|Eliglustat|eliglustat|mesh-list
25585661|NCT00891202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585662|NCT00891202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585663|NCT00891228|ST 1435|st 1435|mesh-list
25585664|NCT00891228|Testosterone|testosterone|mesh-list
25585665|NCT00891228|Androgens|androgens|mesh-ancestor
25585666|NCT00891228|Hormones|hormones|mesh-ancestor
25585667|NCT00891228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25585668|NCT00891228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585669|NCT00891228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25585670|NCT00891228|Contraceptive Agents|contraceptive agents|mesh-ancestor
25585671|NCT00891228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25585672|NCT00891228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25585673|NCT00891293|Fenofibrate|fenofibrate|mesh-list
25585674|NCT00891293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25585675|NCT00891293|Antimetabolites|antimetabolites|mesh-ancestor
25585676|NCT00891293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585677|NCT00891293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25585678|NCT00891371|Lanreotide|lanreotide|mesh-list
25585679|NCT00891371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24937278|NCT04030663|Nitroglycerin|nitroglycerin|mesh-list
25585680|NCT00891436|Fluticasone|fluticasone|mesh-list
25585681|NCT00891436|Xhance|xhance|mesh-list
25585682|NCT00891436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25585683|NCT00891436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25585684|NCT00891436|Autonomic Agents|autonomic agents|mesh-ancestor
25585685|NCT00891436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25585686|NCT00891436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585687|NCT00891436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25585688|NCT00891436|Respiratory System Agents|respiratory system agents|mesh-ancestor
25585689|NCT00891436|Dermatologic Agents|dermatologic agents|mesh-ancestor
25585690|NCT00891436|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25585692|NCT00891462|Anticonvulsants|anticonvulsants|mesh-ancestor
25585693|NCT00891527|Bevacizumab|bevacizumab|mesh-list
25585694|NCT00891527|Imatinib Mesylate|imatinib mesylate|mesh-list
25585695|NCT00891527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25585696|NCT00891527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585697|NCT00891527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25585698|NCT00891527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25585699|NCT00891527|Growth Substances|growth substances|mesh-ancestor
25585700|NCT00891527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585701|NCT00891527|Growth Inhibitors|growth inhibitors|mesh-ancestor
25585702|NCT00891527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25585703|NCT00891527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585704|NCT00891527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585705|NCT00891735|Ranibizumab|ranibizumab|mesh-list
25585706|NCT00891735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25585707|NCT00891735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25585708|NCT00891735|Growth Substances|growth substances|mesh-ancestor
25585709|NCT00891735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585710|NCT00891735|Growth Inhibitors|growth inhibitors|mesh-ancestor
25585711|NCT00891735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25653145|NCT01535001|Sensory System Agents|sensory system agents|mesh-ancestor
25653146|NCT01535001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937320|NCT04030533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937321|NCT04030572|Clonidine|clonidine|mesh-list
25653147|NCT01535001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653148|NCT01535001|Antipyretics|antipyretics|mesh-ancestor
25653149|NCT01535001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25653150|NCT01535001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25653151|NCT01535001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25653152|NCT01535001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653153|NCT01535001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653154|NCT01535040|Memantine|memantine|mesh-list
25653155|NCT01535040|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25653156|NCT01535040|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25653157|NCT01535040|Dopamine Agents|dopamine agents|mesh-ancestor
25653158|NCT01535040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25653159|NCT01535040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653160|NCT01535040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653161|NCT01535040|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25653162|NCT01535040|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25653163|NCT01535235|Lisinopril|lisinopril|mesh-list
25653164|NCT01535235|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25653165|NCT01535235|Protease Inhibitors|protease inhibitors|mesh-ancestor
25653166|NCT01535235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653167|NCT01535235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653168|NCT01535235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25653169|NCT01535235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25653170|NCT01535235|Protective Agents|protective agents|mesh-ancestor
25653171|NCT01535235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653172|NCT01535261|Ranibizumab|ranibizumab|mesh-list
25653173|NCT01535261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25653174|NCT01535261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25653175|NCT01535261|Growth Substances|growth substances|mesh-ancestor
25653176|NCT01535261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653177|NCT01535261|Growth Inhibitors|growth inhibitors|mesh-ancestor
25653178|NCT01535261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25653179|NCT01535287|Dexmedetomidine|dexmedetomidine|mesh-list
25653180|NCT01535287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25653181|NCT01535287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25653182|NCT01535287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653183|NCT01535287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25653184|NCT01535287|Analgesics|analgesics|mesh-ancestor
25653185|NCT01535287|Sensory System Agents|sensory system agents|mesh-ancestor
25653186|NCT01535287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653187|NCT01535287|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25653188|NCT01535287|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25653189|NCT01535287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25480395|NCT00108355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25585712|NCT00891813|Ergocalciferols|ergocalciferols|mesh-list
25585713|NCT00891813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25585714|NCT00891813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585715|NCT00891813|Vitamins|vitamins|mesh-ancestor
25585716|NCT00891813|Micronutrients|micronutrients|mesh-ancestor
25585717|NCT00891813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25585718|NCT00891839|Rituximab|rituximab|mesh-list
25585719|NCT00891839|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25585720|NCT00891839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25585721|NCT00891839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585722|NCT00891839|Immunologic Factors|immunologic factors|mesh-ancestor
25585723|NCT00891839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585724|NCT00891839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25585725|NCT00891839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25585726|NCT00891839|Alkylating Agents|alkylating agents|mesh-ancestor
25585727|NCT00891839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585728|NCT00891878|Capecitabine|capecitabine|mesh-list
25585729|NCT00891878|Sunitinib|sunitinib|mesh-list
25585730|NCT00891878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25585731|NCT00891878|Antimetabolites|antimetabolites|mesh-ancestor
25585732|NCT00891878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585733|NCT00891878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585734|NCT00891878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25585735|NCT00891878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25585736|NCT00891878|Growth Substances|growth substances|mesh-ancestor
25585737|NCT00891878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585738|NCT00891878|Growth Inhibitors|growth inhibitors|mesh-ancestor
25585739|NCT00891878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25585740|NCT00891878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585741|NCT00891930|Irinotecan|irinotecan|mesh-list
25585742|NCT00891930|Panitumumab|panitumumab|mesh-list
25585743|NCT00891930|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25585744|NCT00891930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25585745|NCT00891930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585746|NCT00891930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585747|NCT00891930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585748|NCT00891930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25585749|NCT00891982|Clindamycin, tretinoin drug combination|clindamycin, tretinoin drug combination|mesh-list
25585750|NCT00891982|Dermatologic Agents|dermatologic agents|mesh-ancestor
25585751|NCT00891995|Insulin|insulin|mesh-list
25585752|NCT00891995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25585753|NCT00891995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585754|NCT00892008|Pregabalin|pregabalin|mesh-list
25585755|NCT00892008|Analgesics|analgesics|mesh-ancestor
25585756|NCT00892008|Sensory System Agents|sensory system agents|mesh-ancestor
25585757|NCT00892008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25585758|NCT00892008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585759|NCT00892008|Anticonvulsants|anticonvulsants|mesh-ancestor
25585760|NCT00892008|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25585761|NCT00892008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25585762|NCT00892008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585763|NCT00892008|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25585764|NCT00892008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25585765|NCT00892008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25585766|NCT00892008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25585767|NCT00892008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25585768|NCT00892047|Aripiprazole|aripiprazole|mesh-list
25585769|NCT00892047|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25585770|NCT00892047|Antidepressive Agents|antidepressive agents|mesh-ancestor
25585771|NCT00892047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25585772|NCT00892047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25585773|NCT00892047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25585774|NCT00892047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25585775|NCT00892047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585776|NCT00892047|Dopamine Agonists|dopamine agonists|mesh-ancestor
25585777|NCT00892047|Dopamine Agents|dopamine agents|mesh-ancestor
25585778|NCT00892047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25585779|NCT00892047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585780|NCT00892047|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25585781|NCT00892047|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25585782|NCT00892047|Serotonin Agents|serotonin agents|mesh-ancestor
25653190|NCT01535287|Adrenergic Agents|adrenergic agents|mesh-ancestor
25480463|NCT00108745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585783|NCT00892047|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25585784|NCT00892047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25585785|NCT00892047|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25585786|NCT00892047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25585787|NCT00892047|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25585788|NCT00892047|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25585789|NCT00892047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25585790|NCT00892047|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25585791|NCT00892099|Vitamin D|vitamin d|mesh-list
25585792|NCT00892099|Ergocalciferols|ergocalciferols|mesh-list
25585793|NCT00892099|Cholecalciferol|cholecalciferol|mesh-list
25585794|NCT00892099|Vitamins|vitamins|mesh-list
25585795|NCT00892099|Micronutrients|micronutrients|mesh-ancestor
25585796|NCT00892099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585797|NCT00892099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25585798|NCT00892099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25585799|NCT00892177|Bevacizumab|bevacizumab|mesh-list
25585800|NCT00892177|Dasatinib|dasatinib|mesh-list
25585801|NCT00892177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25585802|NCT00892177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585803|NCT00892177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24937565|NCT04027751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25585804|NCT00892177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25585805|NCT00892177|Growth Substances|growth substances|mesh-ancestor
25585806|NCT00892177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585807|NCT00892177|Growth Inhibitors|growth inhibitors|mesh-ancestor
25585808|NCT00892177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25585809|NCT00892177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585810|NCT00892177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585811|NCT00892437|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25585812|NCT00892437|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25585813|NCT00892437|Cobicistat|cobicistat|mesh-list
25585814|NCT00892437|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25585815|NCT00892437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25585816|NCT00892437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585817|NCT00892437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585818|NCT00892437|Antiviral Agents|antiviral agents|mesh-ancestor
25585819|NCT00892437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25585820|NCT00892437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25585821|NCT00892437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25585822|NCT00892437|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25585823|NCT00892437|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25585824|NCT00892437|Protease Inhibitors|protease inhibitors|mesh-ancestor
25585825|NCT00892437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25585826|NCT00892437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25585827|NCT00892606|Morphine|morphine|mesh-list
25585828|NCT00892606|Methadone|methadone|mesh-list
25585829|NCT00892606|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25585830|NCT00892606|Narcotics|narcotics|mesh-ancestor
25585831|NCT00892606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25585832|NCT00892606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585833|NCT00892606|Analgesics|analgesics|mesh-ancestor
25585834|NCT00892606|Sensory System Agents|sensory system agents|mesh-ancestor
25585835|NCT00892606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25585836|NCT00892606|Antitussive Agents|antitussive agents|mesh-ancestor
25585837|NCT00892606|Respiratory System Agents|respiratory system agents|mesh-ancestor
25585838|NCT00892697|Ribavirin|ribavirin|mesh-list
25585839|NCT00892697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25585840|NCT00892697|Antimetabolites|antimetabolites|mesh-ancestor
25585841|NCT00892697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585842|NCT00892697|Antiviral Agents|antiviral agents|mesh-ancestor
25585843|NCT00892697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25585844|NCT00892710|Bevacizumab|bevacizumab|mesh-list
25585845|NCT00892710|Carboplatin|carboplatin|mesh-list
25585846|NCT00892710|Pemetrexed|pemetrexed|mesh-list
25585847|NCT00892710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25585848|NCT00892710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585849|NCT00892710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25585850|NCT00892710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25585851|NCT00892710|Growth Substances|growth substances|mesh-ancestor
25585852|NCT00892710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585853|NCT00892710|Growth Inhibitors|growth inhibitors|mesh-ancestor
25585854|NCT00892710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585855|NCT00892710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585856|NCT00892710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25585857|NCT00892710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25585858|NCT00892957|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25585859|NCT00892957|Thrombin|thrombin|mesh-list
25585860|NCT00892957|Aprotinin|aprotinin|mesh-list
25585861|NCT00892957|Hemostatics|hemostatics|mesh-ancestor
25585862|NCT00892957|Coagulants|coagulants|mesh-ancestor
25585863|NCT00892957|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25585864|NCT00892957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25585865|NCT00892957|Protease Inhibitors|protease inhibitors|mesh-ancestor
25585866|NCT00892957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585867|NCT00892957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585868|NCT00893074|Dronabinol|dronabinol|mesh-list
25585869|NCT00893074|Hallucinogens|hallucinogens|mesh-ancestor
25585870|NCT00893074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585871|NCT00893074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25585872|NCT00893074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25585873|NCT00893074|Analgesics|analgesics|mesh-ancestor
25585874|NCT00893074|Sensory System Agents|sensory system agents|mesh-ancestor
25585875|NCT00893074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25585876|NCT00893074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25585877|NCT00893074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25585878|NCT00893074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25585879|NCT00893074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585880|NCT00893074|Hormones|hormones|mesh-ancestor
25585881|NCT00893074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25585882|NCT00893113|Alfuzosin|alfuzosin|mesh-list
25585883|NCT00893113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25585884|NCT00893113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25585885|NCT00893113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25585886|NCT00893113|Adrenergic Agents|adrenergic agents|mesh-ancestor
25585887|NCT00893113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25585888|NCT00893113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585889|NCT00893113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585890|NCT00893113|Urological Agents|urological agents|mesh-ancestor
25585891|NCT00893464|Ixazomib|ixazomib|mesh-list
25585892|NCT00893464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585893|NCT00893464|Protease Inhibitors|protease inhibitors|mesh-ancestor
25585894|NCT00893464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585895|NCT00893464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585896|NCT00893737|Naproxen|naproxen|mesh-list
25585897|NCT00893737|Sumatriptan|sumatriptan|mesh-list
25585898|NCT00893737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25585899|NCT00893737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25585900|NCT00893737|Analgesics|analgesics|mesh-ancestor
25585901|NCT00893737|Sensory System Agents|sensory system agents|mesh-ancestor
25585902|NCT00893737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25585903|NCT00893737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585904|NCT00893737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25585905|NCT00893737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25585906|NCT00893737|Gout Suppressants|gout suppressants|mesh-ancestor
25585907|NCT00893737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25585908|NCT00893737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585909|NCT00893737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937717|NCT04026282|Hormones|hormones|mesh-ancestor
25585910|NCT00893737|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25585911|NCT00893737|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25585912|NCT00893737|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25585913|NCT00893737|Serotonin Agents|serotonin agents|mesh-ancestor
25585914|NCT00893737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25585915|NCT00893984|Nebivolol|nebivolol|mesh-list
25585916|NCT00893984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25585917|NCT00893984|Vasodilator Agents|vasodilator agents|mesh-ancestor
25585918|NCT00893984|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25585919|NCT00893984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25585920|NCT00893984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25585921|NCT00893984|Adrenergic Agents|adrenergic agents|mesh-ancestor
25585922|NCT00893984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25653191|NCT01535287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25480595|NCT00109837|Mitosis Modulators|mitosis modulators|mesh-ancestor
25480596|NCT00109837|Analgesics|analgesics|mesh-ancestor
25480597|NCT00109837|Sensory System Agents|sensory system agents|mesh-ancestor
25480598|NCT00109837|Gout Suppressants|gout suppressants|mesh-ancestor
25480599|NCT00109837|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25480600|NCT00109837|Antioxidants|antioxidants|mesh-ancestor
25480602|NCT00109837|Renal Agents|renal agents|mesh-ancestor
25585923|NCT00893984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585924|NCT00893984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585925|NCT00893997|Vaccines|vaccines|mesh-list
25585926|NCT00893997|Immunologic Factors|immunologic factors|mesh-ancestor
25585927|NCT00893997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585928|NCT00894166|Bupropion|bupropion|mesh-list
25585929|NCT00894166|Nicotine|nicotine|mesh-list
24937760|NCT04025918|Sympathomimetics|sympathomimetics|mesh-ancestor
24534300|NCT00646620|Glucocorticoids|glucocorticoids|mesh-ancestor
24534302|NCT00646620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24762621|NCT01768897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24762622|NCT01768897|Antiviral Agents|antiviral agents|mesh-ancestor
24762623|NCT01768897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24762624|NCT01768897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24762625|NCT01768897|Immunologic Factors|immunologic factors|mesh-ancestor
24762626|NCT01768897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762627|NCT01768897|Analgesics|analgesics|mesh-ancestor
25585930|NCT00894166|Varenicline|varenicline|mesh-list
25585931|NCT00894166|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25585932|NCT00894166|Autonomic Agents|autonomic agents|mesh-ancestor
25585933|NCT00894166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25585934|NCT00894166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585935|NCT00894166|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25585936|NCT00894166|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25585937|NCT00894166|Cholinergic Agents|cholinergic agents|mesh-ancestor
25585938|NCT00894166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25585939|NCT00894166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585940|NCT00894166|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25585941|NCT00894166|Antidepressive Agents|antidepressive agents|mesh-ancestor
25585942|NCT00894166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25585943|NCT00894166|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25585944|NCT00894166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25585945|NCT00894166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25585946|NCT00894166|Dopamine Agents|dopamine agents|mesh-ancestor
25585947|NCT00894166|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25585948|NCT00894166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25585949|NCT00894166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585950|NCT00894322|Exenatide|exenatide|mesh-list
25585951|NCT00894322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25585952|NCT00894322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585953|NCT00894322|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25585954|NCT00894322|Incretins|incretins|mesh-ancestor
25585955|NCT00894322|Hormones|hormones|mesh-ancestor
25585956|NCT00894322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25585957|NCT00894413|Tadalafil|tadalafil|mesh-list
25585958|NCT00894413|Vasodilator Agents|vasodilator agents|mesh-ancestor
25585959|NCT00894413|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25585960|NCT00894413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25585961|NCT00894413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585962|NCT00894413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585963|NCT00894413|Urological Agents|urological agents|mesh-ancestor
25585964|NCT00894465|Midazolam|midazolam|mesh-list
25585965|NCT00894465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25585966|NCT00894465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25585967|NCT00894465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25585968|NCT00894465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704562|NCT02182492|Hormones|hormones|mesh-ancestor
25585969|NCT00894465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25585970|NCT00894465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25585971|NCT00894465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25585972|NCT00894465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25585973|NCT00894465|Anesthetics, General|anesthetics, general|mesh-ancestor
25585974|NCT00894465|Anesthetics|anesthetics|mesh-ancestor
25585975|NCT00894465|GABA Modulators|gaba modulators|mesh-ancestor
25585976|NCT00894465|GABA Agents|gaba agents|mesh-ancestor
25585977|NCT00894465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25585978|NCT00894465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585979|NCT00894504|Gemcitabine|gemcitabine|mesh-list
25585980|NCT00894504|Carboplatin|carboplatin|mesh-list
25585981|NCT00894504|Panitumumab|panitumumab|mesh-list
25585982|NCT00894504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25585983|NCT00894504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25585984|NCT00894504|Antimetabolites|antimetabolites|mesh-ancestor
25585985|NCT00894504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585986|NCT00894504|Antiviral Agents|antiviral agents|mesh-ancestor
25585987|NCT00894504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25585988|NCT00894504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25585989|NCT00894504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25585990|NCT00894504|Immunologic Factors|immunologic factors|mesh-ancestor
25585991|NCT00894504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25585992|NCT00894504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25585993|NCT00894517|Botulinum Toxins|botulinum toxins|mesh-list
25585994|NCT00894517|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25480658|NCT00110019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25480659|NCT00110019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480666|NCT00110084|Gemcitabine|gemcitabine|mesh-list
25585995|NCT00894517|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25585996|NCT00894517|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25585997|NCT00894517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25585998|NCT00894517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25585999|NCT00894517|Cholinergic Agents|cholinergic agents|mesh-ancestor
25586000|NCT00894517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25586001|NCT00894517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586002|NCT00894517|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25586003|NCT00894517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25586005|NCT00894543|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25586006|NCT00894543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25586007|NCT00894543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25586008|NCT00894543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586009|NCT00894543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25586010|NCT00894543|Serotonin Agents|serotonin agents|mesh-ancestor
25586011|NCT00894543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586012|NCT00894543|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25586013|NCT00894543|Antidepressive Agents|antidepressive agents|mesh-ancestor
25586014|NCT00894543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25586015|NCT00894647|Imiquimod|imiquimod|mesh-list
25586016|NCT00894647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25586017|NCT00894647|Immunologic Factors|immunologic factors|mesh-ancestor
25586018|NCT00894647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586019|NCT00894647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25586020|NCT00894647|Interferon Inducers|interferon inducers|mesh-ancestor
25586021|NCT00894699|Sufentanil|sufentanil|mesh-list
25586022|NCT00894699|Triazolam|triazolam|mesh-list
25586023|NCT00894699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25586024|NCT00894699|Narcotics|narcotics|mesh-ancestor
25586025|NCT00894699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25586026|NCT00894699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586027|NCT00894699|Analgesics|analgesics|mesh-ancestor
25586028|NCT00894699|Sensory System Agents|sensory system agents|mesh-ancestor
25586029|NCT00894699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25586030|NCT00894699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25586031|NCT00894699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25586032|NCT00894699|Anesthetics, General|anesthetics, general|mesh-ancestor
25586033|NCT00894699|Anesthetics|anesthetics|mesh-ancestor
25586034|NCT00894699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25586035|NCT00894699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25586036|NCT00894699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25586037|NCT00894699|GABA Modulators|gaba modulators|mesh-ancestor
25586038|NCT00894699|GABA Agents|gaba agents|mesh-ancestor
25586039|NCT00894699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25586040|NCT00894699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586041|NCT00894803|Eptifibatide|eptifibatide|mesh-list
25586042|NCT00894803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25586043|NCT00895037|Factor VIII|factor viii|mesh-list
25586044|NCT00895037|Coagulants|coagulants|mesh-ancestor
25586045|NCT00895180|Ramucirumab|ramucirumab|mesh-list
25586046|NCT00895180|Olaratumab|olaratumab|mesh-list
25586047|NCT00895180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25586048|NCT00895193|Aspirin|aspirin|mesh-list
25586049|NCT00895193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25586050|NCT00895193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25586051|NCT00895193|Analgesics|analgesics|mesh-ancestor
25586052|NCT00895193|Sensory System Agents|sensory system agents|mesh-ancestor
25586053|NCT00895193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25586054|NCT00895193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586055|NCT00895193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25586056|NCT00895193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25586057|NCT00895193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25586058|NCT00895193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25586059|NCT00895193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586060|NCT00895193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25586061|NCT00895193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25586062|NCT00895193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586063|NCT00895193|Antipyretics|antipyretics|mesh-ancestor
25586064|NCT00895232|Iron|iron|mesh-list
25586065|NCT00895232|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25586066|NCT00895232|Trace Elements|trace elements|mesh-ancestor
25586067|NCT00895232|Micronutrients|micronutrients|mesh-ancestor
25586068|NCT00895232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586069|NCT00895232|Hematinics|hematinics|mesh-ancestor
25480731|NCT00110305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25586071|NCT00895245|Cisplatin|cisplatin|mesh-list
25586072|NCT00895245|Palonosetron|palonosetron|mesh-list
25586073|NCT00895245|Fosaprepitant|fosaprepitant|mesh-list
25586074|NCT00895245|Aprepitant|aprepitant|mesh-list
25586075|NCT00895245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25586076|NCT00895245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25586077|NCT00895245|Antiemetics|antiemetics|mesh-ancestor
25586078|NCT00895245|Autonomic Agents|autonomic agents|mesh-ancestor
25586079|NCT00895245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25586080|NCT00895245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586081|NCT00895245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25586082|NCT00895245|Glucocorticoids|glucocorticoids|mesh-ancestor
25586083|NCT00895245|Hormones|hormones|mesh-ancestor
25586084|NCT00895245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25586085|NCT00895245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25586086|NCT00895245|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25586087|NCT00895245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25586088|NCT00895245|Serotonin Agents|serotonin agents|mesh-ancestor
25586089|NCT00895245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25586090|NCT00895245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586091|NCT00895245|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25586092|NCT00895310|Ketoconazole|ketoconazole|mesh-list
25586093|NCT00895310|Hydrocortisone|hydrocortisone|mesh-list
25586094|NCT00895310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25586095|NCT00895310|Antifungal Agents|antifungal agents|mesh-ancestor
25586096|NCT00895310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25586097|NCT00895310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25586098|NCT00895310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25586099|NCT00895310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586100|NCT00895310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586101|NCT00895310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25586102|NCT00895310|Hormone Antagonists|hormone antagonists|mesh-ancestor
25586103|NCT00895310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25586104|NCT00895310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586105|NCT00895310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25586106|NCT00895414|Doxorubicin|doxorubicin|mesh-list
25586107|NCT00895414|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25586108|NCT00895414|Enalapril|enalapril|mesh-list
25586109|NCT00895414|Enalaprilat|enalaprilat|mesh-list
25586110|NCT00895414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25586111|NCT00895414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25586112|NCT00895414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25586113|NCT00895414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25586114|NCT00895414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586115|NCT00895414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586116|NCT00895414|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25586117|NCT00895414|Protease Inhibitors|protease inhibitors|mesh-ancestor
25586118|NCT00895414|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25586119|NCT00895453|Iron|iron|mesh-list
25586120|NCT00895453|Itraconazole|itraconazole|mesh-list
25586121|NCT00895453|Antifungal Agents|antifungal agents|mesh-ancestor
25586122|NCT00895453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25586123|NCT00895453|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25586124|NCT00895453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24701645|NCT01460069|Liraglutide|liraglutide|mesh-list
25586125|NCT00895453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586126|NCT00895453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586127|NCT00895453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25586128|NCT00895453|Hormone Antagonists|hormone antagonists|mesh-ancestor
25586129|NCT00895453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25586130|NCT00895453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586131|NCT00895453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25586132|NCT00895453|Trace Elements|trace elements|mesh-ancestor
25586133|NCT00895453|Micronutrients|micronutrients|mesh-ancestor
25586134|NCT00895531|Morphine|morphine|mesh-list
25586135|NCT00895531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25586136|NCT00895531|Narcotics|narcotics|mesh-ancestor
25480792|NCT00110890|Hormone Antagonists|hormone antagonists|mesh-ancestor
25480793|NCT00110890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25480794|NCT00110994|Sorafenib|sorafenib|mesh-list
25480795|NCT00110994|Dacarbazine|dacarbazine|mesh-list
25480796|NCT00110994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480797|NCT00110994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25586137|NCT00895531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25586138|NCT00895531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586139|NCT00895531|Analgesics|analgesics|mesh-ancestor
25586140|NCT00895531|Sensory System Agents|sensory system agents|mesh-ancestor
25586141|NCT00895531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25586142|NCT00895583|Sirolimus|sirolimus|mesh-list
25586143|NCT00895583|Tacrolimus|tacrolimus|mesh-list
25586144|NCT00895583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25586145|NCT00895583|Immunologic Factors|immunologic factors|mesh-ancestor
25586146|NCT00895583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586147|NCT00895583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25586148|NCT00895583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586149|NCT00895583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586150|NCT00895583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25586151|NCT00895583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25586152|NCT00895583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25586153|NCT00895583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25586154|NCT00895583|Antifungal Agents|antifungal agents|mesh-ancestor
25586155|NCT00895661|Rituximab|rituximab|mesh-list
25586156|NCT00895661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25586157|NCT00895661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25586158|NCT00895661|Immunologic Factors|immunologic factors|mesh-ancestor
25586159|NCT00895661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586160|NCT00895661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25586161|NCT00895752|Riluzole|riluzole|mesh-list
25586162|NCT00895752|Anticonvulsants|anticonvulsants|mesh-ancestor
25586163|NCT00895752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25586164|NCT00895752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25586165|NCT00895752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25586166|NCT00895752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702499|NCT01466114|Hormones|hormones|mesh-ancestor
25586167|NCT00895752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586168|NCT00895752|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25586169|NCT00895752|Protective Agents|protective agents|mesh-ancestor
25586170|NCT00895817|Fluticasone|fluticasone|mesh-list
25586171|NCT00895817|Esomeprazole|esomeprazole|mesh-list
25586172|NCT00895817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25586173|NCT00895817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25586174|NCT00895817|Autonomic Agents|autonomic agents|mesh-ancestor
25586175|NCT00895817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25586176|NCT00895817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586177|NCT00895817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25586178|NCT00895817|Respiratory System Agents|respiratory system agents|mesh-ancestor
25586179|NCT00895817|Dermatologic Agents|dermatologic agents|mesh-ancestor
25586180|NCT00895817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25586181|NCT00895817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25586182|NCT00895817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25586183|NCT00895817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25586184|NCT00895817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586185|NCT00895817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586186|NCT00895843|Ibuprofen|ibuprofen|mesh-list
25586187|NCT00895843|Epinephrine|epinephrine|mesh-list
25586188|NCT00895843|Bupivacaine|bupivacaine|mesh-list
25586189|NCT00895843|Anesthetics, Local|anesthetics, local|mesh-ancestor
25586190|NCT00895843|Anesthetics|anesthetics|mesh-ancestor
25586191|NCT00895843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25586192|NCT00895843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586193|NCT00895843|Sensory System Agents|sensory system agents|mesh-ancestor
25586194|NCT00895843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25586195|NCT00895843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25586196|NCT00895843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25586197|NCT00895843|Analgesics|analgesics|mesh-ancestor
25586198|NCT00895843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25586199|NCT00895843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25586200|NCT00895843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25586201|NCT00895843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586202|NCT00895843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586203|NCT00895843|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25586204|NCT00895843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25586205|NCT00895843|Adrenergic Agents|adrenergic agents|mesh-ancestor
25586206|NCT00895843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25586207|NCT00895843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25586208|NCT00895843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25586209|NCT00895843|Autonomic Agents|autonomic agents|mesh-ancestor
25586210|NCT00895843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25586211|NCT00895843|Respiratory System Agents|respiratory system agents|mesh-ancestor
25586212|NCT00895843|Mydriatics|mydriatics|mesh-ancestor
25586213|NCT00895843|Sympathomimetics|sympathomimetics|mesh-ancestor
25586214|NCT00895843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25586215|NCT00895895|Donepezil|donepezil|mesh-list
25586216|NCT00895895|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25586217|NCT00895895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586218|NCT00895895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586219|NCT00895895|Cholinergic Agents|cholinergic agents|mesh-ancestor
25586220|NCT00895895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25586221|NCT00895895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586222|NCT00895895|Nootropic Agents|nootropic agents|mesh-ancestor
25586223|NCT00895921|Olanzapine|olanzapine|mesh-list
25586224|NCT00895921|Aripiprazole|aripiprazole|mesh-list
25586225|NCT00895921|Antiemetics|antiemetics|mesh-ancestor
25586226|NCT00895921|Autonomic Agents|autonomic agents|mesh-ancestor
25586227|NCT00895921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25586228|NCT00895921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586229|NCT00895921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25586230|NCT00895921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25586231|NCT00895921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25586232|NCT00895921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25586233|NCT00895921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25586234|NCT00895921|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25586235|NCT00895921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25586236|NCT00895921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25586237|NCT00895921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586238|NCT00895921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25586239|NCT00895921|Serotonin Agents|serotonin agents|mesh-ancestor
25586240|NCT00895921|Antidepressive Agents|antidepressive agents|mesh-ancestor
25586241|NCT00895921|Dopamine Agonists|dopamine agonists|mesh-ancestor
25586242|NCT00895921|Dopamine Agents|dopamine agents|mesh-ancestor
24938089|NCT04022161|Nitric Oxide|nitric oxide|mesh-list
25586243|NCT00895921|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25586244|NCT00895921|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25586245|NCT00895921|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25586246|NCT00895921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25586247|NCT00895921|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25586248|NCT00895921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25586249|NCT00895934|Azacitidine|azacitidine|mesh-list
25586250|NCT00895934|Vorinostat|vorinostat|mesh-list
25586251|NCT00895934|Gemtuzumab|gemtuzumab|mesh-list
25586252|NCT00895934|Calicheamicins|calicheamicins|mesh-list
25586253|NCT00895934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25586254|NCT00895934|Antimetabolites|antimetabolites|mesh-ancestor
25586255|NCT00895934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586256|NCT00895934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25586257|NCT00895934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586258|NCT00895934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25586259|NCT00895934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25586260|NCT00895934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25586261|NCT00895947|Interferons|interferons|mesh-list
25586262|NCT00895947|Interferon-alpha|interferon-alpha|mesh-list
25586263|NCT00895947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25586264|NCT00895947|Antiviral Agents|antiviral agents|mesh-ancestor
25586265|NCT00895947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25586266|NCT00895947|Immunologic Factors|immunologic factors|mesh-ancestor
25586267|NCT00895947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586268|NCT00896012|Sirolimus|sirolimus|mesh-list
25586269|NCT00896012|Tacrolimus|tacrolimus|mesh-list
25586270|NCT00896012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25586271|NCT00896012|Immunologic Factors|immunologic factors|mesh-ancestor
25586272|NCT00896012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586273|NCT00896012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25586274|NCT00896012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586275|NCT00896012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586276|NCT00896012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25586277|NCT00896012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25586278|NCT00896012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24704036|NCT01476280|Ramosetron|ramosetron|mesh-list
25586279|NCT00896012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25586280|NCT00896012|Antifungal Agents|antifungal agents|mesh-ancestor
25586281|NCT00896038|Aprepitant|aprepitant|mesh-list
25586282|NCT00896038|Antiemetics|antiemetics|mesh-ancestor
25586283|NCT00896038|Autonomic Agents|autonomic agents|mesh-ancestor
25586284|NCT00896038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25586285|NCT00896038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586286|NCT00896038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25586287|NCT00896038|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25586288|NCT00896038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25586289|NCT00896038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586290|NCT00896051|Ritonavir|ritonavir|mesh-list
25586291|NCT00896051|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25586292|NCT00896051|Tenofovir|tenofovir|mesh-list
25586293|NCT00896051|Etravirine|etravirine|mesh-list
25586294|NCT00896051|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
25586295|NCT00896051|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25586296|NCT00896051|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25586297|NCT00896051|Protease Inhibitors|protease inhibitors|mesh-ancestor
25586298|NCT00896051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586299|NCT00896051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586300|NCT00896051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25586301|NCT00896051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25586302|NCT00896051|Antiviral Agents|antiviral agents|mesh-ancestor
25586303|NCT00896051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25586304|NCT00896051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25586305|NCT00896051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25586306|NCT00896051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25586307|NCT00896064|Vaccines|vaccines|mesh-list
25586308|NCT00896064|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25586309|NCT00896064|Immunologic Factors|immunologic factors|mesh-ancestor
25586310|NCT00896064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586311|NCT00896168|Methotrexate|methotrexate|mesh-list
25586312|NCT00896168|Infliximab|infliximab|mesh-list
25586313|NCT00896168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25586314|NCT00896168|Abortifacient Agents|abortifacient agents|mesh-ancestor
25586315|NCT00896168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24704649|NCT01479504|Nedaplatin|nedaplatin|mesh-list
25586316|NCT00896168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586317|NCT00896168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25586318|NCT00896168|Antimetabolites|antimetabolites|mesh-ancestor
25586319|NCT00896168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586320|NCT00896168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25586321|NCT00896168|Dermatologic Agents|dermatologic agents|mesh-ancestor
25586322|NCT00896168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586323|NCT00896168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25586324|NCT00896168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25586325|NCT00896168|Immunologic Factors|immunologic factors|mesh-ancestor
25586326|NCT00896168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25586327|NCT00896168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25586328|NCT00896168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25586329|NCT00896181|Cisplatin|cisplatin|mesh-list
25586330|NCT00896181|Carboplatin|carboplatin|mesh-list
25586331|NCT00896181|Docetaxel|docetaxel|mesh-list
25586332|NCT00896181|Fluorouracil|fluorouracil|mesh-list
25586333|NCT00896181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25586334|NCT00896181|Tubulin Modulators|tubulin modulators|mesh-ancestor
25586335|NCT00896181|Antimitotic Agents|antimitotic agents|mesh-ancestor
25586336|NCT00896181|Mitosis Modulators|mitosis modulators|mesh-ancestor
25586337|NCT00896181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586338|NCT00896181|Antimetabolites|antimetabolites|mesh-ancestor
25586339|NCT00896181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25586340|NCT00896181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25586341|NCT00896181|Immunologic Factors|immunologic factors|mesh-ancestor
25586342|NCT00896181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586343|NCT00896441|Citalopram|citalopram|mesh-list
25586344|NCT00896441|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25586345|NCT00896441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25586346|NCT00896441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25586347|NCT00896441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586348|NCT00896441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25586349|NCT00896441|Serotonin Agents|serotonin agents|mesh-ancestor
25586350|NCT00896441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586351|NCT00896441|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25586352|NCT00896441|Antidepressive Agents|antidepressive agents|mesh-ancestor
25586353|NCT00896441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25586354|NCT00896454|Denosumab|denosumab|mesh-list
25586355|NCT00896454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25586356|NCT00896454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586357|NCT00896779|Ranibizumab|ranibizumab|mesh-list
25586358|NCT00896779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25586359|NCT00896779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24705187|NCT01482728|Dasatinib|dasatinib|mesh-list
25586360|NCT00896779|Growth Substances|growth substances|mesh-ancestor
25586361|NCT00896779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586362|NCT00896779|Growth Inhibitors|growth inhibitors|mesh-ancestor
25586363|NCT00896779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25586364|NCT00897390|Metformin|metformin|mesh-list
25586365|NCT00897390|Saxagliptin|saxagliptin|mesh-list
25586366|NCT00897390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25586367|NCT00897390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586368|NCT00897390|Incretins|incretins|mesh-ancestor
25586369|NCT00897390|Hormones|hormones|mesh-ancestor
25586370|NCT00897390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25586371|NCT00897390|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25586372|NCT00897390|Protease Inhibitors|protease inhibitors|mesh-ancestor
25586373|NCT00897390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586374|NCT00897390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586375|NCT00897715|Rilonacept|rilonacept|mesh-list
25586376|NCT00897715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25586377|NCT00898222|Aspirin|aspirin|mesh-list
25586378|NCT00898222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25586379|NCT00898222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25586380|NCT00898222|Analgesics|analgesics|mesh-ancestor
25586381|NCT00898222|Sensory System Agents|sensory system agents|mesh-ancestor
25586382|NCT00898222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25586383|NCT00898222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586384|NCT00898222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25586385|NCT00898222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25586386|NCT00898222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25586387|NCT00898222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25586388|NCT00898222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586389|NCT00898222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25586390|NCT00898222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25586391|NCT00898222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586392|NCT00898222|Antipyretics|antipyretics|mesh-ancestor
25586393|NCT00898443|Anesthetics|anesthetics|mesh-list
25586394|NCT00898443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25586395|NCT00898443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586396|NCT00898560|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25586397|NCT00898560|Anticonvulsants|anticonvulsants|mesh-ancestor
25586398|NCT00898560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25586399|NCT00898560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25586400|NCT00898560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25586401|NCT00898560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586402|NCT00898807|Citalopram|citalopram|mesh-list
25586403|NCT00898807|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25586404|NCT00898807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25586405|NCT00898807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25586406|NCT00898807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586407|NCT00898807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25586408|NCT00898807|Serotonin Agents|serotonin agents|mesh-ancestor
25586409|NCT00898807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586410|NCT00898807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25586411|NCT00898807|Antidepressive Agents|antidepressive agents|mesh-ancestor
25586412|NCT00898807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25586413|NCT00899431|Vidarabine|vidarabine|mesh-list
25586414|NCT00899431|Rituximab|rituximab|mesh-list
25586415|NCT00899431|Fludarabine|fludarabine|mesh-list
25586416|NCT00899431|Fludarabine phosphate|fludarabine phosphate|mesh-list
25586417|NCT00899431|Lenalidomide|lenalidomide|mesh-list
25586418|NCT00899431|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24938257|NCT04020588|Celecoxib|celecoxib|mesh-list
25586419|NCT00899431|Allopurinol|allopurinol|mesh-list
25586420|NCT00899431|Thymoglobulin|thymoglobulin|mesh-list
25586421|NCT00899431|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25586422|NCT00899431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25586423|NCT00899431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25586424|NCT00899431|Immunologic Factors|immunologic factors|mesh-ancestor
25586425|NCT00899431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586426|NCT00899431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25586427|NCT00899431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25586428|NCT00899431|Antimetabolites|antimetabolites|mesh-ancestor
25586429|NCT00899431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586430|NCT00899431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25586431|NCT00899431|Antiviral Agents|antiviral agents|mesh-ancestor
25586432|NCT00899431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25586433|NCT00899431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25586434|NCT00899431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25586435|NCT00899431|Growth Substances|growth substances|mesh-ancestor
25586436|NCT00899431|Growth Inhibitors|growth inhibitors|mesh-ancestor
25586437|NCT00899431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25586438|NCT00899431|Alkylating Agents|alkylating agents|mesh-ancestor
25586439|NCT00899431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586440|NCT00899431|Gout Suppressants|gout suppressants|mesh-ancestor
25586441|NCT00899431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25586443|NCT00899431|Protective Agents|protective agents|mesh-ancestor
25586444|NCT00899470|Metformin|metformin|mesh-list
25586445|NCT00899470|Saxagliptin|saxagliptin|mesh-list
25586446|NCT00899470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25586447|NCT00899470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586448|NCT00899470|Incretins|incretins|mesh-ancestor
25586449|NCT00899470|Hormones|hormones|mesh-ancestor
25586450|NCT00899470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25586451|NCT00899470|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25481128|NCT00113295|Antidepressive Agents|antidepressive agents|mesh-ancestor
25481129|NCT00113295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24938290|NCT04020328|Hormones|hormones|mesh-ancestor
25481130|NCT00113295|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25481131|NCT00113295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25481132|NCT00113295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25481133|NCT00113295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481134|NCT00113295|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25481135|NCT00113295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25481136|NCT00113295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25481137|NCT00113295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481138|NCT00113295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25481139|NCT00113295|Serotonin Agents|serotonin agents|mesh-ancestor
25481140|NCT00113295|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25481141|NCT00113295|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25481142|NCT00113295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25481143|NCT00113295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481144|NCT00113321|Decitabine|decitabine|mesh-list
25481145|NCT00113321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25481146|NCT00113321|Antimetabolites|antimetabolites|mesh-ancestor
25481147|NCT00113321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481148|NCT00113321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481149|NCT00113321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481150|NCT00113360|Everolimus|everolimus|mesh-list
25481151|NCT00113360|Octreotide|octreotide|mesh-list
25481152|NCT00113360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481153|NCT00113360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25481154|NCT00113360|Immunologic Factors|immunologic factors|mesh-ancestor
25481155|NCT00113360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586452|NCT00899470|Protease Inhibitors|protease inhibitors|mesh-ancestor
25586453|NCT00899470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586454|NCT00899470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586455|NCT00899574|Imiquimod|imiquimod|mesh-list
25586456|NCT00899574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25586457|NCT00899574|Immunologic Factors|immunologic factors|mesh-ancestor
25586458|NCT00899574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586459|NCT00899574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25586460|NCT00899574|Interferon Inducers|interferon inducers|mesh-ancestor
25586461|NCT00899600|Ketamine|ketamine|mesh-list
25586462|NCT00899600|Analgesics|analgesics|mesh-ancestor
25586463|NCT00899600|Sensory System Agents|sensory system agents|mesh-ancestor
25586464|NCT00899600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25586465|NCT00899600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586466|NCT00899600|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25586467|NCT00899600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25586468|NCT00899600|Anesthetics, General|anesthetics, general|mesh-ancestor
25586469|NCT00899600|Anesthetics|anesthetics|mesh-ancestor
25586470|NCT00899600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25586471|NCT00899600|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25586472|NCT00899600|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25586473|NCT00899600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25586474|NCT00899600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586475|NCT00899678|Certolizumab Pegol|certolizumab pegol|mesh-list
25586476|NCT00899678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25586477|NCT00899678|Immunologic Factors|immunologic factors|mesh-ancestor
25586478|NCT00899678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586479|NCT00899678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25586480|NCT00899717|Salicylic Acid|salicylic acid|mesh-list
25586481|NCT00899717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25586482|NCT00899717|Antifungal Agents|antifungal agents|mesh-ancestor
25586483|NCT00899717|Keratolytic Agents|keratolytic agents|mesh-ancestor
25586484|NCT00899717|Dermatologic Agents|dermatologic agents|mesh-ancestor
25586485|NCT00899847|Acetaminophen|acetaminophen|mesh-list
25586486|NCT00899847|Diphenhydramine|diphenhydramine|mesh-list
25586487|NCT00899847|Promethazine|promethazine|mesh-list
25586488|NCT00899847|Cyclosporine|cyclosporine|mesh-list
25586489|NCT00899847|Mycophenolic Acid|mycophenolic acid|mesh-list
25586490|NCT00899847|Hydrocortisone|hydrocortisone|mesh-list
25586491|NCT00899847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25586492|NCT00899847|Cyclophosphamide|cyclophosphamide|mesh-list
25586493|NCT00899847|Melphalan|melphalan|mesh-list
25586494|NCT00899847|Mechlorethamine|mechlorethamine|mesh-list
25586495|NCT00899847|Cyclosporins|cyclosporins|mesh-list
25586496|NCT00899847|Thymoglobulin|thymoglobulin|mesh-list
25586497|NCT00899847|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25586498|NCT00899847|Lenograstim|lenograstim|mesh-list
25586499|NCT00899847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25586500|NCT00899847|Immunologic Factors|immunologic factors|mesh-ancestor
25586501|NCT00899847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586502|NCT00899847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25586503|NCT00899847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25586504|NCT00899847|Alkylating Agents|alkylating agents|mesh-ancestor
25586505|NCT00899847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586506|NCT00899847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25586507|NCT00899847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25586508|NCT00899847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25586509|NCT00899847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586510|NCT00899847|Antifungal Agents|antifungal agents|mesh-ancestor
25586511|NCT00899847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25586512|NCT00899847|Dermatologic Agents|dermatologic agents|mesh-ancestor
25586513|NCT00899847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25586514|NCT00899847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25586515|NCT00899847|Analgesics|analgesics|mesh-ancestor
25586516|NCT00899847|Sensory System Agents|sensory system agents|mesh-ancestor
25586517|NCT00899847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25586518|NCT00899847|Antipyretics|antipyretics|mesh-ancestor
25586519|NCT00899847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25586520|NCT00899847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25586521|NCT00899847|Antitubercular Agents|antitubercular agents|mesh-ancestor
25586522|NCT00899847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25586523|NCT00899847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25586524|NCT00899847|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25586525|NCT00899847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25586526|NCT00899847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25586527|NCT00899847|Anesthetics, Local|anesthetics, local|mesh-ancestor
25586528|NCT00899847|Anesthetics|anesthetics|mesh-ancestor
25586529|NCT00899847|Antiemetics|antiemetics|mesh-ancestor
25586530|NCT00899847|Autonomic Agents|autonomic agents|mesh-ancestor
25586531|NCT00899847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25586532|NCT00899847|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25586533|NCT00899847|Histamine Antagonists|histamine antagonists|mesh-ancestor
25586534|NCT00899847|Histamine Agents|histamine agents|mesh-ancestor
25586535|NCT00899847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25586536|NCT00899847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25586537|NCT00899847|Antipruritics|antipruritics|mesh-ancestor
25586538|NCT00899847|Glucocorticoids|glucocorticoids|mesh-ancestor
25586539|NCT00899847|Hormones|hormones|mesh-ancestor
25586540|NCT00899847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25586541|NCT00899847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25586542|NCT00899847|Protective Agents|protective agents|mesh-ancestor
25586543|NCT00899847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25653192|NCT01535287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653193|NCT01535443|Bromfenac|bromfenac|mesh-list
25653194|NCT01535443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25653195|NCT01535443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25653196|NCT01535443|Analgesics|analgesics|mesh-ancestor
25653197|NCT01535443|Sensory System Agents|sensory system agents|mesh-ancestor
25653198|NCT01535443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653199|NCT01535443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653200|NCT01535443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25653201|NCT01535443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25653202|NCT01535573|Dexetimide|dexetimide|mesh-list
25653203|NCT01535573|Citalopram|citalopram|mesh-list
25653204|NCT01535573|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25653205|NCT01535573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25653206|NCT01535573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25586544|NCT00900146|Metformin|metformin|mesh-list
25586545|NCT00900146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25586546|NCT00900146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586547|NCT00900159|Eszopiclone|eszopiclone|mesh-list
25586548|NCT00900159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25586549|NCT00900159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25586550|NCT00900159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586551|NCT00900237|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25586552|NCT00900237|Oxcarbazepine|oxcarbazepine|mesh-list
25586553|NCT00900237|Anticonvulsants|anticonvulsants|mesh-ancestor
25586554|NCT00900237|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25586555|NCT00900237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25586556|NCT00900237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25586557|NCT00900237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586558|NCT00900237|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25586559|NCT00900237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25586560|NCT00900627|Paclitaxel|paclitaxel|mesh-list
25586561|NCT00900627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25586562|NCT00900627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25586563|NCT00900627|Tubulin Modulators|tubulin modulators|mesh-ancestor
25586564|NCT00900627|Antimitotic Agents|antimitotic agents|mesh-ancestor
25586565|NCT00900627|Mitosis Modulators|mitosis modulators|mesh-ancestor
25586566|NCT00900627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586567|NCT00900666|Botulinum Toxins|botulinum toxins|mesh-list
25586568|NCT00900666|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25586569|NCT00900666|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25586570|NCT00900666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25586571|NCT00900666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25586572|NCT00900666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586573|NCT00900666|Cholinergic Agents|cholinergic agents|mesh-ancestor
25586574|NCT00900666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25586575|NCT00900666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586576|NCT00900666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25586577|NCT00900666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25586578|NCT00900731|Tiotropium Bromide|tiotropium bromide|mesh-list
25586579|NCT00900731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25586580|NCT00900731|Autonomic Agents|autonomic agents|mesh-ancestor
25586581|NCT00900731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25586582|NCT00900731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586583|NCT00900731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25586584|NCT00900731|Respiratory System Agents|respiratory system agents|mesh-ancestor
25586585|NCT00900731|Parasympatholytics|parasympatholytics|mesh-ancestor
25586586|NCT00900731|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25586587|NCT00900731|Cholinergic Agents|cholinergic agents|mesh-ancestor
25586588|NCT00900731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25586589|NCT00900731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586590|NCT00900757|Palonosetron|palonosetron|mesh-list
25586591|NCT00900757|Antiemetics|antiemetics|mesh-ancestor
25586592|NCT00900757|Autonomic Agents|autonomic agents|mesh-ancestor
25586593|NCT00900757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25586594|NCT00900757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586595|NCT00900757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25586596|NCT00900757|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25586597|NCT00900757|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25586598|NCT00900757|Serotonin Agents|serotonin agents|mesh-ancestor
25586599|NCT00900757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25586600|NCT00900757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586601|NCT00901186|Ranibizumab|ranibizumab|mesh-list
25586602|NCT00901186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25586603|NCT00901186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25586604|NCT00901186|Growth Substances|growth substances|mesh-ancestor
25586605|NCT00901186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586606|NCT00901186|Growth Inhibitors|growth inhibitors|mesh-ancestor
25586607|NCT00901186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25586608|NCT00901199|Deferasirox|deferasirox|mesh-list
25586609|NCT00901199|Deferoxamine|deferoxamine|mesh-list
25586610|NCT00901199|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25586611|NCT00901199|Chelating Agents|chelating agents|mesh-ancestor
25586612|NCT00901199|Sequestering Agents|sequestering agents|mesh-ancestor
25586613|NCT00901199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586614|NCT00901199|Siderophores|siderophores|mesh-ancestor
25586615|NCT00901225|Plerixafor|plerixafor|mesh-list
25586616|NCT00901225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25586617|NCT00901225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25586618|NCT00901225|Antiviral Agents|antiviral agents|mesh-ancestor
25586619|NCT00901225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25586620|NCT00901394|Folic Acid|folic acid|mesh-list
25586621|NCT00901394|Nitrous Oxide|nitrous oxide|mesh-list
25586622|NCT00901394|Hematinics|hematinics|mesh-ancestor
25586623|NCT00901394|Vitamin B Complex|vitamin b complex|mesh-ancestor
25586624|NCT00901394|Vitamins|vitamins|mesh-ancestor
25586625|NCT00901394|Micronutrients|micronutrients|mesh-ancestor
25586626|NCT00901394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586627|NCT00901394|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25586628|NCT00901394|Anesthetics, General|anesthetics, general|mesh-ancestor
25586629|NCT00901394|Anesthetics|anesthetics|mesh-ancestor
25586630|NCT00901394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25586631|NCT00901394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25586632|NCT00901394|Analgesics|analgesics|mesh-ancestor
25586633|NCT00901394|Sensory System Agents|sensory system agents|mesh-ancestor
25586634|NCT00901394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25586635|NCT00901576|Methylphenidate|methylphenidate|mesh-list
25586636|NCT00901576|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25586637|NCT00901576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586638|NCT00901576|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25586639|NCT00901576|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25586640|NCT00901576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25586641|NCT00901576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586642|NCT00901576|Dopamine Agents|dopamine agents|mesh-ancestor
25586643|NCT00901576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25586644|NCT00901628|Cefuroxime|cefuroxime|mesh-list
25586645|NCT00901628|Cefuroxime axetil|cefuroxime axetil|mesh-list
25586646|NCT00901628|Ketorolac|ketorolac|mesh-list
25586647|NCT00901628|Epinephrine|epinephrine|mesh-list
25586648|NCT00901628|Morphine|morphine|mesh-list
25586649|NCT00901628|Ropivacaine|ropivacaine|mesh-list
25586650|NCT00901628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25586651|NCT00901628|Narcotics|narcotics|mesh-ancestor
25586652|NCT00901628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25586653|NCT00901628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586654|NCT00901628|Analgesics|analgesics|mesh-ancestor
25586655|NCT00901628|Sensory System Agents|sensory system agents|mesh-ancestor
25586656|NCT00901628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25586657|NCT00901628|Anesthetics, Local|anesthetics, local|mesh-ancestor
25586658|NCT00901628|Anesthetics|anesthetics|mesh-ancestor
25586659|NCT00901628|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25586660|NCT00901628|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25586661|NCT00901628|Adrenergic Agents|adrenergic agents|mesh-ancestor
25586662|NCT00901628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25586663|NCT00901628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586664|NCT00901628|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25586665|NCT00901628|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25586666|NCT00901628|Autonomic Agents|autonomic agents|mesh-ancestor
25586667|NCT00901628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25586668|NCT00901628|Respiratory System Agents|respiratory system agents|mesh-ancestor
25586669|NCT00901628|Mydriatics|mydriatics|mesh-ancestor
25586670|NCT00901628|Sympathomimetics|sympathomimetics|mesh-ancestor
25586671|NCT00901628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25586672|NCT00901628|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25586673|NCT00901628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25586674|NCT00901628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25586675|NCT00901628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25586676|NCT00901628|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25586677|NCT00901628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586678|NCT00901628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25586679|NCT00901628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25586680|NCT00901901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25586681|NCT00901901|Sorafenib|sorafenib|mesh-list
25586682|NCT00901901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25586683|NCT00901901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25586684|NCT00901901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586685|NCT00901901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586686|NCT00901927|Rituximab|rituximab|mesh-list
25586687|NCT00901927|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25586688|NCT00901927|Mitoxantrone|mitoxantrone|mesh-list
25586689|NCT00901927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25586690|NCT00901927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25586691|NCT00901927|Immunologic Factors|immunologic factors|mesh-ancestor
25586692|NCT00901927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586693|NCT00901927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25586694|NCT00901927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25586695|NCT00901927|Alkylating Agents|alkylating agents|mesh-ancestor
25586696|NCT00901927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586697|NCT00901927|Analgesics|analgesics|mesh-ancestor
25586698|NCT00901927|Sensory System Agents|sensory system agents|mesh-ancestor
25586699|NCT00901927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25586700|NCT00901927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25586701|NCT00901927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25586702|NCT00901927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586703|NCT00902161|Propranolol|propranolol|mesh-list
25586704|NCT00902161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25586705|NCT00902161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25586706|NCT00902161|Adrenergic Agents|adrenergic agents|mesh-ancestor
25586707|NCT00902161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25586708|NCT00902161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586709|NCT00902161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586710|NCT00902161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25586711|NCT00902161|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25586712|NCT00902161|Vasodilator Agents|vasodilator agents|mesh-ancestor
25586713|NCT00902174|Imatinib Mesylate|imatinib mesylate|mesh-list
25586714|NCT00902174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25586715|NCT00902174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25586716|NCT00902174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586717|NCT00902174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586718|NCT00902226|Citalopram|citalopram|mesh-list
25586719|NCT00902226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25586720|NCT00902226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25586721|NCT00902226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25586722|NCT00902226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586723|NCT00902226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25586724|NCT00902226|Serotonin Agents|serotonin agents|mesh-ancestor
25586725|NCT00902226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586726|NCT00902226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25586727|NCT00902226|Antidepressive Agents|antidepressive agents|mesh-ancestor
25586728|NCT00902226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25586729|NCT00902265|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25586730|NCT00902265|Hemostatics|hemostatics|mesh-ancestor
25586731|NCT00902265|Coagulants|coagulants|mesh-ancestor
25586732|NCT00902265|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25586733|NCT00902265|Natriuretic Agents|natriuretic agents|mesh-ancestor
25586734|NCT00902265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586735|NCT00902304|Amlodipine|amlodipine|mesh-list
25586736|NCT00902304|Valsartan|valsartan|mesh-list
25586737|NCT00902304|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25586738|NCT00902304|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
25586739|NCT00902304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25586740|NCT00902304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25586741|NCT00902304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25586742|NCT00902304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586743|NCT00902304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25586744|NCT00902304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586745|NCT00902304|Vasodilator Agents|vasodilator agents|mesh-ancestor
25586746|NCT00902304|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25586747|NCT00902304|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25586748|NCT00902304|Diuretics|diuretics|mesh-ancestor
25586749|NCT00902304|Natriuretic Agents|natriuretic agents|mesh-ancestor
25586750|NCT00902304|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25586751|NCT00902538|Amlodipine|amlodipine|mesh-list
25586752|NCT00902538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25586753|NCT00902538|Olmesartan|olmesartan|mesh-list
25586754|NCT00902538|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25586755|NCT00902538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25586756|NCT00902538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25586757|NCT00902538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25586758|NCT00902538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586759|NCT00902538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25586760|NCT00902538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586761|NCT00902538|Vasodilator Agents|vasodilator agents|mesh-ancestor
25586762|NCT00902538|Diuretics|diuretics|mesh-ancestor
25586763|NCT00902538|Natriuretic Agents|natriuretic agents|mesh-ancestor
25586764|NCT00902538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25586765|NCT00902538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25586766|NCT00902538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25586768|NCT00902564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25586769|NCT00902564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25586770|NCT00902564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25586771|NCT00902564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586772|NCT00902564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25586773|NCT00902564|Serotonin Agents|serotonin agents|mesh-ancestor
25586774|NCT00902564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586775|NCT00902564|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25586776|NCT00902564|Antidepressive Agents|antidepressive agents|mesh-ancestor
25586777|NCT00902564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25586778|NCT00902577|Misonidazole|misonidazole|mesh-list
25586779|NCT00902577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25586780|NCT00902577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25586781|NCT00902577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25586782|NCT00902577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25586783|NCT00903162|Zoledronic Acid|zoledronic acid|mesh-list
25586784|NCT00903162|Letrozole|letrozole|mesh-list
25586785|NCT00903162|Leuprolide|leuprolide|mesh-list
25586786|NCT00903162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25586787|NCT00903162|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25586788|NCT00903162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25586789|NCT00903162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586790|NCT00903162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586791|NCT00903162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25586792|NCT00903162|Hormone Antagonists|hormone antagonists|mesh-ancestor
25586793|NCT00903162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25586794|NCT00903162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586795|NCT00903162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25586796|NCT00903162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25586797|NCT00903162|Fertility Agents|fertility agents|mesh-ancestor
25586798|NCT00903162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25586799|NCT00903162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25586800|NCT00903175|Everolimus|everolimus|mesh-list
25586801|NCT00903175|Sunitinib|sunitinib|mesh-list
25586802|NCT00903175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25586803|NCT00903175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25586804|NCT00903175|Immunologic Factors|immunologic factors|mesh-ancestor
25586805|NCT00903175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586806|NCT00903175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25586807|NCT00903175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25586808|NCT00903175|Growth Substances|growth substances|mesh-ancestor
25586809|NCT00903175|Growth Inhibitors|growth inhibitors|mesh-ancestor
25586810|NCT00903175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25586811|NCT00903175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586812|NCT00903175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586813|NCT00903331|Macitentan|macitentan|mesh-list
25586814|NCT00903331|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25586815|NCT00903331|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25586816|NCT00903331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586817|NCT00903331|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25586818|NCT00903344|Vitamin D|vitamin d|mesh-list
25586819|NCT00903344|Cholecalciferol|cholecalciferol|mesh-list
25586820|NCT00903344|Vitamins|vitamins|mesh-ancestor
25586821|NCT00903344|Micronutrients|micronutrients|mesh-ancestor
25586822|NCT00903344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586823|NCT00903344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25586824|NCT00903344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25586825|NCT00903357|Ascorbic Acid|ascorbic acid|mesh-list
25586826|NCT00903357|Montelukast|montelukast|mesh-list
25586827|NCT00903357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25586828|NCT00903357|Respiratory System Agents|respiratory system agents|mesh-ancestor
25586829|NCT00903357|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25586830|NCT00903357|Hormone Antagonists|hormone antagonists|mesh-ancestor
25586831|NCT00903357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25586832|NCT00903357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586833|NCT00903357|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25586834|NCT00903357|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25586835|NCT00903357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586836|NCT00903357|Antioxidants|antioxidants|mesh-ancestor
25586837|NCT00903357|Protective Agents|protective agents|mesh-ancestor
25586838|NCT00903357|Vitamins|vitamins|mesh-ancestor
25586839|NCT00903357|Micronutrients|micronutrients|mesh-ancestor
25586840|NCT00903409|Simvastatin|simvastatin|mesh-list
25586841|NCT00903409|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25586842|NCT00903409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25586843|NCT00903409|Antimetabolites|antimetabolites|mesh-ancestor
25586844|NCT00903409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586845|NCT00903409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25586846|NCT00903409|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25586847|NCT00903409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586848|NCT00903448|Omeprazole|omeprazole|mesh-list
25586849|NCT00903448|Lansoprazole|lansoprazole|mesh-list
25586850|NCT00903448|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25586851|NCT00903448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25586852|NCT00903448|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25586853|NCT00903448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586854|NCT00903448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586856|NCT00903617|Nicotinic Acids|nicotinic acids|mesh-list
25586857|NCT00903617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25586858|NCT00903617|Antimetabolites|antimetabolites|mesh-ancestor
25586859|NCT00903617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586860|NCT00903617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25586861|NCT00903617|Vasodilator Agents|vasodilator agents|mesh-ancestor
25586862|NCT00903617|Vitamin B Complex|vitamin b complex|mesh-ancestor
25586863|NCT00903617|Vitamins|vitamins|mesh-ancestor
25586864|NCT00903617|Micronutrients|micronutrients|mesh-ancestor
25586865|NCT00903617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586866|NCT00903630|Doxorubicin|doxorubicin|mesh-list
25586867|NCT00903630|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25586868|NCT00903630|Lenalidomide|lenalidomide|mesh-list
25586869|NCT00903630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25586870|NCT00903630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25586871|NCT00903630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25586872|NCT00903630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25586873|NCT00903630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586874|NCT00903630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586875|NCT00903630|Immunologic Factors|immunologic factors|mesh-ancestor
25586876|NCT00903630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586877|NCT00903630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25586878|NCT00903630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25586879|NCT00903630|Growth Substances|growth substances|mesh-ancestor
25586880|NCT00903630|Growth Inhibitors|growth inhibitors|mesh-ancestor
25586881|NCT00903682|Efavirenz|efavirenz|mesh-list
25586882|NCT00903682|Etravirine|etravirine|mesh-list
25586883|NCT00903682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25586884|NCT00903682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25586885|NCT00903682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586886|NCT00903682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586887|NCT00903682|Antiviral Agents|antiviral agents|mesh-ancestor
25586888|NCT00903682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25586889|NCT00903682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25586890|NCT00903682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25586891|NCT00903682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25586892|NCT00903682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25586893|NCT00903682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25586894|NCT00903682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25586895|NCT00903760|Decitabine|decitabine|mesh-list
25586896|NCT00903760|Clofarabine|clofarabine|mesh-list
25586897|NCT00903760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25586898|NCT00903760|Antimetabolites|antimetabolites|mesh-ancestor
25586899|NCT00903760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586900|NCT00903760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25586901|NCT00903760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586902|NCT00903968|Plerixafor|plerixafor|mesh-list
25586903|NCT00903968|Dexamethasone|dexamethasone|mesh-list
25586904|NCT00903968|Bortezomib|bortezomib|mesh-list
25586905|NCT00903968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25586906|NCT00903968|Antiemetics|antiemetics|mesh-ancestor
25586907|NCT00903968|Autonomic Agents|autonomic agents|mesh-ancestor
25586908|NCT00903968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25586909|NCT00903968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586910|NCT00903968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25586911|NCT00903968|Glucocorticoids|glucocorticoids|mesh-ancestor
25586912|NCT00903968|Hormones|hormones|mesh-ancestor
25586913|NCT00903968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25586914|NCT00903968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25586915|NCT00903968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25586916|NCT00903968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25586917|NCT00903968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25586918|NCT00903968|Antiviral Agents|antiviral agents|mesh-ancestor
25586919|NCT00903968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25586920|NCT00904033|Calcitriol|calcitriol|mesh-list
25586921|NCT00904033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25586922|NCT00904033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586923|NCT00904033|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25586924|NCT00904033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25586925|NCT00904033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586926|NCT00904033|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25586927|NCT00904033|Vitamins|vitamins|mesh-ancestor
25586928|NCT00904033|Micronutrients|micronutrients|mesh-ancestor
25586929|NCT00904033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25586930|NCT00904215|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25586931|NCT00904215|Telmisartan|telmisartan|mesh-list
25586932|NCT00904215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25586933|NCT00904215|Diuretics|diuretics|mesh-ancestor
25586934|NCT00904215|Natriuretic Agents|natriuretic agents|mesh-ancestor
25586935|NCT00904215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586936|NCT00904215|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25586937|NCT00904215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25586938|NCT00904215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586939|NCT00904215|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25586940|NCT00904215|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25586941|NCT00904345|Cetuximab|cetuximab|mesh-list
25586942|NCT00904345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25586943|NCT00904345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25586944|NCT00904488|Metolazone|metolazone|mesh-list
25586945|NCT00904488|Furosemide|furosemide|mesh-list
25586946|NCT00904488|Diuretics|diuretics|mesh-ancestor
25586947|NCT00904488|Natriuretic Agents|natriuretic agents|mesh-ancestor
25586948|NCT00904488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586949|NCT00904488|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25586950|NCT00904488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25586951|NCT00904488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586952|NCT00904488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25586953|NCT00904488|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25586954|NCT00904618|Lidocaine|lidocaine|mesh-list
25586955|NCT00904618|Anesthetics, Local|anesthetics, local|mesh-ancestor
25586956|NCT00904618|Anesthetics|anesthetics|mesh-ancestor
25586957|NCT00904618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25586958|NCT00904618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586959|NCT00904618|Sensory System Agents|sensory system agents|mesh-ancestor
25586960|NCT00904618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25586961|NCT00904618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25586962|NCT00904618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25586963|NCT00904618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25586964|NCT00904618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25586965|NCT00904618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586966|NCT00904670|Methylphenidate|methylphenidate|mesh-list
25586967|NCT00904670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25586968|NCT00904670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586969|NCT00904670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25586970|NCT00904670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25586971|NCT00904670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25586972|NCT00904670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586973|NCT00904670|Dopamine Agents|dopamine agents|mesh-ancestor
25586974|NCT00904670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25586975|NCT00904722|Rituximab|rituximab|mesh-list
25586976|NCT00904722|Pidilizumab|pidilizumab|mesh-list
25586977|NCT00904722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25586978|NCT00904722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25586979|NCT00904722|Immunologic Factors|immunologic factors|mesh-ancestor
25586980|NCT00904722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25586981|NCT00904722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25586982|NCT00904748|Sildenafil Citrate|sildenafil citrate|mesh-list
25586983|NCT00904748|Citric Acid|citric acid|mesh-list
25586984|NCT00904748|Sodium Citrate|sodium citrate|mesh-list
25586985|NCT00904748|Anticoagulants|anticoagulants|mesh-ancestor
25586986|NCT00904748|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25586987|NCT00904748|Chelating Agents|chelating agents|mesh-ancestor
25586988|NCT00904748|Sequestering Agents|sequestering agents|mesh-ancestor
25586989|NCT00904748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25586990|NCT00904748|Vasodilator Agents|vasodilator agents|mesh-ancestor
25586991|NCT00904748|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25586992|NCT00904748|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25586993|NCT00904748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25586994|NCT00904748|Urological Agents|urological agents|mesh-ancestor
25586995|NCT00904826|Eculizumab|eculizumab|mesh-list
25586996|NCT00904826|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25586997|NCT00904826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25586998|NCT00904826|Immunologic Factors|immunologic factors|mesh-ancestor
25586999|NCT00904826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587000|NCT00904839|Bevacizumab|bevacizumab|mesh-list
25587001|NCT00904839|Nintedanib|nintedanib|mesh-list
25587002|NCT00904839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25587003|NCT00904839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587004|NCT00904839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25587005|NCT00904839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25587006|NCT00904839|Growth Substances|growth substances|mesh-ancestor
25587007|NCT00904839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587008|NCT00904839|Growth Inhibitors|growth inhibitors|mesh-ancestor
25587009|NCT00904839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25587010|NCT00904839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25587011|NCT00904839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587012|NCT00904995|Voriconazole|voriconazole|mesh-list
25587013|NCT00904995|Antifungal Agents|antifungal agents|mesh-ancestor
25587014|NCT00904995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25587015|NCT00904995|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24938692|NCT04016389|Paclitaxel|paclitaxel|mesh-list
25587016|NCT00904995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25587017|NCT00904995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25587018|NCT00904995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587019|NCT00904995|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25587020|NCT00904995|Hormone Antagonists|hormone antagonists|mesh-ancestor
25587021|NCT00904995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25587022|NCT00904995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587023|NCT00904995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25587024|NCT00905021|Sunitinib|sunitinib|mesh-list
25587025|NCT00905021|Exemestane|exemestane|mesh-list
25587026|NCT00905021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587027|NCT00905021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25587028|NCT00905021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25587029|NCT00905021|Growth Substances|growth substances|mesh-ancestor
25587030|NCT00905021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587031|NCT00905021|Growth Inhibitors|growth inhibitors|mesh-ancestor
25587032|NCT00905021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25587033|NCT00905021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25587034|NCT00905021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587035|NCT00905021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25587036|NCT00905021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25587037|NCT00905021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25587038|NCT00905021|Hormone Antagonists|hormone antagonists|mesh-ancestor
25587039|NCT00905021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25587040|NCT00905034|Dexamethasone|dexamethasone|mesh-list
25587041|NCT00905034|Rituximab|rituximab|mesh-list
25587042|NCT00905034|Methotrexate|methotrexate|mesh-list
25587043|NCT00905034|Vincristine|vincristine|mesh-list
25587044|NCT00905034|Asparaginase|asparaginase|mesh-list
25587045|NCT00905034|Pegaspargase|pegaspargase|mesh-list
25587046|NCT00905034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25587047|NCT00905034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587048|NCT00905034|Immunologic Factors|immunologic factors|mesh-ancestor
25587049|NCT00905034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587050|NCT00905034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25587051|NCT00905034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25587052|NCT00905034|Antiemetics|antiemetics|mesh-ancestor
25587053|NCT00905034|Autonomic Agents|autonomic agents|mesh-ancestor
25587054|NCT00905034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25587055|NCT00905034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24763456|NCT01773772|Hormones|hormones|mesh-ancestor
25587056|NCT00905034|Glucocorticoids|glucocorticoids|mesh-ancestor
25587057|NCT00905034|Hormones|hormones|mesh-ancestor
25587058|NCT00905034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25587059|NCT00905034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25587060|NCT00905034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25481639|NCT00118209|Tubulin Modulators|tubulin modulators|mesh-ancestor
25587061|NCT00905034|Abortifacient Agents|abortifacient agents|mesh-ancestor
25587062|NCT00905034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25587063|NCT00905034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25587064|NCT00905034|Antimetabolites|antimetabolites|mesh-ancestor
25587065|NCT00905034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587066|NCT00905034|Dermatologic Agents|dermatologic agents|mesh-ancestor
25587067|NCT00905034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25587068|NCT00905034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25587069|NCT00905034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25587070|NCT00905034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25587071|NCT00905034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25587072|NCT00905034|Tubulin Modulators|tubulin modulators|mesh-ancestor
25587073|NCT00905034|Antimitotic Agents|antimitotic agents|mesh-ancestor
25587074|NCT00905034|Mitosis Modulators|mitosis modulators|mesh-ancestor
25587075|NCT00905060|Temozolomide|temozolomide|mesh-list
25587076|NCT00905060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25587077|NCT00905060|Alkylating Agents|alkylating agents|mesh-ancestor
25587078|NCT00905060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587079|NCT00905060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587080|NCT00905255|Lixisenatide|lixisenatide|mesh-list
25587081|NCT00905255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25587082|NCT00905255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587083|NCT00905268|Idebenone|idebenone|mesh-list
25587084|NCT00905268|Antioxidants|antioxidants|mesh-ancestor
25587085|NCT00905268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587086|NCT00905268|Protective Agents|protective agents|mesh-ancestor
25587087|NCT00905268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587088|NCT00905307|Aripiprazole|aripiprazole|mesh-list
25587089|NCT00905307|Antidepressive Agents|antidepressive agents|mesh-ancestor
25587090|NCT00905307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25587091|NCT00905307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25587092|NCT00905307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25587093|NCT00905307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25587094|NCT00905307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587095|NCT00905307|Dopamine Agonists|dopamine agonists|mesh-ancestor
25587096|NCT00905307|Dopamine Agents|dopamine agents|mesh-ancestor
25587097|NCT00905307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25587098|NCT00905307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587099|NCT00905307|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25587100|NCT00905307|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25587101|NCT00905307|Serotonin Agents|serotonin agents|mesh-ancestor
25587102|NCT00905307|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25587103|NCT00905307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25587104|NCT00905307|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25587105|NCT00905307|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25587106|NCT00905424|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25587107|NCT00905424|Antidepressive Agents|antidepressive agents|mesh-list
25587108|NCT00905424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25587109|NCT00905424|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25587110|NCT00905424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587111|NCT00905424|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25587112|NCT00905424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25587113|NCT00905424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25587114|NCT00905424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587115|NCT00905424|Dopamine Agents|dopamine agents|mesh-ancestor
25587116|NCT00905424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25587117|NCT00905437|Pregabalin|pregabalin|mesh-list
25587118|NCT00905437|Analgesics|analgesics|mesh-ancestor
25587119|NCT00905437|Sensory System Agents|sensory system agents|mesh-ancestor
25587120|NCT00905437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25587121|NCT00905437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587122|NCT00905437|Anticonvulsants|anticonvulsants|mesh-ancestor
25587123|NCT00905437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25587124|NCT00905437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25587125|NCT00905437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587126|NCT00905437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25587127|NCT00905437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25587128|NCT00905437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25587129|NCT00905437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25587130|NCT00905437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25587131|NCT00905489|Nevirapine|nevirapine|mesh-list
25587132|NCT00905489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25481712|NCT00118365|Analgesics|analgesics|mesh-ancestor
25587133|NCT00905489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25587135|NCT00905489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587136|NCT00905489|Antiviral Agents|antiviral agents|mesh-ancestor
25587137|NCT00905489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25587138|NCT00905489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25587139|NCT00905489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25587140|NCT00905489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25587141|NCT00905489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25587142|NCT00905515|Cyclosporine|cyclosporine|mesh-list
25587143|NCT00905515|Tacrolimus|tacrolimus|mesh-list
25587144|NCT00905515|Cyclosporins|cyclosporins|mesh-list
25587145|NCT00905515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25587146|NCT00905515|Immunologic Factors|immunologic factors|mesh-ancestor
25587147|NCT00905515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587148|NCT00905515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25587149|NCT00905515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25587150|NCT00905515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587151|NCT00905515|Antifungal Agents|antifungal agents|mesh-ancestor
25587152|NCT00905515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25587153|NCT00905515|Dermatologic Agents|dermatologic agents|mesh-ancestor
25587154|NCT00905515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25587155|NCT00905580|Pregabalin|pregabalin|mesh-list
25587156|NCT00905580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587157|NCT00905580|Analgesics|analgesics|mesh-ancestor
25587158|NCT00905580|Sensory System Agents|sensory system agents|mesh-ancestor
25587159|NCT00905580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25587160|NCT00905580|Anticonvulsants|anticonvulsants|mesh-ancestor
25587161|NCT00905580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25587162|NCT00905580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25587163|NCT00905580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587164|NCT00905580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25587165|NCT00905580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25587166|NCT00905580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25587167|NCT00905580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25587168|NCT00905580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25587169|NCT00906087|Timolol|timolol|mesh-list
25587170|NCT00906087|Dorzolamide|dorzolamide|mesh-list
25587171|NCT00906087|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25587172|NCT00906087|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25587173|NCT00906087|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25587174|NCT00906087|Adrenergic Agents|adrenergic agents|mesh-ancestor
25587175|NCT00906087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050451|NCT00501709|Immunologic Factors|immunologic factors|mesh-ancestor
25587176|NCT00906087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587177|NCT00906087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587178|NCT00906087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25587179|NCT00906087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25587180|NCT00906087|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25587181|NCT00906087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25587182|NCT00906087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25653207|NCT01535573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653208|NCT01535573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25653209|NCT01535573|Serotonin Agents|serotonin agents|mesh-ancestor
25653210|NCT01535573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653211|NCT01535573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25653212|NCT01535573|Antidepressive Agents|antidepressive agents|mesh-ancestor
25653213|NCT01535573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25653214|NCT01535573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25653215|NCT01535573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25653216|NCT01535573|Parasympatholytics|parasympatholytics|mesh-ancestor
25653217|NCT01535573|Autonomic Agents|autonomic agents|mesh-ancestor
25653218|NCT01535573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653219|NCT01535573|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25653220|NCT01535573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25653221|NCT01535573|Cholinergic Agents|cholinergic agents|mesh-ancestor
25653222|NCT01535664|4-Aminopyridine|4-aminopyridine|mesh-list
25653223|NCT01535664|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25653224|NCT01535664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25653225|NCT01535664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653226|NCT01535924|Gemcitabine|gemcitabine|mesh-list
25653227|NCT01535924|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25653228|NCT01535924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25653229|NCT01535924|Antimetabolites|antimetabolites|mesh-ancestor
25587183|NCT00906204|Thymoglobulin|thymoglobulin|mesh-list
25587184|NCT00906204|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25587185|NCT00906204|Immunologic Factors|immunologic factors|mesh-ancestor
25587186|NCT00906204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587187|NCT00906204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25587188|NCT00906282|Carboplatin|carboplatin|mesh-list
25587189|NCT00906282|Pemetrexed|pemetrexed|mesh-list
25587190|NCT00906282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587191|NCT00906282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25587192|NCT00906282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587193|NCT00906282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25587194|NCT00906282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25587195|NCT00906347|Misoprostol|misoprostol|mesh-list
25587196|NCT00906347|Oxytocin|oxytocin|mesh-list
25587197|NCT00906347|Oxytocics|oxytocics|mesh-ancestor
25587198|NCT00906347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25587199|NCT00906347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587200|NCT00906347|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25587201|NCT00906347|Abortifacient Agents|abortifacient agents|mesh-ancestor
25587202|NCT00906347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25587203|NCT00906347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25587204|NCT00906373|Sorafenib|sorafenib|mesh-list
25587205|NCT00906373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25587206|NCT00906373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587207|NCT00906373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25587208|NCT00906373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25587209|NCT00906373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728358|NCT01615627|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25587210|NCT00906373|Immunologic Factors|immunologic factors|mesh-ancestor
25587211|NCT00906373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587212|NCT00906399|Interferons|interferons|mesh-list
25587213|NCT00906399|Interferon-beta|interferon-beta|mesh-list
25587214|NCT00906399|Interferon beta-1a|interferon beta-1a|mesh-list
25587215|NCT00906399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587216|NCT00906399|Antiviral Agents|antiviral agents|mesh-ancestor
25587217|NCT00906399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25587218|NCT00906399|Immunologic Factors|immunologic factors|mesh-ancestor
25587219|NCT00906399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587220|NCT00906399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25587221|NCT00906503|Dexamethasone|dexamethasone|mesh-list
25587222|NCT00906503|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25587223|NCT00906503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25587224|NCT00906503|Antiemetics|antiemetics|mesh-ancestor
25587225|NCT00906503|Autonomic Agents|autonomic agents|mesh-ancestor
25587226|NCT00906503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25587227|NCT00906503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587228|NCT00906503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25587229|NCT00906503|Glucocorticoids|glucocorticoids|mesh-ancestor
25587230|NCT00906503|Hormones|hormones|mesh-ancestor
25587231|NCT00906503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25587232|NCT00906503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25587233|NCT00906503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587234|NCT00906503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25587235|NCT00906503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852377|NCT02262455|Doxorubicin|doxorubicin|mesh-list
25587236|NCT00906698|Vinorelbine|vinorelbine|mesh-list
25587237|NCT00906698|Afatinib|afatinib|mesh-list
25587238|NCT00906698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25587239|NCT00906698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587240|NCT00906698|Tubulin Modulators|tubulin modulators|mesh-ancestor
25587241|NCT00906698|Antimitotic Agents|antimitotic agents|mesh-ancestor
25587242|NCT00906698|Mitosis Modulators|mitosis modulators|mesh-ancestor
25587243|NCT00906698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587244|NCT00906698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25587245|NCT00906698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25587246|NCT00906945|Cytarabine|cytarabine|mesh-list
25587247|NCT00906945|Plerixafor|plerixafor|mesh-list
25587248|NCT00906945|Etoposide|etoposide|mesh-list
25587249|NCT00906945|Mitoxantrone|mitoxantrone|mesh-list
25587250|NCT00906945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25587251|NCT00906945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587252|NCT00906945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25587253|NCT00906945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25587254|NCT00906945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25587255|NCT00906945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587256|NCT00906945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25481857|NCT00119106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25587257|NCT00906945|Antimetabolites|antimetabolites|mesh-ancestor
25587258|NCT00906945|Antiviral Agents|antiviral agents|mesh-ancestor
25587259|NCT00906945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25587260|NCT00906945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25587261|NCT00906945|Immunologic Factors|immunologic factors|mesh-ancestor
25587262|NCT00906945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587263|NCT00906945|Analgesics|analgesics|mesh-ancestor
25587264|NCT00906945|Sensory System Agents|sensory system agents|mesh-ancestor
25587265|NCT00906945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25587266|NCT00906945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25587267|NCT00906945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25587268|NCT00907153|Vitamin D|vitamin d|mesh-list
25587269|NCT00907153|Vitamins|vitamins|mesh-ancestor
25587270|NCT00907153|Micronutrients|micronutrients|mesh-ancestor
25587271|NCT00907153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481930|NCT00119379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481931|NCT00119379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25481932|NCT00119379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25481933|NCT00119392|Cyclosporine|cyclosporine|mesh-list
25481934|NCT00119392|Mycophenolic Acid|mycophenolic acid|mesh-list
25481935|NCT00119392|Rituximab|rituximab|mesh-list
25481936|NCT00119392|Fludarabine|fludarabine|mesh-list
25481937|NCT00119392|Fludarabine phosphate|fludarabine phosphate|mesh-list
25481938|NCT00119392|Cyclosporins|cyclosporins|mesh-list
25481939|NCT00119392|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25481940|NCT00119392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25481941|NCT00119392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481942|NCT00119392|Immunologic Factors|immunologic factors|mesh-ancestor
25481943|NCT00119392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852426|NCT02262546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24537308|NCT00654277|Ondansetron|ondansetron|mesh-list
25481944|NCT00119392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25481945|NCT00119392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25481946|NCT00119392|Antimetabolites|antimetabolites|mesh-ancestor
25481947|NCT00119392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481948|NCT00119392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25481949|NCT00119392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481950|NCT00119392|Antifungal Agents|antifungal agents|mesh-ancestor
25481951|NCT00119392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25481952|NCT00119392|Dermatologic Agents|dermatologic agents|mesh-ancestor
25481953|NCT00119392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25481954|NCT00119392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25481955|NCT00119392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25481956|NCT00119392|Antitubercular Agents|antitubercular agents|mesh-ancestor
25481957|NCT00119392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25481958|NCT00119678|Prednisone|prednisone|mesh-list
25481959|NCT00119678|Abatacept|abatacept|mesh-list
25481960|NCT00119678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25587272|NCT00907153|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25587273|NCT00907257|Tretinoin|tretinoin|mesh-list
25587274|NCT00907257|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25587275|NCT00907257|Dermatologic Agents|dermatologic agents|mesh-ancestor
25587276|NCT00907257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587277|NCT00907257|Keratolytic Agents|keratolytic agents|mesh-ancestor
25587278|NCT00907335|Tretinoin|tretinoin|mesh-list
25587279|NCT00907335|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25587280|NCT00907335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587281|NCT00907335|Keratolytic Agents|keratolytic agents|mesh-ancestor
25587282|NCT00907335|Dermatologic Agents|dermatologic agents|mesh-ancestor
25587283|NCT00907374|Benazepril|benazepril|mesh-list
25587284|NCT00907374|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25587285|NCT00907374|Protease Inhibitors|protease inhibitors|mesh-ancestor
25587286|NCT00907374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25587287|NCT00907374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587288|NCT00907374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25587289|NCT00907426|Bimatoprost|bimatoprost|mesh-list
25587290|NCT00907426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25587291|NCT00907426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25587292|NCT00907517|Cytarabine|cytarabine|mesh-list
25587293|NCT00907517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25587294|NCT00907517|Antimetabolites|antimetabolites|mesh-ancestor
25587295|NCT00907517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587296|NCT00907517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587297|NCT00907517|Antiviral Agents|antiviral agents|mesh-ancestor
25587298|NCT00907517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25587299|NCT00907517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25587300|NCT00907517|Immunologic Factors|immunologic factors|mesh-ancestor
25587301|NCT00907517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587302|NCT00907738|Vorinostat|vorinostat|mesh-list
25587303|NCT00907738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587304|NCT00907738|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25587305|NCT00907738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25587306|NCT00907738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587307|NCT00907777|Vaccines|vaccines|mesh-list
25587308|NCT00907777|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25587309|NCT00907777|Immunologic Factors|immunologic factors|mesh-ancestor
25587310|NCT00907777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587311|NCT00908011|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25587312|NCT00908011|Ezetimibe|ezetimibe|mesh-list
25587313|NCT00908011|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25587314|NCT00908011|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25587315|NCT00908011|Antimetabolites|antimetabolites|mesh-ancestor
25587316|NCT00908011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587317|NCT00908011|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25587318|NCT00908011|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25587319|NCT00908011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25587320|NCT00908076|Lubiprostone|lubiprostone|mesh-list
25587321|NCT00908076|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25587322|NCT00908076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25587323|NCT00908076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587324|NCT00908141|Sargramostim|sargramostim|mesh-list
25587325|NCT00908141|Immunologic Factors|immunologic factors|mesh-ancestor
25587326|NCT00908141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587327|NCT00908232|Dexamethasone|dexamethasone|mesh-list
25587328|NCT00908232|Cyclophosphamide|cyclophosphamide|mesh-list
25587329|NCT00908232|Lenalidomide|lenalidomide|mesh-list
25587330|NCT00908232|Bortezomib|bortezomib|mesh-list
25587331|NCT00908232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25587332|NCT00908232|Immunologic Factors|immunologic factors|mesh-ancestor
25587333|NCT00908232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587334|NCT00908232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25587335|NCT00908232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25587336|NCT00908232|Alkylating Agents|alkylating agents|mesh-ancestor
25587337|NCT00908232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587338|NCT00908232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587339|NCT00908232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25587340|NCT00908232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25587341|NCT00908232|Antiemetics|antiemetics|mesh-ancestor
25587342|NCT00908232|Autonomic Agents|autonomic agents|mesh-ancestor
25587343|NCT00908232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25587344|NCT00908232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25587345|NCT00908232|Glucocorticoids|glucocorticoids|mesh-ancestor
25587346|NCT00908232|Hormones|hormones|mesh-ancestor
25587347|NCT00908232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25587348|NCT00908232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25587349|NCT00908232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25587350|NCT00908232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25587351|NCT00908232|Growth Substances|growth substances|mesh-ancestor
25587352|NCT00908232|Growth Inhibitors|growth inhibitors|mesh-ancestor
25587353|NCT00908349|Oxcarbazepine|oxcarbazepine|mesh-list
25587354|NCT00908349|Anticonvulsants|anticonvulsants|mesh-ancestor
25587355|NCT00908349|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25587356|NCT00908349|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25587357|NCT00908349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25587358|NCT00908349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075943|NCT03377101|Palbociclib|palbociclib|mesh-list
24852487|NCT02262611|Diuretics|diuretics|mesh-ancestor
24537907|NCT00656747|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25587359|NCT00908349|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25587360|NCT00908349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25587361|NCT00908375|Pregabalin|pregabalin|mesh-list
25587362|NCT00908375|Analgesics|analgesics|mesh-ancestor
25587363|NCT00908375|Sensory System Agents|sensory system agents|mesh-ancestor
25587364|NCT00908375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25587365|NCT00908375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587366|NCT00908375|Anticonvulsants|anticonvulsants|mesh-ancestor
25587367|NCT00908375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25587368|NCT00908375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25587369|NCT00908375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587370|NCT00908375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25587371|NCT00908375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25587372|NCT00908375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25587373|NCT00908375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25587374|NCT00908375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25587375|NCT00908466|Sirolimus|sirolimus|mesh-list
25587376|NCT00908466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25587377|NCT00908466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25481976|NCT00120289|Niacin|niacin|mesh-list
25587378|NCT00908466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25587379|NCT00908466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587380|NCT00908466|Antifungal Agents|antifungal agents|mesh-ancestor
25587381|NCT00908466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25587382|NCT00908466|Immunologic Factors|immunologic factors|mesh-ancestor
25587383|NCT00908466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587384|NCT00908583|Methylprednisolone|methylprednisolone|mesh-list
25587385|NCT00908583|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24538168|NCT00657774|Hormones|hormones|mesh-ancestor
25587386|NCT00908583|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25587387|NCT00908583|Prednisolone|prednisolone|mesh-list
25587388|NCT00908583|Prednisolone acetate|prednisolone acetate|mesh-list
25587389|NCT00908583|Rituximab|rituximab|mesh-list
25587390|NCT00908583|Bortezomib|bortezomib|mesh-list
25587391|NCT00908583|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25587392|NCT00908583|Prednisolone phosphate|prednisolone phosphate|mesh-list
25587393|NCT00908583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25587394|NCT00908583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587395|NCT00908583|Immunologic Factors|immunologic factors|mesh-ancestor
25587396|NCT00908583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587397|NCT00908583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25587398|NCT00908583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25587399|NCT00908583|Antiemetics|antiemetics|mesh-ancestor
25587400|NCT00908583|Autonomic Agents|autonomic agents|mesh-ancestor
25587401|NCT00908583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25587402|NCT00908583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25587403|NCT00908583|Glucocorticoids|glucocorticoids|mesh-ancestor
25587404|NCT00908583|Hormones|hormones|mesh-ancestor
25587405|NCT00908583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25587406|NCT00908583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25587407|NCT00908583|Protective Agents|protective agents|mesh-ancestor
25587408|NCT00908583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25587409|NCT00908960|Enoxaparin|enoxaparin|mesh-list
25587410|NCT00908960|Anticoagulants|anticoagulants|mesh-ancestor
25587411|NCT00908960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25587412|NCT00908960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25587413|NCT00908960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587414|NCT00909064|PENTA|penta|mesh-list
25587415|NCT00909064|Fondaparinux|fondaparinux|mesh-list
25587416|NCT00909064|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25587417|NCT00909064|Antithrombins|antithrombins|mesh-ancestor
25587418|NCT00909064|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25587419|NCT00909064|Protease Inhibitors|protease inhibitors|mesh-ancestor
25587420|NCT00909064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25587421|NCT00909064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587422|NCT00909064|Anticoagulants|anticoagulants|mesh-ancestor
25587423|NCT00909064|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25587424|NCT00909064|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25587425|NCT00909155|Fluoxetine|fluoxetine|mesh-list
25587426|NCT00909155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25587427|NCT00909155|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25587428|NCT00909155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25587429|NCT00909155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25587430|NCT00909155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587431|NCT00909155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25587432|NCT00909155|Serotonin Agents|serotonin agents|mesh-ancestor
25587433|NCT00909155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587434|NCT00909155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25587435|NCT00909155|Antidepressive Agents|antidepressive agents|mesh-ancestor
25587436|NCT00909155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25587437|NCT00909155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25587438|NCT00909155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25587439|NCT00909155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25587440|NCT00909155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25587441|NCT00909181|Mandelic Acids|mandelic acids|mesh-list
25587442|NCT00909181|Oxybutynin|oxybutynin|mesh-list
25587443|NCT00909181|Parasympatholytics|parasympatholytics|mesh-ancestor
25587444|NCT00909181|Autonomic Agents|autonomic agents|mesh-ancestor
25587445|NCT00909181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25587446|NCT00909181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587447|NCT00909181|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25587448|NCT00909181|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25587449|NCT00909181|Cholinergic Agents|cholinergic agents|mesh-ancestor
25587450|NCT00909181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25587451|NCT00909181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587452|NCT00909181|Urological Agents|urological agents|mesh-ancestor
25587453|NCT00909181|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25587454|NCT00909181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25587455|NCT00909181|Renal Agents|renal agents|mesh-ancestor
25587456|NCT00909428|Solifenacin Succinate|solifenacin succinate|mesh-list
25587457|NCT00909428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25587458|NCT00909428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25587459|NCT00909428|Cholinergic Agents|cholinergic agents|mesh-ancestor
25587460|NCT00909428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25587461|NCT00909428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587462|NCT00909428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587463|NCT00909428|Urological Agents|urological agents|mesh-ancestor
25587464|NCT00909480|Insulin|insulin|mesh-list
25587465|NCT00909480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25587466|NCT00909480|Insulin Glargine|insulin glargine|mesh-list
25587467|NCT00909480|Insulin Detemir|insulin detemir|mesh-list
25587468|NCT00909480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25587469|NCT00909480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740888|NCT01690559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24740889|NCT01690559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25587470|NCT00909532|Ivacaftor|ivacaftor|mesh-list
25587471|NCT00909532|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25587472|NCT00909532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25587473|NCT00909532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587474|NCT00909545|Isradipine|isradipine|mesh-list
25587475|NCT00909545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25587476|NCT00909545|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25587477|NCT00909545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25587478|NCT00909545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587479|NCT00909545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25587480|NCT00909545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587481|NCT00909545|Vasodilator Agents|vasodilator agents|mesh-ancestor
25587482|NCT00909727|Ivacaftor|ivacaftor|mesh-list
25587483|NCT00909727|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25587484|NCT00909727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25587485|NCT00909727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587486|NCT00909779|Formoterol Fumarate|formoterol fumarate|mesh-list
25587487|NCT00909779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25587488|NCT00909779|Autonomic Agents|autonomic agents|mesh-ancestor
25587489|NCT00909779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25587490|NCT00909779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587491|NCT00909779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25587492|NCT00909779|Respiratory System Agents|respiratory system agents|mesh-ancestor
25587493|NCT00909779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25587494|NCT00909779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25587495|NCT00909779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25587496|NCT00909779|Adrenergic Agents|adrenergic agents|mesh-ancestor
25587497|NCT00909779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25587498|NCT00909779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587499|NCT00909844|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25587500|NCT00909844|Luteolytic Agents|luteolytic agents|mesh-ancestor
25587501|NCT00909844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25587502|NCT00909844|Contraceptive Agents|contraceptive agents|mesh-ancestor
25587503|NCT00909844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25587504|NCT00909844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587505|NCT00909844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25587506|NCT00909844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25587507|NCT00909844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587508|NCT00909857|Dienogest|dienogest|mesh-list
25587509|NCT00909857|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25587510|NCT00909857|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25587511|NCT00909857|Levonorgestrel|levonorgestrel|mesh-list
25587512|NCT00909857|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25587513|NCT00909857|Estradiol|estradiol|mesh-list
25587514|NCT00909857|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25587515|NCT00909857|Estrogens|estrogens|mesh-ancestor
25587516|NCT00909857|Hormones|hormones|mesh-ancestor
25587517|NCT00909857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25587518|NCT00909857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587519|NCT00909857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25587520|NCT00909857|Contraceptive Agents|contraceptive agents|mesh-ancestor
25587521|NCT00909857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25587522|NCT00909857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25587523|NCT00909857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25587524|NCT00909857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25587525|NCT00909857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25587526|NCT00909857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25587527|NCT00909857|Hormone Antagonists|hormone antagonists|mesh-ancestor
25587528|NCT00909857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25587529|NCT00909857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587530|NCT00910000|Gemcitabine|gemcitabine|mesh-list
25587531|NCT00910000|Carboplatin|carboplatin|mesh-list
25587532|NCT00910000|Vorinostat|vorinostat|mesh-list
25587533|NCT00910000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587534|NCT00910000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25587535|NCT00910000|Antimetabolites|antimetabolites|mesh-ancestor
25587536|NCT00910000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587537|NCT00910000|Antiviral Agents|antiviral agents|mesh-ancestor
25587538|NCT00910000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25587539|NCT00910000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25587540|NCT00910000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25587541|NCT00910000|Immunologic Factors|immunologic factors|mesh-ancestor
25587542|NCT00910000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587543|NCT00910000|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25587544|NCT00910039|Sunitinib|sunitinib|mesh-list
25587545|NCT00910039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587546|NCT00910039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25587547|NCT00910039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25587548|NCT00910039|Growth Substances|growth substances|mesh-ancestor
25587549|NCT00910039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587550|NCT00910039|Growth Inhibitors|growth inhibitors|mesh-ancestor
25587551|NCT00910039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25587552|NCT00910039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25587553|NCT00910039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587554|NCT00910091|Megestrol|megestrol|mesh-list
25587555|NCT00910091|Megestrol Acetate|megestrol acetate|mesh-list
25587556|NCT00910091|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25587557|NCT00910091|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25587558|NCT00910091|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25587559|NCT00910091|Contraceptive Agents|contraceptive agents|mesh-ancestor
25587560|NCT00910091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25587561|NCT00910091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587562|NCT00910091|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25587563|NCT00910091|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25587564|NCT00910091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25587565|NCT00910091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587566|NCT00910091|Appetite Stimulants|appetite stimulants|mesh-ancestor
25587567|NCT00910091|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25587568|NCT00910208|Morphine|morphine|mesh-list
25587569|NCT00910208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25587570|NCT00910208|Narcotics|narcotics|mesh-ancestor
25587571|NCT00910208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25587572|NCT00910208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587573|NCT00910208|Analgesics|analgesics|mesh-ancestor
25587574|NCT00910208|Sensory System Agents|sensory system agents|mesh-ancestor
25587575|NCT00910208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25587576|NCT00910247|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25587577|NCT00910247|Anticonvulsants|anticonvulsants|mesh-ancestor
25587578|NCT00910247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25587579|NCT00910247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25587580|NCT00910247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25587581|NCT00910247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587582|NCT00910273|Etanercept|etanercept|mesh-list
25587583|NCT00910273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25587584|NCT00910273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25587585|NCT00910273|Analgesics|analgesics|mesh-ancestor
25587586|NCT00910273|Sensory System Agents|sensory system agents|mesh-ancestor
25587587|NCT00910273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25587588|NCT00910273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587589|NCT00910273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25587590|NCT00910273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25587591|NCT00910273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25587592|NCT00910273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25587593|NCT00910273|Immunologic Factors|immunologic factors|mesh-ancestor
25587594|NCT00910299|Clopidogrel|clopidogrel|mesh-list
25587595|NCT00910299|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25587596|NCT00910299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25587597|NCT00910299|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25587598|NCT00910299|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25587599|NCT00910299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25587600|NCT00910299|Purinergic Agents|purinergic agents|mesh-ancestor
25587601|NCT00910299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25587602|NCT00910299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587603|NCT00910299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587604|NCT00910429|Riociguat|riociguat|mesh-list
25587605|NCT00910429|Enzyme Activators|enzyme activators|mesh-ancestor
25587606|NCT00910429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587607|NCT00910520|Botulinum Toxins|botulinum toxins|mesh-list
25587608|NCT00910520|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24451419|NCT00323583|Vitamins|vitamins|mesh-ancestor
25587609|NCT00910520|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25587610|NCT00910520|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25587611|NCT00910520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25587612|NCT00910520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587613|NCT00910520|Cholinergic Agents|cholinergic agents|mesh-ancestor
25587614|NCT00910520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25587615|NCT00910520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587616|NCT00910520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25587617|NCT00910520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25587618|NCT00910624|Ribavirin|ribavirin|mesh-list
25587619|NCT00910624|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25587620|NCT00910624|Antimetabolites|antimetabolites|mesh-ancestor
25587621|NCT00910624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587622|NCT00910624|Antiviral Agents|antiviral agents|mesh-ancestor
25587623|NCT00910624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25587624|NCT00910663|Mycophenolic Acid|mycophenolic acid|mesh-list
25587625|NCT00910663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25587626|NCT00910663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587627|NCT00910663|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25587628|NCT00910663|Antitubercular Agents|antitubercular agents|mesh-ancestor
25587629|NCT00910663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25587630|NCT00910663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25587631|NCT00910663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25587632|NCT00910663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587633|NCT00910689|Propranolol|propranolol|mesh-list
25587634|NCT00910689|Nadolol|nadolol|mesh-list
25587635|NCT00910689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25587636|NCT00910689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25587637|NCT00910689|Adrenergic Agents|adrenergic agents|mesh-ancestor
25587638|NCT00910689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25587639|NCT00910689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587640|NCT00910689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587641|NCT00910689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25587642|NCT00910689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25587643|NCT00910689|Vasodilator Agents|vasodilator agents|mesh-ancestor
25587644|NCT00910689|Sympatholytics|sympatholytics|mesh-ancestor
25587645|NCT00910689|Autonomic Agents|autonomic agents|mesh-ancestor
25587646|NCT00910689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25587647|NCT00910715|Doxycycline|doxycycline|mesh-list
25587648|NCT00910715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25587649|NCT00910715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25587650|NCT00910715|Antimalarials|antimalarials|mesh-ancestor
25587651|NCT00910715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25587652|NCT00910715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25587653|NCT00910845|Botulinum Toxins|botulinum toxins|mesh-list
25587654|NCT00910845|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25587655|NCT00910845|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25587656|NCT00910845|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24743360|NCT04869605|Sensory System Agents|sensory system agents|mesh-ancestor
25587657|NCT00910845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25587658|NCT00910845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587659|NCT00910845|Cholinergic Agents|cholinergic agents|mesh-ancestor
25587660|NCT00910845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25587661|NCT00910845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587662|NCT00910845|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25587663|NCT00910845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25587664|NCT00910858|Lenalidomide|lenalidomide|mesh-list
25587665|NCT00910858|Epoetin Alfa|epoetin alfa|mesh-list
25587666|NCT00910858|Immunologic Factors|immunologic factors|mesh-ancestor
25587667|NCT00910858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587668|NCT00910858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25587669|NCT00910858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25587670|NCT00910858|Growth Substances|growth substances|mesh-ancestor
25587671|NCT00910858|Growth Inhibitors|growth inhibitors|mesh-ancestor
25587672|NCT00910858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587673|NCT00910858|Hematinics|hematinics|mesh-ancestor
25587674|NCT00910871|Bedaquiline|bedaquiline|mesh-list
25587675|NCT00910871|Antitubercular Agents|antitubercular agents|mesh-ancestor
25587676|NCT00910871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25587677|NCT00910871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25587678|NCT00910910|Lenalidomide|lenalidomide|mesh-list
25587679|NCT00910910|Chlorambucil|chlorambucil|mesh-list
25587680|NCT00910910|Immunologic Factors|immunologic factors|mesh-ancestor
25587681|NCT00910910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587682|NCT00910910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25587683|NCT00910910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25587684|NCT00910910|Growth Substances|growth substances|mesh-ancestor
25587685|NCT00910910|Growth Inhibitors|growth inhibitors|mesh-ancestor
25587686|NCT00910910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587687|NCT00910910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25587688|NCT00910910|Alkylating Agents|alkylating agents|mesh-ancestor
25587689|NCT00910910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587690|NCT00910988|Olanzapine|olanzapine|mesh-list
25587691|NCT00910988|Ziprasidone|ziprasidone|mesh-list
25587692|NCT00910988|Antiemetics|antiemetics|mesh-ancestor
25587693|NCT00910988|Autonomic Agents|autonomic agents|mesh-ancestor
25587694|NCT00910988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25587695|NCT00910988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587696|NCT00910988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25587697|NCT00910988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25587698|NCT00910988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25587699|NCT00910988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25587700|NCT00910988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25587701|NCT00910988|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25587702|NCT00910988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25587703|NCT00910988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25587704|NCT00910988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587705|NCT00910988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25587706|NCT00910988|Serotonin Agents|serotonin agents|mesh-ancestor
25587707|NCT00910988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25587708|NCT00910988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25587709|NCT00910988|Dopamine Agents|dopamine agents|mesh-ancestor
25587710|NCT00911144|Vaccines|vaccines|mesh-list
25587711|NCT00911144|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25587712|NCT00911144|Immunologic Factors|immunologic factors|mesh-ancestor
25587713|NCT00911144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587714|NCT00911157|Heparin|heparin|mesh-list
25587715|NCT00911157|Calcium heparin|calcium heparin|mesh-list
25587716|NCT00911157|PENTA|penta|mesh-list
25587717|NCT00911157|Fondaparinux|fondaparinux|mesh-list
25587718|NCT00911157|Anticoagulants|anticoagulants|mesh-ancestor
25587719|NCT00911157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25587720|NCT00911157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25587721|NCT00911157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587722|NCT00911157|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25587723|NCT00911157|Antithrombins|antithrombins|mesh-ancestor
25587724|NCT00911157|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25587725|NCT00911157|Protease Inhibitors|protease inhibitors|mesh-ancestor
25587726|NCT00911157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25587727|NCT00911170|Bevacizumab|bevacizumab|mesh-list
25587728|NCT00911170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25587729|NCT00911170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587730|NCT00911170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25587731|NCT00911170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25587732|NCT00911170|Growth Substances|growth substances|mesh-ancestor
25587733|NCT00911170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587734|NCT00911170|Growth Inhibitors|growth inhibitors|mesh-ancestor
25587735|NCT00911300|Vitamin K|vitamin k|mesh-list
25587736|NCT00911300|Heparin|heparin|mesh-list
25587737|NCT00911300|Calcium heparin|calcium heparin|mesh-list
25587738|NCT00911300|PENTA|penta|mesh-list
25587739|NCT00911300|Fondaparinux|fondaparinux|mesh-list
25587740|NCT00911300|Vitamins|vitamins|mesh-ancestor
25587741|NCT00911300|Micronutrients|micronutrients|mesh-ancestor
25587742|NCT00911300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587743|NCT00911300|Anticoagulants|anticoagulants|mesh-ancestor
25587744|NCT00911300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25587745|NCT00911300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25587746|NCT00911300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587747|NCT00911300|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25587748|NCT00911300|Hemostatics|hemostatics|mesh-ancestor
25587749|NCT00911300|Coagulants|coagulants|mesh-ancestor
25587750|NCT00911300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25587751|NCT00911300|Antithrombins|antithrombins|mesh-ancestor
25587752|NCT00911300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25587753|NCT00911300|Protease Inhibitors|protease inhibitors|mesh-ancestor
25587754|NCT00911300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25587755|NCT00911326|Dextrans|dextrans|mesh-list
25587756|NCT00911326|Technetium Tc 99m Pentetate|technetium tc 99m pentetate|mesh-list
25587757|NCT00911326|Anticoagulants|anticoagulants|mesh-ancestor
25587758|NCT00911326|Plasma Substitutes|plasma substitutes|mesh-ancestor
25587759|NCT00911326|Blood Substitutes|blood substitutes|mesh-ancestor
25587760|NCT00911326|Chelating Agents|chelating agents|mesh-ancestor
25587761|NCT00911326|Sequestering Agents|sequestering agents|mesh-ancestor
25587762|NCT00911326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587763|NCT00911326|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25587764|NCT00911534|Rabeprazole|rabeprazole|mesh-list
25587765|NCT00911534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25587766|NCT00911534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25587767|NCT00911534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25587768|NCT00911534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25587769|NCT00911534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587770|NCT00911586|Methyltestosterone|methyltestosterone|mesh-list
25587771|NCT00911586|Testosterone|testosterone|mesh-list
25587772|NCT00911586|Testosterone undecanoate|testosterone undecanoate|mesh-list
25587773|NCT00911586|Testosterone enanthate|testosterone enanthate|mesh-list
25587774|NCT00911586|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25587775|NCT00911586|Androgens|androgens|mesh-ancestor
25587776|NCT00911586|Hormones|hormones|mesh-ancestor
25587777|NCT00911586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25587778|NCT00911586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587779|NCT00911586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25587780|NCT00911586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587781|NCT00911586|Anabolic Agents|anabolic agents|mesh-ancestor
25587782|NCT00911612|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
25587783|NCT00911612|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25587784|NCT00911612|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25587785|NCT00911612|Antimetabolites|antimetabolites|mesh-ancestor
25587786|NCT00911612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587787|NCT00911612|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25587788|NCT00911625|Insulin|insulin|mesh-list
25587789|NCT00911625|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25587790|NCT00911625|Insulin Glargine|insulin glargine|mesh-list
25587791|NCT00911625|Insulin glulisine|insulin glulisine|mesh-list
25587792|NCT00911625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25587793|NCT00911625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587794|NCT00911742|Tramadol|tramadol|mesh-list
25587795|NCT00911742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25587796|NCT00911742|Narcotics|narcotics|mesh-ancestor
25587797|NCT00911742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25587798|NCT00911742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587799|NCT00911742|Analgesics|analgesics|mesh-ancestor
25587800|NCT00911742|Sensory System Agents|sensory system agents|mesh-ancestor
25587801|NCT00911742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25587802|NCT00911807|Cerebrolysin|cerebrolysin|mesh-list
25587803|NCT00911807|Donepezil|donepezil|mesh-list
25587804|NCT00911807|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25587805|NCT00911807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25587806|NCT00911807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587807|NCT00911807|Cholinergic Agents|cholinergic agents|mesh-ancestor
25587808|NCT00911807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25587809|NCT00911807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587810|NCT00911807|Nootropic Agents|nootropic agents|mesh-ancestor
25587811|NCT00911807|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25587812|NCT00911807|Protective Agents|protective agents|mesh-ancestor
25653230|NCT01535924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653231|NCT01535924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25653232|NCT01535924|Antiviral Agents|antiviral agents|mesh-ancestor
25653233|NCT01535924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25653234|NCT01535924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653235|NCT01535924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25653236|NCT01535924|Immunologic Factors|immunologic factors|mesh-ancestor
24745668|NCT03651102|Immunologic Factors|immunologic factors|mesh-ancestor
25653237|NCT01535924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653238|NCT01535924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25653239|NCT01535924|Alkylating Agents|alkylating agents|mesh-ancestor
25653240|NCT01535937|Midazolam|midazolam|mesh-list
25653241|NCT01535937|Ketamine|ketamine|mesh-list
25482415|NCT00124579|Hormones|hormones|mesh-ancestor
25653242|NCT01535937|Analgesics|analgesics|mesh-ancestor
25653243|NCT01535937|Sensory System Agents|sensory system agents|mesh-ancestor
25653244|NCT01535937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653245|NCT01535937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587813|NCT00911820|Bevacizumab|bevacizumab|mesh-list
25587814|NCT00911820|Cisplatin|cisplatin|mesh-list
25587815|NCT00911820|Docetaxel|docetaxel|mesh-list
25587816|NCT00911820|Irinotecan|irinotecan|mesh-list
25587817|NCT00911820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25587818|NCT00911820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587819|NCT00911820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25587820|NCT00911820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25587821|NCT00911820|Growth Substances|growth substances|mesh-ancestor
25587822|NCT00911820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587823|NCT00911820|Growth Inhibitors|growth inhibitors|mesh-ancestor
25587824|NCT00911820|Tubulin Modulators|tubulin modulators|mesh-ancestor
25587825|NCT00911820|Antimitotic Agents|antimitotic agents|mesh-ancestor
25587826|NCT00911820|Mitosis Modulators|mitosis modulators|mesh-ancestor
25587827|NCT00911820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587828|NCT00911820|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25587829|NCT00911820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25587830|NCT00911820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25587831|NCT00911859|Prednisone|prednisone|mesh-list
25587832|NCT00911859|Bortezomib|bortezomib|mesh-list
25587833|NCT00911859|Melphalan|melphalan|mesh-list
25587834|NCT00911859|Siltuximab|siltuximab|mesh-list
25587835|NCT00911859|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25587836|NCT00911859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25587837|NCT00911859|Glucocorticoids|glucocorticoids|mesh-ancestor
25587838|NCT00911859|Hormones|hormones|mesh-ancestor
25587839|NCT00911859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25587840|NCT00911859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587841|NCT00911859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25587842|NCT00911859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587843|NCT00911859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25587844|NCT00911859|Alkylating Agents|alkylating agents|mesh-ancestor
25587845|NCT00911859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587846|NCT00911859|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25587847|NCT00911859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25587848|NCT00911859|Immunologic Factors|immunologic factors|mesh-ancestor
25587849|NCT00911937|Fesoterodine|fesoterodine|mesh-list
25587850|NCT00911937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25587851|NCT00911937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25587852|NCT00911937|Cholinergic Agents|cholinergic agents|mesh-ancestor
25587853|NCT00911937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24747693|NCT03178487|Upadacitinib|upadacitinib|mesh-list
25587854|NCT00911937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587855|NCT00911937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587856|NCT00911937|Urological Agents|urological agents|mesh-ancestor
25587857|NCT00912015|Tramadol|tramadol|mesh-list
25587858|NCT00912015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25587859|NCT00912015|Narcotics|narcotics|mesh-ancestor
25587860|NCT00912015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25587861|NCT00912015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587862|NCT00912015|Analgesics|analgesics|mesh-ancestor
25587863|NCT00912015|Sensory System Agents|sensory system agents|mesh-ancestor
25587864|NCT00912015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25587865|NCT00912093|Icatibant|icatibant|mesh-list
25587866|NCT00912093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25587867|NCT00912093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25587868|NCT00912093|Analgesics|analgesics|mesh-ancestor
25587869|NCT00912093|Sensory System Agents|sensory system agents|mesh-ancestor
25587870|NCT00912093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25587871|NCT00912093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587872|NCT00912093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25587873|NCT00912093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25587874|NCT00912093|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
25587875|NCT00912093|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
25587876|NCT00912093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587877|NCT00912093|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25587878|NCT00912093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25587879|NCT00912093|Immunologic Factors|immunologic factors|mesh-ancestor
25587880|NCT00912301|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
25587881|NCT00912301|Cathartics|cathartics|mesh-ancestor
25587882|NCT00912301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25587883|NCT00912340|Trastuzumab|trastuzumab|mesh-list
25587884|NCT00912340|Everolimus|everolimus|mesh-list
25587885|NCT00912340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25587886|NCT00912340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587887|NCT00912340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25587888|NCT00912340|Immunologic Factors|immunologic factors|mesh-ancestor
25587889|NCT00912340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587890|NCT00912509|Riboflavin|riboflavin|mesh-list
25587891|NCT00912509|Vitamin B Complex|vitamin b complex|mesh-ancestor
25587892|NCT00912509|Vitamins|vitamins|mesh-ancestor
25587893|NCT00912509|Micronutrients|micronutrients|mesh-ancestor
25587894|NCT00912509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587895|NCT00912509|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25587896|NCT00912509|Dermatologic Agents|dermatologic agents|mesh-ancestor
25587897|NCT00912743|Olaparib|olaparib|mesh-list
25587898|NCT00912743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25587899|NCT00912743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25587900|NCT00912743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587901|NCT00912743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587902|NCT00912782|Vitamin D|vitamin d|mesh-list
25587903|NCT00912782|Cholecalciferol|cholecalciferol|mesh-list
25587904|NCT00912782|Vitamins|vitamins|mesh-ancestor
25587905|NCT00912782|Micronutrients|micronutrients|mesh-ancestor
25587906|NCT00912782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587907|NCT00912782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25587908|NCT00912782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25587909|NCT00912808|Donepezil|donepezil|mesh-list
25587910|NCT00912808|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25587911|NCT00912808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25587912|NCT00912808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587913|NCT00912808|Cholinergic Agents|cholinergic agents|mesh-ancestor
25587914|NCT00912808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25587915|NCT00912808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587916|NCT00912808|Nootropic Agents|nootropic agents|mesh-ancestor
25587917|NCT00912873|Ropivacaine|ropivacaine|mesh-list
25587918|NCT00912873|Anesthetics, Local|anesthetics, local|mesh-ancestor
25587919|NCT00912873|Anesthetics|anesthetics|mesh-ancestor
25587920|NCT00912873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25587921|NCT00912873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587922|NCT00912873|Sensory System Agents|sensory system agents|mesh-ancestor
25587923|NCT00912873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25587924|NCT00912912|Sunitinib|sunitinib|mesh-list
25587925|NCT00912912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587926|NCT00912912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25587927|NCT00912912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25587928|NCT00912912|Growth Substances|growth substances|mesh-ancestor
25587929|NCT00912912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587930|NCT00912912|Growth Inhibitors|growth inhibitors|mesh-ancestor
25587931|NCT00912912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25587932|NCT00912912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25587933|NCT00912912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587934|NCT00912964|Mirabegron|mirabegron|mesh-list
25587935|NCT00912964|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25587936|NCT00912964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25587937|NCT00912964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25587938|NCT00912964|Adrenergic Agents|adrenergic agents|mesh-ancestor
25587939|NCT00912964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25587940|NCT00912964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587941|NCT00912964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587942|NCT00912964|Urological Agents|urological agents|mesh-ancestor
25587943|NCT00912990|Cisatracurium|cisatracurium|mesh-list
25587944|NCT00912990|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25587945|NCT00912990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25587946|NCT00912990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25587947|NCT00912990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587948|NCT00913003|Lidocaine|lidocaine|mesh-list
25587949|NCT00913003|Anesthetics, Local|anesthetics, local|mesh-ancestor
25587950|NCT00913003|Anesthetics|anesthetics|mesh-ancestor
25587951|NCT00913003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25587952|NCT00913003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587953|NCT00913003|Sensory System Agents|sensory system agents|mesh-ancestor
25587954|NCT00913003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25587955|NCT00913003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25587956|NCT00913003|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25587957|NCT00913003|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25587958|NCT00913003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25587959|NCT00913003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587960|NCT00913068|Lidocaine|lidocaine|mesh-list
25587961|NCT00913068|Ropivacaine|ropivacaine|mesh-list
25587962|NCT00913068|Anesthetics, Local|anesthetics, local|mesh-ancestor
25587963|NCT00913068|Anesthetics|anesthetics|mesh-ancestor
25587964|NCT00913068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25587965|NCT00913068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587966|NCT00913068|Sensory System Agents|sensory system agents|mesh-ancestor
25587967|NCT00913068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25587968|NCT00913068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25587969|NCT00913068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25587970|NCT00913068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25587971|NCT00913068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25587972|NCT00913068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587973|NCT00913081|Quercetin|quercetin|mesh-list
25587974|NCT00913081|Antioxidants|antioxidants|mesh-ancestor
25587975|NCT00913081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587976|NCT00913081|Protective Agents|protective agents|mesh-ancestor
25587977|NCT00913081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587978|NCT00913133|Desirudin|desirudin|mesh-list
25587979|NCT00913133|Anticoagulants|anticoagulants|mesh-ancestor
25587980|NCT00913133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25587981|NCT00913133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25587982|NCT00913133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25587983|NCT00913263|Flutamide|flutamide|mesh-list
25587984|NCT00913263|Hydroxyflutamide|hydroxyflutamide|mesh-list
25587985|NCT00913263|Androgen Antagonists|androgen antagonists|mesh-ancestor
25587986|NCT00913263|Hormone Antagonists|hormone antagonists|mesh-ancestor
25587987|NCT00913263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25587988|NCT00913263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587989|NCT00913263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25587990|NCT00913263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587991|NCT00913458|Etanercept|etanercept|mesh-list
25587992|NCT00913458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25587993|NCT00913458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25587994|NCT00913458|Analgesics|analgesics|mesh-ancestor
25587995|NCT00913458|Sensory System Agents|sensory system agents|mesh-ancestor
24539074|NCT00662233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25587996|NCT00913458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25587997|NCT00913458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25587998|NCT00913458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25587999|NCT00913458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25588000|NCT00913458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25588001|NCT00913458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25588002|NCT00913458|Immunologic Factors|immunologic factors|mesh-ancestor
25588003|NCT00913510|Cholinergic Antagonists|cholinergic antagonists|mesh-list
25588004|NCT00913510|Cholinergic Agents|cholinergic agents|mesh-ancestor
25588005|NCT00913510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25588006|NCT00913510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588007|NCT00913510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588008|NCT00913627|Ibuprofen|ibuprofen|mesh-list
25588009|NCT00913627|Naproxen|naproxen|mesh-list
25588010|NCT00913627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25588011|NCT00913627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25588012|NCT00913627|Analgesics|analgesics|mesh-ancestor
25588013|NCT00913627|Sensory System Agents|sensory system agents|mesh-ancestor
25588014|NCT00913627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25588015|NCT00913627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588016|NCT00913627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25588017|NCT00913627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25588018|NCT00913627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25588019|NCT00913627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588020|NCT00913627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588021|NCT00913627|Gout Suppressants|gout suppressants|mesh-ancestor
25588022|NCT00913770|Buprenorphine|buprenorphine|mesh-list
25588023|NCT00913770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25588024|NCT00913770|Narcotics|narcotics|mesh-ancestor
25588025|NCT00913770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25588026|NCT00913770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588027|NCT00913770|Analgesics|analgesics|mesh-ancestor
25588028|NCT00913770|Sensory System Agents|sensory system agents|mesh-ancestor
25588029|NCT00913770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25588030|NCT00913770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25588031|NCT00913835|Doxorubicin|doxorubicin|mesh-list
25588032|NCT00913835|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25588033|NCT00913835|Olaratumab|olaratumab|mesh-list
25588034|NCT00913835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25482627|NCT00126438|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24506319|NCT00544609|Sorafenib|sorafenib|mesh-list
25482628|NCT00126438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482632|NCT00126490|Aldesleukin|aldesleukin|mesh-list
25588035|NCT00913835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588036|NCT00913835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25588037|NCT00913835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25588038|NCT00913835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588039|NCT00913835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588040|NCT00913913|Bevacizumab|bevacizumab|mesh-list
25588041|NCT00913913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25588042|NCT00913913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588043|NCT00913913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25588044|NCT00913913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25588045|NCT00913913|Growth Substances|growth substances|mesh-ancestor
25588046|NCT00913913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588047|NCT00913913|Growth Inhibitors|growth inhibitors|mesh-ancestor
25588048|NCT00914316|Ranolazine|ranolazine|mesh-list
25588049|NCT00914316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25588050|NCT00914316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25588051|NCT00914316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588052|NCT00914459|Factor VIII|factor viii|mesh-list
25588053|NCT00914459|Coagulants|coagulants|mesh-ancestor
25588054|NCT00914732|Vaccines|vaccines|mesh-list
25588055|NCT00914732|Immunologic Factors|immunologic factors|mesh-ancestor
25588056|NCT00914732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588057|NCT00914810|Vitamin D|vitamin d|mesh-list
25588058|NCT00914810|Cholecalciferol|cholecalciferol|mesh-list
25588059|NCT00914810|Vitamins|vitamins|mesh-ancestor
25588060|NCT00914810|Micronutrients|micronutrients|mesh-ancestor
25588061|NCT00914810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588062|NCT00914810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25588063|NCT00914810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25588064|NCT00914849|Plerixafor|plerixafor|mesh-list
25588065|NCT00914849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25588066|NCT00914849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25588067|NCT00914849|Antiviral Agents|antiviral agents|mesh-ancestor
25588068|NCT00914849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25588069|NCT00914940|Fludarabine|fludarabine|mesh-list
25588070|NCT00914940|Fludarabine phosphate|fludarabine phosphate|mesh-list
25588071|NCT00914940|Thiotepa|thiotepa|mesh-list
25588072|NCT00914940|Tacrolimus|tacrolimus|mesh-list
25588073|NCT00914940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588074|NCT00914940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25588075|NCT00914940|Antimetabolites|antimetabolites|mesh-ancestor
25588076|NCT00914940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588077|NCT00914940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25588078|NCT00914940|Immunologic Factors|immunologic factors|mesh-ancestor
25588079|NCT00914940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588080|NCT00914940|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25588081|NCT00914940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588082|NCT00914940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25588083|NCT00914940|Alkylating Agents|alkylating agents|mesh-ancestor
25588084|NCT00914940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25588085|NCT00914966|Complement C1s|complement c1s|mesh-list
25588086|NCT00914966|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25588087|NCT00914966|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
25588088|NCT00914966|Immunologic Factors|immunologic factors|mesh-ancestor
25588089|NCT00914966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588090|NCT00914966|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25588091|NCT00914966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25588092|NCT00915005|Paclitaxel|paclitaxel|mesh-list
25588093|NCT00915005|Carboplatin|carboplatin|mesh-list
25588094|NCT00915005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25588095|NCT00915005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588096|NCT00915005|Tubulin Modulators|tubulin modulators|mesh-ancestor
25588097|NCT00915005|Antimitotic Agents|antimitotic agents|mesh-ancestor
25588098|NCT00915005|Mitosis Modulators|mitosis modulators|mesh-ancestor
25588099|NCT00915005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588100|NCT00915018|Paclitaxel|paclitaxel|mesh-list
25588101|NCT00915018|Trastuzumab|trastuzumab|mesh-list
25588102|NCT00915018|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25588103|NCT00915018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25588104|NCT00915018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482701|NCT00126594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482702|NCT00127036|Bevacizumab|bevacizumab|mesh-list
25482703|NCT00127036|Capecitabine|capecitabine|mesh-list
25588105|NCT00915018|Tubulin Modulators|tubulin modulators|mesh-ancestor
25482704|NCT00127036|Oxaliplatin|oxaliplatin|mesh-list
25588106|NCT00915018|Antimitotic Agents|antimitotic agents|mesh-ancestor
25588107|NCT00915018|Mitosis Modulators|mitosis modulators|mesh-ancestor
25822730|NCT00004585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25822731|NCT00004585|Antimetabolites|antimetabolites|mesh-ancestor
25822732|NCT00004585|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24507119|NCT00548821|Cisplatin|cisplatin|mesh-list
25588108|NCT00915018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482773|NCT00127218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25482774|NCT00127218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25482775|NCT00127218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482776|NCT00127218|Vasodilator Agents|vasodilator agents|mesh-ancestor
25482777|NCT00127218|Vitamin B Complex|vitamin b complex|mesh-ancestor
25482779|NCT00127218|Micronutrients|micronutrients|mesh-ancestor
25482780|NCT00127218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482781|NCT00127530|4-Aminopyridine|4-aminopyridine|mesh-list
25482782|NCT00127530|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25482783|NCT00127530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25482784|NCT00127530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979633|NCT03386214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979647|NCT03369665|Immunologic Factors|immunologic factors|mesh-ancestor
24979648|NCT03369665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979650|NCT03220178|Fulvestrant|fulvestrant|mesh-list
24979651|NCT03220178|Palbociclib|palbociclib|mesh-list
24979652|NCT03220178|Anastrozole|anastrozole|mesh-list
24979653|NCT03220178|Exemestane|exemestane|mesh-list
24979654|NCT03220178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979655|NCT03220178|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24979656|NCT03220178|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24979657|NCT03220178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24979658|NCT03220178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433442|NCT00258336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24433443|NCT00258375|Docetaxel|docetaxel|mesh-list
24433444|NCT00258375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433445|NCT00258375|Tubulin Modulators|tubulin modulators|mesh-ancestor
24433446|NCT00258375|Antimitotic Agents|antimitotic agents|mesh-ancestor
24433461|NCT00258388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24433463|NCT00258479|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24433464|NCT00258479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433474|NCT00258557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433475|NCT00258557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24433476|NCT00258557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24433477|NCT00258557|Antiviral Agents|antiviral agents|mesh-ancestor
24979659|NCT03220178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24979660|NCT03220178|Hormone Antagonists|hormone antagonists|mesh-ancestor
24979661|NCT03220178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24979662|NCT03220178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979663|NCT03220178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24979664|NCT03220178|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24979665|NCT03220178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24979667|NCT03034356|Anticonvulsants|anticonvulsants|mesh-ancestor
24979668|NCT03034356|Nootropic Agents|nootropic agents|mesh-ancestor
24979669|NCT03032510|Levofloxacin|levofloxacin|mesh-list
24979672|NCT03032510|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24979673|NCT03032510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24979674|NCT03032510|Renal Agents|renal agents|mesh-ancestor
24979675|NCT03032510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24979676|NCT03032510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24507131|NCT00548938|Temozolomide|temozolomide|mesh-list
24979677|NCT03032510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24979679|NCT03032510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588109|NCT00915018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25588110|NCT00915343|Hydrocortisone|hydrocortisone|mesh-list
25588111|NCT00915343|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25588112|NCT00915343|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25588113|NCT00915343|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25588114|NCT00915343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25588115|NCT00915473|Methylprednisolone|methylprednisolone|mesh-list
25588116|NCT00915473|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25588117|NCT00915473|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25588118|NCT00915473|Prednisolone|prednisolone|mesh-list
25588119|NCT00915473|Prednisolone acetate|prednisolone acetate|mesh-list
25588120|NCT00915473|Lidocaine|lidocaine|mesh-list
25588121|NCT00915473|Bupivacaine|bupivacaine|mesh-list
25588122|NCT00915473|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25588123|NCT00915473|Prednisolone phosphate|prednisolone phosphate|mesh-list
25588124|NCT00915473|Anesthetics, Local|anesthetics, local|mesh-ancestor
25588125|NCT00915473|Anesthetics|anesthetics|mesh-ancestor
25588126|NCT00915473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25588127|NCT00915473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588128|NCT00915473|Sensory System Agents|sensory system agents|mesh-ancestor
25588129|NCT00915473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25588130|NCT00915473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25588131|NCT00915473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25588132|NCT00915473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25588133|NCT00915473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25588134|NCT00915473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588135|NCT00915473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25588136|NCT00915473|Antiemetics|antiemetics|mesh-ancestor
25588137|NCT00915473|Autonomic Agents|autonomic agents|mesh-ancestor
25588138|NCT00915473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25588139|NCT00915473|Glucocorticoids|glucocorticoids|mesh-ancestor
25588140|NCT00915473|Hormones|hormones|mesh-ancestor
25588141|NCT00915473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25588142|NCT00915473|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25588143|NCT00915473|Protective Agents|protective agents|mesh-ancestor
25588144|NCT00915473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25588145|NCT00915473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588146|NCT00915525|Botulinum Toxins|botulinum toxins|mesh-list
25588147|NCT00915525|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25588148|NCT00915525|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25588149|NCT00915525|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25588150|NCT00915525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25588151|NCT00915525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588152|NCT00915525|Cholinergic Agents|cholinergic agents|mesh-ancestor
25588153|NCT00915525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25588154|NCT00915525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588155|NCT00915525|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25588156|NCT00915525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25588157|NCT00915538|Budesonide|budesonide|mesh-list
25588158|NCT00915538|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25588159|NCT00915538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25588160|NCT00915538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25588161|NCT00915538|Autonomic Agents|autonomic agents|mesh-ancestor
25588162|NCT00915538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25588163|NCT00915538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588164|NCT00915538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25588165|NCT00915538|Respiratory System Agents|respiratory system agents|mesh-ancestor
25588166|NCT00915538|Glucocorticoids|glucocorticoids|mesh-ancestor
25588167|NCT00915538|Hormones|hormones|mesh-ancestor
25588168|NCT00915538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25588169|NCT00915590|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25588170|NCT00915590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25588171|NCT00915603|Paclitaxel|paclitaxel|mesh-list
25588172|NCT00915603|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25588173|NCT00915603|Bevacizumab|bevacizumab|mesh-list
25588174|NCT00915603|Everolimus|everolimus|mesh-list
25588175|NCT00915603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25588176|NCT00915603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588177|NCT00915603|Tubulin Modulators|tubulin modulators|mesh-ancestor
25588178|NCT00915603|Antimitotic Agents|antimitotic agents|mesh-ancestor
25588179|NCT00915603|Mitosis Modulators|mitosis modulators|mesh-ancestor
25588180|NCT00915603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588181|NCT00915603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25588182|NCT00915603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25588183|NCT00915603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25588184|NCT00915603|Growth Substances|growth substances|mesh-ancestor
25588185|NCT00915603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588186|NCT00915603|Growth Inhibitors|growth inhibitors|mesh-ancestor
25588187|NCT00915603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25588188|NCT00915603|Immunologic Factors|immunologic factors|mesh-ancestor
25588189|NCT00915655|Ritonavir|ritonavir|mesh-list
25588190|NCT00915655|Darunavir|darunavir|mesh-list
25588191|NCT00915655|Lamivudine|lamivudine|mesh-list
25588192|NCT00915655|Zidovudine|zidovudine|mesh-list
25588193|NCT00915655|Abacavir|abacavir|mesh-list
25588194|NCT00915655|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25588195|NCT00915655|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25588196|NCT00915655|Protease Inhibitors|protease inhibitors|mesh-ancestor
25588197|NCT00915655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588198|NCT00915655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588200|NCT00915655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25704817|NCT02188719|Ganciclovir|ganciclovir|mesh-list
25704818|NCT02188719|Anti-Infective Agents|anti-infective agents|mesh-list
25588201|NCT00915655|Antiviral Agents|antiviral agents|mesh-ancestor
25588202|NCT00915655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25588203|NCT00915655|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25588204|NCT00915655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25588205|NCT00915655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25588206|NCT00915655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25588207|NCT00915655|Antimetabolites|antimetabolites|mesh-ancestor
25588208|NCT00915772|Metformin|metformin|mesh-list
25588209|NCT00915772|Linagliptin|linagliptin|mesh-list
25588210|NCT00915772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25588211|NCT00915772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588212|NCT00915772|Incretins|incretins|mesh-ancestor
25588213|NCT00915772|Hormones|hormones|mesh-ancestor
25588214|NCT00915772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25588215|NCT00915772|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25588216|NCT00915772|Protease Inhibitors|protease inhibitors|mesh-ancestor
25588217|NCT00915772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588218|NCT00915772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588219|NCT00915928|Perindopril|perindopril|mesh-list
25588220|NCT00915928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25588221|NCT00915928|Protease Inhibitors|protease inhibitors|mesh-ancestor
25588222|NCT00915928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588223|NCT00915928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588224|NCT00915928|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25588225|NCT00915967|Vancomycin|vancomycin|mesh-list
25588226|NCT00915967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25588227|NCT00915967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25588228|NCT00916032|Factor VIII|factor viii|mesh-list
25588229|NCT00916032|Coagulants|coagulants|mesh-ancestor
25588230|NCT00916058|Melphalan|melphalan|mesh-list
25588231|NCT00916058|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25588232|NCT00916058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25588233|NCT00916058|Alkylating Agents|alkylating agents|mesh-ancestor
25588234|NCT00916058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588235|NCT00916058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588236|NCT00916058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25588237|NCT00916058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25588238|NCT00916058|Immunologic Factors|immunologic factors|mesh-ancestor
25588239|NCT00916058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588240|NCT00916149|Lamotrigine|lamotrigine|mesh-list
25588241|NCT00916149|Levetiracetam|levetiracetam|mesh-list
25588242|NCT00916149|Anticonvulsants|anticonvulsants|mesh-ancestor
25588243|NCT00916149|Nootropic Agents|nootropic agents|mesh-ancestor
25588244|NCT00916149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25588245|NCT00916149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25588246|NCT00916149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588247|NCT00916149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25588248|NCT00916149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588249|NCT00916149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25588250|NCT00916149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25588251|NCT00916149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25588252|NCT00916149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25588253|NCT00916149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25588254|NCT00916279|Paclitaxel|paclitaxel|mesh-list
24509132|NCT00558662|Ionophores|ionophores|mesh-ancestor
25588255|NCT00916279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25588256|NCT00916279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588257|NCT00916279|Tubulin Modulators|tubulin modulators|mesh-ancestor
25588258|NCT00916279|Antimitotic Agents|antimitotic agents|mesh-ancestor
25588259|NCT00916279|Mitosis Modulators|mitosis modulators|mesh-ancestor
25588260|NCT00916279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588261|NCT00916357|Insulin|insulin|mesh-list
25588262|NCT00916357|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25588263|NCT00916357|Insulin Lispro|insulin lispro|mesh-list
25588264|NCT00916357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25588265|NCT00916357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588266|NCT00916383|Donepezil|donepezil|mesh-list
25588267|NCT00916383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25588268|NCT00916383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588269|NCT00916383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588270|NCT00916383|Cholinergic Agents|cholinergic agents|mesh-ancestor
25588271|NCT00916383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25482873|NCT00128401|Cycloserine|cycloserine|mesh-list
25588272|NCT00916383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588273|NCT00916383|Nootropic Agents|nootropic agents|mesh-ancestor
25588274|NCT00916539|Calpastatin|calpastatin|mesh-list
25588275|NCT00916539|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25588276|NCT00916539|Protease Inhibitors|protease inhibitors|mesh-ancestor
25588277|NCT00916539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588278|NCT00916539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588279|NCT00916578|Capecitabine|capecitabine|mesh-list
25588280|NCT00916578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25588281|NCT00916578|Antimetabolites|antimetabolites|mesh-ancestor
25588282|NCT00916578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588283|NCT00916578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588284|NCT00916721|Propranolol|propranolol|mesh-list
25588285|NCT00916721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25588286|NCT00916721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25588287|NCT00916721|Adrenergic Agents|adrenergic agents|mesh-ancestor
25588288|NCT00916721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25588289|NCT00916721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588290|NCT00916721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588291|NCT00916721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25588292|NCT00916721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25588293|NCT00916721|Vasodilator Agents|vasodilator agents|mesh-ancestor
25588294|NCT00917267|Exenatide|exenatide|mesh-list
25588295|NCT00917267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25588296|NCT00917267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588297|NCT00917267|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25588298|NCT00917267|Incretins|incretins|mesh-ancestor
25588299|NCT00917267|Hormones|hormones|mesh-ancestor
25588300|NCT00917267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25588301|NCT00917384|Ramucirumab|ramucirumab|mesh-list
25588302|NCT00917384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588303|NCT00917462|Sorafenib|sorafenib|mesh-list
25588304|NCT00917462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588305|NCT00917462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25588306|NCT00917462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588307|NCT00917462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588308|NCT00917553|Doxycycline|doxycycline|mesh-list
25588309|NCT00917553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25588310|NCT00917553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25588311|NCT00917553|Antimalarials|antimalarials|mesh-ancestor
25588312|NCT00917553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25588313|NCT00917553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25653246|NCT01535937|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25653247|NCT01535937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25653248|NCT01535937|Anesthetics, General|anesthetics, general|mesh-ancestor
25653249|NCT01535937|Anesthetics|anesthetics|mesh-ancestor
25653250|NCT01535937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25653251|NCT01535937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25653252|NCT01535937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25653253|NCT01535937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25653254|NCT01535937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653255|NCT01535937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25653256|NCT01535937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25653257|NCT01535937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25653258|NCT01535937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25653259|NCT01535937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25653260|NCT01535937|GABA Modulators|gaba modulators|mesh-ancestor
25653261|NCT01535937|GABA Agents|gaba agents|mesh-ancestor
25653262|NCT01535976|Ketamine|ketamine|mesh-list
25653263|NCT01535976|Analgesics|analgesics|mesh-ancestor
25653264|NCT01535976|Sensory System Agents|sensory system agents|mesh-ancestor
25653265|NCT01535976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653266|NCT01535976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653267|NCT01535976|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25653268|NCT01535976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25653269|NCT01535976|Anesthetics, General|anesthetics, general|mesh-ancestor
25653270|NCT01535976|Anesthetics|anesthetics|mesh-ancestor
25653271|NCT01535976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25653272|NCT01535976|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25653273|NCT01535976|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25653274|NCT01535976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25653275|NCT01535976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653276|NCT01536067|Bortezomib|bortezomib|mesh-list
25653277|NCT01536067|Ofatumumab|ofatumumab|mesh-list
25653278|NCT01536067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588314|NCT00917579|Atorvastatin|atorvastatin|mesh-list
25588315|NCT00917579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25588316|NCT00917579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25588317|NCT00917579|Antimetabolites|antimetabolites|mesh-ancestor
25588318|NCT00917579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588319|NCT00917579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25588320|NCT00917579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25588321|NCT00917579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588322|NCT00917644|Atorvastatin|atorvastatin|mesh-list
25588323|NCT00917644|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25588324|NCT00917644|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25588325|NCT00917644|Antimetabolites|antimetabolites|mesh-ancestor
25588326|NCT00917644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588327|NCT00917644|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25588328|NCT00917644|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25588329|NCT00917644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588330|NCT00918138|Metformin|metformin|mesh-list
25588331|NCT00918138|Saxagliptin|saxagliptin|mesh-list
25588332|NCT00918138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25588333|NCT00918138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588334|NCT00918138|Incretins|incretins|mesh-ancestor
25588335|NCT00918138|Hormones|hormones|mesh-ancestor
25588336|NCT00918138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25588337|NCT00918138|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25588338|NCT00918138|Protease Inhibitors|protease inhibitors|mesh-ancestor
25588339|NCT00918138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588340|NCT00918138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588341|NCT00918203|Paclitaxel|paclitaxel|mesh-list
25588342|NCT00918203|Carboplatin|carboplatin|mesh-list
25588343|NCT00918203|Olaratumab|olaratumab|mesh-list
25588344|NCT00918203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25588345|NCT00918203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588346|NCT00918203|Tubulin Modulators|tubulin modulators|mesh-ancestor
25588347|NCT00918203|Antimitotic Agents|antimitotic agents|mesh-ancestor
25588348|NCT00918203|Mitosis Modulators|mitosis modulators|mesh-ancestor
25588349|NCT00918203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588350|NCT00918255|Adalimumab|adalimumab|mesh-list
25588351|NCT00918255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25588352|NCT00918255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25588353|NCT00918333|Everolimus|everolimus|mesh-list
25588354|NCT00918333|Panobinostat|panobinostat|mesh-list
25588355|NCT00918333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25588356|NCT00918333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588357|NCT00918333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25588358|NCT00918333|Immunologic Factors|immunologic factors|mesh-ancestor
25588359|NCT00918333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588360|NCT00918333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588361|NCT00918333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588362|NCT00918385|Dasatinib|dasatinib|mesh-list
25588363|NCT00918385|Nilutamide|nilutamide|mesh-list
25588364|NCT00918385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588365|NCT00918385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25588366|NCT00918385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588367|NCT00918385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588368|NCT00918385|Androgen Antagonists|androgen antagonists|mesh-ancestor
25588369|NCT00918385|Hormone Antagonists|hormone antagonists|mesh-ancestor
25588370|NCT00918385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25588371|NCT00918385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588372|NCT00918567|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25588373|NCT00918567|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25588374|NCT00918567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25588375|NCT00918567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25588376|NCT00918567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588377|NCT00918567|Adrenergic Agents|adrenergic agents|mesh-ancestor
25588378|NCT00918567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25588379|NCT00918567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588380|NCT00918684|Citalopram|citalopram|mesh-list
25588381|NCT00918684|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25588382|NCT00918684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25588383|NCT00918684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25588384|NCT00918684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588385|NCT00918684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24406859|NCT00171483|Tegaserod|tegaserod|mesh-list
25482996|NCT00129376|Tubulin Modulators|tubulin modulators|mesh-ancestor
25588386|NCT00918684|Serotonin Agents|serotonin agents|mesh-ancestor
25588387|NCT00918684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588388|NCT00918684|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25588389|NCT00918684|Antidepressive Agents|antidepressive agents|mesh-ancestor
25588390|NCT00918684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25588391|NCT00918723|Cyclophosphamide|cyclophosphamide|mesh-list
25588392|NCT00918723|Rituximab|rituximab|mesh-list
25588393|NCT00918723|Fludarabine|fludarabine|mesh-list
25588394|NCT00918723|Fludarabine phosphate|fludarabine phosphate|mesh-list
25588395|NCT00918723|Vorinostat|vorinostat|mesh-list
25588396|NCT00918723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25588397|NCT00918723|Immunologic Factors|immunologic factors|mesh-ancestor
25588398|NCT00918723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588399|NCT00918723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25588400|NCT00918723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25588401|NCT00918723|Alkylating Agents|alkylating agents|mesh-ancestor
25588402|NCT00918723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588403|NCT00918723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588404|NCT00918723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25588405|NCT00918723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25588406|NCT00918723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25588407|NCT00918723|Antimetabolites|antimetabolites|mesh-ancestor
25588408|NCT00918723|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25588409|NCT00918723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588410|NCT00918736|Hyaluronic Acid|hyaluronic acid|mesh-list
25588411|NCT00918736|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25588412|NCT00918736|Immunologic Factors|immunologic factors|mesh-ancestor
25588413|NCT00918736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588414|NCT00918736|Viscosupplements|viscosupplements|mesh-ancestor
25588415|NCT00918736|Protective Agents|protective agents|mesh-ancestor
25588416|NCT00918879|Saxagliptin|saxagliptin|mesh-list
25588417|NCT00918879|Incretins|incretins|mesh-ancestor
25588418|NCT00918879|Hormones|hormones|mesh-ancestor
25588419|NCT00918879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25588420|NCT00918879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588421|NCT00918879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25588422|NCT00918879|Protease Inhibitors|protease inhibitors|mesh-ancestor
25588423|NCT00918879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588424|NCT00918879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588425|NCT00918879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25588426|NCT00918931|Obatoclax|obatoclax|mesh-list
25588427|NCT00918931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588428|NCT00918931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588429|NCT00918957|Tobramycin|tobramycin|mesh-list
25588430|NCT00918957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25588431|NCT00918957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25588432|NCT00919035|Sirolimus|sirolimus|mesh-list
25588433|NCT00919035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25588434|NCT00919035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25588435|NCT00919035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25588436|NCT00919035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588437|NCT00919035|Antifungal Agents|antifungal agents|mesh-ancestor
25588438|NCT00919035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25588439|NCT00919035|Immunologic Factors|immunologic factors|mesh-ancestor
25588440|NCT00919035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588441|NCT00919061|Gemcitabine|gemcitabine|mesh-list
25588442|NCT00919061|Cisplatin|cisplatin|mesh-list
25588443|NCT00919061|Sorafenib|sorafenib|mesh-list
25588444|NCT00919061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588445|NCT00919061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25588446|NCT00919061|Antimetabolites|antimetabolites|mesh-ancestor
25588447|NCT00919061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588448|NCT00919061|Antiviral Agents|antiviral agents|mesh-ancestor
25588449|NCT00919061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25588450|NCT00919061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588451|NCT00919061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25588452|NCT00919061|Immunologic Factors|immunologic factors|mesh-ancestor
25588453|NCT00919061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588454|NCT00919061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25588455|NCT00919126|Xenon|xenon|mesh-list
25588456|NCT00919126|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25588457|NCT00919126|Anesthetics, General|anesthetics, general|mesh-ancestor
25588458|NCT00919126|Anesthetics|anesthetics|mesh-ancestor
25588459|NCT00919126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25588460|NCT00919126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588461|NCT00919191|Adapalene|adapalene|mesh-list
25588462|NCT00919191|Tretinoin|tretinoin|mesh-list
25588463|NCT00919191|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25588464|NCT00919191|Dermatologic Agents|dermatologic agents|mesh-ancestor
25588465|NCT00919191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25588466|NCT00919191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25588467|NCT00919191|Analgesics|analgesics|mesh-ancestor
25588468|NCT00919191|Sensory System Agents|sensory system agents|mesh-ancestor
25588469|NCT00919191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25588470|NCT00919191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588471|NCT00919191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25588472|NCT00919191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25588473|NCT00919191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588474|NCT00919191|Keratolytic Agents|keratolytic agents|mesh-ancestor
25588475|NCT00919503|Cyclosporine|cyclosporine|mesh-list
25588476|NCT00919503|Mycophenolic Acid|mycophenolic acid|mesh-list
25588477|NCT00919503|Methotrexate|methotrexate|mesh-list
25588478|NCT00919503|Fludarabine phosphate|fludarabine phosphate|mesh-list
25588479|NCT00919503|Fludarabine|fludarabine|mesh-list
25588480|NCT00919503|Treosulfan|treosulfan|mesh-list
25588481|NCT00919503|Busulfan|busulfan|mesh-list
25588482|NCT00919503|Tacrolimus|tacrolimus|mesh-list
25588483|NCT00919503|Cyclosporins|cyclosporins|mesh-list
25588484|NCT00919503|Thymoglobulin|thymoglobulin|mesh-list
25588485|NCT00919503|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25588486|NCT00919503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25588487|NCT00919503|Abortifacient Agents|abortifacient agents|mesh-ancestor
25588488|NCT00919503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25588489|NCT00919503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588490|NCT00919503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25588491|NCT00919503|Antimetabolites|antimetabolites|mesh-ancestor
25588492|NCT00919503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588493|NCT00919503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588494|NCT00919503|Dermatologic Agents|dermatologic agents|mesh-ancestor
25588495|NCT00919503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588496|NCT00919503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25588497|NCT00919503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25588498|NCT00919503|Immunologic Factors|immunologic factors|mesh-ancestor
25588499|NCT00919503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25588500|NCT00919503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25588501|NCT00919503|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25588502|NCT00919503|Antifungal Agents|antifungal agents|mesh-ancestor
25588503|NCT00919503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25588504|NCT00919503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25588505|NCT00919503|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25588506|NCT00919503|Antitubercular Agents|antitubercular agents|mesh-ancestor
25588507|NCT00919503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25588508|NCT00919503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25588509|NCT00919503|Alkylating Agents|alkylating agents|mesh-ancestor
25588510|NCT00919503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25588511|NCT00919633|Interferons|interferons|mesh-list
25588512|NCT00919633|Ribavirin|ribavirin|mesh-list
25588513|NCT00919633|Interferon-alpha|interferon-alpha|mesh-list
25588514|NCT00919633|Interferon alpha-2|interferon alpha-2|mesh-list
25588515|NCT00919633|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25588516|NCT00919633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588517|NCT00919633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588518|NCT00919633|Antiviral Agents|antiviral agents|mesh-ancestor
25588519|NCT00919633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25588520|NCT00919633|Antimetabolites|antimetabolites|mesh-ancestor
25588521|NCT00919633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588522|NCT00919633|Immunologic Factors|immunologic factors|mesh-ancestor
25588523|NCT00919711|Denosumab|denosumab|mesh-list
25588524|NCT00919711|Risedronic Acid|risedronic acid|mesh-list
25588525|NCT00919711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25588526|NCT00919711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588527|NCT00919711|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25588528|NCT00919711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25588529|NCT00919711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588530|NCT00919711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25588531|NCT00919802|Oxytocin|oxytocin|mesh-list
25588532|NCT00919802|Oxytocics|oxytocics|mesh-ancestor
25588533|NCT00919802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25588534|NCT00919802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588535|NCT00919854|Ritonavir|ritonavir|mesh-list
25588536|NCT00919854|Darunavir|darunavir|mesh-list
25588537|NCT00919854|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25588538|NCT00919854|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25588539|NCT00919854|Protease Inhibitors|protease inhibitors|mesh-ancestor
25588540|NCT00919854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588541|NCT00919854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588542|NCT00919854|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25588543|NCT00919854|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25588544|NCT00919854|Antiviral Agents|antiviral agents|mesh-ancestor
25588545|NCT00919854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25588546|NCT00919854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25588547|NCT00919854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25588548|NCT00919867|Guanfacine|guanfacine|mesh-list
25588549|NCT00919867|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25588550|NCT00919867|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25588551|NCT00919867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588552|NCT00919867|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25588553|NCT00919867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25588554|NCT00919867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25588555|NCT00919867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588556|NCT00919867|Dopamine Agents|dopamine agents|mesh-ancestor
25588557|NCT00919867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25588558|NCT00919867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25588559|NCT00919867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25588560|NCT00919867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25588561|NCT00919867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25588562|NCT00919867|Adrenergic Agents|adrenergic agents|mesh-ancestor
25588563|NCT00920075|Alendronate|alendronate|mesh-list
25588564|NCT00920075|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25588565|NCT00920075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588566|NCT00920140|Trametinib|trametinib|mesh-list
25588567|NCT00920140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588568|NCT00920140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25588569|NCT00920140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588570|NCT00920140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588571|NCT00920218|Vaccines|vaccines|mesh-list
25588572|NCT00920218|Immunologic Factors|immunologic factors|mesh-ancestor
25588573|NCT00920218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588574|NCT00920426|Cabotegravir|cabotegravir|mesh-list
25588575|NCT00920426|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25588576|NCT00920426|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25588577|NCT00920426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588578|NCT00920426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588579|NCT00920426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25588580|NCT00920426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25588581|NCT00920426|Antiviral Agents|antiviral agents|mesh-ancestor
25588582|NCT00920426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25588583|NCT00920556|Bortezomib|bortezomib|mesh-list
25588584|NCT00920556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588585|NCT00920686|Sumatriptan|sumatriptan|mesh-list
25588586|NCT00920686|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25588587|NCT00920686|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25588588|NCT00920686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25588589|NCT00920686|Serotonin Agents|serotonin agents|mesh-ancestor
25588590|NCT00920686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25588591|NCT00920686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588592|NCT00920686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588593|NCT00920699|Ubiquinone|ubiquinone|mesh-list
25588594|NCT00920699|Coenzyme Q10|coenzyme q10|mesh-list
25588595|NCT00920699|Micronutrients|micronutrients|mesh-ancestor
25588596|NCT00920699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588597|NCT00920699|Vitamins|vitamins|mesh-ancestor
25588598|NCT00920790|Mogamulizumab|mogamulizumab|mesh-list
25588599|NCT00920790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588600|NCT00920829|Naltrexone|naltrexone|mesh-list
25588601|NCT00920829|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25588602|NCT00920829|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25588603|NCT00920829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588604|NCT00920829|Sensory System Agents|sensory system agents|mesh-ancestor
25588605|NCT00920829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25588606|NCT00920855|Bortezomib|bortezomib|mesh-list
25588607|NCT00920855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25588608|NCT00920855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588609|NCT00920855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25588610|NCT00920855|Alkylating Agents|alkylating agents|mesh-ancestor
25588611|NCT00920855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588612|NCT00920907|Ipilimumab|ipilimumab|mesh-list
25588613|NCT00920907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25588614|NCT00920907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588615|NCT00920907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25588616|NCT00920907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588617|NCT00921024|Ceftazidime|ceftazidime|mesh-list
25588618|NCT00921024|Ceftolozane|ceftolozane|mesh-list
25588619|NCT00921024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25588620|NCT00921024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25588621|NCT00921310|Sirolimus|sirolimus|mesh-list
25588622|NCT00921310|Pemetrexed|pemetrexed|mesh-list
25588623|NCT00921310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588624|NCT00921310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588625|NCT00921310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588626|NCT00921310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25588627|NCT00921310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25588628|NCT00921310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25588629|NCT00921310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25588630|NCT00921310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25588631|NCT00921310|Antifungal Agents|antifungal agents|mesh-ancestor
25588632|NCT00921310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25588633|NCT00921310|Immunologic Factors|immunologic factors|mesh-ancestor
25588634|NCT00921310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588635|NCT00921557|Vitamin D|vitamin d|mesh-list
25588636|NCT00921557|Alendronate|alendronate|mesh-list
25588637|NCT00921557|Calcium Carbonate|calcium carbonate|mesh-list
25588638|NCT00921557|Calcium|calcium|mesh-list
25588639|NCT00921557|Vitamins|vitamins|mesh-ancestor
25588640|NCT00921557|Micronutrients|micronutrients|mesh-ancestor
25588641|NCT00921557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588642|NCT00921557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25588643|NCT00921557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25588644|NCT00921557|Antacids|antacids|mesh-ancestor
25588645|NCT00921557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588646|NCT00921557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25588647|NCT00921843|Methadone|methadone|mesh-list
25588648|NCT00921843|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25588649|NCT00921843|Narcotics|narcotics|mesh-ancestor
25588650|NCT00921843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25588651|NCT00921843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588652|NCT00921843|Analgesics|analgesics|mesh-ancestor
25588653|NCT00921843|Sensory System Agents|sensory system agents|mesh-ancestor
25588654|NCT00921843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25588655|NCT00921843|Antitussive Agents|antitussive agents|mesh-ancestor
25588656|NCT00921843|Respiratory System Agents|respiratory system agents|mesh-ancestor
25588657|NCT00922116|Epoetin Alfa|epoetin alfa|mesh-list
25588658|NCT00922116|Hematinics|hematinics|mesh-ancestor
25588659|NCT00922194|Metformin|metformin|mesh-list
25588660|NCT00922194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25588661|NCT00922194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588662|NCT00922207|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25588663|NCT00922207|Entecavir|entecavir|mesh-list
25588664|NCT00922207|Adefovir|adefovir|mesh-list
25588665|NCT00922207|Antiviral Agents|antiviral agents|mesh-ancestor
25588666|NCT00922207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25588667|NCT00922207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25588668|NCT00922207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25588669|NCT00922207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588670|NCT00922207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588671|NCT00922233|Levonorgestrel|levonorgestrel|mesh-list
25588672|NCT00922233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25588673|NCT00922233|Contraceptive Agents|contraceptive agents|mesh-ancestor
25588674|NCT00922233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25588675|NCT00922233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588676|NCT00922233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25588677|NCT00922233|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25588678|NCT00922233|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25704856|NCT02188719|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25588679|NCT00922272|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25588680|NCT00922272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25588681|NCT00922272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588682|NCT00922272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25588683|NCT00922272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25588684|NCT00922272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25588685|NCT00922272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588686|NCT00922272|Dopamine Agents|dopamine agents|mesh-ancestor
25588687|NCT00922272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25588688|NCT00922441|Valsartan|valsartan|mesh-list
25588689|NCT00922441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25588690|NCT00922441|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25588691|NCT00922441|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25588692|NCT00922441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588693|NCT00922480|Losartan|losartan|mesh-list
25588694|NCT00922480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25588695|NCT00922480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25588696|NCT00922480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25588697|NCT00922480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25588698|NCT00922480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588699|NCT00922636|Methylphenidate|methylphenidate|mesh-list
25588700|NCT00922636|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25588701|NCT00922636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588702|NCT00922636|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25588703|NCT00922636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25588704|NCT00922636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25588705|NCT00922636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588706|NCT00922636|Dopamine Agents|dopamine agents|mesh-ancestor
25588707|NCT00922636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25588708|NCT00922766|Dalteparin|dalteparin|mesh-list
25588709|NCT00922766|Tinzaparin|tinzaparin|mesh-list
25588710|NCT00922766|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25588711|NCT00922766|Anticoagulants|anticoagulants|mesh-ancestor
25588712|NCT00922766|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25588713|NCT00922766|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25588714|NCT00922766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588715|NCT00922779|Ribavirin|ribavirin|mesh-list
25588716|NCT00922779|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25588717|NCT00922779|Antimetabolites|antimetabolites|mesh-ancestor
25588718|NCT00922779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588719|NCT00922779|Antiviral Agents|antiviral agents|mesh-ancestor
25588720|NCT00922779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25588721|NCT00922987|Pregabalin|pregabalin|mesh-list
25588722|NCT00922987|Analgesics|analgesics|mesh-ancestor
25588723|NCT00922987|Sensory System Agents|sensory system agents|mesh-ancestor
25588724|NCT00922987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25588725|NCT00922987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588726|NCT00922987|Anticonvulsants|anticonvulsants|mesh-ancestor
25588727|NCT00922987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25588728|NCT00922987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25588729|NCT00922987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588730|NCT00922987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25588731|NCT00922987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25588732|NCT00922987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25588733|NCT00922987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25588734|NCT00922987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25588735|NCT00923091|Amlodipine|amlodipine|mesh-list
25588736|NCT00923091|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25588737|NCT00923091|Olmesartan|olmesartan|mesh-list
25588738|NCT00923091|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25588739|NCT00923091|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
25588740|NCT00923091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25588741|NCT00923091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25588742|NCT00923091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25588743|NCT00923091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588744|NCT00923091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25588745|NCT00923091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588746|NCT00923091|Vasodilator Agents|vasodilator agents|mesh-ancestor
25588747|NCT00923091|Diuretics|diuretics|mesh-ancestor
25588748|NCT00923091|Natriuretic Agents|natriuretic agents|mesh-ancestor
25588749|NCT00923091|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25588750|NCT00923091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25588751|NCT00923091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25588752|NCT00923117|Sunitinib|sunitinib|mesh-list
25588753|NCT00923117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588754|NCT00923117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25588755|NCT00923117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25588756|NCT00923117|Growth Substances|growth substances|mesh-ancestor
25588757|NCT00923117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588758|NCT00923117|Growth Inhibitors|growth inhibitors|mesh-ancestor
25588759|NCT00923117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25588760|NCT00923117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588761|NCT00923117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588762|NCT00923130|Bevacizumab|bevacizumab|mesh-list
25588763|NCT00923130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25588764|NCT00923130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588765|NCT00923130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25588766|NCT00923130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25588767|NCT00923130|Growth Substances|growth substances|mesh-ancestor
25588768|NCT00923130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588769|NCT00923130|Growth Inhibitors|growth inhibitors|mesh-ancestor
25588770|NCT00923156|Ramipril|ramipril|mesh-list
25588771|NCT00923156|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25588772|NCT00923156|Protease Inhibitors|protease inhibitors|mesh-ancestor
25588773|NCT00923156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588774|NCT00923156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588775|NCT00923156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25588776|NCT00923195|Aldesleukin|aldesleukin|mesh-list
25588777|NCT00923195|Cyclophosphamide|cyclophosphamide|mesh-list
25588778|NCT00923195|Fludarabine|fludarabine|mesh-list
25588779|NCT00923195|Interleukin-2|interleukin-2|mesh-list
25588780|NCT00923195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25588781|NCT00923195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25588782|NCT00923195|Immunologic Factors|immunologic factors|mesh-ancestor
25588783|NCT00923195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588784|NCT00923195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25588785|NCT00923195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25588786|NCT00923195|Alkylating Agents|alkylating agents|mesh-ancestor
25588787|NCT00923195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588788|NCT00923195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588789|NCT00923195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25588790|NCT00923195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25588791|NCT00923195|Analgesics|analgesics|mesh-ancestor
25588792|NCT00923195|Sensory System Agents|sensory system agents|mesh-ancestor
25588793|NCT00923195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25588794|NCT00923195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25588795|NCT00923195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25588796|NCT00923195|Antiviral Agents|antiviral agents|mesh-ancestor
25588797|NCT00923195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25588798|NCT00923195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25588799|NCT00923273|Folic Acid|folic acid|mesh-list
25588800|NCT00923273|Vitamin B 12|vitamin b 12|mesh-list
25588801|NCT00923273|Hydroxocobalamin|hydroxocobalamin|mesh-list
25588802|NCT00923273|Sirolimus|sirolimus|mesh-list
25588803|NCT00923273|Dexamethasone|dexamethasone|mesh-list
25588804|NCT00923273|Pemetrexed|pemetrexed|mesh-list
25588805|NCT00923273|Vitamins|vitamins|mesh-ancestor
25588806|NCT00923273|Micronutrients|micronutrients|mesh-ancestor
25588807|NCT00923273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588808|NCT00923273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25588809|NCT00923273|Antiemetics|antiemetics|mesh-ancestor
25588810|NCT00923273|Autonomic Agents|autonomic agents|mesh-ancestor
25588811|NCT00923273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25588812|NCT00923273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25588813|NCT00923273|Glucocorticoids|glucocorticoids|mesh-ancestor
25588814|NCT00923273|Hormones|hormones|mesh-ancestor
25588815|NCT00923273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25588816|NCT00923273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25588817|NCT00923273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588818|NCT00923273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542993|NCT00681395|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25588819|NCT00923273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588820|NCT00923273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25588821|NCT00923273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25588822|NCT00923273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25588823|NCT00923273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25588824|NCT00923273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25588825|NCT00923273|Antifungal Agents|antifungal agents|mesh-ancestor
25588826|NCT00923273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25588827|NCT00923273|Immunologic Factors|immunologic factors|mesh-ancestor
25588828|NCT00923273|Hematinics|hematinics|mesh-ancestor
25588829|NCT00923273|Vitamin B Complex|vitamin b complex|mesh-ancestor
25588830|NCT00923351|Vaccines|vaccines|mesh-list
25588831|NCT00923351|Immunologic Factors|immunologic factors|mesh-ancestor
25588832|NCT00923351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588833|NCT00923364|Cyclophosphamide|cyclophosphamide|mesh-list
25588834|NCT00923364|Fludarabine|fludarabine|mesh-list
25588835|NCT00923364|Fludarabine phosphate|fludarabine phosphate|mesh-list
25588836|NCT00923364|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25588837|NCT00923364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25588838|NCT00923364|Immunologic Factors|immunologic factors|mesh-ancestor
25588839|NCT00923364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588840|NCT00923364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25588841|NCT00923364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25588842|NCT00923364|Alkylating Agents|alkylating agents|mesh-ancestor
25588843|NCT00923364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588844|NCT00923364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588845|NCT00923364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25588846|NCT00923364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25588847|NCT00923364|Antimetabolites|antimetabolites|mesh-ancestor
25588848|NCT00923845|Sirolimus|sirolimus|mesh-list
25588849|NCT00923845|Cyclophosphamide|cyclophosphamide|mesh-list
25588850|NCT00923845|Pentostatin|pentostatin|mesh-list
25588851|NCT00923845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25588852|NCT00923845|Immunologic Factors|immunologic factors|mesh-ancestor
25588853|NCT00923845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588854|NCT00923845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25588855|NCT00923845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25588856|NCT00923845|Alkylating Agents|alkylating agents|mesh-ancestor
25588857|NCT00923845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588858|NCT00923845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588859|NCT00923845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25588860|NCT00923845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25588861|NCT00923845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25588862|NCT00923845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25588863|NCT00923845|Antifungal Agents|antifungal agents|mesh-ancestor
25588864|NCT00923845|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25588865|NCT00923845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588866|NCT00923910|Acetaminophen|acetaminophen|mesh-list
25588867|NCT00923910|Diphenhydramine|diphenhydramine|mesh-list
25588868|NCT00923910|Promethazine|promethazine|mesh-list
25588869|NCT00923910|Interleukin-4|interleukin-4|mesh-list
25588870|NCT00923910|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
25588871|NCT00923910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25588872|NCT00923910|Analgesics|analgesics|mesh-ancestor
25588873|NCT00923910|Sensory System Agents|sensory system agents|mesh-ancestor
25588874|NCT00923910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25588875|NCT00923910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588876|NCT00923910|Antipyretics|antipyretics|mesh-ancestor
25588877|NCT00923910|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25588878|NCT00923910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25588879|NCT00923910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25588880|NCT00923910|Anesthetics, Local|anesthetics, local|mesh-ancestor
25588881|NCT00923910|Anesthetics|anesthetics|mesh-ancestor
25588882|NCT00923910|Antiemetics|antiemetics|mesh-ancestor
25588883|NCT00923910|Autonomic Agents|autonomic agents|mesh-ancestor
25588884|NCT00923910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25588885|NCT00923910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25588886|NCT00923910|Histamine Antagonists|histamine antagonists|mesh-ancestor
25588887|NCT00923910|Histamine Agents|histamine agents|mesh-ancestor
25588888|NCT00923910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25588889|NCT00923910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588890|NCT00923910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25588891|NCT00923910|Antipruritics|antipruritics|mesh-ancestor
25588892|NCT00923910|Dermatologic Agents|dermatologic agents|mesh-ancestor
25588893|NCT00923910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25588894|NCT00923910|Immunologic Factors|immunologic factors|mesh-ancestor
25588895|NCT00923910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588896|NCT00923910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25588897|NCT00923936|Bevacizumab|bevacizumab|mesh-list
25588898|NCT00923936|Doxorubicin|doxorubicin|mesh-list
25588899|NCT00923936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25588900|NCT00923936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25588901|NCT00923936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588902|NCT00923936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25588903|NCT00923936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25588904|NCT00923936|Growth Substances|growth substances|mesh-ancestor
25588905|NCT00923936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588906|NCT00923936|Growth Inhibitors|growth inhibitors|mesh-ancestor
25588907|NCT00923936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25588908|NCT00923936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25588909|NCT00923936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25588910|NCT00923936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588911|NCT00923936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588912|NCT00923949|Pioglitazone|pioglitazone|mesh-list
25588913|NCT00923949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25588914|NCT00923949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588915|NCT00924001|Aldesleukin|aldesleukin|mesh-list
25588916|NCT00924001|Cyclophosphamide|cyclophosphamide|mesh-list
25588917|NCT00924001|Fludarabine|fludarabine|mesh-list
25588918|NCT00924001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25588919|NCT00924001|Immunologic Factors|immunologic factors|mesh-ancestor
25588920|NCT00924001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588921|NCT00924001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25588922|NCT00924001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25588923|NCT00924001|Alkylating Agents|alkylating agents|mesh-ancestor
25588924|NCT00924001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588925|NCT00924001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588926|NCT00924001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25588927|NCT00924001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25588928|NCT00924001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25588929|NCT00924001|Antiviral Agents|antiviral agents|mesh-ancestor
25588930|NCT00924001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25653279|NCT01536262|Tiotropium Bromide|tiotropium bromide|mesh-list
25653280|NCT01536262|Olodaterol|olodaterol|mesh-list
25653281|NCT01536262|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25653282|NCT01536262|Autonomic Agents|autonomic agents|mesh-ancestor
25653283|NCT01536262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653284|NCT01536262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653285|NCT01536262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25653286|NCT01536262|Respiratory System Agents|respiratory system agents|mesh-ancestor
25653287|NCT01536262|Parasympatholytics|parasympatholytics|mesh-ancestor
25653288|NCT01536262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25653289|NCT01536262|Cholinergic Agents|cholinergic agents|mesh-ancestor
25653290|NCT01536262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25653291|NCT01536262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653292|NCT01536366|Repaglinide|repaglinide|mesh-list
25653293|NCT01536366|Opicapone|opicapone|mesh-list
25653294|NCT01536366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25653295|NCT01536366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653296|NCT01536366|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25653297|NCT01536366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653298|NCT01536366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939717|NCT04007588|Nivolumab|nivolumab|mesh-list
25653299|NCT01536366|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25653300|NCT01536366|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25653301|NCT01536379|Belimumab|belimumab|mesh-list
25653302|NCT01536379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25653303|NCT01536379|Immunologic Factors|immunologic factors|mesh-ancestor
25653304|NCT01536379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653305|NCT01536392|Ondansetron|ondansetron|mesh-list
25653306|NCT01536392|Granisetron|granisetron|mesh-list
25653307|NCT01536392|Antiemetics|antiemetics|mesh-ancestor
25653308|NCT01536392|Autonomic Agents|autonomic agents|mesh-ancestor
25653309|NCT01536392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653310|NCT01536392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653311|NCT01536392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25653312|NCT01536392|Antipruritics|antipruritics|mesh-ancestor
25653313|NCT01536392|Dermatologic Agents|dermatologic agents|mesh-ancestor
25653314|NCT01536392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25653315|NCT01536392|Serotonin Agents|serotonin agents|mesh-ancestor
25653316|NCT01536392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25653317|NCT01536392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653318|NCT01536392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25653319|NCT01536392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25653320|NCT01536392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25483543|NCT00134056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483544|NCT00134056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25483545|NCT00134056|Glucocorticoids|glucocorticoids|mesh-ancestor
25483546|NCT00134056|Hormones|hormones|mesh-ancestor
25483547|NCT00134056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25483548|NCT00134056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653321|NCT01536392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25653322|NCT01536392|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25653323|NCT01536535|Prednisone|prednisone|mesh-list
25653324|NCT01536535|Mesalamine|mesalamine|mesh-list
25653325|NCT01536535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25653326|NCT01536535|Glucocorticoids|glucocorticoids|mesh-ancestor
25653327|NCT01536535|Hormones|hormones|mesh-ancestor
25653328|NCT01536535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25653329|NCT01536535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653330|NCT01536535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25588931|NCT00924053|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25588932|NCT00924053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853113|NCT02265874|Nicotine|nicotine|mesh-list
25588933|NCT00924053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25588934|NCT00924053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588935|NCT00924066|Epothilones|epothilones|mesh-list
25588936|NCT00924066|Tubulin Modulators|tubulin modulators|mesh-ancestor
25588937|NCT00924066|Antimitotic Agents|antimitotic agents|mesh-ancestor
25588938|NCT00924066|Mitosis Modulators|mitosis modulators|mesh-ancestor
25588939|NCT00924066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588940|NCT00924066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588941|NCT00924209|Gemcitabine|gemcitabine|mesh-list
25588942|NCT00924209|Bevacizumab|bevacizumab|mesh-list
25588944|NCT00924209|Etoposide|etoposide|mesh-list
25588945|NCT00924209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25588946|NCT00924209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588947|NCT00924209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25588948|NCT00924209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25588949|NCT00924209|Growth Substances|growth substances|mesh-ancestor
25588950|NCT00924209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588951|NCT00924209|Growth Inhibitors|growth inhibitors|mesh-ancestor
25588952|NCT00924209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25588953|NCT00924209|Antimetabolites|antimetabolites|mesh-ancestor
25588954|NCT00924209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588955|NCT00924209|Antiviral Agents|antiviral agents|mesh-ancestor
25588956|NCT00924209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25588957|NCT00924209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588958|NCT00924209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25588959|NCT00924209|Immunologic Factors|immunologic factors|mesh-ancestor
25588960|NCT00924209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25588961|NCT00924209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25588962|NCT00924209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25588963|NCT00924287|Aldesleukin|aldesleukin|mesh-list
25588964|NCT00924287|Cyclophosphamide|cyclophosphamide|mesh-list
25588965|NCT00924287|Fludarabine|fludarabine|mesh-list
25588966|NCT00924287|Interleukin-2|interleukin-2|mesh-list
25588967|NCT00924287|Mesna|mesna|mesh-list
25588968|NCT00924287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25588969|NCT00924287|Immunologic Factors|immunologic factors|mesh-ancestor
25588970|NCT00924287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25588971|NCT00924287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25588972|NCT00924287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25588973|NCT00924287|Alkylating Agents|alkylating agents|mesh-ancestor
25588974|NCT00924287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588975|NCT00924287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588976|NCT00924287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25588977|NCT00924287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25588978|NCT00924287|Analgesics|analgesics|mesh-ancestor
25588979|NCT00924287|Sensory System Agents|sensory system agents|mesh-ancestor
25588980|NCT00924287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25588981|NCT00924287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25588982|NCT00924287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25588983|NCT00924287|Antiviral Agents|antiviral agents|mesh-ancestor
25588984|NCT00924287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25588985|NCT00924287|Protective Agents|protective agents|mesh-ancestor
25588986|NCT00924352|Dasatinib|dasatinib|mesh-list
25588987|NCT00924352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588988|NCT00924352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25588989|NCT00924352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25588990|NCT00924352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588991|NCT00924443|Clofarabine|clofarabine|mesh-list
25588992|NCT00924443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25588993|NCT00924443|Antimetabolites|antimetabolites|mesh-ancestor
25588994|NCT00924443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25588995|NCT00924443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25588996|NCT00924469|Prednisone|prednisone|mesh-list
25588997|NCT00924469|Leuprolide|leuprolide|mesh-list
25588998|NCT00924469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25588999|NCT00924469|Glucocorticoids|glucocorticoids|mesh-ancestor
25589000|NCT00924469|Hormones|hormones|mesh-ancestor
25589001|NCT00924469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25589002|NCT00924469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589003|NCT00924469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25589004|NCT00924469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25589005|NCT00924469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25589007|NCT00924469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25589008|NCT00924508|Triamcinolone|triamcinolone|mesh-list
25589009|NCT00924508|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25589010|NCT00924508|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25589011|NCT00924508|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25589012|NCT00924508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25589013|NCT00924508|Glucocorticoids|glucocorticoids|mesh-ancestor
25589014|NCT00924508|Hormones|hormones|mesh-ancestor
25589015|NCT00924508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25589016|NCT00924508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589017|NCT00924508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25589018|NCT00924508|Immunologic Factors|immunologic factors|mesh-ancestor
25589019|NCT00924508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25589020|NCT00924508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589021|NCT00924560|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25589022|NCT00924560|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25589023|NCT00924560|Levonorgestrel|levonorgestrel|mesh-list
25589024|NCT00924560|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25589025|NCT00924560|Contraceptive Agents|contraceptive agents|mesh-list
25589026|NCT00924560|Contraceptives, Oral|contraceptives, oral|mesh-list
25589027|NCT00924560|Estradiol|estradiol|mesh-list
25589028|NCT00924560|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24545016|NCT00691392|Linezolid|linezolid|mesh-list
25589029|NCT00924560|Estrogens|estrogens|mesh-ancestor
25589030|NCT00924560|Hormones|hormones|mesh-ancestor
25589031|NCT00924560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25589032|NCT00924560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589033|NCT00924560|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25589034|NCT00924560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25589035|NCT00924560|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25589036|NCT00924560|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25589037|NCT00924560|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25589038|NCT00924612|Methyltestosterone|methyltestosterone|mesh-list
25589039|NCT00924612|Testosterone|testosterone|mesh-list
25589040|NCT00924612|Testosterone undecanoate|testosterone undecanoate|mesh-list
25589041|NCT00924612|Testosterone enanthate|testosterone enanthate|mesh-list
25589042|NCT00924612|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25589043|NCT00924612|Androgens|androgens|mesh-ancestor
25589044|NCT00924612|Hormones|hormones|mesh-ancestor
25589045|NCT00924612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25589046|NCT00924612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589047|NCT00924612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25589048|NCT00924612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25589049|NCT00924612|Anabolic Agents|anabolic agents|mesh-ancestor
25589050|NCT00924664|Tanezumab|tanezumab|mesh-list
25589051|NCT00924664|Analgesics|analgesics|mesh-ancestor
25589052|NCT00924664|Sensory System Agents|sensory system agents|mesh-ancestor
25589053|NCT00924664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25589054|NCT00924664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589055|NCT00924729|Moxifloxacin|moxifloxacin|mesh-list
25589056|NCT00924729|Besifloxacin|besifloxacin|mesh-list
25589057|NCT00924729|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25589058|NCT00924729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25589059|NCT00924729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25589060|NCT00924729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25589061|NCT00924729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25589062|NCT00924729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25589063|NCT00924729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25589064|NCT00924729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589065|NCT00924729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25589066|NCT00924781|Epoetin Alfa|epoetin alfa|mesh-list
25589067|NCT00924781|Hematinics|hematinics|mesh-ancestor
25589068|NCT00924820|Bevacizumab|bevacizumab|mesh-list
25589069|NCT00924820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25589070|NCT00924820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25589071|NCT00924820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25589072|NCT00924820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25589073|NCT00924820|Growth Substances|growth substances|mesh-ancestor
25589074|NCT00924820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589075|NCT00924820|Growth Inhibitors|growth inhibitors|mesh-ancestor
25589076|NCT00924898|Tenofovir|tenofovir|mesh-list
25589077|NCT00924898|Emtricitabine|emtricitabine|mesh-list
25483681|NCT00136084|Alkylating Agents|alkylating agents|mesh-ancestor
25589078|NCT00924898|Efavirenz|efavirenz|mesh-list
25589079|NCT00924898|Antiviral Agents|antiviral agents|mesh-ancestor
25589080|NCT00924898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25589081|NCT00924898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24601007|NCT00961857|Incretins|incretins|mesh-ancestor
25589082|NCT00924898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25589083|NCT00924898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25589084|NCT00924898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589085|NCT00924898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25589086|NCT00924898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25589087|NCT00924898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25589088|NCT00924898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25589089|NCT00924898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25589090|NCT00924898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25589091|NCT00924898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25589092|NCT00924898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25589093|NCT00924950|Calcitriol|calcitriol|mesh-list
25589094|NCT00924950|Betamethasone|betamethasone|mesh-list
25589095|NCT00924950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25589096|NCT00924950|Glucocorticoids|glucocorticoids|mesh-ancestor
25589097|NCT00924950|Hormones|hormones|mesh-ancestor
25589098|NCT00924950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25589099|NCT00924950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589100|NCT00924950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25589101|NCT00924950|Respiratory System Agents|respiratory system agents|mesh-ancestor
25589102|NCT00924950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25589103|NCT00924950|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25589104|NCT00924950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25589105|NCT00924950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589106|NCT00924950|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25589107|NCT00924950|Vitamins|vitamins|mesh-ancestor
25589108|NCT00924950|Micronutrients|micronutrients|mesh-ancestor
25589109|NCT00924950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25589110|NCT00925015|Irinotecan|irinotecan|mesh-list
25589111|NCT00925015|Cetuximab|cetuximab|mesh-list
25589112|NCT00925015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25589113|NCT00925015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25589114|NCT00925015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25589115|NCT00925015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25589116|NCT00925015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589117|NCT00925015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25589118|NCT00925015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25589119|NCT00925015|Immunologic Factors|immunologic factors|mesh-ancestor
25589120|NCT00925015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589121|NCT00925119|Atenolol|atenolol|mesh-list
25589122|NCT00925119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25589123|NCT00925119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25589124|NCT00925119|Sympatholytics|sympatholytics|mesh-ancestor
25589125|NCT00925119|Autonomic Agents|autonomic agents|mesh-ancestor
25589126|NCT00925119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25589127|NCT00925119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589128|NCT00925119|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25589129|NCT00925119|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25589130|NCT00925119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25589131|NCT00925119|Adrenergic Agents|adrenergic agents|mesh-ancestor
25589132|NCT00925119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25589133|NCT00925119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589134|NCT00925132|Temozolomide|temozolomide|mesh-list
25589135|NCT00925132|Decitabine|decitabine|mesh-list
25589136|NCT00925132|Panobinostat|panobinostat|mesh-list
25589137|NCT00925132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25589138|NCT00925132|Alkylating Agents|alkylating agents|mesh-ancestor
25589139|NCT00925132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589140|NCT00925132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25589141|NCT00925132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25589142|NCT00925132|Antimetabolites|antimetabolites|mesh-ancestor
25589143|NCT00925132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25589144|NCT00925132|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25589145|NCT00925288|Vaccines|vaccines|mesh-list
25589146|NCT00925288|Immunologic Factors|immunologic factors|mesh-ancestor
25589147|NCT00925288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589148|NCT00925353|Lidocaine|lidocaine|mesh-list
25589149|NCT00925353|Anesthetics, Local|anesthetics, local|mesh-ancestor
25589150|NCT00925353|Anesthetics|anesthetics|mesh-ancestor
25589151|NCT00925353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25589152|NCT00925353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589153|NCT00925353|Sensory System Agents|sensory system agents|mesh-ancestor
25589154|NCT00925353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25589155|NCT00925353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25589156|NCT00925353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25589157|NCT00925353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25589158|NCT00925353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25589159|NCT00925353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589160|NCT00925587|Darbepoetin alfa|darbepoetin alfa|mesh-list
25589161|NCT00925587|Hematinics|hematinics|mesh-ancestor
25589162|NCT00925600|Denosumab|denosumab|mesh-list
25589163|NCT00925600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25589164|NCT00925600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589165|NCT00925704|Calcitriol|calcitriol|mesh-list
25589166|NCT00925704|Sevelamer|sevelamer|mesh-list
25589167|NCT00925704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25589168|NCT00925704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589169|NCT00925704|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25589170|NCT00925704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25589171|NCT00925704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589172|NCT00925704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25589173|NCT00925704|Vitamins|vitamins|mesh-ancestor
25589174|NCT00925704|Micronutrients|micronutrients|mesh-ancestor
25589175|NCT00925704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25589176|NCT00925704|Chelating Agents|chelating agents|mesh-ancestor
25589177|NCT00925704|Sequestering Agents|sequestering agents|mesh-ancestor
25589178|NCT00925756|Maraviroc|maraviroc|mesh-list
25589179|NCT00925756|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25589180|NCT00925756|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25589181|NCT00925756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589182|NCT00925756|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25589183|NCT00925756|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25589184|NCT00925756|Antiviral Agents|antiviral agents|mesh-ancestor
25589185|NCT00925756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25589186|NCT00925756|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25589187|NCT00925769|Bevacizumab|bevacizumab|mesh-list
25589188|NCT00925769|Capecitabine|capecitabine|mesh-list
25589189|NCT00925769|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25589190|NCT00925769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25589191|NCT00925769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25589192|NCT00925769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25589193|NCT00925769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25589194|NCT00925769|Growth Substances|growth substances|mesh-ancestor
25589195|NCT00925769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589196|NCT00925769|Growth Inhibitors|growth inhibitors|mesh-ancestor
25589197|NCT00925769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25589198|NCT00925769|Antimetabolites|antimetabolites|mesh-ancestor
25589199|NCT00925769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589200|NCT00925769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25589201|NCT00925769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25589202|NCT00925782|Melphalan|melphalan|mesh-list
25589203|NCT00925782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25589204|NCT00925782|Alkylating Agents|alkylating agents|mesh-ancestor
25589205|NCT00925782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589206|NCT00925782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25589207|NCT00925782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25589208|NCT00925782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25589209|NCT00925782|Immunologic Factors|immunologic factors|mesh-ancestor
25589210|NCT00925782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589211|NCT00925899|Melatonin|melatonin|mesh-list
25589212|NCT00925899|Antioxidants|antioxidants|mesh-ancestor
25589213|NCT00925899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589214|NCT00925899|Protective Agents|protective agents|mesh-ancestor
25589215|NCT00925899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589216|NCT00925899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25589217|NCT00925938|Misoprostol|misoprostol|mesh-list
25589218|NCT00925938|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25589219|NCT00925938|Abortifacient Agents|abortifacient agents|mesh-ancestor
24955947|NCT03859102|Dexamethasone|dexamethasone|mesh-list
25589220|NCT00925938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25589221|NCT00925938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589222|NCT00925938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25589223|NCT00925938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25589224|NCT00925938|Oxytocics|oxytocics|mesh-ancestor
25589225|NCT00925990|Ribavirin|ribavirin|mesh-list
25589226|NCT00925990|Antimetabolites|antimetabolites|mesh-ancestor
25653331|NCT01536535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25589227|NCT00925990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589229|NCT00925990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25589230|NCT00926029|Listerine|listerine|mesh-list
25589231|NCT00926029|Triclosan|triclosan|mesh-list
25589232|NCT00926029|Fluorides|fluorides|mesh-list
25589233|NCT00926029|Sodium Fluoride|sodium fluoride|mesh-list
25589234|NCT00926029|Cariostatic Agents|cariostatic agents|mesh-ancestor
25589235|NCT00926029|Protective Agents|protective agents|mesh-ancestor
25589236|NCT00926029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589237|NCT00926029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25589238|NCT00926029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25589239|NCT00926029|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25589240|NCT00926029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25589241|NCT00926029|Antimetabolites|antimetabolites|mesh-ancestor
25589242|NCT00926029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589243|NCT00926029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25589244|NCT00926185|Lifitegrast|lifitegrast|mesh-list
25589245|NCT00926185|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25589246|NCT00926185|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25589247|NCT00926263|Moxifloxacin|moxifloxacin|mesh-list
25589248|NCT00926263|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25589249|NCT00926263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25589250|NCT00926263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25589251|NCT00926263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25589252|NCT00926263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25589253|NCT00926263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25589254|NCT00926263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589255|NCT00926263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25589256|NCT00926263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589257|NCT00926263|Immunologic Factors|immunologic factors|mesh-ancestor
25589258|NCT00926289|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25589259|NCT00926289|Telmisartan|telmisartan|mesh-list
25589260|NCT00926289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25589261|NCT00926289|Diuretics|diuretics|mesh-ancestor
25589262|NCT00926289|Natriuretic Agents|natriuretic agents|mesh-ancestor
25589263|NCT00926289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589264|NCT00926289|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25589265|NCT00926289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25589266|NCT00926289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589267|NCT00926289|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25589268|NCT00926289|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25589269|NCT00926328|Triclosan|triclosan|mesh-list
25589270|NCT00926328|Fluorides|fluorides|mesh-list
25589271|NCT00926328|Cariostatic Agents|cariostatic agents|mesh-ancestor
25589272|NCT00926328|Protective Agents|protective agents|mesh-ancestor
25589273|NCT00926328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589274|NCT00926328|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25589275|NCT00926328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25589276|NCT00926328|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25589277|NCT00926328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25589278|NCT00926328|Antimetabolites|antimetabolites|mesh-ancestor
25589279|NCT00926328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589280|NCT00926328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25589281|NCT00926367|Clindamycin|clindamycin|mesh-list
25589282|NCT00926367|Clindamycin palmitate|clindamycin palmitate|mesh-list
25589283|NCT00926367|Clindamycin phosphate|clindamycin phosphate|mesh-list
25589284|NCT00926367|Adapalene|adapalene|mesh-list
25589285|NCT00926367|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25589286|NCT00926367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25589287|NCT00926367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25589288|NCT00926367|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25589289|NCT00926367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25589290|NCT00926367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589291|NCT00926367|Dermatologic Agents|dermatologic agents|mesh-ancestor
25589292|NCT00926367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25589293|NCT00926367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25589294|NCT00926367|Analgesics|analgesics|mesh-ancestor
25589295|NCT00926367|Sensory System Agents|sensory system agents|mesh-ancestor
25589296|NCT00926367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25589297|NCT00926367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589298|NCT00926367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25589299|NCT00926367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25589300|NCT00926380|Denosumab|denosumab|mesh-list
25589301|NCT00926380|Teriparatide|teriparatide|mesh-list
25589303|NCT00926380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589304|NCT00926380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25589305|NCT00926393|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25589306|NCT00926393|Antidepressive Agents|antidepressive agents|mesh-ancestor
25589307|NCT00926393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24545867|NCT00695344|Antimetabolites|antimetabolites|mesh-ancestor
24545869|NCT00695344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25589308|NCT00926393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25589309|NCT00926393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25589310|NCT00926393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25589311|NCT00926393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589312|NCT00926588|Analgesics|analgesics|mesh-list
25589313|NCT00926588|Sensory System Agents|sensory system agents|mesh-ancestor
25589314|NCT00926588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25589315|NCT00926588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589316|NCT00926796|Azithromycin|azithromycin|mesh-list
25589317|NCT00926796|Gentamicins|gentamicins|mesh-list
25589318|NCT00926796|Gemifloxacin|gemifloxacin|mesh-list
25589319|NCT00926796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25589320|NCT00926796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25589321|NCT00926796|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25589322|NCT00926796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25589323|NCT00926796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589324|NCT00926796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25589325|NCT00926796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25589326|NCT00926796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25589327|NCT00926952|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
25589328|NCT00926952|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25589329|NCT00926952|Dermatologic Agents|dermatologic agents|mesh-ancestor
25589330|NCT00927069|Adalimumab|adalimumab|mesh-list
25589331|NCT00927069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25589332|NCT00927069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25589333|NCT00927082|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25589334|NCT00927082|Antiviral Agents|antiviral agents|mesh-ancestor
25589335|NCT00927082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25589336|NCT00927095|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
25589337|NCT00927095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25589338|NCT00927095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589339|NCT00927186|Zoledronic Acid|zoledronic acid|mesh-list
25589340|NCT00927186|Teriparatide|teriparatide|mesh-list
25589341|NCT00927186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25589342|NCT00927186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589343|NCT00927186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25589344|NCT00927355|Pioglitazone|pioglitazone|mesh-list
25589345|NCT00927355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25589346|NCT00927355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589347|NCT00927394|Valsartan|valsartan|mesh-list
25589348|NCT00927394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25589349|NCT00927394|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25589350|NCT00927394|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25589351|NCT00927394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589352|NCT00927472|Permethrin|permethrin|mesh-list
25589353|NCT00927472|Malathion|malathion|mesh-list
25589354|NCT00927472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25589355|NCT00927472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589356|NCT00927472|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25589357|NCT00927472|Cholinergic Agents|cholinergic agents|mesh-ancestor
24545942|NCT00696033|Antiemetics|antiemetics|mesh-ancestor
24545943|NCT00696033|Autonomic Agents|autonomic agents|mesh-ancestor
25589358|NCT00927472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25589359|NCT00927472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589360|NCT00927485|Curcumin|curcumin|mesh-list
25589361|NCT00927485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25589362|NCT00927485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25589363|NCT00927485|Analgesics|analgesics|mesh-ancestor
25589364|NCT00927485|Sensory System Agents|sensory system agents|mesh-ancestor
25589365|NCT00927485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25589366|NCT00927485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589367|NCT00927485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25589368|NCT00927485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25589369|NCT00927485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25589370|NCT00927485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25589371|NCT00927485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589372|NCT00927563|Tolcapone|tolcapone|mesh-list
25589373|NCT00927563|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25589374|NCT00927563|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25589375|NCT00927563|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25589376|NCT00927563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25589377|NCT00927563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589378|NCT00927589|Carboplatin|carboplatin|mesh-list
25589379|NCT00927589|Docetaxel|docetaxel|mesh-list
25589380|NCT00927589|Trastuzumab|trastuzumab|mesh-list
25589381|NCT00927589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25589382|NCT00927589|Tubulin Modulators|tubulin modulators|mesh-ancestor
25589383|NCT00927589|Antimitotic Agents|antimitotic agents|mesh-ancestor
25589384|NCT00927589|Mitosis Modulators|mitosis modulators|mesh-ancestor
25589385|NCT00927589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589386|NCT00927589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25589387|NCT00927758|Fluticasone|fluticasone|mesh-list
25589389|NCT00927758|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25589390|NCT00927758|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25589391|NCT00927758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25589392|NCT00927758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25589393|NCT00927758|Autonomic Agents|autonomic agents|mesh-ancestor
25589394|NCT00927758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25589395|NCT00927758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589396|NCT00927758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25589397|NCT00927758|Respiratory System Agents|respiratory system agents|mesh-ancestor
25589398|NCT00927758|Dermatologic Agents|dermatologic agents|mesh-ancestor
25589399|NCT00927758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25589400|NCT00927758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25589401|NCT00927758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25589402|NCT00927758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25589403|NCT00927758|Adrenergic Agents|adrenergic agents|mesh-ancestor
25589404|NCT00927758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25589405|NCT00927758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589406|NCT00927758|Glucocorticoids|glucocorticoids|mesh-ancestor
25589407|NCT00927758|Hormones|hormones|mesh-ancestor
25589408|NCT00927758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25589409|NCT00927758|Sympathomimetics|sympathomimetics|mesh-ancestor
25589410|NCT00927849|Nitroglycerin|nitroglycerin|mesh-list
25589411|NCT00927849|Botulinum Toxins|botulinum toxins|mesh-list
25589412|NCT00927849|Glycerol|glycerol|mesh-list
25589413|NCT00927849|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25589414|NCT00927849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25589415|NCT00927849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589416|NCT00927849|Cholinergic Agents|cholinergic agents|mesh-ancestor
25589417|NCT00927849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25589418|NCT00927849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589419|NCT00927849|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25589420|NCT00927849|Protective Agents|protective agents|mesh-ancestor
25589421|NCT00927849|Vasodilator Agents|vasodilator agents|mesh-ancestor
25589422|NCT00927862|Warfarin|warfarin|mesh-list
25589423|NCT00927862|Anticoagulants|anticoagulants|mesh-ancestor
25589424|NCT00927888|Bupivacaine|bupivacaine|mesh-list
25589425|NCT00927888|Anesthetics, Local|anesthetics, local|mesh-ancestor
25589426|NCT00927888|Anesthetics|anesthetics|mesh-ancestor
25589427|NCT00927888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25589428|NCT00927888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589429|NCT00927888|Sensory System Agents|sensory system agents|mesh-ancestor
25589430|NCT00927888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25589431|NCT00927901|Maleic acid|maleic acid|mesh-list
25589432|NCT00927901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25589433|NCT00927901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589434|NCT00928018|Cyclosporine|cyclosporine|mesh-list
25589435|NCT00928018|Sirolimus|sirolimus|mesh-list
25589436|NCT00928018|Mycophenolic Acid|mycophenolic acid|mesh-list
25589437|NCT00928018|Methotrexate|methotrexate|mesh-list
25589438|NCT00928018|Tacrolimus|tacrolimus|mesh-list
25589439|NCT00928018|Cyclosporins|cyclosporins|mesh-list
25589440|NCT00928018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25589441|NCT00928018|Abortifacient Agents|abortifacient agents|mesh-ancestor
25589442|NCT00928018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25589443|NCT00928018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589444|NCT00928018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25589445|NCT00928018|Antimetabolites|antimetabolites|mesh-ancestor
25589446|NCT00928018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589447|NCT00928018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25589448|NCT00928018|Dermatologic Agents|dermatologic agents|mesh-ancestor
25589449|NCT00928018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25589450|NCT00928018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25589451|NCT00928018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25589453|NCT00928018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25589454|NCT00928018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25589455|NCT00928018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25589456|NCT00928018|Antifungal Agents|antifungal agents|mesh-ancestor
25589457|NCT00928018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25589458|NCT00928018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25589459|NCT00928018|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25589460|NCT00928018|Antitubercular Agents|antitubercular agents|mesh-ancestor
25589461|NCT00928018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25589462|NCT00928070|Fesoterodine|fesoterodine|mesh-list
25589463|NCT00928070|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25589464|NCT00928070|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24528252|NCT00620581|Paroxetine|paroxetine|mesh-list
25589465|NCT00928070|Cholinergic Agents|cholinergic agents|mesh-ancestor
25589466|NCT00928070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25589467|NCT00928070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589468|NCT00928070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589469|NCT00928070|Urological Agents|urological agents|mesh-ancestor
25589470|NCT00928083|Artefenomel|artefenomel|mesh-list
25589471|NCT00928083|Antimalarials|antimalarials|mesh-ancestor
25589472|NCT00928083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25589473|NCT00928083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25589474|NCT00928083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25589475|NCT00928174|Fluorides|fluorides|mesh-list
25589476|NCT00928174|Cariostatic Agents|cariostatic agents|mesh-ancestor
25589477|NCT00928174|Protective Agents|protective agents|mesh-ancestor
25589478|NCT00928174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589479|NCT00928187|Ritonavir|ritonavir|mesh-list
25589480|NCT00928187|Lopinavir|lopinavir|mesh-list
25589481|NCT00928187|Darunavir|darunavir|mesh-list
25589482|NCT00928187|Tenofovir|tenofovir|mesh-list
25589483|NCT00928187|Emtricitabine|emtricitabine|mesh-list
25589484|NCT00928187|Abacavir|abacavir|mesh-list
25589485|NCT00928187|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25589486|NCT00928187|Didanosine|didanosine|mesh-list
25589487|NCT00928187|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25589488|NCT00928187|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25589489|NCT00928187|Protease Inhibitors|protease inhibitors|mesh-ancestor
25589490|NCT00928187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25589491|NCT00928187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589492|NCT00928187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24636289|NCT01144533|Viscosupplements|viscosupplements|mesh-ancestor
25589493|NCT00928187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25589494|NCT00928187|Antiviral Agents|antiviral agents|mesh-ancestor
25589495|NCT00928187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25589496|NCT00928187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25589497|NCT00928187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25589498|NCT00928187|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25589499|NCT00928187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24542897|NCT00680732|Vitamin B Complex|vitamin b complex|mesh-ancestor
25589500|NCT00928187|Antimetabolites|antimetabolites|mesh-ancestor
25589501|NCT00928200|Cytarabine|cytarabine|mesh-list
25589502|NCT00928200|Dexamethasone|dexamethasone|mesh-list
25589503|NCT00928200|Dexamethasone acetate|dexamethasone acetate|mesh-list
25589504|NCT00928200|Doxorubicin|doxorubicin|mesh-list
25589505|NCT00928200|Methotrexate|methotrexate|mesh-list
25589506|NCT00928200|Vincristine|vincristine|mesh-list
25589507|NCT00928200|Asparaginase|asparaginase|mesh-list
25589508|NCT00928200|Dexrazoxane|dexrazoxane|mesh-list
25589509|NCT00928200|Razoxane|razoxane|mesh-list
25589510|NCT00928200|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25589511|NCT00928200|BB 1101|bb 1101|mesh-list
25589512|NCT00928200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25589513|NCT00928200|Antiemetics|antiemetics|mesh-ancestor
25589514|NCT00928200|Autonomic Agents|autonomic agents|mesh-ancestor
25589515|NCT00928200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25589516|NCT00928200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589517|NCT00928200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25589518|NCT00928200|Glucocorticoids|glucocorticoids|mesh-ancestor
25589519|NCT00928200|Hormones|hormones|mesh-ancestor
25589520|NCT00928200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25589521|NCT00928200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25589522|NCT00928200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25589523|NCT00928200|Protease Inhibitors|protease inhibitors|mesh-ancestor
25589524|NCT00928200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25589525|NCT00928200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589526|NCT00928200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25589527|NCT00928200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25589528|NCT00928200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25589529|NCT00928200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25589530|NCT00928200|Abortifacient Agents|abortifacient agents|mesh-ancestor
25589531|NCT00928200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25589532|NCT00928200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25589533|NCT00928200|Antimetabolites|antimetabolites|mesh-ancestor
25589534|NCT00928200|Dermatologic Agents|dermatologic agents|mesh-ancestor
25589535|NCT00928200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25589536|NCT00928200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25589537|NCT00928200|Immunologic Factors|immunologic factors|mesh-ancestor
25589538|NCT00928200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25589539|NCT00928200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25589540|NCT00928200|Antiviral Agents|antiviral agents|mesh-ancestor
25589541|NCT00928200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25589542|NCT00928200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25589543|NCT00928200|Tubulin Modulators|tubulin modulators|mesh-ancestor
25589544|NCT00928200|Antimitotic Agents|antimitotic agents|mesh-ancestor
25589545|NCT00928200|Mitosis Modulators|mitosis modulators|mesh-ancestor
25589546|NCT00928200|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25589547|NCT00928200|Protective Agents|protective agents|mesh-ancestor
25589548|NCT00928252|Fluorides|fluorides|mesh-list
25589549|NCT00928252|Cariostatic Agents|cariostatic agents|mesh-ancestor
25589550|NCT00928252|Protective Agents|protective agents|mesh-ancestor
25589551|NCT00928252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589552|NCT00928408|Cinacalcet|cinacalcet|mesh-list
25589553|NCT00928408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25589554|NCT00928408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589555|NCT00928408|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25589556|NCT00928408|Hormone Antagonists|hormone antagonists|mesh-ancestor
25589557|NCT00928408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25653332|NCT01536535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25653333|NCT01536535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25653334|NCT01536535|Analgesics|analgesics|mesh-ancestor
25653335|NCT01536535|Sensory System Agents|sensory system agents|mesh-ancestor
25653336|NCT01536535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653337|NCT01536535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25653338|NCT01536561|Tositumomab I-131|tositumomab i-131|mesh-list
25653339|NCT01536561|Antibodies|antibodies|mesh-list
25653340|NCT01536561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25653341|NCT01536561|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
25653342|NCT01536561|Immunologic Factors|immunologic factors|mesh-ancestor
25653343|NCT01536561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653344|NCT01536561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25653345|NCT01536574|Ropinirole|ropinirole|mesh-list
25653346|NCT01536574|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25653347|NCT01536574|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25653348|NCT01536574|Dopamine Agonists|dopamine agonists|mesh-ancestor
25653349|NCT01536574|Dopamine Agents|dopamine agents|mesh-ancestor
25653350|NCT01536574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25653351|NCT01536574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653352|NCT01536574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653353|NCT01536587|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25653354|NCT01536587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25653355|NCT01536587|Autonomic Agents|autonomic agents|mesh-ancestor
25653356|NCT01536587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653357|NCT01536587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653358|NCT01536587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25653359|NCT01536587|Respiratory System Agents|respiratory system agents|mesh-ancestor
25653360|NCT01536587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25653361|NCT01536587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25653362|NCT01536587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25653363|NCT01536587|Adrenergic Agents|adrenergic agents|mesh-ancestor
25653364|NCT01536587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25653365|NCT01536587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653366|NCT01536704|Nicotine|nicotine|mesh-list
25653367|NCT01536704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25653368|NCT01536704|Autonomic Agents|autonomic agents|mesh-ancestor
25653369|NCT01536704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653370|NCT01536704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653371|NCT01536704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25653372|NCT01536704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25653373|NCT01536704|Cholinergic Agents|cholinergic agents|mesh-ancestor
25484176|NCT00142168|Rituximab|rituximab|mesh-list
25653374|NCT01536704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25589558|NCT00928421|Polidocanol|polidocanol|mesh-list
25589559|NCT00928421|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25589560|NCT00928421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25589561|NCT00928434|Leuprolide|leuprolide|mesh-list
25589562|NCT00928434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25589563|NCT00928434|Fertility Agents|fertility agents|mesh-ancestor
25589564|NCT00928434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25589565|NCT00928434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589566|NCT00928434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25589567|NCT00928434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25589568|NCT00928486|Dexamethasone|dexamethasone|mesh-list
25589569|NCT00928486|Lenalidomide|lenalidomide|mesh-list
25589570|NCT00928486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25589571|NCT00928486|Antiemetics|antiemetics|mesh-ancestor
25589572|NCT00928486|Autonomic Agents|autonomic agents|mesh-ancestor
25589573|NCT00928486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25589574|NCT00928486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589575|NCT00928486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25589576|NCT00928486|Glucocorticoids|glucocorticoids|mesh-ancestor
25589577|NCT00928486|Hormones|hormones|mesh-ancestor
25589578|NCT00928486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25589579|NCT00928486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25589580|NCT00928486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25589581|NCT00928486|Immunologic Factors|immunologic factors|mesh-ancestor
25589582|NCT00928486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25589583|NCT00928486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25589584|NCT00928486|Growth Substances|growth substances|mesh-ancestor
25589585|NCT00928486|Growth Inhibitors|growth inhibitors|mesh-ancestor
25589586|NCT00928642|Gemcitabine|gemcitabine|mesh-list
25589587|NCT00928642|Imatinib Mesylate|imatinib mesylate|mesh-list
25589588|NCT00928642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25589589|NCT00928642|Antimetabolites|antimetabolites|mesh-ancestor
25589590|NCT00928642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589591|NCT00928642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25589592|NCT00928642|Antiviral Agents|antiviral agents|mesh-ancestor
25589593|NCT00928642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25589594|NCT00928642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25589595|NCT00928642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25589596|NCT00928642|Immunologic Factors|immunologic factors|mesh-ancestor
25589597|NCT00928642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589598|NCT00928642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25589599|NCT00928668|Olodaterol|olodaterol|mesh-list
25589600|NCT00928668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25589601|NCT00928668|Autonomic Agents|autonomic agents|mesh-ancestor
25589602|NCT00928668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25589603|NCT00928668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589604|NCT00928668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25589605|NCT00928668|Respiratory System Agents|respiratory system agents|mesh-ancestor
25589606|NCT00928694|Fenofibrate|fenofibrate|mesh-list
25589607|NCT00928694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25589608|NCT00928694|Antimetabolites|antimetabolites|mesh-ancestor
25589609|NCT00928694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589610|NCT00928694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25589611|NCT00928707|Hydroxyurea|hydroxyurea|mesh-list
25589612|NCT00928707|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
25589613|NCT00928707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25589614|NCT00928707|Antisickling Agents|antisickling agents|mesh-ancestor
25589615|NCT00928707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25589616|NCT00928707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589617|NCT00928707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25589618|NCT00928707|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25589619|NCT00928746|Bromides|bromides|mesh-list
25705020|NCT02192684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705021|NCT02192814|Lacosamide|lacosamide|mesh-list
24940049|NCT04004117|Fentanyl|fentanyl|mesh-list
24940050|NCT04004117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25589620|NCT00928746|Ipratropium|ipratropium|mesh-list
25589621|NCT00928746|Anticonvulsants|anticonvulsants|mesh-ancestor
25589622|NCT00928746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25589623|NCT00928746|Autonomic Agents|autonomic agents|mesh-ancestor
25589624|NCT00928746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25589625|NCT00928746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589626|NCT00928746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25589627|NCT00928746|Respiratory System Agents|respiratory system agents|mesh-ancestor
25589628|NCT00928746|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25589629|NCT00928746|Cholinergic Agents|cholinergic agents|mesh-ancestor
25589630|NCT00928746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25589631|NCT00928746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589632|NCT00928772|Midazolam|midazolam|mesh-list
25589633|NCT00928772|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25589634|NCT00928772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25589635|NCT00928772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25589636|NCT00928772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589637|NCT00928772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25589638|NCT00928772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25589639|NCT00928772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25589640|NCT00928772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25589641|NCT00928772|Anesthetics, General|anesthetics, general|mesh-ancestor
25589642|NCT00928772|Anesthetics|anesthetics|mesh-ancestor
25589643|NCT00928772|GABA Modulators|gaba modulators|mesh-ancestor
25589644|NCT00928772|GABA Agents|gaba agents|mesh-ancestor
25589645|NCT00928772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25589646|NCT00928772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589647|NCT00928889|Acarbose|acarbose|mesh-list
25589648|NCT00928889|Nateglinide|nateglinide|mesh-list
25589649|NCT00928889|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25589650|NCT00928889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25589651|NCT00928889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589652|NCT00928889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25589653|NCT00928889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589654|NCT00928954|Gabapentin|gabapentin|mesh-list
25589655|NCT00928954|Memantine|memantine|mesh-list
25589656|NCT00928954|Analgesics|analgesics|mesh-ancestor
25589657|NCT00928954|Sensory System Agents|sensory system agents|mesh-ancestor
25589658|NCT00928954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25589659|NCT00928954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589660|NCT00928954|Anticonvulsants|anticonvulsants|mesh-ancestor
25589661|NCT00928954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25589662|NCT00928954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25589663|NCT00928954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25589664|NCT00928954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25589665|NCT00928954|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25589666|NCT00928954|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25589667|NCT00928954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25589668|NCT00928954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589669|NCT00928954|Antimanic Agents|antimanic agents|mesh-ancestor
25589670|NCT00928954|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25589671|NCT00928954|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25589672|NCT00928954|Dopamine Agents|dopamine agents|mesh-ancestor
25589673|NCT00929071|Lidocaine|lidocaine|mesh-list
25589674|NCT00929071|Anesthetics, Local|anesthetics, local|mesh-list
25589675|NCT00929071|Anesthetics|anesthetics|mesh-list
25589676|NCT00929071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25589677|NCT00929071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589678|NCT00929071|Sensory System Agents|sensory system agents|mesh-ancestor
25589679|NCT00929071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25589680|NCT00929071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25589681|NCT00929071|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25589682|NCT00929071|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25589683|NCT00929071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25589684|NCT00929071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589685|NCT00929110|Glycopyrrolate|glycopyrrolate|mesh-list
25589686|NCT00929110|Bromides|bromides|mesh-list
25589687|NCT00929110|Tiotropium Bromide|tiotropium bromide|mesh-list
25589688|NCT00929110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25589689|NCT00929110|Autonomic Agents|autonomic agents|mesh-ancestor
25589690|NCT00929110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25589691|NCT00929110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589692|NCT00929110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25589693|NCT00929110|Respiratory System Agents|respiratory system agents|mesh-ancestor
25589694|NCT00929110|Parasympatholytics|parasympatholytics|mesh-ancestor
25589695|NCT00929110|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25589696|NCT00929110|Cholinergic Agents|cholinergic agents|mesh-ancestor
25589697|NCT00929110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25589698|NCT00929110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589699|NCT00929110|Anticonvulsants|anticonvulsants|mesh-ancestor
25589700|NCT00929110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25589701|NCT00929110|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25589702|NCT00929162|Paclitaxel|paclitaxel|mesh-list
25589703|NCT00929162|Carboplatin|carboplatin|mesh-list
25589704|NCT00929162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25589705|NCT00929162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484313|NCT00144300|Pramipexole|pramipexole|mesh-list
25484314|NCT00144300|Antioxidants|antioxidants|mesh-ancestor
25589706|NCT00929162|Tubulin Modulators|tubulin modulators|mesh-ancestor
25589707|NCT00929162|Antimitotic Agents|antimitotic agents|mesh-ancestor
25484385|NCT00145327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25484386|NCT00145327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484387|NCT00145418|Docetaxel|docetaxel|mesh-list
25484388|NCT00145418|Oxaliplatin|oxaliplatin|mesh-list
25484389|NCT00145418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484390|NCT00145418|Tubulin Modulators|tubulin modulators|mesh-ancestor
25484391|NCT00145418|Antimitotic Agents|antimitotic agents|mesh-ancestor
25484392|NCT00145418|Mitosis Modulators|mitosis modulators|mesh-ancestor
25484393|NCT00145418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484394|NCT00145574|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
25484395|NCT00145574|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25484396|NCT00145574|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25484397|NCT00145574|Antimetabolites|antimetabolites|mesh-ancestor
25484398|NCT00145574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484399|NCT00145574|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25484400|NCT00145587|Antibodies|antibodies|mesh-list
25484401|NCT00145587|Immunologic Factors|immunologic factors|mesh-ancestor
25484402|NCT00145587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484403|NCT00145626|Cyclophosphamide|cyclophosphamide|mesh-list
25484404|NCT00145626|Melphalan|melphalan|mesh-list
25484405|NCT00145626|Thiotepa|thiotepa|mesh-list
25484406|NCT00145626|Fludarabine|fludarabine|mesh-list
25484407|NCT00145626|Antibodies|antibodies|mesh-list
25484408|NCT00145626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25484409|NCT00145626|Immunologic Factors|immunologic factors|mesh-ancestor
25484410|NCT00145626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484411|NCT00145626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25484412|NCT00145626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25484413|NCT00145626|Alkylating Agents|alkylating agents|mesh-ancestor
25484414|NCT00145626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484415|NCT00145626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484416|NCT00145626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24445832|NCT00302692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979680|NCT03032510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979681|NCT03032510|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24979682|NCT03032510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24979683|NCT03029000|Lenograstim|lenograstim|mesh-list
24536659|NCT00652002|Budesonide|budesonide|mesh-list
25822733|NCT00004585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24433478|NCT00258557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24433519|NCT00258739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25589708|NCT00929162|Mitosis Modulators|mitosis modulators|mesh-ancestor
24433520|NCT00258739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433521|NCT00258739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24433522|NCT00258739|Immunologic Factors|immunologic factors|mesh-ancestor
25589709|NCT00929162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589710|NCT00929201|Metformin|metformin|mesh-list
25589711|NCT00929201|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25589712|NCT00929201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25589713|NCT00929201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589714|NCT00929201|Incretins|incretins|mesh-ancestor
25589715|NCT00929201|Hormones|hormones|mesh-ancestor
25589716|NCT00929201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25589717|NCT00929201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25589718|NCT00929201|Protease Inhibitors|protease inhibitors|mesh-ancestor
25589719|NCT00929201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25589720|NCT00929201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589721|NCT00929240|Bevacizumab|bevacizumab|mesh-list
25589722|NCT00929240|Capecitabine|capecitabine|mesh-list
25589723|NCT00929240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25589724|NCT00929240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25589725|NCT00929240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25589726|NCT00929240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25589727|NCT00929240|Growth Substances|growth substances|mesh-ancestor
25589728|NCT00929240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589729|NCT00929240|Growth Inhibitors|growth inhibitors|mesh-ancestor
25589730|NCT00929240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25589731|NCT00929240|Antimetabolites|antimetabolites|mesh-ancestor
25589732|NCT00929240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589733|NCT00929344|Pregabalin|pregabalin|mesh-list
25589734|NCT00929344|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25589735|NCT00929344|Analgesics|analgesics|mesh-ancestor
25589736|NCT00929344|Sensory System Agents|sensory system agents|mesh-ancestor
25589737|NCT00929344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25589738|NCT00929344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589739|NCT00929344|Anticonvulsants|anticonvulsants|mesh-ancestor
25589740|NCT00929344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25589741|NCT00929344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25589742|NCT00929344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589743|NCT00929344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25589744|NCT00929344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25589745|NCT00929344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25589746|NCT00929344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25589747|NCT00929344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25589748|NCT00929344|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25589749|NCT00929344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24863937|NCT02837783|Linaclotide|linaclotide|mesh-list
24863938|NCT02837783|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25589750|NCT00929344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25589751|NCT00929344|Antidepressive Agents|antidepressive agents|mesh-ancestor
25589752|NCT00929344|Dopamine Agents|dopamine agents|mesh-ancestor
25589753|NCT00929383|Hemostatics|hemostatics|mesh-list
25589754|NCT00929383|Coagulants|coagulants|mesh-ancestor
25589755|NCT00929578|Fluphenazine|fluphenazine|mesh-list
25589756|NCT00929578|Fluphenazine depot|fluphenazine depot|mesh-list
25589757|NCT00929578|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
25589758|NCT00929578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25589759|NCT00929578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25589760|NCT00929578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25589761|NCT00929578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589762|NCT00929578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25589763|NCT00929578|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25589764|NCT00929578|Dopamine Agents|dopamine agents|mesh-ancestor
25589765|NCT00929578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25589766|NCT00929578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589767|NCT00929669|Pasireotide|pasireotide|mesh-list
25589768|NCT00929669|Hormones|hormones|mesh-ancestor
25589769|NCT00929669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25589770|NCT00929669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589771|NCT00929695|Prednisone|prednisone|mesh-list
25589772|NCT00929695|Methylprednisolone|methylprednisolone|mesh-list
25589773|NCT00929695|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25589774|NCT00929695|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25589775|NCT00929695|Prednisolone|prednisolone|mesh-list
25589776|NCT00929695|Prednisolone acetate|prednisolone acetate|mesh-list
25589777|NCT00929695|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25589778|NCT00929695|Prednisolone phosphate|prednisolone phosphate|mesh-list
25589779|NCT00929695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25589780|NCT00929695|Glucocorticoids|glucocorticoids|mesh-ancestor
25589781|NCT00929695|Hormones|hormones|mesh-ancestor
25589782|NCT00929695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25589783|NCT00929695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589784|NCT00929695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25589785|NCT00929695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25589786|NCT00929695|Antiemetics|antiemetics|mesh-ancestor
25589787|NCT00929695|Autonomic Agents|autonomic agents|mesh-ancestor
25589788|NCT00929695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25589789|NCT00929695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25589790|NCT00929695|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25589791|NCT00929695|Protective Agents|protective agents|mesh-ancestor
25589792|NCT00929708|Formoterol Fumarate|formoterol fumarate|mesh-list
25589793|NCT00929708|AZD-3199|azd-3199|mesh-list
25589794|NCT00929708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25589795|NCT00929708|Autonomic Agents|autonomic agents|mesh-ancestor
25589796|NCT00929708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25589797|NCT00929708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589798|NCT00929708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25589799|NCT00929708|Respiratory System Agents|respiratory system agents|mesh-ancestor
25589800|NCT00929708|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25589801|NCT00929708|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25589802|NCT00929708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25589803|NCT00929708|Adrenergic Agents|adrenergic agents|mesh-ancestor
25589804|NCT00929708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25589805|NCT00929708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589806|NCT00929734|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25589807|NCT00929734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
25589808|NCT00929734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25589809|NCT00929734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25589810|NCT00929734|Antimetabolites|antimetabolites|mesh-ancestor
25657197|NCT01584232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589811|NCT00929734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589812|NCT00929734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25589813|NCT00929734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25589814|NCT00929864|Adalimumab|adalimumab|mesh-list
25589815|NCT00929864|Abatacept|abatacept|mesh-list
25589816|NCT00929864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25589817|NCT00929864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25589818|NCT00929864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25589819|NCT00929864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589820|NCT00929864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25589821|NCT00929864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25589822|NCT00929864|Immunologic Factors|immunologic factors|mesh-ancestor
25589823|NCT00929864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589824|NCT00929981|Methylprednisolone|methylprednisolone|mesh-list
25589825|NCT00929981|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25589826|NCT00929981|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25589827|NCT00929981|Prednisolone|prednisolone|mesh-list
25589828|NCT00929981|Prednisolone acetate|prednisolone acetate|mesh-list
25589829|NCT00929981|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25589830|NCT00929981|Prednisolone phosphate|prednisolone phosphate|mesh-list
25589831|NCT00929981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25589832|NCT00929981|Antiemetics|antiemetics|mesh-ancestor
25589833|NCT00929981|Autonomic Agents|autonomic agents|mesh-ancestor
25589834|NCT00929981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25589835|NCT00929981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589836|NCT00929981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25589837|NCT00929981|Glucocorticoids|glucocorticoids|mesh-ancestor
25589838|NCT00929981|Hormones|hormones|mesh-ancestor
25589839|NCT00929981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25589840|NCT00929981|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25589841|NCT00929981|Protective Agents|protective agents|mesh-ancestor
25589842|NCT00929981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25705054|NCT02193776|Moxifloxacin|moxifloxacin|mesh-list
25589843|NCT00929981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25589844|NCT00930046|Ropivacaine|ropivacaine|mesh-list
25589845|NCT00930046|Anesthetics, Local|anesthetics, local|mesh-ancestor
25589846|NCT00930046|Anesthetics|anesthetics|mesh-ancestor
25589847|NCT00930046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25589848|NCT00930046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589849|NCT00930046|Sensory System Agents|sensory system agents|mesh-ancestor
25589850|NCT00930046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25589851|NCT00930293|Dexetimide|dexetimide|mesh-list
25589852|NCT00930293|Citalopram|citalopram|mesh-list
25589853|NCT00930293|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25589854|NCT00930293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25589855|NCT00930293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25589856|NCT00930293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589857|NCT00930293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25589858|NCT00930293|Serotonin Agents|serotonin agents|mesh-ancestor
25589859|NCT00930293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589860|NCT00930293|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25589861|NCT00930293|Antidepressive Agents|antidepressive agents|mesh-ancestor
25589862|NCT00930293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25589863|NCT00930293|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25589864|NCT00930293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25589865|NCT00930293|Parasympatholytics|parasympatholytics|mesh-ancestor
25589866|NCT00930293|Autonomic Agents|autonomic agents|mesh-ancestor
25589867|NCT00930293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25589868|NCT00930293|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25589869|NCT00930293|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25589870|NCT00930293|Cholinergic Agents|cholinergic agents|mesh-ancestor
25589871|NCT00930553|Alemtuzumab|alemtuzumab|mesh-list
25589872|NCT00930553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25589873|NCT00930553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25589874|NCT00930644|Teduglutide|teduglutide|mesh-list
25589875|NCT00930644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25589876|NCT00930644|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25589877|NCT00930644|Protective Agents|protective agents|mesh-ancestor
25589878|NCT00930644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589879|NCT00930930|Paclitaxel|paclitaxel|mesh-list
25589880|NCT00930930|Cisplatin|cisplatin|mesh-list
25589881|NCT00930930|Everolimus|everolimus|mesh-list
25709653|NCT02271854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24548447|NCT00709553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25589882|NCT00930930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25589883|NCT00930930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25589884|NCT00930930|Tubulin Modulators|tubulin modulators|mesh-ancestor
25589885|NCT00930930|Antimitotic Agents|antimitotic agents|mesh-ancestor
25589886|NCT00930930|Mitosis Modulators|mitosis modulators|mesh-ancestor
25589887|NCT00930930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589888|NCT00930930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25589889|NCT00930930|Immunologic Factors|immunologic factors|mesh-ancestor
25589890|NCT00930930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589891|NCT00930982|Ciprofloxacin|ciprofloxacin|mesh-list
25589892|NCT00930982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25589893|NCT00930982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25589894|NCT00930982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25589895|NCT00930982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25589896|NCT00930982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25589897|NCT00930982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589898|NCT00930982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25589899|NCT00930982|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25589900|NCT00930982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25589901|NCT00931164|Sodium Oxybate|sodium oxybate|mesh-list
25589902|NCT00931164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25589903|NCT00931164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25589904|NCT00931164|Anesthetics, General|anesthetics, general|mesh-ancestor
25589905|NCT00931164|Anesthetics|anesthetics|mesh-ancestor
25589906|NCT00931164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25589907|NCT00931164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589908|NCT00931242|Thalidomide|thalidomide|mesh-list
25589910|NCT00931242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25589911|NCT00931242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25589912|NCT00931242|Analgesics|analgesics|mesh-ancestor
25589913|NCT00931242|Sensory System Agents|sensory system agents|mesh-ancestor
25589914|NCT00931242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25589915|NCT00931242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589916|NCT00931242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25589917|NCT00931242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25589918|NCT00931242|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25589919|NCT00931242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25589920|NCT00931242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25589921|NCT00931242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589922|NCT00931242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25589923|NCT00931242|Immunologic Factors|immunologic factors|mesh-ancestor
25589924|NCT00931242|Leprostatic Agents|leprostatic agents|mesh-ancestor
25589925|NCT00931242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25589926|NCT00931242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25589927|NCT00931242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25589928|NCT00931242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25589929|NCT00931242|Growth Substances|growth substances|mesh-ancestor
25589930|NCT00931242|Growth Inhibitors|growth inhibitors|mesh-ancestor
25589931|NCT00931242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25589932|NCT00931385|Formoterol Fumarate|formoterol fumarate|mesh-list
25589933|NCT00931385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25589934|NCT00931385|Autonomic Agents|autonomic agents|mesh-ancestor
25589935|NCT00931385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25589936|NCT00931385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589937|NCT00931385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25589938|NCT00931385|Respiratory System Agents|respiratory system agents|mesh-ancestor
25589939|NCT00931385|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25589940|NCT00931385|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24823584|NCT02117986|Colistin|colistin|mesh-list
25589941|NCT00931385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25589942|NCT00931385|Adrenergic Agents|adrenergic agents|mesh-ancestor
25589943|NCT00931385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25589944|NCT00931385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589945|NCT00931463|Ritonavir|ritonavir|mesh-list
25589946|NCT00931463|Lopinavir|lopinavir|mesh-list
25589947|NCT00931463|Raltegravir Potassium|raltegravir potassium|mesh-list
25589948|NCT00931463|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25589949|NCT00931463|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25589950|NCT00931463|Protease Inhibitors|protease inhibitors|mesh-ancestor
25589951|NCT00931463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25589952|NCT00931463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589953|NCT00931463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25589954|NCT00931463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25589955|NCT00931463|Antiviral Agents|antiviral agents|mesh-ancestor
25589956|NCT00931463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25589957|NCT00931463|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25589958|NCT00931463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25589959|NCT00931463|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25589960|NCT00931463|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25589962|NCT00931489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25589963|NCT00931489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25589964|NCT00931489|Growth Substances|growth substances|mesh-ancestor
25589965|NCT00931489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589966|NCT00931489|Growth Inhibitors|growth inhibitors|mesh-ancestor
25589967|NCT00931489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25589968|NCT00931528|Tadalafil|tadalafil|mesh-list
25589969|NCT00931528|Vasodilator Agents|vasodilator agents|mesh-ancestor
25589970|NCT00931528|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25589971|NCT00931528|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25589972|NCT00931528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25589973|NCT00931528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589974|NCT00931528|Urological Agents|urological agents|mesh-ancestor
25589975|NCT00931632|Nitric Oxide|nitric oxide|mesh-list
25589976|NCT00931632|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25589977|NCT00931632|Autonomic Agents|autonomic agents|mesh-ancestor
25589978|NCT00931632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25589979|NCT00931632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25589980|NCT00931632|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25589981|NCT00931632|Respiratory System Agents|respiratory system agents|mesh-ancestor
25589982|NCT00931632|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25589983|NCT00931632|Antioxidants|antioxidants|mesh-ancestor
25589984|NCT00931632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589985|NCT00931632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25589986|NCT00931632|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25589987|NCT00931632|Vasodilator Agents|vasodilator agents|mesh-ancestor
25589988|NCT00931632|Gasotransmitters|gasotransmitters|mesh-ancestor
25589989|NCT00931632|Protective Agents|protective agents|mesh-ancestor
25589990|NCT00931710|Losartan|losartan|mesh-list
25589991|NCT00931710|Amlodipine|amlodipine|mesh-list
25589992|NCT00931710|Valsartan|valsartan|mesh-list
25589993|NCT00931710|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25589994|NCT00931710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25589995|NCT00931710|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25589996|NCT00931710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25589997|NCT00931710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25589998|NCT00931710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25589999|NCT00931710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590000|NCT00931710|Vasodilator Agents|vasodilator agents|mesh-ancestor
25590001|NCT00931710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25590002|NCT00931710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25590003|NCT00931710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25590004|NCT00931710|Diuretics|diuretics|mesh-ancestor
25590005|NCT00931710|Natriuretic Agents|natriuretic agents|mesh-ancestor
25590006|NCT00931710|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25590007|NCT00931723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25590008|NCT00931723|Antidepressive Agents|antidepressive agents|mesh-ancestor
25590009|NCT00931723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25590010|NCT00931723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25590011|NCT00931723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25590012|NCT00931723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25590013|NCT00931723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590014|NCT00931762|Panobinostat|panobinostat|mesh-list
25590015|NCT00931762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590016|NCT00931762|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25590017|NCT00931762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590018|NCT00931762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590019|NCT00931801|Tenofovir|tenofovir|mesh-list
25590020|NCT00931801|Emtricitabine|emtricitabine|mesh-list
25590021|NCT00931801|Raltegravir Potassium|raltegravir potassium|mesh-list
25590022|NCT00931801|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25590023|NCT00931801|Antiviral Agents|antiviral agents|mesh-ancestor
25590024|NCT00931801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25590025|NCT00931801|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25590026|NCT00931801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25590027|NCT00931801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590028|NCT00931801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590029|NCT00931801|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25590030|NCT00931801|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25590031|NCT00931801|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25590032|NCT00931801|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25590033|NCT00931801|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25590034|NCT00931801|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25590035|NCT00931801|Protease Inhibitors|protease inhibitors|mesh-ancestor
25590036|NCT00931918|Prednisone|prednisone|mesh-list
25590037|NCT00931918|Cyclophosphamide|cyclophosphamide|mesh-list
25590038|NCT00931918|Rituximab|rituximab|mesh-list
25590039|NCT00931918|Doxorubicin|doxorubicin|mesh-list
25590040|NCT00931918|Vincristine|vincristine|mesh-list
25590041|NCT00931918|Bortezomib|bortezomib|mesh-list
25590042|NCT00931918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25590043|NCT00931918|Immunologic Factors|immunologic factors|mesh-ancestor
24419269|NCT00211588|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25590044|NCT00931918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590045|NCT00931918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25590046|NCT00931918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25590047|NCT00931918|Alkylating Agents|alkylating agents|mesh-ancestor
25590048|NCT00931918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590049|NCT00931918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590050|NCT00931918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25590051|NCT00931918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25590052|NCT00931918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25590053|NCT00931918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25590054|NCT00931918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25590055|NCT00931918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590056|NCT00931918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25590057|NCT00931918|Glucocorticoids|glucocorticoids|mesh-ancestor
25590058|NCT00931918|Hormones|hormones|mesh-ancestor
25590059|NCT00931918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25590060|NCT00931918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25590061|NCT00931918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25590062|NCT00931918|Tubulin Modulators|tubulin modulators|mesh-ancestor
25590063|NCT00931918|Antimitotic Agents|antimitotic agents|mesh-ancestor
25590064|NCT00931918|Mitosis Modulators|mitosis modulators|mesh-ancestor
25590065|NCT00931944|Pramipexole|pramipexole|mesh-list
25590066|NCT00931944|Antioxidants|antioxidants|mesh-ancestor
25590067|NCT00931944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590068|NCT00931944|Protective Agents|protective agents|mesh-ancestor
25590069|NCT00931944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590070|NCT00931944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25590071|NCT00931944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25590072|NCT00931944|Dopamine Agonists|dopamine agonists|mesh-ancestor
25590073|NCT00931944|Dopamine Agents|dopamine agents|mesh-ancestor
25590074|NCT00931944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25590075|NCT00931996|Antipsychotic Agents|antipsychotic agents|mesh-list
25590076|NCT00931996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25590077|NCT00931996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25590078|NCT00931996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590079|NCT00931996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25590080|NCT00932022|Trospium chloride|trospium chloride|mesh-list
25590081|NCT00932022|Parasympatholytics|parasympatholytics|mesh-ancestor
25590082|NCT00932022|Autonomic Agents|autonomic agents|mesh-ancestor
25590083|NCT00932022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25590084|NCT00932022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590085|NCT00932022|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25590086|NCT00932022|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25590087|NCT00932022|Cholinergic Agents|cholinergic agents|mesh-ancestor
25590088|NCT00932022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25590089|NCT00932022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590090|NCT00932022|Urological Agents|urological agents|mesh-ancestor
25590091|NCT00932113|Folic Acid|folic acid|mesh-list
25590092|NCT00932113|Adalimumab|adalimumab|mesh-list
25590093|NCT00932113|Methotrexate|methotrexate|mesh-list
25590094|NCT00932113|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25590095|NCT00932113|Abortifacient Agents|abortifacient agents|mesh-ancestor
25590096|NCT00932113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25590097|NCT00932113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590098|NCT00932113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25590099|NCT00932113|Antimetabolites|antimetabolites|mesh-ancestor
25590100|NCT00932113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590101|NCT00932113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590102|NCT00932113|Dermatologic Agents|dermatologic agents|mesh-ancestor
25590103|NCT00932113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590104|NCT00932113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25590105|NCT00932113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25590106|NCT00932113|Immunologic Factors|immunologic factors|mesh-ancestor
25590107|NCT00932113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25590108|NCT00932113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25590109|NCT00932113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25590110|NCT00932113|Hematinics|hematinics|mesh-ancestor
25590111|NCT00932113|Vitamin B Complex|vitamin b complex|mesh-ancestor
25590112|NCT00932113|Vitamins|vitamins|mesh-ancestor
25590113|NCT00932113|Micronutrients|micronutrients|mesh-ancestor
25590114|NCT00932165|Exemestane|exemestane|mesh-list
24868008|NCT04285684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25590115|NCT00932165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590116|NCT00932165|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25590117|NCT00932165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25590118|NCT00932165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590119|NCT00932165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590120|NCT00932165|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24420536|NCT00216268|Ribavirin|ribavirin|mesh-list
25590121|NCT00932165|Hormone Antagonists|hormone antagonists|mesh-ancestor
25590122|NCT00932165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25590123|NCT00932165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590124|NCT00932282|Omalizumab|omalizumab|mesh-list
25590125|NCT00932282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25590126|NCT00932282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25590127|NCT00932282|Respiratory System Agents|respiratory system agents|mesh-ancestor
25590128|NCT00932321|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25590129|NCT00932321|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25590130|NCT00932321|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25590131|NCT00932321|Norethindrone|norethindrone|mesh-list
25590132|NCT00932321|Norethindrone Acetate|norethindrone acetate|mesh-list
25590133|NCT00932321|Estradiol|estradiol|mesh-list
25590134|NCT00932321|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25590135|NCT00932321|Estrogens|estrogens|mesh-ancestor
25590136|NCT00932321|Hormones|hormones|mesh-ancestor
25590137|NCT00932321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25590138|NCT00932321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590139|NCT00932321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25590140|NCT00932321|Contraceptive Agents|contraceptive agents|mesh-ancestor
25590141|NCT00932321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25590142|NCT00932321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25590143|NCT00932321|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25590144|NCT00932321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25590145|NCT00932321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25590146|NCT00932373|Trastuzumab|trastuzumab|mesh-list
25590147|NCT00932373|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25590148|NCT00932373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25590149|NCT00932373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590150|NCT00932373|Tubulin Modulators|tubulin modulators|mesh-ancestor
25590151|NCT00932373|Antimitotic Agents|antimitotic agents|mesh-ancestor
25590152|NCT00932373|Mitosis Modulators|mitosis modulators|mesh-ancestor
25590153|NCT00932373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590154|NCT00932438|Leucovorin|leucovorin|mesh-list
25590155|NCT00932438|Bevacizumab|bevacizumab|mesh-list
25590156|NCT00932438|Fluorouracil|fluorouracil|mesh-list
25590157|NCT00932438|Oxaliplatin|oxaliplatin|mesh-list
25590158|NCT00932438|Irinotecan|irinotecan|mesh-list
25590159|NCT00932438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25590160|NCT00932438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590161|NCT00932438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25590162|NCT00932438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25590163|NCT00932438|Growth Substances|growth substances|mesh-ancestor
25590164|NCT00932438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590165|NCT00932438|Growth Inhibitors|growth inhibitors|mesh-ancestor
25590166|NCT00932438|Antimetabolites|antimetabolites|mesh-ancestor
25590167|NCT00932438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590168|NCT00932438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25590169|NCT00932438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25590170|NCT00932438|Immunologic Factors|immunologic factors|mesh-ancestor
25590171|NCT00932438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25590172|NCT00932438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25590173|NCT00932438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590174|NCT00932438|Antidotes|antidotes|mesh-ancestor
25590175|NCT00932438|Protective Agents|protective agents|mesh-ancestor
25590176|NCT00932438|Vitamin B Complex|vitamin b complex|mesh-ancestor
25590177|NCT00932438|Vitamins|vitamins|mesh-ancestor
25590178|NCT00932438|Micronutrients|micronutrients|mesh-ancestor
25590179|NCT00932451|Crizotinib|crizotinib|mesh-list
25590180|NCT00932451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590181|NCT00932451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25590182|NCT00932451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590183|NCT00932451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422394|NCT00222443|Irinotecan|irinotecan|mesh-list
25590184|NCT00932477|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25590185|NCT00932477|Lubricant Eye Drops|lubricant eye drops|mesh-list
25590186|NCT00932477|Glycerol|glycerol|mesh-list
25590187|NCT00932477|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25590188|NCT00932477|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25590189|NCT00932477|Laxatives|laxatives|mesh-ancestor
25590190|NCT00932477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25590191|NCT00932477|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25590192|NCT00932477|Protective Agents|protective agents|mesh-ancestor
25590193|NCT00932477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590194|NCT00932620|Simvastatin|simvastatin|mesh-list
25590195|NCT00932620|Ezetimibe|ezetimibe|mesh-list
25590196|NCT00932620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25590197|NCT00932620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25590198|NCT00932620|Antimetabolites|antimetabolites|mesh-ancestor
25590199|NCT00932620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590200|NCT00932620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25590201|NCT00932620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25590202|NCT00932620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590203|NCT00932646|Olodaterol|olodaterol|mesh-list
25590204|NCT00932646|Formoterol Fumarate|formoterol fumarate|mesh-list
25590205|NCT00932646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25590206|NCT00932646|Autonomic Agents|autonomic agents|mesh-ancestor
25590207|NCT00932646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25590208|NCT00932646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590209|NCT00932646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25590210|NCT00932646|Respiratory System Agents|respiratory system agents|mesh-ancestor
25590211|NCT00932646|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25590212|NCT00932646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25590213|NCT00932646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25590214|NCT00932646|Adrenergic Agents|adrenergic agents|mesh-ancestor
25590215|NCT00932646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25590216|NCT00932646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590217|NCT00932698|Ixazomib|ixazomib|mesh-list
25590218|NCT00932698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590219|NCT00932698|Protease Inhibitors|protease inhibitors|mesh-ancestor
25590220|NCT00932698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590221|NCT00932698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590222|NCT00932828|Immunologic Factors|immunologic factors|mesh-list
25590223|NCT00932828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590224|NCT00932893|Docetaxel|docetaxel|mesh-list
25590225|NCT00932893|Pemetrexed|pemetrexed|mesh-list
25590226|NCT00932893|Crizotinib|crizotinib|mesh-list
25590227|NCT00932893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590228|NCT00932893|Tubulin Modulators|tubulin modulators|mesh-ancestor
25590229|NCT00932893|Antimitotic Agents|antimitotic agents|mesh-ancestor
25590230|NCT00932893|Mitosis Modulators|mitosis modulators|mesh-ancestor
25590231|NCT00932893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590232|NCT00932893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590233|NCT00932893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25590234|NCT00932893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24869395|NCT04156698|Capecitabine|capecitabine|mesh-list
25590235|NCT00932893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25590236|NCT00933244|Vitamin D|vitamin d|mesh-list
25590237|NCT00933244|Ergocalciferols|ergocalciferols|mesh-list
25590238|NCT00933244|Cholecalciferol|cholecalciferol|mesh-list
25590239|NCT00933244|Vitamins|vitamins|mesh-list
25590240|NCT00933244|Micronutrients|micronutrients|mesh-ancestor
25590241|NCT00933244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590242|NCT00933244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25590243|NCT00933244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25590244|NCT00933335|Tositumomab I-131|tositumomab i-131|mesh-list
25590245|NCT00933335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590246|NCT00933608|Memantine|memantine|mesh-list
25590247|NCT00933608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25590248|NCT00933608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25590249|NCT00933608|Dopamine Agents|dopamine agents|mesh-ancestor
25590250|NCT00933608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25590251|NCT00933608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590252|NCT00933608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590253|NCT00933608|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25590254|NCT00933608|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25590255|NCT00934024|Varenicline|varenicline|mesh-list
25590256|NCT00934024|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25590257|NCT00934024|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25590258|NCT00934024|Cholinergic Agents|cholinergic agents|mesh-ancestor
25590259|NCT00934024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25590260|NCT00934024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590261|NCT00934024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653375|NCT01536704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653377|NCT01536886|Calcipotriene|calcipotriene|mesh-list
25653378|NCT01536886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25653379|NCT01536886|Glucocorticoids|glucocorticoids|mesh-ancestor
25653380|NCT01536886|Hormones|hormones|mesh-ancestor
25653381|NCT01536886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25653382|NCT01536886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653383|NCT01536886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25653384|NCT01536886|Respiratory System Agents|respiratory system agents|mesh-ancestor
25653385|NCT01536886|Dermatologic Agents|dermatologic agents|mesh-ancestor
25653386|NCT01536938|Calcitriol|calcitriol|mesh-list
25653387|NCT01536938|Betamethasone|betamethasone|mesh-list
25653388|NCT01536938|Betamethasone Valerate|betamethasone valerate|mesh-list
25653389|NCT01536938|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25653390|NCT01536938|Betamethasone benzoate|betamethasone benzoate|mesh-list
25653391|NCT01536938|Calcipotriene|calcipotriene|mesh-list
25653392|NCT01536938|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25705218|NCT02195687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25653393|NCT01536938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25653394|NCT01536938|Glucocorticoids|glucocorticoids|mesh-ancestor
25653395|NCT01536938|Hormones|hormones|mesh-ancestor
25653396|NCT01536938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25653397|NCT01536938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653398|NCT01536938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25653399|NCT01536938|Respiratory System Agents|respiratory system agents|mesh-ancestor
24428586|NCT00240773|Analgesics|analgesics|mesh-ancestor
25653400|NCT01536938|Dermatologic Agents|dermatologic agents|mesh-ancestor
25653401|NCT01536938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25653402|NCT01536938|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25653403|NCT01536938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25653404|NCT01536938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653405|NCT01536938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25653406|NCT01536938|Vitamins|vitamins|mesh-ancestor
25653407|NCT01536938|Micronutrients|micronutrients|mesh-ancestor
25653408|NCT01536938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25653409|NCT01536951|Moxifloxacin|moxifloxacin|mesh-list
25653410|NCT01536951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25653411|NCT01536951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25653412|NCT01536951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25653413|NCT01536951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25653414|NCT01536951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653415|NCT01536951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653416|NCT01536951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25653417|NCT01537029|Cyclophosphamide|cyclophosphamide|mesh-list
25653418|NCT01537029|Doxorubicin|doxorubicin|mesh-list
25653419|NCT01537029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25653420|NCT01537029|Immunologic Factors|immunologic factors|mesh-ancestor
25653421|NCT01537029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653422|NCT01537029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25653423|NCT01537029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25653424|NCT01537029|Alkylating Agents|alkylating agents|mesh-ancestor
25653425|NCT01537029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653426|NCT01537029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25653427|NCT01537029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25653428|NCT01537029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25653429|NCT01537029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25653430|NCT01537029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25653431|NCT01537029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653432|NCT01537042|Rotigotine|rotigotine|mesh-list
25653433|NCT01537042|Dopamine Agonists|dopamine agonists|mesh-ancestor
25653434|NCT01537042|Dopamine Agents|dopamine agents|mesh-ancestor
25653435|NCT01537042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25653436|NCT01537042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653437|NCT01537042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653438|NCT01537068|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25653439|NCT01537068|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25653440|NCT01537068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25653441|NCT01537068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25653442|NCT01537068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653443|NCT01537068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25653444|NCT01537068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484925|NCT00153816|Vitamin D|vitamin d|mesh-list
25590263|NCT00934050|Vitamin B Complex|vitamin b complex|mesh-ancestor
25590264|NCT00934050|Vitamins|vitamins|mesh-ancestor
25590265|NCT00934050|Micronutrients|micronutrients|mesh-ancestor
25590266|NCT00934050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590267|NCT00934089|Latanoprost|latanoprost|mesh-list
25590268|NCT00934089|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25590269|NCT00934089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25590270|NCT00934362|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25590271|NCT00934362|Respiratory System Agents|respiratory system agents|mesh-ancestor
25590272|NCT00934375|Donepezil|donepezil|mesh-list
25590273|NCT00934375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25590274|NCT00934375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590275|NCT00934375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590276|NCT00934375|Cholinergic Agents|cholinergic agents|mesh-ancestor
25590277|NCT00934375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25590278|NCT00934375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590279|NCT00934375|Nootropic Agents|nootropic agents|mesh-ancestor
25590280|NCT00934440|Bevacizumab|bevacizumab|mesh-list
25590281|NCT00934440|Azacitidine|azacitidine|mesh-list
25590282|NCT00934440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25590283|NCT00934440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590284|NCT00934440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25590285|NCT00934440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25590286|NCT00934440|Growth Substances|growth substances|mesh-ancestor
25590287|NCT00934440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590288|NCT00934440|Growth Inhibitors|growth inhibitors|mesh-ancestor
25590289|NCT00934440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25590290|NCT00934440|Antimetabolites|antimetabolites|mesh-ancestor
25590291|NCT00934440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590292|NCT00934440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590293|NCT00934635|Risperidone|risperidone|mesh-list
25590294|NCT00934635|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25590295|NCT00934635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25590296|NCT00934635|Serotonin Agents|serotonin agents|mesh-ancestor
25590297|NCT00934635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25590298|NCT00934635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590299|NCT00934635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590300|NCT00934635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25590301|NCT00934635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25590302|NCT00934635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25590303|NCT00934635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25590304|NCT00934635|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25590305|NCT00934635|Dopamine Agents|dopamine agents|mesh-ancestor
25590306|NCT00934635|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25590307|NCT00934635|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25590308|NCT00934648|Rituximab|rituximab|mesh-list
25590309|NCT00934648|Methotrexate|methotrexate|mesh-list
25590310|NCT00934648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25590311|NCT00934648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590312|NCT00934648|Immunologic Factors|immunologic factors|mesh-ancestor
25590313|NCT00934648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590314|NCT00934648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25590315|NCT00934648|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25590316|NCT00934648|Abortifacient Agents|abortifacient agents|mesh-ancestor
25590317|NCT00934648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25590318|NCT00934648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25590319|NCT00934648|Antimetabolites|antimetabolites|mesh-ancestor
25590320|NCT00934648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590321|NCT00934648|Dermatologic Agents|dermatologic agents|mesh-ancestor
25590322|NCT00934648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590323|NCT00934648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25590324|NCT00934648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25590325|NCT00934648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25590326|NCT00934661|Morphine|morphine|mesh-list
25590327|NCT00934661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25590328|NCT00934661|Narcotics|narcotics|mesh-ancestor
25590329|NCT00934661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25590330|NCT00934661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590331|NCT00934661|Analgesics|analgesics|mesh-ancestor
25590332|NCT00934661|Sensory System Agents|sensory system agents|mesh-ancestor
25590333|NCT00934661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25590334|NCT00934843|Methylprednisolone|methylprednisolone|mesh-list
25590335|NCT00934843|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25590336|NCT00934843|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25590337|NCT00934843|Prednisolone|prednisolone|mesh-list
25590338|NCT00934843|Prednisolone acetate|prednisolone acetate|mesh-list
25590339|NCT00934843|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25590340|NCT00934843|Prednisolone phosphate|prednisolone phosphate|mesh-list
25590341|NCT00934843|Glucocorticoids|glucocorticoids|mesh-list
25590342|NCT00934843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25590343|NCT00934843|Antiemetics|antiemetics|mesh-ancestor
25590344|NCT00934843|Autonomic Agents|autonomic agents|mesh-ancestor
25590345|NCT00934843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25590346|NCT00934843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590347|NCT00934843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25590348|NCT00934843|Hormones|hormones|mesh-ancestor
25590349|NCT00934843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25590350|NCT00934843|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25590351|NCT00934843|Protective Agents|protective agents|mesh-ancestor
25590352|NCT00934843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25590353|NCT00934843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590354|NCT00934856|Docetaxel|docetaxel|mesh-list
25590355|NCT00934856|Trastuzumab|trastuzumab|mesh-list
25590356|NCT00934856|Pertuzumab|pertuzumab|mesh-list
25590357|NCT00934856|Maytansine|maytansine|mesh-list
25590358|NCT00934856|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25590359|NCT00934856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590360|NCT00934856|Tubulin Modulators|tubulin modulators|mesh-ancestor
25590361|NCT00934856|Antimitotic Agents|antimitotic agents|mesh-ancestor
25590362|NCT00934856|Mitosis Modulators|mitosis modulators|mesh-ancestor
25590363|NCT00934856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590364|NCT00934856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25590365|NCT00934856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24880189|NCT03986996|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25590366|NCT00934934|Anidulafungin|anidulafungin|mesh-list
25590367|NCT00934934|Antifungal Agents|antifungal agents|mesh-ancestor
25590368|NCT00934934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25590369|NCT00934947|Propranolol|propranolol|mesh-list
25590370|NCT00934947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25590371|NCT00934947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25590372|NCT00934947|Adrenergic Agents|adrenergic agents|mesh-ancestor
25590373|NCT00934947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25590374|NCT00934947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590375|NCT00934947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590376|NCT00934947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25590377|NCT00934947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25590378|NCT00934947|Vasodilator Agents|vasodilator agents|mesh-ancestor
24435050|NCT00264953|Bleomycin|bleomycin|mesh-list
25590379|NCT00935220|Linagliptin|linagliptin|mesh-list
25590380|NCT00935220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25590381|NCT00935220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590382|NCT00935220|Incretins|incretins|mesh-ancestor
25590383|NCT00935220|Hormones|hormones|mesh-ancestor
25590384|NCT00935220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25590385|NCT00935220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25590386|NCT00935220|Protease Inhibitors|protease inhibitors|mesh-ancestor
25590387|NCT00935220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590388|NCT00935220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590389|NCT00935259|Simvastatin|simvastatin|mesh-list
25590390|NCT00935259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25590391|NCT00935259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25590392|NCT00935259|Antimetabolites|antimetabolites|mesh-ancestor
25590393|NCT00935259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590394|NCT00935259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25590395|NCT00935259|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25590396|NCT00935259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590397|NCT00935311|Acetaminophen|acetaminophen|mesh-list
25590398|NCT00935311|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25590399|NCT00935311|Hydrocodone|hydrocodone|mesh-list
25590400|NCT00935311|Oxycodone|oxycodone|mesh-list
25590401|NCT00935311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25590402|NCT00935311|Analgesics|analgesics|mesh-ancestor
25590403|NCT00935311|Sensory System Agents|sensory system agents|mesh-ancestor
25590404|NCT00935311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25590405|NCT00935311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590406|NCT00935311|Antipyretics|antipyretics|mesh-ancestor
25590407|NCT00935311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25590408|NCT00935311|Narcotics|narcotics|mesh-ancestor
25590409|NCT00935311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25485070|NCT00156819|Adrenergic Agents|adrenergic agents|mesh-ancestor
25590410|NCT00935311|Antitussive Agents|antitussive agents|mesh-ancestor
25590411|NCT00935311|Respiratory System Agents|respiratory system agents|mesh-ancestor
25485144|NCT00157196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25485145|NCT00157209|Cyclophosphamide|cyclophosphamide|mesh-list
25485146|NCT00157209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25485147|NCT00157209|Immunologic Factors|immunologic factors|mesh-ancestor
25485148|NCT00157209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485149|NCT00157209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25485150|NCT00157209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25485151|NCT00157209|Alkylating Agents|alkylating agents|mesh-ancestor
25485152|NCT00157209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485153|NCT00157209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485154|NCT00157209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25485155|NCT00157248|Dabigatran|dabigatran|mesh-list
25485156|NCT00157248|Antithrombins|antithrombins|mesh-ancestor
25485157|NCT00157248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25485158|NCT00157248|Protease Inhibitors|protease inhibitors|mesh-ancestor
25485159|NCT00157248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485160|NCT00157248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485161|NCT00157248|Anticoagulants|anticoagulants|mesh-ancestor
25485162|NCT00157573|Sargramostim|sargramostim|mesh-list
25485163|NCT00157573|Immunologic Factors|immunologic factors|mesh-ancestor
25485164|NCT00157573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608026|NCT02618577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017569|NCT00413764|Anabolic Agents|anabolic agents|mesh-ancestor
25017570|NCT00408863|Tibolone|tibolone|mesh-list
25017571|NCT00408863|Androgen Antagonists|androgen antagonists|mesh-ancestor
24608027|NCT02618577|Anticoagulants|anticoagulants|mesh-ancestor
24605271|NCT00984360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24605272|NCT00984386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24605273|NCT00984386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24605274|NCT00984386|Estradiol|estradiol|mesh-list
24605275|NCT00984386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24605276|NCT00984386|Estrogens|estrogens|mesh-ancestor
24605277|NCT00984386|Hormones|hormones|mesh-ancestor
24605298|NCT00984425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979684|NCT03029000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25123965|NCT03080324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24979685|NCT03029000|Immunologic Factors|immunologic factors|mesh-ancestor
24979686|NCT03029000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979687|NCT03022292|Aflibercept|aflibercept|mesh-list
24979688|NCT03022292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25705344|NCT02197247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979689|NCT03022292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24979690|NCT03022292|Growth Substances|growth substances|mesh-ancestor
25590412|NCT00935311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25590413|NCT00935311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25590414|NCT00935311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25590415|NCT00935493|Guanfacine|guanfacine|mesh-list
25590416|NCT00935493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25590417|NCT00935493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25590418|NCT00935493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25590419|NCT00935493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25590420|NCT00935493|Adrenergic Agents|adrenergic agents|mesh-ancestor
25590421|NCT00935493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25590422|NCT00935493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590423|NCT00935493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590424|NCT00935532|Insulin|insulin|mesh-list
25590425|NCT00935532|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25590426|NCT00935532|Insulin Glargine|insulin glargine|mesh-list
25590427|NCT00935532|Exenatide|exenatide|mesh-list
25590428|NCT00935532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25590429|NCT00935532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590430|NCT00935532|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25590431|NCT00935532|Incretins|incretins|mesh-ancestor
25590432|NCT00935532|Hormones|hormones|mesh-ancestor
25590433|NCT00935532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25590434|NCT00935792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25590435|NCT00935792|Alemtuzumab|alemtuzumab|mesh-list
25590436|NCT00935792|Everolimus|everolimus|mesh-list
25590437|NCT00935792|Antibodies|antibodies|mesh-list
25590438|NCT00935792|Immunoglobulins|immunoglobulins|mesh-list
25590439|NCT00935792|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25590440|NCT00935792|Immunologic Factors|immunologic factors|mesh-ancestor
25590441|NCT00935792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590442|NCT00935792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590443|NCT00935792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25590444|NCT00935818|Bupropion|bupropion|mesh-list
25590445|NCT00935818|Varenicline|varenicline|mesh-list
25590446|NCT00935818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25590447|NCT00935818|Antidepressive Agents|antidepressive agents|mesh-ancestor
25590448|NCT00935818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25590449|NCT00935818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25590450|NCT00935818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25590451|NCT00935818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25590452|NCT00935818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590453|NCT00935818|Dopamine Agents|dopamine agents|mesh-ancestor
25590454|NCT00935818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25590455|NCT00935818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590456|NCT00935818|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25590457|NCT00935818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25590458|NCT00935818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590459|NCT00935818|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25590460|NCT00935818|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25590461|NCT00935818|Cholinergic Agents|cholinergic agents|mesh-ancestor
25590462|NCT00935883|Eculizumab|eculizumab|mesh-list
25590463|NCT00935883|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24979960|NCT04851522|Eusol|eusol|mesh-list
25590464|NCT00935883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25590465|NCT00935883|Immunologic Factors|immunologic factors|mesh-ancestor
25590466|NCT00935883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590467|NCT00936065|Etanercept|etanercept|mesh-list
25590468|NCT00936065|Acitretin|acitretin|mesh-list
25590469|NCT00936065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25590470|NCT00936065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25590471|NCT00936065|Analgesics|analgesics|mesh-ancestor
25590472|NCT00936065|Sensory System Agents|sensory system agents|mesh-ancestor
25590473|NCT00936065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25590474|NCT00936065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590475|NCT00936065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25590476|NCT00936065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25590477|NCT00936065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25590478|NCT00936065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25590479|NCT00936065|Immunologic Factors|immunologic factors|mesh-ancestor
25590480|NCT00936065|Keratolytic Agents|keratolytic agents|mesh-ancestor
25590481|NCT00936065|Dermatologic Agents|dermatologic agents|mesh-ancestor
25590482|NCT00936117|Posaconazole|posaconazole|mesh-list
25590483|NCT00936117|Antifungal Agents|antifungal agents|mesh-ancestor
25590484|NCT00936117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25590485|NCT00936117|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25590486|NCT00936117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25590487|NCT00936117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25590488|NCT00936117|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25590489|NCT00936117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25590490|NCT00936117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590491|NCT00936117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590492|NCT00936117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25590493|NCT00936117|Hormone Antagonists|hormone antagonists|mesh-ancestor
25590494|NCT00936117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25590495|NCT00936117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590496|NCT00936221|Dacarbazine|dacarbazine|mesh-list
25590497|NCT00936221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25590498|NCT00936221|Alkylating Agents|alkylating agents|mesh-ancestor
25590499|NCT00936221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590500|NCT00936221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590501|NCT00936299|Bupropion|bupropion|mesh-list
25590502|NCT00936299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25590503|NCT00936299|Antidepressive Agents|antidepressive agents|mesh-ancestor
25590504|NCT00936299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25590505|NCT00936299|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25590506|NCT00936299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25590507|NCT00936299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25590508|NCT00936299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590509|NCT00936299|Dopamine Agents|dopamine agents|mesh-ancestor
25590510|NCT00936299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25590511|NCT00936299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590512|NCT00936299|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25590513|NCT00936299|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25590514|NCT00936299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590515|NCT00936377|Dexmedetomidine|dexmedetomidine|mesh-list
25590516|NCT00936377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25657198|NCT01584388|Rituximab|rituximab|mesh-list
25590517|NCT00936377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25590518|NCT00936377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590519|NCT00936377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25590521|NCT00936377|Sensory System Agents|sensory system agents|mesh-ancestor
25590522|NCT00936377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25590523|NCT00936377|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25590524|NCT00936377|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25590525|NCT00936377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25590526|NCT00936377|Adrenergic Agents|adrenergic agents|mesh-ancestor
25590527|NCT00936377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25590528|NCT00936377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590529|NCT00936611|Panobinostat|panobinostat|mesh-list
25590530|NCT00936611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590531|NCT00936611|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25590532|NCT00936611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590533|NCT00936611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590534|NCT00936663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25590535|NCT00936663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25590536|NCT00936663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590537|NCT00936663|Incretins|incretins|mesh-ancestor
25590538|NCT00936663|Hormones|hormones|mesh-ancestor
25590539|NCT00936663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25590540|NCT00936663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25590541|NCT00936663|Protease Inhibitors|protease inhibitors|mesh-ancestor
25590542|NCT00936663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590543|NCT00936663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590544|NCT00936702|Paclitaxel|paclitaxel|mesh-list
25590545|NCT00936702|Carboplatin|carboplatin|mesh-list
25590546|NCT00936702|Everolimus|everolimus|mesh-list
25590547|NCT00936702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25590548|NCT00936702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590549|NCT00936702|Tubulin Modulators|tubulin modulators|mesh-ancestor
25590550|NCT00936702|Antimitotic Agents|antimitotic agents|mesh-ancestor
25590551|NCT00936702|Mitosis Modulators|mitosis modulators|mesh-ancestor
25590552|NCT00936702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590553|NCT00936702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25590554|NCT00936702|Immunologic Factors|immunologic factors|mesh-ancestor
25590555|NCT00936702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590556|NCT00936715|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25705387|NCT02197377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25705388|NCT02197377|Disinfectants|disinfectants|mesh-ancestor
25705389|NCT02197416|Dabigatran|dabigatran|mesh-list
25705390|NCT02197416|Antithrombins|antithrombins|mesh-ancestor
24980034|NCT04671875|Immunologic Factors|immunologic factors|mesh-ancestor
25590557|NCT00936715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25590558|NCT00936715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25590559|NCT00936715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590560|NCT00936715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590561|NCT00936715|Antiviral Agents|antiviral agents|mesh-ancestor
25590562|NCT00936715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25590563|NCT00936715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25590564|NCT00936715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25590565|NCT00936741|Mifepristone|mifepristone|mesh-list
25590566|NCT00936741|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25590567|NCT00936741|Abortifacient Agents|abortifacient agents|mesh-ancestor
25590568|NCT00936741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25590569|NCT00936741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590570|NCT00936741|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25590571|NCT00936741|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25590572|NCT00936741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25590573|NCT00936741|Contraceptive Agents|contraceptive agents|mesh-ancestor
25590574|NCT00936741|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25590575|NCT00936741|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25590576|NCT00936741|Hormone Antagonists|hormone antagonists|mesh-ancestor
25590577|NCT00936741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25590578|NCT00936741|Luteolytic Agents|luteolytic agents|mesh-ancestor
25590579|NCT00936741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25590580|NCT00936741|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25590581|NCT00936858|Everolimus|everolimus|mesh-list
25590582|NCT00936858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590583|NCT00936858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25590584|NCT00936858|Immunologic Factors|immunologic factors|mesh-ancestor
25590585|NCT00936858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590586|NCT00936884|Methylnaltrexone|methylnaltrexone|mesh-list
25590587|NCT00936884|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25590588|NCT00936884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590589|NCT00936884|Sensory System Agents|sensory system agents|mesh-ancestor
25590590|NCT00936884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25590591|NCT00936897|Denosumab|denosumab|mesh-list
25590592|NCT00936897|Ibandronic Acid|ibandronic acid|mesh-list
25590593|NCT00936897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25590594|NCT00936897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883088|NCT04539730|Ropivacaine|ropivacaine|mesh-list
24439954|NCT00280969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439955|NCT00280969|Antiviral Agents|antiviral agents|mesh-ancestor
24440052|NCT00281567|Cholinergic Agents|cholinergic agents|mesh-ancestor
24440053|NCT00281567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24440054|NCT00281567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440145|NCT00281905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25590595|NCT00936910|Amphotericin B|amphotericin b|mesh-list
25590596|NCT00936910|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25590597|NCT00936910|Amebicides|amebicides|mesh-ancestor
25590598|NCT00936910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25590599|NCT00936910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25590600|NCT00936910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25590601|NCT00936910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25590602|NCT00936910|Antifungal Agents|antifungal agents|mesh-ancestor
25590603|NCT00936975|Listerine|listerine|mesh-list
25590604|NCT00936975|Fluorides|fluorides|mesh-list
24883125|NCT04452383|Propofol|propofol|mesh-list
25590605|NCT00936975|Sodium Fluoride|sodium fluoride|mesh-list
25590606|NCT00936975|Cariostatic Agents|cariostatic agents|mesh-ancestor
25590607|NCT00936975|Protective Agents|protective agents|mesh-ancestor
25590608|NCT00936975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590609|NCT00936975|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25590610|NCT00936975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25590611|NCT00937157|Glatiramer Acetate|glatiramer acetate|mesh-list
25590612|NCT00937157|(T,G)-A-L|(t,g)-a-l|mesh-list
25590613|NCT00937157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25590614|NCT00937157|Immunologic Factors|immunologic factors|mesh-ancestor
25590615|NCT00937157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590616|NCT00937157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25590617|NCT00937157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25590618|NCT00937235|Varenicline|varenicline|mesh-list
25590619|NCT00937235|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25590620|NCT00937235|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25590621|NCT00937235|Cholinergic Agents|cholinergic agents|mesh-ancestor
25590622|NCT00937235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25590623|NCT00937235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590624|NCT00937235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590625|NCT00937495|Bortezomib|bortezomib|mesh-list
25590626|NCT00937495|Vorinostat|vorinostat|mesh-list
25590627|NCT00937495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590628|NCT00937495|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25590629|NCT00937495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590630|NCT00937495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590631|NCT00937521|Antipyretics|antipyretics|mesh-list
25590632|NCT00937521|Vaccines|vaccines|mesh-list
25590633|NCT00937521|Immunologic Factors|immunologic factors|mesh-ancestor
25590634|NCT00937521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590635|NCT00937560|Paclitaxel|paclitaxel|mesh-list
25590636|NCT00937560|Bevacizumab|bevacizumab|mesh-list
25590637|NCT00937560|Carboplatin|carboplatin|mesh-list
25590638|NCT00937560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25590639|NCT00937560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590640|NCT00937560|Tubulin Modulators|tubulin modulators|mesh-ancestor
25590641|NCT00937560|Antimitotic Agents|antimitotic agents|mesh-ancestor
25590642|NCT00937560|Mitosis Modulators|mitosis modulators|mesh-ancestor
25590643|NCT00937560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590644|NCT00937560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25590645|NCT00937560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25590646|NCT00937560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25590647|NCT00937560|Growth Substances|growth substances|mesh-ancestor
25590648|NCT00937560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590649|NCT00937560|Growth Inhibitors|growth inhibitors|mesh-ancestor
25590650|NCT00937768|Leuprolide|leuprolide|mesh-list
25590651|NCT00937768|Goserelin|goserelin|mesh-list
25590652|NCT00937768|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25590653|NCT00937768|Fertility Agents|fertility agents|mesh-ancestor
25590654|NCT00937768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25590655|NCT00937768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590656|NCT00937768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25590657|NCT00937768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590658|NCT00938041|Tositumomab I-131|tositumomab i-131|mesh-list
25590659|NCT00938041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590660|NCT00938314|Epoetin Alfa|epoetin alfa|mesh-list
25590661|NCT00938314|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25590662|NCT00938314|Hematinics|hematinics|mesh-ancestor
25590663|NCT00938314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25590664|NCT00938314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590665|NCT00938366|Cladribine|cladribine|mesh-list
25590666|NCT00938366|Pantoprazole|pantoprazole|mesh-list
25590667|NCT00938366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25590668|NCT00938366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25590669|NCT00938366|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25590670|NCT00938366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590671|NCT00938366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590672|NCT00938366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590673|NCT00938366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25590674|NCT00938366|Immunologic Factors|immunologic factors|mesh-ancestor
25590675|NCT00938366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590676|NCT00938392|Vaccines|vaccines|mesh-list
25590677|NCT00938392|Immunologic Factors|immunologic factors|mesh-ancestor
25590678|NCT00938392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590679|NCT00938431|Lacosamide|lacosamide|mesh-list
25590680|NCT00938431|Anticonvulsants|anticonvulsants|mesh-ancestor
25590681|NCT00938431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25590682|NCT00938431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25590683|NCT00938431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25590684|NCT00938431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590685|NCT00938470|Docetaxel|docetaxel|mesh-list
25590686|NCT00938470|Fluorouracil|fluorouracil|mesh-list
25590687|NCT00938470|Capecitabine|capecitabine|mesh-list
25590688|NCT00938470|Oxaliplatin|oxaliplatin|mesh-list
25590689|NCT00938470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590690|NCT00938470|Tubulin Modulators|tubulin modulators|mesh-ancestor
25590691|NCT00938470|Antimitotic Agents|antimitotic agents|mesh-ancestor
25590692|NCT00938470|Mitosis Modulators|mitosis modulators|mesh-ancestor
25590693|NCT00938470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590694|NCT00938470|Antimetabolites|antimetabolites|mesh-ancestor
25590695|NCT00938470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25590696|NCT00938470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25590697|NCT00938470|Immunologic Factors|immunologic factors|mesh-ancestor
25590698|NCT00938470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590699|NCT00938548|Pregabalin|pregabalin|mesh-list
25590700|NCT00938548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590701|NCT00938548|Analgesics|analgesics|mesh-ancestor
25590702|NCT00938548|Sensory System Agents|sensory system agents|mesh-ancestor
25590703|NCT00938548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25590704|NCT00938548|Anticonvulsants|anticonvulsants|mesh-ancestor
25590705|NCT00938548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25590706|NCT00938548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25590707|NCT00938548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590708|NCT00938548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25590709|NCT00938548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25590710|NCT00938548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25590711|NCT00938548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25590712|NCT00938548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25590713|NCT00938704|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25590714|NCT00938704|Hyaluronic Acid|hyaluronic acid|mesh-list
25590715|NCT00938704|Glycerol|glycerol|mesh-list
25590716|NCT00938704|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25590717|NCT00938704|Immunologic Factors|immunologic factors|mesh-ancestor
25590718|NCT00938704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590719|NCT00938704|Viscosupplements|viscosupplements|mesh-ancestor
25590720|NCT00938704|Protective Agents|protective agents|mesh-ancestor
25590721|NCT00938704|Laxatives|laxatives|mesh-ancestor
25590722|NCT00938704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25590723|NCT00938704|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25590724|NCT00938717|Linaclotide|linaclotide|mesh-list
25590725|NCT00938717|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25590726|NCT00938717|Enzyme Activators|enzyme activators|mesh-ancestor
24883279|NCT04058990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980124|NCT05441631|Insulin|insulin|mesh-list
25590727|NCT00938717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590728|NCT00938717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25590729|NCT00938860|Cyclosporine|cyclosporine|mesh-list
25590730|NCT00938860|Tacrolimus|tacrolimus|mesh-list
25590731|NCT00938860|Cyclosporins|cyclosporins|mesh-list
25590732|NCT00938860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25590733|NCT00938860|Immunologic Factors|immunologic factors|mesh-ancestor
25590734|NCT00938860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590735|NCT00938860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25590736|NCT00938860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590737|NCT00938860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485381|NCT00162097|Efavirenz|efavirenz|mesh-list
25590738|NCT00938860|Antifungal Agents|antifungal agents|mesh-ancestor
25590739|NCT00938860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25590740|NCT00938860|Dermatologic Agents|dermatologic agents|mesh-ancestor
25590742|NCT00938886|Naltrexone|naltrexone|mesh-list
25590743|NCT00938886|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25590744|NCT00938886|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25590745|NCT00938886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590746|NCT00938886|Sensory System Agents|sensory system agents|mesh-ancestor
25590747|NCT00938886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25590748|NCT00938964|Lidocaine|lidocaine|mesh-list
25590749|NCT00938964|Anesthetics, Local|anesthetics, local|mesh-ancestor
25590750|NCT00938964|Anesthetics|anesthetics|mesh-ancestor
25590751|NCT00938964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25590752|NCT00938964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590753|NCT00938964|Sensory System Agents|sensory system agents|mesh-ancestor
25590754|NCT00938964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25590755|NCT00938964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25590756|NCT00938964|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25590757|NCT00938964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25590758|NCT00938964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25590759|NCT00938964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590760|NCT00939003|Adalimumab|adalimumab|mesh-list
25590761|NCT00939003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25590762|NCT00939003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25590763|NCT00939029|Nicotine|nicotine|mesh-list
25590764|NCT00939029|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25590765|NCT00939029|Autonomic Agents|autonomic agents|mesh-ancestor
25590766|NCT00939029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25590767|NCT00939029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590768|NCT00939029|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25590769|NCT00939029|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25590770|NCT00939029|Cholinergic Agents|cholinergic agents|mesh-ancestor
25590771|NCT00939029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25590772|NCT00939029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590773|NCT00939120|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25590774|NCT00939120|Dutasteride|dutasteride|mesh-list
25590775|NCT00939120|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25590776|NCT00939120|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25590777|NCT00939120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590778|NCT00939120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590779|NCT00939120|Hormone Antagonists|hormone antagonists|mesh-ancestor
25590780|NCT00939120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25590781|NCT00939120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590782|NCT00939120|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25590783|NCT00939120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25590784|NCT00939120|Cholinergic Agents|cholinergic agents|mesh-ancestor
25590785|NCT00939120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25590786|NCT00939120|Urological Agents|urological agents|mesh-ancestor
25590787|NCT00939159|Panobinostat|panobinostat|mesh-list
25590788|NCT00939159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590789|NCT00939159|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25590790|NCT00939159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590791|NCT00939159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590792|NCT00939185|Azithromycin|azithromycin|mesh-list
25590793|NCT00939185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25590794|NCT00939185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25590795|NCT00939211|Tiotropium Bromide|tiotropium bromide|mesh-list
25590796|NCT00939211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25590797|NCT00939211|Autonomic Agents|autonomic agents|mesh-ancestor
25590798|NCT00939211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25590799|NCT00939211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590800|NCT00939211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25590801|NCT00939211|Respiratory System Agents|respiratory system agents|mesh-ancestor
25590802|NCT00939211|Parasympatholytics|parasympatholytics|mesh-ancestor
25590803|NCT00939211|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25590804|NCT00939211|Cholinergic Agents|cholinergic agents|mesh-ancestor
25590805|NCT00939211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25590806|NCT00939211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590807|NCT00939341|Budesonide|budesonide|mesh-list
25590808|NCT00939341|Formoterol Fumarate|formoterol fumarate|mesh-list
25590809|NCT00939341|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25590810|NCT00939341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25590811|NCT00939341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25590812|NCT00939341|Autonomic Agents|autonomic agents|mesh-ancestor
25485453|NCT00165646|Rabeprazole|rabeprazole|mesh-list
25590813|NCT00939341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25590814|NCT00939341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590815|NCT00939341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25590816|NCT00939341|Respiratory System Agents|respiratory system agents|mesh-ancestor
25705438|NCT02198235|Analgesics|analgesics|mesh-ancestor
25590817|NCT00939341|Glucocorticoids|glucocorticoids|mesh-ancestor
25590818|NCT00939341|Hormones|hormones|mesh-ancestor
25590819|NCT00939341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25590820|NCT00939341|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25590821|NCT00939341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25590822|NCT00939341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25590823|NCT00939341|Adrenergic Agents|adrenergic agents|mesh-ancestor
25590824|NCT00939341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25590825|NCT00939341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653445|NCT01537068|Antidepressive Agents|antidepressive agents|mesh-ancestor
25653446|NCT01537068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25653447|NCT01537081|Phenylpropanolamine|phenylpropanolamine|mesh-list
25653448|NCT01537081|Guaifenesin|guaifenesin|mesh-list
25653449|NCT01537081|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
25653450|NCT01537081|Expectorants|expectorants|mesh-ancestor
25653451|NCT01537081|Respiratory System Agents|respiratory system agents|mesh-ancestor
25653452|NCT01537081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25653453|NCT01537081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25653454|NCT01537081|Adrenergic Agents|adrenergic agents|mesh-ancestor
25653455|NCT01537081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25653456|NCT01537081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653457|NCT01537081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653458|NCT01537081|Appetite Depressants|appetite depressants|mesh-ancestor
25653459|NCT01537081|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25653460|NCT01537081|Sympathomimetics|sympathomimetics|mesh-ancestor
25653461|NCT01537081|Autonomic Agents|autonomic agents|mesh-ancestor
25653462|NCT01537081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653463|NCT01537081|Nasal Decongestants|nasal decongestants|mesh-ancestor
25653464|NCT01537081|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25653465|NCT01537120|Vildagliptin|vildagliptin|mesh-list
25653466|NCT01537120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25653467|NCT01537120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653468|NCT01537120|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25653469|NCT01537120|Protease Inhibitors|protease inhibitors|mesh-ancestor
25653470|NCT01537120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653471|NCT01537120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653472|NCT01537133|Fluticasone|fluticasone|mesh-list
25653473|NCT01537133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25653474|NCT01537133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25653475|NCT01537133|Autonomic Agents|autonomic agents|mesh-ancestor
25653476|NCT01537133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24883743|NCT05004038|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24883746|NCT04982172|Infliximab|infliximab|mesh-list
25653477|NCT01537133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653478|NCT01537133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25653479|NCT01537133|Respiratory System Agents|respiratory system agents|mesh-ancestor
25653480|NCT01537133|Dermatologic Agents|dermatologic agents|mesh-ancestor
25653481|NCT01537133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25653482|NCT01537185|Aluminum sulfate|aluminum sulfate|mesh-list
25653483|NCT01537185|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25653484|NCT01537185|Immunologic Factors|immunologic factors|mesh-ancestor
25653485|NCT01537185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653486|NCT01537315|Hydroxychloroquine|hydroxychloroquine|mesh-list
25653487|NCT01537315|Antimalarials|antimalarials|mesh-ancestor
25653488|NCT01537315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25653489|NCT01537315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25653490|NCT01537315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25653491|NCT01537315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653492|NCT01537315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653493|NCT01537315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25653494|NCT01537549|Thioctic Acid|thioctic acid|mesh-list
25653495|NCT01537549|Acetylcarnitine|acetylcarnitine|mesh-list
25653496|NCT01537549|Antioxidants|antioxidants|mesh-ancestor
25653497|NCT01537549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653498|NCT01537549|Protective Agents|protective agents|mesh-ancestor
25653499|NCT01537549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653500|NCT01537549|Vitamin B Complex|vitamin b complex|mesh-ancestor
25653501|NCT01537549|Vitamins|vitamins|mesh-ancestor
25653502|NCT01537549|Micronutrients|micronutrients|mesh-ancestor
25653503|NCT01537549|Nootropic Agents|nootropic agents|mesh-ancestor
25653504|NCT01537666|Vancomycin|vancomycin|mesh-list
25653505|NCT01537666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25485515|NCT00166166|Fluconazole|fluconazole|mesh-list
25590826|NCT00939367|Zolpidem|zolpidem|mesh-list
25590827|NCT00939367|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25590828|NCT00939367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25590829|NCT00939367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25590830|NCT00939367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590831|NCT00939367|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25590832|NCT00939367|GABA Agonists|gaba agonists|mesh-ancestor
25590833|NCT00939367|GABA Agents|gaba agents|mesh-ancestor
25590834|NCT00939367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25590835|NCT00939367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590836|NCT00939510|Lenalidomide|lenalidomide|mesh-list
25590837|NCT00939510|Sargramostim|sargramostim|mesh-list
25590838|NCT00939510|Immunologic Factors|immunologic factors|mesh-ancestor
25590839|NCT00939510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590840|NCT00939510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25590841|NCT00939510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25590842|NCT00939510|Growth Substances|growth substances|mesh-ancestor
25590843|NCT00939510|Growth Inhibitors|growth inhibitors|mesh-ancestor
25590844|NCT00939510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590845|NCT00939523|Lapatinib|lapatinib|mesh-list
25590846|NCT00939523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590847|NCT00939523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25590848|NCT00939523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590849|NCT00939523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590850|NCT00939536|Zolpidem|zolpidem|mesh-list
25590851|NCT00939536|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25590852|NCT00939536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25590853|NCT00939536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25590854|NCT00939536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590855|NCT00939536|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25590856|NCT00939536|GABA Agonists|gaba agonists|mesh-ancestor
25590857|NCT00939536|GABA Agents|gaba agents|mesh-ancestor
25590858|NCT00939536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25590859|NCT00939536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590860|NCT00939562|Doxycycline|doxycycline|mesh-list
25590861|NCT00939562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25590862|NCT00939562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25590863|NCT00939562|Antimalarials|antimalarials|mesh-ancestor
25590864|NCT00939562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25590865|NCT00939562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25590866|NCT00939627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25590867|NCT00939627|Cetuximab|cetuximab|mesh-list
25590868|NCT00939627|Sorafenib|sorafenib|mesh-list
25590869|NCT00939627|Antibodies|antibodies|mesh-list
25590870|NCT00939627|Immunoglobulins|immunoglobulins|mesh-list
25590871|NCT00939627|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25590872|NCT00939627|Immunologic Factors|immunologic factors|mesh-ancestor
25590873|NCT00939627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590874|NCT00939627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590875|NCT00939627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25590876|NCT00939627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590877|NCT00939627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590878|NCT00939653|Cytarabine|cytarabine|mesh-list
25590879|NCT00939653|Cyclophosphamide|cyclophosphamide|mesh-list
25590880|NCT00939653|Etoposide|etoposide|mesh-list
25590881|NCT00939653|Clofarabine|clofarabine|mesh-list
25590882|NCT00939653|Lenograstim|lenograstim|mesh-list
25590883|NCT00939653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25590884|NCT00939653|Immunologic Factors|immunologic factors|mesh-ancestor
25590885|NCT00939653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590886|NCT00939653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25590887|NCT00939653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25590888|NCT00939653|Alkylating Agents|alkylating agents|mesh-ancestor
25590889|NCT00939653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590890|NCT00939653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590891|NCT00939653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25590892|NCT00939653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25590893|NCT00939653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25590894|NCT00939653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25590895|NCT00939653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590896|NCT00939653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25590897|NCT00939653|Antimetabolites|antimetabolites|mesh-ancestor
25590898|NCT00939653|Antiviral Agents|antiviral agents|mesh-ancestor
25590899|NCT00939653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25590900|NCT00939653|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25485580|NCT00166712|Sirolimus|sirolimus|mesh-list
25590901|NCT00939692|Topiramate|topiramate|mesh-list
25590902|NCT00939692|Anticonvulsants|anticonvulsants|mesh-ancestor
25590903|NCT00939692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25590904|NCT00939692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590905|NCT00939705|Topiramate|topiramate|mesh-list
25590906|NCT00939705|Anticonvulsants|anticonvulsants|mesh-ancestor
25590907|NCT00939705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25590908|NCT00939705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590909|NCT00939731|Crizotinib|crizotinib|mesh-list
25590910|NCT00939731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590911|NCT00939731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25590912|NCT00939731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590913|NCT00939731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590914|NCT00939770|Crizotinib|crizotinib|mesh-list
25590915|NCT00939770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590916|NCT00939770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25590917|NCT00939770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590918|NCT00939770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590919|NCT00939822|Simvastatin|simvastatin|mesh-list
25590920|NCT00939822|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25590921|NCT00939822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25590922|NCT00939822|Antimetabolites|antimetabolites|mesh-ancestor
24443424|NCT00294892|Sensory System Agents|sensory system agents|mesh-ancestor
25590923|NCT00939822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590924|NCT00939822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25590925|NCT00939822|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25590926|NCT00939822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590927|NCT00939874|Raltegravir Potassium|raltegravir potassium|mesh-list
25590928|NCT00939874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25590929|NCT00939874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25590930|NCT00939874|Antiviral Agents|antiviral agents|mesh-ancestor
25590931|NCT00939874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25590932|NCT00939874|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25590933|NCT00939874|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25590934|NCT00939874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590935|NCT00939874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590936|NCT00939900|Zoledronic Acid|zoledronic acid|mesh-list
25590937|NCT00939900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25590938|NCT00939900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590939|NCT00939952|Ertapenem|ertapenem|mesh-list
25590940|NCT00939952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25590941|NCT00939952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25590942|NCT00939991|Bevacizumab|bevacizumab|mesh-list
25590943|NCT00939991|Temozolomide|temozolomide|mesh-list
25590944|NCT00939991|Vorinostat|vorinostat|mesh-list
25590945|NCT00939991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25590946|NCT00939991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590947|NCT00939991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25590948|NCT00939991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25590949|NCT00939991|Growth Substances|growth substances|mesh-ancestor
25590950|NCT00939991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590951|NCT00939991|Growth Inhibitors|growth inhibitors|mesh-ancestor
25590952|NCT00939991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25590953|NCT00939991|Alkylating Agents|alkylating agents|mesh-ancestor
25590954|NCT00939991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590955|NCT00939991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25590956|NCT00939991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590957|NCT00940017|Voriconazole|voriconazole|mesh-list
25590958|NCT00940017|Anidulafungin|anidulafungin|mesh-list
25590959|NCT00940017|Antifungal Agents|antifungal agents|mesh-ancestor
25590960|NCT00940017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25590961|NCT00940017|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25590962|NCT00940017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25590963|NCT00940017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590964|NCT00940017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590965|NCT00940017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25590966|NCT00940017|Hormone Antagonists|hormone antagonists|mesh-ancestor
25590967|NCT00940017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25590968|NCT00940017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590969|NCT00940017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25590970|NCT00940316|Irinotecan|irinotecan|mesh-list
25590971|NCT00940316|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25590972|NCT00940316|Panitumumab|panitumumab|mesh-list
25590973|NCT00940316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25590974|NCT00940316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25590975|NCT00940316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25590976|NCT00940316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590977|NCT00940316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980795|NCT04941105|Evolocumab|evolocumab|mesh-list
25590978|NCT00940316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25590979|NCT00940316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25590980|NCT00940342|Rituximab|rituximab|mesh-list
25590981|NCT00940342|Molgramostim|molgramostim|mesh-list
25590982|NCT00940342|Sargramostim|sargramostim|mesh-list
25590983|NCT00940342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25590984|NCT00940342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25590985|NCT00940342|Immunologic Factors|immunologic factors|mesh-ancestor
25590986|NCT00940342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590987|NCT00940342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25590988|NCT00940485|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25590989|NCT00940485|Entecavir|entecavir|mesh-list
25590990|NCT00940485|Antiviral Agents|antiviral agents|mesh-ancestor
25590991|NCT00940485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25590992|NCT00940589|Melatonin|melatonin|mesh-list
25590993|NCT00940589|Antioxidants|antioxidants|mesh-ancestor
25590994|NCT00940589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25590995|NCT00940589|Protective Agents|protective agents|mesh-ancestor
25590996|NCT00940589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25590997|NCT00940589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25590998|NCT00940602|Deferasirox|deferasirox|mesh-list
25590999|NCT00940602|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25591000|NCT00940602|Chelating Agents|chelating agents|mesh-ancestor
25591001|NCT00940602|Sequestering Agents|sequestering agents|mesh-ancestor
25591002|NCT00940602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505410|NCT00541112|Leucovorin|leucovorin|mesh-list
25591003|NCT00940771|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25591004|NCT00940771|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25591005|NCT00940771|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25591006|NCT00940771|Protease Inhibitors|protease inhibitors|mesh-ancestor
25591007|NCT00940771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591008|NCT00940771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591009|NCT00940771|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25591010|NCT00940771|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25591011|NCT00940771|Antiviral Agents|antiviral agents|mesh-ancestor
25591012|NCT00940771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25591013|NCT00940875|Gemcitabine|gemcitabine|mesh-list
25591014|NCT00940875|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25591015|NCT00940875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25591016|NCT00940875|Antimetabolites|antimetabolites|mesh-ancestor
25591017|NCT00940875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591018|NCT00940875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591019|NCT00940875|Antiviral Agents|antiviral agents|mesh-ancestor
25591020|NCT00940875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25591021|NCT00940875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591022|NCT00940875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25591023|NCT00940875|Immunologic Factors|immunologic factors|mesh-ancestor
25591024|NCT00940875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591025|NCT00940875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25591026|NCT00940901|Sildenafil Citrate|sildenafil citrate|mesh-list
25591027|NCT00940901|Vasodilator Agents|vasodilator agents|mesh-ancestor
25591028|NCT00940901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25591029|NCT00940901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25591030|NCT00940901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591031|NCT00940901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591032|NCT00940901|Urological Agents|urological agents|mesh-ancestor
25591033|NCT00940927|Albuterol|albuterol|mesh-list
25591034|NCT00940927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25591035|NCT00940927|Autonomic Agents|autonomic agents|mesh-ancestor
25591036|NCT00940927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25591037|NCT00940927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591038|NCT00940927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25591039|NCT00940927|Respiratory System Agents|respiratory system agents|mesh-ancestor
25591040|NCT00940927|Tocolytic Agents|tocolytic agents|mesh-ancestor
25591041|NCT00940927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25591042|NCT00940927|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25591043|NCT00940927|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25591044|NCT00940927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25591045|NCT00940927|Adrenergic Agents|adrenergic agents|mesh-ancestor
25591046|NCT00940927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25591047|NCT00940927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591048|NCT00941031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25591049|NCT00941031|Immunologic Factors|immunologic factors|mesh-ancestor
25485729|NCT00168454|Botulinum Toxins|botulinum toxins|mesh-list
25591050|NCT00941031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591051|NCT00941070|Cisplatin|cisplatin|mesh-list
25591052|NCT00941070|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25591053|NCT00941070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591054|NCT00941070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25591055|NCT00941070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591056|NCT00941304|Oxycodone|oxycodone|mesh-list
25591057|NCT00941304|Buprenorphine|buprenorphine|mesh-list
25591058|NCT00941304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25591059|NCT00941304|Narcotics|narcotics|mesh-ancestor
24506443|NCT00545311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25591060|NCT00941304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25591061|NCT00941304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591062|NCT00941304|Analgesics|analgesics|mesh-ancestor
25591063|NCT00941304|Sensory System Agents|sensory system agents|mesh-ancestor
25591064|NCT00941304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25591065|NCT00941304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25591066|NCT00941330|Cyclophosphamide|cyclophosphamide|mesh-list
25591067|NCT00941330|Docetaxel|docetaxel|mesh-list
25591068|NCT00941330|Exemestane|exemestane|mesh-list
25591069|NCT00941330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25591070|NCT00941330|Immunologic Factors|immunologic factors|mesh-ancestor
25591071|NCT00941330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591072|NCT00941330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25591073|NCT00941330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25591074|NCT00941330|Alkylating Agents|alkylating agents|mesh-ancestor
25591075|NCT00941330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591076|NCT00941330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591077|NCT00941330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25591078|NCT00941330|Tubulin Modulators|tubulin modulators|mesh-ancestor
25591079|NCT00941330|Antimitotic Agents|antimitotic agents|mesh-ancestor
25591080|NCT00941330|Mitosis Modulators|mitosis modulators|mesh-ancestor
25591081|NCT00941330|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25591082|NCT00941330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25591083|NCT00941330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591084|NCT00941330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25591085|NCT00941330|Hormone Antagonists|hormone antagonists|mesh-ancestor
25591086|NCT00941330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25591087|NCT00941655|Leucovorin|leucovorin|mesh-list
25591088|NCT00941655|Fluorouracil|fluorouracil|mesh-list
25591089|NCT00941655|Oxaliplatin|oxaliplatin|mesh-list
25591090|NCT00941655|Irinotecan|irinotecan|mesh-list
25591091|NCT00941655|Antimetabolites|antimetabolites|mesh-ancestor
25591092|NCT00941655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784029|NCT01905566|Ticagrelor|ticagrelor|mesh-list
25591093|NCT00941655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25591094|NCT00941655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591095|NCT00941655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25591096|NCT00941655|Immunologic Factors|immunologic factors|mesh-ancestor
25591097|NCT00941655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591098|NCT00941655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25591099|NCT00941655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25591100|NCT00941655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591101|NCT00941655|Antidotes|antidotes|mesh-ancestor
25591102|NCT00941655|Protective Agents|protective agents|mesh-ancestor
25591103|NCT00941655|Vitamin B Complex|vitamin b complex|mesh-ancestor
25591104|NCT00941655|Vitamins|vitamins|mesh-ancestor
25591105|NCT00941655|Micronutrients|micronutrients|mesh-ancestor
25591106|NCT00941668|Triclosan|triclosan|mesh-list
25591107|NCT00941668|Fluorides|fluorides|mesh-list
25591108|NCT00941668|Fluorophosphate|fluorophosphate|mesh-list
25591109|NCT00941668|Cariostatic Agents|cariostatic agents|mesh-ancestor
25591110|NCT00941668|Protective Agents|protective agents|mesh-ancestor
25591111|NCT00941668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591112|NCT00941668|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25591113|NCT00941668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25591114|NCT00941668|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25591115|NCT00941668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25591116|NCT00941668|Antimetabolites|antimetabolites|mesh-ancestor
25591117|NCT00941668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591118|NCT00941668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25591119|NCT00941720|Cyclophosphamide|cyclophosphamide|mesh-list
25591120|NCT00941720|Busulfan|busulfan|mesh-list
25591121|NCT00941720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25485794|NCT00169104|Antimitotic Agents|antimitotic agents|mesh-ancestor
25591122|NCT00941720|Immunologic Factors|immunologic factors|mesh-ancestor
25591123|NCT00941720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591124|NCT00941720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25591125|NCT00941720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25591126|NCT00941720|Alkylating Agents|alkylating agents|mesh-ancestor
25485865|NCT00171158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25485866|NCT00171158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24981345|NCT03648892|Raclopride|raclopride|mesh-list
25485867|NCT00171158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485868|NCT00171210|Deferasirox|deferasirox|mesh-list
25485869|NCT00171210|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25485870|NCT00171210|Chelating Agents|chelating agents|mesh-ancestor
25485871|NCT00171210|Sequestering Agents|sequestering agents|mesh-ancestor
25485872|NCT00171210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485873|NCT00171223|Imatinib Mesylate|imatinib mesylate|mesh-list
25485874|NCT00171223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485875|NCT00171223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25485876|NCT00171223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485877|NCT00171223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485878|NCT00171249|Imatinib Mesylate|imatinib mesylate|mesh-list
25485879|NCT00171249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485880|NCT00171249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25485881|NCT00171249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485882|NCT00171249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485883|NCT00171301|Deferasirox|deferasirox|mesh-list
25485884|NCT00171301|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25485885|NCT00171301|Chelating Agents|chelating agents|mesh-ancestor
25485886|NCT00171301|Sequestering Agents|sequestering agents|mesh-ancestor
25485887|NCT00171301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927042|NCT04136470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24927043|NCT04136470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927044|NCT04136600|Antibodies|antibodies|mesh-list
24979691|NCT03022292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979692|NCT03022292|Growth Inhibitors|growth inhibitors|mesh-ancestor
24979693|NCT03022292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433523|NCT00258739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123966|NCT03080324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24433524|NCT00258739|Tubulin Modulators|tubulin modulators|mesh-ancestor
24433525|NCT00258739|Antimitotic Agents|antimitotic agents|mesh-ancestor
24433526|NCT00258739|Mitosis Modulators|mitosis modulators|mesh-ancestor
24433527|NCT00258765|Zoledronic Acid|zoledronic acid|mesh-list
24433528|NCT00258765|Docetaxel|docetaxel|mesh-list
24433530|NCT00258765|Tubulin Modulators|tubulin modulators|mesh-ancestor
24433539|NCT00258791|Analgesics|analgesics|mesh-ancestor
24433540|NCT00258791|Sensory System Agents|sensory system agents|mesh-ancestor
24433547|NCT00258791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433549|NCT00258804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24433550|NCT00258804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433551|NCT00258843|Vaccines|vaccines|mesh-list
24433552|NCT00258843|Immunologic Factors|immunologic factors|mesh-ancestor
24433553|NCT00258843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433554|NCT00259051|Omeprazole|omeprazole|mesh-list
24433555|NCT00259051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24507858|NCT00552747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449469|NCT00315744|Dermatologic Agents|dermatologic agents|mesh-ancestor
24449470|NCT00315744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24449471|NCT00315744|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24449472|NCT00315744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24449473|NCT00315744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24449474|NCT00315744|Adrenergic Agents|adrenergic agents|mesh-ancestor
25591127|NCT00941720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591128|NCT00941720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591129|NCT00941720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25591130|NCT00941798|Mometasone Furoate|mometasone furoate|mesh-list
25591131|NCT00941798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25591132|NCT00941798|Dermatologic Agents|dermatologic agents|mesh-ancestor
25591133|NCT00941798|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25591134|NCT00941863|Sorafenib|sorafenib|mesh-list
25591135|NCT00941863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591136|NCT00941863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25591137|NCT00941863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591138|NCT00941863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508264|NCT00554710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24508265|NCT00554710|Antimetabolites|antimetabolites|mesh-ancestor
24508266|NCT00554710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512847|NCT00577109|Growth Substances|growth substances|mesh-ancestor
24512848|NCT00577109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981585|NCT02393625|Nivolumab|nivolumab|mesh-list
24981586|NCT02393625|Ceritinib|ceritinib|mesh-list
24981587|NCT02393625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24981588|NCT02393625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24981589|NCT02393625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24981590|NCT02393625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981591|NCT02393625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24981592|NCT02393625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24981593|NCT02343042|Clarithromycin|clarithromycin|mesh-list
24981594|NCT02343042|Dexamethasone|dexamethasone|mesh-list
24981595|NCT02343042|Lenalidomide|lenalidomide|mesh-list
24981596|NCT02343042|Bortezomib|bortezomib|mesh-list
24981597|NCT02343042|Daratumumab|daratumumab|mesh-list
24981598|NCT02343042|Pomalidomide|pomalidomide|mesh-list
24981599|NCT02343042|Ixazomib|ixazomib|mesh-list
24981600|NCT02343042|Elotuzumab|elotuzumab|mesh-list
24981601|NCT02343042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24981602|NCT02343042|Antiemetics|antiemetics|mesh-ancestor
24981603|NCT02343042|Autonomic Agents|autonomic agents|mesh-ancestor
24981604|NCT02343042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24981611|NCT02343042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591139|NCT00942084|Acyclovir|acyclovir|mesh-list
25591140|NCT00942084|Antiviral Agents|antiviral agents|mesh-ancestor
25591141|NCT00942084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25591142|NCT00942149|Daptomycin|daptomycin|mesh-list
25591143|NCT00942149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25591144|NCT00942149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25591145|NCT00942175|Esomeprazole|esomeprazole|mesh-list
25591146|NCT00942175|Omeprazole|omeprazole|mesh-list
25591147|NCT00942175|Lansoprazole|lansoprazole|mesh-list
25591148|NCT00942175|Dexlansoprazole|dexlansoprazole|mesh-list
25591149|NCT00942175|Clopidogrel|clopidogrel|mesh-list
25591150|NCT00942175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25591151|NCT00942175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25591152|NCT00942175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25591153|NCT00942175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25591154|NCT00942175|Purinergic Agents|purinergic agents|mesh-ancestor
25591155|NCT00942175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25591156|NCT00942175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591157|NCT00942175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884749|NCT03636451|Sensory System Agents|sensory system agents|mesh-ancestor
24884750|NCT03636451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24981618|NCT02343042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24981619|NCT02343042|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24981620|NCT02343042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24981621|NCT02343042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981622|NCT02343042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24981623|NCT02343042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24981624|NCT02343042|Protease Inhibitors|protease inhibitors|mesh-ancestor
24981625|NCT02317991|Paclitaxel|paclitaxel|mesh-list
24981626|NCT02317991|Ramucirumab|ramucirumab|mesh-list
24981627|NCT02317991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24981628|NCT02317991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24981634|NCT02260193|Glycine Agents|glycine agents|mesh-ancestor
24576162|NCT00837187|Adrenergic Agents|adrenergic agents|mesh-ancestor
24459354|NCT00344422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25106190|NCT04210180|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25106191|NCT04210180|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25106192|NCT04210180|Cholinergic Agents|cholinergic agents|mesh-ancestor
25106193|NCT04210180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25106194|NCT04210180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591158|NCT00942175|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25591159|NCT00942175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25591160|NCT00942175|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25591161|NCT00942175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591162|NCT00942266|Calcium, Dietary|calcium, dietary|mesh-list
25591163|NCT00942266|Leucovorin|leucovorin|mesh-list
25591164|NCT00942266|Fluorouracil|fluorouracil|mesh-list
25591165|NCT00942266|Vorinostat|vorinostat|mesh-list
25591166|NCT00942266|Calcium|calcium|mesh-list
25591167|NCT00942266|Levoleucovorin|levoleucovorin|mesh-list
25591168|NCT00942266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25591169|NCT00942266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591170|NCT00942266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25591171|NCT00942266|Antimetabolites|antimetabolites|mesh-ancestor
25591172|NCT00942266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591173|NCT00942266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25591174|NCT00942266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591175|NCT00942266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25591176|NCT00942266|Immunologic Factors|immunologic factors|mesh-ancestor
25591177|NCT00942266|Antidotes|antidotes|mesh-ancestor
25591178|NCT00942266|Protective Agents|protective agents|mesh-ancestor
25591179|NCT00942266|Vitamin B Complex|vitamin b complex|mesh-ancestor
25591180|NCT00942266|Vitamins|vitamins|mesh-ancestor
25591181|NCT00942266|Micronutrients|micronutrients|mesh-ancestor
25591182|NCT00942266|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25591183|NCT00942266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591184|NCT00942305|Brincidofovir|brincidofovir|mesh-list
25591185|NCT00942305|Antiviral Agents|antiviral agents|mesh-ancestor
25591186|NCT00942305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25591187|NCT00942357|Paclitaxel|paclitaxel|mesh-list
25591188|NCT00942357|Cisplatin|cisplatin|mesh-list
25591189|NCT00942357|Carboplatin|carboplatin|mesh-list
25591190|NCT00942357|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25591191|NCT00942357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25591192|NCT00942357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591193|NCT00942357|Tubulin Modulators|tubulin modulators|mesh-ancestor
25591194|NCT00942357|Antimitotic Agents|antimitotic agents|mesh-ancestor
24795641|NCT01097746|Bevacizumab|bevacizumab|mesh-list
24981750|NCT01858740|Thiotepa|thiotepa|mesh-list
24981751|NCT01858740|Tacrolimus|tacrolimus|mesh-list
24981752|NCT01858740|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24981753|NCT01858740|Abortifacient Agents|abortifacient agents|mesh-ancestor
24981754|NCT01858740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24981755|NCT01858740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981787|NCT01759238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24981788|NCT01759238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24981789|NCT01759238|Growth Substances|growth substances|mesh-ancestor
24981790|NCT01759238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981791|NCT01759238|Growth Inhibitors|growth inhibitors|mesh-ancestor
24981792|NCT01759238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25591195|NCT00942357|Mitosis Modulators|mitosis modulators|mesh-ancestor
25591196|NCT00942357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591197|NCT00942422|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
25591198|NCT00942422|Antioxidants|antioxidants|mesh-ancestor
25591199|NCT00942422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591200|NCT00942422|Protective Agents|protective agents|mesh-ancestor
25591201|NCT00942422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591202|NCT00942422|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25591203|NCT00942422|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25591204|NCT00942422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24452118|NCT00326092|Brinzolamide|brinzolamide|mesh-list
24452155|NCT00326235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24452156|NCT00326235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24452157|NCT00326235|Serotonin Agents|serotonin agents|mesh-ancestor
24452158|NCT00326235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25106237|NCT04031729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25106238|NCT04031729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25106239|NCT04031729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25106240|NCT04031729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25106241|NCT04031729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106242|NCT04031729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25106243|NCT04031729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25106244|NCT04031729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25106249|NCT03977363|Anticoagulants|anticoagulants|mesh-list
25591205|NCT00942422|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25591206|NCT00942448|Diclofenac|diclofenac|mesh-list
25591207|NCT00942448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25591208|NCT00942448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25591209|NCT00942448|Analgesics|analgesics|mesh-ancestor
25591210|NCT00942448|Sensory System Agents|sensory system agents|mesh-ancestor
25591211|NCT00942448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25591212|NCT00942448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705512|NCT02199574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24885141|NCT02346630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510024|NCT00563108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510026|NCT00563147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25709667|NCT02272413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795685|NCT01042379|Cemiplimab|cemiplimab|mesh-list
24795686|NCT01042379|Talazoparib|talazoparib|mesh-list
24795687|NCT01042379|Trebananib|trebananib|mesh-list
24795688|NCT01042379|Tucatinib|tucatinib|mesh-list
24450664|NCT00319917|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24795698|NCT01042379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24795699|NCT01042379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24795700|NCT01042379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795701|NCT01042379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24795702|NCT01042379|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24450665|NCT00319917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450666|NCT00319917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450668|NCT00320021|Vitamin B Complex|vitamin b complex|mesh-ancestor
24450683|NCT00320034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24450684|NCT00320034|Adrenergic Agents|adrenergic agents|mesh-ancestor
24450685|NCT00320034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24450686|NCT00320034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709668|NCT02272413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25709669|NCT02272413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25709670|NCT02272413|Growth Substances|growth substances|mesh-ancestor
25709671|NCT02272413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709672|NCT02272413|Growth Inhibitors|growth inhibitors|mesh-ancestor
25591213|NCT00942448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25591214|NCT00942448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25591215|NCT00942448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25591216|NCT00942448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591217|NCT00942448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591218|NCT00942578|Prednisone|prednisone|mesh-list
25591219|NCT00942578|Bevacizumab|bevacizumab|mesh-list
25591220|NCT00942578|Lenalidomide|lenalidomide|mesh-list
25591221|NCT00942578|Docetaxel|docetaxel|mesh-list
25591222|NCT00942578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25591223|NCT00942578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591224|NCT00942578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25591225|NCT00942578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25485888|NCT00171314|Zoledronic Acid|zoledronic acid|mesh-list
25591226|NCT00942578|Growth Substances|growth substances|mesh-ancestor
25591227|NCT00942578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591228|NCT00942578|Growth Inhibitors|growth inhibitors|mesh-ancestor
25591229|NCT00942578|Tubulin Modulators|tubulin modulators|mesh-ancestor
25591230|NCT00942578|Antimitotic Agents|antimitotic agents|mesh-ancestor
25591231|NCT00942578|Mitosis Modulators|mitosis modulators|mesh-ancestor
25591232|NCT00942578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591233|NCT00942578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25591234|NCT00942578|Glucocorticoids|glucocorticoids|mesh-ancestor
25591235|NCT00942578|Hormones|hormones|mesh-ancestor
24510361|NCT00564408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510362|NCT00564408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24510363|NCT00564408|Analgesics|analgesics|mesh-ancestor
24510365|NCT00564408|Protective Agents|protective agents|mesh-ancestor
24450690|NCT00320047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24981897|NCT01081951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24981898|NCT01081951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24981899|NCT01081951|Tubulin Modulators|tubulin modulators|mesh-ancestor
24981900|NCT01081951|Antimitotic Agents|antimitotic agents|mesh-ancestor
24981901|NCT01081951|Mitosis Modulators|mitosis modulators|mesh-ancestor
24981902|NCT01081951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981903|NCT01081951|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24981904|NCT01081951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24981920|NCT00852696|Solifenacin Succinate|solifenacin succinate|mesh-list
24452354|NCT00327197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981949|NCT00493961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981950|NCT04623099|Citalopram|citalopram|mesh-list
24981951|NCT04623099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24981952|NCT04623099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24981953|NCT04623099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25591236|NCT00942578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25591237|NCT00942578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25591238|NCT00942578|Immunologic Factors|immunologic factors|mesh-ancestor
25591239|NCT00942708|Fluoxetine|fluoxetine|mesh-list
25591240|NCT00942708|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25591241|NCT00942708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25591242|NCT00942708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25591243|NCT00942708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591244|NCT00942708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25591245|NCT00942708|Serotonin Agents|serotonin agents|mesh-ancestor
25591246|NCT00942708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591247|NCT00942708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25591248|NCT00942708|Antidepressive Agents|antidepressive agents|mesh-ancestor
25591249|NCT00942708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25591250|NCT00942708|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25591251|NCT00942708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25591252|NCT00942708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591253|NCT00942734|Everolimus|everolimus|mesh-list
25591254|NCT00942734|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25591255|NCT00942734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591256|NCT00942734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25591257|NCT00942734|Immunologic Factors|immunologic factors|mesh-ancestor
25591258|NCT00942734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510757|NCT00565500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24510765|NCT00565591|Albuterol|albuterol|mesh-list
24981954|NCT04623099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981955|NCT04623099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24981956|NCT04623099|Serotonin Agents|serotonin agents|mesh-ancestor
24981957|NCT04623099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981958|NCT04623099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24981959|NCT04623099|Antidepressive Agents|antidepressive agents|mesh-ancestor
24981960|NCT04623099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24981975|NCT04508855|Anticoagulants|anticoagulants|mesh-ancestor
24981976|NCT04508855|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24981977|NCT04508855|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24981978|NCT04508855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981979|NCT04499950|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
24981981|NCT04499950|Bupropion|bupropion|mesh-list
24981982|NCT04499950|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24981995|NCT04499950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25705521|NCT02199652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705522|NCT02199743|Haloperidol|haloperidol|mesh-list
25705523|NCT02199743|Haloperidol decanoate|haloperidol decanoate|mesh-list
25705524|NCT02199743|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25591259|NCT00942734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25591260|NCT00942734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591261|NCT00942734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591262|NCT00942825|Cisplatin|cisplatin|mesh-list
25591263|NCT00942825|Pemetrexed|pemetrexed|mesh-list
25591264|NCT00942825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591265|NCT00942825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591266|NCT00942825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591267|NCT00942825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25591268|NCT00942825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25591269|NCT00942968|Dalteparin|dalteparin|mesh-list
25591270|NCT00942968|Tinzaparin|tinzaparin|mesh-list
25591271|NCT00942968|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25591272|NCT00942968|Anticoagulants|anticoagulants|mesh-ancestor
25591273|NCT00942968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25591274|NCT00942968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25591275|NCT00942968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591276|NCT00942994|Amlodipine|amlodipine|mesh-list
25591277|NCT00942994|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25591278|NCT00942994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25591279|NCT00942994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25591280|NCT00942994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25591281|NCT00942994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591282|NCT00942994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25591283|NCT00942994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591284|NCT00942994|Vasodilator Agents|vasodilator agents|mesh-ancestor
25591285|NCT00942994|Diuretics|diuretics|mesh-ancestor
25591286|NCT00942994|Natriuretic Agents|natriuretic agents|mesh-ancestor
24885625|NCT05024513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885626|NCT05024513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24885627|NCT05024513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885628|NCT05024513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24885629|NCT05024513|Immunologic Factors|immunologic factors|mesh-ancestor
24885630|NCT05024513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511058|NCT00567177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982000|NCT04495621|Cetuximab|cetuximab|mesh-list
24982010|NCT04463394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982012|NCT04454476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24982013|NCT04454476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24982014|NCT04454476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24982015|NCT04454476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982016|NCT04454411|Naltrexone|naltrexone|mesh-list
24982017|NCT04454411|Buprenorphine|buprenorphine|mesh-list
24795703|NCT01042379|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25705531|NCT02199743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25705532|NCT02199743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25705533|NCT02199743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25705534|NCT02199743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25591287|NCT00942994|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25591288|NCT00943072|Aflibercept|aflibercept|mesh-list
25591289|NCT00943072|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25591290|NCT00943072|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25591291|NCT00943072|Growth Substances|growth substances|mesh-ancestor
25591292|NCT00943072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591293|NCT00943072|Growth Inhibitors|growth inhibitors|mesh-ancestor
25591294|NCT00943072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591295|NCT00943098|Diclofenac|diclofenac|mesh-list
25591296|NCT00943098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25591297|NCT00943098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25591298|NCT00943098|Analgesics|analgesics|mesh-ancestor
25591299|NCT00943098|Sensory System Agents|sensory system agents|mesh-ancestor
25591300|NCT00943098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25591301|NCT00943098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591302|NCT00943098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25591303|NCT00943098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25591304|NCT00943098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25591305|NCT00943098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795704|NCT01042379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24795705|NCT01042379|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24795706|NCT01042379|Hormone Antagonists|hormone antagonists|mesh-ancestor
24795707|NCT01042379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24795708|NCT01042379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24795709|NCT01042379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24795710|NCT01042379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24795711|NCT01042379|Growth Substances|growth substances|mesh-ancestor
24795712|NCT01042379|Growth Inhibitors|growth inhibitors|mesh-ancestor
24982020|NCT04454411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24982021|NCT04454411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982022|NCT04454411|Analgesics|analgesics|mesh-ancestor
24982023|NCT04454411|Sensory System Agents|sensory system agents|mesh-ancestor
24982024|NCT04454411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24982047|NCT04391855|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24982048|NCT04391855|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24982049|NCT04391855|Adrenergic Agents|adrenergic agents|mesh-ancestor
24982050|NCT04391855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25591306|NCT00943098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591307|NCT00943111|Eliglustat|eliglustat|mesh-list
25591308|NCT00943111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591309|NCT00943111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591310|NCT00943124|Niacin|niacin|mesh-list
25591311|NCT00943124|Niacinamide|niacinamide|mesh-list
25591312|NCT00943124|Nicotinic Acids|nicotinic acids|mesh-list
25591313|NCT00943124|Simvastatin|simvastatin|mesh-list
25591314|NCT00943124|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25591315|NCT00943124|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25591316|NCT00943124|Antimetabolites|antimetabolites|mesh-ancestor
25591317|NCT00943124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591318|NCT00943124|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25591319|NCT00943124|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25591320|NCT00943124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24511515|NCT00569296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24982051|NCT04391855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982052|NCT04391855|Anesthetics, Local|anesthetics, local|mesh-ancestor
24982053|NCT04391855|Anesthetics|anesthetics|mesh-ancestor
24459601|NCT00345202|Antimetabolites|antimetabolites|mesh-ancestor
24450792|NCT00320580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24452697|NCT05457751|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24452698|NCT05457751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24452699|NCT05457751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982065|NCT04371380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24982066|NCT04371380|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24982067|NCT04371380|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24982068|NCT04297618|Lifitegrast|lifitegrast|mesh-list
24982069|NCT04297618|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24982070|NCT04297618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24784123|NCT01906294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784124|NCT01906307|Angiotensin II|angiotensin ii|mesh-list
24784126|NCT01906307|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24459616|NCT00345501|Vasodilator Agents|vasodilator agents|mesh-ancestor
25705539|NCT02199743|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25705540|NCT02199743|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25705541|NCT02199743|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25705542|NCT02199743|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25591321|NCT00943124|Vasodilator Agents|vasodilator agents|mesh-ancestor
25591322|NCT00943124|Vitamin B Complex|vitamin b complex|mesh-ancestor
25591323|NCT00943124|Vitamins|vitamins|mesh-ancestor
25591324|NCT00943124|Micronutrients|micronutrients|mesh-ancestor
25591325|NCT00943124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591326|NCT00943202|Vaccines|vaccines|mesh-list
25591327|NCT00943202|Immunologic Factors|immunologic factors|mesh-ancestor
25591328|NCT00943202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591329|NCT00943319|Fludarabine|fludarabine|mesh-list
25591330|NCT00943319|Busulfan|busulfan|mesh-list
25591331|NCT00943319|Alemtuzumab|alemtuzumab|mesh-list
25591332|NCT00943319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591333|NCT00943319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591334|NCT00943319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25591335|NCT00943319|Immunologic Factors|immunologic factors|mesh-ancestor
25591336|NCT00943319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886612|NCT04524728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24886613|NCT04524897|Triamcinolone|triamcinolone|mesh-list
24886614|NCT04524897|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24886615|NCT04524897|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24886616|NCT04524897|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24512195|NCT00573547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24512196|NCT00573547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512197|NCT00573599|Diphenhydramine|diphenhydramine|mesh-list
24512212|NCT00573599|Histamine Agents|histamine agents|mesh-ancestor
24512213|NCT00573599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24886888|NCT04522037|Morphine|morphine|mesh-list
24805980|NCT02013115|Respiratory System Agents|respiratory system agents|mesh-ancestor
25705543|NCT02199743|Adrenergic Agents|adrenergic agents|mesh-ancestor
25705544|NCT02199743|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25705545|NCT02199743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25705546|NCT02199743|Serotonin Agents|serotonin agents|mesh-ancestor
25705547|NCT02199743|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25705548|NCT02199964|Cyclosporine|cyclosporine|mesh-list
25705549|NCT02199964|Lubricant Eye Drops|lubricant eye drops|mesh-list
25705550|NCT02199964|Cyclosporins|cyclosporins|mesh-list
25705551|NCT02199964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25705552|NCT02199964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705553|NCT02199964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25705554|NCT02199964|Immunologic Factors|immunologic factors|mesh-ancestor
25705555|NCT02199964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591337|NCT00943319|Alkylating Agents|alkylating agents|mesh-ancestor
25591338|NCT00943319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25591339|NCT00943319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25591340|NCT00943319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25591341|NCT00943592|Melphalan|melphalan|mesh-list
25591342|NCT00943592|Alemtuzumab|alemtuzumab|mesh-list
25591343|NCT00943592|Clofarabine|clofarabine|mesh-list
25591344|NCT00943592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25591345|NCT00943592|Alkylating Agents|alkylating agents|mesh-ancestor
25591346|NCT00943592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591347|NCT00943592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591348|NCT00943592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25591349|NCT00943592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25591350|NCT00943592|Immunologic Factors|immunologic factors|mesh-ancestor
25591351|NCT00943592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591352|NCT00943592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25591353|NCT00943592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25591354|NCT00943592|Antimetabolites|antimetabolites|mesh-ancestor
25591355|NCT00943670|Trastuzumab|trastuzumab|mesh-list
25591356|NCT00943670|Pertuzumab|pertuzumab|mesh-list
25591357|NCT00943670|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25591358|NCT00943670|Maytansine|maytansine|mesh-list
25591359|NCT00943670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25591360|NCT00943670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591361|NCT00943670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25591362|NCT00943670|Tubulin Modulators|tubulin modulators|mesh-ancestor
25591363|NCT00943670|Antimitotic Agents|antimitotic agents|mesh-ancestor
25591364|NCT00943670|Mitosis Modulators|mitosis modulators|mesh-ancestor
25591365|NCT00943670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591366|NCT00943735|Fesoterodine|fesoterodine|mesh-list
24887122|NCT04520139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887210|NCT04518618|Sensory System Agents|sensory system agents|mesh-ancestor
24887211|NCT04518618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24887212|NCT04518618|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24887213|NCT04518618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24887450|NCT04516174|Analgesics|analgesics|mesh-ancestor
25106263|NCT03651206|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25106264|NCT03651206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25106265|NCT03651206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106266|NCT03651206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106267|NCT03573817|Formoterol Fumarate|formoterol fumarate|mesh-list
25106268|NCT03573817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25106304|NCT03107871|Antiviral Agents|antiviral agents|mesh-ancestor
25106305|NCT03107871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25591367|NCT00943735|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25591368|NCT00943735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25591369|NCT00943735|Cholinergic Agents|cholinergic agents|mesh-ancestor
25591370|NCT00943735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25591371|NCT00943735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591372|NCT00943735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591373|NCT00943735|Urological Agents|urological agents|mesh-ancestor
25591374|NCT00943761|Interferons|interferons|mesh-list
25591375|NCT00943761|Ribavirin|ribavirin|mesh-list
25591376|NCT00943761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591377|NCT00943761|Antiviral Agents|antiviral agents|mesh-ancestor
25591378|NCT00943761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25591379|NCT00943761|Antimetabolites|antimetabolites|mesh-ancestor
25591380|NCT00943761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591381|NCT00943787|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25591382|NCT00943787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591383|NCT00943800|Vidarabine|vidarabine|mesh-list
25591384|NCT00943800|Fludarabine|fludarabine|mesh-list
25591385|NCT00943800|Fludarabine phosphate|fludarabine phosphate|mesh-list
25591386|NCT00943800|Melphalan|melphalan|mesh-list
25591387|NCT00943800|Busulfan|busulfan|mesh-list
25591388|NCT00943800|Thiotepa|thiotepa|mesh-list
25591389|NCT00943800|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25591390|NCT00943800|Thymoglobulin|thymoglobulin|mesh-list
25591391|NCT00943800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591392|NCT00943800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25591393|NCT00943800|Antimetabolites|antimetabolites|mesh-ancestor
25591394|NCT00943800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591395|NCT00943800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25591396|NCT00943800|Immunologic Factors|immunologic factors|mesh-ancestor
25591397|NCT00943800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591398|NCT00943800|Antiviral Agents|antiviral agents|mesh-ancestor
24887886|NCT04511000|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25106312|NCT03095456|Respiratory System Agents|respiratory system agents|mesh-ancestor
25106313|NCT03095456|Parasympatholytics|parasympatholytics|mesh-ancestor
25106314|NCT03095456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25106315|NCT03095456|Cholinergic Agents|cholinergic agents|mesh-ancestor
25106316|NCT03095456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25106317|NCT03095456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784129|NCT01906411|Sympathomimetics|sympathomimetics|mesh-ancestor
24982090|NCT04250636|Immunoglobulins|immunoglobulins|mesh-list
24982091|NCT04250636|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24982092|NCT04250636|Immunologic Factors|immunologic factors|mesh-ancestor
24982102|NCT04245748|Citalopram|citalopram|mesh-list
25705565|NCT02201212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25705566|NCT02201212|Immunologic Factors|immunologic factors|mesh-ancestor
25705567|NCT02201212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705568|NCT02201329|Azacitidine|azacitidine|mesh-list
25705569|NCT02201329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25705570|NCT02201329|Antimetabolites|antimetabolites|mesh-ancestor
25705571|NCT02201329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591399|NCT00943800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25591400|NCT00943800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25591401|NCT00943800|Alkylating Agents|alkylating agents|mesh-ancestor
25591402|NCT00943800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25591403|NCT00943826|Bevacizumab|bevacizumab|mesh-list
25591404|NCT00943826|Temozolomide|temozolomide|mesh-list
25591405|NCT00943826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25591406|NCT00943826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591407|NCT00943826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25591408|NCT00943826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25591409|NCT00943826|Growth Substances|growth substances|mesh-ancestor
25591410|NCT00943826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887961|NCT04510337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24887962|NCT04510337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887963|NCT04510337|Anesthetics|anesthetics|mesh-ancestor
24512721|NCT00576329|Analgesics|analgesics|mesh-ancestor
24888106|NCT04509258|Antiviral Agents|antiviral agents|mesh-ancestor
24982114|NCT04245748|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24982115|NCT04245748|Analgesics|analgesics|mesh-ancestor
24982116|NCT04245748|Sensory System Agents|sensory system agents|mesh-ancestor
24982117|NCT04245748|Dopamine Agents|dopamine agents|mesh-ancestor
24982118|NCT04245436|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24982120|NCT04245436|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24982121|NCT04245436|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24982122|NCT04245436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25591411|NCT00943826|Growth Inhibitors|growth inhibitors|mesh-ancestor
25591412|NCT00943826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25591413|NCT00943826|Alkylating Agents|alkylating agents|mesh-ancestor
25591414|NCT00943826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591415|NCT00943878|Vaccines|vaccines|mesh-list
25591416|NCT00943878|Immunologic Factors|immunologic factors|mesh-ancestor
25591417|NCT00943878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591418|NCT00943917|Exenatide|exenatide|mesh-list
25591419|NCT00943917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25591420|NCT00943917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591421|NCT00943917|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25591422|NCT00943917|Incretins|incretins|mesh-ancestor
25591423|NCT00943917|Hormones|hormones|mesh-ancestor
25591424|NCT00943917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25653506|NCT01537666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25653507|NCT01537783|Chlorhexidine|chlorhexidine|mesh-list
25653508|NCT01537783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25653509|NCT01537783|Mupirocin|mupirocin|mesh-list
25653510|NCT01537783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25653511|NCT01537783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25653512|NCT01537783|Disinfectants|disinfectants|mesh-ancestor
25653513|NCT01537783|Dermatologic Agents|dermatologic agents|mesh-ancestor
25705583|NCT02201394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25705584|NCT02201394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25705585|NCT02201394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24516803|NCT00603759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25705586|NCT02201394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705587|NCT02201394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25705588|NCT02201394|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24982162|NCT03837860|Ziprasidone|ziprasidone|mesh-list
24982163|NCT03837860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24982164|NCT03837860|Narcotics|narcotics|mesh-ancestor
24982165|NCT03837860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24982166|NCT03837860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982169|NCT03837860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24982170|NCT03837860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24982171|NCT03837860|Serotonin Agents|serotonin agents|mesh-ancestor
24982172|NCT03837860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24982173|NCT03837860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982174|NCT03837860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25653514|NCT01537783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25653515|NCT01537783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25653516|NCT01537783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653517|NCT01537783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653518|NCT01537835|Anti-Infective Agents|anti-infective agents|mesh-list
25653519|NCT01537835|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25653520|NCT01537887|Moxifloxacin|moxifloxacin|mesh-list
25653521|NCT01537887|Evacetrapib|evacetrapib|mesh-list
25653522|NCT01537887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25653523|NCT01537887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25653524|NCT01537887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25653525|NCT01537887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25653526|NCT01537887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653527|NCT01537887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653528|NCT01537887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25653529|NCT01537887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25653530|NCT01537887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25653531|NCT01537887|Antimetabolites|antimetabolites|mesh-ancestor
25653532|NCT01537887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25653533|NCT01537900|Grazoprevir|grazoprevir|mesh-list
25653534|NCT01537900|Antiviral Agents|antiviral agents|mesh-ancestor
25653535|NCT01537900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25653536|NCT01537926|Acetylcysteine|acetylcysteine|mesh-list
25653537|NCT01537926|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25591425|NCT00944047|Paclitaxel|paclitaxel|mesh-list
25591426|NCT00944047|Cyclophosphamide|cyclophosphamide|mesh-list
24982204|NCT03501381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24982205|NCT03501381|Analgesics|analgesics|mesh-ancestor
24982206|NCT03501381|Sensory System Agents|sensory system agents|mesh-ancestor
24982207|NCT03501381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24982208|NCT03501381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982209|NCT03501381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24982210|NCT03501381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24982211|NCT03501381|Antiviral Agents|antiviral agents|mesh-ancestor
24982212|NCT03501381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24982213|NCT03501381|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24982214|NCT03501381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450814|NCT00320658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450819|NCT00320697|Nicotine|nicotine|mesh-list
25705592|NCT02201394|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25705593|NCT02201394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25705594|NCT02201394|Purinergic Agents|purinergic agents|mesh-ancestor
25705595|NCT02201394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25705596|NCT02201524|Abrocitinib|abrocitinib|mesh-list
25705597|NCT02201524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25106318|NCT03084523|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25705598|NCT02201524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709673|NCT02272725|Ibuprofen|ibuprofen|mesh-list
25591427|NCT00944047|Doxorubicin|doxorubicin|mesh-list
25591428|NCT00944047|Trastuzumab|trastuzumab|mesh-list
25591429|NCT00944047|Mitogens|mitogens|mesh-list
25591430|NCT00944047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25591431|NCT00944047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591432|NCT00944047|Tubulin Modulators|tubulin modulators|mesh-ancestor
25591433|NCT00944047|Antimitotic Agents|antimitotic agents|mesh-ancestor
25591434|NCT00944047|Mitosis Modulators|mitosis modulators|mesh-ancestor
25591435|NCT00944047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591436|NCT00944047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25591437|NCT00944047|Immunologic Factors|immunologic factors|mesh-ancestor
25591438|NCT00944047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591439|NCT00944047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25591440|NCT00944047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25591441|NCT00944047|Alkylating Agents|alkylating agents|mesh-ancestor
25705599|NCT02201524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513132|NCT00579046|Darbepoetin alfa|darbepoetin alfa|mesh-list
24889670|NCT04490967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24982237|NCT03442413|Nicotine|nicotine|mesh-list
24982238|NCT03442413|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24982239|NCT03442413|Autonomic Agents|autonomic agents|mesh-ancestor
24982240|NCT03442413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24982241|NCT03442413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982242|NCT03442413|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24982243|NCT03442413|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24982244|NCT03442413|Cholinergic Agents|cholinergic agents|mesh-ancestor
24982245|NCT03442413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24982246|NCT03442413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982247|NCT03386500|Manganese|manganese|mesh-list
24982248|NCT03386500|Trace Elements|trace elements|mesh-ancestor
24982249|NCT03386500|Micronutrients|micronutrients|mesh-ancestor
24982250|NCT03386500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982251|NCT03379727|Midostaurin|midostaurin|mesh-list
24982252|NCT03379727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25705600|NCT02201771|Aspirin|aspirin|mesh-list
25705601|NCT02201771|Ticagrelor|ticagrelor|mesh-list
25705602|NCT02201771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25705603|NCT02201771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25705604|NCT02201771|Analgesics|analgesics|mesh-ancestor
25705605|NCT02201771|Sensory System Agents|sensory system agents|mesh-ancestor
25705606|NCT02201771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25705607|NCT02201771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705608|NCT02201771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25591442|NCT00944047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25591443|NCT00944047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25591444|NCT00944047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25591445|NCT00944047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25591446|NCT00944047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591447|NCT00944047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25591448|NCT00944450|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25591449|NCT00944450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25591450|NCT00944450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591451|NCT00944450|Incretins|incretins|mesh-ancestor
25591452|NCT00944450|Hormones|hormones|mesh-ancestor
25591453|NCT00944450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25591454|NCT00944450|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24890091|NCT04485988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890092|NCT04485780|Botulinum Toxins|botulinum toxins|mesh-list
24453430|NCT05008224|Prednisone|prednisone|mesh-list
24453431|NCT05008224|Cyclophosphamide|cyclophosphamide|mesh-list
24453432|NCT05008224|Dacarbazine|dacarbazine|mesh-list
24795739|NCT00003641|Antiviral Agents|antiviral agents|mesh-ancestor
24795740|NCT00003641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24795741|NCT00003641|Immunologic Factors|immunologic factors|mesh-ancestor
24982327|NCT03073785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982328|NCT03073785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24982329|NCT03073785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24982330|NCT03073785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25591455|NCT00944450|Protease Inhibitors|protease inhibitors|mesh-ancestor
25591456|NCT00944450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591457|NCT00944450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591458|NCT00944554|Varenicline|varenicline|mesh-list
25591459|NCT00944554|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25591460|NCT00944554|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25591461|NCT00944554|Cholinergic Agents|cholinergic agents|mesh-ancestor
25591462|NCT00944554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25591463|NCT00944554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591464|NCT00944554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591466|NCT00944645|Niacinamide|niacinamide|mesh-list
25591467|NCT00944645|Nicotinic Acids|nicotinic acids|mesh-list
25591468|NCT00944645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25591469|NCT00944645|Antimetabolites|antimetabolites|mesh-ancestor
25591470|NCT00944645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591471|NCT00944645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25591472|NCT00944645|Vasodilator Agents|vasodilator agents|mesh-ancestor
25591473|NCT00944645|Vitamin B Complex|vitamin b complex|mesh-ancestor
25591474|NCT00944645|Vitamins|vitamins|mesh-ancestor
25591475|NCT00944645|Micronutrients|micronutrients|mesh-ancestor
25591476|NCT00944645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591477|NCT00944658|Apremilast|apremilast|mesh-list
25591478|NCT00944658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25591479|NCT00944658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24890354|NCT04483830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890355|NCT04483765|Anesthetics|anesthetics|mesh-list
24890356|NCT04483765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24890357|NCT04483765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890358|NCT04483596|Melatonin|melatonin|mesh-list
24890359|NCT04483596|Antioxidants|antioxidants|mesh-ancestor
25591480|NCT00944658|Analgesics|analgesics|mesh-ancestor
25591481|NCT00944658|Sensory System Agents|sensory system agents|mesh-ancestor
25591482|NCT00944658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25591483|NCT00944658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591484|NCT00944658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25591485|NCT00944658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25591486|NCT00944658|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25591487|NCT00944658|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25591488|NCT00944658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591489|NCT00944658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591490|NCT00944671|Calcium, Dietary|calcium, dietary|mesh-list
25591491|NCT00944671|Calcium Carbonate|calcium carbonate|mesh-list
25591492|NCT00944671|Magnesium Hydroxide|magnesium hydroxide|mesh-list
24890774|NCT04480333|Remdesivir|remdesivir|mesh-list
25106386|NCT02820311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106387|NCT02820311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106388|NCT02812667|Nivolumab|nivolumab|mesh-list
24784259|NCT01907165|Copper|copper|mesh-list
25591493|NCT00944671|Famotidine|famotidine|mesh-list
25591494|NCT00944671|Calcium|calcium|mesh-list
25591495|NCT00944671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25591496|NCT00944671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591497|NCT00944671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25591498|NCT00944671|Antacids|antacids|mesh-ancestor
25591499|NCT00944671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591500|NCT00944671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25591501|NCT00944671|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25591502|NCT00944671|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25591503|NCT00944671|Histamine Antagonists|histamine antagonists|mesh-ancestor
25591504|NCT00944671|Histamine Agents|histamine agents|mesh-ancestor
25591505|NCT00944671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25591507|NCT00944697|Naloxone|naloxone|mesh-list
25591508|NCT00944697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25591509|NCT00944697|Narcotics|narcotics|mesh-ancestor
25591510|NCT00944697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25591511|NCT00944697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591512|NCT00944697|Analgesics|analgesics|mesh-ancestor
25591513|NCT00944697|Sensory System Agents|sensory system agents|mesh-ancestor
25591514|NCT00944697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25591515|NCT00944697|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25591516|NCT00944710|Atropine|atropine|mesh-list
25591517|NCT00944710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25591518|NCT00944710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25591519|NCT00944710|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25591520|NCT00944710|Autonomic Agents|autonomic agents|mesh-ancestor
25106406|NCT02797275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25106407|NCT02797275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106417|NCT02790138|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25106418|NCT02790138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25106419|NCT02790138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25106424|NCT02744053|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
25106425|NCT02744053|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25591521|NCT00944710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25591522|NCT00944710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591523|NCT00944710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25591524|NCT00944710|Respiratory System Agents|respiratory system agents|mesh-ancestor
25591525|NCT00944710|Mydriatics|mydriatics|mesh-ancestor
25591526|NCT00944710|Parasympatholytics|parasympatholytics|mesh-ancestor
25591527|NCT00944710|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25591528|NCT00944710|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25591529|NCT00944710|Cholinergic Agents|cholinergic agents|mesh-ancestor
25591530|NCT00944710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25591531|NCT00944710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591532|NCT00944749|Cyclosporine|cyclosporine|mesh-list
25591533|NCT00944749|Cyclosporins|cyclosporins|mesh-list
25591534|NCT00944749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591535|NCT00944749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591536|NCT00944749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25591537|NCT00944749|Immunologic Factors|immunologic factors|mesh-ancestor
25591538|NCT00944749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591539|NCT00944749|Antifungal Agents|antifungal agents|mesh-ancestor
25591540|NCT00944749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25705626|NCT02201784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25705627|NCT02201784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982578|NCT01524536|Prednisone|prednisone|mesh-list
24982579|NCT01524536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24982580|NCT01524536|Glucocorticoids|glucocorticoids|mesh-ancestor
24982581|NCT01524536|Hormones|hormones|mesh-ancestor
24982582|NCT01524536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24795757|NCT01945892|Antiemetics|antiemetics|mesh-ancestor
24795758|NCT01945892|Autonomic Agents|autonomic agents|mesh-ancestor
24795759|NCT01945892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24795760|NCT01945892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795761|NCT01945892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24795762|NCT01945892|Glucocorticoids|glucocorticoids|mesh-ancestor
24795763|NCT01945892|Hormones|hormones|mesh-ancestor
24795764|NCT01945892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24795765|NCT01945892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24795766|NCT01945892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25705630|NCT02201901|Sofosbuvir|sofosbuvir|mesh-list
25591541|NCT00944749|Dermatologic Agents|dermatologic agents|mesh-ancestor
25591542|NCT00944749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25591543|NCT00944749|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25591544|NCT00945139|Bevacizumab|bevacizumab|mesh-list
25591545|NCT00945139|Doxorubicin|doxorubicin|mesh-list
25591546|NCT00945139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25591547|NCT00945139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591548|NCT00945139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25591549|NCT00945139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25591550|NCT00945139|Growth Substances|growth substances|mesh-ancestor
25591551|NCT00945139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891240|NCT04474093|Autonomic Agents|autonomic agents|mesh-ancestor
24982656|NCT01307046|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24982657|NCT01307046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982659|NCT01307033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24982660|NCT01307033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24982661|NCT01307033|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24982662|NCT01307033|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24982663|NCT01307033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982665|NCT01041807|Amlodipine|amlodipine|mesh-list
24982666|NCT01041807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24982667|NCT01041807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24982668|NCT01041807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24982669|NCT01041807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591552|NCT00945139|Growth Inhibitors|growth inhibitors|mesh-ancestor
25591553|NCT00945139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25591554|NCT00945139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25591555|NCT00945139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25591556|NCT00945139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591557|NCT00945139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591558|NCT00945191|Paclitaxel|paclitaxel|mesh-list
25591559|NCT00945191|Carboplatin|carboplatin|mesh-list
25591560|NCT00945191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25591561|NCT00945191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591562|NCT00945191|Tubulin Modulators|tubulin modulators|mesh-ancestor
25591563|NCT00945191|Antimitotic Agents|antimitotic agents|mesh-ancestor
25591564|NCT00945191|Mitosis Modulators|mitosis modulators|mesh-ancestor
25591565|NCT00945191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591566|NCT00945256|Nitroprusside|nitroprusside|mesh-list
25591567|NCT00945256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25591568|NCT00945256|Vasodilator Agents|vasodilator agents|mesh-ancestor
25591569|NCT00945256|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25591570|NCT00945256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591571|NCT00945282|Ritonavir|ritonavir|mesh-list
25591572|NCT00945282|Lopinavir|lopinavir|mesh-list
24982729|NCT00480805|Protease Inhibitors|protease inhibitors|mesh-ancestor
24982730|NCT00480805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24982731|NCT00479713|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24982732|NCT00479713|Simvastatin|simvastatin|mesh-list
24982733|NCT00479713|Ezetimibe|ezetimibe|mesh-list
24982734|NCT00479713|Calcium|calcium|mesh-list
24982735|NCT00479713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24982736|NCT00479713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982737|NCT00479713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24982738|NCT00479713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25591573|NCT00945282|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25591574|NCT00945282|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25486252|NCT00176878|Fludarabine|fludarabine|mesh-list
25591575|NCT00945282|Protease Inhibitors|protease inhibitors|mesh-ancestor
25591576|NCT00945282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591577|NCT00945282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591578|NCT00945282|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25591579|NCT00945282|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25591580|NCT00945282|Antiviral Agents|antiviral agents|mesh-ancestor
25591581|NCT00945282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25591582|NCT00945282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25591583|NCT00945282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25591584|NCT00945295|Botulinum Toxins|botulinum toxins|mesh-list
25591585|NCT00945295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25591586|NCT00945295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25591587|NCT00945295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25591588|NCT00945295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24891412|NCT04471441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891413|NCT04471415|Atezolizumab|atezolizumab|mesh-list
24891414|NCT04471415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24891415|NCT04470908|Rifabutin|rifabutin|mesh-list
24891416|NCT04470908|Zanubrutinib|zanubrutinib|mesh-list
24891417|NCT04470908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24982744|NCT00457275|Ezetimibe|ezetimibe|mesh-list
25591589|NCT00945295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591590|NCT00945295|Cholinergic Agents|cholinergic agents|mesh-ancestor
25591591|NCT00945295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25591592|NCT00945295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591593|NCT00945295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25591594|NCT00945295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25591595|NCT00945321|Aprepitant|aprepitant|mesh-list
25591596|NCT00945321|Fosaprepitant|fosaprepitant|mesh-list
25591597|NCT00945321|Antiemetics|antiemetics|mesh-ancestor
25591598|NCT00945321|Autonomic Agents|autonomic agents|mesh-ancestor
25591599|NCT00945321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25591600|NCT00945321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591601|NCT00945321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25591602|NCT00945321|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25591603|NCT00945321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25591604|NCT00945321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591605|NCT00945334|Rifaximin|rifaximin|mesh-list
25591606|NCT00945334|Neomycin|neomycin|mesh-list
25591607|NCT00945334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25591608|NCT00945334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25591609|NCT00945334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25591610|NCT00945334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25591611|NCT00945334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24891555|NCT04469829|Methotrexate|methotrexate|mesh-list
25591612|NCT00945334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591613|NCT00945555|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25591614|NCT00945555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25591615|NCT00945750|Famotidine|famotidine|mesh-list
25591616|NCT00945750|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25591617|NCT00945750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25591618|NCT00945750|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25591619|NCT00945750|Histamine Antagonists|histamine antagonists|mesh-ancestor
25591620|NCT00945750|Histamine Agents|histamine agents|mesh-ancestor
25591621|NCT00945750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25591622|NCT00945750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591623|NCT00945750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591624|NCT00945815|Cytarabine|cytarabine|mesh-list
25591625|NCT00945815|Clofarabine|clofarabine|mesh-list
25591626|NCT00945815|Epratuzumab|epratuzumab|mesh-list
25591627|NCT00945815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25591628|NCT00945815|Antimetabolites|antimetabolites|mesh-ancestor
25591629|NCT00945815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591630|NCT00945815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591631|NCT00945815|Antiviral Agents|antiviral agents|mesh-ancestor
25591632|NCT00945815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25591633|NCT00945815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24795867|NCT01946555|Oxycodone|oxycodone|mesh-list
25591634|NCT00945815|Immunologic Factors|immunologic factors|mesh-ancestor
25591635|NCT00945815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591636|NCT00945815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25591637|NCT00945906|Fibrinolysin|fibrinolysin|mesh-list
25591638|NCT00945906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25591639|NCT00945906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25591640|NCT00945906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591641|NCT00945945|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25591642|NCT00945945|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25591643|NCT00945945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25591644|NCT00945945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25591645|NCT00945945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591646|NCT00945945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25591647|NCT00945945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591648|NCT00945945|Analgesics|analgesics|mesh-ancestor
25591649|NCT00945945|Sensory System Agents|sensory system agents|mesh-ancestor
25591650|NCT00945945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25591651|NCT00945945|Antidepressive Agents|antidepressive agents|mesh-ancestor
25591652|NCT00945945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25591653|NCT00945945|Dopamine Agents|dopamine agents|mesh-ancestor
25591654|NCT00946023|Mycophenolic Acid|mycophenolic acid|mesh-list
25591655|NCT00946023|Cyclophosphamide|cyclophosphamide|mesh-list
25591656|NCT00946023|Rituximab|rituximab|mesh-list
25591657|NCT00946023|Fludarabine|fludarabine|mesh-list
25591658|NCT00946023|Tacrolimus|tacrolimus|mesh-list
25591659|NCT00946023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24982928|NCT00157963|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25591660|NCT00946023|Immunologic Factors|immunologic factors|mesh-ancestor
25591661|NCT00946023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591662|NCT00946023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25591663|NCT00946023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25591664|NCT00946023|Alkylating Agents|alkylating agents|mesh-ancestor
25591665|NCT00946023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591666|NCT00946023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591667|NCT00946023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25591668|NCT00946023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25591669|NCT00946023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25591670|NCT00946023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591671|NCT00946023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25591672|NCT00946023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25591673|NCT00946023|Antitubercular Agents|antitubercular agents|mesh-ancestor
25591674|NCT00946023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25591675|NCT00946023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25591676|NCT00946088|Progesterone|progesterone|mesh-list
25591677|NCT00946088|Progestins|progestins|mesh-ancestor
25591678|NCT00946088|Hormones|hormones|mesh-ancestor
25591679|NCT00946088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25591680|NCT00946088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591681|NCT00946114|Sildenafil Citrate|sildenafil citrate|mesh-list
25591682|NCT00946114|Vasodilator Agents|vasodilator agents|mesh-ancestor
25591683|NCT00946114|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25591684|NCT00946114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25591685|NCT00946114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591686|NCT00946114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591687|NCT00946114|Urological Agents|urological agents|mesh-ancestor
25591688|NCT00946153|Lenvatinib|lenvatinib|mesh-list
25591689|NCT00946153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591690|NCT00946153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25591691|NCT00946153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591692|NCT00946153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983074|NCT00090168|Simvastatin|simvastatin|mesh-list
25591693|NCT00946192|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25591694|NCT00946192|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25591695|NCT00946192|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25591696|NCT00946192|Desogestrel|desogestrel|mesh-list
25591697|NCT00946192|Estradiol|estradiol|mesh-list
25591698|NCT00946192|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25591699|NCT00946192|Progesterone|progesterone|mesh-list
25591700|NCT00946192|Estrogens|estrogens|mesh-ancestor
25591701|NCT00946192|Hormones|hormones|mesh-ancestor
25591702|NCT00946192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25591703|NCT00946192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591704|NCT00946192|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25591705|NCT00946192|Contraceptive Agents|contraceptive agents|mesh-ancestor
25591706|NCT00946192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25591707|NCT00946192|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25591708|NCT00946192|Progestins|progestins|mesh-ancestor
25591709|NCT00946192|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25591710|NCT00946192|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25591711|NCT00946192|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25591712|NCT00946270|Thalidomide|thalidomide|mesh-list
25591713|NCT00946270|Prednisone|prednisone|mesh-list
25591714|NCT00946270|Pomalidomide|pomalidomide|mesh-list
25591715|NCT00946270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25591716|NCT00946270|Glucocorticoids|glucocorticoids|mesh-ancestor
25591717|NCT00946270|Hormones|hormones|mesh-ancestor
25591718|NCT00946270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25591719|NCT00946270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591720|NCT00946270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25591721|NCT00946270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591722|NCT00946270|Immunologic Factors|immunologic factors|mesh-ancestor
25591723|NCT00946270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25591724|NCT00946270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25591725|NCT00946270|Growth Substances|growth substances|mesh-ancestor
25591726|NCT00946270|Growth Inhibitors|growth inhibitors|mesh-ancestor
25591727|NCT00946270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25591728|NCT00946270|Leprostatic Agents|leprostatic agents|mesh-ancestor
25591729|NCT00946270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25591730|NCT00946270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25591731|NCT00946309|Sulforaphane|sulforaphane|mesh-list
25591732|NCT00946309|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25591733|NCT00946309|Protective Agents|protective agents|mesh-ancestor
25591734|NCT00946309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591735|NCT00946309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591737|NCT00946348|Hallucinogens|hallucinogens|mesh-ancestor
25591738|NCT00946348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591739|NCT00946348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25591740|NCT00946348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25591741|NCT00946348|Analgesics|analgesics|mesh-ancestor
25591742|NCT00946348|Sensory System Agents|sensory system agents|mesh-ancestor
25591743|NCT00946348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25591744|NCT00946348|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25591745|NCT00946348|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25591746|NCT00946348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25591747|NCT00946348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591748|NCT00946348|Hormones|hormones|mesh-ancestor
25591749|NCT00946348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25591750|NCT00946478|Pimecrolimus|pimecrolimus|mesh-list
25591751|NCT00946478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25591752|NCT00946478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25591753|NCT00946478|Analgesics|analgesics|mesh-ancestor
25591754|NCT00946478|Sensory System Agents|sensory system agents|mesh-ancestor
25591755|NCT00946478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25591756|NCT00946478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591757|NCT00946478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25591758|NCT00946478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25591759|NCT00946478|Dermatologic Agents|dermatologic agents|mesh-ancestor
25591760|NCT00946478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25591761|NCT00946478|Immunologic Factors|immunologic factors|mesh-ancestor
25591762|NCT00946478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25591763|NCT00946478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591764|NCT00946478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591765|NCT00946647|Azacitidine|azacitidine|mesh-list
25591766|NCT00946647|Panobinostat|panobinostat|mesh-list
25591767|NCT00946647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25591768|NCT00946647|Antimetabolites|antimetabolites|mesh-ancestor
25591769|NCT00946647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591770|NCT00946647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106586|NCT02245672|Fluticasone|fluticasone|mesh-list
25591771|NCT00946647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591772|NCT00946647|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25591773|NCT00946712|Paclitaxel|paclitaxel|mesh-list
25591774|NCT00946712|Bevacizumab|bevacizumab|mesh-list
25591775|NCT00946712|Carboplatin|carboplatin|mesh-list
25591776|NCT00946712|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25591777|NCT00946712|Cetuximab|cetuximab|mesh-list
25591778|NCT00946712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25591779|NCT00946712|Endothelial Growth Factors|endothelial growth factors|mesh-list
25591780|NCT00946712|Antibodies|antibodies|mesh-list
25591781|NCT00946712|Immunoglobulins|immunoglobulins|mesh-list
25591782|NCT00946712|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25591783|NCT00946712|Immunoglobulin G|immunoglobulin g|mesh-list
25591784|NCT00946712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25591785|NCT00946712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591786|NCT00946712|Tubulin Modulators|tubulin modulators|mesh-ancestor
25591787|NCT00946712|Antimitotic Agents|antimitotic agents|mesh-ancestor
25591788|NCT00946712|Mitosis Modulators|mitosis modulators|mesh-ancestor
25591789|NCT00946712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591790|NCT00946712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25591791|NCT00946712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25591792|NCT00946712|Growth Substances|growth substances|mesh-ancestor
25591793|NCT00946712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591794|NCT00946712|Growth Inhibitors|growth inhibitors|mesh-ancestor
25591795|NCT00946712|Immunologic Factors|immunologic factors|mesh-ancestor
25591796|NCT00946920|Goserelin|goserelin|mesh-list
25486466|NCT00178646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25486467|NCT00178841|Rosiglitazone|rosiglitazone|mesh-list
25591797|NCT00946920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25591798|NCT00946920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591799|NCT00946998|Sertraline|sertraline|mesh-list
25591800|NCT00946998|Antidepressive Agents|antidepressive agents|mesh-ancestor
25591801|NCT00946998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25591802|NCT00946998|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25591803|NCT00946998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24893032|NCT04455958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25591804|NCT00946998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25591805|NCT00946998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591806|NCT00946998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25591807|NCT00946998|Serotonin Agents|serotonin agents|mesh-ancestor
25591808|NCT00946998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591809|NCT00947154|Aripiprazole|aripiprazole|mesh-list
25591810|NCT00947154|Antidepressive Agents|antidepressive agents|mesh-ancestor
25591811|NCT00947154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25591812|NCT00947154|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25591813|NCT00947154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25591814|NCT00947154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25591815|NCT00947154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591816|NCT00947154|Dopamine Agonists|dopamine agonists|mesh-ancestor
25591817|NCT00947154|Dopamine Agents|dopamine agents|mesh-ancestor
25591818|NCT00947154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25591819|NCT00947154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591820|NCT00947154|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25591821|NCT00947154|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25591822|NCT00947154|Serotonin Agents|serotonin agents|mesh-ancestor
25591823|NCT00947154|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25591824|NCT00947154|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25591825|NCT00947154|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25591826|NCT00947154|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25591827|NCT00947167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25591828|NCT00947167|Pertuzumab|pertuzumab|mesh-list
25591829|NCT00947167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591830|NCT00947167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25591831|NCT00947167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591832|NCT00947167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591833|NCT00947167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25591834|NCT00947297|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25591835|NCT00947297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591836|NCT00947349|Interferons|interferons|mesh-list
25591837|NCT00947349|Ribavirin|ribavirin|mesh-list
25591838|NCT00947349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591839|NCT00947349|Antiviral Agents|antiviral agents|mesh-ancestor
25591840|NCT00947349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25591841|NCT00947349|Antimetabolites|antimetabolites|mesh-ancestor
25591842|NCT00947349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591843|NCT00947427|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25591844|NCT00947427|Immunologic Factors|immunologic factors|mesh-ancestor
25591845|NCT00947427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591846|NCT00947531|Cerebrolysin|cerebrolysin|mesh-list
25591847|NCT00947531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25591848|NCT00947531|Protective Agents|protective agents|mesh-ancestor
25591849|NCT00947531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591850|NCT00947531|Nootropic Agents|nootropic agents|mesh-ancestor
25591851|NCT00947544|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25591852|NCT00947544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591853|NCT00947752|Glatiramer Acetate|glatiramer acetate|mesh-list
25591854|NCT00947752|(T,G)-A-L|(t,g)-a-l|mesh-list
25591855|NCT00947752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25591856|NCT00947752|Immunologic Factors|immunologic factors|mesh-ancestor
25591857|NCT00947752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591858|NCT00947752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25591859|NCT00947752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25591860|NCT00947765|Prednisolone|prednisolone|mesh-list
25591861|NCT00947765|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25591862|NCT00947765|Methylprednisolone|methylprednisolone|mesh-list
25591863|NCT00947765|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25591864|NCT00947765|Prednisolone acetate|prednisolone acetate|mesh-list
25591865|NCT00947765|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25591866|NCT00947765|Prednisolone phosphate|prednisolone phosphate|mesh-list
25591867|NCT00947765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25591868|NCT00947765|Glucocorticoids|glucocorticoids|mesh-ancestor
25591869|NCT00947765|Hormones|hormones|mesh-ancestor
25591870|NCT00947765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25591871|NCT00947765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591872|NCT00947765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25591873|NCT00947765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591874|NCT00947765|Antiemetics|antiemetics|mesh-ancestor
25591875|NCT00947765|Autonomic Agents|autonomic agents|mesh-ancestor
25591876|NCT00947765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25591877|NCT00947765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25591878|NCT00947765|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25591879|NCT00947765|Protective Agents|protective agents|mesh-ancestor
25591880|NCT00947856|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25591881|NCT00947856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25591882|NCT00947856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591883|NCT00948064|Azacitidine|azacitidine|mesh-list
25591884|NCT00948064|Vorinostat|vorinostat|mesh-list
25591885|NCT00948064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25591886|NCT00948064|Antimetabolites|antimetabolites|mesh-ancestor
25591887|NCT00948064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591888|NCT00948064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591889|NCT00948064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591890|NCT00948064|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25591891|NCT00948090|Cyclophosphamide|cyclophosphamide|mesh-list
25591892|NCT00948090|Busulfan|busulfan|mesh-list
25591893|NCT00948090|Etoposide|etoposide|mesh-list
25591894|NCT00948090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25591895|NCT00948090|Immunologic Factors|immunologic factors|mesh-ancestor
25591896|NCT00948090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591897|NCT00948090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25591898|NCT00948090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25591899|NCT00948090|Alkylating Agents|alkylating agents|mesh-ancestor
25591900|NCT00948090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591901|NCT00948090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591902|NCT00948090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25591903|NCT00948090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25591904|NCT00948090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25591905|NCT00948090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25591906|NCT00948090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591907|NCT00948155|Varenicline|varenicline|mesh-list
25591908|NCT00948155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25591909|NCT00948155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25591910|NCT00948155|Cholinergic Agents|cholinergic agents|mesh-ancestor
25591911|NCT00948155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25591912|NCT00948155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591913|NCT00948155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591914|NCT00948298|Vitamin D|vitamin d|mesh-list
25591915|NCT00948298|Vitamins|vitamins|mesh-ancestor
25591916|NCT00948298|Micronutrients|micronutrients|mesh-ancestor
25591917|NCT00948298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591918|NCT00948298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25591919|NCT00948389|Dasatinib|dasatinib|mesh-list
25591920|NCT00948389|Lomustine|lomustine|mesh-list
25591921|NCT00948389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591922|NCT00948389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25591923|NCT00948389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591924|NCT00948389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591925|NCT00948389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25591926|NCT00948389|Alkylating Agents|alkylating agents|mesh-ancestor
25591927|NCT00948428|Imiquimod|imiquimod|mesh-list
25591928|NCT00948428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25591929|NCT00948428|Immunologic Factors|immunologic factors|mesh-ancestor
25591930|NCT00948428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591931|NCT00948428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591932|NCT00948428|Interferon Inducers|interferon inducers|mesh-ancestor
25591933|NCT00948441|Ethanol|ethanol|mesh-list
25591934|NCT00948441|Heparin|heparin|mesh-list
25591935|NCT00948441|Anticoagulants|anticoagulants|mesh-ancestor
25591936|NCT00948441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25591937|NCT00948441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25591938|NCT00948441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591939|NCT00948441|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25591940|NCT00948441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25591941|NCT00948441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25591942|NCT00948441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591943|NCT00948506|Cidofovir|cidofovir|mesh-list
25591944|NCT00948506|Antiviral Agents|antiviral agents|mesh-ancestor
25486609|NCT00180674|Warfarin|warfarin|mesh-list
25591945|NCT00948506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25591946|NCT00948506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591947|NCT00948506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591948|NCT00948610|Infliximab|infliximab|mesh-list
25591949|NCT00948610|Dermatologic Agents|dermatologic agents|mesh-ancestor
25591950|NCT00948610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25486661|NCT00181844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25486662|NCT00181844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486663|NCT00181844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25486664|NCT00181844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25486665|NCT00181844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25486666|NCT00181844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25486667|NCT00181844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25486668|NCT00181883|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25486669|NCT00181883|Antidepressive Agents|antidepressive agents|mesh-ancestor
25486670|NCT00181883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25486671|NCT00181883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25486672|NCT00181883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25486673|NCT00181883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25486674|NCT00181883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486675|NCT00182000|Cycloserine|cycloserine|mesh-list
25486676|NCT00182000|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25486677|NCT00182000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25486678|NCT00182000|Renal Agents|renal agents|mesh-ancestor
25486679|NCT00182000|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25486680|NCT00182000|Antitubercular Agents|antitubercular agents|mesh-ancestor
25486681|NCT00182000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25486682|NCT00182000|Antimetabolites|antimetabolites|mesh-ancestor
25486683|NCT00182000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486684|NCT00182078|Sertraline|sertraline|mesh-list
25486685|NCT00182078|Antidepressive Agents|antidepressive agents|mesh-ancestor
25486686|NCT00182078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25486687|NCT00182078|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25486688|NCT00182078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25486689|NCT00182078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25486690|NCT00182078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486691|NCT00182078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25486692|NCT00182078|Serotonin Agents|serotonin agents|mesh-ancestor
25486693|NCT00182078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486694|NCT00182091|Hormones|hormones|mesh-list
25486696|NCT00182091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591951|NCT00948610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25591952|NCT00948675|Paclitaxel|paclitaxel|mesh-list
25591953|NCT00948675|Bevacizumab|bevacizumab|mesh-list
25591954|NCT00948675|Carboplatin|carboplatin|mesh-list
25591955|NCT00948675|Pemetrexed|pemetrexed|mesh-list
24514514|NCT00591188|Interferons|interferons|mesh-list
25591956|NCT00948675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25591957|NCT00948675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591958|NCT00948675|Tubulin Modulators|tubulin modulators|mesh-ancestor
25591959|NCT00948675|Antimitotic Agents|antimitotic agents|mesh-ancestor
25591960|NCT00948675|Mitosis Modulators|mitosis modulators|mesh-ancestor
25591961|NCT00948675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591962|NCT00948675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25591963|NCT00948675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25591964|NCT00948675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25591965|NCT00948675|Growth Substances|growth substances|mesh-ancestor
25591966|NCT00948675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591967|NCT00948675|Growth Inhibitors|growth inhibitors|mesh-ancestor
25591968|NCT00948675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591969|NCT00948675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25591970|NCT00948675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25591971|NCT00948688|Vorinostat|vorinostat|mesh-list
25591972|NCT00948688|Fluorouracil|fluorouracil|mesh-list
25591973|NCT00948688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25591974|NCT00948688|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25591975|NCT00948688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591976|NCT00948688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591977|NCT00948688|Antimetabolites|antimetabolites|mesh-ancestor
25591978|NCT00948688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25591979|NCT00948688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25591980|NCT00948688|Immunologic Factors|immunologic factors|mesh-ancestor
25591981|NCT00948688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25591982|NCT00948766|Rivastigmine|rivastigmine|mesh-list
25591983|NCT00948766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25591984|NCT00948766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25591985|NCT00948766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591986|NCT00948766|Cholinergic Agents|cholinergic agents|mesh-ancestor
25591987|NCT00948766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25591988|NCT00948766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514711|NCT00592410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25591989|NCT00948766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25591990|NCT00948766|Protective Agents|protective agents|mesh-ancestor
25591991|NCT00948818|Linaclotide|linaclotide|mesh-list
25591992|NCT00948818|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25591993|NCT00948818|Enzyme Activators|enzyme activators|mesh-ancestor
25591994|NCT00948818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25591995|NCT00948818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25591996|NCT00948857|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25591997|NCT00948857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25591998|NCT00948857|Immunologic Factors|immunologic factors|mesh-ancestor
25591999|NCT00948857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592000|NCT00948896|Pyrimethamine|pyrimethamine|mesh-list
25592001|NCT00948896|Piperaquine|piperaquine|mesh-list
25592002|NCT00948896|Sulfadoxine|sulfadoxine|mesh-list
25592003|NCT00948896|Trimethoprim|trimethoprim|mesh-list
25592004|NCT00948896|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25592005|NCT00948896|Artenimol|artenimol|mesh-list
25592006|NCT00948896|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25592007|NCT00948896|Sulfamethoxazole|sulfamethoxazole|mesh-list
25592008|NCT00948896|Antimalarials|antimalarials|mesh-ancestor
25592009|NCT00948896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25592010|NCT00948896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25592011|NCT00948896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25592012|NCT00948896|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25592013|NCT00948896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592014|NCT00948896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592015|NCT00948896|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25592016|NCT00948896|Renal Agents|renal agents|mesh-ancestor
25592017|NCT00948896|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25592018|NCT00948896|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25592019|NCT00948896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25592020|NCT00948896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25592021|NCT00948922|Fludarabine|fludarabine|mesh-list
25592022|NCT00948922|Bortezomib|bortezomib|mesh-list
25592023|NCT00948922|Melphalan|melphalan|mesh-list
25592024|NCT00948922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25592025|NCT00948922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592026|NCT00948922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25592027|NCT00948922|Immunologic Factors|immunologic factors|mesh-ancestor
25592028|NCT00948922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592029|NCT00948922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25592030|NCT00948922|Alkylating Agents|alkylating agents|mesh-ancestor
25592031|NCT00948922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25592032|NCT00948935|Gemcitabine|gemcitabine|mesh-list
25592033|NCT00948935|Irinotecan|irinotecan|mesh-list
25592034|NCT00948935|Panitumumab|panitumumab|mesh-list
25592035|NCT00948935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25592036|NCT00948935|Antimetabolites|antimetabolites|mesh-ancestor
25592037|NCT00948935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592038|NCT00948935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25592039|NCT00948935|Antiviral Agents|antiviral agents|mesh-ancestor
25592040|NCT00948935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24784639|NCT01909752|Imiquimod|imiquimod|mesh-list
25592041|NCT00948935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592042|NCT00948935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25592043|NCT00948935|Immunologic Factors|immunologic factors|mesh-ancestor
25592044|NCT00948935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592045|NCT00948935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25592046|NCT00948935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25592047|NCT00948935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25592048|NCT00949078|Omalizumab|omalizumab|mesh-list
25592049|NCT00949078|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25592050|NCT00949078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25592051|NCT00949078|Respiratory System Agents|respiratory system agents|mesh-ancestor
25592052|NCT00949117|Cyproheptadine|cyproheptadine|mesh-list
25592053|NCT00949117|Antipruritics|antipruritics|mesh-ancestor
25592054|NCT00949117|Dermatologic Agents|dermatologic agents|mesh-ancestor
25592055|NCT00949117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25592056|NCT00949117|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25592057|NCT00949117|Histamine Antagonists|histamine antagonists|mesh-ancestor
25592058|NCT00949117|Histamine Agents|histamine agents|mesh-ancestor
25592059|NCT00949117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24984257|NCT04702789|Latanoprost|latanoprost|mesh-list
25653538|NCT01537926|Antiviral Agents|antiviral agents|mesh-ancestor
25592060|NCT00949117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592061|NCT00949117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592062|NCT00949117|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25592063|NCT00949117|Serotonin Agents|serotonin agents|mesh-ancestor
25592064|NCT00949117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25592065|NCT00949234|Ritonavir|ritonavir|mesh-list
25592066|NCT00949234|Lopinavir|lopinavir|mesh-list
25592067|NCT00949234|Tenofovir|tenofovir|mesh-list
25592068|NCT00949234|Emtricitabine|emtricitabine|mesh-list
25592069|NCT00949234|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25592070|NCT00949234|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24515447|NCT00597259|Entecavir|entecavir|mesh-list
25592071|NCT00949234|Protease Inhibitors|protease inhibitors|mesh-ancestor
25592072|NCT00949234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592073|NCT00949234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592074|NCT00949234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25592075|NCT00949234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25592076|NCT00949234|Antiviral Agents|antiviral agents|mesh-ancestor
25592077|NCT00949234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25592078|NCT00949234|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25592079|NCT00949234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25592080|NCT00949234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25592081|NCT00949234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25592082|NCT00949325|Sirolimus|sirolimus|mesh-list
25592083|NCT00949325|Doxorubicin|doxorubicin|mesh-list
25592084|NCT00949325|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25592085|NCT00949325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25592086|NCT00949325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25592087|NCT00949325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25592088|NCT00949325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25592089|NCT00949325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592090|NCT00949325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592091|NCT00949325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25592092|NCT00949325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25592093|NCT00949325|Antifungal Agents|antifungal agents|mesh-ancestor
25592094|NCT00949325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25592095|NCT00949325|Immunologic Factors|immunologic factors|mesh-ancestor
25592096|NCT00949325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592097|NCT00949533|Oseltamivir|oseltamivir|mesh-list
25592098|NCT00949533|Antiviral Agents|antiviral agents|mesh-ancestor
25592099|NCT00949533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25592100|NCT00949533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592101|NCT00949533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592102|NCT00949650|Cisplatin|cisplatin|mesh-list
25592103|NCT00949650|Pemetrexed|pemetrexed|mesh-list
25592104|NCT00949650|Afatinib|afatinib|mesh-list
25592105|NCT00949650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25592106|NCT00949650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592107|NCT00949650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592108|NCT00949650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25592109|NCT00949650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25592110|NCT00949650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25592111|NCT00949702|Vemurafenib|vemurafenib|mesh-list
25592112|NCT00949702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25592113|NCT00949702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25592114|NCT00949702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592115|NCT00949702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592116|NCT00949884|Losartan|losartan|mesh-list
25592117|NCT00949884|Olmesartan|olmesartan|mesh-list
25592118|NCT00949884|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25592119|NCT00949884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25592120|NCT00949884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25592121|NCT00949884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25592122|NCT00949884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25592123|NCT00949884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653539|NCT01537926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25653540|NCT01537926|Expectorants|expectorants|mesh-ancestor
25653541|NCT01537926|Respiratory System Agents|respiratory system agents|mesh-ancestor
25653542|NCT01537926|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25653543|NCT01537926|Antioxidants|antioxidants|mesh-ancestor
25653544|NCT01537926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653545|NCT01537926|Protective Agents|protective agents|mesh-ancestor
25653546|NCT01537926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653547|NCT01537926|Antidotes|antidotes|mesh-ancestor
25653548|NCT01538472|Cytarabine|cytarabine|mesh-list
25653549|NCT01538472|Rituximab|rituximab|mesh-list
25592124|NCT00949910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25592125|NCT00949910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25592126|NCT00949910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25592127|NCT00949910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592128|NCT00949910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592129|NCT00950170|Factor VIII|factor viii|mesh-list
25592130|NCT00950170|Coagulants|coagulants|mesh-ancestor
25592131|NCT00950248|Idebenone|idebenone|mesh-list
25592132|NCT00950248|Antioxidants|antioxidants|mesh-ancestor
25592133|NCT00950248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592134|NCT00950248|Protective Agents|protective agents|mesh-ancestor
25592135|NCT00950248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592136|NCT00950300|Cyclophosphamide|cyclophosphamide|mesh-list
25592137|NCT00950300|Docetaxel|docetaxel|mesh-list
25592138|NCT00950300|Fluorouracil|fluorouracil|mesh-list
25592139|NCT00950300|Trastuzumab|trastuzumab|mesh-list
25592140|NCT00950300|Epirubicin|epirubicin|mesh-list
25592141|NCT00950300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25592142|NCT00950300|Immunologic Factors|immunologic factors|mesh-ancestor
25592143|NCT00950300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896489|NCT04435704|Oxytocin|oxytocin|mesh-list
25592144|NCT00950300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25592145|NCT00950300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25592146|NCT00950300|Alkylating Agents|alkylating agents|mesh-ancestor
25592147|NCT00950300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592148|NCT00950300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25592149|NCT00950300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25592150|NCT00950300|Tubulin Modulators|tubulin modulators|mesh-ancestor
25592151|NCT00950300|Antimitotic Agents|antimitotic agents|mesh-ancestor
25592152|NCT00950300|Mitosis Modulators|mitosis modulators|mesh-ancestor
25592153|NCT00950300|Antimetabolites|antimetabolites|mesh-ancestor
25592154|NCT00950300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25592155|NCT00950300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25592156|NCT00950300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24896676|NCT04434144|Ivermectin|ivermectin|mesh-list
25592157|NCT00950300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25592158|NCT00950300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25592159|NCT00950300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592160|NCT00950352|Choline|choline|mesh-list
25592161|NCT00950352|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
25592162|NCT00950352|Lipotropic Agents|lipotropic agents|mesh-ancestor
25592163|NCT00950352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25592164|NCT00950352|Antimetabolites|antimetabolites|mesh-ancestor
25592165|NCT00950352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592166|NCT00950352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25592167|NCT00950352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25592168|NCT00950352|Nootropic Agents|nootropic agents|mesh-ancestor
25592169|NCT00950365|Pemetrexed|pemetrexed|mesh-list
25592170|NCT00950365|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25592171|NCT00950365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25592172|NCT00950365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592173|NCT00950365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592174|NCT00950365|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25592175|NCT00950365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25592176|NCT00950365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25592177|NCT00950599|Saxagliptin|saxagliptin|mesh-list
25592178|NCT00950599|Incretins|incretins|mesh-ancestor
25592179|NCT00950599|Hormones|hormones|mesh-ancestor
25592180|NCT00950599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25592181|NCT00950599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592182|NCT00950599|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25592183|NCT00950599|Protease Inhibitors|protease inhibitors|mesh-ancestor
25592184|NCT00950599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592185|NCT00950599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592186|NCT00950599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25592187|NCT00950651|Tramadol|tramadol|mesh-list
25592188|NCT00950651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25592189|NCT00950651|Narcotics|narcotics|mesh-ancestor
25592190|NCT00950651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25592191|NCT00950651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592192|NCT00950651|Analgesics|analgesics|mesh-ancestor
25592193|NCT00950651|Sensory System Agents|sensory system agents|mesh-ancestor
25592194|NCT00950651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25592195|NCT00950664|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25592196|NCT00950664|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25592197|NCT00950664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25486869|NCT00183625|Olanzapine|olanzapine|mesh-list
25592198|NCT00950664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25592199|NCT00950664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592200|NCT00950664|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25592201|NCT00950664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25592202|NCT00950664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592203|NCT00950664|Cholinergic Agents|cholinergic agents|mesh-ancestor
25592204|NCT00950664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25592205|NCT00950742|Trastuzumab|trastuzumab|mesh-list
25592206|NCT00950742|Afatinib|afatinib|mesh-list
25592207|NCT00950742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25592208|NCT00950742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25592209|NCT00950742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25592210|NCT00950742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592211|NCT00950742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592212|NCT00950755|Tositumomab I-131|tositumomab i-131|mesh-list
25592213|NCT00950755|Antibodies|antibodies|mesh-list
25592214|NCT00950755|Immunologic Factors|immunologic factors|mesh-ancestor
25592215|NCT00950755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592216|NCT00950755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25592217|NCT00950807|Tiotropium Bromide|tiotropium bromide|mesh-list
25592218|NCT00950807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25592219|NCT00950807|Autonomic Agents|autonomic agents|mesh-ancestor
25592220|NCT00950807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25592221|NCT00950807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592222|NCT00950807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25592223|NCT00950807|Respiratory System Agents|respiratory system agents|mesh-ancestor
25592224|NCT00950807|Parasympatholytics|parasympatholytics|mesh-ancestor
25592225|NCT00950807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25592226|NCT00950807|Cholinergic Agents|cholinergic agents|mesh-ancestor
25592227|NCT00950807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25592228|NCT00950807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592229|NCT00950833|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25592230|NCT00950833|Immunologic Factors|immunologic factors|mesh-ancestor
25592231|NCT00950833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592232|NCT00950859|Dolutegravir|dolutegravir|mesh-list
25592233|NCT00950859|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25592234|NCT00950859|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25592235|NCT00950859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592236|NCT00950859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592237|NCT00950859|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25592238|NCT00950859|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25592239|NCT00950859|Antiviral Agents|antiviral agents|mesh-ancestor
25592240|NCT00950859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25592241|NCT00950911|Denosumab|denosumab|mesh-list
25592242|NCT00950911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25592243|NCT00950911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592244|NCT00951015|Efavirenz|efavirenz|mesh-list
25592245|NCT00951015|Dolutegravir|dolutegravir|mesh-list
25592246|NCT00951015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25592247|NCT00951015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25592248|NCT00951015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592249|NCT00951015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592250|NCT00951015|Antiviral Agents|antiviral agents|mesh-ancestor
25592251|NCT00951015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25592252|NCT00951015|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25592253|NCT00951015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25592254|NCT00951015|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25592255|NCT00951015|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25592256|NCT00951015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25592257|NCT00951015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25592258|NCT00951015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25592259|NCT00951015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25592260|NCT00951015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25592261|NCT00951015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25592262|NCT00951041|Vaccines|vaccines|mesh-list
25592263|NCT00951041|Immunologic Factors|immunologic factors|mesh-ancestor
25592264|NCT00951041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592265|NCT00951275|Antirheumatic Agents|antirheumatic agents|mesh-list
25592266|NCT00951379|Pioglitazone|pioglitazone|mesh-list
25592267|NCT00951379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25592268|NCT00951379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592269|NCT00951483|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25592270|NCT00951483|Antidepressive Agents|antidepressive agents|mesh-ancestor
25592271|NCT00951483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25592272|NCT00951483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25592273|NCT00951483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25592274|NCT00951483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25592275|NCT00951483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592276|NCT00951496|Paclitaxel|paclitaxel|mesh-list
25592277|NCT00951496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25592278|NCT00951496|Bevacizumab|bevacizumab|mesh-list
25592279|NCT00951496|Cisplatin|cisplatin|mesh-list
25592280|NCT00951496|Carboplatin|carboplatin|mesh-list
25592281|NCT00951496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25592282|NCT00951496|Endothelial Growth Factors|endothelial growth factors|mesh-list
25592283|NCT00951496|Antibodies|antibodies|mesh-list
25592284|NCT00951496|Immunoglobulins|immunoglobulins|mesh-list
25592285|NCT00951496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25592286|NCT00951496|Immunoglobulin G|immunoglobulin g|mesh-list
25592287|NCT00951496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25592288|NCT00951496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25592289|NCT00951496|Tubulin Modulators|tubulin modulators|mesh-ancestor
25592290|NCT00951496|Antimitotic Agents|antimitotic agents|mesh-ancestor
25592291|NCT00951496|Mitosis Modulators|mitosis modulators|mesh-ancestor
25592292|NCT00951496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592293|NCT00951496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25592294|NCT00951496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25592295|NCT00951496|Growth Substances|growth substances|mesh-ancestor
25592296|NCT00951496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592297|NCT00951496|Growth Inhibitors|growth inhibitors|mesh-ancestor
25592298|NCT00951496|Immunologic Factors|immunologic factors|mesh-ancestor
25592299|NCT00951561|Ibuprofen|ibuprofen|mesh-list
25592300|NCT00951561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25592301|NCT00951561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25592302|NCT00951561|Analgesics|analgesics|mesh-ancestor
25592303|NCT00951561|Sensory System Agents|sensory system agents|mesh-ancestor
25592304|NCT00951561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25592305|NCT00951561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592306|NCT00951561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25592307|NCT00951561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25592308|NCT00951561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25592309|NCT00951561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24985272|NCT03522844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25592310|NCT00951561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592311|NCT00951665|Paclitaxel|paclitaxel|mesh-list
25592312|NCT00951665|Maytansine|maytansine|mesh-list
25592313|NCT00951665|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25592314|NCT00951665|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25592315|NCT00951665|Trastuzumab|trastuzumab|mesh-list
25592316|NCT00951665|Pertuzumab|pertuzumab|mesh-list
25592317|NCT00951665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25592318|NCT00951665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25592319|NCT00951665|Tubulin Modulators|tubulin modulators|mesh-ancestor
25592320|NCT00951665|Antimitotic Agents|antimitotic agents|mesh-ancestor
25592321|NCT00951665|Mitosis Modulators|mitosis modulators|mesh-ancestor
25592322|NCT00951665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592323|NCT00951665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25592324|NCT00951899|Metformin|metformin|mesh-list
25592325|NCT00951899|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
25592326|NCT00951899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25592327|NCT00951899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592328|NCT00951899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25592329|NCT00951899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25592330|NCT00951899|Antimetabolites|antimetabolites|mesh-ancestor
25592331|NCT00951899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592332|NCT00951899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25592333|NCT00951912|Genistein|genistein|mesh-list
25592334|NCT00951912|Daidzein|daidzein|mesh-list
25592335|NCT00951912|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25592336|NCT00951912|Protective Agents|protective agents|mesh-ancestor
25592337|NCT00951912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592338|NCT00951912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25592339|NCT00951912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25592340|NCT00951912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592341|NCT00951912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592342|NCT00951912|Phytoestrogens|phytoestrogens|mesh-ancestor
25592343|NCT00951912|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25592344|NCT00951912|Estrogens|estrogens|mesh-ancestor
25592345|NCT00951912|Hormones|hormones|mesh-ancestor
25592346|NCT00951912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25592347|NCT00952068|Tramadol|tramadol|mesh-list
25592348|NCT00952068|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25592349|NCT00952068|Narcotics|narcotics|mesh-ancestor
25592350|NCT00952068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25592351|NCT00952068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592352|NCT00952068|Analgesics|analgesics|mesh-ancestor
25592353|NCT00952068|Sensory System Agents|sensory system agents|mesh-ancestor
25592354|NCT00952068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25592355|NCT00952081|Clevidipine|clevidipine|mesh-list
25592356|NCT00952081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25592357|NCT00952081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25592358|NCT00952081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592359|NCT00952081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25592360|NCT00952081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592361|NCT00952133|Dexamethasone|dexamethasone|mesh-list
25592362|NCT00952133|Dexamethasone acetate|dexamethasone acetate|mesh-list
25592363|NCT00952133|Palonosetron|palonosetron|mesh-list
25592364|NCT00952133|BB 1101|bb 1101|mesh-list
25592365|NCT00952133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25592366|NCT00952133|Antiemetics|antiemetics|mesh-ancestor
25592367|NCT00952133|Autonomic Agents|autonomic agents|mesh-ancestor
25592368|NCT00952133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25592369|NCT00952133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592370|NCT00952133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25592371|NCT00952133|Glucocorticoids|glucocorticoids|mesh-ancestor
25592372|NCT00952133|Hormones|hormones|mesh-ancestor
25592373|NCT00952133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25592374|NCT00952133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25592375|NCT00952133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25592376|NCT00952133|Protease Inhibitors|protease inhibitors|mesh-ancestor
25592377|NCT00952133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592378|NCT00952133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592379|NCT00952133|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25592380|NCT00952133|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25592381|NCT00952133|Serotonin Agents|serotonin agents|mesh-ancestor
25592382|NCT00952133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25592383|NCT00952276|Vaccines|vaccines|mesh-list
25592384|NCT00952276|Immunologic Factors|immunologic factors|mesh-ancestor
25592385|NCT00952276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592386|NCT00952341|Dexamethasone|dexamethasone|mesh-list
25592387|NCT00952341|Dexamethasone acetate|dexamethasone acetate|mesh-list
25592388|NCT00952341|Aprepitant|aprepitant|mesh-list
25592389|NCT00952341|Fosaprepitant|fosaprepitant|mesh-list
25592390|NCT00952341|Granisetron|granisetron|mesh-list
25592391|NCT00952341|BB 1101|bb 1101|mesh-list
25592392|NCT00952341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25592393|NCT00952341|Antiemetics|antiemetics|mesh-ancestor
25592394|NCT00952341|Autonomic Agents|autonomic agents|mesh-ancestor
25592395|NCT00952341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25592396|NCT00952341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592397|NCT00952341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25592398|NCT00952341|Glucocorticoids|glucocorticoids|mesh-ancestor
25592399|NCT00952341|Hormones|hormones|mesh-ancestor
25592400|NCT00952341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25592401|NCT00952341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25592402|NCT00952341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25592403|NCT00952341|Protease Inhibitors|protease inhibitors|mesh-ancestor
25592404|NCT00952341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592405|NCT00952341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592406|NCT00952341|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25592407|NCT00952341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25592408|NCT00952341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25592409|NCT00952341|Serotonin Agents|serotonin agents|mesh-ancestor
25592410|NCT00952380|Dalteparin|dalteparin|mesh-list
25592411|NCT00952380|Tinzaparin|tinzaparin|mesh-list
25592412|NCT00952380|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25592413|NCT00952380|Anticoagulants|anticoagulants|mesh-ancestor
25592414|NCT00952380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25592415|NCT00952380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25592416|NCT00952380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592417|NCT00952419|Vaccines|vaccines|mesh-list
25592418|NCT00952419|Immunologic Factors|immunologic factors|mesh-ancestor
25592419|NCT00952419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592420|NCT00952484|Immunoglobulin G|immunoglobulin g|mesh-list
25592421|NCT00952484|Immunologic Factors|immunologic factors|mesh-ancestor
25592422|NCT00952484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592423|NCT00952523|Adapalene|adapalene|mesh-list
25592424|NCT00952523|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
25592425|NCT00952523|Tretinoin|tretinoin|mesh-list
25592426|NCT00952523|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25592427|NCT00952523|Dermatologic Agents|dermatologic agents|mesh-ancestor
25592428|NCT00952523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25592429|NCT00952523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25592430|NCT00952523|Analgesics|analgesics|mesh-ancestor
25592431|NCT00952523|Sensory System Agents|sensory system agents|mesh-ancestor
25592432|NCT00952523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25592433|NCT00952523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592434|NCT00952523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25592435|NCT00952523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25592436|NCT00952523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25592437|NCT00952523|Keratolytic Agents|keratolytic agents|mesh-ancestor
25592438|NCT00952614|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
25592439|NCT00952614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25592440|NCT00952614|Glucocorticoids|glucocorticoids|mesh-ancestor
25592441|NCT00952614|Hormones|hormones|mesh-ancestor
25592442|NCT00952614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25592443|NCT00952614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592444|NCT00952653|Midazolam|midazolam|mesh-list
25592445|NCT00952653|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25592446|NCT00952653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25592447|NCT00952653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25592448|NCT00952653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24985501|NCT03273413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592449|NCT00952653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592450|NCT00952653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25592451|NCT00952653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25592452|NCT00952653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25592453|NCT00952653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25592454|NCT00952653|Anesthetics, General|anesthetics, general|mesh-ancestor
25592455|NCT00952653|Anesthetics|anesthetics|mesh-ancestor
25592456|NCT00952653|GABA Modulators|gaba modulators|mesh-ancestor
25592457|NCT00952653|GABA Agents|gaba agents|mesh-ancestor
25592458|NCT00952653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25592459|NCT00952653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592460|NCT00952653|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25592461|NCT00952653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25592462|NCT00952653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25592463|NCT00952653|Antidepressive Agents|antidepressive agents|mesh-ancestor
25592464|NCT00952731|Tamoxifen|tamoxifen|mesh-list
25592465|NCT00952731|Afimoxifene|afimoxifene|mesh-list
25592466|NCT00952731|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25592467|NCT00952731|Hormone Antagonists|hormone antagonists|mesh-ancestor
25592468|NCT00952731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24796239|NCT01948804|Hormones|hormones|mesh-ancestor
25592469|NCT00952731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592470|NCT00952731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25592471|NCT00952731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25592472|NCT00952731|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25592473|NCT00952731|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25592474|NCT00952731|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25592475|NCT00952822|Factor VIII|factor viii|mesh-list
25592476|NCT00952822|Coagulants|coagulants|mesh-ancestor
25592477|NCT00953017|Bisacodyl|bisacodyl|mesh-list
25592478|NCT00953017|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25592479|NCT00953017|Lubiprostone|lubiprostone|mesh-list
25592480|NCT00953017|Cathartics|cathartics|mesh-ancestor
25592481|NCT00953017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25592482|NCT00953017|Laxatives|laxatives|mesh-ancestor
25592483|NCT00953017|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25592484|NCT00953017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25592485|NCT00953017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592486|NCT00953043|Lubiprostone|lubiprostone|mesh-list
25592487|NCT00953043|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25592488|NCT00953043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25592489|NCT00953043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592490|NCT00953056|Vaccines|vaccines|mesh-list
25592491|NCT00953056|Immunologic Factors|immunologic factors|mesh-ancestor
25592492|NCT00953056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592493|NCT00953121|Bevacizumab|bevacizumab|mesh-list
25592494|NCT00953121|Carboplatin|carboplatin|mesh-list
25592495|NCT00953121|Irinotecan|irinotecan|mesh-list
25592496|NCT00953121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25487117|NCT00185692|Hormones|hormones|mesh-ancestor
25592497|NCT00953121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25592498|NCT00953121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25592499|NCT00953121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25592500|NCT00953121|Growth Substances|growth substances|mesh-ancestor
25592501|NCT00953121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592502|NCT00953121|Growth Inhibitors|growth inhibitors|mesh-ancestor
25592503|NCT00953121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24589727|NCT00908713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25592504|NCT00953121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25592505|NCT00953121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592506|NCT00953121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592507|NCT00953147|Ciclesonide|ciclesonide|mesh-list
25592508|NCT00953147|Glucocorticoids|glucocorticoids|mesh-ancestor
25592510|NCT00953147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25592511|NCT00953147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592512|NCT00953147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25592513|NCT00953199|Lidocaine|lidocaine|mesh-list
25592514|NCT00953199|Anesthetics, Local|anesthetics, local|mesh-ancestor
25592515|NCT00953199|Anesthetics|anesthetics|mesh-ancestor
25592516|NCT00953199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25592517|NCT00953199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592518|NCT00953199|Sensory System Agents|sensory system agents|mesh-ancestor
25592519|NCT00953199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25592520|NCT00953199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25592521|NCT00953199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25592522|NCT00953199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25592523|NCT00953199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25592524|NCT00953199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897817|NCT04421742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897818|NCT04421742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24897822|NCT04421742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24505962|NCT00543504|Growth Substances|growth substances|mesh-ancestor
25592525|NCT00953212|Ascorbic Acid|ascorbic acid|mesh-list
25592526|NCT00953212|Amiodarone|amiodarone|mesh-list
25592527|NCT00953212|Metoprolol|metoprolol|mesh-list
25592528|NCT00953212|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25592529|NCT00953212|Vitamins|vitamins|mesh-ancestor
25592530|NCT00953212|Micronutrients|micronutrients|mesh-ancestor
25592531|NCT00953212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592532|NCT00953212|Antioxidants|antioxidants|mesh-ancestor
25592533|NCT00953212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592534|NCT00953212|Protective Agents|protective agents|mesh-ancestor
25592535|NCT00953212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25592536|NCT00953212|Vasodilator Agents|vasodilator agents|mesh-ancestor
25592537|NCT00953212|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25592538|NCT00953212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25592539|NCT00953212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25592540|NCT00953212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25592541|NCT00953212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25592542|NCT00953212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592543|NCT00953212|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24475015|NCT00408538|UC-781|uc-781|mesh-list
25592544|NCT00953212|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25592545|NCT00953212|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25592546|NCT00953212|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25592547|NCT00953212|Adrenergic Agents|adrenergic agents|mesh-ancestor
25592548|NCT00953212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25592549|NCT00953212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25592550|NCT00953212|Sympatholytics|sympatholytics|mesh-ancestor
25592551|NCT00953212|Autonomic Agents|autonomic agents|mesh-ancestor
25592552|NCT00953212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25592553|NCT00953212|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25592554|NCT00953225|Vitamin D|vitamin d|mesh-list
25592555|NCT00953225|Cholecalciferol|cholecalciferol|mesh-list
25592556|NCT00953225|Vitamins|vitamins|mesh-ancestor
25592557|NCT00953225|Micronutrients|micronutrients|mesh-ancestor
25592558|NCT00953225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592559|NCT00953225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25592560|NCT00953225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25592561|NCT00953524|Vaccines|vaccines|mesh-list
25592562|NCT00953524|Immunologic Factors|immunologic factors|mesh-ancestor
25592563|NCT00953524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592564|NCT00953576|Ketoconazole|ketoconazole|mesh-list
25592565|NCT00953576|Hydrocortisone|hydrocortisone|mesh-list
25592566|NCT00953576|Lapatinib|lapatinib|mesh-list
25592567|NCT00953576|Dutasteride|dutasteride|mesh-list
25592568|NCT00953576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25592569|NCT00953576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25592570|NCT00953576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25592571|NCT00953576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592572|NCT00953576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592573|NCT00953576|Antifungal Agents|antifungal agents|mesh-ancestor
25592574|NCT00953576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25592575|NCT00953576|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25592576|NCT00953576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25592577|NCT00953576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25592578|NCT00953576|Hormone Antagonists|hormone antagonists|mesh-ancestor
25592579|NCT00953576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25592580|NCT00953576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592581|NCT00953576|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25592582|NCT00953576|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25592583|NCT00953667|Niacin|niacin|mesh-list
25592584|NCT00953667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25592585|NCT00953667|Antimetabolites|antimetabolites|mesh-ancestor
25592586|NCT00953667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592587|NCT00953667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25592588|NCT00953667|Vasodilator Agents|vasodilator agents|mesh-ancestor
25592589|NCT00953667|Vitamin B Complex|vitamin b complex|mesh-ancestor
25592590|NCT00953667|Vitamins|vitamins|mesh-ancestor
25592591|NCT00953667|Micronutrients|micronutrients|mesh-ancestor
25592592|NCT00953667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592593|NCT00953706|Ivacaftor|ivacaftor|mesh-list
25592594|NCT00953706|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25592595|NCT00953706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25592596|NCT00953706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592597|NCT00953745|Aripiprazole|aripiprazole|mesh-list
25592598|NCT00953745|Citalopram|citalopram|mesh-list
25592599|NCT00953745|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25592600|NCT00953745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25592601|NCT00953745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25592602|NCT00953745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592603|NCT00953745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25592604|NCT00953745|Serotonin Agents|serotonin agents|mesh-ancestor
25592605|NCT00953745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592606|NCT00953745|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25592607|NCT00953745|Antidepressive Agents|antidepressive agents|mesh-ancestor
25592608|NCT00953745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25592609|NCT00953745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25592610|NCT00953745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25592611|NCT00953745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25592612|NCT00953745|Dopamine Agonists|dopamine agonists|mesh-ancestor
25592613|NCT00953745|Dopamine Agents|dopamine agents|mesh-ancestor
25592614|NCT00953745|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25592615|NCT00953745|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25592616|NCT00953745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25592617|NCT00953745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25592618|NCT00953745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25592619|NCT00953745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25592620|NCT00953849|Calcitriol|calcitriol|mesh-list
25592621|NCT00953849|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
25592622|NCT00953849|Vitamin D|vitamin d|mesh-list
25592623|NCT00953849|Celecoxib|celecoxib|mesh-list
25592624|NCT00953849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25592625|NCT00953849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25592626|NCT00953849|Analgesics|analgesics|mesh-ancestor
25592627|NCT00953849|Sensory System Agents|sensory system agents|mesh-ancestor
25592628|NCT00953849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25592629|NCT00953849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592630|NCT00953849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25592631|NCT00953849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25592632|NCT00953849|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25592633|NCT00953849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25592634|NCT00953849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592635|NCT00953849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592636|NCT00953849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25592637|NCT00953849|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25592638|NCT00953849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25592639|NCT00953849|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25592640|NCT00953849|Vitamins|vitamins|mesh-ancestor
25592641|NCT00953849|Micronutrients|micronutrients|mesh-ancestor
25592642|NCT00953849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25592643|NCT00953862|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25592644|NCT00953862|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25653550|NCT01538472|Melphalan|melphalan|mesh-list
25592645|NCT00953862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25592646|NCT00953862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25592647|NCT00953862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592648|NCT00953862|Adrenergic Agents|adrenergic agents|mesh-ancestor
25592649|NCT00953862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25592650|NCT00953862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592651|NCT00954122|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25592652|NCT00954122|Antidepressive Agents|antidepressive agents|mesh-ancestor
25592653|NCT00954122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25592654|NCT00954122|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25592655|NCT00954122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25592656|NCT00954122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25592657|NCT00954122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592658|NCT00954174|Paclitaxel|paclitaxel|mesh-list
25592659|NCT00954174|Carboplatin|carboplatin|mesh-list
25592660|NCT00954174|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25592661|NCT00954174|Ifosfamide|ifosfamide|mesh-list
25592662|NCT00954174|Isophosphamide mustard|isophosphamide mustard|mesh-list
25592663|NCT00954174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25592664|NCT00954174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25592665|NCT00954174|Tubulin Modulators|tubulin modulators|mesh-ancestor
25592666|NCT00954174|Antimitotic Agents|antimitotic agents|mesh-ancestor
25592667|NCT00954174|Mitosis Modulators|mitosis modulators|mesh-ancestor
25592668|NCT00954174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592669|NCT00954174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25592670|NCT00954174|Alkylating Agents|alkylating agents|mesh-ancestor
25592671|NCT00954447|Linagliptin|linagliptin|mesh-list
25592672|NCT00954447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25592673|NCT00954447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592674|NCT00954447|Incretins|incretins|mesh-ancestor
25592675|NCT00954447|Hormones|hormones|mesh-ancestor
25592676|NCT00954447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25592677|NCT00954447|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25592678|NCT00954447|Protease Inhibitors|protease inhibitors|mesh-ancestor
25592679|NCT00954447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592680|NCT00954447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592681|NCT00954512|Leucovorin|leucovorin|mesh-list
25592682|NCT00954512|Folic Acid|folic acid|mesh-list
25592683|NCT00954512|Gemcitabine|gemcitabine|mesh-list
25592684|NCT00954512|Carboplatin|carboplatin|mesh-list
25592685|NCT00954512|Trastuzumab|trastuzumab|mesh-list
25592686|NCT00954512|Irinotecan|irinotecan|mesh-list
25592687|NCT00954512|Cetuximab|cetuximab|mesh-list
25592688|NCT00954512|Everolimus|everolimus|mesh-list
25592689|NCT00954512|Epirubicin|epirubicin|mesh-list
25592690|NCT00954512|Levoleucovorin|levoleucovorin|mesh-list
25592691|NCT00954512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25592692|NCT00954512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592693|NCT00954512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25592694|NCT00954512|Antimetabolites|antimetabolites|mesh-ancestor
25592695|NCT00954512|Antiviral Agents|antiviral agents|mesh-ancestor
25592696|NCT00954512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25592697|NCT00954512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592698|NCT00954512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25592699|NCT00954512|Immunologic Factors|immunologic factors|mesh-ancestor
25592700|NCT00954512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592701|NCT00954512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25592702|NCT00954512|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25592703|NCT00954512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24986274|NCT02004275|Ixazomib|ixazomib|mesh-list
25592704|NCT00954512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25592705|NCT00954512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25592706|NCT00954512|Antidotes|antidotes|mesh-ancestor
25592707|NCT00954512|Protective Agents|protective agents|mesh-ancestor
25592708|NCT00954512|Vitamin B Complex|vitamin b complex|mesh-ancestor
25592709|NCT00954512|Vitamins|vitamins|mesh-ancestor
25592710|NCT00954512|Micronutrients|micronutrients|mesh-ancestor
25592711|NCT00954512|Hematinics|hematinics|mesh-ancestor
25592712|NCT00954681|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24899587|NCT04402320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24899588|NCT04402320|Anesthetics, General|anesthetics, general|mesh-ancestor
24899589|NCT04402320|Anesthetics|anesthetics|mesh-ancestor
25705985|NCT02207374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899590|NCT04402320|GABA Modulators|gaba modulators|mesh-ancestor
24899591|NCT04402320|GABA Agents|gaba agents|mesh-ancestor
24899592|NCT04402320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24518383|NCT05132595|Ketorolac|ketorolac|mesh-list
24986347|NCT01817166|Micronutrients|micronutrients|mesh-ancestor
24986348|NCT01817166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796394|NCT01949805|Antiviral Agents|antiviral agents|mesh-ancestor
25592713|NCT00954681|Antidepressive Agents|antidepressive agents|mesh-ancestor
25592714|NCT00954681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25592715|NCT00954681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25592716|NCT00954681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25592717|NCT00954681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25592718|NCT00954681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592719|NCT00954707|Aspirin|aspirin|mesh-list
25592720|NCT00954707|Clopidogrel|clopidogrel|mesh-list
25592721|NCT00954707|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25592722|NCT00954707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25592723|NCT00954707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25592724|NCT00954707|Analgesics|analgesics|mesh-ancestor
25592725|NCT00954707|Sensory System Agents|sensory system agents|mesh-ancestor
25592726|NCT00954707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25592727|NCT00954707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592728|NCT00954707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25592729|NCT00954707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25592730|NCT00954707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25592731|NCT00954707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25592732|NCT00954707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592733|NCT00954707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25592734|NCT00954707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25592735|NCT00954707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592736|NCT00954707|Antipyretics|antipyretics|mesh-ancestor
25592737|NCT00954707|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25592738|NCT00954707|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25592739|NCT00954707|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25592740|NCT00954707|Purinergic Agents|purinergic agents|mesh-ancestor
25592741|NCT00954707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25592742|NCT00954941|Ondansetron|ondansetron|mesh-list
25592743|NCT00954941|Aprepitant|aprepitant|mesh-list
25592744|NCT00954941|Antiemetics|antiemetics|mesh-ancestor
25592745|NCT00954941|Autonomic Agents|autonomic agents|mesh-ancestor
25592746|NCT00954941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25592747|NCT00954941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592748|NCT00954941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25592749|NCT00954941|Antipruritics|antipruritics|mesh-ancestor
25592750|NCT00954941|Dermatologic Agents|dermatologic agents|mesh-ancestor
25592751|NCT00954941|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25592752|NCT00954941|Serotonin Agents|serotonin agents|mesh-ancestor
25592753|NCT00954941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25592754|NCT00954941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592755|NCT00954941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25592756|NCT00954941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25592757|NCT00954941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25592758|NCT00954941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25592759|NCT00954941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25592760|NCT00954941|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25592761|NCT00955110|Oxymorphone|oxymorphone|mesh-list
25592762|NCT00955110|Oxycodone|oxycodone|mesh-list
25592763|NCT00955110|Hydromorphone|hydromorphone|mesh-list
25592764|NCT00955110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25592765|NCT00955110|Narcotics|narcotics|mesh-ancestor
25592766|NCT00955110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25592767|NCT00955110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592768|NCT00955110|Analgesics|analgesics|mesh-ancestor
25592769|NCT00955110|Sensory System Agents|sensory system agents|mesh-ancestor
25592770|NCT00955110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25592771|NCT00955110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25592772|NCT00955253|Guanfacine|guanfacine|mesh-list
25592773|NCT00955253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25592774|NCT00955253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25592775|NCT00955253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25592776|NCT00955253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25592777|NCT00955253|Adrenergic Agents|adrenergic agents|mesh-ancestor
25592778|NCT00955253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25592779|NCT00955253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592780|NCT00955253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653551|NCT01538472|Carmustine|carmustine|mesh-list
25653552|NCT01538472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25653553|NCT01538472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25653554|NCT01538472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25653555|NCT01538472|Immunologic Factors|immunologic factors|mesh-ancestor
25653556|NCT01538472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653557|NCT01538472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25653558|NCT01538472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25653559|NCT01538472|Antimetabolites|antimetabolites|mesh-ancestor
25653560|NCT01538472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653561|NCT01538472|Antiviral Agents|antiviral agents|mesh-ancestor
25653562|NCT01538472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25653563|NCT01538472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25653564|NCT01538472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25653565|NCT01538472|Alkylating Agents|alkylating agents|mesh-ancestor
25592782|NCT00955266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25592783|NCT00955266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592784|NCT00955279|Golimumab|golimumab|mesh-list
25592785|NCT00955279|Ustekinumab|ustekinumab|mesh-list
25592786|NCT00955279|Dermatologic Agents|dermatologic agents|mesh-ancestor
25592787|NCT00955279|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25592788|NCT00955279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25592789|NCT00955279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25592790|NCT00955279|Immunologic Factors|immunologic factors|mesh-ancestor
25592791|NCT00955279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592792|NCT00955305|Paclitaxel|paclitaxel|mesh-list
25592793|NCT00955305|Bevacizumab|bevacizumab|mesh-list
25592794|NCT00955305|Carboplatin|carboplatin|mesh-list
25592795|NCT00955305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25592796|NCT00955305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25592797|NCT00955305|Tubulin Modulators|tubulin modulators|mesh-ancestor
25592798|NCT00955305|Antimitotic Agents|antimitotic agents|mesh-ancestor
25592799|NCT00955305|Mitosis Modulators|mitosis modulators|mesh-ancestor
25592800|NCT00955305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592801|NCT00955305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24986576|NCT00116142|Estrogens|estrogens|mesh-ancestor
25592802|NCT00955305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25592803|NCT00955305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25592804|NCT00955305|Growth Substances|growth substances|mesh-ancestor
25592805|NCT00955305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592806|NCT00955305|Growth Inhibitors|growth inhibitors|mesh-ancestor
25592807|NCT00955357|Lacosamide|lacosamide|mesh-list
25592808|NCT00955357|Anticonvulsants|anticonvulsants|mesh-ancestor
25592809|NCT00955357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25592810|NCT00955357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25592811|NCT00955357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25592812|NCT00955357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592813|NCT00955409|Saponin QA-21V1|saponin qa-21v1|mesh-list
25592814|NCT00955409|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25592815|NCT00955409|Immunologic Factors|immunologic factors|mesh-ancestor
25592816|NCT00955409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592817|NCT00955474|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25592818|NCT00955474|Citalopram|citalopram|mesh-list
25592819|NCT00955474|Sertraline|sertraline|mesh-list
25592820|NCT00955474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25592821|NCT00955474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25592822|NCT00955474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25592823|NCT00955474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592824|NCT00955474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25592825|NCT00955474|Serotonin Agents|serotonin agents|mesh-ancestor
25592826|NCT00955474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592827|NCT00955474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25592828|NCT00955474|Antidepressive Agents|antidepressive agents|mesh-ancestor
25592829|NCT00955474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25592830|NCT00955474|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25592831|NCT00955474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25592832|NCT00955474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25592833|NCT00955487|Nitric Oxide|nitric oxide|mesh-list
25592834|NCT00955487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25592835|NCT00955487|Autonomic Agents|autonomic agents|mesh-ancestor
25592836|NCT00955487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25592837|NCT00955487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512597|NCT00575848|Glycine|glycine|mesh-list
25592838|NCT00955487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25592839|NCT00955487|Respiratory System Agents|respiratory system agents|mesh-ancestor
25592840|NCT00955487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25592841|NCT00955487|Antioxidants|antioxidants|mesh-ancestor
25592842|NCT00955487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592843|NCT00955487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25592844|NCT00955487|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25592845|NCT00955487|Vasodilator Agents|vasodilator agents|mesh-ancestor
25592846|NCT00955487|Gasotransmitters|gasotransmitters|mesh-ancestor
25592847|NCT00955487|Protective Agents|protective agents|mesh-ancestor
25592848|NCT00955513|Diclofenac|diclofenac|mesh-list
25592849|NCT00955513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25592850|NCT00955513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25592851|NCT00955513|Analgesics|analgesics|mesh-ancestor
25592852|NCT00955513|Sensory System Agents|sensory system agents|mesh-ancestor
25592853|NCT00955513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25487460|NCT00189137|Gemcitabine|gemcitabine|mesh-list
25592854|NCT00955513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592855|NCT00955513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25592856|NCT00955513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25592857|NCT00955513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25592858|NCT00955513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592859|NCT00955513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592860|NCT00955721|Gemcitabine|gemcitabine|mesh-list
25592861|NCT00955721|Oxaliplatin|oxaliplatin|mesh-list
25592862|NCT00955721|Sorafenib|sorafenib|mesh-list
25592863|NCT00955721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25592864|NCT00955721|Antimetabolites|antimetabolites|mesh-ancestor
25592865|NCT00955721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592866|NCT00955721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25592867|NCT00955721|Antiviral Agents|antiviral agents|mesh-ancestor
25592868|NCT00955721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25592869|NCT00955721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592870|NCT00955721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25592871|NCT00955721|Immunologic Factors|immunologic factors|mesh-ancestor
25592872|NCT00955721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592873|NCT00955721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25592874|NCT00955747|Tagatose|tagatose|mesh-list
25592875|NCT00955747|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25592876|NCT00955747|Chelating Agents|chelating agents|mesh-ancestor
25592877|NCT00955747|Sequestering Agents|sequestering agents|mesh-ancestor
25592878|NCT00955747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592879|NCT00955877|Morphine|morphine|mesh-list
25592880|NCT00955877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25592881|NCT00955877|Narcotics|narcotics|mesh-ancestor
25592882|NCT00955877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25592883|NCT00955877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592884|NCT00955877|Analgesics|analgesics|mesh-ancestor
25592885|NCT00955877|Sensory System Agents|sensory system agents|mesh-ancestor
25592886|NCT00955877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25592887|NCT00955916|Cytarabine|cytarabine|mesh-list
25592888|NCT00955916|Imatinib Mesylate|imatinib mesylate|mesh-list
25592889|NCT00955916|Cladribine|cladribine|mesh-list
25592890|NCT00955916|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25592891|NCT00955916|Antimetabolites|antimetabolites|mesh-ancestor
25592892|NCT00955916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592893|NCT00955916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25592894|NCT00955916|Antiviral Agents|antiviral agents|mesh-ancestor
25592895|NCT00955916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25592896|NCT00955916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25592897|NCT00955916|Immunologic Factors|immunologic factors|mesh-ancestor
25592898|NCT00955916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592899|NCT00955916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25592900|NCT00955916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592901|NCT00955968|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25592902|NCT00955968|Antiviral Agents|antiviral agents|mesh-ancestor
25592903|NCT00955968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25592904|NCT00956085|Memantine|memantine|mesh-list
25592905|NCT00956085|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25592906|NCT00956085|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25592907|NCT00956085|Dopamine Agents|dopamine agents|mesh-ancestor
25592908|NCT00956085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25592909|NCT00956085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592910|NCT00956085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592911|NCT00956085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25592912|NCT00956085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25592913|NCT00956254|Fentanyl|fentanyl|mesh-list
25592914|NCT00956254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25592915|NCT00956254|Narcotics|narcotics|mesh-ancestor
24902335|NCT04374318|Analgesics|analgesics|mesh-ancestor
25592916|NCT00956254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25592917|NCT00956254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592918|NCT00956254|Analgesics|analgesics|mesh-ancestor
25592919|NCT00956254|Sensory System Agents|sensory system agents|mesh-ancestor
25592920|NCT00956254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25592921|NCT00956254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25592922|NCT00956254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25592923|NCT00956254|Anesthetics, General|anesthetics, general|mesh-ancestor
25592924|NCT00956254|Anesthetics|anesthetics|mesh-ancestor
25487541|NCT00189488|Methotrexate|methotrexate|mesh-list
25592925|NCT00956293|Cyclosporine|cyclosporine|mesh-list
25592926|NCT00956293|Mycophenolic Acid|mycophenolic acid|mesh-list
25592927|NCT00956293|Everolimus|everolimus|mesh-list
25592928|NCT00956293|Cyclosporins|cyclosporins|mesh-list
25592929|NCT00956293|Basiliximab|basiliximab|mesh-list
25592930|NCT00956293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592931|NCT00956293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592932|NCT00956293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25592933|NCT00956293|Immunologic Factors|immunologic factors|mesh-ancestor
25592934|NCT00956293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592935|NCT00956293|Antifungal Agents|antifungal agents|mesh-ancestor
25592936|NCT00956293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25592937|NCT00956293|Dermatologic Agents|dermatologic agents|mesh-ancestor
25592938|NCT00956293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25592939|NCT00956293|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25592940|NCT00956293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25592941|NCT00956293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25592942|NCT00956293|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25592943|NCT00956293|Antitubercular Agents|antitubercular agents|mesh-ancestor
25592944|NCT00956293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25592945|NCT00956709|Ropivacaine|ropivacaine|mesh-list
25592946|NCT00956709|Levobupivacaine|levobupivacaine|mesh-list
25592947|NCT00956709|Anesthetics, Local|anesthetics, local|mesh-ancestor
25592948|NCT00956709|Anesthetics|anesthetics|mesh-ancestor
25592949|NCT00956709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25592950|NCT00956709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592951|NCT00956709|Sensory System Agents|sensory system agents|mesh-ancestor
25592952|NCT00956709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25592953|NCT00956839|Vitamin D|vitamin d|mesh-list
25592954|NCT00956839|Ergocalciferols|ergocalciferols|mesh-list
25592955|NCT00956839|Cholecalciferol|cholecalciferol|mesh-list
25592956|NCT00956839|Vitamins|vitamins|mesh-list
25592957|NCT00956839|Micronutrients|micronutrients|mesh-ancestor
25592958|NCT00956839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592959|NCT00956839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25706111|NCT02208050|4-Aminopyridine|4-aminopyridine|mesh-list
25592960|NCT00956839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25592961|NCT00956930|Doxorubicin|doxorubicin|mesh-list
25592962|NCT00956930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25592963|NCT00956930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25592964|NCT00956930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25592965|NCT00956930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25592966|NCT00956930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25592967|NCT00956930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592968|NCT00956930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592969|NCT00956943|Nicotine|nicotine|mesh-list
25592970|NCT00956943|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25592971|NCT00956943|Autonomic Agents|autonomic agents|mesh-ancestor
25592972|NCT00956943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25592973|NCT00956943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592974|NCT00956943|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25592975|NCT00956943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25592976|NCT00956943|Cholinergic Agents|cholinergic agents|mesh-ancestor
25592977|NCT00956943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25592978|NCT00956943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592979|NCT00957047|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25592980|NCT00957047|Anticonvulsants|anticonvulsants|mesh-ancestor
25592981|NCT00957047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25592982|NCT00957047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25592983|NCT00957047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25592984|NCT00957047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592985|NCT00957242|Warfarin|warfarin|mesh-list
25592986|NCT00957242|Anticoagulants|anticoagulants|mesh-ancestor
25592987|NCT00957268|Alogliptin|alogliptin|mesh-list
25592988|NCT00957268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25592989|NCT00957268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25592990|NCT00957268|Incretins|incretins|mesh-ancestor
25592991|NCT00957268|Hormones|hormones|mesh-ancestor
25592992|NCT00957268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25592993|NCT00957268|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25592994|NCT00957268|Protease Inhibitors|protease inhibitors|mesh-ancestor
25592995|NCT00957268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25592996|NCT00957268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25592997|NCT00957333|Ketamine|ketamine|mesh-list
25592998|NCT00957333|Analgesics|analgesics|mesh-ancestor
25592999|NCT00957333|Sensory System Agents|sensory system agents|mesh-ancestor
25593000|NCT00957333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25593001|NCT00957333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593002|NCT00957333|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25593003|NCT00957333|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25593004|NCT00957333|Anesthetics, General|anesthetics, general|mesh-ancestor
25593005|NCT00957333|Anesthetics|anesthetics|mesh-ancestor
25593006|NCT00957333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25593007|NCT00957333|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25593008|NCT00957333|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25593009|NCT00957333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25593010|NCT00957333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593011|NCT00957359|Niacin|niacin|mesh-list
25593012|NCT00957359|Psilocybin|psilocybin|mesh-list
25593013|NCT00957359|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
25706130|NCT02208310|Vitamins|vitamins|mesh-list
25593014|NCT00957359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25593015|NCT00957359|Antimetabolites|antimetabolites|mesh-ancestor
25593016|NCT00957359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593017|NCT00957359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25593018|NCT00957359|Vasodilator Agents|vasodilator agents|mesh-ancestor
25593019|NCT00957359|Vitamin B Complex|vitamin b complex|mesh-ancestor
25593020|NCT00957359|Vitamins|vitamins|mesh-ancestor
25593021|NCT00957359|Micronutrients|micronutrients|mesh-ancestor
25593022|NCT00957359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593023|NCT00957359|Hallucinogens|hallucinogens|mesh-ancestor
25593024|NCT00957359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25593025|NCT00957359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25593026|NCT00957359|Serotonin Agents|serotonin agents|mesh-ancestor
25593027|NCT00957359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25593028|NCT00957359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25593029|NCT00957372|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25593030|NCT00957372|Anticonvulsants|anticonvulsants|mesh-ancestor
25593031|NCT00957372|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25593032|NCT00957372|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25593033|NCT00957372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25593034|NCT00957372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593035|NCT00957424|Nicotine|nicotine|mesh-list
25593036|NCT00957424|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25593037|NCT00957424|Autonomic Agents|autonomic agents|mesh-ancestor
25593038|NCT00957424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25593039|NCT00957424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593040|NCT00957424|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25593041|NCT00957424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25593042|NCT00957424|Cholinergic Agents|cholinergic agents|mesh-ancestor
25593043|NCT00957424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25593044|NCT00957424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593045|NCT00957528|Methyltestosterone|methyltestosterone|mesh-list
25593046|NCT00957528|Testosterone|testosterone|mesh-list
25593047|NCT00957528|Testosterone undecanoate|testosterone undecanoate|mesh-list
25593048|NCT00957528|Testosterone enanthate|testosterone enanthate|mesh-list
25593049|NCT00957528|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25593050|NCT00957528|Androgens|androgens|mesh-ancestor
25593051|NCT00957528|Hormones|hormones|mesh-ancestor
25593052|NCT00957528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25593053|NCT00957528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593054|NCT00957528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25593055|NCT00957528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25593056|NCT00957528|Anabolic Agents|anabolic agents|mesh-ancestor
25593057|NCT00957580|Niacinamide|niacinamide|mesh-list
25593058|NCT00957580|Vitamin B Complex|vitamin b complex|mesh-ancestor
25593059|NCT00957580|Vitamins|vitamins|mesh-ancestor
25593060|NCT00957580|Micronutrients|micronutrients|mesh-ancestor
25593061|NCT00957580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593062|NCT00957593|Oxytocin|oxytocin|mesh-list
25593063|NCT00957593|Oxytocics|oxytocics|mesh-ancestor
25593064|NCT00957593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25593065|NCT00957593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593066|NCT00957671|Hormones|hormones|mesh-list
25593067|NCT00957671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25593068|NCT00957671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593069|NCT00957684|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25593070|NCT00957684|Anticonvulsants|anticonvulsants|mesh-ancestor
25593071|NCT00957684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25593072|NCT00957684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25593073|NCT00957684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25593074|NCT00957684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593075|NCT00957801|Methylprednisolone|methylprednisolone|mesh-list
25593076|NCT00957801|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25593077|NCT00957801|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25593078|NCT00957801|Prednisolone|prednisolone|mesh-list
25593079|NCT00957801|Prednisolone acetate|prednisolone acetate|mesh-list
25593080|NCT00957801|Methyltestosterone|methyltestosterone|mesh-list
25593081|NCT00957801|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25593082|NCT00957801|Prednisolone phosphate|prednisolone phosphate|mesh-list
25593083|NCT00957801|Testosterone|testosterone|mesh-list
25593084|NCT00957801|Testosterone undecanoate|testosterone undecanoate|mesh-list
25593085|NCT00957801|Testosterone enanthate|testosterone enanthate|mesh-list
25593086|NCT00957801|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25593087|NCT00957801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24987744|NCT05042947|Hormones|hormones|mesh-ancestor
25593088|NCT00957801|Antiemetics|antiemetics|mesh-ancestor
25593089|NCT00957801|Autonomic Agents|autonomic agents|mesh-ancestor
25593090|NCT00957801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25593091|NCT00957801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593092|NCT00957801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25593093|NCT00957801|Glucocorticoids|glucocorticoids|mesh-ancestor
25593094|NCT00957801|Hormones|hormones|mesh-ancestor
25593095|NCT00957801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25593096|NCT00957801|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25593097|NCT00957801|Protective Agents|protective agents|mesh-ancestor
25593098|NCT00957801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25593099|NCT00957801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25593100|NCT00957801|Androgens|androgens|mesh-ancestor
25593101|NCT00957801|Anabolic Agents|anabolic agents|mesh-ancestor
25593102|NCT00957853|Cetuximab|cetuximab|mesh-list
25593103|NCT00957853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25593104|NCT00957853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25593105|NCT00957905|Calcium, Dietary|calcium, dietary|mesh-list
25593106|NCT00957905|Leucovorin|leucovorin|mesh-list
25593107|NCT00957905|Folic Acid|folic acid|mesh-list
25593108|NCT00957905|Fluorouracil|fluorouracil|mesh-list
25593109|NCT00957905|Oxaliplatin|oxaliplatin|mesh-list
25593110|NCT00957905|Alvocidib|alvocidib|mesh-list
25593111|NCT00957905|Calcium|calcium|mesh-list
25593112|NCT00957905|Levoleucovorin|levoleucovorin|mesh-list
25593113|NCT00957905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25593114|NCT00957905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593115|NCT00957905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25593116|NCT00957905|Antimetabolites|antimetabolites|mesh-ancestor
25593117|NCT00957905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593118|NCT00957905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25593119|NCT00957905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25593120|NCT00957905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25593121|NCT00957905|Immunologic Factors|immunologic factors|mesh-ancestor
25593122|NCT00957905|Antidotes|antidotes|mesh-ancestor
25593123|NCT00957905|Protective Agents|protective agents|mesh-ancestor
25593124|NCT00957905|Vitamin B Complex|vitamin b complex|mesh-ancestor
25593125|NCT00957905|Vitamins|vitamins|mesh-ancestor
25593126|NCT00957905|Micronutrients|micronutrients|mesh-ancestor
25593127|NCT00957905|Hematinics|hematinics|mesh-ancestor
24905469|NCT04347577|Analgesics|analgesics|mesh-ancestor
25593128|NCT00957905|Growth Inhibitors|growth inhibitors|mesh-ancestor
25593129|NCT00957905|Growth Substances|growth substances|mesh-ancestor
25593130|NCT00957905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25593131|NCT00957905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593132|NCT00957944|Rotigotine|rotigotine|mesh-list
25593133|NCT00957944|Dopamine Agonists|dopamine agonists|mesh-ancestor
25593134|NCT00957944|Dopamine Agents|dopamine agents|mesh-ancestor
25593135|NCT00957944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25593136|NCT00957944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593137|NCT00957944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593138|NCT00957996|Peramivir|peramivir|mesh-list
25593139|NCT00957996|Antiviral Agents|antiviral agents|mesh-ancestor
25593140|NCT00957996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25593141|NCT00957996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593142|NCT00957996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593143|NCT00958035|Bimatoprost|bimatoprost|mesh-list
25593144|NCT00958035|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25593145|NCT00958035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25593146|NCT00958074|Vorinostat|vorinostat|mesh-list
25593147|NCT00958074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25593148|NCT00958074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25593149|NCT00958074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593150|NCT00958074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593151|NCT00958243|Vaccines|vaccines|mesh-list
25593152|NCT00958243|Immunologic Factors|immunologic factors|mesh-ancestor
25593153|NCT00958243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593154|NCT00958256|Cyclophosphamide|cyclophosphamide|mesh-list
25593155|NCT00958256|Rituximab|rituximab|mesh-list
25487747|NCT00191477|Gemcitabine|gemcitabine|mesh-list
25593156|NCT00958256|Bortezomib|bortezomib|mesh-list
25593157|NCT00958256|Lenograstim|lenograstim|mesh-list
25593158|NCT00958256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25593159|NCT00958256|Immunologic Factors|immunologic factors|mesh-ancestor
25593160|NCT00958256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593161|NCT00958256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25593162|NCT00958256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25593163|NCT00958256|Alkylating Agents|alkylating agents|mesh-ancestor
25593164|NCT00958256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593165|NCT00958256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25593166|NCT00958256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25593167|NCT00958256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25593168|NCT00958256|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25593169|NCT00958282|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25593170|NCT00958282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25593171|NCT00958282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593172|NCT00958282|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25593173|NCT00958282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25593174|NCT00958282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25593175|NCT00958282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593176|NCT00958282|Dopamine Agents|dopamine agents|mesh-ancestor
25593177|NCT00958282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25593178|NCT00958438|Rilonacept|rilonacept|mesh-list
25593179|NCT00958438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25593180|NCT00958568|Olanzapine|olanzapine|mesh-list
25593181|NCT00958568|Fluoxetine|fluoxetine|mesh-list
25593182|NCT00958568|Antiemetics|antiemetics|mesh-ancestor
25593183|NCT00958568|Autonomic Agents|autonomic agents|mesh-ancestor
25593184|NCT00958568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25593185|NCT00958568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593186|NCT00958568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25593187|NCT00958568|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25593188|NCT00958568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25593189|NCT00958568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25593190|NCT00958568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25593191|NCT00958568|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25593192|NCT00958568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25593193|NCT00958568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25593194|NCT00958568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593195|NCT00958568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25593196|NCT00958568|Serotonin Agents|serotonin agents|mesh-ancestor
25593197|NCT00958568|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25593198|NCT00958568|Antidepressive Agents|antidepressive agents|mesh-ancestor
25593199|NCT00958568|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25593200|NCT00958568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25593201|NCT00958568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593202|NCT00958581|Tranexamic Acid|tranexamic acid|mesh-list
25593203|NCT00958581|Aminocaproic Acid|aminocaproic acid|mesh-list
25593204|NCT00958581|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25593205|NCT00958581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25593206|NCT00958581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593207|NCT00958581|Hemostatics|hemostatics|mesh-ancestor
25593208|NCT00958581|Coagulants|coagulants|mesh-ancestor
25593209|NCT00958724|Vinorelbine|vinorelbine|mesh-list
25593210|NCT00958724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25593211|NCT00958724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25593212|NCT00958724|Tubulin Modulators|tubulin modulators|mesh-ancestor
24796751|NCT01951885|Methotrexate|methotrexate|mesh-list
25487798|NCT00191789|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25487799|NCT00191815|Gemcitabine|gemcitabine|mesh-list
25487800|NCT00191815|Cisplatin|cisplatin|mesh-list
25487801|NCT00191815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487802|NCT00191815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25487803|NCT00191815|Antimetabolites|antimetabolites|mesh-ancestor
25487804|NCT00191815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487805|NCT00191815|Antiviral Agents|antiviral agents|mesh-ancestor
25487806|NCT00191815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25487807|NCT00191815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593213|NCT00958724|Antimitotic Agents|antimitotic agents|mesh-ancestor
25593214|NCT00958724|Mitosis Modulators|mitosis modulators|mesh-ancestor
25593215|NCT00958724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593216|NCT00958776|Peramivir|peramivir|mesh-list
25593217|NCT00958776|Antiviral Agents|antiviral agents|mesh-ancestor
25593218|NCT00958776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24818697|NCT02090322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25593219|NCT00958776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593220|NCT00958776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593221|NCT00958841|Pasireotide|pasireotide|mesh-list
25593222|NCT00958841|Hormones|hormones|mesh-ancestor
25593223|NCT00958841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25593224|NCT00958841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593225|NCT00958880|Yohimbine|yohimbine|mesh-list
25593226|NCT00958880|Mydriatics|mydriatics|mesh-ancestor
25593227|NCT00958880|Autonomic Agents|autonomic agents|mesh-ancestor
25593228|NCT00958880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25593229|NCT00958880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593230|NCT00958880|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25593231|NCT00958880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25593232|NCT00958880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25593233|NCT00958880|Adrenergic Agents|adrenergic agents|mesh-ancestor
25593234|NCT00958880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25593235|NCT00958880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593236|NCT00958880|Urological Agents|urological agents|mesh-ancestor
25593237|NCT00958919|Naloxone|naloxone|mesh-list
25593238|NCT00958919|Endorphins|endorphins|mesh-list
25593239|NCT00958919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25593240|NCT00958919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593241|NCT00958919|Sensory System Agents|sensory system agents|mesh-ancestor
25593242|NCT00958919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25593243|NCT00958919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25593244|NCT00958919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593245|NCT00959049|Vaccines|vaccines|mesh-list
25593246|NCT00959049|Immunologic Factors|immunologic factors|mesh-ancestor
25593247|NCT00959049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593248|NCT00959192|Saponin QA-21V1|saponin qa-21v1|mesh-list
24987878|NCT04770272|Carboplatin|carboplatin|mesh-list
25593249|NCT00959192|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25593250|NCT00959192|Immunologic Factors|immunologic factors|mesh-ancestor
25593251|NCT00959192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593252|NCT00959647|Bevacizumab|bevacizumab|mesh-list
25593253|NCT00959647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25593254|NCT00959647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25593255|NCT00959647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25593256|NCT00959647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25593257|NCT00959647|Growth Substances|growth substances|mesh-ancestor
25593258|NCT00959647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593259|NCT00959647|Growth Inhibitors|growth inhibitors|mesh-ancestor
25593260|NCT00959699|Interferons|interferons|mesh-list
25593261|NCT00959699|Ribavirin|ribavirin|mesh-list
25593262|NCT00959699|Interferon-alpha|interferon-alpha|mesh-list
25593263|NCT00959699|Interferon alpha-2|interferon alpha-2|mesh-list
25593264|NCT00959699|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25593265|NCT00959699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25593266|NCT00959699|Antiviral Agents|antiviral agents|mesh-ancestor
25593267|NCT00959699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25593268|NCT00959699|Antimetabolites|antimetabolites|mesh-ancestor
25593269|NCT00959699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593270|NCT00959699|Immunologic Factors|immunologic factors|mesh-ancestor
25593271|NCT00959699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593272|NCT00959764|Calcitonin|calcitonin|mesh-list
25593273|NCT00959764|Salmon calcitonin|salmon calcitonin|mesh-list
25593274|NCT00959764|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
25593275|NCT00959764|Katacalcin|katacalcin|mesh-list
25593276|NCT00959764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25593277|NCT00959764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593278|NCT00959764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25593279|NCT00959764|Vasodilator Agents|vasodilator agents|mesh-ancestor
25593280|NCT00959894|Tenofovir|tenofovir|mesh-list
25593281|NCT00959894|Emtricitabine|emtricitabine|mesh-list
25593282|NCT00959894|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25593283|NCT00959894|Etravirine|etravirine|mesh-list
25593284|NCT00959894|Antiviral Agents|antiviral agents|mesh-ancestor
25593285|NCT00959894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25593286|NCT00959894|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25593287|NCT00959894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25593288|NCT00959894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593289|NCT00959894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593290|NCT00959894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25593291|NCT00959894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25593292|NCT00959907|Botulinum Toxins|botulinum toxins|mesh-list
25593293|NCT00959907|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25593294|NCT00959907|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25593295|NCT00959907|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25593296|NCT00959907|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25593297|NCT00959907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25593298|NCT00959907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593299|NCT00959907|Cholinergic Agents|cholinergic agents|mesh-ancestor
25593300|NCT00959907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25593301|NCT00959907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593302|NCT00959907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25593303|NCT00959907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25593304|NCT00959946|Capecitabine|capecitabine|mesh-list
25593305|NCT00959946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25593306|NCT00959946|Antimetabolites|antimetabolites|mesh-ancestor
25593307|NCT00959946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593308|NCT00959946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25593309|NCT00960063|Cyclophosphamide|cyclophosphamide|mesh-list
25593310|NCT00960063|Temozolomide|temozolomide|mesh-list
25593311|NCT00960063|Ifosfamide|ifosfamide|mesh-list
25593312|NCT00960063|Doxorubicin|doxorubicin|mesh-list
25593313|NCT00960063|Irinotecan|irinotecan|mesh-list
25593314|NCT00960063|Etoposide|etoposide|mesh-list
25593315|NCT00960063|Vincristine|vincristine|mesh-list
25593316|NCT00960063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25593317|NCT00960063|Immunologic Factors|immunologic factors|mesh-ancestor
25593318|NCT00960063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593319|NCT00960063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25593320|NCT00960063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25593321|NCT00960063|Alkylating Agents|alkylating agents|mesh-ancestor
25593322|NCT00960063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593323|NCT00960063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25593324|NCT00960063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25593325|NCT00960063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25593326|NCT00960063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25593327|NCT00960063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25593328|NCT00960063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593329|NCT00960063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25593330|NCT00960063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25593331|NCT00960063|Tubulin Modulators|tubulin modulators|mesh-ancestor
25593332|NCT00960063|Antimitotic Agents|antimitotic agents|mesh-ancestor
25593333|NCT00960063|Mitosis Modulators|mitosis modulators|mesh-ancestor
25593334|NCT00960076|Metformin|metformin|mesh-list
25593335|NCT00960076|Saxagliptin|saxagliptin|mesh-list
25593336|NCT00960076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25593337|NCT00960076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593338|NCT00960076|Incretins|incretins|mesh-ancestor
25593339|NCT00960076|Hormones|hormones|mesh-ancestor
25593340|NCT00960076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25593341|NCT00960076|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25593342|NCT00960076|Protease Inhibitors|protease inhibitors|mesh-ancestor
25593343|NCT00960076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593344|NCT00960076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653566|NCT01538472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25653567|NCT01538719|Rilonacept|rilonacept|mesh-list
25653568|NCT01538719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25656959|NCT01581307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656960|NCT01581307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25656961|NCT01581307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656962|NCT01581307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25656963|NCT01581307|Immunologic Factors|immunologic factors|mesh-ancestor
25656964|NCT01581307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656965|NCT01581307|Antidotes|antidotes|mesh-ancestor
25656966|NCT01581307|Protective Agents|protective agents|mesh-ancestor
25656967|NCT01581307|Vitamin B Complex|vitamin b complex|mesh-ancestor
25656968|NCT01581307|Vitamins|vitamins|mesh-ancestor
25656969|NCT01581307|Micronutrients|micronutrients|mesh-ancestor
25656970|NCT01581307|Hematinics|hematinics|mesh-ancestor
25656971|NCT01581541|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
25656972|NCT01581541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656973|NCT01581658|Empagliflozin|empagliflozin|mesh-list
25656974|NCT01581658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25656975|NCT01581658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656976|NCT01581658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25656977|NCT01581658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656978|NCT01581710|Montelukast|montelukast|mesh-list
25656979|NCT01581710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25656980|NCT01581710|Respiratory System Agents|respiratory system agents|mesh-ancestor
25656981|NCT01581710|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25593345|NCT00960115|Cyclophosphamide|cyclophosphamide|mesh-list
25593346|NCT00960115|Immunologic Factors|immunologic factors|mesh-ancestor
25593347|NCT00960115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593348|NCT00960115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25593349|NCT00960115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25593350|NCT00960115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25593351|NCT00960115|Alkylating Agents|alkylating agents|mesh-ancestor
25593352|NCT00960115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593353|NCT00960115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25593354|NCT00960115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25593355|NCT00960193|Colchicine|colchicine|mesh-list
25593356|NCT00960193|Gout Suppressants|gout suppressants|mesh-ancestor
25593357|NCT00960193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25593358|NCT00960193|Tubulin Modulators|tubulin modulators|mesh-ancestor
25593359|NCT00960193|Antimitotic Agents|antimitotic agents|mesh-ancestor
25593360|NCT00960193|Mitosis Modulators|mitosis modulators|mesh-ancestor
25593361|NCT00960193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593362|NCT00960193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25593363|NCT00960323|Colchicine|colchicine|mesh-list
25593364|NCT00960323|Atorvastatin|atorvastatin|mesh-list
25593365|NCT00960323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25593366|NCT00960323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25593367|NCT00960323|Antimetabolites|antimetabolites|mesh-ancestor
25593368|NCT00960323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593369|NCT00960323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25593370|NCT00960323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25593371|NCT00960323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593372|NCT00960323|Gout Suppressants|gout suppressants|mesh-ancestor
25593373|NCT00960323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25593374|NCT00960323|Tubulin Modulators|tubulin modulators|mesh-ancestor
25593375|NCT00960323|Antimitotic Agents|antimitotic agents|mesh-ancestor
25593376|NCT00960323|Mitosis Modulators|mitosis modulators|mesh-ancestor
25593377|NCT00960323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25593378|NCT00960440|Tofacitinib|tofacitinib|mesh-list
25593379|NCT00960440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25593380|NCT00960440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593381|NCT00960440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593382|NCT00960531|Saponin QA-21V1|saponin qa-21v1|mesh-list
25593383|NCT00960531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25593384|NCT00960531|Immunologic Factors|immunologic factors|mesh-ancestor
25593385|NCT00960531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593386|NCT00960570|Efavirenz|efavirenz|mesh-list
25593387|NCT00960570|Fenofibric acid|fenofibric acid|mesh-list
25593388|NCT00960570|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25593389|NCT00960570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25593390|NCT00960570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593391|NCT00960570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593392|NCT00960570|Antiviral Agents|antiviral agents|mesh-ancestor
25593393|NCT00960570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25593394|NCT00960570|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25593395|NCT00960570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25593396|NCT00960570|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24517214|NCT00606541|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25593397|NCT00960570|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25593398|NCT00960570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25593399|NCT00960570|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25593400|NCT00960570|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25593401|NCT00960570|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25593402|NCT00960570|Antimetabolites|antimetabolites|mesh-ancestor
25593403|NCT00960570|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25593404|NCT00960622|Tenofovir|tenofovir|mesh-list
25593405|NCT00960622|Lamivudine|lamivudine|mesh-list
25593406|NCT00960622|Zidovudine|zidovudine|mesh-list
25593407|NCT00960622|Emtricitabine|emtricitabine|mesh-list
25593408|NCT00960622|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25593409|NCT00960622|Abacavir|abacavir|mesh-list
25593410|NCT00960622|Dideoxynucleosides|dideoxynucleosides|mesh-list
25593411|NCT00960622|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25593412|NCT00960622|Antiviral Agents|antiviral agents|mesh-ancestor
25593413|NCT00960622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25593414|NCT00960622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25593415|NCT00960622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25593416|NCT00960622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593417|NCT00960622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593418|NCT00960622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25593419|NCT00960622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25593420|NCT00960622|Antimetabolites|antimetabolites|mesh-ancestor
25593421|NCT00960661|Insulin|insulin|mesh-list
25593422|NCT00960661|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25593423|NCT00960661|Metformin|metformin|mesh-list
25593424|NCT00960661|Exenatide|exenatide|mesh-list
25593425|NCT00960661|Insulin Lispro|insulin lispro|mesh-list
25593426|NCT00960661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25593427|NCT00960661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593428|NCT00960661|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25593429|NCT00960661|Incretins|incretins|mesh-ancestor
25593430|NCT00960661|Hormones|hormones|mesh-ancestor
25593431|NCT00960661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25593432|NCT00960687|Fenofibrate|fenofibrate|mesh-list
25593433|NCT00960687|Fenofibric acid|fenofibric acid|mesh-list
25593434|NCT00960687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25593435|NCT00960687|Antimetabolites|antimetabolites|mesh-ancestor
25593436|NCT00960687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593437|NCT00960687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25593438|NCT00960687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25593439|NCT00960778|Nicotine|nicotine|mesh-list
25593440|NCT00960778|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25593441|NCT00960778|Autonomic Agents|autonomic agents|mesh-ancestor
25593442|NCT00960778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25593443|NCT00960778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593444|NCT00960778|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25593445|NCT00960778|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25593446|NCT00960778|Cholinergic Agents|cholinergic agents|mesh-ancestor
25593447|NCT00960778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25593448|NCT00960778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593449|NCT00960804|Tanezumab|tanezumab|mesh-list
25593450|NCT00960804|Analgesics|analgesics|mesh-ancestor
25593451|NCT00960804|Sensory System Agents|sensory system agents|mesh-ancestor
25593452|NCT00960804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25593453|NCT00960804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593454|NCT00960856|Fenofibric acid|fenofibric acid|mesh-list
25593455|NCT00960856|Fenofibrate|fenofibrate|mesh-list
25593456|NCT00960856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25593457|NCT00960856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25593458|NCT00960856|Antimetabolites|antimetabolites|mesh-ancestor
25593459|NCT00960856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593460|NCT00960856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25593461|NCT00960869|Aspirin|aspirin|mesh-list
25593462|NCT00960869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25593463|NCT00960869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25593464|NCT00960869|Analgesics|analgesics|mesh-ancestor
25593465|NCT00960869|Sensory System Agents|sensory system agents|mesh-ancestor
25593466|NCT00960869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24909457|NCT04308525|Analgesics, Opioid|analgesics, opioid|mesh-list
25593467|NCT00960869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593468|NCT00960869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25593469|NCT00960869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25593470|NCT00960869|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25593471|NCT00960869|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25593472|NCT00960869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593473|NCT00960869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25593474|NCT00960869|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25593475|NCT00960869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593476|NCT00960869|Antipyretics|antipyretics|mesh-ancestor
25593477|NCT00960934|Vitamin D|vitamin d|mesh-list
25593478|NCT00960934|Cholecalciferol|cholecalciferol|mesh-list
25593479|NCT00960934|Calcium Carbonate|calcium carbonate|mesh-list
25593480|NCT00960934|Calcium|calcium|mesh-list
25593481|NCT00960934|Vitamins|vitamins|mesh-ancestor
25593482|NCT00960934|Micronutrients|micronutrients|mesh-ancestor
25593483|NCT00960934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593484|NCT00960934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25593485|NCT00960934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25593486|NCT00960934|Antacids|antacids|mesh-ancestor
25593487|NCT00960934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593488|NCT00960934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25593489|NCT00960986|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25593490|NCT00960986|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25593491|NCT00960986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25593492|NCT00960986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25593493|NCT00960986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653569|NCT01538745|Ketamine|ketamine|mesh-list
25593494|NCT00960986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25593495|NCT00960986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593496|NCT00960986|Analgesics|analgesics|mesh-ancestor
25593497|NCT00960986|Sensory System Agents|sensory system agents|mesh-ancestor
25593498|NCT00960986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25593499|NCT00960986|Antidepressive Agents|antidepressive agents|mesh-ancestor
25593500|NCT00960986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25593501|NCT00960986|Dopamine Agents|dopamine agents|mesh-ancestor
25593502|NCT00961116|Fenofibrate|fenofibrate|mesh-list
25593503|NCT00961116|Fenofibric acid|fenofibric acid|mesh-list
25593504|NCT00961116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25593505|NCT00961116|Antimetabolites|antimetabolites|mesh-ancestor
25593506|NCT00961116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593507|NCT00961116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25593508|NCT00961116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25593509|NCT00961181|Paclitaxel|paclitaxel|mesh-list
25593510|NCT00961181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25593511|NCT00961181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25593512|NCT00961181|Tubulin Modulators|tubulin modulators|mesh-ancestor
25593513|NCT00961181|Antimitotic Agents|antimitotic agents|mesh-ancestor
25593514|NCT00961181|Mitosis Modulators|mitosis modulators|mesh-ancestor
25593515|NCT00961181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593516|NCT00961220|Carmustine|carmustine|mesh-list
25593517|NCT00961220|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
25593518|NCT00961220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25593519|NCT00961220|Alkylating Agents|alkylating agents|mesh-ancestor
25593520|NCT00961220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593521|NCT00961220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25593522|NCT00961220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593523|NCT00961233|Budesonide|budesonide|mesh-list
25593524|NCT00961233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25593525|NCT00961233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25593526|NCT00961233|Autonomic Agents|autonomic agents|mesh-ancestor
25593527|NCT00961233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25593528|NCT00961233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593529|NCT00961233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25593530|NCT00961233|Respiratory System Agents|respiratory system agents|mesh-ancestor
25593531|NCT00961233|Glucocorticoids|glucocorticoids|mesh-ancestor
25593532|NCT00961233|Hormones|hormones|mesh-ancestor
25593533|NCT00961233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25593534|NCT00961259|Fenofibric acid|fenofibric acid|mesh-list
25593535|NCT00961259|Fenofibrate|fenofibrate|mesh-list
25593536|NCT00961259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25593537|NCT00961259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25593538|NCT00961259|Antimetabolites|antimetabolites|mesh-ancestor
25593539|NCT00961259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593540|NCT00961259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25593541|NCT00961298|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25593542|NCT00961298|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25593543|NCT00961298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25593544|NCT00961298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25593545|NCT00961298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593546|NCT00961298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24988930|NCT05189483|Paclitaxel|paclitaxel|mesh-list
25593547|NCT00961298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593548|NCT00961298|Analgesics|analgesics|mesh-ancestor
25593549|NCT00961298|Sensory System Agents|sensory system agents|mesh-ancestor
25593550|NCT00961298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25593551|NCT00961298|Antidepressive Agents|antidepressive agents|mesh-ancestor
25593552|NCT00961298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25593553|NCT00961298|Dopamine Agents|dopamine agents|mesh-ancestor
25593554|NCT00961350|Aspirin|aspirin|mesh-list
25593555|NCT00961350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25593556|NCT00961350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25593557|NCT00961350|Analgesics|analgesics|mesh-ancestor
25593558|NCT00961350|Sensory System Agents|sensory system agents|mesh-ancestor
25593559|NCT00961350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25593560|NCT00961350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593561|NCT00961350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25593562|NCT00961350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25593563|NCT00961350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25593564|NCT00961350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25593565|NCT00961350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593566|NCT00961350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25653570|NCT01538745|Morphine|morphine|mesh-list
25593567|NCT00961350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24517997|NCT00611000|Folic Acid|folic acid|mesh-list
25593568|NCT00961350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593569|NCT00961350|Antipyretics|antipyretics|mesh-ancestor
25593570|NCT00961415|Bevacizumab|bevacizumab|mesh-list
25593571|NCT00961415|Cisplatin|cisplatin|mesh-list
25593572|NCT00961415|Pemetrexed|pemetrexed|mesh-list
25593573|NCT00961415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25593574|NCT00961415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25593575|NCT00961415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25593576|NCT00961415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25593577|NCT00961415|Growth Substances|growth substances|mesh-ancestor
25593578|NCT00961415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593579|NCT00961415|Growth Inhibitors|growth inhibitors|mesh-ancestor
25593580|NCT00961415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593581|NCT00961415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593582|NCT00961415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25593583|NCT00961415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25593584|NCT00961441|Levetiracetam|levetiracetam|mesh-list
25593585|NCT00961441|Anticonvulsants|anticonvulsants|mesh-ancestor
25593586|NCT00961441|Nootropic Agents|nootropic agents|mesh-ancestor
25593587|NCT00961532|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25593588|NCT00961532|Hemostatics|hemostatics|mesh-ancestor
25593589|NCT00961532|Coagulants|coagulants|mesh-ancestor
25593590|NCT00961532|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25593591|NCT00961532|Natriuretic Agents|natriuretic agents|mesh-ancestor
25593592|NCT00961532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593593|NCT00961571|Capecitabine|capecitabine|mesh-list
25593594|NCT00961571|Sunitinib|sunitinib|mesh-list
25593595|NCT00961571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25593596|NCT00961571|Antimetabolites|antimetabolites|mesh-ancestor
25593597|NCT00961571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593598|NCT00961571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25593599|NCT00961571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25593600|NCT00961571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25593601|NCT00961571|Growth Substances|growth substances|mesh-ancestor
25593602|NCT00961571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593603|NCT00961571|Growth Inhibitors|growth inhibitors|mesh-ancestor
25593604|NCT00961571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25593605|NCT00961571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593606|NCT00961636|Niacin|niacin|mesh-list
25593607|NCT00961636|Niacinamide|niacinamide|mesh-list
25593608|NCT00961636|Nicotinic Acids|nicotinic acids|mesh-list
25593609|NCT00961636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25593610|NCT00961636|Antimetabolites|antimetabolites|mesh-ancestor
25593611|NCT00961636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593612|NCT00961636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25593613|NCT00961636|Vasodilator Agents|vasodilator agents|mesh-ancestor
25593614|NCT00961636|Vitamin B Complex|vitamin b complex|mesh-ancestor
25593615|NCT00961636|Vitamins|vitamins|mesh-ancestor
25593616|NCT00961636|Micronutrients|micronutrients|mesh-ancestor
25593617|NCT00961636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593618|NCT00961649|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25593619|NCT00961649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25593620|NCT00961649|Brinzolamide|brinzolamide|mesh-list
25593621|NCT00961649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25593622|NCT00961649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25593623|NCT00961649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25593624|NCT00961649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25593625|NCT00961649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25593626|NCT00961649|Adrenergic Agents|adrenergic agents|mesh-ancestor
25593627|NCT00961649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25593628|NCT00961649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593629|NCT00961649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593630|NCT00961649|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25593631|NCT00961649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593632|NCT00961662|Tagatose|tagatose|mesh-list
25706285|NCT02212678|Antioxidants|antioxidants|mesh-ancestor
25593633|NCT00961662|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25593634|NCT00961662|Chelating Agents|chelating agents|mesh-ancestor
25593635|NCT00961662|Sequestering Agents|sequestering agents|mesh-ancestor
25593636|NCT00961662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593637|NCT00961961|Lithium Carbonate|lithium carbonate|mesh-list
25593638|NCT00961961|Fluoxetine|fluoxetine|mesh-list
25593639|NCT00961961|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25593640|NCT00961961|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25593641|NCT00961961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25593642|NCT00961961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593643|NCT00961961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25593644|NCT00961961|Serotonin Agents|serotonin agents|mesh-ancestor
25593645|NCT00961961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593646|NCT00961961|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25593647|NCT00961961|Antidepressive Agents|antidepressive agents|mesh-ancestor
25593648|NCT00961961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25593649|NCT00961961|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25593650|NCT00961961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25593651|NCT00961961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593652|NCT00961961|Antimanic Agents|antimanic agents|mesh-ancestor
25593653|NCT00961961|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25593654|NCT00961961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25593655|NCT00962039|Citalopram|citalopram|mesh-list
25593656|NCT00962039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25593657|NCT00962039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25593658|NCT00962039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25593659|NCT00962039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593660|NCT00962039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25593661|NCT00962039|Serotonin Agents|serotonin agents|mesh-ancestor
25593662|NCT00962039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912107|NCT04280874|Oxytocics|oxytocics|mesh-ancestor
25593663|NCT00962039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25593664|NCT00962039|Antidepressive Agents|antidepressive agents|mesh-ancestor
25593665|NCT00962039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25593666|NCT00962065|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25593667|NCT00962065|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25593668|NCT00962065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593669|NCT00962065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25593670|NCT00962065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593671|NCT00962104|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25593672|NCT00962104|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25593673|NCT00962104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25593674|NCT00962104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25593675|NCT00962104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593676|NCT00962104|Adrenergic Agents|adrenergic agents|mesh-ancestor
25593677|NCT00962104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25593678|NCT00962104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593679|NCT00962390|Equol|equol|mesh-list
25593680|NCT00962390|Phytoestrogens|phytoestrogens|mesh-ancestor
25593681|NCT00962390|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25593682|NCT00962390|Estrogens|estrogens|mesh-ancestor
25593683|NCT00962390|Hormones|hormones|mesh-ancestor
25593684|NCT00962390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25593685|NCT00962390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593686|NCT00962585|Equol|equol|mesh-list
25593687|NCT00962585|Phytoestrogens|phytoestrogens|mesh-ancestor
25593688|NCT00962585|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25593689|NCT00962585|Estrogens|estrogens|mesh-ancestor
25593690|NCT00962585|Hormones|hormones|mesh-ancestor
25593691|NCT00962585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25593692|NCT00962585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593693|NCT00962741|Etanercept|etanercept|mesh-list
25593694|NCT00962741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25593695|NCT00962741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25593696|NCT00962741|Analgesics|analgesics|mesh-ancestor
25593697|NCT00962741|Sensory System Agents|sensory system agents|mesh-ancestor
25593698|NCT00962741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25593699|NCT00962741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593700|NCT00962741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25593701|NCT00962741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25593702|NCT00962741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25593703|NCT00962741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25593704|NCT00962741|Immunologic Factors|immunologic factors|mesh-ancestor
25593705|NCT00962780|Vaccines|vaccines|mesh-list
25593706|NCT00962780|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25593707|NCT00962780|Immunologic Factors|immunologic factors|mesh-ancestor
25593708|NCT00962780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593709|NCT00962871|Tenofovir|tenofovir|mesh-list
25593710|NCT00962871|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25593711|NCT00962871|Antiviral Agents|antiviral agents|mesh-ancestor
25593712|NCT00962871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25653571|NCT01538745|Analgesics|analgesics|mesh-ancestor
25488272|NCT00195039|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25593713|NCT00962871|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25593714|NCT00962871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25593715|NCT00962871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593716|NCT00962871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593717|NCT00962871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25593718|NCT00962871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25593719|NCT00962949|Angiotensin II|angiotensin ii|mesh-list
25593720|NCT00962949|Giapreza|giapreza|mesh-list
25593721|NCT00962949|Angiotensinogen|angiotensinogen|mesh-list
25593722|NCT00962949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25593723|NCT00962949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25593724|NCT00962949|Protease Inhibitors|protease inhibitors|mesh-ancestor
25593725|NCT00962949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24797209|NCT01954368|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25593726|NCT00962949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593727|NCT00963105|Lenalidomide|lenalidomide|mesh-list
25593728|NCT00963105|Immunologic Factors|immunologic factors|mesh-ancestor
25593729|NCT00963105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593730|NCT00963105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25593731|NCT00963105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25593732|NCT00963105|Growth Substances|growth substances|mesh-ancestor
25593733|NCT00963105|Growth Inhibitors|growth inhibitors|mesh-ancestor
25593734|NCT00963105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25593735|NCT00963235|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25593736|NCT00963235|Immunologic Factors|immunologic factors|mesh-ancestor
25593737|NCT00963235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593738|NCT00963508|Permethrin|permethrin|mesh-list
25593739|NCT00963508|Malathion|malathion|mesh-list
25593740|NCT00963508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593741|NCT00963508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593742|NCT00963508|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25593743|NCT00963508|Cholinergic Agents|cholinergic agents|mesh-ancestor
25593744|NCT00963508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25593745|NCT00963508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593746|NCT00963547|Trastuzumab|trastuzumab|mesh-list
25593747|NCT00963547|Lapatinib|lapatinib|mesh-list
25593748|NCT00963547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25593749|NCT00963547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25593750|NCT00963547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25593751|NCT00963547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593752|NCT00963547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593753|NCT00963807|Deoxyglucose|deoxyglucose|mesh-list
25593754|NCT00963807|Alovudine|alovudine|mesh-list
25593755|NCT00963807|Dideoxynucleosides|dideoxynucleosides|mesh-list
25593756|NCT00963807|Cisplatin|cisplatin|mesh-list
25593757|NCT00963807|Docetaxel|docetaxel|mesh-list
25593758|NCT00963807|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25593759|NCT00963807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25593760|NCT00963807|Tubulin Modulators|tubulin modulators|mesh-ancestor
25593761|NCT00963807|Antimitotic Agents|antimitotic agents|mesh-ancestor
25593762|NCT00963807|Mitosis Modulators|mitosis modulators|mesh-ancestor
25593763|NCT00963807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593764|NCT00963807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25593765|NCT00963807|Antimetabolites|antimetabolites|mesh-ancestor
25593766|NCT00963807|Antiviral Agents|antiviral agents|mesh-ancestor
25593767|NCT00963807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25593768|NCT00963807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25593769|NCT00963807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25593770|NCT00963807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593771|NCT00963820|Ixazomib|ixazomib|mesh-list
25593772|NCT00963820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593773|NCT00963820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25593774|NCT00963820|Protease Inhibitors|protease inhibitors|mesh-ancestor
25593775|NCT00963820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593776|NCT00963872|Cyclophosphamide|cyclophosphamide|mesh-list
25593777|NCT00963872|Fludarabine|fludarabine|mesh-list
25593778|NCT00963872|Fludarabine phosphate|fludarabine phosphate|mesh-list
25593779|NCT00963872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25593780|NCT00963872|Immunologic Factors|immunologic factors|mesh-ancestor
25593781|NCT00963872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593782|NCT00963872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25593783|NCT00963872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25593784|NCT00963872|Alkylating Agents|alkylating agents|mesh-ancestor
25593785|NCT00963872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593786|NCT00963872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656982|NCT01581710|Hormone Antagonists|hormone antagonists|mesh-ancestor
25488347|NCT00195429|Antifungal Agents|antifungal agents|mesh-ancestor
25593787|NCT00963872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25593788|NCT00963872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25593789|NCT00963872|Antimetabolites|antimetabolites|mesh-ancestor
25593790|NCT00963924|Cycloserine|cycloserine|mesh-list
25593791|NCT00963924|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25593792|NCT00963924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25593793|NCT00963924|Renal Agents|renal agents|mesh-ancestor
25593794|NCT00963924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25593795|NCT00963924|Antitubercular Agents|antitubercular agents|mesh-ancestor
25593796|NCT00963924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25593797|NCT00963924|Antimetabolites|antimetabolites|mesh-ancestor
25593798|NCT00963924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593799|NCT00963937|Sumatriptan|sumatriptan|mesh-list
25593800|NCT00963937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25593801|NCT00963937|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25593802|NCT00963937|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25593803|NCT00963937|Serotonin Agents|serotonin agents|mesh-ancestor
25593804|NCT00963937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25593805|NCT00963937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593806|NCT00963937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593807|NCT00964223|Clindamycin|clindamycin|mesh-list
25593808|NCT00964223|Clindamycin palmitate|clindamycin palmitate|mesh-list
25593809|NCT00964223|Clindamycin phosphate|clindamycin phosphate|mesh-list
25593810|NCT00964223|Adapalene|adapalene|mesh-list
24913687|NCT04262193|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25593811|NCT00964223|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
25593812|NCT00964223|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25593813|NCT00964223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25593814|NCT00964223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25593815|NCT00964223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25593816|NCT00964223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593817|NCT00964223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593818|NCT00964223|Dermatologic Agents|dermatologic agents|mesh-ancestor
25593819|NCT00964223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25593820|NCT00964223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25593821|NCT00964223|Analgesics|analgesics|mesh-ancestor
25593822|NCT00964223|Sensory System Agents|sensory system agents|mesh-ancestor
25593823|NCT00964223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25593824|NCT00964223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593825|NCT00964223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25593826|NCT00964223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25593827|NCT00964353|Warfarin|warfarin|mesh-list
25593828|NCT00964353|Anticoagulants|anticoagulants|mesh-ancestor
25593829|NCT00964366|Clindamycin|clindamycin|mesh-list
25593830|NCT00964366|Clindamycin palmitate|clindamycin palmitate|mesh-list
25593831|NCT00964366|Clindamycin phosphate|clindamycin phosphate|mesh-list
25593832|NCT00964366|Dapsone|dapsone|mesh-list
25593833|NCT00964366|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25593834|NCT00964366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25593835|NCT00964366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25593836|NCT00964366|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25593837|NCT00964366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593838|NCT00964366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593839|NCT00964366|Dermatologic Agents|dermatologic agents|mesh-ancestor
25593840|NCT00964366|Antimalarials|antimalarials|mesh-ancestor
24913890|NCT04260269|Antiviral Agents|antiviral agents|mesh-ancestor
25593841|NCT00964366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25593842|NCT00964366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25593843|NCT00964366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25593844|NCT00964366|Leprostatic Agents|leprostatic agents|mesh-ancestor
25593845|NCT00964431|Celecoxib|celecoxib|mesh-list
25593846|NCT00964431|Indomethacin|indomethacin|mesh-list
25593847|NCT00964431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25593848|NCT00964431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25593849|NCT00964431|Analgesics|analgesics|mesh-ancestor
25593850|NCT00964431|Sensory System Agents|sensory system agents|mesh-ancestor
25593851|NCT00964431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25593852|NCT00964431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593853|NCT00964431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25593854|NCT00964431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25593855|NCT00964431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25593856|NCT00964431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25593857|NCT00964431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593858|NCT00964431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593859|NCT00964431|Gout Suppressants|gout suppressants|mesh-ancestor
25593860|NCT00964431|Tocolytic Agents|tocolytic agents|mesh-ancestor
25593861|NCT00964431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25593863|NCT00964496|Ferrous succinate|ferrous succinate|mesh-list
25593864|NCT00964496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25593865|NCT00964496|Immunologic Factors|immunologic factors|mesh-ancestor
25593866|NCT00964496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593867|NCT00964496|Leprostatic Agents|leprostatic agents|mesh-ancestor
25593868|NCT00964496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25593869|NCT00964496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25593870|NCT00964496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25593871|NCT00964496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25593872|NCT00964496|Growth Substances|growth substances|mesh-ancestor
25593873|NCT00964496|Growth Inhibitors|growth inhibitors|mesh-ancestor
25593874|NCT00964496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25593875|NCT00964496|Hematinics|hematinics|mesh-ancestor
25593876|NCT00964548|Dantrolene|dantrolene|mesh-list
25593877|NCT00964548|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25593878|NCT00964548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593879|NCT00964548|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25593880|NCT00964548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25593881|NCT00964678|Carvedilol|carvedilol|mesh-list
25593882|NCT00964678|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25593883|NCT00964678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25593884|NCT00964678|Adrenergic Agents|adrenergic agents|mesh-ancestor
25593885|NCT00964678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25593886|NCT00964678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593887|NCT00964678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593888|NCT00964678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25593889|NCT00964678|Antioxidants|antioxidants|mesh-ancestor
25593890|NCT00964678|Protective Agents|protective agents|mesh-ancestor
25593891|NCT00964678|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25593892|NCT00964678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25593893|NCT00964678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25593894|NCT00964678|Vasodilator Agents|vasodilator agents|mesh-ancestor
25593895|NCT00964678|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25593896|NCT00964678|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25593897|NCT00964743|Cytarabine|cytarabine|mesh-list
25593898|NCT00964743|Sorafenib|sorafenib|mesh-list
25593899|NCT00964743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25593900|NCT00964743|Antimetabolites|antimetabolites|mesh-ancestor
25593901|NCT00964743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593902|NCT00964743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25593903|NCT00964743|Antiviral Agents|antiviral agents|mesh-ancestor
25593904|NCT00964743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25593905|NCT00964743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25593906|NCT00964743|Immunologic Factors|immunologic factors|mesh-ancestor
25593907|NCT00964743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593908|NCT00964743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25593909|NCT00964743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593910|NCT00964782|Sildenafil Citrate|sildenafil citrate|mesh-list
25593911|NCT00964782|Vasodilator Agents|vasodilator agents|mesh-ancestor
25593912|NCT00964782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25593913|NCT00964782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25593914|NCT00964782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593915|NCT00964782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533443|NCT00644020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24533444|NCT00644020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533446|NCT00644033|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24991029|NCT03082729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25593916|NCT00964782|Urological Agents|urological agents|mesh-ancestor
25593917|NCT00964795|Aflibercept|aflibercept|mesh-list
25593918|NCT00964795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25593919|NCT00964795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25593920|NCT00964795|Growth Substances|growth substances|mesh-ancestor
25593921|NCT00964795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593922|NCT00964795|Growth Inhibitors|growth inhibitors|mesh-ancestor
25593923|NCT00964795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25593924|NCT00964886|Benztropine|benztropine|mesh-list
25593925|NCT00964886|Desipramine|desipramine|mesh-list
25593926|NCT00964886|Clomipramine|clomipramine|mesh-list
25593927|NCT00964886|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25593928|NCT00964886|Antidepressive Agents|antidepressive agents|mesh-ancestor
25593929|NCT00964886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25593930|NCT00964886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593931|NCT00964886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593932|NCT00964886|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25593933|NCT00964886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25593934|NCT00964886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25593935|NCT00964886|Adrenergic Agents|adrenergic agents|mesh-ancestor
25593936|NCT00964886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25593937|NCT00964886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593938|NCT00964886|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25593939|NCT00964886|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25593940|NCT00964886|Parasympatholytics|parasympatholytics|mesh-ancestor
25593941|NCT00964886|Autonomic Agents|autonomic agents|mesh-ancestor
25593942|NCT00964886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25593943|NCT00964886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24914349|NCT04255498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24991159|NCT02417142|Exenatide|exenatide|mesh-list
25593944|NCT00964886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25593945|NCT00964886|Cholinergic Agents|cholinergic agents|mesh-ancestor
25593946|NCT00964886|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25593947|NCT00964886|Dopamine Agents|dopamine agents|mesh-ancestor
25593948|NCT00964886|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25593949|NCT00964886|Serotonin Agents|serotonin agents|mesh-ancestor
25593950|NCT00965081|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25593951|NCT00965081|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25593952|NCT00965081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25593953|NCT00965081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25593954|NCT00965081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593955|NCT00965081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25593956|NCT00965081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593958|NCT00965081|Sensory System Agents|sensory system agents|mesh-ancestor
25593959|NCT00965081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25593960|NCT00965081|Antidepressive Agents|antidepressive agents|mesh-ancestor
25593961|NCT00965081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25593962|NCT00965081|Dopamine Agents|dopamine agents|mesh-ancestor
25593963|NCT00965094|Mycophenolic Acid|mycophenolic acid|mesh-list
25593964|NCT00965094|Everolimus|everolimus|mesh-list
25593965|NCT00965094|Tacrolimus|tacrolimus|mesh-list
25593966|NCT00965094|Basiliximab|basiliximab|mesh-list
25593967|NCT00965094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25593968|NCT00965094|Immunologic Factors|immunologic factors|mesh-ancestor
25593969|NCT00965094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593970|NCT00965094|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25593971|NCT00965094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593972|NCT00965094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593973|NCT00965094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25593974|NCT00965094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25593975|NCT00965094|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25593976|NCT00965094|Antitubercular Agents|antitubercular agents|mesh-ancestor
25593977|NCT00965094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25593978|NCT00965094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25593979|NCT00965185|Atorvastatin|atorvastatin|mesh-list
25593980|NCT00965185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25593981|NCT00965185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25593982|NCT00965185|Antimetabolites|antimetabolites|mesh-ancestor
25593983|NCT00965185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593984|NCT00965185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25593985|NCT00965185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25593986|NCT00965185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25593987|NCT00965263|Cocaine|cocaine|mesh-list
25593988|NCT00965263|Anesthetics, Local|anesthetics, local|mesh-ancestor
25593989|NCT00965263|Anesthetics|anesthetics|mesh-ancestor
25593990|NCT00965263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25593991|NCT00965263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25593992|NCT00965263|Sensory System Agents|sensory system agents|mesh-ancestor
25593993|NCT00965263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24916354|NCT04241744|Vancomycin|vancomycin|mesh-list
24991337|NCT05195086|Antitubercular Agents|antitubercular agents|mesh-ancestor
24991338|NCT05195086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24991339|NCT05195086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24991340|NCT05195086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991342|NCT05194904|Dexmedetomidine|dexmedetomidine|mesh-list
24991360|NCT05194904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991361|NCT05194852|Anesthetics|anesthetics|mesh-list
24449704|NCT00316745|Leucovorin|leucovorin|mesh-list
25593994|NCT00965263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25593995|NCT00965263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25593996|NCT00965263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25593997|NCT00965263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25593998|NCT00965263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25593999|NCT00965263|Dopamine Agents|dopamine agents|mesh-ancestor
25594000|NCT00965263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25594001|NCT00965341|Methyltestosterone|methyltestosterone|mesh-list
25594002|NCT00965341|Testosterone|testosterone|mesh-list
25594003|NCT00965341|Testosterone undecanoate|testosterone undecanoate|mesh-list
25594004|NCT00965341|Testosterone enanthate|testosterone enanthate|mesh-list
25594005|NCT00965341|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25594006|NCT00965341|Androgens|androgens|mesh-ancestor
25594007|NCT00965341|Hormones|hormones|mesh-ancestor
25594008|NCT00965341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25706408|NCT02214628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916360|NCT04241601|Aldesleukin|aldesleukin|mesh-list
25107447|NCT03139708|Mydriatics|mydriatics|mesh-ancestor
25107448|NCT03139708|Autonomic Agents|autonomic agents|mesh-ancestor
25107449|NCT03139708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25107450|NCT03139708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107451|NCT03139708|Sympathomimetics|sympathomimetics|mesh-ancestor
25107452|NCT03139708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25107476|NCT03140033|Oxytocics|oxytocics|mesh-ancestor
25594009|NCT00965341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594010|NCT00965341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25594011|NCT00965341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594012|NCT00965341|Anabolic Agents|anabolic agents|mesh-ancestor
25653572|NCT01538745|Sensory System Agents|sensory system agents|mesh-ancestor
25653573|NCT01538745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653574|NCT01538745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653575|NCT01538745|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25653576|NCT01538745|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25653577|NCT01538745|Anesthetics, General|anesthetics, general|mesh-ancestor
25653578|NCT01538745|Anesthetics|anesthetics|mesh-ancestor
25653579|NCT01538745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25653580|NCT01538745|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25653581|NCT01538745|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25653582|NCT01538745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24916967|NCT04235270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916968|NCT04235270|Urological Agents|urological agents|mesh-ancestor
24916969|NCT04235270|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
24916970|NCT04235270|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24916971|NCT04235270|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
24520591|NCT05336825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520592|NCT05336825|Sensory System Agents|sensory system agents|mesh-ancestor
24616256|NCT01035320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24616257|NCT01035320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107496|NCT03139487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107497|NCT03139487|Anticoagulants|anticoagulants|mesh-ancestor
25107505|NCT03139253|Tinidazole|tinidazole|mesh-list
25653583|NCT01538745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653584|NCT01538745|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25653585|NCT01538745|Narcotics|narcotics|mesh-ancestor
25653586|NCT01538862|Lenograstim|lenograstim|mesh-list
25653587|NCT01538862|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25653588|NCT01538862|Immunologic Factors|immunologic factors|mesh-ancestor
25653589|NCT01538862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653590|NCT01539083|Thalidomide|thalidomide|mesh-list
25653591|NCT01539083|Dexamethasone|dexamethasone|mesh-list
25653592|NCT01539083|Prednisolone|prednisolone|mesh-list
25653593|NCT01539083|Cyclophosphamide|cyclophosphamide|mesh-list
25653594|NCT01539083|Bortezomib|bortezomib|mesh-list
25653595|NCT01539083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25653596|NCT01539083|Immunologic Factors|immunologic factors|mesh-ancestor
24917497|NCT04229264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653597|NCT01539083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653598|NCT01539083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25653599|NCT01539083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25653600|NCT01539083|Alkylating Agents|alkylating agents|mesh-ancestor
25653601|NCT01539083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653602|NCT01539083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25653603|NCT01539083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25653604|NCT01539083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25653605|NCT01539083|Antiemetics|antiemetics|mesh-ancestor
25653606|NCT01539083|Autonomic Agents|autonomic agents|mesh-ancestor
25653607|NCT01539083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653608|NCT01539083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25653609|NCT01539083|Glucocorticoids|glucocorticoids|mesh-ancestor
25653610|NCT01539083|Hormones|hormones|mesh-ancestor
25653611|NCT01539083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25653612|NCT01539083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25653613|NCT01539083|Leprostatic Agents|leprostatic agents|mesh-ancestor
25653614|NCT01539083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25653615|NCT01539083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25653616|NCT01539083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25653617|NCT01539083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25653618|NCT01539083|Growth Substances|growth substances|mesh-ancestor
25653619|NCT01539083|Growth Inhibitors|growth inhibitors|mesh-ancestor
25653620|NCT01539135|Methylene Blue|methylene blue|mesh-list
25653621|NCT01539135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653622|NCT01539135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653623|NCT01539291|Idelalisib|idelalisib|mesh-list
25653624|NCT01539291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25653625|NCT01539291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653626|NCT01539291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653627|NCT01539317|Lidocaine|lidocaine|mesh-list
25653628|NCT01539317|Anesthetics, Local|anesthetics, local|mesh-ancestor
25653629|NCT01539317|Anesthetics|anesthetics|mesh-ancestor
25653630|NCT01539317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25653631|NCT01539317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653632|NCT01539317|Sensory System Agents|sensory system agents|mesh-ancestor
25653633|NCT01539317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653634|NCT01539317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25653635|NCT01539317|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24918065|NCT04223973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918128|NCT04223219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24918129|NCT04223219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24918132|NCT04223219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24865368|NCT03317795|Levonorgestrel|levonorgestrel|mesh-list
25653636|NCT01539317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25653637|NCT01539317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25653638|NCT01539317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653639|NCT01539512|Rituximab|rituximab|mesh-list
25653640|NCT01539512|Idelalisib|idelalisib|mesh-list
25488643|NCT00200967|Hormones|hormones|mesh-ancestor
25594013|NCT00965458|Alefacept|alefacept|mesh-list
25594014|NCT00965458|Dermatologic Agents|dermatologic agents|mesh-ancestor
25594015|NCT00965458|Immunologic Factors|immunologic factors|mesh-ancestor
25594016|NCT00965458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594017|NCT00965497|Citalopram|citalopram|mesh-list
25594018|NCT00965497|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25594019|NCT00965497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25594020|NCT00965497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25594021|NCT00965497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594022|NCT00965497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25594023|NCT00965497|Serotonin Agents|serotonin agents|mesh-ancestor
25594024|NCT00965497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594025|NCT00965497|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25594026|NCT00965497|Antidepressive Agents|antidepressive agents|mesh-ancestor
25594027|NCT00965497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25594028|NCT00965562|Fluoxetine|fluoxetine|mesh-list
24520975|NCT05210764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24520997|NCT05210374|Copper|copper|mesh-list
24797360|NCT01955200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24797361|NCT01955200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24797362|NCT01955200|Purinergic Agents|purinergic agents|mesh-ancestor
24797363|NCT01955200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24797364|NCT01955200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797365|NCT01955200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797366|NCT01955200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24797367|NCT01955200|Autonomic Agents|autonomic agents|mesh-ancestor
25107519|NCT03139253|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25594029|NCT00965562|Calcium|calcium|mesh-list
25594030|NCT00965562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25594031|NCT00965562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594032|NCT00965562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25594033|NCT00965562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25594034|NCT00965562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25594035|NCT00965562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594036|NCT00965562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25594037|NCT00965562|Serotonin Agents|serotonin agents|mesh-ancestor
25594038|NCT00965562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25594039|NCT00965562|Antidepressive Agents|antidepressive agents|mesh-ancestor
25594040|NCT00965562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25594041|NCT00965562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25594042|NCT00965562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25594043|NCT00965562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25594044|NCT00965575|Melatonin|melatonin|mesh-list
25594045|NCT00965575|Antioxidants|antioxidants|mesh-ancestor
25594046|NCT00965575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594047|NCT00965575|Protective Agents|protective agents|mesh-ancestor
25594048|NCT00965575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594049|NCT00965575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25594050|NCT00965731|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25594051|NCT00965731|Crizotinib|crizotinib|mesh-list
25594052|NCT00965731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488676|NCT00201734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488677|NCT00201734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25488678|NCT00201734|Antimetabolites|antimetabolites|mesh-ancestor
25488679|NCT00201760|Gemcitabine|gemcitabine|mesh-list
25488680|NCT00201760|Cisplatin|cisplatin|mesh-list
25488681|NCT00201760|Trastuzumab|trastuzumab|mesh-list
25488682|NCT00201760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488683|NCT00201760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25488684|NCT00201760|Antimetabolites|antimetabolites|mesh-ancestor
25488685|NCT00201760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488686|NCT00201760|Antiviral Agents|antiviral agents|mesh-ancestor
25488687|NCT00201760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25488688|NCT00201760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25488689|NCT00201760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25488690|NCT00201760|Immunologic Factors|immunologic factors|mesh-ancestor
25488691|NCT00201760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594053|NCT00965731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25706444|NCT02215967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25706445|NCT02216071|Ciprofloxacin|ciprofloxacin|mesh-list
25706446|NCT02216071|Dexamethasone|dexamethasone|mesh-list
25594054|NCT00965731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25594055|NCT00965731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594056|NCT00965848|Doripenem|doripenem|mesh-list
25594057|NCT00965848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25594058|NCT00965848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25594059|NCT00966277|Dalteparin|dalteparin|mesh-list
25594060|NCT00966277|Tinzaparin|tinzaparin|mesh-list
25594061|NCT00966277|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25594062|NCT00966277|Anticoagulants|anticoagulants|mesh-ancestor
25594063|NCT00966277|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25594064|NCT00966277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25488692|NCT00201760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25594065|NCT00966277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594066|NCT00966355|Octreotide|octreotide|mesh-list
25594067|NCT00966355|Terlipressin|terlipressin|mesh-list
25594068|NCT00966355|Somatostatin|somatostatin|mesh-list
25594069|NCT00966355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25594070|NCT00966355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25594071|NCT00966355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594072|NCT00966355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25594073|NCT00966355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25594075|NCT00966355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25594076|NCT00966355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594077|NCT00966641|Naproxen|naproxen|mesh-list
25594078|NCT00966641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25594079|NCT00966641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25594080|NCT00966641|Analgesics|analgesics|mesh-ancestor
24521135|NCT05104554|Hematinics|hematinics|mesh-ancestor
24521136|NCT05104554|Vitamin B Complex|vitamin b complex|mesh-ancestor
25594081|NCT00966641|Sensory System Agents|sensory system agents|mesh-ancestor
25594082|NCT00966641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25594083|NCT00966641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594084|NCT00966641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25594085|NCT00966641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25594086|NCT00966641|Gout Suppressants|gout suppressants|mesh-ancestor
25594087|NCT00966641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25594088|NCT00966641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25594089|NCT00966641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594090|NCT00966693|Thalidomide|thalidomide|mesh-list
25594091|NCT00966693|Dexamethasone|dexamethasone|mesh-list
25594092|NCT00966693|Dexamethasone acetate|dexamethasone acetate|mesh-list
25594093|NCT00966693|Lenalidomide|lenalidomide|mesh-list
25594094|NCT00966693|Ichthammol|ichthammol|mesh-list
25594095|NCT00966693|BB 1101|bb 1101|mesh-list
25594096|NCT00966693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25594097|NCT00966693|Antiemetics|antiemetics|mesh-ancestor
25594098|NCT00966693|Autonomic Agents|autonomic agents|mesh-ancestor
25594099|NCT00966693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25594100|NCT00966693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594101|NCT00966693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25594102|NCT00966693|Glucocorticoids|glucocorticoids|mesh-ancestor
25594103|NCT00966693|Hormones|hormones|mesh-ancestor
25594104|NCT00966693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25594105|NCT00966693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25594106|NCT00966693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594107|NCT00966693|Immunologic Factors|immunologic factors|mesh-ancestor
25594108|NCT00966693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25594109|NCT00966693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25594110|NCT00966693|Growth Substances|growth substances|mesh-ancestor
25594111|NCT00966693|Growth Inhibitors|growth inhibitors|mesh-ancestor
25594112|NCT00966693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25594113|NCT00966693|Leprostatic Agents|leprostatic agents|mesh-ancestor
25594114|NCT00966693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25594115|NCT00966693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24919584|NCT04209920|Chromium|chromium|mesh-list
24919585|NCT04209920|Nickel|nickel|mesh-list
25594116|NCT00966693|Protease Inhibitors|protease inhibitors|mesh-ancestor
25594117|NCT00966693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25594118|NCT00966693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594119|NCT00966693|Dermatologic Agents|dermatologic agents|mesh-ancestor
25594120|NCT00966875|Ixekizumab|ixekizumab|mesh-list
25594121|NCT00966875|Dermatologic Agents|dermatologic agents|mesh-ancestor
25594122|NCT00966940|Travoprost|travoprost|mesh-list
25594123|NCT00966940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25594124|NCT00966940|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25594125|NCT00966940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25594126|NCT00967005|Acetylcysteine|acetylcysteine|mesh-list
25594127|NCT00967005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25594128|NCT00967005|Antiviral Agents|antiviral agents|mesh-ancestor
25594129|NCT00967005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25594130|NCT00967005|Expectorants|expectorants|mesh-ancestor
25594131|NCT00967005|Respiratory System Agents|respiratory system agents|mesh-ancestor
25594132|NCT00967005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25594133|NCT00967005|Antioxidants|antioxidants|mesh-ancestor
25594134|NCT00967005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594135|NCT00967005|Protective Agents|protective agents|mesh-ancestor
25594136|NCT00967005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594137|NCT00967005|Antidotes|antidotes|mesh-ancestor
25594138|NCT00967044|Everolimus|everolimus|mesh-list
25594139|NCT00967044|Panobinostat|panobinostat|mesh-list
25594140|NCT00967044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594141|NCT00967044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25594142|NCT00967044|Immunologic Factors|immunologic factors|mesh-ancestor
25594143|NCT00967044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594144|NCT00967044|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25594145|NCT00967044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25594146|NCT00967044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706473|NCT02216123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24991758|NCT05032950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24991759|NCT05032950|Antiviral Agents|antiviral agents|mesh-ancestor
24991760|NCT05032950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24991761|NCT05032950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24991762|NCT05032950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24991778|NCT05008276|Anticoagulants|anticoagulants|mesh-ancestor
24991781|NCT05005312|Ritonavir|ritonavir|mesh-list
25594147|NCT00967226|Prednisolone|prednisolone|mesh-list
25594148|NCT00967226|Propranolol|propranolol|mesh-list
25594149|NCT00967226|Prednisolone phosphate|prednisolone phosphate|mesh-list
25594150|NCT00967226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25594151|NCT00967226|Glucocorticoids|glucocorticoids|mesh-ancestor
25594152|NCT00967226|Hormones|hormones|mesh-ancestor
25594153|NCT00967226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25594154|NCT00967226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594155|NCT00967226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25594156|NCT00967226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594157|NCT00967226|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25594158|NCT00967226|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25594159|NCT00967226|Adrenergic Agents|adrenergic agents|mesh-ancestor
25594160|NCT00967226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25594161|NCT00967226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594162|NCT00967226|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25594163|NCT00967226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25594164|NCT00967226|Vasodilator Agents|vasodilator agents|mesh-ancestor
25594165|NCT00967330|Bevacizumab|bevacizumab|mesh-list
25594166|NCT00967330|Irinotecan|irinotecan|mesh-list
24920103|NCT04205201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25594167|NCT00967330|Temozolomide|temozolomide|mesh-list
25594168|NCT00967330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25594169|NCT00967330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594170|NCT00967330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25594171|NCT00967330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25594172|NCT00967330|Growth Substances|growth substances|mesh-ancestor
25594173|NCT00967330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594174|NCT00967330|Growth Inhibitors|growth inhibitors|mesh-ancestor
25594175|NCT00967330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25594176|NCT00967330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25594177|NCT00967330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25594178|NCT00967330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594179|NCT00967330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25594180|NCT00967330|Alkylating Agents|alkylating agents|mesh-ancestor
25594181|NCT00967369|Carboplatin|carboplatin|mesh-list
25594182|NCT00967369|Etoposide|etoposide|mesh-list
25594183|NCT00967369|Bortezomib|bortezomib|mesh-list
25594184|NCT00967369|Etoposide phosphate|etoposide phosphate|mesh-list
25594185|NCT00967369|Ifosfamide|ifosfamide|mesh-list
25594186|NCT00967369|Isophosphamide mustard|isophosphamide mustard|mesh-list
25594187|NCT00967369|Podophyllotoxin|podophyllotoxin|mesh-list
25594188|NCT00967369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594189|NCT00967369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25594190|NCT00967369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25594191|NCT00967369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25594192|NCT00967369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25594193|NCT00967369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594194|NCT00967369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25594195|NCT00967369|Alkylating Agents|alkylating agents|mesh-ancestor
25594196|NCT00967369|Keratolytic Agents|keratolytic agents|mesh-ancestor
25594197|NCT00967369|Dermatologic Agents|dermatologic agents|mesh-ancestor
25594198|NCT00967369|Tubulin Modulators|tubulin modulators|mesh-ancestor
25594199|NCT00967369|Antimitotic Agents|antimitotic agents|mesh-ancestor
25594200|NCT00967369|Mitosis Modulators|mitosis modulators|mesh-ancestor
25594201|NCT00967499|Ondansetron|ondansetron|mesh-list
24797414|NCT01955460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797420|NCT01955460|Sensory System Agents|sensory system agents|mesh-ancestor
24797421|NCT01955460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24797422|NCT01955460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24797423|NCT01955460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24797424|NCT01955460|Antiviral Agents|antiviral agents|mesh-ancestor
24797426|NCT01955512|Clopidogrel|clopidogrel|mesh-list
25594202|NCT00967499|Palonosetron|palonosetron|mesh-list
25594203|NCT00967499|Antiemetics|antiemetics|mesh-ancestor
25594204|NCT00967499|Autonomic Agents|autonomic agents|mesh-ancestor
25594205|NCT00967499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25594206|NCT00967499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594207|NCT00967499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25594208|NCT00967499|Antipruritics|antipruritics|mesh-ancestor
25594209|NCT00967499|Dermatologic Agents|dermatologic agents|mesh-ancestor
25594210|NCT00967499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25594211|NCT00967499|Serotonin Agents|serotonin agents|mesh-ancestor
25594212|NCT00967499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25594213|NCT00967499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594214|NCT00967499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25594215|NCT00967499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25594216|NCT00967499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25594217|NCT00967499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25594218|NCT00967499|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25594219|NCT00967499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25488786|NCT00202449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25594220|NCT00967551|Zinc|zinc|mesh-list
25594221|NCT00967551|Trace Elements|trace elements|mesh-list
25594222|NCT00967551|Micronutrients|micronutrients|mesh-list
25594223|NCT00967551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594224|NCT00967616|Leucovorin|leucovorin|mesh-list
25594225|NCT00967616|Fluorouracil|fluorouracil|mesh-list
25594226|NCT00967616|Irinotecan|irinotecan|mesh-list
25594227|NCT00967616|Efatutazone|efatutazone|mesh-list
25594228|NCT00967616|Levoleucovorin|levoleucovorin|mesh-list
25594229|NCT00967616|Antimetabolites|antimetabolites|mesh-ancestor
25594230|NCT00967616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594231|NCT00967616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25594232|NCT00967616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594233|NCT00967616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25594234|NCT00967616|Immunologic Factors|immunologic factors|mesh-ancestor
25594235|NCT00967616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594236|NCT00967616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25594237|NCT00967616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25594238|NCT00967616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25594239|NCT00967616|Antidotes|antidotes|mesh-ancestor
25594240|NCT00967616|Protective Agents|protective agents|mesh-ancestor
24920724|NCT04198727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920725|NCT04198727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24920726|NCT04198571|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
25594241|NCT00967616|Vitamin B Complex|vitamin b complex|mesh-ancestor
25594242|NCT00967616|Vitamins|vitamins|mesh-ancestor
25594243|NCT00967616|Micronutrients|micronutrients|mesh-ancestor
25594244|NCT00967694|Nitrous Oxide|nitrous oxide|mesh-list
25594245|NCT00967694|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25594246|NCT00967694|Anesthetics, General|anesthetics, general|mesh-ancestor
25594247|NCT00967694|Anesthetics|anesthetics|mesh-ancestor
25594248|NCT00967694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25594249|NCT00967694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594250|NCT00967694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25594251|NCT00967694|Analgesics|analgesics|mesh-ancestor
25594252|NCT00967694|Sensory System Agents|sensory system agents|mesh-ancestor
25594253|NCT00967694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25594254|NCT00967798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25594255|NCT00967798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25594256|NCT00967798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594257|NCT00967798|Incretins|incretins|mesh-ancestor
25594258|NCT00967798|Hormones|hormones|mesh-ancestor
25594259|NCT00967798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25594260|NCT00967798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25594261|NCT00967798|Protease Inhibitors|protease inhibitors|mesh-ancestor
25594262|NCT00967798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25594263|NCT00967798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594264|NCT00968071|Decitabine|decitabine|mesh-list
25594265|NCT00968071|Gemtuzumab|gemtuzumab|mesh-list
25594266|NCT00968071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25594267|NCT00968071|Antimetabolites|antimetabolites|mesh-ancestor
25594268|NCT00968071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594269|NCT00968071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594270|NCT00968071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25594271|NCT00968071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25594272|NCT00968253|Cytarabine|cytarabine|mesh-list
25594273|NCT00968253|Dexamethasone|dexamethasone|mesh-list
25594274|NCT00968253|Methylprednisolone|methylprednisolone|mesh-list
25594275|NCT00968253|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25594276|NCT00968253|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25594277|NCT00968253|Prednisolone|prednisolone|mesh-list
24522564|NCT03651011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24522565|NCT03651011|Growth Substances|growth substances|mesh-ancestor
25706489|NCT02216422|Ritonavir|ritonavir|mesh-list
25706490|NCT02216422|Ribavirin|ribavirin|mesh-list
25706491|NCT02216422|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24785534|NCT01914965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24785535|NCT01914965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24785540|NCT01914965|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24785541|NCT01914965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25107537|NCT03139591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25107539|NCT03139591|Anesthetics, Local|anesthetics, local|mesh-ancestor
25107540|NCT03139591|Anesthetics|anesthetics|mesh-ancestor
25107541|NCT03139591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25107550|NCT03139409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25594278|NCT00968253|Prednisolone acetate|prednisolone acetate|mesh-list
25594279|NCT00968253|Cyclophosphamide|cyclophosphamide|mesh-list
25594280|NCT00968253|Doxorubicin|doxorubicin|mesh-list
25594281|NCT00968253|Methotrexate|methotrexate|mesh-list
25594282|NCT00968253|Vincristine|vincristine|mesh-list
25594283|NCT00968253|Everolimus|everolimus|mesh-list
25594284|NCT00968253|Lenograstim|lenograstim|mesh-list
25594285|NCT00968253|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25594286|NCT00968253|Prednisolone phosphate|prednisolone phosphate|mesh-list
25594287|NCT00968253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25594288|NCT00968253|Immunologic Factors|immunologic factors|mesh-ancestor
25594289|NCT00968253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594290|NCT00968253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25594291|NCT00968253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25594292|NCT00968253|Alkylating Agents|alkylating agents|mesh-ancestor
25488856|NCT00203229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25594293|NCT00968253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594294|NCT00968253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594295|NCT00968253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25594296|NCT00968253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25594297|NCT00968253|Antiemetics|antiemetics|mesh-ancestor
25594298|NCT00968253|Autonomic Agents|autonomic agents|mesh-ancestor
25594299|NCT00968253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25594300|NCT00968253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25594301|NCT00968253|Glucocorticoids|glucocorticoids|mesh-ancestor
25594302|NCT00968253|Hormones|hormones|mesh-ancestor
25594303|NCT00968253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25594304|NCT00968253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25594305|NCT00968253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25594306|NCT00968253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25594307|NCT00968253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25594308|NCT00968253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25594309|NCT00968253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25594310|NCT00968253|Abortifacient Agents|abortifacient agents|mesh-ancestor
25594311|NCT00968253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25594312|NCT00968253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25594313|NCT00968253|Antimetabolites|antimetabolites|mesh-ancestor
25594314|NCT00968253|Dermatologic Agents|dermatologic agents|mesh-ancestor
25594315|NCT00968253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25594316|NCT00968253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25594317|NCT00968253|Antiviral Agents|antiviral agents|mesh-ancestor
25594318|NCT00968253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25594319|NCT00968253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25594320|NCT00968253|Tubulin Modulators|tubulin modulators|mesh-ancestor
25594321|NCT00968253|Antimitotic Agents|antimitotic agents|mesh-ancestor
25594322|NCT00968253|Mitosis Modulators|mitosis modulators|mesh-ancestor
25594323|NCT00968253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25594324|NCT00968253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25594325|NCT00968253|Protective Agents|protective agents|mesh-ancestor
25594326|NCT00968539|Vaccines|vaccines|mesh-list
25594327|NCT00968539|Immunologic Factors|immunologic factors|mesh-ancestor
25594328|NCT00968539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107554|NCT03139422|Calcium|calcium|mesh-list
25107555|NCT03139422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25107556|NCT03139422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107557|NCT03139422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25107560|NCT03139422|Hemostatics|hemostatics|mesh-ancestor
25594329|NCT00968617|Darbepoetin alfa|darbepoetin alfa|mesh-list
25594330|NCT00968617|Hematinics|hematinics|mesh-ancestor
25594331|NCT00968708|Alogliptin|alogliptin|mesh-list
25594332|NCT00968708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25594333|NCT00968708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594334|NCT00968708|Incretins|incretins|mesh-ancestor
25594335|NCT00968708|Hormones|hormones|mesh-ancestor
25594336|NCT00968708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25594337|NCT00968708|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25594338|NCT00968708|Protease Inhibitors|protease inhibitors|mesh-ancestor
25594339|NCT00968708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25594340|NCT00968708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594341|NCT00968799|Cisplatin|cisplatin|mesh-list
25594342|NCT00968799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594343|NCT00968812|Metformin|metformin|mesh-list
25594344|NCT00968812|Glimepiride|glimepiride|mesh-list
25594345|NCT00968812|Canagliflozin|canagliflozin|mesh-list
25594346|NCT00968812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25594347|NCT00968812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594348|NCT00968812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25594349|NCT00968812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24921603|NCT04189666|Rivastigmine|rivastigmine|mesh-list
24921609|NCT04189666|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24921615|NCT04189198|Carticaine|carticaine|mesh-list
25594350|NCT00968812|Immunologic Factors|immunologic factors|mesh-ancestor
25594351|NCT00968812|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25594352|NCT00968812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594353|NCT00968890|Vaccines|vaccines|mesh-list
25594354|NCT00968890|Immunologic Factors|immunologic factors|mesh-ancestor
25594355|NCT00968890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594356|NCT00968968|Trastuzumab|trastuzumab|mesh-list
25594357|NCT00968968|Lapatinib|lapatinib|mesh-list
25594358|NCT00968968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25594359|NCT00968968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594360|NCT00968968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25594361|NCT00968968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25594362|NCT00968968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594363|NCT00969150|Milnacipran|milnacipran|mesh-list
25594364|NCT00969150|Levomilnacipran|levomilnacipran|mesh-list
25594365|NCT00969150|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25594366|NCT00969150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25594367|NCT00969150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25594368|NCT00969150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594369|NCT00969150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25594370|NCT00969150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594371|NCT00969150|Antidepressive Agents|antidepressive agents|mesh-ancestor
25594372|NCT00969150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25594373|NCT00969150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25594374|NCT00969150|Analgesics|analgesics|mesh-ancestor
25594375|NCT00969150|Sensory System Agents|sensory system agents|mesh-ancestor
25594376|NCT00969150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25594377|NCT00969618|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25594378|NCT00969618|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25594379|NCT00969618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25594380|NCT00969618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25594381|NCT00969618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594382|NCT00969618|Adrenergic Agents|adrenergic agents|mesh-ancestor
25594383|NCT00969618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25594384|NCT00969618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594385|NCT00969709|Milnacipran|milnacipran|mesh-list
25594386|NCT00969709|Levomilnacipran|levomilnacipran|mesh-list
25594387|NCT00969709|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25594388|NCT00969709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25594389|NCT00969709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24921825|NCT04186559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24921826|NCT04186559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921827|NCT04186559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921828|NCT04186559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24921839|NCT04186897|Dermatologic Agents|dermatologic agents|mesh-ancestor
24921840|NCT04186299|Clonidine|clonidine|mesh-list
24921842|NCT04186299|Carticaine|carticaine|mesh-list
24921901|NCT04185649|Antimetabolites|antimetabolites|mesh-ancestor
24991925|NCT04731233|Mitosis Modulators|mitosis modulators|mesh-ancestor
24991926|NCT04726475|Cannabidiol|cannabidiol|mesh-list
25594390|NCT00969709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594391|NCT00969709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25594392|NCT00969709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594393|NCT00969709|Antidepressive Agents|antidepressive agents|mesh-ancestor
25594394|NCT00969709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25594395|NCT00969709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25594396|NCT00969709|Analgesics|analgesics|mesh-ancestor
25594397|NCT00969709|Sensory System Agents|sensory system agents|mesh-ancestor
25594398|NCT00969709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25594399|NCT00969878|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25594400|NCT00969878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25594401|NCT00969878|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25594402|NCT00969878|Immunologic Factors|immunologic factors|mesh-ancestor
25594403|NCT00969878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922367|NCT04181489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25594405|NCT00969878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594406|NCT00969878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25594407|NCT00970073|Mycophenolic Acid|mycophenolic acid|mesh-list
25594408|NCT00970073|Tacrolimus|tacrolimus|mesh-list
25594409|NCT00970073|Thymoglobulin|thymoglobulin|mesh-list
25594410|NCT00970073|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25594411|NCT00970073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25594412|NCT00970073|Immunologic Factors|immunologic factors|mesh-ancestor
25594413|NCT00970073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594414|NCT00970073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25594415|NCT00970073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25594416|NCT00970073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594417|NCT00970073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25594418|NCT00970073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594419|NCT00970073|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25594420|NCT00970073|Antitubercular Agents|antitubercular agents|mesh-ancestor
25594421|NCT00970073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25594422|NCT00970073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25594423|NCT00970203|Vaccines|vaccines|mesh-list
25594424|NCT00970203|Androgens|androgens|mesh-list
25594425|NCT00970203|Immunologic Factors|immunologic factors|mesh-ancestor
25594426|NCT00970203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594427|NCT00970203|Hormones|hormones|mesh-ancestor
25594428|NCT00970203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25594429|NCT00970216|Telbivudine|telbivudine|mesh-list
25594430|NCT00970216|Antiviral Agents|antiviral agents|mesh-ancestor
25594431|NCT00970216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25594432|NCT00970216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25594433|NCT00970216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25594434|NCT00970216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594435|NCT00970268|Bromides|bromides|mesh-list
25594436|NCT00970268|Anticonvulsants|anticonvulsants|mesh-ancestor
25594437|NCT00970281|Olanzapine|olanzapine|mesh-list
25594438|NCT00970281|Antiemetics|antiemetics|mesh-ancestor
25594439|NCT00970281|Autonomic Agents|autonomic agents|mesh-ancestor
25594440|NCT00970281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25594441|NCT00970281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594442|NCT00970281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25594443|NCT00970281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25594444|NCT00970281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25594445|NCT00970281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25594446|NCT00970281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25594447|NCT00970281|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25594448|NCT00970281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25594449|NCT00970281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25594450|NCT00970281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594451|NCT00970281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25594452|NCT00970281|Serotonin Agents|serotonin agents|mesh-ancestor
25594453|NCT00970307|Vaccines|vaccines|mesh-list
25594454|NCT00970307|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25594455|NCT00970307|Immunologic Factors|immunologic factors|mesh-ancestor
25594456|NCT00970307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594457|NCT00970502|Celecoxib|celecoxib|mesh-list
25594458|NCT00970502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25594459|NCT00970502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594460|NCT00970502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25594461|NCT00970502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25594462|NCT00970502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594463|NCT00970502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25594464|NCT00970502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25594465|NCT00970502|Analgesics|analgesics|mesh-ancestor
25594466|NCT00970502|Sensory System Agents|sensory system agents|mesh-ancestor
25594467|NCT00970502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25594468|NCT00970502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594469|NCT00970502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25594470|NCT00970502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25594471|NCT00970502|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25594472|NCT00970502|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25594473|NCT00970632|Tadalafil|tadalafil|mesh-list
25594474|NCT00970632|Tamsulosin|tamsulosin|mesh-list
25594475|NCT00970632|Vasodilator Agents|vasodilator agents|mesh-ancestor
25594476|NCT00970632|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25594477|NCT00970632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25594478|NCT00970632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25594479|NCT00970632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594480|NCT00970632|Urological Agents|urological agents|mesh-ancestor
25594481|NCT00970632|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25594482|NCT00970632|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25594483|NCT00970632|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25594484|NCT00970632|Adrenergic Agents|adrenergic agents|mesh-ancestor
25594485|NCT00970632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25594486|NCT00970632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594487|NCT00970814|Levetiracetam|levetiracetam|mesh-list
25594488|NCT00970814|Anticonvulsants|anticonvulsants|mesh-ancestor
25594489|NCT00970814|Nootropic Agents|nootropic agents|mesh-ancestor
25594490|NCT00970944|Amantadine|amantadine|mesh-list
25594491|NCT00970944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25594492|NCT00970944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25594493|NCT00970944|Antiviral Agents|antiviral agents|mesh-ancestor
25594494|NCT00970944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25594495|NCT00970944|Dopamine Agents|dopamine agents|mesh-ancestor
25594496|NCT00970944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25594497|NCT00970944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594498|NCT00970944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594499|NCT00970944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25594500|NCT00970944|Analgesics|analgesics|mesh-ancestor
25594501|NCT00970944|Sensory System Agents|sensory system agents|mesh-ancestor
25594502|NCT00970944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25594503|NCT00971178|Dexmedetomidine|dexmedetomidine|mesh-list
25594504|NCT00971178|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25594505|NCT00971178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25594506|NCT00971178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594507|NCT00971178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25594508|NCT00971178|Analgesics|analgesics|mesh-ancestor
25594509|NCT00971178|Sensory System Agents|sensory system agents|mesh-ancestor
25594510|NCT00971178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25594511|NCT00971178|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25594512|NCT00971178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25594513|NCT00971178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25594514|NCT00971178|Adrenergic Agents|adrenergic agents|mesh-ancestor
25594515|NCT00971178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25594516|NCT00971178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594517|NCT00971243|Metformin|metformin|mesh-list
25594518|NCT00971243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25489072|NCT00205777|Bazedoxifene|bazedoxifene|mesh-list
25594519|NCT00971243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594520|NCT00971295|Metformin|metformin|mesh-list
25594521|NCT00971295|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25594522|NCT00971295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25594523|NCT00971295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594524|NCT00971295|Anticonvulsants|anticonvulsants|mesh-ancestor
25594525|NCT00971295|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25594526|NCT00971295|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25594527|NCT00971295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25594528|NCT00971295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594529|NCT00971620|Botulinum Toxins|botulinum toxins|mesh-list
25594530|NCT00971620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25594531|NCT00971620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25594532|NCT00971620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25594533|NCT00971620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25594534|NCT00971620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594535|NCT00971620|Cholinergic Agents|cholinergic agents|mesh-ancestor
25594536|NCT00971620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25594537|NCT00971620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594538|NCT00971620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25594539|NCT00971620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25594540|NCT00971633|Ondansetron|ondansetron|mesh-list
25594541|NCT00971633|Antiemetics|antiemetics|mesh-ancestor
25594542|NCT00971633|Autonomic Agents|autonomic agents|mesh-ancestor
25594543|NCT00971633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25594544|NCT00971633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594545|NCT00971633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25594546|NCT00971633|Antipruritics|antipruritics|mesh-ancestor
25594547|NCT00971633|Dermatologic Agents|dermatologic agents|mesh-ancestor
25594548|NCT00971633|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25594549|NCT00971633|Serotonin Agents|serotonin agents|mesh-ancestor
25594550|NCT00971633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25594551|NCT00971633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594552|NCT00971633|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25594553|NCT00971633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25594554|NCT00971633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25594555|NCT00971633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25594556|NCT00971633|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25594557|NCT00971737|Cyclophosphamide|cyclophosphamide|mesh-list
25594558|NCT00971737|Trastuzumab|trastuzumab|mesh-list
25594559|NCT00971737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25594560|NCT00971737|Immunologic Factors|immunologic factors|mesh-ancestor
25594561|NCT00971737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594562|NCT00971737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25594563|NCT00971737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25594564|NCT00971737|Alkylating Agents|alkylating agents|mesh-ancestor
25594565|NCT00971737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594566|NCT00971737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594567|NCT00971737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25594568|NCT00971737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25594569|NCT00971789|Sirolimus|sirolimus|mesh-list
25594570|NCT00971789|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25594571|NCT00971789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25594572|NCT00971789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25594573|NCT00971789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25594574|NCT00971789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594575|NCT00971789|Antifungal Agents|antifungal agents|mesh-ancestor
25594576|NCT00971789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25594577|NCT00971789|Immunologic Factors|immunologic factors|mesh-ancestor
25594578|NCT00971789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594579|NCT00971789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25594580|NCT00971789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653641|NCT01539512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25653642|NCT01539512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25653643|NCT01539512|Immunologic Factors|immunologic factors|mesh-ancestor
25653644|NCT01539512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653645|NCT01539512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25653646|NCT01539512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653647|NCT01539512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653648|NCT01539538|Sufentanil|sufentanil|mesh-list
25653649|NCT01539538|Morphine|morphine|mesh-list
25653650|NCT01539538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25653651|NCT01539538|Narcotics|narcotics|mesh-ancestor
25653652|NCT01539538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25594582|NCT00971841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25594583|NCT00971841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594584|NCT00971841|Tubulin Modulators|tubulin modulators|mesh-ancestor
25594585|NCT00971841|Antimitotic Agents|antimitotic agents|mesh-ancestor
25594586|NCT00971841|Mitosis Modulators|mitosis modulators|mesh-ancestor
25594587|NCT00971841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594588|NCT00971932|Cisplatin|cisplatin|mesh-list
25594589|NCT00971932|Carboplatin|carboplatin|mesh-list
25594590|NCT00971932|Fluorouracil|fluorouracil|mesh-list
25594591|NCT00971932|Cetuximab|cetuximab|mesh-list
25594592|NCT00971932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594593|NCT00971932|Antimetabolites|antimetabolites|mesh-ancestor
25594594|NCT00971932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594595|NCT00971932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25594596|NCT00971932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25594597|NCT00971932|Immunologic Factors|immunologic factors|mesh-ancestor
25594598|NCT00971932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594599|NCT00971932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25594600|NCT00971945|Paclitaxel|paclitaxel|mesh-list
25594601|NCT00971945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25594602|NCT00971945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594603|NCT00971945|Tubulin Modulators|tubulin modulators|mesh-ancestor
25594604|NCT00971945|Antimitotic Agents|antimitotic agents|mesh-ancestor
25594605|NCT00971945|Mitosis Modulators|mitosis modulators|mesh-ancestor
25594606|NCT00971945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594607|NCT00971997|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
25594608|NCT00971997|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25594609|NCT00971997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594610|NCT00972205|Paclitaxel|paclitaxel|mesh-list
25594611|NCT00972205|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
25594612|NCT00972205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25594613|NCT00972205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594614|NCT00972205|Tubulin Modulators|tubulin modulators|mesh-ancestor
25594615|NCT00972205|Antimitotic Agents|antimitotic agents|mesh-ancestor
25594616|NCT00972205|Mitosis Modulators|mitosis modulators|mesh-ancestor
25594617|NCT00972205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594618|NCT00972205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25594619|NCT00972244|Dapagliflozin|dapagliflozin|mesh-list
25594620|NCT00972244|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25594621|NCT00972244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594622|NCT00972244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25594623|NCT00972244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594624|NCT00972283|Insulin|insulin|mesh-list
25594625|NCT00972283|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25594626|NCT00972283|Insulin Glargine|insulin glargine|mesh-list
25594627|NCT00972283|Insulin Aspart|insulin aspart|mesh-list
25594628|NCT00972283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25594629|NCT00972283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594630|NCT00972335|Bevacizumab|bevacizumab|mesh-list
25594631|NCT00972335|Everolimus|everolimus|mesh-list
25594632|NCT00972335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25594633|NCT00972335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594634|NCT00972335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25594635|NCT00972335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25594636|NCT00972335|Growth Substances|growth substances|mesh-ancestor
25594637|NCT00972335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594638|NCT00972335|Growth Inhibitors|growth inhibitors|mesh-ancestor
25594639|NCT00972335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25594640|NCT00972335|Immunologic Factors|immunologic factors|mesh-ancestor
25594641|NCT00972374|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25594642|NCT00972374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25594643|NCT00972374|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25594644|NCT00972374|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25594645|NCT00972374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25594646|NCT00972374|Adrenergic Agents|adrenergic agents|mesh-ancestor
25594647|NCT00972374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25594648|NCT00972374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594649|NCT00972374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594650|NCT00972439|Contraceptive Agents|contraceptive agents|mesh-list
25594651|NCT00972439|Norinyl|norinyl|mesh-list
25594652|NCT00972439|Contraceptives, Oral|contraceptives, oral|mesh-list
25594653|NCT00972439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25489217|NCT00208767|Valsartan|valsartan|mesh-list
25594654|NCT00972439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594655|NCT00972439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25594656|NCT00972439|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25594657|NCT00972439|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25594658|NCT00972439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25594659|NCT00972504|Cetirizine|cetirizine|mesh-list
25594660|NCT00972504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25594661|NCT00972504|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25594662|NCT00972504|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25594663|NCT00972504|Histamine Antagonists|histamine antagonists|mesh-ancestor
25594664|NCT00972504|Histamine Agents|histamine agents|mesh-ancestor
25594665|NCT00972504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25594666|NCT00972504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594667|NCT00972504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594668|NCT00972543|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25594669|NCT00972543|Immunologic Factors|immunologic factors|mesh-ancestor
25594670|NCT00972543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594671|NCT00972595|Ondansetron|ondansetron|mesh-list
25594672|NCT00972595|Antiemetics|antiemetics|mesh-ancestor
25594673|NCT00972595|Autonomic Agents|autonomic agents|mesh-ancestor
25594674|NCT00972595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25594675|NCT00972595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594676|NCT00972595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25594677|NCT00972595|Antipruritics|antipruritics|mesh-ancestor
25594678|NCT00972595|Dermatologic Agents|dermatologic agents|mesh-ancestor
25594679|NCT00972595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25594680|NCT00972595|Serotonin Agents|serotonin agents|mesh-ancestor
25594681|NCT00972595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25594682|NCT00972595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594683|NCT00972595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25594684|NCT00972595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25594685|NCT00972595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25594686|NCT00972595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25594687|NCT00972595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25594688|NCT00972725|Chloroquine|chloroquine|mesh-list
25594689|NCT00972725|Amebicides|amebicides|mesh-ancestor
25594690|NCT00972725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25594691|NCT00972725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25594692|NCT00972725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25594693|NCT00972725|Antimalarials|antimalarials|mesh-ancestor
25594694|NCT00972725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25594695|NCT00972777|Besifloxacin|besifloxacin|mesh-list
25594696|NCT00972777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25594697|NCT00972777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25594698|NCT00972777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25594699|NCT00972777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25594700|NCT00972777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25594701|NCT00972777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594702|NCT00972777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594703|NCT00972959|Zoledronic Acid|zoledronic acid|mesh-list
25594704|NCT00972959|Dexamethasone|dexamethasone|mesh-list
25594705|NCT00972959|Bortezomib|bortezomib|mesh-list
24992339|NCT03944577|Evolocumab|evolocumab|mesh-list
24992340|NCT03944577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24992345|NCT03931291|Azacitidine|azacitidine|mesh-list
24785613|NCT01915459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785614|NCT01915459|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24785615|NCT01915459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24785617|NCT01915472|Labetuzumab|labetuzumab|mesh-list
24785618|NCT01915472|Immunoconjugates|immunoconjugates|mesh-list
24785619|NCT01915472|Immunologic Factors|immunologic factors|mesh-ancestor
25594706|NCT00972959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25594707|NCT00972959|Antiemetics|antiemetics|mesh-ancestor
25594708|NCT00972959|Autonomic Agents|autonomic agents|mesh-ancestor
25594709|NCT00972959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25594710|NCT00972959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594711|NCT00972959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25594712|NCT00972959|Glucocorticoids|glucocorticoids|mesh-ancestor
25594713|NCT00972959|Hormones|hormones|mesh-ancestor
25594714|NCT00972959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25594715|NCT00972959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25594716|NCT00972959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594717|NCT00972959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25594718|NCT00973102|Estrogens|estrogens|mesh-list
25594719|NCT00973102|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25594720|NCT00973102|Hormones|hormones|mesh-ancestor
25594721|NCT00973102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25594722|NCT00973102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594723|NCT00973479|Golimumab|golimumab|mesh-list
25594724|NCT00973479|Methotrexate|methotrexate|mesh-list
25594725|NCT00973479|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25594726|NCT00973479|Abortifacient Agents|abortifacient agents|mesh-ancestor
25594727|NCT00973479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25594728|NCT00973479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594729|NCT00973479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25594730|NCT00973479|Antimetabolites|antimetabolites|mesh-ancestor
25594731|NCT00973479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594732|NCT00973479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594733|NCT00973479|Dermatologic Agents|dermatologic agents|mesh-ancestor
25594734|NCT00973479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25594735|NCT00973479|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25594736|NCT00973479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24606653|NCT00991627|Parasympatholytics|parasympatholytics|mesh-ancestor
24606654|NCT00991627|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24606655|NCT00991627|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24606656|NCT00991627|Cholinergic Agents|cholinergic agents|mesh-ancestor
24606657|NCT00991627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24606673|NCT00991744|Cortisone|cortisone|mesh-list
24606678|NCT00991744|Prednisolone acetate|prednisolone acetate|mesh-list
24606679|NCT00991744|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24785621|NCT01915472|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25594737|NCT00973479|Immunologic Factors|immunologic factors|mesh-ancestor
25594738|NCT00973479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25594739|NCT00973479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25594740|NCT00973479|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25594741|NCT00973479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25594742|NCT00973674|Estrogens|estrogens|mesh-list
25594743|NCT00973674|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25594744|NCT00973674|Hormones|hormones|mesh-ancestor
25594745|NCT00973674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25594746|NCT00973674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594747|NCT00973739|Lapatinib|lapatinib|mesh-list
25594748|NCT00973739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594749|NCT00973739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25594750|NCT00973739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25594751|NCT00973739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594752|NCT00973752|Cytarabine|cytarabine|mesh-list
25594753|NCT00973752|Prednisone|prednisone|mesh-list
25594754|NCT00973752|Doxorubicin|doxorubicin|mesh-list
25594755|NCT00973752|Methotrexate|methotrexate|mesh-list
25594756|NCT00973752|Vincristine|vincristine|mesh-list
25594757|NCT00973752|Asparaginase|asparaginase|mesh-list
25594758|NCT00973752|Mercaptopurine|mercaptopurine|mesh-list
25594759|NCT00973752|Clofarabine|clofarabine|mesh-list
25594760|NCT00973752|Pegaspargase|pegaspargase|mesh-list
25594761|NCT00973752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25594762|NCT00973752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594763|NCT00973752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25594764|NCT00973752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25594765|NCT00973752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25594766|NCT00973752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594767|NCT00973752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25594768|NCT00973752|Glucocorticoids|glucocorticoids|mesh-ancestor
25594769|NCT00973752|Hormones|hormones|mesh-ancestor
25594770|NCT00973752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25594771|NCT00973752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594772|NCT00973752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25594773|NCT00973752|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25594774|NCT00973752|Abortifacient Agents|abortifacient agents|mesh-ancestor
25594775|NCT00973752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25594776|NCT00973752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25594777|NCT00973752|Antimetabolites|antimetabolites|mesh-ancestor
25594778|NCT00973752|Dermatologic Agents|dermatologic agents|mesh-ancestor
25594779|NCT00973752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25594780|NCT00973752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25594781|NCT00973752|Immunologic Factors|immunologic factors|mesh-ancestor
25594782|NCT00973752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25594783|NCT00973752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25594784|NCT00973752|Antiviral Agents|antiviral agents|mesh-ancestor
25594785|NCT00973752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25594786|NCT00973752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25594787|NCT00973752|Tubulin Modulators|tubulin modulators|mesh-ancestor
25594788|NCT00973752|Antimitotic Agents|antimitotic agents|mesh-ancestor
25594789|NCT00973752|Mitosis Modulators|mitosis modulators|mesh-ancestor
25594790|NCT00973765|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25594791|NCT00973765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25594792|NCT00973765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25594793|NCT00973765|Renal Agents|renal agents|mesh-ancestor
25594794|NCT00973765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25594795|NCT00973765|Antimalarials|antimalarials|mesh-ancestor
25594796|NCT00973765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25594797|NCT00973765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25594798|NCT00974051|Insulin|insulin|mesh-list
25594799|NCT00974051|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25594800|NCT00974051|Terbutaline|terbutaline|mesh-list
25594801|NCT00974051|Adrenergic Agonists|adrenergic agonists|mesh-list
25594802|NCT00974051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25594803|NCT00974051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489365|NCT00211185|Glucocorticoids|glucocorticoids|mesh-ancestor
25594804|NCT00974051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25594805|NCT00974051|Autonomic Agents|autonomic agents|mesh-ancestor
25594806|NCT00974051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25594807|NCT00974051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25594808|NCT00974051|Respiratory System Agents|respiratory system agents|mesh-ancestor
25594809|NCT00974051|Sympathomimetics|sympathomimetics|mesh-ancestor
25594810|NCT00974051|Tocolytic Agents|tocolytic agents|mesh-ancestor
25594811|NCT00974051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25594812|NCT00974051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25594813|NCT00974051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25594814|NCT00974051|Adrenergic Agents|adrenergic agents|mesh-ancestor
25594815|NCT00974051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25594816|NCT00974051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594817|NCT00974090|Glimepiride|glimepiride|mesh-list
25594818|NCT00974090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25594819|NCT00974090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25594820|NCT00974090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594821|NCT00974090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25594822|NCT00974090|Immunologic Factors|immunologic factors|mesh-ancestor
25594823|NCT00974142|Cyclosporine|cyclosporine|mesh-list
25594824|NCT00974142|Cyclosporins|cyclosporins|mesh-list
25594825|NCT00974142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25594826|NCT00974142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594827|NCT00974142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25594828|NCT00974142|Immunologic Factors|immunologic factors|mesh-ancestor
25594829|NCT00974142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594830|NCT00974142|Antifungal Agents|antifungal agents|mesh-ancestor
25594831|NCT00974142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25594832|NCT00974142|Dermatologic Agents|dermatologic agents|mesh-ancestor
25594833|NCT00974142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25594834|NCT00974142|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25594835|NCT00974220|Fentanyl|fentanyl|mesh-list
25594836|NCT00974220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25594837|NCT00974220|Narcotics|narcotics|mesh-ancestor
25594838|NCT00974220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25594839|NCT00974220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594840|NCT00974220|Analgesics|analgesics|mesh-ancestor
25594841|NCT00974220|Sensory System Agents|sensory system agents|mesh-ancestor
25594842|NCT00974220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25594843|NCT00974220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25594844|NCT00974220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25594845|NCT00974220|Anesthetics, General|anesthetics, general|mesh-ancestor
25594846|NCT00974220|Anesthetics|anesthetics|mesh-ancestor
25594847|NCT00974233|Rituximab|rituximab|mesh-list
25594848|NCT00974233|Lenalidomide|lenalidomide|mesh-list
25594849|NCT00974233|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25594850|NCT00974233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25594851|NCT00974233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594852|NCT00974233|Immunologic Factors|immunologic factors|mesh-ancestor
24609301|NCT00996021|Moxifloxacin|moxifloxacin|mesh-list
25594853|NCT00974233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594854|NCT00974233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25594855|NCT00974233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25594856|NCT00974233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25594857|NCT00974233|Growth Substances|growth substances|mesh-ancestor
25594858|NCT00974233|Growth Inhibitors|growth inhibitors|mesh-ancestor
25594859|NCT00974233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25594860|NCT00974233|Alkylating Agents|alkylating agents|mesh-ancestor
25594861|NCT00974233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594862|NCT00974246|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25594863|NCT00974246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25594864|NCT00974246|Autonomic Agents|autonomic agents|mesh-ancestor
25594865|NCT00974246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25594866|NCT00974246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594867|NCT00974246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25594868|NCT00974246|Respiratory System Agents|respiratory system agents|mesh-ancestor
25594869|NCT00974246|Glucocorticoids|glucocorticoids|mesh-ancestor
25594870|NCT00974246|Hormones|hormones|mesh-ancestor
25594871|NCT00974246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25594872|NCT00974246|Sympathomimetics|sympathomimetics|mesh-ancestor
25594873|NCT00974350|Bupivacaine|bupivacaine|mesh-list
25489433|NCT00213135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489434|NCT00213148|Anastrozole|anastrozole|mesh-list
25594874|NCT00974350|Anesthetics, Local|anesthetics, local|mesh-ancestor
25594875|NCT00974350|Anesthetics|anesthetics|mesh-ancestor
25594876|NCT00974350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25594877|NCT00974350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594878|NCT00974350|Sensory System Agents|sensory system agents|mesh-ancestor
25594879|NCT00974350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25594880|NCT00974376|Gabapentin|gabapentin|mesh-list
25594881|NCT00974376|Analgesics|analgesics|mesh-ancestor
25594882|NCT00974376|Sensory System Agents|sensory system agents|mesh-ancestor
25594883|NCT00974376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25594884|NCT00974376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594885|NCT00974376|Anticonvulsants|anticonvulsants|mesh-ancestor
25594886|NCT00974376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25594887|NCT00974376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25594888|NCT00974376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25594889|NCT00974376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25594890|NCT00974376|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25594891|NCT00974376|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25594892|NCT00974376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25594893|NCT00974376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594894|NCT00974376|Antimanic Agents|antimanic agents|mesh-ancestor
25594895|NCT00974480|Tretinoin|tretinoin|mesh-list
25594896|NCT00974480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594897|NCT00974480|Keratolytic Agents|keratolytic agents|mesh-ancestor
25594898|NCT00974480|Dermatologic Agents|dermatologic agents|mesh-ancestor
25594899|NCT00974493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25594900|NCT00974493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25594901|NCT00974493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25594902|NCT00974493|Antitubercular Agents|antitubercular agents|mesh-ancestor
25594903|NCT00974675|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25594904|NCT00974675|Immunologic Factors|immunologic factors|mesh-ancestor
25594905|NCT00974675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594906|NCT00974818|Mitomycins|mitomycins|mesh-list
25594907|NCT00974818|Mitomycin|mitomycin|mesh-list
25594908|NCT00974818|BCG Vaccine|bcg vaccine|mesh-list
25594909|NCT00974818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25594910|NCT00974818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25594911|NCT00974818|Alkylating Agents|alkylating agents|mesh-ancestor
25594912|NCT00974818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594913|NCT00974818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25594914|NCT00974818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25594915|NCT00974818|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25594916|NCT00974818|Immunologic Factors|immunologic factors|mesh-ancestor
25594917|NCT00974818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594918|NCT00974974|Levodopa|levodopa|mesh-list
25594919|NCT00974974|Carbidopa|carbidopa|mesh-list
25594920|NCT00974974|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25594921|NCT00974974|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25594922|NCT00974974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25594923|NCT00974974|Dopamine Agents|dopamine agents|mesh-ancestor
25594924|NCT00974974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25594925|NCT00974974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594926|NCT00974974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594927|NCT00974974|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25594928|NCT00974974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25594929|NCT00974974|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25594930|NCT00974974|Immunologic Factors|immunologic factors|mesh-ancestor
25594931|NCT00974974|Dopamine Agonists|dopamine agonists|mesh-ancestor
25594932|NCT00975000|Cinacalcet|cinacalcet|mesh-list
25594933|NCT00975000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25594934|NCT00975000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594935|NCT00975000|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25594936|NCT00975000|Hormone Antagonists|hormone antagonists|mesh-ancestor
25594937|NCT00975000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25594938|NCT00975130|Golimumab|golimumab|mesh-list
25594939|NCT00975130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25594940|NCT00975130|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25594941|NCT00975130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25594942|NCT00975130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25594943|NCT00975130|Immunologic Factors|immunologic factors|mesh-ancestor
25594944|NCT00975130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594945|NCT00975143|Isotretinoin|isotretinoin|mesh-list
25594946|NCT00975143|Dermatologic Agents|dermatologic agents|mesh-ancestor
25594947|NCT00975195|Fluticasone|fluticasone|mesh-list
25594948|NCT00975195|Xhance|xhance|mesh-list
25594949|NCT00975195|Tiotropium Bromide|tiotropium bromide|mesh-list
25489498|NCT00214890|Tenofovir|tenofovir|mesh-list
25594950|NCT00975195|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25594951|NCT00975195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25594952|NCT00975195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25594953|NCT00975195|Autonomic Agents|autonomic agents|mesh-ancestor
25594954|NCT00975195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25594955|NCT00975195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594956|NCT00975195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25594957|NCT00975195|Respiratory System Agents|respiratory system agents|mesh-ancestor
25594958|NCT00975195|Dermatologic Agents|dermatologic agents|mesh-ancestor
25594959|NCT00975195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25594960|NCT00975195|Parasympatholytics|parasympatholytics|mesh-ancestor
25594961|NCT00975195|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25594962|NCT00975195|Cholinergic Agents|cholinergic agents|mesh-ancestor
25594963|NCT00975195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25594964|NCT00975195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594965|NCT00975195|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25594966|NCT00975195|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25594967|NCT00975195|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25594968|NCT00975195|Adrenergic Agents|adrenergic agents|mesh-ancestor
25594969|NCT00975221|Cinacalcet|cinacalcet|mesh-list
25594970|NCT00975221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25594971|NCT00975221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594972|NCT00975221|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25594973|NCT00975221|Hormone Antagonists|hormone antagonists|mesh-ancestor
25594974|NCT00975221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25594975|NCT00975286|Metformin|metformin|mesh-list
25594976|NCT00975286|Insulin Glargine|insulin glargine|mesh-list
25594977|NCT00975286|Lixisenatide|lixisenatide|mesh-list
25594978|NCT00975286|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
25594979|NCT00975286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25594980|NCT00975286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594981|NCT00975416|Oxytocin|oxytocin|mesh-list
25594982|NCT00975416|Oxytocics|oxytocics|mesh-ancestor
25594983|NCT00975416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25594984|NCT00975416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594985|NCT00975481|Alprazolam|alprazolam|mesh-list
25594986|NCT00975481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25594987|NCT00975481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25594988|NCT00975481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25594989|NCT00975481|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25594990|NCT00975481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25594991|NCT00975481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25594992|NCT00975481|GABA Modulators|gaba modulators|mesh-ancestor
25594993|NCT00975481|GABA Agents|gaba agents|mesh-ancestor
25594994|NCT00975481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25594995|NCT00975481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25594996|NCT00975637|Brodalumab|brodalumab|mesh-list
25594997|NCT00975637|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25594998|NCT00975637|Dermatologic Agents|dermatologic agents|mesh-ancestor
25594999|NCT00975637|Immunologic Factors|immunologic factors|mesh-ancestor
25595000|NCT00975637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595001|NCT00975650|Testosterone|testosterone|mesh-list
25595002|NCT00975650|Androgens|androgens|mesh-ancestor
25595003|NCT00975650|Hormones|hormones|mesh-ancestor
25595004|NCT00975650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25595005|NCT00975650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595006|NCT00975689|Acetylcysteine|acetylcysteine|mesh-list
25595007|NCT00975689|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25595008|NCT00975689|Antiviral Agents|antiviral agents|mesh-ancestor
25595009|NCT00975689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25595010|NCT00975689|Expectorants|expectorants|mesh-ancestor
25595011|NCT00975689|Respiratory System Agents|respiratory system agents|mesh-ancestor
25595012|NCT00975689|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25595013|NCT00975689|Antioxidants|antioxidants|mesh-ancestor
25595014|NCT00975689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595015|NCT00975689|Protective Agents|protective agents|mesh-ancestor
25595016|NCT00975689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595017|NCT00975689|Antidotes|antidotes|mesh-ancestor
25595018|NCT00975806|Lenalidomide|lenalidomide|mesh-list
25595019|NCT00975806|Sunitinib|sunitinib|mesh-list
25595020|NCT00975806|Immunologic Factors|immunologic factors|mesh-ancestor
25595021|NCT00975806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595022|NCT00975806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25595023|NCT00975806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25595024|NCT00975806|Growth Substances|growth substances|mesh-ancestor
25595025|NCT00975806|Growth Inhibitors|growth inhibitors|mesh-ancestor
25489589|NCT00215943|Hormones|hormones|mesh-ancestor
25595026|NCT00975806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595027|NCT00975806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25595028|NCT00975806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595029|NCT00975806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595030|NCT00975975|Basiliximab|basiliximab|mesh-list
25595031|NCT00975975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25595032|NCT00975975|Immunologic Factors|immunologic factors|mesh-ancestor
25595033|NCT00975975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595035|NCT00976027|Immunologic Factors|immunologic factors|mesh-ancestor
25595036|NCT00976027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595037|NCT00976183|Vorinostat|vorinostat|mesh-list
25595038|NCT00976183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595039|NCT00976183|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25595040|NCT00976183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595041|NCT00976183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595042|NCT00976209|Phenylephrine|phenylephrine|mesh-list
25595043|NCT00976209|Oxymetazoline|oxymetazoline|mesh-list
25595044|NCT00976209|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25595045|NCT00976209|Mydriatics|mydriatics|mesh-ancestor
25595046|NCT00976209|Autonomic Agents|autonomic agents|mesh-ancestor
25595047|NCT00976209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25595048|NCT00976209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595049|NCT00976209|Sympathomimetics|sympathomimetics|mesh-ancestor
25595050|NCT00976209|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25595051|NCT00976209|Nasal Decongestants|nasal decongestants|mesh-ancestor
25595052|NCT00976209|Respiratory System Agents|respiratory system agents|mesh-ancestor
25595053|NCT00976209|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25595054|NCT00976209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25595055|NCT00976209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25595056|NCT00976209|Adrenergic Agents|adrenergic agents|mesh-ancestor
25595057|NCT00976209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25595058|NCT00976209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595059|NCT00976209|Protective Agents|protective agents|mesh-ancestor
25595060|NCT00976248|Everolimus|everolimus|mesh-list
25595061|NCT00976248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595062|NCT00976248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25595063|NCT00976248|Immunologic Factors|immunologic factors|mesh-ancestor
25595064|NCT00976248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595065|NCT00976391|Insulin|insulin|mesh-list
25595066|NCT00976391|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25595067|NCT00976391|Insulin Glargine|insulin glargine|mesh-list
25595068|NCT00976391|Insulin Lispro|insulin lispro|mesh-list
25595069|NCT00976391|rGLP-1 protein|rglp-1 protein|mesh-list
25595070|NCT00976391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25595071|NCT00976391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595072|NCT00976391|Incretins|incretins|mesh-ancestor
25595073|NCT00976391|Hormones|hormones|mesh-ancestor
25595074|NCT00976391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25595075|NCT00976404|Raltegravir Potassium|raltegravir potassium|mesh-list
25595076|NCT00976404|Maraviroc|maraviroc|mesh-list
25595077|NCT00976404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25595078|NCT00976404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25595079|NCT00976404|Antiviral Agents|antiviral agents|mesh-ancestor
25595080|NCT00976404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25595081|NCT00976404|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25595082|NCT00976404|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25595083|NCT00976404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595084|NCT00976404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595085|NCT00976404|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25595086|NCT00976404|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25595087|NCT00976404|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25595088|NCT00976456|Bevacizumab|bevacizumab|mesh-list
25595089|NCT00976456|Carboplatin|carboplatin|mesh-list
25595090|NCT00976456|Pemetrexed|pemetrexed|mesh-list
25595091|NCT00976456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25595092|NCT00976456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595093|NCT00976456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25595094|NCT00976456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25595095|NCT00976456|Growth Substances|growth substances|mesh-ancestor
25595096|NCT00976456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595097|NCT00976456|Growth Inhibitors|growth inhibitors|mesh-ancestor
25595098|NCT00976456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595099|NCT00976456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595100|NCT00976456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25595101|NCT00976456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25489638|NCT00216099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25595102|NCT00976495|Dapagliflozin|dapagliflozin|mesh-list
25595103|NCT00976495|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25595104|NCT00976495|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25595105|NCT00976495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595106|NCT00976495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25595107|NCT00976495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595108|NCT00976495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25595109|NCT00976495|Diuretics|diuretics|mesh-ancestor
25595110|NCT00976495|Natriuretic Agents|natriuretic agents|mesh-ancestor
25595111|NCT00976495|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25595112|NCT00976495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25595114|NCT00976521|Anticoagulants|anticoagulants|mesh-ancestor
25595115|NCT00976521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25595116|NCT00976573|Paclitaxel|paclitaxel|mesh-list
25595117|NCT00976573|Bevacizumab|bevacizumab|mesh-list
25595118|NCT00976573|Carboplatin|carboplatin|mesh-list
25595119|NCT00976573|Everolimus|everolimus|mesh-list
25595120|NCT00976573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25595121|NCT00976573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595122|NCT00976573|Tubulin Modulators|tubulin modulators|mesh-ancestor
25595123|NCT00976573|Antimitotic Agents|antimitotic agents|mesh-ancestor
25595124|NCT00976573|Mitosis Modulators|mitosis modulators|mesh-ancestor
25595125|NCT00976573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595126|NCT00976573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25595127|NCT00976573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25595128|NCT00976573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25595129|NCT00976573|Growth Substances|growth substances|mesh-ancestor
25595130|NCT00976573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595131|NCT00976573|Growth Inhibitors|growth inhibitors|mesh-ancestor
25595132|NCT00976573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25595133|NCT00976573|Immunologic Factors|immunologic factors|mesh-ancestor
25595134|NCT00976599|Methotrexate|methotrexate|mesh-list
25595135|NCT00976599|Tofacitinib|tofacitinib|mesh-list
25595136|NCT00976599|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25595137|NCT00976599|Abortifacient Agents|abortifacient agents|mesh-ancestor
25595138|NCT00976599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25595139|NCT00976599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595140|NCT00976599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25595141|NCT00976599|Antimetabolites|antimetabolites|mesh-ancestor
25595142|NCT00976599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595143|NCT00976599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595144|NCT00976599|Dermatologic Agents|dermatologic agents|mesh-ancestor
25595145|NCT00976599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595146|NCT00976599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25595147|NCT00976599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25595148|NCT00976599|Immunologic Factors|immunologic factors|mesh-ancestor
25595149|NCT00976599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25595150|NCT00976599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25595151|NCT00976599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25595152|NCT00976677|Paclitaxel|paclitaxel|mesh-list
25595153|NCT00976677|Bevacizumab|bevacizumab|mesh-list
25595154|NCT00976677|Carboplatin|carboplatin|mesh-list
25595155|NCT00976677|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25595156|NCT00976677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25595157|NCT00976677|Antibodies|antibodies|mesh-list
25595158|NCT00976677|Immunoglobulins|immunoglobulins|mesh-list
25595159|NCT00976677|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25595160|NCT00976677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25595161|NCT00976677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595162|NCT00976677|Tubulin Modulators|tubulin modulators|mesh-ancestor
25595163|NCT00976677|Antimitotic Agents|antimitotic agents|mesh-ancestor
25595164|NCT00976677|Mitosis Modulators|mitosis modulators|mesh-ancestor
25595165|NCT00976677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595166|NCT00976677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25595167|NCT00976677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25595168|NCT00976677|Growth Substances|growth substances|mesh-ancestor
25595169|NCT00976677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595170|NCT00976677|Growth Inhibitors|growth inhibitors|mesh-ancestor
25595171|NCT00976677|Immunologic Factors|immunologic factors|mesh-ancestor
25595172|NCT00976677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25595173|NCT00976677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595174|NCT00976716|Celecoxib|celecoxib|mesh-list
25595175|NCT00976716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25595176|NCT00976716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25595177|NCT00976716|Analgesics|analgesics|mesh-ancestor
25595178|NCT00976716|Sensory System Agents|sensory system agents|mesh-ancestor
25595179|NCT00976716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25595180|NCT00976716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595181|NCT00976716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25595182|NCT00976716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25595183|NCT00976716|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25595184|NCT00976716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25595185|NCT00976716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595186|NCT00976716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595187|NCT00976937|Metformin|metformin|mesh-list
25595188|NCT00976937|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25595189|NCT00976937|Lixisenatide|lixisenatide|mesh-list
25595190|NCT00976937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24993918|NCT05199311|Dexamethasone|dexamethasone|mesh-list
25595191|NCT00976937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595192|NCT00976937|Incretins|incretins|mesh-ancestor
25595193|NCT00976937|Hormones|hormones|mesh-ancestor
25595194|NCT00976937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25595195|NCT00976937|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25595196|NCT00976937|Protease Inhibitors|protease inhibitors|mesh-ancestor
25595197|NCT00976937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595198|NCT00976937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595199|NCT00976950|Ritonavir|ritonavir|mesh-list
25595200|NCT00976950|Tipranavir|tipranavir|mesh-list
25595201|NCT00976950|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25595202|NCT00976950|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25595203|NCT00976950|Protease Inhibitors|protease inhibitors|mesh-ancestor
25595204|NCT00976950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595205|NCT00976950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595206|NCT00976950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25595207|NCT00976950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25595208|NCT00976950|Antiviral Agents|antiviral agents|mesh-ancestor
25595209|NCT00976950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25595210|NCT00976950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25595211|NCT00976950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25595212|NCT00976989|Docetaxel|docetaxel|mesh-list
25595213|NCT00976989|Trastuzumab|trastuzumab|mesh-list
25595214|NCT00976989|Pertuzumab|pertuzumab|mesh-list
25595215|NCT00976989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595216|NCT00976989|Tubulin Modulators|tubulin modulators|mesh-ancestor
25595217|NCT00976989|Antimitotic Agents|antimitotic agents|mesh-ancestor
25595218|NCT00976989|Mitosis Modulators|mitosis modulators|mesh-ancestor
25595219|NCT00976989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595220|NCT00976989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25595221|NCT00977080|Cinacalcet|cinacalcet|mesh-list
25595222|NCT00977080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25595223|NCT00977080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595224|NCT00977080|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25595225|NCT00977080|Hormone Antagonists|hormone antagonists|mesh-ancestor
25595226|NCT00977080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25595227|NCT00977171|Droxidopa|droxidopa|mesh-list
25595228|NCT00977171|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25595229|NCT00977171|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25653653|NCT01539538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653654|NCT01539538|Analgesics|analgesics|mesh-ancestor
25653655|NCT01539538|Sensory System Agents|sensory system agents|mesh-ancestor
25653656|NCT01539538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653657|NCT01539538|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25653658|NCT01539538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25653659|NCT01539538|Anesthetics, General|anesthetics, general|mesh-ancestor
25653660|NCT01539538|Anesthetics|anesthetics|mesh-ancestor
25653661|NCT01539642|Sufentanil|sufentanil|mesh-list
25653662|NCT01539642|Dsuvia|dsuvia|mesh-list
25653663|NCT01539642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25653664|NCT01539642|Narcotics|narcotics|mesh-ancestor
25653665|NCT01539642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25653666|NCT01539642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653667|NCT01539642|Analgesics|analgesics|mesh-ancestor
25653668|NCT01539642|Sensory System Agents|sensory system agents|mesh-ancestor
25653669|NCT01539642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653670|NCT01539642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25653671|NCT01539642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25653672|NCT01539642|Anesthetics, General|anesthetics, general|mesh-ancestor
25653673|NCT01539642|Anesthetics|anesthetics|mesh-ancestor
25653674|NCT01539837|Deferiprone|deferiprone|mesh-list
25653675|NCT01539837|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25653676|NCT01539837|Chelating Agents|chelating agents|mesh-ancestor
25595230|NCT00977197|Pregabalin|pregabalin|mesh-list
25595231|NCT00977197|Analgesics|analgesics|mesh-ancestor
25595232|NCT00977197|Sensory System Agents|sensory system agents|mesh-ancestor
25595233|NCT00977197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25595234|NCT00977197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595235|NCT00977197|Anticonvulsants|anticonvulsants|mesh-ancestor
25595236|NCT00977197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25595237|NCT00977197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25595238|NCT00977197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595239|NCT00977197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25595240|NCT00977197|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25595241|NCT00977197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25595242|NCT00977197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25595243|NCT00977197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25595244|NCT00977379|Capecitabine|capecitabine|mesh-list
25595245|NCT00977379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25595246|NCT00977379|Antimetabolites|antimetabolites|mesh-ancestor
25595247|NCT00977379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595248|NCT00977379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595249|NCT00977431|Temozolomide|temozolomide|mesh-list
25595250|NCT00977431|Afatinib|afatinib|mesh-list
25595251|NCT00977431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25595252|NCT00977431|Alkylating Agents|alkylating agents|mesh-ancestor
25595253|NCT00977431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595254|NCT00977431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595255|NCT00977431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25595256|NCT00977431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595257|NCT00977470|Hydroxychloroquine|hydroxychloroquine|mesh-list
25595258|NCT00977470|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25595259|NCT00977470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595260|NCT00977470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25595261|NCT00977470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595262|NCT00977470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595263|NCT00977470|Antimalarials|antimalarials|mesh-ancestor
25595264|NCT00977470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25595265|NCT00977470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25595266|NCT00977470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25595267|NCT00977470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25595268|NCT00977548|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25595269|NCT00977548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595270|NCT00977548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25595271|NCT00977548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595272|NCT00977548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595273|NCT00977561|Cisplatin|cisplatin|mesh-list
25595274|NCT00977561|Carboplatin|carboplatin|mesh-list
25595275|NCT00977561|Etoposide|etoposide|mesh-list
25595276|NCT00977561|Etoposide phosphate|etoposide phosphate|mesh-list
25595277|NCT00977561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595278|NCT00977561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25595279|NCT00977561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25595280|NCT00977561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25595281|NCT00977561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595282|NCT00977561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595283|NCT00977665|Rasagiline|rasagiline|mesh-list
25595284|NCT00977665|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25595285|NCT00977665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595286|NCT00977665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595287|NCT00977665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25595288|NCT00977665|Protective Agents|protective agents|mesh-ancestor
25595289|NCT00977665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595290|NCT00977769|Oxytocin|oxytocin|mesh-list
25595291|NCT00977769|Carbetocin|carbetocin|mesh-list
25595292|NCT00977769|Oxytocics|oxytocics|mesh-ancestor
25595293|NCT00977769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24994406|NCT04300231|Narcotics|narcotics|mesh-ancestor
25595294|NCT00977769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595295|NCT00977938|Aspirin|aspirin|mesh-list
25595296|NCT00977938|Clopidogrel|clopidogrel|mesh-list
25595297|NCT00977938|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25595298|NCT00977938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25595299|NCT00977938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25595300|NCT00977938|Analgesics|analgesics|mesh-ancestor
25595301|NCT00977938|Sensory System Agents|sensory system agents|mesh-ancestor
25595302|NCT00977938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25595303|NCT00977938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653677|NCT01539837|Sequestering Agents|sequestering agents|mesh-ancestor
25595304|NCT00977938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25595305|NCT00977938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25595306|NCT00977938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25595307|NCT00977938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25595308|NCT00977938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595309|NCT00977938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25595310|NCT00977938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25595311|NCT00977938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595312|NCT00977938|Antipyretics|antipyretics|mesh-ancestor
25595313|NCT00977938|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25595314|NCT00977938|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25595315|NCT00977938|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25595316|NCT00977938|Purinergic Agents|purinergic agents|mesh-ancestor
25595317|NCT00977938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25595318|NCT00978068|Ritonavir|ritonavir|mesh-list
25595319|NCT00978068|Lopinavir|lopinavir|mesh-list
25595320|NCT00978068|Nevirapine|nevirapine|mesh-list
25595321|NCT00978068|Efavirenz|efavirenz|mesh-list
25595322|NCT00978068|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
25595323|NCT00978068|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25595324|NCT00978068|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25595325|NCT00978068|Protease Inhibitors|protease inhibitors|mesh-ancestor
25595326|NCT00978068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595327|NCT00978068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595328|NCT00978068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25595329|NCT00978068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25595330|NCT00978068|Antiviral Agents|antiviral agents|mesh-ancestor
25595331|NCT00978068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25595332|NCT00978068|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25595333|NCT00978068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25595334|NCT00978068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24675747|NCT01344720|Analgesics|analgesics|mesh-ancestor
25595335|NCT00978068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25595336|NCT00978068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25595337|NCT00978068|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25595338|NCT00978068|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25595339|NCT00978068|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25595340|NCT00978120|Vaccines|vaccines|mesh-list
25595341|NCT00978120|Immunologic Factors|immunologic factors|mesh-ancestor
25595342|NCT00978120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595343|NCT00978250|Tetrahydrouridine|tetrahydrouridine|mesh-list
25595344|NCT00978250|Antimetabolites|antimetabolites|mesh-ancestor
25595345|NCT00978250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595346|NCT00978341|Pregabalin|pregabalin|mesh-list
25595347|NCT00978341|Analgesics|analgesics|mesh-ancestor
25595348|NCT00978341|Sensory System Agents|sensory system agents|mesh-ancestor
25595349|NCT00978341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25595350|NCT00978341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595351|NCT00978341|Anticonvulsants|anticonvulsants|mesh-ancestor
25595352|NCT00978341|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25595353|NCT00978341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25595354|NCT00978341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595355|NCT00978341|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25595356|NCT00978341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25595357|NCT00978341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25595358|NCT00978341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25595359|NCT00978341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25595360|NCT00978432|Everolimus|everolimus|mesh-list
25595361|NCT00978432|Panobinostat|panobinostat|mesh-list
25595362|NCT00978432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595363|NCT00978432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25595364|NCT00978432|Immunologic Factors|immunologic factors|mesh-ancestor
25595365|NCT00978432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595366|NCT00978432|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25595367|NCT00978432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595368|NCT00978432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595369|NCT00978627|Insulin|insulin|mesh-list
25595370|NCT00978627|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25595371|NCT00978627|Insulin Aspart|insulin aspart|mesh-list
25595372|NCT00978627|Insulin, Long-Acting|insulin, long-acting|mesh-list
25595373|NCT00978627|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25595374|NCT00978627|Insulin Detemir|insulin detemir|mesh-list
25595375|NCT00978627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25489928|NCT00218491|Expectorants|expectorants|mesh-ancestor
25595376|NCT00978627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595378|NCT00978731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595379|NCT00978731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25595380|NCT00978731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595381|NCT00978731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595382|NCT00978757|Ketamine|ketamine|mesh-list
25595383|NCT00978757|Analgesics|analgesics|mesh-ancestor
25595384|NCT00978757|Sensory System Agents|sensory system agents|mesh-ancestor
25595385|NCT00978757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24675928|NCT01346670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595386|NCT00978757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595387|NCT00978757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25595388|NCT00978757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25595389|NCT00978757|Anesthetics, General|anesthetics, general|mesh-ancestor
25595390|NCT00978757|Anesthetics|anesthetics|mesh-ancestor
25595391|NCT00978757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25595392|NCT00978757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25595393|NCT00978757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25595394|NCT00978757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25595395|NCT00978757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595396|NCT00979017|Bevacizumab|bevacizumab|mesh-list
25595397|NCT00979017|Irinotecan|irinotecan|mesh-list
25595398|NCT00979017|Temozolomide|temozolomide|mesh-list
25595399|NCT00979017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25595400|NCT00979017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595401|NCT00979017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25595402|NCT00979017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25595403|NCT00979017|Growth Substances|growth substances|mesh-ancestor
25595404|NCT00979017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595405|NCT00979017|Growth Inhibitors|growth inhibitors|mesh-ancestor
25595406|NCT00979017|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25595407|NCT00979017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25595408|NCT00979017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595409|NCT00979017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595410|NCT00979017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24676288|NCT01349387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676318|NCT01349556|Dermatologic Agents|dermatologic agents|mesh-ancestor
24676320|NCT01349647|Immunologic Factors|immunologic factors|mesh-ancestor
24676321|NCT01349647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676322|NCT01349699|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24676323|NCT01349699|Deferasirox|deferasirox|mesh-list
24676324|NCT01349699|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25595411|NCT00979017|Alkylating Agents|alkylating agents|mesh-ancestor
25595412|NCT00979121|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25595413|NCT00979121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25595414|NCT00979121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25595415|NCT00979121|Antimetabolites|antimetabolites|mesh-ancestor
25595416|NCT00979121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595417|NCT00979121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25595418|NCT00979121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25595419|NCT00979121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595420|NCT00979407|Vaccines|vaccines|mesh-list
25595421|NCT00979407|Immunologic Factors|immunologic factors|mesh-ancestor
25706644|NCT02218320|Antiviral Agents|antiviral agents|mesh-ancestor
25706645|NCT02218320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24610816|NCT01005303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24610818|NCT01005381|Vitamin D|vitamin d|mesh-list
24610819|NCT01005381|Calcium Carbonate|calcium carbonate|mesh-list
25108021|NCT03135106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25108022|NCT03135106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25108023|NCT03135106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25108024|NCT03135106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25108025|NCT03135106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108026|NCT03135106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25108027|NCT03135106|Hormone Antagonists|hormone antagonists|mesh-ancestor
24994929|NCT00446225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994930|NCT00446225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24814614|NCT02065843|Midazolam|midazolam|mesh-list
24451788|NCT00324818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24451789|NCT00324818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24602597|NCT00969696|Galantamine|galantamine|mesh-list
24994931|NCT00446225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24994957|NCT00089245|Cadexomer iodine|cadexomer iodine|mesh-list
24994958|NCT00089245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24994959|NCT00089245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24994960|NCT00089245|Trace Elements|trace elements|mesh-ancestor
24994961|NCT00089245|Micronutrients|micronutrients|mesh-ancestor
24994962|NCT00089245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994963|NCT05418946|Dapagliflozin|dapagliflozin|mesh-list
24622120|NCT01065701|Analgesics|analgesics|mesh-ancestor
25595422|NCT00979407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595423|NCT00979576|Pemetrexed|pemetrexed|mesh-list
25595424|NCT00979576|Nintedanib|nintedanib|mesh-list
25595425|NCT00979576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595426|NCT00979576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595427|NCT00979576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595428|NCT00979576|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25595429|NCT00979576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25595430|NCT00979576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25595431|NCT00979615|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25595432|NCT00979615|Azelastine|azelastine|mesh-list
25595433|NCT00979615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25595434|NCT00979615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25595435|NCT00979615|Analgesics|analgesics|mesh-ancestor
24676894|NCT01352988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24676895|NCT01352988|Immunologic Factors|immunologic factors|mesh-ancestor
24622122|NCT01065701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24622123|NCT01065701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24622124|NCT01065701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24622125|NCT01065701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25595436|NCT00979615|Sensory System Agents|sensory system agents|mesh-ancestor
25595437|NCT00979615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25595438|NCT00979615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595439|NCT00979615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25595440|NCT00979615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25595441|NCT00979615|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25595442|NCT00979615|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25595443|NCT00979615|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25595444|NCT00979615|Histamine Antagonists|histamine antagonists|mesh-ancestor
25595445|NCT00979615|Histamine Agents|histamine agents|mesh-ancestor
25595446|NCT00979615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25595447|NCT00979615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677660|NCT01357681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995079|NCT05418244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24995080|NCT05418166|Evolocumab|evolocumab|mesh-list
24995081|NCT05418166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24995082|NCT05418166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24995083|NCT05418166|Antimetabolites|antimetabolites|mesh-ancestor
25595448|NCT00979615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25595449|NCT00979615|Autonomic Agents|autonomic agents|mesh-ancestor
25595450|NCT00979615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25595451|NCT00979615|Respiratory System Agents|respiratory system agents|mesh-ancestor
25595452|NCT00979615|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25595453|NCT00979615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595454|NCT00979628|Insulin|insulin|mesh-list
25595455|NCT00979628|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25595456|NCT00979628|Insulin Glargine|insulin glargine|mesh-list
25595457|NCT00979628|Insulin glulisine|insulin glulisine|mesh-list
25595458|NCT00979628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25595459|NCT00979628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595460|NCT00979654|Sifalimumab|sifalimumab|mesh-list
25595461|NCT00979654|Immunologic Factors|immunologic factors|mesh-ancestor
25595462|NCT00979654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595463|NCT00979732|Grape Seed Extract|grape seed extract|mesh-list
25595464|NCT00979732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25595465|NCT00979732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595466|NCT00979732|Antioxidants|antioxidants|mesh-ancestor
25595467|NCT00979732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595468|NCT00979732|Protective Agents|protective agents|mesh-ancestor
25595469|NCT00979732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595470|NCT00979745|Afamelanotide|afamelanotide|mesh-list
25595471|NCT00979745|Dermatologic Agents|dermatologic agents|mesh-ancestor
25595472|NCT00979875|Insulin|insulin|mesh-list
25595473|NCT00979875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25595474|NCT00979875|Insulin Aspart|insulin aspart|mesh-list
25595475|NCT00979875|Insulin Lispro|insulin lispro|mesh-list
25595476|NCT00979875|Insulin glulisine|insulin glulisine|mesh-list
25595477|NCT00979875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25595478|NCT00979875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595479|NCT00979940|Atorvastatin|atorvastatin|mesh-list
25595480|NCT00979940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25595481|NCT00979940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25595482|NCT00979940|Antimetabolites|antimetabolites|mesh-ancestor
25595483|NCT00979940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595484|NCT00979940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25595485|NCT00979940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25595486|NCT00979940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595487|NCT00979953|Oxycodone|oxycodone|mesh-list
25595488|NCT00979953|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25595489|NCT00979953|Narcotics|narcotics|mesh-ancestor
25595490|NCT00979953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24995254|NCT05416957|Vortioxetine|vortioxetine|mesh-list
25595491|NCT00979953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595492|NCT00979953|Analgesics|analgesics|mesh-ancestor
25595493|NCT00979953|Sensory System Agents|sensory system agents|mesh-ancestor
25595494|NCT00979953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25595495|NCT00979992|Sunitinib|sunitinib|mesh-list
25595496|NCT00979992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595497|NCT00979992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25595498|NCT00979992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25595499|NCT00979992|Growth Substances|growth substances|mesh-ancestor
25595500|NCT00979992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595501|NCT00979992|Growth Inhibitors|growth inhibitors|mesh-ancestor
25595502|NCT00979992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25595503|NCT00979992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595504|NCT00979992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595505|NCT00980044|Tramadol|tramadol|mesh-list
25595506|NCT00980044|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25595507|NCT00980044|Narcotics|narcotics|mesh-ancestor
25595508|NCT00980044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25595509|NCT00980044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595510|NCT00980044|Analgesics|analgesics|mesh-ancestor
25595511|NCT00980044|Sensory System Agents|sensory system agents|mesh-ancestor
25595512|NCT00980044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25595513|NCT00980148|Azithromycin|azithromycin|mesh-list
25595514|NCT00980148|Doxycycline|doxycycline|mesh-list
25595515|NCT00980148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25595516|NCT00980148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25595517|NCT00980148|Antimalarials|antimalarials|mesh-ancestor
25595518|NCT00980148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25595519|NCT00980148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25595520|NCT00980174|Denosumab|denosumab|mesh-list
25595521|NCT00980174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25595522|NCT00980174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595523|NCT00980330|Ribavirin|ribavirin|mesh-list
25595524|NCT00980330|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25595525|NCT00980330|Interferon alpha-2|interferon alpha-2|mesh-list
25490074|NCT00220961|Pioglitazone|pioglitazone|mesh-list
25595526|NCT00980330|Simeprevir|simeprevir|mesh-list
25595527|NCT00980330|Antimetabolites|antimetabolites|mesh-ancestor
25595528|NCT00980330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595529|NCT00980330|Antiviral Agents|antiviral agents|mesh-ancestor
25595530|NCT00980330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25595531|NCT00980330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595532|NCT00980330|Protease Inhibitors|protease inhibitors|mesh-ancestor
25595533|NCT00980330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595534|NCT00980395|Rituximab|rituximab|mesh-list
25595535|NCT00980395|Bortezomib|bortezomib|mesh-list
25595536|NCT00980395|Cladribine|cladribine|mesh-list
25595537|NCT00980395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25595538|NCT00980395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595539|NCT00980395|Immunologic Factors|immunologic factors|mesh-ancestor
25595540|NCT00980395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595541|NCT00980395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25595542|NCT00980395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25595543|NCT00980681|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
25595544|NCT00980681|Chelating Agents|chelating agents|mesh-ancestor
25595545|NCT00980681|Sequestering Agents|sequestering agents|mesh-ancestor
25595546|NCT00980681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595547|NCT00980746|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25595548|NCT00980746|Anticonvulsants|anticonvulsants|mesh-ancestor
25595549|NCT00980746|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25595550|NCT00980746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25595551|NCT00980746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24682635|NCT01387295|Capecitabine|capecitabine|mesh-list
25595552|NCT00980746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595553|NCT00980785|Ramipril|ramipril|mesh-list
25595554|NCT00980785|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25595555|NCT00980785|Protease Inhibitors|protease inhibitors|mesh-ancestor
25595556|NCT00980785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595557|NCT00980785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595558|NCT00980785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25595559|NCT00980798|Hydromorphone|hydromorphone|mesh-list
25595560|NCT00980798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25595561|NCT00980798|Narcotics|narcotics|mesh-ancestor
25595562|NCT00980798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25595563|NCT00980798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595564|NCT00980798|Analgesics|analgesics|mesh-ancestor
25595565|NCT00980798|Sensory System Agents|sensory system agents|mesh-ancestor
25595566|NCT00980798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25595567|NCT00980980|Chlorhexidine|chlorhexidine|mesh-list
25595568|NCT00980980|Mupirocin|mupirocin|mesh-list
25595569|NCT00980980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25595570|NCT00980980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25595571|NCT00980980|Disinfectants|disinfectants|mesh-ancestor
25595572|NCT00980980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25595573|NCT00980980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25595574|NCT00980980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595575|NCT00980980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595576|NCT00981045|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25595577|NCT00981045|Hematinics|hematinics|mesh-ancestor
25595578|NCT00981084|Modafinil|modafinil|mesh-list
25595579|NCT00981084|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25595580|NCT00981084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595581|NCT00981084|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25595582|NCT00981084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25595583|NCT00981084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25595584|NCT00981084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595585|NCT00981149|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25595586|NCT00981149|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25595587|NCT00981149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25595588|NCT00981149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25595589|NCT00981149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595590|NCT00981149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25595591|NCT00981149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595592|NCT00981149|Analgesics|analgesics|mesh-ancestor
25595593|NCT00981149|Sensory System Agents|sensory system agents|mesh-ancestor
25595594|NCT00981149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25595595|NCT00981149|Antidepressive Agents|antidepressive agents|mesh-ancestor
25595596|NCT00981149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25595597|NCT00981149|Dopamine Agents|dopamine agents|mesh-ancestor
25595598|NCT00981214|Pancrelipase|pancrelipase|mesh-list
25595599|NCT00981214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25595600|NCT00981227|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25595601|NCT00981227|Anticonvulsants|anticonvulsants|mesh-ancestor
25595602|NCT00981227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25595603|NCT00981227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25595604|NCT00981227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25595605|NCT00981227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595606|NCT00981409|Heparin|heparin|mesh-list
25595607|NCT00981409|Calcium heparin|calcium heparin|mesh-list
25595608|NCT00981409|PENTA|penta|mesh-list
25595609|NCT00981409|Fondaparinux|fondaparinux|mesh-list
25595610|NCT00981409|Anticoagulants|anticoagulants|mesh-ancestor
25595611|NCT00981409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25595612|NCT00981409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25595613|NCT00981409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595614|NCT00981409|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25595615|NCT00981409|Antithrombins|antithrombins|mesh-ancestor
25595616|NCT00981409|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25595617|NCT00981409|Protease Inhibitors|protease inhibitors|mesh-ancestor
25595618|NCT00981409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595619|NCT00981435|Prednisolone|prednisolone|mesh-list
25595620|NCT00981435|Prednisolone acetate|prednisolone acetate|mesh-list
25595621|NCT00981435|Ketorolac|ketorolac|mesh-list
24798090|NCT01960543|Bupivacaine|bupivacaine|mesh-list
25595622|NCT00981435|Lubricant Eye Drops|lubricant eye drops|mesh-list
25595623|NCT00981435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25595624|NCT00981435|Glucocorticoids|glucocorticoids|mesh-ancestor
25595625|NCT00981435|Hormones|hormones|mesh-ancestor
25595626|NCT00981435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25595627|NCT00981435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595628|NCT00981435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25595629|NCT00981435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595630|NCT00981435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25595631|NCT00981435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25595632|NCT00981435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25595633|NCT00981435|Analgesics|analgesics|mesh-ancestor
25595634|NCT00981435|Sensory System Agents|sensory system agents|mesh-ancestor
25595635|NCT00981435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25595636|NCT00981435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25595637|NCT00981435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595638|NCT00981435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595639|NCT00981435|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25595640|NCT00981435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25595641|NCT00981526|Telmisartan|telmisartan|mesh-list
25595642|NCT00981526|Olanzapine|olanzapine|mesh-list
25595643|NCT00981526|Clozapine|clozapine|mesh-list
25595644|NCT00981526|Antiemetics|antiemetics|mesh-ancestor
25595645|NCT00981526|Autonomic Agents|autonomic agents|mesh-ancestor
25595646|NCT00981526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25595647|NCT00981526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595648|NCT00981526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25595649|NCT00981526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25595650|NCT00981526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25595651|NCT00981526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25595652|NCT00981526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25595653|NCT00981526|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25595654|NCT00981526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25595655|NCT00981526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25595656|NCT00981526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595657|NCT00981526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25595658|NCT00981526|Serotonin Agents|serotonin agents|mesh-ancestor
25595659|NCT00981526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25595660|NCT00981526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25595661|NCT00981526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25595662|NCT00981526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25595663|NCT00981526|GABA Antagonists|gaba antagonists|mesh-ancestor
25595664|NCT00981526|GABA Agents|gaba agents|mesh-ancestor
25595665|NCT00981669|Vaccines|vaccines|mesh-list
25595666|NCT00981669|Immunologic Factors|immunologic factors|mesh-ancestor
25595667|NCT00981669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595668|NCT00981747|Losartan|losartan|mesh-list
25595669|NCT00981747|Sildenafil Citrate|sildenafil citrate|mesh-list
25595670|NCT00981747|Vasodilator Agents|vasodilator agents|mesh-ancestor
25595671|NCT00981747|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25595672|NCT00981747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25595673|NCT00981747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657199|NCT01584388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25490225|NCT00223665|Leuprolide|leuprolide|mesh-list
25595674|NCT00981747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595675|NCT00981747|Urological Agents|urological agents|mesh-ancestor
25595676|NCT00981747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25595677|NCT00981747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25595678|NCT00981747|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25595679|NCT00981747|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25595680|NCT00981799|Cyclophosphamide|cyclophosphamide|mesh-list
25595681|NCT00981799|Methotrexate|methotrexate|mesh-list
25595682|NCT00981799|Etoposide|etoposide|mesh-list
25595683|NCT00981799|Lenograstim|lenograstim|mesh-list
25595684|NCT00981799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25595685|NCT00981799|Immunologic Factors|immunologic factors|mesh-ancestor
25595686|NCT00981799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595687|NCT00981799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24688830|NCT02636322|Antibodies|antibodies|mesh-list
25595688|NCT00981799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25595689|NCT00981799|Alkylating Agents|alkylating agents|mesh-ancestor
25595690|NCT00981799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595691|NCT00981799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595692|NCT00981799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25595693|NCT00981799|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25595694|NCT00981799|Abortifacient Agents|abortifacient agents|mesh-ancestor
25595695|NCT00981799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25595696|NCT00981799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25595697|NCT00981799|Antimetabolites|antimetabolites|mesh-ancestor
25595698|NCT00981799|Dermatologic Agents|dermatologic agents|mesh-ancestor
25595699|NCT00981799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595700|NCT00981799|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25595701|NCT00981799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25595702|NCT00981799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25595703|NCT00981799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25595704|NCT00981799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25595705|NCT00981799|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25595706|NCT00981825|Listerine|listerine|mesh-list
25595707|NCT00981825|Triclosan|triclosan|mesh-list
25595708|NCT00981825|Fluorides|fluorides|mesh-list
25595709|NCT00981825|Sodium Fluoride|sodium fluoride|mesh-list
25595710|NCT00981825|Cariostatic Agents|cariostatic agents|mesh-ancestor
25595711|NCT00981825|Protective Agents|protective agents|mesh-ancestor
25595712|NCT00981825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595713|NCT00981825|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25595714|NCT00981825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25595715|NCT00981825|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25595716|NCT00981825|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25595717|NCT00981825|Antimetabolites|antimetabolites|mesh-ancestor
25595718|NCT00981825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595719|NCT00981825|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25595720|NCT00982007|Ferric Compounds|ferric compounds|mesh-list
25595721|NCT00982007|Hematinics|hematinics|mesh-ancestor
25595722|NCT00982020|Olanzapine|olanzapine|mesh-list
25595723|NCT00982020|Antiemetics|antiemetics|mesh-ancestor
24844919|NCT02235324|Leucovorin|leucovorin|mesh-list
25595724|NCT00982020|Autonomic Agents|autonomic agents|mesh-ancestor
25595725|NCT00982020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25595726|NCT00982020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595727|NCT00982020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25595728|NCT00982020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25595729|NCT00982020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25595730|NCT00982020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25595731|NCT00982020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25595732|NCT00982020|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25595733|NCT00982020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25595734|NCT00982020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25595735|NCT00982020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595736|NCT00982020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25595737|NCT00982020|Serotonin Agents|serotonin agents|mesh-ancestor
25595738|NCT00982072|Prednisolone|prednisolone|mesh-list
25595739|NCT00982072|Tacrolimus|tacrolimus|mesh-list
25595740|NCT00982072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25595741|NCT00982072|Immunologic Factors|immunologic factors|mesh-ancestor
25595742|NCT00982072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595743|NCT00982072|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25595744|NCT00982072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595745|NCT00982072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490285|NCT00224016|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25595746|NCT00982072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25595747|NCT00982072|Glucocorticoids|glucocorticoids|mesh-ancestor
25595749|NCT00982072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25595750|NCT00982072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25595751|NCT00982072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595752|NCT00982189|Lisinopril|lisinopril|mesh-list
25595753|NCT00982189|Pravastatin|pravastatin|mesh-list
25595754|NCT00982189|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25595755|NCT00982189|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25595756|NCT00982189|Antimetabolites|antimetabolites|mesh-ancestor
25595757|NCT00982189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595758|NCT00982189|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25595759|NCT00982189|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25595760|NCT00982189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595761|NCT00982189|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25595762|NCT00982189|Protease Inhibitors|protease inhibitors|mesh-ancestor
25595763|NCT00982189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25595764|NCT00982189|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25595765|NCT00982189|Protective Agents|protective agents|mesh-ancestor
25595766|NCT00982189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595767|NCT00982228|Insulin|insulin|mesh-list
25595768|NCT00982228|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25595769|NCT00982228|Insulin Glargine|insulin glargine|mesh-list
25595770|NCT00982228|Insulin Aspart|insulin aspart|mesh-list
25595771|NCT00982228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25595772|NCT00982228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595773|NCT00982280|Tapentadol|tapentadol|mesh-list
25595774|NCT00982280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25595775|NCT00982280|Narcotics|narcotics|mesh-ancestor
25595776|NCT00982280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24693091|NCT01418183|Levobupivacaine|levobupivacaine|mesh-list
25595777|NCT00982280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595778|NCT00982280|Analgesics|analgesics|mesh-ancestor
25595779|NCT00982280|Sensory System Agents|sensory system agents|mesh-ancestor
25490358|NCT00224874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25490359|NCT00224874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25490360|NCT00224874|Analgesics|analgesics|mesh-ancestor
25490361|NCT00224874|Sensory System Agents|sensory system agents|mesh-ancestor
25490362|NCT00224874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25490363|NCT00224874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490364|NCT00224874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25490365|NCT00224874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25490366|NCT00224874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25490367|NCT00224874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25490368|NCT00224874|Immunologic Factors|immunologic factors|mesh-ancestor
25490369|NCT00224874|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25490370|NCT00224952|Carbamazepine|carbamazepine|mesh-list
25490371|NCT00224952|Valproic Acid|valproic acid|mesh-list
25490372|NCT00224952|Anticonvulsants|anticonvulsants|mesh-ancestor
25490373|NCT00224952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490374|NCT00224952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490375|NCT00224952|GABA Agents|gaba agents|mesh-ancestor
25490376|NCT00224952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25490377|NCT00224952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490378|NCT00224952|Antimanic Agents|antimanic agents|mesh-ancestor
25595780|NCT00982280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25595781|NCT00982280|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25595782|NCT00982280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25595783|NCT00982280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25595784|NCT00982280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595785|NCT00982280|Adrenergic Agents|adrenergic agents|mesh-ancestor
25595786|NCT00982280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25595787|NCT00982345|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25595788|NCT00982345|Antidepressive Agents|antidepressive agents|mesh-ancestor
25595789|NCT00982345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25595790|NCT00982345|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25595791|NCT00982345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25595792|NCT00982345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25706824|NCT02221349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25595793|NCT00982345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653678|NCT01539837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653679|NCT01540487|Metformin|metformin|mesh-list
25653680|NCT01540487|Linagliptin|linagliptin|mesh-list
25653681|NCT01540487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25653682|NCT01540487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653683|NCT01540487|Incretins|incretins|mesh-ancestor
25653684|NCT01540487|Hormones|hormones|mesh-ancestor
25595794|NCT00982423|Furosemide|furosemide|mesh-list
25595795|NCT00982423|Diuretics|diuretics|mesh-ancestor
25595796|NCT00982423|Natriuretic Agents|natriuretic agents|mesh-ancestor
25595797|NCT00982423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595798|NCT00982423|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25595799|NCT00982423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25706840|NCT02221674|Analgesics|analgesics|mesh-ancestor
25595800|NCT00982423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595801|NCT00982488|Imatinib Mesylate|imatinib mesylate|mesh-list
25595802|NCT00982488|Dasatinib|dasatinib|mesh-list
25595803|NCT00982488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595804|NCT00982488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25595805|NCT00982488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595806|NCT00982488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595807|NCT00982553|Ribavirin|ribavirin|mesh-list
25595808|NCT00982553|Raltegravir Potassium|raltegravir potassium|mesh-list
25595809|NCT00982553|Antimetabolites|antimetabolites|mesh-ancestor
24695804|NCT01231906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25595810|NCT00982553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595811|NCT00982553|Antiviral Agents|antiviral agents|mesh-ancestor
25595812|NCT00982553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25595813|NCT00982553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25595814|NCT00982553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25595815|NCT00982553|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25595816|NCT00982553|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25595817|NCT00982553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595818|NCT00982592|Leucovorin|leucovorin|mesh-list
25595819|NCT00982592|Fluorouracil|fluorouracil|mesh-list
25595820|NCT00982592|Oxaliplatin|oxaliplatin|mesh-list
25595821|NCT00982592|Calcium|calcium|mesh-list
25595822|NCT00982592|Levoleucovorin|levoleucovorin|mesh-list
25595823|NCT00982592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25595824|NCT00982592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595825|NCT00982592|Antimetabolites|antimetabolites|mesh-ancestor
25595826|NCT00982592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595827|NCT00982592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25595828|NCT00982592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595829|NCT00982592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25595830|NCT00982592|Immunologic Factors|immunologic factors|mesh-ancestor
25595831|NCT00982592|Antidotes|antidotes|mesh-ancestor
25595832|NCT00982592|Protective Agents|protective agents|mesh-ancestor
25595833|NCT00982592|Vitamin B Complex|vitamin b complex|mesh-ancestor
25595834|NCT00982592|Vitamins|vitamins|mesh-ancestor
25595835|NCT00982592|Micronutrients|micronutrients|mesh-ancestor
25595836|NCT00982644|Insulin|insulin|mesh-list
25595837|NCT00982644|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25595838|NCT00982644|Insulin Glargine|insulin glargine|mesh-list
25595839|NCT00982644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25595840|NCT00982644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595841|NCT00982657|Sunitinib|sunitinib|mesh-list
25595842|NCT00982657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595843|NCT00982657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25595844|NCT00982657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25595845|NCT00982657|Growth Substances|growth substances|mesh-ancestor
25595846|NCT00982657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595847|NCT00982657|Growth Inhibitors|growth inhibitors|mesh-ancestor
25595848|NCT00982657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25595849|NCT00982657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595850|NCT00982657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595851|NCT00982865|Niacinamide|niacinamide|mesh-list
25595852|NCT00982865|Vitamin B Complex|vitamin b complex|mesh-ancestor
25595853|NCT00982865|Vitamins|vitamins|mesh-ancestor
25595854|NCT00982865|Micronutrients|micronutrients|mesh-ancestor
25595855|NCT00982865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595856|NCT00982878|Maraviroc|maraviroc|mesh-list
25595857|NCT00982878|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25595858|NCT00982878|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25595859|NCT00982878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595860|NCT00982878|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25595861|NCT00982878|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25595862|NCT00982878|Antiviral Agents|antiviral agents|mesh-ancestor
25595863|NCT00982878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25595864|NCT00982878|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25595865|NCT00982930|Tobramycin|tobramycin|mesh-list
25595866|NCT00982930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25490411|NCT00225251|Bupropion|bupropion|mesh-list
25595867|NCT00982930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25595868|NCT00983073|Tapentadol|tapentadol|mesh-list
25595869|NCT00983073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25595870|NCT00983073|Narcotics|narcotics|mesh-ancestor
25595871|NCT00983073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25595872|NCT00983073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595873|NCT00983073|Analgesics|analgesics|mesh-ancestor
25595874|NCT00983073|Sensory System Agents|sensory system agents|mesh-ancestor
25595875|NCT00983073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803877|NCT01999270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595876|NCT00983073|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25595877|NCT00983073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25595878|NCT00983073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25595879|NCT00983073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595880|NCT00983073|Adrenergic Agents|adrenergic agents|mesh-ancestor
25595881|NCT00983073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25595882|NCT00983216|Ketoconazole|ketoconazole|mesh-list
25595883|NCT00983216|Colchicine|colchicine|mesh-list
25595884|NCT00983216|Gout Suppressants|gout suppressants|mesh-ancestor
25595885|NCT00983216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25595886|NCT00983216|Tubulin Modulators|tubulin modulators|mesh-ancestor
25595887|NCT00983216|Antimitotic Agents|antimitotic agents|mesh-ancestor
25595888|NCT00983216|Mitosis Modulators|mitosis modulators|mesh-ancestor
25595889|NCT00983216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595890|NCT00983216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595891|NCT00983216|Antifungal Agents|antifungal agents|mesh-ancestor
25595892|NCT00983216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25595893|NCT00983216|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25595894|NCT00983216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25595895|NCT00983216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595896|NCT00983216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25595897|NCT00983216|Hormone Antagonists|hormone antagonists|mesh-ancestor
25595898|NCT00983216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25595899|NCT00983216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595900|NCT00983216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25595901|NCT00983242|Colchicine|colchicine|mesh-list
25595902|NCT00983242|Verapamil|verapamil|mesh-list
25595903|NCT00983242|Gout Suppressants|gout suppressants|mesh-ancestor
25595904|NCT00983242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25595905|NCT00983242|Tubulin Modulators|tubulin modulators|mesh-ancestor
25595906|NCT00983242|Antimitotic Agents|antimitotic agents|mesh-ancestor
25595907|NCT00983242|Mitosis Modulators|mitosis modulators|mesh-ancestor
25595908|NCT00983242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595909|NCT00983242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595910|NCT00983242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25595911|NCT00983242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24804678|NCT02004314|Amebicides|amebicides|mesh-ancestor
25595912|NCT00983242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25595913|NCT00983242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25595914|NCT00983242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595915|NCT00983242|Vasodilator Agents|vasodilator agents|mesh-ancestor
25595916|NCT00983294|Azithromycin|azithromycin|mesh-list
25595917|NCT00983294|Colchicine|colchicine|mesh-list
25595918|NCT00983294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25595919|NCT00983294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25595920|NCT00983294|Gout Suppressants|gout suppressants|mesh-ancestor
25595921|NCT00983294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25595922|NCT00983294|Tubulin Modulators|tubulin modulators|mesh-ancestor
25595923|NCT00983294|Antimitotic Agents|antimitotic agents|mesh-ancestor
25595924|NCT00983294|Mitosis Modulators|mitosis modulators|mesh-ancestor
25595925|NCT00983294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595926|NCT00983294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595927|NCT00983307|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25595928|NCT00983307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595929|NCT00983307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25595930|NCT00983307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595931|NCT00983307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595932|NCT00983346|Bortezomib|bortezomib|mesh-list
25595933|NCT00983346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595934|NCT00983372|Colchicine|colchicine|mesh-list
25595935|NCT00983372|Diltiazem|diltiazem|mesh-list
25595936|NCT00983372|Gout Suppressants|gout suppressants|mesh-ancestor
25595937|NCT00983372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25595938|NCT00983372|Tubulin Modulators|tubulin modulators|mesh-ancestor
25595939|NCT00983372|Antimitotic Agents|antimitotic agents|mesh-ancestor
25595940|NCT00983372|Mitosis Modulators|mitosis modulators|mesh-ancestor
25595941|NCT00983372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595942|NCT00983372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595943|NCT00983372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25595944|NCT00983372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25595945|NCT00983372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25595946|NCT00983372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25595947|NCT00983372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595948|NCT00983372|Vasodilator Agents|vasodilator agents|mesh-ancestor
25595950|NCT00983385|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25595951|NCT00983385|Narcotics|narcotics|mesh-ancestor
25595952|NCT00983385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25595953|NCT00983385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25595954|NCT00983385|Analgesics|analgesics|mesh-ancestor
25595955|NCT00983385|Sensory System Agents|sensory system agents|mesh-ancestor
25595956|NCT00983385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25595957|NCT00983385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25595958|NCT00983385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25595959|NCT00983385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25595960|NCT00983385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595961|NCT00983385|Adrenergic Agents|adrenergic agents|mesh-ancestor
25595962|NCT00983385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25595963|NCT00983515|Ritonavir|ritonavir|mesh-list
25595964|NCT00983515|Colchicine|colchicine|mesh-list
25595965|NCT00983515|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25595966|NCT00983515|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25595967|NCT00983515|Protease Inhibitors|protease inhibitors|mesh-ancestor
25595968|NCT00983515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595969|NCT00983515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595970|NCT00983515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25595971|NCT00983515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25595972|NCT00983515|Antiviral Agents|antiviral agents|mesh-ancestor
25595973|NCT00983515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24823669|NCT02118467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25595974|NCT00983515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25595975|NCT00983515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25595976|NCT00983515|Gout Suppressants|gout suppressants|mesh-ancestor
25595977|NCT00983515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25595978|NCT00983515|Tubulin Modulators|tubulin modulators|mesh-ancestor
25595979|NCT00983515|Antimitotic Agents|antimitotic agents|mesh-ancestor
25595980|NCT00983515|Mitosis Modulators|mitosis modulators|mesh-ancestor
25595981|NCT00983515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595982|NCT00983528|Alemtuzumab|alemtuzumab|mesh-list
25595983|NCT00983528|Clofarabine|clofarabine|mesh-list
25595984|NCT00983528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25595985|NCT00983528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595986|NCT00983528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25595987|NCT00983528|Antimetabolites|antimetabolites|mesh-ancestor
25595988|NCT00983528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595989|NCT00983541|Gemcitabine|gemcitabine|mesh-list
25595990|NCT00983541|Fluorouracil|fluorouracil|mesh-list
25595991|NCT00983541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25595992|NCT00983541|Antimetabolites|antimetabolites|mesh-ancestor
25595993|NCT00983541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25595994|NCT00983541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25595995|NCT00983541|Antiviral Agents|antiviral agents|mesh-ancestor
25595996|NCT00983541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25595997|NCT00983541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25595998|NCT00983541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25595999|NCT00983541|Immunologic Factors|immunologic factors|mesh-ancestor
25596000|NCT00983541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596001|NCT00983580|Aspirin|aspirin|mesh-list
25596002|NCT00983580|Eflornithine|eflornithine|mesh-list
25596003|NCT00983580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25596004|NCT00983580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25596005|NCT00983580|Analgesics|analgesics|mesh-ancestor
25596006|NCT00983580|Sensory System Agents|sensory system agents|mesh-ancestor
25596007|NCT00983580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25596008|NCT00983580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596009|NCT00983580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25596010|NCT00983580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25596011|NCT00983580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25596012|NCT00983580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25596013|NCT00983580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596014|NCT00983580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25596015|NCT00983580|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25596016|NCT00983580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25596017|NCT00983580|Antipyretics|antipyretics|mesh-ancestor
25490543|NCT00226811|Growth Substances|growth substances|mesh-ancestor
25596019|NCT00983580|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25596020|NCT00983580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25596021|NCT00983580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25596022|NCT00983580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25596023|NCT00983580|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
25596024|NCT00983619|Rituximab|rituximab|mesh-list
25596025|NCT00983619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25596026|NCT00983619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596027|NCT00983619|Immunologic Factors|immunologic factors|mesh-ancestor
25596028|NCT00983619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596029|NCT00983619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25596030|NCT00983853|Ribavirin|ribavirin|mesh-list
25596031|NCT00983853|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25596032|NCT00983853|Antimetabolites|antimetabolites|mesh-ancestor
25596033|NCT00983853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596034|NCT00983853|Antiviral Agents|antiviral agents|mesh-ancestor
25596035|NCT00983853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25596036|NCT00983905|Colchicine|colchicine|mesh-list
25596037|NCT00983905|Theophylline|theophylline|mesh-list
25596038|NCT00983905|Gout Suppressants|gout suppressants|mesh-ancestor
25596039|NCT00983905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25596040|NCT00983905|Tubulin Modulators|tubulin modulators|mesh-ancestor
25596041|NCT00983905|Antimitotic Agents|antimitotic agents|mesh-ancestor
25596042|NCT00983905|Mitosis Modulators|mitosis modulators|mesh-ancestor
25596043|NCT00983905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596044|NCT00983905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596045|NCT00983905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25596046|NCT00983905|Autonomic Agents|autonomic agents|mesh-ancestor
25596047|NCT00983905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25596048|NCT00983905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596049|NCT00983905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25596050|NCT00983905|Respiratory System Agents|respiratory system agents|mesh-ancestor
25596051|NCT00983905|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25596052|NCT00983905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25596053|NCT00983905|Vasodilator Agents|vasodilator agents|mesh-ancestor
25596054|NCT00983905|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25596055|NCT00983905|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25596056|NCT00983905|Purinergic Agents|purinergic agents|mesh-ancestor
25596057|NCT00983905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25596058|NCT00983918|Propofol|propofol|mesh-list
25596059|NCT00983918|Sevoflurane|sevoflurane|mesh-list
25596060|NCT00983918|Desflurane|desflurane|mesh-list
25596061|NCT00983918|Isoflurane|isoflurane|mesh-list
25596062|NCT00983918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25596063|NCT00983918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25596064|NCT00983918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596065|NCT00983918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25596066|NCT00983918|Anesthetics, General|anesthetics, general|mesh-ancestor
25596067|NCT00983918|Anesthetics|anesthetics|mesh-ancestor
25596068|NCT00983918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25596069|NCT00983918|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25596070|NCT00983931|Cyclosporine|cyclosporine|mesh-list
25596071|NCT00983931|Colchicine|colchicine|mesh-list
25596072|NCT00983931|Cyclosporins|cyclosporins|mesh-list
25596073|NCT00983931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25596074|NCT00983931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596075|NCT00983931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25596076|NCT00983931|Immunologic Factors|immunologic factors|mesh-ancestor
25596077|NCT00983931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596078|NCT00983931|Antifungal Agents|antifungal agents|mesh-ancestor
25596079|NCT00983931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25596080|NCT00983931|Dermatologic Agents|dermatologic agents|mesh-ancestor
25596081|NCT00983931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25596082|NCT00983931|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25596083|NCT00983931|Gout Suppressants|gout suppressants|mesh-ancestor
25596084|NCT00983931|Tubulin Modulators|tubulin modulators|mesh-ancestor
25596085|NCT00983931|Antimitotic Agents|antimitotic agents|mesh-ancestor
25596086|NCT00983931|Mitosis Modulators|mitosis modulators|mesh-ancestor
25596087|NCT00983931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596088|NCT00983957|Moxifloxacin|moxifloxacin|mesh-list
25596089|NCT00983957|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25596090|NCT00983957|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25596091|NCT00983957|Contraceptive Agents|contraceptive agents|mesh-ancestor
25596092|NCT00983957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25490626|NCT00227370|Valganciclovir|valganciclovir|mesh-list
25596093|NCT00983957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596094|NCT00983957|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25596095|NCT00983957|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25596096|NCT00983957|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25596097|NCT00983957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25596098|NCT00983957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25596099|NCT00983957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25596100|NCT00983957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25596101|NCT00983957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25596102|NCT00983957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596103|NCT00983957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596104|NCT00984009|Colchicine|colchicine|mesh-list
25596105|NCT00984009|Gout Suppressants|gout suppressants|mesh-ancestor
25596106|NCT00984009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25596107|NCT00984009|Tubulin Modulators|tubulin modulators|mesh-ancestor
25596108|NCT00984009|Antimitotic Agents|antimitotic agents|mesh-ancestor
25596109|NCT00984009|Mitosis Modulators|mitosis modulators|mesh-ancestor
25596110|NCT00984009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596111|NCT00984009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596112|NCT00984022|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25596113|NCT00984022|Laxatives|laxatives|mesh-ancestor
25596114|NCT00984022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25596115|NCT00984061|Clarithromycin|clarithromycin|mesh-list
25596116|NCT00984061|Colchicine|colchicine|mesh-list
25596117|NCT00984061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25596118|NCT00984061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25596119|NCT00984061|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25596120|NCT00984061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25596121|NCT00984061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596122|NCT00984061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25596123|NCT00984061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25596124|NCT00984061|Gout Suppressants|gout suppressants|mesh-ancestor
25596125|NCT00984061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25596126|NCT00984061|Tubulin Modulators|tubulin modulators|mesh-ancestor
25596127|NCT00984061|Antimitotic Agents|antimitotic agents|mesh-ancestor
25596128|NCT00984061|Mitosis Modulators|mitosis modulators|mesh-ancestor
25596129|NCT00984061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596130|NCT00984126|Factor VIII|factor viii|mesh-list
25596131|NCT00984126|Coagulants|coagulants|mesh-ancestor
25596132|NCT00984139|Vaccines|vaccines|mesh-list
25596133|NCT00984139|Immunologic Factors|immunologic factors|mesh-ancestor
25596134|NCT00984139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596135|NCT00984256|Atovaquone|atovaquone|mesh-list
25596136|NCT00984256|Proguanil|proguanil|mesh-list
25596137|NCT00984256|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
25596138|NCT00984256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25596139|NCT00984256|Antimalarials|antimalarials|mesh-ancestor
25596140|NCT00984256|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25596141|NCT00984256|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25596142|NCT00984256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25596143|NCT00984256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596144|NCT00984256|Antimetabolites|antimetabolites|mesh-ancestor
25596145|NCT00984282|Sorafenib|sorafenib|mesh-list
25596146|NCT00984282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596147|NCT00984282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25596148|NCT00984282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25596149|NCT00984282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596150|NCT00984334|Naloxone|naloxone|mesh-list
25596151|NCT00984334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25596152|NCT00984334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596153|NCT00984334|Sensory System Agents|sensory system agents|mesh-ancestor
25596154|NCT00984334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25596155|NCT00984542|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25596156|NCT00984542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24635019|NCT01136421|Cholinergic Agents|cholinergic agents|mesh-ancestor
24534099|NCT00646035|Vitamins|vitamins|mesh-ancestor
24458375|NCT00337649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24458377|NCT00337649|Tubulin Modulators|tubulin modulators|mesh-ancestor
25596157|NCT00984542|Alkylating Agents|alkylating agents|mesh-ancestor
25596158|NCT00984542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596159|NCT00984542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596160|NCT00984568|Aminosalicylic Acid|aminosalicylic acid|mesh-list
25596161|NCT00984568|Prednisolone|prednisolone|mesh-list
25596162|NCT00984568|Mesalamine|mesalamine|mesh-list
25596163|NCT00984568|Azathioprine|azathioprine|mesh-list
25596164|NCT00984568|Infliximab|infliximab|mesh-list
25596165|NCT00984568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25596166|NCT00984568|Glucocorticoids|glucocorticoids|mesh-ancestor
25596167|NCT00984568|Hormones|hormones|mesh-ancestor
25596168|NCT00984568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25596169|NCT00984568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596170|NCT00984568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25596171|NCT00984568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596172|NCT00984568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25596173|NCT00984568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25596174|NCT00984568|Dermatologic Agents|dermatologic agents|mesh-ancestor
25596175|NCT00984568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25596176|NCT00984568|Antimetabolites|antimetabolites|mesh-ancestor
25596177|NCT00984568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596178|NCT00984568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25596179|NCT00984568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25596180|NCT00984568|Immunologic Factors|immunologic factors|mesh-ancestor
25596181|NCT00984568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25596182|NCT00984568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25596183|NCT00984568|Analgesics|analgesics|mesh-ancestor
25596184|NCT00984568|Sensory System Agents|sensory system agents|mesh-ancestor
25596185|NCT00984568|Antitubercular Agents|antitubercular agents|mesh-ancestor
25596186|NCT00984568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25596187|NCT00984568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25596188|NCT00984620|Interferons|interferons|mesh-list
25596189|NCT00984620|Ribavirin|ribavirin|mesh-list
25596190|NCT00984620|Interferon-alpha|interferon-alpha|mesh-list
25596191|NCT00984620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596192|NCT00984620|Antiviral Agents|antiviral agents|mesh-ancestor
25596193|NCT00984620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25596194|NCT00984620|Antimetabolites|antimetabolites|mesh-ancestor
25596195|NCT00984620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596196|NCT00984620|Immunologic Factors|immunologic factors|mesh-ancestor
25596197|NCT00984620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596198|NCT00984659|Fluticasone|fluticasone|mesh-list
25596199|NCT00984659|Xhance|xhance|mesh-list
25596200|NCT00984659|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25596201|NCT00984659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25596202|NCT00984659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25596203|NCT00984659|Autonomic Agents|autonomic agents|mesh-ancestor
25596204|NCT00984659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25596205|NCT00984659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596206|NCT00984659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25596207|NCT00984659|Respiratory System Agents|respiratory system agents|mesh-ancestor
25596208|NCT00984659|Dermatologic Agents|dermatologic agents|mesh-ancestor
25596209|NCT00984659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25596210|NCT00984659|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25596211|NCT00984659|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25596212|NCT00984659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25596213|NCT00984659|Adrenergic Agents|adrenergic agents|mesh-ancestor
25596214|NCT00984659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25596215|NCT00984659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596216|NCT00984867|Dapagliflozin|dapagliflozin|mesh-list
25596217|NCT00984867|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25596218|NCT00984867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596219|NCT00984867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25596220|NCT00984867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596221|NCT00985192|Everolimus|everolimus|mesh-list
25596222|NCT00985192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596223|NCT00985192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25596224|NCT00985192|Immunologic Factors|immunologic factors|mesh-ancestor
25596225|NCT00985192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596226|NCT00985426|Vaccines|vaccines|mesh-list
25596227|NCT00985426|Immunologic Factors|immunologic factors|mesh-ancestor
25596228|NCT00985426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596229|NCT00985439|Celecoxib|celecoxib|mesh-list
25596230|NCT00985439|Diclofenac|diclofenac|mesh-list
25596231|NCT00985439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25596232|NCT00985439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25596233|NCT00985439|Analgesics|analgesics|mesh-ancestor
25596234|NCT00985439|Sensory System Agents|sensory system agents|mesh-ancestor
25596235|NCT00985439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25596236|NCT00985439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596237|NCT00985439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25596238|NCT00985439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25596239|NCT00985439|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25596240|NCT00985439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25596241|NCT00985439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25596242|NCT00985439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596243|NCT00985465|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25596244|NCT00985465|Immunologic Factors|immunologic factors|mesh-ancestor
25596245|NCT00985465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596246|NCT00985504|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25596247|NCT00985504|Citalopram|citalopram|mesh-list
25596248|NCT00985504|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25596249|NCT00985504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25596250|NCT00985504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25596251|NCT00985504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596252|NCT00985504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25596253|NCT00985504|Serotonin Agents|serotonin agents|mesh-ancestor
25596254|NCT00985504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596255|NCT00985504|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25596256|NCT00985504|Antidepressive Agents|antidepressive agents|mesh-ancestor
25596257|NCT00985504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25596258|NCT00985504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25596259|NCT00985504|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25596260|NCT00985504|Analgesics|analgesics|mesh-ancestor
25596261|NCT00985504|Sensory System Agents|sensory system agents|mesh-ancestor
25596262|NCT00985504|Dopamine Agents|dopamine agents|mesh-ancestor
25596263|NCT00985543|Ritonavir|ritonavir|mesh-list
25596264|NCT00985543|Lopinavir|lopinavir|mesh-list
25596265|NCT00985543|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25596266|NCT00985543|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25596267|NCT00985543|Protease Inhibitors|protease inhibitors|mesh-ancestor
25596268|NCT00985543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25596269|NCT00985543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596270|NCT00985543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25596271|NCT00985543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25596272|NCT00985543|Antiviral Agents|antiviral agents|mesh-ancestor
25596273|NCT00985543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25596274|NCT00985543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25596275|NCT00985543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25596276|NCT00985621|Oxycodone|oxycodone|mesh-list
25596277|NCT00985621|Tanezumab|tanezumab|mesh-list
25596278|NCT00985621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25596279|NCT00985621|Narcotics|narcotics|mesh-ancestor
25596280|NCT00985621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25596281|NCT00985621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596282|NCT00985621|Analgesics|analgesics|mesh-ancestor
25596283|NCT00985621|Sensory System Agents|sensory system agents|mesh-ancestor
25596284|NCT00985621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25596285|NCT00985712|Insulin Lispro|insulin lispro|mesh-list
25596286|NCT00985712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25596287|NCT00985712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596288|NCT00985725|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25596289|NCT00985725|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25596290|NCT00985725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596291|NCT00985725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25596292|NCT00985725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25596293|NCT00985725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25596294|NCT00985725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596295|NCT00985725|Dopamine Agents|dopamine agents|mesh-ancestor
25596296|NCT00985725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25596297|NCT00985751|Vaccines|vaccines|mesh-list
25596298|NCT00985751|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25596299|NCT00985751|Immunologic Factors|immunologic factors|mesh-ancestor
25596300|NCT00985751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596301|NCT00985907|Bortezomib|bortezomib|mesh-list
25596302|NCT00985907|Melphalan|melphalan|mesh-list
25596303|NCT00985907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25596304|NCT00985907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596305|NCT00985907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25596306|NCT00985907|Alkylating Agents|alkylating agents|mesh-ancestor
25596307|NCT00985907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596308|NCT00985907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25596309|NCT00985907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25596310|NCT00985907|Immunologic Factors|immunologic factors|mesh-ancestor
25596311|NCT00985907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596312|NCT00985907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25596313|NCT00985946|Panobinostat|panobinostat|mesh-list
25596314|NCT00985946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596315|NCT00985946|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25596316|NCT00985946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25596317|NCT00985946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596318|NCT00985959|Prednisolone|prednisolone|mesh-list
25596319|NCT00985959|Bortezomib|bortezomib|mesh-list
25596320|NCT00985959|Melphalan|melphalan|mesh-list
25596321|NCT00985959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596322|NCT00985959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25596323|NCT00985959|Alkylating Agents|alkylating agents|mesh-ancestor
25596324|NCT00985959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596325|NCT00985959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25596326|NCT00985959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25596327|NCT00985959|Immunologic Factors|immunologic factors|mesh-ancestor
25596328|NCT00985959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596329|NCT00985959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25596330|NCT00985959|Glucocorticoids|glucocorticoids|mesh-ancestor
25596331|NCT00985959|Hormones|hormones|mesh-ancestor
25596332|NCT00985959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25596333|NCT00985959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25596334|NCT00985985|Nicotine|nicotine|mesh-list
25596335|NCT00985985|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25596336|NCT00985985|Autonomic Agents|autonomic agents|mesh-ancestor
25596337|NCT00985985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25596338|NCT00985985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596339|NCT00985985|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25596340|NCT00985985|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25596341|NCT00985985|Cholinergic Agents|cholinergic agents|mesh-ancestor
25596342|NCT00985985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25596343|NCT00985985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596344|NCT00986102|Doripenem|doripenem|mesh-list
25596345|NCT00986102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25596346|NCT00986102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25596347|NCT00986154|Heparin|heparin|mesh-list
25596348|NCT00986154|Calcium heparin|calcium heparin|mesh-list
25596349|NCT00986154|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25596350|NCT00986154|Tinzaparin|tinzaparin|mesh-list
25596351|NCT00986154|Dalteparin|dalteparin|mesh-list
25596352|NCT00986154|Warfarin|warfarin|mesh-list
25596353|NCT00986154|Edoxaban|edoxaban|mesh-list
25596354|NCT00986154|Anticoagulants|anticoagulants|mesh-ancestor
25596355|NCT00986154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25596356|NCT00986154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25596357|NCT00986154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596358|NCT00986154|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25596359|NCT00986154|Antithrombins|antithrombins|mesh-ancestor
25596360|NCT00986154|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25596361|NCT00986154|Protease Inhibitors|protease inhibitors|mesh-ancestor
25596362|NCT00986154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25596363|NCT00986180|Oxycodone|oxycodone|mesh-list
25596364|NCT00986180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25596365|NCT00986180|Narcotics|narcotics|mesh-ancestor
25596366|NCT00986180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25596367|NCT00986180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596368|NCT00986180|Analgesics|analgesics|mesh-ancestor
25596369|NCT00986180|Sensory System Agents|sensory system agents|mesh-ancestor
25596370|NCT00986180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25596371|NCT00986245|Ropinirole|ropinirole|mesh-list
25596372|NCT00986245|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25596373|NCT00986245|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25596374|NCT00986245|Dopamine Agonists|dopamine agonists|mesh-ancestor
25596375|NCT00986245|Dopamine Agents|dopamine agents|mesh-ancestor
25596376|NCT00986245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25596377|NCT00986245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596378|NCT00986245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596379|NCT00986258|Tapentadol|tapentadol|mesh-list
25596380|NCT00986258|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25596381|NCT00986258|Narcotics|narcotics|mesh-ancestor
25596382|NCT00986258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25596383|NCT00986258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596384|NCT00986258|Analgesics|analgesics|mesh-ancestor
25596385|NCT00986258|Sensory System Agents|sensory system agents|mesh-ancestor
25596386|NCT00986258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25596387|NCT00986258|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25490875|NCT00232505|Carboplatin|carboplatin|mesh-list
25490876|NCT00232505|Cetuximab|cetuximab|mesh-list
25490877|NCT00232505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596388|NCT00986258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25490879|NCT00232583|Metformin|metformin|mesh-list
25596389|NCT00986258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25596390|NCT00986258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596391|NCT00986258|Adrenergic Agents|adrenergic agents|mesh-ancestor
25596392|NCT00986258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25596394|NCT00986401|Trospium chloride|trospium chloride|mesh-list
25596395|NCT00986401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25596396|NCT00986401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596397|NCT00986401|Parasympatholytics|parasympatholytics|mesh-ancestor
25596398|NCT00986401|Autonomic Agents|autonomic agents|mesh-ancestor
25596399|NCT00986401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25596400|NCT00986401|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25596401|NCT00986401|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25596402|NCT00986401|Cholinergic Agents|cholinergic agents|mesh-ancestor
25596403|NCT00986401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25596404|NCT00986401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596405|NCT00986401|Urological Agents|urological agents|mesh-ancestor
25596406|NCT00986427|Cyclosporine|cyclosporine|mesh-list
25596407|NCT00986427|Cyclosporins|cyclosporins|mesh-list
25596408|NCT00986427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25596409|NCT00986427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596410|NCT00986427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25596411|NCT00986427|Immunologic Factors|immunologic factors|mesh-ancestor
25596412|NCT00986427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596413|NCT00986427|Antifungal Agents|antifungal agents|mesh-ancestor
25596414|NCT00986427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25596415|NCT00986427|Dermatologic Agents|dermatologic agents|mesh-ancestor
25596416|NCT00986427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25596417|NCT00986427|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25596418|NCT00986440|Efatutazone|efatutazone|mesh-list
25596419|NCT00986440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596420|NCT00986570|Botulinum Toxins|botulinum toxins|mesh-list
25596421|NCT00986570|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25596422|NCT00986570|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25596423|NCT00986570|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25596424|NCT00986570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25596425|NCT00986570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596426|NCT00986570|Cholinergic Agents|cholinergic agents|mesh-ancestor
25596427|NCT00986570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25596428|NCT00986570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596429|NCT00986570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25596430|NCT00986570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653685|NCT01540487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25653686|NCT01540487|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25653687|NCT01540487|Protease Inhibitors|protease inhibitors|mesh-ancestor
25653688|NCT01540487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653689|NCT01540487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653690|NCT01540565|Veliparib|veliparib|mesh-list
25653691|NCT01540565|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25653692|NCT01540565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653693|NCT01540565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653694|NCT01540565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25653695|NCT01540838|Acetaminophen|acetaminophen|mesh-list
25653696|NCT01540838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25653697|NCT01540838|Analgesics|analgesics|mesh-ancestor
25653698|NCT01540838|Sensory System Agents|sensory system agents|mesh-ancestor
25653699|NCT01540838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653700|NCT01540838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653701|NCT01540838|Antipyretics|antipyretics|mesh-ancestor
25653702|NCT01541215|Metformin|metformin|mesh-list
25653703|NCT01541215|Liraglutide|liraglutide|mesh-list
25653704|NCT01541215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25653705|NCT01541215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653706|NCT01541215|Incretins|incretins|mesh-ancestor
25653707|NCT01541215|Hormones|hormones|mesh-ancestor
25653708|NCT01541215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25653709|NCT01541358|Listerine|listerine|mesh-list
25653710|NCT01541358|Fluorides|fluorides|mesh-list
25653711|NCT01541358|Sodium Fluoride|sodium fluoride|mesh-list
25653712|NCT01541358|Cariostatic Agents|cariostatic agents|mesh-ancestor
25653713|NCT01541358|Protective Agents|protective agents|mesh-ancestor
25653714|NCT01541358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653715|NCT01541358|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25653716|NCT01541358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25596431|NCT00986583|Succinylcholine|succinylcholine|mesh-list
25596432|NCT00986583|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
25596433|NCT00986583|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25596434|NCT00986583|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25596435|NCT00986583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25596436|NCT00986583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596437|NCT00986674|Paclitaxel|paclitaxel|mesh-list
25596438|NCT00986674|Carboplatin|carboplatin|mesh-list
25596439|NCT00986674|Cetuximab|cetuximab|mesh-list
25596440|NCT00986674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25596441|NCT00986674|Antibodies|antibodies|mesh-list
25596442|NCT00986674|Immunoglobulins|immunoglobulins|mesh-list
25596443|NCT00986674|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25596444|NCT00986674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25596445|NCT00986674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596446|NCT00986674|Tubulin Modulators|tubulin modulators|mesh-ancestor
25596447|NCT00986674|Antimitotic Agents|antimitotic agents|mesh-ancestor
25596448|NCT00986674|Mitosis Modulators|mitosis modulators|mesh-ancestor
25596449|NCT00986674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596450|NCT00986674|Immunologic Factors|immunologic factors|mesh-ancestor
25596451|NCT00986674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596452|NCT00986856|Fusidic Acid|fusidic acid|mesh-list
25596453|NCT00986856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25596454|NCT00986856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25596455|NCT00986856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25596456|NCT00986856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25596457|NCT00986856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596458|NCT00986921|Mifepristone|mifepristone|mesh-list
25596459|NCT00986921|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25596460|NCT00986921|Abortifacient Agents|abortifacient agents|mesh-ancestor
25596461|NCT00986921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25596462|NCT00986921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596463|NCT00986921|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25596464|NCT00986921|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25596465|NCT00986921|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25596466|NCT00986921|Contraceptive Agents|contraceptive agents|mesh-ancestor
25596467|NCT00986921|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25596468|NCT00986921|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25596469|NCT00986921|Hormone Antagonists|hormone antagonists|mesh-ancestor
25596470|NCT00986921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25596471|NCT00986921|Luteolytic Agents|luteolytic agents|mesh-ancestor
25596472|NCT00986921|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25596473|NCT00986921|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25596474|NCT00986986|Niacin|niacin|mesh-list
25596475|NCT00986986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25596476|NCT00986986|Antimetabolites|antimetabolites|mesh-ancestor
25596477|NCT00986986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596478|NCT00986986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25596479|NCT00986986|Vasodilator Agents|vasodilator agents|mesh-ancestor
25596480|NCT00986986|Vitamin B Complex|vitamin b complex|mesh-ancestor
25596481|NCT00986986|Vitamins|vitamins|mesh-ancestor
25596482|NCT00986986|Micronutrients|micronutrients|mesh-ancestor
25596483|NCT00986986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596484|NCT00987389|Glucocorticoids|glucocorticoids|mesh-list
25596485|NCT00987389|Hormones|hormones|mesh-ancestor
25596486|NCT00987389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25596487|NCT00987389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596488|NCT00987402|Ethanol|ethanol|mesh-list
25596489|NCT00987402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25596490|NCT00987402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25596491|NCT00987402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25596492|NCT00987402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596493|NCT00987415|Allopurinol|allopurinol|mesh-list
25596494|NCT00987415|Antimetabolites|antimetabolites|mesh-ancestor
25596495|NCT00987415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596496|NCT00987415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25596497|NCT00987415|Gout Suppressants|gout suppressants|mesh-ancestor
25596498|NCT00987415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25596499|NCT00987415|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25596500|NCT00987415|Antioxidants|antioxidants|mesh-ancestor
25596501|NCT00987415|Protective Agents|protective agents|mesh-ancestor
25596502|NCT00987415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491000|NCT00234065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491009|NCT00234065|Antipyretics|antipyretics|mesh-ancestor
25491065|NCT00235443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25491066|NCT00235443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25491067|NCT00235443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25491068|NCT00235443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491069|NCT00235573|Vitamin B 12|vitamin b 12|mesh-list
25491070|NCT00235573|Hydroxocobalamin|hydroxocobalamin|mesh-list
25491071|NCT00235573|Vitamins|vitamins|mesh-ancestor
25491072|NCT00235573|Micronutrients|micronutrients|mesh-ancestor
25491073|NCT00235573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491074|NCT00235573|Vitamin B Complex|vitamin b complex|mesh-ancestor
25491075|NCT00235573|Hematinics|hematinics|mesh-ancestor
25491076|NCT00235716|Vitamins|vitamins|mesh-list
25491077|NCT00235716|Vitamin E|vitamin e|mesh-list
25491078|NCT00235716|Tocopherols|tocopherols|mesh-list
25491079|NCT00235716|Tocotrienols|tocotrienols|mesh-list
25491080|NCT00235716|alpha-Tocopherol|alpha-tocopherol|mesh-list
25491081|NCT00235716|Memantine|memantine|mesh-list
25491082|NCT00235716|Micronutrients|micronutrients|mesh-ancestor
25491083|NCT00235716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491084|NCT00235716|Antioxidants|antioxidants|mesh-ancestor
25491085|NCT00235716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491086|NCT00235716|Protective Agents|protective agents|mesh-ancestor
25491087|NCT00235716|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25491088|NCT00235716|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25491089|NCT00235716|Dopamine Agents|dopamine agents|mesh-ancestor
25491090|NCT00235716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25491091|NCT00235716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25491092|NCT00235716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25491093|NCT00235755|Ezogabine|ezogabine|mesh-list
25491094|NCT00235755|Anticonvulsants|anticonvulsants|mesh-ancestor
25491095|NCT00235755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25491096|NCT00235755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491097|NCT00235833|Adalimumab|adalimumab|mesh-list
25491098|NCT00235833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25491099|NCT00235833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24433556|NCT00259051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24433557|NCT00259051|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24433558|NCT00259051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822734|NCT00004585|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24433672|NCT00259675|Immunologic Factors|immunologic factors|mesh-ancestor
24433673|NCT00259675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433674|NCT00259701|Nitroglycerin|nitroglycerin|mesh-list
24433675|NCT00259701|Acetylcholine|acetylcholine|mesh-list
25596503|NCT00987467|Cyclosporine|cyclosporine|mesh-list
25596504|NCT00987467|Cyclosporins|cyclosporins|mesh-list
25596505|NCT00987467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25596506|NCT00987467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596507|NCT00987467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25596508|NCT00987467|Immunologic Factors|immunologic factors|mesh-ancestor
25596509|NCT00987467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596510|NCT00987467|Antifungal Agents|antifungal agents|mesh-ancestor
25596511|NCT00987467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25596512|NCT00987467|Dermatologic Agents|dermatologic agents|mesh-ancestor
25596513|NCT00987467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25596514|NCT00987467|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25596515|NCT00987480|Cyclosporine|cyclosporine|mesh-list
25596516|NCT00987480|Cyclophosphamide|cyclophosphamide|mesh-list
25596517|NCT00987480|Busulfan|busulfan|mesh-list
25596518|NCT00987480|Fludarabine|fludarabine|mesh-list
25596519|NCT00987480|Cyclosporins|cyclosporins|mesh-list
25596520|NCT00987480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25596521|NCT00987480|Immunologic Factors|immunologic factors|mesh-ancestor
25596522|NCT00987480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596523|NCT00987480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25596524|NCT00987480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25596525|NCT00987480|Alkylating Agents|alkylating agents|mesh-ancestor
25596526|NCT00987480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596527|NCT00987480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596528|NCT00987480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25596529|NCT00987480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25596530|NCT00987480|Antifungal Agents|antifungal agents|mesh-ancestor
25596531|NCT00987480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25596532|NCT00987480|Dermatologic Agents|dermatologic agents|mesh-ancestor
25596533|NCT00987480|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25596534|NCT00987558|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25596535|NCT00987558|Simvastatin|simvastatin|mesh-list
25596536|NCT00987558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25596537|NCT00987558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25596538|NCT00987558|Antimetabolites|antimetabolites|mesh-ancestor
25596539|NCT00987558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596540|NCT00987558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25596541|NCT00987558|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25596542|NCT00987558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25596543|NCT00987558|Anticonvulsants|anticonvulsants|mesh-ancestor
25596544|NCT00987558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25596545|NCT00987558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25596546|NCT00987558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25596547|NCT00987727|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25596548|NCT00987727|Hyaluronic Acid|hyaluronic acid|mesh-list
25596549|NCT00987727|Glycerol|glycerol|mesh-list
25596550|NCT00987727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25596551|NCT00987727|Immunologic Factors|immunologic factors|mesh-ancestor
25596552|NCT00987727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596553|NCT00987727|Viscosupplements|viscosupplements|mesh-ancestor
25596554|NCT00987727|Protective Agents|protective agents|mesh-ancestor
25596555|NCT00987727|Laxatives|laxatives|mesh-ancestor
25596556|NCT00987727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25596557|NCT00987727|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25596558|NCT00987831|Methylprednisolone|methylprednisolone|mesh-list
25596559|NCT00987831|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25596560|NCT00987831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25596561|NCT00987831|Antiemetics|antiemetics|mesh-ancestor
25596562|NCT00987831|Autonomic Agents|autonomic agents|mesh-ancestor
25596563|NCT00987831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25596564|NCT00987831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596565|NCT00987831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25596566|NCT00987831|Glucocorticoids|glucocorticoids|mesh-ancestor
25596567|NCT00987831|Hormones|hormones|mesh-ancestor
25596568|NCT00987831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25596569|NCT00987831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25596570|NCT00987831|Protective Agents|protective agents|mesh-ancestor
25596571|NCT00987935|Sorafenib|sorafenib|mesh-list
25596572|NCT00987935|Nintedanib|nintedanib|mesh-list
25596573|NCT00987935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596574|NCT00987935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25596575|NCT00987935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25596576|NCT00987935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596577|NCT00987948|Maraviroc|maraviroc|mesh-list
25596578|NCT00987948|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25596579|NCT00987948|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25596580|NCT00987948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596581|NCT00987948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25596582|NCT00987948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25596583|NCT00987948|Antiviral Agents|antiviral agents|mesh-ancestor
25596584|NCT00987948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25596585|NCT00987948|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25596586|NCT00988091|Hyaluronic Acid|hyaluronic acid|mesh-list
25596587|NCT00988091|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25596588|NCT00988091|Immunologic Factors|immunologic factors|mesh-ancestor
25596589|NCT00988091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596590|NCT00988091|Viscosupplements|viscosupplements|mesh-ancestor
25596591|NCT00988091|Protective Agents|protective agents|mesh-ancestor
25596592|NCT00988117|Rivastigmine|rivastigmine|mesh-list
25596593|NCT00988117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25596594|NCT00988117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25596595|NCT00988117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596596|NCT00988117|Cholinergic Agents|cholinergic agents|mesh-ancestor
25596597|NCT00988117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25596598|NCT00988117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596599|NCT00988117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25596600|NCT00988117|Protective Agents|protective agents|mesh-ancestor
25596601|NCT00988143|Vaccines|vaccines|mesh-list
25596602|NCT00988143|Immunologic Factors|immunologic factors|mesh-ancestor
25596603|NCT00988143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596604|NCT00988156|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25596605|NCT00988156|Anticonvulsants|anticonvulsants|mesh-ancestor
24640500|NCT01168531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596606|NCT00988156|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25596607|NCT00988156|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25596608|NCT00988156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25596609|NCT00988156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596610|NCT00988169|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25491100|NCT00235872|Adalimumab|adalimumab|mesh-list
25596611|NCT00988169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596612|NCT00988169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25596613|NCT00988169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25596614|NCT00988169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596616|NCT00988208|Docetaxel|docetaxel|mesh-list
25596617|NCT00988208|Lenalidomide|lenalidomide|mesh-list
25596618|NCT00988208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596619|NCT00988208|Tubulin Modulators|tubulin modulators|mesh-ancestor
25596620|NCT00988208|Antimitotic Agents|antimitotic agents|mesh-ancestor
25596621|NCT00988208|Mitosis Modulators|mitosis modulators|mesh-ancestor
25596622|NCT00988208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596623|NCT00988208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25596624|NCT00988208|Glucocorticoids|glucocorticoids|mesh-ancestor
25596625|NCT00988208|Hormones|hormones|mesh-ancestor
25596626|NCT00988208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25596627|NCT00988208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596628|NCT00988208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25596629|NCT00988208|Immunologic Factors|immunologic factors|mesh-ancestor
25596630|NCT00988208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25596631|NCT00988208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25596632|NCT00988208|Growth Substances|growth substances|mesh-ancestor
25596633|NCT00988208|Growth Inhibitors|growth inhibitors|mesh-ancestor
25596634|NCT00988325|Oseltamivir|oseltamivir|mesh-list
25596635|NCT00988325|Antiviral Agents|antiviral agents|mesh-ancestor
25596636|NCT00988325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25596637|NCT00988325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25596638|NCT00988325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596639|NCT00988429|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25596640|NCT00988429|Anticonvulsants|anticonvulsants|mesh-ancestor
25596641|NCT00988429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25596642|NCT00988429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25596643|NCT00988429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25596644|NCT00988429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596645|NCT00988533|Ivermectin|ivermectin|mesh-list
25596646|NCT00988533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25596647|NCT00988533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25706941|NCT02223260|Antithrombins|antithrombins|mesh-ancestor
24637495|NCT01150747|Azithromycin|azithromycin|mesh-list
25596648|NCT00988559|Imiquimod|imiquimod|mesh-list
25596649|NCT00988559|Vaccines|vaccines|mesh-list
25596650|NCT00988559|Immunologic Factors|immunologic factors|mesh-ancestor
25596651|NCT00988559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596652|NCT00988559|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25596653|NCT00988559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596654|NCT00988559|Interferon Inducers|interferon inducers|mesh-ancestor
25596655|NCT00988832|Infliximab|infliximab|mesh-list
25596656|NCT00988832|Dermatologic Agents|dermatologic agents|mesh-ancestor
25596657|NCT00988832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25596658|NCT00988832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25596659|NCT00988858|Pemetrexed|pemetrexed|mesh-list
25596660|NCT00988858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596661|NCT00988858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25596662|NCT00988858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596663|NCT00988858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25596664|NCT00988858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25596665|NCT00989092|Darbepoetin alfa|darbepoetin alfa|mesh-list
25596666|NCT00989092|Hematinics|hematinics|mesh-ancestor
25596667|NCT00989157|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25596668|NCT00989157|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25596669|NCT00989157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25596670|NCT00989157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25596671|NCT00989157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596672|NCT00989157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25596673|NCT00989157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596674|NCT00989157|Analgesics|analgesics|mesh-ancestor
25596675|NCT00989157|Sensory System Agents|sensory system agents|mesh-ancestor
25596676|NCT00989157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25596677|NCT00989157|Antidepressive Agents|antidepressive agents|mesh-ancestor
25596678|NCT00989157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25596679|NCT00989157|Dopamine Agents|dopamine agents|mesh-ancestor
25596680|NCT00989196|Factor VIII|factor viii|mesh-list
25596681|NCT00989196|Coagulants|coagulants|mesh-ancestor
25596682|NCT00989235|Abatacept|abatacept|mesh-list
25596683|NCT00989235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25596684|NCT00989235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596685|NCT00989235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596686|NCT00989235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25596687|NCT00989235|Immunologic Factors|immunologic factors|mesh-ancestor
25596688|NCT00989235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596689|NCT00989235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25596690|NCT00989586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25596691|NCT00989586|Veltuzumab|veltuzumab|mesh-list
25596692|NCT00989586|Antibodies|antibodies|mesh-list
25596693|NCT00989586|Immunoglobulins|immunoglobulins|mesh-list
25596694|NCT00989586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25596695|NCT00989586|Immunologic Factors|immunologic factors|mesh-ancestor
25596696|NCT00989586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596697|NCT00989586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596698|NCT00989664|Tositumomab I-131|tositumomab i-131|mesh-list
25596699|NCT00989664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596700|NCT00989768|Botulinum Toxins|botulinum toxins|mesh-list
25596701|NCT00989768|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25596702|NCT00989768|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25596703|NCT00989768|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25596704|NCT00989768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25596705|NCT00989768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596706|NCT00989768|Cholinergic Agents|cholinergic agents|mesh-ancestor
25596707|NCT00989768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25596708|NCT00989768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596709|NCT00989768|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25596710|NCT00989768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25596711|NCT00989781|Dexamethasone|dexamethasone|mesh-list
25596712|NCT00989781|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25596713|NCT00989781|Hormones|hormones|mesh-list
25596714|NCT00989781|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25596715|NCT00989781|Cosyntropin|cosyntropin|mesh-list
25596716|NCT00989781|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25596717|NCT00989781|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
25596718|NCT00989781|beta-Endorphin|beta-endorphin|mesh-list
25596719|NCT00989781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25596720|NCT00989781|Antiemetics|antiemetics|mesh-ancestor
25596721|NCT00989781|Autonomic Agents|autonomic agents|mesh-ancestor
25596722|NCT00989781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25596723|NCT00989781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596724|NCT00989781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25596725|NCT00989781|Glucocorticoids|glucocorticoids|mesh-ancestor
25596726|NCT00989781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25596727|NCT00989781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25596728|NCT00989781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596729|NCT00989781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25596730|NCT00989781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25596731|NCT00989781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596732|NCT00989833|Budesonide|budesonide|mesh-list
25596733|NCT00989833|Terbutaline|terbutaline|mesh-list
25596734|NCT00989833|Formoterol Fumarate|formoterol fumarate|mesh-list
25596735|NCT00989833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25596736|NCT00989833|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25596737|NCT00989833|Autonomic Agents|autonomic agents|mesh-ancestor
25596738|NCT00989833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25596739|NCT00989833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596740|NCT00989833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25596741|NCT00989833|Respiratory System Agents|respiratory system agents|mesh-ancestor
24534790|NCT00648011|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24534803|NCT00648024|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24638277|NCT01155791|Mitosis Modulators|mitosis modulators|mesh-ancestor
24638278|NCT01155791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638280|NCT01155791|Glucocorticoids|glucocorticoids|mesh-ancestor
25596742|NCT00989833|Glucocorticoids|glucocorticoids|mesh-ancestor
25596743|NCT00989833|Hormones|hormones|mesh-ancestor
25596744|NCT00989833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25596745|NCT00989833|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25596746|NCT00989833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25596747|NCT00989833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25596748|NCT00989833|Adrenergic Agents|adrenergic agents|mesh-ancestor
25596749|NCT00989833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25596750|NCT00989833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596751|NCT00989833|Sympathomimetics|sympathomimetics|mesh-ancestor
25596752|NCT00989833|Tocolytic Agents|tocolytic agents|mesh-ancestor
25596753|NCT00989833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25596754|NCT00989911|Bosentan|bosentan|mesh-list
25596755|NCT00989911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25596756|NCT00989911|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25596757|NCT00989911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491249|NCT00238433|Melphalan|melphalan|mesh-list
25596758|NCT00989950|Methylphenidate|methylphenidate|mesh-list
25596759|NCT00989950|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25596760|NCT00989950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596761|NCT00989950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25596762|NCT00989950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25596763|NCT00989950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25596764|NCT00989950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596765|NCT00989950|Dopamine Agents|dopamine agents|mesh-ancestor
25596766|NCT00989950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25596767|NCT00989963|Beraprost|beraprost|mesh-list
25596768|NCT00989963|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25596769|NCT00989963|Vasodilator Agents|vasodilator agents|mesh-ancestor
25596770|NCT00989989|Ranibizumab|ranibizumab|mesh-list
25596771|NCT00989989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25596772|NCT00989989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25596773|NCT00989989|Growth Substances|growth substances|mesh-ancestor
25596774|NCT00989989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596775|NCT00989989|Growth Inhibitors|growth inhibitors|mesh-ancestor
25596776|NCT00989989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596777|NCT00990106|Prazosin|prazosin|mesh-list
25596778|NCT00990106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25596779|NCT00990106|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25596780|NCT00990106|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25596781|NCT00990106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25596782|NCT00990106|Adrenergic Agents|adrenergic agents|mesh-ancestor
25596783|NCT00990106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25596784|NCT00990106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596785|NCT00990106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596786|NCT00990184|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
25596787|NCT00990184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25596788|NCT00990184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25596789|NCT00990184|Antimetabolites|antimetabolites|mesh-ancestor
25596790|NCT00990184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596791|NCT00990184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25596792|NCT00990236|Enoxaparin|enoxaparin|mesh-list
25596793|NCT00990236|Enoxaparin sodium|enoxaparin sodium|mesh-list
25596794|NCT00990236|Anticoagulants|anticoagulants|mesh-ancestor
25596795|NCT00990236|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25596796|NCT00990236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25596797|NCT00990236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596798|NCT00990249|Busulfan|busulfan|mesh-list
25596799|NCT00990249|Clofarabine|clofarabine|mesh-list
25596800|NCT00990249|Thymoglobulin|thymoglobulin|mesh-list
25596801|NCT00990249|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25596802|NCT00990249|Alkylating Agents|alkylating agents|mesh-ancestor
25596803|NCT00990249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596804|NCT00990249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25596805|NCT00990249|Immunologic Factors|immunologic factors|mesh-ancestor
25596806|NCT00990249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596807|NCT00990249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25596808|NCT00990249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596809|NCT00990249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24450300|NCT00318630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450301|NCT00318669|Paroxetine|paroxetine|mesh-list
25596810|NCT00990249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25596811|NCT00990249|Antimetabolites|antimetabolites|mesh-ancestor
25596812|NCT00990288|Thrombin|thrombin|mesh-list
25596813|NCT00990288|Hemostatics|hemostatics|mesh-list
25596814|NCT00990288|Coagulants|coagulants|mesh-ancestor
25596815|NCT00990314|Epoprostenol|epoprostenol|mesh-list
25596816|NCT00990314|Beraprost|beraprost|mesh-list
25596817|NCT00990314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25596818|NCT00990314|Vasodilator Agents|vasodilator agents|mesh-ancestor
25596819|NCT00990314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25596820|NCT00990561|Clobetasol|clobetasol|mesh-list
25596821|NCT00990561|Halobetasol|halobetasol|mesh-list
25596822|NCT00990561|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25596823|NCT00990561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25596824|NCT00990561|Glucocorticoids|glucocorticoids|mesh-ancestor
25596825|NCT00990561|Hormones|hormones|mesh-ancestor
25596826|NCT00990561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25596827|NCT00990561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596828|NCT00990652|Bortezomib|bortezomib|mesh-list
25596829|NCT00990652|Temozolomide|temozolomide|mesh-list
25596830|NCT00990652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596831|NCT00990652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25596832|NCT00990652|Alkylating Agents|alkylating agents|mesh-ancestor
25596833|NCT00990652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596834|NCT00990665|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25596835|NCT00990665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25596836|NCT00990665|Contraceptive Agents|contraceptive agents|mesh-ancestor
25596837|NCT00990665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25596838|NCT00990665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596839|NCT00990665|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25596840|NCT00990665|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25596841|NCT00990665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25596842|NCT00990704|Maxacalcitol|maxacalcitol|mesh-list
25596843|NCT00990704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596844|NCT00990704|Dermatologic Agents|dermatologic agents|mesh-ancestor
25596845|NCT00990704|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25596846|NCT00990704|Protective Agents|protective agents|mesh-ancestor
25596847|NCT00990704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596848|NCT00990769|Anesthetics|anesthetics|mesh-list
25596849|NCT00990769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25596850|NCT00990769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596851|NCT00990821|Midazolam|midazolam|mesh-list
25596852|NCT00990821|Aprepitant|aprepitant|mesh-list
25596853|NCT00990821|Fosaprepitant|fosaprepitant|mesh-list
25596854|NCT00990821|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25596855|NCT00990821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25596856|NCT00990821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25596857|NCT00990821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596858|NCT00990821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25596859|NCT00990821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25596860|NCT00990821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25596861|NCT00990821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25596862|NCT00990821|Anesthetics, General|anesthetics, general|mesh-ancestor
25596863|NCT00990821|Anesthetics|anesthetics|mesh-ancestor
25596864|NCT00990821|GABA Modulators|gaba modulators|mesh-ancestor
25596865|NCT00990821|GABA Agents|gaba agents|mesh-ancestor
25596866|NCT00990821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25596867|NCT00990821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596868|NCT00990821|Antiemetics|antiemetics|mesh-ancestor
25596869|NCT00990821|Autonomic Agents|autonomic agents|mesh-ancestor
25596870|NCT00990821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25596871|NCT00990821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25596872|NCT00990821|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25596873|NCT00991029|Clopidogrel|clopidogrel|mesh-list
25596874|NCT00991029|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25596875|NCT00991029|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25596876|NCT00991029|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25596877|NCT00991029|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25596878|NCT00991029|Purinergic Agents|purinergic agents|mesh-ancestor
25596879|NCT00991029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25596880|NCT00991029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596881|NCT00991029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596882|NCT00991081|Bupropion|bupropion|mesh-list
25596883|NCT00991081|Nicotine|nicotine|mesh-list
25596884|NCT00991081|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25596885|NCT00991081|Autonomic Agents|autonomic agents|mesh-ancestor
25596886|NCT00991081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25596887|NCT00991081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596888|NCT00991081|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25596889|NCT00991081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25596890|NCT00991081|Cholinergic Agents|cholinergic agents|mesh-ancestor
25596891|NCT00991081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25596892|NCT00991081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596893|NCT00991081|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25596894|NCT00991081|Antidepressive Agents|antidepressive agents|mesh-ancestor
25596895|NCT00991081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25596896|NCT00991081|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25596897|NCT00991081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25596898|NCT00991081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25596899|NCT00991081|Dopamine Agents|dopamine agents|mesh-ancestor
25596900|NCT00991081|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25596901|NCT00991081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25596902|NCT00991081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25596903|NCT00991276|Pregabalin|pregabalin|mesh-list
25596904|NCT00991276|Pramipexole|pramipexole|mesh-list
25596905|NCT00991276|Analgesics|analgesics|mesh-ancestor
25596906|NCT00991276|Sensory System Agents|sensory system agents|mesh-ancestor
25596907|NCT00991276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25596908|NCT00991276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596909|NCT00991276|Anticonvulsants|anticonvulsants|mesh-ancestor
25596910|NCT00991276|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25596911|NCT00991276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25596912|NCT00991276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596913|NCT00991276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25596914|NCT00991276|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25596915|NCT00991276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25596916|NCT00991276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25596917|NCT00991276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25596918|NCT00991276|Antioxidants|antioxidants|mesh-ancestor
25596919|NCT00991276|Protective Agents|protective agents|mesh-ancestor
25596920|NCT00991276|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25596921|NCT00991276|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25596922|NCT00991276|Dopamine Agonists|dopamine agonists|mesh-ancestor
25596923|NCT00991276|Dopamine Agents|dopamine agents|mesh-ancestor
25596924|NCT00991276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25596925|NCT00991289|Interferons|interferons|mesh-list
25596926|NCT00991289|Ribavirin|ribavirin|mesh-list
25596927|NCT00991289|Interferon-alpha|interferon-alpha|mesh-list
25596928|NCT00991289|Interferon alpha-2|interferon alpha-2|mesh-list
25596929|NCT00991289|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25596930|NCT00991289|Nitazoxanide|nitazoxanide|mesh-list
25596931|NCT00991289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596932|NCT00991289|Antiviral Agents|antiviral agents|mesh-ancestor
25596933|NCT00991289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25596934|NCT00991289|Antimetabolites|antimetabolites|mesh-ancestor
25596935|NCT00991289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596936|NCT00991289|Immunologic Factors|immunologic factors|mesh-ancestor
25596937|NCT00991289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596938|NCT00991289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25596939|NCT00991458|Cyclosporine|cyclosporine|mesh-list
24643631|NCT01186445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24450491|NCT00319306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24450492|NCT00319306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450493|NCT00319319|Mecamylamine|mecamylamine|mesh-list
24458593|NCT00338481|Morphine|morphine|mesh-list
25596940|NCT00991458|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25596941|NCT00991458|Cyclosporins|cyclosporins|mesh-list
25596942|NCT00991458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25596943|NCT00991458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596944|NCT00991458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25596945|NCT00991458|Immunologic Factors|immunologic factors|mesh-ancestor
25596946|NCT00991458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596947|NCT00991458|Antifungal Agents|antifungal agents|mesh-ancestor
25596948|NCT00991458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25596949|NCT00991458|Dermatologic Agents|dermatologic agents|mesh-ancestor
25596950|NCT00991458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25596951|NCT00991458|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25596952|NCT00991458|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25596953|NCT00991510|Mycophenolic Acid|mycophenolic acid|mesh-list
25596954|NCT00991510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25596955|NCT00991510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25596956|NCT00991510|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25596957|NCT00991510|Antitubercular Agents|antitubercular agents|mesh-ancestor
25596958|NCT00991510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25596959|NCT00991510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25596960|NCT00991510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25596961|NCT00991510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596962|NCT00991809|Diphenhydramine|diphenhydramine|mesh-list
25596963|NCT00991809|Promethazine|promethazine|mesh-list
25596964|NCT00991809|Alfentanil|alfentanil|mesh-list
25596965|NCT00991809|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25596966|NCT00991809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25596967|NCT00991809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25596968|NCT00991809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596969|NCT00991809|Anesthetics, Local|anesthetics, local|mesh-ancestor
25596970|NCT00991809|Anesthetics|anesthetics|mesh-ancestor
25596971|NCT00991809|Sensory System Agents|sensory system agents|mesh-ancestor
25596972|NCT00991809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25596973|NCT00991809|Antiemetics|antiemetics|mesh-ancestor
25596974|NCT00991809|Autonomic Agents|autonomic agents|mesh-ancestor
25596975|NCT00991809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25596976|NCT00991809|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25596977|NCT00991809|Histamine Antagonists|histamine antagonists|mesh-ancestor
25596978|NCT00991809|Histamine Agents|histamine agents|mesh-ancestor
25596979|NCT00991809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25596980|NCT00991809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25596981|NCT00991809|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25596982|NCT00991809|Antipruritics|antipruritics|mesh-ancestor
25596983|NCT00991809|Dermatologic Agents|dermatologic agents|mesh-ancestor
25596984|NCT00991809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25596985|NCT00991809|Narcotics|narcotics|mesh-ancestor
25596986|NCT00991809|Analgesics|analgesics|mesh-ancestor
25596987|NCT00991809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25596988|NCT00991809|Anesthetics, General|anesthetics, general|mesh-ancestor
25596989|NCT00991939|Dexamethasone|dexamethasone|mesh-list
25596990|NCT00991939|Prednisone|prednisone|mesh-list
25596991|NCT00991939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25596992|NCT00991939|Antiemetics|antiemetics|mesh-ancestor
25596993|NCT00991939|Autonomic Agents|autonomic agents|mesh-ancestor
25596994|NCT00991939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25596995|NCT00991939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25596996|NCT00991939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25596997|NCT00991939|Glucocorticoids|glucocorticoids|mesh-ancestor
25596998|NCT00991939|Hormones|hormones|mesh-ancestor
25596999|NCT00991939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25597000|NCT00991939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25597001|NCT00991939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597002|NCT00991952|Irinotecan|irinotecan|mesh-list
25597003|NCT00991952|Alvocidib|alvocidib|mesh-list
25597004|NCT00991952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24644310|NCT01190293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25706955|NCT02223338|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25597005|NCT00991952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25597006|NCT00991952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597007|NCT00991952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597008|NCT00991952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597009|NCT00991952|Growth Inhibitors|growth inhibitors|mesh-ancestor
25597010|NCT00991952|Growth Substances|growth substances|mesh-ancestor
25597011|NCT00991952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597012|NCT00991952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25597013|NCT00992056|Metoprolol|metoprolol|mesh-list
25597014|NCT00992056|Nebivolol|nebivolol|mesh-list
25597015|NCT00992056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25597016|NCT00992056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25597017|NCT00992056|Sympatholytics|sympatholytics|mesh-ancestor
25597018|NCT00992056|Autonomic Agents|autonomic agents|mesh-ancestor
25597019|NCT00992056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25597020|NCT00992056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597021|NCT00992056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25597022|NCT00992056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25597023|NCT00992056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25597024|NCT00992056|Adrenergic Agents|adrenergic agents|mesh-ancestor
25597025|NCT00992056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25597026|NCT00992056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597027|NCT00992056|Vasodilator Agents|vasodilator agents|mesh-ancestor
25597028|NCT00992056|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25597029|NCT00992056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25597030|NCT00992056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25597031|NCT00992108|Lidocaine|lidocaine|mesh-list
25597032|NCT00992108|Anesthetics, Local|anesthetics, local|mesh-ancestor
25597033|NCT00992108|Anesthetics|anesthetics|mesh-ancestor
25597034|NCT00992108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25597035|NCT00992108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597036|NCT00992108|Sensory System Agents|sensory system agents|mesh-ancestor
25597037|NCT00992108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25597038|NCT00992108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25597039|NCT00992108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25597040|NCT00992108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25597041|NCT00992108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25597042|NCT00992108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597043|NCT00992394|Etanercept|etanercept|mesh-list
25597044|NCT00992394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25597045|NCT00992394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25597046|NCT00992394|Analgesics|analgesics|mesh-ancestor
25597047|NCT00992394|Sensory System Agents|sensory system agents|mesh-ancestor
25597048|NCT00992394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25597049|NCT00992394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597050|NCT00992394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25597051|NCT00992394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25597052|NCT00992394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25597053|NCT00992394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25597054|NCT00992394|Immunologic Factors|immunologic factors|mesh-ancestor
25597055|NCT00992407|Risperidone|risperidone|mesh-list
25597056|NCT00992407|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25597057|NCT00992407|Serotonin Agents|serotonin agents|mesh-ancestor
25597058|NCT00992407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25491526|NCT00242502|Bevacizumab|bevacizumab|mesh-list
25653717|NCT01541371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25597059|NCT00992407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597060|NCT00992407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597061|NCT00992407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25597062|NCT00992407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25597063|NCT00992407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25597064|NCT00992407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25597065|NCT00992407|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25597067|NCT00992446|Cytarabine|cytarabine|mesh-list
25597068|NCT00992446|Rituximab|rituximab|mesh-list
25597069|NCT00992446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25597070|NCT00992446|Etoposide|etoposide|mesh-list
25597071|NCT00992446|Bortezomib|bortezomib|mesh-list
25597072|NCT00992446|Etoposide phosphate|etoposide phosphate|mesh-list
25597073|NCT00992446|Melphalan|melphalan|mesh-list
25597074|NCT00992446|Mechlorethamine|mechlorethamine|mesh-list
25597075|NCT00992446|Vorinostat|vorinostat|mesh-list
25597076|NCT00992446|Carmustine|carmustine|mesh-list
25597077|NCT00992446|Podophyllotoxin|podophyllotoxin|mesh-list
25597078|NCT00992446|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25597079|NCT00992446|Antibodies|antibodies|mesh-list
25597080|NCT00992446|Immunoglobulins|immunoglobulins|mesh-list
25597081|NCT00992446|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25597082|NCT00992446|Immunologic Factors|immunologic factors|mesh-ancestor
25597083|NCT00992446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597084|NCT00992446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597085|NCT00992446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25597086|NCT00992446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25597087|NCT00992446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25597088|NCT00992446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25597089|NCT00992446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597090|NCT00992446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597091|NCT00992446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25597092|NCT00992446|Antimetabolites|antimetabolites|mesh-ancestor
25597093|NCT00992446|Antiviral Agents|antiviral agents|mesh-ancestor
25597094|NCT00992446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25597095|NCT00992446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25597096|NCT00992446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25597097|NCT00992446|Alkylating Agents|alkylating agents|mesh-ancestor
25597098|NCT00992446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25597099|NCT00992446|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25597100|NCT00992446|Keratolytic Agents|keratolytic agents|mesh-ancestor
25597101|NCT00992446|Dermatologic Agents|dermatologic agents|mesh-ancestor
25597102|NCT00992446|Tubulin Modulators|tubulin modulators|mesh-ancestor
25597103|NCT00992446|Antimitotic Agents|antimitotic agents|mesh-ancestor
25597104|NCT00992446|Mitosis Modulators|mitosis modulators|mesh-ancestor
25597105|NCT00992459|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25597106|NCT00992459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597107|NCT00992511|Vaccines|vaccines|mesh-list
25597108|NCT00992511|Immunologic Factors|immunologic factors|mesh-ancestor
25597109|NCT00992511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653718|NCT01541371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25653719|NCT01541371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25653720|NCT01541371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25653721|NCT01541371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653722|NCT01541371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25653723|NCT01541371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25653724|NCT01541371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25653725|NCT01541371|Serotonin Agents|serotonin agents|mesh-ancestor
25653726|NCT01541371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25653727|NCT01541371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653728|NCT01541371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25653729|NCT01541371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25653730|NCT01541371|Dopamine Agents|dopamine agents|mesh-ancestor
25653731|NCT01541735|Pantoprazole|pantoprazole|mesh-list
25653732|NCT01541735|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25653733|NCT01541735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25653734|NCT01541735|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25653735|NCT01541735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653736|NCT01541735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653737|NCT01541891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25653738|NCT01541891|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25653739|NCT01541930|Metronidazole|metronidazole|mesh-list
25653740|NCT01541930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25653741|NCT01541930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25491616|NCT00243347|Cediranib|cediranib|mesh-list
25653742|NCT01541930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25597110|NCT00992589|Rabeprazole|rabeprazole|mesh-list
25597111|NCT00992589|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25597112|NCT00992589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25597113|NCT00992589|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25597114|NCT00992589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597115|NCT00992589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597116|NCT00992602|Cytarabine|cytarabine|mesh-list
25597117|NCT00992602|Methotrexate|methotrexate|mesh-list
25597118|NCT00992602|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24450521|NCT00319488|Autonomic Agents|autonomic agents|mesh-ancestor
25597119|NCT00992602|Abortifacient Agents|abortifacient agents|mesh-ancestor
25597120|NCT00992602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25597121|NCT00992602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597122|NCT00992602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25597123|NCT00992602|Antimetabolites|antimetabolites|mesh-ancestor
25597124|NCT00992602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597125|NCT00992602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597126|NCT00992602|Dermatologic Agents|dermatologic agents|mesh-ancestor
25597127|NCT00992602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597128|NCT00992602|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25597129|NCT00992602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25597130|NCT00992602|Immunologic Factors|immunologic factors|mesh-ancestor
25597131|NCT00992602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25597132|NCT00992602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25597133|NCT00992602|Antiviral Agents|antiviral agents|mesh-ancestor
25597134|NCT00992602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25597135|NCT00992992|Tositumomab I-131|tositumomab i-131|mesh-list
25597136|NCT00992992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597137|NCT00993031|Ritonavir|ritonavir|mesh-list
25597138|NCT00993031|Lopinavir|lopinavir|mesh-list
25597139|NCT00993031|Lamivudine|lamivudine|mesh-list
25597140|NCT00993031|Zidovudine|zidovudine|mesh-list
25597141|NCT00993031|Efavirenz|efavirenz|mesh-list
25597142|NCT00993031|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25597143|NCT00993031|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25597144|NCT00993031|Protease Inhibitors|protease inhibitors|mesh-ancestor
25597145|NCT00993031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597146|NCT00993031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597147|NCT00993031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25597148|NCT00993031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25597149|NCT00993031|Antiviral Agents|antiviral agents|mesh-ancestor
25597150|NCT00993031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25597151|NCT00993031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25597152|NCT00993031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25597153|NCT00993031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25597154|NCT00993031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25597155|NCT00993031|Antimetabolites|antimetabolites|mesh-ancestor
25597156|NCT00993031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25597157|NCT00993031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25597158|NCT00993031|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25597159|NCT00993031|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25597160|NCT00993031|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25597161|NCT00993044|Bevacizumab|bevacizumab|mesh-list
25597162|NCT00993044|Irinotecan|irinotecan|mesh-list
25597163|NCT00993044|Vincristine|vincristine|mesh-list
25597164|NCT00993044|Temozolomide|temozolomide|mesh-list
25597165|NCT00993044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25597166|NCT00993044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597167|NCT00993044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25597168|NCT00993044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25597169|NCT00993044|Growth Substances|growth substances|mesh-ancestor
25597170|NCT00993044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597171|NCT00993044|Growth Inhibitors|growth inhibitors|mesh-ancestor
25597172|NCT00993044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25597173|NCT00993044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25597174|NCT00993044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597175|NCT00993044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597176|NCT00993044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25597177|NCT00993044|Tubulin Modulators|tubulin modulators|mesh-ancestor
25597178|NCT00993044|Antimitotic Agents|antimitotic agents|mesh-ancestor
25597179|NCT00993044|Mitosis Modulators|mitosis modulators|mesh-ancestor
25597180|NCT00993044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25597181|NCT00993044|Alkylating Agents|alkylating agents|mesh-ancestor
25597182|NCT00993148|Ritonavir|ritonavir|mesh-list
25597183|NCT00993148|Darunavir|darunavir|mesh-list
25597184|NCT00993148|Maraviroc|maraviroc|mesh-list
25597185|NCT00993148|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24645444|NCT01198249|Losartan|losartan|mesh-list
24535102|NCT00648570|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24458683|NCT00338910|Metronidazole|metronidazole|mesh-list
25597186|NCT00993148|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25597187|NCT00993148|Protease Inhibitors|protease inhibitors|mesh-ancestor
25597188|NCT00993148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597189|NCT00993148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597190|NCT00993148|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25597191|NCT00993148|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25597192|NCT00993148|Antiviral Agents|antiviral agents|mesh-ancestor
25597193|NCT00993148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25597194|NCT00993148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25597195|NCT00993148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25597196|NCT00993148|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25597197|NCT00993148|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25597198|NCT00993148|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25597199|NCT00993187|Metformin|metformin|mesh-list
25597200|NCT00993187|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25597201|NCT00993187|Glimepiride|glimepiride|mesh-list
25597202|NCT00993187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25597203|NCT00993187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597204|NCT00993187|Incretins|incretins|mesh-ancestor
25597205|NCT00993187|Hormones|hormones|mesh-ancestor
25597206|NCT00993187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25597207|NCT00993187|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25597208|NCT00993187|Protease Inhibitors|protease inhibitors|mesh-ancestor
25597209|NCT00993187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597210|NCT00993187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597211|NCT00993187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25597212|NCT00993187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25597213|NCT00993187|Immunologic Factors|immunologic factors|mesh-ancestor
25597214|NCT00993200|Warfarin|warfarin|mesh-list
25597215|NCT00993200|Anticoagulants|anticoagulants|mesh-ancestor
25597216|NCT00993226|Bupivacaine|bupivacaine|mesh-list
25597217|NCT00993226|Anesthetics, Local|anesthetics, local|mesh-ancestor
25597218|NCT00993226|Anesthetics|anesthetics|mesh-ancestor
25597219|NCT00993226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25597220|NCT00993226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597221|NCT00993226|Sensory System Agents|sensory system agents|mesh-ancestor
25597222|NCT00993226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25597223|NCT00993265|Acetylcysteine|acetylcysteine|mesh-list
25597224|NCT00993265|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25597225|NCT00993265|Antiviral Agents|antiviral agents|mesh-ancestor
25597226|NCT00993265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25597227|NCT00993265|Expectorants|expectorants|mesh-ancestor
25597228|NCT00993265|Respiratory System Agents|respiratory system agents|mesh-ancestor
25597229|NCT00993265|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24645675|NCT01199328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24458758|NCT00339131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458760|NCT00339157|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24458761|NCT00339157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25597230|NCT00993265|Antioxidants|antioxidants|mesh-ancestor
25597231|NCT00993265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597232|NCT00993265|Protective Agents|protective agents|mesh-ancestor
25597233|NCT00993265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597234|NCT00993265|Antidotes|antidotes|mesh-ancestor
25597235|NCT00993317|Methotrexate|methotrexate|mesh-list
25597236|NCT00993317|Certolizumab Pegol|certolizumab pegol|mesh-list
25597237|NCT00993317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25597238|NCT00993317|Abortifacient Agents|abortifacient agents|mesh-ancestor
25597239|NCT00993317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25597240|NCT00993317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597241|NCT00993317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25597242|NCT00993317|Antimetabolites|antimetabolites|mesh-ancestor
25597243|NCT00993317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597244|NCT00993317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597245|NCT00993317|Dermatologic Agents|dermatologic agents|mesh-ancestor
25597246|NCT00993317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597247|NCT00993317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25597248|NCT00993317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25597249|NCT00993317|Immunologic Factors|immunologic factors|mesh-ancestor
25597250|NCT00993317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25597251|NCT00993317|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25597252|NCT00993421|Sibutramine|sibutramine|mesh-list
25597253|NCT00993421|Metoprolol|metoprolol|mesh-list
25597254|NCT00993421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25597255|NCT00993421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25597256|NCT00993421|Sympatholytics|sympatholytics|mesh-ancestor
25597257|NCT00993421|Autonomic Agents|autonomic agents|mesh-ancestor
25597258|NCT00993421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25597259|NCT00993421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491749|NCT00245011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491815|NCT00245063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491816|NCT00245063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491817|NCT00245063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25491818|NCT00245102|Sorafenib|sorafenib|mesh-list
25491819|NCT00245102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491820|NCT00245102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24458843|NCT00341250|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24458864|NCT00342381|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24458868|NCT00342849|Antidotes|antidotes|mesh-ancestor
25491821|NCT00245102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491822|NCT00245102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129806|NCT03038256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129807|NCT03038256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25129808|NCT03038230|Antibodies|antibodies|mesh-list
25129809|NCT03038230|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25129810|NCT03038230|Immunologic Factors|immunologic factors|mesh-ancestor
25129813|NCT03038334|Analgesics|analgesics|mesh-ancestor
24433676|NCT00259701|Vasodilator Agents|vasodilator agents|mesh-ancestor
24433677|NCT00259701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24433678|NCT00259701|Cholinergic Agents|cholinergic agents|mesh-ancestor
24433679|NCT00259701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24433680|NCT00259701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433682|NCT00259714|Dialysis Solutions|dialysis solutions|mesh-list
24433723|NCT00259779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24433724|NCT00259779|Adrenergic Agents|adrenergic agents|mesh-ancestor
24842404|NCT02221063|Thiamine|thiamine|mesh-list
24433816|NCT00260052|Epoetin Alfa|epoetin alfa|mesh-list
24433817|NCT00260052|Hematinics|hematinics|mesh-ancestor
24433829|NCT00260143|Anabolic Agents|anabolic agents|mesh-ancestor
25162116|NCT02908126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433830|NCT00260247|Carbamazepine|carbamazepine|mesh-list
24433831|NCT00260247|Oxcarbazepine|oxcarbazepine|mesh-list
24433882|NCT00260364|Growth Inhibitors|growth inhibitors|mesh-ancestor
24433883|NCT00260364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24433884|NCT00260364|Antimetabolites|antimetabolites|mesh-ancestor
24433885|NCT00260364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162117|NCT02907957|Anesthetics|anesthetics|mesh-list
24433888|NCT00260364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433889|NCT00260364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24433890|NCT00260364|Immunologic Factors|immunologic factors|mesh-ancestor
24433918|NCT00260624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24433922|NCT00260624|Serotonin Agents|serotonin agents|mesh-ancestor
24433923|NCT00260624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433924|NCT00260624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24433980|NCT00261118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24434108|NCT00261508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24434109|NCT00261508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434110|NCT00261508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434155|NCT00261586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24795504|NCT02220426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795507|NCT02034110|Trametinib|trametinib|mesh-list
24795508|NCT02034110|Dabrafenib|dabrafenib|mesh-list
24795509|NCT02034110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917677|NCT04227522|Rucaparib|rucaparib|mesh-list
24979725|NCT02832648|Selenium|selenium|mesh-list
24979726|NCT02832648|Antioxidants|antioxidants|mesh-ancestor
25124039|NCT03079895|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24979727|NCT02832648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979728|NCT02832648|Protective Agents|protective agents|mesh-ancestor
24979729|NCT02832648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979730|NCT02832648|Trace Elements|trace elements|mesh-ancestor
24979731|NCT02832648|Micronutrients|micronutrients|mesh-ancestor
24434166|NCT00261599|Midazolam|midazolam|mesh-list
24434167|NCT00261599|Fospropofol|fospropofol|mesh-list
24434253|NCT00261820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597260|NCT00993421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25597261|NCT00993421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25597262|NCT00993421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25597263|NCT00993421|Adrenergic Agents|adrenergic agents|mesh-ancestor
25597264|NCT00993421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25597265|NCT00993421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597266|NCT00993421|Antidepressive Agents|antidepressive agents|mesh-ancestor
25597267|NCT00993421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25597268|NCT00993421|Appetite Depressants|appetite depressants|mesh-ancestor
25597269|NCT00993421|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25597270|NCT00993473|Insulin|insulin|mesh-list
25597271|NCT00993473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25597272|NCT00993473|Insulin Glargine|insulin glargine|mesh-list
25597273|NCT00993473|Insulin Lispro|insulin lispro|mesh-list
25597275|NCT00993473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25597276|NCT00993473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597277|NCT00993473|Heparin Antagonists|heparin antagonists|mesh-ancestor
24641092|NCT01171833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597278|NCT00993473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597279|NCT00993473|Coagulants|coagulants|mesh-ancestor
25597280|NCT00993499|Sirolimus|sirolimus|mesh-list
25597281|NCT00993499|Afatinib|afatinib|mesh-list
25597282|NCT00993499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25597283|NCT00993499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25597284|NCT00993499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25597285|NCT00993499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597286|NCT00993499|Antifungal Agents|antifungal agents|mesh-ancestor
25597287|NCT00993499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25597288|NCT00993499|Immunologic Factors|immunologic factors|mesh-ancestor
25597289|NCT00993499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597290|NCT00993499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25597291|NCT00993499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597292|NCT00993499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597293|NCT00993616|Carboplatin|carboplatin|mesh-list
25597294|NCT00993616|Belinostat|belinostat|mesh-list
25597295|NCT00993616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597296|NCT00993616|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25597297|NCT00993616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597298|NCT00993616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597299|NCT00993655|Paclitaxel|paclitaxel|mesh-list
25597300|NCT00993655|Cisplatin|cisplatin|mesh-list
25597301|NCT00993655|Carboplatin|carboplatin|mesh-list
25597302|NCT00993655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25597303|NCT00993655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597304|NCT00993655|Tubulin Modulators|tubulin modulators|mesh-ancestor
25597305|NCT00993655|Antimitotic Agents|antimitotic agents|mesh-ancestor
25597306|NCT00993655|Mitosis Modulators|mitosis modulators|mesh-ancestor
25597307|NCT00993655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597308|NCT00993668|Certolizumab Pegol|certolizumab pegol|mesh-list
25597309|NCT00993668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25597310|NCT00993668|Immunologic Factors|immunologic factors|mesh-ancestor
25597311|NCT00993668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597312|NCT00993668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25597313|NCT00993798|Bupivacaine|bupivacaine|mesh-list
25597314|NCT00993798|Anesthetics, Local|anesthetics, local|mesh-ancestor
25597315|NCT00993798|Anesthetics|anesthetics|mesh-ancestor
25597316|NCT00993798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25597317|NCT00993798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597318|NCT00993798|Sensory System Agents|sensory system agents|mesh-ancestor
25597319|NCT00993798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25597320|NCT00993824|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
25597321|NCT00993824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25597322|NCT00993824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25597323|NCT00993824|Antimetabolites|antimetabolites|mesh-ancestor
25597324|NCT00993824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597325|NCT00993824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25597326|NCT00993915|Atorvastatin|atorvastatin|mesh-list
25597327|NCT00993915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25597328|NCT00993915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25597329|NCT00993915|Antimetabolites|antimetabolites|mesh-ancestor
25597330|NCT00993915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597331|NCT00993915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25597332|NCT00993915|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25597333|NCT00993915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597334|NCT00993967|Idebenone|idebenone|mesh-list
25597335|NCT00993967|Antioxidants|antioxidants|mesh-ancestor
25706958|NCT02223351|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25706959|NCT02223351|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25597336|NCT00993967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597337|NCT00993967|Protective Agents|protective agents|mesh-ancestor
25597338|NCT00993967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597339|NCT00994110|Pasireotide|pasireotide|mesh-list
25597340|NCT00994110|Hormones|hormones|mesh-ancestor
25597341|NCT00994110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25597342|NCT00994110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597343|NCT00994123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25597344|NCT00994123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597345|NCT00994123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25597346|NCT00994123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597347|NCT00994123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597348|NCT00994175|Pioglitazone|pioglitazone|mesh-list
25597349|NCT00994175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25597350|NCT00994175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597351|NCT00994318|Ferric Compounds|ferric compounds|mesh-list
25597352|NCT00994318|Hematinics|hematinics|mesh-ancestor
25597353|NCT00994422|Ivermectin|ivermectin|mesh-list
25597354|NCT00994422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25597355|NCT00994422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25597356|NCT00994448|Bupropion|bupropion|mesh-list
25597357|NCT00994448|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25597358|NCT00994448|Antidepressive Agents|antidepressive agents|mesh-ancestor
25597359|NCT00994448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25597360|NCT00994448|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25597361|NCT00994448|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25597362|NCT00994448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25597363|NCT00994448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597364|NCT00994448|Dopamine Agents|dopamine agents|mesh-ancestor
25597365|NCT00994448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25597366|NCT00994448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597367|NCT00994448|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25597368|NCT00994448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25597369|NCT00994448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597370|NCT00994461|Celecoxib|celecoxib|mesh-list
25597371|NCT00994461|Loxoprofen|loxoprofen|mesh-list
25597372|NCT00994461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25597373|NCT00994461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25597374|NCT00994461|Analgesics|analgesics|mesh-ancestor
25597375|NCT00994461|Sensory System Agents|sensory system agents|mesh-ancestor
25597376|NCT00994461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25597377|NCT00994461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597378|NCT00994461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25597379|NCT00994461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25597380|NCT00994461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25597381|NCT00994461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25597382|NCT00994461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597383|NCT00994461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597384|NCT00994643|Aldesleukin|aldesleukin|mesh-list
25597385|NCT00994643|Rituximab|rituximab|mesh-list
25597386|NCT00994643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25597387|NCT00994643|Interleukin-2|interleukin-2|mesh-list
25597388|NCT00994643|Antibodies|antibodies|mesh-list
25597389|NCT00994643|Immunoglobulins|immunoglobulins|mesh-list
25597390|NCT00994643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25597391|NCT00994643|Immunologic Factors|immunologic factors|mesh-ancestor
25597392|NCT00994643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597393|NCT00994643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597394|NCT00994643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25597395|NCT00994643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25597396|NCT00994643|Analgesics|analgesics|mesh-ancestor
25597397|NCT00994643|Sensory System Agents|sensory system agents|mesh-ancestor
25597398|NCT00994643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25597399|NCT00994643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25597400|NCT00994643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25597401|NCT00994643|Antiviral Agents|antiviral agents|mesh-ancestor
25597402|NCT00994643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25597403|NCT00994682|Pioglitazone|pioglitazone|mesh-list
25597404|NCT00994682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25597405|NCT00994682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597406|NCT00994760|Fentanyl|fentanyl|mesh-list
25597407|NCT00994760|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25597408|NCT00994760|Narcotics|narcotics|mesh-ancestor
25597409|NCT00994760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25597410|NCT00994760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597411|NCT00994760|Analgesics|analgesics|mesh-ancestor
25597412|NCT00994760|Sensory System Agents|sensory system agents|mesh-ancestor
25597413|NCT00994760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25597414|NCT00994760|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25597415|NCT00994760|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25597416|NCT00994760|Anesthetics, General|anesthetics, general|mesh-ancestor
25597417|NCT00994760|Anesthetics|anesthetics|mesh-ancestor
25597418|NCT00994890|Tanezumab|tanezumab|mesh-list
25597419|NCT00994890|Analgesics|analgesics|mesh-ancestor
25597420|NCT00994890|Sensory System Agents|sensory system agents|mesh-ancestor
25597421|NCT00994890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25597422|NCT00994890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491917|NCT00246376|Niacin|niacin|mesh-list
25597423|NCT00994929|Oprelvekin|oprelvekin|mesh-list
25597424|NCT00994929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597425|NCT00995007|Carboplatin|carboplatin|mesh-list
25597426|NCT00995007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597427|NCT00995072|Metoprolol|metoprolol|mesh-list
25597428|NCT00995072|Nebivolol|nebivolol|mesh-list
25597429|NCT00995072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25597430|NCT00995072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25597431|NCT00995072|Sympatholytics|sympatholytics|mesh-ancestor
25597432|NCT00995072|Autonomic Agents|autonomic agents|mesh-ancestor
25597433|NCT00995072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25597434|NCT00995072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597435|NCT00995072|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25597436|NCT00995072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25597437|NCT00995072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25597438|NCT00995072|Adrenergic Agents|adrenergic agents|mesh-ancestor
25597439|NCT00995072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25597440|NCT00995072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597441|NCT00995072|Vasodilator Agents|vasodilator agents|mesh-ancestor
25597442|NCT00995072|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25597443|NCT00995072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25597444|NCT00995072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25597445|NCT00995085|Pyridoxine|pyridoxine|mesh-list
25597446|NCT00995085|Metadoxine|metadoxine|mesh-list
25597447|NCT00995085|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25597448|NCT00995085|Vitamin B Complex|vitamin b complex|mesh-ancestor
25597449|NCT00995085|Vitamins|vitamins|mesh-ancestor
25597450|NCT00995085|Micronutrients|micronutrients|mesh-ancestor
25597451|NCT00995085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597452|NCT00995475|Fluticasone|fluticasone|mesh-list
25597453|NCT00995475|Xhance|xhance|mesh-list
25597454|NCT00995475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25597455|NCT00995475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25597456|NCT00995475|Autonomic Agents|autonomic agents|mesh-ancestor
25597457|NCT00995475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25597458|NCT00995475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597459|NCT00995475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25597460|NCT00995475|Respiratory System Agents|respiratory system agents|mesh-ancestor
25597461|NCT00995475|Dermatologic Agents|dermatologic agents|mesh-ancestor
25597462|NCT00995475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25597463|NCT00995488|Paclitaxel|paclitaxel|mesh-list
25597464|NCT00995488|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25597465|NCT00995488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25597466|NCT00995488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597467|NCT00995488|Tubulin Modulators|tubulin modulators|mesh-ancestor
25597468|NCT00995488|Antimitotic Agents|antimitotic agents|mesh-ancestor
25597469|NCT00995488|Mitosis Modulators|mitosis modulators|mesh-ancestor
25597470|NCT00995488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597471|NCT00995501|Insulin|insulin|mesh-list
25597472|NCT00995501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25597473|NCT00995501|Dexamethasone|dexamethasone|mesh-list
25597474|NCT00995501|Dexamethasone acetate|dexamethasone acetate|mesh-list
25597475|NCT00995501|Anesthetics|anesthetics|mesh-list
25597476|NCT00995501|Sodium sulfate|sodium sulfate|mesh-list
25597477|NCT00995501|BB 1101|bb 1101|mesh-list
25597478|NCT00995501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25597479|NCT00995501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597480|NCT00995501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25597481|NCT00995501|Antiemetics|antiemetics|mesh-ancestor
25597482|NCT00995501|Autonomic Agents|autonomic agents|mesh-ancestor
25597483|NCT00995501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25597484|NCT00995501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25597485|NCT00995501|Glucocorticoids|glucocorticoids|mesh-ancestor
25597486|NCT00995501|Hormones|hormones|mesh-ancestor
25597487|NCT00995501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25597488|NCT00995501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25597489|NCT00995501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597490|NCT00995501|Protease Inhibitors|protease inhibitors|mesh-ancestor
24459033|NCT00343408|Gemcitabine|gemcitabine|mesh-list
24459063|NCT00343447|Immunologic Factors|immunologic factors|mesh-ancestor
24459064|NCT00343447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459065|NCT00343447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24450605|NCT00319800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24450606|NCT00319800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25597491|NCT00995501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597492|NCT00995501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597493|NCT00995501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25597494|NCT00995501|Cathartics|cathartics|mesh-ancestor
25597495|NCT00995566|Sitaxsentan|sitaxsentan|mesh-list
25597496|NCT00995566|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25597497|NCT00995566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597498|NCT00995670|Ascorbic Acid|ascorbic acid|mesh-list
25597499|NCT00995670|Sevoflurane|sevoflurane|mesh-list
25597500|NCT00995670|Simvastatin|simvastatin|mesh-list
25597501|NCT00995670|Vitamins|vitamins|mesh-ancestor
25597502|NCT00995670|Micronutrients|micronutrients|mesh-ancestor
25597503|NCT00995670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597504|NCT00995670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25597505|NCT00995670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25597506|NCT00995670|Antimetabolites|antimetabolites|mesh-ancestor
25597507|NCT00995670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597508|NCT00995670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25597509|NCT00995670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25597510|NCT00995670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597511|NCT00995670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25597512|NCT00995670|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25597513|NCT00995670|Anesthetics, General|anesthetics, general|mesh-ancestor
25597514|NCT00995670|Anesthetics|anesthetics|mesh-ancestor
25597515|NCT00995670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25597516|NCT00995670|Antioxidants|antioxidants|mesh-ancestor
25597517|NCT00995670|Protective Agents|protective agents|mesh-ancestor
25597518|NCT00995709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25597519|NCT00995709|Immunologic Factors|immunologic factors|mesh-ancestor
25597520|NCT00995709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597521|NCT00995722|Prednisone|prednisone|mesh-list
25597522|NCT00995722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25597523|NCT00995722|Glucocorticoids|glucocorticoids|mesh-ancestor
25597524|NCT00995722|Hormones|hormones|mesh-ancestor
25597525|NCT00995722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25597526|NCT00995722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597527|NCT00995722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24459248|NCT00344058|Magnesium Sulfate|magnesium sulfate|mesh-list
25597528|NCT00995722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597529|NCT00995761|Cisplatin|cisplatin|mesh-list
25597530|NCT00995761|Docetaxel|docetaxel|mesh-list
25597531|NCT00995761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597532|NCT00995761|Tubulin Modulators|tubulin modulators|mesh-ancestor
25597533|NCT00995761|Antimitotic Agents|antimitotic agents|mesh-ancestor
25597534|NCT00995761|Mitosis Modulators|mitosis modulators|mesh-ancestor
25597535|NCT00995761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597536|NCT00996034|Nicotine|nicotine|mesh-list
25597537|NCT00996034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597538|NCT00996034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25597539|NCT00996034|Autonomic Agents|autonomic agents|mesh-ancestor
25597540|NCT00996034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25597541|NCT00996034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25597542|NCT00996034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25597543|NCT00996034|Cholinergic Agents|cholinergic agents|mesh-ancestor
25597544|NCT00996034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25597545|NCT00996034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597546|NCT00996203|Antirheumatic Agents|antirheumatic agents|mesh-list
25597547|NCT00996216|Antiviral Agents|antiviral agents|mesh-list
25597548|NCT00996216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25597549|NCT00996281|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25597550|NCT00996281|Olmesartan|olmesartan|mesh-list
25597551|NCT00996281|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25597552|NCT00996281|Chlorthalidone|chlorthalidone|mesh-list
25597553|NCT00996281|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25597554|NCT00996281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25597555|NCT00996281|Diuretics|diuretics|mesh-ancestor
25597556|NCT00996281|Natriuretic Agents|natriuretic agents|mesh-ancestor
25597557|NCT00996281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597558|NCT00996281|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25597559|NCT00996281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25597560|NCT00996281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597561|NCT00996281|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25597562|NCT00996281|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25597563|NCT00996307|MF59 oil emulsion|mf59 oil emulsion|mesh-list
25597564|NCT00996307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25597565|NCT00996307|Immunologic Factors|immunologic factors|mesh-ancestor
25597566|NCT00996307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597567|NCT00996346|Sirolimus|sirolimus|mesh-list
25597568|NCT00996346|Irinotecan|irinotecan|mesh-list
25597569|NCT00996346|Complement Factor H|complement factor h|mesh-list
25597570|NCT00996346|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25597571|NCT00996346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25597572|NCT00996346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597573|NCT00996346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597574|NCT00996346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597575|NCT00996346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25597576|NCT00996346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25597577|NCT00996346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25597578|NCT00996346|Antifungal Agents|antifungal agents|mesh-ancestor
25597579|NCT00996346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25597580|NCT00996346|Immunologic Factors|immunologic factors|mesh-ancestor
25597581|NCT00996346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597582|NCT00996346|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25597583|NCT00996437|Ranibizumab|ranibizumab|mesh-list
25597584|NCT00996437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25597585|NCT00996437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25597586|NCT00996437|Growth Substances|growth substances|mesh-ancestor
25597587|NCT00996437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597588|NCT00996437|Growth Inhibitors|growth inhibitors|mesh-ancestor
25597589|NCT00996437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597590|NCT00996476|Simeprevir|simeprevir|mesh-list
25597591|NCT00996476|Antiviral Agents|antiviral agents|mesh-ancestor
25597592|NCT00996476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25597593|NCT00996476|Protease Inhibitors|protease inhibitors|mesh-ancestor
25597594|NCT00996476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597595|NCT00996476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597596|NCT00996580|Levonorgestrel|levonorgestrel|mesh-list
25597597|NCT00996580|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25597598|NCT00996580|Estradiol|estradiol|mesh-list
25597599|NCT00996580|Estrogens|estrogens|mesh-ancestor
25597600|NCT00996580|Hormones|hormones|mesh-ancestor
25597601|NCT00996580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25597602|NCT00996580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597603|NCT00996580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25597604|NCT00996580|Contraceptive Agents|contraceptive agents|mesh-ancestor
25597605|NCT00996580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25597606|NCT00996580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25597607|NCT00996580|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25597608|NCT00996580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25597609|NCT00996580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25597610|NCT00996593|Iodine|iodine|mesh-list
25597611|NCT00996593|Tositumomab I-131|tositumomab i-131|mesh-list
25597612|NCT00996593|Antibodies|antibodies|mesh-list
25597613|NCT00996593|Immunoglobulins|immunoglobulins|mesh-list
25597614|NCT00996593|Immunologic Factors|immunologic factors|mesh-ancestor
25597615|NCT00996593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597616|NCT00996593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25597617|NCT00996593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25597618|NCT00996593|Trace Elements|trace elements|mesh-ancestor
25597619|NCT00996593|Micronutrients|micronutrients|mesh-ancestor
25597620|NCT00996593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597621|NCT00996658|Linagliptin|linagliptin|mesh-list
25597622|NCT00996658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25597623|NCT00996658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597624|NCT00996658|Incretins|incretins|mesh-ancestor
25597625|NCT00996658|Hormones|hormones|mesh-ancestor
25597626|NCT00996658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25597627|NCT00996658|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25597628|NCT00996658|Protease Inhibitors|protease inhibitors|mesh-ancestor
25597629|NCT00996658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597630|NCT00996658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597631|NCT00996736|Voriconazole|voriconazole|mesh-list
25597632|NCT00996736|Natamycin|natamycin|mesh-list
25597633|NCT00996736|Antifungal Agents|antifungal agents|mesh-ancestor
25597634|NCT00996736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25597635|NCT00996736|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25597636|NCT00996736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25597637|NCT00996736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597638|NCT00996736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597639|NCT00996736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25597640|NCT00996736|Hormone Antagonists|hormone antagonists|mesh-ancestor
25597641|NCT00996736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25597642|NCT00996736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597643|NCT00996736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25597644|NCT00996736|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25597645|NCT00996736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25597646|NCT00996801|Vitamin D|vitamin d|mesh-list
25597647|NCT00996801|Cholecalciferol|cholecalciferol|mesh-list
25597648|NCT00996801|Alendronate|alendronate|mesh-list
25597649|NCT00996801|Calcium Carbonate|calcium carbonate|mesh-list
25597650|NCT00996801|Calcium|calcium|mesh-list
25597651|NCT00996801|Vitamins|vitamins|mesh-ancestor
25492091|NCT00248534|Antiemetics|antiemetics|mesh-ancestor
25597652|NCT00996801|Micronutrients|micronutrients|mesh-ancestor
25653743|NCT01541930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25597653|NCT00996801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597654|NCT00996801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25597655|NCT00996801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25597657|NCT00996801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597658|NCT00996801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25597659|NCT00996931|Lenalidomide|lenalidomide|mesh-list
25597660|NCT00996931|Immunologic Factors|immunologic factors|mesh-ancestor
25597661|NCT00996931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597662|NCT00996931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25597663|NCT00996931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25597664|NCT00996931|Growth Substances|growth substances|mesh-ancestor
25597665|NCT00996931|Growth Inhibitors|growth inhibitors|mesh-ancestor
25597666|NCT00996931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597667|NCT00996944|Ropinirole|ropinirole|mesh-list
25597668|NCT00996944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25597669|NCT00996944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25597670|NCT00996944|Dopamine Agonists|dopamine agonists|mesh-ancestor
25597671|NCT00996944|Dopamine Agents|dopamine agents|mesh-ancestor
25597672|NCT00996944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25597673|NCT00996944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597674|NCT00996944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597675|NCT00996996|Iodine|iodine|mesh-list
25597676|NCT00996996|Tositumomab I-131|tositumomab i-131|mesh-list
25597677|NCT00996996|Antibodies|antibodies|mesh-list
25597678|NCT00996996|Immunoglobulins|immunoglobulins|mesh-list
25597679|NCT00996996|Immunologic Factors|immunologic factors|mesh-ancestor
24459393|NCT00344526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24459394|NCT00344526|Alkylating Agents|alkylating agents|mesh-ancestor
25597680|NCT00996996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597681|NCT00996996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25597682|NCT00996996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25597683|NCT00996996|Trace Elements|trace elements|mesh-ancestor
25597684|NCT00996996|Micronutrients|micronutrients|mesh-ancestor
25597685|NCT00996996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597686|NCT00997035|Voriconazole|voriconazole|mesh-list
25597687|NCT00997035|Antifungal Agents|antifungal agents|mesh-ancestor
25597688|NCT00997035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25597689|NCT00997035|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25597690|NCT00997035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25597691|NCT00997035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597692|NCT00997035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597693|NCT00997035|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25597694|NCT00997035|Hormone Antagonists|hormone antagonists|mesh-ancestor
25597695|NCT00997035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25597696|NCT00997035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597697|NCT00997035|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25597698|NCT00997113|Alfentanil|alfentanil|mesh-list
25597699|NCT00997113|Propofol|propofol|mesh-list
25597700|NCT00997113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25597701|NCT00997113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25597702|NCT00997113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597703|NCT00997113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25597704|NCT00997113|Anesthetics, General|anesthetics, general|mesh-ancestor
25597705|NCT00997113|Anesthetics|anesthetics|mesh-ancestor
25597706|NCT00997113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25597707|NCT00997113|Narcotics|narcotics|mesh-ancestor
25597708|NCT00997113|Analgesics|analgesics|mesh-ancestor
25597709|NCT00997113|Sensory System Agents|sensory system agents|mesh-ancestor
25597710|NCT00997113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25597711|NCT00997126|Alfentanil|alfentanil|mesh-list
25597712|NCT00997126|Propofol|propofol|mesh-list
25597713|NCT00997126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25597714|NCT00997126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25597715|NCT00997126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597716|NCT00997126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25597717|NCT00997126|Anesthetics, General|anesthetics, general|mesh-ancestor
25597718|NCT00997126|Anesthetics|anesthetics|mesh-ancestor
25597719|NCT00997126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25597720|NCT00997126|Narcotics|narcotics|mesh-ancestor
25597721|NCT00997126|Analgesics|analgesics|mesh-ancestor
25597722|NCT00997126|Sensory System Agents|sensory system agents|mesh-ancestor
25597723|NCT00997126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25597724|NCT00997139|Polymyxins|polymyxins|mesh-list
25597725|NCT00997139|Neomycin|neomycin|mesh-list
25597726|NCT00997139|Bacitracin|bacitracin|mesh-list
25597727|NCT00997139|Polymyxin B|polymyxin b|mesh-list
25597728|NCT00997139|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
25597729|NCT00997139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25597730|NCT00997139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24450796|NCT00320619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450797|NCT00320619|Hemostatics|hemostatics|mesh-ancestor
24450798|NCT00320619|Coagulants|coagulants|mesh-ancestor
24459478|NCT00344812|Methadone|methadone|mesh-list
25597731|NCT00997139|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25597732|NCT00997139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597733|NCT00997139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597734|NCT00997139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25597736|NCT00997204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25597737|NCT00997204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25597738|NCT00997204|Analgesics|analgesics|mesh-ancestor
25597739|NCT00997204|Sensory System Agents|sensory system agents|mesh-ancestor
25597740|NCT00997204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25597741|NCT00997204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597742|NCT00997204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25597743|NCT00997204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25597744|NCT00997204|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
25597745|NCT00997204|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
25597746|NCT00997204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597747|NCT00997204|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25597748|NCT00997204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25597749|NCT00997204|Immunologic Factors|immunologic factors|mesh-ancestor
25597750|NCT00997243|Azacitidine|azacitidine|mesh-list
25597751|NCT00997243|Lintuzumab|lintuzumab|mesh-list
25597752|NCT00997243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25597753|NCT00997243|Antimetabolites|antimetabolites|mesh-ancestor
25597754|NCT00997243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597755|NCT00997243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597756|NCT00997243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597757|NCT00997243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25597758|NCT00997321|Ketamine|ketamine|mesh-list
25597759|NCT00997321|Propofol|propofol|mesh-list
25597760|NCT00997321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25597761|NCT00997321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25597762|NCT00997321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597763|NCT00997321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25597764|NCT00997321|Anesthetics, General|anesthetics, general|mesh-ancestor
25597765|NCT00997321|Anesthetics|anesthetics|mesh-ancestor
25597766|NCT00997321|Analgesics|analgesics|mesh-ancestor
25597767|NCT00997321|Sensory System Agents|sensory system agents|mesh-ancestor
25597768|NCT00997321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25597769|NCT00997321|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25597770|NCT00997321|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25597771|NCT00997321|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25597772|NCT00997321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25597773|NCT00997321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653744|NCT01542034|Deoxycholic Acid|deoxycholic acid|mesh-list
25653745|NCT01542034|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25653746|NCT01542034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25653747|NCT01542125|Lidocaine|lidocaine|mesh-list
25653748|NCT01542125|Anesthetics, Local|anesthetics, local|mesh-ancestor
25653749|NCT01542125|Anesthetics|anesthetics|mesh-ancestor
25653750|NCT01542125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25653751|NCT01542125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653752|NCT01542125|Sensory System Agents|sensory system agents|mesh-ancestor
25653753|NCT01542125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653754|NCT01542125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25653755|NCT01542125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25653756|NCT01542125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25653757|NCT01542125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25653758|NCT01542125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653759|NCT01542255|Cyclophosphamide|cyclophosphamide|mesh-list
25653760|NCT01542255|Dacarbazine|dacarbazine|mesh-list
25653761|NCT01542255|Vinblastine|vinblastine|mesh-list
25653762|NCT01542255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25653763|NCT01542255|Immunologic Factors|immunologic factors|mesh-ancestor
24536894|NCT00652808|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24653281|NCT01243060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25653764|NCT01542255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653765|NCT01542255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25653766|NCT01542255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25653767|NCT01542255|Alkylating Agents|alkylating agents|mesh-ancestor
25653768|NCT01542255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653769|NCT01542255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25653770|NCT01542255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25597774|NCT00997334|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25597775|NCT00997334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597776|NCT00997334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25597777|NCT00997334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597778|NCT00997334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597779|NCT00997373|Letrozole|letrozole|mesh-list
25597780|NCT00997373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597781|NCT00997373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25597782|NCT00997373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25597783|NCT00997373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597784|NCT00997373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597785|NCT00997373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25597786|NCT00997373|Hormone Antagonists|hormone antagonists|mesh-ancestor
25597787|NCT00997373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25597788|NCT00997373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597789|NCT00997438|Thioctic Acid|thioctic acid|mesh-list
25597790|NCT00997438|Antioxidants|antioxidants|mesh-ancestor
25597791|NCT00997438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597792|NCT00997438|Protective Agents|protective agents|mesh-ancestor
25597793|NCT00997438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597794|NCT00997438|Vitamin B Complex|vitamin b complex|mesh-ancestor
25597795|NCT00997438|Vitamins|vitamins|mesh-ancestor
25597796|NCT00997438|Micronutrients|micronutrients|mesh-ancestor
25597797|NCT00997503|Aspirin|aspirin|mesh-list
25597798|NCT00997503|Paclitaxel|paclitaxel|mesh-list
25597799|NCT00997503|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25597800|NCT00997503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25597801|NCT00997503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597802|NCT00997503|Tubulin Modulators|tubulin modulators|mesh-ancestor
25597803|NCT00997503|Antimitotic Agents|antimitotic agents|mesh-ancestor
25597804|NCT00997503|Mitosis Modulators|mitosis modulators|mesh-ancestor
25597805|NCT00997503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597806|NCT00997503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25597807|NCT00997503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25597808|NCT00997503|Analgesics|analgesics|mesh-ancestor
25597809|NCT00997503|Sensory System Agents|sensory system agents|mesh-ancestor
25597810|NCT00997503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25597811|NCT00997503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597812|NCT00997503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25597813|NCT00997503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25597814|NCT00997503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25597815|NCT00997503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25597816|NCT00997503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25597817|NCT00997503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25597818|NCT00997503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597819|NCT00997503|Antipyretics|antipyretics|mesh-ancestor
25597820|NCT00997620|Fluticasone|fluticasone|mesh-list
25597821|NCT00997620|Xhance|xhance|mesh-list
25597822|NCT00997620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25597823|NCT00997620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25597824|NCT00997620|Autonomic Agents|autonomic agents|mesh-ancestor
25597825|NCT00997620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25597826|NCT00997620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597827|NCT00997620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25597828|NCT00997620|Respiratory System Agents|respiratory system agents|mesh-ancestor
25597829|NCT00997620|Dermatologic Agents|dermatologic agents|mesh-ancestor
25597830|NCT00997620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25597831|NCT00997672|Lithium Carbonate|lithium carbonate|mesh-list
25597832|NCT00997672|Antidepressive Agents|antidepressive agents|mesh-ancestor
25597833|NCT00997672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25597834|NCT00997672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597835|NCT00997672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597836|NCT00997672|Antimanic Agents|antimanic agents|mesh-ancestor
25597837|NCT00997672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25597838|NCT00997672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25597839|NCT00997672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597840|NCT00997893|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25597841|NCT00997893|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25597842|NCT00997893|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25597843|NCT00997893|Medroxyprogesterone|medroxyprogesterone|mesh-list
25597844|NCT00997893|Estradiol|estradiol|mesh-list
25597845|NCT00997893|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25597846|NCT00997893|Estrogens|estrogens|mesh-list
25597847|NCT00997893|Phytoestrogens|phytoestrogens|mesh-list
25597848|NCT00997893|Hormones|hormones|mesh-ancestor
25653771|NCT01542255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25597849|NCT00997893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25597850|NCT00997893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597851|NCT00997893|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25597852|NCT00997893|Contraceptive Agents|contraceptive agents|mesh-ancestor
25597853|NCT00997893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25597854|NCT00997893|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25597855|NCT00997893|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25597856|NCT00997893|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25597857|NCT00997893|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25597858|NCT00997893|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25597859|NCT00997893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25597860|NCT00997893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597861|NCT00997893|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25597862|NCT00997932|Contraceptive Agents|contraceptive agents|mesh-list
24653959|NCT01246362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653960|NCT01246440|Catumaxomab|catumaxomab|mesh-list
25597863|NCT00997932|Levonorgestrel|levonorgestrel|mesh-list
25597864|NCT00997932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25597865|NCT00997932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597866|NCT00997932|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25597867|NCT00997932|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25597868|NCT00997932|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25597869|NCT00997932|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25597870|NCT00997984|Guanfacine|guanfacine|mesh-list
25597871|NCT00997984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25597872|NCT00997984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25597873|NCT00997984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25597874|NCT00997984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25597875|NCT00997984|Adrenergic Agents|adrenergic agents|mesh-ancestor
25597876|NCT00997984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25597877|NCT00997984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597878|NCT00997984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597879|NCT00998010|Bortezomib|bortezomib|mesh-list
25597880|NCT00998010|Temozolomide|temozolomide|mesh-list
25597881|NCT00998010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597882|NCT00998010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25597883|NCT00998010|Alkylating Agents|alkylating agents|mesh-ancestor
25597884|NCT00998010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597885|NCT00998049|Plerixafor|plerixafor|mesh-list
25597886|NCT00998049|Lenograstim|lenograstim|mesh-list
25597887|NCT00998049|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25597888|NCT00998049|Immunologic Factors|immunologic factors|mesh-ancestor
25597889|NCT00998049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597890|NCT00998049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25597891|NCT00998049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25597892|NCT00998049|Antiviral Agents|antiviral agents|mesh-ancestor
25597893|NCT00998049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25597894|NCT00998205|Atropine|atropine|mesh-list
25597895|NCT00998205|Dobutamine|dobutamine|mesh-list
25597896|NCT00998205|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25597897|NCT00998205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25597898|NCT00998205|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25597899|NCT00998205|Autonomic Agents|autonomic agents|mesh-ancestor
25597900|NCT00998205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25597901|NCT00998205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597902|NCT00998205|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25597903|NCT00998205|Respiratory System Agents|respiratory system agents|mesh-ancestor
25597904|NCT00998205|Mydriatics|mydriatics|mesh-ancestor
25597905|NCT00998205|Parasympatholytics|parasympatholytics|mesh-ancestor
25597906|NCT00998205|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25597907|NCT00998205|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25597908|NCT00998205|Cholinergic Agents|cholinergic agents|mesh-ancestor
25597909|NCT00998205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25597910|NCT00998205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597911|NCT00998205|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25597912|NCT00998205|Sympathomimetics|sympathomimetics|mesh-ancestor
25597913|NCT00998205|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25597914|NCT00998205|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25597915|NCT00998205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25597916|NCT00998205|Adrenergic Agents|adrenergic agents|mesh-ancestor
25597917|NCT00998205|Protective Agents|protective agents|mesh-ancestor
25597918|NCT00998296|Nintedanib|nintedanib|mesh-list
25597919|NCT00998296|Afatinib|afatinib|mesh-list
25597920|NCT00998296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597921|NCT00998296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25597922|NCT00998296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492389|NCT00251589|Vorinostat|vorinostat|mesh-list
25597923|NCT00998296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597925|NCT00998309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25597926|NCT00998309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25597927|NCT00998335|Insulin|insulin|mesh-list
25597928|NCT00998335|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25597929|NCT00998335|Insulin Aspart|insulin aspart|mesh-list
25707016|NCT02224157|Budesonide|budesonide|mesh-list
25597930|NCT00998335|Insulin, Long-Acting|insulin, long-acting|mesh-list
25597931|NCT00998335|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25597932|NCT00998335|Insulin Detemir|insulin detemir|mesh-list
25597933|NCT00998335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25597934|NCT00998335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597935|NCT00998426|Immunoglobulins|immunoglobulins|mesh-list
25597936|NCT00998426|Antibodies|antibodies|mesh-list
25597937|NCT00998426|gamma-Globulins|gamma-globulins|mesh-list
25597938|NCT00998426|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25597939|NCT00998426|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25597940|NCT00998426|Immunoglobulin G|immunoglobulin g|mesh-list
25597941|NCT00998426|Immunologic Factors|immunologic factors|mesh-ancestor
25597942|NCT00998426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597943|NCT00998582|Tenofovir|tenofovir|mesh-list
25597944|NCT00998582|Antiviral Agents|antiviral agents|mesh-ancestor
25597945|NCT00998582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25597946|NCT00998582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25597947|NCT00998582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25597948|NCT00998582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597949|NCT00998582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597950|NCT00998582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25597951|NCT00998582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25597952|NCT00998946|Vitamins|vitamins|mesh-list
25597953|NCT00998946|Folic Acid|folic acid|mesh-list
25597954|NCT00998946|Vitamin B 12|vitamin b 12|mesh-list
25597955|NCT00998946|Hydroxocobalamin|hydroxocobalamin|mesh-list
25597956|NCT00998946|Vitamin B Complex|vitamin b complex|mesh-list
25597957|NCT00998946|10-deazaaminopterin|10-deazaaminopterin|mesh-list
24655683|NCT01257594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655685|NCT01257672|Domperidone|domperidone|mesh-list
24655686|NCT01257672|Antiemetics|antiemetics|mesh-ancestor
24655687|NCT01257672|Autonomic Agents|autonomic agents|mesh-ancestor
24655860|NCT01258439|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25597958|NCT00998946|Micronutrients|micronutrients|mesh-ancestor
25597959|NCT00998946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597960|NCT00998946|Hematinics|hematinics|mesh-ancestor
25597961|NCT00998946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25597962|NCT00998946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25597963|NCT00998946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25597964|NCT00998946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597965|NCT00998985|Grazoprevir|grazoprevir|mesh-list
25597966|NCT00998985|Antiviral Agents|antiviral agents|mesh-ancestor
25597967|NCT00998985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25597968|NCT00999037|Sevelamer|sevelamer|mesh-list
25597969|NCT00999037|Chelating Agents|chelating agents|mesh-ancestor
25597970|NCT00999037|Sequestering Agents|sequestering agents|mesh-ancestor
25597971|NCT00999037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597972|NCT00999102|Metoprolol|metoprolol|mesh-list
25597973|NCT00999102|Nebivolol|nebivolol|mesh-list
25597974|NCT00999102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25597975|NCT00999102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25597976|NCT00999102|Sympatholytics|sympatholytics|mesh-ancestor
25597977|NCT00999102|Autonomic Agents|autonomic agents|mesh-ancestor
25597978|NCT00999102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25597979|NCT00999102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25597980|NCT00999102|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25597981|NCT00999102|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25597982|NCT00999102|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25597983|NCT00999102|Adrenergic Agents|adrenergic agents|mesh-ancestor
25597984|NCT00999102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25597985|NCT00999102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25597986|NCT00999102|Vasodilator Agents|vasodilator agents|mesh-ancestor
25597987|NCT00999102|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25597988|NCT00999102|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25597989|NCT00999102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25597990|NCT00999518|Tanezumab|tanezumab|mesh-list
25597991|NCT00999518|Analgesics|analgesics|mesh-ancestor
25597992|NCT00999518|Sensory System Agents|sensory system agents|mesh-ancestor
25597993|NCT00999518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25597994|NCT00999518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492450|NCT00251979|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25597995|NCT00999544|Oxycodone|oxycodone|mesh-list
25597996|NCT00999544|Aprepitant|aprepitant|mesh-list
25597997|NCT00999544|Fosaprepitant|fosaprepitant|mesh-list
25597998|NCT00999544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25597999|NCT00999544|Narcotics|narcotics|mesh-ancestor
25598000|NCT00999544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25598001|NCT00999544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598002|NCT00999544|Analgesics|analgesics|mesh-ancestor
25598003|NCT00999544|Sensory System Agents|sensory system agents|mesh-ancestor
25598004|NCT00999544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25598005|NCT00999544|Antiemetics|antiemetics|mesh-ancestor
25598006|NCT00999544|Autonomic Agents|autonomic agents|mesh-ancestor
25598007|NCT00999544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25598008|NCT00999544|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25598009|NCT00999544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25598010|NCT00999544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598011|NCT00999713|Calfactant|calfactant|mesh-list
25598012|NCT00999713|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
25598013|NCT00999713|Respiratory System Agents|respiratory system agents|mesh-ancestor
25598014|NCT00999908|Tiotropium Bromide|tiotropium bromide|mesh-list
24459681|NCT00345787|Narcotics|narcotics|mesh-ancestor
24459684|NCT00345787|Analgesics|analgesics|mesh-ancestor
24657615|NCT01268670|Ibuprofen|ibuprofen|mesh-list
25598015|NCT00999908|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25598016|NCT00999908|Autonomic Agents|autonomic agents|mesh-ancestor
25598017|NCT00999908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25598018|NCT00999908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492523|NCT00252967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25492524|NCT00252967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492525|NCT00253370|Cisplatin|cisplatin|mesh-list
25492526|NCT00253370|Docetaxel|docetaxel|mesh-list
25492527|NCT00253370|Sorafenib|sorafenib|mesh-list
25492528|NCT00253370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492529|NCT00253370|Tubulin Modulators|tubulin modulators|mesh-ancestor
25492530|NCT00253370|Antimitotic Agents|antimitotic agents|mesh-ancestor
25492531|NCT00253370|Mitosis Modulators|mitosis modulators|mesh-ancestor
25492532|NCT00253370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492533|NCT00253370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25492534|NCT00253370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492535|NCT00253435|Carboplatin|carboplatin|mesh-list
25492536|NCT00253435|Etoposide|etoposide|mesh-list
25492537|NCT00253435|Melphalan|melphalan|mesh-list
25492538|NCT00253435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492539|NCT00253435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25492540|NCT00253435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25492541|NCT00253435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25492542|NCT00253435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492543|NCT00253435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492544|NCT00253435|Immunologic Factors|immunologic factors|mesh-ancestor
25492545|NCT00253435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492546|NCT00253435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25492547|NCT00253435|Alkylating Agents|alkylating agents|mesh-ancestor
25492548|NCT00253435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25492549|NCT00253435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25492550|NCT00253513|Fludarabine|fludarabine|mesh-list
25598019|NCT00999908|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25598020|NCT00999908|Respiratory System Agents|respiratory system agents|mesh-ancestor
25598021|NCT00999908|Parasympatholytics|parasympatholytics|mesh-ancestor
25598022|NCT00999908|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25598023|NCT00999908|Cholinergic Agents|cholinergic agents|mesh-ancestor
25598024|NCT00999908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25598025|NCT00999908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598026|NCT00999921|Tamoxifen|tamoxifen|mesh-list
25598027|NCT00999921|Evening primrose oil|evening primrose oil|mesh-list
25598028|NCT00999921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25598029|NCT00999921|Hormone Antagonists|hormone antagonists|mesh-ancestor
25598030|NCT00999921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25598031|NCT00999921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598032|NCT00999921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25598033|NCT00999921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598034|NCT00999921|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25598035|NCT00999921|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25598036|NCT00999921|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25598037|NCT00999921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25598038|NCT00999921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25598039|NCT00999921|Analgesics|analgesics|mesh-ancestor
25598040|NCT00999921|Sensory System Agents|sensory system agents|mesh-ancestor
25598041|NCT00999921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25598042|NCT00999921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25598043|NCT00999921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25598044|NCT00999921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25598045|NCT00999921|Antimetabolites|antimetabolites|mesh-ancestor
25598046|NCT00999921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598047|NCT00999921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25598048|NCT00999921|Dermatologic Agents|dermatologic agents|mesh-ancestor
25598049|NCT01000064|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25598050|NCT01000064|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25598051|NCT01000064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598052|NCT01000064|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25598053|NCT01000064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25598054|NCT01000064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25598055|NCT01000064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598056|NCT01000064|Dopamine Agents|dopamine agents|mesh-ancestor
25598057|NCT01000064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25598058|NCT01000155|Vorinostat|vorinostat|mesh-list
25598059|NCT01000155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598060|NCT01000155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25598061|NCT01000155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598062|NCT01000155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598063|NCT01000285|Raltegravir Potassium|raltegravir potassium|mesh-list
25598064|NCT01000285|Prednisone|prednisone|mesh-list
25598065|NCT01000285|Cyclophosphamide|cyclophosphamide|mesh-list
25598066|NCT01000285|Doxorubicin|doxorubicin|mesh-list
25598067|NCT01000285|Etoposide|etoposide|mesh-list
25598068|NCT01000285|Vincristine|vincristine|mesh-list
25598069|NCT01000285|Bortezomib|bortezomib|mesh-list
25598070|NCT01000285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25598071|NCT01000285|Immunologic Factors|immunologic factors|mesh-ancestor
25598072|NCT01000285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598073|NCT01000285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25598074|NCT01000285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25598075|NCT01000285|Alkylating Agents|alkylating agents|mesh-ancestor
25598076|NCT01000285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598077|NCT01000285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598078|NCT01000285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25598079|NCT01000285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25598080|NCT01000285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25598081|NCT01000285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25598082|NCT01000285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598083|NCT01000285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25598084|NCT01000285|Glucocorticoids|glucocorticoids|mesh-ancestor
25598085|NCT01000285|Hormones|hormones|mesh-ancestor
25598086|NCT01000285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25598087|NCT01000285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25598088|NCT01000285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25598089|NCT01000285|Tubulin Modulators|tubulin modulators|mesh-ancestor
24394251|NCT00132743|Cilostazol|cilostazol|mesh-list
25598090|NCT01000285|Antimitotic Agents|antimitotic agents|mesh-ancestor
25598091|NCT01000285|Mitosis Modulators|mitosis modulators|mesh-ancestor
25598092|NCT01000285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25598093|NCT01000285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25598094|NCT01000285|Antiviral Agents|antiviral agents|mesh-ancestor
25598095|NCT01000285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25598096|NCT01000285|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25598097|NCT01000285|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25598098|NCT01000311|Vaccines|vaccines|mesh-list
25598099|NCT01000311|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25598100|NCT01000311|Immunologic Factors|immunologic factors|mesh-ancestor
25598101|NCT01000311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598102|NCT01000337|Propofol|propofol|mesh-list
25598103|NCT01000337|Sevoflurane|sevoflurane|mesh-list
25598104|NCT01000337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25598105|NCT01000337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25598106|NCT01000337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598107|NCT01000337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25598108|NCT01000337|Anesthetics, General|anesthetics, general|mesh-ancestor
25598109|NCT01000337|Anesthetics|anesthetics|mesh-ancestor
25598110|NCT01000337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25598111|NCT01000337|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25598112|NCT01000376|Ketoconazole|ketoconazole|mesh-list
25598113|NCT01000376|Antifungal Agents|antifungal agents|mesh-ancestor
25598114|NCT01000376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25598115|NCT01000376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25598116|NCT01000376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25598117|NCT01000376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598118|NCT01000376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598119|NCT01000376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25598120|NCT01000376|Hormone Antagonists|hormone antagonists|mesh-ancestor
25598121|NCT01000376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25598122|NCT01000376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394434|NCT00133315|Adalimumab|adalimumab|mesh-list
25598123|NCT01000376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25598124|NCT01000480|Cisplatin|cisplatin|mesh-list
25598125|NCT01000480|Pemetrexed|pemetrexed|mesh-list
25598126|NCT01000480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598127|NCT01000480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598128|NCT01000480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598129|NCT01000480|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25598130|NCT01000480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25598131|NCT01000610|Methylprednisolone|methylprednisolone|mesh-list
25598132|NCT01000610|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25598133|NCT01000610|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25598134|NCT01000610|Prednisolone|prednisolone|mesh-list
25598135|NCT01000610|Prednisolone acetate|prednisolone acetate|mesh-list
25598136|NCT01000610|Rituximab|rituximab|mesh-list
25598137|NCT01000610|Methotrexate|methotrexate|mesh-list
25598138|NCT01000610|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25598139|NCT01000610|Prednisolone phosphate|prednisolone phosphate|mesh-list
25598140|NCT01000610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25598141|NCT01000610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598142|NCT01000610|Immunologic Factors|immunologic factors|mesh-ancestor
25598143|NCT01000610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598144|NCT01000610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25598145|NCT01000610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25598146|NCT01000610|Abortifacient Agents|abortifacient agents|mesh-ancestor
25598147|NCT01000610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25598148|NCT01000610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25598149|NCT01000610|Antimetabolites|antimetabolites|mesh-ancestor
25598150|NCT01000610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598151|NCT01000610|Dermatologic Agents|dermatologic agents|mesh-ancestor
25598152|NCT01000610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598153|NCT01000610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25598154|NCT01000610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25598155|NCT01000610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25598156|NCT01000610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25598157|NCT01000610|Antiemetics|antiemetics|mesh-ancestor
25598158|NCT01000610|Autonomic Agents|autonomic agents|mesh-ancestor
25598159|NCT01000610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25598160|NCT01000610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25598161|NCT01000610|Glucocorticoids|glucocorticoids|mesh-ancestor
25598162|NCT01000610|Hormones|hormones|mesh-ancestor
25598163|NCT01000610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25598164|NCT01000610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25598165|NCT01000610|Protective Agents|protective agents|mesh-ancestor
25598166|NCT01000610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25598167|NCT01000636|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
25598168|NCT01000636|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25598169|NCT01000636|Dermatologic Agents|dermatologic agents|mesh-ancestor
25598170|NCT01000649|Vasopressins|vasopressins|mesh-list
25598171|NCT01000649|Hemostatics|hemostatics|mesh-ancestor
25598172|NCT01000649|Coagulants|coagulants|mesh-ancestor
25598173|NCT01000649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25598174|NCT01000649|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25598175|NCT01000649|Natriuretic Agents|natriuretic agents|mesh-ancestor
25598176|NCT01000649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598177|NCT01000727|Darapladib|darapladib|mesh-list
25598178|NCT01000727|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
25598179|NCT01000727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598180|NCT01000727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598181|NCT01000805|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25598182|NCT01000805|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25598183|NCT01000805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25598184|NCT01000805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24459716|NCT00346099|Oxaliplatin|oxaliplatin|mesh-list
25598185|NCT01000805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598186|NCT01000805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25598187|NCT01000805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598188|NCT01000805|Analgesics|analgesics|mesh-ancestor
25598189|NCT01000805|Sensory System Agents|sensory system agents|mesh-ancestor
25598190|NCT01000805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25492653|NCT00254488|Valproic Acid|valproic acid|mesh-list
25598191|NCT01000805|Antidepressive Agents|antidepressive agents|mesh-ancestor
25598192|NCT01000805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25598193|NCT01000805|Dopamine Agents|dopamine agents|mesh-ancestor
25598194|NCT01000818|Raltegravir Potassium|raltegravir potassium|mesh-list
25598195|NCT01000818|Omeprazole|omeprazole|mesh-list
25598196|NCT01000818|Famotidine|famotidine|mesh-list
25598197|NCT01000818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25598198|NCT01000818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25598199|NCT01000818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25598200|NCT01000818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598201|NCT01000818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598202|NCT01000818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25598203|NCT01000818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25598204|NCT01000818|Antiviral Agents|antiviral agents|mesh-ancestor
25598205|NCT01000818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25598206|NCT01000818|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25598207|NCT01000818|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25598208|NCT01000818|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25598209|NCT01000818|Histamine Antagonists|histamine antagonists|mesh-ancestor
25598210|NCT01000818|Histamine Agents|histamine agents|mesh-ancestor
25598211|NCT01000818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25598212|NCT01000818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598213|NCT01000961|Cysteamine|cysteamine|mesh-list
25598214|NCT01000961|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
25598215|NCT01000961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598216|NCT01000974|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25598217|NCT01000974|Immunologic Factors|immunologic factors|mesh-ancestor
25598218|NCT01000974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598219|NCT01000987|Varenicline|varenicline|mesh-list
25598220|NCT01000987|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25598221|NCT01000987|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25598222|NCT01000987|Cholinergic Agents|cholinergic agents|mesh-ancestor
25598223|NCT01000987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25598224|NCT01000987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598225|NCT01000987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598226|NCT01001052|Colchicine|colchicine|mesh-list
25598227|NCT01001052|Gout Suppressants|gout suppressants|mesh-ancestor
25598228|NCT01001052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25598229|NCT01001052|Tubulin Modulators|tubulin modulators|mesh-ancestor
25598230|NCT01001052|Antimitotic Agents|antimitotic agents|mesh-ancestor
25598231|NCT01001052|Mitosis Modulators|mitosis modulators|mesh-ancestor
25598232|NCT01001052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598233|NCT01001052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598234|NCT01001104|Dulaglutide|dulaglutide|mesh-list
25598235|NCT01001104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25598236|NCT01001104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598237|NCT01001195|Bimatoprost|bimatoprost|mesh-list
25598238|NCT01001195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25598239|NCT01001195|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25598240|NCT01001195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25598241|NCT01001208|Etanercept|etanercept|mesh-list
25598242|NCT01001208|Methotrexate|methotrexate|mesh-list
25598243|NCT01001208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25598244|NCT01001208|Abortifacient Agents|abortifacient agents|mesh-ancestor
25598245|NCT01001208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25598246|NCT01001208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598247|NCT01001208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25598248|NCT01001208|Antimetabolites|antimetabolites|mesh-ancestor
25598249|NCT01001208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598250|NCT01001208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598251|NCT01001208|Dermatologic Agents|dermatologic agents|mesh-ancestor
25598252|NCT01001208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24647085|NCT01206153|Metformin|metformin|mesh-list
24408898|NCT00180024|Irbesartan|irbesartan|mesh-list
25598253|NCT01001208|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25598254|NCT01001208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25598255|NCT01001208|Immunologic Factors|immunologic factors|mesh-ancestor
25598256|NCT01001208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25598257|NCT01001208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25598258|NCT01001208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25598259|NCT01001208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25598260|NCT01001208|Analgesics|analgesics|mesh-ancestor
25598261|NCT01001208|Sensory System Agents|sensory system agents|mesh-ancestor
25598262|NCT01001208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25598263|NCT01001208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25598264|NCT01001208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25598265|NCT01001221|Gemcitabine|gemcitabine|mesh-list
25598266|NCT01001221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25598267|NCT01001221|Antimetabolites|antimetabolites|mesh-ancestor
25598268|NCT01001221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598269|NCT01001221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598270|NCT01001221|Antiviral Agents|antiviral agents|mesh-ancestor
25598271|NCT01001221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25598272|NCT01001221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598273|NCT01001221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25598274|NCT01001221|Immunologic Factors|immunologic factors|mesh-ancestor
25598275|NCT01001221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598276|NCT01001403|Nafamostat|nafamostat|mesh-list
25598277|NCT01001403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25598278|NCT01001403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25598279|NCT01001403|Analgesics|analgesics|mesh-ancestor
25598280|NCT01001403|Sensory System Agents|sensory system agents|mesh-ancestor
25598281|NCT01001403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25598282|NCT01001403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598283|NCT01001403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25598284|NCT01001403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25598285|NCT01001403|Anticoagulants|anticoagulants|mesh-ancestor
25598286|NCT01001403|Protease Inhibitors|protease inhibitors|mesh-ancestor
25598287|NCT01001403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598288|NCT01001403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598289|NCT01001403|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25598290|NCT01001403|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25598291|NCT01001403|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25598292|NCT01001403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25598293|NCT01001403|Immunologic Factors|immunologic factors|mesh-ancestor
25598294|NCT01001429|Dexmedetomidine|dexmedetomidine|mesh-list
25598295|NCT01001429|Propofol|propofol|mesh-list
25598296|NCT01001429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25598297|NCT01001429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25598298|NCT01001429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598299|NCT01001429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25598300|NCT01001429|Anesthetics, General|anesthetics, general|mesh-ancestor
25598301|NCT01001429|Anesthetics|anesthetics|mesh-ancestor
25598302|NCT01001429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25598303|NCT01001429|Analgesics|analgesics|mesh-ancestor
25598304|NCT01001429|Sensory System Agents|sensory system agents|mesh-ancestor
25598305|NCT01001429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25598306|NCT01001429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25598307|NCT01001429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25598308|NCT01001429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25598309|NCT01001429|Adrenergic Agents|adrenergic agents|mesh-ancestor
25598310|NCT01001429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25598311|NCT01001429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598312|NCT01001442|Maytansine|maytansine|mesh-list
25598313|NCT01001442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25598314|NCT01001442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598315|NCT01001442|Tubulin Modulators|tubulin modulators|mesh-ancestor
25598316|NCT01001442|Antimitotic Agents|antimitotic agents|mesh-ancestor
25598317|NCT01001442|Mitosis Modulators|mitosis modulators|mesh-ancestor
25598318|NCT01001442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598319|NCT01001494|Bromides|bromides|mesh-list
25598320|NCT01001494|Anticonvulsants|anticonvulsants|mesh-ancestor
25598321|NCT01001520|Tolcapone|tolcapone|mesh-list
25598322|NCT01001520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25598323|NCT01001520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25598324|NCT01001520|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25598325|NCT01001520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598326|NCT01001520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598327|NCT01001559|Norepinephrine|norepinephrine|mesh-list
25598328|NCT01001559|Serotonin|serotonin|mesh-list
25598329|NCT01001559|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25598330|NCT01001559|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
25598331|NCT01001559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25598332|NCT01001559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25598333|NCT01001559|Adrenergic Agents|adrenergic agents|mesh-ancestor
25598334|NCT01001559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25598335|NCT01001559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598336|NCT01001559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598337|NCT01001559|Sympathomimetics|sympathomimetics|mesh-ancestor
25598338|NCT01001559|Autonomic Agents|autonomic agents|mesh-ancestor
25598339|NCT01001559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25598340|NCT01001559|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25598341|NCT01001559|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25598342|NCT01001559|Serotonin Agents|serotonin agents|mesh-ancestor
25598343|NCT01001559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25598344|NCT01001559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25598345|NCT01001572|Amlodipine|amlodipine|mesh-list
25598346|NCT01001572|Valsartan|valsartan|mesh-list
25598347|NCT01001572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25598348|NCT01001572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25598349|NCT01001572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25598350|NCT01001572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598351|NCT01001572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25598352|NCT01001572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598353|NCT01001572|Vasodilator Agents|vasodilator agents|mesh-ancestor
25598354|NCT01001572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25598355|NCT01001572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25598356|NCT01001598|Danazol|danazol|mesh-list
25598357|NCT01001598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25598358|NCT01001598|Hormone Antagonists|hormone antagonists|mesh-ancestor
25598359|NCT01001598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25598360|NCT01001598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598361|NCT01001702|Aripiprazole|aripiprazole|mesh-list
25598362|NCT01001702|Antidepressive Agents|antidepressive agents|mesh-ancestor
25598363|NCT01001702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25598364|NCT01001702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25598365|NCT01001702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25598366|NCT01001702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25598367|NCT01001702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598368|NCT01001702|Dopamine Agonists|dopamine agonists|mesh-ancestor
25598369|NCT01001702|Dopamine Agents|dopamine agents|mesh-ancestor
25598370|NCT01001702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25598371|NCT01001702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598372|NCT01001702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25598373|NCT01001702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25598374|NCT01001702|Serotonin Agents|serotonin agents|mesh-ancestor
25598375|NCT01001702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25598376|NCT01001702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25598377|NCT01001702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25598378|NCT01001702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25598379|NCT01001806|Ketorolac|ketorolac|mesh-list
25598380|NCT01001806|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25598381|NCT01001806|Nepafenac|nepafenac|mesh-list
25598382|NCT01001806|Bromfenac|bromfenac|mesh-list
25598383|NCT01001806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25598384|NCT01001806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25598385|NCT01001806|Analgesics|analgesics|mesh-ancestor
25598386|NCT01001806|Sensory System Agents|sensory system agents|mesh-ancestor
25598387|NCT01001806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25598388|NCT01001806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598389|NCT01001806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25598390|NCT01001806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25598391|NCT01001806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25598392|NCT01001806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598393|NCT01001806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598394|NCT01001832|Abatacept|abatacept|mesh-list
25598395|NCT01001832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25598396|NCT01001832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598397|NCT01001832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598398|NCT01001832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25598399|NCT01001832|Immunologic Factors|immunologic factors|mesh-ancestor
25598400|NCT01001832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598401|NCT01001832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25598402|NCT01001910|Carboplatin|carboplatin|mesh-list
25598403|NCT01001910|Pemetrexed|pemetrexed|mesh-list
25598404|NCT01001910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598405|NCT01001910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598406|NCT01001910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598407|NCT01001910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25598408|NCT01001910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25598409|NCT01001975|Sunscreening Agents|sunscreening agents|mesh-list
25598410|NCT01001975|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25598411|NCT01001975|Protective Agents|protective agents|mesh-ancestor
25598412|NCT01001975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598413|NCT01001975|Dermatologic Agents|dermatologic agents|mesh-ancestor
25598415|NCT01002105|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25598416|NCT01002105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598417|NCT01002105|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25598418|NCT01002105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25598419|NCT01002105|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25598420|NCT01002105|GABA Agonists|gaba agonists|mesh-ancestor
25598421|NCT01002105|GABA Agents|gaba agents|mesh-ancestor
25598422|NCT01002105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25598423|NCT01002105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598424|NCT01002339|Mycophenolic Acid|mycophenolic acid|mesh-list
25598425|NCT01002339|Cyclosporine|cyclosporine|mesh-list
25598426|NCT01002339|Prednisone|prednisone|mesh-list
25598427|NCT01002339|Tacrolimus|tacrolimus|mesh-list
25598428|NCT01002339|Basiliximab|basiliximab|mesh-list
25598429|NCT01002339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25598430|NCT01002339|Immunologic Factors|immunologic factors|mesh-ancestor
25598431|NCT01002339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598432|NCT01002339|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25598433|NCT01002339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598434|NCT01002339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598435|NCT01002339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25598436|NCT01002339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598437|NCT01002339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25598438|NCT01002339|Antitubercular Agents|antitubercular agents|mesh-ancestor
25598439|NCT01002339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25598440|NCT01002339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25598441|NCT01002339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25598442|NCT01002339|Glucocorticoids|glucocorticoids|mesh-ancestor
25598443|NCT01002339|Hormones|hormones|mesh-ancestor
25598444|NCT01002339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25598445|NCT01002339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25598446|NCT01002339|Antifungal Agents|antifungal agents|mesh-ancestor
25598447|NCT01002339|Dermatologic Agents|dermatologic agents|mesh-ancestor
25598448|NCT01002339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25598449|NCT01002547|Vitamins|vitamins|mesh-list
25598450|NCT01002547|Vitamin E|vitamin e|mesh-list
25598451|NCT01002547|Tocopherols|tocopherols|mesh-list
25598452|NCT01002547|Tocotrienols|tocotrienols|mesh-list
25598453|NCT01002547|alpha-Tocopherol|alpha-tocopherol|mesh-list
25598454|NCT01002547|Pioglitazone|pioglitazone|mesh-list
25598455|NCT01002547|Micronutrients|micronutrients|mesh-ancestor
25598456|NCT01002547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598457|NCT01002547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25598458|NCT01002547|Antioxidants|antioxidants|mesh-ancestor
25598459|NCT01002547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598460|NCT01002547|Protective Agents|protective agents|mesh-ancestor
25653772|NCT01542255|Tubulin Modulators|tubulin modulators|mesh-ancestor
25653773|NCT01542255|Antimitotic Agents|antimitotic agents|mesh-ancestor
25653774|NCT01542255|Mitosis Modulators|mitosis modulators|mesh-ancestor
25653775|NCT01542372|Prazosin|prazosin|mesh-list
25653776|NCT01542372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25653777|NCT01542372|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25653778|NCT01542372|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25653779|NCT01542372|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25653780|NCT01542372|Adrenergic Agents|adrenergic agents|mesh-ancestor
25653781|NCT01542372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25653782|NCT01542372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653783|NCT01542372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653784|NCT01542502|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25653785|NCT01542502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25653786|NCT01542541|Rifaximin|rifaximin|mesh-list
25653787|NCT01542541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25653788|NCT01542541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25653789|NCT01542541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25653790|NCT01542645|Fentanyl|fentanyl|mesh-list
25653791|NCT01542645|Analgesics, Opioid|analgesics, opioid|mesh-list
25653792|NCT01542645|Methadone|methadone|mesh-list
25653793|NCT01542645|Narcotics|narcotics|mesh-ancestor
25653794|NCT01542645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25653795|NCT01542645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653796|NCT01542645|Analgesics|analgesics|mesh-ancestor
25653797|NCT01542645|Sensory System Agents|sensory system agents|mesh-ancestor
25653798|NCT01542645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653799|NCT01542645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25653800|NCT01542645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25492919|NCT00256451|Ethanol|ethanol|mesh-list
25598461|NCT01002573|Acetaminophen|acetaminophen|mesh-list
25598462|NCT01002573|Ibuprofen|ibuprofen|mesh-list
25598463|NCT01002573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25598464|NCT01002573|Analgesics|analgesics|mesh-ancestor
25598465|NCT01002573|Sensory System Agents|sensory system agents|mesh-ancestor
25598466|NCT01002573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25598467|NCT01002573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598468|NCT01002573|Antipyretics|antipyretics|mesh-ancestor
25598469|NCT01002573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25598470|NCT01002573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25598471|NCT01002573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25598472|NCT01002573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25598473|NCT01002573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598474|NCT01002573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598475|NCT01002742|Mycophenolic Acid|mycophenolic acid|mesh-list
25598476|NCT01002742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25598477|NCT01002742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598478|NCT01002742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25598479|NCT01002742|Antitubercular Agents|antitubercular agents|mesh-ancestor
25598480|NCT01002742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25598481|NCT01002742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25598482|NCT01002742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598483|NCT01002742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598484|NCT01002755|Lenalidomide|lenalidomide|mesh-list
25598485|NCT01002755|Ofatumumab|ofatumumab|mesh-list
25598486|NCT01002755|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25598487|NCT01002755|Immunologic Factors|immunologic factors|mesh-ancestor
25598488|NCT01002755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598489|NCT01002755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25598490|NCT01002755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25598491|NCT01002755|Growth Substances|growth substances|mesh-ancestor
25598492|NCT01002755|Growth Inhibitors|growth inhibitors|mesh-ancestor
25598493|NCT01002755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598494|NCT01003080|Hemostatics|hemostatics|mesh-list
25598495|NCT01003080|Coagulants|coagulants|mesh-ancestor
25598496|NCT01003106|Ranibizumab|ranibizumab|mesh-list
25598497|NCT01003106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25598498|NCT01003106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25598499|NCT01003106|Growth Substances|growth substances|mesh-ancestor
25598500|NCT01003106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598501|NCT01003106|Growth Inhibitors|growth inhibitors|mesh-ancestor
25598502|NCT01003106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598503|NCT01003184|Exenatide|exenatide|mesh-list
25598504|NCT01003184|Insulin Detemir|insulin detemir|mesh-list
25598505|NCT01003184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25598506|NCT01003184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598507|NCT01003184|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25598508|NCT01003184|Incretins|incretins|mesh-ancestor
25598509|NCT01003184|Hormones|hormones|mesh-ancestor
25598510|NCT01003184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25598511|NCT01003249|Baclofen|baclofen|mesh-list
25598512|NCT01003249|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25598513|NCT01003249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598514|NCT01003249|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25598515|NCT01003249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25598516|NCT01003249|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25598517|NCT01003249|GABA Agonists|gaba agonists|mesh-ancestor
25598518|NCT01003249|GABA Agents|gaba agents|mesh-ancestor
25598519|NCT01003249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25598520|NCT01003249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598521|NCT01003301|Omalizumab|omalizumab|mesh-list
25598522|NCT01003301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25598523|NCT01003301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25598524|NCT01003301|Respiratory System Agents|respiratory system agents|mesh-ancestor
25598525|NCT01003418|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25598526|NCT01003418|Immunologic Factors|immunologic factors|mesh-ancestor
25598527|NCT01003418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598528|NCT01003639|Aspirin|aspirin|mesh-list
25598529|NCT01003639|Acetaminophen|acetaminophen|mesh-list
25598530|NCT01003639|Ibuprofen|ibuprofen|mesh-list
25598531|NCT01003639|Naproxen|naproxen|mesh-list
25598532|NCT01003639|Acetazolamide|acetazolamide|mesh-list
25598533|NCT01003639|Codeine|codeine|mesh-list
25492988|NCT00256997|Risperidone|risperidone|mesh-list
25598534|NCT01003639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25598535|NCT01003639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25598536|NCT01003639|Analgesics|analgesics|mesh-ancestor
25598537|NCT01003639|Sensory System Agents|sensory system agents|mesh-ancestor
25598538|NCT01003639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25598539|NCT01003639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598540|NCT01003639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25598541|NCT01003639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25598542|NCT01003639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25598543|NCT01003639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25598544|NCT01003639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598545|NCT01003639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25598546|NCT01003639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25598547|NCT01003639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598548|NCT01003639|Antipyretics|antipyretics|mesh-ancestor
25598549|NCT01003639|Gout Suppressants|gout suppressants|mesh-ancestor
25598550|NCT01003639|Anticonvulsants|anticonvulsants|mesh-ancestor
25598551|NCT01003639|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25598552|NCT01003639|Diuretics|diuretics|mesh-ancestor
25598553|NCT01003639|Natriuretic Agents|natriuretic agents|mesh-ancestor
25598554|NCT01003639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25598555|NCT01003639|Narcotics|narcotics|mesh-ancestor
25598556|NCT01003639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25598557|NCT01003639|Antitussive Agents|antitussive agents|mesh-ancestor
25598558|NCT01003639|Respiratory System Agents|respiratory system agents|mesh-ancestor
25598559|NCT01003769|Acetic Acid|acetic acid|mesh-list
25598560|NCT01003769|Lenalidomide|lenalidomide|mesh-list
25598561|NCT01003769|Retinol acetate|retinol acetate|mesh-list
25598562|NCT01003769|Gossypol acetic acid|gossypol acetic acid|mesh-list
25598563|NCT01003769|Gossypol|gossypol|mesh-list
24650803|NCT01228110|Hydrocortisone|hydrocortisone|mesh-list
25598564|NCT01003769|Immunologic Factors|immunologic factors|mesh-ancestor
25598565|NCT01003769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598566|NCT01003769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25598567|NCT01003769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25598568|NCT01003769|Growth Substances|growth substances|mesh-ancestor
25598569|NCT01003769|Growth Inhibitors|growth inhibitors|mesh-ancestor
25598570|NCT01003769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598571|NCT01003769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25598572|NCT01003769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25598573|NCT01003769|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25598574|NCT01003769|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25598575|NCT01003769|Protective Agents|protective agents|mesh-ancestor
25598576|NCT01003769|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25598577|NCT01003769|Contraceptive Agents|contraceptive agents|mesh-ancestor
25598578|NCT01003769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25598579|NCT01003769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25598580|NCT01003769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25598581|NCT01003769|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
25598582|NCT01003769|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
25598583|NCT01003886|Doxazosin|doxazosin|mesh-list
25598584|NCT01003886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25598585|NCT01003886|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25598586|NCT01003886|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25598587|NCT01003886|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25598588|NCT01003886|Adrenergic Agents|adrenergic agents|mesh-ancestor
25598589|NCT01003886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25598590|NCT01003886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598591|NCT01003886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598592|NCT01003899|Afatinib|afatinib|mesh-list
24859157|NCT02302274|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24859158|NCT02302274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24859159|NCT02302274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859161|NCT02302326|Inositol|inositol|mesh-list
24859162|NCT02302326|Metformin|metformin|mesh-list
24651358|NCT01231165|Analgesics|analgesics|mesh-ancestor
24651359|NCT01231165|Sensory System Agents|sensory system agents|mesh-ancestor
24651360|NCT01231165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24651361|NCT01231165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859167|NCT02302326|Vitamins|vitamins|mesh-ancestor
25598593|NCT01003899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598594|NCT01003899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25598595|NCT01003899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598596|NCT01003899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598597|NCT01003938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25598598|NCT01003938|Topotecan|topotecan|mesh-list
25598599|NCT01003938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598600|NCT01003938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25598601|NCT01003938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598602|NCT01003938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598603|NCT01003938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25598604|NCT01003938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25598605|NCT01003990|Ritonavir|ritonavir|mesh-list
25598606|NCT01003990|Lopinavir|lopinavir|mesh-list
25598607|NCT01003990|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25598608|NCT01003990|Tenofovir|tenofovir|mesh-list
25598609|NCT01003990|Emtricitabine|emtricitabine|mesh-list
25598610|NCT01003990|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25598611|NCT01003990|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25598612|NCT01003990|Protease Inhibitors|protease inhibitors|mesh-ancestor
25598613|NCT01003990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598614|NCT01003990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598615|NCT01003990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25598616|NCT01003990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25598617|NCT01003990|Antiviral Agents|antiviral agents|mesh-ancestor
25598618|NCT01003990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25598619|NCT01003990|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25598620|NCT01003990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25598621|NCT01003990|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25598622|NCT01003990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25598623|NCT01004003|Sorafenib|sorafenib|mesh-list
25598624|NCT01004003|Nintedanib|nintedanib|mesh-list
25598625|NCT01004003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598626|NCT01004003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25598627|NCT01004003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598628|NCT01004003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598629|NCT01004042|Botulinum Toxins|botulinum toxins|mesh-list
25598630|NCT01004042|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25598631|NCT01004042|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25598632|NCT01004042|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25598633|NCT01004042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25598634|NCT01004042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598635|NCT01004042|Cholinergic Agents|cholinergic agents|mesh-ancestor
25598636|NCT01004042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25598637|NCT01004042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598638|NCT01004042|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25598639|NCT01004042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25598640|NCT01004159|Irinotecan|irinotecan|mesh-list
25598641|NCT01004159|Cetuximab|cetuximab|mesh-list
25598642|NCT01004159|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25598643|NCT01004159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25598644|NCT01004159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598645|NCT01004159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598646|NCT01004159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598647|NCT01004159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25598648|NCT01004172|Bevacizumab|bevacizumab|mesh-list
25598649|NCT01004172|Trastuzumab|trastuzumab|mesh-list
25598650|NCT01004172|Carboplatin|carboplatin|mesh-list
25598651|NCT01004172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25598652|NCT01004172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598653|NCT01004172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25598654|NCT01004172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25598655|NCT01004172|Growth Substances|growth substances|mesh-ancestor
25598656|NCT01004172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598657|NCT01004172|Growth Inhibitors|growth inhibitors|mesh-ancestor
25598658|NCT01004185|Aminosalicylic Acid|aminosalicylic acid|mesh-list
25598659|NCT01004185|Mesalamine|mesalamine|mesh-list
25598660|NCT01004185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25598661|NCT01004185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25598662|NCT01004185|Analgesics|analgesics|mesh-ancestor
25598663|NCT01004185|Sensory System Agents|sensory system agents|mesh-ancestor
25598664|NCT01004185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25598665|NCT01004185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598666|NCT01004185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25598667|NCT01004185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25598668|NCT01004185|Antitubercular Agents|antitubercular agents|mesh-ancestor
25598669|NCT01004185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25598670|NCT01004185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25598671|NCT01004250|Bevacizumab|bevacizumab|mesh-list
25598672|NCT01004250|Cisplatin|cisplatin|mesh-list
25598673|NCT01004250|Pemetrexed|pemetrexed|mesh-list
25598674|NCT01004250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25598675|NCT01004250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598676|NCT01004250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25598677|NCT01004250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25598678|NCT01004250|Growth Substances|growth substances|mesh-ancestor
25598679|NCT01004250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598680|NCT01004250|Growth Inhibitors|growth inhibitors|mesh-ancestor
25598681|NCT01004250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535254|NCT00648843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25598682|NCT01004250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598683|NCT01004250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25598684|NCT01004250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25598685|NCT01004354|Ergocalciferols|ergocalciferols|mesh-list
25598686|NCT01004354|Vitamin D|vitamin d|mesh-list
25598687|NCT01004354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25598688|NCT01004354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598689|NCT01004354|Vitamins|vitamins|mesh-ancestor
25598690|NCT01004354|Micronutrients|micronutrients|mesh-ancestor
25598691|NCT01004354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25598692|NCT01004393|Bromides|bromides|mesh-list
25598693|NCT01004393|Methylnaltrexone|methylnaltrexone|mesh-list
25598694|NCT01004393|Anticonvulsants|anticonvulsants|mesh-ancestor
25598695|NCT01004393|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25598696|NCT01004393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598697|NCT01004393|Sensory System Agents|sensory system agents|mesh-ancestor
25598698|NCT01004393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25598699|NCT01004406|Atorvastatin|atorvastatin|mesh-list
25598700|NCT01004406|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
25598701|NCT01004406|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25598702|NCT01004406|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25598703|NCT01004406|Antimetabolites|antimetabolites|mesh-ancestor
25598704|NCT01004406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598705|NCT01004406|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25598706|NCT01004406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598707|NCT01004432|Golimumab|golimumab|mesh-list
25598708|NCT01004432|Methotrexate|methotrexate|mesh-list
25598709|NCT01004432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25598710|NCT01004432|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25598711|NCT01004432|Abortifacient Agents|abortifacient agents|mesh-ancestor
25598712|NCT01004432|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25598713|NCT01004432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598714|NCT01004432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25598715|NCT01004432|Antimetabolites|antimetabolites|mesh-ancestor
25598716|NCT01004432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598717|NCT01004432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598718|NCT01004432|Dermatologic Agents|dermatologic agents|mesh-ancestor
25598719|NCT01004432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598720|NCT01004432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25598721|NCT01004432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25598722|NCT01004432|Immunologic Factors|immunologic factors|mesh-ancestor
25598723|NCT01004432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25598724|NCT01004432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25598725|NCT01004432|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25598726|NCT01004432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25598727|NCT01004614|Amlodipine|amlodipine|mesh-list
25598728|NCT01004614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25598729|NCT01004614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25598730|NCT01004614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25598731|NCT01004614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598732|NCT01004614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25598733|NCT01004614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598734|NCT01004614|Vasodilator Agents|vasodilator agents|mesh-ancestor
25598735|NCT01004705|Aspirin|aspirin|mesh-list
25598736|NCT01004705|Ramipril|ramipril|mesh-list
25598737|NCT01004705|Simvastatin|simvastatin|mesh-list
25598738|NCT01004705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25598739|NCT01004705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25598740|NCT01004705|Antimetabolites|antimetabolites|mesh-ancestor
25598741|NCT01004705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598742|NCT01004705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25598743|NCT01004705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25598744|NCT01004705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598745|NCT01004705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25598746|NCT01004705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25598747|NCT01004705|Analgesics|analgesics|mesh-ancestor
25598748|NCT01004705|Sensory System Agents|sensory system agents|mesh-ancestor
25598749|NCT01004705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25598750|NCT01004705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598751|NCT01004705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25598752|NCT01004705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25598753|NCT01004705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25598754|NCT01004705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25598755|NCT01004705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25598756|NCT01004705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25598757|NCT01004705|Antipyretics|antipyretics|mesh-ancestor
25598758|NCT01004705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25598759|NCT01004705|Protease Inhibitors|protease inhibitors|mesh-ancestor
25598760|NCT01004705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25598761|NCT01004718|Deoxyglucose|deoxyglucose|mesh-list
25598762|NCT01004718|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25598763|NCT01004718|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25598764|NCT01004718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598765|NCT01004718|Antimetabolites|antimetabolites|mesh-ancestor
25598766|NCT01004718|Antiviral Agents|antiviral agents|mesh-ancestor
25598767|NCT01004718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25598768|NCT01004744|Anastrozole|anastrozole|mesh-list
25598769|NCT01004744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25598770|NCT01004744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598771|NCT01004744|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25598772|NCT01004744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25598773|NCT01004744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598774|NCT01004744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598775|NCT01004744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25598776|NCT01004744|Hormone Antagonists|hormone antagonists|mesh-ancestor
25598777|NCT01004744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25598778|NCT01004744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598779|NCT01004939|PENTA|penta|mesh-list
25598780|NCT01004939|Fondaparinux|fondaparinux|mesh-list
25707049|NCT02224313|Progesterone|progesterone|mesh-list
24860452|NCT02309970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598781|NCT01004939|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25598782|NCT01004939|Antithrombins|antithrombins|mesh-ancestor
25598783|NCT01004939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25598784|NCT01004939|Protease Inhibitors|protease inhibitors|mesh-ancestor
25598785|NCT01004939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598786|NCT01004939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598787|NCT01004939|Anticoagulants|anticoagulants|mesh-ancestor
25598788|NCT01004939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25598789|NCT01004939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25598790|NCT01004991|Prednisone|prednisone|mesh-list
25598791|NCT01004991|Cyclophosphamide|cyclophosphamide|mesh-list
25598792|NCT01004991|Rituximab|rituximab|mesh-list
25598793|NCT01004991|Doxorubicin|doxorubicin|mesh-list
25598794|NCT01004991|Vincristine|vincristine|mesh-list
25598795|NCT01004991|Azacitidine|azacitidine|mesh-list
25598796|NCT01004991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25598797|NCT01004991|Immunologic Factors|immunologic factors|mesh-ancestor
25598798|NCT01004991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598799|NCT01004991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25598800|NCT01004991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25598801|NCT01004991|Alkylating Agents|alkylating agents|mesh-ancestor
25598802|NCT01004991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598803|NCT01004991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598804|NCT01004991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25598805|NCT01004991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25598806|NCT01004991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25598807|NCT01004991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25598808|NCT01004991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25598809|NCT01004991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598810|NCT01004991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25598811|NCT01004991|Glucocorticoids|glucocorticoids|mesh-ancestor
25598812|NCT01004991|Hormones|hormones|mesh-ancestor
25598813|NCT01004991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25598814|NCT01004991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25598815|NCT01004991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25598816|NCT01004991|Tubulin Modulators|tubulin modulators|mesh-ancestor
24860561|NCT02311088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24860563|NCT02311088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24860564|NCT02311088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860566|NCT02311088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25598817|NCT01004991|Antimitotic Agents|antimitotic agents|mesh-ancestor
25598818|NCT01004991|Mitosis Modulators|mitosis modulators|mesh-ancestor
25598819|NCT01004991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25598820|NCT01004991|Antimetabolites|antimetabolites|mesh-ancestor
25598821|NCT01005251|Lesogaberan|lesogaberan|mesh-list
25598822|NCT01005251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25598823|NCT01005251|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25598824|NCT01005251|GABA Agonists|gaba agonists|mesh-ancestor
25598825|NCT01005251|GABA Agents|gaba agents|mesh-ancestor
25598826|NCT01005251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25598827|NCT01005251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598828|NCT01005251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598829|NCT01005290|Ramipril|ramipril|mesh-list
25598830|NCT01005290|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25598831|NCT01005290|Protease Inhibitors|protease inhibitors|mesh-ancestor
25598832|NCT01005290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598833|NCT01005290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598834|NCT01005290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25598835|NCT01005316|Mycophenolic Acid|mycophenolic acid|mesh-list
25598836|NCT01005316|Prednisone|prednisone|mesh-list
25598837|NCT01005316|Tacrolimus|tacrolimus|mesh-list
24540956|NCT00670293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24860616|NCT02311530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24860617|NCT02311530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24860618|NCT02311530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24860630|NCT02311569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598838|NCT01005316|Immunoglobulins|immunoglobulins|mesh-list
25598839|NCT01005316|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25598840|NCT01005316|Antibodies|antibodies|mesh-list
25598841|NCT01005316|gamma-Globulins|gamma-globulins|mesh-list
25598842|NCT01005316|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25598843|NCT01005316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25598844|NCT01005316|Glucocorticoids|glucocorticoids|mesh-ancestor
25598845|NCT01005316|Hormones|hormones|mesh-ancestor
25598846|NCT01005316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25598847|NCT01005316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598848|NCT01005316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25598849|NCT01005316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598850|NCT01005316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25598851|NCT01005316|Immunologic Factors|immunologic factors|mesh-ancestor
25598852|NCT01005316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25598853|NCT01005316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598854|NCT01005316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598855|NCT01005316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25598856|NCT01005316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25598857|NCT01005316|Antitubercular Agents|antitubercular agents|mesh-ancestor
25598858|NCT01005316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25598859|NCT01005316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25598860|NCT01005329|Paclitaxel|paclitaxel|mesh-list
25598861|NCT01005329|Bevacizumab|bevacizumab|mesh-list
25598862|NCT01005329|Cisplatin|cisplatin|mesh-list
24541035|NCT00670566|Diuretics|diuretics|mesh-ancestor
25598863|NCT01005329|Carboplatin|carboplatin|mesh-list
25598864|NCT01005329|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25598865|NCT01005329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25598866|NCT01005329|Endothelial Growth Factors|endothelial growth factors|mesh-list
25598867|NCT01005329|Antibodies|antibodies|mesh-list
25598868|NCT01005329|Immunoglobulins|immunoglobulins|mesh-list
25598869|NCT01005329|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25598870|NCT01005329|Immunoglobulin G|immunoglobulin g|mesh-list
25598871|NCT01005329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25598872|NCT01005329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598873|NCT01005329|Tubulin Modulators|tubulin modulators|mesh-ancestor
25598874|NCT01005329|Antimitotic Agents|antimitotic agents|mesh-ancestor
25598875|NCT01005329|Mitosis Modulators|mitosis modulators|mesh-ancestor
25598876|NCT01005329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598877|NCT01005329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25598878|NCT01005329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25598879|NCT01005329|Growth Substances|growth substances|mesh-ancestor
25598880|NCT01005329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493343|NCT00260962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25493344|NCT00260962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25493345|NCT00260962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25493346|NCT00260962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25493347|NCT00260962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25493348|NCT00260962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24537029|NCT00653341|Insulin|insulin|mesh-list
24537030|NCT00653341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24860773|NCT02312544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860774|NCT02312544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860775|NCT02312544|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24860780|NCT02312635|Cycloserine|cycloserine|mesh-list
25493349|NCT00260962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25493350|NCT00260962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25493351|NCT00260962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493352|NCT00260962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25493353|NCT00260962|Serotonin Agents|serotonin agents|mesh-ancestor
25493354|NCT00261443|Valproic Acid|valproic acid|mesh-list
25493355|NCT00261443|Aripiprazole|aripiprazole|mesh-list
25493356|NCT00261443|Lithium Carbonate|lithium carbonate|mesh-list
25493357|NCT00261443|Antidepressive Agents|antidepressive agents|mesh-ancestor
25598881|NCT01005329|Growth Inhibitors|growth inhibitors|mesh-ancestor
25598882|NCT01005329|Immunologic Factors|immunologic factors|mesh-ancestor
25598883|NCT01005355|Ramucirumab|ramucirumab|mesh-list
25598884|NCT01005355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598885|NCT01005407|Vaccines|vaccines|mesh-list
25598886|NCT01005407|Immunologic Factors|immunologic factors|mesh-ancestor
25598887|NCT01005407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598888|NCT01005459|Bupivacaine|bupivacaine|mesh-list
25598889|NCT01005459|Tetracaine|tetracaine|mesh-list
25598890|NCT01005459|Anesthetics, Local|anesthetics, local|mesh-ancestor
25598891|NCT01005459|Anesthetics|anesthetics|mesh-ancestor
25598892|NCT01005459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24860863|NCT02313272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24860864|NCT02313272|Growth Substances|growth substances|mesh-ancestor
24860865|NCT02313272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860866|NCT02313272|Growth Inhibitors|growth inhibitors|mesh-ancestor
24682485|NCT01386580|Doxorubicin|doxorubicin|mesh-list
24860867|NCT02313337|Fentanyl|fentanyl|mesh-list
24860868|NCT02313337|Midazolam|midazolam|mesh-list
24860869|NCT02313337|Anesthetics|anesthetics|mesh-list
24860870|NCT02313337|Propofol|propofol|mesh-list
25598893|NCT01005459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598894|NCT01005459|Sensory System Agents|sensory system agents|mesh-ancestor
25598895|NCT01005459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25598896|NCT01005576|Fludarabine|fludarabine|mesh-list
25598897|NCT01005576|Melphalan|melphalan|mesh-list
25598898|NCT01005576|Alemtuzumab|alemtuzumab|mesh-list
25598899|NCT01005576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598900|NCT01005576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598901|NCT01005576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25598902|NCT01005576|Immunologic Factors|immunologic factors|mesh-ancestor
25598903|NCT01005576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598904|NCT01005576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25598905|NCT01005576|Alkylating Agents|alkylating agents|mesh-ancestor
25598906|NCT01005576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25598907|NCT01005576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25598908|NCT01005602|Digoxin|digoxin|mesh-list
25598909|NCT01005602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25598910|NCT01005602|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25598911|NCT01005602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598912|NCT01005602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598913|NCT01005602|Protective Agents|protective agents|mesh-ancestor
25598914|NCT01005602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598915|NCT01005680|Gemcitabine|gemcitabine|mesh-list
25598916|NCT01005680|Cisplatin|cisplatin|mesh-list
25598917|NCT01005680|Pemetrexed|pemetrexed|mesh-list
25598918|NCT01005680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598919|NCT01005680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25598920|NCT01005680|Antimetabolites|antimetabolites|mesh-ancestor
25598921|NCT01005680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598922|NCT01005680|Antiviral Agents|antiviral agents|mesh-ancestor
25598923|NCT01005680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25598924|NCT01005680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598925|NCT01005680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25598926|NCT01005680|Immunologic Factors|immunologic factors|mesh-ancestor
25598927|NCT01005680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598928|NCT01005680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25598929|NCT01005680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25598930|NCT01005706|Mycophenolic Acid|mycophenolic acid|mesh-list
25598931|NCT01005706|Sirolimus|sirolimus|mesh-list
25598932|NCT01005706|Tacrolimus|tacrolimus|mesh-list
25598933|NCT01005706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25598934|NCT01005706|Immunologic Factors|immunologic factors|mesh-ancestor
25598935|NCT01005706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598936|NCT01005706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25598937|NCT01005706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598938|NCT01005706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598939|NCT01005706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25598940|NCT01005706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598941|NCT01005706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25598942|NCT01005706|Antitubercular Agents|antitubercular agents|mesh-ancestor
25598943|NCT01005706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25598944|NCT01005706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25598945|NCT01005706|Antifungal Agents|antifungal agents|mesh-ancestor
25598946|NCT01005719|Omeprazole|omeprazole|mesh-list
25598947|NCT01005719|Lansoprazole|lansoprazole|mesh-list
25598948|NCT01005719|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
25598949|NCT01005719|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25598950|NCT01005719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25598951|NCT01005719|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25598952|NCT01005719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598953|NCT01005719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598954|NCT01005810|Acetylcysteine|acetylcysteine|mesh-list
25598955|NCT01005810|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25598956|NCT01005810|Antiviral Agents|antiviral agents|mesh-ancestor
25598957|NCT01005810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25598958|NCT01005810|Expectorants|expectorants|mesh-ancestor
25598959|NCT01005810|Respiratory System Agents|respiratory system agents|mesh-ancestor
25598960|NCT01005810|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25598961|NCT01005810|Antioxidants|antioxidants|mesh-ancestor
25598962|NCT01005810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598963|NCT01005810|Protective Agents|protective agents|mesh-ancestor
25598964|NCT01005810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598965|NCT01005810|Antidotes|antidotes|mesh-ancestor
25598966|NCT01005875|Sorafenib|sorafenib|mesh-list
25598967|NCT01005875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25598968|NCT01005875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25598969|NCT01005875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25598970|NCT01005875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598971|NCT01005888|Complement C1s|complement c1s|mesh-list
25598972|NCT01005888|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
24451397|NCT00323544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24451398|NCT00323544|Antimetabolites|antimetabolites|mesh-ancestor
24451399|NCT00323583|Leucovorin|leucovorin|mesh-list
24451400|NCT00323583|Paclitaxel|paclitaxel|mesh-list
24451401|NCT00323583|Fluorouracil|fluorouracil|mesh-list
24451402|NCT00323583|Oxaliplatin|oxaliplatin|mesh-list
24451403|NCT00323583|Calcium|calcium|mesh-list
24860971|NCT02314208|Atorvastatin|atorvastatin|mesh-list
25493399|NCT00262002|Vaccines|vaccines|mesh-list
25598973|NCT01005888|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
25598974|NCT01005888|Immunologic Factors|immunologic factors|mesh-ancestor
25598975|NCT01005888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598976|NCT01005888|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25598977|NCT01005888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25598979|NCT01005901|Bromides|bromides|mesh-list
25598980|NCT01005901|Anticonvulsants|anticonvulsants|mesh-ancestor
25598981|NCT01005901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25598982|NCT01005901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25598983|NCT01005901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25598984|NCT01005901|Cholinergic Agents|cholinergic agents|mesh-ancestor
25598985|NCT01005901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25598986|NCT01005901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25598987|NCT01005901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598988|NCT01005966|Listerine|listerine|mesh-list
25598989|NCT01005966|Fluorides|fluorides|mesh-list
25598990|NCT01005966|Sodium Fluoride|sodium fluoride|mesh-list
25598991|NCT01005966|Fluorophosphate|fluorophosphate|mesh-list
25598992|NCT01005966|Cariostatic Agents|cariostatic agents|mesh-ancestor
25598993|NCT01005966|Protective Agents|protective agents|mesh-ancestor
25598994|NCT01005966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25598995|NCT01005966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25598996|NCT01005966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25598997|NCT01006252|Paclitaxel|paclitaxel|mesh-list
25598998|NCT01006252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25598999|NCT01006252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599000|NCT01006252|Tubulin Modulators|tubulin modulators|mesh-ancestor
25599001|NCT01006252|Antimitotic Agents|antimitotic agents|mesh-ancestor
25599002|NCT01006252|Mitosis Modulators|mitosis modulators|mesh-ancestor
25599003|NCT01006252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599004|NCT01006291|Insulin|insulin|mesh-list
25599005|NCT01006291|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25599006|NCT01006291|Insulin Glargine|insulin glargine|mesh-list
25599007|NCT01006291|Insulin, Long-Acting|insulin, long-acting|mesh-list
25599008|NCT01006291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25599009|NCT01006291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599010|NCT01006356|Hydromorphone|hydromorphone|mesh-list
25599011|NCT01006356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25599012|NCT01006356|Narcotics|narcotics|mesh-ancestor
25599013|NCT01006356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25599014|NCT01006356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599015|NCT01006356|Analgesics|analgesics|mesh-ancestor
25599016|NCT01006356|Sensory System Agents|sensory system agents|mesh-ancestor
25599017|NCT01006356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25599018|NCT01006369|Hydroxychloroquine|hydroxychloroquine|mesh-list
25599019|NCT01006369|Antimalarials|antimalarials|mesh-ancestor
25599020|NCT01006369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25599021|NCT01006369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25599022|NCT01006369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25599023|NCT01006369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25599024|NCT01006369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599025|NCT01006369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25599026|NCT01006538|Ranibizumab|ranibizumab|mesh-list
25599027|NCT01006538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25599028|NCT01006538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25599029|NCT01006538|Growth Substances|growth substances|mesh-ancestor
25599030|NCT01006538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599031|NCT01006538|Growth Inhibitors|growth inhibitors|mesh-ancestor
25599032|NCT01006538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599033|NCT01006590|Metformin|metformin|mesh-list
25599034|NCT01006590|Saxagliptin|saxagliptin|mesh-list
25599035|NCT01006590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25599036|NCT01006590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599037|NCT01006590|Incretins|incretins|mesh-ancestor
24861090|NCT02314754|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24861091|NCT02314754|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24861092|NCT02314754|Hormone Antagonists|hormone antagonists|mesh-ancestor
24861093|NCT02314754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25599038|NCT01006590|Hormones|hormones|mesh-ancestor
25599039|NCT01006590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25599040|NCT01006590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25599041|NCT01006590|Protease Inhibitors|protease inhibitors|mesh-ancestor
25599042|NCT01006590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25599043|NCT01006590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599044|NCT01006603|Glimepiride|glimepiride|mesh-list
25599045|NCT01006603|Saxagliptin|saxagliptin|mesh-list
25599046|NCT01006603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25599047|NCT01006603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25599048|NCT01006603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599049|NCT01006603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25599050|NCT01006603|Immunologic Factors|immunologic factors|mesh-ancestor
25599051|NCT01006603|Incretins|incretins|mesh-ancestor
25599052|NCT01006603|Hormones|hormones|mesh-ancestor
25599053|NCT01006603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25599054|NCT01006603|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25599055|NCT01006603|Protease Inhibitors|protease inhibitors|mesh-ancestor
25599056|NCT01006603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25599057|NCT01006603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599058|NCT01006629|Palivizumab|palivizumab|mesh-list
25599059|NCT01006629|Antiviral Agents|antiviral agents|mesh-ancestor
25599060|NCT01006629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25599061|NCT01006655|Beclomethasone|beclomethasone|mesh-list
25599062|NCT01006655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25599063|NCT01006655|Glucocorticoids|glucocorticoids|mesh-ancestor
25707068|NCT02224729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861105|NCT02314806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24861106|NCT02314806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861107|NCT02314871|Morphine|morphine|mesh-list
24861108|NCT02314871|Pirinitramide|pirinitramide|mesh-list
24861109|NCT02314871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24861110|NCT02314871|Narcotics|narcotics|mesh-ancestor
24861111|NCT02314871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24861112|NCT02314871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599064|NCT01006655|Hormones|hormones|mesh-ancestor
25599065|NCT01006655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25599066|NCT01006655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599067|NCT01006655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25599068|NCT01006655|Respiratory System Agents|respiratory system agents|mesh-ancestor
25599069|NCT01006707|Ondansetron|ondansetron|mesh-list
25599070|NCT01006707|Antiemetics|antiemetics|mesh-ancestor
25599071|NCT01006707|Autonomic Agents|autonomic agents|mesh-ancestor
25599072|NCT01006707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25599073|NCT01006707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599074|NCT01006707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25599075|NCT01006707|Antipruritics|antipruritics|mesh-ancestor
25599076|NCT01006707|Dermatologic Agents|dermatologic agents|mesh-ancestor
25599077|NCT01006707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25599078|NCT01006707|Serotonin Agents|serotonin agents|mesh-ancestor
25599079|NCT01006707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25599080|NCT01006707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599081|NCT01006707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25599082|NCT01006707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25599083|NCT01006707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25599084|NCT01006707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25599085|NCT01006707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25599086|NCT01006889|Exenatide|exenatide|mesh-list
25599087|NCT01006889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25599088|NCT01006889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599089|NCT01006889|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25599090|NCT01006889|Incretins|incretins|mesh-ancestor
25599091|NCT01006889|Hormones|hormones|mesh-ancestor
25599092|NCT01006889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25599093|NCT01006980|Dacarbazine|dacarbazine|mesh-list
25599094|NCT01006980|Vemurafenib|vemurafenib|mesh-list
25599095|NCT01006980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25599096|NCT01006980|Alkylating Agents|alkylating agents|mesh-ancestor
25599097|NCT01006980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599098|NCT01006980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599099|NCT01006980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25599100|NCT01006980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25599101|NCT01007071|Hormones|hormones|mesh-list
25599102|NCT01007071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25599103|NCT01007071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599104|NCT01007149|Omalizumab|omalizumab|mesh-list
25599105|NCT01007149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25599106|NCT01007149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25599107|NCT01007149|Respiratory System Agents|respiratory system agents|mesh-ancestor
25599108|NCT01007253|Fluticasone|fluticasone|mesh-list
25599109|NCT01007253|Xhance|xhance|mesh-list
25599110|NCT01007253|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25599111|NCT01007253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24541463|NCT00672971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541464|NCT00673088|Ropinirole|ropinirole|mesh-list
24541465|NCT00673088|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24541466|NCT00673088|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24541467|NCT00673088|Dopamine Agonists|dopamine agonists|mesh-ancestor
24541468|NCT00673088|Dopamine Agents|dopamine agents|mesh-ancestor
24541469|NCT00673088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25599112|NCT01007253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25599113|NCT01007253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25599114|NCT01007253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25599115|NCT01007253|Autonomic Agents|autonomic agents|mesh-ancestor
25599116|NCT01007253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25599117|NCT01007253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599118|NCT01007253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25599119|NCT01007253|Respiratory System Agents|respiratory system agents|mesh-ancestor
25599120|NCT01007253|Dermatologic Agents|dermatologic agents|mesh-ancestor
25599121|NCT01007253|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25599122|NCT01007253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25599123|NCT01007253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25599124|NCT01007253|Analgesics|analgesics|mesh-ancestor
25599125|NCT01007253|Sensory System Agents|sensory system agents|mesh-ancestor
25599126|NCT01007253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25599127|NCT01007253|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25599128|NCT01007253|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25599129|NCT01007253|Histamine Antagonists|histamine antagonists|mesh-ancestor
25599130|NCT01007253|Histamine Agents|histamine agents|mesh-ancestor
25599131|NCT01007253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25599132|NCT01007253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599133|NCT01007435|Methotrexate|methotrexate|mesh-list
25599134|NCT01007435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25599135|NCT01007435|Abortifacient Agents|abortifacient agents|mesh-ancestor
25599136|NCT01007435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25599137|NCT01007435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599138|NCT01007435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25599139|NCT01007435|Antimetabolites|antimetabolites|mesh-ancestor
25707086|NCT02225106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25707087|NCT02225106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861188|NCT02315573|Adrenergic Agents|adrenergic agents|mesh-ancestor
24861201|NCT02315651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861203|NCT02315690|Piperaquine|piperaquine|mesh-list
24861204|NCT02315690|Artenimol|artenimol|mesh-list
24861205|NCT02315690|Antimalarials|antimalarials|mesh-ancestor
25599140|NCT01007435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599141|NCT01007435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599142|NCT01007435|Dermatologic Agents|dermatologic agents|mesh-ancestor
25599143|NCT01007435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25599144|NCT01007435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25599145|NCT01007435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25599146|NCT01007435|Immunologic Factors|immunologic factors|mesh-ancestor
25599147|NCT01007435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25599148|NCT01007435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25599149|NCT01007448|Bexarotene|bexarotene|mesh-list
25599150|NCT01007448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599151|NCT01007552|Gemcitabine|gemcitabine|mesh-list
25599152|NCT01007552|Bevacizumab|bevacizumab|mesh-list
25599153|NCT01007552|Capecitabine|capecitabine|mesh-list
25599154|NCT01007552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25599155|NCT01007552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599156|NCT01007552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25599157|NCT01007552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25599158|NCT01007552|Growth Substances|growth substances|mesh-ancestor
25599159|NCT01007552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599160|NCT01007552|Growth Inhibitors|growth inhibitors|mesh-ancestor
25599161|NCT01007552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25599162|NCT01007552|Antimetabolites|antimetabolites|mesh-ancestor
25599163|NCT01007552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599164|NCT01007552|Antiviral Agents|antiviral agents|mesh-ancestor
25599165|NCT01007552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25599166|NCT01007552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25599167|NCT01007552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25599168|NCT01007552|Immunologic Factors|immunologic factors|mesh-ancestor
25599169|NCT01007591|Hydrocortisone|hydrocortisone|mesh-list
25599170|NCT01007591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25599171|NCT01007942|Trastuzumab|trastuzumab|mesh-list
25599172|NCT01007942|Everolimus|everolimus|mesh-list
25599173|NCT01007942|Vinorelbine|vinorelbine|mesh-list
25599174|NCT01007942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25599175|NCT01007942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599176|NCT01007942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25599177|NCT01007942|Immunologic Factors|immunologic factors|mesh-ancestor
25599178|NCT01007942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599179|NCT01007942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25599180|NCT01007942|Tubulin Modulators|tubulin modulators|mesh-ancestor
25599181|NCT01007942|Antimitotic Agents|antimitotic agents|mesh-ancestor
25599182|NCT01007942|Mitosis Modulators|mitosis modulators|mesh-ancestor
25599183|NCT01007942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599184|NCT01007994|Propranolol|propranolol|mesh-list
25599185|NCT01007994|Enalapril|enalapril|mesh-list
25707095|NCT02225132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541509|NCT00673504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25599186|NCT01007994|Isradipine|isradipine|mesh-list
25599187|NCT01007994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25599188|NCT01007994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25599189|NCT01007994|Adrenergic Agents|adrenergic agents|mesh-ancestor
25599190|NCT01007994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25599191|NCT01007994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599192|NCT01007994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599193|NCT01007994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25599194|NCT01007994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25599195|NCT01007994|Vasodilator Agents|vasodilator agents|mesh-ancestor
25599196|NCT01007994|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25599197|NCT01007994|Protease Inhibitors|protease inhibitors|mesh-ancestor
25599198|NCT01007994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813376|NCT02058199|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24813377|NCT02058199|Protease Inhibitors|protease inhibitors|mesh-ancestor
24813378|NCT02058199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813379|NCT02058199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813381|NCT02058212|Vitamin E|vitamin e|mesh-list
24813382|NCT02058212|Selenium|selenium|mesh-list
24813383|NCT02058212|Vitamins|vitamins|mesh-ancestor
24813384|NCT02058212|Micronutrients|micronutrients|mesh-ancestor
24813386|NCT02058212|Antioxidants|antioxidants|mesh-ancestor
25599199|NCT01007994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25599200|NCT01007994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25599201|NCT01007994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25599203|NCT01008059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25599204|NCT01008059|Narcotics|narcotics|mesh-ancestor
25599205|NCT01008059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25599206|NCT01008059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599207|NCT01008059|Analgesics|analgesics|mesh-ancestor
25599208|NCT01008059|Sensory System Agents|sensory system agents|mesh-ancestor
25599209|NCT01008059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25599210|NCT01008059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25599211|NCT01008059|Anesthetics, General|anesthetics, general|mesh-ancestor
25599212|NCT01008059|Anesthetics|anesthetics|mesh-ancestor
25599213|NCT01008150|Paclitaxel|paclitaxel|mesh-list
25599214|NCT01008150|Cyclophosphamide|cyclophosphamide|mesh-list
25599215|NCT01008150|Doxorubicin|doxorubicin|mesh-list
25599216|NCT01008150|Trastuzumab|trastuzumab|mesh-list
25599217|NCT01008150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25599218|NCT01008150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599219|NCT01008150|Tubulin Modulators|tubulin modulators|mesh-ancestor
25599220|NCT01008150|Antimitotic Agents|antimitotic agents|mesh-ancestor
25599221|NCT01008150|Mitosis Modulators|mitosis modulators|mesh-ancestor
25599222|NCT01008150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813392|NCT02058277|Autonomic Agents|autonomic agents|mesh-ancestor
24813393|NCT02058277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24813394|NCT02058277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813395|NCT02058277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24813396|NCT02058277|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24813397|NCT02058277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24813398|NCT02058277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813400|NCT02058303|Anesthetics, Local|anesthetics, local|mesh-ancestor
24813401|NCT02058303|Anesthetics|anesthetics|mesh-ancestor
24813402|NCT02058303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24682932|NCT01389271|Iloprost|iloprost|mesh-list
24861277|NCT02316496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24861278|NCT02316496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861279|NCT02316496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861280|NCT02316496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24861282|NCT02316535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24861283|NCT02316535|Antimetabolites|antimetabolites|mesh-ancestor
24861284|NCT02316535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861285|NCT02316535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861287|NCT02316626|Progestins|progestins|mesh-ancestor
24861288|NCT02316626|Hormones|hormones|mesh-ancestor
24861289|NCT02316626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24541601|NCT00674063|Immunologic Factors|immunologic factors|mesh-ancestor
25599223|NCT01008150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25599224|NCT01008150|Immunologic Factors|immunologic factors|mesh-ancestor
25599225|NCT01008150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599226|NCT01008150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25599227|NCT01008150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25599228|NCT01008150|Alkylating Agents|alkylating agents|mesh-ancestor
25599229|NCT01008150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25599230|NCT01008150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25599231|NCT01008150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25599232|NCT01008150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25599233|NCT01008150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25599234|NCT01008150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25599235|NCT01008280|Baclofen|baclofen|mesh-list
25599236|NCT01008280|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24451502|NCT00323973|Autonomic Agents|autonomic agents|mesh-ancestor
24451503|NCT00323973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24861290|NCT02316626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861291|NCT02316704|Tacrine|tacrine|mesh-list
24861292|NCT02316704|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24861293|NCT02316704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24861294|NCT02316704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861295|NCT02316704|Cholinergic Agents|cholinergic agents|mesh-ancestor
24861296|NCT02316704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24861297|NCT02316704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861298|NCT02316704|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24861299|NCT02316704|Autonomic Agents|autonomic agents|mesh-ancestor
24861300|NCT02316704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24861301|NCT02316704|Nootropic Agents|nootropic agents|mesh-ancestor
24861302|NCT02316899|Linaclotide|linaclotide|mesh-list
24861303|NCT02316899|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
24861304|NCT02316899|Enzyme Activators|enzyme activators|mesh-ancestor
24861305|NCT02316899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541627|NCT00674167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541629|NCT00674167|Antimetabolites|antimetabolites|mesh-ancestor
24541630|NCT00674232|Misoprostol|misoprostol|mesh-list
24541631|NCT00674232|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25599237|NCT01008280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599238|NCT01008280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25599239|NCT01008280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25599240|NCT01008280|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25599241|NCT01008280|GABA Agonists|gaba agonists|mesh-ancestor
25599242|NCT01008280|GABA Agents|gaba agents|mesh-ancestor
25599243|NCT01008280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25599244|NCT01008280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599245|NCT01008319|Citric Acid|citric acid|mesh-list
25599246|NCT01008319|Sodium Citrate|sodium citrate|mesh-list
25599247|NCT01008319|Clomiphene|clomiphene|mesh-list
25599248|NCT01008319|Enclomiphene|enclomiphene|mesh-list
25599249|NCT01008319|Zuclomiphene|zuclomiphene|mesh-list
25599250|NCT01008319|Anticoagulants|anticoagulants|mesh-ancestor
25599251|NCT01008319|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25599252|NCT01008319|Chelating Agents|chelating agents|mesh-ancestor
25599253|NCT01008319|Sequestering Agents|sequestering agents|mesh-ancestor
25599254|NCT01008319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599255|NCT01008319|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25599256|NCT01008319|Hormone Antagonists|hormone antagonists|mesh-ancestor
25599257|NCT01008319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25599258|NCT01008319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599259|NCT01008319|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25599260|NCT01008319|Fertility Agents|fertility agents|mesh-ancestor
25599261|NCT01008319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25599262|NCT01008319|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25599263|NCT01008319|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25599264|NCT01008410|Budesonide|budesonide|mesh-list
25599265|NCT01008410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25599266|NCT01008410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25599267|NCT01008410|Autonomic Agents|autonomic agents|mesh-ancestor
25599268|NCT01008410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25707097|NCT02225132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25707098|NCT02225132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861333|NCT02317146|Anticonvulsants|anticonvulsants|mesh-ancestor
25599269|NCT01008410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599270|NCT01008410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25599271|NCT01008410|Respiratory System Agents|respiratory system agents|mesh-ancestor
25599272|NCT01008410|Glucocorticoids|glucocorticoids|mesh-ancestor
25599273|NCT01008410|Hormones|hormones|mesh-ancestor
25599274|NCT01008410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25599275|NCT01008423|Budesonide|budesonide|mesh-list
25599276|NCT01008423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25599277|NCT01008423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25599278|NCT01008423|Autonomic Agents|autonomic agents|mesh-ancestor
25707104|NCT02225353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707105|NCT02225587|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24861369|NCT02317341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861370|NCT02317341|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24861373|NCT02317341|Anesthetics|anesthetics|mesh-ancestor
24541673|NCT00674557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24861390|NCT02317419|Tubulin Modulators|tubulin modulators|mesh-ancestor
24861391|NCT02317419|Antimitotic Agents|antimitotic agents|mesh-ancestor
24861392|NCT02317419|Mitosis Modulators|mitosis modulators|mesh-ancestor
24861393|NCT02317419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446622|NCT00305474|Dopamine Agents|dopamine agents|mesh-ancestor
24446623|NCT00305487|Ciclesonide|ciclesonide|mesh-list
24541677|NCT00674596|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24861407|NCT02317484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24861410|NCT02317601|Methylprednisolone|methylprednisolone|mesh-list
25599279|NCT01008423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25599280|NCT01008423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599281|NCT01008423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25599282|NCT01008423|Respiratory System Agents|respiratory system agents|mesh-ancestor
25599283|NCT01008423|Glucocorticoids|glucocorticoids|mesh-ancestor
25599284|NCT01008423|Hormones|hormones|mesh-ancestor
25599285|NCT01008423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25599286|NCT01008462|Cytarabine|cytarabine|mesh-list
25599287|NCT01008462|Mycophenolic Acid|mycophenolic acid|mesh-list
25599288|NCT01008462|Cyclophosphamide|cyclophosphamide|mesh-list
25599289|NCT01008462|Melphalan|melphalan|mesh-list
25599290|NCT01008462|Mechlorethamine|mechlorethamine|mesh-list
25599291|NCT01008462|Carmustine|carmustine|mesh-list
25599292|NCT01008462|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25599293|NCT01008462|Fludarabine|fludarabine|mesh-list
25599294|NCT01008462|Fludarabine phosphate|fludarabine phosphate|mesh-list
25599295|NCT01008462|Etoposide|etoposide|mesh-list
25599296|NCT01008462|Etoposide phosphate|etoposide phosphate|mesh-list
25599297|NCT01008462|Podophyllotoxin|podophyllotoxin|mesh-list
25599298|NCT01008462|Tacrolimus|tacrolimus|mesh-list
25599299|NCT01008462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25599300|NCT01008462|Immunologic Factors|immunologic factors|mesh-ancestor
25707114|NCT02225665|Alkylating Agents|alkylating agents|mesh-ancestor
24541703|NCT00674713|Ondansetron|ondansetron|mesh-list
25599301|NCT01008462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599302|NCT01008462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25599303|NCT01008462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25599304|NCT01008462|Alkylating Agents|alkylating agents|mesh-ancestor
25599305|NCT01008462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599306|NCT01008462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599307|NCT01008462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25599308|NCT01008462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25599309|NCT01008462|Antimetabolites|antimetabolites|mesh-ancestor
25599310|NCT01008462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25599311|NCT01008462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25599312|NCT01008462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25599313|NCT01008462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25599314|NCT01008462|Antiviral Agents|antiviral agents|mesh-ancestor
25599315|NCT01008462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25599316|NCT01008462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25599317|NCT01008462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25599318|NCT01008462|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24861571|NCT02318810|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24861572|NCT02318810|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24861573|NCT02318810|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24861574|NCT02318810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24541746|NCT00674921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24541747|NCT00674999|Bacitracin|bacitracin|mesh-list
25599319|NCT01008462|Antitubercular Agents|antitubercular agents|mesh-ancestor
25599320|NCT01008462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25599321|NCT01008462|Keratolytic Agents|keratolytic agents|mesh-ancestor
25599322|NCT01008462|Dermatologic Agents|dermatologic agents|mesh-ancestor
25599323|NCT01008462|Tubulin Modulators|tubulin modulators|mesh-ancestor
25599324|NCT01008462|Antimitotic Agents|antimitotic agents|mesh-ancestor
25599325|NCT01008462|Mitosis Modulators|mitosis modulators|mesh-ancestor
25599326|NCT01008475|Irinotecan|irinotecan|mesh-list
25599327|NCT01008475|Cetuximab|cetuximab|mesh-list
25599328|NCT01008475|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25599329|NCT01008475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25707128|NCT02226003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25707129|NCT02226003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541784|NCT00675207|Adrenergic Agents|adrenergic agents|mesh-ancestor
24541785|NCT00675207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24541786|NCT00675207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541787|NCT00675207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541788|NCT00675207|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24657655|NCT01268761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657656|NCT01268761|Hormone Antagonists|hormone antagonists|mesh-ancestor
24657658|NCT01268839|Efavirenz|efavirenz|mesh-list
25599330|NCT01008475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25599331|NCT01008475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599332|NCT01008475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599333|NCT01008475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25599334|NCT01008553|Fentanyl|fentanyl|mesh-list
25599335|NCT01008553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25599336|NCT01008553|Narcotics|narcotics|mesh-ancestor
25599337|NCT01008553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25599338|NCT01008553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599339|NCT01008553|Analgesics|analgesics|mesh-ancestor
25599340|NCT01008553|Sensory System Agents|sensory system agents|mesh-ancestor
25599341|NCT01008553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25599342|NCT01008553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25599343|NCT01008553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25599344|NCT01008553|Anesthetics, General|anesthetics, general|mesh-ancestor
25599345|NCT01008553|Anesthetics|anesthetics|mesh-ancestor
25599346|NCT01008618|Fentanyl|fentanyl|mesh-list
25599347|NCT01008618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25493772|NCT00264875|Anticonvulsants|anticonvulsants|mesh-ancestor
25599348|NCT01008618|Narcotics|narcotics|mesh-ancestor
25599349|NCT01008618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25599350|NCT01008618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599351|NCT01008618|Analgesics|analgesics|mesh-ancestor
25599352|NCT01008618|Sensory System Agents|sensory system agents|mesh-ancestor
25599353|NCT01008618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25599354|NCT01008618|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25599355|NCT01008618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25599356|NCT01008618|Anesthetics, General|anesthetics, general|mesh-ancestor
25599357|NCT01008618|Anesthetics|anesthetics|mesh-ancestor
24541814|NCT00675285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24541815|NCT00675285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24541816|NCT00675285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541817|NCT00675350|Homoharringtonine|homoharringtonine|mesh-list
24541818|NCT00675350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25599358|NCT01008696|Rabeprazole|rabeprazole|mesh-list
25599359|NCT01008696|Lansoprazole|lansoprazole|mesh-list
25599360|NCT01008696|Dexlansoprazole|dexlansoprazole|mesh-list
25599361|NCT01008696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25599362|NCT01008696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25599363|NCT01008696|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25599364|NCT01008696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25599365|NCT01008696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599366|NCT01008748|Nicotine|nicotine|mesh-list
25599367|NCT01008748|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24541830|NCT00675545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861793|NCT02320240|Sertraline|sertraline|mesh-list
24541831|NCT00675545|Tubulin Modulators|tubulin modulators|mesh-ancestor
24541832|NCT00675545|Antimitotic Agents|antimitotic agents|mesh-ancestor
24861816|NCT02320240|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24861817|NCT02320240|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24861834|NCT02320448|Cisplatin|cisplatin|mesh-list
24541833|NCT00675545|Mitosis Modulators|mitosis modulators|mesh-ancestor
24813406|NCT02058407|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24861890|NCT02321267|Verteporfin|verteporfin|mesh-list
24861891|NCT02321267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24861892|NCT02321267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24861893|NCT02321267|Growth Substances|growth substances|mesh-ancestor
24861894|NCT02321267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861895|NCT02321267|Growth Inhibitors|growth inhibitors|mesh-ancestor
24861896|NCT02321267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861897|NCT02321267|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24541835|NCT00675649|Golimumab|golimumab|mesh-list
24541836|NCT00675649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25599368|NCT01008748|Autonomic Agents|autonomic agents|mesh-ancestor
25599369|NCT01008748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25599370|NCT01008748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599371|NCT01008748|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25599372|NCT01008748|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25599373|NCT01008748|Cholinergic Agents|cholinergic agents|mesh-ancestor
25599374|NCT01008748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25599375|NCT01008748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707159|NCT02226653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24451550|NCT00324142|Alkylating Agents|alkylating agents|mesh-ancestor
24451551|NCT00324142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451553|NCT00324142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24451554|NCT00324142|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
24451555|NCT00324142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24451556|NCT00324142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24451557|NCT00324194|Mocetinostat|mocetinostat|mesh-list
24451558|NCT00324194|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24451559|NCT00324194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541886|NCT00675714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541887|NCT00675714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24541888|NCT00675714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25599376|NCT01008904|Magnesium Oxide|magnesium oxide|mesh-list
25599377|NCT01008904|Antacids|antacids|mesh-ancestor
25599378|NCT01008904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599379|NCT01008904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25599380|NCT01008995|Ustekinumab|ustekinumab|mesh-list
25599381|NCT01008995|Dermatologic Agents|dermatologic agents|mesh-ancestor
25599382|NCT01009047|Aripiprazole|aripiprazole|mesh-list
25599383|NCT01009047|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25599384|NCT01009047|Antidepressive Agents|antidepressive agents|mesh-ancestor
25599385|NCT01009047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24813444|NCT02058485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24813445|NCT02058485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24813446|NCT02058485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24813447|NCT02058485|Anesthetics, General|anesthetics, general|mesh-ancestor
24813448|NCT02058485|Anesthetics|anesthetics|mesh-ancestor
24813449|NCT02058485|GABA Modulators|gaba modulators|mesh-ancestor
24813450|NCT02058485|GABA Agents|gaba agents|mesh-ancestor
24813451|NCT02058576|Tamsulosin|tamsulosin|mesh-list
24813452|NCT02058576|Dutasteride|dutasteride|mesh-list
24813453|NCT02058576|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24541944|NCT00676039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658290|NCT01271166|Leucovorin|leucovorin|mesh-list
24683893|NCT01394640|Vaccines|vaccines|mesh-list
24862099|NCT02323139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24862100|NCT02323139|Antimetabolites|antimetabolites|mesh-ancestor
24862101|NCT02323139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862102|NCT02323139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24862103|NCT02323139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24862104|NCT02323191|Atezolizumab|atezolizumab|mesh-list
24541987|NCT00676286|Choline|choline|mesh-list
24541988|NCT00676286|Lipotropic Agents|lipotropic agents|mesh-ancestor
24541989|NCT00676286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24541990|NCT00676286|Antimetabolites|antimetabolites|mesh-ancestor
24541991|NCT00676286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541992|NCT00676286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24541993|NCT00676286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24541994|NCT00676286|Nootropic Agents|nootropic agents|mesh-ancestor
24541995|NCT00676377|Neostigmine|neostigmine|mesh-list
24541996|NCT00676377|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24541997|NCT00676377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541998|NCT00676377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599386|NCT01009047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25599387|NCT01009047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25599388|NCT01009047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25599389|NCT01009047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599390|NCT01009047|Dopamine Agonists|dopamine agonists|mesh-ancestor
25599391|NCT01009047|Dopamine Agents|dopamine agents|mesh-ancestor
25599392|NCT01009047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25599393|NCT01009047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707165|NCT02227108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24444133|NCT00296777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24862105|NCT02323191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24862106|NCT02323230|Cyclophosphamide|cyclophosphamide|mesh-list
24862107|NCT02323230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24862108|NCT02323230|Immunologic Factors|immunologic factors|mesh-ancestor
24862109|NCT02323230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862110|NCT02323230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24862111|NCT02323230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24862112|NCT02323230|Alkylating Agents|alkylating agents|mesh-ancestor
24862113|NCT02323230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862123|NCT02323282|Anesthetics|anesthetics|mesh-ancestor
24862124|NCT02323282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24862125|NCT02323282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862126|NCT02323282|Sensory System Agents|sensory system agents|mesh-ancestor
24862127|NCT02323282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24862128|NCT02323347|Progesterone|progesterone|mesh-list
24862129|NCT02323347|Progestins|progestins|mesh-ancestor
24862130|NCT02323347|Hormones|hormones|mesh-ancestor
24862134|NCT02323373|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24862135|NCT02323373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24862136|NCT02323373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862137|NCT02323373|Hemostatics|hemostatics|mesh-ancestor
24862138|NCT02323373|Coagulants|coagulants|mesh-ancestor
25599394|NCT01009047|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25599395|NCT01009047|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25599396|NCT01009047|Serotonin Agents|serotonin agents|mesh-ancestor
25599397|NCT01009047|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25599398|NCT01009047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25599399|NCT01009047|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25599400|NCT01009047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25599401|NCT01009086|Ustekinumab|ustekinumab|mesh-list
25599402|NCT01009086|Dermatologic Agents|dermatologic agents|mesh-ancestor
25599403|NCT01009203|Sirolimus|sirolimus|mesh-list
25599404|NCT01009203|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25707172|NCT02227316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707173|NCT02227316|Antipyretics|antipyretics|mesh-ancestor
24862149|NCT02323399|Respiratory System Agents|respiratory system agents|mesh-ancestor
24862150|NCT02323399|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24862151|NCT02323399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24862152|NCT02323399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24862153|NCT02323399|Adrenergic Agents|adrenergic agents|mesh-ancestor
24862154|NCT02323399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24862155|NCT02323399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862164|NCT02323438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24862165|NCT02323438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862166|NCT02323438|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24862167|NCT02323438|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24862168|NCT02323438|Cholinergic Agents|cholinergic agents|mesh-ancestor
24862169|NCT02323438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24862170|NCT02323438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862171|NCT02323438|Antipruritics|antipruritics|mesh-ancestor
24683896|NCT01394653|Ramosetron|ramosetron|mesh-list
24862172|NCT02323438|Dermatologic Agents|dermatologic agents|mesh-ancestor
24862174|NCT02323451|Hyaluronic Acid|hyaluronic acid|mesh-list
24862175|NCT02323451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24862176|NCT02323451|Immunologic Factors|immunologic factors|mesh-ancestor
24542039|NCT00676533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24669254|NCT04164212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862191|NCT02323516|Antidiarrheals|antidiarrheals|mesh-list
24862192|NCT02323516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24862208|NCT02323529|Nitisinone|nitisinone|mesh-list
24862210|NCT02323529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862211|NCT02323594|Asunaprevir|asunaprevir|mesh-list
24862212|NCT02323594|Protease Inhibitors|protease inhibitors|mesh-ancestor
25599405|NCT01009203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599406|NCT01009203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25599407|NCT01009203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25599408|NCT01009203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599409|NCT01009203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25599410|NCT01009203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25599411|NCT01009203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25599412|NCT01009203|Antifungal Agents|antifungal agents|mesh-ancestor
25599413|NCT01009203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25599414|NCT01009203|Immunologic Factors|immunologic factors|mesh-ancestor
24862214|NCT02323594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862215|NCT02323607|Cytarabine|cytarabine|mesh-list
24862228|NCT02323607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24862230|NCT02323607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24862232|NCT02323737|Irinotecan|irinotecan|mesh-list
24862233|NCT02323737|Etoposide|etoposide|mesh-list
24862234|NCT02323737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24862235|NCT02323737|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24862236|NCT02323737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24862238|NCT02323737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862239|NCT02323737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24862249|NCT02323971|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24862250|NCT02323971|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24862251|NCT02323971|Purinergic Agents|purinergic agents|mesh-ancestor
24542088|NCT00676819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24542089|NCT00676819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707175|NCT02227316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25707176|NCT02227316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25707177|NCT02227316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25707178|NCT02227316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25599415|NCT01009203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599416|NCT01009346|Cisplatin|cisplatin|mesh-list
25599417|NCT01009346|Carboplatin|carboplatin|mesh-list
25599418|NCT01009346|Cetuximab|cetuximab|mesh-list
25599419|NCT01009346|Everolimus|everolimus|mesh-list
25599420|NCT01009346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599421|NCT01009346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25599422|NCT01009346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25599423|NCT01009346|Immunologic Factors|immunologic factors|mesh-ancestor
25599424|NCT01009346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599425|NCT01009515|Paclitaxel|paclitaxel|mesh-list
25599426|NCT01009515|Carboplatin|carboplatin|mesh-list
25599427|NCT01009515|Temozolomide|temozolomide|mesh-list
25599428|NCT01009515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25599429|NCT01009515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599430|NCT01009515|Tubulin Modulators|tubulin modulators|mesh-ancestor
25599431|NCT01009515|Antimitotic Agents|antimitotic agents|mesh-ancestor
25599432|NCT01009515|Mitosis Modulators|mitosis modulators|mesh-ancestor
25599433|NCT01009515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542132|NCT00677118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24542133|NCT00677118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24542134|NCT00677118|Immunologic Factors|immunologic factors|mesh-ancestor
24542135|NCT00677118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862305|NCT02324296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24862306|NCT02324296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24862307|NCT02324296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24862308|NCT02324296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24862309|NCT02324296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24862310|NCT02324296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862311|NCT02324296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24862312|NCT02324296|Alkylating Agents|alkylating agents|mesh-ancestor
24862316|NCT02324413|Clonidine|clonidine|mesh-list
24862317|NCT02324413|Analgesics|analgesics|mesh-ancestor
24862318|NCT02324413|Sensory System Agents|sensory system agents|mesh-ancestor
24862319|NCT02324413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24862320|NCT02324413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862321|NCT02324413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24862322|NCT02324413|Sympatholytics|sympatholytics|mesh-ancestor
24542136|NCT00677144|Capecitabine|capecitabine|mesh-list
24542137|NCT00677144|Oxaliplatin|oxaliplatin|mesh-list
24451644|NCT00324467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24451645|NCT00324467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24862324|NCT02324413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24542171|NCT00677300|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24542172|NCT00677300|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25599434|NCT01009515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25599435|NCT01009515|Alkylating Agents|alkylating agents|mesh-ancestor
25599436|NCT01009554|Listerine|listerine|mesh-list
25599437|NCT01009554|Fluorides|fluorides|mesh-list
25599438|NCT01009554|Sodium Fluoride|sodium fluoride|mesh-list
25599439|NCT01009554|Cariostatic Agents|cariostatic agents|mesh-ancestor
25599440|NCT01009554|Protective Agents|protective agents|mesh-ancestor
25599441|NCT01009554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599442|NCT01009554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25599443|NCT01009554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25599444|NCT01009580|Insulin|insulin|mesh-list
25599445|NCT01009580|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24862370|NCT02324933|Narcotics|narcotics|mesh-ancestor
24862371|NCT02324933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24862372|NCT02324933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862373|NCT02324933|Analgesics|analgesics|mesh-ancestor
24532397|NCT00639756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532398|NCT00639873|Doxycycline|doxycycline|mesh-list
24532399|NCT00639873|Artesunate|artesunate|mesh-list
24532400|NCT00639873|Quinine|quinine|mesh-list
24532401|NCT00639873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24532502|NCT00640159|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24862391|NCT02325011|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24862392|NCT02325011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24862393|NCT02325011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24862394|NCT02325011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862395|NCT02325011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24862396|NCT02325011|Hormone Antagonists|hormone antagonists|mesh-ancestor
24862397|NCT02325011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24862401|NCT02325011|Analgesics|analgesics|mesh-ancestor
24862420|NCT02325063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862421|NCT02325063|Cholinergic Agents|cholinergic agents|mesh-ancestor
24862422|NCT02325063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24862423|NCT02325063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862425|NCT02325180|Artemether|artemether|mesh-list
24862426|NCT02325180|Piperaquine|piperaquine|mesh-list
24862427|NCT02325180|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24862428|NCT02325180|Artenimol|artenimol|mesh-list
25709736|NCT02274038|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25709737|NCT02274038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25709738|NCT02274311|Clomiphene|clomiphene|mesh-list
25709739|NCT02274311|Enclomiphene|enclomiphene|mesh-list
25599446|NCT01009580|Insulin Aspart|insulin aspart|mesh-list
25599447|NCT01009580|Insulin, Long-Acting|insulin, long-acting|mesh-list
25599448|NCT01009580|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25599449|NCT01009580|Biphasic Insulins|biphasic insulins|mesh-list
25599450|NCT01009580|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
25599451|NCT01009580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25599452|NCT01009580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599453|NCT01009619|Azithromycin|azithromycin|mesh-list
25599454|NCT01009619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25599455|NCT01009619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25599456|NCT01009814|Ritonavir|ritonavir|mesh-list
25599457|NCT01009814|Fostemsavir|fostemsavir|mesh-list
25599458|NCT01009814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25599459|NCT01009814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25599460|NCT01009814|Protease Inhibitors|protease inhibitors|mesh-ancestor
25599461|NCT01009814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25599462|NCT01009814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599463|NCT01009814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25599464|NCT01009814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25599465|NCT01009814|Antiviral Agents|antiviral agents|mesh-ancestor
25599466|NCT01009814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25599467|NCT01009814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25599468|NCT01009814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25599469|NCT01009814|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24542218|NCT00677664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24542219|NCT00677729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24542220|NCT00677729|Albuterol|albuterol|mesh-list
24542221|NCT00677729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24446745|NCT00305812|Immunologic Factors|immunologic factors|mesh-ancestor
24862488|NCT02325882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456493|NCT00331305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456494|NCT00331435|Verteporfin|verteporfin|mesh-list
24862491|NCT02325882|Sensory System Agents|sensory system agents|mesh-ancestor
24862492|NCT02325882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24862493|NCT02325882|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24862498|NCT02325882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862499|NCT02325882|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24862500|NCT02325882|Narcotics|narcotics|mesh-ancestor
24862501|NCT02325882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24862502|NCT02325882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24862503|NCT02325882|Anesthetics, General|anesthetics, general|mesh-ancestor
24862504|NCT02325882|Anesthetics|anesthetics|mesh-ancestor
24862505|NCT02325934|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25599470|NCT01009814|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25599471|NCT01009840|Bortezomib|bortezomib|mesh-list
25599472|NCT01009840|Busulfan|busulfan|mesh-list
25599473|NCT01009840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599474|NCT01009840|Alkylating Agents|alkylating agents|mesh-ancestor
25599475|NCT01009840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599476|NCT01009840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25599477|NCT01009840|Immunologic Factors|immunologic factors|mesh-ancestor
25599478|NCT01009840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599479|NCT01009840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25599480|NCT01009840|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25599481|NCT01009918|Carvedilol|carvedilol|mesh-list
25599482|NCT01009918|Lisinopril|lisinopril|mesh-list
25599483|NCT01009918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25599484|NCT01009918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25599485|NCT01009918|Adrenergic Agents|adrenergic agents|mesh-ancestor
25599486|NCT01009918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25599487|NCT01009918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599488|NCT01009918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599489|NCT01009918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25599490|NCT01009918|Antioxidants|antioxidants|mesh-ancestor
25599491|NCT01009918|Protective Agents|protective agents|mesh-ancestor
25599492|NCT01009918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25599493|NCT01009918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25599494|NCT01009918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25599495|NCT01009918|Vasodilator Agents|vasodilator agents|mesh-ancestor
24862515|NCT05143723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24862516|NCT05143723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862518|NCT05143281|Dexamethasone acetate|dexamethasone acetate|mesh-list
24862519|NCT05143281|BB 1101|bb 1101|mesh-list
24862520|NCT05143281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24862521|NCT05143281|Antiemetics|antiemetics|mesh-ancestor
24862522|NCT05143281|Autonomic Agents|autonomic agents|mesh-ancestor
24862523|NCT05143281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24542487|NCT00678964|Mitosis Modulators|mitosis modulators|mesh-ancestor
24542315|NCT00678236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24542317|NCT00678236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24542318|NCT00678236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24542319|NCT00678236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24542320|NCT00678275|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24542321|NCT00678275|Immunologic Factors|immunologic factors|mesh-ancestor
24862531|NCT05143281|Protease Inhibitors|protease inhibitors|mesh-ancestor
24862532|NCT05143281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24862533|NCT05143281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862534|NCT05143125|Decitabine|decitabine|mesh-list
24862535|NCT05143125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24862536|NCT05143125|Antimetabolites|antimetabolites|mesh-ancestor
25599496|NCT01009918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25599497|NCT01009918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25599498|NCT01009918|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25599499|NCT01009918|Protease Inhibitors|protease inhibitors|mesh-ancestor
25599500|NCT01009918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25599501|NCT01009918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25599502|NCT01009983|Paclitaxel|paclitaxel|mesh-list
25493919|NCT00265850|Vitamin B Complex|vitamin b complex|mesh-ancestor
25599503|NCT01009983|Carboplatin|carboplatin|mesh-list
25599504|NCT01009983|Panitumumab|panitumumab|mesh-list
25707179|NCT02227316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707180|NCT02227329|Ethanol|ethanol|mesh-list
25707181|NCT02227329|Heparin|heparin|mesh-list
24542330|NCT00678314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24542331|NCT00678327|Prednisolone|prednisolone|mesh-list
24542332|NCT00678327|Cyclophosphamide|cyclophosphamide|mesh-list
24542333|NCT00678327|Dacarbazine|dacarbazine|mesh-list
24542334|NCT00678327|Doxorubicin|doxorubicin|mesh-list
24542335|NCT00678327|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24862537|NCT05143125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862538|NCT05143125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24862539|NCT05143125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24862540|NCT05142904|Iodine|iodine|mesh-list
24862541|NCT05142904|Cadexomer iodine|cadexomer iodine|mesh-list
24813507|NCT02058823|Valsartan|valsartan|mesh-list
24862560|NCT05118737|Colchicine|colchicine|mesh-list
24862561|NCT05118737|Gout Suppressants|gout suppressants|mesh-ancestor
24542344|NCT00678327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24542345|NCT00678327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24542346|NCT00678327|Alkylating Agents|alkylating agents|mesh-ancestor
24862562|NCT05118737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25599505|NCT01009983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25599506|NCT01009983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599507|NCT01009983|Tubulin Modulators|tubulin modulators|mesh-ancestor
25599508|NCT01009983|Antimitotic Agents|antimitotic agents|mesh-ancestor
25599509|NCT01009983|Mitosis Modulators|mitosis modulators|mesh-ancestor
25599510|NCT01009983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599511|NCT01009983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25599512|NCT01010009|Resveratrol|resveratrol|mesh-list
25599513|NCT01010009|Antioxidants|antioxidants|mesh-ancestor
25599514|NCT01010009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599515|NCT01010009|Protective Agents|protective agents|mesh-ancestor
25599516|NCT01010009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599517|NCT01010009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25599518|NCT01010009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25599519|NCT01010061|Rituximab|rituximab|mesh-list
25599520|NCT01010061|Obinutuzumab|obinutuzumab|mesh-list
24542364|NCT00678431|Antioxidants|antioxidants|mesh-ancestor
24862582|NCT05042466|Psilocybin|psilocybin|mesh-list
24862583|NCT05042466|Hallucinogens|hallucinogens|mesh-ancestor
24542369|NCT00678431|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24542371|NCT00678457|Olanzapine|olanzapine|mesh-list
24542372|NCT00678457|Antiemetics|antiemetics|mesh-ancestor
24542373|NCT00678457|Autonomic Agents|autonomic agents|mesh-ancestor
24862603|NCT05021926|Viscosupplements|viscosupplements|mesh-ancestor
24862604|NCT05021926|Protective Agents|protective agents|mesh-ancestor
24862605|NCT05021913|Lidocaine|lidocaine|mesh-list
24862609|NCT05021913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24862610|NCT05021913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862611|NCT05021913|Sensory System Agents|sensory system agents|mesh-ancestor
25599521|NCT01010061|Chlorambucil|chlorambucil|mesh-list
25599522|NCT01010061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25599523|NCT01010061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599524|NCT01010061|Immunologic Factors|immunologic factors|mesh-ancestor
25599525|NCT01010061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599526|NCT01010061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25599527|NCT01010061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25599528|NCT01010061|Alkylating Agents|alkylating agents|mesh-ancestor
25599529|NCT01010061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599530|NCT01010126|Sirolimus|sirolimus|mesh-list
25599531|NCT01010126|Bevacizumab|bevacizumab|mesh-list
25599532|NCT01010126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25599533|NCT01010126|Endothelial Growth Factors|endothelial growth factors|mesh-list
25599534|NCT01010126|Antibodies|antibodies|mesh-list
25599535|NCT01010126|Immunoglobulins|immunoglobulins|mesh-list
25599536|NCT01010126|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25599537|NCT01010126|Immunoglobulin G|immunoglobulin g|mesh-list
25599538|NCT01010126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599539|NCT01010126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25599540|NCT01010126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25599541|NCT01010126|Growth Substances|growth substances|mesh-ancestor
25707208|NCT02227368|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24540826|NCT00669773|Doxorubicin|doxorubicin|mesh-list
25707209|NCT02227368|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24542557|NCT00679237|Natriuretic Agents|natriuretic agents|mesh-ancestor
24862859|NCT04120454|Ramucirumab|ramucirumab|mesh-list
24862860|NCT04120454|Antibodies|antibodies|mesh-list
24862861|NCT04120454|Immunoglobulins|immunoglobulins|mesh-list
24862862|NCT04120454|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24862863|NCT04120454|Lexatumumab|lexatumumab|mesh-list
24862864|NCT04120454|Immunologic Factors|immunologic factors|mesh-ancestor
24862865|NCT04120454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862866|NCT04120454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24862867|NCT04107168|Bevacizumab|bevacizumab|mesh-list
24862868|NCT04107168|Pembrolizumab|pembrolizumab|mesh-list
24862869|NCT04107168|Nivolumab|nivolumab|mesh-list
24542688|NCT00679705|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24542690|NCT00679705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24542691|NCT00679705|Adrenergic Agents|adrenergic agents|mesh-ancestor
24542692|NCT00679705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24542693|NCT00679705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542694|NCT00679718|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24542695|NCT00679718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24862973|NCT03823534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25707210|NCT02227368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25707211|NCT02227368|Purinergic Agents|purinergic agents|mesh-ancestor
25707212|NCT02227368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24542762|NCT00680329|Timolol|timolol|mesh-list
25707213|NCT02227446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25707214|NCT02227446|Vancomycin|vancomycin|mesh-list
25707215|NCT02227446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25599542|NCT01010126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599543|NCT01010126|Growth Inhibitors|growth inhibitors|mesh-ancestor
25599544|NCT01010126|Immunologic Factors|immunologic factors|mesh-ancestor
25599545|NCT01010126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25599546|NCT01010126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25599547|NCT01010126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25599548|NCT01010126|Antifungal Agents|antifungal agents|mesh-ancestor
25599549|NCT01010126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25599550|NCT01010204|Varenicline|varenicline|mesh-list
25599551|NCT01010204|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25707216|NCT02227485|Chlorhexidine|chlorhexidine|mesh-list
24862986|NCT03823534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24862987|NCT03823534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862988|NCT03823534|Antitussive Agents|antitussive agents|mesh-ancestor
24862989|NCT03823534|Respiratory System Agents|respiratory system agents|mesh-ancestor
24862991|NCT03812991|Salmon calcitonin|salmon calcitonin|mesh-list
24862992|NCT03812991|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
24862993|NCT03812991|Katacalcin|katacalcin|mesh-list
24862994|NCT03812991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24542832|NCT00680498|Ranibizumab|ranibizumab|mesh-list
25599552|NCT01010204|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25599553|NCT01010204|Cholinergic Agents|cholinergic agents|mesh-ancestor
25599554|NCT01010204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25599555|NCT01010204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599556|NCT01010204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599557|NCT01010217|Vidarabine|vidarabine|mesh-list
25599558|NCT01010217|Mycophenolic Acid|mycophenolic acid|mesh-list
25599559|NCT01010217|Cyclophosphamide|cyclophosphamide|mesh-list
25599560|NCT01010217|Melphalan|melphalan|mesh-list
25599561|NCT01010217|Thiotepa|thiotepa|mesh-list
25599562|NCT01010217|Rituximab|rituximab|mesh-list
25599563|NCT01010217|Fludarabine|fludarabine|mesh-list
25599564|NCT01010217|Fludarabine phosphate|fludarabine phosphate|mesh-list
25599565|NCT01010217|Tacrolimus|tacrolimus|mesh-list
25599566|NCT01010217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25599567|NCT01010217|Immunologic Factors|immunologic factors|mesh-ancestor
25599568|NCT01010217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599569|NCT01010217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25599570|NCT01010217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24475356|NCT00410033|Insulin|insulin|mesh-list
25599571|NCT01010217|Alkylating Agents|alkylating agents|mesh-ancestor
25599572|NCT01010217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599573|NCT01010217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599574|NCT01010217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25599575|NCT01010217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25599576|NCT01010217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25493997|NCT00266630|Olanzapine|olanzapine|mesh-list
25599577|NCT01010217|Antimetabolites|antimetabolites|mesh-ancestor
25599578|NCT01010217|Antiviral Agents|antiviral agents|mesh-ancestor
25599579|NCT01010217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25599580|NCT01010217|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25599581|NCT01010217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25599582|NCT01010217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25599583|NCT01010217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25599584|NCT01010217|Antitubercular Agents|antitubercular agents|mesh-ancestor
25599585|NCT01010217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25599586|NCT01010282|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25599587|NCT01010282|Lubricant Eye Drops|lubricant eye drops|mesh-list
25599588|NCT01010282|Glycerol|glycerol|mesh-list
25599589|NCT01010282|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25599590|NCT01010282|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25599591|NCT01010282|Laxatives|laxatives|mesh-ancestor
25599592|NCT01010282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25599593|NCT01010282|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25599594|NCT01010282|Protective Agents|protective agents|mesh-ancestor
25599595|NCT01010282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599596|NCT01010399|Ritonavir|ritonavir|mesh-list
25599597|NCT01010399|Fosamprenavir|fosamprenavir|mesh-list
25599598|NCT01010399|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25599599|NCT01010399|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25599600|NCT01010399|Protease Inhibitors|protease inhibitors|mesh-ancestor
25599601|NCT01010399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25599602|NCT01010399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599603|NCT01010399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25599604|NCT01010399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25599605|NCT01010399|Antiviral Agents|antiviral agents|mesh-ancestor
25599606|NCT01010399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25599607|NCT01010399|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25599608|NCT01010399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25599609|NCT01010477|Nicotine|nicotine|mesh-list
25599610|NCT01010477|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25599611|NCT01010477|Autonomic Agents|autonomic agents|mesh-ancestor
25599612|NCT01010477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25599613|NCT01010477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599614|NCT01010477|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25599615|NCT01010477|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25599616|NCT01010477|Cholinergic Agents|cholinergic agents|mesh-ancestor
25599617|NCT01010477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25599618|NCT01010477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599619|NCT01010568|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25599620|NCT01010568|Ofatumumab|ofatumumab|mesh-list
25599621|NCT01010568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25599622|NCT01010568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25599623|NCT01010568|Alkylating Agents|alkylating agents|mesh-ancestor
25599624|NCT01010568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599625|NCT01010568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599626|NCT01010568|Immunologic Factors|immunologic factors|mesh-ancestor
25599627|NCT01010568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599628|NCT01010633|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25599629|NCT01010633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25599630|NCT01010750|Amphetamine|amphetamine|mesh-list
25599631|NCT01010750|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25599632|NCT01010750|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25599633|NCT01010750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599634|NCT01010750|Sympathomimetics|sympathomimetics|mesh-ancestor
25599635|NCT01010750|Autonomic Agents|autonomic agents|mesh-ancestor
25599636|NCT01010750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25599637|NCT01010750|Dopamine Agents|dopamine agents|mesh-ancestor
25599638|NCT01010750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25599639|NCT01010750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599640|NCT01010750|Adrenergic Agents|adrenergic agents|mesh-ancestor
25599641|NCT01010750|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25599642|NCT01010750|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25599643|NCT01010750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25599644|NCT01010750|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25599645|NCT01010776|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25599646|NCT01010776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25599647|NCT01010776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25599648|NCT01010776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25599649|NCT01010776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599650|NCT01010776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25599651|NCT01010776|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25494067|NCT00266864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599652|NCT01010776|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25599653|NCT01010776|Serotonin Agents|serotonin agents|mesh-ancestor
25599654|NCT01010776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24806316|NCT02015169|Lapatinib|lapatinib|mesh-list
25599655|NCT01010776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599656|NCT01010776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24542985|NCT00681343|Alemtuzumab|alemtuzumab|mesh-list
25599657|NCT01010776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25599658|NCT01010776|Dopamine Agents|dopamine agents|mesh-ancestor
25599659|NCT01010932|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
25599660|NCT01010932|Chelating Agents|chelating agents|mesh-ancestor
25599661|NCT01010932|Sequestering Agents|sequestering agents|mesh-ancestor
25599662|NCT01010932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599663|NCT01010971|Ciclesonide|ciclesonide|mesh-list
25599664|NCT01010971|Glucocorticoids|glucocorticoids|mesh-ancestor
25599665|NCT01010971|Hormones|hormones|mesh-ancestor
25599666|NCT01010971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25599667|NCT01010971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599668|NCT01010971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25599669|NCT01010984|Doxorubicin|doxorubicin|mesh-list
25599670|NCT01010984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25599671|NCT01010984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599672|NCT01010984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25599673|NCT01010984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25599674|NCT01010984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25599675|NCT01010984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599676|NCT01011049|Vaccines|vaccines|mesh-list
25599677|NCT01011049|Immunologic Factors|immunologic factors|mesh-ancestor
25599678|NCT01011049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599679|NCT01011075|Paclitaxel|paclitaxel|mesh-list
25599680|NCT01011075|Imatinib Mesylate|imatinib mesylate|mesh-list
25599681|NCT01011075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25599682|NCT01011075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599683|NCT01011075|Tubulin Modulators|tubulin modulators|mesh-ancestor
25599684|NCT01011075|Antimitotic Agents|antimitotic agents|mesh-ancestor
25599685|NCT01011075|Mitosis Modulators|mitosis modulators|mesh-ancestor
25599686|NCT01011075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599687|NCT01011075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25599688|NCT01011075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25599689|NCT01011218|Modafinil|modafinil|mesh-list
25599690|NCT01011218|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25599691|NCT01011218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599692|NCT01011218|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25599693|NCT01011218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25599694|NCT01011218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25599695|NCT01011218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599696|NCT01011283|Azacitidine|azacitidine|mesh-list
25599697|NCT01011283|Decitabine|decitabine|mesh-list
25599698|NCT01011283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25599699|NCT01011283|Antimetabolites|antimetabolites|mesh-ancestor
25599700|NCT01011283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599701|NCT01011283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599702|NCT01011283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25599703|NCT01011309|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
25599704|NCT01011309|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25599705|NCT01011309|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25599706|NCT01011309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25599707|NCT01011309|Schistosomicides|schistosomicides|mesh-ancestor
25599708|NCT01011309|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25599709|NCT01011309|Anthelmintics|anthelmintics|mesh-ancestor
25599710|NCT01011413|Efavirenz|efavirenz|mesh-list
25599711|NCT01011413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25599712|NCT01011413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25599713|NCT01011413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25599714|NCT01011413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599715|NCT01011413|Antiviral Agents|antiviral agents|mesh-ancestor
25599716|NCT01011413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25599717|NCT01011413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25599718|NCT01011413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25599719|NCT01011413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25599720|NCT01011413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25599721|NCT01011413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24545344|NCT00693108|Androgens|androgens|mesh-ancestor
25599722|NCT01011413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25599723|NCT01011439|Maleic acid|maleic acid|mesh-list
25494213|NCT00267865|Methotrexate|methotrexate|mesh-list
25494214|NCT00267865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25494215|NCT00267865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494216|NCT00267865|Immunologic Factors|immunologic factors|mesh-ancestor
25494217|NCT00267865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494218|NCT00267865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25494219|NCT00267865|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25494220|NCT00267865|Abortifacient Agents|abortifacient agents|mesh-ancestor
25494221|NCT00267865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25494222|NCT00267865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25494223|NCT00267865|Antimetabolites|antimetabolites|mesh-ancestor
25494224|NCT00267865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494225|NCT00267865|Dermatologic Agents|dermatologic agents|mesh-ancestor
25494226|NCT00267865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494227|NCT00267865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25494228|NCT00267865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25494229|NCT00267865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25494230|NCT00267865|Antidotes|antidotes|mesh-ancestor
25494231|NCT00267865|Protective Agents|protective agents|mesh-ancestor
25494232|NCT00267865|Vitamin B Complex|vitamin b complex|mesh-ancestor
25494233|NCT00267865|Vitamins|vitamins|mesh-ancestor
25494234|NCT00267865|Micronutrients|micronutrients|mesh-ancestor
25145283|NCT02931071|Plerixafor|plerixafor|mesh-list
24434254|NCT00261820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434255|NCT00261820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24434256|NCT00261820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24434257|NCT00261820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24434274|NCT00261872|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24434275|NCT00261872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434389|NCT00262405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24434390|NCT00262405|Glucocorticoids|glucocorticoids|mesh-ancestor
24434391|NCT00262405|Hormones|hormones|mesh-ancestor
24434392|NCT00262405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24434393|NCT00262405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434394|NCT00262405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24434395|NCT00262405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24434396|NCT00262405|Antimetabolites|antimetabolites|mesh-ancestor
24434397|NCT00262405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477392|NCT00418496|Aldesleukin|aldesleukin|mesh-list
25124045|NCT03079687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25124049|NCT03079440|Capecitabine|capecitabine|mesh-list
24546839|NCT00700687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24434398|NCT00262405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24434399|NCT00262405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24434400|NCT00262405|Immunologic Factors|immunologic factors|mesh-ancestor
24434401|NCT00262405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24434402|NCT00262405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24434403|NCT00262405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24434404|NCT00262405|Analgesics|analgesics|mesh-ancestor
24434405|NCT00262405|Sensory System Agents|sensory system agents|mesh-ancestor
24434903|NCT00264225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25599724|NCT01011439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25599725|NCT01011439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599726|NCT01011465|Oxytocin|oxytocin|mesh-list
25599727|NCT01011465|Oxytocics|oxytocics|mesh-ancestor
25599728|NCT01011465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25599729|NCT01011465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599730|NCT01011556|Teriparatide|teriparatide|mesh-list
25599731|NCT01011556|Hormones|hormones|mesh-list
25599732|NCT01011556|Parathyroid Hormone|parathyroid hormone|mesh-list
25599733|NCT01011556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25599734|NCT01011556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599735|NCT01011556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25599736|NCT01011556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25599737|NCT01011673|Ketorolac|ketorolac|mesh-list
25599738|NCT01011673|Metoclopramide|metoclopramide|mesh-list
25599739|NCT01011673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25599740|NCT01011673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25599741|NCT01011673|Analgesics|analgesics|mesh-ancestor
25599742|NCT01011673|Sensory System Agents|sensory system agents|mesh-ancestor
25599743|NCT01011673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25599744|NCT01011673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599745|NCT01011673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25599746|NCT01011673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25599747|NCT01011673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25599748|NCT01011673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25599749|NCT01011673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599750|NCT01011673|Antiemetics|antiemetics|mesh-ancestor
25599751|NCT01011673|Autonomic Agents|autonomic agents|mesh-ancestor
25599752|NCT01011673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24478179|NCT00421811|Melphalan|melphalan|mesh-list
25599753|NCT01011673|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25599754|NCT01011673|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25599755|NCT01011673|Dopamine Agents|dopamine agents|mesh-ancestor
25599756|NCT01011673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25599757|NCT01011816|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25599758|NCT01011816|Hemostatics|hemostatics|mesh-ancestor
25599759|NCT01011816|Coagulants|coagulants|mesh-ancestor
25599760|NCT01011829|Varenicline|varenicline|mesh-list
25599761|NCT01011829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25599762|NCT01011829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25599763|NCT01011829|Cholinergic Agents|cholinergic agents|mesh-ancestor
25599764|NCT01011829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25599765|NCT01011829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599766|NCT01011829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599767|NCT01011868|Empagliflozin|empagliflozin|mesh-list
25599768|NCT01011868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25599769|NCT01011868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599770|NCT01011868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25599771|NCT01011868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599772|NCT01011894|Lenalidomide|lenalidomide|mesh-list
25599773|NCT01011894|Immunologic Factors|immunologic factors|mesh-ancestor
25599774|NCT01011894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599775|NCT01011894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25599776|NCT01011894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25599777|NCT01011894|Growth Substances|growth substances|mesh-ancestor
25599778|NCT01011894|Growth Inhibitors|growth inhibitors|mesh-ancestor
25599779|NCT01011894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599780|NCT01011907|Varenicline|varenicline|mesh-list
25599781|NCT01011907|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25599782|NCT01011907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25599783|NCT01011907|Cholinergic Agents|cholinergic agents|mesh-ancestor
25599784|NCT01011907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25599785|NCT01011907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599786|NCT01011907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599787|NCT01012037|Linagliptin|linagliptin|mesh-list
25599788|NCT01012037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25599789|NCT01012037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599790|NCT01012037|Incretins|incretins|mesh-ancestor
25599791|NCT01012037|Hormones|hormones|mesh-ancestor
25599792|NCT01012037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25599793|NCT01012037|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25599794|NCT01012037|Protease Inhibitors|protease inhibitors|mesh-ancestor
25599795|NCT01012037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478933|NCT00425035|Panitumumab|panitumumab|mesh-list
25599796|NCT01012037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599797|NCT01012089|Daptomycin|daptomycin|mesh-list
25599798|NCT01012089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25599799|NCT01012089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25599800|NCT01012219|Aspirin|aspirin|mesh-list
25599801|NCT01012219|Niacin|niacin|mesh-list
25599802|NCT01012219|Clopidogrel|clopidogrel|mesh-list
25599803|NCT01012219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25599804|NCT01012219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25599805|NCT01012219|Analgesics|analgesics|mesh-ancestor
25599806|NCT01012219|Sensory System Agents|sensory system agents|mesh-ancestor
25599807|NCT01012219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24479061|NCT00425451|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25599808|NCT01012219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599809|NCT01012219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25599810|NCT01012219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25599811|NCT01012219|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25599812|NCT01012219|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25599813|NCT01012219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599814|NCT01012219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25599815|NCT01012219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25599816|NCT01012219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25599817|NCT01012219|Antipyretics|antipyretics|mesh-ancestor
25599818|NCT01012219|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25599819|NCT01012219|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25494235|NCT00267956|Ustekinumab|ustekinumab|mesh-list
25599820|NCT01012219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25599821|NCT01012219|Purinergic Agents|purinergic agents|mesh-ancestor
25599822|NCT01012219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25599823|NCT01012219|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25599824|NCT01012219|Antimetabolites|antimetabolites|mesh-ancestor
25599825|NCT01012219|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25599826|NCT01012219|Vasodilator Agents|vasodilator agents|mesh-ancestor
25599827|NCT01012219|Vitamin B Complex|vitamin b complex|mesh-ancestor
25599828|NCT01012219|Vitamins|vitamins|mesh-ancestor
25599829|NCT01012219|Micronutrients|micronutrients|mesh-ancestor
25599830|NCT01012258|Cetuximab|cetuximab|mesh-list
25599831|NCT01012258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25599832|NCT01012258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599833|NCT01012297|Gemcitabine|gemcitabine|mesh-list
25599834|NCT01012297|Bevacizumab|bevacizumab|mesh-list
25599835|NCT01012297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25599836|NCT01012297|Docetaxel|docetaxel|mesh-list
25599837|NCT01012297|Endothelial Growth Factors|endothelial growth factors|mesh-list
25599838|NCT01012297|Antibodies|antibodies|mesh-list
25599839|NCT01012297|Immunoglobulins|immunoglobulins|mesh-list
25599840|NCT01012297|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25599841|NCT01012297|Lenograstim|lenograstim|mesh-list
25599842|NCT01012297|Immunoglobulin G|immunoglobulin g|mesh-list
25599843|NCT01012297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599844|NCT01012297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25599845|NCT01012297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25599846|NCT01012297|Growth Substances|growth substances|mesh-ancestor
24480015|NCT00429533|Antimalarials|antimalarials|mesh-ancestor
25599847|NCT01012297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599848|NCT01012297|Growth Inhibitors|growth inhibitors|mesh-ancestor
25599849|NCT01012297|Immunologic Factors|immunologic factors|mesh-ancestor
25599850|NCT01012297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25599851|NCT01012297|Antimetabolites|antimetabolites|mesh-ancestor
25599852|NCT01012297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599853|NCT01012297|Antiviral Agents|antiviral agents|mesh-ancestor
25599854|NCT01012297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25599855|NCT01012297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25599856|NCT01012297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25599857|NCT01012297|Tubulin Modulators|tubulin modulators|mesh-ancestor
25599858|NCT01012297|Antimitotic Agents|antimitotic agents|mesh-ancestor
25599859|NCT01012297|Mitosis Modulators|mitosis modulators|mesh-ancestor
25599860|NCT01012297|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25599861|NCT01012323|Immunoglobulins|immunoglobulins|mesh-list
25599862|NCT01012323|Immunologic Factors|immunologic factors|mesh-ancestor
25599863|NCT01012323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599864|NCT01012336|Dexamethasone|dexamethasone|mesh-list
25599865|NCT01012336|Aprepitant|aprepitant|mesh-list
25599866|NCT01012336|Ramosetron|ramosetron|mesh-list
25599867|NCT01012336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25599868|NCT01012336|Antiemetics|antiemetics|mesh-ancestor
25599869|NCT01012336|Autonomic Agents|autonomic agents|mesh-ancestor
25599870|NCT01012336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25599871|NCT01012336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480591|NCT00431392|Atropine|atropine|mesh-list
25599872|NCT01012336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25599873|NCT01012336|Glucocorticoids|glucocorticoids|mesh-ancestor
25599874|NCT01012336|Hormones|hormones|mesh-ancestor
25599875|NCT01012336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25599876|NCT01012336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25599877|NCT01012336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599878|NCT01012336|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25599879|NCT01012336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24480748|NCT00432016|Antiviral Agents|antiviral agents|mesh-ancestor
24480891|NCT00432575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24480892|NCT00432575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599880|NCT01012336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599881|NCT01012336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25599882|NCT01012336|Serotonin Agents|serotonin agents|mesh-ancestor
25599883|NCT01012492|Abatacept|abatacept|mesh-list
25599884|NCT01012492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25599885|NCT01012492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599886|NCT01012492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599887|NCT01012492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25599888|NCT01012492|Immunologic Factors|immunologic factors|mesh-ancestor
25599889|NCT01012492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599890|NCT01012492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25599891|NCT01012622|Methylphenidate|methylphenidate|mesh-list
25599892|NCT01012622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25599893|NCT01012622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599894|NCT01012622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25599895|NCT01012622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25494311|NCT00269113|Rituximab|rituximab|mesh-list
25599896|NCT01012622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25599897|NCT01012622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599899|NCT01012622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24481766|NCT00436761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24481872|NCT00437164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24481873|NCT00437164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481874|NCT00437177|Apomorphine|apomorphine|mesh-list
24481875|NCT00437177|Emetics|emetics|mesh-ancestor
24481876|NCT00437177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481877|NCT00437177|Autonomic Agents|autonomic agents|mesh-ancestor
25599900|NCT01012661|Lidocaine|lidocaine|mesh-list
25599901|NCT01012661|Anesthetics, Local|anesthetics, local|mesh-ancestor
25599902|NCT01012661|Anesthetics|anesthetics|mesh-ancestor
25599903|NCT01012661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25599904|NCT01012661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599905|NCT01012661|Sensory System Agents|sensory system agents|mesh-ancestor
25599906|NCT01012661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25599907|NCT01012661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25599908|NCT01012661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25599909|NCT01012661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25599910|NCT01012661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25599911|NCT01012661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599912|NCT01012674|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
25599913|NCT01012674|Chelating Agents|chelating agents|mesh-ancestor
25599914|NCT01012674|Sequestering Agents|sequestering agents|mesh-ancestor
25599915|NCT01012674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599916|NCT01012713|Calcitriol|calcitriol|mesh-list
25599917|NCT01012713|Clobetasol|clobetasol|mesh-list
25599918|NCT01012713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25599919|NCT01012713|Glucocorticoids|glucocorticoids|mesh-ancestor
25599920|NCT01012713|Hormones|hormones|mesh-ancestor
25599921|NCT01012713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25599922|NCT01012713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599923|NCT01012713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25599924|NCT01012713|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25599925|NCT01012713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25599926|NCT01012713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599927|NCT01012713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25599928|NCT01012713|Vitamins|vitamins|mesh-ancestor
25599929|NCT01012713|Micronutrients|micronutrients|mesh-ancestor
25599930|NCT01012713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25599931|NCT01012765|Tiotropium Bromide|tiotropium bromide|mesh-list
25599932|NCT01012765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25599933|NCT01012765|Autonomic Agents|autonomic agents|mesh-ancestor
25599934|NCT01012765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24482365|NCT00438828|Dexamethasone|dexamethasone|mesh-list
25599935|NCT01012765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599936|NCT01012765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25599937|NCT01012765|Respiratory System Agents|respiratory system agents|mesh-ancestor
25599938|NCT01012765|Parasympatholytics|parasympatholytics|mesh-ancestor
25599939|NCT01012765|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25599940|NCT01012765|Cholinergic Agents|cholinergic agents|mesh-ancestor
25599941|NCT01012765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25599942|NCT01012765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599943|NCT01012973|Aflibercept|aflibercept|mesh-list
25599944|NCT01012973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25599945|NCT01012973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25599946|NCT01012973|Growth Substances|growth substances|mesh-ancestor
25599947|NCT01012973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599948|NCT01012973|Growth Inhibitors|growth inhibitors|mesh-ancestor
25599949|NCT01012973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24482778|NCT00440622|Capecitabine|capecitabine|mesh-list
25653801|NCT01542645|Anesthetics, General|anesthetics, general|mesh-ancestor
25653802|NCT01542645|Anesthetics|anesthetics|mesh-ancestor
25653803|NCT01542645|Antitussive Agents|antitussive agents|mesh-ancestor
25653804|NCT01542645|Respiratory System Agents|respiratory system agents|mesh-ancestor
25653805|NCT01542684|Azacitidine|azacitidine|mesh-list
25653806|NCT01542684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25653807|NCT01542684|Antimetabolites|antimetabolites|mesh-ancestor
25653808|NCT01542684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653809|NCT01542684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25653810|NCT01542684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653811|NCT01542788|Sofosbuvir|sofosbuvir|mesh-list
25653812|NCT01542788|Antiviral Agents|antiviral agents|mesh-ancestor
25653813|NCT01542788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25653814|NCT01543074|Allyl sulfide|allyl sulfide|mesh-list
25653815|NCT01543074|Antioxidants|antioxidants|mesh-ancestor
25653816|NCT01543074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653817|NCT01543074|Protective Agents|protective agents|mesh-ancestor
25653818|NCT01543074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599950|NCT01012999|Sufentanil|sufentanil|mesh-list
25599951|NCT01012999|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25599952|NCT01012999|Narcotics|narcotics|mesh-ancestor
25599953|NCT01012999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25599954|NCT01012999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599955|NCT01012999|Analgesics|analgesics|mesh-ancestor
25599956|NCT01012999|Sensory System Agents|sensory system agents|mesh-ancestor
25599957|NCT01012999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25599958|NCT01012999|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25599959|NCT01012999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25599960|NCT01012999|Anesthetics, General|anesthetics, general|mesh-ancestor
25599961|NCT01012999|Anesthetics|anesthetics|mesh-ancestor
25599962|NCT01013285|Bevacizumab|bevacizumab|mesh-list
25599963|NCT01013285|Temozolomide|temozolomide|mesh-list
25599964|NCT01013285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25599965|NCT01013285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24454761|NCT03715972|Hydroxyurea|hydroxyurea|mesh-list
24484933|NCT00450827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599966|NCT01013285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25599967|NCT01013285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25599968|NCT01013285|Growth Substances|growth substances|mesh-ancestor
24484934|NCT00450827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24484935|NCT00450827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24484936|NCT00450827|Growth Substances|growth substances|mesh-ancestor
24484937|NCT00450827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599969|NCT01013285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599970|NCT01013285|Growth Inhibitors|growth inhibitors|mesh-ancestor
25599971|NCT01013285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25599972|NCT01013285|Alkylating Agents|alkylating agents|mesh-ancestor
25599973|NCT01013285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599974|NCT01013597|Panobinostat|panobinostat|mesh-list
25599975|NCT01013597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599976|NCT01013597|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25707402|NCT02230696|Xhance|xhance|mesh-list
25599977|NCT01013597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25599978|NCT01013597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599979|NCT01013740|Capecitabine|capecitabine|mesh-list
25599980|NCT01013740|Vinorelbine|vinorelbine|mesh-list
25599981|NCT01013740|Lapatinib|lapatinib|mesh-list
25599982|NCT01013740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25599983|NCT01013740|Antimetabolites|antimetabolites|mesh-ancestor
25599984|NCT01013740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25599985|NCT01013740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25599986|NCT01013740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25599987|NCT01013740|Tubulin Modulators|tubulin modulators|mesh-ancestor
25599988|NCT01013740|Antimitotic Agents|antimitotic agents|mesh-ancestor
25599989|NCT01013740|Mitosis Modulators|mitosis modulators|mesh-ancestor
25599990|NCT01013740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25599991|NCT01013740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25599992|NCT01013753|Formoterol Fumarate|formoterol fumarate|mesh-list
25599993|NCT01013753|Olodaterol|olodaterol|mesh-list
25599994|NCT01013753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25599995|NCT01013753|Autonomic Agents|autonomic agents|mesh-ancestor
25599996|NCT01013753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25599997|NCT01013753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25599998|NCT01013753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25599999|NCT01013753|Respiratory System Agents|respiratory system agents|mesh-ancestor
25600000|NCT01013753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25600001|NCT01013753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25600002|NCT01013753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25600003|NCT01013753|Adrenergic Agents|adrenergic agents|mesh-ancestor
25600004|NCT01013753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25600005|NCT01013753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600006|NCT01013870|Atorvastatin|atorvastatin|mesh-list
25600007|NCT01013870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25600008|NCT01013870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25600009|NCT01013870|Antimetabolites|antimetabolites|mesh-ancestor
25600010|NCT01013870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600011|NCT01013870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25600012|NCT01013870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25600013|NCT01013870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25600014|NCT01013961|Rituximab|rituximab|mesh-list
25600015|NCT01013961|Alemtuzumab|alemtuzumab|mesh-list
24808742|NCT02028923|Morphine|morphine|mesh-list
25600016|NCT01013961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25600017|NCT01013961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600018|NCT01013961|Immunologic Factors|immunologic factors|mesh-ancestor
25600019|NCT01013961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600020|NCT01013961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25600021|NCT01014013|Ceftriaxone|ceftriaxone|mesh-list
25600022|NCT01014013|Ertapenem|ertapenem|mesh-list
25600023|NCT01014013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25600024|NCT01014013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25600025|NCT01014143|Chlorhexidine|chlorhexidine|mesh-list
25600026|NCT01014143|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24486161|NCT00456586|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25600027|NCT01014143|Triclosan|triclosan|mesh-list
25600028|NCT01014143|Fluorides|fluorides|mesh-list
25600029|NCT01014143|Cariostatic Agents|cariostatic agents|mesh-ancestor
25600030|NCT01014143|Protective Agents|protective agents|mesh-ancestor
25600031|NCT01014143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600032|NCT01014143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25600033|NCT01014143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24486318|NCT00457106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24486319|NCT00457106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25600034|NCT01014143|Disinfectants|disinfectants|mesh-ancestor
25600035|NCT01014143|Dermatologic Agents|dermatologic agents|mesh-ancestor
25600036|NCT01014143|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25600037|NCT01014143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25600038|NCT01014143|Antimetabolites|antimetabolites|mesh-ancestor
25600039|NCT01014143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600040|NCT01014143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25600041|NCT01014208|Rituximab|rituximab|mesh-list
25600042|NCT01014208|Ofatumumab|ofatumumab|mesh-list
25600043|NCT01014208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25600044|NCT01014208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600045|NCT01014208|Immunologic Factors|immunologic factors|mesh-ancestor
25600046|NCT01014208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600047|NCT01014208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25600048|NCT01014351|Paclitaxel|paclitaxel|mesh-list
25600049|NCT01014351|Carboplatin|carboplatin|mesh-list
25600050|NCT01014351|Everolimus|everolimus|mesh-list
24486320|NCT00457119|Everolimus|everolimus|mesh-list
24486321|NCT00457119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486322|NCT00457119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24486325|NCT00457145|Ranibizumab|ranibizumab|mesh-list
25600051|NCT01014351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25600052|NCT01014351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600053|NCT01014351|Tubulin Modulators|tubulin modulators|mesh-ancestor
25600054|NCT01014351|Antimitotic Agents|antimitotic agents|mesh-ancestor
25600055|NCT01014351|Mitosis Modulators|mitosis modulators|mesh-ancestor
25600056|NCT01014351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600057|NCT01014351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25600058|NCT01014351|Immunologic Factors|immunologic factors|mesh-ancestor
24487303|NCT00462592|Hormones|hormones|mesh-ancestor
25600059|NCT01014351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600060|NCT01014403|Enoxaparin|enoxaparin|mesh-list
25600061|NCT01014403|Anticoagulants|anticoagulants|mesh-ancestor
25600062|NCT01014403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25600063|NCT01014403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25600064|NCT01014403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600065|NCT01014442|Mycophenolic Acid|mycophenolic acid|mesh-list
25600066|NCT01014442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25600067|NCT01014442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600068|NCT01014442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25600069|NCT01014442|Antitubercular Agents|antitubercular agents|mesh-ancestor
25600070|NCT01014442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25600071|NCT01014442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25600072|NCT01014442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25600073|NCT01014442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600074|NCT01014533|Gabapentin|gabapentin|mesh-list
25600075|NCT01014533|Analgesics|analgesics|mesh-ancestor
24488002|NCT00466154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24488003|NCT00466154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488015|NCT00466180|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25600076|NCT01014533|Sensory System Agents|sensory system agents|mesh-ancestor
25600077|NCT01014533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25600078|NCT01014533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600079|NCT01014533|Anticonvulsants|anticonvulsants|mesh-ancestor
25600080|NCT01014533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25600081|NCT01014533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25600082|NCT01014533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25600083|NCT01014533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25600084|NCT01014533|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25600085|NCT01014533|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25600086|NCT01014533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25600087|NCT01014533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600088|NCT01014533|Antimanic Agents|antimanic agents|mesh-ancestor
25600089|NCT01014585|Milnacipran|milnacipran|mesh-list
25600090|NCT01014585|Levomilnacipran|levomilnacipran|mesh-list
25600091|NCT01014585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25600092|NCT01014585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25600093|NCT01014585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25600094|NCT01014585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494539|NCT00272987|Paclitaxel|paclitaxel|mesh-list
25600095|NCT01014585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25600096|NCT01014585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600097|NCT01014585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25707456|NCT02231086|Protective Agents|protective agents|mesh-ancestor
25600098|NCT01014585|Analgesics|analgesics|mesh-ancestor
25600099|NCT01014585|Sensory System Agents|sensory system agents|mesh-ancestor
25600100|NCT01014585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25600101|NCT01014585|Antidepressive Agents|antidepressive agents|mesh-ancestor
25600102|NCT01014585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25600103|NCT01014624|Clopidogrel|clopidogrel|mesh-list
25600104|NCT01014624|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25600105|NCT01014624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25600106|NCT01014624|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25600107|NCT01014624|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25600108|NCT01014624|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25600109|NCT01014624|Purinergic Agents|purinergic agents|mesh-ancestor
25600110|NCT01014624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25600111|NCT01014624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600112|NCT01014624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600113|NCT01014689|Lymecycline|lymecycline|mesh-list
25600114|NCT01014689|Adapalene|adapalene|mesh-list
25600115|NCT01014689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25600116|NCT01014689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25600117|NCT01014689|Analgesics|analgesics|mesh-ancestor
25600118|NCT01014689|Sensory System Agents|sensory system agents|mesh-ancestor
25600119|NCT01014689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25600120|NCT01014689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600121|NCT01014689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25600122|NCT01014689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25600123|NCT01014689|Dermatologic Agents|dermatologic agents|mesh-ancestor
24809322|NCT02033018|Aflibercept|aflibercept|mesh-list
25600124|NCT01014689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25600125|NCT01014689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25600126|NCT01014728|Propofol|propofol|mesh-list
25600127|NCT01014728|Sevoflurane|sevoflurane|mesh-list
25600128|NCT01014728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25600129|NCT01014728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25600130|NCT01014728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600131|NCT01014728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25600132|NCT01014728|Anesthetics, General|anesthetics, general|mesh-ancestor
25600133|NCT01014728|Anesthetics|anesthetics|mesh-ancestor
25600134|NCT01014728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25600135|NCT01014728|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25600136|NCT01014741|Ibutilide|ibutilide|mesh-list
25600137|NCT01014741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25600138|NCT01014871|Botulinum Toxins|botulinum toxins|mesh-list
25600139|NCT01014871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25600140|NCT01014871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25600141|NCT01014871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25600142|NCT01014871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25600143|NCT01014871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600144|NCT01014871|Cholinergic Agents|cholinergic agents|mesh-ancestor
25600145|NCT01014871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25600146|NCT01014871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600147|NCT01014871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25600148|NCT01014871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25600149|NCT01014975|Fibrinolysin|fibrinolysin|mesh-list
25600150|NCT01014975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25600151|NCT01014975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25600152|NCT01014975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600153|NCT01014988|Zanamivir|zanamivir|mesh-list
25600154|NCT01014988|Antiviral Agents|antiviral agents|mesh-ancestor
25600155|NCT01014988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25600156|NCT01014988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25600157|NCT01014988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600158|NCT01015118|Paclitaxel|paclitaxel|mesh-list
25600159|NCT01015118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25600160|NCT01015118|Carboplatin|carboplatin|mesh-list
25600161|NCT01015118|Nintedanib|nintedanib|mesh-list
25600162|NCT01015118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25600163|NCT01015118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600164|NCT01015118|Tubulin Modulators|tubulin modulators|mesh-ancestor
25600165|NCT01015118|Antimitotic Agents|antimitotic agents|mesh-ancestor
25600166|NCT01015118|Mitosis Modulators|mitosis modulators|mesh-ancestor
25600167|NCT01015118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600168|NCT01015118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25600169|NCT01015118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25600170|NCT01015131|Alovudine|alovudine|mesh-list
25600171|NCT01015131|Antiviral Agents|antiviral agents|mesh-ancestor
25600172|NCT01015131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25600173|NCT01015170|Bupropion|bupropion|mesh-list
25600174|NCT01015170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25600175|NCT01015170|Antidepressive Agents|antidepressive agents|mesh-ancestor
25600176|NCT01015170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25600177|NCT01015170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25600178|NCT01015170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25600179|NCT01015170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25600180|NCT01015170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600181|NCT01015170|Dopamine Agents|dopamine agents|mesh-ancestor
25600182|NCT01015170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25600183|NCT01015170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600184|NCT01015170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25600185|NCT01015170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25600186|NCT01015170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25600187|NCT01015287|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24493132|NCT00489658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25600188|NCT01015287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25600189|NCT01015443|Cyclophosphamide|cyclophosphamide|mesh-list
25600190|NCT01015443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25600191|NCT01015443|Immunologic Factors|immunologic factors|mesh-ancestor
25600192|NCT01015443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600193|NCT01015443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25600194|NCT01015443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25600195|NCT01015443|Alkylating Agents|alkylating agents|mesh-ancestor
25600196|NCT01015443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600197|NCT01015443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600198|NCT01015443|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25600199|NCT01015534|Temozolomide|temozolomide|mesh-list
25600200|NCT01015534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25600201|NCT01015534|Alkylating Agents|alkylating agents|mesh-ancestor
25600202|NCT01015534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600203|NCT01015534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600205|NCT01015560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25600206|NCT01015560|Immunologic Factors|immunologic factors|mesh-ancestor
25600207|NCT01015560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600208|NCT01015586|Lamotrigine|lamotrigine|mesh-list
25600209|NCT01015586|Anticonvulsants|anticonvulsants|mesh-ancestor
25600210|NCT01015586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25600211|NCT01015586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25600212|NCT01015586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600213|NCT01015586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25600214|NCT01015586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600215|NCT01015586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25600216|NCT01015586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25600217|NCT01015586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25600218|NCT01015586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25600219|NCT01015586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25600220|NCT01015638|Clindamycin|clindamycin|mesh-list
25600221|NCT01015638|Clindamycin palmitate|clindamycin palmitate|mesh-list
25600222|NCT01015638|Clindamycin phosphate|clindamycin phosphate|mesh-list
25600223|NCT01015638|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25600224|NCT01015638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25600225|NCT01015638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25600226|NCT01015638|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25600227|NCT01015638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25600228|NCT01015638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600229|NCT01015638|Dermatologic Agents|dermatologic agents|mesh-ancestor
25600230|NCT01015677|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25600231|NCT01015677|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25600232|NCT01015677|Estradiol|estradiol|mesh-list
25600233|NCT01015677|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25600234|NCT01015677|Estrogens|estrogens|mesh-ancestor
25600235|NCT01015677|Hormones|hormones|mesh-ancestor
25707513|NCT02232802|Enoxaparin|enoxaparin|mesh-list
24496725|NCT00506298|Analgesics|analgesics|mesh-ancestor
25600236|NCT01015677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25600237|NCT01015677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707527|NCT02233296|Serotonin Agents|serotonin agents|mesh-ancestor
25600238|NCT01015677|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25600239|NCT01015677|Contraceptive Agents|contraceptive agents|mesh-ancestor
25600240|NCT01015677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25600241|NCT01015677|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25600242|NCT01015807|Clonidine|clonidine|mesh-list
25600243|NCT01015807|Bupivacaine|bupivacaine|mesh-list
25600244|NCT01015807|Anesthetics, Local|anesthetics, local|mesh-ancestor
25600245|NCT01015807|Anesthetics|anesthetics|mesh-ancestor
25494663|NCT00274924|Ifosfamide|ifosfamide|mesh-list
25600246|NCT01015807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25600247|NCT01015807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600248|NCT01015807|Sensory System Agents|sensory system agents|mesh-ancestor
25600249|NCT01015807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25600250|NCT01015807|Analgesics|analgesics|mesh-ancestor
25600251|NCT01015807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25600252|NCT01015807|Sympatholytics|sympatholytics|mesh-ancestor
25600253|NCT01015807|Autonomic Agents|autonomic agents|mesh-ancestor
25600254|NCT01015807|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25600255|NCT01015807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25600256|NCT01015807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25600257|NCT01015807|Adrenergic Agents|adrenergic agents|mesh-ancestor
25600258|NCT01015807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25600259|NCT01015807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600260|NCT01016015|Sirolimus|sirolimus|mesh-list
25600261|NCT01016015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25600262|NCT01016015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25600263|NCT01016015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25600264|NCT01016015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25600265|NCT01016015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600266|NCT01016015|Antifungal Agents|antifungal agents|mesh-ancestor
25600267|NCT01016015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25600268|NCT01016015|Immunologic Factors|immunologic factors|mesh-ancestor
25600269|NCT01016015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600270|NCT01016262|Mesalamine|mesalamine|mesh-list
25600271|NCT01016262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25600272|NCT01016262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25600273|NCT01016262|Analgesics|analgesics|mesh-ancestor
25600274|NCT01016262|Sensory System Agents|sensory system agents|mesh-ancestor
25600275|NCT01016262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25600276|NCT01016262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600277|NCT01016262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25600278|NCT01016262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25600279|NCT01016483|Gemcitabine|gemcitabine|mesh-list
25600280|NCT01016483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25600281|NCT01016483|Antimetabolites|antimetabolites|mesh-ancestor
25600282|NCT01016483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600283|NCT01016483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600284|NCT01016483|Antiviral Agents|antiviral agents|mesh-ancestor
25600285|NCT01016483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25600286|NCT01016483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25600287|NCT01016483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25600288|NCT01016483|Immunologic Factors|immunologic factors|mesh-ancestor
25600289|NCT01016483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600290|NCT01016600|Lenalidomide|lenalidomide|mesh-list
25600291|NCT01016600|Azacitidine|azacitidine|mesh-list
25600292|NCT01016600|Immunologic Factors|immunologic factors|mesh-ancestor
25600293|NCT01016600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600294|NCT01016600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25600295|NCT01016600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25600296|NCT01016600|Growth Substances|growth substances|mesh-ancestor
25600297|NCT01016600|Growth Inhibitors|growth inhibitors|mesh-ancestor
25600298|NCT01016600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498915|NCT00516828|Antimetabolites|antimetabolites|mesh-ancestor
25600299|NCT01016600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25600300|NCT01016600|Antimetabolites|antimetabolites|mesh-ancestor
25600301|NCT01016600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600302|NCT01016600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25600303|NCT01016678|Naproxen|naproxen|mesh-list
25600304|NCT01016678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25600305|NCT01016678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25600306|NCT01016678|Analgesics|analgesics|mesh-ancestor
25600307|NCT01016678|Sensory System Agents|sensory system agents|mesh-ancestor
25600308|NCT01016678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25600309|NCT01016678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600310|NCT01016678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25600311|NCT01016678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25600312|NCT01016678|Gout Suppressants|gout suppressants|mesh-ancestor
25600313|NCT01016678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25600314|NCT01016678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25600315|NCT01016678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600316|NCT01016691|Bimatoprost|bimatoprost|mesh-list
25600317|NCT01016691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25600318|NCT01016769|Sirolimus|sirolimus|mesh-list
25600319|NCT01016769|Paclitaxel|paclitaxel|mesh-list
25600320|NCT01016769|Carboplatin|carboplatin|mesh-list
25600321|NCT01016769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25600322|NCT01016769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600323|NCT01016769|Tubulin Modulators|tubulin modulators|mesh-ancestor
25600324|NCT01016769|Antimitotic Agents|antimitotic agents|mesh-ancestor
25600325|NCT01016769|Mitosis Modulators|mitosis modulators|mesh-ancestor
25600326|NCT01016769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600327|NCT01016769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25600328|NCT01016769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24500211|NCT00523263|Heparin|heparin|mesh-list
25600329|NCT01016769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25600330|NCT01016769|Antifungal Agents|antifungal agents|mesh-ancestor
25600331|NCT01016769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25600332|NCT01016769|Immunologic Factors|immunologic factors|mesh-ancestor
25600333|NCT01016769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600334|NCT01016834|Sumatriptan|sumatriptan|mesh-list
25600335|NCT01016834|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25600336|NCT01016834|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25600337|NCT01016834|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25600338|NCT01016834|Serotonin Agents|serotonin agents|mesh-ancestor
24500727|NCT00525577|Antimetabolites|antimetabolites|mesh-ancestor
25600339|NCT01016834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25600340|NCT01016834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600341|NCT01016834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600342|NCT01016912|Ribavirin|ribavirin|mesh-list
25600343|NCT01016912|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24501061|NCT00526448|Antiviral Agents|antiviral agents|mesh-ancestor
25600344|NCT01016912|Antimetabolites|antimetabolites|mesh-ancestor
25600345|NCT01016912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600346|NCT01016912|Antiviral Agents|antiviral agents|mesh-ancestor
25600347|NCT01016912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25600348|NCT01016977|Nicotinic Acids|nicotinic acids|mesh-list
25600349|NCT01016977|Clindamycin|clindamycin|mesh-list
25600350|NCT01016977|Clindamycin palmitate|clindamycin palmitate|mesh-list
25600351|NCT01016977|Clindamycin phosphate|clindamycin phosphate|mesh-list
25600352|NCT01016977|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25600353|NCT01016977|Tazarotene|tazarotene|mesh-list
25600354|NCT01016977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25600355|NCT01016977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25600356|NCT01016977|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25600357|NCT01016977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25600358|NCT01016977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600359|NCT01016977|Dermatologic Agents|dermatologic agents|mesh-ancestor
25600360|NCT01016977|Keratolytic Agents|keratolytic agents|mesh-ancestor
25600361|NCT01016977|Vitamin B Complex|vitamin b complex|mesh-ancestor
25600362|NCT01016977|Vitamins|vitamins|mesh-ancestor
25600363|NCT01016977|Micronutrients|micronutrients|mesh-ancestor
25600364|NCT01016977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600365|NCT01017003|Colchicine|colchicine|mesh-list
25600366|NCT01017003|Gout Suppressants|gout suppressants|mesh-ancestor
25600367|NCT01017003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25600368|NCT01017003|Tubulin Modulators|tubulin modulators|mesh-ancestor
25600369|NCT01017003|Antimitotic Agents|antimitotic agents|mesh-ancestor
25600370|NCT01017003|Mitosis Modulators|mitosis modulators|mesh-ancestor
25600371|NCT01017003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600372|NCT01017003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600373|NCT01017029|Mycophenolic Acid|mycophenolic acid|mesh-list
25600374|NCT01017029|Everolimus|everolimus|mesh-list
25600375|NCT01017029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600376|NCT01017029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25600377|NCT01017029|Immunologic Factors|immunologic factors|mesh-ancestor
25600378|NCT01017029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600379|NCT01017029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25600380|NCT01017029|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25600381|NCT01017029|Antitubercular Agents|antitubercular agents|mesh-ancestor
25600382|NCT01017029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25600383|NCT01017029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25600384|NCT01017029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25600385|NCT01017029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600386|NCT01017042|Colchicine|colchicine|mesh-list
25600387|NCT01017042|Gout Suppressants|gout suppressants|mesh-ancestor
25600388|NCT01017042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25600389|NCT01017042|Tubulin Modulators|tubulin modulators|mesh-ancestor
25600390|NCT01017042|Antimitotic Agents|antimitotic agents|mesh-ancestor
25707571|NCT02233803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25707572|NCT02233803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24502881|NCT04107675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502882|NCT04107675|Antifungal Agents|antifungal agents|mesh-ancestor
24502883|NCT04107675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24502884|NCT04107675|Dermatologic Agents|dermatologic agents|mesh-ancestor
24502885|NCT04107675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25600391|NCT01017042|Mitosis Modulators|mitosis modulators|mesh-ancestor
25600392|NCT01017042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600393|NCT01017042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600394|NCT01017120|Tazarotene|tazarotene|mesh-list
25600395|NCT01017120|Dermatologic Agents|dermatologic agents|mesh-ancestor
25600396|NCT01017120|Keratolytic Agents|keratolytic agents|mesh-ancestor
25600398|NCT01017146|Dermatologic Agents|dermatologic agents|mesh-ancestor
25600399|NCT01017146|Keratolytic Agents|keratolytic agents|mesh-ancestor
25600400|NCT01017237|Midazolam|midazolam|mesh-list
24503462|NCT01220583|Cisplatin|cisplatin|mesh-list
25600401|NCT01017237|Dexmedetomidine|dexmedetomidine|mesh-list
25600402|NCT01017237|Ketamine|ketamine|mesh-list
25600403|NCT01017237|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25600404|NCT01017237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25600405|NCT01017237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600406|NCT01017237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25600407|NCT01017237|Analgesics|analgesics|mesh-ancestor
25600408|NCT01017237|Sensory System Agents|sensory system agents|mesh-ancestor
25600409|NCT01017237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25600410|NCT01017237|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25600411|NCT01017237|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25600412|NCT01017237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25600413|NCT01017237|Adrenergic Agents|adrenergic agents|mesh-ancestor
25600414|NCT01017237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25600415|NCT01017237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600416|NCT01017237|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25600417|NCT01017237|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25600418|NCT01017237|Anesthetics, General|anesthetics, general|mesh-ancestor
25600419|NCT01017237|Anesthetics|anesthetics|mesh-ancestor
25600420|NCT01017237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25600421|NCT01017237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25600422|NCT01017237|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25600423|NCT01017237|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25600424|NCT01017237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25600425|NCT01017237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25600426|NCT01017237|GABA Modulators|gaba modulators|mesh-ancestor
25600427|NCT01017237|GABA Agents|gaba agents|mesh-ancestor
25600428|NCT01017250|Bevacizumab|bevacizumab|mesh-list
25600429|NCT01017250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25600430|NCT01017250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600431|NCT01017250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25600432|NCT01017250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25600433|NCT01017250|Growth Substances|growth substances|mesh-ancestor
25600434|NCT01017250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600435|NCT01017250|Growth Inhibitors|growth inhibitors|mesh-ancestor
25600436|NCT01017575|Ribavirin|ribavirin|mesh-list
25600437|NCT01017575|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25600438|NCT01017575|Antimetabolites|antimetabolites|mesh-ancestor
25600439|NCT01017575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600440|NCT01017575|Antiviral Agents|antiviral agents|mesh-ancestor
25600441|NCT01017575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25600442|NCT01017653|Irinotecan|irinotecan|mesh-list
25600443|NCT01017653|Panitumumab|panitumumab|mesh-list
25600444|NCT01017653|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25600445|NCT01017653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25600446|NCT01017653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25600447|NCT01017653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600448|NCT01017653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600449|NCT01017653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25600450|NCT01017731|Diphenhydramine|diphenhydramine|mesh-list
25600451|NCT01017731|Promethazine|promethazine|mesh-list
25600452|NCT01017731|Moxifloxacin|moxifloxacin|mesh-list
25600453|NCT01017731|Ramucirumab|ramucirumab|mesh-list
25600454|NCT01017731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25600455|NCT01017731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25600456|NCT01017731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25600457|NCT01017731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25600458|NCT01017731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25600459|NCT01017731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600460|NCT01017731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600461|NCT01017731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600462|NCT01017731|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25600463|NCT01017731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25600464|NCT01017731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25600465|NCT01017731|Anesthetics, Local|anesthetics, local|mesh-ancestor
25600466|NCT01017731|Anesthetics|anesthetics|mesh-ancestor
25600467|NCT01017731|Sensory System Agents|sensory system agents|mesh-ancestor
25600468|NCT01017731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25600469|NCT01017731|Antiemetics|antiemetics|mesh-ancestor
25600470|NCT01017731|Autonomic Agents|autonomic agents|mesh-ancestor
24504633|NCT00537524|Vaccines|vaccines|mesh-list
25600471|NCT01017731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25600472|NCT01017731|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25600473|NCT01017731|Histamine Antagonists|histamine antagonists|mesh-ancestor
25600474|NCT01017731|Histamine Agents|histamine agents|mesh-ancestor
25600475|NCT01017731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25600476|NCT01017731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25600477|NCT01017731|Antipruritics|antipruritics|mesh-ancestor
25600478|NCT01017731|Dermatologic Agents|dermatologic agents|mesh-ancestor
25600479|NCT01017874|Cisplatin|cisplatin|mesh-list
25494957|NCT00278161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25494958|NCT00278161|Immunologic Factors|immunologic factors|mesh-ancestor
25494959|NCT00278161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494960|NCT00278161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25494961|NCT00278161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25494962|NCT00278161|Alkylating Agents|alkylating agents|mesh-ancestor
25494963|NCT00278161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494964|NCT00278161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494965|NCT00278161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25494966|NCT00278161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25494967|NCT00278395|Vorinostat|vorinostat|mesh-list
25494968|NCT00278395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494969|NCT00278395|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25494970|NCT00278395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494971|NCT00278395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494972|NCT00278512|Cyclophosphamide|cyclophosphamide|mesh-list
25494973|NCT00278512|Fludarabine|fludarabine|mesh-list
25494974|NCT00278512|Alemtuzumab|alemtuzumab|mesh-list
25494975|NCT00278512|Tacrolimus|tacrolimus|mesh-list
25494976|NCT00278512|Thymoglobulin|thymoglobulin|mesh-list
25494977|NCT00278512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25494978|NCT00278512|Immunologic Factors|immunologic factors|mesh-ancestor
25494979|NCT00278512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494980|NCT00278512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25494981|NCT00278512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25494982|NCT00278512|Alkylating Agents|alkylating agents|mesh-ancestor
25494983|NCT00278512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494984|NCT00278512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494985|NCT00278512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25494986|NCT00278512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25494987|NCT00278512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494988|NCT00278512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25148111|NCT05312242|Folic Acid|folic acid|mesh-list
25148112|NCT05312242|Micronutrients|micronutrients|mesh-list
25600480|NCT01017874|Pemetrexed|pemetrexed|mesh-list
25600481|NCT01017874|Gefitinib|gefitinib|mesh-list
25600482|NCT01017874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600483|NCT01017874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25600484|NCT01017874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600485|NCT01017874|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25600486|NCT01017874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24536816|NCT00652600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25600487|NCT01017874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25600488|NCT01018056|Riluzole|riluzole|mesh-list
25600489|NCT01018056|Anticonvulsants|anticonvulsants|mesh-ancestor
25600490|NCT01018056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25600491|NCT01018056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25600492|NCT01018056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25600493|NCT01018056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600494|NCT01018056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600495|NCT01018056|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25600496|NCT01018056|Protective Agents|protective agents|mesh-ancestor
25600497|NCT01018095|Metronidazole|metronidazole|mesh-list
25600498|NCT01018095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25600499|NCT01018095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25600500|NCT01018095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25600501|NCT01018095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25600502|NCT01018134|Desoximetasone|desoximetasone|mesh-list
25600503|NCT01018134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25600504|NCT01018134|Glucocorticoids|glucocorticoids|mesh-ancestor
25600505|NCT01018134|Hormones|hormones|mesh-ancestor
25600506|NCT01018134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25600507|NCT01018134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600508|NCT01018186|Fluticasone|fluticasone|mesh-list
25600509|NCT01018186|Xhance|xhance|mesh-list
25600510|NCT01018186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25600511|NCT01018186|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24461665|NCT00353041|Lidocaine|lidocaine|mesh-list
25600512|NCT01018186|Autonomic Agents|autonomic agents|mesh-ancestor
25600513|NCT01018186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25600514|NCT01018186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600515|NCT01018186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25600516|NCT01018186|Respiratory System Agents|respiratory system agents|mesh-ancestor
25600517|NCT01018186|Dermatologic Agents|dermatologic agents|mesh-ancestor
25600518|NCT01018186|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25600519|NCT01018264|Solifenacin Succinate|solifenacin succinate|mesh-list
25600520|NCT01018264|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24461910|NCT00354354|Autonomic Agents|autonomic agents|mesh-ancestor
25600521|NCT01018264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25600522|NCT01018264|Cholinergic Agents|cholinergic agents|mesh-ancestor
25600523|NCT01018264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25600524|NCT01018264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600525|NCT01018264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600526|NCT01018264|Urological Agents|urological agents|mesh-ancestor
25600527|NCT01018394|Nicotine|nicotine|mesh-list
25600528|NCT01018394|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25600529|NCT01018394|Autonomic Agents|autonomic agents|mesh-ancestor
25600530|NCT01018394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25600531|NCT01018394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600532|NCT01018394|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25600533|NCT01018394|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25600534|NCT01018394|Cholinergic Agents|cholinergic agents|mesh-ancestor
25600535|NCT01018394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25600536|NCT01018394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600537|NCT01018420|Moxifloxacin|moxifloxacin|mesh-list
25600538|NCT01018420|Colchicine|colchicine|mesh-list
25600539|NCT01018420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25600540|NCT01018420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24631397|NCT01117376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25600541|NCT01018420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25600542|NCT01018420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25600543|NCT01018420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25600544|NCT01018420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600545|NCT01018420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600546|NCT01018420|Gout Suppressants|gout suppressants|mesh-ancestor
25600547|NCT01018420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25600548|NCT01018420|Tubulin Modulators|tubulin modulators|mesh-ancestor
25600549|NCT01018420|Antimitotic Agents|antimitotic agents|mesh-ancestor
25600550|NCT01018420|Mitosis Modulators|mitosis modulators|mesh-ancestor
25600551|NCT01018511|Tamsulosin|tamsulosin|mesh-list
24631398|NCT01117376|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25600552|NCT01018511|Solifenacin Succinate|solifenacin succinate|mesh-list
25600553|NCT01018511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25600554|NCT01018511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25600555|NCT01018511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25600556|NCT01018511|Adrenergic Agents|adrenergic agents|mesh-ancestor
25600557|NCT01018511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25600558|NCT01018511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600559|NCT01018511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632389|NCT01123538|Hormones|hormones|mesh-ancestor
24811277|NCT02046044|Digoxin|digoxin|mesh-list
25600560|NCT01018511|Urological Agents|urological agents|mesh-ancestor
25600561|NCT01018511|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25600562|NCT01018511|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25600563|NCT01018511|Cholinergic Agents|cholinergic agents|mesh-ancestor
25600564|NCT01018680|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25600565|NCT01018680|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25600566|NCT01018680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25600567|NCT01018680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25600568|NCT01018680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600569|NCT01018680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25600570|NCT01018680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600571|NCT01018680|Analgesics|analgesics|mesh-ancestor
25600572|NCT01018680|Sensory System Agents|sensory system agents|mesh-ancestor
25600573|NCT01018680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25600574|NCT01018680|Antidepressive Agents|antidepressive agents|mesh-ancestor
25600575|NCT01018680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25600576|NCT01018680|Dopamine Agents|dopamine agents|mesh-ancestor
25600577|NCT01018732|Lactitol|lactitol|mesh-list
25600578|NCT01018732|Cathartics|cathartics|mesh-ancestor
25600579|NCT01018732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25600580|NCT01018862|Azelastine|azelastine|mesh-list
25600581|NCT01018862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25600582|NCT01018862|Autonomic Agents|autonomic agents|mesh-ancestor
25600583|NCT01018862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25600584|NCT01018862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600585|NCT01018862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25600586|NCT01018862|Respiratory System Agents|respiratory system agents|mesh-ancestor
25600587|NCT01018862|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25600588|NCT01018862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395862|NCT00137033|Gout Suppressants|gout suppressants|mesh-ancestor
25600589|NCT01018862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600590|NCT01018862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25600591|NCT01018862|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25600592|NCT01018862|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25600593|NCT01018862|Histamine Antagonists|histamine antagonists|mesh-ancestor
25600594|NCT01018862|Histamine Agents|histamine agents|mesh-ancestor
25600595|NCT01018862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25653819|NCT01543074|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25653820|NCT01543074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25653821|NCT01543074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25653822|NCT01543074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653823|NCT01543152|Cyclophosphamide|cyclophosphamide|mesh-list
25653824|NCT01543152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25653825|NCT01543152|Immunologic Factors|immunologic factors|mesh-ancestor
25653826|NCT01543152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653827|NCT01543152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25653828|NCT01543152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25653829|NCT01543152|Alkylating Agents|alkylating agents|mesh-ancestor
25653830|NCT01543152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653831|NCT01543152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25653832|NCT01543152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25653834|NCT01543178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25653835|NCT01543178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25653836|NCT01543178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25653837|NCT01543204|Etanercept|etanercept|mesh-list
25653838|NCT01543204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25653839|NCT01543204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25653840|NCT01543204|Analgesics|analgesics|mesh-ancestor
25653841|NCT01543204|Sensory System Agents|sensory system agents|mesh-ancestor
25653842|NCT01543204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653843|NCT01543204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653844|NCT01543204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25707624|NCT02234427|Aspirin|aspirin|mesh-list
24397421|NCT00141544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397423|NCT00141544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25653845|NCT01543204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25653846|NCT01543204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25653847|NCT01543204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25653848|NCT01543204|Immunologic Factors|immunologic factors|mesh-ancestor
25653849|NCT01543568|Aflibercept|aflibercept|mesh-list
25653850|NCT01543568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25653851|NCT01543568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25653852|NCT01543568|Growth Substances|growth substances|mesh-ancestor
25653853|NCT01543568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653854|NCT01543568|Growth Inhibitors|growth inhibitors|mesh-ancestor
25653855|NCT01543568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25653856|NCT01543685|Celecoxib|celecoxib|mesh-list
25653857|NCT01543685|Indomethacin|indomethacin|mesh-list
25653858|NCT01543685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25653859|NCT01543685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25653860|NCT01543685|Analgesics|analgesics|mesh-ancestor
25653861|NCT01543685|Sensory System Agents|sensory system agents|mesh-ancestor
25653862|NCT01543685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653863|NCT01543685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653864|NCT01543685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25653865|NCT01543685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25653866|NCT01543685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25653867|NCT01543685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25653868|NCT01543685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653869|NCT01543685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653870|NCT01543685|Gout Suppressants|gout suppressants|mesh-ancestor
25653871|NCT01543685|Tocolytic Agents|tocolytic agents|mesh-ancestor
25653872|NCT01543685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25653873|NCT01543776|Abiraterone Acetate|abiraterone acetate|mesh-list
25653874|NCT01543776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25653875|NCT01543776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25653876|NCT01543776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653877|NCT01543776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653878|NCT01543776|Hormone Antagonists|hormone antagonists|mesh-ancestor
25653879|NCT01543776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25653880|NCT01543776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653881|NCT01543776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25653882|NCT01543958|Sevelamer|sevelamer|mesh-list
25653883|NCT01543958|Chelating Agents|chelating agents|mesh-ancestor
25600596|NCT01019317|Vidarabine|vidarabine|mesh-list
25600597|NCT01019317|Cytarabine|cytarabine|mesh-list
25600598|NCT01019317|Fludarabine|fludarabine|mesh-list
25600599|NCT01019317|Fludarabine phosphate|fludarabine phosphate|mesh-list
25600600|NCT01019317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600601|NCT01019317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24400872|NCT00151528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24399280|NCT00147355|Sensory System Agents|sensory system agents|mesh-ancestor
25600602|NCT01019317|Antimetabolites|antimetabolites|mesh-ancestor
25600603|NCT01019317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600604|NCT01019317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25600605|NCT01019317|Immunologic Factors|immunologic factors|mesh-ancestor
25600606|NCT01019317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600607|NCT01019317|Antiviral Agents|antiviral agents|mesh-ancestor
25600608|NCT01019317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25600609|NCT01019369|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25600610|NCT01019369|Medroxyprogesterone|medroxyprogesterone|mesh-list
25600611|NCT01019369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25600612|NCT01019369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25600613|NCT01019369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25600614|NCT01019369|Contraceptive Agents|contraceptive agents|mesh-ancestor
25600615|NCT01019369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25600616|NCT01019369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600617|NCT01019369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25600618|NCT01019369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25600619|NCT01019369|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25600620|NCT01019369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25600621|NCT01019369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600622|NCT01019486|Regadenoson|regadenoson|mesh-list
25600623|NCT01019486|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
25600624|NCT01019486|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25600625|NCT01019486|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25600626|NCT01019486|Purinergic Agonists|purinergic agonists|mesh-ancestor
25600627|NCT01019486|Purinergic Agents|purinergic agents|mesh-ancestor
25600628|NCT01019486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25600629|NCT01019486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600630|NCT01019486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600631|NCT01019486|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25600632|NCT01019694|Albuterol|albuterol|mesh-list
25600633|NCT01019694|Ipratropium|ipratropium|mesh-list
25600634|NCT01019694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25600635|NCT01019694|Autonomic Agents|autonomic agents|mesh-ancestor
25600636|NCT01019694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25600637|NCT01019694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400936|NCT00151697|Insulin Aspart|insulin aspart|mesh-list
25600638|NCT01019694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25600639|NCT01019694|Respiratory System Agents|respiratory system agents|mesh-ancestor
25600640|NCT01019694|Tocolytic Agents|tocolytic agents|mesh-ancestor
25600641|NCT01019694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25600642|NCT01019694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25600643|NCT01019694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25600644|NCT01019694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25600645|NCT01019694|Adrenergic Agents|adrenergic agents|mesh-ancestor
25600646|NCT01019694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25600647|NCT01019694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600648|NCT01019694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25600649|NCT01019694|Cholinergic Agents|cholinergic agents|mesh-ancestor
25600650|NCT01019707|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25600651|NCT01019707|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25600652|NCT01019707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25600653|NCT01019707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25600654|NCT01019707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600655|NCT01019707|Adrenergic Agents|adrenergic agents|mesh-ancestor
25600656|NCT01019707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25600657|NCT01019707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600658|NCT01020006|Gemcitabine|gemcitabine|mesh-list
25600659|NCT01020006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25600660|NCT01020006|Antimetabolites|antimetabolites|mesh-ancestor
25600661|NCT01020006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600662|NCT01020006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600663|NCT01020006|Antiviral Agents|antiviral agents|mesh-ancestor
25600664|NCT01020006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25600665|NCT01020006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25600666|NCT01020006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25495125|NCT00280150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600667|NCT01020006|Immunologic Factors|immunologic factors|mesh-ancestor
25600668|NCT01020006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600669|NCT01020019|Lofexidine|lofexidine|mesh-list
25600670|NCT01020019|Dronabinol|dronabinol|mesh-list
25600671|NCT01020019|Hallucinogens|hallucinogens|mesh-ancestor
25600672|NCT01020019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600673|NCT01020019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25600674|NCT01020019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25600675|NCT01020019|Analgesics|analgesics|mesh-ancestor
25600676|NCT01020019|Sensory System Agents|sensory system agents|mesh-ancestor
25600677|NCT01020019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25600678|NCT01020019|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25600679|NCT01020019|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25600680|NCT01020019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25600681|NCT01020019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600682|NCT01020019|Hormones|hormones|mesh-ancestor
25600683|NCT01020019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25600684|NCT01020019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25600685|NCT01020019|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25600686|NCT01020019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25600687|NCT01020019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25600688|NCT01020019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25600689|NCT01020019|Adrenergic Agents|adrenergic agents|mesh-ancestor
25600690|NCT01020123|Glipizide|glipizide|mesh-list
25600691|NCT01020123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25600692|NCT01020123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600693|NCT01020305|Sirolimus|sirolimus|mesh-list
25600694|NCT01020305|Bicalutamide|bicalutamide|mesh-list
25600695|NCT01020305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25600696|NCT01020305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25600697|NCT01020305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25600698|NCT01020305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600699|NCT01020305|Antifungal Agents|antifungal agents|mesh-ancestor
25600700|NCT01020305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25600701|NCT01020305|Immunologic Factors|immunologic factors|mesh-ancestor
25600702|NCT01020305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600703|NCT01020305|Androgen Antagonists|androgen antagonists|mesh-ancestor
25600704|NCT01020305|Hormone Antagonists|hormone antagonists|mesh-ancestor
25600705|NCT01020305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25600706|NCT01020448|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25600707|NCT01020448|Luteolytic Agents|luteolytic agents|mesh-ancestor
25600708|NCT01020448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25600709|NCT01020448|Contraceptive Agents|contraceptive agents|mesh-ancestor
25600710|NCT01020448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25600711|NCT01020448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600712|NCT01020448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25600713|NCT01020448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25600714|NCT01020448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600715|NCT01020474|Pregabalin|pregabalin|mesh-list
25600716|NCT01020474|Analgesics|analgesics|mesh-ancestor
25600717|NCT01020474|Sensory System Agents|sensory system agents|mesh-ancestor
25600718|NCT01020474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25600719|NCT01020474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600720|NCT01020474|Anticonvulsants|anticonvulsants|mesh-ancestor
24401727|NCT00153881|Antimetabolites|antimetabolites|mesh-ancestor
25600721|NCT01020474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25600722|NCT01020474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25600723|NCT01020474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600724|NCT01020474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25600725|NCT01020474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25600726|NCT01020474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25600727|NCT01020474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25600728|NCT01020474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25600729|NCT01020526|Pregabalin|pregabalin|mesh-list
25600730|NCT01020526|Analgesics|analgesics|mesh-ancestor
25600731|NCT01020526|Sensory System Agents|sensory system agents|mesh-ancestor
25600732|NCT01020526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25600733|NCT01020526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600734|NCT01020526|Anticonvulsants|anticonvulsants|mesh-ancestor
25600735|NCT01020526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25600736|NCT01020526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25600737|NCT01020526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600738|NCT01020526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25600739|NCT01020526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25495187|NCT00280566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25600740|NCT01020526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25600741|NCT01020526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25600742|NCT01020526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25600743|NCT01020747|Bevacizumab|bevacizumab|mesh-list
25600744|NCT01020747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25600745|NCT01020747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600746|NCT01020747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25600747|NCT01020747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25600748|NCT01020747|Growth Substances|growth substances|mesh-ancestor
25600749|NCT01020747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600750|NCT01020747|Growth Inhibitors|growth inhibitors|mesh-ancestor
25600751|NCT01020786|Carboplatin|carboplatin|mesh-list
25600752|NCT01020786|Pemetrexed|pemetrexed|mesh-list
25600753|NCT01020786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600754|NCT01020786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25600755|NCT01020786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600756|NCT01020786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25600757|NCT01020786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25600758|NCT01020799|Citalopram|citalopram|mesh-list
25600759|NCT01020799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25600760|NCT01020799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25600761|NCT01020799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25600762|NCT01020799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600763|NCT01020799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25600764|NCT01020799|Serotonin Agents|serotonin agents|mesh-ancestor
25600765|NCT01020799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600766|NCT01020799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25600767|NCT01020799|Antidepressive Agents|antidepressive agents|mesh-ancestor
25600768|NCT01020799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25600769|NCT01020877|Metronidazole|metronidazole|mesh-list
25600770|NCT01020877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25600771|NCT01020877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25600772|NCT01020877|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25600773|NCT01020877|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25600774|NCT01021020|Colchicine|colchicine|mesh-list
25600775|NCT01021020|Probenecid|probenecid|mesh-list
25600776|NCT01021020|Gout Suppressants|gout suppressants|mesh-ancestor
25600777|NCT01021020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25600778|NCT01021020|Tubulin Modulators|tubulin modulators|mesh-ancestor
25600779|NCT01021020|Antimitotic Agents|antimitotic agents|mesh-ancestor
25600780|NCT01021020|Mitosis Modulators|mitosis modulators|mesh-ancestor
25600781|NCT01021020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600782|NCT01021020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600783|NCT01021020|Uricosuric Agents|uricosuric agents|mesh-ancestor
25600784|NCT01021020|Renal Agents|renal agents|mesh-ancestor
25600785|NCT01021215|Celecoxib|celecoxib|mesh-list
25600786|NCT01021215|Zileuton|zileuton|mesh-list
25600787|NCT01021215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25600788|NCT01021215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25600789|NCT01021215|Analgesics|analgesics|mesh-ancestor
25600790|NCT01021215|Sensory System Agents|sensory system agents|mesh-ancestor
25600791|NCT01021215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25600792|NCT01021215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600793|NCT01021215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25600794|NCT01021215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25600795|NCT01021215|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25600796|NCT01021215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25600797|NCT01021215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25600798|NCT01021215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600799|NCT01021215|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25600800|NCT01021215|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25600801|NCT01021215|Hormone Antagonists|hormone antagonists|mesh-ancestor
25600802|NCT01021215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25600803|NCT05395962|Carboplatin|carboplatin|mesh-list
25600804|NCT05395962|Bleomycin|bleomycin|mesh-list
25600805|NCT05395962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600806|NCT05395962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25600807|NCT05395702|Interferons|interferons|mesh-list
25600808|NCT05395702|Interferon-gamma|interferon-gamma|mesh-list
25600809|NCT05395702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600810|NCT05395702|Antiviral Agents|antiviral agents|mesh-ancestor
25600811|NCT05395702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25600812|NCT05395533|Antibodies|antibodies|mesh-list
25600813|NCT05395533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25600814|NCT05395533|Immunologic Factors|immunologic factors|mesh-ancestor
25600815|NCT05395533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600816|NCT05395299|Ethylene|ethylene|mesh-list
25600817|NCT05395299|Plant Growth Regulators|plant growth regulators|mesh-ancestor
25600818|NCT05395299|Growth Substances|growth substances|mesh-ancestor
25600819|NCT05395299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600820|NCT05395143|Zinc Sulfate|zinc sulfate|mesh-list
25600821|NCT05395143|Astringents|astringents|mesh-ancestor
25600822|NCT05395143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600823|NCT05395143|Dermatologic Agents|dermatologic agents|mesh-ancestor
25600824|NCT05394909|Methylprednisolone|methylprednisolone|mesh-list
25600825|NCT05394909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25600826|NCT05394909|Antiemetics|antiemetics|mesh-ancestor
25600827|NCT05394909|Autonomic Agents|autonomic agents|mesh-ancestor
25600828|NCT05394909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25600829|NCT05394909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600830|NCT05394909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25600831|NCT05394909|Glucocorticoids|glucocorticoids|mesh-ancestor
25600832|NCT05394909|Hormones|hormones|mesh-ancestor
25600833|NCT05394909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25600834|NCT05394909|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25600835|NCT05394909|Protective Agents|protective agents|mesh-ancestor
25600836|NCT05394740|Leucovorin|leucovorin|mesh-list
25600837|NCT05394740|Fluorouracil|fluorouracil|mesh-list
25600838|NCT05394740|Capecitabine|capecitabine|mesh-list
25600839|NCT05394740|Oxaliplatin|oxaliplatin|mesh-list
25600840|NCT05394740|Nivolumab|nivolumab|mesh-list
25600841|NCT05394740|Antimetabolites|antimetabolites|mesh-ancestor
25600842|NCT05394740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600843|NCT05394740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25600844|NCT05394740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600845|NCT05394740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25600846|NCT05394740|Immunologic Factors|immunologic factors|mesh-ancestor
25600847|NCT05394740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600848|NCT05394740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25600849|NCT05394740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25600850|NCT05394740|Antidotes|antidotes|mesh-ancestor
25600851|NCT05394740|Protective Agents|protective agents|mesh-ancestor
25600852|NCT05394740|Vitamin B Complex|vitamin b complex|mesh-ancestor
25600853|NCT05394740|Vitamins|vitamins|mesh-ancestor
25600854|NCT05394740|Micronutrients|micronutrients|mesh-ancestor
25600855|NCT05394727|Insulin|insulin|mesh-list
25600856|NCT05394727|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25600857|NCT05394727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25600858|NCT05394727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600859|NCT05394493|Avelumab|avelumab|mesh-list
25600860|NCT05394493|Axitinib|axitinib|mesh-list
25600861|NCT05394493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25600862|NCT05394493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600863|NCT05394493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25600864|NCT05394493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25600865|NCT05394493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600866|NCT05394480|Hydrocortisone|hydrocortisone|mesh-list
25600867|NCT05394480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25600868|NCT05394415|Paclitaxel|paclitaxel|mesh-list
25600869|NCT05394415|Carboplatin|carboplatin|mesh-list
25600870|NCT05394415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25600871|NCT05394415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600872|NCT05394415|Tubulin Modulators|tubulin modulators|mesh-ancestor
25600873|NCT05394415|Antimitotic Agents|antimitotic agents|mesh-ancestor
25600874|NCT05394415|Mitosis Modulators|mitosis modulators|mesh-ancestor
25600875|NCT05394415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600876|NCT05394233|Bevacizumab|bevacizumab|mesh-list
25600877|NCT05394233|Pemetrexed|pemetrexed|mesh-list
25600878|NCT05394233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25600879|NCT05394233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600880|NCT05394233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25600881|NCT05394233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25600882|NCT05394233|Growth Substances|growth substances|mesh-ancestor
25600883|NCT05394233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600884|NCT05394233|Growth Inhibitors|growth inhibitors|mesh-ancestor
25600885|NCT05394233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25600886|NCT05394233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402875|NCT00158652|Carboplatin|carboplatin|mesh-list
25600887|NCT05394233|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25600888|NCT05394233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25653884|NCT01543958|Sequestering Agents|sequestering agents|mesh-ancestor
25653885|NCT01543958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653886|NCT01544062|Acetaminophen|acetaminophen|mesh-list
25653887|NCT01544062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25600890|NCT05388500|Trastuzumab|trastuzumab|mesh-list
25600891|NCT05388500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25600892|NCT05388500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600893|NCT05388500|Tubulin Modulators|tubulin modulators|mesh-ancestor
25600894|NCT05388500|Antimitotic Agents|antimitotic agents|mesh-ancestor
25600895|NCT05388500|Mitosis Modulators|mitosis modulators|mesh-ancestor
25600896|NCT05388500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600897|NCT05388500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25600898|NCT05388487|Complement Factor H|complement factor h|mesh-list
25600899|NCT05388487|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25600900|NCT05388487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25600901|NCT05388487|Immunologic Factors|immunologic factors|mesh-ancestor
25600902|NCT05388487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403336|NCT00159809|Vasodilator Agents|vasodilator agents|mesh-ancestor
24403342|NCT00159835|Simvastatin|simvastatin|mesh-list
24403343|NCT00159835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24403344|NCT00159835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24403345|NCT00159835|Antimetabolites|antimetabolites|mesh-ancestor
24403347|NCT00159835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25600903|NCT05386953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25600904|NCT05386888|Paclitaxel|paclitaxel|mesh-list
25600905|NCT05386888|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25600906|NCT05386888|Cisplatin|cisplatin|mesh-list
25600907|NCT05386888|Carboplatin|carboplatin|mesh-list
25600908|NCT05386888|Pemetrexed|pemetrexed|mesh-list
25600909|NCT05386888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25600910|NCT05386888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600911|NCT05386888|Tubulin Modulators|tubulin modulators|mesh-ancestor
25600912|NCT05386888|Antimitotic Agents|antimitotic agents|mesh-ancestor
25600913|NCT05386888|Mitosis Modulators|mitosis modulators|mesh-ancestor
25600914|NCT05386888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600915|NCT05386888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25600916|NCT05386888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25600917|NCT05386888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25600918|NCT05386459|Interferons|interferons|mesh-list
25600919|NCT05386459|Interferon-gamma|interferon-gamma|mesh-list
25600920|NCT05386459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600921|NCT05386459|Antiviral Agents|antiviral agents|mesh-ancestor
25600922|NCT05386459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25600923|NCT05349838|Dolutegravir|dolutegravir|mesh-list
25600924|NCT05349838|Rilpivirine|rilpivirine|mesh-list
25600925|NCT05349838|Protease Inhibitors|protease inhibitors|mesh-list
25600926|NCT05349838|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25600927|NCT05349838|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25600928|NCT05349838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25600929|NCT05349838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600930|NCT05349838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25600931|NCT05349838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25600932|NCT05349838|Antiviral Agents|antiviral agents|mesh-ancestor
25600933|NCT05349838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25600934|NCT05349838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25600935|NCT05349838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25600936|NCT05250895|Misonidazole|misonidazole|mesh-list
25600937|NCT05250895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600938|NCT05250895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25600939|NCT05250895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25600940|NCT05250895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25600941|NCT05234099|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25600942|NCT05234099|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25600943|NCT05234099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600944|NCT05206500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25600945|NCT05206500|Amoxicillin|amoxicillin|mesh-list
25600946|NCT05206500|Metronidazole|metronidazole|mesh-list
25600947|NCT05206500|Clindamycin|clindamycin|mesh-list
25600948|NCT05206500|Linezolid|linezolid|mesh-list
25600949|NCT05206500|Tetracycline|tetracycline|mesh-list
25600950|NCT05206500|Penicillins|penicillins|mesh-list
25600951|NCT05206500|Ampicillin|ampicillin|mesh-list
25600952|NCT05206500|Fosfomycin|fosfomycin|mesh-list
25600953|NCT05206500|Nitrofurantoin|nitrofurantoin|mesh-list
25600954|NCT05206500|Cephalosporins|cephalosporins|mesh-list
25600955|NCT05206500|Fluoroquinolones|fluoroquinolones|mesh-list
25600956|NCT05206500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25600957|NCT05206500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25600958|NCT05206500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25600959|NCT05206500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25600960|NCT05206500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25600961|NCT05206500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600962|NCT05206500|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25600963|NCT05206500|Renal Agents|renal agents|mesh-ancestor
25600964|NCT05206500|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25600965|NCT05199909|Zanubrutinib|zanubrutinib|mesh-list
25600966|NCT05199909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600967|NCT05199909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25600968|NCT05199909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25600969|NCT05199909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600970|NCT05197426|Azacitidine|azacitidine|mesh-list
25600971|NCT05197426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25600972|NCT05197426|Antimetabolites|antimetabolites|mesh-ancestor
25600973|NCT05197426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600974|NCT05197426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600975|NCT05197426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25600976|NCT05161208|Varenicline|varenicline|mesh-list
25600977|NCT05161208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25600978|NCT05161208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25600979|NCT05161208|Cholinergic Agents|cholinergic agents|mesh-ancestor
25600980|NCT05161208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25600981|NCT05161208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600982|NCT05161208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653888|NCT01544062|Analgesics|analgesics|mesh-ancestor
25653889|NCT01544062|Sensory System Agents|sensory system agents|mesh-ancestor
25653890|NCT01544062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653891|NCT01544062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653892|NCT01544062|Antipyretics|antipyretics|mesh-ancestor
25653893|NCT01544114|Naproxen|naproxen|mesh-list
25653894|NCT01544114|Esomeprazole|esomeprazole|mesh-list
25653895|NCT01544114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25653896|NCT01544114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25653897|NCT01544114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25653898|NCT01544114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653899|NCT01544114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653900|NCT01544114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25653901|NCT01544114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25653902|NCT01544114|Analgesics|analgesics|mesh-ancestor
25653903|NCT01544114|Sensory System Agents|sensory system agents|mesh-ancestor
25653904|NCT01544114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653905|NCT01544114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653906|NCT01544114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25653907|NCT01544114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25653908|NCT01544114|Gout Suppressants|gout suppressants|mesh-ancestor
25653909|NCT01544114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25653910|NCT01544153|Nicotine|nicotine|mesh-list
25653911|NCT01544153|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25653912|NCT01544153|Autonomic Agents|autonomic agents|mesh-ancestor
25653913|NCT01544153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653914|NCT01544153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653915|NCT01544153|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25653916|NCT01544153|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25653917|NCT01544153|Cholinergic Agents|cholinergic agents|mesh-ancestor
25653918|NCT01544153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25653919|NCT01544153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653920|NCT01544179|Cisplatin|cisplatin|mesh-list
25653921|NCT01544179|Pemetrexed|pemetrexed|mesh-list
25653922|NCT01544179|Gefitinib|gefitinib|mesh-list
25653923|NCT01544179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25653924|NCT01544179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653925|NCT01544179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653926|NCT01544179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25653927|NCT01544179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25653928|NCT01544179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25653929|NCT01544309|Atorvastatin|atorvastatin|mesh-list
25653930|NCT01544309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25653931|NCT01544309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25653932|NCT01544309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25653933|NCT01544309|Antimetabolites|antimetabolites|mesh-ancestor
25653934|NCT01544309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653935|NCT01544309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25653936|NCT01544309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25653937|NCT01544309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653938|NCT01544348|Omalizumab|omalizumab|mesh-list
25653939|NCT01544348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25653940|NCT01544348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25653941|NCT01544348|Respiratory System Agents|respiratory system agents|mesh-ancestor
25653942|NCT01544491|Everolimus|everolimus|mesh-list
25653943|NCT01544491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25653944|NCT01544491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25653945|NCT01544491|Immunologic Factors|immunologic factors|mesh-ancestor
25653946|NCT01544491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600984|NCT05086224|Anesthetics, Local|anesthetics, local|mesh-list
25600985|NCT05086224|Anesthetics|anesthetics|mesh-list
25600986|NCT05086224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25600987|NCT05086224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25600988|NCT05086224|Sensory System Agents|sensory system agents|mesh-ancestor
25600989|NCT05086224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25600990|NCT05086224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25600991|NCT05086224|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25600992|NCT05086224|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24404330|NCT00163137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404331|NCT00163137|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24404332|NCT00163137|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24811550|NCT02047162|Bismuth|bismuth|mesh-list
25600993|NCT05086224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25600994|NCT05086224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25600995|NCT05022394|Nivolumab|nivolumab|mesh-list
25600996|NCT05022394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25600997|NCT05022394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25600998|NCT05022394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25600999|NCT05022394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601000|NCT05017584|Bupivacaine|bupivacaine|mesh-list
25601001|NCT05017584|Anesthetics, Local|anesthetics, local|mesh-ancestor
25601002|NCT05017584|Anesthetics|anesthetics|mesh-ancestor
25601003|NCT05017584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25601004|NCT05017584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601005|NCT05017584|Sensory System Agents|sensory system agents|mesh-ancestor
25601006|NCT05017584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25601007|NCT04999332|Leucovorin|leucovorin|mesh-list
25601008|NCT04999332|Docetaxel|docetaxel|mesh-list
25601009|NCT04999332|Oxaliplatin|oxaliplatin|mesh-list
25601010|NCT04999332|Levoleucovorin|levoleucovorin|mesh-list
24404446|NCT00163449|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25601011|NCT04999332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601012|NCT04999332|Tubulin Modulators|tubulin modulators|mesh-ancestor
25601013|NCT04999332|Antimitotic Agents|antimitotic agents|mesh-ancestor
25601014|NCT04999332|Mitosis Modulators|mitosis modulators|mesh-ancestor
25601015|NCT04999332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601016|NCT04999332|Antidotes|antidotes|mesh-ancestor
25601017|NCT04999332|Protective Agents|protective agents|mesh-ancestor
25601018|NCT04999332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601019|NCT04999332|Vitamin B Complex|vitamin b complex|mesh-ancestor
25601020|NCT04999332|Vitamins|vitamins|mesh-ancestor
25601021|NCT04999332|Micronutrients|micronutrients|mesh-ancestor
25601022|NCT04998617|Curcumin|curcumin|mesh-list
25601023|NCT04998617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25601024|NCT04998617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25601025|NCT04998617|Analgesics|analgesics|mesh-ancestor
25601026|NCT04998617|Sensory System Agents|sensory system agents|mesh-ancestor
25601027|NCT04998617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25601028|NCT04998617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601029|NCT04998617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25601030|NCT04998617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25601031|NCT04998617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601032|NCT04998617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25601033|NCT04998617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601034|NCT04973345|Terbutaline|terbutaline|mesh-list
25601035|NCT04973345|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25601036|NCT04973345|Autonomic Agents|autonomic agents|mesh-ancestor
25601037|NCT04973345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25601038|NCT04973345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601039|NCT04973345|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25601040|NCT04973345|Respiratory System Agents|respiratory system agents|mesh-ancestor
25601041|NCT04973345|Sympathomimetics|sympathomimetics|mesh-ancestor
25601042|NCT04973345|Tocolytic Agents|tocolytic agents|mesh-ancestor
25601043|NCT04973345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25601044|NCT04973345|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25601045|NCT04973345|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25601046|NCT04973345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25601047|NCT04973345|Adrenergic Agents|adrenergic agents|mesh-ancestor
25601048|NCT04973345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25601049|NCT04973345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601050|NCT04794790|Buprenorphine|buprenorphine|mesh-list
25601051|NCT04794790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25601052|NCT04794790|Naloxone|naloxone|mesh-list
25495533|NCT00283062|Fertility Agents|fertility agents|mesh-ancestor
25495534|NCT00283062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25495535|NCT00283062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495536|NCT00283062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25601053|NCT04794790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25601054|NCT04794790|Narcotics|narcotics|mesh-ancestor
25601055|NCT04794790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25601056|NCT04794790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601057|NCT04794790|Analgesics|analgesics|mesh-ancestor
25601058|NCT04794790|Sensory System Agents|sensory system agents|mesh-ancestor
25601059|NCT04794790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25601060|NCT04794790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25601061|NCT04708054|Fludarabine|fludarabine|mesh-list
25601062|NCT04708054|Fludarabine phosphate|fludarabine phosphate|mesh-list
25601063|NCT04708054|Busulfan|busulfan|mesh-list
25601064|NCT04708054|Venetoclax|venetoclax|mesh-list
25601065|NCT04708054|Thiotepa|thiotepa|mesh-list
25601066|NCT04708054|Cladribine|cladribine|mesh-list
25601067|NCT04708054|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
25601068|NCT04708054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601069|NCT04708054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25601070|NCT04708054|Antimetabolites|antimetabolites|mesh-ancestor
25601071|NCT04708054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601072|NCT04708054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25601073|NCT04708054|Immunologic Factors|immunologic factors|mesh-ancestor
25601074|NCT04708054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601075|NCT04708054|Alkylating Agents|alkylating agents|mesh-ancestor
25601076|NCT04708054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25601077|NCT04708054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25601078|NCT04697329|Levobupivacaine|levobupivacaine|mesh-list
25601079|NCT04697329|Anesthetics, Local|anesthetics, local|mesh-ancestor
25601080|NCT04697329|Anesthetics|anesthetics|mesh-ancestor
25601081|NCT04697329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25601082|NCT04697329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601083|NCT04697329|Sensory System Agents|sensory system agents|mesh-ancestor
25601084|NCT04697329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25601085|NCT04662073|Camostat|camostat|mesh-list
25601086|NCT04662073|Protease Inhibitors|protease inhibitors|mesh-ancestor
25601087|NCT04662073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25601088|NCT04662073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601089|NCT04662073|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25601090|NCT04662073|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25601091|NCT04639245|Cyclophosphamide|cyclophosphamide|mesh-list
25601092|NCT04639245|Fludarabine|fludarabine|mesh-list
25601093|NCT04639245|Atezolizumab|atezolizumab|mesh-list
25601094|NCT04639245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25601095|NCT04639245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25601096|NCT04639245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25601097|NCT04639245|Immunologic Factors|immunologic factors|mesh-ancestor
25601098|NCT04639245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601099|NCT04639245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25601100|NCT04639245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25601101|NCT04639245|Alkylating Agents|alkylating agents|mesh-ancestor
25601102|NCT04639245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601103|NCT04639245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601104|NCT04639245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25601105|NCT04493138|Azacitidine|azacitidine|mesh-list
25601106|NCT04493138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25601107|NCT04493138|Antimetabolites|antimetabolites|mesh-ancestor
25601108|NCT04493138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601109|NCT04493138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601110|NCT04493138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25601111|NCT04468360|Pregnanolone|pregnanolone|mesh-list
25601112|NCT04468360|Brexanolone|brexanolone|mesh-list
25601113|NCT04468360|Anesthetics|anesthetics|mesh-ancestor
25601114|NCT04468360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25601115|NCT04468360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601116|NCT04468360|Neurosteroids|neurosteroids|mesh-ancestor
25601117|NCT04468360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25601118|NCT04468360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601119|NCT04468360|GABA Modulators|gaba modulators|mesh-ancestor
25601120|NCT04468360|GABA Agents|gaba agents|mesh-ancestor
25601121|NCT04444843|Mycophenolic Acid|mycophenolic acid|mesh-list
25601122|NCT04444843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25601123|NCT04444843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601124|NCT04444843|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25601125|NCT04444843|Antitubercular Agents|antitubercular agents|mesh-ancestor
25495596|NCT00283803|Sensory System Agents|sensory system agents|mesh-ancestor
25601126|NCT04444843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25601127|NCT04444843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25601128|NCT04444843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25601129|NCT04444843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601130|NCT04434040|Atezolizumab|atezolizumab|mesh-list
25601131|NCT04434040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601132|NCT04416269|Insulin|insulin|mesh-list
25601133|NCT04416269|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25601134|NCT04416269|Metformin|metformin|mesh-list
25601135|NCT04416269|Pioglitazone|pioglitazone|mesh-list
25601136|NCT04416269|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25601137|NCT04416269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25601138|NCT04416269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601139|NCT04416269|Protease Inhibitors|protease inhibitors|mesh-ancestor
25601140|NCT04416269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404511|NCT00163748|Immunologic Factors|immunologic factors|mesh-ancestor
24404512|NCT00163748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404513|NCT00163748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24404514|NCT00163748|Tubulin Modulators|tubulin modulators|mesh-ancestor
24404515|NCT00163748|Antimitotic Agents|antimitotic agents|mesh-ancestor
24404516|NCT00163748|Mitosis Modulators|mitosis modulators|mesh-ancestor
24404517|NCT00163761|Gemcitabine|gemcitabine|mesh-list
24404518|NCT00163761|Vinorelbine|vinorelbine|mesh-list
24404519|NCT00163761|Ifosfamide|ifosfamide|mesh-list
24404520|NCT00163761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24404521|NCT00163761|Antimetabolites|antimetabolites|mesh-ancestor
24464191|NCT00363753|Clopidogrel|clopidogrel|mesh-list
24404554|NCT00163982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24404555|NCT00163982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25601141|NCT04416269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601142|NCT04409600|Botulinum Toxins|botulinum toxins|mesh-list
25601143|NCT04409600|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25601144|NCT04409600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25601145|NCT04409600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601146|NCT04409600|Cholinergic Agents|cholinergic agents|mesh-ancestor
25601147|NCT04409600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25601148|NCT04409600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601149|NCT04374903|Sirolimus|sirolimus|mesh-list
25601150|NCT04374903|Azithromycin|azithromycin|mesh-list
25601151|NCT04374903|Hydroxychloroquine|hydroxychloroquine|mesh-list
25601152|NCT04374903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25601153|NCT04374903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25601154|NCT04374903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25601155|NCT04374903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601156|NCT04374903|Antifungal Agents|antifungal agents|mesh-ancestor
25601157|NCT04374903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25601158|NCT04374903|Immunologic Factors|immunologic factors|mesh-ancestor
25601159|NCT04374903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601160|NCT04374903|Antimalarials|antimalarials|mesh-ancestor
25601161|NCT04374903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25601162|NCT04374903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25601163|NCT04374903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25601164|NCT04374903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601165|NCT04374903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25601166|NCT04341883|Paclitaxel|paclitaxel|mesh-list
24404557|NCT00163982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601167|NCT04341883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25601168|NCT04341883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25601169|NCT04341883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601170|NCT04341883|Tubulin Modulators|tubulin modulators|mesh-ancestor
25601171|NCT04341883|Antimitotic Agents|antimitotic agents|mesh-ancestor
25601172|NCT04341883|Mitosis Modulators|mitosis modulators|mesh-ancestor
25601173|NCT04341883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601174|NCT04320342|Beclomethasone|beclomethasone|mesh-list
25601175|NCT04320342|Glycopyrrolate|glycopyrrolate|mesh-list
25601176|NCT04320342|Bromides|bromides|mesh-list
25601177|NCT04320342|Formoterol Fumarate|formoterol fumarate|mesh-list
25601178|NCT04320342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25601179|NCT04320342|Autonomic Agents|autonomic agents|mesh-ancestor
25601180|NCT04320342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25601181|NCT04320342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601182|NCT04320342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25601183|NCT04320342|Respiratory System Agents|respiratory system agents|mesh-ancestor
25601184|NCT04320342|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25601185|NCT04320342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24443933|NCT00296218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24404658|NCT00164359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24404659|NCT00164359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601186|NCT04320342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25601187|NCT04320342|Adrenergic Agents|adrenergic agents|mesh-ancestor
25601188|NCT04320342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25601189|NCT04320342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601190|NCT04320342|Anticonvulsants|anticonvulsants|mesh-ancestor
25601191|NCT04320342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25601192|NCT04320342|Glucocorticoids|glucocorticoids|mesh-ancestor
25601193|NCT04320342|Hormones|hormones|mesh-ancestor
25601194|NCT04320342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25601195|NCT04320342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25601196|NCT04320342|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25601197|NCT04320342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25601198|NCT04320342|Cholinergic Agents|cholinergic agents|mesh-ancestor
25601199|NCT04263610|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25601200|NCT04263610|Dermatologic Agents|dermatologic agents|mesh-ancestor
24404831|NCT00164996|Anesthetics|anesthetics|mesh-list
25601201|NCT04263610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25601202|NCT04263610|Immunologic Factors|immunologic factors|mesh-ancestor
25495727|NCT00285857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25495728|NCT00285857|Antimetabolites|antimetabolites|mesh-ancestor
25495729|NCT00285857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495730|NCT00285857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25495731|NCT00285857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25495732|NCT00285857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24405007|NCT00165295|Vasodilator Agents|vasodilator agents|mesh-ancestor
24405011|NCT00165295|Urological Agents|urological agents|mesh-ancestor
24405013|NCT00165308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24445655|NCT00301951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24540493|NCT00668122|Ciprofloxacin|ciprofloxacin|mesh-list
24540494|NCT00668122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24540495|NCT00668122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25495733|NCT00285857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25150423|NCT05258279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25150424|NCT05258279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25150425|NCT05258279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25150426|NCT05258279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150427|NCT05258279|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25150428|NCT05258279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25150429|NCT05258279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25150436|NCT05242081|Ketamine|ketamine|mesh-list
25150437|NCT05242081|Esketamine|esketamine|mesh-list
25150438|NCT05242081|Analgesics|analgesics|mesh-ancestor
24434904|NCT00264225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783896|NCT01904695|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24783897|NCT01904695|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
24783898|NCT01904695|Natriuretic Agents|natriuretic agents|mesh-ancestor
24540496|NCT00668122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24540497|NCT00668122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24540498|NCT00668122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405038|NCT00165360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405039|NCT00165360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405040|NCT00165373|Endostatins|endostatins|mesh-list
24811612|NCT02047422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24811613|NCT02047422|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24405043|NCT00165373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24405044|NCT00165373|Growth Substances|growth substances|mesh-ancestor
24405047|NCT00165399|Docetaxel|docetaxel|mesh-list
24405051|NCT00165399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405052|NCT00165399|Tubulin Modulators|tubulin modulators|mesh-ancestor
24405053|NCT00165399|Antimitotic Agents|antimitotic agents|mesh-ancestor
24405054|NCT00165399|Mitosis Modulators|mitosis modulators|mesh-ancestor
24783899|NCT01904695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783900|NCT01904695|Protease Inhibitors|protease inhibitors|mesh-ancestor
24783901|NCT01904695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783902|NCT01904695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783903|NCT01904695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24783905|NCT01904734|Enclomiphene|enclomiphene|mesh-list
24783906|NCT01904734|Zuclomiphene|zuclomiphene|mesh-list
24783907|NCT01904734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24783908|NCT01904734|Hormone Antagonists|hormone antagonists|mesh-ancestor
24783909|NCT01904734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24783910|NCT01904734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783911|NCT01904734|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24783912|NCT01904734|Fertility Agents|fertility agents|mesh-ancestor
24783913|NCT01904734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24783914|NCT01904734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25106030|NCT04630938|Lidocaine|lidocaine|mesh-list
25106031|NCT04630938|Morphine|morphine|mesh-list
25106032|NCT04630938|Anesthetics, Local|anesthetics, local|mesh-ancestor
24405063|NCT00165451|Thalidomide|thalidomide|mesh-list
25124101|NCT03079388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106033|NCT04630938|Anesthetics|anesthetics|mesh-ancestor
25106034|NCT04630938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25106035|NCT04630938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106036|NCT04630938|Sensory System Agents|sensory system agents|mesh-ancestor
25106037|NCT04630938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24434973|NCT00264615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434974|NCT00264615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24434975|NCT00264615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434976|NCT00264615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24434977|NCT00264615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24434978|NCT00264615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24434979|NCT00264615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25601203|NCT04263610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601204|NCT04225390|Dacarbazine|dacarbazine|mesh-list
25601205|NCT04225390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25601206|NCT04225390|Alkylating Agents|alkylating agents|mesh-ancestor
24464630|NCT00365638|Simvastatin|simvastatin|mesh-list
24405139|NCT00165555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25601207|NCT04225390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601208|NCT04225390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601209|NCT04147416|Propofol|propofol|mesh-list
25601210|NCT04147416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25601211|NCT04147416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25601212|NCT04147416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601213|NCT04147416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25601214|NCT04147416|Anesthetics, General|anesthetics, general|mesh-ancestor
25601215|NCT04147416|Anesthetics|anesthetics|mesh-ancestor
25601216|NCT04143724|Luspatercept|luspatercept|mesh-list
25601217|NCT04143724|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
25601218|NCT04143724|Hematinics|hematinics|mesh-ancestor
25601219|NCT04143724|Immunologic Factors|immunologic factors|mesh-ancestor
25601220|NCT04143724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601221|NCT04101838|Vaccines|vaccines|mesh-list
25601222|NCT04101838|Immunologic Factors|immunologic factors|mesh-ancestor
25601223|NCT04101838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601224|NCT04098432|Nivolumab|nivolumab|mesh-list
25601225|NCT04098432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25601226|NCT04098432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601227|NCT04098432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25601228|NCT04098432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653947|NCT01544920|Interferons|interferons|mesh-list
25653948|NCT01544920|Ribavirin|ribavirin|mesh-list
25653949|NCT01544920|Interferon-alpha|interferon-alpha|mesh-list
25653950|NCT01544920|Interferon alpha-2|interferon alpha-2|mesh-list
25653951|NCT01544920|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25653952|NCT01544920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405273|NCT00166400|Adrenergic Agents|adrenergic agents|mesh-ancestor
24405308|NCT00166465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405309|NCT00166465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24405310|NCT00166465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405311|NCT00166465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24405312|NCT00166465|Immunologic Factors|immunologic factors|mesh-ancestor
24405314|NCT00166465|Antidotes|antidotes|mesh-ancestor
24405413|NCT00166829|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25653953|NCT01544920|Antiviral Agents|antiviral agents|mesh-ancestor
25653954|NCT01544920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25653955|NCT01544920|Antimetabolites|antimetabolites|mesh-ancestor
25653956|NCT01544920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653957|NCT01544920|Immunologic Factors|immunologic factors|mesh-ancestor
25653958|NCT01544920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653959|NCT01544998|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25653960|NCT01544998|Tadalafil|tadalafil|mesh-list
25653961|NCT01544998|Vasodilator Agents|vasodilator agents|mesh-ancestor
25653962|NCT01544998|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25653963|NCT01544998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25653964|NCT01544998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653965|NCT01544998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653966|NCT01544998|Urological Agents|urological agents|mesh-ancestor
25653967|NCT01544998|Natriuretic Agents|natriuretic agents|mesh-ancestor
25653968|NCT01544998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653969|NCT01545076|Immunoglobulin G|immunoglobulin g|mesh-list
25653970|NCT01545076|Immunologic Factors|immunologic factors|mesh-ancestor
25653971|NCT01545076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653972|NCT01545141|Interferons|interferons|mesh-list
25653973|NCT01545141|Interferon-alpha|interferon-alpha|mesh-list
25653974|NCT01545141|Interferon alpha-2|interferon alpha-2|mesh-list
25653975|NCT01545141|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
25653976|NCT01545141|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
25653977|NCT01545141|Poly I-C|poly i-c|mesh-list
25653978|NCT01545141|Celecoxib|celecoxib|mesh-list
25653979|NCT01545141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25653980|NCT01545141|Antiviral Agents|antiviral agents|mesh-ancestor
25653981|NCT01545141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25653982|NCT01545141|Immunologic Factors|immunologic factors|mesh-ancestor
25653983|NCT01545141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25653984|NCT01545141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25653985|NCT01545141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25653986|NCT01545141|Analgesics|analgesics|mesh-ancestor
25653987|NCT01545141|Sensory System Agents|sensory system agents|mesh-ancestor
25653988|NCT01545141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25653989|NCT01545141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25653990|NCT01545141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25653991|NCT01545141|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24405524|NCT00167557|Ribavirin|ribavirin|mesh-list
24405525|NCT00167557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405526|NCT00167557|Antiviral Agents|antiviral agents|mesh-ancestor
24405527|NCT00167557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24405528|NCT00167557|Antimetabolites|antimetabolites|mesh-ancestor
24405529|NCT00167557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405531|NCT00167583|Interferon-alpha|interferon-alpha|mesh-list
24405532|NCT00167583|Interferon alpha-2|interferon alpha-2|mesh-list
24405533|NCT00167583|Cyclosporine|cyclosporine|mesh-list
24405540|NCT00167583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24811714|NCT02048085|Ticagrelor|ticagrelor|mesh-list
24405547|NCT00167609|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24405551|NCT00167648|Leuprolide|leuprolide|mesh-list
25653992|NCT01545141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25653993|NCT01545141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25653994|NCT01545141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25653995|NCT01545141|Interferon Inducers|interferon inducers|mesh-ancestor
25653996|NCT01545336|Anastrozole|anastrozole|mesh-list
25653997|NCT01545336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25653998|NCT01545336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25653999|NCT01545336|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25654000|NCT01545336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25654001|NCT01545336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25654002|NCT01545336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654003|NCT01545336|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25654004|NCT01545336|Hormone Antagonists|hormone antagonists|mesh-ancestor
25654005|NCT01545336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25654006|NCT01545336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654007|NCT01545375|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25654008|NCT01545375|Immunologic Factors|immunologic factors|mesh-ancestor
25654009|NCT01545375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654010|NCT01545388|Metformin|metformin|mesh-list
25654011|NCT01545388|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24405642|NCT00167817|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24405643|NCT00167817|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24405644|NCT00167843|Pyrimethamine|pyrimethamine|mesh-list
24405645|NCT00167843|Sulfadoxine|sulfadoxine|mesh-list
24405646|NCT00167843|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24405647|NCT00167843|Antimalarials|antimalarials|mesh-ancestor
24405648|NCT00167843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24811756|NCT02048228|Purinergic Agents|purinergic agents|mesh-ancestor
24811757|NCT02048228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24811758|NCT02048228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811759|NCT02048228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811760|NCT02048293|Remifentanil|remifentanil|mesh-list
24811761|NCT02048293|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24811762|NCT02048293|Narcotics|narcotics|mesh-ancestor
24811763|NCT02048293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24678281|NCT01360749|Anesthetics|anesthetics|mesh-ancestor
24405655|NCT00167843|Renal Agents|renal agents|mesh-ancestor
25654012|NCT01545388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25654013|NCT01545388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654014|NCT01545388|Incretins|incretins|mesh-ancestor
25601230|NCT04021264|Ropivacaine|ropivacaine|mesh-list
25601231|NCT04021264|Anesthetics, Local|anesthetics, local|mesh-ancestor
25601232|NCT04021264|Anesthetics|anesthetics|mesh-ancestor
25601233|NCT04021264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25601234|NCT04021264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601235|NCT04021264|Sensory System Agents|sensory system agents|mesh-ancestor
25601236|NCT04021264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25601237|NCT04021264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25601238|NCT04021264|Narcotics|narcotics|mesh-ancestor
25601239|NCT04021264|Analgesics|analgesics|mesh-ancestor
24405773|NCT00168402|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24405774|NCT00168402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24405775|NCT00168402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405776|NCT00168402|Cholinergic Agents|cholinergic agents|mesh-ancestor
24405777|NCT00168402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24405778|NCT00168402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405779|NCT00168402|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24405780|NCT00168402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24405781|NCT00168415|Botulinum Toxins|botulinum toxins|mesh-list
24405782|NCT00168415|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24405783|NCT00168415|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24405784|NCT00168415|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24405785|NCT00168415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24405786|NCT00168415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405787|NCT00168415|Cholinergic Agents|cholinergic agents|mesh-ancestor
24405789|NCT00168415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405790|NCT00168415|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24405791|NCT00168415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24405792|NCT00168441|Botulinum Toxins|botulinum toxins|mesh-list
24405793|NCT00168441|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24405794|NCT00168441|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24405795|NCT00168441|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24405813|NCT00168480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25601240|NCT04021264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25601241|NCT04021264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25601242|NCT04021264|Anesthetics, General|anesthetics, general|mesh-ancestor
25601243|NCT04005716|Cisplatin|cisplatin|mesh-list
25601244|NCT04005716|Carboplatin|carboplatin|mesh-list
25601245|NCT04005716|Etoposide|etoposide|mesh-list
25601246|NCT04005716|Etoposide phosphate|etoposide phosphate|mesh-list
25601247|NCT04005716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601248|NCT04005716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25601249|NCT04005716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25601250|NCT04005716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25601251|NCT04005716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25601252|NCT04005716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601253|NCT03941288|Cannabidiol|cannabidiol|mesh-list
25601254|NCT03941288|Anticonvulsants|anticonvulsants|mesh-ancestor
25601255|NCT03933397|Morphine|morphine|mesh-list
25601256|NCT03933397|Hydromorphone|hydromorphone|mesh-list
25601257|NCT03933397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24465775|NCT00370669|Immunologic Factors|immunologic factors|mesh-ancestor
24811795|NCT02048358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24678616|NCT01363271|Vancomycin|vancomycin|mesh-list
24405864|NCT00168623|Vitamin A|vitamin a|mesh-list
24405865|NCT00168623|Vitamins|vitamins|mesh-ancestor
24405866|NCT00168623|Micronutrients|micronutrients|mesh-ancestor
24405867|NCT00168623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405868|NCT00168636|Vitamin A|vitamin a|mesh-list
24405869|NCT00168636|Vitamins|vitamins|mesh-ancestor
24405870|NCT00168636|Micronutrients|micronutrients|mesh-ancestor
24405871|NCT00168636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405872|NCT00168649|Vitamin A|vitamin a|mesh-list
24405873|NCT00168649|Vitamins|vitamins|mesh-ancestor
24405874|NCT00168649|Micronutrients|micronutrients|mesh-ancestor
24405892|NCT00168714|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24811812|NCT02048423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811813|NCT02048423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24811814|NCT02048423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24811816|NCT02048423|Anesthetics|anesthetics|mesh-ancestor
24811818|NCT02048423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24811819|NCT02048423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24811820|NCT02048423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24540824|NCT00669747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24811835|NCT02048540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24811836|NCT02048540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24811837|NCT02048540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24811838|NCT02048540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24811839|NCT02048540|Growth Substances|growth substances|mesh-ancestor
24811840|NCT02048540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601258|NCT03933397|Narcotics|narcotics|mesh-ancestor
25601259|NCT03933397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25601260|NCT03933397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601261|NCT03933397|Analgesics|analgesics|mesh-ancestor
25601262|NCT03933397|Sensory System Agents|sensory system agents|mesh-ancestor
25601263|NCT03933397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25601264|NCT03907852|Cyclophosphamide|cyclophosphamide|mesh-list
25601265|NCT03907852|Nivolumab|nivolumab|mesh-list
25601266|NCT03907852|Fludarabine|fludarabine|mesh-list
25601267|NCT03907852|Ipilimumab|ipilimumab|mesh-list
25601268|NCT03907852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25601269|NCT03907852|Immunologic Factors|immunologic factors|mesh-ancestor
24405952|NCT00168870|Antiviral Agents|antiviral agents|mesh-ancestor
24405975|NCT00168896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405976|NCT00168896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811842|NCT02048540|Tubulin Modulators|tubulin modulators|mesh-ancestor
24811843|NCT02048540|Antimitotic Agents|antimitotic agents|mesh-ancestor
24811844|NCT02048540|Mitosis Modulators|mitosis modulators|mesh-ancestor
24811845|NCT02048540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811846|NCT02048644|Beclomethasone|beclomethasone|mesh-list
24811847|NCT02048644|Formoterol Fumarate|formoterol fumarate|mesh-list
24811848|NCT02048644|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24811849|NCT02048644|Autonomic Agents|autonomic agents|mesh-ancestor
24811850|NCT02048644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24811851|NCT02048644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811852|NCT02048644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24811853|NCT02048644|Respiratory System Agents|respiratory system agents|mesh-ancestor
24811857|NCT02048644|Adrenergic Agents|adrenergic agents|mesh-ancestor
25601270|NCT03907852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601271|NCT03907852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25601272|NCT03907852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25601273|NCT03907852|Alkylating Agents|alkylating agents|mesh-ancestor
25601274|NCT03907852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601275|NCT03907852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601276|NCT03907852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25601277|NCT03907852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25601278|NCT03907852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25601279|NCT03891953|Spartalizumab|spartalizumab|mesh-list
25601280|NCT03891953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25601281|NCT03891953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601282|NCT03891953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601283|NCT03867175|Pembrolizumab|pembrolizumab|mesh-list
25601284|NCT03867175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25601285|NCT03867175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601286|NCT03866837|Micronutrients|micronutrients|mesh-list
25601287|NCT03866837|Trace Elements|trace elements|mesh-list
25601288|NCT03866837|Lactoferrin|lactoferrin|mesh-list
25601289|NCT03866837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601290|NCT03866837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25601291|NCT03845621|Salicylic Acid|salicylic acid|mesh-list
25601292|NCT03845621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25601293|NCT03845621|Antifungal Agents|antifungal agents|mesh-ancestor
25601294|NCT03845621|Keratolytic Agents|keratolytic agents|mesh-ancestor
25601295|NCT03845621|Dermatologic Agents|dermatologic agents|mesh-ancestor
25601296|NCT03760263|Tacrolimus|tacrolimus|mesh-list
24811881|NCT02048852|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24811882|NCT02048852|Autonomic Agents|autonomic agents|mesh-ancestor
24811883|NCT02048852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24811884|NCT02048852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811885|NCT02048852|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25601297|NCT03760263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25601298|NCT03760263|Immunologic Factors|immunologic factors|mesh-ancestor
25601299|NCT03760263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601300|NCT03760263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25601301|NCT03760263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25601302|NCT03760263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601303|NCT03747484|Pembrolizumab|pembrolizumab|mesh-list
25601304|NCT03747484|Avelumab|avelumab|mesh-list
25601305|NCT03747484|Immunoglobulins|immunoglobulins|mesh-list
25601306|NCT03747484|Immunoglobulin G|immunoglobulin g|mesh-list
25601318|NCT03688178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25601319|NCT03688178|Alkylating Agents|alkylating agents|mesh-ancestor
25601320|NCT03688178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601321|NCT03688178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601322|NCT03461406|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25601323|NCT03461406|Hemostatics|hemostatics|mesh-ancestor
25601324|NCT03461406|Coagulants|coagulants|mesh-ancestor
25601325|NCT03442751|Riboflavin|riboflavin|mesh-list
25601326|NCT03442751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25601327|NCT03442751|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25601328|NCT03442751|Vitamin B Complex|vitamin b complex|mesh-ancestor
25601329|NCT03442751|Vitamins|vitamins|mesh-ancestor
25601330|NCT03442751|Micronutrients|micronutrients|mesh-ancestor
24550677|NCT00721604|Plasma Substitutes|plasma substitutes|mesh-ancestor
24550686|NCT00721747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24550884|NCT00723060|Antidepressive Agents|antidepressive agents|mesh-ancestor
24550952|NCT00723385|Cholecalciferol|cholecalciferol|mesh-list
24811938|NCT02048943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25601331|NCT03442751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601332|NCT03442751|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25601333|NCT03442751|Dermatologic Agents|dermatologic agents|mesh-ancestor
25601334|NCT03425006|Pembrolizumab|pembrolizumab|mesh-list
25601335|NCT03425006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25601336|NCT03425006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601337|NCT03420521|Nivolumab|nivolumab|mesh-list
25601338|NCT03420521|Ipilimumab|ipilimumab|mesh-list
25601339|NCT03420521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25601340|NCT03420521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601341|NCT03420521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25601342|NCT03420521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601343|NCT03404661|Secretin|secretin|mesh-list
24406181|NCT00169195|Antimetabolites|antimetabolites|mesh-ancestor
25601344|NCT03404661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25601345|NCT03404661|Hormones|hormones|mesh-ancestor
25601346|NCT03404661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25601347|NCT03404661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601348|NCT03398356|Metformin|metformin|mesh-list
25601349|NCT03398356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25601350|NCT03398356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601351|NCT03365791|Spartalizumab|spartalizumab|mesh-list
25601352|NCT03365791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24466833|NCT00375258|Tranexamic Acid|tranexamic acid|mesh-list
24466936|NCT00375648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24466937|NCT00375648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466938|NCT00375661|Interferons|interferons|mesh-list
25601353|NCT03365791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601354|NCT03365791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601355|NCT03159897|Doxorubicin|doxorubicin|mesh-list
25601356|NCT03159897|Bleomycin|bleomycin|mesh-list
25601357|NCT03159897|Dacarbazine|dacarbazine|mesh-list
25601358|NCT03159897|Vinblastine|vinblastine|mesh-list
25601359|NCT03159897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25601360|NCT03159897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601361|NCT03159897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25601362|NCT03159897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25601363|NCT03159897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25601364|NCT03159897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466939|NCT00375661|Ribavirin|ribavirin|mesh-list
25601365|NCT03159897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25601366|NCT03159897|Alkylating Agents|alkylating agents|mesh-ancestor
25601367|NCT03159897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25601368|NCT03159897|Tubulin Modulators|tubulin modulators|mesh-ancestor
25601369|NCT03159897|Antimitotic Agents|antimitotic agents|mesh-ancestor
25601370|NCT03159897|Mitosis Modulators|mitosis modulators|mesh-ancestor
25601371|NCT03150693|Cytarabine|cytarabine|mesh-list
25601372|NCT03150693|Dexamethasone|dexamethasone|mesh-list
25601373|NCT03150693|Cyclophosphamide|cyclophosphamide|mesh-list
25601374|NCT03150693|Rituximab|rituximab|mesh-list
25601375|NCT03150693|Doxorubicin|doxorubicin|mesh-list
25601376|NCT03150693|Methotrexate|methotrexate|mesh-list
25601377|NCT03150693|Vincristine|vincristine|mesh-list
25601378|NCT03150693|Daunorubicin|daunorubicin|mesh-list
25601379|NCT03150693|Asparaginase|asparaginase|mesh-list
24541188|NCT00671372|Growth Substances|growth substances|mesh-ancestor
24541189|NCT00671372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541190|NCT00671372|Growth Inhibitors|growth inhibitors|mesh-ancestor
24406586|NCT00170833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24565713|NCT00782041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24565770|NCT00782405|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24565772|NCT00782405|Histamine Agents|histamine agents|mesh-ancestor
24566329|NCT00785200|Chlorhexidine|chlorhexidine|mesh-list
24566407|NCT00785473|Vitamins|vitamins|mesh-ancestor
24567065|NCT00789386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679609|NCT01369368|Azacitidine|azacitidine|mesh-list
24406596|NCT00170872|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24406598|NCT00170872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25601380|NCT03150693|Mercaptopurine|mercaptopurine|mesh-list
25601381|NCT03150693|Thioguanine|thioguanine|mesh-list
25495879|NCT00287586|Hormones|hormones|mesh-ancestor
25601382|NCT03150693|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25601383|NCT03150693|Pegaspargase|pegaspargase|mesh-list
25601384|NCT03150693|Allopurinol|allopurinol|mesh-list
25601385|NCT03150693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25601386|NCT03150693|Immunologic Factors|immunologic factors|mesh-ancestor
25601387|NCT03150693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601388|NCT03150693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25601389|NCT03150693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25601390|NCT03150693|Alkylating Agents|alkylating agents|mesh-ancestor
25601391|NCT03150693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601392|NCT03150693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601393|NCT03150693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25601394|NCT03150693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25601395|NCT03150693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25601396|NCT03150693|Antiemetics|antiemetics|mesh-ancestor
25601397|NCT03150693|Autonomic Agents|autonomic agents|mesh-ancestor
25601398|NCT03150693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25601399|NCT03150693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25601400|NCT03150693|Glucocorticoids|glucocorticoids|mesh-ancestor
25601401|NCT03150693|Hormones|hormones|mesh-ancestor
24406688|NCT00171015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25601402|NCT03150693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25601403|NCT03150693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25601404|NCT03150693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25601405|NCT03150693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25601406|NCT03150693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25601407|NCT03150693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25601408|NCT03150693|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25601409|NCT03150693|Abortifacient Agents|abortifacient agents|mesh-ancestor
25601410|NCT03150693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25601411|NCT03150693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25601412|NCT03150693|Antimetabolites|antimetabolites|mesh-ancestor
25601413|NCT03150693|Dermatologic Agents|dermatologic agents|mesh-ancestor
25601414|NCT03150693|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25601415|NCT03150693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25601416|NCT03150693|Antiviral Agents|antiviral agents|mesh-ancestor
25601417|NCT03150693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25601418|NCT03150693|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25601419|NCT03150693|Tubulin Modulators|tubulin modulators|mesh-ancestor
25601420|NCT03150693|Antimitotic Agents|antimitotic agents|mesh-ancestor
25601421|NCT03150693|Mitosis Modulators|mitosis modulators|mesh-ancestor
25601422|NCT03150693|Gout Suppressants|gout suppressants|mesh-ancestor
25601423|NCT03150693|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25601424|NCT03150693|Antioxidants|antioxidants|mesh-ancestor
25601425|NCT03150693|Protective Agents|protective agents|mesh-ancestor
25601426|NCT03115047|Meperidine|meperidine|mesh-list
25601427|NCT03115047|Dexmedetomidine|dexmedetomidine|mesh-list
25601428|NCT03115047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25601429|NCT03115047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25601430|NCT03115047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601431|NCT03115047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25601432|NCT03115047|Analgesics|analgesics|mesh-ancestor
25601433|NCT03115047|Sensory System Agents|sensory system agents|mesh-ancestor
25601434|NCT03115047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25601435|NCT03115047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25601436|NCT03115047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25601437|NCT03115047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25601438|NCT03115047|Adrenergic Agents|adrenergic agents|mesh-ancestor
25601439|NCT03115047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25601440|NCT03115047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601441|NCT03115047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25601442|NCT03115047|Narcotics|narcotics|mesh-ancestor
25601443|NCT03115047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25601444|NCT03105336|Cyclophosphamide|cyclophosphamide|mesh-list
25601445|NCT03105336|Fludarabine|fludarabine|mesh-list
25601446|NCT03105336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25601447|NCT03105336|Immunologic Factors|immunologic factors|mesh-ancestor
25601448|NCT03105336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601449|NCT03105336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25601450|NCT03105336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25601451|NCT03105336|Alkylating Agents|alkylating agents|mesh-ancestor
25601452|NCT03105336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601453|NCT03105336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601454|NCT03105336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25601455|NCT03099265|Leucovorin|leucovorin|mesh-list
25601456|NCT03099265|Fluorouracil|fluorouracil|mesh-list
25601457|NCT03099265|Oxaliplatin|oxaliplatin|mesh-list
24467275|NCT00376831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24467276|NCT00376831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24467277|NCT00376831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24407279|NCT00174200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25601458|NCT03099265|Irinotecan|irinotecan|mesh-list
25601459|NCT03099265|Antimetabolites|antimetabolites|mesh-ancestor
25601460|NCT03099265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601461|NCT03099265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25601462|NCT03099265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601463|NCT03099265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25601464|NCT03099265|Immunologic Factors|immunologic factors|mesh-ancestor
25601465|NCT03099265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601466|NCT03099265|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25601467|NCT03099265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25601468|NCT03099265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25601469|NCT03099265|Antidotes|antidotes|mesh-ancestor
25601470|NCT03099265|Protective Agents|protective agents|mesh-ancestor
25601471|NCT03099265|Vitamin B Complex|vitamin b complex|mesh-ancestor
25601472|NCT03099265|Vitamins|vitamins|mesh-ancestor
25601473|NCT03099265|Micronutrients|micronutrients|mesh-ancestor
25601474|NCT03083353|Isradipine|isradipine|mesh-list
25601475|NCT03083353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25601476|NCT03083353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25601477|NCT03083353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25601478|NCT03083353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601479|NCT03083353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25601480|NCT03083353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601481|NCT03083353|Vasodilator Agents|vasodilator agents|mesh-ancestor
25654015|NCT01545388|Hormones|hormones|mesh-ancestor
25654016|NCT01545388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25654017|NCT01545388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25654018|NCT01545388|Protease Inhibitors|protease inhibitors|mesh-ancestor
25654019|NCT01545388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25654020|NCT01545388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654021|NCT01545700|Dexamethasone|dexamethasone|mesh-list
25654022|NCT01545700|Dexamethasone acetate|dexamethasone acetate|mesh-list
25654023|NCT01545700|BB 1101|bb 1101|mesh-list
25654024|NCT01545700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25654025|NCT01545700|Antiemetics|antiemetics|mesh-ancestor
25654026|NCT01545700|Autonomic Agents|autonomic agents|mesh-ancestor
24407591|NCT00174759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25654027|NCT01545700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25654028|NCT01545700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654029|NCT01545700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25654030|NCT01545700|Glucocorticoids|glucocorticoids|mesh-ancestor
25654031|NCT01545700|Hormones|hormones|mesh-ancestor
25654032|NCT01545700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25654033|NCT01545700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25654034|NCT01545700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25654035|NCT01545700|Protease Inhibitors|protease inhibitors|mesh-ancestor
25654036|NCT01545700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25654037|NCT01545700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656983|NCT01581710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25656984|NCT01581710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656985|NCT01581710|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25656986|NCT01581710|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25656987|NCT01581710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656988|NCT01581931|Metformin|metformin|mesh-list
25656989|NCT01581931|Linagliptin|linagliptin|mesh-list
25656990|NCT01581931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25656991|NCT01581931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656992|NCT01581931|Incretins|incretins|mesh-ancestor
25656993|NCT01581931|Hormones|hormones|mesh-ancestor
25656994|NCT01581931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25656995|NCT01581931|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25656996|NCT01581931|Protease Inhibitors|protease inhibitors|mesh-ancestor
25656997|NCT01581931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25656998|NCT01581931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656999|NCT01581970|Cyclophosphamide|cyclophosphamide|mesh-list
25657000|NCT01581970|Cetuximab|cetuximab|mesh-list
25657001|NCT01581970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25657002|NCT01581970|Immunologic Factors|immunologic factors|mesh-ancestor
25657003|NCT01581970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657004|NCT01581970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25657005|NCT01581970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25657006|NCT01581970|Alkylating Agents|alkylating agents|mesh-ancestor
25657007|NCT01581970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495997|NCT00288587|Diuretics|diuretics|mesh-list
25601482|NCT02955823|Dexamethasone|dexamethasone|mesh-list
25601484|NCT02955823|Lenalidomide|lenalidomide|mesh-list
25601485|NCT02955823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25601486|NCT02955823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601487|NCT02955823|Immunologic Factors|immunologic factors|mesh-ancestor
25601488|NCT02955823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601489|NCT02955823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25601490|NCT02955823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25601491|NCT02955823|Antiemetics|antiemetics|mesh-ancestor
25601492|NCT02955823|Autonomic Agents|autonomic agents|mesh-ancestor
25601493|NCT02955823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25601494|NCT02955823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25601495|NCT02955823|Glucocorticoids|glucocorticoids|mesh-ancestor
25601496|NCT02955823|Hormones|hormones|mesh-ancestor
25601497|NCT02955823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25601498|NCT02955823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25601499|NCT02955823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25601500|NCT02955823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24408159|NCT00176774|Fluorouracil|fluorouracil|mesh-list
25601501|NCT02955823|Growth Substances|growth substances|mesh-ancestor
25601502|NCT02955823|Growth Inhibitors|growth inhibitors|mesh-ancestor
25601503|NCT02940509|Magnesium Sulfate|magnesium sulfate|mesh-list
25601504|NCT02940509|Ketamine|ketamine|mesh-list
25601505|NCT02940509|Analgesics|analgesics|mesh-ancestor
25601506|NCT02940509|Sensory System Agents|sensory system agents|mesh-ancestor
25601507|NCT02940509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25601508|NCT02940509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601509|NCT02940509|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25601510|NCT02940509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25601511|NCT02940509|Anesthetics, General|anesthetics, general|mesh-ancestor
25601512|NCT02940509|Anesthetics|anesthetics|mesh-ancestor
25601513|NCT02940509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25601514|NCT02940509|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25601515|NCT02940509|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25601516|NCT02940509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25601517|NCT02940509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601518|NCT02940509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25601519|NCT02940509|Anticonvulsants|anticonvulsants|mesh-ancestor
25601520|NCT02940509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25601521|NCT02940509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25601522|NCT02940509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25601523|NCT02940509|Tocolytic Agents|tocolytic agents|mesh-ancestor
25601524|NCT02940509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25601525|NCT02847559|Bevacizumab|bevacizumab|mesh-list
25601526|NCT02847559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25601527|NCT02847559|Endothelial Growth Factors|endothelial growth factors|mesh-list
25601528|NCT02847559|Antibodies|antibodies|mesh-list
25601529|NCT02847559|Immunoglobulins|immunoglobulins|mesh-list
25601530|NCT02847559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25601531|NCT02847559|Immunoglobulin G|immunoglobulin g|mesh-list
25601532|NCT02847559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601533|NCT02847559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25707805|NCT02237989|Acetaminophen|acetaminophen|mesh-list
24408732|NCT00179244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24408733|NCT00179244|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24408734|NCT00179244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24408735|NCT00179244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24408736|NCT00179244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408737|NCT00179244|Dopamine Agents|dopamine agents|mesh-ancestor
24820338|NCT02099240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24820339|NCT02099240|Antimalarials|antimalarials|mesh-ancestor
24820340|NCT02099240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24820341|NCT02099240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24820342|NCT02099240|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24820343|NCT02099240|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24408741|NCT00179244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24408753|NCT00179283|Sertraline|sertraline|mesh-list
25601534|NCT02847559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25601535|NCT02847559|Growth Substances|growth substances|mesh-ancestor
25601536|NCT02847559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601537|NCT02847559|Growth Inhibitors|growth inhibitors|mesh-ancestor
25601538|NCT02847559|Immunologic Factors|immunologic factors|mesh-ancestor
25601539|NCT02819440|Tadalafil|tadalafil|mesh-list
25601540|NCT02819440|Vasodilator Agents|vasodilator agents|mesh-ancestor
25601541|NCT02819440|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25601542|NCT02819440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25601543|NCT02819440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25601544|NCT02819440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601545|NCT02819440|Urological Agents|urological agents|mesh-ancestor
25601546|NCT02808364|Vaccines|vaccines|mesh-list
25601547|NCT02808364|Immunologic Factors|immunologic factors|mesh-ancestor
25601548|NCT02808364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601549|NCT02754141|Nivolumab|nivolumab|mesh-list
25601550|NCT02754141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25601551|NCT02754141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601552|NCT02754141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25601553|NCT02754141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601554|NCT02722616|Pancrelipase|pancrelipase|mesh-list
25601555|NCT02722616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25601556|NCT02709616|Vaccines|vaccines|mesh-list
25601557|NCT02709616|Immunologic Factors|immunologic factors|mesh-ancestor
25601558|NCT02709616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601559|NCT02662062|Cisplatin|cisplatin|mesh-list
25601560|NCT02662062|Pembrolizumab|pembrolizumab|mesh-list
25601561|NCT02662062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601562|NCT02662062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25601563|NCT02641028|Aticaprant|aticaprant|mesh-list
25601564|NCT02641028|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25601565|NCT02641028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601566|NCT02641028|Sensory System Agents|sensory system agents|mesh-ancestor
25601567|NCT02641028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25601568|NCT02530697|Miltefosine|miltefosine|mesh-list
25601569|NCT02530697|Meglumine Antimoniate|meglumine antimoniate|mesh-list
25601570|NCT02530697|Pentoxifylline|pentoxifylline|mesh-list
25601571|NCT02530697|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25601572|NCT02530697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25601573|NCT02530697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408764|NCT00179283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24408765|NCT00179283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24408767|NCT00179465|Antipsychotic Agents|antipsychotic agents|mesh-list
25601574|NCT02530697|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25601575|NCT02530697|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25601576|NCT02530697|Protective Agents|protective agents|mesh-ancestor
25601577|NCT02530697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601578|NCT02530697|Vasodilator Agents|vasodilator agents|mesh-ancestor
25601579|NCT02530697|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25601580|NCT02530697|Antioxidants|antioxidants|mesh-ancestor
25601581|NCT02530697|Antifungal Agents|antifungal agents|mesh-ancestor
25601582|NCT02530697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25601583|NCT02530697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601584|NCT02530697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25601585|NCT02530697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25601586|NCT02485691|Prednisone|prednisone|mesh-list
25601587|NCT02485691|Abiraterone Acetate|abiraterone acetate|mesh-list
25601588|NCT02485691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25601589|NCT02485691|Glucocorticoids|glucocorticoids|mesh-ancestor
25601590|NCT02485691|Hormones|hormones|mesh-ancestor
25601591|NCT02485691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25601592|NCT02485691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601593|NCT02485691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24408840|NCT00179738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24408841|NCT00179738|Growth Substances|growth substances|mesh-ancestor
24408842|NCT00179738|Growth Inhibitors|growth inhibitors|mesh-ancestor
24408846|NCT00179751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24408847|NCT00179751|Antimetabolites|antimetabolites|mesh-ancestor
25601594|NCT02485691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601595|NCT02485691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25601596|NCT02485691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25601597|NCT02485691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601598|NCT02485691|Hormone Antagonists|hormone antagonists|mesh-ancestor
25601599|NCT02485691|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25601600|NCT02466074|Acetazolamide|acetazolamide|mesh-list
25601601|NCT02466074|Anticonvulsants|anticonvulsants|mesh-ancestor
25601602|NCT02466074|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25601603|NCT02466074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25601604|NCT02466074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601605|NCT02466074|Diuretics|diuretics|mesh-ancestor
25601606|NCT02466074|Natriuretic Agents|natriuretic agents|mesh-ancestor
25601607|NCT02466074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601608|NCT02406222|Dexamethasone|dexamethasone|mesh-list
25601609|NCT02406222|Cyclophosphamide|cyclophosphamide|mesh-list
25601610|NCT02406222|Pomalidomide|pomalidomide|mesh-list
25601611|NCT02406222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25601612|NCT02406222|Immunologic Factors|immunologic factors|mesh-ancestor
24542080|NCT00676741|Insulin Detemir|insulin detemir|mesh-list
24409185|NCT00181220|Antimanic Agents|antimanic agents|mesh-ancestor
25601613|NCT02406222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601614|NCT02406222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25601615|NCT02406222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25601616|NCT02406222|Alkylating Agents|alkylating agents|mesh-ancestor
25601617|NCT02406222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601618|NCT02406222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601619|NCT02406222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25601620|NCT02406222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25601621|NCT02406222|Antiemetics|antiemetics|mesh-ancestor
25601622|NCT02406222|Autonomic Agents|autonomic agents|mesh-ancestor
25601623|NCT02406222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25601624|NCT02406222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25601625|NCT02406222|Glucocorticoids|glucocorticoids|mesh-ancestor
25601626|NCT02406222|Hormones|hormones|mesh-ancestor
25601627|NCT02406222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25601628|NCT02406222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25601629|NCT02406222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25601630|NCT02406222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25601631|NCT02406222|Growth Substances|growth substances|mesh-ancestor
25601632|NCT02406222|Growth Inhibitors|growth inhibitors|mesh-ancestor
25601633|NCT02201251|Topiramate|topiramate|mesh-list
25601634|NCT02201251|Levetiracetam|levetiracetam|mesh-list
25601635|NCT02201251|Anticonvulsants|anticonvulsants|mesh-ancestor
25601636|NCT02201251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25601637|NCT02201251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601638|NCT02201251|Nootropic Agents|nootropic agents|mesh-ancestor
25601639|NCT02187198|Buprenorphine|buprenorphine|mesh-list
25601640|NCT02187198|Naloxone|naloxone|mesh-list
25601641|NCT02187198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25601642|NCT02187198|Narcotics|narcotics|mesh-ancestor
25601643|NCT02187198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25601644|NCT02187198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601645|NCT02187198|Analgesics|analgesics|mesh-ancestor
25601646|NCT02187198|Sensory System Agents|sensory system agents|mesh-ancestor
25601647|NCT02187198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25601648|NCT02187198|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25601649|NCT02150785|Streptokinase|streptokinase|mesh-list
25601650|NCT02150785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25601651|NCT02150785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25601652|NCT02150785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601653|NCT02144831|Aspirin|aspirin|mesh-list
25601654|NCT02144831|Clopidogrel|clopidogrel|mesh-list
25601655|NCT02144831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25601656|NCT02144831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25601657|NCT02144831|Analgesics|analgesics|mesh-ancestor
25601658|NCT02144831|Sensory System Agents|sensory system agents|mesh-ancestor
25601659|NCT02144831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25601660|NCT02144831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601661|NCT02144831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25601662|NCT02144831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25601663|NCT02144831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25601664|NCT02144831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25601665|NCT02144831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601666|NCT02144831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25601667|NCT02144831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25601668|NCT02144831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25601669|NCT02144831|Antipyretics|antipyretics|mesh-ancestor
25601670|NCT02144831|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25601671|NCT02144831|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25601672|NCT02144831|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25601673|NCT02144831|Purinergic Agents|purinergic agents|mesh-ancestor
25601674|NCT02144831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25601675|NCT02000596|Trastuzumab|trastuzumab|mesh-list
25601676|NCT02000596|Pertuzumab|pertuzumab|mesh-list
25601677|NCT02000596|Fulvestrant|fulvestrant|mesh-list
25601678|NCT02000596|Anastrozole|anastrozole|mesh-list
25601679|NCT02000596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25601680|NCT02000596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24821029|NCT02103166|Anticonvulsants|anticonvulsants|mesh-ancestor
24821030|NCT02103166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24821031|NCT02103166|Antiemetics|antiemetics|mesh-ancestor
24821032|NCT02103166|Autonomic Agents|autonomic agents|mesh-ancestor
24821033|NCT02103166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24683055|NCT01389713|Clomiphene|clomiphene|mesh-list
24410196|NCT00184847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24410197|NCT00184847|Vasodilator Agents|vasodilator agents|mesh-ancestor
24410198|NCT00184847|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24821104|NCT02103569|Norethindrone Acetate|norethindrone acetate|mesh-list
24821105|NCT02103569|Estradiol|estradiol|mesh-list
24821106|NCT02103569|Asunaprevir|asunaprevir|mesh-list
24821107|NCT02103569|Estrogens|estrogens|mesh-ancestor
24410327|NCT00185094|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24410328|NCT00185094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24410329|NCT00185094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24410330|NCT00185094|Adrenergic Agents|adrenergic agents|mesh-ancestor
24410331|NCT00185094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24410333|NCT00185107|Ezetimibe|ezetimibe|mesh-list
24410334|NCT00185107|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
24470217|NCT00389272|Ibuprofen|ibuprofen|mesh-list
25601681|NCT02000596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25601682|NCT02000596|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25601683|NCT02000596|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25601684|NCT02000596|Hormone Antagonists|hormone antagonists|mesh-ancestor
25601685|NCT02000596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25601686|NCT02000596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601687|NCT02000596|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25601688|NCT02000596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25601689|NCT02000596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25601690|NCT02000596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601691|NCT01884922|Vinblastine|vinblastine|mesh-list
25601692|NCT01884922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25601693|NCT01884922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601694|NCT01884922|Tubulin Modulators|tubulin modulators|mesh-ancestor
25601695|NCT01884922|Antimitotic Agents|antimitotic agents|mesh-ancestor
25601696|NCT01884922|Mitosis Modulators|mitosis modulators|mesh-ancestor
25601697|NCT01884922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821215|NCT02103881|Ketamine|ketamine|mesh-list
25601698|NCT01788020|Dexamethasone|dexamethasone|mesh-list
25601699|NCT01788020|Dexamethasone acetate|dexamethasone acetate|mesh-list
25601700|NCT01788020|Cyclophosphamide|cyclophosphamide|mesh-list
25601701|NCT01788020|Rituximab|rituximab|mesh-list
25601702|NCT01788020|Bortezomib|bortezomib|mesh-list
25601703|NCT01788020|BB 1101|bb 1101|mesh-list
25601704|NCT01788020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25601705|NCT01788020|Immunologic Factors|immunologic factors|mesh-ancestor
25601706|NCT01788020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601707|NCT01788020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25601708|NCT01788020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25601709|NCT01788020|Alkylating Agents|alkylating agents|mesh-ancestor
25601710|NCT01788020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601711|NCT01788020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601712|NCT01788020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25601713|NCT01788020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25601714|NCT01788020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25601715|NCT01788020|Antiemetics|antiemetics|mesh-ancestor
25601716|NCT01788020|Autonomic Agents|autonomic agents|mesh-ancestor
25601717|NCT01788020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25601718|NCT01788020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25601719|NCT01788020|Glucocorticoids|glucocorticoids|mesh-ancestor
25601720|NCT01788020|Hormones|hormones|mesh-ancestor
25601721|NCT01788020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25601722|NCT01788020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25601723|NCT01788020|Protease Inhibitors|protease inhibitors|mesh-ancestor
24413096|NCT00193115|Docetaxel|docetaxel|mesh-list
25601724|NCT01788020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25601725|NCT01608893|Metoprolol|metoprolol|mesh-list
25601726|NCT01608893|Carvedilol|carvedilol|mesh-list
25601727|NCT01608893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25601728|NCT01608893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25601729|NCT01608893|Sympatholytics|sympatholytics|mesh-ancestor
25601730|NCT01608893|Autonomic Agents|autonomic agents|mesh-ancestor
25707839|NCT02238626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25601731|NCT01608893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25601732|NCT01608893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601733|NCT01608893|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25601734|NCT01608893|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25601735|NCT01608893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25601736|NCT01608893|Adrenergic Agents|adrenergic agents|mesh-ancestor
25601737|NCT01608893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25601738|NCT01608893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601739|NCT01608893|Antioxidants|antioxidants|mesh-ancestor
24414505|NCT00197834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414506|NCT00197834|GABA Agents|gaba agents|mesh-ancestor
24414507|NCT00197834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24414509|NCT00197834|Antimanic Agents|antimanic agents|mesh-ancestor
24822443|NCT02111707|Gout Suppressants|gout suppressants|mesh-ancestor
24822444|NCT02111707|Tocolytic Agents|tocolytic agents|mesh-ancestor
24822445|NCT02111707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24822446|NCT02111707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24822448|NCT02111707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601740|NCT01608893|Protective Agents|protective agents|mesh-ancestor
25601741|NCT01608893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25601742|NCT01608893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25601743|NCT01608893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25601744|NCT01608893|Vasodilator Agents|vasodilator agents|mesh-ancestor
25601745|NCT01608893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25601746|NCT01608893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25601747|NCT01517451|Androgens|androgens|mesh-list
25601748|NCT01517451|Hormones|hormones|mesh-ancestor
25601749|NCT01517451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25601750|NCT01517451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601751|NCT01502917|Antibodies|antibodies|mesh-list
25601752|NCT01502917|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25601753|NCT01502917|Immunologic Factors|immunologic factors|mesh-ancestor
24822497|NCT02112214|Antacids|antacids|mesh-ancestor
25601754|NCT01502917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601755|NCT00929253|Buprenorphine|buprenorphine|mesh-list
25601756|NCT00929253|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25601757|NCT00929253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25601758|NCT00929253|Narcotics|narcotics|mesh-ancestor
25601759|NCT00929253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25601760|NCT00929253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601761|NCT00929253|Analgesics|analgesics|mesh-ancestor
25601762|NCT00929253|Sensory System Agents|sensory system agents|mesh-ancestor
25601763|NCT00929253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25601764|NCT00929253|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25601765|NCT00834093|Vaccines|vaccines|mesh-list
25601766|NCT00834093|Immunologic Factors|immunologic factors|mesh-ancestor
25601767|NCT00834093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601768|NCT00812032|Aspirin|aspirin|mesh-list
25601769|NCT00812032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25601770|NCT00812032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25601771|NCT00812032|Analgesics|analgesics|mesh-ancestor
25601772|NCT00812032|Sensory System Agents|sensory system agents|mesh-ancestor
25601773|NCT00812032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25601774|NCT00812032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601775|NCT00812032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25601776|NCT00812032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25601777|NCT00812032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25601778|NCT00812032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25601779|NCT00812032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601780|NCT00812032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25496260|NCT00290589|Hormones|hormones|mesh-ancestor
25601781|NCT00812032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25601782|NCT00812032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25601783|NCT00812032|Antipyretics|antipyretics|mesh-ancestor
25601784|NCT00771693|Insulin Aspart|insulin aspart|mesh-list
25601785|NCT00771693|Insulin, Long-Acting|insulin, long-acting|mesh-list
25601786|NCT00771693|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25601787|NCT00771693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25601788|NCT00771693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601789|NCT00657241|Valsartan|valsartan|mesh-list
25601790|NCT00657241|Carvedilol|carvedilol|mesh-list
25601791|NCT00657241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25601792|NCT00657241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25601793|NCT00657241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25601794|NCT00657241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601795|NCT00657241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25601796|NCT00657241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25601797|NCT00657241|Adrenergic Agents|adrenergic agents|mesh-ancestor
25601798|NCT00657241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24420076|NCT00215124|Lenograstim|lenograstim|mesh-list
25601799|NCT00657241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601800|NCT00657241|Antioxidants|antioxidants|mesh-ancestor
25601801|NCT00657241|Protective Agents|protective agents|mesh-ancestor
25601802|NCT00657241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25601803|NCT00657241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25601804|NCT00657241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25601805|NCT00657241|Vasodilator Agents|vasodilator agents|mesh-ancestor
25601806|NCT00657241|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25601807|NCT00657241|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25601808|NCT00478465|Valganciclovir|valganciclovir|mesh-list
25601809|NCT00478465|Antiviral Agents|antiviral agents|mesh-ancestor
25601810|NCT00478465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25601811|NCT00458796|Zoledronic Acid|zoledronic acid|mesh-list
25601812|NCT00458796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25601813|NCT00458796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601814|NCT00417664|Midazolam|midazolam|mesh-list
25601815|NCT00417664|Dexmedetomidine|dexmedetomidine|mesh-list
25601816|NCT00417664|Propofol|propofol|mesh-list
25601817|NCT00417664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25601818|NCT00417664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25601819|NCT00417664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421078|NCT00217568|Carboplatin|carboplatin|mesh-list
25601820|NCT00417664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25601821|NCT00417664|Anesthetics, General|anesthetics, general|mesh-ancestor
25601822|NCT00417664|Anesthetics|anesthetics|mesh-ancestor
25601823|NCT00417664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25601824|NCT00417664|Analgesics|analgesics|mesh-ancestor
25601825|NCT00417664|Sensory System Agents|sensory system agents|mesh-ancestor
25601826|NCT00417664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25601827|NCT00417664|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25601828|NCT00417664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25601829|NCT00417664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25601830|NCT00417664|Adrenergic Agents|adrenergic agents|mesh-ancestor
25601831|NCT00417664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25601832|NCT00417664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601833|NCT00417664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25601834|NCT00417664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25601835|NCT00417664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25601836|NCT00417664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25601837|NCT00417664|GABA Modulators|gaba modulators|mesh-ancestor
25601838|NCT00417664|GABA Agents|gaba agents|mesh-ancestor
25601839|NCT00042341|Clofarabine|clofarabine|mesh-list
25601840|NCT00042341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25601841|NCT00042341|Antimetabolites|antimetabolites|mesh-ancestor
25601842|NCT00042341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601843|NCT00042341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601844|NCT01021332|Tamsulosin|tamsulosin|mesh-list
25601845|NCT01021332|Solifenacin Succinate|solifenacin succinate|mesh-list
25601846|NCT01021332|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25496315|NCT00290732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25496316|NCT00290732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25496317|NCT00290732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496319|NCT00290745|Tamoxifen|tamoxifen|mesh-list
25601847|NCT01021332|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25601848|NCT01021332|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25601849|NCT01021332|Adrenergic Agents|adrenergic agents|mesh-ancestor
25601850|NCT01021332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25601851|NCT01021332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601852|NCT01021332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601853|NCT01021332|Urological Agents|urological agents|mesh-ancestor
25601854|NCT01021332|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25601855|NCT01021332|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25601856|NCT01021332|Cholinergic Agents|cholinergic agents|mesh-ancestor
25601857|NCT01021423|Lenalidomide|lenalidomide|mesh-list
25601858|NCT01021423|Immunologic Factors|immunologic factors|mesh-ancestor
25601859|NCT01021423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601860|NCT01021423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25601861|NCT01021423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25601862|NCT01021423|Growth Substances|growth substances|mesh-ancestor
25601863|NCT01021423|Growth Inhibitors|growth inhibitors|mesh-ancestor
25601864|NCT01021423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601865|NCT01021553|Diketopiperazines|diketopiperazines|mesh-list
25601866|NCT01021553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25601867|NCT01021553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25601868|NCT01021618|Dipyridamole|dipyridamole|mesh-list
25601869|NCT01021618|Regadenoson|regadenoson|mesh-list
25601870|NCT01021618|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25601871|NCT01021618|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25601872|NCT01021618|Purinergic Agonists|purinergic agonists|mesh-ancestor
25601873|NCT01021618|Purinergic Agents|purinergic agents|mesh-ancestor
25601874|NCT01021618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25601875|NCT01021618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601876|NCT01021618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601877|NCT01021618|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25601878|NCT01021618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25601879|NCT01021618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25601880|NCT01021618|Vasodilator Agents|vasodilator agents|mesh-ancestor
25601881|NCT01021683|Itraconazole|itraconazole|mesh-list
25601882|NCT01021683|Antifungal Agents|antifungal agents|mesh-ancestor
25601883|NCT01021683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25601884|NCT01021683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25601885|NCT01021683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25601886|NCT01021683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25601887|NCT01021683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601888|NCT01021683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25601889|NCT01021683|Hormone Antagonists|hormone antagonists|mesh-ancestor
25601890|NCT01021683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25601891|NCT01021683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601892|NCT01021683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25601894|NCT01021761|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25601895|NCT01021761|Nepafenac|nepafenac|mesh-list
25601896|NCT01021761|Bromfenac|bromfenac|mesh-list
25601897|NCT01021761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25601898|NCT01021761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25601899|NCT01021761|Analgesics|analgesics|mesh-ancestor
25601900|NCT01021761|Sensory System Agents|sensory system agents|mesh-ancestor
25601901|NCT01021761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25601902|NCT01021761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601903|NCT01021761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25601904|NCT01021761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25601905|NCT01021761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25601906|NCT01021761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24424510|NCT00229567|Analgesics|analgesics|mesh-ancestor
25601907|NCT01021761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601908|NCT01021813|Suvorexant|suvorexant|mesh-list
25601909|NCT01021813|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25601910|NCT01021813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25601911|NCT01021813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25601912|NCT01021813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601913|NCT01021813|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25601914|NCT01021813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24424539|NCT00229684|Pioglitazone|pioglitazone|mesh-list
25601915|NCT01021813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601916|NCT01021878|Icodextrin|icodextrin|mesh-list
25601917|NCT01021878|Dialysis Solutions|dialysis solutions|mesh-ancestor
25601918|NCT01021878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25601919|NCT01022190|Etoricoxib|etoricoxib|mesh-list
25601920|NCT01022190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25601921|NCT01022190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25601922|NCT01022190|Analgesics|analgesics|mesh-ancestor
25601923|NCT01022190|Sensory System Agents|sensory system agents|mesh-ancestor
25601924|NCT01022190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24426052|NCT00234975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25601925|NCT01022190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601926|NCT01022190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25601927|NCT01022190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25601928|NCT01022190|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25601929|NCT01022190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25601930|NCT01022190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25601931|NCT01022190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601933|NCT01022424|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25601934|NCT01022424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601935|NCT01022424|Natriuretic Agents|natriuretic agents|mesh-ancestor
25601936|NCT01022424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601937|NCT01022567|Ertapenem|ertapenem|mesh-list
25601938|NCT01022567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25601939|NCT01022567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25601940|NCT01022580|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25601941|NCT01022580|Calfactant|calfactant|mesh-list
25601942|NCT01022580|Respiratory System Agents|respiratory system agents|mesh-ancestor
25601943|NCT01022762|Repaglinide|repaglinide|mesh-list
25601944|NCT01022762|Gliclazide|gliclazide|mesh-list
25601945|NCT01022762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25601946|NCT01022762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601947|NCT01022853|Nintedanib|nintedanib|mesh-list
25601948|NCT01022853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601949|NCT01022853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25601950|NCT01022853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25601951|NCT01022853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601952|NCT01022996|Everolimus|everolimus|mesh-list
25601953|NCT01022996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601954|NCT01022996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25601955|NCT01022996|Immunologic Factors|immunologic factors|mesh-ancestor
24547358|NCT00703625|Docetaxel|docetaxel|mesh-list
25601956|NCT01022996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601957|NCT01023035|Ribavirin|ribavirin|mesh-list
25601958|NCT01023035|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25601959|NCT01023035|Epoetin Alfa|epoetin alfa|mesh-list
25601960|NCT01023035|Antimetabolites|antimetabolites|mesh-ancestor
25601961|NCT01023035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601962|NCT01023035|Antiviral Agents|antiviral agents|mesh-ancestor
25601963|NCT01023035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25601964|NCT01023035|Hematinics|hematinics|mesh-ancestor
25601965|NCT01023061|Prednisone|prednisone|mesh-list
25601966|NCT01023061|Leuprolide|leuprolide|mesh-list
25601967|NCT01023061|Goserelin|goserelin|mesh-list
25601968|NCT01023061|Abiraterone Acetate|abiraterone acetate|mesh-list
25601969|NCT01023061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25601970|NCT01023061|Glucocorticoids|glucocorticoids|mesh-ancestor
25601971|NCT01023061|Hormones|hormones|mesh-ancestor
25601972|NCT01023061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25601973|NCT01023061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601974|NCT01023061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25601975|NCT01023061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25601976|NCT01023061|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25601977|NCT01023061|Fertility Agents|fertility agents|mesh-ancestor
25601978|NCT01023061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25601979|NCT01023061|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25601980|NCT01023061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25601981|NCT01023061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25601982|NCT01023061|Hormone Antagonists|hormone antagonists|mesh-ancestor
25601983|NCT01023061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25601984|NCT01023178|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25601985|NCT01023178|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25601986|NCT01023178|Estradiol|estradiol|mesh-list
25601987|NCT01023178|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25601988|NCT01023178|Estrogens|estrogens|mesh-list
25601989|NCT01023178|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25601990|NCT01023178|Progesterone|progesterone|mesh-list
25601991|NCT01023178|Hormones|hormones|mesh-ancestor
25601992|NCT01023178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25601993|NCT01023178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25601994|NCT01023178|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25601995|NCT01023178|Contraceptive Agents|contraceptive agents|mesh-ancestor
25601996|NCT01023178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25601997|NCT01023178|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25601998|NCT01023178|Progestins|progestins|mesh-ancestor
25601999|NCT01023217|Lamivudine|lamivudine|mesh-list
25602000|NCT01023217|Adefovir|adefovir|mesh-list
25602001|NCT01023217|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25602002|NCT01023217|Entecavir|entecavir|mesh-list
25602003|NCT01023217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25602004|NCT01023217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25602005|NCT01023217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602006|NCT01023217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602007|NCT01023217|Antiviral Agents|antiviral agents|mesh-ancestor
25602008|NCT01023217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25602009|NCT01023217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25602010|NCT01023217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25602011|NCT01023256|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25602012|NCT01023256|Immunologic Factors|immunologic factors|mesh-ancestor
25602013|NCT01023256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602014|NCT01023308|Dexamethasone|dexamethasone|mesh-list
25602015|NCT01023308|Bortezomib|bortezomib|mesh-list
25602016|NCT01023308|Panobinostat|panobinostat|mesh-list
25602017|NCT01023308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25602018|NCT01023308|Antiemetics|antiemetics|mesh-ancestor
25602019|NCT01023308|Autonomic Agents|autonomic agents|mesh-ancestor
25602020|NCT01023308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25602021|NCT01023308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602022|NCT01023308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25602023|NCT01023308|Glucocorticoids|glucocorticoids|mesh-ancestor
25602024|NCT01023308|Hormones|hormones|mesh-ancestor
25602025|NCT01023308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25602026|NCT01023308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25602027|NCT01023308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602028|NCT01023308|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25602029|NCT01023308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602030|NCT01023308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654038|NCT01545765|Lidocaine|lidocaine|mesh-list
25654039|NCT01545765|Tetracaine|tetracaine|mesh-list
25654040|NCT01545765|Anesthetics, Local|anesthetics, local|mesh-ancestor
25654041|NCT01545765|Anesthetics|anesthetics|mesh-ancestor
25654042|NCT01545765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25654043|NCT01545765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654044|NCT01545765|Sensory System Agents|sensory system agents|mesh-ancestor
25654045|NCT01545765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25654046|NCT01545765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25654047|NCT01545765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25654048|NCT01545765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25654049|NCT01545765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25654050|NCT01545765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654051|NCT01545817|Everolimus|everolimus|mesh-list
25654052|NCT01545817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25654053|NCT01545817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25654054|NCT01545817|Immunologic Factors|immunologic factors|mesh-ancestor
25654055|NCT01545817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654056|NCT01545843|Fluoxetine|fluoxetine|mesh-list
25707952|NCT02240628|Lidocaine|lidocaine|mesh-list
25654057|NCT01545843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25654058|NCT01545843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25654059|NCT01545843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25707960|NCT02240628|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25654060|NCT01545843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654061|NCT01545843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25654062|NCT01545843|Serotonin Agents|serotonin agents|mesh-ancestor
25654063|NCT01545843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654064|NCT01545843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25654065|NCT01545843|Antidepressive Agents|antidepressive agents|mesh-ancestor
25654066|NCT01545843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25654067|NCT01545843|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25654068|NCT01545843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25654069|NCT01545843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25654070|NCT01546038|Cytarabine|cytarabine|mesh-list
25654071|NCT01546038|Decitabine|decitabine|mesh-list
25654072|NCT01546038|Daunorubicin|daunorubicin|mesh-list
25654073|NCT01546038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25654074|NCT01546038|Antimetabolites|antimetabolites|mesh-ancestor
25654075|NCT01546038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654076|NCT01546038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25654077|NCT01546038|Antiviral Agents|antiviral agents|mesh-ancestor
25654078|NCT01546038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25654079|NCT01546038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25654080|NCT01546038|Immunologic Factors|immunologic factors|mesh-ancestor
25496519|NCT00292591|Vitamin D|vitamin d|mesh-list
25602031|NCT01023477|Chloroquine|chloroquine|mesh-list
25602032|NCT01023477|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
25602033|NCT01023477|Amebicides|amebicides|mesh-ancestor
25602034|NCT01023477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25602035|NCT01023477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25602036|NCT01023477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24775590|NCT01853566|Hormones|hormones|mesh-list
25602037|NCT01023477|Antimalarials|antimalarials|mesh-ancestor
25602038|NCT01023477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25602039|NCT01023477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25602040|NCT01023477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25602041|NCT01023477|Analgesics|analgesics|mesh-ancestor
25602042|NCT01023477|Sensory System Agents|sensory system agents|mesh-ancestor
25602043|NCT01023477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25602044|NCT01023477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602045|NCT01023477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25602046|NCT01023477|Filaricides|filaricides|mesh-ancestor
25602047|NCT01023477|Antinematodal Agents|antinematodal agents|mesh-ancestor
25602048|NCT01023477|Anthelmintics|anthelmintics|mesh-ancestor
25602049|NCT01023581|Metformin|metformin|mesh-list
25602050|NCT01023581|Alogliptin|alogliptin|mesh-list
25602051|NCT01023581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24914044|NCT04258163|Letrozole|letrozole|mesh-list
25602052|NCT01023581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602053|NCT01023581|Incretins|incretins|mesh-ancestor
25602054|NCT01023581|Hormones|hormones|mesh-ancestor
25602055|NCT01023581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25602056|NCT01023581|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25602057|NCT01023581|Protease Inhibitors|protease inhibitors|mesh-ancestor
25602058|NCT01023581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602059|NCT01023581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602060|NCT01023659|Bupropion|bupropion|mesh-list
25602061|NCT01023659|Varenicline|varenicline|mesh-list
25602062|NCT01023659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24778249|NCT01870050|Dapsone|dapsone|mesh-list
25602063|NCT01023659|Antidepressive Agents|antidepressive agents|mesh-ancestor
25602064|NCT01023659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25602065|NCT01023659|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24477720|NCT00419783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25602066|NCT01023659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25602067|NCT01023659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25602068|NCT01023659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602069|NCT01023659|Dopamine Agents|dopamine agents|mesh-ancestor
25602070|NCT01023659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25602071|NCT01023659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602072|NCT01023659|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25602073|NCT01023659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25602074|NCT01023659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602075|NCT01023659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25602076|NCT01023659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25602077|NCT01023659|Cholinergic Agents|cholinergic agents|mesh-ancestor
25602078|NCT01023672|Modafinil|modafinil|mesh-list
25602079|NCT01023672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25602080|NCT01023672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602081|NCT01023672|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25602082|NCT01023672|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24477973|NCT00421083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602083|NCT01023672|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25602084|NCT01023672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602085|NCT01023711|Vaccines|vaccines|mesh-list
25602086|NCT01023711|Immunologic Factors|immunologic factors|mesh-ancestor
24478604|NCT00423696|Antidotes|antidotes|mesh-ancestor
25602087|NCT01023711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602088|NCT01023724|Ketorolac|ketorolac|mesh-list
25602089|NCT01023724|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25602090|NCT01023724|Bromfenac|bromfenac|mesh-list
25602091|NCT01023724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25602092|NCT01023724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25602093|NCT01023724|Analgesics|analgesics|mesh-ancestor
25602094|NCT01023724|Sensory System Agents|sensory system agents|mesh-ancestor
25602095|NCT01023724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25602096|NCT01023724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602097|NCT01023724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25602098|NCT01023724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25602099|NCT01023724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25602100|NCT01023724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602101|NCT01023724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602102|NCT01023776|Vaccines|vaccines|mesh-list
25602103|NCT01023776|Immunologic Factors|immunologic factors|mesh-ancestor
25602104|NCT01023776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602105|NCT01023815|Cyclosporine|cyclosporine|mesh-list
25602106|NCT01023815|Everolimus|everolimus|mesh-list
25602107|NCT01023815|Cyclosporins|cyclosporins|mesh-list
25602108|NCT01023815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780412|NCT01884298|Narcotics|narcotics|mesh-ancestor
25602109|NCT01023815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602110|NCT01023815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25602111|NCT01023815|Immunologic Factors|immunologic factors|mesh-ancestor
25602112|NCT01023815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602113|NCT01023815|Antifungal Agents|antifungal agents|mesh-ancestor
25602114|NCT01023815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25602115|NCT01023815|Dermatologic Agents|dermatologic agents|mesh-ancestor
25602116|NCT01023815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25602117|NCT01023815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25602118|NCT01023815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602119|NCT01023841|Bimatoprost|bimatoprost|mesh-list
24781303|NCT01888835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25602120|NCT01023841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25602121|NCT01023841|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25602122|NCT01023841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25602123|NCT01024010|Vidarabine|vidarabine|mesh-list
25602124|NCT01024010|Cyclophosphamide|cyclophosphamide|mesh-list
25602125|NCT01024010|Ofatumumab|ofatumumab|mesh-list
25602126|NCT01024010|Pentostatin|pentostatin|mesh-list
25602127|NCT01024010|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25602128|NCT01024010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25602129|NCT01024010|Immunologic Factors|immunologic factors|mesh-ancestor
25602130|NCT01024010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602131|NCT01024010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25602132|NCT01024010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25602133|NCT01024010|Alkylating Agents|alkylating agents|mesh-ancestor
25602134|NCT01024010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602135|NCT01024010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602136|NCT01024010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25602137|NCT01024010|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25602138|NCT01024010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602139|NCT01024010|Antimetabolites|antimetabolites|mesh-ancestor
25602140|NCT01024010|Antiviral Agents|antiviral agents|mesh-ancestor
25602141|NCT01024010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25602142|NCT01024036|Siltuximab|siltuximab|mesh-list
25602143|NCT01024036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602144|NCT01024231|Nivolumab|nivolumab|mesh-list
25602145|NCT01024231|Ipilimumab|ipilimumab|mesh-list
25602146|NCT01024231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25602147|NCT01024231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602148|NCT01024231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25602149|NCT01024231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602150|NCT01024335|Naltrexone|naltrexone|mesh-list
25602151|NCT01024335|Dronabinol|dronabinol|mesh-list
25602152|NCT01024335|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25602153|NCT01024335|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25602154|NCT01024335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602155|NCT01024335|Sensory System Agents|sensory system agents|mesh-ancestor
25602156|NCT01024335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25602157|NCT01024335|Hallucinogens|hallucinogens|mesh-ancestor
25602158|NCT01024335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24480997|NCT00433069|Immunologic Factors|immunologic factors|mesh-ancestor
25602159|NCT01024335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25602160|NCT01024335|Analgesics|analgesics|mesh-ancestor
25602161|NCT01024335|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25602162|NCT01024335|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25602163|NCT01024335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25602164|NCT01024335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602165|NCT01024335|Hormones|hormones|mesh-ancestor
24491478|NCT00482716|Iron|iron|mesh-list
25602166|NCT01024335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25602167|NCT01024686|Vaccines|vaccines|mesh-list
25602168|NCT01024686|Immunologic Factors|immunologic factors|mesh-ancestor
25602169|NCT01024686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602170|NCT01024738|Chlorhexidine|chlorhexidine|mesh-list
25602171|NCT01024738|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25602172|NCT01024738|Triclosan|triclosan|mesh-list
25602173|NCT01024738|Fluorides|fluorides|mesh-list
25602174|NCT01024738|Cariostatic Agents|cariostatic agents|mesh-ancestor
25602175|NCT01024738|Protective Agents|protective agents|mesh-ancestor
25602176|NCT01024738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602177|NCT01024738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25602178|NCT01024738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25602179|NCT01024738|Disinfectants|disinfectants|mesh-ancestor
25602180|NCT01024738|Dermatologic Agents|dermatologic agents|mesh-ancestor
25602181|NCT01024738|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25602182|NCT01024738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25602183|NCT01024738|Antimetabolites|antimetabolites|mesh-ancestor
25602184|NCT01024738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602185|NCT01024738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25602186|NCT01024751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25602187|NCT01024920|Sunitinib|sunitinib|mesh-list
25602188|NCT01024920|Nintedanib|nintedanib|mesh-list
25602189|NCT01024920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602190|NCT01024920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25602191|NCT01024920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25602192|NCT01024920|Growth Substances|growth substances|mesh-ancestor
25602193|NCT01024920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602194|NCT01024920|Growth Inhibitors|growth inhibitors|mesh-ancestor
25602195|NCT01024920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25602196|NCT01024920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783738|NCT01903694|Sorafenib|sorafenib|mesh-list
25602197|NCT01024920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602198|NCT01024946|Everolimus|everolimus|mesh-list
25602199|NCT01024946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602200|NCT01024946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25602201|NCT01024946|Immunologic Factors|immunologic factors|mesh-ancestor
25602202|NCT01024946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602203|NCT01024972|Mannitol|mannitol|mesh-list
25602204|NCT01024972|Dantrolene|dantrolene|mesh-list
25602205|NCT01024972|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25602206|NCT01024972|Diuretics|diuretics|mesh-ancestor
25602207|NCT01024972|Natriuretic Agents|natriuretic agents|mesh-ancestor
25602208|NCT01024972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602209|NCT01024972|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25602210|NCT01024972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25602211|NCT01024972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25602212|NCT01025154|Cytarabine|cytarabine|mesh-list
25602213|NCT01025154|Clofarabine|clofarabine|mesh-list
25602214|NCT01025154|Idarubicin|idarubicin|mesh-list
25602215|NCT01025154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25602216|NCT01025154|Antimetabolites|antimetabolites|mesh-ancestor
25602217|NCT01025154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602218|NCT01025154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602219|NCT01025154|Antiviral Agents|antiviral agents|mesh-ancestor
25602220|NCT01025154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25602221|NCT01025154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25602222|NCT01025154|Immunologic Factors|immunologic factors|mesh-ancestor
25602223|NCT01025154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602224|NCT01025154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25602225|NCT01025154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25602226|NCT01025154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25602227|NCT01025154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602228|NCT01025193|Belimumab|belimumab|mesh-list
25602229|NCT01025193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24787689|NCT01926587|ON 01910|on 01910|mesh-list
25602230|NCT01025193|Immunologic Factors|immunologic factors|mesh-ancestor
25602231|NCT01025193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602232|NCT01025232|Ranibizumab|ranibizumab|mesh-list
25602233|NCT01025232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25602234|NCT01025232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25602235|NCT01025232|Growth Substances|growth substances|mesh-ancestor
25602236|NCT01025232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602237|NCT01025232|Growth Inhibitors|growth inhibitors|mesh-ancestor
25602238|NCT01025232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602239|NCT01025284|Lenograstim|lenograstim|mesh-list
25602240|NCT01025284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25602241|NCT01025284|Immunologic Factors|immunologic factors|mesh-ancestor
25602242|NCT01025284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602243|NCT01025427|Tenofovir|tenofovir|mesh-list
25602244|NCT01025427|Emtricitabine|emtricitabine|mesh-list
25602245|NCT01025427|Raltegravir Potassium|raltegravir potassium|mesh-list
25602246|NCT01025427|Antiviral Agents|antiviral agents|mesh-ancestor
25602247|NCT01025427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25602248|NCT01025427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25602249|NCT01025427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25602250|NCT01025427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602251|NCT01025427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602252|NCT01025427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25602253|NCT01025427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25602254|NCT01025427|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25602255|NCT01025427|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25602256|NCT01025453|Sirolimus|sirolimus|mesh-list
25602257|NCT01025453|Sorafenib|sorafenib|mesh-list
25602258|NCT01025453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602259|NCT01025453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25602260|NCT01025453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602261|NCT01025453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602262|NCT01025453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25602263|NCT01025453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25602264|NCT01025453|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25602265|NCT01025453|Antifungal Agents|antifungal agents|mesh-ancestor
24792604|NCT04917055|Autonomic Agents|autonomic agents|mesh-ancestor
25602266|NCT01025453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25602267|NCT01025453|Immunologic Factors|immunologic factors|mesh-ancestor
25602268|NCT01025453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602269|NCT01025635|Azelaic acid|azelaic acid|mesh-list
25602270|NCT01025635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602271|NCT01025635|Dermatologic Agents|dermatologic agents|mesh-ancestor
25602272|NCT01025817|Mycophenolic Acid|mycophenolic acid|mesh-list
25602273|NCT01025817|Everolimus|everolimus|mesh-list
25602274|NCT01025817|Tacrolimus|tacrolimus|mesh-list
25602275|NCT01025817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25602276|NCT01025817|Immunologic Factors|immunologic factors|mesh-ancestor
25602277|NCT01025817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486780|NCT00460083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25602278|NCT01025817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25602279|NCT01025817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602280|NCT01025817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602281|NCT01025817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602282|NCT01025817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25602283|NCT01025817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25602284|NCT01025817|Antitubercular Agents|antitubercular agents|mesh-ancestor
25602285|NCT01025817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24967661|NCT03757650|Antacids|antacids|mesh-ancestor
25602286|NCT01025817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25602287|NCT01025830|Lamivudine|lamivudine|mesh-list
25602288|NCT01025830|Nevirapine|nevirapine|mesh-list
25602289|NCT01025830|Stavudine|stavudine|mesh-list
25602290|NCT01025830|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
25602291|NCT01025830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24967876|NCT03756090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25602292|NCT01025830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25602293|NCT01025830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602294|NCT01025830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602295|NCT01025830|Antiviral Agents|antiviral agents|mesh-ancestor
25602296|NCT01025830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25602297|NCT01025830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25602298|NCT01025830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25602299|NCT01025830|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25602300|NCT01025830|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25602301|NCT01025830|Antimetabolites|antimetabolites|mesh-ancestor
25602302|NCT01025843|Candesartan|candesartan|mesh-list
24487909|NCT00465543|Antioxidants|antioxidants|mesh-ancestor
25602303|NCT01025843|Candesartan cilexetil|candesartan cilexetil|mesh-list
25602304|NCT01025843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25602305|NCT01025843|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25602306|NCT01025843|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25602307|NCT01025843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602308|NCT01026038|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25602309|NCT01026038|Immunologic Factors|immunologic factors|mesh-ancestor
25602310|NCT01026038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602311|NCT01026142|Capecitabine|capecitabine|mesh-list
25602312|NCT01026142|Trastuzumab|trastuzumab|mesh-list
25602313|NCT01026142|Pertuzumab|pertuzumab|mesh-list
24488166|NCT00466895|Lenalidomide|lenalidomide|mesh-list
25602314|NCT01026142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25602315|NCT01026142|Antimetabolites|antimetabolites|mesh-ancestor
25602316|NCT01026142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602317|NCT01026142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602318|NCT01026142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25602319|NCT01026194|Pioglitazone|pioglitazone|mesh-list
25602320|NCT01026194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25602321|NCT01026194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489114|NCT00471484|Antimetabolites|antimetabolites|mesh-ancestor
25602322|NCT01026324|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
25602323|NCT01026324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25602324|NCT01026324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602325|NCT01026324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499175|NCT00518141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602326|NCT01026389|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
25602327|NCT01026389|Chelating Agents|chelating agents|mesh-ancestor
24491480|NCT00482716|Epoetin Alfa|epoetin alfa|mesh-list
25602328|NCT01026389|Sequestering Agents|sequestering agents|mesh-ancestor
24492592|NCT00487032|Xhance|xhance|mesh-list
25602329|NCT01026389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496763|NCT00294658|Hormones|hormones|mesh-ancestor
25602331|NCT01026454|Acyclovir|acyclovir|mesh-list
25602332|NCT01026454|Antiviral Agents|antiviral agents|mesh-ancestor
25602333|NCT01026454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25602334|NCT01026493|Temozolomide|temozolomide|mesh-list
25602335|NCT01026493|Veliparib|veliparib|mesh-list
25602336|NCT01026493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25602337|NCT01026493|Alkylating Agents|alkylating agents|mesh-ancestor
25602338|NCT01026493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602339|NCT01026493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602340|NCT01026493|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25602341|NCT01026493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602342|NCT01026623|Sirolimus|sirolimus|mesh-list
25602343|NCT01026623|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25602344|NCT01026623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25602345|NCT01026623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25602346|NCT01026623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25602347|NCT01026623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602348|NCT01026623|Antifungal Agents|antifungal agents|mesh-ancestor
25602349|NCT01026623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25602350|NCT01026623|Immunologic Factors|immunologic factors|mesh-ancestor
25602351|NCT01026623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602352|NCT01026792|Sirolimus|sirolimus|mesh-list
25602353|NCT01026792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25602354|NCT01026792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25602355|NCT01026792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25602356|NCT01026792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602357|NCT01026792|Antifungal Agents|antifungal agents|mesh-ancestor
25602358|NCT01026792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25602359|NCT01026792|Immunologic Factors|immunologic factors|mesh-ancestor
25602360|NCT01026792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602361|NCT01026818|Tadalafil|tadalafil|mesh-list
25602362|NCT01026818|Vasodilator Agents|vasodilator agents|mesh-ancestor
25602363|NCT01026818|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25602364|NCT01026818|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25602365|NCT01026818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908253|NCT04322175|Meloxicam|meloxicam|mesh-list
25602366|NCT01026818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602367|NCT01026818|Urological Agents|urological agents|mesh-ancestor
25602368|NCT01026831|Timolol|timolol|mesh-list
25602369|NCT01026831|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25602370|NCT01026831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25602371|NCT01026831|Adrenergic Agents|adrenergic agents|mesh-ancestor
25602372|NCT01026831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24971023|NCT03729128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25602373|NCT01026831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971202|NCT03727607|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25602374|NCT01026831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602375|NCT01026831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25602376|NCT01026831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25602377|NCT01026844|Hydroxychloroquine|hydroxychloroquine|mesh-list
25602378|NCT01026844|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25602379|NCT01026844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602380|NCT01026844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25602381|NCT01026844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602382|NCT01026844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602383|NCT01026844|Antimalarials|antimalarials|mesh-ancestor
25602384|NCT01026844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25602385|NCT01026844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25602386|NCT01026844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25602387|NCT01026844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25602388|NCT01026909|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25602389|NCT01026909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25602390|NCT01026948|Dinoprostone|dinoprostone|mesh-list
25602391|NCT01026948|Oxytocics|oxytocics|mesh-ancestor
24971324|NCT03726593|Anthelmintics|anthelmintics|mesh-ancestor
25602392|NCT01026948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25602393|NCT01026948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602394|NCT01027000|Sirolimus|sirolimus|mesh-list
25602395|NCT01027000|Cyclophosphamide|cyclophosphamide|mesh-list
25602396|NCT01027000|Busulfan|busulfan|mesh-list
25602397|NCT01027000|Rituximab|rituximab|mesh-list
25602398|NCT01027000|Methotrexate|methotrexate|mesh-list
25602399|NCT01027000|Fludarabine|fludarabine|mesh-list
25602400|NCT01027000|Fludarabine phosphate|fludarabine phosphate|mesh-list
25602401|NCT01027000|Tacrolimus|tacrolimus|mesh-list
25602402|NCT01027000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25602403|NCT01027000|Immunologic Factors|immunologic factors|mesh-ancestor
25496839|NCT00295503|Bevacizumab|bevacizumab|mesh-list
25602404|NCT01027000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602405|NCT01027000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25602406|NCT01027000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25602407|NCT01027000|Alkylating Agents|alkylating agents|mesh-ancestor
25602408|NCT01027000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602409|NCT01027000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602410|NCT01027000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25602411|NCT01027000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25602412|NCT01027000|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25602413|NCT01027000|Abortifacient Agents|abortifacient agents|mesh-ancestor
25602414|NCT01027000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25602415|NCT01027000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25602416|NCT01027000|Antimetabolites|antimetabolites|mesh-ancestor
25602417|NCT01027000|Dermatologic Agents|dermatologic agents|mesh-ancestor
25602418|NCT01027000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602419|NCT01027000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24971801|NCT03722420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602420|NCT01027000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25602421|NCT01027000|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25602422|NCT01027000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25602423|NCT01027000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25602424|NCT01027000|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25602425|NCT01027000|Antifungal Agents|antifungal agents|mesh-ancestor
25602426|NCT01027351|Vaccines|vaccines|mesh-list
25602427|NCT01027351|Immunologic Factors|immunologic factors|mesh-ancestor
25602428|NCT01027351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602429|NCT01027416|Tamoxifen|tamoxifen|mesh-list
25602430|NCT01027416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25602431|NCT01027416|Hormone Antagonists|hormone antagonists|mesh-ancestor
25602432|NCT01027416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25602433|NCT01027416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602434|NCT01027416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25602435|NCT01027416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602436|NCT01027416|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25602437|NCT01027416|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25602438|NCT01027416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25602439|NCT01027468|Bevacizumab|bevacizumab|mesh-list
25602440|NCT01027468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25602441|NCT01027468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602442|NCT01027468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25602443|NCT01027468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25602444|NCT01027468|Growth Substances|growth substances|mesh-ancestor
25602445|NCT01027468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602446|NCT01027468|Growth Inhibitors|growth inhibitors|mesh-ancestor
25602447|NCT01027559|Sertraline|sertraline|mesh-list
25602448|NCT01027559|Antidepressive Agents|antidepressive agents|mesh-ancestor
25602449|NCT01027559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25602450|NCT01027559|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25602451|NCT01027559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25602452|NCT01027559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25602453|NCT01027559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602454|NCT01027559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25602455|NCT01027559|Serotonin Agents|serotonin agents|mesh-ancestor
25602456|NCT01027559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602457|NCT01027598|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25602458|NCT01027598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602459|NCT01027598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25602460|NCT01027598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602461|NCT01027598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602462|NCT01027650|Dexamethasone|dexamethasone|mesh-list
25602463|NCT01027650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25602464|NCT01027650|Antiemetics|antiemetics|mesh-ancestor
25602465|NCT01027650|Autonomic Agents|autonomic agents|mesh-ancestor
25602466|NCT01027650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25602467|NCT01027650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602468|NCT01027650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25602469|NCT01027650|Glucocorticoids|glucocorticoids|mesh-ancestor
25602470|NCT01027650|Hormones|hormones|mesh-ancestor
24504576|NCT00537121|Fluorouracil|fluorouracil|mesh-list
25602471|NCT01027650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25602472|NCT01027650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25602473|NCT01027650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602474|NCT01027754|Varenicline|varenicline|mesh-list
25602475|NCT01027754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25602476|NCT01027754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25602477|NCT01027754|Cholinergic Agents|cholinergic agents|mesh-ancestor
25602478|NCT01027754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24794658|NCT04776850|Fludarabine|fludarabine|mesh-list
25602479|NCT01027754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602480|NCT01027754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602482|NCT01027793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602483|NCT01027793|Keratolytic Agents|keratolytic agents|mesh-ancestor
25602484|NCT01027793|Dermatologic Agents|dermatologic agents|mesh-ancestor
25602485|NCT01027806|Montelukast|montelukast|mesh-list
25602486|NCT01027806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25602487|NCT01027806|Respiratory System Agents|respiratory system agents|mesh-ancestor
25602488|NCT01027806|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25602489|NCT01027806|Hormone Antagonists|hormone antagonists|mesh-ancestor
25602490|NCT01027806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25602491|NCT01027806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602492|NCT01027806|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25602493|NCT01027806|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25602494|NCT01027806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602495|NCT01027845|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25602496|NCT01027845|Immunologic Factors|immunologic factors|mesh-ancestor
25602497|NCT01027845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602498|NCT01027871|Insulin Glargine|insulin glargine|mesh-list
25602499|NCT01027871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25602500|NCT01027871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602501|NCT01027884|Idebenone|idebenone|mesh-list
25602502|NCT01027884|Antioxidants|antioxidants|mesh-ancestor
24629413|NCT01105234|Vitamins|vitamins|mesh-ancestor
25602503|NCT01027884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602504|NCT01027884|Protective Agents|protective agents|mesh-ancestor
25602505|NCT01027884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602506|NCT01027897|Doripenem|doripenem|mesh-list
25602507|NCT01027897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25602508|NCT01027897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25602509|NCT01027910|Doxorubicin|doxorubicin|mesh-list
25602510|NCT01027910|Abexinostat|abexinostat|mesh-list
25602511|NCT01027910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24973757|NCT03707418|Heparin|heparin|mesh-list
24794660|NCT04776850|Bortezomib|bortezomib|mesh-list
25602512|NCT01027910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602513|NCT01027910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25602514|NCT01027910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25602515|NCT01027910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602516|NCT01027910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602517|NCT01027910|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25602518|NCT01027949|Treprostinil|treprostinil|mesh-list
25602519|NCT01027949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25602520|NCT01028014|Pseudoephedrine|pseudoephedrine|mesh-list
25602521|NCT01028014|Ephedrine|ephedrine|mesh-list
25602522|NCT01028014|Cyclobenzaprine|cyclobenzaprine|mesh-list
25602523|NCT01028014|Imipramine|imipramine|mesh-list
25602524|NCT01028014|Tamsulosin|tamsulosin|mesh-list
25602525|NCT01028014|Solifenacin Succinate|solifenacin succinate|mesh-list
25602526|NCT01028014|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25602527|NCT01028014|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25602528|NCT01028014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25602529|NCT01028014|Adrenergic Agents|adrenergic agents|mesh-ancestor
25602530|NCT01028014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25602531|NCT01028014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602532|NCT01028014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602533|NCT01028014|Urological Agents|urological agents|mesh-ancestor
25602534|NCT01028014|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25602535|NCT01028014|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25602536|NCT01028014|Cholinergic Agents|cholinergic agents|mesh-ancestor
25602537|NCT01028014|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25602538|NCT01028014|Autonomic Agents|autonomic agents|mesh-ancestor
25602539|NCT01028014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25602540|NCT01028014|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25602541|NCT01028014|Respiratory System Agents|respiratory system agents|mesh-ancestor
25602542|NCT01028014|Nasal Decongestants|nasal decongestants|mesh-ancestor
25602543|NCT01028014|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25602544|NCT01028014|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25602545|NCT01028014|Sympathomimetics|sympathomimetics|mesh-ancestor
25602546|NCT01028014|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25602547|NCT01028014|Antidepressive Agents|antidepressive agents|mesh-ancestor
25602548|NCT01028014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25602549|NCT01028014|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25602550|NCT01028014|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25602551|NCT01028014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25602552|NCT01028014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25602553|NCT01028014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25602554|NCT01028014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25602555|NCT01028014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25602556|NCT01028027|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25602557|NCT01028027|Tobramycin|tobramycin|mesh-list
25602558|NCT01028027|Dexamethasone|dexamethasone|mesh-list
25602559|NCT01028027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25602560|NCT01028027|Antiemetics|antiemetics|mesh-ancestor
25602561|NCT01028027|Autonomic Agents|autonomic agents|mesh-ancestor
25602562|NCT01028027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25602563|NCT01028027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602564|NCT01028027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25602565|NCT01028027|Glucocorticoids|glucocorticoids|mesh-ancestor
25602566|NCT01028027|Hormones|hormones|mesh-ancestor
25602567|NCT01028027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25602568|NCT01028027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25602569|NCT01028027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602570|NCT01028027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25602571|NCT01028027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25602572|NCT01028027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25602573|NCT01028053|Flutemetamol|flutemetamol|mesh-list
25602574|NCT01028053|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25602575|NCT01028053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602576|NCT01028222|Dacarbazine|dacarbazine|mesh-list
25602577|NCT01028222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25602578|NCT01028222|Alkylating Agents|alkylating agents|mesh-ancestor
25602579|NCT01028222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602580|NCT01028222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602581|NCT01028352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25602582|NCT01028352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25602583|NCT01028352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25602584|NCT01028352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25602585|NCT01028352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602586|NCT01028352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25602587|NCT01028352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602588|NCT01028352|Analgesics|analgesics|mesh-ancestor
25084748|NCT03303651|Analgesics|analgesics|mesh-ancestor
25602589|NCT01028352|Sensory System Agents|sensory system agents|mesh-ancestor
25602590|NCT01028352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25602591|NCT01028352|Antidepressive Agents|antidepressive agents|mesh-ancestor
25602592|NCT01028352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25084940|NCT03302299|Pyridoxine|pyridoxine|mesh-list
25602593|NCT01028352|Dopamine Agents|dopamine agents|mesh-ancestor
25602594|NCT01028391|Metformin|metformin|mesh-list
25602595|NCT01028391|Pioglitazone|pioglitazone|mesh-list
25602596|NCT01028391|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25602597|NCT01028391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25602598|NCT01028391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602599|NCT01028391|Incretins|incretins|mesh-ancestor
25602600|NCT01028391|Hormones|hormones|mesh-ancestor
25602601|NCT01028391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25602602|NCT01028391|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25602603|NCT01028391|Protease Inhibitors|protease inhibitors|mesh-ancestor
25602604|NCT01028391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24410615|NCT00186745|Dalteparin|dalteparin|mesh-list
25602605|NCT01028391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602606|NCT01028651|Treprostinil|treprostinil|mesh-list
25602607|NCT01028651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25602608|NCT01028677|Oxytocin|oxytocin|mesh-list
25602609|NCT01028677|Oxytocics|oxytocics|mesh-ancestor
25602610|NCT01028677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25602611|NCT01028677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602612|NCT01028820|Aripiprazole|aripiprazole|mesh-list
25602613|NCT01028820|Antidepressive Agents|antidepressive agents|mesh-ancestor
25602614|NCT01028820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25602615|NCT01028820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25602616|NCT01028820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25086327|NCT03290417|Antioxidants|antioxidants|mesh-ancestor
25602617|NCT01028820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25602618|NCT01028820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602619|NCT01028820|Dopamine Agonists|dopamine agonists|mesh-ancestor
25602620|NCT01028820|Dopamine Agents|dopamine agents|mesh-ancestor
24411548|NCT00189384|Penicillin G|penicillin g|mesh-list
25602621|NCT01028820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25602622|NCT01028820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087203|NCT03281187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602623|NCT01028820|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25497014|NCT00296491|Xhance|xhance|mesh-list
25602624|NCT01028820|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25602626|NCT01028820|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25602627|NCT01028820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25602628|NCT01028820|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25602629|NCT01028820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25654081|NCT01546038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654082|NCT01546038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25654083|NCT01546038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25654084|NCT01546038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25654085|NCT01546038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25654086|NCT01546142|Deoxycholic Acid|deoxycholic acid|mesh-list
25654087|NCT01546142|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25654088|NCT01546142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25654089|NCT01546402|Dexamethasone|dexamethasone|mesh-list
25654090|NCT01546402|Dexamethasone acetate|dexamethasone acetate|mesh-list
25654091|NCT01546402|BB 1101|bb 1101|mesh-list
25654092|NCT01546402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25654093|NCT01546402|Antiemetics|antiemetics|mesh-ancestor
25654094|NCT01546402|Autonomic Agents|autonomic agents|mesh-ancestor
25654095|NCT01546402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25654096|NCT01546402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654097|NCT01546402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25654098|NCT01546402|Glucocorticoids|glucocorticoids|mesh-ancestor
25654099|NCT01546402|Hormones|hormones|mesh-ancestor
25654100|NCT01546402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25654101|NCT01546402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25654102|NCT01546402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25654103|NCT01546402|Protease Inhibitors|protease inhibitors|mesh-ancestor
25654104|NCT01546402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25088889|NCT03270839|Scopolamine|scopolamine|mesh-list
25654105|NCT01546402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654106|NCT01546454|Leuprolide|leuprolide|mesh-list
25654107|NCT01546454|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25654108|NCT01546454|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25654109|NCT01546454|Levonorgestrel|levonorgestrel|mesh-list
25654110|NCT01546454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25654111|NCT01546454|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25654112|NCT01546454|Estradiol|estradiol|mesh-list
25654113|NCT01546454|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25654114|NCT01546454|Progesterone|progesterone|mesh-list
25654115|NCT01546454|Estrogens|estrogens|mesh-ancestor
25654116|NCT01546454|Hormones|hormones|mesh-ancestor
25654117|NCT01546454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25654118|NCT01546454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654119|NCT01546454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25654120|NCT01546454|Contraceptive Agents|contraceptive agents|mesh-ancestor
25654121|NCT01546454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25654122|NCT01546454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25654123|NCT01546454|Progestins|progestins|mesh-ancestor
25654124|NCT01546454|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25654125|NCT01546454|Fertility Agents|fertility agents|mesh-ancestor
25654126|NCT01546454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25654127|NCT01546454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25654128|NCT01546454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25654129|NCT01546454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25654130|NCT01546454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25654131|NCT01546454|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25654132|NCT01546623|Leuprolide|leuprolide|mesh-list
25654133|NCT01546623|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25654134|NCT01546623|Fertility Agents|fertility agents|mesh-ancestor
25654135|NCT01546623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25654136|NCT01546623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654137|NCT01546623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25654138|NCT01546623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25654139|NCT01546649|Leuprolide|leuprolide|mesh-list
25654140|NCT01546649|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25654141|NCT01546649|Fertility Agents|fertility agents|mesh-ancestor
25654142|NCT01546649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25654143|NCT01546649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654144|NCT01546649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25654145|NCT01546649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25654146|NCT01546688|Zonisamide|zonisamide|mesh-list
25654147|NCT01546688|Anticonvulsants|anticonvulsants|mesh-ancestor
25654148|NCT01546688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25654149|NCT01546688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25602631|NCT01029054|Dexamethasone acetate|dexamethasone acetate|mesh-list
25602632|NCT01029054|Lenalidomide|lenalidomide|mesh-list
25602633|NCT01029054|BB 1101|bb 1101|mesh-list
25602634|NCT01029054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25602635|NCT01029054|Antiemetics|antiemetics|mesh-ancestor
25602636|NCT01029054|Autonomic Agents|autonomic agents|mesh-ancestor
25602637|NCT01029054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24399314|NCT00147381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24399315|NCT00147381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24399434|NCT00147771|Imiquimod|imiquimod|mesh-list
25602638|NCT01029054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602639|NCT01029054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25602640|NCT01029054|Glucocorticoids|glucocorticoids|mesh-ancestor
25602641|NCT01029054|Hormones|hormones|mesh-ancestor
25602642|NCT01029054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25602643|NCT01029054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25602644|NCT01029054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602645|NCT01029054|Protease Inhibitors|protease inhibitors|mesh-ancestor
25602646|NCT01029054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602647|NCT01029054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602648|NCT01029054|Immunologic Factors|immunologic factors|mesh-ancestor
25602649|NCT01029054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25602650|NCT01029054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25602651|NCT01029054|Growth Substances|growth substances|mesh-ancestor
25602652|NCT01029054|Growth Inhibitors|growth inhibitors|mesh-ancestor
25602653|NCT01029262|Lenalidomide|lenalidomide|mesh-list
25602654|NCT01029262|Immunologic Factors|immunologic factors|mesh-ancestor
24400556|NCT00150839|Histamine Agents|histamine agents|mesh-ancestor
24400557|NCT00150839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24400602|NCT00150982|Immunologic Factors|immunologic factors|mesh-ancestor
24400603|NCT00150982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400604|NCT00150995|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
25602655|NCT01029262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602656|NCT01029262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25602657|NCT01029262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25602658|NCT01029262|Growth Substances|growth substances|mesh-ancestor
25602659|NCT01029262|Growth Inhibitors|growth inhibitors|mesh-ancestor
25602660|NCT01029262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602661|NCT01029340|Factor VIII|factor viii|mesh-list
25602662|NCT01029340|Coagulants|coagulants|mesh-ancestor
25602663|NCT01029392|Vitamin D|vitamin d|mesh-list
25602664|NCT01029392|Cholecalciferol|cholecalciferol|mesh-list
25602665|NCT01029392|Vitamins|vitamins|mesh-ancestor
25602666|NCT01029392|Micronutrients|micronutrients|mesh-ancestor
25602667|NCT01029392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602668|NCT01029392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25602669|NCT01029392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25602670|NCT01029535|Hyaluronic Acid|hyaluronic acid|mesh-list
25602671|NCT01029535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25602672|NCT01029535|Immunologic Factors|immunologic factors|mesh-ancestor
25602673|NCT01029535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602674|NCT01029535|Viscosupplements|viscosupplements|mesh-ancestor
25602675|NCT01029535|Protective Agents|protective agents|mesh-ancestor
25602676|NCT01029587|Eculizumab|eculizumab|mesh-list
24421613|NCT00219765|Imatinib Mesylate|imatinib mesylate|mesh-list
24403073|NCT00159159|Cyclosporine|cyclosporine|mesh-list
24403208|NCT00159653|Timolol|timolol|mesh-list
25602677|NCT01029587|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25602678|NCT01029587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25602679|NCT01029587|Immunologic Factors|immunologic factors|mesh-ancestor
25602680|NCT01029587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602681|NCT01029652|Triamcinolone|triamcinolone|mesh-list
25602682|NCT01029652|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25602683|NCT01029652|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25602684|NCT01029652|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25602685|NCT01029652|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25602686|NCT01029652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25602687|NCT01029652|Glucocorticoids|glucocorticoids|mesh-ancestor
25602688|NCT01029652|Hormones|hormones|mesh-ancestor
24405689|NCT00167947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24405690|NCT00167947|Immunologic Factors|immunologic factors|mesh-ancestor
24405691|NCT00167947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405692|NCT00167947|Antifungal Agents|antifungal agents|mesh-ancestor
24405693|NCT00167947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24405694|NCT00167947|Dermatologic Agents|dermatologic agents|mesh-ancestor
24405695|NCT00167947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24405696|NCT00167947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24405697|NCT00167947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25090848|NCT03253224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24405831|NCT00168519|Nitroprusside|nitroprusside|mesh-list
25602689|NCT01029652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25602690|NCT01029652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602691|NCT01029652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25602692|NCT01029652|Immunologic Factors|immunologic factors|mesh-ancestor
25602693|NCT01029652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602694|NCT01029652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602695|NCT01029704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25602696|NCT01029704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602697|NCT01029704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25602698|NCT01029704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602699|NCT01029730|Rituximab|rituximab|mesh-list
25602700|NCT01029730|Bortezomib|bortezomib|mesh-list
25602701|NCT01029730|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25602702|NCT01029730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25602703|NCT01029730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602704|NCT01029730|Immunologic Factors|immunologic factors|mesh-ancestor
25602705|NCT01029730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602706|NCT01029730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24431035|NCT00250081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25602707|NCT01029730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25602708|NCT01029730|Alkylating Agents|alkylating agents|mesh-ancestor
25602709|NCT01029730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602710|NCT01029782|Cefazolin|cefazolin|mesh-list
25602711|NCT01029782|Cephalexin|cephalexin|mesh-list
25602712|NCT01029782|Probenecid|probenecid|mesh-list
25602713|NCT01029782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25602714|NCT01029782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25602715|NCT01029782|Uricosuric Agents|uricosuric agents|mesh-ancestor
25602716|NCT01029782|Gout Suppressants|gout suppressants|mesh-ancestor
25602717|NCT01029782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25602718|NCT01029782|Renal Agents|renal agents|mesh-ancestor
25602719|NCT01029795|Glyburide|glyburide|mesh-list
25602720|NCT01029795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25602721|NCT01029795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602722|NCT01029886|Liraglutide|liraglutide|mesh-list
25602723|NCT01029886|Exenatide|exenatide|mesh-list
25602724|NCT01029886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25602725|NCT01029886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602726|NCT01029886|Incretins|incretins|mesh-ancestor
25602727|NCT01029886|Hormones|hormones|mesh-ancestor
25602728|NCT01029886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25602729|NCT01029886|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25602730|NCT01030458|Amlodipine|amlodipine|mesh-list
25602731|NCT01030458|Valsartan|valsartan|mesh-list
25602732|NCT01030458|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25602733|NCT01030458|Bisoprolol|bisoprolol|mesh-list
25602734|NCT01030458|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25602735|NCT01030458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25602736|NCT01030458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25602737|NCT01030458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602738|NCT01030458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25602739|NCT01030458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602740|NCT01030458|Vasodilator Agents|vasodilator agents|mesh-ancestor
25602741|NCT01030458|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25602742|NCT01030458|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25602743|NCT01030458|Diuretics|diuretics|mesh-ancestor
25602744|NCT01030458|Natriuretic Agents|natriuretic agents|mesh-ancestor
25602745|NCT01030458|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25602746|NCT01030458|Sympatholytics|sympatholytics|mesh-ancestor
25602747|NCT01030458|Autonomic Agents|autonomic agents|mesh-ancestor
25602748|NCT01030458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25602749|NCT01030458|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25602750|NCT01030458|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25602751|NCT01030458|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25602752|NCT01030458|Adrenergic Agents|adrenergic agents|mesh-ancestor
25602753|NCT01030458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25602754|NCT01030536|Immunotoxin HA22|immunotoxin ha22|mesh-list
25602755|NCT01030536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602756|NCT01030653|Voriconazole|voriconazole|mesh-list
25602757|NCT01030653|Antifungal Agents|antifungal agents|mesh-ancestor
25602758|NCT01030653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25602759|NCT01030653|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25602760|NCT01030653|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25602761|NCT01030653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602762|NCT01030653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602763|NCT01030653|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25602764|NCT01030653|Hormone Antagonists|hormone antagonists|mesh-ancestor
25602765|NCT01030653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25602766|NCT01030653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602767|NCT01030653|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25602768|NCT01030666|Chlorhexidine|chlorhexidine|mesh-list
25602769|NCT01030666|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25602770|NCT01030666|Doxycycline|doxycycline|mesh-list
25602771|NCT01030666|Ibuprofen|ibuprofen|mesh-list
25602772|NCT01030666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25602773|NCT01030666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25602774|NCT01030666|Analgesics|analgesics|mesh-ancestor
25602775|NCT01030666|Sensory System Agents|sensory system agents|mesh-ancestor
25602776|NCT01030666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25602777|NCT01030666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602778|NCT01030666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25602779|NCT01030666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25497279|NCT00298610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25497280|NCT00298610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497281|NCT00298610|Antiviral Agents|antiviral agents|mesh-ancestor
25497282|NCT00298610|Schistosomicides|schistosomicides|mesh-ancestor
25497283|NCT00298610|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25497284|NCT00298610|Anthelmintics|anthelmintics|mesh-ancestor
25497285|NCT00298610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497286|NCT00298610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497287|NCT00298610|Antimetabolites|antimetabolites|mesh-ancestor
25497288|NCT00298610|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25497289|NCT00298610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25497290|NCT00298610|Adrenergic Agents|adrenergic agents|mesh-ancestor
25097134|NCT03206671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497291|NCT00298610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25497292|NCT00298610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497293|NCT00298610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25497294|NCT00298610|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25497295|NCT00298610|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25497296|NCT00298610|Cholinergic Agents|cholinergic agents|mesh-ancestor
25497297|NCT00298610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25497298|NCT00298610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25497299|NCT00298610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25497300|NCT00298610|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25497301|NCT00298610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25497302|NCT00298766|Bortezomib|bortezomib|mesh-list
25097416|NCT03204032|Thalidomide|thalidomide|mesh-list
25497303|NCT00298766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497304|NCT00298831|Rocuronium|rocuronium|mesh-list
25497305|NCT00298831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25497306|NCT00298831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25497307|NCT00298831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25497308|NCT00298831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25497309|NCT00298831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772636|NCT01834820|Mydriatics|mydriatics|mesh-ancestor
25067280|NCT03444649|Cytarabine|cytarabine|mesh-list
24434980|NCT00264615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24434991|NCT00264654|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25708343|NCT02249585|Iodine|iodine|mesh-list
24434992|NCT00264654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24434993|NCT00264654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24434994|NCT00264654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434995|NCT00264654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24434996|NCT00264654|Serotonin Agents|serotonin agents|mesh-ancestor
25124102|NCT03079544|Asparaginase|asparaginase|mesh-list
25708353|NCT02249949|Efatutazone|efatutazone|mesh-list
25602780|NCT01030666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25602781|NCT01030666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602782|NCT01030666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602783|NCT01030666|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25602784|NCT01030666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25602785|NCT01030666|Disinfectants|disinfectants|mesh-ancestor
25602786|NCT01030666|Dermatologic Agents|dermatologic agents|mesh-ancestor
25602787|NCT01030666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25602788|NCT01030666|Antimalarials|antimalarials|mesh-ancestor
25602789|NCT01030666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25602790|NCT01030666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25602791|NCT01030718|Dasatinib|dasatinib|mesh-list
25602792|NCT01030718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602793|NCT01030718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25602794|NCT01030718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602795|NCT01030718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602796|NCT01030783|Sorafenib|sorafenib|mesh-list
25602797|NCT01030783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602798|NCT01030783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25602799|NCT01030783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602800|NCT01030783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602801|NCT01030822|Vaccines|vaccines|mesh-list
25602802|NCT01030822|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25602803|NCT01030822|Immunologic Factors|immunologic factors|mesh-ancestor
25602804|NCT01030822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602805|NCT01030952|Acarbose|acarbose|mesh-list
25602806|NCT01030952|Nateglinide|nateglinide|mesh-list
25602807|NCT01030952|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25602808|NCT01030952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602809|NCT01030952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602810|NCT01030952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25098106|NCT03199339|Dopamine Agents|dopamine agents|mesh-ancestor
25602811|NCT01030952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602812|NCT01031043|Bethanechol|bethanechol|mesh-list
25602813|NCT01031043|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25602814|NCT01031043|Autonomic Agents|autonomic agents|mesh-ancestor
25602815|NCT01031043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25602816|NCT01031043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602817|NCT01031043|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25602818|NCT01031043|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25602819|NCT01031043|Cholinergic Agents|cholinergic agents|mesh-ancestor
25602820|NCT01031043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25602821|NCT01031043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602823|NCT01031069|Immunologic Factors|immunologic factors|mesh-ancestor
25602824|NCT01031069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602825|NCT01031381|Bevacizumab|bevacizumab|mesh-list
25602826|NCT01031381|Everolimus|everolimus|mesh-list
25602827|NCT01031381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25602828|NCT01031381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602829|NCT01031381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25602830|NCT01031381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25602831|NCT01031381|Growth Substances|growth substances|mesh-ancestor
25602832|NCT01031381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602833|NCT01031381|Growth Inhibitors|growth inhibitors|mesh-ancestor
25602834|NCT01031381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25602835|NCT01031381|Immunologic Factors|immunologic factors|mesh-ancestor
25602836|NCT01031420|Doxorubicin|doxorubicin|mesh-list
25602837|NCT01031420|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25602838|NCT01031420|Methotrexate|methotrexate|mesh-list
25602839|NCT01031420|Vinblastine|vinblastine|mesh-list
25602840|NCT01031420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25602841|NCT01031420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602842|NCT01031420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25602843|NCT01031420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25602844|NCT01031420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602845|NCT01031420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099126|NCT03193424|Docetaxel|docetaxel|mesh-list
25602846|NCT01031420|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25602847|NCT01031420|Abortifacient Agents|abortifacient agents|mesh-ancestor
25602848|NCT01031420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25602849|NCT01031420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602850|NCT01031420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25602851|NCT01031420|Antimetabolites|antimetabolites|mesh-ancestor
25602852|NCT01031420|Dermatologic Agents|dermatologic agents|mesh-ancestor
25602853|NCT01031420|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25602854|NCT01031420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25602855|NCT01031420|Immunologic Factors|immunologic factors|mesh-ancestor
25602856|NCT01031420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25602857|NCT01031420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25602858|NCT01031420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25602859|NCT01031420|Tubulin Modulators|tubulin modulators|mesh-ancestor
25602860|NCT01031420|Antimitotic Agents|antimitotic agents|mesh-ancestor
25602861|NCT01031420|Mitosis Modulators|mitosis modulators|mesh-ancestor
25602862|NCT01031446|Paclitaxel|paclitaxel|mesh-list
25602863|NCT01031446|Cisplatin|cisplatin|mesh-list
25602864|NCT01031446|Everolimus|everolimus|mesh-list
25602865|NCT01031446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25602866|NCT01031446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602867|NCT01031446|Tubulin Modulators|tubulin modulators|mesh-ancestor
25602868|NCT01031446|Antimitotic Agents|antimitotic agents|mesh-ancestor
25602869|NCT01031446|Mitosis Modulators|mitosis modulators|mesh-ancestor
25602870|NCT01031446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602871|NCT01031446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25602872|NCT01031446|Immunologic Factors|immunologic factors|mesh-ancestor
25602873|NCT01031446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602874|NCT01031498|Ondansetron|ondansetron|mesh-list
25602875|NCT01031498|Palonosetron|palonosetron|mesh-list
25602876|NCT01031498|Antiemetics|antiemetics|mesh-ancestor
25602877|NCT01031498|Autonomic Agents|autonomic agents|mesh-ancestor
25602878|NCT01031498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25602879|NCT01031498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602880|NCT01031498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25602881|NCT01031498|Antipruritics|antipruritics|mesh-ancestor
25602882|NCT01031498|Dermatologic Agents|dermatologic agents|mesh-ancestor
25602883|NCT01031498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25602884|NCT01031498|Serotonin Agents|serotonin agents|mesh-ancestor
25602885|NCT01031498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25602886|NCT01031498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602887|NCT01031498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25602888|NCT01031498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25602889|NCT01031498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25602890|NCT01031498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25602891|NCT01031498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25602892|NCT01031498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25602893|NCT01031680|Dapagliflozin|dapagliflozin|mesh-list
25602894|NCT01031680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25602895|NCT01031680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602896|NCT01031680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25602897|NCT01031680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602898|NCT01031810|Tranylcypromine|tranylcypromine|mesh-list
25602899|NCT01031810|Antidepressive Agents|antidepressive agents|mesh-ancestor
25602900|NCT01031810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25104447|NCT03152955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25602901|NCT01031810|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25602902|NCT01031810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602903|NCT01031810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602904|NCT01031810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25602905|NCT01031810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25602906|NCT01031810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25602907|NCT01031810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602908|NCT01031836|Sifalimumab|sifalimumab|mesh-list
25602909|NCT01031836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25602910|NCT01031836|Immunologic Factors|immunologic factors|mesh-ancestor
25602911|NCT01031836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602912|NCT01031953|Fosaprepitant|fosaprepitant|mesh-list
25602913|NCT01031953|Aprepitant|aprepitant|mesh-list
25602914|NCT01031953|Antiemetics|antiemetics|mesh-ancestor
25602915|NCT01031953|Autonomic Agents|autonomic agents|mesh-ancestor
25602916|NCT01031953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25602917|NCT01031953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602918|NCT01031953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25602919|NCT01031953|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25602920|NCT01031953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25602921|NCT01031953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602922|NCT01031979|Yohimbine|yohimbine|mesh-list
25602923|NCT01031979|Mydriatics|mydriatics|mesh-ancestor
25602924|NCT01031979|Autonomic Agents|autonomic agents|mesh-ancestor
25602925|NCT01031979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25602926|NCT01031979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602927|NCT01031979|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25602928|NCT01031979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25602929|NCT01031979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25602930|NCT01031979|Adrenergic Agents|adrenergic agents|mesh-ancestor
25602931|NCT01031979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25708488|NCT02252081|Metformin|metformin|mesh-list
25602932|NCT01031979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602933|NCT01031979|Urological Agents|urological agents|mesh-ancestor
25602934|NCT01032018|Bupropion|bupropion|mesh-list
25602935|NCT01032018|Citalopram|citalopram|mesh-list
25602936|NCT01032018|Sertraline|sertraline|mesh-list
25602937|NCT01032018|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25602938|NCT01032018|Antidepressive Agents|antidepressive agents|mesh-ancestor
25602939|NCT01032018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25602940|NCT01032018|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25602941|NCT01032018|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25602942|NCT01032018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25602943|NCT01032018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602944|NCT01032018|Dopamine Agents|dopamine agents|mesh-ancestor
24448237|NCT00310843|Nevirapine|nevirapine|mesh-list
25602945|NCT01032018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25602946|NCT01032018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602947|NCT01032018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25602948|NCT01032018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25602949|NCT01032018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602950|NCT01032018|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25602951|NCT01032018|Serotonin Agents|serotonin agents|mesh-ancestor
25602952|NCT01032070|Etoposide|etoposide|mesh-list
25602953|NCT01032070|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25602954|NCT01032070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25602955|NCT01032070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602956|NCT01032070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25602957|NCT01032070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25602958|NCT01032070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602959|NCT01032070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497391|NCT00299182|Antiemetics|antiemetics|mesh-ancestor
25602960|NCT01032070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25602961|NCT01032174|Azithromycin|azithromycin|mesh-list
25602962|NCT01032174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25602963|NCT01032174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25602964|NCT01032200|Modafinil|modafinil|mesh-list
25602965|NCT01032200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25602966|NCT01032200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416654|NCT00203697|Minocycline|minocycline|mesh-list
25602967|NCT01032200|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25602968|NCT01032200|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25602969|NCT01032200|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25602970|NCT01032200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602971|NCT01032239|Baclofen|baclofen|mesh-list
25602972|NCT01032239|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25602973|NCT01032239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602974|NCT01032239|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25602975|NCT01032239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25602976|NCT01032239|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25602977|NCT01032239|GABA Agonists|gaba agonists|mesh-ancestor
25602978|NCT01032239|GABA Agents|gaba agents|mesh-ancestor
25602979|NCT01032239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25602980|NCT01032239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602981|NCT01032291|Lenalidomide|lenalidomide|mesh-list
25602982|NCT01032291|Cetuximab|cetuximab|mesh-list
25602983|NCT01032291|Immunologic Factors|immunologic factors|mesh-ancestor
25602984|NCT01032291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25602985|NCT01032291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25602986|NCT01032291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25602987|NCT01032291|Growth Substances|growth substances|mesh-ancestor
25602988|NCT01032291|Growth Inhibitors|growth inhibitors|mesh-ancestor
25602989|NCT01032291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25602990|NCT01032291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25602991|NCT01032382|Gentamicins|gentamicins|mesh-list
25602992|NCT01032382|Paromomycin|paromomycin|mesh-list
25602993|NCT01032382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25602994|NCT01032382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25602995|NCT01032382|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25602996|NCT01032382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25602997|NCT01032382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25602998|NCT01032382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25602999|NCT01032382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25603000|NCT01032629|Canagliflozin|canagliflozin|mesh-list
25603001|NCT01032629|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25708528|NCT02252588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25603002|NCT01032629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603003|NCT01032629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25603004|NCT01032629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603005|NCT01032694|Azithromycin|azithromycin|mesh-list
25603006|NCT01032694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25603007|NCT01032694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25603008|NCT01032759|Memantine|memantine|mesh-list
25603009|NCT01032759|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25603010|NCT01032759|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25603011|NCT01032759|Dopamine Agents|dopamine agents|mesh-ancestor
25603012|NCT01032759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25603013|NCT01032759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603014|NCT01032759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603015|NCT01032759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25603016|NCT01032759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25603017|NCT01032837|Oseltamivir|oseltamivir|mesh-list
25603018|NCT01032837|Antiviral Agents|antiviral agents|mesh-ancestor
25603019|NCT01032837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25603020|NCT01032837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603021|NCT01032837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603022|NCT01032850|Capecitabine|capecitabine|mesh-list
25603023|NCT01032850|Sorafenib|sorafenib|mesh-list
25603024|NCT01032850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25603025|NCT01032850|Antimetabolites|antimetabolites|mesh-ancestor
25603026|NCT01032850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603027|NCT01032850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603028|NCT01032850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25603029|NCT01032850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603030|NCT01032889|Deoxycholic Acid|deoxycholic acid|mesh-list
25603031|NCT01032889|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25603032|NCT01032889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25603033|NCT01032915|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25603034|NCT01032915|Immunologic Factors|immunologic factors|mesh-ancestor
25603035|NCT01032915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603036|NCT01032954|Botulinum Toxins|botulinum toxins|mesh-list
25603037|NCT01032954|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25603038|NCT01032954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25603039|NCT01032954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603040|NCT01032954|Cholinergic Agents|cholinergic agents|mesh-ancestor
25603041|NCT01032954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25603042|NCT01032954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603043|NCT01032993|Ubiquinone|ubiquinone|mesh-list
25603044|NCT01032993|Coenzyme Q10|coenzyme q10|mesh-list
25603045|NCT01032993|Micronutrients|micronutrients|mesh-ancestor
25603046|NCT01032993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603047|NCT01032993|Vitamins|vitamins|mesh-ancestor
25603048|NCT01033071|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25603049|NCT01033071|Olmesartan|olmesartan|mesh-list
25603050|NCT01033071|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25603051|NCT01033071|Chlorthalidone|chlorthalidone|mesh-list
25603052|NCT01033071|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25603053|NCT01033071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25603054|NCT01033071|Diuretics|diuretics|mesh-ancestor
25603055|NCT01033071|Natriuretic Agents|natriuretic agents|mesh-ancestor
25603056|NCT01033071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603057|NCT01033071|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25603058|NCT01033071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25603059|NCT01033071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603060|NCT01033071|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25603061|NCT01033071|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25603062|NCT01033240|Sorafenib|sorafenib|mesh-list
25603063|NCT01033240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603064|NCT01033240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25603065|NCT01033240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603066|NCT01033240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603067|NCT01033448|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25603068|NCT01033448|Antiviral Agents|antiviral agents|mesh-ancestor
25603069|NCT01033448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25603070|NCT01033565|Melatonin|melatonin|mesh-list
25603071|NCT01033565|Antioxidants|antioxidants|mesh-ancestor
25603072|NCT01033565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603073|NCT01033565|Protective Agents|protective agents|mesh-ancestor
25603074|NCT01033565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603075|NCT01033565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25603076|NCT01033734|Oseltamivir|oseltamivir|mesh-list
25603077|NCT01033734|Antiviral Agents|antiviral agents|mesh-ancestor
25603078|NCT01033734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25603079|NCT01033734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603080|NCT01033734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603081|NCT01033747|Deferasirox|deferasirox|mesh-list
25603082|NCT01033747|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25603083|NCT01033747|Chelating Agents|chelating agents|mesh-ancestor
25603084|NCT01033747|Sequestering Agents|sequestering agents|mesh-ancestor
25603085|NCT01033747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603086|NCT01033773|Metformin|metformin|mesh-list
25603087|NCT01033773|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25603088|NCT01033773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603089|NCT01033825|Ciclesonide|ciclesonide|mesh-list
25603090|NCT01033825|Dexamethasone|dexamethasone|mesh-list
25603091|NCT01033825|Dexamethasone acetate|dexamethasone acetate|mesh-list
25603092|NCT01033825|BB 1101|bb 1101|mesh-list
25603093|NCT01033825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25603094|NCT01033825|Antiemetics|antiemetics|mesh-ancestor
25603095|NCT01033825|Autonomic Agents|autonomic agents|mesh-ancestor
25603096|NCT01033825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25603097|NCT01033825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603098|NCT01033825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25603099|NCT01033825|Glucocorticoids|glucocorticoids|mesh-ancestor
25603100|NCT01033825|Hormones|hormones|mesh-ancestor
25603101|NCT01033825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25603102|NCT01033825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25603103|NCT01033825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603104|NCT01033825|Protease Inhibitors|protease inhibitors|mesh-ancestor
25603105|NCT01033825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534238|NCT00646529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24857456|NCT02291666|Dopamine Agents|dopamine agents|mesh-ancestor
25603106|NCT01033825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603107|NCT01033825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25603108|NCT01033864|Mycophenolic Acid|mycophenolic acid|mesh-list
25603109|NCT01033864|Prednisone|prednisone|mesh-list
25603110|NCT01033864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25603111|NCT01033864|Glucocorticoids|glucocorticoids|mesh-ancestor
25603112|NCT01033864|Hormones|hormones|mesh-ancestor
25603113|NCT01033864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25603114|NCT01033864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603115|NCT01033864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25603116|NCT01033864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603117|NCT01033864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25603118|NCT01033864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25603119|NCT01033864|Antitubercular Agents|antitubercular agents|mesh-ancestor
25603120|NCT01033864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25603121|NCT01033864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25603122|NCT01033864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603123|NCT01033864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603124|NCT01033942|Tenofovir|tenofovir|mesh-list
25603125|NCT01033942|Emtricitabine|emtricitabine|mesh-list
25603126|NCT01033942|Antiviral Agents|antiviral agents|mesh-ancestor
25603127|NCT01033942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25603128|NCT01033942|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25603129|NCT01033942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25603130|NCT01033942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603131|NCT01033942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603132|NCT01033942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25603133|NCT01033942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25603134|NCT01034111|Metformin|metformin|mesh-list
25603135|NCT01034111|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25603136|NCT01034111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25603137|NCT01034111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603138|NCT01034111|Incretins|incretins|mesh-ancestor
25603139|NCT01034111|Hormones|hormones|mesh-ancestor
25603140|NCT01034111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25603141|NCT01034111|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25603142|NCT01034111|Protease Inhibitors|protease inhibitors|mesh-ancestor
25603143|NCT01034111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603144|NCT01034111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603145|NCT01034137|Methotrexate|methotrexate|mesh-list
25603146|NCT01034137|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25603147|NCT01034137|Abortifacient Agents|abortifacient agents|mesh-ancestor
25603148|NCT01034137|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25603149|NCT01034137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603150|NCT01034137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25603151|NCT01034137|Antimetabolites|antimetabolites|mesh-ancestor
25603152|NCT01034137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603153|NCT01034137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603154|NCT01034137|Dermatologic Agents|dermatologic agents|mesh-ancestor
25603155|NCT01034137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603156|NCT01034137|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25603157|NCT01034137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25603158|NCT01034137|Immunologic Factors|immunologic factors|mesh-ancestor
25603159|NCT01034137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25603160|NCT01034137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25603161|NCT01034163|Panobinostat|panobinostat|mesh-list
25603162|NCT01034163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603163|NCT01034163|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25603164|NCT01034163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603165|NCT01034163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603166|NCT01034176|Levofloxacin|levofloxacin|mesh-list
25603167|NCT01034176|Ofloxacin|ofloxacin|mesh-list
25603168|NCT01034176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25603169|NCT01034176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25603170|NCT01034176|Renal Agents|renal agents|mesh-ancestor
25603171|NCT01034176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25603172|NCT01034176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25603173|NCT01034176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25603174|NCT01034176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603175|NCT01034176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603176|NCT01034176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603177|NCT01034176|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25603178|NCT01034176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25603179|NCT01034462|Milnacipran|milnacipran|mesh-list
25603180|NCT01034462|Levomilnacipran|levomilnacipran|mesh-list
25603181|NCT01034462|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25603182|NCT01034462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25603183|NCT01034462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25603184|NCT01034462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603185|NCT01034462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25603186|NCT01034462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603187|NCT01034462|Antidepressive Agents|antidepressive agents|mesh-ancestor
25603188|NCT01034462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25603189|NCT01034462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25603190|NCT01034462|Analgesics|analgesics|mesh-ancestor
25603191|NCT01034462|Sensory System Agents|sensory system agents|mesh-ancestor
25603192|NCT01034462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25654150|NCT01546688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654151|NCT01546688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25654152|NCT01546688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654153|NCT01546857|Gabapentin|gabapentin|mesh-list
25654154|NCT01546857|Analgesics|analgesics|mesh-ancestor
25654155|NCT01546857|Sensory System Agents|sensory system agents|mesh-ancestor
25654156|NCT01546857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25654157|NCT01546857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654158|NCT01546857|Anticonvulsants|anticonvulsants|mesh-ancestor
25654159|NCT01546857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25654160|NCT01546857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25654161|NCT01546857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25654162|NCT01546857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25654163|NCT01546857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25654164|NCT01546857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25654165|NCT01546857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25654166|NCT01546857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654167|NCT01546857|Antimanic Agents|antimanic agents|mesh-ancestor
25654168|NCT01546922|Hydrocortisone|hydrocortisone|mesh-list
25654169|NCT01546922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25654170|NCT01547000|Guanfacine|guanfacine|mesh-list
25654171|NCT01547000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25654172|NCT01547000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25654173|NCT01547000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25654174|NCT01547000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25654175|NCT01547000|Adrenergic Agents|adrenergic agents|mesh-ancestor
25654176|NCT01547000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25654177|NCT01547000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654178|NCT01547000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654179|NCT01547286|Methacholine Chloride|methacholine chloride|mesh-list
25654180|NCT01547286|Miotics|miotics|mesh-ancestor
25654181|NCT01547286|Autonomic Agents|autonomic agents|mesh-ancestor
25654182|NCT01547286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25654183|NCT01547286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654184|NCT01547286|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25654185|NCT01547286|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
25654186|NCT01547286|Respiratory System Agents|respiratory system agents|mesh-ancestor
25654187|NCT01547286|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25654188|NCT01547286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25654189|NCT01547286|Cholinergic Agents|cholinergic agents|mesh-ancestor
25654190|NCT01547286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25654191|NCT01547286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654192|NCT01547299|Leuprolide|leuprolide|mesh-list
25654193|NCT01547299|Dutasteride|dutasteride|mesh-list
25654194|NCT01547299|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25654195|NCT01547299|Fertility Agents|fertility agents|mesh-ancestor
25654196|NCT01547299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25654197|NCT01547299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654198|NCT01547299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25654199|NCT01547299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25654200|NCT01547299|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25654201|NCT01547299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25654202|NCT01547299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25654203|NCT01547299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654204|NCT01547299|Hormone Antagonists|hormone antagonists|mesh-ancestor
25654205|NCT01547299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25654206|NCT01547390|Aspirin|aspirin|mesh-list
25654207|NCT01547390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25654208|NCT01547390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25654209|NCT01547390|Analgesics|analgesics|mesh-ancestor
25654210|NCT01547390|Sensory System Agents|sensory system agents|mesh-ancestor
25603193|NCT01034553|Bortezomib|bortezomib|mesh-list
25603194|NCT01034553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603195|NCT01034592|Lenalidomide|lenalidomide|mesh-list
25603196|NCT01034592|Immunologic Factors|immunologic factors|mesh-ancestor
25603197|NCT01034592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603198|NCT01034592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25603199|NCT01034592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25603200|NCT01034592|Growth Substances|growth substances|mesh-ancestor
25603201|NCT01034592|Growth Inhibitors|growth inhibitors|mesh-ancestor
25603202|NCT01034592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603203|NCT01034657|Panobinostat|panobinostat|mesh-list
25603204|NCT01034657|Epoetin Alfa|epoetin alfa|mesh-list
25603205|NCT01034657|Hematinics|hematinics|mesh-ancestor
25603206|NCT01034657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603207|NCT01034657|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25603208|NCT01034657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603209|NCT01034657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603210|NCT01035099|Letrozole|letrozole|mesh-list
25603211|NCT01035099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603212|NCT01035099|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25603213|NCT01035099|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25603214|NCT01035099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603215|NCT01035099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603216|NCT01035099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25603217|NCT01035099|Hormone Antagonists|hormone antagonists|mesh-ancestor
25603218|NCT01035099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25603219|NCT01035099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603220|NCT01035229|Everolimus|everolimus|mesh-list
25603221|NCT01035229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24534871|NCT00648180|Antimalarials|antimalarials|mesh-ancestor
25603222|NCT01035229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25603223|NCT01035229|Immunologic Factors|immunologic factors|mesh-ancestor
25603224|NCT01035229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603225|NCT01035255|Enalapril|enalapril|mesh-list
25603226|NCT01035255|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25603227|NCT01035255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25603228|NCT01035255|Protease Inhibitors|protease inhibitors|mesh-ancestor
25603229|NCT01035255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603230|NCT01035255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603231|NCT01035255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25603232|NCT01035255|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25603233|NCT01035333|Orlistat|orlistat|mesh-list
25603234|NCT01035333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603235|NCT01035333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603236|NCT01035333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25603237|NCT01035333|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25603238|NCT01035346|Ibuprofen|ibuprofen|mesh-list
25603239|NCT01035346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25603240|NCT01035346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25603241|NCT01035346|Analgesics|analgesics|mesh-ancestor
25603242|NCT01035346|Sensory System Agents|sensory system agents|mesh-ancestor
25603243|NCT01035346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25603244|NCT01035346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603245|NCT01035346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25603246|NCT01035346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25603247|NCT01035346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25603248|NCT01035346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603249|NCT01035346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603250|NCT01035463|Cytarabine|cytarabine|mesh-list
25603251|NCT01035463|Rituximab|rituximab|mesh-list
25603252|NCT01035463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25603253|NCT01035463|Etoposide|etoposide|mesh-list
25603254|NCT01035463|Lenalidomide|lenalidomide|mesh-list
25603255|NCT01035463|Etoposide phosphate|etoposide phosphate|mesh-list
25603256|NCT01035463|Melphalan|melphalan|mesh-list
25603257|NCT01035463|Mechlorethamine|mechlorethamine|mesh-list
25603258|NCT01035463|Carmustine|carmustine|mesh-list
25603259|NCT01035463|Podophyllotoxin|podophyllotoxin|mesh-list
25603260|NCT01035463|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25603261|NCT01035463|Antibodies|antibodies|mesh-list
25603262|NCT01035463|Immunoglobulins|immunoglobulins|mesh-list
25603263|NCT01035463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25603264|NCT01035463|Immunologic Factors|immunologic factors|mesh-ancestor
25603265|NCT01035463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603266|NCT01035463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603267|NCT01035463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25603268|NCT01035463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25603269|NCT01035463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25603270|NCT01035463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25603271|NCT01035463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448910|NCT00313534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25603272|NCT01035463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603273|NCT01035463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25603274|NCT01035463|Antimetabolites|antimetabolites|mesh-ancestor
25603275|NCT01035463|Antiviral Agents|antiviral agents|mesh-ancestor
25603276|NCT01035463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25603277|NCT01035463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25603278|NCT01035463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25603279|NCT01035463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25603280|NCT01035463|Growth Substances|growth substances|mesh-ancestor
25603281|NCT01035463|Growth Inhibitors|growth inhibitors|mesh-ancestor
25603282|NCT01035463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25603283|NCT01035463|Alkylating Agents|alkylating agents|mesh-ancestor
25603284|NCT01035463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25603285|NCT01035463|Keratolytic Agents|keratolytic agents|mesh-ancestor
25603286|NCT01035463|Dermatologic Agents|dermatologic agents|mesh-ancestor
25603287|NCT01035463|Tubulin Modulators|tubulin modulators|mesh-ancestor
25603288|NCT01035463|Antimitotic Agents|antimitotic agents|mesh-ancestor
25603289|NCT01035463|Mitosis Modulators|mitosis modulators|mesh-ancestor
25603290|NCT01035658|Doxorubicin|doxorubicin|mesh-list
25603291|NCT01035658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25603292|NCT01035658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25603293|NCT01035658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603294|NCT01035658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25603295|NCT01035658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25603296|NCT01035658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603297|NCT01035658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603299|NCT01035749|Immunologic Factors|immunologic factors|mesh-ancestor
25603300|NCT01035749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603301|NCT01036594|Ketoconazole|ketoconazole|mesh-list
25603302|NCT01036594|Dexamethasone|dexamethasone|mesh-list
25603303|NCT01036594|Dexamethasone acetate|dexamethasone acetate|mesh-list
25603304|NCT01036594|Hydrocortisone|hydrocortisone|mesh-list
25603305|NCT01036594|BB 1101|bb 1101|mesh-list
25603306|NCT01036594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25603307|NCT01036594|Antiemetics|antiemetics|mesh-ancestor
25603308|NCT01036594|Autonomic Agents|autonomic agents|mesh-ancestor
25603309|NCT01036594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25603310|NCT01036594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603311|NCT01036594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25603312|NCT01036594|Glucocorticoids|glucocorticoids|mesh-ancestor
25603313|NCT01036594|Hormones|hormones|mesh-ancestor
25603314|NCT01036594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25603315|NCT01036594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25603316|NCT01036594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603317|NCT01036594|Protease Inhibitors|protease inhibitors|mesh-ancestor
25603318|NCT01036594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603319|NCT01036594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603320|NCT01036594|Antifungal Agents|antifungal agents|mesh-ancestor
25603321|NCT01036594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25603322|NCT01036594|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25603323|NCT01036594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25603324|NCT01036594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25603325|NCT01036594|Hormone Antagonists|hormone antagonists|mesh-ancestor
25603326|NCT01036594|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25603327|NCT01036802|Warfarin|warfarin|mesh-list
25603328|NCT01036802|Anticoagulants|anticoagulants|mesh-ancestor
25603329|NCT01037127|Trametinib|trametinib|mesh-list
25603330|NCT01037127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603331|NCT01037127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25603332|NCT01037127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603333|NCT01037127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603334|NCT01037192|Vancomycin|vancomycin|mesh-list
25603335|NCT01037192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25603336|NCT01037192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25603337|NCT01037218|Udenafil|udenafil|mesh-list
25603338|NCT01037218|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25603339|NCT01037218|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25603340|NCT01037218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603341|NCT01037218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603342|NCT01037244|Udenafil|udenafil|mesh-list
25603343|NCT01037244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25603344|NCT01037244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25603345|NCT01037244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603346|NCT01037244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603347|NCT01037452|Calcium, Dietary|calcium, dietary|mesh-list
25603348|NCT01037452|Lansoprazole|lansoprazole|mesh-list
25603349|NCT01037452|Dexlansoprazole|dexlansoprazole|mesh-list
25603350|NCT01037452|Calcium Carbonate|calcium carbonate|mesh-list
25603351|NCT01037452|Magnesium Hydroxide|magnesium hydroxide|mesh-list
25603352|NCT01037452|Calcium|calcium|mesh-list
25603353|NCT01037452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25603354|NCT01037452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603355|NCT01037452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25603356|NCT01037452|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25603357|NCT01037452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25603358|NCT01037452|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25603359|NCT01037452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603360|NCT01037452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603361|NCT01037452|Antacids|antacids|mesh-ancestor
25603362|NCT01037790|Palbociclib|palbociclib|mesh-list
25603363|NCT01037790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603364|NCT01037790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25603365|NCT01037790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603366|NCT01037790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603367|NCT01037881|Pimecrolimus|pimecrolimus|mesh-list
25603368|NCT01037881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25603369|NCT01037881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25603370|NCT01037881|Analgesics|analgesics|mesh-ancestor
25603371|NCT01037881|Sensory System Agents|sensory system agents|mesh-ancestor
24535379|NCT00649064|Serotonin Agents|serotonin agents|mesh-ancestor
25603372|NCT01037881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25603373|NCT01037881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603374|NCT01037881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25603375|NCT01037881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25603376|NCT01037881|Dermatologic Agents|dermatologic agents|mesh-ancestor
25603377|NCT01037881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25603378|NCT01037881|Immunologic Factors|immunologic factors|mesh-ancestor
25603379|NCT01037881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25603380|NCT01037881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603381|NCT01037881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603382|NCT01038128|Memantine|memantine|mesh-list
25603383|NCT01038128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25603384|NCT01038128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25603385|NCT01038128|Dopamine Agents|dopamine agents|mesh-ancestor
25603386|NCT01038128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25603387|NCT01038128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603388|NCT01038128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603389|NCT01038128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25603390|NCT01038128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25603391|NCT01038323|Milnacipran|milnacipran|mesh-list
25603392|NCT01038323|Levomilnacipran|levomilnacipran|mesh-list
25603393|NCT01038323|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25603394|NCT01038323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25603395|NCT01038323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25603396|NCT01038323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603397|NCT01038323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25603398|NCT01038323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603399|NCT01038323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25603400|NCT01038323|Analgesics|analgesics|mesh-ancestor
25603401|NCT01038323|Sensory System Agents|sensory system agents|mesh-ancestor
25603402|NCT01038323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25603403|NCT01038323|Antidepressive Agents|antidepressive agents|mesh-ancestor
25603404|NCT01038323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25603405|NCT01038427|Mometasone Furoate|mometasone furoate|mesh-list
25603406|NCT01038427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25603407|NCT01038427|Dermatologic Agents|dermatologic agents|mesh-ancestor
25603408|NCT01038427|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25603409|NCT01038609|Acetaminophen|acetaminophen|mesh-list
25603410|NCT01038609|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25603411|NCT01038609|Morphine|morphine|mesh-list
25603412|NCT01038609|Hydrocodone|hydrocodone|mesh-list
25603413|NCT01038609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25603414|NCT01038609|Narcotics|narcotics|mesh-ancestor
25603415|NCT01038609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25603416|NCT01038609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603417|NCT01038609|Analgesics|analgesics|mesh-ancestor
25603418|NCT01038609|Sensory System Agents|sensory system agents|mesh-ancestor
25603419|NCT01038609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25603420|NCT01038609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25603421|NCT01038609|Antipyretics|antipyretics|mesh-ancestor
25603422|NCT01038609|Antitussive Agents|antitussive agents|mesh-ancestor
25603423|NCT01038609|Respiratory System Agents|respiratory system agents|mesh-ancestor
25603424|NCT01038609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25603425|NCT01038609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25603426|NCT01038609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25603427|NCT01038635|Lenalidomide|lenalidomide|mesh-list
25603428|NCT01038635|Azacitidine|azacitidine|mesh-list
25603429|NCT01038635|Immunologic Factors|immunologic factors|mesh-ancestor
25603430|NCT01038635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603431|NCT01038635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25603432|NCT01038635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25603433|NCT01038635|Growth Substances|growth substances|mesh-ancestor
25603434|NCT01038635|Growth Inhibitors|growth inhibitors|mesh-ancestor
25603435|NCT01038635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603436|NCT01038635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25603437|NCT01038635|Antimetabolites|antimetabolites|mesh-ancestor
25603438|NCT01038635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603439|NCT01038635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603440|NCT01038856|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25603441|NCT01038856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603442|NCT01038856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25603443|NCT01038856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603444|NCT01038856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603445|NCT01038869|Azelaic acid|azelaic acid|mesh-list
25603446|NCT01038869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603447|NCT01038869|Dermatologic Agents|dermatologic agents|mesh-ancestor
25603448|NCT01038921|Melatonin|melatonin|mesh-list
25603449|NCT01038921|Antioxidants|antioxidants|mesh-ancestor
25603450|NCT01038921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603451|NCT01038921|Protective Agents|protective agents|mesh-ancestor
25603452|NCT01038921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603453|NCT01038921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25603454|NCT01039207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25603455|NCT01039207|Rilotumumab|rilotumumab|mesh-list
25603456|NCT01039207|Antibodies|antibodies|mesh-list
25603457|NCT01039207|Immunoglobulins|immunoglobulins|mesh-list
25603458|NCT01039207|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25603459|NCT01039207|Immunologic Factors|immunologic factors|mesh-ancestor
25603460|NCT01039207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603461|NCT01039207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603462|NCT01039376|Ofatumumab|ofatumumab|mesh-list
25603463|NCT01039376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603464|NCT01039584|Butoconazole|butoconazole|mesh-list
25603465|NCT01039584|Antifungal Agents|antifungal agents|mesh-ancestor
25603466|NCT01039584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25603467|NCT01039688|Antirheumatic Agents|antirheumatic agents|mesh-list
25603468|NCT01039688|Tofacitinib|tofacitinib|mesh-list
25603469|NCT01039688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25603470|NCT01039688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603471|NCT01039688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603472|NCT01039792|Vitamin B 12|vitamin b 12|mesh-list
25603473|NCT01039792|Vitamins|vitamins|mesh-ancestor
25603474|NCT01039792|Micronutrients|micronutrients|mesh-ancestor
25603475|NCT01039792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603476|NCT01039792|Vitamin B Complex|vitamin b complex|mesh-ancestor
25603477|NCT01040130|Olodaterol|olodaterol|mesh-list
25603478|NCT01040130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25603479|NCT01040130|Autonomic Agents|autonomic agents|mesh-ancestor
25603480|NCT01040130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25603481|NCT01040130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603482|NCT01040130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25603483|NCT01040130|Respiratory System Agents|respiratory system agents|mesh-ancestor
25603484|NCT01040169|Calcium Carbonate|calcium carbonate|mesh-list
25603485|NCT01040169|Calcium|calcium|mesh-list
25603486|NCT01040169|Fluorides|fluorides|mesh-list
25603487|NCT01040169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24536030|NCT00650208|Anticonvulsants|anticonvulsants|mesh-ancestor
25603488|NCT01040169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603489|NCT01040169|Cariostatic Agents|cariostatic agents|mesh-ancestor
25603490|NCT01040169|Protective Agents|protective agents|mesh-ancestor
25603491|NCT01040169|Antacids|antacids|mesh-ancestor
25603492|NCT01040169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603493|NCT01040169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25497927|NCT00302848|Hormones|hormones|mesh-ancestor
25603495|NCT01040260|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25603496|NCT01040260|Autonomic Agents|autonomic agents|mesh-ancestor
25603497|NCT01040260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25603498|NCT01040260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603499|NCT01040260|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25603500|NCT01040260|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25603501|NCT01040260|Cholinergic Agents|cholinergic agents|mesh-ancestor
25603502|NCT01040260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25603503|NCT01040260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603504|NCT01040403|Bromides|bromides|mesh-list
25603505|NCT01040403|Tiotropium Bromide|tiotropium bromide|mesh-list
25603506|NCT01040403|Olodaterol|olodaterol|mesh-list
25603507|NCT01040403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25603508|NCT01040403|Autonomic Agents|autonomic agents|mesh-ancestor
25603509|NCT01040403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25603510|NCT01040403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603511|NCT01040403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25603512|NCT01040403|Respiratory System Agents|respiratory system agents|mesh-ancestor
25603513|NCT01040403|Parasympatholytics|parasympatholytics|mesh-ancestor
25603514|NCT01040403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25603515|NCT01040403|Cholinergic Agents|cholinergic agents|mesh-ancestor
25603516|NCT01040403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25603517|NCT01040403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603518|NCT01040403|Anticonvulsants|anticonvulsants|mesh-ancestor
25603519|NCT01040689|Tiotropium Bromide|tiotropium bromide|mesh-list
25603520|NCT01040689|Olodaterol|olodaterol|mesh-list
25603521|NCT01040689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25603522|NCT01040689|Autonomic Agents|autonomic agents|mesh-ancestor
25603523|NCT01040689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25603524|NCT01040689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603525|NCT01040689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25603526|NCT01040689|Respiratory System Agents|respiratory system agents|mesh-ancestor
25603527|NCT01040689|Parasympatholytics|parasympatholytics|mesh-ancestor
25603528|NCT01040689|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25603529|NCT01040689|Cholinergic Agents|cholinergic agents|mesh-ancestor
25603530|NCT01040689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25603531|NCT01040689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603532|NCT01040728|Tiotropium Bromide|tiotropium bromide|mesh-list
25603533|NCT01040728|Olodaterol|olodaterol|mesh-list
25603534|NCT01040728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25603535|NCT01040728|Autonomic Agents|autonomic agents|mesh-ancestor
25603536|NCT01040728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25603537|NCT01040728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603538|NCT01040728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25603539|NCT01040728|Respiratory System Agents|respiratory system agents|mesh-ancestor
25603540|NCT01040728|Parasympatholytics|parasympatholytics|mesh-ancestor
25603541|NCT01040728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25603542|NCT01040728|Cholinergic Agents|cholinergic agents|mesh-ancestor
25603543|NCT01040728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24536433|NCT00651287|Natriuretic Agents|natriuretic agents|mesh-ancestor
25603544|NCT01040728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603545|NCT01040780|Gefitinib|gefitinib|mesh-list
25603546|NCT01040780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603547|NCT01040780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25603548|NCT01040780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603549|NCT01040780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603550|NCT01040793|Olodaterol|olodaterol|mesh-list
25603551|NCT01040793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25603552|NCT01040793|Autonomic Agents|autonomic agents|mesh-ancestor
25603553|NCT01040793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25603554|NCT01040793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603555|NCT01040793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25603556|NCT01040793|Respiratory System Agents|respiratory system agents|mesh-ancestor
25603557|NCT01040819|Pioglitazone|pioglitazone|mesh-list
25603558|NCT01040819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25603559|NCT01040819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603560|NCT01040832|Cetuximab|cetuximab|mesh-list
25603561|NCT01040832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25603562|NCT01040832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603563|NCT01040845|Colchicine|colchicine|mesh-list
25603564|NCT01040845|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25603565|NCT01040845|Norethindrone|norethindrone|mesh-list
25603566|NCT01040845|Norethindrone Acetate|norethindrone acetate|mesh-list
25603567|NCT01040845|Estradiol|estradiol|mesh-list
25603568|NCT01040845|Estrogens|estrogens|mesh-ancestor
25603569|NCT01040845|Hormones|hormones|mesh-ancestor
25603570|NCT01040845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25603571|NCT01040845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603572|NCT01040845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25603573|NCT01040845|Contraceptive Agents|contraceptive agents|mesh-ancestor
25603574|NCT01040845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25603575|NCT01040845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25603576|NCT01040845|Gout Suppressants|gout suppressants|mesh-ancestor
25603577|NCT01040845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25603578|NCT01040845|Tubulin Modulators|tubulin modulators|mesh-ancestor
25603579|NCT01040845|Antimitotic Agents|antimitotic agents|mesh-ancestor
25603580|NCT01040845|Mitosis Modulators|mitosis modulators|mesh-ancestor
25603581|NCT01040845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603582|NCT01040845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603583|NCT01040845|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25603584|NCT01040845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25603585|NCT01040845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25603587|NCT01040871|Cyclophosphamide|cyclophosphamide|mesh-list
25603588|NCT01040871|Rituximab|rituximab|mesh-list
25603589|NCT01040871|Doxorubicin|doxorubicin|mesh-list
25603590|NCT01040871|Vincristine|vincristine|mesh-list
25603591|NCT01040871|Bortezomib|bortezomib|mesh-list
25603592|NCT01040871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25603593|NCT01040871|Immunologic Factors|immunologic factors|mesh-ancestor
25603594|NCT01040871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603595|NCT01040871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25603596|NCT01040871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25603597|NCT01040871|Alkylating Agents|alkylating agents|mesh-ancestor
25603598|NCT01040871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603599|NCT01040871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603600|NCT01040871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25603601|NCT01040871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25603602|NCT01040871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25603603|NCT01040871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25603604|NCT01040871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25603605|NCT01040871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603606|NCT01040871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25603607|NCT01040871|Glucocorticoids|glucocorticoids|mesh-ancestor
25603608|NCT01040871|Hormones|hormones|mesh-ancestor
25603609|NCT01040871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25603610|NCT01040871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25603611|NCT01040871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25603612|NCT01040871|Tubulin Modulators|tubulin modulators|mesh-ancestor
25603613|NCT01040871|Antimitotic Agents|antimitotic agents|mesh-ancestor
25603614|NCT01040871|Mitosis Modulators|mitosis modulators|mesh-ancestor
25603615|NCT01041209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25603616|NCT01041209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25603617|NCT01041274|Citalopram|citalopram|mesh-list
25603618|NCT01041274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25603619|NCT01041274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25603620|NCT01041274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25603621|NCT01041274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603622|NCT01041274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25603623|NCT01041274|Serotonin Agents|serotonin agents|mesh-ancestor
25603624|NCT01041274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603625|NCT01041274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25603626|NCT01041274|Antidepressive Agents|antidepressive agents|mesh-ancestor
25603627|NCT01041274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25603628|NCT01041287|Metoprolol|metoprolol|mesh-list
25603629|NCT01041287|Nebivolol|nebivolol|mesh-list
25603630|NCT01041287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25603631|NCT01041287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25603632|NCT01041287|Sympatholytics|sympatholytics|mesh-ancestor
25603633|NCT01041287|Autonomic Agents|autonomic agents|mesh-ancestor
25603634|NCT01041287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25603635|NCT01041287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603636|NCT01041287|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25603637|NCT01041287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25603638|NCT01041287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25603639|NCT01041287|Adrenergic Agents|adrenergic agents|mesh-ancestor
25603640|NCT01041287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25603641|NCT01041287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498065|NCT00303823|Antioxidants|antioxidants|mesh-ancestor
25603642|NCT01041287|Vasodilator Agents|vasodilator agents|mesh-ancestor
25603643|NCT01041287|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25603644|NCT01041287|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25603645|NCT01041287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25603646|NCT01041404|Cisplatin|cisplatin|mesh-list
25603647|NCT01041404|Fluorouracil|fluorouracil|mesh-list
25603648|NCT01041404|Capecitabine|capecitabine|mesh-list
25603649|NCT01041404|Trastuzumab|trastuzumab|mesh-list
25603650|NCT01041404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603651|NCT01041404|Antimetabolites|antimetabolites|mesh-ancestor
25603652|NCT01041404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603653|NCT01041404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25603654|NCT01041404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25603655|NCT01041404|Immunologic Factors|immunologic factors|mesh-ancestor
25603656|NCT01041404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603657|NCT01041404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25603658|NCT01041417|Molgramostim|molgramostim|mesh-list
25603659|NCT01041417|Sargramostim|sargramostim|mesh-list
25603660|NCT01041417|Immunologic Factors|immunologic factors|mesh-ancestor
25603661|NCT01041417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603662|NCT01041417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603663|NCT01041495|Cyclobenzaprine|cyclobenzaprine|mesh-list
25603664|NCT01041495|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25603665|NCT01041495|Antidepressive Agents|antidepressive agents|mesh-ancestor
25603666|NCT01041495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25603667|NCT01041495|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25603668|NCT01041495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603669|NCT01041495|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25603670|NCT01041495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25603671|NCT01041495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25603672|NCT01041495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25603673|NCT01041573|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25603674|NCT01041573|Immunologic Factors|immunologic factors|mesh-ancestor
25603675|NCT01041573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603676|NCT01041638|Vitamin A|vitamin a|mesh-list
25498132|NCT00304278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498133|NCT00304278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498134|NCT00304356|Nitazoxanide|nitazoxanide|mesh-list
25498135|NCT00304356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25498136|NCT00304356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25498137|NCT00304707|Bupropion|bupropion|mesh-list
25498138|NCT00304707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25498139|NCT00304707|Antidepressive Agents|antidepressive agents|mesh-ancestor
25498140|NCT00304707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25498141|NCT00304707|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25498142|NCT00304707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24537399|NCT00654524|Vitamins|vitamins|mesh-ancestor
25498143|NCT00304707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25498144|NCT00304707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498145|NCT00304707|Dopamine Agents|dopamine agents|mesh-ancestor
25498146|NCT00304707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25498147|NCT00304707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498148|NCT00304707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25498149|NCT00304707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25498150|NCT00304707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603677|NCT01041638|Aldesleukin|aldesleukin|mesh-list
25603678|NCT01041638|Interleukin-2|interleukin-2|mesh-list
25603679|NCT01041638|Tretinoin|tretinoin|mesh-list
25603680|NCT01041638|Dinutuximab|dinutuximab|mesh-list
25603681|NCT01041638|Isotretinoin|isotretinoin|mesh-list
25603682|NCT01041638|Sargramostim|sargramostim|mesh-list
25603683|NCT01041638|Vitamins|vitamins|mesh-ancestor
25603684|NCT01041638|Micronutrients|micronutrients|mesh-ancestor
25603685|NCT01041638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603686|NCT01041638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603687|NCT01041638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25603688|NCT01041638|Analgesics|analgesics|mesh-ancestor
25603689|NCT01041638|Sensory System Agents|sensory system agents|mesh-ancestor
25603690|NCT01041638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25603691|NCT01041638|Immunologic Factors|immunologic factors|mesh-ancestor
25603692|NCT01041638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25603693|NCT01041638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25603694|NCT01041638|Antiviral Agents|antiviral agents|mesh-ancestor
25603695|NCT01041638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25603696|NCT01041638|Keratolytic Agents|keratolytic agents|mesh-ancestor
25603697|NCT01041638|Dermatologic Agents|dermatologic agents|mesh-ancestor
25603698|NCT01041781|Gemcitabine|gemcitabine|mesh-list
25603699|NCT01041781|Celecoxib|celecoxib|mesh-list
25603700|NCT01041781|Carboplatin|carboplatin|mesh-list
25603701|NCT01041781|Pemetrexed|pemetrexed|mesh-list
25603702|NCT01041781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603703|NCT01041781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25603704|NCT01041781|Antimetabolites|antimetabolites|mesh-ancestor
25603705|NCT01041781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603706|NCT01041781|Antiviral Agents|antiviral agents|mesh-ancestor
25603707|NCT01041781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25603708|NCT01041781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603709|NCT01041781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25603710|NCT01041781|Immunologic Factors|immunologic factors|mesh-ancestor
25603711|NCT01041781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603712|NCT01041781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25603713|NCT01041781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25603714|NCT01041781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25603715|NCT01041781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25603716|NCT01041781|Analgesics|analgesics|mesh-ancestor
25603717|NCT01041781|Sensory System Agents|sensory system agents|mesh-ancestor
25603718|NCT01041781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25603719|NCT01041781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25603720|NCT01041781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25603721|NCT01041781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25603722|NCT01041781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25603723|NCT01041859|Tapentadol|tapentadol|mesh-list
25603724|NCT01041859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25603725|NCT01041859|Narcotics|narcotics|mesh-ancestor
25603726|NCT01041859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25603727|NCT01041859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603728|NCT01041859|Analgesics|analgesics|mesh-ancestor
25603729|NCT01041859|Sensory System Agents|sensory system agents|mesh-ancestor
25603730|NCT01041859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25603731|NCT01041859|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25603732|NCT01041859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25603733|NCT01041859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25603734|NCT01041859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603735|NCT01041859|Adrenergic Agents|adrenergic agents|mesh-ancestor
25603736|NCT01041859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25603737|NCT01042093|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25603738|NCT01042093|Clonidine|clonidine|mesh-list
25603739|NCT01042093|Epinephrine|epinephrine|mesh-list
25603740|NCT01042093|Ropivacaine|ropivacaine|mesh-list
25603741|NCT01042093|Anesthetics, Local|anesthetics, local|mesh-ancestor
25603742|NCT01042093|Anesthetics|anesthetics|mesh-ancestor
25603743|NCT01042093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25603744|NCT01042093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603745|NCT01042093|Sensory System Agents|sensory system agents|mesh-ancestor
25603746|NCT01042093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25603747|NCT01042093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25603748|NCT01042093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25603749|NCT01042093|Adrenergic Agents|adrenergic agents|mesh-ancestor
25603750|NCT01042093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25603751|NCT01042093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603752|NCT01042093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25603753|NCT01042093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25603754|NCT01042093|Autonomic Agents|autonomic agents|mesh-ancestor
25603755|NCT01042093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25603756|NCT01042093|Respiratory System Agents|respiratory system agents|mesh-ancestor
25603757|NCT01042093|Mydriatics|mydriatics|mesh-ancestor
25603758|NCT01042093|Sympathomimetics|sympathomimetics|mesh-ancestor
25603759|NCT01042093|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25603760|NCT01042093|Analgesics|analgesics|mesh-ancestor
25603761|NCT01042093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25603762|NCT01042093|Sympatholytics|sympatholytics|mesh-ancestor
25603763|NCT01042093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25603764|NCT01042093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25603765|NCT01042093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25603766|NCT01042093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25603767|NCT01042093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25603768|NCT01042093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25603769|NCT01042093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603770|NCT01042145|Dexamethasone|dexamethasone|mesh-list
25603771|NCT01042145|Prednisone|prednisone|mesh-list
25603772|NCT01042145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25603773|NCT01042145|Antiemetics|antiemetics|mesh-ancestor
25603774|NCT01042145|Autonomic Agents|autonomic agents|mesh-ancestor
25603775|NCT01042145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25603776|NCT01042145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603777|NCT01042145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25603778|NCT01042145|Glucocorticoids|glucocorticoids|mesh-ancestor
25603779|NCT01042145|Hormones|hormones|mesh-ancestor
25603780|NCT01042145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25603781|NCT01042145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25603782|NCT01042145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603783|NCT01042158|Ambrisentan|ambrisentan|mesh-list
25603784|NCT01042158|Tadalafil|tadalafil|mesh-list
25603785|NCT01042158|Vasodilator Agents|vasodilator agents|mesh-ancestor
25603786|NCT01042158|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25603787|NCT01042158|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25603788|NCT01042158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603789|NCT01042158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603790|NCT01042158|Urological Agents|urological agents|mesh-ancestor
25603791|NCT01042158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25603792|NCT01042236|Fesoterodine|fesoterodine|mesh-list
25603793|NCT01042236|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25603794|NCT01042236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25603795|NCT01042236|Cholinergic Agents|cholinergic agents|mesh-ancestor
25603796|NCT01042236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25603797|NCT01042236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603798|NCT01042236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603799|NCT01042236|Urological Agents|urological agents|mesh-ancestor
25603800|NCT01042288|Carboplatin|carboplatin|mesh-list
25603801|NCT01042288|Pemetrexed|pemetrexed|mesh-list
25603802|NCT01042288|Panitumumab|panitumumab|mesh-list
25603803|NCT01042288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603804|NCT01042288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603805|NCT01042288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603806|NCT01042288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25603807|NCT01042288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25603808|NCT01042288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25654211|NCT01547390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25654212|NCT01547390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654213|NCT01547390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25654214|NCT01547390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25654215|NCT01547390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25654216|NCT01547390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25654217|NCT01547390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654218|NCT01547390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25654219|NCT01547390|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25654220|NCT01547390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25654221|NCT01547390|Antipyretics|antipyretics|mesh-ancestor
25654222|NCT01547598|Timolol|timolol|mesh-list
25654223|NCT01547598|Bimatoprost|bimatoprost|mesh-list
25654224|NCT01547598|Travoprost|travoprost|mesh-list
25654225|NCT01547598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25654226|NCT01547598|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25654227|NCT01547598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25654228|NCT01547598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25654229|NCT01547598|Adrenergic Agents|adrenergic agents|mesh-ancestor
25654230|NCT01547598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25654231|NCT01547598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654232|NCT01547598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654233|NCT01547598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25654234|NCT01547598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25654235|NCT01547806|Plerixafor|plerixafor|mesh-list
25654236|NCT01547806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25654237|NCT01547806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25654238|NCT01547806|Antiviral Agents|antiviral agents|mesh-ancestor
25654239|NCT01547806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25654240|NCT01548417|Mifepristone|mifepristone|mesh-list
25654241|NCT01548417|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25654242|NCT01548417|Abortifacient Agents|abortifacient agents|mesh-ancestor
25654243|NCT01548417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25654244|NCT01548417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654245|NCT01548417|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25654246|NCT01548417|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25654247|NCT01548417|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25654248|NCT01548417|Contraceptive Agents|contraceptive agents|mesh-ancestor
25654249|NCT01548417|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25654250|NCT01548417|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25603810|NCT01042392|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25603811|NCT01042392|Protease Inhibitors|protease inhibitors|mesh-ancestor
25603812|NCT01042392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603813|NCT01042392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603814|NCT01042392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25603815|NCT01042496|Lamotrigine|lamotrigine|mesh-list
25603816|NCT01042496|Anticonvulsants|anticonvulsants|mesh-ancestor
25603817|NCT01042496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25603818|NCT01042496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25603819|NCT01042496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708631|NCT02255500|Anesthetics|anesthetics|mesh-ancestor
25603820|NCT01042496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25603821|NCT01042496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603822|NCT01042496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25603823|NCT01042496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25603824|NCT01042496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25603825|NCT01042496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25603826|NCT01042496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25603827|NCT01042509|Rituximab|rituximab|mesh-list
25603828|NCT01042509|Alemtuzumab|alemtuzumab|mesh-list
25603829|NCT01042509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25603830|NCT01042509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603831|NCT01042509|Immunologic Factors|immunologic factors|mesh-ancestor
25603832|NCT01042509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603833|NCT01042509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25603834|NCT01042535|Tryptophan|tryptophan|mesh-list
25603835|NCT01042535|Vaccines|vaccines|mesh-list
25603836|NCT01042535|Immunologic Factors|immunologic factors|mesh-ancestor
25603837|NCT01042535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603838|NCT01042535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25603839|NCT01042535|Antidepressive Agents|antidepressive agents|mesh-ancestor
25603840|NCT01042535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25603841|NCT01042795|Sunitinib|sunitinib|mesh-list
25603842|NCT01042795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603843|NCT01042795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25603844|NCT01042795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25603845|NCT01042795|Growth Substances|growth substances|mesh-ancestor
25603846|NCT01042795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603847|NCT01042795|Growth Inhibitors|growth inhibitors|mesh-ancestor
25603848|NCT01042795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25603849|NCT01042795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603850|NCT01042795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603851|NCT01042938|Curcumin|curcumin|mesh-list
25603852|NCT01042938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25603853|NCT01042938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25603854|NCT01042938|Analgesics|analgesics|mesh-ancestor
25603855|NCT01042938|Sensory System Agents|sensory system agents|mesh-ancestor
25603856|NCT01042938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25603857|NCT01042938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603858|NCT01042938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25603859|NCT01042938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25603860|NCT01042938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603861|NCT01042938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603862|NCT01042938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603863|NCT01042977|Dapagliflozin|dapagliflozin|mesh-list
25603864|NCT01042977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25603865|NCT01042977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603866|NCT01042977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25603867|NCT01042977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603868|NCT01043094|Pitavastatin|pitavastatin|mesh-list
25603869|NCT01043094|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25603870|NCT01043094|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25603871|NCT01043094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25603872|NCT01043094|Antimetabolites|antimetabolites|mesh-ancestor
25603873|NCT01043094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603874|NCT01043094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603875|NCT01043094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24543689|NCT00685022|Albuterol|albuterol|mesh-list
25603876|NCT01043185|Lesogaberan|lesogaberan|mesh-list
25603877|NCT01043185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25603878|NCT01043185|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25603879|NCT01043185|GABA Agonists|gaba agonists|mesh-ancestor
25603880|NCT01043185|GABA Agents|gaba agents|mesh-ancestor
25603881|NCT01043185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25498392|NCT05117034|Narcotics|narcotics|mesh-ancestor
25498393|NCT05117034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25498394|NCT05117034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498395|NCT05117034|Analgesics|analgesics|mesh-ancestor
25498396|NCT05117034|Sensory System Agents|sensory system agents|mesh-ancestor
25498397|NCT05117034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25498398|NCT05031806|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25498399|NCT05031806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25498400|NCT04974216|Rituximab|rituximab|mesh-list
25498401|NCT04974216|Lenalidomide|lenalidomide|mesh-list
25498402|NCT04974216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25498403|NCT04974216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498404|NCT04974216|Immunologic Factors|immunologic factors|mesh-ancestor
25498405|NCT04974216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498406|NCT04974216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25498407|NCT04974216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25498408|NCT04974216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25498409|NCT04974216|Growth Substances|growth substances|mesh-ancestor
25498410|NCT04974216|Growth Inhibitors|growth inhibitors|mesh-ancestor
25498411|NCT04754321|Pembrolizumab|pembrolizumab|mesh-list
25498412|NCT04754321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25498413|NCT04754321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24785010|NCT01911494|Tocolytic Agents|tocolytic agents|mesh-ancestor
24959066|NCT03827408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25166654|NCT03828019|Antimetabolites|antimetabolites|mesh-ancestor
25120095|NCT04712734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25120096|NCT04712734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124103|NCT03079544|Pegaspargase|pegaspargase|mesh-list
25124104|NCT03079544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25124105|NCT03079505|Dasatinib|dasatinib|mesh-list
25124106|NCT03079505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435035|NCT00264914|Satavaptan|satavaptan|mesh-list
24435047|NCT00264953|Vincristine|vincristine|mesh-list
24435048|NCT00264953|Doxorubicin|doxorubicin|mesh-list
24435049|NCT00264953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24435140|NCT00265278|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24435141|NCT00265278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435143|NCT00265291|Desipramine|desipramine|mesh-list
24435144|NCT00265291|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24435145|NCT00265291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24435146|NCT00265291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24435147|NCT00265291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435148|NCT00265291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24435149|NCT00265291|Serotonin Agents|serotonin agents|mesh-ancestor
24435150|NCT00265291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435151|NCT00265291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24435152|NCT00265291|Antidepressive Agents|antidepressive agents|mesh-ancestor
25106038|NCT04630938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25603882|NCT01043185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603883|NCT01043185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603884|NCT01043393|Desoximetasone|desoximetasone|mesh-list
25603885|NCT01043393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25603886|NCT01043393|Glucocorticoids|glucocorticoids|mesh-ancestor
25603887|NCT01043393|Hormones|hormones|mesh-ancestor
25603888|NCT01043393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25603889|NCT01043393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603890|NCT01043640|Cyclosporine|cyclosporine|mesh-list
25603891|NCT01043640|Mycophenolic Acid|mycophenolic acid|mesh-list
25603892|NCT01043640|Cyclophosphamide|cyclophosphamide|mesh-list
25603893|NCT01043640|Busulfan|busulfan|mesh-list
25603894|NCT01043640|Alemtuzumab|alemtuzumab|mesh-list
25603895|NCT01043640|Cyclosporins|cyclosporins|mesh-list
25603896|NCT01043640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25603897|NCT01043640|Immunologic Factors|immunologic factors|mesh-ancestor
25603898|NCT01043640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603899|NCT01043640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25603900|NCT01043640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25603901|NCT01043640|Alkylating Agents|alkylating agents|mesh-ancestor
25603902|NCT01043640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603903|NCT01043640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603904|NCT01043640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25603905|NCT01043640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603906|NCT01043640|Antifungal Agents|antifungal agents|mesh-ancestor
25603907|NCT01043640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25603908|NCT01043640|Dermatologic Agents|dermatologic agents|mesh-ancestor
25603909|NCT01043640|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25603910|NCT01043640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25603911|NCT01043640|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25603912|NCT01043640|Antitubercular Agents|antitubercular agents|mesh-ancestor
25603913|NCT01043640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25603914|NCT01043640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25603915|NCT01043926|Suvorexant|suvorexant|mesh-list
25603916|NCT01043926|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25603917|NCT01043926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25603918|NCT01043926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25603919|NCT01043926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603920|NCT01043926|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25603921|NCT01043926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25603922|NCT01043926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603923|NCT01044212|Psyllium|psyllium|mesh-list
25603924|NCT01044212|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
25603925|NCT01044212|Cathartics|cathartics|mesh-ancestor
25603926|NCT01044212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25603927|NCT01044212|Antidiarrheals|antidiarrheals|mesh-ancestor
25603928|NCT01044264|Clindamycin|clindamycin|mesh-list
25603929|NCT01044264|Clindamycin palmitate|clindamycin palmitate|mesh-list
25603930|NCT01044264|Clindamycin phosphate|clindamycin phosphate|mesh-list
25603931|NCT01044264|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25603932|NCT01044264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25603933|NCT01044264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25603934|NCT01044264|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25603935|NCT01044264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603936|NCT01044264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603937|NCT01044264|Dermatologic Agents|dermatologic agents|mesh-ancestor
25603938|NCT01044303|Mycophenolic Acid|mycophenolic acid|mesh-list
25603939|NCT01044303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25603940|NCT01044303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603941|NCT01044303|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25603942|NCT01044303|Antitubercular Agents|antitubercular agents|mesh-ancestor
25603943|NCT01044303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25603944|NCT01044303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25603945|NCT01044303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603946|NCT01044303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603947|NCT01044433|Capecitabine|capecitabine|mesh-list
25603948|NCT01044433|Lapatinib|lapatinib|mesh-list
25603949|NCT01044433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25603950|NCT01044433|Antimetabolites|antimetabolites|mesh-ancestor
25603951|NCT01044433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603952|NCT01044433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603953|NCT01044433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25603954|NCT01044433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603955|NCT01044459|Bromides|bromides|mesh-list
25603956|NCT01044459|Anticonvulsants|anticonvulsants|mesh-ancestor
25603957|NCT01044498|Norinyl|norinyl|mesh-list
25603958|NCT01044498|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25603959|NCT01044498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25603960|NCT01044498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25603961|NCT01044498|Contraceptive Agents|contraceptive agents|mesh-ancestor
25603962|NCT01044498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25603963|NCT01044498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603964|NCT01044498|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25603965|NCT01044498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25603966|NCT01044693|Metoprolol|metoprolol|mesh-list
25603967|NCT01044693|Nebivolol|nebivolol|mesh-list
25603968|NCT01044693|Sildenafil Citrate|sildenafil citrate|mesh-list
25603969|NCT01044693|Vasodilator Agents|vasodilator agents|mesh-ancestor
25603970|NCT01044693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25603971|NCT01044693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25603972|NCT01044693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25603973|NCT01044693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25603974|NCT01044693|Urological Agents|urological agents|mesh-ancestor
25603975|NCT01044693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25603976|NCT01044693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25603977|NCT01044693|Sympatholytics|sympatholytics|mesh-ancestor
25603978|NCT01044693|Autonomic Agents|autonomic agents|mesh-ancestor
25603979|NCT01044693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25603980|NCT01044693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603981|NCT01044693|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25603982|NCT01044693|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25603983|NCT01044693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25603984|NCT01044693|Adrenergic Agents|adrenergic agents|mesh-ancestor
25603985|NCT01044693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25603986|NCT01044693|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25603987|NCT01044693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25603988|NCT01044693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25603989|NCT01044706|Bicalutamide|bicalutamide|mesh-list
25603990|NCT01044706|Androgen Antagonists|androgen antagonists|mesh-ancestor
25603991|NCT01044706|Hormone Antagonists|hormone antagonists|mesh-ancestor
25603992|NCT01044706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25603993|NCT01044706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25603994|NCT01044706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25603995|NCT01044745|Mycophenolic Acid|mycophenolic acid|mesh-list
25603996|NCT01044745|Cyclophosphamide|cyclophosphamide|mesh-list
25603997|NCT01044745|Busulfan|busulfan|mesh-list
25603998|NCT01044745|Rituximab|rituximab|mesh-list
25603999|NCT01044745|Fludarabine|fludarabine|mesh-list
25604000|NCT01044745|Fludarabine phosphate|fludarabine phosphate|mesh-list
25604001|NCT01044745|Tacrolimus|tacrolimus|mesh-list
25604002|NCT01044745|Thymoglobulin|thymoglobulin|mesh-list
25604003|NCT01044745|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25604004|NCT01044745|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25604005|NCT01044745|Immunologic Factors|immunologic factors|mesh-ancestor
25604006|NCT01044745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604007|NCT01044745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25604008|NCT01044745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25604009|NCT01044745|Alkylating Agents|alkylating agents|mesh-ancestor
25604010|NCT01044745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604011|NCT01044745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25604012|NCT01044745|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25604013|NCT01044745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25604014|NCT01044745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25604015|NCT01044745|Antimetabolites|antimetabolites|mesh-ancestor
25604016|NCT01044745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25604017|NCT01044745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604018|NCT01044745|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25604019|NCT01044745|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25604020|NCT01044745|Antitubercular Agents|antitubercular agents|mesh-ancestor
25604021|NCT01044745|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25604022|NCT01044745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25604023|NCT01044758|Levetiracetam|levetiracetam|mesh-list
25604024|NCT01044758|Anticonvulsants|anticonvulsants|mesh-ancestor
25604025|NCT01044758|Nootropic Agents|nootropic agents|mesh-ancestor
25604026|NCT01044771|Tenofovir|tenofovir|mesh-list
25604027|NCT01044771|Raltegravir Potassium|raltegravir potassium|mesh-list
25604028|NCT01044771|Antiviral Agents|antiviral agents|mesh-ancestor
25604029|NCT01044771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25604030|NCT01044771|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25604031|NCT01044771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25604032|NCT01044771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604033|NCT01044771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604034|NCT01044771|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25604035|NCT01044771|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25604036|NCT01044771|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25604037|NCT01044771|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25604038|NCT01044862|Letrozole|letrozole|mesh-list
25604039|NCT01044862|Clomiphene|clomiphene|mesh-list
25604040|NCT01044862|Enclomiphene|enclomiphene|mesh-list
25604041|NCT01044862|Zuclomiphene|zuclomiphene|mesh-list
25604042|NCT01044862|Hormones|hormones|mesh-list
25604043|NCT01044862|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25604044|NCT01044862|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25604045|NCT01044862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604046|NCT01044862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25604047|NCT01044862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604048|NCT01044862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25604049|NCT01044862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25604050|NCT01044862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604051|NCT01044862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25604052|NCT01044862|Hormone Antagonists|hormone antagonists|mesh-ancestor
25604053|NCT01044862|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25604054|NCT01044862|Fertility Agents|fertility agents|mesh-ancestor
25604055|NCT01044862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25604056|NCT01044862|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25604057|NCT01044862|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25604058|NCT01044966|Temozolomide|temozolomide|mesh-list
25604059|NCT01044966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25604060|NCT01044966|Alkylating Agents|alkylating agents|mesh-ancestor
25604061|NCT01044966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604062|NCT01044966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25604063|NCT01045096|Dexlansoprazole|dexlansoprazole|mesh-list
25604064|NCT01045096|Lansoprazole|lansoprazole|mesh-list
25604065|NCT01045096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25604066|NCT01045096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25604067|NCT01045096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25604068|NCT01045096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604069|NCT01045096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604070|NCT01045122|Dexmedetomidine|dexmedetomidine|mesh-list
25604071|NCT01045122|Propofol|propofol|mesh-list
25604072|NCT01045122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25604073|NCT01045122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25604074|NCT01045122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604075|NCT01045122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25604076|NCT01045122|Anesthetics, General|anesthetics, general|mesh-ancestor
25604077|NCT01045122|Anesthetics|anesthetics|mesh-ancestor
25604078|NCT01045122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25604079|NCT01045122|Analgesics|analgesics|mesh-ancestor
25604080|NCT01045122|Sensory System Agents|sensory system agents|mesh-ancestor
25708662|NCT02256189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25604081|NCT01045122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604082|NCT01045122|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25604083|NCT01045122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25604084|NCT01045122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25604085|NCT01045122|Adrenergic Agents|adrenergic agents|mesh-ancestor
25604086|NCT01045122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25604087|NCT01045122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604088|NCT01045161|Bromides|bromides|mesh-list
25604089|NCT01045161|Anticonvulsants|anticonvulsants|mesh-ancestor
25604090|NCT01045447|Insulin|insulin|mesh-list
25604091|NCT01045447|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25604092|NCT01045447|Insulin Glargine|insulin glargine|mesh-list
25604093|NCT01045447|Insulin Aspart|insulin aspart|mesh-list
25604094|NCT01045447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25604095|NCT01045447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604096|NCT01045460|Cyclophosphamide|cyclophosphamide|mesh-list
25604097|NCT01045460|Melphalan|melphalan|mesh-list
25604098|NCT01045460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25604099|NCT01045460|Immunologic Factors|immunologic factors|mesh-ancestor
25604100|NCT01045460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604101|NCT01045460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25604102|NCT01045460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25604103|NCT01045460|Alkylating Agents|alkylating agents|mesh-ancestor
25604104|NCT01045460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604105|NCT01045460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25604106|NCT01045460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25604107|NCT01045551|Apremilast|apremilast|mesh-list
25604108|NCT01045551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25604109|NCT01045551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25604110|NCT01045551|Analgesics|analgesics|mesh-ancestor
25604111|NCT01045551|Sensory System Agents|sensory system agents|mesh-ancestor
25604112|NCT01045551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604113|NCT01045551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604114|NCT01045551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25604115|NCT01045551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25604116|NCT01045551|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25604117|NCT01045551|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25604118|NCT01045551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604119|NCT01045551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604120|NCT01045707|Insulin|insulin|mesh-list
25604121|NCT01045707|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25604122|NCT01045707|Insulin Glargine|insulin glargine|mesh-list
25604123|NCT01045707|Insulin Aspart|insulin aspart|mesh-list
25604124|NCT01045707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25604125|NCT01045707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604126|NCT01045798|Caspofungin|caspofungin|mesh-list
25604127|NCT01045798|Antifungal Agents|antifungal agents|mesh-ancestor
25604128|NCT01045798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25604129|NCT01045798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604130|NCT01045798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604131|NCT01045967|Lansoprazole|lansoprazole|mesh-list
25604132|NCT01045967|Dexlansoprazole|dexlansoprazole|mesh-list
25604133|NCT01045967|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25498561|NCT04339426|Antimalarials|antimalarials|mesh-ancestor
25604134|NCT01045967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25604135|NCT01045967|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25604136|NCT01045967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604137|NCT01045967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604138|NCT01045993|Analgesics|analgesics|mesh-list
25604139|NCT01045993|Sensory System Agents|sensory system agents|mesh-ancestor
25604140|NCT01045993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604141|NCT01045993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604142|NCT01046084|Lansoprazole|lansoprazole|mesh-list
25604143|NCT01046084|Dexlansoprazole|dexlansoprazole|mesh-list
25604144|NCT01046084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25604145|NCT01046084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25604146|NCT01046084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25604147|NCT01046084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604148|NCT01046084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604149|NCT01046110|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25604150|NCT01046110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25604151|NCT01046110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604152|NCT01046110|Incretins|incretins|mesh-ancestor
25604153|NCT01046110|Hormones|hormones|mesh-ancestor
25604154|NCT01046110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25604155|NCT01046110|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25604156|NCT01046110|Protease Inhibitors|protease inhibitors|mesh-ancestor
25604157|NCT01046110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604158|NCT01046110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604159|NCT01046136|Phenylpropanolamine|phenylpropanolamine|mesh-list
25604160|NCT01046136|Guaifenesin|guaifenesin|mesh-list
25604161|NCT01046136|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
25604162|NCT01046136|Expectorants|expectorants|mesh-ancestor
25604163|NCT01046136|Respiratory System Agents|respiratory system agents|mesh-ancestor
25604164|NCT01046136|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25604165|NCT01046136|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25604166|NCT01046136|Adrenergic Agents|adrenergic agents|mesh-ancestor
25604167|NCT01046136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25604168|NCT01046136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604169|NCT01046136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604170|NCT01046136|Appetite Depressants|appetite depressants|mesh-ancestor
25604171|NCT01046136|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25604172|NCT01046136|Sympathomimetics|sympathomimetics|mesh-ancestor
25604173|NCT01046136|Autonomic Agents|autonomic agents|mesh-ancestor
25604174|NCT01046136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604175|NCT01046136|Nasal Decongestants|nasal decongestants|mesh-ancestor
25604176|NCT01046136|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25604177|NCT01046253|Lansoprazole|lansoprazole|mesh-list
25604178|NCT01046253|Dexlansoprazole|dexlansoprazole|mesh-list
25604179|NCT01046253|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25604180|NCT01046253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25604181|NCT01046253|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25604182|NCT01046253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604183|NCT01046253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604184|NCT01046643|Estradiol|estradiol|mesh-list
25604185|NCT01046643|Progesterone|progesterone|mesh-list
24858364|NCT02296671|Pemetrexed|pemetrexed|mesh-list
25604186|NCT01046643|Estrogens|estrogens|mesh-ancestor
25604187|NCT01046643|Hormones|hormones|mesh-ancestor
25604188|NCT01046643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25604189|NCT01046643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604190|NCT01046643|Progestins|progestins|mesh-ancestor
25604191|NCT01046682|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
25604192|NCT01046682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25604193|NCT01046682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25604194|NCT01046682|Analgesics|analgesics|mesh-ancestor
25604195|NCT01046682|Sensory System Agents|sensory system agents|mesh-ancestor
25604196|NCT01046682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604197|NCT01046682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604198|NCT01046682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25604199|NCT01046682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25604200|NCT01046903|Dalteparin|dalteparin|mesh-list
25604201|NCT01046903|Tinzaparin|tinzaparin|mesh-list
25604202|NCT01046903|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25604203|NCT01046903|Anticoagulants|anticoagulants|mesh-ancestor
25604204|NCT01046903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25604205|NCT01046903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25604206|NCT01046903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604207|NCT01047007|Cisplatin|cisplatin|mesh-list
25604208|NCT01047007|Adavosertib|adavosertib|mesh-list
25604209|NCT01047007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25604210|NCT01047007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604211|NCT01047007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604212|NCT01047189|Clindamycin|clindamycin|mesh-list
25604213|NCT01047189|Clindamycin palmitate|clindamycin palmitate|mesh-list
25604214|NCT01047189|Clindamycin phosphate|clindamycin phosphate|mesh-list
25604215|NCT01047189|Tretinoin|tretinoin|mesh-list
25604216|NCT01047189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25604217|NCT01047189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25604218|NCT01047189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25604219|NCT01047189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604220|NCT01047189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604221|NCT01047189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25604222|NCT01047189|Keratolytic Agents|keratolytic agents|mesh-ancestor
25604223|NCT01047189|Dermatologic Agents|dermatologic agents|mesh-ancestor
25604224|NCT01047241|Sufentanil|sufentanil|mesh-list
25604225|NCT01047241|Ketamine|ketamine|mesh-list
25604226|NCT01047241|Analgesics|analgesics|mesh-ancestor
25604227|NCT01047241|Sensory System Agents|sensory system agents|mesh-ancestor
25604228|NCT01047241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604229|NCT01047241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604230|NCT01047241|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25604231|NCT01047241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25604232|NCT01047241|Anesthetics, General|anesthetics, general|mesh-ancestor
25604233|NCT01047241|Anesthetics|anesthetics|mesh-ancestor
25604234|NCT01047241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25604235|NCT01047241|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25604236|NCT01047241|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25604237|NCT01047241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25604238|NCT01047241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604239|NCT01047241|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25604240|NCT01047241|Narcotics|narcotics|mesh-ancestor
25604241|NCT01047241|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25604242|NCT01047293|Leucovorin|leucovorin|mesh-list
25604243|NCT01047293|Bevacizumab|bevacizumab|mesh-list
25604244|NCT01047293|Oxaliplatin|oxaliplatin|mesh-list
25604245|NCT01047293|Everolimus|everolimus|mesh-list
25604246|NCT01047293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25604247|NCT01047293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25604248|NCT01047293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25604249|NCT01047293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25604250|NCT01047293|Growth Substances|growth substances|mesh-ancestor
25604251|NCT01047293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604252|NCT01047293|Growth Inhibitors|growth inhibitors|mesh-ancestor
25604253|NCT01047293|Antidotes|antidotes|mesh-ancestor
25604254|NCT01047293|Protective Agents|protective agents|mesh-ancestor
25498708|NCT04016142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25498709|NCT04016142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498710|NCT04016142|Tubulin Modulators|tubulin modulators|mesh-ancestor
25498711|NCT04016142|Antimitotic Agents|antimitotic agents|mesh-ancestor
25498712|NCT04016142|Mitosis Modulators|mitosis modulators|mesh-ancestor
25498713|NCT04016142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498714|NCT04005287|Pirenzepine|pirenzepine|mesh-list
25498715|NCT04005287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25498716|NCT04005287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25498717|NCT04005287|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25498718|NCT04005287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25498719|NCT04005287|Cholinergic Agents|cholinergic agents|mesh-ancestor
25498720|NCT04005287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25498723|NCT03999554|Vaccines|vaccines|mesh-list
25604255|NCT01047293|Vitamin B Complex|vitamin b complex|mesh-ancestor
25604256|NCT01047293|Vitamins|vitamins|mesh-ancestor
25604257|NCT01047293|Micronutrients|micronutrients|mesh-ancestor
25604258|NCT01047293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25604259|NCT01047293|Immunologic Factors|immunologic factors|mesh-ancestor
25604260|NCT01047358|Exemestane|exemestane|mesh-list
25604261|NCT01047358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25604262|NCT01047358|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25604263|NCT01047358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25604264|NCT01047358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604265|NCT01047358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604266|NCT01047358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25604267|NCT01047358|Hormone Antagonists|hormone antagonists|mesh-ancestor
25604268|NCT01047358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25604269|NCT01047358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604270|NCT01047436|Artemether|artemether|mesh-list
25604271|NCT01047436|Quinine|quinine|mesh-list
25604272|NCT01047436|Antimalarials|antimalarials|mesh-ancestor
25604273|NCT01047436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25604274|NCT01047436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25604275|NCT01047436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25604276|NCT01047436|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25604277|NCT01047436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604278|NCT01047436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25604279|NCT01047436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604280|NCT01047436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25604281|NCT01047436|Analgesics|analgesics|mesh-ancestor
25604282|NCT01047436|Sensory System Agents|sensory system agents|mesh-ancestor
25604283|NCT01047527|Nicotine|nicotine|mesh-list
25604284|NCT01047527|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25604285|NCT01047527|Autonomic Agents|autonomic agents|mesh-ancestor
25604286|NCT01047527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604287|NCT01047527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604288|NCT01047527|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25604289|NCT01047527|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25604290|NCT01047527|Cholinergic Agents|cholinergic agents|mesh-ancestor
25604291|NCT01047527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25604292|NCT01047527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604293|NCT01047553|Formoterol Fumarate|formoterol fumarate|mesh-list
25604294|NCT01047553|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25604295|NCT01047553|Autonomic Agents|autonomic agents|mesh-ancestor
25604296|NCT01047553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604297|NCT01047553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604298|NCT01047553|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25604299|NCT01047553|Respiratory System Agents|respiratory system agents|mesh-ancestor
25604300|NCT01047553|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25604301|NCT01047553|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25604302|NCT01047553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25604303|NCT01047553|Adrenergic Agents|adrenergic agents|mesh-ancestor
25604304|NCT01047553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25604305|NCT01047553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604306|NCT01048099|Trastuzumab|trastuzumab|mesh-list
25604307|NCT01048099|Pertuzumab|pertuzumab|mesh-list
25604308|NCT01048099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25604309|NCT01048099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25604310|NCT01048333|Formoterol Fumarate|formoterol fumarate|mesh-list
25604311|NCT01048333|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25604312|NCT01048333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25604313|NCT01048333|Autonomic Agents|autonomic agents|mesh-ancestor
25604314|NCT01048333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604315|NCT01048333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604316|NCT01048333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25604317|NCT01048333|Respiratory System Agents|respiratory system agents|mesh-ancestor
25604318|NCT01048333|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25604319|NCT01048333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25604320|NCT01048333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25604321|NCT01048333|Adrenergic Agents|adrenergic agents|mesh-ancestor
25604322|NCT01048333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25604323|NCT01048333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604324|NCT01048502|Fenofibrate|fenofibrate|mesh-list
25604325|NCT01048502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25604326|NCT01048502|Antimetabolites|antimetabolites|mesh-ancestor
25604327|NCT01048502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604328|NCT01048502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25604329|NCT01048606|Phytoestrogens|phytoestrogens|mesh-list
25604330|NCT01048606|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25604331|NCT01048606|Estrogens|estrogens|mesh-ancestor
25604332|NCT01048606|Hormones|hormones|mesh-ancestor
25604333|NCT01048606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25604334|NCT01048606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604335|NCT01048658|Sevoflurane|sevoflurane|mesh-list
25604336|NCT01048658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25604337|NCT01048658|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25604338|NCT01048658|Anesthetics, General|anesthetics, general|mesh-ancestor
25604339|NCT01048658|Anesthetics|anesthetics|mesh-ancestor
25604340|NCT01048658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25604341|NCT01048658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604342|NCT01048671|Raltegravir Potassium|raltegravir potassium|mesh-list
25604343|NCT01048671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25604344|NCT01048671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25498761|NCT03765983|Trastuzumab|trastuzumab|mesh-list
25604345|NCT01048671|Antiviral Agents|antiviral agents|mesh-ancestor
25604346|NCT01048671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25604347|NCT01048671|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25604348|NCT01048671|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25604349|NCT01048671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604350|NCT01048671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604352|NCT01048697|Antitubercular Agents|antitubercular agents|mesh-ancestor
25604353|NCT01048697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25604354|NCT01048697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25604355|NCT01048788|Tolvaptan|tolvaptan|mesh-list
25604356|NCT01048788|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25604357|NCT01048788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604358|NCT01048788|Natriuretic Agents|natriuretic agents|mesh-ancestor
25604359|NCT01048788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604360|NCT01048866|Acetaminophen|acetaminophen|mesh-list
25604361|NCT01048866|Flurbiprofen|flurbiprofen|mesh-list
25604362|NCT01048866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25604363|NCT01048866|Analgesics|analgesics|mesh-ancestor
25604364|NCT01048866|Sensory System Agents|sensory system agents|mesh-ancestor
25604365|NCT01048866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604366|NCT01048866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604367|NCT01048866|Antipyretics|antipyretics|mesh-ancestor
25604368|NCT01048866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25604369|NCT01048866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25604370|NCT01048866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25604371|NCT01048866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25604372|NCT01048866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604373|NCT01048866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604374|NCT01048879|Oseltamivir|oseltamivir|mesh-list
25604375|NCT01048879|Dialysis Solutions|dialysis solutions|mesh-list
24447621|NCT00309218|Glucocorticoids|glucocorticoids|mesh-ancestor
25604376|NCT01048879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25604377|NCT01048879|Antiviral Agents|antiviral agents|mesh-ancestor
25604378|NCT01048879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25604379|NCT01048879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604380|NCT01048879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654251|NCT01548417|Hormone Antagonists|hormone antagonists|mesh-ancestor
25654252|NCT01548417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25654253|NCT01548417|Luteolytic Agents|luteolytic agents|mesh-ancestor
25654254|NCT01548417|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25654255|NCT01548417|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25654256|NCT01548573|Thalidomide|thalidomide|mesh-list
25654257|NCT01548573|Dexamethasone|dexamethasone|mesh-list
25654258|NCT01548573|Cyclophosphamide|cyclophosphamide|mesh-list
25654259|NCT01548573|Melphalan|melphalan|mesh-list
25654260|NCT01548573|Doxorubicin|doxorubicin|mesh-list
25654261|NCT01548573|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25654262|NCT01548573|Etoposide|etoposide|mesh-list
25654263|NCT01548573|Bortezomib|bortezomib|mesh-list
25654264|NCT01548573|Etoposide phosphate|etoposide phosphate|mesh-list
25654265|NCT01548573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25654266|NCT01548573|Immunologic Factors|immunologic factors|mesh-ancestor
25654267|NCT01548573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654268|NCT01548573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25654269|NCT01548573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25654270|NCT01548573|Alkylating Agents|alkylating agents|mesh-ancestor
25654271|NCT01548573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654272|NCT01548573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25654273|NCT01548573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25654274|NCT01548573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25654275|NCT01548573|Antiemetics|antiemetics|mesh-ancestor
25654276|NCT01548573|Autonomic Agents|autonomic agents|mesh-ancestor
25654277|NCT01548573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25654278|NCT01548573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25654279|NCT01548573|Glucocorticoids|glucocorticoids|mesh-ancestor
25654280|NCT01548573|Hormones|hormones|mesh-ancestor
25654281|NCT01548573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25654282|NCT01548573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25654283|NCT01548573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25654284|NCT01548573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25654285|NCT01548573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25654286|NCT01548573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25654287|NCT01548573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25654288|NCT01548573|Leprostatic Agents|leprostatic agents|mesh-ancestor
25498845|NCT03518034|Hormones|hormones|mesh-ancestor
25604381|NCT01048944|Bupropion|bupropion|mesh-list
25604382|NCT01048944|Nicotine|nicotine|mesh-list
25604383|NCT01048944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25604384|NCT01048944|Autonomic Agents|autonomic agents|mesh-ancestor
25604385|NCT01048944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604386|NCT01048944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604387|NCT01048944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25604388|NCT01048944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25604389|NCT01048944|Cholinergic Agents|cholinergic agents|mesh-ancestor
25604390|NCT01048944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25604391|NCT01048944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604392|NCT01048944|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25604393|NCT01048944|Antidepressive Agents|antidepressive agents|mesh-ancestor
25604394|NCT01048944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25604395|NCT01048944|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25604396|NCT01048944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25604397|NCT01048944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25604398|NCT01048944|Dopamine Agents|dopamine agents|mesh-ancestor
25604399|NCT01048944|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25604400|NCT01048944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25604401|NCT01048944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604402|NCT01049009|Metoprolol|metoprolol|mesh-list
25604403|NCT01049009|Nebivolol|nebivolol|mesh-list
25604404|NCT01049009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25604405|NCT01049009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25604406|NCT01049009|Sympatholytics|sympatholytics|mesh-ancestor
25604407|NCT01049009|Autonomic Agents|autonomic agents|mesh-ancestor
25604408|NCT01049009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604409|NCT01049009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604410|NCT01049009|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25604411|NCT01049009|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25604412|NCT01049009|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25604413|NCT01049009|Adrenergic Agents|adrenergic agents|mesh-ancestor
25604414|NCT01049009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25604415|NCT01049009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604416|NCT01049009|Vasodilator Agents|vasodilator agents|mesh-ancestor
25604417|NCT01049009|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25604418|NCT01049009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25604419|NCT01049009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25604420|NCT01049217|Pregabalin|pregabalin|mesh-list
25604421|NCT01049217|Analgesics|analgesics|mesh-ancestor
25604422|NCT01049217|Sensory System Agents|sensory system agents|mesh-ancestor
25604423|NCT01049217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604424|NCT01049217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604425|NCT01049217|Anticonvulsants|anticonvulsants|mesh-ancestor
25604426|NCT01049217|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25604427|NCT01049217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25604428|NCT01049217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604429|NCT01049217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25604430|NCT01049217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25604431|NCT01049217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25604432|NCT01049217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25604433|NCT01049217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25604434|NCT01049243|Fluocinonide|fluocinonide|mesh-list
25604435|NCT01049243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25604436|NCT01049243|Glucocorticoids|glucocorticoids|mesh-ancestor
25604437|NCT01049243|Hormones|hormones|mesh-ancestor
25604438|NCT01049243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25604439|NCT01049243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604440|NCT01049243|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25604441|NCT01049334|Flurbiprofen|flurbiprofen|mesh-list
25604442|NCT01049334|Analgesics|analgesics|mesh-ancestor
25604443|NCT01049334|Sensory System Agents|sensory system agents|mesh-ancestor
25604444|NCT01049334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604445|NCT01049334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604446|NCT01049334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25604447|NCT01049334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25604448|NCT01049334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25604449|NCT01049334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25604450|NCT01049334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25604451|NCT01049334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604452|NCT01049334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498918|NCT03120780|Anesthetics|anesthetics|mesh-ancestor
25604453|NCT01049360|Formoterol Fumarate|formoterol fumarate|mesh-list
25604454|NCT01049360|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25604455|NCT01049360|Autonomic Agents|autonomic agents|mesh-ancestor
25604456|NCT01049360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604457|NCT01049360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604458|NCT01049360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25604459|NCT01049360|Respiratory System Agents|respiratory system agents|mesh-ancestor
25604460|NCT01049360|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25604461|NCT01049360|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25604462|NCT01049360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25604463|NCT01049360|Adrenergic Agents|adrenergic agents|mesh-ancestor
25604464|NCT01049360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25604465|NCT01049360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604466|NCT01049412|Insulin Glargine|insulin glargine|mesh-list
25604467|NCT01049412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25604468|NCT01049412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604469|NCT01049503|Fluorides|fluorides|mesh-list
25604470|NCT01049503|Cariostatic Agents|cariostatic agents|mesh-ancestor
25604471|NCT01049503|Protective Agents|protective agents|mesh-ancestor
25604472|NCT01049503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604473|NCT01049945|Dexamethasone|dexamethasone|mesh-list
25604474|NCT01049945|Lenalidomide|lenalidomide|mesh-list
25604475|NCT01049945|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25604476|NCT01049945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25604477|NCT01049945|Antiemetics|antiemetics|mesh-ancestor
25604478|NCT01049945|Autonomic Agents|autonomic agents|mesh-ancestor
24549481|NCT00715637|Amonafide|amonafide|mesh-list
25604479|NCT01049945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604480|NCT01049945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604481|NCT01049945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25604482|NCT01049945|Glucocorticoids|glucocorticoids|mesh-ancestor
25604483|NCT01049945|Hormones|hormones|mesh-ancestor
25604484|NCT01049945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25604485|NCT01049945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25604486|NCT01049945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25604487|NCT01049945|Immunologic Factors|immunologic factors|mesh-ancestor
25604488|NCT01049945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25604489|NCT01049945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25604490|NCT01049945|Growth Substances|growth substances|mesh-ancestor
25604491|NCT01049945|Growth Inhibitors|growth inhibitors|mesh-ancestor
25604492|NCT01049945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25604493|NCT01049945|Alkylating Agents|alkylating agents|mesh-ancestor
25604494|NCT01049945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604495|NCT01049984|Rasagiline|rasagiline|mesh-list
25604496|NCT01049984|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25604497|NCT01049984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604498|NCT01049984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604499|NCT01049984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25604500|NCT01049984|Protective Agents|protective agents|mesh-ancestor
25604501|NCT01049984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604502|NCT01050062|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25604503|NCT01050062|Telmisartan|telmisartan|mesh-list
25604504|NCT01050062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25604505|NCT01050062|Diuretics|diuretics|mesh-ancestor
25604506|NCT01050062|Natriuretic Agents|natriuretic agents|mesh-ancestor
25604507|NCT01050062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604508|NCT01050062|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25604509|NCT01050062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25604510|NCT01050062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604511|NCT01050062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25604512|NCT01050062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25604513|NCT01050153|Aspirin|aspirin|mesh-list
25604514|NCT01050153|Dalteparin|dalteparin|mesh-list
25604515|NCT01050153|Tinzaparin|tinzaparin|mesh-list
25604516|NCT01050153|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25604517|NCT01050153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25604518|NCT01050153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25604519|NCT01050153|Analgesics|analgesics|mesh-ancestor
25604520|NCT01050153|Sensory System Agents|sensory system agents|mesh-ancestor
25604521|NCT01050153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604522|NCT01050153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604523|NCT01050153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25604524|NCT01050153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25604525|NCT01050153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25604527|NCT01050153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604528|NCT01050153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25604529|NCT01050153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25604530|NCT01050153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604531|NCT01050153|Antipyretics|antipyretics|mesh-ancestor
25604532|NCT01050153|Anticoagulants|anticoagulants|mesh-ancestor
25604533|NCT01050257|Oseltamivir|oseltamivir|mesh-list
25604534|NCT01050257|Antiviral Agents|antiviral agents|mesh-ancestor
25604535|NCT01050257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25604536|NCT01050257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604537|NCT01050257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604538|NCT01050530|Tolvaptan|tolvaptan|mesh-list
25604539|NCT01050530|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25604540|NCT01050530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604541|NCT01050530|Natriuretic Agents|natriuretic agents|mesh-ancestor
24447780|NCT00309569|Methotrexate|methotrexate|mesh-list
25604542|NCT01050530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604543|NCT01050543|Neostigmine|neostigmine|mesh-list
25604544|NCT01050543|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25604545|NCT01050543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604546|NCT01050543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604547|NCT01050543|Cholinergic Agents|cholinergic agents|mesh-ancestor
25604548|NCT01050543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25604549|NCT01050543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604550|NCT01050543|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25604551|NCT01050543|Autonomic Agents|autonomic agents|mesh-ancestor
25604552|NCT01050543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604553|NCT01050569|Nicotine|nicotine|mesh-list
25604554|NCT01050569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25604555|NCT01050569|Autonomic Agents|autonomic agents|mesh-ancestor
25604556|NCT01050569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604557|NCT01050569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604558|NCT01050569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25604559|NCT01050569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25604560|NCT01050569|Cholinergic Agents|cholinergic agents|mesh-ancestor
25604561|NCT01050569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25604562|NCT01050569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604563|NCT01050582|Risperidone|risperidone|mesh-list
25604564|NCT01050582|Antipsychotic Agents|antipsychotic agents|mesh-list
25604565|NCT01050582|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25604566|NCT01050582|Serotonin Agents|serotonin agents|mesh-ancestor
25604567|NCT01050582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25604568|NCT01050582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550007|NCT00718536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24550008|NCT00718536|Antiviral Agents|antiviral agents|mesh-ancestor
24550009|NCT00718536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24550101|NCT00719095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604569|NCT01050582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604570|NCT01050582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25604571|NCT01050582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25604572|NCT01050582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25604573|NCT01050582|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25604574|NCT01050582|Dopamine Agents|dopamine agents|mesh-ancestor
25604575|NCT01050634|Exemestane|exemestane|mesh-list
25604576|NCT01050634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25604577|NCT01050634|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25604578|NCT01050634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25604579|NCT01050634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25708773|NCT02257372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25708774|NCT02257372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708775|NCT02257372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25708776|NCT02257372|Respiratory System Agents|respiratory system agents|mesh-ancestor
24447826|NCT00309673|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24801412|NCT01983462|Sympatholytics|sympatholytics|mesh-ancestor
24801413|NCT01983462|Autonomic Agents|autonomic agents|mesh-ancestor
24447827|NCT00309686|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24447828|NCT00309686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24447849|NCT00309699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24447851|NCT00309699|Serotonin Agents|serotonin agents|mesh-ancestor
24447852|NCT00309699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24447856|NCT00309699|Dopamine Agents|dopamine agents|mesh-ancestor
24447872|NCT00309725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708777|NCT02257372|Tocolytic Agents|tocolytic agents|mesh-ancestor
25708778|NCT02257372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25708779|NCT02257372|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25604580|NCT01050634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604581|NCT01050634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25604582|NCT01050634|Hormone Antagonists|hormone antagonists|mesh-ancestor
25604583|NCT01050634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25604584|NCT01050634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604585|NCT01050647|Castor Oil|castor oil|mesh-list
25604586|NCT01050647|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
25604587|NCT01050647|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
25604588|NCT01050647|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25604589|NCT01050647|Hormone Antagonists|hormone antagonists|mesh-ancestor
25604590|NCT01050647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25604591|NCT01050647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604592|NCT01050647|Progestins|progestins|mesh-ancestor
25604593|NCT01050647|Hormones|hormones|mesh-ancestor
25604594|NCT01050647|Cathartics|cathartics|mesh-ancestor
25604595|NCT01050647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25604596|NCT01050660|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25604597|NCT01050660|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
25604598|NCT01050660|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25604599|NCT01050660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25604600|NCT01050764|Vidarabine|vidarabine|mesh-list
25604601|NCT01050764|Fludarabine|fludarabine|mesh-list
25604602|NCT01050764|Fludarabine phosphate|fludarabine phosphate|mesh-list
25604603|NCT01050764|Melphalan|melphalan|mesh-list
25604604|NCT01050764|Thiotepa|thiotepa|mesh-list
25604605|NCT01050764|Thymoglobulin|thymoglobulin|mesh-list
25604606|NCT01050764|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25604607|NCT01050764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708780|NCT02257372|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24801453|NCT01983540|Immunologic Factors|immunologic factors|mesh-ancestor
24801454|NCT01983540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708781|NCT02257372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25708782|NCT02257372|Adrenergic Agents|adrenergic agents|mesh-ancestor
25708783|NCT02257372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25708784|NCT02257372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709758|NCT02274766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709759|NCT02274766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25709760|NCT02274766|Analgesics|analgesics|mesh-ancestor
25709761|NCT02274766|Sensory System Agents|sensory system agents|mesh-ancestor
25604608|NCT01050764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25604609|NCT01050764|Antimetabolites|antimetabolites|mesh-ancestor
25604610|NCT01050764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604611|NCT01050764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25604612|NCT01050764|Immunologic Factors|immunologic factors|mesh-ancestor
25604613|NCT01050764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604614|NCT01050764|Antiviral Agents|antiviral agents|mesh-ancestor
25604615|NCT01050764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25604616|NCT01050764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25604617|NCT01050764|Alkylating Agents|alkylating agents|mesh-ancestor
25604618|NCT01050764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25604619|NCT01050790|Lenalidomide|lenalidomide|mesh-list
24801472|NCT01983735|Antimetabolites|antimetabolites|mesh-ancestor
25708785|NCT02257385|Albuterol|albuterol|mesh-list
25708786|NCT02257385|Tiotropium Bromide|tiotropium bromide|mesh-list
25708787|NCT02257385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25708788|NCT02257385|Autonomic Agents|autonomic agents|mesh-ancestor
25708789|NCT02257385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25708790|NCT02257385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708791|NCT02257385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25708792|NCT02257385|Respiratory System Agents|respiratory system agents|mesh-ancestor
25708793|NCT02257385|Parasympatholytics|parasympatholytics|mesh-ancestor
25708794|NCT02257385|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25708795|NCT02257385|Cholinergic Agents|cholinergic agents|mesh-ancestor
25604620|NCT01050790|Azacitidine|azacitidine|mesh-list
25604621|NCT01050790|Immunologic Factors|immunologic factors|mesh-ancestor
25604622|NCT01050790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604623|NCT01050790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25604624|NCT01050790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25604625|NCT01050790|Growth Substances|growth substances|mesh-ancestor
25604626|NCT01050790|Growth Inhibitors|growth inhibitors|mesh-ancestor
25604627|NCT01050790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25604628|NCT01050790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25604629|NCT01050790|Antimetabolites|antimetabolites|mesh-ancestor
25604630|NCT01050790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604631|NCT01050790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604632|NCT01050907|Miltefosine|miltefosine|mesh-list
25604633|NCT01050907|Antifungal Agents|antifungal agents|mesh-ancestor
25604634|NCT01050907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25604635|NCT01050907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25604636|NCT01050907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25604637|NCT01050907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25604638|NCT01050998|Mavrilimumab|mavrilimumab|mesh-list
25604639|NCT01050998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25604640|NCT01050998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25604641|NCT01050998|Immunologic Factors|immunologic factors|mesh-ancestor
25604642|NCT01050998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604643|NCT01051349|Daclizumab|daclizumab|mesh-list
25708796|NCT02257385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25708797|NCT02257385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708798|NCT02257385|Tocolytic Agents|tocolytic agents|mesh-ancestor
25708799|NCT02257385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25708800|NCT02257385|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24801502|NCT01983761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24801503|NCT01983800|Midazolam|midazolam|mesh-list
24801504|NCT01983800|Propofol|propofol|mesh-list
24801505|NCT01983800|Isoflurane|isoflurane|mesh-list
24801506|NCT01983800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24801507|NCT01983800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24454255|NCT04266730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25708801|NCT02257385|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25708802|NCT02257385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25708803|NCT02257385|Adrenergic Agents|adrenergic agents|mesh-ancestor
25708804|NCT02257541|Imatinib Mesylate|imatinib mesylate|mesh-list
25708805|NCT02257541|Infigratinib|infigratinib|mesh-list
25708806|NCT02257541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25604644|NCT01051349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25604645|NCT01051349|Immunologic Factors|immunologic factors|mesh-ancestor
25604646|NCT01051349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604647|NCT01051440|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25604648|NCT01051440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25604649|NCT01051440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604650|NCT01051440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24801516|NCT01983800|GABA Modulators|gaba modulators|mesh-ancestor
24801517|NCT01983800|GABA Agents|gaba agents|mesh-ancestor
24801518|NCT01983800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24801519|NCT01983800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556374|NCT00747383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25708807|NCT02257541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25708808|NCT02257541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25708809|NCT02257541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708810|NCT02257632|Ranibizumab|ranibizumab|mesh-list
25708811|NCT02257632|Aflibercept|aflibercept|mesh-list
25708812|NCT02257632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25708813|NCT02257632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25708814|NCT02257632|Growth Substances|growth substances|mesh-ancestor
25708815|NCT02257632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604651|NCT01051440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25604652|NCT01051440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25604653|NCT01051440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604654|NCT01051440|Dopamine Agents|dopamine agents|mesh-ancestor
25604655|NCT01051440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25604656|NCT01051466|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25604657|NCT01051466|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25604658|NCT01051466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24801536|NCT01984008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801537|NCT01984008|Cathartics|cathartics|mesh-ancestor
24801538|NCT01984008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24801539|NCT01984008|Antacids|antacids|mesh-ancestor
24801541|NCT01984073|Niacinamide|niacinamide|mesh-list
24801542|NCT01984073|Nicotinic Acids|nicotinic acids|mesh-list
24801543|NCT01984073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24454260|NCT04231773|Nitric Oxide|nitric oxide|mesh-list
24454261|NCT04231773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24454262|NCT04231773|Autonomic Agents|autonomic agents|mesh-ancestor
24454263|NCT04231773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24454264|NCT04231773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24454265|NCT04231773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24454266|NCT04231773|Respiratory System Agents|respiratory system agents|mesh-ancestor
24454267|NCT04231773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24454268|NCT04231773|Antioxidants|antioxidants|mesh-ancestor
24454269|NCT04231773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24454270|NCT04231773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24454271|NCT04231773|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24454272|NCT04231773|Vasodilator Agents|vasodilator agents|mesh-ancestor
24454273|NCT04231773|Gasotransmitters|gasotransmitters|mesh-ancestor
24454274|NCT04231773|Protective Agents|protective agents|mesh-ancestor
25604659|NCT01051466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25499073|NCT01880541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25499074|NCT01880541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499075|NCT01650350|Naltrexone|naltrexone|mesh-list
25604660|NCT01051466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604661|NCT01051466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25604662|NCT01051466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604663|NCT01051466|Analgesics|analgesics|mesh-ancestor
25708816|NCT02257632|Growth Inhibitors|growth inhibitors|mesh-ancestor
24454310|NCT04109482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24801551|NCT01984073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801553|NCT01984086|Charcoal|charcoal|mesh-list
24801554|NCT01984086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24801555|NCT01984086|Autonomic Agents|autonomic agents|mesh-ancestor
24801556|NCT01984086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24801558|NCT01984086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24801567|NCT01984086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801569|NCT01984086|Protective Agents|protective agents|mesh-ancestor
24801570|NCT01984099|Folic Acid|folic acid|mesh-list
24801579|NCT01984099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24801580|NCT01984099|Antimetabolites|antimetabolites|mesh-ancestor
25708817|NCT02257632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708818|NCT02257957|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25708819|NCT02257957|Hyaluronic Acid|hyaluronic acid|mesh-list
25708820|NCT02257957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25708821|NCT02257957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25604664|NCT01051466|Sensory System Agents|sensory system agents|mesh-ancestor
25499076|NCT01650350|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25499077|NCT01650350|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25499078|NCT01650350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499079|NCT01650350|Sensory System Agents|sensory system agents|mesh-ancestor
25604665|NCT01051466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604666|NCT01051466|Antidepressive Agents|antidepressive agents|mesh-ancestor
25604667|NCT01051466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25604668|NCT01051466|Dopamine Agents|dopamine agents|mesh-ancestor
25604670|NCT01051557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25604671|NCT01051557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25708822|NCT02257957|Immunologic Factors|immunologic factors|mesh-ancestor
24447882|NCT00309790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447883|NCT00309790|Urological Agents|urological agents|mesh-ancestor
24447892|NCT00309855|Testosterone|testosterone|mesh-list
24447893|NCT00309855|Dutasteride|dutasteride|mesh-list
24447894|NCT00309855|Androgens|androgens|mesh-ancestor
24447896|NCT00309855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24447897|NCT00309855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447898|NCT00309855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24447899|NCT00309855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447900|NCT00309855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24447901|NCT00309855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24447902|NCT00309855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24447903|NCT00309855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447905|NCT00309855|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24447906|NCT00309855|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24447907|NCT00309881|Prednisone|prednisone|mesh-list
24447908|NCT00309881|Cyclophosphamide|cyclophosphamide|mesh-list
24447909|NCT00309881|Rituximab|rituximab|mesh-list
24447910|NCT00309881|Doxorubicin|doxorubicin|mesh-list
25708823|NCT02257957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447911|NCT00309881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25708824|NCT02257957|Viscosupplements|viscosupplements|mesh-ancestor
25708825|NCT02257957|Protective Agents|protective agents|mesh-ancestor
25708826|NCT02257970|Ketoprofen|ketoprofen|mesh-list
24447912|NCT00309881|Vincristine|vincristine|mesh-list
24447913|NCT00309881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24447914|NCT00309881|Immunologic Factors|immunologic factors|mesh-ancestor
25604672|NCT01051557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25604673|NCT01051557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25604674|NCT01051557|Antifungal Agents|antifungal agents|mesh-ancestor
25604675|NCT01051557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25604676|NCT01051557|Immunologic Factors|immunologic factors|mesh-ancestor
25604677|NCT01051557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604678|NCT01051570|Prednisone|prednisone|mesh-list
25604679|NCT01051570|Carboplatin|carboplatin|mesh-list
25604680|NCT01051570|Everolimus|everolimus|mesh-list
25604681|NCT01051570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25604682|NCT01051570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25604683|NCT01051570|Glucocorticoids|glucocorticoids|mesh-ancestor
25604684|NCT01051570|Hormones|hormones|mesh-ancestor
25604685|NCT01051570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25604686|NCT01051570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604687|NCT01051570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25604688|NCT01051570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25604689|NCT01051570|Immunologic Factors|immunologic factors|mesh-ancestor
25604690|NCT01051596|Temozolomide|temozolomide|mesh-list
25604691|NCT01051596|Veliparib|veliparib|mesh-list
25604692|NCT01051596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25604693|NCT01051596|Alkylating Agents|alkylating agents|mesh-ancestor
25604694|NCT01051596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604695|NCT01051596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25604696|NCT01051596|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25604697|NCT01051596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604698|NCT01051661|Vaccines|vaccines|mesh-list
24447915|NCT00309881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708827|NCT02257970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25708828|NCT02257970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25708829|NCT02257970|Analgesics|analgesics|mesh-ancestor
25708830|NCT02257970|Sensory System Agents|sensory system agents|mesh-ancestor
25708831|NCT02257970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25708832|NCT02257970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708833|NCT02257970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25708834|NCT02257970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25604699|NCT01051661|Immunologic Factors|immunologic factors|mesh-ancestor
25604700|NCT01051661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604701|NCT01051778|Aspirin|aspirin|mesh-list
25604702|NCT01051778|Heparin|heparin|mesh-list
25604703|NCT01051778|Enoxaparin|enoxaparin|mesh-list
25604704|NCT01051778|Calcium heparin|calcium heparin|mesh-list
25604705|NCT01051778|Calcium|calcium|mesh-list
25604706|NCT01051778|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25604707|NCT01051778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604708|NCT01051778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25604709|NCT01051778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25604710|NCT01051778|Analgesics|analgesics|mesh-ancestor
25604711|NCT01051778|Sensory System Agents|sensory system agents|mesh-ancestor
25604712|NCT01051778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604713|NCT01051778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25604714|NCT01051778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25604715|NCT01051778|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25604716|NCT01051778|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25604717|NCT01051778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604718|NCT01051778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25604719|NCT01051778|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25604720|NCT01051778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604721|NCT01051778|Antipyretics|antipyretics|mesh-ancestor
25604722|NCT01051778|Anticoagulants|anticoagulants|mesh-ancestor
25604723|NCT01051791|Everolimus|everolimus|mesh-list
25604724|NCT01051791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25604725|NCT01051791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25604726|NCT01051791|Immunologic Factors|immunologic factors|mesh-ancestor
24801626|NCT01984567|Micronutrients|micronutrients|mesh-ancestor
24801627|NCT01984567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801628|NCT01984567|Antioxidants|antioxidants|mesh-ancestor
24801629|NCT01984567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801630|NCT01984567|Protective Agents|protective agents|mesh-ancestor
24801631|NCT01984567|Vitamin B Complex|vitamin b complex|mesh-ancestor
24801632|NCT01984606|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24801633|NCT01984606|Empagliflozin|empagliflozin|mesh-list
24801634|NCT01984606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24801635|NCT01984606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604727|NCT01051791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604728|NCT01051960|Ambrisentan|ambrisentan|mesh-list
25604729|NCT01051960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25604730|NCT01052012|Bupivacaine|bupivacaine|mesh-list
25604731|NCT01052012|Anesthetics, Local|anesthetics, local|mesh-ancestor
25604732|NCT01052012|Anesthetics|anesthetics|mesh-ancestor
25604733|NCT01052012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25604734|NCT01052012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604735|NCT01052012|Sensory System Agents|sensory system agents|mesh-ancestor
25604736|NCT01052012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604737|NCT01052038|Dexamethasone|dexamethasone|mesh-list
25604738|NCT01052038|Dexamethasone acetate|dexamethasone acetate|mesh-list
25604739|NCT01052038|BB 1101|bb 1101|mesh-list
25604740|NCT01052038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25604741|NCT01052038|Antiemetics|antiemetics|mesh-ancestor
25604742|NCT01052038|Autonomic Agents|autonomic agents|mesh-ancestor
25604743|NCT01052038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604744|NCT01052038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604745|NCT01052038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25708835|NCT02257970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25708836|NCT02257970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622336|NCT01066676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708837|NCT02257970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708838|NCT02258074|Niacinamide|niacinamide|mesh-list
25708839|NCT02258074|Niacin|niacin|mesh-list
25708840|NCT02258074|Nicotinic Acids|nicotinic acids|mesh-list
25708841|NCT02258074|Vitamin B Complex|vitamin b complex|mesh-ancestor
25708842|NCT02258074|Vitamins|vitamins|mesh-ancestor
25708843|NCT02258074|Micronutrients|micronutrients|mesh-ancestor
25604746|NCT01052038|Glucocorticoids|glucocorticoids|mesh-ancestor
25604747|NCT01052038|Hormones|hormones|mesh-ancestor
25604748|NCT01052038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25604749|NCT01052038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25604750|NCT01052038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25604751|NCT01052038|Protease Inhibitors|protease inhibitors|mesh-ancestor
25604752|NCT01052038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604753|NCT01052038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604754|NCT01052077|Antidepressive Agents|antidepressive agents|mesh-list
25604755|NCT01052077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25604756|NCT01052272|Allopurinol|allopurinol|mesh-list
25604757|NCT01052272|Candesartan|candesartan|mesh-list
25604758|NCT01052272|Candesartan cilexetil|candesartan cilexetil|mesh-list
25604759|NCT01052272|Ramipril|ramipril|mesh-list
25604760|NCT01052272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25604761|NCT01052272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25604762|NCT01052272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25604763|NCT01052272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604764|NCT01052272|Antimetabolites|antimetabolites|mesh-ancestor
25604765|NCT01052272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604766|NCT01052272|Gout Suppressants|gout suppressants|mesh-ancestor
25604767|NCT01052272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25604768|NCT01052272|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24622337|NCT01066676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24558062|NCT00755313|Docetaxel|docetaxel|mesh-list
24622341|NCT01066676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708844|NCT02258074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708845|NCT02258074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25708846|NCT02258074|Antimetabolites|antimetabolites|mesh-ancestor
25708847|NCT02258074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708848|NCT02258074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25708849|NCT02258074|Vasodilator Agents|vasodilator agents|mesh-ancestor
25708850|NCT02258217|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25708851|NCT02258217|Hormones|hormones|mesh-ancestor
25604769|NCT01052272|Antioxidants|antioxidants|mesh-ancestor
25604770|NCT01052272|Protective Agents|protective agents|mesh-ancestor
25604771|NCT01052272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604772|NCT01052272|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25604773|NCT01052272|Protease Inhibitors|protease inhibitors|mesh-ancestor
25604774|NCT01052428|Metoprolol|metoprolol|mesh-list
25604775|NCT01052428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25604776|NCT01052428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25604777|NCT01052428|Sympatholytics|sympatholytics|mesh-ancestor
25604778|NCT01052428|Autonomic Agents|autonomic agents|mesh-ancestor
25604779|NCT01052428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604780|NCT01052428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604781|NCT01052428|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25604782|NCT01052428|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25604783|NCT01052428|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25604784|NCT01052428|Adrenergic Agents|adrenergic agents|mesh-ancestor
25604785|NCT01052428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25604786|NCT01052428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604787|NCT01052493|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
25604788|NCT01052493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25604789|NCT01052493|Hormones|hormones|mesh-ancestor
25604790|NCT01052493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25604791|NCT01052493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604792|NCT01052662|Memantine|memantine|mesh-list
25604793|NCT01052662|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25604794|NCT01052662|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25604795|NCT01052662|Dopamine Agents|dopamine agents|mesh-ancestor
25604796|NCT01052662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25604797|NCT01052662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604798|NCT01052662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604799|NCT01052662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25604800|NCT01052662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25604801|NCT01052701|Ribavirin|ribavirin|mesh-list
25604802|NCT01052701|Abacavir|abacavir|mesh-list
25604803|NCT01052701|Antimetabolites|antimetabolites|mesh-ancestor
25604804|NCT01052701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604805|NCT01052701|Antiviral Agents|antiviral agents|mesh-ancestor
25604806|NCT01052701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25604807|NCT01052701|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25604808|NCT01052701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25604809|NCT01052701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604810|NCT01052701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25604811|NCT01052701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25604812|NCT01052779|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25604813|NCT01052779|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25604814|NCT01052779|Hematinics|hematinics|mesh-ancestor
24447966|NCT00309920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25604815|NCT01052779|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25604816|NCT01052779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25604817|NCT01052831|Naltrexone|naltrexone|mesh-list
25604818|NCT01052831|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25604819|NCT01052831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25604820|NCT01052831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708852|NCT02258217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25604821|NCT01052831|Sensory System Agents|sensory system agents|mesh-ancestor
25604822|NCT01052831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604823|NCT01052844|Gabapentin|gabapentin|mesh-list
25604824|NCT01052844|Analgesics|analgesics|mesh-ancestor
25604825|NCT01052844|Sensory System Agents|sensory system agents|mesh-ancestor
25604826|NCT01052844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604827|NCT01052844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604828|NCT01052844|Anticonvulsants|anticonvulsants|mesh-ancestor
25604829|NCT01052844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25604830|NCT01052844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25604831|NCT01052844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25604832|NCT01052844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25604833|NCT01052844|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25604834|NCT01052844|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25604835|NCT01052844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25604836|NCT01052844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604837|NCT01052844|Antimanic Agents|antimanic agents|mesh-ancestor
25604838|NCT01053000|Tazarotene|tazarotene|mesh-list
25604839|NCT01053000|Dermatologic Agents|dermatologic agents|mesh-ancestor
25604840|NCT01053000|Keratolytic Agents|keratolytic agents|mesh-ancestor
25604841|NCT01053078|Naltrexone|naltrexone|mesh-list
25604842|NCT01053078|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25604843|NCT01053078|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25604844|NCT01053078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604845|NCT01053078|Sensory System Agents|sensory system agents|mesh-ancestor
25604846|NCT01053078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604847|NCT01053156|Minocycline|minocycline|mesh-list
25604848|NCT01053156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25604849|NCT01053156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25604850|NCT01053247|Tacrolimus|tacrolimus|mesh-list
25604851|NCT01053247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25604852|NCT01053247|Immunologic Factors|immunologic factors|mesh-ancestor
25604853|NCT01053247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604854|NCT01053247|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25604855|NCT01053247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604856|NCT01053247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604857|NCT01053312|Flutemetamol|flutemetamol|mesh-list
25708853|NCT02258217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708854|NCT02258334|Vaccines|vaccines|mesh-list
24448002|NCT00310011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708855|NCT02258334|Immunologic Factors|immunologic factors|mesh-ancestor
25708856|NCT02258334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708857|NCT02258412|Ethanol|ethanol|mesh-list
25708858|NCT02258412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
25708859|NCT02258412|Hand Sanitizers|hand sanitizers|mesh-list
25708860|NCT02258412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24615458|NCT01029769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25604858|NCT01053312|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25604859|NCT01053312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604860|NCT01053429|Ziprasidone|ziprasidone|mesh-list
25604861|NCT01053429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25604862|NCT01053429|Serotonin Agents|serotonin agents|mesh-ancestor
25604863|NCT01053429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25604864|NCT01053429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604865|NCT01053429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604866|NCT01053429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25604867|NCT01053429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25604868|NCT01053429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25604869|NCT01053429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25604870|NCT01053429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25604871|NCT01053429|Dopamine Agents|dopamine agents|mesh-ancestor
25604872|NCT01053507|Naproxen|naproxen|mesh-list
25604873|NCT01053507|Sumatriptan|sumatriptan|mesh-list
25604874|NCT01053507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25604875|NCT01053507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25604876|NCT01053507|Analgesics|analgesics|mesh-ancestor
25604877|NCT01053507|Sensory System Agents|sensory system agents|mesh-ancestor
25604878|NCT01053507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604879|NCT01053507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604880|NCT01053507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25604881|NCT01053507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25604882|NCT01053507|Gout Suppressants|gout suppressants|mesh-ancestor
25604883|NCT01053507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25604884|NCT01053507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25604885|NCT01053507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604886|NCT01053507|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25604887|NCT01053507|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25604888|NCT01053507|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25604889|NCT01053507|Serotonin Agents|serotonin agents|mesh-ancestor
25604890|NCT01053507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25604891|NCT01053663|Oseltamivir|oseltamivir|mesh-list
25604892|NCT01053663|Antiviral Agents|antiviral agents|mesh-ancestor
25604893|NCT01053663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25604894|NCT01053663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859007|NCT02301000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24622424|NCT01066962|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24801645|NCT01984749|Gout Suppressants|gout suppressants|mesh-ancestor
24801646|NCT01984749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25604895|NCT01053663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604896|NCT01053741|Plasma-lyte 148|plasma-lyte 148|mesh-list
25604897|NCT01053741|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25604898|NCT01053741|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25604899|NCT01053819|Etanercept|etanercept|mesh-list
25604900|NCT01053819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25604901|NCT01053819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25604902|NCT01053819|Analgesics|analgesics|mesh-ancestor
25604903|NCT01053819|Sensory System Agents|sensory system agents|mesh-ancestor
25604904|NCT01053819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604905|NCT01053819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604906|NCT01053819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25604907|NCT01053819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25604908|NCT01053819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25604909|NCT01053819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25604910|NCT01053819|Immunologic Factors|immunologic factors|mesh-ancestor
25604911|NCT01053962|Plecanatide|plecanatide|mesh-list
25604912|NCT01053962|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25708861|NCT02258412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25708862|NCT02258412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708863|NCT02258412|Disinfectants|disinfectants|mesh-ancestor
25708864|NCT02258464|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
24801647|NCT01984827|Moxifloxacin|moxifloxacin|mesh-list
24801648|NCT01984827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24559137|NCT05271071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24559138|NCT05271071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24559139|NCT05271071|Sensory System Agents|sensory system agents|mesh-ancestor
24801668|NCT01984931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25708865|NCT02258464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708866|NCT02258529|Rituximab|rituximab|mesh-list
25708867|NCT02258529|Idelalisib|idelalisib|mesh-list
25708868|NCT02258529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25604913|NCT01053962|Enzyme Activators|enzyme activators|mesh-ancestor
25604914|NCT01053962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604915|NCT01053962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25604916|NCT01054079|Cinacalcet|cinacalcet|mesh-list
25604917|NCT01054079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25604918|NCT01054079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604919|NCT01054079|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25604920|NCT01054079|Hormone Antagonists|hormone antagonists|mesh-ancestor
25604921|NCT01054079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25604922|NCT01054144|Dexamethasone|dexamethasone|mesh-list
25604923|NCT01054144|Prednisone|prednisone|mesh-list
25604924|NCT01054144|Lenalidomide|lenalidomide|mesh-list
25604925|NCT01054144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25604926|NCT01054144|Antiemetics|antiemetics|mesh-ancestor
25604927|NCT01054144|Autonomic Agents|autonomic agents|mesh-ancestor
25604928|NCT01054144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25604929|NCT01054144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604930|NCT01054144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25604931|NCT01054144|Glucocorticoids|glucocorticoids|mesh-ancestor
25604932|NCT01054144|Hormones|hormones|mesh-ancestor
25604933|NCT01054144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25604934|NCT01054144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25604935|NCT01054144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25604936|NCT01054144|Immunologic Factors|immunologic factors|mesh-ancestor
25604937|NCT01054144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25604938|NCT01054144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25604939|NCT01054144|Growth Substances|growth substances|mesh-ancestor
24801682|NCT01984931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24559583|NCT04640168|Remdesivir|remdesivir|mesh-list
24505109|NCT00539877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801683|NCT01984931|GABA Modulators|gaba modulators|mesh-ancestor
24801684|NCT01984931|GABA Agents|gaba agents|mesh-ancestor
24448041|NCT00310128|Rituximab|rituximab|mesh-list
24448042|NCT00310128|Etoposide|etoposide|mesh-list
24448043|NCT00310128|Antibodies|antibodies|mesh-list
24448044|NCT00310128|Immunoglobulins|immunoglobulins|mesh-list
24448045|NCT00310128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24448046|NCT00310128|Immunologic Factors|immunologic factors|mesh-ancestor
24448047|NCT00310128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448048|NCT00310128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25604940|NCT01054144|Growth Inhibitors|growth inhibitors|mesh-ancestor
25604941|NCT01054222|Fesoterodine|fesoterodine|mesh-list
25604942|NCT01054222|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25604943|NCT01054222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25604944|NCT01054222|Cholinergic Agents|cholinergic agents|mesh-ancestor
25604945|NCT01054222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25604946|NCT01054222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604947|NCT01054222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604948|NCT01054222|Urological Agents|urological agents|mesh-ancestor
25604949|NCT01054300|Ertugliflozin|ertugliflozin|mesh-list
25604950|NCT01054300|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25604951|NCT01054300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604952|NCT01054300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25604953|NCT01054300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604954|NCT01054404|Furosemide|furosemide|mesh-list
25604955|NCT01054404|Diuretics|diuretics|mesh-ancestor
25604956|NCT01054404|Natriuretic Agents|natriuretic agents|mesh-ancestor
25604957|NCT01054404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604958|NCT01054404|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25604959|NCT01054404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25604960|NCT01054404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604961|NCT01054573|Interferons|interferons|mesh-list
25604962|NCT01054573|Ribavirin|ribavirin|mesh-list
25604963|NCT01054573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499327|NCT00305877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25604964|NCT01054573|Antiviral Agents|antiviral agents|mesh-ancestor
25604965|NCT01054573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25708869|NCT02258529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708870|NCT02258529|Immunologic Factors|immunologic factors|mesh-ancestor
24801687|NCT01984931|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24448049|NCT00310128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24448050|NCT00310128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24448051|NCT00310128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24448052|NCT00310128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24448053|NCT00310128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24448054|NCT00310128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448055|NCT00310128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406186|NCT03575325|Antimetabolites|antimetabolites|mesh-ancestor
25708871|NCT02258529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708872|NCT02258529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25708873|NCT02258529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25708874|NCT02258529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708875|NCT02259010|Itraconazole|itraconazole|mesh-list
25708876|NCT02259010|Antifungal Agents|antifungal agents|mesh-ancestor
25708877|NCT02259010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25708878|NCT02259010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25604966|NCT01054573|Antimetabolites|antimetabolites|mesh-ancestor
25604967|NCT01054573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604968|NCT01054599|Memantine|memantine|mesh-list
25604969|NCT01054599|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25604970|NCT01054599|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25604971|NCT01054599|Dopamine Agents|dopamine agents|mesh-ancestor
25604972|NCT01054599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25604973|NCT01054599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604974|NCT01054599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604975|NCT01054599|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25604976|NCT01054599|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25604977|NCT01054625|Zalutumumab|zalutumumab|mesh-list
25604978|NCT01054625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25604979|NCT01054625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25654289|NCT01548573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25654290|NCT01548573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25654291|NCT01548573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25654292|NCT01548573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25654293|NCT01548573|Growth Substances|growth substances|mesh-ancestor
25654294|NCT01548573|Growth Inhibitors|growth inhibitors|mesh-ancestor
25654295|NCT01548638|Galantamine|galantamine|mesh-list
25654296|NCT01548638|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25654297|NCT01548638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25654298|NCT01548638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654299|NCT01548638|Cholinergic Agents|cholinergic agents|mesh-ancestor
25654300|NCT01548638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25654301|NCT01548638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654302|NCT01548638|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25708885|NCT02259010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708886|NCT02259010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25708887|NCT02259088|Ranibizumab|ranibizumab|mesh-list
25708888|NCT02259088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24801693|NCT01985061|Immunologic Factors|immunologic factors|mesh-ancestor
24801694|NCT01985061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801695|NCT01985061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25654303|NCT01548638|Autonomic Agents|autonomic agents|mesh-ancestor
25654304|NCT01548638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25654305|NCT01548638|Nootropic Agents|nootropic agents|mesh-ancestor
25654306|NCT01548690|Phenylacetic acid|phenylacetic acid|mesh-list
25654307|NCT01548690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25654308|NCT01548690|Antimetabolites|antimetabolites|mesh-ancestor
25654309|NCT01548690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654310|NCT01548690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25654311|NCT01548768|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
25654312|NCT01548768|Antirheumatic Agents|antirheumatic agents|mesh-list
25654313|NCT01548768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25654314|NCT01549002|Fentanyl|fentanyl|mesh-list
25654315|NCT01549002|Morphine|morphine|mesh-list
25654316|NCT01549002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25654317|NCT01549002|Narcotics|narcotics|mesh-ancestor
25654318|NCT01549002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25654319|NCT01549002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654320|NCT01549002|Analgesics|analgesics|mesh-ancestor
25654321|NCT01549002|Sensory System Agents|sensory system agents|mesh-ancestor
25654322|NCT01549002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25654323|NCT01549002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25654324|NCT01549002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25654325|NCT01549002|Anesthetics, General|anesthetics, general|mesh-ancestor
25654326|NCT01549002|Anesthetics|anesthetics|mesh-ancestor
25654327|NCT01549041|Asenapine|asenapine|mesh-list
25654328|NCT01549041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25654329|NCT01549041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25654330|NCT01549041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25654331|NCT01549041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654332|NCT01549041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25654333|NCT01549223|Misoprostol|misoprostol|mesh-list
25654334|NCT01549223|Oxytocin|oxytocin|mesh-list
25654335|NCT01549223|Methylergonovine|methylergonovine|mesh-list
25654336|NCT01549223|Carboprost tromethamine|carboprost tromethamine|mesh-list
25708889|NCT02259088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25708890|NCT02259088|Growth Substances|growth substances|mesh-ancestor
25708891|NCT02259088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708892|NCT02259088|Growth Inhibitors|growth inhibitors|mesh-ancestor
25708893|NCT02259088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708894|NCT02259231|Nivolumab|nivolumab|mesh-list
25708895|NCT02259231|Ipilimumab|ipilimumab|mesh-list
25708896|NCT02259231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25654337|NCT01549223|Carboprost|carboprost|mesh-list
25654338|NCT01549223|Maleic acid|maleic acid|mesh-list
25654339|NCT01549223|Oxytocics|oxytocics|mesh-ancestor
25654340|NCT01549223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25654341|NCT01549223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654342|NCT01549223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25654343|NCT01549223|Abortifacient Agents|abortifacient agents|mesh-ancestor
25654344|NCT01549223|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25654345|NCT01549223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25654346|NCT01549223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25654347|NCT01549223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499403|NCT00306670|Hormones|hormones|mesh-ancestor
25604980|NCT01054729|Sofosbuvir|sofosbuvir|mesh-list
25604981|NCT01054729|Antiviral Agents|antiviral agents|mesh-ancestor
25604982|NCT01054729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25604983|NCT01054742|Ribavirin|ribavirin|mesh-list
25604984|NCT01054742|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25604985|NCT01054742|Antimetabolites|antimetabolites|mesh-ancestor
25604986|NCT01054742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604987|NCT01054742|Antiviral Agents|antiviral agents|mesh-ancestor
25604988|NCT01054742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25604989|NCT01054768|Thioctic Acid|thioctic acid|mesh-list
25604990|NCT01054768|Acetylcarnitine|acetylcarnitine|mesh-list
24801718|NCT01985256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801719|NCT01985373|Immunoglobulins|immunoglobulins|mesh-list
24801720|NCT01985373|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24801722|NCT01985373|gamma-Globulins|gamma-globulins|mesh-list
24595941|NCT00941057|Calcium, Dietary|calcium, dietary|mesh-list
24801723|NCT01985373|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24801725|NCT01985373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801726|NCT01985451|Temozolomide|temozolomide|mesh-list
24801727|NCT01985451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24801728|NCT01985451|Alkylating Agents|alkylating agents|mesh-ancestor
24801729|NCT01985451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801730|NCT01985451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25604991|NCT01054768|Antioxidants|antioxidants|mesh-ancestor
25604992|NCT01054768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25604993|NCT01054768|Protective Agents|protective agents|mesh-ancestor
25604994|NCT01054768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25604995|NCT01054768|Vitamin B Complex|vitamin b complex|mesh-ancestor
25604996|NCT01054768|Vitamins|vitamins|mesh-ancestor
25604997|NCT01054768|Micronutrients|micronutrients|mesh-ancestor
25604998|NCT01054768|Nootropic Agents|nootropic agents|mesh-ancestor
25604999|NCT01054820|Diclofenac|diclofenac|mesh-list
25605000|NCT01054820|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
25605001|NCT01054820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25605002|NCT01054820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25605003|NCT01054820|Analgesics|analgesics|mesh-ancestor
25708897|NCT02259231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708898|NCT02259231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25708899|NCT02259231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708900|NCT02259348|Aldesleukin|aldesleukin|mesh-list
25708901|NCT02259348|Cyclophosphamide|cyclophosphamide|mesh-list
25708902|NCT02259348|Melphalan|melphalan|mesh-list
24801742|NCT01985477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24801743|NCT01985477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24801744|NCT01985477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24801745|NCT01985477|Immunologic Factors|immunologic factors|mesh-ancestor
25708903|NCT02259348|Mechlorethamine|mechlorethamine|mesh-list
25708904|NCT02259348|Thiotepa|thiotepa|mesh-list
25708905|NCT02259348|Rituximab|rituximab|mesh-list
25708906|NCT02259348|Fludarabine|fludarabine|mesh-list
25708907|NCT02259348|Fludarabine phosphate|fludarabine phosphate|mesh-list
25605004|NCT01054820|Sensory System Agents|sensory system agents|mesh-ancestor
25605005|NCT01054820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25605006|NCT01054820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605007|NCT01054820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25605008|NCT01054820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25605009|NCT01054820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25605010|NCT01054820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25605011|NCT01054820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605012|NCT01054911|Sunitinib|sunitinib|mesh-list
25605013|NCT01054911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605014|NCT01054911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25605015|NCT01054911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25605016|NCT01054911|Growth Substances|growth substances|mesh-ancestor
25605017|NCT01054911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605018|NCT01054911|Growth Inhibitors|growth inhibitors|mesh-ancestor
25605019|NCT01054911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25605020|NCT01054911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25605021|NCT01054911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605022|NCT01054976|Galantamine|galantamine|mesh-list
25605023|NCT01054976|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25605024|NCT01054976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25605025|NCT01054976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605026|NCT01054976|Cholinergic Agents|cholinergic agents|mesh-ancestor
25605027|NCT01054976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24801762|NCT01985594|Progestins|progestins|mesh-ancestor
24801763|NCT01985594|Hormones|hormones|mesh-ancestor
24801764|NCT01985594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24801765|NCT01985724|Cyclophosphamide|cyclophosphamide|mesh-list
24801766|NCT01985724|Docetaxel|docetaxel|mesh-list
24801767|NCT01985724|Epirubicin|epirubicin|mesh-list
24801768|NCT01985724|Fluorouracil|fluorouracil|mesh-list
25605028|NCT01054976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605029|NCT01054976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25605030|NCT01054976|Autonomic Agents|autonomic agents|mesh-ancestor
25605031|NCT01054976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25708908|NCT02259348|Interleukin-2|interleukin-2|mesh-list
25605032|NCT01054976|Nootropic Agents|nootropic agents|mesh-ancestor
25605033|NCT01055028|Paclitaxel|paclitaxel|mesh-list
25605034|NCT01055028|Bevacizumab|bevacizumab|mesh-list
25605035|NCT01055028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25605036|NCT01055028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605037|NCT01055028|Tubulin Modulators|tubulin modulators|mesh-ancestor
25605038|NCT01055028|Antimitotic Agents|antimitotic agents|mesh-ancestor
25605039|NCT01055028|Mitosis Modulators|mitosis modulators|mesh-ancestor
25605040|NCT01055028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605041|NCT01055028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25605042|NCT01055028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25605043|NCT01055028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25605044|NCT01055028|Growth Substances|growth substances|mesh-ancestor
25605045|NCT01055028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708909|NCT02259348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25708910|NCT02259348|Immunologic Factors|immunologic factors|mesh-ancestor
25708911|NCT02259348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859009|NCT02301026|Hematinics|hematinics|mesh-ancestor
24859010|NCT02301091|Mitomycins|mitomycins|mesh-list
24801858|NCT01985893|Trastuzumab|trastuzumab|mesh-list
24561469|NCT00760864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561470|NCT00760864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24561471|NCT00760864|Antimetabolites|antimetabolites|mesh-ancestor
25708912|NCT02259348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25708913|NCT02259348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25708914|NCT02259348|Alkylating Agents|alkylating agents|mesh-ancestor
25605046|NCT01055028|Growth Inhibitors|growth inhibitors|mesh-ancestor
25605047|NCT01055171|Propranolol|propranolol|mesh-list
25605048|NCT01055171|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25605049|NCT01055171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25605050|NCT01055171|Adrenergic Agents|adrenergic agents|mesh-ancestor
25605051|NCT01055171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25605052|NCT01055171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605053|NCT01055171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605054|NCT01055171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25605055|NCT01055171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25605056|NCT01055171|Vasodilator Agents|vasodilator agents|mesh-ancestor
25605057|NCT01055184|Vaccines|vaccines|mesh-list
25605058|NCT01055184|Immunologic Factors|immunologic factors|mesh-ancestor
25605059|NCT01055184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709762|NCT02274766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25709763|NCT02274792|Etanercept|etanercept|mesh-list
24801859|NCT01985893|Lapatinib|lapatinib|mesh-list
24801804|NCT01985789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801806|NCT01985789|Anesthetics|anesthetics|mesh-ancestor
24561932|NCT00763763|Hormones|hormones|mesh-ancestor
25709764|NCT02274792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25709765|NCT02274792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25709766|NCT02274792|Analgesics|analgesics|mesh-ancestor
25709767|NCT02274792|Sensory System Agents|sensory system agents|mesh-ancestor
25709768|NCT02274792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25709769|NCT02274792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605060|NCT01055223|Troglitazone|troglitazone|mesh-list
25605061|NCT01055223|Amiloride|amiloride|mesh-list
25605062|NCT01055223|Spironolactone|spironolactone|mesh-list
25605063|NCT01055223|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25605064|NCT01055223|Hormone Antagonists|hormone antagonists|mesh-ancestor
25605065|NCT01055223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25605066|NCT01055223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605067|NCT01055223|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25605068|NCT01055223|Diuretics|diuretics|mesh-ancestor
25605069|NCT01055223|Natriuretic Agents|natriuretic agents|mesh-ancestor
25605070|NCT01055223|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
25605071|NCT01055223|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25605072|NCT01055223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25605073|NCT01055223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605074|NCT01055223|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
25605075|NCT01055223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25605076|NCT01055314|Dactinomycin|dactinomycin|mesh-list
25605077|NCT01055314|Cyclophosphamide|cyclophosphamide|mesh-list
25605078|NCT01055314|Temozolomide|temozolomide|mesh-list
25605079|NCT01055314|Ifosfamide|ifosfamide|mesh-list
25605080|NCT01055314|Isophosphamide mustard|isophosphamide mustard|mesh-list
25605081|NCT01055314|Doxorubicin|doxorubicin|mesh-list
25605082|NCT01055314|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25605083|NCT01055314|Irinotecan|irinotecan|mesh-list
25605084|NCT01055314|Etoposide|etoposide|mesh-list
25605085|NCT01055314|Vincristine|vincristine|mesh-list
25708915|NCT02259348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708916|NCT02259348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448150|NCT00310518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24801818|NCT01985789|Antipruritics|antipruritics|mesh-ancestor
24801819|NCT01985789|Dermatologic Agents|dermatologic agents|mesh-ancestor
24859011|NCT02301091|Mitomycin|mitomycin|mesh-list
24801824|NCT01985828|Hormones|hormones|mesh-ancestor
25708917|NCT02259348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25605086|NCT01055314|Etoposide phosphate|etoposide phosphate|mesh-list
25605087|NCT01055314|Podophyllotoxin|podophyllotoxin|mesh-list
25605088|NCT01055314|Camptothecin|camptothecin|mesh-list
25605089|NCT01055314|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25605090|NCT01055314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25605091|NCT01055314|Immunologic Factors|immunologic factors|mesh-ancestor
25605092|NCT01055314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605093|NCT01055314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24801825|NCT01985828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24801826|NCT01985828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605094|NCT01055314|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25605095|NCT01055314|Alkylating Agents|alkylating agents|mesh-ancestor
25605096|NCT01055314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605097|NCT01055314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605098|NCT01055314|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25605099|NCT01055314|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25605100|NCT01055314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25605101|NCT01055314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25605102|NCT01055314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25605103|NCT01055314|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24801827|NCT01985841|Cyclophosphamide|cyclophosphamide|mesh-list
24801828|NCT01985841|Docetaxel|docetaxel|mesh-list
24801829|NCT01985841|Fluorouracil|fluorouracil|mesh-list
24801830|NCT01985841|Epirubicin|epirubicin|mesh-list
24801831|NCT01985841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24801832|NCT01985841|Immunologic Factors|immunologic factors|mesh-ancestor
24801835|NCT01985841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24801836|NCT01985841|Alkylating Agents|alkylating agents|mesh-ancestor
24448207|NCT00310765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24448260|NCT00310908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24448261|NCT00310921|Misoprostol|misoprostol|mesh-list
25708918|NCT02259348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25708919|NCT02259348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25708920|NCT02259348|Antimetabolites|antimetabolites|mesh-ancestor
25708921|NCT02259348|Antiviral Agents|antiviral agents|mesh-ancestor
25708922|NCT02259348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25708923|NCT02259348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25708924|NCT02259348|Analgesics|analgesics|mesh-ancestor
25708925|NCT02259348|Sensory System Agents|sensory system agents|mesh-ancestor
25708926|NCT02259348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25708927|NCT02259348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25708928|NCT02259348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25708929|NCT02259582|Carboplatin|carboplatin|mesh-list
25708930|NCT02259582|Pemetrexed|pemetrexed|mesh-list
25605104|NCT01055314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25605105|NCT01055314|Tubulin Modulators|tubulin modulators|mesh-ancestor
25605106|NCT01055314|Antimitotic Agents|antimitotic agents|mesh-ancestor
25605107|NCT01055314|Mitosis Modulators|mitosis modulators|mesh-ancestor
25605108|NCT01055314|Keratolytic Agents|keratolytic agents|mesh-ancestor
25605109|NCT01055314|Dermatologic Agents|dermatologic agents|mesh-ancestor
25605110|NCT01055314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25605111|NCT01055314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25605112|NCT01055314|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25605113|NCT01055314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25605114|NCT01055457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25605115|NCT01055496|Gemcitabine|gemcitabine|mesh-list
25605116|NCT01055496|Dexamethasone|dexamethasone|mesh-list
25605117|NCT01055496|Prednisone|prednisone|mesh-list
25605118|NCT01055496|Cyclophosphamide|cyclophosphamide|mesh-list
25605119|NCT01055496|Rituximab|rituximab|mesh-list
25605120|NCT01055496|Vincristine|vincristine|mesh-list
25605121|NCT01055496|Cisplatin|cisplatin|mesh-list
25605122|NCT01055496|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25605123|NCT01055496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25605124|NCT01055496|Immunologic Factors|immunologic factors|mesh-ancestor
25605125|NCT01055496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605126|NCT01055496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25605127|NCT01055496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24563032|NCT00769522|Rituximab|rituximab|mesh-list
25708931|NCT02259582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708932|NCT02259582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25708933|NCT02259582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708934|NCT02259582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25708935|NCT02259582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25605128|NCT01055496|Alkylating Agents|alkylating agents|mesh-ancestor
25605129|NCT01055496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605130|NCT01055496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605131|NCT01055496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25605132|NCT01055496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25605133|NCT01055496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25605134|NCT01055496|Antiemetics|antiemetics|mesh-ancestor
25605135|NCT01055496|Autonomic Agents|autonomic agents|mesh-ancestor
25605136|NCT01055496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25605137|NCT01055496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25605138|NCT01055496|Glucocorticoids|glucocorticoids|mesh-ancestor
25605139|NCT01055496|Hormones|hormones|mesh-ancestor
25605140|NCT01055496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25605141|NCT01055496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25605142|NCT01055496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25605143|NCT01055496|Antimetabolites|antimetabolites|mesh-ancestor
25605144|NCT01055496|Antiviral Agents|antiviral agents|mesh-ancestor
25605145|NCT01055496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25605146|NCT01055496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25605147|NCT01055496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25605148|NCT01055496|Tubulin Modulators|tubulin modulators|mesh-ancestor
25605149|NCT01055496|Antimitotic Agents|antimitotic agents|mesh-ancestor
25605150|NCT01055496|Mitosis Modulators|mitosis modulators|mesh-ancestor
25605151|NCT01055496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25605152|NCT01055613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25605153|NCT01055704|Naltrexone|naltrexone|mesh-list
25605154|NCT01055704|Codeine|codeine|mesh-list
25605155|NCT01055704|Methylnaltrexone|methylnaltrexone|mesh-list
25605156|NCT01055704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25605157|NCT01055704|Narcotics|narcotics|mesh-ancestor
25605158|NCT01055704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25605159|NCT01055704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605160|NCT01055704|Analgesics|analgesics|mesh-ancestor
24801903|NCT01986270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801904|NCT01986270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563248|NCT00770731|Topotecan|topotecan|mesh-list
24563249|NCT00770731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24801950|NCT01986465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24801965|NCT01986582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801967|NCT01986582|Sympathomimetics|sympathomimetics|mesh-ancestor
24801972|NCT01986582|Respiratory System Agents|respiratory system agents|mesh-ancestor
24801973|NCT01986582|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24801974|NCT01986582|Mydriatics|mydriatics|mesh-ancestor
24801975|NCT01986582|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24563765|NCT00773331|Hematinics|hematinics|mesh-ancestor
24563774|NCT00773578|Nitric Oxide|nitric oxide|mesh-list
25605161|NCT01055704|Sensory System Agents|sensory system agents|mesh-ancestor
25605162|NCT01055704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25605163|NCT01055704|Antitussive Agents|antitussive agents|mesh-ancestor
25605164|NCT01055704|Respiratory System Agents|respiratory system agents|mesh-ancestor
25605165|NCT01055704|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25605166|NCT01055704|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25605167|NCT01055769|Linezolid|linezolid|mesh-list
25605168|NCT01055769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25708936|NCT02259608|BCG Vaccine|bcg vaccine|mesh-list
24802000|NCT01986673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802001|NCT01986673|Urological Agents|urological agents|mesh-ancestor
24596247|NCT00942539|Anesthetics|anesthetics|mesh-ancestor
24596322|NCT00942773|Hormone Antagonists|hormone antagonists|mesh-ancestor
24596323|NCT00942773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24596324|NCT00942773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596325|NCT00942773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24622433|NCT01066962|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24622434|NCT01066962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25708937|NCT02259608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25708938|NCT02259608|Immunologic Factors|immunologic factors|mesh-ancestor
25708939|NCT02259608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708940|NCT02260154|Mebeverine|mebeverine|mesh-list
25708941|NCT02260154|Alverine|alverine|mesh-list
25605169|NCT01055769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25605170|NCT01055769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25605171|NCT01055769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25605172|NCT01055769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605173|NCT01055834|Eszopiclone|eszopiclone|mesh-list
25605174|NCT01055834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25605175|NCT01055834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25605176|NCT01055834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605177|NCT01055886|Nicotine|nicotine|mesh-list
25605178|NCT01055886|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25605179|NCT01055886|Autonomic Agents|autonomic agents|mesh-ancestor
25605180|NCT01055886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25605181|NCT01055886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605182|NCT01055886|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25605183|NCT01055886|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25605184|NCT01055886|Cholinergic Agents|cholinergic agents|mesh-ancestor
25605185|NCT01055886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25605186|NCT01055886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605187|NCT01056107|Glucagon|glucagon|mesh-list
25605188|NCT01056107|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25605189|NCT01056107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25605190|NCT01056107|Hormones|hormones|mesh-ancestor
25605191|NCT01056107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24622463|NCT01067118|Insulin Lispro|insulin lispro|mesh-list
24622464|NCT01067118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24622465|NCT01067118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622466|NCT01067222|Modafinil|modafinil|mesh-list
24622467|NCT01067222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24622468|NCT01067222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622469|NCT01067222|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24622470|NCT01067222|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24622471|NCT01067222|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24622473|NCT01067235|Modafinil|modafinil|mesh-list
24622481|NCT01067274|Azacitidine|azacitidine|mesh-list
24622482|NCT01067274|Tretinoin|tretinoin|mesh-list
24622483|NCT01067274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24622484|NCT01067274|Antimetabolites|antimetabolites|mesh-ancestor
25708942|NCT02260154|Anticonvulsants|anticonvulsants|mesh-ancestor
25708943|NCT02260154|Parasympatholytics|parasympatholytics|mesh-ancestor
25708944|NCT02260154|Autonomic Agents|autonomic agents|mesh-ancestor
25708945|NCT02260154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25708946|NCT02260154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708947|NCT02260258|Rocuronium|rocuronium|mesh-list
25708948|NCT02260258|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25708949|NCT02260258|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25605192|NCT01056107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605193|NCT01056107|Incretins|incretins|mesh-ancestor
25605194|NCT01056263|Axitinib|axitinib|mesh-list
25605195|NCT01056263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605196|NCT01056263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25605197|NCT01056263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25605198|NCT01056263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605199|NCT01056276|Dexamethasone|dexamethasone|mesh-list
25605200|NCT01056276|Bortezomib|bortezomib|mesh-list
25605201|NCT01056276|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25605202|NCT01056276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25605203|NCT01056276|Antiemetics|antiemetics|mesh-ancestor
25605204|NCT01056276|Autonomic Agents|autonomic agents|mesh-ancestor
25605205|NCT01056276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25605206|NCT01056276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605207|NCT01056276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25605208|NCT01056276|Glucocorticoids|glucocorticoids|mesh-ancestor
25605209|NCT01056276|Hormones|hormones|mesh-ancestor
25605210|NCT01056276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25605211|NCT01056276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25605212|NCT01056276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605213|NCT01056276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25605214|NCT01056276|Alkylating Agents|alkylating agents|mesh-ancestor
25605215|NCT01056276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605216|NCT01056289|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25605217|NCT01056289|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25605218|NCT01056289|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25605219|NCT01056289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25605220|NCT01056289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605221|NCT01056289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24802007|NCT01986764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802008|NCT01986764|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24802009|NCT01986764|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24802010|NCT01986764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24448456|NCT00311870|Vasodilator Agents|vasodilator agents|mesh-ancestor
24448457|NCT00311883|Hydroxychloroquine|hydroxychloroquine|mesh-list
24448458|NCT00311883|Antimalarials|antimalarials|mesh-ancestor
24448459|NCT00311883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24448460|NCT00311883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24448461|NCT00311883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24448462|NCT00311883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448463|NCT00311883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448464|NCT00311883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24448466|NCT00311896|Anticoagulants|anticoagulants|mesh-ancestor
24448468|NCT00311961|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24448469|NCT00311961|Methylprednisolone|methylprednisolone|mesh-list
24448507|NCT00312039|Lamivudine|lamivudine|mesh-list
25605222|NCT01056289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605223|NCT01056289|Antidepressive Agents|antidepressive agents|mesh-ancestor
25605224|NCT01056289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25605225|NCT01056341|Propranolol|propranolol|mesh-list
25605226|NCT01056341|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25605227|NCT01056341|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25605228|NCT01056341|Adrenergic Agents|adrenergic agents|mesh-ancestor
25605229|NCT01056341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25605230|NCT01056341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605231|NCT01056341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605232|NCT01056341|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25605233|NCT01056341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25605234|NCT01056341|Vasodilator Agents|vasodilator agents|mesh-ancestor
25605235|NCT01056380|Nitazoxanide|nitazoxanide|mesh-list
25605236|NCT01056380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25605237|NCT01056380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25605238|NCT01056510|Rituximab|rituximab|mesh-list
25605239|NCT01056510|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25605240|NCT01056510|Chlorambucil|chlorambucil|mesh-list
25605241|NCT01056510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25605242|NCT01056510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605243|NCT01056510|Immunologic Factors|immunologic factors|mesh-ancestor
25605244|NCT01056510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605245|NCT01056510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25605246|NCT01056510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25605247|NCT01056510|Alkylating Agents|alkylating agents|mesh-ancestor
25605248|NCT01056510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605249|NCT01056523|Cytarabine|cytarabine|mesh-list
25605250|NCT01056523|Ribavirin|ribavirin|mesh-list
25605251|NCT01056523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25605252|NCT01056523|Antimetabolites|antimetabolites|mesh-ancestor
25605253|NCT01056523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605254|NCT01056523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448691|NCT00312598|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24448692|NCT00312598|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24448693|NCT00312598|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25406341|NCT03565835|Hormones|hormones|mesh-ancestor
25605255|NCT01056523|Antiviral Agents|antiviral agents|mesh-ancestor
25605256|NCT01056523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25605257|NCT01056523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25605258|NCT01056523|Immunologic Factors|immunologic factors|mesh-ancestor
25605259|NCT01056523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605260|NCT01056601|Bortezomib|bortezomib|mesh-list
25708950|NCT02260258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25605261|NCT01056601|Panobinostat|panobinostat|mesh-list
25605262|NCT01056601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605263|NCT01056601|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25605264|NCT01056601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25605265|NCT01056601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605266|NCT01056718|Nebivolol|nebivolol|mesh-list
25605267|NCT01056718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25605268|NCT01056718|Vasodilator Agents|vasodilator agents|mesh-ancestor
25605269|NCT01056718|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25605270|NCT01056718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25605271|NCT01056718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25605272|NCT01056718|Adrenergic Agents|adrenergic agents|mesh-ancestor
25605273|NCT01056718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25605274|NCT01056718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605275|NCT01056718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605276|NCT01057017|Panitumumab|panitumumab|mesh-list
25605277|NCT01057017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25605278|NCT01057017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605279|NCT01057225|Thalidomide|thalidomide|mesh-list
25605281|NCT01057225|Cyclophosphamide|cyclophosphamide|mesh-list
25605282|NCT01057225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25605283|NCT01057225|Immunologic Factors|immunologic factors|mesh-ancestor
25605284|NCT01057225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605285|NCT01057225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25605286|NCT01057225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25605287|NCT01057225|Alkylating Agents|alkylating agents|mesh-ancestor
25605288|NCT01057225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605289|NCT01057225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605290|NCT01057225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25605291|NCT01057225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25605292|NCT01057225|Antiemetics|antiemetics|mesh-ancestor
25605293|NCT01057225|Autonomic Agents|autonomic agents|mesh-ancestor
25605294|NCT01057225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25708951|NCT02260258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25708952|NCT02260258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708953|NCT02260388|Mexiletine|mexiletine|mesh-list
25708954|NCT02260388|Pregabalin|pregabalin|mesh-list
25708955|NCT02260388|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25708956|NCT02260388|Nortriptyline|nortriptyline|mesh-list
25708957|NCT02260388|Analgesics|analgesics|mesh-ancestor
25708958|NCT02260388|Sensory System Agents|sensory system agents|mesh-ancestor
25708959|NCT02260388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25605295|NCT01057225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25605296|NCT01057225|Glucocorticoids|glucocorticoids|mesh-ancestor
25605297|NCT01057225|Hormones|hormones|mesh-ancestor
25605298|NCT01057225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25605299|NCT01057225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25605300|NCT01057225|Leprostatic Agents|leprostatic agents|mesh-ancestor
25605301|NCT01057225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25605302|NCT01057225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25605303|NCT01057225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25605304|NCT01057225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25605305|NCT01057225|Growth Substances|growth substances|mesh-ancestor
25605306|NCT01057225|Growth Inhibitors|growth inhibitors|mesh-ancestor
25605307|NCT01057251|Nebivolol|nebivolol|mesh-list
25605308|NCT01057251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25605309|NCT01057251|Vasodilator Agents|vasodilator agents|mesh-ancestor
25605310|NCT01057251|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25605311|NCT01057251|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25605312|NCT01057251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25605313|NCT01057251|Adrenergic Agents|adrenergic agents|mesh-ancestor
25605314|NCT01057251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25605315|NCT01057251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605316|NCT01057251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605317|NCT01057277|Everolimus|everolimus|mesh-list
25605318|NCT01057277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605319|NCT01057277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25605320|NCT01057277|Immunologic Factors|immunologic factors|mesh-ancestor
25605321|NCT01057277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605322|NCT01057381|Dexmedetomidine|dexmedetomidine|mesh-list
25605323|NCT01057381|Morphine|morphine|mesh-list
25605324|NCT01057381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25605325|NCT01057381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25605326|NCT01057381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605327|NCT01057381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25605328|NCT01057381|Analgesics|analgesics|mesh-ancestor
25605329|NCT01057381|Sensory System Agents|sensory system agents|mesh-ancestor
25605330|NCT01057381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25605331|NCT01057381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25708960|NCT02260388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802098|NCT01987297|Immunologic Factors|immunologic factors|mesh-ancestor
24802099|NCT01987297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802100|NCT01987297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24802101|NCT01987297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24802102|NCT01987297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25708961|NCT02260388|Anticonvulsants|anticonvulsants|mesh-ancestor
25708962|NCT02260388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25708963|NCT02260388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25708964|NCT02260388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708965|NCT02260388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25708966|NCT02260388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25708967|NCT02260388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25708968|NCT02260388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25708969|NCT02260388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25708970|NCT02260388|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25708971|NCT02260388|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25605332|NCT01057381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25605333|NCT01057381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25605334|NCT01057381|Adrenergic Agents|adrenergic agents|mesh-ancestor
25605335|NCT01057381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25605336|NCT01057381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605337|NCT01057381|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25605338|NCT01057381|Narcotics|narcotics|mesh-ancestor
25605339|NCT01057433|Ritonavir|ritonavir|mesh-list
25605340|NCT01057433|Lopinavir|lopinavir|mesh-list
25605341|NCT01057433|Pitavastatin|pitavastatin|mesh-list
25605342|NCT01057433|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25605343|NCT01057433|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25605344|NCT01057433|Protease Inhibitors|protease inhibitors|mesh-ancestor
25605345|NCT01057433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25605346|NCT01057433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605347|NCT01057433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25605348|NCT01057433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25605349|NCT01057433|Antiviral Agents|antiviral agents|mesh-ancestor
25605350|NCT01057433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25605351|NCT01057433|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25605352|NCT01057433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25499747|NCT00309907|Analgesics|analgesics|mesh-ancestor
25605353|NCT01057433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25605354|NCT01057433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25605355|NCT01057433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25605356|NCT01057433|Antimetabolites|antimetabolites|mesh-ancestor
25605357|NCT01057433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25605358|NCT01057589|Folic Acid|folic acid|mesh-list
25605359|NCT01057589|Vitamin B 12|vitamin b 12|mesh-list
25605360|NCT01057589|Hydroxocobalamin|hydroxocobalamin|mesh-list
25605361|NCT01057589|Pemetrexed|pemetrexed|mesh-list
25605362|NCT01057589|Cetuximab|cetuximab|mesh-list
25605363|NCT01057589|Vitamins|vitamins|mesh-ancestor
25605364|NCT01057589|Micronutrients|micronutrients|mesh-ancestor
25605365|NCT01057589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605366|NCT01057589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605367|NCT01057589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25605368|NCT01057589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605369|NCT01057589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25605370|NCT01057589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25605371|NCT01057589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25605372|NCT01057589|Hematinics|hematinics|mesh-ancestor
25605373|NCT01057589|Vitamin B Complex|vitamin b complex|mesh-ancestor
24455137|NCT02819843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24455138|NCT02808585|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
24455139|NCT02808585|Vasodilator Agents|vasodilator agents|mesh-ancestor
24455140|NCT02676791|Povidone-Iodine|povidone-iodine|mesh-list
24802110|NCT01987310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455142|NCT02676791|Plasma Substitutes|plasma substitutes|mesh-ancestor
24455143|NCT02676791|Blood Substitutes|blood substitutes|mesh-ancestor
24455144|NCT02676791|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24449004|NCT00313885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24449005|NCT00313885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449006|NCT00313898|Sildenafil Citrate|sildenafil citrate|mesh-list
24449007|NCT00313898|Vasodilator Agents|vasodilator agents|mesh-ancestor
24449008|NCT00313898|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24802120|NCT01987570|Allopurinol|allopurinol|mesh-list
24802121|NCT01987570|Antimetabolites|antimetabolites|mesh-ancestor
24859013|NCT02301091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25605374|NCT01057693|Pregabalin|pregabalin|mesh-list
25605375|NCT01057693|Analgesics|analgesics|mesh-ancestor
25605376|NCT01057693|Sensory System Agents|sensory system agents|mesh-ancestor
25605377|NCT01057693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25605378|NCT01057693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605379|NCT01057693|Anticonvulsants|anticonvulsants|mesh-ancestor
25605380|NCT01057693|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25605381|NCT01057693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25605382|NCT01057693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605383|NCT01057693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25605384|NCT01057693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25605385|NCT01057693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25605386|NCT01057693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25605387|NCT01057693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25605388|NCT01057810|Ipilimumab|ipilimumab|mesh-list
25605389|NCT01057810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25605390|NCT01057810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605391|NCT01057810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25605392|NCT01057810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605393|NCT01057862|Naltrexone|naltrexone|mesh-list
25605394|NCT01057862|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25605395|NCT01057862|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25605396|NCT01057862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605397|NCT01057862|Sensory System Agents|sensory system agents|mesh-ancestor
25605398|NCT01057862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25605399|NCT01058005|Interferons|interferons|mesh-list
25605400|NCT01058005|Interferon-beta|interferon-beta|mesh-list
25605401|NCT01058005|Interferon beta-1a|interferon beta-1a|mesh-list
25605402|NCT01058005|Glatiramer Acetate|glatiramer acetate|mesh-list
25605403|NCT01058005|Natalizumab|natalizumab|mesh-list
25605404|NCT01058005|(T,G)-A-L|(t,g)-a-l|mesh-list
24802125|NCT01987570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24802126|NCT01987570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24802127|NCT01987570|Antioxidants|antioxidants|mesh-ancestor
24802128|NCT01987570|Protective Agents|protective agents|mesh-ancestor
24628049|NCT01096329|Androgens|androgens|mesh-ancestor
24449312|NCT00314977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24449313|NCT00314977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24449314|NCT00314977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24449315|NCT00314977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449317|NCT00314990|Pyridoxine|pyridoxine|mesh-list
24449382|NCT00315367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25708972|NCT02260388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25708973|NCT02260388|Antidepressive Agents|antidepressive agents|mesh-ancestor
25708974|NCT02260388|Dopamine Agents|dopamine agents|mesh-ancestor
25708975|NCT02260388|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25708976|NCT02260388|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25605405|NCT01058005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605406|NCT01058005|Antiviral Agents|antiviral agents|mesh-ancestor
25605407|NCT01058005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25605408|NCT01058005|Immunologic Factors|immunologic factors|mesh-ancestor
25605409|NCT01058005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605410|NCT01058005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25605411|NCT01058005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25605412|NCT01058005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25605413|NCT01058096|Cariprazine|cariprazine|mesh-list
25605414|NCT01058096|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25605415|NCT01058096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25605416|NCT01058096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25499798|NCT00310401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25499799|NCT00310401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25499800|NCT00310401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25499801|NCT00310401|Adrenergic Agents|adrenergic agents|mesh-ancestor
25499802|NCT00310401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25499804|NCT00310791|Levonorgestrel|levonorgestrel|mesh-list
25605417|NCT01058096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605418|NCT01058096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25605419|NCT01058239|Rituximab|rituximab|mesh-list
25605420|NCT01058239|Bortezomib|bortezomib|mesh-list
25605421|NCT01058239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25605422|NCT01058239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605423|NCT01058239|Immunologic Factors|immunologic factors|mesh-ancestor
25605424|NCT01058239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605425|NCT01058239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25605426|NCT01058395|Minocycline|minocycline|mesh-list
25605427|NCT01058395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25605428|NCT01058395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25605429|NCT01058655|Everolimus|everolimus|mesh-list
25605430|NCT01058655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605431|NCT01058655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25605432|NCT01058655|Immunologic Factors|immunologic factors|mesh-ancestor
25605433|NCT01058655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605434|NCT01058668|Cariprazine|cariprazine|mesh-list
25605435|NCT01058668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24455167|NCT02544750|Cannabidiol|cannabidiol|mesh-list
24727607|NCT01611415|Furosemide|furosemide|mesh-list
24802169|NCT01988298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24802170|NCT01988298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24802171|NCT01988298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24802172|NCT01988298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802174|NCT01988311|Hallucinogens|hallucinogens|mesh-ancestor
24802175|NCT01988311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802176|NCT01988311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24802177|NCT01988428|Ceftriaxone|ceftriaxone|mesh-list
24802178|NCT01988428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24802179|NCT01988428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24802180|NCT01988506|Interleukin-2|interleukin-2|mesh-list
24802181|NCT01988506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24802182|NCT01988506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24802183|NCT01988506|Analgesics|analgesics|mesh-ancestor
24802184|NCT01988506|Sensory System Agents|sensory system agents|mesh-ancestor
24802185|NCT01988506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25605436|NCT01058668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25605437|NCT01058668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25605438|NCT01058668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605439|NCT01058668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25605440|NCT01058863|Albuterol|albuterol|mesh-list
25605441|NCT01058863|Procaterol|procaterol|mesh-list
25605442|NCT01058863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25605443|NCT01058863|Autonomic Agents|autonomic agents|mesh-ancestor
25605444|NCT01058863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25605445|NCT01058863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605446|NCT01058863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25605447|NCT01058863|Respiratory System Agents|respiratory system agents|mesh-ancestor
25605448|NCT01058863|Tocolytic Agents|tocolytic agents|mesh-ancestor
25605449|NCT01058863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24802229|NCT01988961|Golimumab|golimumab|mesh-list
24567496|NCT00791349|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24567497|NCT00791349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24393318|NCT00129597|Anesthetics|anesthetics|mesh-ancestor
24393319|NCT00129597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24393320|NCT00129597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24393321|NCT00129597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24393322|NCT00129597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24393323|NCT00129597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393324|NCT00129688|Amikacin|amikacin|mesh-list
24393325|NCT00129688|Cloxacillin|cloxacillin|mesh-list
24393326|NCT00129688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24393327|NCT00129688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24802246|NCT01989000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567689|NCT00792181|Midazolam|midazolam|mesh-list
24393541|NCT00130325|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24393542|NCT00130325|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24393543|NCT00130325|Antimetabolites|antimetabolites|mesh-ancestor
24393544|NCT00130325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393545|NCT00130325|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24393546|NCT00130338|Rivastigmine|rivastigmine|mesh-list
24393547|NCT00130338|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24393548|NCT00130338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24393549|NCT00130338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859014|NCT02301091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393596|NCT00130455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24393606|NCT00130468|Immunologic Factors|immunologic factors|mesh-ancestor
25605450|NCT01058863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25605451|NCT01058863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25605452|NCT01058863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25605453|NCT01058863|Adrenergic Agents|adrenergic agents|mesh-ancestor
25605454|NCT01058863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25605455|NCT01058863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605456|NCT01058863|Sympathomimetics|sympathomimetics|mesh-ancestor
25605457|NCT01058941|Thioctic Acid|thioctic acid|mesh-list
25605458|NCT01058941|Antioxidants|antioxidants|mesh-ancestor
25605459|NCT01058941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605460|NCT01058941|Protective Agents|protective agents|mesh-ancestor
25605461|NCT01058941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393612|NCT00130481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24393613|NCT00130481|Antimetabolites|antimetabolites|mesh-ancestor
24393614|NCT00130481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455224|NCT02329080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24455225|NCT02244125|Dexamethasone|dexamethasone|mesh-list
24455226|NCT02244125|Cyclophosphamide|cyclophosphamide|mesh-list
24455227|NCT02244125|Pomalidomide|pomalidomide|mesh-list
24393700|NCT00130767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24393701|NCT00130767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393702|NCT00130767|Urological Agents|urological agents|mesh-ancestor
24393703|NCT00130819|Buprenorphine|buprenorphine|mesh-list
24393704|NCT00130819|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24393705|NCT00130819|Narcotics|narcotics|mesh-ancestor
24393706|NCT00130819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24393707|NCT00130819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393708|NCT00130819|Analgesics|analgesics|mesh-ancestor
24393709|NCT00130819|Sensory System Agents|sensory system agents|mesh-ancestor
24393835|NCT00131053|Dexamethasone|dexamethasone|mesh-list
24393836|NCT00131053|Prednisolone|prednisolone|mesh-list
24802256|NCT01989052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802257|NCT01989078|Losartan|losartan|mesh-list
24802258|NCT01989078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24393949|NCT00131339|Antitubercular Agents|antitubercular agents|mesh-ancestor
25605462|NCT01058941|Vitamin B Complex|vitamin b complex|mesh-ancestor
25605463|NCT01058941|Vitamins|vitamins|mesh-ancestor
24393988|NCT00131495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393990|NCT00131521|Antiviral Agents|antiviral agents|mesh-ancestor
24393991|NCT00131521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24393992|NCT00131521|Expectorants|expectorants|mesh-ancestor
24393993|NCT00131521|Respiratory System Agents|respiratory system agents|mesh-ancestor
24393994|NCT00131521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25708977|NCT02260388|Adrenergic Agents|adrenergic agents|mesh-ancestor
25708978|NCT02260388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25605464|NCT01058941|Micronutrients|micronutrients|mesh-ancestor
25605465|NCT01058993|Plerixafor|plerixafor|mesh-list
25605466|NCT01058993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25605467|NCT01058993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25605468|NCT01058993|Antiviral Agents|antiviral agents|mesh-ancestor
25605469|NCT01058993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25605470|NCT01059305|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25708979|NCT02260388|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25708980|NCT02260388|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25708981|NCT02260440|Pembrolizumab|pembrolizumab|mesh-list
25708982|NCT02260440|Azacitidine|azacitidine|mesh-list
25708983|NCT02260440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25708984|NCT02260440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708985|NCT02260440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25708986|NCT02260440|Antimetabolites|antimetabolites|mesh-ancestor
25605471|NCT01059305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708987|NCT02260440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463073|NCT00358553|Insulin|insulin|mesh-list
24463074|NCT00358553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25605472|NCT01059305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25605473|NCT01059305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25605474|NCT01059305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605475|NCT01059318|Everolimus|everolimus|mesh-list
25605476|NCT01059318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605477|NCT01059318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25605478|NCT01059318|Immunologic Factors|immunologic factors|mesh-ancestor
25605479|NCT01059318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605480|NCT01059526|Ecallantide|ecallantide|mesh-list
25605481|NCT01059526|Analgesics|analgesics|mesh-ancestor
25605482|NCT01059526|Sensory System Agents|sensory system agents|mesh-ancestor
25605483|NCT01059526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25605484|NCT01059526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605485|NCT01059526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25605486|NCT01059526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25605487|NCT01059526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25605488|NCT01059526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25605489|NCT01059539|Cariprazine|cariprazine|mesh-list
25605490|NCT01059539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25605491|NCT01059539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24463206|NCT00359333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463244|NCT00359658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802344|NCT01989676|Trastuzumab|trastuzumab|mesh-list
25708988|NCT02260440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25708989|NCT02260492|Fluticasone|fluticasone|mesh-list
25708990|NCT02260492|Xhance|xhance|mesh-list
25708991|NCT02260492|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25708992|NCT02260492|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25708993|NCT02260492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25708994|NCT02260492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25605492|NCT01059539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25605493|NCT01059539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605494|NCT01059539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25605495|NCT01059617|Vaccines|vaccines|mesh-list
25605496|NCT01059617|Immunologic Factors|immunologic factors|mesh-ancestor
25499852|NCT00311311|Sirolimus|sirolimus|mesh-list
25605497|NCT01059617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605498|NCT01059630|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25605499|NCT01059630|Obinutuzumab|obinutuzumab|mesh-list
25605500|NCT01059630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25605501|NCT01059630|Alkylating Agents|alkylating agents|mesh-ancestor
24463365|NCT00360386|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24463366|NCT00360386|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24463367|NCT00360386|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24463491|NCT00361166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24463492|NCT00361166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463493|NCT00361166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24463494|NCT00361166|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24463495|NCT00361166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24463496|NCT00361166|Serotonin Agents|serotonin agents|mesh-ancestor
24463497|NCT00361166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24463498|NCT00361166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412533|NCT00191568|Gemcitabine|gemcitabine|mesh-list
24802442|NCT01990118|Cyclosporine|cyclosporine|mesh-list
24802443|NCT01990118|Cyclosporins|cyclosporins|mesh-list
24802444|NCT01990118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24569516|NCT00800826|Adrenergic Agents|adrenergic agents|mesh-ancestor
24463562|NCT00361413|Immunologic Factors|immunologic factors|mesh-ancestor
24463563|NCT00361413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463564|NCT00361452|Epinephrine|epinephrine|mesh-list
25708995|NCT02260492|Autonomic Agents|autonomic agents|mesh-ancestor
25708996|NCT02260492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25708997|NCT02260492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708998|NCT02260492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25605502|NCT01059630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605503|NCT01059630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605504|NCT01059630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25605505|NCT01059682|Dalcetrapib|dalcetrapib|mesh-list
25605506|NCT01059682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25605507|NCT01059682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25605508|NCT01059682|Antimetabolites|antimetabolites|mesh-ancestor
25605509|NCT01059682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605510|NCT01059682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25605511|NCT01059773|Methotrexate|methotrexate|mesh-list
25605512|NCT01059773|Ustekinumab|ustekinumab|mesh-list
25605513|NCT01059773|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25605514|NCT01059773|Abortifacient Agents|abortifacient agents|mesh-ancestor
25708999|NCT02260492|Respiratory System Agents|respiratory system agents|mesh-ancestor
25709000|NCT02260492|Dermatologic Agents|dermatologic agents|mesh-ancestor
25709001|NCT02260492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25709002|NCT02260492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25709003|NCT02260492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24802472|NCT01990378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24802458|NCT01990144|Immunologic Factors|immunologic factors|mesh-ancestor
24802459|NCT01990144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802460|NCT01990144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24802461|NCT01990144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24802462|NCT01990144|Alkylating Agents|alkylating agents|mesh-ancestor
24802463|NCT01990144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709004|NCT02260492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25709005|NCT02260492|Adrenergic Agents|adrenergic agents|mesh-ancestor
25709006|NCT02260492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25709770|NCT02274792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25605515|NCT01059773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25605516|NCT01059773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605517|NCT01059773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25605518|NCT01059773|Antimetabolites|antimetabolites|mesh-ancestor
25605519|NCT01059773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605520|NCT01059773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605521|NCT01059773|Dermatologic Agents|dermatologic agents|mesh-ancestor
25605522|NCT01059773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25605523|NCT01059773|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25605524|NCT01059773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25709007|NCT02260492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463637|NCT00361686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24463638|NCT00361686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463639|NCT00361686|Analgesics|analgesics|mesh-ancestor
24463640|NCT00361686|Sensory System Agents|sensory system agents|mesh-ancestor
24463641|NCT00361686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24463642|NCT00361751|Fenofibrate|fenofibrate|mesh-list
24463643|NCT00361751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24463644|NCT00361751|Antimetabolites|antimetabolites|mesh-ancestor
24628088|NCT01096511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24802471|NCT01990378|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24463665|NCT00361790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24463684|NCT00361868|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24463685|NCT00361881|Acyclovir|acyclovir|mesh-list
24463686|NCT00361881|Hydrocortisone|hydrocortisone|mesh-list
24463687|NCT00361881|Antiviral Agents|antiviral agents|mesh-ancestor
24463688|NCT00361881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24463689|NCT00361881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24463690|NCT00361894|Enoxaparin|enoxaparin|mesh-list
24463691|NCT00361894|Rivaroxaban|rivaroxaban|mesh-list
24463692|NCT00361894|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24463693|NCT00361894|Antithrombins|antithrombins|mesh-ancestor
24463694|NCT00361894|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24463695|NCT00361894|Protease Inhibitors|protease inhibitors|mesh-ancestor
25605525|NCT01059773|Immunologic Factors|immunologic factors|mesh-ancestor
25605526|NCT01059773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25605527|NCT01059773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25605528|NCT01059799|Insulin|insulin|mesh-list
25605529|NCT01059799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25605530|NCT01059799|Insulin Glargine|insulin glargine|mesh-list
25605531|NCT01059799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25605532|NCT01059799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605533|NCT01059812|Insulin|insulin|mesh-list
25605534|NCT01059812|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25605535|NCT01059812|Insulin Aspart|insulin aspart|mesh-list
25605536|NCT01059812|Insulin, Long-Acting|insulin, long-acting|mesh-list
25605537|NCT01059812|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25605538|NCT01059812|Biphasic Insulins|biphasic insulins|mesh-list
25605539|NCT01059812|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
25605540|NCT01059812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25605541|NCT01059812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605542|NCT01059825|Metformin|metformin|mesh-list
25605543|NCT01059825|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25605544|NCT01059825|Ertugliflozin|ertugliflozin|mesh-list
25605545|NCT01059825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25605546|NCT01059825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605547|NCT01059825|Incretins|incretins|mesh-ancestor
25605548|NCT01059825|Hormones|hormones|mesh-ancestor
25605549|NCT01059825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25605550|NCT01059825|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25605551|NCT01059825|Protease Inhibitors|protease inhibitors|mesh-ancestor
25605552|NCT01059825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24802481|NCT01990404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802482|NCT01990404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24802483|NCT01990404|Analgesics|analgesics|mesh-ancestor
24570009|NCT00802646|Mydriatics|mydriatics|mesh-ancestor
24463755|NCT00362037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463757|NCT00362063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24802487|NCT01990443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24802488|NCT01990443|Respiratory System Agents|respiratory system agents|mesh-ancestor
24802490|NCT01990586|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24463766|NCT00362089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24463767|NCT00362089|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24463768|NCT00362089|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24598093|NCT00953771|Danazol|danazol|mesh-list
25709016|NCT02260622|Rivaroxaban|rivaroxaban|mesh-list
25709017|NCT02260622|Clopidogrel|clopidogrel|mesh-list
24463770|NCT00362089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605553|NCT01059825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605554|NCT01059825|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25605555|NCT01059851|Suvorexant|suvorexant|mesh-list
25605556|NCT01059851|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25605557|NCT01059851|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25605558|NCT01059851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25605559|NCT01059851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605560|NCT01059851|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25605561|NCT01059851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25605562|NCT01059851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605563|NCT01059864|Atorvastatin|atorvastatin|mesh-list
25605564|NCT01059864|Tofacitinib|tofacitinib|mesh-list
25605565|NCT01059864|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25605566|NCT01059864|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25605567|NCT01059864|Antimetabolites|antimetabolites|mesh-ancestor
24463771|NCT00362089|Hormones|hormones|mesh-ancestor
24463772|NCT00362089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24463773|NCT00362102|Cetuximab|cetuximab|mesh-list
24463775|NCT00362102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463776|NCT00362141|Levetiracetam|levetiracetam|mesh-list
24463777|NCT00362141|Anticonvulsants|anticonvulsants|mesh-ancestor
24463778|NCT00362141|Nootropic Agents|nootropic agents|mesh-ancestor
24463779|NCT00362206|Simvastatin|simvastatin|mesh-list
24463785|NCT00362206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463786|NCT00362206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24463787|NCT00362206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24463788|NCT00362206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24463789|NCT00362245|Amikacin|amikacin|mesh-list
24463806|NCT00362271|Dopamine Agents|dopamine agents|mesh-ancestor
24463807|NCT00362271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24463808|NCT00362271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463809|NCT00362271|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24463810|NCT00362271|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24463811|NCT00362271|Serotonin Agents|serotonin agents|mesh-ancestor
25709018|NCT02260622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25709019|NCT02260622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25709020|NCT02260622|Analgesics|analgesics|mesh-ancestor
25709021|NCT02260622|Sensory System Agents|sensory system agents|mesh-ancestor
25709022|NCT02260622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25709023|NCT02260622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605568|NCT01059864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605569|NCT01059864|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25605570|NCT01059864|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25605571|NCT01059864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25605572|NCT01059864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25605573|NCT01059903|Rotigotine|rotigotine|mesh-list
25605574|NCT01059903|Dopamine Agonists|dopamine agonists|mesh-ancestor
25605575|NCT01059903|Dopamine Agents|dopamine agents|mesh-ancestor
25605576|NCT01059903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25605577|NCT01059903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605578|NCT01059903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605579|NCT01059929|Fentanyl|fentanyl|mesh-list
25709024|NCT02260622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24463812|NCT00362271|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25605580|NCT01059929|Midazolam|midazolam|mesh-list
25605581|NCT01059929|Dexmedetomidine|dexmedetomidine|mesh-list
25605582|NCT01059929|Propofol|propofol|mesh-list
25605583|NCT01059929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25605584|NCT01059929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25605585|NCT01059929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605586|NCT01059929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25605587|NCT01059929|Anesthetics, General|anesthetics, general|mesh-ancestor
25605588|NCT01059929|Anesthetics|anesthetics|mesh-ancestor
25605589|NCT01059929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25605590|NCT01059929|Analgesics|analgesics|mesh-ancestor
25605591|NCT01059929|Sensory System Agents|sensory system agents|mesh-ancestor
25605592|NCT01059929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25605593|NCT01059929|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24412880|NCT00192621|Lopinavir|lopinavir|mesh-list
24463879|NCT00362596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24463880|NCT00362635|Clevudine|clevudine|mesh-list
24463881|NCT00362635|Antiviral Agents|antiviral agents|mesh-ancestor
24463882|NCT00362635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24463883|NCT00362661|Hydrocortisone|hydrocortisone|mesh-list
24802511|NCT01990755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24802512|NCT01990755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24802513|NCT01990755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802514|NCT01990755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24802515|NCT01990755|Serotonin Agents|serotonin agents|mesh-ancestor
24802516|NCT01990755|Anticonvulsants|anticonvulsants|mesh-ancestor
24802517|NCT01990781|Dexamethasone|dexamethasone|mesh-list
24802518|NCT01990781|Dexamethasone acetate|dexamethasone acetate|mesh-list
24802522|NCT01990781|Antiemetics|antiemetics|mesh-ancestor
24802523|NCT01990781|Autonomic Agents|autonomic agents|mesh-ancestor
24802524|NCT01990781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25709025|NCT02260622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25709026|NCT02260622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25709027|NCT02260622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25709030|NCT02260622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25605594|NCT01059929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25605595|NCT01059929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25605596|NCT01059929|Adrenergic Agents|adrenergic agents|mesh-ancestor
25605597|NCT01059929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25605598|NCT01059929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605599|NCT01059929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25605600|NCT01059929|Narcotics|narcotics|mesh-ancestor
25605601|NCT01059929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25605602|NCT01059929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25605603|NCT01059929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25605604|NCT01059929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25605605|NCT01059929|GABA Modulators|gaba modulators|mesh-ancestor
25605606|NCT01059929|GABA Agents|gaba agents|mesh-ancestor
25605607|NCT01059994|Sildenafil Citrate|sildenafil citrate|mesh-list
25605608|NCT01059994|Vasodilator Agents|vasodilator agents|mesh-ancestor
25605609|NCT01059994|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25605610|NCT01059994|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25605611|NCT01059994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25605612|NCT01059994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605613|NCT01059994|Urological Agents|urological agents|mesh-ancestor
25605614|NCT01060007|Leucovorin|leucovorin|mesh-list
25605615|NCT01060007|Fluorouracil|fluorouracil|mesh-list
25605616|NCT01060007|Capecitabine|capecitabine|mesh-list
25605617|NCT01060007|Oxaliplatin|oxaliplatin|mesh-list
25605618|NCT01060007|Antimetabolites|antimetabolites|mesh-ancestor
25605619|NCT01060007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605620|NCT01060007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25605621|NCT01060007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605622|NCT01060007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25605623|NCT01060007|Immunologic Factors|immunologic factors|mesh-ancestor
25605624|NCT01060007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605625|NCT01060007|Antidotes|antidotes|mesh-ancestor
25605626|NCT01060007|Protective Agents|protective agents|mesh-ancestor
25605627|NCT01060007|Vitamin B Complex|vitamin b complex|mesh-ancestor
25605628|NCT01060007|Vitamins|vitamins|mesh-ancestor
25709033|NCT02260622|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24463953|NCT00362869|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24463954|NCT00362869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25709034|NCT02260622|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25709035|NCT02260622|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25709036|NCT02260622|Purinergic Agents|purinergic agents|mesh-ancestor
25709037|NCT02260622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25709038|NCT02260622|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25709039|NCT02260622|Antithrombins|antithrombins|mesh-ancestor
25709040|NCT02260622|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25709041|NCT02260622|Protease Inhibitors|protease inhibitors|mesh-ancestor
25605629|NCT01060007|Micronutrients|micronutrients|mesh-ancestor
25654348|NCT01549587|Listerine|listerine|mesh-list
25654349|NCT01549587|Cetylpyridinium|cetylpyridinium|mesh-list
25654350|NCT01549587|Fluorides|fluorides|mesh-list
25654351|NCT01549587|Sodium Fluoride|sodium fluoride|mesh-list
25654352|NCT01549587|Tin Fluorides|tin fluorides|mesh-list
25654353|NCT01549587|Cariostatic Agents|cariostatic agents|mesh-ancestor
25654354|NCT01549587|Protective Agents|protective agents|mesh-ancestor
25654355|NCT01549587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654356|NCT01549587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25654357|NCT01549587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25654358|NCT01549613|Vancomycin|vancomycin|mesh-list
25654359|NCT01549613|Daptomycin|daptomycin|mesh-list
25654360|NCT01549613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25654361|NCT01549613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25654362|NCT01549652|Morphine|morphine|mesh-list
25654363|NCT01549652|Ondansetron|ondansetron|mesh-list
25654364|NCT01549652|Naloxone|naloxone|mesh-list
25654365|NCT01549652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25654366|NCT01549652|Narcotics|narcotics|mesh-ancestor
25654367|NCT01549652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25654368|NCT01549652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654369|NCT01549652|Analgesics|analgesics|mesh-ancestor
25654370|NCT01549652|Sensory System Agents|sensory system agents|mesh-ancestor
24463977|NCT00362895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24600281|NCT01446133|Rituximab|rituximab|mesh-list
24463979|NCT00362895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463980|NCT00362895|Protease Inhibitors|protease inhibitors|mesh-ancestor
24463981|NCT00362895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24463982|NCT00362895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463983|NCT00362895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24463984|NCT00362895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24570627|NCT00805519|Protective Agents|protective agents|mesh-ancestor
24463985|NCT00362895|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24463986|NCT00362895|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25709042|NCT02260622|Anticoagulants|anticoagulants|mesh-ancestor
25709043|NCT02260635|Evacetrapib|evacetrapib|mesh-list
25709044|NCT02260635|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25709045|NCT02260635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25709046|NCT02260635|Antimetabolites|antimetabolites|mesh-ancestor
25709047|NCT02260635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709048|NCT02260635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25709049|NCT02260648|Atorvastatin|atorvastatin|mesh-list
25709050|NCT02260648|Ezetimibe|ezetimibe|mesh-list
25709051|NCT02260648|Evacetrapib|evacetrapib|mesh-list
25709052|NCT02260648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25709053|NCT02260648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25709054|NCT02260648|Antimetabolites|antimetabolites|mesh-ancestor
25709055|NCT02260648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605630|NCT01060020|Sildenafil Citrate|sildenafil citrate|mesh-list
25605631|NCT01060020|Vasodilator Agents|vasodilator agents|mesh-ancestor
25605632|NCT01060020|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25605633|NCT01060020|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25605634|NCT01060020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25605635|NCT01060020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605636|NCT01060020|Urological Agents|urological agents|mesh-ancestor
25605638|NCT01060059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25605639|NCT01060059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605640|NCT01060059|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25605641|NCT01060059|Incretins|incretins|mesh-ancestor
25605642|NCT01060059|Hormones|hormones|mesh-ancestor
25605643|NCT01060059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25605644|NCT01060072|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25605645|NCT01060072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25605646|NCT01060098|Adalimumab|adalimumab|mesh-list
25605647|NCT01060098|Etanercept|etanercept|mesh-list
25605648|NCT01060098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25605649|NCT01060098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24802529|NCT01990781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24802530|NCT01990781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24464043|NCT00363090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24452513|NCT05458479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24452544|NCT05458180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24452546|NCT05458180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452548|NCT05458180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24452549|NCT05458180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24464062|NCT00363116|Daclizumab|daclizumab|mesh-list
24464063|NCT00363116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24464064|NCT00363116|Immunologic Factors|immunologic factors|mesh-ancestor
25605650|NCT01060098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25605651|NCT01060098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24464095|NCT00363337|Dopamine Agonists|dopamine agonists|mesh-ancestor
24802536|NCT01990781|Anesthetics|anesthetics|mesh-ancestor
24802537|NCT01990781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24802538|NCT01990781|Sensory System Agents|sensory system agents|mesh-ancestor
24464126|NCT00363376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464127|NCT00363376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24464128|NCT00363376|Serotonin Agents|serotonin agents|mesh-ancestor
25605652|NCT01060098|Analgesics|analgesics|mesh-ancestor
25605653|NCT01060098|Sensory System Agents|sensory system agents|mesh-ancestor
25605654|NCT01060098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25605655|NCT01060098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605656|NCT01060098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25605657|NCT01060098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25605658|NCT01060098|Immunologic Factors|immunologic factors|mesh-ancestor
25605659|NCT01060111|Topiramate|topiramate|mesh-list
25605660|NCT01060111|Propranolol|propranolol|mesh-list
25605661|NCT01060111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25605662|NCT01060111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25605663|NCT01060111|Adrenergic Agents|adrenergic agents|mesh-ancestor
25605664|NCT01060111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25605665|NCT01060111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464129|NCT00363376|Anticonvulsants|anticonvulsants|mesh-ancestor
24464165|NCT00363571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464167|NCT00363584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25709056|NCT02260648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25709057|NCT02260648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25709058|NCT02260648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709059|NCT02260791|Adalimumab|adalimumab|mesh-list
25709060|NCT02260791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25709061|NCT02260791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25709062|NCT02260804|Rituximab|rituximab|mesh-list
25709063|NCT02260804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25709064|NCT02260804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605666|NCT01060111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605667|NCT01060111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25605668|NCT01060111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25605669|NCT01060111|Vasodilator Agents|vasodilator agents|mesh-ancestor
25605670|NCT01060111|Anticonvulsants|anticonvulsants|mesh-ancestor
25605671|NCT01060111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24464209|NCT00363753|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24464210|NCT00363753|Purinergic Agents|purinergic agents|mesh-ancestor
24464255|NCT00363935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24464256|NCT00363935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24464257|NCT00363935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464258|NCT00363935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24464259|NCT00363935|Analgesics|analgesics|mesh-ancestor
24464260|NCT00363935|Sensory System Agents|sensory system agents|mesh-ancestor
24452687|NCT05457829|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24596991|NCT00946725|Autonomic Agents|autonomic agents|mesh-ancestor
25605672|NCT01060124|Fentanyl|fentanyl|mesh-list
25605673|NCT01060124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25605674|NCT01060124|Narcotics|narcotics|mesh-ancestor
25605675|NCT01060124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25605676|NCT01060124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605677|NCT01060124|Analgesics|analgesics|mesh-ancestor
25605678|NCT01060124|Sensory System Agents|sensory system agents|mesh-ancestor
25605679|NCT01060124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25605680|NCT01060124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24596992|NCT00946725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24596993|NCT00946725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596994|NCT00946725|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24596995|NCT00946725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24596996|NCT00946725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24596997|NCT00946725|Adrenergic Agents|adrenergic agents|mesh-ancestor
24596998|NCT00946725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25709065|NCT02260804|Immunologic Factors|immunologic factors|mesh-ancestor
25709066|NCT02260804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709067|NCT02260804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25709068|NCT02260817|Choline|choline|mesh-list
25709069|NCT02260817|Lipotropic Agents|lipotropic agents|mesh-ancestor
25709070|NCT02260817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25709071|NCT02260817|Antimetabolites|antimetabolites|mesh-ancestor
25709072|NCT02260817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709073|NCT02260817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25709074|NCT02260817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25709075|NCT02260817|Nootropic Agents|nootropic agents|mesh-ancestor
25709077|NCT02260882|Immunologic Factors|immunologic factors|mesh-ancestor
25605681|NCT01060124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25605682|NCT01060124|Anesthetics, General|anesthetics, general|mesh-ancestor
25605683|NCT01060124|Anesthetics|anesthetics|mesh-ancestor
25605684|NCT01060150|Methylphenidate|methylphenidate|mesh-list
25605685|NCT01060150|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25605686|NCT01060150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605687|NCT01060150|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25709078|NCT02260882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605688|NCT01060150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25605689|NCT01060150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25605690|NCT01060150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605691|NCT01060150|Dopamine Agents|dopamine agents|mesh-ancestor
25605692|NCT01060150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25605693|NCT01060384|Lenalidomide|lenalidomide|mesh-list
25709079|NCT02260934|Acetaminophen|acetaminophen|mesh-list
25709080|NCT02260934|Diphenhydramine|diphenhydramine|mesh-list
25709081|NCT02260934|Promethazine|promethazine|mesh-list
25709082|NCT02260934|Prednisone|prednisone|mesh-list
25709083|NCT02260934|Methylprednisolone|methylprednisolone|mesh-list
24596999|NCT00946725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597000|NCT00946751|Levetiracetam|levetiracetam|mesh-list
24597001|NCT00946751|Anticonvulsants|anticonvulsants|mesh-ancestor
24597002|NCT00946751|Nootropic Agents|nootropic agents|mesh-ancestor
24622498|NCT01067365|Citric Acid|citric acid|mesh-list
24622499|NCT01067365|Sodium Citrate|sodium citrate|mesh-list
24464320|NCT00364273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24464382|NCT00364559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464384|NCT00364559|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24464503|NCT00365222|Alkylating Agents|alkylating agents|mesh-ancestor
24464505|NCT00365222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24464512|NCT00365287|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24464513|NCT00365287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24464736|NCT00366418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24464737|NCT00366418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24464738|NCT00366418|Immunologic Factors|immunologic factors|mesh-ancestor
24464739|NCT00366418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464740|NCT00366418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24464741|NCT00366470|Cholecalciferol|cholecalciferol|mesh-list
25709084|NCT02260934|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25605694|NCT01060384|Ofatumumab|ofatumumab|mesh-list
25605695|NCT01060384|Immunologic Factors|immunologic factors|mesh-ancestor
25605696|NCT01060384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605697|NCT01060384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25605698|NCT01060384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25605699|NCT01060384|Growth Substances|growth substances|mesh-ancestor
25605700|NCT01060384|Growth Inhibitors|growth inhibitors|mesh-ancestor
25605701|NCT01060384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605702|NCT01061034|Aspirin|aspirin|mesh-list
25500066|NCT00313300|Apixaban|apixaban|mesh-list
25605703|NCT01061034|Omeprazole|omeprazole|mesh-list
25605704|NCT01061034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24464743|NCT00366470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24464744|NCT00366470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802578|NCT01991054|Vitamins|vitamins|mesh-ancestor
24464802|NCT00366873|Calcium|calcium|mesh-list
25605705|NCT01061034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25605706|NCT01061034|Analgesics|analgesics|mesh-ancestor
25605707|NCT01061034|Sensory System Agents|sensory system agents|mesh-ancestor
25605708|NCT01061034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25605709|NCT01061034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605710|NCT01061034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24464803|NCT00366873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24464804|NCT00366873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464818|NCT00367068|Baclofen|baclofen|mesh-list
25709096|NCT02260934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25709097|NCT02260934|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25709098|NCT02260934|Alkylating Agents|alkylating agents|mesh-ancestor
25709099|NCT02260934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709100|NCT02260934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25709101|NCT02260934|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25709102|NCT02260934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25709103|NCT02260934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25709104|NCT02260934|Glucocorticoids|glucocorticoids|mesh-ancestor
25709105|NCT02260934|Hormones|hormones|mesh-ancestor
25605711|NCT01061034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25605712|NCT01061034|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25605713|NCT01061034|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25605714|NCT01061034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605715|NCT01061034|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25605716|NCT01061034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25605717|NCT01061034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25605718|NCT01061034|Antipyretics|antipyretics|mesh-ancestor
25605719|NCT01061034|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25605720|NCT01061034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25605721|NCT01061034|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25605722|NCT01061333|Mometasone Furoate|mometasone furoate|mesh-list
25709106|NCT02260934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24464958|NCT00367419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24464959|NCT00367419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24464960|NCT00367419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24464961|NCT00367419|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24464962|NCT00367419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464963|NCT00367419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572016|NCT00812669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24802586|NCT01991119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24802587|NCT01991119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24572090|NCT00813059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25709107|NCT02260934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25709108|NCT02260934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25709109|NCT02260934|Analgesics|analgesics|mesh-ancestor
25709110|NCT02260934|Sensory System Agents|sensory system agents|mesh-ancestor
25709111|NCT02260934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25709112|NCT02260934|Antipyretics|antipyretics|mesh-ancestor
25605723|NCT01061333|Nedocromil|nedocromil|mesh-list
25605724|NCT01061333|Montelukast|montelukast|mesh-list
25605725|NCT01061333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25605726|NCT01061333|Respiratory System Agents|respiratory system agents|mesh-ancestor
25605727|NCT01061333|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25605728|NCT01061333|Hormone Antagonists|hormone antagonists|mesh-ancestor
25605729|NCT01061333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25605730|NCT01061333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605731|NCT01061333|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25605732|NCT01061333|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25605733|NCT01061333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709113|NCT02260934|Antiemetics|antiemetics|mesh-ancestor
24572267|NCT00814021|Growth Inhibitors|growth inhibitors|mesh-ancestor
24802589|NCT01991119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802590|NCT01991145|Epoetin Alfa|epoetin alfa|mesh-list
24802591|NCT01991145|Hematinics|hematinics|mesh-ancestor
24802592|NCT01991158|Gemcitabine|gemcitabine|mesh-list
24802593|NCT01991158|Dexamethasone|dexamethasone|mesh-list
24465018|NCT00367536|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24465020|NCT00367536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24465022|NCT00367562|Enalapril|enalapril|mesh-list
24465023|NCT00367562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24465024|NCT00367562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24465025|NCT00367562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25709114|NCT02260934|Autonomic Agents|autonomic agents|mesh-ancestor
25709115|NCT02260934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25709116|NCT02260934|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25709117|NCT02260934|Protective Agents|protective agents|mesh-ancestor
25709118|NCT02260934|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25709119|NCT02260934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25709120|NCT02260934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25709121|NCT02260934|Anesthetics, Local|anesthetics, local|mesh-ancestor
25605734|NCT01061333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25605735|NCT01061333|Dermatologic Agents|dermatologic agents|mesh-ancestor
25605736|NCT01061333|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25709122|NCT02260934|Anesthetics|anesthetics|mesh-ancestor
24802601|NCT01991158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25605737|NCT01061333|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
25605738|NCT01061333|Immunologic Factors|immunologic factors|mesh-ancestor
25605739|NCT01061359|Epirubicin|epirubicin|mesh-list
25605740|NCT01061359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25605741|NCT01061359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24802602|NCT01991158|Glucocorticoids|glucocorticoids|mesh-ancestor
24802603|NCT01991158|Hormones|hormones|mesh-ancestor
24802604|NCT01991158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24802605|NCT01991158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24802606|NCT01991158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24802607|NCT01991158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24802608|NCT01991158|Antimetabolites|antimetabolites|mesh-ancestor
24802609|NCT01991158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802610|NCT01991158|Antiviral Agents|antiviral agents|mesh-ancestor
24802611|NCT01991158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24465051|NCT00367653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24465052|NCT00367653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24465062|NCT00367731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24465063|NCT00367822|Ropinirole|ropinirole|mesh-list
24465064|NCT00367822|Lisuride|lisuride|mesh-list
24465065|NCT00367822|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24465066|NCT00367822|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24465067|NCT00367822|Dopamine Agonists|dopamine agonists|mesh-ancestor
24465068|NCT00367822|Dopamine Agents|dopamine agents|mesh-ancestor
24465069|NCT00367822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25605742|NCT01061359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25605743|NCT01061359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25605744|NCT01061359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25605745|NCT01061359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605746|NCT01061528|Nicotine|nicotine|mesh-list
25605747|NCT01061528|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25605748|NCT01061528|Autonomic Agents|autonomic agents|mesh-ancestor
25605749|NCT01061528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25605750|NCT01061528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605751|NCT01061528|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25605752|NCT01061528|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25605753|NCT01061528|Cholinergic Agents|cholinergic agents|mesh-ancestor
24465072|NCT00367822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24465073|NCT00367822|Serotonin Agents|serotonin agents|mesh-ancestor
24465074|NCT00367861|Imatinib Mesylate|imatinib mesylate|mesh-list
24465075|NCT00367861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465076|NCT00367861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24465077|NCT00367861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24465078|NCT00367861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465079|NCT00367874|Buprenorphine|buprenorphine|mesh-list
24465080|NCT00367874|Valproic Acid|valproic acid|mesh-list
24465124|NCT00367939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24465125|NCT00367939|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24465126|NCT00367939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24465157|NCT00368056|Eszopiclone|eszopiclone|mesh-list
24465158|NCT00368056|Zopiclone|zopiclone|mesh-list
24465159|NCT00368056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24572856|NCT00816959|Alkylating Agents|alkylating agents|mesh-ancestor
24465182|NCT00368134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465208|NCT00368238|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24465209|NCT00368238|Purinergic Agents|purinergic agents|mesh-ancestor
24465210|NCT00368238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24465213|NCT00368264|Dermatologic Agents|dermatologic agents|mesh-ancestor
24465214|NCT00368264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24465215|NCT00368264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24465217|NCT00368303|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24465218|NCT00368303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24465219|NCT00368303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25709131|NCT02260986|Immunologic Factors|immunologic factors|mesh-ancestor
25709132|NCT02260986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709133|NCT02261467|Botulinum Toxins|botulinum toxins|mesh-list
25709134|NCT02261467|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25709135|NCT02261467|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25605754|NCT01061528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25605755|NCT01061528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605756|NCT01061606|Sirolimus|sirolimus|mesh-list
25605757|NCT01061606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25605758|NCT01061606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25605759|NCT01061606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25605760|NCT01061606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605761|NCT01061606|Antifungal Agents|antifungal agents|mesh-ancestor
25605762|NCT01061606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25605763|NCT01061606|Immunologic Factors|immunologic factors|mesh-ancestor
25605764|NCT01061606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605765|NCT01061671|Simvastatin|simvastatin|mesh-list
25605766|NCT01061671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25605767|NCT01061671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25605768|NCT01061671|Antimetabolites|antimetabolites|mesh-ancestor
25605769|NCT01061671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605770|NCT01061671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25605771|NCT01061671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25605772|NCT01061671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25605773|NCT01061710|Varenicline|varenicline|mesh-list
25605774|NCT01061710|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25605775|NCT01061710|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25605776|NCT01061710|Cholinergic Agents|cholinergic agents|mesh-ancestor
25605777|NCT01061710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25605778|NCT01061710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605779|NCT01061710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605781|NCT01061736|Methotrexate|methotrexate|mesh-list
25605782|NCT01061736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25605783|NCT01061736|Abortifacient Agents|abortifacient agents|mesh-ancestor
25605784|NCT01061736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25605785|NCT01061736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605786|NCT01061736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25605787|NCT01061736|Antimetabolites|antimetabolites|mesh-ancestor
25605788|NCT01061736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605789|NCT01061736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605790|NCT01061736|Dermatologic Agents|dermatologic agents|mesh-ancestor
25605791|NCT01061736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25605792|NCT01061736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25605793|NCT01061736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25605794|NCT01061736|Immunologic Factors|immunologic factors|mesh-ancestor
25605795|NCT01061736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25605796|NCT01061736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24465220|NCT00368303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465221|NCT00368303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24465252|NCT00368342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465253|NCT00368342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24465254|NCT00368342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24465255|NCT00368342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24465257|NCT00368381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24465269|NCT00368589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24465289|NCT00368706|Urological Agents|urological agents|mesh-ancestor
25605797|NCT01061736|Hematinics|hematinics|mesh-ancestor
25605798|NCT01061736|Vitamin B Complex|vitamin b complex|mesh-ancestor
25605799|NCT01061736|Vitamins|vitamins|mesh-ancestor
25605800|NCT01061736|Micronutrients|micronutrients|mesh-ancestor
25605801|NCT01061775|Exenatide|exenatide|mesh-list
25605802|NCT01061775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25605803|NCT01061775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605804|NCT01061775|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25605805|NCT01061775|Incretins|incretins|mesh-ancestor
25605806|NCT01061775|Hormones|hormones|mesh-ancestor
25605807|NCT01061775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25605808|NCT01061866|Thalidomide|thalidomide|mesh-list
25605809|NCT01061866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25605810|NCT01061866|Immunologic Factors|immunologic factors|mesh-ancestor
25605811|NCT01061866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605812|NCT01061866|Leprostatic Agents|leprostatic agents|mesh-ancestor
25605813|NCT01061866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25605814|NCT01061866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25605815|NCT01061866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25605816|NCT01061866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25605817|NCT01061866|Growth Substances|growth substances|mesh-ancestor
25605818|NCT01061866|Growth Inhibitors|growth inhibitors|mesh-ancestor
25605819|NCT01061866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605820|NCT01062009|Zinc Sulfate|zinc sulfate|mesh-list
25605821|NCT01062009|Astringents|astringents|mesh-ancestor
25605822|NCT01062009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605823|NCT01062009|Dermatologic Agents|dermatologic agents|mesh-ancestor
25605824|NCT01062113|Celecoxib|celecoxib|mesh-list
25605825|NCT01062113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25605826|NCT01062113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25605827|NCT01062113|Analgesics|analgesics|mesh-ancestor
25605828|NCT01062113|Sensory System Agents|sensory system agents|mesh-ancestor
25605829|NCT01062113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24465326|NCT00369018|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
24465327|NCT00369018|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24465329|NCT00369031|polysaccharide-K|polysaccharide-k|mesh-list
24465330|NCT00369031|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24465331|NCT00369031|Immunologic Factors|immunologic factors|mesh-ancestor
24465332|NCT00369031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465333|NCT00369031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24465334|NCT00369031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24802714|NCT01991873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465380|NCT00369356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24465381|NCT00369356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465382|NCT00369356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24465383|NCT00369356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465384|NCT00369395|Volociximab|volociximab|mesh-list
24465385|NCT00369395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24465386|NCT00369395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24465387|NCT00369395|Growth Substances|growth substances|mesh-ancestor
25605830|NCT01062113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605831|NCT01062113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25605832|NCT01062113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25605833|NCT01062113|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25605834|NCT01062113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25605835|NCT01062113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25605836|NCT01062113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605837|NCT01062165|Caspofungin|caspofungin|mesh-list
25605838|NCT01062165|Antifungal Agents|antifungal agents|mesh-ancestor
25605839|NCT01062165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25605840|NCT01062165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25605841|NCT01062165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605842|NCT01062230|Bortezomib|bortezomib|mesh-list
25605843|NCT01062230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605844|NCT01062256|Phenylpropanolamine|phenylpropanolamine|mesh-list
25605845|NCT01062256|Guaifenesin|guaifenesin|mesh-list
24802720|NCT01991873|Hematinics|hematinics|mesh-ancestor
24465388|NCT00369395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465389|NCT00369395|Growth Inhibitors|growth inhibitors|mesh-ancestor
24465390|NCT00369395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465392|NCT00369408|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24465393|NCT00369408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24465394|NCT00369408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465395|NCT00369408|Sensory System Agents|sensory system agents|mesh-ancestor
24465396|NCT00369408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24465397|NCT00369434|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24465399|NCT00369434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24465403|NCT00369434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465404|NCT00369434|Antidepressive Agents|antidepressive agents|mesh-ancestor
24465461|NCT00369798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24465462|NCT00369798|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24465463|NCT00369798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24465464|NCT00369798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25605846|NCT01062256|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
25605847|NCT01062256|Expectorants|expectorants|mesh-ancestor
25605848|NCT01062256|Respiratory System Agents|respiratory system agents|mesh-ancestor
25605849|NCT01062256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25605850|NCT01062256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25605851|NCT01062256|Adrenergic Agents|adrenergic agents|mesh-ancestor
25605852|NCT01062256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25605853|NCT01062256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605854|NCT01062256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605855|NCT01062256|Appetite Depressants|appetite depressants|mesh-ancestor
25605856|NCT01062256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25605857|NCT01062256|Sympathomimetics|sympathomimetics|mesh-ancestor
25605858|NCT01062256|Autonomic Agents|autonomic agents|mesh-ancestor
25605859|NCT01062256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25605860|NCT01062256|Nasal Decongestants|nasal decongestants|mesh-ancestor
25605861|NCT01062256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25605862|NCT01062269|Cholestyramine Resin|cholestyramine resin|mesh-list
25605863|NCT01062269|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25605864|NCT01062269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25605865|NCT01062269|Antimetabolites|antimetabolites|mesh-ancestor
25605866|NCT01062269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605867|NCT01062269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25605868|NCT01062555|Cyclosporine|cyclosporine|mesh-list
25605869|NCT01062555|Sirolimus|sirolimus|mesh-list
25605870|NCT01062555|Mycophenolic Acid|mycophenolic acid|mesh-list
25605871|NCT01062555|Tacrolimus|tacrolimus|mesh-list
25605872|NCT01062555|Cyclosporins|cyclosporins|mesh-list
24465564|NCT00370045|Anticoagulants|anticoagulants|mesh-ancestor
25605873|NCT01062555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25605874|NCT01062555|Immunologic Factors|immunologic factors|mesh-ancestor
25605875|NCT01062555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605876|NCT01062555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25605877|NCT01062555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25605878|NCT01062555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605879|NCT01062555|Antifungal Agents|antifungal agents|mesh-ancestor
25605880|NCT01062555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25605881|NCT01062555|Dermatologic Agents|dermatologic agents|mesh-ancestor
25605882|NCT01062555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25605883|NCT01062555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25605884|NCT01062555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605885|NCT01062555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25605886|NCT01062555|Antitubercular Agents|antitubercular agents|mesh-ancestor
25605887|NCT01062555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25605888|NCT01062568|Dexamethasone|dexamethasone|mesh-list
25605889|NCT01062568|Cosyntropin|cosyntropin|mesh-list
25605890|NCT01062568|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25605891|NCT01062568|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
25605892|NCT01062568|beta-Endorphin|beta-endorphin|mesh-list
25605893|NCT01062568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25605894|NCT01062568|Antiemetics|antiemetics|mesh-ancestor
25605895|NCT01062568|Autonomic Agents|autonomic agents|mesh-ancestor
25605896|NCT01062568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25605897|NCT01062568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605898|NCT01062568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25605899|NCT01062568|Glucocorticoids|glucocorticoids|mesh-ancestor
24465831|NCT00370760|Tubulin Modulators|tubulin modulators|mesh-ancestor
24465853|NCT00370799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24465854|NCT00370799|Respiratory System Agents|respiratory system agents|mesh-ancestor
24465855|NCT00370825|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24465857|NCT00370825|Antifungal Agents|antifungal agents|mesh-ancestor
24803089|NCT01994642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24465913|NCT00371072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24465914|NCT00371111|Triamcinolone|triamcinolone|mesh-list
25605900|NCT01062568|Hormones|hormones|mesh-ancestor
25605901|NCT01062568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25605902|NCT01062568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25605903|NCT01062568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605904|NCT01062568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25605905|NCT01062568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605906|NCT01062763|Spironolactone|spironolactone|mesh-list
25605907|NCT01062763|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25605908|NCT01062763|Hormone Antagonists|hormone antagonists|mesh-ancestor
25605909|NCT01062763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25605910|NCT01062763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709150|NCT02261493|Cholinergic Agents|cholinergic agents|mesh-ancestor
25709151|NCT02261493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24617374|NCT01042717|Plerixafor|plerixafor|mesh-list
24803355|NCT01996085|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25605911|NCT01062763|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25605912|NCT01062763|Diuretics|diuretics|mesh-ancestor
25605913|NCT01062763|Natriuretic Agents|natriuretic agents|mesh-ancestor
25605914|NCT01062971|Timolol|timolol|mesh-list
25605915|NCT01062971|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25605916|NCT01062971|Dorzolamide|dorzolamide|mesh-list
25605917|NCT01062971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25605918|NCT01062971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24803384|NCT01996306|Leucovorin|leucovorin|mesh-list
25605919|NCT01062971|Adrenergic Agents|adrenergic agents|mesh-ancestor
25605920|NCT01062971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25605921|NCT01062971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605922|NCT01062971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605923|NCT01062971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25605924|NCT01062971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25605925|NCT01062971|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25605926|NCT01062971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25605927|NCT01062971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25605928|NCT01062971|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25605929|NCT01062971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25605930|NCT01063036|Tenofovir|tenofovir|mesh-list
25605931|NCT01063036|Entecavir|entecavir|mesh-list
25605932|NCT01063036|Antiviral Agents|antiviral agents|mesh-ancestor
25605933|NCT01063036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25605934|NCT01063036|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25605935|NCT01063036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25605936|NCT01063036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709170|NCT02261727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25605937|NCT01063036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605938|NCT01063036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25605939|NCT01063036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25605940|NCT01063049|Bisacodyl|bisacodyl|mesh-list
25605941|NCT01063049|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25605942|NCT01063049|Cathartics|cathartics|mesh-ancestor
25605943|NCT01063049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25605944|NCT01063049|Laxatives|laxatives|mesh-ancestor
25709190|NCT02261948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24804309|NCT02001974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24804310|NCT02001974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804311|NCT02001974|Tubulin Modulators|tubulin modulators|mesh-ancestor
25605945|NCT01063062|Methotrexate|methotrexate|mesh-list
25605946|NCT01063062|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25605947|NCT01063062|Abortifacient Agents|abortifacient agents|mesh-ancestor
25605948|NCT01063062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25605949|NCT01063062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605950|NCT01063062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25605951|NCT01063062|Antimetabolites|antimetabolites|mesh-ancestor
25605952|NCT01063062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605953|NCT01063062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804538|NCT02002962|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24804539|NCT02002962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25605954|NCT01063062|Dermatologic Agents|dermatologic agents|mesh-ancestor
25605955|NCT01063062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25605956|NCT01063062|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25605957|NCT01063062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25605958|NCT01063062|Immunologic Factors|immunologic factors|mesh-ancestor
25605959|NCT01063062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25605960|NCT01063062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25605961|NCT01063075|Carboplatin|carboplatin|mesh-list
25605962|NCT01063075|Cetuximab|cetuximab|mesh-list
25605963|NCT01063075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605964|NCT01063075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25605965|NCT01063153|Methylphenidate|methylphenidate|mesh-list
25605966|NCT01063153|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25605967|NCT01063153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605968|NCT01063153|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25605969|NCT01063153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25605970|NCT01063153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25605971|NCT01063153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605972|NCT01063153|Dopamine Agents|dopamine agents|mesh-ancestor
25605973|NCT01063153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25605974|NCT01063283|Bevacizumab|bevacizumab|mesh-list
25605975|NCT01063283|Carboplatin|carboplatin|mesh-list
25605976|NCT01063283|Pemetrexed|pemetrexed|mesh-list
25605977|NCT01063283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25605978|NCT01063283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25605979|NCT01063283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25605980|NCT01063283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25605981|NCT01063283|Growth Substances|growth substances|mesh-ancestor
25605982|NCT01063283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605983|NCT01063283|Growth Inhibitors|growth inhibitors|mesh-ancestor
25605984|NCT01063283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25605985|NCT01063283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605986|NCT01063283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25605987|NCT01063283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25605988|NCT01063348|Acetylcysteine|acetylcysteine|mesh-list
25605989|NCT01063348|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25605990|NCT01063348|Antiviral Agents|antiviral agents|mesh-ancestor
25605991|NCT01063348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25605992|NCT01063348|Expectorants|expectorants|mesh-ancestor
25605993|NCT01063348|Respiratory System Agents|respiratory system agents|mesh-ancestor
25605994|NCT01063348|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25605995|NCT01063348|Antioxidants|antioxidants|mesh-ancestor
24805034|NCT02006966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24805035|NCT02006966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24466930|NCT00375622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24466949|NCT00375687|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24466950|NCT00375687|Luteolytic Agents|luteolytic agents|mesh-ancestor
24466951|NCT00375687|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24466952|NCT00375687|Contraceptive Agents|contraceptive agents|mesh-ancestor
24467002|NCT00376012|Isoniazid|isoniazid|mesh-list
24467003|NCT00376012|Pyrazinamide|pyrazinamide|mesh-list
24467004|NCT00376012|Ethambutol|ethambutol|mesh-list
24467005|NCT00376012|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24813899|NCT02060916|PAZ320|paz320|mesh-list
25605996|NCT01063348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25605997|NCT01063348|Protective Agents|protective agents|mesh-ancestor
25605998|NCT01063348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25605999|NCT01063348|Antidotes|antidotes|mesh-ancestor
25606000|NCT01063764|Levetiracetam|levetiracetam|mesh-list
25606001|NCT01063764|Anticonvulsants|anticonvulsants|mesh-ancestor
25606002|NCT01063764|Nootropic Agents|nootropic agents|mesh-ancestor
25606003|NCT01063829|Letermovir|letermovir|mesh-list
25606004|NCT01063829|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25606005|NCT01063829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606006|NCT01063829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606007|NCT01063829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25606008|NCT01063829|Antiviral Agents|antiviral agents|mesh-ancestor
25606009|NCT01063829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25606010|NCT01063855|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
25606011|NCT01063855|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25606012|NCT01063855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606013|NCT01063855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805137|NCT02007837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24805138|NCT02007837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24467522|NCT00377975|Purinergic Agents|purinergic agents|mesh-ancestor
24805158|NCT02007928|Aripiprazole|aripiprazole|mesh-list
24805159|NCT02007928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24805160|NCT02007928|Serotonin Agents|serotonin agents|mesh-ancestor
24805161|NCT02007928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24577072|NCT00841880|Ramipril|ramipril|mesh-list
24467523|NCT00377975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24467524|NCT00377975|Sympathomimetics|sympathomimetics|mesh-ancestor
24467525|NCT00377975|Autonomic Agents|autonomic agents|mesh-ancestor
24467526|NCT00377975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24467527|NCT00377975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24467528|NCT00377975|Adrenergic Agents|adrenergic agents|mesh-ancestor
24467529|NCT00377988|Contraceptive Agents|contraceptive agents|mesh-list
24467530|NCT00377988|Norgestimate|norgestimate|mesh-list
24467589|NCT00378144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24467590|NCT00378144|Respiratory System Agents|respiratory system agents|mesh-ancestor
24467591|NCT00378144|Nasal Decongestants|nasal decongestants|mesh-ancestor
24467592|NCT00378144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24467688|NCT00378456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606014|NCT01063868|Oxycodone|oxycodone|mesh-list
25606015|NCT01063868|Tapentadol|tapentadol|mesh-list
25606016|NCT01063868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25606017|NCT01063868|Narcotics|narcotics|mesh-ancestor
25606018|NCT01063868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25606019|NCT01063868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606020|NCT01063868|Analgesics|analgesics|mesh-ancestor
25606021|NCT01063868|Sensory System Agents|sensory system agents|mesh-ancestor
25606022|NCT01063868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24467901|NCT00379028|Adrenergic Agents|adrenergic agents|mesh-ancestor
24468015|NCT00379457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468038|NCT00379509|Lapatinib|lapatinib|mesh-list
25709211|NCT02262754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25709212|NCT02262754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709213|NCT02262754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24468254|NCT00380770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468255|NCT00380770|Antiviral Agents|antiviral agents|mesh-ancestor
24468321|NCT00381030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24805255|NCT02008214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469149|NCT00384657|Iron|iron|mesh-list
25606023|NCT01063868|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25606024|NCT01063868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25606025|NCT01063868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25606026|NCT01063868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606027|NCT01063868|Adrenergic Agents|adrenergic agents|mesh-ancestor
25606028|NCT01063868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25606029|NCT01063907|Bortezomib|bortezomib|mesh-list
25606030|NCT01063907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25606031|NCT01064167|Tranexamic Acid|tranexamic acid|mesh-list
25606032|NCT01064167|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25606033|NCT01064167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25606034|NCT01064167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606035|NCT01064167|Hemostatics|hemostatics|mesh-ancestor
25606036|NCT01064167|Coagulants|coagulants|mesh-ancestor
25606037|NCT01064284|Factor VIII|factor viii|mesh-list
25606038|NCT01064284|Coagulants|coagulants|mesh-ancestor
25606039|NCT01064297|Lamotrigine|lamotrigine|mesh-list
25606040|NCT01064297|Anticonvulsants|anticonvulsants|mesh-list
25606041|NCT01064297|Valproic Acid|valproic acid|mesh-list
25606042|NCT01064297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25606043|NCT01064297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25606044|NCT01064297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606045|NCT01064297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25606046|NCT01064297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606047|NCT01064297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25606048|NCT01064297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25606049|NCT01064297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25606050|NCT01064297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25606051|NCT01064297|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25606052|NCT01064297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606053|NCT01064297|GABA Agents|gaba agents|mesh-ancestor
25606054|NCT01064297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25606055|NCT01064297|Antimanic Agents|antimanic agents|mesh-ancestor
25606056|NCT01064310|Sunitinib|sunitinib|mesh-list
25606057|NCT01064310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25606058|NCT01064310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24469159|NCT00384696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469303|NCT00385411|Anticonvulsants|anticonvulsants|mesh-ancestor
25606059|NCT01064310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25606060|NCT01064310|Growth Substances|growth substances|mesh-ancestor
25606061|NCT01064310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606062|NCT01064310|Growth Inhibitors|growth inhibitors|mesh-ancestor
25606063|NCT01064310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25606064|NCT01064310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606065|NCT01064310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606066|NCT01064362|Heparin|heparin|mesh-list
25606067|NCT01064362|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25606068|NCT01064362|Tinzaparin|tinzaparin|mesh-list
25709230|NCT02263079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24469549|NCT00386282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469550|NCT00386282|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25606069|NCT01064362|Dalteparin|dalteparin|mesh-list
25606070|NCT01064362|PENTA|penta|mesh-list
24470162|NCT00389025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606071|NCT01064362|Fondaparinux|fondaparinux|mesh-list
25606072|NCT01064362|Anticoagulants|anticoagulants|mesh-ancestor
25606073|NCT01064362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25606074|NCT01064362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25606075|NCT01064362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606076|NCT01064362|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25606077|NCT01064362|Antithrombins|antithrombins|mesh-ancestor
25606078|NCT01064362|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25606079|NCT01064362|Protease Inhibitors|protease inhibitors|mesh-ancestor
25500434|NCT00316914|Calcium|calcium|mesh-list
25500488|NCT00318136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500489|NCT00318136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25500490|NCT00318136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25500491|NCT00318136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25500492|NCT00318136|Growth Substances|growth substances|mesh-ancestor
25500493|NCT00318136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500494|NCT00318136|Growth Inhibitors|growth inhibitors|mesh-ancestor
24470163|NCT00389038|Amitriptyline|amitriptyline|mesh-list
24470275|NCT00389428|Antiviral Agents|antiviral agents|mesh-ancestor
24470276|NCT00389428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24470277|NCT00389428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24470278|NCT00389428|Immunologic Factors|immunologic factors|mesh-ancestor
24470528|NCT00390403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470529|NCT00390403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470530|NCT00390403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24470531|NCT00390403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24470729|NCT00391248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500495|NCT00318149|Vaccines|vaccines|mesh-list
25500496|NCT00318149|Immunologic Factors|immunologic factors|mesh-ancestor
25500497|NCT00318149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500498|NCT00318292|Epinephrine|epinephrine|mesh-list
25500499|NCT00318292|Bupivacaine|bupivacaine|mesh-list
25500500|NCT00318292|Anesthetics, Local|anesthetics, local|mesh-ancestor
25500501|NCT00318292|Anesthetics|anesthetics|mesh-ancestor
25500502|NCT00318292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24805406|NCT02009306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24805407|NCT02009306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24471553|NCT00395902|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24471554|NCT00395902|Hormone Antagonists|hormone antagonists|mesh-ancestor
24471555|NCT00395902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24471556|NCT00395915|Aripiprazole|aripiprazole|mesh-list
24805470|NCT02009488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471669|NCT00396500|Anticestodal Agents|anticestodal agents|mesh-ancestor
24471670|NCT00396500|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24471671|NCT00396500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24471672|NCT00396500|Tubulin Modulators|tubulin modulators|mesh-ancestor
24471673|NCT00396500|Antimitotic Agents|antimitotic agents|mesh-ancestor
24471674|NCT00396500|Mitosis Modulators|mitosis modulators|mesh-ancestor
24471676|NCT00396513|Simvastatin|simvastatin|mesh-list
24471705|NCT00396669|Bupropion|bupropion|mesh-list
24471706|NCT00396669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25500503|NCT00318292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500504|NCT00318292|Sensory System Agents|sensory system agents|mesh-ancestor
25500505|NCT00318292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25500506|NCT00318292|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25500507|NCT00318292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25500508|NCT00318292|Adrenergic Agents|adrenergic agents|mesh-ancestor
25500509|NCT00318292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25500510|NCT00318292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500511|NCT00318292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25500512|NCT00318292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25500513|NCT00318292|Autonomic Agents|autonomic agents|mesh-ancestor
24472160|NCT00398489|Epirubicin|epirubicin|mesh-list
24472161|NCT00398489|Anastrozole|anastrozole|mesh-list
24472162|NCT00398489|Goserelin|goserelin|mesh-list
24600193|NCT02008292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24579727|NCT00857168|Testosterone|testosterone|mesh-list
24472182|NCT00398489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24472183|NCT00398489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24472184|NCT00398489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24472185|NCT00398489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24472186|NCT00398489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24472187|NCT00398489|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24472188|NCT00398489|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24472189|NCT00398515|Sirolimus|sirolimus|mesh-list
24472190|NCT00398515|Lenalidomide|lenalidomide|mesh-list
24472191|NCT00398515|Immunologic Factors|immunologic factors|mesh-ancestor
24472192|NCT00398515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472193|NCT00398515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24472319|NCT00398853|Chromium|chromium|mesh-list
24472320|NCT00398853|Picolinic acid|picolinic acid|mesh-list
24472321|NCT00398853|Trace Elements|trace elements|mesh-ancestor
24738365|NCT01675076|Rivaroxaban|rivaroxaban|mesh-list
24805537|NCT02010723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24805538|NCT02010762|Vitamin D|vitamin d|mesh-list
24805539|NCT02010762|Vitamins|vitamins|mesh-ancestor
24472709|NCT00400335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472742|NCT00400387|Folic Acid|folic acid|mesh-list
24472851|NCT00400777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472852|NCT00400777|Vasodilator Agents|vasodilator agents|mesh-ancestor
24472853|NCT00400777|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24805572|NCT02010944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805573|NCT02010944|Urological Agents|urological agents|mesh-ancestor
25500514|NCT00318292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25500515|NCT00318292|Respiratory System Agents|respiratory system agents|mesh-ancestor
25500516|NCT00318292|Mydriatics|mydriatics|mesh-ancestor
25500517|NCT00318292|Sympathomimetics|sympathomimetics|mesh-ancestor
25500518|NCT00318292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25168027|NCT02339064|Emetics|emetics|mesh-ancestor
25106039|NCT04630938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25106040|NCT04630938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25106041|NCT04630938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25106042|NCT04630938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106043|NCT04630938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25106045|NCT04630938|Analgesics|analgesics|mesh-ancestor
25106046|NCT04624451|Dalbavancin|dalbavancin|mesh-list
24738806|NCT01677559|Paclitaxel|paclitaxel|mesh-list
24444281|NCT00297349|Anticonvulsants|anticonvulsants|mesh-ancestor
24444282|NCT00297349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24444283|NCT00297349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444284|NCT00297362|Galantamine|galantamine|mesh-list
24444285|NCT00297362|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24444286|NCT00297362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444287|NCT00297362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444288|NCT00297362|Cholinergic Agents|cholinergic agents|mesh-ancestor
24444289|NCT00297362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24473039|NCT00401609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25106047|NCT04624451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25106048|NCT04624451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24800810|NCT01978483|Denosumab|denosumab|mesh-list
25822735|NCT00004585|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25606080|NCT01064362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606081|NCT01064401|Interferons|interferons|mesh-list
25606082|NCT01064401|Interferon-beta|interferon-beta|mesh-list
25606083|NCT01064401|Interferon beta-1a|interferon beta-1a|mesh-list
25606084|NCT01064401|Daclizumab|daclizumab|mesh-list
25606085|NCT01064401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25606086|NCT01064401|Antiviral Agents|antiviral agents|mesh-ancestor
25606087|NCT01064401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25606088|NCT01064401|Immunologic Factors|immunologic factors|mesh-ancestor
25606089|NCT01064401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606090|NCT01064401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25606091|NCT01064401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25606092|NCT01064414|Canagliflozin|canagliflozin|mesh-list
25606093|NCT01064414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25606094|NCT01064414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606184|NCT01065766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25606185|NCT01065766|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25606186|NCT01065766|Protease Inhibitors|protease inhibitors|mesh-ancestor
25606187|NCT01065766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606188|NCT01065766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606189|NCT01065844|Nelfinavir|nelfinavir|mesh-list
25606190|NCT01065844|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25606191|NCT01065844|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25606192|NCT01065844|Protease Inhibitors|protease inhibitors|mesh-ancestor
25606193|NCT01065844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606194|NCT01065844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606195|NCT01065844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25606196|NCT01065844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25606197|NCT01065844|Antiviral Agents|antiviral agents|mesh-ancestor
25606198|NCT01065844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25606199|NCT01066000|Epoetin Alfa|epoetin alfa|mesh-list
25606200|NCT01066000|Hematinics|hematinics|mesh-ancestor
25606201|NCT01066026|Hyaluronic Acid|hyaluronic acid|mesh-list
25606202|NCT01066026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25606203|NCT01066026|Immunologic Factors|immunologic factors|mesh-ancestor
25606204|NCT01066026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606205|NCT01066026|Viscosupplements|viscosupplements|mesh-ancestor
25606206|NCT01066026|Protective Agents|protective agents|mesh-ancestor
25606207|NCT01066039|Bisoprolol|bisoprolol|mesh-list
25606208|NCT01066039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25606209|NCT01066039|Sympatholytics|sympatholytics|mesh-ancestor
25606210|NCT01066039|Autonomic Agents|autonomic agents|mesh-ancestor
25606211|NCT01066039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25606212|NCT01066039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606213|NCT01066039|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25606214|NCT01066039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25606215|NCT01066039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25606216|NCT01066039|Adrenergic Agents|adrenergic agents|mesh-ancestor
25606217|NCT01066039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25606218|NCT01066039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606219|NCT01066104|Omalizumab|omalizumab|mesh-list
25606220|NCT01066104|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25606221|NCT01066104|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25606222|NCT01066104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24905894|NCT04344236|Disinfectants|disinfectants|mesh-ancestor
24905895|NCT04344236|Plasma Substitutes|plasma substitutes|mesh-ancestor
24818567|NCT02089438|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24818568|NCT02089438|Vildagliptin|vildagliptin|mesh-list
24818569|NCT02089438|Saxagliptin|saxagliptin|mesh-list
24818570|NCT02089438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24481615|NCT00435955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481616|NCT00435955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25606223|NCT01066104|Respiratory System Agents|respiratory system agents|mesh-ancestor
25606224|NCT01066104|Immunologic Factors|immunologic factors|mesh-ancestor
25606225|NCT01066104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606226|NCT01066143|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25606227|NCT01066143|Antidepressive Agents|antidepressive agents|mesh-ancestor
25606228|NCT01066143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25606229|NCT01066143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25606230|NCT01066143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25606231|NCT01066143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25606232|NCT01066143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606233|NCT01066156|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25606234|NCT01066156|Antidepressive Agents|antidepressive agents|mesh-ancestor
25606235|NCT01066156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25606236|NCT01066156|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25606237|NCT01066156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25606238|NCT01066156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25606239|NCT01066156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606240|NCT01066364|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
25606241|NCT01066364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25606242|NCT01066364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24905947|NCT04343742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905948|NCT04343768|Interferons|interferons|mesh-list
24905950|NCT04343768|Lopinavir|lopinavir|mesh-list
24905986|NCT04343729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24906116|NCT04342650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25606243|NCT01066364|Antimetabolites|antimetabolites|mesh-ancestor
24906117|NCT04342650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25606244|NCT01066364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606245|NCT01066364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25606246|NCT01066520|Diclofenac|diclofenac|mesh-list
25606247|NCT01066520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24906189|NCT04342351|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24906431|NCT04340778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25606248|NCT01066520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25606249|NCT01066520|Analgesics|analgesics|mesh-ancestor
25606250|NCT01066520|Sensory System Agents|sensory system agents|mesh-ancestor
25606251|NCT01066520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25606252|NCT01066520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606253|NCT01066520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25606254|NCT01066520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25606255|NCT01066520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24818744|NCT02090543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24818745|NCT02090543|Protease Inhibitors|protease inhibitors|mesh-ancestor
25709823|NCT02276040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25606256|NCT01066520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606257|NCT01066520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606258|NCT01066585|Ivermectin|ivermectin|mesh-list
25606259|NCT01066585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25606260|NCT01066585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25654371|NCT01549652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25654372|NCT01549652|Antiemetics|antiemetics|mesh-ancestor
25606261|NCT01066624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25606262|NCT01066624|Calcium|calcium|mesh-list
25606263|NCT01066624|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25606264|NCT01066624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606265|NCT01066793|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25606266|NCT01066793|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25606267|NCT01066793|Antiviral Agents|antiviral agents|mesh-ancestor
25709824|NCT02276222|Glycopyrrolate|glycopyrrolate|mesh-list
25606268|NCT01066793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25606269|NCT01066819|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25606270|NCT01066819|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24908070|NCT04324346|Mitosis Modulators|mitosis modulators|mesh-ancestor
24908664|NCT04318262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25606271|NCT01066819|Antiviral Agents|antiviral agents|mesh-ancestor
25606272|NCT01066819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25606273|NCT01066897|Pramipexole|pramipexole|mesh-list
25606274|NCT01066897|Antioxidants|antioxidants|mesh-ancestor
25606275|NCT01066897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606276|NCT01066897|Protective Agents|protective agents|mesh-ancestor
25606277|NCT01066897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606278|NCT01066897|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25606279|NCT01066897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25606280|NCT01066897|Dopamine Agonists|dopamine agonists|mesh-ancestor
25606281|NCT01066897|Dopamine Agents|dopamine agents|mesh-ancestor
25606282|NCT01066897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25606283|NCT01066923|Aspirin|aspirin|mesh-list
25606284|NCT01066923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25606285|NCT01066923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25606286|NCT01066923|Analgesics|analgesics|mesh-ancestor
25606287|NCT01066923|Sensory System Agents|sensory system agents|mesh-ancestor
24908665|NCT04318067|Melatonin|melatonin|mesh-list
24908666|NCT04318067|Antioxidants|antioxidants|mesh-ancestor
25606288|NCT01066923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25606289|NCT01066923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606290|NCT01066923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25606291|NCT01066923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25606292|NCT01066923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25606293|NCT01066923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25606294|NCT01066923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606295|NCT01066923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25606296|NCT01066923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25606297|NCT01066923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606298|NCT01066923|Antipyretics|antipyretics|mesh-ancestor
25606299|NCT01067105|Ciclesonide|ciclesonide|mesh-list
25606300|NCT01067105|Glucocorticoids|glucocorticoids|mesh-ancestor
25606301|NCT01067105|Hormones|hormones|mesh-ancestor
25606302|NCT01067105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25606303|NCT01067105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606304|NCT01067105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25606305|NCT01067339|Darapladib|darapladib|mesh-list
25606306|NCT01067339|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
25606307|NCT01067339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606308|NCT01067339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606309|NCT01067352|Hormones|hormones|mesh-list
25606310|NCT01067352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25606311|NCT01067352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606312|NCT01067469|Bevacizumab|bevacizumab|mesh-list
25606313|NCT01067469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25606314|NCT01067469|Lomustine|lomustine|mesh-list
25606315|NCT01067469|Antibodies|antibodies|mesh-list
25606316|NCT01067469|Immunoglobulins|immunoglobulins|mesh-list
25606317|NCT01067469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25606318|NCT01067469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25606319|NCT01067469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25606320|NCT01067469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25606321|NCT01067469|Growth Substances|growth substances|mesh-ancestor
25606322|NCT01067469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606323|NCT01067469|Growth Inhibitors|growth inhibitors|mesh-ancestor
25606324|NCT01067469|Immunologic Factors|immunologic factors|mesh-ancestor
25606325|NCT01067469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25606326|NCT01067469|Alkylating Agents|alkylating agents|mesh-ancestor
25606327|NCT01067469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606328|NCT01067846|Cycloserine|cycloserine|mesh-list
25606329|NCT01067846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25606330|NCT01067846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25606331|NCT01067846|Renal Agents|renal agents|mesh-ancestor
25606332|NCT01067846|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25606333|NCT01067846|Antitubercular Agents|antitubercular agents|mesh-ancestor
25606334|NCT01067846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25606335|NCT01067846|Antimetabolites|antimetabolites|mesh-ancestor
25500669|NCT00320216|Ustekinumab|ustekinumab|mesh-list
25606336|NCT01067846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606337|NCT01068158|Ivermectin|ivermectin|mesh-list
25606338|NCT01068158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25606339|NCT01068158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25606340|NCT01068418|Vitamin D|vitamin d|mesh-list
25606341|NCT01068418|Cholecalciferol|cholecalciferol|mesh-list
25606342|NCT01068418|Vitamins|vitamins|mesh-ancestor
25606343|NCT01068418|Micronutrients|micronutrients|mesh-ancestor
25606344|NCT01068418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606345|NCT01068418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25606346|NCT01068418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25606347|NCT01068626|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25606348|NCT01068626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25606349|NCT01068626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25606350|NCT01068626|Antimetabolites|antimetabolites|mesh-ancestor
25709866|NCT02276612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25709867|NCT02276612|Antiviral Agents|antiviral agents|mesh-ancestor
25606351|NCT01068626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606352|NCT01068626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25606353|NCT01068626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25606354|NCT01068626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606355|NCT01068652|Insulin|insulin|mesh-list
25606356|NCT01068652|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25606357|NCT01068652|Metformin|metformin|mesh-list
25606358|NCT01068652|Insulin Aspart|insulin aspart|mesh-list
25606359|NCT01068652|Insulin, Long-Acting|insulin, long-acting|mesh-list
25606360|NCT01068652|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24915371|NCT03196180|Imiquimod|imiquimod|mesh-list
25606361|NCT01068652|Insulin Detemir|insulin detemir|mesh-list
25606362|NCT01068652|Biphasic Insulins|biphasic insulins|mesh-list
25606363|NCT01068652|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
25606364|NCT01068652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25606365|NCT01068652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606366|NCT01068665|Insulin|insulin|mesh-list
25606367|NCT01068665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25606368|NCT01068665|Insulin Glargine|insulin glargine|mesh-list
25606369|NCT01068665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25606370|NCT01068665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606371|NCT01068678|Insulin|insulin|mesh-list
25606372|NCT01068678|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25606373|NCT01068678|Insulin Glargine|insulin glargine|mesh-list
25606374|NCT01068678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25606375|NCT01068678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606376|NCT01068717|Metformin|metformin|mesh-list
25606377|NCT01068717|Saxagliptin|saxagliptin|mesh-list
25606378|NCT01068717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25606379|NCT01068717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606380|NCT01068717|Incretins|incretins|mesh-ancestor
25606381|NCT01068717|Hormones|hormones|mesh-ancestor
25606382|NCT01068717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25606383|NCT01068717|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25606384|NCT01068717|Protease Inhibitors|protease inhibitors|mesh-ancestor
25606385|NCT01068717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606386|NCT01068717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606387|NCT01068730|Metformin|metformin|mesh-list
25606388|NCT01068730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25606389|NCT01068730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606390|NCT01068743|Metformin|metformin|mesh-list
25606391|NCT01068743|Saxagliptin|saxagliptin|mesh-list
25606392|NCT01068743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25606393|NCT01068743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606394|NCT01068743|Incretins|incretins|mesh-ancestor
25606395|NCT01068743|Hormones|hormones|mesh-ancestor
25606396|NCT01068743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25606397|NCT01068743|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25606398|NCT01068743|Protease Inhibitors|protease inhibitors|mesh-ancestor
24490985|NCT00480675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25606399|NCT01068743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606400|NCT01068743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606401|NCT01068860|Insulin|insulin|mesh-list
25606402|NCT01068860|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25606403|NCT01068860|Metformin|metformin|mesh-list
25606404|NCT01068860|Glimepiride|glimepiride|mesh-list
25606405|NCT01068860|Insulin Lispro|insulin lispro|mesh-list
25606406|NCT01068860|Insulin, Isophane|insulin, isophane|mesh-list
25606407|NCT01068860|Glyburide|glyburide|mesh-list
25606408|NCT01068860|Glipizide|glipizide|mesh-list
25606409|NCT01068860|Troglitazone|troglitazone|mesh-list
25606410|NCT01068860|Tolbutamide|tolbutamide|mesh-list
25606411|NCT01068860|Acetohexamide|acetohexamide|mesh-list
25606412|NCT01068860|Chlorpropamide|chlorpropamide|mesh-list
25606413|NCT01068860|Tolazamide|tolazamide|mesh-list
25606414|NCT01068860|Insulin, Regular, Pork|insulin, regular, pork|mesh-list
25606415|NCT01068860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25606416|NCT01068860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25606417|NCT01068860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916401|NCT04241276|Gemcitabine|gemcitabine|mesh-list
25606418|NCT01068860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25606419|NCT01068860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25606420|NCT01068860|Immunologic Factors|immunologic factors|mesh-ancestor
25606421|NCT01068873|Ritonavir|ritonavir|mesh-list
25606422|NCT01068873|Lopinavir|lopinavir|mesh-list
25606423|NCT01068873|Maraviroc|maraviroc|mesh-list
25606424|NCT01068873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25606425|NCT01068873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25606426|NCT01068873|Protease Inhibitors|protease inhibitors|mesh-ancestor
25606427|NCT01068873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606428|NCT01068873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606429|NCT01068873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25606430|NCT01068873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25606431|NCT01068873|Antiviral Agents|antiviral agents|mesh-ancestor
25606432|NCT01068873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25606433|NCT01068873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25606434|NCT01068873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25606435|NCT01068873|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25606436|NCT01068873|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25606437|NCT01068873|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25606438|NCT01068912|Favipiravir|favipiravir|mesh-list
25606439|NCT01068912|Antiviral Agents|antiviral agents|mesh-ancestor
25606440|NCT01068912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25606441|NCT01068964|Timolol|timolol|mesh-list
25606442|NCT01068964|Bimatoprost|bimatoprost|mesh-list
25606443|NCT01068964|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25606444|NCT01068964|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25606445|NCT01068964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25606446|NCT01068964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25606447|NCT01068964|Adrenergic Agents|adrenergic agents|mesh-ancestor
25606448|NCT01068964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25606449|NCT01068964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606450|NCT01068964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606451|NCT01068964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25606452|NCT01068964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25606453|NCT01069172|Dipivefrin|dipivefrin|mesh-list
25606454|NCT01069172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25606455|NCT01069172|Adrenergic Agents|adrenergic agents|mesh-ancestor
25606456|NCT01069172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25606457|NCT01069172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606458|NCT01069172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606459|NCT01069289|Budesonide|budesonide|mesh-list
25606460|NCT01069289|Formoterol Fumarate|formoterol fumarate|mesh-list
25606461|NCT01069289|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25606462|NCT01069289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25606463|NCT01069289|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25606464|NCT01069289|Autonomic Agents|autonomic agents|mesh-ancestor
25606465|NCT01069289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25606466|NCT01069289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606467|NCT01069289|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25606468|NCT01069289|Respiratory System Agents|respiratory system agents|mesh-ancestor
25606469|NCT01069289|Glucocorticoids|glucocorticoids|mesh-ancestor
25606470|NCT01069289|Hormones|hormones|mesh-ancestor
25606471|NCT01069289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25606472|NCT01069289|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25606473|NCT01069289|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25606474|NCT01069289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25606475|NCT01069289|Adrenergic Agents|adrenergic agents|mesh-ancestor
25606476|NCT01069289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25606477|NCT01069289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606478|NCT01069341|Ranibizumab|ranibizumab|mesh-list
25606479|NCT01069341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25606480|NCT01069341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25606481|NCT01069341|Growth Substances|growth substances|mesh-ancestor
25606482|NCT01069341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606483|NCT01069341|Growth Inhibitors|growth inhibitors|mesh-ancestor
25606484|NCT01069341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25606485|NCT01069354|Lidocaine|lidocaine|mesh-list
25606486|NCT01069354|Anesthetics, Local|anesthetics, local|mesh-ancestor
25606487|NCT01069354|Anesthetics|anesthetics|mesh-ancestor
25606488|NCT01069354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25654373|NCT01549652|Autonomic Agents|autonomic agents|mesh-ancestor
25606489|NCT01069354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606490|NCT01069354|Sensory System Agents|sensory system agents|mesh-ancestor
25606491|NCT01069354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25606492|NCT01069354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25606493|NCT01069354|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25606494|NCT01069354|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25606495|NCT01069354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25606496|NCT01069354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606497|NCT01069510|Spironolactone|spironolactone|mesh-list
25606498|NCT01069510|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25606499|NCT01069510|Hormone Antagonists|hormone antagonists|mesh-ancestor
25606500|NCT01069510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25606501|NCT01069510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606502|NCT01069510|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25606503|NCT01069510|Diuretics|diuretics|mesh-ancestor
25606504|NCT01069510|Natriuretic Agents|natriuretic agents|mesh-ancestor
25606505|NCT01069523|Guanfacine|guanfacine|mesh-list
25606506|NCT01069523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25606507|NCT01069523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25606508|NCT01069523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25606509|NCT01069523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25606510|NCT01069523|Adrenergic Agents|adrenergic agents|mesh-ancestor
25606511|NCT01069523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25606512|NCT01069523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606513|NCT01069523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606514|NCT01069627|Bevacizumab|bevacizumab|mesh-list
25606515|NCT01069627|Fotemustine|fotemustine|mesh-list
25606516|NCT01069627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25606517|NCT01069627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25606518|NCT01069627|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25606519|NCT01069627|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25606520|NCT01069627|Growth Substances|growth substances|mesh-ancestor
25606521|NCT01069627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606522|NCT01069627|Growth Inhibitors|growth inhibitors|mesh-ancestor
25606523|NCT01069705|Tobramycin|tobramycin|mesh-list
25606524|NCT01069705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25606525|NCT01069705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25606526|NCT01069900|Amoxicillin|amoxicillin|mesh-list
25606527|NCT01069900|Moxifloxacin|moxifloxacin|mesh-list
25606528|NCT01069900|Clavulanic Acid|clavulanic acid|mesh-list
25606529|NCT01069900|Clavulanic Acids|clavulanic acids|mesh-list
25606530|NCT01069900|Ertapenem|ertapenem|mesh-list
25606531|NCT01069900|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25606532|NCT01069900|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25606533|NCT01069900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25606534|NCT01069900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25606535|NCT01069900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25606536|NCT01069900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25606537|NCT01069900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606538|NCT01069900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606539|NCT01069900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25606540|NCT01069900|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25606541|NCT01069900|Contraceptive Agents|contraceptive agents|mesh-ancestor
25606542|NCT01069900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25606543|NCT01069900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606544|NCT01069900|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25606545|NCT01069900|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25606546|NCT01069900|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25606547|NCT01069900|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25606548|NCT01069939|Esomeprazole|esomeprazole|mesh-list
25606549|NCT01069939|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25606550|NCT01069939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25606551|NCT01069939|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25606552|NCT01069939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606553|NCT01069939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606554|NCT01070043|Amlodipine|amlodipine|mesh-list
25606555|NCT01070043|Valsartan|valsartan|mesh-list
25606556|NCT01070043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25606557|NCT01070043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25606558|NCT01070043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25606559|NCT01070043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606560|NCT01070043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25606561|NCT01070043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930100|NCT04105374|Temozolomide|temozolomide|mesh-list
25606562|NCT01070043|Vasodilator Agents|vasodilator agents|mesh-ancestor
25606563|NCT01070043|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25606564|NCT01070043|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25606565|NCT01070303|Adalimumab|adalimumab|mesh-list
25606566|NCT01070303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25606567|NCT01070303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25606568|NCT01070316|Everolimus|everolimus|mesh-list
25606569|NCT01070316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25606570|NCT01070316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25606571|NCT01070316|Immunologic Factors|immunologic factors|mesh-ancestor
25606572|NCT01070316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606573|NCT01070329|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25606574|NCT01070329|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25606575|NCT01070329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25606576|NCT01070329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25606577|NCT01070329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606578|NCT01070329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25606579|NCT01070329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606580|NCT01070329|Analgesics|analgesics|mesh-ancestor
25606581|NCT01070329|Sensory System Agents|sensory system agents|mesh-ancestor
25606582|NCT01070329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25606583|NCT01070329|Antidepressive Agents|antidepressive agents|mesh-ancestor
25606584|NCT01070329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25606585|NCT01070329|Dopamine Agents|dopamine agents|mesh-ancestor
25606586|NCT01070394|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25606587|NCT01070394|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25606588|NCT01070394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606589|NCT01070394|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25606590|NCT01070394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25606591|NCT01070394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25606592|NCT01070394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606593|NCT01070394|Dopamine Agents|dopamine agents|mesh-ancestor
25606594|NCT01070394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25606595|NCT01070550|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25606596|NCT01070550|Antiviral Agents|antiviral agents|mesh-ancestor
25606597|NCT01070550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25606598|NCT01070784|Budesonide|budesonide|mesh-list
25606599|NCT01070784|Formoterol Fumarate|formoterol fumarate|mesh-list
25606600|NCT01070784|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25606601|NCT01070784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25606602|NCT01070784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24934327|NCT04061772|Etoposide|etoposide|mesh-list
24934328|NCT04061772|Bortezomib|bortezomib|mesh-list
25606603|NCT01070784|Autonomic Agents|autonomic agents|mesh-ancestor
25606604|NCT01070784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25606605|NCT01070784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606606|NCT01070784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25606607|NCT01070784|Respiratory System Agents|respiratory system agents|mesh-ancestor
25606608|NCT01070784|Glucocorticoids|glucocorticoids|mesh-ancestor
25606609|NCT01070784|Hormones|hormones|mesh-ancestor
25499145|NCT00743197|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25709948|NCT02278614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25709949|NCT02278614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25709950|NCT02278614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25004737|NCT01858922|Cyclophosphamide|cyclophosphamide|mesh-list
25004738|NCT01858922|Cisplatin|cisplatin|mesh-list
25004739|NCT01858922|Doxorubicin|doxorubicin|mesh-list
25004740|NCT01858922|Etoposide|etoposide|mesh-list
25004741|NCT01858922|Etoposide phosphate|etoposide phosphate|mesh-list
25004742|NCT01858922|Vincristine|vincristine|mesh-list
25004743|NCT01858922|Bleomycin|bleomycin|mesh-list
25004744|NCT01858922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24670937|NCT00680901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24670938|NCT00680901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24455578|NCT00327834|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24455579|NCT00327834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24455580|NCT00327834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24455581|NCT00327834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455582|NCT00327834|Adrenergic Agents|adrenergic agents|mesh-ancestor
24455583|NCT00327834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24455584|NCT00327834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455585|NCT00327847|Vitamin D|vitamin d|mesh-list
24455586|NCT00327847|Vitamins|vitamins|mesh-ancestor
24455764|NCT00328900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24455765|NCT00328900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455768|NCT00328913|Antidepressive Agents|antidepressive agents|mesh-ancestor
25606610|NCT01070784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25606611|NCT01070784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25606612|NCT01070784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25606613|NCT01070784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25606614|NCT01070784|Adrenergic Agents|adrenergic agents|mesh-ancestor
25606615|NCT01070784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25606616|NCT01070784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606617|NCT01070810|Thiamine|thiamine|mesh-list
25606618|NCT01070810|Vitamin B Complex|vitamin b complex|mesh-ancestor
25606619|NCT01070810|Vitamins|vitamins|mesh-ancestor
25606620|NCT01070810|Micronutrients|micronutrients|mesh-ancestor
25606621|NCT01070810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606622|NCT01070888|Budesonide|budesonide|mesh-list
25606623|NCT01070888|Formoterol Fumarate|formoterol fumarate|mesh-list
25709970|NCT02279641|Antioxidants|antioxidants|mesh-ancestor
25005017|NCT05170893|Coenzyme Q10|coenzyme q10|mesh-list
25606624|NCT01070888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25606625|NCT01070888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25606626|NCT01070888|Autonomic Agents|autonomic agents|mesh-ancestor
25606627|NCT01070888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25606628|NCT01070888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606629|NCT01070888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25606630|NCT01070888|Respiratory System Agents|respiratory system agents|mesh-ancestor
25606631|NCT01070888|Glucocorticoids|glucocorticoids|mesh-ancestor
25606632|NCT01070888|Hormones|hormones|mesh-ancestor
25654374|NCT01549652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25606633|NCT01070888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25606634|NCT01070888|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25606635|NCT01070888|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25606636|NCT01070888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25606637|NCT01070888|Adrenergic Agents|adrenergic agents|mesh-ancestor
25606638|NCT01070888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25606639|NCT01070888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606640|NCT01070979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25606641|NCT01070979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25606643|NCT01070979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25606644|NCT01070979|Estrogens|estrogens|mesh-list
25606645|NCT01070979|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25606646|NCT01070979|Hormones|hormones|mesh-ancestor
25709997|NCT02280044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25606647|NCT01070979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25606648|NCT01070979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606649|NCT01070979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25606650|NCT01070979|Contraceptive Agents|contraceptive agents|mesh-ancestor
25606651|NCT01070979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25606652|NCT01070979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25606653|NCT01071044|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25606654|NCT01071044|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25606655|NCT01071044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606656|NCT01071044|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25606657|NCT01071044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25606658|NCT01071044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25606659|NCT01071044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606660|NCT01071044|Dopamine Agents|dopamine agents|mesh-ancestor
25606661|NCT01071044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25606662|NCT01071083|Interferons|interferons|mesh-list
25606663|NCT01071083|Interferon-beta|interferon-beta|mesh-list
25606664|NCT01071083|Interferon beta-1a|interferon beta-1a|mesh-list
24519699|NCT05287360|Apatinib|apatinib|mesh-list
25606665|NCT01071083|Methylprednisolone|methylprednisolone|mesh-list
24526345|NCT00611286|Sirolimus|sirolimus|mesh-list
25606666|NCT01071083|Glatiramer Acetate|glatiramer acetate|mesh-list
25606667|NCT01071083|Natalizumab|natalizumab|mesh-list
25606668|NCT01071083|(T,G)-A-L|(t,g)-a-l|mesh-list
25606669|NCT01071083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25606670|NCT01071083|Antiviral Agents|antiviral agents|mesh-ancestor
25606671|NCT01071083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25606672|NCT01071083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25606673|NCT01071083|Antiemetics|antiemetics|mesh-ancestor
25606674|NCT01071083|Autonomic Agents|autonomic agents|mesh-ancestor
25606675|NCT01071083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25606676|NCT01071083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606677|NCT01071083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25606678|NCT01071083|Glucocorticoids|glucocorticoids|mesh-ancestor
25606679|NCT01071083|Hormones|hormones|mesh-ancestor
25606680|NCT01071083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25606681|NCT01071083|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25606682|NCT01071083|Protective Agents|protective agents|mesh-ancestor
25606683|NCT01071083|Immunologic Factors|immunologic factors|mesh-ancestor
25606684|NCT01071083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25606685|NCT01071083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25606686|NCT01071083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25606687|NCT01071096|Botulinum Toxins|botulinum toxins|mesh-list
25606688|NCT01071096|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25606689|NCT01071096|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25606690|NCT01071096|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25606691|NCT01071096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25606692|NCT01071096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606693|NCT01071096|Cholinergic Agents|cholinergic agents|mesh-ancestor
25606694|NCT01071096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25606695|NCT01071096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606696|NCT01071096|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25606697|NCT01071096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25606698|NCT01071200|Hormones|hormones|mesh-list
25606699|NCT01071200|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25606700|NCT01071200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25606701|NCT01071200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606702|NCT01071317|Naproxen|naproxen|mesh-list
25606703|NCT01071317|Sumatriptan|sumatriptan|mesh-list
25606704|NCT01071317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25606705|NCT01071317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25606706|NCT01071317|Analgesics|analgesics|mesh-ancestor
25606707|NCT01071317|Sensory System Agents|sensory system agents|mesh-ancestor
25606708|NCT01071317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25606709|NCT01071317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606710|NCT01071317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25606711|NCT01071317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25606712|NCT01071317|Gout Suppressants|gout suppressants|mesh-ancestor
25606713|NCT01071317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25606714|NCT01071317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606715|NCT01071317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606716|NCT01071317|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25606717|NCT01071317|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25606718|NCT01071317|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25606719|NCT01071317|Serotonin Agents|serotonin agents|mesh-ancestor
25606720|NCT01071317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25606721|NCT01071395|Amantadine|amantadine|mesh-list
25606722|NCT01071395|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25606723|NCT01071395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25606724|NCT01071395|Antiviral Agents|antiviral agents|mesh-ancestor
25606725|NCT01071395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25606726|NCT01071395|Dopamine Agents|dopamine agents|mesh-ancestor
25606727|NCT01071395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25606728|NCT01071395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606729|NCT01071395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606730|NCT01071395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25606731|NCT01071395|Analgesics|analgesics|mesh-ancestor
25606732|NCT01071395|Sensory System Agents|sensory system agents|mesh-ancestor
25606733|NCT01071395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25606734|NCT01071512|Natalizumab|natalizumab|mesh-list
25606735|NCT01071512|Immunologic Factors|immunologic factors|mesh-ancestor
25606736|NCT01071512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606737|NCT01071538|Buprenorphine|buprenorphine|mesh-list
25606738|NCT01071538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25606739|NCT01071538|Narcotics|narcotics|mesh-ancestor
25606740|NCT01071538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25606741|NCT01071538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606742|NCT01071538|Analgesics|analgesics|mesh-ancestor
25606743|NCT01071538|Sensory System Agents|sensory system agents|mesh-ancestor
25606744|NCT01071538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25606745|NCT01071538|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25606746|NCT01071798|Rituximab|rituximab|mesh-list
25606747|NCT01071798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25606748|NCT01071798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25606749|NCT01071798|Immunologic Factors|immunologic factors|mesh-ancestor
25606750|NCT01071798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606751|NCT01071798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25606752|NCT01072136|Azithromycin|azithromycin|mesh-list
25606753|NCT01072136|Cefixime|cefixime|mesh-list
25710085|NCT02281773|BI 409306|bi 409306|mesh-list
25606754|NCT01072136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25606755|NCT01072136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714092|NCT01529164|Leucovorin|leucovorin|mesh-list
25606756|NCT01072149|Fluticasone|fluticasone|mesh-list
25606757|NCT01072149|Xhance|xhance|mesh-list
25606758|NCT01072149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25606759|NCT01072149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25606760|NCT01072149|Autonomic Agents|autonomic agents|mesh-ancestor
24715095|NCT01534442|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25606761|NCT01072149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25606762|NCT01072149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606763|NCT01072149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25710091|NCT02282293|Artenimol|artenimol|mesh-list
25606764|NCT01072149|Respiratory System Agents|respiratory system agents|mesh-ancestor
25710098|NCT02282293|Renal Agents|renal agents|mesh-ancestor
25606765|NCT01072149|Dermatologic Agents|dermatologic agents|mesh-ancestor
25606766|NCT01072149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25606767|NCT01072188|Calcium Carbonate|calcium carbonate|mesh-list
25606768|NCT01072188|Calcium|calcium|mesh-list
25606769|NCT01072188|Fluorides|fluorides|mesh-list
24718602|NCT01555879|Abatacept|abatacept|mesh-list
24506193|NCT00544232|Abortifacient Agents|abortifacient agents|mesh-ancestor
25606770|NCT01072188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25606771|NCT01072188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606772|NCT01072188|Cariostatic Agents|cariostatic agents|mesh-ancestor
25606773|NCT01072188|Protective Agents|protective agents|mesh-ancestor
25606774|NCT01072188|Antacids|antacids|mesh-ancestor
25606775|NCT01072188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606776|NCT01072188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25606777|NCT01072201|Triclosan|triclosan|mesh-list
25606778|NCT01072201|Fluorides|fluorides|mesh-list
25606779|NCT01072201|Cariostatic Agents|cariostatic agents|mesh-ancestor
25606780|NCT01072201|Protective Agents|protective agents|mesh-ancestor
25606781|NCT01072201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606782|NCT01072201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25501168|NCT00323362|Gemcitabine|gemcitabine|mesh-list
25501169|NCT00323362|Imatinib Mesylate|imatinib mesylate|mesh-list
25501170|NCT00323362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25501171|NCT00323362|Antimetabolites|antimetabolites|mesh-ancestor
25501172|NCT00323362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501173|NCT00323362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501174|NCT00323362|Antiviral Agents|antiviral agents|mesh-ancestor
25501175|NCT00323362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25501176|NCT00323362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501177|NCT00323362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25501178|NCT00323362|Immunologic Factors|immunologic factors|mesh-ancestor
25501179|NCT00323362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501180|NCT00323362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25117303|NCT05361330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25117304|NCT05350917|Maleic acid|maleic acid|mesh-list
25117305|NCT05350917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701824|NCT01461460|Tedizolid|tedizolid|mesh-list
25117517|NCT05092451|Antimetabolites|antimetabolites|mesh-ancestor
25117518|NCT05092451|Antiviral Agents|antiviral agents|mesh-ancestor
25117519|NCT05092451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24529423|NCT00625911|Ketamine|ketamine|mesh-list
24529435|NCT00625911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24529436|NCT00625911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24529437|NCT00625911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615420|NCT01029743|PENTA|penta|mesh-list
24529438|NCT00625911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24529439|NCT00625911|Narcotics|narcotics|mesh-ancestor
24529441|NCT00625937|Tegafur|tegafur|mesh-list
25158536|NCT04254692|Anesthetics, Local|anesthetics, local|mesh-ancestor
25822736|NCT00004585|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24435153|NCT00265291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24435154|NCT00265291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24435155|NCT00265291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24435545|NCT00266786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24435546|NCT00266786|Analgesics|analgesics|mesh-ancestor
24435547|NCT00266786|Sensory System Agents|sensory system agents|mesh-ancestor
24435548|NCT00266786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24435549|NCT00266786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435550|NCT00266786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24435570|NCT00267163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435571|NCT00267163|Cholinergic Agents|cholinergic agents|mesh-ancestor
24435572|NCT00267163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24435573|NCT00267163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435574|NCT00267163|Nootropic Agents|nootropic agents|mesh-ancestor
25124187|NCT03078829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25606783|NCT01072201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25606784|NCT01072201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25606785|NCT01072201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25606786|NCT01072201|Antimetabolites|antimetabolites|mesh-ancestor
25606787|NCT01072201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606788|NCT01072201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25606789|NCT01072357|Bevacizumab|bevacizumab|mesh-list
25606790|NCT01072357|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25606791|NCT01072357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25710131|NCT02282527|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25606792|NCT01072357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25606793|NCT01072357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25606794|NCT01072357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25606795|NCT01072357|Growth Substances|growth substances|mesh-ancestor
25606796|NCT01072357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606797|NCT01072357|Growth Inhibitors|growth inhibitors|mesh-ancestor
24616426|NCT01037140|Vitamins|vitamins|mesh-ancestor
25606798|NCT01072357|Laxatives|laxatives|mesh-ancestor
25606799|NCT01072357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25606800|NCT01072396|Tiotropium Bromide|tiotropium bromide|mesh-list
25606801|NCT01072396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25606802|NCT01072396|Autonomic Agents|autonomic agents|mesh-ancestor
25606803|NCT01072396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25606804|NCT01072396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606805|NCT01072396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25606806|NCT01072396|Respiratory System Agents|respiratory system agents|mesh-ancestor
25606807|NCT01072396|Parasympatholytics|parasympatholytics|mesh-ancestor
25606808|NCT01072396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25606809|NCT01072396|Cholinergic Agents|cholinergic agents|mesh-ancestor
25710144|NCT02282813|Calcifediol|calcifediol|mesh-list
25606810|NCT01072396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25606811|NCT01072396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606812|NCT01072539|Tigecycline|tigecycline|mesh-list
25606813|NCT01072539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25606814|NCT01072539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25606815|NCT01072539|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25606816|NCT01072539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606817|NCT01072539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654375|NCT01549652|Antipruritics|antipruritics|mesh-ancestor
25654376|NCT01549652|Dermatologic Agents|dermatologic agents|mesh-ancestor
25654377|NCT01549652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25654378|NCT01549652|Serotonin Agents|serotonin agents|mesh-ancestor
25654379|NCT01549652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25654380|NCT01549652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654381|NCT01549652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25654382|NCT01549652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25654383|NCT01549652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25654384|NCT01549652|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25654385|NCT01549652|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25654386|NCT01549873|Propofol|propofol|mesh-list
25654387|NCT01549873|Desflurane|desflurane|mesh-list
25654388|NCT01549873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25654389|NCT01549873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25654390|NCT01549873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654391|NCT01549873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25654392|NCT01549873|Anesthetics, General|anesthetics, general|mesh-ancestor
25654393|NCT01549873|Anesthetics|anesthetics|mesh-ancestor
25654394|NCT01549873|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25654395|NCT01549886|Rituximab|rituximab|mesh-list
25654396|NCT01549886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25654397|NCT01549886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25654398|NCT01549886|Immunologic Factors|immunologic factors|mesh-ancestor
25654399|NCT01549886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654400|NCT01549886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25654401|NCT01549951|Prednisone|prednisone|mesh-list
25654402|NCT01549951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25654403|NCT01549951|Glucocorticoids|glucocorticoids|mesh-ancestor
25654404|NCT01549951|Hormones|hormones|mesh-ancestor
25654405|NCT01549951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25654406|NCT01549951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654407|NCT01549951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25654408|NCT01549951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25654409|NCT01549964|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25654410|NCT01549964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25654411|NCT01549964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654412|NCT01549964|Incretins|incretins|mesh-ancestor
25654413|NCT01549964|Hormones|hormones|mesh-ancestor
25654414|NCT01549964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25654415|NCT01549964|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25654416|NCT01549964|Protease Inhibitors|protease inhibitors|mesh-ancestor
25654417|NCT01549964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25654418|NCT01549964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654419|NCT01550224|Temozolomide|temozolomide|mesh-list
25654420|NCT01550224|Vorinostat|vorinostat|mesh-list
25654421|NCT01550224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25654422|NCT01550224|Alkylating Agents|alkylating agents|mesh-ancestor
25654423|NCT01550224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654424|NCT01550224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25654425|NCT01550224|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25654426|NCT01550224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25654427|NCT01550341|Buprenorphine|buprenorphine|mesh-list
25654428|NCT01550341|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25654429|NCT01550341|Naloxone|naloxone|mesh-list
25654430|NCT01550341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25654431|NCT01550341|Narcotics|narcotics|mesh-ancestor
25654432|NCT01550341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25654433|NCT01550341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654434|NCT01550341|Analgesics|analgesics|mesh-ancestor
25654435|NCT01550341|Sensory System Agents|sensory system agents|mesh-ancestor
25654436|NCT01550341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24733753|NCT01648257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25654437|NCT01550341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25654438|NCT01550367|Hydroxychloroquine|hydroxychloroquine|mesh-list
25501181|NCT00323479|Anastrozole|anastrozole|mesh-list
25654439|NCT01550367|Aldesleukin|aldesleukin|mesh-list
25654440|NCT01550367|Antimalarials|antimalarials|mesh-ancestor
25654441|NCT01550367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25606818|NCT01072630|Modafinil|modafinil|mesh-list
24734254|NCT01651390|Sirolimus|sirolimus|mesh-list
25606819|NCT01072630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24506690|NCT00546533|Etanercept|etanercept|mesh-list
25606820|NCT01072630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606821|NCT01072630|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25606822|NCT01072630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25606823|NCT01072630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25606824|NCT01072630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606825|NCT01072643|Dexmedetomidine|dexmedetomidine|mesh-list
25606826|NCT01072643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25606827|NCT01072643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25606828|NCT01072643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606829|NCT01072643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25606830|NCT01072643|Analgesics|analgesics|mesh-ancestor
24736735|NCT01664845|Ribavirin|ribavirin|mesh-list
25606831|NCT01072643|Sensory System Agents|sensory system agents|mesh-ancestor
25606832|NCT01072643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25606833|NCT01072643|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25606834|NCT01072643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25606835|NCT01072643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24741359|NCT01693640|Abatacept|abatacept|mesh-list
25606836|NCT01072643|Adrenergic Agents|adrenergic agents|mesh-ancestor
25606837|NCT01072643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25606838|NCT01072643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606839|NCT01072669|Ambrisentan|ambrisentan|mesh-list
25606840|NCT01072669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25606841|NCT01072773|Dexamethasone|dexamethasone|mesh-list
25606842|NCT01072773|Cyclophosphamide|cyclophosphamide|mesh-list
25606843|NCT01072773|Bortezomib|bortezomib|mesh-list
25606844|NCT01072773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25606845|NCT01072773|Immunologic Factors|immunologic factors|mesh-ancestor
25606846|NCT01072773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606847|NCT01072773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25606848|NCT01072773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25606849|NCT01072773|Alkylating Agents|alkylating agents|mesh-ancestor
25606850|NCT01072773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606851|NCT01072773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25606852|NCT01072773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25606853|NCT01072773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25606854|NCT01072773|Antiemetics|antiemetics|mesh-ancestor
25606855|NCT01072773|Autonomic Agents|autonomic agents|mesh-ancestor
25606856|NCT01072773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25606857|NCT01072773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25606858|NCT01072773|Glucocorticoids|glucocorticoids|mesh-ancestor
25606859|NCT01072773|Hormones|hormones|mesh-ancestor
24749224|NCT01414777|Antipruritics|antipruritics|mesh-ancestor
25606860|NCT01072773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25606861|NCT01072773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25606862|NCT01072877|Polidocanol|polidocanol|mesh-list
25606863|NCT01072877|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
24754207|NCT01719627|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25606864|NCT01072877|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25606865|NCT01072929|Modafinil|modafinil|mesh-list
25606866|NCT01072929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25606867|NCT01072929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606868|NCT01072929|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25606869|NCT01072929|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25606870|NCT01072929|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25606871|NCT01072929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606872|NCT01073163|Rituximab|rituximab|mesh-list
25606873|NCT01073163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25606874|NCT01073163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25606875|NCT01073163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25606876|NCT01073163|Immunologic Factors|immunologic factors|mesh-ancestor
25606877|NCT01073163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606878|NCT01073163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24758344|NCT01745549|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25606879|NCT01073163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24424986|NCT00231569|Mipomersen|mipomersen|mesh-list
25606880|NCT01073163|Alkylating Agents|alkylating agents|mesh-ancestor
24512666|NCT00576069|Glucocorticoids|glucocorticoids|mesh-ancestor
25606881|NCT01073163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606882|NCT01073566|Insulin|insulin|mesh-list
25606883|NCT01073566|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25606884|NCT01073566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25606885|NCT01073566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606886|NCT01073618|Voriconazole|voriconazole|mesh-list
25606887|NCT01073618|Antifungal Agents|antifungal agents|mesh-ancestor
24513699|NCT00584571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24790329|NCT01942109|Torsemide|torsemide|mesh-list
25606888|NCT01073618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25606889|NCT01073618|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25654442|NCT01550367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24432867|NCT00256542|Anticoagulants|anticoagulants|mesh-ancestor
24460363|NCT00348244|Analgesics|analgesics|mesh-ancestor
25606890|NCT01073618|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25606891|NCT01073618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606892|NCT01073618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606893|NCT01073618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25606894|NCT01073618|Hormone Antagonists|hormone antagonists|mesh-ancestor
25606895|NCT01073618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25606896|NCT01073618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606897|NCT01073618|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25606898|NCT01073631|Voriconazole|voriconazole|mesh-list
25606899|NCT01073631|Antifungal Agents|antifungal agents|mesh-ancestor
25606900|NCT01073631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25606901|NCT01073631|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25606902|NCT01073631|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25606903|NCT01073631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606904|NCT01073631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606905|NCT01073631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25606906|NCT01073631|Hormone Antagonists|hormone antagonists|mesh-ancestor
25606907|NCT01073631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25606908|NCT01073631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606909|NCT01073631|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25606911|NCT01073865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25606912|NCT01073865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25606913|NCT01073930|Bisacodyl|bisacodyl|mesh-list
25606914|NCT01073930|Picosulfate sodium|picosulfate sodium|mesh-list
25606915|NCT01073930|Cathartics|cathartics|mesh-ancestor
25606916|NCT01073930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25606917|NCT01073930|Laxatives|laxatives|mesh-ancestor
25606918|NCT01073943|Bisacodyl|bisacodyl|mesh-list
25606919|NCT01073943|Picosulfate sodium|picosulfate sodium|mesh-list
25606920|NCT01073943|Cathartics|cathartics|mesh-ancestor
25606921|NCT01073943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25606922|NCT01073943|Laxatives|laxatives|mesh-ancestor
25606923|NCT01074008|Ritonavir|ritonavir|mesh-list
25606924|NCT01074008|Ribavirin|ribavirin|mesh-list
25606925|NCT01074008|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25606926|NCT01074008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25606927|NCT01074008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25606928|NCT01074008|Protease Inhibitors|protease inhibitors|mesh-ancestor
25606929|NCT01074008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606930|NCT01074008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606931|NCT01074008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25606932|NCT01074008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25606933|NCT01074008|Antiviral Agents|antiviral agents|mesh-ancestor
25606934|NCT01074008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25606935|NCT01074008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25606936|NCT01074008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25606937|NCT01074008|Antimetabolites|antimetabolites|mesh-ancestor
25606938|NCT01074047|Azacitidine|azacitidine|mesh-list
25606939|NCT01074047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25606940|NCT01074047|Antimetabolites|antimetabolites|mesh-ancestor
25606941|NCT01074047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606942|NCT01074047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25606943|NCT01074047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606944|NCT01074177|Afatinib|afatinib|mesh-list
25606945|NCT01074177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25606946|NCT01074177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25606947|NCT01074177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25606948|NCT01074177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606949|NCT01074216|Vitamin D|vitamin d|mesh-list
25606950|NCT01074216|Ergocalciferols|ergocalciferols|mesh-list
25606951|NCT01074216|Cholecalciferol|cholecalciferol|mesh-list
25606952|NCT01074216|Vitamins|vitamins|mesh-list
25606953|NCT01074216|Micronutrients|micronutrients|mesh-ancestor
25606954|NCT01074216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606955|NCT01074216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25606956|NCT01074216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25606957|NCT01074229|Ropivacaine|ropivacaine|mesh-list
25606958|NCT01074229|Anesthetics, Local|anesthetics, local|mesh-ancestor
25606959|NCT01074229|Anesthetics|anesthetics|mesh-ancestor
25606960|NCT01074229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25606961|NCT01074229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606962|NCT01074229|Sensory System Agents|sensory system agents|mesh-ancestor
25501317|NCT00324649|Antiviral Agents|antiviral agents|mesh-ancestor
24516393|NCT00601887|Analgesics|analgesics|mesh-ancestor
25606963|NCT01074229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25606964|NCT01074255|Aprepitant|aprepitant|mesh-list
25606965|NCT01074255|Antiemetics|antiemetics|mesh-ancestor
25606966|NCT01074255|Autonomic Agents|autonomic agents|mesh-ancestor
25606967|NCT01074255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25606968|NCT01074255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606969|NCT01074255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25606970|NCT01074255|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25606971|NCT01074255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25606972|NCT01074255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606973|NCT01074268|Insulin|insulin|mesh-list
25606974|NCT01074268|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25606975|NCT01074268|Insulin Aspart|insulin aspart|mesh-list
25606976|NCT01074268|Insulin Detemir|insulin detemir|mesh-list
25606977|NCT01074268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25606978|NCT01074268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606979|NCT01074307|Bisoprolol|bisoprolol|mesh-list
25606980|NCT01074307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25606981|NCT01074307|Sympatholytics|sympatholytics|mesh-ancestor
25606982|NCT01074307|Autonomic Agents|autonomic agents|mesh-ancestor
25606983|NCT01074307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25606984|NCT01074307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606985|NCT01074307|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25606986|NCT01074307|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25606987|NCT01074307|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25606988|NCT01074307|Adrenergic Agents|adrenergic agents|mesh-ancestor
25606989|NCT01074307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25606990|NCT01074307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606991|NCT01074450|Pramipexole|pramipexole|mesh-list
25606992|NCT01074450|Antioxidants|antioxidants|mesh-ancestor
25606993|NCT01074450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25606994|NCT01074450|Protective Agents|protective agents|mesh-ancestor
25606995|NCT01074450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25606996|NCT01074450|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25606997|NCT01074450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25606998|NCT01074450|Dopamine Agonists|dopamine agonists|mesh-ancestor
25606999|NCT01074450|Dopamine Agents|dopamine agents|mesh-ancestor
25607000|NCT01074450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25607001|NCT01074463|Pramipexole|pramipexole|mesh-list
25607002|NCT01074463|Antioxidants|antioxidants|mesh-ancestor
25607003|NCT01074463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607004|NCT01074463|Protective Agents|protective agents|mesh-ancestor
25607005|NCT01074463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607006|NCT01074463|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25607007|NCT01074463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25607008|NCT01074463|Dopamine Agonists|dopamine agonists|mesh-ancestor
25607009|NCT01074463|Dopamine Agents|dopamine agents|mesh-ancestor
25607010|NCT01074463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25607011|NCT01074554|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25607012|NCT01074554|Azithromycin|azithromycin|mesh-list
25607013|NCT01074554|Levofloxacin|levofloxacin|mesh-list
25607014|NCT01074554|Rifampin|rifampin|mesh-list
25607015|NCT01074554|Ethambutol|ethambutol|mesh-list
25607016|NCT01074554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25607017|NCT01074554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25607018|NCT01074554|Antitubercular Agents|antitubercular agents|mesh-ancestor
25607019|NCT01074554|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25607020|NCT01074554|Renal Agents|renal agents|mesh-ancestor
25607021|NCT01074554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25607022|NCT01074554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25607023|NCT01074554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607024|NCT01074554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607025|NCT01074554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25607026|NCT01074554|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25607027|NCT01074554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25607028|NCT01074554|Leprostatic Agents|leprostatic agents|mesh-ancestor
25607029|NCT01074554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25607030|NCT01074554|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25607031|NCT01074554|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25607032|NCT01074554|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25607033|NCT01074554|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25607034|NCT01074554|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25607035|NCT01074554|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25607036|NCT01074931|Ritonavir|ritonavir|mesh-list
25607037|NCT01074931|Lopinavir|lopinavir|mesh-list
25607038|NCT01074931|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25607039|NCT01074931|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25607040|NCT01074931|Protease Inhibitors|protease inhibitors|mesh-ancestor
25607041|NCT01074931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607042|NCT01074931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607043|NCT01074931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25607044|NCT01074931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25607045|NCT01074931|Antiviral Agents|antiviral agents|mesh-ancestor
25607046|NCT01074931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25607047|NCT01074931|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25607048|NCT01074931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25607049|NCT01074944|Eliglustat|eliglustat|mesh-list
25607050|NCT01074944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607051|NCT01074944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607052|NCT01075048|Irinotecan|irinotecan|mesh-list
25607053|NCT01075048|Cetuximab|cetuximab|mesh-list
25607054|NCT01075048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25607055|NCT01075048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25607056|NCT01075048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24555856|NCT00743964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25607057|NCT01075048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607058|NCT01075048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710267|NCT02284464|Glucocorticoids|glucocorticoids|mesh-ancestor
25607059|NCT01075048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25710276|NCT02284555|Mupirocin|mupirocin|mesh-list
25607060|NCT01075087|Ropivacaine|ropivacaine|mesh-list
25607061|NCT01075087|Anesthetics, Local|anesthetics, local|mesh-ancestor
25607062|NCT01075087|Anesthetics|anesthetics|mesh-ancestor
24519995|NCT04286529|Calcitriol|calcitriol|mesh-list
25607063|NCT01075087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25607064|NCT01075087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563861|NCT00774111|Dolutegravir|dolutegravir|mesh-list
25607065|NCT01075087|Sensory System Agents|sensory system agents|mesh-ancestor
25607066|NCT01075087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25607067|NCT01075100|Carboplatin|carboplatin|mesh-list
25607068|NCT01075100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25607069|NCT01075152|Lamivudine|lamivudine|mesh-list
25607070|NCT01075152|Zidovudine|zidovudine|mesh-list
25607071|NCT01075152|Efavirenz|efavirenz|mesh-list
25607072|NCT01075152|Stavudine|stavudine|mesh-list
25607073|NCT01075152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24521073|NCT05116826|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25607074|NCT01075152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25607075|NCT01075152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607076|NCT01075152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607077|NCT01075152|Antiviral Agents|antiviral agents|mesh-ancestor
25607078|NCT01075152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25607079|NCT01075152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25607080|NCT01075152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25607081|NCT01075152|Antimetabolites|antimetabolites|mesh-ancestor
25607082|NCT01075152|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25607083|NCT01075152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25607084|NCT01075152|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25607085|NCT01075152|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25607086|NCT01075152|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25607087|NCT01075152|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25607088|NCT01075204|Clarithromycin|clarithromycin|mesh-list
25607089|NCT01075204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25607090|NCT01075204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25607091|NCT01075204|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25607092|NCT01075204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607093|NCT01075204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607094|NCT01075204|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25607095|NCT01075204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25607096|NCT01075243|Acetaminophen|acetaminophen|mesh-list
25607097|NCT01075243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25607098|NCT01075243|Analgesics|analgesics|mesh-ancestor
25607099|NCT01075243|Sensory System Agents|sensory system agents|mesh-ancestor
25607100|NCT01075243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25607101|NCT01075243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607102|NCT01075243|Antipyretics|antipyretics|mesh-ancestor
25607103|NCT01075256|Calcium, Dietary|calcium, dietary|mesh-list
25607104|NCT01075256|Calcium|calcium|mesh-list
25607105|NCT01075256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25607106|NCT01075256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607107|NCT01075256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25607108|NCT01075282|Metformin|metformin|mesh-list
25607109|NCT01075282|Insulin Glargine|insulin glargine|mesh-list
25607110|NCT01075282|Glimepiride|glimepiride|mesh-list
25607111|NCT01075282|Dulaglutide|dulaglutide|mesh-list
25607112|NCT01075282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25607113|NCT01075282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607114|NCT01075282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25607115|NCT01075282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25607116|NCT01075282|Immunologic Factors|immunologic factors|mesh-ancestor
25607118|NCT01075321|Everolimus|everolimus|mesh-list
25607119|NCT01075321|Immunologic Factors|immunologic factors|mesh-ancestor
25607120|NCT01075321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607121|NCT01075321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25607122|NCT01075321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25607123|NCT01075321|Growth Substances|growth substances|mesh-ancestor
25607124|NCT01075321|Growth Inhibitors|growth inhibitors|mesh-ancestor
25607125|NCT01075321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25607126|NCT01075321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25607127|NCT01075399|Imidazole|imidazole|mesh-list
25607128|NCT01075399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607129|NCT01075399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607130|NCT01075646|Ropivacaine|ropivacaine|mesh-list
25607131|NCT01075646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25607132|NCT01075646|Anesthetics, Local|anesthetics, local|mesh-ancestor
25607133|NCT01075646|Anesthetics|anesthetics|mesh-ancestor
25607134|NCT01075646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25607135|NCT01075646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607136|NCT01075646|Sensory System Agents|sensory system agents|mesh-ancestor
25607137|NCT01075646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25607138|NCT01075763|Interferons|interferons|mesh-list
25607139|NCT01075763|Interferon-beta|interferon-beta|mesh-list
25607140|NCT01075763|Interferon beta-1a|interferon beta-1a|mesh-list
25607141|NCT01075763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25607142|NCT01075763|Antiviral Agents|antiviral agents|mesh-ancestor
25607143|NCT01075763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25607144|NCT01075763|Immunologic Factors|immunologic factors|mesh-ancestor
25607145|NCT01075763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607146|NCT01075763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25607147|NCT01075815|Hormones|hormones|mesh-list
25607148|NCT01075815|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25607149|NCT01075815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25607150|NCT01075815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607151|NCT01075971|Buprenorphine|buprenorphine|mesh-list
25607152|NCT01075971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25607153|NCT01075971|Narcotics|narcotics|mesh-ancestor
25607154|NCT01075971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25607155|NCT01075971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607156|NCT01075971|Analgesics|analgesics|mesh-ancestor
25607157|NCT01075971|Sensory System Agents|sensory system agents|mesh-ancestor
25607158|NCT01075971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24524398|NCT04973891|Metformin|metformin|mesh-list
25607159|NCT01075971|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25607160|NCT01075984|Posaconazole|posaconazole|mesh-list
25607161|NCT01075984|Antifungal Agents|antifungal agents|mesh-ancestor
25607162|NCT01075984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25607163|NCT01075984|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25607164|NCT01075984|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25607165|NCT01075984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25607166|NCT01075984|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25607167|NCT01075984|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24568654|NCT00796887|Niacinamide|niacinamide|mesh-list
25607168|NCT01075984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607169|NCT01075984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607170|NCT01075984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25607171|NCT01075984|Hormone Antagonists|hormone antagonists|mesh-ancestor
25607172|NCT01075984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25607173|NCT01075984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607174|NCT01076010|Sorafenib|sorafenib|mesh-list
25009241|NCT02717416|Hemostatics|hemostatics|mesh-list
25607175|NCT01076010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25607176|NCT01076010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25607177|NCT01076010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607178|NCT01076010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607179|NCT01076075|Metformin|metformin|mesh-list
25607180|NCT01076075|Pioglitazone|pioglitazone|mesh-list
25607181|NCT01076075|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25607182|NCT01076075|Glimepiride|glimepiride|mesh-list
25607183|NCT01076075|Gliclazide|gliclazide|mesh-list
25607184|NCT01076075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24572693|NCT00816335|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25607185|NCT01076075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607186|NCT01076075|Incretins|incretins|mesh-ancestor
25607187|NCT01076075|Hormones|hormones|mesh-ancestor
25501521|NCT00326612|Anesthetics|anesthetics|mesh-ancestor
25607188|NCT01076075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25607189|NCT01076075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25607190|NCT01076075|Protease Inhibitors|protease inhibitors|mesh-ancestor
25607191|NCT01076075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607192|NCT01076075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607193|NCT01076075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25607194|NCT01076075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25607195|NCT01076075|Immunologic Factors|immunologic factors|mesh-ancestor
25607196|NCT01076088|Metformin|metformin|mesh-list
25607197|NCT01076088|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25607198|NCT01076088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25607199|NCT01076088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607200|NCT01076088|Incretins|incretins|mesh-ancestor
25607201|NCT01076088|Hormones|hormones|mesh-ancestor
25607202|NCT01076088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25607203|NCT01076088|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25607204|NCT01076088|Protease Inhibitors|protease inhibitors|mesh-ancestor
25607205|NCT01076088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607206|NCT01076088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607207|NCT01076153|Clarithromycin|clarithromycin|mesh-list
25607208|NCT01076153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25607209|NCT01076153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25607210|NCT01076153|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25607211|NCT01076153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607212|NCT01076153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607213|NCT01076153|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25607214|NCT01076153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25607215|NCT01076166|Clarithromycin|clarithromycin|mesh-list
25607216|NCT01076166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25607217|NCT01076166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25607218|NCT01076166|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25607219|NCT01076166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607220|NCT01076166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607221|NCT01076166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25607222|NCT01076166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25607223|NCT01076231|Cisplatin|cisplatin|mesh-list
25607224|NCT01076231|Etoposide|etoposide|mesh-list
25607225|NCT01076231|Etoposide phosphate|etoposide phosphate|mesh-list
25607226|NCT01076231|Podophyllotoxin|podophyllotoxin|mesh-list
25607227|NCT01076231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25607228|NCT01076231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25607229|NCT01076231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25607230|NCT01076231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25607231|NCT01076231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573690|NCT00821535|Maraviroc|maraviroc|mesh-list
25607232|NCT01076231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607233|NCT01076231|Keratolytic Agents|keratolytic agents|mesh-ancestor
25607234|NCT01076231|Dermatologic Agents|dermatologic agents|mesh-ancestor
25607235|NCT01076231|Tubulin Modulators|tubulin modulators|mesh-ancestor
25607236|NCT01076231|Antimitotic Agents|antimitotic agents|mesh-ancestor
25607237|NCT01076231|Mitosis Modulators|mitosis modulators|mesh-ancestor
25607238|NCT01076270|Plerixafor|plerixafor|mesh-list
25607239|NCT01076270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25607240|NCT01076270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25607241|NCT01076270|Antiviral Agents|antiviral agents|mesh-ancestor
25607242|NCT01076270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25607243|NCT01076283|Cyproheptadine|cyproheptadine|mesh-list
25607244|NCT01076283|Baclofen|baclofen|mesh-list
25607245|NCT01076283|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25607246|NCT01076283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607247|NCT01076283|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25607248|NCT01076283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25607249|NCT01076283|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25607250|NCT01076283|GABA Agonists|gaba agonists|mesh-ancestor
25607251|NCT01076283|GABA Agents|gaba agents|mesh-ancestor
24573817|NCT00822133|Analgesics|analgesics|mesh-ancestor
25607252|NCT01076283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25607253|NCT01076283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607254|NCT01076283|Antipruritics|antipruritics|mesh-ancestor
25607255|NCT01076283|Dermatologic Agents|dermatologic agents|mesh-ancestor
25607256|NCT01076283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24574297|NCT00824811|Hormones|hormones|mesh-ancestor
25607257|NCT01076283|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25607258|NCT01076283|Histamine Antagonists|histamine antagonists|mesh-ancestor
25607259|NCT01076283|Histamine Agents|histamine agents|mesh-ancestor
25607260|NCT01076283|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25607261|NCT01076283|Serotonin Agents|serotonin agents|mesh-ancestor
25607262|NCT01076283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25607263|NCT01076335|Docetaxel|docetaxel|mesh-list
25607264|NCT01076335|Leuprolide|leuprolide|mesh-list
25607265|NCT01076335|Goserelin|goserelin|mesh-list
25607266|NCT01076335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25607267|NCT01076335|Tubulin Modulators|tubulin modulators|mesh-ancestor
25607268|NCT01076335|Antimitotic Agents|antimitotic agents|mesh-ancestor
25607269|NCT01076335|Mitosis Modulators|mitosis modulators|mesh-ancestor
25607270|NCT01076335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607271|NCT01076335|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25607272|NCT01076335|Fertility Agents|fertility agents|mesh-ancestor
25607273|NCT01076335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25607274|NCT01076335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607275|NCT01076335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25607276|NCT01076400|Cisplatin|cisplatin|mesh-list
25607277|NCT01076400|Topotecan|topotecan|mesh-list
25607278|NCT01076400|Adavosertib|adavosertib|mesh-list
25607279|NCT01076400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25607280|NCT01076400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25607281|NCT01076400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25607282|NCT01076400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607283|NCT01076400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607284|NCT01076504|Carboplatin|carboplatin|mesh-list
25607285|NCT01076504|Amrubicin|amrubicin|mesh-list
25607286|NCT01076504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25607287|NCT01076543|Sirolimus|sirolimus|mesh-list
24574559|NCT00826254|Vitamins|vitamins|mesh-list
25607288|NCT01076543|Lenalidomide|lenalidomide|mesh-list
25607289|NCT01076543|Immunologic Factors|immunologic factors|mesh-ancestor
25607290|NCT01076543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607291|NCT01076543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25607292|NCT01076543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25607293|NCT01076543|Growth Substances|growth substances|mesh-ancestor
25607294|NCT01076543|Growth Inhibitors|growth inhibitors|mesh-ancestor
25607295|NCT01076543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24574808|NCT00827554|Nadroparin|nadroparin|mesh-list
25607296|NCT01076543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25607297|NCT01076543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25607298|NCT01076543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25607299|NCT01076543|Antifungal Agents|antifungal agents|mesh-ancestor
25607300|NCT01076543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25607301|NCT01076647|Insulin|insulin|mesh-list
25607302|NCT01076647|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25607303|NCT01076647|Insulin Glargine|insulin glargine|mesh-list
25607304|NCT01076647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25607305|NCT01076647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607306|NCT01076972|Ritonavir|ritonavir|mesh-list
25607307|NCT01076972|Lopinavir|lopinavir|mesh-list
25607308|NCT01076972|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25607309|NCT01076972|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25607310|NCT01076972|Protease Inhibitors|protease inhibitors|mesh-ancestor
25607311|NCT01076972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607312|NCT01076972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607313|NCT01076972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25607314|NCT01076972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25607315|NCT01076972|Antiviral Agents|antiviral agents|mesh-ancestor
25607316|NCT01076972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25607317|NCT01076972|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25607318|NCT01076972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25607319|NCT01076985|Ritonavir|ritonavir|mesh-list
25607320|NCT01076985|Lopinavir|lopinavir|mesh-list
25607321|NCT01076985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25607322|NCT01076985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25607323|NCT01076985|Protease Inhibitors|protease inhibitors|mesh-ancestor
25607324|NCT01076985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25009641|NCT05210595|Ticagrelor|ticagrelor|mesh-list
25607325|NCT01076985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607326|NCT01076985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25607327|NCT01076985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25607328|NCT01076985|Antiviral Agents|antiviral agents|mesh-ancestor
25607329|NCT01076985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25607330|NCT01076985|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25607331|NCT01076985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25607332|NCT01077076|Omeprazole|omeprazole|mesh-list
25607333|NCT01077076|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
25607334|NCT01077076|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25607335|NCT01077076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25607336|NCT01077076|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25607337|NCT01077076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607338|NCT01077076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607339|NCT01077154|Denosumab|denosumab|mesh-list
25607340|NCT01077154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24575453|NCT00831649|Natalizumab|natalizumab|mesh-list
25607341|NCT01077154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654443|NCT01550367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25654444|NCT01550367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25654445|NCT01550367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654446|NCT01550367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25654447|NCT01550367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24575564|NCT00832442|Bucindolol|bucindolol|mesh-list
25654448|NCT01550367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25654449|NCT01550367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25654450|NCT01550367|Antiviral Agents|antiviral agents|mesh-ancestor
25654451|NCT01550471|Ciclesonide|ciclesonide|mesh-list
25654452|NCT01550471|Beclomethasone|beclomethasone|mesh-list
25654453|NCT01550471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25654454|NCT01550471|Glucocorticoids|glucocorticoids|mesh-ancestor
25654455|NCT01550471|Hormones|hormones|mesh-ancestor
24575981|NCT00835965|Protease Inhibitors|protease inhibitors|mesh-ancestor
25654456|NCT01550471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25654457|NCT01550471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654458|NCT01550471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25654459|NCT01550471|Respiratory System Agents|respiratory system agents|mesh-ancestor
25654460|NCT01550471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25654461|NCT01550705|Isoniazid|isoniazid|mesh-list
25654462|NCT01550705|Antitubercular Agents|antitubercular agents|mesh-ancestor
25654463|NCT01550705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25654464|NCT01550705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25654465|NCT01550705|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25654466|NCT01550705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25654467|NCT01550705|Antimetabolites|antimetabolites|mesh-ancestor
25654468|NCT01550705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654469|NCT01550705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24578760|NCT00851565|Infliximab|infliximab|mesh-list
25654470|NCT01550744|Ustekinumab|ustekinumab|mesh-list
25654471|NCT01550744|Dermatologic Agents|dermatologic agents|mesh-ancestor
25654472|NCT01550965|Adalimumab|adalimumab|mesh-list
25654473|NCT01550965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25654474|NCT01550965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25654475|NCT01551056|Cetirizine|cetirizine|mesh-list
25654476|NCT01551056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24580097|NCT00860275|Fluconazole|fluconazole|mesh-list
25010053|NCT04700007|Histamine Agents|histamine agents|mesh-ancestor
25654477|NCT01551056|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25654478|NCT01551056|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25654479|NCT01551056|Histamine Antagonists|histamine antagonists|mesh-ancestor
25654480|NCT01551056|Histamine Agents|histamine agents|mesh-ancestor
25654481|NCT01551056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25654482|NCT01551056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654483|NCT01551056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654484|NCT01551212|Everolimus|everolimus|mesh-list
25654485|NCT01551212|Tacrolimus|tacrolimus|mesh-list
25654486|NCT01551212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25654487|NCT01551212|Immunologic Factors|immunologic factors|mesh-ancestor
25654488|NCT01551212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654489|NCT01551212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25654490|NCT01551212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25654491|NCT01551212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654492|NCT01551212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25654493|NCT01551303|Oxytocin|oxytocin|mesh-list
25654494|NCT01551303|Oxytocics|oxytocics|mesh-ancestor
25654495|NCT01551303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25654496|NCT01551303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654497|NCT01551745|Bevacizumab|bevacizumab|mesh-list
25654498|NCT01551745|Vaccines|vaccines|mesh-list
25654499|NCT01551745|Immunologic Factors|immunologic factors|mesh-ancestor
25654500|NCT01551745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654501|NCT01551745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25654502|NCT01551745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25654503|NCT01551745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25654504|NCT01551745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25654505|NCT01551745|Growth Substances|growth substances|mesh-ancestor
25654506|NCT01551745|Growth Inhibitors|growth inhibitors|mesh-ancestor
25654507|NCT01551888|Formoterol Fumarate|formoterol fumarate|mesh-list
25654508|NCT01551888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25654509|NCT01551888|Autonomic Agents|autonomic agents|mesh-ancestor
25654510|NCT01551888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25654511|NCT01551888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011339|NCT05216419|Vitamins|vitamins|mesh-ancestor
25654512|NCT01551888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25654513|NCT01551888|Respiratory System Agents|respiratory system agents|mesh-ancestor
25654514|NCT01551888|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25654515|NCT01551888|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25501817|NCT00329797|Vitamin D|vitamin d|mesh-list
25501818|NCT00329797|Zoledronic Acid|zoledronic acid|mesh-list
25501819|NCT00329797|Calcium|calcium|mesh-list
25501820|NCT00329797|Vitamins|vitamins|mesh-ancestor
25501821|NCT00329797|Micronutrients|micronutrients|mesh-ancestor
25501822|NCT00329797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501823|NCT00329797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25501824|NCT00329797|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25124188|NCT03078829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25124189|NCT03079050|Dexlansoprazole|dexlansoprazole|mesh-list
25124190|NCT03079050|Lansoprazole|lansoprazole|mesh-list
25106051|NCT04594746|Vasodilator Agents|vasodilator agents|mesh-ancestor
24842795|NCT02223884|Carboplatin|carboplatin|mesh-list
24435689|NCT00267657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435690|NCT00267657|Adrenergic Agents|adrenergic agents|mesh-ancestor
24435698|NCT00267709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435699|NCT00267722|Visilizumab|visilizumab|mesh-list
24435700|NCT00267722|Immunologic Factors|immunologic factors|mesh-ancestor
25124209|NCT03079141|Diuretics|diuretics|mesh-ancestor
25124210|NCT03079141|Natriuretic Agents|natriuretic agents|mesh-ancestor
25124211|NCT03079141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25124212|NCT03079115|Atorvastatin|atorvastatin|mesh-list
25124213|NCT03079115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25124214|NCT03079115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25124215|NCT03079115|Antimetabolites|antimetabolites|mesh-ancestor
25124216|NCT03079115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124217|NCT03079115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25124218|NCT03079115|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24435701|NCT00267722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435702|NCT00267813|Bupropion|bupropion|mesh-list
24435703|NCT00267813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25110455|NCT05463367|Levodopa|levodopa|mesh-list
24435704|NCT00267813|Antidepressive Agents|antidepressive agents|mesh-ancestor
25013629|NCT01446016|Docetaxel|docetaxel|mesh-list
24435705|NCT00267813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24435706|NCT00267813|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24435895|NCT00268411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24435896|NCT00268411|Immunologic Factors|immunologic factors|mesh-ancestor
24435910|NCT00268489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24436010|NCT00268671|Mitosis Modulators|mitosis modulators|mesh-ancestor
24436013|NCT00268684|Temozolomide|temozolomide|mesh-list
24436068|NCT00268814|Antitussive Agents|antitussive agents|mesh-ancestor
24436069|NCT00268814|Respiratory System Agents|respiratory system agents|mesh-ancestor
24436070|NCT00268840|Gemcitabine|gemcitabine|mesh-list
24436071|NCT00268840|Docetaxel|docetaxel|mesh-list
24436072|NCT00268840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25124225|NCT03078725|Glyburide|glyburide|mesh-list
25124226|NCT03078725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25124227|NCT03078725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436073|NCT00268840|Antimetabolites|antimetabolites|mesh-ancestor
24436074|NCT00268840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436090|NCT00268879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436091|NCT00268918|Docetaxel|docetaxel|mesh-list
24436092|NCT00268918|Vatalanib|vatalanib|mesh-list
24436145|NCT00269126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979770|NCT05241132|Tubulin Modulators|tubulin modulators|mesh-ancestor
24979771|NCT05241132|Antimitotic Agents|antimitotic agents|mesh-ancestor
24979772|NCT05241132|Mitosis Modulators|mitosis modulators|mesh-ancestor
25710572|NCT02288377|Lanreotide|lanreotide|mesh-list
24979773|NCT05241132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979774|NCT05241093|Cytarabine|cytarabine|mesh-list
24979775|NCT05241093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24979776|NCT05241093|Antimetabolites|antimetabolites|mesh-ancestor
24979777|NCT05241093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979778|NCT05241093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979779|NCT05241093|Antiviral Agents|antiviral agents|mesh-ancestor
24979780|NCT05241093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24979781|NCT05241093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24979782|NCT05241093|Immunologic Factors|immunologic factors|mesh-ancestor
25015125|NCT03126968|Autonomic Agents|autonomic agents|mesh-ancestor
25015501|NCT02245230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24979783|NCT05241093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979784|NCT05241054|Acetaminophen|acetaminophen|mesh-list
25124247|NCT03078374|Warfarin|warfarin|mesh-list
25607342|NCT01077284|Allopurinol|allopurinol|mesh-list
25607343|NCT01077284|Febuxostat|febuxostat|mesh-list
25607344|NCT01077284|Antimetabolites|antimetabolites|mesh-ancestor
25607345|NCT01077284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607346|NCT01077284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607347|NCT01077284|Gout Suppressants|gout suppressants|mesh-ancestor
25607348|NCT01077284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25607349|NCT01077284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25607350|NCT01077284|Antioxidants|antioxidants|mesh-ancestor
25607351|NCT01077284|Protective Agents|protective agents|mesh-ancestor
25607352|NCT01077284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607353|NCT01077310|Naltrexone|naltrexone|mesh-list
25607354|NCT01077310|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25607355|NCT01077310|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25607356|NCT01077310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607357|NCT01077310|Sensory System Agents|sensory system agents|mesh-ancestor
25607358|NCT01077310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25607359|NCT01077323|Exenatide|exenatide|mesh-list
25607360|NCT01077323|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25607361|NCT01077323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607362|NCT01077323|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25607363|NCT01077323|Incretins|incretins|mesh-ancestor
25607364|NCT01077323|Hormones|hormones|mesh-ancestor
25607365|NCT01077323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25607366|NCT01077362|Ustekinumab|ustekinumab|mesh-list
25607367|NCT01077362|Dermatologic Agents|dermatologic agents|mesh-ancestor
25607368|NCT01077375|Milnacipran|milnacipran|mesh-list
25607369|NCT01077375|Levomilnacipran|levomilnacipran|mesh-list
25607370|NCT01077375|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25607371|NCT01077375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25607372|NCT01077375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25607373|NCT01077375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607374|NCT01077375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25607375|NCT01077375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607376|NCT01077375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25607377|NCT01077375|Analgesics|analgesics|mesh-ancestor
25607378|NCT01077375|Sensory System Agents|sensory system agents|mesh-ancestor
25607379|NCT01077375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25607380|NCT01077375|Antidepressive Agents|antidepressive agents|mesh-ancestor
25607381|NCT01077375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25607382|NCT01077401|Ranibizumab|ranibizumab|mesh-list
25607383|NCT01077401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25607384|NCT01077401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25607385|NCT01077401|Growth Substances|growth substances|mesh-ancestor
25607386|NCT01077401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607387|NCT01077401|Growth Inhibitors|growth inhibitors|mesh-ancestor
25607388|NCT01077401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25607389|NCT01077518|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25607390|NCT01077518|Ofatumumab|ofatumumab|mesh-list
25607391|NCT01077518|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25607392|NCT01077518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25607393|NCT01077518|Alkylating Agents|alkylating agents|mesh-ancestor
25607394|NCT01077518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607395|NCT01077518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25607396|NCT01077518|Immunologic Factors|immunologic factors|mesh-ancestor
25607397|NCT01077518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607398|NCT01077596|Bupropion|bupropion|mesh-list
25607399|NCT01077596|Antidepressive Agents|antidepressive agents|mesh-list
25607400|NCT01077596|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
25607401|NCT01077596|Serotonin|serotonin|mesh-list
25607402|NCT01077596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25607403|NCT01077596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25607404|NCT01077596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25607405|NCT01077596|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25607406|NCT01077596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25607407|NCT01077596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25607408|NCT01077596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607409|NCT01077596|Dopamine Agents|dopamine agents|mesh-ancestor
25607410|NCT01077596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25021612|NCT03669757|Betamethasone|betamethasone|mesh-list
25607411|NCT01077596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607412|NCT01077596|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25607413|NCT01077596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25607414|NCT01077596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607415|NCT01077596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25607416|NCT01077596|Serotonin Agents|serotonin agents|mesh-ancestor
25607417|NCT01077622|Ofatumumab|ofatumumab|mesh-list
25607418|NCT01077622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25607419|NCT01077713|Gemcitabine|gemcitabine|mesh-list
25607420|NCT01077713|Bevacizumab|bevacizumab|mesh-list
25607421|NCT01077713|Cisplatin|cisplatin|mesh-list
25607422|NCT01077713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25607423|NCT01077713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25607424|NCT01077713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25607425|NCT01077713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25607426|NCT01077713|Growth Substances|growth substances|mesh-ancestor
25607427|NCT01077713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607428|NCT01077713|Growth Inhibitors|growth inhibitors|mesh-ancestor
25607429|NCT01077713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25607430|NCT01077713|Antimetabolites|antimetabolites|mesh-ancestor
25607431|NCT01077713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607432|NCT01077713|Antiviral Agents|antiviral agents|mesh-ancestor
25607433|NCT01077713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25607434|NCT01077713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607435|NCT01077713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25607436|NCT01077713|Immunologic Factors|immunologic factors|mesh-ancestor
25607437|NCT01077739|Leucovorin|leucovorin|mesh-list
25607438|NCT01077739|Bevacizumab|bevacizumab|mesh-list
25607439|NCT01077739|Fluorouracil|fluorouracil|mesh-list
25607440|NCT01077739|Capecitabine|capecitabine|mesh-list
25023759|NCT03651934|Iron|iron|mesh-list
25607441|NCT01077739|Oxaliplatin|oxaliplatin|mesh-list
25607442|NCT01077739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25607443|NCT01077739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25607444|NCT01077739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25607445|NCT01077739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25607446|NCT01077739|Growth Substances|growth substances|mesh-ancestor
25607447|NCT01077739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607448|NCT01077739|Growth Inhibitors|growth inhibitors|mesh-ancestor
25607449|NCT01077739|Antimetabolites|antimetabolites|mesh-ancestor
25607450|NCT01077739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607451|NCT01077739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25607452|NCT01077739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25607453|NCT01077739|Immunologic Factors|immunologic factors|mesh-ancestor
25607454|NCT01077739|Antidotes|antidotes|mesh-ancestor
25607455|NCT01077739|Protective Agents|protective agents|mesh-ancestor
25607456|NCT01077739|Vitamin B Complex|vitamin b complex|mesh-ancestor
25607457|NCT01077739|Vitamins|vitamins|mesh-ancestor
25607458|NCT01077739|Micronutrients|micronutrients|mesh-ancestor
25607459|NCT01077921|Propranolol|propranolol|mesh-list
25607460|NCT01077921|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25607461|NCT01077921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25607462|NCT01077921|Adrenergic Agents|adrenergic agents|mesh-ancestor
25607463|NCT01077921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25607464|NCT01077921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607465|NCT01077921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607466|NCT01077921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25607467|NCT01077921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25607468|NCT01077921|Vasodilator Agents|vasodilator agents|mesh-ancestor
25607469|NCT01077960|Hormones|hormones|mesh-list
25607470|NCT01077960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25607471|NCT01077960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607472|NCT01077973|Ibuprofen|ibuprofen|mesh-list
25607473|NCT01077973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25607474|NCT01077973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25607475|NCT01077973|Analgesics|analgesics|mesh-ancestor
25607476|NCT01077973|Sensory System Agents|sensory system agents|mesh-ancestor
25607477|NCT01077973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25607478|NCT01077973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607479|NCT01077973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25607480|NCT01077973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25607481|NCT01077973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25607482|NCT01077973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607483|NCT01077973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607484|NCT01078168|Acitretin|acitretin|mesh-list
25607485|NCT01078168|Keratolytic Agents|keratolytic agents|mesh-ancestor
25607486|NCT01078168|Dermatologic Agents|dermatologic agents|mesh-ancestor
25607487|NCT01078298|Varenicline|varenicline|mesh-list
25607488|NCT01078298|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25607489|NCT01078298|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25607490|NCT01078298|Cholinergic Agents|cholinergic agents|mesh-ancestor
25607491|NCT01078298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25607492|NCT01078298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607493|NCT01078298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607494|NCT01078363|Ramipril|ramipril|mesh-list
25607495|NCT01078363|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25607496|NCT01078363|Protease Inhibitors|protease inhibitors|mesh-ancestor
25607497|NCT01078363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25026357|NCT03629418|Respiratory System Agents|respiratory system agents|mesh-ancestor
25607498|NCT01078363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501901|NCT00330733|Analgesics|analgesics|mesh-ancestor
25607499|NCT01078363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25607500|NCT01078376|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25607501|NCT01078376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25607502|NCT01078376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25607503|NCT01078376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607504|NCT01078389|Febuxostat|febuxostat|mesh-list
25607505|NCT01078389|Gout Suppressants|gout suppressants|mesh-ancestor
25607506|NCT01078389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25607507|NCT01078441|Dexamethasone|dexamethasone|mesh-list
25607508|NCT01078441|Cyclophosphamide|cyclophosphamide|mesh-list
25607509|NCT01078441|Doxorubicin|doxorubicin|mesh-list
25607510|NCT01078441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25607511|NCT01078441|Bortezomib|bortezomib|mesh-list
25607512|NCT01078441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25607513|NCT01078441|Immunologic Factors|immunologic factors|mesh-ancestor
25607514|NCT01078441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607515|NCT01078441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25607516|NCT01078441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25607517|NCT01078441|Alkylating Agents|alkylating agents|mesh-ancestor
25607518|NCT01078441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607519|NCT01078441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25607520|NCT01078441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25607521|NCT01078441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25607522|NCT01078441|Antiemetics|antiemetics|mesh-ancestor
25607523|NCT01078441|Autonomic Agents|autonomic agents|mesh-ancestor
25607524|NCT01078441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25607525|NCT01078441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25607526|NCT01078441|Glucocorticoids|glucocorticoids|mesh-ancestor
25607527|NCT01078441|Hormones|hormones|mesh-ancestor
25029497|NCT03602430|Vitamin D|vitamin d|mesh-list
25607528|NCT01078441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25607529|NCT01078441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25607530|NCT01078441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25607531|NCT01078441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25607532|NCT01078441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25607533|NCT01078441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607534|NCT01078545|Leuprolide|leuprolide|mesh-list
25607535|NCT01078545|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25607536|NCT01078545|Fertility Agents|fertility agents|mesh-ancestor
25607537|NCT01078545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25607538|NCT01078545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607539|NCT01078545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25607540|NCT01078545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25607541|NCT01078571|Adalimumab|adalimumab|mesh-list
25607542|NCT01078571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25607543|NCT01078571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25607544|NCT01078623|Formoterol Fumarate|formoterol fumarate|mesh-list
25607545|NCT01078623|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25607546|NCT01078623|Autonomic Agents|autonomic agents|mesh-ancestor
25607547|NCT01078623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25607548|NCT01078623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607549|NCT01078623|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25607550|NCT01078623|Respiratory System Agents|respiratory system agents|mesh-ancestor
25607551|NCT01078623|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25607552|NCT01078623|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25607553|NCT01078623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25607554|NCT01078623|Adrenergic Agents|adrenergic agents|mesh-ancestor
25607555|NCT01078623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25607556|NCT01078623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607557|NCT01078675|Calcium, Dietary|calcium, dietary|mesh-list
25607558|NCT01078675|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25607559|NCT01078675|Calcium|calcium|mesh-list
25607560|NCT01078675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25607561|NCT01078675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607562|NCT01078675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25607563|NCT01078675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25607564|NCT01078675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25607565|NCT01078675|Antimetabolites|antimetabolites|mesh-ancestor
25607566|NCT01078675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607567|NCT01078675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25607568|NCT01078675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25607569|NCT01078675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25035726|NCT03553433|Analgesics|analgesics|mesh-ancestor
25770655|NCT03557333|Dihydroergotamine|dihydroergotamine|mesh-list
25607570|NCT01078753|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25607571|NCT01078753|Hemostatics|hemostatics|mesh-ancestor
25501976|NCT00331162|Alemtuzumab|alemtuzumab|mesh-list
25607572|NCT01078753|Coagulants|coagulants|mesh-ancestor
25607573|NCT01078753|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25607574|NCT01078753|Natriuretic Agents|natriuretic agents|mesh-ancestor
25607575|NCT01078753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607576|NCT01078805|Teriparatide|teriparatide|mesh-list
25036837|NCT03542825|Iron Chelating Agents|iron chelating agents|mesh-list
25607577|NCT01078805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25607578|NCT01078805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607579|NCT01078805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25607580|NCT01078922|Ofatumumab|ofatumumab|mesh-list
25607581|NCT01078922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25607582|NCT01078974|Dexamethasone|dexamethasone|mesh-list
25607583|NCT01078974|Rituximab|rituximab|mesh-list
24996402|NCT03566511|Diazoxide|diazoxide|mesh-list
25607584|NCT01078974|Pomalidomide|pomalidomide|mesh-list
24450427|NCT00319007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607585|NCT01078974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24608738|NCT00993343|Tacrolimus|tacrolimus|mesh-list
25607586|NCT01078974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25607587|NCT01078974|Immunologic Factors|immunologic factors|mesh-ancestor
25607588|NCT01078974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607589|NCT01078974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25607590|NCT01078974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25607591|NCT01078974|Antiemetics|antiemetics|mesh-ancestor
25607592|NCT01078974|Autonomic Agents|autonomic agents|mesh-ancestor
25607593|NCT01078974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25607594|NCT01078974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25607595|NCT01078974|Glucocorticoids|glucocorticoids|mesh-ancestor
25607596|NCT01078974|Hormones|hormones|mesh-ancestor
25607597|NCT01078974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25607598|NCT01078974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25607599|NCT01078974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25607600|NCT01078974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25607601|NCT01078974|Growth Substances|growth substances|mesh-ancestor
25607602|NCT01078974|Growth Inhibitors|growth inhibitors|mesh-ancestor
25607603|NCT01079130|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25607604|NCT01079130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25607605|NCT01079130|Autonomic Agents|autonomic agents|mesh-ancestor
25607606|NCT01079130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25607607|NCT01079130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607608|NCT01079130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25607609|NCT01079130|Respiratory System Agents|respiratory system agents|mesh-ancestor
25607610|NCT01079130|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25607611|NCT01079130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25607612|NCT01079130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25607613|NCT01079130|Adrenergic Agents|adrenergic agents|mesh-ancestor
25607614|NCT01079130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25607615|NCT01079130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607616|NCT01079143|Cyclosporine|cyclosporine|mesh-list
25607617|NCT01079143|Mycophenolic Acid|mycophenolic acid|mesh-list
25607618|NCT01079143|Everolimus|everolimus|mesh-list
25607619|NCT01079143|Cyclosporins|cyclosporins|mesh-list
25607620|NCT01079143|Basiliximab|basiliximab|mesh-list
25607621|NCT01079143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607622|NCT01079143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607623|NCT01079143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25607624|NCT01079143|Immunologic Factors|immunologic factors|mesh-ancestor
25607625|NCT01079143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607626|NCT01079143|Antifungal Agents|antifungal agents|mesh-ancestor
25607627|NCT01079143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24671787|NCT01327625|Azithromycin|azithromycin|mesh-list
25607628|NCT01079143|Dermatologic Agents|dermatologic agents|mesh-ancestor
25607629|NCT01079143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25607630|NCT01079143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25607631|NCT01079143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25607632|NCT01079143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25607633|NCT01079143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25607634|NCT01079143|Antitubercular Agents|antitubercular agents|mesh-ancestor
25607635|NCT01079143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25607636|NCT01079234|Insulin|insulin|mesh-list
25607637|NCT01079234|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25607638|NCT01079234|Insulin Glargine|insulin glargine|mesh-list
25607639|NCT01079234|Insulin Aspart|insulin aspart|mesh-list
25607640|NCT01079234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25607641|NCT01079234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607642|NCT01079663|Chlorhexidine|chlorhexidine|mesh-list
25607643|NCT01079663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25607644|NCT01079663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25607645|NCT01079663|Disinfectants|disinfectants|mesh-ancestor
25502042|NCT00331630|Paclitaxel|paclitaxel|mesh-list
25607646|NCT01079741|Poly I-C|poly i-c|mesh-list
25607647|NCT01079741|Mineral Oil|mineral oil|mesh-list
25654516|NCT01551888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25607648|NCT01079741|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25607649|NCT01079741|Poly ICLC|poly iclc|mesh-list
25607650|NCT01079741|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
24672362|NCT01331785|Midodrine|midodrine|mesh-list
25607651|NCT01079741|Freund's Adjuvant|freund's adjuvant|mesh-list
25607652|NCT01079741|Interferon Inducers|interferon inducers|mesh-ancestor
25607653|NCT01079741|Immunologic Factors|immunologic factors|mesh-ancestor
25710748|NCT02291289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25607654|NCT01079741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607655|NCT01079741|Laxatives|laxatives|mesh-ancestor
25607656|NCT01079741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25607657|NCT01079741|Antiviral Agents|antiviral agents|mesh-ancestor
25607658|NCT01079741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25607659|NCT01079741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25607660|NCT01079741|Emollients|emollients|mesh-ancestor
25607661|NCT01079741|Dermatologic Agents|dermatologic agents|mesh-ancestor
25607662|NCT01079806|Entecavir|entecavir|mesh-list
25607663|NCT01079806|Antiviral Agents|antiviral agents|mesh-ancestor
25607664|NCT01079806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25607665|NCT01079936|Lenalidomide|lenalidomide|mesh-list
25607666|NCT01079936|Melphalan|melphalan|mesh-list
25607667|NCT01079936|Immunologic Factors|immunologic factors|mesh-ancestor
25607668|NCT01079936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607669|NCT01079936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25607670|NCT01079936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25607671|NCT01079936|Growth Substances|growth substances|mesh-ancestor
25607672|NCT01079936|Growth Inhibitors|growth inhibitors|mesh-ancestor
25607673|NCT01079936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25607674|NCT01079936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25607675|NCT01079936|Alkylating Agents|alkylating agents|mesh-ancestor
25607676|NCT01079936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607677|NCT01079936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25607678|NCT01079936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25607679|NCT01079949|Cetrorelix|cetrorelix|mesh-list
25607680|NCT01079949|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25607681|NCT01079949|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24674979|NCT03685188|Dsuvia|dsuvia|mesh-list
25607682|NCT01079949|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25607683|NCT01079949|Fertility Agents|fertility agents|mesh-ancestor
25607684|NCT01079949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25607685|NCT01079949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607686|NCT01079949|Hormone Antagonists|hormone antagonists|mesh-ancestor
25607687|NCT01079949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25607688|NCT01079949|Hormones|hormones|mesh-ancestor
25607689|NCT01079962|Atenolol|atenolol|mesh-list
25607690|NCT01079962|Bisoprolol|bisoprolol|mesh-list
25607691|NCT01079962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25607692|NCT01079962|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25607693|NCT01079962|Sympatholytics|sympatholytics|mesh-ancestor
25607694|NCT01079962|Autonomic Agents|autonomic agents|mesh-ancestor
25607695|NCT01079962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25607696|NCT01079962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607697|NCT01079962|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25607698|NCT01079962|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25710786|NCT02291679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25710795|NCT02291913|Immunologic Factors|immunologic factors|mesh-ancestor
24679812|NCT01370889|Protective Agents|protective agents|mesh-ancestor
25777735|NCT03219372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607699|NCT01079962|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25607700|NCT01079962|Adrenergic Agents|adrenergic agents|mesh-ancestor
25607701|NCT01079962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24854711|NCT02274974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25607702|NCT01079962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607703|NCT01079988|Cyclosporine|cyclosporine|mesh-list
25607704|NCT01079988|Methotrexate|methotrexate|mesh-list
25607705|NCT01079988|Cyclosporins|cyclosporins|mesh-list
25607706|NCT01079988|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25607707|NCT01079988|Abortifacient Agents|abortifacient agents|mesh-ancestor
25607708|NCT01079988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24682567|NCT01386853|Atorvastatin|atorvastatin|mesh-list
25607709|NCT01079988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607710|NCT01079988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25607711|NCT01079988|Antimetabolites|antimetabolites|mesh-ancestor
25607712|NCT01079988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607713|NCT01079988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25607714|NCT01079988|Dermatologic Agents|dermatologic agents|mesh-ancestor
25607715|NCT01079988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607716|NCT01079988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25607717|NCT01079988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25607718|NCT01079988|Immunologic Factors|immunologic factors|mesh-ancestor
25607719|NCT01079988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25607720|NCT01079988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25607721|NCT01079988|Antifungal Agents|antifungal agents|mesh-ancestor
25607722|NCT01079988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25502111|NCT00332241|Dopamine Agents|dopamine agents|mesh-ancestor
25607723|NCT01079988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25607724|NCT01080131|Triamcinolone|triamcinolone|mesh-list
25607725|NCT01080131|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25607726|NCT01080131|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25607727|NCT01080131|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25607728|NCT01080131|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25607729|NCT01080131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25607730|NCT01080131|Glucocorticoids|glucocorticoids|mesh-ancestor
25607731|NCT01080131|Hormones|hormones|mesh-ancestor
25607732|NCT01080131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25607733|NCT01080131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607734|NCT01080131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25607735|NCT01080131|Immunologic Factors|immunologic factors|mesh-ancestor
25607736|NCT01080131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607737|NCT01080131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607738|NCT01080248|Gemcitabine|gemcitabine|mesh-list
25607739|NCT01080248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25607740|NCT01080248|Antimetabolites|antimetabolites|mesh-ancestor
24686113|NCT05051150|Racepinephrine|racepinephrine|mesh-list
25607741|NCT01080248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607742|NCT01080248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25607743|NCT01080248|Antiviral Agents|antiviral agents|mesh-ancestor
25607744|NCT01080248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25607745|NCT01080248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607746|NCT01080248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25607747|NCT01080248|Immunologic Factors|immunologic factors|mesh-ancestor
24688133|NCT03328676|Chlorophyllin|chlorophyllin|mesh-list
25607748|NCT01080248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607749|NCT01080300|Gabapentin|gabapentin|mesh-list
25607750|NCT01080300|Analgesics|analgesics|mesh-ancestor
25607751|NCT01080300|Sensory System Agents|sensory system agents|mesh-ancestor
25607752|NCT01080300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25607753|NCT01080300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607754|NCT01080300|Anticonvulsants|anticonvulsants|mesh-ancestor
25607755|NCT01080300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25607756|NCT01080300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25607757|NCT01080300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24613233|NCT01017796|Antidotes|antidotes|mesh-ancestor
25607758|NCT01080300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25607759|NCT01080300|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25607760|NCT01080300|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25607761|NCT01080300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25607762|NCT01080300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607763|NCT01080300|Antimanic Agents|antimanic agents|mesh-ancestor
25607764|NCT01080625|Phenylephrine|phenylephrine|mesh-list
25607765|NCT01080625|Epinephrine|epinephrine|mesh-list
25607766|NCT01080625|Oxymetazoline|oxymetazoline|mesh-list
25607767|NCT01080625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25607768|NCT01080625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25607769|NCT01080625|Adrenergic Agents|adrenergic agents|mesh-ancestor
25607770|NCT01080625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24635338|NCT01138553|Contraceptive Agents|contraceptive agents|mesh-ancestor
25607771|NCT01080625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607772|NCT01080625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607773|NCT01080625|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25607774|NCT01080625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25607775|NCT01080625|Autonomic Agents|autonomic agents|mesh-ancestor
25607776|NCT01080625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25607777|NCT01080625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25607778|NCT01080625|Respiratory System Agents|respiratory system agents|mesh-ancestor
25607779|NCT01080625|Mydriatics|mydriatics|mesh-ancestor
25607780|NCT01080625|Sympathomimetics|sympathomimetics|mesh-ancestor
25607781|NCT01080625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25607782|NCT01080625|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24637354|NCT01149967|Dexetimide|dexetimide|mesh-list
25607783|NCT01080625|Nasal Decongestants|nasal decongestants|mesh-ancestor
25607784|NCT01080625|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25607785|NCT01080625|Protective Agents|protective agents|mesh-ancestor
25607786|NCT01080677|Propranolol|propranolol|mesh-list
25607787|NCT01080677|Caffeine|caffeine|mesh-list
25607788|NCT01080677|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25607789|NCT01080677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607790|NCT01080677|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25607791|NCT01080677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607792|NCT01080677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607793|NCT01080677|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25607794|NCT01080677|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25607795|NCT01080677|Purinergic Agents|purinergic agents|mesh-ancestor
24638773|NCT01158014|Hemostatics|hemostatics|mesh-ancestor
25502174|NCT00332644|Dopamine Agents|dopamine agents|mesh-ancestor
25607796|NCT01080677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25607797|NCT01080677|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25607798|NCT01080677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25607799|NCT01080677|Adrenergic Agents|adrenergic agents|mesh-ancestor
25607800|NCT01080677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25607801|NCT01080677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25607802|NCT01080677|Vasodilator Agents|vasodilator agents|mesh-ancestor
25607803|NCT01080716|Vaccines|vaccines|mesh-list
25607804|NCT01080716|Complement Factor H|complement factor h|mesh-list
25607805|NCT01080716|Immunologic Factors|immunologic factors|mesh-ancestor
24855651|NCT02280525|Vidarabine|vidarabine|mesh-list
25607806|NCT01080716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607807|NCT01080716|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25607808|NCT01080716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25607809|NCT01080807|Modafinil|modafinil|mesh-list
25607810|NCT01080807|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25607811|NCT01080807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607812|NCT01080807|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25607813|NCT01080807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25607814|NCT01080807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25607815|NCT01080807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607816|NCT01081041|Cisplatin|cisplatin|mesh-list
25607817|NCT01081041|Carboplatin|carboplatin|mesh-list
25607818|NCT01081041|Fluorouracil|fluorouracil|mesh-list
25607819|NCT01081041|Cetuximab|cetuximab|mesh-list
25607820|NCT01081041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25607821|NCT01081041|Antimetabolites|antimetabolites|mesh-ancestor
25607822|NCT01081041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607823|NCT01081041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25607824|NCT01081041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25607825|NCT01081041|Immunologic Factors|immunologic factors|mesh-ancestor
25607826|NCT01081041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607827|NCT01081041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25607828|NCT01081132|Guanfacine|guanfacine|mesh-list
25607829|NCT01081132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25607830|NCT01081132|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25607831|NCT01081132|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25607832|NCT01081132|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25607833|NCT01081132|Adrenergic Agents|adrenergic agents|mesh-ancestor
25607834|NCT01081132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24855790|NCT02281006|Antitubercular Agents|antitubercular agents|mesh-ancestor
25607835|NCT01081132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607836|NCT01081132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607837|NCT01081145|Guanfacine|guanfacine|mesh-list
25607838|NCT01081145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25607839|NCT01081145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25607840|NCT01081145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25607841|NCT01081145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25607842|NCT01081145|Adrenergic Agents|adrenergic agents|mesh-ancestor
25607843|NCT01081145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25607844|NCT01081145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607845|NCT01081145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607846|NCT01081249|Oxytocin|oxytocin|mesh-list
25607847|NCT01081249|Oxytocics|oxytocics|mesh-ancestor
25607848|NCT01081249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25607849|NCT01081249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607850|NCT01081626|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25607851|NCT01081626|Hormones|hormones|mesh-ancestor
25607852|NCT01081626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25607853|NCT01081626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607854|NCT01081769|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25710874|NCT02292784|Hormone Antagonists|hormone antagonists|mesh-ancestor
24644019|NCT01188317|Ibuprofen|ibuprofen|mesh-list
25607855|NCT01081769|Antipsychotic Agents|antipsychotic agents|mesh-list
25607856|NCT01081769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24644461|NCT01191060|Bortezomib|bortezomib|mesh-list
25607857|NCT01081769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24645895|NCT01200641|Anticonvulsants|anticonvulsants|mesh-ancestor
25710880|NCT02293096|Dextromethorphan|dextromethorphan|mesh-list
25607858|NCT01081769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856318|NCT02283710|Antioxidants|antioxidants|mesh-ancestor
25607859|NCT01081769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25607860|NCT01081769|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25607861|NCT01081769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25607862|NCT01081769|Serotonin Agents|serotonin agents|mesh-ancestor
25607863|NCT01081769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25607864|NCT01081769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607865|NCT01081769|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25607866|NCT01081769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25607867|NCT01081769|Dopamine Agents|dopamine agents|mesh-ancestor
25607868|NCT01081795|Topiramate|topiramate|mesh-list
25607869|NCT01081795|Anticonvulsants|anticonvulsants|mesh-ancestor
25502243|NCT00333177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25607870|NCT01081795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25607871|NCT01081795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607872|NCT01081834|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25607873|NCT01081834|Canagliflozin|canagliflozin|mesh-list
25607874|NCT01081834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25607875|NCT01081834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607876|NCT01081834|Incretins|incretins|mesh-ancestor
25607877|NCT01081834|Hormones|hormones|mesh-ancestor
25607878|NCT01081834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25607879|NCT01081834|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25607880|NCT01081834|Protease Inhibitors|protease inhibitors|mesh-ancestor
25607881|NCT01081834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607882|NCT01081834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607883|NCT01081834|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25607884|NCT01081873|Leuprolide|leuprolide|mesh-list
25607885|NCT01081873|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25607886|NCT01081873|Fertility Agents|fertility agents|mesh-ancestor
25607887|NCT01081873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25607888|NCT01081873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607889|NCT01081873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25607890|NCT01081873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25607891|NCT01081912|Hydrocodone|hydrocodone|mesh-list
25607892|NCT01081912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25607893|NCT01081912|Narcotics|narcotics|mesh-ancestor
24459380|NCT00344526|Dexamethasone|dexamethasone|mesh-list
25607894|NCT01081912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25607895|NCT01081912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607896|NCT01081912|Analgesics|analgesics|mesh-ancestor
25607897|NCT01081912|Sensory System Agents|sensory system agents|mesh-ancestor
25607898|NCT01081912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25607899|NCT01081912|Antitussive Agents|antitussive agents|mesh-ancestor
25607900|NCT01081912|Respiratory System Agents|respiratory system agents|mesh-ancestor
25607901|NCT01082081|Acetaminophen|acetaminophen|mesh-list
25607902|NCT01082081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24856995|NCT02288338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607903|NCT01082081|Analgesics|analgesics|mesh-ancestor
25607904|NCT01082081|Sensory System Agents|sensory system agents|mesh-ancestor
25607905|NCT01082081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25607906|NCT01082081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607907|NCT01082081|Antipyretics|antipyretics|mesh-ancestor
25607908|NCT01082380|Crizotinib|crizotinib|mesh-list
25607909|NCT01082380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25607910|NCT01082380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25607911|NCT01082380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648793|NCT01216852|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24648795|NCT01216878|Losartan|losartan|mesh-list
25607912|NCT01082380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607913|NCT01082588|Pravastatin|pravastatin|mesh-list
25607914|NCT01082588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25607915|NCT01082588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25607916|NCT01082588|Antimetabolites|antimetabolites|mesh-ancestor
25607917|NCT01082588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607918|NCT01082588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25607919|NCT01082588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25607920|NCT01082588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607921|NCT01082640|Febuxostat|febuxostat|mesh-list
25607922|NCT01082640|Gout Suppressants|gout suppressants|mesh-ancestor
25607923|NCT01082640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25607924|NCT01082874|Aspirin|aspirin|mesh-list
25607925|NCT01082874|Clonidine|clonidine|mesh-list
25607926|NCT01082874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25607927|NCT01082874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25607928|NCT01082874|Analgesics|analgesics|mesh-ancestor
25607929|NCT01082874|Sensory System Agents|sensory system agents|mesh-ancestor
25607930|NCT01082874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25607931|NCT01082874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607932|NCT01082874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25607933|NCT01082874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25607934|NCT01082874|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25607935|NCT01082874|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25607936|NCT01082874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607937|NCT01082874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25607938|NCT01082874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25607939|NCT01082874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607940|NCT01082874|Antipyretics|antipyretics|mesh-ancestor
25607941|NCT01082874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25607942|NCT01082874|Sympatholytics|sympatholytics|mesh-ancestor
25607943|NCT01082874|Autonomic Agents|autonomic agents|mesh-ancestor
25607944|NCT01082874|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25607945|NCT01082874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24649865|NCT01222221|Sargramostim|sargramostim|mesh-list
25607946|NCT01082874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25607947|NCT01082874|Adrenergic Agents|adrenergic agents|mesh-ancestor
25607948|NCT01082874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25607949|NCT01082939|Vidarabine|vidarabine|mesh-list
25607950|NCT01082939|Cyclophosphamide|cyclophosphamide|mesh-list
25607951|NCT01082939|Rituximab|rituximab|mesh-list
25607952|NCT01082939|Fludarabine|fludarabine|mesh-list
25607953|NCT01082939|Fludarabine phosphate|fludarabine phosphate|mesh-list
25607954|NCT01082939|Alemtuzumab|alemtuzumab|mesh-list
25607955|NCT01082939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25607956|NCT01082939|Immunologic Factors|immunologic factors|mesh-ancestor
25607957|NCT01082939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607958|NCT01082939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25607959|NCT01082939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25607960|NCT01082939|Alkylating Agents|alkylating agents|mesh-ancestor
24650355|NCT01225341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24650356|NCT01225341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650428|NCT01225744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24650656|NCT01227200|Analgesics|analgesics|mesh-ancestor
24650657|NCT01227200|Sensory System Agents|sensory system agents|mesh-ancestor
24650658|NCT01227200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24650659|NCT01227226|Lubricant Eye Drops|lubricant eye drops|mesh-list
24650660|NCT01227226|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25607961|NCT01082939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607962|NCT01082939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25607963|NCT01082939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25607964|NCT01082939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25607965|NCT01082939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25607966|NCT01082939|Antimetabolites|antimetabolites|mesh-ancestor
25607967|NCT01082939|Antiviral Agents|antiviral agents|mesh-ancestor
25607968|NCT01082939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25607969|NCT01082965|Donepezil|donepezil|mesh-list
25607970|NCT01082965|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25607971|NCT01082965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25607972|NCT01082965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25607973|NCT01082965|Cholinergic Agents|cholinergic agents|mesh-ancestor
25607974|NCT01082965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25607975|NCT01082965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607976|NCT01082965|Nootropic Agents|nootropic agents|mesh-ancestor
25607977|NCT01083316|Dexamethasone|dexamethasone|mesh-list
25607978|NCT01083316|Bortezomib|bortezomib|mesh-list
25607979|NCT01083316|Melphalan|melphalan|mesh-list
25607980|NCT01083316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25607981|NCT01083316|Antiemetics|antiemetics|mesh-ancestor
25607982|NCT01083316|Autonomic Agents|autonomic agents|mesh-ancestor
25607983|NCT01083316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24651903|NCT01234454|Dopamine Agents|dopamine agents|mesh-ancestor
25607984|NCT01083316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607985|NCT01083316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25607986|NCT01083316|Glucocorticoids|glucocorticoids|mesh-ancestor
25607987|NCT01083316|Hormones|hormones|mesh-ancestor
24652777|NCT01240096|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25607988|NCT01083316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25607989|NCT01083316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25607990|NCT01083316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25607991|NCT01083316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25607992|NCT01083316|Alkylating Agents|alkylating agents|mesh-ancestor
25607993|NCT01083316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654390|NCT01249352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654391|NCT01249352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24813045|NCT02056223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24813046|NCT02056223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25607994|NCT01083316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25607995|NCT01083316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25607996|NCT01083316|Immunologic Factors|immunologic factors|mesh-ancestor
25654517|NCT01551888|Adrenergic Agents|adrenergic agents|mesh-ancestor
25654518|NCT01551888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25654519|NCT01551888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654520|NCT01552057|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25654521|NCT01552057|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25654522|NCT01552057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24657576|NCT01268371|Immunologic Factors|immunologic factors|mesh-ancestor
25654523|NCT01552057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25654524|NCT01552057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654525|NCT01552057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25654526|NCT01552057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654527|NCT01552057|Analgesics|analgesics|mesh-ancestor
25654528|NCT01552057|Sensory System Agents|sensory system agents|mesh-ancestor
25654529|NCT01552057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25654530|NCT01552057|Antidepressive Agents|antidepressive agents|mesh-ancestor
25654531|NCT01552057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25654532|NCT01552057|Dopamine Agents|dopamine agents|mesh-ancestor
25654533|NCT01552343|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25654534|NCT01552343|Hemostatics|hemostatics|mesh-ancestor
25654535|NCT01552343|Coagulants|coagulants|mesh-ancestor
24659724|NCT01279499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654536|NCT01552343|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25654537|NCT01552343|Natriuretic Agents|natriuretic agents|mesh-ancestor
25654538|NCT01552343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654539|NCT01552369|Valganciclovir|valganciclovir|mesh-list
25607997|NCT01083368|Sirolimus|sirolimus|mesh-list
25607998|NCT01083368|Bevacizumab|bevacizumab|mesh-list
25607999|NCT01083368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25608000|NCT01083368|Antibodies|antibodies|mesh-list
25608001|NCT01083368|Immunoglobulins|immunoglobulins|mesh-list
25608002|NCT01083368|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24662229|NCT01293630|Paclitaxel|paclitaxel|mesh-list
25710937|NCT02293902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25710938|NCT02293902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608003|NCT01083368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608004|NCT01083368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25608005|NCT01083368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25608006|NCT01083368|Growth Substances|growth substances|mesh-ancestor
25608007|NCT01083368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608008|NCT01083368|Growth Inhibitors|growth inhibitors|mesh-ancestor
25608009|NCT01083368|Immunologic Factors|immunologic factors|mesh-ancestor
25608010|NCT01083368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25608011|NCT01083368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25608012|NCT01083368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25608013|NCT01083368|Antifungal Agents|antifungal agents|mesh-ancestor
25608014|NCT01083368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25608015|NCT01083485|Oxycodone|oxycodone|mesh-list
25608016|NCT01083485|Naloxone|naloxone|mesh-list
25608017|NCT01083485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25608018|NCT01083485|Narcotics|narcotics|mesh-ancestor
25608019|NCT01083485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25608020|NCT01083485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608021|NCT01083485|Analgesics|analgesics|mesh-ancestor
25608022|NCT01083485|Sensory System Agents|sensory system agents|mesh-ancestor
25608023|NCT01083485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25608024|NCT01083485|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25608025|NCT01083576|Gentamicins|gentamicins|mesh-list
25608026|NCT01083576|Paromomycin|paromomycin|mesh-list
25608027|NCT01083576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24666401|NCT01319019|Adrenergic Agents|adrenergic agents|mesh-ancestor
24666402|NCT01319019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24666404|NCT01319188|Ranibizumab|ranibizumab|mesh-list
25608028|NCT01083576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25608029|NCT01083576|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25608030|NCT01083576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608031|NCT01083576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608032|NCT01083576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25608033|NCT01083576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25608034|NCT01083602|Dexamethasone|dexamethasone|mesh-list
25608035|NCT01083602|Bortezomib|bortezomib|mesh-list
25608036|NCT01083602|Panobinostat|panobinostat|mesh-list
25608037|NCT01083602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25608038|NCT01083602|Antiemetics|antiemetics|mesh-ancestor
25608039|NCT01083602|Autonomic Agents|autonomic agents|mesh-ancestor
25608040|NCT01083602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25608041|NCT01083602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608042|NCT01083602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25608043|NCT01083602|Glucocorticoids|glucocorticoids|mesh-ancestor
25608044|NCT01083602|Hormones|hormones|mesh-ancestor
25608045|NCT01083602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25608046|NCT01083602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25608047|NCT01083602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608048|NCT01083602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25608049|NCT01083602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608050|NCT01083602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608051|NCT01083641|Estradiol|estradiol|mesh-list
25608052|NCT01083641|Estrogens|estrogens|mesh-ancestor
25608053|NCT01083641|Hormones|hormones|mesh-ancestor
25608054|NCT01083641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25608055|NCT01083641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608056|NCT01083667|Pyrimethamine|pyrimethamine|mesh-list
25608057|NCT01083667|Antimalarials|antimalarials|mesh-ancestor
25608058|NCT01083667|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25608059|NCT01083667|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25608060|NCT01083667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25608061|NCT01083667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25608062|NCT01083667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608063|NCT01083667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608064|NCT01083706|Azacitidine|azacitidine|mesh-list
25608065|NCT01083706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25608066|NCT01083706|Antimetabolites|antimetabolites|mesh-ancestor
25608067|NCT01083706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608068|NCT01083706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608069|NCT01083706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608070|NCT01083732|Dabigatran|dabigatran|mesh-list
24533512|NCT00644293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25608071|NCT01083732|Antithrombins|antithrombins|mesh-ancestor
25608072|NCT01083732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25608073|NCT01083732|Protease Inhibitors|protease inhibitors|mesh-ancestor
25608074|NCT01083732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608075|NCT01083732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608076|NCT01083732|Anticoagulants|anticoagulants|mesh-ancestor
25608077|NCT01083810|Ritonavir|ritonavir|mesh-list
25608078|NCT01083810|Lopinavir|lopinavir|mesh-list
25608079|NCT01083810|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25608080|NCT01083810|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25608081|NCT01083810|Protease Inhibitors|protease inhibitors|mesh-ancestor
25608082|NCT01083810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608083|NCT01083810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608084|NCT01083810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25608085|NCT01083810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25608086|NCT01083810|Antiviral Agents|antiviral agents|mesh-ancestor
25608087|NCT01083810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25608088|NCT01083810|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25608089|NCT01083810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25608090|NCT01084005|Linagliptin|linagliptin|mesh-list
25608091|NCT01084005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25608092|NCT01084005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608093|NCT01084005|Incretins|incretins|mesh-ancestor
25608094|NCT01084005|Hormones|hormones|mesh-ancestor
25608095|NCT01084005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25608096|NCT01084005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25608097|NCT01084005|Protease Inhibitors|protease inhibitors|mesh-ancestor
25608098|NCT01084005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608099|NCT01084005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608100|NCT01084083|Paclitaxel|paclitaxel|mesh-list
25608101|NCT01084083|Cisplatin|cisplatin|mesh-list
25608102|NCT01084083|Cetuximab|cetuximab|mesh-list
25608103|NCT01084083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25608104|NCT01084083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608105|NCT01084083|Tubulin Modulators|tubulin modulators|mesh-ancestor
25608106|NCT01084083|Antimitotic Agents|antimitotic agents|mesh-ancestor
25608107|NCT01084083|Mitosis Modulators|mitosis modulators|mesh-ancestor
25608108|NCT01084083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608109|NCT01084083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25608110|NCT01084135|Rivastigmine|rivastigmine|mesh-list
25608111|NCT01084135|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25608112|NCT01084135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608113|NCT01084135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608114|NCT01084135|Cholinergic Agents|cholinergic agents|mesh-ancestor
25608115|NCT01084135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25608116|NCT01084135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608117|NCT01084135|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25608118|NCT01084135|Protective Agents|protective agents|mesh-ancestor
25608119|NCT01084148|V0034CR|v0034cr|mesh-list
25608120|NCT01084148|Emollients|emollients|mesh-ancestor
25608121|NCT01084148|Dermatologic Agents|dermatologic agents|mesh-ancestor
25608122|NCT01084265|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25608123|NCT01084265|Hormones|hormones|mesh-list
25608124|NCT01084265|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25608125|NCT01084265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25608126|NCT01084265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608127|NCT01084265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25608128|NCT01084278|Colchicine|colchicine|mesh-list
25608129|NCT01084278|Gout Suppressants|gout suppressants|mesh-ancestor
25608130|NCT01084278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25608131|NCT01084278|Tubulin Modulators|tubulin modulators|mesh-ancestor
25608132|NCT01084278|Antimitotic Agents|antimitotic agents|mesh-ancestor
25608133|NCT01084278|Mitosis Modulators|mitosis modulators|mesh-ancestor
25710964|NCT02294019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25608134|NCT01084278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608135|NCT01084278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608136|NCT01084499|Letrozole|letrozole|mesh-list
25608137|NCT01084499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608138|NCT01084499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25608139|NCT01084499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25608140|NCT01084499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608141|NCT01084499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608142|NCT01084499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25608143|NCT01084499|Hormone Antagonists|hormone antagonists|mesh-ancestor
25608144|NCT01084499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25608145|NCT01084499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608146|NCT01084538|Ergocalciferols|ergocalciferols|mesh-list
25608147|NCT01084538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25608148|NCT01084538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608149|NCT01084538|Vitamins|vitamins|mesh-ancestor
25608150|NCT01084538|Micronutrients|micronutrients|mesh-ancestor
25608151|NCT01084538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25608152|NCT01084603|Nicotine|nicotine|mesh-list
25608153|NCT01084603|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25608154|NCT01084603|Autonomic Agents|autonomic agents|mesh-ancestor
25608155|NCT01084603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25608156|NCT01084603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608157|NCT01084603|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25608158|NCT01084603|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25608159|NCT01084603|Cholinergic Agents|cholinergic agents|mesh-ancestor
25608160|NCT01084603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25608161|NCT01084603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608162|NCT01084655|Prednisone|prednisone|mesh-list
25608163|NCT01084655|Docetaxel|docetaxel|mesh-list
25608164|NCT01084655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608165|NCT01084655|Tubulin Modulators|tubulin modulators|mesh-ancestor
25608166|NCT01084655|Antimitotic Agents|antimitotic agents|mesh-ancestor
25608167|NCT01084655|Mitosis Modulators|mitosis modulators|mesh-ancestor
25608168|NCT01084655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608169|NCT01084655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25608170|NCT01084655|Glucocorticoids|glucocorticoids|mesh-ancestor
25608171|NCT01084655|Hormones|hormones|mesh-ancestor
25608172|NCT01084655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25608173|NCT01084655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608174|NCT01084655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25608175|NCT01084707|Nicotine|nicotine|mesh-list
25608176|NCT01084707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25608177|NCT01084707|Autonomic Agents|autonomic agents|mesh-ancestor
25608178|NCT01084707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25608179|NCT01084707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608180|NCT01084707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25608181|NCT01084707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25608182|NCT01084707|Cholinergic Agents|cholinergic agents|mesh-ancestor
25608183|NCT01084707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25608184|NCT01084707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608185|NCT01084759|Etoposide|etoposide|mesh-list
25608186|NCT01084759|Methyltestosterone|methyltestosterone|mesh-list
25608187|NCT01084759|Testosterone|testosterone|mesh-list
25608188|NCT01084759|Testosterone undecanoate|testosterone undecanoate|mesh-list
25608189|NCT01084759|Testosterone enanthate|testosterone enanthate|mesh-list
25608190|NCT01084759|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25608191|NCT01084759|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25608192|NCT01084759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608193|NCT01084759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25608194|NCT01084759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25608195|NCT01084759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608196|NCT01084759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608197|NCT01084759|Androgens|androgens|mesh-ancestor
25608198|NCT01084759|Hormones|hormones|mesh-ancestor
25608199|NCT01084759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25608200|NCT01084759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608201|NCT01084759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25608202|NCT01084759|Anabolic Agents|anabolic agents|mesh-ancestor
25608203|NCT01085006|Tranexamic Acid|tranexamic acid|mesh-list
25608204|NCT01085006|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25608205|NCT01085006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25608206|NCT01085006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608207|NCT01085006|Hemostatics|hemostatics|mesh-ancestor
25608208|NCT01085006|Coagulants|coagulants|mesh-ancestor
25608209|NCT01085045|Bromides|bromides|mesh-list
25608210|NCT01085045|Formoterol Fumarate|formoterol fumarate|mesh-list
25608211|NCT01085045|Tiotropium Bromide|tiotropium bromide|mesh-list
25608212|NCT01085045|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25608213|NCT01085045|Autonomic Agents|autonomic agents|mesh-ancestor
25608214|NCT01085045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25608215|NCT01085045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608216|NCT01085045|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25608217|NCT01085045|Respiratory System Agents|respiratory system agents|mesh-ancestor
25608218|NCT01085045|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25608219|NCT01085045|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25608220|NCT01085045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25608221|NCT01085045|Adrenergic Agents|adrenergic agents|mesh-ancestor
25502610|NCT00335972|Analgesics|analgesics|mesh-ancestor
25608222|NCT01085045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25608223|NCT01085045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608224|NCT01085045|Parasympatholytics|parasympatholytics|mesh-ancestor
25608225|NCT01085045|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25608226|NCT01085045|Cholinergic Agents|cholinergic agents|mesh-ancestor
25608227|NCT01085045|Anticonvulsants|anticonvulsants|mesh-ancestor
25608228|NCT01085136|Afatinib|afatinib|mesh-list
25608229|NCT01085136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608230|NCT01085136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25608231|NCT01085136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608232|NCT01085136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608233|NCT01085201|Regadenoson|regadenoson|mesh-list
25608234|NCT01085201|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25608235|NCT01085201|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25608236|NCT01085201|Purinergic Agonists|purinergic agonists|mesh-ancestor
25608237|NCT01085201|Purinergic Agents|purinergic agents|mesh-ancestor
25608238|NCT01085201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25608239|NCT01085201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608240|NCT01085201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608241|NCT01085344|Factor VIII|factor viii|mesh-list
25608242|NCT01085344|Coagulants|coagulants|mesh-ancestor
25608243|NCT01085591|Vancomycin|vancomycin|mesh-list
25608244|NCT01085591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25608245|NCT01085591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25608246|NCT01085630|Pemetrexed|pemetrexed|mesh-list
25608247|NCT01085630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710985|NCT02294253|Narcotics|narcotics|mesh-ancestor
25608248|NCT01085630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431506|NCT00251940|Glyburide|glyburide|mesh-list
25608249|NCT01085630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608250|NCT01085630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25608251|NCT01085630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25608252|NCT01085734|Bevacizumab|bevacizumab|mesh-list
25608253|NCT01085734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25608254|NCT01085734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608255|NCT01085734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25608256|NCT01085734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25608257|NCT01085734|Growth Substances|growth substances|mesh-ancestor
25608258|NCT01085734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608259|NCT01085734|Growth Inhibitors|growth inhibitors|mesh-ancestor
25608260|NCT01085760|Metronidazole|metronidazole|mesh-list
25608261|NCT01085760|Vancomycin|vancomycin|mesh-list
25608262|NCT01085760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25608263|NCT01085760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25608264|NCT01085760|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25502678|NCT00336583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25502679|NCT00336583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25502680|NCT00336583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25502681|NCT00336583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502682|NCT00336583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502683|NCT00336583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25502684|NCT00336583|Antimetabolites|antimetabolites|mesh-ancestor
25502685|NCT00336583|Antiviral Agents|antiviral agents|mesh-ancestor
25502686|NCT00336583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25502687|NCT00336583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25502688|NCT00336583|Immunologic Factors|immunologic factors|mesh-ancestor
25502689|NCT00336583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502690|NCT00336583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25502691|NCT00336583|Antiemetics|antiemetics|mesh-ancestor
25502696|NCT00336583|Hormones|hormones|mesh-ancestor
25608265|NCT01085760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25608266|NCT01085786|Amoxicillin|amoxicillin|mesh-list
25608267|NCT01085786|Metronidazole|metronidazole|mesh-list
25608268|NCT01085786|Clarithromycin|clarithromycin|mesh-list
25608269|NCT01085786|Esomeprazole|esomeprazole|mesh-list
25608270|NCT01085786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25608271|NCT01085786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25608272|NCT01085786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25608273|NCT01085786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25608274|NCT01085786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25608275|NCT01085786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25608276|NCT01085786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25608277|NCT01085786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608278|NCT01085786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608279|NCT01085786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25608280|NCT01085786|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25608281|NCT01085786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25608282|NCT01085812|Milnacipran|milnacipran|mesh-list
25608283|NCT01085812|Levomilnacipran|levomilnacipran|mesh-list
25608284|NCT01085812|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25608285|NCT01085812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25608286|NCT01085812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25608287|NCT01085812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608288|NCT01085812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25608289|NCT01085812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608290|NCT01085812|Antidepressive Agents|antidepressive agents|mesh-ancestor
25608291|NCT01085812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25608292|NCT01085812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25608293|NCT01085812|Analgesics|analgesics|mesh-ancestor
25608294|NCT01085812|Sensory System Agents|sensory system agents|mesh-ancestor
25608295|NCT01085812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25608296|NCT01085903|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25608297|NCT01085903|Modafinil|modafinil|mesh-list
25608298|NCT01085903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25608299|NCT01085903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608300|NCT01085903|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25608301|NCT01085903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25608302|NCT01085903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25608303|NCT01085903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608304|NCT01086150|Lidocaine|lidocaine|mesh-list
25608305|NCT01086150|Anesthetics, Local|anesthetics, local|mesh-ancestor
25608306|NCT01086150|Anesthetics|anesthetics|mesh-ancestor
25608307|NCT01086150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25608308|NCT01086150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608309|NCT01086150|Sensory System Agents|sensory system agents|mesh-ancestor
25608310|NCT01086150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25608311|NCT01086150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25608312|NCT01086150|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25608313|NCT01086150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25608314|NCT01086150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25608315|NCT01086150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608316|NCT01086358|Naproxen|naproxen|mesh-list
25608317|NCT01086358|Sumatriptan|sumatriptan|mesh-list
25608318|NCT01086358|Naratriptan|naratriptan|mesh-list
25608319|NCT01086358|Zolmitriptan|zolmitriptan|mesh-list
25608320|NCT01086358|Rizatriptan|rizatriptan|mesh-list
25608321|NCT01086358|Eletriptan|eletriptan|mesh-list
25608322|NCT01086358|Almotriptan|almotriptan|mesh-list
25608323|NCT01086358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25608324|NCT01086358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25608325|NCT01086358|Analgesics|analgesics|mesh-ancestor
25608326|NCT01086358|Sensory System Agents|sensory system agents|mesh-ancestor
25608327|NCT01086358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25608328|NCT01086358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608329|NCT01086358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25608330|NCT01086358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25608331|NCT01086358|Gout Suppressants|gout suppressants|mesh-ancestor
25608332|NCT01086358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25608333|NCT01086358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608334|NCT01086358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608335|NCT01086358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25608336|NCT01086358|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25608337|NCT01086358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25608338|NCT01086358|Serotonin Agents|serotonin agents|mesh-ancestor
25608339|NCT01086358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25608340|NCT01086384|Fluticasone|fluticasone|mesh-list
25608341|NCT01086384|Xhance|xhance|mesh-list
25608342|NCT01086384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25608343|NCT01086384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25608344|NCT01086384|Autonomic Agents|autonomic agents|mesh-ancestor
25608345|NCT01086384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25608346|NCT01086384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608347|NCT01086384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25608348|NCT01086384|Respiratory System Agents|respiratory system agents|mesh-ancestor
25608349|NCT01086384|Dermatologic Agents|dermatologic agents|mesh-ancestor
25608350|NCT01086384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25608351|NCT01086410|Fluticasone|fluticasone|mesh-list
25608352|NCT01086410|Xhance|xhance|mesh-list
25608353|NCT01086410|Prednisolone|prednisolone|mesh-list
25608354|NCT01086410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25608355|NCT01086410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25608356|NCT01086410|Autonomic Agents|autonomic agents|mesh-ancestor
25608357|NCT01086410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25608358|NCT01086410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608359|NCT01086410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25608360|NCT01086410|Respiratory System Agents|respiratory system agents|mesh-ancestor
25608361|NCT01086410|Dermatologic Agents|dermatologic agents|mesh-ancestor
25608362|NCT01086410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25608363|NCT01086410|Glucocorticoids|glucocorticoids|mesh-ancestor
25608364|NCT01086410|Hormones|hormones|mesh-ancestor
25608365|NCT01086410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25608366|NCT01086410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25608367|NCT01086410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608368|NCT01086475|Cycloserine|cycloserine|mesh-list
25608369|NCT01086475|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25608370|NCT01086475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25608371|NCT01086475|Renal Agents|renal agents|mesh-ancestor
25608372|NCT01086475|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25608373|NCT01086475|Antitubercular Agents|antitubercular agents|mesh-ancestor
25608374|NCT01086475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25608375|NCT01086475|Antimetabolites|antimetabolites|mesh-ancestor
25608376|NCT01086475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608377|NCT01086540|Acetaminophen|acetaminophen|mesh-list
25608378|NCT01086540|Diphenhydramine|diphenhydramine|mesh-list
25608379|NCT01086540|Promethazine|promethazine|mesh-list
25608380|NCT01086540|Prednisone|prednisone|mesh-list
25608381|NCT01086540|Methylprednisolone|methylprednisolone|mesh-list
25608382|NCT01086540|Rituximab|rituximab|mesh-list
25608383|NCT01086540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25608384|NCT01086540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608385|NCT01086540|Immunologic Factors|immunologic factors|mesh-ancestor
25608386|NCT01086540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608387|NCT01086540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25608388|NCT01086540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25608389|NCT01086540|Glucocorticoids|glucocorticoids|mesh-ancestor
25608390|NCT01086540|Hormones|hormones|mesh-ancestor
25608391|NCT01086540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25608392|NCT01086540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25608393|NCT01086540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25608394|NCT01086540|Analgesics|analgesics|mesh-ancestor
25608395|NCT01086540|Sensory System Agents|sensory system agents|mesh-ancestor
25608396|NCT01086540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25608397|NCT01086540|Antipyretics|antipyretics|mesh-ancestor
25608398|NCT01086540|Antiemetics|antiemetics|mesh-ancestor
25608399|NCT01086540|Autonomic Agents|autonomic agents|mesh-ancestor
25608400|NCT01086540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25608401|NCT01086540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25608402|NCT01086540|Protective Agents|protective agents|mesh-ancestor
25608403|NCT01086540|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25608404|NCT01086540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25608405|NCT01086540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25608406|NCT01086540|Anesthetics, Local|anesthetics, local|mesh-ancestor
25608407|NCT01086540|Anesthetics|anesthetics|mesh-ancestor
25608408|NCT01086540|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25608409|NCT01086540|Histamine Antagonists|histamine antagonists|mesh-ancestor
25608410|NCT01086540|Histamine Agents|histamine agents|mesh-ancestor
25608411|NCT01086540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25608412|NCT01086540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608413|NCT01086540|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25608414|NCT01086540|Antipruritics|antipruritics|mesh-ancestor
25608415|NCT01086540|Dermatologic Agents|dermatologic agents|mesh-ancestor
25608416|NCT01086605|Pixantrone|pixantrone|mesh-list
25608417|NCT01086605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25608418|NCT01086605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25608419|NCT01086605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608420|NCT01086605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608421|NCT01086605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608422|NCT01087489|Lidocaine|lidocaine|mesh-list
25608423|NCT01087489|Anesthetics, Local|anesthetics, local|mesh-ancestor
25608424|NCT01087489|Anesthetics|anesthetics|mesh-ancestor
24825637|NCT02129322|Oxaliplatin|oxaliplatin|mesh-list
24825638|NCT02129322|Sorafenib|sorafenib|mesh-list
25608425|NCT01087489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25608426|NCT01087489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608427|NCT01087489|Sensory System Agents|sensory system agents|mesh-ancestor
25608428|NCT01087489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25608429|NCT01087489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25608430|NCT01087489|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25608431|NCT01087489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25654540|NCT01552369|Antiviral Agents|antiviral agents|mesh-ancestor
25608432|NCT01087489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25608433|NCT01087489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608434|NCT01087502|Glimepiride|glimepiride|mesh-list
25608435|NCT01087502|Linagliptin|linagliptin|mesh-list
25608436|NCT01087502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25608437|NCT01087502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25608438|NCT01087502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608439|NCT01087502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25608440|NCT01087502|Immunologic Factors|immunologic factors|mesh-ancestor
25608441|NCT01087502|Incretins|incretins|mesh-ancestor
25608442|NCT01087502|Hormones|hormones|mesh-ancestor
25608443|NCT01087502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25711060|NCT02295280|Promethazine|promethazine|mesh-list
24438632|NCT00276575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24438633|NCT00276575|Growth Substances|growth substances|mesh-ancestor
24438634|NCT00276575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438661|NCT00276601|Daunorubicin|daunorubicin|mesh-list
25608444|NCT01087502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25608445|NCT01087502|Protease Inhibitors|protease inhibitors|mesh-ancestor
25608446|NCT01087502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608447|NCT01087502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608448|NCT01087723|Heparin|heparin|mesh-list
25608449|NCT01087723|Bivalirudin|bivalirudin|mesh-list
25608450|NCT01087723|Anticoagulants|anticoagulants|mesh-ancestor
25608451|NCT01087723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25608452|NCT01087723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25608453|NCT01087723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608454|NCT01087723|Antithrombins|antithrombins|mesh-ancestor
25608455|NCT01087723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25608456|NCT01087723|Protease Inhibitors|protease inhibitors|mesh-ancestor
25608457|NCT01087723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608458|NCT01087736|Topiramate|topiramate|mesh-list
25608459|NCT01087736|Anticonvulsants|anticonvulsants|mesh-ancestor
25608460|NCT01087736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25608461|NCT01087736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439324|NCT00278278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24439325|NCT00278278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24439372|NCT00278408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608462|NCT01087762|Certolizumab Pegol|certolizumab pegol|mesh-list
25608463|NCT01087762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25608464|NCT01087762|Immunologic Factors|immunologic factors|mesh-ancestor
25608465|NCT01087762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608466|NCT01087762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25608467|NCT01087788|Certolizumab Pegol|certolizumab pegol|mesh-list
25608468|NCT01087788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25608469|NCT01087788|Immunologic Factors|immunologic factors|mesh-ancestor
25608470|NCT01087788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608471|NCT01087788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25608472|NCT01087814|Efavirenz|efavirenz|mesh-list
25608473|NCT01087814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25711078|NCT02295280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440393|NCT00282932|Cholinergic Agents|cholinergic agents|mesh-ancestor
25608474|NCT01087814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25608475|NCT01087814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608476|NCT01087814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608477|NCT01087814|Antiviral Agents|antiviral agents|mesh-ancestor
25608478|NCT01087814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25608479|NCT01087814|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25608480|NCT01087814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25608481|NCT01087814|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25608482|NCT01087814|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25608483|NCT01087814|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25608484|NCT01087814|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25608485|NCT01087905|Nicotine|nicotine|mesh-list
25608486|NCT01087905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25608487|NCT01087905|Autonomic Agents|autonomic agents|mesh-ancestor
25608488|NCT01087905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25608489|NCT01087905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608490|NCT01087905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25608491|NCT01087905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25608492|NCT01087905|Cholinergic Agents|cholinergic agents|mesh-ancestor
25608493|NCT01087905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25608494|NCT01087905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608495|NCT01087931|Bupivacaine|bupivacaine|mesh-list
25608496|NCT01087931|Anesthetics, Local|anesthetics, local|mesh-ancestor
25608497|NCT01087931|Anesthetics|anesthetics|mesh-ancestor
25608498|NCT01087931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25608499|NCT01087931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608500|NCT01087931|Sensory System Agents|sensory system agents|mesh-ancestor
25608501|NCT01087931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25608502|NCT01087970|Cisplatin|cisplatin|mesh-list
24607230|NCT04951206|Clobetasol|clobetasol|mesh-list
24441528|NCT00287781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24441529|NCT00287781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24441530|NCT00287781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441531|NCT00287794|Diazepam|diazepam|mesh-list
24441532|NCT00287794|Melatonin|melatonin|mesh-list
24441581|NCT00287859|Topotecan|topotecan|mesh-list
25608503|NCT01087970|Carboplatin|carboplatin|mesh-list
25608504|NCT01087970|Pemetrexed|pemetrexed|mesh-list
25608505|NCT01087970|Cetuximab|cetuximab|mesh-list
25608506|NCT01087970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608507|NCT01087970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441882|NCT00288717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25608508|NCT01087970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608509|NCT01087970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25608510|NCT01087970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25608511|NCT01087970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25608513|NCT01088048|Fludarabine|fludarabine|mesh-list
25608514|NCT01088048|Lenalidomide|lenalidomide|mesh-list
25608515|NCT01088048|Everolimus|everolimus|mesh-list
25608516|NCT01088048|Bortezomib|bortezomib|mesh-list
25608517|NCT01088048|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25608518|NCT01088048|Ofatumumab|ofatumumab|mesh-list
25608519|NCT01088048|Idelalisib|idelalisib|mesh-list
25608520|NCT01088048|Chlorambucil|chlorambucil|mesh-list
25608521|NCT01088048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25608522|NCT01088048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608523|NCT01088048|Immunologic Factors|immunologic factors|mesh-ancestor
25608524|NCT01088048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608525|NCT01088048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25608526|NCT01088048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608527|NCT01088048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25608528|NCT01088048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25608529|NCT01088048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25608530|NCT01088048|Growth Substances|growth substances|mesh-ancestor
25608531|NCT01088048|Growth Inhibitors|growth inhibitors|mesh-ancestor
25608532|NCT01088048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25608533|NCT01088048|Alkylating Agents|alkylating agents|mesh-ancestor
25608534|NCT01088048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608535|NCT01088243|Mesalamine|mesalamine|mesh-list
25608536|NCT01088243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25608537|NCT01088243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25608538|NCT01088243|Analgesics|analgesics|mesh-ancestor
25608539|NCT01088243|Sensory System Agents|sensory system agents|mesh-ancestor
25608540|NCT01088243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25608541|NCT01088243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608542|NCT01088243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25608543|NCT01088243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25608544|NCT01088295|Telmisartan|telmisartan|mesh-list
25608545|NCT01088295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25608546|NCT01088295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25608547|NCT01088295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25608548|NCT01088295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608549|NCT01088464|Necitumumab|necitumumab|mesh-list
25608550|NCT01088464|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25608551|NCT01088464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25608552|NCT01088464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608553|NCT01088464|Immunologic Factors|immunologic factors|mesh-ancestor
25608554|NCT01088464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608555|NCT01088529|Prednisone|prednisone|mesh-list
25608556|NCT01088529|Leuprolide|leuprolide|mesh-list
25608557|NCT01088529|Goserelin|goserelin|mesh-list
25608558|NCT01088529|Abiraterone Acetate|abiraterone acetate|mesh-list
25711114|NCT02296099|Sensory System Agents|sensory system agents|mesh-ancestor
25711115|NCT02296099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24442811|NCT00292747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608559|NCT01088529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25608560|NCT01088529|Glucocorticoids|glucocorticoids|mesh-ancestor
25608561|NCT01088529|Hormones|hormones|mesh-ancestor
25608562|NCT01088529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25608563|NCT01088529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608564|NCT01088529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25608565|NCT01088529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608566|NCT01088529|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25608567|NCT01088529|Fertility Agents|fertility agents|mesh-ancestor
25608568|NCT01088529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25608569|NCT01088529|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25608570|NCT01088529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608571|NCT01088529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608572|NCT01088529|Hormone Antagonists|hormone antagonists|mesh-ancestor
25608573|NCT01088529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25654541|NCT01552369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25654542|NCT01552408|Ranibizumab|ranibizumab|mesh-list
25654543|NCT01552408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25654544|NCT01552408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25654545|NCT01552408|Growth Substances|growth substances|mesh-ancestor
25654546|NCT01552408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502948|NCT00338286|Epoetin Alfa|epoetin alfa|mesh-list
25654547|NCT01552408|Growth Inhibitors|growth inhibitors|mesh-ancestor
25608574|NCT01088984|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25608575|NCT01088984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25608576|NCT01088984|Alkylating Agents|alkylating agents|mesh-ancestor
25608577|NCT01088984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608578|NCT01088984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608579|NCT01088997|Milrinone|milrinone|mesh-list
25608580|NCT01088997|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25608581|NCT01088997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25608582|NCT01088997|Vasodilator Agents|vasodilator agents|mesh-ancestor
25608583|NCT01088997|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25608584|NCT01088997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25608585|NCT01088997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608586|NCT01088997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608587|NCT01088997|Protective Agents|protective agents|mesh-ancestor
25608588|NCT01088997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608589|NCT01089062|Dihydroergotamine|dihydroergotamine|mesh-list
25608590|NCT01089062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25608591|NCT01089062|Dopamine Agonists|dopamine agonists|mesh-ancestor
25608592|NCT01089062|Dopamine Agents|dopamine agents|mesh-ancestor
25608593|NCT01089062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25608594|NCT01089062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608595|NCT01089062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608596|NCT01089062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25608597|NCT01089062|Analgesics|analgesics|mesh-ancestor
25608598|NCT01089062|Sensory System Agents|sensory system agents|mesh-ancestor
25608599|NCT01089062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25608600|NCT01089127|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25608601|NCT01089127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25608602|NCT01089127|Autonomic Agents|autonomic agents|mesh-ancestor
25608603|NCT01089127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25608604|NCT01089127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608605|NCT01089127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25608606|NCT01089127|Respiratory System Agents|respiratory system agents|mesh-ancestor
25608607|NCT01089127|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25608608|NCT01089127|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25608609|NCT01089127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25608610|NCT01089127|Adrenergic Agents|adrenergic agents|mesh-ancestor
25608611|NCT01089127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25608612|NCT01089127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608613|NCT01089361|Ketamine|ketamine|mesh-list
25608614|NCT01089361|Analgesics|analgesics|mesh-ancestor
25608615|NCT01089361|Sensory System Agents|sensory system agents|mesh-ancestor
25608616|NCT01089361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25608617|NCT01089361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608618|NCT01089361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25608619|NCT01089361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25608620|NCT01089361|Anesthetics, General|anesthetics, general|mesh-ancestor
25608621|NCT01089361|Anesthetics|anesthetics|mesh-ancestor
25608622|NCT01089361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25608623|NCT01089361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25608624|NCT01089361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25608625|NCT01089361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25608626|NCT01089361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608627|NCT01089413|Bevacizumab|bevacizumab|mesh-list
25608628|NCT01089413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25608629|NCT01089413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608630|NCT01089413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25608631|NCT01089413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25608632|NCT01089413|Growth Substances|growth substances|mesh-ancestor
25608633|NCT01089413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608634|NCT01089413|Growth Inhibitors|growth inhibitors|mesh-ancestor
25608635|NCT01089504|Phenobarbital|phenobarbital|mesh-list
25608636|NCT01089504|Anticonvulsants|anticonvulsants|mesh-ancestor
25608637|NCT01089504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25608638|NCT01089504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25608639|NCT01089504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608640|NCT01089504|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25608641|NCT01089504|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25608642|NCT01089504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25608643|NCT01089504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608644|NCT01089504|GABA Modulators|gaba modulators|mesh-ancestor
25503021|NCT00338988|Capecitabine|capecitabine|mesh-list
25608645|NCT01089504|GABA Agents|gaba agents|mesh-ancestor
25608646|NCT01089504|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25608647|NCT01089504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25608648|NCT01089504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24825894|NCT02130830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24825895|NCT02130830|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25711134|NCT02296164|Mechlorethamine|mechlorethamine|mesh-list
25711135|NCT02296164|Alkylating Agents|alkylating agents|mesh-ancestor
25711136|NCT02296164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711137|NCT02296164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25711138|NCT02296164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711139|NCT02296190|Etripamil|etripamil|mesh-list
25711140|NCT02296190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25608649|NCT01089517|Ranibizumab|ranibizumab|mesh-list
25608650|NCT01089517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25608651|NCT01089517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25608652|NCT01089517|Growth Substances|growth substances|mesh-ancestor
25608653|NCT01089517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608654|NCT01089517|Growth Inhibitors|growth inhibitors|mesh-ancestor
25608655|NCT01089517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608656|NCT01089543|Rabeprazole|rabeprazole|mesh-list
25608657|NCT01089543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25608658|NCT01089543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25608659|NCT01089543|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25608660|NCT01089543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608661|NCT01089543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608662|NCT01089556|Pregabalin|pregabalin|mesh-list
25608663|NCT01089556|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25608664|NCT01089556|Analgesics|analgesics|mesh-ancestor
25608665|NCT01089556|Sensory System Agents|sensory system agents|mesh-ancestor
25608666|NCT01089556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25608667|NCT01089556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608668|NCT01089556|Anticonvulsants|anticonvulsants|mesh-ancestor
25608669|NCT01089556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25608670|NCT01089556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25608671|NCT01089556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608672|NCT01089556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25608673|NCT01089556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25608674|NCT01089556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25608675|NCT01089556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25608676|NCT01089556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25608677|NCT01089556|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25608678|NCT01089556|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25608679|NCT01089556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25608680|NCT01089556|Antidepressive Agents|antidepressive agents|mesh-ancestor
25608681|NCT01089556|Dopamine Agents|dopamine agents|mesh-ancestor
25608682|NCT01089569|Insulin Glargine|insulin glargine|mesh-list
25608683|NCT01089569|Exenatide|exenatide|mesh-list
25608684|NCT01089569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25608685|NCT01089569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608686|NCT01089569|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25608687|NCT01089569|Incretins|incretins|mesh-ancestor
25608688|NCT01089569|Hormones|hormones|mesh-ancestor
25608689|NCT01089569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25608690|NCT01089595|Imatinib Mesylate|imatinib mesylate|mesh-list
25608691|NCT01089595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608692|NCT01089595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25608693|NCT01089595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608694|NCT01089595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608695|NCT01089608|Azithromycin|azithromycin|mesh-list
25608696|NCT01089608|Povidone|povidone|mesh-list
25608697|NCT01089608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25608698|NCT01089608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25608699|NCT01089608|Plasma Substitutes|plasma substitutes|mesh-ancestor
25608700|NCT01089608|Blood Substitutes|blood substitutes|mesh-ancestor
25608701|NCT01089647|Budesonide|budesonide|mesh-list
25608702|NCT01089647|Montelukast|montelukast|mesh-list
25608703|NCT01089647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25608704|NCT01089647|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25608705|NCT01089647|Autonomic Agents|autonomic agents|mesh-ancestor
25608706|NCT01089647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25608707|NCT01089647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608708|NCT01089647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25608709|NCT01089647|Respiratory System Agents|respiratory system agents|mesh-ancestor
25608710|NCT01089647|Glucocorticoids|glucocorticoids|mesh-ancestor
25608711|NCT01089647|Hormones|hormones|mesh-ancestor
24825920|NCT02130869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24825921|NCT02130869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24443029|NCT00293475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24443075|NCT00293592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25608712|NCT01089647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25608713|NCT01089647|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25608714|NCT01089647|Hormone Antagonists|hormone antagonists|mesh-ancestor
25608715|NCT01089647|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25608716|NCT01089647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25608717|NCT01089647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608718|NCT01089725|Tanezumab|tanezumab|mesh-list
25608719|NCT01089725|Analgesics|analgesics|mesh-ancestor
25608720|NCT01089725|Sensory System Agents|sensory system agents|mesh-ancestor
25608721|NCT01089725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25608722|NCT01089725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608723|NCT01089751|Trospium chloride|trospium chloride|mesh-list
25608724|NCT01089751|Parasympatholytics|parasympatholytics|mesh-ancestor
25608725|NCT01089751|Autonomic Agents|autonomic agents|mesh-ancestor
25608726|NCT01089751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25608727|NCT01089751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608728|NCT01089751|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25608729|NCT01089751|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25608730|NCT01089751|Cholinergic Agents|cholinergic agents|mesh-ancestor
25608731|NCT01089751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25608732|NCT01089751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608733|NCT01089751|Urological Agents|urological agents|mesh-ancestor
25608734|NCT01090011|Cetuximab|cetuximab|mesh-list
25608735|NCT01090011|Afatinib|afatinib|mesh-list
25608736|NCT01090011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25608737|NCT01090011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608738|NCT01090011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25608739|NCT01090011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608740|NCT01090011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608741|NCT01090050|Naproxen|naproxen|mesh-list
25608742|NCT01090050|Sumatriptan|sumatriptan|mesh-list
25608743|NCT01090050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25608744|NCT01090050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25608745|NCT01090050|Analgesics|analgesics|mesh-ancestor
25608746|NCT01090050|Sensory System Agents|sensory system agents|mesh-ancestor
25608747|NCT01090050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25608748|NCT01090050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608749|NCT01090050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25608750|NCT01090050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25608751|NCT01090050|Gout Suppressants|gout suppressants|mesh-ancestor
25608752|NCT01090050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25608753|NCT01090050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608754|NCT01090050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608755|NCT01090050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25608756|NCT01090050|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25608757|NCT01090050|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25608758|NCT01090050|Serotonin Agents|serotonin agents|mesh-ancestor
25608759|NCT01090050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25608760|NCT01090063|Ustekinumab|ustekinumab|mesh-list
25608761|NCT01090063|Dermatologic Agents|dermatologic agents|mesh-ancestor
25608762|NCT01090102|Aminosalicylic Acid|aminosalicylic acid|mesh-list
25608763|NCT01090102|Mesalamine|mesalamine|mesh-list
25608764|NCT01090102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25608765|NCT01090102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25608766|NCT01090102|Analgesics|analgesics|mesh-ancestor
25608767|NCT01090102|Sensory System Agents|sensory system agents|mesh-ancestor
25608768|NCT01090102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25608769|NCT01090102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608770|NCT01090102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25608771|NCT01090102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25608772|NCT01090102|Antitubercular Agents|antitubercular agents|mesh-ancestor
25608773|NCT01090102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25608774|NCT01090102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25608775|NCT01090180|Dexamethasone|dexamethasone|mesh-list
25608776|NCT01090180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25608777|NCT01090180|Antiemetics|antiemetics|mesh-ancestor
25608778|NCT01090180|Autonomic Agents|autonomic agents|mesh-ancestor
25608779|NCT01090180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25608780|NCT01090180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608781|NCT01090180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25608782|NCT01090180|Glucocorticoids|glucocorticoids|mesh-ancestor
25608783|NCT01090180|Hormones|hormones|mesh-ancestor
25608784|NCT01090180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25608785|NCT01090180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25608786|NCT01090180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608787|NCT01090323|Deferasirox|deferasirox|mesh-list
25608788|NCT01090323|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25608789|NCT01090323|Chelating Agents|chelating agents|mesh-ancestor
25608790|NCT01090323|Sequestering Agents|sequestering agents|mesh-ancestor
25608791|NCT01090323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608792|NCT01090414|Idelalisib|idelalisib|mesh-list
25608793|NCT01090414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503160|NCT00343083|Paclitaxel|paclitaxel|mesh-list
25608794|NCT01090414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608795|NCT01090414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608796|NCT01090427|Ustekinumab|ustekinumab|mesh-list
25608797|NCT01090427|Dermatologic Agents|dermatologic agents|mesh-ancestor
25608798|NCT01090453|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25608799|NCT01090453|Immunologic Factors|immunologic factors|mesh-ancestor
25608800|NCT01090453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608801|NCT01090479|Chlorhexidine|chlorhexidine|mesh-list
25608802|NCT01090479|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25608803|NCT01090479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25608804|NCT01090479|Disinfectants|disinfectants|mesh-ancestor
25608806|NCT01090752|Pioglitazone|pioglitazone|mesh-list
25608807|NCT01090752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25608808|NCT01090752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608809|NCT01090921|Bortezomib|bortezomib|mesh-list
25608810|NCT01090921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608811|NCT01090973|Panobinostat|panobinostat|mesh-list
25711148|NCT02296346|Prednisolone|prednisolone|mesh-list
24825960|NCT02131246|Insulin, Long-Acting|insulin, long-acting|mesh-list
25711154|NCT02296346|Hormones|hormones|mesh-ancestor
25608812|NCT01090973|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25608813|NCT01090973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608814|NCT01090973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608815|NCT01090973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608816|NCT01091116|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|mesh-list
25608817|NCT01091116|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
25608818|NCT01091116|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
25608819|NCT01091116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608820|NCT01091116|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25608821|NCT01091116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25608822|NCT01091116|Immunologic Factors|immunologic factors|mesh-ancestor
25608823|NCT01091116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608824|NCT01091168|Alkylating Agents|alkylating agents|mesh-list
25608825|NCT01091168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608826|NCT01091259|Bevacizumab|bevacizumab|mesh-list
25608827|NCT01091259|Irinotecan|irinotecan|mesh-list
25608828|NCT01091259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25608829|NCT01091259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608830|NCT01091259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25608831|NCT01091259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25608832|NCT01091259|Growth Substances|growth substances|mesh-ancestor
25608833|NCT01091259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608834|NCT01091259|Growth Inhibitors|growth inhibitors|mesh-ancestor
25608835|NCT01091259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25608836|NCT01091259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25608837|NCT01091259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608838|NCT01091259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608839|NCT01091428|Paclitaxel|paclitaxel|mesh-list
25608840|NCT01091428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25608841|NCT01091428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608842|NCT01091428|Tubulin Modulators|tubulin modulators|mesh-ancestor
25608843|NCT01091428|Antimitotic Agents|antimitotic agents|mesh-ancestor
25608844|NCT01091428|Mitosis Modulators|mitosis modulators|mesh-ancestor
25608845|NCT01091428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608846|NCT01091454|Cisplatin|cisplatin|mesh-list
25608847|NCT01091454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711163|NCT02296346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25711164|NCT02296346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25711165|NCT02296424|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24825998|NCT02131506|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24826000|NCT02131506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826001|NCT02131506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24826067|NCT02132234|Dermatologic Agents|dermatologic agents|mesh-ancestor
24613709|NCT01020383|Abciximab|abciximab|mesh-list
25608848|NCT01091519|Fesoterodine|fesoterodine|mesh-list
25608849|NCT01091519|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25608850|NCT01091519|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25608851|NCT01091519|Cholinergic Agents|cholinergic agents|mesh-ancestor
25608852|NCT01091519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25608853|NCT01091519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608854|NCT01091519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608855|NCT01091519|Urological Agents|urological agents|mesh-ancestor
25608856|NCT01091662|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25608857|NCT01091662|Anticonvulsants|anticonvulsants|mesh-ancestor
25608858|NCT01091662|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25608859|NCT01091662|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25608860|NCT01091662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25608861|NCT01091662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608862|NCT01091675|Etoricoxib|etoricoxib|mesh-list
25608863|NCT01091675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25608864|NCT01091675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25608865|NCT01091675|Analgesics|analgesics|mesh-ancestor
25608866|NCT01091675|Sensory System Agents|sensory system agents|mesh-ancestor
25608867|NCT01091675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25608868|NCT01091675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608869|NCT01091675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25608870|NCT01091675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25608871|NCT01091675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25608872|NCT01091675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25608873|NCT01091675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608874|NCT01091675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608875|NCT01091974|Modafinil|modafinil|mesh-list
25608876|NCT01091974|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25608877|NCT01091974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608878|NCT01091974|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25608879|NCT01091974|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25608880|NCT01091974|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25608881|NCT01091974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608882|NCT01092182|Prednisone|prednisone|mesh-list
25608883|NCT01092182|Cyclophosphamide|cyclophosphamide|mesh-list
25608884|NCT01092182|Rituximab|rituximab|mesh-list
25608885|NCT01092182|Doxorubicin|doxorubicin|mesh-list
25608886|NCT01092182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25608887|NCT01092182|Etoposide|etoposide|mesh-list
25608888|NCT01092182|Etoposide phosphate|etoposide phosphate|mesh-list
25608889|NCT01092182|Vincristine|vincristine|mesh-list
25608890|NCT01092182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25608891|NCT01092182|Immunologic Factors|immunologic factors|mesh-ancestor
25608892|NCT01092182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608893|NCT01092182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25608894|NCT01092182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25608895|NCT01092182|Alkylating Agents|alkylating agents|mesh-ancestor
25608896|NCT01092182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608897|NCT01092182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608898|NCT01092182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25608899|NCT01092182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25608900|NCT01092182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25608901|NCT01092182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25608902|NCT01092182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25608903|NCT01092182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608904|NCT01092182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25608905|NCT01092182|Glucocorticoids|glucocorticoids|mesh-ancestor
25608906|NCT01092182|Hormones|hormones|mesh-ancestor
25608907|NCT01092182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25608908|NCT01092182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25608909|NCT01092182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25608910|NCT01092182|Tubulin Modulators|tubulin modulators|mesh-ancestor
25608911|NCT01092182|Antimitotic Agents|antimitotic agents|mesh-ancestor
25608912|NCT01092182|Mitosis Modulators|mitosis modulators|mesh-ancestor
25608913|NCT01092338|Vitamin D|vitamin d|mesh-list
25608914|NCT01092338|Cholecalciferol|cholecalciferol|mesh-list
25608915|NCT01092338|Vitamins|vitamins|mesh-ancestor
25608916|NCT01092338|Micronutrients|micronutrients|mesh-ancestor
25608917|NCT01092338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608918|NCT01092338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25608919|NCT01092338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25608920|NCT01092507|Vaccines|vaccines|mesh-list
25608921|NCT01092507|Immunologic Factors|immunologic factors|mesh-ancestor
25608922|NCT01092507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608923|NCT01092546|Flutemetamol|flutemetamol|mesh-list
25608924|NCT01092546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25608925|NCT01092546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608926|NCT01092559|Nitric Oxide|nitric oxide|mesh-list
25608927|NCT01092559|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25608928|NCT01092559|Autonomic Agents|autonomic agents|mesh-ancestor
25608929|NCT01092559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25608930|NCT01092559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608931|NCT01092559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25608932|NCT01092559|Respiratory System Agents|respiratory system agents|mesh-ancestor
25608933|NCT01092559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25608934|NCT01092559|Antioxidants|antioxidants|mesh-ancestor
25608935|NCT01092559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608936|NCT01092559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25608937|NCT01092559|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25608938|NCT01092559|Vasodilator Agents|vasodilator agents|mesh-ancestor
25608939|NCT01092559|Gasotransmitters|gasotransmitters|mesh-ancestor
25608940|NCT01092559|Protective Agents|protective agents|mesh-ancestor
25608941|NCT01092663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25608942|NCT01092663|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
25608943|NCT01092663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25608944|NCT01092663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608946|NCT01092663|Hormones|hormones|mesh-ancestor
25608947|NCT01092663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25608948|NCT01092663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25608949|NCT01092663|Protease Inhibitors|protease inhibitors|mesh-ancestor
25608950|NCT01092663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707356|NCT01495338|Cetirizine|cetirizine|mesh-list
24826264|NCT02133755|Bromocriptine|bromocriptine|mesh-list
25608951|NCT01092663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608952|NCT01092663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25608953|NCT01092663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25608954|NCT01092663|Antimetabolites|antimetabolites|mesh-ancestor
25608955|NCT01092663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25608956|NCT01092676|Ibuprofen|ibuprofen|mesh-list
25608957|NCT01092676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25608958|NCT01092676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25608959|NCT01092676|Analgesics|analgesics|mesh-ancestor
25608960|NCT01092676|Sensory System Agents|sensory system agents|mesh-ancestor
25608961|NCT01092676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25608962|NCT01092676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608963|NCT01092676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25608964|NCT01092676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25608965|NCT01092676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25608966|NCT01092676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608967|NCT01092676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608968|NCT01092702|Varenicline|varenicline|mesh-list
25608969|NCT01092702|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25608970|NCT01092702|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25608971|NCT01092702|Cholinergic Agents|cholinergic agents|mesh-ancestor
25608972|NCT01092702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25608973|NCT01092702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608974|NCT01092702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608975|NCT01092728|Dasatinib|dasatinib|mesh-list
25608976|NCT01092728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25608977|NCT01092728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24826306|NCT02133989|Clopidogrel|clopidogrel|mesh-list
24826307|NCT02133989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24826308|NCT02133989|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24826309|NCT02133989|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24707952|NCT01498926|Insulin|insulin|mesh-list
25608978|NCT01092728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608979|NCT01092728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608980|NCT01092780|Modafinil|modafinil|mesh-list
25608981|NCT01092780|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25608982|NCT01092780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608983|NCT01092780|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25608984|NCT01092780|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25608985|NCT01092780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25608986|NCT01092780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608987|NCT01092832|Voriconazole|voriconazole|mesh-list
25608988|NCT01092832|Antifungal Agents|antifungal agents|mesh-ancestor
25608989|NCT01092832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25608990|NCT01092832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25608991|NCT01092832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25608992|NCT01092832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25608993|NCT01092832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25608994|NCT01092832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25608995|NCT01092832|Hormone Antagonists|hormone antagonists|mesh-ancestor
25608996|NCT01092832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25608997|NCT01092832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25608998|NCT01092832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25608999|NCT01092923|Sevoflurane|sevoflurane|mesh-list
25609000|NCT01092923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25609001|NCT01092923|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25609002|NCT01092923|Anesthetics, General|anesthetics, general|mesh-ancestor
25609003|NCT01092923|Anesthetics|anesthetics|mesh-ancestor
25609004|NCT01092923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25609005|NCT01092923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609006|NCT01093183|Cyclophosphamide|cyclophosphamide|mesh-list
25711187|NCT02296840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24443436|NCT00294931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24443437|NCT00294931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24443438|NCT00294931|Growth Substances|growth substances|mesh-ancestor
24443439|NCT00294931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443440|NCT00294931|Growth Inhibitors|growth inhibitors|mesh-ancestor
24443441|NCT00294931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24443442|NCT00294931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24443443|NCT00294931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443444|NCT00294931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443445|NCT00294944|Idazoxan|idazoxan|mesh-list
25609007|NCT01093183|Lenalidomide|lenalidomide|mesh-list
25609008|NCT01093183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25503378|NCT00345046|Methylprednisolone|methylprednisolone|mesh-list
25609010|NCT01093183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609011|NCT01093183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25609012|NCT01093183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25609013|NCT01093183|Alkylating Agents|alkylating agents|mesh-ancestor
25609014|NCT01093183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609015|NCT01093183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25609016|NCT01093183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25609017|NCT01093183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25609018|NCT01093183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25609019|NCT01093183|Growth Substances|growth substances|mesh-ancestor
25609020|NCT01093183|Growth Inhibitors|growth inhibitors|mesh-ancestor
25609021|NCT01093222|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25609022|NCT01093222|Sorafenib|sorafenib|mesh-list
25609023|NCT01093222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25609024|NCT01093222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25609025|NCT01093222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25609026|NCT01093222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609027|NCT01093417|Vitamin D|vitamin d|mesh-list
25609028|NCT01093417|Vitamins|vitamins|mesh-ancestor
25609029|NCT01093417|Micronutrients|micronutrients|mesh-ancestor
25609030|NCT01093417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609031|NCT01093417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25609032|NCT01093469|Decanoic acid|decanoic acid|mesh-list
25609033|NCT01093469|Petrolatum|petrolatum|mesh-list
25609034|NCT01093469|Emollients|emollients|mesh-ancestor
25609035|NCT01093469|Dermatologic Agents|dermatologic agents|mesh-ancestor
25609036|NCT01093469|Antifungal Agents|antifungal agents|mesh-ancestor
25609037|NCT01093469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25609038|NCT01093521|Gallium nitrate|gallium nitrate|mesh-list
25609039|NCT01093521|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25609040|NCT01093521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609041|NCT01093521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25609042|NCT01093534|Solifenacin Succinate|solifenacin succinate|mesh-list
25609043|NCT01093534|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25609044|NCT01093534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25609045|NCT01093534|Cholinergic Agents|cholinergic agents|mesh-ancestor
25609046|NCT01093534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25609047|NCT01093534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609048|NCT01093534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609049|NCT01093534|Urological Agents|urological agents|mesh-ancestor
25609050|NCT01093586|Cyclosporine|cyclosporine|mesh-list
25609051|NCT01093586|Mycophenolic Acid|mycophenolic acid|mesh-list
25609052|NCT01093586|Methylprednisolone|methylprednisolone|mesh-list
25609053|NCT01093586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25609054|NCT01093586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25609055|NCT01093586|Prednisolone|prednisolone|mesh-list
25609056|NCT01093586|Prednisolone acetate|prednisolone acetate|mesh-list
25609057|NCT01093586|Cyclophosphamide|cyclophosphamide|mesh-list
25609058|NCT01093586|Busulfan|busulfan|mesh-list
25609059|NCT01093586|Cyclosporins|cyclosporins|mesh-list
25609060|NCT01093586|Thymoglobulin|thymoglobulin|mesh-list
25609061|NCT01093586|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25609062|NCT01093586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25609063|NCT01093586|Prednisolone phosphate|prednisolone phosphate|mesh-list
25609064|NCT01093586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25609065|NCT01093586|Immunologic Factors|immunologic factors|mesh-ancestor
25609066|NCT01093586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609067|NCT01093586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25609068|NCT01093586|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25609069|NCT01093586|Alkylating Agents|alkylating agents|mesh-ancestor
25609070|NCT01093586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609071|NCT01093586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25609072|NCT01093586|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25609073|NCT01093586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25609074|NCT01093586|Antifungal Agents|antifungal agents|mesh-ancestor
25609075|NCT01093586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25609076|NCT01093586|Dermatologic Agents|dermatologic agents|mesh-ancestor
25609077|NCT01093586|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25609078|NCT01093586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25609079|NCT01093586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25609080|NCT01093586|Antitubercular Agents|antitubercular agents|mesh-ancestor
25609081|NCT01093586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25609082|NCT01093586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25609083|NCT01093586|Antiemetics|antiemetics|mesh-ancestor
25609084|NCT01093586|Autonomic Agents|autonomic agents|mesh-ancestor
25822737|NCT00004585|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25503524|NCT00346268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503525|NCT00346268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503526|NCT00346268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25503527|NCT00346268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25503528|NCT00346268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25503529|NCT00346268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25503530|NCT00346775|Beclomethasone|beclomethasone|mesh-list
25503531|NCT00346775|Flunisolide|flunisolide|mesh-list
25503532|NCT00346775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25503533|NCT00346775|Glucocorticoids|glucocorticoids|mesh-ancestor
25503534|NCT00346775|Hormones|hormones|mesh-ancestor
25503535|NCT00346775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25503536|NCT00346775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503537|NCT00346775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25503538|NCT00346775|Respiratory System Agents|respiratory system agents|mesh-ancestor
25503539|NCT00347009|Adefovir|adefovir|mesh-list
25503540|NCT00347009|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25503541|NCT00347009|Antiviral Agents|antiviral agents|mesh-ancestor
25503542|NCT00347009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25503543|NCT00347009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25503544|NCT00347009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25503545|NCT00347009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503546|NCT00347009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503547|NCT00347269|Psychotropic Drugs|psychotropic drugs|mesh-list
24533698|NCT00644800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24533699|NCT00644800|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25040729|NCT02918019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25124248|NCT03078374|Anticoagulants|anticoagulants|mesh-ancestor
25124249|NCT03078309|Cannabidiol|cannabidiol|mesh-list
25124250|NCT03078309|Anticonvulsants|anticonvulsants|mesh-ancestor
25124251|NCT03078569|Testosterone|testosterone|mesh-list
25124252|NCT03078569|Androgens|androgens|mesh-ancestor
25124253|NCT03078569|Hormones|hormones|mesh-ancestor
25124254|NCT03078569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25124255|NCT03078569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800939|NCT01979653|GABA Agents|gaba agents|mesh-ancestor
25124256|NCT03078257|Aspirin|aspirin|mesh-list
25124257|NCT03078257|Tirofiban|tirofiban|mesh-list
25124258|NCT03078257|Fibrinolysin|fibrinolysin|mesh-list
25124259|NCT03078257|Clopidogrel|clopidogrel|mesh-list
25077981|NCT03360123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24740283|NCT01687491|Anticoagulants|anticoagulants|mesh-ancestor
24740284|NCT01687491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24740285|NCT01687491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24740286|NCT01687491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740287|NCT01687517|Vaccines|vaccines|mesh-list
24740288|NCT01687517|Immunologic Factors|immunologic factors|mesh-ancestor
25609085|NCT01093586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25609086|NCT01093586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25609087|NCT01093586|Glucocorticoids|glucocorticoids|mesh-ancestor
25609088|NCT01093586|Hormones|hormones|mesh-ancestor
25609089|NCT01093586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25609090|NCT01093586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25609091|NCT01093586|Protective Agents|protective agents|mesh-ancestor
25609092|NCT01093586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25609093|NCT01093651|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25609094|NCT01093651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25609095|NCT01093651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609096|NCT01093651|Incretins|incretins|mesh-ancestor
25609097|NCT01093651|Hormones|hormones|mesh-ancestor
25609098|NCT01093651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25609099|NCT01093651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25609100|NCT01093651|Protease Inhibitors|protease inhibitors|mesh-ancestor
25609101|NCT01093651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25609102|NCT01093651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609103|NCT01093690|Metoclopramide|metoclopramide|mesh-list
25609104|NCT01093690|Antiemetics|antiemetics|mesh-ancestor
25609105|NCT01093690|Autonomic Agents|autonomic agents|mesh-ancestor
25609106|NCT01093690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25609107|NCT01093690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609108|NCT01093690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25609109|NCT01093690|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25609110|NCT01093690|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25609111|NCT01093690|Dopamine Agents|dopamine agents|mesh-ancestor
25609112|NCT01093690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25609113|NCT01093690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609114|NCT01093755|Omeprazole|omeprazole|mesh-list
25609115|NCT01093755|Dexlansoprazole|dexlansoprazole|mesh-list
25609116|NCT01093755|Lansoprazole|lansoprazole|mesh-list
25609117|NCT01093755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25609118|NCT01093755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25609119|NCT01093755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25609120|NCT01093755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25609121|NCT01093755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609122|NCT01093794|Metformin|metformin|mesh-list
25609123|NCT01093794|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25609124|NCT01093794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25609125|NCT01093794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609126|NCT01093794|Incretins|incretins|mesh-ancestor
25609127|NCT01093794|Hormones|hormones|mesh-ancestor
25609128|NCT01093794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25609129|NCT01093794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25609130|NCT01093794|Protease Inhibitors|protease inhibitors|mesh-ancestor
25609131|NCT01093794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25609132|NCT01093794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609133|NCT01093885|Ambrisentan|ambrisentan|mesh-list
25609134|NCT01093885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25609135|NCT01093976|Dronabinol|dronabinol|mesh-list
25609136|NCT01093976|Hallucinogens|hallucinogens|mesh-ancestor
25609137|NCT01093976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609138|NCT01093976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25609139|NCT01093976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25609140|NCT01093976|Analgesics|analgesics|mesh-ancestor
25609141|NCT01093976|Sensory System Agents|sensory system agents|mesh-ancestor
25609142|NCT01093976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25609143|NCT01093976|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25609144|NCT01093976|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25609145|NCT01093976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25609146|NCT01093976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609147|NCT01093976|Hormones|hormones|mesh-ancestor
25609148|NCT01093976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25609149|NCT01094106|Ropivacaine|ropivacaine|mesh-list
25609150|NCT01094106|Anesthetics, Local|anesthetics, local|mesh-ancestor
25609151|NCT01094106|Anesthetics|anesthetics|mesh-ancestor
25609152|NCT01094106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25609153|NCT01094106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609154|NCT01094106|Sensory System Agents|sensory system agents|mesh-ancestor
25609155|NCT01094106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25609156|NCT01094184|Paclitaxel|paclitaxel|mesh-list
25609157|NCT01094184|Docetaxel|docetaxel|mesh-list
25609158|NCT01094184|Bevacizumab|bevacizumab|mesh-list
25609159|NCT01094184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25609160|NCT01094184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25609161|NCT01094184|Tubulin Modulators|tubulin modulators|mesh-ancestor
25609162|NCT01094184|Antimitotic Agents|antimitotic agents|mesh-ancestor
25609163|NCT01094184|Mitosis Modulators|mitosis modulators|mesh-ancestor
25609164|NCT01094184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609165|NCT01094184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25609166|NCT01094184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25609167|NCT01094184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25609168|NCT01094184|Growth Substances|growth substances|mesh-ancestor
25609169|NCT01094184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609170|NCT01094184|Growth Inhibitors|growth inhibitors|mesh-ancestor
25609171|NCT01094288|Docetaxel|docetaxel|mesh-list
25609172|NCT01094288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25609173|NCT01094288|Tubulin Modulators|tubulin modulators|mesh-ancestor
25609174|NCT01094288|Antimitotic Agents|antimitotic agents|mesh-ancestor
25609175|NCT01094288|Mitosis Modulators|mitosis modulators|mesh-ancestor
25609176|NCT01094288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609177|NCT01094522|Morphine|morphine|mesh-list
25609178|NCT01094522|Methadone|methadone|mesh-list
25609179|NCT01094522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25609180|NCT01094522|Narcotics|narcotics|mesh-ancestor
25609181|NCT01094522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25609182|NCT01094522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609183|NCT01094522|Analgesics|analgesics|mesh-ancestor
25609184|NCT01094522|Sensory System Agents|sensory system agents|mesh-ancestor
25609185|NCT01094522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25609186|NCT01094522|Antitussive Agents|antitussive agents|mesh-ancestor
25609187|NCT01094522|Respiratory System Agents|respiratory system agents|mesh-ancestor
25609188|NCT01094548|Cyclophosphamide|cyclophosphamide|mesh-list
25609189|NCT01094548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25609190|NCT01094548|Immunologic Factors|immunologic factors|mesh-ancestor
25609191|NCT01094548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609192|NCT01094548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25609193|NCT01094548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25711222|NCT02296931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25609194|NCT01094548|Alkylating Agents|alkylating agents|mesh-ancestor
25609195|NCT01094548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609196|NCT01094548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25609197|NCT01094548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25609198|NCT01094574|Propranolol|propranolol|mesh-list
25609199|NCT01094574|Alfentanil|alfentanil|mesh-list
25609200|NCT01094574|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25609201|NCT01094574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25609202|NCT01094574|Adrenergic Agents|adrenergic agents|mesh-ancestor
25609203|NCT01094574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25609204|NCT01094574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609205|NCT01094574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609206|NCT01094574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25609207|NCT01094574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25609208|NCT01094574|Vasodilator Agents|vasodilator agents|mesh-ancestor
25609209|NCT01094574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25609210|NCT01094574|Narcotics|narcotics|mesh-ancestor
25609211|NCT01094574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25609212|NCT01094574|Analgesics|analgesics|mesh-ancestor
25609213|NCT01094574|Sensory System Agents|sensory system agents|mesh-ancestor
25609214|NCT01094574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25609215|NCT01094574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25609216|NCT01094574|Anesthetics, General|anesthetics, general|mesh-ancestor
25609217|NCT01094574|Anesthetics|anesthetics|mesh-ancestor
25609218|NCT01094717|Tazarotene|tazarotene|mesh-list
25609219|NCT01094717|Acitretin|acitretin|mesh-list
25609220|NCT01094717|Dermatologic Agents|dermatologic agents|mesh-ancestor
25609221|NCT01094717|Keratolytic Agents|keratolytic agents|mesh-ancestor
25654548|NCT01552408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25654549|NCT01552603|Pancrelipase|pancrelipase|mesh-list
25654550|NCT01552603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25654551|NCT01552681|Immunoglobulins|immunoglobulins|mesh-list
25654552|NCT01552681|Immunologic Factors|immunologic factors|mesh-ancestor
25654553|NCT01552681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654554|NCT01552694|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25654555|NCT01552694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25654556|NCT01552694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654557|NCT01552694|Incretins|incretins|mesh-ancestor
25654558|NCT01552694|Hormones|hormones|mesh-ancestor
25654559|NCT01552694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25654560|NCT01552694|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25654561|NCT01552694|Protease Inhibitors|protease inhibitors|mesh-ancestor
25654562|NCT01552694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25654563|NCT01552694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654564|NCT01552772|Aripiprazole|aripiprazole|mesh-list
25654565|NCT01552772|Antidepressive Agents|antidepressive agents|mesh-ancestor
25654566|NCT01552772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25654567|NCT01552772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25654568|NCT01552772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25654569|NCT01552772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25654570|NCT01552772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654571|NCT01552772|Dopamine Agonists|dopamine agonists|mesh-ancestor
25654572|NCT01552772|Dopamine Agents|dopamine agents|mesh-ancestor
25654573|NCT01552772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25654574|NCT01552772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654575|NCT01552772|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24826602|NCT02135263|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24443657|NCT00295672|Antimitotic Agents|antimitotic agents|mesh-ancestor
24443658|NCT00295672|Mitosis Modulators|mitosis modulators|mesh-ancestor
25654576|NCT01552772|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25654577|NCT01552772|Serotonin Agents|serotonin agents|mesh-ancestor
25654578|NCT01552772|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25654579|NCT01552772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25654580|NCT01552772|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25654581|NCT01552772|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25654582|NCT01552902|Methylphenidate|methylphenidate|mesh-list
25654583|NCT01552902|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25654584|NCT01552902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25654585|NCT01552902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654586|NCT01552902|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25822738|NCT00004637|Vitamin E|vitamin e|mesh-list
25609222|NCT01094808|Pregabalin|pregabalin|mesh-list
25609223|NCT01094808|Analgesics|analgesics|mesh-ancestor
25609224|NCT01094808|Sensory System Agents|sensory system agents|mesh-ancestor
25609225|NCT01094808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25609226|NCT01094808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609227|NCT01094808|Anticonvulsants|anticonvulsants|mesh-ancestor
25609228|NCT01094808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25609229|NCT01094808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25609230|NCT01094808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609231|NCT01094808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25609232|NCT01094808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25609233|NCT01094808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25609234|NCT01094808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25609235|NCT01094808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25609236|NCT01094886|Rivaroxaban|rivaroxaban|mesh-list
25609237|NCT01094886|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25609238|NCT01094886|Antithrombins|antithrombins|mesh-ancestor
25609239|NCT01094886|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25609240|NCT01094886|Protease Inhibitors|protease inhibitors|mesh-ancestor
25609241|NCT01094886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25609242|NCT01094886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609243|NCT01094886|Anticoagulants|anticoagulants|mesh-ancestor
25609244|NCT01095094|Ritonavir|ritonavir|mesh-list
25609245|NCT01095094|Lopinavir|lopinavir|mesh-list
25609246|NCT01095094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25609247|NCT01095094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25609248|NCT01095094|Protease Inhibitors|protease inhibitors|mesh-ancestor
25609249|NCT01095094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25609250|NCT01095094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609251|NCT01095094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25609252|NCT01095094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25609253|NCT01095094|Antiviral Agents|antiviral agents|mesh-ancestor
25609254|NCT01095094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25609255|NCT01095094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25609256|NCT01095094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25609257|NCT01095497|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25609258|NCT01095497|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25609259|NCT01095497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25609260|NCT01095497|Immunologic Factors|immunologic factors|mesh-ancestor
24826668|NCT02135588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826671|NCT02135627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25609261|NCT01095497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609262|NCT01095510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25609263|NCT01095510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25609264|NCT01095510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25609265|NCT01095510|Immunologic Factors|immunologic factors|mesh-ancestor
25609266|NCT01095510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609267|NCT01095653|Metformin|metformin|mesh-list
25609268|NCT01095653|Dapagliflozin|dapagliflozin|mesh-list
25609269|NCT01095653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25609270|NCT01095653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609271|NCT01095653|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25609272|NCT01095653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609273|NCT01095666|Metformin|metformin|mesh-list
25609274|NCT01095666|Pioglitazone|pioglitazone|mesh-list
25609275|NCT01095666|Dapagliflozin|dapagliflozin|mesh-list
25609276|NCT01095666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25609277|NCT01095666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609278|NCT01095666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25609279|NCT01095666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609280|NCT01095757|Plerixafor|plerixafor|mesh-list
25609281|NCT01095757|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25609282|NCT01095757|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25609283|NCT01095757|Antiviral Agents|antiviral agents|mesh-ancestor
25609284|NCT01095757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25609285|NCT01095796|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25609286|NCT01095796|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25609287|NCT01095796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25609288|NCT01095796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25609289|NCT01095796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25609290|NCT01095796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609291|NCT01095796|Antiviral Agents|antiviral agents|mesh-ancestor
25609292|NCT01095796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25609293|NCT01095796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25609294|NCT01095796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25609296|NCT01095835|Lamivudine|lamivudine|mesh-list
25609297|NCT01095835|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25609298|NCT01095835|Interferon-alpha|interferon-alpha|mesh-list
25609299|NCT01095835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25609300|NCT01095835|Antiviral Agents|antiviral agents|mesh-ancestor
25609301|NCT01095835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25609302|NCT01095835|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25609303|NCT01095835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25609304|NCT01095835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25609305|NCT01095835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443732|NCT00295893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443733|NCT00295893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24443734|NCT00295919|Ketoconazole|ketoconazole|mesh-list
24443735|NCT00295919|Fenretinide|fenretinide|mesh-list
25609306|NCT01095835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25609307|NCT01095835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25609308|NCT01095835|Immunologic Factors|immunologic factors|mesh-ancestor
25609309|NCT01095835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609310|NCT01095887|Eculizumab|eculizumab|mesh-list
25609311|NCT01095887|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25609312|NCT01095887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25609313|NCT01095887|Immunologic Factors|immunologic factors|mesh-ancestor
25609314|NCT01095887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609315|NCT01095978|Clarithromycin|clarithromycin|mesh-list
25609316|NCT01095978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25609317|NCT01095978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25609318|NCT01095978|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25609319|NCT01095978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25609320|NCT01095978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609321|NCT01095978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25609322|NCT01095978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25609323|NCT01096017|Albuterol|albuterol|mesh-list
25609324|NCT01096017|Terbutaline|terbutaline|mesh-list
25609325|NCT01096017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25609326|NCT01096017|Autonomic Agents|autonomic agents|mesh-ancestor
25609327|NCT01096017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25609328|NCT01096017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609329|NCT01096017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25609330|NCT01096017|Respiratory System Agents|respiratory system agents|mesh-ancestor
25609331|NCT01096017|Tocolytic Agents|tocolytic agents|mesh-ancestor
25609332|NCT01096017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25609333|NCT01096017|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25609334|NCT01096017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25609335|NCT01096017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25609336|NCT01096017|Adrenergic Agents|adrenergic agents|mesh-ancestor
25609337|NCT01096017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25609338|NCT01096017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609339|NCT01096017|Sympathomimetics|sympathomimetics|mesh-ancestor
25609340|NCT01096056|Vaccines|vaccines|mesh-list
25609341|NCT01096056|Immunologic Factors|immunologic factors|mesh-ancestor
25609342|NCT01096056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609343|NCT01096186|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25609344|NCT01096186|Carbidopa|carbidopa|mesh-list
25609345|NCT01096186|Levodopa|levodopa|mesh-list
25609346|NCT01096186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25609347|NCT01096186|Immunologic Factors|immunologic factors|mesh-ancestor
25609348|NCT01096186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609349|NCT01096186|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25609350|NCT01096186|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25609351|NCT01096186|Dopamine Agonists|dopamine agonists|mesh-ancestor
25609352|NCT01096186|Dopamine Agents|dopamine agents|mesh-ancestor
25609353|NCT01096186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25609354|NCT01096186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609355|NCT01096186|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25609356|NCT01096186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25609357|NCT01096290|Lubiprostone|lubiprostone|mesh-list
25609358|NCT01096290|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25609359|NCT01096290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25609360|NCT01096290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609361|NCT01096342|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
25609362|NCT01096342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25609363|NCT01096342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826705|NCT02135822|Antiviral Agents|antiviral agents|mesh-ancestor
25609364|NCT01096342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609365|NCT01096446|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25609366|NCT01096446|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
25609367|NCT01096446|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25609368|NCT01096446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25609369|NCT01096589|Monensin|monensin|mesh-list
25609370|NCT01096589|Antifungal Agents|antifungal agents|mesh-ancestor
25609371|NCT01096589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25609372|NCT01096589|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25609373|NCT01096589|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25609374|NCT01096589|Coccidiostats|coccidiostats|mesh-ancestor
25609375|NCT01096589|Proton Ionophores|proton ionophores|mesh-ancestor
25609376|NCT01096589|Uncoupling Agents|uncoupling agents|mesh-ancestor
25609377|NCT01096589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25609378|NCT01096589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609379|NCT01096589|Ionophores|ionophores|mesh-ancestor
25609380|NCT01096589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25609381|NCT01096589|Sodium Ionophores|sodium ionophores|mesh-ancestor
25609382|NCT01096667|Ertugliflozin|ertugliflozin|mesh-list
25609383|NCT01096667|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25609384|NCT01096667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25609385|NCT01096667|Diuretics|diuretics|mesh-ancestor
25609386|NCT01096667|Natriuretic Agents|natriuretic agents|mesh-ancestor
25609387|NCT01096667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609388|NCT01096667|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25609389|NCT01096667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25609390|NCT01096667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609391|NCT01096667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25609392|NCT01096667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25609393|NCT01096680|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25609394|NCT01096680|Modafinil|modafinil|mesh-list
25609395|NCT01096680|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25609396|NCT01096680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609397|NCT01096680|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25609398|NCT01096680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25609399|NCT01096680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25609400|NCT01096680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609401|NCT01096680|Dopamine Agents|dopamine agents|mesh-ancestor
25609402|NCT01096680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25609403|NCT01096680|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25609404|NCT01096680|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24443776|NCT00295971|Antimetabolites|antimetabolites|mesh-ancestor
24443844|NCT00296010|Abortifacient Agents|abortifacient agents|mesh-ancestor
24443845|NCT00296010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24443846|NCT00296010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24443855|NCT00296023|Tacrolimus|tacrolimus|mesh-list
25609405|NCT01096680|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25609406|NCT01096771|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25609407|NCT01096771|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25609408|NCT01096771|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25609409|NCT01096771|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25609410|NCT01096784|Mecasermin|mecasermin|mesh-list
25609411|NCT01096784|Growth Substances|growth substances|mesh-ancestor
25609412|NCT01096784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609413|NCT01096849|Levofloxacin|levofloxacin|mesh-list
25609414|NCT01096849|Ofloxacin|ofloxacin|mesh-list
25609415|NCT01096849|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25609416|NCT01096849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25609417|NCT01096849|Renal Agents|renal agents|mesh-ancestor
25609418|NCT01096849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25609419|NCT01096849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25609420|NCT01096849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25609421|NCT01096849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25609422|NCT01096849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609423|NCT01096849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25609424|NCT01096849|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25609425|NCT01096849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25609426|NCT01096875|Atorvastatin|atorvastatin|mesh-list
25609427|NCT01096875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25609428|NCT01096875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25609429|NCT01096875|Antimetabolites|antimetabolites|mesh-ancestor
25609430|NCT01096875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609431|NCT01096875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25609432|NCT01096875|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25609433|NCT01096875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25609434|NCT01096992|Vidarabine|vidarabine|mesh-list
25609435|NCT01096992|Rituximab|rituximab|mesh-list
25609436|NCT01096992|Fludarabine|fludarabine|mesh-list
25609437|NCT01096992|Fludarabine phosphate|fludarabine phosphate|mesh-list
24826810|NCT02136147|Guanfacine|guanfacine|mesh-list
25609438|NCT01096992|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25609439|NCT01096992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25822739|NCT00004637|Vitamins|vitamins|mesh-ancestor
25609440|NCT01096992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25609441|NCT01096992|Immunologic Factors|immunologic factors|mesh-ancestor
25609442|NCT01096992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609443|NCT01096992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25609444|NCT01096992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25609445|NCT01096992|Antimetabolites|antimetabolites|mesh-ancestor
25609446|NCT01096992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609447|NCT01096992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25609448|NCT01096992|Antiviral Agents|antiviral agents|mesh-ancestor
25609449|NCT01096992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25609450|NCT01096992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25609451|NCT01096992|Alkylating Agents|alkylating agents|mesh-ancestor
25609452|NCT01097044|Afamelanotide|afamelanotide|mesh-list
25770666|NCT03557658|Bexagliflozin|bexagliflozin|mesh-list
25609453|NCT01097044|Dermatologic Agents|dermatologic agents|mesh-ancestor
25609454|NCT01097057|Plerixafor|plerixafor|mesh-list
25609455|NCT01097057|Rituximab|rituximab|mesh-list
25609456|NCT01097057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25609457|NCT01097057|Carboplatin|carboplatin|mesh-list
25609458|NCT01097057|Etoposide|etoposide|mesh-list
25609459|NCT01097057|Etoposide phosphate|etoposide phosphate|mesh-list
25609460|NCT01097057|Ifosfamide|ifosfamide|mesh-list
25609461|NCT01097057|Isophosphamide mustard|isophosphamide mustard|mesh-list
25609462|NCT01097057|Podophyllotoxin|podophyllotoxin|mesh-list
25609463|NCT01097057|Antibodies|antibodies|mesh-list
25609464|NCT01097057|Immunoglobulins|immunoglobulins|mesh-list
25609465|NCT01097057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25609466|NCT01097057|Lenograstim|lenograstim|mesh-list
25609467|NCT01097057|Immunologic Factors|immunologic factors|mesh-ancestor
25609468|NCT01097057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609469|NCT01097057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25609470|NCT01097057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25609471|NCT01097057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25609472|NCT01097057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25609473|NCT01097057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25609474|NCT01097057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25609475|NCT01097057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609476|NCT01097057|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25609477|NCT01097057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25609478|NCT01097057|Alkylating Agents|alkylating agents|mesh-ancestor
25609479|NCT01097057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25609480|NCT01097057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25609481|NCT01097057|Antiviral Agents|antiviral agents|mesh-ancestor
25609482|NCT01097057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25609483|NCT01097057|Keratolytic Agents|keratolytic agents|mesh-ancestor
25609484|NCT01097057|Dermatologic Agents|dermatologic agents|mesh-ancestor
25609485|NCT01097057|Tubulin Modulators|tubulin modulators|mesh-ancestor
25609486|NCT01097057|Antimitotic Agents|antimitotic agents|mesh-ancestor
25609487|NCT01097057|Mitosis Modulators|mitosis modulators|mesh-ancestor
25609488|NCT01097304|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25609489|NCT01097304|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25609490|NCT01097304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25609491|NCT01097330|Amiodarone|amiodarone|mesh-list
25609492|NCT01097330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25609493|NCT01097330|Vasodilator Agents|vasodilator agents|mesh-ancestor
25609494|NCT01097330|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25609495|NCT01097330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25609496|NCT01097330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609497|NCT01097330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25609498|NCT01097330|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25609499|NCT01097330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25609500|NCT01097330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25609501|NCT01097330|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25609502|NCT01097330|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25609503|NCT01097330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25609504|NCT01097343|Clopidogrel|clopidogrel|mesh-list
24583946|NCT00877734|Baclofen|baclofen|mesh-list
25609505|NCT01097343|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25609506|NCT01097343|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25609507|NCT01097343|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25609508|NCT01097343|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25609509|NCT01097343|Purinergic Agents|purinergic agents|mesh-ancestor
25609510|NCT01097343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25609511|NCT01097343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503933|NCT00351039|Bevacizumab|bevacizumab|mesh-list
25609512|NCT01097343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609513|NCT01097395|Ribavirin|ribavirin|mesh-list
25609514|NCT01097395|Antimetabolites|antimetabolites|mesh-ancestor
25609515|NCT01097395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609516|NCT01097395|Antiviral Agents|antiviral agents|mesh-ancestor
25609517|NCT01097395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25609518|NCT01097421|Pramipexole|pramipexole|mesh-list
25609519|NCT01097421|Antioxidants|antioxidants|mesh-ancestor
25609520|NCT01097421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609521|NCT01097421|Protective Agents|protective agents|mesh-ancestor
25609522|NCT01097421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609523|NCT01097421|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25609524|NCT01097421|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25609525|NCT01097421|Dopamine Agonists|dopamine agonists|mesh-ancestor
25609526|NCT01097421|Dopamine Agents|dopamine agents|mesh-ancestor
25609527|NCT01097421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25609528|NCT01097460|Trastuzumab|trastuzumab|mesh-list
25609529|NCT01097460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25609530|NCT01097460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25609531|NCT01097577|Pregabalin|pregabalin|mesh-list
25609532|NCT01097577|Analgesics|analgesics|mesh-ancestor
25609533|NCT01097577|Sensory System Agents|sensory system agents|mesh-ancestor
25609534|NCT01097577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25609535|NCT01097577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609536|NCT01097577|Anticonvulsants|anticonvulsants|mesh-ancestor
25609537|NCT01097577|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25609538|NCT01097577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25609539|NCT01097577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609540|NCT01097577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25609541|NCT01097577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25609542|NCT01097577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25609543|NCT01097577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25609544|NCT01097577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25609545|NCT01097616|Suvorexant|suvorexant|mesh-list
25609546|NCT01097616|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25609547|NCT01097616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25609548|NCT01097616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25609549|NCT01097616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609550|NCT01097616|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25609551|NCT01097616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25609552|NCT01097616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609553|NCT01097629|Suvorexant|suvorexant|mesh-list
25609554|NCT01097629|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25609555|NCT01097629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25609556|NCT01097629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25609557|NCT01097629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609558|NCT01097629|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25711270|NCT02298868|Baclofen|baclofen|mesh-list
25609559|NCT01097629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25609560|NCT01097629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609561|NCT01097642|Cetuximab|cetuximab|mesh-list
25609562|NCT01097642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25609563|NCT01097642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25609564|NCT01097694|Imatinib Mesylate|imatinib mesylate|mesh-list
25609565|NCT01097694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25609566|NCT01097694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25609567|NCT01097694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25609568|NCT01097694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654587|NCT01552902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25654588|NCT01552902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25654589|NCT01552902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654590|NCT01552902|Dopamine Agents|dopamine agents|mesh-ancestor
25654591|NCT01552902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25657008|NCT01581970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25657009|NCT01581970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25657010|NCT01581970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25657011|NCT01582061|Pasireotide|pasireotide|mesh-list
25657012|NCT01582061|Hormones|hormones|mesh-ancestor
25657013|NCT01582061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25657014|NCT01582061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657015|NCT01582152|Bevacizumab|bevacizumab|mesh-list
25657016|NCT01582152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25657017|NCT01582152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25657018|NCT01582152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25657019|NCT01582152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25657020|NCT01582152|Growth Substances|growth substances|mesh-ancestor
25609569|NCT01097785|Simvastatin|simvastatin|mesh-list
25609570|NCT01097785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25609571|NCT01097785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25609572|NCT01097785|Antimetabolites|antimetabolites|mesh-ancestor
25609573|NCT01097785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609574|NCT01097785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25609575|NCT01097785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25609576|NCT01097785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25609577|NCT01098097|Ribavirin|ribavirin|mesh-list
25609578|NCT01098097|Antimetabolites|antimetabolites|mesh-ancestor
25609579|NCT01098097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609580|NCT01098097|Antiviral Agents|antiviral agents|mesh-ancestor
25609581|NCT01098097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25609582|NCT01098305|Varenicline|varenicline|mesh-list
25609583|NCT01098305|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25609584|NCT01098305|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25609585|NCT01098305|Cholinergic Agents|cholinergic agents|mesh-ancestor
25609586|NCT01098305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25609587|NCT01098305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609588|NCT01098305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609589|NCT01098318|Sertraline|sertraline|mesh-list
25609590|NCT01098318|Antidepressive Agents|antidepressive agents|mesh-ancestor
25609591|NCT01098318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25609592|NCT01098318|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25609593|NCT01098318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25609594|NCT01098318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25609595|NCT01098318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609596|NCT01098318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25609597|NCT01098318|Serotonin Agents|serotonin agents|mesh-ancestor
25609598|NCT01098318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609599|NCT01098461|rGLP-1 protein|rglp-1 protein|mesh-list
25609600|NCT01098461|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25609601|NCT01098461|Incretins|incretins|mesh-ancestor
25609602|NCT01098461|Hormones|hormones|mesh-ancestor
25609603|NCT01098461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25609604|NCT01098461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609605|NCT01098474|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25609606|NCT01098474|Immunologic Factors|immunologic factors|mesh-ancestor
25609607|NCT01098474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609608|NCT01098539|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25609609|NCT01098539|rGLP-1 protein|rglp-1 protein|mesh-list
25609610|NCT01098539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25609611|NCT01098539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609612|NCT01098539|Incretins|incretins|mesh-ancestor
25609613|NCT01098539|Hormones|hormones|mesh-ancestor
25609614|NCT01098539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25609615|NCT01098539|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25609616|NCT01098539|Protease Inhibitors|protease inhibitors|mesh-ancestor
25609617|NCT01098539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25609618|NCT01098539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609619|NCT01098747|Ibuprofen|ibuprofen|mesh-list
25609620|NCT01098747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25609621|NCT01098747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25609622|NCT01098747|Analgesics|analgesics|mesh-ancestor
25609623|NCT01098747|Sensory System Agents|sensory system agents|mesh-ancestor
25609624|NCT01098747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25609625|NCT01098747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609626|NCT01098747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25609627|NCT01098747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25609628|NCT01098747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25609629|NCT01098747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25609630|NCT01098747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609631|NCT01099202|Epoetin Alfa|epoetin alfa|mesh-list
25609632|NCT01099202|Hematinics|hematinics|mesh-ancestor
25609633|NCT01099358|Cisplatin|cisplatin|mesh-list
25609634|NCT01099358|Fluorouracil|fluorouracil|mesh-list
25609635|NCT01099358|Cetuximab|cetuximab|mesh-list
25609636|NCT01099358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25609637|NCT01099358|Antimetabolites|antimetabolites|mesh-ancestor
25609638|NCT01099358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609639|NCT01099358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25609640|NCT01099358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25609641|NCT01099358|Immunologic Factors|immunologic factors|mesh-ancestor
25654592|NCT01552915|Methylphenidate|methylphenidate|mesh-list
25609642|NCT01099358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609643|NCT01099358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25609644|NCT01099449|Oxaliplatin|oxaliplatin|mesh-list
25609645|NCT01099449|Magnesium Sulfate|magnesium sulfate|mesh-list
25609646|NCT01099449|Calcium|calcium|mesh-list
25609647|NCT01099449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25609648|NCT01099449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609649|NCT01099449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25609650|NCT01099449|Analgesics|analgesics|mesh-ancestor
25609651|NCT01099449|Sensory System Agents|sensory system agents|mesh-ancestor
25609652|NCT01099449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25609653|NCT01099449|Anesthetics|anesthetics|mesh-ancestor
25609654|NCT01099449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25609655|NCT01099449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25609656|NCT01099449|Anticonvulsants|anticonvulsants|mesh-ancestor
25609657|NCT01099449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25609658|NCT01099449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25609659|NCT01099449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609660|NCT01099449|Tocolytic Agents|tocolytic agents|mesh-ancestor
25609661|NCT01099449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25609662|NCT01099579|Ritonavir|ritonavir|mesh-list
25609663|NCT01099579|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25609664|NCT01099579|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25609665|NCT01099579|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25609666|NCT01099579|Protease Inhibitors|protease inhibitors|mesh-ancestor
25609667|NCT01099579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25609668|NCT01099579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609669|NCT01099579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25609670|NCT01099579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25609671|NCT01099579|Antiviral Agents|antiviral agents|mesh-ancestor
25609672|NCT01099579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25609673|NCT01099579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25609674|NCT01099579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25609675|NCT01099618|Metformin|metformin|mesh-list
25609676|NCT01099618|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25609677|NCT01099618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25609678|NCT01099618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609679|NCT01099618|Incretins|incretins|mesh-ancestor
25609680|NCT01099618|Hormones|hormones|mesh-ancestor
25609681|NCT01099618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25609682|NCT01099618|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25609683|NCT01099618|Protease Inhibitors|protease inhibitors|mesh-ancestor
25609684|NCT01099618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25609685|NCT01099618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609686|NCT01099709|Oxycodone|oxycodone|mesh-list
25609687|NCT01099709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25609688|NCT01099709|Narcotics|narcotics|mesh-ancestor
25609689|NCT01099709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25609690|NCT01099709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609691|NCT01099709|Analgesics|analgesics|mesh-ancestor
25609692|NCT01099709|Sensory System Agents|sensory system agents|mesh-ancestor
25609693|NCT01099709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25609694|NCT01099774|Bimatoprost|bimatoprost|mesh-list
25609695|NCT01099774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25609696|NCT01099774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25609697|NCT01099774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25609698|NCT01100034|Etanercept|etanercept|mesh-list
25609699|NCT01100034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25609700|NCT01100034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25609701|NCT01100034|Analgesics|analgesics|mesh-ancestor
25609702|NCT01100034|Sensory System Agents|sensory system agents|mesh-ancestor
25609703|NCT01100034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25609704|NCT01100034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609705|NCT01100034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25609706|NCT01100034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25504137|NCT00352794|Hormones|hormones|mesh-ancestor
25504138|NCT00352794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25504139|NCT00352794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504140|NCT00352794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25504141|NCT00352794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25609707|NCT01100034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25609708|NCT01100034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25504142|NCT00352794|Immunologic Factors|immunologic factors|mesh-ancestor
25504143|NCT00352794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25609709|NCT01100034|Immunologic Factors|immunologic factors|mesh-ancestor
25609710|NCT01100086|Oxycodone|oxycodone|mesh-list
25609711|NCT01100086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25609712|NCT01100086|Narcotics|narcotics|mesh-ancestor
25609713|NCT01100086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25609714|NCT01100086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609715|NCT01100086|Analgesics|analgesics|mesh-ancestor
25609716|NCT01100086|Sensory System Agents|sensory system agents|mesh-ancestor
25609717|NCT01100086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25609718|NCT01100112|Budesonide|budesonide|mesh-list
25609719|NCT01100112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25609720|NCT01100112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25609721|NCT01100112|Autonomic Agents|autonomic agents|mesh-ancestor
25609722|NCT01100112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25609723|NCT01100112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609724|NCT01100112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25609725|NCT01100112|Respiratory System Agents|respiratory system agents|mesh-ancestor
25609726|NCT01100112|Glucocorticoids|glucocorticoids|mesh-ancestor
25609727|NCT01100112|Hormones|hormones|mesh-ancestor
25609728|NCT01100112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25609729|NCT01100242|Bortezomib|bortezomib|mesh-list
25609730|NCT01100242|Sorafenib|sorafenib|mesh-list
25609731|NCT01100242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25609732|NCT01100242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25609733|NCT01100242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25609734|NCT01100242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609735|NCT01100255|Ketamine|ketamine|mesh-list
25609736|NCT01100255|Analgesics|analgesics|mesh-ancestor
25609737|NCT01100255|Sensory System Agents|sensory system agents|mesh-ancestor
25609738|NCT01100255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25609739|NCT01100255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609740|NCT01100255|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25609741|NCT01100255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25609742|NCT01100255|Anesthetics, General|anesthetics, general|mesh-ancestor
25609743|NCT01100255|Anesthetics|anesthetics|mesh-ancestor
25609744|NCT01100255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25609745|NCT01100255|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25609746|NCT01100255|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25609747|NCT01100255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25609748|NCT01100255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609749|NCT01100268|Methylphenidate|methylphenidate|mesh-list
25609750|NCT01100268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25609751|NCT01100268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609752|NCT01100268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25609753|NCT01100268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25609754|NCT01100268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25609755|NCT01100268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609756|NCT01100268|Dopamine Agents|dopamine agents|mesh-ancestor
25609757|NCT01100268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25609758|NCT01100320|Oxycodone|oxycodone|mesh-list
25609759|NCT01100320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25609760|NCT01100320|Narcotics|narcotics|mesh-ancestor
25609761|NCT01100320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25609762|NCT01100320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609763|NCT01100320|Analgesics|analgesics|mesh-ancestor
25609764|NCT01100320|Sensory System Agents|sensory system agents|mesh-ancestor
25609765|NCT01100320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25609766|NCT01100437|Naltrexone|naltrexone|mesh-list
25609767|NCT01100437|Morphine|morphine|mesh-list
25609768|NCT01100437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25609769|NCT01100437|Narcotics|narcotics|mesh-ancestor
25609770|NCT01100437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25609771|NCT01100437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609772|NCT01100437|Analgesics|analgesics|mesh-ancestor
25609773|NCT01100437|Sensory System Agents|sensory system agents|mesh-ancestor
25609774|NCT01100437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25609775|NCT01100437|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25609776|NCT01100437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25609777|NCT01100502|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25609778|NCT01100502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25609779|NCT01100502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25609780|NCT01100528|Interferons|interferons|mesh-list
25609781|NCT01100528|Interferon-alpha|interferon-alpha|mesh-list
25609782|NCT01100528|Interferon alpha-2|interferon alpha-2|mesh-list
25609783|NCT01100528|Dacarbazine|dacarbazine|mesh-list
25609784|NCT01100528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25609785|NCT01100528|Antiviral Agents|antiviral agents|mesh-ancestor
25609786|NCT01100528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25609787|NCT01100528|Immunologic Factors|immunologic factors|mesh-ancestor
25609788|NCT01100528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609789|NCT01100528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25609790|NCT01100528|Alkylating Agents|alkylating agents|mesh-ancestor
25609791|NCT01100528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609793|NCT01100606|Pancreatin|pancreatin|mesh-list
25609794|NCT01100606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25654593|NCT01552915|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25654594|NCT01552915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25654595|NCT01552915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654596|NCT01552915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25654597|NCT01552915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25654598|NCT01552915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25654599|NCT01552915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654600|NCT01552915|Dopamine Agents|dopamine agents|mesh-ancestor
25654601|NCT01552915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25654602|NCT01552928|Moxifloxacin|moxifloxacin|mesh-list
25654603|NCT01552928|Anagrelide|anagrelide|mesh-list
25654604|NCT01552928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25654605|NCT01552928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25654606|NCT01552928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25654607|NCT01552928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25654608|NCT01552928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25654609|NCT01552928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654610|NCT01552928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25654611|NCT01552928|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25654612|NCT01552928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25654613|NCT01552928|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25654614|NCT01552954|Angiotensin II|angiotensin ii|mesh-list
25654615|NCT01552954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25654616|NCT01553058|Adalimumab|adalimumab|mesh-list
25654617|NCT01553058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25654618|NCT01553058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25654619|NCT01553084|Nicotine|nicotine|mesh-list
25654620|NCT01553084|Varenicline|varenicline|mesh-list
25654621|NCT01553084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25654622|NCT01553084|Autonomic Agents|autonomic agents|mesh-ancestor
25654623|NCT01553084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25654624|NCT01553084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654625|NCT01553084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25654626|NCT01553084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25654627|NCT01553084|Cholinergic Agents|cholinergic agents|mesh-ancestor
25654628|NCT01553084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25654629|NCT01553084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654630|NCT01553136|Varenicline|varenicline|mesh-list
25654631|NCT01553136|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25654632|NCT01553136|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25654633|NCT01553136|Cholinergic Agents|cholinergic agents|mesh-ancestor
25654634|NCT01553136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25654635|NCT01553136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654636|NCT01553136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654637|NCT01553188|Prednisone|prednisone|mesh-list
25654638|NCT01553188|Trebananib|trebananib|mesh-list
25654639|NCT01553188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25654640|NCT01553188|Glucocorticoids|glucocorticoids|mesh-ancestor
25654641|NCT01553188|Hormones|hormones|mesh-ancestor
25654642|NCT01553188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25654643|NCT01553188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654644|NCT01553188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25654645|NCT01553188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25654646|NCT01553188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25654647|NCT01553188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25654648|NCT01553188|Growth Substances|growth substances|mesh-ancestor
25654649|NCT01553188|Growth Inhibitors|growth inhibitors|mesh-ancestor
25654650|NCT01553201|Botulinum Toxins|botulinum toxins|mesh-list
25654651|NCT01553201|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25654652|NCT01553201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25654653|NCT01553201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654654|NCT01553201|Cholinergic Agents|cholinergic agents|mesh-ancestor
25654655|NCT01553201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25504274|NCT00353704|Pregabalin|pregabalin|mesh-list
25609795|NCT01100723|Vitamin D|vitamin d|mesh-list
25609796|NCT01100723|Calcitriol|calcitriol|mesh-list
25609797|NCT01100723|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
25609798|NCT01100723|Cinacalcet|cinacalcet|mesh-list
25609799|NCT01100723|Vitamins|vitamins|mesh-ancestor
25609800|NCT01100723|Micronutrients|micronutrients|mesh-ancestor
25609801|NCT01100723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609802|NCT01100723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25609803|NCT01100723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25609804|NCT01100723|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25609805|NCT01100723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25609806|NCT01100723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609807|NCT01100723|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25609808|NCT01100723|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25609809|NCT01100723|Hormone Antagonists|hormone antagonists|mesh-ancestor
25609810|NCT01100723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25609811|NCT01100853|Naltrexone|naltrexone|mesh-list
25609812|NCT01100853|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25609813|NCT01100853|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25609814|NCT01100853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609815|NCT01100853|Sensory System Agents|sensory system agents|mesh-ancestor
25609816|NCT01100853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25609817|NCT01100931|Paclitaxel|paclitaxel|mesh-list
25609818|NCT01100931|Carboplatin|carboplatin|mesh-list
25609819|NCT01100931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25609820|NCT01100931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25609821|NCT01100931|Tubulin Modulators|tubulin modulators|mesh-ancestor
25609822|NCT01100931|Antimitotic Agents|antimitotic agents|mesh-ancestor
25609823|NCT01100931|Mitosis Modulators|mitosis modulators|mesh-ancestor
25609824|NCT01100931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609825|NCT01100944|Cyclophosphamide|cyclophosphamide|mesh-list
25609826|NCT01100944|Cisplatin|cisplatin|mesh-list
25609827|NCT01100944|Doxorubicin|doxorubicin|mesh-list
25609828|NCT01100944|Belinostat|belinostat|mesh-list
25609829|NCT01100944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25609830|NCT01100944|Immunologic Factors|immunologic factors|mesh-ancestor
25609831|NCT01100944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609832|NCT01100944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25609833|NCT01100944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25609834|NCT01100944|Alkylating Agents|alkylating agents|mesh-ancestor
25609835|NCT01100944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609836|NCT01100944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25609837|NCT01100944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25609838|NCT01100944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25609839|NCT01100944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25609840|NCT01100944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25609841|NCT01100944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25609842|NCT01100944|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25609843|NCT01101022|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25609844|NCT01101022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25609845|NCT01101022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609846|NCT01101022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25609847|NCT01101022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25609848|NCT01101022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25609849|NCT01101022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609850|NCT01101022|Dopamine Agents|dopamine agents|mesh-ancestor
25609851|NCT01101022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25609852|NCT01101035|Allopurinol|allopurinol|mesh-list
25609853|NCT01101035|Febuxostat|febuxostat|mesh-list
25609854|NCT01101035|Antimetabolites|antimetabolites|mesh-ancestor
25609855|NCT01101035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609856|NCT01101035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25609857|NCT01101035|Gout Suppressants|gout suppressants|mesh-ancestor
24719557|NCT01562483|Dronabinol|dronabinol|mesh-list
25609858|NCT01101035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25609859|NCT01101035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25609860|NCT01101035|Antioxidants|antioxidants|mesh-ancestor
25609861|NCT01101035|Protective Agents|protective agents|mesh-ancestor
25609862|NCT01101035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609863|NCT01101100|Brodalumab|brodalumab|mesh-list
25609864|NCT01101100|Dermatologic Agents|dermatologic agents|mesh-ancestor
25609865|NCT01101165|Oxycodone|oxycodone|mesh-list
25609866|NCT01101165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25609867|NCT01101165|Narcotics|narcotics|mesh-ancestor
25609868|NCT01101165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25609869|NCT01101165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504427|NCT00354224|Capecitabine|capecitabine|mesh-list
25504428|NCT00354224|Oxaliplatin|oxaliplatin|mesh-list
25504429|NCT00354224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25504430|NCT00354224|Antimetabolites|antimetabolites|mesh-ancestor
25504431|NCT00354224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504432|NCT00354224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504433|NCT00354341|Epoetin Alfa|epoetin alfa|mesh-list
25504434|NCT00354341|Hematinics|hematinics|mesh-ancestor
25504435|NCT00354432|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25504437|NCT00354432|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25504438|NCT00354432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25504439|NCT00354432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25504440|NCT00354432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504441|NCT00354432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25504442|NCT00354432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504443|NCT00354432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25504444|NCT00354432|Antidepressive Agents|antidepressive agents|mesh-ancestor
25504445|NCT00354432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25504446|NCT00354432|Chelating Agents|chelating agents|mesh-ancestor
25504447|NCT00354432|Sequestering Agents|sequestering agents|mesh-ancestor
25504448|NCT00354601|Docetaxel|docetaxel|mesh-list
25504449|NCT00354601|Capecitabine|capecitabine|mesh-list
25504450|NCT00354601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504451|NCT00354601|Tubulin Modulators|tubulin modulators|mesh-ancestor
25504452|NCT00354601|Antimitotic Agents|antimitotic agents|mesh-ancestor
25504453|NCT00354601|Mitosis Modulators|mitosis modulators|mesh-ancestor
25504454|NCT00354601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504455|NCT00354601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25504456|NCT00354601|Antimetabolites|antimetabolites|mesh-ancestor
24422620|NCT00223223|Nootropic Agents|nootropic agents|mesh-ancestor
24740289|NCT01687517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740290|NCT01687582|Liraglutide|liraglutide|mesh-list
24740291|NCT01687582|Exenatide|exenatide|mesh-list
24979785|NCT05241054|Nitroglycerin|nitroglycerin|mesh-list
24979786|NCT05241054|Fentanyl|fentanyl|mesh-list
24979787|NCT05241054|Bupivacaine|bupivacaine|mesh-list
24979788|NCT05241054|Propofol|propofol|mesh-list
24979789|NCT05241054|Sevoflurane|sevoflurane|mesh-list
24979790|NCT05241054|Atracurium|atracurium|mesh-list
24436146|NCT00269126|Glucocorticoids|glucocorticoids|mesh-ancestor
24436147|NCT00269126|Hormones|hormones|mesh-ancestor
24436148|NCT00269126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25609870|NCT01101165|Analgesics|analgesics|mesh-ancestor
24436149|NCT00269126|Sympathomimetics|sympathomimetics|mesh-ancestor
24436150|NCT00269204|Niacin|niacin|mesh-list
24436189|NCT00269334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25609871|NCT01101165|Sensory System Agents|sensory system agents|mesh-ancestor
25609872|NCT01101165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25609873|NCT01101178|Oxycodone|oxycodone|mesh-list
25609874|NCT01101178|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25609875|NCT01101178|Narcotics|narcotics|mesh-ancestor
25711314|NCT02299297|Tofacitinib|tofacitinib|mesh-list
25609876|NCT01101178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25609877|NCT01101178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609878|NCT01101178|Analgesics|analgesics|mesh-ancestor
25609879|NCT01101178|Sensory System Agents|sensory system agents|mesh-ancestor
25609880|NCT01101178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25609881|NCT01101191|Oxycodone|oxycodone|mesh-list
25609882|NCT01101191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25609883|NCT01101191|Narcotics|narcotics|mesh-ancestor
25609884|NCT01101191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25609885|NCT01101191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609886|NCT01101191|Analgesics|analgesics|mesh-ancestor
25609887|NCT01101191|Sensory System Agents|sensory system agents|mesh-ancestor
25609888|NCT01101191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25609889|NCT01101308|Oxycodone|oxycodone|mesh-list
25609890|NCT01101308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25609891|NCT01101308|Narcotics|narcotics|mesh-ancestor
25609892|NCT01101308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25609893|NCT01101308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609894|NCT01101308|Analgesics|analgesics|mesh-ancestor
25609895|NCT01101308|Sensory System Agents|sensory system agents|mesh-ancestor
25609896|NCT01101308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25609897|NCT01101321|Oxycodone|oxycodone|mesh-list
25609898|NCT01101321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25609899|NCT01101321|Narcotics|narcotics|mesh-ancestor
25609900|NCT01101321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25609901|NCT01101321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609902|NCT01101321|Analgesics|analgesics|mesh-ancestor
25609903|NCT01101321|Sensory System Agents|sensory system agents|mesh-ancestor
25609904|NCT01101321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25609905|NCT01101334|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25609906|NCT01101334|Efatutazone|efatutazone|mesh-list
25609907|NCT01101334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25609908|NCT01101334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25609909|NCT01101334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25609910|NCT01101334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609911|NCT01101750|Vaccines|vaccines|mesh-list
25609912|NCT01101750|Immunologic Factors|immunologic factors|mesh-ancestor
25609913|NCT01101750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609914|NCT01101841|Paroxetine|paroxetine|mesh-list
25609915|NCT01101841|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25609916|NCT01101841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25609917|NCT01101841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25609918|NCT01101841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609919|NCT01101841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25609920|NCT01101841|Serotonin Agents|serotonin agents|mesh-ancestor
25609921|NCT01101841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609922|NCT01101841|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25609923|NCT01101841|Antidepressive Agents|antidepressive agents|mesh-ancestor
25609924|NCT01101841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25609925|NCT01101841|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25609926|NCT01101841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25609927|NCT01101841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25609928|NCT01101867|Insulin Aspart|insulin aspart|mesh-list
25609929|NCT01101867|Insulin, Long-Acting|insulin, long-acting|mesh-list
25609930|NCT01101867|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25609931|NCT01101867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25609932|NCT01101867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609933|NCT01101880|Cytarabine|cytarabine|mesh-list
25609934|NCT01101880|Clofarabine|clofarabine|mesh-list
25609935|NCT01101880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25609936|NCT01101880|Antimetabolites|antimetabolites|mesh-ancestor
25609937|NCT01101880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609938|NCT01101880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25609939|NCT01101880|Antiviral Agents|antiviral agents|mesh-ancestor
25609940|NCT01101880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25609941|NCT01101880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25609942|NCT01101880|Immunologic Factors|immunologic factors|mesh-ancestor
25609943|NCT01101880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609944|NCT01102218|Pentoxifylline|pentoxifylline|mesh-list
25609945|NCT01102218|Epoetin Alfa|epoetin alfa|mesh-list
25609946|NCT01102218|Hematinics|hematinics|mesh-ancestor
25609947|NCT01102218|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25609948|NCT01102218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25609949|NCT01102218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609950|NCT01102218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25609951|NCT01102218|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25609952|NCT01102218|Protective Agents|protective agents|mesh-ancestor
25609953|NCT01102218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609954|NCT01102218|Vasodilator Agents|vasodilator agents|mesh-ancestor
25609955|NCT01102218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25609956|NCT01102218|Antioxidants|antioxidants|mesh-ancestor
25609957|NCT01102231|Cetuximab|cetuximab|mesh-list
25609958|NCT01102231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25609959|NCT01102231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25609960|NCT01102270|Eszopiclone|eszopiclone|mesh-list
25609961|NCT01102270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25609962|NCT01102270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25609963|NCT01102270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609964|NCT01102374|Vitamin D|vitamin d|mesh-list
25609965|NCT01102374|Ergocalciferols|ergocalciferols|mesh-list
25609966|NCT01102374|Cholecalciferol|cholecalciferol|mesh-list
25609967|NCT01102374|Vitamins|vitamins|mesh-list
25609968|NCT01102374|Micronutrients|micronutrients|mesh-ancestor
25609969|NCT01102374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609970|NCT01102374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25609971|NCT01102374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25609972|NCT01102426|Dexamethasone|dexamethasone|mesh-list
25609973|NCT01102426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25609974|NCT01102426|Antiemetics|antiemetics|mesh-ancestor
25609975|NCT01102426|Autonomic Agents|autonomic agents|mesh-ancestor
25609976|NCT01102426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25609977|NCT01102426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609978|NCT01102426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25609979|NCT01102426|Glucocorticoids|glucocorticoids|mesh-ancestor
25609981|NCT01102426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25609982|NCT01102426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25609983|NCT01102426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25609984|NCT01102491|Ramosetron|ramosetron|mesh-list
25609985|NCT01102491|Antiemetics|antiemetics|mesh-ancestor
25609986|NCT01102491|Autonomic Agents|autonomic agents|mesh-ancestor
25609987|NCT01102491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25609988|NCT01102491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25609989|NCT01102491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25609990|NCT01102491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25609991|NCT01102491|Serotonin Agents|serotonin agents|mesh-ancestor
25609992|NCT01102491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25609993|NCT01102491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25609994|NCT01102803|Cycloserine|cycloserine|mesh-list
25609995|NCT01102803|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25609996|NCT01102803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25609997|NCT01102803|Renal Agents|renal agents|mesh-ancestor
25609998|NCT01102803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25609999|NCT01102803|Antitubercular Agents|antitubercular agents|mesh-ancestor
25610000|NCT01102803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25610001|NCT01102803|Antimetabolites|antimetabolites|mesh-ancestor
25610002|NCT01102803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610003|NCT01102972|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25610004|NCT01102972|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25610005|NCT01102972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25610006|NCT01102972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25610007|NCT01102972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610008|NCT01102972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610009|NCT01102972|Antiviral Agents|antiviral agents|mesh-ancestor
25711322|NCT02299336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610010|NCT01102972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25610011|NCT01102972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25610012|NCT01102972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25610013|NCT01102972|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25610014|NCT01102972|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25610015|NCT01102972|Protease Inhibitors|protease inhibitors|mesh-ancestor
25610016|NCT01103063|Azithromycin|azithromycin|mesh-list
25610017|NCT01103063|Chloroquine|chloroquine|mesh-list
25610018|NCT01103063|Pyrimethamine|pyrimethamine|mesh-list
25610019|NCT01103063|Sulfadoxine|sulfadoxine|mesh-list
25610020|NCT01103063|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25610021|NCT01103063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25610022|NCT01103063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25610023|NCT01103063|Amebicides|amebicides|mesh-ancestor
25610024|NCT01103063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25610025|NCT01103063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25610026|NCT01103063|Antimalarials|antimalarials|mesh-ancestor
25610027|NCT01103063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25610028|NCT01103063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25610029|NCT01103063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610030|NCT01103063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610031|NCT01103063|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25610032|NCT01103063|Renal Agents|renal agents|mesh-ancestor
25610033|NCT01103245|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25610034|NCT01103245|Spironolactone|spironolactone|mesh-list
25610035|NCT01103245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25610036|NCT01103245|Diuretics|diuretics|mesh-ancestor
25610037|NCT01103245|Natriuretic Agents|natriuretic agents|mesh-ancestor
25610038|NCT01103245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610039|NCT01103245|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25610040|NCT01103245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25610041|NCT01103245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610042|NCT01103245|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25610043|NCT01103245|Hormone Antagonists|hormone antagonists|mesh-ancestor
25610044|NCT01103245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25610045|NCT01103245|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25610046|NCT01103414|Pioglitazone|pioglitazone|mesh-list
25610047|NCT01103414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25610048|NCT01103414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610049|NCT01103440|polysaccharide-K|polysaccharide-k|mesh-list
25610050|NCT01103440|Tirofiban|tirofiban|mesh-list
25610051|NCT01103440|Ticlopidine|ticlopidine|mesh-list
25610052|NCT01103440|Abciximab|abciximab|mesh-list
25610053|NCT01103440|Clopidogrel|clopidogrel|mesh-list
25610054|NCT01103440|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25610055|NCT01103440|Cangrelor|cangrelor|mesh-list
25610056|NCT01103440|Eptifibatide|eptifibatide|mesh-list
25610057|NCT01103440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25610058|NCT01103440|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25610059|NCT01103440|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25610060|NCT01103440|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25610061|NCT01103440|Purinergic Agents|purinergic agents|mesh-ancestor
25610062|NCT01103440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25610063|NCT01103440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610064|NCT01103440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610065|NCT01103440|Anticoagulants|anticoagulants|mesh-ancestor
25610066|NCT01103440|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25610067|NCT01103440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25610068|NCT01103440|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25610069|NCT01103440|Immunologic Factors|immunologic factors|mesh-ancestor
25610070|NCT01103440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25610071|NCT01103440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25610072|NCT01103440|Antiviral Agents|antiviral agents|mesh-ancestor
25610073|NCT01103440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25610074|NCT01103440|Interferon Inducers|interferon inducers|mesh-ancestor
25610075|NCT01103440|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25610076|NCT01103440|Protective Agents|protective agents|mesh-ancestor
25610077|NCT01103440|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25610078|NCT01103440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25610079|NCT01103440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610080|NCT01103713|Azithromycin|azithromycin|mesh-list
25610081|NCT01103713|Chloroquine|chloroquine|mesh-list
25610082|NCT01103713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25610083|NCT01103713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25610084|NCT01103713|Amebicides|amebicides|mesh-ancestor
25610085|NCT01103713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25610086|NCT01103713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25610087|NCT01103713|Antimalarials|antimalarials|mesh-ancestor
25610088|NCT01103713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25610089|NCT01103778|Bortezomib|bortezomib|mesh-list
25610090|NCT01103778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25610091|NCT01103934|Vitamin D|vitamin d|mesh-list
25610092|NCT01103934|Cholecalciferol|cholecalciferol|mesh-list
25610093|NCT01103934|Fluticasone|fluticasone|mesh-list
25610094|NCT01103934|Xhance|xhance|mesh-list
25610095|NCT01103934|Vitamins|vitamins|mesh-ancestor
25610096|NCT01103934|Micronutrients|micronutrients|mesh-ancestor
25610097|NCT01103934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610098|NCT01103934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25610099|NCT01103934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25610100|NCT01103934|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25610101|NCT01103934|Autonomic Agents|autonomic agents|mesh-ancestor
25610102|NCT01103934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25610103|NCT01103934|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25610104|NCT01103934|Respiratory System Agents|respiratory system agents|mesh-ancestor
25610105|NCT01103934|Dermatologic Agents|dermatologic agents|mesh-ancestor
25610106|NCT01103934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25610107|NCT01103934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25610108|NCT01103960|Amlodipine|amlodipine|mesh-list
25610109|NCT01103960|Telmisartan|telmisartan|mesh-list
25610110|NCT01103960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25610111|NCT01103960|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25610112|NCT01103960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25610113|NCT01103960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610114|NCT01103960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25610115|NCT01103960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610116|NCT01103960|Vasodilator Agents|vasodilator agents|mesh-ancestor
25610117|NCT01103960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25610118|NCT01103960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25610119|NCT01104025|Dexamethasone|dexamethasone|mesh-list
25610120|NCT01104025|Hydrocortisone|hydrocortisone|mesh-list
25610121|NCT01104025|Methotrexate|methotrexate|mesh-list
25610122|NCT01104025|Etoposide|etoposide|mesh-list
25610123|NCT01104025|Thymoglobulin|thymoglobulin|mesh-list
25610124|NCT01104025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25610125|NCT01104025|Antiemetics|antiemetics|mesh-ancestor
25610126|NCT01104025|Autonomic Agents|autonomic agents|mesh-ancestor
25610127|NCT01104025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25610128|NCT01104025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610129|NCT01104025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25610130|NCT01104025|Glucocorticoids|glucocorticoids|mesh-ancestor
25610131|NCT01104025|Hormones|hormones|mesh-ancestor
25711339|NCT02299349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25610132|NCT01104025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25610133|NCT01104025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25610134|NCT01104025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25610135|NCT01104025|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25610136|NCT01104025|Abortifacient Agents|abortifacient agents|mesh-ancestor
25610137|NCT01104025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25610138|NCT01104025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25610139|NCT01104025|Antimetabolites|antimetabolites|mesh-ancestor
25610140|NCT01104025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610141|NCT01104025|Dermatologic Agents|dermatologic agents|mesh-ancestor
25610142|NCT01104025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610143|NCT01104025|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25610144|NCT01104025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25610145|NCT01104025|Immunologic Factors|immunologic factors|mesh-ancestor
25610146|NCT01104025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25610147|NCT01104025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25610148|NCT01104025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25610149|NCT01104025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25610150|NCT01104025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25610151|NCT01104155|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25610152|NCT01104155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25610153|NCT01104155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25610154|NCT01104155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610155|NCT01104155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610156|NCT01104246|Testosterone|testosterone|mesh-list
25610157|NCT01104246|Androgens|androgens|mesh-ancestor
25610158|NCT01104246|Hormones|hormones|mesh-ancestor
25610159|NCT01104246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25610160|NCT01104246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610161|NCT01104376|Efavirenz|efavirenz|mesh-list
25610162|NCT01104376|Voriconazole|voriconazole|mesh-list
25610163|NCT01104376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25610164|NCT01104376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25610165|NCT01104376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610166|NCT01104376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610167|NCT01104376|Antiviral Agents|antiviral agents|mesh-ancestor
25610168|NCT01104376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25610169|NCT01104376|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25610170|NCT01104376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25610171|NCT01104376|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25610172|NCT01104376|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25610173|NCT01104376|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25610174|NCT01104376|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25610175|NCT01104376|Antifungal Agents|antifungal agents|mesh-ancestor
25610176|NCT01104376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25610177|NCT01104376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25610178|NCT01104376|Hormone Antagonists|hormone antagonists|mesh-ancestor
25610179|NCT01104376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25610180|NCT01104376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610181|NCT01104376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25610182|NCT01104558|Bisoprolol|bisoprolol|mesh-list
25610183|NCT01104558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25610184|NCT01104558|Sympatholytics|sympatholytics|mesh-ancestor
25610185|NCT01104558|Autonomic Agents|autonomic agents|mesh-ancestor
25610186|NCT01104558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25610187|NCT01104558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610188|NCT01104558|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25610189|NCT01104558|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25610190|NCT01104558|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25610191|NCT01104558|Adrenergic Agents|adrenergic agents|mesh-ancestor
25610192|NCT01104558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25610193|NCT01104558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610194|NCT01104636|Varenicline|varenicline|mesh-list
25610195|NCT01104636|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25610196|NCT01104636|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25610197|NCT01104636|Cholinergic Agents|cholinergic agents|mesh-ancestor
25610198|NCT01104636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25610199|NCT01104636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610200|NCT01104636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610201|NCT01104662|Vancomycin|vancomycin|mesh-list
25610202|NCT01104662|Daptomycin|daptomycin|mesh-list
25610203|NCT01104662|Penicillins|penicillins|mesh-list
25610204|NCT01104662|Cloxacillin|cloxacillin|mesh-list
25610205|NCT01104662|Oxacillin|oxacillin|mesh-list
25610206|NCT01104662|Nafcillin|nafcillin|mesh-list
25610207|NCT01104662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25610208|NCT01104662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25610209|NCT01104701|Exenatide|exenatide|mesh-list
25610210|NCT01104701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25610211|NCT01104701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610212|NCT01104701|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25610213|NCT01104701|Incretins|incretins|mesh-ancestor
25610214|NCT01104701|Hormones|hormones|mesh-ancestor
25610215|NCT01104701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25610216|NCT01104766|Aripiprazole|aripiprazole|mesh-list
25610217|NCT01104766|Cariprazine|cariprazine|mesh-list
25610218|NCT01104766|Antidepressive Agents|antidepressive agents|mesh-ancestor
25610219|NCT01104766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25610220|NCT01104766|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25610221|NCT01104766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25610222|NCT01104766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25610223|NCT01104766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610224|NCT01104766|Dopamine Agonists|dopamine agonists|mesh-ancestor
25610225|NCT01104766|Dopamine Agents|dopamine agents|mesh-ancestor
25610226|NCT01104766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25610227|NCT01104766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610228|NCT01104766|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25610229|NCT01104766|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25610230|NCT01104766|Serotonin Agents|serotonin agents|mesh-ancestor
25610231|NCT01104766|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25610232|NCT01104766|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25610233|NCT01104766|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25610234|NCT01104766|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25610235|NCT01104779|Cariprazine|cariprazine|mesh-list
25610236|NCT01104779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25610237|NCT01104779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25610238|NCT01104779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25610239|NCT01104779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610240|NCT01104779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25610241|NCT01104792|Cariprazine|cariprazine|mesh-list
25610242|NCT01104792|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25610243|NCT01104792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25610244|NCT01104792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25610245|NCT01104792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610246|NCT01104792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25610247|NCT01104870|Treprostinil|treprostinil|mesh-list
25610248|NCT01104870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25610249|NCT01105065|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25610250|NCT01105065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25610251|NCT01105065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25610252|NCT01105065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25610253|NCT01105065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25610254|NCT01105065|Adrenergic Agents|adrenergic agents|mesh-ancestor
25610255|NCT01105065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25610256|NCT01105065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610257|NCT01105065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610258|NCT01105091|Epoprostenol|epoprostenol|mesh-list
25610259|NCT01105091|Tezosentan|tezosentan|mesh-list
25610260|NCT01105091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25610261|NCT01105091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25610262|NCT01105091|Vasodilator Agents|vasodilator agents|mesh-ancestor
25610263|NCT01105117|Epoprostenol|epoprostenol|mesh-list
25610264|NCT01105117|Tezosentan|tezosentan|mesh-list
25610265|NCT01105117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25610266|NCT01105117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25610267|NCT01105117|Vasodilator Agents|vasodilator agents|mesh-ancestor
25610268|NCT01105312|Letrozole|letrozole|mesh-list
25610269|NCT01105312|Panobinostat|panobinostat|mesh-list
25610270|NCT01105312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25610271|NCT01105312|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25504755|NCT00356525|Antimetabolites|antimetabolites|mesh-ancestor
25610272|NCT01105312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25610273|NCT01105312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610274|NCT01105312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610275|NCT01105312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25610276|NCT01105312|Hormone Antagonists|hormone antagonists|mesh-ancestor
25610277|NCT01105312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25610278|NCT01105312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610279|NCT01105312|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25610281|NCT01105377|Entinostat|entinostat|mesh-list
25610282|NCT01105377|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25610283|NCT01105377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25610284|NCT01105377|Antimetabolites|antimetabolites|mesh-ancestor
25610285|NCT01105377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610286|NCT01105377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25610287|NCT01105377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610288|NCT01105650|Cyclosporine|cyclosporine|mesh-list
25610289|NCT01105650|Methylprednisolone|methylprednisolone|mesh-list
25610290|NCT01105650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25610291|NCT01105650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25610292|NCT01105650|Prednisolone|prednisolone|mesh-list
25610293|NCT01105650|Prednisolone acetate|prednisolone acetate|mesh-list
25610294|NCT01105650|Cyclophosphamide|cyclophosphamide|mesh-list
25610295|NCT01105650|Fludarabine|fludarabine|mesh-list
25610296|NCT01105650|Interleukin-2|interleukin-2|mesh-list
25610297|NCT01105650|Cyclosporins|cyclosporins|mesh-list
25610298|NCT01105650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25610299|NCT01105650|Prednisolone phosphate|prednisolone phosphate|mesh-list
25610300|NCT01105650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25610301|NCT01105650|Immunologic Factors|immunologic factors|mesh-ancestor
25610302|NCT01105650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610303|NCT01105650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25610304|NCT01105650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25610305|NCT01105650|Alkylating Agents|alkylating agents|mesh-ancestor
25610306|NCT01105650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610307|NCT01105650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25610308|NCT01105650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25610309|NCT01105650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610310|NCT01105650|Antifungal Agents|antifungal agents|mesh-ancestor
25610311|NCT01105650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25610312|NCT01105650|Dermatologic Agents|dermatologic agents|mesh-ancestor
25610313|NCT01105650|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25610314|NCT01105650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25610315|NCT01105650|Antiemetics|antiemetics|mesh-ancestor
25610316|NCT01105650|Autonomic Agents|autonomic agents|mesh-ancestor
25610317|NCT01105650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25610318|NCT01105650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25610319|NCT01105650|Glucocorticoids|glucocorticoids|mesh-ancestor
25610320|NCT01105650|Hormones|hormones|mesh-ancestor
25610321|NCT01105650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25610322|NCT01105650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25610323|NCT01105650|Protective Agents|protective agents|mesh-ancestor
25610324|NCT01105650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25610325|NCT01105650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25610326|NCT01105650|Analgesics|analgesics|mesh-ancestor
25610327|NCT01105650|Sensory System Agents|sensory system agents|mesh-ancestor
25610328|NCT01105702|Bevacizumab|bevacizumab|mesh-list
25610329|NCT01105702|Temozolomide|temozolomide|mesh-list
25610330|NCT01105702|Lithium Carbonate|lithium carbonate|mesh-list
25610331|NCT01105702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25610332|NCT01105702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25610333|NCT01105702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25610334|NCT01105702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25610335|NCT01105702|Growth Substances|growth substances|mesh-ancestor
25610336|NCT01105702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610337|NCT01105702|Growth Inhibitors|growth inhibitors|mesh-ancestor
25610338|NCT01105702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25610339|NCT01105702|Alkylating Agents|alkylating agents|mesh-ancestor
25610340|NCT01105702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610341|NCT01105702|Antidepressive Agents|antidepressive agents|mesh-ancestor
25610342|NCT01105702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25610343|NCT01105702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610344|NCT01105702|Antimanic Agents|antimanic agents|mesh-ancestor
25610345|NCT01105702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25610346|NCT01105702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25610347|NCT01105767|Chlorhexidine|chlorhexidine|mesh-list
25610348|NCT01105767|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25610349|NCT01105767|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25610350|NCT01105767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25610351|NCT01105767|Disinfectants|disinfectants|mesh-ancestor
25610352|NCT01105767|Dermatologic Agents|dermatologic agents|mesh-ancestor
25610353|NCT01105936|Acetaminophen|acetaminophen|mesh-list
25610354|NCT01105936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25610355|NCT01105936|Analgesics|analgesics|mesh-ancestor
25610356|NCT01105936|Sensory System Agents|sensory system agents|mesh-ancestor
25610357|NCT01105936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25610358|NCT01105936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610359|NCT01105936|Antipyretics|antipyretics|mesh-ancestor
25610360|NCT01105975|Atorvastatin|atorvastatin|mesh-list
25610361|NCT01105975|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25610362|NCT01105975|Simvastatin|simvastatin|mesh-list
25610363|NCT01105975|Evacetrapib|evacetrapib|mesh-list
25610364|NCT01105975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25610365|NCT01105975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25610366|NCT01105975|Antimetabolites|antimetabolites|mesh-ancestor
25610367|NCT01105975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610368|NCT01105975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25610369|NCT01105975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25610370|NCT01105975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610371|NCT01106014|Selexipag|selexipag|mesh-list
25610372|NCT01106014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25610373|NCT01106027|Eculizumab|eculizumab|mesh-list
25610374|NCT01106027|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25610375|NCT01106027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25610376|NCT01106027|Immunologic Factors|immunologic factors|mesh-ancestor
25610377|NCT01106027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610378|NCT01106092|Vaccines|vaccines|mesh-list
25610379|NCT01106092|Immunologic Factors|immunologic factors|mesh-ancestor
24828033|NCT02142868|Letrozole|letrozole|mesh-list
25610380|NCT01106092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610381|NCT01106157|Thymoglobulin|thymoglobulin|mesh-list
25610382|NCT01106157|Immunologic Factors|immunologic factors|mesh-ancestor
25610383|NCT01106157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610384|NCT01106157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25654656|NCT01553201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654657|NCT01553279|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25654658|NCT01553279|Immunologic Factors|immunologic factors|mesh-ancestor
25654659|NCT01553279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654660|NCT01553292|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25654661|NCT01553292|Respiratory System Agents|respiratory system agents|mesh-ancestor
25654662|NCT01553318|Ketotifen|ketotifen|mesh-list
25654663|NCT01553318|Antipruritics|antipruritics|mesh-ancestor
25654664|NCT01553318|Dermatologic Agents|dermatologic agents|mesh-ancestor
25654665|NCT01553318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25654666|NCT01553318|Histamine Antagonists|histamine antagonists|mesh-ancestor
25654667|NCT01553318|Histamine Agents|histamine agents|mesh-ancestor
25654668|NCT01553318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25654669|NCT01553318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654670|NCT01553318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654671|NCT01553318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25654672|NCT01553539|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
25654673|NCT01553539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25654674|NCT01553539|Vasodilator Agents|vasodilator agents|mesh-ancestor
25654675|NCT01553591|Eluxadoline|eluxadoline|mesh-list
25654676|NCT01553591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25654677|NCT01553708|Sulfadiazine|sulfadiazine|mesh-list
25654678|NCT01553708|Silver Sulfadiazine|silver sulfadiazine|mesh-list
25654679|NCT01553708|Mitogens|mitogens|mesh-list
25654680|NCT01553708|Mitosis Modulators|mitosis modulators|mesh-ancestor
25654681|NCT01553708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654682|NCT01553708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25654683|NCT01553708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25654684|NCT01553708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25654685|NCT01553708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25654686|NCT01553708|Coccidiostats|coccidiostats|mesh-ancestor
25654687|NCT01553708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25654688|NCT01553747|Eluxadoline|eluxadoline|mesh-list
25654689|NCT01553747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25654690|NCT01553851|Trametinib|trametinib|mesh-list
25654691|NCT01553851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25654692|NCT01553851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25654693|NCT01553851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25654694|NCT01553851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504890|NCT00357396|Melphalan|melphalan|mesh-list
25654695|NCT01553916|Lithium Carbonate|lithium carbonate|mesh-list
25654696|NCT01553916|Antidepressive Agents|antidepressive agents|mesh-ancestor
25504946|NCT00357552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504948|NCT00357552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25504949|NCT00357552|Antiviral Agents|antiviral agents|mesh-ancestor
25504950|NCT00357552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25504951|NCT00357552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25504952|NCT00357552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25504953|NCT00357552|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25504954|NCT00357552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25504955|NCT00357656|Factor VIII|factor viii|mesh-list
25504956|NCT00357656|Coagulants|coagulants|mesh-ancestor
25504957|NCT00357734|Gefitinib|gefitinib|mesh-list
25504958|NCT00357734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504959|NCT00357734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25504960|NCT00357734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25504961|NCT00357734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504962|NCT00357760|Aflibercept|aflibercept|mesh-list
25504963|NCT00357760|Endothelial Growth Factors|endothelial growth factors|mesh-list
25504964|NCT00357760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25504965|NCT00357760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25504966|NCT00357760|Growth Substances|growth substances|mesh-ancestor
25504967|NCT00357760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504968|NCT00357760|Growth Inhibitors|growth inhibitors|mesh-ancestor
25504969|NCT00357760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25124260|NCT03078257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25124261|NCT03078257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25124262|NCT03078257|Analgesics|analgesics|mesh-ancestor
25124263|NCT03078257|Sensory System Agents|sensory system agents|mesh-ancestor
24436197|NCT00269334|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24436198|NCT00269334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24436199|NCT00269334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24436200|NCT00269386|Clarithromycin|clarithromycin|mesh-list
24436201|NCT00269386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24436202|NCT00269386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24436329|NCT00269750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436330|NCT00269750|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24436331|NCT00269750|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24436332|NCT00269750|Cholinergic Agents|cholinergic agents|mesh-ancestor
24436333|NCT00269750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24436334|NCT00269750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436335|NCT00269750|Urological Agents|urological agents|mesh-ancestor
25124270|NCT03078257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436415|NCT00269867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24436417|NCT00269867|Antibodies|antibodies|mesh-list
24436418|NCT00269867|Immunoglobulins|immunoglobulins|mesh-list
24436419|NCT00269867|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24436431|NCT00269880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436432|NCT00269880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24436434|NCT00269893|Anticoagulants|anticoagulants|mesh-ancestor
25610385|NCT01106352|Docetaxel|docetaxel|mesh-list
25610386|NCT01106352|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25610387|NCT01106352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25610388|NCT01106352|Tubulin Modulators|tubulin modulators|mesh-ancestor
25610389|NCT01106352|Antimitotic Agents|antimitotic agents|mesh-ancestor
25610390|NCT01106352|Mitosis Modulators|mitosis modulators|mesh-ancestor
25610391|NCT01106352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610392|NCT01106430|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25610393|NCT01106430|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25610394|NCT01106430|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25610395|NCT01106430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25610396|NCT01106430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25610397|NCT01106430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610398|NCT01106430|Adrenergic Agents|adrenergic agents|mesh-ancestor
25610399|NCT01106430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25610400|NCT01106430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610401|NCT01106430|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25610402|NCT01106430|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25610403|NCT01106430|Dopamine Agents|dopamine agents|mesh-ancestor
25610404|NCT01106586|Ritonavir|ritonavir|mesh-list
25610405|NCT01106586|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25610406|NCT01106586|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25610407|NCT01106586|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25610408|NCT01106586|Protease Inhibitors|protease inhibitors|mesh-ancestor
25610409|NCT01106586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610410|NCT01106586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610411|NCT01106586|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25610412|NCT01106586|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25610413|NCT01106586|Antiviral Agents|antiviral agents|mesh-ancestor
25610414|NCT01106586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25610415|NCT01106586|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25610416|NCT01106586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25610417|NCT01106625|Metformin|metformin|mesh-list
25610418|NCT01106625|Canagliflozin|canagliflozin|mesh-list
25610419|NCT01106625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25610420|NCT01106625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610421|NCT01106625|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25610422|NCT01106625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610423|NCT01106651|Canagliflozin|canagliflozin|mesh-list
25610424|NCT01106651|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25610425|NCT01106651|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25610426|NCT01106651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610427|NCT01106651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610428|NCT01106677|Metformin|metformin|mesh-list
25610429|NCT01106677|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25610430|NCT01106677|Canagliflozin|canagliflozin|mesh-list
25610431|NCT01106677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25610432|NCT01106677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610433|NCT01106677|Incretins|incretins|mesh-ancestor
25610434|NCT01106677|Hormones|hormones|mesh-ancestor
25610435|NCT01106677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25610436|NCT01106677|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25610437|NCT01106677|Protease Inhibitors|protease inhibitors|mesh-ancestor
25610438|NCT01106677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610439|NCT01106677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610440|NCT01106677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25610441|NCT01106690|Metformin|metformin|mesh-list
25610442|NCT01106690|Pioglitazone|pioglitazone|mesh-list
25610443|NCT01106690|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25610444|NCT01106690|Canagliflozin|canagliflozin|mesh-list
25610445|NCT01106690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25610446|NCT01106690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610447|NCT01106690|Incretins|incretins|mesh-ancestor
25610448|NCT01106690|Hormones|hormones|mesh-ancestor
25610449|NCT01106690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25610450|NCT01106690|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25610451|NCT01106690|Protease Inhibitors|protease inhibitors|mesh-ancestor
25610452|NCT01106690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610453|NCT01106690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610454|NCT01106690|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25610455|NCT01106833|Sirolimus|sirolimus|mesh-list
25610456|NCT01106833|Prednisone|prednisone|mesh-list
25610457|NCT01106833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
25610458|NCT01106833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25610459|NCT01106833|Glucocorticoids|glucocorticoids|mesh-ancestor
25610460|NCT01106833|Hormones|hormones|mesh-ancestor
25610461|NCT01106833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25610462|NCT01106833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610463|NCT01106833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25610464|NCT01106833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25610465|NCT01106833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25610466|NCT01106833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25610467|NCT01106833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25610468|NCT01106833|Antifungal Agents|antifungal agents|mesh-ancestor
25610469|NCT01106833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25610470|NCT01106833|Immunologic Factors|immunologic factors|mesh-ancestor
25610471|NCT01106833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610472|NCT01106833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610473|NCT01106846|Ketamine|ketamine|mesh-list
25610474|NCT01106846|Analgesics|analgesics|mesh-ancestor
25610475|NCT01106846|Sensory System Agents|sensory system agents|mesh-ancestor
25610476|NCT01106846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25610477|NCT01106846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610478|NCT01106846|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25610479|NCT01106846|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25610480|NCT01106846|Anesthetics, General|anesthetics, general|mesh-ancestor
25610481|NCT01106846|Anesthetics|anesthetics|mesh-ancestor
25610482|NCT01106846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25610483|NCT01106846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25610484|NCT01106846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25610485|NCT01106846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25610486|NCT01106846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610487|NCT01106859|Zolpidem|zolpidem|mesh-list
25610488|NCT01106859|Zopiclone|zopiclone|mesh-list
25610489|NCT01106859|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25610490|NCT01106859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25610491|NCT01106859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25610492|NCT01106859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610493|NCT01106859|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25610494|NCT01106859|GABA Agonists|gaba agonists|mesh-ancestor
25610495|NCT01106859|GABA Agents|gaba agents|mesh-ancestor
25610496|NCT01106859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25610497|NCT01106859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610498|NCT01106898|Paclitaxel|paclitaxel|mesh-list
25610499|NCT01106898|Cyclophosphamide|cyclophosphamide|mesh-list
25610500|NCT01106898|Trastuzumab|trastuzumab|mesh-list
25610501|NCT01106898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25610502|NCT01106898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25610503|NCT01106898|Tubulin Modulators|tubulin modulators|mesh-ancestor
25610504|NCT01106898|Antimitotic Agents|antimitotic agents|mesh-ancestor
25610505|NCT01106898|Mitosis Modulators|mitosis modulators|mesh-ancestor
25610506|NCT01106898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610507|NCT01106898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25610508|NCT01106898|Immunologic Factors|immunologic factors|mesh-ancestor
25610509|NCT01106898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610510|NCT01106898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25610511|NCT01106898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25610512|NCT01106898|Alkylating Agents|alkylating agents|mesh-ancestor
25610513|NCT01106898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25610514|NCT01106898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25610515|NCT01106950|Cyclophosphamide|cyclophosphamide|mesh-list
25610516|NCT01106950|Fludarabine|fludarabine|mesh-list
25610517|NCT01106950|Interleukin-2|interleukin-2|mesh-list
25610518|NCT01106950|Denileukin diftitox|denileukin diftitox|mesh-list
25610519|NCT01106950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25610520|NCT01106950|Immunologic Factors|immunologic factors|mesh-ancestor
25610521|NCT01106950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610522|NCT01106950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25610523|NCT01106950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25610524|NCT01106950|Alkylating Agents|alkylating agents|mesh-ancestor
25610525|NCT01106950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610526|NCT01106950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25610527|NCT01106950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25610528|NCT01106950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25610529|NCT01106950|Analgesics|analgesics|mesh-ancestor
25610530|NCT01106950|Sensory System Agents|sensory system agents|mesh-ancestor
25610531|NCT01106950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25610532|NCT01107353|Imipramine|imipramine|mesh-list
25610533|NCT01107353|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24828746|NCT02147379|Serotonin Agents|serotonin agents|mesh-ancestor
25610534|NCT01107353|Antidepressive Agents|antidepressive agents|mesh-ancestor
25610535|NCT01107353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25610536|NCT01107353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25610537|NCT01107353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25610538|NCT01107353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25610539|NCT01107353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610540|NCT01107353|Adrenergic Agents|adrenergic agents|mesh-ancestor
25610541|NCT01107353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25610542|NCT01107353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610543|NCT01107392|Botulinum Toxins|botulinum toxins|mesh-list
25610544|NCT01107392|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25610545|NCT01107392|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25610546|NCT01107392|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25610547|NCT01107392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25610548|NCT01107392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610549|NCT01107392|Cholinergic Agents|cholinergic agents|mesh-ancestor
25610550|NCT01107392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25610551|NCT01107392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610552|NCT01107392|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25610553|NCT01107392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25610554|NCT01107405|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25610555|NCT01107405|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25610556|NCT01107444|Docetaxel|docetaxel|mesh-list
25610557|NCT01107444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25610558|NCT01107444|Tubulin Modulators|tubulin modulators|mesh-ancestor
25610559|NCT01107444|Antimitotic Agents|antimitotic agents|mesh-ancestor
25610560|NCT01107444|Mitosis Modulators|mitosis modulators|mesh-ancestor
25610561|NCT01107444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610562|NCT01107457|Ixekizumab|ixekizumab|mesh-list
25610563|NCT01107457|Dermatologic Agents|dermatologic agents|mesh-ancestor
25610564|NCT01107535|Palivizumab|palivizumab|mesh-list
25610565|NCT01107535|Antibodies|antibodies|mesh-list
25610566|NCT01107535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25610567|NCT01107535|Immunologic Factors|immunologic factors|mesh-ancestor
25610568|NCT01107535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610569|NCT01107535|Antiviral Agents|antiviral agents|mesh-ancestor
25610570|NCT01107535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25610571|NCT01107665|Paclitaxel|paclitaxel|mesh-list
25610572|NCT01107665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25610573|NCT01107665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25610574|NCT01107665|Tubulin Modulators|tubulin modulators|mesh-ancestor
25610575|NCT01107665|Antimitotic Agents|antimitotic agents|mesh-ancestor
25610576|NCT01107665|Mitosis Modulators|mitosis modulators|mesh-ancestor
25610577|NCT01107665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610578|NCT01107730|Ascorbic Acid|ascorbic acid|mesh-list
25610579|NCT01107730|Vitamins|vitamins|mesh-ancestor
25610580|NCT01107730|Micronutrients|micronutrients|mesh-ancestor
25610581|NCT01107730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610582|NCT01107730|Antioxidants|antioxidants|mesh-ancestor
25610583|NCT01107730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610584|NCT01107730|Protective Agents|protective agents|mesh-ancestor
25610585|NCT01107743|Amlodipine|amlodipine|mesh-list
25610586|NCT01107743|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
25610587|NCT01107743|Atorvastatin|atorvastatin|mesh-list
25610588|NCT01107743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25610589|NCT01107743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25610590|NCT01107743|Antimetabolites|antimetabolites|mesh-ancestor
25610591|NCT01107743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610592|NCT01107743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25610593|NCT01107743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24828866|NCT02148016|Levofloxacin|levofloxacin|mesh-list
25610594|NCT01107743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610595|NCT01107743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25610596|NCT01107743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25610597|NCT01107743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25610598|NCT01107743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25610599|NCT01107743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610600|NCT01107743|Vasodilator Agents|vasodilator agents|mesh-ancestor
25610601|NCT01107886|Saxagliptin|saxagliptin|mesh-list
25610602|NCT01107886|Incretins|incretins|mesh-ancestor
25610603|NCT01107886|Hormones|hormones|mesh-ancestor
25610604|NCT01107886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25610605|NCT01107886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610606|NCT01107886|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25610607|NCT01107886|Protease Inhibitors|protease inhibitors|mesh-ancestor
25610608|NCT01107886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610609|NCT01107886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610610|NCT01107886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25610611|NCT01107899|Clopidogrel|clopidogrel|mesh-list
25610612|NCT01107899|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25610613|NCT01107899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25610614|NCT01107899|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25610615|NCT01107899|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25610616|NCT01107899|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25610617|NCT01107899|Purinergic Agents|purinergic agents|mesh-ancestor
25610618|NCT01107899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25610619|NCT01107899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610620|NCT01107899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610621|NCT01107912|Clopidogrel|clopidogrel|mesh-list
25610622|NCT01107912|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25610623|NCT01107912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25610624|NCT01107912|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25610625|NCT01107912|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25610626|NCT01107912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25610627|NCT01107912|Purinergic Agents|purinergic agents|mesh-ancestor
25610628|NCT01107912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25610629|NCT01107912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610630|NCT01107912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610631|NCT01107925|Clopidogrel|clopidogrel|mesh-list
25610632|NCT01107925|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25610633|NCT01107925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25610634|NCT01107925|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25610635|NCT01107925|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25610636|NCT01107925|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25610637|NCT01107925|Purinergic Agents|purinergic agents|mesh-ancestor
25610638|NCT01107925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25610639|NCT01107925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610640|NCT01107925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610641|NCT01108068|Lithium Carbonate|lithium carbonate|mesh-list
25610642|NCT01108068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505192|NCT00359788|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25505193|NCT00359788|Cholinergic Agents|cholinergic agents|mesh-ancestor
25505194|NCT00359788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25711418|NCT02300259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25505195|NCT00359788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505196|NCT00359788|Tocolytic Agents|tocolytic agents|mesh-ancestor
25505197|NCT00359788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25505198|NCT00359788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25505199|NCT00359788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25505200|NCT00359788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25505201|NCT00359788|Adrenergic Agents|adrenergic agents|mesh-ancestor
25505202|NCT00359801|Insulin|insulin|mesh-list
25505203|NCT00359801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25505204|NCT00359801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25505205|NCT00359801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505206|NCT00360126|Lamotrigine|lamotrigine|mesh-list
25505207|NCT00360126|Anticonvulsants|anticonvulsants|mesh-ancestor
25505208|NCT00360126|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25505209|NCT00360126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25505210|NCT00360126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505211|NCT00360126|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25505212|NCT00360126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505213|NCT00360126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25505214|NCT00360126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25505215|NCT00360126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25505216|NCT00360126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25505217|NCT00360126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25505218|NCT00360230|Vaccines|vaccines|mesh-list
25505219|NCT00360230|Immunologic Factors|immunologic factors|mesh-ancestor
25610643|NCT01108068|Antidepressive Agents|antidepressive agents|mesh-ancestor
25610644|NCT01108068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25610645|NCT01108068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610646|NCT01108068|Antimanic Agents|antimanic agents|mesh-ancestor
25610647|NCT01108068|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25610648|NCT01108068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25610649|NCT01108068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610650|NCT01108094|Itraconazole|itraconazole|mesh-list
25610651|NCT01108094|Antifungal Agents|antifungal agents|mesh-ancestor
25610652|NCT01108094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25610653|NCT01108094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25610654|NCT01108094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25610655|NCT01108094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610656|NCT01108094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610657|NCT01108094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25610658|NCT01108094|Hormone Antagonists|hormone antagonists|mesh-ancestor
25610659|NCT01108094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25610660|NCT01108094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610661|NCT01108094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25610662|NCT01108341|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25610663|NCT01108341|Ofatumumab|ofatumumab|mesh-list
25610664|NCT01108341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25610665|NCT01108341|Alkylating Agents|alkylating agents|mesh-ancestor
25610666|NCT01108341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610667|NCT01108341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25610668|NCT01108445|Everolimus|everolimus|mesh-list
25610670|NCT01108445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25610671|NCT01108445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25610672|NCT01108445|Immunologic Factors|immunologic factors|mesh-ancestor
25610673|NCT01108445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610674|NCT01108445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25610675|NCT01108445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25610676|NCT01108445|Growth Substances|growth substances|mesh-ancestor
25610677|NCT01108445|Growth Inhibitors|growth inhibitors|mesh-ancestor
25610678|NCT01108445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25610679|NCT01108445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610680|NCT01108445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610681|NCT01108458|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25610682|NCT01108458|Pertuzumab|pertuzumab|mesh-list
25610683|NCT01108458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25610684|NCT01108458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25610685|NCT01108458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610686|NCT01108458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610687|NCT01108458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25610688|NCT01108510|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25610689|NCT01108510|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25610690|NCT01108510|Cobicistat|cobicistat|mesh-list
25610691|NCT01108510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25610692|NCT01108510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25610693|NCT01108510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610694|NCT01108510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610695|NCT01108510|Antiviral Agents|antiviral agents|mesh-ancestor
25610696|NCT01108510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25610697|NCT01108510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25610698|NCT01108510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25610699|NCT01108510|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25610700|NCT01108510|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25610701|NCT01108510|Protease Inhibitors|protease inhibitors|mesh-ancestor
25610702|NCT01108510|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25610703|NCT01108510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25610704|NCT01108731|Milnacipran|milnacipran|mesh-list
25610705|NCT01108731|Levomilnacipran|levomilnacipran|mesh-list
25610706|NCT01108731|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25610707|NCT01108731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25610708|NCT01108731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25610709|NCT01108731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610710|NCT01108731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25610711|NCT01108731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711442|NCT02300311|Capsaicin|capsaicin|mesh-list
25610712|NCT01108731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25610713|NCT01108731|Analgesics|analgesics|mesh-ancestor
25610714|NCT01108731|Sensory System Agents|sensory system agents|mesh-ancestor
25610715|NCT01108731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25610716|NCT01108731|Antidepressive Agents|antidepressive agents|mesh-ancestor
25610717|NCT01108731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25610718|NCT01108757|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25610719|NCT01108757|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25610720|NCT01108757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25610721|NCT01108757|Renal Agents|renal agents|mesh-ancestor
25610722|NCT01108757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25610723|NCT01108757|Antimalarials|antimalarials|mesh-ancestor
25610724|NCT01108757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25610725|NCT01108757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25610726|NCT01108809|Telmisartan|telmisartan|mesh-list
25610727|NCT01108809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25610728|NCT01108809|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25610729|NCT01108809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25610730|NCT01108809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610731|NCT01109056|Cyclosporine|cyclosporine|mesh-list
25610732|NCT01109056|Cyclosporins|cyclosporins|mesh-list
25610733|NCT01109056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610734|NCT01109056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610735|NCT01109056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25610736|NCT01109056|Immunologic Factors|immunologic factors|mesh-ancestor
25505235|NCT00360334|Insulin Glargine|insulin glargine|mesh-list
25505236|NCT00360334|Exenatide|exenatide|mesh-list
25505237|NCT00360334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25505241|NCT00360334|Hormones|hormones|mesh-ancestor
25610737|NCT01109056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610738|NCT01109056|Antifungal Agents|antifungal agents|mesh-ancestor
25610739|NCT01109056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25610740|NCT01109056|Dermatologic Agents|dermatologic agents|mesh-ancestor
25610741|NCT01109056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25610742|NCT01109056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25610743|NCT01109173|Nepafenac|nepafenac|mesh-list
25610744|NCT01109173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25610745|NCT01109173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25610746|NCT01109173|Analgesics|analgesics|mesh-ancestor
25610747|NCT01109173|Sensory System Agents|sensory system agents|mesh-ancestor
25610748|NCT01109173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25610749|NCT01109173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610750|NCT01109173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25610751|NCT01109173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25610752|NCT01109316|Insulin|insulin|mesh-list
25610753|NCT01109316|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25610754|NCT01109316|Insulin Aspart|insulin aspart|mesh-list
25610755|NCT01109316|Insulin Lispro|insulin lispro|mesh-list
25610756|NCT01109316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25610757|NCT01109316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610758|NCT01109524|Cisplatin|cisplatin|mesh-list
25610759|NCT01109524|Cetuximab|cetuximab|mesh-list
25610760|NCT01109524|Vinorelbine|vinorelbine|mesh-list
25610761|NCT01109524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25610762|NCT01109524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25610763|NCT01109524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25610764|NCT01109524|Tubulin Modulators|tubulin modulators|mesh-ancestor
25610765|NCT01109524|Antimitotic Agents|antimitotic agents|mesh-ancestor
25610766|NCT01109524|Mitosis Modulators|mitosis modulators|mesh-ancestor
25610767|NCT01109524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610768|NCT01109849|Methylphenidate|methylphenidate|mesh-list
25610769|NCT01109849|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
25610770|NCT01109849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610771|NCT01109849|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25610772|NCT01109849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25610773|NCT01109849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25610774|NCT01109849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610775|NCT01109849|Dopamine Agents|dopamine agents|mesh-ancestor
25610776|NCT01109849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25610777|NCT01109979|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25610778|NCT01109979|Drospirenone|drospirenone|mesh-list
25610779|NCT01109979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25610780|NCT01109979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25610781|NCT01109979|Medroxyprogesterone|medroxyprogesterone|mesh-list
25610782|NCT01109979|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
25610783|NCT01109979|Estradiol|estradiol|mesh-list
25610784|NCT01109979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25610785|NCT01109979|Estrogens|estrogens|mesh-ancestor
25610786|NCT01109979|Hormones|hormones|mesh-ancestor
24829332|NCT02151604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25610787|NCT01109979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25610788|NCT01109979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610789|NCT01109979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25610790|NCT01109979|Contraceptive Agents|contraceptive agents|mesh-ancestor
25610791|NCT01109979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25610792|NCT01109979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25610793|NCT01109979|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25610794|NCT01109979|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25610795|NCT01109979|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25610796|NCT01109979|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25610797|NCT01109979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25610798|NCT01109979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25610799|NCT01109979|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25610800|NCT01109979|Hormone Antagonists|hormone antagonists|mesh-ancestor
25610801|NCT01109979|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25610802|NCT01109979|Diuretics|diuretics|mesh-ancestor
25610803|NCT01109979|Natriuretic Agents|natriuretic agents|mesh-ancestor
25610804|NCT01109992|Regadenoson|regadenoson|mesh-list
25610805|NCT01109992|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25610806|NCT01109992|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25610807|NCT01109992|Purinergic Agonists|purinergic agonists|mesh-ancestor
25610808|NCT01109992|Purinergic Agents|purinergic agents|mesh-ancestor
25610809|NCT01109992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25654697|NCT01553916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25505302|NCT00360568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610810|NCT01109992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610811|NCT01109992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610812|NCT01110005|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25610814|NCT01110135|Etoposide|etoposide|mesh-list
25610815|NCT01110135|Etoposide phosphate|etoposide phosphate|mesh-list
25610816|NCT01110135|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25610817|NCT01110135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25610818|NCT01110135|Antiemetics|antiemetics|mesh-ancestor
25610819|NCT01110135|Autonomic Agents|autonomic agents|mesh-ancestor
25610820|NCT01110135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25610821|NCT01110135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610822|NCT01110135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25610823|NCT01110135|Glucocorticoids|glucocorticoids|mesh-ancestor
25610824|NCT01110135|Hormones|hormones|mesh-ancestor
25610825|NCT01110135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25610826|NCT01110135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25610827|NCT01110135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25610828|NCT01110135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25610829|NCT01110135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25610830|NCT01110135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25610831|NCT01110135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610832|NCT01110135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610833|NCT01110135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25610834|NCT01110135|Alkylating Agents|alkylating agents|mesh-ancestor
25610835|NCT01110187|Lacosamide|lacosamide|mesh-list
25610836|NCT01110187|Fosphenytoin|fosphenytoin|mesh-list
25610837|NCT01110187|Anticonvulsants|anticonvulsants|mesh-ancestor
25610838|NCT01110187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25610839|NCT01110187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25610840|NCT01110187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25610841|NCT01110187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610842|NCT01110200|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25610843|NCT01110200|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25610844|NCT01110200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25610845|NCT01110200|Autonomic Agents|autonomic agents|mesh-ancestor
25610846|NCT01110200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25610847|NCT01110200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610848|NCT01110200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25610849|NCT01110200|Respiratory System Agents|respiratory system agents|mesh-ancestor
25610850|NCT01110200|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25610851|NCT01110200|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25610852|NCT01110200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25610853|NCT01110200|Adrenergic Agents|adrenergic agents|mesh-ancestor
25610854|NCT01110200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25610855|NCT01110200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610856|NCT01110200|Glucocorticoids|glucocorticoids|mesh-ancestor
25610857|NCT01110200|Hormones|hormones|mesh-ancestor
25610858|NCT01110200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25610859|NCT01110200|Sympathomimetics|sympathomimetics|mesh-ancestor
25610860|NCT01110330|Ketoconazole|ketoconazole|mesh-list
25610861|NCT01110330|Antifungal Agents|antifungal agents|mesh-ancestor
25610862|NCT01110330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25610863|NCT01110330|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25610864|NCT01110330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25610865|NCT01110330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610866|NCT01110330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610867|NCT01110330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25610868|NCT01110330|Hormone Antagonists|hormone antagonists|mesh-ancestor
25610869|NCT01110330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25610870|NCT01110330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610871|NCT01110330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25610872|NCT01110382|Amoxicillin|amoxicillin|mesh-list
25610873|NCT01110382|Meropenem|meropenem|mesh-list
25610874|NCT01110382|Clavulanic Acid|clavulanic acid|mesh-list
25610875|NCT01110382|Clavulanic Acids|clavulanic acids|mesh-list
25610876|NCT01110382|Doripenem|doripenem|mesh-list
25610877|NCT01110382|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25610878|NCT01110382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25610879|NCT01110382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25610880|NCT01110382|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25505386|NCT00361218|Citalopram|citalopram|mesh-list
25610881|NCT01110382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610882|NCT01110382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610883|NCT01110408|Amoxicillin|amoxicillin|mesh-list
25610884|NCT01110408|Clavulanic Acid|clavulanic acid|mesh-list
25610885|NCT01110408|Clavulanic Acids|clavulanic acids|mesh-list
25610886|NCT01110408|Cefepime|cefepime|mesh-list
25610887|NCT01110408|Doripenem|doripenem|mesh-list
25610888|NCT01110408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25610889|NCT01110408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25610890|NCT01110408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25610891|NCT01110408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25610892|NCT01110408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610893|NCT01110408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610894|NCT01110421|Amoxicillin|amoxicillin|mesh-list
25610895|NCT01110421|Clavulanic Acid|clavulanic acid|mesh-list
25610896|NCT01110421|Clavulanic Acids|clavulanic acids|mesh-list
25610897|NCT01110421|Cefepime|cefepime|mesh-list
25610898|NCT01110421|Doripenem|doripenem|mesh-list
25610899|NCT01110421|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25610900|NCT01110421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25610901|NCT01110421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25610902|NCT01110421|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25610903|NCT01110421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610904|NCT01110421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610905|NCT01110434|Topiramate|topiramate|mesh-list
25610906|NCT01110434|Anticonvulsants|anticonvulsants|mesh-ancestor
25610907|NCT01110434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25610908|NCT01110434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610909|NCT01110499|Bimatoprost|bimatoprost|mesh-list
25610910|NCT01110499|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25610911|NCT01110499|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25610912|NCT01110499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25610913|NCT01110707|Hormones|hormones|mesh-list
25610914|NCT01110707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25610915|NCT01110707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25610916|NCT01110707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610917|NCT01110876|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25610918|NCT01110876|Temozolomide|temozolomide|mesh-list
25610919|NCT01110876|Vorinostat|vorinostat|mesh-list
25610920|NCT01110876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25610921|NCT01110876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25610922|NCT01110876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610923|NCT01110876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610924|NCT01110876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25610925|NCT01110876|Alkylating Agents|alkylating agents|mesh-ancestor
25610926|NCT01110876|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25610927|NCT01111058|Everolimus|everolimus|mesh-list
25610928|NCT01111058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25610929|NCT01111058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25610930|NCT01111058|Immunologic Factors|immunologic factors|mesh-ancestor
25610931|NCT01111058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610932|NCT01111123|Halobetasol|halobetasol|mesh-list
25610933|NCT01111123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25610934|NCT01111149|Bupropion|bupropion|mesh-list
25610935|NCT01111149|Varenicline|varenicline|mesh-list
25610936|NCT01111149|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25610937|NCT01111149|Antidepressive Agents|antidepressive agents|mesh-ancestor
25610938|NCT01111149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25610939|NCT01111149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25610940|NCT01111149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25610941|NCT01111149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25610942|NCT01111149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610943|NCT01111149|Dopamine Agents|dopamine agents|mesh-ancestor
25610944|NCT01111149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25610945|NCT01111149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610946|NCT01111149|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25610947|NCT01111149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25610948|NCT01111149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610949|NCT01111149|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25610950|NCT01111149|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25610951|NCT01111149|Cholinergic Agents|cholinergic agents|mesh-ancestor
25610952|NCT01111292|Inositol|inositol|mesh-list
25610953|NCT01111292|Vitamin B Complex|vitamin b complex|mesh-ancestor
25610954|NCT01111292|Vitamins|vitamins|mesh-ancestor
25610955|NCT01111292|Micronutrients|micronutrients|mesh-ancestor
24829466|NCT02152514|Sufentanil|sufentanil|mesh-list
25610956|NCT01111292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610957|NCT01111318|Empagliflozin|empagliflozin|mesh-list
25610958|NCT01111318|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25610959|NCT01111318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610960|NCT01111318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25610961|NCT01111318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610962|NCT01111331|Empagliflozin|empagliflozin|mesh-list
25610963|NCT01111331|Warfarin|warfarin|mesh-list
25610964|NCT01111331|Anticoagulants|anticoagulants|mesh-ancestor
25610965|NCT01111331|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25610966|NCT01111331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610967|NCT01111331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25610968|NCT01111331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610969|NCT01111461|Lenvatinib|lenvatinib|mesh-list
25610970|NCT01111461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25610971|NCT01111461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25610972|NCT01111461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610973|NCT01111461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610974|NCT01111526|Panobinostat|panobinostat|mesh-list
25610975|NCT01111526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25610976|NCT01111526|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25610977|NCT01111526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25610978|NCT01111526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610979|NCT01111539|Aripiprazole|aripiprazole|mesh-list
25610980|NCT01111539|Citalopram|citalopram|mesh-list
25610981|NCT01111539|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25610982|NCT01111539|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25610983|NCT01111539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25610984|NCT01111539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25610985|NCT01111539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25610986|NCT01111539|Serotonin Agents|serotonin agents|mesh-ancestor
25610987|NCT01111539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25610988|NCT01111539|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25610989|NCT01111539|Antidepressive Agents|antidepressive agents|mesh-ancestor
25610990|NCT01111539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25610991|NCT01111539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25610992|NCT01111539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25610993|NCT01111539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25610994|NCT01111539|Dopamine Agonists|dopamine agonists|mesh-ancestor
25610995|NCT01111539|Dopamine Agents|dopamine agents|mesh-ancestor
25610996|NCT01111539|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25610997|NCT01111539|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25610998|NCT01111539|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25610999|NCT01111539|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25611000|NCT01111539|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25611001|NCT01111539|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25611002|NCT01111552|Aripiprazole|aripiprazole|mesh-list
25611003|NCT01111552|Citalopram|citalopram|mesh-list
25611004|NCT01111552|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25611005|NCT01111552|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25611006|NCT01111552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25611007|NCT01111552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611008|NCT01111552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25611009|NCT01111552|Serotonin Agents|serotonin agents|mesh-ancestor
25611010|NCT01111552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611011|NCT01111552|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25611012|NCT01111552|Antidepressive Agents|antidepressive agents|mesh-ancestor
25611013|NCT01111552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25611014|NCT01111552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25611015|NCT01111552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25611016|NCT01111552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25611017|NCT01111552|Dopamine Agonists|dopamine agonists|mesh-ancestor
25611018|NCT01111552|Dopamine Agents|dopamine agents|mesh-ancestor
25611019|NCT01111552|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25611020|NCT01111552|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25611021|NCT01111552|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25611022|NCT01111552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25611023|NCT01111552|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25611024|NCT01111552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25654698|NCT01553916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505518|NCT00362180|Mipomersen|mipomersen|mesh-list
25505519|NCT00362180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25505521|NCT00362180|Antimetabolites|antimetabolites|mesh-ancestor
25611025|NCT01111604|Ramucirumab|ramucirumab|mesh-list
25611026|NCT01111604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611027|NCT01111825|Sirolimus|sirolimus|mesh-list
25611028|NCT01111825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25611029|NCT01111825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25611030|NCT01111825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25611031|NCT01111825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611032|NCT01111825|Antifungal Agents|antifungal agents|mesh-ancestor
25611033|NCT01111825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25611034|NCT01111825|Immunologic Factors|immunologic factors|mesh-ancestor
25611035|NCT01111825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611036|NCT01111851|Dexamethasone|dexamethasone|mesh-list
25611037|NCT01111851|Dexamethasone acetate|dexamethasone acetate|mesh-list
25611038|NCT01111851|Ondansetron|ondansetron|mesh-list
25611039|NCT01111851|Aprepitant|aprepitant|mesh-list
25611040|NCT01111851|Fosaprepitant|fosaprepitant|mesh-list
25611041|NCT01111851|BB 1101|bb 1101|mesh-list
25611042|NCT01111851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25611043|NCT01111851|Antiemetics|antiemetics|mesh-ancestor
25611044|NCT01111851|Autonomic Agents|autonomic agents|mesh-ancestor
24691736|NCT01408927|Aspirin|aspirin|mesh-list
25611045|NCT01111851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25611046|NCT01111851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611047|NCT01111851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25611048|NCT01111851|Glucocorticoids|glucocorticoids|mesh-ancestor
25611049|NCT01111851|Hormones|hormones|mesh-ancestor
25611050|NCT01111851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25611051|NCT01111851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25611052|NCT01111851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611053|NCT01111851|Protease Inhibitors|protease inhibitors|mesh-ancestor
25611054|NCT01111851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25611055|NCT01111851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611056|NCT01111851|Antipruritics|antipruritics|mesh-ancestor
25611057|NCT01111851|Dermatologic Agents|dermatologic agents|mesh-ancestor
25611058|NCT01111851|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25611059|NCT01111851|Serotonin Agents|serotonin agents|mesh-ancestor
25611060|NCT01111851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25611061|NCT01111851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25611062|NCT01111851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25611063|NCT01111851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25611064|NCT01111851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25611065|NCT01111851|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25611066|NCT01111851|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25611067|NCT01112059|Doxycycline|doxycycline|mesh-list
25611068|NCT01112059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25611069|NCT01112059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25611070|NCT01112059|Antimalarials|antimalarials|mesh-ancestor
25611071|NCT01112059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25611072|NCT01112059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25611073|NCT01112241|Albuterol|albuterol|mesh-list
25611074|NCT01112241|Tiotropium Bromide|tiotropium bromide|mesh-list
25611075|NCT01112241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25611076|NCT01112241|Autonomic Agents|autonomic agents|mesh-ancestor
25611077|NCT01112241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25611078|NCT01112241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611079|NCT01112241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25611080|NCT01112241|Respiratory System Agents|respiratory system agents|mesh-ancestor
25611081|NCT01112241|Parasympatholytics|parasympatholytics|mesh-ancestor
25611082|NCT01112241|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25611083|NCT01112241|Cholinergic Agents|cholinergic agents|mesh-ancestor
25611084|NCT01112241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25611085|NCT01112241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611086|NCT01112241|Tocolytic Agents|tocolytic agents|mesh-ancestor
25611087|NCT01112241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25611088|NCT01112241|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25611089|NCT01112241|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25611090|NCT01112241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25611091|NCT01112241|Adrenergic Agents|adrenergic agents|mesh-ancestor
25611092|NCT01112267|Acetaminophen|acetaminophen|mesh-list
25611093|NCT01112267|Tramadol|tramadol|mesh-list
25611094|NCT01112267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25611095|NCT01112267|Analgesics|analgesics|mesh-ancestor
25611096|NCT01112267|Sensory System Agents|sensory system agents|mesh-ancestor
25611097|NCT01112267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25611098|NCT01112267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611099|NCT01112267|Antipyretics|antipyretics|mesh-ancestor
25611100|NCT01112267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25611101|NCT01112267|Narcotics|narcotics|mesh-ancestor
25611102|NCT01112267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25611104|NCT01112358|Progesterone|progesterone|mesh-list
25711519|NCT02301416|Topiramate|topiramate|mesh-list
25611105|NCT01112358|Progestins|progestins|mesh-ancestor
25611106|NCT01112358|Hormones|hormones|mesh-ancestor
25611107|NCT01112358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25611108|NCT01112358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611109|NCT01112358|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25611110|NCT01112358|Fertility Agents|fertility agents|mesh-ancestor
25611111|NCT01112358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25611112|NCT01112358|Hormone Antagonists|hormone antagonists|mesh-ancestor
25611113|NCT01112670|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25611114|NCT01112670|Atorvastatin|atorvastatin|mesh-list
25611115|NCT01112670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25611116|NCT01112670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25611117|NCT01112670|Antimetabolites|antimetabolites|mesh-ancestor
25611118|NCT01112670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611119|NCT01112670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25611120|NCT01112670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25611121|NCT01112670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25611122|NCT01112670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25611123|NCT01112670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611124|NCT01112670|Incretins|incretins|mesh-ancestor
25611125|NCT01112670|Hormones|hormones|mesh-ancestor
25611126|NCT01112670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25611127|NCT01112670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25611128|NCT01112670|Protease Inhibitors|protease inhibitors|mesh-ancestor
25611129|NCT01112683|Memantine|memantine|mesh-list
25611130|NCT01112683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25611131|NCT01112683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25611132|NCT01112683|Dopamine Agents|dopamine agents|mesh-ancestor
25611133|NCT01112683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25611134|NCT01112683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611135|NCT01112683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611136|NCT01112683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25611137|NCT01112683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25611138|NCT01112735|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25611139|NCT01112735|Hemostatics|hemostatics|mesh-ancestor
25611140|NCT01112735|Coagulants|coagulants|mesh-ancestor
25611141|NCT01112982|Colchicine|colchicine|mesh-list
25611142|NCT01112982|Febuxostat|febuxostat|mesh-list
25611143|NCT01112982|Gout Suppressants|gout suppressants|mesh-ancestor
25611144|NCT01112982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25611145|NCT01112982|Tubulin Modulators|tubulin modulators|mesh-ancestor
25611146|NCT01112982|Antimitotic Agents|antimitotic agents|mesh-ancestor
25611147|NCT01112982|Mitosis Modulators|mitosis modulators|mesh-ancestor
25611148|NCT01112982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611149|NCT01112982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611150|NCT01113398|Bevacizumab|bevacizumab|mesh-list
25611151|NCT01113398|Rilotumumab|rilotumumab|mesh-list
25611152|NCT01113398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25611153|NCT01113398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611154|NCT01113398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25611155|NCT01113398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25611156|NCT01113398|Growth Substances|growth substances|mesh-ancestor
25611157|NCT01113398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611158|NCT01113398|Growth Inhibitors|growth inhibitors|mesh-ancestor
25611159|NCT01113541|Ziprasidone|ziprasidone|mesh-list
25611160|NCT01113541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25611161|NCT01113541|Serotonin Agents|serotonin agents|mesh-ancestor
25611162|NCT01113541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25611163|NCT01113541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711522|NCT02301416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25611164|NCT01113541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611165|NCT01113541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25611166|NCT01113541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25611167|NCT01113541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25611168|NCT01113541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25611169|NCT01113541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25611170|NCT01113541|Dopamine Agents|dopamine agents|mesh-ancestor
25611171|NCT01113632|Ofatumumab|ofatumumab|mesh-list
25611172|NCT01113632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611173|NCT01113710|Rotigotine|rotigotine|mesh-list
25611174|NCT01113710|Dopamine Agonists|dopamine agonists|mesh-ancestor
25611175|NCT01113710|Dopamine Agents|dopamine agents|mesh-ancestor
25611176|NCT01113710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25505664|NCT00363480|Autonomic Agents|autonomic agents|mesh-ancestor
25611177|NCT01113710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611178|NCT01113710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611179|NCT01113931|Doxycycline|doxycycline|mesh-list
25611180|NCT01113931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25611181|NCT01113931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25611182|NCT01113931|Antimalarials|antimalarials|mesh-ancestor
25611183|NCT01113931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25611184|NCT01113931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25611185|NCT01114360|Melatonin|melatonin|mesh-list
25611186|NCT01114360|Antioxidants|antioxidants|mesh-ancestor
25611187|NCT01114360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611188|NCT01114360|Protective Agents|protective agents|mesh-ancestor
25611189|NCT01114360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611190|NCT01114360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25611191|NCT01114373|Melatonin|melatonin|mesh-list
25611192|NCT01114373|Antioxidants|antioxidants|mesh-ancestor
25611193|NCT01114373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611194|NCT01114373|Protective Agents|protective agents|mesh-ancestor
25611195|NCT01114373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611196|NCT01114373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25611197|NCT01114503|Methylprednisolone|methylprednisolone|mesh-list
25611198|NCT01114503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25611199|NCT01114503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25611200|NCT01114503|Prednisolone|prednisolone|mesh-list
25611201|NCT01114503|Prednisolone acetate|prednisolone acetate|mesh-list
25611202|NCT01114503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25611203|NCT01114503|Prednisolone phosphate|prednisolone phosphate|mesh-list
25611204|NCT01114503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25611205|NCT01114503|Antiemetics|antiemetics|mesh-ancestor
25611206|NCT01114503|Autonomic Agents|autonomic agents|mesh-ancestor
24829688|NCT02153944|Propranolol|propranolol|mesh-list
24829689|NCT02153944|Methylphenidate|methylphenidate|mesh-list
25611207|NCT01114503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25611208|NCT01114503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611209|NCT01114503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25611210|NCT01114503|Glucocorticoids|glucocorticoids|mesh-ancestor
25611211|NCT01114503|Hormones|hormones|mesh-ancestor
25611212|NCT01114503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25611213|NCT01114503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25611214|NCT01114503|Protective Agents|protective agents|mesh-ancestor
25611215|NCT01114503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25611216|NCT01114503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611217|NCT01114516|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25611218|NCT01114516|Clindamycin|clindamycin|mesh-list
25611219|NCT01114516|Clindamycin palmitate|clindamycin palmitate|mesh-list
25611220|NCT01114516|Clindamycin phosphate|clindamycin phosphate|mesh-list
25611221|NCT01114516|Cefazolin|cefazolin|mesh-list
25611222|NCT01114516|Indomethacin|indomethacin|mesh-list
25611223|NCT01114516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25611224|NCT01114516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25611225|NCT01114516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25611226|NCT01114516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611227|NCT01114516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25611228|NCT01114516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25611229|NCT01114516|Analgesics|analgesics|mesh-ancestor
25611230|NCT01114516|Sensory System Agents|sensory system agents|mesh-ancestor
25611231|NCT01114516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25611232|NCT01114516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611233|NCT01114516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25611234|NCT01114516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25611235|NCT01114516|Gout Suppressants|gout suppressants|mesh-ancestor
25611236|NCT01114516|Tocolytic Agents|tocolytic agents|mesh-ancestor
25611237|NCT01114516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25611238|NCT01114516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25611239|NCT01114529|Cyclosporine|cyclosporine|mesh-list
25611240|NCT01114529|Everolimus|everolimus|mesh-list
25611241|NCT01114529|Tacrolimus|tacrolimus|mesh-list
25611242|NCT01114529|Cyclosporins|cyclosporins|mesh-list
25611243|NCT01114529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25611244|NCT01114529|Immunologic Factors|immunologic factors|mesh-ancestor
25611245|NCT01114529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611246|NCT01114529|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25611247|NCT01114529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25611248|NCT01114529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611249|NCT01114529|Antifungal Agents|antifungal agents|mesh-ancestor
25611250|NCT01114529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25611251|NCT01114529|Dermatologic Agents|dermatologic agents|mesh-ancestor
25611252|NCT01114529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25505739|NCT00364533|Oxycodone|oxycodone|mesh-list
25505740|NCT00364533|Tapentadol|tapentadol|mesh-list
25611253|NCT01114529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611254|NCT01114555|Bevacizumab|bevacizumab|mesh-list
25611255|NCT01114555|Irinotecan|irinotecan|mesh-list
25611256|NCT01114555|Temozolomide|temozolomide|mesh-list
25611257|NCT01114555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25611258|NCT01114555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611259|NCT01114555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25611260|NCT01114555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25611261|NCT01114555|Growth Substances|growth substances|mesh-ancestor
25611262|NCT01114555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611263|NCT01114555|Growth Inhibitors|growth inhibitors|mesh-ancestor
25611264|NCT01114555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25611265|NCT01114555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25611266|NCT01114555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25611267|NCT01114555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611268|NCT01114555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25611269|NCT01114555|Alkylating Agents|alkylating agents|mesh-ancestor
25611270|NCT01114581|Phenylpropanolamine|phenylpropanolamine|mesh-list
25611271|NCT01114581|Guaifenesin|guaifenesin|mesh-list
25611272|NCT01114581|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
25611273|NCT01114581|Expectorants|expectorants|mesh-ancestor
25611274|NCT01114581|Respiratory System Agents|respiratory system agents|mesh-ancestor
25611275|NCT01114581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25611276|NCT01114581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25611277|NCT01114581|Adrenergic Agents|adrenergic agents|mesh-ancestor
25611278|NCT01114581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25611279|NCT01114581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611280|NCT01114581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611281|NCT01114581|Appetite Depressants|appetite depressants|mesh-ancestor
25611282|NCT01114581|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25611283|NCT01114581|Sympathomimetics|sympathomimetics|mesh-ancestor
25611284|NCT01114581|Autonomic Agents|autonomic agents|mesh-ancestor
25611285|NCT01114581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25611286|NCT01114581|Nasal Decongestants|nasal decongestants|mesh-ancestor
25611287|NCT01114581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25611288|NCT01114672|Ergocalciferols|ergocalciferols|mesh-list
25611289|NCT01114672|Vitamin D|vitamin d|mesh-list
25611290|NCT01114672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25611291|NCT01114672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611292|NCT01114672|Vitamins|vitamins|mesh-ancestor
25611293|NCT01114672|Micronutrients|micronutrients|mesh-ancestor
25611294|NCT01114672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25611295|NCT01114737|Verapamil|verapamil|mesh-list
25611296|NCT01114737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25611297|NCT01114737|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25611298|NCT01114737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25611299|NCT01114737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611300|NCT01114737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25611301|NCT01114737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611302|NCT01114737|Vasodilator Agents|vasodilator agents|mesh-ancestor
25611303|NCT01114828|Tolvaptan|tolvaptan|mesh-list
25611304|NCT01114828|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25611305|NCT01114828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611306|NCT01114828|Natriuretic Agents|natriuretic agents|mesh-ancestor
25611307|NCT01114828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611308|NCT01114880|Adalimumab|adalimumab|mesh-list
25611309|NCT01114880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25611310|NCT01114880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25611311|NCT01114893|Travoprost|travoprost|mesh-list
25611312|NCT01114893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25611313|NCT01114971|Labetalol|labetalol|mesh-list
25611314|NCT01114971|Fentanyl|fentanyl|mesh-list
25611315|NCT01114971|Esmolol|esmolol|mesh-list
25611316|NCT01114971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25611317|NCT01114971|Narcotics|narcotics|mesh-ancestor
25611318|NCT01114971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25611319|NCT01114971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611320|NCT01114971|Analgesics|analgesics|mesh-ancestor
25505806|NCT00365053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505807|NCT00365105|Vitamin D|vitamin d|mesh-list
25505808|NCT00365105|Zoledronic Acid|zoledronic acid|mesh-list
25505809|NCT00365105|Calcium|calcium|mesh-list
25611321|NCT01114971|Sensory System Agents|sensory system agents|mesh-ancestor
25505810|NCT00365105|Vitamins|vitamins|mesh-ancestor
25611322|NCT01114971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25822740|NCT00004637|Micronutrients|micronutrients|mesh-ancestor
25611323|NCT01114971|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25611324|NCT01114971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25611325|NCT01114971|Anesthetics, General|anesthetics, general|mesh-ancestor
25611326|NCT01114971|Anesthetics|anesthetics|mesh-ancestor
25711563|NCT02301988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611327|NCT01114971|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25611328|NCT01114971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25611329|NCT01114971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25611330|NCT01114971|Adrenergic Agents|adrenergic agents|mesh-ancestor
25611331|NCT01114971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25611332|NCT01114971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611333|NCT01114971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25611334|NCT01114971|Sympathomimetics|sympathomimetics|mesh-ancestor
25611335|NCT01114971|Autonomic Agents|autonomic agents|mesh-ancestor
25611336|NCT01114971|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25611337|NCT01114971|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25611338|NCT01114997|Lidocaine|lidocaine|mesh-list
25611339|NCT01114997|Esmolol|esmolol|mesh-list
25611340|NCT01114997|Anesthetics, Local|anesthetics, local|mesh-ancestor
25611341|NCT01114997|Anesthetics|anesthetics|mesh-ancestor
25611342|NCT01114997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25611343|NCT01114997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611344|NCT01114997|Sensory System Agents|sensory system agents|mesh-ancestor
25611345|NCT01114997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25611346|NCT01114997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25611347|NCT01114997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25611348|NCT01114997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25611349|NCT01114997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25611350|NCT01114997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611351|NCT01114997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25611352|NCT01114997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25611353|NCT01114997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25611354|NCT01114997|Adrenergic Agents|adrenergic agents|mesh-ancestor
25611355|NCT01114997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25611356|NCT01115101|Pirinitramide|pirinitramide|mesh-list
25611357|NCT01115101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25611358|NCT01115101|Narcotics|narcotics|mesh-ancestor
25611359|NCT01115101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25611360|NCT01115101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611361|NCT01115101|Analgesics|analgesics|mesh-ancestor
25611362|NCT01115101|Sensory System Agents|sensory system agents|mesh-ancestor
25611363|NCT01115101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25611364|NCT01115491|Bevacizumab|bevacizumab|mesh-list
25611365|NCT01115491|Temozolomide|temozolomide|mesh-list
25611366|NCT01115491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25611367|NCT01115491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611368|NCT01115491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25611369|NCT01115491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25611370|NCT01115491|Growth Substances|growth substances|mesh-ancestor
25611371|NCT01115491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611372|NCT01115491|Growth Inhibitors|growth inhibitors|mesh-ancestor
25611373|NCT01115491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25611374|NCT01115491|Alkylating Agents|alkylating agents|mesh-ancestor
25611375|NCT01115491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611376|NCT01115517|Bevacizumab|bevacizumab|mesh-list
25611377|NCT01115517|Mitomycins|mitomycins|mesh-list
25611378|NCT01115517|Mitomycin|mitomycin|mesh-list
25611379|NCT01115517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25611380|NCT01115517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611381|NCT01115517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25611382|NCT01115517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25611383|NCT01115517|Growth Substances|growth substances|mesh-ancestor
25611384|NCT01115517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611385|NCT01115517|Growth Inhibitors|growth inhibitors|mesh-ancestor
25611386|NCT01115517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25611387|NCT01115517|Alkylating Agents|alkylating agents|mesh-ancestor
25611388|NCT01115517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611389|NCT01115517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25611390|NCT01115517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25611391|NCT01115556|Ranibizumab|ranibizumab|mesh-list
25611392|NCT01115556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25611393|NCT01115556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25611394|NCT01115556|Growth Substances|growth substances|mesh-ancestor
25611395|NCT01115556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611396|NCT01115556|Growth Inhibitors|growth inhibitors|mesh-ancestor
25611397|NCT01115556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611398|NCT01115569|Hydrocodone|hydrocodone|mesh-list
25611399|NCT01115569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25611400|NCT01115569|Narcotics|narcotics|mesh-ancestor
25611401|NCT01115569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25611402|NCT01115569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611403|NCT01115569|Analgesics|analgesics|mesh-ancestor
25611404|NCT01115569|Sensory System Agents|sensory system agents|mesh-ancestor
25611405|NCT01115569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25611406|NCT01115569|Antitussive Agents|antitussive agents|mesh-ancestor
25611407|NCT01115569|Respiratory System Agents|respiratory system agents|mesh-ancestor
25611408|NCT01115582|Cholic Acids|cholic acids|mesh-list
25611409|NCT01115582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25611410|NCT01115673|Acetaminophen|acetaminophen|mesh-list
25611411|NCT01115673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25611412|NCT01115673|Analgesics|analgesics|mesh-ancestor
25611413|NCT01115673|Sensory System Agents|sensory system agents|mesh-ancestor
25611414|NCT01115673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25611415|NCT01115673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611416|NCT01115673|Antipyretics|antipyretics|mesh-ancestor
25611417|NCT01115738|Clopidogrel|clopidogrel|mesh-list
25611418|NCT01115738|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25611419|NCT01115738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25611420|NCT01115738|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25611421|NCT01115738|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25611422|NCT01115738|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25611423|NCT01115738|Purinergic Agents|purinergic agents|mesh-ancestor
25611424|NCT01115738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25611425|NCT01115738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611426|NCT01115738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611427|NCT01115803|Everolimus|everolimus|mesh-list
25611428|NCT01115803|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25611429|NCT01115803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611430|NCT01115803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25611431|NCT01115803|Immunologic Factors|immunologic factors|mesh-ancestor
25611432|NCT01115803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611433|NCT01115803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25611434|NCT01115803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25611435|NCT01115803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611436|NCT01115855|Eplerenone|eplerenone|mesh-list
25611437|NCT01115855|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25611438|NCT01115855|Hormone Antagonists|hormone antagonists|mesh-ancestor
25611439|NCT01115855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25611440|NCT01115855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611441|NCT01115855|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25611442|NCT01115855|Diuretics|diuretics|mesh-ancestor
25611443|NCT01115855|Natriuretic Agents|natriuretic agents|mesh-ancestor
25611444|NCT01115855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25611445|NCT01116102|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25611446|NCT01116401|Leuprolide|leuprolide|mesh-list
25611447|NCT01116401|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25611448|NCT01116401|Fertility Agents|fertility agents|mesh-ancestor
25611449|NCT01116401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25611450|NCT01116401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611451|NCT01116401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25611452|NCT01116401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611453|NCT01116427|Abatacept|abatacept|mesh-list
25611454|NCT01116427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25611455|NCT01116427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611456|NCT01116427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24830617|NCT02160236|Tenoxicam|tenoxicam|mesh-list
25611457|NCT01116427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25611458|NCT01116427|Immunologic Factors|immunologic factors|mesh-ancestor
25611459|NCT01116427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611460|NCT01116427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25611461|NCT01116687|R04929097|r04929097|mesh-list
25611462|NCT01116687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25611463|NCT01116687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611464|NCT01116739|Fluorides|fluorides|mesh-list
25611465|NCT01116739|Fluorides, Topical|fluorides, topical|mesh-list
25505928|NCT00365391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25505929|NCT00365391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25505930|NCT00365391|Growth Substances|growth substances|mesh-ancestor
25505931|NCT00365391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505997|NCT00365547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505998|NCT00365599|Tamoxifen|tamoxifen|mesh-list
25505999|NCT00365599|Vorinostat|vorinostat|mesh-list
25506000|NCT00365599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506001|NCT00365599|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25506002|NCT00365599|Hormone Antagonists|hormone antagonists|mesh-ancestor
25506003|NCT00365599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25506004|NCT00365599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506005|NCT00365599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25506006|NCT00365599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506007|NCT00365599|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25506008|NCT00365599|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25506009|NCT00365599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25506010|NCT00365599|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25506011|NCT00365599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506012|NCT00365716|Vaccines|vaccines|mesh-list
25506013|NCT00365716|Immunologic Factors|immunologic factors|mesh-ancestor
25506014|NCT00365716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506015|NCT00365794|Testosterone|testosterone|mesh-list
25506016|NCT00365794|Androgens|androgens|mesh-ancestor
25506017|NCT00365794|Hormones|hormones|mesh-ancestor
25506018|NCT00365794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25506019|NCT00365794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433480|NCT00258596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24433515|NCT00258739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24433517|NCT00258739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433518|NCT00258739|Antiviral Agents|antiviral agents|mesh-ancestor
25123941|NCT03080415|Sofosbuvir|sofosbuvir|mesh-list
24979827|NCT05240456|Adrenergic Agonists|adrenergic agonists|mesh-list
24979828|NCT05240456|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
24979829|NCT05240456|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24979830|NCT05240456|Cholinergic Agents|cholinergic agents|mesh-ancestor
24979831|NCT05240456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25124284|NCT03078062|Dexamethasone|dexamethasone|mesh-list
24979832|NCT05240456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436536|NCT00270400|Natriuretic Agents|natriuretic agents|mesh-ancestor
24436537|NCT00270400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436539|NCT00270413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24436540|NCT00270413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24436541|NCT00270413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24436566|NCT00270491|Tubulin Modulators|tubulin modulators|mesh-ancestor
24436567|NCT00270491|Antimitotic Agents|antimitotic agents|mesh-ancestor
24436571|NCT00270491|Antimetabolites|antimetabolites|mesh-ancestor
24436578|NCT00270530|Antimalarials|antimalarials|mesh-ancestor
25611466|NCT01116739|Cariostatic Agents|cariostatic agents|mesh-ancestor
25611467|NCT01116739|Protective Agents|protective agents|mesh-ancestor
25611468|NCT01116739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611469|NCT01116921|Pulmonary Surfactants|pulmonary surfactants|mesh-list
24830721|NCT02160587|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24830738|NCT02160743|Metformin|metformin|mesh-list
25611470|NCT01116921|Respiratory System Agents|respiratory system agents|mesh-ancestor
25611471|NCT01116986|Nicotine|nicotine|mesh-list
25611472|NCT01116986|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25611473|NCT01116986|Autonomic Agents|autonomic agents|mesh-ancestor
25611474|NCT01116986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25611475|NCT01116986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611476|NCT01116986|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25611477|NCT01116986|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25611478|NCT01116986|Cholinergic Agents|cholinergic agents|mesh-ancestor
25611479|NCT01116986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25611480|NCT01116986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611481|NCT01117012|Ivacaftor|ivacaftor|mesh-list
25611482|NCT01117012|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25611483|NCT01117012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25611484|NCT01117012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611485|NCT01117051|Prucalopride|prucalopride|mesh-list
25611486|NCT01117051|Laxatives|laxatives|mesh-ancestor
25611487|NCT01117051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25611488|NCT01117051|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
25611489|NCT01117051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25611490|NCT01117051|Serotonin Agents|serotonin agents|mesh-ancestor
25611491|NCT01117051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25611492|NCT01117051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611493|NCT01117051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611494|NCT01117181|Methylphenidate|methylphenidate|mesh-list
25611495|NCT01117181|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25611496|NCT01117181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611497|NCT01117181|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25611498|NCT01117181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25611499|NCT01117181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25611500|NCT01117181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611501|NCT01117181|Dopamine Agents|dopamine agents|mesh-ancestor
25611502|NCT01117181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25611503|NCT01117350|Metformin|metformin|mesh-list
25611504|NCT01117350|Insulin Glargine|insulin glargine|mesh-list
25611505|NCT01117350|Liraglutide|liraglutide|mesh-list
25611506|NCT01117350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25611507|NCT01117350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611508|NCT01117350|Incretins|incretins|mesh-ancestor
25611509|NCT01117350|Hormones|hormones|mesh-ancestor
25611510|NCT01117350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25611511|NCT01117454|Flecainide|flecainide|mesh-list
25611512|NCT01117454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25611513|NCT01117454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25611514|NCT01117454|Adrenergic Agents|adrenergic agents|mesh-ancestor
25611515|NCT01117454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25611516|NCT01117454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611517|NCT01117454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611518|NCT01117454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25611519|NCT01117454|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25611520|NCT01117454|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25611521|NCT01117454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24830757|NCT02161159|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24451681|NCT00324480|Growth Substances|growth substances|mesh-ancestor
24451682|NCT00324480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711594|NCT02302807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711595|NCT02302846|Ixazomib|ixazomib|mesh-list
25711596|NCT02302846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711597|NCT02302846|Protease Inhibitors|protease inhibitors|mesh-ancestor
25654699|NCT01553916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654700|NCT01553916|Antimanic Agents|antimanic agents|mesh-ancestor
25654701|NCT01553916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25654702|NCT01553916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25654703|NCT01553916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654704|NCT01554241|Vitamin D|vitamin d|mesh-list
25654705|NCT01554241|Cholecalciferol|cholecalciferol|mesh-list
25654706|NCT01554241|Vitamins|vitamins|mesh-ancestor
25654707|NCT01554241|Micronutrients|micronutrients|mesh-ancestor
25654708|NCT01554241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654709|NCT01554241|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25654710|NCT01554241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25654711|NCT01554371|Cyclophosphamide|cyclophosphamide|mesh-list
25654712|NCT01554371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25654713|NCT01554371|Immunologic Factors|immunologic factors|mesh-ancestor
25654714|NCT01554371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654715|NCT01554371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25654716|NCT01554371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25654717|NCT01554371|Alkylating Agents|alkylating agents|mesh-ancestor
25654718|NCT01554371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654719|NCT01554371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25654720|NCT01554371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25654721|NCT01554488|Fluticasone|fluticasone|mesh-list
25654722|NCT01554488|Xhance|xhance|mesh-list
25654723|NCT01554488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25654724|NCT01554488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25654725|NCT01554488|Autonomic Agents|autonomic agents|mesh-ancestor
25654726|NCT01554488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25654727|NCT01554488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654728|NCT01554488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25654729|NCT01554488|Respiratory System Agents|respiratory system agents|mesh-ancestor
25654730|NCT01554488|Dermatologic Agents|dermatologic agents|mesh-ancestor
25654731|NCT01554488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25654732|NCT01554514|Rituximab|rituximab|mesh-list
25654733|NCT01554514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25654734|NCT01554514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25654735|NCT01554514|Immunologic Factors|immunologic factors|mesh-ancestor
25654736|NCT01554514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654737|NCT01554514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25654738|NCT01554618|Exenatide|exenatide|mesh-list
25654739|NCT01554618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25654740|NCT01554618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654741|NCT01554618|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25654742|NCT01554618|Incretins|incretins|mesh-ancestor
25654743|NCT01554618|Hormones|hormones|mesh-ancestor
25654744|NCT01554618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25611522|NCT01117766|Pregabalin|pregabalin|mesh-list
25611523|NCT01117766|Analgesics|analgesics|mesh-ancestor
25611524|NCT01117766|Sensory System Agents|sensory system agents|mesh-ancestor
25611525|NCT01117766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25611526|NCT01117766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611527|NCT01117766|Anticonvulsants|anticonvulsants|mesh-ancestor
25611528|NCT01117766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25611529|NCT01117766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25611530|NCT01117766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611531|NCT01117766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25611532|NCT01117766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25611533|NCT01117766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25611534|NCT01117766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25611535|NCT01117766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25611536|NCT01117857|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25611537|NCT01117857|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25611538|NCT01117857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25611539|NCT01117857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24463042|NCT00358384|Hormones|hormones|mesh-ancestor
25611540|NCT01117857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611541|NCT01117857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25611542|NCT01117857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611543|NCT01117857|Analgesics|analgesics|mesh-ancestor
25611544|NCT01117857|Sensory System Agents|sensory system agents|mesh-ancestor
25611545|NCT01117857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25611546|NCT01117857|Antidepressive Agents|antidepressive agents|mesh-ancestor
25611547|NCT01117857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25611548|NCT01117857|Dopamine Agents|dopamine agents|mesh-ancestor
25611549|NCT01117948|Lornoxicam|lornoxicam|mesh-list
25611550|NCT01117948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25611551|NCT01117948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25611552|NCT01117948|Analgesics|analgesics|mesh-ancestor
25611553|NCT01117948|Sensory System Agents|sensory system agents|mesh-ancestor
25611554|NCT01117948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25611555|NCT01117948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611556|NCT01117948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25611557|NCT01117948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25611558|NCT01117987|Imatinib Mesylate|imatinib mesylate|mesh-list
25611559|NCT01117987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611560|NCT01117987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25611561|NCT01117987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25611562|NCT01117987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611563|NCT01118091|Aldesleukin|aldesleukin|mesh-list
25611564|NCT01118091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611565|NCT01118091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25611566|NCT01118091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25611567|NCT01118091|Antiviral Agents|antiviral agents|mesh-ancestor
25611568|NCT01118091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25611569|NCT01118273|Diphenhydramine|diphenhydramine|mesh-list
25611570|NCT01118273|Promethazine|promethazine|mesh-list
25611571|NCT01118273|Ibuprofen|ibuprofen|mesh-list
25611572|NCT01118273|Naproxen|naproxen|mesh-list
25611573|NCT01118273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611574|NCT01118273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25611575|NCT01118273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25611576|NCT01118273|Analgesics|analgesics|mesh-ancestor
25611577|NCT01118273|Sensory System Agents|sensory system agents|mesh-ancestor
25611578|NCT01118273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25611579|NCT01118273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611580|NCT01118273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25611581|NCT01118273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25611582|NCT01118273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25611583|NCT01118273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25611584|NCT01118273|Gout Suppressants|gout suppressants|mesh-ancestor
25611585|NCT01118273|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25611586|NCT01118273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25611587|NCT01118273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25611588|NCT01118273|Anesthetics, Local|anesthetics, local|mesh-ancestor
25611589|NCT01118273|Anesthetics|anesthetics|mesh-ancestor
25611590|NCT01118273|Antiemetics|antiemetics|mesh-ancestor
25611591|NCT01118273|Autonomic Agents|autonomic agents|mesh-ancestor
25611592|NCT01118273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25611593|NCT01118273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25611594|NCT01118273|Histamine Antagonists|histamine antagonists|mesh-ancestor
25611595|NCT01118273|Histamine Agents|histamine agents|mesh-ancestor
25654745|NCT01554683|Levetiracetam|levetiracetam|mesh-list
25611596|NCT01118273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25611597|NCT01118273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25611598|NCT01118273|Antipruritics|antipruritics|mesh-ancestor
25611599|NCT01118273|Dermatologic Agents|dermatologic agents|mesh-ancestor
25611600|NCT01118312|Mometasone Furoate|mometasone furoate|mesh-list
25611601|NCT01118312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25611602|NCT01118312|Dermatologic Agents|dermatologic agents|mesh-ancestor
25611603|NCT01118312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25611604|NCT01118325|Clopidogrel|clopidogrel|mesh-list
25611605|NCT01118325|Ticagrelor|ticagrelor|mesh-list
25611606|NCT01118325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25611607|NCT01118325|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25611608|NCT01118325|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25611609|NCT01118325|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25611610|NCT01118325|Purinergic Agents|purinergic agents|mesh-ancestor
25611611|NCT01118325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25611612|NCT01118325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611613|NCT01118325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611614|NCT01118351|Sunitinib|sunitinib|mesh-list
25611615|NCT01118351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611616|NCT01118351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25611617|NCT01118351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25611618|NCT01118351|Growth Substances|growth substances|mesh-ancestor
25611619|NCT01118351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611620|NCT01118351|Growth Inhibitors|growth inhibitors|mesh-ancestor
25611621|NCT01118351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25611622|NCT01118351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25611623|NCT01118351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611624|NCT01118377|Capecitabine|capecitabine|mesh-list
25611625|NCT01118377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25611626|NCT01118377|Antimetabolites|antimetabolites|mesh-ancestor
25611627|NCT01118377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611628|NCT01118377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611629|NCT01118455|Anticonvulsants|anticonvulsants|mesh-list
25611630|NCT01118520|Amlodipine|amlodipine|mesh-list
25611631|NCT01118520|Perindopril|perindopril|mesh-list
25611632|NCT01118520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25611633|NCT01118520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25611634|NCT01118520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25611635|NCT01118520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611636|NCT01118520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25611637|NCT01118520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611638|NCT01118520|Vasodilator Agents|vasodilator agents|mesh-ancestor
25611639|NCT01118520|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25611640|NCT01118520|Protease Inhibitors|protease inhibitors|mesh-ancestor
25611641|NCT01118520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25611642|NCT01118624|Vitamins|vitamins|mesh-list
25611643|NCT01118624|Folic Acid|folic acid|mesh-list
25611644|NCT01118624|Vitamin B 12|vitamin b 12|mesh-list
25611645|NCT01118624|Hydroxocobalamin|hydroxocobalamin|mesh-list
25611646|NCT01118624|Vitamin B Complex|vitamin b complex|mesh-list
25611647|NCT01118624|10-deazaaminopterin|10-deazaaminopterin|mesh-list
25611648|NCT01118624|Aminopterin|aminopterin|mesh-list
25611649|NCT01118624|Micronutrients|micronutrients|mesh-ancestor
25611650|NCT01118624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611651|NCT01118624|Hematinics|hematinics|mesh-ancestor
25611652|NCT01118624|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25611653|NCT01118624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25611654|NCT01118624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611655|NCT01118624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611656|NCT01118663|Acetylcysteine|acetylcysteine|mesh-list
25611657|NCT01118663|Edetic Acid|edetic acid|mesh-list
25611658|NCT01118663|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25611659|NCT01118663|Pentetic Acid|pentetic acid|mesh-list
25611660|NCT01118663|Antiviral Agents|antiviral agents|mesh-ancestor
25611661|NCT01118663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25611662|NCT01118663|Expectorants|expectorants|mesh-ancestor
25611663|NCT01118663|Respiratory System Agents|respiratory system agents|mesh-ancestor
25611664|NCT01118663|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25611665|NCT01118663|Antioxidants|antioxidants|mesh-ancestor
25611666|NCT01118663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611667|NCT01118663|Protective Agents|protective agents|mesh-ancestor
25611668|NCT01118663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611669|NCT01118663|Antidotes|antidotes|mesh-ancestor
25611670|NCT01118663|Anticoagulants|anticoagulants|mesh-ancestor
25611671|NCT01118663|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25611672|NCT01118663|Chelating Agents|chelating agents|mesh-ancestor
25611673|NCT01118663|Sequestering Agents|sequestering agents|mesh-ancestor
25611674|NCT01118663|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25611675|NCT01118741|Disulfiram|disulfiram|mesh-list
25611676|NCT01118741|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25611677|NCT01118741|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25611678|NCT01118741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25611679|NCT01118741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611680|NCT01118780|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25611681|NCT01118780|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25611682|NCT01118780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25611683|NCT01118780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25611684|NCT01118780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611685|NCT01118780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25611686|NCT01118780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611687|NCT01118780|Analgesics|analgesics|mesh-ancestor
25611688|NCT01118780|Sensory System Agents|sensory system agents|mesh-ancestor
25611689|NCT01118780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25611690|NCT01118780|Antidepressive Agents|antidepressive agents|mesh-ancestor
25611691|NCT01118780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25611692|NCT01118780|Dopamine Agents|dopamine agents|mesh-ancestor
25611693|NCT01118845|Rituximab|rituximab|mesh-list
25611694|NCT01118845|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25611695|NCT01118845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25611696|NCT01118845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611697|NCT01118845|Immunologic Factors|immunologic factors|mesh-ancestor
25611698|NCT01118845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611699|NCT01118845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25611700|NCT01118845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25611701|NCT01118845|Alkylating Agents|alkylating agents|mesh-ancestor
25611702|NCT01118845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611703|NCT01118949|Lacosamide|lacosamide|mesh-list
25611704|NCT01118949|Anticonvulsants|anticonvulsants|mesh-ancestor
25611705|NCT01118949|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25611706|NCT01118949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25611707|NCT01118949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25611708|NCT01118949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611709|NCT01118962|Lacosamide|lacosamide|mesh-list
25611710|NCT01118962|Anticonvulsants|anticonvulsants|mesh-ancestor
25611711|NCT01118962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25611712|NCT01118962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25611713|NCT01118962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25611714|NCT01118962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611715|NCT01118975|Lapatinib|lapatinib|mesh-list
25611716|NCT01118975|Vorinostat|vorinostat|mesh-list
25611717|NCT01118975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611718|NCT01118975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25611719|NCT01118975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25611720|NCT01118975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611721|NCT01118975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25611722|NCT01119105|Vancomycin|vancomycin|mesh-list
25611723|NCT01119105|Lefamulin|lefamulin|mesh-list
25611724|NCT01119105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25611725|NCT01119105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25611726|NCT01119131|Vitamin D|vitamin d|mesh-list
25611727|NCT01119131|Cholecalciferol|cholecalciferol|mesh-list
25611728|NCT01119131|Calcium|calcium|mesh-list
25611729|NCT01119131|Vitamins|vitamins|mesh-ancestor
25611730|NCT01119131|Micronutrients|micronutrients|mesh-ancestor
25611731|NCT01119131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611732|NCT01119131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25611733|NCT01119131|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25611734|NCT01119222|Diphenhydramine|diphenhydramine|mesh-list
25611735|NCT01119222|Promethazine|promethazine|mesh-list
25611736|NCT01119222|Morphine|morphine|mesh-list
25611737|NCT01119222|Gabapentin|gabapentin|mesh-list
25611738|NCT01119222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25611739|NCT01119222|Narcotics|narcotics|mesh-ancestor
25611740|NCT01119222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25611741|NCT01119222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611742|NCT01119222|Analgesics|analgesics|mesh-ancestor
25611743|NCT01119222|Sensory System Agents|sensory system agents|mesh-ancestor
25611744|NCT01119222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25611745|NCT01119222|Anticonvulsants|anticonvulsants|mesh-ancestor
25611746|NCT01119222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25611747|NCT01119222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25611748|NCT01119222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25611749|NCT01119222|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25611750|NCT01119222|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25611751|NCT01119222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25611752|NCT01119222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611753|NCT01119222|Antimanic Agents|antimanic agents|mesh-ancestor
25611754|NCT01119222|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25611755|NCT01119222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25611756|NCT01119222|Anesthetics, Local|anesthetics, local|mesh-ancestor
25611757|NCT01119222|Anesthetics|anesthetics|mesh-ancestor
25611758|NCT01119222|Antiemetics|antiemetics|mesh-ancestor
25611759|NCT01119222|Autonomic Agents|autonomic agents|mesh-ancestor
25611760|NCT01119222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25611761|NCT01119222|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25611762|NCT01119222|Histamine Antagonists|histamine antagonists|mesh-ancestor
25611763|NCT01119222|Histamine Agents|histamine agents|mesh-ancestor
25611764|NCT01119222|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25611765|NCT01119222|Antipruritics|antipruritics|mesh-ancestor
25611766|NCT01119222|Dermatologic Agents|dermatologic agents|mesh-ancestor
25611767|NCT01119287|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
24830889|NCT02161965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830890|NCT02161965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830914|NCT02162121|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24830915|NCT02162121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24830916|NCT02162121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24830924|NCT02162134|Ketorolac|ketorolac|mesh-list
25611768|NCT01119287|Dexamethasone|dexamethasone|mesh-list
25611769|NCT01119287|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25611770|NCT01119287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25611771|NCT01119287|Antiemetics|antiemetics|mesh-ancestor
25611772|NCT01119287|Autonomic Agents|autonomic agents|mesh-ancestor
25611773|NCT01119287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25611774|NCT01119287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611775|NCT01119287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25611776|NCT01119287|Glucocorticoids|glucocorticoids|mesh-ancestor
25611777|NCT01119287|Hormones|hormones|mesh-ancestor
25611778|NCT01119287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25611779|NCT01119287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25611780|NCT01119287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611781|NCT01119287|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25611782|NCT01119287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25611783|NCT01119287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25611784|NCT01119287|Analgesics|analgesics|mesh-ancestor
25611785|NCT01119287|Sensory System Agents|sensory system agents|mesh-ancestor
25611786|NCT01119287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25611787|NCT01119287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25611788|NCT01119287|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25611789|NCT01119287|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25611790|NCT01119287|Histamine Antagonists|histamine antagonists|mesh-ancestor
25611791|NCT01119287|Histamine Agents|histamine agents|mesh-ancestor
25611792|NCT01119287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25611793|NCT01119287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611794|NCT01119508|Temozolomide|temozolomide|mesh-list
25611795|NCT01119508|Ipilimumab|ipilimumab|mesh-list
25611796|NCT01119508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25611797|NCT01119508|Alkylating Agents|alkylating agents|mesh-ancestor
25611798|NCT01119508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611799|NCT01119508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611800|NCT01119508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25611801|NCT01119508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25611802|NCT01119625|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25611803|NCT01119625|Immunologic Factors|immunologic factors|mesh-ancestor
25611804|NCT01119625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611805|NCT01119703|Vaccines|vaccines|mesh-list
25611806|NCT01119703|Immunologic Factors|immunologic factors|mesh-ancestor
25611807|NCT01119703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611808|NCT01119768|Esomeprazole|esomeprazole|mesh-list
25611809|NCT01119768|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25611810|NCT01119768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25611811|NCT01119768|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25611812|NCT01119768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25611813|NCT01119768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611814|NCT01119794|Bortezomib|bortezomib|mesh-list
25611815|NCT01119794|Ofatumumab|ofatumumab|mesh-list
25611816|NCT01119794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611817|NCT01119846|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25611818|NCT01119846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24731970|NCT01637259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25611819|NCT01119846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611820|NCT01119846|Incretins|incretins|mesh-ancestor
25506338|NCT00368875|Paclitaxel|paclitaxel|mesh-list
25611821|NCT01119846|Hormones|hormones|mesh-ancestor
25654746|NCT01554683|Anticonvulsants|anticonvulsants|mesh-ancestor
25611822|NCT01119846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25611823|NCT01119846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25611824|NCT01119846|Protease Inhibitors|protease inhibitors|mesh-ancestor
25611825|NCT01119846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25611826|NCT01119846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611827|NCT01119859|Adalimumab|adalimumab|mesh-list
25611828|NCT01119859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25611829|NCT01119859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25611830|NCT01119898|Diclofenac|diclofenac|mesh-list
25611831|NCT01119898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25611832|NCT01119898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25611833|NCT01119898|Analgesics|analgesics|mesh-ancestor
25611834|NCT01119898|Sensory System Agents|sensory system agents|mesh-ancestor
25611835|NCT01119898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25611836|NCT01119898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611837|NCT01119898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25611838|NCT01119898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25611839|NCT01119898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25611840|NCT01119898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25611841|NCT01119898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611842|NCT01119937|Glycopyrrolate|glycopyrrolate|mesh-list
25611843|NCT01119937|Tiotropium Bromide|tiotropium bromide|mesh-list
25611844|NCT01119937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25611845|NCT01119937|Autonomic Agents|autonomic agents|mesh-ancestor
25611846|NCT01119937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25611847|NCT01119937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611848|NCT01119937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25611849|NCT01119937|Respiratory System Agents|respiratory system agents|mesh-ancestor
25611850|NCT01119937|Parasympatholytics|parasympatholytics|mesh-ancestor
25611851|NCT01119937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25611852|NCT01119937|Cholinergic Agents|cholinergic agents|mesh-ancestor
25611853|NCT01119937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25611854|NCT01119937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611855|NCT01119937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25611856|NCT01119937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25611857|NCT01119950|Glycopyrrolate|glycopyrrolate|mesh-list
25611858|NCT01119950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25611859|NCT01119950|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25611860|NCT01119950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25611861|NCT01119950|Cholinergic Agents|cholinergic agents|mesh-ancestor
25611862|NCT01119950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25611863|NCT01119950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611864|NCT01119950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611865|NCT01119963|Castor Oil|castor oil|mesh-list
25611866|NCT01119963|Progesterone|progesterone|mesh-list
25611867|NCT01119963|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
25611868|NCT01119963|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
25611869|NCT01119963|Progestins|progestins|mesh-ancestor
25611870|NCT01119963|Hormones|hormones|mesh-ancestor
24831057|NCT02162784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25611871|NCT01119963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25611872|NCT01119963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611873|NCT01119963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25611874|NCT01119963|Hormone Antagonists|hormone antagonists|mesh-ancestor
25611875|NCT01119963|Cathartics|cathartics|mesh-ancestor
25611876|NCT01119963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25611877|NCT01120028|Sirolimus|sirolimus|mesh-list
25611878|NCT01120028|Alemtuzumab|alemtuzumab|mesh-list
25611879|NCT01120028|Tacrolimus|tacrolimus|mesh-list
25611880|NCT01120028|Basiliximab|basiliximab|mesh-list
25611881|NCT01120028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25611882|NCT01120028|Immunologic Factors|immunologic factors|mesh-ancestor
25611883|NCT01120028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611884|NCT01120028|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25611885|NCT01120028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25611886|NCT01120028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611887|NCT01120028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25611888|NCT01120028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25611889|NCT01120028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25611890|NCT01120028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611891|NCT01120028|Antifungal Agents|antifungal agents|mesh-ancestor
25611892|NCT01120028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25611893|NCT01120093|Bromides|bromides|mesh-list
25611894|NCT01120093|Formoterol Fumarate|formoterol fumarate|mesh-list
25506389|NCT00368992|Immunoglobulins|immunoglobulins|mesh-list
25611895|NCT01120093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25611896|NCT01120093|Autonomic Agents|autonomic agents|mesh-ancestor
25611897|NCT01120093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25611898|NCT01120093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611899|NCT01120093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25611900|NCT01120093|Respiratory System Agents|respiratory system agents|mesh-ancestor
25611901|NCT01120093|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25611902|NCT01120093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25611903|NCT01120093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25611904|NCT01120093|Adrenergic Agents|adrenergic agents|mesh-ancestor
25611905|NCT01120093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25611906|NCT01120093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831174|NCT02163980|Ropivacaine|ropivacaine|mesh-list
25611907|NCT01120093|Anticonvulsants|anticonvulsants|mesh-ancestor
25611908|NCT01120184|Paclitaxel|paclitaxel|mesh-list
25611909|NCT01120184|Maytansine|maytansine|mesh-list
25611910|NCT01120184|Docetaxel|docetaxel|mesh-list
25611911|NCT01120184|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25611912|NCT01120184|Trastuzumab|trastuzumab|mesh-list
25611913|NCT01120184|Pertuzumab|pertuzumab|mesh-list
25611914|NCT01120184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25611915|NCT01120184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611916|NCT01120184|Tubulin Modulators|tubulin modulators|mesh-ancestor
25611917|NCT01120184|Antimitotic Agents|antimitotic agents|mesh-ancestor
25611918|NCT01120184|Mitosis Modulators|mitosis modulators|mesh-ancestor
25611919|NCT01120184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611920|NCT01120184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25611921|NCT01120236|Leuprolide|leuprolide|mesh-list
25611922|NCT01120236|Goserelin|goserelin|mesh-list
25611923|NCT01120236|Bicalutamide|bicalutamide|mesh-list
25611924|NCT01120236|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25611925|NCT01120236|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25611926|NCT01120236|Fertility Agents|fertility agents|mesh-ancestor
25611927|NCT01120236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25611928|NCT01120236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611929|NCT01120236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25611930|NCT01120236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611931|NCT01120236|Androgen Antagonists|androgen antagonists|mesh-ancestor
25611932|NCT01120236|Hormone Antagonists|hormone antagonists|mesh-ancestor
25611933|NCT01120236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25611934|NCT01120236|Immunologic Factors|immunologic factors|mesh-ancestor
25611935|NCT01120275|R04929097|r04929097|mesh-list
25611936|NCT01120275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25611937|NCT01120275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611938|NCT01120405|Sevoflurane|sevoflurane|mesh-list
25611939|NCT01120405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25611940|NCT01120405|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25611941|NCT01120405|Anesthetics, General|anesthetics, general|mesh-ancestor
25611942|NCT01120405|Anesthetics|anesthetics|mesh-ancestor
25611943|NCT01120405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25611944|NCT01120405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611945|NCT01120600|Vitamin D|vitamin d|mesh-list
25611946|NCT01120600|Cholecalciferol|cholecalciferol|mesh-list
25611947|NCT01120600|Calcium Carbonate|calcium carbonate|mesh-list
25611948|NCT01120600|Calcium|calcium|mesh-list
25611949|NCT01120600|Vitamins|vitamins|mesh-ancestor
25611950|NCT01120600|Micronutrients|micronutrients|mesh-ancestor
25611951|NCT01120600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611952|NCT01120600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25611953|NCT01120600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25611954|NCT01120600|Antacids|antacids|mesh-ancestor
25611955|NCT01120600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611956|NCT01120600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25611957|NCT01120626|Donepezil|donepezil|mesh-list
25611958|NCT01120626|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25611959|NCT01120626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25611960|NCT01120626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611961|NCT01120626|Cholinergic Agents|cholinergic agents|mesh-ancestor
25611962|NCT01120626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25611963|NCT01120626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611964|NCT01120626|Nootropic Agents|nootropic agents|mesh-ancestor
25611965|NCT01120639|Temozolomide|temozolomide|mesh-list
25611966|NCT01120639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25611967|NCT01120639|Alkylating Agents|alkylating agents|mesh-ancestor
25611968|NCT01120639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611969|NCT01120639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25611970|NCT01120691|Glycopyrrolate|glycopyrrolate|mesh-list
25611971|NCT01120691|Albuterol|albuterol|mesh-list
25611972|NCT01120691|Tiotropium Bromide|tiotropium bromide|mesh-list
25611973|NCT01120691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25611974|NCT01120691|Autonomic Agents|autonomic agents|mesh-ancestor
25611975|NCT01120691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25611976|NCT01120691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611977|NCT01120691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25611978|NCT01120691|Respiratory System Agents|respiratory system agents|mesh-ancestor
25611979|NCT01120691|Parasympatholytics|parasympatholytics|mesh-ancestor
25611980|NCT01120691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25611981|NCT01120691|Cholinergic Agents|cholinergic agents|mesh-ancestor
25611982|NCT01120691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25611983|NCT01120691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25611984|NCT01120691|Tocolytic Agents|tocolytic agents|mesh-ancestor
25611985|NCT01120691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25611986|NCT01120691|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25611987|NCT01120691|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25611988|NCT01120691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25611989|NCT01120691|Adrenergic Agents|adrenergic agents|mesh-ancestor
25611990|NCT01120691|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24831369|NCT02165033|Procaterol|procaterol|mesh-list
25611991|NCT01120691|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25611992|NCT01120704|Nicotine|nicotine|mesh-list
25611993|NCT01120704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25611994|NCT01120704|Autonomic Agents|autonomic agents|mesh-ancestor
25611995|NCT01120704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25611996|NCT01120704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25611997|NCT01120704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25611998|NCT01120704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25611999|NCT01120704|Cholinergic Agents|cholinergic agents|mesh-ancestor
25612000|NCT01120704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25612001|NCT01120704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612002|NCT01120834|Azacitidine|azacitidine|mesh-list
25612003|NCT01120834|Vorinostat|vorinostat|mesh-list
25612004|NCT01120834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25612005|NCT01120834|Antimetabolites|antimetabolites|mesh-ancestor
25612006|NCT01120834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612007|NCT01120834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612008|NCT01120834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25612009|NCT01120834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25612010|NCT01120899|Minocycline|minocycline|mesh-list
25612011|NCT01120899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25612012|NCT01120899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25612013|NCT01121211|Testosterone|testosterone|mesh-list
25612014|NCT01121211|Androgens|androgens|mesh-ancestor
25612015|NCT01121211|Hormones|hormones|mesh-ancestor
25612016|NCT01121211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25612017|NCT01121211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612018|NCT01121393|Gemcitabine|gemcitabine|mesh-list
25612019|NCT01121393|Cisplatin|cisplatin|mesh-list
25612020|NCT01121393|Afatinib|afatinib|mesh-list
25612021|NCT01121393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612022|NCT01121393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25612023|NCT01121393|Antimetabolites|antimetabolites|mesh-ancestor
24831909|NCT02169843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25612024|NCT01121393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612025|NCT01121393|Antiviral Agents|antiviral agents|mesh-ancestor
25612026|NCT01121393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25612027|NCT01121393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25612028|NCT01121393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25612029|NCT01121393|Immunologic Factors|immunologic factors|mesh-ancestor
25612030|NCT01121393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612031|NCT01121393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25612032|NCT01121406|Gemcitabine|gemcitabine|mesh-list
25612033|NCT01121406|Paclitaxel|paclitaxel|mesh-list
25612034|NCT01121406|Doxorubicin|doxorubicin|mesh-list
25612035|NCT01121406|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25612036|NCT01121406|Topotecan|topotecan|mesh-list
25612037|NCT01121406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25612038|NCT01121406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612039|NCT01121406|Tubulin Modulators|tubulin modulators|mesh-ancestor
25612040|NCT01121406|Antimitotic Agents|antimitotic agents|mesh-ancestor
25612041|NCT01121406|Mitosis Modulators|mitosis modulators|mesh-ancestor
25612042|NCT01121406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612043|NCT01121406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25612044|NCT01121406|Antimetabolites|antimetabolites|mesh-ancestor
25612045|NCT01121406|Antiviral Agents|antiviral agents|mesh-ancestor
25612046|NCT01121406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25612047|NCT01121406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25612048|NCT01121406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25612049|NCT01121406|Immunologic Factors|immunologic factors|mesh-ancestor
25612050|NCT01121406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612051|NCT01121406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25612052|NCT01121406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25612053|NCT01121406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25612054|NCT01121406|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25612055|NCT01121484|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25612056|NCT01121484|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25612057|NCT01121484|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25612058|NCT01121484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25612059|NCT01121484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612060|NCT01121484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25612061|NCT01121484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612062|NCT01121484|Antidepressive Agents|antidepressive agents|mesh-ancestor
25612063|NCT01121484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25612064|NCT01121536|Modafinil|modafinil|mesh-list
25612065|NCT01121536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25612066|NCT01121536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612067|NCT01121536|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25612068|NCT01121536|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25612069|NCT01121536|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25612070|NCT01121536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612071|NCT01121549|Exemestane|exemestane|mesh-list
25612072|NCT01121549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612073|NCT01121549|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25612074|NCT01121549|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25612075|NCT01121549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25612076|NCT01121549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612077|NCT01121549|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25612078|NCT01121549|Hormone Antagonists|hormone antagonists|mesh-ancestor
25612079|NCT01121549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25612080|NCT01121549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612081|NCT01121562|Sunitinib|sunitinib|mesh-list
25612082|NCT01121562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612083|NCT01121562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25612084|NCT01121562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25612085|NCT01121562|Growth Substances|growth substances|mesh-ancestor
25612086|NCT01121562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612087|NCT01121562|Growth Inhibitors|growth inhibitors|mesh-ancestor
25612088|NCT01121562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25612089|NCT01121562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25612090|NCT01121562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612091|NCT01121575|Crizotinib|crizotinib|mesh-list
25612092|NCT01121575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612093|NCT01121575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25612094|NCT01121575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25612095|NCT01121575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612096|NCT01121666|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25506598|NCT00369915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25506599|NCT00369915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506600|NCT00369915|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25506601|NCT00369915|Parasympatholytics|parasympatholytics|mesh-ancestor
25506602|NCT00369941|Tenofovir|tenofovir|mesh-list
25506603|NCT00369941|Emtricitabine|emtricitabine|mesh-list
25506604|NCT00369941|Efavirenz|efavirenz|mesh-list
25506605|NCT00369941|Raltegravir Potassium|raltegravir potassium|mesh-list
25506606|NCT00369941|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25506607|NCT00369941|Antiviral Agents|antiviral agents|mesh-ancestor
25506608|NCT00369941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25506609|NCT00369941|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25612097|NCT01121666|Hormones|hormones|mesh-ancestor
25612098|NCT01121666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25612099|NCT01121666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612100|NCT01121757|Lenalidomide|lenalidomide|mesh-list
25612101|NCT01121757|Azacitidine|azacitidine|mesh-list
25612102|NCT01121757|Immunologic Factors|immunologic factors|mesh-ancestor
25612103|NCT01121757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612104|NCT01121757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25612105|NCT01121757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25612106|NCT01121757|Growth Substances|growth substances|mesh-ancestor
25612107|NCT01121757|Growth Inhibitors|growth inhibitors|mesh-ancestor
25612108|NCT01121757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612109|NCT01121757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25612110|NCT01121757|Antimetabolites|antimetabolites|mesh-ancestor
25612111|NCT01121757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612112|NCT01121757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25612113|NCT01121900|Trazodone|trazodone|mesh-list
25612114|NCT01121900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25612115|NCT01121900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25612116|NCT01121900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25612117|NCT01121900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612118|NCT01121900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25612119|NCT01121900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25612120|NCT01121900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25612121|NCT01121900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25612122|NCT01121900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612123|NCT01121900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25612124|NCT01121900|Serotonin Agents|serotonin agents|mesh-ancestor
25612125|NCT01121900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25612126|NCT01121900|Antidepressive Agents|antidepressive agents|mesh-ancestor
25612127|NCT01121913|Trazodone|trazodone|mesh-list
25612128|NCT01121913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25612129|NCT01121913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25612130|NCT01121913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25612131|NCT01121913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612132|NCT01121913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25612133|NCT01121913|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25612134|NCT01121913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25612135|NCT01121913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25612136|NCT01121913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612137|NCT01121913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25612138|NCT01121913|Serotonin Agents|serotonin agents|mesh-ancestor
25612139|NCT01121913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25612140|NCT01121913|Antidepressive Agents|antidepressive agents|mesh-ancestor
25612141|NCT01121926|Trazodone|trazodone|mesh-list
25612142|NCT01121926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25612143|NCT01121926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25612144|NCT01121926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25612145|NCT01121926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612146|NCT01121926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25612147|NCT01121926|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25612148|NCT01121926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25612149|NCT01121926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25612150|NCT01121926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612151|NCT01121926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25612152|NCT01121926|Serotonin Agents|serotonin agents|mesh-ancestor
25612153|NCT01121926|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25612154|NCT01121926|Antidepressive Agents|antidepressive agents|mesh-ancestor
25612155|NCT01121939|Bevacizumab|bevacizumab|mesh-list
25612156|NCT01121939|Pertuzumab|pertuzumab|mesh-list
25612157|NCT01121939|Octreotide|octreotide|mesh-list
25612158|NCT01121939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25612159|NCT01121939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612160|NCT01121939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25612161|NCT01121939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25612162|NCT01121939|Growth Substances|growth substances|mesh-ancestor
25612163|NCT01121939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612164|NCT01121939|Growth Inhibitors|growth inhibitors|mesh-ancestor
25612165|NCT01121939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25612166|NCT01121939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25612167|NCT01121991|Hormones|hormones|mesh-list
25612168|NCT01121991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25612169|NCT01121991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612170|NCT01122108|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
25612171|NCT01122108|Cholestyramine Resin|cholestyramine resin|mesh-list
25612172|NCT01122108|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25612173|NCT01122108|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25612174|NCT01122108|Antimetabolites|antimetabolites|mesh-ancestor
25612175|NCT01122108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612176|NCT01122108|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25612177|NCT01122160|Omeprazole|omeprazole|mesh-list
25612178|NCT01122160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25612180|NCT01122160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25612181|NCT01122160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25612182|NCT01122160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654747|NCT01554683|Nootropic Agents|nootropic agents|mesh-ancestor
25654748|NCT01555125|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25654749|NCT01555125|Immunologic Factors|immunologic factors|mesh-ancestor
25654750|NCT01555125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654751|NCT01555138|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25654752|NCT01555138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25654753|NCT01555138|Autonomic Agents|autonomic agents|mesh-ancestor
25654754|NCT01555138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25654755|NCT01555138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654756|NCT01555138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25654757|NCT01555138|Respiratory System Agents|respiratory system agents|mesh-ancestor
25654758|NCT01555138|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25654759|NCT01555138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25654760|NCT01555138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25654761|NCT01555138|Adrenergic Agents|adrenergic agents|mesh-ancestor
25654762|NCT01555138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25654763|NCT01555138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654764|NCT01555151|Mometasone Furoate|mometasone furoate|mesh-list
25654765|NCT01555151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25654766|NCT01555151|Dermatologic Agents|dermatologic agents|mesh-ancestor
25654767|NCT01555151|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25654768|NCT01555164|Metformin|metformin|mesh-list
25654769|NCT01555164|Ranolazine|ranolazine|mesh-list
25654770|NCT01555164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25654771|NCT01555164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654772|NCT01555164|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25654773|NCT01555164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25654774|NCT01555164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654775|NCT01555463|Azelaic acid|azelaic acid|mesh-list
25654776|NCT01555463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25654777|NCT01555463|Dermatologic Agents|dermatologic agents|mesh-ancestor
25654778|NCT01555671|Meperidine|meperidine|mesh-list
25654779|NCT01555671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25654780|NCT01555671|Narcotics|narcotics|mesh-ancestor
25654781|NCT01555671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25654782|NCT01555671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654783|NCT01555671|Analgesics|analgesics|mesh-ancestor
25654784|NCT01555671|Sensory System Agents|sensory system agents|mesh-ancestor
25654785|NCT01555671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25654786|NCT01555671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25711674|NCT02304926|Ezetimibe|ezetimibe|mesh-list
25654787|NCT01555931|Levonorgestrel|levonorgestrel|mesh-list
25654788|NCT01555931|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25654789|NCT01555931|Contraceptive Agents|contraceptive agents|mesh-ancestor
25654790|NCT01555931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25654791|NCT01555931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654792|NCT01555931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25654793|NCT01555931|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25654794|NCT01555931|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25654795|NCT01556165|Rasagiline|rasagiline|mesh-list
25654796|NCT01556165|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25654797|NCT01556165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25654798|NCT01556165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654799|NCT01556165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25654800|NCT01556165|Protective Agents|protective agents|mesh-ancestor
25654801|NCT01556165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654802|NCT01556347|Rituximab|rituximab|mesh-list
25654803|NCT01556347|Bortezomib|bortezomib|mesh-list
25654804|NCT01556347|Thymoglobulin|thymoglobulin|mesh-list
25654805|NCT01556347|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25654806|NCT01556347|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25654807|NCT01556347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25654808|NCT01556347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25654809|NCT01556347|Immunologic Factors|immunologic factors|mesh-ancestor
25654810|NCT01556347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654811|NCT01556347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25654812|NCT01556347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25654813|NCT01556425|Naltrexone|naltrexone|mesh-list
25654814|NCT01556425|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25654815|NCT01556425|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25654816|NCT01556425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654817|NCT01556425|Sensory System Agents|sensory system agents|mesh-ancestor
25612184|NCT01122238|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25612185|NCT01122238|Autonomic Agents|autonomic agents|mesh-ancestor
25612186|NCT01122238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25612187|NCT01122238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612188|NCT01122238|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25612189|NCT01122238|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25612190|NCT01122238|Cholinergic Agents|cholinergic agents|mesh-ancestor
25612191|NCT01122238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25612192|NCT01122238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612193|NCT01122264|Sildenafil Citrate|sildenafil citrate|mesh-list
25612194|NCT01122264|Tadalafil|tadalafil|mesh-list
25612195|NCT01122264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612196|NCT01122264|Vasodilator Agents|vasodilator agents|mesh-ancestor
25612197|NCT01122264|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25612198|NCT01122264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25612199|NCT01122264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25612200|NCT01122264|Urological Agents|urological agents|mesh-ancestor
25612201|NCT01122316|Metformin|metformin|mesh-list
25612202|NCT01122316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25612203|NCT01122316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612204|NCT01122680|Bromides|bromides|mesh-list
25612205|NCT01122680|Tiotropium Bromide|tiotropium bromide|mesh-list
25612206|NCT01122680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25612207|NCT01122680|Autonomic Agents|autonomic agents|mesh-ancestor
25612208|NCT01122680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25612209|NCT01122680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612210|NCT01122680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25612211|NCT01122680|Respiratory System Agents|respiratory system agents|mesh-ancestor
25612212|NCT01122680|Parasympatholytics|parasympatholytics|mesh-ancestor
25612213|NCT01122680|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25612214|NCT01122680|Cholinergic Agents|cholinergic agents|mesh-ancestor
25612215|NCT01122680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25612216|NCT01122680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612217|NCT01122680|Anticonvulsants|anticonvulsants|mesh-ancestor
25612218|NCT01122862|Chlorhexidine|chlorhexidine|mesh-list
25612219|NCT01122862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25612220|NCT01122862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25612221|NCT01122862|Disinfectants|disinfectants|mesh-ancestor
25612222|NCT01122901|R04929097|r04929097|mesh-list
25612223|NCT01122901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25612224|NCT01122901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612225|NCT01122927|Aripiprazole|aripiprazole|mesh-list
25612226|NCT01122927|Antidepressive Agents|antidepressive agents|mesh-ancestor
25612227|NCT01122927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25612228|NCT01122927|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25612229|NCT01122927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25612230|NCT01122927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25612231|NCT01122927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612232|NCT01122927|Dopamine Agonists|dopamine agonists|mesh-ancestor
25612233|NCT01122927|Dopamine Agents|dopamine agents|mesh-ancestor
25612234|NCT01122927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25612235|NCT01122927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612236|NCT01122927|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25612237|NCT01122927|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25612238|NCT01122927|Serotonin Agents|serotonin agents|mesh-ancestor
25612239|NCT01122927|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25612240|NCT01122927|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25612241|NCT01122927|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25612242|NCT01122927|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25612243|NCT01123070|Rituximab|rituximab|mesh-list
25612244|NCT01123070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25612245|NCT01123070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711689|NCT02305017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612246|NCT01123070|Immunologic Factors|immunologic factors|mesh-ancestor
25612247|NCT01123070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612248|NCT01123070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25612249|NCT01123083|Muromonab-CD3|muromonab-cd3|mesh-list
25612250|NCT01123083|Immunologic Factors|immunologic factors|mesh-ancestor
25612251|NCT01123083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612252|NCT01123083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25612253|NCT01123356|Lenalidomide|lenalidomide|mesh-list
25612254|NCT01123356|Ofatumumab|ofatumumab|mesh-list
25612255|NCT01123356|Immunologic Factors|immunologic factors|mesh-ancestor
25612256|NCT01123356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612257|NCT01123356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25612258|NCT01123356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25612259|NCT01123356|Growth Substances|growth substances|mesh-ancestor
25612260|NCT01123356|Growth Inhibitors|growth inhibitors|mesh-ancestor
25612261|NCT01123356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612262|NCT01123395|Colchicine|colchicine|mesh-list
25612263|NCT01123395|Gout Suppressants|gout suppressants|mesh-ancestor
25612264|NCT01123395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25612265|NCT01123395|Tubulin Modulators|tubulin modulators|mesh-ancestor
25612266|NCT01123395|Antimitotic Agents|antimitotic agents|mesh-ancestor
25612267|NCT01123395|Mitosis Modulators|mitosis modulators|mesh-ancestor
25612268|NCT01123395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612269|NCT01123395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612270|NCT01123889|Lidocaine|lidocaine|mesh-list
25612271|NCT01123889|Ropivacaine|ropivacaine|mesh-list
25612272|NCT01123889|Anesthetics, Local|anesthetics, local|mesh-ancestor
25612273|NCT01123889|Anesthetics|anesthetics|mesh-ancestor
25612274|NCT01123889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25612275|NCT01123889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612276|NCT01123889|Sensory System Agents|sensory system agents|mesh-ancestor
25612277|NCT01123889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25612278|NCT01123889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25612279|NCT01123889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25612280|NCT01123889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25612281|NCT01123889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25612282|NCT01123889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612283|NCT01123980|Insulin|insulin|mesh-list
25612284|NCT01123980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25612285|NCT01123980|Metformin|metformin|mesh-list
25612286|NCT01123980|Insulin Glargine|insulin glargine|mesh-list
25612287|NCT01123980|Insulin Aspart|insulin aspart|mesh-list
25612288|NCT01123980|Glimepiride|glimepiride|mesh-list
25612289|NCT01123980|Biphasic Insulins|biphasic insulins|mesh-list
25612290|NCT01123980|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
25612291|NCT01123980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25612292|NCT01123980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612293|NCT01123980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25612294|NCT01123980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25612295|NCT01123980|Immunologic Factors|immunologic factors|mesh-ancestor
25612296|NCT01124045|Prednisolone|prednisolone|mesh-list
24832812|NCT02172287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24832813|NCT02172287|Respiratory System Agents|respiratory system agents|mesh-ancestor
24832814|NCT02172287|Parasympatholytics|parasympatholytics|mesh-ancestor
24832838|NCT02172326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25711699|NCT02305238|Growth Substances|growth substances|mesh-ancestor
25711700|NCT02305238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711701|NCT02305238|Growth Inhibitors|growth inhibitors|mesh-ancestor
25711702|NCT02305238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711703|NCT02305277|Opicapone|opicapone|mesh-list
25711704|NCT02305277|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25711705|NCT02305277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711706|NCT02305277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612297|NCT01124045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25612298|NCT01124045|Methylprednisolone|methylprednisolone|mesh-list
25612299|NCT01124045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25612300|NCT01124045|Prednisolone acetate|prednisolone acetate|mesh-list
25612301|NCT01124045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25612302|NCT01124045|Prednisolone phosphate|prednisolone phosphate|mesh-list
25612303|NCT01124045|Difluprednate|difluprednate|mesh-list
25612304|NCT01124045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25612305|NCT01124045|Glucocorticoids|glucocorticoids|mesh-ancestor
25612306|NCT01124045|Hormones|hormones|mesh-ancestor
25612307|NCT01124045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25612308|NCT01124045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612309|NCT01124045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25612310|NCT01124045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612311|NCT01124045|Antiemetics|antiemetics|mesh-ancestor
25612312|NCT01124045|Autonomic Agents|autonomic agents|mesh-ancestor
25612313|NCT01124045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25612314|NCT01124045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25612315|NCT01124045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25612316|NCT01124045|Protective Agents|protective agents|mesh-ancestor
25612317|NCT01124097|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25612318|NCT01124097|Anticonvulsants|anticonvulsants|mesh-ancestor
25612319|NCT01124097|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25612320|NCT01124097|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24832841|NCT02172326|Respiratory System Agents|respiratory system agents|mesh-ancestor
24451927|NCT00325286|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24451928|NCT00325286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24451929|NCT00325286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24451930|NCT00325286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24832853|NCT02172339|Respiratory System Agents|respiratory system agents|mesh-ancestor
24832854|NCT02172339|Parasympatholytics|parasympatholytics|mesh-ancestor
24832855|NCT02172339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24832856|NCT02172339|Cholinergic Agents|cholinergic agents|mesh-ancestor
24739864|NCT01684787|Antiviral Agents|antiviral agents|mesh-ancestor
25612321|NCT01124097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25612322|NCT01124097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612323|NCT01124149|Mesalamine|mesalamine|mesh-list
25612324|NCT01124149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25612325|NCT01124149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25612326|NCT01124149|Analgesics|analgesics|mesh-ancestor
25612327|NCT01124149|Sensory System Agents|sensory system agents|mesh-ancestor
25612328|NCT01124149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25612329|NCT01124149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612330|NCT01124149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25612331|NCT01124149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25612332|NCT01124162|Losartan|losartan|mesh-list
25506879|NCT05250050|Renal Agents|renal agents|mesh-ancestor
25506944|NCT05187286|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25506945|NCT05187286|Antithrombins|antithrombins|mesh-ancestor
25506946|NCT05187286|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25506947|NCT05187286|Protease Inhibitors|protease inhibitors|mesh-ancestor
25506948|NCT05187286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711707|NCT02305277|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24832862|NCT02172352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24832863|NCT02172352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711708|NCT02305277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25711709|NCT02305316|Opicapone|opicapone|mesh-list
25711710|NCT02305316|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25711711|NCT02305316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711712|NCT02305316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711713|NCT02305316|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25711714|NCT02305316|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25506949|NCT05187286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506950|NCT05187286|Anticoagulants|anticoagulants|mesh-ancestor
25506951|NCT05143502|Fluticasone|fluticasone|mesh-list
25506953|NCT05143502|Prednisolone|prednisolone|mesh-list
25506954|NCT05143502|Montelukast|montelukast|mesh-list
25506955|NCT05143502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25506956|NCT05143502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25506957|NCT05143502|Autonomic Agents|autonomic agents|mesh-ancestor
25506958|NCT05143502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25506959|NCT05143502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506960|NCT05143502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25506961|NCT05143502|Respiratory System Agents|respiratory system agents|mesh-ancestor
25711715|NCT02305329|Opicapone|opicapone|mesh-list
25711716|NCT02305329|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25711717|NCT02305329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711718|NCT02305329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832878|NCT02172378|Parasympatholytics|parasympatholytics|mesh-ancestor
24832879|NCT02172378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24832880|NCT02172378|Cholinergic Agents|cholinergic agents|mesh-ancestor
24832881|NCT02172378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24832883|NCT02172391|Tiotropium Bromide|tiotropium bromide|mesh-list
24832887|NCT02172391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832888|NCT02172391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24451984|NCT00325637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451986|NCT00325676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24832891|NCT02172391|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24832893|NCT02172391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25711719|NCT02305329|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25711720|NCT02305329|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25711721|NCT02305563|Cytarabine|cytarabine|mesh-list
25404037|NCT03686124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25506962|NCT05143502|Dermatologic Agents|dermatologic agents|mesh-ancestor
25506963|NCT05143502|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25506964|NCT05143502|Glucocorticoids|glucocorticoids|mesh-ancestor
25506965|NCT05143502|Hormones|hormones|mesh-ancestor
25506966|NCT05143502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25506967|NCT05143502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25506968|NCT05143502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506969|NCT05143502|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25506970|NCT05143502|Hormone Antagonists|hormone antagonists|mesh-ancestor
25506971|NCT05143502|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25506972|NCT05143502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24832894|NCT02172391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451987|NCT00325676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24451988|NCT00325676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24451989|NCT00325676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451990|NCT00325676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451991|NCT00325689|Risperidone|risperidone|mesh-list
24451992|NCT00325689|Aripiprazole|aripiprazole|mesh-list
24451993|NCT00325689|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24451994|NCT00325689|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24451995|NCT00325689|Serotonin Agents|serotonin agents|mesh-ancestor
25711722|NCT02305563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25711723|NCT02305563|Antimetabolites|antimetabolites|mesh-ancestor
25711724|NCT02305563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711725|NCT02305563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711726|NCT02305563|Antiviral Agents|antiviral agents|mesh-ancestor
25711727|NCT02305563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25711728|NCT02305563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25711729|NCT02305563|Immunologic Factors|immunologic factors|mesh-ancestor
25711730|NCT02305563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711731|NCT02305758|Bevacizumab|bevacizumab|mesh-list
25506973|NCT05143502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979996|NCT04756765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24436579|NCT00270530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24436580|NCT00270530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25124297|NCT03078101|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25124298|NCT03078101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124299|NCT03078101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25124300|NCT03078101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124301|NCT03077633|Progesterone|progesterone|mesh-list
25124302|NCT03077633|Progestins|progestins|mesh-ancestor
25124303|NCT03077633|Hormones|hormones|mesh-ancestor
25124304|NCT03077633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25124305|NCT03077633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466518|NCT00373776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24466519|NCT00373776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24452001|NCT00325689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24452002|NCT00325689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24452003|NCT00325689|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24452004|NCT00325689|Dopamine Agents|dopamine agents|mesh-ancestor
24452005|NCT00325689|Antidepressive Agents|antidepressive agents|mesh-ancestor
24452006|NCT00325689|Dopamine Agonists|dopamine agonists|mesh-ancestor
24452007|NCT00325689|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24452008|NCT00325689|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25711732|NCT02305758|Fluorouracil|fluorouracil|mesh-list
25711733|NCT02305758|Veliparib|veliparib|mesh-list
25711734|NCT02305758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25711735|NCT02305758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711736|NCT02305758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25711737|NCT02305758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25711738|NCT02305758|Growth Substances|growth substances|mesh-ancestor
25711739|NCT02305758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711740|NCT02305758|Growth Inhibitors|growth inhibitors|mesh-ancestor
25711741|NCT02305758|Antimetabolites|antimetabolites|mesh-ancestor
25124306|NCT03077581|Anesthetics|anesthetics|mesh-list
25612333|NCT01124162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25612334|NCT01124162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25612335|NCT01124162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25612336|NCT01124162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25612337|NCT01124162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612338|NCT01124175|Losartan|losartan|mesh-list
25612339|NCT01124175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25612340|NCT01124175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25612341|NCT01124175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25612342|NCT01124175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25612343|NCT01124175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612344|NCT01124188|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25612345|NCT01124188|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25612346|NCT01124188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24832946|NCT02172443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832948|NCT02172443|Respiratory System Agents|respiratory system agents|mesh-ancestor
24466684|NCT00374621|Isosorbide|isosorbide|mesh-list
25612347|NCT01124188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25612348|NCT01124188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612349|NCT01124188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25612350|NCT01124188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612351|NCT01124188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25612352|NCT01124188|Antidepressive Agents|antidepressive agents|mesh-ancestor
25612353|NCT01124188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25612354|NCT01124422|Fluticasone|fluticasone|mesh-list
25612355|NCT01124422|Xhance|xhance|mesh-list
25612356|NCT01124422|Bromides|bromides|mesh-list
25612357|NCT01124422|Tiotropium Bromide|tiotropium bromide|mesh-list
25612358|NCT01124422|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25612359|NCT01124422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25612360|NCT01124422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25612362|NCT01124422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25612363|NCT01124422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612364|NCT01124422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24701064|NCT01456546|Antimalarials|antimalarials|mesh-ancestor
24701105|NCT01456689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452062|NCT00325936|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24452063|NCT00325936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24452064|NCT00325936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452065|NCT00325936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24452067|NCT00325949|Acetaminophen|acetaminophen|mesh-list
24452068|NCT00325949|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
24452069|NCT00325949|Hydrocodone|hydrocodone|mesh-list
24452070|NCT00325949|Oxycodone|oxycodone|mesh-list
24452071|NCT00325949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24452072|NCT00325949|Analgesics|analgesics|mesh-ancestor
24452073|NCT00325949|Sensory System Agents|sensory system agents|mesh-ancestor
25612365|NCT01124422|Respiratory System Agents|respiratory system agents|mesh-ancestor
25612366|NCT01124422|Dermatologic Agents|dermatologic agents|mesh-ancestor
25612367|NCT01124422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25612368|NCT01124422|Parasympatholytics|parasympatholytics|mesh-ancestor
25612369|NCT01124422|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25612370|NCT01124422|Cholinergic Agents|cholinergic agents|mesh-ancestor
25612371|NCT01124422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25612372|NCT01124422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612373|NCT01124422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25612374|NCT01124422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25612375|NCT01124422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25612376|NCT01124422|Adrenergic Agents|adrenergic agents|mesh-ancestor
24832988|NCT02172482|Respiratory System Agents|respiratory system agents|mesh-ancestor
24832989|NCT02172482|Parasympatholytics|parasympatholytics|mesh-ancestor
24832990|NCT02172482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24832991|NCT02172482|Cholinergic Agents|cholinergic agents|mesh-ancestor
24832992|NCT02172482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24741390|NCT01693809|Caffeine|caffeine|mesh-list
24832993|NCT02172482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741468|NCT05288725|Hormones|hormones|mesh-ancestor
24833001|NCT02172495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24833002|NCT02172495|Respiratory System Agents|respiratory system agents|mesh-ancestor
24833003|NCT02172495|Parasympatholytics|parasympatholytics|mesh-ancestor
24833004|NCT02172495|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24833005|NCT02172495|Cholinergic Agents|cholinergic agents|mesh-ancestor
25612377|NCT01124422|Anticonvulsants|anticonvulsants|mesh-ancestor
25612378|NCT01124448|TFF1 protein, human|tff1 protein, human|mesh-list
25612379|NCT01124448|Growth Inhibitors|growth inhibitors|mesh-ancestor
25612380|NCT01124448|Growth Substances|growth substances|mesh-ancestor
25612381|NCT01124448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612382|NCT01124604|Tapentadol|tapentadol|mesh-list
25612383|NCT01124604|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25612384|NCT01124604|Narcotics|narcotics|mesh-ancestor
25612385|NCT01124604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25612386|NCT01124604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612387|NCT01124604|Analgesics|analgesics|mesh-ancestor
25612388|NCT01124604|Sensory System Agents|sensory system agents|mesh-ancestor
25612389|NCT01124604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25612390|NCT01124604|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25612391|NCT01124604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25612392|NCT01124604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25612393|NCT01124604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612394|NCT01124604|Adrenergic Agents|adrenergic agents|mesh-ancestor
25612395|NCT01124604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25612396|NCT01124617|Tapentadol|tapentadol|mesh-list
25612397|NCT01124617|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25612398|NCT01124617|Narcotics|narcotics|mesh-ancestor
25612399|NCT01124617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25612400|NCT01124617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612401|NCT01124617|Analgesics|analgesics|mesh-ancestor
25612402|NCT01124617|Sensory System Agents|sensory system agents|mesh-ancestor
25612403|NCT01124617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25612404|NCT01124617|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25612405|NCT01124617|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25612406|NCT01124617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25612407|NCT01124617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612408|NCT01124617|Adrenergic Agents|adrenergic agents|mesh-ancestor
25612409|NCT01124617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25612410|NCT01124734|Temozolomide|temozolomide|mesh-list
25612411|NCT01124734|Interleukin-2|interleukin-2|mesh-list
25612412|NCT01124734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25612413|NCT01124734|Alkylating Agents|alkylating agents|mesh-ancestor
25612414|NCT01124734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612415|NCT01124734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612416|NCT01124734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25612417|NCT01124734|Analgesics|analgesics|mesh-ancestor
25612418|NCT01124734|Sensory System Agents|sensory system agents|mesh-ancestor
25711742|NCT02305758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833015|NCT02172508|Respiratory System Agents|respiratory system agents|mesh-ancestor
24833016|NCT02172508|Parasympatholytics|parasympatholytics|mesh-ancestor
24833044|NCT02172534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24833045|NCT02172534|Cholinergic Agents|cholinergic agents|mesh-ancestor
24833046|NCT02172534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24833047|NCT02172534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833048|NCT02172534|Anticonvulsants|anticonvulsants|mesh-ancestor
24833049|NCT02172547|Tiotropium Bromide|tiotropium bromide|mesh-list
24833054|NCT02172547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24833055|NCT02172547|Respiratory System Agents|respiratory system agents|mesh-ancestor
24833056|NCT02172547|Parasympatholytics|parasympatholytics|mesh-ancestor
24833057|NCT02172547|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24833060|NCT02172547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833061|NCT02172560|Tiotropium Bromide|tiotropium bromide|mesh-list
24833062|NCT02172560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24833063|NCT02172560|Autonomic Agents|autonomic agents|mesh-ancestor
24833064|NCT02172560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25711743|NCT02305758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25711744|NCT02305758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25711745|NCT02305758|Immunologic Factors|immunologic factors|mesh-ancestor
25711746|NCT02305758|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25711747|NCT02305758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711748|NCT02305797|Lorazepam|lorazepam|mesh-list
25711749|NCT02305797|Anticonvulsants|anticonvulsants|mesh-ancestor
25612419|NCT01124734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25612420|NCT01124734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612421|NCT01124786|Gemcitabine|gemcitabine|mesh-list
25612422|NCT01124786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25612423|NCT01124786|Antimetabolites|antimetabolites|mesh-ancestor
25612424|NCT01124786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612425|NCT01124786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612426|NCT01124786|Antiviral Agents|antiviral agents|mesh-ancestor
25612427|NCT01124786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25612428|NCT01124786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25612429|NCT01124786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25612430|NCT01124786|Immunologic Factors|immunologic factors|mesh-ancestor
25506974|NCT05126238|Lithium Carbonate|lithium carbonate|mesh-list
25506975|NCT05126238|Antidepressive Agents|antidepressive agents|mesh-ancestor
25506976|NCT05126238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25612431|NCT01124786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612432|NCT01124838|Prednisone|prednisone|mesh-list
25612433|NCT01124838|Adalimumab|adalimumab|mesh-list
25612434|NCT01124838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25612435|NCT01124838|Glucocorticoids|glucocorticoids|mesh-ancestor
25612436|NCT01124838|Hormones|hormones|mesh-ancestor
24833085|NCT02172573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24833086|NCT02172586|Losartan|losartan|mesh-list
24833087|NCT02172586|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24833088|NCT02172586|Telmisartan|telmisartan|mesh-list
24833089|NCT02172586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24833090|NCT02172586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25612437|NCT01124838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25612438|NCT01124838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612439|NCT01124838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25612440|NCT01124838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612441|NCT01124838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25612442|NCT01125046|Bevacizumab|bevacizumab|mesh-list
25612443|NCT01125046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25612444|NCT01125046|Antibodies|antibodies|mesh-list
25612445|NCT01125046|Immunoglobulins|immunoglobulins|mesh-list
25612446|NCT01125046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25612447|NCT01125046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612448|NCT01125046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25612449|NCT01125046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24833143|NCT02172794|Adrenergic Agents|adrenergic agents|mesh-ancestor
24833145|NCT02172807|Oxitropium|oxitropium|mesh-list
24833146|NCT02172807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24833147|NCT02172807|Autonomic Agents|autonomic agents|mesh-ancestor
24833160|NCT02172846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24833161|NCT02172846|Tubulin Modulators|tubulin modulators|mesh-ancestor
24833162|NCT02172846|Antimitotic Agents|antimitotic agents|mesh-ancestor
24833163|NCT02172846|Mitosis Modulators|mitosis modulators|mesh-ancestor
24833164|NCT02172846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833165|NCT02172976|Gemcitabine|gemcitabine|mesh-list
24833166|NCT02172976|Fluorouracil|fluorouracil|mesh-list
24833185|NCT02173093|Analgesics|analgesics|mesh-ancestor
24833186|NCT02173093|Sensory System Agents|sensory system agents|mesh-ancestor
24833187|NCT02173093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24833188|NCT02173093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833189|NCT02173093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24833190|NCT02173093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24833191|NCT02173093|Antiviral Agents|antiviral agents|mesh-ancestor
24833192|NCT02173093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24833193|NCT02173106|Cyclosporine|cyclosporine|mesh-list
24833194|NCT02173106|Cyclosporins|cyclosporins|mesh-list
24833195|NCT02173106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24452187|NCT00326352|Narcotics|narcotics|mesh-ancestor
24452198|NCT00326391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24452199|NCT00326391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612450|NCT01125046|Growth Substances|growth substances|mesh-ancestor
25612451|NCT01125046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612452|NCT01125046|Growth Inhibitors|growth inhibitors|mesh-ancestor
25612453|NCT01125046|Immunologic Factors|immunologic factors|mesh-ancestor
25612454|NCT01125098|Amoxicillin|amoxicillin|mesh-list
25612455|NCT01125098|Clavulanic Acid|clavulanic acid|mesh-list
25612456|NCT01125098|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25612457|NCT01125098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25612458|NCT01125098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25612459|NCT01125098|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25612460|NCT01125098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25612461|NCT01125098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612462|NCT01125163|Iron|iron|mesh-list
25612463|NCT01125163|Trace Elements|trace elements|mesh-ancestor
25612464|NCT01125163|Micronutrients|micronutrients|mesh-ancestor
25612465|NCT01125163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711750|NCT02305797|Antiemetics|antiemetics|mesh-ancestor
25711751|NCT02305797|Autonomic Agents|autonomic agents|mesh-ancestor
24467535|NCT00377988|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24833256|NCT02173418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833257|NCT02173418|Sensory System Agents|sensory system agents|mesh-ancestor
24833258|NCT02173418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24833259|NCT02173457|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24833260|NCT02173457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24833261|NCT02173457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833262|NCT02173457|Incretins|incretins|mesh-ancestor
24833264|NCT02173457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25711752|NCT02305797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25711753|NCT02305797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711754|NCT02305797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25711755|NCT02305797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25711756|NCT02305797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25612466|NCT01125189|Interferons|interferons|mesh-list
25612467|NCT01125189|Ribavirin|ribavirin|mesh-list
25612468|NCT01125189|Interferon-alpha|interferon-alpha|mesh-list
25612469|NCT01125189|Interferon alpha-2|interferon alpha-2|mesh-list
25612470|NCT01125189|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25612471|NCT01125189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612472|NCT01125189|Antiviral Agents|antiviral agents|mesh-ancestor
25612473|NCT01125189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25612474|NCT01125189|Antimetabolites|antimetabolites|mesh-ancestor
25612475|NCT01125189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612476|NCT01125189|Immunologic Factors|immunologic factors|mesh-ancestor
25612477|NCT01125189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612478|NCT01125293|Rituximab|rituximab|mesh-list
25612479|NCT01125293|Everolimus|everolimus|mesh-list
25612480|NCT01125293|Bortezomib|bortezomib|mesh-list
25612481|NCT01125293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25612482|NCT01125293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612483|NCT01125293|Immunologic Factors|immunologic factors|mesh-ancestor
25612484|NCT01125293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612485|NCT01125293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25612486|NCT01125293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25612487|NCT05308160|Dapagliflozin|dapagliflozin|mesh-list
25612488|NCT05308160|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25612489|NCT05308160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612490|NCT05308160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25612491|NCT05308160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612492|NCT05308056|Anesthetics|anesthetics|mesh-list
25612493|NCT05308056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25612494|NCT05308056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833275|NCT02173639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24833276|NCT02173639|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24833283|NCT02173652|Incretins|incretins|mesh-ancestor
24833419|NCT02173886|Bupropion|bupropion|mesh-list
25711757|NCT02305797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25711758|NCT02305797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25711759|NCT02305797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25711760|NCT02305797|GABA Modulators|gaba modulators|mesh-ancestor
25711761|NCT02305797|GABA Agents|gaba agents|mesh-ancestor
25711762|NCT02305797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25711763|NCT02305797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711764|NCT02305849|Methotrexate|methotrexate|mesh-list
25711765|NCT02305849|Peficitinib|peficitinib|mesh-list
25612495|NCT05307835|Molgramostim|molgramostim|mesh-list
25612496|NCT05307835|Sargramostim|sargramostim|mesh-list
25612497|NCT05307835|Immunologic Factors|immunologic factors|mesh-ancestor
25507040|NCT04901975|Natriuretic Agents|natriuretic agents|mesh-ancestor
25507041|NCT04899388|Fentanyl|fentanyl|mesh-list
25507042|NCT04899388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25507043|NCT04899388|Narcotics|narcotics|mesh-ancestor
25507044|NCT04899388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25507045|NCT04899388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612498|NCT05307835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612499|NCT05307835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612500|NCT05307731|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25654818|NCT01556425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25612501|NCT05307731|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25612502|NCT05307731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612503|NCT05307731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25612504|NCT05307731|Immunologic Factors|immunologic factors|mesh-ancestor
25612505|NCT05307731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612506|NCT05307718|Anticoagulants|anticoagulants|mesh-list
25612507|NCT05307718|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
25612508|NCT05307718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25612509|NCT05307718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
25612510|NCT05307718|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
25612511|NCT05307718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25612512|NCT05307718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25612513|NCT05307718|Antimetabolites|antimetabolites|mesh-ancestor
25612514|NCT05307718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612515|NCT05307718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25612516|NCT05307718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25612517|NCT05307718|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25612518|NCT05307718|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25612519|NCT05307718|Purinergic Agents|purinergic agents|mesh-ancestor
25612520|NCT05307718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25612521|NCT05307718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612522|NCT05307718|Antithrombins|antithrombins|mesh-ancestor
25612523|NCT05307718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25612524|NCT05307718|Protease Inhibitors|protease inhibitors|mesh-ancestor
25612525|NCT05307627|Naltrexone|naltrexone|mesh-list
25612526|NCT05307627|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25612527|NCT05307627|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25612528|NCT05307627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833350|NCT02173756|Narcotics|narcotics|mesh-ancestor
24742946|NCT05096325|Insulin|insulin|mesh-list
24833351|NCT02173756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24833355|NCT02173756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24833356|NCT02173782|Fenoterol|fenoterol|mesh-list
24591493|NCT00916942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25612529|NCT05307627|Sensory System Agents|sensory system agents|mesh-ancestor
25612530|NCT05307627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25612531|NCT05307614|Moxifloxacin|moxifloxacin|mesh-list
25612532|NCT05307614|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25612533|NCT05307614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25612534|NCT05307614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25612535|NCT05307614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24833359|NCT02173782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24833360|NCT02173782|Autonomic Agents|autonomic agents|mesh-ancestor
24833361|NCT02173782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24833362|NCT02173782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612536|NCT05307614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25612537|NCT05307614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25612538|NCT05307614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612539|NCT05307614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612540|NCT05307614|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25612541|NCT05307614|Contraceptive Agents|contraceptive agents|mesh-ancestor
25612542|NCT05307614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25612543|NCT05307614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612544|NCT05307614|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25612545|NCT05307614|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25612546|NCT05307614|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25612547|NCT05307458|Buprenorphine|buprenorphine|mesh-list
25612548|NCT05307458|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25711766|NCT02305849|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25711767|NCT02305849|Abortifacient Agents|abortifacient agents|mesh-ancestor
24833618|NCT02174718|Vitamin D|vitamin d|mesh-list
24833619|NCT02174718|Cholecalciferol|cholecalciferol|mesh-list
24833620|NCT02174718|Vitamins|vitamins|mesh-ancestor
24833621|NCT02174718|Micronutrients|micronutrients|mesh-ancestor
24833622|NCT02174718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833625|NCT02174757|Doxycycline|doxycycline|mesh-list
25612549|NCT05307458|Naloxone|naloxone|mesh-list
25612550|NCT05307458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25612551|NCT05307458|Narcotics|narcotics|mesh-ancestor
25612552|NCT05307458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25612553|NCT05307458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612554|NCT05307458|Analgesics|analgesics|mesh-ancestor
25612555|NCT05307458|Sensory System Agents|sensory system agents|mesh-ancestor
25612556|NCT05307458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25612557|NCT05307458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25612558|NCT05307341|Sufentanil|sufentanil|mesh-list
25612559|NCT05307341|Dsuvia|dsuvia|mesh-list
25612560|NCT05307341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25612561|NCT05307341|Narcotics|narcotics|mesh-ancestor
25612562|NCT05307341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25612563|NCT05307341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612564|NCT05307341|Analgesics|analgesics|mesh-ancestor
25612565|NCT05307341|Sensory System Agents|sensory system agents|mesh-ancestor
25612566|NCT05307341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25612567|NCT05307341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25612568|NCT05307341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24834374|NCT02178124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25612569|NCT05307341|Anesthetics, General|anesthetics, general|mesh-ancestor
25612570|NCT05307341|Anesthetics|anesthetics|mesh-ancestor
25612571|NCT05307042|Vasopressins|vasopressins|mesh-list
25612572|NCT05307042|Arginine Vasopressin|arginine vasopressin|mesh-list
25612573|NCT05307042|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25612574|NCT05307042|Hemostatics|hemostatics|mesh-ancestor
25612576|NCT05307042|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25612577|NCT05307042|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25612578|NCT05307042|Natriuretic Agents|natriuretic agents|mesh-ancestor
25612579|NCT05307042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612580|NCT05306990|Atorvastatin|atorvastatin|mesh-list
25612581|NCT05306990|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25612582|NCT05306990|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25612583|NCT05306990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25612584|NCT05306990|Antimetabolites|antimetabolites|mesh-ancestor
25612585|NCT05306990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834518|NCT02179268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24834519|NCT02179268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24834520|NCT02179268|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24834521|NCT02179268|Adrenergic Agents|adrenergic agents|mesh-ancestor
24834522|NCT02179294|Meperidine|meperidine|mesh-list
24834553|NCT02179645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24834554|NCT02179645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25612586|NCT05306990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25612587|NCT05306990|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25612588|NCT05306990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25654819|NCT01556438|Dexamethasone|dexamethasone|mesh-list
25654820|NCT01556438|Bortezomib|bortezomib|mesh-list
25654821|NCT01556438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25654822|NCT01556438|Antiemetics|antiemetics|mesh-ancestor
25654823|NCT01556438|Autonomic Agents|autonomic agents|mesh-ancestor
25654824|NCT01556438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25654825|NCT01556438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654826|NCT01556438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25654827|NCT01556438|Glucocorticoids|glucocorticoids|mesh-ancestor
25654828|NCT01556438|Hormones|hormones|mesh-ancestor
25654829|NCT01556438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24835050|NCT02182167|Acetylcysteine|acetylcysteine|mesh-list
24835051|NCT02182167|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24835052|NCT02182167|Antiviral Agents|antiviral agents|mesh-ancestor
24835053|NCT02182167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24835054|NCT02182167|Expectorants|expectorants|mesh-ancestor
24835085|NCT02182232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835086|NCT02182232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24835087|NCT02182232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835150|NCT02182336|Hemostatics|hemostatics|mesh-ancestor
24469756|NCT00386997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24835152|NCT02182336|Antitussive Agents|antitussive agents|mesh-ancestor
24835153|NCT02182336|Respiratory System Agents|respiratory system agents|mesh-ancestor
24835154|NCT02182336|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24835155|NCT02182336|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24835156|NCT02182375|Raltegravir Potassium|raltegravir potassium|mesh-list
24835157|NCT02182375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24835158|NCT02182375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24835159|NCT02182375|Antiviral Agents|antiviral agents|mesh-ancestor
24835160|NCT02182375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24835161|NCT02182375|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24835193|NCT02182479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654830|NCT01556438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25654831|NCT01556438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25654832|NCT01556594|Glucagon|glucagon|mesh-list
25654833|NCT01556594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25654834|NCT01556594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25654835|NCT01556594|Hormones|hormones|mesh-ancestor
25654836|NCT01556594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25654837|NCT01556594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654838|NCT01556594|Incretins|incretins|mesh-ancestor
25654839|NCT01556633|Oseltamivir|oseltamivir|mesh-list
25654840|NCT01556633|Antiviral Agents|antiviral agents|mesh-ancestor
25654841|NCT01556633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24835194|NCT02182479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24745337|NCT03816397|Adalimumab|adalimumab|mesh-list
24835226|NCT02182505|Cholinergic Agents|cholinergic agents|mesh-ancestor
24835227|NCT02182518|Pseudoephedrine|pseudoephedrine|mesh-list
24835228|NCT02182518|Ephedrine|ephedrine|mesh-list
24835229|NCT02182518|Epinastine|epinastine|mesh-list
24835230|NCT02182518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24835231|NCT02182518|Autonomic Agents|autonomic agents|mesh-ancestor
24835232|NCT02182518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24593732|NCT00930839|Aspirin|aspirin|mesh-list
24835233|NCT02182518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835241|NCT02182518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24618561|NCT01048983|Analgesics|analgesics|mesh-ancestor
24835288|NCT02182570|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25654842|NCT01556633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25654843|NCT01556633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654844|NCT01556724|Ropivacaine|ropivacaine|mesh-list
25654845|NCT01556724|Anesthetics, Local|anesthetics, local|mesh-ancestor
25654846|NCT01556724|Anesthetics|anesthetics|mesh-ancestor
25654847|NCT01556724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25654848|NCT01556724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654849|NCT01556724|Sensory System Agents|sensory system agents|mesh-ancestor
25654850|NCT01556724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25654851|NCT01556763|Antipsychotic Agents|antipsychotic agents|mesh-list
25654852|NCT01556763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25654853|NCT01556763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25654854|NCT01556763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654855|NCT01556763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25654856|NCT01556932|Diphenhydramine|diphenhydramine|mesh-list
25654857|NCT01556932|Promethazine|promethazine|mesh-list
24835489|NCT02183025|Meloxicam|meloxicam|mesh-list
24835541|NCT02183064|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24835542|NCT02183064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24835543|NCT02183064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835544|NCT02183064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835566|NCT02183090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24835567|NCT02183090|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24835568|NCT02183090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24835569|NCT02183090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835570|NCT02183090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835574|NCT02183103|Analgesics|analgesics|mesh-ancestor
25654858|NCT01556932|Lorazepam|lorazepam|mesh-list
25654859|NCT01556932|Haloperidol|haloperidol|mesh-list
25654860|NCT01556932|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25654861|NCT01556932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25654862|NCT01556932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25654863|NCT01556932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654864|NCT01556932|Anesthetics, Local|anesthetics, local|mesh-ancestor
25654865|NCT01556932|Anesthetics|anesthetics|mesh-ancestor
25654866|NCT01556932|Sensory System Agents|sensory system agents|mesh-ancestor
25654867|NCT01556932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25654868|NCT01556932|Antiemetics|antiemetics|mesh-ancestor
25654869|NCT01556932|Autonomic Agents|autonomic agents|mesh-ancestor
25654870|NCT01556932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25654871|NCT01556932|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25654872|NCT01556932|Histamine Antagonists|histamine antagonists|mesh-ancestor
25654873|NCT01556932|Histamine Agents|histamine agents|mesh-ancestor
25654874|NCT01556932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25777794|NCT03150160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835733|NCT02183324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24835734|NCT02183324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835735|NCT02183324|Incretins|incretins|mesh-ancestor
24835736|NCT02183324|Hormones|hormones|mesh-ancestor
24835738|NCT02183324|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24835739|NCT02183324|Protease Inhibitors|protease inhibitors|mesh-ancestor
24835753|NCT02183350|Linagliptin|linagliptin|mesh-list
24835754|NCT02183350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24835755|NCT02183350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835756|NCT02183350|Incretins|incretins|mesh-ancestor
24835757|NCT02183350|Hormones|hormones|mesh-ancestor
24835758|NCT02183350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24835759|NCT02183350|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24835765|NCT02183363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835766|NCT02183363|Incretins|incretins|mesh-ancestor
24835767|NCT02183363|Hormones|hormones|mesh-ancestor
24835768|NCT02183363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24618564|NCT01048983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24835769|NCT02183363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24835770|NCT02183363|Protease Inhibitors|protease inhibitors|mesh-ancestor
24835771|NCT02183363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835774|NCT02183376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24835782|NCT02183376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777795|NCT03109418|Ketamine|ketamine|mesh-list
25777796|NCT03109418|Analgesics|analgesics|mesh-ancestor
25654875|NCT01556932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654876|NCT01556932|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25654877|NCT01556932|Antipruritics|antipruritics|mesh-ancestor
25654878|NCT01556932|Dermatologic Agents|dermatologic agents|mesh-ancestor
25654879|NCT01556932|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25654880|NCT01556932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25612589|NCT05306587|Daratumumab|daratumumab|mesh-list
25612590|NCT05306587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612591|NCT05306405|Misoprostol|misoprostol|mesh-list
25612592|NCT05306405|Estradiol|estradiol|mesh-list
25612593|NCT05306405|Estrogens|estrogens|mesh-ancestor
25612594|NCT05306405|Hormones|hormones|mesh-ancestor
24835875|NCT02183493|Linagliptin|linagliptin|mesh-list
25612595|NCT05306405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25612596|NCT05306405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612597|NCT05306405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25612598|NCT05306405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25612599|NCT05306405|Abortifacient Agents|abortifacient agents|mesh-ancestor
25612600|NCT05306405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25612601|NCT05306405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25612602|NCT05306405|Oxytocics|oxytocics|mesh-ancestor
25612603|NCT05305508|Mannitol|mannitol|mesh-list
25612604|NCT05305508|Calcium Dobesilate|calcium dobesilate|mesh-list
25612605|NCT05305508|Calcium|calcium|mesh-list
25612606|NCT05305508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25612607|NCT05305508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612608|NCT05305508|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25612609|NCT05305508|Diuretics|diuretics|mesh-ancestor
25612610|NCT05305508|Natriuretic Agents|natriuretic agents|mesh-ancestor
25612611|NCT05305508|Hemostatics|hemostatics|mesh-ancestor
25612612|NCT05305508|Coagulants|coagulants|mesh-ancestor
25612613|NCT05304546|Pembrolizumab|pembrolizumab|mesh-list
25612614|NCT05304546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25612615|NCT05304546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612616|NCT05296460|Dapsone|dapsone|mesh-list
25612617|NCT05296460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25612618|NCT05296460|Antimalarials|antimalarials|mesh-ancestor
25612619|NCT05296460|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24836120|NCT02184247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24836121|NCT02184247|Respiratory System Agents|respiratory system agents|mesh-ancestor
24836137|NCT02184260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24836138|NCT02184260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24836140|NCT02184273|Dipyrone|dipyrone|mesh-list
24836143|NCT02184273|Analgesics|analgesics|mesh-ancestor
24836162|NCT02184286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24836163|NCT02184286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24836164|NCT02184286|Protease Inhibitors|protease inhibitors|mesh-ancestor
24836172|NCT02184299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24836173|NCT02184299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836174|NCT02184299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24836178|NCT02184299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836195|NCT02184312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24836196|NCT02184312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24836199|NCT02184351|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25612620|NCT05296460|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25612621|NCT05296460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25612622|NCT05296460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25612623|NCT05296460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612624|NCT05296460|Leprostatic Agents|leprostatic agents|mesh-ancestor
25612625|NCT05296460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25612626|NCT05289856|Avelumab|avelumab|mesh-list
25612627|NCT05289856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25612628|NCT05289856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711806|NCT02307513|Sensory System Agents|sensory system agents|mesh-ancestor
24836274|NCT02184858|Protective Agents|protective agents|mesh-ancestor
24747145|NCT01746173|Vincristine|vincristine|mesh-list
24836317|NCT02185222|Micronutrients|micronutrients|mesh-ancestor
24836318|NCT02185222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24836319|NCT02185261|Interferons|interferons|mesh-list
24836320|NCT02185261|Interferon-alpha|interferon-alpha|mesh-list
24836321|NCT02185261|Interferon alpha-2|interferon alpha-2|mesh-list
24836322|NCT02185261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24836323|NCT02185261|Antiviral Agents|antiviral agents|mesh-ancestor
24836324|NCT02185261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24836325|NCT02185261|Immunologic Factors|immunologic factors|mesh-ancestor
24836326|NCT02185261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836327|NCT02185300|Dolutegravir|dolutegravir|mesh-list
24836328|NCT02185300|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24836329|NCT02185300|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24836330|NCT02185300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836331|NCT02185300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836332|NCT02185300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25612629|NCT05289167|Cyclophosphamide|cyclophosphamide|mesh-list
25612630|NCT05289167|Bortezomib|bortezomib|mesh-list
25612631|NCT05289167|Abatacept|abatacept|mesh-list
25612632|NCT05289167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25612633|NCT05289167|Immunologic Factors|immunologic factors|mesh-ancestor
25612634|NCT05289167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612635|NCT05289167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25612636|NCT05289167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25612637|NCT05289167|Alkylating Agents|alkylating agents|mesh-ancestor
25612638|NCT05289167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612639|NCT05289167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612640|NCT05289167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25612641|NCT05289167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25612642|NCT05273320|Dronabinol|dronabinol|mesh-list
25612643|NCT05273320|Nabilone|nabilone|mesh-list
25612644|NCT05273320|Antiemetics|antiemetics|mesh-ancestor
25612645|NCT05273320|Autonomic Agents|autonomic agents|mesh-ancestor
25612646|NCT05273320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25612647|NCT05273320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612648|NCT05273320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25612649|NCT05273320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25612650|NCT05273320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25612651|NCT05273320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25612652|NCT05273320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25612653|NCT05273320|Hallucinogens|hallucinogens|mesh-ancestor
25612654|NCT05273320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25612655|NCT05273320|Analgesics|analgesics|mesh-ancestor
25612656|NCT05273320|Sensory System Agents|sensory system agents|mesh-ancestor
25612657|NCT05273320|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25612658|NCT05273320|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25612659|NCT05273320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25612660|NCT05273320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836369|NCT02185456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24836370|NCT02185456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836371|NCT02185456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836372|NCT02185456|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24836421|NCT02185833|Dirithromycin|dirithromycin|mesh-list
24836436|NCT02185859|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24836437|NCT02185859|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24836438|NCT02185859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24836439|NCT02185859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836440|NCT02185859|Analgesics|analgesics|mesh-ancestor
25612661|NCT05273320|Hormones|hormones|mesh-ancestor
25612662|NCT05273320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25612663|NCT05272397|Methylphenidate|methylphenidate|mesh-list
25612664|NCT05272397|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25654881|NCT01556932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25507262|NCT03873805|Vidarabine|vidarabine|mesh-list
25612665|NCT05272397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612666|NCT05272397|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25612667|NCT05272397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25612668|NCT05272397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25612669|NCT05272397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612670|NCT05272397|Dopamine Agents|dopamine agents|mesh-ancestor
25711818|NCT02307526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25711819|NCT02307526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836478|NCT02185963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24836479|NCT02185963|Antimetabolites|antimetabolites|mesh-ancestor
24836480|NCT02185963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836481|NCT02185963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24836482|NCT02185963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24836483|NCT02185963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836484|NCT02186028|Vitamin D|vitamin d|mesh-list
24836495|NCT02186106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24836497|NCT02186119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24836498|NCT02186119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24836499|NCT02186119|Growth Substances|growth substances|mesh-ancestor
24836500|NCT02186119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836501|NCT02186119|Growth Inhibitors|growth inhibitors|mesh-ancestor
24836502|NCT02186119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711820|NCT02307526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711821|NCT02307526|Cholinergic Agents|cholinergic agents|mesh-ancestor
25711822|NCT02307526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25711823|NCT02307526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711824|NCT02307682|Aflibercept|aflibercept|mesh-list
25711825|NCT02307682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25711826|NCT02307682|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25612671|NCT05272397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25612672|NCT05269628|Dronabinol|dronabinol|mesh-list
25612673|NCT05269628|Cannabidiol|cannabidiol|mesh-list
25612674|NCT05269628|Anticonvulsants|anticonvulsants|mesh-ancestor
25612675|NCT05269628|Hallucinogens|hallucinogens|mesh-ancestor
25612676|NCT05269628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612677|NCT05269628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25612678|NCT05269628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25612679|NCT05269628|Analgesics|analgesics|mesh-ancestor
25612680|NCT05269628|Sensory System Agents|sensory system agents|mesh-ancestor
25612681|NCT05269628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25612682|NCT05269628|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25612683|NCT05269628|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25612684|NCT05269628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25612685|NCT05269628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612686|NCT05269628|Hormones|hormones|mesh-ancestor
25612687|NCT05269628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25612688|NCT05254418|Dulaglutide|dulaglutide|mesh-list
25612689|NCT05254418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25612690|NCT05254418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612691|NCT05223335|Clopidogrel|clopidogrel|mesh-list
25612692|NCT05223335|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25711827|NCT02307682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24836507|NCT02186132|Autonomic Agents|autonomic agents|mesh-ancestor
24836508|NCT02186132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24836509|NCT02186132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836510|NCT02186132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24836511|NCT02186132|Respiratory System Agents|respiratory system agents|mesh-ancestor
24836512|NCT02186132|Mydriatics|mydriatics|mesh-ancestor
24836513|NCT02186132|Parasympatholytics|parasympatholytics|mesh-ancestor
24836514|NCT02186132|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24836515|NCT02186132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24836516|NCT02186132|Cholinergic Agents|cholinergic agents|mesh-ancestor
24836517|NCT02186132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24836518|NCT02186132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836519|NCT02186145|Metronidazole|metronidazole|mesh-list
24836520|NCT02186145|Nystatin|nystatin|mesh-list
24836521|NCT02186145|Dexamethasone|dexamethasone|mesh-list
24836592|NCT02186496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836593|NCT02186496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25612693|NCT05223335|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25612694|NCT05223335|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25612695|NCT05223335|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25612696|NCT05223335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25612697|NCT05223335|Purinergic Agents|purinergic agents|mesh-ancestor
25612698|NCT05223335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25612699|NCT05223335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612700|NCT05223335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612701|NCT05215067|Docetaxel|docetaxel|mesh-list
25612702|NCT05215067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612703|NCT05215067|Tubulin Modulators|tubulin modulators|mesh-ancestor
25612704|NCT05215067|Antimitotic Agents|antimitotic agents|mesh-ancestor
25612705|NCT05215067|Mitosis Modulators|mitosis modulators|mesh-ancestor
25612706|NCT05215067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612707|NCT05177510|Mifepristone|mifepristone|mesh-list
25612708|NCT05177510|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25612709|NCT05177510|Abortifacient Agents|abortifacient agents|mesh-ancestor
25612710|NCT05177510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25612711|NCT05177510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612712|NCT05177510|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25612713|NCT05177510|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25612714|NCT05177510|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25612715|NCT05177510|Contraceptive Agents|contraceptive agents|mesh-ancestor
25711835|NCT02307916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711836|NCT02308007|Metronidazole|metronidazole|mesh-list
25711837|NCT02308007|Terconazole|terconazole|mesh-list
24836618|NCT02186600|Calcium|calcium|mesh-list
24836619|NCT02186600|Vitamins|vitamins|mesh-ancestor
24836620|NCT02186600|Micronutrients|micronutrients|mesh-ancestor
24472194|NCT00398515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24472195|NCT00398515|Growth Substances|growth substances|mesh-ancestor
24472196|NCT00398515|Growth Inhibitors|growth inhibitors|mesh-ancestor
24472197|NCT00398515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472198|NCT00398515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24472199|NCT00398515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24472200|NCT00398515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24472201|NCT00398515|Antifungal Agents|antifungal agents|mesh-ancestor
24836644|NCT02186782|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24836645|NCT02186782|Clomiphene|clomiphene|mesh-list
24836646|NCT02186782|Enclomiphene|enclomiphene|mesh-list
24836647|NCT02186782|Zuclomiphene|zuclomiphene|mesh-list
24836648|NCT02186782|Estradiol|estradiol|mesh-list
24836649|NCT02186782|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24836650|NCT02186782|Anticoagulants|anticoagulants|mesh-ancestor
24836651|NCT02186782|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25711838|NCT02308007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25711843|NCT02308033|Metronidazole|metronidazole|mesh-list
25612716|NCT05177510|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25612717|NCT05177510|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25612718|NCT05177510|Hormone Antagonists|hormone antagonists|mesh-ancestor
25612719|NCT05177510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25612720|NCT05177510|Luteolytic Agents|luteolytic agents|mesh-ancestor
25612721|NCT05177510|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25612722|NCT05177510|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25612723|NCT05160987|Midazolam|midazolam|mesh-list
25612724|NCT05160987|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25612725|NCT05160987|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25711846|NCT02308033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25711847|NCT02308033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25711848|NCT02308046|Terconazole|terconazole|mesh-list
25711849|NCT02308046|Antifungal Agents|antifungal agents|mesh-ancestor
25711850|NCT02308046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24836659|NCT02186782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24836660|NCT02186782|Contraceptive Agents|contraceptive agents|mesh-ancestor
24836661|NCT02186782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24836662|NCT02186782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24836663|NCT02186782|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24836664|NCT02186782|Hormone Antagonists|hormone antagonists|mesh-ancestor
24836665|NCT02186782|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24836666|NCT02186782|Fertility Agents|fertility agents|mesh-ancestor
24836667|NCT02186782|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24836668|NCT02186782|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24836669|NCT02186886|Golimumab|golimumab|mesh-list
24836670|NCT02186886|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24836671|NCT02186886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24836672|NCT02186886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24836673|NCT02186886|Immunologic Factors|immunologic factors|mesh-ancestor
24836675|NCT02186899|Anesthetics|anesthetics|mesh-list
24836684|NCT02186951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836685|NCT02186951|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24836686|NCT02186990|Propofol|propofol|mesh-list
24836687|NCT02186990|Etomidate|etomidate|mesh-list
24836688|NCT02186990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25612726|NCT05160987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25612727|NCT05160987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612728|NCT05160987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25612729|NCT05160987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25612730|NCT05160987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25612731|NCT05160987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25612732|NCT05160987|Anesthetics, General|anesthetics, general|mesh-ancestor
25612733|NCT05160987|Anesthetics|anesthetics|mesh-ancestor
25612734|NCT05160987|GABA Modulators|gaba modulators|mesh-ancestor
25612735|NCT05160987|GABA Agents|gaba agents|mesh-ancestor
25612736|NCT05160987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25654882|NCT01556932|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25612737|NCT05160987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612738|NCT05106296|Cyclophosphamide|cyclophosphamide|mesh-list
25612739|NCT05106296|Etoposide|etoposide|mesh-list
25612740|NCT05106296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25612741|NCT05106296|Immunologic Factors|immunologic factors|mesh-ancestor
25612742|NCT05106296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612743|NCT05106296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25612744|NCT05106296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25612745|NCT05106296|Alkylating Agents|alkylating agents|mesh-ancestor
25612746|NCT05106296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612747|NCT05106296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612748|NCT05106296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25711855|NCT02308124|Sympathomimetics|sympathomimetics|mesh-ancestor
25711856|NCT02308124|Autonomic Agents|autonomic agents|mesh-ancestor
25711857|NCT02308124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24836756|NCT02187315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711858|NCT02308124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711859|NCT02308124|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25711860|NCT02308124|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25711861|NCT02308124|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25711862|NCT02308124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25711863|NCT02308124|Adrenergic Agents|adrenergic agents|mesh-ancestor
25612749|NCT05106296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25612750|NCT05106296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25612751|NCT05106296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25612752|NCT05106296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25612753|NCT05042648|Buprenorphine|buprenorphine|mesh-list
25612754|NCT05042648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25612755|NCT05042648|Narcotics|narcotics|mesh-ancestor
25612756|NCT05042648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25612757|NCT05042648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507412|NCT03636503|Avelumab|avelumab|mesh-list
25507413|NCT03636503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25507414|NCT03636503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25770763|NCT03566979|Analgesics|analgesics|mesh-ancestor
24836772|NCT02187445|Budesonide|budesonide|mesh-list
24836773|NCT02187445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24836774|NCT02187445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24836775|NCT02187445|Autonomic Agents|autonomic agents|mesh-ancestor
24836776|NCT02187445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24836777|NCT02187445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836778|NCT02187445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24836800|NCT02187523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24836801|NCT02187523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836802|NCT02187523|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24836803|NCT02187523|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24836804|NCT02187536|Telmisartan|telmisartan|mesh-list
24836805|NCT02187536|Simvastatin|simvastatin|mesh-list
24836806|NCT02187536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24836807|NCT02187536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24836808|NCT02187536|Antimetabolites|antimetabolites|mesh-ancestor
24836809|NCT02187536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836810|NCT02187536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24836812|NCT02187536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836834|NCT02187588|Ibuprofen|ibuprofen|mesh-list
24836850|NCT02187614|Narcotics|narcotics|mesh-ancestor
24836851|NCT02187614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25507415|NCT03636503|Immunologic Factors|immunologic factors|mesh-ancestor
25507416|NCT03636503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507417|NCT03636503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25507418|NCT03561584|Sulfasalazine|sulfasalazine|mesh-list
25507419|NCT03561584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25507420|NCT03561584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25507421|NCT03561584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25507422|NCT03561584|Analgesics|analgesics|mesh-ancestor
24836867|NCT02187679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24836868|NCT02187679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836869|NCT02187679|Cholinergic Agents|cholinergic agents|mesh-ancestor
24836870|NCT02187679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24836871|NCT02187679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836872|NCT02187679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24836873|NCT02187679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24836874|NCT02187705|Telmisartan|telmisartan|mesh-list
24836875|NCT02187705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24836876|NCT02187705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24836877|NCT02187705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24836881|NCT02187718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836883|NCT02187822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24836885|NCT02187874|Oxytocics|oxytocics|mesh-ancestor
24836886|NCT02187874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24836887|NCT02187874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836888|NCT02187900|Mycophenolic Acid|mycophenolic acid|mesh-list
24836889|NCT02187900|Cardiac Glycosides|cardiac glycosides|mesh-list
24472673|NCT00400088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24472674|NCT00400114|Irinotecan|irinotecan|mesh-list
24472675|NCT00400114|Sunitinib|sunitinib|mesh-list
24472676|NCT00400114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472677|NCT00400114|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25507423|NCT03561584|Sensory System Agents|sensory system agents|mesh-ancestor
25507424|NCT03561584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25507425|NCT03561584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507426|NCT03561584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25507427|NCT03561584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25507428|NCT03561584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25507429|NCT03554083|Atezolizumab|atezolizumab|mesh-list
25507430|NCT03554083|Vemurafenib|vemurafenib|mesh-list
25507431|NCT03554083|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25507432|NCT03554083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507433|NCT03554083|Immunologic Factors|immunologic factors|mesh-ancestor
25507434|NCT03554083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507435|NCT03554083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24836955|NCT02188277|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24836956|NCT02188277|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24836957|NCT02188277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24836958|NCT02188277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836959|NCT02188277|Cholinergic Agents|cholinergic agents|mesh-ancestor
24836960|NCT02188277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24836961|NCT02188277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836963|NCT02188277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24836964|NCT02188368|Clarithromycin|clarithromycin|mesh-list
24836965|NCT02188368|Dexamethasone|dexamethasone|mesh-list
24836966|NCT02188368|Prednisone|prednisone|mesh-list
24836967|NCT02188368|Cyclophosphamide|cyclophosphamide|mesh-list
24836968|NCT02188368|Bortezomib|bortezomib|mesh-list
24836969|NCT02188368|Pomalidomide|pomalidomide|mesh-list
24836970|NCT02188368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24836971|NCT02188368|Immunologic Factors|immunologic factors|mesh-ancestor
24836972|NCT02188368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836973|NCT02188368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24836979|NCT02188368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24836981|NCT02188368|Autonomic Agents|autonomic agents|mesh-ancestor
24836985|NCT02188368|Hormones|hormones|mesh-ancestor
25507436|NCT03554083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25507437|NCT03554083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507441|NCT03430700|Pembrolizumab|pembrolizumab|mesh-list
25612758|NCT05042648|Analgesics|analgesics|mesh-ancestor
25612759|NCT05042648|Sensory System Agents|sensory system agents|mesh-ancestor
25612760|NCT05042648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25612761|NCT05042648|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25612762|NCT05004025|Nivolumab|nivolumab|mesh-list
25612763|NCT05004025|Ipilimumab|ipilimumab|mesh-list
25612764|NCT05004025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25612765|NCT05004025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612766|NCT05004025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24837005|NCT02188407|Propofol|propofol|mesh-list
24837006|NCT02188407|Sevoflurane|sevoflurane|mesh-list
24837007|NCT02188407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24837008|NCT02188407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24837009|NCT02188407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837010|NCT02188407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24837011|NCT02188407|Anesthetics, General|anesthetics, general|mesh-ancestor
24837012|NCT02188407|Anesthetics|anesthetics|mesh-ancestor
24837013|NCT02188407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24837014|NCT02188407|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24837054|NCT02188537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24837076|NCT02188550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24837077|NCT02188615|Vinorelbine|vinorelbine|mesh-list
24837078|NCT02188615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24837079|NCT02188615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24837080|NCT02188615|Tubulin Modulators|tubulin modulators|mesh-ancestor
25770771|NCT03566979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770772|NCT03566979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770773|NCT03567382|Tenofovir|tenofovir|mesh-list
25770774|NCT03567382|Antiviral Agents|antiviral agents|mesh-ancestor
25770775|NCT03567382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25770776|NCT03567382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25770777|NCT03567382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25770778|NCT03567382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770779|NCT03567382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770780|NCT03567382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25612767|NCT05004025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612768|NCT04974151|Folic Acid|folic acid|mesh-list
25612769|NCT04974151|Amlodipine|amlodipine|mesh-list
25612770|NCT04974151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25612771|NCT04974151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25612772|NCT04974151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25612773|NCT04974151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612774|NCT04974151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25612775|NCT04974151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612776|NCT04974151|Vasodilator Agents|vasodilator agents|mesh-ancestor
25612777|NCT04974151|Hematinics|hematinics|mesh-ancestor
25612778|NCT04974151|Vitamin B Complex|vitamin b complex|mesh-ancestor
25612779|NCT04974151|Vitamins|vitamins|mesh-ancestor
25612780|NCT04974151|Micronutrients|micronutrients|mesh-ancestor
25612781|NCT04974138|Folic Acid|folic acid|mesh-list
25612782|NCT04974138|Amlodipine|amlodipine|mesh-list
25612783|NCT04974138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25711879|NCT02308163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25711880|NCT02308163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25711881|NCT02308163|Immunologic Factors|immunologic factors|mesh-ancestor
24837095|NCT02188810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837116|NCT02189304|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24837117|NCT02189304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24837118|NCT02189304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24837119|NCT02189304|Autonomic Agents|autonomic agents|mesh-ancestor
24837120|NCT02189304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24837121|NCT02189304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837122|NCT02189304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24837150|NCT02189343|Hormones|hormones|mesh-ancestor
24837151|NCT02189343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24837152|NCT02189343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24837153|NCT02189343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24837154|NCT02189343|Protease Inhibitors|protease inhibitors|mesh-ancestor
24837155|NCT02189343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837156|NCT02189343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711882|NCT02308163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711883|NCT02308163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711884|NCT02308228|Metformin|metformin|mesh-list
25711885|NCT02308228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25711886|NCT02308228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711887|NCT02308501|Alcaftadine|alcaftadine|mesh-list
25612784|NCT04974138|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25612785|NCT04974138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25612786|NCT04974138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612787|NCT04974138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25612788|NCT04974138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612789|NCT04974138|Vasodilator Agents|vasodilator agents|mesh-ancestor
25612790|NCT04974138|Hematinics|hematinics|mesh-ancestor
25612791|NCT04974138|Vitamin B Complex|vitamin b complex|mesh-ancestor
25612792|NCT04974138|Vitamins|vitamins|mesh-ancestor
24837157|NCT02189343|Immunologic Factors|immunologic factors|mesh-ancestor
24837158|NCT02189343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24837159|NCT02189343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24837160|NCT02189343|Growth Substances|growth substances|mesh-ancestor
24837161|NCT02189343|Growth Inhibitors|growth inhibitors|mesh-ancestor
24837162|NCT02189343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24837163|NCT02189343|Leprostatic Agents|leprostatic agents|mesh-ancestor
24837164|NCT02189343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24837165|NCT02189343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24837166|NCT02189343|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24837167|NCT02189395|Insulin|insulin|mesh-list
24837168|NCT02189395|Insulin Lispro|insulin lispro|mesh-list
24837169|NCT02189395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24837170|NCT02189395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24837172|NCT02189577|Glycopyrrolate|glycopyrrolate|mesh-list
24837174|NCT02189577|Anticonvulsants|anticonvulsants|mesh-ancestor
24837228|NCT02190357|Rifaximin|rifaximin|mesh-list
25612793|NCT04974138|Micronutrients|micronutrients|mesh-ancestor
25612794|NCT04973982|Tacrolimus|tacrolimus|mesh-list
25612795|NCT04973982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25612796|NCT04973982|Immunologic Factors|immunologic factors|mesh-ancestor
25612797|NCT04973982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612798|NCT04973982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25612799|NCT04973982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837402|NCT02191202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25612800|NCT04973982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654883|NCT01556932|Dopamine Agents|dopamine agents|mesh-ancestor
25654884|NCT01556932|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25654885|NCT01556932|Anticonvulsants|anticonvulsants|mesh-ancestor
25654886|NCT01556932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25654887|NCT01556932|GABA Modulators|gaba modulators|mesh-ancestor
25654888|NCT01556932|GABA Agents|gaba agents|mesh-ancestor
25654889|NCT01556997|Amlodipine|amlodipine|mesh-list
25654890|NCT01556997|Perindopril|perindopril|mesh-list
25654891|NCT01556997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25654892|NCT01556997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25654893|NCT01556997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25654894|NCT01556997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837894|NCT02194192|Ondansetron|ondansetron|mesh-list
24837895|NCT02194192|Antiemetics|antiemetics|mesh-ancestor
24837896|NCT02194192|Autonomic Agents|autonomic agents|mesh-ancestor
24837897|NCT02194192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24837898|NCT02194192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837899|NCT02194192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24473318|NCT00402545|Mitosis Modulators|mitosis modulators|mesh-ancestor
24473319|NCT00402545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473320|NCT00402545|Antimetabolites|antimetabolites|mesh-ancestor
25654895|NCT01556997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25654896|NCT01556997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654897|NCT01556997|Vasodilator Agents|vasodilator agents|mesh-ancestor
25654898|NCT01556997|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25654899|NCT01556997|Protease Inhibitors|protease inhibitors|mesh-ancestor
25654900|NCT01556997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25654901|NCT01557166|Liraglutide|liraglutide|mesh-list
25654902|NCT01557166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25654903|NCT01557166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654904|NCT01557166|Incretins|incretins|mesh-ancestor
25654905|NCT01557166|Hormones|hormones|mesh-ancestor
25654906|NCT01557166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25654907|NCT01557244|Fesoterodine|fesoterodine|mesh-list
25654908|NCT01557244|Oxybutynin|oxybutynin|mesh-list
25654909|NCT01557244|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25654910|NCT01557244|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25654911|NCT01557244|Cholinergic Agents|cholinergic agents|mesh-ancestor
25654912|NCT01557244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25654913|NCT01557244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654914|NCT01557244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654915|NCT01557244|Urological Agents|urological agents|mesh-ancestor
25654916|NCT01557244|Parasympatholytics|parasympatholytics|mesh-ancestor
25654917|NCT01557244|Autonomic Agents|autonomic agents|mesh-ancestor
25711900|NCT02308748|Mexiletine|mexiletine|mesh-list
25654918|NCT01557244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25654919|NCT01557283|Etanercept|etanercept|mesh-list
25654920|NCT01557283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25654921|NCT01557283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25654922|NCT01557283|Analgesics|analgesics|mesh-ancestor
25654923|NCT01557283|Sensory System Agents|sensory system agents|mesh-ancestor
25654924|NCT01557283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25654925|NCT01557283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654926|NCT01557283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25654927|NCT01557283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25654928|NCT01557283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25654929|NCT01557283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25654930|NCT01557283|Immunologic Factors|immunologic factors|mesh-ancestor
25654931|NCT01557322|Etanercept|etanercept|mesh-list
25654932|NCT01557322|Methotrexate|methotrexate|mesh-list
25654933|NCT01557322|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25654934|NCT01557322|Abortifacient Agents|abortifacient agents|mesh-ancestor
25654935|NCT01557322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24838426|NCT02197884|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24838427|NCT02197884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24838428|NCT02197884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838530|NCT02198404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25654936|NCT01557322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654937|NCT01557322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25507451|NCT03320564|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25507452|NCT03320564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25654938|NCT01557322|Antimetabolites|antimetabolites|mesh-ancestor
25507453|NCT03320564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612801|NCT04944654|Emtricitabine|emtricitabine|mesh-list
25612802|NCT04944654|Antiviral Agents|antiviral agents|mesh-ancestor
24838900|NCT02201043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24838901|NCT02201043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24838902|NCT02201043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24838903|NCT02201043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24838904|NCT02201043|Growth Substances|growth substances|mesh-ancestor
24838905|NCT02201043|Growth Inhibitors|growth inhibitors|mesh-ancestor
24838906|NCT02201043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24838908|NCT02201082|Amikacin|amikacin|mesh-list
25612803|NCT04944654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25612804|NCT04944654|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25612805|NCT04944654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25612806|NCT04944654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25612807|NCT04944654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612808|NCT04944654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25612809|NCT04944654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25612810|NCT04822363|Aspirin|aspirin|mesh-list
25612811|NCT04822363|Clopidogrel|clopidogrel|mesh-list
25612812|NCT04822363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25612813|NCT04822363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24839486|NCT02204683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24839487|NCT02204683|Growth Substances|growth substances|mesh-ancestor
24839489|NCT02204683|Growth Inhibitors|growth inhibitors|mesh-ancestor
24839532|NCT02205112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24839533|NCT02205112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25612814|NCT04822363|Analgesics|analgesics|mesh-ancestor
25612815|NCT04822363|Sensory System Agents|sensory system agents|mesh-ancestor
25612816|NCT04822363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25612817|NCT04822363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612818|NCT04822363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25612819|NCT04822363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25612820|NCT04822363|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25612821|NCT04822363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25612822|NCT04822363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612823|NCT04822363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25612824|NCT04822363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25612825|NCT04822363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25612826|NCT04822363|Antipyretics|antipyretics|mesh-ancestor
25612827|NCT04822363|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25612828|NCT04822363|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25612829|NCT04822363|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25612830|NCT04822363|Purinergic Agents|purinergic agents|mesh-ancestor
25612831|NCT04822363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25612832|NCT04766437|Ticagrelor|ticagrelor|mesh-list
24840197|NCT02208505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24840220|NCT02208583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24840221|NCT02208583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24840222|NCT02208583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840224|NCT02208596|Propofol|propofol|mesh-list
24840225|NCT02208596|Etomidate|etomidate|mesh-list
24840226|NCT02208596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25612833|NCT04766437|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25612834|NCT04766437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25612835|NCT04766437|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25612836|NCT04766437|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25612837|NCT04766437|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25612838|NCT04766437|Purinergic Agents|purinergic agents|mesh-ancestor
25612839|NCT04766437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25612840|NCT04766437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612841|NCT04766437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612842|NCT04762160|Rituximab|rituximab|mesh-list
25612843|NCT04762160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25612844|NCT04762160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612845|NCT04762160|Immunologic Factors|immunologic factors|mesh-ancestor
25612846|NCT04762160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612847|NCT04762160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25612848|NCT04704531|Hyaluronic Acid|hyaluronic acid|mesh-list
25612849|NCT04704531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25612850|NCT04704531|Immunologic Factors|immunologic factors|mesh-ancestor
25612851|NCT04704531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612852|NCT04704531|Viscosupplements|viscosupplements|mesh-ancestor
25612853|NCT04704531|Protective Agents|protective agents|mesh-ancestor
24840544|NCT02210819|Protease Inhibitors|protease inhibitors|mesh-ancestor
24840545|NCT02210819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24599972|NCT02940522|Progestins|progestins|mesh-ancestor
24840546|NCT02210819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840547|NCT02210819|Anticoagulants|anticoagulants|mesh-ancestor
24840548|NCT02210858|Tipifarnib|tipifarnib|mesh-list
25612854|NCT04573322|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
25612855|NCT04573322|Antioxidants|antioxidants|mesh-ancestor
25612856|NCT04573322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612857|NCT04573322|Protective Agents|protective agents|mesh-ancestor
24841093|NCT02213913|Hormones|hormones|mesh-ancestor
25612858|NCT04573322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612859|NCT04573322|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25612860|NCT04573322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612861|NCT04513145|Ropivacaine|ropivacaine|mesh-list
25612862|NCT04513145|Anesthetics, Local|anesthetics, local|mesh-ancestor
25612863|NCT04513145|Anesthetics|anesthetics|mesh-ancestor
25612864|NCT04513145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25612865|NCT04513145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612866|NCT04513145|Sensory System Agents|sensory system agents|mesh-ancestor
25612867|NCT04513145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25612868|NCT04498351|Magnesium Sulfate|magnesium sulfate|mesh-list
25612869|NCT04498351|Dexmedetomidine|dexmedetomidine|mesh-list
25612870|NCT04498351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25612871|NCT04498351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25612872|NCT04498351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612873|NCT04498351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25612874|NCT04498351|Analgesics|analgesics|mesh-ancestor
25612875|NCT04498351|Sensory System Agents|sensory system agents|mesh-ancestor
25612876|NCT04498351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24841627|NCT02217163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24841628|NCT02217163|Immunologic Factors|immunologic factors|mesh-ancestor
24841629|NCT02217163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841630|NCT02217163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24841631|NCT02217163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24841632|NCT02217163|Alkylating Agents|alkylating agents|mesh-ancestor
24841823|NCT02218359|Amikacin|amikacin|mesh-list
25612877|NCT04498351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25612878|NCT04498351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25612879|NCT04498351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25612880|NCT04498351|Adrenergic Agents|adrenergic agents|mesh-ancestor
25612881|NCT04498351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25612882|NCT04498351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612883|NCT04498351|Anesthetics|anesthetics|mesh-ancestor
25612884|NCT04498351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25612885|NCT04498351|Anticonvulsants|anticonvulsants|mesh-ancestor
25612886|NCT04498351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25612887|NCT04498351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25612888|NCT04498351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25612889|NCT04498351|Tocolytic Agents|tocolytic agents|mesh-ancestor
25612890|NCT04498351|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25612891|NCT04447534|Hydroxychloroquine|hydroxychloroquine|mesh-list
25612892|NCT04447534|Chloroquine|chloroquine|mesh-list
25612893|NCT04447534|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
25612894|NCT04447534|Antimalarials|antimalarials|mesh-ancestor
25612895|NCT04447534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25612896|NCT04447534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25612897|NCT04447534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24842251|NCT02220335|Protective Agents|protective agents|mesh-ancestor
24842252|NCT02220335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842253|NCT02220335|Natriuretic Agents|natriuretic agents|mesh-ancestor
24842254|NCT02220335|Protease Inhibitors|protease inhibitors|mesh-ancestor
24842255|NCT02220335|Hormone Antagonists|hormone antagonists|mesh-ancestor
24842256|NCT02220335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24842257|NCT02220335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24842258|NCT02220348|Linaclotide|linaclotide|mesh-list
24842259|NCT02220348|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
24842438|NCT02221180|Canagliflozin|canagliflozin|mesh-list
25612898|NCT04447534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25612899|NCT04447534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612900|NCT04447534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25612901|NCT04447534|Amebicides|amebicides|mesh-ancestor
25612902|NCT04447534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25612903|NCT04447534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25612904|NCT04447534|Analgesics|analgesics|mesh-ancestor
25711954|NCT02309515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25711955|NCT02309515|Growth Substances|growth substances|mesh-ancestor
25711956|NCT02309515|Growth Inhibitors|growth inhibitors|mesh-ancestor
25711957|NCT02309515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24842552|NCT02221752|Micronutrients|micronutrients|mesh-ancestor
24842553|NCT02221752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842554|NCT02221765|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
24842555|NCT02221765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24842556|NCT02221765|Hormones|hormones|mesh-ancestor
24842557|NCT02221765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24842559|NCT02221830|Oxytocin|oxytocin|mesh-list
25612905|NCT04447534|Sensory System Agents|sensory system agents|mesh-ancestor
25612906|NCT04447534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25612907|NCT04447534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612908|NCT04447534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25612909|NCT04447534|Filaricides|filaricides|mesh-ancestor
25612910|NCT04447534|Antinematodal Agents|antinematodal agents|mesh-ancestor
25612911|NCT04447534|Anthelmintics|anthelmintics|mesh-ancestor
25612912|NCT04395001|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25612913|NCT04395001|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25711963|NCT02310568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711964|NCT02310581|Buprenorphine|buprenorphine|mesh-list
25711965|NCT02310581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24842869|NCT02224131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24842870|NCT02224131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842871|NCT02224131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24842968|NCT02224534|Purinergic Agents|purinergic agents|mesh-ancestor
24842969|NCT02224534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24842970|NCT02224534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842977|NCT02224937|Melatonin|melatonin|mesh-list
24843050|NCT02225210|Anesthetics, General|anesthetics, general|mesh-ancestor
24843051|NCT02225210|Anesthetics|anesthetics|mesh-ancestor
24843052|NCT02225210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24843053|NCT02225210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24843054|NCT02225210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24843055|NCT02225210|GABA Modulators|gaba modulators|mesh-ancestor
24843056|NCT02225210|GABA Agents|gaba agents|mesh-ancestor
25612914|NCT04395001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25612915|NCT04395001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25612916|NCT04395001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612917|NCT04395001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25612918|NCT04395001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612919|NCT04395001|Analgesics|analgesics|mesh-ancestor
25612920|NCT04395001|Sensory System Agents|sensory system agents|mesh-ancestor
25612921|NCT04395001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25612922|NCT04395001|Antidepressive Agents|antidepressive agents|mesh-ancestor
25612923|NCT04395001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25612924|NCT04395001|Dopamine Agents|dopamine agents|mesh-ancestor
25612925|NCT04391309|Remdesivir|remdesivir|mesh-list
25612926|NCT04391309|Antimetabolites|antimetabolites|mesh-ancestor
25711971|NCT02310581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25711972|NCT02310581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25711973|NCT02310672|Macitentan|macitentan|mesh-list
24843261|NCT02226588|Abortifacient Agents|abortifacient agents|mesh-ancestor
24843262|NCT02226588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24843263|NCT02226588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843264|NCT02226588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24843265|NCT02226588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24843266|NCT02226588|Oxytocics|oxytocics|mesh-ancestor
24843267|NCT02226601|Aprepitant|aprepitant|mesh-list
24843268|NCT02226601|Antiemetics|antiemetics|mesh-ancestor
24843269|NCT02226601|Autonomic Agents|autonomic agents|mesh-ancestor
24843270|NCT02226601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24843271|NCT02226601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843272|NCT02226601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25612927|NCT04391309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612928|NCT04391309|Antiviral Agents|antiviral agents|mesh-ancestor
25612929|NCT04391309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25612930|NCT04361656|Lubiprostone|lubiprostone|mesh-list
25612931|NCT04361656|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25612932|NCT04361656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25612933|NCT04361656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612934|NCT04354155|Enoxaparin|enoxaparin|mesh-list
25612935|NCT04354155|Anticoagulants|anticoagulants|mesh-ancestor
25612936|NCT04354155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25711982|NCT02310789|Ivacaftor|ivacaftor|mesh-list
25612937|NCT04354155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25612938|NCT04354155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612939|NCT04312139|Lincomycin|lincomycin|mesh-list
25612940|NCT04312139|Calcium|calcium|mesh-list
25612941|NCT04312139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25612942|NCT04312139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612943|NCT04312139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25612944|NCT04312139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24843822|NCT02229747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24843825|NCT02229760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24756412|NCT01733095|Ambrisentan|ambrisentan|mesh-list
24843906|NCT02229955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24843907|NCT02229955|Immunologic Factors|immunologic factors|mesh-ancestor
24843908|NCT02229955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843909|NCT02229955|Antifungal Agents|antifungal agents|mesh-ancestor
24843910|NCT02229955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24843911|NCT02229955|Dermatologic Agents|dermatologic agents|mesh-ancestor
24843912|NCT02229955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24843918|NCT02230033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24843919|NCT02230033|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24843920|NCT02230033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24843921|NCT02230033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24843922|NCT02230033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843923|NCT02230033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24843924|NCT02230033|Hormone Antagonists|hormone antagonists|mesh-ancestor
24843925|NCT02230033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24843926|NCT02230033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843927|NCT02230033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24843988|NCT02230553|Lapatinib|lapatinib|mesh-list
25612945|NCT04312139|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25612946|NCT04312139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25507586|NCT02845882|Antimetabolites|antimetabolites|mesh-ancestor
25612947|NCT04312139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612948|NCT04255602|Ticagrelor|ticagrelor|mesh-list
25612949|NCT04255602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25612950|NCT04255602|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25612951|NCT04255602|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25612952|NCT04255602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25612953|NCT04255602|Purinergic Agents|purinergic agents|mesh-ancestor
25612954|NCT04255602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25612955|NCT04255602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612956|NCT04255602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612957|NCT04238637|Durvalumab|durvalumab|mesh-list
25612958|NCT04238637|Tremelimumab|tremelimumab|mesh-list
25612959|NCT04238637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24843996|NCT02230618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24843997|NCT02230618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843998|NCT02230735|Epinephrine|epinephrine|mesh-list
24843999|NCT02230735|Racepinephrine|racepinephrine|mesh-list
24844000|NCT02230735|Epinephryl borate|epinephryl borate|mesh-list
24844001|NCT02230735|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24844040|NCT02230930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24844041|NCT02230930|Dopamine Agonists|dopamine agonists|mesh-ancestor
24844042|NCT02230930|Dopamine Agents|dopamine agents|mesh-ancestor
24844043|NCT02230930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24844044|NCT02230930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612960|NCT04238637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612961|NCT04224766|Bupivacaine|bupivacaine|mesh-list
25612962|NCT04224766|Anesthetics, Local|anesthetics, local|mesh-ancestor
25612963|NCT04224766|Anesthetics|anesthetics|mesh-ancestor
25612964|NCT04224766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25612965|NCT04224766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612966|NCT04224766|Sensory System Agents|sensory system agents|mesh-ancestor
25612967|NCT04224766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25612968|NCT04187352|Cisplatin|cisplatin|mesh-list
25612969|NCT04187352|Fluorouracil|fluorouracil|mesh-list
25612970|NCT04187352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612971|NCT04187352|Antimetabolites|antimetabolites|mesh-ancestor
25612972|NCT04187352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711989|NCT02310789|Autonomic Agents|autonomic agents|mesh-ancestor
25711990|NCT02310789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25711991|NCT02310789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711992|NCT02310789|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25711993|NCT02310789|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24844294|NCT02232269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24844295|NCT02232269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24844341|NCT02232360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24844432|NCT02232685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844433|NCT02232685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24844434|NCT02232685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24844435|NCT02232685|Nootropic Agents|nootropic agents|mesh-ancestor
24844437|NCT02232724|Lipotropic Agents|lipotropic agents|mesh-ancestor
24844438|NCT02232724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24844440|NCT02232724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844465|NCT02232776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844466|NCT02232789|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
24844467|NCT02232789|Hallucinogens|hallucinogens|mesh-ancestor
24844468|NCT02232789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844469|NCT02232789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25612973|NCT04187352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25612974|NCT04187352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25612975|NCT04187352|Immunologic Factors|immunologic factors|mesh-ancestor
25612976|NCT04187352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612977|NCT04142892|Onapristone|onapristone|mesh-list
25612978|NCT04142892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25612979|NCT04142892|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25612980|NCT04142892|Fertility Agents|fertility agents|mesh-ancestor
25612981|NCT04142892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25612982|NCT04142892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612983|NCT04142892|Hormone Antagonists|hormone antagonists|mesh-ancestor
25711998|NCT02311361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25711999|NCT02311361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712000|NCT02311881|Acetaminophen|acetaminophen|mesh-list
25712001|NCT02311881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24844703|NCT02233894|Respiratory System Agents|respiratory system agents|mesh-ancestor
24844704|NCT02233894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24844705|NCT02233894|Cholinergic Agents|cholinergic agents|mesh-ancestor
24844706|NCT02233894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24844755|NCT02234193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24844757|NCT02234193|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25612984|NCT04142892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25612985|NCT04071977|Antioxidants|antioxidants|mesh-list
25612986|NCT04071977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25612987|NCT04071977|Protective Agents|protective agents|mesh-ancestor
25612988|NCT04071977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612989|NCT04051944|Rozanolixizumab|rozanolixizumab|mesh-list
25612990|NCT04051944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25612991|NCT04051944|Immunologic Factors|immunologic factors|mesh-ancestor
25612992|NCT04051944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612993|NCT04039204|Contraceptive Agents|contraceptive agents|mesh-list
25612994|NCT04039204|Contraceptives, Oral|contraceptives, oral|mesh-list
25612995|NCT04039204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25612996|NCT04039204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25612997|NCT04039204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25612998|NCT04037241|Leucovorin|leucovorin|mesh-list
25612999|NCT04037241|Gemcitabine|gemcitabine|mesh-list
25613000|NCT04037241|Paclitaxel|paclitaxel|mesh-list
25613001|NCT04037241|Capecitabine|capecitabine|mesh-list
25613002|NCT04037241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25613003|NCT04037241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613004|NCT04037241|Tubulin Modulators|tubulin modulators|mesh-ancestor
25712016|NCT02311933|Tamoxifen|tamoxifen|mesh-list
25712017|NCT02311933|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25712018|NCT02311933|Hormone Antagonists|hormone antagonists|mesh-ancestor
25712019|NCT02311933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24845299|NCT02237443|Bromides|bromides|mesh-list
24845300|NCT02237443|Rocuronium|rocuronium|mesh-list
24845301|NCT02237443|Vecuronium Bromide|vecuronium bromide|mesh-list
25613005|NCT04037241|Antimitotic Agents|antimitotic agents|mesh-ancestor
25613006|NCT04037241|Mitosis Modulators|mitosis modulators|mesh-ancestor
25613007|NCT04037241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613008|NCT04037241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25613009|NCT04037241|Antimetabolites|antimetabolites|mesh-ancestor
25613010|NCT04037241|Antiviral Agents|antiviral agents|mesh-ancestor
25613011|NCT04037241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25613012|NCT04037241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25613013|NCT04037241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25613014|NCT04037241|Immunologic Factors|immunologic factors|mesh-ancestor
25613015|NCT04037241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613016|NCT04037241|Antidotes|antidotes|mesh-ancestor
25507659|NCT02405676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507660|NCT02405676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24845660|NCT02238392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845661|NCT02238392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24845662|NCT02238392|Vasodilator Agents|vasodilator agents|mesh-ancestor
24845663|NCT02238392|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24845664|NCT02238392|Purinergic Agonists|purinergic agonists|mesh-ancestor
24845665|NCT02238392|Purinergic Agents|purinergic agents|mesh-ancestor
24845666|NCT02238392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845667|NCT02238392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845668|NCT02238418|Cholecalciferol|cholecalciferol|mesh-list
24845670|NCT02238418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24845759|NCT02238717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845760|NCT02238717|Anticonvulsants|anticonvulsants|mesh-ancestor
24845761|NCT02238717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24845763|NCT02238717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845764|NCT02238717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24845765|NCT02238717|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24845766|NCT02238717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24845767|NCT02238717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24845768|NCT02238717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24845769|NCT02238717|GABA Modulators|gaba modulators|mesh-ancestor
24845771|NCT02238717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845772|NCT02238808|Estradiol|estradiol|mesh-list
24845773|NCT02238808|Estrogens|estrogens|mesh-list
24845774|NCT02238808|Hormones|hormones|mesh-ancestor
24845837|NCT02239484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845840|NCT02239523|Teriparatide|teriparatide|mesh-list
24845888|NCT02239913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845903|NCT02239952|Sunitinib|sunitinib|mesh-list
25507661|NCT02405676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25507662|NCT02405676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25613017|NCT04037241|Protective Agents|protective agents|mesh-ancestor
25613018|NCT04037241|Vitamin B Complex|vitamin b complex|mesh-ancestor
25613020|NCT04037241|Micronutrients|micronutrients|mesh-ancestor
25613021|NCT04004793|Dapagliflozin|dapagliflozin|mesh-list
25613022|NCT04004793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25613023|NCT04004793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613024|NCT04004793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25613025|NCT04004793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613026|NCT03943589|Immunoglobulins|immunoglobulins|mesh-list
25770792|NCT03567616|Hormones|hormones|mesh-ancestor
24846066|NCT02241083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24846067|NCT02241083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24846068|NCT02241083|Adrenergic Agents|adrenergic agents|mesh-ancestor
24846116|NCT02241278|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24476754|NCT00416390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24846145|NCT02241460|Anesthetics|anesthetics|mesh-ancestor
24846146|NCT02241460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24846174|NCT02241564|Immunologic Factors|immunologic factors|mesh-ancestor
24846175|NCT02241564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846176|NCT02241590|Entecavir|entecavir|mesh-list
24846177|NCT02241590|Antiviral Agents|antiviral agents|mesh-ancestor
24846178|NCT02241590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24846179|NCT02241616|Entecavir|entecavir|mesh-list
24846187|NCT02241759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24846188|NCT02241759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846189|NCT02241759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24846259|NCT02242253|Parasympatholytics|parasympatholytics|mesh-ancestor
24846260|NCT02242253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24846261|NCT02242253|Cholinergic Agents|cholinergic agents|mesh-ancestor
24846262|NCT02242253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24846263|NCT02242253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846264|NCT02242253|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24846265|NCT02242253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24846266|NCT02242253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24846267|NCT02242253|Adrenergic Agents|adrenergic agents|mesh-ancestor
24846296|NCT02242292|Autonomic Agents|autonomic agents|mesh-ancestor
25770795|NCT03567616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613027|NCT03943589|Immunoglobulin G|immunoglobulin g|mesh-list
25613028|NCT03943589|Immunologic Factors|immunologic factors|mesh-ancestor
25613029|NCT03943589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613030|NCT03886649|Venetoclax|venetoclax|mesh-list
25613031|NCT03886649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613032|NCT03877991|Cannabidiol|cannabidiol|mesh-list
25613033|NCT03877991|Anticonvulsants|anticonvulsants|mesh-ancestor
25613034|NCT03872947|Leucovorin|leucovorin|mesh-list
25613035|NCT03872947|Gemcitabine|gemcitabine|mesh-list
25613036|NCT03872947|Bevacizumab|bevacizumab|mesh-list
25613037|NCT03872947|Carboplatin|carboplatin|mesh-list
25613038|NCT03872947|Pembrolizumab|pembrolizumab|mesh-list
25613039|NCT03872947|Nivolumab|nivolumab|mesh-list
25613040|NCT03872947|Irinotecan|irinotecan|mesh-list
25613041|NCT03872947|Topotecan|topotecan|mesh-list
25613042|NCT03872947|Imiquimod|imiquimod|mesh-list
25613043|NCT03872947|Ramucirumab|ramucirumab|mesh-list
25613044|NCT03872947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613045|NCT03872947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613046|NCT03872947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25613047|NCT03872947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25613048|NCT03872947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25613049|NCT03872947|Growth Substances|growth substances|mesh-ancestor
25613050|NCT03872947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613051|NCT03872947|Growth Inhibitors|growth inhibitors|mesh-ancestor
25613052|NCT03872947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25613053|NCT03872947|Antimetabolites|antimetabolites|mesh-ancestor
25613054|NCT03872947|Antiviral Agents|antiviral agents|mesh-ancestor
25613055|NCT03872947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25712023|NCT02311933|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25712024|NCT02311933|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25712025|NCT02311933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24477712|NCT00419731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24477713|NCT00419731|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25404043|NCT03685773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25712026|NCT02312063|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25712027|NCT02312063|Glimepiride|glimepiride|mesh-list
25712028|NCT02312063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25712029|NCT02312063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712030|NCT02312063|Incretins|incretins|mesh-ancestor
25712031|NCT02312063|Hormones|hormones|mesh-ancestor
25712032|NCT02312063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25770800|NCT03567616|Growth Inhibitors|growth inhibitors|mesh-ancestor
25613056|NCT03872947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25613057|NCT03872947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25613058|NCT03872947|Immunologic Factors|immunologic factors|mesh-ancestor
25613059|NCT03872947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25613060|NCT03872947|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25613061|NCT03872947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25613062|NCT03872947|Antidotes|antidotes|mesh-ancestor
25613063|NCT03872947|Protective Agents|protective agents|mesh-ancestor
25613064|NCT03872947|Vitamin B Complex|vitamin b complex|mesh-ancestor
25613065|NCT03872947|Vitamins|vitamins|mesh-ancestor
25613066|NCT03872947|Micronutrients|micronutrients|mesh-ancestor
25613067|NCT03872947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25613068|NCT03872947|Interferon Inducers|interferon inducers|mesh-ancestor
25654939|NCT01557322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712033|NCT02312063|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24452754|NCT05453045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24452755|NCT05453045|Anticestodal Agents|anticestodal agents|mesh-ancestor
24846554|NCT02243098|Digoxin|digoxin|mesh-list
24846555|NCT02243098|Atorvastatin|atorvastatin|mesh-list
24846556|NCT02243098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24846557|NCT02243098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24846558|NCT02243098|Antimetabolites|antimetabolites|mesh-ancestor
24846559|NCT02243098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846560|NCT02243098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24846601|NCT02243241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24846602|NCT02243241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24846603|NCT02243241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24846604|NCT02243241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846605|NCT02243241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24846606|NCT02243241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24846607|NCT02243241|Contraceptive Agents|contraceptive agents|mesh-ancestor
24846659|NCT02243436|Autonomic Agents|autonomic agents|mesh-ancestor
24846660|NCT02243436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25712034|NCT02312063|Protease Inhibitors|protease inhibitors|mesh-ancestor
25712035|NCT02312063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712036|NCT02312063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712037|NCT02312063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25712038|NCT02312063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25654940|NCT01557322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25654941|NCT01557322|Dermatologic Agents|dermatologic agents|mesh-ancestor
25654942|NCT01557322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25654943|NCT01557322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25654944|NCT01557322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25654945|NCT01557322|Immunologic Factors|immunologic factors|mesh-ancestor
25654946|NCT01557322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25654947|NCT01557322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25654948|NCT01557322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25654949|NCT01557322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25654950|NCT01557322|Analgesics|analgesics|mesh-ancestor
25654951|NCT01557322|Sensory System Agents|sensory system agents|mesh-ancestor
25654952|NCT01557322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25654953|NCT01557322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25654954|NCT01557322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25654955|NCT01557452|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
25654956|NCT01557452|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24846721|NCT02243553|Respiratory System Agents|respiratory system agents|mesh-ancestor
24846722|NCT02243553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24846741|NCT02243618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846742|NCT02243618|Protective Agents|protective agents|mesh-ancestor
24846743|NCT02243618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846744|NCT02243618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479411|NCT00426647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24479412|NCT00426673|Brivaracetam|brivaracetam|mesh-list
24479413|NCT00426673|Anticonvulsants|anticonvulsants|mesh-ancestor
24846766|NCT02243800|Cholecalciferol|cholecalciferol|mesh-list
25712039|NCT02312063|Immunologic Factors|immunologic factors|mesh-ancestor
25712040|NCT02312219|Folic Acid|folic acid|mesh-list
25712041|NCT02312219|Methotrexate|methotrexate|mesh-list
25712042|NCT02312219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25712043|NCT02312219|Abortifacient Agents|abortifacient agents|mesh-ancestor
25712044|NCT02312219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25712045|NCT02312219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712046|NCT02312219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25712047|NCT02312219|Antimetabolites|antimetabolites|mesh-ancestor
25654957|NCT01557452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25654958|NCT01557452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654959|NCT01557504|Metformin|metformin|mesh-list
25654960|NCT01557504|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25654961|NCT01557504|Hormones|hormones|mesh-list
25654962|NCT01557504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25654963|NCT01557504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507732|NCT02335580|Somatostatin|somatostatin|mesh-list
25613069|NCT03872388|Capecitabine|capecitabine|mesh-list
25613070|NCT03872388|Atorvastatin|atorvastatin|mesh-list
25613071|NCT03872388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25613072|NCT03872388|Antimetabolites|antimetabolites|mesh-ancestor
25613073|NCT03872388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613074|NCT03872388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613075|NCT03872388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25613076|NCT03872388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25613077|NCT03872388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25613078|NCT03872388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25613079|NCT03872388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25613080|NCT03835949|Atezolizumab|atezolizumab|mesh-list
25613081|NCT03835949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613082|NCT03815890|Nivolumab|nivolumab|mesh-list
25613083|NCT03815890|Ipilimumab|ipilimumab|mesh-list
25613084|NCT03815890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24453071|NCT05309629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24453072|NCT05309629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24453074|NCT05309629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24453075|NCT05309629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24453076|NCT05301192|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
24453077|NCT05301192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24453078|NCT05301192|Vasodilator Agents|vasodilator agents|mesh-ancestor
24453079|NCT05296070|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
24453080|NCT05296070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24453081|NCT05296070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24846767|NCT02243800|Vitamin D|vitamin d|mesh-list
24846768|NCT02243800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24846769|NCT02243800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846770|NCT02243800|Vitamins|vitamins|mesh-ancestor
24846771|NCT02243800|Micronutrients|micronutrients|mesh-ancestor
24630126|NCT01109654|Cetrorelix|cetrorelix|mesh-list
25613085|NCT03815890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613086|NCT03815890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25613087|NCT03815890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613088|NCT03809780|Dexamethasone|dexamethasone|mesh-list
25613089|NCT03809780|Lenalidomide|lenalidomide|mesh-list
25613090|NCT03809780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25613091|NCT03809780|Antiemetics|antiemetics|mesh-ancestor
25613092|NCT03809780|Autonomic Agents|autonomic agents|mesh-ancestor
25613093|NCT03809780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25613094|NCT03809780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613095|NCT03809780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25613096|NCT03809780|Glucocorticoids|glucocorticoids|mesh-ancestor
25613097|NCT03809780|Hormones|hormones|mesh-ancestor
25613098|NCT03809780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25613099|NCT03809780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25613100|NCT03809780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24846793|NCT02244073|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24846794|NCT02244073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24846795|NCT02244073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846822|NCT02244151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24846823|NCT02244151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846824|NCT02244151|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24846825|NCT02244151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24846826|NCT02244151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24846827|NCT02244164|Liraglutide|liraglutide|mesh-list
24846828|NCT02244164|Exenatide|exenatide|mesh-list
24846829|NCT02244164|Lixisenatide|lixisenatide|mesh-list
24846830|NCT02244164|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24846832|NCT02244164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846834|NCT02244164|Hormones|hormones|mesh-ancestor
25712048|NCT02312219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712049|NCT02312219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712050|NCT02312219|Dermatologic Agents|dermatologic agents|mesh-ancestor
25404044|NCT03685773|Antimetabolites|antimetabolites|mesh-ancestor
25712051|NCT02312219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712052|NCT02312219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25712053|NCT02312219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25712054|NCT02312219|Immunologic Factors|immunologic factors|mesh-ancestor
25613101|NCT03809780|Immunologic Factors|immunologic factors|mesh-ancestor
25613102|NCT03809780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25613103|NCT03809780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25613104|NCT03809780|Growth Substances|growth substances|mesh-ancestor
25613105|NCT03809780|Growth Inhibitors|growth inhibitors|mesh-ancestor
25613106|NCT03780543|Tenofovir|tenofovir|mesh-list
25613107|NCT03780543|Entecavir|entecavir|mesh-list
25613108|NCT03780543|Antiviral Agents|antiviral agents|mesh-ancestor
25613109|NCT03780543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25613110|NCT03780543|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25613111|NCT03780543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25613112|NCT03780543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25613113|NCT03780543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613114|NCT03780543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25613115|NCT03780543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25613116|NCT03715465|Melatonin|melatonin|mesh-list
25613117|NCT03715465|Antioxidants|antioxidants|mesh-ancestor
25613118|NCT03715465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613119|NCT03715465|Protective Agents|protective agents|mesh-ancestor
25613120|NCT03715465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613121|NCT03715465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25613122|NCT03713528|Vancomycin|vancomycin|mesh-list
25613123|NCT03713528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25613124|NCT03713528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25613125|NCT03709459|Doxycycline|doxycycline|mesh-list
25613126|NCT03709459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25613127|NCT03709459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25613128|NCT03709459|Antimalarials|antimalarials|mesh-ancestor
25613129|NCT03709459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25613130|NCT03709459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25613131|NCT03702374|Antioxidants|antioxidants|mesh-list
24846848|NCT02244190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24846849|NCT02244190|Antiviral Agents|antiviral agents|mesh-ancestor
24846850|NCT02244190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24846851|NCT02244190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24846852|NCT02244190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24846853|NCT02244216|Fenoterol|fenoterol|mesh-list
24846854|NCT02244216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24846855|NCT02244216|Autonomic Agents|autonomic agents|mesh-ancestor
24846856|NCT02244216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24846857|NCT02244216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846896|NCT02244255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24846897|NCT02244255|Adrenergic Agents|adrenergic agents|mesh-ancestor
25712055|NCT02312219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25712056|NCT02312219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25712057|NCT02312219|Hematinics|hematinics|mesh-ancestor
25712058|NCT02312219|Vitamin B Complex|vitamin b complex|mesh-ancestor
25712059|NCT02312219|Vitamins|vitamins|mesh-ancestor
25712060|NCT02312219|Micronutrients|micronutrients|mesh-ancestor
25712061|NCT02312622|Irinotecan|irinotecan|mesh-list
25712062|NCT02312622|Etirinotecan pegol|etirinotecan pegol|mesh-list
25712063|NCT02312622|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25712064|NCT02312622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25613132|NCT03702374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613133|NCT03702374|Protective Agents|protective agents|mesh-ancestor
25613134|NCT03702374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613135|NCT03697356|Dexamethasone|dexamethasone|mesh-list
25613136|NCT03697356|Rituximab|rituximab|mesh-list
25613137|NCT03697356|Lenalidomide|lenalidomide|mesh-list
25613138|NCT03697356|Bortezomib|bortezomib|mesh-list
25613139|NCT03697356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25613140|NCT03697356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613141|NCT03697356|Immunologic Factors|immunologic factors|mesh-ancestor
25613142|NCT03697356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613143|NCT03697356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25613144|NCT03697356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25613146|NCT03697356|Autonomic Agents|autonomic agents|mesh-ancestor
25613147|NCT03697356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25613148|NCT03697356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25613149|NCT03697356|Glucocorticoids|glucocorticoids|mesh-ancestor
25613150|NCT03697356|Hormones|hormones|mesh-ancestor
25613151|NCT03697356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25613152|NCT03697356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25613153|NCT03697356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25613154|NCT03697356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25613155|NCT03697356|Growth Substances|growth substances|mesh-ancestor
25613156|NCT03697356|Growth Inhibitors|growth inhibitors|mesh-ancestor
25613157|NCT03683524|Darunavir|darunavir|mesh-list
25613158|NCT03683524|Dolutegravir|dolutegravir|mesh-list
25613159|NCT03683524|Cobicistat|cobicistat|mesh-list
25613160|NCT03683524|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
25613161|NCT03683524|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25613162|NCT03683524|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25712065|NCT02312622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712066|NCT02312622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846933|NCT02244307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712067|NCT02312622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712068|NCT02312622|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25712069|NCT02312739|Ketorolac|ketorolac|mesh-list
25712070|NCT02312739|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25712071|NCT02312739|Nitrous Oxide|nitrous oxide|mesh-list
25712072|NCT02312739|Analgesics|analgesics|mesh-list
25712073|NCT02312739|Lorazepam|lorazepam|mesh-list
25712074|NCT02312739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25613163|NCT03683524|Protease Inhibitors|protease inhibitors|mesh-ancestor
25613164|NCT03683524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25613165|NCT03683524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613166|NCT03683524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25613167|NCT03683524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25613168|NCT03683524|Antiviral Agents|antiviral agents|mesh-ancestor
25613169|NCT03683524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25613170|NCT03683524|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25613171|NCT03683524|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25613172|NCT03683524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25613173|NCT03683524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25613174|NCT03660683|Dapagliflozin|dapagliflozin|mesh-list
25613175|NCT03660683|Saxagliptin|saxagliptin|mesh-list
25613176|NCT03660683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25613177|NCT03660683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613178|NCT03660683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25613179|NCT03660683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613180|NCT03660683|Incretins|incretins|mesh-ancestor
25613181|NCT03660683|Hormones|hormones|mesh-ancestor
25613182|NCT03660683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25613183|NCT03660683|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25712075|NCT02312739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25712076|NCT02312739|Sensory System Agents|sensory system agents|mesh-ancestor
24451291|NCT00323011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24451292|NCT00323011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24451293|NCT00323011|Growth Substances|growth substances|mesh-ancestor
24451294|NCT00323011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451295|NCT00323011|Growth Inhibitors|growth inhibitors|mesh-ancestor
24451296|NCT00323011|Antimetabolites|antimetabolites|mesh-ancestor
24847029|NCT02244710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24847030|NCT02244710|Purinergic Agents|purinergic agents|mesh-ancestor
24847031|NCT02244710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24847032|NCT02244710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847033|NCT02244710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847034|NCT02244762|Hydrocodone|hydrocodone|mesh-list
24847035|NCT02244762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24847036|NCT02244762|Narcotics|narcotics|mesh-ancestor
24847037|NCT02244762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24847039|NCT02244762|Analgesics|analgesics|mesh-ancestor
25613184|NCT03660683|Protease Inhibitors|protease inhibitors|mesh-ancestor
25613185|NCT03660683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25613186|NCT03621696|Cisplatin|cisplatin|mesh-list
25613187|NCT03621696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613188|NCT03616782|Ixazomib|ixazomib|mesh-list
25613189|NCT03616782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613190|NCT03616782|Protease Inhibitors|protease inhibitors|mesh-ancestor
25613191|NCT03616782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25613192|NCT03616782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613193|NCT03574571|Docetaxel|docetaxel|mesh-list
25613194|NCT03574571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613195|NCT03574571|Tubulin Modulators|tubulin modulators|mesh-ancestor
25613196|NCT03574571|Antimitotic Agents|antimitotic agents|mesh-ancestor
25712085|NCT02312739|Anesthetics, General|anesthetics, general|mesh-ancestor
25712086|NCT02312739|Anesthetics|anesthetics|mesh-ancestor
25712087|NCT02312739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25712088|NCT02312739|Anticonvulsants|anticonvulsants|mesh-ancestor
25712089|NCT02312739|Antiemetics|antiemetics|mesh-ancestor
25712090|NCT02312739|Autonomic Agents|autonomic agents|mesh-ancestor
25712091|NCT02312739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25712092|NCT02312739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25613197|NCT03574571|Mitosis Modulators|mitosis modulators|mesh-ancestor
25613198|NCT03574571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613199|NCT03465527|Prednisolone|prednisolone|mesh-list
25613200|NCT03465527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25613201|NCT03465527|Glucocorticoids|glucocorticoids|mesh-ancestor
25613202|NCT03465527|Hormones|hormones|mesh-ancestor
25613203|NCT03465527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25712093|NCT02312739|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25712094|NCT02312739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25712095|NCT02312739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25712096|NCT02312739|GABA Modulators|gaba modulators|mesh-ancestor
25712097|NCT02312739|GABA Agents|gaba agents|mesh-ancestor
25712098|NCT02312739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25712099|NCT02312882|Tofacitinib|tofacitinib|mesh-list
25712100|NCT02312882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25712101|NCT02312882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25613204|NCT03465527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613205|NCT03465527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25613206|NCT03465527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613207|NCT03418805|Ibuprofen|ibuprofen|mesh-list
25613208|NCT03418805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25613209|NCT03418805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25613210|NCT03418805|Analgesics|analgesics|mesh-ancestor
25613211|NCT03418805|Sensory System Agents|sensory system agents|mesh-ancestor
25613212|NCT03418805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25613213|NCT03418805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613214|NCT03418805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25613215|NCT03418805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25613216|NCT03418805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24633959|NCT01131754|Heparin|heparin|mesh-list
24847258|NCT02245555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847284|NCT02245932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847286|NCT02245932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847287|NCT02245932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24847288|NCT02245932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24847289|NCT02246023|Propofol|propofol|mesh-list
24847290|NCT02246023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24847291|NCT02246023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24847293|NCT02246023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24847302|NCT02246049|Levoleucovorin|levoleucovorin|mesh-list
25613217|NCT03418805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25507875|NCT01730833|Paclitaxel|paclitaxel|mesh-list
25613218|NCT03418805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613219|NCT03413384|Ceftriaxone|ceftriaxone|mesh-list
25613220|NCT03413384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25613221|NCT03413384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25613222|NCT03399981|Natalizumab|natalizumab|mesh-list
25613223|NCT03399981|Immunologic Factors|immunologic factors|mesh-ancestor
24847303|NCT02246049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24847314|NCT02246049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24847315|NCT02246049|Immunologic Factors|immunologic factors|mesh-ancestor
24847316|NCT02246049|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24847317|NCT02246049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24847318|NCT02246049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24847320|NCT02246049|Protective Agents|protective agents|mesh-ancestor
25613224|NCT03399981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613225|NCT03385928|Tranexamic Acid|tranexamic acid|mesh-list
25613226|NCT03385928|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25613227|NCT03385928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25613228|NCT03385928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613229|NCT03385928|Hemostatics|hemostatics|mesh-ancestor
25613230|NCT03385928|Coagulants|coagulants|mesh-ancestor
25613231|NCT03380559|Botulinum Toxins|botulinum toxins|mesh-list
25613232|NCT03380559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25613233|NCT03380559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25613234|NCT03380559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613235|NCT03380559|Cholinergic Agents|cholinergic agents|mesh-ancestor
25613236|NCT03380559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25613237|NCT03380559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613238|NCT03375385|Dexmedetomidine|dexmedetomidine|mesh-list
25613239|NCT03375385|Propofol|propofol|mesh-list
25712102|NCT02312882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847403|NCT02246816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24847404|NCT02246816|Antitussive Agents|antitussive agents|mesh-ancestor
24847405|NCT02246816|Respiratory System Agents|respiratory system agents|mesh-ancestor
24847406|NCT02246842|Immunoglobulins|immunoglobulins|mesh-list
24847407|NCT02246842|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24847408|NCT02246842|Antibodies|antibodies|mesh-list
24847409|NCT02246842|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24847410|NCT02246842|gamma-Globulins|gamma-globulins|mesh-list
24847411|NCT02246842|Immunologic Factors|immunologic factors|mesh-ancestor
24847417|NCT02246855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847418|NCT02246868|Factor VIII|factor viii|mesh-list
24847419|NCT02246868|Coagulants|coagulants|mesh-ancestor
24847420|NCT02246881|Factor VIII|factor viii|mesh-list
24847421|NCT02246881|Coagulants|coagulants|mesh-ancestor
24847422|NCT02246894|Factor VIII|factor viii|mesh-list
24847423|NCT02246894|Coagulants|coagulants|mesh-ancestor
24847424|NCT02246920|Fluticasone|fluticasone|mesh-list
24847437|NCT02247128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24847438|NCT02247128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24847439|NCT02247128|Analgesics|analgesics|mesh-ancestor
24635406|NCT01138956|Antioxidants|antioxidants|mesh-ancestor
24635407|NCT01138956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635408|NCT01138956|Protective Agents|protective agents|mesh-ancestor
25712103|NCT02312934|Nicotine|nicotine|mesh-list
25712104|NCT02312934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25613240|NCT03375385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25613241|NCT03375385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25613242|NCT03375385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613243|NCT03375385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25613244|NCT03375385|Anesthetics, General|anesthetics, general|mesh-ancestor
25613245|NCT03375385|Anesthetics|anesthetics|mesh-ancestor
25613246|NCT03375385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25613247|NCT03375385|Analgesics|analgesics|mesh-ancestor
25613248|NCT03375385|Sensory System Agents|sensory system agents|mesh-ancestor
25613249|NCT03375385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24847519|NCT02247505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24847520|NCT02247505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24847521|NCT02247505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847522|NCT02247505|Urological Agents|urological agents|mesh-ancestor
24847523|NCT02247505|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24635503|NCT01139749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24847641|NCT02248168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24847642|NCT02248168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24847643|NCT02248168|Dopamine Agonists|dopamine agonists|mesh-ancestor
24847644|NCT02248168|Dopamine Agents|dopamine agents|mesh-ancestor
24847645|NCT02248168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24847646|NCT02248181|Pramipexole|pramipexole|mesh-list
24847647|NCT02248181|Antioxidants|antioxidants|mesh-ancestor
24847648|NCT02248181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847649|NCT02248181|Protective Agents|protective agents|mesh-ancestor
24847650|NCT02248181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847651|NCT02248181|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24847652|NCT02248181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24847653|NCT02248181|Dopamine Agonists|dopamine agonists|mesh-ancestor
24635747|NCT01140997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24453479|NCT04998669|Rituximab|rituximab|mesh-list
24484624|NCT00449449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24484625|NCT00449449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484626|NCT00449449|Sensory System Agents|sensory system agents|mesh-ancestor
24484627|NCT00449449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25712113|NCT02313675|Acetaminophen|acetaminophen|mesh-list
25712114|NCT02313675|Ketorolac|ketorolac|mesh-list
25712115|NCT02313675|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25712116|NCT02313675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25712117|NCT02313675|Analgesics|analgesics|mesh-ancestor
25712118|NCT02313675|Sensory System Agents|sensory system agents|mesh-ancestor
25613250|NCT03375385|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25613251|NCT03375385|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25613252|NCT03375385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25613253|NCT03375385|Adrenergic Agents|adrenergic agents|mesh-ancestor
25613254|NCT03375385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25613255|NCT03375385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613256|NCT03371108|Insulin Glargine|insulin glargine|mesh-list
25613257|NCT03371108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25613258|NCT03371108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613259|NCT03319667|Dexamethasone|dexamethasone|mesh-list
25613260|NCT03319667|Lenalidomide|lenalidomide|mesh-list
24847723|NCT02248428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24847724|NCT02248428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24847725|NCT02248428|Leprostatic Agents|leprostatic agents|mesh-ancestor
24847755|NCT02248493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24847756|NCT02248493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24847757|NCT02248493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24847758|NCT02248493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847759|NCT02248506|Clotrimazole|clotrimazole|mesh-list
24847770|NCT02248506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24847771|NCT02248506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847772|NCT02248506|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24847773|NCT02248506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24435399|NCT00266149|Anticonvulsants|anticonvulsants|mesh-ancestor
24847777|NCT05354635|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24847812|NCT05353673|Protease Inhibitors|protease inhibitors|mesh-ancestor
25613261|NCT03319667|Bortezomib|bortezomib|mesh-list
25613262|NCT03319667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25613263|NCT03319667|Antiemetics|antiemetics|mesh-ancestor
25613264|NCT03319667|Autonomic Agents|autonomic agents|mesh-ancestor
25613265|NCT03319667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25613266|NCT03319667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613267|NCT03319667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25613268|NCT03319667|Glucocorticoids|glucocorticoids|mesh-ancestor
25613269|NCT03319667|Hormones|hormones|mesh-ancestor
25613270|NCT03319667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25613271|NCT03319667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25613272|NCT03319667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712129|NCT02313909|Rivaroxaban|rivaroxaban|mesh-list
24636951|NCT01148173|Alkylating Agents|alkylating agents|mesh-ancestor
24637004|NCT01148303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24637005|NCT01148303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24637006|NCT01148303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24637007|NCT01148303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637008|NCT01148303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485925|NCT00455442|Abortifacient Agents|abortifacient agents|mesh-ancestor
24637293|NCT01149668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637295|NCT01149746|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24637296|NCT01149746|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25712130|NCT02313909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25712131|NCT02313909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25712132|NCT02313909|Analgesics|analgesics|mesh-ancestor
25712133|NCT02313909|Sensory System Agents|sensory system agents|mesh-ancestor
25712134|NCT02313909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25712135|NCT02313909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613273|NCT03319667|Immunologic Factors|immunologic factors|mesh-ancestor
25613274|NCT03319667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25613275|NCT03319667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25613276|NCT03319667|Growth Substances|growth substances|mesh-ancestor
25613277|NCT03319667|Growth Inhibitors|growth inhibitors|mesh-ancestor
25613278|NCT03245489|Aspirin|aspirin|mesh-list
25613279|NCT03245489|Pembrolizumab|pembrolizumab|mesh-list
25613280|NCT03245489|Clopidogrel|clopidogrel|mesh-list
25613281|NCT03245489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25613282|NCT03245489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613283|NCT03245489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24848384|NCT04509336|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24859046|NCT02301286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24848396|NCT04509336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24848397|NCT04509336|Cholinergic Agents|cholinergic agents|mesh-ancestor
24848398|NCT04509336|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
24848399|NCT04509336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25770801|NCT03568500|Olanzapine|olanzapine|mesh-list
25770802|NCT03568500|Risperidone|risperidone|mesh-list
25770803|NCT03568500|Aripiprazole|aripiprazole|mesh-list
25770804|NCT03568500|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25770805|NCT03568500|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25770806|NCT03568500|Serotonin Agents|serotonin agents|mesh-ancestor
25770807|NCT03568500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25770808|NCT03568500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613284|NCT03245489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25613285|NCT03245489|Analgesics|analgesics|mesh-ancestor
25613286|NCT03245489|Sensory System Agents|sensory system agents|mesh-ancestor
25613287|NCT03245489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25507927|NCT01653223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25507928|NCT01653223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25507929|NCT01653223|Antimetabolites|antimetabolites|mesh-ancestor
25507930|NCT01653223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507934|NCT01527149|Cytarabine|cytarabine|mesh-list
25613288|NCT03245489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613289|NCT03245489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25613290|NCT03245489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25613291|NCT03245489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25613292|NCT03245489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25613293|NCT03245489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613294|NCT03245489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25613295|NCT03245489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25613296|NCT03245489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25613297|NCT03245489|Antipyretics|antipyretics|mesh-ancestor
25613298|NCT03245489|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25613299|NCT03245489|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24486993|NCT00460863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24486995|NCT00460876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24486996|NCT00460876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24486997|NCT00460876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24848475|NCT04079621|Antimalarials|antimalarials|mesh-ancestor
24848507|NCT04014387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24848508|NCT04014387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24848535|NCT03970096|Cyclosporine|cyclosporine|mesh-list
24848538|NCT03970096|Busulfan|busulfan|mesh-list
24848550|NCT03970096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848551|NCT03970096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24848552|NCT03970096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24848553|NCT03970096|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24848554|NCT03970096|Abortifacient Agents|abortifacient agents|mesh-ancestor
24848555|NCT03970096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24848556|NCT03970096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24848557|NCT03970096|Antimetabolites|antimetabolites|mesh-ancestor
24848558|NCT03970096|Dermatologic Agents|dermatologic agents|mesh-ancestor
24848559|NCT03970096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24848560|NCT03970096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24848561|NCT03970096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25712136|NCT02313909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25712137|NCT02313909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25613300|NCT03245489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25613301|NCT03245489|Purinergic Agents|purinergic agents|mesh-ancestor
25613302|NCT03245489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25613303|NCT03112993|Neostigmine|neostigmine|mesh-list
25613304|NCT03112993|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25613305|NCT03112993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25613306|NCT03112993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613307|NCT03112993|Cholinergic Agents|cholinergic agents|mesh-ancestor
25712144|NCT02313909|Antipyretics|antipyretics|mesh-ancestor
24848562|NCT03970096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24848563|NCT03970096|Antifungal Agents|antifungal agents|mesh-ancestor
24639033|NCT01159652|Zaleplon|zaleplon|mesh-list
24848567|NCT03954379|Dexamethasone|dexamethasone|mesh-list
24848585|NCT03954379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24848586|NCT03954379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848587|NCT03954379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24848588|NCT03954379|Sensory System Agents|sensory system agents|mesh-ancestor
24848590|NCT03910387|Paclitaxel|paclitaxel|mesh-list
24848591|NCT03910387|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24848626|NCT03843463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24848627|NCT03843463|Parasympatholytics|parasympatholytics|mesh-ancestor
24848628|NCT03843463|Autonomic Agents|autonomic agents|mesh-ancestor
24848629|NCT03843463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24848630|NCT03843463|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24848631|NCT03843463|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24848632|NCT03843463|Cholinergic Agents|cholinergic agents|mesh-ancestor
24848633|NCT03842709|Pramipexole|pramipexole|mesh-list
24848634|NCT03842709|Antioxidants|antioxidants|mesh-ancestor
24848635|NCT03842709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848636|NCT03842709|Protective Agents|protective agents|mesh-ancestor
24848637|NCT03842709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848638|NCT03842709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24848667|NCT03728361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24848742|NCT03573947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24848743|NCT03561870|Olaparib|olaparib|mesh-list
24848744|NCT03561870|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24848745|NCT03561870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25613308|NCT03112993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25613309|NCT03112993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613310|NCT03112993|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25613311|NCT03112993|Autonomic Agents|autonomic agents|mesh-ancestor
25613312|NCT03112993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25613314|NCT03110315|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25613315|NCT03110315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25613316|NCT03110315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25613317|NCT03110315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613318|NCT03110315|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25613319|NCT03110315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25613320|NCT03110315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613321|NCT03088137|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25613322|NCT03088137|Hormones|hormones|mesh-ancestor
25613323|NCT03088137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25613324|NCT03088137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613325|NCT02955355|Immunoglobulins|immunoglobulins|mesh-list
24488033|NCT00466232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488035|NCT00466232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24488058|NCT00466401|Antimetabolites|antimetabolites|mesh-ancestor
24488059|NCT00466401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488060|NCT00466401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24488061|NCT00466401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24488062|NCT00466401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488076|NCT00466479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488078|NCT00466518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24488079|NCT00466518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848825|NCT03440190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24848971|NCT03170882|Antiemetics|antiemetics|mesh-ancestor
25613326|NCT02955355|Immunologic Factors|immunologic factors|mesh-ancestor
25613327|NCT02955355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613328|NCT02930044|Insulin|insulin|mesh-list
25613329|NCT02930044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25613330|NCT02930044|Insulin Glargine|insulin glargine|mesh-list
25613331|NCT02930044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25613332|NCT02930044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613333|NCT02926196|Avelumab|avelumab|mesh-list
25613334|NCT02926196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25613335|NCT02926196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613336|NCT02819024|Alovudine|alovudine|mesh-list
25613337|NCT02819024|Dideoxynucleosides|dideoxynucleosides|mesh-list
25613338|NCT02819024|Dexamethasone|dexamethasone|mesh-list
25613339|NCT02819024|Dexamethasone acetate|dexamethasone acetate|mesh-list
24488425|NCT00468520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488433|NCT00468533|Dopamine Agonists|dopamine agonists|mesh-ancestor
24488434|NCT00468533|Dopamine Agents|dopamine agents|mesh-ancestor
24488435|NCT00468533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24488485|NCT00468936|Mycophenolic Acid|mycophenolic acid|mesh-list
24488486|NCT00468936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24488537|NCT00469261|Doxycycline|doxycycline|mesh-list
24488540|NCT00469261|Antimalarials|antimalarials|mesh-ancestor
24488548|NCT00469326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24488549|NCT00469326|Antimetabolites|antimetabolites|mesh-ancestor
24488550|NCT00469326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488551|NCT00469326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24488552|NCT00469326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24488553|NCT00469326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488554|NCT00469352|Ranibizumab|ranibizumab|mesh-list
24488555|NCT00469352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24488612|NCT00469469|Growth Inhibitors|growth inhibitors|mesh-ancestor
24488613|NCT00469495|Anthelmintics|anthelmintics|mesh-list
24488614|NCT00469495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24488615|NCT00469495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24488616|NCT00469547|Ethanol|ethanol|mesh-list
24488617|NCT00469547|Anti-Infective Agents|anti-infective agents|mesh-list
24488618|NCT00469547|Emollients|emollients|mesh-list
24488619|NCT00469547|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24488620|NCT00469547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24488621|NCT00469547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613340|NCT02819024|Ichthammol|ichthammol|mesh-list
25613341|NCT02819024|BB 1101|bb 1101|mesh-list
25613342|NCT02819024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25613343|NCT02819024|Antiemetics|antiemetics|mesh-ancestor
25613344|NCT02819024|Autonomic Agents|autonomic agents|mesh-ancestor
25613345|NCT02819024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25613346|NCT02819024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613347|NCT02819024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25613348|NCT02819024|Glucocorticoids|glucocorticoids|mesh-ancestor
25613349|NCT02819024|Hormones|hormones|mesh-ancestor
25613350|NCT02819024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25613351|NCT02819024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25613352|NCT02819024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613353|NCT02819024|Protease Inhibitors|protease inhibitors|mesh-ancestor
25613354|NCT02819024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712153|NCT02314104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24849247|NCT01767129|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24849248|NCT01767129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24849249|NCT01767129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849250|NCT01767129|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24849251|NCT01767129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24849252|NCT01767129|Cholinergic Agents|cholinergic agents|mesh-ancestor
24849253|NCT01767129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24849370|NCT00454753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24849382|NCT00358163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24849383|NCT00358163|Tubulin Modulators|tubulin modulators|mesh-ancestor
24849384|NCT00358163|Antimitotic Agents|antimitotic agents|mesh-ancestor
24849385|NCT00358163|Mitosis Modulators|mitosis modulators|mesh-ancestor
24849516|NCT02248883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24849517|NCT02248883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24849518|NCT02248883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849519|NCT02248883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849520|NCT02248883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24849521|NCT02248896|Telmisartan|telmisartan|mesh-list
24849522|NCT02248896|Antihypertensive Agents|antihypertensive agents|mesh-list
24849523|NCT02248896|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24849524|NCT02248896|Enzyme Inhibitors|enzyme inhibitors|mesh-list
24849525|NCT02248896|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24849526|NCT02248896|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24849528|NCT02248896|Protease Inhibitors|protease inhibitors|mesh-ancestor
25613355|NCT02819024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613356|NCT02819024|Dermatologic Agents|dermatologic agents|mesh-ancestor
25613357|NCT02819024|Antiviral Agents|antiviral agents|mesh-ancestor
25613358|NCT02819024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25613359|NCT02819024|Antimetabolites|antimetabolites|mesh-ancestor
25613360|NCT02819024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25613361|NCT02819024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25613362|NCT02802969|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
24489876|NCT00475800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489877|NCT00475800|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24849590|NCT02249234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24849591|NCT02249234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24849592|NCT02249234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24849593|NCT02249234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849620|NCT02249416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24849668|NCT02249663|Xhance|xhance|mesh-list
25712161|NCT02314117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712162|NCT02314117|Antimetabolites|antimetabolites|mesh-ancestor
25712163|NCT02314117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712164|NCT02314117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25613363|NCT02802969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25613364|NCT02802969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613365|NCT02733185|Vitamins|vitamins|mesh-list
25613366|NCT02733185|Edetic Acid|edetic acid|mesh-list
25613367|NCT02733185|Pentetic Acid|pentetic acid|mesh-list
25613368|NCT02733185|Micronutrients|micronutrients|mesh-ancestor
25613369|NCT02733185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613370|NCT02733185|Anticoagulants|anticoagulants|mesh-ancestor
25613371|NCT02733185|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24849672|NCT02249663|Autonomic Agents|autonomic agents|mesh-ancestor
24849673|NCT02249663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24849674|NCT02249663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849675|NCT02249663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24849676|NCT02249663|Respiratory System Agents|respiratory system agents|mesh-ancestor
24490419|NCT00478075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24490421|NCT00478075|Sensory System Agents|sensory system agents|mesh-ancestor
24849715|NCT02249871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849716|NCT02249871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849717|NCT02249884|Carbamide Peroxide|carbamide peroxide|mesh-list
24849718|NCT02249884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24849719|NCT02249884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24849720|NCT02249897|Cholestyramine Resin|cholestyramine resin|mesh-list
24849721|NCT02249897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24849722|NCT02249897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24849723|NCT02249897|Antimetabolites|antimetabolites|mesh-ancestor
24849730|NCT02249910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24849731|NCT02249910|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24849732|NCT02249910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849733|NCT02249910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849734|NCT02249910|Protective Agents|protective agents|mesh-ancestor
25712165|NCT02314117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25712166|NCT02314117|Immunologic Factors|immunologic factors|mesh-ancestor
25712167|NCT02314117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712168|NCT02314143|Trametinib|trametinib|mesh-list
25613372|NCT02733185|Chelating Agents|chelating agents|mesh-ancestor
25613373|NCT02733185|Sequestering Agents|sequestering agents|mesh-ancestor
25613374|NCT02733185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613375|NCT02733185|Antidotes|antidotes|mesh-ancestor
25613376|NCT02733185|Protective Agents|protective agents|mesh-ancestor
25613377|NCT02733185|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25613378|NCT02647437|Levetiracetam|levetiracetam|mesh-list
25613379|NCT02647437|Anticonvulsants|anticonvulsants|mesh-ancestor
25613380|NCT02647437|Nootropic Agents|nootropic agents|mesh-ancestor
25613381|NCT02623426|Dexamethasone|dexamethasone|mesh-list
25613382|NCT02623426|Methotrexate|methotrexate|mesh-list
25613383|NCT02623426|Ranibizumab|ranibizumab|mesh-list
25613384|NCT02623426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25508068|NCT00638898|Lenograstim|lenograstim|mesh-list
24849737|NCT02249936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24849738|NCT02249936|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24849739|NCT02249936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849740|NCT02249936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446942|NCT00306696|Hormone Antagonists|hormone antagonists|mesh-ancestor
24849761|NCT02250300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849763|NCT02250482|Coagulants|coagulants|mesh-ancestor
24849764|NCT02250508|Factor VIII|factor viii|mesh-list
24849765|NCT02250508|Coagulants|coagulants|mesh-ancestor
24849766|NCT02250534|Nicotine|nicotine|mesh-list
24849767|NCT02250534|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24642499|NCT01179776|Iloprost|iloprost|mesh-list
24849773|NCT02250534|Cholinergic Agents|cholinergic agents|mesh-ancestor
24849774|NCT02250534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24849775|NCT02250534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712169|NCT02314143|Dabrafenib|dabrafenib|mesh-list
25712170|NCT02314143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712171|NCT02314143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25712172|NCT02314143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712173|NCT02314143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712174|NCT02314403|Rituximab|rituximab|mesh-list
25712175|NCT02314403|Abatacept|abatacept|mesh-list
25712176|NCT02314403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25508069|NCT00638898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25508070|NCT00638898|Immunologic Factors|immunologic factors|mesh-ancestor
25508071|NCT00638898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508072|NCT00638898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25508073|NCT00638898|Alkylating Agents|alkylating agents|mesh-ancestor
25508074|NCT00638898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508075|NCT00638898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508076|NCT00638898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25508077|NCT00638898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25508078|NCT00638898|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24849792|NCT02250664|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24849793|NCT02250664|Autonomic Agents|autonomic agents|mesh-ancestor
24849794|NCT02250664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24849795|NCT02250664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849796|NCT02250664|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24849797|NCT02250664|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24849798|NCT02250664|Cholinergic Agents|cholinergic agents|mesh-ancestor
24849799|NCT02250664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24849802|NCT02250729|Analgesics|analgesics|mesh-ancestor
24849803|NCT02250729|Sensory System Agents|sensory system agents|mesh-ancestor
24849804|NCT02250729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24849805|NCT02250729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849806|NCT02250729|Antitussive Agents|antitussive agents|mesh-ancestor
24849807|NCT02250729|Respiratory System Agents|respiratory system agents|mesh-ancestor
24642682|NCT01180933|Folic Acid|folic acid|mesh-list
24442291|NCT00290667|Prednisone|prednisone|mesh-list
24849808|NCT02250781|TIC10 compound|tic10 compound|mesh-list
24849809|NCT02250781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24849810|NCT02250794|Insulin|insulin|mesh-list
24849811|NCT02250794|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24849812|NCT02250794|Metformin|metformin|mesh-list
24849813|NCT02250794|Insulin Glargine|insulin glargine|mesh-list
24849814|NCT02250794|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24849815|NCT02250794|Insulin Lispro|insulin lispro|mesh-list
24849816|NCT02250794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24849817|NCT02250794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849818|NCT02250794|Incretins|incretins|mesh-ancestor
24849819|NCT02250794|Hormones|hormones|mesh-ancestor
24849820|NCT02250794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24849857|NCT02250872|Cisplatin|cisplatin|mesh-list
24849858|NCT02250872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607415|NCT04665037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607416|NCT04664738|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25508079|NCT00638898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24607417|NCT04664738|Hemostatics|hemostatics|mesh-ancestor
24607418|NCT04664738|Coagulants|coagulants|mesh-ancestor
24607419|NCT04649229|Aprepitant|aprepitant|mesh-list
24607420|NCT04649229|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24811964|NCT02049073|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24811965|NCT02049073|Prednisolone|prednisolone|mesh-list
24811966|NCT02049073|Prednisolone acetate|prednisolone acetate|mesh-list
24811967|NCT02049073|Zonisamide|zonisamide|mesh-list
25508080|NCT00638898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508081|NCT00577278|Sirolimus|sirolimus|mesh-list
25508082|NCT00577278|Rituximab|rituximab|mesh-list
25508083|NCT00577278|Fludarabine|fludarabine|mesh-list
25508084|NCT00577278|Fludarabine phosphate|fludarabine phosphate|mesh-list
25508085|NCT00577278|Melphalan|melphalan|mesh-list
25508086|NCT00577278|Tacrolimus|tacrolimus|mesh-list
25508087|NCT00577278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25508088|NCT00577278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25508089|NCT00577278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508090|NCT00577278|Immunologic Factors|immunologic factors|mesh-ancestor
25508091|NCT00577278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508092|NCT00577278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25508093|NCT00577278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25822741|NCT00004637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613385|NCT02623426|Antiemetics|antiemetics|mesh-ancestor
25613386|NCT02623426|Autonomic Agents|autonomic agents|mesh-ancestor
25613387|NCT02623426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25613388|NCT02623426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811968|NCT02049073|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24812005|NCT02049255|Chloroprocaine|chloroprocaine|mesh-list
24812006|NCT02049255|Anesthetics, Local|anesthetics, local|mesh-ancestor
24812007|NCT02049255|Anesthetics|anesthetics|mesh-ancestor
24493250|NCT00490178|Antimetabolites|antimetabolites|mesh-ancestor
25712177|NCT02314403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712178|NCT02314403|Immunologic Factors|immunologic factors|mesh-ancestor
25712179|NCT02314403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712180|NCT02314403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25712181|NCT02314403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25712182|NCT02314403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712183|NCT02314403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25712184|NCT02314546|Lidocaine|lidocaine|mesh-list
25712185|NCT02314546|Midazolam|midazolam|mesh-list
25712186|NCT02314546|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25613389|NCT02623426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25613390|NCT02623426|Glucocorticoids|glucocorticoids|mesh-ancestor
25613391|NCT02623426|Hormones|hormones|mesh-ancestor
25613392|NCT02623426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25613393|NCT02623426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25613394|NCT02623426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613395|NCT02623426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25613396|NCT02623426|Abortifacient Agents|abortifacient agents|mesh-ancestor
25613397|NCT02623426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25613398|NCT02623426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25613399|NCT02623426|Antimetabolites|antimetabolites|mesh-ancestor
25613400|NCT02623426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613401|NCT02623426|Dermatologic Agents|dermatologic agents|mesh-ancestor
25613402|NCT02623426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25613403|NCT02623426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25613404|NCT02623426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25613405|NCT02623426|Immunologic Factors|immunologic factors|mesh-ancestor
25613406|NCT02623426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25613407|NCT02623426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25613408|NCT02623426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25613409|NCT02623426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25613410|NCT02623426|Growth Substances|growth substances|mesh-ancestor
25613411|NCT02623426|Growth Inhibitors|growth inhibitors|mesh-ancestor
25654964|NCT01557504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25654965|NCT01557504|Incretins|incretins|mesh-ancestor
25654966|NCT01557504|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25654967|NCT01557504|Protease Inhibitors|protease inhibitors|mesh-ancestor
25654968|NCT01557504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24659211|NCT01276210|Sorafenib|sorafenib|mesh-list
24444209|NCT00296959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491783|NCT00483964|Serotonin Agents|serotonin agents|mesh-ancestor
24444216|NCT00296972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491784|NCT00483990|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24491785|NCT00483990|Anesthetics, Local|anesthetics, local|mesh-ancestor
24491786|NCT00483990|Anesthetics|anesthetics|mesh-ancestor
24494901|NCT00497497|Cetuximab|cetuximab|mesh-list
24492505|NCT00486486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492617|NCT00487032|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25654969|NCT01557504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654970|NCT01557517|Clobetasol|clobetasol|mesh-list
25654971|NCT01557517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25654972|NCT01557517|Glucocorticoids|glucocorticoids|mesh-ancestor
25654973|NCT01557517|Hormones|hormones|mesh-ancestor
25654974|NCT01557517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25654975|NCT01557517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654976|NCT01557569|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25654977|NCT01557569|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25654978|NCT01557569|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25654979|NCT01557569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25654980|NCT01557569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25654981|NCT01557569|Adrenergic Agents|adrenergic agents|mesh-ancestor
25654982|NCT01557569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25654983|NCT01557569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654984|NCT01557868|Hyaluronic Acid|hyaluronic acid|mesh-list
25654985|NCT01557868|Hylan|hylan|mesh-list
25654986|NCT01557868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25654987|NCT01557868|Immunologic Factors|immunologic factors|mesh-ancestor
25654988|NCT01557868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654989|NCT01557868|Viscosupplements|viscosupplements|mesh-ancestor
25654990|NCT01557868|Protective Agents|protective agents|mesh-ancestor
25654991|NCT01557920|Propofol|propofol|mesh-list
25654992|NCT01557920|Sevoflurane|sevoflurane|mesh-list
25654993|NCT01557920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25654994|NCT01557920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25654995|NCT01557920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25654996|NCT01557920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25654997|NCT01557920|Anesthetics, General|anesthetics, general|mesh-ancestor
25654998|NCT01557920|Anesthetics|anesthetics|mesh-ancestor
25654999|NCT01557920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25655000|NCT01557920|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25655001|NCT01557946|Citalopram|citalopram|mesh-list
24492855|NCT00488306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492856|NCT00488371|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24492857|NCT00488371|Immunologic Factors|immunologic factors|mesh-ancestor
24850096|NCT02251769|Protease Inhibitors|protease inhibitors|mesh-ancestor
24850097|NCT02251769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655002|NCT01557946|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25655003|NCT01557946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25655004|NCT01557946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25655005|NCT01557946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655006|NCT01557946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25655007|NCT01557946|Serotonin Agents|serotonin agents|mesh-ancestor
25655008|NCT01557946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655009|NCT01557946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25655010|NCT01557946|Antidepressive Agents|antidepressive agents|mesh-ancestor
25655011|NCT01557946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25655012|NCT01557959|Cisplatin|cisplatin|mesh-list
25655013|NCT01557959|Docetaxel|docetaxel|mesh-list
25655014|NCT01557959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25655015|NCT01557959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25655016|NCT01557959|Tubulin Modulators|tubulin modulators|mesh-ancestor
25655017|NCT01557959|Antimitotic Agents|antimitotic agents|mesh-ancestor
25655018|NCT01557959|Mitosis Modulators|mitosis modulators|mesh-ancestor
25655019|NCT01557959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655020|NCT01557959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25655021|NCT01557959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655022|NCT01558063|Ketamine|ketamine|mesh-list
25655023|NCT01558063|Analgesics|analgesics|mesh-ancestor
25655024|NCT01558063|Sensory System Agents|sensory system agents|mesh-ancestor
25655025|NCT01558063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25655026|NCT01558063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655027|NCT01558063|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25655028|NCT01558063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25655029|NCT01558063|Anesthetics, General|anesthetics, general|mesh-ancestor
25655030|NCT01558063|Anesthetics|anesthetics|mesh-ancestor
25655031|NCT01558063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25655032|NCT01558063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25655033|NCT01558063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25655034|NCT01558063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25508106|NCT00576979|Cyclophosphamide|cyclophosphamide|mesh-list
25508107|NCT00576979|Etoposide|etoposide|mesh-list
25613412|NCT02451943|Doxorubicin|doxorubicin|mesh-list
25613414|NCT02451943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25613415|NCT02451943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613416|NCT02451943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25613417|NCT02451943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25613418|NCT02451943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25613419|NCT02451943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613420|NCT02410512|Atezolizumab|atezolizumab|mesh-list
25613421|NCT02410512|Antibodies|antibodies|mesh-list
25613422|NCT02410512|Immunoglobulins|immunoglobulins|mesh-list
25613423|NCT02410512|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25613424|NCT02410512|Immunologic Factors|immunologic factors|mesh-ancestor
25613425|NCT02410512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613426|NCT02410512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613427|NCT02390427|Paclitaxel|paclitaxel|mesh-list
25613428|NCT02390427|Maytansine|maytansine|mesh-list
25613429|NCT02390427|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25613430|NCT02390427|Trastuzumab|trastuzumab|mesh-list
25613431|NCT02390427|Pertuzumab|pertuzumab|mesh-list
25613432|NCT02390427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25613433|NCT02390427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613434|NCT02390427|Tubulin Modulators|tubulin modulators|mesh-ancestor
25613435|NCT02390427|Antimitotic Agents|antimitotic agents|mesh-ancestor
25613436|NCT02390427|Mitosis Modulators|mitosis modulators|mesh-ancestor
25613437|NCT02390427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613438|NCT02390427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25613439|NCT02193191|Plerixafor|plerixafor|mesh-list
25613440|NCT02193191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25613441|NCT02193191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25613442|NCT02193191|Antiviral Agents|antiviral agents|mesh-ancestor
25613443|NCT02193191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25613444|NCT02066623|Everolimus|everolimus|mesh-list
25613445|NCT02066623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613446|NCT02066623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25613447|NCT02066623|Immunologic Factors|immunologic factors|mesh-ancestor
24850417|NCT02252926|Antipyretics|antipyretics|mesh-ancestor
25613448|NCT02066623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613449|NCT01924819|Leucovorin|leucovorin|mesh-list
24444867|NCT00299455|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24444868|NCT00299455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444869|NCT00299455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444870|NCT00299520|Linezolid|linezolid|mesh-list
24445163|NCT00300664|Hormones|hormones|mesh-list
25613450|NCT01924819|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
25613451|NCT01924819|Cisplatin|cisplatin|mesh-list
25613452|NCT01924819|Docetaxel|docetaxel|mesh-list
25613453|NCT01924819|Fluorouracil|fluorouracil|mesh-list
25613454|NCT01924819|Capecitabine|capecitabine|mesh-list
25613455|NCT01924819|Oxaliplatin|oxaliplatin|mesh-list
25613456|NCT01924819|Epirubicin|epirubicin|mesh-list
25613457|NCT01924819|Levoleucovorin|levoleucovorin|mesh-list
25613458|NCT01924819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613459|NCT01924819|Tubulin Modulators|tubulin modulators|mesh-ancestor
25613460|NCT01924819|Antimitotic Agents|antimitotic agents|mesh-ancestor
25613461|NCT01924819|Mitosis Modulators|mitosis modulators|mesh-ancestor
25613462|NCT01924819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613463|NCT01924819|Antimetabolites|antimetabolites|mesh-ancestor
25613464|NCT01924819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25613465|NCT01924819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25613466|NCT01924819|Immunologic Factors|immunologic factors|mesh-ancestor
25613467|NCT01924819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613468|NCT01924819|Antidotes|antidotes|mesh-ancestor
25613469|NCT01924819|Protective Agents|protective agents|mesh-ancestor
25613470|NCT01924819|Vitamin B Complex|vitamin b complex|mesh-ancestor
25613471|NCT01924819|Vitamins|vitamins|mesh-ancestor
25613472|NCT01924819|Micronutrients|micronutrients|mesh-ancestor
25613473|NCT01924819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25613474|NCT01924819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25613475|NCT01924819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25712232|NCT02315872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613476|NCT01924819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25613477|NCT01126255|Clobetasol|clobetasol|mesh-list
25613478|NCT01126255|Progesterone|progesterone|mesh-list
25613479|NCT01126255|Progestins|progestins|mesh-ancestor
25613480|NCT01126255|Hormones|hormones|mesh-ancestor
25613481|NCT01126255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25613482|NCT01126255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613483|NCT01126255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25613484|NCT01126255|Glucocorticoids|glucocorticoids|mesh-ancestor
25613485|NCT00433589|Tamoxifen|tamoxifen|mesh-list
25613486|NCT00433589|Docetaxel|docetaxel|mesh-list
25613487|NCT00433589|Capecitabine|capecitabine|mesh-list
25613488|NCT00433589|Letrozole|letrozole|mesh-list
25613489|NCT00433589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613490|NCT00433589|Tubulin Modulators|tubulin modulators|mesh-ancestor
25613491|NCT00433589|Antimitotic Agents|antimitotic agents|mesh-ancestor
25613492|NCT00433589|Mitosis Modulators|mitosis modulators|mesh-ancestor
25613493|NCT00433589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613494|NCT00433589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25613495|NCT00433589|Antimetabolites|antimetabolites|mesh-ancestor
25613496|NCT00433589|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25613497|NCT00433589|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25613498|NCT00433589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25613499|NCT00433589|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25613500|NCT00433589|Hormone Antagonists|hormone antagonists|mesh-ancestor
25613501|NCT00433589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25613502|NCT00433589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613503|NCT00433589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25613504|NCT00433589|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25613505|NCT00433589|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25613506|NCT00433589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25613507|NCT00308685|Albuterol|albuterol|mesh-list
25613508|NCT00308685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25613509|NCT00308685|Autonomic Agents|autonomic agents|mesh-ancestor
25613510|NCT00308685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24592349|NCT00921388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24592456|NCT00921804|Risperidone|risperidone|mesh-list
24592457|NCT00921804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24592458|NCT00921804|Serotonin Agents|serotonin agents|mesh-ancestor
25613511|NCT00308685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613512|NCT00308685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25613513|NCT00308685|Respiratory System Agents|respiratory system agents|mesh-ancestor
25613514|NCT00308685|Tocolytic Agents|tocolytic agents|mesh-ancestor
25613515|NCT00308685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25613516|NCT00308685|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25613517|NCT00308685|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25613518|NCT00308685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25613519|NCT00308685|Adrenergic Agents|adrenergic agents|mesh-ancestor
25613520|NCT00308685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25613521|NCT00308685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613522|NCT00255138|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25613523|NCT00255138|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25613524|NCT00255138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25613525|NCT00255138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24592464|NCT00921804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24592471|NCT00921830|Analgesics|analgesics|mesh-ancestor
25613526|NCT00255138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613527|NCT00255138|Adrenergic Agents|adrenergic agents|mesh-ancestor
25613528|NCT00255138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25613529|NCT00255138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613530|NCT01125514|Furosemide|furosemide|mesh-list
25613531|NCT01125514|Diuretics|diuretics|mesh-ancestor
25613532|NCT01125514|Natriuretic Agents|natriuretic agents|mesh-ancestor
25613533|NCT01125514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613534|NCT01125514|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25613535|NCT01125514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25613536|NCT01125514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613537|NCT01125566|Trastuzumab|trastuzumab|mesh-list
25613538|NCT01125566|Vinorelbine|vinorelbine|mesh-list
25613539|NCT01125566|Afatinib|afatinib|mesh-list
25613540|NCT01125566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25613541|NCT01125566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613542|NCT01125566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25613543|NCT01125566|Tubulin Modulators|tubulin modulators|mesh-ancestor
25613544|NCT01125566|Antimitotic Agents|antimitotic agents|mesh-ancestor
25613545|NCT01125566|Mitosis Modulators|mitosis modulators|mesh-ancestor
25613546|NCT01125566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613547|NCT01125566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25613548|NCT01125566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25613549|NCT01125748|Omalizumab|omalizumab|mesh-list
25613550|NCT01125748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25613551|NCT01125748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25613552|NCT01125748|Respiratory System Agents|respiratory system agents|mesh-ancestor
25613553|NCT01125813|Factor VIII|factor viii|mesh-list
25613554|NCT01125813|Coagulants|coagulants|mesh-ancestor
25613555|NCT01125917|Buprenorphine|buprenorphine|mesh-list
25613556|NCT01125917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25613557|NCT01125917|Narcotics|narcotics|mesh-ancestor
25613558|NCT01125917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25613559|NCT01125917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613560|NCT01125917|Analgesics|analgesics|mesh-ancestor
25613561|NCT01125917|Sensory System Agents|sensory system agents|mesh-ancestor
25613562|NCT01125917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25613563|NCT01125917|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25508241|NCT00371761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613564|NCT01125930|Tretinoin|tretinoin|mesh-list
25613565|NCT01125930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613566|NCT01125930|Keratolytic Agents|keratolytic agents|mesh-ancestor
25613567|NCT01125930|Dermatologic Agents|dermatologic agents|mesh-ancestor
25613568|NCT01126060|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25613569|NCT01126060|Hemostatics|hemostatics|mesh-ancestor
25613570|NCT01126060|Coagulants|coagulants|mesh-ancestor
25613571|NCT01126099|Prazosin|prazosin|mesh-list
25613572|NCT01126099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25613573|NCT01126099|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25613574|NCT01126099|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25613575|NCT01126099|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25613576|NCT01126099|Adrenergic Agents|adrenergic agents|mesh-ancestor
25613577|NCT01126099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25613578|NCT01126099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613579|NCT01126099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613580|NCT01126268|Retapamulin|retapamulin|mesh-list
25613581|NCT01126268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25613582|NCT01126268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25613583|NCT01126359|Lidocaine|lidocaine|mesh-list
25613584|NCT01126359|Anesthetics, Local|anesthetics, local|mesh-ancestor
25613585|NCT01126359|Anesthetics|anesthetics|mesh-ancestor
25613586|NCT01126359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25613587|NCT01126359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613588|NCT01126359|Sensory System Agents|sensory system agents|mesh-ancestor
25613589|NCT01126359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25613590|NCT01126359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25613591|NCT01126359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25613592|NCT01126359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25613593|NCT01126359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25613594|NCT01126359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613595|NCT01126424|Solifenacin Succinate|solifenacin succinate|mesh-list
25613596|NCT01126424|Oxybutynin|oxybutynin|mesh-list
25613597|NCT01126424|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25613598|NCT01126424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25613599|NCT01126424|Cholinergic Agents|cholinergic agents|mesh-ancestor
25613600|NCT01126424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25613601|NCT01126424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613602|NCT01126424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613603|NCT01126424|Urological Agents|urological agents|mesh-ancestor
25613604|NCT01126424|Parasympatholytics|parasympatholytics|mesh-ancestor
25613605|NCT01126424|Autonomic Agents|autonomic agents|mesh-ancestor
25613606|NCT01126424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25613607|NCT01126437|Tiotropium Bromide|tiotropium bromide|mesh-list
25613608|NCT01126437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25613609|NCT01126437|Autonomic Agents|autonomic agents|mesh-ancestor
25613610|NCT01126437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25613611|NCT01126437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613612|NCT01126437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25613613|NCT01126437|Respiratory System Agents|respiratory system agents|mesh-ancestor
25613614|NCT01126437|Parasympatholytics|parasympatholytics|mesh-ancestor
25613615|NCT01126437|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25613616|NCT01126437|Cholinergic Agents|cholinergic agents|mesh-ancestor
25613617|NCT01126437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24600018|NCT02879409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600019|NCT02879409|Incretins|incretins|mesh-ancestor
24600020|NCT02879409|Hormones|hormones|mesh-ancestor
25613618|NCT01126437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613619|NCT01126541|Rituximab|rituximab|mesh-list
25613620|NCT01126541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25613621|NCT01126541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613622|NCT01126541|Immunologic Factors|immunologic factors|mesh-ancestor
25613623|NCT01126541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613624|NCT01126541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25613625|NCT01126580|Metformin|metformin|mesh-list
25613626|NCT01126580|Dulaglutide|dulaglutide|mesh-list
25613627|NCT01126580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25613628|NCT01126580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613629|NCT01126593|Bupivacaine|bupivacaine|mesh-list
25613630|NCT01126593|Anesthetics, Local|anesthetics, local|mesh-ancestor
25613631|NCT01126593|Anesthetics|anesthetics|mesh-ancestor
25613632|NCT01126593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25613633|NCT01126593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613634|NCT01126593|Sensory System Agents|sensory system agents|mesh-ancestor
25613635|NCT01126593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25613636|NCT01126671|Vitamin D|vitamin d|mesh-list
25613637|NCT01126671|Vitamins|vitamins|mesh-ancestor
25508307|NCT00372424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25613638|NCT01126671|Micronutrients|micronutrients|mesh-ancestor
25613639|NCT01126671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613640|NCT01126671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25613641|NCT01127165|Zonisamide|zonisamide|mesh-list
25613642|NCT01127165|Anticonvulsants|anticonvulsants|mesh-ancestor
25613643|NCT01127165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25613644|NCT01127165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25613645|NCT01127165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613646|NCT01127165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25613647|NCT01127165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613648|NCT01127438|Fospropofol|fospropofol|mesh-list
25613649|NCT01127438|Propofol|propofol|mesh-list
25613650|NCT01127438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25613651|NCT01127438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25613652|NCT01127438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613653|NCT01127438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24605050|NCT00983047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613654|NCT01127438|Anesthetics, General|anesthetics, general|mesh-ancestor
25613655|NCT01127438|Anesthetics|anesthetics|mesh-ancestor
25613656|NCT01127581|Dinoprostone|dinoprostone|mesh-list
25613657|NCT01127581|Oxytocics|oxytocics|mesh-ancestor
25613658|NCT01127581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25613659|NCT01127581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613660|NCT01127607|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25613661|NCT01127607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25613662|NCT01127607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613663|NCT01127607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25613664|NCT01127607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25613665|NCT01127607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25613666|NCT01127607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613667|NCT01127607|Dopamine Agents|dopamine agents|mesh-ancestor
25613668|NCT01127607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25613669|NCT01127646|Methylphenidate|methylphenidate|mesh-list
25613670|NCT01127646|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25613671|NCT01127646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25613672|NCT01127646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613673|NCT01127646|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25613674|NCT01127646|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25613675|NCT01127646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24605415|NCT00984971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24605937|NCT00988039|Lopinavir|lopinavir|mesh-list
25613676|NCT01127646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613677|NCT01127646|Dopamine Agents|dopamine agents|mesh-ancestor
25613678|NCT01127646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25613679|NCT01127646|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25613680|NCT01127646|Adrenergic Agents|adrenergic agents|mesh-ancestor
25613681|NCT01127659|Testosterone|testosterone|mesh-list
25613682|NCT01127659|Androgens|androgens|mesh-ancestor
25613683|NCT01127659|Hormones|hormones|mesh-ancestor
25613684|NCT01127659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25613685|NCT01127659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613686|NCT01127763|Carboplatin|carboplatin|mesh-list
25613687|NCT01127763|Everolimus|everolimus|mesh-list
25613688|NCT01127763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613689|NCT01127763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25613690|NCT01127763|Immunologic Factors|immunologic factors|mesh-ancestor
25613691|NCT01127763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613692|NCT01127893|Tanezumab|tanezumab|mesh-list
25613693|NCT01127893|Analgesics|analgesics|mesh-ancestor
25613694|NCT01127893|Sensory System Agents|sensory system agents|mesh-ancestor
25613695|NCT01127893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25613696|NCT01127893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613697|NCT01128153|Saxagliptin|saxagliptin|mesh-list
25613698|NCT01128153|Incretins|incretins|mesh-ancestor
25613699|NCT01128153|Hormones|hormones|mesh-ancestor
25613700|NCT01128153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25613701|NCT01128153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613702|NCT01128153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25613703|NCT01128153|Protease Inhibitors|protease inhibitors|mesh-ancestor
25613704|NCT01128153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25613705|NCT01128153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613706|NCT01128153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25613707|NCT01128192|Pasireotide|pasireotide|mesh-list
25613708|NCT01128192|Hormones|hormones|mesh-ancestor
25613709|NCT01128192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25508363|NCT00372619|Cytarabine|cytarabine|mesh-list
25613710|NCT01128192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613711|NCT01128244|Pyridoxine|pyridoxine|mesh-list
25613712|NCT01128244|Pyridoxal|pyridoxal|mesh-list
25613713|NCT01128244|Vitamin B 6|vitamin b 6|mesh-list
25613714|NCT01128244|Vitamins|vitamins|mesh-ancestor
25613715|NCT01128244|Micronutrients|micronutrients|mesh-ancestor
25613716|NCT01128244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613717|NCT01128244|Vitamin B Complex|vitamin b complex|mesh-ancestor
25613718|NCT01128270|Chloral Hydrate|chloral hydrate|mesh-list
25613719|NCT01128270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25613720|NCT01128270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25613721|NCT01128270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613722|NCT01128296|Gemcitabine|gemcitabine|mesh-list
25613723|NCT01128296|Hydroxychloroquine|hydroxychloroquine|mesh-list
25613724|NCT01128296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25613725|NCT01128296|Antimetabolites|antimetabolites|mesh-ancestor
25613726|NCT01128296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613727|NCT01128296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613728|NCT01128296|Antiviral Agents|antiviral agents|mesh-ancestor
25613729|NCT01128296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25613730|NCT01128296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25613731|NCT01128296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25613732|NCT01128296|Immunologic Factors|immunologic factors|mesh-ancestor
25613733|NCT01128296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613734|NCT01128296|Antimalarials|antimalarials|mesh-ancestor
25613735|NCT01128296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25613736|NCT01128296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25613737|NCT01128296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25613738|NCT01128387|Panitumumab|panitumumab|mesh-list
25613739|NCT01128387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25613740|NCT01128387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613741|NCT01128543|Vinorelbine|vinorelbine|mesh-list
25613742|NCT01128543|Lapatinib|lapatinib|mesh-list
25613743|NCT01128543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25613744|NCT01128543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613745|NCT01128543|Tubulin Modulators|tubulin modulators|mesh-ancestor
25613746|NCT01128543|Antimitotic Agents|antimitotic agents|mesh-ancestor
25613747|NCT01128543|Mitosis Modulators|mitosis modulators|mesh-ancestor
25613748|NCT01128543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613749|NCT01128543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25613750|NCT01128543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25613751|NCT01128569|Fluticasone|fluticasone|mesh-list
25613752|NCT01128569|Xhance|xhance|mesh-list
25613753|NCT01128569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25613754|NCT01128569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25613755|NCT01128569|Autonomic Agents|autonomic agents|mesh-ancestor
25613756|NCT01128569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25613757|NCT01128569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613758|NCT01128569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25613759|NCT01128569|Respiratory System Agents|respiratory system agents|mesh-ancestor
25613760|NCT01128569|Dermatologic Agents|dermatologic agents|mesh-ancestor
25613761|NCT01128569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25613762|NCT01128595|Fluticasone|fluticasone|mesh-list
25613763|NCT01128595|Xhance|xhance|mesh-list
25613764|NCT01128595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25613765|NCT01128595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25613766|NCT01128595|Autonomic Agents|autonomic agents|mesh-ancestor
25613767|NCT01128595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25613768|NCT01128595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613769|NCT01128595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25613770|NCT01128595|Respiratory System Agents|respiratory system agents|mesh-ancestor
25613771|NCT01128595|Dermatologic Agents|dermatologic agents|mesh-ancestor
25613772|NCT01128595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25613773|NCT01128621|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25613774|NCT01128621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25613775|NCT01128621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613776|NCT01128621|Incretins|incretins|mesh-ancestor
25613777|NCT01128621|Hormones|hormones|mesh-ancestor
25613778|NCT01128621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25613779|NCT01128621|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25613780|NCT01128621|Protease Inhibitors|protease inhibitors|mesh-ancestor
25613781|NCT01128621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25613782|NCT01128621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613783|NCT01128842|Capecitabine|capecitabine|mesh-list
25613784|NCT01128842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25613785|NCT01128842|Antimetabolites|antimetabolites|mesh-ancestor
25657021|NCT01582152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613786|NCT01128842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613787|NCT01128842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613788|NCT01128894|Liraglutide|liraglutide|mesh-list
25613789|NCT01128894|rGLP-1 protein|rglp-1 protein|mesh-list
25613790|NCT01128894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25613791|NCT01128894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613792|NCT01128894|Incretins|incretins|mesh-ancestor
25613793|NCT01128894|Hormones|hormones|mesh-ancestor
25613794|NCT01128894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25613795|NCT01128959|Carbamazepine|carbamazepine|mesh-list
25613796|NCT01128959|Anticonvulsants|anticonvulsants|mesh-ancestor
25613797|NCT01128959|Antimanic Agents|antimanic agents|mesh-ancestor
25613798|NCT01128959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25613799|NCT01128959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25613800|NCT01128959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613801|NCT01128959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25613802|NCT01128959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25613803|NCT01128959|Analgesics|analgesics|mesh-ancestor
25613804|NCT01128959|Sensory System Agents|sensory system agents|mesh-ancestor
25613805|NCT01128959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25613806|NCT01128959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25613807|NCT01128959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25613808|NCT01128959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613809|NCT01128959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25613810|NCT01128959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25613811|NCT01128972|Listerine|listerine|mesh-list
25613812|NCT01128972|Fluorides|fluorides|mesh-list
25613813|NCT01128972|Sodium Fluoride|sodium fluoride|mesh-list
24533561|NCT00644449|Azithromycin|azithromycin|mesh-list
25613814|NCT01128972|Cariostatic Agents|cariostatic agents|mesh-ancestor
25613815|NCT01128972|Protective Agents|protective agents|mesh-ancestor
25613816|NCT01128972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613817|NCT01128972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25613818|NCT01128972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25655035|NCT01558063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655036|NCT01558089|Etanercept|etanercept|mesh-list
25655037|NCT01558089|Methotrexate|methotrexate|mesh-list
25655038|NCT01558089|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25655039|NCT01558089|Abortifacient Agents|abortifacient agents|mesh-ancestor
25655040|NCT01558089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25655041|NCT01558089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655042|NCT01558089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25655043|NCT01558089|Antimetabolites|antimetabolites|mesh-ancestor
25655044|NCT01558089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655045|NCT01558089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25655046|NCT01558089|Dermatologic Agents|dermatologic agents|mesh-ancestor
25655047|NCT01558089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655048|NCT01558089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25655049|NCT01558089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25655050|NCT01558089|Immunologic Factors|immunologic factors|mesh-ancestor
25655051|NCT01558089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25655052|NCT01558089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25655053|NCT01558089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25655054|NCT01558089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25655055|NCT01558089|Analgesics|analgesics|mesh-ancestor
25655056|NCT01558089|Sensory System Agents|sensory system agents|mesh-ancestor
25655057|NCT01558089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25655058|NCT01558089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25655059|NCT01558089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25655060|NCT01558128|Amiodarone|amiodarone|mesh-list
25655061|NCT01558128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25655062|NCT01558128|Vasodilator Agents|vasodilator agents|mesh-ancestor
25655063|NCT01558128|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25655064|NCT01558128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25655065|NCT01558128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655066|NCT01558128|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25655067|NCT01558128|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25655068|NCT01558128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25655069|NCT01558128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655070|NCT01558128|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25655071|NCT01558128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25655072|NCT01558128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25655073|NCT01558271|Liraglutide|liraglutide|mesh-list
25655074|NCT01558271|Dulaglutide|dulaglutide|mesh-list
25613819|NCT01129206|Deoxyglucose|deoxyglucose|mesh-list
25613820|NCT01129206|Docetaxel|docetaxel|mesh-list
25613821|NCT01129206|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25613822|NCT01129206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613823|NCT01129206|Tubulin Modulators|tubulin modulators|mesh-ancestor
25613824|NCT01129206|Antimitotic Agents|antimitotic agents|mesh-ancestor
25712351|NCT02318693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25712352|NCT02318693|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24533638|NCT00644696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24923343|NCT04171284|Docetaxel|docetaxel|mesh-list
25613825|NCT01129206|Mitosis Modulators|mitosis modulators|mesh-ancestor
25613826|NCT01129206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613827|NCT01129206|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25613828|NCT01129206|Antimetabolites|antimetabolites|mesh-ancestor
25613829|NCT01129206|Antiviral Agents|antiviral agents|mesh-ancestor
25613830|NCT01129206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25613831|NCT01129245|Celecoxib|celecoxib|mesh-list
25613832|NCT01129245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25613833|NCT01129245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25613834|NCT01129245|Analgesics|analgesics|mesh-ancestor
25613835|NCT01129245|Sensory System Agents|sensory system agents|mesh-ancestor
25613836|NCT01129245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25613837|NCT01129245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613838|NCT01129245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25613839|NCT01129245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25613840|NCT01129245|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25613841|NCT01129245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25613842|NCT01129245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25613843|NCT01129245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613844|NCT01129284|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25613845|NCT01129284|Hormones|hormones|mesh-ancestor
25613846|NCT01129284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25613847|NCT01129284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613848|NCT01129336|Zoledronic Acid|zoledronic acid|mesh-list
25613849|NCT01129336|Diphosphonates|diphosphonates|mesh-list
25613850|NCT01129336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25613851|NCT01129336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613852|NCT01129440|Fluorides|fluorides|mesh-list
25613853|NCT01129440|Fluorides, Topical|fluorides, topical|mesh-list
25613854|NCT01129440|Cariostatic Agents|cariostatic agents|mesh-ancestor
25613855|NCT01129440|Protective Agents|protective agents|mesh-ancestor
25613856|NCT01129440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613857|NCT01129557|Valsartan|valsartan|mesh-list
25613858|NCT01129557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25613859|NCT01129557|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25613860|NCT01129557|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25613861|NCT01129557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613862|NCT01129583|Botulinum Toxins|botulinum toxins|mesh-list
25613863|NCT01129583|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25613864|NCT01129583|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25613865|NCT01129583|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25613866|NCT01129583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25613867|NCT01129583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613868|NCT01129583|Cholinergic Agents|cholinergic agents|mesh-ancestor
25613869|NCT01129583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25613870|NCT01129583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613871|NCT01129583|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25613872|NCT01129583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25613873|NCT01129622|Letrozole|letrozole|mesh-list
25613874|NCT01129622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613875|NCT01129622|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25613876|NCT01129622|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25613877|NCT01129622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25613878|NCT01129622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613879|NCT01129622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25613880|NCT01129622|Hormone Antagonists|hormone antagonists|mesh-ancestor
25613881|NCT01129622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25613882|NCT01129622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613883|NCT01129778|Omeprazole|omeprazole|mesh-list
25613884|NCT01129778|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25613885|NCT01129778|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
25613886|NCT01129778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25613887|NCT01129778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25613888|NCT01129778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25613889|NCT01129778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613890|NCT01129882|Aripiprazole|aripiprazole|mesh-list
25613891|NCT01129882|Antidepressive Agents|antidepressive agents|mesh-ancestor
25613892|NCT01129882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25613893|NCT01129882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25613894|NCT01129882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25613895|NCT01129882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24450171|NCT00317876|Antimetabolites|antimetabolites|mesh-ancestor
25613896|NCT01129882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613897|NCT01129882|Dopamine Agonists|dopamine agonists|mesh-ancestor
25613898|NCT01129882|Dopamine Agents|dopamine agents|mesh-ancestor
25613899|NCT01129882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25613900|NCT01129882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613901|NCT01129882|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25613902|NCT01129882|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25613903|NCT01129882|Serotonin Agents|serotonin agents|mesh-ancestor
25613904|NCT01129882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25613905|NCT01129882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25613906|NCT01129882|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25613907|NCT01129882|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25613908|NCT01129960|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25613909|NCT01129960|Anticonvulsants|anticonvulsants|mesh-ancestor
25613910|NCT01129960|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25613911|NCT01129960|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25613912|NCT01129960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25613913|NCT01129960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613914|NCT01130051|Colchicine|colchicine|mesh-list
25613915|NCT01130051|Gout Suppressants|gout suppressants|mesh-ancestor
25613916|NCT01130051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25613917|NCT01130051|Tubulin Modulators|tubulin modulators|mesh-ancestor
25613918|NCT01130051|Antimitotic Agents|antimitotic agents|mesh-ancestor
25613919|NCT01130051|Mitosis Modulators|mitosis modulators|mesh-ancestor
25613920|NCT01130051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613921|NCT01130051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613922|NCT01130103|Paroxetine|paroxetine|mesh-list
25613923|NCT01130103|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25613924|NCT01130103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25613925|NCT01130103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25613926|NCT01130103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613927|NCT01130103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25613928|NCT01130103|Serotonin Agents|serotonin agents|mesh-ancestor
25613929|NCT01130103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613930|NCT01130103|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25613931|NCT01130103|Antidepressive Agents|antidepressive agents|mesh-ancestor
25613932|NCT01130103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25613933|NCT01130103|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25613934|NCT01130103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25613935|NCT01130103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25613936|NCT01130168|Amlodipine|amlodipine|mesh-list
25613937|NCT01130168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25613938|NCT01130168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25613939|NCT01130168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25613940|NCT01130168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613941|NCT01130168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25613942|NCT01130168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613943|NCT01130168|Vasodilator Agents|vasodilator agents|mesh-ancestor
25613944|NCT01130272|Eluxadoline|eluxadoline|mesh-list
25613945|NCT01130272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25613946|NCT01130337|Capecitabine|capecitabine|mesh-list
25613947|NCT01130337|Oxaliplatin|oxaliplatin|mesh-list
25613948|NCT01130337|Trastuzumab|trastuzumab|mesh-list
25613949|NCT01130337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25613950|NCT01130337|Antimetabolites|antimetabolites|mesh-ancestor
25613951|NCT01130337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613952|NCT01130337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25613953|NCT01130337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25613954|NCT01130493|Levodopa|levodopa|mesh-list
25613955|NCT01130493|Carbidopa|carbidopa|mesh-list
25613956|NCT01130493|Entacapone|entacapone|mesh-list
25613957|NCT01130493|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25613958|NCT01130493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25613959|NCT01130493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25613960|NCT01130493|Dopamine Agents|dopamine agents|mesh-ancestor
25613961|NCT01130493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25613962|NCT01130493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613963|NCT01130493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613964|NCT01130493|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25613965|NCT01130493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25613966|NCT01130493|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25613967|NCT01130493|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25613968|NCT01130493|Immunologic Factors|immunologic factors|mesh-ancestor
25613969|NCT01130493|Dopamine Agonists|dopamine agonists|mesh-ancestor
25613970|NCT01130532|Tadalafil|tadalafil|mesh-list
25613971|NCT01130532|Vasodilator Agents|vasodilator agents|mesh-ancestor
25613972|NCT01130532|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25613973|NCT01130532|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25613974|NCT01130532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25613975|NCT01130532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25613976|NCT01130532|Urological Agents|urological agents|mesh-ancestor
25613977|NCT01130597|Spironolactone|spironolactone|mesh-list
25613978|NCT01130597|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25613979|NCT01130597|Hormone Antagonists|hormone antagonists|mesh-ancestor
25613980|NCT01130597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25613981|NCT01130597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613982|NCT01130597|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25613983|NCT01130597|Diuretics|diuretics|mesh-ancestor
25613984|NCT01130597|Natriuretic Agents|natriuretic agents|mesh-ancestor
25613985|NCT01130844|Mesalamine|mesalamine|mesh-list
25613986|NCT01130844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25613987|NCT01130844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25613988|NCT01130844|Analgesics|analgesics|mesh-ancestor
25613989|NCT01130844|Sensory System Agents|sensory system agents|mesh-ancestor
25613990|NCT01130844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25613991|NCT01130844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25613992|NCT01130844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25613993|NCT01130844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25613994|NCT01131052|Insulin|insulin|mesh-list
25613995|NCT01131052|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25613996|NCT01131052|Insulin Glargine|insulin glargine|mesh-list
25613997|NCT01131052|Insulin glulisine|insulin glulisine|mesh-list
25613998|NCT01131052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25613999|NCT01131052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614000|NCT01131065|Immunoglobulins|immunoglobulins|mesh-list
25614001|NCT01131065|Antibodies|antibodies|mesh-list
25614002|NCT01131065|gamma-Globulins|gamma-globulins|mesh-list
25614003|NCT01131065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25614004|NCT01131065|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25614005|NCT01131065|Immunologic Factors|immunologic factors|mesh-ancestor
25614006|NCT01131065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614007|NCT01131078|Bevacizumab|bevacizumab|mesh-list
25614008|NCT01131078|Capecitabine|capecitabine|mesh-list
25614009|NCT01131078|Irinotecan|irinotecan|mesh-list
25614010|NCT01131078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25614011|NCT01131078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614012|NCT01131078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25614013|NCT01131078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25614014|NCT01131078|Growth Substances|growth substances|mesh-ancestor
25614015|NCT01131078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614016|NCT01131078|Growth Inhibitors|growth inhibitors|mesh-ancestor
25614017|NCT01131078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25614018|NCT01131078|Antimetabolites|antimetabolites|mesh-ancestor
25712370|NCT02319148|Verapamil|verapamil|mesh-list
25614019|NCT01131078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614020|NCT01131078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25614021|NCT01131078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25614022|NCT01131078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614023|NCT01131104|Sildenafil Citrate|sildenafil citrate|mesh-list
25614024|NCT01131104|Tadalafil|tadalafil|mesh-list
25614025|NCT01131104|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
25614026|NCT01131104|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
25614027|NCT01131104|Vasodilator Agents|vasodilator agents|mesh-ancestor
25614028|NCT01131104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25614029|NCT01131104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614030|NCT01131104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614031|NCT01131104|Urological Agents|urological agents|mesh-ancestor
25614032|NCT01131507|Pancrelipase|pancrelipase|mesh-list
25614033|NCT01131507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25614034|NCT01131585|Ranibizumab|ranibizumab|mesh-list
25614035|NCT01131585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25508677|NCT00375609|Protease Inhibitors|protease inhibitors|mesh-ancestor
25614036|NCT01131585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25614037|NCT01131585|Growth Substances|growth substances|mesh-ancestor
25655075|NCT01558271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25614038|NCT01131585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614039|NCT01131585|Growth Inhibitors|growth inhibitors|mesh-ancestor
25614040|NCT01131585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614041|NCT01131676|Empagliflozin|empagliflozin|mesh-list
25614042|NCT01131676|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25614043|NCT01131676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614044|NCT01131676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25614045|NCT01131676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614046|NCT01132118|Hydroxychloroquine|hydroxychloroquine|mesh-list
25614047|NCT01132118|Antimalarials|antimalarials|mesh-ancestor
25614048|NCT01132118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25614049|NCT01132118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25614050|NCT01132118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25614051|NCT01132118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614052|NCT01132118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614053|NCT01132118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25614054|NCT01132313|Ribavirin|ribavirin|mesh-list
25712378|NCT02319148|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25770858|NCT03570554|Antipyretics|antipyretics|mesh-ancestor
25614055|NCT01132313|Antimetabolites|antimetabolites|mesh-ancestor
25614056|NCT01132313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614057|NCT01132313|Antiviral Agents|antiviral agents|mesh-ancestor
25614058|NCT01132313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25614059|NCT01132326|Droxidopa|droxidopa|mesh-list
25614060|NCT01132326|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25614061|NCT01132326|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25614062|NCT01132482|Sildenafil Citrate|sildenafil citrate|mesh-list
25614063|NCT01132482|Vasodilator Agents|vasodilator agents|mesh-ancestor
25614064|NCT01132482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25508750|NCT00375973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25508751|NCT00375973|Antidepressive Agents|antidepressive agents|mesh-ancestor
25508752|NCT00375973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25508753|NCT00375973|Dopamine Agents|dopamine agents|mesh-ancestor
25508754|NCT00375999|Docetaxel|docetaxel|mesh-list
25508755|NCT00375999|Epirubicin|epirubicin|mesh-list
25508756|NCT00375999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508757|NCT00375999|Tubulin Modulators|tubulin modulators|mesh-ancestor
25508758|NCT00375999|Antimitotic Agents|antimitotic agents|mesh-ancestor
25508759|NCT00375999|Mitosis Modulators|mitosis modulators|mesh-ancestor
25508760|NCT00375999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508761|NCT00375999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25508762|NCT00375999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25508763|NCT00375999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25508764|NCT00375999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508765|NCT00376220|Riluzole|riluzole|mesh-list
25508766|NCT00376220|Anticonvulsants|anticonvulsants|mesh-ancestor
25508767|NCT00376220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25508768|NCT00376220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25508769|NCT00376220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25508770|NCT00376220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508771|NCT00376220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508772|NCT00376220|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25614065|NCT01132482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25614066|NCT01132482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712404|NCT02319369|Azacitidine|azacitidine|mesh-list
25614067|NCT01132482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614068|NCT01132482|Urological Agents|urological agents|mesh-ancestor
25614069|NCT01132547|Cyproheptadine|cyproheptadine|mesh-list
25614070|NCT01132547|Antipruritics|antipruritics|mesh-ancestor
25614071|NCT01132547|Dermatologic Agents|dermatologic agents|mesh-ancestor
25614072|NCT01132547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25614073|NCT01132547|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25614074|NCT01132547|Histamine Antagonists|histamine antagonists|mesh-ancestor
25614075|NCT01132547|Histamine Agents|histamine agents|mesh-ancestor
25614076|NCT01132547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25614077|NCT01132547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614078|NCT01132547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614079|NCT01132547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25614080|NCT01132547|Serotonin Agents|serotonin agents|mesh-ancestor
25614081|NCT01132547|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24503065|NCT03403569|Triptolide|triptolide|mesh-list
25614082|NCT01132664|Capecitabine|capecitabine|mesh-list
25614083|NCT01132664|Trastuzumab|trastuzumab|mesh-list
25614084|NCT01132664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25614085|NCT01132664|Antimetabolites|antimetabolites|mesh-ancestor
25614086|NCT01132664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614087|NCT01132664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614088|NCT01132664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25614090|NCT01132807|Cyclophosphamide|cyclophosphamide|mesh-list
25614091|NCT01132807|Dacarbazine|dacarbazine|mesh-list
25614092|NCT01132807|Doxorubicin|doxorubicin|mesh-list
25614093|NCT01132807|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25614094|NCT01132807|Etoposide|etoposide|mesh-list
25614095|NCT01132807|Bleomycin|bleomycin|mesh-list
25614096|NCT01132807|Vinblastine|vinblastine|mesh-list
25614097|NCT01132807|Etoposide phosphate|etoposide phosphate|mesh-list
25614098|NCT01132807|Procarbazine|procarbazine|mesh-list
25614099|NCT01132807|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25614100|NCT01132807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25614101|NCT01132807|Immunologic Factors|immunologic factors|mesh-ancestor
25614102|NCT01132807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614103|NCT01132807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25614104|NCT01132807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25614105|NCT01132807|Alkylating Agents|alkylating agents|mesh-ancestor
25712460|NCT02320695|Bacitracin|bacitracin|mesh-list
25614106|NCT01132807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614107|NCT01132807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614108|NCT01132807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25614109|NCT01132807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25614110|NCT01132807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25614111|NCT01132807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25614112|NCT01132807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614113|NCT01132807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25614114|NCT01132807|Glucocorticoids|glucocorticoids|mesh-ancestor
25614115|NCT01132807|Hormones|hormones|mesh-ancestor
25614116|NCT01132807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25614117|NCT01132807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25614118|NCT01132807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25614119|NCT01132807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25614120|NCT01132807|Tubulin Modulators|tubulin modulators|mesh-ancestor
25614121|NCT01132807|Antimitotic Agents|antimitotic agents|mesh-ancestor
25614122|NCT01132807|Mitosis Modulators|mitosis modulators|mesh-ancestor
25614123|NCT01132820|Cediranib|cediranib|mesh-list
25614124|NCT01132820|Maleic acid|maleic acid|mesh-list
25614125|NCT01132820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712471|NCT02320695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614126|NCT01132820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614127|NCT01132820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614128|NCT01132820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25614129|NCT01132846|Dopamine|dopamine|mesh-list
25614130|NCT01132846|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25614131|NCT01132846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25614132|NCT01132846|Sympathomimetics|sympathomimetics|mesh-ancestor
25614133|NCT01132846|Autonomic Agents|autonomic agents|mesh-ancestor
25614134|NCT01132846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25614135|NCT01132846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614136|NCT01132846|Dopamine Agents|dopamine agents|mesh-ancestor
25614137|NCT01132846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25614138|NCT01132846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614139|NCT01132846|Protective Agents|protective agents|mesh-ancestor
25614140|NCT01132846|Natriuretic Agents|natriuretic agents|mesh-ancestor
25614141|NCT01133158|Dexamethasone|dexamethasone|mesh-list
25614142|NCT01133158|Rituximab|rituximab|mesh-list
25614143|NCT01133158|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25614144|NCT01133158|Mitoxantrone|mitoxantrone|mesh-list
25614145|NCT01133158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25614146|NCT01133158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614147|NCT01133158|Immunologic Factors|immunologic factors|mesh-ancestor
25614148|NCT01133158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614149|NCT01133158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25614150|NCT01133158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25614151|NCT01133158|Antiemetics|antiemetics|mesh-ancestor
25614152|NCT01133158|Autonomic Agents|autonomic agents|mesh-ancestor
25614153|NCT01133158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25614154|NCT01133158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25614155|NCT01133158|Glucocorticoids|glucocorticoids|mesh-ancestor
25614156|NCT01133158|Hormones|hormones|mesh-ancestor
25614157|NCT01133158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25614158|NCT01133158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25614159|NCT01133158|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25614160|NCT01133158|Alkylating Agents|alkylating agents|mesh-ancestor
25508789|NCT00376675|Methylphenidate|methylphenidate|mesh-list
25508790|NCT00376675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25508791|NCT00376675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508792|NCT00376675|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25614161|NCT01133158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614162|NCT01133158|Analgesics|analgesics|mesh-ancestor
25614163|NCT01133158|Sensory System Agents|sensory system agents|mesh-ancestor
25614164|NCT01133158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25614165|NCT01133158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25614166|NCT01133158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614167|NCT01133275|Prednisone|prednisone|mesh-list
25614168|NCT01133275|Lenalidomide|lenalidomide|mesh-list
25614169|NCT01133275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25614170|NCT01133275|Glucocorticoids|glucocorticoids|mesh-ancestor
25614171|NCT01133275|Hormones|hormones|mesh-ancestor
25614172|NCT01133275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25614173|NCT01133275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614174|NCT01133275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25614175|NCT01133275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934785|NCT04058236|Polygeline|polygeline|mesh-list
25614176|NCT01133275|Immunologic Factors|immunologic factors|mesh-ancestor
25614177|NCT01133275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25614178|NCT01133275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25614179|NCT01133275|Growth Substances|growth substances|mesh-ancestor
25614180|NCT01133275|Growth Inhibitors|growth inhibitors|mesh-ancestor
25614181|NCT01133379|Fluorides|fluorides|mesh-list
25614182|NCT01133379|Cariostatic Agents|cariostatic agents|mesh-ancestor
25614183|NCT01133379|Protective Agents|protective agents|mesh-ancestor
25614184|NCT01133379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614185|NCT01133392|Insulin|insulin|mesh-list
25614186|NCT01133392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25614187|NCT01133392|Insulin Lispro|insulin lispro|mesh-list
25614188|NCT01133392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25614189|NCT01133392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614190|NCT01133522|Evolocumab|evolocumab|mesh-list
25614191|NCT01133522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25614192|NCT01133522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25614193|NCT01133522|Antimetabolites|antimetabolites|mesh-ancestor
25614194|NCT01133522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614195|NCT01133522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25614196|NCT01133626|Prednisone|prednisone|mesh-list
25614197|NCT01133626|Beclomethasone|beclomethasone|mesh-list
25614198|NCT01133626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25614199|NCT01133626|Glucocorticoids|glucocorticoids|mesh-ancestor
25614200|NCT01133626|Hormones|hormones|mesh-ancestor
25614201|NCT01133626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25614202|NCT01133626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614203|NCT01133626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25614204|NCT01133626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614205|NCT01133626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25614206|NCT01133626|Respiratory System Agents|respiratory system agents|mesh-ancestor
25614207|NCT01133665|Lenalidomide|lenalidomide|mesh-list
25614208|NCT01133665|Cetuximab|cetuximab|mesh-list
25614209|NCT01133665|Immunologic Factors|immunologic factors|mesh-ancestor
25614210|NCT01133665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614211|NCT01133665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25614212|NCT01133665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25614213|NCT01133665|Growth Substances|growth substances|mesh-ancestor
25614214|NCT01133665|Growth Inhibitors|growth inhibitors|mesh-ancestor
25614215|NCT01133665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614216|NCT01133665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25614217|NCT01133678|Paclitaxel|paclitaxel|mesh-list
24531180|NCT00634413|Budesonide|budesonide|mesh-list
24531194|NCT00634413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614218|NCT01133678|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25614219|NCT01133678|Cisplatin|cisplatin|mesh-list
25614220|NCT01133678|Cetuximab|cetuximab|mesh-list
25614221|NCT01133678|Everolimus|everolimus|mesh-list
25614222|NCT01133678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25614223|NCT01133678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614224|NCT01133678|Tubulin Modulators|tubulin modulators|mesh-ancestor
25614225|NCT01133678|Antimitotic Agents|antimitotic agents|mesh-ancestor
25614226|NCT01133678|Mitosis Modulators|mitosis modulators|mesh-ancestor
25712542|NCT02322216|Histamine Agents|histamine agents|mesh-ancestor
25614227|NCT01133678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614228|NCT01133678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25614229|NCT01133678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25614230|NCT01133678|Immunologic Factors|immunologic factors|mesh-ancestor
25614231|NCT01133678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614232|NCT01133756|Gemcitabine|gemcitabine|mesh-list
25614233|NCT01133756|Carboplatin|carboplatin|mesh-list
25614234|NCT01133756|Lenvatinib|lenvatinib|mesh-list
25614235|NCT01133756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614236|NCT01133756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25614237|NCT01133756|Antimetabolites|antimetabolites|mesh-ancestor
25614238|NCT01133756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614239|NCT01133756|Antiviral Agents|antiviral agents|mesh-ancestor
25614240|NCT01133756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25614241|NCT01133756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614242|NCT01133756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25614243|NCT01133756|Immunologic Factors|immunologic factors|mesh-ancestor
25614244|NCT01133756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614245|NCT01133756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25614246|NCT01133821|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25712566|NCT02322281|Pemetrexed|pemetrexed|mesh-list
25614247|NCT01133821|Antidepressive Agents|antidepressive agents|mesh-ancestor
25614248|NCT01133821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25614249|NCT01133821|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25614250|NCT01133821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25614251|NCT01133821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25614252|NCT01133821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614253|NCT01133847|Guanfacine|guanfacine|mesh-list
25614254|NCT01133847|Methylphenidate|methylphenidate|mesh-list
25614255|NCT01133847|Amphetamine|amphetamine|mesh-list
25614256|NCT01133847|Adderall|adderall|mesh-list
25614257|NCT01133847|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25614258|NCT01133847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24532966|NCT00641810|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25614259|NCT01133847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614260|NCT01133847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25614261|NCT01133847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25614262|NCT01133847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25614263|NCT01133847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614264|NCT01133847|Dopamine Agents|dopamine agents|mesh-ancestor
25614265|NCT01133847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25614266|NCT01133847|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25614267|NCT01133847|Adrenergic Agents|adrenergic agents|mesh-ancestor
25614268|NCT01133847|Sympathomimetics|sympathomimetics|mesh-ancestor
25614269|NCT01133847|Autonomic Agents|autonomic agents|mesh-ancestor
25614270|NCT01133847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25614271|NCT01133847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25614272|NCT01133847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25614273|NCT01133847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25614274|NCT01133847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25614275|NCT01133977|Lenvatinib|lenvatinib|mesh-list
25614276|NCT01133977|Dacarbazine|dacarbazine|mesh-list
25614277|NCT01133977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614278|NCT01133977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25614279|NCT01133977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614280|NCT01133977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614281|NCT01133977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25614282|NCT01133977|Alkylating Agents|alkylating agents|mesh-ancestor
25614283|NCT01134042|Fluticasone|fluticasone|mesh-list
25614284|NCT01134042|Xhance|xhance|mesh-list
25614285|NCT01134042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25614286|NCT01134042|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25614287|NCT01134042|Autonomic Agents|autonomic agents|mesh-ancestor
25614288|NCT01134042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25614289|NCT01134042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614290|NCT01134042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25614291|NCT01134042|Respiratory System Agents|respiratory system agents|mesh-ancestor
25614292|NCT01134042|Dermatologic Agents|dermatologic agents|mesh-ancestor
25614293|NCT01134042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25614294|NCT01134055|Ranibizumab|ranibizumab|mesh-list
25614295|NCT01134055|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25614296|NCT01134055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25614297|NCT01134055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25614298|NCT01134055|Growth Substances|growth substances|mesh-ancestor
25614299|NCT01134055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614300|NCT01134055|Growth Inhibitors|growth inhibitors|mesh-ancestor
25614301|NCT01134055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614302|NCT01134055|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25614303|NCT01134107|Insulin|insulin|mesh-list
25614304|NCT01134107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25614305|NCT01134107|Insulin Aspart|insulin aspart|mesh-list
25614306|NCT01134107|Insulin Lispro|insulin lispro|mesh-list
25614307|NCT01134107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25614308|NCT01134107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614309|NCT01134198|Mifepristone|mifepristone|mesh-list
25614310|NCT01134198|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25614311|NCT01134198|Abortifacient Agents|abortifacient agents|mesh-ancestor
25614312|NCT01134198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25508935|NCT00377403|Expectorants|expectorants|mesh-ancestor
25614313|NCT01134198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614314|NCT01134198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24670721|NCT01998971|Melphalan|melphalan|mesh-list
25614315|NCT01134198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25614316|NCT01134198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25614317|NCT01134198|Contraceptive Agents|contraceptive agents|mesh-ancestor
25614318|NCT01134198|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25614319|NCT01134198|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25614320|NCT01134198|Hormone Antagonists|hormone antagonists|mesh-ancestor
25614321|NCT01134198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25614322|NCT01134198|Luteolytic Agents|luteolytic agents|mesh-ancestor
25614323|NCT01134198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25614324|NCT01134198|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25614325|NCT01134263|Vaccines|vaccines|mesh-list
25614326|NCT01134263|Immunologic Factors|immunologic factors|mesh-ancestor
25614327|NCT01134263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614328|NCT01134315|Calcitriol|calcitriol|mesh-list
25614329|NCT01134315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25614330|NCT01134315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614331|NCT01134315|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25614332|NCT01134315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25614333|NCT01134315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614334|NCT01134315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25614335|NCT01134315|Vitamins|vitamins|mesh-ancestor
25614336|NCT01134315|Micronutrients|micronutrients|mesh-ancestor
25614337|NCT01134315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25614338|NCT01134393|Amlodipine|amlodipine|mesh-list
25614339|NCT01134393|Telmisartan|telmisartan|mesh-list
25614340|NCT01134393|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
25614341|NCT01134393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25614342|NCT01134393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25614343|NCT01134393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25614344|NCT01134393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614345|NCT01134393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25614346|NCT01134393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533321|NCT00643136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24533322|NCT00643136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533323|NCT00643136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24456631|NCT00331825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24456632|NCT00331825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25712605|NCT02322788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25712606|NCT02322788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25712607|NCT02322788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25712608|NCT02322788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25712609|NCT02322788|Adrenergic Agents|adrenergic agents|mesh-ancestor
25712610|NCT02322788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25712611|NCT02322788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712612|NCT02322814|Paclitaxel|paclitaxel|mesh-list
25712613|NCT02322814|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25712614|NCT02322814|Atezolizumab|atezolizumab|mesh-list
25712615|NCT02322814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25614347|NCT01134393|Vasodilator Agents|vasodilator agents|mesh-ancestor
25614348|NCT01134393|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25614349|NCT01134393|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25614350|NCT01134510|Complement C1s|complement c1s|mesh-list
25614351|NCT01134510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25614352|NCT01134510|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
25614353|NCT01134510|Immunologic Factors|immunologic factors|mesh-ancestor
25614354|NCT01134510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614355|NCT01134510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25614356|NCT01134510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25614357|NCT01129011|Naproxen|naproxen|mesh-list
25614358|NCT01129011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25614359|NCT01129011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25614360|NCT01129011|Analgesics|analgesics|mesh-ancestor
25614361|NCT01129011|Sensory System Agents|sensory system agents|mesh-ancestor
25614362|NCT01129011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25614363|NCT01129011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614364|NCT01129011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25614365|NCT01129011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25614366|NCT01129011|Gout Suppressants|gout suppressants|mesh-ancestor
25614367|NCT01129011|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25614368|NCT01129011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614369|NCT01129011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614370|NCT01134575|Rituximab|rituximab|mesh-list
25614371|NCT01134575|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25614372|NCT01134575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25614373|NCT01134575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614374|NCT01134575|Immunologic Factors|immunologic factors|mesh-ancestor
25614375|NCT01134575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614376|NCT01134575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25614377|NCT01134575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25614378|NCT01134627|Minocycline|minocycline|mesh-list
25614379|NCT01134627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25614380|NCT01134627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25655076|NCT01558271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655077|NCT01558271|Incretins|incretins|mesh-ancestor
25655078|NCT01558271|Hormones|hormones|mesh-ancestor
25508987|NCT00377741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25614381|NCT01134705|Beclomethasone|beclomethasone|mesh-list
25614382|NCT01134705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25614383|NCT01134705|Glucocorticoids|glucocorticoids|mesh-ancestor
25614384|NCT01134705|Hormones|hormones|mesh-ancestor
25614385|NCT01134705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25614386|NCT01134705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614387|NCT01134705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25614388|NCT01134705|Respiratory System Agents|respiratory system agents|mesh-ancestor
25614389|NCT01134731|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25712616|NCT02322814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24533338|NCT00643227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533339|NCT00643227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24538338|NCT00658931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24415916|NCT00201422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415921|NCT00201435|Docetaxel|docetaxel|mesh-list
24399254|NCT00147186|Hylan|hylan|mesh-list
24446791|NCT00305903|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25712617|NCT02322814|Tubulin Modulators|tubulin modulators|mesh-ancestor
25712618|NCT02322814|Antimitotic Agents|antimitotic agents|mesh-ancestor
25712619|NCT02322814|Mitosis Modulators|mitosis modulators|mesh-ancestor
25614390|NCT01134731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25614391|NCT01134731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614392|NCT01134731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25614393|NCT01134731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25614394|NCT01134731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614395|NCT01134731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25614396|NCT01134731|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25614397|NCT01134731|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25614398|NCT01134731|Serotonin Agents|serotonin agents|mesh-ancestor
25614399|NCT01134731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25614400|NCT01134731|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25614401|NCT01134731|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25614402|NCT01134731|Dopamine Agents|dopamine agents|mesh-ancestor
25614403|NCT01134952|Mycophenolic Acid|mycophenolic acid|mesh-list
25614404|NCT01134952|Sirolimus|sirolimus|mesh-list
25614405|NCT01134952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25614406|NCT01134952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614407|NCT01134952|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25614408|NCT01134952|Antitubercular Agents|antitubercular agents|mesh-ancestor
24455502|NCT00327587|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24455503|NCT00327587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24456672|NCT00331981|Amisulpride|amisulpride|mesh-list
25614409|NCT01134952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25614410|NCT01134952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25614411|NCT01134952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614412|NCT01134952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614413|NCT01134952|Antifungal Agents|antifungal agents|mesh-ancestor
25614414|NCT01134952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25614415|NCT01134952|Immunologic Factors|immunologic factors|mesh-ancestor
25614416|NCT01134952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614417|NCT01135017|Dronedarone|dronedarone|mesh-list
25614418|NCT01135017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25614419|NCT01135069|Tretinoin|tretinoin|mesh-list
25614420|NCT01135069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614421|NCT01135069|Keratolytic Agents|keratolytic agents|mesh-ancestor
25614422|NCT01135069|Dermatologic Agents|dermatologic agents|mesh-ancestor
25614423|NCT01135186|Verapamil|verapamil|mesh-list
25614424|NCT01135186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25614425|NCT01135186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25614426|NCT01135186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25614427|NCT01135186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614428|NCT01135186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25614429|NCT01135186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614430|NCT01135186|Vasodilator Agents|vasodilator agents|mesh-ancestor
25614431|NCT01135329|Mycophenolic Acid|mycophenolic acid|mesh-list
25614432|NCT01135329|Cyclophosphamide|cyclophosphamide|mesh-list
25614433|NCT01135329|Busulfan|busulfan|mesh-list
25614434|NCT01135329|Fludarabine|fludarabine|mesh-list
25614435|NCT01135329|Tacrolimus|tacrolimus|mesh-list
25614436|NCT01135329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25614437|NCT01135329|Immunologic Factors|immunologic factors|mesh-ancestor
25614438|NCT01135329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614439|NCT01135329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25614440|NCT01135329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25614441|NCT01135329|Alkylating Agents|alkylating agents|mesh-ancestor
25614442|NCT01135329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455630|NCT00328367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24455638|NCT00328367|Serotonin Agents|serotonin agents|mesh-ancestor
24455639|NCT00328367|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24456692|NCT00332020|Antithrombins|antithrombins|mesh-ancestor
24455733|NCT00328809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24455734|NCT00328809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614443|NCT01135329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614444|NCT01135329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25614445|NCT01135329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25614446|NCT01135329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614447|NCT01135329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25614448|NCT01135329|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25614449|NCT01135329|Antitubercular Agents|antitubercular agents|mesh-ancestor
25614450|NCT01135329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25614451|NCT01135329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25614452|NCT01135368|Lansoprazole|lansoprazole|mesh-list
25614453|NCT01135368|Dexlansoprazole|dexlansoprazole|mesh-list
25614454|NCT01135368|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25614455|NCT01135368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25614456|NCT01135368|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25614457|NCT01135368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614458|NCT01135368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614459|NCT01135394|Pioglitazone|pioglitazone|mesh-list
25614460|NCT01135394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25614461|NCT01135394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614462|NCT01135498|Bevacizumab|bevacizumab|mesh-list
25614463|NCT01135498|Capecitabine|capecitabine|mesh-list
25614464|NCT01135498|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25614465|NCT01135498|Oxaliplatin|oxaliplatin|mesh-list
25614466|NCT01135498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25614467|NCT01135498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614468|NCT01135498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25614469|NCT01135498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25614470|NCT01135498|Growth Substances|growth substances|mesh-ancestor
25614471|NCT01135498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614472|NCT01135498|Growth Inhibitors|growth inhibitors|mesh-ancestor
25614473|NCT01135498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25614474|NCT01135498|Antimetabolites|antimetabolites|mesh-ancestor
25614475|NCT01135498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614476|NCT01135498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25614477|NCT01135498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614478|NCT01135511|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25614479|NCT01135511|Tofacitinib|tofacitinib|mesh-list
25614480|NCT01135511|Hyaluronic Acid|hyaluronic acid|mesh-list
25614481|NCT01135511|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25614482|NCT01135511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25614483|NCT01135511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712638|NCT02323048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712639|NCT02323048|Adrenergic Agents|adrenergic agents|mesh-ancestor
24456006|NCT00329511|Adrenergic Agents|adrenergic agents|mesh-ancestor
25614484|NCT01135511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614485|NCT01135511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25614486|NCT01135511|Immunologic Factors|immunologic factors|mesh-ancestor
25614487|NCT01135511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614488|NCT01135511|Viscosupplements|viscosupplements|mesh-ancestor
25614489|NCT01135511|Protective Agents|protective agents|mesh-ancestor
25614490|NCT01135524|Buprenorphine|buprenorphine|mesh-list
25614491|NCT01135524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25614492|NCT01135524|Narcotics|narcotics|mesh-ancestor
25614493|NCT01135524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25614494|NCT01135524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614495|NCT01135524|Analgesics|analgesics|mesh-ancestor
25614496|NCT01135524|Sensory System Agents|sensory system agents|mesh-ancestor
25614497|NCT01135524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25614498|NCT01135524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25614499|NCT01135537|Thymoglobulin|thymoglobulin|mesh-list
25614500|NCT01135537|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25614501|NCT01135537|Immunologic Factors|immunologic factors|mesh-ancestor
25712650|NCT02323217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25712651|NCT02323217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712652|NCT02323217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712653|NCT02323217|Antidepressive Agents|antidepressive agents|mesh-ancestor
25712654|NCT02323217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25712655|NCT02323217|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25770867|NCT03571516|Teduglutide|teduglutide|mesh-list
25770868|NCT03571516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25770869|NCT03571516|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24456235|NCT00330772|Aspirin|aspirin|mesh-list
24456236|NCT00330772|Clopidogrel|clopidogrel|mesh-list
24456238|NCT00330772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24456250|NCT00330772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456252|NCT00330772|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25614502|NCT01135537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614503|NCT01135537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25614504|NCT01135914|Ranibizumab|ranibizumab|mesh-list
25614505|NCT01135914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25614506|NCT01135914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25614507|NCT01135914|Growth Substances|growth substances|mesh-ancestor
25614508|NCT01135914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614509|NCT01135914|Growth Inhibitors|growth inhibitors|mesh-ancestor
25614510|NCT01135914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614511|NCT01135992|Insulin|insulin|mesh-list
25614512|NCT01135992|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25614513|NCT01135992|Insulin Glargine|insulin glargine|mesh-list
25614514|NCT01135992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25614515|NCT01135992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614516|NCT01136174|Nintedanib|nintedanib|mesh-list
25614517|NCT01136174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614518|NCT01136174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25614519|NCT01136174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614520|NCT01136174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614521|NCT01136226|Leuprolide|leuprolide|mesh-list
25614522|NCT01136226|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25614523|NCT01136226|Fertility Agents|fertility agents|mesh-ancestor
25614524|NCT01136226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25614525|NCT01136226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614526|NCT01136226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25614527|NCT01136226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614528|NCT01136356|Morphine|morphine|mesh-list
25614529|NCT01136356|Buprenorphine|buprenorphine|mesh-list
25614530|NCT01136356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25614531|NCT01136356|Narcotics|narcotics|mesh-ancestor
25614532|NCT01136356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25614533|NCT01136356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614534|NCT01136356|Analgesics|analgesics|mesh-ancestor
25614535|NCT01136356|Sensory System Agents|sensory system agents|mesh-ancestor
25614536|NCT01136356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25614537|NCT01136356|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24456750|NCT00332124|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24456751|NCT00332124|Antimetabolites|antimetabolites|mesh-ancestor
24456755|NCT00332124|Nootropic Agents|nootropic agents|mesh-ancestor
24538126|NCT00657527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24538127|NCT00657527|Antimetabolites|antimetabolites|mesh-ancestor
24538128|NCT00657527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538129|NCT00657527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24538130|NCT00657527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24538131|NCT00657527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538267|NCT00658255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614538|NCT01136382|Budesonide|budesonide|mesh-list
25614539|NCT01136382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25614540|NCT01136382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25614541|NCT01136382|Autonomic Agents|autonomic agents|mesh-ancestor
25614542|NCT01136382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25614543|NCT01136382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614544|NCT01136382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25614545|NCT01136382|Respiratory System Agents|respiratory system agents|mesh-ancestor
25614546|NCT01136382|Glucocorticoids|glucocorticoids|mesh-ancestor
25614547|NCT01136382|Hormones|hormones|mesh-ancestor
25614548|NCT01136382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25614549|NCT01136408|Warfarin|warfarin|mesh-list
25614550|NCT01136408|Dabigatran|dabigatran|mesh-list
25614551|NCT01136408|Anticoagulants|anticoagulants|mesh-ancestor
25614552|NCT01136408|Antithrombins|antithrombins|mesh-ancestor
25614553|NCT01136408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25614554|NCT01136408|Protease Inhibitors|protease inhibitors|mesh-ancestor
25614555|NCT01136408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614556|NCT01136408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614557|NCT01136655|Budesonide|budesonide|mesh-list
25614558|NCT01136655|Formoterol Fumarate|formoterol fumarate|mesh-list
25614559|NCT01136655|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25614560|NCT01136655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25614561|NCT01136655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25614562|NCT01136655|Autonomic Agents|autonomic agents|mesh-ancestor
25614563|NCT01136655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25614564|NCT01136655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614565|NCT01136655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25614566|NCT01136655|Respiratory System Agents|respiratory system agents|mesh-ancestor
25614567|NCT01136655|Glucocorticoids|glucocorticoids|mesh-ancestor
25614568|NCT01136655|Hormones|hormones|mesh-ancestor
25499146|NCT00743197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538356|NCT00658970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538357|NCT00658970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538358|NCT00659022|Bevacizumab|bevacizumab|mesh-list
24538359|NCT00659022|Capecitabine|capecitabine|mesh-list
25614569|NCT01136655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25614570|NCT01136655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25614571|NCT01136655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25614572|NCT01136655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25614573|NCT01136655|Adrenergic Agents|adrenergic agents|mesh-ancestor
25614574|NCT01136655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25614575|NCT01136655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614576|NCT01136733|Everolimus|everolimus|mesh-list
25614577|NCT01136733|Lenvatinib|lenvatinib|mesh-list
25614578|NCT01136733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614579|NCT01136733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25614580|NCT01136733|Immunologic Factors|immunologic factors|mesh-ancestor
25614581|NCT01136733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614582|NCT01136733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25614583|NCT01136733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614584|NCT01136733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614585|NCT01136746|Insulin|insulin|mesh-list
25614586|NCT01136746|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25614587|NCT01136746|Insulin Glargine|insulin glargine|mesh-list
25614588|NCT01136746|Insulin Lispro|insulin lispro|mesh-list
25614589|NCT01136746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25614590|NCT01136746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614591|NCT01136772|Haloperidol|haloperidol|mesh-list
25614592|NCT01136772|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25614593|NCT01136772|Haloperidol decanoate|haloperidol decanoate|mesh-list
25614594|NCT01136772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25614595|NCT01136772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25614596|NCT01136772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25614597|NCT01136772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614598|NCT01136772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25614599|NCT01136772|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25614600|NCT01136772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25614601|NCT01136772|Serotonin Agents|serotonin agents|mesh-ancestor
24539679|NCT00664963|Antifungal Agents|antifungal agents|mesh-ancestor
24539680|NCT00664963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24539769|NCT00665522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24539770|NCT00665522|Anesthetics, General|anesthetics, general|mesh-ancestor
24539822|NCT00665717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24539973|NCT00666068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539975|NCT00666107|Immunologic Factors|immunologic factors|mesh-ancestor
24539976|NCT00666107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539977|NCT00666159|Pimecrolimus|pimecrolimus|mesh-list
24539978|NCT00666159|Tacrolimus|tacrolimus|mesh-list
24418378|NCT00209495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25712666|NCT02323334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25712667|NCT02323334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712668|NCT02323334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25712669|NCT02324153|Riboflavin|riboflavin|mesh-list
25712670|NCT02324153|Vitamin B Complex|vitamin b complex|mesh-ancestor
25712671|NCT02324153|Vitamins|vitamins|mesh-ancestor
25712672|NCT02324153|Micronutrients|micronutrients|mesh-ancestor
25712673|NCT02324153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614602|NCT01136772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25614603|NCT01136772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614604|NCT01136772|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25614605|NCT01136772|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25509188|NCT00379574|Bortezomib|bortezomib|mesh-list
25614606|NCT01136772|Dopamine Agents|dopamine agents|mesh-ancestor
25614607|NCT01136772|Antiemetics|antiemetics|mesh-ancestor
25614608|NCT01136772|Autonomic Agents|autonomic agents|mesh-ancestor
25614609|NCT01136772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25614610|NCT01136772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25614611|NCT01136772|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25614612|NCT01136798|Exenatide|exenatide|mesh-list
25614613|NCT01136798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25614614|NCT01136798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614615|NCT01136798|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25614616|NCT01136798|Incretins|incretins|mesh-ancestor
25614617|NCT01136798|Hormones|hormones|mesh-ancestor
25614618|NCT01136798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25614619|NCT01136954|Zonisamide|zonisamide|mesh-list
25614620|NCT01136954|Anticonvulsants|anticonvulsants|mesh-ancestor
25614621|NCT01136954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25614622|NCT01136954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25614623|NCT01136954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614624|NCT01136954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25614625|NCT01136954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614626|NCT01137071|Antibodies|antibodies|mesh-list
25614627|NCT01137071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25614628|NCT01137071|Immunologic Factors|immunologic factors|mesh-ancestor
25614629|NCT01137071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614630|NCT01137292|Voriconazole|voriconazole|mesh-list
25614631|NCT01137292|Antifungal Agents|antifungal agents|mesh-ancestor
25614632|NCT01137292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25614633|NCT01137292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25614634|NCT01137292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25614635|NCT01137292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614636|NCT01137292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614637|NCT01137292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25614638|NCT01137292|Hormone Antagonists|hormone antagonists|mesh-ancestor
25614639|NCT01137292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25614640|NCT01137292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614641|NCT01137292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25614642|NCT01137396|Modafinil|modafinil|mesh-list
25614643|NCT01137396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25614644|NCT01137396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614645|NCT01137396|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25614646|NCT01137396|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25614647|NCT01137396|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25614648|NCT01137396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614649|NCT01137474|Dapagliflozin|dapagliflozin|mesh-list
25614650|NCT01137474|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25614651|NCT01137474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614652|NCT01137474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25614653|NCT01137474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614654|NCT01137682|Octreotide|octreotide|mesh-list
25712682|NCT02324270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25712683|NCT02324270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712684|NCT02324270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25712685|NCT02324270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25712686|NCT02324270|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25712687|NCT02324270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547096|NCT00702416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24547097|NCT00702416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24547098|NCT00702416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24547099|NCT00702416|Anesthetics, General|anesthetics, general|mesh-ancestor
24547101|NCT00702416|Antipyretics|antipyretics|mesh-ancestor
24547142|NCT00702637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614655|NCT01137682|Lanreotide|lanreotide|mesh-list
25614656|NCT01137682|Pasireotide|pasireotide|mesh-list
25614657|NCT01137682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25614658|NCT01137682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25614659|NCT01137682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614660|NCT01137682|Hormones|hormones|mesh-ancestor
25614661|NCT01137682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25614662|NCT01137682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614663|NCT01137812|Metformin|metformin|mesh-list
25614664|NCT01137812|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25614665|NCT01137812|Canagliflozin|canagliflozin|mesh-list
25614666|NCT01137812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25614667|NCT01137812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614668|NCT01137812|Incretins|incretins|mesh-ancestor
25614669|NCT01137812|Hormones|hormones|mesh-ancestor
25614670|NCT01137812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25614671|NCT01137812|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25614672|NCT01137812|Protease Inhibitors|protease inhibitors|mesh-ancestor
25614673|NCT01137812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614674|NCT01137812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614675|NCT01137812|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25614676|NCT01137890|Zonisamide|zonisamide|mesh-list
25614677|NCT01137890|Cocaine|cocaine|mesh-list
25509274|NCT00379834|Timolol|timolol|mesh-list
25614678|NCT01137890|Anticonvulsants|anticonvulsants|mesh-ancestor
25614679|NCT01137890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25614680|NCT01137890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25614681|NCT01137890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614682|NCT01137890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25614683|NCT01137890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614684|NCT01137890|Anesthetics, Local|anesthetics, local|mesh-ancestor
25614685|NCT01137890|Anesthetics|anesthetics|mesh-ancestor
25614686|NCT01137890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25614687|NCT01137890|Sensory System Agents|sensory system agents|mesh-ancestor
25614688|NCT01137890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25614689|NCT01137890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25614690|NCT01137890|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25614691|NCT01137890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25614692|NCT01137890|Dopamine Agents|dopamine agents|mesh-ancestor
25614693|NCT01137890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25614694|NCT01138046|Paclitaxel|paclitaxel|mesh-list
25614695|NCT01138046|Lapatinib|lapatinib|mesh-list
25614696|NCT01138046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25614697|NCT01138046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614698|NCT01138046|Tubulin Modulators|tubulin modulators|mesh-ancestor
25712692|NCT02324543|Capecitabine|capecitabine|mesh-list
24516210|NCT00600990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449711|NCT00316745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24456779|NCT00332293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24456780|NCT00332293|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24456781|NCT00332293|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24456782|NCT00332293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24456783|NCT00332293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25712693|NCT02324543|Irinotecan|irinotecan|mesh-list
25712694|NCT02324543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712695|NCT02324543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25712696|NCT02324543|Antimetabolites|antimetabolites|mesh-ancestor
25712697|NCT02324543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614699|NCT01138046|Antimitotic Agents|antimitotic agents|mesh-ancestor
25614700|NCT01138046|Mitosis Modulators|mitosis modulators|mesh-ancestor
25614701|NCT01138046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614702|NCT01138046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25614703|NCT01138046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614704|NCT01138124|Gabapentin|gabapentin|mesh-list
25614705|NCT01138124|Analgesics|analgesics|mesh-ancestor
25614706|NCT01138124|Sensory System Agents|sensory system agents|mesh-ancestor
25614707|NCT01138124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25614708|NCT01138124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614709|NCT01138124|Anticonvulsants|anticonvulsants|mesh-ancestor
25614710|NCT01138124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25614711|NCT01138124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25614712|NCT01138124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25614713|NCT01138124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25614714|NCT01138124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25614715|NCT01138124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25614716|NCT01138124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25614717|NCT01138124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614718|NCT01138124|Antimanic Agents|antimanic agents|mesh-ancestor
25614719|NCT01138150|Naproxen|naproxen|mesh-list
25614720|NCT01138150|Sumatriptan|sumatriptan|mesh-list
25614721|NCT01138150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25614722|NCT01138150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25614723|NCT01138150|Analgesics|analgesics|mesh-ancestor
25614724|NCT01138150|Sensory System Agents|sensory system agents|mesh-ancestor
25614725|NCT01138150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25614726|NCT01138150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614727|NCT01138150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25614728|NCT01138150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25614729|NCT01138150|Gout Suppressants|gout suppressants|mesh-ancestor
25614730|NCT01138150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25614731|NCT01138150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614732|NCT01138150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614733|NCT01138150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25614734|NCT01138150|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25614735|NCT01138150|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25614736|NCT01138150|Serotonin Agents|serotonin agents|mesh-ancestor
25614737|NCT01138150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25614738|NCT01138475|Cholecalciferol|cholecalciferol|mesh-list
25614739|NCT01138475|Vitamin D|vitamin d|mesh-list
25614740|NCT01138475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25614741|NCT01138475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614742|NCT01138475|Vitamins|vitamins|mesh-ancestor
25614743|NCT01138475|Micronutrients|micronutrients|mesh-ancestor
24449760|NCT00316927|Fosfestrol|fosfestrol|mesh-list
24449761|NCT00316927|Diethylstilbestrol|diethylstilbestrol|mesh-list
25712700|NCT02324543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712701|NCT02324543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25712702|NCT02324543|Immunologic Factors|immunologic factors|mesh-ancestor
25712703|NCT02324543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712704|NCT02324543|Tubulin Modulators|tubulin modulators|mesh-ancestor
25712705|NCT02324543|Antimitotic Agents|antimitotic agents|mesh-ancestor
25712706|NCT02324543|Mitosis Modulators|mitosis modulators|mesh-ancestor
25712707|NCT02324543|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25614744|NCT01138475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25614745|NCT01138501|Factor VIII|factor viii|mesh-list
25614746|NCT01138501|Coagulants|coagulants|mesh-ancestor
25614747|NCT01138514|Clindamycin|clindamycin|mesh-list
25614748|NCT01138514|Clindamycin palmitate|clindamycin palmitate|mesh-list
25614749|NCT01138514|Clindamycin phosphate|clindamycin phosphate|mesh-list
25614750|NCT01138514|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25614751|NCT01138514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25614752|NCT01138514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25614753|NCT01138514|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25614754|NCT01138514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614755|NCT01138514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614756|NCT01138514|Dermatologic Agents|dermatologic agents|mesh-ancestor
25614757|NCT01138657|Prednisone|prednisone|mesh-list
25614758|NCT01138657|Adalimumab|adalimumab|mesh-list
25614759|NCT01138657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25614760|NCT01138657|Glucocorticoids|glucocorticoids|mesh-ancestor
25614761|NCT01138657|Hormones|hormones|mesh-ancestor
25614762|NCT01138657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25614763|NCT01138657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614764|NCT01138657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25614765|NCT01138657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614766|NCT01138657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25614767|NCT01138735|Adapalene|adapalene|mesh-list
25614768|NCT01138735|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
25614769|NCT01138735|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25614770|NCT01138735|Dermatologic Agents|dermatologic agents|mesh-ancestor
25712708|NCT02324543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25712709|NCT02324673|Cannabidiol|cannabidiol|mesh-list
25712710|NCT02324673|Anticonvulsants|anticonvulsants|mesh-ancestor
24456793|NCT00332293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24456794|NCT00332293|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24456795|NCT00332293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24456797|NCT00332306|Efavirenz|efavirenz|mesh-list
24456801|NCT00332306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24456802|NCT00332306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516468|NCT00602082|Antimetabolites|antimetabolites|mesh-ancestor
24420236|NCT00215410|Autonomic Agents|autonomic agents|mesh-ancestor
24449778|NCT00316927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24449779|NCT00316927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25712711|NCT02324699|Prednisone|prednisone|mesh-list
25712712|NCT02324699|Vedolizumab|vedolizumab|mesh-list
25712713|NCT02324699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25712714|NCT02324699|Glucocorticoids|glucocorticoids|mesh-ancestor
25712715|NCT02324699|Hormones|hormones|mesh-ancestor
25614771|NCT01138735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25614772|NCT01138735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25614773|NCT01138735|Analgesics|analgesics|mesh-ancestor
25614774|NCT01138735|Sensory System Agents|sensory system agents|mesh-ancestor
25614775|NCT01138735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25614776|NCT01138735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614777|NCT01138735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25614778|NCT01138735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25614779|NCT01138826|Amlodipine|amlodipine|mesh-list
25614780|NCT01138826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25614781|NCT01138826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25614782|NCT01138826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25614783|NCT01138826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614784|NCT01138826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25614785|NCT01138826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614786|NCT01138826|Vasodilator Agents|vasodilator agents|mesh-ancestor
25614787|NCT01138969|Esomeprazole|esomeprazole|mesh-list
25712716|NCT02324699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25712717|NCT02324699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712718|NCT02324699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25712719|NCT02324699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516580|NCT00602511|Thalidomide|thalidomide|mesh-list
24456807|NCT00332306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24456808|NCT00332306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24420590|NCT00216385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712720|NCT02324699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25712721|NCT02324842|Liraglutide|liraglutide|mesh-list
25712722|NCT02324842|Canagliflozin|canagliflozin|mesh-list
25712723|NCT02324842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25614788|NCT01138969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25614789|NCT01138969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25614790|NCT01138969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25614791|NCT01138969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614792|NCT01138969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614793|NCT01139190|Naproxen|naproxen|mesh-list
25614794|NCT01139190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25614795|NCT01139190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25614796|NCT01139190|Analgesics|analgesics|mesh-ancestor
25614797|NCT01139190|Sensory System Agents|sensory system agents|mesh-ancestor
25614798|NCT01139190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25614799|NCT01139190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614800|NCT01139190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25614801|NCT01139190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25614802|NCT01139190|Gout Suppressants|gout suppressants|mesh-ancestor
25614803|NCT01139190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25614804|NCT01139190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614805|NCT01139190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614806|NCT01139450|Tacrolimus|tacrolimus|mesh-list
25614807|NCT01139450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25614808|NCT01139450|Immunologic Factors|immunologic factors|mesh-ancestor
25614809|NCT01139450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614810|NCT01139450|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25614811|NCT01139450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614812|NCT01139450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614813|NCT01139515|Eletriptan|eletriptan|mesh-list
25614814|NCT01139515|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25614815|NCT01139515|Serotonin Agents|serotonin agents|mesh-ancestor
25614816|NCT01139515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25614817|NCT01139515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614818|NCT01139515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614819|NCT01139580|Calcipotriene|calcipotriene|mesh-list
25712724|NCT02324842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712725|NCT02324842|Incretins|incretins|mesh-ancestor
24420724|NCT00216645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420725|NCT00216658|Fentanyl|fentanyl|mesh-list
24420726|NCT00216658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24449843|NCT00317252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449844|NCT00317330|Rifampin|rifampin|mesh-list
24420815|NCT00216840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24420816|NCT00216840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420817|NCT00216840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24516755|NCT00603109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516756|NCT00603109|Hormones|hormones|mesh-ancestor
24516759|NCT00603135|Levetiracetam|levetiracetam|mesh-list
25712726|NCT02324842|Hormones|hormones|mesh-ancestor
25712727|NCT02324842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25712728|NCT02324842|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25712729|NCT02324842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712730|NCT02325219|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25614820|NCT01139580|Dermatologic Agents|dermatologic agents|mesh-ancestor
25614821|NCT01139762|Tadalafil|tadalafil|mesh-list
25614822|NCT01139762|Finasteride|finasteride|mesh-list
25614823|NCT01139762|Vasodilator Agents|vasodilator agents|mesh-ancestor
25614824|NCT01139762|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25614825|NCT01139762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25614826|NCT01139762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614827|NCT01139762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614828|NCT01139762|Urological Agents|urological agents|mesh-ancestor
25614829|NCT01139762|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25614830|NCT01139762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25614831|NCT01139762|Hormone Antagonists|hormone antagonists|mesh-ancestor
25614832|NCT01139762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25614833|NCT01139762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614834|NCT01139775|Cisplatin|cisplatin|mesh-list
25614835|NCT01139775|Pemetrexed|pemetrexed|mesh-list
25614836|NCT01139775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614837|NCT01139775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614838|NCT01139775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614839|NCT01139775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25614840|NCT01139775|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25614841|NCT01139801|Misoprostol|misoprostol|mesh-list
25614842|NCT01139801|Oxytocin|oxytocin|mesh-list
25614843|NCT01139801|Oxytocics|oxytocics|mesh-ancestor
25614844|NCT01139801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25614845|NCT01139801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614846|NCT01139801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25614847|NCT01139801|Abortifacient Agents|abortifacient agents|mesh-ancestor
25614848|NCT01139801|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25614849|NCT01139801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25614850|NCT01140061|MK 0873|mk 0873|mesh-list
25614851|NCT01140061|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25614852|NCT01140061|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25614853|NCT01140061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614854|NCT01140061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614855|NCT01140191|Gentamicins|gentamicins|mesh-list
25614856|NCT01140191|Paromomycin|paromomycin|mesh-list
25614857|NCT01140191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25614858|NCT01140191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25614859|NCT01140191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25614860|NCT01140191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614861|NCT01140191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614862|NCT01140191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25712731|NCT02325219|Immunologic Factors|immunologic factors|mesh-ancestor
25712732|NCT02325219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712733|NCT02325401|Metformin|metformin|mesh-list
25712734|NCT02325401|Cisplatin|cisplatin|mesh-list
24516763|NCT00603317|Clavulanic Acids|clavulanic acids|mesh-list
24420887|NCT00217178|Folic Acid|folic acid|mesh-list
24516764|NCT00603317|Clavulanic Acid|clavulanic acid|mesh-list
24516766|NCT00603317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25712735|NCT02325401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712736|NCT02325401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25712737|NCT02325401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712738|NCT02325414|Zoledronic Acid|zoledronic acid|mesh-list
25712739|NCT02325414|Diphosphonates|diphosphonates|mesh-list
25712740|NCT02325414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25614863|NCT01140191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25614864|NCT01140347|Ramucirumab|ramucirumab|mesh-list
25614865|NCT01140347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614866|NCT01140360|Imatinib Mesylate|imatinib mesylate|mesh-list
25614867|NCT01140360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614868|NCT01140360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25614869|NCT01140360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614870|NCT01140360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614871|NCT01140503|Apremilast|apremilast|mesh-list
25614872|NCT01140503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25614873|NCT01140503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25614874|NCT01140503|Analgesics|analgesics|mesh-ancestor
25614875|NCT01140503|Sensory System Agents|sensory system agents|mesh-ancestor
25614876|NCT01140503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25614877|NCT01140503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712741|NCT02325414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712742|NCT02325518|Timolol|timolol|mesh-list
25712743|NCT02325518|Dorzolamide|dorzolamide|mesh-list
24516798|NCT00603759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25712744|NCT02325518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25712745|NCT02325518|Maleic acid|maleic acid|mesh-list
25712746|NCT02325518|Brinzolamide|brinzolamide|mesh-list
25712747|NCT02325518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25712748|NCT02325518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25712749|NCT02325518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25712750|NCT02325518|Adrenergic Agents|adrenergic agents|mesh-ancestor
25614878|NCT01140503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25614879|NCT01140503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25614880|NCT01140503|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25614881|NCT01140503|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25614882|NCT01140503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614883|NCT01140503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614884|NCT01140880|Tenofovir|tenofovir|mesh-list
25614885|NCT01140880|Emtricitabine|emtricitabine|mesh-list
25614886|NCT01140880|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25614887|NCT01140880|Antiviral Agents|antiviral agents|mesh-ancestor
25614888|NCT01140880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25614889|NCT01140880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25614890|NCT01140880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25614891|NCT01140880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614892|NCT01140880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614893|NCT01140880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25614894|NCT01140880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25614895|NCT01140906|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25614896|NCT01140906|Vortioxetine|vortioxetine|mesh-list
25657022|NCT01582152|Growth Inhibitors|growth inhibitors|mesh-ancestor
25509466|NCT00381680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25509467|NCT00381680|Glucocorticoids|glucocorticoids|mesh-ancestor
25614897|NCT01140906|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25614898|NCT01140906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25614899|NCT01140906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25614900|NCT01140906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614901|NCT01140906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25614902|NCT01140906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614904|NCT01140906|Sensory System Agents|sensory system agents|mesh-ancestor
25614905|NCT01140906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25614906|NCT01140906|Antidepressive Agents|antidepressive agents|mesh-ancestor
25614907|NCT01140906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25712751|NCT02325518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24421235|NCT00218166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24421236|NCT00218166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24421237|NCT00218166|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24421238|NCT00218166|GABA Agents|gaba agents|mesh-ancestor
24421239|NCT00218166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24421240|NCT00218166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421241|NCT00218166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24516858|NCT00604253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24516859|NCT00604253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516860|NCT00604344|Insulin|insulin|mesh-list
25712752|NCT02325518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712753|NCT02325518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712754|NCT02325518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25712755|NCT02325518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25614908|NCT01140906|Dopamine Agents|dopamine agents|mesh-ancestor
25614909|NCT01140906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25614910|NCT01140906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25614911|NCT01140906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25614912|NCT01140906|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25614913|NCT01140906|Serotonin Agents|serotonin agents|mesh-ancestor
25614914|NCT01140906|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25614915|NCT01140906|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25614916|NCT01140906|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25614917|NCT01140906|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25614918|NCT01141049|Gabapentin|gabapentin|mesh-list
25614919|NCT01141049|Analgesics|analgesics|mesh-ancestor
25614920|NCT01141049|Sensory System Agents|sensory system agents|mesh-ancestor
25614921|NCT01141049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25614922|NCT01141049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614923|NCT01141049|Anticonvulsants|anticonvulsants|mesh-ancestor
25614924|NCT01141049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25614925|NCT01141049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25614926|NCT01141049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25614927|NCT01141049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25614928|NCT01141049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25614929|NCT01141049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25614930|NCT01141049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25614931|NCT01141049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614932|NCT01141049|Antimanic Agents|antimanic agents|mesh-ancestor
25614933|NCT01141283|Buprenorphine|buprenorphine|mesh-list
25614934|NCT01141283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25614935|NCT01141283|Narcotics|narcotics|mesh-ancestor
25614936|NCT01141283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25712765|NCT02325739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712766|NCT02326025|Doxorubicin|doxorubicin|mesh-list
24516917|NCT00604630|Hematinics|hematinics|mesh-ancestor
24516918|NCT00604656|Insulin Aspart|insulin aspart|mesh-list
25712767|NCT02326025|Olaratumab|olaratumab|mesh-list
25712768|NCT02326025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25712769|NCT02326025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614937|NCT01141283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614938|NCT01141283|Analgesics|analgesics|mesh-ancestor
25614939|NCT01141283|Sensory System Agents|sensory system agents|mesh-ancestor
25614940|NCT01141283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25614941|NCT01141283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25614942|NCT01141478|Sorafenib|sorafenib|mesh-list
25614943|NCT01141478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614944|NCT01141478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25614945|NCT01141478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614946|NCT01141478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614947|NCT01141491|Vaccines|vaccines|mesh-list
25614948|NCT01141491|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
25614949|NCT01141491|Immunologic Factors|immunologic factors|mesh-ancestor
25614950|NCT01141491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614951|NCT01141569|R04929097|r04929097|mesh-list
25614952|NCT01141569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614953|NCT01141569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655079|NCT01558271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25655080|NCT01558661|Axitinib|axitinib|mesh-list
25655081|NCT01558661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25655082|NCT01558661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25655083|NCT01558661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655084|NCT01558661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655085|NCT01558674|Torsemide|torsemide|mesh-list
25655086|NCT01558674|Furosemide|furosemide|mesh-list
25655087|NCT01558674|Diuretics|diuretics|mesh-ancestor
25655088|NCT01558674|Natriuretic Agents|natriuretic agents|mesh-ancestor
25655089|NCT01558674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655090|NCT01558674|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25655091|NCT01558674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25655092|NCT01558674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509533|NCT00381797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25614954|NCT01141595|Verapamil|verapamil|mesh-list
25614955|NCT01141595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25614956|NCT01141595|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25614957|NCT01141595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25614958|NCT01141595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614959|NCT01141595|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24517031|NCT00605683|Cabergoline|cabergoline|mesh-list
24517158|NCT00606268|Antifungal Agents|antifungal agents|mesh-ancestor
24456850|NCT00332397|Sirolimus|sirolimus|mesh-list
25614960|NCT01141595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614961|NCT01141595|Vasodilator Agents|vasodilator agents|mesh-ancestor
25614962|NCT01141725|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25614963|NCT01141725|Idarubicin|idarubicin|mesh-list
25614964|NCT01141725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25614965|NCT01141725|Alkylating Agents|alkylating agents|mesh-ancestor
25614966|NCT01141725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614967|NCT01141725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614968|NCT01141725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25614969|NCT01141725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25614970|NCT01141725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25614971|NCT01141725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25614972|NCT01142089|Rifamycins|rifamycins|mesh-list
25614973|NCT01142089|Rifamycin SV|rifamycin sv|mesh-list
25614974|NCT01142089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25614975|NCT01142089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25614976|NCT01142089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25614977|NCT01142193|Topiramate|topiramate|mesh-list
25614978|NCT01142193|Anticonvulsants|anticonvulsants|mesh-ancestor
25614979|NCT01142193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25614980|NCT01142193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614981|NCT01142232|Lenalidomide|lenalidomide|mesh-list
25614982|NCT01142232|Melphalan|melphalan|mesh-list
25614983|NCT01142232|Immunologic Factors|immunologic factors|mesh-ancestor
25614984|NCT01142232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25614985|NCT01142232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25614986|NCT01142232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25614987|NCT01142232|Growth Substances|growth substances|mesh-ancestor
25712770|NCT02326025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25712771|NCT02326025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25712772|NCT02326025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712773|NCT02326025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712774|NCT02326272|Certolizumab Pegol|certolizumab pegol|mesh-list
25712775|NCT02326272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24517276|NCT00607074|Albendazole|albendazole|mesh-list
24422091|NCT00221390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24422092|NCT00221390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422093|NCT00221390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24454869|NCT03412591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456857|NCT00332397|Immunologic Factors|immunologic factors|mesh-ancestor
24456858|NCT00332397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456859|NCT00332436|Timolol|timolol|mesh-list
24456860|NCT00332436|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25712776|NCT02326272|Immunologic Factors|immunologic factors|mesh-ancestor
25614988|NCT01142232|Growth Inhibitors|growth inhibitors|mesh-ancestor
25614989|NCT01142232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25614990|NCT01142232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25614991|NCT01142232|Alkylating Agents|alkylating agents|mesh-ancestor
25614992|NCT01142232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25614993|NCT01142232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25614994|NCT01142232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25614995|NCT01142310|Lamotrigine|lamotrigine|mesh-list
25614996|NCT01142310|Anticonvulsants|anticonvulsants|mesh-ancestor
25614997|NCT01142310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25614998|NCT01142310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25614999|NCT01142310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615000|NCT01142310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25615001|NCT01142310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615002|NCT01142310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25615003|NCT01142310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25615004|NCT01142310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25615005|NCT01142310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25615006|NCT01142310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25615007|NCT01142323|Fenofibrate|fenofibrate|mesh-list
25615008|NCT01142323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25615009|NCT01142323|Antimetabolites|antimetabolites|mesh-ancestor
25615010|NCT01142323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615011|NCT01142323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25615012|NCT01142336|Simvastatin|simvastatin|mesh-list
25615013|NCT01142336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25615014|NCT01142336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25615015|NCT01142336|Antimetabolites|antimetabolites|mesh-ancestor
25615016|NCT01142336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615017|NCT01142336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25615018|NCT01142336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25615019|NCT01142336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25615020|NCT01142466|Interferons|interferons|mesh-list
25615021|NCT01142466|Interferon-beta|interferon-beta|mesh-list
25615022|NCT01142466|Interferon beta-1a|interferon beta-1a|mesh-list
25615023|NCT01142466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25615024|NCT01142466|Antiviral Agents|antiviral agents|mesh-ancestor
25615025|NCT01142466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25615026|NCT01142466|Immunologic Factors|immunologic factors|mesh-ancestor
25509611|NCT00381862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25615027|NCT01142466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615028|NCT01142466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25615030|NCT01142726|Abatacept|abatacept|mesh-list
25712777|NCT02326272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712778|NCT02326272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24517358|NCT00607581|Dexamethasone|dexamethasone|mesh-list
25712779|NCT02326298|Certolizumab Pegol|certolizumab pegol|mesh-list
25712780|NCT02326298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25712781|NCT02326298|Immunologic Factors|immunologic factors|mesh-ancestor
25712782|NCT02326298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712783|NCT02326298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25712784|NCT02326467|Chlorhexidine|chlorhexidine|mesh-list
25712785|NCT02326467|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25615031|NCT01142726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25615032|NCT01142726|Abortifacient Agents|abortifacient agents|mesh-ancestor
25615033|NCT01142726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25615034|NCT01142726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615035|NCT01142726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25615036|NCT01142726|Antimetabolites|antimetabolites|mesh-ancestor
25615037|NCT01142726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615038|NCT01142726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25615039|NCT01142726|Dermatologic Agents|dermatologic agents|mesh-ancestor
25615040|NCT01142726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25615041|NCT01142726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25615042|NCT01142726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25615043|NCT01142726|Immunologic Factors|immunologic factors|mesh-ancestor
25615044|NCT01142726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25615045|NCT01142726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25615046|NCT01142726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25615047|NCT01142947|Beclomethasone|beclomethasone|mesh-list
25615048|NCT01142947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25615049|NCT01142947|Glucocorticoids|glucocorticoids|mesh-ancestor
25615050|NCT01142947|Hormones|hormones|mesh-ancestor
25615051|NCT01142947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25615052|NCT01142947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615053|NCT01142947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25615054|NCT01142947|Respiratory System Agents|respiratory system agents|mesh-ancestor
25615055|NCT01143051|Epinephrine|epinephrine|mesh-list
25615056|NCT01143051|Racepinephrine|racepinephrine|mesh-list
25615057|NCT01143051|Epinephryl borate|epinephryl borate|mesh-list
25615058|NCT01143051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25615059|NCT01143051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25615060|NCT01143051|Adrenergic Agents|adrenergic agents|mesh-ancestor
25615061|NCT01143051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25615062|NCT01143051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615063|NCT01143051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615064|NCT01143051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25615065|NCT01143051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25615066|NCT01143051|Autonomic Agents|autonomic agents|mesh-ancestor
25712786|NCT02326467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24517423|NCT00607932|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24422253|NCT00221754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456862|NCT00332436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24456863|NCT00332436|Adrenergic Agents|adrenergic agents|mesh-ancestor
24517480|NCT00608101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712787|NCT02326467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25712788|NCT02326467|Disinfectants|disinfectants|mesh-ancestor
25712789|NCT02326467|Dermatologic Agents|dermatologic agents|mesh-ancestor
25712790|NCT02326805|Metronidazole|metronidazole|mesh-list
25712791|NCT02326805|Vaccines|vaccines|mesh-list
25712792|NCT02326805|Immunologic Factors|immunologic factors|mesh-ancestor
24456865|NCT00332436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712793|NCT02326805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712794|NCT02326805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25615067|NCT01143051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25615068|NCT01143051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25615069|NCT01143051|Respiratory System Agents|respiratory system agents|mesh-ancestor
25615070|NCT01143051|Mydriatics|mydriatics|mesh-ancestor
25615071|NCT01143051|Sympathomimetics|sympathomimetics|mesh-ancestor
25615072|NCT01143051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25615073|NCT01143077|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25615074|NCT01143077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25615075|NCT01143077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25615076|NCT01143077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25615077|NCT01143077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615078|NCT01143077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25615079|NCT01143077|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25615080|NCT01143077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25615081|NCT01143077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25615082|NCT01143077|Adrenergic Agents|adrenergic agents|mesh-ancestor
25615083|NCT01143077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25615084|NCT01143077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615085|NCT01143077|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25615086|NCT01143077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25615087|NCT01143077|Serotonin Agents|serotonin agents|mesh-ancestor
25615088|NCT01143077|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25615089|NCT01143077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25615090|NCT01143077|Dopamine Agents|dopamine agents|mesh-ancestor
25615091|NCT01143090|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25615092|NCT01143090|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25615093|NCT01143090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25615094|NCT01143090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25615095|NCT01143090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615096|NCT01143090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25509677|NCT00382109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509678|NCT00382109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509679|NCT00382109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25615097|NCT01143090|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25615098|NCT01143090|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25615099|NCT01143090|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25615100|NCT01143090|Adrenergic Agents|adrenergic agents|mesh-ancestor
25615101|NCT01143090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25615102|NCT01143090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615103|NCT01143090|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25615104|NCT01143090|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25615105|NCT01143090|Serotonin Agents|serotonin agents|mesh-ancestor
24456866|NCT00332436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464473|NCT00365001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24465494|NCT00369863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24465495|NCT00369863|Immunologic Factors|immunologic factors|mesh-ancestor
24449940|NCT00317408|Antimitotic Agents|antimitotic agents|mesh-ancestor
24449941|NCT00317408|Mitosis Modulators|mitosis modulators|mesh-ancestor
24449943|NCT00317421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449944|NCT00317421|Vasodilator Agents|vasodilator agents|mesh-ancestor
24449945|NCT00317421|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25615106|NCT01143090|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25615107|NCT01143090|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25615108|NCT01143090|Dopamine Agents|dopamine agents|mesh-ancestor
25615109|NCT01143181|Brincidofovir|brincidofovir|mesh-list
25615110|NCT01143181|Antiviral Agents|antiviral agents|mesh-ancestor
25615111|NCT01143181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25615112|NCT01143207|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25615113|NCT01143207|Medroxyprogesterone|medroxyprogesterone|mesh-list
25615114|NCT01143207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25615115|NCT01143207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25615116|NCT01143207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25615117|NCT01143207|Contraceptive Agents|contraceptive agents|mesh-ancestor
25615118|NCT01143207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25615119|NCT01143207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615120|NCT01143207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25615121|NCT01143207|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25615122|NCT01143207|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25615123|NCT01143207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25615124|NCT01143207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25615125|NCT01143259|Alvimopan|alvimopan|mesh-list
25615126|NCT01143259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25615127|NCT01143337|Methotrexate|methotrexate|mesh-list
25615128|NCT01143337|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25615129|NCT01143337|Abortifacient Agents|abortifacient agents|mesh-ancestor
25615130|NCT01143337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25615131|NCT01143337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615132|NCT01143337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25615133|NCT01143337|Antimetabolites|antimetabolites|mesh-ancestor
25615134|NCT01143337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615135|NCT01143337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25615136|NCT01143337|Dermatologic Agents|dermatologic agents|mesh-ancestor
25615137|NCT01143337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25615138|NCT01143337|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25615139|NCT01143337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25615140|NCT01143337|Immunologic Factors|immunologic factors|mesh-ancestor
25615141|NCT01143337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25615142|NCT01143337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25615143|NCT01143389|Riboflavin|riboflavin|mesh-list
25615144|NCT01143389|Vitamin B Complex|vitamin b complex|mesh-ancestor
25615145|NCT01143389|Vitamins|vitamins|mesh-ancestor
25615146|NCT01143389|Micronutrients|micronutrients|mesh-ancestor
25615147|NCT01143389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615148|NCT01143389|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25615149|NCT01143389|Dermatologic Agents|dermatologic agents|mesh-ancestor
25615150|NCT01143402|Temozolomide|temozolomide|mesh-list
25615151|NCT01143402|Dacarbazine|dacarbazine|mesh-list
25615152|NCT01143402|Imidazole|imidazole|mesh-list
25615153|NCT01143402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25615154|NCT01143402|Alkylating Agents|alkylating agents|mesh-ancestor
25615155|NCT01143402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615156|NCT01143402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25615157|NCT01143402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25615158|NCT01143688|Albuterol|albuterol|mesh-list
25615159|NCT01143688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25615160|NCT01143688|Autonomic Agents|autonomic agents|mesh-ancestor
25615161|NCT01143688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25615162|NCT01143688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615163|NCT01143688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25615164|NCT01143688|Respiratory System Agents|respiratory system agents|mesh-ancestor
25615165|NCT01143688|Tocolytic Agents|tocolytic agents|mesh-ancestor
25615166|NCT01143688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25615167|NCT01143688|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25615168|NCT01143688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25615169|NCT01143688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25509748|NCT00382993|Naproxen|naproxen|mesh-list
25615170|NCT01143688|Adrenergic Agents|adrenergic agents|mesh-ancestor
25615171|NCT01143688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25615172|NCT01143688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615174|NCT01143714|Emollients|emollients|mesh-ancestor
25615175|NCT01143714|Dermatologic Agents|dermatologic agents|mesh-ancestor
25615176|NCT01143766|Gabapentin|gabapentin|mesh-list
25615177|NCT01143766|Analgesics|analgesics|mesh-ancestor
25615178|NCT01143766|Sensory System Agents|sensory system agents|mesh-ancestor
25615179|NCT01143766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25615180|NCT01143766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615181|NCT01143766|Anticonvulsants|anticonvulsants|mesh-ancestor
25615182|NCT01143766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25615183|NCT01143766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25615184|NCT01143766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25615185|NCT01143766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25615186|NCT01143766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25615187|NCT01143766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25615188|NCT01143766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25615189|NCT01143766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615190|NCT01143766|Antimanic Agents|antimanic agents|mesh-ancestor
25615191|NCT01143818|Methyltestosterone|methyltestosterone|mesh-list
25615192|NCT01143818|Testosterone|testosterone|mesh-list
25615193|NCT01143818|Testosterone undecanoate|testosterone undecanoate|mesh-list
25615194|NCT01143818|Testosterone enanthate|testosterone enanthate|mesh-list
25615195|NCT01143818|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25615196|NCT01143818|Androgens|androgens|mesh-ancestor
25615197|NCT01143818|Hormones|hormones|mesh-ancestor
25615198|NCT01143818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25615199|NCT01143818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615200|NCT01143818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25615201|NCT01143818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25615202|NCT01143818|Anabolic Agents|anabolic agents|mesh-ancestor
25615203|NCT01144052|Interferons|interferons|mesh-list
25615204|NCT01144052|Interferon-beta|interferon-beta|mesh-list
25615205|NCT01144052|Natalizumab|natalizumab|mesh-list
25615206|NCT01144052|Interferon beta-1b|interferon beta-1b|mesh-list
25615207|NCT01144052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25615208|NCT01144052|Antiviral Agents|antiviral agents|mesh-ancestor
25615209|NCT01144052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25615210|NCT01144052|Immunologic Factors|immunologic factors|mesh-ancestor
25615211|NCT01144052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615212|NCT01144052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25615213|NCT01144143|Methylprednisolone|methylprednisolone|mesh-list
25615214|NCT01144143|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25615215|NCT01144143|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25615216|NCT01144143|Prednisolone|prednisolone|mesh-list
25615217|NCT01144143|Prednisolone acetate|prednisolone acetate|mesh-list
25615218|NCT01144143|Infliximab|infliximab|mesh-list
25615219|NCT01144143|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25615220|NCT01144143|Prednisolone phosphate|prednisolone phosphate|mesh-list
25615221|NCT01144143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25615222|NCT01144143|Antiemetics|antiemetics|mesh-ancestor
25615223|NCT01144143|Autonomic Agents|autonomic agents|mesh-ancestor
25615224|NCT01144143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25615225|NCT01144143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615226|NCT01144143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25615227|NCT01144143|Glucocorticoids|glucocorticoids|mesh-ancestor
25615228|NCT01144143|Hormones|hormones|mesh-ancestor
25615229|NCT01144143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25615230|NCT01144143|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25615231|NCT01144143|Protective Agents|protective agents|mesh-ancestor
25615232|NCT01144143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25615233|NCT01144143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25615234|NCT01144143|Dermatologic Agents|dermatologic agents|mesh-ancestor
25615235|NCT01144143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25615236|NCT01144338|Exenatide|exenatide|mesh-list
25615237|NCT01144338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25615238|NCT01144338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615239|NCT01144338|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25615240|NCT01144338|Incretins|incretins|mesh-ancestor
25615241|NCT01144338|Hormones|hormones|mesh-ancestor
25615242|NCT01144338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25615243|NCT01144364|Rituximab|rituximab|mesh-list
25615244|NCT01144364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25615245|NCT01144364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25615246|NCT01144364|Immunologic Factors|immunologic factors|mesh-ancestor
25615247|NCT01144364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615248|NCT01144364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25615249|NCT01144403|Cyclophosphamide|cyclophosphamide|mesh-list
25615250|NCT01144403|Rituximab|rituximab|mesh-list
25615251|NCT01144403|Fludarabine|fludarabine|mesh-list
25615252|NCT01144403|Mitoxantrone|mitoxantrone|mesh-list
25615253|NCT01144403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25615254|NCT01144403|Immunologic Factors|immunologic factors|mesh-ancestor
25615255|NCT01144403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615256|NCT01144403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25615257|NCT01144403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25615258|NCT01144403|Alkylating Agents|alkylating agents|mesh-ancestor
25615259|NCT01144403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615260|NCT01144403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25615261|NCT01144403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25615262|NCT01144403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25615263|NCT01144403|Analgesics|analgesics|mesh-ancestor
25615264|NCT01144403|Sensory System Agents|sensory system agents|mesh-ancestor
25615265|NCT01144403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25615266|NCT01144403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25615267|NCT01144403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25615268|NCT01144403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25615269|NCT01144442|Paclitaxel|paclitaxel|mesh-list
25615270|NCT01144442|Carboplatin|carboplatin|mesh-list
25615271|NCT01144442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25615272|NCT01144442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25615273|NCT01144442|Tubulin Modulators|tubulin modulators|mesh-ancestor
25615274|NCT01144442|Antimitotic Agents|antimitotic agents|mesh-ancestor
25615275|NCT01144442|Mitosis Modulators|mitosis modulators|mesh-ancestor
25615276|NCT01144442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615277|NCT01144455|Gemcitabine|gemcitabine|mesh-list
25615278|NCT01144455|Phosphoramide Mustards|phosphoramide mustards|mesh-list
25615279|NCT01144455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25615280|NCT01144455|Antimetabolites|antimetabolites|mesh-ancestor
25615281|NCT01144455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615282|NCT01144455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25615283|NCT01144455|Antiviral Agents|antiviral agents|mesh-ancestor
25615284|NCT01144455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25615285|NCT01144455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25615286|NCT01144455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25615287|NCT01144455|Immunologic Factors|immunologic factors|mesh-ancestor
25615288|NCT01144455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615289|NCT01144455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25615290|NCT01144455|Alkylating Agents|alkylating agents|mesh-ancestor
25615291|NCT01144494|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25615292|NCT01144494|Lubricant Eye Drops|lubricant eye drops|mesh-list
25615293|NCT01144494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25615294|NCT01144494|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25615295|NCT01144494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25615296|NCT01144494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25615297|NCT01144494|Adrenergic Agents|adrenergic agents|mesh-ancestor
25615298|NCT01144494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25615299|NCT01144494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615300|NCT01144494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615301|NCT01144494|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25615302|NCT01144494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25615303|NCT01144949|Silodosin|silodosin|mesh-list
25615304|NCT01144949|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25615305|NCT01144949|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25615306|NCT01144949|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25615307|NCT01144949|Adrenergic Agents|adrenergic agents|mesh-ancestor
25615308|NCT01144949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25615309|NCT01144949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615310|NCT01144949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615311|NCT01144949|Urological Agents|urological agents|mesh-ancestor
25615312|NCT01145001|Nicotine|nicotine|mesh-list
25615313|NCT01145001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25615314|NCT01145001|Autonomic Agents|autonomic agents|mesh-ancestor
25615315|NCT01145001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25615316|NCT01145001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615317|NCT01145001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25615318|NCT01145001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25615319|NCT01145001|Cholinergic Agents|cholinergic agents|mesh-ancestor
25615320|NCT01145001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25657023|NCT01582243|Vildagliptin|vildagliptin|mesh-list
25615321|NCT01145001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456896|NCT00332553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24456897|NCT00332553|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24456898|NCT00332553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24423288|NCT00225290|Growth Inhibitors|growth inhibitors|mesh-ancestor
25615322|NCT01145066|Borage oil|borage oil|mesh-list
25615323|NCT01145066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25615324|NCT01145183|Doxazosin|doxazosin|mesh-list
25615325|NCT01145183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25615326|NCT01145183|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25615327|NCT01145183|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25615328|NCT01145183|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25615329|NCT01145183|Adrenergic Agents|adrenergic agents|mesh-ancestor
25615330|NCT01145183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25615331|NCT01145183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615332|NCT01145183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615333|NCT01145222|Midazolam|midazolam|mesh-list
25615334|NCT01145222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25615335|NCT01145222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25615336|NCT01145222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25615337|NCT01145222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615338|NCT01145222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25615339|NCT01145222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25615340|NCT01145222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25615341|NCT01145222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25615342|NCT01145222|Anesthetics, General|anesthetics, general|mesh-ancestor
25615343|NCT01145222|Anesthetics|anesthetics|mesh-ancestor
25615344|NCT01145222|GABA Modulators|gaba modulators|mesh-ancestor
25615345|NCT01145222|GABA Agents|gaba agents|mesh-ancestor
25615346|NCT01145222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25615347|NCT01145222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615348|NCT01145352|Etanercept|etanercept|mesh-list
25615349|NCT01145352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25615350|NCT01145352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25615351|NCT01145352|Analgesics|analgesics|mesh-ancestor
25615352|NCT01145352|Sensory System Agents|sensory system agents|mesh-ancestor
25615353|NCT01145352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25615354|NCT01145352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615355|NCT01145352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25615356|NCT01145352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25615357|NCT01145352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25615358|NCT01145352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25615359|NCT01145352|Immunologic Factors|immunologic factors|mesh-ancestor
25615360|NCT01145417|Pregabalin|pregabalin|mesh-list
25615361|NCT01145417|Analgesics|analgesics|mesh-ancestor
25615362|NCT01145417|Sensory System Agents|sensory system agents|mesh-ancestor
25615363|NCT01145417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25615364|NCT01145417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615365|NCT01145417|Anticonvulsants|anticonvulsants|mesh-ancestor
25615366|NCT01145417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25615367|NCT01145417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25615368|NCT01145417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615369|NCT01145417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25615370|NCT01145417|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25615371|NCT01145417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25615372|NCT01145417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25615373|NCT01145417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25615374|NCT01145482|Insulin|insulin|mesh-list
25615375|NCT01145482|Insulin Aspart|insulin aspart|mesh-list
25615376|NCT01145482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25615377|NCT01145482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615378|NCT01145508|Metronidazole|metronidazole|mesh-list
25615379|NCT01145508|Prednisone|prednisone|mesh-list
25615380|NCT01145508|Cortisone|cortisone|mesh-list
25615381|NCT01145508|Docetaxel|docetaxel|mesh-list
25615382|NCT01145508|Vaccines|vaccines|mesh-list
25615383|NCT01145508|Immunologic Factors|immunologic factors|mesh-ancestor
25615384|NCT01145508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615385|NCT01145508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25615386|NCT01145508|Tubulin Modulators|tubulin modulators|mesh-ancestor
25615387|NCT01145508|Antimitotic Agents|antimitotic agents|mesh-ancestor
25615388|NCT01145508|Mitosis Modulators|mitosis modulators|mesh-ancestor
25615389|NCT01145508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615390|NCT01145508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25615391|NCT01145508|Glucocorticoids|glucocorticoids|mesh-ancestor
25615392|NCT01145508|Hormones|hormones|mesh-ancestor
25615393|NCT01145508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25615394|NCT01145508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25615395|NCT01145508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25615396|NCT01145508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25615397|NCT01145508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25615398|NCT01145508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25615399|NCT01145625|Minoxidil|minoxidil|mesh-list
25615400|NCT01145625|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25615401|NCT01145625|Vasodilator Agents|vasodilator agents|mesh-ancestor
25615402|NCT01145638|Iron|iron|mesh-list
25615403|NCT01145638|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25615404|NCT01145638|Trace Elements|trace elements|mesh-ancestor
25615405|NCT01145638|Micronutrients|micronutrients|mesh-ancestor
25615406|NCT01145638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615407|NCT01145638|Hematinics|hematinics|mesh-ancestor
25615408|NCT01145755|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25615409|NCT01145755|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25615410|NCT01145755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25615411|NCT01145755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25615412|NCT01145755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615413|NCT01145755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25615414|NCT01145755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615415|NCT01145755|Analgesics|analgesics|mesh-ancestor
25615416|NCT01145755|Sensory System Agents|sensory system agents|mesh-ancestor
25615417|NCT01145755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25615418|NCT01145755|Antidepressive Agents|antidepressive agents|mesh-ancestor
25615419|NCT01145755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25615420|NCT01145755|Dopamine Agents|dopamine agents|mesh-ancestor
25615421|NCT01145898|Timolol|timolol|mesh-list
25615422|NCT01145898|Dorzolamide|dorzolamide|mesh-list
25615423|NCT01145898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25615424|NCT01145898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25615425|NCT01145898|Adrenergic Agents|adrenergic agents|mesh-ancestor
25615426|NCT01145898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25615427|NCT01145898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615428|NCT01145898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615429|NCT01145898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25615430|NCT01145898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25615431|NCT01145898|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25615432|NCT01145898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25615433|NCT01146054|Gemcitabine|gemcitabine|mesh-list
25615434|NCT01146054|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25615435|NCT01146054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25615436|NCT01146054|Antimetabolites|antimetabolites|mesh-ancestor
25615437|NCT01146054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615438|NCT01146054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25615439|NCT01146054|Antiviral Agents|antiviral agents|mesh-ancestor
25615440|NCT01146054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25615441|NCT01146054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25615442|NCT01146054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25615443|NCT01146054|Immunologic Factors|immunologic factors|mesh-ancestor
25615444|NCT01146054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615445|NCT01146054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25615446|NCT01146288|Furosemide|furosemide|mesh-list
25615447|NCT01146288|Acetazolamide|acetazolamide|mesh-list
24480360|NCT00430807|Hydroxychloroquine|hydroxychloroquine|mesh-list
25615448|NCT01146288|Diuretics|diuretics|mesh-ancestor
25615449|NCT01146288|Natriuretic Agents|natriuretic agents|mesh-ancestor
25615450|NCT01146288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615451|NCT01146288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25615452|NCT01146288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25615453|NCT01146288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615454|NCT01146288|Anticonvulsants|anticonvulsants|mesh-ancestor
25615455|NCT01146288|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25615456|NCT01146288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25615457|NCT01146457|Morphine|morphine|mesh-list
25615458|NCT01146457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25615459|NCT01146457|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25615460|NCT01146457|Narcotics|narcotics|mesh-ancestor
25615461|NCT01146457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25615462|NCT01146457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615463|NCT01146457|Analgesics|analgesics|mesh-ancestor
25615464|NCT01146457|Sensory System Agents|sensory system agents|mesh-ancestor
25615465|NCT01146457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25615466|NCT01146561|Tanezumab|tanezumab|mesh-list
25615467|NCT01146561|Analgesics|analgesics|mesh-ancestor
25615468|NCT01146561|Sensory System Agents|sensory system agents|mesh-ancestor
25615469|NCT01146561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25510020|NCT00384956|Azacitidine|azacitidine|mesh-list
25615470|NCT01146561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615471|NCT01146600|Clarithromycin|clarithromycin|mesh-list
25615472|NCT01146600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25615473|NCT01146600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25615474|NCT01146600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25615475|NCT01146600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25615476|NCT01146600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615477|NCT01146600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25615478|NCT01146600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25615479|NCT01146613|Varenicline|varenicline|mesh-list
25615480|NCT01146613|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25615481|NCT01146613|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25615482|NCT01146613|Cholinergic Agents|cholinergic agents|mesh-ancestor
25615483|NCT01146613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25615484|NCT01146613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615485|NCT01146613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615486|NCT01146795|Paclitaxel|paclitaxel|mesh-list
25615487|NCT01146795|Bevacizumab|bevacizumab|mesh-list
25615488|NCT01146795|Carboplatin|carboplatin|mesh-list
25615489|NCT01146795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25615490|NCT01146795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25615491|NCT01146795|Tubulin Modulators|tubulin modulators|mesh-ancestor
25615492|NCT01146795|Antimitotic Agents|antimitotic agents|mesh-ancestor
25615493|NCT01146795|Mitosis Modulators|mitosis modulators|mesh-ancestor
25615494|NCT01146795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615495|NCT01146795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25615496|NCT01146795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25615497|NCT01146795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25615498|NCT01146795|Growth Substances|growth substances|mesh-ancestor
25615499|NCT01146795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615500|NCT01146795|Growth Inhibitors|growth inhibitors|mesh-ancestor
25615501|NCT01146808|Adefovir|adefovir|mesh-list
25615502|NCT01146808|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25615503|NCT01146808|Antiviral Agents|antiviral agents|mesh-ancestor
25615504|NCT01146808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25615505|NCT01146808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25615506|NCT01146808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25615507|NCT01146808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25615508|NCT01146808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615509|NCT01146834|Plerixafor|plerixafor|mesh-list
25615510|NCT01146834|Cyclophosphamide|cyclophosphamide|mesh-list
25615511|NCT01146834|Bortezomib|bortezomib|mesh-list
25615512|NCT01146834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25615513|NCT01146834|Immunologic Factors|immunologic factors|mesh-ancestor
25615514|NCT01146834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615515|NCT01146834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25615516|NCT01146834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25615517|NCT01146834|Alkylating Agents|alkylating agents|mesh-ancestor
25615518|NCT01146834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615519|NCT01146834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25615520|NCT01146834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25615521|NCT01146834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25615522|NCT01146834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25615523|NCT01146834|Antiviral Agents|antiviral agents|mesh-ancestor
25615524|NCT01146834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25615525|NCT01146873|Ritonavir|ritonavir|mesh-list
25615526|NCT01146873|Lopinavir|lopinavir|mesh-list
25615527|NCT01146873|Abacavir|abacavir|mesh-list
25615528|NCT01146873|Stavudine|stavudine|mesh-list
25615529|NCT01146873|Efavirenz|efavirenz|mesh-list
25615530|NCT01146873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25615531|NCT01146873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25615532|NCT01146873|Protease Inhibitors|protease inhibitors|mesh-ancestor
25615533|NCT01146873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25615534|NCT01146873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615535|NCT01146873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25615536|NCT01146873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25615537|NCT01146873|Antiviral Agents|antiviral agents|mesh-ancestor
25615538|NCT01146873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25615539|NCT01146873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25615540|NCT01146873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25615541|NCT01146873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25615542|NCT01146873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25615543|NCT01146873|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25615544|NCT01146873|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25615545|NCT01146873|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25615546|NCT01146873|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25615547|NCT01146873|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25615548|NCT01146873|Antimetabolites|antimetabolites|mesh-ancestor
25615549|NCT01146951|Rufinamide|rufinamide|mesh-list
25615550|NCT01146951|Anticonvulsants|anticonvulsants|mesh-ancestor
25615551|NCT01146951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25615552|NCT01146951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25615553|NCT01146951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25615554|NCT01146951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655093|NCT01558674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25655094|NCT01558700|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25655095|NCT01558700|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25655096|NCT01558700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25655097|NCT01558700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25655098|NCT01558700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655099|NCT01558700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25655100|NCT01558700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655101|NCT01558700|Analgesics|analgesics|mesh-ancestor
25655102|NCT01558700|Sensory System Agents|sensory system agents|mesh-ancestor
25655103|NCT01558700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25655104|NCT01558700|Antidepressive Agents|antidepressive agents|mesh-ancestor
25655105|NCT01558700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25655106|NCT01558700|Dopamine Agents|dopamine agents|mesh-ancestor
25655107|NCT01559012|Clonidine|clonidine|mesh-list
25655108|NCT01559012|Analgesics|analgesics|mesh-ancestor
25655109|NCT01559012|Sensory System Agents|sensory system agents|mesh-ancestor
25655110|NCT01559012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25655111|NCT01559012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655112|NCT01559012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25655113|NCT01559012|Sympatholytics|sympatholytics|mesh-ancestor
25655114|NCT01559012|Autonomic Agents|autonomic agents|mesh-ancestor
25655115|NCT01559012|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25655116|NCT01559012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25655117|NCT01559012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25655118|NCT01559012|Adrenergic Agents|adrenergic agents|mesh-ancestor
25655119|NCT01559012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25655120|NCT01559012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655121|NCT01559064|Lidocaine|lidocaine|mesh-list
25655122|NCT01559064|Hyaluronic Acid|hyaluronic acid|mesh-list
25655123|NCT01559064|Anesthetics, Local|anesthetics, local|mesh-ancestor
25655124|NCT01559064|Anesthetics|anesthetics|mesh-ancestor
24499326|NCT00519012|Sertraline|sertraline|mesh-list
25655125|NCT01559064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25655126|NCT01559064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655127|NCT01559064|Sensory System Agents|sensory system agents|mesh-ancestor
25655128|NCT01559064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25655129|NCT01559064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25655130|NCT01559064|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25655131|NCT01559064|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25655132|NCT01559064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25655133|NCT01559064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655134|NCT01559064|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25655135|NCT01559064|Immunologic Factors|immunologic factors|mesh-ancestor
25655136|NCT01559064|Viscosupplements|viscosupplements|mesh-ancestor
25655137|NCT01559064|Protective Agents|protective agents|mesh-ancestor
25655138|NCT01559090|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25655139|NCT01559090|Immunologic Factors|immunologic factors|mesh-ancestor
25655140|NCT01559090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655141|NCT01559116|Tiotropium Bromide|tiotropium bromide|mesh-list
25655142|NCT01559116|Olodaterol|olodaterol|mesh-list
25655143|NCT01559116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25655144|NCT01559116|Autonomic Agents|autonomic agents|mesh-ancestor
25655145|NCT01559116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25655146|NCT01559116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655147|NCT01559116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25655148|NCT01559116|Respiratory System Agents|respiratory system agents|mesh-ancestor
25655149|NCT01559116|Parasympatholytics|parasympatholytics|mesh-ancestor
25655150|NCT01559116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25655151|NCT01559116|Cholinergic Agents|cholinergic agents|mesh-ancestor
25655152|NCT01559116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25655153|NCT01559116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655154|NCT01559129|Pomalidomide|pomalidomide|mesh-list
25655155|NCT01559129|Immunologic Factors|immunologic factors|mesh-ancestor
25510166|NCT00385788|Gemcitabine|gemcitabine|mesh-list
25615555|NCT01147055|Rifampin|rifampin|mesh-list
25615556|NCT01147055|Crizotinib|crizotinib|mesh-list
25615557|NCT01147055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25615558|NCT01147055|Antitubercular Agents|antitubercular agents|mesh-ancestor
25615559|NCT01147055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25615560|NCT01147055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25615561|NCT01147055|Leprostatic Agents|leprostatic agents|mesh-ancestor
25615562|NCT01147055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25615563|NCT01147055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25615564|NCT01147055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615565|NCT01147055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25615566|NCT01147055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25615567|NCT01147055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25615568|NCT01147055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25615569|NCT01147055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25615570|NCT01147055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25615571|NCT01147055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25615572|NCT01147055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25615573|NCT01147068|Hemagglutinins|hemagglutinins|mesh-list
25615574|NCT01147068|Agglutinins|agglutinins|mesh-ancestor
25615575|NCT01147068|Immunologic Factors|immunologic factors|mesh-ancestor
25615576|NCT01147068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615577|NCT01147107|Efavirenz|efavirenz|mesh-list
25615578|NCT01147107|Raltegravir Potassium|raltegravir potassium|mesh-list
25615579|NCT01147107|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25615580|NCT01147107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25615581|NCT01147107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25615582|NCT01147107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615583|NCT01147107|Antiviral Agents|antiviral agents|mesh-ancestor
25615584|NCT01147107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25615585|NCT01147107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25615586|NCT01147107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25615587|NCT01147107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24532892|NCT00641472|Hormones|hormones|mesh-ancestor
25615588|NCT01147107|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25615589|NCT01147107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25615590|NCT01147107|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25615591|NCT01147107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25615592|NCT01147107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25615593|NCT01147107|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25615594|NCT01147107|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25615595|NCT01147250|Lixisenatide|lixisenatide|mesh-list
25615596|NCT01147250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25615597|NCT01147250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615598|NCT01147302|Complement C1s|complement c1s|mesh-list
25615599|NCT01147302|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25615600|NCT01147302|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
25615601|NCT01147302|Immunologic Factors|immunologic factors|mesh-ancestor
25615602|NCT01147302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615603|NCT01147302|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25615604|NCT01147302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25615605|NCT01147341|Certolizumab Pegol|certolizumab pegol|mesh-list
25615606|NCT01147341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25615607|NCT01147341|Immunologic Factors|immunologic factors|mesh-ancestor
25615608|NCT01147341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615609|NCT01147341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25615610|NCT01147458|Naproxen|naproxen|mesh-list
25615611|NCT01147458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25615612|NCT01147458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25615613|NCT01147458|Analgesics|analgesics|mesh-ancestor
25615614|NCT01147458|Sensory System Agents|sensory system agents|mesh-ancestor
25615615|NCT01147458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25615616|NCT01147458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615617|NCT01147458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25615618|NCT01147458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25615619|NCT01147458|Gout Suppressants|gout suppressants|mesh-ancestor
25615620|NCT01147458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25615621|NCT01147458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25615622|NCT01147458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615623|NCT01147497|Misoprostol|misoprostol|mesh-list
25615624|NCT01147497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25615625|NCT01147497|Abortifacient Agents|abortifacient agents|mesh-ancestor
25615626|NCT01147497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25657024|NCT01582243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25615627|NCT01147497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615628|NCT01147497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25615629|NCT01147497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25615630|NCT01147497|Oxytocics|oxytocics|mesh-ancestor
25615631|NCT01147601|Timolol|timolol|mesh-list
25615632|NCT01147601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25615633|NCT01147601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25615634|NCT01147601|Adrenergic Agents|adrenergic agents|mesh-ancestor
25615635|NCT01147601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25615636|NCT01147601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615637|NCT01147601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615638|NCT01147601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25615639|NCT01147601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25615640|NCT01147627|Insulin|insulin|mesh-list
25615641|NCT01147627|Pioglitazone|pioglitazone|mesh-list
25615642|NCT01147627|Exenatide|exenatide|mesh-list
25615643|NCT01147627|Insulin Lispro|insulin lispro|mesh-list
25615644|NCT01147627|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25615645|NCT01147627|Protamines|protamines|mesh-list
25615646|NCT01147627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25615647|NCT01147627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435176|NCT00265408|Analgesics|analgesics|mesh-ancestor
25615648|NCT01147627|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25615649|NCT01147627|Incretins|incretins|mesh-ancestor
25615650|NCT01147627|Hormones|hormones|mesh-ancestor
25615651|NCT01147627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25615652|NCT01147627|Heparin Antagonists|heparin antagonists|mesh-ancestor
25615653|NCT01147627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615654|NCT01147627|Coagulants|coagulants|mesh-ancestor
25615655|NCT01147640|Metronidazole|metronidazole|mesh-list
25615656|NCT01147640|Meropenem|meropenem|mesh-list
25615657|NCT01147640|Tazobactam|tazobactam|mesh-list
25615658|NCT01147640|Ceftolozane|ceftolozane|mesh-list
25615659|NCT01147640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25615660|NCT01147640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25615661|NCT01147640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25615662|NCT01147640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25615663|NCT01147640|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25615664|NCT01147640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25615665|NCT01147640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615666|NCT01147744|Fluticasone|fluticasone|mesh-list
25615667|NCT01147744|Xhance|xhance|mesh-list
25615668|NCT01147744|Montelukast|montelukast|mesh-list
25615669|NCT01147744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25615670|NCT01147744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25615671|NCT01147744|Autonomic Agents|autonomic agents|mesh-ancestor
25615672|NCT01147744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25615673|NCT01147744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615674|NCT01147744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25615675|NCT01147744|Respiratory System Agents|respiratory system agents|mesh-ancestor
25615676|NCT01147744|Dermatologic Agents|dermatologic agents|mesh-ancestor
25615677|NCT01147744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25615678|NCT01147744|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25615679|NCT01147744|Hormone Antagonists|hormone antagonists|mesh-ancestor
25615680|NCT01147744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25615681|NCT01147744|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25615682|NCT01147744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25615683|NCT01147744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615684|NCT01147848|Fluticasone|fluticasone|mesh-list
25615685|NCT01147848|Xhance|xhance|mesh-list
25615686|NCT01147848|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25615687|NCT01147848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25615688|NCT01147848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25615689|NCT01147848|Autonomic Agents|autonomic agents|mesh-ancestor
25615690|NCT01147848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25615691|NCT01147848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615692|NCT01147848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25615693|NCT01147848|Respiratory System Agents|respiratory system agents|mesh-ancestor
25615694|NCT01147848|Dermatologic Agents|dermatologic agents|mesh-ancestor
25615695|NCT01147848|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25615696|NCT01147848|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25615697|NCT01147848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25615698|NCT01147848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25615699|NCT01147848|Adrenergic Agents|adrenergic agents|mesh-ancestor
25615700|NCT01147848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25615701|NCT01147848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615702|NCT01147926|Prucalopride|prucalopride|mesh-list
25615703|NCT01147926|Laxatives|laxatives|mesh-ancestor
24458231|NCT00337246|Rituximab|rituximab|mesh-list
25615704|NCT01147926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25615705|NCT01147926|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
25615706|NCT01147926|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25615707|NCT01147926|Serotonin Agents|serotonin agents|mesh-ancestor
25615708|NCT01147926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25615709|NCT01147926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615710|NCT01147926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615712|NCT01148225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25615713|NCT01148225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25615714|NCT01148420|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25615715|NCT01148420|Medroxyprogesterone|medroxyprogesterone|mesh-list
25615716|NCT01148420|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25615717|NCT01148420|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25615718|NCT01148420|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25615719|NCT01148420|Contraceptive Agents|contraceptive agents|mesh-ancestor
25615720|NCT01148420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25615721|NCT01148420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615722|NCT01148420|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25615723|NCT01148420|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25615724|NCT01148420|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25615725|NCT01148420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25615726|NCT01148420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25615727|NCT01148459|Vaccines|vaccines|mesh-list
25615728|NCT01148459|Immunologic Factors|immunologic factors|mesh-ancestor
25615729|NCT01148459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615730|NCT01148511|Ranibizumab|ranibizumab|mesh-list
25615731|NCT01148511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25615732|NCT01148511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25615733|NCT01148511|Growth Substances|growth substances|mesh-ancestor
25615734|NCT01148511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615735|NCT01148511|Growth Inhibitors|growth inhibitors|mesh-ancestor
25615736|NCT01148511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25615737|NCT01148524|Vaccines|vaccines|mesh-list
25615738|NCT01148524|Immunologic Factors|immunologic factors|mesh-ancestor
25615739|NCT01148524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615740|NCT01148537|Moxifloxacin|moxifloxacin|mesh-list
25615741|NCT01148537|Buprenorphine|buprenorphine|mesh-list
25615742|NCT01148537|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25615743|NCT01148537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25615744|NCT01148537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25615745|NCT01148537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25615746|NCT01148537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25615747|NCT01148537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25615748|NCT01148537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615749|NCT01148537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25615750|NCT01148537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25615751|NCT01148537|Contraceptive Agents|contraceptive agents|mesh-ancestor
25615752|NCT01148537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25615753|NCT01148537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615754|NCT01148537|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25615755|NCT01148537|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25615756|NCT01148537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25615757|NCT01148537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25615758|NCT01148537|Narcotics|narcotics|mesh-ancestor
25615759|NCT01148537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25615760|NCT01148537|Analgesics|analgesics|mesh-ancestor
25615761|NCT01148537|Sensory System Agents|sensory system agents|mesh-ancestor
25615762|NCT01148537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25615763|NCT01148537|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25615764|NCT01148693|Gentamicins|gentamicins|mesh-list
25615765|NCT01148693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25615766|NCT01148693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25615767|NCT01148693|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25615768|NCT01148693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25615769|NCT01148693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615770|NCT01148745|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25615771|NCT01148745|Hematinics|hematinics|mesh-ancestor
25615772|NCT01148745|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25615773|NCT01148745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25615774|NCT01148771|Ertapenem|ertapenem|mesh-list
25615775|NCT01148771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25615776|NCT01148771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25615777|NCT01148810|Siponimod|siponimod|mesh-list
25615778|NCT01148810|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25615779|NCT01148810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615780|NCT01148810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25615781|NCT01148810|Immunologic Factors|immunologic factors|mesh-ancestor
25615782|NCT01148810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615783|NCT01148836|Ubiquinone|ubiquinone|mesh-list
25615784|NCT01148836|Coenzyme Q10|coenzyme q10|mesh-list
25615785|NCT01148836|Micronutrients|micronutrients|mesh-ancestor
25615786|NCT01148836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615787|NCT01148836|Vitamins|vitamins|mesh-ancestor
25615788|NCT01148979|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25615789|NCT01148979|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25615790|NCT01148979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615791|NCT01148979|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25615792|NCT01148979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25615793|NCT01148979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25615794|NCT01148979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615795|NCT01148979|Dopamine Agents|dopamine agents|mesh-ancestor
25615796|NCT01148979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25615797|NCT01149096|Lenograstim|lenograstim|mesh-list
25615798|NCT01149096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25615799|NCT01149096|Immunologic Factors|immunologic factors|mesh-ancestor
25615800|NCT01149096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615801|NCT01149369|Aprepitant|aprepitant|mesh-list
25615802|NCT01149369|Antiemetics|antiemetics|mesh-ancestor
25615803|NCT01149369|Autonomic Agents|autonomic agents|mesh-ancestor
25615804|NCT01149369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25615805|NCT01149369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615806|NCT01149369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25615807|NCT01149369|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25615808|NCT01149369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25615809|NCT01149369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615810|NCT01149421|Dulaglutide|dulaglutide|mesh-list
25615811|NCT01149421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25615812|NCT01149421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615813|NCT01149434|Everolimus|everolimus|mesh-list
25615814|NCT01149434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25615815|NCT01149434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25615816|NCT01149434|Immunologic Factors|immunologic factors|mesh-ancestor
25615817|NCT01149434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615818|NCT01149460|Valacyclovir|valacyclovir|mesh-list
25615819|NCT01149460|Antiviral Agents|antiviral agents|mesh-ancestor
25615820|NCT01149460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25615821|NCT01149473|Losartan|losartan|mesh-list
25615822|NCT01149473|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25615823|NCT01149473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25615824|NCT01149473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25615825|NCT01149473|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25615826|NCT01149473|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25615827|NCT01149473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615828|NCT01149473|Diuretics|diuretics|mesh-ancestor
25615829|NCT01149473|Natriuretic Agents|natriuretic agents|mesh-ancestor
25615830|NCT01149473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615831|NCT01149473|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25615832|NCT01149473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25615833|NCT01149486|Losartan|losartan|mesh-list
25615834|NCT01149486|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25615835|NCT01149486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25615836|NCT01149486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25615837|NCT01149486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25615838|NCT01149486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25615839|NCT01149486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615840|NCT01149486|Diuretics|diuretics|mesh-ancestor
25615841|NCT01149486|Natriuretic Agents|natriuretic agents|mesh-ancestor
25615842|NCT01149486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615843|NCT01149486|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25615844|NCT01149486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25615845|NCT01149538|Choline|choline|mesh-list
25615846|NCT01149538|Lipotropic Agents|lipotropic agents|mesh-ancestor
25615847|NCT01149538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25615848|NCT01149538|Antimetabolites|antimetabolites|mesh-ancestor
25615849|NCT01149538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615850|NCT01149538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25615851|NCT01149538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25615852|NCT01149538|Nootropic Agents|nootropic agents|mesh-ancestor
25615854|NCT01149616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25615855|NCT01149616|Antiemetics|antiemetics|mesh-ancestor
25615856|NCT01149616|Autonomic Agents|autonomic agents|mesh-ancestor
25615857|NCT01149616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25615858|NCT01149616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615859|NCT01149616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25615860|NCT01149616|Glucocorticoids|glucocorticoids|mesh-ancestor
25615861|NCT01149616|Hormones|hormones|mesh-ancestor
25615862|NCT01149616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25615863|NCT01149616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25615864|NCT01149616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25615865|NCT01149655|Aripiprazole|aripiprazole|mesh-list
25615866|NCT01149655|Antidepressive Agents|antidepressive agents|mesh-ancestor
25615867|NCT01149655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25615868|NCT01149655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25615869|NCT01149655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25615870|NCT01149655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25615871|NCT01149655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615872|NCT01149655|Dopamine Agonists|dopamine agonists|mesh-ancestor
25615873|NCT01149655|Dopamine Agents|dopamine agents|mesh-ancestor
25615874|NCT01149655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25615875|NCT01149655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615876|NCT01149655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25615877|NCT01149655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25615878|NCT01149655|Serotonin Agents|serotonin agents|mesh-ancestor
25615879|NCT01149655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25615880|NCT01149655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25615881|NCT01149655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25615882|NCT01149655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25615883|NCT01149733|Tamsulosin|tamsulosin|mesh-list
25712945|NCT02330549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25615884|NCT01149733|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25615885|NCT01149733|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25615886|NCT01149733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25615887|NCT01149733|Adrenergic Agents|adrenergic agents|mesh-ancestor
25615888|NCT01149733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25615889|NCT01149733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615890|NCT01149733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615891|NCT01149733|Urological Agents|urological agents|mesh-ancestor
25615892|NCT01149759|Cyclosporine|cyclosporine|mesh-list
25615893|NCT01149759|Cyclosporins|cyclosporins|mesh-list
25615894|NCT01149759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25615895|NCT01149759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615896|NCT01149759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25615897|NCT01149759|Immunologic Factors|immunologic factors|mesh-ancestor
25615898|NCT01149759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615899|NCT01149759|Antifungal Agents|antifungal agents|mesh-ancestor
25615900|NCT01149759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25615901|NCT01149759|Dermatologic Agents|dermatologic agents|mesh-ancestor
25615902|NCT01149759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25615903|NCT01149759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25615904|NCT01149785|Ketoconazole|ketoconazole|mesh-list
25615905|NCT01149785|Crizotinib|crizotinib|mesh-list
25615906|NCT01149785|Antifungal Agents|antifungal agents|mesh-ancestor
25615907|NCT01149785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25510489|NCT00387959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510490|NCT00387959|Antifungal Agents|antifungal agents|mesh-ancestor
25510491|NCT00387959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25510492|NCT00387959|Dermatologic Agents|dermatologic agents|mesh-ancestor
25510493|NCT00387959|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25510494|NCT00387959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25510495|NCT00387959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25510496|NCT00387959|Antitubercular Agents|antitubercular agents|mesh-ancestor
25615908|NCT01149785|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25615909|NCT01149785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25615910|NCT01149785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25615911|NCT01149785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615912|NCT01149785|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25615913|NCT01149785|Hormone Antagonists|hormone antagonists|mesh-ancestor
25615914|NCT01149785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25510497|NCT00387959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25615915|NCT01149785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615916|NCT01149785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25615917|NCT01149785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25615918|NCT01149785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25615919|NCT01149863|Plerixafor|plerixafor|mesh-list
25615920|NCT01149863|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25615921|NCT01149863|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25615922|NCT01149863|Antiviral Agents|antiviral agents|mesh-ancestor
25615923|NCT01149863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25615924|NCT01149876|Tretinoin|tretinoin|mesh-list
25615925|NCT01149876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712956|NCT02331095|Anticoagulants|anticoagulants|mesh-ancestor
25615926|NCT01149876|Keratolytic Agents|keratolytic agents|mesh-ancestor
25615927|NCT01149876|Dermatologic Agents|dermatologic agents|mesh-ancestor
25615928|NCT01150097|Everolimus|everolimus|mesh-list
25615929|NCT01150097|Tacrolimus|tacrolimus|mesh-list
25615930|NCT01150097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25615931|NCT01150097|Immunologic Factors|immunologic factors|mesh-ancestor
25615932|NCT01150097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615933|NCT01150097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25615934|NCT01150097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25615935|NCT01150097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615936|NCT01150097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25615937|NCT01150123|Vaccines|vaccines|mesh-list
25615938|NCT01150123|Immunologic Factors|immunologic factors|mesh-ancestor
25615939|NCT01150123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615940|NCT01150461|Losartan|losartan|mesh-list
25615941|NCT01150461|Angiotensin II|angiotensin ii|mesh-list
25615942|NCT01150461|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
25615943|NCT01150461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25615944|NCT01150461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25615945|NCT01150461|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25615946|NCT01150461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615947|NCT01150461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25615948|NCT01150500|Sirolimus|sirolimus|mesh-list
25615949|NCT01150500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25615950|NCT01150500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25615951|NCT01150500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25615952|NCT01150500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25615953|NCT01150500|Antifungal Agents|antifungal agents|mesh-ancestor
25615954|NCT01150500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25615955|NCT01150500|Immunologic Factors|immunologic factors|mesh-ancestor
25615956|NCT01150500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615957|NCT01150760|Alvimopan|alvimopan|mesh-list
25615958|NCT01150760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25615959|NCT01150838|Propofol|propofol|mesh-list
25615960|NCT01150838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25615961|NCT01150838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25615962|NCT01150838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615963|NCT01150838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25615964|NCT01150838|Anesthetics, General|anesthetics, general|mesh-ancestor
25615965|NCT01150838|Anesthetics|anesthetics|mesh-ancestor
25615966|NCT01150981|Rosiglitazone|rosiglitazone|mesh-list
25615967|NCT01150981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25615968|NCT01150981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615969|NCT01151046|Exemestane|exemestane|mesh-list
25615970|NCT01151046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25615971|NCT01151046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25615972|NCT01151046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25615973|NCT01151046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499147|NCT00743197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24437327|NCT00273429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437328|NCT00273429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437329|NCT00273429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24437330|NCT00273429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24437331|NCT00273429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24437332|NCT00273429|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24437333|NCT00273429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24437334|NCT00273429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24437335|NCT00273442|Timolol|timolol|mesh-list
24533398|NCT00643734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24533401|NCT00643734|Renal Agents|renal agents|mesh-ancestor
24437492|NCT00273871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437493|NCT00273871|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25615974|NCT01151046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615975|NCT01151046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25615976|NCT01151046|Hormone Antagonists|hormone antagonists|mesh-ancestor
25615977|NCT01151046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25615978|NCT01151046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615979|NCT01151085|Voriconazole|voriconazole|mesh-list
25615980|NCT01151085|Antifungal Agents|antifungal agents|mesh-ancestor
25615981|NCT01151085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25615982|NCT01151085|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25615983|NCT01151085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25615984|NCT01151085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25615985|NCT01151085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25615986|NCT01151085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25615987|NCT01151085|Hormone Antagonists|hormone antagonists|mesh-ancestor
25615988|NCT01151085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25510545|NCT00388362|Sirolimus|sirolimus|mesh-list
25615989|NCT01151085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615990|NCT01151085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25615991|NCT01151098|Buprenorphine|buprenorphine|mesh-list
25615992|NCT01151098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25615993|NCT01151098|Narcotics|narcotics|mesh-ancestor
25615994|NCT01151098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25615995|NCT01151098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25615996|NCT01151098|Analgesics|analgesics|mesh-ancestor
25615997|NCT01151098|Sensory System Agents|sensory system agents|mesh-ancestor
25615998|NCT01151098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25615999|NCT01151098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25616000|NCT01151137|Dronedarone|dronedarone|mesh-list
25616001|NCT01151137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25616002|NCT01151215|Anastrozole|anastrozole|mesh-list
25616003|NCT01151215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25616004|NCT01151215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25616005|NCT01151215|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25616006|NCT01151215|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25616007|NCT01151215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616008|NCT01151215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616009|NCT01151215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25616010|NCT01151215|Hormone Antagonists|hormone antagonists|mesh-ancestor
25616011|NCT01151215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25616012|NCT01151215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616013|NCT01151410|Enalapril|enalapril|mesh-list
25616014|NCT01151410|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25616015|NCT01151410|Protease Inhibitors|protease inhibitors|mesh-ancestor
25616016|NCT01151410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616017|NCT01151410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616018|NCT01151410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25616019|NCT01151436|Hyaluronic Acid|hyaluronic acid|mesh-list
25616020|NCT01151436|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25616021|NCT01151436|Immunologic Factors|immunologic factors|mesh-ancestor
25616022|NCT01151436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616023|NCT01151436|Viscosupplements|viscosupplements|mesh-ancestor
25616024|NCT01151436|Protective Agents|protective agents|mesh-ancestor
25616025|NCT01151449|R04929097|r04929097|mesh-list
25616026|NCT01151449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616027|NCT01151449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616028|NCT01151540|Rufinamide|rufinamide|mesh-list
25616029|NCT01151540|Anticonvulsants|anticonvulsants|mesh-ancestor
25616030|NCT01151540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25616031|NCT01151540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25712964|NCT02331108|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24897696|NCT04423276|Nootropic Agents|nootropic agents|mesh-ancestor
25616032|NCT01151540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25616033|NCT01151540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616034|NCT01151579|Albuterol|albuterol|mesh-list
25616035|NCT01151579|Ipratropium|ipratropium|mesh-list
25616036|NCT01151579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25616037|NCT01151579|Autonomic Agents|autonomic agents|mesh-ancestor
25616038|NCT01151579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25616039|NCT01151579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616040|NCT01151579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25616041|NCT01151579|Respiratory System Agents|respiratory system agents|mesh-ancestor
25616042|NCT01151579|Tocolytic Agents|tocolytic agents|mesh-ancestor
25616043|NCT01151579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25616044|NCT01151579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25616045|NCT01151579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25616046|NCT01151579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25616047|NCT01151579|Adrenergic Agents|adrenergic agents|mesh-ancestor
25616048|NCT01151579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25616049|NCT01151579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616050|NCT01151579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25616051|NCT01151579|Cholinergic Agents|cholinergic agents|mesh-ancestor
25616052|NCT01151761|Gemcitabine|gemcitabine|mesh-list
25616053|NCT01151761|Cisplatin|cisplatin|mesh-list
25616054|NCT01151761|Carboplatin|carboplatin|mesh-list
25616055|NCT01151761|Fluorouracil|fluorouracil|mesh-list
25616056|NCT01151761|Capecitabine|capecitabine|mesh-list
25616057|NCT01151761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25616058|NCT01151761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25616059|NCT01151761|Antimetabolites|antimetabolites|mesh-ancestor
25616060|NCT01151761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616061|NCT01151761|Antiviral Agents|antiviral agents|mesh-ancestor
25616062|NCT01151761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25616063|NCT01151761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616064|NCT01151761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25616065|NCT01151761|Immunologic Factors|immunologic factors|mesh-ancestor
25616066|NCT01151761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616067|NCT01151813|Varenicline|varenicline|mesh-list
25616068|NCT01151813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25616069|NCT01151813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25616070|NCT01151813|Cholinergic Agents|cholinergic agents|mesh-ancestor
25616071|NCT01151813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25616072|NCT01151813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616073|NCT01151813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616074|NCT01151852|Imatinib Mesylate|imatinib mesylate|mesh-list
25616075|NCT01151852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25616076|NCT01151852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25616077|NCT01151852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616078|NCT01151852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616079|NCT01152021|Dexmedetomidine|dexmedetomidine|mesh-list
25616080|NCT01152021|Propofol|propofol|mesh-list
25616081|NCT01152021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25616082|NCT01152021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25616083|NCT01152021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616084|NCT01152021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25616085|NCT01152021|Anesthetics, General|anesthetics, general|mesh-ancestor
25616086|NCT01152021|Anesthetics|anesthetics|mesh-ancestor
25616087|NCT01152021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25616088|NCT01152021|Analgesics|analgesics|mesh-ancestor
25616089|NCT01152021|Sensory System Agents|sensory system agents|mesh-ancestor
25616090|NCT01152021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25616091|NCT01152021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25616092|NCT01152021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25616093|NCT01152021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25616094|NCT01152021|Adrenergic Agents|adrenergic agents|mesh-ancestor
25616095|NCT01152021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25616096|NCT01152021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616097|NCT01152190|Tadalafil|tadalafil|mesh-list
25616098|NCT01152190|Vasodilator Agents|vasodilator agents|mesh-ancestor
25616099|NCT01152190|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25616100|NCT01152190|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25616101|NCT01152190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616102|NCT01152190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616103|NCT01152190|Urological Agents|urological agents|mesh-ancestor
25616104|NCT01152437|Cetuximab|cetuximab|mesh-list
25616105|NCT01152437|Afatinib|afatinib|mesh-list
25616106|NCT01152437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25616107|NCT01152437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25616108|NCT01152437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25616109|NCT01152437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616110|NCT01152437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616111|NCT01152450|Tiotropium Bromide|tiotropium bromide|mesh-list
25616112|NCT01152450|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25616113|NCT01152450|Autonomic Agents|autonomic agents|mesh-ancestor
25616114|NCT01152450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25616115|NCT01152450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616116|NCT01152450|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25616117|NCT01152450|Respiratory System Agents|respiratory system agents|mesh-ancestor
25616118|NCT01152450|Parasympatholytics|parasympatholytics|mesh-ancestor
25616119|NCT01152450|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25616120|NCT01152450|Cholinergic Agents|cholinergic agents|mesh-ancestor
25616121|NCT01152450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25616122|NCT01152450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616123|NCT01152515|Remifentanil|remifentanil|mesh-list
25616124|NCT01152515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25616125|NCT01152515|Narcotics|narcotics|mesh-ancestor
25616126|NCT01152515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25616127|NCT01152515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616128|NCT01152515|Analgesics|analgesics|mesh-ancestor
25616129|NCT01152515|Sensory System Agents|sensory system agents|mesh-ancestor
25616130|NCT01152515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25616131|NCT01152580|Melatonin|melatonin|mesh-list
25616132|NCT01152580|Antioxidants|antioxidants|mesh-ancestor
25616133|NCT01152580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616134|NCT01152580|Protective Agents|protective agents|mesh-ancestor
25616135|NCT01152580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437884|NCT00274612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25616136|NCT01152580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25655156|NCT01559129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616137|NCT01152697|Haloperidol|haloperidol|mesh-list
25616138|NCT01152697|Haloperidol decanoate|haloperidol decanoate|mesh-list
25616139|NCT01152697|Antiemetics|antiemetics|mesh-ancestor
25616140|NCT01152697|Autonomic Agents|autonomic agents|mesh-ancestor
25616141|NCT01152697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25616142|NCT01152697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616143|NCT01152697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25616144|NCT01152697|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25616145|NCT01152697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25616146|NCT01152697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25616147|NCT01152697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25616148|NCT01152697|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25616149|NCT01152697|Dopamine Agents|dopamine agents|mesh-ancestor
25616150|NCT01152697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25616151|NCT01152697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616152|NCT01152697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25616153|NCT01152788|Dacarbazine|dacarbazine|mesh-list
25616154|NCT01152788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25616155|NCT01152788|Alkylating Agents|alkylating agents|mesh-ancestor
25616156|NCT01152788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616157|NCT01152788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25616158|NCT01152996|Vortioxetine|vortioxetine|mesh-list
25616159|NCT01152996|Antidepressive Agents|antidepressive agents|mesh-ancestor
25616160|NCT01152996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24701632|NCT01459887|Hormones|hormones|mesh-ancestor
25616161|NCT01152996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25616162|NCT01152996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25616163|NCT01152996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24702371|NCT01465503|Bivalirudin|bivalirudin|mesh-list
25616164|NCT01152996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616165|NCT01152996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25616166|NCT01152996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24703259|NCT01470495|Sorafenib|sorafenib|mesh-list
25616167|NCT01152996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24703709|NCT01473303|Antidotes|antidotes|mesh-ancestor
25616168|NCT01152996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616169|NCT01152996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25616170|NCT01152996|Serotonin Agents|serotonin agents|mesh-ancestor
24704288|NCT01477606|Cytarabine|cytarabine|mesh-list
25713005|NCT02332291|Bupropion|bupropion|mesh-list
25616171|NCT01152996|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25616172|NCT01152996|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25616173|NCT01152996|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25616174|NCT01152996|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25616175|NCT01153009|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25616176|NCT01153009|Vortioxetine|vortioxetine|mesh-list
25616177|NCT01153009|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25616178|NCT01153009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25616179|NCT01153009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25616180|NCT01153009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616181|NCT01153009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25616182|NCT01153009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616183|NCT01153009|Analgesics|analgesics|mesh-ancestor
25616184|NCT01153009|Sensory System Agents|sensory system agents|mesh-ancestor
25616185|NCT01153009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25616186|NCT01153009|Antidepressive Agents|antidepressive agents|mesh-ancestor
25616187|NCT01153009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25616188|NCT01153009|Dopamine Agents|dopamine agents|mesh-ancestor
25616189|NCT01153009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25616190|NCT01153009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25616191|NCT01153009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25616192|NCT01153009|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25616193|NCT01153009|Serotonin Agents|serotonin agents|mesh-ancestor
25616194|NCT01153009|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25616195|NCT01153009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25616196|NCT01153009|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25616197|NCT01153009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25616198|NCT01153269|Ritonavir|ritonavir|mesh-list
25616199|NCT01153269|Lopinavir|lopinavir|mesh-list
25616200|NCT01153269|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25616201|NCT01153269|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25616202|NCT01153269|Protease Inhibitors|protease inhibitors|mesh-ancestor
25616203|NCT01153269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616204|NCT01153269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616205|NCT01153269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25616206|NCT01153269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25616207|NCT01153269|Antiviral Agents|antiviral agents|mesh-ancestor
25616208|NCT01153269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25822742|NCT00004637|Antioxidants|antioxidants|mesh-ancestor
25616209|NCT01153269|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25616210|NCT01153269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25616212|NCT01153425|Teriparatide|teriparatide|mesh-list
25616213|NCT01153425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25616214|NCT01153425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616215|NCT01153425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25616216|NCT01153581|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25616217|NCT01153581|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25616218|NCT01153581|Estradiol|estradiol|mesh-list
25616219|NCT01153581|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25616220|NCT01153581|Progesterone|progesterone|mesh-list
25616221|NCT01153581|Ganirelix|ganirelix|mesh-list
25616222|NCT01153581|Estrogens|estrogens|mesh-ancestor
25616223|NCT01153581|Hormones|hormones|mesh-ancestor
25616224|NCT01153581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25616225|NCT01153581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616226|NCT01153581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25713055|NCT02332902|Everolimus|everolimus|mesh-list
25616227|NCT01153581|Contraceptive Agents|contraceptive agents|mesh-ancestor
25616228|NCT01153581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25616229|NCT01153581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25616230|NCT01153581|Progestins|progestins|mesh-ancestor
25616231|NCT01153581|Hormone Antagonists|hormone antagonists|mesh-ancestor
25616232|NCT01153620|Polihexanide|polihexanide|mesh-list
25616233|NCT01153620|Disinfectants|disinfectants|mesh-ancestor
25616234|NCT01153620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25616235|NCT01153672|Letrozole|letrozole|mesh-list
25616236|NCT01153672|Anastrozole|anastrozole|mesh-list
25616237|NCT01153672|Vorinostat|vorinostat|mesh-list
25616238|NCT01153672|Exemestane|exemestane|mesh-list
25616239|NCT01153672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25616240|NCT01153672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25616241|NCT01153672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25616242|NCT01153672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616243|NCT01153672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616244|NCT01153672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25616245|NCT01153672|Hormone Antagonists|hormone antagonists|mesh-ancestor
25616246|NCT01153672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25616247|NCT01153672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616248|NCT01153672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25616249|NCT01153672|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25616250|NCT01153698|Dabigatran|dabigatran|mesh-list
25616251|NCT01153698|Antithrombins|antithrombins|mesh-ancestor
25616252|NCT01153698|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25616253|NCT01153698|Protease Inhibitors|protease inhibitors|mesh-ancestor
24711833|NCT01517321|Hormones|hormones|mesh-ancestor
25616254|NCT01153698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616255|NCT01153698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616256|NCT01153698|Anticoagulants|anticoagulants|mesh-ancestor
25616257|NCT01153711|Ketoconazole|ketoconazole|mesh-list
25616258|NCT01153711|Antifungal Agents|antifungal agents|mesh-ancestor
25616259|NCT01153711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25616260|NCT01153711|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25616261|NCT01153711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25616262|NCT01153711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616263|NCT01153711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616264|NCT01153711|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25616265|NCT01153711|Hormone Antagonists|hormone antagonists|mesh-ancestor
25616266|NCT01153711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25616267|NCT01153711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614496|NCT01024491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616268|NCT01153711|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25616269|NCT01153724|Fluconazole|fluconazole|mesh-list
25616270|NCT01153724|Antifungal Agents|antifungal agents|mesh-ancestor
25616271|NCT01153724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25616272|NCT01153724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25616273|NCT01153724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25616274|NCT01153724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616275|NCT01153724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616276|NCT01153724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25616277|NCT01153724|Hormone Antagonists|hormone antagonists|mesh-ancestor
25616278|NCT01153724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25616279|NCT01153724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616280|NCT01153724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24712345|NCT01520077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25616281|NCT01153724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25616283|NCT01153763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25616284|NCT01153763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25616285|NCT01153763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24712709|NCT01522534|Analgesics|analgesics|mesh-ancestor
25616286|NCT01153763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616287|NCT01153815|Botulinum Toxins|botulinum toxins|mesh-list
25616288|NCT01153815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25616289|NCT01153815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25616290|NCT01153815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25616291|NCT01153815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25616292|NCT01153815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616293|NCT01153815|Cholinergic Agents|cholinergic agents|mesh-ancestor
25616294|NCT01153815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25616295|NCT01153815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616296|NCT01153815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25616297|NCT01153815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24503357|NCT01824537|Vaccines|vaccines|mesh-list
25616298|NCT01153893|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25616299|NCT01153893|Immunologic Factors|immunologic factors|mesh-ancestor
25616300|NCT01153893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616301|NCT01153958|Metronidazole|metronidazole|mesh-list
25616302|NCT01153958|Chlorquinaldol|chlorquinaldol|mesh-list
25616303|NCT01153958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25616304|NCT01153958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25616305|NCT01153958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25616306|NCT01153958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25616307|NCT01153971|Rituximab|rituximab|mesh-list
25616308|NCT01153971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25616309|NCT01153971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25616310|NCT01153971|Immunologic Factors|immunologic factors|mesh-ancestor
25616311|NCT01153971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616312|NCT01153971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25616313|NCT01153984|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25616314|NCT01153984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25616315|NCT01153984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25616316|NCT01153984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616317|NCT01153984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616318|NCT01154127|Glycopyrrolate|glycopyrrolate|mesh-list
25616319|NCT01154127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25616320|NCT01154127|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25616321|NCT01154127|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25616322|NCT01154127|Cholinergic Agents|cholinergic agents|mesh-ancestor
25616323|NCT01154127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25499148|NCT00743197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25616324|NCT01154127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616325|NCT01154127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616326|NCT01154153|Loratadine|loratadine|mesh-list
25616327|NCT01154153|Triamcinolone|triamcinolone|mesh-list
25616328|NCT01154153|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25616329|NCT01154153|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25616330|NCT01154153|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25616331|NCT01154153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25616332|NCT01154153|Glucocorticoids|glucocorticoids|mesh-ancestor
25616333|NCT01154153|Hormones|hormones|mesh-ancestor
25616334|NCT01154153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25616335|NCT01154153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616336|NCT01154153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25616337|NCT01154153|Immunologic Factors|immunologic factors|mesh-ancestor
25616338|NCT01154153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616339|NCT01154153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616340|NCT01154153|Antipruritics|antipruritics|mesh-ancestor
25616341|NCT01154153|Dermatologic Agents|dermatologic agents|mesh-ancestor
25616342|NCT01154153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25616343|NCT01154153|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25616344|NCT01154153|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25616345|NCT01154153|Histamine Antagonists|histamine antagonists|mesh-ancestor
25616346|NCT01154153|Histamine Agents|histamine agents|mesh-ancestor
25616347|NCT01154153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25616348|NCT01154166|Ropinirole|ropinirole|mesh-list
25616349|NCT01154166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25616350|NCT01154166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25616351|NCT01154166|Dopamine Agonists|dopamine agonists|mesh-ancestor
25616352|NCT01154166|Dopamine Agents|dopamine agents|mesh-ancestor
25510914|NCT00391092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25510923|NCT00391118|Paclitaxel|paclitaxel|mesh-list
25616353|NCT01154166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25616354|NCT01154166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616355|NCT01154166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616356|NCT01154192|Dexamethasone|dexamethasone|mesh-list
25616357|NCT01154192|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25616358|NCT01154192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25616359|NCT01154192|Antiemetics|antiemetics|mesh-ancestor
25616360|NCT01154192|Autonomic Agents|autonomic agents|mesh-ancestor
25616361|NCT01154192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25616362|NCT01154192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616363|NCT01154192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25616364|NCT01154192|Glucocorticoids|glucocorticoids|mesh-ancestor
25616366|NCT01154192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25616367|NCT01154192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25616368|NCT01154192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25616369|NCT01154192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25616370|NCT01154218|Crizotinib|crizotinib|mesh-list
25616371|NCT01154218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25616372|NCT01154218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25616373|NCT01154218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616374|NCT01154218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616375|NCT01154452|R04929097|r04929097|mesh-list
25616376|NCT01154452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616377|NCT01154452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616378|NCT01154673|Ritonavir|ritonavir|mesh-list
25616379|NCT01154673|Lopinavir|lopinavir|mesh-list
25616380|NCT01154673|Tenofovir|tenofovir|mesh-list
25616381|NCT01154673|Emtricitabine|emtricitabine|mesh-list
25616382|NCT01154673|Raltegravir Potassium|raltegravir potassium|mesh-list
25616383|NCT01154673|Maraviroc|maraviroc|mesh-list
25616384|NCT01154673|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25616385|NCT01154673|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25616386|NCT01154673|Protease Inhibitors|protease inhibitors|mesh-ancestor
25616387|NCT01154673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616388|NCT01154673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616389|NCT01154673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25616390|NCT01154673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24617214|NCT01041690|Bevacizumab|bevacizumab|mesh-list
25616391|NCT01154673|Antiviral Agents|antiviral agents|mesh-ancestor
25713153|NCT02335294|Analgesics|analgesics|mesh-ancestor
25616392|NCT01154673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25616393|NCT01154673|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25616394|NCT01154673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25616395|NCT01154673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25616396|NCT01154673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24737358|NCT01668550|AZD-0424|azd-0424|mesh-list
25616397|NCT01154673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25616398|NCT01154673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25616399|NCT01154673|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25616400|NCT01154673|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25616401|NCT01154673|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25616402|NCT01155063|Exemestane|exemestane|mesh-list
25616403|NCT01155063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25616404|NCT01155063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25616405|NCT01155063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25616406|NCT01155063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616407|NCT01155063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616408|NCT01155063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25616409|NCT01155063|Hormone Antagonists|hormone antagonists|mesh-ancestor
25499149|NCT00743197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616410|NCT01155063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25616411|NCT01155063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616412|NCT01155154|Clindamycin|clindamycin|mesh-list
25616413|NCT01155154|Clindamycin palmitate|clindamycin palmitate|mesh-list
25616414|NCT01155154|Clindamycin phosphate|clindamycin phosphate|mesh-list
25616415|NCT01155154|Cephalexin|cephalexin|mesh-list
25616416|NCT01155154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24741089|NCT01691742|Laxatives|laxatives|mesh-list
25616417|NCT01155154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25616418|NCT01155154|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25616419|NCT01155154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616420|NCT01155154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616421|NCT01155167|Lidocaine|lidocaine|mesh-list
25616422|NCT01155167|Nitroglycerin|nitroglycerin|mesh-list
25616423|NCT01155167|Anesthetics, Local|anesthetics, local|mesh-ancestor
25616424|NCT01155167|Anesthetics|anesthetics|mesh-ancestor
25616425|NCT01155167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25616426|NCT01155167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616427|NCT01155167|Sensory System Agents|sensory system agents|mesh-ancestor
25616428|NCT01155167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25616429|NCT01155167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25616430|NCT01155167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25616431|NCT01155167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25616432|NCT01155167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25616433|NCT01155167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616434|NCT01155167|Vasodilator Agents|vasodilator agents|mesh-ancestor
25616435|NCT01155219|Latanoprost|latanoprost|mesh-list
25616436|NCT01155219|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25616437|NCT01155219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25616438|NCT01155284|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25616439|NCT01155284|Lansoprazole|lansoprazole|mesh-list
25616440|NCT01155284|Dexlansoprazole|dexlansoprazole|mesh-list
25616441|NCT01155284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25616442|NCT01155284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616443|NCT01155284|Incretins|incretins|mesh-ancestor
25616444|NCT01155284|Hormones|hormones|mesh-ancestor
25616445|NCT01155284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25616446|NCT01155284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25616447|NCT01155284|Protease Inhibitors|protease inhibitors|mesh-ancestor
25616448|NCT01155284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616449|NCT01155284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616450|NCT01155284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25616451|NCT01155284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25616452|NCT01155284|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25616453|NCT01155466|Rasagiline|rasagiline|mesh-list
25616454|NCT01155466|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25616455|NCT01155466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616456|NCT01155466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616457|NCT01155466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25616458|NCT01155466|Protective Agents|protective agents|mesh-ancestor
25616459|NCT01155466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616460|NCT01155479|Rasagiline|rasagiline|mesh-list
25616461|NCT01155479|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25616462|NCT01155479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616463|NCT01155479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616464|NCT01155479|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25616465|NCT01155479|Protective Agents|protective agents|mesh-ancestor
25616466|NCT01155479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616467|NCT01155531|Sertraline|sertraline|mesh-list
25616468|NCT01155531|Telenzepine|telenzepine|mesh-list
25616469|NCT01155531|Antidepressive Agents|antidepressive agents|mesh-ancestor
25616470|NCT01155531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25616471|NCT01155531|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25616472|NCT01155531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25616473|NCT01155531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25616474|NCT01155531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616475|NCT01155531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25616476|NCT01155531|Serotonin Agents|serotonin agents|mesh-ancestor
25616477|NCT01155531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616478|NCT01155531|Parasympatholytics|parasympatholytics|mesh-ancestor
25616479|NCT01155531|Autonomic Agents|autonomic agents|mesh-ancestor
25616480|NCT01155531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25616481|NCT01155583|Dexamethasone|dexamethasone|mesh-list
25616482|NCT01155583|Lenalidomide|lenalidomide|mesh-list
25616483|NCT01155583|Azacitidine|azacitidine|mesh-list
25616484|NCT01155583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25616485|NCT01155583|Antiemetics|antiemetics|mesh-ancestor
25616486|NCT01155583|Autonomic Agents|autonomic agents|mesh-ancestor
25616487|NCT01155583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25616488|NCT01155583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616489|NCT01155583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25616490|NCT01155583|Glucocorticoids|glucocorticoids|mesh-ancestor
25616491|NCT01155583|Hormones|hormones|mesh-ancestor
25616492|NCT01155583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25616493|NCT01155583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25616494|NCT01155583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25616495|NCT01155583|Immunologic Factors|immunologic factors|mesh-ancestor
25616496|NCT01155583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25616497|NCT01155583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25616498|NCT01155583|Growth Substances|growth substances|mesh-ancestor
25616499|NCT01155583|Growth Inhibitors|growth inhibitors|mesh-ancestor
25616500|NCT01155583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25616502|NCT01155583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616503|NCT01155583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616504|NCT01155661|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
25616505|NCT01155661|Serotonin|serotonin|mesh-list
25616506|NCT01155661|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25616507|NCT01155661|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25616508|NCT01155661|Serotonin Agents|serotonin agents|mesh-ancestor
25616509|NCT01155661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25616510|NCT01155661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616511|NCT01155661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744807|NCT04133922|Insulin|insulin|mesh-list
25616512|NCT01155661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25616513|NCT01155661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25616514|NCT01155661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25616515|NCT01155661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25616516|NCT01155661|Disinfectants|disinfectants|mesh-ancestor
25616517|NCT01155869|Naltrexone|naltrexone|mesh-list
25616518|NCT01155869|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25616519|NCT01155869|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25616520|NCT01155869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616521|NCT01155869|Sensory System Agents|sensory system agents|mesh-ancestor
25616522|NCT01155869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25616523|NCT01155999|Tobramycin|tobramycin|mesh-list
24746692|NCT04312009|Losartan|losartan|mesh-list
25616524|NCT01155999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25616525|NCT01155999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25616526|NCT01156051|Guanfacine|guanfacine|mesh-list
25616527|NCT01156051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25616528|NCT01156051|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25616529|NCT01156051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25616530|NCT01156051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25616531|NCT01156051|Adrenergic Agents|adrenergic agents|mesh-ancestor
25616532|NCT01156051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25616533|NCT01156051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616534|NCT01156051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616535|NCT01156142|Doxepin|doxepin|mesh-list
25616536|NCT01156142|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25616537|NCT01156142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25616538|NCT01156142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25616539|NCT01156142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616540|NCT01156142|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25616541|NCT01156142|Antidepressive Agents|antidepressive agents|mesh-ancestor
25616542|NCT01156142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25616543|NCT01156142|Histamine Antagonists|histamine antagonists|mesh-ancestor
25616544|NCT01156142|Histamine Agents|histamine agents|mesh-ancestor
24750076|NCT01696448|Thioctic Acid|thioctic acid|mesh-list
25616545|NCT01156142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25616546|NCT01156142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616547|NCT01156311|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25616548|NCT01156311|Dermatologic Agents|dermatologic agents|mesh-ancestor
25616549|NCT01156311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25616550|NCT01156311|Immunologic Factors|immunologic factors|mesh-ancestor
25616551|NCT01156311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616552|NCT01156363|Epoetin Alfa|epoetin alfa|mesh-list
25616553|NCT01156363|Hematinics|hematinics|mesh-ancestor
25616554|NCT01156376|Listerine|listerine|mesh-list
25616555|NCT01156376|Fluorides|fluorides|mesh-list
25616556|NCT01156376|Cariostatic Agents|cariostatic agents|mesh-ancestor
25616557|NCT01156376|Protective Agents|protective agents|mesh-ancestor
25616558|NCT01156376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616559|NCT01156376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25616560|NCT01156376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25616561|NCT01156480|Hydrocortisone|hydrocortisone|mesh-list
25616562|NCT01156480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25616563|NCT01156571|Clopidogrel|clopidogrel|mesh-list
25616564|NCT01156571|Cangrelor|cangrelor|mesh-list
25616565|NCT01156571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25616566|NCT01156571|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25616567|NCT01156571|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25616568|NCT01156571|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25616569|NCT01156571|Purinergic Agents|purinergic agents|mesh-ancestor
25616570|NCT01156571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25616571|NCT01156571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616572|NCT01156571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616573|NCT01156597|Pioglitazone|pioglitazone|mesh-list
25616574|NCT01156597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25616575|NCT01156597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616576|NCT01156701|Zanamivir|zanamivir|mesh-list
25616577|NCT01156701|Antiviral Agents|antiviral agents|mesh-ancestor
25616578|NCT01156701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25616579|NCT01156701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616580|NCT01156701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616581|NCT01156792|Montelukast|montelukast|mesh-list
25616582|NCT01156792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25616583|NCT01156792|Respiratory System Agents|respiratory system agents|mesh-ancestor
25616584|NCT01156792|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25616585|NCT01156792|Hormone Antagonists|hormone antagonists|mesh-ancestor
25616586|NCT01156792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25616587|NCT01156792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616588|NCT01156792|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25616589|NCT01156792|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25616590|NCT01156792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616591|NCT01157065|Ranibizumab|ranibizumab|mesh-list
25616592|NCT01157065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25616593|NCT01157065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25616594|NCT01157065|Growth Substances|growth substances|mesh-ancestor
25616595|NCT01157065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616596|NCT01157065|Growth Inhibitors|growth inhibitors|mesh-ancestor
25616597|NCT01157065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25616598|NCT01157117|Omalizumab|omalizumab|mesh-list
25616599|NCT01157117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25616600|NCT01157117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25616601|NCT01157117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25616602|NCT01157117|Respiratory System Agents|respiratory system agents|mesh-ancestor
25616603|NCT01157117|Immunologic Factors|immunologic factors|mesh-ancestor
25616604|NCT01157117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616605|NCT01157169|Buprenorphine|buprenorphine|mesh-list
25616606|NCT01157169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25616607|NCT01157169|Narcotics|narcotics|mesh-ancestor
25616608|NCT01157169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25616609|NCT01157169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616610|NCT01157169|Analgesics|analgesics|mesh-ancestor
25616611|NCT01157169|Sensory System Agents|sensory system agents|mesh-ancestor
25616612|NCT01157169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25616613|NCT01157169|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25616614|NCT01157182|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25616615|NCT01157182|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25616616|NCT01157182|Norethindrone|norethindrone|mesh-list
25616617|NCT01157182|Norethindrone Acetate|norethindrone acetate|mesh-list
25616618|NCT01157182|Estradiol|estradiol|mesh-list
24756264|NCT01731899|S 20098|s 20098|mesh-list
25616619|NCT01157182|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25616620|NCT01157182|Estrogens|estrogens|mesh-ancestor
25616621|NCT01157182|Hormones|hormones|mesh-ancestor
25616622|NCT01157182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25616623|NCT01157182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616624|NCT01157182|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25616625|NCT01157182|Contraceptive Agents|contraceptive agents|mesh-ancestor
25616626|NCT01157182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25616627|NCT01157182|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25616628|NCT01157182|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25616629|NCT01157182|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25616630|NCT01157182|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24619776|NCT01053650|Antipyretics|antipyretics|mesh-ancestor
24757551|NCT01740960|Hallucinogens|hallucinogens|mesh-ancestor
24548103|NCT00707642|Vaccines|vaccines|mesh-list
24422273|NCT00221871|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24757575|NCT01741142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24757576|NCT01741142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24422319|NCT00222053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24422320|NCT00222053|Growth Substances|growth substances|mesh-ancestor
24757706|NCT01742247|Palmidrol|palmidrol|mesh-list
25616631|NCT01157234|Metoprolol|metoprolol|mesh-list
25616632|NCT01157234|Nebivolol|nebivolol|mesh-list
25616633|NCT01157234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25616634|NCT01157234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25616635|NCT01157234|Sympatholytics|sympatholytics|mesh-ancestor
25616636|NCT01157234|Autonomic Agents|autonomic agents|mesh-ancestor
25616637|NCT01157234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25616638|NCT01157234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616639|NCT01157234|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25616640|NCT01157234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25616641|NCT01157234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25616642|NCT01157234|Adrenergic Agents|adrenergic agents|mesh-ancestor
25616643|NCT01157234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25616644|NCT01157234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616645|NCT01157234|Vasodilator Agents|vasodilator agents|mesh-ancestor
25616646|NCT01157234|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25616647|NCT01157234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25616648|NCT01157234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25713303|NCT02337907|Donepezil|donepezil|mesh-list
25616650|NCT01157351|Risperidone|risperidone|mesh-list
25616651|NCT01157351|Aripiprazole|aripiprazole|mesh-list
25616652|NCT01157351|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25616653|NCT01157351|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25616654|NCT01157351|Perphenazine|perphenazine|mesh-list
25616655|NCT01157351|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25616656|NCT01157351|Serotonin Agents|serotonin agents|mesh-ancestor
25616657|NCT01157351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25616658|NCT01157351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616659|NCT01157351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616660|NCT01157351|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25616661|NCT01157351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25616662|NCT01157351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25616663|NCT01157351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25616664|NCT01157351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25616665|NCT01157351|Dopamine Agents|dopamine agents|mesh-ancestor
25616666|NCT01157351|Antiemetics|antiemetics|mesh-ancestor
25616667|NCT01157351|Autonomic Agents|autonomic agents|mesh-ancestor
25616668|NCT01157351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25616669|NCT01157351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25616670|NCT01157351|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25616671|NCT01157351|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25616672|NCT01157351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25616673|NCT01157351|Antidepressive Agents|antidepressive agents|mesh-ancestor
25616674|NCT01157351|Dopamine Agonists|dopamine agonists|mesh-ancestor
25616675|NCT01157351|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25616676|NCT01157351|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25616677|NCT01157351|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25713313|NCT02337933|Ursolic acid|ursolic acid|mesh-list
25616678|NCT01157351|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25616679|NCT01157364|Bimatoprost|bimatoprost|mesh-list
25616680|NCT01157364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25616681|NCT01157416|Cycloserine|cycloserine|mesh-list
25616682|NCT01157416|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25616683|NCT01157416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25616684|NCT01157416|Renal Agents|renal agents|mesh-ancestor
25616685|NCT01157416|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25616686|NCT01157416|Antitubercular Agents|antitubercular agents|mesh-ancestor
25616687|NCT01157416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25616688|NCT01157416|Antimetabolites|antimetabolites|mesh-ancestor
25616689|NCT01157416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616690|NCT01157429|Cycloserine|cycloserine|mesh-list
25616691|NCT01157429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25616692|NCT01157429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25616693|NCT01157429|Renal Agents|renal agents|mesh-ancestor
25616694|NCT01157429|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25616695|NCT01157429|Antitubercular Agents|antitubercular agents|mesh-ancestor
25616696|NCT01157429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25616697|NCT01157429|Antimetabolites|antimetabolites|mesh-ancestor
25616698|NCT01157429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655157|NCT01559129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25655158|NCT01559129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25655159|NCT01559129|Growth Substances|growth substances|mesh-ancestor
25655160|NCT01559129|Growth Inhibitors|growth inhibitors|mesh-ancestor
25655161|NCT01559129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25655162|NCT01559259|Acetaminophen|acetaminophen|mesh-list
25655163|NCT01559259|Ibuprofen|ibuprofen|mesh-list
25655164|NCT01559259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25655165|NCT01559259|Analgesics|analgesics|mesh-ancestor
25655166|NCT01559259|Sensory System Agents|sensory system agents|mesh-ancestor
25655167|NCT01559259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25655168|NCT01559259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655169|NCT01559259|Antipyretics|antipyretics|mesh-ancestor
25655170|NCT01559259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25655171|NCT01559259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25655172|NCT01559259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25655173|NCT01559259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25655174|NCT01559259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655175|NCT01559259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655176|NCT01559389|Solifenacin Succinate|solifenacin succinate|mesh-list
25655177|NCT01559389|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25655178|NCT01559389|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25655179|NCT01559389|Cholinergic Agents|cholinergic agents|mesh-ancestor
25655180|NCT01559389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25616699|NCT01158118|Plerixafor|plerixafor|mesh-list
25616700|NCT01158118|Sargramostim|sargramostim|mesh-list
25616701|NCT01158118|Immunologic Factors|immunologic factors|mesh-ancestor
25616702|NCT01158118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616703|NCT01158118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25616704|NCT01158118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25616705|NCT01158118|Antiviral Agents|antiviral agents|mesh-ancestor
25616706|NCT01158118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25616707|NCT01158222|Sunitinib|sunitinib|mesh-list
25616708|NCT01158222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25616709|NCT01158222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25616710|NCT01158222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25616711|NCT01158222|Growth Substances|growth substances|mesh-ancestor
25616712|NCT01158222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616713|NCT01158222|Growth Inhibitors|growth inhibitors|mesh-ancestor
25616714|NCT01158222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25616715|NCT01158222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616716|NCT01158222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616717|NCT01158261|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25616718|NCT01158261|Hemostatics|hemostatics|mesh-ancestor
25616719|NCT01158261|Coagulants|coagulants|mesh-ancestor
25616720|NCT01158534|Interferons|interferons|mesh-list
25616721|NCT01158534|Interferon-alpha|interferon-alpha|mesh-list
25616722|NCT01158534|Interferon alpha-2|interferon alpha-2|mesh-list
25616723|NCT01158534|Celecoxib|celecoxib|mesh-list
25616724|NCT01158534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25616725|NCT01158534|Antiviral Agents|antiviral agents|mesh-ancestor
25616726|NCT01158534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25616727|NCT01158534|Immunologic Factors|immunologic factors|mesh-ancestor
25616728|NCT01158534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616729|NCT01158534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25616730|NCT01158534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25616731|NCT01158534|Analgesics|analgesics|mesh-ancestor
25616732|NCT01158534|Sensory System Agents|sensory system agents|mesh-ancestor
25616733|NCT01158534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25616734|NCT01158534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25616735|NCT01158534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25616736|NCT01158534|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25616737|NCT01158534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25616738|NCT01158534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616739|NCT01158534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616740|NCT01158651|Everolimus|everolimus|mesh-list
25616741|NCT01158651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25616742|NCT01158651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25616743|NCT01158651|Immunologic Factors|immunologic factors|mesh-ancestor
25499150|NCT00743197|Antipyretics|antipyretics|mesh-ancestor
24396124|NCT00137826|Growth Inhibitors|growth inhibitors|mesh-ancestor
24394278|NCT00132821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25616744|NCT01158651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616745|NCT01158703|Aspirin|aspirin|mesh-list
25616746|NCT01158703|Clopidogrel|clopidogrel|mesh-list
25616747|NCT01158703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25616748|NCT01158703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25616749|NCT01158703|Analgesics|analgesics|mesh-ancestor
25616750|NCT01158703|Sensory System Agents|sensory system agents|mesh-ancestor
25616751|NCT01158703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25616752|NCT01158703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616753|NCT01158703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25616754|NCT01158703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25616755|NCT01158703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25616756|NCT01158703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24399639|NCT00148291|Tubulin Modulators|tubulin modulators|mesh-ancestor
24399640|NCT00148291|Antimitotic Agents|antimitotic agents|mesh-ancestor
24399641|NCT00148291|Mitosis Modulators|mitosis modulators|mesh-ancestor
24399642|NCT00148291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459867|NCT00346684|Immunologic Factors|immunologic factors|mesh-ancestor
24400092|NCT00149656|Antioxidants|antioxidants|mesh-ancestor
25616757|NCT01158703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616758|NCT01158703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25616759|NCT01158703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25616760|NCT01158703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616761|NCT01158703|Antipyretics|antipyretics|mesh-ancestor
25616762|NCT01158703|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25616763|NCT01158703|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25616764|NCT01158703|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25616765|NCT01158703|Purinergic Agents|purinergic agents|mesh-ancestor
25616766|NCT01158703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25616767|NCT01158820|Diphenhydramine|diphenhydramine|mesh-list
25616768|NCT01158820|Fentanyl|fentanyl|mesh-list
25616769|NCT01158820|Midazolam|midazolam|mesh-list
25616770|NCT01158820|Dexmedetomidine|dexmedetomidine|mesh-list
25616771|NCT01158820|Ketamine|ketamine|mesh-list
25616772|NCT01158820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25713347|NCT02337946|Vitamin B Complex|vitamin b complex|mesh-ancestor
25616773|NCT01158820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25616774|NCT01158820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511310|NCT00392925|Pramlintide|pramlintide|mesh-list
25616775|NCT01158820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25616776|NCT01158820|Analgesics|analgesics|mesh-ancestor
25616777|NCT01158820|Sensory System Agents|sensory system agents|mesh-ancestor
25616778|NCT01158820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25616779|NCT01158820|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25616780|NCT01158820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25616781|NCT01158820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25616782|NCT01158820|Adrenergic Agents|adrenergic agents|mesh-ancestor
25616783|NCT01158820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25713360|NCT02338362|Xhance|xhance|mesh-list
25713366|NCT02338362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25616784|NCT01158820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616785|NCT01158820|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25616786|NCT01158820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25616787|NCT01158820|Anesthetics, General|anesthetics, general|mesh-ancestor
25616788|NCT01158820|Anesthetics|anesthetics|mesh-ancestor
25616789|NCT01158820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25616790|NCT01158820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25616791|NCT01158820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25616792|NCT01158820|Narcotics|narcotics|mesh-ancestor
25616793|NCT01158820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25616794|NCT01158820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25616795|NCT01158820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25616796|NCT01158820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25616797|NCT01158820|GABA Modulators|gaba modulators|mesh-ancestor
25616798|NCT01158820|GABA Agents|gaba agents|mesh-ancestor
25616799|NCT01158820|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25616800|NCT01158820|Anesthetics, Local|anesthetics, local|mesh-ancestor
25616801|NCT01158820|Antiemetics|antiemetics|mesh-ancestor
25616802|NCT01158820|Autonomic Agents|autonomic agents|mesh-ancestor
25616803|NCT01158820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25616804|NCT01158820|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25616805|NCT01158820|Histamine Antagonists|histamine antagonists|mesh-ancestor
25616806|NCT01158820|Histamine Agents|histamine agents|mesh-ancestor
25616807|NCT01158820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25616808|NCT01158885|Cytarabine|cytarabine|mesh-list
25616809|NCT01158885|Methotrexate|methotrexate|mesh-list
25616810|NCT01158885|Clofarabine|clofarabine|mesh-list
25713387|NCT02339038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25616811|NCT01158885|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25616812|NCT01158885|Abortifacient Agents|abortifacient agents|mesh-ancestor
25616813|NCT01158885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25616814|NCT01158885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616815|NCT01158885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25616816|NCT01158885|Antimetabolites|antimetabolites|mesh-ancestor
25616817|NCT01158885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616818|NCT01158885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25616819|NCT01158885|Dermatologic Agents|dermatologic agents|mesh-ancestor
25616820|NCT01158885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616821|NCT01158885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25616822|NCT01158885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25616823|NCT01158885|Immunologic Factors|immunologic factors|mesh-ancestor
25616824|NCT01158885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25616825|NCT01158885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25616826|NCT01158885|Antiviral Agents|antiviral agents|mesh-ancestor
25616827|NCT01158885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25616828|NCT01158950|Tolcapone|tolcapone|mesh-list
25616829|NCT01158950|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25616830|NCT01158950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25616831|NCT01158950|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25616832|NCT01158950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616833|NCT01158950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616834|NCT01159054|Niacin|niacin|mesh-list
25616835|NCT01159054|Nicotinic Acids|nicotinic acids|mesh-list
25616836|NCT01159054|Niacinamide|niacinamide|mesh-list
25616837|NCT01159054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25616838|NCT01159054|Antimetabolites|antimetabolites|mesh-ancestor
25616839|NCT01159054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616840|NCT01159054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25616841|NCT01159054|Vasodilator Agents|vasodilator agents|mesh-ancestor
25616842|NCT01159054|Vitamin B Complex|vitamin b complex|mesh-ancestor
25616843|NCT01159054|Vitamins|vitamins|mesh-ancestor
25616844|NCT01159054|Micronutrients|micronutrients|mesh-ancestor
25616845|NCT01159054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616846|NCT01159067|Deferasirox|deferasirox|mesh-list
25616847|NCT01159067|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25616848|NCT01159067|Chelating Agents|chelating agents|mesh-ancestor
25616849|NCT01159067|Sequestering Agents|sequestering agents|mesh-ancestor
25616850|NCT01159067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616851|NCT01159171|Bevacizumab|bevacizumab|mesh-list
25616853|NCT01159171|Oxaliplatin|oxaliplatin|mesh-list
25616854|NCT01159171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25616855|NCT01159171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25616856|NCT01159171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25616857|NCT01159171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25616858|NCT01159171|Growth Substances|growth substances|mesh-ancestor
25616859|NCT01159171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616860|NCT01159171|Growth Inhibitors|growth inhibitors|mesh-ancestor
25616861|NCT01159171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25616862|NCT01159171|Antimetabolites|antimetabolites|mesh-ancestor
25616863|NCT01159171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616864|NCT01159262|Fentanyl|fentanyl|mesh-list
25616865|NCT01159262|Midazolam|midazolam|mesh-list
25616866|NCT01159262|Dexmedetomidine|dexmedetomidine|mesh-list
25616867|NCT01159262|Morphine|morphine|mesh-list
25616868|NCT01159262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25616869|NCT01159262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25616870|NCT01159262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616871|NCT01159262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25616872|NCT01159262|Analgesics|analgesics|mesh-ancestor
25616873|NCT01159262|Sensory System Agents|sensory system agents|mesh-ancestor
25616874|NCT01159262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25616875|NCT01159262|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25616876|NCT01159262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25511452|NCT00393367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25511453|NCT00393367|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25511454|NCT00393367|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25511455|NCT00393367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25511456|NCT00393367|Adrenergic Agents|adrenergic agents|mesh-ancestor
25511457|NCT00393367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25713409|NCT02339246|Tacrolimus|tacrolimus|mesh-list
25713410|NCT02339246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25511458|NCT00393367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511459|NCT00393367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25511460|NCT00393367|Cholinergic Agents|cholinergic agents|mesh-ancestor
25511461|NCT00393380|Teriparatide|teriparatide|mesh-list
25511462|NCT00393380|Hormones|hormones|mesh-list
25511463|NCT00393380|Parathyroid Hormone|parathyroid hormone|mesh-list
25511464|NCT00393380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25511465|NCT00393380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511466|NCT00393380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25511467|NCT00393380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25511468|NCT00393458|Formoterol Fumarate|formoterol fumarate|mesh-list
25511469|NCT00393458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25511470|NCT00393458|Autonomic Agents|autonomic agents|mesh-ancestor
25511471|NCT00393458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25511472|NCT00393458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511473|NCT00393458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25511474|NCT00393458|Respiratory System Agents|respiratory system agents|mesh-ancestor
25511481|NCT00393484|Lamivudine|lamivudine|mesh-list
25616877|NCT01159262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25616878|NCT01159262|Adrenergic Agents|adrenergic agents|mesh-ancestor
25616879|NCT01159262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25616880|NCT01159262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616881|NCT01159262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25616882|NCT01159262|Narcotics|narcotics|mesh-ancestor
25616883|NCT01159262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25616884|NCT01159262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25616885|NCT01159262|Anesthetics, General|anesthetics, general|mesh-ancestor
25616886|NCT01159262|Anesthetics|anesthetics|mesh-ancestor
25616887|NCT01159262|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25616888|NCT01159262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25616889|NCT01159262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25616890|NCT01159262|GABA Modulators|gaba modulators|mesh-ancestor
25616891|NCT01159262|GABA Agents|gaba agents|mesh-ancestor
25616892|NCT01159574|Clarithromycin|clarithromycin|mesh-list
25616893|NCT01159574|Dexamethasone|dexamethasone|mesh-list
25616894|NCT01159574|Pomalidomide|pomalidomide|mesh-list
25616895|NCT01159574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25616896|NCT01159574|Antiemetics|antiemetics|mesh-ancestor
25616897|NCT01159574|Autonomic Agents|autonomic agents|mesh-ancestor
25616898|NCT01159574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25616899|NCT01159574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616900|NCT01159574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25616901|NCT01159574|Glucocorticoids|glucocorticoids|mesh-ancestor
25616902|NCT01159574|Hormones|hormones|mesh-ancestor
25616903|NCT01159574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25616904|NCT01159574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25616905|NCT01159574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25616906|NCT01159574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25616907|NCT01159574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25616908|NCT01159574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25616909|NCT01159574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616910|NCT01159574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461228|NCT00351507|Protease Inhibitors|protease inhibitors|mesh-ancestor
25616911|NCT01159574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25616912|NCT01159574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25616913|NCT01159574|Immunologic Factors|immunologic factors|mesh-ancestor
25616914|NCT01159574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25616915|NCT01159574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25616916|NCT01159574|Growth Substances|growth substances|mesh-ancestor
25616917|NCT01159574|Growth Inhibitors|growth inhibitors|mesh-ancestor
25616919|NCT01159600|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25616920|NCT01159600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616921|NCT01159600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25616922|NCT01159600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616923|NCT01159665|Plasminogen|plasminogen|mesh-list
25616924|NCT01159665|Fibrinolysin|fibrinolysin|mesh-list
25616925|NCT01159665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25616926|NCT01159665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25616927|NCT01159665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616928|NCT01159769|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25616929|NCT01159769|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25616930|NCT01159769|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25616931|NCT01159769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25616932|NCT01159769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25616933|NCT01159769|Analgesics|analgesics|mesh-ancestor
25616934|NCT01159769|Sensory System Agents|sensory system agents|mesh-ancestor
25616935|NCT01159769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25616936|NCT01159769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616937|NCT01159769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25616938|NCT01159769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25616939|NCT01159769|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25616940|NCT01159769|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25616941|NCT01159769|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25616942|NCT01159769|Histamine Antagonists|histamine antagonists|mesh-ancestor
25616943|NCT01159769|Histamine Agents|histamine agents|mesh-ancestor
25616944|NCT01159769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25616945|NCT01159769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616946|NCT01159912|Fluticasone|fluticasone|mesh-list
25616947|NCT01159912|Xhance|xhance|mesh-list
24555887|NCT00744107|Cobalt|cobalt|mesh-list
25616948|NCT01159912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25616949|NCT01159912|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25616950|NCT01159912|Autonomic Agents|autonomic agents|mesh-ancestor
25616951|NCT01159912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25616952|NCT01159912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616953|NCT01159912|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25616954|NCT01159912|Respiratory System Agents|respiratory system agents|mesh-ancestor
25616955|NCT01159912|Dermatologic Agents|dermatologic agents|mesh-ancestor
25616956|NCT01159912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25616957|NCT01159938|Insulin Lispro|insulin lispro|mesh-list
25616958|NCT01159938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25616959|NCT01159938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616960|NCT01160198|Ascorbic Acid|ascorbic acid|mesh-list
25616961|NCT01160198|Chelating Agents|chelating agents|mesh-list
25616962|NCT01160198|Glycine|glycine|mesh-list
25616963|NCT01160198|Sequestering Agents|sequestering agents|mesh-ancestor
25616964|NCT01160198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616965|NCT01160198|Glycine Agents|glycine agents|mesh-ancestor
25616966|NCT01160198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25616967|NCT01160198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616968|NCT01160198|Antioxidants|antioxidants|mesh-ancestor
25616969|NCT01160198|Protective Agents|protective agents|mesh-ancestor
25616970|NCT01160198|Vitamins|vitamins|mesh-ancestor
25616971|NCT01160198|Micronutrients|micronutrients|mesh-ancestor
25616972|NCT01160289|Tadalafil|tadalafil|mesh-list
25616973|NCT01160289|Vasodilator Agents|vasodilator agents|mesh-ancestor
25616974|NCT01160289|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25616975|NCT01160289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25511496|NCT00393718|Liraglutide|liraglutide|mesh-list
25616976|NCT01160289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25616977|NCT01160289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616978|NCT01160289|Urological Agents|urological agents|mesh-ancestor
25616980|NCT01160354|Clofarabine|clofarabine|mesh-list
25616981|NCT01160354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25616982|NCT01160354|Antimetabolites|antimetabolites|mesh-ancestor
25616983|NCT01160354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616984|NCT01160354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25616985|NCT01160354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25616986|NCT01160354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25616987|NCT01160354|Antiviral Agents|antiviral agents|mesh-ancestor
25616988|NCT01160354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24566910|NCT00788515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566911|NCT00788515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24566912|NCT00788515|Serotonin Agents|serotonin agents|mesh-ancestor
25616989|NCT01160380|Modafinil|modafinil|mesh-list
25616990|NCT01160380|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25616991|NCT01160380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25616992|NCT01160380|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25616993|NCT01160380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25616994|NCT01160380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24569463|NCT00800709|Memantine|memantine|mesh-list
25616995|NCT01160380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25616996|NCT01160445|Aldesleukin|aldesleukin|mesh-list
25616997|NCT01160445|Zanolimumab|zanolimumab|mesh-list
25616998|NCT01160445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25616999|NCT01160445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25617000|NCT01160445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25617001|NCT01160445|Antiviral Agents|antiviral agents|mesh-ancestor
25617002|NCT01160445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25617003|NCT01160445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25617004|NCT01160484|Lenalidomide|lenalidomide|mesh-list
25617005|NCT01160484|Immunologic Factors|immunologic factors|mesh-ancestor
25617006|NCT01160484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617007|NCT01160484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25617008|NCT01160484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25617009|NCT01160484|Growth Substances|growth substances|mesh-ancestor
25617010|NCT01160484|Growth Inhibitors|growth inhibitors|mesh-ancestor
25617011|NCT01160484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617012|NCT01160614|Oxycodone|oxycodone|mesh-list
25617013|NCT01160614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25617014|NCT01160614|Narcotics|narcotics|mesh-ancestor
25617015|NCT01160614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25617016|NCT01160614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617017|NCT01160614|Analgesics|analgesics|mesh-ancestor
25617018|NCT01160614|Sensory System Agents|sensory system agents|mesh-ancestor
25617019|NCT01160614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25617020|NCT01160640|Metronidazole|metronidazole|mesh-list
25617021|NCT01160640|Doxycycline|doxycycline|mesh-list
25617022|NCT01160640|Ceftriaxone|ceftriaxone|mesh-list
25617023|NCT01160640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25617024|NCT01160640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25617025|NCT01160640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25617026|NCT01160640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25617027|NCT01160640|Antimalarials|antimalarials|mesh-ancestor
25617028|NCT01160744|Gemcitabine|gemcitabine|mesh-list
25617029|NCT01160744|Cisplatin|cisplatin|mesh-list
25617030|NCT01160744|Carboplatin|carboplatin|mesh-list
25617031|NCT01160744|Pemetrexed|pemetrexed|mesh-list
25617032|NCT01160744|Ramucirumab|ramucirumab|mesh-list
25617033|NCT01160744|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25617034|NCT01160744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617035|NCT01160744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25617036|NCT01160744|Antimetabolites|antimetabolites|mesh-ancestor
25617037|NCT01160744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617038|NCT01160744|Antiviral Agents|antiviral agents|mesh-ancestor
25617039|NCT01160744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25713479|NCT02340949|Aflibercept|aflibercept|mesh-list
25617040|NCT01160744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617041|NCT01160744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25617042|NCT01160744|Immunologic Factors|immunologic factors|mesh-ancestor
25617043|NCT01160744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617044|NCT01160744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25617045|NCT01160744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25617046|NCT01160770|Clobazam|clobazam|mesh-list
25617047|NCT01160770|Anticonvulsants|anticonvulsants|mesh-ancestor
25617048|NCT01160770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25617049|NCT01160770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25617050|NCT01160770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25617051|NCT01160770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617052|NCT01160770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25617053|NCT01160770|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25617054|NCT01160770|GABA Agonists|gaba agonists|mesh-ancestor
25617055|NCT01160770|GABA Agents|gaba agents|mesh-ancestor
25617056|NCT01160770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25617057|NCT01160770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617058|NCT01160822|Naproxen|naproxen|mesh-list
25617059|NCT01160822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25617060|NCT01160822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25617061|NCT01160822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25617062|NCT01160822|Analgesics|analgesics|mesh-ancestor
25617063|NCT01160822|Sensory System Agents|sensory system agents|mesh-ancestor
25617064|NCT01160822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25617065|NCT01160822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617066|NCT01160822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25617067|NCT01160822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25617068|NCT01160822|Gout Suppressants|gout suppressants|mesh-ancestor
25617069|NCT01160822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25617070|NCT01160822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617071|NCT01160822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617072|NCT01160822|Immunologic Factors|immunologic factors|mesh-ancestor
25617073|NCT01160848|Ethanol|ethanol|mesh-list
25617074|NCT01160848|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25617075|NCT01160848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25617076|NCT01160848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25713509|NCT02340975|Tremelimumab|tremelimumab|mesh-list
25617077|NCT01160848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617078|NCT01161121|Adenosine|adenosine|mesh-list
25617079|NCT01161121|Regadenoson|regadenoson|mesh-list
25617080|NCT01161121|Analgesics|analgesics|mesh-ancestor
25617081|NCT01161121|Sensory System Agents|sensory system agents|mesh-ancestor
25617082|NCT01161121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25617083|NCT01161121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617084|NCT01161121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25617085|NCT01161121|Vasodilator Agents|vasodilator agents|mesh-ancestor
25617086|NCT01161121|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25617087|NCT01161121|Purinergic Agonists|purinergic agonists|mesh-ancestor
25617088|NCT01161121|Purinergic Agents|purinergic agents|mesh-ancestor
25617089|NCT01161121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25617090|NCT01161121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617091|NCT01161121|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25617092|NCT01161173|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25617093|NCT01161173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617094|NCT01161173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25617095|NCT01161173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617096|NCT01161173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617097|NCT01161407|Calcium Carbonate|calcium carbonate|mesh-list
25617098|NCT01161407|Calcium|calcium|mesh-list
25617099|NCT01161407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25617100|NCT01161407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617101|NCT01161407|Antacids|antacids|mesh-ancestor
25617102|NCT01161407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617103|NCT01161407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25617104|NCT01161446|Antibodies|antibodies|mesh-list
25617105|NCT01161446|Immunoglobulins|immunoglobulins|mesh-list
25617106|NCT01161446|Immunologic Factors|immunologic factors|mesh-ancestor
25617107|NCT01161446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617108|NCT01161472|Alprazolam|alprazolam|mesh-list
25617109|NCT01161472|Fesoterodine|fesoterodine|mesh-list
25617110|NCT01161472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25617111|NCT01161472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25617112|NCT01161472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617113|NCT01161472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25617114|NCT01161472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25617115|NCT01161472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25617116|NCT01161472|GABA Modulators|gaba modulators|mesh-ancestor
25617117|NCT01161472|GABA Agents|gaba agents|mesh-ancestor
25617118|NCT01161472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25617119|NCT01161472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617120|NCT01161472|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25617121|NCT01161472|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25617122|NCT01161472|Cholinergic Agents|cholinergic agents|mesh-ancestor
25617123|NCT01161472|Urological Agents|urological agents|mesh-ancestor
25617124|NCT01161498|Cisplatin|cisplatin|mesh-list
25617125|NCT01161498|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25617126|NCT01161498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617127|NCT01161498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25617129|NCT01161537|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25617130|NCT01161537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25617131|NCT01161537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617132|NCT01161563|Leuprolide|leuprolide|mesh-list
25617133|NCT01161563|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25617134|NCT01161563|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25617135|NCT01161563|Fertility Agents|fertility agents|mesh-ancestor
25617136|NCT01161563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25617137|NCT01161563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617138|NCT01161563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25617139|NCT01161563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617140|NCT01161563|Luteolytic Agents|luteolytic agents|mesh-ancestor
25713525|NCT02341417|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25713526|NCT02341417|Hormone Antagonists|hormone antagonists|mesh-ancestor
25713527|NCT02341417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24600145|NCT02465138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600146|NCT02440425|Paclitaxel|paclitaxel|mesh-list
24636351|NCT01144923|Nortriptyline|nortriptyline|mesh-list
24600280|NCT01529593|Immunologic Factors|immunologic factors|mesh-ancestor
24600282|NCT01446133|Lenalidomide|lenalidomide|mesh-list
24600283|NCT01446133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24600284|NCT01446133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600285|NCT01446133|Immunologic Factors|immunologic factors|mesh-ancestor
24600286|NCT01446133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600287|NCT01446133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24600288|NCT01446133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24600289|NCT01446133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24600290|NCT01446133|Growth Substances|growth substances|mesh-ancestor
24600291|NCT01446133|Growth Inhibitors|growth inhibitors|mesh-ancestor
24600292|NCT01264679|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24600293|NCT01264679|Hematinics|hematinics|mesh-ancestor
24600294|NCT01264679|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24600298|NCT01155388|Hematinics|hematinics|mesh-ancestor
24863094|NCT03261830|Cefazolin|cefazolin|mesh-list
24863112|NCT03088059|Durvalumab|durvalumab|mesh-list
25617141|NCT01161563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25617142|NCT01161563|Contraceptive Agents|contraceptive agents|mesh-ancestor
25617143|NCT01161563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25617144|NCT01161628|Rituximab|rituximab|mesh-list
25617145|NCT01161628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25617146|NCT01161628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617147|NCT01161628|Immunologic Factors|immunologic factors|mesh-ancestor
25617148|NCT01161628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617149|NCT01161628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25617150|NCT01161862|Glucagon|glucagon|mesh-list
25617151|NCT01161862|Pancrelipase|pancrelipase|mesh-list
25617152|NCT01161862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617153|NCT01161862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25713535|NCT02341456|Mitosis Modulators|mitosis modulators|mesh-ancestor
25713536|NCT02341456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863170|NCT02934529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24863171|NCT02934529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542940|NCT00681148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24542941|NCT00681148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24542949|NCT00681174|Morphine|morphine|mesh-list
24863178|NCT02934529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863179|NCT02934529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24863180|NCT02934529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24863182|NCT02934529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24863183|NCT02934529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24863184|NCT02934529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24863185|NCT02934529|Antidotes|antidotes|mesh-ancestor
24863284|NCT01024608|Beclomethasone|beclomethasone|mesh-list
24863285|NCT01024608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24863286|NCT01024608|Glucocorticoids|glucocorticoids|mesh-ancestor
24863287|NCT01024608|Hormones|hormones|mesh-ancestor
24863288|NCT01024608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24863289|NCT01024608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543043|NCT00681746|Flumazenil|flumazenil|mesh-list
24543065|NCT00681876|Cetuximab|cetuximab|mesh-list
24543066|NCT00681876|Irinotecan|irinotecan|mesh-list
24543067|NCT00681876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25713537|NCT02341456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770910|NCT03573908|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25770911|NCT03573908|Enzyme Activators|enzyme activators|mesh-ancestor
25770912|NCT03573908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770913|NCT03573908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25617154|NCT01161862|Hormones|hormones|mesh-ancestor
25617155|NCT01161862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25617156|NCT01162005|Tacrolimus|tacrolimus|mesh-list
25617157|NCT01162005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25617158|NCT01162005|Immunologic Factors|immunologic factors|mesh-ancestor
25617159|NCT01162005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617160|NCT01162005|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25617161|NCT01162005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617162|NCT01162005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617163|NCT01162122|Vaccines|vaccines|mesh-list
25617164|NCT01162122|Immunologic Factors|immunologic factors|mesh-ancestor
25713538|NCT02341482|Itraconazole|itraconazole|mesh-list
24863312|NCT00838981|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24863313|NCT00838981|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24863314|NCT00838981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24863315|NCT00838981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863317|NCT00730639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24863318|NCT00730639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863319|NCT00730639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24863320|NCT00730639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863321|NCT00363038|Vitamins|vitamins|mesh-list
24863340|NCT05146245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24863341|NCT05146245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813588|NCT02059564|Exenatide|exenatide|mesh-list
24813589|NCT02059564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24813590|NCT02059564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813595|NCT02059590|Isavuconazole|isavuconazole|mesh-list
25617165|NCT01162122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617166|NCT01162135|Digoxin|digoxin|mesh-list
25617167|NCT01162135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25617168|NCT01162135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25617169|NCT01162135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617170|NCT01162135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617171|NCT01162135|Protective Agents|protective agents|mesh-ancestor
25617172|NCT01162135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617173|NCT01162239|Varenicline|varenicline|mesh-list
25617174|NCT01162239|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25617175|NCT01162239|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25617176|NCT01162239|Cholinergic Agents|cholinergic agents|mesh-ancestor
25617177|NCT01162239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24863384|NCT05145270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24863385|NCT05145270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24863386|NCT05145270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863387|NCT05145270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24863388|NCT05145270|Serotonin Agents|serotonin agents|mesh-ancestor
24863389|NCT05145270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863390|NCT05145270|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24863391|NCT05145270|Antidepressive Agents|antidepressive agents|mesh-ancestor
24863392|NCT05145270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24863393|NCT05145270|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24863394|NCT05145270|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24863395|NCT05145270|Parasympatholytics|parasympatholytics|mesh-ancestor
24863396|NCT05145270|Autonomic Agents|autonomic agents|mesh-ancestor
24863447|NCT04956302|Dexamethasone acetate|dexamethasone acetate|mesh-list
25617178|NCT01162239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617179|NCT01162239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617180|NCT01162421|Adalimumab|adalimumab|mesh-list
25617181|NCT01162421|Methotrexate|methotrexate|mesh-list
25617182|NCT01162421|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25617183|NCT01162421|Abortifacient Agents|abortifacient agents|mesh-ancestor
25617184|NCT01162421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25617185|NCT01162421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617186|NCT01162421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25617187|NCT01162421|Antimetabolites|antimetabolites|mesh-ancestor
25617188|NCT01162421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617189|NCT01162421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617190|NCT01162421|Dermatologic Agents|dermatologic agents|mesh-ancestor
25617191|NCT01162421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617192|NCT01162421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25617193|NCT01162421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25617194|NCT01162421|Immunologic Factors|immunologic factors|mesh-ancestor
25617195|NCT01162421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25617196|NCT01162421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25617197|NCT01162421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25617198|NCT01162473|Caseins|caseins|mesh-list
25617199|NCT01162473|Chelating Agents|chelating agents|mesh-ancestor
25511715|NCT00394914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25511716|NCT00394953|Darbepoetin alfa|darbepoetin alfa|mesh-list
25511717|NCT00394953|Hematinics|hematinics|mesh-ancestor
25617200|NCT01162473|Sequestering Agents|sequestering agents|mesh-ancestor
25617201|NCT01162473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617203|NCT01162486|Rifapentine|rifapentine|mesh-list
25617204|NCT01162486|Midazolam|midazolam|mesh-list
25617205|NCT01162486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25617206|NCT01162486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25617207|NCT01162486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25617208|NCT01162486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617209|NCT01162486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25617210|NCT01162486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25617211|NCT01162486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25617212|NCT01162486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25617213|NCT01162486|Anesthetics, General|anesthetics, general|mesh-ancestor
25617214|NCT01162486|Anesthetics|anesthetics|mesh-ancestor
25617215|NCT01162486|GABA Modulators|gaba modulators|mesh-ancestor
25617216|NCT01162486|GABA Agents|gaba agents|mesh-ancestor
25617217|NCT01162486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25617218|NCT01162486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617219|NCT01162486|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25617220|NCT01162486|Antitubercular Agents|antitubercular agents|mesh-ancestor
25617221|NCT01162486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25617222|NCT01162486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25617223|NCT01162486|Leprostatic Agents|leprostatic agents|mesh-ancestor
25617224|NCT01162486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25617225|NCT01162486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713569|NCT02342223|Immunologic Factors|immunologic factors|mesh-ancestor
25617226|NCT01162486|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25617227|NCT01162486|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25617228|NCT01162486|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25617229|NCT01162486|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25617230|NCT01162486|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25617231|NCT01162486|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25617232|NCT01162551|Sirolimus|sirolimus|mesh-list
25617233|NCT01162551|Methotrexate|methotrexate|mesh-list
25617234|NCT01162551|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25617235|NCT01162551|Abortifacient Agents|abortifacient agents|mesh-ancestor
25617236|NCT01162551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25617237|NCT01162551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617238|NCT01162551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25617239|NCT01162551|Antimetabolites|antimetabolites|mesh-ancestor
25617240|NCT01162551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617241|NCT01162551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617242|NCT01162551|Dermatologic Agents|dermatologic agents|mesh-ancestor
25617243|NCT01162551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617244|NCT01162551|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25617245|NCT01162551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25617246|NCT01162551|Immunologic Factors|immunologic factors|mesh-ancestor
25617247|NCT01162551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25713578|NCT02342379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617248|NCT01162551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25617249|NCT01162551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25617250|NCT01162551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25617251|NCT01162551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25617252|NCT01162551|Antifungal Agents|antifungal agents|mesh-ancestor
25617253|NCT01162733|Vancomycin|vancomycin|mesh-list
25617254|NCT01162733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25617255|NCT01162733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25617256|NCT01162863|Lubiprostone|lubiprostone|mesh-list
25617257|NCT01162863|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25617258|NCT01162863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25617259|NCT01162863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617260|NCT01163097|Heparin|heparin|mesh-list
25617261|NCT01163097|Anticoagulants|anticoagulants|mesh-ancestor
25617262|NCT01163097|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25617263|NCT01163097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25617264|NCT01163097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617265|NCT01163149|Immunoglobulin G|immunoglobulin g|mesh-list
25617266|NCT01163149|Immunologic Factors|immunologic factors|mesh-ancestor
25617267|NCT01163149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617268|NCT01163214|Ropivacaine|ropivacaine|mesh-list
25617269|NCT01163214|Anesthetics, Local|anesthetics, local|mesh-ancestor
25617270|NCT01163214|Anesthetics|anesthetics|mesh-ancestor
25617271|NCT01163214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25617272|NCT01163214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617273|NCT01163214|Sensory System Agents|sensory system agents|mesh-ancestor
25617274|NCT01163214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25617275|NCT01163253|Tofacitinib|tofacitinib|mesh-list
25617276|NCT01163253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25617277|NCT01163253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617278|NCT01163253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617279|NCT01163266|Vortioxetine|vortioxetine|mesh-list
25617280|NCT01163266|Antidepressive Agents|antidepressive agents|mesh-ancestor
25617281|NCT01163266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25617282|NCT01163266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25617283|NCT01163266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25617284|NCT01163266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25617285|NCT01163266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617286|NCT01163266|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25617287|NCT01163266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25617288|NCT01163266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25617289|NCT01163266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617290|NCT01163266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25617291|NCT01163266|Serotonin Agents|serotonin agents|mesh-ancestor
25617292|NCT01163266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25617293|NCT01163266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25617294|NCT01163266|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25617295|NCT01163266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25617296|NCT01163604|Aspirin|aspirin|mesh-list
25617297|NCT01163604|Argatroban|argatroban|mesh-list
25617298|NCT01163604|Clopidogrel|clopidogrel|mesh-list
25617299|NCT01163604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25617300|NCT01163604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25617301|NCT01163604|Analgesics|analgesics|mesh-ancestor
25617302|NCT01163604|Sensory System Agents|sensory system agents|mesh-ancestor
25617303|NCT01163604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25617304|NCT01163604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617305|NCT01163604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25617306|NCT01163604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25617307|NCT01163604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25617308|NCT01163604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25617309|NCT01163604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617310|NCT01163604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25617311|NCT01163604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25617312|NCT01163604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617313|NCT01163604|Antipyretics|antipyretics|mesh-ancestor
25617314|NCT01163604|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25617315|NCT01163604|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25617316|NCT01163604|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25617317|NCT01163604|Purinergic Agents|purinergic agents|mesh-ancestor
25617318|NCT01163604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25617319|NCT01163604|Antithrombins|antithrombins|mesh-ancestor
25617320|NCT01163604|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25617321|NCT01163604|Protease Inhibitors|protease inhibitors|mesh-ancestor
25617322|NCT01163604|Anticoagulants|anticoagulants|mesh-ancestor
25617323|NCT01163617|Adalimumab|adalimumab|mesh-list
25617324|NCT01163617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25617325|NCT01163617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25617326|NCT01163656|Cobalt|cobalt|mesh-list
25617327|NCT01163656|Trace Elements|trace elements|mesh-ancestor
25617328|NCT01163656|Micronutrients|micronutrients|mesh-ancestor
25617329|NCT01163656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617330|NCT01163721|Ranolazine|ranolazine|mesh-list
25617331|NCT01163721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25617332|NCT01163721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25617333|NCT01163721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617334|NCT01163747|Methotrexate|methotrexate|mesh-list
25617335|NCT01163747|Vaccines|vaccines|mesh-list
25617336|NCT01163747|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25617337|NCT01163747|Immunologic Factors|immunologic factors|mesh-ancestor
25617338|NCT01163747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617339|NCT01163747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25617340|NCT01163747|Abortifacient Agents|abortifacient agents|mesh-ancestor
25617341|NCT01163747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25617342|NCT01163747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25617343|NCT01163747|Antimetabolites|antimetabolites|mesh-ancestor
25617344|NCT01163747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617345|NCT01163747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617346|NCT01163747|Dermatologic Agents|dermatologic agents|mesh-ancestor
25713594|NCT02342704|Natalizumab|natalizumab|mesh-list
25511864|NCT00396019|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25617347|NCT01163747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617348|NCT01163747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25617349|NCT01163747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25617350|NCT01163747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25617351|NCT01163747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25617352|NCT01163786|Bortezomib|bortezomib|mesh-list
25617353|NCT01163786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617354|NCT01163851|Bococizumab|bococizumab|mesh-list
25617355|NCT01163851|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25617356|NCT01163851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25617357|NCT01163851|Antimetabolites|antimetabolites|mesh-ancestor
25617358|NCT01163851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617359|NCT01163851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25655181|NCT01559389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655182|NCT01559389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655183|NCT01559389|Urological Agents|urological agents|mesh-ancestor
25655184|NCT01559454|Buprenorphine|buprenorphine|mesh-list
25655185|NCT01559454|Methadone|methadone|mesh-list
25655186|NCT01559454|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25655187|NCT01559454|Naloxone|naloxone|mesh-list
25655188|NCT01559454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25655189|NCT01559454|Narcotics|narcotics|mesh-ancestor
24868018|NCT04079218|Estradiol|estradiol|mesh-list
25655190|NCT01559454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25655191|NCT01559454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655192|NCT01559454|Analgesics|analgesics|mesh-ancestor
25655193|NCT01559454|Sensory System Agents|sensory system agents|mesh-ancestor
25655194|NCT01559454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25655195|NCT01559454|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25655196|NCT01559454|Antitussive Agents|antitussive agents|mesh-ancestor
25655197|NCT01559454|Respiratory System Agents|respiratory system agents|mesh-ancestor
25657025|NCT01582243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657026|NCT01582243|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25657027|NCT01582243|Protease Inhibitors|protease inhibitors|mesh-ancestor
25657028|NCT01582243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657029|NCT01582243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657030|NCT01582282|Psyllium|psyllium|mesh-list
25657031|NCT01582282|Calcium polycarbophil|calcium polycarbophil|mesh-list
25657032|NCT01582282|Cathartics|cathartics|mesh-ancestor
25657033|NCT01582282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25657034|NCT01582282|Antidiarrheals|antidiarrheals|mesh-ancestor
25657035|NCT01582308|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25657036|NCT01582308|Vildagliptin|vildagliptin|mesh-list
25657037|NCT01582308|Saxagliptin|saxagliptin|mesh-list
25657038|NCT01582308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25657039|NCT01582308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657040|NCT01582308|Incretins|incretins|mesh-ancestor
25657041|NCT01582308|Hormones|hormones|mesh-ancestor
25657042|NCT01582308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25657043|NCT01582308|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25657044|NCT01582308|Protease Inhibitors|protease inhibitors|mesh-ancestor
25657045|NCT01582308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657046|NCT01582308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657047|NCT01582451|Insulin|insulin|mesh-list
25657048|NCT01582451|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25657049|NCT01582451|Insulin Glargine|insulin glargine|mesh-list
25657050|NCT01582451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25657051|NCT01582451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657052|NCT01582477|Bupivacaine|bupivacaine|mesh-list
25657053|NCT01582477|Anesthetics, Local|anesthetics, local|mesh-ancestor
25657054|NCT01582477|Anesthetics|anesthetics|mesh-ancestor
25657055|NCT01582477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25657056|NCT01582477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657057|NCT01582477|Sensory System Agents|sensory system agents|mesh-ancestor
25657058|NCT01582477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25657059|NCT01582490|Bupivacaine|bupivacaine|mesh-list
24868632|NCT03998293|Hormones|hormones|mesh-ancestor
25657060|NCT01582490|Anesthetics, Local|anesthetics, local|mesh-ancestor
25657061|NCT01582490|Anesthetics|anesthetics|mesh-ancestor
25657062|NCT01582490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25657063|NCT01582490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657064|NCT01582490|Sensory System Agents|sensory system agents|mesh-ancestor
25657065|NCT01582490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25657066|NCT01582854|Actovegin|actovegin|mesh-list
25511942|NCT00396565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25657067|NCT01582854|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25657068|NCT01582854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657069|NCT01582854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25617360|NCT01164007|Bevacizumab|bevacizumab|mesh-list
25617361|NCT01164007|Dacarbazine|dacarbazine|mesh-list
25617362|NCT01164007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25617363|NCT01164007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617364|NCT01164007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25617365|NCT01164007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25617366|NCT01164007|Growth Substances|growth substances|mesh-ancestor
25617367|NCT01164007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617368|NCT01164007|Growth Inhibitors|growth inhibitors|mesh-ancestor
25617369|NCT01164007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25617370|NCT01164007|Alkylating Agents|alkylating agents|mesh-ancestor
25617371|NCT01164007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617372|NCT01164098|Rituximab|rituximab|mesh-list
25617373|NCT01164098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25617374|NCT01164098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617375|NCT01164098|Immunologic Factors|immunologic factors|mesh-ancestor
25617376|NCT01164098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617377|NCT01164098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25617378|NCT01164475|Plerixafor|plerixafor|mesh-list
25617379|NCT01164475|Lenograstim|lenograstim|mesh-list
25617380|NCT01164475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25617381|NCT01164475|Immunologic Factors|immunologic factors|mesh-ancestor
25617382|NCT01164475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617383|NCT01164475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25617384|NCT01164475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25617385|NCT01164475|Antiviral Agents|antiviral agents|mesh-ancestor
25617386|NCT01164475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25617387|NCT01164501|Empagliflozin|empagliflozin|mesh-list
25617388|NCT01164501|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25617389|NCT01164501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617390|NCT01164501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25617391|NCT01164501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617392|NCT01164579|Methotrexate|methotrexate|mesh-list
25617393|NCT01164579|Tofacitinib|tofacitinib|mesh-list
25617394|NCT01164579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25617395|NCT01164579|Abortifacient Agents|abortifacient agents|mesh-ancestor
25617396|NCT01164579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25617397|NCT01164579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617398|NCT01164579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25617399|NCT01164579|Antimetabolites|antimetabolites|mesh-ancestor
25617400|NCT01164579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617401|NCT01164579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617402|NCT01164579|Dermatologic Agents|dermatologic agents|mesh-ancestor
25617403|NCT01164579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617404|NCT01164579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25617405|NCT01164579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25617406|NCT01164579|Immunologic Factors|immunologic factors|mesh-ancestor
25617407|NCT01164579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25617408|NCT01164579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25617409|NCT01164579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25617410|NCT01164956|Methylphenidate|methylphenidate|mesh-list
25617411|NCT01164956|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25617412|NCT01164956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617413|NCT01164956|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25617414|NCT01164956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25617415|NCT01164956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25617416|NCT01164956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617417|NCT01164956|Dopamine Agents|dopamine agents|mesh-ancestor
25617418|NCT01164956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25617419|NCT01165021|Folic Acid|folic acid|mesh-list
25617420|NCT01165021|Vitamin B 12|vitamin b 12|mesh-list
25617421|NCT01165021|Hydroxocobalamin|hydroxocobalamin|mesh-list
25617422|NCT01165021|Dexamethasone|dexamethasone|mesh-list
25617423|NCT01165021|Pemetrexed|pemetrexed|mesh-list
25617424|NCT01165021|Vitamins|vitamins|mesh-ancestor
25617425|NCT01165021|Micronutrients|micronutrients|mesh-ancestor
25617426|NCT01165021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617427|NCT01165021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617428|NCT01165021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25617429|NCT01165021|Antiemetics|antiemetics|mesh-ancestor
25617430|NCT01165021|Autonomic Agents|autonomic agents|mesh-ancestor
25617431|NCT01165021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25617432|NCT01165021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25617433|NCT01165021|Glucocorticoids|glucocorticoids|mesh-ancestor
25617434|NCT01165021|Hormones|hormones|mesh-ancestor
25655198|NCT01559675|Hydrocortisone|hydrocortisone|mesh-list
25617435|NCT01165021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25617436|NCT01165021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25617437|NCT01165021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617438|NCT01165021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617439|NCT01165021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25617440|NCT01165021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25617441|NCT01165021|Hematinics|hematinics|mesh-ancestor
25617442|NCT01165021|Vitamin B Complex|vitamin b complex|mesh-ancestor
25617443|NCT01165047|Nitric Oxide|nitric oxide|mesh-list
25617444|NCT01165047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25617445|NCT01165047|Autonomic Agents|autonomic agents|mesh-ancestor
25617446|NCT01165047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25617447|NCT01165047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617448|NCT01165047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25617449|NCT01165047|Respiratory System Agents|respiratory system agents|mesh-ancestor
24814642|NCT02065947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24869221|NCT04278404|Labetalol|labetalol|mesh-list
24869222|NCT04278404|Nicardipine|nicardipine|mesh-list
24869245|NCT04278404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869248|NCT04278404|Hormones|hormones|mesh-ancestor
25617450|NCT01165047|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25617451|NCT01165047|Antioxidants|antioxidants|mesh-ancestor
25617452|NCT01165047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617453|NCT01165047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25617454|NCT01165047|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25617455|NCT01165047|Vasodilator Agents|vasodilator agents|mesh-ancestor
25617456|NCT01165047|Gasotransmitters|gasotransmitters|mesh-ancestor
25617457|NCT01165047|Protective Agents|protective agents|mesh-ancestor
25617458|NCT01165112|Rituximab|rituximab|mesh-list
25617459|NCT01165112|Carboplatin|carboplatin|mesh-list
25617460|NCT01165112|Etoposide|etoposide|mesh-list
25617461|NCT01165112|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25617462|NCT01165112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25617463|NCT01165112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617464|NCT01165112|Immunologic Factors|immunologic factors|mesh-ancestor
25617465|NCT01165112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617466|NCT01165112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25617467|NCT01165112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25617468|NCT01165112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25617469|NCT01165112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25617470|NCT01165112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617471|NCT01165112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617472|NCT01165112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25617473|NCT01165112|Alkylating Agents|alkylating agents|mesh-ancestor
25617474|NCT01165138|Fluticasone|fluticasone|mesh-list
25617475|NCT01165138|Xhance|xhance|mesh-list
25617476|NCT01165138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25617477|NCT01165138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25617478|NCT01165138|Autonomic Agents|autonomic agents|mesh-ancestor
25617479|NCT01165138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25617480|NCT01165138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617481|NCT01165138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25617482|NCT01165138|Respiratory System Agents|respiratory system agents|mesh-ancestor
25617483|NCT01165138|Dermatologic Agents|dermatologic agents|mesh-ancestor
25617484|NCT01165138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25617485|NCT01165203|Vaccines|vaccines|mesh-list
25617486|NCT01165203|Immunologic Factors|immunologic factors|mesh-ancestor
25617487|NCT01165203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617488|NCT01165216|Paclitaxel|paclitaxel|mesh-list
25617489|NCT01165216|Carboplatin|carboplatin|mesh-list
25617490|NCT01165216|Ipilimumab|ipilimumab|mesh-list
25617491|NCT01165216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25512085|NCT00397904|Cisplatin|cisplatin|mesh-list
25512086|NCT00397904|Irinotecan|irinotecan|mesh-list
25512087|NCT00397904|Cetuximab|cetuximab|mesh-list
25512088|NCT00397904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512089|NCT00397904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25512090|NCT00397904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25512091|NCT00397904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499151|NCT00743197|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25512092|NCT00397904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512093|NCT00397904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25512094|NCT00397943|Vaccines|vaccines|mesh-list
25617492|NCT01165216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617493|NCT01165216|Tubulin Modulators|tubulin modulators|mesh-ancestor
25617494|NCT01165216|Antimitotic Agents|antimitotic agents|mesh-ancestor
25617495|NCT01165216|Mitosis Modulators|mitosis modulators|mesh-ancestor
25617496|NCT01165216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617497|NCT01165216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25617498|NCT01165216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25617499|NCT01165281|Oxycodone|oxycodone|mesh-list
25617500|NCT01165281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25617501|NCT01165281|Narcotics|narcotics|mesh-ancestor
25617502|NCT01165281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25617503|NCT01165281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617504|NCT01165281|Analgesics|analgesics|mesh-ancestor
25617505|NCT01165281|Sensory System Agents|sensory system agents|mesh-ancestor
25617506|NCT01165281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25617507|NCT01165307|Naproxen|naproxen|mesh-list
25617508|NCT01165307|Levonorgestrel|levonorgestrel|mesh-list
25617509|NCT01165307|Contraceptive Agents|contraceptive agents|mesh-list
25617510|NCT01165307|Contraceptives, Oral|contraceptives, oral|mesh-list
25617511|NCT01165307|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25617512|NCT01165307|Estradiol|estradiol|mesh-list
25617513|NCT01165307|Estrogens|estrogens|mesh-ancestor
25617514|NCT01165307|Hormones|hormones|mesh-ancestor
25617515|NCT01165307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25617516|NCT01165307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617517|NCT01165307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25617518|NCT01165307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25617519|NCT01165307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25617520|NCT01165307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25617521|NCT01165307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25617522|NCT01165307|Analgesics|analgesics|mesh-ancestor
25617523|NCT01165307|Sensory System Agents|sensory system agents|mesh-ancestor
25617524|NCT01165307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25617525|NCT01165307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25617526|NCT01165307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25617527|NCT01165307|Gout Suppressants|gout suppressants|mesh-ancestor
25617528|NCT01165307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25617529|NCT01165307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617530|NCT01165307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617531|NCT01165307|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25617532|NCT01165320|Caspofungin|caspofungin|mesh-list
25617533|NCT01165320|Antifungal Agents|antifungal agents|mesh-ancestor
25617534|NCT01165320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25617535|NCT01165320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617536|NCT01165320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617537|NCT01165541|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25617538|NCT01165541|Mirtazapine|mirtazapine|mesh-list
25617539|NCT01165541|Antidepressive Agents|antidepressive agents|mesh-ancestor
25617540|NCT01165541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25617541|NCT01165541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25617542|NCT01165541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25617543|NCT01165541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25617544|NCT01165541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617545|NCT01165541|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25617546|NCT01165541|Histamine Antagonists|histamine antagonists|mesh-ancestor
25617547|NCT01165541|Histamine Agents|histamine agents|mesh-ancestor
25617548|NCT01165541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25617549|NCT01165541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617550|NCT01165541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25617551|NCT01165541|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25617552|NCT01165541|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25617553|NCT01165541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25617554|NCT01165541|Adrenergic Agents|adrenergic agents|mesh-ancestor
25617555|NCT01165541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25617556|NCT01165541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25617557|NCT01165541|Serotonin Agents|serotonin agents|mesh-ancestor
25617558|NCT01165541|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25617559|NCT01165554|Flutemetamol|flutemetamol|mesh-list
25617560|NCT01165554|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25617561|NCT01165554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617562|NCT01165684|Insulin|insulin|mesh-list
25617563|NCT01165684|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25617564|NCT01165684|Insulin Aspart|insulin aspart|mesh-list
25617565|NCT01165684|Insulin, Long-Acting|insulin, long-acting|mesh-list
25617566|NCT01165684|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25617567|NCT01165684|Insulin Detemir|insulin detemir|mesh-list
25617568|NCT01165684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25617569|NCT01165684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617570|NCT01165840|Dapsone|dapsone|mesh-list
25617571|NCT01165840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25617572|NCT01165840|Antimalarials|antimalarials|mesh-ancestor
25617573|NCT01165840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25512152|NCT00398216|Edoxaban|edoxaban|mesh-list
25617574|NCT01165840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25617575|NCT01165840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25617576|NCT01165840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617577|NCT01165840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617578|NCT01165840|Leprostatic Agents|leprostatic agents|mesh-ancestor
25617579|NCT01165840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25617580|NCT01165996|Decitabine|decitabine|mesh-list
25617581|NCT01165996|Azacitidine|azacitidine|mesh-list
25617582|NCT01165996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25617583|NCT01165996|Antimetabolites|antimetabolites|mesh-ancestor
25499152|NCT00743197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25617584|NCT01165996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617585|NCT01165996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617586|NCT01165996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617587|NCT01166126|Sirolimus|sirolimus|mesh-list
25617588|NCT01166126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25617589|NCT01166126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25617590|NCT01166126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25617591|NCT01166126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617592|NCT01166126|Antifungal Agents|antifungal agents|mesh-ancestor
25617593|NCT01166126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25617594|NCT01166126|Immunologic Factors|immunologic factors|mesh-ancestor
25617595|NCT01166126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617596|NCT01166282|Adalimumab|adalimumab|mesh-list
25617597|NCT01166282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25617598|NCT01166282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25617599|NCT01166438|Solifenacin Succinate|solifenacin succinate|mesh-list
25617600|NCT01166438|Trospium chloride|trospium chloride|mesh-list
25617601|NCT01166438|Botulinum Toxins|botulinum toxins|mesh-list
25617602|NCT01166438|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25617603|NCT01166438|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25617604|NCT01166438|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25617605|NCT01166438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25617606|NCT01166438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617607|NCT01166438|Cholinergic Agents|cholinergic agents|mesh-ancestor
24872265|NCT05398055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25617608|NCT01166438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25617609|NCT01166438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617610|NCT01166438|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25617611|NCT01166438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25617612|NCT01166438|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25617613|NCT01166438|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25617614|NCT01166438|Urological Agents|urological agents|mesh-ancestor
25617615|NCT01166438|Parasympatholytics|parasympatholytics|mesh-ancestor
25617616|NCT01166438|Autonomic Agents|autonomic agents|mesh-ancestor
25617617|NCT01166646|Clobetasol|clobetasol|mesh-list
25617618|NCT01166646|Halobetasol|halobetasol|mesh-list
25617619|NCT01166646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25617620|NCT01166646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25617621|NCT01166646|Glucocorticoids|glucocorticoids|mesh-ancestor
25617622|NCT01166646|Hormones|hormones|mesh-ancestor
25617623|NCT01166646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25617624|NCT01166646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617625|NCT01166763|Vitamin D|vitamin d|mesh-list
25617626|NCT01166763|Cholecalciferol|cholecalciferol|mesh-list
25713684|NCT02343939|Antimetabolites|antimetabolites|mesh-ancestor
25617627|NCT01166763|Vitamins|vitamins|mesh-ancestor
25617628|NCT01166763|Micronutrients|micronutrients|mesh-ancestor
25617629|NCT01166763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617630|NCT01166763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25617631|NCT01166763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25617632|NCT01166945|Amoxicillin|amoxicillin|mesh-list
25617633|NCT01166945|Clavulanic Acid|clavulanic acid|mesh-list
25617634|NCT01166945|Clavulanic Acids|clavulanic acids|mesh-list
25617635|NCT01166945|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25617636|NCT01166945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25617637|NCT01166945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25617638|NCT01166945|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25617639|NCT01166945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617640|NCT01166945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617641|NCT01166958|Teriparatide|teriparatide|mesh-list
25617642|NCT01166958|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25617643|NCT01166958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25617644|NCT01166958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617645|NCT01166958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25512227|NCT00398866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25512228|NCT00398866|Glucocorticoids|glucocorticoids|mesh-ancestor
25617646|NCT01166958|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25512229|NCT00398866|Hormones|hormones|mesh-ancestor
25617647|NCT01166958|Hormone Antagonists|hormone antagonists|mesh-ancestor
25617648|NCT01166958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25617649|NCT01166958|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25617650|NCT01166958|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25617651|NCT01166997|Heparin|heparin|mesh-list
25617652|NCT01166997|Calcium heparin|calcium heparin|mesh-list
25617653|NCT01166997|Anticoagulants|anticoagulants|mesh-ancestor
25617654|NCT01166997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25617655|NCT01166997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25617656|NCT01166997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617657|NCT01167023|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24873775|NCT05025423|Venetoclax|venetoclax|mesh-list
25617658|NCT01167023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25617659|NCT01167153|Amlodipine|amlodipine|mesh-list
25617660|NCT01167153|Valsartan|valsartan|mesh-list
25617661|NCT01167153|Nifedipine|nifedipine|mesh-list
25617662|NCT01167153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25617663|NCT01167153|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25617664|NCT01167153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25617665|NCT01167153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617666|NCT01167153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25617667|NCT01167153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713701|NCT02344225|Caffeine|caffeine|mesh-list
25713702|NCT02344225|Caffeine citrate|caffeine citrate|mesh-list
24874414|NCT04767594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25617668|NCT01167153|Vasodilator Agents|vasodilator agents|mesh-ancestor
25617669|NCT01167153|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25617670|NCT01167153|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25617671|NCT01167153|Tocolytic Agents|tocolytic agents|mesh-ancestor
25617672|NCT01167153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25617673|NCT01167192|Cisplatin|cisplatin|mesh-list
25617674|NCT01167192|Carboplatin|carboplatin|mesh-list
25617675|NCT01167192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617676|NCT01167257|Botulinum Toxins|botulinum toxins|mesh-list
25617677|NCT01167257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25617678|NCT01167257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25617679|NCT01167257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25617680|NCT01167257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25617681|NCT01167257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617682|NCT01167257|Cholinergic Agents|cholinergic agents|mesh-ancestor
25617683|NCT01167257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25617684|NCT01167257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617685|NCT01167257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25617686|NCT01167257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25617687|NCT01167426|Glatiramer Acetate|glatiramer acetate|mesh-list
24698862|NCT01443195|Iron|iron|mesh-list
25617688|NCT01167426|(T,G)-A-L|(t,g)-a-l|mesh-list
25617689|NCT01167426|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25617690|NCT01167426|Immunologic Factors|immunologic factors|mesh-ancestor
25617691|NCT01167426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617692|NCT01167426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25617693|NCT01167426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25617694|NCT01167452|Trimethoprim|trimethoprim|mesh-list
25617695|NCT01167452|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25617696|NCT01167452|Sulfamethoxazole|sulfamethoxazole|mesh-list
25617697|NCT01167452|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25617698|NCT01167452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25617699|NCT01167452|Renal Agents|renal agents|mesh-ancestor
25617700|NCT01167452|Antimalarials|antimalarials|mesh-ancestor
25617701|NCT01167452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25617702|NCT01167452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25617703|NCT01167452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25617704|NCT01167452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617705|NCT01167452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617706|NCT01167452|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25617707|NCT01167452|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25617708|NCT01167452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25617709|NCT01167452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25617710|NCT01167569|Ascorbic Acid|ascorbic acid|mesh-list
25617711|NCT01167569|Vitamins|vitamins|mesh-ancestor
25617712|NCT01167569|Micronutrients|micronutrients|mesh-ancestor
25617713|NCT01167569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617714|NCT01167569|Antioxidants|antioxidants|mesh-ancestor
25617715|NCT01167569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617716|NCT01167569|Protective Agents|protective agents|mesh-ancestor
25617717|NCT01167829|Testosterone|testosterone|mesh-list
25617718|NCT01167829|Acyline|acyline|mesh-list
25617719|NCT01167829|Androgens|androgens|mesh-ancestor
25617720|NCT01167829|Hormones|hormones|mesh-ancestor
25657070|NCT01582854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25617721|NCT01167829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25617722|NCT01167829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617723|NCT01167829|Hormone Antagonists|hormone antagonists|mesh-ancestor
25617724|NCT01167881|Glimepiride|glimepiride|mesh-list
25617725|NCT01167881|Empagliflozin|empagliflozin|mesh-list
25617726|NCT01167881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25617727|NCT01167881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25617728|NCT01167881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617729|NCT01167881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25617730|NCT01167881|Immunologic Factors|immunologic factors|mesh-ancestor
25617731|NCT01167881|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25617732|NCT01167881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617733|NCT01167907|Ropivacaine|ropivacaine|mesh-list
25617734|NCT01167907|Anesthetics, Local|anesthetics, local|mesh-ancestor
25617735|NCT01167907|Anesthetics|anesthetics|mesh-ancestor
25617736|NCT01167907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25617737|NCT01167907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617738|NCT01167907|Sensory System Agents|sensory system agents|mesh-ancestor
25617739|NCT01167907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25617740|NCT01168232|Epothilones|epothilones|mesh-list
25617741|NCT01168232|Epothilone B|epothilone b|mesh-list
25617742|NCT01168232|Tubulin Modulators|tubulin modulators|mesh-ancestor
25617743|NCT01168232|Antimitotic Agents|antimitotic agents|mesh-ancestor
25617744|NCT01168232|Mitosis Modulators|mitosis modulators|mesh-ancestor
25617745|NCT01168232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617746|NCT01168232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617747|NCT01168349|Epoetin Alfa|epoetin alfa|mesh-list
25617748|NCT01168349|Hematinics|hematinics|mesh-ancestor
25617749|NCT01168596|Rasagiline|rasagiline|mesh-list
25617750|NCT01168596|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25713718|NCT02344225|Purinergic Agents|purinergic agents|mesh-ancestor
25617751|NCT01168596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617752|NCT01168596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617753|NCT01168596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25617754|NCT01168596|Protective Agents|protective agents|mesh-ancestor
25617755|NCT01168596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617756|NCT01168674|Ziprasidone|ziprasidone|mesh-list
25617757|NCT01168674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25617758|NCT01168674|Serotonin Agents|serotonin agents|mesh-ancestor
25617759|NCT01168674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25617760|NCT01168674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617761|NCT01168674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617762|NCT01168674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25617763|NCT01168674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25617764|NCT01168674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25617765|NCT01168674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25617766|NCT01168674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25617767|NCT01168674|Dopamine Agents|dopamine agents|mesh-ancestor
25617768|NCT01168687|Levetiracetam|levetiracetam|mesh-list
25617769|NCT01168687|Anticonvulsants|anticonvulsants|mesh-ancestor
25617770|NCT01168687|Nootropic Agents|nootropic agents|mesh-ancestor
25617771|NCT01168908|Sildenafil Citrate|sildenafil citrate|mesh-list
24881114|NCT03003962|Gemcitabine|gemcitabine|mesh-list
25617772|NCT01168908|Vasodilator Agents|vasodilator agents|mesh-ancestor
25617773|NCT01168908|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25617774|NCT01168908|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25617775|NCT01168908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617776|NCT01168908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617777|NCT01168908|Urological Agents|urological agents|mesh-ancestor
25617778|NCT01168934|Crizotinib|crizotinib|mesh-list
25617779|NCT01168934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617780|NCT01168934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25617781|NCT01168934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617782|NCT01168934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617783|NCT01168973|Docetaxel|docetaxel|mesh-list
25617784|NCT01168973|Ramucirumab|ramucirumab|mesh-list
25617785|NCT01168973|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25617786|NCT01168973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617787|NCT01168973|Tubulin Modulators|tubulin modulators|mesh-ancestor
25512374|NCT00400569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512375|NCT00400569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512376|NCT00400686|Epoetin Alfa|epoetin alfa|mesh-list
25617788|NCT01168973|Antimitotic Agents|antimitotic agents|mesh-ancestor
25512377|NCT00400686|Hematinics|hematinics|mesh-ancestor
25617789|NCT01168973|Mitosis Modulators|mitosis modulators|mesh-ancestor
25617790|NCT01168973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617791|NCT01168973|Immunologic Factors|immunologic factors|mesh-ancestor
25617792|NCT01168973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617793|NCT01169038|Azithromycin|azithromycin|mesh-list
25617794|NCT01169038|Rifampin|rifampin|mesh-list
25617795|NCT01169038|Ethambutol|ethambutol|mesh-list
25617796|NCT01169038|Levofloxacin|levofloxacin|mesh-list
25617797|NCT01169038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25617798|NCT01169038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25617799|NCT01169038|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25617800|NCT01169038|Antitubercular Agents|antitubercular agents|mesh-ancestor
25617801|NCT01169038|Leprostatic Agents|leprostatic agents|mesh-ancestor
25617802|NCT01169038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25617803|NCT01169038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617804|NCT01169038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617805|NCT01169038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25617806|NCT01169038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25617807|NCT01169038|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25617808|NCT01169038|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25617809|NCT01169038|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25617810|NCT01169038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25617811|NCT01169038|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25617812|NCT01169038|Renal Agents|renal agents|mesh-ancestor
24881232|NCT02921893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25617813|NCT01169038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25617814|NCT01169038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25617815|NCT01169038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617816|NCT01169038|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25617817|NCT01169038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25617818|NCT01169103|Hormones|hormones|mesh-list
25617819|NCT01169103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25617820|NCT01169103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617821|NCT01169337|Lenalidomide|lenalidomide|mesh-list
25617822|NCT01169337|Immunologic Factors|immunologic factors|mesh-ancestor
25617823|NCT01169337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617824|NCT01169337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25617825|NCT01169337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25617826|NCT01169337|Growth Substances|growth substances|mesh-ancestor
25617827|NCT01169337|Growth Inhibitors|growth inhibitors|mesh-ancestor
25617828|NCT01169337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617829|NCT01169350|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25617830|NCT01169350|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25617831|NCT01169350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617832|NCT01169467|Dexmedetomidine|dexmedetomidine|mesh-list
25617833|NCT01169467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25617834|NCT01169467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25617835|NCT01169467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617836|NCT01169467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25617837|NCT01169467|Analgesics|analgesics|mesh-ancestor
25713736|NCT02344628|Azithromycin|azithromycin|mesh-list
25617838|NCT01169467|Sensory System Agents|sensory system agents|mesh-ancestor
25617839|NCT01169467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25617840|NCT01169467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25617841|NCT01169467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25617842|NCT01169467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25617843|NCT01169467|Adrenergic Agents|adrenergic agents|mesh-ancestor
25617844|NCT01169467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25617845|NCT01169467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617846|NCT01169519|Sildenafil Citrate|sildenafil citrate|mesh-list
25617847|NCT01169519|Vasodilator Agents|vasodilator agents|mesh-ancestor
25617848|NCT01169519|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25617849|NCT01169519|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25617850|NCT01169519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617851|NCT01169519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617852|NCT01169519|Urological Agents|urological agents|mesh-ancestor
25617853|NCT01169532|Vorinostat|vorinostat|mesh-list
25617854|NCT01169532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617855|NCT01169532|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25617856|NCT01169532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617857|NCT01169532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617858|NCT01169558|Bevacizumab|bevacizumab|mesh-list
25617859|NCT01169558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25617860|NCT01169558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617861|NCT01169558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25617862|NCT01169558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25617863|NCT01169558|Growth Substances|growth substances|mesh-ancestor
25617864|NCT01169558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882694|NCT05111912|Glucagon|glucagon|mesh-list
25617865|NCT01169558|Growth Inhibitors|growth inhibitors|mesh-ancestor
25617867|NCT01169636|Etoposide|etoposide|mesh-list
25617868|NCT01169636|Ifosfamide|ifosfamide|mesh-list
25617869|NCT01169636|Panobinostat|panobinostat|mesh-list
25617870|NCT01169636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617871|NCT01169636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25617872|NCT01169636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25617873|NCT01169636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25617874|NCT01169636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617875|NCT01169636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617876|NCT01169636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25617877|NCT01169636|Alkylating Agents|alkylating agents|mesh-ancestor
25617878|NCT01169636|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25617879|NCT01169675|Pemetrexed|pemetrexed|mesh-list
25617880|NCT01169675|Afatinib|afatinib|mesh-list
25617881|NCT01169675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617882|NCT01169675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617883|NCT01169675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617884|NCT01169675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25617885|NCT01169675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25617886|NCT01169675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25617887|NCT01169701|Mycophenolic Acid|mycophenolic acid|mesh-list
25617888|NCT01169701|Everolimus|everolimus|mesh-list
25617889|NCT01169701|Tacrolimus|tacrolimus|mesh-list
25617890|NCT01169701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25617891|NCT01169701|Immunologic Factors|immunologic factors|mesh-ancestor
25617892|NCT01169701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617893|NCT01169701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25617894|NCT01169701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617895|NCT01169701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617896|NCT01169701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617897|NCT01169701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25617898|NCT01169701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25617899|NCT01169701|Antitubercular Agents|antitubercular agents|mesh-ancestor
25617900|NCT01169701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25617901|NCT01169701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25617902|NCT01169779|Metformin|metformin|mesh-list
25617903|NCT01169779|Lixisenatide|lixisenatide|mesh-list
25617904|NCT01169779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25617905|NCT01169779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617906|NCT01170039|Lubiprostone|lubiprostone|mesh-list
25617907|NCT01170039|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25617908|NCT01170039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25617909|NCT01170039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655199|NCT01559675|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25655200|NCT01559675|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25655201|NCT01559675|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25655202|NCT01559675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25655203|NCT01559675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25655204|NCT01559675|Methylprednisolone|methylprednisolone|mesh-list
25655205|NCT01559675|Prednisolone|prednisolone|mesh-list
25655206|NCT01559675|Prednisolone acetate|prednisolone acetate|mesh-list
25655207|NCT01559675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25655208|NCT01559675|Prednisolone phosphate|prednisolone phosphate|mesh-list
25655209|NCT01559675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25655210|NCT01559675|Glucocorticoids|glucocorticoids|mesh-ancestor
25655211|NCT01559675|Hormones|hormones|mesh-ancestor
25655212|NCT01559675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25655213|NCT01559675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655214|NCT01559675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25655215|NCT01559675|Protective Agents|protective agents|mesh-ancestor
25655216|NCT01559675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25655217|NCT01559675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25655218|NCT01559675|Antiemetics|antiemetics|mesh-ancestor
25655219|NCT01559675|Autonomic Agents|autonomic agents|mesh-ancestor
25655220|NCT01559675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25512508|NCT00401843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25512509|NCT00401843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25512510|NCT00401843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512511|NCT00401882|Metoprolol|metoprolol|mesh-list
25512512|NCT00401882|Epinephrine|epinephrine|mesh-list
25512513|NCT00401882|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25617910|NCT01170065|Nintedanib|nintedanib|mesh-list
25617911|NCT01170065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617912|NCT01170065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25617913|NCT01170065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617914|NCT01170065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617915|NCT01170117|Olanzapine|olanzapine|mesh-list
25617916|NCT01170117|Antiemetics|antiemetics|mesh-ancestor
25617917|NCT01170117|Autonomic Agents|autonomic agents|mesh-ancestor
25617918|NCT01170117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25617919|NCT01170117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617920|NCT01170117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25617921|NCT01170117|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25617922|NCT01170117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25617923|NCT01170117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25617924|NCT01170117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25617925|NCT01170117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25617926|NCT01170117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24883268|NCT04147546|Artenimol|artenimol|mesh-list
25617927|NCT01170117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25617928|NCT01170117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617929|NCT01170117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25617930|NCT01170117|Serotonin Agents|serotonin agents|mesh-ancestor
25617931|NCT01170208|Insulin|insulin|mesh-list
25617932|NCT01170208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25617933|NCT01170208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617934|NCT01170221|Linezolid|linezolid|mesh-list
25617935|NCT01170221|Tedizolid phosphate|tedizolid phosphate|mesh-list
25617936|NCT01170221|Tedizolid|tedizolid|mesh-list
25617937|NCT01170221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25617938|NCT01170221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25617939|NCT01170221|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25617940|NCT01170221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617941|NCT01170221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617942|NCT01170247|Ketamine|ketamine|mesh-list
25617943|NCT01170247|Analgesics|analgesics|mesh-ancestor
25617944|NCT01170247|Sensory System Agents|sensory system agents|mesh-ancestor
25617945|NCT01170247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25617946|NCT01170247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617947|NCT01170247|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25617948|NCT01170247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25617949|NCT01170247|Anesthetics, General|anesthetics, general|mesh-ancestor
25617950|NCT01170247|Anesthetics|anesthetics|mesh-ancestor
25617951|NCT01170247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25617952|NCT01170247|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25617953|NCT01170247|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25617954|NCT01170247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25617955|NCT01170247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617956|NCT01170273|Vitamin D|vitamin d|mesh-list
25617957|NCT01170273|Vitamins|vitamins|mesh-ancestor
25617958|NCT01170273|Micronutrients|micronutrients|mesh-ancestor
25617959|NCT01170273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617960|NCT01170273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25617961|NCT01170364|Sibutramine|sibutramine|mesh-list
25617962|NCT01170364|Antidepressive Agents|antidepressive agents|mesh-ancestor
25617963|NCT01170364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25617964|NCT01170364|Appetite Depressants|appetite depressants|mesh-ancestor
25617965|NCT01170364|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25617966|NCT01170390|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25617967|NCT01170390|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25617968|NCT01170390|Levonorgestrel|levonorgestrel|mesh-list
25617969|NCT01170390|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25499153|NCT00743197|Antimetabolites|antimetabolites|mesh-ancestor
25617970|NCT01170390|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25617971|NCT01170390|Estradiol|estradiol|mesh-list
25617972|NCT01170390|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25617973|NCT01170390|Estrogens|estrogens|mesh-ancestor
25617974|NCT01170390|Hormones|hormones|mesh-ancestor
25617975|NCT01170390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25617976|NCT01170390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25617977|NCT01170390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25617978|NCT01170390|Contraceptive Agents|contraceptive agents|mesh-ancestor
25617979|NCT01170390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25617980|NCT01170390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25617981|NCT01170390|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25617982|NCT01170390|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25617983|NCT01170390|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25617984|NCT01170390|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25617985|NCT01170533|Omeprazole|omeprazole|mesh-list
25617986|NCT01170533|Pantoprazole|pantoprazole|mesh-list
25617987|NCT01170533|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25617988|NCT01170533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25617989|NCT01170533|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25617990|NCT01170533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25617991|NCT01170533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25617992|NCT01170663|Paclitaxel|paclitaxel|mesh-list
25617993|NCT01170663|Ramucirumab|ramucirumab|mesh-list
25617994|NCT01170663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25617995|NCT01170663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25617996|NCT01170663|Tubulin Modulators|tubulin modulators|mesh-ancestor
25617997|NCT01170663|Antimitotic Agents|antimitotic agents|mesh-ancestor
25617998|NCT01170663|Mitosis Modulators|mitosis modulators|mesh-ancestor
25617999|NCT01170663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618000|NCT01170715|Etanercept|etanercept|mesh-list
25618001|NCT01170715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25618002|NCT01170715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25618003|NCT01170715|Analgesics|analgesics|mesh-ancestor
25618004|NCT01170715|Sensory System Agents|sensory system agents|mesh-ancestor
25618005|NCT01170715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25618006|NCT01170715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618007|NCT01170715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25618008|NCT01170715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25618009|NCT01170715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25618010|NCT01170715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25618011|NCT01170715|Immunologic Factors|immunologic factors|mesh-ancestor
25618012|NCT01170754|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25618013|NCT01170754|Laxatives|laxatives|mesh-ancestor
25618014|NCT01170754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25618015|NCT01170884|Timolol|timolol|mesh-list
25618016|NCT01170884|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25618017|NCT01170884|Bimatoprost|bimatoprost|mesh-list
25618018|NCT01170884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25618019|NCT01170884|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25618020|NCT01170884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25618021|NCT01170884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25618022|NCT01170884|Adrenergic Agents|adrenergic agents|mesh-ancestor
25618023|NCT01170884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25618024|NCT01170884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618025|NCT01170884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618026|NCT01170884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25618027|NCT01170884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25618028|NCT01170884|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25618029|NCT01170884|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25618030|NCT01170884|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25618031|NCT01170949|Miltefosine|miltefosine|mesh-list
25618032|NCT01170949|Antifungal Agents|antifungal agents|mesh-ancestor
25618033|NCT01170949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25618034|NCT01170949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25618035|NCT01170949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25618036|NCT01170949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25618037|NCT01170962|Ribavirin|ribavirin|mesh-list
25618038|NCT01170962|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25618039|NCT01170962|Antimetabolites|antimetabolites|mesh-ancestor
25618040|NCT01170962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618041|NCT01170962|Antiviral Agents|antiviral agents|mesh-ancestor
25618042|NCT01170962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25618043|NCT01171118|Physostigmine|physostigmine|mesh-list
25618044|NCT01171118|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25618045|NCT01171118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25618046|NCT01171118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618047|NCT01171118|Cholinergic Agents|cholinergic agents|mesh-ancestor
25618048|NCT01171118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25618049|NCT01171118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618050|NCT01171118|Miotics|miotics|mesh-ancestor
25618051|NCT01171118|Autonomic Agents|autonomic agents|mesh-ancestor
25618052|NCT01171118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25618053|NCT01171183|Carvedilol|carvedilol|mesh-list
25618054|NCT01171183|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25618055|NCT01171183|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25618056|NCT01171183|Adrenergic Agents|adrenergic agents|mesh-ancestor
25618057|NCT01171183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25618058|NCT01171183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618059|NCT01171183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618060|NCT01171183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25618061|NCT01171183|Antioxidants|antioxidants|mesh-ancestor
25618062|NCT01171183|Protective Agents|protective agents|mesh-ancestor
25618063|NCT01171183|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25618064|NCT01171183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25618065|NCT01171183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25618066|NCT01171183|Vasodilator Agents|vasodilator agents|mesh-ancestor
25618067|NCT01171183|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25618068|NCT01171183|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25618069|NCT01171690|Teriparatide|teriparatide|mesh-list
25618070|NCT01171690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25618071|NCT01171690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618072|NCT01171690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25618073|NCT01171794|Ibuprofen|ibuprofen|mesh-list
25618074|NCT01171794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25618075|NCT01171794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25618076|NCT01171794|Analgesics|analgesics|mesh-ancestor
25618077|NCT01171794|Sensory System Agents|sensory system agents|mesh-ancestor
25618078|NCT01171794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25618079|NCT01171794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618080|NCT01171794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25618081|NCT01171794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25618082|NCT01171794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25618083|NCT01171794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25618084|NCT01171794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618085|NCT01171963|Vaccines|vaccines|mesh-list
25618086|NCT01171963|Immunologic Factors|immunologic factors|mesh-ancestor
25618087|NCT01171963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618088|NCT01171976|Ranibizumab|ranibizumab|mesh-list
25618089|NCT01171976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25618090|NCT01171976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25618091|NCT01171976|Growth Substances|growth substances|mesh-ancestor
25618092|NCT01171976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618093|NCT01171976|Growth Inhibitors|growth inhibitors|mesh-ancestor
25618094|NCT01171976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25618095|NCT01172145|Modafinil|modafinil|mesh-list
25618096|NCT01172145|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25618097|NCT01172145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618098|NCT01172145|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25618099|NCT01172145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25618100|NCT01172145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25618101|NCT01172145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618102|NCT01172197|Ropivacaine|ropivacaine|mesh-list
25618103|NCT01172197|Levobupivacaine|levobupivacaine|mesh-list
25618104|NCT01172197|Anesthetics, Local|anesthetics, local|mesh-ancestor
25618105|NCT01172197|Anesthetics|anesthetics|mesh-ancestor
25618106|NCT01172197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25618107|NCT01172197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618108|NCT01172197|Sensory System Agents|sensory system agents|mesh-ancestor
25618109|NCT01172197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25618110|NCT01172275|Acetylcysteine|acetylcysteine|mesh-list
25618111|NCT01172275|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25618112|NCT01172275|Antiviral Agents|antiviral agents|mesh-ancestor
25618113|NCT01172275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25618114|NCT01172275|Expectorants|expectorants|mesh-ancestor
25618115|NCT01172275|Respiratory System Agents|respiratory system agents|mesh-ancestor
25618116|NCT01172275|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25618117|NCT01172275|Antioxidants|antioxidants|mesh-ancestor
25618118|NCT01172275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618119|NCT01172275|Protective Agents|protective agents|mesh-ancestor
24883991|NCT03730662|Hormones|hormones|mesh-ancestor
25618120|NCT01172275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618121|NCT01172275|Antidotes|antidotes|mesh-ancestor
25618122|NCT01172288|Acetylcysteine|acetylcysteine|mesh-list
25618123|NCT01172288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25618124|NCT01172288|Antiviral Agents|antiviral agents|mesh-ancestor
25618125|NCT01172288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25618126|NCT01172288|Expectorants|expectorants|mesh-ancestor
25618127|NCT01172288|Respiratory System Agents|respiratory system agents|mesh-ancestor
25618128|NCT01172288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25618129|NCT01172288|Antioxidants|antioxidants|mesh-ancestor
25618130|NCT01172288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618131|NCT01172288|Protective Agents|protective agents|mesh-ancestor
25618132|NCT01172288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618133|NCT01172288|Antidotes|antidotes|mesh-ancestor
25618134|NCT01172418|Alemtuzumab|alemtuzumab|mesh-list
25618135|NCT01172418|Thymoglobulin|thymoglobulin|mesh-list
25618136|NCT01172418|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25618138|NCT01172418|Immunologic Factors|immunologic factors|mesh-ancestor
25618139|NCT01172418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618140|NCT01172418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25618141|NCT01172418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25618142|NCT01172418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25618143|NCT01172522|Fexofenadine|fexofenadine|mesh-list
25618144|NCT01172522|Terfenadine|terfenadine|mesh-list
25618145|NCT01172522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25618146|NCT01172522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25618147|NCT01172522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25618148|NCT01172522|Histamine Antagonists|histamine antagonists|mesh-ancestor
25618149|NCT01172522|Histamine Agents|histamine agents|mesh-ancestor
25618150|NCT01172522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25618151|NCT01172522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618152|NCT01172522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618153|NCT01172535|Ritonavir|ritonavir|mesh-list
25618154|NCT01172535|Lopinavir|lopinavir|mesh-list
25618155|NCT01172535|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25618156|NCT01172535|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25618157|NCT01172535|Protease Inhibitors|protease inhibitors|mesh-ancestor
25618158|NCT01172535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25618159|NCT01172535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618160|NCT01172535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25618161|NCT01172535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25618162|NCT01172535|Antiviral Agents|antiviral agents|mesh-ancestor
25618163|NCT01172535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25618164|NCT01172535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25618165|NCT01172535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25618166|NCT01172600|Nitrous Oxide|nitrous oxide|mesh-list
25618167|NCT01172600|Entonox|entonox|mesh-list
25618168|NCT01172600|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25618169|NCT01172600|Anesthetics, General|anesthetics, general|mesh-ancestor
25618170|NCT01172600|Anesthetics|anesthetics|mesh-ancestor
25618171|NCT01172600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25618172|NCT01172600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713791|NCT02346240|Etanercept|etanercept|mesh-list
25618173|NCT01172600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25618174|NCT01172600|Analgesics|analgesics|mesh-ancestor
25618175|NCT01172600|Sensory System Agents|sensory system agents|mesh-ancestor
25618176|NCT01172600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25618177|NCT01172600|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25618178|NCT01172639|Sulfasalazine|sulfasalazine|mesh-list
25618179|NCT01172639|Prednisone|prednisone|mesh-list
25618180|NCT01172639|Methotrexate|methotrexate|mesh-list
25618181|NCT01172639|Leflunomide|leflunomide|mesh-list
25618182|NCT01172639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25618183|NCT01172639|Glucocorticoids|glucocorticoids|mesh-ancestor
25618184|NCT01172639|Hormones|hormones|mesh-ancestor
25618185|NCT01172639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25618186|NCT01172639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618187|NCT01172639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25618188|NCT01172639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25618189|NCT01172639|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25618190|NCT01172639|Abortifacient Agents|abortifacient agents|mesh-ancestor
25618191|NCT01172639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25618192|NCT01172639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25618193|NCT01172639|Antimetabolites|antimetabolites|mesh-ancestor
25618194|NCT01172639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618195|NCT01172639|Dermatologic Agents|dermatologic agents|mesh-ancestor
25618196|NCT01172639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25618197|NCT01172639|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25618198|NCT01172639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25618199|NCT01172639|Immunologic Factors|immunologic factors|mesh-ancestor
25618200|NCT01172639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25618201|NCT01172639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25618202|NCT01172639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25618203|NCT01172639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25618204|NCT01172639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25618205|NCT01172639|Analgesics|analgesics|mesh-ancestor
25512795|NCT00403273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25618206|NCT01172639|Sensory System Agents|sensory system agents|mesh-ancestor
25618207|NCT01172639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25618208|NCT01172639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25618209|NCT01172808|Tiotropium Bromide|tiotropium bromide|mesh-list
25618210|NCT01172808|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25618211|NCT01172808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25618212|NCT01172808|Autonomic Agents|autonomic agents|mesh-ancestor
25618213|NCT01172808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25618214|NCT01172808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618215|NCT01172808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25618216|NCT01172808|Respiratory System Agents|respiratory system agents|mesh-ancestor
25618217|NCT01172808|Parasympatholytics|parasympatholytics|mesh-ancestor
25618218|NCT01172808|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25618219|NCT01172808|Cholinergic Agents|cholinergic agents|mesh-ancestor
25618220|NCT01172808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25618221|NCT01172808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618222|NCT01172808|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25618223|NCT01172808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25618224|NCT01172808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25618225|NCT01172808|Adrenergic Agents|adrenergic agents|mesh-ancestor
25618226|NCT01172821|Tiotropium Bromide|tiotropium bromide|mesh-list
24507089|NCT00548678|Aspirin|aspirin|mesh-list
25618227|NCT01172821|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25618228|NCT01172821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25618229|NCT01172821|Autonomic Agents|autonomic agents|mesh-ancestor
25618230|NCT01172821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25618231|NCT01172821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618232|NCT01172821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25618233|NCT01172821|Respiratory System Agents|respiratory system agents|mesh-ancestor
25618234|NCT01172821|Parasympatholytics|parasympatholytics|mesh-ancestor
25618235|NCT01172821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25618236|NCT01172821|Cholinergic Agents|cholinergic agents|mesh-ancestor
25618237|NCT01172821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25618238|NCT01172821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618239|NCT01172821|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25618240|NCT01172821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25618241|NCT01172821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24507345|NCT00550004|Gemcitabine|gemcitabine|mesh-list
25618242|NCT01172821|Adrenergic Agents|adrenergic agents|mesh-ancestor
25618244|NCT01172847|Rimantadine|rimantadine|mesh-list
25618245|NCT01172847|Antiviral Agents|antiviral agents|mesh-ancestor
25618246|NCT01172847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25618247|NCT01172847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512878|NCT00577200|Midazolam|midazolam|mesh-list
25618248|NCT01172847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618249|NCT01172847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25618250|NCT01172873|Cycloserine|cycloserine|mesh-list
25618251|NCT01172873|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25618252|NCT01172873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25618253|NCT01172873|Renal Agents|renal agents|mesh-ancestor
25618254|NCT01172873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25618255|NCT01172873|Antitubercular Agents|antitubercular agents|mesh-ancestor
25618256|NCT01172873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25618257|NCT01172873|Antimetabolites|antimetabolites|mesh-ancestor
25618258|NCT01172873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618259|NCT01172938|Thalidomide|thalidomide|mesh-list
25618260|NCT01172938|Apremilast|apremilast|mesh-list
25618261|NCT01172938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25618262|NCT01172938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25618263|NCT01172938|Analgesics|analgesics|mesh-ancestor
25618264|NCT01172938|Sensory System Agents|sensory system agents|mesh-ancestor
25618265|NCT01172938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25618266|NCT01172938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618267|NCT01172938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25618268|NCT01172938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25618269|NCT01172938|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25618270|NCT01172938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25618271|NCT01172938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25618272|NCT01172938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618273|NCT01172938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25618274|NCT01172938|Immunologic Factors|immunologic factors|mesh-ancestor
25618275|NCT01172938|Leprostatic Agents|leprostatic agents|mesh-ancestor
25618276|NCT01172938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25618277|NCT01172938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25618278|NCT01172938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25512860|NCT00403585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512861|NCT00403754|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25512862|NCT00403754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25618279|NCT01172938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25618280|NCT01172938|Growth Substances|growth substances|mesh-ancestor
25618281|NCT01172938|Growth Inhibitors|growth inhibitors|mesh-ancestor
25618282|NCT01172938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25618283|NCT01173029|Antihypertensive Agents|antihypertensive agents|mesh-list
25618284|NCT01173029|Calcium Channel Blockers|calcium channel blockers|mesh-list
25618285|NCT01173029|Diuretics|diuretics|mesh-list
25618286|NCT01173029|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25618287|NCT01173029|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
25618288|NCT01173029|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
25618289|NCT01173029|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
25618290|NCT01173029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25618291|NCT01173029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618292|NCT01173029|Natriuretic Agents|natriuretic agents|mesh-ancestor
24884939|NCT03193333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25618293|NCT01173029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618294|NCT01173029|Protease Inhibitors|protease inhibitors|mesh-ancestor
25618295|NCT01173029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25618296|NCT01173029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25618297|NCT01173029|Hormone Antagonists|hormone antagonists|mesh-ancestor
25618298|NCT01173029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25618299|NCT01173029|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25618300|NCT01173055|Milnacipran|milnacipran|mesh-list
25618301|NCT01173055|Levomilnacipran|levomilnacipran|mesh-list
25618302|NCT01173055|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25618303|NCT01173055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25618304|NCT01173055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25618305|NCT01173055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618306|NCT01173055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25618307|NCT01173055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618308|NCT01173055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25618309|NCT01173055|Analgesics|analgesics|mesh-ancestor
25618310|NCT01173055|Sensory System Agents|sensory system agents|mesh-ancestor
25618311|NCT01173055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25618312|NCT01173055|Antidepressive Agents|antidepressive agents|mesh-ancestor
25618313|NCT01173055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25618314|NCT01173120|Abatacept|abatacept|mesh-list
25618315|NCT01173120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25618316|NCT01173120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618317|NCT01173120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25618318|NCT01173120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25618319|NCT01173120|Immunologic Factors|immunologic factors|mesh-ancestor
25618320|NCT01173120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618321|NCT01173120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25618322|NCT01173211|Vaccines|vaccines|mesh-list
25618323|NCT01173211|Immunologic Factors|immunologic factors|mesh-ancestor
25618324|NCT01173211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618325|NCT01173471|Niacinamide|niacinamide|mesh-list
25618326|NCT01173471|Vitamin B Complex|vitamin b complex|mesh-ancestor
25618327|NCT01173471|Vitamins|vitamins|mesh-ancestor
25618328|NCT01173471|Micronutrients|micronutrients|mesh-ancestor
25618329|NCT01173471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618330|NCT01173601|Serotonin|serotonin|mesh-list
25618331|NCT01173601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25618332|NCT01173601|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25618333|NCT01173601|Serotonin Agents|serotonin agents|mesh-ancestor
25618334|NCT01173601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25618335|NCT01173601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618336|NCT01173601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618337|NCT01173601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25618338|NCT01173601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25618339|NCT01173679|Rituximab|rituximab|mesh-list
25618340|NCT01173679|Fludarabine|fludarabine|mesh-list
25618341|NCT01173679|Dasatinib|dasatinib|mesh-list
25618342|NCT01173679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25618343|NCT01173679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25618344|NCT01173679|Immunologic Factors|immunologic factors|mesh-ancestor
25618345|NCT01173679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618346|NCT01173679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25618347|NCT01173679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618348|NCT01173679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25618349|NCT01173679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25618350|NCT01173692|Minocycline|minocycline|mesh-list
25618351|NCT01173692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25657071|NCT01582854|Antioxidants|antioxidants|mesh-ancestor
25618352|NCT01173692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25618354|NCT01173848|Vitamin D|vitamin d|mesh-list
25618355|NCT01173848|Ergocalciferols|ergocalciferols|mesh-list
25618356|NCT01173848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25618357|NCT01173848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618358|NCT01173848|Vitamins|vitamins|mesh-ancestor
25618359|NCT01173848|Micronutrients|micronutrients|mesh-ancestor
25618360|NCT01173848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25618361|NCT01174004|Pimavanserin|pimavanserin|mesh-list
25618362|NCT01174004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25618363|NCT01174004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25618364|NCT01174004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25618365|NCT01174004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25618366|NCT01174004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25618367|NCT01174004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618368|NCT01174004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25618369|NCT01174004|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24885512|NCT05171660|Capecitabine|capecitabine|mesh-list
25618370|NCT01174004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25618371|NCT01174004|Serotonin Agents|serotonin agents|mesh-ancestor
25618372|NCT01174004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25618373|NCT01174004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618374|NCT01174043|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25618375|NCT01174043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25618376|NCT01174043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25618377|NCT01174043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25618378|NCT01174043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618379|NCT01174082|Vaccines|vaccines|mesh-list
25618380|NCT01174082|Sargramostim|sargramostim|mesh-list
25618381|NCT01174082|Immunologic Factors|immunologic factors|mesh-ancestor
25618382|NCT01174082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618383|NCT01174173|Ranolazine|ranolazine|mesh-list
25618384|NCT01174173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25618385|NCT01174173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25618386|NCT01174173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618387|NCT01174186|Adalimumab|adalimumab|mesh-list
25618388|NCT01174186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25618389|NCT01174186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25618390|NCT01174238|Paclitaxel|paclitaxel|mesh-list
25618391|NCT01174238|Carboplatin|carboplatin|mesh-list
25618392|NCT01174238|Axitinib|axitinib|mesh-list
25618393|NCT01174238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25618394|NCT01174238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25618395|NCT01174238|Tubulin Modulators|tubulin modulators|mesh-ancestor
25618396|NCT01174238|Antimitotic Agents|antimitotic agents|mesh-ancestor
25618397|NCT01174238|Mitosis Modulators|mitosis modulators|mesh-ancestor
25618398|NCT01174238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713878|NCT02347332|Methotrexate|methotrexate|mesh-list
25618399|NCT01174238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25618400|NCT01174238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25618401|NCT01174823|Bepotastine besilate|bepotastine besilate|mesh-list
25618402|NCT01174823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25618403|NCT01174823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25618404|NCT01174823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25618405|NCT01175018|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25618406|NCT01175018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25618407|NCT01175135|Risperidone|risperidone|mesh-list
25618408|NCT01175135|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25618409|NCT01175135|Serotonin Agents|serotonin agents|mesh-ancestor
25618410|NCT01175135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25618411|NCT01175135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618412|NCT01175135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618413|NCT01175135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25618414|NCT01175135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25618415|NCT01175135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25618416|NCT01175135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25618417|NCT01175135|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25618418|NCT01175135|Dopamine Agents|dopamine agents|mesh-ancestor
25618419|NCT01175148|Atorvastatin|atorvastatin|mesh-list
25618420|NCT01175148|Calcium|calcium|mesh-list
25618421|NCT01175148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25618422|NCT01175148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618423|NCT01175148|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25618424|NCT01175148|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25618425|NCT01175148|Antimetabolites|antimetabolites|mesh-ancestor
25618426|NCT01175148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618427|NCT01175148|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25499154|NCT00743197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25618428|NCT01175148|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25618429|NCT01175148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25618430|NCT01175213|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25618431|NCT01175213|gamma-Globulins|gamma-globulins|mesh-list
25618432|NCT01175213|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25618433|NCT01175213|Immunologic Factors|immunologic factors|mesh-ancestor
25618434|NCT01175213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618435|NCT01175343|R04929097|r04929097|mesh-list
25618436|NCT01175343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713906|NCT02347605|Cholinergic Agents|cholinergic agents|mesh-ancestor
25618437|NCT01175343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618438|NCT01175382|Tamsulosin|tamsulosin|mesh-list
25618439|NCT01175382|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25618440|NCT01175382|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25618441|NCT01175382|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25618442|NCT01175382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25618443|NCT01175382|Adrenergic Agents|adrenergic agents|mesh-ancestor
25618444|NCT01175382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25618445|NCT01175382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618446|NCT01175382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618447|NCT01175382|Urological Agents|urological agents|mesh-ancestor
25618448|NCT01175382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25618449|NCT01175382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25618450|NCT01175382|Cholinergic Agents|cholinergic agents|mesh-ancestor
25618451|NCT01175395|Triamcinolone|triamcinolone|mesh-list
25618452|NCT01175395|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25618453|NCT01175395|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25618454|NCT01175395|Ranibizumab|ranibizumab|mesh-list
25618455|NCT01175395|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25618456|NCT01175395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25618457|NCT01175395|Glucocorticoids|glucocorticoids|mesh-ancestor
25618458|NCT01175395|Hormones|hormones|mesh-ancestor
25713916|NCT02347657|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25618459|NCT01175395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25618460|NCT01175395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618461|NCT01175395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25618462|NCT01175395|Immunologic Factors|immunologic factors|mesh-ancestor
25618463|NCT01175395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25618464|NCT01175395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618465|NCT01175395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25618466|NCT01175395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25618467|NCT01175395|Growth Substances|growth substances|mesh-ancestor
25618468|NCT01175395|Growth Inhibitors|growth inhibitors|mesh-ancestor
25618469|NCT01175395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25618470|NCT01175473|Metformin|metformin|mesh-list
25618471|NCT01175473|Liraglutide|liraglutide|mesh-list
25618472|NCT01175473|Lixisenatide|lixisenatide|mesh-list
25618473|NCT01175473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25618474|NCT01175473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618475|NCT01175473|Incretins|incretins|mesh-ancestor
25618476|NCT01175473|Hormones|hormones|mesh-ancestor
25618477|NCT01175473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25618478|NCT01175590|Besifloxacin|besifloxacin|mesh-list
25618479|NCT01175590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25618480|NCT01175590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25618481|NCT01175590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25618482|NCT01175590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25618483|NCT01175590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25618484|NCT01175590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618485|NCT01175590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25618486|NCT01175668|Clonidine|clonidine|mesh-list
25618487|NCT01175668|Phenobarbital|phenobarbital|mesh-list
25618488|NCT01175668|Analgesics|analgesics|mesh-ancestor
25618489|NCT01175668|Sensory System Agents|sensory system agents|mesh-ancestor
25618490|NCT01175668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25618491|NCT01175668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618492|NCT01175668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25618493|NCT01175668|Sympatholytics|sympatholytics|mesh-ancestor
25618494|NCT01175668|Autonomic Agents|autonomic agents|mesh-ancestor
25618495|NCT01175668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25618496|NCT01175668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25618497|NCT01175668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25618498|NCT01175668|Adrenergic Agents|adrenergic agents|mesh-ancestor
25618499|NCT01175668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25618500|NCT01175668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618501|NCT01175668|Anticonvulsants|anticonvulsants|mesh-ancestor
25618502|NCT01175668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25618503|NCT01175668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25618504|NCT01175668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25618505|NCT01175668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25618506|NCT01175668|GABA Modulators|gaba modulators|mesh-ancestor
25618507|NCT01175668|GABA Agents|gaba agents|mesh-ancestor
25618508|NCT01175668|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25618509|NCT01175668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25618510|NCT01175668|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25618511|NCT01175707|Vancomycin|vancomycin|mesh-list
25618512|NCT01175707|Daptomycin|daptomycin|mesh-list
25618513|NCT01175707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25618514|NCT01175707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25618515|NCT01175798|Vitamin D|vitamin d|mesh-list
25618516|NCT01175798|Cholecalciferol|cholecalciferol|mesh-list
25618517|NCT01175798|Vitamins|vitamins|mesh-ancestor
25618518|NCT01175798|Micronutrients|micronutrients|mesh-ancestor
25618519|NCT01175798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618520|NCT01175798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25618521|NCT01175798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25618522|NCT01175811|Insulin|insulin|mesh-list
25618523|NCT01175811|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25618524|NCT01175811|Insulin Glargine|insulin glargine|mesh-list
25618525|NCT01175811|Insulin Lispro|insulin lispro|mesh-list
25618526|NCT01175811|Insulin, Isophane|insulin, isophane|mesh-list
25618527|NCT01175811|Biphasic Insulins|biphasic insulins|mesh-list
25618528|NCT01175811|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
25618529|NCT01175811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24891946|NCT04466423|Sulfamethazine|sulfamethazine|mesh-list
25618530|NCT01175811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618531|NCT01175824|Insulin|insulin|mesh-list
25618532|NCT01175824|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25618533|NCT01175824|Insulin Glargine|insulin glargine|mesh-list
24892139|NCT04465357|Erenumab|erenumab|mesh-list
25618534|NCT01175824|Insulin Lispro|insulin lispro|mesh-list
25618535|NCT01175824|Protamines|protamines|mesh-list
25618536|NCT01175824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25618537|NCT01175824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618538|NCT01175824|Heparin Antagonists|heparin antagonists|mesh-ancestor
25618539|NCT01175824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618540|NCT01175824|Coagulants|coagulants|mesh-ancestor
25655221|NCT01559675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25655222|NCT01559844|Ribavirin|ribavirin|mesh-list
25655223|NCT01559844|Sofosbuvir|sofosbuvir|mesh-list
25655224|NCT01559844|Antimetabolites|antimetabolites|mesh-ancestor
25655225|NCT01559844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655226|NCT01559844|Antiviral Agents|antiviral agents|mesh-ancestor
25655227|NCT01559844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25655228|NCT01559857|Pioglitazone|pioglitazone|mesh-list
25655229|NCT01559857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25655230|NCT01559857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655231|NCT01559922|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
25655232|NCT01559922|Vasodilator Agents|vasodilator agents|mesh-ancestor
25655233|NCT01559922|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25655234|NCT01559922|Protective Agents|protective agents|mesh-ancestor
25655235|NCT01559922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655236|NCT01560143|Tigecycline|tigecycline|mesh-list
25655237|NCT01560143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25655238|NCT01560143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25655239|NCT01560143|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25655240|NCT01560143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655241|NCT01560143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655242|NCT01560403|Teduglutide|teduglutide|mesh-list
25655243|NCT01560403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25655244|NCT01560403|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25655245|NCT01560403|Protective Agents|protective agents|mesh-ancestor
24469534|NCT00386269|Codeine|codeine|mesh-list
25655246|NCT01560403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655247|NCT01560416|Fulvestrant|fulvestrant|mesh-list
25655248|NCT01560416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25655249|NCT01560416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25655250|NCT01560416|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25655251|NCT01560416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25655252|NCT01560416|Hormone Antagonists|hormone antagonists|mesh-ancestor
25655253|NCT01560416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25655254|NCT01560416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655255|NCT01560624|Treprostinil|treprostinil|mesh-list
25655256|NCT01560624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25655257|NCT01560780|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25655258|NCT01560780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25618541|NCT01175902|Timolol|timolol|mesh-list
25618542|NCT01175902|Dorzolamide|dorzolamide|mesh-list
25618543|NCT01175902|Latanoprost|latanoprost|mesh-list
25618544|NCT01175902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25618545|NCT01175902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25618546|NCT01175902|Adrenergic Agents|adrenergic agents|mesh-ancestor
25618547|NCT01175902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25618548|NCT01175902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618549|NCT01175902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618550|NCT01175902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25618551|NCT01175902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25618552|NCT01175902|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25618553|NCT01175902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25618554|NCT01175902|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25618555|NCT01175902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25618556|NCT01175980|Vorinostat|vorinostat|mesh-list
25618557|NCT01175980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25618558|NCT01175980|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25618559|NCT01175980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25618560|NCT01175980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618561|NCT01176032|Losartan|losartan|mesh-list
25618562|NCT01176032|Amlodipine|amlodipine|mesh-list
25618563|NCT01176032|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25618564|NCT01176032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25618565|NCT01176032|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25618566|NCT01176032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25618567|NCT01176032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618568|NCT01176032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25618569|NCT01176032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618570|NCT01176032|Vasodilator Agents|vasodilator agents|mesh-ancestor
25618571|NCT01176032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25618572|NCT01176032|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25618573|NCT01176032|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25618574|NCT01176032|Diuretics|diuretics|mesh-ancestor
25618575|NCT01176032|Natriuretic Agents|natriuretic agents|mesh-ancestor
25618576|NCT01176032|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25618577|NCT01176058|Fluconazole|fluconazole|mesh-list
25618578|NCT01176058|Anidulafungin|anidulafungin|mesh-list
25618579|NCT01176058|Antifungal Agents|antifungal agents|mesh-ancestor
25618580|NCT01176058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25618581|NCT01176058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25618582|NCT01176058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25618583|NCT01176058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25618584|NCT01176058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618585|NCT01176058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25618586|NCT01176058|Hormone Antagonists|hormone antagonists|mesh-ancestor
25618587|NCT01176058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25618588|NCT01176058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618589|NCT01176058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25618590|NCT01176058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25618591|NCT01176240|Mannitol|mannitol|mesh-list
25618592|NCT01176240|Droxidopa|droxidopa|mesh-list
25618593|NCT01176240|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25618594|NCT01176240|Diuretics|diuretics|mesh-ancestor
25713986|NCT02349152|Narcotics|narcotics|mesh-ancestor
25618595|NCT01176240|Natriuretic Agents|natriuretic agents|mesh-ancestor
25618596|NCT01176240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618597|NCT01176240|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25618598|NCT01176240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25618599|NCT01176435|Levodopa|levodopa|mesh-list
25618600|NCT01176435|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25618601|NCT01176435|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25618602|NCT01176435|Dopamine Agents|dopamine agents|mesh-ancestor
25618603|NCT01176435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25618604|NCT01176435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618605|NCT01176435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618606|NCT01176565|Nicardipine|nicardipine|mesh-list
25618607|NCT01176565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25618608|NCT01176565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25618609|NCT01176565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25618610|NCT01176565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618611|NCT01176565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25618612|NCT01176565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618613|NCT01176565|Vasodilator Agents|vasodilator agents|mesh-ancestor
25618614|NCT01176591|Aprepitant|aprepitant|mesh-list
25618615|NCT01176591|Fosaprepitant|fosaprepitant|mesh-list
25618616|NCT01176591|Antiemetics|antiemetics|mesh-ancestor
25618617|NCT01176591|Autonomic Agents|autonomic agents|mesh-ancestor
25618618|NCT01176591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25618619|NCT01176591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618620|NCT01176591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25618621|NCT01176591|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25618622|NCT01176591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25618623|NCT01176591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618624|NCT01176773|Hyaluronic Acid|hyaluronic acid|mesh-list
25618625|NCT01176773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25618626|NCT01176773|Immunologic Factors|immunologic factors|mesh-ancestor
25618627|NCT01176773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618628|NCT01176773|Viscosupplements|viscosupplements|mesh-ancestor
25618629|NCT01176773|Protective Agents|protective agents|mesh-ancestor
25618630|NCT01176916|Exemestane|exemestane|mesh-list
25618631|NCT01176916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25618632|NCT01176916|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25618633|NCT01176916|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25618634|NCT01176916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25618635|NCT01176916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618636|NCT01176916|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25618637|NCT01176916|Hormone Antagonists|hormone antagonists|mesh-ancestor
25618638|NCT01176916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25618639|NCT01176916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618640|NCT01176955|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25618641|NCT01176955|Dermatologic Agents|dermatologic agents|mesh-ancestor
25618642|NCT01176968|Eplerenone|eplerenone|mesh-list
25618643|NCT01176968|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25618644|NCT01176968|Hormone Antagonists|hormone antagonists|mesh-ancestor
25618645|NCT01176968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25618646|NCT01176968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618647|NCT01176968|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25618648|NCT01176968|Diuretics|diuretics|mesh-ancestor
25618649|NCT01176968|Natriuretic Agents|natriuretic agents|mesh-ancestor
25618650|NCT01176968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25618651|NCT01176981|Methotrexate|methotrexate|mesh-list
25618652|NCT01176981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25618653|NCT01176981|Abortifacient Agents|abortifacient agents|mesh-ancestor
25618654|NCT01176981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25618655|NCT01176981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618656|NCT01176981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25618657|NCT01176981|Antimetabolites|antimetabolites|mesh-ancestor
25618658|NCT01176981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618659|NCT01176981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25618660|NCT01176981|Dermatologic Agents|dermatologic agents|mesh-ancestor
25618661|NCT01176981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25618662|NCT01176981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25618663|NCT01176981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25618664|NCT01176981|Immunologic Factors|immunologic factors|mesh-ancestor
25618665|NCT01176981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25618666|NCT01176981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25618667|NCT01177098|Timolol|timolol|mesh-list
25618668|NCT01177098|Bimatoprost|bimatoprost|mesh-list
25618669|NCT01177098|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25618670|NCT01177098|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25618671|NCT01177098|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25618672|NCT01177098|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25618673|NCT01177098|Adrenergic Agents|adrenergic agents|mesh-ancestor
25618674|NCT01177098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25618675|NCT01177098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618676|NCT01177098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618677|NCT01177098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25618678|NCT01177098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25618679|NCT01177189|Ascorbic Acid|ascorbic acid|mesh-list
25618680|NCT01177189|Thioctic Acid|thioctic acid|mesh-list
25618681|NCT01177189|Vitamins|vitamins|mesh-ancestor
25618682|NCT01177189|Micronutrients|micronutrients|mesh-ancestor
25618683|NCT01177189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618684|NCT01177189|Antioxidants|antioxidants|mesh-ancestor
25618685|NCT01177189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618686|NCT01177189|Protective Agents|protective agents|mesh-ancestor
25618687|NCT01177189|Vitamin B Complex|vitamin b complex|mesh-ancestor
25618688|NCT01177228|Vedolizumab|vedolizumab|mesh-list
25618689|NCT01177228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25618690|NCT01177293|Amlodipine|amlodipine|mesh-list
25618691|NCT01177293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25618692|NCT01177293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25618693|NCT01177293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25618694|NCT01177293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618695|NCT01177293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25618696|NCT01177293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618697|NCT01177293|Vasodilator Agents|vasodilator agents|mesh-ancestor
25618698|NCT01177384|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25618699|NCT01177384|Glimepiride|glimepiride|mesh-list
25618700|NCT01177384|Acarbose|acarbose|mesh-list
25618701|NCT01177384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25618702|NCT01177384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618703|NCT01177384|Incretins|incretins|mesh-ancestor
25618704|NCT01177384|Hormones|hormones|mesh-ancestor
25618705|NCT01177384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25618706|NCT01177384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25618707|NCT01177384|Protease Inhibitors|protease inhibitors|mesh-ancestor
25618708|NCT01177384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25618709|NCT01177384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618710|NCT01177384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25618711|NCT01177384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25618712|NCT01177384|Immunologic Factors|immunologic factors|mesh-ancestor
25618713|NCT01177384|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25618714|NCT01177410|Mesalamine|mesalamine|mesh-list
25618715|NCT01177410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25618716|NCT01177410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25618717|NCT01177410|Analgesics|analgesics|mesh-ancestor
25618718|NCT01177410|Sensory System Agents|sensory system agents|mesh-ancestor
25618719|NCT01177410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25618720|NCT01177410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618721|NCT01177410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25618722|NCT01177410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25618723|NCT01177709|Metformin|metformin|mesh-list
25618724|NCT01177709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25618725|NCT01177709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618726|NCT01177722|Vaccines|vaccines|mesh-list
25618727|NCT01177722|Immunologic Factors|immunologic factors|mesh-ancestor
25618728|NCT01177722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618729|NCT01177735|Pomalidomide|pomalidomide|mesh-list
25618730|NCT01177735|Immunologic Factors|immunologic factors|mesh-ancestor
25618731|NCT01177735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618732|NCT01177735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25618733|NCT01177735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25618734|NCT01177735|Growth Substances|growth substances|mesh-ancestor
25618735|NCT01177735|Growth Inhibitors|growth inhibitors|mesh-ancestor
25618736|NCT01177735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25618737|NCT01177800|Infliximab|infliximab|mesh-list
25618738|NCT01177800|Dermatologic Agents|dermatologic agents|mesh-ancestor
25618739|NCT01177800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25618740|NCT01177800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25618741|NCT01177813|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25618742|NCT01177813|Empagliflozin|empagliflozin|mesh-list
25618743|NCT01177813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25618744|NCT01177813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618745|NCT01177813|Incretins|incretins|mesh-ancestor
25618746|NCT01177813|Hormones|hormones|mesh-ancestor
25618747|NCT01177813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25618748|NCT01177813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25618749|NCT01177813|Protease Inhibitors|protease inhibitors|mesh-ancestor
25618750|NCT01177813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25618751|NCT01177813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618752|NCT01177813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25618753|NCT01177943|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25618754|NCT01177943|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25618755|NCT01177943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25618756|NCT01177943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25618757|NCT01177943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618758|NCT01177943|Adrenergic Agents|adrenergic agents|mesh-ancestor
25618759|NCT01177943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25618760|NCT01177943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618761|NCT01177956|Cisplatin|cisplatin|mesh-list
25618762|NCT01177956|Fluorouracil|fluorouracil|mesh-list
25618764|NCT01177956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25618765|NCT01177956|Antimetabolites|antimetabolites|mesh-ancestor
25618766|NCT01177956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618767|NCT01177956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25618768|NCT01177956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25618769|NCT01177956|Immunologic Factors|immunologic factors|mesh-ancestor
25618770|NCT01177956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618771|NCT01177956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25618772|NCT01178073|Ambrisentan|ambrisentan|mesh-list
25618773|NCT01178073|Tadalafil|tadalafil|mesh-list
25618774|NCT01178073|Vasodilator Agents|vasodilator agents|mesh-ancestor
25618775|NCT01178073|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25618776|NCT01178073|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25618777|NCT01178073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25618778|NCT01178073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618779|NCT01178073|Urological Agents|urological agents|mesh-ancestor
25618780|NCT01178073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25618781|NCT01178086|Rituximab|rituximab|mesh-list
25618782|NCT01178086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25618783|NCT01178086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25618784|NCT01178086|Immunologic Factors|immunologic factors|mesh-ancestor
25618785|NCT01178086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618786|NCT01178086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25618787|NCT01178099|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25618788|NCT01178099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25618789|NCT01178138|Prazosin|prazosin|mesh-list
25618790|NCT01178138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25618791|NCT01178138|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25618792|NCT01178138|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25618793|NCT01178138|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25618794|NCT01178138|Adrenergic Agents|adrenergic agents|mesh-ancestor
25618795|NCT01178138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25618796|NCT01178138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618797|NCT01178138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618798|NCT01178216|Rituximab|rituximab|mesh-list
25618799|NCT01178216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25618800|NCT01178216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25618801|NCT01178216|Immunologic Factors|immunologic factors|mesh-ancestor
25618802|NCT01178216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618803|NCT01178216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25618804|NCT01178281|Thalidomide|thalidomide|mesh-list
25618805|NCT01178281|Pomalidomide|pomalidomide|mesh-list
25618806|NCT01178281|Immunologic Factors|immunologic factors|mesh-ancestor
25618807|NCT01178281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618808|NCT01178281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25618809|NCT01178281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25618810|NCT01178281|Growth Substances|growth substances|mesh-ancestor
25618811|NCT01178281|Growth Inhibitors|growth inhibitors|mesh-ancestor
25618812|NCT01178281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25618813|NCT01178281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25618814|NCT01178281|Leprostatic Agents|leprostatic agents|mesh-ancestor
25618815|NCT01178281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25618816|NCT01178281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25618817|NCT01178528|Carvedilol|carvedilol|mesh-list
25618818|NCT01178528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25618819|NCT01178528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25618820|NCT01178528|Adrenergic Agents|adrenergic agents|mesh-ancestor
25618821|NCT01178528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25618822|NCT01178528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618823|NCT01178528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618824|NCT01178528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25618825|NCT01178528|Antioxidants|antioxidants|mesh-ancestor
25618826|NCT01178528|Protective Agents|protective agents|mesh-ancestor
25618827|NCT01178528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25618828|NCT01178528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25618829|NCT01178528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25618830|NCT01178528|Vasodilator Agents|vasodilator agents|mesh-ancestor
25618831|NCT01178528|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25618832|NCT01178528|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25618833|NCT01178671|Mirtazapine|mirtazapine|mesh-list
25618834|NCT01178671|Sertraline|sertraline|mesh-list
25618835|NCT01178671|Antidepressive Agents|antidepressive agents|mesh-ancestor
25513452|NCT00408070|Paclitaxel|paclitaxel|mesh-list
25618836|NCT01178671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25618837|NCT01178671|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25618838|NCT01178671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25618839|NCT01178671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25618840|NCT01178671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618841|NCT01178671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25618842|NCT01178671|Serotonin Agents|serotonin agents|mesh-ancestor
25618843|NCT01178671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618844|NCT01178671|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25618845|NCT01178671|Histamine Antagonists|histamine antagonists|mesh-ancestor
25618846|NCT01178671|Histamine Agents|histamine agents|mesh-ancestor
25618847|NCT01178671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25618848|NCT01178671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25618849|NCT01178671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25618850|NCT01178671|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25618851|NCT01178671|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25618852|NCT01178671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25618853|NCT01178671|Adrenergic Agents|adrenergic agents|mesh-ancestor
25770974|NCT03577730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25618854|NCT01178671|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25618855|NCT01178671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25618856|NCT01178671|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25618857|NCT01178762|Azithromycin|azithromycin|mesh-list
25618858|NCT01178762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25618859|NCT01178762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25618860|NCT01178827|Mandelic Acids|mandelic acids|mesh-list
25618861|NCT01178827|Oxybutynin|oxybutynin|mesh-list
25618862|NCT01178827|Trospium chloride|trospium chloride|mesh-list
25618863|NCT01178827|Parasympatholytics|parasympatholytics|mesh-ancestor
25618864|NCT01178827|Autonomic Agents|autonomic agents|mesh-ancestor
25618865|NCT01178827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25618866|NCT01178827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618867|NCT01178827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25618868|NCT01178827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25618869|NCT01178827|Cholinergic Agents|cholinergic agents|mesh-ancestor
25618870|NCT01178827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25618871|NCT01178827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897196|NCT04427826|Morphine|morphine|mesh-list
25618872|NCT01178827|Urological Agents|urological agents|mesh-ancestor
25618873|NCT01178827|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25618874|NCT01178827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25618875|NCT01178827|Renal Agents|renal agents|mesh-ancestor
25618876|NCT01178853|Warfarin|warfarin|mesh-list
25618877|NCT01178853|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25618878|NCT01178853|Pitavastatin|pitavastatin|mesh-list
25618879|NCT01178853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25618880|NCT01178853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25618881|NCT01178853|Antimetabolites|antimetabolites|mesh-ancestor
25618882|NCT01178853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618883|NCT01178853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25618884|NCT01178853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25618885|NCT01178853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25618886|NCT01178853|Anticoagulants|anticoagulants|mesh-ancestor
25618887|NCT01178944|Oxaliplatin|oxaliplatin|mesh-list
25618888|NCT01178944|10-deazaaminopterin|10-deazaaminopterin|mesh-list
25618889|NCT01178944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25618890|NCT01178944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25618891|NCT01178944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25618892|NCT01178944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618893|NCT01179048|Liraglutide|liraglutide|mesh-list
25618894|NCT01179048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25618895|NCT01179048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618896|NCT01179048|Incretins|incretins|mesh-ancestor
25618897|NCT01179048|Hormones|hormones|mesh-ancestor
25618898|NCT01179048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25618899|NCT01179113|Esmolol|esmolol|mesh-list
25618900|NCT01179113|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25618901|NCT01179113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25618902|NCT01179113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25618903|NCT01179113|Adrenergic Agents|adrenergic agents|mesh-ancestor
25618904|NCT01179113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25618905|NCT01179113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516667|NCT00602706|Melphalan|melphalan|mesh-list
25618906|NCT01179113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618907|NCT01179191|Naltrexone|naltrexone|mesh-list
25618908|NCT01179191|Morphine|morphine|mesh-list
25618909|NCT01179191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25618910|NCT01179191|Narcotics|narcotics|mesh-ancestor
25618911|NCT01179191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25618912|NCT01179191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618913|NCT01179191|Analgesics|analgesics|mesh-ancestor
25618914|NCT01179191|Sensory System Agents|sensory system agents|mesh-ancestor
25618915|NCT01179191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25618916|NCT01179191|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25618917|NCT01179191|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25618918|NCT01179334|Sildenafil Citrate|sildenafil citrate|mesh-list
25618919|NCT01179334|Riociguat|riociguat|mesh-list
25618920|NCT01179334|Vasodilator Agents|vasodilator agents|mesh-ancestor
25618921|NCT01179334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25618922|NCT01179334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25618923|NCT01179334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25618924|NCT01179334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618925|NCT01179334|Urological Agents|urological agents|mesh-ancestor
25618926|NCT01179334|Enzyme Activators|enzyme activators|mesh-ancestor
25618927|NCT01179347|Tiotropium Bromide|tiotropium bromide|mesh-list
24897291|NCT04426669|Aldesleukin|aldesleukin|mesh-list
25618928|NCT01179347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25618929|NCT01179347|Autonomic Agents|autonomic agents|mesh-ancestor
25618930|NCT01179347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25618931|NCT01179347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618932|NCT01179347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25618933|NCT01179347|Respiratory System Agents|respiratory system agents|mesh-ancestor
25618934|NCT01179347|Parasympatholytics|parasympatholytics|mesh-ancestor
25618935|NCT01179347|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25618936|NCT01179347|Cholinergic Agents|cholinergic agents|mesh-ancestor
25618937|NCT01179347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25618938|NCT01179347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618939|NCT01179490|Prednisolone|prednisolone|mesh-list
25618940|NCT01179490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25618941|NCT01179490|Glucocorticoids|glucocorticoids|mesh-ancestor
25618942|NCT01179490|Hormones|hormones|mesh-ancestor
25618943|NCT01179490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25618944|NCT01179490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618945|NCT01179490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25618946|NCT01179490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25618947|NCT01179516|Vortioxetine|vortioxetine|mesh-list
25618948|NCT01179516|Antidepressive Agents|antidepressive agents|mesh-ancestor
25618949|NCT01179516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25618950|NCT01179516|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25618951|NCT01179516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25618952|NCT01179516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25618953|NCT01179516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618954|NCT01179516|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25618955|NCT01179516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25618956|NCT01179516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25618957|NCT01179516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618958|NCT01179516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25618959|NCT01179516|Serotonin Agents|serotonin agents|mesh-ancestor
25618960|NCT01179516|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24897344|NCT04425993|Analgesics|analgesics|mesh-ancestor
25618961|NCT01179516|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25618962|NCT01179516|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25618963|NCT01179516|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25618964|NCT01179568|Citalopram|citalopram|mesh-list
25618965|NCT01179568|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25618966|NCT01179568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25618967|NCT01179568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25618968|NCT01179568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618969|NCT01179568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25618970|NCT01179568|Serotonin Agents|serotonin agents|mesh-ancestor
25618971|NCT01179568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618972|NCT01179568|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25618973|NCT01179568|Antidepressive Agents|antidepressive agents|mesh-ancestor
25618974|NCT01179568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25618975|NCT01179672|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25618976|NCT01179672|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25618977|NCT01179672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25618978|NCT01179672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25618979|NCT01179672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618980|NCT01179672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25618981|NCT01179672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25618982|NCT01179672|Analgesics|analgesics|mesh-ancestor
25618983|NCT01179672|Sensory System Agents|sensory system agents|mesh-ancestor
25618984|NCT01179672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25618985|NCT01179672|Antidepressive Agents|antidepressive agents|mesh-ancestor
25618986|NCT01179672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25618987|NCT01179672|Dopamine Agents|dopamine agents|mesh-ancestor
25618988|NCT01179919|Oseltamivir|oseltamivir|mesh-list
25618989|NCT01179919|Antiviral Agents|antiviral agents|mesh-ancestor
25618990|NCT01179919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25618991|NCT01179919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25618992|NCT01179919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25618993|NCT01180036|Cyclosporine|cyclosporine|mesh-list
25618994|NCT01180036|Rituximab|rituximab|mesh-list
25618995|NCT01180036|Cyclosporins|cyclosporins|mesh-list
25618996|NCT01180036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25618997|NCT01180036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25618998|NCT01180036|Immunologic Factors|immunologic factors|mesh-ancestor
25618999|NCT01180036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619000|NCT01180036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25619001|NCT01180036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619002|NCT01180036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619003|NCT01180036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25619004|NCT01180036|Antifungal Agents|antifungal agents|mesh-ancestor
25619005|NCT01180036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25619006|NCT01180036|Dermatologic Agents|dermatologic agents|mesh-ancestor
25619007|NCT01180036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25619008|NCT01180049|Sirolimus|sirolimus|mesh-list
25619009|NCT01180049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25619010|NCT01180049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25619011|NCT01180049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25619012|NCT01180049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619013|NCT01180049|Antifungal Agents|antifungal agents|mesh-ancestor
25619014|NCT01180049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25619015|NCT01180049|Immunologic Factors|immunologic factors|mesh-ancestor
25619016|NCT01180049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619017|NCT01180296|Progesterone|progesterone|mesh-list
25619018|NCT01180296|Progestins|progestins|mesh-ancestor
25619019|NCT01180296|Hormones|hormones|mesh-ancestor
25619020|NCT01180296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25619021|NCT01180296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619022|NCT01180647|Naltrexone|naltrexone|mesh-list
25619023|NCT01180647|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25619024|NCT01180647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25619025|NCT01180647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619026|NCT01180647|Sensory System Agents|sensory system agents|mesh-ancestor
25619027|NCT01180647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25619028|NCT01180660|Lidocaine|lidocaine|mesh-list
25619029|NCT01180660|Anesthetics, Local|anesthetics, local|mesh-ancestor
25619030|NCT01180660|Anesthetics|anesthetics|mesh-ancestor
25619031|NCT01180660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25619032|NCT01180660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619033|NCT01180660|Sensory System Agents|sensory system agents|mesh-ancestor
25619034|NCT01180660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25619035|NCT01180660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25714133|NCT02351934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25619036|NCT01180660|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25619037|NCT01180660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25619038|NCT01180660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25619039|NCT01180660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619040|NCT01180790|Interferons|interferons|mesh-list
25619041|NCT01180790|Ribavirin|ribavirin|mesh-list
25619042|NCT01180790|Interferon-alpha|interferon-alpha|mesh-list
25619043|NCT01180790|Interferon alpha-2|interferon alpha-2|mesh-list
25619044|NCT01180790|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25619045|NCT01180790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619046|NCT01180790|Antiviral Agents|antiviral agents|mesh-ancestor
25619047|NCT01180790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25619048|NCT01180790|Antimetabolites|antimetabolites|mesh-ancestor
25619049|NCT01180790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619050|NCT01180790|Immunologic Factors|immunologic factors|mesh-ancestor
25619051|NCT01180790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619052|NCT01180894|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25619053|NCT01180894|Hematinics|hematinics|mesh-ancestor
25619054|NCT01181011|Amlodipine|amlodipine|mesh-list
25619055|NCT01181011|Telmisartan|telmisartan|mesh-list
25513649|NCT00409292|Immunologic Factors|immunologic factors|mesh-ancestor
24898120|NCT04418128|Nafamostat|nafamostat|mesh-list
25619056|NCT01181011|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
25655259|NCT01560923|Tryptophan|tryptophan|mesh-list
25619057|NCT01181011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25619058|NCT01181011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25619059|NCT01181011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25619060|NCT01181011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619061|NCT01181011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25619062|NCT01181011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619063|NCT01181011|Vasodilator Agents|vasodilator agents|mesh-ancestor
25619064|NCT01181011|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25619065|NCT01181011|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25619066|NCT01181102|Enoxaparin|enoxaparin|mesh-list
25619067|NCT01181102|Enoxaparin sodium|enoxaparin sodium|mesh-list
25619068|NCT01181102|Edoxaban|edoxaban|mesh-list
25619069|NCT01181102|Anticoagulants|anticoagulants|mesh-ancestor
25619070|NCT01181102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25619071|NCT01181102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25619072|NCT01181102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619073|NCT01181102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25619074|NCT01181102|Antithrombins|antithrombins|mesh-ancestor
25619075|NCT01181102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25619076|NCT01181102|Protease Inhibitors|protease inhibitors|mesh-ancestor
25619077|NCT01181102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619078|NCT01181128|Factor VIII|factor viii|mesh-list
25619079|NCT01181128|Coagulants|coagulants|mesh-ancestor
25619080|NCT01181141|Enoxaparin|enoxaparin|mesh-list
25619081|NCT01181141|Enoxaparin sodium|enoxaparin sodium|mesh-list
25619082|NCT01181141|Edoxaban|edoxaban|mesh-list
25619083|NCT01181141|Anticoagulants|anticoagulants|mesh-ancestor
25619084|NCT01181141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25619085|NCT01181141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25619086|NCT01181141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619087|NCT01181141|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25619088|NCT01181141|Antithrombins|antithrombins|mesh-ancestor
25619089|NCT01181141|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25619090|NCT01181141|Protease Inhibitors|protease inhibitors|mesh-ancestor
25619091|NCT01181141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619092|NCT01181167|Enoxaparin|enoxaparin|mesh-list
25619093|NCT01181167|Enoxaparin sodium|enoxaparin sodium|mesh-list
25619094|NCT01181167|Edoxaban|edoxaban|mesh-list
24898761|NCT04410874|Vaccines|vaccines|mesh-list
25619095|NCT01181167|Anticoagulants|anticoagulants|mesh-ancestor
25619096|NCT01181167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25619097|NCT01181167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25619098|NCT01181167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619099|NCT01181167|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25619100|NCT01181167|Antithrombins|antithrombins|mesh-ancestor
25619101|NCT01181167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25619102|NCT01181167|Protease Inhibitors|protease inhibitors|mesh-ancestor
25619103|NCT01181167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619104|NCT01181258|Methylprednisolone|methylprednisolone|mesh-list
25619105|NCT01181258|Cyclophosphamide|cyclophosphamide|mesh-list
25619106|NCT01181258|Rituximab|rituximab|mesh-list
25619107|NCT01181258|Fludarabine|fludarabine|mesh-list
25619108|NCT01181258|Interleukin-2|interleukin-2|mesh-list
25619109|NCT01181258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25619110|NCT01181258|Immunologic Factors|immunologic factors|mesh-ancestor
25619111|NCT01181258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619112|NCT01181258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25619113|NCT01181258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25619114|NCT01181258|Alkylating Agents|alkylating agents|mesh-ancestor
25619115|NCT01181258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619116|NCT01181258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619117|NCT01181258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25619118|NCT01181258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25619119|NCT01181258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25619120|NCT01181258|Antiemetics|antiemetics|mesh-ancestor
25619121|NCT01181258|Autonomic Agents|autonomic agents|mesh-ancestor
25619122|NCT01181258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25619123|NCT01181258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25619124|NCT01181258|Glucocorticoids|glucocorticoids|mesh-ancestor
25619125|NCT01181258|Hormones|hormones|mesh-ancestor
25619126|NCT01181258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25619127|NCT01181258|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25619128|NCT01181258|Protective Agents|protective agents|mesh-ancestor
25619129|NCT01181258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25619130|NCT01181258|Analgesics|analgesics|mesh-ancestor
25619131|NCT01181258|Sensory System Agents|sensory system agents|mesh-ancestor
25619132|NCT01181271|Sirolimus|sirolimus|mesh-list
25619133|NCT01181271|Cyclophosphamide|cyclophosphamide|mesh-list
25619134|NCT01181271|Busulfan|busulfan|mesh-list
25619135|NCT01181271|Methotrexate|methotrexate|mesh-list
25619136|NCT01181271|Fludarabine|fludarabine|mesh-list
25619137|NCT01181271|Etoposide|etoposide|mesh-list
25619138|NCT01181271|Tacrolimus|tacrolimus|mesh-list
25619139|NCT01181271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25619140|NCT01181271|Immunologic Factors|immunologic factors|mesh-ancestor
24817785|NCT02085590|Vaccines|vaccines|mesh-list
25619141|NCT01181271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619142|NCT01181271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25619143|NCT01181271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25619144|NCT01181271|Alkylating Agents|alkylating agents|mesh-ancestor
25619145|NCT01181271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619146|NCT01181271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619147|NCT01181271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25619148|NCT01181271|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25619149|NCT01181271|Abortifacient Agents|abortifacient agents|mesh-ancestor
25619150|NCT01181271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25619151|NCT01181271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25619152|NCT01181271|Antimetabolites|antimetabolites|mesh-ancestor
25619153|NCT01181271|Dermatologic Agents|dermatologic agents|mesh-ancestor
25619154|NCT01181271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619155|NCT01181271|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25619156|NCT01181271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25619157|NCT01181271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25619158|NCT01181271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25619159|NCT01181271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25619160|NCT01181271|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25619161|NCT01181271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25619162|NCT01181271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25619163|NCT01181271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25619164|NCT01181271|Antifungal Agents|antifungal agents|mesh-ancestor
25619165|NCT01181323|Vaccines|vaccines|mesh-list
25619166|NCT01181323|Immunologic Factors|immunologic factors|mesh-ancestor
25619167|NCT01181323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619168|NCT01181349|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
25619169|NCT01181349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25619170|NCT01181349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24476193|NCT00413426|Cholinergic Agents|cholinergic agents|mesh-ancestor
25619171|NCT01181349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619172|NCT01181531|Vitamin D|vitamin d|mesh-list
25619173|NCT01181531|Cinacalcet|cinacalcet|mesh-list
25619174|NCT01181531|Vitamins|vitamins|mesh-ancestor
25619175|NCT01181531|Micronutrients|micronutrients|mesh-ancestor
25619176|NCT01181531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619177|NCT01181531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25619178|NCT01181531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25619179|NCT01181531|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25619180|NCT01181531|Hormone Antagonists|hormone antagonists|mesh-ancestor
25619181|NCT01181531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25619182|NCT01181609|Bevacizumab|bevacizumab|mesh-list
25619183|NCT01181609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25619184|NCT01181609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619185|NCT01181609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25619186|NCT01181609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25619187|NCT01181609|Growth Substances|growth substances|mesh-ancestor
25619188|NCT01181609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619189|NCT01181609|Growth Inhibitors|growth inhibitors|mesh-ancestor
25655260|NCT01560923|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25655261|NCT01560923|Antidepressive Agents|antidepressive agents|mesh-ancestor
25655262|NCT01560923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25655263|NCT01560949|Gemcitabine|gemcitabine|mesh-list
25655264|NCT01560949|Fluorouracil|fluorouracil|mesh-list
25513791|NCT00410410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513792|NCT00410410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25513793|NCT00410423|Cytarabine|cytarabine|mesh-list
25513794|NCT00410423|Etoposide|etoposide|mesh-list
25513795|NCT00410423|Mitoxantrone|mitoxantrone|mesh-list
25513796|NCT00410423|Bortezomib|bortezomib|mesh-list
25513797|NCT00410423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25513798|NCT00410423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25655265|NCT01560949|Oxaliplatin|oxaliplatin|mesh-list
25655266|NCT01560949|Irinotecan|irinotecan|mesh-list
25655267|NCT01560949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25655268|NCT01560949|Antimetabolites|antimetabolites|mesh-ancestor
25655269|NCT01560949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655270|NCT01560949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25655271|NCT01560949|Antiviral Agents|antiviral agents|mesh-ancestor
25655272|NCT01560949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25619190|NCT01181674|Insulin|insulin|mesh-list
25619191|NCT01181674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25619192|NCT01181674|Metformin|metformin|mesh-list
25619193|NCT01181674|Insulin Glargine|insulin glargine|mesh-list
25619194|NCT01181674|Acarbose|acarbose|mesh-list
25619195|NCT01181674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25619196|NCT01181674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619197|NCT01181674|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25619198|NCT01181674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619199|NCT01181674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619200|NCT01181726|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25619201|NCT01181726|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25619202|NCT01181726|Norethindrone|norethindrone|mesh-list
25619203|NCT01181726|Norethindrone Acetate|norethindrone acetate|mesh-list
25619204|NCT01181726|Estradiol|estradiol|mesh-list
25619205|NCT01181726|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25619206|NCT01181726|Estrogens|estrogens|mesh-ancestor
25619207|NCT01181726|Hormones|hormones|mesh-ancestor
25619208|NCT01181726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25619209|NCT01181726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619210|NCT01181726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25619211|NCT01181726|Contraceptive Agents|contraceptive agents|mesh-ancestor
25619212|NCT01181726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25619213|NCT01181726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25619214|NCT01181726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25619215|NCT01181726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25619216|NCT01181726|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25619217|NCT01181895|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25619218|NCT01181895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25619219|NCT01181895|Autonomic Agents|autonomic agents|mesh-ancestor
25619220|NCT01181895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25619221|NCT01181895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619222|NCT01181895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25619223|NCT01181895|Respiratory System Agents|respiratory system agents|mesh-ancestor
25619224|NCT01181895|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25619225|NCT01181895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25619226|NCT01181895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25619227|NCT01181895|Adrenergic Agents|adrenergic agents|mesh-ancestor
25619228|NCT01181895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25619229|NCT01181895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619230|NCT01181986|Exenatide|exenatide|mesh-list
25619231|NCT01181986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25619232|NCT01181986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619233|NCT01181986|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25619234|NCT01181986|Incretins|incretins|mesh-ancestor
25619235|NCT01181986|Hormones|hormones|mesh-ancestor
25714199|NCT02353169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24900535|NCT04393025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25619236|NCT01181986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25619237|NCT01182181|Anastrozole|anastrozole|mesh-list
25619238|NCT01182181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25619239|NCT01182181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619240|NCT01182181|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25619241|NCT01182181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25619242|NCT01182181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619243|NCT01182181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619244|NCT01182181|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25619245|NCT01182181|Hormone Antagonists|hormone antagonists|mesh-ancestor
24900759|NCT04391478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619246|NCT01182181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25619247|NCT01182181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619248|NCT01182194|Drospirenone|drospirenone|mesh-list
25619249|NCT01182194|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25619250|NCT01182194|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25619251|NCT01182194|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25619252|NCT01182194|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
25619253|NCT01182194|Estradiol|estradiol|mesh-list
25619254|NCT01182194|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25619255|NCT01182194|Estrogens|estrogens|mesh-ancestor
25619256|NCT01182194|Hormones|hormones|mesh-ancestor
25619257|NCT01182194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25619258|NCT01182194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619259|NCT01182194|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25513851|NCT00410514|Mirabegron|mirabegron|mesh-list
25513852|NCT00410514|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25513853|NCT00410514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25513854|NCT00410514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25619260|NCT01182194|Contraceptive Agents|contraceptive agents|mesh-ancestor
25619261|NCT01182194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25619262|NCT01182194|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25619263|NCT01182194|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25619264|NCT01182194|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25619265|NCT01182194|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25619266|NCT01182194|Hormone Antagonists|hormone antagonists|mesh-ancestor
25619267|NCT01182194|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25619268|NCT01182194|Diuretics|diuretics|mesh-ancestor
25619269|NCT01182194|Natriuretic Agents|natriuretic agents|mesh-ancestor
25619270|NCT01182207|Drospirenone|drospirenone|mesh-list
25619271|NCT01182207|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25619272|NCT01182207|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25619273|NCT01182207|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25619274|NCT01182207|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
25619275|NCT01182207|Estradiol|estradiol|mesh-list
25619276|NCT01182207|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25619277|NCT01182207|Estrogens|estrogens|mesh-ancestor
25619278|NCT01182207|Hormones|hormones|mesh-ancestor
25619279|NCT01182207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25619280|NCT01182207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619281|NCT01182207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25619282|NCT01182207|Contraceptive Agents|contraceptive agents|mesh-ancestor
25619283|NCT01182207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25619284|NCT01182207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25619285|NCT01182207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25619286|NCT01182207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25619287|NCT01182207|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25619288|NCT01182207|Hormone Antagonists|hormone antagonists|mesh-ancestor
25619289|NCT01182207|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25619290|NCT01182207|Diuretics|diuretics|mesh-ancestor
25619291|NCT01182207|Natriuretic Agents|natriuretic agents|mesh-ancestor
25619292|NCT01182285|Valproic Acid|valproic acid|mesh-list
25619293|NCT01182285|Anticonvulsants|anticonvulsants|mesh-ancestor
25619294|NCT01182285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619295|NCT01182285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619296|NCT01182285|GABA Agents|gaba agents|mesh-ancestor
25619297|NCT01182285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25619298|NCT01182285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619299|NCT01182285|Antimanic Agents|antimanic agents|mesh-ancestor
25619300|NCT01182285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25619301|NCT01182285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25619302|NCT01182285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25619303|NCT01182350|Bevacizumab|bevacizumab|mesh-list
25619304|NCT01182350|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25619305|NCT01182350|Temozolomide|temozolomide|mesh-list
25619306|NCT01182350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25619307|NCT01182350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619308|NCT01182350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25619309|NCT01182350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25619310|NCT01182350|Growth Substances|growth substances|mesh-ancestor
25619311|NCT01182350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619312|NCT01182350|Growth Inhibitors|growth inhibitors|mesh-ancestor
25619313|NCT01182350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25619314|NCT01182350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619315|NCT01182350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901746|NCT04381377|Bromides|bromides|mesh-list
25619316|NCT01182350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25714247|NCT02353806|Amlodipine|amlodipine|mesh-list
25619317|NCT01182350|Alkylating Agents|alkylating agents|mesh-ancestor
25619318|NCT01182376|Dronedarone|dronedarone|mesh-list
25619319|NCT01182376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25619320|NCT01182441|Warfarin|warfarin|mesh-list
25619321|NCT01182441|Anticoagulants|anticoagulants|mesh-ancestor
25619322|NCT01182493|Insulin|insulin|mesh-list
25619323|NCT01182493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25619324|NCT01182493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619325|NCT01182675|Plerixafor|plerixafor|mesh-list
25619326|NCT01182675|Alemtuzumab|alemtuzumab|mesh-list
25619327|NCT01182675|Lenograstim|lenograstim|mesh-list
24902015|NCT04379102|Anesthetics, Local|anesthetics, local|mesh-list
25619328|NCT01182675|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25619329|NCT01182675|Immunologic Factors|immunologic factors|mesh-ancestor
25619330|NCT01182675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619331|NCT01182675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25619332|NCT01182675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513930|NCT00411398|Memantine|memantine|mesh-list
25619333|NCT01182675|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25619334|NCT01182675|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25619335|NCT01182675|Antiviral Agents|antiviral agents|mesh-ancestor
25619336|NCT01182675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25619337|NCT01183013|Pioglitazone|pioglitazone|mesh-list
25619338|NCT01183013|Linagliptin|linagliptin|mesh-list
25619339|NCT01183013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25619340|NCT01183013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619341|NCT01183013|Incretins|incretins|mesh-ancestor
25619342|NCT01183013|Hormones|hormones|mesh-ancestor
25619343|NCT01183013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25619344|NCT01183013|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25619345|NCT01183013|Protease Inhibitors|protease inhibitors|mesh-ancestor
25619346|NCT01183013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619347|NCT01183013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619348|NCT01183065|Folic Acid|folic acid|mesh-list
25619349|NCT01183065|Vitamin B 12|vitamin b 12|mesh-list
25619350|NCT01183065|Hydroxocobalamin|hydroxocobalamin|mesh-list
25619351|NCT01183065|Vitamins|vitamins|mesh-ancestor
25619352|NCT01183065|Micronutrients|micronutrients|mesh-ancestor
25619353|NCT01183065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619354|NCT01183065|Hematinics|hematinics|mesh-ancestor
25619355|NCT01183065|Vitamin B Complex|vitamin b complex|mesh-ancestor
25619356|NCT01183104|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25619357|NCT01183104|Glimepiride|glimepiride|mesh-list
25619358|NCT01183104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25619359|NCT01183104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619360|NCT01183104|Incretins|incretins|mesh-ancestor
25619361|NCT01183104|Hormones|hormones|mesh-ancestor
25619362|NCT01183104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25619363|NCT01183104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25619364|NCT01183104|Protease Inhibitors|protease inhibitors|mesh-ancestor
25619365|NCT01183104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619366|NCT01183104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619367|NCT01183104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25619368|NCT01183104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25619369|NCT01183104|Immunologic Factors|immunologic factors|mesh-ancestor
25619370|NCT01183143|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25619371|NCT01183143|Hormones|hormones|mesh-ancestor
25619372|NCT01183143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25619373|NCT01183143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619374|NCT01183169|Ribavirin|ribavirin|mesh-list
25619375|NCT01183169|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25619376|NCT01183169|Antimetabolites|antimetabolites|mesh-ancestor
25619377|NCT01183169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619378|NCT01183169|Antiviral Agents|antiviral agents|mesh-ancestor
25619379|NCT01183169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25619380|NCT01183234|Methylphenidate|methylphenidate|mesh-list
25619381|NCT01183234|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25619382|NCT01183234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619383|NCT01183234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24904129|NCT04358770|Glucocorticoids|glucocorticoids|mesh-ancestor
25619384|NCT01183234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25619385|NCT01183234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25619386|NCT01183234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619387|NCT01183234|Dopamine Agents|dopamine agents|mesh-ancestor
25619388|NCT01183234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25619389|NCT01183312|Flumazenil|flumazenil|mesh-list
25619390|NCT01183312|Antidotes|antidotes|mesh-ancestor
25619391|NCT01183312|Protective Agents|protective agents|mesh-ancestor
25619392|NCT01183312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619393|NCT01183312|GABA Modulators|gaba modulators|mesh-ancestor
25619394|NCT01183312|GABA Agents|gaba agents|mesh-ancestor
25619395|NCT01183312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25619396|NCT01183312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619397|NCT01183390|Anastrozole|anastrozole|mesh-list
25619398|NCT01183390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25619399|NCT01183390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619400|NCT01183390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25619401|NCT01183390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25619402|NCT01183390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619403|NCT01183390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480839|NCT00432367|Renal Agents|renal agents|mesh-ancestor
25619404|NCT01183390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25619405|NCT01183390|Hormone Antagonists|hormone antagonists|mesh-ancestor
25619406|NCT01183390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25619407|NCT01183390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619408|NCT01183481|Aprepitant|aprepitant|mesh-list
25619409|NCT01183481|Granisetron|granisetron|mesh-list
25619410|NCT01183481|Antiemetics|antiemetics|mesh-ancestor
25619411|NCT01183481|Autonomic Agents|autonomic agents|mesh-ancestor
25619412|NCT01183481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25619413|NCT01183481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619414|NCT01183481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25619415|NCT01183481|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25619416|NCT01183481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25619417|NCT01183481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619418|NCT01183481|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25619419|NCT01183481|Serotonin Agents|serotonin agents|mesh-ancestor
25619420|NCT01183533|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25619421|NCT01183533|Plasminogen|plasminogen|mesh-list
25619422|NCT01183533|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25619423|NCT01183533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25619424|NCT01183533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619425|NCT01183559|Paclitaxel|paclitaxel|mesh-list
25619426|NCT01183559|Carboplatin|carboplatin|mesh-list
25619427|NCT01183559|Fluorouracil|fluorouracil|mesh-list
25619428|NCT01183559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25619429|NCT01183559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619430|NCT01183559|Tubulin Modulators|tubulin modulators|mesh-ancestor
25619431|NCT01183559|Antimitotic Agents|antimitotic agents|mesh-ancestor
25619432|NCT01183559|Mitosis Modulators|mitosis modulators|mesh-ancestor
24905712|NCT04345744|Disinfectants|disinfectants|mesh-ancestor
25619433|NCT01183559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619434|NCT01183559|Antimetabolites|antimetabolites|mesh-ancestor
25619435|NCT01183559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25619436|NCT01183559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25619437|NCT01183559|Immunologic Factors|immunologic factors|mesh-ancestor
25619438|NCT01183559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619439|NCT01183650|Tadalafil|tadalafil|mesh-list
25619440|NCT01183650|Vasodilator Agents|vasodilator agents|mesh-ancestor
25619441|NCT01183650|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25619442|NCT01183650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25619443|NCT01183650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619444|NCT01183650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619445|NCT01183650|Urological Agents|urological agents|mesh-ancestor
25619446|NCT01183780|Leucovorin|leucovorin|mesh-list
25619447|NCT01183780|Folic Acid|folic acid|mesh-list
25619448|NCT01183780|Fluorouracil|fluorouracil|mesh-list
25619449|NCT01183780|Irinotecan|irinotecan|mesh-list
25619450|NCT01183780|Ramucirumab|ramucirumab|mesh-list
25619451|NCT01183780|Levoleucovorin|levoleucovorin|mesh-list
25619452|NCT01183780|Antimetabolites|antimetabolites|mesh-ancestor
25619453|NCT01183780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619454|NCT01183780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25619455|NCT01183780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619456|NCT01183780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25619457|NCT01183780|Immunologic Factors|immunologic factors|mesh-ancestor
25619458|NCT01183780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619459|NCT01183780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25619460|NCT01183780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25619461|NCT01183780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619462|NCT01183780|Antidotes|antidotes|mesh-ancestor
25619463|NCT01183780|Protective Agents|protective agents|mesh-ancestor
25619464|NCT01183780|Vitamin B Complex|vitamin b complex|mesh-ancestor
25619465|NCT01183780|Vitamins|vitamins|mesh-ancestor
25619466|NCT01183780|Micronutrients|micronutrients|mesh-ancestor
25619467|NCT01183780|Hematinics|hematinics|mesh-ancestor
25619468|NCT01183858|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25619469|NCT01183858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619470|NCT01183858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25619471|NCT01183858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619472|NCT01183858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619473|NCT01184014|Insulin|insulin|mesh-list
25619474|NCT01184014|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25619475|NCT01184014|Insulin Glargine|insulin glargine|mesh-list
25619476|NCT01184014|Insulin Lispro|insulin lispro|mesh-list
25619477|NCT01184014|Insulin, Isophane|insulin, isophane|mesh-list
25619478|NCT01184014|Isophane Insulin, Human|isophane insulin, human|mesh-list
25619479|NCT01184014|Isophane insulin, beef|isophane insulin, beef|mesh-list
25619480|NCT01184014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25619481|NCT01184014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619482|NCT01184053|Arsenic Trioxide|arsenic trioxide|mesh-list
25619483|NCT01184053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619484|NCT01184079|Vaccines|vaccines|mesh-list
25619485|NCT01184079|Immunologic Factors|immunologic factors|mesh-ancestor
25655273|NCT01560949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619486|NCT01184079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619487|NCT01184118|Fluticasone|fluticasone|mesh-list
25619488|NCT01184118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25619489|NCT01184118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25619490|NCT01184118|Autonomic Agents|autonomic agents|mesh-ancestor
25619491|NCT01184118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25619492|NCT01184118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619493|NCT01184118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25619494|NCT01184118|Respiratory System Agents|respiratory system agents|mesh-ancestor
25619495|NCT01184118|Dermatologic Agents|dermatologic agents|mesh-ancestor
25619496|NCT01184118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25619497|NCT01184326|Everolimus|everolimus|mesh-list
25619498|NCT01184326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619499|NCT01184326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25619500|NCT01184326|Immunologic Factors|immunologic factors|mesh-ancestor
25619501|NCT01184326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619502|NCT01184417|Phenobarbital|phenobarbital|mesh-list
25619503|NCT01184417|Anticonvulsants|anticonvulsants|mesh-ancestor
25619504|NCT01184417|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25619505|NCT01184417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25619506|NCT01184417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619507|NCT01184417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25619508|NCT01184417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25619509|NCT01184417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25619510|NCT01184417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619511|NCT01184417|GABA Modulators|gaba modulators|mesh-ancestor
25619512|NCT01184417|GABA Agents|gaba agents|mesh-ancestor
25619513|NCT01184417|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25619514|NCT01184417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25619515|NCT01184417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25619516|NCT01184846|Immunoglobulins|immunoglobulins|mesh-list
25619517|NCT01184846|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25619518|NCT01184846|Antibodies|antibodies|mesh-list
25619519|NCT01184846|Immunologic Factors|immunologic factors|mesh-ancestor
25619520|NCT01184846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619521|NCT01184859|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25619522|NCT01184859|Hemostatics|hemostatics|mesh-ancestor
25619523|NCT01184859|Coagulants|coagulants|mesh-ancestor
25619524|NCT01184859|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25619525|NCT01184859|Natriuretic Agents|natriuretic agents|mesh-ancestor
25619526|NCT01184859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619527|NCT01184872|Vancomycin|vancomycin|mesh-list
25619528|NCT01184872|Daptomycin|daptomycin|mesh-list
25619529|NCT01184872|Penicillins|penicillins|mesh-list
25619530|NCT01184872|Floxacillin|floxacillin|mesh-list
25619531|NCT01184872|Cloxacillin|cloxacillin|mesh-list
25619532|NCT01184872|Oxacillin|oxacillin|mesh-list
25619533|NCT01184872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25619534|NCT01184872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25619535|NCT01184885|Sirolimus|sirolimus|mesh-list
25619536|NCT01184885|Cyclophosphamide|cyclophosphamide|mesh-list
25619537|NCT01184885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25619538|NCT01184885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619539|NCT01184885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619540|NCT01184885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25619541|NCT01184885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25619542|NCT01184885|Antifungal Agents|antifungal agents|mesh-ancestor
25619543|NCT01184885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25619544|NCT01184885|Immunologic Factors|immunologic factors|mesh-ancestor
25619545|NCT01184885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619546|NCT01184885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25619547|NCT01184885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25619548|NCT01184885|Alkylating Agents|alkylating agents|mesh-ancestor
24907797|NCT04327401|Hormones|hormones|mesh-ancestor
25619549|NCT01184885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25619550|NCT01184898|Cytarabine|cytarabine|mesh-list
25619551|NCT01184898|Sirolimus|sirolimus|mesh-list
25619552|NCT01184898|Etoposide|etoposide|mesh-list
25619553|NCT01184898|Mitoxantrone|mitoxantrone|mesh-list
25619554|NCT01184898|Etoposide phosphate|etoposide phosphate|mesh-list
25619555|NCT01184898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25619556|NCT01184898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619557|NCT01184898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25619558|NCT01184898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25619559|NCT01184898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619560|NCT01184898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619561|NCT01184898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25619562|NCT01184898|Antimetabolites|antimetabolites|mesh-ancestor
25619564|NCT01184898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25619565|NCT01184898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25619566|NCT01184898|Immunologic Factors|immunologic factors|mesh-ancestor
25619567|NCT01184898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619568|NCT01184898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25619569|NCT01184898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25619570|NCT01184898|Antifungal Agents|antifungal agents|mesh-ancestor
25619571|NCT01184898|Analgesics|analgesics|mesh-ancestor
25619572|NCT01184898|Sensory System Agents|sensory system agents|mesh-ancestor
25619573|NCT01184898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25619574|NCT01184989|Dabigatran|dabigatran|mesh-list
25619575|NCT01184989|Antithrombins|antithrombins|mesh-ancestor
25619576|NCT01184989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25619577|NCT01184989|Protease Inhibitors|protease inhibitors|mesh-ancestor
25619578|NCT01184989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619579|NCT01184989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619580|NCT01184989|Anticoagulants|anticoagulants|mesh-ancestor
25619581|NCT01185028|Interferons|interferons|mesh-list
25619582|NCT01185028|Ribavirin|ribavirin|mesh-list
25619583|NCT01185028|Nitazoxanide|nitazoxanide|mesh-list
25619584|NCT01185028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619585|NCT01185028|Antiviral Agents|antiviral agents|mesh-ancestor
25619586|NCT01185028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25619587|NCT01185028|Antimetabolites|antimetabolites|mesh-ancestor
24908548|NCT04319614|Coagulants|coagulants|mesh-ancestor
25619588|NCT01185028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619589|NCT01185028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25619590|NCT01185080|Adenosine|adenosine|mesh-list
25619591|NCT01185080|Analgesics|analgesics|mesh-ancestor
25619592|NCT01185080|Sensory System Agents|sensory system agents|mesh-ancestor
25619593|NCT01185080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25619594|NCT01185080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619595|NCT01185080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25619596|NCT01185080|Vasodilator Agents|vasodilator agents|mesh-ancestor
25619597|NCT01185080|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25619598|NCT01185080|Purinergic Agonists|purinergic agonists|mesh-ancestor
25619599|NCT01185080|Purinergic Agents|purinergic agents|mesh-ancestor
25619600|NCT01185080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25619601|NCT01185080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619602|NCT01185171|Gefitinib|gefitinib|mesh-list
25619603|NCT01185171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619604|NCT01185171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25619605|NCT01185171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619606|NCT01185171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619607|NCT01185288|Adalimumab|adalimumab|mesh-list
25619608|NCT01185288|Methotrexate|methotrexate|mesh-list
25619609|NCT01185288|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25619610|NCT01185288|Abortifacient Agents|abortifacient agents|mesh-ancestor
25619611|NCT01185288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25619612|NCT01185288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619613|NCT01185288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25619614|NCT01185288|Antimetabolites|antimetabolites|mesh-ancestor
25619615|NCT01185288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619616|NCT01185288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619617|NCT01185288|Dermatologic Agents|dermatologic agents|mesh-ancestor
25619618|NCT01185288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619619|NCT01185288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25619620|NCT01185288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25619621|NCT01185288|Immunologic Factors|immunologic factors|mesh-ancestor
25619622|NCT01185288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25619623|NCT01185288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25619624|NCT01185288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25619625|NCT01185301|Adalimumab|adalimumab|mesh-list
25619626|NCT01185301|Methotrexate|methotrexate|mesh-list
25619627|NCT01185301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25619628|NCT01185301|Abortifacient Agents|abortifacient agents|mesh-ancestor
25619629|NCT01185301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25619630|NCT01185301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619631|NCT01185301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25619632|NCT01185301|Antimetabolites|antimetabolites|mesh-ancestor
25619633|NCT01185301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619634|NCT01185301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619635|NCT01185301|Dermatologic Agents|dermatologic agents|mesh-ancestor
25619636|NCT01185301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619637|NCT01185301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25619638|NCT01185301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25619639|NCT01185301|Immunologic Factors|immunologic factors|mesh-ancestor
25619640|NCT01185301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25619641|NCT01185301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25619642|NCT01185301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25619643|NCT01185340|Serotonin|serotonin|mesh-list
25619644|NCT01185340|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25619645|NCT01185340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25619646|NCT01185340|Serotonin Agents|serotonin agents|mesh-ancestor
25619647|NCT01185340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25619648|NCT01185340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619649|NCT01185340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619650|NCT01185340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25619651|NCT01185340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25619652|NCT01185353|Methotrexate|methotrexate|mesh-list
25619653|NCT01185353|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25619654|NCT01185353|Abortifacient Agents|abortifacient agents|mesh-ancestor
25619655|NCT01185353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25619656|NCT01185353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619657|NCT01185353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25619658|NCT01185353|Antimetabolites|antimetabolites|mesh-ancestor
25619659|NCT01185353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619660|NCT01185353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619661|NCT01185353|Dermatologic Agents|dermatologic agents|mesh-ancestor
25619662|NCT01185353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619663|NCT01185353|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25619664|NCT01185353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25619665|NCT01185353|Immunologic Factors|immunologic factors|mesh-ancestor
25619666|NCT01185353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25619667|NCT01185353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25619668|NCT01185366|Everolimus|everolimus|mesh-list
25619669|NCT01185366|Sunitinib|sunitinib|mesh-list
25619670|NCT01185366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619671|NCT01185366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25619672|NCT01185366|Immunologic Factors|immunologic factors|mesh-ancestor
25619673|NCT01185366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619674|NCT01185366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25619675|NCT01185366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25619676|NCT01185366|Growth Substances|growth substances|mesh-ancestor
25619677|NCT01185366|Growth Inhibitors|growth inhibitors|mesh-ancestor
25619678|NCT01185366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25619679|NCT01185366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619680|NCT01185366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619681|NCT01185509|Trastuzumab|trastuzumab|mesh-list
25619682|NCT01185509|Vinorelbine|vinorelbine|mesh-list
25619683|NCT01185509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25619684|NCT01185509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619685|NCT01185509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25619686|NCT01185509|Tubulin Modulators|tubulin modulators|mesh-ancestor
25619687|NCT01185509|Antimitotic Agents|antimitotic agents|mesh-ancestor
25619688|NCT01185509|Mitosis Modulators|mitosis modulators|mesh-ancestor
25619689|NCT01185509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619690|NCT01185548|Tolbutamide|tolbutamide|mesh-list
25619691|NCT01185548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25619692|NCT01185548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619693|NCT01185704|Cetrorelix|cetrorelix|mesh-list
25619694|NCT01185704|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25619695|NCT01185704|Hormones|hormones|mesh-list
25619696|NCT01185704|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25619697|NCT01185704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25619698|NCT01185704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619699|NCT01185704|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25619700|NCT01185704|Fertility Agents|fertility agents|mesh-ancestor
25619701|NCT01185704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25619702|NCT01185704|Hormone Antagonists|hormone antagonists|mesh-ancestor
25619703|NCT01185782|Gonadotropins, Pituitary|gonadotropins, pituitary|mesh-list
25514264|NCT00413166|Arsenic Trioxide|arsenic trioxide|mesh-list
25514265|NCT00413166|Gemtuzumab|gemtuzumab|mesh-list
25514266|NCT00413166|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25514267|NCT00413166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514268|NCT00413166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25619704|NCT01185782|Hormones|hormones|mesh-list
25619705|NCT01185782|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25514269|NCT00413166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25619706|NCT01185782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25619707|NCT01185782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619708|NCT01185782|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25619709|NCT01185782|Fertility Agents|fertility agents|mesh-ancestor
25619710|NCT01185782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25619711|NCT01185782|Fertility Agents, Male|fertility agents, male|mesh-ancestor
25619712|NCT01185821|Siponimod|siponimod|mesh-list
25619713|NCT01185821|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25619714|NCT01185821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619715|NCT01185821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25619716|NCT01185821|Immunologic Factors|immunologic factors|mesh-ancestor
25619717|NCT01185821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619718|NCT01185964|Doxorubicin|doxorubicin|mesh-list
25619719|NCT01185964|Olaratumab|olaratumab|mesh-list
25619720|NCT01185964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25619721|NCT01185964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619722|NCT01185964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25619723|NCT01185964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25619724|NCT01185964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619725|NCT01185964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619726|NCT01186250|Pioglitazone|pioglitazone|mesh-list
25619727|NCT01186250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25619728|NCT01186250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619729|NCT01186328|Cytarabine|cytarabine|mesh-list
25619730|NCT01186328|Prednisone|prednisone|mesh-list
25619731|NCT01186328|Hydrocortisone|hydrocortisone|mesh-list
25619732|NCT01186328|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25619733|NCT01186328|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25619734|NCT01186328|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25619735|NCT01186328|Cortisone|cortisone|mesh-list
25619736|NCT01186328|Doxorubicin|doxorubicin|mesh-list
25619737|NCT01186328|Methotrexate|methotrexate|mesh-list
25619738|NCT01186328|Vincristine|vincristine|mesh-list
25619739|NCT01186328|Asparaginase|asparaginase|mesh-list
25619740|NCT01186328|Pegaspargase|pegaspargase|mesh-list
25619741|NCT01186328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25619742|NCT01186328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619743|NCT01186328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25619744|NCT01186328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25619745|NCT01186328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619746|NCT01186328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619747|NCT01186328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25619748|NCT01186328|Glucocorticoids|glucocorticoids|mesh-ancestor
25619749|NCT01186328|Hormones|hormones|mesh-ancestor
25619750|NCT01186328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25619751|NCT01186328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619752|NCT01186328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25619753|NCT01186328|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25619754|NCT01186328|Abortifacient Agents|abortifacient agents|mesh-ancestor
25619755|NCT01186328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25619756|NCT01186328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25619757|NCT01186328|Antimetabolites|antimetabolites|mesh-ancestor
25619758|NCT01186328|Dermatologic Agents|dermatologic agents|mesh-ancestor
25619759|NCT01186328|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25619760|NCT01186328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25619761|NCT01186328|Immunologic Factors|immunologic factors|mesh-ancestor
25619762|NCT01186328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25619763|NCT01186328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25619764|NCT01186328|Antiviral Agents|antiviral agents|mesh-ancestor
25619765|NCT01186328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25619766|NCT01186328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25619767|NCT01186328|Tubulin Modulators|tubulin modulators|mesh-ancestor
25619768|NCT01186328|Antimitotic Agents|antimitotic agents|mesh-ancestor
25619769|NCT01186328|Mitosis Modulators|mitosis modulators|mesh-ancestor
25619770|NCT01186406|Bevacizumab|bevacizumab|mesh-list
25619771|NCT01186406|Temozolomide|temozolomide|mesh-list
25619772|NCT01186406|Carmustine|carmustine|mesh-list
25619773|NCT01186406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25619774|NCT01186406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619775|NCT01186406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25619776|NCT01186406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25619777|NCT01186406|Growth Substances|growth substances|mesh-ancestor
25619778|NCT01186406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619779|NCT01186406|Growth Inhibitors|growth inhibitors|mesh-ancestor
25619780|NCT01186406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25619782|NCT01186406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619783|NCT01186458|Rituximab|rituximab|mesh-list
25619784|NCT01186458|Fludarabine|fludarabine|mesh-list
25619785|NCT01186458|Bortezomib|bortezomib|mesh-list
25619786|NCT01186458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25619787|NCT01186458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619788|NCT01186458|Immunologic Factors|immunologic factors|mesh-ancestor
25619789|NCT01186458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619790|NCT01186458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25619791|NCT01186562|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25619792|NCT01186562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25619793|NCT01186562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619794|NCT01186562|Incretins|incretins|mesh-ancestor
25619795|NCT01186562|Hormones|hormones|mesh-ancestor
25619796|NCT01186562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25619797|NCT01186562|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25619798|NCT01186562|Protease Inhibitors|protease inhibitors|mesh-ancestor
25619799|NCT01186562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619800|NCT01186562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619801|NCT01186744|Tofacitinib|tofacitinib|mesh-list
25619802|NCT01186744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25619803|NCT01186744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619804|NCT01186744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619805|NCT01186770|Methylnaltrexone|methylnaltrexone|mesh-list
25619806|NCT01186770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25619807|NCT01186770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619808|NCT01186770|Sensory System Agents|sensory system agents|mesh-ancestor
25619809|NCT01186770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25619810|NCT01186796|Fulvestrant|fulvestrant|mesh-list
25619811|NCT01186796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25619812|NCT01186796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619813|NCT01186796|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25619814|NCT01186796|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25619815|NCT01186796|Hormone Antagonists|hormone antagonists|mesh-ancestor
25619816|NCT01186796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25619817|NCT01186796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619818|NCT01186939|Azacitidine|azacitidine|mesh-list
25619819|NCT01186939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24910939|NCT04292691|Ropivacaine|ropivacaine|mesh-list
25619820|NCT01186939|Antimetabolites|antimetabolites|mesh-ancestor
25619821|NCT01186939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619822|NCT01186939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619823|NCT01186939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619824|NCT01187017|Cyclophosphamide|cyclophosphamide|mesh-list
25619825|NCT01187017|Fludarabine|fludarabine|mesh-list
25619826|NCT01187017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25619827|NCT01187017|Immunologic Factors|immunologic factors|mesh-ancestor
25619828|NCT01187017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619829|NCT01187017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25619830|NCT01187017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25619831|NCT01187017|Alkylating Agents|alkylating agents|mesh-ancestor
25619832|NCT01187017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619833|NCT01187017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619834|NCT01187017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25619835|NCT01187355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25619836|NCT01187381|Trastuzumab|trastuzumab|mesh-list
25714449|NCT02356562|Ribavirin|ribavirin|mesh-list
25619837|NCT01187381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25619838|NCT01187381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619839|NCT01187407|Serotonin|serotonin|mesh-list
25619840|NCT01187407|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25619841|NCT01187407|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25619842|NCT01187407|Serotonin Agents|serotonin agents|mesh-ancestor
25619843|NCT01187407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25619844|NCT01187407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619845|NCT01187407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619846|NCT01187407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25619847|NCT01187407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25619848|NCT01187446|Vorinostat|vorinostat|mesh-list
25619849|NCT01187446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619850|NCT01187446|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25619851|NCT01187446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619852|NCT01187446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619853|NCT01187498|Oxybutynin|oxybutynin|mesh-list
25619854|NCT01187498|Parasympatholytics|parasympatholytics|mesh-ancestor
25619855|NCT01187498|Autonomic Agents|autonomic agents|mesh-ancestor
25619856|NCT01187498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25619857|NCT01187498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619858|NCT01187498|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25619859|NCT01187498|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25619860|NCT01187498|Cholinergic Agents|cholinergic agents|mesh-ancestor
25619861|NCT01187498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25619862|NCT01187498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619863|NCT01187498|Urological Agents|urological agents|mesh-ancestor
25619864|NCT01187550|Hormones|hormones|mesh-list
25619865|NCT01187550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25619866|NCT01187550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619867|NCT01187901|Sulindac|sulindac|mesh-list
25619868|NCT01187901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25619869|NCT01187901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619870|NCT01187901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25619871|NCT01187901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619872|NCT01187901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619873|NCT01187901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25619874|NCT01187901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25619875|NCT01187901|Analgesics|analgesics|mesh-ancestor
25619876|NCT01187901|Sensory System Agents|sensory system agents|mesh-ancestor
25619877|NCT01187901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25619878|NCT01187901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619879|NCT01187901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25619880|NCT01187901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25619881|NCT01187901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25619882|NCT01187953|Tacrolimus|tacrolimus|mesh-list
25619883|NCT01187953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25619884|NCT01187953|Immunologic Factors|immunologic factors|mesh-ancestor
25619885|NCT01187953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619886|NCT01187953|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25619887|NCT01187953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619888|NCT01187953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619889|NCT01188109|Gemcitabine|gemcitabine|mesh-list
25619890|NCT01188109|Cisplatin|cisplatin|mesh-list
25619891|NCT01188109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25619892|NCT01188109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25619893|NCT01188109|Antimetabolites|antimetabolites|mesh-ancestor
25619894|NCT01188109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619895|NCT01188109|Antiviral Agents|antiviral agents|mesh-ancestor
25619896|NCT01188109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25619897|NCT01188109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619898|NCT01188109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25619899|NCT01188109|Immunologic Factors|immunologic factors|mesh-ancestor
25619900|NCT01188109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619901|NCT01188369|Simendan|simendan|mesh-list
25619902|NCT01188369|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25619903|NCT01188369|Vasodilator Agents|vasodilator agents|mesh-ancestor
25619904|NCT01188369|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25619905|NCT01188369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25619906|NCT01188369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25619907|NCT01188369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619908|NCT01188369|Protective Agents|protective agents|mesh-ancestor
25619909|NCT01188369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619910|NCT01188421|Clonidine|clonidine|mesh-list
25619911|NCT01188421|Buprenorphine|buprenorphine|mesh-list
25619912|NCT01188421|Tramadol|tramadol|mesh-list
25619913|NCT01188421|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25619914|NCT01188421|Naloxone|naloxone|mesh-list
25619915|NCT01188421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25619916|NCT01188421|Narcotics|narcotics|mesh-ancestor
25619917|NCT01188421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25619918|NCT01188421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619919|NCT01188421|Analgesics|analgesics|mesh-ancestor
25619920|NCT01188421|Sensory System Agents|sensory system agents|mesh-ancestor
25619921|NCT01188421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25619922|NCT01188421|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25619923|NCT01188421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25619924|NCT01188421|Sympatholytics|sympatholytics|mesh-ancestor
25514467|NCT00414310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514468|NCT00414310|Antimanic Agents|antimanic agents|mesh-ancestor
25514469|NCT00414310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25619925|NCT01188421|Autonomic Agents|autonomic agents|mesh-ancestor
25619926|NCT01188421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25619927|NCT01188421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25619928|NCT01188421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25619929|NCT01188421|Adrenergic Agents|adrenergic agents|mesh-ancestor
25619930|NCT01188421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25619931|NCT01188421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619932|NCT01188538|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
25619933|NCT01188538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25619934|NCT01188538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25619935|NCT01188538|Analgesics|analgesics|mesh-ancestor
25619936|NCT01188538|Sensory System Agents|sensory system agents|mesh-ancestor
25619937|NCT01188538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25619938|NCT01188538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619939|NCT01188538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25619940|NCT01188538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25619941|NCT01188538|Dermatologic Agents|dermatologic agents|mesh-ancestor
25619942|NCT01188551|Fentanyl|fentanyl|mesh-list
25619943|NCT01188551|Midazolam|midazolam|mesh-list
25619944|NCT01188551|Dexmedetomidine|dexmedetomidine|mesh-list
25514539|NCT00415168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514540|NCT00415168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514541|NCT00415168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25714488|NCT02357290|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25514542|NCT00415168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25514543|NCT00415194|Cisplatin|cisplatin|mesh-list
25514544|NCT00415194|Pemetrexed|pemetrexed|mesh-list
25514545|NCT00415194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514546|NCT00415194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514547|NCT00415194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514548|NCT00415194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25514549|NCT00415194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25514550|NCT00415506|Rituximab|rituximab|mesh-list
25514551|NCT00415506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25514552|NCT00415506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514553|NCT00415506|Immunologic Factors|immunologic factors|mesh-ancestor
25514554|NCT00415506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514555|NCT00415506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25514556|NCT00415519|Edaravone|edaravone|mesh-list
25514557|NCT00415519|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25514558|NCT00415519|Antioxidants|antioxidants|mesh-ancestor
25514559|NCT00415519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514560|NCT00415519|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25514561|NCT00415519|Protective Agents|protective agents|mesh-ancestor
25514562|NCT00415519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514563|NCT00415597|Naltrexone|naltrexone|mesh-list
25514564|NCT00415597|Morphine|morphine|mesh-list
25514565|NCT00415597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25514566|NCT00415597|Narcotics|narcotics|mesh-ancestor
25619945|NCT01188551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25619946|NCT01188551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25619947|NCT01188551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619948|NCT01188551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25619949|NCT01188551|Analgesics|analgesics|mesh-ancestor
25619950|NCT01188551|Sensory System Agents|sensory system agents|mesh-ancestor
25619951|NCT01188551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25619952|NCT01188551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25619953|NCT01188551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25619954|NCT01188551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25619955|NCT01188551|Adrenergic Agents|adrenergic agents|mesh-ancestor
25619956|NCT01188551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25619957|NCT01188551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619958|NCT01188551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25619959|NCT01188551|Narcotics|narcotics|mesh-ancestor
25619960|NCT01188551|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25619961|NCT01188551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25619962|NCT01188551|Anesthetics, General|anesthetics, general|mesh-ancestor
25619963|NCT01188551|Anesthetics|anesthetics|mesh-ancestor
25619964|NCT01188551|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25619965|NCT01188551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25619966|NCT01188551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25619967|NCT01188551|GABA Modulators|gaba modulators|mesh-ancestor
25619968|NCT01188551|GABA Agents|gaba agents|mesh-ancestor
25619969|NCT01188577|Epinephrine|epinephrine|mesh-list
25619970|NCT01188577|Racepinephrine|racepinephrine|mesh-list
25619971|NCT01188577|Epinephryl borate|epinephryl borate|mesh-list
25619972|NCT01188577|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25619973|NCT01188577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25619974|NCT01188577|Adrenergic Agents|adrenergic agents|mesh-ancestor
25619975|NCT01188577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25619976|NCT01188577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25619977|NCT01188577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520026|NCT04029116|Ibrexafungerp|ibrexafungerp|mesh-list
25619978|NCT01188577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25619979|NCT01188577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25619980|NCT01188577|Autonomic Agents|autonomic agents|mesh-ancestor
25619981|NCT01188577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25619982|NCT01188577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25619983|NCT01188577|Respiratory System Agents|respiratory system agents|mesh-ancestor
25619985|NCT01188577|Sympathomimetics|sympathomimetics|mesh-ancestor
25619986|NCT01188577|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25619987|NCT01188655|Etanercept|etanercept|mesh-list
25619988|NCT01188655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25619989|NCT01188655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25619990|NCT01188655|Analgesics|analgesics|mesh-ancestor
25619991|NCT01188655|Sensory System Agents|sensory system agents|mesh-ancestor
25619992|NCT01188655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25619993|NCT01188655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25619994|NCT01188655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25619995|NCT01188655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25619996|NCT01188655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25619997|NCT01188655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25619998|NCT01188655|Immunologic Factors|immunologic factors|mesh-ancestor
25619999|NCT01188668|Aripiprazole|aripiprazole|mesh-list
25620000|NCT01188668|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25620001|NCT01188668|Antidepressive Agents|antidepressive agents|mesh-ancestor
25620002|NCT01188668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25620003|NCT01188668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25620004|NCT01188668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25620005|NCT01188668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25620006|NCT01188668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620007|NCT01188668|Dopamine Agonists|dopamine agonists|mesh-ancestor
25620008|NCT01188668|Dopamine Agents|dopamine agents|mesh-ancestor
25620009|NCT01188668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25620010|NCT01188668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620011|NCT01188668|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25620012|NCT01188668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25620013|NCT01188668|Serotonin Agents|serotonin agents|mesh-ancestor
25620014|NCT01188668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25620015|NCT01188668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25620016|NCT01188668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25620017|NCT01188668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25620018|NCT01188668|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25620019|NCT01188668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25620020|NCT01188668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25620021|NCT01188681|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25620022|NCT01188681|Immunoglobulin G|immunoglobulin g|mesh-list
25620023|NCT01188681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25620024|NCT01188681|Alkylating Agents|alkylating agents|mesh-ancestor
25620025|NCT01188681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620026|NCT01188681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620027|NCT01188681|Immunologic Factors|immunologic factors|mesh-ancestor
25620028|NCT01188681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620029|NCT01188694|Methylene Blue|methylene blue|mesh-list
25620030|NCT01188694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620031|NCT01188694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620032|NCT01188772|Sofosbuvir|sofosbuvir|mesh-list
25620033|NCT01188772|Antiviral Agents|antiviral agents|mesh-ancestor
25620034|NCT01188772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25620035|NCT01188811|Thioctic Acid|thioctic acid|mesh-list
25620036|NCT01188811|Antioxidants|antioxidants|mesh-ancestor
25620037|NCT01188811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514574|NCT00415610|Nicardipine|nicardipine|mesh-list
25514575|NCT00415610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25514576|NCT00415610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25514577|NCT00415610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25514578|NCT00415610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514579|NCT00415610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25620038|NCT01188811|Protective Agents|protective agents|mesh-ancestor
25620039|NCT01188811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620040|NCT01188811|Vitamin B Complex|vitamin b complex|mesh-ancestor
25620041|NCT01188811|Vitamins|vitamins|mesh-ancestor
25620042|NCT01188811|Micronutrients|micronutrients|mesh-ancestor
25620043|NCT01188876|Folic Acid|folic acid|mesh-list
25620044|NCT01188876|Vitamin B 12|vitamin b 12|mesh-list
25620045|NCT01188876|Hydroxocobalamin|hydroxocobalamin|mesh-list
25620046|NCT01188876|Carboplatin|carboplatin|mesh-list
25620047|NCT01188876|Vitamins|vitamins|mesh-ancestor
25620048|NCT01188876|Micronutrients|micronutrients|mesh-ancestor
25620049|NCT01188876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620050|NCT01188876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620051|NCT01188876|Hematinics|hematinics|mesh-ancestor
25620052|NCT01188876|Vitamin B Complex|vitamin b complex|mesh-ancestor
25620053|NCT01188928|Betamethasone|betamethasone|mesh-list
25620054|NCT01188928|Betamethasone Valerate|betamethasone valerate|mesh-list
25620055|NCT01188928|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25620056|NCT01188928|Betamethasone benzoate|betamethasone benzoate|mesh-list
25620057|NCT01188928|Calcipotriene|calcipotriene|mesh-list
25620058|NCT01188928|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25620059|NCT01188928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25620060|NCT01188928|Glucocorticoids|glucocorticoids|mesh-ancestor
25620061|NCT01188928|Hormones|hormones|mesh-ancestor
25620062|NCT01188928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25620063|NCT01188928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620064|NCT01188928|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24913484|NCT04264130|Pyronaridine|pyronaridine|mesh-list
25620065|NCT01188928|Respiratory System Agents|respiratory system agents|mesh-ancestor
25620066|NCT01188928|Dermatologic Agents|dermatologic agents|mesh-ancestor
25620067|NCT01189032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25620068|NCT01189032|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25620069|NCT01189201|Linagliptin|linagliptin|mesh-list
25620070|NCT01189201|Empagliflozin|empagliflozin|mesh-list
25620071|NCT01189201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25620072|NCT01189201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620073|NCT01189201|Incretins|incretins|mesh-ancestor
25620074|NCT01189201|Hormones|hormones|mesh-ancestor
25620075|NCT01189201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25620076|NCT01189201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25620077|NCT01189201|Protease Inhibitors|protease inhibitors|mesh-ancestor
25620078|NCT01189201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620079|NCT01189201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620080|NCT01189201|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25620081|NCT01189240|Bevacizumab|bevacizumab|mesh-list
25620082|NCT01189240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25620083|NCT01189240|Antibodies|antibodies|mesh-list
25620084|NCT01189240|Immunoglobulins|immunoglobulins|mesh-list
25620085|NCT01189240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25620086|NCT01189240|R04929097|r04929097|mesh-list
25620087|NCT01189240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620088|NCT01189240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25620089|NCT01189240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25620090|NCT01189240|Growth Substances|growth substances|mesh-ancestor
25620091|NCT01189240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620092|NCT01189240|Growth Inhibitors|growth inhibitors|mesh-ancestor
25620093|NCT01189240|Immunologic Factors|immunologic factors|mesh-ancestor
25620094|NCT01189240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620095|NCT01189240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620096|NCT01189266|Vorinostat|vorinostat|mesh-list
25620097|NCT01189266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620098|NCT01189266|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25620099|NCT01189266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620100|NCT01189266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620101|NCT01189279|Bimatoprost|bimatoprost|mesh-list
24520413|NCT02074631|Vitamins|vitamins|mesh-ancestor
25620102|NCT01189279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25620103|NCT01189292|Dexamethasone|dexamethasone|mesh-list
25620104|NCT01189292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25620105|NCT01189292|Antiemetics|antiemetics|mesh-ancestor
25620106|NCT01189292|Autonomic Agents|autonomic agents|mesh-ancestor
25620107|NCT01189292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25620108|NCT01189292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620109|NCT01189292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25620110|NCT01189292|Glucocorticoids|glucocorticoids|mesh-ancestor
25620111|NCT01189292|Hormones|hormones|mesh-ancestor
25620112|NCT01189292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25620113|NCT01189292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25620114|NCT01189292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620115|NCT01189370|Sorafenib|sorafenib|mesh-list
25620116|NCT01189370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620117|NCT01189370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25620118|NCT01189370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620119|NCT01189370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620120|NCT01189409|Sennosides|sennosides|mesh-list
25620121|NCT01189409|Laxatives|laxatives|mesh-ancestor
25620122|NCT01189409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25620123|NCT01189487|Ampicillin|ampicillin|mesh-list
25620124|NCT01189487|Sulbactam|sulbactam|mesh-list
25620125|NCT01189487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25620126|NCT01189487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25620127|NCT01189487|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25620128|NCT01189487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620129|NCT01189487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620130|NCT01189500|Tamoxifen|tamoxifen|mesh-list
25620131|NCT01189500|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25620132|NCT01189500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25620133|NCT01189500|Hormone Antagonists|hormone antagonists|mesh-ancestor
25620134|NCT01189500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25620135|NCT01189500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620136|NCT01189500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25620137|NCT01189500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620138|NCT01189500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25620139|NCT01189500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25620140|NCT01189500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25620141|NCT01189500|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25620142|NCT01189500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25620143|NCT01189500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24819451|NCT02095665|Mirabegron|mirabegron|mesh-list
25620144|NCT01189500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620145|NCT01189500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25620146|NCT01189500|Antidepressive Agents|antidepressive agents|mesh-ancestor
25620147|NCT01189500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25620148|NCT01189604|Propofol|propofol|mesh-list
25620149|NCT01189604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25620150|NCT01189604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25620151|NCT01189604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620152|NCT01189604|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25620153|NCT01189604|Anesthetics, General|anesthetics, general|mesh-ancestor
25620154|NCT01189604|Anesthetics|anesthetics|mesh-ancestor
25620155|NCT01189747|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25620156|NCT01189747|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25620157|NCT01189747|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25620158|NCT01189747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25620159|NCT01189747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620160|NCT01189747|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25620161|NCT01189747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25620162|NCT01189747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620163|NCT01189747|Cholinergic Agents|cholinergic agents|mesh-ancestor
25620164|NCT01189747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25620165|NCT01189760|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25620166|NCT01189760|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25620167|NCT01189760|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25620168|NCT01189760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25620169|NCT01189760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620170|NCT01189760|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25620171|NCT01189760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25620172|NCT01189760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620173|NCT01189760|Cholinergic Agents|cholinergic agents|mesh-ancestor
25620174|NCT01189760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25620175|NCT01189812|Lithium Carbonate|lithium carbonate|mesh-list
25620176|NCT01189812|Citalopram|citalopram|mesh-list
25620177|NCT01189812|Antidepressive Agents|antidepressive agents|mesh-ancestor
25620178|NCT01189812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25620179|NCT01189812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620180|NCT01189812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620181|NCT01189812|Antimanic Agents|antimanic agents|mesh-ancestor
25620182|NCT01189812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25620183|NCT01189812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25620184|NCT01189812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620185|NCT01189812|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25620186|NCT01189812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25620187|NCT01189812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25620188|NCT01189812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25620189|NCT01189812|Serotonin Agents|serotonin agents|mesh-ancestor
25620190|NCT01189812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25620191|NCT01189890|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25620192|NCT01189890|Glimepiride|glimepiride|mesh-list
24915963|NCT04246697|Anesthetics, Local|anesthetics, local|mesh-ancestor
24915964|NCT04246697|Anesthetics|anesthetics|mesh-ancestor
24915965|NCT04246697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24915966|NCT04246697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819710|NCT02096926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819711|NCT02096939|Antihypertensive Agents|antihypertensive agents|mesh-list
24916238|NCT04243109|Alkylating Agents|alkylating agents|mesh-ancestor
24916239|NCT04243109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620193|NCT01189890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25620194|NCT01189890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620195|NCT01189890|Incretins|incretins|mesh-ancestor
25620196|NCT01189890|Hormones|hormones|mesh-ancestor
24916785|NCT04237493|Glimepiride|glimepiride|mesh-list
25620197|NCT01189890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24917297|NCT04231448|Hormones|hormones|mesh-ancestor
25620198|NCT01189890|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25620199|NCT01189890|Protease Inhibitors|protease inhibitors|mesh-ancestor
25620200|NCT01189890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620201|NCT01189890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620202|NCT01189890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25620203|NCT01189890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25620204|NCT01189890|Immunologic Factors|immunologic factors|mesh-ancestor
25620205|NCT01190007|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
25620206|NCT01190007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25620207|NCT01190007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25620208|NCT01190007|Antimetabolites|antimetabolites|mesh-ancestor
25620209|NCT01190007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620210|NCT01190007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25620211|NCT01190007|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24918063|NCT04223973|Insulin|insulin|mesh-list
25620212|NCT01190007|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25620213|NCT01190007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25620214|NCT01190007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25620215|NCT01190007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620216|NCT01190007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25620217|NCT01190007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620218|NCT01190020|Lubiprostone|lubiprostone|mesh-list
25620219|NCT01190020|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25620220|NCT01190020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25620221|NCT01190020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620222|NCT01190098|Lacosamide|lacosamide|mesh-list
25620223|NCT01190098|Anticonvulsants|anticonvulsants|mesh-ancestor
25620224|NCT01190098|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25620225|NCT01190098|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25620226|NCT01190098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25620227|NCT01190098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620228|NCT01190150|Tranexamic Acid|tranexamic acid|mesh-list
25620229|NCT01190150|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25620230|NCT01190150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25620231|NCT01190150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620232|NCT01190150|Hemostatics|hemostatics|mesh-ancestor
25620233|NCT01190150|Coagulants|coagulants|mesh-ancestor
25620234|NCT01190410|Certolizumab Pegol|certolizumab pegol|mesh-list
25620235|NCT01190410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25620236|NCT01190410|Immunologic Factors|immunologic factors|mesh-ancestor
25620237|NCT01190410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620238|NCT01190410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25620239|NCT01190436|Bisoprolol|bisoprolol|mesh-list
25620240|NCT01190436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25620241|NCT01190436|Sympatholytics|sympatholytics|mesh-ancestor
25620242|NCT01190436|Autonomic Agents|autonomic agents|mesh-ancestor
25620243|NCT01190436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25620244|NCT01190436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620245|NCT01190436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25620246|NCT01190436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25620247|NCT01190436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25620248|NCT01190436|Adrenergic Agents|adrenergic agents|mesh-ancestor
25620249|NCT01190436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25620250|NCT01190436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620251|NCT01190449|Ofatumumab|ofatumumab|mesh-list
25620252|NCT01190449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620253|NCT01190514|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25620254|NCT01190514|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25620255|NCT01190514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25620256|NCT01190514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24918846|NCT04215731|Bevacizumab|bevacizumab|mesh-list
25620257|NCT01190514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620258|NCT01190514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25620259|NCT01190514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620260|NCT01190514|Antidepressive Agents|antidepressive agents|mesh-ancestor
25620261|NCT01190514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25620262|NCT01190813|Levodopa|levodopa|mesh-list
25620263|NCT01190813|Carbidopa|carbidopa|mesh-list
25620264|NCT01190813|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25714625|NCT02358863|Irinotecan|irinotecan|mesh-list
25620265|NCT01190813|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25620266|NCT01190813|Dopamine Agents|dopamine agents|mesh-ancestor
25620267|NCT01190813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25620268|NCT01190813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620269|NCT01190813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620270|NCT01190813|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25620271|NCT01190813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620272|NCT01190839|Infliximab|infliximab|mesh-list
25620273|NCT01190839|Dermatologic Agents|dermatologic agents|mesh-ancestor
25620274|NCT01190839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25620275|NCT01190839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25620276|NCT01190878|Bromfenac|bromfenac|mesh-list
25620277|NCT01190878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25620278|NCT01190878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25620279|NCT01190878|Analgesics|analgesics|mesh-ancestor
25620280|NCT01190878|Sensory System Agents|sensory system agents|mesh-ancestor
25714637|NCT02358863|Antidotes|antidotes|mesh-ancestor
25620281|NCT01190878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25620282|NCT01190878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620283|NCT01190878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25620284|NCT01190878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25620285|NCT01191008|Timolol|timolol|mesh-list
25620286|NCT01191008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25620287|NCT01191008|Latanoprost|latanoprost|mesh-list
25620288|NCT01191008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25620289|NCT01191008|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25620290|NCT01191008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25620291|NCT01191008|Adrenergic Agents|adrenergic agents|mesh-ancestor
25620292|NCT01191008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25620293|NCT01191008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620294|NCT01191008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620295|NCT01191008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25620296|NCT01191008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25620297|NCT01191086|Topiramate|topiramate|mesh-list
25620298|NCT01191086|Anticonvulsants|anticonvulsants|mesh-ancestor
25620299|NCT01191086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25620300|NCT01191086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620301|NCT01191190|Ofatumumab|ofatumumab|mesh-list
25620302|NCT01191190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620303|NCT01191255|Sevelamer|sevelamer|mesh-list
25620304|NCT01191255|Chelating Agents|chelating agents|mesh-ancestor
25620305|NCT01191255|Sequestering Agents|sequestering agents|mesh-ancestor
25620306|NCT01191255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620307|NCT01191268|Insulin|insulin|mesh-list
25620308|NCT01191268|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25620309|NCT01191268|Insulin Glargine|insulin glargine|mesh-list
25620310|NCT01191268|Insulin Lispro|insulin lispro|mesh-list
25620311|NCT01191268|Dulaglutide|dulaglutide|mesh-list
25620312|NCT01191268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25620313|NCT01191268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620314|NCT01191320|Enclomiphene|enclomiphene|mesh-list
25620315|NCT01191320|Clomiphene|clomiphene|mesh-list
25620316|NCT01191320|Zuclomiphene|zuclomiphene|mesh-list
25620317|NCT01191320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25620318|NCT01191320|Hormone Antagonists|hormone antagonists|mesh-ancestor
25620319|NCT01191320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25620320|NCT01191320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620321|NCT01191320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25620322|NCT01191320|Fertility Agents|fertility agents|mesh-ancestor
25620323|NCT01191320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25620324|NCT01191320|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25620325|NCT01191320|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25620326|NCT01191398|Atropine|atropine|mesh-list
25620327|NCT01191398|Glycopyrrolate|glycopyrrolate|mesh-list
25620328|NCT01191398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25620329|NCT01191398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25620330|NCT01191398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25620331|NCT01191398|Autonomic Agents|autonomic agents|mesh-ancestor
25620332|NCT01191398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25620333|NCT01191398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620334|NCT01191398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25620335|NCT01191398|Respiratory System Agents|respiratory system agents|mesh-ancestor
25620336|NCT01191398|Mydriatics|mydriatics|mesh-ancestor
25620337|NCT01191398|Parasympatholytics|parasympatholytics|mesh-ancestor
25620338|NCT01191398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25620339|NCT01191398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25620340|NCT01191398|Cholinergic Agents|cholinergic agents|mesh-ancestor
25620341|NCT01191398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25620342|NCT01191398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620343|NCT01191476|Propofol|propofol|mesh-list
25620344|NCT01191476|Sevoflurane|sevoflurane|mesh-list
25620345|NCT01191476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25620346|NCT01191476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25620347|NCT01191476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920490|NCT04202406|Narcotics|narcotics|mesh-ancestor
25620348|NCT01191476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25620349|NCT01191476|Anesthetics, General|anesthetics, general|mesh-ancestor
25620350|NCT01191476|Anesthetics|anesthetics|mesh-ancestor
25620351|NCT01191476|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25620352|NCT01191476|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25620353|NCT01191723|Moxifloxacin|moxifloxacin|mesh-list
25620354|NCT01191723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25620355|NCT01191723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25620356|NCT01191723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25620357|NCT01191723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25620358|NCT01191723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620359|NCT01191723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620360|NCT01191723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620361|NCT01191749|Alemtuzumab|alemtuzumab|mesh-list
25620362|NCT01191749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25620363|NCT01191749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620364|NCT01191762|Sevelamer|sevelamer|mesh-list
25620365|NCT01191762|Chelating Agents|chelating agents|mesh-ancestor
25620366|NCT01191762|Sequestering Agents|sequestering agents|mesh-ancestor
25620367|NCT01191762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620368|NCT01191801|Cytarabine|cytarabine|mesh-list
24920811|NCT04197349|Sumatriptan|sumatriptan|mesh-list
25620369|NCT01191801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25620370|NCT01191801|Antimetabolites|antimetabolites|mesh-ancestor
25620371|NCT01191801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620372|NCT01191801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620373|NCT01191801|Antiviral Agents|antiviral agents|mesh-ancestor
25620374|NCT01191801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25620375|NCT01191801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25620376|NCT01191801|Immunologic Factors|immunologic factors|mesh-ancestor
25620377|NCT01191801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620378|NCT01191840|Vancomycin|vancomycin|mesh-list
25620379|NCT01191840|Cefazolin|cefazolin|mesh-list
25620380|NCT01191840|Daptomycin|daptomycin|mesh-list
25620381|NCT01191840|Cloxacillin|cloxacillin|mesh-list
25620382|NCT01191840|Oxacillin|oxacillin|mesh-list
25620383|NCT01191840|Nafcillin|nafcillin|mesh-list
25620384|NCT01191840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25620385|NCT01191840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25620386|NCT01191944|Pramipexole|pramipexole|mesh-list
25620387|NCT01191944|Antioxidants|antioxidants|mesh-ancestor
25620388|NCT01191944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620389|NCT01191944|Protective Agents|protective agents|mesh-ancestor
25620390|NCT01191944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620391|NCT01191944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25620392|NCT01191944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25620393|NCT01191944|Dopamine Agonists|dopamine agonists|mesh-ancestor
25620394|NCT01191944|Dopamine Agents|dopamine agents|mesh-ancestor
25620395|NCT01191944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25620396|NCT01192139|Metformin|metformin|mesh-list
25620397|NCT01192139|Saxagliptin|saxagliptin|mesh-list
25620398|NCT01192139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25620399|NCT01192139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620400|NCT01192139|Incretins|incretins|mesh-ancestor
25620401|NCT01192139|Hormones|hormones|mesh-ancestor
25620402|NCT01192139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25620403|NCT01192139|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25620404|NCT01192139|Protease Inhibitors|protease inhibitors|mesh-ancestor
25620405|NCT01192139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620406|NCT01192139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620407|NCT01192152|Metformin|metformin|mesh-list
25620408|NCT01192152|Saxagliptin|saxagliptin|mesh-list
24921553|NCT04189484|Evolocumab|evolocumab|mesh-list
25620409|NCT01192152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25620410|NCT01192152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620411|NCT01192152|Incretins|incretins|mesh-ancestor
25620412|NCT01192152|Hormones|hormones|mesh-ancestor
25620413|NCT01192152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25620414|NCT01192152|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25620415|NCT01192152|Protease Inhibitors|protease inhibitors|mesh-ancestor
25620416|NCT01192152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620417|NCT01192152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620418|NCT01192178|Fluticasone|fluticasone|mesh-list
25620419|NCT01192178|Xhance|xhance|mesh-list
25620420|NCT01192178|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24921694|NCT04188184|Mydriatics|mydriatics|mesh-ancestor
25620421|NCT01192178|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25620422|NCT01192178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25620423|NCT01192178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25620424|NCT01192178|Autonomic Agents|autonomic agents|mesh-ancestor
25620425|NCT01192178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25620426|NCT01192178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620427|NCT01192178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25620428|NCT01192178|Respiratory System Agents|respiratory system agents|mesh-ancestor
25620429|NCT01192178|Dermatologic Agents|dermatologic agents|mesh-ancestor
25620430|NCT01192178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25620431|NCT01192178|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25714708|NCT02359552|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25714709|NCT02359552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24922237|NCT04182828|Lidocaine|lidocaine|mesh-list
24922238|NCT04182828|Anesthetics, Local|anesthetics, local|mesh-ancestor
25620432|NCT01192178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25620433|NCT01192178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25620434|NCT01192178|Adrenergic Agents|adrenergic agents|mesh-ancestor
24601170|NCT00963222|Micronutrients|micronutrients|mesh-ancestor
25620435|NCT01192178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25620436|NCT01192178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620437|NCT01192178|Glucocorticoids|glucocorticoids|mesh-ancestor
25620438|NCT01192178|Hormones|hormones|mesh-ancestor
25620439|NCT01192178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25620440|NCT01192178|Sympathomimetics|sympathomimetics|mesh-ancestor
25620441|NCT01192191|Fluticasone|fluticasone|mesh-list
25620442|NCT01192191|Xhance|xhance|mesh-list
25620443|NCT01192191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25620444|NCT01192191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25620445|NCT01192191|Autonomic Agents|autonomic agents|mesh-ancestor
25620446|NCT01192191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25620447|NCT01192191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620448|NCT01192191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25620449|NCT01192191|Respiratory System Agents|respiratory system agents|mesh-ancestor
25620450|NCT01192191|Dermatologic Agents|dermatologic agents|mesh-ancestor
25620451|NCT01192191|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25655274|NCT01560949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25655275|NCT01560949|Immunologic Factors|immunologic factors|mesh-ancestor
25655276|NCT01560949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655277|NCT01560949|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25655278|NCT01560949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25655279|NCT01561053|Immunoglobulins|immunoglobulins|mesh-list
25655280|NCT01561053|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25655281|NCT01561053|Antibodies|antibodies|mesh-list
25655282|NCT01561053|Immunologic Factors|immunologic factors|mesh-ancestor
25655283|NCT01561053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655284|NCT01561079|Buprenorphine|buprenorphine|mesh-list
25655285|NCT01561079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25655286|NCT01561079|Narcotics|narcotics|mesh-ancestor
25655287|NCT01561079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25655288|NCT01561079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655289|NCT01561079|Analgesics|analgesics|mesh-ancestor
25655290|NCT01561079|Sensory System Agents|sensory system agents|mesh-ancestor
25655291|NCT01561079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25655292|NCT01561079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25655293|NCT01561313|Adalimumab|adalimumab|mesh-list
25655294|NCT01561313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25655295|NCT01561313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25655296|NCT01561469|Vancomycin|vancomycin|mesh-list
25655297|NCT01561469|Linezolid|linezolid|mesh-list
25655298|NCT01561469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25655299|NCT01561469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25655300|NCT01561469|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25655301|NCT01561469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655302|NCT01561469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603951|NCT00976300|Cyclosporine|cyclosporine|mesh-list
25655303|NCT01561703|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25655304|NCT01561703|Amoxicillin|amoxicillin|mesh-list
25655305|NCT01561703|Azithromycin|azithromycin|mesh-list
25655306|NCT01561703|Clindamycin|clindamycin|mesh-list
25655307|NCT01561703|Clavulanic Acid|clavulanic acid|mesh-list
25514995|NCT00419757|Glucocorticoids|glucocorticoids|mesh-ancestor
25655308|NCT01561703|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25655309|NCT01561703|Cephalexin|cephalexin|mesh-list
25655310|NCT01561703|Cefdinir|cefdinir|mesh-list
25620452|NCT01192295|Oxycodone|oxycodone|mesh-list
25620453|NCT01192295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25620454|NCT01192295|Narcotics|narcotics|mesh-ancestor
25620455|NCT01192295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25620456|NCT01192295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620457|NCT01192295|Analgesics|analgesics|mesh-ancestor
25620458|NCT01192295|Sensory System Agents|sensory system agents|mesh-ancestor
25620459|NCT01192295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25620460|NCT01192399|Eculizumab|eculizumab|mesh-list
25620461|NCT01192399|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25620462|NCT01192399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25620463|NCT01192399|Immunologic Factors|immunologic factors|mesh-ancestor
25620464|NCT01192399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620465|NCT01192815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25620466|NCT01192815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620467|NCT01192815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25620468|NCT01192815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620469|NCT01192815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620470|NCT01193049|Prednisone|prednisone|mesh-list
25620471|NCT01193049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25620472|NCT01193049|Glucocorticoids|glucocorticoids|mesh-ancestor
25620473|NCT01193049|Hormones|hormones|mesh-ancestor
25620474|NCT01193049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25620475|NCT01193049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620476|NCT01193049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25620477|NCT01193049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620478|NCT01193101|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25620479|NCT01193101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25620480|NCT01193101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620481|NCT01193127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25620482|NCT01193127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25620483|NCT01193127|Mydriatics|mydriatics|mesh-list
25620484|NCT01193127|Autonomic Agents|autonomic agents|mesh-ancestor
25620485|NCT01193127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25620486|NCT01193127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620487|NCT01193153|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25620488|NCT01193153|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25620489|NCT01193153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25620490|NCT01193153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25620491|NCT01193153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620492|NCT01193153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25620493|NCT01193153|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25620494|NCT01193153|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25620495|NCT01193153|Serotonin Agents|serotonin agents|mesh-ancestor
25620496|NCT01193153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25620497|NCT01193153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620498|NCT01193153|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25620499|NCT01193153|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25620500|NCT01193153|Dopamine Agents|dopamine agents|mesh-ancestor
25620501|NCT01193218|Empagliflozin|empagliflozin|mesh-list
25620502|NCT01193218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25620503|NCT01193218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620504|NCT01193218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25620505|NCT01193218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620506|NCT01193244|Prednisone|prednisone|mesh-list
24606087|NCT00988845|Indole-3-carbinol|indole-3-carbinol|mesh-list
25620507|NCT01193244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25620508|NCT01193244|Glucocorticoids|glucocorticoids|mesh-ancestor
25620509|NCT01193244|Hormones|hormones|mesh-ancestor
25620510|NCT01193244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25620511|NCT01193244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620512|NCT01193244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25620513|NCT01193244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620514|NCT01193257|Prednisone|prednisone|mesh-list
25620515|NCT01193257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25620516|NCT01193257|Glucocorticoids|glucocorticoids|mesh-ancestor
25620517|NCT01193257|Hormones|hormones|mesh-ancestor
25620518|NCT01193257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25620519|NCT01193257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620520|NCT01193257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25620521|NCT01193257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620522|NCT01193283|Cyclosporine|cyclosporine|mesh-list
25620523|NCT01193283|Cyclophosphamide|cyclophosphamide|mesh-list
25515071|NCT00420017|Amiodarone|amiodarone|mesh-list
25620524|NCT01193283|Cyclosporins|cyclosporins|mesh-list
25620525|NCT01193283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25620526|NCT01193283|Immunologic Factors|immunologic factors|mesh-ancestor
25620527|NCT01193283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620528|NCT01193283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25620529|NCT01193283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25620530|NCT01193283|Alkylating Agents|alkylating agents|mesh-ancestor
25620531|NCT01193283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620532|NCT01193283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620533|NCT01193283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25620534|NCT01193283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620535|NCT01193283|Antifungal Agents|antifungal agents|mesh-ancestor
25620536|NCT01193283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25620537|NCT01193283|Dermatologic Agents|dermatologic agents|mesh-ancestor
25620538|NCT01193283|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25620540|NCT01193335|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25620541|NCT01193335|Immunologic Factors|immunologic factors|mesh-ancestor
25620542|NCT01193335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620543|NCT01193348|Eculizumab|eculizumab|mesh-list
25620544|NCT01193348|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25620545|NCT01193348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25620546|NCT01193348|Immunologic Factors|immunologic factors|mesh-ancestor
25620547|NCT01193348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620548|NCT01193517|Capecitabine|capecitabine|mesh-list
25620549|NCT01193517|Azacitidine|azacitidine|mesh-list
25620550|NCT01193517|Decitabine|decitabine|mesh-list
25620551|NCT01193517|Oxaliplatin|oxaliplatin|mesh-list
25620552|NCT01193517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25620553|NCT01193517|Antimetabolites|antimetabolites|mesh-ancestor
24671353|NCT01325168|Oxytocin|oxytocin|mesh-list
25620554|NCT01193517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620555|NCT01193517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620556|NCT01193517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620557|NCT01193582|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25620558|NCT01193582|Immunologic Factors|immunologic factors|mesh-ancestor
25620559|NCT01193582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620560|NCT01193660|Epoetin Alfa|epoetin alfa|mesh-list
25620561|NCT01193660|Hematinics|hematinics|mesh-ancestor
25620562|NCT01193868|R04929097|r04929097|mesh-list
25620563|NCT01193868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620564|NCT01193868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620565|NCT01193920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25620566|NCT01193920|Vaccines|vaccines|mesh-list
25620567|NCT01193920|Immunologic Factors|immunologic factors|mesh-ancestor
25620568|NCT01193920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620569|NCT01194089|Nicotine|nicotine|mesh-list
25620570|NCT01194089|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25620571|NCT01194089|Autonomic Agents|autonomic agents|mesh-ancestor
25620572|NCT01194089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25620573|NCT01194089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620574|NCT01194089|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25620575|NCT01194089|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25620576|NCT01194089|Cholinergic Agents|cholinergic agents|mesh-ancestor
25620577|NCT01194089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25620578|NCT01194089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620579|NCT01194154|Epoetin Alfa|epoetin alfa|mesh-list
25620580|NCT01194154|Hematinics|hematinics|mesh-ancestor
25620581|NCT01194245|Insulin|insulin|mesh-list
25620582|NCT01194245|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25620583|NCT01194245|Insulin Glargine|insulin glargine|mesh-list
25620584|NCT01194245|Insulin Aspart|insulin aspart|mesh-list
25620585|NCT01194245|Insulin Lispro|insulin lispro|mesh-list
25620586|NCT01194245|Insulin glulisine|insulin glulisine|mesh-list
25620587|NCT01194245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25620588|NCT01194245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620589|NCT01194258|Insulin|insulin|mesh-list
25620590|NCT01194258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25620591|NCT01194258|Insulin Glargine|insulin glargine|mesh-list
25620592|NCT01194258|Insulin Aspart|insulin aspart|mesh-list
25620593|NCT01194258|Insulin Lispro|insulin lispro|mesh-list
25620594|NCT01194258|Insulin glulisine|insulin glulisine|mesh-list
25620595|NCT01194258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25620596|NCT01194258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620597|NCT01194271|Ipilimumab|ipilimumab|mesh-list
25620598|NCT01194271|Leuprolide|leuprolide|mesh-list
25620599|NCT01194271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25620600|NCT01194271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620601|NCT01194271|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25620602|NCT01194271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620603|NCT01194271|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25620604|NCT01194271|Fertility Agents|fertility agents|mesh-ancestor
25620605|NCT01194271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25620606|NCT01194271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620607|NCT01194271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25620608|NCT01194297|Vaccines|vaccines|mesh-list
25620609|NCT01194297|Immunologic Factors|immunologic factors|mesh-ancestor
25620610|NCT01194297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620611|NCT01194414|Antirheumatic Agents|antirheumatic agents|mesh-list
25620612|NCT01194440|Zoledronic Acid|zoledronic acid|mesh-list
25620613|NCT01194440|Letrozole|letrozole|mesh-list
25620614|NCT01194440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620615|NCT01194440|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25620616|NCT01194440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25620617|NCT01194440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620618|NCT01194440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620619|NCT01194440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25620620|NCT01194440|Hormone Antagonists|hormone antagonists|mesh-ancestor
25620621|NCT01194440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25620622|NCT01194440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620623|NCT01194440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25620624|NCT01194453|Folic Acid|folic acid|mesh-list
25620625|NCT01194453|Vitamin B 12|vitamin b 12|mesh-list
25620626|NCT01194453|Hydroxocobalamin|hydroxocobalamin|mesh-list
25620627|NCT01194453|Gemcitabine|gemcitabine|mesh-list
25620628|NCT01194453|Dexamethasone|dexamethasone|mesh-list
25620629|NCT01194453|Cisplatin|cisplatin|mesh-list
25620630|NCT01194453|Vitamins|vitamins|mesh-ancestor
25620631|NCT01194453|Micronutrients|micronutrients|mesh-ancestor
25620632|NCT01194453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620633|NCT01194453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620634|NCT01194453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25620635|NCT01194453|Antiemetics|antiemetics|mesh-ancestor
25620636|NCT01194453|Autonomic Agents|autonomic agents|mesh-ancestor
25620637|NCT01194453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25620638|NCT01194453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25620639|NCT01194453|Glucocorticoids|glucocorticoids|mesh-ancestor
25620640|NCT01194453|Hormones|hormones|mesh-ancestor
25620641|NCT01194453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25620642|NCT01194453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25620643|NCT01194453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25620644|NCT01194453|Antimetabolites|antimetabolites|mesh-ancestor
25620645|NCT01194453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620646|NCT01194453|Antiviral Agents|antiviral agents|mesh-ancestor
25620647|NCT01194453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25620648|NCT01194453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620649|NCT01194453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25620650|NCT01194453|Immunologic Factors|immunologic factors|mesh-ancestor
25620651|NCT01194453|Hematinics|hematinics|mesh-ancestor
25620652|NCT01194453|Vitamin B Complex|vitamin b complex|mesh-ancestor
25620653|NCT01194479|Formoterol Fumarate|formoterol fumarate|mesh-list
25620654|NCT01194479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25620655|NCT01194479|Autonomic Agents|autonomic agents|mesh-ancestor
25620656|NCT01194479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25620657|NCT01194479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620658|NCT01194479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25620659|NCT01194479|Respiratory System Agents|respiratory system agents|mesh-ancestor
25620660|NCT01194479|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25620661|NCT01194479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25620662|NCT01194479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25620663|NCT01194479|Adrenergic Agents|adrenergic agents|mesh-ancestor
25620664|NCT01194479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25620665|NCT01194479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620666|NCT01194674|Plasminogen|plasminogen|mesh-list
25620667|NCT01194674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25620668|NCT01194674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25620669|NCT01194674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620670|NCT01194804|Eculizumab|eculizumab|mesh-list
25620671|NCT01194804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25620672|NCT01194804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25620673|NCT01194804|Immunologic Factors|immunologic factors|mesh-ancestor
25620674|NCT01194804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620675|NCT01194830|Linagliptin|linagliptin|mesh-list
25620676|NCT01194830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25620677|NCT01194830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620678|NCT01194830|Incretins|incretins|mesh-ancestor
25620679|NCT01194830|Hormones|hormones|mesh-ancestor
24610026|NCT00999479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25620680|NCT01194830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25620681|NCT01194830|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25620682|NCT01194830|Protease Inhibitors|protease inhibitors|mesh-ancestor
25620683|NCT01194830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620684|NCT01194830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620685|NCT01194869|Paclitaxel|paclitaxel|mesh-list
25620686|NCT01194869|Cisplatin|cisplatin|mesh-list
25620687|NCT01194869|Sorafenib|sorafenib|mesh-list
25620688|NCT01194869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25620689|NCT01194869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620690|NCT01194869|Tubulin Modulators|tubulin modulators|mesh-ancestor
25620691|NCT01194869|Antimitotic Agents|antimitotic agents|mesh-ancestor
25620692|NCT01194869|Mitosis Modulators|mitosis modulators|mesh-ancestor
25620693|NCT01194869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620694|NCT01194869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25620695|NCT01194869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620696|NCT01194973|Eculizumab|eculizumab|mesh-list
25620697|NCT01194973|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25620698|NCT01194973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25620699|NCT01194973|Immunologic Factors|immunologic factors|mesh-ancestor
25620700|NCT01194973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620701|NCT01195025|Chrysarobin|chrysarobin|mesh-list
25620702|NCT01195025|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
25620703|NCT01195025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24503215|NCT02665143|Nintedanib|nintedanib|mesh-list
25620704|NCT01195025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25620705|NCT01195025|Analgesics|analgesics|mesh-ancestor
25620706|NCT01195025|Sensory System Agents|sensory system agents|mesh-ancestor
25620707|NCT01195025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25620708|NCT01195025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620709|NCT01195025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25620710|NCT01195025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25620711|NCT01195025|Plasma Substitutes|plasma substitutes|mesh-ancestor
25620712|NCT01195025|Blood Substitutes|blood substitutes|mesh-ancestor
25620713|NCT01195090|Pioglitazone|pioglitazone|mesh-list
25620714|NCT01195090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25620715|NCT01195090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25620716|NCT01195090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620717|NCT01195090|Incretins|incretins|mesh-ancestor
25620718|NCT01195090|Hormones|hormones|mesh-ancestor
25620719|NCT01195090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24671825|NCT01328106|Trametinib|trametinib|mesh-list
25620720|NCT01195090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25620721|NCT01195090|Protease Inhibitors|protease inhibitors|mesh-ancestor
25620722|NCT01195090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620723|NCT01195090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620724|NCT01195103|Fentanyl|fentanyl|mesh-list
25620725|NCT01195103|Midazolam|midazolam|mesh-list
25620726|NCT01195103|Propofol|propofol|mesh-list
25620727|NCT01195103|Fospropofol|fospropofol|mesh-list
25620728|NCT01195103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25620729|NCT01195103|Narcotics|narcotics|mesh-ancestor
25620730|NCT01195103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25620731|NCT01195103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620732|NCT01195103|Analgesics|analgesics|mesh-ancestor
25620733|NCT01195103|Sensory System Agents|sensory system agents|mesh-ancestor
25620734|NCT01195103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25620735|NCT01195103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25620736|NCT01195103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25620737|NCT01195103|Anesthetics, General|anesthetics, general|mesh-ancestor
25620738|NCT01195103|Anesthetics|anesthetics|mesh-ancestor
25620739|NCT01195103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25620740|NCT01195103|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25620741|NCT01195103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25620742|NCT01195103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25620743|NCT01195103|GABA Modulators|gaba modulators|mesh-ancestor
25620744|NCT01195103|GABA Agents|gaba agents|mesh-ancestor
25620745|NCT01195103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25620746|NCT01195103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620747|NCT01195116|Dexmedetomidine|dexmedetomidine|mesh-list
25620748|NCT01195116|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25620749|NCT01195116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25620750|NCT01195116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620751|NCT01195116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25515280|NCT00420992|Naltrexone|naltrexone|mesh-list
25515342|NCT00421733|Micronutrients|micronutrients|mesh-ancestor
25515343|NCT00421733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25124307|NCT03077581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25124308|NCT03077581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124309|NCT03077828|Carboplatin|carboplatin|mesh-list
24740707|NCT01689987|Dexamethasone acetate|dexamethasone acetate|mesh-list
24740708|NCT01689987|Cyclophosphamide|cyclophosphamide|mesh-list
24740709|NCT01689987|Ichthammol|ichthammol|mesh-list
24740710|NCT01689987|BB 1101|bb 1101|mesh-list
24740711|NCT01689987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24740712|NCT01689987|Immunologic Factors|immunologic factors|mesh-ancestor
24673031|NCT01334905|Mirabegron|mirabegron|mesh-list
24740713|NCT01689987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740714|NCT01689987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24740715|NCT01689987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24436581|NCT00270530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24436582|NCT00270530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24436583|NCT00270530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24436584|NCT00270530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436585|NCT00270530|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24436586|NCT00270530|Renal Agents|renal agents|mesh-ancestor
24436587|NCT00270543|Leucovorin|leucovorin|mesh-list
24436657|NCT00270777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436658|NCT00270777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979845|NCT05240261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979846|NCT05240157|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25124310|NCT03077828|Pembrolizumab|pembrolizumab|mesh-list
25124311|NCT03077828|Etoposide|etoposide|mesh-list
25124312|NCT03077828|Etoposide phosphate|etoposide phosphate|mesh-list
25124313|NCT03077828|Ifosfamide|ifosfamide|mesh-list
25124314|NCT03077828|Isophosphamide mustard|isophosphamide mustard|mesh-list
25124315|NCT03077828|Podophyllotoxin|podophyllotoxin|mesh-list
25124316|NCT03077828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25124317|NCT03077828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25124318|NCT03077828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25124319|NCT03077828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25124320|NCT03077828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25124321|NCT03077828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124322|NCT03077828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124323|NCT03077828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25124324|NCT03077828|Alkylating Agents|alkylating agents|mesh-ancestor
24979847|NCT05240157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24979848|NCT05224895|Anesthetics|anesthetics|mesh-list
24979849|NCT05224895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24979850|NCT05224895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436704|NCT00270907|Gemcitabine|gemcitabine|mesh-list
24436705|NCT00270907|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
24436706|NCT00270907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24436707|NCT00270907|Antimetabolites|antimetabolites|mesh-ancestor
24436708|NCT00270907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436709|NCT00270907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24436856|NCT00271583|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24436858|NCT00271635|Ascorbic Acid|ascorbic acid|mesh-list
24436860|NCT00271635|Micronutrients|micronutrients|mesh-ancestor
24436861|NCT00271635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436862|NCT00271635|Antioxidants|antioxidants|mesh-ancestor
25162118|NCT02907957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24436864|NCT00271635|Protective Agents|protective agents|mesh-ancestor
25829659|NCT00006246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436865|NCT00271713|Calcium, Dietary|calcium, dietary|mesh-list
24436866|NCT00271713|Vitamin D|vitamin d|mesh-list
24436980|NCT00272428|Ascorbic Acid|ascorbic acid|mesh-list
24437021|NCT00272467|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25124325|NCT03077828|Keratolytic Agents|keratolytic agents|mesh-ancestor
25124327|NCT03077828|Tubulin Modulators|tubulin modulators|mesh-ancestor
25124328|NCT03077828|Antimitotic Agents|antimitotic agents|mesh-ancestor
25124329|NCT03077828|Mitosis Modulators|mitosis modulators|mesh-ancestor
25124352|NCT03077516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25124353|NCT03077516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25124354|NCT03077516|Analgesics|analgesics|mesh-ancestor
25124355|NCT03077516|Sensory System Agents|sensory system agents|mesh-ancestor
25124356|NCT03077516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24437022|NCT00272467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24437023|NCT00272467|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24437024|NCT00272467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620752|NCT01195116|Analgesics|analgesics|mesh-ancestor
25620753|NCT01195116|Sensory System Agents|sensory system agents|mesh-ancestor
25620754|NCT01195116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25620755|NCT01195116|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25620756|NCT01195116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25620757|NCT01195116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25620758|NCT01195116|Adrenergic Agents|adrenergic agents|mesh-ancestor
25620759|NCT01195116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25620760|NCT01195116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620761|NCT01195363|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25620762|NCT01195363|Antidepressive Agents|antidepressive agents|mesh-ancestor
25620763|NCT01195363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25620764|NCT01195363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25620765|NCT01195363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25620766|NCT01195363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25620767|NCT01195363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620768|NCT01195415|Gemcitabine|gemcitabine|mesh-list
25620769|NCT01195415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25620770|NCT01195415|Antimetabolites|antimetabolites|mesh-ancestor
25620771|NCT01195415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620772|NCT01195415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620773|NCT01195415|Antiviral Agents|antiviral agents|mesh-ancestor
25620774|NCT01195415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25620775|NCT01195415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620776|NCT01195415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25620777|NCT01195415|Immunologic Factors|immunologic factors|mesh-ancestor
25620778|NCT01195415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620779|NCT01195467|Tenofovir|tenofovir|mesh-list
25620780|NCT01195467|Emtricitabine|emtricitabine|mesh-list
25620781|NCT01195467|Efavirenz|efavirenz|mesh-list
25620782|NCT01195467|Raltegravir Potassium|raltegravir potassium|mesh-list
25620783|NCT01195467|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25620784|NCT01195467|Antiviral Agents|antiviral agents|mesh-ancestor
25620785|NCT01195467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25620786|NCT01195467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25620787|NCT01195467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25620788|NCT01195467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620789|NCT01195467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620790|NCT01195467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25620791|NCT01195467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25620792|NCT01195467|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25620793|NCT01195467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25620794|NCT01195467|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25620795|NCT01195467|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25620796|NCT01195467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25620797|NCT01195467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25620798|NCT01195467|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25620799|NCT01195467|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25620800|NCT01195597|Nicotine|nicotine|mesh-list
25620801|NCT01195597|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25620802|NCT01195597|Autonomic Agents|autonomic agents|mesh-ancestor
25620803|NCT01195597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25620804|NCT01195597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620805|NCT01195597|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25620806|NCT01195597|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25620807|NCT01195597|Cholinergic Agents|cholinergic agents|mesh-ancestor
25620808|NCT01195597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25620809|NCT01195597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620810|NCT01195662|Dapagliflozin|dapagliflozin|mesh-list
25620811|NCT01195662|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25620812|NCT01195662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620813|NCT01195662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25620814|NCT01195662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620815|NCT01195675|Empagliflozin|empagliflozin|mesh-list
25620816|NCT01195675|Moxifloxacin|moxifloxacin|mesh-list
25620817|NCT01195675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25620818|NCT01195675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25620819|NCT01195675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25620820|NCT01195675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25620821|NCT01195675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620822|NCT01195675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620823|NCT01195675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620824|NCT01195675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620825|NCT01195675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25620826|NCT01195675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25620828|NCT01195779|Immunologic Factors|immunologic factors|mesh-ancestor
25620829|NCT01195779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620830|NCT01195831|Calcipotriene|calcipotriene|mesh-list
24675833|NCT01345708|Prednisone|prednisone|mesh-list
25620831|NCT01195831|Dermatologic Agents|dermatologic agents|mesh-ancestor
25620832|NCT01195922|Sirolimus|sirolimus|mesh-list
25620833|NCT01195922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25620834|NCT01195922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25620835|NCT01195922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25620836|NCT01195922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620837|NCT01195922|Antifungal Agents|antifungal agents|mesh-ancestor
25620838|NCT01195922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25620839|NCT01195922|Immunologic Factors|immunologic factors|mesh-ancestor
25620840|NCT01195922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620841|NCT01196052|Trastuzumab|trastuzumab|mesh-list
25620842|NCT01196052|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25620843|NCT01196052|Maytansine|maytansine|mesh-list
25620844|NCT01196052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25620845|NCT01196052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620846|NCT01196052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25620847|NCT01196052|Tubulin Modulators|tubulin modulators|mesh-ancestor
25620848|NCT01196052|Antimitotic Agents|antimitotic agents|mesh-ancestor
25620849|NCT01196052|Mitosis Modulators|mitosis modulators|mesh-ancestor
24676041|NCT01347957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25620850|NCT01196052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620851|NCT01196078|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25620852|NCT01196078|Vinorelbine|vinorelbine|mesh-list
25620853|NCT01196078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620854|NCT01196078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25620855|NCT01196078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620856|NCT01196078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620857|NCT01196078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25620858|NCT01196078|Tubulin Modulators|tubulin modulators|mesh-ancestor
25620859|NCT01196078|Antimitotic Agents|antimitotic agents|mesh-ancestor
25620860|NCT01196078|Mitosis Modulators|mitosis modulators|mesh-ancestor
25620861|NCT01196091|Antimalarials|antimalarials|mesh-list
25620862|NCT01196091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25620863|NCT01196091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25620864|NCT01196091|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25620865|NCT01196091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25620866|NCT01196091|Analgesics|analgesics|mesh-ancestor
25620867|NCT01196091|Sensory System Agents|sensory system agents|mesh-ancestor
25620868|NCT01196091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25620869|NCT01196091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620870|NCT01196091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25620871|NCT01196091|Immunologic Factors|immunologic factors|mesh-ancestor
25620872|NCT01196091|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25620873|NCT01196091|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25620874|NCT01196091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25620875|NCT01196104|Insulin|insulin|mesh-list
25620876|NCT01196104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25620877|NCT01196104|Insulin Glargine|insulin glargine|mesh-list
25620878|NCT01196104|Insulin Aspart|insulin aspart|mesh-list
25620879|NCT01196104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25620880|NCT01196104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620881|NCT01196377|Albuterol|albuterol|mesh-list
25777230|NCT03726996|Desipramine|desipramine|mesh-list
25620882|NCT01196377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25620883|NCT01196377|Autonomic Agents|autonomic agents|mesh-ancestor
25620884|NCT01196377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25620885|NCT01196377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620886|NCT01196377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25620887|NCT01196377|Respiratory System Agents|respiratory system agents|mesh-ancestor
25620888|NCT01196377|Tocolytic Agents|tocolytic agents|mesh-ancestor
25620889|NCT01196377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25620890|NCT01196377|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25620891|NCT01196377|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25620892|NCT01196377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25620893|NCT01196377|Adrenergic Agents|adrenergic agents|mesh-ancestor
25620894|NCT01196377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25620895|NCT01196377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620896|NCT01196416|Cisplatin|cisplatin|mesh-list
25620897|NCT01196416|Temozolomide|temozolomide|mesh-list
25620898|NCT01196416|Vinblastine|vinblastine|mesh-list
25620899|NCT01196416|R04929097|r04929097|mesh-list
25620900|NCT01196416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620901|NCT01196416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25620902|NCT01196416|Alkylating Agents|alkylating agents|mesh-ancestor
25620903|NCT01196416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620904|NCT01196416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25620905|NCT01196416|Tubulin Modulators|tubulin modulators|mesh-ancestor
25620906|NCT01196416|Antimitotic Agents|antimitotic agents|mesh-ancestor
25620907|NCT01196416|Mitosis Modulators|mitosis modulators|mesh-ancestor
25620908|NCT01196416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620909|NCT01196429|Sirolimus|sirolimus|mesh-list
25620910|NCT01196429|Paclitaxel|paclitaxel|mesh-list
25620911|NCT01196429|Docetaxel|docetaxel|mesh-list
25620912|NCT01196429|Carboplatin|carboplatin|mesh-list
25620913|NCT01196429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25620914|NCT01196429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25620915|NCT01196429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24677758|NCT01358253|Methotrexate|methotrexate|mesh-list
25620916|NCT01196429|Tubulin Modulators|tubulin modulators|mesh-ancestor
25620917|NCT01196429|Antimitotic Agents|antimitotic agents|mesh-ancestor
25620918|NCT01196429|Mitosis Modulators|mitosis modulators|mesh-ancestor
25620919|NCT01196429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620920|NCT01196429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25620921|NCT01196429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25620922|NCT01196429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25620923|NCT01196429|Antifungal Agents|antifungal agents|mesh-ancestor
25620924|NCT01196429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25620925|NCT01196429|Immunologic Factors|immunologic factors|mesh-ancestor
25620926|NCT01196429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620927|NCT01196741|Paclitaxel|paclitaxel|mesh-list
25620928|NCT01196741|Saracatinib|saracatinib|mesh-list
25620929|NCT01196741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25620930|NCT01196741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620931|NCT01196741|Tubulin Modulators|tubulin modulators|mesh-ancestor
25620932|NCT01196741|Antimitotic Agents|antimitotic agents|mesh-ancestor
25620933|NCT01196741|Mitosis Modulators|mitosis modulators|mesh-ancestor
25620934|NCT01196741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620935|NCT01196741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620936|NCT01196975|Vaccines|vaccines|mesh-list
25620937|NCT01196975|Immunologic Factors|immunologic factors|mesh-ancestor
25620938|NCT01196975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620939|NCT01196988|Vaccines|vaccines|mesh-list
25620940|NCT01196988|Immunologic Factors|immunologic factors|mesh-ancestor
25620941|NCT01196988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620942|NCT01197300|Zoledronic Acid|zoledronic acid|mesh-list
25620943|NCT01197300|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25620944|NCT01197300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620945|NCT01197378|Cysteamine|cysteamine|mesh-list
25620946|NCT01197378|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
25620947|NCT01197378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620948|NCT01197417|Magnesium Sulfate|magnesium sulfate|mesh-list
25620949|NCT01197417|Analgesics|analgesics|mesh-ancestor
25620950|NCT01197417|Sensory System Agents|sensory system agents|mesh-ancestor
25620951|NCT01197417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25620952|NCT01197417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620953|NCT01197417|Anesthetics|anesthetics|mesh-ancestor
25620954|NCT01197417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25620955|NCT01197417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25620956|NCT01197417|Anticonvulsants|anticonvulsants|mesh-ancestor
25620957|NCT01197417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25620958|NCT01197417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25620959|NCT01197417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620960|NCT01197417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25620961|NCT01197417|Tocolytic Agents|tocolytic agents|mesh-ancestor
25620962|NCT01197417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25620963|NCT01197495|Hyaluronic Acid|hyaluronic acid|mesh-list
25620964|NCT01197495|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25620965|NCT01197495|Immunologic Factors|immunologic factors|mesh-ancestor
25620966|NCT01197495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620967|NCT01197495|Viscosupplements|viscosupplements|mesh-ancestor
25620968|NCT01197495|Protective Agents|protective agents|mesh-ancestor
25620969|NCT01197560|Gemcitabine|gemcitabine|mesh-list
25620970|NCT01197560|Rituximab|rituximab|mesh-list
25620971|NCT01197560|Oxaliplatin|oxaliplatin|mesh-list
25620972|NCT01197560|Etoposide|etoposide|mesh-list
25620973|NCT01197560|Lenalidomide|lenalidomide|mesh-list
24611499|NCT01009853|Sensory System Agents|sensory system agents|mesh-ancestor
25620974|NCT01197560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25620975|NCT01197560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25620976|NCT01197560|Immunologic Factors|immunologic factors|mesh-ancestor
25515481|NCT00422227|Analgesics|analgesics|mesh-ancestor
25655311|NCT01561703|Cefaclor|cefaclor|mesh-list
25620977|NCT01197560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25620979|NCT01197560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25620980|NCT01197560|Antimetabolites|antimetabolites|mesh-ancestor
25620981|NCT01197560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620982|NCT01197560|Antiviral Agents|antiviral agents|mesh-ancestor
25620983|NCT01197560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25620984|NCT01197560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25620985|NCT01197560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25620986|NCT01197560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25620987|NCT01197560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25620988|NCT01197560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25620989|NCT01197560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25620990|NCT01197560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25620991|NCT01197560|Growth Substances|growth substances|mesh-ancestor
25620992|NCT01197560|Growth Inhibitors|growth inhibitors|mesh-ancestor
25620993|NCT01197573|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25620994|NCT01197573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25620995|NCT01197573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25620996|NCT01197573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25620997|NCT01197612|Budesonide|budesonide|mesh-list
25620998|NCT01197612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25620999|NCT01197612|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25621000|NCT01197612|Autonomic Agents|autonomic agents|mesh-ancestor
25621001|NCT01197612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25621002|NCT01197612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621003|NCT01197612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25621004|NCT01197612|Respiratory System Agents|respiratory system agents|mesh-ancestor
25621005|NCT01197612|Glucocorticoids|glucocorticoids|mesh-ancestor
25621006|NCT01197612|Hormones|hormones|mesh-ancestor
25621007|NCT01197612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25655312|NCT01561703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25655313|NCT01561703|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25655314|NCT01561703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655315|NCT01561703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655316|NCT01561703|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25655317|NCT01561755|Immunoglobulins|immunoglobulins|mesh-list
25655318|NCT01561755|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25655319|NCT01561755|Antibodies|antibodies|mesh-list
25655320|NCT01561755|gamma-Globulins|gamma-globulins|mesh-list
25655321|NCT01561755|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25655322|NCT01561755|Immunologic Factors|immunologic factors|mesh-ancestor
25655323|NCT01561755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655324|NCT01561833|Sorafenib|sorafenib|mesh-list
25655325|NCT01561833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25655326|NCT01561833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25655327|NCT01561833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655328|NCT01561833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655329|NCT01561898|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25655330|NCT01561898|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25655331|NCT01561898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25655332|NCT01561898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25655333|NCT01561898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655334|NCT01561898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25655335|NCT01561898|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25655336|NCT01561898|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25655337|NCT01561898|Serotonin Agents|serotonin agents|mesh-ancestor
25655338|NCT01561898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25655339|NCT01561898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655340|NCT01561898|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25655341|NCT01561898|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25655342|NCT01561898|Dopamine Agents|dopamine agents|mesh-ancestor
25655343|NCT01561963|Rifampin|rifampin|mesh-list
25655344|NCT01561963|Apremilast|apremilast|mesh-list
25655345|NCT01561963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25655346|NCT01561963|Antitubercular Agents|antitubercular agents|mesh-ancestor
25655347|NCT01561963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25655348|NCT01561963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25655349|NCT01561963|Leprostatic Agents|leprostatic agents|mesh-ancestor
25655350|NCT01561963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25655351|NCT01561963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655352|NCT01561963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515550|NCT00423098|Prednisone|prednisone|mesh-list
25621009|NCT01197833|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25621010|NCT01197833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25621011|NCT01198002|Methotrexate|methotrexate|mesh-list
25621012|NCT01198002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25621013|NCT01198002|Abortifacient Agents|abortifacient agents|mesh-ancestor
25621014|NCT01198002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25621015|NCT01198002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621016|NCT01198002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25621017|NCT01198002|Antimetabolites|antimetabolites|mesh-ancestor
25621018|NCT01198002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621019|NCT01198002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621020|NCT01198002|Dermatologic Agents|dermatologic agents|mesh-ancestor
25621021|NCT01198002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621022|NCT01198002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25621023|NCT01198002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25621024|NCT01198002|Immunologic Factors|immunologic factors|mesh-ancestor
25621025|NCT01198002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25621026|NCT01198002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25621027|NCT01198028|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25621028|NCT01198028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621029|NCT01198028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25621030|NCT01198028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621031|NCT01198028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621032|NCT01198132|Vitamin D|vitamin d|mesh-list
25621033|NCT01198132|Ergocalciferols|ergocalciferols|mesh-list
25621034|NCT01198132|Cholecalciferol|cholecalciferol|mesh-list
25621035|NCT01198132|Vitamins|vitamins|mesh-list
25621036|NCT01198132|Interferons|interferons|mesh-list
25621037|NCT01198132|Interferon-beta|interferon-beta|mesh-list
25621038|NCT01198132|Interferon beta-1a|interferon beta-1a|mesh-list
25621039|NCT01198132|Micronutrients|micronutrients|mesh-ancestor
25621040|NCT01198132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621041|NCT01198132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25621042|NCT01198132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25621043|NCT01198132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621044|NCT01198132|Antiviral Agents|antiviral agents|mesh-ancestor
25621045|NCT01198132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25621046|NCT01198132|Immunologic Factors|immunologic factors|mesh-ancestor
25621047|NCT01198132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25621048|NCT01198145|Sulfasalazine|sulfasalazine|mesh-list
25621049|NCT01198145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25621050|NCT01198145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25621051|NCT01198145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25621052|NCT01198145|Analgesics|analgesics|mesh-ancestor
25621053|NCT01198145|Sensory System Agents|sensory system agents|mesh-ancestor
25621054|NCT01198145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25621055|NCT01198145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621056|NCT01198145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24691365|NCT01406262|Incretins|incretins|mesh-ancestor
25621057|NCT01198145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25621058|NCT01198145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25621059|NCT01198158|Bevacizumab|bevacizumab|mesh-list
25621060|NCT01198158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25621061|NCT01198158|Everolimus|everolimus|mesh-list
25621062|NCT01198158|Endothelial Growth Factors|endothelial growth factors|mesh-list
25621063|NCT01198158|Antibodies|antibodies|mesh-list
25621064|NCT01198158|Immunoglobulins|immunoglobulins|mesh-list
25621065|NCT01198158|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25621066|NCT01198158|Immunoglobulin G|immunoglobulin g|mesh-list
25621067|NCT01198158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621068|NCT01198158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25621069|NCT01198158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25621070|NCT01198158|Growth Substances|growth substances|mesh-ancestor
25621071|NCT01198158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621072|NCT01198158|Growth Inhibitors|growth inhibitors|mesh-ancestor
25621073|NCT01198158|Immunologic Factors|immunologic factors|mesh-ancestor
25621074|NCT01198158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25621075|NCT01198275|Amiodarone|amiodarone|mesh-list
25621076|NCT01198275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25621077|NCT01198275|Vasodilator Agents|vasodilator agents|mesh-ancestor
25621078|NCT01198275|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25621079|NCT01198275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25621080|NCT01198275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621081|NCT01198275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25621082|NCT01198275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25621083|NCT01198275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25621084|NCT01198275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621085|NCT01198275|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25621086|NCT01198275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25621087|NCT01198275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25621088|NCT01198327|Ranibizumab|ranibizumab|mesh-list
25621089|NCT01198327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25621090|NCT01198327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25621091|NCT01198327|Growth Substances|growth substances|mesh-ancestor
24693146|NCT01418534|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24693147|NCT01418534|Diuretics|diuretics|mesh-ancestor
24693466|NCT01420575|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25621092|NCT01198327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621093|NCT01198327|Growth Inhibitors|growth inhibitors|mesh-ancestor
25621094|NCT01198327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621095|NCT01198509|Vancomycin|vancomycin|mesh-list
25621096|NCT01198509|Doxycycline|doxycycline|mesh-list
25621097|NCT01198509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25621098|NCT01198509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25621099|NCT01198509|Antimalarials|antimalarials|mesh-ancestor
25621100|NCT01198509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25621101|NCT01198509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25621102|NCT01198574|Vitamins|vitamins|mesh-list
25621103|NCT01198574|Folic Acid|folic acid|mesh-list
25621104|NCT01198574|Vitamin A|vitamin a|mesh-list
25621105|NCT01198574|Iron|iron|mesh-list
25621106|NCT01198574|Retinol palmitate|retinol palmitate|mesh-list
25621107|NCT01198574|Micronutrients|micronutrients|mesh-ancestor
25621108|NCT01198574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621109|NCT01198574|Trace Elements|trace elements|mesh-ancestor
25621110|NCT01198574|Hematinics|hematinics|mesh-ancestor
25621111|NCT01198574|Vitamin B Complex|vitamin b complex|mesh-ancestor
25621112|NCT01198574|Antioxidants|antioxidants|mesh-ancestor
25621113|NCT01198574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621114|NCT01198574|Protective Agents|protective agents|mesh-ancestor
25621115|NCT01198574|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25621116|NCT01198574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621117|NCT01198587|Zinc Sulfate|zinc sulfate|mesh-list
25621118|NCT01198587|Astringents|astringents|mesh-ancestor
25621119|NCT01198587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621120|NCT01198587|Dermatologic Agents|dermatologic agents|mesh-ancestor
25621121|NCT01198756|Vaccines|vaccines|mesh-list
25621122|NCT01198756|Immunologic Factors|immunologic factors|mesh-ancestor
25621123|NCT01198756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621124|NCT01198795|Citalopram|citalopram|mesh-list
25621125|NCT01198795|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25621126|NCT01198795|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25621127|NCT01198795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25621128|NCT01198795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621129|NCT01198795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25621130|NCT01198795|Serotonin Agents|serotonin agents|mesh-ancestor
25621131|NCT01198795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621132|NCT01198795|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25621133|NCT01198795|Antidepressive Agents|antidepressive agents|mesh-ancestor
25621134|NCT01198795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25621135|NCT01198873|Dronedarone|dronedarone|mesh-list
25621136|NCT01198873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25621137|NCT01199055|Paclitaxel|paclitaxel|mesh-list
25621138|NCT01199055|Carboplatin|carboplatin|mesh-list
25621139|NCT01199055|Efatutazone|efatutazone|mesh-list
25621140|NCT01199055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25621141|NCT01199055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621142|NCT01199055|Tubulin Modulators|tubulin modulators|mesh-ancestor
25621143|NCT01199055|Antimitotic Agents|antimitotic agents|mesh-ancestor
24695623|NCT02547662|Hormones|hormones|mesh-ancestor
25621144|NCT01199055|Mitosis Modulators|mitosis modulators|mesh-ancestor
25621145|NCT01199055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621146|NCT01199068|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25621147|NCT01199068|Efatutazone|efatutazone|mesh-list
25621148|NCT01199068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621149|NCT01199068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25621150|NCT01199068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621151|NCT01199068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621152|NCT01199146|Abiraterone Acetate|abiraterone acetate|mesh-list
25621153|NCT01199146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621154|NCT01199146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25621155|NCT01199146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621156|NCT01199146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621157|NCT01199146|Hormone Antagonists|hormone antagonists|mesh-ancestor
25621158|NCT01199146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25621159|NCT01199146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621160|NCT01199146|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25621161|NCT01199198|Tolvaptan|tolvaptan|mesh-list
25621162|NCT01199198|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25621163|NCT01199198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621164|NCT01199198|Natriuretic Agents|natriuretic agents|mesh-ancestor
25621165|NCT01199198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621166|NCT01199237|Glycopyrrolate|glycopyrrolate|mesh-list
25621167|NCT01199237|Sevoflurane|sevoflurane|mesh-list
25621168|NCT01199237|Desflurane|desflurane|mesh-list
25621169|NCT01199237|Rocuronium|rocuronium|mesh-list
25621170|NCT01199237|Neostigmine|neostigmine|mesh-list
25621171|NCT01199237|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25621172|NCT01199237|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25621173|NCT01199237|Anesthetics, General|anesthetics, general|mesh-ancestor
25621174|NCT01199237|Anesthetics|anesthetics|mesh-ancestor
25621175|NCT01199237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25621176|NCT01199237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714948|NCT02364947|Sensory System Agents|sensory system agents|mesh-ancestor
24696050|NCT01427114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696051|NCT01427114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24696052|NCT01427114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24696053|NCT01427114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24696055|NCT01427114|Tubulin Modulators|tubulin modulators|mesh-ancestor
25621177|NCT01199237|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25621178|NCT01199237|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25621179|NCT01199237|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25621180|NCT01199237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25621181|NCT01199237|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25621182|NCT01199237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621183|NCT01199237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621184|NCT01199237|Cholinergic Agents|cholinergic agents|mesh-ancestor
25621185|NCT01199237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25621186|NCT01199237|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25621187|NCT01199237|Autonomic Agents|autonomic agents|mesh-ancestor
25621188|NCT01199237|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25621189|NCT01199237|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25621190|NCT01199237|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25621191|NCT01199263|Paclitaxel|paclitaxel|mesh-list
25621192|NCT01199263|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25621193|NCT01199263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25621194|NCT01199263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621195|NCT01199263|Tubulin Modulators|tubulin modulators|mesh-ancestor
25621196|NCT01199263|Antimitotic Agents|antimitotic agents|mesh-ancestor
25621197|NCT01199263|Mitosis Modulators|mitosis modulators|mesh-ancestor
25621198|NCT01199263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621199|NCT01199289|Brodalumab|brodalumab|mesh-list
25621200|NCT01199289|Dermatologic Agents|dermatologic agents|mesh-ancestor
25621201|NCT01199575|Rituximab|rituximab|mesh-list
25621202|NCT01199575|Lenalidomide|lenalidomide|mesh-list
25621203|NCT01199575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25621204|NCT01199575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621205|NCT01199575|Immunologic Factors|immunologic factors|mesh-ancestor
25621206|NCT01199575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621207|NCT01199575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25621208|NCT01199575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25621209|NCT01199575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25621210|NCT01199575|Growth Substances|growth substances|mesh-ancestor
25621211|NCT01199575|Growth Inhibitors|growth inhibitors|mesh-ancestor
25621212|NCT01199705|Immunoglobulins|immunoglobulins|mesh-list
25621213|NCT01199705|Antibodies|antibodies|mesh-list
25621214|NCT01199705|gamma-Globulins|gamma-globulins|mesh-list
25621215|NCT01199705|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25621216|NCT01199705|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25621217|NCT01199705|Immunologic Factors|immunologic factors|mesh-ancestor
25621218|NCT01199705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621219|NCT01199731|Etravirine|etravirine|mesh-list
25621220|NCT01199731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25621221|NCT01199731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25621222|NCT01199731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621223|NCT01199731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621224|NCT01199731|Antiviral Agents|antiviral agents|mesh-ancestor
25621225|NCT01199731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25621226|NCT01199744|Zanamivir|zanamivir|mesh-list
25621227|NCT01199744|Antiviral Agents|antiviral agents|mesh-ancestor
25621228|NCT01199744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25621229|NCT01199744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621230|NCT01199744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621231|NCT01199822|Olaratumab|olaratumab|mesh-list
25621232|NCT01199822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621233|NCT01199861|Vaccines|vaccines|mesh-list
25515764|NCT00423943|Modafinil|modafinil|mesh-list
25621234|NCT01199861|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25621235|NCT01199861|Immunologic Factors|immunologic factors|mesh-ancestor
25621236|NCT01199861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621237|NCT01199861|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25621238|NCT01199861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621239|NCT01199861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25621240|NCT01199926|Vitamin D|vitamin d|mesh-list
25621241|NCT01199926|Cholecalciferol|cholecalciferol|mesh-list
25621242|NCT01199926|Vitamins|vitamins|mesh-ancestor
25621243|NCT01199926|Micronutrients|micronutrients|mesh-ancestor
25621244|NCT01199926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621245|NCT01199926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25621246|NCT01199926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25621247|NCT01199939|Ritonavir|ritonavir|mesh-list
25621248|NCT01199939|Darunavir|darunavir|mesh-list
25621249|NCT01199939|Etravirine|etravirine|mesh-list
25621250|NCT01199939|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25621251|NCT01199939|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25621252|NCT01199939|Protease Inhibitors|protease inhibitors|mesh-ancestor
25621253|NCT01199939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621254|NCT01199939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621255|NCT01199939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25621256|NCT01199939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25621257|NCT01199939|Antiviral Agents|antiviral agents|mesh-ancestor
25621258|NCT01199939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25621259|NCT01199939|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25621260|NCT01199939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25621261|NCT01199939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25621262|NCT01199939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25621263|NCT01199965|Dihydroergotamine|dihydroergotamine|mesh-list
24697910|NCT01437826|Selenium|selenium|mesh-list
25621264|NCT01199965|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25621265|NCT01199965|Dopamine Agonists|dopamine agonists|mesh-ancestor
25621266|NCT01199965|Dopamine Agents|dopamine agents|mesh-ancestor
25621267|NCT01199965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25621268|NCT01199965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621269|NCT01199965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621270|NCT01199965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25621271|NCT01199965|Analgesics|analgesics|mesh-ancestor
25621272|NCT01199965|Sensory System Agents|sensory system agents|mesh-ancestor
25621273|NCT01199965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25621274|NCT01200069|Ibuprofen|ibuprofen|mesh-list
25621275|NCT01200069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25621276|NCT01200069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25621277|NCT01200069|Analgesics|analgesics|mesh-ancestor
25621278|NCT01200069|Sensory System Agents|sensory system agents|mesh-ancestor
24698259|NCT01440127|Metformin|metformin|mesh-list
25621279|NCT01200069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25621280|NCT01200069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621281|NCT01200069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25621282|NCT01200069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25621283|NCT01200069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25621284|NCT01200069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621285|NCT01200069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621286|NCT01200160|Niacin|niacin|mesh-list
25621287|NCT01200160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25621288|NCT01200160|Antimetabolites|antimetabolites|mesh-ancestor
25621289|NCT01200160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621290|NCT01200160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25621291|NCT01200160|Vasodilator Agents|vasodilator agents|mesh-ancestor
25621292|NCT01200160|Vitamin B Complex|vitamin b complex|mesh-ancestor
25621293|NCT01200160|Vitamins|vitamins|mesh-ancestor
25621294|NCT01200160|Micronutrients|micronutrients|mesh-ancestor
25621295|NCT01200160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621296|NCT01200329|Gemcitabine|gemcitabine|mesh-list
25621297|NCT01200329|Melphalan|melphalan|mesh-list
25621298|NCT01200329|Busulfan|busulfan|mesh-list
25621299|NCT01200329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25621300|NCT01200329|Antimetabolites|antimetabolites|mesh-ancestor
24699172|NCT01445236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621301|NCT01200329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621302|NCT01200329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621303|NCT01200329|Antiviral Agents|antiviral agents|mesh-ancestor
25621304|NCT01200329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25621305|NCT01200329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621306|NCT01200329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25621307|NCT01200329|Immunologic Factors|immunologic factors|mesh-ancestor
25621308|NCT01200329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621309|NCT01200329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25621310|NCT01200329|Alkylating Agents|alkylating agents|mesh-ancestor
25621311|NCT01200329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25621312|NCT01200342|Paclitaxel|paclitaxel|mesh-list
25621313|NCT01200342|Carboplatin|carboplatin|mesh-list
25621314|NCT01200342|Oblimersen|oblimersen|mesh-list
25621315|NCT01200342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25621316|NCT01200342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621317|NCT01200342|Tubulin Modulators|tubulin modulators|mesh-ancestor
25621318|NCT01200342|Antimitotic Agents|antimitotic agents|mesh-ancestor
25621319|NCT01200342|Mitosis Modulators|mitosis modulators|mesh-ancestor
25621320|NCT01200342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621321|NCT01200355|Posaconazole|posaconazole|mesh-list
25621322|NCT01200355|Micafungin|micafungin|mesh-list
25621323|NCT01200355|Antifungal Agents|antifungal agents|mesh-ancestor
25621324|NCT01200355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25621325|NCT01200355|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25621326|NCT01200355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25621327|NCT01200355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25621328|NCT01200355|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25621329|NCT01200355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25621330|NCT01200355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621331|NCT01200355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621332|NCT01200355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25621333|NCT01200355|Hormone Antagonists|hormone antagonists|mesh-ancestor
25621334|NCT01200355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25621335|NCT01200355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621336|NCT01200368|Vaccines|vaccines|mesh-list
25621337|NCT01200368|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25715001|NCT02365870|Dopamine Agents|dopamine agents|mesh-ancestor
25621338|NCT01200368|Immunologic Factors|immunologic factors|mesh-ancestor
25621339|NCT01200368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621340|NCT01200407|Amlodipine|amlodipine|mesh-list
25621341|NCT01200407|Olmesartan|olmesartan|mesh-list
25621342|NCT01200407|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25621343|NCT01200407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25621344|NCT01200407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25621345|NCT01200407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25621346|NCT01200407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621347|NCT01200407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25621348|NCT01200407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621349|NCT01200407|Vasodilator Agents|vasodilator agents|mesh-ancestor
25621350|NCT01200407|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25621351|NCT01200407|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25621352|NCT01200433|Dexmedetomidine|dexmedetomidine|mesh-list
25621353|NCT01200433|Propofol|propofol|mesh-list
25621354|NCT01200433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25621355|NCT01200433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25621356|NCT01200433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621357|NCT01200433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25621358|NCT01200433|Anesthetics, General|anesthetics, general|mesh-ancestor
25621359|NCT01200433|Anesthetics|anesthetics|mesh-ancestor
25621360|NCT01200433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25621361|NCT01200433|Analgesics|analgesics|mesh-ancestor
25621362|NCT01200433|Sensory System Agents|sensory system agents|mesh-ancestor
25621363|NCT01200433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25621364|NCT01200433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24635857|NCT01141465|Xhance|xhance|mesh-list
25621365|NCT01200433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25621366|NCT01200433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25621367|NCT01200433|Adrenergic Agents|adrenergic agents|mesh-ancestor
25621368|NCT01200433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25621369|NCT01200433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621370|NCT01200485|Allopurinol|allopurinol|mesh-list
25621371|NCT01200485|Rasburicase|rasburicase|mesh-list
25621372|NCT01200485|Antimetabolites|antimetabolites|mesh-ancestor
25621373|NCT01200485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621374|NCT01200485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621375|NCT01200485|Gout Suppressants|gout suppressants|mesh-ancestor
25621376|NCT01200485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25621377|NCT01200485|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25621378|NCT01200485|Antioxidants|antioxidants|mesh-ancestor
25621379|NCT01200485|Protective Agents|protective agents|mesh-ancestor
25515882|NCT00424489|Antiemetics|antiemetics|mesh-ancestor
25621380|NCT01200485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621381|NCT01200589|Rituximab|rituximab|mesh-list
25621382|NCT01200589|Ofatumumab|ofatumumab|mesh-list
25621383|NCT01200589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25621384|NCT01200589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25621385|NCT01200589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621386|NCT01200589|Immunologic Factors|immunologic factors|mesh-ancestor
25621387|NCT01200589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621388|NCT01200589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25621389|NCT01200758|Prednisone|prednisone|mesh-list
25621390|NCT01200758|Prednisolone|prednisolone|mesh-list
25621391|NCT01200758|Cyclophosphamide|cyclophosphamide|mesh-list
25621392|NCT01200758|Rituximab|rituximab|mesh-list
25621393|NCT01200758|Doxorubicin|doxorubicin|mesh-list
25621394|NCT01200758|Vincristine|vincristine|mesh-list
25621395|NCT01200758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25621396|NCT01200758|Immunologic Factors|immunologic factors|mesh-ancestor
25621397|NCT01200758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621398|NCT01200758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25621399|NCT01200758|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25621400|NCT01200758|Alkylating Agents|alkylating agents|mesh-ancestor
25621401|NCT01200758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621402|NCT01200758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621403|NCT01200758|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25621404|NCT01200758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25621405|NCT01200758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25621406|NCT01200758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25621407|NCT01200758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25621408|NCT01200758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621409|NCT01200758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25621410|NCT01200758|Glucocorticoids|glucocorticoids|mesh-ancestor
25621411|NCT01200758|Hormones|hormones|mesh-ancestor
25621412|NCT01200758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25621413|NCT01200758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24636182|NCT01143662|Antiviral Agents|antiviral agents|mesh-ancestor
25621414|NCT01200758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25621415|NCT01200758|Tubulin Modulators|tubulin modulators|mesh-ancestor
25621416|NCT01200758|Antimitotic Agents|antimitotic agents|mesh-ancestor
25621417|NCT01200758|Mitosis Modulators|mitosis modulators|mesh-ancestor
25621418|NCT01200810|Bicalutamide|bicalutamide|mesh-list
25621419|NCT01200810|R04929097|r04929097|mesh-list
25621420|NCT01200810|Androgen Antagonists|androgen antagonists|mesh-ancestor
25621421|NCT01200810|Hormone Antagonists|hormone antagonists|mesh-ancestor
25621422|NCT01200810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25621423|NCT01200810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621424|NCT01200810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621425|NCT01200810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621426|NCT01200810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621427|NCT01200992|Mitomycins|mitomycins|mesh-list
25621428|NCT01200992|Mitomycin|mitomycin|mesh-list
25621429|NCT01200992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25621430|NCT01200992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621431|NCT01200992|Alkylating Agents|alkylating agents|mesh-ancestor
25621432|NCT01200992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621433|NCT01200992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25621434|NCT01200992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621435|NCT01201265|Gemcitabine|gemcitabine|mesh-list
25621436|NCT01201265|Bevacizumab|bevacizumab|mesh-list
25621437|NCT01201265|Carboplatin|carboplatin|mesh-list
25621438|NCT01201265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25621439|NCT01201265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621440|NCT01201265|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25621441|NCT01201265|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25621442|NCT01201265|Growth Substances|growth substances|mesh-ancestor
25621443|NCT01201265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621444|NCT01201265|Growth Inhibitors|growth inhibitors|mesh-ancestor
25621445|NCT01201265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25621446|NCT01201265|Antimetabolites|antimetabolites|mesh-ancestor
25621447|NCT01201265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621448|NCT01201265|Antiviral Agents|antiviral agents|mesh-ancestor
25621449|NCT01201265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25621450|NCT01201265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621451|NCT01201265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25621452|NCT01201265|Immunologic Factors|immunologic factors|mesh-ancestor
25621453|NCT01201343|Interferons|interferons|mesh-list
25621454|NCT01201343|Interferon-beta|interferon-beta|mesh-list
25621455|NCT01201343|Interferon beta-1a|interferon beta-1a|mesh-list
25621456|NCT01201343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621457|NCT01201343|Antiviral Agents|antiviral agents|mesh-ancestor
25621458|NCT01201343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25621459|NCT01201343|Immunologic Factors|immunologic factors|mesh-ancestor
25621460|NCT01201343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621461|NCT01201343|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25621462|NCT01201356|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24639572|NCT01162902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24639573|NCT01162902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24639574|NCT01162902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24639576|NCT01162902|Vasodilator Agents|vasodilator agents|mesh-ancestor
25621463|NCT01201356|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25621464|NCT01201356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621465|NCT01201356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25621466|NCT01201356|Immunologic Factors|immunologic factors|mesh-ancestor
25621467|NCT01201356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621468|NCT01201759|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
25621469|NCT01201759|Sodium Salicylate|sodium salicylate|mesh-list
25621470|NCT01201759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25621471|NCT01201759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25621472|NCT01201759|Analgesics|analgesics|mesh-ancestor
25621473|NCT01201759|Sensory System Agents|sensory system agents|mesh-ancestor
25621474|NCT01201759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25621475|NCT01201759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621476|NCT01201759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25621477|NCT01201759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25621478|NCT01201759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25621479|NCT01201759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640760|NCT01169870|Mitosis Modulators|mitosis modulators|mesh-ancestor
25621480|NCT01201759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621481|NCT01201772|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25621482|NCT01201772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25621484|NCT01201785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25621485|NCT01201785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25621486|NCT01201785|Analgesics|analgesics|mesh-ancestor
25621487|NCT01201785|Sensory System Agents|sensory system agents|mesh-ancestor
25621488|NCT01201785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25621489|NCT01201785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621490|NCT01201785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25621491|NCT01201785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25621492|NCT01201785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25621493|NCT01201785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25621494|NCT01201785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621495|NCT01201785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25621496|NCT01201785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25621497|NCT01201785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621498|NCT01201785|Antipyretics|antipyretics|mesh-ancestor
25621499|NCT01201798|Prednisolone|prednisolone|mesh-list
25621500|NCT01201798|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25621501|NCT01201798|Methylprednisolone|methylprednisolone|mesh-list
25715073|NCT02366143|Immunologic Factors|immunologic factors|mesh-ancestor
25621502|NCT01201798|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25621503|NCT01201798|Prednisolone acetate|prednisolone acetate|mesh-list
25621504|NCT01201798|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25621505|NCT01201798|Prednisolone phosphate|prednisolone phosphate|mesh-list
25621506|NCT01201798|Difluprednate|difluprednate|mesh-list
25621507|NCT01201798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25621508|NCT01201798|Glucocorticoids|glucocorticoids|mesh-ancestor
25621509|NCT01201798|Hormones|hormones|mesh-ancestor
25621510|NCT01201798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25621511|NCT01201798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621512|NCT01201798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25621513|NCT01201798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621514|NCT01201798|Antiemetics|antiemetics|mesh-ancestor
24643036|NCT01183442|Micronutrients|micronutrients|mesh-ancestor
25621515|NCT01201798|Autonomic Agents|autonomic agents|mesh-ancestor
25621516|NCT01201798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25621517|NCT01201798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25621518|NCT01201798|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25621519|NCT01201798|Protective Agents|protective agents|mesh-ancestor
25621520|NCT01201811|Azacitidine|azacitidine|mesh-list
25621521|NCT01201811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25621522|NCT01201811|Antimetabolites|antimetabolites|mesh-ancestor
25621523|NCT01201811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621524|NCT01201811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621525|NCT01201811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621526|NCT01201850|Bevacizumab|bevacizumab|mesh-list
25621527|NCT01201850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25621528|NCT01201850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621529|NCT01201850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25715089|NCT02366663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25715090|NCT02366663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25715091|NCT02366663|Immunologic Factors|immunologic factors|mesh-ancestor
25621530|NCT01201850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25621531|NCT01201850|Growth Substances|growth substances|mesh-ancestor
25621532|NCT01201850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621533|NCT01201850|Growth Inhibitors|growth inhibitors|mesh-ancestor
25621534|NCT01201863|Testosterone|testosterone|mesh-list
25621535|NCT01201863|Androgens|androgens|mesh-ancestor
25621536|NCT01201863|Hormones|hormones|mesh-ancestor
25621537|NCT01201863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25621538|NCT01201863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621539|NCT01202071|Rabeprazole|rabeprazole|mesh-list
25621540|NCT01202071|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25621541|NCT01202071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25621542|NCT01202071|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25621543|NCT01202071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621544|NCT01202071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621545|NCT01202162|Sevoflurane|sevoflurane|mesh-list
25621546|NCT01202162|Desflurane|desflurane|mesh-list
25621547|NCT01202162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25621548|NCT01202162|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25715097|NCT02366663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643577|NCT01186146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25621549|NCT01202162|Anesthetics, General|anesthetics, general|mesh-ancestor
25621550|NCT01202162|Anesthetics|anesthetics|mesh-ancestor
25621551|NCT01202162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25621552|NCT01202162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621553|NCT01202175|Nebivolol|nebivolol|mesh-list
25621554|NCT01202175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25621555|NCT01202175|Vasodilator Agents|vasodilator agents|mesh-ancestor
25621556|NCT01202175|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25621557|NCT01202175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25621558|NCT01202175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25621559|NCT01202175|Adrenergic Agents|adrenergic agents|mesh-ancestor
25621560|NCT01202175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24644047|NCT01188733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644048|NCT01188759|Voriconazole|voriconazole|mesh-list
24644049|NCT01188759|Anidulafungin|anidulafungin|mesh-list
25621561|NCT01202175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621562|NCT01202175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621563|NCT01202188|Glycopyrrolate|glycopyrrolate|mesh-list
25621564|NCT01202188|Tiotropium Bromide|tiotropium bromide|mesh-list
25621565|NCT01202188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25621566|NCT01202188|Autonomic Agents|autonomic agents|mesh-ancestor
25621567|NCT01202188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25621568|NCT01202188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621569|NCT01202188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25621570|NCT01202188|Respiratory System Agents|respiratory system agents|mesh-ancestor
25621571|NCT01202188|Parasympatholytics|parasympatholytics|mesh-ancestor
25621572|NCT01202188|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25621573|NCT01202188|Cholinergic Agents|cholinergic agents|mesh-ancestor
25621574|NCT01202188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25621575|NCT01202188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621576|NCT01202188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25621577|NCT01202188|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25621578|NCT01202227|Pregabalin|pregabalin|mesh-list
25621579|NCT01202227|Analgesics|analgesics|mesh-ancestor
25621580|NCT01202227|Sensory System Agents|sensory system agents|mesh-ancestor
25621581|NCT01202227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25621582|NCT01202227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621583|NCT01202227|Anticonvulsants|anticonvulsants|mesh-ancestor
25621584|NCT01202227|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25621585|NCT01202227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25621586|NCT01202227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621587|NCT01202227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25621588|NCT01202227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25621589|NCT01202227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25621590|NCT01202227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25621591|NCT01202227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25621592|NCT01202253|Anidulafungin|anidulafungin|mesh-list
25621593|NCT01202253|Antifungal Agents|antifungal agents|mesh-ancestor
24644673|NCT01192490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24644674|NCT01192490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644675|NCT01192490|Sensory System Agents|sensory system agents|mesh-ancestor
25621594|NCT01202253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25621595|NCT01202279|Phenylpropanolamine|phenylpropanolamine|mesh-list
25621596|NCT01202279|Pseudoephedrine|pseudoephedrine|mesh-list
25621597|NCT01202279|Guaifenesin|guaifenesin|mesh-list
25621598|NCT01202279|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
25621599|NCT01202279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25621600|NCT01202279|Autonomic Agents|autonomic agents|mesh-ancestor
25621601|NCT01202279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25621602|NCT01202279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621603|NCT01202279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25621604|NCT01202279|Respiratory System Agents|respiratory system agents|mesh-ancestor
25715127|NCT02366871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24644731|NCT01192724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24644732|NCT01192724|Protective Agents|protective agents|mesh-ancestor
24644754|NCT01192854|Clevudine|clevudine|mesh-list
25516164|NCT00426361|Immunologic Factors|immunologic factors|mesh-ancestor
25516165|NCT00426361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437025|NCT00272467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843012|NCT02225067|Calcium|calcium|mesh-list
24979855|NCT05186623|Vedolizumab|vedolizumab|mesh-list
24979856|NCT05186623|Tofacitinib|tofacitinib|mesh-list
24979857|NCT05186623|Dermatologic Agents|dermatologic agents|mesh-ancestor
24979858|NCT05186623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24979859|NCT05186623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24979860|NCT05186623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979861|NCT05186623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24979862|NCT05118724|Atezolizumab|atezolizumab|mesh-list
24979863|NCT05118724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979864|NCT05099666|Doxorubicin|doxorubicin|mesh-list
24979865|NCT05099666|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24979866|NCT05099666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979867|NCT05099666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24979868|NCT05099666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24979869|NCT05099666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24979870|NCT05099666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979871|NCT05095064|Irinotecan|irinotecan|mesh-list
24979872|NCT05095064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24979873|NCT05095064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25124369|NCT03077555|Estrogens|estrogens|mesh-ancestor
25124370|NCT03077555|Hormones|hormones|mesh-ancestor
25124371|NCT03077555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25124372|NCT03077555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645111|NCT01195805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24979874|NCT05095064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24979875|NCT05095064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979876|NCT05095064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979877|NCT05093959|Metformin|metformin|mesh-list
24979878|NCT05093959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24979879|NCT05093959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979886|NCT04984083|Vitamin K|vitamin k|mesh-list
24979887|NCT04984083|Vitamins|vitamins|mesh-ancestor
25124394|NCT03076710|Anesthetics|anesthetics|mesh-ancestor
25124395|NCT03076710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25124396|NCT03076710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124397|NCT03076710|Sensory System Agents|sensory system agents|mesh-ancestor
25124398|NCT03076710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124399|NCT03076762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25124400|NCT03076762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25124401|NCT03076762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25124402|NCT03076762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24458479|NCT00338117|Galantamine|galantamine|mesh-list
24437082|NCT00272636|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24437089|NCT00272636|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24437109|NCT00272701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24437110|NCT00272701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795510|NCT02034110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24795511|NCT02034110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795512|NCT02034110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437160|NCT00272805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24437184|NCT00272870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437185|NCT00272896|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
24437186|NCT00272896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24437187|NCT00272896|Vasodilator Agents|vasodilator agents|mesh-ancestor
24437188|NCT00272896|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25124404|NCT03076762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25124405|NCT03076762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25124406|NCT03076762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124407|NCT03076762|Cholinergic Agents|cholinergic agents|mesh-ancestor
25124410|NCT03076684|Antimetabolites|antimetabolites|mesh-ancestor
25124411|NCT03076684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124412|NCT03076684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124413|NCT03076684|Gout Suppressants|gout suppressants|mesh-ancestor
25124414|NCT03076684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25124415|NCT03076684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25124416|NCT03076684|Antioxidants|antioxidants|mesh-ancestor
25621605|NCT01202279|Nasal Decongestants|nasal decongestants|mesh-ancestor
25621606|NCT01202279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25621607|NCT01202279|Sympathomimetics|sympathomimetics|mesh-ancestor
25621609|NCT01202279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25621610|NCT01202279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621611|NCT01202279|Expectorants|expectorants|mesh-ancestor
24646517|NCT01204164|Dexamethasone|dexamethasone|mesh-list
25621612|NCT01202279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25621613|NCT01202279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25621614|NCT01202279|Appetite Depressants|appetite depressants|mesh-ancestor
25621615|NCT01202279|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25621616|NCT01202409|Panitumumab|panitumumab|mesh-list
25621617|NCT01202409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25621618|NCT01202409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621619|NCT01202591|Fulvestrant|fulvestrant|mesh-list
25621620|NCT01202591|Exemestane|exemestane|mesh-list
25621621|NCT01202591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25621622|NCT01202591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648221|NCT01213147|Clomiphene|clomiphene|mesh-list
25621623|NCT01202591|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25621624|NCT01202591|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25621625|NCT01202591|Hormone Antagonists|hormone antagonists|mesh-ancestor
25621626|NCT01202591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25621627|NCT01202591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621628|NCT01202591|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25621629|NCT01202591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25621630|NCT01202591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621631|NCT01202591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621632|NCT01202721|Atenolol|atenolol|mesh-list
25621633|NCT01202721|Telmisartan|telmisartan|mesh-list
25621634|NCT01202721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25621635|NCT01202721|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25621636|NCT01202721|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25621637|NCT01202721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621638|NCT01202721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25621639|NCT01202721|Sympatholytics|sympatholytics|mesh-ancestor
25621640|NCT01202721|Autonomic Agents|autonomic agents|mesh-ancestor
25621641|NCT01202721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25621642|NCT01202721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621643|NCT01202721|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25621644|NCT01202721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25621645|NCT01202721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25621646|NCT01202721|Adrenergic Agents|adrenergic agents|mesh-ancestor
25621647|NCT01202721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25655353|NCT01561963|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25655354|NCT01561963|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25655355|NCT01561963|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25655356|NCT01561963|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25655357|NCT01561963|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25655358|NCT01561963|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25655359|NCT01561963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25655360|NCT01561963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25655361|NCT01561963|Analgesics|analgesics|mesh-ancestor
25655362|NCT01561963|Sensory System Agents|sensory system agents|mesh-ancestor
25655363|NCT01561963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25655364|NCT01561963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655365|NCT01561963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25655366|NCT01561963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25655367|NCT01561963|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25655368|NCT01561963|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25655369|NCT01561976|Metformin|metformin|mesh-list
25655370|NCT01561976|Glimepiride|glimepiride|mesh-list
25655371|NCT01561976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25655372|NCT01561976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655373|NCT01561976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25655374|NCT01561976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24650015|NCT01223326|Expectorants|expectorants|mesh-ancestor
25655375|NCT01561976|Immunologic Factors|immunologic factors|mesh-ancestor
25655376|NCT01562041|Ranolazine|ranolazine|mesh-list
25655377|NCT01562041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25655378|NCT01562041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25655379|NCT01562041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655380|NCT01562132|Fluconazole|fluconazole|mesh-list
25655381|NCT01562132|Flucytosine|flucytosine|mesh-list
25655382|NCT01562132|Antifungal Agents|antifungal agents|mesh-ancestor
25655383|NCT01562132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25655384|NCT01562132|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25621648|NCT01202877|Azacitidine|azacitidine|mesh-list
25621649|NCT01202877|Midostaurin|midostaurin|mesh-list
25621650|NCT01202877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25621651|NCT01202877|Antimetabolites|antimetabolites|mesh-ancestor
25621652|NCT01202877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621653|NCT01202877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25771088|NCT03586544|Adrenergic Agents|adrenergic agents|mesh-ancestor
24650732|NCT01227720|Autonomic Agents|autonomic agents|mesh-ancestor
24650811|NCT01228214|Aspirin|aspirin|mesh-list
25621654|NCT01202877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621655|NCT01202877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25621656|NCT01202903|Omalizumab|omalizumab|mesh-list
25621657|NCT01202903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25621658|NCT01202903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25621659|NCT01202903|Respiratory System Agents|respiratory system agents|mesh-ancestor
25621660|NCT01202955|Tolcapone|tolcapone|mesh-list
25621661|NCT01202955|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25621662|NCT01202955|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25621663|NCT01202955|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25621664|NCT01202955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621665|NCT01202955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621666|NCT01202994|Flutemetamol|flutemetamol|mesh-list
25621667|NCT01202994|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25621668|NCT01202994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621669|NCT01203046|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25621670|NCT01203046|Ertapenem|ertapenem|mesh-list
25621671|NCT01203046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25621672|NCT01203072|Edoxaban|edoxaban|mesh-list
25621673|NCT01203072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25621674|NCT01203072|Antithrombins|antithrombins|mesh-ancestor
25621675|NCT01203072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25621676|NCT01203072|Protease Inhibitors|protease inhibitors|mesh-ancestor
25621677|NCT01203072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621678|NCT01203072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715205|NCT02368431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25621679|NCT01203072|Anticoagulants|anticoagulants|mesh-ancestor
25621680|NCT01203098|Enoxaparin|enoxaparin|mesh-list
25621681|NCT01203098|Enoxaparin sodium|enoxaparin sodium|mesh-list
25621682|NCT01203098|Edoxaban|edoxaban|mesh-list
25621683|NCT01203098|Anticoagulants|anticoagulants|mesh-ancestor
25621684|NCT01203098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25621685|NCT01203098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25621686|NCT01203098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621687|NCT01203098|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25621688|NCT01203098|Antithrombins|antithrombins|mesh-ancestor
25621689|NCT01203098|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25621690|NCT01203098|Protease Inhibitors|protease inhibitors|mesh-ancestor
25621691|NCT01203098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621692|NCT01203189|Ketoconazole|ketoconazole|mesh-list
24652193|NCT01236963|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24652194|NCT01236963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24652195|NCT01236989|Liver Extracts|liver extracts|mesh-list
24652196|NCT01236989|Hematinics|hematinics|mesh-ancestor
24652197|NCT01237028|Calcitriol|calcitriol|mesh-list
24652198|NCT01237028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24652199|NCT01237028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621693|NCT01203189|Antifungal Agents|antifungal agents|mesh-ancestor
25621694|NCT01203189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25621695|NCT01203189|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25621696|NCT01203189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25621697|NCT01203189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621698|NCT01203189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621699|NCT01203189|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25621700|NCT01203189|Hormone Antagonists|hormone antagonists|mesh-ancestor
25621701|NCT01203189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25621702|NCT01203189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621703|NCT01203189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25621704|NCT01203319|Vaccines|vaccines|mesh-list
25621705|NCT01203319|Immunologic Factors|immunologic factors|mesh-ancestor
25621706|NCT01203319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621707|NCT01203644|Bupivacaine|bupivacaine|mesh-list
25621708|NCT01203644|Anesthetics, Local|anesthetics, local|mesh-ancestor
25621709|NCT01203644|Anesthetics|anesthetics|mesh-ancestor
25621710|NCT01203644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25621711|NCT01203644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621712|NCT01203644|Sensory System Agents|sensory system agents|mesh-ancestor
25621713|NCT01203644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25621714|NCT01203774|Insulin Glargine|insulin glargine|mesh-list
25621715|NCT01203774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25621716|NCT01203774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621717|NCT01203787|Sorafenib|sorafenib|mesh-list
25621718|NCT01203787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621719|NCT01203787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25621720|NCT01203787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621721|NCT01203787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516244|NCT00427297|Didanosine|didanosine|mesh-list
25621722|NCT01203852|Metoprolol|metoprolol|mesh-list
25621723|NCT01203852|Chlorthalidone|chlorthalidone|mesh-list
25621724|NCT01203852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25621725|NCT01203852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25621726|NCT01203852|Sympatholytics|sympatholytics|mesh-ancestor
25621727|NCT01203852|Autonomic Agents|autonomic agents|mesh-ancestor
25621728|NCT01203852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25621729|NCT01203852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621730|NCT01203852|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25621731|NCT01203852|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25621732|NCT01203852|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25621733|NCT01203852|Adrenergic Agents|adrenergic agents|mesh-ancestor
25621734|NCT01203852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25621735|NCT01203852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621736|NCT01203852|Diuretics|diuretics|mesh-ancestor
25621737|NCT01203852|Natriuretic Agents|natriuretic agents|mesh-ancestor
25621738|NCT01203852|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25621739|NCT01203852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25621740|NCT01203878|Imiquimod|imiquimod|mesh-list
25621741|NCT01203878|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25621742|NCT01203878|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25621743|NCT01203878|Immunologic Factors|immunologic factors|mesh-ancestor
25621744|NCT01203878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621745|NCT01203878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621746|NCT01203878|Interferon Inducers|interferon inducers|mesh-ancestor
25621747|NCT01203878|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25621748|NCT01203878|Dermatologic Agents|dermatologic agents|mesh-ancestor
25621749|NCT01203917|Gefitinib|gefitinib|mesh-list
25621750|NCT01203917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621751|NCT01203917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25621752|NCT01203917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621753|NCT01203917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621754|NCT01203930|Rituximab|rituximab|mesh-list
25621755|NCT01203930|Idelalisib|idelalisib|mesh-list
25621756|NCT01203930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25621757|NCT01203930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621758|NCT01203930|Immunologic Factors|immunologic factors|mesh-ancestor
25621759|NCT01203930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621760|NCT01203930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25621761|NCT01203930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621762|NCT01203930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621763|NCT01204203|Zoledronic Acid|zoledronic acid|mesh-list
25621764|NCT01204203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25621765|NCT01204203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621766|NCT01204255|Diphenhydramine|diphenhydramine|mesh-list
25621767|NCT01204255|Promethazine|promethazine|mesh-list
25621768|NCT01204255|Lorazepam|lorazepam|mesh-list
25621769|NCT01204255|Haloperidol|haloperidol|mesh-list
25621770|NCT01204255|Haloperidol decanoate|haloperidol decanoate|mesh-list
25621771|NCT01204255|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25621772|NCT01204255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25621773|NCT01204255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25621774|NCT01204255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621775|NCT01204255|Anesthetics, Local|anesthetics, local|mesh-ancestor
25621776|NCT01204255|Anesthetics|anesthetics|mesh-ancestor
25621777|NCT01204255|Sensory System Agents|sensory system agents|mesh-ancestor
25621778|NCT01204255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25621779|NCT01204255|Antiemetics|antiemetics|mesh-ancestor
25715249|NCT02369172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25715251|NCT02369172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25621780|NCT01204255|Autonomic Agents|autonomic agents|mesh-ancestor
25621781|NCT01204255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25621782|NCT01204255|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25621783|NCT01204255|Histamine Antagonists|histamine antagonists|mesh-ancestor
25621784|NCT01204255|Histamine Agents|histamine agents|mesh-ancestor
25621785|NCT01204255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25621786|NCT01204255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621787|NCT01204255|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25621788|NCT01204255|Antipruritics|antipruritics|mesh-ancestor
25621789|NCT01204255|Dermatologic Agents|dermatologic agents|mesh-ancestor
25621790|NCT01204255|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25621791|NCT01204255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25621792|NCT01204255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25621793|NCT01204255|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25621794|NCT01204255|Dopamine Agents|dopamine agents|mesh-ancestor
25621795|NCT01204255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25621796|NCT01204255|Anticonvulsants|anticonvulsants|mesh-ancestor
25621797|NCT01204255|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25621798|NCT01204255|GABA Modulators|gaba modulators|mesh-ancestor
25621799|NCT01204255|GABA Agents|gaba agents|mesh-ancestor
25621800|NCT01204294|Metformin|metformin|mesh-list
25621801|NCT01204294|Linagliptin|linagliptin|mesh-list
25621802|NCT01204294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25621803|NCT01204294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621804|NCT01204294|Incretins|incretins|mesh-ancestor
25621805|NCT01204294|Hormones|hormones|mesh-ancestor
25621806|NCT01204294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25621807|NCT01204294|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25621808|NCT01204294|Protease Inhibitors|protease inhibitors|mesh-ancestor
24659664|NCT01279213|GABA Antagonists|gaba antagonists|mesh-ancestor
25621809|NCT01204294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621810|NCT01204294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621811|NCT01204398|Amlodipine|amlodipine|mesh-list
25621812|NCT01204398|Telmisartan|telmisartan|mesh-list
25621813|NCT01204398|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
25621814|NCT01204398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25621815|NCT01204398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25621816|NCT01204398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25621817|NCT01204398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621818|NCT01204398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25621819|NCT01204398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621820|NCT01204398|Vasodilator Agents|vasodilator agents|mesh-ancestor
25621821|NCT01204398|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25621822|NCT01204398|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25621823|NCT01204658|Vaccines|vaccines|mesh-list
25621824|NCT01204658|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25621825|NCT01204658|Immunologic Factors|immunologic factors|mesh-ancestor
25621826|NCT01204658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621827|NCT01204671|Vaccines|vaccines|mesh-list
25621828|NCT01204671|Immunologic Factors|immunologic factors|mesh-ancestor
25621829|NCT01204671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621830|NCT01204697|Docetaxel|docetaxel|mesh-list
25621831|NCT01204697|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25621832|NCT01204697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621833|NCT01204697|Tubulin Modulators|tubulin modulators|mesh-ancestor
25621834|NCT01204697|Antimitotic Agents|antimitotic agents|mesh-ancestor
25621835|NCT01204697|Mitosis Modulators|mitosis modulators|mesh-ancestor
25621836|NCT01204697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621837|NCT01204697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25621838|NCT01204697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24662760|NCT01296555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25621839|NCT01204710|Prednisone|prednisone|mesh-list
25621840|NCT01204710|Mitoxantrone|mitoxantrone|mesh-list
25621841|NCT01204710|Olaratumab|olaratumab|mesh-list
25621842|NCT01204710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25621843|NCT01204710|Glucocorticoids|glucocorticoids|mesh-ancestor
25621844|NCT01204710|Hormones|hormones|mesh-ancestor
25621845|NCT01204710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25621846|NCT01204710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621847|NCT01204710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25621848|NCT01204710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621849|NCT01204710|Analgesics|analgesics|mesh-ancestor
25621850|NCT01204710|Sensory System Agents|sensory system agents|mesh-ancestor
25621851|NCT01204710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25621852|NCT01204710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25621853|NCT01204710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25621854|NCT01204710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621855|NCT01204710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621856|NCT01204775|Metformin|metformin|mesh-list
25621857|NCT01204775|Saxagliptin|saxagliptin|mesh-list
25621858|NCT01204775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25621859|NCT01204775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621860|NCT01204775|Incretins|incretins|mesh-ancestor
25621861|NCT01204775|Hormones|hormones|mesh-ancestor
25621862|NCT01204775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24664249|NCT01305707|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24664250|NCT01305707|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24664251|NCT01305733|Ketorolac|ketorolac|mesh-list
24664252|NCT01305733|Epinephrine|epinephrine|mesh-list
24664276|NCT01305733|Autonomic Agents|autonomic agents|mesh-ancestor
24664277|NCT01305733|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25621863|NCT01204775|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25621864|NCT01204775|Protease Inhibitors|protease inhibitors|mesh-ancestor
25621865|NCT01204775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621866|NCT01204775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621867|NCT01204853|Sitaxsentan|sitaxsentan|mesh-list
25621868|NCT01204853|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25621869|NCT01204853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621870|NCT01204905|Raltegravir Potassium|raltegravir potassium|mesh-list
25621871|NCT01204905|Maraviroc|maraviroc|mesh-list
25621872|NCT01204905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25621873|NCT01204905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25621875|NCT01204905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25621876|NCT01204905|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25621877|NCT01204905|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25621878|NCT01204905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621879|NCT01204905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621880|NCT01204905|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25621881|NCT01204905|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25621882|NCT01204905|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25621883|NCT01204918|Riluzole|riluzole|mesh-list
25621884|NCT01204918|Anticonvulsants|anticonvulsants|mesh-ancestor
25621885|NCT01204918|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25621886|NCT01204918|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25621887|NCT01204918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25621888|NCT01204918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621889|NCT01204918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621890|NCT01204918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25621891|NCT01204918|Protective Agents|protective agents|mesh-ancestor
25621892|NCT01205035|Ranibizumab|ranibizumab|mesh-list
25621893|NCT01205035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25621894|NCT01205035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25621895|NCT01205035|Growth Substances|growth substances|mesh-ancestor
25621896|NCT01205035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621897|NCT01205035|Growth Inhibitors|growth inhibitors|mesh-ancestor
25621898|NCT01205035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621899|NCT01205126|Oxycodone|oxycodone|mesh-list
25621900|NCT01205126|Hydromorphone|hydromorphone|mesh-list
25621901|NCT01205126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25621902|NCT01205126|Narcotics|narcotics|mesh-ancestor
25621903|NCT01205126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25621904|NCT01205126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621905|NCT01205126|Analgesics|analgesics|mesh-ancestor
25621906|NCT01205126|Sensory System Agents|sensory system agents|mesh-ancestor
25621907|NCT01205126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25621908|NCT01205451|Botulinum Toxins|botulinum toxins|mesh-list
25621909|NCT01205451|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25621910|NCT01205451|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25621911|NCT01205451|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24665555|NCT01313390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621912|NCT01205451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25621913|NCT01205451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621914|NCT01205451|Cholinergic Agents|cholinergic agents|mesh-ancestor
25621915|NCT01205451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25621916|NCT01205451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621917|NCT01205451|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25621918|NCT01205451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25621919|NCT01205503|Cyclophosphamide|cyclophosphamide|mesh-list
25621920|NCT01205503|Doxorubicin|doxorubicin|mesh-list
25621921|NCT01205503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25621922|NCT01205503|Immunologic Factors|immunologic factors|mesh-ancestor
25621923|NCT01205503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621924|NCT01205503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25621925|NCT01205503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25621926|NCT01205503|Alkylating Agents|alkylating agents|mesh-ancestor
25621927|NCT01205503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621928|NCT01205503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621929|NCT01205503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25621930|NCT01205503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25621931|NCT01205503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25621932|NCT01205503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25621933|NCT01205503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621934|NCT01205529|Procainamide|procainamide|mesh-list
25621935|NCT01205529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25621936|NCT01205529|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25621937|NCT01205529|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25621938|NCT01205529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25621939|NCT01205529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621940|NCT01205581|Vaccines|vaccines|mesh-list
25621941|NCT01205581|Immunologic Factors|immunologic factors|mesh-ancestor
25621942|NCT01205581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621943|NCT01205646|Zoledronic Acid|zoledronic acid|mesh-list
25621944|NCT01205646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25621945|NCT01205646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516477|NCT00428441|Warfarin|warfarin|mesh-list
25621946|NCT01205685|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25621947|NCT01205685|Letrozole|letrozole|mesh-list
25621948|NCT01205685|Goserelin|goserelin|mesh-list
25621949|NCT01205685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621950|NCT01205685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25621951|NCT01205685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621952|NCT01205685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621953|NCT01205685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25621954|NCT01205685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25621955|NCT01205685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25621956|NCT01205685|Hormone Antagonists|hormone antagonists|mesh-ancestor
25621957|NCT01205685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25621958|NCT01205685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533634|NCT00644696|Irinotecan|irinotecan|mesh-list
24533635|NCT00644696|Bortezomib|bortezomib|mesh-list
24533824|NCT00645242|Hormone Antagonists|hormone antagonists|mesh-ancestor
25621959|NCT01205685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25621960|NCT01205828|Temozolomide|temozolomide|mesh-list
25621961|NCT01205828|Veliparib|veliparib|mesh-list
25621962|NCT01205828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25621963|NCT01205828|Alkylating Agents|alkylating agents|mesh-ancestor
25621964|NCT01205828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25621965|NCT01205828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621966|NCT01205828|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25621967|NCT01205828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25621968|NCT01206140|Sirolimus|sirolimus|mesh-list
25621969|NCT01206140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25621970|NCT01206140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25621971|NCT01206140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25621972|NCT01206140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621973|NCT01206140|Antifungal Agents|antifungal agents|mesh-ancestor
25621974|NCT01206140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25621975|NCT01206140|Immunologic Factors|immunologic factors|mesh-ancestor
25621976|NCT01206140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621977|NCT01206322|Insulin|insulin|mesh-list
25621978|NCT01206322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25621979|NCT01206322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621980|NCT01206387|Desoximetasone|desoximetasone|mesh-list
25621981|NCT01206387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25621982|NCT01206387|Glucocorticoids|glucocorticoids|mesh-ancestor
25621983|NCT01206387|Hormones|hormones|mesh-ancestor
25621984|NCT01206387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25621985|NCT01206387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621986|NCT01206452|Prednisone|prednisone|mesh-list
25621987|NCT01206452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25621988|NCT01206452|Glucocorticoids|glucocorticoids|mesh-ancestor
25621989|NCT01206452|Hormones|hormones|mesh-ancestor
25621990|NCT01206452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25621991|NCT01206452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25621992|NCT01206452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25621993|NCT01206452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621994|NCT01206465|Fluorouracil|fluorouracil|mesh-list
25621995|NCT01206465|Antimetabolites|antimetabolites|mesh-ancestor
25621996|NCT01206465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715323|NCT02370615|Digoxin|digoxin|mesh-list
25621997|NCT01206465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25621998|NCT01206465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25621999|NCT01206465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25622000|NCT01206465|Immunologic Factors|immunologic factors|mesh-ancestor
25622001|NCT01206465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622002|NCT01206478|Megestrol|megestrol|mesh-list
25622003|NCT01206478|Amitriptyline|amitriptyline|mesh-list
25622004|NCT01206478|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25622005|NCT01206478|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25622006|NCT01206478|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25622007|NCT01206478|Contraceptive Agents|contraceptive agents|mesh-ancestor
25622008|NCT01206478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25622009|NCT01206478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622010|NCT01206478|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25622011|NCT01206478|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25622012|NCT01206478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25622013|NCT01206478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622014|NCT01206478|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25622015|NCT01206478|Antidepressive Agents|antidepressive agents|mesh-ancestor
25622016|NCT01206478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25622017|NCT01206478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25622018|NCT01206478|Analgesics|analgesics|mesh-ancestor
25622019|NCT01206478|Sensory System Agents|sensory system agents|mesh-ancestor
25622020|NCT01206478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25622021|NCT01206478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25622022|NCT01206478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25622023|NCT01206478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25622024|NCT01206478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622025|NCT01206478|Adrenergic Agents|adrenergic agents|mesh-ancestor
25622026|NCT01206478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25622027|NCT01206595|Bupivacaine|bupivacaine|mesh-list
25622028|NCT01206595|Anesthetics, Local|anesthetics, local|mesh-ancestor
25622029|NCT01206595|Anesthetics|anesthetics|mesh-ancestor
25622030|NCT01206595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25622031|NCT01206595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622032|NCT01206595|Sensory System Agents|sensory system agents|mesh-ancestor
25622033|NCT01206595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25622034|NCT01206608|Bupivacaine|bupivacaine|mesh-list
25622035|NCT01206608|Anesthetics, Local|anesthetics, local|mesh-ancestor
25622036|NCT01206608|Anesthetics|anesthetics|mesh-ancestor
25622037|NCT01206608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25622038|NCT01206608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715336|NCT02370615|GABA Modulators|gaba modulators|mesh-ancestor
25622039|NCT01206608|Sensory System Agents|sensory system agents|mesh-ancestor
25622040|NCT01206608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25622041|NCT01206660|Desoximetasone|desoximetasone|mesh-list
25622042|NCT01206660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25622043|NCT01206660|Glucocorticoids|glucocorticoids|mesh-ancestor
25622044|NCT01206660|Hormones|hormones|mesh-ancestor
25622045|NCT01206660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25622046|NCT01206660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622047|NCT01206764|Everolimus|everolimus|mesh-list
25622048|NCT01206764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622049|NCT01206764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25622050|NCT01206764|Immunologic Factors|immunologic factors|mesh-ancestor
25622051|NCT01206764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622052|NCT01206777|Rituximab|rituximab|mesh-list
25622053|NCT01206777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25622054|NCT01206777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622055|NCT01206777|Immunologic Factors|immunologic factors|mesh-ancestor
25622056|NCT01206777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622057|NCT01206777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25622058|NCT01206816|Afatinib|afatinib|mesh-list
25622059|NCT01206816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622060|NCT01206816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25622061|NCT01206816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25622062|NCT01206816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622063|NCT01207388|Blinatumomab|blinatumomab|mesh-list
25622064|NCT01207388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622065|NCT01207401|Lidocaine|lidocaine|mesh-list
25622066|NCT01207401|Anesthetics, Local|anesthetics, local|mesh-ancestor
25622067|NCT01207401|Anesthetics|anesthetics|mesh-ancestor
25622068|NCT01207401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25622069|NCT01207401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622070|NCT01207401|Sensory System Agents|sensory system agents|mesh-ancestor
25622071|NCT01207401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25622072|NCT01207401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25622073|NCT01207401|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25622074|NCT01207401|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24535442|NCT00649155|Ciprofloxacin|ciprofloxacin|mesh-list
25622075|NCT01207401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25622076|NCT01207401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622077|NCT01207414|Iloperidone|iloperidone|mesh-list
25622078|NCT01207414|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25622079|NCT01207414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25622080|NCT01207414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25622081|NCT01207414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622082|NCT01207414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25622083|NCT01207440|Ponatinib|ponatinib|mesh-list
25622084|NCT01207440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622085|NCT01207440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25622086|NCT01207440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25622087|NCT01207440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622088|NCT01207453|Milnacipran|milnacipran|mesh-list
25622089|NCT01207453|Levomilnacipran|levomilnacipran|mesh-list
25622090|NCT01207453|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25622091|NCT01207453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25622092|NCT01207453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25622093|NCT01207453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622094|NCT01207453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25622095|NCT01207453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622096|NCT01207453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25622097|NCT01207453|Analgesics|analgesics|mesh-ancestor
25622098|NCT01207453|Sensory System Agents|sensory system agents|mesh-ancestor
25622099|NCT01207453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25622100|NCT01207453|Antidepressive Agents|antidepressive agents|mesh-ancestor
25622101|NCT01207453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25622102|NCT01207596|Hydromorphone|hydromorphone|mesh-list
25622103|NCT01207596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25622104|NCT01207596|Narcotics|narcotics|mesh-ancestor
25622105|NCT01207596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25622106|NCT01207596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622107|NCT01207596|Analgesics|analgesics|mesh-ancestor
25622108|NCT01207596|Sensory System Agents|sensory system agents|mesh-ancestor
25622109|NCT01207596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25622110|NCT01207687|Bevacizumab|bevacizumab|mesh-list
25622111|NCT01207687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25622112|NCT01207687|Antibodies|antibodies|mesh-list
25622113|NCT01207687|Immunoglobulins|immunoglobulins|mesh-list
25622114|NCT01207687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25622115|NCT01207687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622116|NCT01207687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25622117|NCT01207687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25622118|NCT01207687|Growth Substances|growth substances|mesh-ancestor
25622119|NCT01207687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622120|NCT01207687|Growth Inhibitors|growth inhibitors|mesh-ancestor
25622121|NCT01207687|Immunologic Factors|immunologic factors|mesh-ancestor
25622122|NCT01207752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25622123|NCT01207752|Lubricant Eye Drops|lubricant eye drops|mesh-list
25622124|NCT01207752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25622125|NCT01207765|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25622126|NCT01207765|Immunologic Factors|immunologic factors|mesh-ancestor
25622127|NCT01207765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622128|NCT01207908|Mecasermin|mecasermin|mesh-list
25622129|NCT01207908|Growth Substances|growth substances|mesh-ancestor
25622130|NCT01207908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622131|NCT01208038|Methyltestosterone|methyltestosterone|mesh-list
25622132|NCT01208038|Testosterone|testosterone|mesh-list
25622133|NCT01208038|Testosterone undecanoate|testosterone undecanoate|mesh-list
25622134|NCT01208038|Testosterone enanthate|testosterone enanthate|mesh-list
25622135|NCT01208038|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25622136|NCT01208038|Androgens|androgens|mesh-ancestor
25622137|NCT01208038|Hormones|hormones|mesh-ancestor
25622138|NCT01208038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25622139|NCT01208038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622140|NCT01208038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25622141|NCT01208038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622142|NCT01208038|Anabolic Agents|anabolic agents|mesh-ancestor
25622143|NCT01208051|Lenalidomide|lenalidomide|mesh-list
25622144|NCT01208051|Cediranib|cediranib|mesh-list
25622145|NCT01208051|Maleic acid|maleic acid|mesh-list
25622146|NCT01208051|Immunologic Factors|immunologic factors|mesh-ancestor
25622147|NCT01208051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622148|NCT01208051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25622149|NCT01208051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25622150|NCT01208051|Growth Substances|growth substances|mesh-ancestor
25622151|NCT01208051|Growth Inhibitors|growth inhibitors|mesh-ancestor
25622152|NCT01208051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622153|NCT01208051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25622154|NCT01208051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622155|NCT01208051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25622156|NCT01208103|Bevacizumab|bevacizumab|mesh-list
25622157|NCT01208103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25622158|NCT01208103|Capecitabine|capecitabine|mesh-list
25622159|NCT01208103|Oxaliplatin|oxaliplatin|mesh-list
24536128|NCT00650390|Adalimumab|adalimumab|mesh-list
25622160|NCT01208103|Endothelial Growth Factors|endothelial growth factors|mesh-list
25622161|NCT01208103|Antibodies|antibodies|mesh-list
25622162|NCT01208103|Immunoglobulins|immunoglobulins|mesh-list
25622163|NCT01208103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25622164|NCT01208103|Immunoglobulin G|immunoglobulin g|mesh-list
25622165|NCT01208103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622166|NCT01208103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25622167|NCT01208103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25622168|NCT01208103|Growth Substances|growth substances|mesh-ancestor
25622169|NCT01208103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622170|NCT01208103|Growth Inhibitors|growth inhibitors|mesh-ancestor
25622171|NCT01208103|Immunologic Factors|immunologic factors|mesh-ancestor
25622172|NCT01208103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25622173|NCT01208103|Antimetabolites|antimetabolites|mesh-ancestor
25622174|NCT01208103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622175|NCT01208233|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1h)-one|mesh-list
25622176|NCT01208233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25622177|NCT01208233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25622178|NCT01208233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25622179|NCT01208233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622180|NCT01208324|Estrogens|estrogens|mesh-list
25622181|NCT01208324|Hormones|hormones|mesh-ancestor
25622182|NCT01208324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25622183|NCT01208324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622184|NCT01208337|Alemtuzumab|alemtuzumab|mesh-list
25622185|NCT01208337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25622186|NCT01208337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622187|NCT01208402|Esmolol|esmolol|mesh-list
25622188|NCT01208402|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25622189|NCT01208402|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25622190|NCT01208402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25622191|NCT01208402|Adrenergic Agents|adrenergic agents|mesh-ancestor
25622192|NCT01208402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25622193|NCT01208402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622194|NCT01208402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622195|NCT01208922|Ciprofloxacin|ciprofloxacin|mesh-list
25622196|NCT01208922|Rifamycins|rifamycins|mesh-list
25622197|NCT01208922|Rifamycin SV|rifamycin sv|mesh-list
25622198|NCT01208922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25622199|NCT01208922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25622200|NCT01208922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25622201|NCT01208922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25622202|NCT01208922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25622203|NCT01208922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622204|NCT01208922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622205|NCT01208922|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25622206|NCT01208922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25622207|NCT01208922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25622208|NCT01209078|Linezolid|linezolid|mesh-list
25622209|NCT01209078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25622210|NCT01209078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25622211|NCT01209078|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25622212|NCT01209078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536390|NCT00651066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25622213|NCT01209078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622214|NCT01209143|Rosiglitazone|rosiglitazone|mesh-list
25622215|NCT01209143|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25622216|NCT01209143|Norethindrone|norethindrone|mesh-list
25622217|NCT01209143|Norethindrone Acetate|norethindrone acetate|mesh-list
25622218|NCT01209143|Estradiol|estradiol|mesh-list
25622219|NCT01209143|Estrogens|estrogens|mesh-ancestor
25622220|NCT01209143|Hormones|hormones|mesh-ancestor
25622221|NCT01209143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25622222|NCT01209143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622223|NCT01209143|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25622224|NCT01209143|Contraceptive Agents|contraceptive agents|mesh-ancestor
25622225|NCT01209143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25622226|NCT01209143|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25622227|NCT01209143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25622228|NCT01209143|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25622229|NCT01209143|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25622230|NCT01209143|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25622231|NCT01209195|Paclitaxel|paclitaxel|mesh-list
25622232|NCT01209195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25622233|NCT01209195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622234|NCT01209195|Tubulin Modulators|tubulin modulators|mesh-ancestor
25622235|NCT01209195|Antimitotic Agents|antimitotic agents|mesh-ancestor
25622236|NCT01209195|Mitosis Modulators|mitosis modulators|mesh-ancestor
25516747|NCT00429949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25516748|NCT00429949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516749|NCT00429949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516750|NCT00430183|Docetaxel|docetaxel|mesh-list
25516751|NCT00430183|Leuprolide|leuprolide|mesh-list
25622237|NCT01209195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622238|NCT01209286|Blinatumomab|blinatumomab|mesh-list
25622239|NCT01209286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25655385|NCT01562132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25655386|NCT01562132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655387|NCT01562132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655388|NCT01562132|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25655389|NCT01562132|Hormone Antagonists|hormone antagonists|mesh-ancestor
25655390|NCT01562132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25655391|NCT01562132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655392|NCT01562132|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25655393|NCT01562132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25655394|NCT01562132|Antimetabolites|antimetabolites|mesh-ancestor
25655395|NCT01562314|Cannabidiol|cannabidiol|mesh-list
25655396|NCT01562314|Anticonvulsants|anticonvulsants|mesh-ancestor
25655397|NCT01562548|Phenylpropanolamine|phenylpropanolamine|mesh-list
25655398|NCT01562548|Guaifenesin|guaifenesin|mesh-list
25655399|NCT01562548|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
25655400|NCT01562548|Expectorants|expectorants|mesh-ancestor
25655401|NCT01562548|Respiratory System Agents|respiratory system agents|mesh-ancestor
25655402|NCT01562548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25655403|NCT01562548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25655404|NCT01562548|Adrenergic Agents|adrenergic agents|mesh-ancestor
25655405|NCT01562548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25655406|NCT01562548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655407|NCT01562548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655408|NCT01562548|Appetite Depressants|appetite depressants|mesh-ancestor
25655409|NCT01562548|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25655410|NCT01562548|Sympathomimetics|sympathomimetics|mesh-ancestor
25655411|NCT01562548|Autonomic Agents|autonomic agents|mesh-ancestor
25655412|NCT01562548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25655413|NCT01562548|Nasal Decongestants|nasal decongestants|mesh-ancestor
25655414|NCT01562548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25655415|NCT01562678|Liraglutide|liraglutide|mesh-list
25655416|NCT01562678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25655417|NCT01562678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655418|NCT01562678|Incretins|incretins|mesh-ancestor
25655419|NCT01562678|Hormones|hormones|mesh-ancestor
25655420|NCT01562678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25655421|NCT01562743|Rotigotine|rotigotine|mesh-list
25655422|NCT01562743|Dopamine Agonists|dopamine agonists|mesh-ancestor
25655423|NCT01562743|Dopamine Agents|dopamine agents|mesh-ancestor
25655424|NCT01562743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25655425|NCT01562743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655426|NCT01562743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655427|NCT01562886|Rilpivirine|rilpivirine|mesh-list
25655428|NCT01562886|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25655429|NCT01562886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25655430|NCT01562886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655431|NCT01562886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655432|NCT01562886|Antiviral Agents|antiviral agents|mesh-ancestor
25655433|NCT01562886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25655434|NCT01562886|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25655435|NCT01562886|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25655436|NCT01563029|Fluticasone|fluticasone|mesh-list
25655437|NCT01563029|Xhance|xhance|mesh-list
25655438|NCT01563029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25655439|NCT01563029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25655440|NCT01563029|Autonomic Agents|autonomic agents|mesh-ancestor
25655441|NCT01563029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25655442|NCT01563029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655443|NCT01563029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25655444|NCT01563029|Respiratory System Agents|respiratory system agents|mesh-ancestor
25655445|NCT01563029|Dermatologic Agents|dermatologic agents|mesh-ancestor
25655446|NCT01563029|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25655447|NCT01563055|Ofatumumab|ofatumumab|mesh-list
25655448|NCT01563055|Chlorambucil|chlorambucil|mesh-list
25655449|NCT01563055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25655450|NCT01563055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25655451|NCT01563055|Alkylating Agents|alkylating agents|mesh-ancestor
25655452|NCT01563055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655453|NCT01563081|Cetirizine|cetirizine|mesh-list
25655454|NCT01563081|Levocetirizine|levocetirizine|mesh-list
25655455|NCT01563081|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25622240|NCT01209442|Bevacizumab|bevacizumab|mesh-list
25622241|NCT01209442|Temozolomide|temozolomide|mesh-list
25622242|NCT01209442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25622243|NCT01209442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622244|NCT01209442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25622245|NCT01209442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25622246|NCT01209442|Growth Substances|growth substances|mesh-ancestor
25622247|NCT01209442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622248|NCT01209442|Growth Inhibitors|growth inhibitors|mesh-ancestor
25622249|NCT01209442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25622250|NCT01209442|Alkylating Agents|alkylating agents|mesh-ancestor
25622251|NCT01209442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622252|NCT01209598|Palbociclib|palbociclib|mesh-list
25622253|NCT01209598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622254|NCT01209598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25622255|NCT01209598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25622256|NCT01209598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622257|NCT01209832|Midazolam|midazolam|mesh-list
25622258|NCT01209832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25622259|NCT01209832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25622260|NCT01209832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25622261|NCT01209832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622262|NCT01209832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25622263|NCT01209832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25622264|NCT01209832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25622265|NCT01209832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25622266|NCT01209832|Anesthetics, General|anesthetics, general|mesh-ancestor
25622267|NCT01209832|Anesthetics|anesthetics|mesh-ancestor
25622268|NCT01209832|GABA Modulators|gaba modulators|mesh-ancestor
25622269|NCT01209832|GABA Agents|gaba agents|mesh-ancestor
25622270|NCT01209832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25622271|NCT01209832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622272|NCT01210001|Empagliflozin|empagliflozin|mesh-list
25622273|NCT01210001|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25622274|NCT01210001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622275|NCT01210001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25622276|NCT01210001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622277|NCT01210079|Gabapentin|gabapentin|mesh-list
25622278|NCT01210079|Analgesics|analgesics|mesh-ancestor
25622279|NCT01210079|Sensory System Agents|sensory system agents|mesh-ancestor
25622280|NCT01210079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25622281|NCT01210079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622282|NCT01210079|Anticonvulsants|anticonvulsants|mesh-ancestor
24537237|NCT00654056|Insulin|insulin|mesh-list
25622283|NCT01210079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25622284|NCT01210079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25622285|NCT01210079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25622286|NCT01210079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25622287|NCT01210079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25622288|NCT01210079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25622289|NCT01210079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25622290|NCT01210079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622291|NCT01210079|Antimanic Agents|antimanic agents|mesh-ancestor
25622292|NCT01210144|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25622293|NCT01210144|Hormones|hormones|mesh-list
25622294|NCT01210144|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25622295|NCT01210144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25622296|NCT01210144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622297|NCT01210144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25622298|NCT01210170|Mometasone Furoate|mometasone furoate|mesh-list
25622299|NCT01210170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25622300|NCT01210170|Dermatologic Agents|dermatologic agents|mesh-ancestor
25622301|NCT01210170|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25622302|NCT01210222|Trebananib|trebananib|mesh-list
25622303|NCT01210222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25622304|NCT01210222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25622305|NCT01210222|Growth Substances|growth substances|mesh-ancestor
25622306|NCT01210222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622307|NCT01210222|Growth Inhibitors|growth inhibitors|mesh-ancestor
25622308|NCT01210222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622309|NCT01210352|Oxymorphone|oxymorphone|mesh-list
25622310|NCT01210352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25622311|NCT01210352|Narcotics|narcotics|mesh-ancestor
25622312|NCT01210352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25622313|NCT01210352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622314|NCT01210352|Analgesics|analgesics|mesh-ancestor
25622315|NCT01210352|Sensory System Agents|sensory system agents|mesh-ancestor
25622316|NCT01210352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25622317|NCT01210352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25622318|NCT01210443|Sitaxsentan|sitaxsentan|mesh-list
25622319|NCT01210443|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25622320|NCT01210443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622321|NCT01210495|Axitinib|axitinib|mesh-list
25622322|NCT01210495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622323|NCT01210495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25622324|NCT01210495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25622325|NCT01210495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622326|NCT01210560|Tolvaptan|tolvaptan|mesh-list
25622327|NCT01210560|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25622328|NCT01210560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622329|NCT01210560|Natriuretic Agents|natriuretic agents|mesh-ancestor
25622330|NCT01210560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622331|NCT01211145|Oxazolidinones|oxazolidinones|mesh-list
25622332|NCT01211145|Zolmitriptan|zolmitriptan|mesh-list
25622333|NCT01211145|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25622334|NCT01211145|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24451252|NCT00322907|Mefloquine|mefloquine|mesh-list
25622335|NCT01211145|Serotonin Agents|serotonin agents|mesh-ancestor
25622336|NCT01211145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25622337|NCT01211145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622338|NCT01211145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622339|NCT01211145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25622340|NCT01211145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25622341|NCT01211145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25622342|NCT01211197|Metformin|metformin|mesh-list
25622343|NCT01211197|Empagliflozin|empagliflozin|mesh-list
25622344|NCT01211197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25622345|NCT01211197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622346|NCT01211197|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25622347|NCT01211197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622348|NCT01211483|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25622349|NCT01211483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622350|NCT01211483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25622351|NCT01211483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25622352|NCT01211483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622353|NCT01211522|Haloperidol|haloperidol|mesh-list
25622354|NCT01211522|Haloperidol decanoate|haloperidol decanoate|mesh-list
25516956|NCT00432172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25516957|NCT00432172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25516958|NCT00432172|Hormone Antagonists|hormone antagonists|mesh-ancestor
25516959|NCT00432172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25516960|NCT00432172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25516961|NCT00432276|Metformin|metformin|mesh-list
25516962|NCT00432276|Pioglitazone|pioglitazone|mesh-list
25516963|NCT00432276|Alogliptin|alogliptin|mesh-list
25516964|NCT00432276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25516965|NCT00432276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516966|NCT00432276|Incretins|incretins|mesh-ancestor
25516967|NCT00432276|Hormones|hormones|mesh-ancestor
25516968|NCT00432276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25516969|NCT00432276|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25516970|NCT00432276|Protease Inhibitors|protease inhibitors|mesh-ancestor
25516971|NCT00432276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516985|NCT00432458|Thalidomide|thalidomide|mesh-list
25622355|NCT01211522|Ziprasidone|ziprasidone|mesh-list
25622356|NCT01211522|Antiemetics|antiemetics|mesh-ancestor
25622357|NCT01211522|Autonomic Agents|autonomic agents|mesh-ancestor
25622358|NCT01211522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25622359|NCT01211522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622360|NCT01211522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25622361|NCT01211522|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25622362|NCT01211522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25622363|NCT01211522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25622364|NCT01211522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24538534|NCT00659750|Ciclesonide|ciclesonide|mesh-list
25622365|NCT01211522|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25622366|NCT01211522|Dopamine Agents|dopamine agents|mesh-ancestor
25622367|NCT01211522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25622368|NCT01211522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622369|NCT01211522|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25622370|NCT01211522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25622372|NCT01211535|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25622373|NCT01211665|Methylprednisolone|methylprednisolone|mesh-list
25622374|NCT01211665|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25622375|NCT01211665|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25622376|NCT01211665|Prednisolone|prednisolone|mesh-list
25622377|NCT01211665|Prednisolone acetate|prednisolone acetate|mesh-list
25622378|NCT01211665|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25622379|NCT01211665|Prednisolone phosphate|prednisolone phosphate|mesh-list
25622380|NCT01211665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25622381|NCT01211665|Antiemetics|antiemetics|mesh-ancestor
25622382|NCT01211665|Autonomic Agents|autonomic agents|mesh-ancestor
25622383|NCT01211665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25622384|NCT01211665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622385|NCT01211665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25622386|NCT01211665|Glucocorticoids|glucocorticoids|mesh-ancestor
25622387|NCT01211665|Hormones|hormones|mesh-ancestor
25622388|NCT01211665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25622389|NCT01211665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25622390|NCT01211665|Protective Agents|protective agents|mesh-ancestor
25622391|NCT01211665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25622392|NCT01211665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622393|NCT01211730|Insulin|insulin|mesh-list
25622394|NCT01211730|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25622395|NCT01211730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25622396|NCT01211730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622397|NCT01211769|Naltrexone|naltrexone|mesh-list
25622398|NCT01211769|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25622399|NCT01211769|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25622400|NCT01211769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622401|NCT01211769|Sensory System Agents|sensory system agents|mesh-ancestor
25622402|NCT01211769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25622403|NCT01211873|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
25622404|NCT01211873|Chelating Agents|chelating agents|mesh-ancestor
25622405|NCT01211873|Sequestering Agents|sequestering agents|mesh-ancestor
25622406|NCT01211873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622407|NCT01212094|Rituximab|rituximab|mesh-list
25622408|NCT01212094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25622409|NCT01212094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622410|NCT01212094|Immunologic Factors|immunologic factors|mesh-ancestor
25622411|NCT01212094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622412|NCT01212094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25622413|NCT01212185|Oxytocin|oxytocin|mesh-list
25622414|NCT01212185|Oxytocics|oxytocics|mesh-ancestor
25622415|NCT01212185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25622416|NCT01212185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622417|NCT01212302|Aspirin|aspirin|mesh-list
25622418|NCT01212302|Clopidogrel|clopidogrel|mesh-list
25622419|NCT01212302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25622420|NCT01212302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25622421|NCT01212302|Analgesics|analgesics|mesh-ancestor
25622422|NCT01212302|Sensory System Agents|sensory system agents|mesh-ancestor
25622423|NCT01212302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25622424|NCT01212302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622425|NCT01212302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25622426|NCT01212302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25622427|NCT01212302|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25622428|NCT01212302|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25622429|NCT01212302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622430|NCT01212302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25622431|NCT01212302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25622432|NCT01212302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25622433|NCT01212302|Antipyretics|antipyretics|mesh-ancestor
25622434|NCT01212302|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25622435|NCT01212302|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25622436|NCT01212302|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25622437|NCT01212302|Purinergic Agents|purinergic agents|mesh-ancestor
25622438|NCT01212302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25622439|NCT01212445|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25622440|NCT01212445|Laxatives|laxatives|mesh-list
25622441|NCT01212445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25622442|NCT01212471|Bromfenac|bromfenac|mesh-list
25622443|NCT01212471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25622444|NCT01212471|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25622445|NCT01212471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25622446|NCT01212471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25622447|NCT01212471|Analgesics|analgesics|mesh-ancestor
25622448|NCT01212471|Sensory System Agents|sensory system agents|mesh-ancestor
25622449|NCT01212471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25622450|NCT01212471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622451|NCT01212471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25622452|NCT01212471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25622453|NCT01212484|Carbidopa|carbidopa|mesh-list
25622454|NCT01212484|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25622455|NCT01212484|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25622456|NCT01212484|Dopamine Agents|dopamine agents|mesh-ancestor
25622457|NCT01212484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25622458|NCT01212484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622459|NCT01212484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622460|NCT01212484|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25622461|NCT01212484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25622462|NCT01212588|Mifepristone|mifepristone|mesh-list
25622463|NCT01212588|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25622464|NCT01212588|Abortifacient Agents|abortifacient agents|mesh-ancestor
25622465|NCT01212588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25622466|NCT01212588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622467|NCT01212588|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25622468|NCT01212588|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25622469|NCT01212588|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25622470|NCT01212588|Contraceptive Agents|contraceptive agents|mesh-ancestor
25622471|NCT01212588|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25622472|NCT01212588|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25622473|NCT01212588|Hormone Antagonists|hormone antagonists|mesh-ancestor
25622474|NCT01212588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25622475|NCT01212588|Luteolytic Agents|luteolytic agents|mesh-ancestor
25622476|NCT01212588|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25622477|NCT01212588|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25622478|NCT01212757|Thalidomide|thalidomide|mesh-list
25622479|NCT01212757|Apremilast|apremilast|mesh-list
25622480|NCT01212757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25622481|NCT01212757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25622482|NCT01212757|Analgesics|analgesics|mesh-ancestor
25622483|NCT01212757|Sensory System Agents|sensory system agents|mesh-ancestor
25622484|NCT01212757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25622485|NCT01212757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622486|NCT01212757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25622487|NCT01212757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25622488|NCT01212757|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25622489|NCT01212757|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25622490|NCT01212757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25622491|NCT01212757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622492|NCT01212757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25622493|NCT01212757|Immunologic Factors|immunologic factors|mesh-ancestor
25622494|NCT01212757|Leprostatic Agents|leprostatic agents|mesh-ancestor
25622495|NCT01212757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25622496|NCT01212757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25622497|NCT01212757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25622498|NCT01212757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25622499|NCT01212757|Growth Substances|growth substances|mesh-ancestor
25622500|NCT01212757|Growth Inhibitors|growth inhibitors|mesh-ancestor
25622501|NCT01212757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622502|NCT01212770|Thalidomide|thalidomide|mesh-list
25622503|NCT01212770|Apremilast|apremilast|mesh-list
25622504|NCT01212770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25622505|NCT01212770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25622506|NCT01212770|Analgesics|analgesics|mesh-ancestor
25622507|NCT01212770|Sensory System Agents|sensory system agents|mesh-ancestor
25622508|NCT01212770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25622509|NCT01212770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622510|NCT01212770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25622511|NCT01212770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25622512|NCT01212770|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25622513|NCT01212770|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25622514|NCT01212770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25622515|NCT01212770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622516|NCT01212770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25622517|NCT01212770|Immunologic Factors|immunologic factors|mesh-ancestor
25622518|NCT01212770|Leprostatic Agents|leprostatic agents|mesh-ancestor
25622519|NCT01212770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25622520|NCT01212770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25622521|NCT01212770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25622522|NCT01212770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25622523|NCT01212770|Growth Substances|growth substances|mesh-ancestor
25622524|NCT01212770|Growth Inhibitors|growth inhibitors|mesh-ancestor
25622525|NCT01212770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622526|NCT01212874|Nitroglycerin|nitroglycerin|mesh-list
25622527|NCT01212874|Esmolol|esmolol|mesh-list
25622528|NCT01212874|Vasodilator Agents|vasodilator agents|mesh-ancestor
25622529|NCT01212874|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25622530|NCT01212874|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25622531|NCT01212874|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25622532|NCT01212874|Adrenergic Agents|adrenergic agents|mesh-ancestor
25622533|NCT01212874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25622534|NCT01212874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622535|NCT01212874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622536|NCT01212900|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
25622537|NCT01212900|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25622538|NCT01212900|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25622539|NCT01212900|Antimetabolites|antimetabolites|mesh-ancestor
25622540|NCT01212900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622541|NCT01212900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25622542|NCT01212900|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25622543|NCT01212952|Dexamethasone|dexamethasone|mesh-list
25622544|NCT01212952|Bortezomib|bortezomib|mesh-list
25622545|NCT01212952|Pomalidomide|pomalidomide|mesh-list
25622546|NCT01212952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25622547|NCT01212952|Antiemetics|antiemetics|mesh-ancestor
25622548|NCT01212952|Autonomic Agents|autonomic agents|mesh-ancestor
25622549|NCT01212952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25622550|NCT01212952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622551|NCT01212952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25622552|NCT01212952|Glucocorticoids|glucocorticoids|mesh-ancestor
25622553|NCT01212952|Hormones|hormones|mesh-ancestor
25622554|NCT01212952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25622555|NCT01212952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25622556|NCT01212952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622557|NCT01212952|Immunologic Factors|immunologic factors|mesh-ancestor
25622558|NCT01212952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25622559|NCT01212952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25622560|NCT01212952|Growth Substances|growth substances|mesh-ancestor
25622561|NCT01212952|Growth Inhibitors|growth inhibitors|mesh-ancestor
25622562|NCT01213043|Protease Inhibitors|protease inhibitors|mesh-list
25622563|NCT01213043|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25622564|NCT01213043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25622565|NCT01213043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622566|NCT01213043|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25622567|NCT01213043|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25622568|NCT01213173|Metoprolol|metoprolol|mesh-list
25622569|NCT01213173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25622570|NCT01213173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25622571|NCT01213173|Sympatholytics|sympatholytics|mesh-ancestor
25622572|NCT01213173|Autonomic Agents|autonomic agents|mesh-ancestor
25622573|NCT01213173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25622574|NCT01213173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622575|NCT01213173|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25622576|NCT01213173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25622577|NCT01213173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25622578|NCT01213173|Adrenergic Agents|adrenergic agents|mesh-ancestor
25622579|NCT01213173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25622580|NCT01213173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622581|NCT01213199|Adapalene|adapalene|mesh-list
25622582|NCT01213199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25622583|NCT01213199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25622584|NCT01213199|Analgesics|analgesics|mesh-ancestor
25622585|NCT01213199|Sensory System Agents|sensory system agents|mesh-ancestor
25622586|NCT01213199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25622587|NCT01213199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622588|NCT01213199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25622589|NCT01213199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25622590|NCT01213199|Dermatologic Agents|dermatologic agents|mesh-ancestor
25517152|NCT00433836|Valsartan|valsartan|mesh-list
25622591|NCT01213264|Anesthetics|anesthetics|mesh-list
25622592|NCT01213264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25622593|NCT01213264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622594|NCT01213316|Raltegravir Potassium|raltegravir potassium|mesh-list
25622595|NCT01213316|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25622596|NCT01213316|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25622597|NCT01213316|Antiviral Agents|antiviral agents|mesh-ancestor
25715448|NCT02372253|Verapamil|verapamil|mesh-list
25622598|NCT01213316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25622599|NCT01213316|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25622600|NCT01213316|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25622601|NCT01213316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25622602|NCT01213316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622603|NCT01213524|Nicotine|nicotine|mesh-list
25622604|NCT01213524|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25622605|NCT01213524|Autonomic Agents|autonomic agents|mesh-ancestor
25622606|NCT01213524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25622607|NCT01213524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622608|NCT01213524|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25622609|NCT01213524|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25622610|NCT01213524|Cholinergic Agents|cholinergic agents|mesh-ancestor
25622611|NCT01213524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25622612|NCT01213524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622613|NCT01213576|Ivermectin|ivermectin|mesh-list
25622614|NCT01213576|Albendazole|albendazole|mesh-list
25622615|NCT01213576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25622616|NCT01213576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25622617|NCT01213576|Anthelmintics|anthelmintics|mesh-ancestor
25622618|NCT01213576|Anticestodal Agents|anticestodal agents|mesh-ancestor
25622619|NCT01213576|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25622620|NCT01213576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25622621|NCT01213576|Tubulin Modulators|tubulin modulators|mesh-ancestor
25622622|NCT01213576|Antimitotic Agents|antimitotic agents|mesh-ancestor
25622623|NCT01213576|Mitosis Modulators|mitosis modulators|mesh-ancestor
25622624|NCT01213576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622625|NCT01213576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622626|NCT01213836|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25622627|NCT01213836|Antidepressive Agents|antidepressive agents|mesh-ancestor
25622628|NCT01213836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25622629|NCT01213836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25622630|NCT01213836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25622631|NCT01213836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25622632|NCT01213836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622633|NCT01213966|Artefenomel|artefenomel|mesh-list
25622634|NCT01213966|Antimalarials|antimalarials|mesh-ancestor
25622635|NCT01213966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25622636|NCT01213966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25622637|NCT01213966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25622638|NCT01214044|Dexetimide|dexetimide|mesh-list
25622639|NCT01214044|Citalopram|citalopram|mesh-list
25622640|NCT01214044|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25622641|NCT01214044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25622642|NCT01214044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25622643|NCT01214044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622644|NCT01214044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25622645|NCT01214044|Serotonin Agents|serotonin agents|mesh-ancestor
25622646|NCT01214044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622647|NCT01214044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25622648|NCT01214044|Antidepressive Agents|antidepressive agents|mesh-ancestor
25622649|NCT01214044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25622650|NCT01214044|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25622651|NCT01214044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25622652|NCT01214044|Parasympatholytics|parasympatholytics|mesh-ancestor
25622653|NCT01214044|Autonomic Agents|autonomic agents|mesh-ancestor
25622654|NCT01214044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25622655|NCT01214044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25622656|NCT01214044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25622657|NCT01214044|Cholinergic Agents|cholinergic agents|mesh-ancestor
25622658|NCT01214057|Remifentanil|remifentanil|mesh-list
25622659|NCT01214057|Propofol|propofol|mesh-list
25622660|NCT01214057|Sevoflurane|sevoflurane|mesh-list
24539308|NCT00663221|Calcium|calcium|mesh-list
25622661|NCT01214057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25622662|NCT01214057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25622663|NCT01214057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622664|NCT01214057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25622665|NCT01214057|Anesthetics, General|anesthetics, general|mesh-ancestor
25622666|NCT01214057|Anesthetics|anesthetics|mesh-ancestor
25622667|NCT01214057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25622668|NCT01214057|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25622669|NCT01214057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25622670|NCT01214057|Narcotics|narcotics|mesh-ancestor
25622671|NCT01214057|Analgesics|analgesics|mesh-ancestor
25622672|NCT01214057|Sensory System Agents|sensory system agents|mesh-ancestor
25622673|NCT01214057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25622674|NCT01214083|Acetylcysteine|acetylcysteine|mesh-list
25622675|NCT01214083|Naltrexone|naltrexone|mesh-list
25622676|NCT01214083|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25622677|NCT01214083|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25622678|NCT01214083|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25622679|NCT01214083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622680|NCT01214083|Sensory System Agents|sensory system agents|mesh-ancestor
25622681|NCT01214083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25622682|NCT01214083|Antiviral Agents|antiviral agents|mesh-ancestor
25622683|NCT01214083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25622684|NCT01214083|Expectorants|expectorants|mesh-ancestor
25622685|NCT01214083|Respiratory System Agents|respiratory system agents|mesh-ancestor
25622686|NCT01214083|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25622687|NCT01214083|Antioxidants|antioxidants|mesh-ancestor
25622688|NCT01214083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622689|NCT01214083|Protective Agents|protective agents|mesh-ancestor
25622690|NCT01214083|Antidotes|antidotes|mesh-ancestor
25622691|NCT01214109|Pramipexole|pramipexole|mesh-list
25622692|NCT01214109|Antioxidants|antioxidants|mesh-ancestor
25622693|NCT01214109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622694|NCT01214109|Protective Agents|protective agents|mesh-ancestor
25622695|NCT01214109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622696|NCT01214109|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25622697|NCT01214109|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25622698|NCT01214109|Dopamine Agonists|dopamine agonists|mesh-ancestor
25622699|NCT01214109|Dopamine Agents|dopamine agents|mesh-ancestor
25622700|NCT01214109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25622701|NCT01214161|Lidocaine|lidocaine|mesh-list
25622702|NCT01214161|Anesthetics, Local|anesthetics, local|mesh-ancestor
25622703|NCT01214161|Anesthetics|anesthetics|mesh-ancestor
25622704|NCT01214161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25622705|NCT01214161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622706|NCT01214161|Sensory System Agents|sensory system agents|mesh-ancestor
25622707|NCT01214161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25622708|NCT01214161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25622709|NCT01214161|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25622710|NCT01214161|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25622711|NCT01214161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25622712|NCT01214161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622713|NCT01214187|Carbon Monoxide|carbon monoxide|mesh-list
25622714|NCT01214187|Antimetabolites|antimetabolites|mesh-ancestor
25622715|NCT01214187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622716|NCT01214187|Gasotransmitters|gasotransmitters|mesh-ancestor
25622717|NCT01214187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25622718|NCT01214187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622719|NCT01214239|Linagliptin|linagliptin|mesh-list
25622720|NCT01214239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25622721|NCT01214239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622722|NCT01214239|Incretins|incretins|mesh-ancestor
25622723|NCT01214239|Hormones|hormones|mesh-ancestor
25622724|NCT01214239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25622725|NCT01214239|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25622726|NCT01214239|Protease Inhibitors|protease inhibitors|mesh-ancestor
25622727|NCT01214239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25715471|NCT02372383|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25622728|NCT01214239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622729|NCT01214317|Mitoxantrone|mitoxantrone|mesh-list
25622730|NCT01214317|Analgesics|analgesics|mesh-ancestor
25622731|NCT01214317|Sensory System Agents|sensory system agents|mesh-ancestor
25622732|NCT01214317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25622733|NCT01214317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622734|NCT01214317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622735|NCT01214317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25622736|NCT01214317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25622737|NCT01214317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25622738|NCT01214317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622739|NCT01214356|Vitamin D|vitamin d|mesh-list
25622740|NCT01214356|Ergocalciferols|ergocalciferols|mesh-list
25622741|NCT01214356|Cholecalciferol|cholecalciferol|mesh-list
25622742|NCT01214356|Vitamins|vitamins|mesh-list
25517300|NCT00434993|Dimercaprol|dimercaprol|mesh-list
25622743|NCT01214356|Micronutrients|micronutrients|mesh-ancestor
25622744|NCT01214356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622745|NCT01214356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25622746|NCT01214356|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25622747|NCT01214395|Tea Tree Oil|tea tree oil|mesh-list
25622748|NCT01214395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25622749|NCT01214395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25622751|NCT01214421|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25622752|NCT01214421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622753|NCT01214421|Natriuretic Agents|natriuretic agents|mesh-ancestor
25622754|NCT01214421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622755|NCT01214434|Emollients|emollients|mesh-list
25622756|NCT01214434|Dermatologic Agents|dermatologic agents|mesh-ancestor
25622757|NCT01214616|Vinorelbine|vinorelbine|mesh-list
25622758|NCT01214616|Afatinib|afatinib|mesh-list
25622759|NCT01214616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25622760|NCT01214616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622761|NCT01214616|Tubulin Modulators|tubulin modulators|mesh-ancestor
25622762|NCT01214616|Antimitotic Agents|antimitotic agents|mesh-ancestor
25622763|NCT01214616|Mitosis Modulators|mitosis modulators|mesh-ancestor
25622764|NCT01214616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622765|NCT01214616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25622766|NCT01214616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25622767|NCT01214668|Doxorubicin|doxorubicin|mesh-list
25622768|NCT01214668|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25622769|NCT01214668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25622770|NCT01214668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622771|NCT01214668|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25622772|NCT01214668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25622773|NCT01214668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25622774|NCT01214668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622775|NCT01214720|Bevacizumab|bevacizumab|mesh-list
25622776|NCT01214720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25622777|NCT01214720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622778|NCT01214720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25622779|NCT01214720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25622780|NCT01214720|Growth Substances|growth substances|mesh-ancestor
25622781|NCT01214720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622782|NCT01214720|Growth Inhibitors|growth inhibitors|mesh-ancestor
25622783|NCT01214759|Tenofovir|tenofovir|mesh-list
25622784|NCT01214759|Emtricitabine|emtricitabine|mesh-list
25622785|NCT01214759|Raltegravir Potassium|raltegravir potassium|mesh-list
25622786|NCT01214759|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25622787|NCT01214759|Antiviral Agents|antiviral agents|mesh-ancestor
25622788|NCT01214759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25622789|NCT01214759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25622790|NCT01214759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25622791|NCT01214759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25622792|NCT01214759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622793|NCT01214759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25622794|NCT01214759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25622795|NCT01214759|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25622796|NCT01214759|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25655456|NCT01563081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25655457|NCT01563081|Histamine Antagonists|histamine antagonists|mesh-ancestor
25655458|NCT01563081|Histamine Agents|histamine agents|mesh-ancestor
25655459|NCT01563081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25655460|NCT01563081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655461|NCT01563081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655462|NCT01563081|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25655463|NCT01563172|Listerine|listerine|mesh-list
25655464|NCT01563172|Fluorides|fluorides|mesh-list
25655465|NCT01563172|Sodium Fluoride|sodium fluoride|mesh-list
25655466|NCT01563172|Cariostatic Agents|cariostatic agents|mesh-ancestor
25655467|NCT01563172|Protective Agents|protective agents|mesh-ancestor
25655468|NCT01563172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655469|NCT01563172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25655470|NCT01563172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25655471|NCT01563185|Ibuprofen|ibuprofen|mesh-list
25655472|NCT01563185|Famotidine|famotidine|mesh-list
25655473|NCT01563185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25655474|NCT01563185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25655475|NCT01563185|Analgesics|analgesics|mesh-ancestor
25622797|NCT01214850|Vaccines|vaccines|mesh-list
25622798|NCT01214850|Immunologic Factors|immunologic factors|mesh-ancestor
25622799|NCT01214850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622800|NCT01214915|Anagrelide|anagrelide|mesh-list
25622801|NCT01214915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25622802|NCT01214915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25622803|NCT01214915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622804|NCT01214915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25622805|NCT01215032|Metformin|metformin|mesh-list
25622806|NCT01215032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25622807|NCT01215032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622808|NCT01215097|Linagliptin|linagliptin|mesh-list
25622809|NCT01215097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25622810|NCT01215097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622811|NCT01215097|Incretins|incretins|mesh-ancestor
25622812|NCT01215097|Hormones|hormones|mesh-ancestor
25622813|NCT01215097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25622814|NCT01215097|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25622815|NCT01215097|Protease Inhibitors|protease inhibitors|mesh-ancestor
25622816|NCT01215097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25622817|NCT01215097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622818|NCT01215110|Bedaquiline|bedaquiline|mesh-list
25622819|NCT01215110|Antitubercular Agents|antitubercular agents|mesh-ancestor
25622820|NCT01215110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25622821|NCT01215110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25622822|NCT01215123|Bevacizumab|bevacizumab|mesh-list
25622823|NCT01215123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25622824|NCT01215123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622825|NCT01215123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25622826|NCT01215123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25622827|NCT01215123|Growth Substances|growth substances|mesh-ancestor
25622828|NCT01215123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622829|NCT01215123|Growth Inhibitors|growth inhibitors|mesh-ancestor
25622830|NCT01215175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25622831|NCT01215175|Immunologic Factors|immunologic factors|mesh-ancestor
25622832|NCT01215175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622833|NCT01215188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25622834|NCT01215188|Immunologic Factors|immunologic factors|mesh-ancestor
25622835|NCT01215188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622836|NCT01215227|Rasagiline|rasagiline|mesh-list
25622837|NCT01215227|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25622838|NCT01215227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25622839|NCT01215227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622840|NCT01215227|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25622841|NCT01215227|Protective Agents|protective agents|mesh-ancestor
25622842|NCT01215227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622843|NCT01215253|Ranolazine|ranolazine|mesh-list
25622844|NCT01215253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25622845|NCT01215253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25622846|NCT01215253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622847|NCT01215292|Ketoconazole|ketoconazole|mesh-list
25622848|NCT01215292|Anastrozole|anastrozole|mesh-list
25622849|NCT01215292|Testosterone|testosterone|mesh-list
25622850|NCT01215292|Dutasteride|dutasteride|mesh-list
25622851|NCT01215292|Acyline|acyline|mesh-list
25622852|NCT01215292|Androgens|androgens|mesh-ancestor
25622853|NCT01215292|Hormones|hormones|mesh-ancestor
25622854|NCT01215292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25622855|NCT01215292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622856|NCT01215292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25622857|NCT01215292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622858|NCT01215292|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25622859|NCT01215292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25622860|NCT01215292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25622861|NCT01215292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622862|NCT01215292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25622863|NCT01215292|Hormone Antagonists|hormone antagonists|mesh-ancestor
25622864|NCT01215292|Antifungal Agents|antifungal agents|mesh-ancestor
25622865|NCT01215292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25622866|NCT01215292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25622867|NCT01215292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25622868|NCT01215292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25622869|NCT01215292|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25622870|NCT01215318|Silicon|silicon|mesh-list
25622871|NCT01215318|Trace Elements|trace elements|mesh-ancestor
25622872|NCT01215318|Micronutrients|micronutrients|mesh-ancestor
25622873|NCT01215318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622875|NCT01215344|Dexamethasone|dexamethasone|mesh-list
25622876|NCT01215344|Dexamethasone acetate|dexamethasone acetate|mesh-list
25622877|NCT01215344|Doxorubicin|doxorubicin|mesh-list
25622878|NCT01215344|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25622879|NCT01215344|Lenalidomide|lenalidomide|mesh-list
25622880|NCT01215344|Bortezomib|bortezomib|mesh-list
25622881|NCT01215344|BB 1101|bb 1101|mesh-list
25622882|NCT01215344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25622883|NCT01215344|Antiemetics|antiemetics|mesh-ancestor
25622884|NCT01215344|Autonomic Agents|autonomic agents|mesh-ancestor
25622885|NCT01215344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25622886|NCT01215344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622887|NCT01215344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25622888|NCT01215344|Glucocorticoids|glucocorticoids|mesh-ancestor
25622889|NCT01215344|Hormones|hormones|mesh-ancestor
25622890|NCT01215344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25622891|NCT01215344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25622892|NCT01215344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622893|NCT01215344|Protease Inhibitors|protease inhibitors|mesh-ancestor
25622894|NCT01215344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25622895|NCT01215344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622896|NCT01215344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25622897|NCT01215344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25622898|NCT01215344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25622899|NCT01215344|Immunologic Factors|immunologic factors|mesh-ancestor
25622900|NCT01215344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25622901|NCT01215344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25622902|NCT01215344|Growth Substances|growth substances|mesh-ancestor
25622903|NCT01215344|Growth Inhibitors|growth inhibitors|mesh-ancestor
25622904|NCT01215344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25622905|NCT01215357|Ecopipam|ecopipam|mesh-list
25622906|NCT01215357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25622907|NCT01215357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25622908|NCT01215357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25622909|NCT01215357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622910|NCT01215357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25622911|NCT01215357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25622912|NCT01215357|Dopamine Agents|dopamine agents|mesh-ancestor
25622913|NCT01215357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25622914|NCT01215357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622915|NCT01215435|Insulin|insulin|mesh-list
25622916|NCT01215435|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25622917|NCT01215435|Insulin Aspart|insulin aspart|mesh-list
25622918|NCT01215435|Insulin, Long-Acting|insulin, long-acting|mesh-list
25622919|NCT01215435|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25622920|NCT01215435|Biphasic Insulins|biphasic insulins|mesh-list
25622921|NCT01215435|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
25622922|NCT01215435|Insulin, Isophane|insulin, isophane|mesh-list
25622923|NCT01215435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25622924|NCT01215435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622925|NCT01215643|Ribavirin|ribavirin|mesh-list
25622926|NCT01215643|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25622927|NCT01215643|Antimetabolites|antimetabolites|mesh-ancestor
25622928|NCT01215643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622929|NCT01215643|Antiviral Agents|antiviral agents|mesh-ancestor
25622930|NCT01215643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25622931|NCT01215721|Solifenacin Succinate|solifenacin succinate|mesh-list
25622932|NCT01215721|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25622933|NCT01215721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25622934|NCT01215721|Cholinergic Agents|cholinergic agents|mesh-ancestor
25622935|NCT01215721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25622936|NCT01215721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622937|NCT01215721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622938|NCT01215721|Urological Agents|urological agents|mesh-ancestor
25622939|NCT01215734|Vaccines|vaccines|mesh-list
25622940|NCT01215734|Immunologic Factors|immunologic factors|mesh-ancestor
25622941|NCT01215734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622942|NCT01215786|Timolol|timolol|mesh-list
25622943|NCT01215786|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25622944|NCT01215786|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25622945|NCT01215786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25517516|NCT00436475|Calcium Carbonate|calcium carbonate|mesh-list
25622946|NCT01215786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25622947|NCT01215786|Adrenergic Agents|adrenergic agents|mesh-ancestor
25622948|NCT01215786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25622949|NCT01215786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622950|NCT01215786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622951|NCT01215786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25622952|NCT01215786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25622953|NCT01215851|Moxifloxacin|moxifloxacin|mesh-list
25622954|NCT01215851|Pyrazinamide|pyrazinamide|mesh-list
25622955|NCT01215851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25622956|NCT01215851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25622957|NCT01215851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25622958|NCT01215851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25622959|NCT01215851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25622960|NCT01215851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622961|NCT01215851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622962|NCT01215851|Antitubercular Agents|antitubercular agents|mesh-ancestor
25622964|NCT01215916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25622965|NCT01215916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25622966|NCT01215916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622967|NCT01215916|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25622968|NCT01215916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25622969|NCT01215929|Dextroamphetamine|dextroamphetamine|mesh-list
25622970|NCT01215929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25622971|NCT01215929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622972|NCT01215929|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25622973|NCT01215929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25622974|NCT01215929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25622975|NCT01215929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622976|NCT01215929|Dopamine Agents|dopamine agents|mesh-ancestor
25622977|NCT01215929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25622978|NCT01215955|Insulin Lispro|insulin lispro|mesh-list
25622979|NCT01215955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25622980|NCT01215955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622981|NCT01215968|Dulaglutide|dulaglutide|mesh-list
25622982|NCT01215968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25622983|NCT01215968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622984|NCT01215981|Vaccines|vaccines|mesh-list
25622985|NCT01215981|Immunologic Factors|immunologic factors|mesh-ancestor
25622986|NCT01215981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622987|NCT01216072|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25622988|NCT01216072|Interferon beta-1b|interferon beta-1b|mesh-list
25622989|NCT01216072|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25622990|NCT01216072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25622991|NCT01216072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25622992|NCT01216072|Immunologic Factors|immunologic factors|mesh-ancestor
25622993|NCT01216072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25622994|NCT01216072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25622995|NCT01216163|Acetaminophen|acetaminophen|mesh-list
25622996|NCT01216163|Ibuprofen|ibuprofen|mesh-list
25622997|NCT01216163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25622998|NCT01216163|Analgesics|analgesics|mesh-ancestor
25622999|NCT01216163|Sensory System Agents|sensory system agents|mesh-ancestor
25623000|NCT01216163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25623001|NCT01216163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623002|NCT01216163|Antipyretics|antipyretics|mesh-ancestor
25623003|NCT01216163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25623004|NCT01216163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25623005|NCT01216163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25623006|NCT01216163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25623007|NCT01216163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25623008|NCT01216163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623009|NCT01216176|Anastrozole|anastrozole|mesh-list
25623010|NCT01216176|Saracatinib|saracatinib|mesh-list
25623011|NCT01216176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25623012|NCT01216176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25623013|NCT01216176|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25623014|NCT01216176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25623015|NCT01216176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25623016|NCT01216176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623017|NCT01216176|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25517614|NCT00437073|Topotecan|topotecan|mesh-list
25623018|NCT01216176|Hormone Antagonists|hormone antagonists|mesh-ancestor
25623019|NCT01216176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25623020|NCT01216176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623021|NCT01216241|Daptomycin|daptomycin|mesh-list
25623022|NCT01216241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25623023|NCT01216241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25623024|NCT01216332|Vaccines|vaccines|mesh-list
25623025|NCT01216332|Immunologic Factors|immunologic factors|mesh-ancestor
25623026|NCT01216332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623027|NCT01216397|Metformin|metformin|mesh-list
25623028|NCT01216397|Linagliptin|linagliptin|mesh-list
25623029|NCT01216397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25623030|NCT01216397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623031|NCT01216397|Incretins|incretins|mesh-ancestor
25623032|NCT01216397|Hormones|hormones|mesh-ancestor
25623033|NCT01216397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25623034|NCT01216397|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25623035|NCT01216397|Protease Inhibitors|protease inhibitors|mesh-ancestor
25623036|NCT01216397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25623037|NCT01216397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623038|NCT01216410|Phenylephrine|phenylephrine|mesh-list
25623039|NCT01216410|Oxymetazoline|oxymetazoline|mesh-list
25623040|NCT01216410|Ondansetron|ondansetron|mesh-list
25623041|NCT01216410|Metoclopramide|metoclopramide|mesh-list
25623042|NCT01216410|Antiemetics|antiemetics|mesh-ancestor
25623043|NCT01216410|Autonomic Agents|autonomic agents|mesh-ancestor
25623044|NCT01216410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25623045|NCT01216410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623046|NCT01216410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25623047|NCT01216410|Antipruritics|antipruritics|mesh-ancestor
25623048|NCT01216410|Dermatologic Agents|dermatologic agents|mesh-ancestor
25623049|NCT01216410|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25623050|NCT01216410|Serotonin Agents|serotonin agents|mesh-ancestor
25623051|NCT01216410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25623052|NCT01216410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623053|NCT01216410|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25623054|NCT01216410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25623055|NCT01216410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25623056|NCT01216410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25623057|NCT01216410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25623058|NCT01216410|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25623059|NCT01216410|Mydriatics|mydriatics|mesh-ancestor
25623060|NCT01216410|Sympathomimetics|sympathomimetics|mesh-ancestor
25623061|NCT01216410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25623062|NCT01216410|Nasal Decongestants|nasal decongestants|mesh-ancestor
25623063|NCT01216410|Respiratory System Agents|respiratory system agents|mesh-ancestor
25623064|NCT01216410|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25623065|NCT01216410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25623066|NCT01216410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25623067|NCT01216410|Adrenergic Agents|adrenergic agents|mesh-ancestor
25623068|NCT01216410|Protective Agents|protective agents|mesh-ancestor
25623069|NCT01216410|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25623070|NCT01216410|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25623071|NCT01216410|Dopamine Agents|dopamine agents|mesh-ancestor
25623072|NCT01216735|Fluticasone|fluticasone|mesh-list
25623073|NCT01216735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25623074|NCT01216735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25623075|NCT01216735|Autonomic Agents|autonomic agents|mesh-ancestor
25623076|NCT01216735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25623077|NCT01216735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623078|NCT01216735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25623079|NCT01216735|Respiratory System Agents|respiratory system agents|mesh-ancestor
25623080|NCT01216735|Dermatologic Agents|dermatologic agents|mesh-ancestor
25623081|NCT01216735|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25623082|NCT01216761|Iodine|iodine|mesh-list
25623083|NCT01216761|Chlorhexidine|chlorhexidine|mesh-list
25623084|NCT01216761|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25623085|NCT01216761|Cadexomer iodine|cadexomer iodine|mesh-list
25623086|NCT01216761|Povidone-Iodine|povidone-iodine|mesh-list
25623087|NCT01216761|Povidone|povidone|mesh-list
25623088|NCT01216761|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25623089|NCT01216761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25623090|NCT01216761|Disinfectants|disinfectants|mesh-ancestor
25623091|NCT01216761|Dermatologic Agents|dermatologic agents|mesh-ancestor
25623092|NCT01216761|Trace Elements|trace elements|mesh-ancestor
25623093|NCT01216761|Micronutrients|micronutrients|mesh-ancestor
25623094|NCT01216761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623095|NCT01216761|Plasma Substitutes|plasma substitutes|mesh-ancestor
25517734|NCT00438360|Cyclosporins|cyclosporins|mesh-list
25517735|NCT00438360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517736|NCT00438360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517737|NCT00438360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25517738|NCT00438360|Immunologic Factors|immunologic factors|mesh-ancestor
25517739|NCT00438360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517740|NCT00438360|Antifungal Agents|antifungal agents|mesh-ancestor
25517741|NCT00438360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25517742|NCT00438360|Dermatologic Agents|dermatologic agents|mesh-ancestor
25517743|NCT00438360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25517744|NCT00438360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25517745|NCT00438451|Lamotrigine|lamotrigine|mesh-list
25517746|NCT00438451|Carbamazepine|carbamazepine|mesh-list
25517747|NCT00438451|Levetiracetam|levetiracetam|mesh-list
25517748|NCT00438451|Anticonvulsants|anticonvulsants|mesh-ancestor
25517749|NCT00438451|Nootropic Agents|nootropic agents|mesh-ancestor
25517750|NCT00438451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25517751|NCT00438451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25517752|NCT00438451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517753|NCT00438451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25517754|NCT00438451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517755|NCT00438451|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25517756|NCT00438451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25517757|NCT00438451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25517758|NCT00438451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25517759|NCT00438451|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25517760|NCT00438451|Antimanic Agents|antimanic agents|mesh-ancestor
25517761|NCT00438451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25517762|NCT00438451|Analgesics|analgesics|mesh-ancestor
25517763|NCT00438451|Sensory System Agents|sensory system agents|mesh-ancestor
25517764|NCT00438451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25517765|NCT00438451|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25517766|NCT00438451|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25137151|NCT02986503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124417|NCT03076684|Protective Agents|protective agents|mesh-ancestor
25124418|NCT03076684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124419|NCT03076151|Tacrolimus|tacrolimus|mesh-list
24954655|NCT03874026|Cetuximab|cetuximab|mesh-list
24741168|NCT01692483|Hormones|hormones|mesh-ancestor
24741169|NCT01692483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25623096|NCT01216761|Blood Substitutes|blood substitutes|mesh-ancestor
25623097|NCT01216943|Timolol|timolol|mesh-list
25623098|NCT01216943|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25623099|NCT01216943|Bimatoprost|bimatoprost|mesh-list
25623100|NCT01216943|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25623101|NCT01216943|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25623102|NCT01216943|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25623103|NCT01216943|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25623104|NCT01216943|Adrenergic Agents|adrenergic agents|mesh-ancestor
25623105|NCT01216943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25623106|NCT01216943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623107|NCT01216943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623108|NCT01216943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25623109|NCT01216943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25623110|NCT01216943|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25623111|NCT01216943|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25623112|NCT01216943|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25623113|NCT01217073|Metformin|metformin|mesh-list
25623114|NCT01217073|Pioglitazone|pioglitazone|mesh-list
25623115|NCT01217073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25623116|NCT01217073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623117|NCT01217112|Cannabidiol|cannabidiol|mesh-list
25623118|NCT01217112|Anticonvulsants|anticonvulsants|mesh-ancestor
25623119|NCT01217190|Ondansetron|ondansetron|mesh-list
25623120|NCT01217190|Antiemetics|antiemetics|mesh-ancestor
25623121|NCT01217190|Autonomic Agents|autonomic agents|mesh-ancestor
25623122|NCT01217190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25623123|NCT01217190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623124|NCT01217190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25623125|NCT01217190|Antipruritics|antipruritics|mesh-ancestor
25623126|NCT01217190|Dermatologic Agents|dermatologic agents|mesh-ancestor
25623127|NCT01217190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25623128|NCT01217190|Serotonin Agents|serotonin agents|mesh-ancestor
25623129|NCT01217190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25623130|NCT01217190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623131|NCT01217190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25623132|NCT01217190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25623133|NCT01217190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25623134|NCT01217190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25623135|NCT01217190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25623137|NCT01217307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25623138|NCT01217307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623139|NCT01217411|R04929097|r04929097|mesh-list
25623140|NCT01217411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25623141|NCT01217411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623142|NCT01217437|Bevacizumab|bevacizumab|mesh-list
25623143|NCT01217437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25623144|NCT01217437|Irinotecan|irinotecan|mesh-list
25623145|NCT01217437|Temozolomide|temozolomide|mesh-list
25623146|NCT01217437|Camptothecin|camptothecin|mesh-list
25623147|NCT01217437|Endothelial Growth Factors|endothelial growth factors|mesh-list
25623148|NCT01217437|Antibodies|antibodies|mesh-list
25623149|NCT01217437|Immunoglobulins|immunoglobulins|mesh-list
25623150|NCT01217437|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25623151|NCT01217437|Immunoglobulin G|immunoglobulin g|mesh-list
25623152|NCT01217437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25623153|NCT01217437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25623154|NCT01217437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25623155|NCT01217437|Growth Substances|growth substances|mesh-ancestor
25623156|NCT01217437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623157|NCT01217437|Growth Inhibitors|growth inhibitors|mesh-ancestor
25623158|NCT01217437|Immunologic Factors|immunologic factors|mesh-ancestor
25623159|NCT01217437|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25623160|NCT01217437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25623161|NCT01217437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25623162|NCT01217437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623163|NCT01217437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25623164|NCT01217437|Alkylating Agents|alkylating agents|mesh-ancestor
25623165|NCT01217437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25623166|NCT01217515|Diltiazem|diltiazem|mesh-list
25623167|NCT01217515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25623168|NCT01217515|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25623169|NCT01217515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25623170|NCT01217515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623171|NCT01217515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25623172|NCT01217515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623173|NCT01217515|Vasodilator Agents|vasodilator agents|mesh-ancestor
25623174|NCT01217606|Timolol|timolol|mesh-list
25623175|NCT01217606|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25623176|NCT01217606|Bimatoprost|bimatoprost|mesh-list
25623177|NCT01217606|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25623178|NCT01217606|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25623179|NCT01217606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25623180|NCT01217606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25623181|NCT01217606|Adrenergic Agents|adrenergic agents|mesh-ancestor
25623182|NCT01217606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25623183|NCT01217606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623184|NCT01217606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623185|NCT01217606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25623186|NCT01217606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25623187|NCT01217606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25623188|NCT01217606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25623189|NCT01217606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25623190|NCT01217749|Ofatumumab|ofatumumab|mesh-list
25623191|NCT01217749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25623192|NCT01217801|Ondansetron|ondansetron|mesh-list
25623193|NCT01217801|Antiemetics|antiemetics|mesh-ancestor
25623194|NCT01217801|Autonomic Agents|autonomic agents|mesh-ancestor
25623195|NCT01217801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25623196|NCT01217801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623197|NCT01217801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25623198|NCT01217801|Antipruritics|antipruritics|mesh-ancestor
25623199|NCT01217801|Dermatologic Agents|dermatologic agents|mesh-ancestor
25623200|NCT01217801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25623201|NCT01217801|Serotonin Agents|serotonin agents|mesh-ancestor
25623202|NCT01217801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25623203|NCT01217801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623204|NCT01217801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25623205|NCT01217801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25623206|NCT01217801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25623207|NCT01217801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25623208|NCT01217801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25623209|NCT01217814|Leucovorin|leucovorin|mesh-list
25623210|NCT01217814|Folic Acid|folic acid|mesh-list
25623211|NCT01217814|Golimumab|golimumab|mesh-list
25623212|NCT01217814|Methotrexate|methotrexate|mesh-list
25623213|NCT01217814|Levoleucovorin|levoleucovorin|mesh-list
25623214|NCT01217814|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25623215|NCT01217814|Abortifacient Agents|abortifacient agents|mesh-ancestor
25623216|NCT01217814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25623217|NCT01217814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623218|NCT01217814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25623219|NCT01217814|Antimetabolites|antimetabolites|mesh-ancestor
25623220|NCT01217814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623221|NCT01217814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25623222|NCT01217814|Dermatologic Agents|dermatologic agents|mesh-ancestor
25623223|NCT01217814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25623224|NCT01217814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25623225|NCT01217814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25623226|NCT01217814|Immunologic Factors|immunologic factors|mesh-ancestor
25623227|NCT01217814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25623228|NCT01217814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25623229|NCT01217814|Antidotes|antidotes|mesh-ancestor
25623230|NCT01217814|Protective Agents|protective agents|mesh-ancestor
25623231|NCT01217814|Vitamin B Complex|vitamin b complex|mesh-ancestor
25623232|NCT01217814|Vitamins|vitamins|mesh-ancestor
25623233|NCT01217814|Micronutrients|micronutrients|mesh-ancestor
25623234|NCT01217814|Hematinics|hematinics|mesh-ancestor
25623235|NCT01217814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25623236|NCT01217814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25623237|NCT01217840|Vitamin D|vitamin d|mesh-list
25623238|NCT01217840|Ergocalciferols|ergocalciferols|mesh-list
25623239|NCT01217840|Vitamins|vitamins|mesh-ancestor
25623240|NCT01217840|Micronutrients|micronutrients|mesh-ancestor
25623241|NCT01217840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623242|NCT01217840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25623243|NCT01217840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25623244|NCT01217892|Metformin|metformin|mesh-list
25623245|NCT01217892|Dapagliflozin|dapagliflozin|mesh-list
25623246|NCT01217892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25623247|NCT01217892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623248|NCT01217892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25623249|NCT01217892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623250|NCT01217944|Ranibizumab|ranibizumab|mesh-list
25623251|NCT01217944|Verteporfin|verteporfin|mesh-list
25623252|NCT01217944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25623253|NCT01217944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25623254|NCT01217944|Growth Substances|growth substances|mesh-ancestor
25623255|NCT01217944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623256|NCT01217944|Growth Inhibitors|growth inhibitors|mesh-ancestor
25623257|NCT01217944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25623258|NCT01217944|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25623259|NCT01217944|Dermatologic Agents|dermatologic agents|mesh-ancestor
25623260|NCT01217957|Dexamethasone|dexamethasone|mesh-list
25623261|NCT01217957|Lenalidomide|lenalidomide|mesh-list
25623262|NCT01217957|Ixazomib|ixazomib|mesh-list
25623263|NCT01217957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25623264|NCT01217957|Antiemetics|antiemetics|mesh-ancestor
25623265|NCT01217957|Autonomic Agents|autonomic agents|mesh-ancestor
25623266|NCT01217957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25623267|NCT01217957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623268|NCT01217957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25623269|NCT01217957|Glucocorticoids|glucocorticoids|mesh-ancestor
25623270|NCT01217957|Hormones|hormones|mesh-ancestor
25623271|NCT01217957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25623272|NCT01217957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25623273|NCT01217957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25623274|NCT01217957|Immunologic Factors|immunologic factors|mesh-ancestor
25623275|NCT01217957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25623276|NCT01217957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25623277|NCT01217957|Growth Substances|growth substances|mesh-ancestor
25623278|NCT01217957|Growth Inhibitors|growth inhibitors|mesh-ancestor
25623279|NCT01217957|Protease Inhibitors|protease inhibitors|mesh-ancestor
25623280|NCT01217957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25623281|NCT01217957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623282|NCT01218009|Albuterol|albuterol|mesh-list
25623283|NCT01218009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25623284|NCT01218009|Autonomic Agents|autonomic agents|mesh-ancestor
25623285|NCT01218009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25623286|NCT01218009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623287|NCT01218009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25623288|NCT01218009|Respiratory System Agents|respiratory system agents|mesh-ancestor
25623289|NCT01218009|Tocolytic Agents|tocolytic agents|mesh-ancestor
25623290|NCT01218009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25623291|NCT01218009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25623292|NCT01218009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25623293|NCT01218009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25623294|NCT01218009|Adrenergic Agents|adrenergic agents|mesh-ancestor
25623295|NCT01218009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25623296|NCT01218009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623297|NCT01218048|Cisplatin|cisplatin|mesh-list
25623298|NCT01218048|Carboplatin|carboplatin|mesh-list
25623299|NCT01218048|Cetuximab|cetuximab|mesh-list
25623300|NCT01218048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25623301|NCT01218048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25623302|NCT01218100|Lisinopril|lisinopril|mesh-list
25623303|NCT01218100|Nebivolol|nebivolol|mesh-list
25623304|NCT01218100|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25623305|NCT01218100|Protease Inhibitors|protease inhibitors|mesh-ancestor
25623306|NCT01218100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25623307|NCT01218100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623308|NCT01218100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25623309|NCT01218100|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25623310|NCT01218100|Protective Agents|protective agents|mesh-ancestor
25623311|NCT01218100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623312|NCT01218100|Vasodilator Agents|vasodilator agents|mesh-ancestor
25623313|NCT01218100|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25623314|NCT01218100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25623315|NCT01218100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25623316|NCT01218100|Adrenergic Agents|adrenergic agents|mesh-ancestor
25623317|NCT01218100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25623318|NCT01218204|Atorvastatin|atorvastatin|mesh-list
25623319|NCT01218204|Ezetimibe|ezetimibe|mesh-list
25623320|NCT01218204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25623321|NCT01218204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25623322|NCT01218204|Antimetabolites|antimetabolites|mesh-ancestor
25623323|NCT01218204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623324|NCT01218204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25623325|NCT01218204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25623326|NCT01218204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25623327|NCT01218308|Vaccines|vaccines|mesh-list
25623328|NCT01218308|Immunologic Factors|immunologic factors|mesh-ancestor
24444068|NCT00296686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25623329|NCT01218308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623330|NCT01218399|Budesonide|budesonide|mesh-list
25623331|NCT01218399|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25623332|NCT01218399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25623333|NCT01218399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25623334|NCT01218399|Autonomic Agents|autonomic agents|mesh-ancestor
25623335|NCT01218399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25623336|NCT01218399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623337|NCT01218399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25623338|NCT01218399|Respiratory System Agents|respiratory system agents|mesh-ancestor
25623339|NCT01218399|Glucocorticoids|glucocorticoids|mesh-ancestor
25623340|NCT01218399|Hormones|hormones|mesh-ancestor
25623341|NCT01218399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25623342|NCT01218438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25623343|NCT01218438|Immunoglobulins|immunoglobulins|mesh-list
25623344|NCT01218438|Antibodies|antibodies|mesh-list
25623345|NCT01218438|gamma-Globulins|gamma-globulins|mesh-list
25623346|NCT01218438|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25623347|NCT01218438|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25623348|NCT01218438|Immunoglobulin G|immunoglobulin g|mesh-list
25623349|NCT01218438|Immunologic Factors|immunologic factors|mesh-ancestor
25623350|NCT01218438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623351|NCT01218477|Dasatinib|dasatinib|mesh-list
25623352|NCT01218477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25623353|NCT01218477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25623354|NCT01218477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25623355|NCT01218477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517906|NCT00439309|Thrombin|thrombin|mesh-list
25623357|NCT01218516|Cisplatin|cisplatin|mesh-list
25623358|NCT01218516|Carboplatin|carboplatin|mesh-list
25623359|NCT01218516|Pemetrexed|pemetrexed|mesh-list
25623360|NCT01218516|Farletuzumab|farletuzumab|mesh-list
25623361|NCT01218516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25623362|NCT01218516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25623363|NCT01218516|Tubulin Modulators|tubulin modulators|mesh-ancestor
25623364|NCT01218516|Antimitotic Agents|antimitotic agents|mesh-ancestor
25623365|NCT01218516|Mitosis Modulators|mitosis modulators|mesh-ancestor
25623366|NCT01218516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623367|NCT01218516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25623368|NCT01218516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25623369|NCT01218516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25623370|NCT01218594|Endostatins|endostatins|mesh-list
25623371|NCT01218594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25623372|NCT01218594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25623373|NCT01218594|Growth Substances|growth substances|mesh-ancestor
25623374|NCT01218594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623375|NCT01218594|Growth Inhibitors|growth inhibitors|mesh-ancestor
25623376|NCT01218594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25623377|NCT01218646|Vaccines|vaccines|mesh-list
25623378|NCT01218646|Immunologic Factors|immunologic factors|mesh-ancestor
25623379|NCT01218646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623380|NCT01218802|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25623381|NCT01218802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25623382|NCT01218802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25623383|NCT01218802|Antimetabolites|antimetabolites|mesh-ancestor
25623384|NCT01218802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623385|NCT01218802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25623386|NCT01218802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25623387|NCT01218802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25623388|NCT01218867|Aldesleukin|aldesleukin|mesh-list
25623389|NCT01218867|Cyclophosphamide|cyclophosphamide|mesh-list
25623390|NCT01218867|Fludarabine|fludarabine|mesh-list
25623391|NCT01218867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25623392|NCT01218867|Immunologic Factors|immunologic factors|mesh-ancestor
25623393|NCT01218867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623394|NCT01218867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25623395|NCT01218867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25623396|NCT01218867|Alkylating Agents|alkylating agents|mesh-ancestor
25623397|NCT01218867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623398|NCT01218867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25623399|NCT01218867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25623400|NCT01218867|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25623401|NCT01218867|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25623402|NCT01218867|Antiviral Agents|antiviral agents|mesh-ancestor
25623403|NCT01218867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25623404|NCT01218958|Naltrexone|naltrexone|mesh-list
25623405|NCT01218958|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25623406|NCT01218958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25623407|NCT01218958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623408|NCT01218958|Sensory System Agents|sensory system agents|mesh-ancestor
25623409|NCT01218958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25623410|NCT01218971|Naltrexone|naltrexone|mesh-list
25623411|NCT01218971|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25623412|NCT01218971|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25623413|NCT01218971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623414|NCT01218971|Sensory System Agents|sensory system agents|mesh-ancestor
25623415|NCT01218971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25623416|NCT01218984|Naltrexone|naltrexone|mesh-list
25623417|NCT01218984|Hydromorphone|hydromorphone|mesh-list
25623418|NCT01218984|Naloxone|naloxone|mesh-list
25623419|NCT01218984|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25623420|NCT01218984|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25623421|NCT01218984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623422|NCT01218984|Sensory System Agents|sensory system agents|mesh-ancestor
25623423|NCT01218984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25623424|NCT01218984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25623425|NCT01218984|Narcotics|narcotics|mesh-ancestor
25623426|NCT01218984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25623427|NCT01218984|Analgesics|analgesics|mesh-ancestor
25623428|NCT01218997|Naltrexone|naltrexone|mesh-list
25623429|NCT01218997|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25623430|NCT01218997|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25623431|NCT01218997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623432|NCT01218997|Sensory System Agents|sensory system agents|mesh-ancestor
25623433|NCT01218997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25623435|NCT01219738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25623436|NCT01219738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25623437|NCT01219738|Autonomic Agents|autonomic agents|mesh-ancestor
25623438|NCT01219738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25623439|NCT01219738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623440|NCT01219738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25623441|NCT01219738|Respiratory System Agents|respiratory system agents|mesh-ancestor
25623442|NCT01219738|Glucocorticoids|glucocorticoids|mesh-ancestor
25623443|NCT01219738|Hormones|hormones|mesh-ancestor
25623444|NCT01219738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25623445|NCT01219777|Paclitaxel|paclitaxel|mesh-list
25623446|NCT01219777|Bevacizumab|bevacizumab|mesh-list
25623447|NCT01219777|Carboplatin|carboplatin|mesh-list
25623448|NCT01219777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25623449|NCT01219777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25623450|NCT01219777|Tubulin Modulators|tubulin modulators|mesh-ancestor
25623451|NCT01219777|Antimitotic Agents|antimitotic agents|mesh-ancestor
25623452|NCT01219777|Mitosis Modulators|mitosis modulators|mesh-ancestor
25623453|NCT01219777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623454|NCT01219777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25623455|NCT01219777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25623456|NCT01219777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25623457|NCT01219777|Growth Substances|growth substances|mesh-ancestor
25623458|NCT01219777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623459|NCT01219777|Growth Inhibitors|growth inhibitors|mesh-ancestor
25623460|NCT01219881|Sevoflurane|sevoflurane|mesh-list
25623461|NCT01219881|Desflurane|desflurane|mesh-list
25623462|NCT01219881|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25623463|NCT01219881|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25623464|NCT01219881|Anesthetics, General|anesthetics, general|mesh-ancestor
25623465|NCT01219881|Anesthetics|anesthetics|mesh-ancestor
25623466|NCT01219881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25623467|NCT01219881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623468|NCT01219933|Methylprednisolone|methylprednisolone|mesh-list
25623469|NCT01219933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25623470|NCT01219933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25623471|NCT01219933|Prednisolone|prednisolone|mesh-list
25623472|NCT01219933|Prednisolone acetate|prednisolone acetate|mesh-list
25623473|NCT01219933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25623474|NCT01219933|Prednisolone phosphate|prednisolone phosphate|mesh-list
25623475|NCT01219933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25623476|NCT01219933|Antiemetics|antiemetics|mesh-ancestor
25623477|NCT01219933|Autonomic Agents|autonomic agents|mesh-ancestor
25623478|NCT01219933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25623479|NCT01219933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623480|NCT01219933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25623481|NCT01219933|Glucocorticoids|glucocorticoids|mesh-ancestor
25623482|NCT01219933|Hormones|hormones|mesh-ancestor
25623483|NCT01219933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25623484|NCT01219933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25623485|NCT01219933|Protective Agents|protective agents|mesh-ancestor
25623486|NCT01219933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25623487|NCT01219933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25623488|NCT01219959|Icodextrin|icodextrin|mesh-list
25623489|NCT01219959|Dialysis Solutions|dialysis solutions|mesh-ancestor
25623490|NCT01219959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25623491|NCT01220024|Bupivacaine|bupivacaine|mesh-list
25623492|NCT01220024|Anesthetics, Local|anesthetics, local|mesh-ancestor
25623493|NCT01220024|Anesthetics|anesthetics|mesh-ancestor
25623494|NCT01220024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25623495|NCT01220024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623496|NCT01220024|Sensory System Agents|sensory system agents|mesh-ancestor
25623497|NCT01220024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25623498|NCT01220128|Paclitaxel|paclitaxel|mesh-list
25623499|NCT01220128|Docetaxel|docetaxel|mesh-list
25623500|NCT01220128|Cyclophosphamide|cyclophosphamide|mesh-list
25623501|NCT01220128|Carboplatin|carboplatin|mesh-list
25623502|NCT01220128|Doxorubicin|doxorubicin|mesh-list
25623503|NCT01220128|Fluorouracil|fluorouracil|mesh-list
25623504|NCT01220128|Trastuzumab|trastuzumab|mesh-list
25623505|NCT01220128|Epirubicin|epirubicin|mesh-list
25623506|NCT01220128|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25623507|NCT01220128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25623508|NCT01220128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25623509|NCT01220128|Tubulin Modulators|tubulin modulators|mesh-ancestor
25623510|NCT01220128|Antimitotic Agents|antimitotic agents|mesh-ancestor
25623511|NCT01220128|Mitosis Modulators|mitosis modulators|mesh-ancestor
25623512|NCT01220128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623513|NCT01220128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25623514|NCT01220128|Immunologic Factors|immunologic factors|mesh-ancestor
25623515|NCT01220128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623516|NCT01220128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25623517|NCT01220128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25623518|NCT01220128|Alkylating Agents|alkylating agents|mesh-ancestor
25623519|NCT01220128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25623520|NCT01220128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25623521|NCT01220128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25623522|NCT01220128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25623523|NCT01220128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25623524|NCT01220128|Antimetabolites|antimetabolites|mesh-ancestor
25623525|NCT01220128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25623526|NCT01220128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25623527|NCT01220128|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25623528|NCT01220128|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25623529|NCT01220128|Hormone Antagonists|hormone antagonists|mesh-ancestor
25623530|NCT01220128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25623531|NCT01220167|Ondansetron|ondansetron|mesh-list
25623532|NCT01220167|Antiemetics|antiemetics|mesh-ancestor
25623533|NCT01220167|Autonomic Agents|autonomic agents|mesh-ancestor
25623534|NCT01220167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25623535|NCT01220167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623536|NCT01220167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25623537|NCT01220167|Antipruritics|antipruritics|mesh-ancestor
25623538|NCT01220167|Dermatologic Agents|dermatologic agents|mesh-ancestor
25623539|NCT01220167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25623540|NCT01220167|Serotonin Agents|serotonin agents|mesh-ancestor
25623541|NCT01220167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25623542|NCT01220167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623543|NCT01220167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25623544|NCT01220167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25623545|NCT01220167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25623546|NCT01220167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25623547|NCT01220167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25655476|NCT01563185|Sensory System Agents|sensory system agents|mesh-ancestor
25655477|NCT01563185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25655478|NCT01563185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655479|NCT01563185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25655480|NCT01563185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25655481|NCT01563185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25655482|NCT01563185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655483|NCT01563185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655484|NCT01563185|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25655485|NCT01563185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25655486|NCT01563185|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25655487|NCT01563185|Histamine Antagonists|histamine antagonists|mesh-ancestor
25655488|NCT01563185|Histamine Agents|histamine agents|mesh-ancestor
25655489|NCT01563185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25655490|NCT01563198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25655491|NCT01563198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25655492|NCT01563198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655493|NCT01563354|Everolimus|everolimus|mesh-list
25655494|NCT01563354|Pasireotide|pasireotide|mesh-list
25655495|NCT01563354|Somatostatin|somatostatin|mesh-list
25655496|NCT01563354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25655497|NCT01563354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25655498|NCT01563354|Immunologic Factors|immunologic factors|mesh-ancestor
25655499|NCT01563354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655500|NCT01563354|Hormones|hormones|mesh-ancestor
25655501|NCT01563354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25655502|NCT01563406|Ethanol|ethanol|mesh-list
25655503|NCT01563406|Chlorhexidine|chlorhexidine|mesh-list
25655504|NCT01563406|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25655505|NCT01563406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25655506|NCT01563406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25655507|NCT01563406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655508|NCT01563406|Disinfectants|disinfectants|mesh-ancestor
25655509|NCT01563536|Ritonavir|ritonavir|mesh-list
25655510|NCT01563536|Ribavirin|ribavirin|mesh-list
25655511|NCT01563536|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25623549|NCT01220180|Analgesics|analgesics|mesh-ancestor
24542966|NCT00681213|Sirolimus|sirolimus|mesh-list
25623550|NCT01220180|Sensory System Agents|sensory system agents|mesh-ancestor
25623551|NCT01220180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25623552|NCT01220180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623553|NCT01220180|Anticonvulsants|anticonvulsants|mesh-ancestor
25623554|NCT01220180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25623555|NCT01220180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25623556|NCT01220180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623557|NCT01220180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25623558|NCT01220180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25623559|NCT01220180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25623560|NCT01220180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25623561|NCT01220180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25623562|NCT01220297|Mycophenolic Acid|mycophenolic acid|mesh-list
25623563|NCT01220297|Sirolimus|sirolimus|mesh-list
25623564|NCT01220297|Cyclophosphamide|cyclophosphamide|mesh-list
25623565|NCT01220297|Carmustine|carmustine|mesh-list
25623566|NCT01220297|Etoposide|etoposide|mesh-list
25623567|NCT01220297|Etoposide phosphate|etoposide phosphate|mesh-list
25623568|NCT01220297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25623569|NCT01220297|Immunologic Factors|immunologic factors|mesh-ancestor
25623570|NCT01220297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623571|NCT01220297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25623572|NCT01220297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25623573|NCT01220297|Alkylating Agents|alkylating agents|mesh-ancestor
25623574|NCT01220297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623575|NCT01220297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25623576|NCT01220297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25623577|NCT01220297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25623578|NCT01220297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25623579|NCT01220297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25623580|NCT01220297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25623581|NCT01220297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25623582|NCT01220297|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24543534|NCT00684164|Conivaptan|conivaptan|mesh-list
25623583|NCT01220297|Antitubercular Agents|antitubercular agents|mesh-ancestor
25623584|NCT01220297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25623585|NCT01220297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25623586|NCT01220297|Antifungal Agents|antifungal agents|mesh-ancestor
25623587|NCT01220414|Naltrexone|naltrexone|mesh-list
25623588|NCT01220414|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25623589|NCT01220414|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25623590|NCT01220414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623591|NCT01220414|Sensory System Agents|sensory system agents|mesh-ancestor
25623592|NCT01220414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25623593|NCT01220557|Insulin|insulin|mesh-list
25623594|NCT01220557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25623595|NCT01220557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623596|NCT01220609|Epothilones|epothilones|mesh-list
25623597|NCT01220609|Tubulin Modulators|tubulin modulators|mesh-ancestor
25623598|NCT01220609|Antimitotic Agents|antimitotic agents|mesh-ancestor
25623599|NCT01220609|Mitosis Modulators|mitosis modulators|mesh-ancestor
25623600|NCT01220609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623601|NCT01220609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25623602|NCT01220687|Nitric Oxide|nitric oxide|mesh-list
25623603|NCT01220687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25623604|NCT01220687|Autonomic Agents|autonomic agents|mesh-ancestor
25623605|NCT01220687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25623606|NCT01220687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623607|NCT01220687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25623608|NCT01220687|Respiratory System Agents|respiratory system agents|mesh-ancestor
25623609|NCT01220687|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25623610|NCT01220687|Antioxidants|antioxidants|mesh-ancestor
25623611|NCT01220687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623612|NCT01220687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25623613|NCT01220687|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25623614|NCT01220687|Vasodilator Agents|vasodilator agents|mesh-ancestor
25623615|NCT01220687|Gasotransmitters|gasotransmitters|mesh-ancestor
25623616|NCT01220687|Protective Agents|protective agents|mesh-ancestor
25623617|NCT01220973|Celecoxib|celecoxib|mesh-list
25623618|NCT01220973|Atorvastatin|atorvastatin|mesh-list
25623619|NCT01220973|Calcium|calcium|mesh-list
25623620|NCT01220973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25623621|NCT01220973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623622|NCT01220973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25623623|NCT01220973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25623625|NCT01220973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623626|NCT01220973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25623627|NCT01220973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25623628|NCT01220973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25623629|NCT01220973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25623630|NCT01220973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25623631|NCT01220973|Analgesics|analgesics|mesh-ancestor
25623632|NCT01220973|Sensory System Agents|sensory system agents|mesh-ancestor
25623633|NCT01220973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25623634|NCT01220973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25623635|NCT01220973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25623636|NCT01220973|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25623637|NCT01220973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25623638|NCT01221181|Eculizumab|eculizumab|mesh-list
25623639|NCT01221181|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25623640|NCT01221181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25623641|NCT01221181|Immunologic Factors|immunologic factors|mesh-ancestor
25623642|NCT01221181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623643|NCT01221207|Calpastatin|calpastatin|mesh-list
25623644|NCT01221207|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25623645|NCT01221207|Protease Inhibitors|protease inhibitors|mesh-ancestor
25623646|NCT01221207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25623647|NCT01221207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623648|NCT01221272|Ranolazine|ranolazine|mesh-list
25623649|NCT01221272|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25623650|NCT01221272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25623651|NCT01221272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623652|NCT01221298|Ritonavir|ritonavir|mesh-list
25623653|NCT01221298|Ribavirin|ribavirin|mesh-list
25623654|NCT01221298|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25623655|NCT01221298|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25623656|NCT01221298|Protease Inhibitors|protease inhibitors|mesh-ancestor
25623657|NCT01221298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25623658|NCT01221298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623659|NCT01221298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25623660|NCT01221298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25623661|NCT01221298|Antiviral Agents|antiviral agents|mesh-ancestor
25623662|NCT01221298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25623663|NCT01221298|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25623664|NCT01221298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25623665|NCT01221298|Antimetabolites|antimetabolites|mesh-ancestor
25623666|NCT01221350|Thioctic Acid|thioctic acid|mesh-list
25623667|NCT01221350|Antioxidants|antioxidants|mesh-ancestor
25623668|NCT01221350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623669|NCT01221350|Protective Agents|protective agents|mesh-ancestor
25623670|NCT01221350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623671|NCT01221350|Vitamin B Complex|vitamin b complex|mesh-ancestor
25623672|NCT01221350|Vitamins|vitamins|mesh-ancestor
25623673|NCT01221350|Micronutrients|micronutrients|mesh-ancestor
25623674|NCT01221727|Denosumab|denosumab|mesh-list
25623675|NCT01221727|Midazolam|midazolam|mesh-list
25623676|NCT01221727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25623677|NCT01221727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25623678|NCT01221727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25623679|NCT01221727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623680|NCT01221727|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25623681|NCT01221727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25623682|NCT01221727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25623683|NCT01221727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25623684|NCT01221727|Anesthetics, General|anesthetics, general|mesh-ancestor
25623685|NCT01221727|Anesthetics|anesthetics|mesh-ancestor
25623686|NCT01221727|GABA Modulators|gaba modulators|mesh-ancestor
25623687|NCT01221727|GABA Agents|gaba agents|mesh-ancestor
25623688|NCT01221727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25623689|NCT01221727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623690|NCT01221727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25623691|NCT01221753|Cisplatin|cisplatin|mesh-list
25623692|NCT01221753|Carboplatin|carboplatin|mesh-list
25623693|NCT01221753|Docetaxel|docetaxel|mesh-list
25623694|NCT01221753|Fluorouracil|fluorouracil|mesh-list
25623695|NCT01221753|Cetuximab|cetuximab|mesh-list
25623696|NCT01221753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25623697|NCT01221753|Tubulin Modulators|tubulin modulators|mesh-ancestor
25623698|NCT01221753|Antimitotic Agents|antimitotic agents|mesh-ancestor
25623700|NCT01221753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623701|NCT01221753|Antimetabolites|antimetabolites|mesh-ancestor
25623702|NCT01221753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25623703|NCT01221753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25623704|NCT01221753|Immunologic Factors|immunologic factors|mesh-ancestor
25623705|NCT01221753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623706|NCT01221753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25623707|NCT01222091|Propranolol|propranolol|mesh-list
25623708|NCT01222091|Remifentanil|remifentanil|mesh-list
25623709|NCT01222091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25623710|NCT01222091|Narcotics|narcotics|mesh-ancestor
25623711|NCT01222091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25623712|NCT01222091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623713|NCT01222091|Analgesics|analgesics|mesh-ancestor
25623714|NCT01222091|Sensory System Agents|sensory system agents|mesh-ancestor
25623715|NCT01222091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25623716|NCT01222091|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25623717|NCT01222091|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25623718|NCT01222091|Adrenergic Agents|adrenergic agents|mesh-ancestor
25623719|NCT01222091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25623720|NCT01222091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623721|NCT01222091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25623722|NCT01222091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25623723|NCT01222091|Vasodilator Agents|vasodilator agents|mesh-ancestor
25623724|NCT01222117|Plasminogen|plasminogen|mesh-list
25623725|NCT01222117|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25623726|NCT01222117|Fibrinolysin|fibrinolysin|mesh-list
25623727|NCT01222117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25623728|NCT01222117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25623729|NCT01222117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623730|NCT01222195|Lenalidomide|lenalidomide|mesh-list
25623731|NCT01222195|Darbepoetin alfa|darbepoetin alfa|mesh-list
25623732|NCT01222195|Immunologic Factors|immunologic factors|mesh-ancestor
25623733|NCT01222195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623734|NCT01222195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25623735|NCT01222195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25623736|NCT01222195|Growth Substances|growth substances|mesh-ancestor
25623737|NCT01222195|Growth Inhibitors|growth inhibitors|mesh-ancestor
25623738|NCT01222195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25623739|NCT01222195|Hematinics|hematinics|mesh-ancestor
25623740|NCT01222234|Vitamin D|vitamin d|mesh-list
25623741|NCT01222234|Ergocalciferols|ergocalciferols|mesh-list
25623742|NCT01222234|Cholecalciferol|cholecalciferol|mesh-list
25623743|NCT01222234|Calcitriol|calcitriol|mesh-list
25623744|NCT01222234|Vitamins|vitamins|mesh-list
25623745|NCT01222234|Micronutrients|micronutrients|mesh-ancestor
25623746|NCT01222234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623747|NCT01222234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25623748|NCT01222234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25623749|NCT01222234|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25623750|NCT01222234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25623751|NCT01222234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623752|NCT01222234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25623753|NCT01222260|Dexamethasone|dexamethasone|mesh-list
25623754|NCT01222260|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25623755|NCT01222260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25623756|NCT01222260|Antiemetics|antiemetics|mesh-ancestor
25623757|NCT01222260|Autonomic Agents|autonomic agents|mesh-ancestor
25623758|NCT01222260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25623759|NCT01222260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623760|NCT01222260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25623761|NCT01222260|Glucocorticoids|glucocorticoids|mesh-ancestor
25623762|NCT01222260|Hormones|hormones|mesh-ancestor
25623763|NCT01222260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25623764|NCT01222260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25623765|NCT01222260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25623766|NCT01222260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25623767|NCT01222260|Alkylating Agents|alkylating agents|mesh-ancestor
25623768|NCT01222260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623769|NCT01222273|Vitamin D|vitamin d|mesh-list
25623770|NCT01222273|Cholecalciferol|cholecalciferol|mesh-list
25623771|NCT01222273|Vitamins|vitamins|mesh-ancestor
25623772|NCT01222273|Micronutrients|micronutrients|mesh-ancestor
25518330|NCT00441974|Adefovir|adefovir|mesh-list
25623773|NCT01222273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623774|NCT01222273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25623775|NCT01222273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25623776|NCT01222299|Bepotastine besilate|bepotastine besilate|mesh-list
25623777|NCT01222299|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25623778|NCT01222403|Vaccines|vaccines|mesh-list
25623779|NCT01222403|MF59 oil emulsion|mf59 oil emulsion|mesh-list
25623780|NCT01222403|Immunologic Factors|immunologic factors|mesh-ancestor
25623781|NCT01222403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623782|NCT01222403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25623783|NCT01222416|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
25623784|NCT01222416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623785|NCT01222520|Amlodipine|amlodipine|mesh-list
25623786|NCT01222520|Telmisartan|telmisartan|mesh-list
25623787|NCT01222520|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
25623788|NCT01222520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25623789|NCT01222520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25623790|NCT01222520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25623791|NCT01222520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623792|NCT01222520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25623793|NCT01222520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623794|NCT01222520|Vasodilator Agents|vasodilator agents|mesh-ancestor
25623795|NCT01222520|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25623796|NCT01222520|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25623797|NCT01222533|Tiotropium Bromide|tiotropium bromide|mesh-list
25623798|NCT01222533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25623799|NCT01222533|Autonomic Agents|autonomic agents|mesh-ancestor
25623800|NCT01222533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25623801|NCT01222533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623802|NCT01222533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25623803|NCT01222533|Respiratory System Agents|respiratory system agents|mesh-ancestor
25623804|NCT01222533|Parasympatholytics|parasympatholytics|mesh-ancestor
25623805|NCT01222533|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25623806|NCT01222533|Cholinergic Agents|cholinergic agents|mesh-ancestor
25623807|NCT01222533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25623808|NCT01222533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623809|NCT01222572|Cisplatin|cisplatin|mesh-list
25623810|NCT01222572|Etoposide|etoposide|mesh-list
25623811|NCT01222572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25623812|NCT01222572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25623813|NCT01222572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25623814|NCT01222572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25623815|NCT01222572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25623816|NCT01222572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623817|NCT01222585|Metronidazole|metronidazole|mesh-list
25623818|NCT01222585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25623819|NCT01222585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25623820|NCT01222585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25623821|NCT01222585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25623822|NCT01222689|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25623823|NCT01222689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25623824|NCT01222689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25623825|NCT01222689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25623826|NCT01222689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623827|NCT01222715|Sirolimus|sirolimus|mesh-list
25623828|NCT01222715|Cyclophosphamide|cyclophosphamide|mesh-list
25623829|NCT01222715|Bevacizumab|bevacizumab|mesh-list
25623830|NCT01222715|Vinorelbine|vinorelbine|mesh-list
25623831|NCT01222715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25623832|NCT01222715|Antibodies|antibodies|mesh-list
25623833|NCT01222715|Immunoglobulins|immunoglobulins|mesh-list
25623834|NCT01222715|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25623835|NCT01222715|Immunoglobulin G|immunoglobulin g|mesh-list
25623836|NCT01222715|Endothelial Growth Factors|endothelial growth factors|mesh-list
25623837|NCT01222715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25623838|NCT01222715|Immunologic Factors|immunologic factors|mesh-ancestor
25623839|NCT01222715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623840|NCT01222715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25623841|NCT01222715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25623842|NCT01222715|Alkylating Agents|alkylating agents|mesh-ancestor
25715646|NCT02374398|Coagulants|coagulants|mesh-ancestor
25623843|NCT01222715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623844|NCT01222715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25623845|NCT01222715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25518391|NCT00442689|Diuretics|diuretics|mesh-ancestor
25623846|NCT01222715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25623847|NCT01222715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25623848|NCT01222715|Growth Substances|growth substances|mesh-ancestor
25623849|NCT01222715|Growth Inhibitors|growth inhibitors|mesh-ancestor
25623850|NCT01222715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25623851|NCT01222715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25623852|NCT01222715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25623853|NCT01222715|Antifungal Agents|antifungal agents|mesh-ancestor
25623854|NCT01222715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25623855|NCT01222715|Tubulin Modulators|tubulin modulators|mesh-ancestor
25623856|NCT01222715|Antimitotic Agents|antimitotic agents|mesh-ancestor
25623857|NCT01222715|Mitosis Modulators|mitosis modulators|mesh-ancestor
25623859|NCT01222832|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25623860|NCT01222832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25623861|NCT01222832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25623862|NCT01222884|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25623863|NCT01222884|Hematinics|hematinics|mesh-ancestor
25623864|NCT01223027|Sorafenib|sorafenib|mesh-list
25623865|NCT01223027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25623866|NCT01223027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25623867|NCT01223027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25623868|NCT01223027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623869|NCT01223196|Pioglitazone|pioglitazone|mesh-list
25623870|NCT01223196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25623871|NCT01223196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623872|NCT01223235|Bevacizumab|bevacizumab|mesh-list
25623873|NCT01223235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25623874|NCT01223235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25623875|NCT01223235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25623876|NCT01223235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25623877|NCT01223235|Growth Substances|growth substances|mesh-ancestor
25623878|NCT01223235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623879|NCT01223235|Growth Inhibitors|growth inhibitors|mesh-ancestor
25623880|NCT01223352|Bosentan|bosentan|mesh-list
25623881|NCT01223352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25623882|NCT01223352|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25623883|NCT01223352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623884|NCT01223365|Hydrocodone|hydrocodone|mesh-list
25623885|NCT01223365|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25623886|NCT01223365|Narcotics|narcotics|mesh-ancestor
25623887|NCT01223365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25623888|NCT01223365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623889|NCT01223365|Analgesics|analgesics|mesh-ancestor
25623890|NCT01223365|Sensory System Agents|sensory system agents|mesh-ancestor
25623891|NCT01223365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25623892|NCT01223365|Antitussive Agents|antitussive agents|mesh-ancestor
25623893|NCT01223365|Respiratory System Agents|respiratory system agents|mesh-ancestor
25623894|NCT01223378|Latanoprost|latanoprost|mesh-list
25623895|NCT01223378|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25623896|NCT01223378|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25623897|NCT01223404|Mecamylamine|mecamylamine|mesh-list
25623898|NCT01223404|Nicotine|nicotine|mesh-list
25623899|NCT01223404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25623900|NCT01223404|Autonomic Agents|autonomic agents|mesh-ancestor
25623901|NCT01223404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25623902|NCT01223404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623903|NCT01223404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25623904|NCT01223404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25623905|NCT01223404|Cholinergic Agents|cholinergic agents|mesh-ancestor
25518456|NCT00443261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518457|NCT00443261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25518458|NCT00443261|Antimetabolites|antimetabolites|mesh-ancestor
25518459|NCT00443261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518460|NCT00443261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518461|NCT00443352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25518463|NCT00443352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25623906|NCT01223404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25623907|NCT01223404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623908|NCT01223404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25623909|NCT01223404|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
25623910|NCT01223404|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25623911|NCT01223404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25623912|NCT01223937|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25623913|NCT01223937|Hemostatics|hemostatics|mesh-ancestor
25623914|NCT01223937|Coagulants|coagulants|mesh-ancestor
25623915|NCT01223937|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25623916|NCT01223937|Natriuretic Agents|natriuretic agents|mesh-ancestor
25623917|NCT01223937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623918|NCT01224015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25623919|NCT01224015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25623920|NCT01224015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25623921|NCT01224015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25623922|NCT01224015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548277|NCT00708656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25623923|NCT01224015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25623924|NCT01224015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25623925|NCT01224015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623926|NCT01224015|Cholinergic Agents|cholinergic agents|mesh-ancestor
25623927|NCT01224015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25623928|NCT01224145|Bupivacaine|bupivacaine|mesh-list
25623929|NCT01224145|Anesthetics, Local|anesthetics, local|mesh-ancestor
25623930|NCT01224145|Anesthetics|anesthetics|mesh-ancestor
25623931|NCT01224145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25623932|NCT01224145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623933|NCT01224145|Sensory System Agents|sensory system agents|mesh-ancestor
25623934|NCT01224145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25623935|NCT01224171|Vedolizumab|vedolizumab|mesh-list
25623936|NCT01224171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25623937|NCT01224210|Ambrisentan|ambrisentan|mesh-list
25623938|NCT01224210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25623939|NCT01224431|Lidocaine|lidocaine|mesh-list
25623940|NCT01224431|Anesthetics, Local|anesthetics, local|mesh-ancestor
25623941|NCT01224431|Anesthetics|anesthetics|mesh-ancestor
25623942|NCT01224431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25623943|NCT01224431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623944|NCT01224431|Sensory System Agents|sensory system agents|mesh-ancestor
25623945|NCT01224431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24548459|NCT00709644|Folic Acid|folic acid|mesh-list
25623946|NCT01224431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25623947|NCT01224431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25623948|NCT01224431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25623949|NCT01224431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25623950|NCT01224431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623951|NCT01224626|Linezolid|linezolid|mesh-list
25623952|NCT01224626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25623953|NCT01224626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25623954|NCT01224626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25623955|NCT01224626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25623956|NCT01224626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623957|NCT01224639|Vaccines|vaccines|mesh-list
25623958|NCT01224639|Immunologic Factors|immunologic factors|mesh-ancestor
25623959|NCT01224639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623960|NCT01224678|Vitamin D|vitamin d|mesh-list
25623961|NCT01224678|Vitamins|vitamins|mesh-ancestor
25623962|NCT01224678|Micronutrients|micronutrients|mesh-ancestor
25623963|NCT01224678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623964|NCT01224678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25623965|NCT01224821|Tositumomab I-131|tositumomab i-131|mesh-list
25623966|NCT01224821|Antibodies|antibodies|mesh-list
25623967|NCT01224821|Immunologic Factors|immunologic factors|mesh-ancestor
25623968|NCT01224821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623969|NCT01224821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25623970|NCT01225055|Teriparatide|teriparatide|mesh-list
25623971|NCT01225055|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25623972|NCT01225055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623973|NCT01225055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25623974|NCT01225068|Milnacipran|milnacipran|mesh-list
25623975|NCT01225068|Levomilnacipran|levomilnacipran|mesh-list
25623976|NCT01225068|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25623977|NCT01225068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25623978|NCT01225068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25623979|NCT01225068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25623980|NCT01225068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25623981|NCT01225068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623982|NCT01225068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25623983|NCT01225068|Analgesics|analgesics|mesh-ancestor
25623984|NCT01225068|Sensory System Agents|sensory system agents|mesh-ancestor
25623985|NCT01225068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25623986|NCT01225068|Antidepressive Agents|antidepressive agents|mesh-ancestor
25623987|NCT01225068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25623988|NCT01225146|Ranibizumab|ranibizumab|mesh-list
25623989|NCT01225146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25623990|NCT01225146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25623991|NCT01225146|Growth Substances|growth substances|mesh-ancestor
25623992|NCT01225146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25623993|NCT01225146|Growth Inhibitors|growth inhibitors|mesh-ancestor
25623994|NCT01225146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25623995|NCT01225172|Letrozole|letrozole|mesh-list
25623996|NCT01225172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25623997|NCT01225172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25623998|NCT01225172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24549825|NCT00717678|Tacrolimus|tacrolimus|mesh-list
25623999|NCT01225172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624000|NCT01225172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624001|NCT01225172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25624002|NCT01225172|Hormone Antagonists|hormone antagonists|mesh-ancestor
25624003|NCT01225172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25624004|NCT01225172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624005|NCT01225211|Ivacaftor|ivacaftor|mesh-list
25624006|NCT01225211|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25624007|NCT01225211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25624008|NCT01225211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624009|NCT01225263|Vitamin D|vitamin d|mesh-list
25624010|NCT01225263|Simvastatin|simvastatin|mesh-list
25624011|NCT01225263|Vitamins|vitamins|mesh-ancestor
25624012|NCT01225263|Micronutrients|micronutrients|mesh-ancestor
25624013|NCT01225263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624014|NCT01225263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25624015|NCT01225263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25624016|NCT01225263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25624017|NCT01225263|Antimetabolites|antimetabolites|mesh-ancestor
25624018|NCT01225263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624019|NCT01225263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25624020|NCT01225263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25624021|NCT01225263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624022|NCT01225289|Vitamin A|vitamin a|mesh-list
25624023|NCT01225289|Retinol palmitate|retinol palmitate|mesh-list
25624024|NCT01225289|Vitamins|vitamins|mesh-ancestor
25624025|NCT01225289|Micronutrients|micronutrients|mesh-ancestor
25624026|NCT01225289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624027|NCT01225289|Antioxidants|antioxidants|mesh-ancestor
25624028|NCT01225289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624029|NCT01225289|Protective Agents|protective agents|mesh-ancestor
25624030|NCT01225289|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25624031|NCT01225289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25624032|NCT01225354|Calcium|calcium|mesh-list
25624033|NCT01225354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25624034|NCT01225354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624035|NCT01225549|Budesonide|budesonide|mesh-list
25624036|NCT01225549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25624037|NCT01225549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25624038|NCT01225549|Autonomic Agents|autonomic agents|mesh-ancestor
25624039|NCT01225549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25624040|NCT01225549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624041|NCT01225549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25624042|NCT01225549|Respiratory System Agents|respiratory system agents|mesh-ancestor
25624043|NCT01225549|Glucocorticoids|glucocorticoids|mesh-ancestor
25624044|NCT01225549|Hormones|hormones|mesh-ancestor
25624045|NCT01225549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25624046|NCT01225562|Ticagrelor|ticagrelor|mesh-list
25624047|NCT01225562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25624048|NCT01225562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25624049|NCT01225562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25624050|NCT01225562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25624051|NCT01225562|Purinergic Agents|purinergic agents|mesh-ancestor
25624052|NCT01225562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25624053|NCT01225562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624054|NCT01225562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624055|NCT01225822|Enoxaparin|enoxaparin|mesh-list
25624056|NCT01225822|Dabigatran|dabigatran|mesh-list
25624057|NCT01225822|Anticoagulants|anticoagulants|mesh-ancestor
25624058|NCT01225822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25624059|NCT01225822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25624060|NCT01225822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624061|NCT01225822|Antithrombins|antithrombins|mesh-ancestor
25624062|NCT01225822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25624063|NCT01225822|Protease Inhibitors|protease inhibitors|mesh-ancestor
25624064|NCT01225822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624065|NCT01225835|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25624066|NCT01225835|Cetrorelix|cetrorelix|mesh-list
25624067|NCT01225835|Menotropins|menotropins|mesh-list
25624068|NCT01225835|Progesterone|progesterone|mesh-list
25624069|NCT01225835|Progestins|progestins|mesh-ancestor
25624070|NCT01225835|Hormones|hormones|mesh-ancestor
25624071|NCT01225835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25624072|NCT01225835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624073|NCT01225835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25624074|NCT01225835|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25624075|NCT01225835|Fertility Agents|fertility agents|mesh-ancestor
25624076|NCT01225835|Hormone Antagonists|hormone antagonists|mesh-ancestor
25624077|NCT01225887|Nintedanib|nintedanib|mesh-list
24550357|NCT00720421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550358|NCT00720421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24550359|NCT00720421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24550360|NCT00720421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24550377|NCT00720447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550378|NCT00720447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550379|NCT00720447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25624078|NCT01225887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25624079|NCT01225887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25624080|NCT01225887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624081|NCT01225887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655512|NCT01563536|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25655513|NCT01563536|Protease Inhibitors|protease inhibitors|mesh-ancestor
25655514|NCT01563536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655515|NCT01563536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655516|NCT01563536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25655517|NCT01563536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25655518|NCT01563536|Antiviral Agents|antiviral agents|mesh-ancestor
25655519|NCT01563536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25655520|NCT01563536|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25715713|NCT02377752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25715714|NCT02377752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25715715|NCT02377752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25715716|NCT02377752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25715717|NCT02377752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25715718|NCT02377752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715719|NCT02378480|Linezolid|linezolid|mesh-list
25655521|NCT01563536|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25655522|NCT01563536|Antimetabolites|antimetabolites|mesh-ancestor
25655523|NCT01564277|Allopurinol|allopurinol|mesh-list
25655524|NCT01564277|Rasburicase|rasburicase|mesh-list
25655525|NCT01564277|Antimetabolites|antimetabolites|mesh-ancestor
25655526|NCT01564277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655527|NCT01564277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655528|NCT01564277|Gout Suppressants|gout suppressants|mesh-ancestor
25655529|NCT01564277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25655530|NCT01564277|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25655531|NCT01564277|Antioxidants|antioxidants|mesh-ancestor
25655532|NCT01564277|Protective Agents|protective agents|mesh-ancestor
25655533|NCT01564277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655534|NCT01564758|Linezolid|linezolid|mesh-list
25655535|NCT01564758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25655536|NCT01564758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25655537|NCT01564758|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25655538|NCT01564758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655539|NCT01564758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655540|NCT01564784|Cytarabine|cytarabine|mesh-list
25655541|NCT01564784|Fludarabine|fludarabine|mesh-list
25655542|NCT01564784|Mitoxantrone|mitoxantrone|mesh-list
25655543|NCT01564784|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25655544|NCT01564784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25655545|NCT01564784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25655546|NCT01564784|Antimetabolites|antimetabolites|mesh-ancestor
25655547|NCT01564784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655548|NCT01564784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25655549|NCT01564784|Immunologic Factors|immunologic factors|mesh-ancestor
25655550|NCT01564784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655551|NCT01564784|Antiviral Agents|antiviral agents|mesh-ancestor
25655552|NCT01564784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25655553|NCT01564784|Analgesics|analgesics|mesh-ancestor
25655554|NCT01564784|Sensory System Agents|sensory system agents|mesh-ancestor
25655555|NCT01564784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25655556|NCT01564784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25655557|NCT01564784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25655558|NCT01564784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655559|NCT01564784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25655560|NCT01564784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25655561|NCT01564862|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25655562|NCT01564862|Vortioxetine|vortioxetine|mesh-list
25655563|NCT01564862|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25655564|NCT01564862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25655565|NCT01564862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25655566|NCT01564862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624083|NCT01225991|Levomilnacipran|levomilnacipran|mesh-list
25624084|NCT01225991|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25715720|NCT02378480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25715721|NCT02378480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25715722|NCT02378480|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25715723|NCT02378480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25715724|NCT02378480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443322|NCT00294463|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24443323|NCT00294463|Anabolic Agents|anabolic agents|mesh-ancestor
24443324|NCT00294463|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24443325|NCT00294463|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24443326|NCT00294463|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24443327|NCT00294463|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24443328|NCT00294502|Minocycline|minocycline|mesh-list
24443329|NCT00294502|Gentamicins|gentamicins|mesh-list
25715725|NCT02378506|Etanercept|etanercept|mesh-list
25715726|NCT02378506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25715727|NCT02378506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25624085|NCT01225991|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25624086|NCT01225991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25624087|NCT01225991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624088|NCT01225991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25624089|NCT01225991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624090|NCT01225991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25624091|NCT01225991|Analgesics|analgesics|mesh-ancestor
25624092|NCT01225991|Sensory System Agents|sensory system agents|mesh-ancestor
25624093|NCT01225991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25624094|NCT01225991|Antidepressive Agents|antidepressive agents|mesh-ancestor
25624095|NCT01225991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25624096|NCT01226043|Insulin Glargine|insulin glargine|mesh-list
25624097|NCT01226043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25624098|NCT01226043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624099|NCT01226420|Alefacept|alefacept|mesh-list
25624100|NCT01226420|Dermatologic Agents|dermatologic agents|mesh-ancestor
25624101|NCT01226420|Immunologic Factors|immunologic factors|mesh-ancestor
25624102|NCT01226420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624103|NCT01226459|Minoxidil|minoxidil|mesh-list
25624104|NCT01226459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25624105|NCT01226459|Vasodilator Agents|vasodilator agents|mesh-ancestor
25624106|NCT01226472|Mogamulizumab|mogamulizumab|mesh-list
25624107|NCT01226472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25624108|NCT01226511|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25624109|NCT01226511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25624110|NCT01226511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25624111|NCT01226511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25624112|NCT01226511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624113|NCT01226511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25624114|NCT01226511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624115|NCT01226511|Analgesics|analgesics|mesh-ancestor
25624116|NCT01226511|Sensory System Agents|sensory system agents|mesh-ancestor
25624117|NCT01226511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25624118|NCT01226511|Antidepressive Agents|antidepressive agents|mesh-ancestor
25624119|NCT01226511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25624120|NCT01226511|Dopamine Agents|dopamine agents|mesh-ancestor
25624121|NCT01226706|Botulinum Toxins|botulinum toxins|mesh-list
25624122|NCT01226706|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25624123|NCT01226706|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25624124|NCT01226706|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25624125|NCT01226706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25624126|NCT01226706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624127|NCT01226706|Cholinergic Agents|cholinergic agents|mesh-ancestor
25624128|NCT01226706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25624129|NCT01226706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624130|NCT01226706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25624131|NCT01226706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25624132|NCT01226719|Leucovorin|leucovorin|mesh-list
25715728|NCT02378506|Analgesics|analgesics|mesh-ancestor
25715729|NCT02378506|Sensory System Agents|sensory system agents|mesh-ancestor
25715730|NCT02378506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25715731|NCT02378506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715732|NCT02378506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25715733|NCT02378506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25715734|NCT02378506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25715735|NCT02378506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25715736|NCT02378506|Immunologic Factors|immunologic factors|mesh-ancestor
25715737|NCT02378714|Varenicline|varenicline|mesh-list
25715738|NCT02378714|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25624133|NCT01226719|Fluorouracil|fluorouracil|mesh-list
25624134|NCT01226719|Oxaliplatin|oxaliplatin|mesh-list
25624135|NCT01226719|Irinotecan|irinotecan|mesh-list
25624136|NCT01226719|Panitumumab|panitumumab|mesh-list
25624137|NCT01226719|Antimetabolites|antimetabolites|mesh-ancestor
25624138|NCT01226719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624139|NCT01226719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25624140|NCT01226719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25624141|NCT01226719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25624142|NCT01226719|Immunologic Factors|immunologic factors|mesh-ancestor
25624143|NCT01226719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624144|NCT01226719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25624145|NCT01226719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25624146|NCT01226719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624147|NCT01226719|Antidotes|antidotes|mesh-ancestor
25624148|NCT01226719|Protective Agents|protective agents|mesh-ancestor
25624149|NCT01226719|Vitamin B Complex|vitamin b complex|mesh-ancestor
25624150|NCT01226719|Vitamins|vitamins|mesh-ancestor
25624151|NCT01226719|Micronutrients|micronutrients|mesh-ancestor
25624152|NCT01226719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25624153|NCT01226745|Ceralifimod|ceralifimod|mesh-list
25624154|NCT01226745|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25518744|NCT00444925|Fesoterodine|fesoterodine|mesh-list
25624155|NCT01226745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624156|NCT01226745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25715739|NCT02378714|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25715740|NCT02378714|Cholinergic Agents|cholinergic agents|mesh-ancestor
25715741|NCT02378714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25715742|NCT02378714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715743|NCT02378714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715744|NCT02378935|Sofosbuvir|sofosbuvir|mesh-list
25715745|NCT02378935|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25715746|NCT02378935|Velpatasvir|velpatasvir|mesh-list
25715747|NCT02378935|Antiviral Agents|antiviral agents|mesh-ancestor
25624157|NCT01226745|Immunologic Factors|immunologic factors|mesh-ancestor
25624158|NCT01226745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624159|NCT01227044|Naltrexone|naltrexone|mesh-list
25624160|NCT01227044|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25624161|NCT01227044|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25624162|NCT01227044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624163|NCT01227044|Sensory System Agents|sensory system agents|mesh-ancestor
25624164|NCT01227044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25624165|NCT01227278|Benralizumab|benralizumab|mesh-list
25624166|NCT01227278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25624167|NCT01227278|Respiratory System Agents|respiratory system agents|mesh-ancestor
25624168|NCT01227395|Azithromycin|azithromycin|mesh-list
25624169|NCT01227395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25624170|NCT01227395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25624171|NCT01227421|Nitazoxanide|nitazoxanide|mesh-list
25624172|NCT01227421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25624173|NCT01227421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25624174|NCT01227434|Palbociclib|palbociclib|mesh-list
25624175|NCT01227434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25624176|NCT01227434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25624177|NCT01227434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624178|NCT01227434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624179|NCT01227512|Tolvaptan|tolvaptan|mesh-list
25624180|NCT01227512|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25624181|NCT01227512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624182|NCT01227512|Natriuretic Agents|natriuretic agents|mesh-ancestor
25624183|NCT01227512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624184|NCT01227564|Saponin QA-21V1|saponin qa-21v1|mesh-list
25624185|NCT01227564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25624186|NCT01227564|Immunologic Factors|immunologic factors|mesh-ancestor
25624187|NCT01227564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624188|NCT01227629|Warfarin|warfarin|mesh-list
25624189|NCT01227629|Dabigatran|dabigatran|mesh-list
25624190|NCT01227629|Anticoagulants|anticoagulants|mesh-ancestor
25624191|NCT01227629|Antithrombins|antithrombins|mesh-ancestor
25715748|NCT02378935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24448068|NCT00310128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24448070|NCT00310128|Protective Agents|protective agents|mesh-ancestor
24448071|NCT00310141|Nicotine|nicotine|mesh-list
24448072|NCT00310141|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24448073|NCT00310141|Autonomic Agents|autonomic agents|mesh-ancestor
25715749|NCT02378961|Sofosbuvir|sofosbuvir|mesh-list
25715750|NCT02378961|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25715751|NCT02378961|Velpatasvir|velpatasvir|mesh-list
25715752|NCT02378961|Antiviral Agents|antiviral agents|mesh-ancestor
25715753|NCT02378961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25715754|NCT02379091|Leucovorin|leucovorin|mesh-list
25715755|NCT02379091|Folic Acid|folic acid|mesh-list
25715756|NCT02379091|Methotrexate|methotrexate|mesh-list
25715757|NCT02379091|Levoleucovorin|levoleucovorin|mesh-list
25624192|NCT01227629|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25624193|NCT01227629|Protease Inhibitors|protease inhibitors|mesh-ancestor
25624194|NCT01227629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624195|NCT01227629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624196|NCT01227655|Levodopa|levodopa|mesh-list
25624197|NCT01227655|Carbidopa|carbidopa|mesh-list
25624198|NCT01227655|Opicapone|opicapone|mesh-list
25624199|NCT01227655|Benserazide|benserazide|mesh-list
25624200|NCT01227655|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25624201|NCT01227655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25624202|NCT01227655|Dopamine Agents|dopamine agents|mesh-ancestor
25624203|NCT01227655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25624204|NCT01227655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624205|NCT01227655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624206|NCT01227655|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25624207|NCT01227655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624208|NCT01227655|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25624209|NCT01227668|Aripiprazole|aripiprazole|mesh-list
25624210|NCT01227668|Antidepressive Agents|antidepressive agents|mesh-ancestor
25715758|NCT02379091|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25715759|NCT02379091|Abortifacient Agents|abortifacient agents|mesh-ancestor
25715760|NCT02379091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25715761|NCT02379091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715762|NCT02379091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24454541|NCT03897868|Amlodipine|amlodipine|mesh-list
25715763|NCT02379091|Antimetabolites|antimetabolites|mesh-ancestor
25715764|NCT02379091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715765|NCT02379091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25715766|NCT02379091|Dermatologic Agents|dermatologic agents|mesh-ancestor
25624211|NCT01227668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25624212|NCT01227668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25624213|NCT01227668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25624214|NCT01227668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25624215|NCT01227668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624216|NCT01227668|Dopamine Agonists|dopamine agonists|mesh-ancestor
25624217|NCT01227668|Dopamine Agents|dopamine agents|mesh-ancestor
25624218|NCT01227668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25624219|NCT01227668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624220|NCT01227668|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25624221|NCT01227668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25624222|NCT01227668|Serotonin Agents|serotonin agents|mesh-ancestor
25624223|NCT01227668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25624224|NCT01227668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25624225|NCT01227668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25624226|NCT01227668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25624227|NCT01227707|Leucovorin|leucovorin|mesh-list
25624228|NCT01227707|Bevacizumab|bevacizumab|mesh-list
25624229|NCT01227707|Fluorouracil|fluorouracil|mesh-list
25624230|NCT01227707|Capecitabine|capecitabine|mesh-list
25624231|NCT01227707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25624232|NCT01227707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25624233|NCT01227707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25624234|NCT01227707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25624235|NCT01227707|Growth Substances|growth substances|mesh-ancestor
25624236|NCT01227707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624237|NCT01227707|Growth Inhibitors|growth inhibitors|mesh-ancestor
25624238|NCT01227707|Antimetabolites|antimetabolites|mesh-ancestor
25624239|NCT01227707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624240|NCT01227707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25624241|NCT01227707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25624242|NCT01227707|Immunologic Factors|immunologic factors|mesh-ancestor
25624243|NCT01227707|Antidotes|antidotes|mesh-ancestor
24454589|NCT03878524|Afatinib|afatinib|mesh-list
24454590|NCT03878524|Panobinostat|panobinostat|mesh-list
24454591|NCT03878524|Vemurafenib|vemurafenib|mesh-list
24454592|NCT03878524|Dabrafenib|dabrafenib|mesh-list
24454593|NCT03878524|Ponatinib|ponatinib|mesh-list
24454594|NCT03878524|Idelalisib|idelalisib|mesh-list
24454595|NCT03878524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24454596|NCT03878524|Losartan|losartan|mesh-list
24454597|NCT03878524|Endothelial Growth Factors|endothelial growth factors|mesh-list
24454598|NCT03878524|Antibodies|antibodies|mesh-list
24454599|NCT03878524|Immunoglobulins|immunoglobulins|mesh-list
25715767|NCT02379091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25715768|NCT02379091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25715769|NCT02379091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25715770|NCT02379091|Immunologic Factors|immunologic factors|mesh-ancestor
25715771|NCT02379091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25715772|NCT02379091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25715773|NCT02379091|Antidotes|antidotes|mesh-ancestor
25715774|NCT02379091|Protective Agents|protective agents|mesh-ancestor
25715775|NCT02379091|Vitamin B Complex|vitamin b complex|mesh-ancestor
25624244|NCT01227707|Protective Agents|protective agents|mesh-ancestor
25624245|NCT01227707|Vitamin B Complex|vitamin b complex|mesh-ancestor
25624246|NCT01227707|Vitamins|vitamins|mesh-ancestor
25624247|NCT01227707|Micronutrients|micronutrients|mesh-ancestor
25624248|NCT01227824|Raltegravir Potassium|raltegravir potassium|mesh-list
25624249|NCT01227824|Dolutegravir|dolutegravir|mesh-list
25624250|NCT01227824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25624251|NCT01227824|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25624252|NCT01227824|Antiviral Agents|antiviral agents|mesh-ancestor
25624253|NCT01227824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25624254|NCT01227824|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25624255|NCT01227824|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25624256|NCT01227824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624257|NCT01227824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624258|NCT01227889|Dacarbazine|dacarbazine|mesh-list
25624259|NCT01227889|Dabrafenib|dabrafenib|mesh-list
25624260|NCT01227889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25624261|NCT01227889|Alkylating Agents|alkylating agents|mesh-ancestor
25624262|NCT01227889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624263|NCT01227889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25624264|NCT01227889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25624265|NCT01227889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624266|NCT01227902|Ezogabine|ezogabine|mesh-list
25624267|NCT01227902|Anticonvulsants|anticonvulsants|mesh-ancestor
25624268|NCT01227902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25624269|NCT01227902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624270|NCT01227967|Ribavirin|ribavirin|mesh-list
25624271|NCT01227967|Oseltamivir|oseltamivir|mesh-list
25624272|NCT01227967|Amantadine|amantadine|mesh-list
25624273|NCT01227967|Antimetabolites|antimetabolites|mesh-ancestor
25624274|NCT01227967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624275|NCT01227967|Antiviral Agents|antiviral agents|mesh-ancestor
25624276|NCT01227967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25624277|NCT01227967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624278|NCT01227967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25624279|NCT01227967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25624280|NCT01227967|Dopamine Agents|dopamine agents|mesh-ancestor
25624281|NCT01227967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25624282|NCT01227967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624283|NCT01227967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25624284|NCT01227967|Analgesics|analgesics|mesh-ancestor
25624285|NCT01227967|Sensory System Agents|sensory system agents|mesh-ancestor
25624286|NCT01227967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25624287|NCT01227993|Finasteride|finasteride|mesh-list
25624288|NCT01227993|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25715776|NCT02379091|Vitamins|vitamins|mesh-ancestor
25715777|NCT02379091|Micronutrients|micronutrients|mesh-ancestor
25715778|NCT02379091|Hematinics|hematinics|mesh-ancestor
25715779|NCT02379195|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25715780|NCT02379195|Cyclophosphamide|cyclophosphamide|mesh-list
25715781|NCT02379195|Fludarabine|fludarabine|mesh-list
25715782|NCT02379195|Interleukin-2|interleukin-2|mesh-list
25715783|NCT02379195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25715784|NCT02379195|Immunologic Factors|immunologic factors|mesh-ancestor
25715785|NCT02379195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715786|NCT02379195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25715787|NCT02379195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25715788|NCT02379195|Alkylating Agents|alkylating agents|mesh-ancestor
25624289|NCT01227993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25624290|NCT01227993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624291|NCT01227993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624292|NCT01227993|Hormone Antagonists|hormone antagonists|mesh-ancestor
25624293|NCT01227993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25624294|NCT01227993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624295|NCT01227993|Urological Agents|urological agents|mesh-ancestor
25624296|NCT01228019|Niacin|niacin|mesh-list
25624297|NCT01228019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25624298|NCT01228019|Antimetabolites|antimetabolites|mesh-ancestor
25624299|NCT01228019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624300|NCT01228019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25624301|NCT01228019|Vasodilator Agents|vasodilator agents|mesh-ancestor
25624302|NCT01228019|Vitamin B Complex|vitamin b complex|mesh-ancestor
25624303|NCT01228019|Vitamins|vitamins|mesh-ancestor
25624304|NCT01228019|Micronutrients|micronutrients|mesh-ancestor
25624305|NCT01228019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624306|NCT01228071|Testosterone|testosterone|mesh-list
25624307|NCT01228071|Androgens|androgens|mesh-ancestor
25624308|NCT01228071|Hormones|hormones|mesh-ancestor
25624309|NCT01228071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25624310|NCT01228071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624311|NCT01228084|Sulforaphane|sulforaphane|mesh-list
25624312|NCT01228084|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25624313|NCT01228084|Protective Agents|protective agents|mesh-ancestor
25624314|NCT01228084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624315|NCT01228084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24454762|NCT03715972|Acetazolamide|acetazolamide|mesh-list
24454763|NCT03715972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24454764|NCT03715972|Antisickling Agents|antisickling agents|mesh-ancestor
24454765|NCT03715972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25715789|NCT02379195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715790|NCT02379195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25715791|NCT02379195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25715792|NCT02379195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25715793|NCT02379195|Analgesics|analgesics|mesh-ancestor
25715794|NCT02379195|Sensory System Agents|sensory system agents|mesh-ancestor
25715795|NCT02379195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25624316|NCT01228149|Acetazolamide|acetazolamide|mesh-list
25624317|NCT01228149|Anticonvulsants|anticonvulsants|mesh-ancestor
25624318|NCT01228149|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25624319|NCT01228149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624320|NCT01228149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624321|NCT01228149|Diuretics|diuretics|mesh-ancestor
25624322|NCT01228149|Natriuretic Agents|natriuretic agents|mesh-ancestor
25624323|NCT01228149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624324|NCT01228175|Riboflavin|riboflavin|mesh-list
25624325|NCT01228175|Varenicline|varenicline|mesh-list
25624326|NCT01228175|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25624327|NCT01228175|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25624328|NCT01228175|Cholinergic Agents|cholinergic agents|mesh-ancestor
25624329|NCT01228175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25624330|NCT01228175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624331|NCT01228175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624332|NCT01228175|Vitamin B Complex|vitamin b complex|mesh-ancestor
25624333|NCT01228175|Vitamins|vitamins|mesh-ancestor
25624334|NCT01228175|Micronutrients|micronutrients|mesh-ancestor
25624335|NCT01228175|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25624336|NCT01228175|Dermatologic Agents|dermatologic agents|mesh-ancestor
25624337|NCT01228318|Zoledronic Acid|zoledronic acid|mesh-list
25624338|NCT01228318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25624339|NCT01228318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624340|NCT01228734|Leucovorin|leucovorin|mesh-list
25624341|NCT01228734|Folic Acid|folic acid|mesh-list
25624342|NCT01228734|Fluorouracil|fluorouracil|mesh-list
25624343|NCT01228734|Oxaliplatin|oxaliplatin|mesh-list
25624344|NCT01228734|Cetuximab|cetuximab|mesh-list
25624345|NCT01228734|Levoleucovorin|levoleucovorin|mesh-list
25624346|NCT01228734|Antimetabolites|antimetabolites|mesh-ancestor
24448086|NCT00310154|Mitosis Modulators|mitosis modulators|mesh-ancestor
25715796|NCT02379195|Antiviral Agents|antiviral agents|mesh-ancestor
25715797|NCT02379195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25715798|NCT02379221|Lidocaine|lidocaine|mesh-list
25715799|NCT02379221|Epinephrine|epinephrine|mesh-list
25715800|NCT02379221|Benzocaine|benzocaine|mesh-list
25715801|NCT02379221|Anesthetics, Local|anesthetics, local|mesh-ancestor
25715802|NCT02379221|Anesthetics|anesthetics|mesh-ancestor
25715803|NCT02379221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25715804|NCT02379221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624347|NCT01228734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624348|NCT01228734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25624349|NCT01228734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25624350|NCT01228734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25624351|NCT01228734|Immunologic Factors|immunologic factors|mesh-ancestor
25624352|NCT01228734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624353|NCT01228734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25624354|NCT01228734|Antidotes|antidotes|mesh-ancestor
25624355|NCT01228734|Protective Agents|protective agents|mesh-ancestor
25624356|NCT01228734|Vitamin B Complex|vitamin b complex|mesh-ancestor
25624357|NCT01228734|Vitamins|vitamins|mesh-ancestor
25624358|NCT01228734|Micronutrients|micronutrients|mesh-ancestor
25624359|NCT01228734|Hematinics|hematinics|mesh-ancestor
25624360|NCT01228747|Levetiracetam|levetiracetam|mesh-list
25624361|NCT01228747|Anticonvulsants|anticonvulsants|mesh-ancestor
25624362|NCT01228747|Nootropic Agents|nootropic agents|mesh-ancestor
25624363|NCT01228903|Allopurinol|allopurinol|mesh-list
25624364|NCT01228903|Antimetabolites|antimetabolites|mesh-ancestor
25624365|NCT01228903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624366|NCT01228903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624367|NCT01228903|Gout Suppressants|gout suppressants|mesh-ancestor
25624368|NCT01228903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25624369|NCT01228903|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25624370|NCT01228903|Antioxidants|antioxidants|mesh-ancestor
25624371|NCT01228903|Protective Agents|protective agents|mesh-ancestor
25624372|NCT01228903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624373|NCT01229111|Leucovorin|leucovorin|mesh-list
25624374|NCT01229111|Fluorouracil|fluorouracil|mesh-list
25624375|NCT01229111|Oxaliplatin|oxaliplatin|mesh-list
25624376|NCT01229111|Cediranib|cediranib|mesh-list
25624377|NCT01229111|Calcium|calcium|mesh-list
25624378|NCT01229111|Levoleucovorin|levoleucovorin|mesh-list
25624379|NCT01229111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25624380|NCT01229111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624381|NCT01229111|Antimetabolites|antimetabolites|mesh-ancestor
25624382|NCT01229111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624383|NCT01229111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25624384|NCT01229111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25624385|NCT01229111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25715805|NCT02379221|Sensory System Agents|sensory system agents|mesh-ancestor
25715806|NCT02379221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25715807|NCT02379221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25715808|NCT02379221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25715809|NCT02379221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25715810|NCT02379221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25715811|NCT02379221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715812|NCT02379221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25715813|NCT02379221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25624386|NCT01229111|Immunologic Factors|immunologic factors|mesh-ancestor
25624387|NCT01229111|Antidotes|antidotes|mesh-ancestor
25624388|NCT01229111|Protective Agents|protective agents|mesh-ancestor
25624389|NCT01229111|Vitamin B Complex|vitamin b complex|mesh-ancestor
25624390|NCT01229111|Vitamins|vitamins|mesh-ancestor
25624391|NCT01229111|Micronutrients|micronutrients|mesh-ancestor
25624392|NCT01229111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624393|NCT01229111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25624394|NCT01229150|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25624395|NCT01229150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25624396|NCT01229150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25624397|NCT01229150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624398|NCT01229150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624399|NCT01229176|Vaccines|vaccines|mesh-list
25624400|NCT01229176|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25624401|NCT01229176|Immunologic Factors|immunologic factors|mesh-ancestor
25624402|NCT01229176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624403|NCT01229228|Naproxen|naproxen|mesh-list
25624404|NCT01229228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25624405|NCT01229228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25624406|NCT01229228|Analgesics|analgesics|mesh-ancestor
25624407|NCT01229228|Sensory System Agents|sensory system agents|mesh-ancestor
25624408|NCT01229228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25624409|NCT01229228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624410|NCT01229228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25624411|NCT01229228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25624412|NCT01229228|Gout Suppressants|gout suppressants|mesh-ancestor
25624413|NCT01229228|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25624414|NCT01229228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624415|NCT01229228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624416|NCT01229254|Amiodarone|amiodarone|mesh-list
25624417|NCT01229254|Betrixaban|betrixaban|mesh-list
25624418|NCT01229254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25624419|NCT01229254|Vasodilator Agents|vasodilator agents|mesh-ancestor
25624420|NCT01229254|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25624421|NCT01229254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25624422|NCT01229254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624423|NCT01229254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25624424|NCT01229254|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25624425|NCT01229254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25624426|NCT01229254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624427|NCT01229254|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25624428|NCT01229254|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25624429|NCT01229254|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25624430|NCT01229254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25624431|NCT01229254|Antithrombins|antithrombins|mesh-ancestor
25624432|NCT01229254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25624433|NCT01229254|Protease Inhibitors|protease inhibitors|mesh-ancestor
25624434|NCT01229254|Anticoagulants|anticoagulants|mesh-ancestor
25624435|NCT01229267|Vaccines|vaccines|mesh-list
25624436|NCT01229267|Immunologic Factors|immunologic factors|mesh-ancestor
25624437|NCT01229267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624438|NCT01229371|Vaccines|vaccines|mesh-list
25624439|NCT01229371|Immunologic Factors|immunologic factors|mesh-ancestor
25624440|NCT01229371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624441|NCT01229410|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25715814|NCT02379221|Adrenergic Agents|adrenergic agents|mesh-ancestor
25715815|NCT02379221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25715816|NCT02379221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25715817|NCT02379221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25715818|NCT02379221|Autonomic Agents|autonomic agents|mesh-ancestor
25715819|NCT02379221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25715820|NCT02379221|Respiratory System Agents|respiratory system agents|mesh-ancestor
25715821|NCT02379221|Mydriatics|mydriatics|mesh-ancestor
25715822|NCT02379221|Sympathomimetics|sympathomimetics|mesh-ancestor
25624442|NCT01229410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25624443|NCT01229410|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25624444|NCT01229410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25624445|NCT01229410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25624446|NCT01229410|Adrenergic Agents|adrenergic agents|mesh-ancestor
25624447|NCT01229410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25624448|NCT01229410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624449|NCT01229410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624450|NCT01229423|Bimatoprost|bimatoprost|mesh-list
25624451|NCT01229423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25624452|NCT01229449|Acetaminophen|acetaminophen|mesh-list
25624453|NCT01229449|Ibuprofen|ibuprofen|mesh-list
25624454|NCT01229449|Codeine|codeine|mesh-list
25624455|NCT01229449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25624456|NCT01229449|Analgesics|analgesics|mesh-ancestor
25624457|NCT01229449|Sensory System Agents|sensory system agents|mesh-ancestor
25624458|NCT01229449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25624459|NCT01229449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519010|NCT00446030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624460|NCT01229449|Antipyretics|antipyretics|mesh-ancestor
25624461|NCT01229449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25624462|NCT01229449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25624463|NCT01229449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25624464|NCT01229449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25624465|NCT01229449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624466|NCT01229449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624467|NCT01229449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25624468|NCT01229449|Narcotics|narcotics|mesh-ancestor
25624469|NCT01229449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25624470|NCT01229449|Antitussive Agents|antitussive agents|mesh-ancestor
25624471|NCT01229449|Respiratory System Agents|respiratory system agents|mesh-ancestor
25624472|NCT01229462|Timolol|timolol|mesh-list
25624473|NCT01229462|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25624474|NCT01229462|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25624475|NCT01229462|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25624476|NCT01229462|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25624477|NCT01229462|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25624478|NCT01229462|Adrenergic Agents|adrenergic agents|mesh-ancestor
24454860|NCT03451799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24454861|NCT03451799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24454862|NCT03412591|Suvorexant|suvorexant|mesh-list
24454863|NCT03412591|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24454864|NCT03412591|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24454865|NCT03412591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25715823|NCT02379221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25715824|NCT02379637|Acetylcysteine|acetylcysteine|mesh-list
25715825|NCT02379637|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25715826|NCT02379637|Antiviral Agents|antiviral agents|mesh-ancestor
25715827|NCT02379637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25715828|NCT02379637|Expectorants|expectorants|mesh-ancestor
25715829|NCT02379637|Respiratory System Agents|respiratory system agents|mesh-ancestor
25715830|NCT02379637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25624479|NCT01229462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25624480|NCT01229462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624481|NCT01229462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624482|NCT01229462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25624483|NCT01229462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25624484|NCT01229462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25624485|NCT01229462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25624486|NCT01229462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25624487|NCT01229527|Meperidine|meperidine|mesh-list
25624488|NCT01229527|Remifentanil|remifentanil|mesh-list
25624489|NCT01229527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25624490|NCT01229527|Narcotics|narcotics|mesh-ancestor
25624491|NCT01229527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25624492|NCT01229527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624493|NCT01229527|Analgesics|analgesics|mesh-ancestor
25624494|NCT01229527|Sensory System Agents|sensory system agents|mesh-ancestor
25624495|NCT01229527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25624496|NCT01229527|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25624497|NCT01229735|Topiramate|topiramate|mesh-list
25624498|NCT01229735|Levetiracetam|levetiracetam|mesh-list
25624499|NCT01229735|Anticonvulsants|anticonvulsants|mesh-ancestor
25624500|NCT01229735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25624501|NCT01229735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624502|NCT01229735|Nootropic Agents|nootropic agents|mesh-ancestor
25624503|NCT01229891|Vitamin D|vitamin d|mesh-list
25624504|NCT01229891|Ergocalciferols|ergocalciferols|mesh-list
25624505|NCT01229891|Cholecalciferol|cholecalciferol|mesh-list
25624506|NCT01229891|Vitamins|vitamins|mesh-list
25624507|NCT01229891|Micronutrients|micronutrients|mesh-ancestor
25624508|NCT01229891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624509|NCT01229891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25624510|NCT01229891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25624511|NCT01230177|Etanercept|etanercept|mesh-list
25624512|NCT01230177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25624513|NCT01230177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25624514|NCT01230177|Analgesics|analgesics|mesh-ancestor
25624515|NCT01230177|Sensory System Agents|sensory system agents|mesh-ancestor
25624516|NCT01230177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25624517|NCT01230177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624518|NCT01230177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25624519|NCT01230177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25624520|NCT01230177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25624521|NCT01230177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25624522|NCT01230177|Immunologic Factors|immunologic factors|mesh-ancestor
25624523|NCT01230424|Triamcinolone|triamcinolone|mesh-list
25624524|NCT01230424|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25624525|NCT01230424|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25624526|NCT01230424|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25624527|NCT01230424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25624528|NCT01230424|Glucocorticoids|glucocorticoids|mesh-ancestor
25624529|NCT01230424|Hormones|hormones|mesh-ancestor
25624530|NCT01230424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25624531|NCT01230424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624532|NCT01230424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25624533|NCT01230424|Immunologic Factors|immunologic factors|mesh-ancestor
25624534|NCT01230424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624535|NCT01230424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624536|NCT01230502|Mycophenolic Acid|mycophenolic acid|mesh-list
24448265|NCT00310921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448266|NCT00310921|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24448268|NCT00310921|Oxytocics|oxytocics|mesh-ancestor
25624537|NCT01230502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25624538|NCT01230502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25624539|NCT01230502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25624540|NCT01230502|Antitubercular Agents|antitubercular agents|mesh-ancestor
25624541|NCT01230502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25624542|NCT01230502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25624543|NCT01230502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624544|NCT01230502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624545|NCT01230593|Tobramycin|tobramycin|mesh-list
25624546|NCT01230593|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
25624547|NCT01230593|Dexamethasone|dexamethasone|mesh-list
25624548|NCT01230593|Dexamethasone acetate|dexamethasone acetate|mesh-list
25624549|NCT01230593|BB 1101|bb 1101|mesh-list
25624550|NCT01230593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25624551|NCT01230593|Antiemetics|antiemetics|mesh-ancestor
25624552|NCT01230593|Autonomic Agents|autonomic agents|mesh-ancestor
25624553|NCT01230593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25624554|NCT01230593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624555|NCT01230593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25624556|NCT01230593|Glucocorticoids|glucocorticoids|mesh-ancestor
25624557|NCT01230593|Hormones|hormones|mesh-ancestor
25624558|NCT01230593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25624559|NCT01230593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25624560|NCT01230593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25624561|NCT01230593|Protease Inhibitors|protease inhibitors|mesh-ancestor
25624562|NCT01230593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624563|NCT01230593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624564|NCT01230593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25624565|NCT01230593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25624566|NCT01230593|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25624567|NCT01230593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25624568|NCT01230710|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25624569|NCT01230710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25624570|NCT01230710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25624571|NCT01230710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624572|NCT01230710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624573|NCT01230749|Pioglitazone|pioglitazone|mesh-list
25624574|NCT01230749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25624575|NCT01230749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624576|NCT01230814|Metronidazole|metronidazole|mesh-list
25624577|NCT01230814|Miconazole|miconazole|mesh-list
25624578|NCT01230814|Clotrimazole|clotrimazole|mesh-list
25624579|NCT01230814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25624580|NCT01230814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25624581|NCT01230814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25624582|NCT01230814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25624583|NCT01230814|Antifungal Agents|antifungal agents|mesh-ancestor
25624584|NCT01230814|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25624585|NCT01230814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25624586|NCT01230814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624587|NCT01230814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624588|NCT01230814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25624589|NCT01230814|Hormone Antagonists|hormone antagonists|mesh-ancestor
25624590|NCT01230814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25624591|NCT01230814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624592|NCT01230814|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25624593|NCT01230814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25624594|NCT01230814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25624595|NCT01230827|Golimumab|golimumab|mesh-list
25624596|NCT01230827|Methotrexate|methotrexate|mesh-list
25624597|NCT01230827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25624598|NCT01230827|Abortifacient Agents|abortifacient agents|mesh-ancestor
25624599|NCT01230827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24448271|NCT00310934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24448272|NCT00310934|Narcotics|narcotics|mesh-ancestor
24448273|NCT00310934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25624600|NCT01230827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624601|NCT01230827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25624602|NCT01230827|Antimetabolites|antimetabolites|mesh-ancestor
25624603|NCT01230827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624604|NCT01230827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25624605|NCT01230827|Dermatologic Agents|dermatologic agents|mesh-ancestor
25624606|NCT01230827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624607|NCT01230827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25624608|NCT01230827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25624609|NCT01230827|Immunologic Factors|immunologic factors|mesh-ancestor
25624610|NCT01230827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25624611|NCT01230827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25624612|NCT01230827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25624613|NCT01230827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25624614|NCT01230892|Atenolol|atenolol|mesh-list
25624615|NCT01230892|Nebivolol|nebivolol|mesh-list
25624616|NCT01230892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25624617|NCT01230892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25624618|NCT01230892|Sympatholytics|sympatholytics|mesh-ancestor
25624619|NCT01230892|Autonomic Agents|autonomic agents|mesh-ancestor
25624620|NCT01230892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25624621|NCT01230892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624622|NCT01230892|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25624623|NCT01230892|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25624624|NCT01230892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25624625|NCT01230892|Adrenergic Agents|adrenergic agents|mesh-ancestor
25624626|NCT01230892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25624627|NCT01230892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624628|NCT01230892|Vasodilator Agents|vasodilator agents|mesh-ancestor
25624629|NCT01230892|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24448299|NCT00311051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448300|NCT00311051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24448301|NCT00311077|Insulin glulisine|insulin glulisine|mesh-list
24448302|NCT00311077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24448304|NCT00311116|Vitamin E|vitamin e|mesh-list
25715842|NCT02380287|Immunologic Factors|immunologic factors|mesh-ancestor
25715843|NCT02380287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715844|NCT02380742|Lidocaine|lidocaine|mesh-list
25715845|NCT02380742|Prilocaine|prilocaine|mesh-list
25715846|NCT02380742|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25715847|NCT02380742|Anesthetics, Local|anesthetics, local|mesh-ancestor
25715848|NCT02380742|Anesthetics|anesthetics|mesh-ancestor
25715849|NCT02380742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25715850|NCT02380742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715851|NCT02380742|Sensory System Agents|sensory system agents|mesh-ancestor
25624630|NCT01230892|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25624631|NCT01230892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25624632|NCT01231230|Fluticasone|fluticasone|mesh-list
25624633|NCT01231230|Xhance|xhance|mesh-list
25624634|NCT01231230|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25624635|NCT01231230|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25624636|NCT01231230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25624637|NCT01231230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25624638|NCT01231230|Autonomic Agents|autonomic agents|mesh-ancestor
25624639|NCT01231230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25624640|NCT01231230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624641|NCT01231230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25624642|NCT01231230|Respiratory System Agents|respiratory system agents|mesh-ancestor
25624643|NCT01231230|Dermatologic Agents|dermatologic agents|mesh-ancestor
25624644|NCT01231230|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25624645|NCT01231230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25624646|NCT01231230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25624647|NCT01231230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25624648|NCT01231230|Adrenergic Agents|adrenergic agents|mesh-ancestor
25624649|NCT01231230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25624650|NCT01231230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624651|NCT01231230|Glucocorticoids|glucocorticoids|mesh-ancestor
25624652|NCT01231230|Hormones|hormones|mesh-ancestor
25624653|NCT01231230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25624654|NCT01231230|Sympathomimetics|sympathomimetics|mesh-ancestor
25624655|NCT01231321|Adalimumab|adalimumab|mesh-list
25624656|NCT01231321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25624657|NCT01231321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24454935|NCT03161353|Tubulin Modulators|tubulin modulators|mesh-ancestor
24454936|NCT03161353|Antimitotic Agents|antimitotic agents|mesh-ancestor
24454937|NCT03161353|Mitosis Modulators|mitosis modulators|mesh-ancestor
24454938|NCT03161353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24454939|NCT03161353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24454940|NCT03161353|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24454961|NCT03122262|Tenofovir|tenofovir|mesh-list
24454962|NCT03122262|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24454963|NCT03122262|Dolutegravir|dolutegravir|mesh-list
24454964|NCT03122262|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24454965|NCT03122262|Antiviral Agents|antiviral agents|mesh-ancestor
24454966|NCT03122262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24454967|NCT03122262|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24454968|NCT03122262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24454969|NCT03122262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24454970|NCT03122262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624658|NCT01231334|Clindamycin|clindamycin|mesh-list
25624659|NCT01231334|Clindamycin palmitate|clindamycin palmitate|mesh-list
25624660|NCT01231334|Clindamycin phosphate|clindamycin phosphate|mesh-list
25624661|NCT01231334|Dapsone|dapsone|mesh-list
25624662|NCT01231334|Adapalene|adapalene|mesh-list
25624663|NCT01231334|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25624664|NCT01231334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25624665|NCT01231334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25624666|NCT01231334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25624667|NCT01231334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624668|NCT01231334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624669|NCT01231334|Dermatologic Agents|dermatologic agents|mesh-ancestor
25624670|NCT01231334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25624671|NCT01231334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25624672|NCT01231334|Analgesics|analgesics|mesh-ancestor
25624673|NCT01231334|Sensory System Agents|sensory system agents|mesh-ancestor
25624674|NCT01231334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25624675|NCT01231334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624676|NCT01231334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25624677|NCT01231334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25624678|NCT01231334|Antimalarials|antimalarials|mesh-ancestor
25624679|NCT01231334|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25624680|NCT01231334|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25624681|NCT01231334|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25624682|NCT01231334|Leprostatic Agents|leprostatic agents|mesh-ancestor
25624683|NCT01231373|Polidocanol|polidocanol|mesh-list
25624684|NCT01231373|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25624685|NCT01231373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25624686|NCT01231399|Calcium, Dietary|calcium, dietary|mesh-list
25624687|NCT01231399|Leucovorin|leucovorin|mesh-list
25624688|NCT01231399|Fluorouracil|fluorouracil|mesh-list
25624689|NCT01231399|Oxaliplatin|oxaliplatin|mesh-list
25624690|NCT01231399|Everolimus|everolimus|mesh-list
25624691|NCT01231399|Calcium|calcium|mesh-list
25624692|NCT01231399|Levoleucovorin|levoleucovorin|mesh-list
25624693|NCT01231399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25624694|NCT01231399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624695|NCT01231399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25624696|NCT01231399|Antimetabolites|antimetabolites|mesh-ancestor
25624697|NCT01231399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448441|NCT00311857|Alkylating Agents|alkylating agents|mesh-ancestor
25624698|NCT01231399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25624699|NCT01231399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25624700|NCT01231399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25624701|NCT01231399|Immunologic Factors|immunologic factors|mesh-ancestor
25624702|NCT01231399|Antidotes|antidotes|mesh-ancestor
25624703|NCT01231399|Protective Agents|protective agents|mesh-ancestor
25624704|NCT01231399|Vitamin B Complex|vitamin b complex|mesh-ancestor
25624705|NCT01231399|Vitamins|vitamins|mesh-ancestor
25624706|NCT01231399|Micronutrients|micronutrients|mesh-ancestor
25624707|NCT01231412|Cyclosporine|cyclosporine|mesh-list
25624708|NCT01231412|Sirolimus|sirolimus|mesh-list
25624709|NCT01231412|Mycophenolic Acid|mycophenolic acid|mesh-list
25624710|NCT01231412|Fludarabine|fludarabine|mesh-list
25624711|NCT01231412|Fludarabine phosphate|fludarabine phosphate|mesh-list
25624712|NCT01231412|Cyclosporins|cyclosporins|mesh-list
25624713|NCT01231412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25624714|NCT01231412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25624715|NCT01231412|Antimetabolites|antimetabolites|mesh-ancestor
25624716|NCT01231412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624717|NCT01231412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25624718|NCT01231412|Immunologic Factors|immunologic factors|mesh-ancestor
25624719|NCT01231412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624720|NCT01231412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624721|NCT01231412|Antifungal Agents|antifungal agents|mesh-ancestor
25624722|NCT01231412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25624723|NCT01231412|Dermatologic Agents|dermatologic agents|mesh-ancestor
25624724|NCT01231412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25624725|NCT01231412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25624726|NCT01231412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25715852|NCT02380742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25715853|NCT02380742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25715854|NCT02380742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24454972|NCT03122262|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25715855|NCT02380742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25715856|NCT02380742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25715857|NCT02380742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715858|NCT02380742|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25715859|NCT02382016|Macitentan|macitentan|mesh-list
25624727|NCT01231412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25624728|NCT01231412|Antitubercular Agents|antitubercular agents|mesh-ancestor
25624729|NCT01231412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25624730|NCT01231464|Fluticasone|fluticasone|mesh-list
25624731|NCT01231464|Xhance|xhance|mesh-list
25624732|NCT01231464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25624733|NCT01231464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25624734|NCT01231464|Autonomic Agents|autonomic agents|mesh-ancestor
25624735|NCT01231464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25624736|NCT01231464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624737|NCT01231464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25624738|NCT01231464|Respiratory System Agents|respiratory system agents|mesh-ancestor
25624739|NCT01231464|Dermatologic Agents|dermatologic agents|mesh-ancestor
25624740|NCT01231464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25624741|NCT01231503|Vaccines|vaccines|mesh-list
25624742|NCT01231503|Immunologic Factors|immunologic factors|mesh-ancestor
25624743|NCT01231503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624744|NCT01231555|Efavirenz|efavirenz|mesh-list
25624745|NCT01231555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25624746|NCT01231555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25624747|NCT01231555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624748|NCT01231555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624749|NCT01231555|Antiviral Agents|antiviral agents|mesh-ancestor
25624750|NCT01231555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25624751|NCT01231555|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25624752|NCT01231555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25624753|NCT01231555|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25624754|NCT01231555|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25519284|NCT00448019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25519285|NCT00448019|Antimetabolites|antimetabolites|mesh-ancestor
25519286|NCT00448019|Antiviral Agents|antiviral agents|mesh-ancestor
25624755|NCT01231555|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25624756|NCT01231555|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25624757|NCT01231581|Gemcitabine|gemcitabine|mesh-list
25624758|NCT01231581|Trametinib|trametinib|mesh-list
25624759|NCT01231581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25624761|NCT01231581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624762|NCT01231581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25624763|NCT01231581|Antiviral Agents|antiviral agents|mesh-ancestor
25624764|NCT01231581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25624765|NCT01231581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624766|NCT01231581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25624767|NCT01231581|Immunologic Factors|immunologic factors|mesh-ancestor
25624768|NCT01231581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624769|NCT01231581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25624770|NCT01231607|Finasteride|finasteride|mesh-list
25624771|NCT01231607|Dutasteride|dutasteride|mesh-list
25624772|NCT01231607|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25624773|NCT01231607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25624774|NCT01231607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624775|NCT01231607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624776|NCT01231607|Hormone Antagonists|hormone antagonists|mesh-ancestor
25624777|NCT01231607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25624778|NCT01231607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624779|NCT01231607|Urological Agents|urological agents|mesh-ancestor
25624780|NCT01231620|Oseltamivir|oseltamivir|mesh-list
25624781|NCT01231620|Zanamivir|zanamivir|mesh-list
25624782|NCT01231620|Antiviral Agents|antiviral agents|mesh-ancestor
25624783|NCT01231620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25624784|NCT01231620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624785|NCT01231620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655567|NCT01564862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25655568|NCT01564862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655569|NCT01564862|Analgesics|analgesics|mesh-ancestor
25655570|NCT01564862|Sensory System Agents|sensory system agents|mesh-ancestor
25655571|NCT01564862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25655572|NCT01564862|Antidepressive Agents|antidepressive agents|mesh-ancestor
25655573|NCT01564862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25715860|NCT02382016|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25715861|NCT02382016|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25715862|NCT02382016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24454979|NCT03031483|Lenalidomide|lenalidomide|mesh-list
25715863|NCT02382016|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25715864|NCT02382276|Nalmefene|nalmefene|mesh-list
25715865|NCT02382276|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25715866|NCT02382276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715867|NCT02382276|Sensory System Agents|sensory system agents|mesh-ancestor
25715868|NCT02382276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25655574|NCT01564862|Dopamine Agents|dopamine agents|mesh-ancestor
25655575|NCT01564862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25655576|NCT01564862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25655577|NCT01564862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25655578|NCT01564862|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25655579|NCT01564862|Serotonin Agents|serotonin agents|mesh-ancestor
25655580|NCT01564862|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25655581|NCT01564862|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25655582|NCT01564862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25655583|NCT01564862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25655584|NCT01564914|Bevacizumab|bevacizumab|mesh-list
25655585|NCT01564914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25655586|NCT01564914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25655587|NCT01564914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25655588|NCT01564914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25655589|NCT01564914|Growth Substances|growth substances|mesh-ancestor
25655590|NCT01564914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655591|NCT01564914|Growth Inhibitors|growth inhibitors|mesh-ancestor
25655592|NCT01565083|Trastuzumab|trastuzumab|mesh-list
25655593|NCT01565083|Pertuzumab|pertuzumab|mesh-list
25655594|NCT01565083|Vinorelbine|vinorelbine|mesh-list
25655595|NCT01565083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25655596|NCT01565083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25655597|NCT01565083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25655598|NCT01565083|Tubulin Modulators|tubulin modulators|mesh-ancestor
25655599|NCT01565083|Antimitotic Agents|antimitotic agents|mesh-ancestor
25655600|NCT01565083|Mitosis Modulators|mitosis modulators|mesh-ancestor
25715869|NCT02382640|Febuxostat|febuxostat|mesh-list
25715870|NCT02382640|Gout Suppressants|gout suppressants|mesh-ancestor
25715871|NCT02382640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25715872|NCT02382848|Prazosin|prazosin|mesh-list
25715873|NCT02382848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25715874|NCT02382848|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25715875|NCT02382848|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25715876|NCT02382848|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25655601|NCT01565083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655602|NCT01565148|Ranibizumab|ranibizumab|mesh-list
25655603|NCT01565148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25655604|NCT01565148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25519345|NCT00448227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519346|NCT00448227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519347|NCT00448279|Trastuzumab|trastuzumab|mesh-list
25519348|NCT00448279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25519350|NCT00448357|Methotrexate|methotrexate|mesh-list
25655605|NCT01565148|Growth Substances|growth substances|mesh-ancestor
25655606|NCT01565148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655607|NCT01565148|Growth Inhibitors|growth inhibitors|mesh-ancestor
25624786|NCT01231633|Dexamethasone|dexamethasone|mesh-list
25624787|NCT01231633|Bevacizumab|bevacizumab|mesh-list
25624788|NCT01231633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25624789|NCT01231633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25624790|NCT01231633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25624791|NCT01231633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25624792|NCT01231633|Growth Substances|growth substances|mesh-ancestor
25715877|NCT02382848|Adrenergic Agents|adrenergic agents|mesh-ancestor
25715878|NCT02382848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25715879|NCT02382848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715880|NCT02382848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715881|NCT02383043|Cocaine|cocaine|mesh-list
25715882|NCT02383043|Amphetamine|amphetamine|mesh-list
24455016|NCT03011268|Adalimumab|adalimumab|mesh-list
24455017|NCT03011268|Golimumab|golimumab|mesh-list
24455018|NCT03011268|Infliximab|infliximab|mesh-list
24455019|NCT03011268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24455020|NCT03011268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24455021|NCT03011268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24455022|NCT03011268|Dermatologic Agents|dermatologic agents|mesh-ancestor
24455025|NCT03011268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24455026|NCT03011268|Immunologic Factors|immunologic factors|mesh-ancestor
24505114|NCT00539968|Docetaxel|docetaxel|mesh-list
25715883|NCT02383043|Dextroamphetamine|dextroamphetamine|mesh-list
25715884|NCT02383043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25715885|NCT02383043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624793|NCT01231633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624794|NCT01231633|Growth Inhibitors|growth inhibitors|mesh-ancestor
25624795|NCT01231633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25624796|NCT01231633|Antiemetics|antiemetics|mesh-ancestor
25624797|NCT01231633|Autonomic Agents|autonomic agents|mesh-ancestor
25624798|NCT01231633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25624799|NCT01231633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25624800|NCT01231633|Glucocorticoids|glucocorticoids|mesh-ancestor
25624801|NCT01231633|Hormones|hormones|mesh-ancestor
25624802|NCT01231633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25624803|NCT01231633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25624804|NCT01231659|Everolimus|everolimus|mesh-list
25624805|NCT01231659|Letrozole|letrozole|mesh-list
25624806|NCT01231659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25624807|NCT01231659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25624808|NCT01231659|Immunologic Factors|immunologic factors|mesh-ancestor
25624809|NCT01231659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624810|NCT01231659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25624811|NCT01231659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25624812|NCT01231659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624813|NCT01231659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624814|NCT01231659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25624815|NCT01231659|Hormone Antagonists|hormone antagonists|mesh-ancestor
25624816|NCT01231659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25624817|NCT01231841|Cyclosporine|cyclosporine|mesh-list
25624818|NCT01231841|Cyclosporins|cyclosporins|mesh-list
25624819|NCT01231841|Thymoglobulin|thymoglobulin|mesh-list
25624820|NCT01231841|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25624821|NCT01231841|Immunoglobulins|immunoglobulins|mesh-list
24448515|NCT00312039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24448542|NCT00312156|Insulin Aspart|insulin aspart|mesh-list
24448543|NCT00312156|Insulin Detemir|insulin detemir|mesh-list
24448544|NCT00312156|Isophane Insulin, Human|isophane insulin, human|mesh-list
24448545|NCT00312156|Insulin, Isophane|insulin, isophane|mesh-list
24448546|NCT00312156|Isophane insulin, beef|isophane insulin, beef|mesh-list
24448547|NCT00312156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24448548|NCT00312156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448549|NCT00312182|Nelfinavir|nelfinavir|mesh-list
24448550|NCT00312182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24448551|NCT00312182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24448552|NCT00312182|Protease Inhibitors|protease inhibitors|mesh-ancestor
24448553|NCT00312182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448554|NCT00312182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715886|NCT02383043|Sympathomimetics|sympathomimetics|mesh-ancestor
25715887|NCT02383043|Autonomic Agents|autonomic agents|mesh-ancestor
25715888|NCT02383043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25715889|NCT02383043|Dopamine Agents|dopamine agents|mesh-ancestor
25715890|NCT02383043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25715891|NCT02383043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715892|NCT02383043|Adrenergic Agents|adrenergic agents|mesh-ancestor
25715893|NCT02383043|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25624822|NCT01231841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624823|NCT01231841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624824|NCT01231841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25624825|NCT01231841|Immunologic Factors|immunologic factors|mesh-ancestor
25624826|NCT01231841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624827|NCT01231841|Antifungal Agents|antifungal agents|mesh-ancestor
25624828|NCT01231841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25624829|NCT01231841|Dermatologic Agents|dermatologic agents|mesh-ancestor
25624830|NCT01231841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25624831|NCT01231841|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25624832|NCT01232127|Ritonavir|ritonavir|mesh-list
25624833|NCT01232127|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25624834|NCT01232127|Tenofovir|tenofovir|mesh-list
25624835|NCT01232127|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
25624836|NCT01232127|Famotidine|famotidine|mesh-list
25624837|NCT01232127|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25624838|NCT01232127|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25624839|NCT01232127|Protease Inhibitors|protease inhibitors|mesh-ancestor
25624840|NCT01232127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624841|NCT01232127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624842|NCT01232127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25624843|NCT01232127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25624844|NCT01232127|Antiviral Agents|antiviral agents|mesh-ancestor
25624845|NCT01232127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25624846|NCT01232127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25624847|NCT01232127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25624848|NCT01232127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25624849|NCT01232127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25624850|NCT01232127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25624851|NCT01232127|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25624852|NCT01232127|Histamine Antagonists|histamine antagonists|mesh-ancestor
25624853|NCT01232127|Histamine Agents|histamine agents|mesh-ancestor
25624854|NCT01232127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25624855|NCT01232127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624856|NCT01232205|Micronutrients|micronutrients|mesh-list
25624857|NCT01232205|Trace Elements|trace elements|mesh-list
25624858|NCT01232205|Antioxidants|antioxidants|mesh-list
25624859|NCT01232205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624860|NCT01232205|Protective Agents|protective agents|mesh-ancestor
25624861|NCT01232205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624863|NCT01232296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25624864|NCT01232296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25624865|NCT01232296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624866|NCT01232296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624867|NCT01232452|Cisplatin|cisplatin|mesh-list
25624868|NCT01232452|Pemetrexed|pemetrexed|mesh-list
25624869|NCT01232452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25624870|NCT01232452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624871|NCT01232452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624872|NCT01232452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25624873|NCT01232452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25624874|NCT01232491|Insulin Detemir|insulin detemir|mesh-list
25624875|NCT01232491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25624876|NCT01232491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624877|NCT01232504|Molgramostim|molgramostim|mesh-list
25624878|NCT01232504|Lenograstim|lenograstim|mesh-list
25624879|NCT01232504|Sargramostim|sargramostim|mesh-list
25624880|NCT01232504|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25624881|NCT01232504|Immunologic Factors|immunologic factors|mesh-ancestor
24448582|NCT00312273|Aminophylline|aminophylline|mesh-list
24448583|NCT00312273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24448584|NCT00312273|Autonomic Agents|autonomic agents|mesh-ancestor
25715894|NCT02383043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25715895|NCT02383043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25715898|NCT02383043|Anesthetics|anesthetics|mesh-ancestor
25624882|NCT01232504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624883|NCT01232504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25624884|NCT01232556|Gemcitabine|gemcitabine|mesh-list
25624885|NCT01232556|Rituximab|rituximab|mesh-list
25624886|NCT01232556|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25624887|NCT01232556|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25624888|NCT01232556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25624889|NCT01232556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25624890|NCT01232556|Immunologic Factors|immunologic factors|mesh-ancestor
25624891|NCT01232556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624892|NCT01232556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25624893|NCT01232556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25624894|NCT01232556|Antimetabolites|antimetabolites|mesh-ancestor
25624895|NCT01232556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624896|NCT01232556|Antiviral Agents|antiviral agents|mesh-ancestor
25624897|NCT01232556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25624898|NCT01232556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624899|NCT01232556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25624900|NCT01232556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25624901|NCT01232556|Alkylating Agents|alkylating agents|mesh-ancestor
25624902|NCT01232556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25624903|NCT01232738|Rasagiline|rasagiline|mesh-list
25624904|NCT01232738|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25624905|NCT01232738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624906|NCT01232738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624907|NCT01232738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25771143|NCT03588910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25715902|NCT02383355|Raltegravir Potassium|raltegravir potassium|mesh-list
25771144|NCT03588910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771145|NCT03588910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771146|NCT03588910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25771147|NCT03588910|Narcotics|narcotics|mesh-ancestor
25771148|NCT03588910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25715903|NCT02383355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25715904|NCT02383355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25715905|NCT02383355|Antiviral Agents|antiviral agents|mesh-ancestor
25715906|NCT02383355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25715907|NCT02383355|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25715908|NCT02383355|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25715909|NCT02383355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771149|NCT03589885|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25624908|NCT01232738|Protective Agents|protective agents|mesh-ancestor
25624909|NCT01232738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624910|NCT01232790|Acetylcysteine|acetylcysteine|mesh-list
25624911|NCT01232790|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25624912|NCT01232790|Antiviral Agents|antiviral agents|mesh-ancestor
25624913|NCT01232790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25624914|NCT01232790|Expectorants|expectorants|mesh-ancestor
25624915|NCT01232790|Respiratory System Agents|respiratory system agents|mesh-ancestor
25624916|NCT01232790|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25624917|NCT01232790|Antioxidants|antioxidants|mesh-ancestor
25624918|NCT01232790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624919|NCT01232790|Protective Agents|protective agents|mesh-ancestor
25624920|NCT01232790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624921|NCT01232790|Antidotes|antidotes|mesh-ancestor
25624922|NCT01232829|R04929097|r04929097|mesh-list
25624923|NCT01232829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624924|NCT01232829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624925|NCT01232920|Mycophenolic Acid|mycophenolic acid|mesh-list
25624926|NCT01232920|Methotrexate|methotrexate|mesh-list
25624927|NCT01232920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24448610|NCT00312325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448611|NCT00312416|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24448612|NCT00312416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24448613|NCT00312416|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24448614|NCT00312416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24448615|NCT00312416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24448616|NCT00312416|Adrenergic Agents|adrenergic agents|mesh-ancestor
24448617|NCT00312416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24448647|NCT00312520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24448648|NCT00312520|Glucocorticoids|glucocorticoids|mesh-ancestor
25715910|NCT02383355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771169|NCT03591146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771170|NCT03591406|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25771171|NCT03591406|Hematinics|hematinics|mesh-ancestor
25771172|NCT03592121|Phenylephrine|phenylephrine|mesh-list
25771173|NCT03592121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25771174|NCT03592121|Mydriatics|mydriatics|mesh-ancestor
25771175|NCT03592121|Autonomic Agents|autonomic agents|mesh-ancestor
25771176|NCT03592121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771177|NCT03592121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771178|NCT03592121|Sympathomimetics|sympathomimetics|mesh-ancestor
25771179|NCT03592121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25771180|NCT03592121|Nasal Decongestants|nasal decongestants|mesh-ancestor
25771181|NCT03592121|Respiratory System Agents|respiratory system agents|mesh-ancestor
25771182|NCT03592121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25771183|NCT03592121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25624928|NCT01232920|Abortifacient Agents|abortifacient agents|mesh-ancestor
25624929|NCT01232920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25624930|NCT01232920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624931|NCT01232920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25624932|NCT01232920|Antimetabolites|antimetabolites|mesh-ancestor
25624933|NCT01232920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624934|NCT01232920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25624935|NCT01232920|Dermatologic Agents|dermatologic agents|mesh-ancestor
25624936|NCT01232920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624937|NCT01232920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25624938|NCT01232920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25624939|NCT01232920|Immunologic Factors|immunologic factors|mesh-ancestor
25624940|NCT01232920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25624941|NCT01232920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25624942|NCT01232920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25624943|NCT01232920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25624944|NCT01232920|Antitubercular Agents|antitubercular agents|mesh-ancestor
25624945|NCT01232920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25624946|NCT01232920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25624948|NCT01232946|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25624949|NCT01232946|Liraglutide|liraglutide|mesh-list
25624950|NCT01232946|Insulin Detemir|insulin detemir|mesh-list
25624951|NCT01232946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25624952|NCT01232946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624953|NCT01232946|Incretins|incretins|mesh-ancestor
25624954|NCT01232946|Hormones|hormones|mesh-ancestor
25624955|NCT01232946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25624956|NCT01233050|Ethanol|ethanol|mesh-list
25624957|NCT01233050|Chlorhexidine|chlorhexidine|mesh-list
25624958|NCT01233050|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25624959|NCT01233050|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25624960|NCT01233050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25624961|NCT01233050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25624962|NCT01233050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624963|NCT01233050|Disinfectants|disinfectants|mesh-ancestor
25624964|NCT01233050|Dermatologic Agents|dermatologic agents|mesh-ancestor
25624965|NCT01233258|Factor VIII|factor viii|mesh-list
25624966|NCT01233258|Coagulants|coagulants|mesh-ancestor
25624967|NCT01233284|Bromides|bromides|mesh-list
25624968|NCT01233284|Tiotropium Bromide|tiotropium bromide|mesh-list
25624969|NCT01233284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25624970|NCT01233284|Autonomic Agents|autonomic agents|mesh-ancestor
25624971|NCT01233284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25624972|NCT01233284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624973|NCT01233284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25624974|NCT01233284|Respiratory System Agents|respiratory system agents|mesh-ancestor
25624975|NCT01233284|Parasympatholytics|parasympatholytics|mesh-ancestor
25624976|NCT01233284|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25624977|NCT01233284|Cholinergic Agents|cholinergic agents|mesh-ancestor
25624978|NCT01233284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25624979|NCT01233284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624980|NCT01233284|Anticonvulsants|anticonvulsants|mesh-ancestor
25624981|NCT01233609|Valproic Acid|valproic acid|mesh-list
25624982|NCT01233609|Anticonvulsants|anticonvulsants|mesh-ancestor
25624983|NCT01233609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624984|NCT01233609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624985|NCT01233609|GABA Agents|gaba agents|mesh-ancestor
24455084|NCT02876107|Paclitaxel|paclitaxel|mesh-list
25715911|NCT02383589|Mycophenolic Acid|mycophenolic acid|mesh-list
25715912|NCT02383589|Rituximab|rituximab|mesh-list
25715913|NCT02383589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25715914|NCT02383589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25715915|NCT02383589|Immunologic Factors|immunologic factors|mesh-ancestor
25715916|NCT02383589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715917|NCT02383589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25624986|NCT01233609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25624987|NCT01233609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25624988|NCT01233609|Antimanic Agents|antimanic agents|mesh-ancestor
25624989|NCT01233609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25624990|NCT01233609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25624991|NCT01233609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25624992|NCT01233687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25624993|NCT01233687|Rilotumumab|rilotumumab|mesh-list
25624994|NCT01233687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25624995|NCT01233687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25624996|NCT01233687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25624997|NCT01233687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25624998|NCT01233687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25624999|NCT01233921|Mitogens|mitogens|mesh-list
25625000|NCT01233921|Mitosis Modulators|mitosis modulators|mesh-ancestor
25625001|NCT01233921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625002|NCT01233999|Botulinum Toxins|botulinum toxins|mesh-list
25625003|NCT01233999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25625004|NCT01233999|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25625005|NCT01233999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25625006|NCT01233999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25625007|NCT01233999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625008|NCT01233999|Cholinergic Agents|cholinergic agents|mesh-ancestor
25625009|NCT01233999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25625010|NCT01233999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625011|NCT01233999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25625012|NCT01233999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25625013|NCT01234337|Capecitabine|capecitabine|mesh-list
25625014|NCT01234337|Sorafenib|sorafenib|mesh-list
25625015|NCT01234337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25625016|NCT01234337|Antimetabolites|antimetabolites|mesh-ancestor
25625017|NCT01234337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625018|NCT01234337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625019|NCT01234337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25625020|NCT01234337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25625021|NCT01234402|Capecitabine|capecitabine|mesh-list
25625022|NCT01234402|Ramucirumab|ramucirumab|mesh-list
25625023|NCT01234402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25625024|NCT01234402|Antimetabolites|antimetabolites|mesh-ancestor
25715918|NCT02383589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25715919|NCT02383589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25715920|NCT02383589|Antitubercular Agents|antitubercular agents|mesh-ancestor
25715921|NCT02383589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25715922|NCT02383589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25715923|NCT02383589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25715924|NCT02383589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715925|NCT02383758|Bisacodyl|bisacodyl|mesh-list
25715926|NCT02383758|Glycerol|glycerol|mesh-list
25625025|NCT01234402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625026|NCT01234402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625027|NCT01234467|Rituximab|rituximab|mesh-list
25625028|NCT01234467|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25625029|NCT01234467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25625030|NCT01234467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625031|NCT01234467|Immunologic Factors|immunologic factors|mesh-ancestor
25625032|NCT01234467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625033|NCT01234467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25625034|NCT01234467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25625035|NCT01234467|Alkylating Agents|alkylating agents|mesh-ancestor
25625036|NCT01234467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625037|NCT01234649|Metformin|metformin|mesh-list
25625038|NCT01234649|Liraglutide|liraglutide|mesh-list
25625039|NCT01234649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25625040|NCT01234649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625041|NCT01234649|Incretins|incretins|mesh-ancestor
25625042|NCT01234649|Hormones|hormones|mesh-ancestor
25625043|NCT01234649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25625044|NCT01234675|Milnacipran|milnacipran|mesh-list
25625045|NCT01234675|Levomilnacipran|levomilnacipran|mesh-list
25625046|NCT01234675|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25625047|NCT01234675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25625048|NCT01234675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25625049|NCT01234675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625050|NCT01234675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25625051|NCT01234675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625052|NCT01234675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25625053|NCT01234675|Analgesics|analgesics|mesh-ancestor
25625054|NCT01234675|Sensory System Agents|sensory system agents|mesh-ancestor
25625055|NCT01234675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25625056|NCT01234675|Antidepressive Agents|antidepressive agents|mesh-ancestor
25625057|NCT01234675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25625058|NCT01234714|Liver Extracts|liver extracts|mesh-list
25625059|NCT01234714|Hematinics|hematinics|mesh-ancestor
25625060|NCT01234766|Rituximab|rituximab|mesh-list
25625061|NCT01234766|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25625062|NCT01234766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25625063|NCT01234766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625064|NCT01234766|Immunologic Factors|immunologic factors|mesh-ancestor
25625065|NCT01234766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625066|NCT01234766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25625067|NCT01234766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25625068|NCT01234766|Alkylating Agents|alkylating agents|mesh-ancestor
25625069|NCT01234766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625070|NCT01234870|Adenosine|adenosine|mesh-list
25625071|NCT01234870|Analgesics|analgesics|mesh-ancestor
25625072|NCT01234870|Sensory System Agents|sensory system agents|mesh-ancestor
25625073|NCT01234870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25625074|NCT01234870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625075|NCT01234870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25625076|NCT01234870|Vasodilator Agents|vasodilator agents|mesh-ancestor
25625077|NCT01234870|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25625078|NCT01234870|Purinergic Agonists|purinergic agonists|mesh-ancestor
25625079|NCT01234870|Purinergic Agents|purinergic agents|mesh-ancestor
25625080|NCT01234870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25715927|NCT02383758|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25715928|NCT02383758|Protective Agents|protective agents|mesh-ancestor
25715929|NCT02383758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715930|NCT02383758|Cathartics|cathartics|mesh-ancestor
25715931|NCT02383758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25715932|NCT02383758|Laxatives|laxatives|mesh-ancestor
25715934|NCT02383940|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25625081|NCT01234870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625082|NCT01234883|Plasma-lyte 148|plasma-lyte 148|mesh-list
25625083|NCT01234883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25625084|NCT01234883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25519618|NCT00449930|Hormones|hormones|mesh-ancestor
25625085|NCT01234922|Losartan|losartan|mesh-list
25625086|NCT01234922|Ramipril|ramipril|mesh-list
25625087|NCT01234922|Lisinopril|lisinopril|mesh-list
25625088|NCT01234922|Benazepril|benazepril|mesh-list
25625089|NCT01234922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25625090|NCT01234922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25625091|NCT01234922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25625092|NCT01234922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25625093|NCT01234922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625094|NCT01234922|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25625095|NCT01234922|Protease Inhibitors|protease inhibitors|mesh-ancestor
25625096|NCT01234922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25625097|NCT01234922|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25625098|NCT01234922|Protective Agents|protective agents|mesh-ancestor
25625099|NCT01234922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625100|NCT01235195|Sertraline|sertraline|mesh-list
25625101|NCT01235195|Antidepressive Agents|antidepressive agents|mesh-ancestor
25625102|NCT01235195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25625103|NCT01235195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25625104|NCT01235195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25625105|NCT01235195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25625106|NCT01235195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625107|NCT01235195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25625108|NCT01235195|Serotonin Agents|serotonin agents|mesh-ancestor
25625109|NCT01235195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715936|NCT02383940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25715937|NCT02383940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715938|NCT02384044|Listerine|listerine|mesh-list
25715939|NCT02384044|Sodium Fluoride|sodium fluoride|mesh-list
25715940|NCT02384044|Cariostatic Agents|cariostatic agents|mesh-ancestor
25715941|NCT02384044|Protective Agents|protective agents|mesh-ancestor
25625110|NCT01235338|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25625111|NCT01235338|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25625112|NCT01235338|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25625113|NCT01235338|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25625114|NCT01235338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25625115|NCT01235338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625116|NCT01235338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25625117|NCT01235338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625118|NCT01235338|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25625119|NCT01235338|Antidepressive Agents|antidepressive agents|mesh-ancestor
25625120|NCT01235338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25625121|NCT01235338|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25625122|NCT01235338|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25625123|NCT01235338|Dopamine Agents|dopamine agents|mesh-ancestor
25625124|NCT01235351|Clopidogrel|clopidogrel|mesh-list
25625125|NCT01235351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25625126|NCT01235351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25625127|NCT01235351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25625128|NCT01235351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25625129|NCT01235351|Purinergic Agents|purinergic agents|mesh-ancestor
25625130|NCT01235351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25625131|NCT01235351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625132|NCT01235351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625133|NCT01235403|Lacosamide|lacosamide|mesh-list
25625134|NCT01235403|Anticonvulsants|anticonvulsants|mesh-ancestor
25625135|NCT01235403|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25625136|NCT01235403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25625137|NCT01235403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25625138|NCT01235403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625139|NCT01235442|Etanercept|etanercept|mesh-list
25625140|NCT01235442|Clobetasol|clobetasol|mesh-list
25625141|NCT01235442|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25625142|NCT01235442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25625143|NCT01235442|Analgesics|analgesics|mesh-ancestor
25625144|NCT01235442|Sensory System Agents|sensory system agents|mesh-ancestor
25625145|NCT01235442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25625146|NCT01235442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625147|NCT01235442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25625148|NCT01235442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25625149|NCT01235442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25625150|NCT01235442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25625151|NCT01235442|Immunologic Factors|immunologic factors|mesh-ancestor
25715942|NCT02384044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448731|NCT00312819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448732|NCT00312871|Epoetin Alfa|epoetin alfa|mesh-list
24448739|NCT00312988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448740|NCT00312988|Antiviral Agents|antiviral agents|mesh-ancestor
24448741|NCT00312988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25715943|NCT02384044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25715944|NCT02384044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25715945|NCT02384070|Aspirin|aspirin|mesh-list
25715946|NCT02384070|Bivalirudin|bivalirudin|mesh-list
25625152|NCT01235442|Glucocorticoids|glucocorticoids|mesh-ancestor
25625153|NCT01235442|Hormones|hormones|mesh-ancestor
25625154|NCT01235442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25625155|NCT01235507|Methotrexate|methotrexate|mesh-list
25519688|NCT00450385|Vincristine|vincristine|mesh-list
25625156|NCT01235507|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25625157|NCT01235507|Abortifacient Agents|abortifacient agents|mesh-ancestor
25625158|NCT01235507|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25625159|NCT01235507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625160|NCT01235507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25625161|NCT01235507|Antimetabolites|antimetabolites|mesh-ancestor
25625162|NCT01235507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625163|NCT01235507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625164|NCT01235507|Dermatologic Agents|dermatologic agents|mesh-ancestor
25625165|NCT01235507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25625166|NCT01235507|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25625167|NCT01235507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25625168|NCT01235507|Immunologic Factors|immunologic factors|mesh-ancestor
25625169|NCT01235507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25625170|NCT01235507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25625171|NCT01235546|Azithromycin|azithromycin|mesh-list
25625172|NCT01235546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25625173|NCT01235546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25625174|NCT01235598|Certolizumab Pegol|certolizumab pegol|mesh-list
25625175|NCT01235598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25625176|NCT01235598|Immunologic Factors|immunologic factors|mesh-ancestor
25625177|NCT01235598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625178|NCT01235598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25625179|NCT01235689|Prednisone|prednisone|mesh-list
25625180|NCT01235689|Adalimumab|adalimumab|mesh-list
25625181|NCT01235689|Azathioprine|azathioprine|mesh-list
25625182|NCT01235689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25625183|NCT01235689|Glucocorticoids|glucocorticoids|mesh-ancestor
25625184|NCT01235689|Hormones|hormones|mesh-ancestor
25625185|NCT01235689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25625186|NCT01235689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625187|NCT01235689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25625188|NCT01235689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625189|NCT01235689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25625190|NCT01235689|Antimetabolites|antimetabolites|mesh-ancestor
25625191|NCT01235689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625192|NCT01235689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25625193|NCT01235689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24455087|NCT02876107|Panitumumab|panitumumab|mesh-list
24448801|NCT00313131|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24448802|NCT00313131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24448803|NCT00313131|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24448804|NCT00313131|Alkylating Agents|alkylating agents|mesh-ancestor
24448805|NCT00313131|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
24448807|NCT00313157|Verapamil|verapamil|mesh-list
25625194|NCT01235689|Immunologic Factors|immunologic factors|mesh-ancestor
25625195|NCT01235715|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25625196|NCT01235715|Hemostatics|hemostatics|mesh-ancestor
25625197|NCT01235715|Coagulants|coagulants|mesh-ancestor
25625198|NCT01235728|Calcitriol|calcitriol|mesh-list
25625199|NCT01235728|MK 0873|mk 0873|mesh-list
25625200|NCT01235728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25625201|NCT01235728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625202|NCT01235728|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25625203|NCT01235728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25625204|NCT01235728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625205|NCT01235728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25625206|NCT01235728|Vitamins|vitamins|mesh-ancestor
25625207|NCT01235728|Micronutrients|micronutrients|mesh-ancestor
25625208|NCT01235728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25625209|NCT01235728|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25625210|NCT01235728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25625211|NCT01235728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25625212|NCT01235741|Pramlintide|pramlintide|mesh-list
25625213|NCT01235741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25625214|NCT01235741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625215|NCT01235793|Temozolomide|temozolomide|mesh-list
25625216|NCT01235793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25625217|NCT01235793|Alkylating Agents|alkylating agents|mesh-ancestor
25625218|NCT01235793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625219|NCT01235793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625220|NCT01235897|Paclitaxel|paclitaxel|mesh-list
25625221|NCT01235897|Trastuzumab|trastuzumab|mesh-list
25625222|NCT01235897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25625223|NCT01235897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625224|NCT01235897|Tubulin Modulators|tubulin modulators|mesh-ancestor
25625225|NCT01235897|Antimitotic Agents|antimitotic agents|mesh-ancestor
25625226|NCT01235897|Mitosis Modulators|mitosis modulators|mesh-ancestor
25625227|NCT01235897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625228|NCT01235897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25625229|NCT01235910|Cyclosporine|cyclosporine|mesh-list
25625230|NCT01235910|Cyclosporins|cyclosporins|mesh-list
25625231|NCT01235910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25625232|NCT01235910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625233|NCT01235910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25625234|NCT01235910|Immunologic Factors|immunologic factors|mesh-ancestor
25625235|NCT01235910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625236|NCT01235910|Antifungal Agents|antifungal agents|mesh-ancestor
25625237|NCT01235910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25625238|NCT01235910|Dermatologic Agents|dermatologic agents|mesh-ancestor
25625239|NCT01235910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25625240|NCT01235910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25625241|NCT01235949|Acetaminophen|acetaminophen|mesh-list
25625242|NCT01235949|Ibuprofen|ibuprofen|mesh-list
25625243|NCT01235949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25625244|NCT01235949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25625245|NCT01235949|Analgesics|analgesics|mesh-ancestor
25625246|NCT01235949|Sensory System Agents|sensory system agents|mesh-ancestor
25625247|NCT01235949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25625248|NCT01235949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625249|NCT01235949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25625250|NCT01235949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25625251|NCT01235949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25715947|NCT02384070|Clopidogrel|clopidogrel|mesh-list
25715948|NCT02384070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25715949|NCT02384070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25715950|NCT02384070|Analgesics|analgesics|mesh-ancestor
25715955|NCT02384070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25625252|NCT01235949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25625253|NCT01235949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625254|NCT01235949|Antipyretics|antipyretics|mesh-ancestor
25625255|NCT01236001|Lacosamide|lacosamide|mesh-list
25625256|NCT01236001|Anticonvulsants|anticonvulsants|mesh-ancestor
25625257|NCT01236001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25625258|NCT01236001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25625259|NCT01236001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25625260|NCT01236001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625261|NCT01236053|Gabapentin|gabapentin|mesh-list
25625262|NCT01236053|Analgesics|analgesics|mesh-ancestor
25625263|NCT01236053|Sensory System Agents|sensory system agents|mesh-ancestor
25625264|NCT01236053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25625265|NCT01236053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625266|NCT01236053|Anticonvulsants|anticonvulsants|mesh-ancestor
25625267|NCT01236053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25625268|NCT01236053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25625269|NCT01236053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25625270|NCT01236053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25625271|NCT01236053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25625272|NCT01236053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25625273|NCT01236053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25625274|NCT01236053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625275|NCT01236053|Antimanic Agents|antimanic agents|mesh-ancestor
25625276|NCT01236105|Charcoal|charcoal|mesh-list
25625277|NCT01236105|Antidotes|antidotes|mesh-ancestor
25625278|NCT01236105|Protective Agents|protective agents|mesh-ancestor
25625279|NCT01236105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625280|NCT01236118|Ixekizumab|ixekizumab|mesh-list
25625281|NCT01236118|Dermatologic Agents|dermatologic agents|mesh-ancestor
25625282|NCT01236365|Atorvastatin|atorvastatin|mesh-list
25625283|NCT01236365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25625284|NCT01236365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25625285|NCT01236365|Antimetabolites|antimetabolites|mesh-ancestor
25625286|NCT01236365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625287|NCT01236365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25715959|NCT02384070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25715960|NCT02384070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25715961|NCT02384070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448851|NCT00313287|Antiviral Agents|antiviral agents|mesh-ancestor
24448852|NCT00313287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24448854|NCT00313391|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24448855|NCT00313391|Serotonin Agents|serotonin agents|mesh-ancestor
24448861|NCT00313391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24448862|NCT00313391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24448863|NCT00313391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24448864|NCT00313391|Dopamine Agents|dopamine agents|mesh-ancestor
25625288|NCT01236365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25625289|NCT01236365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25625290|NCT01236378|Sirolimus|sirolimus|mesh-list
25625291|NCT01236378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25625292|NCT01236378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25625293|NCT01236378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25625294|NCT01236378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625295|NCT01236378|Antifungal Agents|antifungal agents|mesh-ancestor
25625296|NCT01236378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25625297|NCT01236378|Immunologic Factors|immunologic factors|mesh-ancestor
25625298|NCT01236378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625299|NCT01236534|Lubiprostone|lubiprostone|mesh-list
25625300|NCT01236534|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25625301|NCT01236534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25625302|NCT01236534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625303|NCT01236573|Cyclophosphamide|cyclophosphamide|mesh-list
25625304|NCT01236573|Fludarabine|fludarabine|mesh-list
25519833|NCT00450801|Serotonin Agents|serotonin agents|mesh-ancestor
25625305|NCT01236573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25625306|NCT01236573|Immunologic Factors|immunologic factors|mesh-ancestor
25625307|NCT01236573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625308|NCT01236573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25625309|NCT01236573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25625310|NCT01236573|Alkylating Agents|alkylating agents|mesh-ancestor
25625311|NCT01236573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625312|NCT01236573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625313|NCT01236573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25625314|NCT01236768|Contraceptive Agents|contraceptive agents|mesh-list
25625315|NCT01236768|Contraceptives, Oral|contraceptives, oral|mesh-list
25625316|NCT01236768|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-list
25625317|NCT01236768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25625318|NCT01236768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625319|NCT01236768|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25625320|NCT01236768|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25625321|NCT01237041|Niacin|niacin|mesh-list
25625322|NCT01237041|Niacinamide|niacinamide|mesh-list
25625323|NCT01237041|Nicotinic Acids|nicotinic acids|mesh-list
25625324|NCT01237041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25625325|NCT01237041|Antimetabolites|antimetabolites|mesh-ancestor
25625326|NCT01237041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625327|NCT01237041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25625328|NCT01237041|Vasodilator Agents|vasodilator agents|mesh-ancestor
25625329|NCT01237041|Vitamin B Complex|vitamin b complex|mesh-ancestor
25625330|NCT01237041|Vitamins|vitamins|mesh-ancestor
25625331|NCT01237041|Micronutrients|micronutrients|mesh-ancestor
25625332|NCT01237041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625333|NCT01237054|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25625334|NCT01237054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25625335|NCT01237054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625336|NCT01237197|Exenatide|exenatide|mesh-list
25625337|NCT01237197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25625338|NCT01237197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625339|NCT01237197|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25625340|NCT01237197|Incretins|incretins|mesh-ancestor
25625341|NCT01237197|Hormones|hormones|mesh-ancestor
25715968|NCT02384070|Antithrombins|antithrombins|mesh-ancestor
25715969|NCT02384070|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25715970|NCT02384070|Protease Inhibitors|protease inhibitors|mesh-ancestor
25715971|NCT02384070|Anticoagulants|anticoagulants|mesh-ancestor
25715972|NCT02384200|Vancomycin|vancomycin|mesh-list
25715973|NCT02384200|Gentamicins|gentamicins|mesh-list
25715974|NCT02384200|Ceftriaxone|ceftriaxone|mesh-list
25715975|NCT02384200|Ampicillin|ampicillin|mesh-list
25715976|NCT02384200|Nitrofurantoin|nitrofurantoin|mesh-list
25715977|NCT02384200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25715978|NCT02384200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25625342|NCT01237197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25625343|NCT01237223|Amlodipine|amlodipine|mesh-list
25625344|NCT01237223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25625345|NCT01237223|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25625346|NCT01237223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25625347|NCT01237223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625348|NCT01237223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25625349|NCT01237223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625350|NCT01237223|Vasodilator Agents|vasodilator agents|mesh-ancestor
25625351|NCT01237327|Exemestane|exemestane|mesh-list
25625352|NCT01237327|Megestrol|megestrol|mesh-list
25625353|NCT01237327|Megestrol Acetate|megestrol acetate|mesh-list
25625354|NCT01237327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625355|NCT01237327|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25625356|NCT01237327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25625357|NCT01237327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25625358|NCT01237327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625359|NCT01237327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25625360|NCT01237327|Hormone Antagonists|hormone antagonists|mesh-ancestor
25625361|NCT01237327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25625362|NCT01237327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625363|NCT01237327|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25625364|NCT01237327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25625365|NCT01237327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25625366|NCT01237327|Contraceptive Agents|contraceptive agents|mesh-ancestor
25625367|NCT01237327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25625368|NCT01237327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25625369|NCT01237327|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25625370|NCT01237327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25625371|NCT01237327|Appetite Stimulants|appetite stimulants|mesh-ancestor
25625372|NCT01237327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25625373|NCT01237353|Rabeprazole|rabeprazole|mesh-list
25625374|NCT01237353|Betaine|betaine|mesh-list
25625375|NCT01237353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25625376|NCT01237353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25625377|NCT01237353|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25715979|NCT02384200|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25715980|NCT02384200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25715981|NCT02384200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715982|NCT02384200|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25715983|NCT02384200|Renal Agents|renal agents|mesh-ancestor
24448960|NCT00313625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25715984|NCT02384395|Lamivudine|lamivudine|mesh-list
25715985|NCT02384395|Abacavir|abacavir|mesh-list
25715986|NCT02384395|Dolutegravir|dolutegravir|mesh-list
25519900|NCT00451178|Alkylating Agents|alkylating agents|mesh-ancestor
25625378|NCT01237353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25625379|NCT01237353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625380|NCT01237353|Lipotropic Agents|lipotropic agents|mesh-ancestor
25625381|NCT01237353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25625382|NCT01237353|Antimetabolites|antimetabolites|mesh-ancestor
25625383|NCT01237353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25625384|NCT01237587|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25625385|NCT01237587|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25625386|NCT01237587|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25625387|NCT01237587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25625388|NCT01237587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625389|NCT01237587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25625390|NCT01237587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625391|NCT01237587|Analgesics|analgesics|mesh-ancestor
25625392|NCT01237587|Sensory System Agents|sensory system agents|mesh-ancestor
25625393|NCT01237587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25625394|NCT01237587|Antidepressive Agents|antidepressive agents|mesh-ancestor
25625395|NCT01237587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25625396|NCT01237587|Dopamine Agents|dopamine agents|mesh-ancestor
25625397|NCT01237678|Carboplatin|carboplatin|mesh-list
25625399|NCT01237678|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
25625400|NCT01237678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625401|NCT01237678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25625402|NCT01237678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25625403|NCT01237678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25625404|NCT01237678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25625405|NCT01237678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625406|NCT01237678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25625407|NCT01237899|Eplerenone|eplerenone|mesh-list
25625408|NCT01237899|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25625409|NCT01237899|Hormone Antagonists|hormone antagonists|mesh-ancestor
25625410|NCT01237899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25625411|NCT01237899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625412|NCT01237899|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25625413|NCT01237899|Diuretics|diuretics|mesh-ancestor
25625414|NCT01237899|Natriuretic Agents|natriuretic agents|mesh-ancestor
25625415|NCT01237899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25625416|NCT01237951|Gemcitabine|gemcitabine|mesh-list
25625417|NCT01237951|Dexamethasone|dexamethasone|mesh-list
25625418|NCT01237951|Melphalan|melphalan|mesh-list
25625419|NCT01237951|Busulfan|busulfan|mesh-list
25625420|NCT01237951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25625421|NCT01237951|Antiemetics|antiemetics|mesh-ancestor
25625422|NCT01237951|Autonomic Agents|autonomic agents|mesh-ancestor
25625423|NCT01237951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25625424|NCT01237951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625425|NCT01237951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25625426|NCT01237951|Glucocorticoids|glucocorticoids|mesh-ancestor
25625427|NCT01237951|Hormones|hormones|mesh-ancestor
25625428|NCT01237951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25625429|NCT01237951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25625430|NCT01237951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625431|NCT01237951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25625432|NCT01237951|Antimetabolites|antimetabolites|mesh-ancestor
25625433|NCT01237951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625434|NCT01237951|Antiviral Agents|antiviral agents|mesh-ancestor
25625435|NCT01237951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25625436|NCT01237951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25625437|NCT01237951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25625438|NCT01237951|Immunologic Factors|immunologic factors|mesh-ancestor
25625439|NCT01237951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25625440|NCT01237951|Alkylating Agents|alkylating agents|mesh-ancestor
25625441|NCT01237951|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25625442|NCT01238120|Ibuprofen|ibuprofen|mesh-list
25625443|NCT01238120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25625444|NCT01238120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25625445|NCT01238120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25625446|NCT01238120|Analgesics|analgesics|mesh-ancestor
25625447|NCT01238120|Sensory System Agents|sensory system agents|mesh-ancestor
25715987|NCT02384395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24447489|NCT00308594|Hormones|hormones|mesh-ancestor
24449456|NCT00315679|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24449457|NCT00315679|Antioxidants|antioxidants|mesh-ancestor
24449458|NCT00315744|Fluticasone|fluticasone|mesh-list
24449460|NCT00315744|Albuterol|albuterol|mesh-list
24449461|NCT00315744|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24449462|NCT00315744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24449463|NCT00315744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24449464|NCT00315744|Autonomic Agents|autonomic agents|mesh-ancestor
24449465|NCT00315744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24449466|NCT00315744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455212|NCT02329080|Dermatologic Agents|dermatologic agents|mesh-ancestor
24455213|NCT02329080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25715989|NCT02384395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25625448|NCT01238120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25625449|NCT01238120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625450|NCT01238120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25625451|NCT01238120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25625452|NCT01238120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25625453|NCT01238120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655608|NCT01565148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25655609|NCT01565499|Paclitaxel|paclitaxel|mesh-list
25655610|NCT01565499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25655611|NCT01565499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25655612|NCT01565499|Tubulin Modulators|tubulin modulators|mesh-ancestor
25655613|NCT01565499|Antimitotic Agents|antimitotic agents|mesh-ancestor
25655614|NCT01565499|Mitosis Modulators|mitosis modulators|mesh-ancestor
25655615|NCT01565499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655616|NCT01565538|Pemetrexed|pemetrexed|mesh-list
25655617|NCT01565538|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25655618|NCT01565538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25715996|NCT02384395|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24455216|NCT02329080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24455217|NCT02329080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24455218|NCT02329080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24455219|NCT02329080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24455220|NCT02329080|Antiviral Agents|antiviral agents|mesh-ancestor
24393155|NCT00128934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24393157|NCT00128934|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24393158|NCT00128934|Contraceptive Agents|contraceptive agents|mesh-ancestor
24393187|NCT00129038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24393204|NCT00129142|Hormone Antagonists|hormone antagonists|mesh-ancestor
24393205|NCT00129142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24393206|NCT00129142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715997|NCT02384941|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25715998|NCT02384941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25715999|NCT02384941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716000|NCT02384941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25716001|NCT02384941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716002|NCT02385097|Ropivacaine|ropivacaine|mesh-list
25716003|NCT02385097|Chloroprocaine|chloroprocaine|mesh-list
25716004|NCT02385097|Anesthetics, Local|anesthetics, local|mesh-ancestor
25716005|NCT02385097|Anesthetics|anesthetics|mesh-ancestor
25716006|NCT02385097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25655619|NCT01565538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655620|NCT01565538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655621|NCT01565538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25655622|NCT01565538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25655623|NCT01565538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25655624|NCT01565616|Fludarabine|fludarabine|mesh-list
25655625|NCT01565616|Busulfan|busulfan|mesh-list
25655626|NCT01565616|Thymoglobulin|thymoglobulin|mesh-list
25655627|NCT01565616|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25655628|NCT01565616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25655629|NCT01565616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655630|NCT01565616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25655631|NCT01565616|Immunologic Factors|immunologic factors|mesh-ancestor
25655632|NCT01565616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655633|NCT01565616|Alkylating Agents|alkylating agents|mesh-ancestor
25655634|NCT01565616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25655635|NCT01565616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25655636|NCT01565694|Solifenacin Succinate|solifenacin succinate|mesh-list
25655637|NCT01565694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25655638|NCT01565694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25655639|NCT01565694|Cholinergic Agents|cholinergic agents|mesh-ancestor
25655640|NCT01565694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25655641|NCT01565694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655642|NCT01565694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655643|NCT01565694|Urological Agents|urological agents|mesh-ancestor
25655644|NCT01565707|Solifenacin Succinate|solifenacin succinate|mesh-list
25655645|NCT01565707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25655646|NCT01565707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25655647|NCT01565707|Cholinergic Agents|cholinergic agents|mesh-ancestor
25655648|NCT01565707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25655649|NCT01565707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655650|NCT01565707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655651|NCT01565707|Urological Agents|urological agents|mesh-ancestor
25655652|NCT01565850|Darunavir|darunavir|mesh-list
25655653|NCT01565850|Cobicistat|cobicistat|mesh-list
25655654|NCT01565850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655655|NCT01565850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655656|NCT01565850|Antiviral Agents|antiviral agents|mesh-ancestor
25655657|NCT01565850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25655658|NCT01565850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25716007|NCT02385097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716008|NCT02385097|Sensory System Agents|sensory system agents|mesh-ancestor
25716009|NCT02385097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25716010|NCT02385240|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24393207|NCT00129142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24393209|NCT00129155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24393210|NCT00129155|Alkylating Agents|alkylating agents|mesh-ancestor
24393211|NCT00129155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393212|NCT00129155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393213|NCT00129168|Cytarabine|cytarabine|mesh-list
25655659|NCT01565850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25655660|NCT01565850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25655661|NCT01565850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25655662|NCT01565850|Protease Inhibitors|protease inhibitors|mesh-ancestor
25655663|NCT01565850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25655664|NCT01565850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25655665|NCT01565889|Ritonavir|ritonavir|mesh-list
25655666|NCT01565889|Ribavirin|ribavirin|mesh-list
25655667|NCT01565889|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25655668|NCT01565889|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25655669|NCT01565889|Protease Inhibitors|protease inhibitors|mesh-ancestor
25655670|NCT01565889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655671|NCT01565889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655672|NCT01565889|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25655673|NCT01565889|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25655674|NCT01565889|Antiviral Agents|antiviral agents|mesh-ancestor
25655675|NCT01565889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25655676|NCT01565889|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25655677|NCT01565889|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25625454|NCT01238471|Propranolol|propranolol|mesh-list
25625455|NCT01238471|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25625456|NCT01238471|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25625457|NCT01238471|Adrenergic Agents|adrenergic agents|mesh-ancestor
25625458|NCT01238471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25625459|NCT01238471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625460|NCT01238471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625461|NCT01238471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25625462|NCT01238471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25625463|NCT01238471|Vasodilator Agents|vasodilator agents|mesh-ancestor
25625464|NCT01238536|Dexamethasone|dexamethasone|mesh-list
25625465|NCT01238536|Betamethasone|betamethasone|mesh-list
25625466|NCT01238536|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25625467|NCT01238536|Lidocaine|lidocaine|mesh-list
25625468|NCT01238536|Anesthetics, Local|anesthetics, local|mesh-list
25716016|NCT02385240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24451905|NCT00325169|Cholinergic Agents|cholinergic agents|mesh-ancestor
24451906|NCT00325169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24451907|NCT00325169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451908|NCT00325169|Glucocorticoids|glucocorticoids|mesh-ancestor
25625469|NCT01238536|Anesthetics|anesthetics|mesh-list
25625470|NCT01238536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25625471|NCT01238536|Antiemetics|antiemetics|mesh-ancestor
25625472|NCT01238536|Autonomic Agents|autonomic agents|mesh-ancestor
25625473|NCT01238536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25625474|NCT01238536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625475|NCT01238536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25625476|NCT01238536|Glucocorticoids|glucocorticoids|mesh-ancestor
25625477|NCT01238536|Hormones|hormones|mesh-ancestor
25625478|NCT01238536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25625479|NCT01238536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25625480|NCT01238536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625481|NCT01238536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625482|NCT01238536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25625483|NCT01238536|Sensory System Agents|sensory system agents|mesh-ancestor
25625484|NCT01238536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25625485|NCT01238536|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25625486|NCT01238536|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25625487|NCT01238536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25625488|NCT01238536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25625489|NCT01238536|Respiratory System Agents|respiratory system agents|mesh-ancestor
25625490|NCT01238575|Guanfacine|guanfacine|mesh-list
25625491|NCT01238575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25625492|NCT01238575|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25625493|NCT01238575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25625494|NCT01238575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25625495|NCT01238575|Adrenergic Agents|adrenergic agents|mesh-ancestor
24393376|NCT00129896|Docetaxel|docetaxel|mesh-list
24393377|NCT00129896|Doxorubicin|doxorubicin|mesh-list
24393378|NCT00129896|Trastuzumab|trastuzumab|mesh-list
24393379|NCT00129896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393380|NCT00129896|Tubulin Modulators|tubulin modulators|mesh-ancestor
24393381|NCT00129896|Antimitotic Agents|antimitotic agents|mesh-ancestor
24393382|NCT00129896|Mitosis Modulators|mitosis modulators|mesh-ancestor
24393383|NCT00129896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393384|NCT00129896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24393385|NCT00129896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24393386|NCT00129896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24393387|NCT00129896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24393388|NCT00129896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24393389|NCT00129922|Paclitaxel|paclitaxel|mesh-list
24393450|NCT00130065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24393451|NCT00130065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393453|NCT00130065|Renal Agents|renal agents|mesh-ancestor
25625496|NCT01238575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25625497|NCT01238575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625498|NCT01238575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625499|NCT01238588|Sevelamer|sevelamer|mesh-list
25625500|NCT01238588|Chelating Agents|chelating agents|mesh-ancestor
25625501|NCT01238588|Sequestering Agents|sequestering agents|mesh-ancestor
25625502|NCT01238588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625503|NCT01238640|Nicotine|nicotine|mesh-list
25625504|NCT01238640|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25625505|NCT01238640|Autonomic Agents|autonomic agents|mesh-ancestor
25625506|NCT01238640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25625507|NCT01238640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625508|NCT01238640|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25625509|NCT01238640|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25625510|NCT01238640|Cholinergic Agents|cholinergic agents|mesh-ancestor
25625511|NCT01238640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24393490|NCT00130195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24393491|NCT00130195|Immunologic Factors|immunologic factors|mesh-ancestor
24393492|NCT00130195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393568|NCT00130364|Pimecrolimus|pimecrolimus|mesh-list
24393617|NCT00130481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24393618|NCT00130494|Zoledronic Acid|zoledronic acid|mesh-list
24393619|NCT00130494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24393620|NCT00130494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393622|NCT00130507|Trastuzumab|trastuzumab|mesh-list
24393623|NCT00130507|Vinorelbine|vinorelbine|mesh-list
24393624|NCT00130507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24393625|NCT00130507|Antimetabolites|antimetabolites|mesh-ancestor
24393626|NCT00130507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393627|NCT00130507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393628|NCT00130507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24393629|NCT00130507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24393750|NCT00130897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393751|NCT00130910|Albendazole|albendazole|mesh-list
24393752|NCT00130910|Anthelmintics|anthelmintics|mesh-ancestor
24393753|NCT00130910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24393754|NCT00130910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24393755|NCT00130910|Anticestodal Agents|anticestodal agents|mesh-ancestor
24393756|NCT00130910|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24393778|NCT00130975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393779|NCT00131027|Cytarabine|cytarabine|mesh-list
24393780|NCT00131027|Dexamethasone|dexamethasone|mesh-list
24393781|NCT00131027|Prednisolone|prednisolone|mesh-list
24393782|NCT00131027|Cyclophosphamide|cyclophosphamide|mesh-list
24393783|NCT00131027|Doxorubicin|doxorubicin|mesh-list
25625512|NCT01238640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625513|NCT01238822|Methylphenidate|methylphenidate|mesh-list
25625514|NCT01238822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25625515|NCT01238822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625516|NCT01238822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25625517|NCT01238822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25625518|NCT01238822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25625519|NCT01238822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625520|NCT01238822|Dopamine Agents|dopamine agents|mesh-ancestor
25625521|NCT01238822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25625522|NCT01238861|Benralizumab|benralizumab|mesh-list
25625523|NCT01238861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25625524|NCT01238861|Respiratory System Agents|respiratory system agents|mesh-ancestor
25625525|NCT01239212|Levetiracetam|levetiracetam|mesh-list
25716033|NCT02385799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24393787|NCT00131027|Daunorubicin|daunorubicin|mesh-list
24393788|NCT00131027|Asparaginase|asparaginase|mesh-list
24393789|NCT00131027|Mercaptopurine|mercaptopurine|mesh-list
24393790|NCT00131027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24393791|NCT00131027|Immunologic Factors|immunologic factors|mesh-ancestor
24393792|NCT00131027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393793|NCT00131027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24393794|NCT00131027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24393795|NCT00131027|Alkylating Agents|alkylating agents|mesh-ancestor
25520093|NCT00452530|Protease Inhibitors|protease inhibitors|mesh-ancestor
25625526|NCT01239212|Anticonvulsants|anticonvulsants|mesh-ancestor
25625527|NCT01239212|Nootropic Agents|nootropic agents|mesh-ancestor
25625529|NCT01239342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625530|NCT01239342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25625531|NCT01239342|Immunologic Factors|immunologic factors|mesh-ancestor
25625532|NCT01239342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625533|NCT01239394|Ofatumumab|ofatumumab|mesh-list
25625534|NCT01239394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625535|NCT01239472|Everolimus|everolimus|mesh-list
25625536|NCT01239472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625537|NCT01239472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25625538|NCT01239472|Immunologic Factors|immunologic factors|mesh-ancestor
25625539|NCT01239472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625540|NCT01239732|Paclitaxel|paclitaxel|mesh-list
25625541|NCT01239732|Bevacizumab|bevacizumab|mesh-list
25625542|NCT01239732|Carboplatin|carboplatin|mesh-list
25625543|NCT01239732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25625544|NCT01239732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625545|NCT01239732|Tubulin Modulators|tubulin modulators|mesh-ancestor
25625546|NCT01239732|Antimitotic Agents|antimitotic agents|mesh-ancestor
25625547|NCT01239732|Mitosis Modulators|mitosis modulators|mesh-ancestor
25625548|NCT01239732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625549|NCT01239732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25625550|NCT01239732|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25625551|NCT01239732|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25625552|NCT01239732|Growth Substances|growth substances|mesh-ancestor
25625553|NCT01239732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625554|NCT01239732|Growth Inhibitors|growth inhibitors|mesh-ancestor
25625555|NCT01239745|Exemestane|exemestane|mesh-list
25625556|NCT01239745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625557|NCT01239745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25625558|NCT01239745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25625559|NCT01239745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25625560|NCT01239745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625561|NCT01239745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24393942|NCT00131326|Protective Agents|protective agents|mesh-ancestor
24393943|NCT00131326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393944|NCT00131339|Cycloserine|cycloserine|mesh-list
24393945|NCT00131339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24393946|NCT00131339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24393947|NCT00131339|Renal Agents|renal agents|mesh-ancestor
24393973|NCT00131430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393975|NCT00131430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25716049|NCT02386098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716050|NCT02386098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25716051|NCT02386098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25716052|NCT02386098|Antiviral Agents|antiviral agents|mesh-ancestor
25716053|NCT02386098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25716054|NCT02386098|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25716055|NCT02386098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25625562|NCT01239745|Hormone Antagonists|hormone antagonists|mesh-ancestor
25625563|NCT01239745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25625564|NCT01239745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625565|NCT01239992|Niacin|niacin|mesh-list
25625566|NCT01239992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25625567|NCT01239992|Antimetabolites|antimetabolites|mesh-ancestor
25625568|NCT01239992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625569|NCT01239992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25625570|NCT01239992|Vasodilator Agents|vasodilator agents|mesh-ancestor
25625571|NCT01239992|Vitamin B Complex|vitamin b complex|mesh-ancestor
25625572|NCT01239992|Vitamins|vitamins|mesh-ancestor
25625573|NCT01239992|Micronutrients|micronutrients|mesh-ancestor
25625574|NCT01239992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625575|NCT01240135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25625576|NCT01240200|Insulin Glargine|insulin glargine|mesh-list
25625577|NCT01240200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25625578|NCT01240200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625579|NCT01240382|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25625580|NCT01240382|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25625581|NCT01240382|Hyaluronic Acid|hyaluronic acid|mesh-list
25625582|NCT01240382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25625583|NCT01240382|Immunologic Factors|immunologic factors|mesh-ancestor
25625584|NCT01240382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625585|NCT01240382|Viscosupplements|viscosupplements|mesh-ancestor
25625586|NCT01240382|Protective Agents|protective agents|mesh-ancestor
25625587|NCT01240590|Cisplatin|cisplatin|mesh-list
25625588|NCT01240590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625589|NCT01240746|Vaccines|vaccines|mesh-list
25625590|NCT01240746|Immunologic Factors|immunologic factors|mesh-ancestor
25716056|NCT02386098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25716057|NCT02386098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25716058|NCT02386098|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25716059|NCT02386098|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25716060|NCT02386319|Melatonin|melatonin|mesh-list
24452052|NCT00325858|Narcotics|narcotics|mesh-ancestor
24452053|NCT00325858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24452054|NCT00325858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452055|NCT00325858|Analgesics|analgesics|mesh-ancestor
24452056|NCT00325858|Sensory System Agents|sensory system agents|mesh-ancestor
24452057|NCT00325858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24452058|NCT00325910|Metformin|metformin|mesh-list
24393976|NCT00131430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393977|NCT00131443|Topiramate|topiramate|mesh-list
24393978|NCT00131443|Anticonvulsants|anticonvulsants|mesh-ancestor
24393979|NCT00131443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24393980|NCT00131443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393987|NCT00131495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25716061|NCT02386319|Antioxidants|antioxidants|mesh-ancestor
25716062|NCT02386319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716063|NCT02386319|Protective Agents|protective agents|mesh-ancestor
25716064|NCT02386319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625591|NCT01240746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625592|NCT01240785|Metformin|metformin|mesh-list
25625593|NCT01240785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25625594|NCT01240785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625595|NCT01240811|Copper|copper|mesh-list
25625596|NCT01240811|Levonorgestrel|levonorgestrel|mesh-list
25625597|NCT01240811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25625598|NCT01240811|Contraceptive Agents|contraceptive agents|mesh-ancestor
25625599|NCT01240811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25625600|NCT01240811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625601|NCT01240811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25625602|NCT01240811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25625603|NCT01240811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25625604|NCT01240811|Trace Elements|trace elements|mesh-ancestor
25625605|NCT01240811|Micronutrients|micronutrients|mesh-ancestor
25625606|NCT01240863|Hydrocodone|hydrocodone|mesh-list
25625607|NCT01240863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25625608|NCT01240863|Narcotics|narcotics|mesh-ancestor
25625609|NCT01240863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25625610|NCT01240863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625611|NCT01240863|Analgesics|analgesics|mesh-ancestor
25625612|NCT01240863|Sensory System Agents|sensory system agents|mesh-ancestor
25625613|NCT01240863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25625614|NCT01240863|Antitussive Agents|antitussive agents|mesh-ancestor
25625615|NCT01240863|Respiratory System Agents|respiratory system agents|mesh-ancestor
25625616|NCT01241240|Timolol|timolol|mesh-list
25625617|NCT01241240|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25625618|NCT01241240|Bimatoprost|bimatoprost|mesh-list
25625619|NCT01241240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25625620|NCT01241240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25625621|NCT01241240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25625622|NCT01241240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25625623|NCT01241240|Adrenergic Agents|adrenergic agents|mesh-ancestor
25625624|NCT01241240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25625625|NCT01241240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625626|NCT01241240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625627|NCT01241240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25625628|NCT01241240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25625629|NCT01241240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25625630|NCT01241240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25625631|NCT01241240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24394042|NCT00131768|Protective Agents|protective agents|mesh-ancestor
24394043|NCT00131768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394047|NCT00131846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394050|NCT00131963|Paclitaxel|paclitaxel|mesh-list
24394066|NCT00131963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24394067|NCT00131963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24394105|NCT00132119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24394106|NCT00132119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394107|NCT00132119|Sensory System Agents|sensory system agents|mesh-ancestor
24394108|NCT00132119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24394109|NCT00132158|Irinotecan|irinotecan|mesh-list
24455238|NCT02244125|Antiemetics|antiemetics|mesh-ancestor
25625632|NCT01241292|Elotuzumab|elotuzumab|mesh-list
25625633|NCT01241292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625634|NCT01241318|Chlorhexidine|chlorhexidine|mesh-list
25625635|NCT01241318|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25625636|NCT01241318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25625637|NCT01241318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25625638|NCT01241318|Disinfectants|disinfectants|mesh-ancestor
25625639|NCT01241318|Dermatologic Agents|dermatologic agents|mesh-ancestor
25625640|NCT01241344|Brincidofovir|brincidofovir|mesh-list
25625641|NCT01241344|Antiviral Agents|antiviral agents|mesh-ancestor
25625642|NCT01241344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25625643|NCT01241539|Dabigatran|dabigatran|mesh-list
25625644|NCT01241539|Antithrombins|antithrombins|mesh-ancestor
25625645|NCT01241539|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25625646|NCT01241539|Protease Inhibitors|protease inhibitors|mesh-ancestor
25625647|NCT01241539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25625648|NCT01241539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625649|NCT01241539|Anticoagulants|anticoagulants|mesh-ancestor
25625650|NCT01241552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25625651|NCT01241552|Immunologic Factors|immunologic factors|mesh-ancestor
25625652|NCT01241552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625653|NCT01241591|Etanercept|etanercept|mesh-list
25625654|NCT01241591|Tofacitinib|tofacitinib|mesh-list
25625655|NCT01241591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25625656|NCT01241591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25625657|NCT01241591|Analgesics|analgesics|mesh-ancestor
25625658|NCT01241591|Sensory System Agents|sensory system agents|mesh-ancestor
25625659|NCT01241591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25625660|NCT01241591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625661|NCT01241591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25625662|NCT01241591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25625663|NCT01241591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25625664|NCT01241591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25625665|NCT01241591|Immunologic Factors|immunologic factors|mesh-ancestor
25716065|NCT02386319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24394149|NCT00132379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394150|NCT00132418|Etanercept|etanercept|mesh-list
24394151|NCT00132418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24394152|NCT00132418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24394153|NCT00132418|Analgesics|analgesics|mesh-ancestor
24394154|NCT00132418|Sensory System Agents|sensory system agents|mesh-ancestor
24394155|NCT00132418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25716066|NCT02387164|Vitamin D|vitamin d|mesh-list
25716067|NCT02387164|Cholecalciferol|cholecalciferol|mesh-list
25716068|NCT02387164|Vitamins|vitamins|mesh-ancestor
25716069|NCT02387164|Micronutrients|micronutrients|mesh-ancestor
25716070|NCT02387164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716071|NCT02387164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25716072|NCT02387164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25625666|NCT01241591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25625667|NCT01241591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25625668|NCT01241591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625669|NCT01241760|Interferons|interferons|mesh-list
25625670|NCT01241760|Ribavirin|ribavirin|mesh-list
25625671|NCT01241760|Interferon-alpha|interferon-alpha|mesh-list
25625672|NCT01241760|Interferon alpha-2|interferon alpha-2|mesh-list
25520234|NCT00453349|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25625673|NCT01241760|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25625674|NCT01241760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625675|NCT01241760|Antiviral Agents|antiviral agents|mesh-ancestor
25625676|NCT01241760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25625677|NCT01241760|Antimetabolites|antimetabolites|mesh-ancestor
25625678|NCT01241760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625679|NCT01241760|Immunologic Factors|immunologic factors|mesh-ancestor
25625680|NCT01241760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625681|NCT01241903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25625682|NCT01241903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25625683|NCT01241903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25625684|NCT01241903|Antimetabolites|antimetabolites|mesh-ancestor
25625685|NCT01241903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625686|NCT01241903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25625687|NCT01241903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25625688|NCT01241903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25625689|NCT01242176|Empagliflozin|empagliflozin|mesh-list
25625690|NCT01242176|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25625691|NCT01242176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625692|NCT01242176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25625693|NCT01242176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625694|NCT01242241|Propofol|propofol|mesh-list
25625695|NCT01242241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25625696|NCT01242241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25625697|NCT01242241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625698|NCT01242241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25625699|NCT01242241|Anesthetics, General|anesthetics, general|mesh-ancestor
25625700|NCT01242241|Anesthetics|anesthetics|mesh-ancestor
25625701|NCT01242644|Ketorolac|ketorolac|mesh-list
25625702|NCT01242644|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25625703|NCT01242644|Morphine|morphine|mesh-list
25625704|NCT01242644|Ropivacaine|ropivacaine|mesh-list
25625705|NCT01242644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25625706|NCT01242644|Narcotics|narcotics|mesh-ancestor
25625707|NCT01242644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25520285|NCT00453921|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25520286|NCT00453921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520287|NCT00453921|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25520288|NCT00453921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25520289|NCT00453921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25520290|NCT00453921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520291|NCT00453921|Dopamine Agents|dopamine agents|mesh-ancestor
25520292|NCT00453921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25520293|NCT00453999|Oseltamivir|oseltamivir|mesh-list
25520294|NCT00453999|Peramivir|peramivir|mesh-list
25520295|NCT00453999|Antiviral Agents|antiviral agents|mesh-ancestor
25520296|NCT00453999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24394156|NCT00132418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394157|NCT00132418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24394158|NCT00132418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24394159|NCT00132418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25520297|NCT00453999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520298|NCT00453999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520299|NCT00454051|Omalizumab|omalizumab|mesh-list
25520300|NCT00454051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25520301|NCT00454051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25520302|NCT00454051|Respiratory System Agents|respiratory system agents|mesh-ancestor
25520303|NCT00454181|Interferons|interferons|mesh-list
25520304|NCT00454181|Interferon-alpha|interferon-alpha|mesh-list
25520305|NCT00454181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520306|NCT00454181|Antiviral Agents|antiviral agents|mesh-ancestor
25520307|NCT00454181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25520310|NCT00454194|Pemetrexed|pemetrexed|mesh-list
25625708|NCT01242644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625709|NCT01242644|Analgesics|analgesics|mesh-ancestor
25625710|NCT01242644|Sensory System Agents|sensory system agents|mesh-ancestor
25625711|NCT01242644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25625712|NCT01242644|Anesthetics, Local|anesthetics, local|mesh-ancestor
25625713|NCT01242644|Anesthetics|anesthetics|mesh-ancestor
25625714|NCT01242644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25625715|NCT01242644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25625716|NCT01242644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25625717|NCT01242644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25625718|NCT01242644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25625719|NCT01242644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25625720|NCT01242644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625721|NCT01242748|Goserelin|goserelin|mesh-list
25625722|NCT01242748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25625723|NCT01242748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625724|NCT01243112|Lidocaine|lidocaine|mesh-list
25625725|NCT01243112|Epinephrine|epinephrine|mesh-list
25625726|NCT01243112|Racepinephrine|racepinephrine|mesh-list
25625727|NCT01243112|Bupivacaine|bupivacaine|mesh-list
25625728|NCT01243112|Epinephryl borate|epinephryl borate|mesh-list
25625729|NCT01243112|Anesthetics, Local|anesthetics, local|mesh-ancestor
25625730|NCT01243112|Anesthetics|anesthetics|mesh-ancestor
25625731|NCT01243112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25625732|NCT01243112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625733|NCT01243112|Sensory System Agents|sensory system agents|mesh-ancestor
25625734|NCT01243112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25625735|NCT01243112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25625736|NCT01243112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24462895|NCT00357825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24462896|NCT00357825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462897|NCT00357851|Aprotinin|aprotinin|mesh-list
24462904|NCT00357851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462906|NCT00357864|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24462907|NCT00357864|Miotics|miotics|mesh-ancestor
24462908|NCT00357864|Autonomic Agents|autonomic agents|mesh-ancestor
24462909|NCT00357864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24462910|NCT00357864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462911|NCT00357864|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24462912|NCT00357864|Cholinergic Agents|cholinergic agents|mesh-ancestor
24462913|NCT00357864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24462915|NCT00357864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24462916|NCT00357864|Analgesics|analgesics|mesh-ancestor
24462917|NCT00357864|Sensory System Agents|sensory system agents|mesh-ancestor
24462918|NCT00357864|Protective Agents|protective agents|mesh-ancestor
24462919|NCT00357890|Insulin Glargine|insulin glargine|mesh-list
24462920|NCT00357890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25625737|NCT01243112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25625738|NCT01243112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25625739|NCT01243112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625740|NCT01243112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25625741|NCT01243112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25625742|NCT01243112|Adrenergic Agents|adrenergic agents|mesh-ancestor
25625743|NCT01243112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25625744|NCT01243112|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25625745|NCT01243112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25625746|NCT01243112|Autonomic Agents|autonomic agents|mesh-ancestor
25625747|NCT01243112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25625748|NCT01243112|Respiratory System Agents|respiratory system agents|mesh-ancestor
25625749|NCT01243112|Mydriatics|mydriatics|mesh-ancestor
25625750|NCT01243112|Sympathomimetics|sympathomimetics|mesh-ancestor
25625751|NCT01243112|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25625752|NCT01243151|Bococizumab|bococizumab|mesh-list
25625753|NCT01243151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25625754|NCT01243151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25625755|NCT01243151|Antimetabolites|antimetabolites|mesh-ancestor
25625756|NCT01243151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625757|NCT01243151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25625758|NCT01243177|Lacosamide|lacosamide|mesh-list
25625759|NCT01243177|Carbamazepine|carbamazepine|mesh-list
25625760|NCT01243177|Anticonvulsants|anticonvulsants|mesh-ancestor
25625761|NCT01243177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25625762|NCT01243177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25625763|NCT01243177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25625764|NCT01243177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625765|NCT01243177|Antimanic Agents|antimanic agents|mesh-ancestor
25625766|NCT01243177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25625767|NCT01243177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25625768|NCT01243177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625769|NCT01243177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25625770|NCT01243177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25625771|NCT01243177|Analgesics|analgesics|mesh-ancestor
25625772|NCT01243177|Sensory System Agents|sensory system agents|mesh-ancestor
25625773|NCT01243177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25625774|NCT01243177|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24462923|NCT00357942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24462924|NCT00357942|Narcotics|narcotics|mesh-ancestor
24462925|NCT00357942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24462926|NCT00357942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462962|NCT00358202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24462963|NCT00358202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24462964|NCT00358228|Rimonabant|rimonabant|mesh-list
24462965|NCT00358228|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24462987|NCT00358293|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24462988|NCT00358293|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24462989|NCT00358293|Parasympatholytics|parasympatholytics|mesh-ancestor
24452202|NCT00326391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24452204|NCT00326391|Dopamine Agents|dopamine agents|mesh-ancestor
25625775|NCT01243177|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25625776|NCT01243242|Metadoxine|metadoxine|mesh-list
25625777|NCT01243242|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25625778|NCT01243268|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
25625779|NCT01243268|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25625780|NCT01243268|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25625781|NCT01243268|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25716073|NCT02387216|Docetaxel|docetaxel|mesh-list
25777819|NCT03113071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25777820|NCT03113071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777821|NCT03113071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25777822|NCT03113071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25777823|NCT03113071|Protective Agents|protective agents|mesh-ancestor
25777824|NCT03113071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716074|NCT02387216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716075|NCT02387216|Tubulin Modulators|tubulin modulators|mesh-ancestor
25716076|NCT02387216|Antimitotic Agents|antimitotic agents|mesh-ancestor
25716077|NCT02387216|Mitosis Modulators|mitosis modulators|mesh-ancestor
25716078|NCT02387216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716079|NCT02387359|Plecanatide|plecanatide|mesh-list
25716080|NCT02387359|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25716081|NCT02387359|Enzyme Activators|enzyme activators|mesh-ancestor
25625782|NCT01243268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625783|NCT01243333|Deoxyglucose|deoxyglucose|mesh-list
25625784|NCT01243333|Alovudine|alovudine|mesh-list
25625785|NCT01243333|Dideoxynucleosides|dideoxynucleosides|mesh-list
25625786|NCT01243333|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25625787|NCT01243333|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25625788|NCT01243333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625789|NCT01243333|Antimetabolites|antimetabolites|mesh-ancestor
25625790|NCT01243333|Antiviral Agents|antiviral agents|mesh-ancestor
25625791|NCT01243333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25625792|NCT01243333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25625793|NCT01243333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25625794|NCT01243333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25625795|NCT01243424|Glimepiride|glimepiride|mesh-list
25625796|NCT01243424|Linagliptin|linagliptin|mesh-list
25625797|NCT01243424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25625798|NCT01243424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25625799|NCT01243424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625800|NCT01243424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25625801|NCT01243424|Immunologic Factors|immunologic factors|mesh-ancestor
25625802|NCT01243424|Incretins|incretins|mesh-ancestor
25625803|NCT01243424|Hormones|hormones|mesh-ancestor
25520337|NCT00454584|Etanercept|etanercept|mesh-list
25625804|NCT01243424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25625805|NCT01243424|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25625806|NCT01243424|Protease Inhibitors|protease inhibitors|mesh-ancestor
25625807|NCT01243424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25625808|NCT01243424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625809|NCT01243450|Tretinoin|tretinoin|mesh-list
25625810|NCT01243450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625811|NCT01243450|Keratolytic Agents|keratolytic agents|mesh-ancestor
25625812|NCT01243450|Dermatologic Agents|dermatologic agents|mesh-ancestor
25625813|NCT01243567|Timolol|timolol|mesh-list
25625814|NCT01243567|Bimatoprost|bimatoprost|mesh-list
25625815|NCT01243567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25625816|NCT01243567|Latanoprost|latanoprost|mesh-list
25625817|NCT01243567|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25625818|NCT01243567|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25625819|NCT01243567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25625820|NCT01243567|Adrenergic Agents|adrenergic agents|mesh-ancestor
25625821|NCT01243567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25625822|NCT01243567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625823|NCT01243567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625824|NCT01243567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25625825|NCT01243567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25625826|NCT01243580|Moxifloxacin|moxifloxacin|mesh-list
25625827|NCT01243580|Contraceptive Agents|contraceptive agents|mesh-list
25625828|NCT01243580|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25625829|NCT01243580|Contraceptives, Oral|contraceptives, oral|mesh-list
25716082|NCT02387359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716083|NCT02387359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25716084|NCT02387372|Tazobactam|tazobactam|mesh-list
25716085|NCT02387372|Ceftolozane|ceftolozane|mesh-list
24463036|NCT00358384|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24463037|NCT00358384|Betamethasone benzoate|betamethasone benzoate|mesh-list
24463038|NCT00358384|Calcipotriene|calcipotriene|mesh-list
24463039|NCT00358384|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25716086|NCT02387372|Cephalosporins|cephalosporins|mesh-list
25716087|NCT02387372|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
25716088|NCT02387372|Penicillanic Acid|penicillanic acid|mesh-list
25716089|NCT02387372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25716090|NCT02387372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25625830|NCT01243580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25625831|NCT01243580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625832|NCT01243580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25625833|NCT01243580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25625834|NCT01243580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25625835|NCT01243580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25625836|NCT01243580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25625837|NCT01243580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25625838|NCT01243580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625839|NCT01243580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625840|NCT01243580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25625841|NCT01243580|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25625842|NCT01243593|Anesthetics|anesthetics|mesh-list
25625843|NCT01243593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25625844|NCT01243593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625845|NCT01243671|Adalimumab|adalimumab|mesh-list
25625846|NCT01243671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25625847|NCT01243671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25625848|NCT01243775|Docetaxel|docetaxel|mesh-list
25625849|NCT01243775|Oxaliplatin|oxaliplatin|mesh-list
25625850|NCT01243775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625851|NCT01243775|Tubulin Modulators|tubulin modulators|mesh-ancestor
25625852|NCT01243775|Antimitotic Agents|antimitotic agents|mesh-ancestor
25625853|NCT01243775|Mitosis Modulators|mitosis modulators|mesh-ancestor
25625854|NCT01243775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625855|NCT01243944|Lenalidomide|lenalidomide|mesh-list
25625856|NCT01243944|Pomalidomide|pomalidomide|mesh-list
25625857|NCT01243944|Hydroxyurea|hydroxyurea|mesh-list
25625858|NCT01243944|Pipobroman|pipobroman|mesh-list
25625859|NCT01243944|Anagrelide|anagrelide|mesh-list
25625860|NCT01243944|Immunologic Factors|immunologic factors|mesh-ancestor
25625861|NCT01243944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625862|NCT01243944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25625863|NCT01243944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25625864|NCT01243944|Growth Substances|growth substances|mesh-ancestor
25625865|NCT01243944|Growth Inhibitors|growth inhibitors|mesh-ancestor
25625866|NCT01243944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625867|NCT01243944|Antisickling Agents|antisickling agents|mesh-ancestor
25625868|NCT01243944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25625869|NCT01243944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625870|NCT01243944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25625871|NCT01243944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25625872|NCT01243944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25625873|NCT01243944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25625874|NCT01243944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25625875|NCT01243944|Alkylating Agents|alkylating agents|mesh-ancestor
25625876|NCT01243957|Fluoxetine|fluoxetine|mesh-list
25625877|NCT01243957|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25655678|NCT01565889|Antimetabolites|antimetabolites|mesh-ancestor
25625878|NCT01243957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25625879|NCT01243957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25625880|NCT01243957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625881|NCT01243957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25625882|NCT01243957|Serotonin Agents|serotonin agents|mesh-ancestor
25625883|NCT01243957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716092|NCT02387372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25716093|NCT02387372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716094|NCT02387372|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25716095|NCT02387372|Renal Agents|renal agents|mesh-ancestor
25716096|NCT02387554|Losartan|losartan|mesh-list
25716097|NCT02387554|Amlodipine|amlodipine|mesh-list
25716098|NCT02387554|Chlorthalidone|chlorthalidone|mesh-list
25716099|NCT02387554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25625884|NCT01243957|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25625885|NCT01243957|Antidepressive Agents|antidepressive agents|mesh-ancestor
25625886|NCT01243957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25625887|NCT01243957|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25625888|NCT01243957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25625889|NCT01243957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25625890|NCT01244061|Varenicline|varenicline|mesh-list
25625891|NCT01244061|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25625892|NCT01244061|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25625893|NCT01244061|Cholinergic Agents|cholinergic agents|mesh-ancestor
25625894|NCT01244061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25625895|NCT01244061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625896|NCT01244061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625897|NCT01244126|Fentanyl|fentanyl|mesh-list
25625898|NCT01244126|Morphine|morphine|mesh-list
25625899|NCT01244126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25625900|NCT01244126|Narcotics|narcotics|mesh-ancestor
25625901|NCT01244126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25625902|NCT01244126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625903|NCT01244126|Analgesics|analgesics|mesh-ancestor
25625904|NCT01244126|Sensory System Agents|sensory system agents|mesh-ancestor
25625905|NCT01244126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25625906|NCT01244126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25625907|NCT01244126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25625908|NCT01244126|Anesthetics, General|anesthetics, general|mesh-ancestor
25625909|NCT01244126|Anesthetics|anesthetics|mesh-ancestor
25625910|NCT01244191|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25625911|NCT01244191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625912|NCT01244191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25625913|NCT01244191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25625914|NCT01244191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625915|NCT01244425|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25625916|NCT01244425|Hemostatics|hemostatics|mesh-ancestor
25625917|NCT01244425|Coagulants|coagulants|mesh-ancestor
25625918|NCT01244451|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25625919|NCT01244451|Ofatumumab|ofatumumab|mesh-list
25625920|NCT01244451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24463117|NCT00358813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24463118|NCT00358813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463120|NCT00358930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24463121|NCT00358930|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24463130|NCT00358969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24463131|NCT00358969|Adrenergic Agents|adrenergic agents|mesh-ancestor
24452298|NCT00327093|Bevacizumab|bevacizumab|mesh-list
25625921|NCT01244451|Alkylating Agents|alkylating agents|mesh-ancestor
25625922|NCT01244451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625923|NCT01244451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625924|NCT01244490|Guanfacine|guanfacine|mesh-list
25625925|NCT01244490|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25625926|NCT01244490|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25625927|NCT01244490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25625928|NCT01244490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25625929|NCT01244490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625930|NCT01244490|Adrenergic Agents|adrenergic agents|mesh-ancestor
25625931|NCT01244490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25625932|NCT01244490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625933|NCT01244490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25625934|NCT01244490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25625935|NCT01244490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25625936|NCT01244490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25655679|NCT01565902|Siponimod|siponimod|mesh-list
25655680|NCT01565902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25655681|NCT01565902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655682|NCT01565902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25655683|NCT01565902|Immunologic Factors|immunologic factors|mesh-ancestor
25655684|NCT01565902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655685|NCT01566162|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25655686|NCT01566162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25655687|NCT01566162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25655688|NCT01566162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25655689|NCT01566162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655690|NCT01566162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25655691|NCT01566162|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25625937|NCT01244633|Ecopipam|ecopipam|mesh-list
25625938|NCT01244633|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25625939|NCT01244633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25625940|NCT01244633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25625941|NCT01244633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625942|NCT01244633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25625943|NCT01244633|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25625944|NCT01244633|Dopamine Agents|dopamine agents|mesh-ancestor
25625945|NCT01244633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24463142|NCT00359125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463143|NCT00359125|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24463146|NCT00359125|Contraceptive Agents|contraceptive agents|mesh-ancestor
25716112|NCT02387580|Artefenomel|artefenomel|mesh-list
25716113|NCT02387580|Antimalarials|antimalarials|mesh-ancestor
25716114|NCT02387580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25716115|NCT02387580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25716116|NCT02387580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25716117|NCT02387710|Tiagabine|tiagabine|mesh-list
25716118|NCT02387710|Anticonvulsants|anticonvulsants|mesh-ancestor
25716119|NCT02387710|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
25716120|NCT02387710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25716121|NCT02387710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25716122|NCT02387710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625946|NCT01244633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625947|NCT01244711|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25625948|NCT01244711|Antidepressive Agents|antidepressive agents|mesh-ancestor
25625949|NCT01244711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25625950|NCT01244711|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25625951|NCT01244711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25625952|NCT01244711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25625953|NCT01244711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625954|NCT01244724|Citalopram|citalopram|mesh-list
25625955|NCT01244724|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25625956|NCT01244724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25625957|NCT01244724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25625958|NCT01244724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625959|NCT01244724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25625960|NCT01244724|Serotonin Agents|serotonin agents|mesh-ancestor
25625961|NCT01244724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625962|NCT01244724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25625963|NCT01244724|Antidepressive Agents|antidepressive agents|mesh-ancestor
25625964|NCT01244724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25625965|NCT01244984|Fluticasone|fluticasone|mesh-list
25625966|NCT01244984|Xhance|xhance|mesh-list
25625967|NCT01244984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25625968|NCT01244984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25625969|NCT01244984|Autonomic Agents|autonomic agents|mesh-ancestor
25625970|NCT01244984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24463202|NCT00359333|Gemcitabine|gemcitabine|mesh-list
24463203|NCT00359333|Docetaxel|docetaxel|mesh-list
24463204|NCT00359333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24463210|NCT00359333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24463211|NCT00359333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24463212|NCT00359333|Immunologic Factors|immunologic factors|mesh-ancestor
24463213|NCT00359333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463233|NCT00359567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463234|NCT00359606|Tetrahydrouridine|tetrahydrouridine|mesh-list
24463235|NCT00359606|Antimetabolites|antimetabolites|mesh-ancestor
24463236|NCT00359606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463237|NCT00359658|Cyclosporine|cyclosporine|mesh-list
24463238|NCT00359658|Prednisolone|prednisolone|mesh-list
24463239|NCT00359658|Cyclosporins|cyclosporins|mesh-list
24463240|NCT00359658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24463241|NCT00359658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716123|NCT02387710|GABA Agents|gaba agents|mesh-ancestor
25716124|NCT02387710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25716125|NCT02387710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716126|NCT02387762|Methotrexate|methotrexate|mesh-list
25716127|NCT02387762|Acalabrutinib|acalabrutinib|mesh-list
25716128|NCT02387762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25716129|NCT02387762|Abortifacient Agents|abortifacient agents|mesh-ancestor
25716130|NCT02387762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25625971|NCT01244984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625972|NCT01244984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25625973|NCT01244984|Respiratory System Agents|respiratory system agents|mesh-ancestor
25625974|NCT01244984|Dermatologic Agents|dermatologic agents|mesh-ancestor
25625975|NCT01244984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25625976|NCT01245062|Trametinib|trametinib|mesh-list
25625977|NCT01245062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625978|NCT01245062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25625979|NCT01245062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25625980|NCT01245062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625981|NCT01245101|Raltegravir Potassium|raltegravir potassium|mesh-list
25625982|NCT01245101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25625983|NCT01245101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25625984|NCT01245101|Antiviral Agents|antiviral agents|mesh-ancestor
25625985|NCT01245101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25625986|NCT01245101|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25625987|NCT01245101|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25625988|NCT01245101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25625989|NCT01245101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25625990|NCT01245140|Alitretinoin|alitretinoin|mesh-list
25625991|NCT01245140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25625992|NCT01245140|Dermatologic Agents|dermatologic agents|mesh-ancestor
25625993|NCT01245595|Aminophylline|aminophylline|mesh-list
25625994|NCT01245595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25625995|NCT01245595|Autonomic Agents|autonomic agents|mesh-ancestor
25716132|NCT02387762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24463303|NCT00359879|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24463305|NCT00359879|Hormones|hormones|mesh-ancestor
24463306|NCT00359879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24463307|NCT00359892|Obatoclax|obatoclax|mesh-list
24463326|NCT00360048|Oxytocin|oxytocin|mesh-list
24463379|NCT00360594|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24463380|NCT00360607|Metronidazole|metronidazole|mesh-list
25716133|NCT02387762|Antimetabolites|antimetabolites|mesh-ancestor
25716134|NCT02387762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716135|NCT02387762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716136|NCT02387762|Dermatologic Agents|dermatologic agents|mesh-ancestor
25716137|NCT02387762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25716138|NCT02387762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25625996|NCT01245595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25625997|NCT01245595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25625998|NCT01245595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25625999|NCT01245595|Respiratory System Agents|respiratory system agents|mesh-ancestor
25626000|NCT01245595|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25626001|NCT01245595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25626002|NCT01245595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626003|NCT01245595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626004|NCT01245595|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25626005|NCT01245595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25626006|NCT01245595|Purinergic Agents|purinergic agents|mesh-ancestor
25626007|NCT01245595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25626008|NCT01245595|Protective Agents|protective agents|mesh-ancestor
25626009|NCT01245647|Naltrexone|naltrexone|mesh-list
25626010|NCT01245647|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25520557|NCT00455962|Progestins|progestins|mesh-ancestor
25626011|NCT01245647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25626012|NCT01245647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626013|NCT01245647|Sensory System Agents|sensory system agents|mesh-ancestor
25626014|NCT01245647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25626015|NCT01245673|Lenalidomide|lenalidomide|mesh-list
25626016|NCT01245673|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25626017|NCT01245673|Poly ICLC|poly iclc|mesh-list
25626018|NCT01245673|Immunologic Factors|immunologic factors|mesh-ancestor
25626019|NCT01245673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626020|NCT01245673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24463381|NCT00360607|Amikacin|amikacin|mesh-list
24463382|NCT00360607|Ceftazidime|ceftazidime|mesh-list
24463383|NCT00360607|Sulbactam|sulbactam|mesh-list
24463384|NCT00360607|Cefoperazone|cefoperazone|mesh-list
24463385|NCT00360607|Sulperazone|sulperazone|mesh-list
24463386|NCT00360607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24463387|NCT00360607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24463388|NCT00360607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24463389|NCT00360607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24463390|NCT00360607|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24463391|NCT00360607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24463392|NCT00360607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463394|NCT00360607|Renal Agents|renal agents|mesh-ancestor
24463395|NCT00360737|Antitoxins|antitoxins|mesh-list
24463396|NCT00360737|Botulinum Antitoxin|botulinum antitoxin|mesh-list
24463397|NCT00360737|Immunologic Factors|immunologic factors|mesh-ancestor
24463398|NCT00360737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463399|NCT00360750|Cytarabine|cytarabine|mesh-list
24463401|NCT00360750|Etoposide|etoposide|mesh-list
25716139|NCT02387762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25716140|NCT02387762|Immunologic Factors|immunologic factors|mesh-ancestor
25716141|NCT02387762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25716142|NCT02387762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25716143|NCT02387801|Ixekizumab|ixekizumab|mesh-list
25716144|NCT02387801|Dermatologic Agents|dermatologic agents|mesh-ancestor
25716145|NCT02387957|Bevacizumab|bevacizumab|mesh-list
25626021|NCT01245673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25626022|NCT01245673|Growth Substances|growth substances|mesh-ancestor
25626023|NCT01245673|Growth Inhibitors|growth inhibitors|mesh-ancestor
25626024|NCT01245673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626025|NCT01245673|Interferon Inducers|interferon inducers|mesh-ancestor
25626026|NCT01246063|Dexamethasone|dexamethasone|mesh-list
25626027|NCT01246063|Doxorubicin|doxorubicin|mesh-list
25626028|NCT01246063|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25626029|NCT01246063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25626030|NCT01246063|Antiemetics|antiemetics|mesh-ancestor
25716148|NCT02387957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25716149|NCT02387957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716150|NCT02387957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25716151|NCT02387957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25716152|NCT02387957|Growth Substances|growth substances|mesh-ancestor
24463402|NCT00360750|Vincristine|vincristine|mesh-list
24463403|NCT00360750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463404|NCT00360750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24463405|NCT00360750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24463406|NCT00360750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24463407|NCT00360750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24463434|NCT00360854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463435|NCT00360945|Temozolomide|temozolomide|mesh-list
24463436|NCT00360945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463437|NCT00360945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24463438|NCT00360945|Alkylating Agents|alkylating agents|mesh-ancestor
24463473|NCT00361114|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24463474|NCT00361114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24463475|NCT00361114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463476|NCT00361114|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24463477|NCT00361114|Renal Agents|renal agents|mesh-ancestor
24463478|NCT00361114|Leprostatic Agents|leprostatic agents|mesh-ancestor
24463479|NCT00361114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24463480|NCT00361153|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
24463481|NCT00361153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24463482|NCT00361153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24463483|NCT00361153|Antimetabolites|antimetabolites|mesh-ancestor
25716153|NCT02387957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716154|NCT02387957|Growth Inhibitors|growth inhibitors|mesh-ancestor
25716155|NCT02387983|Posaconazole|posaconazole|mesh-list
25626031|NCT01246063|Autonomic Agents|autonomic agents|mesh-ancestor
25626032|NCT01246063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25626033|NCT01246063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626034|NCT01246063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25626035|NCT01246063|Glucocorticoids|glucocorticoids|mesh-ancestor
25626036|NCT01246063|Hormones|hormones|mesh-ancestor
25626037|NCT01246063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25626038|NCT01246063|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25716156|NCT02387983|Antifungal Agents|antifungal agents|mesh-ancestor
25716157|NCT02387983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25716158|NCT02387983|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24463500|NCT00361244|Cetuximab|cetuximab|mesh-list
24463501|NCT00361244|Sunitinib|sunitinib|mesh-list
24463502|NCT00361244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24463544|NCT00361322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24463545|NCT00361322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24463546|NCT00361348|Heparin|heparin|mesh-list
24452383|NCT00327353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24452384|NCT00327353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452385|NCT00327353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24452386|NCT00327353|Respiratory System Agents|respiratory system agents|mesh-ancestor
24452393|NCT00327379|Aprotinin|aprotinin|mesh-list
24452394|NCT00327379|Hemostatics|hemostatics|mesh-ancestor
24452395|NCT00327379|Coagulants|coagulants|mesh-ancestor
24452396|NCT00327379|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24452397|NCT00327379|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24452398|NCT00327379|Protease Inhibitors|protease inhibitors|mesh-ancestor
24452399|NCT00327379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24452400|NCT00327379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452401|NCT00327418|Atorvastatin|atorvastatin|mesh-list
24452402|NCT00327418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24452403|NCT00327418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24452404|NCT00327418|Antimetabolites|antimetabolites|mesh-ancestor
24452405|NCT00327418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716159|NCT02387983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25716160|NCT02387983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25716161|NCT02387983|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25716162|NCT02387983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25716163|NCT02387983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626039|NCT01246063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626040|NCT01246063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25626041|NCT01246063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25626042|NCT01246063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25626043|NCT01246063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626044|NCT01246063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626045|NCT01246076|Lenalidomide|lenalidomide|mesh-list
25626046|NCT01246076|Immunologic Factors|immunologic factors|mesh-ancestor
25626047|NCT01246076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626048|NCT01246076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25626049|NCT01246076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25626050|NCT01246076|Growth Substances|growth substances|mesh-ancestor
25626051|NCT01246076|Growth Inhibitors|growth inhibitors|mesh-ancestor
25626052|NCT01246076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626053|NCT01246206|Tacrolimus|tacrolimus|mesh-list
25626054|NCT01246206|Thymoglobulin|thymoglobulin|mesh-list
25626055|NCT01246206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25626056|NCT01246206|Immunologic Factors|immunologic factors|mesh-ancestor
25626057|NCT01246206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626058|NCT01246206|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25716164|NCT02387983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716165|NCT02387983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24463565|NCT00361452|Albuterol|albuterol|mesh-list
24463566|NCT00361452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24463567|NCT00361452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24463568|NCT00361452|Adrenergic Agents|adrenergic agents|mesh-ancestor
24463569|NCT00361452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24463570|NCT00361452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463574|NCT00361452|Autonomic Agents|autonomic agents|mesh-ancestor
24463575|NCT00361452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24463576|NCT00361452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24463577|NCT00361452|Respiratory System Agents|respiratory system agents|mesh-ancestor
24463599|NCT00361543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24463600|NCT00361543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463601|NCT00361543|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24463602|NCT00361543|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24463603|NCT00361543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24463605|NCT00361621|Cyclophosphamide|cyclophosphamide|mesh-list
24463607|NCT00361621|Doxorubicin|doxorubicin|mesh-list
25716166|NCT02387983|Hormone Antagonists|hormone antagonists|mesh-ancestor
25716167|NCT02387983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25716168|NCT02387983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716169|NCT02388165|Vaccines|vaccines|mesh-list
25716170|NCT02388165|Immunologic Factors|immunologic factors|mesh-ancestor
25626059|NCT01246206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626060|NCT01246206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626061|NCT01246401|Naltrexone|naltrexone|mesh-list
25626062|NCT01246401|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25626063|NCT01246401|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25626064|NCT01246401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626065|NCT01246401|Sensory System Agents|sensory system agents|mesh-ancestor
25626066|NCT01246401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25626067|NCT01246583|Tofacitinib|tofacitinib|mesh-list
25626068|NCT01246583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25626069|NCT01246583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626070|NCT01246583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626071|NCT01246713|Acetaminophen|acetaminophen|mesh-list
25626072|NCT01246713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25626073|NCT01246713|Analgesics|analgesics|mesh-ancestor
25626074|NCT01246713|Sensory System Agents|sensory system agents|mesh-ancestor
25626075|NCT01246713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25626076|NCT01246713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626077|NCT01246713|Antipyretics|antipyretics|mesh-ancestor
25626078|NCT01246791|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25626079|NCT01246791|Norethindrone|norethindrone|mesh-list
25626080|NCT01246791|Norinyl|norinyl|mesh-list
25626081|NCT01246791|Estradiol|estradiol|mesh-list
25626082|NCT01246791|Estrogens|estrogens|mesh-ancestor
25626083|NCT01246791|Hormones|hormones|mesh-ancestor
25626084|NCT01246791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25626085|NCT01246791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520640|NCT00456521|Dopamine Agents|dopamine agents|mesh-ancestor
25626086|NCT01246791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25626087|NCT01246791|Contraceptive Agents|contraceptive agents|mesh-ancestor
25626088|NCT01246791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25626089|NCT01246791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25626090|NCT01246791|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25626091|NCT01246791|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25626092|NCT01246791|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25626093|NCT01246791|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25626094|NCT01246960|Leucovorin|leucovorin|mesh-list
25626095|NCT01246960|Fluorouracil|fluorouracil|mesh-list
25626096|NCT01246960|Oxaliplatin|oxaliplatin|mesh-list
25626097|NCT01246960|Ramucirumab|ramucirumab|mesh-list
25626098|NCT01246960|Antimetabolites|antimetabolites|mesh-ancestor
25626099|NCT01246960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626100|NCT01246960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25626101|NCT01246960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626102|NCT01246960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25626103|NCT01246960|Immunologic Factors|immunologic factors|mesh-ancestor
25716171|NCT02388165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716172|NCT02388191|Naproxen|naproxen|mesh-list
25716173|NCT02388191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25716174|NCT02388191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25716175|NCT02388191|Analgesics|analgesics|mesh-ancestor
25716176|NCT02388191|Sensory System Agents|sensory system agents|mesh-ancestor
25716177|NCT02388191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25716178|NCT02388191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716179|NCT02388191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25626104|NCT01246960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626105|NCT01246960|Antidotes|antidotes|mesh-ancestor
25626106|NCT01246960|Protective Agents|protective agents|mesh-ancestor
25626107|NCT01246960|Vitamin B Complex|vitamin b complex|mesh-ancestor
25626108|NCT01246960|Vitamins|vitamins|mesh-ancestor
25626109|NCT01246960|Micronutrients|micronutrients|mesh-ancestor
25626110|NCT01246973|Curcumin|curcumin|mesh-list
25626111|NCT01246973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25626112|NCT01246973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25626113|NCT01246973|Analgesics|analgesics|mesh-ancestor
25626114|NCT01246973|Sensory System Agents|sensory system agents|mesh-ancestor
25626115|NCT01246973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25626116|NCT01246973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626117|NCT01246973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24463626|NCT00361621|Hormones|hormones|mesh-ancestor
24463627|NCT00361621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24463628|NCT00361621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24463656|NCT00361790|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24463657|NCT00361790|Antidepressive Agents|antidepressive agents|mesh-ancestor
24463669|NCT00361790|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25716180|NCT02388191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25716181|NCT02388191|Gout Suppressants|gout suppressants|mesh-ancestor
25716182|NCT02388191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25716183|NCT02388191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25716184|NCT02388191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716185|NCT02388321|Fentanyl|fentanyl|mesh-list
25716186|NCT02388321|Ketamine|ketamine|mesh-list
25716187|NCT02388321|Analgesics|analgesics|mesh-ancestor
25716188|NCT02388321|Sensory System Agents|sensory system agents|mesh-ancestor
25626118|NCT01246973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25626119|NCT01246973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626120|NCT01246973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626121|NCT01246973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626122|NCT01246986|Sorafenib|sorafenib|mesh-list
25626123|NCT01246986|Ramucirumab|ramucirumab|mesh-list
25626124|NCT01246986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626125|NCT01246986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25626126|NCT01246986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626127|NCT01246986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626128|NCT01246999|Vaccines|vaccines|mesh-list
25626129|NCT01246999|Immunologic Factors|immunologic factors|mesh-ancestor
25626130|NCT01246999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626131|NCT01247064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25626132|NCT01247090|Vasopressins|vasopressins|mesh-list
25626133|NCT01247090|Arginine Vasopressin|arginine vasopressin|mesh-list
25626134|NCT01247090|Hemostatics|hemostatics|mesh-ancestor
25626135|NCT01247090|Coagulants|coagulants|mesh-ancestor
25626136|NCT01247090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25626137|NCT01247090|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25716189|NCT02388321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25716190|NCT02388321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463671|NCT00361803|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24463672|NCT00361803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24463673|NCT00361803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25716191|NCT02388321|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25716192|NCT02388321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25716193|NCT02388321|Anesthetics, General|anesthetics, general|mesh-ancestor
25716194|NCT02388321|Anesthetics|anesthetics|mesh-ancestor
25716195|NCT02388321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25716196|NCT02388321|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25716197|NCT02388321|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25716198|NCT02388321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25716199|NCT02388321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716200|NCT02388321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25626138|NCT01247090|Natriuretic Agents|natriuretic agents|mesh-ancestor
25626139|NCT01247090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626140|NCT01247220|Ranibizumab|ranibizumab|mesh-list
25626141|NCT01247220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25626142|NCT01247220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25626143|NCT01247220|Growth Substances|growth substances|mesh-ancestor
25626144|NCT01247220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626145|NCT01247220|Growth Inhibitors|growth inhibitors|mesh-ancestor
25626146|NCT01247220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626147|NCT01247272|Fluoxetine|fluoxetine|mesh-list
25626148|NCT01247272|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25626149|NCT01247272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25626150|NCT01247272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25626151|NCT01247272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626152|NCT01247272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25626153|NCT01247272|Serotonin Agents|serotonin agents|mesh-ancestor
25626154|NCT01247272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626155|NCT01247272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25626156|NCT01247272|Antidepressive Agents|antidepressive agents|mesh-ancestor
25626157|NCT01247272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25626158|NCT01247272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25626159|NCT01247272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25520705|NCT00457366|Lorazepam|lorazepam|mesh-list
25626160|NCT01247272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24463791|NCT00362245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24463792|NCT00362258|Irbesartan|irbesartan|mesh-list
24463793|NCT00362258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24463794|NCT00362258|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24463818|NCT00362271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24463819|NCT00362271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24463822|NCT00362310|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24463824|NCT00362310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24463825|NCT00362310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463826|NCT00362310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24463827|NCT00362310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24463828|NCT00362310|Antiviral Agents|antiviral agents|mesh-ancestor
24463829|NCT00362310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24463831|NCT00362323|Fenofibrate|fenofibrate|mesh-list
24463832|NCT00362323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24463857|NCT00362544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24463858|NCT00362544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25626161|NCT01247285|Fluoxetine|fluoxetine|mesh-list
25626162|NCT01247285|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25626163|NCT01247285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25626164|NCT01247285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25626165|NCT01247285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626166|NCT01247285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25626167|NCT01247285|Serotonin Agents|serotonin agents|mesh-ancestor
25626168|NCT01247285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626169|NCT01247285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25626170|NCT01247285|Antidepressive Agents|antidepressive agents|mesh-ancestor
25626171|NCT01247285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25626172|NCT01247285|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25626173|NCT01247285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25626174|NCT01247285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626175|NCT01247363|Globalagliatin|globalagliatin|mesh-list
25626176|NCT01247363|Enzyme Activators|enzyme activators|mesh-ancestor
25626177|NCT01247363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626178|NCT01247922|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25626179|NCT01247922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626180|NCT01247922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25626181|NCT01247922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626182|NCT01247922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626183|NCT01248065|Vitamin D|vitamin d|mesh-list
25626184|NCT01248065|Cholecalciferol|cholecalciferol|mesh-list
25626185|NCT01248065|Ciclesonide|ciclesonide|mesh-list
25626186|NCT01248065|Vitamins|vitamins|mesh-ancestor
25626187|NCT01248065|Micronutrients|micronutrients|mesh-ancestor
25626188|NCT01248065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626189|NCT01248065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24463867|NCT00362583|Narcotics|narcotics|mesh-ancestor
24463868|NCT00362583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24463869|NCT00362583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463887|NCT00362661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24463892|NCT00362687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463893|NCT00362687|Antiviral Agents|antiviral agents|mesh-ancestor
24463894|NCT00362687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24463895|NCT00362687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24463896|NCT00362687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24463898|NCT00362700|Antiviral Agents|antiviral agents|mesh-ancestor
24463899|NCT00362700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24463900|NCT00362713|Ipilimumab|ipilimumab|mesh-list
24463901|NCT00362713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24463902|NCT00362713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463903|NCT00362713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25716210|NCT02388737|Lansoprazole|lansoprazole|mesh-list
25716211|NCT02388737|Dexlansoprazole|dexlansoprazole|mesh-list
25716212|NCT02388737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25716213|NCT02388737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25716214|NCT02388737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25626190|NCT01248065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25626191|NCT01248065|Glucocorticoids|glucocorticoids|mesh-ancestor
25626192|NCT01248065|Hormones|hormones|mesh-ancestor
25626193|NCT01248065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25626194|NCT01248065|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25626195|NCT01248104|Tranexamic Acid|tranexamic acid|mesh-list
25626196|NCT01248104|Aminocaproic Acid|aminocaproic acid|mesh-list
25626197|NCT01248104|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25626198|NCT01248104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25626199|NCT01248104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626200|NCT01248104|Hemostatics|hemostatics|mesh-ancestor
25626201|NCT01248104|Coagulants|coagulants|mesh-ancestor
25626202|NCT01248364|Empagliflozin|empagliflozin|mesh-list
25626203|NCT01248364|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25626204|NCT01248364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626205|NCT01248364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25626206|NCT01248364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626207|NCT01248416|Letrozole|letrozole|mesh-list
25626208|NCT01248416|Anastrozole|anastrozole|mesh-list
25626209|NCT01248416|Hormones|hormones|mesh-list
25626210|NCT01248416|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25626211|NCT01248416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25626212|NCT01248416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463904|NCT00362713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463905|NCT00362726|Rosiglitazone|rosiglitazone|mesh-list
24463906|NCT00362726|Ritonavir|ritonavir|mesh-list
24463915|NCT00362726|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24463917|NCT00362726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24463918|NCT00362726|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24463919|NCT00362726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24463920|NCT00362726|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24463921|NCT00362726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463922|NCT00362752|Norfloxacin|norfloxacin|mesh-list
24463923|NCT00362752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24463924|NCT00362752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24463930|NCT00362752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24463931|NCT00362752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25716220|NCT02388997|Respiratory System Agents|respiratory system agents|mesh-ancestor
25716221|NCT02389088|Letrozole|letrozole|mesh-list
25716222|NCT02389088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716223|NCT02389088|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25716224|NCT02389088|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25716225|NCT02389088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25716226|NCT02389088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716227|NCT02389088|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25716228|NCT02389088|Hormone Antagonists|hormone antagonists|mesh-ancestor
25626213|NCT01248416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626214|NCT01248416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25626215|NCT01248416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626216|NCT01248416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626217|NCT01248416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25626218|NCT01248416|Hormone Antagonists|hormone antagonists|mesh-ancestor
25626219|NCT01248416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25626220|NCT01248468|Aspirin|aspirin|mesh-list
25626221|NCT01248468|Acetaminophen|acetaminophen|mesh-list
25626222|NCT01248468|Sumatriptan|sumatriptan|mesh-list
25626223|NCT01248468|Caffeine|caffeine|mesh-list
25626224|NCT01248468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25626225|NCT01248468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25626226|NCT01248468|Analgesics|analgesics|mesh-ancestor
25626227|NCT01248468|Sensory System Agents|sensory system agents|mesh-ancestor
25626228|NCT01248468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25626229|NCT01248468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626230|NCT01248468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25626231|NCT01248468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25626232|NCT01248468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25626233|NCT01248468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25655692|NCT01566162|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25626234|NCT01248468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626235|NCT01248468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25626236|NCT01248468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25626237|NCT01248468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626239|NCT01248468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25626240|NCT01248468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25626241|NCT01248468|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25626242|NCT01248468|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25626243|NCT01248468|Purinergic Agents|purinergic agents|mesh-ancestor
25626244|NCT01248468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25626245|NCT01248468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25626246|NCT01248468|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25626247|NCT01248468|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25626248|NCT01248468|Serotonin Agents|serotonin agents|mesh-ancestor
25626249|NCT01248585|Dexamethasone|dexamethasone|mesh-list
25716229|NCT02389088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25716230|NCT02389088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716231|NCT02389361|Acetaminophen|acetaminophen|mesh-list
25716232|NCT02389361|Tramadol|tramadol|mesh-list
25716233|NCT02389361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25716234|NCT02389361|Analgesics|analgesics|mesh-ancestor
25716235|NCT02389361|Sensory System Agents|sensory system agents|mesh-ancestor
25716236|NCT02389361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25716237|NCT02389361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716238|NCT02389361|Antipyretics|antipyretics|mesh-ancestor
25626250|NCT01248585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25626251|NCT01248585|Antiemetics|antiemetics|mesh-ancestor
25626252|NCT01248585|Autonomic Agents|autonomic agents|mesh-ancestor
25626253|NCT01248585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25626254|NCT01248585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626255|NCT01248585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25626256|NCT01248585|Glucocorticoids|glucocorticoids|mesh-ancestor
25626257|NCT01248585|Hormones|hormones|mesh-ancestor
25626258|NCT01248585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25626259|NCT01248585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25716239|NCT02389361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25716240|NCT02389361|Narcotics|narcotics|mesh-ancestor
25716241|NCT02389361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25716242|NCT02389452|Hylan|hylan|mesh-list
24464027|NCT00363025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24464028|NCT00363025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24464029|NCT00363025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24464030|NCT00363025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24464031|NCT00363025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464032|NCT00363025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464033|NCT00363090|Prednisone|prednisone|mesh-list
24464034|NCT00363090|Cyclophosphamide|cyclophosphamide|mesh-list
24464035|NCT00363090|Doxorubicin|doxorubicin|mesh-list
24464036|NCT00363090|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24464037|NCT00363090|Vincristine|vincristine|mesh-list
24464038|NCT00363090|Alemtuzumab|alemtuzumab|mesh-list
24464078|NCT00363285|Hormones|hormones|mesh-list
24464080|NCT00363285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24464081|NCT00363285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464082|NCT00363285|Androgen Antagonists|androgen antagonists|mesh-ancestor
24464083|NCT00363285|Hormone Antagonists|hormone antagonists|mesh-ancestor
24464084|NCT00363285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24464085|NCT00363285|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24464086|NCT00363285|Contraceptive Agents|contraceptive agents|mesh-ancestor
24464087|NCT00363285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24464088|NCT00363337|Aripiprazole|aripiprazole|mesh-list
25716243|NCT02389452|Viscosupplements|viscosupplements|mesh-ancestor
25716244|NCT02389452|Protective Agents|protective agents|mesh-ancestor
25716245|NCT02389452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716246|NCT02389738|Temozolomide|temozolomide|mesh-list
25716247|NCT02389738|Regadenoson|regadenoson|mesh-list
25626260|NCT01248585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626261|NCT01248715|Oseltamivir|oseltamivir|mesh-list
25626262|NCT01248715|Antiviral Agents|antiviral agents|mesh-ancestor
25626263|NCT01248715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25626264|NCT01248715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626265|NCT01248715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626266|NCT01248780|Golimumab|golimumab|mesh-list
25626267|NCT01248780|Methotrexate|methotrexate|mesh-list
25626268|NCT01248780|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25626269|NCT01248780|Abortifacient Agents|abortifacient agents|mesh-ancestor
25626270|NCT01248780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25626271|NCT01248780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626272|NCT01248780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25626273|NCT01248780|Antimetabolites|antimetabolites|mesh-ancestor
25626274|NCT01248780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626275|NCT01248780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716248|NCT02389738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25716249|NCT02389738|Alkylating Agents|alkylating agents|mesh-ancestor
25716250|NCT02389738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716251|NCT02389738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716252|NCT02389738|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25716253|NCT02389738|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24464148|NCT00363519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464149|NCT00363519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464150|NCT00363532|Calcitonin|calcitonin|mesh-list
24464151|NCT00363532|Salmon calcitonin|salmon calcitonin|mesh-list
24464154|NCT00363532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24464155|NCT00363532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464156|NCT00363532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24464157|NCT00363532|Vasodilator Agents|vasodilator agents|mesh-ancestor
24464158|NCT00363571|Acetazolamide|acetazolamide|mesh-list
24464159|NCT00363571|Anticonvulsants|anticonvulsants|mesh-ancestor
24464160|NCT00363571|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24464161|NCT00363571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464162|NCT00363571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464163|NCT00363571|Diuretics|diuretics|mesh-ancestor
24464164|NCT00363571|Natriuretic Agents|natriuretic agents|mesh-ancestor
24464166|NCT00363584|Capecitabine|capecitabine|mesh-list
25716254|NCT02389738|Purinergic Agonists|purinergic agonists|mesh-ancestor
25626276|NCT01248780|Dermatologic Agents|dermatologic agents|mesh-ancestor
25626277|NCT01248780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626278|NCT01248780|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25626279|NCT01248780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25626280|NCT01248780|Immunologic Factors|immunologic factors|mesh-ancestor
25626281|NCT01248780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25626282|NCT01248780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25626283|NCT01248780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25626284|NCT01248780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25626285|NCT01248793|Golimumab|golimumab|mesh-list
25626286|NCT01248793|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25626287|NCT01248793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25626288|NCT01248793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25626289|NCT01248793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25626290|NCT01248793|Immunologic Factors|immunologic factors|mesh-ancestor
25626291|NCT01248793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626292|NCT01248884|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25626293|NCT01248884|Immunologic Factors|immunologic factors|mesh-ancestor
25626294|NCT01248884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626295|NCT01248949|Paclitaxel|paclitaxel|mesh-list
25626296|NCT01248949|Bevacizumab|bevacizumab|mesh-list
25626297|NCT01248949|Carboplatin|carboplatin|mesh-list
25626298|NCT01248949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25626299|NCT01248949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626300|NCT01248949|Tubulin Modulators|tubulin modulators|mesh-ancestor
25626301|NCT01248949|Antimitotic Agents|antimitotic agents|mesh-ancestor
25626302|NCT01248949|Mitosis Modulators|mitosis modulators|mesh-ancestor
25626303|NCT01248949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626304|NCT01248949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25626305|NCT01248949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25626306|NCT01248949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25716255|NCT02389738|Purinergic Agents|purinergic agents|mesh-ancestor
25716256|NCT02389738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25716257|NCT02389738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716258|NCT02389764|Nintedanib|nintedanib|mesh-list
25716259|NCT02389764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716260|NCT02389764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25716261|NCT02389764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25716262|NCT02389764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716263|NCT02389816|Vortioxetine|vortioxetine|mesh-list
25716264|NCT02389816|Antidepressive Agents|antidepressive agents|mesh-ancestor
25626307|NCT01248949|Growth Substances|growth substances|mesh-ancestor
25626308|NCT01248949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626309|NCT01248949|Growth Inhibitors|growth inhibitors|mesh-ancestor
25626310|NCT01248962|Carboplatin|carboplatin|mesh-list
25626311|NCT01248962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626312|NCT01249027|Everolimus|everolimus|mesh-list
25626313|NCT01249027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626314|NCT01249027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25626315|NCT01249027|Immunologic Factors|immunologic factors|mesh-ancestor
25626316|NCT01249027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626317|NCT01249092|Pentoxifylline|pentoxifylline|mesh-list
25626318|NCT01249092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25626319|NCT01249092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626320|NCT01249092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626321|NCT01249092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25626322|NCT01249092|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25626323|NCT01249092|Protective Agents|protective agents|mesh-ancestor
25626324|NCT01249092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626325|NCT01249092|Vasodilator Agents|vasodilator agents|mesh-ancestor
25626326|NCT01249092|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25626327|NCT01249092|Antioxidants|antioxidants|mesh-ancestor
25716265|NCT02389816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24464189|NCT00363727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464192|NCT00363753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24464193|NCT00363753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24464194|NCT00363753|Analgesics|analgesics|mesh-ancestor
24464195|NCT00363753|Sensory System Agents|sensory system agents|mesh-ancestor
24464196|NCT00363753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24464197|NCT00363753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464198|NCT00363753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24464199|NCT00363753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24464200|NCT00363753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24464201|NCT00363753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24464229|NCT00363857|Dopamine Agonists|dopamine agonists|mesh-ancestor
24464230|NCT00363857|Dopamine Agents|dopamine agents|mesh-ancestor
24464233|NCT00363857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716266|NCT02389816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25716267|NCT02389816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25716268|NCT02389816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25716269|NCT02389816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716270|NCT02389816|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25716271|NCT02389816|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25716272|NCT02389816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25626328|NCT01249261|Risedronic Acid|risedronic acid|mesh-list
25626329|NCT01249261|Etidronic Acid|etidronic acid|mesh-list
25626330|NCT01249261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25626331|NCT01249261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25626332|NCT01249261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626333|NCT01249261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25626334|NCT01249261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626335|NCT01249261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25626336|NCT01249274|Progesterone|progesterone|mesh-list
25716273|NCT02389816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716274|NCT02389816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25716275|NCT02389816|Serotonin Agents|serotonin agents|mesh-ancestor
24464237|NCT00363909|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24464239|NCT00363909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464240|NCT00363909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25716276|NCT02389816|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25716277|NCT02389816|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25716278|NCT02389816|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25716279|NCT02389816|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25716280|NCT02389829|Diphenhydramine|diphenhydramine|mesh-list
25626337|NCT01249274|Progestins|progestins|mesh-ancestor
25626338|NCT01249274|Hormones|hormones|mesh-ancestor
25626339|NCT01249274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25626340|NCT01249274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626341|NCT01249651|Esomeprazole|esomeprazole|mesh-list
25626342|NCT01249651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25626343|NCT01249651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25626344|NCT01249651|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25626345|NCT01249651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626346|NCT01249651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626347|NCT01249664|Aflibercept|aflibercept|mesh-list
25626348|NCT01249664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25626349|NCT01249664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25626350|NCT01249664|Growth Substances|growth substances|mesh-ancestor
25716281|NCT02389829|Promethazine|promethazine|mesh-list
25716282|NCT02389829|Hydromorphone|hydromorphone|mesh-list
24464270|NCT00363948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464272|NCT00363948|Hormones|hormones|mesh-ancestor
24464273|NCT00363948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24464274|NCT00363948|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24464275|NCT00363948|Protease Inhibitors|protease inhibitors|mesh-ancestor
24464276|NCT00363948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464277|NCT00363948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464278|NCT00364000|Calcium|calcium|mesh-list
24464279|NCT00364000|Sevelamer|sevelamer|mesh-list
24464280|NCT00364000|Calcium acetate|calcium acetate|mesh-list
24452742|NCT05455944|Anticonvulsants|anticonvulsants|mesh-ancestor
24452743|NCT05455944|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24452744|NCT05455944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24452745|NCT05455944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452746|NCT05455944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25716283|NCT02389829|Prochlorperazine|prochlorperazine|mesh-list
25716284|NCT02389829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25716285|NCT02389829|Narcotics|narcotics|mesh-ancestor
25716286|NCT02389829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25716287|NCT02389829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716288|NCT02389829|Analgesics|analgesics|mesh-ancestor
25716289|NCT02389829|Sensory System Agents|sensory system agents|mesh-ancestor
25716290|NCT02389829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25716291|NCT02389829|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25626351|NCT01249664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626352|NCT01249664|Growth Inhibitors|growth inhibitors|mesh-ancestor
25626353|NCT01249664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626354|NCT01249833|Oseltamivir|oseltamivir|mesh-list
25626355|NCT01249833|Antiviral Agents|antiviral agents|mesh-ancestor
25626356|NCT01249833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25626357|NCT01249833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626358|NCT01249833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626359|NCT01249872|Morphine|morphine|mesh-list
25626360|NCT01249872|Levobupivacaine|levobupivacaine|mesh-list
25626361|NCT01249872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25626362|NCT01249872|Narcotics|narcotics|mesh-ancestor
25626363|NCT01249872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25626364|NCT01249872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626365|NCT01249872|Analgesics|analgesics|mesh-ancestor
25626366|NCT01249872|Sensory System Agents|sensory system agents|mesh-ancestor
25626367|NCT01249872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25626368|NCT01249872|Anesthetics, Local|anesthetics, local|mesh-ancestor
25626369|NCT01249872|Anesthetics|anesthetics|mesh-ancestor
25626370|NCT01250002|Lidocaine|lidocaine|mesh-list
25626371|NCT01250002|Anesthetics, Local|anesthetics, local|mesh-ancestor
25626372|NCT01250002|Anesthetics|anesthetics|mesh-ancestor
25626373|NCT01250002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25626374|NCT01250002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626375|NCT01250002|Sensory System Agents|sensory system agents|mesh-ancestor
25626376|NCT01250002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25626377|NCT01250002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25626378|NCT01250002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24464352|NCT00364442|Fluticasone|fluticasone|mesh-list
24464354|NCT00364442|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24464355|NCT00364442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24464356|NCT00364442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24464357|NCT00364442|Autonomic Agents|autonomic agents|mesh-ancestor
24464358|NCT00364442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24464359|NCT00364442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464360|NCT00364442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24464361|NCT00364442|Respiratory System Agents|respiratory system agents|mesh-ancestor
24464362|NCT00364442|Dermatologic Agents|dermatologic agents|mesh-ancestor
24464363|NCT00364442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24464364|NCT00364442|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24464365|NCT00364442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24464366|NCT00364442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25716292|NCT02389829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25716293|NCT02389829|Anesthetics, Local|anesthetics, local|mesh-ancestor
25716294|NCT02389829|Anesthetics|anesthetics|mesh-ancestor
25716295|NCT02389829|Antiemetics|antiemetics|mesh-ancestor
25716296|NCT02389829|Autonomic Agents|autonomic agents|mesh-ancestor
25716297|NCT02389829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25716298|NCT02389829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25716299|NCT02389829|Histamine Antagonists|histamine antagonists|mesh-ancestor
25716300|NCT02389829|Histamine Agents|histamine agents|mesh-ancestor
25716301|NCT02389829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25626379|NCT01250002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25626380|NCT01250002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25520920|NCT00458822|Hormones|hormones|mesh-ancestor
25626381|NCT01250002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626382|NCT01250119|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25626383|NCT01250119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626384|NCT01250119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25626386|NCT01250119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626387|NCT01250145|Teriparatide|teriparatide|mesh-list
25626388|NCT01250145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25626389|NCT01250145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626390|NCT01250145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25626391|NCT01250184|Lidocaine|lidocaine|mesh-list
25626392|NCT01250184|Anesthetics, Local|anesthetics, local|mesh-ancestor
25626393|NCT01250184|Anesthetics|anesthetics|mesh-ancestor
25626394|NCT01250184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25626395|NCT01250184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626396|NCT01250184|Sensory System Agents|sensory system agents|mesh-ancestor
25626397|NCT01250184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25626398|NCT01250184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25626399|NCT01250184|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25626400|NCT01250184|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25626401|NCT01250184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25626402|NCT01250184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626403|NCT01250210|Levonorgestrel|levonorgestrel|mesh-list
25716302|NCT02389829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716303|NCT02389829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25716304|NCT02389829|Antipruritics|antipruritics|mesh-ancestor
25716305|NCT02389829|Dermatologic Agents|dermatologic agents|mesh-ancestor
24464455|NCT00364988|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24464456|NCT00364988|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24464457|NCT00364988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464460|NCT00365001|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24464461|NCT00365001|Abortifacient Agents|abortifacient agents|mesh-ancestor
24464465|NCT00365001|Antimetabolites|antimetabolites|mesh-ancestor
24464489|NCT00365170|Insulin Aspart|insulin aspart|mesh-list
24464490|NCT00365170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24464491|NCT00365170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464492|NCT00365183|Pemetrexed|pemetrexed|mesh-list
24464493|NCT00365183|Motexafin gadolinium|motexafin gadolinium|mesh-list
24464494|NCT00365183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24464495|NCT00365183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464496|NCT00365183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626404|NCT01250210|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25626405|NCT01250210|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25626406|NCT01250210|Estradiol|estradiol|mesh-list
25626407|NCT01250210|Estrogens|estrogens|mesh-ancestor
25626408|NCT01250210|Hormones|hormones|mesh-ancestor
25626409|NCT01250210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25626410|NCT01250210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626411|NCT01250210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25626412|NCT01250210|Contraceptive Agents|contraceptive agents|mesh-ancestor
25626413|NCT01250210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25626414|NCT01250210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24464571|NCT00365339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24464572|NCT00365339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24464573|NCT00365339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464574|NCT00365339|Dopamine Agonists|dopamine agonists|mesh-ancestor
24464575|NCT00365339|Dopamine Agents|dopamine agents|mesh-ancestor
24464576|NCT00365339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24464608|NCT00365586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24464621|NCT00365612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464623|NCT00365612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24464624|NCT00365612|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24464706|NCT00366067|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24464707|NCT00366067|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24464708|NCT00366093|Eszopiclone|eszopiclone|mesh-list
24464709|NCT00366093|Zopiclone|zopiclone|mesh-list
24464710|NCT00366093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24464711|NCT00366093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24464712|NCT00366093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464713|NCT00366119|Ramipril|ramipril|mesh-list
24464714|NCT00366119|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24464730|NCT00366262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24464843|NCT00367094|Benazepril|benazepril|mesh-list
25626415|NCT01250210|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25626416|NCT01250210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25626417|NCT01250210|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25626418|NCT01250210|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25626419|NCT01250379|Bevacizumab|bevacizumab|mesh-list
25626420|NCT01250379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25626421|NCT01250379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716318|NCT02389959|Growth Inhibitors|growth inhibitors|mesh-ancestor
24464861|NCT00367120|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24464862|NCT00367120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464863|NCT00367120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464864|NCT00367172|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24464865|NCT00367172|Antiviral Agents|antiviral agents|mesh-ancestor
24453203|NCT05238831|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24453204|NCT05238831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24453205|NCT05238831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24453206|NCT05238831|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24453207|NCT05238831|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24453208|NCT05238831|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24453209|NCT05238831|Hormone Antagonists|hormone antagonists|mesh-ancestor
24453211|NCT05238831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24453215|NCT05226299|Capsaicin|capsaicin|mesh-list
24453216|NCT05226299|Antipruritics|antipruritics|mesh-ancestor
24453217|NCT05226299|Dermatologic Agents|dermatologic agents|mesh-ancestor
24453218|NCT05226299|Sensory System Agents|sensory system agents|mesh-ancestor
24453219|NCT05226299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24464988|NCT00367497|Immunologic Factors|immunologic factors|mesh-ancestor
24464989|NCT00367497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464990|NCT00367497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24464991|NCT00367497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25716319|NCT02389998|Hyoscyamine|hyoscyamine|mesh-list
25716320|NCT02389998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25716321|NCT02389998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25716322|NCT02389998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25716323|NCT02389998|Autonomic Agents|autonomic agents|mesh-ancestor
25716324|NCT02389998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25716325|NCT02389998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716326|NCT02389998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25626422|NCT01250379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25626423|NCT01250379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25626424|NCT01250379|Growth Substances|growth substances|mesh-ancestor
25626425|NCT01250379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626426|NCT01250379|Growth Inhibitors|growth inhibitors|mesh-ancestor
25626427|NCT01250418|Ketamine|ketamine|mesh-list
25626428|NCT01250418|Analgesics|analgesics|mesh-ancestor
25626429|NCT01250418|Sensory System Agents|sensory system agents|mesh-ancestor
25626430|NCT01250418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25626431|NCT01250418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626432|NCT01250418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25626433|NCT01250418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25626434|NCT01250418|Anesthetics, General|anesthetics, general|mesh-ancestor
25626435|NCT01250418|Anesthetics|anesthetics|mesh-ancestor
25626436|NCT01250418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25626437|NCT01250418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25626438|NCT01250418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25626439|NCT01250418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25626440|NCT01250418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626441|NCT01250717|Dexamethasone|dexamethasone|mesh-list
25626442|NCT01250717|Goserelin|goserelin|mesh-list
25626443|NCT01250717|Estramustine|estramustine|mesh-list
25626444|NCT01250717|Docetaxel|docetaxel|mesh-list
25626445|NCT01250717|Bicalutamide|bicalutamide|mesh-list
25626446|NCT01250717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24465094|NCT00367874|Antimanic Agents|antimanic agents|mesh-ancestor
24465095|NCT00367874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24465096|NCT00367874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24465098|NCT00367913|Ciprofloxacin|ciprofloxacin|mesh-list
24465101|NCT00367913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24465121|NCT00367913|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24465122|NCT00367939|Amlodipine|amlodipine|mesh-list
24465138|NCT00367978|Amlodipine|amlodipine|mesh-list
24465139|NCT00367978|Benazepril|benazepril|mesh-list
24465235|NCT00368329|Antimetabolites|antimetabolites|mesh-ancestor
25716327|NCT02389998|Respiratory System Agents|respiratory system agents|mesh-ancestor
25716328|NCT02389998|Mydriatics|mydriatics|mesh-ancestor
25716329|NCT02389998|Parasympatholytics|parasympatholytics|mesh-ancestor
25716330|NCT02389998|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25716331|NCT02389998|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25716332|NCT02389998|Cholinergic Agents|cholinergic agents|mesh-ancestor
25716333|NCT02389998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25716334|NCT02389998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626447|NCT01250717|Antiemetics|antiemetics|mesh-ancestor
25626448|NCT01250717|Autonomic Agents|autonomic agents|mesh-ancestor
25626449|NCT01250717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25626450|NCT01250717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626451|NCT01250717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25626452|NCT01250717|Glucocorticoids|glucocorticoids|mesh-ancestor
25626453|NCT01250717|Hormones|hormones|mesh-ancestor
25626454|NCT01250717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25626455|NCT01250717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25626456|NCT01250717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626457|NCT01250717|Tubulin Modulators|tubulin modulators|mesh-ancestor
25626458|NCT01250717|Antimitotic Agents|antimitotic agents|mesh-ancestor
25626459|NCT01250717|Mitosis Modulators|mitosis modulators|mesh-ancestor
25626460|NCT01250717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626461|NCT01250717|Androgen Antagonists|androgen antagonists|mesh-ancestor
25626462|NCT01250717|Hormone Antagonists|hormone antagonists|mesh-ancestor
25626463|NCT01250717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25626464|NCT01250717|Alkylating Agents|alkylating agents|mesh-ancestor
25626465|NCT01250730|Crizotinib|crizotinib|mesh-list
25626466|NCT01250730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626467|NCT01250730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25626468|NCT01250730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626469|NCT01250730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626470|NCT01250756|Vaccines|vaccines|mesh-list
25626471|NCT01250756|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25626472|NCT01250756|Immunologic Factors|immunologic factors|mesh-ancestor
25626473|NCT01250756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716335|NCT02390050|Bexagliflozin|bexagliflozin|mesh-list
25716336|NCT02390050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25716337|NCT02390050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465236|NCT00368329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465239|NCT00368329|Immunologic Factors|immunologic factors|mesh-ancestor
24465291|NCT00368719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24465292|NCT00368719|Immunologic Factors|immunologic factors|mesh-ancestor
24465293|NCT00368719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465294|NCT00368719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24465295|NCT00368719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24465296|NCT00368719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465320|NCT00368914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465321|NCT00368914|Antifungal Agents|antifungal agents|mesh-ancestor
24465322|NCT00368914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24465323|NCT00368914|Immunologic Factors|immunologic factors|mesh-ancestor
24465324|NCT00368914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465325|NCT00369018|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25716338|NCT02390219|Ivacaftor|ivacaftor|mesh-list
25716339|NCT02390219|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25716340|NCT02390219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25716342|NCT02391337|Digoxin|digoxin|mesh-list
25626474|NCT01250834|Dulaglutide|dulaglutide|mesh-list
25626475|NCT01250834|Atorvastatin|atorvastatin|mesh-list
25626476|NCT01250834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25626477|NCT01250834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25626478|NCT01250834|Antimetabolites|antimetabolites|mesh-ancestor
25626479|NCT01250834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626480|NCT01250834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25626481|NCT01250834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25626482|NCT01250834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626483|NCT01250834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25626484|NCT01250834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626485|NCT01250873|Sertraline|sertraline|mesh-list
25626486|NCT01250873|Antidepressive Agents|antidepressive agents|mesh-ancestor
25626487|NCT01250873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25626488|NCT01250873|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25626489|NCT01250873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25626490|NCT01250873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25626491|NCT01250873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626492|NCT01250873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25626493|NCT01250873|Serotonin Agents|serotonin agents|mesh-ancestor
25626494|NCT01250873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655693|NCT01566162|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25655694|NCT01566162|Adrenergic Agents|adrenergic agents|mesh-ancestor
25655695|NCT01566162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25655696|NCT01566162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655697|NCT01566162|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25655698|NCT01566162|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25655699|NCT01566162|Serotonin Agents|serotonin agents|mesh-ancestor
25655700|NCT01566162|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25655701|NCT01566162|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25655702|NCT01566162|Dopamine Agents|dopamine agents|mesh-ancestor
25657072|NCT01582854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657073|NCT01582854|Protective Agents|protective agents|mesh-ancestor
25657074|NCT01582854|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25657075|NCT01582880|Riboflavin|riboflavin|mesh-list
25657076|NCT01582880|Vitamins|vitamins|mesh-ancestor
25657077|NCT01582880|Micronutrients|micronutrients|mesh-ancestor
25657078|NCT01582880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657079|NCT01582880|Vitamin B Complex|vitamin b complex|mesh-ancestor
25657080|NCT01582880|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25657081|NCT01582880|Dermatologic Agents|dermatologic agents|mesh-ancestor
24465357|NCT00369239|Risperidone|risperidone|mesh-list
24465358|NCT00369239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24465422|NCT00369551|Bevacizumab|bevacizumab|mesh-list
24465423|NCT00369551|Carboplatin|carboplatin|mesh-list
24465424|NCT00369551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24465425|NCT00369551|Antibodies|antibodies|mesh-list
24465426|NCT00369551|Immunoglobulins|immunoglobulins|mesh-list
24465427|NCT00369551|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24465428|NCT00369551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24465429|NCT00369551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25657082|NCT01582945|Ketamine|ketamine|mesh-list
25657083|NCT01582945|Analgesics|analgesics|mesh-ancestor
25657084|NCT01582945|Sensory System Agents|sensory system agents|mesh-ancestor
25657085|NCT01582945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25657086|NCT01582945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657087|NCT01582945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25657088|NCT01582945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25657089|NCT01582945|Anesthetics, General|anesthetics, general|mesh-ancestor
25657090|NCT01582945|Anesthetics|anesthetics|mesh-ancestor
25657091|NCT01582945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25657092|NCT01582945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25521072|NCT00459706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25521143|NCT00460031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25521144|NCT00460031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521145|NCT00460031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521146|NCT00460031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25521147|NCT00460031|Hormone Antagonists|hormone antagonists|mesh-ancestor
25521148|NCT00460031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25521149|NCT00460031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25521151|NCT00460109|Denileukin diftitox|denileukin diftitox|mesh-list
25521152|NCT00460109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25521153|NCT00460109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521154|NCT00460109|Immunologic Factors|immunologic factors|mesh-ancestor
25521155|NCT00460109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521156|NCT00460109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25521157|NCT00460239|Morphine|morphine|mesh-list
25521158|NCT00460239|Buprenorphine|buprenorphine|mesh-list
25521159|NCT00460239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25521160|NCT00460239|Narcotics|narcotics|mesh-ancestor
24465520|NCT00369954|Immunologic Factors|immunologic factors|mesh-ancestor
25521161|NCT00460239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25521162|NCT00460239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521163|NCT00460239|Analgesics|analgesics|mesh-ancestor
25521164|NCT00460239|Sensory System Agents|sensory system agents|mesh-ancestor
25521165|NCT00460239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25521166|NCT00460239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25521167|NCT00460551|Zalutumumab|zalutumumab|mesh-list
24465765|NCT00370669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24465766|NCT00370669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24465767|NCT00370669|Growth Substances|growth substances|mesh-ancestor
24414974|NCT00199017|Vincristine|vincristine|mesh-list
24465768|NCT00370669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465769|NCT00370669|Growth Inhibitors|growth inhibitors|mesh-ancestor
24465770|NCT00370669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24465771|NCT00370669|Glucocorticoids|glucocorticoids|mesh-ancestor
24465773|NCT00370669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24465774|NCT00370669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24465776|NCT00370669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521168|NCT00460551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25521169|NCT00460551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24437189|NCT00272896|Protective Agents|protective agents|mesh-ancestor
24437190|NCT00272896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437191|NCT00272909|Piclozotan|piclozotan|mesh-list
24437192|NCT00272909|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24437193|NCT00272909|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24437194|NCT00272909|Serotonin Agents|serotonin agents|mesh-ancestor
24437195|NCT00272909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24437196|NCT00272909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437197|NCT00272909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437198|NCT00272935|Estrogens|estrogens|mesh-list
24437199|NCT00272935|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24437200|NCT00272935|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
24437201|NCT00272935|Hormones|hormones|mesh-ancestor
24437203|NCT00272935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437231|NCT00273026|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24437235|NCT00273026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25716366|NCT02391714|Chlorhexidine|chlorhexidine|mesh-list
24466362|NCT00373282|Triamcinolone|triamcinolone|mesh-list
24466404|NCT00373464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24466405|NCT00373464|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24466406|NCT00373464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24415685|NCT00200512|Apomorphine|apomorphine|mesh-list
24466407|NCT00373464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466409|NCT00373503|Lofexidine|lofexidine|mesh-list
24437236|NCT00273026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437247|NCT00273039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24437283|NCT00273338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626495|NCT01250899|Vitamin D|vitamin d|mesh-list
25626496|NCT01250899|Vitamins|vitamins|mesh-ancestor
25626497|NCT01250899|Micronutrients|micronutrients|mesh-ancestor
25626498|NCT01250899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626499|NCT01250899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25626500|NCT01250977|Donepezil|donepezil|mesh-list
25626501|NCT01250977|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25626502|NCT01250977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626503|NCT01250977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626504|NCT01250977|Cholinergic Agents|cholinergic agents|mesh-ancestor
25626505|NCT01250977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25626506|NCT01250977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626507|NCT01250977|Nootropic Agents|nootropic agents|mesh-ancestor
25626508|NCT01250990|Niacin|niacin|mesh-list
25626509|NCT01250990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25626510|NCT01250990|Antimetabolites|antimetabolites|mesh-ancestor
25626511|NCT01250990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626512|NCT01250990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25626513|NCT01250990|Vasodilator Agents|vasodilator agents|mesh-ancestor
25626514|NCT01250990|Vitamin B Complex|vitamin b complex|mesh-ancestor
25626515|NCT01250990|Vitamins|vitamins|mesh-ancestor
25626516|NCT01250990|Micronutrients|micronutrients|mesh-ancestor
25626517|NCT01250990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626518|NCT01251146|Atenolol|atenolol|mesh-list
25626519|NCT01251146|Bisoprolol|bisoprolol|mesh-list
25626520|NCT01251146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25626521|NCT01251146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25626522|NCT01251146|Sympatholytics|sympatholytics|mesh-ancestor
25626523|NCT01251146|Autonomic Agents|autonomic agents|mesh-ancestor
25626524|NCT01251146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25626525|NCT01251146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466500|NCT00373659|Ranibizumab|ranibizumab|mesh-list
25626526|NCT01251146|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25626527|NCT01251146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25626528|NCT01251146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25626529|NCT01251146|Adrenergic Agents|adrenergic agents|mesh-ancestor
25626530|NCT01251146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25626531|NCT01251146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626532|NCT01251315|Acetylcysteine|acetylcysteine|mesh-list
25626533|NCT01251315|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25626534|NCT01251315|Antiviral Agents|antiviral agents|mesh-ancestor
25626535|NCT01251315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25626536|NCT01251315|Expectorants|expectorants|mesh-ancestor
25626537|NCT01251315|Respiratory System Agents|respiratory system agents|mesh-ancestor
25626538|NCT01251315|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25626539|NCT01251315|Antioxidants|antioxidants|mesh-ancestor
24466591|NCT00374075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25626540|NCT01251315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626541|NCT01251315|Protective Agents|protective agents|mesh-ancestor
25626542|NCT01251315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626543|NCT01251315|Antidotes|antidotes|mesh-ancestor
25626544|NCT01251393|Biperiden|biperiden|mesh-list
25626545|NCT01251393|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25626546|NCT01251393|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25626547|NCT01251393|Parasympatholytics|parasympatholytics|mesh-ancestor
25626548|NCT01251393|Autonomic Agents|autonomic agents|mesh-ancestor
25626549|NCT01251393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25626550|NCT01251393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626551|NCT01251393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25626552|NCT01251393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25626553|NCT01251393|Cholinergic Agents|cholinergic agents|mesh-ancestor
24466749|NCT00374855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24466750|NCT00374855|Diuretics|diuretics|mesh-ancestor
24466765|NCT00374881|Sensory System Agents|sensory system agents|mesh-ancestor
24466766|NCT00374881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24466767|NCT00374881|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24466768|NCT00374881|Mydriatics|mydriatics|mesh-ancestor
24466769|NCT00374881|Autonomic Agents|autonomic agents|mesh-ancestor
24466770|NCT00374881|Sympathomimetics|sympathomimetics|mesh-ancestor
24466771|NCT00374881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24466772|NCT00374881|Nasal Decongestants|nasal decongestants|mesh-ancestor
24466773|NCT00374881|Respiratory System Agents|respiratory system agents|mesh-ancestor
24466803|NCT00375050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24466804|NCT00375050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24466805|NCT00375050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466806|NCT00375050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466807|NCT00375050|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24466808|NCT00375050|Protective Agents|protective agents|mesh-ancestor
24466827|NCT00375245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24466828|NCT00375245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466829|NCT00375245|Antifungal Agents|antifungal agents|mesh-ancestor
24466830|NCT00375245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24466831|NCT00375245|Immunologic Factors|immunologic factors|mesh-ancestor
24466832|NCT00375245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466835|NCT00375258|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25716397|NCT02392286|Prednisone|prednisone|mesh-list
25626554|NCT01251393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25626555|NCT01251393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626556|NCT01251536|Cetuximab|cetuximab|mesh-list
25626557|NCT01251536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25626558|NCT01251536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626559|NCT01251575|Cyclosporine|cyclosporine|mesh-list
25626560|NCT01251575|Sirolimus|sirolimus|mesh-list
25626561|NCT01251575|Mycophenolic Acid|mycophenolic acid|mesh-list
25626562|NCT01251575|Fludarabine|fludarabine|mesh-list
25626563|NCT01251575|Fludarabine phosphate|fludarabine phosphate|mesh-list
25626564|NCT01251575|Cyclosporins|cyclosporins|mesh-list
25626565|NCT01251575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716404|NCT02392286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24466836|NCT00375258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466837|NCT00375258|Hemostatics|hemostatics|mesh-ancestor
24466838|NCT00375258|Coagulants|coagulants|mesh-ancestor
24466839|NCT00375284|Pramipexole|pramipexole|mesh-list
24466840|NCT00375284|Antioxidants|antioxidants|mesh-ancestor
24466850|NCT00375297|Vasodilator Agents|vasodilator agents|mesh-ancestor
24466851|NCT00375297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24466852|NCT00375297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24466897|NCT00375557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466898|NCT00375557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716405|NCT02392286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716406|NCT02392286|Antiemetics|antiemetics|mesh-ancestor
25716407|NCT02392286|Autonomic Agents|autonomic agents|mesh-ancestor
25716408|NCT02392286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25716409|NCT02392286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25716410|NCT02392286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25716411|NCT02392286|Protective Agents|protective agents|mesh-ancestor
25716412|NCT02392507|Paclitaxel|paclitaxel|mesh-list
25626566|NCT01251575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25626567|NCT01251575|Antimetabolites|antimetabolites|mesh-ancestor
25626568|NCT01251575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626569|NCT01251575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25626570|NCT01251575|Immunologic Factors|immunologic factors|mesh-ancestor
25626571|NCT01251575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626572|NCT01251575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626573|NCT01251575|Antifungal Agents|antifungal agents|mesh-ancestor
25626574|NCT01251575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25626575|NCT01251575|Dermatologic Agents|dermatologic agents|mesh-ancestor
25626576|NCT01251575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25626577|NCT01251575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25626578|NCT01251575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25626579|NCT01251575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25626580|NCT01251575|Antitubercular Agents|antitubercular agents|mesh-ancestor
25626581|NCT01251575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25626582|NCT01251614|Adalimumab|adalimumab|mesh-list
25771195|NCT03593902|Prednisolone|prednisolone|mesh-list
24466964|NCT00375765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24466972|NCT00375778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466973|NCT00375778|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24466974|NCT00375778|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24466975|NCT00375843|Citalopram|citalopram|mesh-list
24466976|NCT00375843|Sertraline|sertraline|mesh-list
24466979|NCT00375843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24466980|NCT00375843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626583|NCT01251614|Methotrexate|methotrexate|mesh-list
25626584|NCT01251614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25626585|NCT01251614|Abortifacient Agents|abortifacient agents|mesh-ancestor
25626586|NCT01251614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25626587|NCT01251614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626588|NCT01251614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25626589|NCT01251614|Antimetabolites|antimetabolites|mesh-ancestor
25626590|NCT01251614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626591|NCT01251614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626592|NCT01251614|Dermatologic Agents|dermatologic agents|mesh-ancestor
25626593|NCT01251614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626594|NCT01251614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25626595|NCT01251614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25521170|NCT00460577|Bromides|bromides|mesh-list
25626596|NCT01251614|Immunologic Factors|immunologic factors|mesh-ancestor
25626597|NCT01251614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25626598|NCT01251614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25626599|NCT01251614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25626600|NCT01251653|Gemcitabine|gemcitabine|mesh-list
25626601|NCT01251653|Docetaxel|docetaxel|mesh-list
25626602|NCT01251653|Afatinib|afatinib|mesh-list
25626603|NCT01251653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25626604|NCT01251653|Antimetabolites|antimetabolites|mesh-ancestor
25626605|NCT01251653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626606|NCT01251653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626607|NCT01251653|Antiviral Agents|antiviral agents|mesh-ancestor
25626608|NCT01251653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25626609|NCT01251653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626610|NCT01251653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25626611|NCT01251653|Immunologic Factors|immunologic factors|mesh-ancestor
25626612|NCT01251653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626613|NCT01251653|Tubulin Modulators|tubulin modulators|mesh-ancestor
25626614|NCT01251653|Antimitotic Agents|antimitotic agents|mesh-ancestor
25626615|NCT01251653|Mitosis Modulators|mitosis modulators|mesh-ancestor
25626616|NCT01251653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25626617|NCT01251978|Ranibizumab|ranibizumab|mesh-list
25626618|NCT01251978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25716420|NCT02392507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716421|NCT02392507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24467151|NCT00376376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24467153|NCT00376428|Gentamicins|gentamicins|mesh-list
25626619|NCT01251978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25626620|NCT01251978|Growth Substances|growth substances|mesh-ancestor
25626621|NCT01251978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626622|NCT01251978|Growth Inhibitors|growth inhibitors|mesh-ancestor
25626623|NCT01251978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626624|NCT01252134|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25626625|NCT01252186|Contraceptive Agents|contraceptive agents|mesh-list
25626626|NCT01252186|Levonorgestrel|levonorgestrel|mesh-list
25626627|NCT01252186|Desogestrel|desogestrel|mesh-list
25626628|NCT01252186|Contraceptives, Oral|contraceptives, oral|mesh-list
25626629|NCT01252186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25626630|NCT01252186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626631|NCT01252186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25626632|NCT01252186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25626633|NCT01252186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25626634|NCT01252186|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25626635|NCT01252186|Progestins|progestins|mesh-ancestor
25626636|NCT01252186|Hormones|hormones|mesh-ancestor
25626637|NCT01252186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25626638|NCT01252238|Amlodipine|amlodipine|mesh-list
25626639|NCT01252238|Valsartan|valsartan|mesh-list
25626640|NCT01252238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25626641|NCT01252238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25626642|NCT01252238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25626643|NCT01252238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626644|NCT01252238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25626645|NCT01252238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626646|NCT01252238|Vasodilator Agents|vasodilator agents|mesh-ancestor
25626647|NCT01252238|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25626648|NCT01252238|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25626649|NCT01252251|Everolimus|everolimus|mesh-list
25626650|NCT01252251|Pasireotide|pasireotide|mesh-list
25626651|NCT01252251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626652|NCT01252251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25626653|NCT01252251|Immunologic Factors|immunologic factors|mesh-ancestor
25626654|NCT01252251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626655|NCT01252251|Hormones|hormones|mesh-ancestor
25626656|NCT01252251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25626657|NCT01252355|Interferons|interferons|mesh-list
25626658|NCT01252355|Interferon-beta|interferon-beta|mesh-list
25626659|NCT01252355|Teriflunomide|teriflunomide|mesh-list
25626660|NCT01252355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626661|NCT01252355|Antiviral Agents|antiviral agents|mesh-ancestor
24467259|NCT00376792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467261|NCT00376818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24467262|NCT00376818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467263|NCT00376831|Fentanyl|fentanyl|mesh-list
24467264|NCT00376831|Midazolam|midazolam|mesh-list
25716431|NCT02392611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716432|NCT02392611|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25716433|NCT02392611|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25716434|NCT02392611|Hormone Antagonists|hormone antagonists|mesh-ancestor
25716435|NCT02392611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25716436|NCT02392611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716437|NCT02392611|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25626662|NCT01252355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25626663|NCT01252355|Immunologic Factors|immunologic factors|mesh-ancestor
25626664|NCT01252355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626665|NCT01252355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25626666|NCT01252355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25626667|NCT01252355|Analgesics|analgesics|mesh-ancestor
25626668|NCT01252355|Sensory System Agents|sensory system agents|mesh-ancestor
25626669|NCT01252355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25626670|NCT01252355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25626671|NCT01252355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25521245|NCT00461123|Urological Agents|urological agents|mesh-ancestor
25626672|NCT01252355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25626673|NCT01252563|Amlodipine|amlodipine|mesh-list
25626674|NCT01252563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25626675|NCT01252563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25626676|NCT01252563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25626677|NCT01252563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626678|NCT01252563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25626679|NCT01252563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626680|NCT01252563|Vasodilator Agents|vasodilator agents|mesh-ancestor
25626681|NCT01252667|Cyclosporine|cyclosporine|mesh-list
25626682|NCT01252667|Mycophenolic Acid|mycophenolic acid|mesh-list
25626683|NCT01252667|Clofarabine|clofarabine|mesh-list
25626684|NCT01252667|Cyclosporins|cyclosporins|mesh-list
25626685|NCT01252667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626686|NCT01252667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626687|NCT01252667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25626688|NCT01252667|Immunologic Factors|immunologic factors|mesh-ancestor
25626689|NCT01252667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626690|NCT01252667|Antifungal Agents|antifungal agents|mesh-ancestor
25626691|NCT01252667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25626692|NCT01252667|Dermatologic Agents|dermatologic agents|mesh-ancestor
25626693|NCT01252667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25626694|NCT01252667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25626695|NCT01252667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25626696|NCT01252667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626697|NCT01252667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25716438|NCT02392611|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25716439|NCT02392611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25716440|NCT02392611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716441|NCT02392624|Omalizumab|omalizumab|mesh-list
24467278|NCT00376831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467280|NCT00376831|Narcotics|narcotics|mesh-ancestor
24467281|NCT00376831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24467282|NCT00376831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25716442|NCT02392624|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25716443|NCT02392624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25716444|NCT02392624|Respiratory System Agents|respiratory system agents|mesh-ancestor
25716445|NCT02393209|Docetaxel|docetaxel|mesh-list
25716446|NCT02393209|Serabelisib|serabelisib|mesh-list
25716447|NCT02393209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626698|NCT01252667|Antitubercular Agents|antitubercular agents|mesh-ancestor
25626699|NCT01252667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25626700|NCT01252667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25626701|NCT01252667|Antimetabolites|antimetabolites|mesh-ancestor
25626702|NCT01252732|Vancomycin|vancomycin|mesh-list
25626703|NCT01252732|Oritavancin|oritavancin|mesh-list
25626704|NCT01252732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25626705|NCT01252732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25626706|NCT01252745|Methyltestosterone|methyltestosterone|mesh-list
25626707|NCT01252745|Testosterone|testosterone|mesh-list
25626708|NCT01252745|Testosterone undecanoate|testosterone undecanoate|mesh-list
25626709|NCT01252745|Testosterone enanthate|testosterone enanthate|mesh-list
25626710|NCT01252745|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25626711|NCT01252745|Androgens|androgens|mesh-ancestor
25626712|NCT01252745|Hormones|hormones|mesh-ancestor
25626713|NCT01252745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25626714|NCT01252745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626715|NCT01252745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25626716|NCT01252745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626717|NCT01252745|Anabolic Agents|anabolic agents|mesh-ancestor
25626718|NCT01252940|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
25626719|NCT01252940|Antiviral Agents|antiviral agents|mesh-ancestor
25626720|NCT01252940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24467283|NCT00376831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24467284|NCT00376831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24467285|NCT00376831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24467286|NCT00376831|GABA Modulators|gaba modulators|mesh-ancestor
24467287|NCT00376831|GABA Agents|gaba agents|mesh-ancestor
24467288|NCT00376870|Pioglitazone|pioglitazone|mesh-list
24467289|NCT00376870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24467290|NCT00376870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467291|NCT00376883|Pamidronate|pamidronate|mesh-list
24467292|NCT00376883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24467293|NCT00376883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467295|NCT00376987|Dermatologic Agents|dermatologic agents|mesh-ancestor
24467296|NCT00376987|Sunscreening Agents|sunscreening agents|mesh-ancestor
24467331|NCT00377078|Lactoferrin|lactoferrin|mesh-list
24467332|NCT00377078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24467333|NCT00377091|PENTA|penta|mesh-list
24467334|NCT00377091|Fondaparinux|fondaparinux|mesh-list
24467336|NCT00377091|Antithrombins|antithrombins|mesh-ancestor
25716448|NCT02393209|Tubulin Modulators|tubulin modulators|mesh-ancestor
25716449|NCT02393209|Antimitotic Agents|antimitotic agents|mesh-ancestor
25716450|NCT02393209|Mitosis Modulators|mitosis modulators|mesh-ancestor
25716451|NCT02393209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716452|NCT02393209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25716453|NCT02393339|Acetaminophen|acetaminophen|mesh-list
25716454|NCT02393339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25716455|NCT02393339|Analgesics|analgesics|mesh-ancestor
25716456|NCT02393339|Sensory System Agents|sensory system agents|mesh-ancestor
25626721|NCT01252940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25626722|NCT01252940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25626723|NCT01252940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626724|NCT01252940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626725|NCT01252940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25626726|NCT01252940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25626727|NCT01253135|Petrolatum|petrolatum|mesh-list
25626728|NCT01253135|Emollients|emollients|mesh-ancestor
25626729|NCT01253135|Dermatologic Agents|dermatologic agents|mesh-ancestor
25626730|NCT01253174|Tetrahydrofolates|tetrahydrofolates|mesh-list
25626731|NCT01253174|Drospirenone|drospirenone|mesh-list
25626732|NCT01253174|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25626733|NCT01253174|Hormone Antagonists|hormone antagonists|mesh-ancestor
25626734|NCT01253174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25626735|NCT01253174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626736|NCT01253174|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25626737|NCT01253174|Diuretics|diuretics|mesh-ancestor
25626738|NCT01253174|Natriuretic Agents|natriuretic agents|mesh-ancestor
25626739|NCT01253174|Vitamin B Complex|vitamin b complex|mesh-ancestor
25716457|NCT02393339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25716458|NCT02393339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467371|NCT00377325|Dermatologic Agents|dermatologic agents|mesh-ancestor
24467372|NCT00377325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24467373|NCT00377325|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24467374|NCT00377390|Omalizumab|omalizumab|mesh-list
24467375|NCT00377390|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25626740|NCT01253174|Vitamins|vitamins|mesh-ancestor
25626741|NCT01253174|Micronutrients|micronutrients|mesh-ancestor
25626742|NCT01253187|Tetrahydrofolates|tetrahydrofolates|mesh-list
25626743|NCT01253187|Drospirenone|drospirenone|mesh-list
25626744|NCT01253187|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25626745|NCT01253187|Hormone Antagonists|hormone antagonists|mesh-ancestor
25626746|NCT01253187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25626747|NCT01253187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626748|NCT01253187|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25626750|NCT01253187|Natriuretic Agents|natriuretic agents|mesh-ancestor
25626751|NCT01253187|Vitamin B Complex|vitamin b complex|mesh-ancestor
25626752|NCT01253187|Vitamins|vitamins|mesh-ancestor
25626753|NCT01253187|Micronutrients|micronutrients|mesh-ancestor
25626754|NCT01253200|Acifluorfen|acifluorfen|mesh-list
25626755|NCT01253200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25716466|NCT02393378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716467|NCT02393378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25716468|NCT02393378|Antimetabolites|antimetabolites|mesh-ancestor
25716469|NCT02393378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467563|NCT00378092|Serotonin Agents|serotonin agents|mesh-ancestor
24467564|NCT00378092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24467565|NCT00378092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467566|NCT00378092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467567|NCT00378092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24467595|NCT00378144|Adrenergic Agents|adrenergic agents|mesh-ancestor
24467596|NCT00378144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24467597|NCT00378144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626756|NCT01253200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626757|NCT01253226|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25626758|NCT01253226|Immunologic Factors|immunologic factors|mesh-ancestor
25626759|NCT01253226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626760|NCT01253265|Ixekizumab|ixekizumab|mesh-list
25626761|NCT01253265|Dermatologic Agents|dermatologic agents|mesh-ancestor
25626762|NCT01253304|Dulaglutide|dulaglutide|mesh-list
25626763|NCT01253304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25626764|NCT01253304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626765|NCT01253317|Mecasermin|mecasermin|mesh-list
25626766|NCT01253317|Growth Substances|growth substances|mesh-ancestor
25626767|NCT01253317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467694|NCT00378495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467695|NCT00378495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24467696|NCT00378495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24467697|NCT00378547|Acetaminophen|acetaminophen|mesh-list
24467698|NCT00378547|Dexamethasone|dexamethasone|mesh-list
24467702|NCT00378547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24467703|NCT00378547|Antiemetics|antiemetics|mesh-ancestor
24467704|NCT00378547|Autonomic Agents|autonomic agents|mesh-ancestor
24467705|NCT00378547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24467706|NCT00378547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467707|NCT00378547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24467708|NCT00378547|Glucocorticoids|glucocorticoids|mesh-ancestor
24467709|NCT00378547|Hormones|hormones|mesh-ancestor
24467711|NCT00378547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24467736|NCT00378612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467737|NCT00378625|Artesunate|artesunate|mesh-list
24467738|NCT00378625|Antimalarials|antimalarials|mesh-ancestor
25626768|NCT01253408|Dronabinol|dronabinol|mesh-list
25626769|NCT01253408|Hallucinogens|hallucinogens|mesh-ancestor
25626770|NCT01253408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626771|NCT01253408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25626772|NCT01253408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25626773|NCT01253408|Analgesics|analgesics|mesh-ancestor
25626774|NCT01253408|Sensory System Agents|sensory system agents|mesh-ancestor
25626775|NCT01253408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25626776|NCT01253408|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25626777|NCT01253408|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25626778|NCT01253408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25626779|NCT01253408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626780|NCT01253408|Hormones|hormones|mesh-ancestor
25626781|NCT01253408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25626782|NCT01253421|Amisulpride|amisulpride|mesh-list
25626783|NCT01253421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25716485|NCT02393547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25716486|NCT02393547|Cholinergic Agents|cholinergic agents|mesh-ancestor
25716487|NCT02393547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24467882|NCT00379028|Fluticasone|fluticasone|mesh-list
24467883|NCT00379028|Budesonide|budesonide|mesh-list
24467884|NCT00379028|Formoterol Fumarate|formoterol fumarate|mesh-list
24467885|NCT00379028|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24467886|NCT00379028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24467887|NCT00379028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24467888|NCT00379028|Autonomic Agents|autonomic agents|mesh-ancestor
24467889|NCT00379028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24467890|NCT00379028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467891|NCT00379028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24467892|NCT00379028|Respiratory System Agents|respiratory system agents|mesh-ancestor
24467995|NCT00379431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25626784|NCT01253421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25626785|NCT01253421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25626786|NCT01253421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626787|NCT01253421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25626788|NCT01253421|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25626789|NCT01253421|Dopamine Agents|dopamine agents|mesh-ancestor
25626790|NCT01253421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24468098|NCT00379756|Urological Agents|urological agents|mesh-ancestor
24468099|NCT00379847|Conivaptan|conivaptan|mesh-list
24468147|NCT00380146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626791|NCT01253421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626792|NCT01253421|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25626793|NCT01253421|Antidepressive Agents|antidepressive agents|mesh-ancestor
25626794|NCT01253460|Cyclophosphamide|cyclophosphamide|mesh-list
25626795|NCT01253460|Rituximab|rituximab|mesh-list
25626796|NCT01253460|Sapacitabine|sapacitabine|mesh-list
25626797|NCT01253460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25626798|NCT01253460|Immunologic Factors|immunologic factors|mesh-ancestor
25626799|NCT01253460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626800|NCT01253460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25626801|NCT01253460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25626802|NCT01253460|Alkylating Agents|alkylating agents|mesh-ancestor
25626803|NCT01253460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626804|NCT01253460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626805|NCT01253460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25626806|NCT01253460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25626807|NCT01253525|Paclitaxel|paclitaxel|mesh-list
25626808|NCT01253525|Ramucirumab|ramucirumab|mesh-list
24468432|NCT00381537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24468433|NCT00381537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24468434|NCT00381537|Analgesics|analgesics|mesh-ancestor
24468435|NCT00381537|Sensory System Agents|sensory system agents|mesh-ancestor
24468436|NCT00381537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24468437|NCT00381537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24468438|NCT00381537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24468439|NCT00381537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468440|NCT00381537|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24468504|NCT00381953|Interferon alpha-2|interferon alpha-2|mesh-list
24468505|NCT00381953|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24468506|NCT00381953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468507|NCT00381953|Antiviral Agents|antiviral agents|mesh-ancestor
24468508|NCT00381953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24468509|NCT00381953|Antimetabolites|antimetabolites|mesh-ancestor
24468510|NCT00381953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449438|NCT00315666|Memantine|memantine|mesh-list
24468512|NCT00381953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468513|NCT00382044|Darbepoetin alfa|darbepoetin alfa|mesh-list
24468514|NCT00382044|Hematinics|hematinics|mesh-ancestor
24468515|NCT00382057|Anastrozole|anastrozole|mesh-list
24468554|NCT00382135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24468555|NCT00382135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25626809|NCT01253525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25626810|NCT01253525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626811|NCT01253525|Tubulin Modulators|tubulin modulators|mesh-ancestor
25626812|NCT01253525|Antimitotic Agents|antimitotic agents|mesh-ancestor
25626813|NCT01253525|Mitosis Modulators|mitosis modulators|mesh-ancestor
25626814|NCT01253525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626815|NCT01253642|Docetaxel|docetaxel|mesh-list
25626816|NCT01253642|Phenelzine|phenelzine|mesh-list
25626817|NCT01253642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626818|NCT01253642|Tubulin Modulators|tubulin modulators|mesh-ancestor
25626819|NCT01253642|Antimitotic Agents|antimitotic agents|mesh-ancestor
25626820|NCT01253642|Mitosis Modulators|mitosis modulators|mesh-ancestor
25626821|NCT01253642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626822|NCT01253642|Antidepressive Agents|antidepressive agents|mesh-ancestor
25626824|NCT01253642|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25626825|NCT01253642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626826|NCT01253824|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25626827|NCT01253824|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24468571|NCT00382239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24468573|NCT00382330|Antifungal Agents|antifungal agents|mesh-ancestor
24468575|NCT00382343|Trimethoprim|trimethoprim|mesh-list
24468637|NCT00382499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24468638|NCT00382499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24468639|NCT00382499|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24468640|NCT00382499|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24468718|NCT00382954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24468719|NCT00382954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468721|NCT00382980|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24468722|NCT00382980|Immunologic Factors|immunologic factors|mesh-ancestor
24468723|NCT00382980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626828|NCT01253824|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25626829|NCT01253824|Norethindrone|norethindrone|mesh-list
25626830|NCT01253824|Norethindrone Acetate|norethindrone acetate|mesh-list
25626831|NCT01253824|Norinyl|norinyl|mesh-list
25626832|NCT01253824|Mestranol|mestranol|mesh-list
25626833|NCT01253824|Estradiol|estradiol|mesh-list
25626834|NCT01253824|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25626835|NCT01253824|Estrogens|estrogens|mesh-ancestor
25626836|NCT01253824|Hormones|hormones|mesh-ancestor
25626837|NCT01253824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25626838|NCT01253824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626839|NCT01253824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25626840|NCT01253824|Contraceptive Agents|contraceptive agents|mesh-ancestor
25626841|NCT01253824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25626842|NCT01253824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25626843|NCT01253824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25626844|NCT01253824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24468816|NCT00383487|Vitamins|vitamins|mesh-ancestor
25626845|NCT01253824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25626846|NCT01253824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25626847|NCT01253902|Bimatoprost|bimatoprost|mesh-list
25626848|NCT01253902|Travoprost|travoprost|mesh-list
25626849|NCT01253902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25626850|NCT01253902|Latanoprost|latanoprost|mesh-list
25626851|NCT01253902|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25626852|NCT01253902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25626853|NCT01253980|Amoxicillin|amoxicillin|mesh-list
25626854|NCT01253980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25626855|NCT01253980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25626856|NCT01254045|Oxytocin|oxytocin|mesh-list
25626857|NCT01254045|Oxytocics|oxytocics|mesh-ancestor
25626858|NCT01254045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25626859|NCT01254045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626860|NCT01254227|Deferasirox|deferasirox|mesh-list
25626861|NCT01254227|Deferoxamine|deferoxamine|mesh-list
25626862|NCT01254227|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25626863|NCT01254227|Chelating Agents|chelating agents|mesh-ancestor
25626864|NCT01254227|Sequestering Agents|sequestering agents|mesh-ancestor
25626865|NCT01254227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626866|NCT01254227|Siderophores|siderophores|mesh-ancestor
25626867|NCT01254292|Levonorgestrel|levonorgestrel|mesh-list
25626868|NCT01254292|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25626869|NCT01254292|Contraceptive Agents|contraceptive agents|mesh-ancestor
25626870|NCT01254292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25626871|NCT01254292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626872|NCT01254292|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25626873|NCT01254292|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25626874|NCT01254292|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25626875|NCT01254305|Milnacipran|milnacipran|mesh-list
25626876|NCT01254305|Sertraline|sertraline|mesh-list
25626877|NCT01254305|Fluoxetine|fluoxetine|mesh-list
25626878|NCT01254305|Paroxetine|paroxetine|mesh-list
25626879|NCT01254305|Citalopram|citalopram|mesh-list
25626880|NCT01254305|Levomilnacipran|levomilnacipran|mesh-list
25626881|NCT01254305|Antidepressive Agents|antidepressive agents|mesh-ancestor
25626882|NCT01254305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25626883|NCT01254305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24469199|NCT00384878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24469200|NCT00384878|Immunologic Factors|immunologic factors|mesh-ancestor
24469201|NCT00384878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469202|NCT00384878|Antidotes|antidotes|mesh-ancestor
24469203|NCT00384878|Protective Agents|protective agents|mesh-ancestor
24469204|NCT00384878|Vitamin B Complex|vitamin b complex|mesh-ancestor
24469205|NCT00384878|Vitamins|vitamins|mesh-ancestor
24469206|NCT00384878|Micronutrients|micronutrients|mesh-ancestor
24469207|NCT00384878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24469208|NCT00384891|BCG Vaccine|bcg vaccine|mesh-list
24469209|NCT00384891|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24469210|NCT00384891|Immunologic Factors|immunologic factors|mesh-ancestor
24469252|NCT00385021|Vitamins|vitamins|mesh-ancestor
24469253|NCT00385021|Micronutrients|micronutrients|mesh-ancestor
24469254|NCT00385086|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
24469255|NCT00385086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25626884|NCT01254305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25626885|NCT01254305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25626886|NCT01254305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626887|NCT01254305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25626888|NCT01254305|Serotonin Agents|serotonin agents|mesh-ancestor
25626889|NCT01254305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626890|NCT01254305|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25626891|NCT01254305|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25626892|NCT01254305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25626893|NCT01254305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626894|NCT01254305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24469882|NCT00387699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24469884|NCT00387699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469886|NCT00387738|Histamine|histamine|mesh-list
24469906|NCT00387868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469907|NCT00387868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469908|NCT00387920|Sunitinib|sunitinib|mesh-list
24469909|NCT00387920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469910|NCT00387920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24469911|NCT00387920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24469912|NCT00387920|Growth Substances|growth substances|mesh-ancestor
25626895|NCT01254305|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25626896|NCT01254305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25626897|NCT01254305|Analgesics|analgesics|mesh-ancestor
25626898|NCT01254305|Sensory System Agents|sensory system agents|mesh-ancestor
25626899|NCT01254344|Metronidazole|metronidazole|mesh-list
25626900|NCT01254344|Ceftriaxone|ceftriaxone|mesh-list
25626901|NCT01254344|Ertapenem|ertapenem|mesh-list
25626902|NCT01254344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25626903|NCT01254344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25626904|NCT01254344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25626905|NCT01254344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25626906|NCT01254396|Sildenafil Citrate|sildenafil citrate|mesh-list
25626907|NCT01254396|Vasodilator Agents|vasodilator agents|mesh-ancestor
25626908|NCT01254396|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25626909|NCT01254396|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25626910|NCT01254396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626911|NCT01254396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626912|NCT01254396|Urological Agents|urological agents|mesh-ancestor
24470882|NCT00392340|Topotecan|topotecan|mesh-list
25626913|NCT01254552|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
25626914|NCT01254552|Chelating Agents|chelating agents|mesh-ancestor
25626915|NCT01254552|Sequestering Agents|sequestering agents|mesh-ancestor
25626916|NCT01254552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626917|NCT01254604|Timolol|timolol|mesh-list
25626918|NCT01254604|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25626919|NCT01254604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25626920|NCT01254604|Adrenergic Agents|adrenergic agents|mesh-ancestor
25626921|NCT01254604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25626922|NCT01254604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626923|NCT01254604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626924|NCT01254604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25626925|NCT01254604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25626926|NCT01254630|Vaccines|vaccines|mesh-list
25626927|NCT01254630|Immunologic Factors|immunologic factors|mesh-ancestor
25626928|NCT01254630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626929|NCT01254656|Efavirenz|efavirenz|mesh-list
25626930|NCT01254656|Etravirine|etravirine|mesh-list
25626931|NCT01254656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25626932|NCT01254656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25626933|NCT01254656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626934|NCT01254656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626935|NCT01254656|Antiviral Agents|antiviral agents|mesh-ancestor
25626936|NCT01254656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25626937|NCT01254656|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25626938|NCT01254656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25626939|NCT01254656|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25626940|NCT01254656|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25716527|NCT02394457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471177|NCT00393679|Piperaquine|piperaquine|mesh-list
24471178|NCT00393679|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24471179|NCT00393679|Amodiaquine|amodiaquine|mesh-list
25626941|NCT01254656|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25626942|NCT01254656|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25626943|NCT01254669|Vaccines|vaccines|mesh-list
25626944|NCT01254669|Immunologic Factors|immunologic factors|mesh-ancestor
25626945|NCT01254669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626946|NCT01254721|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25626947|NCT01254721|Antidepressive Agents|antidepressive agents|mesh-ancestor
25626948|NCT01254721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25626949|NCT01254721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25626950|NCT01254721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25626951|NCT01254721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25626952|NCT01254721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626953|NCT01254877|Ondansetron|ondansetron|mesh-list
25626954|NCT01254877|Antiemetics|antiemetics|mesh-ancestor
25626955|NCT01254877|Autonomic Agents|autonomic agents|mesh-ancestor
25626956|NCT01254877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25626957|NCT01254877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626958|NCT01254877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25626959|NCT01254877|Antipruritics|antipruritics|mesh-ancestor
25626960|NCT01254877|Dermatologic Agents|dermatologic agents|mesh-ancestor
25626961|NCT01254877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25626962|NCT01254877|Serotonin Agents|serotonin agents|mesh-ancestor
25626963|NCT01254877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25626964|NCT01254877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626965|NCT01254877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25626966|NCT01254877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25626967|NCT01254877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25626968|NCT01254877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25626969|NCT01254877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25626970|NCT01254890|Azacitidine|azacitidine|mesh-list
25626971|NCT01254890|Sorafenib|sorafenib|mesh-list
25626972|NCT01254890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25626973|NCT01254890|Antimetabolites|antimetabolites|mesh-ancestor
25626974|NCT01254890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626975|NCT01254890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626976|NCT01254890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626977|NCT01254890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25626978|NCT01255137|Axitinib|axitinib|mesh-list
25716539|NCT02394951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24471271|NCT00394368|Respiratory System Agents|respiratory system agents|mesh-ancestor
24471272|NCT00394368|Dermatologic Agents|dermatologic agents|mesh-ancestor
24471280|NCT00394368|Glucocorticoids|glucocorticoids|mesh-ancestor
25626979|NCT01255137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25626980|NCT01255137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25626981|NCT01255137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25626982|NCT01255137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626983|NCT01255163|Exenatide|exenatide|mesh-list
25626984|NCT01255163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25626985|NCT01255163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626986|NCT01255163|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25626987|NCT01255163|Incretins|incretins|mesh-ancestor
25626988|NCT01255163|Hormones|hormones|mesh-ancestor
25626989|NCT01255163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25626990|NCT01255306|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25626991|NCT01255306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25626992|NCT01255306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25626993|NCT01255306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25626994|NCT01255306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25626995|NCT01255306|Adrenergic Agents|adrenergic agents|mesh-ancestor
25626996|NCT01255306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25626997|NCT01255306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25626998|NCT01255306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25626999|NCT01255423|Diclofenac|diclofenac|mesh-list
25627000|NCT01255423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25627001|NCT01255423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25627002|NCT01255423|Analgesics|analgesics|mesh-ancestor
25627003|NCT01255423|Sensory System Agents|sensory system agents|mesh-ancestor
25716550|NCT02395081|Vitamins|vitamins|mesh-list
24471497|NCT00395551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24471499|NCT00395655|Valproic Acid|valproic acid|mesh-list
24471500|NCT00395655|Anticonvulsants|anticonvulsants|mesh-ancestor
24471536|NCT00395772|Micronutrients|micronutrients|mesh-ancestor
24471537|NCT00395772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471538|NCT00395772|Anticoagulants|anticoagulants|mesh-ancestor
24471539|NCT00395772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24471540|NCT00395772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24471541|NCT00395772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471542|NCT00395772|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24471543|NCT00395772|Antithrombins|antithrombins|mesh-ancestor
24471561|NCT00395915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24471562|NCT00395915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471563|NCT00395915|Dopamine Agonists|dopamine agonists|mesh-ancestor
24471564|NCT00395915|Dopamine Agents|dopamine agents|mesh-ancestor
24471601|NCT00396071|Protease Inhibitors|protease inhibitors|mesh-ancestor
24471602|NCT00396071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24471603|NCT00396071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627004|NCT01255423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25627005|NCT01255423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627006|NCT01255423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25627007|NCT01255423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25627008|NCT01255423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25627009|NCT01255423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627010|NCT01255423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627011|NCT01255449|Albuterol|albuterol|mesh-list
25627012|NCT01255449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25627013|NCT01255449|Autonomic Agents|autonomic agents|mesh-ancestor
25627014|NCT01255449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25627015|NCT01255449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627016|NCT01255449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25627017|NCT01255449|Respiratory System Agents|respiratory system agents|mesh-ancestor
25627018|NCT01255449|Tocolytic Agents|tocolytic agents|mesh-ancestor
25716558|NCT02395172|Tubulin Modulators|tubulin modulators|mesh-ancestor
25716559|NCT02395172|Antimitotic Agents|antimitotic agents|mesh-ancestor
25716560|NCT02395172|Mitosis Modulators|mitosis modulators|mesh-ancestor
25716561|NCT02395172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716562|NCT02395172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25716563|NCT02395627|Tamoxifen|tamoxifen|mesh-list
25716564|NCT02395627|Pembrolizumab|pembrolizumab|mesh-list
25716565|NCT02395627|Vorinostat|vorinostat|mesh-list
24471660|NCT00396500|Albendazole|albendazole|mesh-list
24471661|NCT00396500|Vitamins|vitamins|mesh-ancestor
24471662|NCT00396500|Micronutrients|micronutrients|mesh-ancestor
24471663|NCT00396500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471664|NCT00396500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471665|NCT00396500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24471666|NCT00396500|Anthelmintics|anthelmintics|mesh-ancestor
24471667|NCT00396500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24471668|NCT00396500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24471677|NCT00396513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24471739|NCT00396721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471740|NCT00396721|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24471741|NCT00396721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24471742|NCT00396721|Antimetabolites|antimetabolites|mesh-ancestor
24471743|NCT00396721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471744|NCT00396721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24471747|NCT00396734|Topiramate|topiramate|mesh-list
25627019|NCT01255449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25627020|NCT01255449|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25627021|NCT01255449|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25627022|NCT01255449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25627023|NCT01255449|Adrenergic Agents|adrenergic agents|mesh-ancestor
25627024|NCT01255449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25627025|NCT01255449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627026|NCT01255670|Metronidazole|metronidazole|mesh-list
25627027|NCT01255670|Penicillins|penicillins|mesh-list
25716568|NCT02395627|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25716569|NCT02395627|Hormone Antagonists|hormone antagonists|mesh-ancestor
25716570|NCT02395627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24471755|NCT00396734|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24471757|NCT00396747|Methylprednisolone|methylprednisolone|mesh-list
24471804|NCT00396786|Rivaroxaban|rivaroxaban|mesh-list
24471805|NCT00396786|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24471806|NCT00396786|Antithrombins|antithrombins|mesh-ancestor
24471838|NCT00396968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24471865|NCT00397176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471866|NCT00397176|Antidepressive Agents|antidepressive agents|mesh-ancestor
24471868|NCT00397241|Timolol|timolol|mesh-list
24471869|NCT00397241|Dorzolamide|dorzolamide|mesh-list
24471870|NCT00397241|Latanoprost|latanoprost|mesh-list
24471871|NCT00397241|Lubricant Eye Drops|lubricant eye drops|mesh-list
24471872|NCT00397241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24471873|NCT00397241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24471874|NCT00397241|Adrenergic Agents|adrenergic agents|mesh-ancestor
24471875|NCT00397241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24471885|NCT00397319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24471886|NCT00397319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471888|NCT00397332|Dermatologic Agents|dermatologic agents|mesh-ancestor
24471889|NCT00397332|Immunologic Factors|immunologic factors|mesh-ancestor
24471890|NCT00397332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471891|NCT00397358|Icodextrin|icodextrin|mesh-list
24471892|NCT00397358|Dialysis Solutions|dialysis solutions|mesh-list
24471893|NCT00397358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24471895|NCT00397384|Cetuximab|cetuximab|mesh-list
25627028|NCT01255670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25627029|NCT01255670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25627030|NCT01255670|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25627031|NCT01255670|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25627032|NCT01255761|Certolizumab Pegol|certolizumab pegol|mesh-list
25627033|NCT01255761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25627034|NCT01255761|Immunologic Factors|immunologic factors|mesh-ancestor
25627035|NCT01255761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627036|NCT01255761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25627037|NCT01255787|Vortioxetine|vortioxetine|mesh-list
25627038|NCT01255787|Antidepressive Agents|antidepressive agents|mesh-ancestor
25627039|NCT01255787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25627040|NCT01255787|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25716576|NCT02395627|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25716577|NCT02395627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25716578|NCT02395627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716579|NCT02395653|Fentanyl|fentanyl|mesh-list
25716580|NCT02395653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25716581|NCT02395653|Narcotics|narcotics|mesh-ancestor
24471946|NCT00397553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24471947|NCT00397553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471948|NCT00397566|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
24471949|NCT00397566|BMS-707035|bms-707035|mesh-list
24471950|NCT00397566|Integrase Inhibitors|integrase inhibitors|mesh-list
24471951|NCT00397566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24471952|NCT00397566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471953|NCT00397566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24471970|NCT00397657|Micronutrients|micronutrients|mesh-ancestor
24471971|NCT00397657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471995|NCT00397722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24472018|NCT00397761|Paclitaxel|paclitaxel|mesh-list
24472019|NCT00397761|Capecitabine|capecitabine|mesh-list
24454052|NCT04485195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24454053|NCT04485195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24454054|NCT04485195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24454055|NCT04478019|Povidone-Iodine|povidone-iodine|mesh-list
24454056|NCT04478019|Povidone|povidone|mesh-list
24472057|NCT00397826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24472058|NCT00397826|Antimetabolites|antimetabolites|mesh-ancestor
25716584|NCT02395653|Analgesics|analgesics|mesh-ancestor
25627041|NCT01255787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25627042|NCT01255787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25627043|NCT01255787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627044|NCT01255787|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25627045|NCT01255787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25627046|NCT01255787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25627047|NCT01255787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716589|NCT02395653|Anesthetics, General|anesthetics, general|mesh-ancestor
24472075|NCT00398008|Narcotics|narcotics|mesh-ancestor
24472078|NCT00398008|Analgesics|analgesics|mesh-ancestor
24472079|NCT00398008|Sensory System Agents|sensory system agents|mesh-ancestor
24472080|NCT00398008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24472081|NCT00398008|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24472082|NCT00398008|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24472083|NCT00398034|Testosterone|testosterone|mesh-list
24472084|NCT00398034|Androgens|androgens|mesh-ancestor
24472100|NCT00398281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24472101|NCT00398281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472104|NCT00398372|Rituximab|rituximab|mesh-list
24472105|NCT00398372|Epratuzumab|epratuzumab|mesh-list
24472106|NCT00398372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24472107|NCT00398372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472108|NCT00398372|Immunologic Factors|immunologic factors|mesh-ancestor
24472109|NCT00398372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472110|NCT00398372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24472111|NCT00398385|Gemcitabine|gemcitabine|mesh-list
24472112|NCT00398385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472113|NCT00398385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25716590|NCT02395653|Anesthetics|anesthetics|mesh-ancestor
24472114|NCT00398385|Antimetabolites|antimetabolites|mesh-ancestor
25716591|NCT02395692|Temozolomide|temozolomide|mesh-list
25627048|NCT01255787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25627049|NCT01255787|Serotonin Agents|serotonin agents|mesh-ancestor
25627050|NCT01255787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25627051|NCT01255787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25627052|NCT01255787|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25627053|NCT01255787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25627054|NCT01255904|Dexmedetomidine|dexmedetomidine|mesh-list
25627055|NCT01255904|Chloral Hydrate|chloral hydrate|mesh-list
25627056|NCT01255904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25627057|NCT01255904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25627058|NCT01255904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627059|NCT01255904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25627060|NCT01255904|Analgesics|analgesics|mesh-ancestor
25627061|NCT01255904|Sensory System Agents|sensory system agents|mesh-ancestor
25627062|NCT01255904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25627063|NCT01255904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25627064|NCT01255904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25627065|NCT01255904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25627066|NCT01255904|Adrenergic Agents|adrenergic agents|mesh-ancestor
25627067|NCT01255904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25627068|NCT01255904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655703|NCT01566409|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25655704|NCT01566409|Laxatives|laxatives|mesh-ancestor
25655705|NCT01566409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25655706|NCT01566435|Paclitaxel|paclitaxel|mesh-list
25655707|NCT01566435|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25655708|NCT01566435|Cisplatin|cisplatin|mesh-list
25655709|NCT01566435|Fluorouracil|fluorouracil|mesh-list
25655710|NCT01566435|Cetuximab|cetuximab|mesh-list
25655711|NCT01566435|Antibodies|antibodies|mesh-list
25655712|NCT01566435|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25655713|NCT01566435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25716592|NCT02395692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25716593|NCT02395692|Alkylating Agents|alkylating agents|mesh-ancestor
25716594|NCT02395692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716595|NCT02395692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716596|NCT02396147|Relugolix|relugolix|mesh-list
24472146|NCT00398463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24472147|NCT00398463|Immunologic Factors|immunologic factors|mesh-ancestor
24472148|NCT00398463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472149|NCT00398463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24472150|NCT00398463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472151|NCT00398463|Antiviral Agents|antiviral agents|mesh-ancestor
24472152|NCT00398463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24472153|NCT00398463|Interferon Inducers|interferon inducers|mesh-ancestor
24472154|NCT00398463|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24472174|NCT00398489|Mitosis Modulators|mitosis modulators|mesh-ancestor
24472210|NCT00398554|Prednisone|prednisone|mesh-list
24472211|NCT00398554|Cyclophosphamide|cyclophosphamide|mesh-list
25655714|NCT01566435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25655715|NCT01566435|Tubulin Modulators|tubulin modulators|mesh-ancestor
25655716|NCT01566435|Antimitotic Agents|antimitotic agents|mesh-ancestor
25655717|NCT01566435|Mitosis Modulators|mitosis modulators|mesh-ancestor
25655718|NCT01566435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655719|NCT01566435|Immunologic Factors|immunologic factors|mesh-ancestor
25655720|NCT01566435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655721|NCT01566435|Antimetabolites|antimetabolites|mesh-ancestor
25655722|NCT01566435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25655723|NCT01566435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25655724|NCT01566435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25655725|NCT01566448|Ketamine|ketamine|mesh-list
25655726|NCT01566448|Analgesics|analgesics|mesh-ancestor
25655727|NCT01566448|Sensory System Agents|sensory system agents|mesh-ancestor
25655728|NCT01566448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25655729|NCT01566448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655730|NCT01566448|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25655731|NCT01566448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25655732|NCT01566448|Anesthetics, General|anesthetics, general|mesh-ancestor
25655733|NCT01566448|Anesthetics|anesthetics|mesh-ancestor
25655734|NCT01566448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25655735|NCT01566448|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25655736|NCT01566448|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25655737|NCT01566448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25655738|NCT01566448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655739|NCT01566526|Dexamethasone|dexamethasone|mesh-list
25655740|NCT01566526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25655741|NCT01566526|Antiemetics|antiemetics|mesh-ancestor
25655742|NCT01566526|Autonomic Agents|autonomic agents|mesh-ancestor
25655743|NCT01566526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25655744|NCT01566526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716600|NCT02396147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472224|NCT00398554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472225|NCT00398554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24472226|NCT00398554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24472227|NCT00398554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24472228|NCT00398554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24472229|NCT00398554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24472230|NCT00398554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24472232|NCT00398554|Hormones|hormones|mesh-ancestor
24472236|NCT00398554|Tubulin Modulators|tubulin modulators|mesh-ancestor
25655745|NCT01566526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25655746|NCT01566526|Glucocorticoids|glucocorticoids|mesh-ancestor
25655747|NCT01566526|Hormones|hormones|mesh-ancestor
25655748|NCT01566526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25655749|NCT01566526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25655750|NCT01566526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25655751|NCT01566539|Vasopressins|vasopressins|mesh-list
25655752|NCT01566539|Arginine Vasopressin|arginine vasopressin|mesh-list
25655753|NCT01566539|Lorazepam|lorazepam|mesh-list
25655754|NCT01566539|Oxytocin|oxytocin|mesh-list
25627069|NCT01256060|Oxytocin|oxytocin|mesh-list
25627070|NCT01256060|Oxytocics|oxytocics|mesh-ancestor
25627071|NCT01256060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25627072|NCT01256060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627073|NCT01256164|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25627074|NCT01256164|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
25627075|NCT01256164|Hemostatics|hemostatics|mesh-ancestor
25627076|NCT01256164|Coagulants|coagulants|mesh-ancestor
25627077|NCT01256177|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25627078|NCT01256177|Antidepressive Agents|antidepressive agents|mesh-ancestor
25627079|NCT01256177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25627080|NCT01256177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25627081|NCT01256177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25627082|NCT01256177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25627083|NCT01256177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627084|NCT01256190|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25627085|NCT01256190|Fibrin Foam|fibrin foam|mesh-list
25627086|NCT01256190|Hemostatics|hemostatics|mesh-ancestor
25627087|NCT01256190|Coagulants|coagulants|mesh-ancestor
25627088|NCT01256294|Tacrolimus|tacrolimus|mesh-list
25627089|NCT01256294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25627090|NCT01256294|Immunologic Factors|immunologic factors|mesh-ancestor
25627091|NCT01256294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472287|NCT00398697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472289|NCT00398749|Hematinics|hematinics|mesh-ancestor
24472290|NCT00398775|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24472292|NCT00398788|Hydromorphone|hydromorphone|mesh-list
24472300|NCT00398814|Sorafenib|sorafenib|mesh-list
24472301|NCT00398814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472309|NCT00398827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24472311|NCT00398827|Sensory System Agents|sensory system agents|mesh-ancestor
24472312|NCT00398827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24472313|NCT00398827|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24472314|NCT00398827|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25627092|NCT01256294|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25627093|NCT01256294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627094|NCT01256294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627095|NCT01256385|Sirolimus|sirolimus|mesh-list
25627096|NCT01256385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25627097|NCT01256385|Cetuximab|cetuximab|mesh-list
25627098|NCT01256385|Antibodies|antibodies|mesh-list
25627099|NCT01256385|Immunoglobulins|immunoglobulins|mesh-list
25627100|NCT01256385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25627101|NCT01256385|Immunologic Factors|immunologic factors|mesh-ancestor
25627102|NCT01256385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627103|NCT01256385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25627104|NCT01256385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25627105|NCT01256385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25627106|NCT01256385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25627107|NCT01256385|Antifungal Agents|antifungal agents|mesh-ancestor
25627108|NCT01256385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25627109|NCT01256411|Amlodipine|amlodipine|mesh-list
24472347|NCT00398957|Naltrexone|naltrexone|mesh-list
24472348|NCT00398957|Hydromorphone|hydromorphone|mesh-list
24472359|NCT00399022|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24472360|NCT00399022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24472361|NCT00399022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24472410|NCT00399087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472411|NCT00399087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24472412|NCT00399087|Glucocorticoids|glucocorticoids|mesh-ancestor
24472413|NCT00399087|Hormones|hormones|mesh-ancestor
24472414|NCT00399087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24472418|NCT00399126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25627110|NCT01256411|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25627111|NCT01256411|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25627112|NCT01256411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25627113|NCT01256411|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25627114|NCT01256411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25627115|NCT01256411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627116|NCT01256411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25627117|NCT01256411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627118|NCT01256411|Vasodilator Agents|vasodilator agents|mesh-ancestor
25627119|NCT01256411|Diuretics|diuretics|mesh-ancestor
25627120|NCT01256411|Natriuretic Agents|natriuretic agents|mesh-ancestor
24472434|NCT00399165|Methyltestosterone|methyltestosterone|mesh-list
24472436|NCT00399165|Testosterone undecanoate|testosterone undecanoate|mesh-list
24472437|NCT00399165|Testosterone enanthate|testosterone enanthate|mesh-list
24472438|NCT00399165|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24472439|NCT00399165|Dutasteride|dutasteride|mesh-list
24472440|NCT00399165|Androgens|androgens|mesh-ancestor
24472441|NCT00399165|Hormones|hormones|mesh-ancestor
24472442|NCT00399165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24472443|NCT00399165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472447|NCT00399165|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24472460|NCT00399243|Serotonin Agents|serotonin agents|mesh-ancestor
24472461|NCT00399243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24472462|NCT00399243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472463|NCT00399243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472464|NCT00399256|Acetylcysteine|acetylcysteine|mesh-list
24472465|NCT00399256|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24472466|NCT00399256|Antiviral Agents|antiviral agents|mesh-ancestor
24472467|NCT00399256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24472468|NCT00399256|Expectorants|expectorants|mesh-ancestor
24472469|NCT00399256|Respiratory System Agents|respiratory system agents|mesh-ancestor
24472476|NCT00399269|Epoetin Alfa|epoetin alfa|mesh-list
24472477|NCT00399269|Hematinics|hematinics|mesh-ancestor
25716616|NCT02396537|Lidocaine|lidocaine|mesh-list
24472479|NCT00399282|Vitamins|vitamins|mesh-ancestor
25716617|NCT02396537|Midazolam|midazolam|mesh-list
25716618|NCT02396537|Anesthetics, Local|anesthetics, local|mesh-ancestor
25716619|NCT02396537|Anesthetics|anesthetics|mesh-ancestor
25716620|NCT02396537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25716621|NCT02396537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716622|NCT02396537|Sensory System Agents|sensory system agents|mesh-ancestor
25716623|NCT02396537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25716624|NCT02396537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25627121|NCT01256411|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25627122|NCT01256411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25627123|NCT01256450|Buprenorphine|buprenorphine|mesh-list
25627124|NCT01256450|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25627125|NCT01256450|Narcotics|narcotics|mesh-ancestor
25627126|NCT01256450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25627127|NCT01256450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627128|NCT01256450|Analgesics|analgesics|mesh-ancestor
25627129|NCT01256450|Sensory System Agents|sensory system agents|mesh-ancestor
25627130|NCT01256450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25627131|NCT01256450|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25627132|NCT01256476|Pravastatin|pravastatin|mesh-list
25627133|NCT01256476|Pitavastatin|pitavastatin|mesh-list
25627134|NCT01256476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25716625|NCT02396537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25716626|NCT02396537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24472523|NCT00399451|Polidocanol|polidocanol|mesh-list
24472524|NCT00399451|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
24472525|NCT00399451|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24472526|NCT00399464|Alfuzosin|alfuzosin|mesh-list
24452474|NCT05458674|Trastuzumab|trastuzumab|mesh-list
24472527|NCT00399464|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24472528|NCT00399464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24472529|NCT00399464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24472531|NCT00399464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24472532|NCT00399464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472533|NCT00399464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472534|NCT00399464|Urological Agents|urological agents|mesh-ancestor
24472541|NCT00399477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24472542|NCT00399477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472543|NCT00399477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472544|NCT00399477|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24472545|NCT00399477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24472546|NCT00399477|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24472547|NCT00399477|Protective Agents|protective agents|mesh-ancestor
24472548|NCT00399477|Antioxidants|antioxidants|mesh-ancestor
24472555|NCT00399633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24472556|NCT00399633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716627|NCT02396537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25716628|NCT02396537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716629|NCT02396537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25627135|NCT01256476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25627136|NCT01256476|Antimetabolites|antimetabolites|mesh-ancestor
25627137|NCT01256476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627138|NCT01256476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25627139|NCT01256476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25627140|NCT01256476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627141|NCT01256567|Docetaxel|docetaxel|mesh-list
25627142|NCT01256567|Ramucirumab|ramucirumab|mesh-list
25627143|NCT01256567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25627144|NCT01256567|Tubulin Modulators|tubulin modulators|mesh-ancestor
25627145|NCT01256567|Antimitotic Agents|antimitotic agents|mesh-ancestor
25627146|NCT01256567|Mitosis Modulators|mitosis modulators|mesh-ancestor
25627147|NCT01256567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627148|NCT01256593|Pregabalin|pregabalin|mesh-list
25627149|NCT01256593|Analgesics|analgesics|mesh-ancestor
24472562|NCT00399659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472567|NCT00399672|Antiviral Agents|antiviral agents|mesh-ancestor
24472568|NCT00399672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24472569|NCT00399672|Antimetabolites|antimetabolites|mesh-ancestor
24472570|NCT00399672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472577|NCT00399685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472579|NCT00399685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24422329|NCT00222144|Docetaxel|docetaxel|mesh-list
24472580|NCT00399685|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24472581|NCT00399685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24472582|NCT00399685|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24472583|NCT00399685|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24472584|NCT00399685|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25627150|NCT01256593|Sensory System Agents|sensory system agents|mesh-ancestor
25627151|NCT01256593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25627152|NCT01256593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627153|NCT01256593|Anticonvulsants|anticonvulsants|mesh-ancestor
25627154|NCT01256593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25627155|NCT01256593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25627156|NCT01256593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627157|NCT01256593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25627158|NCT01256593|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25627159|NCT01256593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25627160|NCT01256593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25627161|NCT01256593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25627162|NCT01256658|Lumefantrine|lumefantrine|mesh-list
25627163|NCT01256658|Artemether|artemether|mesh-list
25716644|NCT02396732|Sensory System Agents|sensory system agents|mesh-ancestor
25716645|NCT02396732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25716646|NCT02396732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716647|NCT02396732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25716648|NCT02396732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25716649|NCT02396732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25716650|NCT02396732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24472719|NCT00400348|Antimitotic Agents|antimitotic agents|mesh-ancestor
24472720|NCT00400348|Mitosis Modulators|mitosis modulators|mesh-ancestor
24472721|NCT00400348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472730|NCT00400374|Analgesics|analgesics|mesh-ancestor
24472731|NCT00400374|Sensory System Agents|sensory system agents|mesh-ancestor
24472732|NCT00400374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24472733|NCT00400374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472734|NCT00400374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24472764|NCT00400478|Rituximab|rituximab|mesh-list
24472765|NCT00400478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24472766|NCT00400478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716651|NCT02396732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716652|NCT02396732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25716653|NCT02396732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25716654|NCT02396732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25716655|NCT02396732|Antipyretics|antipyretics|mesh-ancestor
25716656|NCT02396732|Anticoagulants|anticoagulants|mesh-ancestor
24472767|NCT00400478|Immunologic Factors|immunologic factors|mesh-ancestor
24472768|NCT00400478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627164|NCT01256658|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25627165|NCT01256658|Antimalarials|antimalarials|mesh-ancestor
25627166|NCT01256658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25627167|NCT01256658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25627168|NCT01256658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25627169|NCT01256671|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25627170|NCT01256671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25627171|NCT01256671|Immunologic Factors|immunologic factors|mesh-ancestor
25627172|NCT01256671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627173|NCT01256684|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25627174|NCT01256684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25627175|NCT01256684|Immunologic Factors|immunologic factors|mesh-ancestor
25627176|NCT01256684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627177|NCT01256879|Cimetidine|cimetidine|mesh-list
25627178|NCT01256879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25627179|NCT01256879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24472769|NCT00400478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24472770|NCT00400491|Vitamin D|vitamin d|mesh-list
24472771|NCT00400491|Ergocalciferols|ergocalciferols|mesh-list
24472772|NCT00400491|Cholecalciferol|cholecalciferol|mesh-list
24472773|NCT00400491|Vitamins|vitamins|mesh-list
24472774|NCT00400491|Micronutrients|micronutrients|mesh-ancestor
24472794|NCT00400595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24472795|NCT00400595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472796|NCT00400608|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24472797|NCT00400608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24472798|NCT00400608|Autonomic Agents|autonomic agents|mesh-ancestor
24472799|NCT00400608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24472811|NCT00400621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24472824|NCT00400725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24472825|NCT00400725|Glucocorticoids|glucocorticoids|mesh-ancestor
24472826|NCT00400725|Hormones|hormones|mesh-ancestor
24472827|NCT00400725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24472829|NCT00400738|Ritonavir|ritonavir|mesh-list
24472840|NCT00400738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24472841|NCT00400738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24472842|NCT00400738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24472843|NCT00400777|Amlodipine|amlodipine|mesh-list
25627180|NCT01256879|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25627181|NCT01256879|Histamine Antagonists|histamine antagonists|mesh-ancestor
25627182|NCT01256879|Histamine Agents|histamine agents|mesh-ancestor
25627183|NCT01256879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25627184|NCT01256879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627185|NCT01256879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627186|NCT01256879|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25627187|NCT01256879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25716657|NCT02396758|Plasminogen|plasminogen|mesh-list
24472910|NCT00401128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24472911|NCT00401128|Antimetabolites|antimetabolites|mesh-ancestor
24472912|NCT00401128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472913|NCT00401128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472914|NCT00401128|Antiviral Agents|antiviral agents|mesh-ancestor
24472915|NCT00401128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24472923|NCT00401167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24472924|NCT00401167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24472925|NCT00401167|Dopamine Agents|dopamine agents|mesh-ancestor
24472926|NCT00401167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24472927|NCT00401167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472928|NCT00401167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472929|NCT00401167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25716658|NCT02396758|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25716659|NCT02396758|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25716660|NCT02396758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25716661|NCT02396758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716662|NCT02396953|Lanreotide|lanreotide|mesh-list
25716663|NCT02396953|Somatostatin|somatostatin|mesh-list
25627188|NCT01256879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627189|NCT01257087|Insulin|insulin|mesh-list
25627190|NCT01257087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25627191|NCT01257087|Insulin Glargine|insulin glargine|mesh-list
25627192|NCT01257087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25627193|NCT01257087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627194|NCT01257204|Interferons|interferons|mesh-list
25627195|NCT01257204|Ribavirin|ribavirin|mesh-list
25627196|NCT01257204|Interferon-alpha|interferon-alpha|mesh-list
25627197|NCT01257204|Interferon alpha-2|interferon alpha-2|mesh-list
25627198|NCT01257204|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25627199|NCT01257204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25627200|NCT01257204|Antiviral Agents|antiviral agents|mesh-ancestor
25627201|NCT01257204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25627202|NCT01257204|Antimetabolites|antimetabolites|mesh-ancestor
25627203|NCT01257204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627204|NCT01257204|Immunologic Factors|immunologic factors|mesh-ancestor
25627205|NCT01257204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627206|NCT01257230|Tiotropium Bromide|tiotropium bromide|mesh-list
25627207|NCT01257230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25627208|NCT01257230|Autonomic Agents|autonomic agents|mesh-ancestor
25627209|NCT01257230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25627210|NCT01257230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472935|NCT00401180|Antimitotic Agents|antimitotic agents|mesh-ancestor
24472936|NCT00401180|Mitosis Modulators|mitosis modulators|mesh-ancestor
24472939|NCT00401180|Alkylating Agents|alkylating agents|mesh-ancestor
24472966|NCT00401323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472968|NCT00401323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24472969|NCT00401323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24422671|NCT00223418|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24472985|NCT00401427|Antimitotic Agents|antimitotic agents|mesh-ancestor
24472986|NCT00401427|Mitosis Modulators|mitosis modulators|mesh-ancestor
24472987|NCT00401427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444184|NCT00296933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444185|NCT00296933|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24444186|NCT00296933|Antidepressive Agents|antidepressive agents|mesh-ancestor
24444360|NCT00297661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473013|NCT00401492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24473014|NCT00401492|Immunologic Factors|immunologic factors|mesh-ancestor
24473015|NCT00401492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473016|NCT00401492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24473017|NCT00401492|Tubulin Modulators|tubulin modulators|mesh-ancestor
24473018|NCT00401492|Antimitotic Agents|antimitotic agents|mesh-ancestor
24473019|NCT00401492|Mitosis Modulators|mitosis modulators|mesh-ancestor
24473021|NCT00401596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24473022|NCT00401596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24473023|NCT00401596|Respiratory System Agents|respiratory system agents|mesh-ancestor
25627211|NCT01257230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25627212|NCT01257230|Respiratory System Agents|respiratory system agents|mesh-ancestor
25627213|NCT01257230|Parasympatholytics|parasympatholytics|mesh-ancestor
25627214|NCT01257230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25627215|NCT01257230|Cholinergic Agents|cholinergic agents|mesh-ancestor
25627216|NCT01257230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25627217|NCT01257230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627218|NCT01257425|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25521807|NCT00464672|Vaccines|vaccines|mesh-list
25627219|NCT01257425|Luteolytic Agents|luteolytic agents|mesh-ancestor
25655755|NCT01566539|Oxytocics|oxytocics|mesh-ancestor
25627220|NCT01257425|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25627221|NCT01257425|Contraceptive Agents|contraceptive agents|mesh-ancestor
25627222|NCT01257425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25627223|NCT01257425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627224|NCT01257425|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25627225|NCT01257425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25627226|NCT01257425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25627228|NCT01257542|Antitussive Agents|antitussive agents|mesh-ancestor
25627229|NCT01257542|Respiratory System Agents|respiratory system agents|mesh-ancestor
25627230|NCT01257542|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25627231|NCT01257542|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25627232|NCT01257542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25627233|NCT01257542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627234|NCT01257542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627235|NCT01257581|Tamoxifen|tamoxifen|mesh-list
25627236|NCT01257581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25627237|NCT01257581|Hormone Antagonists|hormone antagonists|mesh-ancestor
25627238|NCT01257581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24473024|NCT00401609|Gemcitabine|gemcitabine|mesh-list
25627239|NCT01257581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627240|NCT01257581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25627241|NCT01257581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25627242|NCT01257581|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25627243|NCT01257581|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25627244|NCT01257581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25627245|NCT01257698|Timolol|timolol|mesh-list
25627246|NCT01257698|Dorzolamide|dorzolamide|mesh-list
25627247|NCT01257698|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25627248|NCT01257698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25627249|NCT01257698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25627250|NCT01257698|Adrenergic Agents|adrenergic agents|mesh-ancestor
25627251|NCT01257698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25627252|NCT01257698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627253|NCT01257698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627254|NCT01257698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25627255|NCT01257698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25627256|NCT01257698|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25627257|NCT01257698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627258|NCT01257698|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25627259|NCT01257737|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25627260|NCT01257737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25627261|NCT01257802|Leuprolide|leuprolide|mesh-list
25627262|NCT01257802|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25627263|NCT01257802|Fertility Agents|fertility agents|mesh-ancestor
25627264|NCT01257802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25627265|NCT01257802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627266|NCT01257802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25627267|NCT01257802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25627268|NCT01258049|Artemether|artemether|mesh-list
25627269|NCT01258049|Quinine|quinine|mesh-list
25627270|NCT01258049|Antimalarials|antimalarials|mesh-ancestor
25627271|NCT01258049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25627272|NCT01258049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25627273|NCT01258049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25627274|NCT01258049|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25627275|NCT01258049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627276|NCT01258049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25627277|NCT01258049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25627278|NCT01258049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25627279|NCT01258049|Analgesics|analgesics|mesh-ancestor
25627280|NCT01258049|Sensory System Agents|sensory system agents|mesh-ancestor
25627281|NCT01258075|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
25627282|NCT01258075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25627283|NCT01258075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24473839|NCT00404326|Hydralazine|hydralazine|mesh-list
25627284|NCT01258075|Antimetabolites|antimetabolites|mesh-ancestor
25627285|NCT01258075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627286|NCT01258075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25627287|NCT01258101|Ribavirin|ribavirin|mesh-list
25627288|NCT01258101|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25627289|NCT01258101|Interferon-alpha|interferon-alpha|mesh-list
25627290|NCT01258101|Antimetabolites|antimetabolites|mesh-ancestor
25627291|NCT01258101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627292|NCT01258101|Antiviral Agents|antiviral agents|mesh-ancestor
25521931|NCT00465972|Temazepam|temazepam|mesh-list
25521932|NCT00465972|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25521933|NCT00465972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25521934|NCT00465972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25521935|NCT00465972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521936|NCT00465972|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25521937|NCT00465972|Antidepressive Agents|antidepressive agents|mesh-ancestor
25521938|NCT00465972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25521939|NCT00465972|Histamine Antagonists|histamine antagonists|mesh-ancestor
25521940|NCT00465972|Histamine Agents|histamine agents|mesh-ancestor
25521941|NCT00465972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25521942|NCT00465972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521943|NCT00465972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25521944|NCT00465972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25521945|NCT00465972|GABA Modulators|gaba modulators|mesh-ancestor
25521946|NCT00465972|GABA Agents|gaba agents|mesh-ancestor
24990453|NCT02983747|Loxoprofen|loxoprofen|mesh-list
24990454|NCT02983747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24990480|NCT02966119|Antipyretics|antipyretics|mesh-ancestor
24990481|NCT02966119|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24990482|NCT02966119|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24990483|NCT02966119|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25124420|NCT03076151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25124421|NCT03076151|Immunologic Factors|immunologic factors|mesh-ancestor
25124422|NCT03076151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124423|NCT03076151|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25124424|NCT03076151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124425|NCT03076151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124426|NCT03076112|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25124427|NCT03076112|Ipragliflozin|ipragliflozin|mesh-list
25124428|NCT03076112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25124429|NCT03076112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124430|NCT03076112|Incretins|incretins|mesh-ancestor
25124431|NCT03076112|Hormones|hormones|mesh-ancestor
24446290|NCT00304317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25124432|NCT03076112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25124433|NCT03076112|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25124434|NCT03076112|Protease Inhibitors|protease inhibitors|mesh-ancestor
25124435|NCT03076112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124436|NCT03076112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124437|NCT03076112|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24741258|NCT01693081|Autonomic Agents|autonomic agents|mesh-ancestor
24437284|NCT00273338|Tubulin Modulators|tubulin modulators|mesh-ancestor
24437285|NCT00273338|Antimitotic Agents|antimitotic agents|mesh-ancestor
24437286|NCT00273338|Mitosis Modulators|mitosis modulators|mesh-ancestor
24795529|NCT01812252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24795530|NCT01812252|Antimetabolites|antimetabolites|mesh-ancestor
24795531|NCT01812252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627293|NCT01258101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25627294|NCT01258101|Immunologic Factors|immunologic factors|mesh-ancestor
25627295|NCT01258101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627296|NCT01258153|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25627297|NCT01258153|MEN 11420|men 11420|mesh-list
25627298|NCT01258153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25627299|NCT01258153|Autonomic Agents|autonomic agents|mesh-ancestor
25627300|NCT01258153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25627301|NCT01258153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627302|NCT01258153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25716681|NCT02397408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24474277|NCT00405418|Insulin|insulin|mesh-list
24446485|NCT00304850|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24474316|NCT00405535|Glycine Agents|glycine agents|mesh-ancestor
24446517|NCT00304993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25627303|NCT01258153|Respiratory System Agents|respiratory system agents|mesh-ancestor
25627304|NCT01258348|Sunitinib|sunitinib|mesh-list
25627305|NCT01258348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25627306|NCT01258348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25627307|NCT01258348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25627308|NCT01258348|Growth Substances|growth substances|mesh-ancestor
25627309|NCT01258348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627310|NCT01258348|Growth Inhibitors|growth inhibitors|mesh-ancestor
25627311|NCT01258348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25627312|NCT01258348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627313|NCT01258348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627314|NCT01258374|Raltegravir Potassium|raltegravir potassium|mesh-list
25627315|NCT01258374|Darunavir|darunavir|mesh-list
25627316|NCT01258374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25627317|NCT01258374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25627318|NCT01258374|Antiviral Agents|antiviral agents|mesh-ancestor
25627319|NCT01258374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25627320|NCT01258374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25627321|NCT01258374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25627322|NCT01258374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627323|NCT01258374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627324|NCT01258374|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25627325|NCT01258374|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25627326|NCT01258374|Protease Inhibitors|protease inhibitors|mesh-ancestor
25627328|NCT01258387|Mitosis Modulators|mitosis modulators|mesh-ancestor
25627329|NCT01258387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627330|NCT01258595|Vaccines|vaccines|mesh-list
25627331|NCT01258595|Immunologic Factors|immunologic factors|mesh-ancestor
25627332|NCT01258595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627333|NCT01258608|Sorafenib|sorafenib|mesh-list
25627334|NCT01258608|Mapatumumab|mapatumumab|mesh-list
25627335|NCT01258608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25627336|NCT01258608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25627337|NCT01258608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627338|NCT01258608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627339|NCT01258660|Folic Acid|folic acid|mesh-list
25627340|NCT01258660|Vitamin B Complex|vitamin b complex|mesh-list
25627341|NCT01258660|Drospirenone|drospirenone|mesh-list
25627342|NCT01258660|Hematinics|hematinics|mesh-ancestor
25627343|NCT01258660|Vitamins|vitamins|mesh-ancestor
25627344|NCT01258660|Micronutrients|micronutrients|mesh-ancestor
25627345|NCT01258660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627346|NCT01258660|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25627347|NCT01258660|Hormone Antagonists|hormone antagonists|mesh-ancestor
25627348|NCT01258660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25627349|NCT01258660|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25627350|NCT01258660|Diuretics|diuretics|mesh-ancestor
25627351|NCT01258660|Natriuretic Agents|natriuretic agents|mesh-ancestor
25627352|NCT01258738|Etanercept|etanercept|mesh-list
25627353|NCT01258738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25627354|NCT01258738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25627355|NCT01258738|Analgesics|analgesics|mesh-ancestor
24474783|NCT00407342|Alefacept|alefacept|mesh-list
25627356|NCT01258738|Sensory System Agents|sensory system agents|mesh-ancestor
25627357|NCT01258738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25627358|NCT01258738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627359|NCT01258738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25627360|NCT01258738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25627361|NCT01258738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25627362|NCT01258738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25627363|NCT01258738|Immunologic Factors|immunologic factors|mesh-ancestor
25627364|NCT01258855|Aldesleukin|aldesleukin|mesh-list
25627365|NCT01258855|Aflibercept|aflibercept|mesh-list
25627366|NCT01258855|Interleukin-2|interleukin-2|mesh-list
25627367|NCT01258855|Endothelial Growth Factors|endothelial growth factors|mesh-list
25627368|NCT01258855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25627369|NCT01258855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25627370|NCT01258855|Growth Substances|growth substances|mesh-ancestor
25627371|NCT01258855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627372|NCT01258855|Growth Inhibitors|growth inhibitors|mesh-ancestor
25627373|NCT01258855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25627374|NCT01258855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25627375|NCT01258855|Analgesics|analgesics|mesh-ancestor
25627376|NCT01258855|Sensory System Agents|sensory system agents|mesh-ancestor
25627377|NCT01258855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25627378|NCT01258855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25627379|NCT01258855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25627380|NCT01258855|Antiviral Agents|antiviral agents|mesh-ancestor
25627381|NCT01258855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25627382|NCT01259063|Gemcitabine|gemcitabine|mesh-list
25627383|NCT01259063|Everolimus|everolimus|mesh-list
25627384|NCT01259063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25627385|NCT01259063|Antimetabolites|antimetabolites|mesh-ancestor
25627386|NCT01259063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627387|NCT01259063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25627388|NCT01259063|Antiviral Agents|antiviral agents|mesh-ancestor
25627389|NCT01259063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25627390|NCT01259063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627391|NCT01259063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25716701|NCT02397837|Dopamine Agents|dopamine agents|mesh-ancestor
25627392|NCT01259063|Immunologic Factors|immunologic factors|mesh-ancestor
25627393|NCT01259063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627395|NCT01259089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25627396|NCT01259089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25627397|NCT01259089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627398|NCT01259089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627399|NCT01259102|Buprenorphine|buprenorphine|mesh-list
25627400|NCT01259102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25627401|NCT01259102|Narcotics|narcotics|mesh-ancestor
25627402|NCT01259102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25627403|NCT01259102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627404|NCT01259102|Analgesics|analgesics|mesh-ancestor
25627405|NCT01259102|Sensory System Agents|sensory system agents|mesh-ancestor
25627406|NCT01259102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25627407|NCT01259102|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25627408|NCT01259115|Ketoconazole|ketoconazole|mesh-list
25627409|NCT01259115|Buprenorphine|buprenorphine|mesh-list
25627410|NCT01259115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25627411|NCT01259115|Narcotics|narcotics|mesh-ancestor
25627412|NCT01259115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25627413|NCT01259115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627414|NCT01259115|Analgesics|analgesics|mesh-ancestor
25627415|NCT01259115|Sensory System Agents|sensory system agents|mesh-ancestor
25627416|NCT01259115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25627417|NCT01259115|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25627418|NCT01259115|Antifungal Agents|antifungal agents|mesh-ancestor
25627419|NCT01259115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25627420|NCT01259115|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24475284|NCT00409721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627421|NCT01259115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25627422|NCT01259115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627423|NCT01259115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627424|NCT01259115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25627425|NCT01259115|Hormone Antagonists|hormone antagonists|mesh-ancestor
25627426|NCT01259115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25627427|NCT01259115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25627428|NCT01259297|Amlodipine|amlodipine|mesh-list
25627429|NCT01259297|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25627430|NCT01259297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25627431|NCT01259297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25627432|NCT01259297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25627433|NCT01259297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627434|NCT01259297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25627435|NCT01259297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627436|NCT01259297|Vasodilator Agents|vasodilator agents|mesh-ancestor
25627437|NCT01259297|Diuretics|diuretics|mesh-ancestor
25627438|NCT01259297|Natriuretic Agents|natriuretic agents|mesh-ancestor
25627439|NCT01259297|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25627440|NCT01259375|Amrubicin|amrubicin|mesh-list
25627441|NCT01259375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25627442|NCT01259388|Lithium Carbonate|lithium carbonate|mesh-list
25627443|NCT01259388|Antidepressive Agents|antidepressive agents|mesh-ancestor
25627444|NCT01259388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25627445|NCT01259388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627446|NCT01259388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627447|NCT01259388|Antimanic Agents|antimanic agents|mesh-ancestor
25627448|NCT01259388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25627449|NCT01259388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25627450|NCT01259388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627451|NCT01259466|Nicotine|nicotine|mesh-list
25627452|NCT01259466|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25627453|NCT01259466|Autonomic Agents|autonomic agents|mesh-ancestor
25627454|NCT01259466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25627455|NCT01259466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627456|NCT01259466|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25627457|NCT01259466|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25627458|NCT01259466|Cholinergic Agents|cholinergic agents|mesh-ancestor
25627459|NCT01259466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25627460|NCT01259466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627461|NCT01259492|Methylphenidate|methylphenidate|mesh-list
25627462|NCT01259492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25627463|NCT01259492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627464|NCT01259492|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25627465|NCT01259492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25627466|NCT01259492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25627467|NCT01259492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627468|NCT01259492|Dopamine Agents|dopamine agents|mesh-ancestor
25627469|NCT01259492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25627470|NCT01259713|Amphotericin B|amphotericin b|mesh-list
25627471|NCT01259713|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25627472|NCT01259713|Amebicides|amebicides|mesh-ancestor
25627473|NCT01259713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25627474|NCT01259713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25627475|NCT01259713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25627476|NCT01259713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25627477|NCT01259713|Antifungal Agents|antifungal agents|mesh-ancestor
25627478|NCT01259856|Aspirin|aspirin|mesh-list
25627479|NCT01259856|Interferons|interferons|mesh-list
25627480|NCT01259856|Interferon-alpha|interferon-alpha|mesh-list
25627481|NCT01259856|Interferon alpha-2|interferon alpha-2|mesh-list
25627482|NCT01259856|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25627483|NCT01259856|Hydroxyurea|hydroxyurea|mesh-list
25627484|NCT01259856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25627485|NCT01259856|Antiviral Agents|antiviral agents|mesh-ancestor
25627486|NCT01259856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25627487|NCT01259856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25627488|NCT01259856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25627489|NCT01259856|Analgesics|analgesics|mesh-ancestor
25627490|NCT01259856|Sensory System Agents|sensory system agents|mesh-ancestor
25627491|NCT01259856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25627492|NCT01259856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627493|NCT01259856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25627494|NCT01259856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25627495|NCT01259856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25627496|NCT01259856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25716726|NCT02397954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25627497|NCT01259856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627498|NCT01259856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25627499|NCT01259856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25627500|NCT01259856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627501|NCT01259856|Antipyretics|antipyretics|mesh-ancestor
25627502|NCT01259856|Immunologic Factors|immunologic factors|mesh-ancestor
25627503|NCT01259856|Antisickling Agents|antisickling agents|mesh-ancestor
25627504|NCT01259856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25627505|NCT01260142|Propofol|propofol|mesh-list
25627506|NCT01260142|Fospropofol|fospropofol|mesh-list
25627507|NCT01260142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25627508|NCT01260142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25627509|NCT01260142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627510|NCT01260142|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25627511|NCT01260142|Anesthetics, General|anesthetics, general|mesh-ancestor
25627512|NCT01260142|Anesthetics|anesthetics|mesh-ancestor
25627513|NCT01260181|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25627514|NCT01260181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25627515|NCT01260181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25627516|NCT01260181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627517|NCT01260181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627518|NCT01260194|Trastuzumab|trastuzumab|mesh-list
25627519|NCT01260194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25627520|NCT01260194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25627521|NCT01260311|Fesoterodine|fesoterodine|mesh-list
25627522|NCT01260311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25627523|NCT01260311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25627524|NCT01260311|Cholinergic Agents|cholinergic agents|mesh-ancestor
25627525|NCT01260311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25627526|NCT01260311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627527|NCT01260311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627528|NCT01260311|Urological Agents|urological agents|mesh-ancestor
25627529|NCT01260350|Sofosbuvir|sofosbuvir|mesh-list
25627530|NCT01260350|Antiviral Agents|antiviral agents|mesh-ancestor
25627531|NCT01260350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25627532|NCT01260454|Capsaicin|capsaicin|mesh-list
25627533|NCT01260454|Antipruritics|antipruritics|mesh-ancestor
25627534|NCT01260454|Dermatologic Agents|dermatologic agents|mesh-ancestor
25627535|NCT01260454|Sensory System Agents|sensory system agents|mesh-ancestor
25627536|NCT01260454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25627537|NCT01260454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627538|NCT01260467|Memantine|memantine|mesh-list
25627539|NCT01260467|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25627540|NCT01260467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25627541|NCT01260467|Dopamine Agents|dopamine agents|mesh-ancestor
25627542|NCT01260467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25627543|NCT01260467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627544|NCT01260467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627545|NCT01260467|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24476074|NCT00412763|Protective Agents|protective agents|mesh-ancestor
25627546|NCT01260467|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25627547|NCT01260584|Clopidogrel|clopidogrel|mesh-list
25627548|NCT01260584|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25627549|NCT01260584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25627550|NCT01260584|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25627551|NCT01260584|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25627552|NCT01260584|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25627553|NCT01260584|Purinergic Agents|purinergic agents|mesh-ancestor
25627554|NCT01260584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25627555|NCT01260584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627556|NCT01260584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627557|NCT01260649|Ketamine|ketamine|mesh-list
25627558|NCT01260649|Anesthetics|anesthetics|mesh-list
25627559|NCT01260649|Analgesics|analgesics|mesh-ancestor
25627560|NCT01260649|Sensory System Agents|sensory system agents|mesh-ancestor
25627561|NCT01260649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25627562|NCT01260649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627563|NCT01260649|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25627564|NCT01260649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25627565|NCT01260649|Anesthetics, General|anesthetics, general|mesh-ancestor
25627566|NCT01260649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25627567|NCT01260649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25627568|NCT01260649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25627569|NCT01260649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25627570|NCT01260649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627571|NCT01260662|Ketamine|ketamine|mesh-list
25627572|NCT01260662|Propofol|propofol|mesh-list
25627573|NCT01260662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25627574|NCT01260662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25627575|NCT01260662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627576|NCT01260662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25627577|NCT01260662|Anesthetics, General|anesthetics, general|mesh-ancestor
25627578|NCT01260662|Anesthetics|anesthetics|mesh-ancestor
25627579|NCT01260662|Analgesics|analgesics|mesh-ancestor
25627580|NCT01260662|Sensory System Agents|sensory system agents|mesh-ancestor
25627581|NCT01260662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25627582|NCT01260662|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25627583|NCT01260662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25627584|NCT01260662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25627585|NCT01260662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25627586|NCT01260662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627587|NCT01260688|Dasatinib|dasatinib|mesh-list
25627588|NCT01260688|Cediranib|cediranib|mesh-list
25627589|NCT01260688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25627590|NCT01260688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25627591|NCT01260688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627592|NCT01260688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627593|NCT01260883|Ketorolac|ketorolac|mesh-list
25627594|NCT01260883|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25627595|NCT01260883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25627596|NCT01260883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25627597|NCT01260883|Analgesics|analgesics|mesh-ancestor
25627598|NCT01260883|Sensory System Agents|sensory system agents|mesh-ancestor
25627599|NCT01260883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25627600|NCT01260883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627601|NCT01260883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25627602|NCT01260883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25627603|NCT01260883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25627604|NCT01260883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627605|NCT01260883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627606|NCT01260896|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25627607|NCT01260896|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25627608|NCT01260896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25627609|NCT01260896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25627610|NCT01260896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627611|NCT01260896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25627612|NCT01260896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627613|NCT01260896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25627614|NCT01260896|Antidepressive Agents|antidepressive agents|mesh-ancestor
24426032|NCT00234962|Ritonavir|ritonavir|mesh-list
25627615|NCT01260896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25627616|NCT01260922|Donepezil|donepezil|mesh-list
25627617|NCT01260922|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25627618|NCT01260922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627619|NCT01260922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627620|NCT01260922|Cholinergic Agents|cholinergic agents|mesh-ancestor
25627621|NCT01260922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25627622|NCT01260922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627623|NCT01260922|Nootropic Agents|nootropic agents|mesh-ancestor
25627624|NCT01260948|Donepezil|donepezil|mesh-list
25627625|NCT01260948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25627626|NCT01260948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627627|NCT01260948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627628|NCT01260948|Cholinergic Agents|cholinergic agents|mesh-ancestor
25627629|NCT01260948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25627630|NCT01260948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627631|NCT01260948|Nootropic Agents|nootropic agents|mesh-ancestor
25627632|NCT01261338|Sucrose polyester|sucrose polyester|mesh-list
25627633|NCT01261338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25627634|NCT01261338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25627635|NCT01261338|Antimetabolites|antimetabolites|mesh-ancestor
25627636|NCT01261338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627637|NCT01261338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25655756|NCT01566539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25655757|NCT01566539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655758|NCT01566539|Anticonvulsants|anticonvulsants|mesh-ancestor
25655759|NCT01566539|Antiemetics|antiemetics|mesh-ancestor
25655760|NCT01566539|Autonomic Agents|autonomic agents|mesh-ancestor
25655761|NCT01566539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25655762|NCT01566539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25655763|NCT01566539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25655764|NCT01566539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25655765|NCT01566539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25655766|NCT01566539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25655767|NCT01566539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25655768|NCT01566539|GABA Modulators|gaba modulators|mesh-ancestor
25655769|NCT01566539|GABA Agents|gaba agents|mesh-ancestor
25655770|NCT01566539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24476233|NCT00413686|Gemcitabine|gemcitabine|mesh-list
25655771|NCT01566539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655772|NCT01566539|Hemostatics|hemostatics|mesh-ancestor
25655773|NCT01566539|Coagulants|coagulants|mesh-ancestor
25655774|NCT01566539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25655775|NCT01566539|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25655776|NCT01566539|Natriuretic Agents|natriuretic agents|mesh-ancestor
25655777|NCT01566604|Glycopyrrolate|glycopyrrolate|mesh-list
25655778|NCT01566604|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25655779|NCT01566604|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25655780|NCT01566604|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25655781|NCT01566604|Cholinergic Agents|cholinergic agents|mesh-ancestor
25655782|NCT01566604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25655783|NCT01566604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476590|NCT00415831|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25655784|NCT01566604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655785|NCT01566721|Trastuzumab|trastuzumab|mesh-list
25655786|NCT01566721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25655787|NCT01566721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25655788|NCT01566773|Bromides|bromides|mesh-list
25655789|NCT01566773|Tiotropium Bromide|tiotropium bromide|mesh-list
25655790|NCT01566773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25655791|NCT01566773|Autonomic Agents|autonomic agents|mesh-ancestor
25655792|NCT01566773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25655793|NCT01566773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655794|NCT01566773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25655795|NCT01566773|Respiratory System Agents|respiratory system agents|mesh-ancestor
25655796|NCT01566773|Parasympatholytics|parasympatholytics|mesh-ancestor
25655797|NCT01566773|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25655798|NCT01566773|Cholinergic Agents|cholinergic agents|mesh-ancestor
25655799|NCT01566773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25655800|NCT01566773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655801|NCT01566773|Anticonvulsants|anticonvulsants|mesh-ancestor
25655802|NCT01566838|Bupivacaine|bupivacaine|mesh-list
25655803|NCT01566838|Anesthetics, Local|anesthetics, local|mesh-ancestor
25655804|NCT01566838|Anesthetics|anesthetics|mesh-ancestor
25655805|NCT01566838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25627638|NCT01261793|Epratuzumab|epratuzumab|mesh-list
25627639|NCT01261793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25627640|NCT01261793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25627641|NCT01262092|Buprenorphine|buprenorphine|mesh-list
25627642|NCT01262092|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25627643|NCT01262092|Narcotics|narcotics|mesh-ancestor
25627644|NCT01262092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25627645|NCT01262092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627646|NCT01262092|Analgesics|analgesics|mesh-ancestor
25627647|NCT01262092|Sensory System Agents|sensory system agents|mesh-ancestor
25627648|NCT01262092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25627649|NCT01262092|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25627650|NCT01262118|Tofacitinib|tofacitinib|mesh-list
25627651|NCT01262118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25627652|NCT01262118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477227|NCT00417898|Sensory System Agents|sensory system agents|mesh-ancestor
25627653|NCT01262118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627654|NCT01262287|Dutasteride|dutasteride|mesh-list
25627655|NCT01262287|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25627656|NCT01262287|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25627657|NCT01262287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627658|NCT01262287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627659|NCT01262287|Hormone Antagonists|hormone antagonists|mesh-ancestor
25627660|NCT01262287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25627661|NCT01262287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627662|NCT01262352|Ivacaftor|ivacaftor|mesh-list
25627663|NCT01262352|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25627664|NCT01262352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25627665|NCT01262352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627666|NCT01262365|Epratuzumab|epratuzumab|mesh-list
25627667|NCT01262365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25627668|NCT01262365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25627669|NCT01262456|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25627670|NCT01262456|Hemostatics|hemostatics|mesh-ancestor
25627671|NCT01262456|Coagulants|coagulants|mesh-ancestor
25627672|NCT01262456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25627673|NCT01262456|Natriuretic Agents|natriuretic agents|mesh-ancestor
25627674|NCT01262456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627675|NCT01262638|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
25627676|NCT01262638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25627677|NCT01262638|Antimetabolites|antimetabolites|mesh-ancestor
25627678|NCT01262638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627679|NCT01262638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25627680|NCT01262638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627681|NCT01262638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25627682|NCT01262638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627683|NCT01262651|Nabiximols|nabiximols|mesh-list
25627684|NCT01262651|Analgesics|analgesics|mesh-ancestor
25627685|NCT01262651|Sensory System Agents|sensory system agents|mesh-ancestor
25627686|NCT01262651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25627687|NCT01262651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627688|NCT01262677|Pregabalin|pregabalin|mesh-list
25627689|NCT01262677|Analgesics|analgesics|mesh-ancestor
25627690|NCT01262677|Sensory System Agents|sensory system agents|mesh-ancestor
25627691|NCT01262677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25627692|NCT01262677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627693|NCT01262677|Anticonvulsants|anticonvulsants|mesh-ancestor
25627694|NCT01262677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25627695|NCT01262677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25627696|NCT01262677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627697|NCT01262677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25627698|NCT01262677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25627699|NCT01262677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25627700|NCT01262677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25627701|NCT01262677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25627702|NCT01262872|Vaccines|vaccines|mesh-list
25627703|NCT01262872|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25627704|NCT01262872|Immunologic Factors|immunologic factors|mesh-ancestor
25627705|NCT01262872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627706|NCT01263015|Lamivudine|lamivudine|mesh-list
25627707|NCT01263015|Abacavir|abacavir|mesh-list
25627708|NCT01263015|Dideoxynucleosides|dideoxynucleosides|mesh-list
25627709|NCT01263015|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25627710|NCT01263015|Dolutegravir|dolutegravir|mesh-list
25627711|NCT01263015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25627712|NCT01263015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25627713|NCT01263015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627714|NCT01263015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627715|NCT01263015|Antiviral Agents|antiviral agents|mesh-ancestor
25627716|NCT01263015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25627717|NCT01263015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25627718|NCT01263015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25627719|NCT01263015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25627720|NCT01263015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25627721|NCT01263015|Antimetabolites|antimetabolites|mesh-ancestor
25627722|NCT01263093|Clopidogrel|clopidogrel|mesh-list
25627723|NCT01263093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25627724|NCT01263093|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25627725|NCT01263093|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25627726|NCT01263093|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25627727|NCT01263093|Purinergic Agents|purinergic agents|mesh-ancestor
25627728|NCT01263093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25627729|NCT01263093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627730|NCT01263093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627731|NCT01263106|Theophylline|theophylline|mesh-list
25627732|NCT01263106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25627733|NCT01263106|Autonomic Agents|autonomic agents|mesh-ancestor
25627734|NCT01263106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25627735|NCT01263106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627736|NCT01263106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25627737|NCT01263106|Respiratory System Agents|respiratory system agents|mesh-ancestor
25627738|NCT01263106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25627739|NCT01263106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627740|NCT01263106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627741|NCT01263106|Vasodilator Agents|vasodilator agents|mesh-ancestor
25627742|NCT01263106|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25627743|NCT01263106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25627744|NCT01263106|Purinergic Agents|purinergic agents|mesh-ancestor
25627745|NCT01263106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25627746|NCT01263119|Warfarin|warfarin|mesh-list
25627747|NCT01263119|Anticoagulants|anticoagulants|mesh-ancestor
25627748|NCT01263132|Thiamine|thiamine|mesh-list
25627749|NCT01263132|Vitamin B 12|vitamin b 12|mesh-list
25627750|NCT01263132|Gabapentin|gabapentin|mesh-list
25627751|NCT01263132|Analgesics|analgesics|mesh-ancestor
25627752|NCT01263132|Sensory System Agents|sensory system agents|mesh-ancestor
25627753|NCT01263132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25627754|NCT01263132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627755|NCT01263132|Anticonvulsants|anticonvulsants|mesh-ancestor
25627756|NCT01263132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25627757|NCT01263132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25627758|NCT01263132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25627759|NCT01263132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25627760|NCT01263132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25627761|NCT01263132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25627762|NCT01263132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25627763|NCT01263132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627764|NCT01263132|Antimanic Agents|antimanic agents|mesh-ancestor
25627765|NCT01263132|Vitamin B Complex|vitamin b complex|mesh-ancestor
25627766|NCT01263132|Vitamins|vitamins|mesh-ancestor
25627767|NCT01263132|Micronutrients|micronutrients|mesh-ancestor
25627768|NCT01263197|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
25627769|NCT01263197|Propranolol|propranolol|mesh-list
25627770|NCT01263197|Albuterol|albuterol|mesh-list
25627771|NCT01263197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25627772|NCT01263197|Autonomic Agents|autonomic agents|mesh-ancestor
25627773|NCT01263197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25627774|NCT01263197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627775|NCT01263197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25627776|NCT01263197|Respiratory System Agents|respiratory system agents|mesh-ancestor
25627777|NCT01263197|Tocolytic Agents|tocolytic agents|mesh-ancestor
25627778|NCT01263197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25627779|NCT01263197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25627780|NCT01263197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25627781|NCT01263197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25627782|NCT01263197|Adrenergic Agents|adrenergic agents|mesh-ancestor
25627783|NCT01263197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25627784|NCT01263197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522376|NCT00468585|Antimetabolites|antimetabolites|mesh-ancestor
25627786|NCT01263197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25627787|NCT01263197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25627788|NCT01263197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25627789|NCT01263197|Vasodilator Agents|vasodilator agents|mesh-ancestor
25627790|NCT01263197|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25627791|NCT01263197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25627792|NCT01263197|Disinfectants|disinfectants|mesh-ancestor
25627793|NCT01263444|Timolol|timolol|mesh-list
25627794|NCT01263444|Bimatoprost|bimatoprost|mesh-list
25627795|NCT01263444|Travoprost|travoprost|mesh-list
25627796|NCT01263444|Latanoprost|latanoprost|mesh-list
25627797|NCT01263444|Brinzolamide|brinzolamide|mesh-list
25627798|NCT01263444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25627799|NCT01263444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25627800|NCT01263444|Adrenergic Agents|adrenergic agents|mesh-ancestor
25627801|NCT01263444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25627802|NCT01263444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627803|NCT01263444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627804|NCT01263444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25627805|NCT01263444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25627806|NCT01263444|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25627807|NCT01263444|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25627808|NCT01263444|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25627809|NCT01263444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627810|NCT01263470|Alogliptin|alogliptin|mesh-list
25627811|NCT01263470|Voglibose|voglibose|mesh-list
25627812|NCT01263470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25627813|NCT01263470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627814|NCT01263470|Incretins|incretins|mesh-ancestor
25627815|NCT01263470|Hormones|hormones|mesh-ancestor
25627816|NCT01263470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25627817|NCT01263470|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25627818|NCT01263470|Protease Inhibitors|protease inhibitors|mesh-ancestor
25627819|NCT01263470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627820|NCT01263470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627821|NCT01263470|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25627822|NCT01263483|Inositol|inositol|mesh-list
25627823|NCT01263483|Alogliptin|alogliptin|mesh-list
25627824|NCT01263483|Voglibose|voglibose|mesh-list
25627825|NCT01263483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25627826|NCT01263483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627827|NCT01263483|Incretins|incretins|mesh-ancestor
25627828|NCT01263483|Hormones|hormones|mesh-ancestor
25627829|NCT01263483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25627830|NCT01263483|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25627831|NCT01263483|Protease Inhibitors|protease inhibitors|mesh-ancestor
25627832|NCT01263483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627833|NCT01263483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627834|NCT01263483|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25627835|NCT01263483|Vitamin B Complex|vitamin b complex|mesh-ancestor
25627836|NCT01263483|Vitamins|vitamins|mesh-ancestor
25627837|NCT01263483|Micronutrients|micronutrients|mesh-ancestor
25627838|NCT01263496|Alogliptin|alogliptin|mesh-list
25627839|NCT01263496|Voglibose|voglibose|mesh-list
25627840|NCT01263496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25627841|NCT01263496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627842|NCT01263496|Incretins|incretins|mesh-ancestor
25627843|NCT01263496|Hormones|hormones|mesh-ancestor
25627844|NCT01263496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25627845|NCT01263496|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25627846|NCT01263496|Protease Inhibitors|protease inhibitors|mesh-ancestor
25627847|NCT01263496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627848|NCT01263496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627849|NCT01263496|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25627850|NCT01263509|Inositol|inositol|mesh-list
25627851|NCT01263509|Alogliptin|alogliptin|mesh-list
25627852|NCT01263509|Voglibose|voglibose|mesh-list
25627853|NCT01263509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25627854|NCT01263509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627855|NCT01263509|Incretins|incretins|mesh-ancestor
25627856|NCT01263509|Hormones|hormones|mesh-ancestor
25499155|NCT00743197|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25627857|NCT01263509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25627858|NCT01263509|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25627859|NCT01263509|Protease Inhibitors|protease inhibitors|mesh-ancestor
25627860|NCT01263509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627861|NCT01263509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627862|NCT01263509|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25627863|NCT01263509|Vitamin B Complex|vitamin b complex|mesh-ancestor
25627864|NCT01263509|Vitamins|vitamins|mesh-ancestor
25627865|NCT01263509|Micronutrients|micronutrients|mesh-ancestor
25627866|NCT01263691|Vaccines|vaccines|mesh-list
25627867|NCT01263691|Immunologic Factors|immunologic factors|mesh-ancestor
25627868|NCT01263691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627869|NCT01263704|Cyclophosphamide|cyclophosphamide|mesh-list
25627870|NCT01263704|Rituximab|rituximab|mesh-list
25627871|NCT01263704|Fludarabine|fludarabine|mesh-list
25627872|NCT01263704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25627873|NCT01263704|Immunologic Factors|immunologic factors|mesh-ancestor
25627874|NCT01263704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627875|NCT01263704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25627876|NCT01263704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25627877|NCT01263704|Alkylating Agents|alkylating agents|mesh-ancestor
25627878|NCT01263704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627879|NCT01263704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25627880|NCT01263704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24480629|NCT00431418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627881|NCT01263704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25627882|NCT01263717|Hormones|hormones|mesh-list
25627883|NCT01263717|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
25627884|NCT01263717|Tesamorelin|tesamorelin|mesh-list
25627885|NCT01263717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25627886|NCT01263717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627887|NCT01263717|Growth Substances|growth substances|mesh-ancestor
25627888|NCT01263782|Bevacizumab|bevacizumab|mesh-list
25627889|NCT01263782|Carboplatin|carboplatin|mesh-list
25627890|NCT01263782|Pemetrexed|pemetrexed|mesh-list
25627891|NCT01263782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25627892|NCT01263782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25627893|NCT01263782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25627894|NCT01263782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25627895|NCT01263782|Growth Substances|growth substances|mesh-ancestor
25627896|NCT01263782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627897|NCT01263782|Growth Inhibitors|growth inhibitors|mesh-ancestor
25627898|NCT01263782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627899|NCT01263782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627900|NCT01263782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25627901|NCT01263782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25627902|NCT01263925|Pentoxifylline|pentoxifylline|mesh-list
25627903|NCT01263925|Alprostadil|alprostadil|mesh-list
25627904|NCT01263925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25627905|NCT01263925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627906|NCT01263925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627907|NCT01263925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25627908|NCT01263925|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25627909|NCT01263925|Protective Agents|protective agents|mesh-ancestor
25627910|NCT01263925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627911|NCT01263925|Vasodilator Agents|vasodilator agents|mesh-ancestor
25627912|NCT01263925|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25627913|NCT01263925|Antioxidants|antioxidants|mesh-ancestor
25627914|NCT01263925|Urological Agents|urological agents|mesh-ancestor
25627915|NCT01263938|Atorvastatin|atorvastatin|mesh-list
25627916|NCT01263938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25627917|NCT01263938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25627918|NCT01263938|Antimetabolites|antimetabolites|mesh-ancestor
25627919|NCT01263938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627920|NCT01263938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25627921|NCT01263938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25627922|NCT01263938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627923|NCT01264081|Lapatinib|lapatinib|mesh-list
25627924|NCT01264081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25627925|NCT01264081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25627926|NCT01264081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627927|NCT01264081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627928|NCT01264705|Sorafenib|sorafenib|mesh-list
25627929|NCT01264705|Bavituximab|bavituximab|mesh-list
25627930|NCT01264705|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25627931|NCT01264705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25627932|NCT01264705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25627933|NCT01264705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25627934|NCT01264705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627935|NCT01264705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25627936|NCT01264705|Immunologic Factors|immunologic factors|mesh-ancestor
25627937|NCT01264705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627938|NCT01264770|Adalimumab|adalimumab|mesh-list
25627939|NCT01264770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25627940|NCT01264770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25627941|NCT01264887|Tapentadol|tapentadol|mesh-list
25627942|NCT01264887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25627943|NCT01264887|Narcotics|narcotics|mesh-ancestor
25627944|NCT01264887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25627945|NCT01264887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627946|NCT01264887|Analgesics|analgesics|mesh-ancestor
25627947|NCT01264887|Sensory System Agents|sensory system agents|mesh-ancestor
25627948|NCT01264887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25627949|NCT01264887|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25627950|NCT01264887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25627951|NCT01264887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25627952|NCT01264887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627953|NCT01264887|Adrenergic Agents|adrenergic agents|mesh-ancestor
25627954|NCT01264887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25627955|NCT01264939|Omalizumab|omalizumab|mesh-list
25627956|NCT01264939|Diphenhydramine|diphenhydramine|mesh-list
25627957|NCT01264939|Promethazine|promethazine|mesh-list
25627958|NCT01264939|Leukotriene Antagonists|leukotriene antagonists|mesh-list
25627959|NCT01264939|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25627960|NCT01264939|Histamine Antagonists|histamine antagonists|mesh-list
25627961|NCT01264939|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25627962|NCT01264939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25627963|NCT01264939|Respiratory System Agents|respiratory system agents|mesh-ancestor
25627964|NCT01264939|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25627965|NCT01264939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25627966|NCT01264939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25627967|NCT01264939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627968|NCT01264939|Anesthetics, Local|anesthetics, local|mesh-ancestor
25627969|NCT01264939|Anesthetics|anesthetics|mesh-ancestor
25627970|NCT01264939|Sensory System Agents|sensory system agents|mesh-ancestor
25627971|NCT01264939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25627972|NCT01264939|Antiemetics|antiemetics|mesh-ancestor
25627973|NCT01264939|Autonomic Agents|autonomic agents|mesh-ancestor
25627974|NCT01264939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25627975|NCT01264939|Histamine Agents|histamine agents|mesh-ancestor
25627976|NCT01264939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25627977|NCT01264939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627978|NCT01264939|Antipruritics|antipruritics|mesh-ancestor
25627979|NCT01264939|Dermatologic Agents|dermatologic agents|mesh-ancestor
25627980|NCT01264939|Hormone Antagonists|hormone antagonists|mesh-ancestor
25627981|NCT01264939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25627982|NCT01265056|Gabapentin|gabapentin|mesh-list
25627983|NCT01265056|Analgesics|analgesics|mesh-ancestor
25627984|NCT01265056|Sensory System Agents|sensory system agents|mesh-ancestor
25627985|NCT01265056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25627986|NCT01265056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25627987|NCT01265056|Anticonvulsants|anticonvulsants|mesh-ancestor
25627988|NCT01265056|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25627989|NCT01265056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24482305|NCT00438568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25627990|NCT01265056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25627991|NCT01265056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25627992|NCT01265056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25627993|NCT01265056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25627994|NCT01265056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25627995|NCT01265056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25627996|NCT01265056|Antimanic Agents|antimanic agents|mesh-ancestor
25627997|NCT01265394|Flutemetamol|flutemetamol|mesh-list
25627998|NCT01265394|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25627999|NCT01265394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628000|NCT01265446|Lidocaine|lidocaine|mesh-list
25628001|NCT01265446|Anesthetics, Local|anesthetics, local|mesh-ancestor
25628002|NCT01265446|Anesthetics|anesthetics|mesh-ancestor
25628003|NCT01265446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25628004|NCT01265446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628005|NCT01265446|Sensory System Agents|sensory system agents|mesh-ancestor
25628006|NCT01265446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25628007|NCT01265446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25628008|NCT01265446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25628009|NCT01265446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25628010|NCT01265446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25628011|NCT01265446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628012|NCT01265498|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
25628013|NCT01265498|Cathartics|cathartics|mesh-ancestor
25628014|NCT01265498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25628015|NCT01265511|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25628016|NCT01265511|Antiviral Agents|antiviral agents|mesh-ancestor
25628017|NCT01265511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25628018|NCT01265537|Tacrolimus|tacrolimus|mesh-list
25628019|NCT01265537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25628020|NCT01265537|Immunologic Factors|immunologic factors|mesh-ancestor
25628021|NCT01265537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628022|NCT01265537|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25628023|NCT01265537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628024|NCT01265537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628025|NCT01265550|Baclofen|baclofen|mesh-list
25628026|NCT01265550|Desipramine|desipramine|mesh-list
25628027|NCT01265550|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25628028|NCT01265550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628029|NCT01265550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25628030|NCT01265550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25628031|NCT01265550|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25628032|NCT01265550|GABA Agonists|gaba agonists|mesh-ancestor
25628033|NCT01265550|GABA Agents|gaba agents|mesh-ancestor
25628034|NCT01265550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25628035|NCT01265550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628036|NCT01265550|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25628037|NCT01265550|Antidepressive Agents|antidepressive agents|mesh-ancestor
25628038|NCT01265550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25628039|NCT01265550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628040|NCT01265550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24482885|NCT00440869|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25628041|NCT01265550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25628042|NCT01265550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25628043|NCT01265550|Adrenergic Agents|adrenergic agents|mesh-ancestor
25628044|NCT01265563|Acetylcysteine|acetylcysteine|mesh-list
25628045|NCT01265563|Silybin|silybin|mesh-list
25628046|NCT01265563|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25628047|NCT01265563|Antiviral Agents|antiviral agents|mesh-ancestor
25628048|NCT01265563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25628049|NCT01265563|Expectorants|expectorants|mesh-ancestor
25628050|NCT01265563|Respiratory System Agents|respiratory system agents|mesh-ancestor
25628051|NCT01265563|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25628052|NCT01265563|Antioxidants|antioxidants|mesh-ancestor
25628053|NCT01265563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628054|NCT01265563|Protective Agents|protective agents|mesh-ancestor
25628055|NCT01265563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628056|NCT01265563|Antidotes|antidotes|mesh-ancestor
25628057|NCT01265563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25628058|NCT01265563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628059|NCT01265615|Cholecalciferol|cholecalciferol|mesh-list
25628060|NCT01265615|Vitamin D|vitamin d|mesh-list
25628061|NCT01265615|Calcitriol|calcitriol|mesh-list
25628062|NCT01265615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25628063|NCT01265615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628064|NCT01265615|Vitamins|vitamins|mesh-ancestor
25628065|NCT01265615|Micronutrients|micronutrients|mesh-ancestor
25628066|NCT01265615|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25628067|NCT01265615|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25628068|NCT01265615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25628069|NCT01265615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628070|NCT01265615|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25628071|NCT01265823|Adalimumab|adalimumab|mesh-list
25628072|NCT01265823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25628073|NCT01265823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25628074|NCT01265875|Secretin|secretin|mesh-list
25628075|NCT01265875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25628076|NCT01265875|Hormones|hormones|mesh-ancestor
25628077|NCT01265875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25628078|NCT01265875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628079|NCT01265953|Sulforaphane|sulforaphane|mesh-list
25628080|NCT01265953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25628081|NCT01265953|Protective Agents|protective agents|mesh-ancestor
25628082|NCT01265953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628083|NCT01265953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628084|NCT01266148|Cyclosporine|cyclosporine|mesh-list
25628085|NCT01266148|Mycophenolic Acid|mycophenolic acid|mesh-list
25628086|NCT01266148|Everolimus|everolimus|mesh-list
25628087|NCT01266148|Cyclosporins|cyclosporins|mesh-list
25628088|NCT01266148|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25628089|NCT01266148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628090|NCT01266148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628091|NCT01266148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25628092|NCT01266148|Immunologic Factors|immunologic factors|mesh-ancestor
25628093|NCT01266148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628094|NCT01266148|Antifungal Agents|antifungal agents|mesh-ancestor
25628095|NCT01266148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25628096|NCT01266148|Dermatologic Agents|dermatologic agents|mesh-ancestor
25628097|NCT01266148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25628098|NCT01266148|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25628099|NCT01266148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628100|NCT01266148|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25628101|NCT01266148|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25628102|NCT01266148|Antitubercular Agents|antitubercular agents|mesh-ancestor
25628103|NCT01266148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25628104|NCT01266161|Ibuprofen|ibuprofen|mesh-list
25628105|NCT01266161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24483717|NCT00444652|Enoxaparin|enoxaparin|mesh-list
25628106|NCT01266161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25628107|NCT01266161|Analgesics|analgesics|mesh-ancestor
25628108|NCT01266161|Sensory System Agents|sensory system agents|mesh-ancestor
25628109|NCT01266161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25628110|NCT01266161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628111|NCT01266161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25628112|NCT01266161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25628113|NCT01266161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25628114|NCT01266161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628115|NCT01266161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628116|NCT01266265|Treprostinil|treprostinil|mesh-list
25628117|NCT01266265|Bosentan|bosentan|mesh-list
25628118|NCT01266265|Ambrisentan|ambrisentan|mesh-list
25628119|NCT01266265|Epoprostenol|epoprostenol|mesh-list
25628120|NCT01266265|Sildenafil Citrate|sildenafil citrate|mesh-list
25628121|NCT01266265|Tadalafil|tadalafil|mesh-list
25628122|NCT01266265|Iloprost|iloprost|mesh-list
25628123|NCT01266265|Tezosentan|tezosentan|mesh-list
25628124|NCT01266265|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
25628125|NCT01266265|Vasodilator Agents|vasodilator agents|mesh-ancestor
25628126|NCT01266265|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25628127|NCT01266265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628128|NCT01266265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628129|NCT01266265|Urological Agents|urological agents|mesh-ancestor
25628130|NCT01266265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25628131|NCT01266265|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25628132|NCT01266265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25628133|NCT01266291|Vigabatrin|vigabatrin|mesh-list
25628134|NCT01266291|Anticonvulsants|anticonvulsants|mesh-ancestor
25628135|NCT01266291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484250|NCT00447356|Interferons|interferons|mesh-list
25628136|NCT01266291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628137|NCT01266291|GABA Agents|gaba agents|mesh-ancestor
25628138|NCT01266291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25628139|NCT01266291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628140|NCT01266317|Rituximab|rituximab|mesh-list
25628141|NCT01266317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25628142|NCT01266317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628143|NCT01266317|Immunologic Factors|immunologic factors|mesh-ancestor
25628144|NCT01266317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628145|NCT01266317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25628146|NCT01266447|Topotecan|topotecan|mesh-list
25628147|NCT01266447|Veliparib|veliparib|mesh-list
25628148|NCT01266447|Lenograstim|lenograstim|mesh-list
25628149|NCT01266447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25628150|NCT01266447|Immunologic Factors|immunologic factors|mesh-ancestor
25628151|NCT01266447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628152|NCT01266447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25628153|NCT01266447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25628154|NCT01266447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628155|NCT01266447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628156|NCT01266447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628157|NCT01266447|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25628158|NCT01266460|Vaccines|vaccines|mesh-list
25628159|NCT01266460|Immunologic Factors|immunologic factors|mesh-ancestor
25628160|NCT01266460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628161|NCT01266590|Digoxin|digoxin|mesh-list
25628162|NCT01266590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25628163|NCT01266590|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25628164|NCT01266590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628165|NCT01266590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628166|NCT01266590|Protective Agents|protective agents|mesh-ancestor
25628167|NCT01266590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628168|NCT01266603|Aldesleukin|aldesleukin|mesh-list
25628169|NCT01266603|Interleukin-2|interleukin-2|mesh-list
25628170|NCT01266603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628171|NCT01266603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25628172|NCT01266603|Analgesics|analgesics|mesh-ancestor
25628173|NCT01266603|Sensory System Agents|sensory system agents|mesh-ancestor
25628174|NCT01266603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25628175|NCT01266603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628176|NCT01266603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25628177|NCT01266603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25628178|NCT01266603|Antiviral Agents|antiviral agents|mesh-ancestor
25628179|NCT01266603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25655806|NCT01566838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655807|NCT01566838|Sensory System Agents|sensory system agents|mesh-ancestor
25655808|NCT01566838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25655809|NCT01567085|Eculizumab|eculizumab|mesh-list
25655810|NCT01567085|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25655811|NCT01567085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25655812|NCT01567085|Immunologic Factors|immunologic factors|mesh-ancestor
25655813|NCT01567085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655814|NCT01567163|Docetaxel|docetaxel|mesh-list
25655815|NCT01567163|Ramucirumab|ramucirumab|mesh-list
25655816|NCT01567163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25655817|NCT01567163|Tubulin Modulators|tubulin modulators|mesh-ancestor
25655818|NCT01567163|Antimitotic Agents|antimitotic agents|mesh-ancestor
25655819|NCT01567163|Mitosis Modulators|mitosis modulators|mesh-ancestor
25655820|NCT01567163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655821|NCT01567527|Aripiprazole|aripiprazole|mesh-list
25655822|NCT01567527|Antidepressive Agents|antidepressive agents|mesh-ancestor
25655823|NCT01567527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25655824|NCT01567527|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25655825|NCT01567527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25655826|NCT01567527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25655827|NCT01567527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655828|NCT01567527|Dopamine Agonists|dopamine agonists|mesh-ancestor
25655829|NCT01567527|Dopamine Agents|dopamine agents|mesh-ancestor
25655830|NCT01567527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25655831|NCT01567527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655832|NCT01567527|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25655833|NCT01567527|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25655834|NCT01567527|Serotonin Agents|serotonin agents|mesh-ancestor
25655835|NCT01567527|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25655836|NCT01567527|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25655837|NCT01567527|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25655838|NCT01567527|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25655839|NCT01567826|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25655840|NCT01567826|Atorvastatin|atorvastatin|mesh-list
25655841|NCT01567826|Simvastatin|simvastatin|mesh-list
25655842|NCT01567826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25655843|NCT01567826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25655844|NCT01567826|Antimetabolites|antimetabolites|mesh-ancestor
25655845|NCT01567826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655846|NCT01567826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25655847|NCT01567826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25655848|NCT01567826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655849|NCT01567852|Ketamine|ketamine|mesh-list
25655850|NCT01567852|Methohexital|methohexital|mesh-list
25655851|NCT01567852|Analgesics|analgesics|mesh-ancestor
25655852|NCT01567852|Sensory System Agents|sensory system agents|mesh-ancestor
25655853|NCT01567852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25655854|NCT01567852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655855|NCT01567852|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25655856|NCT01567852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25655857|NCT01567852|Anesthetics, General|anesthetics, general|mesh-ancestor
25655858|NCT01567852|Anesthetics|anesthetics|mesh-ancestor
25655859|NCT01567852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25655860|NCT01567852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25655861|NCT01567852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25655862|NCT01567852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25628180|NCT01266902|Rilpivirine|rilpivirine|mesh-list
25628181|NCT01266902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25628182|NCT01266902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25628183|NCT01266902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628184|NCT01266902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628185|NCT01266902|Antiviral Agents|antiviral agents|mesh-ancestor
25628186|NCT01266902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25628187|NCT01266902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25628188|NCT01266902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25628189|NCT01266967|Dabrafenib|dabrafenib|mesh-list
25628190|NCT01266967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628191|NCT01266967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25628192|NCT01266967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628193|NCT01266967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628194|NCT01267136|Acetaminophen|acetaminophen|mesh-list
25628195|NCT01267136|Tramadol|tramadol|mesh-list
25628196|NCT01267136|Codeine|codeine|mesh-list
25628197|NCT01267136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25628198|NCT01267136|Analgesics|analgesics|mesh-ancestor
25628199|NCT01267136|Sensory System Agents|sensory system agents|mesh-ancestor
25628200|NCT01267136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25628201|NCT01267136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628202|NCT01267136|Antipyretics|antipyretics|mesh-ancestor
25628203|NCT01267136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24487081|NCT00461578|Artesunate|artesunate|mesh-list
25628204|NCT01267136|Narcotics|narcotics|mesh-ancestor
25628205|NCT01267136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25628206|NCT01267136|Antitussive Agents|antitussive agents|mesh-ancestor
25628207|NCT01267136|Respiratory System Agents|respiratory system agents|mesh-ancestor
25628208|NCT01267175|Insulin|insulin|mesh-list
25628209|NCT01267175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25628210|NCT01267175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628211|NCT01267201|Methylprednisolone|methylprednisolone|mesh-list
25628212|NCT01267201|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25628213|NCT01267201|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25628214|NCT01267201|Prednisolone|prednisolone|mesh-list
25628215|NCT01267201|Prednisolone acetate|prednisolone acetate|mesh-list
25628216|NCT01267201|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25628217|NCT01267201|Prednisolone phosphate|prednisolone phosphate|mesh-list
25628218|NCT01267201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25628219|NCT01267201|Antiemetics|antiemetics|mesh-ancestor
25628220|NCT01267201|Autonomic Agents|autonomic agents|mesh-ancestor
25628221|NCT01267201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25628222|NCT01267201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628223|NCT01267201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25628224|NCT01267201|Glucocorticoids|glucocorticoids|mesh-ancestor
25628225|NCT01267201|Hormones|hormones|mesh-ancestor
25628226|NCT01267201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25628227|NCT01267201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25628228|NCT01267201|Protective Agents|protective agents|mesh-ancestor
25628229|NCT01267201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25628230|NCT01267201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628231|NCT01267240|Capecitabine|capecitabine|mesh-list
25628232|NCT01267240|Vorinostat|vorinostat|mesh-list
25628233|NCT01267240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25628234|NCT01267240|Antimetabolites|antimetabolites|mesh-ancestor
25628235|NCT01267240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628236|NCT01267240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628237|NCT01267240|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25628238|NCT01267240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628239|NCT01267266|Hydrocortisone|hydrocortisone|mesh-list
25628240|NCT01267266|Saracatinib|saracatinib|mesh-list
25628241|NCT01267266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25628242|NCT01267266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628243|NCT01267266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628244|NCT01267266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628245|NCT01267279|Zoledronic Acid|zoledronic acid|mesh-list
25628246|NCT01267279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25628247|NCT01267279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628248|NCT01267292|Buspirone|buspirone|mesh-list
25628249|NCT01267292|Methylphenidate|methylphenidate|mesh-list
25628250|NCT01267292|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25628251|NCT01267292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628252|NCT01267292|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25628253|NCT01267292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25522871|NCT00472641|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25628254|NCT01267292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25628255|NCT01267292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628257|NCT01267292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25628258|NCT01267292|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25628259|NCT01267292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25628260|NCT01267292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25628261|NCT01267292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25628262|NCT01267292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25628263|NCT01267292|Serotonin Agents|serotonin agents|mesh-ancestor
25628264|NCT01267656|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25628265|NCT01267656|Lubricant Eye Drops|lubricant eye drops|mesh-list
25628266|NCT01267656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25628267|NCT01267864|Ketorolac|ketorolac|mesh-list
25628268|NCT01267864|Valproic Acid|valproic acid|mesh-list
25628269|NCT01267864|Metoclopramide|metoclopramide|mesh-list
24488176|NCT00466999|Misoprostol|misoprostol|mesh-list
25628270|NCT01267864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25628271|NCT01267864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25628272|NCT01267864|Analgesics|analgesics|mesh-ancestor
25628273|NCT01267864|Sensory System Agents|sensory system agents|mesh-ancestor
25628274|NCT01267864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25628275|NCT01267864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628276|NCT01267864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25628277|NCT01267864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25628278|NCT01267864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25628279|NCT01267864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628280|NCT01267864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628281|NCT01267864|Anticonvulsants|anticonvulsants|mesh-ancestor
25628282|NCT01267864|GABA Agents|gaba agents|mesh-ancestor
25628283|NCT01267864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25628284|NCT01267864|Antimanic Agents|antimanic agents|mesh-ancestor
25628285|NCT01267864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25628286|NCT01267864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25628287|NCT01267864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24488901|NCT00470522|Folic Acid|folic acid|mesh-list
24489318|NCT00472355|Emetics|emetics|mesh-ancestor
25628288|NCT01267864|Antiemetics|antiemetics|mesh-ancestor
25628289|NCT01267864|Autonomic Agents|autonomic agents|mesh-ancestor
25628290|NCT01267864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25628291|NCT01267864|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25628292|NCT01267864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25628293|NCT01267864|Dopamine Agents|dopamine agents|mesh-ancestor
25628294|NCT01267994|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25628295|NCT01267994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25628296|NCT01268046|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24441307|NCT00287157|Tizanidine|tizanidine|mesh-list
25628297|NCT01268046|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25628298|NCT01268046|Estradiol|estradiol|mesh-list
25628299|NCT01268046|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25628300|NCT01268046|Estrogens|estrogens|mesh-list
25628301|NCT01268046|Hormones|hormones|mesh-ancestor
25628302|NCT01268046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25628303|NCT01268046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628304|NCT01268046|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25628305|NCT01268046|Contraceptive Agents|contraceptive agents|mesh-ancestor
25628306|NCT01268046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25628307|NCT01268046|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25628308|NCT01268059|Paclitaxel|paclitaxel|mesh-list
25628309|NCT01268059|Carboplatin|carboplatin|mesh-list
25628310|NCT01268059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25628311|NCT01268059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628312|NCT01268059|Tubulin Modulators|tubulin modulators|mesh-ancestor
25628313|NCT01268059|Antimitotic Agents|antimitotic agents|mesh-ancestor
25628314|NCT01268059|Mitosis Modulators|mitosis modulators|mesh-ancestor
25628315|NCT01268059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628316|NCT01268111|Ergocalciferols|ergocalciferols|mesh-list
25628317|NCT01268111|Vitamin D|vitamin d|mesh-list
25628318|NCT01268111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25628319|NCT01268111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628320|NCT01268111|Vitamins|vitamins|mesh-ancestor
25628321|NCT01268111|Micronutrients|micronutrients|mesh-ancestor
25628322|NCT01268111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25628323|NCT01268293|Lenvatinib|lenvatinib|mesh-list
25628324|NCT01268293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628325|NCT01268293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25628326|NCT01268293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628327|NCT01268293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628328|NCT01268527|Calcipotriene|calcipotriene|mesh-list
25628329|NCT01268527|Dermatologic Agents|dermatologic agents|mesh-ancestor
25628330|NCT01268553|Treprostinil|treprostinil|mesh-list
25628331|NCT01268553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25628332|NCT01268683|Glyburide|glyburide|mesh-list
25628333|NCT01268683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25628334|NCT01268683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628335|NCT01268891|Rasagiline|rasagiline|mesh-list
25628336|NCT01268891|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25628337|NCT01268891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492915|NCT00488605|Dermatologic Agents|dermatologic agents|mesh-ancestor
25628338|NCT01268891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628339|NCT01268891|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25628340|NCT01268891|Protective Agents|protective agents|mesh-ancestor
25628341|NCT01268891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628342|NCT01268943|Capecitabine|capecitabine|mesh-list
25628343|NCT01268943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25628344|NCT01268943|Antimetabolites|antimetabolites|mesh-ancestor
25628345|NCT01268943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628346|NCT01268943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628347|NCT01269047|Exenatide|exenatide|mesh-list
25628348|NCT01269047|Pramlintide|pramlintide|mesh-list
25628349|NCT01269047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25628350|NCT01269047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628351|NCT01269047|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25628352|NCT01269047|Incretins|incretins|mesh-ancestor
25628353|NCT01269047|Hormones|hormones|mesh-ancestor
25628354|NCT01269047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25628355|NCT01269125|Leuprolide|leuprolide|mesh-list
25628356|NCT01269125|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25628357|NCT01269125|Fertility Agents|fertility agents|mesh-ancestor
25628358|NCT01269125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25628359|NCT01269125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628360|NCT01269125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25628361|NCT01269125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628362|NCT01269385|Rituximab|rituximab|mesh-list
25628363|NCT01269385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25628364|NCT01269385|Alemtuzumab|alemtuzumab|mesh-list
25628365|NCT01269385|Antibodies|antibodies|mesh-list
25628366|NCT01269385|Immunoglobulins|immunoglobulins|mesh-list
25628367|NCT01269385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25628368|NCT01269385|Immunologic Factors|immunologic factors|mesh-ancestor
25628369|NCT01269385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628370|NCT01269385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628371|NCT01269385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25628372|NCT01269801|Botulinum Toxins|botulinum toxins|mesh-list
25628373|NCT01269801|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25628374|NCT01269801|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25628375|NCT01269801|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25628376|NCT01269801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25628377|NCT01269801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628378|NCT01269801|Cholinergic Agents|cholinergic agents|mesh-ancestor
25628379|NCT01269801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25628380|NCT01269801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628381|NCT01269801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25628382|NCT01269801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25628383|NCT01269918|Dexmedetomidine|dexmedetomidine|mesh-list
25628384|NCT01269918|Remifentanil|remifentanil|mesh-list
25628385|NCT01269918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25628386|NCT01269918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25628387|NCT01269918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628388|NCT01269918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25628389|NCT01269918|Analgesics|analgesics|mesh-ancestor
25628390|NCT01269918|Sensory System Agents|sensory system agents|mesh-ancestor
25628391|NCT01269918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25628392|NCT01269918|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25628393|NCT01269918|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25628394|NCT01269918|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25628395|NCT01269918|Adrenergic Agents|adrenergic agents|mesh-ancestor
25628396|NCT01269918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25628397|NCT01269918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628398|NCT01269918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25628399|NCT01269918|Narcotics|narcotics|mesh-ancestor
25628400|NCT01270256|Budesonide|budesonide|mesh-list
25628401|NCT01270256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25628402|NCT01270256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25628403|NCT01270256|Autonomic Agents|autonomic agents|mesh-ancestor
25628404|NCT01270256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25628405|NCT01270256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628406|NCT01270256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24501266|NCT00527761|Antimitotic Agents|antimitotic agents|mesh-ancestor
25628407|NCT01270256|Respiratory System Agents|respiratory system agents|mesh-ancestor
25628408|NCT01270256|Glucocorticoids|glucocorticoids|mesh-ancestor
25628409|NCT01270256|Hormones|hormones|mesh-ancestor
25628410|NCT01270256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25628411|NCT01270321|Everolimus|everolimus|mesh-list
25628412|NCT01270321|Pasireotide|pasireotide|mesh-list
25628413|NCT01270321|Somatostatin|somatostatin|mesh-list
25628414|NCT01270321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628415|NCT01270321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25628416|NCT01270321|Immunologic Factors|immunologic factors|mesh-ancestor
25628417|NCT01270321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628418|NCT01270321|Hormones|hormones|mesh-ancestor
25628419|NCT01270321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25628420|NCT01270464|Reslizumab|reslizumab|mesh-list
25628421|NCT01270464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25628422|NCT01270464|Respiratory System Agents|respiratory system agents|mesh-ancestor
25628423|NCT01270542|Bevacizumab|bevacizumab|mesh-list
25628424|NCT01270542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25628425|NCT01270542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628426|NCT01270542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25628427|NCT01270542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25628428|NCT01270542|Growth Substances|growth substances|mesh-ancestor
25628429|NCT01270542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628430|NCT01270542|Growth Inhibitors|growth inhibitors|mesh-ancestor
25628431|NCT01270555|Bupropion|bupropion|mesh-list
25628432|NCT01270555|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25628433|NCT01270555|Antidepressive Agents|antidepressive agents|mesh-ancestor
25628434|NCT01270555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25628435|NCT01270555|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25628436|NCT01270555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25628437|NCT01270555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25628438|NCT01270555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628439|NCT01270555|Dopamine Agents|dopamine agents|mesh-ancestor
25628440|NCT01270555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25628441|NCT01270555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628442|NCT01270555|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25628443|NCT01270555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25628444|NCT01270555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628445|NCT01270620|Propofol|propofol|mesh-list
25628446|NCT01270620|Desflurane|desflurane|mesh-list
25628447|NCT01270620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25628448|NCT01270620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25628449|NCT01270620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628450|NCT01270620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25628451|NCT01270620|Anesthetics, General|anesthetics, general|mesh-ancestor
25628452|NCT01270620|Anesthetics|anesthetics|mesh-ancestor
25628453|NCT01270620|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25628454|NCT01270659|Acetaminophen|acetaminophen|mesh-list
25628455|NCT01270659|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25628456|NCT01270659|Fentanyl|fentanyl|mesh-list
25628457|NCT01270659|Oxycodone|oxycodone|mesh-list
25628458|NCT01270659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25628459|NCT01270659|Narcotics|narcotics|mesh-ancestor
25628460|NCT01270659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25628461|NCT01270659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628462|NCT01270659|Analgesics|analgesics|mesh-ancestor
25628463|NCT01270659|Sensory System Agents|sensory system agents|mesh-ancestor
25628464|NCT01270659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25628465|NCT01270659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25628466|NCT01270659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25628467|NCT01270659|Anesthetics, General|anesthetics, general|mesh-ancestor
25628468|NCT01270659|Anesthetics|anesthetics|mesh-ancestor
25628469|NCT01270659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25628470|NCT01270659|Antipyretics|antipyretics|mesh-ancestor
25628471|NCT01270659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25628472|NCT01270659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25628473|NCT01270659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25628474|NCT01270802|Tenofovir|tenofovir|mesh-list
25628475|NCT01270802|Emtricitabine|emtricitabine|mesh-list
25628476|NCT01270802|Efavirenz|efavirenz|mesh-list
25628477|NCT01270802|Raltegravir Potassium|raltegravir potassium|mesh-list
25628478|NCT01270802|Antiviral Agents|antiviral agents|mesh-ancestor
25628479|NCT01270802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25628480|NCT01270802|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25628481|NCT01270802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25628482|NCT01270802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628483|NCT01270802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628484|NCT01270802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25628485|NCT01270802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25628486|NCT01270802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25628487|NCT01270802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25628488|NCT01270802|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25628489|NCT01270802|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25628490|NCT01270802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25628491|NCT01270802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25628492|NCT01270802|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25628493|NCT01270802|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25628494|NCT01270828|Pregabalin|pregabalin|mesh-list
25628495|NCT01270828|Analgesics|analgesics|mesh-ancestor
24462424|NCT00356083|Analgesics|analgesics|mesh-ancestor
25628496|NCT01270828|Sensory System Agents|sensory system agents|mesh-ancestor
25628497|NCT01270828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25628498|NCT01270828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628499|NCT01270828|Anticonvulsants|anticonvulsants|mesh-ancestor
25628500|NCT01270828|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25628501|NCT01270828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25628502|NCT01270828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628503|NCT01270828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25628504|NCT01270828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25628505|NCT01270828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25628506|NCT01270828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25628507|NCT01270828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25628508|NCT01270841|Enclomiphene|enclomiphene|mesh-list
25628509|NCT01270841|Clomiphene|clomiphene|mesh-list
25628510|NCT01270841|Zuclomiphene|zuclomiphene|mesh-list
25628511|NCT01270841|Testosterone|testosterone|mesh-list
25628512|NCT01270841|Androgens|androgens|mesh-ancestor
25628513|NCT01270841|Hormones|hormones|mesh-ancestor
25628514|NCT01270841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25628515|NCT01270841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628516|NCT01270841|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25628517|NCT01270841|Hormone Antagonists|hormone antagonists|mesh-ancestor
25628518|NCT01270841|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25628519|NCT01270841|Fertility Agents|fertility agents|mesh-ancestor
25628520|NCT01270841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25628521|NCT01270841|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25628522|NCT01270841|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25628523|NCT01270971|Tavaborole|tavaborole|mesh-list
25628524|NCT01270971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25628525|NCT01270971|Antifungal Agents|antifungal agents|mesh-ancestor
25628526|NCT01270971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25628527|NCT01271010|Cyclophosphamide|cyclophosphamide|mesh-list
25628528|NCT01271010|Rituximab|rituximab|mesh-list
25628529|NCT01271010|Fludarabine|fludarabine|mesh-list
25628530|NCT01271010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25628531|NCT01271010|Immunologic Factors|immunologic factors|mesh-ancestor
25628532|NCT01271010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628533|NCT01271010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25628534|NCT01271010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25628535|NCT01271010|Alkylating Agents|alkylating agents|mesh-ancestor
25628536|NCT01271010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628537|NCT01271010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628538|NCT01271010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25628539|NCT01271010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25628540|NCT01271244|Citalopram|citalopram|mesh-list
25628541|NCT01271244|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25628542|NCT01271244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25628543|NCT01271244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25628544|NCT01271244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628545|NCT01271244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25628546|NCT01271244|Serotonin Agents|serotonin agents|mesh-ancestor
25628547|NCT01271244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628548|NCT01271244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25628549|NCT01271244|Antidepressive Agents|antidepressive agents|mesh-ancestor
25628550|NCT01271244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25628551|NCT01271452|Botulinum Toxins|botulinum toxins|mesh-list
25628552|NCT01271452|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25628553|NCT01271452|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25523162|NCT00474630|Dopamine Agents|dopamine agents|mesh-ancestor
25628554|NCT01271452|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25628555|NCT01271452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25628556|NCT01271452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628557|NCT01271452|Cholinergic Agents|cholinergic agents|mesh-ancestor
25628558|NCT01271452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25628559|NCT01271452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628560|NCT01271452|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25628561|NCT01271452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25628562|NCT01271504|Sorafenib|sorafenib|mesh-list
25628563|NCT01271504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628564|NCT01271504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25628565|NCT01271504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628566|NCT01271504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628567|NCT01271686|Bimatoprost|bimatoprost|mesh-list
25628568|NCT01271686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25628569|NCT01271725|Paclitaxel|paclitaxel|mesh-list
25628570|NCT01271725|Vinorelbine|vinorelbine|mesh-list
25628571|NCT01271725|Afatinib|afatinib|mesh-list
25628572|NCT01271725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25628573|NCT01271725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628574|NCT01271725|Tubulin Modulators|tubulin modulators|mesh-ancestor
25628575|NCT01271725|Antimitotic Agents|antimitotic agents|mesh-ancestor
25628576|NCT01271725|Mitosis Modulators|mitosis modulators|mesh-ancestor
25628577|NCT01271725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628578|NCT01271725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25628579|NCT01271725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628580|NCT01271803|Vemurafenib|vemurafenib|mesh-list
25628581|NCT01271803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628582|NCT01271803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25628583|NCT01271803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628584|NCT01271803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628585|NCT01271855|Glycerol|glycerol|mesh-list
25628586|NCT01271855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628587|NCT01271855|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25628588|NCT01271855|Protective Agents|protective agents|mesh-ancestor
25628589|NCT01271907|Aldesleukin|aldesleukin|mesh-list
25628590|NCT01271907|Cyclophosphamide|cyclophosphamide|mesh-list
25628591|NCT01271907|Fludarabine|fludarabine|mesh-list
25628592|NCT01271907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25628593|NCT01271907|Immunologic Factors|immunologic factors|mesh-ancestor
25628594|NCT01271907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628595|NCT01271907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25628596|NCT01271907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25628597|NCT01271907|Alkylating Agents|alkylating agents|mesh-ancestor
25628598|NCT01271907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628599|NCT01271907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628600|NCT01271907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25628601|NCT01271907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25628602|NCT01271907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25628603|NCT01271907|Antiviral Agents|antiviral agents|mesh-ancestor
24759376|NCT01750983|Ipilimumab|ipilimumab|mesh-list
24461565|NCT00352677|Bafetinib|bafetinib|mesh-list
25628604|NCT01271907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25628605|NCT01271933|Pregabalin|pregabalin|mesh-list
25628606|NCT01271933|Analgesics|analgesics|mesh-ancestor
25628607|NCT01271933|Sensory System Agents|sensory system agents|mesh-ancestor
25628608|NCT01271933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25628609|NCT01271933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628610|NCT01271933|Anticonvulsants|anticonvulsants|mesh-ancestor
25628611|NCT01271933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25628612|NCT01271933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24629723|NCT01107431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628613|NCT01271933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628614|NCT01271933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25628615|NCT01271933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25628616|NCT01271933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25628617|NCT01271933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25628618|NCT01271933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25628619|NCT01272180|Vaccines|vaccines|mesh-list
25628620|NCT01272180|Immunologic Factors|immunologic factors|mesh-ancestor
25628621|NCT01272180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628622|NCT01272193|Insulin|insulin|mesh-list
25628623|NCT01272193|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25628624|NCT01272193|Insulin Glargine|insulin glargine|mesh-list
25628625|NCT01272193|Insulin Aspart|insulin aspart|mesh-list
25628626|NCT01272193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25628627|NCT01272193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628628|NCT01272219|Liraglutide|liraglutide|mesh-list
25628629|NCT01272219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25628630|NCT01272219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628631|NCT01272219|Incretins|incretins|mesh-ancestor
25628632|NCT01272219|Hormones|hormones|mesh-ancestor
25628633|NCT01272219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25628634|NCT01272232|Liraglutide|liraglutide|mesh-list
25628635|NCT01272232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25628636|NCT01272232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628637|NCT01272232|Incretins|incretins|mesh-ancestor
25628638|NCT01272232|Hormones|hormones|mesh-ancestor
25628639|NCT01272232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25628640|NCT01272245|Cytarabine|cytarabine|mesh-list
25628641|NCT01272245|Homoharringtonine|homoharringtonine|mesh-list
25628642|NCT01272245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24632195|NCT01122602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24632197|NCT01122602|Sensory System Agents|sensory system agents|mesh-ancestor
24632198|NCT01122602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24632201|NCT01122602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25628643|NCT01272245|Antimetabolites|antimetabolites|mesh-ancestor
24633678|NCT01130688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628644|NCT01272245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628645|NCT01272245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628646|NCT01272245|Antiviral Agents|antiviral agents|mesh-ancestor
25628647|NCT01272245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25717015|NCT02404220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628648|NCT01272245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24397064|NCT00140712|Dopamine Agents|dopamine agents|mesh-ancestor
25628649|NCT01272245|Immunologic Factors|immunologic factors|mesh-ancestor
25628650|NCT01272245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628651|NCT01272245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25628652|NCT01272245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25628653|NCT01272245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628654|NCT01272388|Tadalafil|tadalafil|mesh-list
24400645|NCT00151060|Paclitaxel|paclitaxel|mesh-list
25628655|NCT01272388|Vasodilator Agents|vasodilator agents|mesh-ancestor
25628656|NCT01272388|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25628657|NCT01272388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25628658|NCT01272388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628659|NCT01272388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628660|NCT01272388|Urological Agents|urological agents|mesh-ancestor
25628661|NCT01272583|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25628662|NCT01272583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25628663|NCT01272583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628664|NCT01272583|Incretins|incretins|mesh-ancestor
25628665|NCT01272583|Hormones|hormones|mesh-ancestor
24402624|NCT00158041|Amifostine|amifostine|mesh-list
24402625|NCT00158041|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24402626|NCT00158041|Protective Agents|protective agents|mesh-ancestor
24402627|NCT00158041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402629|NCT00158093|Atenolol|atenolol|mesh-list
24402652|NCT00158093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24402831|NCT00158548|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24402832|NCT00158548|Anthelmintics|anthelmintics|mesh-ancestor
24402834|NCT00158548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24402835|NCT00158561|Pyrimethamine|pyrimethamine|mesh-list
24402836|NCT00158561|Sulfadoxine|sulfadoxine|mesh-list
24402837|NCT00158561|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24402923|NCT00158821|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24402926|NCT00158834|Fluticasone|fluticasone|mesh-list
25628666|NCT01272583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25628667|NCT01272583|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25628668|NCT01272583|Protease Inhibitors|protease inhibitors|mesh-ancestor
25628669|NCT01272583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628670|NCT01272583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628671|NCT01272635|Azithromycin|azithromycin|mesh-list
25628672|NCT01272635|Prednisolone|prednisolone|mesh-list
25628673|NCT01272635|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25628674|NCT01272635|Methylprednisolone|methylprednisolone|mesh-list
24403647|NCT00161200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403648|NCT00161200|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24403649|NCT00161200|Histamine Antagonists|histamine antagonists|mesh-ancestor
24403650|NCT00161200|Histamine Agents|histamine agents|mesh-ancestor
24403694|NCT00161291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24403695|NCT00161291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403696|NCT00161291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24403697|NCT00161291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24403698|NCT00161291|Growth Substances|growth substances|mesh-ancestor
24403699|NCT00161291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403700|NCT00161291|Growth Inhibitors|growth inhibitors|mesh-ancestor
24403722|NCT00161330|Clavulanic Acids|clavulanic acids|mesh-list
24403723|NCT00161330|Clavulanic Acid|clavulanic acid|mesh-list
24403724|NCT00161330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24403725|NCT00161330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25628675|NCT01272635|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25628676|NCT01272635|Prednisolone acetate|prednisolone acetate|mesh-list
25628677|NCT01272635|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25628678|NCT01272635|Prednisolone phosphate|prednisolone phosphate|mesh-list
25628679|NCT01272635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25628680|NCT01272635|Glucocorticoids|glucocorticoids|mesh-ancestor
25628681|NCT01272635|Hormones|hormones|mesh-ancestor
25628682|NCT01272635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25628683|NCT01272635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628684|NCT01272635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25628685|NCT01272635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628686|NCT01272635|Antiemetics|antiemetics|mesh-ancestor
25628687|NCT01272635|Autonomic Agents|autonomic agents|mesh-ancestor
25628688|NCT01272635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25628689|NCT01272635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24405911|NCT00168766|Antiemetics|antiemetics|mesh-ancestor
24405912|NCT00168766|Autonomic Agents|autonomic agents|mesh-ancestor
24406048|NCT00169039|Autonomic Agents|autonomic agents|mesh-ancestor
24406049|NCT00169039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24406050|NCT00169039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24406051|NCT00169039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24406052|NCT00169039|Dopamine Agents|dopamine agents|mesh-ancestor
24406053|NCT00169065|Olanzapine|olanzapine|mesh-list
24406054|NCT00169065|Clozapine|clozapine|mesh-list
24406055|NCT00169065|Antiemetics|antiemetics|mesh-ancestor
24406056|NCT00169065|Autonomic Agents|autonomic agents|mesh-ancestor
24406057|NCT00169065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24406058|NCT00169065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717027|NCT02404493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25717028|NCT02404610|Propofol|propofol|mesh-list
24406972|NCT00171652|Sensory System Agents|sensory system agents|mesh-ancestor
24406973|NCT00171652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24407231|NCT00173862|Gemcitabine|gemcitabine|mesh-list
25628690|NCT01272635|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25628691|NCT01272635|Protective Agents|protective agents|mesh-ancestor
25628692|NCT01272635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25628693|NCT01272635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25628694|NCT01272908|Rituximab|rituximab|mesh-list
25628695|NCT01272908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25628696|NCT01272908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628697|NCT01272908|Immunologic Factors|immunologic factors|mesh-ancestor
25628698|NCT01272908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628699|NCT01272908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25655863|NCT01567852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655864|NCT01567865|Vaccines|vaccines|mesh-list
25655865|NCT01567865|Immunologic Factors|immunologic factors|mesh-ancestor
25655866|NCT01567865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655867|NCT01568008|Bimatoprost|bimatoprost|mesh-list
24410251|NCT00184938|Sensory System Agents|sensory system agents|mesh-ancestor
25655868|NCT01568008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25628700|NCT01272921|Bupivacaine|bupivacaine|mesh-list
25628701|NCT01272921|Ropivacaine|ropivacaine|mesh-list
25628702|NCT01272921|Anesthetics, Local|anesthetics, local|mesh-ancestor
25628703|NCT01272921|Anesthetics|anesthetics|mesh-ancestor
25628704|NCT01272921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25628705|NCT01272921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628706|NCT01272921|Sensory System Agents|sensory system agents|mesh-ancestor
24410451|NCT00185328|Estrogens|estrogens|mesh-ancestor
24410452|NCT00185328|Hormones|hormones|mesh-ancestor
24410453|NCT00185328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24410454|NCT00185328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410455|NCT00185419|Desogestrel|desogestrel|mesh-list
24410463|NCT00185419|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24410464|NCT00185419|Progestins|progestins|mesh-ancestor
24410465|NCT00185419|Hormones|hormones|mesh-ancestor
24410466|NCT00185419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24410467|NCT00185445|Fludarabine|fludarabine|mesh-list
24410492|NCT00185510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24410493|NCT00185510|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24410494|NCT00185510|Protective Agents|protective agents|mesh-ancestor
24410495|NCT00185510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25628707|NCT01272921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25628709|NCT01272934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25628710|NCT01272934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25628711|NCT01272934|Analgesics|analgesics|mesh-ancestor
25628712|NCT01272934|Sensory System Agents|sensory system agents|mesh-ancestor
25628713|NCT01272934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25628714|NCT01272934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628715|NCT01272934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25628716|NCT01272934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25628717|NCT01272934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25628718|NCT01272934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628719|NCT01272934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628720|NCT01272947|Diclofenac|diclofenac|mesh-list
25628721|NCT01272947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25628722|NCT01272947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25628723|NCT01272947|Analgesics|analgesics|mesh-ancestor
25628724|NCT01272947|Sensory System Agents|sensory system agents|mesh-ancestor
25628725|NCT01272947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25628726|NCT01272947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628727|NCT01272947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25628728|NCT01272947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25628729|NCT01272947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25628730|NCT01272947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628731|NCT01272947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628732|NCT01272960|Levonorgestrel|levonorgestrel|mesh-list
24411634|NCT00189618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25717058|NCT02406261|Midazolam|midazolam|mesh-list
25628733|NCT01272960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25628734|NCT01272960|Contraceptive Agents|contraceptive agents|mesh-ancestor
25628735|NCT01272960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25628736|NCT01272960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628737|NCT01272960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25628738|NCT01272960|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25628739|NCT01272960|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25628740|NCT01273155|Belinostat|belinostat|mesh-list
25628741|NCT01273155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628742|NCT01273155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25628743|NCT01273155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25717075|NCT02406261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25628744|NCT01273155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628745|NCT01273181|Aldesleukin|aldesleukin|mesh-list
25628746|NCT01273181|Cyclophosphamide|cyclophosphamide|mesh-list
25628747|NCT01273181|Fludarabine|fludarabine|mesh-list
24414204|NCT00196599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25628748|NCT01273181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25628749|NCT01273181|Immunologic Factors|immunologic factors|mesh-ancestor
24416474|NCT00203164|Rasagiline|rasagiline|mesh-list
25628750|NCT01273181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628751|NCT01273181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25628752|NCT01273181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24418531|NCT00209742|Tegafur|tegafur|mesh-list
25628753|NCT01273181|Alkylating Agents|alkylating agents|mesh-ancestor
25628754|NCT01273181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628755|NCT01273181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628756|NCT01273181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25628757|NCT01273181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25628758|NCT01273181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25628759|NCT01273181|Antiviral Agents|antiviral agents|mesh-ancestor
25628760|NCT01273181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25628761|NCT01273207|Cyclosporine|cyclosporine|mesh-list
25628762|NCT01273207|Cyclosporins|cyclosporins|mesh-list
25628763|NCT01273207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628764|NCT01273207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628765|NCT01273207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25628766|NCT01273207|Immunologic Factors|immunologic factors|mesh-ancestor
25628767|NCT01273207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628768|NCT01273207|Antifungal Agents|antifungal agents|mesh-ancestor
25628769|NCT01273207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25628770|NCT01273207|Dermatologic Agents|dermatologic agents|mesh-ancestor
25628771|NCT01273207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25628772|NCT01273207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25628773|NCT01273766|Deferasirox|deferasirox|mesh-list
25628774|NCT01273766|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25628775|NCT01273766|Chelating Agents|chelating agents|mesh-ancestor
25628776|NCT01273766|Sequestering Agents|sequestering agents|mesh-ancestor
24420681|NCT00216567|Topiramate|topiramate|mesh-list
25628777|NCT01273766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628778|NCT01273805|Hydroxychloroquine|hydroxychloroquine|mesh-list
25628779|NCT01273805|Antimalarials|antimalarials|mesh-ancestor
25628780|NCT01273805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25628781|NCT01273805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25628782|NCT01273805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25628783|NCT01273805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628784|NCT01273805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628785|NCT01273805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25628786|NCT01273818|Gentamicins|gentamicins|mesh-list
25628787|NCT01273818|Cefazolin|cefazolin|mesh-list
25628788|NCT01273818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25628789|NCT01273818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25628790|NCT01273818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25628791|NCT01273818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628792|NCT01273818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628793|NCT01274182|Rituximab|rituximab|mesh-list
25628794|NCT01274182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25628795|NCT01274182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628796|NCT01274182|Immunologic Factors|immunologic factors|mesh-ancestor
25717135|NCT02407704|Lorazepam|lorazepam|mesh-list
25628797|NCT01274182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628798|NCT01274182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25628799|NCT01274338|Interferons|interferons|mesh-list
25628800|NCT01274338|Interferon-alpha|interferon-alpha|mesh-list
25628801|NCT01274338|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
25628802|NCT01274338|Ipilimumab|ipilimumab|mesh-list
25628803|NCT01274338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628804|NCT01274338|Antiviral Agents|antiviral agents|mesh-ancestor
25628805|NCT01274338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25628806|NCT01274338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25628807|NCT01274338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25628808|NCT01274338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628809|NCT01274338|Immunologic Factors|immunologic factors|mesh-ancestor
25628810|NCT01274338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628811|NCT01274637|Dalteparin|dalteparin|mesh-list
25628812|NCT01274637|Tinzaparin|tinzaparin|mesh-list
25628813|NCT01274637|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25628814|NCT01274637|Anticoagulants|anticoagulants|mesh-ancestor
25628815|NCT01274637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25628816|NCT01274637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25628817|NCT01274637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628818|NCT01274897|Lactitol|lactitol|mesh-list
24437319|NCT00273429|Timolol|timolol|mesh-list
25628819|NCT01274897|Cathartics|cathartics|mesh-ancestor
25628820|NCT01274897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25628821|NCT01275131|Insulin Aspart|insulin aspart|mesh-list
25628822|NCT01275131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25628823|NCT01275131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628824|NCT01275144|Lorazepam|lorazepam|mesh-list
25628825|NCT01275144|Anticonvulsants|anticonvulsants|mesh-ancestor
25628826|NCT01275144|Antiemetics|antiemetics|mesh-ancestor
25628827|NCT01275144|Autonomic Agents|autonomic agents|mesh-ancestor
25628828|NCT01275144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25628829|NCT01275144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628830|NCT01275144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25628831|NCT01275144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25628832|NCT01275144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25628833|NCT01275144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25628834|NCT01275144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25628835|NCT01275144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25628836|NCT01275144|GABA Modulators|gaba modulators|mesh-ancestor
25628837|NCT01275144|GABA Agents|gaba agents|mesh-ancestor
25628838|NCT01275144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25628839|NCT01275144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628840|NCT01275170|Imipenem|imipenem|mesh-list
25628841|NCT01275170|Relebactam|relebactam|mesh-list
25628842|NCT01275170|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
25628843|NCT01275170|Midazolam|midazolam|mesh-list
25628844|NCT01275170|Caffeine|caffeine|mesh-list
25628845|NCT01275170|Omeprazole|omeprazole|mesh-list
25628846|NCT01275170|Cilastatin|cilastatin|mesh-list
25628847|NCT01275170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25628848|NCT01275170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25628849|NCT01275170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25628850|NCT01275170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628851|NCT01275170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25628852|NCT01275170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25628853|NCT01275170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24439160|NCT00277706|Vitamin D|vitamin d|mesh-list
25628854|NCT01275170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25628855|NCT01275170|Anesthetics, General|anesthetics, general|mesh-ancestor
25628857|NCT01275170|GABA Modulators|gaba modulators|mesh-ancestor
25628858|NCT01275170|GABA Agents|gaba agents|mesh-ancestor
25628859|NCT01275170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25628860|NCT01275170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628861|NCT01275170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25628862|NCT01275170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25628863|NCT01275170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25628864|NCT01275170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628865|NCT01275170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25628866|NCT01275170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25628867|NCT01275170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25628868|NCT01275170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25628869|NCT01275170|Purinergic Agents|purinergic agents|mesh-ancestor
25628870|NCT01275170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25628871|NCT01275170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25628872|NCT01275170|Protease Inhibitors|protease inhibitors|mesh-ancestor
25628873|NCT01275170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25628874|NCT01275196|Imatinib Mesylate|imatinib mesylate|mesh-list
25628875|NCT01275196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628876|NCT01275196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25628877|NCT01275196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628878|NCT01275196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628879|NCT01275222|Everolimus|everolimus|mesh-list
25628880|NCT01275222|Imatinib Mesylate|imatinib mesylate|mesh-list
25628881|NCT01275222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628882|NCT01275222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25628883|NCT01275222|Immunologic Factors|immunologic factors|mesh-ancestor
24440346|NCT00282503|Methylprednisolone|methylprednisolone|mesh-list
25628884|NCT01275222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628885|NCT01275222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25628886|NCT01275222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628887|NCT01275222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628888|NCT01275300|Aspirin|aspirin|mesh-list
25628889|NCT01275300|Niacin|niacin|mesh-list
25628890|NCT01275300|Niacinamide|niacinamide|mesh-list
25628891|NCT01275300|Nicotinic Acids|nicotinic acids|mesh-list
25628892|NCT01275300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25628893|NCT01275300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25628894|NCT01275300|Analgesics|analgesics|mesh-ancestor
25628895|NCT01275300|Sensory System Agents|sensory system agents|mesh-ancestor
25628896|NCT01275300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25628897|NCT01275300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628898|NCT01275300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25628899|NCT01275300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25628900|NCT01275300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25628901|NCT01275300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25628902|NCT01275300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628903|NCT01275300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25628904|NCT01275300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25628905|NCT01275300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628906|NCT01275300|Antipyretics|antipyretics|mesh-ancestor
25628907|NCT01275300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25628908|NCT01275300|Antimetabolites|antimetabolites|mesh-ancestor
25628909|NCT01275300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25628910|NCT01275300|Vasodilator Agents|vasodilator agents|mesh-ancestor
25628911|NCT01275300|Vitamin B Complex|vitamin b complex|mesh-ancestor
25628912|NCT01275300|Vitamins|vitamins|mesh-ancestor
25628913|NCT01275300|Micronutrients|micronutrients|mesh-ancestor
25628914|NCT01275339|Tadalafil|tadalafil|mesh-list
25628915|NCT01275339|Vasodilator Agents|vasodilator agents|mesh-ancestor
25628916|NCT01275339|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25628917|NCT01275339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25628918|NCT01275339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628919|NCT01275339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628920|NCT01275339|Urological Agents|urological agents|mesh-ancestor
25628921|NCT01275365|Methyltestosterone|methyltestosterone|mesh-list
25628922|NCT01275365|Testosterone|testosterone|mesh-list
25628923|NCT01275365|Testosterone undecanoate|testosterone undecanoate|mesh-list
25628924|NCT01275365|Testosterone enanthate|testosterone enanthate|mesh-list
25628925|NCT01275365|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25628926|NCT01275365|Androgens|androgens|mesh-ancestor
25628927|NCT01275365|Hormones|hormones|mesh-ancestor
25523571|NCT00476957|Antifungal Agents|antifungal agents|mesh-ancestor
25523572|NCT00476957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25523573|NCT00476957|Immunologic Factors|immunologic factors|mesh-ancestor
25523574|NCT00476957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523576|NCT00476996|Leflunomide|leflunomide|mesh-list
25523577|NCT00476996|Ocrelizumab|ocrelizumab|mesh-list
25523578|NCT00476996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25523579|NCT00476996|Abortifacient Agents|abortifacient agents|mesh-ancestor
25523580|NCT00476996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25523581|NCT00476996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523582|NCT00476996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25523583|NCT00476996|Antimetabolites|antimetabolites|mesh-ancestor
25523584|NCT00476996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523585|NCT00476996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523586|NCT00476996|Dermatologic Agents|dermatologic agents|mesh-ancestor
25523587|NCT00476996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523588|NCT00476996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25523589|NCT00476996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25523590|NCT00476996|Immunologic Factors|immunologic factors|mesh-ancestor
25523591|NCT00476996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25523592|NCT00476996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25523593|NCT00477087|Molgramostim|molgramostim|mesh-list
25523594|NCT00477087|Mitoxantrone|mitoxantrone|mesh-list
25523595|NCT00477087|Sargramostim|sargramostim|mesh-list
25523596|NCT00477087|Immunologic Factors|immunologic factors|mesh-ancestor
25523597|NCT00477087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523598|NCT00477087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523599|NCT00477087|Analgesics|analgesics|mesh-ancestor
25523600|NCT00477087|Sensory System Agents|sensory system agents|mesh-ancestor
25523601|NCT00477087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25523602|NCT00477087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25523603|NCT00477087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25523604|NCT00477087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523605|NCT00477087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991544|NCT05139875|Hormones|hormones|mesh-ancestor
24979888|NCT04984083|Micronutrients|micronutrients|mesh-ancestor
24979889|NCT04984083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979896|NCT04976777|Dexamethasone acetate|dexamethasone acetate|mesh-list
24979898|NCT04976777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25628928|NCT01275365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25628929|NCT01275365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628930|NCT01275365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25628931|NCT01275365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628932|NCT01275365|Anabolic Agents|anabolic agents|mesh-ancestor
25628933|NCT01275625|Maraviroc|maraviroc|mesh-list
25628934|NCT01275625|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25628935|NCT01275625|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25628936|NCT01275625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628937|NCT01275625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25628938|NCT01275625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25628939|NCT01275625|Antiviral Agents|antiviral agents|mesh-ancestor
25628940|NCT01275625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25628941|NCT01275625|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25628942|NCT01275664|Dexamethasone|dexamethasone|mesh-list
25628943|NCT01275664|Dexamethasone acetate|dexamethasone acetate|mesh-list
25628944|NCT01275664|Cisplatin|cisplatin|mesh-list
25628945|NCT01275664|Carboplatin|carboplatin|mesh-list
25628946|NCT01275664|Aprepitant|aprepitant|mesh-list
25628947|NCT01275664|Granisetron|granisetron|mesh-list
25628948|NCT01275664|Ichthammol|ichthammol|mesh-list
25628949|NCT01275664|BB 1101|bb 1101|mesh-list
25628950|NCT01275664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628951|NCT01275664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25628952|NCT01275664|Antiemetics|antiemetics|mesh-ancestor
25628953|NCT01275664|Autonomic Agents|autonomic agents|mesh-ancestor
25628954|NCT01275664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25628955|NCT01275664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628956|NCT01275664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25628957|NCT01275664|Glucocorticoids|glucocorticoids|mesh-ancestor
25628958|NCT01275664|Hormones|hormones|mesh-ancestor
25628959|NCT01275664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25628960|NCT01275664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25628961|NCT01275664|Protease Inhibitors|protease inhibitors|mesh-ancestor
25628962|NCT01275664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25628963|NCT01275664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628964|NCT01275664|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25628965|NCT01275664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25628966|NCT01275664|Dermatologic Agents|dermatologic agents|mesh-ancestor
25628967|NCT01275664|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25628968|NCT01275664|Serotonin Agents|serotonin agents|mesh-ancestor
25628969|NCT01276041|Paclitaxel|paclitaxel|mesh-list
25628970|NCT01276041|Trastuzumab|trastuzumab|mesh-list
25628971|NCT01276041|Pertuzumab|pertuzumab|mesh-list
25628972|NCT01276041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25628973|NCT01276041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25628974|NCT01276041|Tubulin Modulators|tubulin modulators|mesh-ancestor
25628975|NCT01276041|Antimitotic Agents|antimitotic agents|mesh-ancestor
25628976|NCT01276041|Mitosis Modulators|mitosis modulators|mesh-ancestor
25628977|NCT01276041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628978|NCT01276041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25628979|NCT01276223|Fluprednisolone|fluprednisolone|mesh-list
25628980|NCT01276223|Difluprednate|difluprednate|mesh-list
25628981|NCT01276223|Glucocorticoids|glucocorticoids|mesh-ancestor
25628982|NCT01276223|Hormones|hormones|mesh-ancestor
25628983|NCT01276223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25628984|NCT01276223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25628985|NCT01276223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25628986|NCT01276236|Maraviroc|maraviroc|mesh-list
25628987|NCT01276236|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25628988|NCT01276236|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25628989|NCT01276236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25628990|NCT01276236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25628991|NCT01276236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25628992|NCT01276236|Antiviral Agents|antiviral agents|mesh-ancestor
25628993|NCT01276236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25628994|NCT01276236|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25628995|NCT01276288|Empagliflozin|empagliflozin|mesh-list
25628996|NCT01276288|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25628997|NCT01276288|Torsemide|torsemide|mesh-list
25628998|NCT01276288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25628999|NCT01276288|Diuretics|diuretics|mesh-ancestor
25629000|NCT01276288|Natriuretic Agents|natriuretic agents|mesh-ancestor
25629001|NCT01276288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629002|NCT01276288|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25629003|NCT01276288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25629004|NCT01276288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629005|NCT01276288|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25629006|NCT01276288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25629007|NCT01276288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25629008|NCT01276301|Empagliflozin|empagliflozin|mesh-list
25629009|NCT01276301|Verapamil|verapamil|mesh-list
25629010|NCT01276301|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25629011|NCT01276301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629012|NCT01276301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25629013|NCT01276301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629014|NCT01276301|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25629015|NCT01276301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25629016|NCT01276301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25629017|NCT01276301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25629018|NCT01276301|Vasodilator Agents|vasodilator agents|mesh-ancestor
25629019|NCT01276314|Prednisolone|prednisolone|mesh-list
25629020|NCT01276314|Etanercept|etanercept|mesh-list
25629021|NCT01276314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25629022|NCT01276314|Glucocorticoids|glucocorticoids|mesh-ancestor
25629023|NCT01276314|Hormones|hormones|mesh-ancestor
25629024|NCT01276314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25629025|NCT01276314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629026|NCT01276314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25629027|NCT01276314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629028|NCT01276314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25629029|NCT01276314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25629030|NCT01276314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25629031|NCT01276314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25629032|NCT01276314|Analgesics|analgesics|mesh-ancestor
25629033|NCT01276314|Sensory System Agents|sensory system agents|mesh-ancestor
25523606|NCT00477165|Citalopram|citalopram|mesh-list
25629034|NCT01276314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25629035|NCT01276314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25629036|NCT01276314|Immunologic Factors|immunologic factors|mesh-ancestor
25629037|NCT01276327|Pioglitazone|pioglitazone|mesh-list
25629038|NCT01276327|Linagliptin|linagliptin|mesh-list
25629039|NCT01276327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25629040|NCT01276327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629041|NCT01276327|Incretins|incretins|mesh-ancestor
25629042|NCT01276327|Hormones|hormones|mesh-ancestor
25629043|NCT01276327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25629044|NCT01276327|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25629045|NCT01276327|Protease Inhibitors|protease inhibitors|mesh-ancestor
25629046|NCT01276327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629047|NCT01276327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629048|NCT01276353|Donepezil|donepezil|mesh-list
25629049|NCT01276353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25629050|NCT01276353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629051|NCT01276353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629052|NCT01276353|Cholinergic Agents|cholinergic agents|mesh-ancestor
25629053|NCT01276353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25629054|NCT01276353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629055|NCT01276353|Nootropic Agents|nootropic agents|mesh-ancestor
25629056|NCT01276379|Leucovorin|leucovorin|mesh-list
25629057|NCT01276379|Folic Acid|folic acid|mesh-list
25629058|NCT01276379|Fluorouracil|fluorouracil|mesh-list
25629059|NCT01276379|Oxaliplatin|oxaliplatin|mesh-list
25629060|NCT01276379|Irinotecan|irinotecan|mesh-list
25629061|NCT01276379|Cetuximab|cetuximab|mesh-list
25629062|NCT01276379|Levoleucovorin|levoleucovorin|mesh-list
25629063|NCT01276379|Antimetabolites|antimetabolites|mesh-ancestor
25629064|NCT01276379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629065|NCT01276379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25629066|NCT01276379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629067|NCT01276379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25629068|NCT01276379|Immunologic Factors|immunologic factors|mesh-ancestor
25629069|NCT01276379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629070|NCT01276379|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25629071|NCT01276379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25629072|NCT01276379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629073|NCT01276379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25629074|NCT01276379|Antidotes|antidotes|mesh-ancestor
25629075|NCT01276379|Protective Agents|protective agents|mesh-ancestor
25629076|NCT01276379|Vitamin B Complex|vitamin b complex|mesh-ancestor
25629077|NCT01276379|Vitamins|vitamins|mesh-ancestor
25629078|NCT01276379|Micronutrients|micronutrients|mesh-ancestor
25629079|NCT01276379|Hematinics|hematinics|mesh-ancestor
25629080|NCT01276457|Cyclosporine|cyclosporine|mesh-list
25629081|NCT01276457|Everolimus|everolimus|mesh-list
25629082|NCT01276457|Cyclosporins|cyclosporins|mesh-list
25629083|NCT01276457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629084|NCT01276457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629085|NCT01276457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25629086|NCT01276457|Immunologic Factors|immunologic factors|mesh-ancestor
25629087|NCT01276457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629088|NCT01276457|Antifungal Agents|antifungal agents|mesh-ancestor
25629089|NCT01276457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25629090|NCT01276457|Dermatologic Agents|dermatologic agents|mesh-ancestor
25629091|NCT01276457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25629092|NCT01276457|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25629093|NCT01276457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629094|NCT01276639|Tofacitinib|tofacitinib|mesh-list
25629095|NCT01276639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25629096|NCT01276639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629097|NCT01276639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629098|NCT01276756|Interferons|interferons|mesh-list
25629099|NCT01276756|Ribavirin|ribavirin|mesh-list
25629100|NCT01276756|Interferon-alpha|interferon-alpha|mesh-list
25629101|NCT01276756|Interferon alpha-2|interferon alpha-2|mesh-list
25629102|NCT01276756|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25629103|NCT01276756|Nitazoxanide|nitazoxanide|mesh-list
25629104|NCT01276756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629105|NCT01276756|Antiviral Agents|antiviral agents|mesh-ancestor
25629106|NCT01276756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25629107|NCT01276756|Antimetabolites|antimetabolites|mesh-ancestor
25629108|NCT01276756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629109|NCT01276756|Immunologic Factors|immunologic factors|mesh-ancestor
25629110|NCT01276756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629111|NCT01276756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25629112|NCT01276821|Epinephrine|epinephrine|mesh-list
25629113|NCT01276821|Racepinephrine|racepinephrine|mesh-list
25629114|NCT01276821|Epinephryl borate|epinephryl borate|mesh-list
25629115|NCT01276821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25629116|NCT01276821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25629117|NCT01276821|Adrenergic Agents|adrenergic agents|mesh-ancestor
25629118|NCT01276821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25629119|NCT01276821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629120|NCT01276821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629121|NCT01276821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25629122|NCT01276821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25629123|NCT01276821|Autonomic Agents|autonomic agents|mesh-ancestor
25629124|NCT01276821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25629125|NCT01276821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25629126|NCT01276821|Respiratory System Agents|respiratory system agents|mesh-ancestor
25629127|NCT01276821|Mydriatics|mydriatics|mesh-ancestor
25629128|NCT01276821|Sympathomimetics|sympathomimetics|mesh-ancestor
25629129|NCT01276821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25629130|NCT01276847|Etanercept|etanercept|mesh-list
25629131|NCT01276847|Ustekinumab|ustekinumab|mesh-list
25629132|NCT01276847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25629133|NCT01276847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25629134|NCT01276847|Analgesics|analgesics|mesh-ancestor
25629135|NCT01276847|Sensory System Agents|sensory system agents|mesh-ancestor
25629136|NCT01276847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25629137|NCT01276847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629138|NCT01276847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25629139|NCT01276847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25629140|NCT01276847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25629141|NCT01276847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25629142|NCT01276847|Immunologic Factors|immunologic factors|mesh-ancestor
25629143|NCT01276847|Dermatologic Agents|dermatologic agents|mesh-ancestor
25629144|NCT01277081|Acetaminophen|acetaminophen|mesh-list
25629145|NCT01277081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25629146|NCT01277081|Analgesics|analgesics|mesh-ancestor
25629147|NCT01277081|Sensory System Agents|sensory system agents|mesh-ancestor
25629148|NCT01277081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25629149|NCT01277081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629150|NCT01277081|Antipyretics|antipyretics|mesh-ancestor
25629151|NCT01277159|Dexamethasone|dexamethasone|mesh-list
25629152|NCT01277159|Dexamethasone acetate|dexamethasone acetate|mesh-list
25629153|NCT01277159|Buprenorphine|buprenorphine|mesh-list
25629154|NCT01277159|BB 1101|bb 1101|mesh-list
25629155|NCT01277159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25629156|NCT01277159|Antiemetics|antiemetics|mesh-ancestor
25629157|NCT01277159|Autonomic Agents|autonomic agents|mesh-ancestor
25629158|NCT01277159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25629159|NCT01277159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629160|NCT01277159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25629161|NCT01277159|Glucocorticoids|glucocorticoids|mesh-ancestor
25629162|NCT01277159|Hormones|hormones|mesh-ancestor
25629163|NCT01277159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25629164|NCT01277159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25629165|NCT01277159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629166|NCT01277159|Protease Inhibitors|protease inhibitors|mesh-ancestor
25629167|NCT01277159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629168|NCT01277159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629169|NCT01277159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25629170|NCT01277159|Narcotics|narcotics|mesh-ancestor
25629171|NCT01277159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25629172|NCT01277159|Analgesics|analgesics|mesh-ancestor
25629173|NCT01277159|Sensory System Agents|sensory system agents|mesh-ancestor
25629174|NCT01277159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25629175|NCT01277302|Ranibizumab|ranibizumab|mesh-list
25629176|NCT01277302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25629177|NCT01277302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25629178|NCT01277302|Growth Substances|growth substances|mesh-ancestor
25629179|NCT01277302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629180|NCT01277302|Growth Inhibitors|growth inhibitors|mesh-ancestor
25629181|NCT01277302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629182|NCT01277341|Bepotastine besilate|bepotastine besilate|mesh-list
25629183|NCT01277341|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25629184|NCT01277510|Cinacalcet|cinacalcet|mesh-list
25629185|NCT01277510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25629186|NCT01277510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629187|NCT01277510|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25629188|NCT01277510|Hormone Antagonists|hormone antagonists|mesh-ancestor
25523753|NCT00477750|Prednisone|prednisone|mesh-list
25655869|NCT01568008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25629189|NCT01277510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25629191|NCT01277523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25629192|NCT01277523|Autonomic Agents|autonomic agents|mesh-ancestor
25629193|NCT01277523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25629194|NCT01277523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629195|NCT01277523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25629196|NCT01277523|Respiratory System Agents|respiratory system agents|mesh-ancestor
25629197|NCT01277523|Parasympatholytics|parasympatholytics|mesh-ancestor
25629198|NCT01277523|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25629199|NCT01277523|Cholinergic Agents|cholinergic agents|mesh-ancestor
25629200|NCT01277523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25629201|NCT01277523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629202|NCT01277601|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25629203|NCT01277601|Antiviral Agents|antiviral agents|mesh-ancestor
25629204|NCT01277601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25629205|NCT01277718|Rabeprazole|rabeprazole|mesh-list
25629206|NCT01277718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25629207|NCT01277718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25629208|NCT01277718|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25629209|NCT01277718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629210|NCT01277718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629211|NCT01277744|Cisplatin|cisplatin|mesh-list
25629212|NCT01277744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629213|NCT01277861|Fentanyl|fentanyl|mesh-list
25629214|NCT01277861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25629215|NCT01277861|Narcotics|narcotics|mesh-ancestor
25629216|NCT01277861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25629217|NCT01277861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629218|NCT01277861|Analgesics|analgesics|mesh-ancestor
25629219|NCT01277861|Sensory System Agents|sensory system agents|mesh-ancestor
25629220|NCT01277861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25629221|NCT01277861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25629222|NCT01277861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25629223|NCT01277861|Anesthetics, General|anesthetics, general|mesh-ancestor
25629224|NCT01277861|Anesthetics|anesthetics|mesh-ancestor
25629225|NCT01278160|Insulin|insulin|mesh-list
25629226|NCT01278160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25629227|NCT01278160|Metformin|metformin|mesh-list
25629228|NCT01278160|Insulin Aspart|insulin aspart|mesh-list
25629229|NCT01278160|Insulin, Long-Acting|insulin, long-acting|mesh-list
25629230|NCT01278160|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25629231|NCT01278160|Biphasic Insulins|biphasic insulins|mesh-list
25629232|NCT01278160|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
25629233|NCT01278160|Insulin, Isophane|insulin, isophane|mesh-list
25629234|NCT01278160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25629235|NCT01278160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629236|NCT01278173|Vigabatrin|vigabatrin|mesh-list
25629237|NCT01278173|Anticonvulsants|anticonvulsants|mesh-ancestor
25629238|NCT01278173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629239|NCT01278173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629240|NCT01278173|GABA Agents|gaba agents|mesh-ancestor
25629241|NCT01278173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25629242|NCT01278173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629243|NCT01278342|Octreotide|octreotide|mesh-list
25629244|NCT01278342|Cabergoline|cabergoline|mesh-list
25629245|NCT01278342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25629246|NCT01278342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25629247|NCT01278342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629248|NCT01278342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25629249|NCT01278342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25629250|NCT01278342|Dopamine Agonists|dopamine agonists|mesh-ancestor
25629251|NCT01278342|Dopamine Agents|dopamine agents|mesh-ancestor
25629252|NCT01278342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25629253|NCT01278342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629254|NCT01278342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629255|NCT01278394|Tavaborole|tavaborole|mesh-list
25629256|NCT01278394|Antifungal Agents|antifungal agents|mesh-ancestor
25629257|NCT01278394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25629258|NCT01278407|Donepezil|donepezil|mesh-list
25629259|NCT01278407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25629260|NCT01278407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629261|NCT01278407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629262|NCT01278407|Cholinergic Agents|cholinergic agents|mesh-ancestor
25629263|NCT01278407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25629264|NCT01278407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629265|NCT01278407|Nootropic Agents|nootropic agents|mesh-ancestor
25629266|NCT01278745|Rituximab|rituximab|mesh-list
25629267|NCT01278745|Tacrolimus|tacrolimus|mesh-list
25629268|NCT01278745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25629269|NCT01278745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629270|NCT01278745|Immunologic Factors|immunologic factors|mesh-ancestor
25629271|NCT01278745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629272|NCT01278745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25629273|NCT01278745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25629274|NCT01278745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25629275|NCT01278745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629276|NCT01278745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629277|NCT01278797|Amlodipine|amlodipine|mesh-list
25629278|NCT01278797|Telmisartan|telmisartan|mesh-list
25629279|NCT01278797|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
25629280|NCT01278797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25629281|NCT01278797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25629282|NCT01278797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25629283|NCT01278797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629284|NCT01278797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25629285|NCT01278797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629286|NCT01278797|Vasodilator Agents|vasodilator agents|mesh-ancestor
25629287|NCT01278797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25629288|NCT01278797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25629289|NCT01279057|Fluticasone|fluticasone|mesh-list
25629290|NCT01279057|Xhance|xhance|mesh-list
25629291|NCT01279057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25629292|NCT01279057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25629293|NCT01279057|Autonomic Agents|autonomic agents|mesh-ancestor
25629294|NCT01279057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25629295|NCT01279057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629296|NCT01279057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25629297|NCT01279057|Respiratory System Agents|respiratory system agents|mesh-ancestor
25629298|NCT01279057|Dermatologic Agents|dermatologic agents|mesh-ancestor
25629299|NCT01279057|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25655870|NCT01568008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25655871|NCT01568034|Levodopa|levodopa|mesh-list
25655872|NCT01568034|Carbidopa|carbidopa|mesh-list
25655873|NCT01568034|Opicapone|opicapone|mesh-list
25655874|NCT01568034|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25655875|NCT01568034|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25655876|NCT01568034|Dopamine Agents|dopamine agents|mesh-ancestor
25655877|NCT01568034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25655878|NCT01568034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655879|NCT01568034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655880|NCT01568034|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25655881|NCT01568034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655882|NCT01568034|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25655883|NCT01568047|Levodopa|levodopa|mesh-list
25655884|NCT01568047|Carbidopa|carbidopa|mesh-list
25655885|NCT01568047|Opicapone|opicapone|mesh-list
25655886|NCT01568047|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25655887|NCT01568047|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25655888|NCT01568047|Dopamine Agents|dopamine agents|mesh-ancestor
25655889|NCT01568047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25655890|NCT01568047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655891|NCT01568047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655892|NCT01568047|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25655893|NCT01568047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655894|NCT01568047|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25655895|NCT01568073|Levodopa|levodopa|mesh-list
25655896|NCT01568073|Carbidopa|carbidopa|mesh-list
25655897|NCT01568073|Opicapone|opicapone|mesh-list
25655898|NCT01568073|Entacapone|entacapone|mesh-list
25655899|NCT01568073|Benserazide|benserazide|mesh-list
25655900|NCT01568073|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25655901|NCT01568073|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25655902|NCT01568073|Dopamine Agents|dopamine agents|mesh-ancestor
25655903|NCT01568073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25655904|NCT01568073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655905|NCT01568073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655906|NCT01568073|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25655907|NCT01568073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655908|NCT01568073|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25629300|NCT01279187|Teriparatide|teriparatide|mesh-list
25629301|NCT01279187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25629302|NCT01279187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629303|NCT01279187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25629304|NCT01279317|Acetic Acid|acetic acid|mesh-list
25629305|NCT01279317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25629306|NCT01279317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25629307|NCT01279343|Misoprostol|misoprostol|mesh-list
25629308|NCT01279343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25629309|NCT01279343|Abortifacient Agents|abortifacient agents|mesh-ancestor
25629310|NCT01279343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25629311|NCT01279343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629312|NCT01279343|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25629313|NCT01279343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25629314|NCT01279343|Oxytocics|oxytocics|mesh-ancestor
25629315|NCT01279447|Bupivacaine|bupivacaine|mesh-list
25629316|NCT01279447|Anesthetics, Local|anesthetics, local|mesh-ancestor
25629317|NCT01279447|Anesthetics|anesthetics|mesh-ancestor
25629318|NCT01279447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25629319|NCT01279447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717264|NCT02410707|Anesthetics, General|anesthetics, general|mesh-ancestor
25629320|NCT01279447|Sensory System Agents|sensory system agents|mesh-ancestor
25629321|NCT01279447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25629322|NCT01279681|Leucovorin|leucovorin|mesh-list
25629323|NCT01279681|Bevacizumab|bevacizumab|mesh-list
25629324|NCT01279681|Fluorouracil|fluorouracil|mesh-list
25629325|NCT01279681|Capecitabine|capecitabine|mesh-list
25629326|NCT01279681|Oxaliplatin|oxaliplatin|mesh-list
25629327|NCT01279681|Calcium|calcium|mesh-list
25629328|NCT01279681|Levoleucovorin|levoleucovorin|mesh-list
25629329|NCT01279681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25629330|NCT01279681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629331|NCT01279681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25629332|NCT01279681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25629333|NCT01279681|Growth Substances|growth substances|mesh-ancestor
25629334|NCT01279681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629335|NCT01279681|Growth Inhibitors|growth inhibitors|mesh-ancestor
25629336|NCT01279681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25629337|NCT01279681|Antimetabolites|antimetabolites|mesh-ancestor
25629338|NCT01279681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629339|NCT01279681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25629340|NCT01279681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25629341|NCT01279681|Immunologic Factors|immunologic factors|mesh-ancestor
25629342|NCT01279681|Antidotes|antidotes|mesh-ancestor
25629343|NCT01279681|Protective Agents|protective agents|mesh-ancestor
25629344|NCT01279681|Vitamin B Complex|vitamin b complex|mesh-ancestor
25629345|NCT01279681|Vitamins|vitamins|mesh-ancestor
25629346|NCT01279681|Micronutrients|micronutrients|mesh-ancestor
25629347|NCT01279850|Pregabalin|pregabalin|mesh-list
25629348|NCT01279850|Analgesics|analgesics|mesh-ancestor
25629349|NCT01279850|Sensory System Agents|sensory system agents|mesh-ancestor
25629350|NCT01279850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25629351|NCT01279850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629352|NCT01279850|Anticonvulsants|anticonvulsants|mesh-ancestor
25629353|NCT01279850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25629354|NCT01279850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25629355|NCT01279850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629356|NCT01279850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25629357|NCT01279850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25629358|NCT01279850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25629359|NCT01279850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25629360|NCT01279850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25629361|NCT01279954|Abatacept|abatacept|mesh-list
25629362|NCT01279954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25629363|NCT01279954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629364|NCT01279954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629365|NCT01279954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25629366|NCT01279954|Immunologic Factors|immunologic factors|mesh-ancestor
25629367|NCT01279954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629368|NCT01279954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25629369|NCT01280058|Paclitaxel|paclitaxel|mesh-list
25629370|NCT01280058|Carboplatin|carboplatin|mesh-list
25629371|NCT01280058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25629372|NCT01280058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25629373|NCT01280058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629374|NCT01280058|Tubulin Modulators|tubulin modulators|mesh-ancestor
25523964|NCT00478426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629375|NCT01280058|Antimitotic Agents|antimitotic agents|mesh-ancestor
25629376|NCT01280058|Mitosis Modulators|mitosis modulators|mesh-ancestor
25629377|NCT01280058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629378|NCT01280110|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25629379|NCT01280110|Laxatives|laxatives|mesh-ancestor
25629380|NCT01280110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25629381|NCT01280123|Pioglitazone|pioglitazone|mesh-list
25629382|NCT01280123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25717273|NCT02410772|Rifampin|rifampin|mesh-list
25629383|NCT01280123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629384|NCT01280266|Amlodipine|amlodipine|mesh-list
25629385|NCT01280266|Udenafil|udenafil|mesh-list
25629386|NCT01280266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25629387|NCT01280266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25629388|NCT01280266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25629389|NCT01280266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629390|NCT01280266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25629391|NCT01280266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629392|NCT01280266|Vasodilator Agents|vasodilator agents|mesh-ancestor
25629393|NCT01280266|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25629394|NCT01280266|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25629395|NCT01280266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629396|NCT01280409|Metformin|metformin|mesh-list
25629397|NCT01280409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25629398|NCT01280409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629399|NCT01280591|Naproxen|naproxen|mesh-list
25629400|NCT01280591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25629401|NCT01280591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25629402|NCT01280591|Analgesics|analgesics|mesh-ancestor
25629403|NCT01280591|Sensory System Agents|sensory system agents|mesh-ancestor
25629404|NCT01280591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25629405|NCT01280591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629406|NCT01280591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25629407|NCT01280591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25629408|NCT01280591|Gout Suppressants|gout suppressants|mesh-ancestor
25629409|NCT01280591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25629410|NCT01280591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629411|NCT01280591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629412|NCT01280604|Fenofibrate|fenofibrate|mesh-list
25629413|NCT01280604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25629414|NCT01280604|Antimetabolites|antimetabolites|mesh-ancestor
25629415|NCT01280604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629416|NCT01280604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25629417|NCT01280617|Thymoglobulin|thymoglobulin|mesh-list
25629418|NCT01280617|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25629419|NCT01280617|Immunologic Factors|immunologic factors|mesh-ancestor
25629420|NCT01280617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629421|NCT01280617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25629422|NCT01280656|Interferons|interferons|mesh-list
25629423|NCT01280656|Ribavirin|ribavirin|mesh-list
25629424|NCT01280656|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25629425|NCT01280656|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25629426|NCT01280656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629427|NCT01280656|Antiviral Agents|antiviral agents|mesh-ancestor
25629428|NCT01280656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25629429|NCT01280656|Antimetabolites|antimetabolites|mesh-ancestor
25629430|NCT01280656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629431|NCT01280695|Pioglitazone|pioglitazone|mesh-list
25629432|NCT01280695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25629433|NCT01280695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629434|NCT01280721|Tolvaptan|tolvaptan|mesh-list
25629435|NCT01280721|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25629436|NCT01280721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629437|NCT01280721|Natriuretic Agents|natriuretic agents|mesh-ancestor
25629438|NCT01280721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629439|NCT01280955|Plerixafor|plerixafor|mesh-list
25629440|NCT01280955|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25629441|NCT01280955|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25629442|NCT01280955|Antiviral Agents|antiviral agents|mesh-ancestor
25629443|NCT01280955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25629444|NCT01280968|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25629445|NCT01280968|Vaccines|vaccines|mesh-list
25629446|NCT01280968|Nicotine|nicotine|mesh-list
25629447|NCT01280968|Immunologic Factors|immunologic factors|mesh-ancestor
25629448|NCT01280968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629449|NCT01280968|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25629450|NCT01280968|Autonomic Agents|autonomic agents|mesh-ancestor
25629451|NCT01280968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25629452|NCT01280968|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25629453|NCT01280968|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25629454|NCT01280968|Cholinergic Agents|cholinergic agents|mesh-ancestor
25629455|NCT01280968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25629456|NCT01280968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629457|NCT01280968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25629458|NCT01280968|Antacids|antacids|mesh-ancestor
25629459|NCT01280968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25629460|NCT01280981|Tranexamic Acid|tranexamic acid|mesh-list
25629461|NCT01280981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25629462|NCT01280981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25629463|NCT01280981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629464|NCT01280981|Hemostatics|hemostatics|mesh-ancestor
25629465|NCT01280981|Coagulants|coagulants|mesh-ancestor
25629466|NCT01281007|Acyclovir|acyclovir|mesh-list
25629467|NCT01281007|Famciclovir|famciclovir|mesh-list
25629468|NCT01281007|Antiviral Agents|antiviral agents|mesh-ancestor
25629469|NCT01281007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25629470|NCT01281007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25629471|NCT01281007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629472|NCT01281007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629473|NCT01281189|Pramipexole|pramipexole|mesh-list
25629474|NCT01281189|Antioxidants|antioxidants|mesh-ancestor
25629475|NCT01281189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629476|NCT01281189|Protective Agents|protective agents|mesh-ancestor
25629477|NCT01281189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629478|NCT01281189|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25629479|NCT01281189|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25629480|NCT01281189|Dopamine Agonists|dopamine agonists|mesh-ancestor
25629481|NCT01281189|Dopamine Agents|dopamine agents|mesh-ancestor
25629482|NCT01281189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25629483|NCT01281202|Vigabatrin|vigabatrin|mesh-list
25629484|NCT01281202|Anticonvulsants|anticonvulsants|mesh-ancestor
25629485|NCT01281202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629486|NCT01281202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629487|NCT01281202|GABA Agents|gaba agents|mesh-ancestor
25629488|NCT01281202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25629489|NCT01281202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629490|NCT01281306|Valsartan|valsartan|mesh-list
25629491|NCT01281306|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25629492|NCT01281306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25629493|NCT01281306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25629494|NCT01281306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25629495|NCT01281306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629496|NCT01281475|Levodopa|levodopa|mesh-list
25629497|NCT01281475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25629498|NCT01281475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25629499|NCT01281475|Dopamine Agents|dopamine agents|mesh-ancestor
25629500|NCT01281475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25629501|NCT01281475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629502|NCT01281475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629503|NCT01281501|Scopolamine|scopolamine|mesh-list
25629504|NCT01281501|Pantoprazole|pantoprazole|mesh-list
25629505|NCT01281501|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
25629506|NCT01281501|Antacids|antacids|mesh-list
25629507|NCT01281501|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25629508|NCT01281501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25629509|NCT01281501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25629510|NCT01281501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629511|NCT01281501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629512|NCT01281501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25629513|NCT01281501|Antiemetics|antiemetics|mesh-ancestor
25629514|NCT01281501|Autonomic Agents|autonomic agents|mesh-ancestor
25629515|NCT01281501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25629516|NCT01281501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629517|NCT01281501|Mydriatics|mydriatics|mesh-ancestor
25629518|NCT01281501|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25629519|NCT01281501|Cholinergic Agents|cholinergic agents|mesh-ancestor
25629520|NCT01281501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25629521|NCT01281501|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25629522|NCT01281501|Parasympatholytics|parasympatholytics|mesh-ancestor
25629523|NCT01281839|Ribavirin|ribavirin|mesh-list
25629524|NCT01281839|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25629525|NCT01281839|Simeprevir|simeprevir|mesh-list
25629526|NCT01281839|Antimetabolites|antimetabolites|mesh-ancestor
25629527|NCT01281839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629528|NCT01281839|Antiviral Agents|antiviral agents|mesh-ancestor
25629529|NCT01281839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25629530|NCT01281839|Protease Inhibitors|protease inhibitors|mesh-ancestor
25629531|NCT01281839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629532|NCT01281865|Everolimus|everolimus|mesh-list
25629533|NCT01281865|Imatinib Mesylate|imatinib mesylate|mesh-list
25629534|NCT01281865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629535|NCT01281865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25629536|NCT01281865|Immunologic Factors|immunologic factors|mesh-ancestor
25629537|NCT01281865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629538|NCT01281865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25629539|NCT01281865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629540|NCT01281865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629541|NCT01281917|Sirolimus|sirolimus|mesh-list
25629542|NCT01281917|Bortezomib|bortezomib|mesh-list
25629543|NCT01281917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629544|NCT01281917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25629545|NCT01281917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25629546|NCT01281917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25629547|NCT01281917|Antifungal Agents|antifungal agents|mesh-ancestor
25629548|NCT01281917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25629549|NCT01281917|Immunologic Factors|immunologic factors|mesh-ancestor
25629550|NCT01281917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629551|NCT01281956|Naluzotan|naluzotan|mesh-list
25629552|NCT01281956|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25629553|NCT01281956|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25629554|NCT01281956|Serotonin Agents|serotonin agents|mesh-ancestor
25629555|NCT01281956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25629556|NCT01281956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629557|NCT01281956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629558|NCT01281969|Immunoglobulins|immunoglobulins|mesh-list
25629559|NCT01281969|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25629560|NCT01281969|Antibodies|antibodies|mesh-list
25629561|NCT01281969|gamma-Globulins|gamma-globulins|mesh-list
25629562|NCT01281969|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25629563|NCT01281969|Immunologic Factors|immunologic factors|mesh-ancestor
25629564|NCT01281969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629565|NCT01282138|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25629566|NCT01282138|Dextrans|dextrans|mesh-list
25629567|NCT01282138|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25629568|NCT01282138|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25629569|NCT01282138|Anticoagulants|anticoagulants|mesh-ancestor
25629570|NCT01282138|Plasma Substitutes|plasma substitutes|mesh-ancestor
25629571|NCT01282138|Blood Substitutes|blood substitutes|mesh-ancestor
25629572|NCT01282138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25629573|NCT01282138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25629574|NCT01282138|Analgesics|analgesics|mesh-ancestor
25629575|NCT01282138|Sensory System Agents|sensory system agents|mesh-ancestor
25629576|NCT01282138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25629577|NCT01282138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629578|NCT01282138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25629579|NCT01282138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25629580|NCT01282138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25629581|NCT01282138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25629582|NCT01282138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25629583|NCT01282138|Histamine Antagonists|histamine antagonists|mesh-ancestor
25629584|NCT01282138|Histamine Agents|histamine agents|mesh-ancestor
25629585|NCT01282138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25629586|NCT01282138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629587|NCT01282164|Insulin|insulin|mesh-list
25629588|NCT01282164|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25629589|NCT01282164|Glucagon|glucagon|mesh-list
25629590|NCT01282164|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25629591|NCT01282164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25629592|NCT01282164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629593|NCT01282164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25629594|NCT01282164|Hormones|hormones|mesh-ancestor
25629595|NCT01282164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25629596|NCT01282164|Incretins|incretins|mesh-ancestor
25629597|NCT01282242|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25629598|NCT01282242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25629599|NCT01282242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25629600|NCT01282242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629601|NCT01282424|Idelalisib|idelalisib|mesh-list
25524175|NCT00480636|Dalteparin|dalteparin|mesh-list
25629602|NCT01282424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629603|NCT01282424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629604|NCT01282424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629606|NCT01282463|Ramucirumab|ramucirumab|mesh-list
25629607|NCT01282463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629608|NCT01282463|Tubulin Modulators|tubulin modulators|mesh-ancestor
25629609|NCT01282463|Antimitotic Agents|antimitotic agents|mesh-ancestor
25629610|NCT01282463|Mitosis Modulators|mitosis modulators|mesh-ancestor
25629611|NCT01282463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629612|NCT01282476|Rituximab|rituximab|mesh-list
25629613|NCT01282476|Panobinostat|panobinostat|mesh-list
25629614|NCT01282476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25629615|NCT01282476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629616|NCT01282476|Immunologic Factors|immunologic factors|mesh-ancestor
25629617|NCT01282476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629618|NCT01282476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25629619|NCT01282476|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25629620|NCT01282476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25717296|NCT02411292|Anticoagulants|anticoagulants|mesh-ancestor
25629621|NCT01282476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629622|NCT01282801|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25629623|NCT01282801|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25629624|NCT01282801|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25629625|NCT01282801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25629626|NCT01282801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629627|NCT01282801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25629628|NCT01282801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629629|NCT01282801|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25629630|NCT01282801|Antidepressive Agents|antidepressive agents|mesh-ancestor
25629631|NCT01282801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25629632|NCT01282814|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25629633|NCT01282814|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25629634|NCT01282814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25629635|NCT01282814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25629636|NCT01282814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629637|NCT01282814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25629638|NCT01282814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629639|NCT01282814|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25629640|NCT01282814|Antidepressive Agents|antidepressive agents|mesh-ancestor
25629641|NCT01282814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25629642|NCT01283009|Methylprednisolone|methylprednisolone|mesh-list
25629643|NCT01283009|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25629644|NCT01283009|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25629645|NCT01283009|Prednisolone|prednisolone|mesh-list
25629646|NCT01283009|Prednisolone acetate|prednisolone acetate|mesh-list
25629647|NCT01283009|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25629648|NCT01283009|Prednisolone phosphate|prednisolone phosphate|mesh-list
25629649|NCT01283009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25629650|NCT01283009|Antiemetics|antiemetics|mesh-ancestor
25629651|NCT01283009|Autonomic Agents|autonomic agents|mesh-ancestor
25629652|NCT01283009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25629653|NCT01283009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629654|NCT01283009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25629655|NCT01283009|Glucocorticoids|glucocorticoids|mesh-ancestor
25629656|NCT01283009|Hormones|hormones|mesh-ancestor
25629657|NCT01283009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25629658|NCT01283009|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25629659|NCT01283009|Protective Agents|protective agents|mesh-ancestor
25629660|NCT01283009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25629661|NCT01283009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629662|NCT01283139|Sifalimumab|sifalimumab|mesh-list
25629663|NCT01283139|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25629664|NCT01283139|Immunologic Factors|immunologic factors|mesh-ancestor
25629665|NCT01283139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629666|NCT01283152|Lactulose|lactulose|mesh-list
25629667|NCT01283152|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25629668|NCT01283152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25629669|NCT01283152|Laxatives|laxatives|mesh-ancestor
25629670|NCT01283282|Clopidogrel|clopidogrel|mesh-list
25629671|NCT01283282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25629672|NCT01283282|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25524247|NCT00481351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25629673|NCT01283282|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25629674|NCT01283282|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25629675|NCT01283282|Purinergic Agents|purinergic agents|mesh-ancestor
25629676|NCT01283282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25629677|NCT01283282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629678|NCT01283282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629679|NCT01283334|Carboplatin|carboplatin|mesh-list
25629680|NCT01283334|Cetuximab|cetuximab|mesh-list
25629681|NCT01283334|Everolimus|everolimus|mesh-list
25629682|NCT01283334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629683|NCT01283334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25629684|NCT01283334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25629685|NCT01283334|Immunologic Factors|immunologic factors|mesh-ancestor
25629686|NCT01283334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629687|NCT01283386|Cyclophosphamide|cyclophosphamide|mesh-list
25629688|NCT01283386|Chlorambucil|chlorambucil|mesh-list
25629689|NCT01283386|Rituximab|rituximab|mesh-list
25629690|NCT01283386|Fludarabine|fludarabine|mesh-list
25629691|NCT01283386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25629692|NCT01283386|Immunologic Factors|immunologic factors|mesh-ancestor
25629693|NCT01283386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629694|NCT01283386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25629695|NCT01283386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25629696|NCT01283386|Alkylating Agents|alkylating agents|mesh-ancestor
25629697|NCT01283386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629698|NCT01283386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629699|NCT01283386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25629700|NCT01283386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25629701|NCT01283464|Vitamin A|vitamin a|mesh-list
25629702|NCT01283464|Tretinoin|tretinoin|mesh-list
25629703|NCT01283464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629704|NCT01283464|Keratolytic Agents|keratolytic agents|mesh-ancestor
25629705|NCT01283464|Dermatologic Agents|dermatologic agents|mesh-ancestor
25629706|NCT01283464|Vitamins|vitamins|mesh-ancestor
25629707|NCT01283464|Micronutrients|micronutrients|mesh-ancestor
25629708|NCT01283464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629709|NCT01283516|Ceritinib|ceritinib|mesh-list
25629710|NCT01283516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629711|NCT01283516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25629712|NCT01283516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629713|NCT01283516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629714|NCT01283542|Pasireotide|pasireotide|mesh-list
25629715|NCT01283542|Hormones|hormones|mesh-ancestor
25629716|NCT01283542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25629717|NCT01283542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629718|NCT01283555|Tenofovir|tenofovir|mesh-list
25629719|NCT01283555|Antiviral Agents|antiviral agents|mesh-ancestor
25629720|NCT01283555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25629721|NCT01283555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25629722|NCT01283555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25629723|NCT01283555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629724|NCT01283555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629725|NCT01283555|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25629726|NCT01283555|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25629727|NCT01283581|Vancomycin|vancomycin|mesh-list
25629728|NCT01283581|Linezolid|linezolid|mesh-list
25629729|NCT01283581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25629730|NCT01283581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25629731|NCT01283581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25629732|NCT01283581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629733|NCT01283581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629734|NCT01283971|Adalimumab|adalimumab|mesh-list
25629735|NCT01283971|Methotrexate|methotrexate|mesh-list
25629736|NCT01283971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25629737|NCT01283971|Abortifacient Agents|abortifacient agents|mesh-ancestor
25629738|NCT01283971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25629739|NCT01283971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629740|NCT01283971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25629741|NCT01283971|Antimetabolites|antimetabolites|mesh-ancestor
25629742|NCT01283971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629743|NCT01283971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629744|NCT01283971|Dermatologic Agents|dermatologic agents|mesh-ancestor
25629745|NCT01283971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629746|NCT01283971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25524322|NCT00481832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25629747|NCT01283971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25629748|NCT01283971|Immunologic Factors|immunologic factors|mesh-ancestor
25629749|NCT01283971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25629750|NCT01283971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25629751|NCT01283971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25629752|NCT01284296|Chrysarobin|chrysarobin|mesh-list
25629753|NCT01284296|Lidocaine|lidocaine|mesh-list
25629754|NCT01284296|Anesthetics, Local|anesthetics, local|mesh-ancestor
25629755|NCT01284296|Anesthetics|anesthetics|mesh-ancestor
25629756|NCT01284296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25629757|NCT01284296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629758|NCT01284296|Sensory System Agents|sensory system agents|mesh-ancestor
25629759|NCT01284296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25629760|NCT01284296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25629761|NCT01284296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25629762|NCT01284296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25629763|NCT01284296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25629764|NCT01284296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629765|NCT01284296|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25629766|NCT01284296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25629767|NCT01284296|Analgesics|analgesics|mesh-ancestor
25629768|NCT01284296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25629769|NCT01284296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25629770|NCT01284335|Gemcitabine|gemcitabine|mesh-list
25629771|NCT01284335|Cisplatin|cisplatin|mesh-list
25629772|NCT01284335|Docetaxel|docetaxel|mesh-list
25629773|NCT01284335|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25629774|NCT01284335|Temozolomide|temozolomide|mesh-list
25629775|NCT01284335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629776|NCT01284335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25629777|NCT01284335|Antimetabolites|antimetabolites|mesh-ancestor
25629778|NCT01284335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629779|NCT01284335|Antiviral Agents|antiviral agents|mesh-ancestor
25629780|NCT01284335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25629781|NCT01284335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629782|NCT01284335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25629783|NCT01284335|Immunologic Factors|immunologic factors|mesh-ancestor
25629784|NCT01284335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629785|NCT01284335|Tubulin Modulators|tubulin modulators|mesh-ancestor
25629786|NCT01284335|Antimitotic Agents|antimitotic agents|mesh-ancestor
25629787|NCT01284335|Mitosis Modulators|mitosis modulators|mesh-ancestor
25629788|NCT01284335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25629789|NCT01284335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25629790|NCT01284335|Alkylating Agents|alkylating agents|mesh-ancestor
25629791|NCT01284517|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25629792|NCT01284517|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25629793|NCT01284517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25629794|NCT01284517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25629795|NCT01284517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629796|NCT01284517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25629797|NCT01284517|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25629798|NCT01284517|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25629799|NCT01284517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25629800|NCT01284517|Adrenergic Agents|adrenergic agents|mesh-ancestor
25629801|NCT01284517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25629802|NCT01284517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629803|NCT01284517|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25629804|NCT01284517|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25629805|NCT01284517|Serotonin Agents|serotonin agents|mesh-ancestor
25629806|NCT01284517|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25629807|NCT01284517|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25629808|NCT01284517|Dopamine Agents|dopamine agents|mesh-ancestor
25629809|NCT01284621|Empagliflozin|empagliflozin|mesh-list
25629810|NCT01284621|Ramipril|ramipril|mesh-list
25717323|NCT02412111|Ivacaftor|ivacaftor|mesh-list
25629811|NCT01284621|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25629812|NCT01284621|Protease Inhibitors|protease inhibitors|mesh-ancestor
25629813|NCT01284621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629814|NCT01284621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629815|NCT01284621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25629816|NCT01284621|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25629817|NCT01284621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25629818|NCT01284621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629819|NCT01284634|Cannabidiol|cannabidiol|mesh-list
25629820|NCT01284634|Anticonvulsants|anticonvulsants|mesh-ancestor
25629821|NCT01284959|Risperidone|risperidone|mesh-list
25629822|NCT01284959|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25629823|NCT01284959|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25629824|NCT01284959|Serotonin Agents|serotonin agents|mesh-ancestor
25629825|NCT01284959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25629826|NCT01284959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629827|NCT01284959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629828|NCT01284959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25629829|NCT01284959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25629830|NCT01284959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25629831|NCT01284959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25629832|NCT01284959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25629833|NCT01284959|Dopamine Agents|dopamine agents|mesh-ancestor
25629834|NCT01284959|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25629835|NCT01284959|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25629836|NCT01285050|Tenofovir|tenofovir|mesh-list
25629837|NCT01285050|Emtricitabine|emtricitabine|mesh-list
25629838|NCT01285050|Raltegravir Potassium|raltegravir potassium|mesh-list
25629839|NCT01285050|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25629840|NCT01285050|Antiviral Agents|antiviral agents|mesh-ancestor
25629841|NCT01285050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25629842|NCT01285050|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25629843|NCT01285050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25629844|NCT01285050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629845|NCT01285050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629846|NCT01285050|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25629847|NCT01285050|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25629848|NCT01285050|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25629849|NCT01285310|Thalidomide|thalidomide|mesh-list
25629850|NCT01285310|Apremilast|apremilast|mesh-list
25629851|NCT01285310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25629852|NCT01285310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25629853|NCT01285310|Analgesics|analgesics|mesh-ancestor
25629854|NCT01285310|Sensory System Agents|sensory system agents|mesh-ancestor
25629855|NCT01285310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25629856|NCT01285310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629857|NCT01285310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25629858|NCT01285310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25629859|NCT01285310|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25629860|NCT01285310|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25629861|NCT01285310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629862|NCT01285310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629863|NCT01285310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25629864|NCT01285310|Immunologic Factors|immunologic factors|mesh-ancestor
25629865|NCT01285310|Leprostatic Agents|leprostatic agents|mesh-ancestor
25629866|NCT01285310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25629867|NCT01285310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25629868|NCT01285310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25629869|NCT01285310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25629870|NCT01285310|Growth Substances|growth substances|mesh-ancestor
25629871|NCT01285310|Growth Inhibitors|growth inhibitors|mesh-ancestor
25629872|NCT01285310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629873|NCT01285323|Reslizumab|reslizumab|mesh-list
25629874|NCT01285323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25629875|NCT01285323|Respiratory System Agents|respiratory system agents|mesh-ancestor
25629876|NCT01285401|Interferons|interferons|mesh-list
25629877|NCT01285401|Interferon-beta|interferon-beta|mesh-list
25629878|NCT01285401|Interferon beta-1a|interferon beta-1a|mesh-list
25629879|NCT01285401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629880|NCT01285401|Antiviral Agents|antiviral agents|mesh-ancestor
25629881|NCT01285401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25629882|NCT01285401|Immunologic Factors|immunologic factors|mesh-ancestor
25629883|NCT01285401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629884|NCT01285401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25629885|NCT01285492|Tiotropium Bromide|tiotropium bromide|mesh-list
25629886|NCT01285492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25629887|NCT01285492|Autonomic Agents|autonomic agents|mesh-ancestor
25629888|NCT01285492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25629889|NCT01285492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629890|NCT01285492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25629891|NCT01285492|Respiratory System Agents|respiratory system agents|mesh-ancestor
25629892|NCT01285492|Parasympatholytics|parasympatholytics|mesh-ancestor
25524460|NCT00482391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629893|NCT01285492|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25629894|NCT01285492|Cholinergic Agents|cholinergic agents|mesh-ancestor
25629895|NCT01285492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25629896|NCT01285492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629898|NCT01285609|Carboplatin|carboplatin|mesh-list
25629899|NCT01285609|Ipilimumab|ipilimumab|mesh-list
25629900|NCT01285609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25629901|NCT01285609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629902|NCT01285609|Tubulin Modulators|tubulin modulators|mesh-ancestor
25629903|NCT01285609|Antimitotic Agents|antimitotic agents|mesh-ancestor
25629904|NCT01285609|Mitosis Modulators|mitosis modulators|mesh-ancestor
25629905|NCT01285609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629906|NCT01285609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25629907|NCT01285609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25629908|NCT01285635|Docetaxel|docetaxel|mesh-list
25629909|NCT01285635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629910|NCT01285635|Tubulin Modulators|tubulin modulators|mesh-ancestor
25629911|NCT01285635|Antimitotic Agents|antimitotic agents|mesh-ancestor
25629912|NCT01285635|Mitosis Modulators|mitosis modulators|mesh-ancestor
25629913|NCT01285635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655909|NCT01568112|Aspirin|aspirin|mesh-list
25655910|NCT01568112|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25655911|NCT01568112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25655912|NCT01568112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25655913|NCT01568112|Analgesics|analgesics|mesh-ancestor
25655914|NCT01568112|Sensory System Agents|sensory system agents|mesh-ancestor
25655915|NCT01568112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25655916|NCT01568112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655917|NCT01568112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25655918|NCT01568112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25655919|NCT01568112|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25655920|NCT01568112|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25655921|NCT01568112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655922|NCT01568112|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25655923|NCT01568112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25655924|NCT01568112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655925|NCT01568112|Antipyretics|antipyretics|mesh-ancestor
25655926|NCT01568112|Dermatologic Agents|dermatologic agents|mesh-ancestor
25655927|NCT01568112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25655928|NCT01568112|Immunologic Factors|immunologic factors|mesh-ancestor
25655929|NCT01568255|Ergocalciferols|ergocalciferols|mesh-list
25655930|NCT01568255|Vitamin D|vitamin d|mesh-list
25655931|NCT01568255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25655932|NCT01568255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655933|NCT01568255|Vitamins|vitamins|mesh-ancestor
25655934|NCT01568255|Micronutrients|micronutrients|mesh-ancestor
25655935|NCT01568255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25655936|NCT01568528|Oxytocin|oxytocin|mesh-list
25655937|NCT01568528|Oxytocics|oxytocics|mesh-ancestor
25655938|NCT01568528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25655939|NCT01568528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655940|NCT01568892|Dolutegravir|dolutegravir|mesh-list
25655941|NCT01568892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25655942|NCT01568892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25655943|NCT01568892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655944|NCT01568892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655945|NCT01568892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25655946|NCT01568892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25655947|NCT01568892|Antiviral Agents|antiviral agents|mesh-ancestor
25655948|NCT01568892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25655949|NCT01568905|Nicotine|nicotine|mesh-list
25655950|NCT01568905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25655951|NCT01568905|Autonomic Agents|autonomic agents|mesh-ancestor
25655952|NCT01568905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25655953|NCT01568905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655954|NCT01568905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25655955|NCT01568905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25655956|NCT01568905|Cholinergic Agents|cholinergic agents|mesh-ancestor
25655957|NCT01568905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25655958|NCT01568905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524531|NCT00482911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25524532|NCT00482911|Alkylating Agents|alkylating agents|mesh-ancestor
25524533|NCT00482911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655959|NCT01568944|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25655960|NCT01568944|Lansoprazole|lansoprazole|mesh-list
25655961|NCT01568944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25655962|NCT01568944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25629915|NCT01285908|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25629916|NCT01285908|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25629917|NCT01285908|Adrenergic Agents|adrenergic agents|mesh-ancestor
25629918|NCT01285908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25629919|NCT01285908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629920|NCT01285908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629921|NCT01285908|Sympathomimetics|sympathomimetics|mesh-ancestor
25629922|NCT01285908|Autonomic Agents|autonomic agents|mesh-ancestor
25629923|NCT01285908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25629924|NCT01285908|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25629925|NCT01286077|Bortezomib|bortezomib|mesh-list
25629926|NCT01286077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629927|NCT01286168|Chlorhexidine|chlorhexidine|mesh-list
25629928|NCT01286168|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25629929|NCT01286168|Sodium Hypochlorite|sodium hypochlorite|mesh-list
25629930|NCT01286168|Eusol|eusol|mesh-list
25629931|NCT01286168|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25629932|NCT01286168|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25629933|NCT01286168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25629934|NCT01286168|Disinfectants|disinfectants|mesh-ancestor
25629935|NCT01286168|Dermatologic Agents|dermatologic agents|mesh-ancestor
25629936|NCT01286259|Disulfiram|disulfiram|mesh-list
25629937|NCT01286259|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25629938|NCT01286259|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25629939|NCT01286259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629940|NCT01286259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629941|NCT01286402|Bupropion|bupropion|mesh-list
25629942|NCT01286402|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25629943|NCT01286402|Antidepressive Agents|antidepressive agents|mesh-ancestor
25629944|NCT01286402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25629945|NCT01286402|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25629946|NCT01286402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25629947|NCT01286402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25629948|NCT01286402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629949|NCT01286402|Dopamine Agents|dopamine agents|mesh-ancestor
25629950|NCT01286402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25629951|NCT01286402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629952|NCT01286402|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25629953|NCT01286402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25629954|NCT01286402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629955|NCT01286454|Fesoterodine|fesoterodine|mesh-list
25629956|NCT01286454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25629957|NCT01286454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25629958|NCT01286454|Cholinergic Agents|cholinergic agents|mesh-ancestor
25629959|NCT01286454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25629960|NCT01286454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629961|NCT01286454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629962|NCT01286454|Urological Agents|urological agents|mesh-ancestor
25629963|NCT01286558|Amlodipine|amlodipine|mesh-list
25629964|NCT01286558|Telmisartan|telmisartan|mesh-list
25629965|NCT01286558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25629966|NCT01286558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25629967|NCT01286558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25629968|NCT01286558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629969|NCT01286558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25629970|NCT01286558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629971|NCT01286558|Vasodilator Agents|vasodilator agents|mesh-ancestor
25629972|NCT01286558|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25629973|NCT01286558|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25629974|NCT01286740|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
25629975|NCT01286740|Antiviral Agents|antiviral agents|mesh-ancestor
25629976|NCT01286740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25629977|NCT01286740|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25629978|NCT01286740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25629979|NCT01286740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25629980|NCT01286740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629981|NCT01286740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25629982|NCT01286740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25629983|NCT01286753|Vemurafenib|vemurafenib|mesh-list
25629984|NCT01286753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25629985|NCT01286753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25629987|NCT01286753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25629988|NCT01286805|Bupivacaine|bupivacaine|mesh-list
25629989|NCT01286805|Anesthetics, Local|anesthetics, local|mesh-ancestor
25629990|NCT01286805|Anesthetics|anesthetics|mesh-ancestor
25629991|NCT01286805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25629992|NCT01286805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25629993|NCT01286805|Sensory System Agents|sensory system agents|mesh-ancestor
25629994|NCT01286805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25629995|NCT01286818|Leucovorin|leucovorin|mesh-list
25629996|NCT01286818|Fluorouracil|fluorouracil|mesh-list
25629997|NCT01286818|Irinotecan|irinotecan|mesh-list
25629998|NCT01286818|Ramucirumab|ramucirumab|mesh-list
25629999|NCT01286818|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25630000|NCT01286818|Levoleucovorin|levoleucovorin|mesh-list
25630001|NCT01286818|Antimetabolites|antimetabolites|mesh-ancestor
25630002|NCT01286818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630003|NCT01286818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25630004|NCT01286818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630005|NCT01286818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25630006|NCT01286818|Immunologic Factors|immunologic factors|mesh-ancestor
25630007|NCT01286818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630008|NCT01286818|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25630009|NCT01286818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25630010|NCT01286818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630011|NCT01286818|Antidotes|antidotes|mesh-ancestor
25630012|NCT01286818|Protective Agents|protective agents|mesh-ancestor
25630013|NCT01286818|Vitamin B Complex|vitamin b complex|mesh-ancestor
25630014|NCT01286818|Vitamins|vitamins|mesh-ancestor
25630015|NCT01286818|Micronutrients|micronutrients|mesh-ancestor
25630016|NCT01286987|Talazoparib|talazoparib|mesh-list
24448229|NCT00310778|Autonomic Agents|autonomic agents|mesh-ancestor
25630017|NCT01286987|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25630018|NCT01286987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630019|NCT01286987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630020|NCT01286987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630021|NCT01287039|Reslizumab|reslizumab|mesh-list
25630022|NCT01287039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25630023|NCT01287039|Respiratory System Agents|respiratory system agents|mesh-ancestor
25630024|NCT01287078|Cyclosporine|cyclosporine|mesh-list
25630025|NCT01287078|Cyclosporins|cyclosporins|mesh-list
25630026|NCT01287078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630027|NCT01287078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630028|NCT01287078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25630029|NCT01287078|Immunologic Factors|immunologic factors|mesh-ancestor
25630030|NCT01287078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630031|NCT01287078|Antifungal Agents|antifungal agents|mesh-ancestor
25630032|NCT01287078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25630033|NCT01287078|Dermatologic Agents|dermatologic agents|mesh-ancestor
25630034|NCT01287078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25630035|NCT01287078|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25630036|NCT01287117|Omalizumab|omalizumab|mesh-list
25630037|NCT01287117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25630038|NCT01287117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25630039|NCT01287117|Respiratory System Agents|respiratory system agents|mesh-ancestor
25630040|NCT01287195|Omeprazole|omeprazole|mesh-list
25630041|NCT01287195|Muromonab-CD3|muromonab-cd3|mesh-list
25630042|NCT01287195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25630043|NCT01287195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25630044|NCT01287195|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25630045|NCT01287195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630046|NCT01287195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630047|NCT01287195|Immunologic Factors|immunologic factors|mesh-ancestor
25630048|NCT01287195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630049|NCT01287195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25630050|NCT01287221|Riboflavin|riboflavin|mesh-list
25630051|NCT01287221|Rifampin|rifampin|mesh-list
25630052|NCT01287221|Vitamins|vitamins|mesh-ancestor
25630053|NCT01287221|Micronutrients|micronutrients|mesh-ancestor
25630054|NCT01287221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630055|NCT01287221|Vitamin B Complex|vitamin b complex|mesh-ancestor
25630056|NCT01287221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25630057|NCT01287221|Antitubercular Agents|antitubercular agents|mesh-ancestor
25630058|NCT01287221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25630059|NCT01287221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25630060|NCT01287221|Leprostatic Agents|leprostatic agents|mesh-ancestor
25630061|NCT01287221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25630062|NCT01287221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630063|NCT01287221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630064|NCT01287221|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25630065|NCT01287221|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25630066|NCT01287221|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25630067|NCT01287221|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25630068|NCT01287221|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25630069|NCT01287221|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25630070|NCT01287221|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25630071|NCT01287221|Dermatologic Agents|dermatologic agents|mesh-ancestor
25630072|NCT01287364|Mometasone Furoate|mometasone furoate|mesh-list
25630073|NCT01287364|Ciclesonide|ciclesonide|mesh-list
25630074|NCT01287364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25630075|NCT01287364|Dermatologic Agents|dermatologic agents|mesh-ancestor
25630076|NCT01287364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25630077|NCT01287364|Glucocorticoids|glucocorticoids|mesh-ancestor
25630078|NCT01287364|Hormones|hormones|mesh-ancestor
25630079|NCT01287364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25630080|NCT01287364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630081|NCT01287377|Nicotine|nicotine|mesh-list
25630082|NCT01287377|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25630083|NCT01287377|Autonomic Agents|autonomic agents|mesh-ancestor
25630084|NCT01287377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25630085|NCT01287377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630086|NCT01287377|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25630087|NCT01287377|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25630088|NCT01287377|Cholinergic Agents|cholinergic agents|mesh-ancestor
25630089|NCT01287377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25630090|NCT01287377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630091|NCT01287520|Carboplatin|carboplatin|mesh-list
25630092|NCT01287520|Pemetrexed|pemetrexed|mesh-list
25630093|NCT01287520|Ranitidine|ranitidine|mesh-list
25630094|NCT01287520|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
25630095|NCT01287520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630096|NCT01287520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630097|NCT01287520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630098|NCT01287520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25630099|NCT01287520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25630100|NCT01287520|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25630101|NCT01287520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25630102|NCT01287520|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25630103|NCT01287520|Histamine Antagonists|histamine antagonists|mesh-ancestor
25630104|NCT01287520|Histamine Agents|histamine agents|mesh-ancestor
25630105|NCT01287520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25630106|NCT01287520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630107|NCT01287754|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25630108|NCT01287754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630109|NCT01287754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25630110|NCT01287754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630111|NCT01287754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630112|NCT01287832|Vancomycin|vancomycin|mesh-list
25630113|NCT01287832|Daptomycin|daptomycin|mesh-list
25630114|NCT01287832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25630115|NCT01287832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25630116|NCT01288079|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25630117|NCT01288079|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25630118|NCT01288079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25630119|NCT01288079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25630120|NCT01288079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630121|NCT01288079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25630122|NCT01288079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630123|NCT01288079|Analgesics|analgesics|mesh-ancestor
25630124|NCT01288079|Sensory System Agents|sensory system agents|mesh-ancestor
25630125|NCT01288079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25630126|NCT01288079|Antidepressive Agents|antidepressive agents|mesh-ancestor
25630127|NCT01288079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25630128|NCT01288079|Dopamine Agents|dopamine agents|mesh-ancestor
25630129|NCT01288209|Ribavirin|ribavirin|mesh-list
25630130|NCT01288209|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25630131|NCT01288209|Simeprevir|simeprevir|mesh-list
25630132|NCT01288209|Antimetabolites|antimetabolites|mesh-ancestor
25630133|NCT01288209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630134|NCT01288209|Antiviral Agents|antiviral agents|mesh-ancestor
25630135|NCT01288209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25630136|NCT01288209|Protease Inhibitors|protease inhibitors|mesh-ancestor
25630137|NCT01288209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630138|NCT01288443|Atorvastatin|atorvastatin|mesh-list
25630139|NCT01288443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25630140|NCT01288443|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25630141|NCT01288443|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25630142|NCT01288443|Antimetabolites|antimetabolites|mesh-ancestor
25630143|NCT01288443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630144|NCT01288443|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25630145|NCT01288443|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25630146|NCT01288443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630147|NCT01288443|Immunologic Factors|immunologic factors|mesh-ancestor
25630148|NCT01288443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630149|NCT01288469|Atorvastatin|atorvastatin|mesh-list
25630150|NCT01288469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25630151|NCT01288469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25630152|NCT01288469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25630153|NCT01288469|Antimetabolites|antimetabolites|mesh-ancestor
25630154|NCT01288469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630155|NCT01288469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25630156|NCT01288469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25630157|NCT01288469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630158|NCT01288469|Immunologic Factors|immunologic factors|mesh-ancestor
25630159|NCT01288469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630160|NCT01288521|Ketoconazole|ketoconazole|mesh-list
25630161|NCT01288521|Tacrolimus|tacrolimus|mesh-list
25630162|NCT01288521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25630163|NCT01288521|Immunologic Factors|immunologic factors|mesh-ancestor
25630164|NCT01288521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630165|NCT01288521|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25630166|NCT01288521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630167|NCT01288521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630168|NCT01288521|Antifungal Agents|antifungal agents|mesh-ancestor
25630169|NCT01288521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25630170|NCT01288521|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25630171|NCT01288521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25630172|NCT01288521|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25630173|NCT01288521|Hormone Antagonists|hormone antagonists|mesh-ancestor
25630174|NCT01288521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25630175|NCT01288521|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25630176|NCT01288781|Acetazolamide|acetazolamide|mesh-list
25630177|NCT01288781|Anticonvulsants|anticonvulsants|mesh-ancestor
25630178|NCT01288781|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25630179|NCT01288781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630180|NCT01288781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630181|NCT01288781|Diuretics|diuretics|mesh-ancestor
25630182|NCT01288781|Natriuretic Agents|natriuretic agents|mesh-ancestor
25630183|NCT01288781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630184|NCT01288807|Milnacipran|milnacipran|mesh-list
25630185|NCT01288807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25630186|NCT01288807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25630187|NCT01288807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25630188|NCT01288807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630189|NCT01288807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25630190|NCT01288807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630191|NCT01288807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25630192|NCT01288807|Analgesics|analgesics|mesh-ancestor
25630193|NCT01288807|Sensory System Agents|sensory system agents|mesh-ancestor
25630194|NCT01288807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25630195|NCT01288859|Curcumin|curcumin|mesh-list
25630196|NCT01288859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25630197|NCT01288859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25630198|NCT01288859|Analgesics|analgesics|mesh-ancestor
25630199|NCT01288859|Sensory System Agents|sensory system agents|mesh-ancestor
25630200|NCT01288859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25630201|NCT01288859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630202|NCT01288859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25630203|NCT01288859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25630204|NCT01288859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630205|NCT01288859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630206|NCT01288859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630207|NCT01288937|Milnacipran|milnacipran|mesh-list
25630208|NCT01288937|Levomilnacipran|levomilnacipran|mesh-list
25630209|NCT01288937|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25630210|NCT01288937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25630211|NCT01288937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25630212|NCT01288937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630213|NCT01288937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25630214|NCT01288937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630215|NCT01288937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25630216|NCT01288937|Analgesics|analgesics|mesh-ancestor
25630217|NCT01288937|Sensory System Agents|sensory system agents|mesh-ancestor
25630218|NCT01288937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25630219|NCT01288937|Antidepressive Agents|antidepressive agents|mesh-ancestor
25630220|NCT01288937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25630221|NCT01289067|Satraplatin|satraplatin|mesh-list
25630222|NCT01289067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630223|NCT01289119|Metformin|metformin|mesh-list
25630224|NCT01289119|Pioglitazone|pioglitazone|mesh-list
25630225|NCT01289119|Alogliptin|alogliptin|mesh-list
25630226|NCT01289119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25630227|NCT01289119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630228|NCT01289119|Incretins|incretins|mesh-ancestor
25630229|NCT01289119|Hormones|hormones|mesh-ancestor
25630230|NCT01289119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25630231|NCT01289119|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25630232|NCT01289119|Protease Inhibitors|protease inhibitors|mesh-ancestor
25630233|NCT01289119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630234|NCT01289119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630235|NCT01289275|Nicotine|nicotine|mesh-list
25630236|NCT01289275|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25630237|NCT01289275|Autonomic Agents|autonomic agents|mesh-ancestor
25630238|NCT01289275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25630239|NCT01289275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630240|NCT01289275|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25630241|NCT01289275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25630242|NCT01289275|Cholinergic Agents|cholinergic agents|mesh-ancestor
25630243|NCT01289275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25630244|NCT01289275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630245|NCT01289353|Carboplatin|carboplatin|mesh-list
25630246|NCT01289353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630247|NCT01289457|Cytarabine|cytarabine|mesh-list
25630248|NCT01289457|Fludarabine|fludarabine|mesh-list
25630249|NCT01289457|Idarubicin|idarubicin|mesh-list
25630250|NCT01289457|Clofarabine|clofarabine|mesh-list
25630251|NCT01289457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630252|NCT01289457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25630253|NCT01289457|Antimetabolites|antimetabolites|mesh-ancestor
25630254|NCT01289457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630255|NCT01289457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25630256|NCT01289457|Immunologic Factors|immunologic factors|mesh-ancestor
25630257|NCT01289457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630258|NCT01289457|Antiviral Agents|antiviral agents|mesh-ancestor
25630259|NCT01289457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25630260|NCT01289457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25630261|NCT01289457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25630262|NCT01289457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25630263|NCT01289457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630264|NCT01289522|Cetuximab|cetuximab|mesh-list
25630265|NCT01289522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25630266|NCT01289522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630267|NCT01289639|Pioglitazone|pioglitazone|mesh-list
25630268|NCT01289639|Fenofibrate|fenofibrate|mesh-list
25630269|NCT01289639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25630270|NCT01289639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630271|NCT01289639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25630272|NCT01289639|Antimetabolites|antimetabolites|mesh-ancestor
25630273|NCT01289639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630274|NCT01289639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25630275|NCT01289678|Interleukin-2|interleukin-2|mesh-list
25630276|NCT01289678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630277|NCT01289678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25630278|NCT01289678|Analgesics|analgesics|mesh-ancestor
25630279|NCT01289678|Sensory System Agents|sensory system agents|mesh-ancestor
25630280|NCT01289678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25630281|NCT01289678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630282|NCT01289782|Ribavirin|ribavirin|mesh-list
25630283|NCT01289782|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25630284|NCT01289782|Simeprevir|simeprevir|mesh-list
25630285|NCT01289782|Antimetabolites|antimetabolites|mesh-ancestor
25630286|NCT01289782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630287|NCT01289782|Antiviral Agents|antiviral agents|mesh-ancestor
25630288|NCT01289782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25630289|NCT01289782|Protease Inhibitors|protease inhibitors|mesh-ancestor
25630290|NCT01289782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630291|NCT01289821|Leucovorin|leucovorin|mesh-list
25630292|NCT01289821|Folic Acid|folic acid|mesh-list
25630293|NCT01289821|Oxaliplatin|oxaliplatin|mesh-list
25630294|NCT01289821|Levoleucovorin|levoleucovorin|mesh-list
25630295|NCT01289821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630296|NCT01289821|Antidotes|antidotes|mesh-ancestor
25630297|NCT01289821|Protective Agents|protective agents|mesh-ancestor
25630298|NCT01289821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630299|NCT01289821|Vitamin B Complex|vitamin b complex|mesh-ancestor
25630300|NCT01289821|Vitamins|vitamins|mesh-ancestor
25630301|NCT01289821|Micronutrients|micronutrients|mesh-ancestor
25630302|NCT01289821|Hematinics|hematinics|mesh-ancestor
25630303|NCT01289847|gamma-Globulins|gamma-globulins|mesh-list
25630304|NCT01289847|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25630305|NCT01289847|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25630306|NCT01289847|Immunologic Factors|immunologic factors|mesh-ancestor
25630307|NCT01289847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630308|NCT01289912|Everolimus|everolimus|mesh-list
25630309|NCT01289912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630310|NCT01289912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25630311|NCT01289912|Immunologic Factors|immunologic factors|mesh-ancestor
25630312|NCT01289912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630313|NCT01289990|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25630314|NCT01289990|Empagliflozin|empagliflozin|mesh-list
25630315|NCT01289990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25630316|NCT01289990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630317|NCT01289990|Incretins|incretins|mesh-ancestor
25630318|NCT01289990|Hormones|hormones|mesh-ancestor
25630319|NCT01289990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25630320|NCT01289990|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25630321|NCT01289990|Protease Inhibitors|protease inhibitors|mesh-ancestor
25630322|NCT01289990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630323|NCT01289990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630324|NCT01289990|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25630325|NCT01290029|Cinacalcet|cinacalcet|mesh-list
25630326|NCT01290029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25630327|NCT01290029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630328|NCT01290029|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25630329|NCT01290029|Hormone Antagonists|hormone antagonists|mesh-ancestor
25630330|NCT01290029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25630331|NCT01290094|Ibandronic Acid|ibandronic acid|mesh-list
25630332|NCT01290094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25630333|NCT01290094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630334|NCT01290237|Vancomycin|vancomycin|mesh-list
25630335|NCT01290237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25630336|NCT01290237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25630337|NCT01290263|Bevacizumab|bevacizumab|mesh-list
25630338|NCT01290263|Trebananib|trebananib|mesh-list
25630339|NCT01290263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25630340|NCT01290263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630341|NCT01290263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25630342|NCT01290263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25630343|NCT01290263|Growth Substances|growth substances|mesh-ancestor
25630344|NCT01290263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630345|NCT01290263|Growth Inhibitors|growth inhibitors|mesh-ancestor
25630346|NCT01290315|Dextrans|dextrans|mesh-list
25630347|NCT01290315|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25630348|NCT01290315|Iron-Dextran Complex|iron-dextran complex|mesh-list
25630349|NCT01290315|Hematinics|hematinics|mesh-ancestor
25630350|NCT01290315|Anticoagulants|anticoagulants|mesh-ancestor
25630351|NCT01290315|Plasma Substitutes|plasma substitutes|mesh-ancestor
25630352|NCT01290315|Blood Substitutes|blood substitutes|mesh-ancestor
25630353|NCT01290341|Naftifine|naftifine|mesh-list
25630354|NCT01290341|Antifungal Agents|antifungal agents|mesh-ancestor
25630355|NCT01290341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25630356|NCT01290445|Varenicline|varenicline|mesh-list
25630357|NCT01290445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25630358|NCT01290445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25630359|NCT01290445|Cholinergic Agents|cholinergic agents|mesh-ancestor
25524981|NCT00486902|Ketamine|ketamine|mesh-list
25630360|NCT01290445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25630361|NCT01290445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630362|NCT01290445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630363|NCT01290484|Sildenafil Citrate|sildenafil citrate|mesh-list
25630364|NCT01290484|Vasodilator Agents|vasodilator agents|mesh-ancestor
25630365|NCT01290484|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25630366|NCT01290484|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25630367|NCT01290484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630368|NCT01290484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630369|NCT01290484|Urological Agents|urological agents|mesh-ancestor
25630370|NCT01290601|Chloroquine|chloroquine|mesh-list
25630371|NCT01290601|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
25630372|NCT01290601|Primaquine|primaquine|mesh-list
25630373|NCT01290601|Tafenoquine|tafenoquine|mesh-list
25630374|NCT01290601|Amebicides|amebicides|mesh-ancestor
25630375|NCT01290601|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25630376|NCT01290601|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25630377|NCT01290601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25630378|NCT01290601|Antimalarials|antimalarials|mesh-ancestor
25630379|NCT01290601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25630380|NCT01290601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25630381|NCT01290601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25630382|NCT01290601|Analgesics|analgesics|mesh-ancestor
25630383|NCT01290601|Sensory System Agents|sensory system agents|mesh-ancestor
25630384|NCT01290601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25630385|NCT01290601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630386|NCT01290601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25630387|NCT01290601|Filaricides|filaricides|mesh-ancestor
25630388|NCT01290601|Antinematodal Agents|antinematodal agents|mesh-ancestor
25630389|NCT01290601|Anthelmintics|anthelmintics|mesh-ancestor
25655963|NCT01568944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25655964|NCT01568944|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25655965|NCT01568944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655966|NCT01568944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655967|NCT01569087|Lenograstim|lenograstim|mesh-list
25655968|NCT01569087|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25655969|NCT01569087|Immunologic Factors|immunologic factors|mesh-ancestor
25655970|NCT01569087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655971|NCT01569126|Fluoxetine|fluoxetine|mesh-list
25655972|NCT01569126|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25655973|NCT01569126|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25655974|NCT01569126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25655975|NCT01569126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655976|NCT01569126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25655977|NCT01569126|Serotonin Agents|serotonin agents|mesh-ancestor
25655978|NCT01569126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655979|NCT01569126|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25655980|NCT01569126|Antidepressive Agents|antidepressive agents|mesh-ancestor
25655981|NCT01569126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25655982|NCT01569126|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25655983|NCT01569126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25655984|NCT01569126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655985|NCT01569152|Methotrexate|methotrexate|mesh-list
25655986|NCT01569152|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25655987|NCT01569152|Abortifacient Agents|abortifacient agents|mesh-ancestor
25655988|NCT01569152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25655989|NCT01569152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25655990|NCT01569152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25655991|NCT01569152|Antimetabolites|antimetabolites|mesh-ancestor
25655992|NCT01569152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25655993|NCT01569152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25655994|NCT01569152|Dermatologic Agents|dermatologic agents|mesh-ancestor
25655995|NCT01569152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25655996|NCT01569152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25655997|NCT01569152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25655998|NCT01569152|Immunologic Factors|immunologic factors|mesh-ancestor
25655999|NCT01569152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25656000|NCT01569152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25656001|NCT01569191|Anti-Allergic Agents|anti-allergic agents|mesh-list
25656002|NCT01569191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25656003|NCT01569191|Lubricant Eye Drops|lubricant eye drops|mesh-list
25656004|NCT01569191|Epinastine|epinastine|mesh-list
25656005|NCT01569191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25656006|NCT01569191|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25656007|NCT01569191|Histamine Antagonists|histamine antagonists|mesh-ancestor
25656008|NCT01569191|Histamine Agents|histamine agents|mesh-ancestor
25656009|NCT01569191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25630390|NCT01290679|Ribavirin|ribavirin|mesh-list
25630391|NCT01290679|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25630392|NCT01290679|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25630393|NCT01290679|Simeprevir|simeprevir|mesh-list
25630394|NCT01290679|Antimetabolites|antimetabolites|mesh-ancestor
25630395|NCT01290679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630396|NCT01290679|Antiviral Agents|antiviral agents|mesh-ancestor
25630397|NCT01290679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25630398|NCT01290679|Protease Inhibitors|protease inhibitors|mesh-ancestor
25630399|NCT01290679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630400|NCT01290731|Interferons|interferons|mesh-list
25630401|NCT01290731|Ribavirin|ribavirin|mesh-list
25630402|NCT01290731|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25630403|NCT01290731|Simeprevir|simeprevir|mesh-list
25630404|NCT01290731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630405|NCT01290731|Antiviral Agents|antiviral agents|mesh-ancestor
25630406|NCT01290731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25630407|NCT01290731|Antimetabolites|antimetabolites|mesh-ancestor
25630408|NCT01290731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630409|NCT01290731|Protease Inhibitors|protease inhibitors|mesh-ancestor
25630410|NCT01290731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630411|NCT01290757|Dabigatran|dabigatran|mesh-list
25630412|NCT01290757|Antithrombins|antithrombins|mesh-ancestor
25630413|NCT01290757|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25630414|NCT01290757|Protease Inhibitors|protease inhibitors|mesh-ancestor
25630415|NCT01290757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630416|NCT01290757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630417|NCT01290757|Anticoagulants|anticoagulants|mesh-ancestor
25630418|NCT01290874|Formoterol Fumarate|formoterol fumarate|mesh-list
25630419|NCT01290874|Tiotropium Bromide|tiotropium bromide|mesh-list
25630420|NCT01290874|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25630421|NCT01290874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25630422|NCT01290874|Autonomic Agents|autonomic agents|mesh-ancestor
25630423|NCT01290874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25630424|NCT01290874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630425|NCT01290874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25630426|NCT01290874|Respiratory System Agents|respiratory system agents|mesh-ancestor
25630427|NCT01290874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25630428|NCT01290874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25630429|NCT01290874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25630430|NCT01290874|Adrenergic Agents|adrenergic agents|mesh-ancestor
25630431|NCT01290874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25630432|NCT01290874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630433|NCT01290874|Parasympatholytics|parasympatholytics|mesh-ancestor
25630434|NCT01290874|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25630435|NCT01290874|Cholinergic Agents|cholinergic agents|mesh-ancestor
25630436|NCT01290887|Reslizumab|reslizumab|mesh-list
25630437|NCT01290887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25630438|NCT01290887|Respiratory System Agents|respiratory system agents|mesh-ancestor
25630439|NCT01290913|Omalizumab|omalizumab|mesh-list
25630440|NCT01290913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25630441|NCT01290913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25630442|NCT01290913|Respiratory System Agents|respiratory system agents|mesh-ancestor
25630443|NCT01291017|Palbociclib|palbociclib|mesh-list
25630444|NCT01291017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630445|NCT01291017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25630446|NCT01291017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630447|NCT01291017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630448|NCT01291056|Clomiphene|clomiphene|mesh-list
25630449|NCT01291056|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25630450|NCT01291056|Hormone Antagonists|hormone antagonists|mesh-ancestor
25630451|NCT01291056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25630452|NCT01291056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630453|NCT01291056|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25630454|NCT01291056|Fertility Agents|fertility agents|mesh-ancestor
25630455|NCT01291056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25630456|NCT01291056|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25630457|NCT01291056|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25630458|NCT01291108|Bimatoprost|bimatoprost|mesh-list
25630459|NCT01291108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25630460|NCT01291173|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25630461|NCT01291173|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25630462|NCT01291173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630463|NCT01291173|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25630464|NCT01291173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25630465|NCT01291173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25630466|NCT01291173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630467|NCT01291173|Dopamine Agents|dopamine agents|mesh-ancestor
25630468|NCT01291173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25630470|NCT01291784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25630471|NCT01291784|Immunologic Factors|immunologic factors|mesh-ancestor
25630472|NCT01291784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630473|NCT01292005|Pentoxifylline|pentoxifylline|mesh-list
25630474|NCT01292005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25630475|NCT01292005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630476|NCT01292005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630477|NCT01292005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25630478|NCT01292005|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25630479|NCT01292005|Protective Agents|protective agents|mesh-ancestor
25630480|NCT01292005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630481|NCT01292005|Vasodilator Agents|vasodilator agents|mesh-ancestor
25630482|NCT01292005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25630483|NCT01292005|Antioxidants|antioxidants|mesh-ancestor
25630484|NCT01292057|Aripiprazole|aripiprazole|mesh-list
25630485|NCT01292057|Antidepressive Agents|antidepressive agents|mesh-ancestor
25630486|NCT01292057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25630487|NCT01292057|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25630488|NCT01292057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25630489|NCT01292057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25630490|NCT01292057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630491|NCT01292057|Dopamine Agonists|dopamine agonists|mesh-ancestor
25630492|NCT01292057|Dopamine Agents|dopamine agents|mesh-ancestor
25630493|NCT01292057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25630494|NCT01292057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630495|NCT01292057|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25630496|NCT01292057|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25630497|NCT01292057|Serotonin Agents|serotonin agents|mesh-ancestor
25630498|NCT01292057|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25630499|NCT01292057|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25630500|NCT01292057|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25630501|NCT01292057|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25630502|NCT01292187|Calcitonin|calcitonin|mesh-list
25630503|NCT01292187|Salmon calcitonin|salmon calcitonin|mesh-list
25630504|NCT01292187|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
25630505|NCT01292187|Katacalcin|katacalcin|mesh-list
25630506|NCT01292187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25630507|NCT01292187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630508|NCT01292187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25630509|NCT01292187|Vasodilator Agents|vasodilator agents|mesh-ancestor
25630510|NCT01292226|Cyclosporine|cyclosporine|mesh-list
25630511|NCT01292226|Mycophenolic Acid|mycophenolic acid|mesh-list
25630512|NCT01292226|Antibodies|antibodies|mesh-list
25630513|NCT01292226|Cyclosporins|cyclosporins|mesh-list
25630514|NCT01292226|Immunologic Factors|immunologic factors|mesh-ancestor
25630515|NCT01292226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630516|NCT01292226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630517|NCT01292226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630518|NCT01292226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25630519|NCT01292226|Antifungal Agents|antifungal agents|mesh-ancestor
25630520|NCT01292226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25630521|NCT01292226|Dermatologic Agents|dermatologic agents|mesh-ancestor
25630522|NCT01292226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25630523|NCT01292226|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25630524|NCT01292226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25630525|NCT01292226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630526|NCT01292226|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25630527|NCT01292226|Antitubercular Agents|antitubercular agents|mesh-ancestor
25630528|NCT01292226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25630529|NCT01292239|Ribavirin|ribavirin|mesh-list
25630530|NCT01292239|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25630531|NCT01292239|Simeprevir|simeprevir|mesh-list
25630532|NCT01292239|Antimetabolites|antimetabolites|mesh-ancestor
25630533|NCT01292239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630534|NCT01292239|Antiviral Agents|antiviral agents|mesh-ancestor
25630535|NCT01292239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25630536|NCT01292239|Protease Inhibitors|protease inhibitors|mesh-ancestor
25630537|NCT01292239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630538|NCT01292252|Teriparatide|teriparatide|mesh-list
25630539|NCT01292252|Parathyroid Hormone|parathyroid hormone|mesh-list
25630540|NCT01292252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630541|NCT01292252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25630542|NCT01292252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25630543|NCT01292304|Tolvaptan|tolvaptan|mesh-list
25630544|NCT01292304|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25630545|NCT01292304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448930|NCT00313599|Paclitaxel|paclitaxel|mesh-list
25630546|NCT01292304|Natriuretic Agents|natriuretic agents|mesh-ancestor
25630547|NCT01292304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630548|NCT01292447|Lidocaine|lidocaine|mesh-list
25630549|NCT01292447|Anesthetics, Local|anesthetics, local|mesh-ancestor
25630550|NCT01292447|Anesthetics|anesthetics|mesh-ancestor
25630551|NCT01292447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25630552|NCT01292447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630553|NCT01292447|Sensory System Agents|sensory system agents|mesh-ancestor
25630554|NCT01292447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25630555|NCT01292447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25630556|NCT01292447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25630557|NCT01292447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25630558|NCT01292447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25630559|NCT01292447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630560|NCT01292473|Omalizumab|omalizumab|mesh-list
25630561|NCT01292473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25630562|NCT01292473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25630563|NCT01292473|Respiratory System Agents|respiratory system agents|mesh-ancestor
25630564|NCT01292603|Cyclophosphamide|cyclophosphamide|mesh-list
25630565|NCT01292603|Rituximab|rituximab|mesh-list
25630566|NCT01292603|Fludarabine|fludarabine|mesh-list
25630567|NCT01292603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25630568|NCT01292603|Immunologic Factors|immunologic factors|mesh-ancestor
25630569|NCT01292603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630570|NCT01292603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25630571|NCT01292603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25630572|NCT01292603|Alkylating Agents|alkylating agents|mesh-ancestor
25630573|NCT01292603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630574|NCT01292603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630575|NCT01292603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25630576|NCT01292603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25630577|NCT01292642|Nicotine|nicotine|mesh-list
25630578|NCT01292642|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25630579|NCT01292642|Autonomic Agents|autonomic agents|mesh-ancestor
25630580|NCT01292642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25630581|NCT01292642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630582|NCT01292642|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25630583|NCT01292642|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25630584|NCT01292642|Cholinergic Agents|cholinergic agents|mesh-ancestor
25630585|NCT01292642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25630586|NCT01292642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630587|NCT01292798|Ranibizumab|ranibizumab|mesh-list
25630588|NCT01292798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25630589|NCT01292798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25630590|NCT01292798|Growth Substances|growth substances|mesh-ancestor
25630591|NCT01292798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630592|NCT01292798|Growth Inhibitors|growth inhibitors|mesh-ancestor
25630593|NCT01292798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630594|NCT01292837|Levetiracetam|levetiracetam|mesh-list
25630595|NCT01292837|Anticonvulsants|anticonvulsants|mesh-ancestor
25630596|NCT01292837|Nootropic Agents|nootropic agents|mesh-ancestor
25630597|NCT01293006|Suvorexant|suvorexant|mesh-list
25630598|NCT01293006|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25630599|NCT01293006|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25630600|NCT01293006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25630601|NCT01293006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630602|NCT01293006|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25630603|NCT01293006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25630604|NCT01293006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630605|NCT01293032|Tamoxifen|tamoxifen|mesh-list
25630606|NCT01293032|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25630607|NCT01293032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630608|NCT01293032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25630609|NCT01293032|Hormone Antagonists|hormone antagonists|mesh-ancestor
25630610|NCT01293032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25630611|NCT01293032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630612|NCT01293032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25525255|NCT00489411|Analgesics|analgesics|mesh-ancestor
25630613|NCT01293032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630614|NCT01293032|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25525319|NCT00489736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25525320|NCT00489853|Budesonide|budesonide|mesh-list
25525321|NCT00489853|Formoterol Fumarate|formoterol fumarate|mesh-list
25525322|NCT00489853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25525323|NCT00489853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25525324|NCT00489853|Autonomic Agents|autonomic agents|mesh-ancestor
25525325|NCT00489853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25525326|NCT00489853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525327|NCT00489853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25525328|NCT00489853|Respiratory System Agents|respiratory system agents|mesh-ancestor
25525329|NCT00489853|Glucocorticoids|glucocorticoids|mesh-ancestor
25525330|NCT00489853|Hormones|hormones|mesh-ancestor
25525331|NCT00489853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25525332|NCT00489853|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25525333|NCT00489853|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25525334|NCT00489853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25525335|NCT00489853|Adrenergic Agents|adrenergic agents|mesh-ancestor
25525336|NCT00489853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25525337|NCT00489853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525338|NCT00489866|Aripiprazole|aripiprazole|mesh-list
25525339|NCT00489866|Antidepressive Agents|antidepressive agents|mesh-ancestor
25525340|NCT00489866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25525341|NCT00489866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25525342|NCT00489866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25525343|NCT00489866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25525344|NCT00489866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525345|NCT00489866|Dopamine Agonists|dopamine agonists|mesh-ancestor
25525346|NCT00489866|Dopamine Agents|dopamine agents|mesh-ancestor
25525347|NCT00489866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25525348|NCT00489866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525349|NCT00489866|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25525350|NCT00489866|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25525351|NCT00489866|Serotonin Agents|serotonin agents|mesh-ancestor
25525352|NCT00489866|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25525353|NCT00489866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24979899|NCT04976777|Antiemetics|antiemetics|mesh-ancestor
25630615|NCT01293032|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25630616|NCT01293032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25630617|NCT01293032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25630618|NCT01293032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630619|NCT01293396|Insulin|insulin|mesh-list
25630620|NCT01293396|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25630621|NCT01293396|Insulin Aspart|insulin aspart|mesh-list
25630622|NCT01293396|Insulin, Long-Acting|insulin, long-acting|mesh-list
25630623|NCT01293396|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25630624|NCT01293396|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
25630625|NCT01293396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25630626|NCT01293396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630627|NCT01293539|Melphalan|melphalan|mesh-list
25630628|NCT01293539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25630629|NCT01293539|Alkylating Agents|alkylating agents|mesh-ancestor
25630630|NCT01293539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630631|NCT01293539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630632|NCT01293539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25630633|NCT01293539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25630634|NCT01293539|Immunologic Factors|immunologic factors|mesh-ancestor
25630635|NCT01293539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630636|NCT01293695|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25630637|NCT01293695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25630638|NCT01293695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630639|NCT01293825|Ziprasidone|ziprasidone|mesh-list
25630640|NCT01293825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25630641|NCT01293825|Serotonin Agents|serotonin agents|mesh-ancestor
25630642|NCT01293825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25630643|NCT01293825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630644|NCT01293825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630645|NCT01293825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25630646|NCT01293825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25630647|NCT01293825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25630648|NCT01293825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25630649|NCT01293825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25630650|NCT01293825|Dopamine Agents|dopamine agents|mesh-ancestor
25630651|NCT01293968|Diphenhydramine|diphenhydramine|mesh-list
25630652|NCT01293968|Promethazine|promethazine|mesh-list
25630653|NCT01293968|Ibuprofen|ibuprofen|mesh-list
25630654|NCT01293968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25630655|NCT01293968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25630656|NCT01293968|Analgesics|analgesics|mesh-ancestor
25630657|NCT01293968|Sensory System Agents|sensory system agents|mesh-ancestor
25630658|NCT01293968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25630659|NCT01293968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630660|NCT01293968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25630661|NCT01293968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25630662|NCT01293968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25630663|NCT01293968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630664|NCT01293968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630665|NCT01293968|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25630666|NCT01293968|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25630667|NCT01293968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25630668|NCT01293968|Anesthetics, Local|anesthetics, local|mesh-ancestor
25630669|NCT01293968|Anesthetics|anesthetics|mesh-ancestor
25630670|NCT01293968|Antiemetics|antiemetics|mesh-ancestor
25630671|NCT01293968|Autonomic Agents|autonomic agents|mesh-ancestor
25630672|NCT01293968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25630673|NCT01293968|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25630674|NCT01293968|Histamine Antagonists|histamine antagonists|mesh-ancestor
25630675|NCT01293968|Histamine Agents|histamine agents|mesh-ancestor
25630676|NCT01293968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25630677|NCT01293968|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25630678|NCT01293968|Antipruritics|antipruritics|mesh-ancestor
25630679|NCT01293968|Dermatologic Agents|dermatologic agents|mesh-ancestor
25630680|NCT01294098|Bupivacaine|bupivacaine|mesh-list
25630681|NCT01294098|Anesthetics, Local|anesthetics, local|mesh-ancestor
25630682|NCT01294098|Anesthetics|anesthetics|mesh-ancestor
25630683|NCT01294098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25630684|NCT01294098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630685|NCT01294098|Sensory System Agents|sensory system agents|mesh-ancestor
25630686|NCT01294098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25630687|NCT01294163|Propofol|propofol|mesh-list
25630688|NCT01294163|Sevoflurane|sevoflurane|mesh-list
25630689|NCT01294163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25630690|NCT01294163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25630691|NCT01294163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630692|NCT01294163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25630693|NCT01294163|Anesthetics, General|anesthetics, general|mesh-ancestor
25630694|NCT01294163|Anesthetics|anesthetics|mesh-ancestor
25630695|NCT01294163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25630696|NCT01294163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25630697|NCT01294306|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25630698|NCT01294306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630699|NCT01294306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25630700|NCT01294306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630701|NCT01294306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630702|NCT01294319|Dexamethasone|dexamethasone|mesh-list
25630703|NCT01294319|Dexamethasone acetate|dexamethasone acetate|mesh-list
25630704|NCT01294319|Spironolactone|spironolactone|mesh-list
25630705|NCT01294319|Mifepristone|mifepristone|mesh-list
25630706|NCT01294319|BB 1101|bb 1101|mesh-list
25630707|NCT01294319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25630708|NCT01294319|Antiemetics|antiemetics|mesh-ancestor
25630709|NCT01294319|Autonomic Agents|autonomic agents|mesh-ancestor
25630710|NCT01294319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25630711|NCT01294319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630712|NCT01294319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25630713|NCT01294319|Glucocorticoids|glucocorticoids|mesh-ancestor
25630714|NCT01294319|Hormones|hormones|mesh-ancestor
25630715|NCT01294319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25630716|NCT01294319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25630717|NCT01294319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630718|NCT01294319|Protease Inhibitors|protease inhibitors|mesh-ancestor
25630719|NCT01294319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630720|NCT01294319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630721|NCT01294319|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25630722|NCT01294319|Hormone Antagonists|hormone antagonists|mesh-ancestor
25630723|NCT01294319|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25630724|NCT01294319|Diuretics|diuretics|mesh-ancestor
25630725|NCT01294319|Natriuretic Agents|natriuretic agents|mesh-ancestor
25630726|NCT01294319|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25630727|NCT01294319|Abortifacient Agents|abortifacient agents|mesh-ancestor
25630728|NCT01294319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25630729|NCT01294319|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25630730|NCT01294319|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25630731|NCT01294319|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25630732|NCT01294319|Contraceptive Agents|contraceptive agents|mesh-ancestor
25630733|NCT01294319|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25630734|NCT01294319|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25630735|NCT01294319|Luteolytic Agents|luteolytic agents|mesh-ancestor
25630736|NCT01294319|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25630737|NCT01294319|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25630738|NCT01294358|Gemcitabine|gemcitabine|mesh-list
25630739|NCT01294358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25630740|NCT01294358|Antimetabolites|antimetabolites|mesh-ancestor
25630741|NCT01294358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630742|NCT01294358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630743|NCT01294358|Antiviral Agents|antiviral agents|mesh-ancestor
25630744|NCT01294358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25630745|NCT01294358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630746|NCT01294358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25630747|NCT01294358|Immunologic Factors|immunologic factors|mesh-ancestor
25630748|NCT01294358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630749|NCT01294384|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25630750|NCT01294384|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25630751|NCT01294384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25630752|NCT01294384|Laxatives|laxatives|mesh-ancestor
25630753|NCT01294384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25630754|NCT01294397|Denosumab|denosumab|mesh-list
25630755|NCT01294397|Etanercept|etanercept|mesh-list
25630756|NCT01294397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25630757|NCT01294397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25630758|NCT01294397|Analgesics|analgesics|mesh-ancestor
25630759|NCT01294397|Sensory System Agents|sensory system agents|mesh-ancestor
25630760|NCT01294397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25630761|NCT01294397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630762|NCT01294397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25630763|NCT01294397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25630764|NCT01294397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25630765|NCT01294397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25630766|NCT01294397|Immunologic Factors|immunologic factors|mesh-ancestor
25630767|NCT01294397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25630768|NCT01294423|Dapagliflozin|dapagliflozin|mesh-list
25630769|NCT01294423|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25630770|NCT01294423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630771|NCT01294423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25630772|NCT01294423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630773|NCT01294436|Dapagliflozin|dapagliflozin|mesh-list
25630774|NCT01294436|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25630775|NCT01294436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630776|NCT01294436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25630777|NCT01294436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630778|NCT01294449|Cytarabine|cytarabine|mesh-list
25630779|NCT01294449|Dexamethasone|dexamethasone|mesh-list
25630780|NCT01294449|Methotrexate|methotrexate|mesh-list
25630781|NCT01294449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25630782|NCT01294449|Antimetabolites|antimetabolites|mesh-ancestor
25630783|NCT01294449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630784|NCT01294449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630785|NCT01294449|Antiviral Agents|antiviral agents|mesh-ancestor
25630786|NCT01294449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25630787|NCT01294449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25630788|NCT01294449|Immunologic Factors|immunologic factors|mesh-ancestor
25630789|NCT01294449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630790|NCT01294449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25630791|NCT01294449|Antiemetics|antiemetics|mesh-ancestor
25630792|NCT01294449|Autonomic Agents|autonomic agents|mesh-ancestor
25630793|NCT01294449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25630794|NCT01294449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25630795|NCT01294449|Glucocorticoids|glucocorticoids|mesh-ancestor
25630796|NCT01294449|Hormones|hormones|mesh-ancestor
25630797|NCT01294449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25630798|NCT01294449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25630799|NCT01294449|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25630800|NCT01294449|Abortifacient Agents|abortifacient agents|mesh-ancestor
25630801|NCT01294449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25630802|NCT01294449|Dermatologic Agents|dermatologic agents|mesh-ancestor
25630803|NCT01294449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630804|NCT01294449|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25630805|NCT01294449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25630806|NCT01294449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25630807|NCT01294462|Aspirin|aspirin|mesh-list
25630808|NCT01294462|Clopidogrel|clopidogrel|mesh-list
25630809|NCT01294462|Ticagrelor|ticagrelor|mesh-list
25630810|NCT01294462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25630811|NCT01294462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25630812|NCT01294462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25630813|NCT01294462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25630814|NCT01294462|Purinergic Agents|purinergic agents|mesh-ancestor
25630815|NCT01294462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24449065|NCT00314158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25630816|NCT01294462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630817|NCT01294462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630818|NCT01294462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25630819|NCT01294462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25630820|NCT01294462|Analgesics|analgesics|mesh-ancestor
25630821|NCT01294462|Sensory System Agents|sensory system agents|mesh-ancestor
25630822|NCT01294462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25630823|NCT01294462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25630824|NCT01294462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25630825|NCT01294462|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25630826|NCT01294462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25630827|NCT01294462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25630828|NCT01294462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630829|NCT01294462|Antipyretics|antipyretics|mesh-ancestor
25630830|NCT01294553|Metformin|metformin|mesh-list
25630831|NCT01294553|Rosiglitazone|rosiglitazone|mesh-list
25630832|NCT01294553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25630833|NCT01294553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630834|NCT01294579|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25630835|NCT01294579|Ofatumumab|ofatumumab|mesh-list
25630836|NCT01294579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25630837|NCT01294579|Alkylating Agents|alkylating agents|mesh-ancestor
25630838|NCT01294579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630839|NCT01294579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630840|NCT01294592|Tamsulosin|tamsulosin|mesh-list
25630841|NCT01294592|Dutasteride|dutasteride|mesh-list
25630842|NCT01294592|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25630843|NCT01294592|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25630844|NCT01294592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25630845|NCT01294592|Adrenergic Agents|adrenergic agents|mesh-ancestor
25630846|NCT01294592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25630847|NCT01294592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630848|NCT01294592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630849|NCT01294592|Urological Agents|urological agents|mesh-ancestor
25630850|NCT01294592|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25630851|NCT01294592|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25630852|NCT01294592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630853|NCT01294592|Hormone Antagonists|hormone antagonists|mesh-ancestor
25630854|NCT01294592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25630855|NCT01294644|Deoxycholic Acid|deoxycholic acid|mesh-list
25630856|NCT01294644|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25630857|NCT01294644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25630858|NCT01294683|Niacin|niacin|mesh-list
25630859|NCT01294683|Niacinamide|niacinamide|mesh-list
25630860|NCT01294683|Nicotinic Acids|nicotinic acids|mesh-list
25630861|NCT01294683|Simvastatin|simvastatin|mesh-list
25630862|NCT01294683|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25630863|NCT01294683|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25630864|NCT01294683|Antimetabolites|antimetabolites|mesh-ancestor
25630865|NCT01294683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630866|NCT01294683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25630867|NCT01294683|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25630868|NCT01294683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630869|NCT01294683|Vasodilator Agents|vasodilator agents|mesh-ancestor
25630870|NCT01294683|Vitamin B Complex|vitamin b complex|mesh-ancestor
25525501|NCT00490646|Docetaxel|docetaxel|mesh-list
25630871|NCT01294683|Vitamins|vitamins|mesh-ancestor
25630872|NCT01294683|Micronutrients|micronutrients|mesh-ancestor
25630873|NCT01294683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630874|NCT01294787|Glycopyrrolate|glycopyrrolate|mesh-list
25630875|NCT01294787|Bromides|bromides|mesh-list
25630876|NCT01294787|Tiotropium Bromide|tiotropium bromide|mesh-list
25630877|NCT01294787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25630878|NCT01294787|Autonomic Agents|autonomic agents|mesh-ancestor
25630879|NCT01294787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25630880|NCT01294787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630881|NCT01294787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25630882|NCT01294787|Respiratory System Agents|respiratory system agents|mesh-ancestor
25630883|NCT01294787|Parasympatholytics|parasympatholytics|mesh-ancestor
25630884|NCT01294787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25630885|NCT01294787|Cholinergic Agents|cholinergic agents|mesh-ancestor
25630886|NCT01294787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25630887|NCT01294787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630888|NCT01294787|Anticonvulsants|anticonvulsants|mesh-ancestor
25630889|NCT01294787|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25630890|NCT01294787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25630891|NCT01295034|Vitamin D|vitamin d|mesh-list
25630892|NCT01295034|Ergocalciferols|ergocalciferols|mesh-list
25630893|NCT01295034|Cholecalciferol|cholecalciferol|mesh-list
25630894|NCT01295034|Vitamins|vitamins|mesh-list
25630895|NCT01295034|Micronutrients|micronutrients|mesh-ancestor
25630896|NCT01295034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630897|NCT01295034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25630898|NCT01295034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25630899|NCT01295112|Dexamethasone|dexamethasone|mesh-list
25630900|NCT01295112|Dexamethasone acetate|dexamethasone acetate|mesh-list
25630901|NCT01295112|Bevacizumab|bevacizumab|mesh-list
25630902|NCT01295112|BB 1101|bb 1101|mesh-list
25630903|NCT01295112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25630904|NCT01295112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630905|NCT01295112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25630906|NCT01295112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25630907|NCT01295112|Growth Substances|growth substances|mesh-ancestor
25630908|NCT01295112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630909|NCT01295112|Growth Inhibitors|growth inhibitors|mesh-ancestor
25630910|NCT01295112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25630911|NCT01295112|Antiemetics|antiemetics|mesh-ancestor
25630912|NCT01295112|Autonomic Agents|autonomic agents|mesh-ancestor
25630913|NCT01295112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25630914|NCT01295112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25630915|NCT01295112|Glucocorticoids|glucocorticoids|mesh-ancestor
25630916|NCT01295112|Hormones|hormones|mesh-ancestor
25630917|NCT01295112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25630918|NCT01295112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25630919|NCT01295112|Protease Inhibitors|protease inhibitors|mesh-ancestor
25630920|NCT01295112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630921|NCT01295112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630922|NCT01295515|Interferons|interferons|mesh-list
25630923|NCT01295515|Interferon-alpha|interferon-alpha|mesh-list
25630924|NCT01295515|Interferon alpha-2|interferon alpha-2|mesh-list
25630925|NCT01295515|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25630926|NCT01295515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630927|NCT01295515|Antiviral Agents|antiviral agents|mesh-ancestor
25630928|NCT01295515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25630929|NCT01295515|Immunologic Factors|immunologic factors|mesh-ancestor
25630930|NCT01295515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630931|NCT01295710|Immunoglobulins|immunoglobulins|mesh-list
25630932|NCT01295710|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25630933|NCT01295710|Immunologic Factors|immunologic factors|mesh-ancestor
25630934|NCT01295710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630935|NCT01295710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25630936|NCT01295814|Adalimumab|adalimumab|mesh-list
25630937|NCT01295814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25630938|NCT01295814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25630939|NCT01295827|Pembrolizumab|pembrolizumab|mesh-list
25630940|NCT01295827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25630941|NCT01295827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630942|NCT01295879|Vitamin D|vitamin d|mesh-list
25630943|NCT01295879|Ergocalciferols|ergocalciferols|mesh-list
25630944|NCT01295879|Vitamins|vitamins|mesh-ancestor
25630945|NCT01295879|Micronutrients|micronutrients|mesh-ancestor
25630946|NCT01295879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630947|NCT01295879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25630948|NCT01295879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25630949|NCT01296035|Panitumumab|panitumumab|mesh-list
25630950|NCT01296035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25630951|NCT01296035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630952|NCT01296152|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25630953|NCT01296152|Medroxyprogesterone|medroxyprogesterone|mesh-list
25630954|NCT01296152|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25630955|NCT01296152|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25630956|NCT01296152|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25630957|NCT01296152|Contraceptive Agents|contraceptive agents|mesh-ancestor
25630958|NCT01296152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25630959|NCT01296152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630960|NCT01296152|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25630961|NCT01296152|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25630962|NCT01296152|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25630963|NCT01296152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25630964|NCT01296152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630965|NCT01296191|Moxifloxacin|moxifloxacin|mesh-list
25630966|NCT01296191|Besifloxacin|besifloxacin|mesh-list
25630967|NCT01296191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25630968|NCT01296191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25630969|NCT01296191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25630970|NCT01296191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25630971|NCT01296191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25630972|NCT01296191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630973|NCT01296191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25630974|NCT01296347|Ketamine|ketamine|mesh-list
25630975|NCT01296347|Analgesics|analgesics|mesh-ancestor
25630976|NCT01296347|Sensory System Agents|sensory system agents|mesh-ancestor
25630977|NCT01296347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25630978|NCT01296347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630979|NCT01296347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25630980|NCT01296347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25630981|NCT01296347|Anesthetics, General|anesthetics, general|mesh-ancestor
25630982|NCT01296347|Anesthetics|anesthetics|mesh-ancestor
25630983|NCT01296347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25630984|NCT01296347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25630985|NCT01296347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25630986|NCT01296347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25630987|NCT01296347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25630988|NCT01296412|Metformin|metformin|mesh-list
25630989|NCT01296412|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25630990|NCT01296412|Liraglutide|liraglutide|mesh-list
25630991|NCT01296412|Glimepiride|glimepiride|mesh-list
25630992|NCT01296412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25630993|NCT01296412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25630994|NCT01296412|Incretins|incretins|mesh-ancestor
25630995|NCT01296412|Hormones|hormones|mesh-ancestor
25630996|NCT01296412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25630997|NCT01296412|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25630998|NCT01296412|Protease Inhibitors|protease inhibitors|mesh-ancestor
25630999|NCT01296412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631000|NCT01296412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631001|NCT01296412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25631002|NCT01296412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25631003|NCT01296412|Immunologic Factors|immunologic factors|mesh-ancestor
25631004|NCT01296542|Moxifloxacin|moxifloxacin|mesh-list
25631005|NCT01296542|Besifloxacin|besifloxacin|mesh-list
25631006|NCT01296542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25631007|NCT01296542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25631008|NCT01296542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25631009|NCT01296542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25631010|NCT01296542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631011|NCT01296542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631012|NCT01296542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25631013|NCT01296568|Gemcitabine|gemcitabine|mesh-list
25631014|NCT01296568|Pemetrexed|pemetrexed|mesh-list
25631015|NCT01296568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25631016|NCT01296568|Antimetabolites|antimetabolites|mesh-ancestor
25631017|NCT01296568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631018|NCT01296568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25631019|NCT01296568|Antiviral Agents|antiviral agents|mesh-ancestor
25631020|NCT01296568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25631021|NCT01296568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631022|NCT01296568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25631023|NCT01296568|Immunologic Factors|immunologic factors|mesh-ancestor
25631024|NCT01296568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631025|NCT01296568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25631026|NCT01296568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25631028|NCT01296646|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25631029|NCT01296646|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25631030|NCT01296646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631031|NCT01296646|Sensory System Agents|sensory system agents|mesh-ancestor
25631032|NCT01296646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25656010|NCT01569191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656011|NCT01569191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656012|NCT01569295|Rituximab|rituximab|mesh-list
25656013|NCT01569295|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25656014|NCT01569295|Idelalisib|idelalisib|mesh-list
25656015|NCT01569295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25656016|NCT01569295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656017|NCT01569295|Immunologic Factors|immunologic factors|mesh-ancestor
25656018|NCT01569295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656019|NCT01569295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25656020|NCT01569295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25656021|NCT01569295|Alkylating Agents|alkylating agents|mesh-ancestor
25656022|NCT01569295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656023|NCT01569295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25656024|NCT01569451|Rituximab|rituximab|mesh-list
25656025|NCT01569451|Glatiramer Acetate|glatiramer acetate|mesh-list
25656026|NCT01569451|(T,G)-A-L|(t,g)-a-l|mesh-list
25656027|NCT01569451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25656028|NCT01569451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656029|NCT01569451|Immunologic Factors|immunologic factors|mesh-ancestor
25656030|NCT01569451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656031|NCT01569451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25656032|NCT01569451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25656033|NCT01569451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25656034|NCT01569464|Rotigotine|rotigotine|mesh-list
25656035|NCT01569464|Dopamine Agonists|dopamine agonists|mesh-ancestor
25656036|NCT01569464|Dopamine Agents|dopamine agents|mesh-ancestor
25656037|NCT01569464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25656038|NCT01569464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656039|NCT01569464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656040|NCT01569815|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25656041|NCT01569815|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25656042|NCT01569815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656043|NCT01569828|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25656044|NCT01569828|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25656045|NCT01569828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656046|NCT01569841|Insulin|insulin|mesh-list
25656047|NCT01569841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25656048|NCT01569841|Insulin Glargine|insulin glargine|mesh-list
25656049|NCT01569841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25656050|NCT01569841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656051|NCT01570036|Trastuzumab|trastuzumab|mesh-list
25656052|NCT01570036|Molgramostim|molgramostim|mesh-list
25656053|NCT01570036|Sargramostim|sargramostim|mesh-list
25656054|NCT01570036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25656055|NCT01570036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656056|NCT01570036|Immunologic Factors|immunologic factors|mesh-ancestor
25656057|NCT01570036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656058|NCT01570192|Vancomycin|vancomycin|mesh-list
25656059|NCT01570192|Gentamicins|gentamicins|mesh-list
25656060|NCT01570192|Meropenem|meropenem|mesh-list
25656061|NCT01570192|Linezolid|linezolid|mesh-list
25656062|NCT01570192|Tobramycin|tobramycin|mesh-list
25656063|NCT01570192|Amikacin|amikacin|mesh-list
25656064|NCT01570192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25656065|NCT01570192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25656066|NCT01570192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25656067|NCT01570192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25656068|NCT01570192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656069|NCT01570244|Levonorgestrel|levonorgestrel|mesh-list
25656070|NCT01570244|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25656071|NCT01570244|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25656072|NCT01570244|Contraceptive Agents|contraceptive agents|mesh-ancestor
25656073|NCT01570244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25525710|NCT00492232|GABA Agonists|gaba agonists|mesh-ancestor
25631033|NCT01296672|Finasteride|finasteride|mesh-list
25631034|NCT01296672|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25631035|NCT01296672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25631036|NCT01296672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631037|NCT01296672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631038|NCT01296672|Hormone Antagonists|hormone antagonists|mesh-ancestor
25631039|NCT01296672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25631040|NCT01296672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631041|NCT01296672|Urological Agents|urological agents|mesh-ancestor
25631042|NCT01296698|Nicotine|nicotine|mesh-list
25631043|NCT01296698|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25631044|NCT01296698|Autonomic Agents|autonomic agents|mesh-ancestor
25631045|NCT01296698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25631046|NCT01296698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631047|NCT01296698|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25631048|NCT01296698|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25631049|NCT01296698|Cholinergic Agents|cholinergic agents|mesh-ancestor
25631050|NCT01296698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25631051|NCT01296698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631052|NCT01296763|Cisplatin|cisplatin|mesh-list
25631053|NCT01296763|Irinotecan|irinotecan|mesh-list
25631054|NCT01296763|Olaparib|olaparib|mesh-list
25631055|NCT01296763|Mitomycins|mitomycins|mesh-list
25631056|NCT01296763|Mitomycin|mitomycin|mesh-list
25631057|NCT01296763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25631058|NCT01296763|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25631059|NCT01296763|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25631060|NCT01296763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631061|NCT01296763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631062|NCT01296763|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25631063|NCT01296763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25631064|NCT01296763|Alkylating Agents|alkylating agents|mesh-ancestor
25631065|NCT01296763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25631066|NCT01296815|Bevacizumab|bevacizumab|mesh-list
25631067|NCT01296815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25631068|NCT01296815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25631069|NCT01296815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25631070|NCT01296815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25631071|NCT01296815|Growth Substances|growth substances|mesh-ancestor
25631072|NCT01296815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631073|NCT01296815|Growth Inhibitors|growth inhibitors|mesh-ancestor
25631074|NCT01296932|BI 836826|bi 836826|mesh-list
25631075|NCT01296932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25631076|NCT01296932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25631077|NCT01297062|Exenatide|exenatide|mesh-list
25631078|NCT01297062|Moxifloxacin|moxifloxacin|mesh-list
25631079|NCT01297062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25631080|NCT01297062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25631081|NCT01297062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25631082|NCT01297062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25631083|NCT01297062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631084|NCT01297062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631085|NCT01297062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25631086|NCT01297062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631087|NCT01297062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25631088|NCT01297062|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25631089|NCT01297062|Incretins|incretins|mesh-ancestor
25631090|NCT01297062|Hormones|hormones|mesh-ancestor
25631091|NCT01297062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25631092|NCT01297335|Clonidine|clonidine|mesh-list
25631093|NCT01297335|Analgesics|analgesics|mesh-ancestor
25631094|NCT01297335|Sensory System Agents|sensory system agents|mesh-ancestor
25631095|NCT01297335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25631096|NCT01297335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631097|NCT01297335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25631098|NCT01297335|Sympatholytics|sympatholytics|mesh-ancestor
25631099|NCT01297335|Autonomic Agents|autonomic agents|mesh-ancestor
25631100|NCT01297335|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25631101|NCT01297335|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25631102|NCT01297335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25631103|NCT01297335|Adrenergic Agents|adrenergic agents|mesh-ancestor
25631104|NCT01297335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25631105|NCT01297335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631106|NCT01297348|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25631107|NCT01297348|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25631108|NCT01297348|Levonorgestrel|levonorgestrel|mesh-list
25631109|NCT01297348|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25631110|NCT01297348|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
25631111|NCT01297348|Norinyl|norinyl|mesh-list
25631112|NCT01297348|Contraceptive Agents|contraceptive agents|mesh-list
25631113|NCT01297348|Contraceptives, Oral|contraceptives, oral|mesh-list
25631114|NCT01297348|Estradiol|estradiol|mesh-list
25631115|NCT01297348|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25631116|NCT01297348|Estrogens|estrogens|mesh-ancestor
25631117|NCT01297348|Hormones|hormones|mesh-ancestor
25631118|NCT01297348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25631119|NCT01297348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631120|NCT01297348|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25631121|NCT01297348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25631122|NCT01297348|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25631123|NCT01297348|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25631124|NCT01297348|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25631125|NCT01297348|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25631126|NCT01297348|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
25631127|NCT01297465|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25631128|NCT01297465|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25631129|NCT01297465|Hormones|hormones|mesh-ancestor
25631130|NCT01297465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25631131|NCT01297465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631132|NCT01297465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25631133|NCT01297517|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25631134|NCT01297517|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25631135|NCT01297517|Brinzolamide|brinzolamide|mesh-list
25631136|NCT01297517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25631137|NCT01297517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25631138|NCT01297517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25631139|NCT01297517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25631140|NCT01297517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25631141|NCT01297517|Adrenergic Agents|adrenergic agents|mesh-ancestor
25631142|NCT01297517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25631143|NCT01297517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631144|NCT01297517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631145|NCT01297517|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25631146|NCT01297517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631147|NCT01297595|Crizotinib|crizotinib|mesh-list
25631148|NCT01297595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25631149|NCT01297595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25631150|NCT01297595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631151|NCT01297595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631152|NCT01297920|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25631153|NCT01297920|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25631154|NCT01297920|Brinzolamide|brinzolamide|mesh-list
25631155|NCT01297920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25631156|NCT01297920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25631157|NCT01297920|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25631158|NCT01297920|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25631159|NCT01297920|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25631160|NCT01297920|Adrenergic Agents|adrenergic agents|mesh-ancestor
25631161|NCT01297920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25631162|NCT01297920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631163|NCT01297920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631164|NCT01297920|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25631165|NCT01297920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631166|NCT01297959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25631167|NCT01298063|Afatinib|afatinib|mesh-list
25631168|NCT01298063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25631169|NCT01298063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25631170|NCT01298063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631171|NCT01298063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631172|NCT01298128|NuvaRing|nuvaring|mesh-list
25631173|NCT01298128|Desogestrel|desogestrel|mesh-list
25631174|NCT01298128|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25631175|NCT01298128|Contraceptive Agents|contraceptive agents|mesh-ancestor
25631176|NCT01298128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25631177|NCT01298128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631178|NCT01298128|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25525901|NCT00493064|Niacin|niacin|mesh-list
25631179|NCT01298128|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25631180|NCT01298128|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25631181|NCT01298128|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25631182|NCT01298128|Progestins|progestins|mesh-ancestor
25631183|NCT01298128|Hormones|hormones|mesh-ancestor
25631184|NCT01298128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25631185|NCT01298193|Phenothiazine|phenothiazine|mesh-list
25631186|NCT01298193|Droperidol|droperidol|mesh-list
25631187|NCT01298193|Haloperidol|haloperidol|mesh-list
25631188|NCT01298193|Aprepitant|aprepitant|mesh-list
25631189|NCT01298193|Metoclopramide|metoclopramide|mesh-list
25631190|NCT01298193|Domperidone|domperidone|mesh-list
25631191|NCT01298193|Alizapride|alizapride|mesh-list
25631192|NCT01298193|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
25631193|NCT01298193|Antiemetics|antiemetics|mesh-ancestor
25631194|NCT01298193|Autonomic Agents|autonomic agents|mesh-ancestor
25631195|NCT01298193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25631196|NCT01298193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631197|NCT01298193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25631198|NCT01298193|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25631199|NCT01298193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25631200|NCT01298193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631201|NCT01298193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25631202|NCT01298193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25631203|NCT01298193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25631204|NCT01298193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25631205|NCT01298193|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25631206|NCT01298193|Dopamine Agents|dopamine agents|mesh-ancestor
25631207|NCT01298193|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25631208|NCT01298193|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25631209|NCT01298193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25631210|NCT01298193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25631211|NCT01298193|Serotonin Agents|serotonin agents|mesh-ancestor
25631212|NCT01298193|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25631213|NCT01298193|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25631214|NCT01298193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25631215|NCT01298219|Lubiprostone|lubiprostone|mesh-list
25631216|NCT01298219|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25631217|NCT01298219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25631218|NCT01298219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631219|NCT01298362|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25631220|NCT01298362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24449289|NCT00314912|Tramiprosate|tramiprosate|mesh-list
25631221|NCT01298362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631222|NCT01298362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631223|NCT01298362|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25631224|NCT01298362|Hormone Antagonists|hormone antagonists|mesh-ancestor
25631225|NCT01298362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25631226|NCT01298362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631227|NCT01298531|Etanercept|etanercept|mesh-list
25631228|NCT01298531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25631229|NCT01298531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25631230|NCT01298531|Analgesics|analgesics|mesh-ancestor
25631231|NCT01298531|Sensory System Agents|sensory system agents|mesh-ancestor
25631232|NCT01298531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25631233|NCT01298531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631234|NCT01298531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25631235|NCT01298531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25631236|NCT01298531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25631237|NCT01298531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25631238|NCT01298531|Immunologic Factors|immunologic factors|mesh-ancestor
25631239|NCT01298570|Leucovorin|leucovorin|mesh-list
25631240|NCT01298570|Fluorouracil|fluorouracil|mesh-list
25631241|NCT01298570|Irinotecan|irinotecan|mesh-list
25631242|NCT01298570|Levoleucovorin|levoleucovorin|mesh-list
25631243|NCT01298570|Antimetabolites|antimetabolites|mesh-ancestor
25631244|NCT01298570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631245|NCT01298570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25631246|NCT01298570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25631247|NCT01298570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25631248|NCT01298570|Immunologic Factors|immunologic factors|mesh-ancestor
25631249|NCT01298570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631250|NCT01298570|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25631251|NCT01298570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25631252|NCT01298570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631253|NCT01298570|Antidotes|antidotes|mesh-ancestor
25525913|NCT00493064|Hormones|hormones|mesh-ancestor
25631254|NCT01298570|Protective Agents|protective agents|mesh-ancestor
25631255|NCT01298570|Vitamin B Complex|vitamin b complex|mesh-ancestor
25631257|NCT01298570|Micronutrients|micronutrients|mesh-ancestor
25631258|NCT01298700|Bimatoprost|bimatoprost|mesh-list
25631259|NCT01298700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25631260|NCT01298700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25631261|NCT01298700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25631262|NCT01298765|Buprenorphine|buprenorphine|mesh-list
25631263|NCT01298765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25631264|NCT01298765|Narcotics|narcotics|mesh-ancestor
25631265|NCT01298765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25631266|NCT01298765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631267|NCT01298765|Analgesics|analgesics|mesh-ancestor
25631268|NCT01298765|Sensory System Agents|sensory system agents|mesh-ancestor
25631269|NCT01298765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25631270|NCT01298765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25631271|NCT01298778|Acetaminophen|acetaminophen|mesh-list
25631272|NCT01298778|Morphine|morphine|mesh-list
25631273|NCT01298778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25631274|NCT01298778|Analgesics|analgesics|mesh-ancestor
25631275|NCT01298778|Sensory System Agents|sensory system agents|mesh-ancestor
25631276|NCT01298778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25631277|NCT01298778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631278|NCT01298778|Antipyretics|antipyretics|mesh-ancestor
25631279|NCT01298778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25631280|NCT01298778|Narcotics|narcotics|mesh-ancestor
25631281|NCT01298778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25631282|NCT01299038|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25631283|NCT01299038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25631284|NCT01299038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25631285|NCT01299038|Antimetabolites|antimetabolites|mesh-ancestor
25631286|NCT01299038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631287|NCT01299038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25717474|NCT02413918|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25631288|NCT01299038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25631289|NCT01299038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631290|NCT01299116|Contraceptive Agents|contraceptive agents|mesh-list
25631291|NCT01299116|Etonogestrel|etonogestrel|mesh-list
25631292|NCT01299116|Contraceptives, Oral|contraceptives, oral|mesh-list
25631293|NCT01299116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25631294|NCT01299116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631295|NCT01299116|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25631296|NCT01299116|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25631297|NCT01299272|Serotonin|serotonin|mesh-list
25631298|NCT01299272|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25631299|NCT01299272|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25631300|NCT01299272|Serotonin Agents|serotonin agents|mesh-ancestor
25631301|NCT01299272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25631302|NCT01299272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631303|NCT01299272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631304|NCT01299272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25631305|NCT01299272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25631306|NCT01299389|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25631307|NCT01299389|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25631308|NCT01299389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25631309|NCT01299389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25631310|NCT01299389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631311|NCT01299389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25631312|NCT01299389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25631313|NCT01299389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25631314|NCT01299389|Serotonin Agents|serotonin agents|mesh-ancestor
25631315|NCT01299389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25631316|NCT01299389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631317|NCT01299389|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25631318|NCT01299389|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25631319|NCT01299389|Dopamine Agents|dopamine agents|mesh-ancestor
25631320|NCT01299480|Vaccines|vaccines|mesh-list
25631321|NCT01299480|Immunologic Factors|immunologic factors|mesh-ancestor
25631322|NCT01299480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631323|NCT01299571|Dutasteride|dutasteride|mesh-list
25631324|NCT01299571|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25631325|NCT01299571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25631326|NCT01299571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631327|NCT01299571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631328|NCT01299571|Hormone Antagonists|hormone antagonists|mesh-ancestor
25631329|NCT01299571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25631330|NCT01299571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631331|NCT01299584|Remifentanil|remifentanil|mesh-list
25631332|NCT01299584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25631333|NCT01299584|Narcotics|narcotics|mesh-ancestor
25631334|NCT01299584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25631335|NCT01299584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631336|NCT01299584|Analgesics|analgesics|mesh-ancestor
25631337|NCT01299584|Sensory System Agents|sensory system agents|mesh-ancestor
25631338|NCT01299584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25631339|NCT01299805|Vortioxetine|vortioxetine|mesh-list
25631340|NCT01299805|Antidepressive Agents|antidepressive agents|mesh-ancestor
25631341|NCT01299805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25631342|NCT01299805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25631343|NCT01299805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25631344|NCT01299805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25631345|NCT01299805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631346|NCT01299805|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25631347|NCT01299805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25631348|NCT01299805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25631349|NCT01299805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631350|NCT01299805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25631351|NCT01299805|Serotonin Agents|serotonin agents|mesh-ancestor
25631352|NCT01299805|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25631353|NCT01299805|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25631354|NCT01299805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25631355|NCT01299805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25631356|NCT01299896|Bupropion|bupropion|mesh-list
25631357|NCT01299896|Nicotine|nicotine|mesh-list
25631358|NCT01299896|Varenicline|varenicline|mesh-list
25631359|NCT01299896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25631360|NCT01299896|Autonomic Agents|autonomic agents|mesh-ancestor
25631361|NCT01299896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25631362|NCT01299896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631363|NCT01299896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25631364|NCT01299896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25631365|NCT01299896|Cholinergic Agents|cholinergic agents|mesh-ancestor
25631366|NCT01299896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25631367|NCT01299896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631368|NCT01299896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25631369|NCT01299896|Antidepressive Agents|antidepressive agents|mesh-ancestor
25631370|NCT01299896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25631371|NCT01299896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25631372|NCT01299896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25631373|NCT01299896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25631374|NCT01299896|Dopamine Agents|dopamine agents|mesh-ancestor
25631375|NCT01299896|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25631376|NCT01299896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25631377|NCT01299896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631378|NCT01299961|Abatacept|abatacept|mesh-list
25631379|NCT01299961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25631380|NCT01299961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631381|NCT01299961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25631382|NCT01299961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25631383|NCT01299961|Immunologic Factors|immunologic factors|mesh-ancestor
25631384|NCT01299961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631385|NCT01299961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25631386|NCT01300234|Tenofovir|tenofovir|mesh-list
25631387|NCT01300234|Adefovir|adefovir|mesh-list
25631388|NCT01300234|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25631389|NCT01300234|Antiviral Agents|antiviral agents|mesh-ancestor
25631390|NCT01300234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25631391|NCT01300234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25631392|NCT01300234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25631393|NCT01300234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631394|NCT01300234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631395|NCT01300234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25631396|NCT01300234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25631397|NCT01300247|Cyclophosphamide|cyclophosphamide|mesh-list
25631398|NCT01300247|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25631399|NCT01300247|Fludarabine|fludarabine|mesh-list
25631400|NCT01300247|Obinutuzumab|obinutuzumab|mesh-list
25631401|NCT01300247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25631403|NCT01300247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631404|NCT01300247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25631405|NCT01300247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25631406|NCT01300247|Alkylating Agents|alkylating agents|mesh-ancestor
25631407|NCT01300247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631408|NCT01300247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25631409|NCT01300247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25631410|NCT01300247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25631411|NCT01300260|Dulaglutide|dulaglutide|mesh-list
25631412|NCT01300260|Glucagon|glucagon|mesh-list
25631413|NCT01300260|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25631414|NCT01300260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25631415|NCT01300260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631416|NCT01300260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25631417|NCT01300260|Hormones|hormones|mesh-ancestor
24450893|NCT00320879|Irbesartan|irbesartan|mesh-list
25631418|NCT01300260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25631419|NCT01300260|Incretins|incretins|mesh-ancestor
25631420|NCT01300351|Fulvestrant|fulvestrant|mesh-list
25631421|NCT01300351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25631422|NCT01300351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25631423|NCT01300351|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25631424|NCT01300351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25631425|NCT01300351|Hormone Antagonists|hormone antagonists|mesh-ancestor
25631426|NCT01300351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25631427|NCT01300351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631428|NCT01300455|Suvorexant|suvorexant|mesh-list
25631429|NCT01300455|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25631430|NCT01300455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25631431|NCT01300455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25631432|NCT01300455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631433|NCT01300455|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25631434|NCT01300455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25631435|NCT01300455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631436|NCT01300546|Naproxen|naproxen|mesh-list
25631437|NCT01300546|Sumatriptan|sumatriptan|mesh-list
25631438|NCT01300546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25631439|NCT01300546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25631440|NCT01300546|Analgesics|analgesics|mesh-ancestor
25631441|NCT01300546|Sensory System Agents|sensory system agents|mesh-ancestor
25631442|NCT01300546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25631443|NCT01300546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631444|NCT01300546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25631445|NCT01300546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25631446|NCT01300546|Gout Suppressants|gout suppressants|mesh-ancestor
25631447|NCT01300546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25631448|NCT01300546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631449|NCT01300546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631450|NCT01300546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25631451|NCT01300546|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25631452|NCT01300546|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25631453|NCT01300546|Serotonin Agents|serotonin agents|mesh-ancestor
25631454|NCT01300546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25631455|NCT01300572|Cyclosporine|cyclosporine|mesh-list
25631456|NCT01300572|Mycophenolic Acid|mycophenolic acid|mesh-list
25631457|NCT01300572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25631458|NCT01300572|Fludarabine|fludarabine|mesh-list
25631459|NCT01300572|Fludarabine phosphate|fludarabine phosphate|mesh-list
25631460|NCT01300572|Antibodies|antibodies|mesh-list
25631461|NCT01300572|Immunoglobulins|immunoglobulins|mesh-list
25631462|NCT01300572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25631463|NCT01300572|Cyclosporins|cyclosporins|mesh-list
25631464|NCT01300572|Immunologic Factors|immunologic factors|mesh-ancestor
25526111|NCT00494780|Alkylating Agents|alkylating agents|mesh-ancestor
25526112|NCT00494780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526113|NCT00494780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526114|NCT00494780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25526115|NCT00494780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24394553|NCT00133549|Immunologic Factors|immunologic factors|mesh-ancestor
25526118|NCT00494780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631465|NCT01300572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631466|NCT01300572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25631467|NCT01300572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25631468|NCT01300572|Antimetabolites|antimetabolites|mesh-ancestor
25631469|NCT01300572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631470|NCT01300572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25631471|NCT01300572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631472|NCT01300572|Antifungal Agents|antifungal agents|mesh-ancestor
25631473|NCT01300572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25631474|NCT01300572|Dermatologic Agents|dermatologic agents|mesh-ancestor
25631475|NCT01300572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25631476|NCT01300572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25631477|NCT01300572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25631478|NCT01300572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25631479|NCT01300572|Antitubercular Agents|antitubercular agents|mesh-ancestor
24452018|NCT00325767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25717482|NCT02414204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25717483|NCT02414204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25717484|NCT02414204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717485|NCT02414204|Urological Agents|urological agents|mesh-ancestor
25717486|NCT02414854|Albuterol|albuterol|mesh-list
25717487|NCT02414854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25717488|NCT02414854|Autonomic Agents|autonomic agents|mesh-ancestor
25717489|NCT02414854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25717490|NCT02414854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717491|NCT02414854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25717492|NCT02414854|Respiratory System Agents|respiratory system agents|mesh-ancestor
25717493|NCT02414854|Tocolytic Agents|tocolytic agents|mesh-ancestor
25631480|NCT01300572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25631481|NCT01300650|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25631482|NCT01300650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25631483|NCT01300741|Contact Lens Solutions|contact lens solutions|mesh-list
25631484|NCT01300741|Disinfectants|disinfectants|mesh-ancestor
25631485|NCT01300741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25631486|NCT01300767|Contact Lens Solutions|contact lens solutions|mesh-list
25631487|NCT01300767|Disinfectants|disinfectants|mesh-ancestor
25631488|NCT01300767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25631489|NCT01300819|Rotigotine|rotigotine|mesh-list
25631490|NCT01300819|Dopamine Agonists|dopamine agonists|mesh-ancestor
25631491|NCT01300819|Dopamine Agents|dopamine agents|mesh-ancestor
25631492|NCT01300819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25631493|NCT01300819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631494|NCT01300819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631495|NCT01300923|Acamprosate|acamprosate|mesh-list
25631496|NCT01300923|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25631497|NCT01301001|Gabapentin|gabapentin|mesh-list
25631498|NCT01301001|Analgesics|analgesics|mesh-ancestor
25631499|NCT01301001|Sensory System Agents|sensory system agents|mesh-ancestor
25631500|NCT01301001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25631501|NCT01301001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631502|NCT01301001|Anticonvulsants|anticonvulsants|mesh-ancestor
25631503|NCT01301001|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25631504|NCT01301001|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25631505|NCT01301001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25631506|NCT01301001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25631507|NCT01301001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25631508|NCT01301001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25631509|NCT01301001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25631510|NCT01301001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631511|NCT01301001|Antimanic Agents|antimanic agents|mesh-ancestor
25631512|NCT01301027|Pioglitazone|pioglitazone|mesh-list
25631513|NCT01301027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25631514|NCT01301027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631515|NCT01301066|Pravastatin|pravastatin|mesh-list
25631516|NCT01301066|Pitavastatin|pitavastatin|mesh-list
25631517|NCT01301066|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25631518|NCT01301066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25631519|NCT01301066|Antimetabolites|antimetabolites|mesh-ancestor
25631520|NCT01301066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631521|NCT01301066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25631522|NCT01301066|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25631523|NCT01301066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631524|NCT01301079|Ketamine|ketamine|mesh-list
25631525|NCT01301079|Analgesics|analgesics|mesh-ancestor
25631526|NCT01301079|Sensory System Agents|sensory system agents|mesh-ancestor
25631527|NCT01301079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25631528|NCT01301079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631529|NCT01301079|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25631530|NCT01301079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25631531|NCT01301079|Anesthetics, General|anesthetics, general|mesh-ancestor
25631532|NCT01301079|Anesthetics|anesthetics|mesh-ancestor
25717494|NCT02414854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25717495|NCT02414854|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25717496|NCT02414854|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25717497|NCT02414854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25717498|NCT02414854|Adrenergic Agents|adrenergic agents|mesh-ancestor
25717499|NCT02414854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25717500|NCT02414854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717501|NCT02414932|Midazolam|midazolam|mesh-list
25631533|NCT01301079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25631534|NCT01301079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25631535|NCT01301079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25631536|NCT01301079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25631537|NCT01301079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631538|NCT01301092|Dulaglutide|dulaglutide|mesh-list
25631539|NCT01301092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25631540|NCT01301092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631541|NCT01301183|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25631542|NCT01301183|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25631543|NCT01301183|Estradiol|estradiol|mesh-list
25631544|NCT01301183|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25631545|NCT01301183|Mecasermin|mecasermin|mesh-list
25631546|NCT01301183|Estrogens|estrogens|mesh-ancestor
25631547|NCT01301183|Hormones|hormones|mesh-ancestor
25631548|NCT01301183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25631549|NCT01301183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631550|NCT01301183|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25631551|NCT01301183|Contraceptive Agents|contraceptive agents|mesh-ancestor
25631552|NCT01301183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25631553|NCT01301183|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25631554|NCT01301183|Growth Substances|growth substances|mesh-ancestor
25631555|NCT01301391|Maleic acid|maleic acid|mesh-list
25631556|NCT01301391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631557|NCT01301391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631558|NCT01301729|Paclitaxel|paclitaxel|mesh-list
25631559|NCT01301729|Docetaxel|docetaxel|mesh-list
25631560|NCT01301729|Trastuzumab|trastuzumab|mesh-list
25631561|NCT01301729|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25631562|NCT01301729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25631563|NCT01301729|Tubulin Modulators|tubulin modulators|mesh-ancestor
25631564|NCT01301729|Antimitotic Agents|antimitotic agents|mesh-ancestor
25631565|NCT01301729|Mitosis Modulators|mitosis modulators|mesh-ancestor
25631566|NCT01301729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631567|NCT01301729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25631568|NCT01301742|Empagliflozin|empagliflozin|mesh-list
25631569|NCT01301742|Gemfibrozil|gemfibrozil|mesh-list
25631570|NCT01301742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25631571|NCT01301742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631572|NCT01301742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25631573|NCT01301742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631574|NCT01301742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25631575|NCT01301742|Antimetabolites|antimetabolites|mesh-ancestor
25631576|NCT01301742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25631577|NCT01301742|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25631578|NCT01301742|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25631579|NCT01301742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631580|NCT01301833|Biguanides|biguanides|mesh-list
25631581|NCT01301833|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
25631582|NCT01301833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25631583|NCT01301833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631584|NCT01301833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631585|NCT01301833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656074|NCT01570244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656075|NCT01570244|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25656076|NCT01570244|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25656077|NCT01570244|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25656078|NCT01570244|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25656079|NCT01570244|Estrogens|estrogens|mesh-ancestor
25656080|NCT01570244|Hormones|hormones|mesh-ancestor
25656081|NCT01570244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25656082|NCT01570309|Ergocalciferols|ergocalciferols|mesh-list
25656083|NCT01570309|Vitamin D|vitamin d|mesh-list
25656084|NCT01570309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25656085|NCT01570309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656086|NCT01570309|Vitamins|vitamins|mesh-ancestor
25656087|NCT01570309|Micronutrients|micronutrients|mesh-ancestor
25656088|NCT01570309|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25656089|NCT01570348|Mycophenolic Acid|mycophenolic acid|mesh-list
25656090|NCT01570348|Cyclophosphamide|cyclophosphamide|mesh-list
25656091|NCT01570348|Fludarabine|fludarabine|mesh-list
25656092|NCT01570348|Fludarabine phosphate|fludarabine phosphate|mesh-list
25656093|NCT01570348|Tacrolimus|tacrolimus|mesh-list
25656094|NCT01570348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25656095|NCT01570348|Immunologic Factors|immunologic factors|mesh-ancestor
25656096|NCT01570348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656097|NCT01570348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25656098|NCT01570348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25656099|NCT01570348|Alkylating Agents|alkylating agents|mesh-ancestor
25656100|NCT01570348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656101|NCT01570348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656102|NCT01570348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25656103|NCT01570348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25656104|NCT01570348|Antimetabolites|antimetabolites|mesh-ancestor
25526238|NCT00496340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25631586|NCT01302054|Fesoterodine|fesoterodine|mesh-list
25631587|NCT01302054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25717502|NCT02414932|Ketamine|ketamine|mesh-list
25717503|NCT02414932|Analgesics|analgesics|mesh-ancestor
25717504|NCT02414932|Sensory System Agents|sensory system agents|mesh-ancestor
25717505|NCT02414932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25717506|NCT02414932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717507|NCT02414932|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25717508|NCT02414932|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25717509|NCT02414932|Anesthetics, General|anesthetics, general|mesh-ancestor
25717510|NCT02414932|Anesthetics|anesthetics|mesh-ancestor
25631588|NCT01302054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25631589|NCT01302054|Cholinergic Agents|cholinergic agents|mesh-ancestor
25631590|NCT01302054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25631591|NCT01302054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631592|NCT01302054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631593|NCT01302054|Urological Agents|urological agents|mesh-ancestor
25631594|NCT01302067|Fesoterodine|fesoterodine|mesh-list
25631595|NCT01302067|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25631596|NCT01302067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25631597|NCT01302067|Cholinergic Agents|cholinergic agents|mesh-ancestor
25631598|NCT01302067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25631599|NCT01302067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631600|NCT01302067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631601|NCT01302067|Urological Agents|urological agents|mesh-ancestor
25631603|NCT01302080|Antidepressive Agents|antidepressive agents|mesh-ancestor
25631604|NCT01302080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25631605|NCT01302080|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25631606|NCT01302080|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25631607|NCT01302080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25631608|NCT01302080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631609|NCT01302080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24452376|NCT00327327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24452377|NCT00327327|Immunologic Factors|immunologic factors|mesh-ancestor
25631610|NCT01302080|Serotonin Agents|serotonin agents|mesh-ancestor
25631611|NCT01302080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631612|NCT01302119|Tavaborole|tavaborole|mesh-list
25631613|NCT01302119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25631614|NCT01302119|Antifungal Agents|antifungal agents|mesh-ancestor
25631615|NCT01302119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25631616|NCT01302379|Metformin|metformin|mesh-list
25631617|NCT01302379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25631618|NCT01302379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631619|NCT01302483|Lidocaine|lidocaine|mesh-list
25631620|NCT01302483|Phenylephrine|phenylephrine|mesh-list
25631621|NCT01302483|Oxymetazoline|oxymetazoline|mesh-list
25631622|NCT01302483|Tetracaine|tetracaine|mesh-list
25631623|NCT01302483|Anesthetics, Local|anesthetics, local|mesh-ancestor
25631624|NCT01302483|Anesthetics|anesthetics|mesh-ancestor
25631625|NCT01302483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25631626|NCT01302483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631627|NCT01302483|Sensory System Agents|sensory system agents|mesh-ancestor
25631628|NCT01302483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25631629|NCT01302483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25631630|NCT01302483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25631631|NCT01302483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25631632|NCT01302483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25631633|NCT01302483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631634|NCT01302483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25631635|NCT01302483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25631636|NCT01302483|Adrenergic Agents|adrenergic agents|mesh-ancestor
25631637|NCT01302483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25631638|NCT01302483|Sympathomimetics|sympathomimetics|mesh-ancestor
25631639|NCT01302483|Autonomic Agents|autonomic agents|mesh-ancestor
25631640|NCT01302483|Nasal Decongestants|nasal decongestants|mesh-ancestor
25631641|NCT01302483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25631642|NCT01302483|Respiratory System Agents|respiratory system agents|mesh-ancestor
25631643|NCT01302483|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25631644|NCT01302483|Mydriatics|mydriatics|mesh-ancestor
25631645|NCT01302483|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25631646|NCT01302483|Protective Agents|protective agents|mesh-ancestor
25631647|NCT01302691|Losartan|losartan|mesh-list
25631648|NCT01302691|Amlodipine|amlodipine|mesh-list
25631649|NCT01302691|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25631650|NCT01302691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25631651|NCT01302691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25631652|NCT01302691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25631653|NCT01302691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631654|NCT01302691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25631655|NCT01302691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631656|NCT01302691|Vasodilator Agents|vasodilator agents|mesh-ancestor
25631657|NCT01302691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25631658|NCT01302691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25631659|NCT01302691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25631660|NCT01302691|Diuretics|diuretics|mesh-ancestor
25631661|NCT01302691|Natriuretic Agents|natriuretic agents|mesh-ancestor
25631662|NCT01302691|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25631663|NCT01302743|Metformin|metformin|mesh-list
25631664|NCT01302743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25631665|NCT01302743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631666|NCT01302808|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25631667|NCT01302808|Romidepsin|romidepsin|mesh-list
25631668|NCT01302808|Antiemetics|antiemetics|mesh-list
25631669|NCT01302808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25631670|NCT01302808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25631671|NCT01302808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631672|NCT01302808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631673|NCT01302808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25631674|NCT01302808|Autonomic Agents|autonomic agents|mesh-ancestor
25631675|NCT01302808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25631676|NCT01302808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631677|NCT01302808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25631678|NCT01302899|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25717511|NCT02414932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25717512|NCT02414932|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25717513|NCT02414932|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25717514|NCT02414932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25717515|NCT02414932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717516|NCT02414932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25717517|NCT02414932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25717518|NCT02414932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25717519|NCT02414932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25717520|NCT02414932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25717521|NCT02414932|GABA Modulators|gaba modulators|mesh-ancestor
25631679|NCT01302899|Ramipril|ramipril|mesh-list
25631680|NCT01302899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25631681|NCT01302899|Diuretics|diuretics|mesh-ancestor
25631682|NCT01302899|Natriuretic Agents|natriuretic agents|mesh-ancestor
25631683|NCT01302899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631684|NCT01302899|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25631685|NCT01302899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25631686|NCT01302899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631687|NCT01302899|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25631688|NCT01302899|Protease Inhibitors|protease inhibitors|mesh-ancestor
25631689|NCT01302899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631690|NCT01302938|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25631691|NCT01302938|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25631692|NCT01302938|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25631693|NCT01302938|Cholinergic Agents|cholinergic agents|mesh-ancestor
25631694|NCT01302938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25631695|NCT01302938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631696|NCT01302938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631697|NCT01302938|Urological Agents|urological agents|mesh-ancestor
25631698|NCT01302964|Mirtazapine|mirtazapine|mesh-list
25631699|NCT01302964|Antidepressive Agents|antidepressive agents|mesh-ancestor
25631700|NCT01302964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25631701|NCT01302964|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25631702|NCT01302964|Histamine Antagonists|histamine antagonists|mesh-ancestor
25631703|NCT01302964|Histamine Agents|histamine agents|mesh-ancestor
25631704|NCT01302964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25717522|NCT02414932|GABA Agents|gaba agents|mesh-ancestor
25717523|NCT02414958|Empagliflozin|empagliflozin|mesh-list
25717524|NCT02414958|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25717525|NCT02414958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717526|NCT02414958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25717527|NCT02414958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717528|NCT02415127|Interferons|interferons|mesh-list
25717529|NCT02415127|Interferon-gamma|interferon-gamma|mesh-list
25631705|NCT01302964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631706|NCT01302964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631707|NCT01302964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25631708|NCT01302964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25631709|NCT01302964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25631710|NCT01302964|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25631711|NCT01302964|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25631712|NCT01302964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25631713|NCT01302964|Adrenergic Agents|adrenergic agents|mesh-ancestor
25631714|NCT01302964|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25631715|NCT01302964|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25631716|NCT01302964|Serotonin Agents|serotonin agents|mesh-ancestor
25631717|NCT01302964|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25631718|NCT01303172|Gemcitabine|gemcitabine|mesh-list
25631719|NCT01303172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25631720|NCT01303172|Antimetabolites|antimetabolites|mesh-ancestor
25631721|NCT01303172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631722|NCT01303172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25631723|NCT01303172|Antiviral Agents|antiviral agents|mesh-ancestor
25631724|NCT01303172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25631725|NCT01303172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631726|NCT01303172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25631727|NCT01303172|Immunologic Factors|immunologic factors|mesh-ancestor
25717530|NCT02415127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25717531|NCT02415127|Antiviral Agents|antiviral agents|mesh-ancestor
24452475|NCT05458674|Tucatinib|tucatinib|mesh-list
24452478|NCT05458674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24452479|NCT05458674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25717532|NCT02415127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25717533|NCT02415400|Aspirin|aspirin|mesh-list
25717534|NCT02415400|Vitamin K|vitamin k|mesh-list
25717535|NCT02415400|Apixaban|apixaban|mesh-list
25717536|NCT02415400|Vitamins|vitamins|mesh-ancestor
25717537|NCT02415400|Micronutrients|micronutrients|mesh-ancestor
25717538|NCT02415400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631728|NCT01303172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631729|NCT01303406|Idebenone|idebenone|mesh-list
25631730|NCT01303406|Antioxidants|antioxidants|mesh-ancestor
25631731|NCT01303406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631732|NCT01303406|Protective Agents|protective agents|mesh-ancestor
25526378|NCT00497055|Serotonin Agents|serotonin agents|mesh-ancestor
25631733|NCT01303406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631735|NCT01303445|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
25631736|NCT01303445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25631737|NCT01303445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25631738|NCT01303445|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25631739|NCT01303445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631740|NCT01303445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631741|NCT01303445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25631742|NCT01303627|Remifentanil|remifentanil|mesh-list
25631743|NCT01303627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25631744|NCT01303627|Narcotics|narcotics|mesh-ancestor
25631745|NCT01303627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25631746|NCT01303627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631747|NCT01303627|Analgesics|analgesics|mesh-ancestor
25631748|NCT01303627|Sensory System Agents|sensory system agents|mesh-ancestor
25631749|NCT01303627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25631750|NCT01303744|Flurbiprofen|flurbiprofen|mesh-list
25631751|NCT01303744|Analgesics|analgesics|mesh-ancestor
25631752|NCT01303744|Sensory System Agents|sensory system agents|mesh-ancestor
25631753|NCT01303744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25631754|NCT01303744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717539|NCT02415400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25717540|NCT02415400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25717541|NCT02415400|Analgesics|analgesics|mesh-ancestor
25717542|NCT02415400|Sensory System Agents|sensory system agents|mesh-ancestor
25717543|NCT02415400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25717544|NCT02415400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25717545|NCT02415400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25717546|NCT02415400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25717547|NCT02415400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25717548|NCT02415400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631755|NCT01303744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25631756|NCT01303744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25631757|NCT01303744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25631758|NCT01303744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25631759|NCT01303744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25631760|NCT01303744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631761|NCT01303744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631762|NCT01303835|Naltrexone|naltrexone|mesh-list
25631763|NCT01303835|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25631764|NCT01303835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25631765|NCT01303835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631766|NCT01303835|Sensory System Agents|sensory system agents|mesh-ancestor
25631767|NCT01303835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25631768|NCT01303861|Bupropion|bupropion|mesh-list
25631769|NCT01303861|Nicotine|nicotine|mesh-list
25631770|NCT01303861|Varenicline|varenicline|mesh-list
25631771|NCT01303861|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25631772|NCT01303861|Autonomic Agents|autonomic agents|mesh-ancestor
25631773|NCT01303861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25631774|NCT01303861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631775|NCT01303861|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25631776|NCT01303861|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25631777|NCT01303861|Cholinergic Agents|cholinergic agents|mesh-ancestor
25631778|NCT01303861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25631779|NCT01303861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631780|NCT01303861|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25631781|NCT01303861|Antidepressive Agents|antidepressive agents|mesh-ancestor
25631782|NCT01303861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25631783|NCT01303861|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25631784|NCT01303861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25631785|NCT01303861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25631786|NCT01303861|Dopamine Agents|dopamine agents|mesh-ancestor
25631787|NCT01303861|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25631788|NCT01303861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25631789|NCT01303861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631790|NCT01303965|Sirolimus|sirolimus|mesh-list
25631791|NCT01303965|Lenalidomide|lenalidomide|mesh-list
25631792|NCT01303965|Tacrolimus|tacrolimus|mesh-list
25631793|NCT01303965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25631794|NCT01303965|Immunologic Factors|immunologic factors|mesh-ancestor
25631795|NCT01303965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631796|NCT01303965|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25631797|NCT01303965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631798|NCT01303965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631799|NCT01303965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25631800|NCT01303965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25631801|NCT01303965|Growth Substances|growth substances|mesh-ancestor
25631802|NCT01303965|Growth Inhibitors|growth inhibitors|mesh-ancestor
25631803|NCT01303965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25631804|NCT01303965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24452498|NCT05458492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24452499|NCT05458492|Antifungal Agents|antifungal agents|mesh-ancestor
24452500|NCT05458492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24452501|NCT05458492|Immunologic Factors|immunologic factors|mesh-ancestor
24452502|NCT05458492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452503|NCT05458479|Fluoxetine|fluoxetine|mesh-list
24452504|NCT05458479|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24452508|NCT05458479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24452509|NCT05458479|Serotonin Agents|serotonin agents|mesh-ancestor
24452510|NCT05458479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526463|NCT00498550|Clozapine|clozapine|mesh-list
25631805|NCT01303965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25631807|NCT01303965|Antifungal Agents|antifungal agents|mesh-ancestor
25631808|NCT01304082|Lidocaine|lidocaine|mesh-list
25631809|NCT01304082|Anesthetics, Local|anesthetics, local|mesh-ancestor
25631810|NCT01304082|Anesthetics|anesthetics|mesh-ancestor
25631811|NCT01304082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25631812|NCT01304082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631813|NCT01304082|Sensory System Agents|sensory system agents|mesh-ancestor
25631814|NCT01304082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25631815|NCT01304082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25631816|NCT01304082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25631817|NCT01304082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25631818|NCT01304082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25631819|NCT01304082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631820|NCT01304147|Ketamine|ketamine|mesh-list
25631821|NCT01304147|Analgesics|analgesics|mesh-ancestor
25631822|NCT01304147|Sensory System Agents|sensory system agents|mesh-ancestor
25631823|NCT01304147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25631824|NCT01304147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631825|NCT01304147|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25631826|NCT01304147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25631827|NCT01304147|Anesthetics, General|anesthetics, general|mesh-ancestor
25631828|NCT01304147|Anesthetics|anesthetics|mesh-ancestor
25631829|NCT01304147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25631830|NCT01304147|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25631831|NCT01304147|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25631832|NCT01304147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25631833|NCT01304147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631834|NCT01304238|PENTA|penta|mesh-list
25631835|NCT01304238|Lepirudin|lepirudin|mesh-list
25631836|NCT01304238|Danaparoid|danaparoid|mesh-list
25631837|NCT01304238|Fondaparinux|fondaparinux|mesh-list
25631838|NCT01304238|Argatroban|argatroban|mesh-list
25717549|NCT02415400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25717550|NCT02415400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25717551|NCT02415400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25717552|NCT02415400|Antipyretics|antipyretics|mesh-ancestor
25717553|NCT02415400|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25717554|NCT02415400|Antithrombins|antithrombins|mesh-ancestor
25717555|NCT02415400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25717556|NCT02415400|Protease Inhibitors|protease inhibitors|mesh-ancestor
25631839|NCT01304238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25631840|NCT01304238|Antithrombins|antithrombins|mesh-ancestor
25631841|NCT01304238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25631842|NCT01304238|Protease Inhibitors|protease inhibitors|mesh-ancestor
25631843|NCT01304238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631844|NCT01304238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631845|NCT01304238|Anticoagulants|anticoagulants|mesh-ancestor
25631846|NCT01304238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25631847|NCT01304238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25631848|NCT01304238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25631849|NCT01304329|Empagliflozin|empagliflozin|mesh-list
25631850|NCT01304329|Simvastatin|simvastatin|mesh-list
25631851|NCT01304329|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25631852|NCT01304329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25631853|NCT01304329|Antimetabolites|antimetabolites|mesh-ancestor
25631854|NCT01304329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631855|NCT01304329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25631856|NCT01304329|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25631857|NCT01304329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631858|NCT01304329|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25631859|NCT01304329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25631860|NCT01304329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631861|NCT01304407|Calcium|calcium|mesh-list
25631862|NCT01304407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25631863|NCT01304407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631864|NCT01304498|Vaccines|vaccines|mesh-list
25631865|NCT01304498|Immunologic Factors|immunologic factors|mesh-ancestor
25631866|NCT01304498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631867|NCT01304589|Milnacipran|milnacipran|mesh-list
25631868|NCT01304589|Levomilnacipran|levomilnacipran|mesh-list
25631869|NCT01304589|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25631870|NCT01304589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25717557|NCT02415400|Anticoagulants|anticoagulants|mesh-ancestor
25717558|NCT02415400|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25717559|NCT02415400|Hemostatics|hemostatics|mesh-ancestor
25717560|NCT02415400|Coagulants|coagulants|mesh-ancestor
25717561|NCT02415595|BMS-955176|bms-955176|mesh-list
25717562|NCT02415595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25717563|NCT02415595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25717564|NCT02415595|Antiviral Agents|antiviral agents|mesh-ancestor
25717565|NCT02415595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25717566|NCT02415855|Dabigatran|dabigatran|mesh-list
25631871|NCT01304589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25631872|NCT01304589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631873|NCT01304589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25631874|NCT01304589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631875|NCT01304589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25631876|NCT01304589|Analgesics|analgesics|mesh-ancestor
25631877|NCT01304589|Sensory System Agents|sensory system agents|mesh-ancestor
25526515|NCT00499031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25631878|NCT01304589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25631879|NCT01304589|Antidepressive Agents|antidepressive agents|mesh-ancestor
25631880|NCT01304589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25631881|NCT01304641|Atorvastatin|atorvastatin|mesh-list
25631882|NCT01304641|Simvastatin|simvastatin|mesh-list
25631883|NCT01304641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25631884|NCT01304641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25631885|NCT01304641|Antimetabolites|antimetabolites|mesh-ancestor
25631886|NCT01304641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631887|NCT01304641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25631888|NCT01304641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25631889|NCT01304641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25717567|NCT02415855|Antithrombins|antithrombins|mesh-ancestor
24452562|NCT05458180|Sensory System Agents|sensory system agents|mesh-ancestor
24452563|NCT05458180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24452608|NCT05457998|Flutemetamol|flutemetamol|mesh-list
25717568|NCT02415855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25717569|NCT02415855|Protease Inhibitors|protease inhibitors|mesh-ancestor
25717570|NCT02415855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25717571|NCT02415855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717572|NCT02415855|Anticoagulants|anticoagulants|mesh-ancestor
25717573|NCT02415959|Pancrelipase|pancrelipase|mesh-list
25717574|NCT02415959|Pancreatin|pancreatin|mesh-list
25717575|NCT02415959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25717576|NCT02416102|Losartan|losartan|mesh-list
25631890|NCT01304693|Ranibizumab|ranibizumab|mesh-list
25631891|NCT01304693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25631892|NCT01304693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25631893|NCT01304693|Growth Substances|growth substances|mesh-ancestor
25631894|NCT01304693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631895|NCT01304693|Growth Inhibitors|growth inhibitors|mesh-ancestor
25631896|NCT01304693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25631897|NCT01304706|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
25631898|NCT01304706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25631899|NCT01304706|Glucocorticoids|glucocorticoids|mesh-ancestor
25631900|NCT01304706|Hormones|hormones|mesh-ancestor
25631901|NCT01304706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25631902|NCT01304706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631903|NCT01305200|Calcium|calcium|mesh-list
25631904|NCT01305200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25631905|NCT01305200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631906|NCT01305213|Bevacizumab|bevacizumab|mesh-list
25631907|NCT01305213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25631908|NCT01305213|Fosbretabulin|fosbretabulin|mesh-list
25717577|NCT02416102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24452686|NCT05457829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717578|NCT02416102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25717579|NCT02416102|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25717580|NCT02416102|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25717581|NCT02416102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717582|NCT02416180|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25717583|NCT02416180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25717584|NCT02416180|Autonomic Agents|autonomic agents|mesh-ancestor
25631909|NCT01305213|Endothelial Growth Factors|endothelial growth factors|mesh-list
25631910|NCT01305213|Antibodies|antibodies|mesh-list
25631911|NCT01305213|Immunoglobulins|immunoglobulins|mesh-list
25631912|NCT01305213|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25631913|NCT01305213|Immunoglobulin G|immunoglobulin g|mesh-list
25631914|NCT01305213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25631915|NCT01305213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25631916|NCT01305213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25631917|NCT01305213|Growth Substances|growth substances|mesh-ancestor
25631918|NCT01305213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631919|NCT01305213|Growth Inhibitors|growth inhibitors|mesh-ancestor
25631920|NCT01305213|Immunologic Factors|immunologic factors|mesh-ancestor
25631921|NCT01305213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25631922|NCT01305239|Exemestane|exemestane|mesh-list
25631923|NCT01305239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25631924|NCT01305239|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25631925|NCT01305239|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25631926|NCT01305239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631927|NCT01305239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631928|NCT01305239|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25631929|NCT01305239|Hormone Antagonists|hormone antagonists|mesh-ancestor
25631930|NCT01305239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25631931|NCT01305239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631932|NCT01305252|Treprostinil|treprostinil|mesh-list
25631933|NCT01305252|Tadalafil|tadalafil|mesh-list
25631934|NCT01305252|Vasodilator Agents|vasodilator agents|mesh-ancestor
25631935|NCT01305252|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25631936|NCT01305252|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25717585|NCT02416180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25717586|NCT02416180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452715|NCT05457530|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
24452716|NCT05457530|Antiviral Agents|antiviral agents|mesh-ancestor
24452717|NCT05457530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25717587|NCT02416180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25717588|NCT02416180|Respiratory System Agents|respiratory system agents|mesh-ancestor
25717589|NCT02416180|Glucocorticoids|glucocorticoids|mesh-ancestor
25717590|NCT02416180|Hormones|hormones|mesh-ancestor
25717591|NCT02416180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25631937|NCT01305252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631938|NCT01305252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631939|NCT01305252|Urological Agents|urological agents|mesh-ancestor
25631940|NCT01305252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25631941|NCT01305408|Modafinil|modafinil|mesh-list
25631942|NCT01305408|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25631943|NCT01305408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631944|NCT01305408|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25631945|NCT01305408|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25631946|NCT01305408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25631947|NCT01305408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631948|NCT01305577|Deoxycholic Acid|deoxycholic acid|mesh-list
25631949|NCT01305577|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25631950|NCT01305577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25631951|NCT01305772|Panitumumab|panitumumab|mesh-list
25631952|NCT01305772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25631954|NCT01305941|Trastuzumab|trastuzumab|mesh-list
25631955|NCT01305941|Everolimus|everolimus|mesh-list
25631956|NCT01305941|Vinorelbine|vinorelbine|mesh-list
25631957|NCT01305941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25631958|NCT01305941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25631959|NCT01305941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25631960|NCT01305941|Immunologic Factors|immunologic factors|mesh-ancestor
25631961|NCT01305941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631962|NCT01305941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25631963|NCT01305941|Tubulin Modulators|tubulin modulators|mesh-ancestor
25631964|NCT01305941|Antimitotic Agents|antimitotic agents|mesh-ancestor
25631965|NCT01305941|Mitosis Modulators|mitosis modulators|mesh-ancestor
24452825|NCT05420402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25717592|NCT02416180|Sympathomimetics|sympathomimetics|mesh-ancestor
25717593|NCT02416193|Vitamin D|vitamin d|mesh-list
25717594|NCT02416193|Ergocalciferols|ergocalciferols|mesh-list
25717595|NCT02416193|Cholecalciferol|cholecalciferol|mesh-list
25717596|NCT02416193|Vitamins|vitamins|mesh-list
25717597|NCT02416193|Micronutrients|micronutrients|mesh-ancestor
25717598|NCT02416193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717599|NCT02416193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25717600|NCT02416193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25717601|NCT02416908|Cytarabine|cytarabine|mesh-list
25717602|NCT02416908|Plerixafor|plerixafor|mesh-list
25717603|NCT02416908|2'-deoxyadenosine|2'-deoxyadenosine|mesh-list
25717604|NCT02416908|Cladribine|cladribine|mesh-list
25631966|NCT01305941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631967|NCT01306032|Cyclophosphamide|cyclophosphamide|mesh-list
25631968|NCT01306032|Veliparib|veliparib|mesh-list
25631969|NCT01306032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25631970|NCT01306032|Immunologic Factors|immunologic factors|mesh-ancestor
25631971|NCT01306032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25631972|NCT01306032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25631973|NCT01306032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25631974|NCT01306032|Alkylating Agents|alkylating agents|mesh-ancestor
25631975|NCT01306032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631976|NCT01306032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25631977|NCT01306032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25631978|NCT01306032|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25631979|NCT01306032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631980|NCT01306058|Sorafenib|sorafenib|mesh-list
25631981|NCT01306058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25631982|NCT01306058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25631983|NCT01306058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631984|NCT01306058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631985|NCT01306162|Dronedarone|dronedarone|mesh-list
25631986|NCT01306162|Dabigatran|dabigatran|mesh-list
25631987|NCT01306162|Antithrombins|antithrombins|mesh-ancestor
25631988|NCT01306162|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25631989|NCT01306162|Protease Inhibitors|protease inhibitors|mesh-ancestor
25631990|NCT01306162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631991|NCT01306162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25631992|NCT01306162|Anticoagulants|anticoagulants|mesh-ancestor
25631993|NCT01306162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25631994|NCT01306175|Empagliflozin|empagliflozin|mesh-list
25631995|NCT01306175|Digoxin|digoxin|mesh-list
25631996|NCT01306175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25631997|NCT01306175|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25631998|NCT01306175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25631999|NCT01306175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632000|NCT01306175|Protective Agents|protective agents|mesh-ancestor
25632001|NCT01306175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632002|NCT01306175|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25632003|NCT01306175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25632004|NCT01306214|Empagliflozin|empagliflozin|mesh-list
25632005|NCT01306214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25632006|NCT01306214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632007|NCT01306214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25632008|NCT01306214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632009|NCT01306617|Ritonavir|ritonavir|mesh-list
25632010|NCT01306617|Ribavirin|ribavirin|mesh-list
25632011|NCT01306617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25632012|NCT01306617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25632013|NCT01306617|Protease Inhibitors|protease inhibitors|mesh-ancestor
25632014|NCT01306617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25632015|NCT01306617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632016|NCT01306617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25632017|NCT01306617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25632018|NCT01306617|Antiviral Agents|antiviral agents|mesh-ancestor
25632019|NCT01306617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25632020|NCT01306617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24452985|NCT05378113|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24452986|NCT05373303|Epoetin Alfa|epoetin alfa|mesh-list
24452987|NCT05373303|Hematinics|hematinics|mesh-ancestor
25632021|NCT01306617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25632022|NCT01306617|Antimetabolites|antimetabolites|mesh-ancestor
25632023|NCT01306643|Idelalisib|idelalisib|mesh-list
25632024|NCT01306643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632025|NCT01306643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25632026|NCT01306643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632028|NCT01306656|Ergocalciferols|ergocalciferols|mesh-list
25632029|NCT01306656|Cholecalciferol|cholecalciferol|mesh-list
25632030|NCT01306656|Vitamins|vitamins|mesh-list
25632031|NCT01306656|Micronutrients|micronutrients|mesh-ancestor
25632032|NCT01306656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632033|NCT01306656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25632034|NCT01306656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25632035|NCT01306942|Paclitaxel|paclitaxel|mesh-list
25632036|NCT01306942|Trastuzumab|trastuzumab|mesh-list
25632037|NCT01306942|Dasatinib|dasatinib|mesh-list
25632038|NCT01306942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25632039|NCT01306942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632040|NCT01306942|Tubulin Modulators|tubulin modulators|mesh-ancestor
25632041|NCT01306942|Antimitotic Agents|antimitotic agents|mesh-ancestor
25632042|NCT01306942|Mitosis Modulators|mitosis modulators|mesh-ancestor
25632043|NCT01306942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632044|NCT01306942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25632045|NCT01306942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25632046|NCT01306942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25632047|NCT01307007|Dextrans|dextrans|mesh-list
25632048|NCT01307007|Iron-Dextran Complex|iron-dextran complex|mesh-list
25632049|NCT01307007|Anticoagulants|anticoagulants|mesh-ancestor
25632050|NCT01307007|Plasma Substitutes|plasma substitutes|mesh-ancestor
25632051|NCT01307007|Blood Substitutes|blood substitutes|mesh-ancestor
25632052|NCT01307007|Hematinics|hematinics|mesh-ancestor
25632053|NCT01307020|Ibuprofen|ibuprofen|mesh-list
25632054|NCT01307020|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
25632055|NCT01307020|Ketoprofen|ketoprofen|mesh-list
25632056|NCT01307020|Tramadol|tramadol|mesh-list
25632057|NCT01307020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25632058|NCT01307020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25632059|NCT01307020|Analgesics|analgesics|mesh-ancestor
25632060|NCT01307020|Sensory System Agents|sensory system agents|mesh-ancestor
24453066|NCT05338580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24453067|NCT05338580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24453068|NCT05309629|Carboplatin|carboplatin|mesh-list
25632061|NCT01307020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632062|NCT01307020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632063|NCT01307020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25632064|NCT01307020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25632065|NCT01307020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25632066|NCT01307020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25632067|NCT01307020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632068|NCT01307020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25632069|NCT01307020|Narcotics|narcotics|mesh-ancestor
25632070|NCT01307020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25632071|NCT01307111|Misoprostol|misoprostol|mesh-list
25632072|NCT01307111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25632073|NCT01307111|Abortifacient Agents|abortifacient agents|mesh-ancestor
25632074|NCT01307111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25632075|NCT01307111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632076|NCT01307111|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25632077|NCT01307111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25632078|NCT01307111|Oxytocics|oxytocics|mesh-ancestor
25632079|NCT01307267|Rituximab|rituximab|mesh-list
25632080|NCT01307267|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25632081|NCT01307267|Immunoglobulin G|immunoglobulin g|mesh-list
25632082|NCT01307267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25632083|NCT01307267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632084|NCT01307267|Immunologic Factors|immunologic factors|mesh-ancestor
25632085|NCT01307267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632086|NCT01307267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25632087|NCT01307319|Beclomethasone|beclomethasone|mesh-list
25632088|NCT01307319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25632089|NCT01307319|Glucocorticoids|glucocorticoids|mesh-ancestor
25632090|NCT01307319|Hormones|hormones|mesh-ancestor
25717605|NCT02416908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25717606|NCT02416908|Antimetabolites|antimetabolites|mesh-ancestor
25717607|NCT02416908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717608|NCT02416908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25717609|NCT02416908|Antiviral Agents|antiviral agents|mesh-ancestor
25717610|NCT02416908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25717611|NCT02416908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25717612|NCT02416908|Immunologic Factors|immunologic factors|mesh-ancestor
25717613|NCT02416908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632091|NCT01307319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25632092|NCT01307319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632093|NCT01307319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25632094|NCT01307319|Respiratory System Agents|respiratory system agents|mesh-ancestor
25632095|NCT01307397|Vemurafenib|vemurafenib|mesh-list
25632096|NCT01307397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632097|NCT01307397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25632098|NCT01307397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25632099|NCT01307397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632100|NCT01307449|Vaccines|vaccines|mesh-list
25717614|NCT02416908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25717615|NCT02416908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25717616|NCT02416934|Dexamethasone|dexamethasone|mesh-list
25717617|NCT02416934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25717618|NCT02416934|Antiemetics|antiemetics|mesh-ancestor
25717619|NCT02416934|Autonomic Agents|autonomic agents|mesh-ancestor
25717620|NCT02416934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25717621|NCT02416934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632101|NCT01307449|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25632102|NCT01307449|Immunologic Factors|immunologic factors|mesh-ancestor
25632103|NCT01307449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632104|NCT01307462|Fluticasone|fluticasone|mesh-list
25632105|NCT01307462|Xhance|xhance|mesh-list
25632106|NCT01307462|Azithromycin|azithromycin|mesh-list
25632107|NCT01307462|Montelukast|montelukast|mesh-list
25632108|NCT01307462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25632109|NCT01307462|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25632110|NCT01307462|Autonomic Agents|autonomic agents|mesh-ancestor
25632111|NCT01307462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632112|NCT01307462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632113|NCT01307462|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25632114|NCT01307462|Respiratory System Agents|respiratory system agents|mesh-ancestor
25632115|NCT01307462|Dermatologic Agents|dermatologic agents|mesh-ancestor
25632116|NCT01307462|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25632117|NCT01307462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25632118|NCT01307462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25632119|NCT01307462|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25632120|NCT01307462|Hormone Antagonists|hormone antagonists|mesh-ancestor
25632121|NCT01307462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25632122|NCT01307462|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25717622|NCT02416934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25717623|NCT02416934|Glucocorticoids|glucocorticoids|mesh-ancestor
25717624|NCT02416934|Hormones|hormones|mesh-ancestor
25717625|NCT02416934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25717626|NCT02416934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25717627|NCT02416934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25717628|NCT02417064|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25717629|NCT02417064|Citalopram|citalopram|mesh-list
25717630|NCT02417064|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25717631|NCT02417064|Sertraline|sertraline|mesh-list
25632123|NCT01307462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25632124|NCT01307462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632125|NCT01307579|Fluconazole|fluconazole|mesh-list
25632126|NCT01307579|Caspofungin|caspofungin|mesh-list
25632127|NCT01307579|Antifungal Agents|antifungal agents|mesh-ancestor
25632128|NCT01307579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25632129|NCT01307579|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25632130|NCT01307579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25632131|NCT01307579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25632132|NCT01307579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632133|NCT01307579|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25632134|NCT01307579|Hormone Antagonists|hormone antagonists|mesh-ancestor
25632135|NCT01307579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25632136|NCT01307579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632137|NCT01307579|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25632138|NCT01307579|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25632139|NCT01307618|Interleukin-12|interleukin-12|mesh-list
25632140|NCT01307618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25632141|NCT01307618|Immunologic Factors|immunologic factors|mesh-ancestor
25632142|NCT01307618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632143|NCT01307618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25632144|NCT01307618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25632145|NCT01307618|Growth Substances|growth substances|mesh-ancestor
25632146|NCT01307618|Growth Inhibitors|growth inhibitors|mesh-ancestor
25632147|NCT01307618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632148|NCT01307891|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25632149|NCT01307891|Paclitaxel|paclitaxel|mesh-list
25632150|NCT01307891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632151|NCT01307891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25632152|NCT01307891|Tubulin Modulators|tubulin modulators|mesh-ancestor
25632153|NCT01307891|Antimitotic Agents|antimitotic agents|mesh-ancestor
25632154|NCT01307891|Mitosis Modulators|mitosis modulators|mesh-ancestor
25632155|NCT01307891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632156|NCT01307930|Anidulafungin|anidulafungin|mesh-list
25632157|NCT01307930|Antifungal Agents|antifungal agents|mesh-ancestor
25632158|NCT01307930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25632159|NCT01307956|Calcium, Dietary|calcium, dietary|mesh-list
25632160|NCT01307956|Leucovorin|leucovorin|mesh-list
25632161|NCT01307956|Folic Acid|folic acid|mesh-list
25632162|NCT01307956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25632163|NCT01307956|Panitumumab|panitumumab|mesh-list
25632164|NCT01307956|Fluorouracil|fluorouracil|mesh-list
25632165|NCT01307956|Oxaliplatin|oxaliplatin|mesh-list
25632166|NCT01307956|Antibodies|antibodies|mesh-list
25632167|NCT01307956|Immunoglobulins|immunoglobulins|mesh-list
25632168|NCT01307956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25632169|NCT01307956|Calcium|calcium|mesh-list
25717632|NCT02417064|Antidepressive Agents|antidepressive agents|mesh-list
25717633|NCT02417064|Esketamine|esketamine|mesh-list
25717634|NCT02417064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25717635|NCT02417064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25717636|NCT02417064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25717637|NCT02417064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717638|NCT02417064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25717639|NCT02417064|Serotonin Agents|serotonin agents|mesh-ancestor
25632170|NCT01307956|Levoleucovorin|levoleucovorin|mesh-list
25632171|NCT01307956|Immunologic Factors|immunologic factors|mesh-ancestor
25632172|NCT01307956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632173|NCT01307956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632174|NCT01307956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25632175|NCT01307956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25632176|NCT01307956|Antimetabolites|antimetabolites|mesh-ancestor
25632177|NCT01307956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632178|NCT01307956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25632179|NCT01307956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25632180|NCT01307956|Antidotes|antidotes|mesh-ancestor
25632181|NCT01307956|Protective Agents|protective agents|mesh-ancestor
25632182|NCT01307956|Vitamin B Complex|vitamin b complex|mesh-ancestor
25632183|NCT01307956|Vitamins|vitamins|mesh-ancestor
25632184|NCT01307956|Micronutrients|micronutrients|mesh-ancestor
25632185|NCT01307956|Hematinics|hematinics|mesh-ancestor
25632186|NCT01308060|Botulinum Toxins|botulinum toxins|mesh-list
25632187|NCT01308060|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25632188|NCT01308060|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25632189|NCT01308060|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25632190|NCT01308060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25632191|NCT01308060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632192|NCT01308060|Cholinergic Agents|cholinergic agents|mesh-ancestor
25632193|NCT01308060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25632194|NCT01308060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632195|NCT01308060|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25632196|NCT01308060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632197|NCT01308294|Vaccines|vaccines|mesh-list
25632198|NCT01308294|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25632199|NCT01308294|Immunologic Factors|immunologic factors|mesh-ancestor
25632200|NCT01308294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632201|NCT01308294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25656105|NCT01570348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25656106|NCT01570348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25656107|NCT01570348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25656108|NCT01570348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25717640|NCT02417064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717641|NCT02417064|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25717642|NCT02417064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25717643|NCT02417064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25717644|NCT02417064|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25717645|NCT02417064|Analgesics|analgesics|mesh-ancestor
25717646|NCT02417064|Sensory System Agents|sensory system agents|mesh-ancestor
25717647|NCT02417064|Dopamine Agents|dopamine agents|mesh-ancestor
25717648|NCT02417129|Rituximab|rituximab|mesh-list
25717649|NCT02417129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25656109|NCT01570348|Antitubercular Agents|antitubercular agents|mesh-ancestor
25656110|NCT01570348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25656111|NCT01570348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25656112|NCT01570361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
25656113|NCT01570387|Dexamethasone|dexamethasone|mesh-list
25656114|NCT01570387|Dexamethasone acetate|dexamethasone acetate|mesh-list
25656115|NCT01570387|Pomalidomide|pomalidomide|mesh-list
25656116|NCT01570387|BB 1101|bb 1101|mesh-list
25656117|NCT01570387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25656118|NCT01570387|Antiemetics|antiemetics|mesh-ancestor
25656119|NCT01570387|Autonomic Agents|autonomic agents|mesh-ancestor
25656120|NCT01570387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25656121|NCT01570387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656122|NCT01570387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25656123|NCT01570387|Glucocorticoids|glucocorticoids|mesh-ancestor
25656124|NCT01570387|Hormones|hormones|mesh-ancestor
25656125|NCT01570387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25656126|NCT01570387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25656127|NCT01570387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656128|NCT01570387|Protease Inhibitors|protease inhibitors|mesh-ancestor
25656129|NCT01570387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25656130|NCT01570387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656131|NCT01570387|Immunologic Factors|immunologic factors|mesh-ancestor
25656132|NCT01570387|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25656133|NCT01570387|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25656134|NCT01570387|Growth Substances|growth substances|mesh-ancestor
25656135|NCT01570387|Growth Inhibitors|growth inhibitors|mesh-ancestor
25656136|NCT01570491|Anesthetics|anesthetics|mesh-list
25656137|NCT01570491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25656138|NCT01570491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656139|NCT01570751|Insulin|insulin|mesh-list
25656140|NCT01570751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25656141|NCT01570751|Insulin Glargine|insulin glargine|mesh-list
25656142|NCT01570751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25656143|NCT01570751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656144|NCT01570868|Ponatinib|ponatinib|mesh-list
25656145|NCT01570868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656146|NCT01570868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25656147|NCT01570868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25656148|NCT01570868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656149|NCT01571232|Dexamethasone|dexamethasone|mesh-list
25656150|NCT01571232|Bevacizumab|bevacizumab|mesh-list
25656151|NCT01571232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25656152|NCT01571232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656153|NCT01571232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25656154|NCT01571232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25656155|NCT01571232|Growth Substances|growth substances|mesh-ancestor
25632202|NCT01308567|Prednisone|prednisone|mesh-list
25632203|NCT01308567|Docetaxel|docetaxel|mesh-list
25632204|NCT01308567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632205|NCT01308567|Tubulin Modulators|tubulin modulators|mesh-ancestor
25632206|NCT01308567|Antimitotic Agents|antimitotic agents|mesh-ancestor
25632207|NCT01308567|Mitosis Modulators|mitosis modulators|mesh-ancestor
25632208|NCT01308567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632209|NCT01308567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25632210|NCT01308567|Glucocorticoids|glucocorticoids|mesh-ancestor
25632211|NCT01308567|Hormones|hormones|mesh-ancestor
25632212|NCT01308567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25632213|NCT01308567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632214|NCT01308567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25632215|NCT01308580|Prednisone|prednisone|mesh-list
25632216|NCT01308580|Prednisolone|prednisolone|mesh-list
25717650|NCT02417129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25717651|NCT02417129|Immunologic Factors|immunologic factors|mesh-ancestor
25717652|NCT02417129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717653|NCT02417129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25717654|NCT02417246|Metoprolol|metoprolol|mesh-list
25717655|NCT02417246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25717656|NCT02417246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25717657|NCT02417246|Sympatholytics|sympatholytics|mesh-ancestor
25717658|NCT02417246|Autonomic Agents|autonomic agents|mesh-ancestor
25717659|NCT02417246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25717660|NCT02417246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632217|NCT01308580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25632218|NCT01308580|Glucocorticoids|glucocorticoids|mesh-ancestor
25632219|NCT01308580|Hormones|hormones|mesh-ancestor
25632220|NCT01308580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25632221|NCT01308580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632222|NCT01308580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25632223|NCT01308580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632224|NCT01308736|Varenicline|varenicline|mesh-list
25632225|NCT01308736|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24453249|NCT05210621|Ocrelizumab|ocrelizumab|mesh-list
24453250|NCT05210621|Immunologic Factors|immunologic factors|mesh-ancestor
25717661|NCT02417246|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25717662|NCT02417246|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25717663|NCT02417246|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25717664|NCT02417246|Adrenergic Agents|adrenergic agents|mesh-ancestor
25717665|NCT02417246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25717666|NCT02417246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771357|NCT03599362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771358|NCT03600376|Dantrolene|dantrolene|mesh-list
25771359|NCT03600376|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25771360|NCT03600376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771361|NCT03600376|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25632226|NCT01308736|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25632227|NCT01308736|Cholinergic Agents|cholinergic agents|mesh-ancestor
25632228|NCT01308736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25632229|NCT01308736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632230|NCT01308736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632231|NCT01308749|Oxytocin|oxytocin|mesh-list
25632232|NCT01308749|Oxytocics|oxytocics|mesh-ancestor
25632233|NCT01308749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25632234|NCT01308749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632235|NCT01308814|Estradiol|estradiol|mesh-list
25632236|NCT01308814|Estrogens|estrogens|mesh-ancestor
25632237|NCT01308814|Hormones|hormones|mesh-ancestor
25632238|NCT01308814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25632239|NCT01308814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632240|NCT01308840|Gemcitabine|gemcitabine|mesh-list
25632241|NCT01308840|Oxaliplatin|oxaliplatin|mesh-list
25632242|NCT01308840|Panitumumab|panitumumab|mesh-list
25632243|NCT01308840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25632244|NCT01308840|Antimetabolites|antimetabolites|mesh-ancestor
25632245|NCT01308840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632246|NCT01308840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632247|NCT01308840|Antiviral Agents|antiviral agents|mesh-ancestor
25632248|NCT01308840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25632249|NCT01308840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25632250|NCT01308840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25632251|NCT01308840|Immunologic Factors|immunologic factors|mesh-ancestor
25632252|NCT01308840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632253|NCT01308840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25632254|NCT01309204|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25632255|NCT01309204|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25632256|NCT01309204|Brinzolamide|brinzolamide|mesh-list
25632257|NCT01309204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25632258|NCT01309204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25632259|NCT01309204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25632260|NCT01309204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25632261|NCT01309204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25632262|NCT01309204|Adrenergic Agents|adrenergic agents|mesh-ancestor
25632263|NCT01309204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25632264|NCT01309204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632265|NCT01309204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632266|NCT01309204|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25632267|NCT01309204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25632268|NCT01309243|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25632269|NCT01309243|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
25632270|NCT01309243|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25632271|NCT01309243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25632272|NCT01309243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25632273|NCT01309243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526948|NCT00501631|Naltrexone|naltrexone|mesh-list
25632275|NCT01309243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25632276|NCT01309243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25632277|NCT01309243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25632278|NCT01309360|Midazolam|midazolam|mesh-list
25632279|NCT01309360|Prilocaine|prilocaine|mesh-list
25632280|NCT01309360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25632281|NCT01309360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25632282|NCT01309360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25632283|NCT01309360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632284|NCT01309360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25632285|NCT01309360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25632286|NCT01309360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25632287|NCT01309360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25632288|NCT01309360|Anesthetics, General|anesthetics, general|mesh-ancestor
25632289|NCT01309360|Anesthetics|anesthetics|mesh-ancestor
25632290|NCT01309360|GABA Modulators|gaba modulators|mesh-ancestor
25632291|NCT01309360|GABA Agents|gaba agents|mesh-ancestor
25632292|NCT01309360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25632293|NCT01309360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632294|NCT01309360|Anesthetics, Local|anesthetics, local|mesh-ancestor
25632295|NCT01309360|Sensory System Agents|sensory system agents|mesh-ancestor
25632296|NCT01309360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632297|NCT01309386|Morphine|morphine|mesh-list
25632298|NCT01309386|Tapentadol|tapentadol|mesh-list
25632299|NCT01309386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25632300|NCT01309386|Narcotics|narcotics|mesh-ancestor
25632301|NCT01309386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25632302|NCT01309386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632303|NCT01309386|Analgesics|analgesics|mesh-ancestor
25632304|NCT01309386|Sensory System Agents|sensory system agents|mesh-ancestor
25632305|NCT01309386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632306|NCT01309386|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25632307|NCT01309386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25527005|NCT00501943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527006|NCT00501943|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25527007|NCT00501943|Protective Agents|protective agents|mesh-ancestor
25527008|NCT00501969|Rotigotine|rotigotine|mesh-list
25527009|NCT00501969|Dopamine Agonists|dopamine agonists|mesh-ancestor
25527010|NCT00501969|Dopamine Agents|dopamine agents|mesh-ancestor
25527011|NCT00501969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25527012|NCT00501969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527013|NCT00501969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527014|NCT00501995|Cyclophosphamide|cyclophosphamide|mesh-list
25527015|NCT00501995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25527016|NCT00501995|Immunologic Factors|immunologic factors|mesh-ancestor
25527017|NCT00501995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527018|NCT00501995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25527019|NCT00501995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25527020|NCT00501995|Alkylating Agents|alkylating agents|mesh-ancestor
25527021|NCT00501995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527022|NCT00501995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527023|NCT00501995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25632308|NCT01309386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25632309|NCT01309386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632310|NCT01309386|Adrenergic Agents|adrenergic agents|mesh-ancestor
25632311|NCT01309386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25632312|NCT01309451|Dexamethasone|dexamethasone|mesh-list
25632313|NCT01309451|Bevacizumab|bevacizumab|mesh-list
25632314|NCT01309451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25632315|NCT01309451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632316|NCT01309451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25632317|NCT01309451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25632318|NCT01309451|Growth Substances|growth substances|mesh-ancestor
25632319|NCT01309451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632320|NCT01309451|Growth Inhibitors|growth inhibitors|mesh-ancestor
25632321|NCT01309451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25632322|NCT01309451|Antiemetics|antiemetics|mesh-ancestor
25632323|NCT01309451|Autonomic Agents|autonomic agents|mesh-ancestor
25632324|NCT01309451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632325|NCT01309451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25632326|NCT01309451|Glucocorticoids|glucocorticoids|mesh-ancestor
25632327|NCT01309451|Hormones|hormones|mesh-ancestor
25632328|NCT01309451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25632329|NCT01309451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25632330|NCT01309659|Iron|iron|mesh-list
25632331|NCT01309659|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25632332|NCT01309659|Trace Elements|trace elements|mesh-ancestor
25632333|NCT01309659|Micronutrients|micronutrients|mesh-ancestor
25632334|NCT01309659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632335|NCT01309659|Hematinics|hematinics|mesh-ancestor
25632336|NCT01309737|Tofacitinib|tofacitinib|mesh-list
25632337|NCT01309737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25632338|NCT01309737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25632339|NCT01309737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717667|NCT02417831|Tamsulosin|tamsulosin|mesh-list
25717668|NCT02417831|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25717669|NCT02417831|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25717670|NCT02417831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25717671|NCT02417831|Adrenergic Agents|adrenergic agents|mesh-ancestor
25717672|NCT02417831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25717673|NCT02417831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717674|NCT02417831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632340|NCT01309802|Botulinum Toxins|botulinum toxins|mesh-list
25632341|NCT01309802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25632342|NCT01309802|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25632343|NCT01309802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25632344|NCT01309802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25632345|NCT01309802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632346|NCT01309802|Cholinergic Agents|cholinergic agents|mesh-ancestor
25632347|NCT01309802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25632348|NCT01309802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632349|NCT01309802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25632350|NCT01309802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632351|NCT01309828|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25632352|NCT01309828|Olmesartan|olmesartan|mesh-list
25632353|NCT01309828|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25632354|NCT01309828|Chlorthalidone|chlorthalidone|mesh-list
25632355|NCT01309828|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25632356|NCT01309828|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25632357|NCT01309828|Diuretics|diuretics|mesh-ancestor
25632358|NCT01309828|Natriuretic Agents|natriuretic agents|mesh-ancestor
25632359|NCT01309828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632360|NCT01309828|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25632361|NCT01309828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25632362|NCT01309828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632363|NCT01309828|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25632364|NCT01309828|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25632365|NCT01309841|Naloxegol|naloxegol|mesh-list
25632366|NCT01309841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24453438|NCT05008224|Bleomycin|bleomycin|mesh-list
24453439|NCT05008224|Vinblastine|vinblastine|mesh-list
24453440|NCT05008224|Procarbazine|procarbazine|mesh-list
25717675|NCT02417831|Urological Agents|urological agents|mesh-ancestor
25717676|NCT02417844|Tamsulosin|tamsulosin|mesh-list
25717677|NCT02417844|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25717678|NCT02417844|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25717679|NCT02417844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25717680|NCT02417844|Adrenergic Agents|adrenergic agents|mesh-ancestor
25717681|NCT02417844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25717682|NCT02417844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632367|NCT01309841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632368|NCT01309841|Sensory System Agents|sensory system agents|mesh-ancestor
25632369|NCT01309841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632370|NCT01309997|Rituximab|rituximab|mesh-list
25632371|NCT01309997|Imatinib Mesylate|imatinib mesylate|mesh-list
25632372|NCT01309997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25632373|NCT01309997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632374|NCT01309997|Immunologic Factors|immunologic factors|mesh-ancestor
25632375|NCT01309997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632376|NCT01309997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25632377|NCT01309997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25632378|NCT01309997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25632379|NCT01309997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632380|NCT01310036|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25632381|NCT01310036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632382|NCT01310036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25632383|NCT01310036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25632384|NCT01310036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632385|NCT01310127|Nepafenac|nepafenac|mesh-list
25632386|NCT01310127|Bromfenac|bromfenac|mesh-list
25632387|NCT01310127|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25632388|NCT01310127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25632389|NCT01310127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25632390|NCT01310127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25632391|NCT01310127|Analgesics|analgesics|mesh-ancestor
25632392|NCT01310127|Sensory System Agents|sensory system agents|mesh-ancestor
25632393|NCT01310127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632394|NCT01310127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632395|NCT01310127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25632396|NCT01310127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25632397|NCT01310179|Fludarabine|fludarabine|mesh-list
25632398|NCT01310179|Fludarabine phosphate|fludarabine phosphate|mesh-list
25632399|NCT01310179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25717683|NCT02417844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24453443|NCT05008224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24453444|NCT05008224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25717684|NCT02417844|Urological Agents|urological agents|mesh-ancestor
25717685|NCT02417935|Pregabalin|pregabalin|mesh-list
25717686|NCT02417935|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25717687|NCT02417935|Analgesics|analgesics|mesh-ancestor
25717688|NCT02417935|Sensory System Agents|sensory system agents|mesh-ancestor
25717689|NCT02417935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25717690|NCT02417935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717691|NCT02417935|Anticonvulsants|anticonvulsants|mesh-ancestor
25717692|NCT02417935|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25632400|NCT01310179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25632401|NCT01310179|Antimetabolites|antimetabolites|mesh-ancestor
25632402|NCT01310179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632403|NCT01310179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25632404|NCT01310179|Immunologic Factors|immunologic factors|mesh-ancestor
25632405|NCT01310179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632406|NCT01310231|Metformin|metformin|mesh-list
25632407|NCT01310231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25632408|NCT01310231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632409|NCT01310582|Sevoflurane|sevoflurane|mesh-list
25632410|NCT01310582|Desflurane|desflurane|mesh-list
25632411|NCT01310582|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25632412|NCT01310582|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25632413|NCT01310582|Anesthetics, General|anesthetics, general|mesh-ancestor
25632414|NCT01310582|Anesthetics|anesthetics|mesh-ancestor
25632415|NCT01310582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25632416|NCT01310582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632417|NCT01310777|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25632418|NCT01310777|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25632419|NCT01310777|Brinzolamide|brinzolamide|mesh-list
25632420|NCT01310777|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25632421|NCT01310777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25632422|NCT01310777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25632423|NCT01310777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25632424|NCT01310777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25632425|NCT01310777|Adrenergic Agents|adrenergic agents|mesh-ancestor
25632426|NCT01310777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25632427|NCT01310777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632428|NCT01310777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632429|NCT01310777|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25632430|NCT01310777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25632431|NCT01310855|Gefitinib|gefitinib|mesh-list
25717693|NCT02417935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25717694|NCT02417935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717695|NCT02417935|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25717696|NCT02417935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25717697|NCT02417935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25717698|NCT02417935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25717699|NCT02417935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25717700|NCT02417935|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25717701|NCT02417935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25717702|NCT02417935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25717703|NCT02417935|Antidepressive Agents|antidepressive agents|mesh-ancestor
25717704|NCT02417935|Dopamine Agents|dopamine agents|mesh-ancestor
25632432|NCT01310855|Cediranib|cediranib|mesh-list
25632433|NCT01310855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25632434|NCT01310855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632435|NCT01310855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632436|NCT01310855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25632437|NCT01310868|Carmustine|carmustine|mesh-list
25632438|NCT01310868|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25632439|NCT01310868|Levulinic acid|levulinic acid|mesh-list
25632440|NCT01310868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25632441|NCT01310868|Alkylating Agents|alkylating agents|mesh-ancestor
25632442|NCT01310868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632443|NCT01310868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632444|NCT01310868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25632445|NCT01310868|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25632446|NCT01310868|Dermatologic Agents|dermatologic agents|mesh-ancestor
25632447|NCT01311024|Vaccines|vaccines|mesh-list
25632448|NCT01311024|Immunologic Factors|immunologic factors|mesh-ancestor
25632449|NCT01311024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632450|NCT01311102|Lidocaine|lidocaine|mesh-list
25632451|NCT01311102|Anesthetics, Local|anesthetics, local|mesh-ancestor
25632452|NCT01311102|Anesthetics|anesthetics|mesh-ancestor
25632453|NCT01311102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25632454|NCT01311102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632455|NCT01311102|Sensory System Agents|sensory system agents|mesh-ancestor
25632456|NCT01311102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632457|NCT01311102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25632458|NCT01311102|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25632459|NCT01311102|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25632460|NCT01311102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25632461|NCT01311102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632462|NCT01311505|Rifampin|rifampin|mesh-list
25632463|NCT01311505|Isoniazid|isoniazid|mesh-list
25632464|NCT01311505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25632465|NCT01311505|Antitubercular Agents|antitubercular agents|mesh-ancestor
25632466|NCT01311505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25632467|NCT01311505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25632468|NCT01311505|Leprostatic Agents|leprostatic agents|mesh-ancestor
25632469|NCT01311505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25632470|NCT01311505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407736|NCT03480438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25717705|NCT02417961|Benralizumab|benralizumab|mesh-list
25717706|NCT02417961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25717707|NCT02417961|Respiratory System Agents|respiratory system agents|mesh-ancestor
25717708|NCT02418182|Acetaminophen|acetaminophen|mesh-list
25717709|NCT02418182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25717710|NCT02418182|Analgesics|analgesics|mesh-ancestor
25717711|NCT02418182|Sensory System Agents|sensory system agents|mesh-ancestor
25717712|NCT02418182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25717713|NCT02418182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717714|NCT02418182|Antipyretics|antipyretics|mesh-ancestor
25632471|NCT01311505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632472|NCT01311505|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25632473|NCT01311505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25632474|NCT01311505|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25527120|NCT00502996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632475|NCT01311505|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25632476|NCT01311505|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25632477|NCT01311505|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25632478|NCT01311505|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25632479|NCT01311505|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25632480|NCT01311505|Antimetabolites|antimetabolites|mesh-ancestor
25717715|NCT02418312|Famotidine|famotidine|mesh-list
25717716|NCT02418312|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
25717717|NCT02418312|Histamine|histamine|mesh-list
25717718|NCT02418312|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25717719|NCT02418312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25717720|NCT02418312|Histamine Antagonists|histamine antagonists|mesh-ancestor
25717721|NCT02418312|Histamine Agents|histamine agents|mesh-ancestor
25717722|NCT02418312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25717723|NCT02418312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717724|NCT02418312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717725|NCT02418312|Histamine Agonists|histamine agonists|mesh-ancestor
25632481|NCT01311505|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25632482|NCT01311648|Factor VIII|factor viii|mesh-list
25632483|NCT01311648|Coagulants|coagulants|mesh-ancestor
25632484|NCT01311661|Olodaterol|olodaterol|mesh-list
25632485|NCT01311661|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25632486|NCT01311661|Autonomic Agents|autonomic agents|mesh-ancestor
25632487|NCT01311661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632488|NCT01311661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632489|NCT01311661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25632490|NCT01311661|Respiratory System Agents|respiratory system agents|mesh-ancestor
25632491|NCT01311674|Vaccines|vaccines|mesh-list
25632492|NCT01311674|Immunologic Factors|immunologic factors|mesh-ancestor
25632493|NCT01311674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632494|NCT01311687|Dexamethasone|dexamethasone|mesh-list
25632495|NCT01311687|Pomalidomide|pomalidomide|mesh-list
25632496|NCT01311687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25632497|NCT01311687|Antiemetics|antiemetics|mesh-ancestor
25717726|NCT02418585|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25717727|NCT02418585|Citalopram|citalopram|mesh-list
25717728|NCT02418585|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25717729|NCT02418585|Sertraline|sertraline|mesh-list
25717730|NCT02418585|Antidepressive Agents|antidepressive agents|mesh-list
25717731|NCT02418585|Esketamine|esketamine|mesh-list
25717732|NCT02418585|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25717733|NCT02418585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25717734|NCT02418585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25717735|NCT02418585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632498|NCT01311687|Autonomic Agents|autonomic agents|mesh-ancestor
25632499|NCT01311687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632500|NCT01311687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632501|NCT01311687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25632502|NCT01311687|Glucocorticoids|glucocorticoids|mesh-ancestor
25632503|NCT01311687|Hormones|hormones|mesh-ancestor
25632504|NCT01311687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25632505|NCT01311687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25632506|NCT01311687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632507|NCT01311687|Immunologic Factors|immunologic factors|mesh-ancestor
25632508|NCT01311687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25632509|NCT01311687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25632510|NCT01311687|Growth Substances|growth substances|mesh-ancestor
25632511|NCT01311687|Growth Inhibitors|growth inhibitors|mesh-ancestor
25632512|NCT01311895|Hydromorphone|hydromorphone|mesh-list
25632513|NCT01311895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25632514|NCT01311895|Narcotics|narcotics|mesh-ancestor
25632515|NCT01311895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25632516|NCT01311895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632517|NCT01311895|Analgesics|analgesics|mesh-ancestor
25632518|NCT01311895|Sensory System Agents|sensory system agents|mesh-ancestor
25632519|NCT01311895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632520|NCT01312038|Simethicone|simethicone|mesh-list
25632521|NCT01312038|Antifoaming Agents|antifoaming agents|mesh-ancestor
25632522|NCT01312038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632523|NCT01312038|Emollients|emollients|mesh-ancestor
25632524|NCT01312038|Dermatologic Agents|dermatologic agents|mesh-ancestor
25632525|NCT01312129|Sulfasalazine|sulfasalazine|mesh-list
25632526|NCT01312129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25632527|NCT01312129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25632528|NCT01312129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25632529|NCT01312129|Analgesics|analgesics|mesh-ancestor
25632530|NCT01312129|Sensory System Agents|sensory system agents|mesh-ancestor
25632531|NCT01312129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632532|NCT01312129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717736|NCT02418585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25717737|NCT02418585|Serotonin Agents|serotonin agents|mesh-ancestor
24453785|NCT04790513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24453786|NCT04790513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24453787|NCT04790513|Antimetabolites|antimetabolites|mesh-ancestor
25717738|NCT02418585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717739|NCT02418585|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25717740|NCT02418585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25717741|NCT02418585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25717742|NCT02418585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25632533|NCT01312129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25632534|NCT01312129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25632535|NCT01312129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25632536|NCT01312272|Oxytocin|oxytocin|mesh-list
25632537|NCT01312272|Oxytocics|oxytocics|mesh-ancestor
25632538|NCT01312272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25632539|NCT01312272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632540|NCT01312389|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
25632541|NCT01312389|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25632542|NCT01312389|Immunologic Factors|immunologic factors|mesh-ancestor
25632543|NCT01312389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632544|NCT01312389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25632545|NCT01312389|Antiviral Agents|antiviral agents|mesh-ancestor
25632546|NCT01312389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25632547|NCT01312467|Metformin|metformin|mesh-list
25632548|NCT01312467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25632549|NCT01312467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632550|NCT01312766|Menotropins|menotropins|mesh-list
25632551|NCT01312766|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25527193|NCT00503906|Growth Substances|growth substances|mesh-ancestor
25632553|NCT01312766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25632554|NCT01312766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632555|NCT01312818|Dexamethasone|dexamethasone|mesh-list
25632556|NCT01312818|Methotrexate|methotrexate|mesh-list
25632557|NCT01312818|Bortezomib|bortezomib|mesh-list
25632558|NCT01312818|Imatinib Mesylate|imatinib mesylate|mesh-list
25717743|NCT02418585|Analgesics|analgesics|mesh-ancestor
25717744|NCT02418585|Sensory System Agents|sensory system agents|mesh-ancestor
25717745|NCT02418585|Dopamine Agents|dopamine agents|mesh-ancestor
25717746|NCT02418676|Insulin|insulin|mesh-list
25717747|NCT02418676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25717748|NCT02418676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717749|NCT02418754|Aflibercept|aflibercept|mesh-list
25717750|NCT02418754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25717751|NCT02418754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25717752|NCT02418754|Growth Substances|growth substances|mesh-ancestor
25717753|NCT02418754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717754|NCT02418754|Growth Inhibitors|growth inhibitors|mesh-ancestor
25717755|NCT02418754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25717756|NCT02418949|Cyproheptadine|cyproheptadine|mesh-list
25717757|NCT02418949|Antipruritics|antipruritics|mesh-ancestor
25717758|NCT02418949|Dermatologic Agents|dermatologic agents|mesh-ancestor
25717759|NCT02418949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25632559|NCT01312818|Vorinostat|vorinostat|mesh-list
25632560|NCT01312818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25632561|NCT01312818|Antiemetics|antiemetics|mesh-ancestor
25632562|NCT01312818|Autonomic Agents|autonomic agents|mesh-ancestor
25632563|NCT01312818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632564|NCT01312818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632565|NCT01312818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25632566|NCT01312818|Glucocorticoids|glucocorticoids|mesh-ancestor
25632567|NCT01312818|Hormones|hormones|mesh-ancestor
25632568|NCT01312818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25632569|NCT01312818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25632570|NCT01312818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632571|NCT01312818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25632572|NCT01312818|Abortifacient Agents|abortifacient agents|mesh-ancestor
25632573|NCT01312818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25632574|NCT01312818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25632575|NCT01312818|Antimetabolites|antimetabolites|mesh-ancestor
25632576|NCT01312818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632577|NCT01312818|Dermatologic Agents|dermatologic agents|mesh-ancestor
25632578|NCT01312818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25632579|NCT01312818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25632580|NCT01312818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25632581|NCT01312818|Immunologic Factors|immunologic factors|mesh-ancestor
25632582|NCT01312818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25632583|NCT01312818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25717760|NCT02418949|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25717761|NCT02418949|Histamine Antagonists|histamine antagonists|mesh-ancestor
25717762|NCT02418949|Histamine Agents|histamine agents|mesh-ancestor
25717763|NCT02418949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25717764|NCT02418949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717765|NCT02418949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717766|NCT02418949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25632584|NCT01312818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25632585|NCT01312818|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25632586|NCT01312844|Scopolamine|scopolamine|mesh-list
25632587|NCT01312844|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25632588|NCT01312844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25632589|NCT01312844|Antiemetics|antiemetics|mesh-ancestor
25632590|NCT01312844|Autonomic Agents|autonomic agents|mesh-ancestor
25632591|NCT01312844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632592|NCT01312844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632593|NCT01312844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25632594|NCT01312844|Mydriatics|mydriatics|mesh-ancestor
25632595|NCT01312844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25632596|NCT01312844|Cholinergic Agents|cholinergic agents|mesh-ancestor
25632597|NCT01312844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25632598|NCT01312844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632599|NCT01312844|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25632600|NCT01312844|Parasympatholytics|parasympatholytics|mesh-ancestor
25632601|NCT01312909|Varenicline|varenicline|mesh-list
25632602|NCT01312909|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25632603|NCT01312909|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25632604|NCT01312909|Cholinergic Agents|cholinergic agents|mesh-ancestor
25632605|NCT01312909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25632606|NCT01312909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632607|NCT01312909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632608|NCT01312961|Fluticasone|fluticasone|mesh-list
25632609|NCT01312961|Xhance|xhance|mesh-list
25632610|NCT01312961|Albuterol|albuterol|mesh-list
25632611|NCT01312961|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25632612|NCT01312961|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25632613|NCT01312961|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25632614|NCT01312961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25632615|NCT01312961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25632616|NCT01312961|Autonomic Agents|autonomic agents|mesh-ancestor
25632617|NCT01312961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632618|NCT01312961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632619|NCT01312961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25632620|NCT01312961|Respiratory System Agents|respiratory system agents|mesh-ancestor
25717767|NCT02418949|Serotonin Agents|serotonin agents|mesh-ancestor
25717768|NCT02418949|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25717769|NCT02419313|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25717770|NCT02419313|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25717771|NCT02419313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25717772|NCT02419313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717773|NCT02419313|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25717774|NCT02419313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25632621|NCT01312961|Dermatologic Agents|dermatologic agents|mesh-ancestor
25527264|NCT00504348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527265|NCT00504348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25527266|NCT00504348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25632622|NCT01312961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25632623|NCT01312961|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25632624|NCT01312961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25632625|NCT01312961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25632626|NCT01312961|Adrenergic Agents|adrenergic agents|mesh-ancestor
25632627|NCT01312961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25632628|NCT01312961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632629|NCT01312961|Tocolytic Agents|tocolytic agents|mesh-ancestor
25632630|NCT01312961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25632631|NCT01312961|Immunologic Factors|immunologic factors|mesh-ancestor
25632632|NCT01312961|Glucocorticoids|glucocorticoids|mesh-ancestor
25632633|NCT01312961|Hormones|hormones|mesh-ancestor
25632634|NCT01312961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25632635|NCT01312961|Sympathomimetics|sympathomimetics|mesh-ancestor
25632636|NCT01313078|Asparaginase|asparaginase|mesh-list
25632637|NCT01313078|Pegaspargase|pegaspargase|mesh-list
25632638|NCT01313078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632639|NCT01313117|Thioctic Acid|thioctic acid|mesh-list
25632640|NCT01313117|Antioxidants|antioxidants|mesh-ancestor
25632641|NCT01313117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632642|NCT01313117|Protective Agents|protective agents|mesh-ancestor
25632643|NCT01313117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632644|NCT01313117|Vitamin B Complex|vitamin b complex|mesh-ancestor
25632645|NCT01313117|Vitamins|vitamins|mesh-ancestor
25632646|NCT01313117|Micronutrients|micronutrients|mesh-ancestor
25632647|NCT01313182|Povidone-Iodine|povidone-iodine|mesh-list
25632648|NCT01313182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
25632649|NCT01313182|Mupirocin|mupirocin|mesh-list
25632650|NCT01313182|Povidone|povidone|mesh-list
25632651|NCT01313182|Calcium|calcium|mesh-list
25632652|NCT01313182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25632653|NCT01313182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717775|NCT02419313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717776|NCT02419313|Cholinergic Agents|cholinergic agents|mesh-ancestor
25717777|NCT02419313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25717778|NCT02419469|Cytarabine|cytarabine|mesh-list
25717779|NCT02419469|Dexamethasone|dexamethasone|mesh-list
25717780|NCT02419469|Prednisone|prednisone|mesh-list
25717781|NCT02419469|Dexamethasone acetate|dexamethasone acetate|mesh-list
25717782|NCT02419469|Cyclophosphamide|cyclophosphamide|mesh-list
25717783|NCT02419469|Rituximab|rituximab|mesh-list
25717784|NCT02419469|Doxorubicin|doxorubicin|mesh-list
25717785|NCT02419469|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25404045|NCT03685773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632654|NCT01313182|Plasma Substitutes|plasma substitutes|mesh-ancestor
25632655|NCT01313182|Blood Substitutes|blood substitutes|mesh-ancestor
25632656|NCT01313182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25632657|NCT01313182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25632658|NCT01313182|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25632659|NCT01313182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25632660|NCT01313182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632661|NCT01313208|Etanercept|etanercept|mesh-list
25632662|NCT01313208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25632663|NCT01313208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25632664|NCT01313208|Analgesics|analgesics|mesh-ancestor
25632665|NCT01313208|Sensory System Agents|sensory system agents|mesh-ancestor
25632666|NCT01313208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632667|NCT01313208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632668|NCT01313208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25632669|NCT01313208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25632670|NCT01313208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25632671|NCT01313208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25632672|NCT01313208|Immunologic Factors|immunologic factors|mesh-ancestor
25632673|NCT01313221|Etanercept|etanercept|mesh-list
25632674|NCT01313221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25632675|NCT01313221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25632676|NCT01313221|Analgesics|analgesics|mesh-ancestor
25632677|NCT01313221|Sensory System Agents|sensory system agents|mesh-ancestor
25632678|NCT01313221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632679|NCT01313221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632680|NCT01313221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25632681|NCT01313221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25632682|NCT01313221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25632683|NCT01313221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25632684|NCT01313221|Immunologic Factors|immunologic factors|mesh-ancestor
25632685|NCT01313286|Globalagliatin|globalagliatin|mesh-list
25632686|NCT01313286|Enzyme Activators|enzyme activators|mesh-ancestor
25632687|NCT01313286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632688|NCT01313494|Albuterol|albuterol|mesh-list
25632689|NCT01313494|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25632690|NCT01313494|Autonomic Agents|autonomic agents|mesh-ancestor
25632691|NCT01313494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632692|NCT01313494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632693|NCT01313494|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25632694|NCT01313494|Respiratory System Agents|respiratory system agents|mesh-ancestor
25632695|NCT01313494|Tocolytic Agents|tocolytic agents|mesh-ancestor
25632696|NCT01313494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25632697|NCT01313494|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25527337|NCT00504751|Cisplatin|cisplatin|mesh-list
25632698|NCT01313494|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25632700|NCT01313494|Adrenergic Agents|adrenergic agents|mesh-ancestor
25632701|NCT01313494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25632702|NCT01313494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632703|NCT01313520|Infliximab|infliximab|mesh-list
25632704|NCT01313520|Dermatologic Agents|dermatologic agents|mesh-ancestor
25632705|NCT01313520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25632706|NCT01313520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25632707|NCT01313559|Everolimus|everolimus|mesh-list
25632708|NCT01313559|Pasireotide|pasireotide|mesh-list
25632709|NCT01313559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632710|NCT01313559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25632711|NCT01313559|Immunologic Factors|immunologic factors|mesh-ancestor
25632712|NCT01313559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632713|NCT01313559|Hormones|hormones|mesh-ancestor
25632714|NCT01313559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25632715|NCT01313637|Bromides|bromides|mesh-list
25632716|NCT01313637|Anticonvulsants|anticonvulsants|mesh-ancestor
25632717|NCT01313663|Pemetrexed|pemetrexed|mesh-list
25632718|NCT01313663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632719|NCT01313663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25632720|NCT01313663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632721|NCT01313663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25632722|NCT01313663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25632723|NCT01313676|Fluticasone|fluticasone|mesh-list
25632724|NCT01313676|Xhance|xhance|mesh-list
25632725|NCT01313676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25632726|NCT01313676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25717786|NCT02419469|Methotrexate|methotrexate|mesh-list
25717787|NCT02419469|Vincristine|vincristine|mesh-list
25717788|NCT02419469|Daunorubicin|daunorubicin|mesh-list
25717789|NCT02419469|Asparaginase|asparaginase|mesh-list
25717790|NCT02419469|Mercaptopurine|mercaptopurine|mesh-list
25717791|NCT02419469|Ofatumumab|ofatumumab|mesh-list
25717792|NCT02419469|Pegaspargase|pegaspargase|mesh-list
25717793|NCT02419469|Thioguanine|thioguanine|mesh-list
25717794|NCT02419469|BB 1101|bb 1101|mesh-list
25717795|NCT02419469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25632727|NCT01313676|Autonomic Agents|autonomic agents|mesh-ancestor
25632728|NCT01313676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632729|NCT01313676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632730|NCT01313676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25632731|NCT01313676|Respiratory System Agents|respiratory system agents|mesh-ancestor
25632732|NCT01313676|Dermatologic Agents|dermatologic agents|mesh-ancestor
25632733|NCT01313676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25632734|NCT01313728|Dapsone|dapsone|mesh-list
25632735|NCT01313728|Tretinoin|tretinoin|mesh-list
25632736|NCT01313728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632737|NCT01313728|Keratolytic Agents|keratolytic agents|mesh-ancestor
25632738|NCT01313728|Dermatologic Agents|dermatologic agents|mesh-ancestor
25632739|NCT01313728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24454128|NCT04392531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24454129|NCT04392531|Immunologic Factors|immunologic factors|mesh-ancestor
24454130|NCT04392531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24454131|NCT04392531|Antifungal Agents|antifungal agents|mesh-ancestor
25717796|NCT02419469|Immunologic Factors|immunologic factors|mesh-ancestor
25717797|NCT02419469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717798|NCT02419469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25717799|NCT02419469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25717800|NCT02419469|Alkylating Agents|alkylating agents|mesh-ancestor
25717801|NCT02419469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717802|NCT02419469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632740|NCT01313728|Antimalarials|antimalarials|mesh-ancestor
25632741|NCT01313728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25632742|NCT01313728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25632743|NCT01313728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25632744|NCT01313728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25632745|NCT01313728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632746|NCT01313728|Leprostatic Agents|leprostatic agents|mesh-ancestor
25632747|NCT01313728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25632748|NCT01313767|Botulinum Toxins|botulinum toxins|mesh-list
25632749|NCT01313767|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25632750|NCT01313767|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25632751|NCT01313767|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25632752|NCT01313767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25632753|NCT01313767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632754|NCT01313767|Cholinergic Agents|cholinergic agents|mesh-ancestor
25632755|NCT01313767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25632756|NCT01313767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632757|NCT01313767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25632758|NCT01313767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632759|NCT01313780|Oxycodone|oxycodone|mesh-list
25632760|NCT01313780|Naloxone|naloxone|mesh-list
25632761|NCT01313780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25632762|NCT01313780|Narcotics|narcotics|mesh-ancestor
25717803|NCT02419469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25717804|NCT02419469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25717805|NCT02419469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25717806|NCT02419469|Antiemetics|antiemetics|mesh-ancestor
25717807|NCT02419469|Autonomic Agents|autonomic agents|mesh-ancestor
25717808|NCT02419469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25717809|NCT02419469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25717810|NCT02419469|Glucocorticoids|glucocorticoids|mesh-ancestor
25632763|NCT01313780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25632764|NCT01313780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632765|NCT01313780|Analgesics|analgesics|mesh-ancestor
25632766|NCT01313780|Sensory System Agents|sensory system agents|mesh-ancestor
25632767|NCT01313780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632768|NCT01313780|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25527405|NCT00505375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25527406|NCT00505375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527407|NCT00505375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527408|NCT00505375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25632769|NCT01313858|Golimumab|golimumab|mesh-list
25632770|NCT01313858|Methotrexate|methotrexate|mesh-list
25632771|NCT01313858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25632772|NCT01313858|Abortifacient Agents|abortifacient agents|mesh-ancestor
25632773|NCT01313858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25632774|NCT01313858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632775|NCT01313858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25632776|NCT01313858|Antimetabolites|antimetabolites|mesh-ancestor
25632777|NCT01313858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632778|NCT01313858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632779|NCT01313858|Dermatologic Agents|dermatologic agents|mesh-ancestor
25632780|NCT01313858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25632781|NCT01313858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25632782|NCT01313858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25632783|NCT01313858|Immunologic Factors|immunologic factors|mesh-ancestor
25632784|NCT01313858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25632785|NCT01313858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25632786|NCT01313858|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25632787|NCT01313858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25632788|NCT01313884|Cyclophosphamide|cyclophosphamide|mesh-list
25632789|NCT01313884|Temozolomide|temozolomide|mesh-list
25632790|NCT01313884|Doxorubicin|doxorubicin|mesh-list
25632791|NCT01313884|Irinotecan|irinotecan|mesh-list
25632792|NCT01313884|Vincristine|vincristine|mesh-list
25632793|NCT01313884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25632794|NCT01313884|Immunologic Factors|immunologic factors|mesh-ancestor
25632795|NCT01313884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632796|NCT01313884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25632797|NCT01313884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25632798|NCT01313884|Alkylating Agents|alkylating agents|mesh-ancestor
25632799|NCT01313884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632800|NCT01313884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632801|NCT01313884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25632802|NCT01313884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25632803|NCT01313884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25632804|NCT01313884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25632805|NCT01313884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25632806|NCT01313884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24444222|NCT00297011|Glucocorticoids|glucocorticoids|mesh-ancestor
25717811|NCT02419469|Hormones|hormones|mesh-ancestor
25717812|NCT02419469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25717813|NCT02419469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25717814|NCT02419469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25717815|NCT02419469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25717816|NCT02419469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25717817|NCT02419469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25632807|NCT01313884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25632808|NCT01313884|Tubulin Modulators|tubulin modulators|mesh-ancestor
25632809|NCT01313884|Antimitotic Agents|antimitotic agents|mesh-ancestor
25632810|NCT01313884|Mitosis Modulators|mitosis modulators|mesh-ancestor
25632811|NCT01313897|Bortezomib|bortezomib|mesh-list
25632812|NCT01313897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632813|NCT01313936|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
25632814|NCT01313936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632815|NCT01313936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25632816|NCT01313936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632817|NCT01313936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25632818|NCT01314001|Nicotine|nicotine|mesh-list
25632819|NCT01314001|Varenicline|varenicline|mesh-list
25632820|NCT01314001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25632821|NCT01314001|Autonomic Agents|autonomic agents|mesh-ancestor
25632822|NCT01314001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632823|NCT01314001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632824|NCT01314001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25632825|NCT01314001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25632826|NCT01314001|Cholinergic Agents|cholinergic agents|mesh-ancestor
25632827|NCT01314001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25632828|NCT01314001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632829|NCT01314105|Carboplatin|carboplatin|mesh-list
25632830|NCT01314105|Nintedanib|nintedanib|mesh-list
25632831|NCT01314105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632832|NCT01314105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25632833|NCT01314105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25632834|NCT01314105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632835|NCT01314261|Interferons|interferons|mesh-list
25632836|NCT01314261|Ribavirin|ribavirin|mesh-list
25632837|NCT01314261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632838|NCT01314261|Antiviral Agents|antiviral agents|mesh-ancestor
25632839|NCT01314261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25632840|NCT01314261|Antimetabolites|antimetabolites|mesh-ancestor
25527474|NCT00505687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527475|NCT00505752|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25527476|NCT00505752|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25527477|NCT00505752|Hormones|hormones|mesh-ancestor
25717818|NCT02419469|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25527478|NCT00505752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25632841|NCT01314261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632842|NCT01314417|Methotrexate|methotrexate|mesh-list
25632843|NCT01314417|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25632844|NCT01314417|Abortifacient Agents|abortifacient agents|mesh-ancestor
25632845|NCT01314417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25632846|NCT01314417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632847|NCT01314417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25632848|NCT01314417|Antimetabolites|antimetabolites|mesh-ancestor
25632849|NCT01314417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632850|NCT01314417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632851|NCT01314417|Dermatologic Agents|dermatologic agents|mesh-ancestor
25632852|NCT01314417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25632853|NCT01314417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25632854|NCT01314417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25632855|NCT01314417|Immunologic Factors|immunologic factors|mesh-ancestor
25632856|NCT01314417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25632857|NCT01314417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25632858|NCT01314443|Vitamin E|vitamin e|mesh-list
25632859|NCT01314443|Tocopherols|tocopherols|mesh-list
25632860|NCT01314443|Tocotrienols|tocotrienols|mesh-list
25632861|NCT01314443|alpha-Tocopherol|alpha-tocopherol|mesh-list
25632862|NCT01314443|gamma-Tocopherol|gamma-tocopherol|mesh-list
25632863|NCT01314443|Nicotine|nicotine|mesh-list
25632864|NCT01314443|Vitamins|vitamins|mesh-ancestor
25632865|NCT01314443|Micronutrients|micronutrients|mesh-ancestor
25632866|NCT01314443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632867|NCT01314443|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25632868|NCT01314443|Autonomic Agents|autonomic agents|mesh-ancestor
25632869|NCT01314443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632870|NCT01314443|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25632871|NCT01314443|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25632872|NCT01314443|Cholinergic Agents|cholinergic agents|mesh-ancestor
25632873|NCT01314443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25632874|NCT01314443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632875|NCT01314443|Antioxidants|antioxidants|mesh-ancestor
25632876|NCT01314443|Protective Agents|protective agents|mesh-ancestor
25656156|NCT01571232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656157|NCT01571232|Growth Inhibitors|growth inhibitors|mesh-ancestor
25656158|NCT01571232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25656159|NCT01571232|Antiemetics|antiemetics|mesh-ancestor
25656160|NCT01571232|Autonomic Agents|autonomic agents|mesh-ancestor
25656161|NCT01571232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25656162|NCT01571232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25656163|NCT01571232|Glucocorticoids|glucocorticoids|mesh-ancestor
25656164|NCT01571232|Hormones|hormones|mesh-ancestor
25656165|NCT01571232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25656166|NCT01571232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25656167|NCT01571284|Aflibercept|aflibercept|mesh-list
25656168|NCT01571284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25656169|NCT01571284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25656170|NCT01571284|Growth Substances|growth substances|mesh-ancestor
25656171|NCT01571284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656172|NCT01571284|Growth Inhibitors|growth inhibitors|mesh-ancestor
25656173|NCT01571284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656174|NCT01571362|Naltrexone|naltrexone|mesh-list
25656175|NCT01571362|Oxycodone|oxycodone|mesh-list
25656176|NCT01571362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25656177|NCT01571362|Narcotics|narcotics|mesh-ancestor
25656178|NCT01571362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25656179|NCT01571362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656180|NCT01571362|Analgesics|analgesics|mesh-ancestor
25656181|NCT01571362|Sensory System Agents|sensory system agents|mesh-ancestor
25656182|NCT01571362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25656183|NCT01571362|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25656184|NCT01571362|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25527535|NCT00505921|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25527536|NCT00505921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25527537|NCT00505921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527538|NCT00505921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25527539|NCT00505921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25527540|NCT00505934|Levetiracetam|levetiracetam|mesh-list
25656185|NCT01571453|Vortioxetine|vortioxetine|mesh-list
25527541|NCT00505934|Anticonvulsants|anticonvulsants|mesh-ancestor
25527542|NCT00505934|Nootropic Agents|nootropic agents|mesh-ancestor
25527543|NCT00506129|Vidarabine|vidarabine|mesh-list
25527544|NCT00506129|Fludarabine|fludarabine|mesh-list
25527545|NCT00506129|Fludarabine phosphate|fludarabine phosphate|mesh-list
25632877|NCT01314872|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25632878|NCT01314872|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25632879|NCT01314872|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25632880|NCT01314872|Cholinergic Agents|cholinergic agents|mesh-ancestor
25632881|NCT01314872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25632882|NCT01314872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632883|NCT01314872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632884|NCT01314872|Urological Agents|urological agents|mesh-ancestor
25632885|NCT01314911|Oseltamivir|oseltamivir|mesh-list
25632886|NCT01314911|Antiviral Agents|antiviral agents|mesh-ancestor
25632887|NCT01314911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25632888|NCT01314911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25717839|NCT02419508|Brinzolamide|brinzolamide|mesh-list
25632889|NCT01314911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632890|NCT01315002|Nicotine|nicotine|mesh-list
25632891|NCT01315002|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25632892|NCT01315002|Autonomic Agents|autonomic agents|mesh-ancestor
25632893|NCT01315002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632894|NCT01315002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632895|NCT01315002|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25632896|NCT01315002|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25632897|NCT01315002|Cholinergic Agents|cholinergic agents|mesh-ancestor
25632898|NCT01315002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25632899|NCT01315002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632900|NCT01315158|Fentanyl|fentanyl|mesh-list
25632901|NCT01315158|Midazolam|midazolam|mesh-list
25632902|NCT01315158|Analgesics, Opioid|analgesics, opioid|mesh-list
25632903|NCT01315158|Propofol|propofol|mesh-list
25632904|NCT01315158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25632905|NCT01315158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25632906|NCT01315158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632907|NCT01315158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25632908|NCT01315158|Anesthetics, General|anesthetics, general|mesh-ancestor
25632909|NCT01315158|Anesthetics|anesthetics|mesh-ancestor
25632910|NCT01315158|Narcotics|narcotics|mesh-ancestor
25632911|NCT01315158|Analgesics|analgesics|mesh-ancestor
25632912|NCT01315158|Sensory System Agents|sensory system agents|mesh-ancestor
25632913|NCT01315158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632914|NCT01315158|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25632915|NCT01315158|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25632916|NCT01315158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25632917|NCT01315158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25632918|NCT01315158|GABA Modulators|gaba modulators|mesh-ancestor
25632919|NCT01315158|GABA Agents|gaba agents|mesh-ancestor
25632920|NCT01315158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25632921|NCT01315158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632922|NCT01315236|Amikacin|amikacin|mesh-list
25632923|NCT01315236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25632924|NCT01315236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25632925|NCT01315249|Fluticasone|fluticasone|mesh-list
25632926|NCT01315249|Xhance|xhance|mesh-list
25632927|NCT01315249|Glycopyrrolate|glycopyrrolate|mesh-list
25632928|NCT01315249|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25632929|NCT01315249|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25632930|NCT01315249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25632931|NCT01315249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25632932|NCT01315249|Autonomic Agents|autonomic agents|mesh-ancestor
25632933|NCT01315249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632934|NCT01315249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632935|NCT01315249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25632936|NCT01315249|Respiratory System Agents|respiratory system agents|mesh-ancestor
25632937|NCT01315249|Dermatologic Agents|dermatologic agents|mesh-ancestor
25632938|NCT01315249|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25632939|NCT01315249|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25632940|NCT01315249|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25632941|NCT01315249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25632942|NCT01315249|Adrenergic Agents|adrenergic agents|mesh-ancestor
25632943|NCT01315249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25632944|NCT01315249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632945|NCT01315249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25632946|NCT01315249|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25632947|NCT01315249|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25632948|NCT01315249|Cholinergic Agents|cholinergic agents|mesh-ancestor
25632949|NCT01315249|Glucocorticoids|glucocorticoids|mesh-ancestor
25632950|NCT01315249|Hormones|hormones|mesh-ancestor
25632951|NCT01315249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25632952|NCT01315249|Sympathomimetics|sympathomimetics|mesh-ancestor
25632954|NCT01315574|Latanoprost|latanoprost|mesh-list
25632955|NCT01315574|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25632956|NCT01315574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25632957|NCT01315574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25632958|NCT01315665|Sulforaphane|sulforaphane|mesh-list
25632959|NCT01315665|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25632960|NCT01315665|Protective Agents|protective agents|mesh-ancestor
25632961|NCT01315665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632962|NCT01315665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632963|NCT01315678|Tobramycin|tobramycin|mesh-list
25632964|NCT01315678|Amikacin|amikacin|mesh-list
25632965|NCT01315678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25632966|NCT01315678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25632967|NCT01316042|Metformin|metformin|mesh-list
25632968|NCT01316042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25632969|NCT01316042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632970|NCT01316055|4-Aminopyridine|4-aminopyridine|mesh-list
25632971|NCT01316055|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25632972|NCT01316055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25632973|NCT01316055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632974|NCT01316263|Olaratumab|olaratumab|mesh-list
25632975|NCT01316263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25632976|NCT01316276|Amikacin|amikacin|mesh-list
25632977|NCT01316276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25632978|NCT01316276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25632979|NCT01316302|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25632980|NCT01316302|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25632981|NCT01316302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25632982|NCT01316302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25632983|NCT01316302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632984|NCT01316302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25632985|NCT01316302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632986|NCT01316302|Antidepressive Agents|antidepressive agents|mesh-ancestor
25632987|NCT01316302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25632988|NCT01316341|Empagliflozin|empagliflozin|mesh-list
25632989|NCT01316341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25632990|NCT01316341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25632991|NCT01316341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25632992|NCT01316341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632993|NCT01316380|Tiotropium Bromide|tiotropium bromide|mesh-list
25632994|NCT01316380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25632995|NCT01316380|Autonomic Agents|autonomic agents|mesh-ancestor
25632996|NCT01316380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25632997|NCT01316380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25632998|NCT01316380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25632999|NCT01316380|Respiratory System Agents|respiratory system agents|mesh-ancestor
25633000|NCT01316380|Parasympatholytics|parasympatholytics|mesh-ancestor
25633001|NCT01316380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25633002|NCT01316380|Cholinergic Agents|cholinergic agents|mesh-ancestor
25633003|NCT01316380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25633004|NCT01316380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633005|NCT01316419|Amlodipine|amlodipine|mesh-list
25633006|NCT01316419|Telmisartan|telmisartan|mesh-list
25633007|NCT01316419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25633008|NCT01316419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25633009|NCT01316419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25633010|NCT01316419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633011|NCT01316419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25633012|NCT01316419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633013|NCT01316419|Vasodilator Agents|vasodilator agents|mesh-ancestor
25633014|NCT01316419|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25633015|NCT01316419|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25633016|NCT01316770|Dexamethasone|dexamethasone|mesh-list
25633017|NCT01316770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25633018|NCT01316770|Antiemetics|antiemetics|mesh-ancestor
25633019|NCT01316770|Autonomic Agents|autonomic agents|mesh-ancestor
25633020|NCT01316770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25633021|NCT01316770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527661|NCT00506675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25527662|NCT00506675|Autonomic Agents|autonomic agents|mesh-ancestor
25527663|NCT00506675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25527664|NCT00506675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633022|NCT01316770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25633023|NCT01316770|Glucocorticoids|glucocorticoids|mesh-ancestor
25633024|NCT01316770|Hormones|hormones|mesh-ancestor
25633025|NCT01316770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25633026|NCT01316770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25633027|NCT01316770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25633028|NCT01316900|Bromides|bromides|mesh-list
25633029|NCT01316900|Tiotropium Bromide|tiotropium bromide|mesh-list
25633030|NCT01316900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25633031|NCT01316900|Autonomic Agents|autonomic agents|mesh-ancestor
25633032|NCT01316900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25633033|NCT01316900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633034|NCT01316900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25633035|NCT01316900|Respiratory System Agents|respiratory system agents|mesh-ancestor
25633036|NCT01316900|Parasympatholytics|parasympatholytics|mesh-ancestor
25633037|NCT01316900|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25633038|NCT01316900|Cholinergic Agents|cholinergic agents|mesh-ancestor
25633039|NCT01316900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25633040|NCT01316900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633041|NCT01316900|Anticonvulsants|anticonvulsants|mesh-ancestor
25633042|NCT01316913|Bromides|bromides|mesh-list
25633043|NCT01316913|Tiotropium Bromide|tiotropium bromide|mesh-list
25633044|NCT01316913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25633045|NCT01316913|Autonomic Agents|autonomic agents|mesh-ancestor
25633046|NCT01316913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25633047|NCT01316913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633048|NCT01316913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25633049|NCT01316913|Respiratory System Agents|respiratory system agents|mesh-ancestor
25633050|NCT01316913|Parasympatholytics|parasympatholytics|mesh-ancestor
25633051|NCT01316913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25633052|NCT01316913|Cholinergic Agents|cholinergic agents|mesh-ancestor
25633053|NCT01316913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25633054|NCT01316913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633055|NCT01316913|Anticonvulsants|anticonvulsants|mesh-ancestor
25633056|NCT01317004|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25633057|NCT01317004|Interferon beta-1b|interferon beta-1b|mesh-list
25633058|NCT01317004|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25633059|NCT01317004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633060|NCT01317004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25633061|NCT01317004|Immunologic Factors|immunologic factors|mesh-ancestor
25633062|NCT01317004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633063|NCT01317004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25633064|NCT01317472|Dexlansoprazole|dexlansoprazole|mesh-list
25633065|NCT01317472|Lansoprazole|lansoprazole|mesh-list
25633066|NCT01317472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25633067|NCT01317472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25633068|NCT01317472|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25633069|NCT01317472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633070|NCT01317472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633071|NCT01317550|Minocycline|minocycline|mesh-list
25633072|NCT01317550|Modafinil|modafinil|mesh-list
25633073|NCT01317550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25633074|NCT01317550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25633075|NCT01317550|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25633076|NCT01317550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633077|NCT01317550|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25633078|NCT01317550|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25633079|NCT01317550|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25633080|NCT01317550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633081|NCT01317615|Paclitaxel|paclitaxel|mesh-list
25633082|NCT01317615|Carboplatin|carboplatin|mesh-list
25633083|NCT01317615|Everolimus|everolimus|mesh-list
25633084|NCT01317615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25633085|NCT01317615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25633086|NCT01317615|Tubulin Modulators|tubulin modulators|mesh-ancestor
25633087|NCT01317615|Antimitotic Agents|antimitotic agents|mesh-ancestor
25633088|NCT01317615|Mitosis Modulators|mitosis modulators|mesh-ancestor
25633089|NCT01317615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633090|NCT01317615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25633091|NCT01317615|Immunologic Factors|immunologic factors|mesh-ancestor
25633092|NCT01317615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633093|NCT01317667|Vaccines|vaccines|mesh-list
25633094|NCT01317667|Immunologic Factors|immunologic factors|mesh-ancestor
25633095|NCT01317667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633096|NCT01317901|Rituximab|rituximab|mesh-list
25633097|NCT01317901|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25633098|NCT01317901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25633099|NCT01317901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25633100|NCT01317901|Immunologic Factors|immunologic factors|mesh-ancestor
25633101|NCT01317901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633102|NCT01317901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25633103|NCT01317901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25633104|NCT01317901|Alkylating Agents|alkylating agents|mesh-ancestor
25633105|NCT01317901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633106|NCT01317940|Calcium, Dietary|calcium, dietary|mesh-list
25633107|NCT01317940|Vitamin D|vitamin d|mesh-list
25633108|NCT01317940|Calcitriol|calcitriol|mesh-list
25633109|NCT01317940|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
25633110|NCT01317940|Calcium Carbonate|calcium carbonate|mesh-list
25633111|NCT01317940|Calcium|calcium|mesh-list
25633112|NCT01317940|Vitamins|vitamins|mesh-ancestor
25633113|NCT01317940|Micronutrients|micronutrients|mesh-ancestor
25633114|NCT01317940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633115|NCT01317940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25633116|NCT01317940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25633117|NCT01317940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633118|NCT01317940|Antacids|antacids|mesh-ancestor
25633119|NCT01317940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25633120|NCT01317940|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25633121|NCT01317940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25633122|NCT01317940|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25633123|NCT01318070|Pioglitazone|pioglitazone|mesh-list
25633124|NCT01318070|Alogliptin|alogliptin|mesh-list
25633125|NCT01318070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25633126|NCT01318070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633127|NCT01318070|Incretins|incretins|mesh-ancestor
25633128|NCT01318070|Hormones|hormones|mesh-ancestor
25633129|NCT01318070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25633130|NCT01318070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25633131|NCT01318070|Protease Inhibitors|protease inhibitors|mesh-ancestor
25633132|NCT01318070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633133|NCT01318070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633134|NCT01318083|Glimepiride|glimepiride|mesh-list
25633135|NCT01318083|Alogliptin|alogliptin|mesh-list
25633136|NCT01318083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25633137|NCT01318083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25633138|NCT01318083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633139|NCT01318083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25633140|NCT01318083|Immunologic Factors|immunologic factors|mesh-ancestor
25633141|NCT01318083|Incretins|incretins|mesh-ancestor
25633142|NCT01318083|Hormones|hormones|mesh-ancestor
25633143|NCT01318083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25633144|NCT01318083|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25633145|NCT01318083|Protease Inhibitors|protease inhibitors|mesh-ancestor
25633146|NCT01318083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633147|NCT01318083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633148|NCT01318109|Metformin|metformin|mesh-list
25633149|NCT01318109|Alogliptin|alogliptin|mesh-list
25633150|NCT01318109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25633151|NCT01318109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633152|NCT01318109|Incretins|incretins|mesh-ancestor
25633153|NCT01318109|Hormones|hormones|mesh-ancestor
25633154|NCT01318109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25633155|NCT01318109|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25633156|NCT01318109|Protease Inhibitors|protease inhibitors|mesh-ancestor
25633157|NCT01318109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633158|NCT01318109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633159|NCT01318122|Pioglitazone|pioglitazone|mesh-list
25633160|NCT01318122|Alogliptin|alogliptin|mesh-list
25633161|NCT01318122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25633162|NCT01318122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633163|NCT01318122|Incretins|incretins|mesh-ancestor
25633164|NCT01318122|Hormones|hormones|mesh-ancestor
25633165|NCT01318122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25633166|NCT01318122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25633167|NCT01318122|Protease Inhibitors|protease inhibitors|mesh-ancestor
25633168|NCT01318122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527798|NCT00507429|Antimitotic Agents|antimitotic agents|mesh-ancestor
25633169|NCT01318122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633170|NCT01318135|Metformin|metformin|mesh-list
25633171|NCT01318135|Glimepiride|glimepiride|mesh-list
25633172|NCT01318135|Alogliptin|alogliptin|mesh-list
25633173|NCT01318135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25633174|NCT01318135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633175|NCT01318135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25633176|NCT01318135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25527864|NCT00507728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25527865|NCT00507728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527866|NCT00507728|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25527867|NCT00507728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25527868|NCT00507728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527869|NCT00507728|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25527870|NCT00507728|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25527871|NCT00507728|Cholinergic Agents|cholinergic agents|mesh-ancestor
25527872|NCT00507767|Dasatinib|dasatinib|mesh-list
25527873|NCT00507767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527874|NCT00507767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25527875|NCT00507767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527876|NCT00507767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527877|NCT00507819|Sildenafil Citrate|sildenafil citrate|mesh-list
25527878|NCT00507819|Vasodilator Agents|vasodilator agents|mesh-ancestor
25527879|NCT00507819|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25527880|NCT00507819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25527881|NCT00507819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527882|NCT00507819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527883|NCT00507819|Urological Agents|urological agents|mesh-ancestor
25527884|NCT00508027|Simvastatin|simvastatin|mesh-list
25527885|NCT00508027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25527886|NCT00508027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25527887|NCT00508027|Antimetabolites|antimetabolites|mesh-ancestor
25527888|NCT00508027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527889|NCT00508027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25527890|NCT00508027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25527891|NCT00508027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527892|NCT00508118|Nicardipine|nicardipine|mesh-list
25527893|NCT00508118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25527894|NCT00508118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25527895|NCT00508118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25527898|NCT00508118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633177|NCT01318135|Immunologic Factors|immunologic factors|mesh-ancestor
25633178|NCT01318135|Incretins|incretins|mesh-ancestor
25633179|NCT01318135|Hormones|hormones|mesh-ancestor
25633180|NCT01318135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25633181|NCT01318135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25633182|NCT01318135|Protease Inhibitors|protease inhibitors|mesh-ancestor
25633183|NCT01318135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633184|NCT01318135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633185|NCT01318278|Dopamine|dopamine|mesh-list
25633186|NCT01318278|Vasopressins|vasopressins|mesh-list
25633187|NCT01318278|Arginine Vasopressin|arginine vasopressin|mesh-list
25633188|NCT01318278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633189|NCT01318278|Hemostatics|hemostatics|mesh-ancestor
25633190|NCT01318278|Coagulants|coagulants|mesh-ancestor
25633191|NCT01318278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25633192|NCT01318278|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25633193|NCT01318278|Natriuretic Agents|natriuretic agents|mesh-ancestor
25633194|NCT01318278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25633195|NCT01318278|Sympathomimetics|sympathomimetics|mesh-ancestor
25633196|NCT01318278|Autonomic Agents|autonomic agents|mesh-ancestor
25633197|NCT01318278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25633198|NCT01318278|Dopamine Agents|dopamine agents|mesh-ancestor
25633199|NCT01318278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25633200|NCT01318278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633201|NCT01318278|Protective Agents|protective agents|mesh-ancestor
25633202|NCT01318356|Doxycycline|doxycycline|mesh-list
25633203|NCT01318356|Tetracycline|tetracycline|mesh-list
25633204|NCT01318356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25633205|NCT01318356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25633206|NCT01318356|Antimalarials|antimalarials|mesh-ancestor
25633207|NCT01318356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25633208|NCT01318356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25633209|NCT01318356|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25633210|NCT01318356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25656186|NCT01571453|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25633211|NCT01318356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633212|NCT01318408|Levetiracetam|levetiracetam|mesh-list
25633213|NCT01318408|Anticonvulsants|anticonvulsants|mesh-ancestor
25633214|NCT01318408|Nootropic Agents|nootropic agents|mesh-ancestor
25633216|NCT01318499|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25633217|NCT01318499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25633218|NCT01318499|Analgesics|analgesics|mesh-ancestor
25633219|NCT01318499|Sensory System Agents|sensory system agents|mesh-ancestor
25633220|NCT01318499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25633221|NCT01318499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633222|NCT01318499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25633223|NCT01318499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25633224|NCT01318577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25633225|NCT01318694|Ribavirin|ribavirin|mesh-list
25633226|NCT01318694|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25633227|NCT01318694|Antimetabolites|antimetabolites|mesh-ancestor
25633228|NCT01318694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633229|NCT01318694|Antiviral Agents|antiviral agents|mesh-ancestor
25633230|NCT01318694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25633231|NCT01318811|Heparin|heparin|mesh-list
25633232|NCT01318811|Calcium heparin|calcium heparin|mesh-list
25633233|NCT01318811|Anticoagulants|anticoagulants|mesh-ancestor
25633234|NCT01318811|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25633235|NCT01318811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25633236|NCT01318811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633237|NCT01318902|Dexamethasone|dexamethasone|mesh-list
25633238|NCT01318902|Ixazomib|ixazomib|mesh-list
25633239|NCT01318902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25633240|NCT01318902|Antiemetics|antiemetics|mesh-ancestor
25633241|NCT01318902|Autonomic Agents|autonomic agents|mesh-ancestor
25633242|NCT01318902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25633243|NCT01318902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633244|NCT01318902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25633245|NCT01318902|Glucocorticoids|glucocorticoids|mesh-ancestor
25633246|NCT01318902|Hormones|hormones|mesh-ancestor
25633247|NCT01318902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25633248|NCT01318902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25633249|NCT01318902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25633250|NCT01318902|Protease Inhibitors|protease inhibitors|mesh-ancestor
25633251|NCT01318902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633252|NCT01318902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633253|NCT01318915|Mycophenolic Acid|mycophenolic acid|mesh-list
25633254|NCT01318915|Sirolimus|sirolimus|mesh-list
25633255|NCT01318915|Rituximab|rituximab|mesh-list
25633256|NCT01318915|Tacrolimus|tacrolimus|mesh-list
25633257|NCT01318915|Thymoglobulin|thymoglobulin|mesh-list
25633258|NCT01318915|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25633259|NCT01318915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25633260|NCT01318915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25633261|NCT01318915|Immunologic Factors|immunologic factors|mesh-ancestor
25633262|NCT01318915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633263|NCT01318915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25633264|NCT01318915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25633265|NCT01318915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25633266|NCT01318915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633267|NCT01318915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633268|NCT01318915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25633269|NCT01318915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25633270|NCT01318915|Antitubercular Agents|antitubercular agents|mesh-ancestor
25633271|NCT01318915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25633272|NCT01318915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25633273|NCT01318915|Antifungal Agents|antifungal agents|mesh-ancestor
25633274|NCT01318967|Furosemide|furosemide|mesh-list
25633275|NCT01318967|Diuretics|diuretics|mesh-ancestor
25633276|NCT01318967|Natriuretic Agents|natriuretic agents|mesh-ancestor
25633277|NCT01318967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633278|NCT01318967|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25633279|NCT01318967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25633280|NCT01318967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633281|NCT01319045|Iloprost|iloprost|mesh-list
25633282|NCT01319045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25633283|NCT01319045|Vasodilator Agents|vasodilator agents|mesh-ancestor
25633284|NCT01319110|Ubiquinone|ubiquinone|mesh-list
25633285|NCT01319110|Coenzyme Q10|coenzyme q10|mesh-list
25633286|NCT01319110|Micronutrients|micronutrients|mesh-ancestor
25633287|NCT01319110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633288|NCT01319110|Vitamins|vitamins|mesh-ancestor
25633289|NCT01319383|Vorinostat|vorinostat|mesh-list
25633290|NCT01319383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25633291|NCT01319383|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25633292|NCT01319383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633293|NCT01319383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633294|NCT01319422|Pomalidomide|pomalidomide|mesh-list
25633295|NCT01319422|Immunologic Factors|immunologic factors|mesh-ancestor
25633296|NCT01319422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633297|NCT01319422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25633298|NCT01319422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25633299|NCT01319422|Growth Substances|growth substances|mesh-ancestor
25633300|NCT01319422|Growth Inhibitors|growth inhibitors|mesh-ancestor
25633301|NCT01319422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25633302|NCT01319721|Mitomycins|mitomycins|mesh-list
25633303|NCT01319721|Mitomycin|mitomycin|mesh-list
25633304|NCT01319721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25633305|NCT01319721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25633306|NCT01319721|Alkylating Agents|alkylating agents|mesh-ancestor
25633307|NCT01319721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633308|NCT01319721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25633309|NCT01319721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633310|NCT01319773|Cyclosporine|cyclosporine|mesh-list
25633311|NCT01319773|Cyclosporins|cyclosporins|mesh-list
25633312|NCT01319773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633313|NCT01319773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633314|NCT01319773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25633315|NCT01319773|Immunologic Factors|immunologic factors|mesh-ancestor
25633316|NCT01319773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633317|NCT01319773|Antifungal Agents|antifungal agents|mesh-ancestor
25633318|NCT01319773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25633319|NCT01319773|Dermatologic Agents|dermatologic agents|mesh-ancestor
25633320|NCT01319773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25633321|NCT01319773|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25633322|NCT01319851|Alefacept|alefacept|mesh-list
25633323|NCT01319851|Dermatologic Agents|dermatologic agents|mesh-ancestor
25633324|NCT01319851|Immunologic Factors|immunologic factors|mesh-ancestor
25633325|NCT01319851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633326|NCT01319929|CB2 receptor agonist LY2828360|cb2 receptor agonist ly2828360|mesh-list
25633327|NCT01319929|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25633328|NCT01319929|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25633329|NCT01319929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25633330|NCT01319929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633331|NCT01319929|Hormones|hormones|mesh-ancestor
25633332|NCT01319929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25633333|NCT01319929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633334|NCT01319994|Metformin|metformin|mesh-list
25633335|NCT01319994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25633336|NCT01319994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633337|NCT01320033|Doxycycline|doxycycline|mesh-list
25633338|NCT01320033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25633339|NCT01320033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25633340|NCT01320033|Antimalarials|antimalarials|mesh-ancestor
25633341|NCT01320033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25633342|NCT01320033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25633343|NCT01320202|Dialysis Solutions|dialysis solutions|mesh-list
25633344|NCT01320202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25633345|NCT01320293|Adalimumab|adalimumab|mesh-list
25633346|NCT01320293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25633347|NCT01320293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25633348|NCT01320722|Vitamin D|vitamin d|mesh-list
25633349|NCT01320722|Ergocalciferols|ergocalciferols|mesh-list
25633350|NCT01320722|Cholecalciferol|cholecalciferol|mesh-list
25633351|NCT01320722|Vitamins|vitamins|mesh-list
25633352|NCT01320722|Allopurinol|allopurinol|mesh-list
25633353|NCT01320722|Probenecid|probenecid|mesh-list
25633354|NCT01320722|Micronutrients|micronutrients|mesh-ancestor
25633355|NCT01320722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633356|NCT01320722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25633357|NCT01320722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25633358|NCT01320722|Antimetabolites|antimetabolites|mesh-ancestor
25633359|NCT01320722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633360|NCT01320722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633361|NCT01320722|Gout Suppressants|gout suppressants|mesh-ancestor
25527969|NCT00508924|Antithrombins|antithrombins|mesh-ancestor
25633362|NCT01320722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25633364|NCT01320722|Antioxidants|antioxidants|mesh-ancestor
25633365|NCT01320722|Protective Agents|protective agents|mesh-ancestor
25633366|NCT01320722|Uricosuric Agents|uricosuric agents|mesh-ancestor
25633367|NCT01320722|Renal Agents|renal agents|mesh-ancestor
25656187|NCT01571453|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25656188|NCT01571453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25656189|NCT01571453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25656190|NCT01571453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656191|NCT01571453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25656192|NCT01571453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656193|NCT01571453|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25656194|NCT01571453|Antidepressive Agents|antidepressive agents|mesh-ancestor
25656195|NCT01571453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25656196|NCT01571453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25656197|NCT01571453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25656198|NCT01571453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25656199|NCT01571453|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25656200|NCT01571453|Serotonin Agents|serotonin agents|mesh-ancestor
25656201|NCT01571453|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25656202|NCT01571453|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25656203|NCT01571453|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25656204|NCT01571453|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25656205|NCT01571557|Dexamethasone|dexamethasone|mesh-list
25656206|NCT01571557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25656207|NCT01571557|Antiemetics|antiemetics|mesh-ancestor
25656208|NCT01571557|Autonomic Agents|autonomic agents|mesh-ancestor
25656209|NCT01571557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25656210|NCT01571557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656211|NCT01571557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25656212|NCT01571557|Glucocorticoids|glucocorticoids|mesh-ancestor
25656213|NCT01571557|Hormones|hormones|mesh-ancestor
25656214|NCT01571557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25656215|NCT01571557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25656216|NCT01571557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656217|NCT01572038|Paclitaxel|paclitaxel|mesh-list
25656218|NCT01572038|Docetaxel|docetaxel|mesh-list
25656219|NCT01572038|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25656220|NCT01572038|Trastuzumab|trastuzumab|mesh-list
25656221|NCT01572038|Pertuzumab|pertuzumab|mesh-list
25656222|NCT01572038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25656223|NCT01572038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656224|NCT01572038|Tubulin Modulators|tubulin modulators|mesh-ancestor
25656225|NCT01572038|Antimitotic Agents|antimitotic agents|mesh-ancestor
25656226|NCT01572038|Mitosis Modulators|mitosis modulators|mesh-ancestor
25656227|NCT01572038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656228|NCT01572038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25656229|NCT01572727|Paclitaxel|paclitaxel|mesh-list
25656230|NCT01572727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25656231|NCT01572727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656232|NCT01572727|Tubulin Modulators|tubulin modulators|mesh-ancestor
25656233|NCT01572727|Antimitotic Agents|antimitotic agents|mesh-ancestor
25656234|NCT01572727|Mitosis Modulators|mitosis modulators|mesh-ancestor
25656235|NCT01572727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656236|NCT01572740|Liraglutide|liraglutide|mesh-list
25656237|NCT01572740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25656238|NCT01572740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656239|NCT01572740|Incretins|incretins|mesh-ancestor
25656240|NCT01572740|Hormones|hormones|mesh-ancestor
25656241|NCT01572740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25656242|NCT01572792|Bromides|bromides|mesh-list
25656243|NCT01572792|Formoterol Fumarate|formoterol fumarate|mesh-list
25656244|NCT01572792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25656245|NCT01572792|Autonomic Agents|autonomic agents|mesh-ancestor
25656246|NCT01572792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25656247|NCT01572792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656248|NCT01572792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25656249|NCT01572792|Respiratory System Agents|respiratory system agents|mesh-ancestor
25656250|NCT01572792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25656251|NCT01572792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25656252|NCT01572792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25656253|NCT01572792|Adrenergic Agents|adrenergic agents|mesh-ancestor
25656254|NCT01572792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25633368|NCT01321151|Resveratrol|resveratrol|mesh-list
25633369|NCT01321151|Antioxidants|antioxidants|mesh-ancestor
25633370|NCT01321151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633371|NCT01321151|Protective Agents|protective agents|mesh-ancestor
25633372|NCT01321151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633373|NCT01321151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633374|NCT01321151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25633375|NCT01321437|Axitinib|axitinib|mesh-list
25633376|NCT01321437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25633377|NCT01321437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25633378|NCT01321437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633379|NCT01321437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633380|NCT01321541|Gemcitabine|gemcitabine|mesh-list
25633381|NCT01321541|Rituximab|rituximab|mesh-list
25633382|NCT01321541|Pixantrone|pixantrone|mesh-list
25633383|NCT01321541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25633384|NCT01321541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25633385|NCT01321541|Immunologic Factors|immunologic factors|mesh-ancestor
25633386|NCT01321541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633387|NCT01321541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25633388|NCT01321541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25633389|NCT01321541|Antimetabolites|antimetabolites|mesh-ancestor
25633390|NCT01321541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633391|NCT01321541|Antiviral Agents|antiviral agents|mesh-ancestor
25633392|NCT01321541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25633393|NCT01321541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633394|NCT01321541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25633395|NCT01321541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25633396|NCT01321541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25633397|NCT01321554|Lenvatinib|lenvatinib|mesh-list
25633398|NCT01321554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25633399|NCT01321554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25633400|NCT01321554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633401|NCT01321554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633402|NCT01321710|Acetaminophen|acetaminophen|mesh-list
25633403|NCT01321710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25633404|NCT01321710|Analgesics|analgesics|mesh-ancestor
25633405|NCT01321710|Sensory System Agents|sensory system agents|mesh-ancestor
25633406|NCT01321710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25633407|NCT01321710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633408|NCT01321710|Antipyretics|antipyretics|mesh-ancestor
25633409|NCT01321723|Teriparatide|teriparatide|mesh-list
25633410|NCT01321723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25633411|NCT01321723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633412|NCT01321723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25633413|NCT01321879|Telavancin|telavancin|mesh-list
25633414|NCT01321879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25633415|NCT01321879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25633416|NCT01322009|Acetylcysteine|acetylcysteine|mesh-list
25633417|NCT01322009|Probenecid|probenecid|mesh-list
25633418|NCT01322009|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25633419|NCT01322009|Antiviral Agents|antiviral agents|mesh-ancestor
25633420|NCT01322009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25633421|NCT01322009|Expectorants|expectorants|mesh-ancestor
25633422|NCT01322009|Respiratory System Agents|respiratory system agents|mesh-ancestor
25633423|NCT01322009|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25633424|NCT01322009|Antioxidants|antioxidants|mesh-ancestor
25633425|NCT01322009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633426|NCT01322009|Protective Agents|protective agents|mesh-ancestor
25633427|NCT01322009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633428|NCT01322009|Antidotes|antidotes|mesh-ancestor
25633429|NCT01322009|Uricosuric Agents|uricosuric agents|mesh-ancestor
25633430|NCT01322009|Gout Suppressants|gout suppressants|mesh-ancestor
25633431|NCT01322009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25633432|NCT01322009|Renal Agents|renal agents|mesh-ancestor
25633433|NCT01322048|Propranolol|propranolol|mesh-list
25633434|NCT01322048|Clonidine|clonidine|mesh-list
25633435|NCT01322048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25633436|NCT01322048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25633437|NCT01322048|Adrenergic Agents|adrenergic agents|mesh-ancestor
25633438|NCT01322048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25633439|NCT01322048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633440|NCT01322048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633441|NCT01322048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25633442|NCT01322048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25633443|NCT01322048|Vasodilator Agents|vasodilator agents|mesh-ancestor
25528120|NCT00509496|Aldesleukin|aldesleukin|mesh-list
25633444|NCT01322048|Analgesics|analgesics|mesh-ancestor
25633445|NCT01322048|Sensory System Agents|sensory system agents|mesh-ancestor
25633446|NCT01322048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25633447|NCT01322048|Sympatholytics|sympatholytics|mesh-ancestor
25633448|NCT01322048|Autonomic Agents|autonomic agents|mesh-ancestor
25633449|NCT01322048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25633450|NCT01322048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25633451|NCT01322048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25633452|NCT01322347|Dialysis Solutions|dialysis solutions|mesh-list
25633453|NCT01322347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25633454|NCT01322360|Morphine|morphine|mesh-list
25633455|NCT01322360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25633456|NCT01322360|Narcotics|narcotics|mesh-ancestor
25633457|NCT01322360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25633458|NCT01322360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633459|NCT01322360|Analgesics|analgesics|mesh-ancestor
25633460|NCT01322360|Sensory System Agents|sensory system agents|mesh-ancestor
25633461|NCT01322360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25633462|NCT01322386|Vancomycin|vancomycin|mesh-list
25633463|NCT01322386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25633464|NCT01322386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25633465|NCT01322490|Molgramostim|molgramostim|mesh-list
25633466|NCT01322490|Sargramostim|sargramostim|mesh-list
25633467|NCT01322490|Immunologic Factors|immunologic factors|mesh-ancestor
25633468|NCT01322490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633469|NCT01322490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25633470|NCT01322815|Leucovorin|leucovorin|mesh-list
25633471|NCT01322815|Fluorouracil|fluorouracil|mesh-list
25633472|NCT01322815|Oxaliplatin|oxaliplatin|mesh-list
25633473|NCT01322815|Irinotecan|irinotecan|mesh-list
25633474|NCT01322815|Bevacizumab|bevacizumab|mesh-list
25633475|NCT01322815|Levoleucovorin|levoleucovorin|mesh-list
25633476|NCT01322815|Antimetabolites|antimetabolites|mesh-ancestor
25633477|NCT01322815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633478|NCT01322815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25633479|NCT01322815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25633480|NCT01322815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25633481|NCT01322815|Immunologic Factors|immunologic factors|mesh-ancestor
25633482|NCT01322815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633483|NCT01322815|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25633484|NCT01322815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25633485|NCT01322815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633486|NCT01322815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25633487|NCT01322815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25633488|NCT01322815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25633489|NCT01322815|Growth Substances|growth substances|mesh-ancestor
25633490|NCT01322815|Growth Inhibitors|growth inhibitors|mesh-ancestor
25633491|NCT01322815|Antidotes|antidotes|mesh-ancestor
25633492|NCT01322815|Protective Agents|protective agents|mesh-ancestor
25633493|NCT01322815|Vitamin B Complex|vitamin b complex|mesh-ancestor
25633494|NCT01322815|Vitamins|vitamins|mesh-ancestor
25633495|NCT01322815|Micronutrients|micronutrients|mesh-ancestor
25633496|NCT01323010|Albuterol|albuterol|mesh-list
25633497|NCT01323010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25633498|NCT01323010|Autonomic Agents|autonomic agents|mesh-ancestor
25633499|NCT01323010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25633500|NCT01323010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633501|NCT01323010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25633502|NCT01323010|Respiratory System Agents|respiratory system agents|mesh-ancestor
25633503|NCT01323010|Tocolytic Agents|tocolytic agents|mesh-ancestor
25633504|NCT01323010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25633505|NCT01323010|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25633506|NCT01323010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25633507|NCT01323010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25633508|NCT01323010|Adrenergic Agents|adrenergic agents|mesh-ancestor
25633509|NCT01323010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25633510|NCT01323010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633511|NCT01323140|Testosterone|testosterone|mesh-list
25633512|NCT01323140|Androgens|androgens|mesh-ancestor
25633513|NCT01323140|Hormones|hormones|mesh-ancestor
25633514|NCT01323140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25633515|NCT01323140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633516|NCT01323153|Dalcetrapib|dalcetrapib|mesh-list
25633517|NCT01323153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25633518|NCT01323153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25633519|NCT01323153|Antimetabolites|antimetabolites|mesh-ancestor
25633520|NCT01323153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633521|NCT01323153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25633523|NCT01323478|Antidepressive Agents|antidepressive agents|mesh-ancestor
25633524|NCT01323478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25633525|NCT01323478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25633526|NCT01323478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25633527|NCT01323478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25633528|NCT01323478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633529|NCT01323478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25633530|NCT01323478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25633531|NCT01323478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25633532|NCT01323478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633533|NCT01323478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25633534|NCT01323478|Serotonin Agents|serotonin agents|mesh-ancestor
25633535|NCT01323478|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25633536|NCT01323478|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25633537|NCT01323478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25633538|NCT01323478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25633539|NCT01323517|Dactinomycin|dactinomycin|mesh-list
25633540|NCT01323517|Ipilimumab|ipilimumab|mesh-list
25633541|NCT01323517|Melphalan|melphalan|mesh-list
25633542|NCT01323517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25633543|NCT01323517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25633544|NCT01323517|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25633545|NCT01323517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633546|NCT01323517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25633547|NCT01323517|Alkylating Agents|alkylating agents|mesh-ancestor
25633548|NCT01323517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25633549|NCT01323517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25633550|NCT01323517|Immunologic Factors|immunologic factors|mesh-ancestor
25633551|NCT01323517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633552|NCT01323517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25633553|NCT01323517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25633554|NCT01323517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25633555|NCT01323517|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25633556|NCT01323517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633557|NCT01323517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25633558|NCT01323530|Capecitabine|capecitabine|mesh-list
25633559|NCT01323530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25633560|NCT01323530|Antimetabolites|antimetabolites|mesh-ancestor
25633561|NCT01323530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633562|NCT01323530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25633563|NCT01323582|Azithromycin|azithromycin|mesh-list
25633564|NCT01323582|Erythromycin|erythromycin|mesh-list
25633565|NCT01323582|Erythromycin Estolate|erythromycin estolate|mesh-list
25633566|NCT01323582|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25633567|NCT01323582|Erythromycin stearate|erythromycin stearate|mesh-list
25633568|NCT01323582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25633569|NCT01323582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25633570|NCT01323582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25633571|NCT01323582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25633572|NCT01323582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633573|NCT01323582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633574|NCT01323595|Celecoxib|celecoxib|mesh-list
25633575|NCT01323595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25633576|NCT01323595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25633577|NCT01323595|Analgesics|analgesics|mesh-ancestor
25633578|NCT01323595|Sensory System Agents|sensory system agents|mesh-ancestor
25633579|NCT01323595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25633580|NCT01323595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633581|NCT01323595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25633582|NCT01323595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25633583|NCT01323595|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25633584|NCT01323595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25633585|NCT01323595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633586|NCT01323595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633587|NCT01323621|Fluticasone|fluticasone|mesh-list
25633588|NCT01323621|Xhance|xhance|mesh-list
25633589|NCT01323621|Albuterol|albuterol|mesh-list
25633590|NCT01323621|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25633591|NCT01323621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25633592|NCT01323621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25633593|NCT01323621|Autonomic Agents|autonomic agents|mesh-ancestor
25633594|NCT01323621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25633595|NCT01323621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633596|NCT01323621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25633597|NCT01323621|Respiratory System Agents|respiratory system agents|mesh-ancestor
25633598|NCT01323621|Dermatologic Agents|dermatologic agents|mesh-ancestor
25633599|NCT01323621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25633600|NCT01323621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25633601|NCT01323621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25633602|NCT01323621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25633603|NCT01323621|Adrenergic Agents|adrenergic agents|mesh-ancestor
25633604|NCT01323621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25633605|NCT01323621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633606|NCT01323621|Tocolytic Agents|tocolytic agents|mesh-ancestor
25633607|NCT01323621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25633608|NCT01323634|Fluticasone|fluticasone|mesh-list
25633609|NCT01323634|Xhance|xhance|mesh-list
25633610|NCT01323634|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25633611|NCT01323634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25633612|NCT01323634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25633613|NCT01323634|Autonomic Agents|autonomic agents|mesh-ancestor
25633614|NCT01323634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25633615|NCT01323634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633616|NCT01323634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25633617|NCT01323634|Respiratory System Agents|respiratory system agents|mesh-ancestor
25633618|NCT01323634|Dermatologic Agents|dermatologic agents|mesh-ancestor
25633619|NCT01323634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25633620|NCT01323634|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25633621|NCT01323634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25633622|NCT01323634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25633623|NCT01323634|Adrenergic Agents|adrenergic agents|mesh-ancestor
25633624|NCT01323634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25633625|NCT01323634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633626|NCT01323673|Clobetasol|clobetasol|mesh-list
25633627|NCT01323673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25633628|NCT01323673|Glucocorticoids|glucocorticoids|mesh-ancestor
25633629|NCT01323673|Hormones|hormones|mesh-ancestor
25633630|NCT01323673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25633631|NCT01323673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633632|NCT01323790|Naloxegol|naloxegol|mesh-list
25633633|NCT01323790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25633634|NCT01323790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633635|NCT01323790|Sensory System Agents|sensory system agents|mesh-ancestor
25633636|NCT01323790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25633637|NCT01323920|Methotrexate|methotrexate|mesh-list
25633638|NCT01323920|Bortezomib|bortezomib|mesh-list
25633639|NCT01323920|Tacrolimus|tacrolimus|mesh-list
25633640|NCT01323920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25633641|NCT01323920|Abortifacient Agents|abortifacient agents|mesh-ancestor
25633642|NCT01323920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25633643|NCT01323920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633644|NCT01323920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25633645|NCT01323920|Antimetabolites|antimetabolites|mesh-ancestor
25633646|NCT01323920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633647|NCT01323920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25633648|NCT01323920|Dermatologic Agents|dermatologic agents|mesh-ancestor
25633649|NCT01323920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633650|NCT01323920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25633651|NCT01323920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25633652|NCT01323920|Immunologic Factors|immunologic factors|mesh-ancestor
25633653|NCT01323920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25633654|NCT01323920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25633655|NCT01323920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25633656|NCT01324024|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25633657|NCT01324024|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24444930|NCT00299754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25633658|NCT01324024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633659|NCT01324024|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25633660|NCT01324024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25633661|NCT01324024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25633662|NCT01324024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633663|NCT01324024|Dopamine Agents|dopamine agents|mesh-ancestor
25633664|NCT01324024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25633665|NCT01324128|Iron|iron|mesh-list
25633666|NCT01324128|Sevelamer|sevelamer|mesh-list
25633667|NCT01324128|Trace Elements|trace elements|mesh-ancestor
25633668|NCT01324128|Micronutrients|micronutrients|mesh-ancestor
25528336|NCT00511147|Immunoglobulins|immunoglobulins|mesh-list
25633669|NCT01324128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633670|NCT01324128|Chelating Agents|chelating agents|mesh-ancestor
25633671|NCT01324128|Sequestering Agents|sequestering agents|mesh-ancestor
25633672|NCT01324128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633673|NCT01324141|Fluorouracil|fluorouracil|mesh-list
25633674|NCT01324141|Mitomycins|mitomycins|mesh-list
25633675|NCT01324141|Mitomycin|mitomycin|mesh-list
25633676|NCT01324141|Tempol|tempol|mesh-list
25633677|NCT01324141|Antimetabolites|antimetabolites|mesh-ancestor
25633678|NCT01324141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633679|NCT01324141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25633680|NCT01324141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25633681|NCT01324141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25633682|NCT01324141|Immunologic Factors|immunologic factors|mesh-ancestor
25633683|NCT01324141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633684|NCT01324141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25633685|NCT01324141|Alkylating Agents|alkylating agents|mesh-ancestor
25633686|NCT01324141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25633687|NCT01324141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633688|NCT01324141|Antioxidants|antioxidants|mesh-ancestor
25633689|NCT01324141|Protective Agents|protective agents|mesh-ancestor
25633690|NCT01324141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25633691|NCT01324141|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25633692|NCT01324141|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25633693|NCT01324232|Quinidine|quinidine|mesh-list
25633694|NCT01324232|Dextromethorphan|dextromethorphan|mesh-list
25633695|NCT01324232|Antitussive Agents|antitussive agents|mesh-ancestor
25633696|NCT01324232|Respiratory System Agents|respiratory system agents|mesh-ancestor
25633697|NCT01324232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25633698|NCT01324232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25633699|NCT01324232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25633700|NCT01324232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633701|NCT01324232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633702|NCT01324232|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25633703|NCT01324232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25633704|NCT01324232|Adrenergic Agents|adrenergic agents|mesh-ancestor
25633705|NCT01324232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25633706|NCT01324232|Antimalarials|antimalarials|mesh-ancestor
25633707|NCT01324232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25633708|NCT01324232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25633709|NCT01324232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25633710|NCT01324232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633711|NCT01324232|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25633712|NCT01324232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25633713|NCT01324232|Cholinergic Agents|cholinergic agents|mesh-ancestor
25633714|NCT01324232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25633715|NCT01324232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25633716|NCT01324232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25633717|NCT01324232|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25633718|NCT01324232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25633719|NCT01324310|Ketoconazole|ketoconazole|mesh-list
25633720|NCT01324310|Romidepsin|romidepsin|mesh-list
25633721|NCT01324310|Antifungal Agents|antifungal agents|mesh-ancestor
25633722|NCT01324310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25633723|NCT01324310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25633724|NCT01324310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25633725|NCT01324310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633726|NCT01324310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633727|NCT01324310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25633728|NCT01324310|Hormone Antagonists|hormone antagonists|mesh-ancestor
25633729|NCT01324310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25633730|NCT01324310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633731|NCT01324310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25633732|NCT01324310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25633733|NCT01324310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25633734|NCT01324323|Rifampin|rifampin|mesh-list
25633735|NCT01324323|Romidepsin|romidepsin|mesh-list
25633736|NCT01324323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25633737|NCT01324323|Antitubercular Agents|antitubercular agents|mesh-ancestor
25633738|NCT01324323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24446074|NCT00303771|Irinotecan|irinotecan|mesh-list
25633739|NCT01324323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25633740|NCT01324323|Leprostatic Agents|leprostatic agents|mesh-ancestor
25633741|NCT01324323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25633742|NCT01324323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633743|NCT01324323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633744|NCT01324323|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25633745|NCT01324323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25633746|NCT01324323|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25633747|NCT01324323|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25633748|NCT01324323|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25633749|NCT01324323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25633750|NCT01324323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25633751|NCT01324323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25633752|NCT01324349|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25633753|NCT01324349|Hemostatics|hemostatics|mesh-list
25633754|NCT01324349|Coagulants|coagulants|mesh-ancestor
25633755|NCT01324388|Dulaglutide|dulaglutide|mesh-list
25633756|NCT01324388|Metoprolol|metoprolol|mesh-list
25633757|NCT01324388|Lisinopril|lisinopril|mesh-list
25633758|NCT01324388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25633759|NCT01324388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25633760|NCT01324388|Sympatholytics|sympatholytics|mesh-ancestor
25633761|NCT01324388|Autonomic Agents|autonomic agents|mesh-ancestor
25633762|NCT01324388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25633763|NCT01324388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633764|NCT01324388|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25633765|NCT01324388|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25633766|NCT01324388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25633767|NCT01324388|Adrenergic Agents|adrenergic agents|mesh-ancestor
25633768|NCT01324388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25633769|NCT01324388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633770|NCT01324388|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25633771|NCT01324388|Protease Inhibitors|protease inhibitors|mesh-ancestor
25633772|NCT01324388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633773|NCT01324388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25633774|NCT01324388|Protective Agents|protective agents|mesh-ancestor
25633775|NCT01324388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25633776|NCT01324570|Buprenorphine|buprenorphine|mesh-list
25633777|NCT01324570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25633778|NCT01324570|Narcotics|narcotics|mesh-ancestor
25633779|NCT01324570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25633780|NCT01324570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633781|NCT01324570|Analgesics|analgesics|mesh-ancestor
25633782|NCT01324570|Sensory System Agents|sensory system agents|mesh-ancestor
25633783|NCT01324570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25633784|NCT01324570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25633785|NCT01324700|Dexetimide|dexetimide|mesh-list
25633786|NCT01324700|Citalopram|citalopram|mesh-list
25633787|NCT01324700|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25633788|NCT01324700|Serotonin|serotonin|mesh-list
25633789|NCT01324700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25633790|NCT01324700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25633791|NCT01324700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633792|NCT01324700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25633793|NCT01324700|Serotonin Agents|serotonin agents|mesh-ancestor
25633794|NCT01324700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633795|NCT01324700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25633796|NCT01324700|Antidepressive Agents|antidepressive agents|mesh-ancestor
25633797|NCT01324700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25633798|NCT01324700|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25633799|NCT01324700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25633800|NCT01324700|Parasympatholytics|parasympatholytics|mesh-ancestor
25633801|NCT01324700|Autonomic Agents|autonomic agents|mesh-ancestor
25633802|NCT01324700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25633803|NCT01324700|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25633804|NCT01324700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25633805|NCT01324700|Cholinergic Agents|cholinergic agents|mesh-ancestor
25633806|NCT01324700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25633807|NCT01324947|Pomalidomide|pomalidomide|mesh-list
25633808|NCT01324947|Immunologic Factors|immunologic factors|mesh-ancestor
25633809|NCT01324947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633810|NCT01324947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25633811|NCT01324947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25633812|NCT01324947|Growth Substances|growth substances|mesh-ancestor
25633813|NCT01324947|Growth Inhibitors|growth inhibitors|mesh-ancestor
25633814|NCT01324947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25633815|NCT01324999|Tadalafil|tadalafil|mesh-list
25633816|NCT01324999|Vasodilator Agents|vasodilator agents|mesh-ancestor
25633817|NCT01324999|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25528559|NCT00513474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528560|NCT00513474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25528561|NCT00513474|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25528562|NCT00513474|Abortifacient Agents|abortifacient agents|mesh-ancestor
25528563|NCT00513474|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25528564|NCT00513474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25528565|NCT00513474|Antimetabolites|antimetabolites|mesh-ancestor
25528566|NCT00513474|Dermatologic Agents|dermatologic agents|mesh-ancestor
25528567|NCT00513474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528568|NCT00513474|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25528569|NCT00513474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25528570|NCT00513474|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25528571|NCT00513474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25528572|NCT00513474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25528573|NCT00513474|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25528574|NCT00513474|Antifungal Agents|antifungal agents|mesh-ancestor
25528575|NCT00513474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25528576|NCT00513474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25528577|NCT00513474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25528578|NCT00513474|Gout Suppressants|gout suppressants|mesh-ancestor
25528579|NCT00513474|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25528580|NCT00513474|Antioxidants|antioxidants|mesh-ancestor
25528581|NCT00513474|Protective Agents|protective agents|mesh-ancestor
24979900|NCT04976777|Autonomic Agents|autonomic agents|mesh-ancestor
25717958|NCT02420041|Anesthetics|anesthetics|mesh-ancestor
24979901|NCT04976777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24437314|NCT00273416|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24437315|NCT00273416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24437316|NCT00273416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24437317|NCT00273416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437318|NCT00273416|Urological Agents|urological agents|mesh-ancestor
24979903|NCT04976777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24979904|NCT04976777|Glucocorticoids|glucocorticoids|mesh-ancestor
24979905|NCT04976777|Hormones|hormones|mesh-ancestor
24979906|NCT04976777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24979907|NCT04976777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24979908|NCT04976777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979909|NCT04976777|Protease Inhibitors|protease inhibitors|mesh-ancestor
24979910|NCT04976777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124472|NCT03076021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124473|NCT03076021|Dermatologic Agents|dermatologic agents|mesh-ancestor
24979911|NCT04976777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979912|NCT04971954|Nicotine|nicotine|mesh-list
24979913|NCT04971954|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24458505|NCT00338221|Glycine|glycine|mesh-list
24843207|NCT02226328|Fentanyl|fentanyl|mesh-list
24437351|NCT00273455|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24437361|NCT00273468|Granisetron|granisetron|mesh-list
24437367|NCT00273468|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24437368|NCT00273468|Serotonin Agents|serotonin agents|mesh-ancestor
24437369|NCT00273468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24437370|NCT00273468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633818|NCT01324999|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25633819|NCT01324999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633820|NCT01324999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633821|NCT01324999|Urological Agents|urological agents|mesh-ancestor
25633822|NCT01325181|Ranibizumab|ranibizumab|mesh-list
25633823|NCT01325181|Verteporfin|verteporfin|mesh-list
25633824|NCT01325181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25633825|NCT01325181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25633826|NCT01325181|Growth Substances|growth substances|mesh-ancestor
25633827|NCT01325181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633828|NCT01325181|Growth Inhibitors|growth inhibitors|mesh-ancestor
25633829|NCT01325181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25633830|NCT01325181|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25633831|NCT01325181|Dermatologic Agents|dermatologic agents|mesh-ancestor
25633832|NCT01325207|Trastuzumab|trastuzumab|mesh-list
25633833|NCT01325207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25633834|NCT01325207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25633835|NCT01325311|Vitamin D|vitamin d|mesh-list
25633836|NCT01325311|Cholecalciferol|cholecalciferol|mesh-list
25633837|NCT01325311|Genistein|genistein|mesh-list
25633838|NCT01325311|Vitamins|vitamins|mesh-ancestor
25633839|NCT01325311|Micronutrients|micronutrients|mesh-ancestor
25633840|NCT01325311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633841|NCT01325311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25633842|NCT01325311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25633843|NCT01325311|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25633844|NCT01325311|Protective Agents|protective agents|mesh-ancestor
25633845|NCT01325311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25633846|NCT01325311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25633847|NCT01325311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633848|NCT01325311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633849|NCT01325311|Phytoestrogens|phytoestrogens|mesh-ancestor
25633850|NCT01325311|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25633851|NCT01325311|Estrogens|estrogens|mesh-ancestor
25633852|NCT01325311|Hormones|hormones|mesh-ancestor
25633853|NCT01325311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25633854|NCT01325337|Bimatoprost|bimatoprost|mesh-list
25633855|NCT01325337|Minoxidil|minoxidil|mesh-list
25633856|NCT01325337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25633857|NCT01325337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25633858|NCT01325337|Vasodilator Agents|vasodilator agents|mesh-ancestor
25633859|NCT01325350|Bimatoprost|bimatoprost|mesh-list
25633860|NCT01325350|Minoxidil|minoxidil|mesh-list
25633861|NCT01325350|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25633862|NCT01325350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25633863|NCT01325350|Vasodilator Agents|vasodilator agents|mesh-ancestor
25633864|NCT01325428|Vinorelbine|vinorelbine|mesh-list
25633865|NCT01325428|Afatinib|afatinib|mesh-list
25633866|NCT01325428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25633867|NCT01325428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25633868|NCT01325428|Tubulin Modulators|tubulin modulators|mesh-ancestor
25633869|NCT01325428|Antimitotic Agents|antimitotic agents|mesh-ancestor
25633870|NCT01325428|Mitosis Modulators|mitosis modulators|mesh-ancestor
25633871|NCT01325428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633872|NCT01325428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25633873|NCT01325428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633874|NCT01325493|Ketamine|ketamine|mesh-list
25633875|NCT01325493|Analgesics|analgesics|mesh-ancestor
25633876|NCT01325493|Sensory System Agents|sensory system agents|mesh-ancestor
25633877|NCT01325493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25633878|NCT01325493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633879|NCT01325493|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25633880|NCT01325493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25633881|NCT01325493|Anesthetics, General|anesthetics, general|mesh-ancestor
25633882|NCT01325493|Anesthetics|anesthetics|mesh-ancestor
25633883|NCT01325493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25633884|NCT01325493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25633885|NCT01325493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25633886|NCT01325493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25633887|NCT01325493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633888|NCT01326026|Insulin|insulin|mesh-list
25633889|NCT01326026|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25717982|NCT02420210|Hormones|hormones|mesh-ancestor
25633890|NCT01326026|Insulin, Long-Acting|insulin, long-acting|mesh-list
25633891|NCT01326026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25633892|NCT01326026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633893|NCT01326481|Capecitabine|capecitabine|mesh-list
25633894|NCT01326481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25633895|NCT01326481|Antimetabolites|antimetabolites|mesh-ancestor
25633896|NCT01326481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633897|NCT01326481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25633898|NCT01326533|Hydroxychloroquine|hydroxychloroquine|mesh-list
25633899|NCT01326533|Antimalarials|antimalarials|mesh-ancestor
25633900|NCT01326533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25633901|NCT01326533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25633902|NCT01326533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25633903|NCT01326533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633904|NCT01326533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633905|NCT01326533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25633906|NCT01326546|Entecavir|entecavir|mesh-list
25633907|NCT01326546|Antiviral Agents|antiviral agents|mesh-ancestor
25633908|NCT01326546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25633909|NCT01326702|Rituximab|rituximab|mesh-list
25633910|NCT01326702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25633911|NCT01326702|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25633912|NCT01326702|Veliparib|veliparib|mesh-list
25633913|NCT01326702|Antibodies|antibodies|mesh-list
25633914|NCT01326702|Immunoglobulins|immunoglobulins|mesh-list
25633915|NCT01326702|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25633916|NCT01326702|Immunologic Factors|immunologic factors|mesh-ancestor
25633917|NCT01326702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528582|NCT00513500|Amoxicillin|amoxicillin|mesh-list
25633918|NCT01326702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25633919|NCT01326702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25633920|NCT01326702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25633921|NCT01326702|Alkylating Agents|alkylating agents|mesh-ancestor
25633922|NCT01326702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633923|NCT01326702|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25633924|NCT01326702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633925|NCT01327157|Salicylic Acid|salicylic acid|mesh-list
25633926|NCT01327157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25633927|NCT01327157|Antifungal Agents|antifungal agents|mesh-ancestor
25633928|NCT01327157|Keratolytic Agents|keratolytic agents|mesh-ancestor
25633929|NCT01327157|Dermatologic Agents|dermatologic agents|mesh-ancestor
25633931|NCT01327300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25633932|NCT01327300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25633933|NCT01327300|Analgesics|analgesics|mesh-ancestor
25633934|NCT01327300|Sensory System Agents|sensory system agents|mesh-ancestor
25633935|NCT01327300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25633936|NCT01327300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633937|NCT01327300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25633938|NCT01327300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25633939|NCT01327339|Ropinirole|ropinirole|mesh-list
25633940|NCT01327339|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25633941|NCT01327339|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25633942|NCT01327339|Dopamine Agonists|dopamine agonists|mesh-ancestor
25633943|NCT01327339|Dopamine Agents|dopamine agents|mesh-ancestor
25633944|NCT01327339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25633945|NCT01327339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633946|NCT01327339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633947|NCT01327482|Raltegravir Potassium|raltegravir potassium|mesh-list
25633948|NCT01327482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25633949|NCT01327482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25633950|NCT01327482|Antiviral Agents|antiviral agents|mesh-ancestor
25633951|NCT01327482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25633952|NCT01327482|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25633953|NCT01327482|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25633954|NCT01327482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25633955|NCT01327482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656255|NCT01572792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717985|NCT02420210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656256|NCT01572792|Anticonvulsants|anticonvulsants|mesh-ancestor
25656257|NCT01572844|Sodium thiosulfate|sodium thiosulfate|mesh-list
25656258|NCT01572844|Antidotes|antidotes|mesh-ancestor
25656259|NCT01572844|Protective Agents|protective agents|mesh-ancestor
25656260|NCT01572844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656261|NCT01572844|Antioxidants|antioxidants|mesh-ancestor
25656262|NCT01572844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656263|NCT01572844|Antitubercular Agents|antitubercular agents|mesh-ancestor
25656264|NCT01572844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25656265|NCT01572844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25656266|NCT01572844|Chelating Agents|chelating agents|mesh-ancestor
25656267|NCT01572844|Sequestering Agents|sequestering agents|mesh-ancestor
25656268|NCT01573000|Tositumomab I-131|tositumomab i-131|mesh-list
25656269|NCT01573000|Antibodies|antibodies|mesh-list
25656270|NCT01573000|Immunoglobulins|immunoglobulins|mesh-list
25656271|NCT01573000|Immunologic Factors|immunologic factors|mesh-ancestor
25656272|NCT01573000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656273|NCT01573000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656274|NCT01573052|Chlordiazepoxide|chlordiazepoxide|mesh-list
25656275|NCT01573052|Gabapentin|gabapentin|mesh-list
25656276|NCT01573052|Analgesics|analgesics|mesh-ancestor
25656277|NCT01573052|Sensory System Agents|sensory system agents|mesh-ancestor
25656278|NCT01573052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25656279|NCT01573052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656280|NCT01573052|Anticonvulsants|anticonvulsants|mesh-ancestor
25656281|NCT01573052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25656282|NCT01573052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25656283|NCT01573052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25656284|NCT01573052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25656285|NCT01573052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25656286|NCT01573052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25656287|NCT01573052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25656288|NCT01573052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656289|NCT01573052|Antimanic Agents|antimanic agents|mesh-ancestor
25656290|NCT01573052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25656291|NCT01573052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25633956|NCT01327495|Methyltestosterone|methyltestosterone|mesh-list
25633957|NCT01327495|Testosterone|testosterone|mesh-list
25633958|NCT01327495|Testosterone undecanoate|testosterone undecanoate|mesh-list
25633959|NCT01327495|Testosterone enanthate|testosterone enanthate|mesh-list
25633960|NCT01327495|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25633961|NCT01327495|Acyline|acyline|mesh-list
25633962|NCT01327495|Androgens|androgens|mesh-ancestor
25633963|NCT01327495|Hormones|hormones|mesh-ancestor
25633964|NCT01327495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25633965|NCT01327495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633966|NCT01327495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25633967|NCT01327495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25633968|NCT01327495|Anabolic Agents|anabolic agents|mesh-ancestor
25633969|NCT01327495|Hormone Antagonists|hormone antagonists|mesh-ancestor
25633970|NCT01327547|Maraviroc|maraviroc|mesh-list
25633971|NCT01327547|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25633972|NCT01327547|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25633973|NCT01327547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633974|NCT01327547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25633975|NCT01327547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25633976|NCT01327547|Antiviral Agents|antiviral agents|mesh-ancestor
25633977|NCT01327547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25633978|NCT01327547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25633979|NCT01327573|Eculizumab|eculizumab|mesh-list
25633980|NCT01327573|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25633981|NCT01327573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25633982|NCT01327573|Immunologic Factors|immunologic factors|mesh-ancestor
25633983|NCT01327573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633984|NCT01327599|Timolol|timolol|mesh-list
25633985|NCT01327599|Travoprost|travoprost|mesh-list
25717991|NCT02420223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25633986|NCT01327599|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25633987|NCT01327599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25633988|NCT01327599|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25633989|NCT01327599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25633990|NCT01327599|Adrenergic Agents|adrenergic agents|mesh-ancestor
25633991|NCT01327599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25633992|NCT01327599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25633993|NCT01327599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25633994|NCT01327599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25633995|NCT01327599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25633996|NCT01327612|Leucovorin|leucovorin|mesh-list
25633997|NCT01327612|Bevacizumab|bevacizumab|mesh-list
25633998|NCT01327612|Conatumumab|conatumumab|mesh-list
25633999|NCT01327612|Fluorouracil|fluorouracil|mesh-list
25634000|NCT01327612|Oxaliplatin|oxaliplatin|mesh-list
25634001|NCT01327612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25634002|NCT01327612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25634003|NCT01327612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25634004|NCT01327612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25634005|NCT01327612|Growth Substances|growth substances|mesh-ancestor
25634006|NCT01327612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634007|NCT01327612|Growth Inhibitors|growth inhibitors|mesh-ancestor
25634008|NCT01327612|Antimetabolites|antimetabolites|mesh-ancestor
25634009|NCT01327612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634010|NCT01327612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25634011|NCT01327612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25634012|NCT01327612|Immunologic Factors|immunologic factors|mesh-ancestor
25634013|NCT01327612|Antidotes|antidotes|mesh-ancestor
25634014|NCT01327612|Protective Agents|protective agents|mesh-ancestor
25634015|NCT01327612|Vitamin B Complex|vitamin b complex|mesh-ancestor
25634016|NCT01327612|Vitamins|vitamins|mesh-ancestor
25634017|NCT01327612|Micronutrients|micronutrients|mesh-ancestor
25634018|NCT01327677|Fentanyl|fentanyl|mesh-list
25634019|NCT01327677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25634020|NCT01327677|Narcotics|narcotics|mesh-ancestor
25634021|NCT01327677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25634022|NCT01327677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634023|NCT01327677|Analgesics|analgesics|mesh-ancestor
25634024|NCT01327677|Sensory System Agents|sensory system agents|mesh-ancestor
25634025|NCT01327677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634026|NCT01327677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25634027|NCT01327677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25634028|NCT01327677|Anesthetics, General|anesthetics, general|mesh-ancestor
25634029|NCT01327677|Anesthetics|anesthetics|mesh-ancestor
25634030|NCT01327703|Pancreatin|pancreatin|mesh-list
25634031|NCT01327703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25634032|NCT01327885|Dacarbazine|dacarbazine|mesh-list
25634033|NCT01327885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25634034|NCT01327885|Alkylating Agents|alkylating agents|mesh-ancestor
25634035|NCT01327885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634036|NCT01327885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25634038|NCT01328002|Levomilnacipran|levomilnacipran|mesh-list
25634039|NCT01328002|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25634040|NCT01328002|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25634041|NCT01328002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25634042|NCT01328002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634043|NCT01328002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25634044|NCT01328002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634045|NCT01328002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25634046|NCT01328002|Analgesics|analgesics|mesh-ancestor
25634047|NCT01328002|Sensory System Agents|sensory system agents|mesh-ancestor
25634048|NCT01328002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25718003|NCT02420262|Insulin Aspart|insulin aspart|mesh-list
25634049|NCT01328002|Antidepressive Agents|antidepressive agents|mesh-ancestor
25634050|NCT01328002|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25634051|NCT01328041|Dolutegravir|dolutegravir|mesh-list
25634052|NCT01328041|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25634053|NCT01328041|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25634054|NCT01328041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25634055|NCT01328041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634056|NCT01328041|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25634057|NCT01328041|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25634058|NCT01328041|Antiviral Agents|antiviral agents|mesh-ancestor
25634059|NCT01328041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25634060|NCT01328054|Lapatinib|lapatinib|mesh-list
25634061|NCT01328054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25634062|NCT01328054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25634063|NCT01328054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25634064|NCT01328054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634065|NCT01328184|Empagliflozin|empagliflozin|mesh-list
25634066|NCT01328184|Levonorgestrel|levonorgestrel|mesh-list
25634067|NCT01328184|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25634068|NCT01328184|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25634069|NCT01328184|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
25634070|NCT01328184|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25634071|NCT01328184|Contraceptive Agents|contraceptive agents|mesh-ancestor
25634072|NCT01328184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25634073|NCT01328184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634074|NCT01328184|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25634075|NCT01328184|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25634076|NCT01328184|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25634077|NCT01328184|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25634078|NCT01328184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634079|NCT01328184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25634080|NCT01328184|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25634081|NCT01328184|Estrogens|estrogens|mesh-ancestor
25634082|NCT01328184|Hormones|hormones|mesh-ancestor
25634083|NCT01328184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25634084|NCT01328184|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25634085|NCT01328184|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
25634086|NCT01328184|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25634087|NCT01328184|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25634088|NCT01328379|4-Aminopyridine|4-aminopyridine|mesh-list
25634089|NCT01328379|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25634090|NCT01328379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25634091|NCT01328379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634092|NCT01328535|Temozolomide|temozolomide|mesh-list
25634093|NCT01328535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25634094|NCT01328535|Alkylating Agents|alkylating agents|mesh-ancestor
25634095|NCT01328535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634096|NCT01328535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25634097|NCT01328548|Vaccines|vaccines|mesh-list
25634098|NCT01328548|Immunologic Factors|immunologic factors|mesh-ancestor
25634099|NCT01328548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634100|NCT01328756|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25634101|NCT01328756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25634102|NCT01328756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634103|NCT01328756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25634104|NCT01328756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25634105|NCT01328756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25634106|NCT01328756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634107|NCT01328756|Dopamine Agents|dopamine agents|mesh-ancestor
25634108|NCT01328756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25634109|NCT01328769|Febuxostat|febuxostat|mesh-list
25634110|NCT01328769|Gout Suppressants|gout suppressants|mesh-ancestor
25634111|NCT01328769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25634112|NCT01328782|Acetaminophen|acetaminophen|mesh-list
25634113|NCT01328782|Oxycodone|oxycodone|mesh-list
25634114|NCT01328782|Bupivacaine|bupivacaine|mesh-list
25634115|NCT01328782|Ropivacaine|ropivacaine|mesh-list
25634116|NCT01328782|Anesthetics, Local|anesthetics, local|mesh-ancestor
25634117|NCT01328782|Anesthetics|anesthetics|mesh-ancestor
25634118|NCT01328782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25634119|NCT01328782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634120|NCT01328782|Sensory System Agents|sensory system agents|mesh-ancestor
25634121|NCT01328782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634122|NCT01328782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25634123|NCT01328782|Analgesics|analgesics|mesh-ancestor
25634124|NCT01328782|Antipyretics|antipyretics|mesh-ancestor
25634125|NCT01328782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25634126|NCT01328782|Narcotics|narcotics|mesh-ancestor
25634127|NCT01328951|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25634128|NCT01328951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25634129|NCT01328951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25634130|NCT01328951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25634131|NCT01328951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634132|NCT01328964|Fluticasone|fluticasone|mesh-list
25634133|NCT01328964|Xhance|xhance|mesh-list
25634134|NCT01328964|Budesonide|budesonide|mesh-list
25634135|NCT01328964|Montelukast|montelukast|mesh-list
25634136|NCT01328964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25634137|NCT01328964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25634138|NCT01328964|Autonomic Agents|autonomic agents|mesh-ancestor
25634139|NCT01328964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634140|NCT01328964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634141|NCT01328964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25634142|NCT01328964|Respiratory System Agents|respiratory system agents|mesh-ancestor
25634143|NCT01328964|Dermatologic Agents|dermatologic agents|mesh-ancestor
25634144|NCT01328964|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25634145|NCT01328964|Glucocorticoids|glucocorticoids|mesh-ancestor
25634146|NCT01328964|Hormones|hormones|mesh-ancestor
25634147|NCT01328964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25634148|NCT01328964|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25634149|NCT01328964|Hormone Antagonists|hormone antagonists|mesh-ancestor
25634150|NCT01328964|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25634151|NCT01328964|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25634152|NCT01328964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634153|NCT01329185|Valganciclovir|valganciclovir|mesh-list
25634154|NCT01329185|Antiviral Agents|antiviral agents|mesh-ancestor
25634155|NCT01329185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25634156|NCT01329263|Menthol|menthol|mesh-list
25634157|NCT01329263|Antipruritics|antipruritics|mesh-ancestor
25634158|NCT01329263|Dermatologic Agents|dermatologic agents|mesh-ancestor
25634159|NCT01329419|Adefovir|adefovir|mesh-list
25634160|NCT01329419|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25634161|NCT01329419|Antiviral Agents|antiviral agents|mesh-ancestor
25634162|NCT01329419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25634163|NCT01329419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25634164|NCT01329419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25634165|NCT01329419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25634166|NCT01329419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634167|NCT01329562|Naproxen|naproxen|mesh-list
25634168|NCT01329562|Sumatriptan|sumatriptan|mesh-list
25718031|NCT02420873|Antimitotic Agents|antimitotic agents|mesh-ancestor
25634169|NCT01329562|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25634170|NCT01329562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25634171|NCT01329562|Analgesics|analgesics|mesh-ancestor
25634172|NCT01329562|Sensory System Agents|sensory system agents|mesh-ancestor
25634173|NCT01329562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634174|NCT01329562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634175|NCT01329562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25634176|NCT01329562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25634177|NCT01329562|Gout Suppressants|gout suppressants|mesh-ancestor
25634178|NCT01329562|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25634179|NCT01329562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25634180|NCT01329562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634181|NCT01329562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25634182|NCT01329562|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25634183|NCT01329562|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25634184|NCT01329562|Serotonin Agents|serotonin agents|mesh-ancestor
25634185|NCT01329562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25634186|NCT01329900|Etoposide|etoposide|mesh-list
25634187|NCT01329900|Ifosfamide|ifosfamide|mesh-list
25634188|NCT01329900|Ofatumumab|ofatumumab|mesh-list
25634189|NCT01329900|Lenograstim|lenograstim|mesh-list
25634190|NCT01329900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25634191|NCT01329900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25634192|NCT01329900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25634193|NCT01329900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25634194|NCT01329900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25634195|NCT01329900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634196|NCT01329900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25634197|NCT01329900|Alkylating Agents|alkylating agents|mesh-ancestor
25634198|NCT01329900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25634199|NCT01329900|Immunologic Factors|immunologic factors|mesh-ancestor
25634200|NCT01329900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634201|NCT01329939|Montelukast|montelukast|mesh-list
25634202|NCT01329939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25634203|NCT01329939|Respiratory System Agents|respiratory system agents|mesh-ancestor
25634204|NCT01329939|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25634205|NCT01329939|Hormone Antagonists|hormone antagonists|mesh-ancestor
25634206|NCT01329939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25634207|NCT01329939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634208|NCT01329939|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25634209|NCT01329939|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25634210|NCT01329939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634211|NCT01329978|Sofosbuvir|sofosbuvir|mesh-list
25634212|NCT01329978|Antiviral Agents|antiviral agents|mesh-ancestor
25634213|NCT01329978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25634214|NCT01330017|Loratadine|loratadine|mesh-list
25634215|NCT01330017|Phenylephrine|phenylephrine|mesh-list
25634216|NCT01330017|Oxymetazoline|oxymetazoline|mesh-list
25634217|NCT01330017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25634218|NCT01330017|Mydriatics|mydriatics|mesh-ancestor
25634219|NCT01330017|Autonomic Agents|autonomic agents|mesh-ancestor
25634220|NCT01330017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634221|NCT01330017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634222|NCT01330017|Sympathomimetics|sympathomimetics|mesh-ancestor
25634223|NCT01330017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25634224|NCT01330017|Nasal Decongestants|nasal decongestants|mesh-ancestor
25634225|NCT01330017|Respiratory System Agents|respiratory system agents|mesh-ancestor
25634226|NCT01330017|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25634227|NCT01330017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25634228|NCT01330017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25634229|NCT01330017|Adrenergic Agents|adrenergic agents|mesh-ancestor
25634230|NCT01330017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25634231|NCT01330017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634232|NCT01330017|Protective Agents|protective agents|mesh-ancestor
25634233|NCT01330017|Antipruritics|antipruritics|mesh-ancestor
25634234|NCT01330017|Dermatologic Agents|dermatologic agents|mesh-ancestor
25634235|NCT01330017|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25634236|NCT01330017|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25634237|NCT01330017|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25634238|NCT01330017|Histamine Antagonists|histamine antagonists|mesh-ancestor
25634239|NCT01330017|Histamine Agents|histamine agents|mesh-ancestor
25634240|NCT01330030|Selegiline|selegiline|mesh-list
25634241|NCT01330030|Antidepressive Agents|antidepressive agents|mesh-ancestor
25634242|NCT01330030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25634243|NCT01330030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25634244|NCT01330030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25634245|NCT01330030|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25634246|NCT01330030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25634247|NCT01330030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634248|NCT01330030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25634249|NCT01330030|Protective Agents|protective agents|mesh-ancestor
25634250|NCT01330030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634251|NCT01330043|Bupropion|bupropion|mesh-list
25634252|NCT01330043|Nicotine|nicotine|mesh-list
25634253|NCT01330043|Varenicline|varenicline|mesh-list
25634254|NCT01330043|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25528966|NCT00515827|Raltegravir Potassium|raltegravir potassium|mesh-list
25634255|NCT01330043|Autonomic Agents|autonomic agents|mesh-ancestor
25634256|NCT01330043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634257|NCT01330043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634258|NCT01330043|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25634259|NCT01330043|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25634260|NCT01330043|Cholinergic Agents|cholinergic agents|mesh-ancestor
25634261|NCT01330043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25634262|NCT01330043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634263|NCT01330043|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25634264|NCT01330043|Antidepressive Agents|antidepressive agents|mesh-ancestor
25634265|NCT01330043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25634266|NCT01330043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25634267|NCT01330043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25634268|NCT01330043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25634270|NCT01330043|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25634271|NCT01330043|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25634272|NCT01330043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25634273|NCT01330108|Ambrisentan|ambrisentan|mesh-list
25634274|NCT01330108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25634275|NCT01330134|Lidocaine|lidocaine|mesh-list
25634276|NCT01330134|Anesthetics, Local|anesthetics, local|mesh-ancestor
25634277|NCT01330134|Anesthetics|anesthetics|mesh-ancestor
25634278|NCT01330134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25634279|NCT01330134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634280|NCT01330134|Sensory System Agents|sensory system agents|mesh-ancestor
25634281|NCT01330134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634282|NCT01330134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25634283|NCT01330134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25634284|NCT01330134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25634285|NCT01330134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25634286|NCT01330134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634287|NCT01330290|Rotigotine|rotigotine|mesh-list
25634288|NCT01330290|Dopamine Agonists|dopamine agonists|mesh-ancestor
25634289|NCT01330290|Dopamine Agents|dopamine agents|mesh-ancestor
25634290|NCT01330290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25634291|NCT01330290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634292|NCT01330290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634293|NCT01330355|Gatifloxacin|gatifloxacin|mesh-list
25634294|NCT01330355|Besifloxacin|besifloxacin|mesh-list
25634295|NCT01330355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25634296|NCT01330355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25634297|NCT01330355|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25634298|NCT01330355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25634299|NCT01330355|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25634300|NCT01330355|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25634301|NCT01330355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25634302|NCT01330355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634303|NCT01330355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25634304|NCT01330381|Prucalopride|prucalopride|mesh-list
25634305|NCT01330381|Laxatives|laxatives|mesh-ancestor
25634306|NCT01330381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25634307|NCT01330381|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
25634308|NCT01330381|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25634309|NCT01330381|Serotonin Agents|serotonin agents|mesh-ancestor
25634310|NCT01330381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25634311|NCT01330381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634312|NCT01330381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634313|NCT01330459|Acetaminophen|acetaminophen|mesh-list
25634314|NCT01330459|Ibuprofen|ibuprofen|mesh-list
25634315|NCT01330459|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25634316|NCT01330459|Lidocaine|lidocaine|mesh-list
25634317|NCT01330459|Hydrocodone|hydrocodone|mesh-list
25634318|NCT01330459|Lorazepam|lorazepam|mesh-list
25634319|NCT01330459|Anesthetics, Local|anesthetics, local|mesh-ancestor
25634320|NCT01330459|Anesthetics|anesthetics|mesh-ancestor
25634321|NCT01330459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25634322|NCT01330459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634323|NCT01330459|Sensory System Agents|sensory system agents|mesh-ancestor
25634324|NCT01330459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634325|NCT01330459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25634326|NCT01330459|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25634327|NCT01330459|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25529055|NCT00516386|Mecasermin|mecasermin|mesh-list
25634328|NCT01330459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25634329|NCT01330459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634330|NCT01330459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25634331|NCT01330459|Analgesics|analgesics|mesh-ancestor
25634332|NCT01330459|Antipyretics|antipyretics|mesh-ancestor
25634333|NCT01330459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25634334|NCT01330459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25634335|NCT01330459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25634336|NCT01330459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25634337|NCT01330459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25634338|NCT01330459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25634339|NCT01330459|Narcotics|narcotics|mesh-ancestor
25634340|NCT01330459|Antitussive Agents|antitussive agents|mesh-ancestor
25634341|NCT01330459|Respiratory System Agents|respiratory system agents|mesh-ancestor
25634342|NCT01330459|Anticonvulsants|anticonvulsants|mesh-ancestor
25634343|NCT01330459|Antiemetics|antiemetics|mesh-ancestor
25634344|NCT01330459|Autonomic Agents|autonomic agents|mesh-ancestor
25634345|NCT01330459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25634346|NCT01330459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25634347|NCT01330459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25634348|NCT01330459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25634349|NCT01330459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25634350|NCT01330459|GABA Modulators|gaba modulators|mesh-ancestor
25634351|NCT01330459|GABA Agents|gaba agents|mesh-ancestor
25634352|NCT01330459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25634353|NCT01331005|Nepafenac|nepafenac|mesh-list
25634354|NCT01331005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25634355|NCT01331005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25634356|NCT01331005|Analgesics|analgesics|mesh-ancestor
25634357|NCT01331005|Sensory System Agents|sensory system agents|mesh-ancestor
25634358|NCT01331005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634359|NCT01331005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634360|NCT01331005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25634361|NCT01331005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25634362|NCT01331109|Milnacipran|milnacipran|mesh-list
25634363|NCT01331109|Levomilnacipran|levomilnacipran|mesh-list
25634364|NCT01331109|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25634365|NCT01331109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25634366|NCT01331109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25634367|NCT01331109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634368|NCT01331109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25634369|NCT01331109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634370|NCT01331109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25634371|NCT01331109|Analgesics|analgesics|mesh-ancestor
25634372|NCT01331109|Sensory System Agents|sensory system agents|mesh-ancestor
25634373|NCT01331109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634374|NCT01331109|Antidepressive Agents|antidepressive agents|mesh-ancestor
25634375|NCT01331109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25634376|NCT01331161|Vaccines|vaccines|mesh-list
25634377|NCT01331161|Immunologic Factors|immunologic factors|mesh-ancestor
25634378|NCT01331161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634379|NCT01331213|Pregabalin|pregabalin|mesh-list
25634380|NCT01331213|Analgesics|analgesics|mesh-ancestor
25634381|NCT01331213|Sensory System Agents|sensory system agents|mesh-ancestor
25634382|NCT01331213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634383|NCT01331213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634384|NCT01331213|Anticonvulsants|anticonvulsants|mesh-ancestor
25634385|NCT01331213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25634386|NCT01331213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25634387|NCT01331213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634388|NCT01331213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25634389|NCT01331213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25634390|NCT01331213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25634391|NCT01331213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25634392|NCT01331213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25634393|NCT01331304|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25634394|NCT01331304|Antidepressive Agents|antidepressive agents|mesh-ancestor
25634395|NCT01331304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25634396|NCT01331304|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25634397|NCT01331304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25634398|NCT01331304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25634399|NCT01331304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634400|NCT01331681|Aflibercept|aflibercept|mesh-list
25634401|NCT01331681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25634402|NCT01331681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25634403|NCT01331681|Growth Substances|growth substances|mesh-ancestor
25634404|NCT01331681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634405|NCT01331681|Growth Inhibitors|growth inhibitors|mesh-ancestor
25634406|NCT01331681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25634407|NCT01331694|Fluticasone|fluticasone|mesh-list
25634408|NCT01331694|Bromides|bromides|mesh-list
25634409|NCT01331694|Albuterol|albuterol|mesh-list
24505629|NCT00541710|Hormones|hormones|mesh-ancestor
25634410|NCT01331694|Tiotropium Bromide|tiotropium bromide|mesh-list
25634411|NCT01331694|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25634412|NCT01331694|Ipratropium|ipratropium|mesh-list
25634413|NCT01331694|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25634414|NCT01331694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25634415|NCT01331694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25634416|NCT01331694|Autonomic Agents|autonomic agents|mesh-ancestor
25634417|NCT01331694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634418|NCT01331694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634419|NCT01331694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25634420|NCT01331694|Respiratory System Agents|respiratory system agents|mesh-ancestor
25634421|NCT01331694|Dermatologic Agents|dermatologic agents|mesh-ancestor
25634422|NCT01331694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25634423|NCT01331694|Parasympatholytics|parasympatholytics|mesh-ancestor
25634424|NCT01331694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25634425|NCT01331694|Cholinergic Agents|cholinergic agents|mesh-ancestor
25634426|NCT01331694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25634427|NCT01331694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634428|NCT01331694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25634429|NCT01331694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25634430|NCT01331694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25634431|NCT01331694|Adrenergic Agents|adrenergic agents|mesh-ancestor
25634432|NCT01331694|Anticonvulsants|anticonvulsants|mesh-ancestor
25634433|NCT01331694|Tocolytic Agents|tocolytic agents|mesh-ancestor
25634434|NCT01331694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25634435|NCT01331694|Glucocorticoids|glucocorticoids|mesh-ancestor
25634436|NCT01331694|Hormones|hormones|mesh-ancestor
25634437|NCT01331694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25634438|NCT01331694|Sympathomimetics|sympathomimetics|mesh-ancestor
25634439|NCT01331824|Amrubicin|amrubicin|mesh-list
25634440|NCT01331824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25634441|NCT01331837|Etanercept|etanercept|mesh-list
25634442|NCT01331837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25634443|NCT01331837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25634444|NCT01331837|Analgesics|analgesics|mesh-ancestor
25634445|NCT01331837|Sensory System Agents|sensory system agents|mesh-ancestor
25634446|NCT01331837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24506414|NCT00545142|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25634447|NCT01331837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634448|NCT01331837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25634449|NCT01331837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25634450|NCT01331837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25634451|NCT01331837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25634452|NCT01331837|Immunologic Factors|immunologic factors|mesh-ancestor
25634453|NCT01332019|Interferons|interferons|mesh-list
25634454|NCT01332019|Interferon-beta|interferon-beta|mesh-list
25634455|NCT01332019|Interferon beta-1a|interferon beta-1a|mesh-list
25634456|NCT01332019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25634457|NCT01332019|Antiviral Agents|antiviral agents|mesh-ancestor
25634458|NCT01332019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25634459|NCT01332019|Immunologic Factors|immunologic factors|mesh-ancestor
25634460|NCT01332019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634461|NCT01332019|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25634462|NCT01332071|Metformin|metformin|mesh-list
25634463|NCT01332071|Rosiglitazone|rosiglitazone|mesh-list
25634464|NCT01332071|Maleic acid|maleic acid|mesh-list
25634465|NCT01332071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25634466|NCT01332071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634467|NCT01332071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25634468|NCT01332071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634469|NCT01332149|Pregabalin|pregabalin|mesh-list
25634470|NCT01332149|Analgesics|analgesics|mesh-ancestor
25634471|NCT01332149|Sensory System Agents|sensory system agents|mesh-ancestor
25634472|NCT01332149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634473|NCT01332149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634474|NCT01332149|Anticonvulsants|anticonvulsants|mesh-ancestor
25634475|NCT01332149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25634476|NCT01332149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25634477|NCT01332149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506828|NCT00547183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25634478|NCT01332149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25634479|NCT01332149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25634480|NCT01332149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25634481|NCT01332149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25634482|NCT01332149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25634483|NCT01332188|Cetirizine|cetirizine|mesh-list
25634484|NCT01332188|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25634485|NCT01332188|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25634486|NCT01332188|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25634487|NCT01332188|Histamine Antagonists|histamine antagonists|mesh-ancestor
25634488|NCT01332188|Histamine Agents|histamine agents|mesh-ancestor
25634489|NCT01332188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25634490|NCT01332188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634491|NCT01332188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634492|NCT01332227|Ritonavir|ritonavir|mesh-list
25634493|NCT01332227|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25634494|NCT01332227|Tenofovir|tenofovir|mesh-list
25634495|NCT01332227|Emtricitabine|emtricitabine|mesh-list
25634496|NCT01332227|Raltegravir Potassium|raltegravir potassium|mesh-list
25634497|NCT01332227|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25634498|NCT01332227|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25634499|NCT01332227|Protease Inhibitors|protease inhibitors|mesh-ancestor
25634500|NCT01332227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25634501|NCT01332227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634502|NCT01332227|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25634503|NCT01332227|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25634504|NCT01332227|Antiviral Agents|antiviral agents|mesh-ancestor
25634505|NCT01332227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25634506|NCT01332227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25634507|NCT01332227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25634508|NCT01332227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25634509|NCT01332227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25634510|NCT01332227|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25634511|NCT01332227|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25634512|NCT01332253|Ibuprofen|ibuprofen|mesh-list
25634513|NCT01332253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25634514|NCT01332253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25634515|NCT01332253|Analgesics|analgesics|mesh-ancestor
25634516|NCT01332253|Sensory System Agents|sensory system agents|mesh-ancestor
25634517|NCT01332253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634518|NCT01332253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634519|NCT01332253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25634520|NCT01332253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25634521|NCT01332253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25634522|NCT01332253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25634523|NCT01332253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634524|NCT01332292|Fluticasone|fluticasone|mesh-list
25634525|NCT01332292|Xhance|xhance|mesh-list
25634526|NCT01332292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25634527|NCT01332292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25634528|NCT01332292|Autonomic Agents|autonomic agents|mesh-ancestor
25634529|NCT01332292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634530|NCT01332292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634531|NCT01332292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25634532|NCT01332292|Respiratory System Agents|respiratory system agents|mesh-ancestor
25634533|NCT01332292|Dermatologic Agents|dermatologic agents|mesh-ancestor
25634534|NCT01332292|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25634535|NCT01332318|Diphenhydramine|diphenhydramine|mesh-list
25634536|NCT01332318|Promethazine|promethazine|mesh-list
25634537|NCT01332318|Gabapentin|gabapentin|mesh-list
25634538|NCT01332318|Analgesics|analgesics|mesh-ancestor
25634539|NCT01332318|Sensory System Agents|sensory system agents|mesh-ancestor
24508259|NCT00554710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508260|NCT00554710|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25634540|NCT01332318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634541|NCT01332318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634542|NCT01332318|Anticonvulsants|anticonvulsants|mesh-ancestor
25634543|NCT01332318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25634544|NCT01332318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25634545|NCT01332318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25634546|NCT01332318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25634547|NCT01332318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25634548|NCT01332318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25634549|NCT01332318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25634550|NCT01332318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634551|NCT01332318|Antimanic Agents|antimanic agents|mesh-ancestor
25634552|NCT01332318|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25634553|NCT01332318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25634554|NCT01332318|Anesthetics, Local|anesthetics, local|mesh-ancestor
25634555|NCT01332318|Anesthetics|anesthetics|mesh-ancestor
25634556|NCT01332318|Antiemetics|antiemetics|mesh-ancestor
25634557|NCT01332318|Autonomic Agents|autonomic agents|mesh-ancestor
25634558|NCT01332318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25634559|NCT01332318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25634560|NCT01332318|Histamine Antagonists|histamine antagonists|mesh-ancestor
25634561|NCT01332318|Histamine Agents|histamine agents|mesh-ancestor
25634562|NCT01332318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25634563|NCT01332318|Antipruritics|antipruritics|mesh-ancestor
25634564|NCT01332318|Dermatologic Agents|dermatologic agents|mesh-ancestor
25634565|NCT01332331|Ambrisentan|ambrisentan|mesh-list
25634566|NCT01332331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25529341|NCT00519623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25529342|NCT00519623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529343|NCT00519636|Fluticasone|fluticasone|mesh-list
25529345|NCT00519636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25529346|NCT00519636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25529347|NCT00519636|Autonomic Agents|autonomic agents|mesh-ancestor
25529348|NCT00519636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25529349|NCT00519636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529350|NCT00519636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25529351|NCT00519636|Respiratory System Agents|respiratory system agents|mesh-ancestor
25529352|NCT00519636|Dermatologic Agents|dermatologic agents|mesh-ancestor
25529353|NCT00519636|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25529354|NCT00519831|Cetuximab|cetuximab|mesh-list
25529355|NCT00519831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25529356|NCT00519831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529357|NCT00519896|Sunitinib|sunitinib|mesh-list
25529358|NCT00519896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529359|NCT00519896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25529360|NCT00519896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25529361|NCT00519896|Growth Substances|growth substances|mesh-ancestor
25529362|NCT00519896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529363|NCT00519896|Growth Inhibitors|growth inhibitors|mesh-ancestor
25529364|NCT00519896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25529365|NCT00519896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529366|NCT00519896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529367|NCT00520013|Paclitaxel|paclitaxel|mesh-list
25529368|NCT00520013|Bevacizumab|bevacizumab|mesh-list
25529369|NCT00520013|Carboplatin|carboplatin|mesh-list
25529370|NCT00520013|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25529371|NCT00520013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25529372|NCT00520013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25634567|NCT01332357|Fluticasone|fluticasone|mesh-list
25634568|NCT01332357|Xhance|xhance|mesh-list
25634569|NCT01332357|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25634570|NCT01332357|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25634571|NCT01332357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25634572|NCT01332357|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25634573|NCT01332357|Autonomic Agents|autonomic agents|mesh-ancestor
25634574|NCT01332357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634575|NCT01332357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634576|NCT01332357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25634577|NCT01332357|Respiratory System Agents|respiratory system agents|mesh-ancestor
25634578|NCT01332357|Dermatologic Agents|dermatologic agents|mesh-ancestor
25634579|NCT01332357|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25634580|NCT01332357|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25634581|NCT01332357|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25634582|NCT01332357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25634583|NCT01332357|Adrenergic Agents|adrenergic agents|mesh-ancestor
25634584|NCT01332357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24509918|NCT00562692|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25634585|NCT01332357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634586|NCT01332357|Glucocorticoids|glucocorticoids|mesh-ancestor
25634587|NCT01332357|Hormones|hormones|mesh-ancestor
25634588|NCT01332357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25634589|NCT01332357|Sympathomimetics|sympathomimetics|mesh-ancestor
25634590|NCT01332461|Fluticasone|fluticasone|mesh-list
25634591|NCT01332461|Xhance|xhance|mesh-list
25634592|NCT01332461|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25634593|NCT01332461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25634594|NCT01332461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25634595|NCT01332461|Autonomic Agents|autonomic agents|mesh-ancestor
25634596|NCT01332461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634597|NCT01332461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634598|NCT01332461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25634599|NCT01332461|Respiratory System Agents|respiratory system agents|mesh-ancestor
25634600|NCT01332461|Dermatologic Agents|dermatologic agents|mesh-ancestor
25634601|NCT01332461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25634602|NCT01332461|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25634603|NCT01332461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25634604|NCT01332461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25634605|NCT01332461|Adrenergic Agents|adrenergic agents|mesh-ancestor
25634606|NCT01332461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25634607|NCT01332461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634608|NCT01332500|Naproxen|naproxen|mesh-list
25634609|NCT01332500|Sumatriptan|sumatriptan|mesh-list
25634610|NCT01332500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25634611|NCT01332500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25634612|NCT01332500|Analgesics|analgesics|mesh-ancestor
25634613|NCT01332500|Sensory System Agents|sensory system agents|mesh-ancestor
25634614|NCT01332500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634615|NCT01332500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634616|NCT01332500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25634617|NCT01332500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25634618|NCT01332500|Gout Suppressants|gout suppressants|mesh-ancestor
25634619|NCT01332500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25634620|NCT01332500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25634621|NCT01332500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634622|NCT01332500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25634623|NCT01332500|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25634624|NCT01332500|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25634625|NCT01332500|Serotonin Agents|serotonin agents|mesh-ancestor
25634626|NCT01332500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25634627|NCT01332578|Acetaminophen|acetaminophen|mesh-list
25634628|NCT01332578|Ascorbic Acid|ascorbic acid|mesh-list
25634629|NCT01332578|Phenylephrine|phenylephrine|mesh-list
25634630|NCT01332578|Oxymetazoline|oxymetazoline|mesh-list
25634631|NCT01332578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25634632|NCT01332578|Analgesics|analgesics|mesh-ancestor
25634633|NCT01332578|Sensory System Agents|sensory system agents|mesh-ancestor
25634634|NCT01332578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634635|NCT01332578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634636|NCT01332578|Antipyretics|antipyretics|mesh-ancestor
25634637|NCT01332578|Antioxidants|antioxidants|mesh-ancestor
25634638|NCT01332578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634639|NCT01332578|Protective Agents|protective agents|mesh-ancestor
25634640|NCT01332578|Vitamins|vitamins|mesh-ancestor
25634641|NCT01332578|Micronutrients|micronutrients|mesh-ancestor
25634642|NCT01332578|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25634643|NCT01332578|Mydriatics|mydriatics|mesh-ancestor
25634644|NCT01332578|Autonomic Agents|autonomic agents|mesh-ancestor
25634645|NCT01332578|Sympathomimetics|sympathomimetics|mesh-ancestor
25634646|NCT01332578|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25634647|NCT01332578|Nasal Decongestants|nasal decongestants|mesh-ancestor
25634648|NCT01332578|Respiratory System Agents|respiratory system agents|mesh-ancestor
25634649|NCT01332578|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25634650|NCT01332578|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25634651|NCT01332578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25634652|NCT01332578|Adrenergic Agents|adrenergic agents|mesh-ancestor
25634653|NCT01332578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25634654|NCT01332630|Diphenhydramine|diphenhydramine|mesh-list
25634655|NCT01332630|Dexamethasone|dexamethasone|mesh-list
25634656|NCT01332630|Ranitidine|ranitidine|mesh-list
25634657|NCT01332630|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
25634658|NCT01332630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25634659|NCT01332630|Antiemetics|antiemetics|mesh-ancestor
25634660|NCT01332630|Autonomic Agents|autonomic agents|mesh-ancestor
25634661|NCT01332630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634662|NCT01332630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634663|NCT01332630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25634664|NCT01332630|Glucocorticoids|glucocorticoids|mesh-ancestor
25634665|NCT01332630|Hormones|hormones|mesh-ancestor
25634666|NCT01332630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25634667|NCT01332630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25634668|NCT01332630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25634669|NCT01332630|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25634670|NCT01332630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25634671|NCT01332630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25634672|NCT01332630|Anesthetics, Local|anesthetics, local|mesh-ancestor
25634673|NCT01332630|Anesthetics|anesthetics|mesh-ancestor
25634674|NCT01332630|Sensory System Agents|sensory system agents|mesh-ancestor
25634675|NCT01332630|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25634676|NCT01332630|Histamine Antagonists|histamine antagonists|mesh-ancestor
25634677|NCT01332630|Histamine Agents|histamine agents|mesh-ancestor
25634678|NCT01332630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25634679|NCT01332630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634680|NCT01332630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25634681|NCT01332630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25634682|NCT01332630|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25634683|NCT01332721|Bevacizumab|bevacizumab|mesh-list
25634684|NCT01332721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25634685|NCT01332721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25634686|NCT01332721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25634687|NCT01332721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25634688|NCT01332721|Growth Substances|growth substances|mesh-ancestor
25634689|NCT01332721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634690|NCT01332721|Growth Inhibitors|growth inhibitors|mesh-ancestor
25656292|NCT01573052|GABA Modulators|gaba modulators|mesh-ancestor
25656293|NCT01573052|GABA Agents|gaba agents|mesh-ancestor
25656294|NCT01573169|Enoxaparin|enoxaparin|mesh-list
25656295|NCT01573169|Anticoagulants|anticoagulants|mesh-ancestor
25656296|NCT01573169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25656297|NCT01573169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25656298|NCT01573169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656299|NCT01573273|Oxytocin|oxytocin|mesh-list
25656300|NCT01573273|Oxytocics|oxytocics|mesh-ancestor
25656301|NCT01573273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25656302|NCT01573273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657093|NCT01582945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25657094|NCT01582945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25657095|NCT01582945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657096|NCT01583166|Epinephrine|epinephrine|mesh-list
25657097|NCT01583166|Bupivacaine|bupivacaine|mesh-list
25657098|NCT01583166|Anesthetics, Local|anesthetics, local|mesh-ancestor
25657099|NCT01583166|Anesthetics|anesthetics|mesh-ancestor
25657100|NCT01583166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25657101|NCT01583166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657102|NCT01583166|Sensory System Agents|sensory system agents|mesh-ancestor
25657103|NCT01583166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25657104|NCT01583166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25657105|NCT01583166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25657106|NCT01583166|Adrenergic Agents|adrenergic agents|mesh-ancestor
25657107|NCT01583166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25657108|NCT01583166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657109|NCT01583166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25657110|NCT01583166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25657111|NCT01583166|Autonomic Agents|autonomic agents|mesh-ancestor
25657112|NCT01583166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25657113|NCT01583166|Respiratory System Agents|respiratory system agents|mesh-ancestor
25657114|NCT01583166|Mydriatics|mydriatics|mesh-ancestor
25657115|NCT01583166|Sympathomimetics|sympathomimetics|mesh-ancestor
25657116|NCT01583166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25657117|NCT01583179|Buprenorphine|buprenorphine|mesh-list
25657118|NCT01583179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25657119|NCT01583179|Narcotics|narcotics|mesh-ancestor
25657120|NCT01583179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25657121|NCT01583179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657122|NCT01583179|Analgesics|analgesics|mesh-ancestor
25657123|NCT01583179|Sensory System Agents|sensory system agents|mesh-ancestor
25657124|NCT01583179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25657125|NCT01583179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25657126|NCT01583218|Enoxaparin|enoxaparin|mesh-list
25657127|NCT01583218|Betrixaban|betrixaban|mesh-list
25657128|NCT01583218|Anticoagulants|anticoagulants|mesh-ancestor
25657129|NCT01583218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25657130|NCT01583218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25657131|NCT01583218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657132|NCT01583218|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25657133|NCT01583218|Antithrombins|antithrombins|mesh-ancestor
25657134|NCT01583218|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25657135|NCT01583218|Protease Inhibitors|protease inhibitors|mesh-ancestor
25657136|NCT01583218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657137|NCT01583374|Thalidomide|thalidomide|mesh-list
25657138|NCT01583374|Apremilast|apremilast|mesh-list
25657139|NCT01583374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25657140|NCT01583374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25657141|NCT01583374|Analgesics|analgesics|mesh-ancestor
25657142|NCT01583374|Sensory System Agents|sensory system agents|mesh-ancestor
25657143|NCT01583374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634691|NCT01332994|Rituximab|rituximab|mesh-list
25634692|NCT01332994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25634693|NCT01332994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25634694|NCT01332994|Immunologic Factors|immunologic factors|mesh-ancestor
25634695|NCT01332994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634696|NCT01332994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25634697|NCT01333033|Leucovorin|leucovorin|mesh-list
25634698|NCT01333033|Paclitaxel|paclitaxel|mesh-list
25634699|NCT01333033|Carboplatin|carboplatin|mesh-list
25634700|NCT01333033|Fluorouracil|fluorouracil|mesh-list
25634701|NCT01333033|Oxaliplatin|oxaliplatin|mesh-list
25634702|NCT01333033|Calcium|calcium|mesh-list
25634703|NCT01333033|Levoleucovorin|levoleucovorin|mesh-list
25634704|NCT01333033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25634705|NCT01333033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25634706|NCT01333033|Tubulin Modulators|tubulin modulators|mesh-ancestor
25634707|NCT01333033|Antimitotic Agents|antimitotic agents|mesh-ancestor
25634708|NCT01333033|Mitosis Modulators|mitosis modulators|mesh-ancestor
25634709|NCT01333033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634710|NCT01333033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25634711|NCT01333033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634712|NCT01333033|Antimetabolites|antimetabolites|mesh-ancestor
25634713|NCT01333033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25634714|NCT01333033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25634715|NCT01333033|Immunologic Factors|immunologic factors|mesh-ancestor
25634716|NCT01333033|Antidotes|antidotes|mesh-ancestor
25634717|NCT01333033|Protective Agents|protective agents|mesh-ancestor
25634718|NCT01333033|Vitamin B Complex|vitamin b complex|mesh-ancestor
25634719|NCT01333033|Vitamins|vitamins|mesh-ancestor
25634720|NCT01333033|Micronutrients|micronutrients|mesh-ancestor
25634721|NCT01333059|Fentanyl|fentanyl|mesh-list
25634722|NCT01333059|Midazolam|midazolam|mesh-list
25634723|NCT01333059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25634724|NCT01333059|Narcotics|narcotics|mesh-ancestor
25634725|NCT01333059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25634726|NCT01333059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634727|NCT01333059|Analgesics|analgesics|mesh-ancestor
25634728|NCT01333059|Sensory System Agents|sensory system agents|mesh-ancestor
25634729|NCT01333059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634730|NCT01333059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25634731|NCT01333059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25634732|NCT01333059|Anesthetics, General|anesthetics, general|mesh-ancestor
25634733|NCT01333059|Anesthetics|anesthetics|mesh-ancestor
25634734|NCT01333059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25634735|NCT01333059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25634736|NCT01333059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25634737|NCT01333059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25634738|NCT01333059|GABA Modulators|gaba modulators|mesh-ancestor
25634739|NCT01333059|GABA Agents|gaba agents|mesh-ancestor
25634740|NCT01333059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25634741|NCT01333059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634742|NCT01333072|Risperidone|risperidone|mesh-list
25634743|NCT01333072|Aripiprazole|aripiprazole|mesh-list
25634744|NCT01333072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25634745|NCT01333072|Serotonin Agents|serotonin agents|mesh-ancestor
25634746|NCT01333072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25634747|NCT01333072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634748|NCT01333072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634749|NCT01333072|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25634750|NCT01333072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25634751|NCT01333072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25634752|NCT01333072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25634753|NCT01333072|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25634754|NCT01333072|Dopamine Agents|dopamine agents|mesh-ancestor
25634755|NCT01333072|Antidepressive Agents|antidepressive agents|mesh-ancestor
25634756|NCT01333072|Dopamine Agonists|dopamine agonists|mesh-ancestor
25634757|NCT01333072|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25634758|NCT01333072|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25634759|NCT01333072|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25634760|NCT01333072|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25634761|NCT01333098|Mifepristone|mifepristone|mesh-list
25634762|NCT01333098|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25634763|NCT01333098|Abortifacient Agents|abortifacient agents|mesh-ancestor
25634764|NCT01333098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25634765|NCT01333098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529537|NCT00520975|Antibodies|antibodies|mesh-list
25634766|NCT01333098|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25634767|NCT01333098|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25634768|NCT01333098|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25634769|NCT01333098|Contraceptive Agents|contraceptive agents|mesh-ancestor
25634770|NCT01333098|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25634771|NCT01333098|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25634772|NCT01333098|Hormone Antagonists|hormone antagonists|mesh-ancestor
25634773|NCT01333098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25634774|NCT01333098|Luteolytic Agents|luteolytic agents|mesh-ancestor
25634775|NCT01333098|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25634776|NCT01333098|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25634778|NCT01333488|Analgesics|analgesics|mesh-ancestor
25634779|NCT01333488|Sensory System Agents|sensory system agents|mesh-ancestor
25634780|NCT01333488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634781|NCT01333488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634782|NCT01333488|Anesthetics|anesthetics|mesh-ancestor
25634783|NCT01333488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25634784|NCT01333488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25634785|NCT01333488|Anticonvulsants|anticonvulsants|mesh-ancestor
25634786|NCT01333488|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25634787|NCT01333488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25634788|NCT01333488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634789|NCT01333488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25634790|NCT01333488|Tocolytic Agents|tocolytic agents|mesh-ancestor
25634791|NCT01333488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25634792|NCT01333501|Interferons|interferons|mesh-list
25634793|NCT01333501|Interferon-beta|interferon-beta|mesh-list
25634794|NCT01333501|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25634795|NCT01333501|Interferon beta-1b|interferon beta-1b|mesh-list
25634796|NCT01333501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25634797|NCT01333501|Antiviral Agents|antiviral agents|mesh-ancestor
25634798|NCT01333501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25634799|NCT01333501|Immunologic Factors|immunologic factors|mesh-ancestor
25634800|NCT01333501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513690|NCT00584571|Serotonin Agents|serotonin agents|mesh-ancestor
25634801|NCT01333501|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25634802|NCT01333501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634803|NCT01333501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25634804|NCT01333501|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25634805|NCT01333592|Mitiglinide|mitiglinide|mesh-list
25634806|NCT01333592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25634807|NCT01333592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634808|NCT01333722|Acetaminophen|acetaminophen|mesh-list
25634809|NCT01333722|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25634810|NCT01333722|Hydrocodone|hydrocodone|mesh-list
25634811|NCT01333722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25634812|NCT01333722|Analgesics|analgesics|mesh-ancestor
25634813|NCT01333722|Sensory System Agents|sensory system agents|mesh-ancestor
25634814|NCT01333722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634815|NCT01333722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634816|NCT01333722|Antipyretics|antipyretics|mesh-ancestor
25634817|NCT01333722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25634818|NCT01333722|Narcotics|narcotics|mesh-ancestor
25634819|NCT01333722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25634820|NCT01333722|Antitussive Agents|antitussive agents|mesh-ancestor
25634821|NCT01333722|Respiratory System Agents|respiratory system agents|mesh-ancestor
25634822|NCT01333722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25634823|NCT01333722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25634824|NCT01333722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25634825|NCT01333865|Memantine|memantine|mesh-list
25634826|NCT01333865|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25634827|NCT01333865|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25634828|NCT01333865|Dopamine Agents|dopamine agents|mesh-ancestor
25634829|NCT01333865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25634830|NCT01333865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634831|NCT01333865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634832|NCT01333865|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25634833|NCT01333865|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25634834|NCT01333956|Pregabalin|pregabalin|mesh-list
25634835|NCT01333956|Analgesics|analgesics|mesh-ancestor
25634836|NCT01333956|Sensory System Agents|sensory system agents|mesh-ancestor
25634837|NCT01333956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634838|NCT01333956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634839|NCT01333956|Anticonvulsants|anticonvulsants|mesh-ancestor
25634840|NCT01333956|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25634841|NCT01333956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25634842|NCT01333956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634843|NCT01333956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25634844|NCT01333956|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25634845|NCT01333956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25634846|NCT01333956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25634847|NCT01333956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25634849|NCT01334086|Antiemetics|antiemetics|mesh-ancestor
25634850|NCT01334086|Autonomic Agents|autonomic agents|mesh-ancestor
25634851|NCT01334086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634852|NCT01334086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634853|NCT01334086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25634854|NCT01334086|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25634855|NCT01334086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25634856|NCT01334086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634857|NCT01334125|Metformin|metformin|mesh-list
25634858|NCT01334125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25634859|NCT01334125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634860|NCT01334229|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25634861|NCT01334229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25634862|NCT01334229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634863|NCT01334229|Incretins|incretins|mesh-ancestor
25634864|NCT01334229|Hormones|hormones|mesh-ancestor
25634865|NCT01334229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25634866|NCT01334229|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25634867|NCT01334229|Protease Inhibitors|protease inhibitors|mesh-ancestor
25634868|NCT01334229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25634869|NCT01334229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634870|NCT01334515|Isotretinoin|isotretinoin|mesh-list
25634871|NCT01334515|Sargramostim|sargramostim|mesh-list
25634872|NCT01334515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634873|NCT01334515|Immunologic Factors|immunologic factors|mesh-ancestor
25634874|NCT01334515|Dermatologic Agents|dermatologic agents|mesh-ancestor
25634875|NCT01334554|Sildenafil Citrate|sildenafil citrate|mesh-list
25634876|NCT01334554|Vasodilator Agents|vasodilator agents|mesh-ancestor
25634877|NCT01334554|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25634878|NCT01334554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25634879|NCT01334554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25634880|NCT01334554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634881|NCT01334554|Urological Agents|urological agents|mesh-ancestor
25634882|NCT01334710|Sorafenib|sorafenib|mesh-list
25634883|NCT01334710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25634884|NCT01334710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25634885|NCT01334710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25634886|NCT01334710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634887|NCT01334723|Finasteride|finasteride|mesh-list
25634888|NCT01334723|Dutasteride|dutasteride|mesh-list
25634889|NCT01334723|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
25634890|NCT01334723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25634891|NCT01334723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25634892|NCT01334723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634893|NCT01334723|Hormone Antagonists|hormone antagonists|mesh-ancestor
25634894|NCT01334723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25634895|NCT01334723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634896|NCT01334723|Urological Agents|urological agents|mesh-ancestor
25634897|NCT01334918|Regadenoson|regadenoson|mesh-list
25634898|NCT01334918|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
25634899|NCT01334918|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25634900|NCT01334918|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25634901|NCT01334918|Purinergic Agonists|purinergic agonists|mesh-ancestor
25634902|NCT01334918|Purinergic Agents|purinergic agents|mesh-ancestor
25634903|NCT01334918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25634904|NCT01334918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634905|NCT01334918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634906|NCT01334918|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25634907|NCT01334944|Ibuprofen|ibuprofen|mesh-list
25634908|NCT01334944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25634909|NCT01334944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25634910|NCT01334944|Analgesics|analgesics|mesh-ancestor
25634911|NCT01334944|Sensory System Agents|sensory system agents|mesh-ancestor
25634912|NCT01334944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634913|NCT01334944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634914|NCT01334944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25634915|NCT01334944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25634916|NCT01334944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25634917|NCT01334944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25634918|NCT01334944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634919|NCT01334957|Ibuprofen|ibuprofen|mesh-list
25634920|NCT01334957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25634921|NCT01334957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25634922|NCT01334957|Analgesics|analgesics|mesh-ancestor
25634923|NCT01334957|Sensory System Agents|sensory system agents|mesh-ancestor
25634924|NCT01334957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634925|NCT01334957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634926|NCT01334957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25634927|NCT01334957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25634928|NCT01334957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25634929|NCT01334957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25634930|NCT01334957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634931|NCT01335009|Antibodies|antibodies|mesh-list
25634932|NCT01335009|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25634933|NCT01335009|Immunologic Factors|immunologic factors|mesh-ancestor
25634934|NCT01335009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634935|NCT01335204|Bavituximab|bavituximab|mesh-list
25634936|NCT01335204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25634937|NCT01335204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25634938|NCT01335464|Nintedanib|nintedanib|mesh-list
25634939|NCT01335464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25634940|NCT01335464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25634941|NCT01335464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25634942|NCT01335464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634943|NCT01335477|Nintedanib|nintedanib|mesh-list
25634944|NCT01335477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25634945|NCT01335477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25634946|NCT01335477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25634947|NCT01335477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634948|NCT01335620|Tenofovir|tenofovir|mesh-list
25634949|NCT01335620|Emtricitabine|emtricitabine|mesh-list
25634950|NCT01335620|Raltegravir Potassium|raltegravir potassium|mesh-list
25634951|NCT01335620|Antiviral Agents|antiviral agents|mesh-ancestor
25634952|NCT01335620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25634953|NCT01335620|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25634954|NCT01335620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25634955|NCT01335620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25634956|NCT01335620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634957|NCT01335620|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25634958|NCT01335620|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25634959|NCT01335620|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25634960|NCT01335620|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25634961|NCT01335698|Ritonavir|ritonavir|mesh-list
25634962|NCT01335698|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25634963|NCT01335698|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25634964|NCT01335698|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25634965|NCT01335698|Protease Inhibitors|protease inhibitors|mesh-ancestor
25634966|NCT01335698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25634967|NCT01335698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634968|NCT01335698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25634969|NCT01335698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25634970|NCT01335698|Antiviral Agents|antiviral agents|mesh-ancestor
25634971|NCT01335698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25634972|NCT01335698|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25634973|NCT01335698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25634974|NCT01335724|Diclofenac|diclofenac|mesh-list
25634975|NCT01335724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25634976|NCT01335724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25634977|NCT01335724|Analgesics|analgesics|mesh-ancestor
25634978|NCT01335724|Sensory System Agents|sensory system agents|mesh-ancestor
25634979|NCT01335724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25634980|NCT01335724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634981|NCT01335724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25634982|NCT01335724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25634983|NCT01335724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25634984|NCT01335724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25634985|NCT01335724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634986|NCT01335750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25634987|NCT01335789|Oxytocin|oxytocin|mesh-list
25634988|NCT01335789|Oxytocics|oxytocics|mesh-ancestor
25634989|NCT01335789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25634990|NCT01335789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634991|NCT01335867|Vigabatrin|vigabatrin|mesh-list
25634992|NCT01335867|Anticonvulsants|anticonvulsants|mesh-ancestor
25634993|NCT01335867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25634994|NCT01335867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25634995|NCT01335867|GABA Agents|gaba agents|mesh-ancestor
25634996|NCT01335867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25634997|NCT01335867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25634998|NCT01335932|Ganciclovir|ganciclovir|mesh-list
25634999|NCT01335932|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25635000|NCT01335932|Antiviral Agents|antiviral agents|mesh-ancestor
25635001|NCT01335932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25635002|NCT01335932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25635003|NCT01335932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635004|NCT01335932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635005|NCT01335971|Sulforaphane|sulforaphane|mesh-list
25635006|NCT01335971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25635007|NCT01335971|Protective Agents|protective agents|mesh-ancestor
25635008|NCT01335971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635009|NCT01335971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25635010|NCT01336023|Insulin|insulin|mesh-list
25635011|NCT01336023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25635012|NCT01336023|Liraglutide|liraglutide|mesh-list
25635013|NCT01336023|Insulin, Long-Acting|insulin, long-acting|mesh-list
25635014|NCT01336023|Xultophy|xultophy|mesh-list
25635015|NCT01336023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25635016|NCT01336023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718163|NCT02423980|Hormones|hormones|mesh-ancestor
25635017|NCT01336023|Incretins|incretins|mesh-ancestor
25635018|NCT01336023|Hormones|hormones|mesh-ancestor
25635019|NCT01336023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25635020|NCT01336140|Aminophylline|aminophylline|mesh-list
25635021|NCT01336140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25635022|NCT01336140|Autonomic Agents|autonomic agents|mesh-ancestor
25635023|NCT01336140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25635024|NCT01336140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635025|NCT01336140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25635026|NCT01336140|Respiratory System Agents|respiratory system agents|mesh-ancestor
25635027|NCT01336140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25635028|NCT01336140|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25635029|NCT01336140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635030|NCT01336140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635031|NCT01336140|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25635032|NCT01336140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25635033|NCT01336140|Purinergic Agents|purinergic agents|mesh-ancestor
25635034|NCT01336140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25635035|NCT01336140|Protective Agents|protective agents|mesh-ancestor
25635036|NCT01336205|Naloxegol|naloxegol|mesh-list
25635037|NCT01336205|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25635038|NCT01336205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635039|NCT01336205|Sensory System Agents|sensory system agents|mesh-ancestor
25635040|NCT01336205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25635041|NCT01336296|Mycophenolic Acid|mycophenolic acid|mesh-list
25635042|NCT01336296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25635043|NCT01336296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25635044|NCT01336296|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25635045|NCT01336296|Antitubercular Agents|antitubercular agents|mesh-ancestor
25635046|NCT01336296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25635047|NCT01336296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25635048|NCT01336296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635049|NCT01336296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635050|NCT01336569|Timolol|timolol|mesh-list
25635051|NCT01336569|Travoprost|travoprost|mesh-list
25635052|NCT01336569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25635053|NCT01336569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25635054|NCT01336569|Adrenergic Agents|adrenergic agents|mesh-ancestor
25635055|NCT01336569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25635056|NCT01336569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635057|NCT01336569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635058|NCT01336569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25635059|NCT01336569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25635060|NCT01336608|Fluticasone|fluticasone|mesh-list
25635062|NCT01336608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25635063|NCT01336608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25635064|NCT01336608|Autonomic Agents|autonomic agents|mesh-ancestor
25635065|NCT01336608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25635066|NCT01336608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635067|NCT01336608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25635068|NCT01336608|Respiratory System Agents|respiratory system agents|mesh-ancestor
25635069|NCT01336608|Dermatologic Agents|dermatologic agents|mesh-ancestor
25635070|NCT01336608|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25635071|NCT01336738|Nicotinic Acids|nicotinic acids|mesh-list
25635072|NCT01336738|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25635073|NCT01336738|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
25635074|NCT01336738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25635075|NCT01336738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635076|NCT01336738|Incretins|incretins|mesh-ancestor
25635077|NCT01336738|Hormones|hormones|mesh-ancestor
25635078|NCT01336738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25635079|NCT01336738|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25635080|NCT01336738|Protease Inhibitors|protease inhibitors|mesh-ancestor
25635081|NCT01336738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635082|NCT01336738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635083|NCT01336738|Vitamin B Complex|vitamin b complex|mesh-ancestor
25635084|NCT01336738|Vitamins|vitamins|mesh-ancestor
25635085|NCT01336738|Micronutrients|micronutrients|mesh-ancestor
25635086|NCT01336803|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25635087|NCT01336803|Hematinics|hematinics|mesh-ancestor
25635088|NCT01336803|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25635089|NCT01336803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25635090|NCT01336933|Prednisone|prednisone|mesh-list
25635091|NCT01336933|Cyclophosphamide|cyclophosphamide|mesh-list
25635092|NCT01336933|Etoposide|etoposide|mesh-list
25635093|NCT01336933|Vincristine|vincristine|mesh-list
25635094|NCT01336933|Etoposide phosphate|etoposide phosphate|mesh-list
25635095|NCT01336933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25635096|NCT01336933|Immunologic Factors|immunologic factors|mesh-ancestor
25635097|NCT01336933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635098|NCT01336933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25635099|NCT01336933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25635100|NCT01336933|Alkylating Agents|alkylating agents|mesh-ancestor
25635101|NCT01336933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635102|NCT01336933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25635103|NCT01336933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25635104|NCT01336933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25635105|NCT01336933|Glucocorticoids|glucocorticoids|mesh-ancestor
25635106|NCT01336933|Hormones|hormones|mesh-ancestor
25635107|NCT01336933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25635108|NCT01336933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25635109|NCT01336933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25635110|NCT01336933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25635111|NCT01336933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25635112|NCT01336933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635113|NCT01336933|Tubulin Modulators|tubulin modulators|mesh-ancestor
25635114|NCT01336933|Antimitotic Agents|antimitotic agents|mesh-ancestor
25635115|NCT01336933|Mitosis Modulators|mitosis modulators|mesh-ancestor
25635116|NCT01336972|Tolvaptan|tolvaptan|mesh-list
25635117|NCT01336972|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25635118|NCT01336972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635119|NCT01336972|Natriuretic Agents|natriuretic agents|mesh-ancestor
25635120|NCT01336972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635121|NCT01337089|Nabiximols|nabiximols|mesh-list
25635122|NCT01337089|Analgesics|analgesics|mesh-ancestor
25635123|NCT01337089|Sensory System Agents|sensory system agents|mesh-ancestor
25635124|NCT01337089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25635125|NCT01337089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635126|NCT01337115|Ropivacaine|ropivacaine|mesh-list
25635127|NCT01337115|Anesthetics, Local|anesthetics, local|mesh-list
25635128|NCT01337115|Anesthetics|anesthetics|mesh-list
25635129|NCT01337115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25635130|NCT01337115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635131|NCT01337115|Sensory System Agents|sensory system agents|mesh-ancestor
25635132|NCT01337115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25635133|NCT01337167|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25635134|NCT01337167|Immunologic Factors|immunologic factors|mesh-ancestor
25635135|NCT01337167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635136|NCT01337336|Fluticasone|fluticasone|mesh-list
25635138|NCT01337336|Tiotropium Bromide|tiotropium bromide|mesh-list
25635139|NCT01337336|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25635140|NCT01337336|Ipratropium|ipratropium|mesh-list
25635141|NCT01337336|Cholinergic Antagonists|cholinergic antagonists|mesh-list
25635142|NCT01337336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25635143|NCT01337336|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25635144|NCT01337336|Autonomic Agents|autonomic agents|mesh-ancestor
25635145|NCT01337336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25635146|NCT01337336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635147|NCT01337336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25635148|NCT01337336|Respiratory System Agents|respiratory system agents|mesh-ancestor
25635149|NCT01337336|Dermatologic Agents|dermatologic agents|mesh-ancestor
25635150|NCT01337336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25635151|NCT01337336|Parasympatholytics|parasympatholytics|mesh-ancestor
25635152|NCT01337336|Cholinergic Agents|cholinergic agents|mesh-ancestor
25635153|NCT01337336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25635154|NCT01337336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635155|NCT01337336|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25635156|NCT01337336|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25635157|NCT01337336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25635158|NCT01337336|Adrenergic Agents|adrenergic agents|mesh-ancestor
25635159|NCT01337635|Vitamin D|vitamin d|mesh-list
25635160|NCT01337635|Vitamins|vitamins|mesh-ancestor
25635161|NCT01337635|Micronutrients|micronutrients|mesh-ancestor
25635162|NCT01337635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635163|NCT01337635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25635164|NCT01337674|Metoprolol|metoprolol|mesh-list
25635165|NCT01337674|Amlodipine|amlodipine|mesh-list
25635166|NCT01337674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25635167|NCT01337674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25635168|NCT01337674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25635169|NCT01337674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635170|NCT01337674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25635171|NCT01337674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635172|NCT01337674|Vasodilator Agents|vasodilator agents|mesh-ancestor
25635173|NCT01337674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25635174|NCT01337674|Sympatholytics|sympatholytics|mesh-ancestor
25635175|NCT01337674|Autonomic Agents|autonomic agents|mesh-ancestor
25635176|NCT01337674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25635177|NCT01337674|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25635178|NCT01337674|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25635179|NCT01337674|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25635180|NCT01337674|Adrenergic Agents|adrenergic agents|mesh-ancestor
25635181|NCT01337674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25635182|NCT01337687|Oxytocin|oxytocin|mesh-list
25635183|NCT01337687|Oxytocics|oxytocics|mesh-ancestor
25635184|NCT01337687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25635185|NCT01337687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635186|NCT01337700|Milnacipran|milnacipran|mesh-list
25635187|NCT01337700|Levomilnacipran|levomilnacipran|mesh-list
25635188|NCT01337700|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25635189|NCT01337700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25635190|NCT01337700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25635191|NCT01337700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635192|NCT01337700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25635193|NCT01337700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635194|NCT01337700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25635195|NCT01337700|Analgesics|analgesics|mesh-ancestor
25635196|NCT01337700|Sensory System Agents|sensory system agents|mesh-ancestor
25635197|NCT01337700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25635198|NCT01337700|Antidepressive Agents|antidepressive agents|mesh-ancestor
25635199|NCT01337700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25635200|NCT01337986|4-Aminopyridine|4-aminopyridine|mesh-list
25635201|NCT01337986|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25635202|NCT01337986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25635203|NCT01337986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635204|NCT01338025|Lamivudine|lamivudine|mesh-list
25635205|NCT01338025|Emtricitabine|emtricitabine|mesh-list
25635206|NCT01338025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25635207|NCT01338025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25635208|NCT01338025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635209|NCT01338025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529984|NCT00524680|Vitamin D|vitamin d|mesh-list
25635210|NCT01338025|Antiviral Agents|antiviral agents|mesh-ancestor
25635211|NCT01338025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25635212|NCT01338025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25635213|NCT01338025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25635214|NCT01338298|Aripiprazole|aripiprazole|mesh-list
25635215|NCT01338298|Antidepressive Agents|antidepressive agents|mesh-ancestor
25635216|NCT01338298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25635217|NCT01338298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25718197|NCT02424578|Diclofenac|diclofenac|mesh-list
25635218|NCT01338298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25635219|NCT01338298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25635220|NCT01338298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635221|NCT01338298|Dopamine Agonists|dopamine agonists|mesh-ancestor
25635222|NCT01338298|Dopamine Agents|dopamine agents|mesh-ancestor
25635223|NCT01338298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25635224|NCT01338298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635225|NCT01338298|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25635226|NCT01338298|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25635227|NCT01338298|Serotonin Agents|serotonin agents|mesh-ancestor
25635228|NCT01338298|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25635229|NCT01338298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25635230|NCT01338298|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25635231|NCT01338298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25635232|NCT01338415|Bosentan|bosentan|mesh-list
25635233|NCT01338415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25635234|NCT01338415|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25635235|NCT01338415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635236|NCT01338610|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25635237|NCT01338610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25635238|NCT01338792|Oxaliplatin|oxaliplatin|mesh-list
25635239|NCT01338792|Pemetrexed|pemetrexed|mesh-list
25635240|NCT01338792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25635241|NCT01338792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635242|NCT01338792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635243|NCT01338792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25635244|NCT01338792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25635245|NCT01338818|Methylphenidate|methylphenidate|mesh-list
25635246|NCT01338818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25635247|NCT01338818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635248|NCT01338818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25635249|NCT01338818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25635250|NCT01338818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25635251|NCT01338818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635252|NCT01338818|Dopamine Agents|dopamine agents|mesh-ancestor
25635253|NCT01338818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25635254|NCT01338857|Sorafenib|sorafenib|mesh-list
25635255|NCT01338857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25635256|NCT01338857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25635257|NCT01338857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635258|NCT01338857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635259|NCT01338870|Nicotinic Acids|nicotinic acids|mesh-list
25635260|NCT01338870|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25635261|NCT01338870|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
25635262|NCT01338870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25635263|NCT01338870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635264|NCT01338870|Incretins|incretins|mesh-ancestor
25635265|NCT01338870|Hormones|hormones|mesh-ancestor
25635266|NCT01338870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25635267|NCT01338870|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25635268|NCT01338870|Protease Inhibitors|protease inhibitors|mesh-ancestor
25635269|NCT01338870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635270|NCT01338870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635271|NCT01338870|Vitamin B Complex|vitamin b complex|mesh-ancestor
25635272|NCT01338870|Vitamins|vitamins|mesh-ancestor
25635273|NCT01338870|Micronutrients|micronutrients|mesh-ancestor
25635274|NCT01338987|Alovudine|alovudine|mesh-list
25635275|NCT01338987|Cyclophosphamide|cyclophosphamide|mesh-list
25635276|NCT01338987|Busulfan|busulfan|mesh-list
25635277|NCT01338987|Methotrexate|methotrexate|mesh-list
25635278|NCT01338987|Fludarabine|fludarabine|mesh-list
25635279|NCT01338987|Leuprolide|leuprolide|mesh-list
25635280|NCT01338987|Tacrolimus|tacrolimus|mesh-list
25635281|NCT01338987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25635282|NCT01338987|Immunologic Factors|immunologic factors|mesh-ancestor
25635283|NCT01338987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635284|NCT01338987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25635285|NCT01338987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25635286|NCT01338987|Alkylating Agents|alkylating agents|mesh-ancestor
25635287|NCT01338987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635288|NCT01338987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25635289|NCT01338987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25635290|NCT01338987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25635291|NCT01338987|Abortifacient Agents|abortifacient agents|mesh-ancestor
25635292|NCT01338987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25635293|NCT01338987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25635294|NCT01338987|Antimetabolites|antimetabolites|mesh-ancestor
25635295|NCT01338987|Dermatologic Agents|dermatologic agents|mesh-ancestor
25635296|NCT01338987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635297|NCT01338987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25635298|NCT01338987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25635299|NCT01338987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25635300|NCT01338987|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25635301|NCT01338987|Fertility Agents|fertility agents|mesh-ancestor
25635302|NCT01338987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25635303|NCT01338987|Antiviral Agents|antiviral agents|mesh-ancestor
25635304|NCT01338987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25635305|NCT01339000|Vaccines|vaccines|mesh-list
25635306|NCT01339000|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25635307|NCT01339000|Immunologic Factors|immunologic factors|mesh-ancestor
25635308|NCT01339000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635309|NCT01339013|Anesthetics|anesthetics|mesh-list
25635310|NCT01339013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25635311|NCT01339013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635312|NCT01339091|Vancomycin|vancomycin|mesh-list
25635313|NCT01339091|Linezolid|linezolid|mesh-list
25635314|NCT01339091|Dalbavancin|dalbavancin|mesh-list
25635315|NCT01339091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25635316|NCT01339091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25635317|NCT01339091|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25635318|NCT01339091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635319|NCT01339091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635320|NCT01339247|Halofantrine|halofantrine|mesh-list
25635321|NCT01339247|Paroxetine|paroxetine|mesh-list
25635322|NCT01339247|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25530132|NCT00525785|Antimetabolites|antimetabolites|mesh-ancestor
25530133|NCT00525785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530134|NCT00525785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25530135|NCT00525785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530136|NCT00525785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25530137|NCT00525785|Immunologic Factors|immunologic factors|mesh-ancestor
25530138|NCT00525785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530139|NCT00525785|Antidotes|antidotes|mesh-ancestor
25530140|NCT00525785|Protective Agents|protective agents|mesh-ancestor
25530141|NCT00525785|Vitamin B Complex|vitamin b complex|mesh-ancestor
25530142|NCT00525785|Vitamins|vitamins|mesh-ancestor
25530143|NCT00525785|Micronutrients|micronutrients|mesh-ancestor
25530144|NCT00525785|Hematinics|hematinics|mesh-ancestor
25530145|NCT00525798|Calcitonin|calcitonin|mesh-list
25530146|NCT00525798|Salmon calcitonin|salmon calcitonin|mesh-list
25530147|NCT00525798|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
25530148|NCT00525798|Katacalcin|katacalcin|mesh-list
25530149|NCT00525798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25530150|NCT00525798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635323|NCT01339247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25635324|NCT01339247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25635325|NCT01339247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635326|NCT01339247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25635327|NCT01339247|Serotonin Agents|serotonin agents|mesh-ancestor
25635328|NCT01339247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635329|NCT01339247|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25635330|NCT01339247|Antidepressive Agents|antidepressive agents|mesh-ancestor
25635331|NCT01339247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25635332|NCT01339247|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25635333|NCT01339247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25635334|NCT01339247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635335|NCT01339247|Antimalarials|antimalarials|mesh-ancestor
25635336|NCT01339247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25635337|NCT01339247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25635338|NCT01339247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25635340|NCT01339260|Palonosetron|palonosetron|mesh-list
25635341|NCT01339260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25635342|NCT01339260|Antiemetics|antiemetics|mesh-ancestor
25635343|NCT01339260|Autonomic Agents|autonomic agents|mesh-ancestor
25635344|NCT01339260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25635345|NCT01339260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635346|NCT01339260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25635347|NCT01339260|Glucocorticoids|glucocorticoids|mesh-ancestor
25635348|NCT01339260|Hormones|hormones|mesh-ancestor
25635349|NCT01339260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25635350|NCT01339260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25635351|NCT01339260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25635352|NCT01339260|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25635353|NCT01339260|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25635354|NCT01339260|Serotonin Agents|serotonin agents|mesh-ancestor
25635355|NCT01339260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25635356|NCT01339260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635357|NCT01339273|Anesthetics|anesthetics|mesh-list
25635358|NCT01339273|Anesthetics, Local|anesthetics, local|mesh-list
25635359|NCT01339273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25635360|NCT01339273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635361|NCT01339273|Sensory System Agents|sensory system agents|mesh-ancestor
25635362|NCT01339273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25635363|NCT01339299|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25635364|NCT01339299|Hormones|hormones|mesh-list
25635365|NCT01339299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25635366|NCT01339299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635367|NCT01339299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25656303|NCT01573442|Testosterone|testosterone|mesh-list
25656304|NCT01573442|Androgens|androgens|mesh-ancestor
25656305|NCT01573442|Hormones|hormones|mesh-ancestor
25656306|NCT01573442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25656307|NCT01573442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656308|NCT01573533|Rituximab|rituximab|mesh-list
25656309|NCT01573533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25656310|NCT01573533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656311|NCT01573533|Immunologic Factors|immunologic factors|mesh-ancestor
25656312|NCT01573533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656313|NCT01573533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25656314|NCT01573702|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25656315|NCT01573702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656316|NCT01573702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25656317|NCT01573702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25656318|NCT01573702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656319|NCT01573767|Fluticasone|fluticasone|mesh-list
25656320|NCT01573767|Xhance|xhance|mesh-list
25656321|NCT01573767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25656322|NCT01573767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25656323|NCT01573767|Autonomic Agents|autonomic agents|mesh-ancestor
25656324|NCT01573767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25656325|NCT01573767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656326|NCT01573767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25656327|NCT01573767|Respiratory System Agents|respiratory system agents|mesh-ancestor
25656328|NCT01573767|Dermatologic Agents|dermatologic agents|mesh-ancestor
25656329|NCT01573767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25656330|NCT01573910|Moxifloxacin|moxifloxacin|mesh-list
25656331|NCT01573910|Ofloxacin|ofloxacin|mesh-list
25656332|NCT01573910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25656333|NCT01573910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25656334|NCT01573910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25656335|NCT01573910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25656336|NCT01573910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25656337|NCT01573910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25656338|NCT01573910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25656339|NCT01573910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656340|NCT01573910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656341|NCT01573910|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25656342|NCT01573910|Renal Agents|renal agents|mesh-ancestor
25656343|NCT01573910|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25656344|NCT01573910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25656345|NCT01573949|Metformin|metformin|mesh-list
25656346|NCT01573949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25656347|NCT01573949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635369|NCT01339559|Anticonvulsants|anticonvulsants|mesh-ancestor
25635370|NCT01339858|Acetylcysteine|acetylcysteine|mesh-list
25635371|NCT01339858|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25635372|NCT01339858|Antiviral Agents|antiviral agents|mesh-ancestor
25635373|NCT01339858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25635374|NCT01339858|Expectorants|expectorants|mesh-ancestor
25635375|NCT01339858|Respiratory System Agents|respiratory system agents|mesh-ancestor
25635376|NCT01339858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24518956|NCT03851627|Hormones|hormones|mesh-ancestor
25635377|NCT01339858|Antioxidants|antioxidants|mesh-ancestor
25635378|NCT01339858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635379|NCT01339858|Protective Agents|protective agents|mesh-ancestor
25635380|NCT01339858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635381|NCT01339858|Antidotes|antidotes|mesh-ancestor
25635382|NCT01339910|Vidarabine|vidarabine|mesh-list
25635383|NCT01339910|Cyclophosphamide|cyclophosphamide|mesh-list
25635384|NCT01339910|Melphalan|melphalan|mesh-list
25635385|NCT01339910|Busulfan|busulfan|mesh-list
25635386|NCT01339910|Fludarabine|fludarabine|mesh-list
25635387|NCT01339910|Fludarabine phosphate|fludarabine phosphate|mesh-list
25635388|NCT01339910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25635389|NCT01339910|Immunologic Factors|immunologic factors|mesh-ancestor
25635390|NCT01339910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635391|NCT01339910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25718244|NCT02424968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718245|NCT02424968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25635392|NCT01339910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25635393|NCT01339910|Alkylating Agents|alkylating agents|mesh-ancestor
25635394|NCT01339910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635395|NCT01339910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25635396|NCT01339910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25635397|NCT01339910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25635398|NCT01339910|Antimetabolites|antimetabolites|mesh-ancestor
25635399|NCT01339910|Antiviral Agents|antiviral agents|mesh-ancestor
25635400|NCT01339910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25635401|NCT01339923|Vaccines|vaccines|mesh-list
25635402|NCT01339923|Immunologic Factors|immunologic factors|mesh-ancestor
25635403|NCT01339923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635404|NCT01339936|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25635405|NCT01339936|Glycerol|glycerol|mesh-list
25635406|NCT01339936|Laxatives|laxatives|mesh-ancestor
25635407|NCT01339936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25635408|NCT01339936|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25635409|NCT01339936|Protective Agents|protective agents|mesh-ancestor
25635410|NCT01339936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635411|NCT01340014|Timolol|timolol|mesh-list
25635412|NCT01340014|Dorzolamide|dorzolamide|mesh-list
25635413|NCT01340014|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25635414|NCT01340014|Brinzolamide|brinzolamide|mesh-list
25635415|NCT01340014|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25635416|NCT01340014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25635417|NCT01340014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25635418|NCT01340014|Adrenergic Agents|adrenergic agents|mesh-ancestor
25635419|NCT01340014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25635420|NCT01340014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635421|NCT01340014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635422|NCT01340014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25635423|NCT01340014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25635424|NCT01340014|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25635425|NCT01340014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635426|NCT01340027|Solifenacin Succinate|solifenacin succinate|mesh-list
25635427|NCT01340027|Mirabegron|mirabegron|mesh-list
25635428|NCT01340027|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25635429|NCT01340027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25635430|NCT01340027|Cholinergic Agents|cholinergic agents|mesh-ancestor
25635431|NCT01340027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25635432|NCT01340027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635433|NCT01340027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635434|NCT01340027|Urological Agents|urological agents|mesh-ancestor
25635435|NCT01340027|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25635436|NCT01340027|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25635437|NCT01340027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25635438|NCT01340027|Adrenergic Agents|adrenergic agents|mesh-ancestor
25635439|NCT01340196|Tenofovir|tenofovir|mesh-list
25635440|NCT01340196|Antiviral Agents|antiviral agents|mesh-ancestor
25635441|NCT01340196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25635442|NCT01340196|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25635443|NCT01340196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25635444|NCT01340196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635445|NCT01340196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635446|NCT01340196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25635447|NCT01340196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25635448|NCT01340209|Tiotropium Bromide|tiotropium bromide|mesh-list
25635449|NCT01340209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25635450|NCT01340209|Autonomic Agents|autonomic agents|mesh-ancestor
25635451|NCT01340209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25635452|NCT01340209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635453|NCT01340209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25635454|NCT01340209|Respiratory System Agents|respiratory system agents|mesh-ancestor
25635455|NCT01340209|Parasympatholytics|parasympatholytics|mesh-ancestor
25635456|NCT01340209|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25635457|NCT01340209|Cholinergic Agents|cholinergic agents|mesh-ancestor
25635458|NCT01340209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25635459|NCT01340209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635461|NCT01340300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25635462|NCT01340300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635463|NCT01340586|Apixaban|apixaban|mesh-list
25635464|NCT01340586|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25635465|NCT01340586|Antithrombins|antithrombins|mesh-ancestor
24524404|NCT04966546|Memantine|memantine|mesh-list
25635466|NCT01340586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25635467|NCT01340586|Protease Inhibitors|protease inhibitors|mesh-ancestor
25635468|NCT01340586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635469|NCT01340586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635470|NCT01340586|Anticoagulants|anticoagulants|mesh-ancestor
25635471|NCT01340625|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25635472|NCT01340625|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25635473|NCT01340625|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25635474|NCT01340625|Norethindrone|norethindrone|mesh-list
25635475|NCT01340625|Norethindrone Acetate|norethindrone acetate|mesh-list
24524612|NCT04658654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635476|NCT01340625|Estradiol|estradiol|mesh-list
25635477|NCT01340625|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25635478|NCT01340625|Estrogens|estrogens|mesh-ancestor
25635479|NCT01340625|Hormones|hormones|mesh-ancestor
25635480|NCT01340625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25635481|NCT01340625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635482|NCT01340625|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25635483|NCT01340625|Contraceptive Agents|contraceptive agents|mesh-ancestor
25635484|NCT01340625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25635485|NCT01340625|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25635486|NCT01340625|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25635487|NCT01340625|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25635488|NCT01340625|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25635489|NCT01340664|Metformin|metformin|mesh-list
25635490|NCT01340664|Canagliflozin|canagliflozin|mesh-list
25635491|NCT01340664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25635492|NCT01340664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635493|NCT01340664|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25635494|NCT01340664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635495|NCT01340768|Metformin|metformin|mesh-list
25635496|NCT01340768|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25635497|NCT01340768|Glimepiride|glimepiride|mesh-list
25635498|NCT01340768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25635499|NCT01340768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635500|NCT01340768|Incretins|incretins|mesh-ancestor
25635501|NCT01340768|Hormones|hormones|mesh-ancestor
25635502|NCT01340768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25635503|NCT01340768|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25635504|NCT01340768|Protease Inhibitors|protease inhibitors|mesh-ancestor
25635505|NCT01340768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635506|NCT01340768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635507|NCT01340768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25635508|NCT01340768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25635509|NCT01340768|Immunologic Factors|immunologic factors|mesh-ancestor
25635510|NCT01340872|Ferric maltol|ferric maltol|mesh-list
25635511|NCT01340872|Hematinics|hematinics|mesh-ancestor
25635512|NCT01340937|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25635513|NCT01340937|Immunologic Factors|immunologic factors|mesh-ancestor
25635514|NCT01340937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635515|NCT01341301|Mycophenolic Acid|mycophenolic acid|mesh-list
25635516|NCT01341301|Cyclophosphamide|cyclophosphamide|mesh-list
25635517|NCT01341301|Tacrolimus|tacrolimus|mesh-list
25635518|NCT01341301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25635519|NCT01341301|Immunologic Factors|immunologic factors|mesh-ancestor
25635520|NCT01341301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635521|NCT01341301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25635522|NCT01341301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25635523|NCT01341301|Alkylating Agents|alkylating agents|mesh-ancestor
25635524|NCT01341301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635525|NCT01341301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25635526|NCT01341301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25635527|NCT01341301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25635528|NCT01341301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635529|NCT01341301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25635530|NCT01341301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25635531|NCT01341301|Antitubercular Agents|antitubercular agents|mesh-ancestor
25635532|NCT01341301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25635533|NCT01341301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25635534|NCT01341457|Gemcitabine|gemcitabine|mesh-list
25635535|NCT01341457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25635536|NCT01341457|Antimetabolites|antimetabolites|mesh-ancestor
25635537|NCT01341457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635538|NCT01341457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25635539|NCT01341457|Antiviral Agents|antiviral agents|mesh-ancestor
25635540|NCT01341457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25635541|NCT01341457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635542|NCT01341457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25635543|NCT01341457|Immunologic Factors|immunologic factors|mesh-ancestor
25635544|NCT01341457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635545|NCT01341639|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25635546|NCT01341639|Immunologic Factors|immunologic factors|mesh-ancestor
25635547|NCT01341639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635548|NCT01341652|Molgramostim|molgramostim|mesh-list
25635549|NCT01341652|Sargramostim|sargramostim|mesh-list
25635550|NCT01341652|Immunologic Factors|immunologic factors|mesh-ancestor
25635551|NCT01341652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635552|NCT01341652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25635553|NCT01341730|Pioglitazone|pioglitazone|mesh-list
25635554|NCT01341730|Atorvastatin|atorvastatin|mesh-list
24529494|NCT00626288|Analgesics|analgesics|mesh-ancestor
25635555|NCT01341730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25635556|NCT01341730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25635557|NCT01341730|Antimetabolites|antimetabolites|mesh-ancestor
25635558|NCT01341730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635559|NCT01341730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25635560|NCT01341730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25635561|NCT01341730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635562|NCT01341730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25635563|NCT01341730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635564|NCT01341782|Ergocalciferols|ergocalciferols|mesh-list
25635566|NCT01341782|Maxacalcitol|maxacalcitol|mesh-list
25635567|NCT01341782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25635568|NCT01341782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635569|NCT01341782|Vitamins|vitamins|mesh-ancestor
25635570|NCT01341782|Micronutrients|micronutrients|mesh-ancestor
25635571|NCT01341782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25635572|NCT01341782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25635573|NCT01341782|Dermatologic Agents|dermatologic agents|mesh-ancestor
25635574|NCT01341782|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25635575|NCT01341782|Protective Agents|protective agents|mesh-ancestor
25635576|NCT01341782|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25635577|NCT01341782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25635578|NCT01341782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635579|NCT01341782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25635580|NCT01341977|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25635581|NCT01341990|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25635582|NCT01342029|Ranolazine|ranolazine|mesh-list
25635583|NCT01342029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25635584|NCT01342029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25635585|NCT01342029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635586|NCT01342081|Timolol|timolol|mesh-list
25635587|NCT01342081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25635588|NCT01342081|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25635589|NCT01342081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25635590|NCT01342081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25635591|NCT01342081|Adrenergic Agents|adrenergic agents|mesh-ancestor
25530412|NCT00527735|Mitosis Modulators|mitosis modulators|mesh-ancestor
25635592|NCT01342081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25635593|NCT01342081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635594|NCT01342081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635595|NCT01342081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25635596|NCT01342081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25635597|NCT01342094|Timolol|timolol|mesh-list
25635598|NCT01342094|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25635599|NCT01342094|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25635600|NCT01342094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25635601|NCT01342094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25635602|NCT01342094|Adrenergic Agents|adrenergic agents|mesh-ancestor
25635603|NCT01342094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25635604|NCT01342094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635605|NCT01342094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635606|NCT01342094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25635607|NCT01342094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25635608|NCT01342107|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25635609|NCT01342172|Lenalidomide|lenalidomide|mesh-list
25635610|NCT01342172|Immunologic Factors|immunologic factors|mesh-ancestor
25635611|NCT01342172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635612|NCT01342172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25635613|NCT01342172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25635614|NCT01342172|Growth Substances|growth substances|mesh-ancestor
25635615|NCT01342172|Growth Inhibitors|growth inhibitors|mesh-ancestor
25635616|NCT01342172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25635617|NCT01342211|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
25635618|NCT01342211|Bococizumab|bococizumab|mesh-list
25635619|NCT01342211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25635620|NCT01342211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25635621|NCT01342211|Antimetabolites|antimetabolites|mesh-ancestor
25635622|NCT01342211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635623|NCT01342211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635624|NCT01342211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25635625|NCT01342341|Chlorzoxazone|chlorzoxazone|mesh-list
25635626|NCT01342341|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25635627|NCT01342341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635628|NCT01342341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25635629|NCT01342341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25635630|NCT01342367|Bicalutamide|bicalutamide|mesh-list
25635631|NCT01342367|Finasteride|finasteride|mesh-list
25635632|NCT01342367|Dutasteride|dutasteride|mesh-list
25635633|NCT01342367|Androgen Antagonists|androgen antagonists|mesh-ancestor
25635634|NCT01342367|Hormone Antagonists|hormone antagonists|mesh-ancestor
25635635|NCT01342367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25635636|NCT01342367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635637|NCT01342367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25635638|NCT01342367|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25635639|NCT01342367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25635640|NCT01342367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635641|NCT01342367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635642|NCT01342367|Urological Agents|urological agents|mesh-ancestor
25635643|NCT01342445|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25635644|NCT01342445|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25635645|NCT01342445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635646|NCT01342445|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25635647|NCT01342445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25635648|NCT01342445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25635649|NCT01342445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635650|NCT01342445|Dopamine Agents|dopamine agents|mesh-ancestor
25635651|NCT01342445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25635652|NCT01342484|Linagliptin|linagliptin|mesh-list
25635653|NCT01342484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25635654|NCT01342484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635655|NCT01342484|Incretins|incretins|mesh-ancestor
25635656|NCT01342484|Hormones|hormones|mesh-ancestor
25635657|NCT01342484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25635658|NCT01342484|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25635659|NCT01342484|Protease Inhibitors|protease inhibitors|mesh-ancestor
25635660|NCT01342484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635661|NCT01342484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635662|NCT01342510|Lidocaine|lidocaine|mesh-list
25635663|NCT01342510|Magnesium Sulfate|magnesium sulfate|mesh-list
25635664|NCT01342510|Anesthetics, Local|anesthetics, local|mesh-ancestor
25635665|NCT01342510|Anesthetics|anesthetics|mesh-ancestor
25635666|NCT01342510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25635667|NCT01342510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635668|NCT01342510|Sensory System Agents|sensory system agents|mesh-ancestor
25635669|NCT01342510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25635670|NCT01342510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25635671|NCT01342510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25635672|NCT01342510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25635673|NCT01342510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25635674|NCT01342510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635675|NCT01342510|Analgesics|analgesics|mesh-ancestor
25635676|NCT01342510|Anticonvulsants|anticonvulsants|mesh-ancestor
25635677|NCT01342510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25635678|NCT01342510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25635679|NCT01342510|Tocolytic Agents|tocolytic agents|mesh-ancestor
25635680|NCT01342510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25635681|NCT01342523|Nicotine|nicotine|mesh-list
25635682|NCT01342523|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25635683|NCT01342523|Autonomic Agents|autonomic agents|mesh-ancestor
25635684|NCT01342523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25635685|NCT01342523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635686|NCT01342523|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25635687|NCT01342523|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25635688|NCT01342523|Cholinergic Agents|cholinergic agents|mesh-ancestor
25635689|NCT01342523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25635690|NCT01342523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635691|NCT01342549|Naltrexone|naltrexone|mesh-list
25635692|NCT01342549|Valproic Acid|valproic acid|mesh-list
25635693|NCT01342549|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25635694|NCT01342549|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25635695|NCT01342549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635696|NCT01342549|Sensory System Agents|sensory system agents|mesh-ancestor
25635697|NCT01342549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25635698|NCT01342549|Anticonvulsants|anticonvulsants|mesh-ancestor
25635699|NCT01342549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635700|NCT01342549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635701|NCT01342549|GABA Agents|gaba agents|mesh-ancestor
25635702|NCT01342549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25635703|NCT01342549|Antimanic Agents|antimanic agents|mesh-ancestor
25635704|NCT01342549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25635705|NCT01342549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25635706|NCT01342549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25635707|NCT01342640|Epoetin Alfa|epoetin alfa|mesh-list
25635708|NCT01342640|Hematinics|hematinics|mesh-ancestor
25635709|NCT01342757|Temozolomide|temozolomide|mesh-list
25635710|NCT01342757|Vorinostat|vorinostat|mesh-list
25635711|NCT01342757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25635712|NCT01342757|Alkylating Agents|alkylating agents|mesh-ancestor
25635713|NCT01342757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635714|NCT01342757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25635715|NCT01342757|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25635716|NCT01342757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635717|NCT01342770|Pioglitazone|pioglitazone|mesh-list
25635718|NCT01342770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25635719|NCT01342770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635720|NCT01342796|Vaccines|vaccines|mesh-list
25635721|NCT01342796|Immunologic Factors|immunologic factors|mesh-ancestor
25635722|NCT01342796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635723|NCT01342887|Cyclosporine|cyclosporine|mesh-list
25635724|NCT01342887|Etoposide|etoposide|mesh-list
25635725|NCT01342887|Mitoxantrone|mitoxantrone|mesh-list
25635726|NCT01342887|Etoposide phosphate|etoposide phosphate|mesh-list
25635727|NCT01342887|Pravastatin|pravastatin|mesh-list
25635728|NCT01342887|Cyclosporins|cyclosporins|mesh-list
25635729|NCT01342887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25635730|NCT01342887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25635731|NCT01342887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25635732|NCT01342887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25635733|NCT01342887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635734|NCT01342887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635735|NCT01342887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25635736|NCT01342887|Immunologic Factors|immunologic factors|mesh-ancestor
25635737|NCT01342887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635738|NCT01342887|Antifungal Agents|antifungal agents|mesh-ancestor
25530560|NCT00528541|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25635739|NCT01342887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25635740|NCT01342887|Dermatologic Agents|dermatologic agents|mesh-ancestor
25635741|NCT01342887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25635742|NCT01342887|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25635743|NCT01342887|Analgesics|analgesics|mesh-ancestor
25635744|NCT01342887|Sensory System Agents|sensory system agents|mesh-ancestor
25635745|NCT01342887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25635746|NCT01342887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25635747|NCT01342887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25635748|NCT01342887|Antimetabolites|antimetabolites|mesh-ancestor
25635749|NCT01342887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25635750|NCT01342887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25635751|NCT01342913|Fluticasone|fluticasone|mesh-list
25635752|NCT01342913|Xhance|xhance|mesh-list
25635753|NCT01342913|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25635754|NCT01342913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25635755|NCT01342913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25635756|NCT01342913|Autonomic Agents|autonomic agents|mesh-ancestor
25635757|NCT01342913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25635758|NCT01342913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635759|NCT01342913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25635760|NCT01342913|Respiratory System Agents|respiratory system agents|mesh-ancestor
25635761|NCT01342913|Dermatologic Agents|dermatologic agents|mesh-ancestor
25635762|NCT01342913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25635763|NCT01342913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25635764|NCT01342913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25635765|NCT01342913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25635766|NCT01342913|Adrenergic Agents|adrenergic agents|mesh-ancestor
25635767|NCT01342913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25635768|NCT01342913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635769|NCT01342965|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25635770|NCT01342965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25635771|NCT01342965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25635772|NCT01342965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635773|NCT01342965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635774|NCT01343004|Teriparatide|teriparatide|mesh-list
25635775|NCT01343004|Abaloparatide|abaloparatide|mesh-list
25635776|NCT01343004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25635777|NCT01343004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635778|NCT01343004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25635779|NCT01343043|Cyclophosphamide|cyclophosphamide|mesh-list
25635780|NCT01343043|Fludarabine|fludarabine|mesh-list
25635781|NCT01343043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25635782|NCT01343043|Immunologic Factors|immunologic factors|mesh-ancestor
25635783|NCT01343043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635784|NCT01343043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25635785|NCT01343043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25635786|NCT01343043|Alkylating Agents|alkylating agents|mesh-ancestor
25635787|NCT01343043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635788|NCT01343043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25635789|NCT01343043|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25635790|NCT01343082|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25635791|NCT01343082|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25635792|NCT01343277|Dacarbazine|dacarbazine|mesh-list
25635793|NCT01343277|Trabectedin|trabectedin|mesh-list
25635794|NCT01343277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25635795|NCT01343277|Alkylating Agents|alkylating agents|mesh-ancestor
25635796|NCT01343277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635797|NCT01343277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25635798|NCT01343368|Leuprolide|leuprolide|mesh-list
25635799|NCT01343368|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25635800|NCT01343368|Fertility Agents|fertility agents|mesh-ancestor
25635801|NCT01343368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25635802|NCT01343368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635803|NCT01343368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25635804|NCT01343368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25635805|NCT01343823|Ecallantide|ecallantide|mesh-list
25635806|NCT01343823|Analgesics|analgesics|mesh-ancestor
25635807|NCT01343823|Sensory System Agents|sensory system agents|mesh-ancestor
25635808|NCT01343823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25635809|NCT01343823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635810|NCT01343823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25635811|NCT01343823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25635812|NCT01343823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25635813|NCT01343823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25635814|NCT01343901|Bevacizumab|bevacizumab|mesh-list
25635815|NCT01343901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25635816|NCT01343901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25635817|NCT01343901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25635818|NCT01343901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25635819|NCT01343901|Growth Substances|growth substances|mesh-ancestor
25635820|NCT01343901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635821|NCT01343901|Growth Inhibitors|growth inhibitors|mesh-ancestor
25635823|NCT01344161|Cholecalciferol|cholecalciferol|mesh-list
25635824|NCT01344161|Vitamins|vitamins|mesh-ancestor
25635825|NCT01344161|Micronutrients|micronutrients|mesh-ancestor
25635826|NCT01344161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635827|NCT01344161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25635828|NCT01344161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25635829|NCT01344226|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25635830|NCT01344226|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25635831|NCT01344226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25635832|NCT01344226|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25635833|NCT01344369|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25635834|NCT01344369|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25635835|NCT01344369|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25635836|NCT01344369|Norethindrone|norethindrone|mesh-list
25635837|NCT01344369|Norethindrone Acetate|norethindrone acetate|mesh-list
25635838|NCT01344369|Estradiol|estradiol|mesh-list
25635839|NCT01344369|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25635840|NCT01344369|Estrogens|estrogens|mesh-ancestor
25635841|NCT01344369|Hormones|hormones|mesh-ancestor
25635842|NCT01344369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25635843|NCT01344369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635844|NCT01344369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25635845|NCT01344369|Contraceptive Agents|contraceptive agents|mesh-ancestor
25635846|NCT01344369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25635847|NCT01344369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25635848|NCT01344369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25635849|NCT01344369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25635850|NCT01344369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25635851|NCT01344629|Telmisartan|telmisartan|mesh-list
25635852|NCT01344629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25635853|NCT01344629|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25635854|NCT01344629|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25635855|NCT01344629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635856|NCT01344759|Dexmedetomidine|dexmedetomidine|mesh-list
25635857|NCT01344759|Propofol|propofol|mesh-list
25635858|NCT01344759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25635859|NCT01344759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25635860|NCT01344759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635861|NCT01344759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25635862|NCT01344759|Anesthetics, General|anesthetics, general|mesh-ancestor
25635863|NCT01344759|Anesthetics|anesthetics|mesh-ancestor
25635864|NCT01344759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25635865|NCT01344759|Analgesics|analgesics|mesh-ancestor
25635866|NCT01344759|Sensory System Agents|sensory system agents|mesh-ancestor
25635867|NCT01344759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25635868|NCT01344759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25635869|NCT01344759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25635870|NCT01344759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25635871|NCT01344759|Adrenergic Agents|adrenergic agents|mesh-ancestor
25635872|NCT01344759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25635873|NCT01344759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635874|NCT01344824|Bevacizumab|bevacizumab|mesh-list
25635875|NCT01344824|Carboplatin|carboplatin|mesh-list
25635876|NCT01344824|Pemetrexed|pemetrexed|mesh-list
25635877|NCT01344824|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25635878|NCT01344824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25635879|NCT01344824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25635880|NCT01344824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25635881|NCT01344824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25635882|NCT01344824|Growth Substances|growth substances|mesh-ancestor
25635883|NCT01344824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635884|NCT01344824|Growth Inhibitors|growth inhibitors|mesh-ancestor
25635885|NCT01344824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635886|NCT01344824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635887|NCT01344824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25635888|NCT01344824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25635889|NCT01344824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25635890|NCT01345019|Zoledronic Acid|zoledronic acid|mesh-list
25635892|NCT01345019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25635893|NCT01345019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635894|NCT01345058|Lacosamide|lacosamide|mesh-list
25635895|NCT01345058|Levetiracetam|levetiracetam|mesh-list
25635896|NCT01345058|Anticonvulsants|anticonvulsants|mesh-ancestor
25635897|NCT01345058|Nootropic Agents|nootropic agents|mesh-ancestor
25635898|NCT01345058|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25635899|NCT01345058|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25635900|NCT01345058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25635901|NCT01345058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635902|NCT01345162|Ketorolac|ketorolac|mesh-list
25635903|NCT01345162|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25635904|NCT01345162|Tramadol|tramadol|mesh-list
25635905|NCT01345162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25635906|NCT01345162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25635907|NCT01345162|Analgesics|analgesics|mesh-ancestor
25635908|NCT01345162|Sensory System Agents|sensory system agents|mesh-ancestor
25635909|NCT01345162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25635910|NCT01345162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635911|NCT01345162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25635912|NCT01345162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25635913|NCT01345162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25635914|NCT01345162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635915|NCT01345162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635916|NCT01345162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25635917|NCT01345162|Narcotics|narcotics|mesh-ancestor
25635918|NCT01345162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25635919|NCT01345188|Ranolazine|ranolazine|mesh-list
25635920|NCT01345188|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25635921|NCT01345188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25635922|NCT01345188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656348|NCT01574183|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
25656349|NCT01574183|Antidepressive Agents|antidepressive agents|mesh-ancestor
25656350|NCT01574183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25656351|NCT01574183|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25656352|NCT01574183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25656353|NCT01574183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25656354|NCT01574183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656355|NCT01574183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25656356|NCT01574183|Serotonin Agents|serotonin agents|mesh-ancestor
25656357|NCT01574183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656358|NCT01574183|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25656359|NCT01574183|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25656360|NCT01574248|Icatibant|icatibant|mesh-list
25656361|NCT01574248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25656362|NCT01574248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25656363|NCT01574248|Analgesics|analgesics|mesh-ancestor
25656364|NCT01574248|Sensory System Agents|sensory system agents|mesh-ancestor
25656365|NCT01574248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25656366|NCT01574248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656367|NCT01574248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25656368|NCT01574248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25656369|NCT01574248|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
25656370|NCT01574248|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
25656371|NCT01574248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656372|NCT01574248|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25656373|NCT01574248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25656374|NCT01574248|Immunologic Factors|immunologic factors|mesh-ancestor
25656375|NCT01574326|Sevelamer|sevelamer|mesh-list
25656376|NCT01574326|Chelating Agents|chelating agents|mesh-ancestor
25656377|NCT01574326|Sequestering Agents|sequestering agents|mesh-ancestor
25656378|NCT01574326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718303|NCT02427737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25718304|NCT02427737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25718305|NCT02427737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656379|NCT01574612|Acyclovir|acyclovir|mesh-list
25656380|NCT01574612|Hydrocortisone|hydrocortisone|mesh-list
25656381|NCT01574612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25656382|NCT01574612|Antiviral Agents|antiviral agents|mesh-ancestor
25656383|NCT01574612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25656384|NCT01574651|Glycopyrrolate|glycopyrrolate|mesh-list
25656385|NCT01574651|Formoterol Fumarate|formoterol fumarate|mesh-list
25656386|NCT01574651|Tiotropium Bromide|tiotropium bromide|mesh-list
25530786|NCT00529802|Everolimus|everolimus|mesh-list
25530846|NCT00530348|Interferon beta-1a|interferon beta-1a|mesh-list
25530847|NCT00530348|Alemtuzumab|alemtuzumab|mesh-list
25530848|NCT00530348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530849|NCT00530348|Antiviral Agents|antiviral agents|mesh-ancestor
25530850|NCT00530348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25530851|NCT00530348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25530852|NCT00530348|Immunologic Factors|immunologic factors|mesh-ancestor
25530853|NCT00530348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530854|NCT00530348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25530855|NCT00530621|Pemetrexed|pemetrexed|mesh-list
25530856|NCT00530621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530857|NCT00530621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530858|NCT00530621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530859|NCT00530621|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25530860|NCT00530621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25530861|NCT00530634|Gemcitabine|gemcitabine|mesh-list
25530862|NCT00530634|Cisplatin|cisplatin|mesh-list
25530863|NCT00530634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530864|NCT00530634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25530865|NCT00530634|Antimetabolites|antimetabolites|mesh-ancestor
25530866|NCT00530634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530867|NCT00530634|Antiviral Agents|antiviral agents|mesh-ancestor
25530868|NCT00530634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25530869|NCT00530634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530870|NCT00530634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25530871|NCT00530634|Immunologic Factors|immunologic factors|mesh-ancestor
25530872|NCT00530634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124483|NCT03076099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25124484|NCT03076099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25124485|NCT03076099|Adrenergic Agents|adrenergic agents|mesh-ancestor
25124486|NCT03076099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24828874|NCT02148016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25124487|NCT03076099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124489|NCT03075657|Risperidone|risperidone|mesh-list
25162119|NCT02907957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162120|NCT02908035|Sirolimus|sirolimus|mesh-list
25040963|NCT02733432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25040964|NCT02733432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040965|NCT02733432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25040966|NCT02733432|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25124501|NCT03075657|Dopamine Agents|dopamine agents|mesh-ancestor
25124502|NCT03075657|Antiemetics|antiemetics|mesh-ancestor
25124503|NCT03075657|Autonomic Agents|autonomic agents|mesh-ancestor
25124504|NCT03075657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25040984|NCT02706795|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25040985|NCT02706795|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25040986|NCT02706795|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25040987|NCT02706795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25635923|NCT01345253|Belimumab|belimumab|mesh-list
25635924|NCT01345253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25635925|NCT01345253|Immunologic Factors|immunologic factors|mesh-ancestor
25635926|NCT01345253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635927|NCT01345292|Listerine|listerine|mesh-list
25635928|NCT01345292|Fluorides|fluorides|mesh-list
25635929|NCT01345292|Sodium Fluoride|sodium fluoride|mesh-list
25635930|NCT01345292|Cariostatic Agents|cariostatic agents|mesh-ancestor
25718310|NCT02427802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718311|NCT02427802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718312|NCT02427841|Gemcitabine|gemcitabine|mesh-list
25718313|NCT02427841|Paclitaxel|paclitaxel|mesh-list
25635931|NCT01345292|Protective Agents|protective agents|mesh-ancestor
25635932|NCT01345292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635933|NCT01345292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25635934|NCT01345292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25635935|NCT01345630|Ritonavir|ritonavir|mesh-list
25635936|NCT01345630|Darunavir|darunavir|mesh-list
25635937|NCT01345630|Tenofovir|tenofovir|mesh-list
25635938|NCT01345630|Emtricitabine|emtricitabine|mesh-list
25635939|NCT01345630|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25635940|NCT01345630|Maraviroc|maraviroc|mesh-list
25635941|NCT01345630|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25635942|NCT01345630|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25635943|NCT01345630|Protease Inhibitors|protease inhibitors|mesh-ancestor
25635944|NCT01345630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635945|NCT01345630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635946|NCT01345630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25635947|NCT01345630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25635948|NCT01345630|Antiviral Agents|antiviral agents|mesh-ancestor
25635949|NCT01345630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25635950|NCT01345630|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25635951|NCT01345630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25635952|NCT01345630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25635953|NCT01345630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25635954|NCT01345630|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25635955|NCT01345630|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25635956|NCT01345630|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25635958|NCT01345669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25635959|NCT01345669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25635960|NCT01345669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635961|NCT01345669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635962|NCT01345682|Methotrexate|methotrexate|mesh-list
25635963|NCT01345682|Afatinib|afatinib|mesh-list
25635964|NCT01345682|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25635965|NCT01345682|Abortifacient Agents|abortifacient agents|mesh-ancestor
25635966|NCT01345682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25635967|NCT01345682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25635968|NCT01345682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25635969|NCT01345682|Antimetabolites|antimetabolites|mesh-ancestor
25635970|NCT01345682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635971|NCT01345682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25635972|NCT01345682|Dermatologic Agents|dermatologic agents|mesh-ancestor
25635973|NCT01345682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635974|NCT01345682|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25635975|NCT01345682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25635976|NCT01345682|Immunologic Factors|immunologic factors|mesh-ancestor
25635977|NCT01345682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25635978|NCT01345682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25635979|NCT01345682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25635980|NCT01345929|Levofloxacin|levofloxacin|mesh-list
25635981|NCT01345929|Ofloxacin|ofloxacin|mesh-list
25635982|NCT01345929|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25635983|NCT01345929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25635984|NCT01345929|Renal Agents|renal agents|mesh-ancestor
25635985|NCT01345929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25635986|NCT01345929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25635987|NCT01345929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25635988|NCT01345929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25635989|NCT01345929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635990|NCT01345929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25635991|NCT01345929|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25635992|NCT01345929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25635993|NCT01346059|Vancomycin|vancomycin|mesh-list
25635994|NCT01346059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25635995|NCT01346059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25635996|NCT01346072|Tolvaptan|tolvaptan|mesh-list
25718318|NCT02427841|Tubulin Modulators|tubulin modulators|mesh-ancestor
25635997|NCT01346072|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25635998|NCT01346072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25635999|NCT01346072|Natriuretic Agents|natriuretic agents|mesh-ancestor
25636000|NCT01346072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636001|NCT01346085|Thymoglobulin|thymoglobulin|mesh-list
25636002|NCT01346085|Immunologic Factors|immunologic factors|mesh-ancestor
25636003|NCT01346085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636004|NCT01346085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25636005|NCT01346371|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25636006|NCT01346371|Lubricant Eye Drops|lubricant eye drops|mesh-list
25636007|NCT01346371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25636008|NCT01346397|Cyclosporine|cyclosporine|mesh-list
25636009|NCT01346397|Tacrolimus|tacrolimus|mesh-list
25636010|NCT01346397|Cyclosporins|cyclosporins|mesh-list
25636011|NCT01346397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25636012|NCT01346397|Immunologic Factors|immunologic factors|mesh-ancestor
25636013|NCT01346397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636014|NCT01346397|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25636015|NCT01346397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636016|NCT01346397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636017|NCT01346397|Antifungal Agents|antifungal agents|mesh-ancestor
25636018|NCT01346397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25636019|NCT01346397|Dermatologic Agents|dermatologic agents|mesh-ancestor
25636020|NCT01346397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25636021|NCT01346475|Valacyclovir|valacyclovir|mesh-list
25636022|NCT01346475|Antiviral Agents|antiviral agents|mesh-ancestor
25530873|NCT00530764|Nabiximols|nabiximols|mesh-list
25636024|NCT01346540|Nintedanib|nintedanib|mesh-list
25636025|NCT01346540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25636026|NCT01346540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25636027|NCT01346540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636028|NCT01346540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636029|NCT01346592|Vaccines|vaccines|mesh-list
25636030|NCT01346592|Immunologic Factors|immunologic factors|mesh-ancestor
25636031|NCT01346592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636032|NCT01347008|Sildenafil Citrate|sildenafil citrate|mesh-list
25636033|NCT01347008|Citric Acid|citric acid|mesh-list
25636034|NCT01347008|Sodium Citrate|sodium citrate|mesh-list
25636035|NCT01347008|Anticoagulants|anticoagulants|mesh-ancestor
25636036|NCT01347008|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25636037|NCT01347008|Chelating Agents|chelating agents|mesh-ancestor
25636038|NCT01347008|Sequestering Agents|sequestering agents|mesh-ancestor
25636039|NCT01347008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636040|NCT01347008|Vasodilator Agents|vasodilator agents|mesh-ancestor
25636041|NCT01347008|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25636042|NCT01347008|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25636043|NCT01347008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636044|NCT01347008|Urological Agents|urological agents|mesh-ancestor
25636045|NCT01347060|Fluticasone|fluticasone|mesh-list
25636046|NCT01347060|Xhance|xhance|mesh-list
25636047|NCT01347060|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25636048|NCT01347060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25636049|NCT01347060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25636050|NCT01347060|Autonomic Agents|autonomic agents|mesh-ancestor
25636051|NCT01347060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25636052|NCT01347060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636053|NCT01347060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25636054|NCT01347060|Respiratory System Agents|respiratory system agents|mesh-ancestor
25636055|NCT01347060|Dermatologic Agents|dermatologic agents|mesh-ancestor
25636056|NCT01347060|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25636057|NCT01347060|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25636058|NCT01347060|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25636059|NCT01347060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25636060|NCT01347060|Adrenergic Agents|adrenergic agents|mesh-ancestor
25636061|NCT01347060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25636062|NCT01347060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636063|NCT01347073|Glycerol|glycerol|mesh-list
25636064|NCT01347073|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25636065|NCT01347073|Protective Agents|protective agents|mesh-ancestor
25636066|NCT01347073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636067|NCT01347112|Varenicline|varenicline|mesh-list
25636068|NCT01347112|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25636069|NCT01347112|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25636070|NCT01347112|Cholinergic Agents|cholinergic agents|mesh-ancestor
25636071|NCT01347112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25636072|NCT01347112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636073|NCT01347112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636074|NCT01347255|Betamethasone|betamethasone|mesh-list
25636075|NCT01347255|Betamethasone Valerate|betamethasone valerate|mesh-list
25636076|NCT01347255|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25636077|NCT01347255|Betamethasone benzoate|betamethasone benzoate|mesh-list
25636078|NCT01347255|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25636079|NCT01347255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25636080|NCT01347255|Glucocorticoids|glucocorticoids|mesh-ancestor
25636081|NCT01347255|Hormones|hormones|mesh-ancestor
25636082|NCT01347255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25636083|NCT01347255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636084|NCT01347255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25636085|NCT01347255|Respiratory System Agents|respiratory system agents|mesh-ancestor
25636086|NCT01347554|Everolimus|everolimus|mesh-list
25636087|NCT01347554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25636088|NCT01347554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25636089|NCT01347554|Immunologic Factors|immunologic factors|mesh-ancestor
25636090|NCT01347554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636091|NCT01347580|Ticagrelor|ticagrelor|mesh-list
25636092|NCT01347580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25636093|NCT01347580|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25636094|NCT01347580|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25636095|NCT01347580|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25636096|NCT01347580|Purinergic Agents|purinergic agents|mesh-ancestor
25636097|NCT01347580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25636098|NCT01347580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636099|NCT01347580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636100|NCT01347710|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
25636101|NCT01347710|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
25636102|NCT01347710|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25636103|NCT01347710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636104|NCT01347762|Nabilone|nabilone|mesh-list
25636105|NCT01347762|Antiemetics|antiemetics|mesh-ancestor
25636106|NCT01347762|Autonomic Agents|autonomic agents|mesh-ancestor
25636107|NCT01347762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25636108|NCT01347762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636109|NCT01347762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25636110|NCT01347762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25636111|NCT01347762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25636112|NCT01347762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25636113|NCT01347762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25636114|NCT01347866|Irinotecan|irinotecan|mesh-list
25636115|NCT01347866|Gedatolisib|gedatolisib|mesh-list
25636116|NCT01347866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25636117|NCT01347866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25636118|NCT01347866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636119|NCT01347866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636120|NCT01347866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25636121|NCT01347866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25636122|NCT01348100|Iloperidone|iloperidone|mesh-list
25636123|NCT01348100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25636124|NCT01348100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25636125|NCT01348100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25636126|NCT01348100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636127|NCT01348100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25636128|NCT01348139|AZD-3199|azd-3199|mesh-list
25636129|NCT01348139|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25636130|NCT01348139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25636131|NCT01348139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25636132|NCT01348139|Adrenergic Agents|adrenergic agents|mesh-ancestor
25636133|NCT01348139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25636134|NCT01348139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636135|NCT01348139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636136|NCT01348542|Trazodone|trazodone|mesh-list
25636137|NCT01348542|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25636138|NCT01348542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25636139|NCT01348542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25636140|NCT01348542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636141|NCT01348542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25636142|NCT01348542|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25636143|NCT01348542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25636144|NCT01348542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25636145|NCT01348542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636146|NCT01348542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25636147|NCT01348542|Serotonin Agents|serotonin agents|mesh-ancestor
25636148|NCT01348542|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25636149|NCT01348542|Antidepressive Agents|antidepressive agents|mesh-ancestor
25636150|NCT01348607|Methylphenidate|methylphenidate|mesh-list
25636151|NCT01348607|Modafinil|modafinil|mesh-list
25636152|NCT01348607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25636153|NCT01348607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636154|NCT01348607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25636155|NCT01348607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25636156|NCT01348607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25636157|NCT01348607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636158|NCT01348607|Dopamine Agents|dopamine agents|mesh-ancestor
25636159|NCT01348607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25636160|NCT01348607|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25636161|NCT01348607|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25636162|NCT01348607|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25636163|NCT01348763|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25636164|NCT01348763|Maraviroc|maraviroc|mesh-list
25636165|NCT01348763|Darunavir|darunavir|mesh-list
25636166|NCT01348763|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25636167|NCT01348763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25636168|NCT01348763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531021|NCT00531284|Glucocorticoids|glucocorticoids|mesh-ancestor
25636169|NCT01348763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636170|NCT01348763|Antiviral Agents|antiviral agents|mesh-ancestor
25636171|NCT01348763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25636172|NCT01348763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25636173|NCT01348763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25636174|NCT01348763|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25636175|NCT01348763|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25636176|NCT01348763|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25718326|NCT02427841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449754|NCT00316875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24449756|NCT00316901|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24449757|NCT00316901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449758|NCT00316927|Aspirin|aspirin|mesh-list
25718327|NCT02427841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25718328|NCT02427841|Immunologic Factors|immunologic factors|mesh-ancestor
25718329|NCT02427841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718330|NCT02428296|Sirolimus|sirolimus|mesh-list
25718331|NCT02428296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25718332|NCT02428296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25636177|NCT01348763|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25636178|NCT01348763|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25636179|NCT01348763|Protease Inhibitors|protease inhibitors|mesh-ancestor
25636180|NCT01349192|Chlorhexidine|chlorhexidine|mesh-list
25636181|NCT01349192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25636182|NCT01349192|Minocycline|minocycline|mesh-list
25636183|NCT01349192|Rifampin|rifampin|mesh-list
25636184|NCT01349192|Trimethoprim|trimethoprim|mesh-list
25636185|NCT01349192|Sulfamethoxazole|sulfamethoxazole|mesh-list
25636186|NCT01349192|Mupirocin|mupirocin|mesh-list
25636187|NCT01349192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25636188|NCT01349192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25636189|NCT01349192|Disinfectants|disinfectants|mesh-ancestor
25636190|NCT01349192|Dermatologic Agents|dermatologic agents|mesh-ancestor
25636191|NCT01349192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25636192|NCT01349192|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25636193|NCT01349192|Antitubercular Agents|antitubercular agents|mesh-ancestor
25636194|NCT01349192|Leprostatic Agents|leprostatic agents|mesh-ancestor
25636195|NCT01349192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25636196|NCT01349192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636197|NCT01349192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636198|NCT01349192|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25636199|NCT01349192|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25636200|NCT01349192|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25636201|NCT01349192|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25636202|NCT01349192|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25636203|NCT01349192|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25636204|NCT01349192|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25636205|NCT01349192|Renal Agents|renal agents|mesh-ancestor
25636206|NCT01349192|Antimalarials|antimalarials|mesh-ancestor
25636207|NCT01349192|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25636208|NCT01349192|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25636209|NCT01349192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25636210|NCT01349192|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25636211|NCT01349192|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25636212|NCT01349192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25636213|NCT01349192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25636214|NCT01349231|Ketamine|ketamine|mesh-list
25636215|NCT01349231|Analgesics|analgesics|mesh-ancestor
25636216|NCT01349231|Sensory System Agents|sensory system agents|mesh-ancestor
25636217|NCT01349231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25636218|NCT01349231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636219|NCT01349231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25636220|NCT01349231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25636221|NCT01349231|Anesthetics, General|anesthetics, general|mesh-ancestor
25636222|NCT01349231|Anesthetics|anesthetics|mesh-ancestor
25636223|NCT01349231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25636224|NCT01349231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25636225|NCT01349231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25636226|NCT01349231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25636227|NCT01349231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636228|NCT01349491|Ranolazine|ranolazine|mesh-list
25636229|NCT01349491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25718334|NCT02428296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25718335|NCT02428296|Antifungal Agents|antifungal agents|mesh-ancestor
25718336|NCT02428296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25718337|NCT02428296|Immunologic Factors|immunologic factors|mesh-ancestor
25718338|NCT02428296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718339|NCT02428478|Desipramine|desipramine|mesh-list
25718340|NCT02428478|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25718341|NCT02428478|Antidepressive Agents|antidepressive agents|mesh-ancestor
25718342|NCT02428478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25718343|NCT02428478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636230|NCT01349491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25636231|NCT01349491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636232|NCT01349569|Lenalidomide|lenalidomide|mesh-list
25636233|NCT01349569|Vaccines|vaccines|mesh-list
25636234|NCT01349569|Immunologic Factors|immunologic factors|mesh-ancestor
25636235|NCT01349569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636236|NCT01349569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25636237|NCT01349569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25636238|NCT01349569|Growth Substances|growth substances|mesh-ancestor
25636239|NCT01349569|Growth Inhibitors|growth inhibitors|mesh-ancestor
25636240|NCT01349569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25636241|NCT01349660|Bevacizumab|bevacizumab|mesh-list
25636242|NCT01349660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25636244|NCT01349660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25636245|NCT01349660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25636246|NCT01349660|Growth Substances|growth substances|mesh-ancestor
25636247|NCT01349660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636248|NCT01349660|Growth Inhibitors|growth inhibitors|mesh-ancestor
25636249|NCT01349673|Budesonide|budesonide|mesh-list
25636250|NCT01349673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25636251|NCT01349673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25636252|NCT01349673|Autonomic Agents|autonomic agents|mesh-ancestor
25636253|NCT01349673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25636254|NCT01349673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636255|NCT01349673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25636256|NCT01349673|Respiratory System Agents|respiratory system agents|mesh-ancestor
25636257|NCT01349673|Glucocorticoids|glucocorticoids|mesh-ancestor
25636258|NCT01349673|Hormones|hormones|mesh-ancestor
25636259|NCT01349673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25636260|NCT01349803|Formoterol Fumarate|formoterol fumarate|mesh-list
25636261|NCT01349803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25636262|NCT01349803|Autonomic Agents|autonomic agents|mesh-ancestor
25636263|NCT01349803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25636264|NCT01349803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636265|NCT01349803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25636266|NCT01349803|Respiratory System Agents|respiratory system agents|mesh-ancestor
25636267|NCT01349803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25636268|NCT01349803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25636269|NCT01349803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25636270|NCT01349803|Adrenergic Agents|adrenergic agents|mesh-ancestor
25636271|NCT01349803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25636272|NCT01349803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636273|NCT01349920|Infliximab|infliximab|mesh-list
25636274|NCT01349920|Dermatologic Agents|dermatologic agents|mesh-ancestor
25636275|NCT01349920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25636276|NCT01349920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25636277|NCT01349972|Cytarabine|cytarabine|mesh-list
25636278|NCT01349972|Daunorubicin|daunorubicin|mesh-list
25636279|NCT01349972|Mitoxantrone|mitoxantrone|mesh-list
25636280|NCT01349972|Alvocidib|alvocidib|mesh-list
25636281|NCT01349972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25636282|NCT01349972|Antimetabolites|antimetabolites|mesh-ancestor
25636283|NCT01349972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636284|NCT01349972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25636285|NCT01349972|Antiviral Agents|antiviral agents|mesh-ancestor
25636286|NCT01349972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25636287|NCT01349972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25636288|NCT01349972|Immunologic Factors|immunologic factors|mesh-ancestor
24449823|NCT00317187|Vaccines|vaccines|mesh-list
25636289|NCT01349972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636290|NCT01349972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25636291|NCT01349972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25636292|NCT01349972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25636293|NCT01349972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636294|NCT01349972|Analgesics|analgesics|mesh-ancestor
25636295|NCT01349972|Sensory System Agents|sensory system agents|mesh-ancestor
25636296|NCT01349972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25636297|NCT01349972|Growth Inhibitors|growth inhibitors|mesh-ancestor
25636298|NCT01349972|Growth Substances|growth substances|mesh-ancestor
25636299|NCT01349972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25636300|NCT01350102|Ascorbic Acid|ascorbic acid|mesh-list
25636301|NCT01350102|Bacitracin|bacitracin|mesh-list
25636302|NCT01350102|Vitamins|vitamins|mesh-ancestor
25636303|NCT01350102|Micronutrients|micronutrients|mesh-ancestor
25636304|NCT01350102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636305|NCT01350102|Antioxidants|antioxidants|mesh-ancestor
25636306|NCT01350102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636307|NCT01350102|Protective Agents|protective agents|mesh-ancestor
25636308|NCT01350102|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25636309|NCT01350102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25636310|NCT01350102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25636311|NCT01350128|Bromides|bromides|mesh-list
25636312|NCT01350128|Ipratropium|ipratropium|mesh-list
25636313|NCT01350128|Anticonvulsants|anticonvulsants|mesh-ancestor
25636314|NCT01350128|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25636315|NCT01350128|Autonomic Agents|autonomic agents|mesh-ancestor
25636316|NCT01350128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25636317|NCT01350128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636318|NCT01350128|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25636319|NCT01350128|Respiratory System Agents|respiratory system agents|mesh-ancestor
25636320|NCT01350128|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25636321|NCT01350128|Cholinergic Agents|cholinergic agents|mesh-ancestor
25636322|NCT01350128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25636323|NCT01350128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636324|NCT01350141|Bococizumab|bococizumab|mesh-list
25636325|NCT01350141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25636326|NCT01350141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25636327|NCT01350141|Antimetabolites|antimetabolites|mesh-ancestor
25636328|NCT01350141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636329|NCT01350141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25636330|NCT01350245|Mycophenolic Acid|mycophenolic acid|mesh-list
25636331|NCT01350245|Cyclophosphamide|cyclophosphamide|mesh-list
25636332|NCT01350245|Tacrolimus|tacrolimus|mesh-list
25636333|NCT01350245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25636334|NCT01350245|Immunologic Factors|immunologic factors|mesh-ancestor
25636335|NCT01350245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636336|NCT01350245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25636337|NCT01350245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25636338|NCT01350245|Alkylating Agents|alkylating agents|mesh-ancestor
25636339|NCT01350245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636340|NCT01350245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25636341|NCT01350245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25636342|NCT01350245|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25636343|NCT01350245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636344|NCT01350245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25636345|NCT01350245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25636346|NCT01350245|Antitubercular Agents|antitubercular agents|mesh-ancestor
25636347|NCT01350245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25636348|NCT01350245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25636349|NCT01350271|Mebendazole|mebendazole|mesh-list
25636350|NCT01350271|Piperazine|piperazine|mesh-list
25636351|NCT01350271|Piperazine citrate|piperazine citrate|mesh-list
25636352|NCT01350271|DMP 777|dmp 777|mesh-list
25636353|NCT01350271|Antinematodal Agents|antinematodal agents|mesh-ancestor
25636354|NCT01350271|Anthelmintics|anthelmintics|mesh-ancestor
25636355|NCT01350271|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25636356|NCT01350271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25636357|NCT01350271|Tubulin Modulators|tubulin modulators|mesh-ancestor
25636358|NCT01350271|Antimitotic Agents|antimitotic agents|mesh-ancestor
25636359|NCT01350271|Mitosis Modulators|mitosis modulators|mesh-ancestor
25636360|NCT01350271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636361|NCT01350271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25636362|NCT01350271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636363|NCT01350388|Febuxostat|febuxostat|mesh-list
25636364|NCT01350388|Gout Suppressants|gout suppressants|mesh-ancestor
25636365|NCT01350388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25636366|NCT01350804|Abatacept|abatacept|mesh-list
25636367|NCT01350804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25636368|NCT01350804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636369|NCT01350804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25636370|NCT01350804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25636371|NCT01350804|Immunologic Factors|immunologic factors|mesh-ancestor
25636372|NCT01350804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636373|NCT01350804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25636374|NCT01350947|Azacitidine|azacitidine|mesh-list
25636375|NCT01350947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25636376|NCT01350947|Antimetabolites|antimetabolites|mesh-ancestor
25636377|NCT01350947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636378|NCT01350947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25636379|NCT01350947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25656387|NCT01574651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25656388|NCT01574651|Autonomic Agents|autonomic agents|mesh-ancestor
25656389|NCT01574651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25656390|NCT01574651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656391|NCT01574651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25656392|NCT01574651|Respiratory System Agents|respiratory system agents|mesh-ancestor
25656393|NCT01574651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25656394|NCT01574651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25656395|NCT01574651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25656396|NCT01574651|Adrenergic Agents|adrenergic agents|mesh-ancestor
25531239|NCT00532493|Adrenergic Agents|adrenergic agents|mesh-ancestor
25656397|NCT01574651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25656398|NCT01574651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656399|NCT01574651|Parasympatholytics|parasympatholytics|mesh-ancestor
25636380|NCT01351025|Atorvastatin|atorvastatin|mesh-list
25636381|NCT01351025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25636382|NCT01351025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25636383|NCT01351025|Antimetabolites|antimetabolites|mesh-ancestor
25636384|NCT01351025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636385|NCT01351025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25636386|NCT01351025|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25636387|NCT01351025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636388|NCT01351090|Ketorolac|ketorolac|mesh-list
25636389|NCT01351090|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25636390|NCT01351090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25636391|NCT01351090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25636392|NCT01351090|Analgesics|analgesics|mesh-ancestor
25636393|NCT01351090|Sensory System Agents|sensory system agents|mesh-ancestor
25636394|NCT01351090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25636395|NCT01351090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636396|NCT01351090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25636397|NCT01351090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25636398|NCT01351090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25636399|NCT01351090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636400|NCT01351090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636401|NCT01351350|Paclitaxel|paclitaxel|mesh-list
25636402|NCT01351350|Trastuzumab|trastuzumab|mesh-list
25636403|NCT01351350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25636404|NCT01351350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25636405|NCT01351350|Tubulin Modulators|tubulin modulators|mesh-ancestor
25636406|NCT01351350|Antimitotic Agents|antimitotic agents|mesh-ancestor
25718344|NCT02428478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718345|NCT02428478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25718346|NCT02428478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25718347|NCT02428478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25718348|NCT02428478|Adrenergic Agents|adrenergic agents|mesh-ancestor
25636407|NCT01351350|Mitosis Modulators|mitosis modulators|mesh-ancestor
25636408|NCT01351350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636409|NCT01351350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25636410|NCT01351415|Bevacizumab|bevacizumab|mesh-list
25636411|NCT01351415|Docetaxel|docetaxel|mesh-list
25636412|NCT01351415|Pemetrexed|pemetrexed|mesh-list
25636413|NCT01351415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25636414|NCT01351415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25636415|NCT01351415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25636416|NCT01351415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25636417|NCT01351415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25636418|NCT01351415|Growth Substances|growth substances|mesh-ancestor
25636419|NCT01351415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636420|NCT01351415|Growth Inhibitors|growth inhibitors|mesh-ancestor
25636421|NCT01351415|Tubulin Modulators|tubulin modulators|mesh-ancestor
25636422|NCT01351415|Antimitotic Agents|antimitotic agents|mesh-ancestor
25636423|NCT01351415|Mitosis Modulators|mitosis modulators|mesh-ancestor
25636424|NCT01351415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636425|NCT01351415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636426|NCT01351415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25636427|NCT01351415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25636428|NCT01351415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25636429|NCT01351480|Abatacept|abatacept|mesh-list
25636430|NCT01351480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25636431|NCT01351480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636432|NCT01351480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25636433|NCT01351480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25636434|NCT01351480|Immunologic Factors|immunologic factors|mesh-ancestor
25636435|NCT01351480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636436|NCT01351480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25636437|NCT01351740|Ritonavir|ritonavir|mesh-list
25636438|NCT01351740|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25636439|NCT01351740|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25636440|NCT01351740|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25636441|NCT01351740|Protease Inhibitors|protease inhibitors|mesh-ancestor
25636442|NCT01351740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636443|NCT01351740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636444|NCT01351740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25636445|NCT01351740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25636446|NCT01351740|Antiviral Agents|antiviral agents|mesh-ancestor
25636447|NCT01351740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25636448|NCT01351740|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25636449|NCT01351740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25636450|NCT01351753|Metformin|metformin|mesh-list
25718351|NCT02428608|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25718352|NCT02428608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25777879|NCT03050398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25718353|NCT02428608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24449916|NCT00317408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25718354|NCT02428608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777880|NCT03050398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636451|NCT01351753|Topiramate|topiramate|mesh-list
25636452|NCT01351753|Orlistat|orlistat|mesh-list
25636453|NCT01351753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25531314|NCT00533429|Pemetrexed|pemetrexed|mesh-list
25636454|NCT01351753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636455|NCT01351753|Anticonvulsants|anticonvulsants|mesh-ancestor
25636456|NCT01351753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636457|NCT01351753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636458|NCT01351753|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25636459|NCT01351753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25636460|NCT01352117|Tenofovir|tenofovir|mesh-list
25636461|NCT01352117|Emtricitabine|emtricitabine|mesh-list
25636462|NCT01352117|Efavirenz|efavirenz|mesh-list
25636463|NCT01352117|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25636464|NCT01352117|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25636465|NCT01352117|Etoposide|etoposide|mesh-list
25636466|NCT01352117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25636467|NCT01352117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25636468|NCT01352117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25636469|NCT01352117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25636470|NCT01352117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636471|NCT01352117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636472|NCT01352117|Antiviral Agents|antiviral agents|mesh-ancestor
25636473|NCT01352117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25636474|NCT01352117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25636475|NCT01352117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25636476|NCT01352117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25636477|NCT01352117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25636478|NCT01352117|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25636479|NCT01352117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25636480|NCT01352117|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25636481|NCT01352117|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25636482|NCT01352117|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25636483|NCT01352117|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25636484|NCT01352182|Pioglitazone|pioglitazone|mesh-list
25636485|NCT01352182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25636486|NCT01352182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636487|NCT01352221|Ferric maltol|ferric maltol|mesh-list
25636488|NCT01352221|Hematinics|hematinics|mesh-ancestor
25636489|NCT01352507|Sildenafil Citrate|sildenafil citrate|mesh-list
25636490|NCT01352507|Tadalafil|tadalafil|mesh-list
25636491|NCT01352507|Vasodilator Agents|vasodilator agents|mesh-ancestor
25636492|NCT01352507|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25636493|NCT01352507|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25636494|NCT01352507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636495|NCT01352507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636496|NCT01352507|Urological Agents|urological agents|mesh-ancestor
25636497|NCT01352585|Anagrelide|anagrelide|mesh-list
25636498|NCT01352585|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25636499|NCT01352585|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25636500|NCT01352585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636501|NCT01352585|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25636502|NCT01352637|Cycloserine|cycloserine|mesh-list
25636503|NCT01352637|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25636504|NCT01352637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25636505|NCT01352637|Renal Agents|renal agents|mesh-ancestor
25636506|NCT01352637|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25636507|NCT01352637|Antitubercular Agents|antitubercular agents|mesh-ancestor
25636508|NCT01352637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25636509|NCT01352637|Antimetabolites|antimetabolites|mesh-ancestor
25636510|NCT01352637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636511|NCT01352715|Ritonavir|ritonavir|mesh-list
25636512|NCT01352715|Lopinavir|lopinavir|mesh-list
25636513|NCT01352715|Tenofovir|tenofovir|mesh-list
25718357|NCT02428608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718360|NCT02428699|Cod Liver Oil|cod liver oil|mesh-list
25636514|NCT01352715|Lamivudine|lamivudine|mesh-list
25636515|NCT01352715|Zidovudine|zidovudine|mesh-list
25636516|NCT01352715|Emtricitabine|emtricitabine|mesh-list
25636517|NCT01352715|Raltegravir Potassium|raltegravir potassium|mesh-list
25636518|NCT01352715|Abacavir|abacavir|mesh-list
25636519|NCT01352715|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25636520|NCT01352715|Dideoxynucleosides|dideoxynucleosides|mesh-list
25636521|NCT01352715|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25636522|NCT01352715|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25636523|NCT01352715|Protease Inhibitors|protease inhibitors|mesh-ancestor
25636524|NCT01352715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636525|NCT01352715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636526|NCT01352715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25636527|NCT01352715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25636528|NCT01352715|Antiviral Agents|antiviral agents|mesh-ancestor
25636529|NCT01352715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25636530|NCT01352715|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25636531|NCT01352715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25636532|NCT01352715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25636533|NCT01352715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25636534|NCT01352715|Antimetabolites|antimetabolites|mesh-ancestor
25636535|NCT01352715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25636536|NCT01352715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25636537|NCT01352741|Pregabalin|pregabalin|mesh-list
25636538|NCT01352741|Tapentadol|tapentadol|mesh-list
25636539|NCT01352741|Analgesics|analgesics|mesh-ancestor
25636540|NCT01352741|Sensory System Agents|sensory system agents|mesh-ancestor
25636541|NCT01352741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25636542|NCT01352741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636543|NCT01352741|Anticonvulsants|anticonvulsants|mesh-ancestor
25636544|NCT01352741|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25636545|NCT01352741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25636546|NCT01352741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636547|NCT01352741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25636548|NCT01352741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25636549|NCT01352741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25636550|NCT01352741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25636551|NCT01352741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25636552|NCT01352741|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25636553|NCT01352741|Narcotics|narcotics|mesh-ancestor
25636554|NCT01352741|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25636555|NCT01352741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25636556|NCT01352741|Adrenergic Agents|adrenergic agents|mesh-ancestor
25636557|NCT01352741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25636558|NCT01353144|Aspirin|aspirin|mesh-list
25636559|NCT01353144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25636560|NCT01353144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25636561|NCT01353144|Analgesics|analgesics|mesh-ancestor
25636562|NCT01353144|Sensory System Agents|sensory system agents|mesh-ancestor
25636563|NCT01353144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25636564|NCT01353144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636565|NCT01353144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25636566|NCT01353144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25718366|NCT02428855|Dasatinib|dasatinib|mesh-list
25718367|NCT02428855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25718368|NCT02428855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25718369|NCT02428855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718370|NCT02428855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718371|NCT02429258|Metformin|metformin|mesh-list
25718372|NCT02429258|Dapagliflozin|dapagliflozin|mesh-list
25718373|NCT02429258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25718374|NCT02429258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636567|NCT01353144|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25636568|NCT01353144|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25636569|NCT01353144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636570|NCT01353144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25636571|NCT01353144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25636572|NCT01353144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636573|NCT01353144|Antipyretics|antipyretics|mesh-ancestor
25636574|NCT01353508|Valsartan|valsartan|mesh-list
25636575|NCT01353508|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25636576|NCT01353508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25636577|NCT01353508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25636578|NCT01353508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25636579|NCT01353508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636580|NCT01353664|Romidepsin|romidepsin|mesh-list
25636581|NCT01353664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25636582|NCT01353664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25636583|NCT01353859|Methotrexate|methotrexate|mesh-list
25636584|NCT01353859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25636585|NCT01353859|Abortifacient Agents|abortifacient agents|mesh-ancestor
25636586|NCT01353859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25636587|NCT01353859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636588|NCT01353859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25636589|NCT01353859|Antimetabolites|antimetabolites|mesh-ancestor
25636590|NCT01353859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636591|NCT01353859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25636592|NCT01353859|Dermatologic Agents|dermatologic agents|mesh-ancestor
25636593|NCT01353859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636594|NCT01353859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25636595|NCT01353859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25636596|NCT01353859|Immunologic Factors|immunologic factors|mesh-ancestor
25636597|NCT01353859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25636598|NCT01353859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25636599|NCT01353911|Interferons|interferons|mesh-list
25636600|NCT01353911|Ribavirin|ribavirin|mesh-list
25636601|NCT01353911|Interferon-alpha|interferon-alpha|mesh-list
25636602|NCT01353911|Interferon alpha-2|interferon alpha-2|mesh-list
25636603|NCT01353911|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25636604|NCT01353911|Grazoprevir|grazoprevir|mesh-list
25636605|NCT01353911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25636606|NCT01353911|Antiviral Agents|antiviral agents|mesh-ancestor
25636607|NCT01353911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25636608|NCT01353911|Antimetabolites|antimetabolites|mesh-ancestor
25636609|NCT01353911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636610|NCT01353911|Immunologic Factors|immunologic factors|mesh-ancestor
25636611|NCT01353911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636612|NCT01353963|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25636613|NCT01353963|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25636614|NCT01353963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25636615|NCT01353963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25636616|NCT01353963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636617|NCT01353963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25636618|NCT01353963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636619|NCT01353963|Antidepressive Agents|antidepressive agents|mesh-ancestor
25636620|NCT01353963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25636621|NCT01353976|Econazole|econazole|mesh-list
25636622|NCT01353976|Antifungal Agents|antifungal agents|mesh-ancestor
25636623|NCT01353976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25636624|NCT01353976|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25636625|NCT01353976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25636626|NCT01353976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636627|NCT01353976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636628|NCT01353976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25636629|NCT01353976|Hormone Antagonists|hormone antagonists|mesh-ancestor
25718375|NCT02429258|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25718377|NCT02429427|Celecoxib|celecoxib|mesh-list
25636630|NCT01353976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25636631|NCT01353976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636632|NCT01354132|Acetylcysteine|acetylcysteine|mesh-list
25636633|NCT01354132|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25636634|NCT01354132|Antiviral Agents|antiviral agents|mesh-ancestor
25636635|NCT01354132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25636636|NCT01354132|Expectorants|expectorants|mesh-ancestor
25636637|NCT01354132|Respiratory System Agents|respiratory system agents|mesh-ancestor
25636638|NCT01354132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25636639|NCT01354132|Antioxidants|antioxidants|mesh-ancestor
25636640|NCT01354132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636641|NCT01354132|Protective Agents|protective agents|mesh-ancestor
25636642|NCT01354132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636643|NCT01354132|Antidotes|antidotes|mesh-ancestor
25636644|NCT01354145|Celecoxib|celecoxib|mesh-list
25636645|NCT01354145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25636646|NCT01354145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25636647|NCT01354145|Analgesics|analgesics|mesh-ancestor
25636648|NCT01354145|Sensory System Agents|sensory system agents|mesh-ancestor
25636649|NCT01354145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25636650|NCT01354145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636651|NCT01354145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25636652|NCT01354145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25636653|NCT01354145|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25636654|NCT01354145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25636655|NCT01354145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636656|NCT01354145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636657|NCT01354314|Fluconazole|fluconazole|mesh-list
25636658|NCT01354314|Paroxetine|paroxetine|mesh-list
25636659|NCT01354314|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25636660|NCT01354314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25636661|NCT01354314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25636662|NCT01354314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636663|NCT01354314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25636664|NCT01354314|Serotonin Agents|serotonin agents|mesh-ancestor
25636665|NCT01354314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636666|NCT01354314|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25636667|NCT01354314|Antidepressive Agents|antidepressive agents|mesh-ancestor
25636668|NCT01354314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25636669|NCT01354314|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25636670|NCT01354314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25636671|NCT01354314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636672|NCT01354314|Antifungal Agents|antifungal agents|mesh-ancestor
25636673|NCT01354314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25636674|NCT01354314|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25636675|NCT01354314|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25636676|NCT01354314|Hormone Antagonists|hormone antagonists|mesh-ancestor
25636677|NCT01354314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25636678|NCT01354314|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25636679|NCT01354314|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25636680|NCT01354444|Carvedilol|carvedilol|mesh-list
25636681|NCT01354444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25636682|NCT01354444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25636683|NCT01354444|Adrenergic Agents|adrenergic agents|mesh-ancestor
25636684|NCT01354444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25636685|NCT01354444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636686|NCT01354444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636687|NCT01354444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25636688|NCT01354444|Antioxidants|antioxidants|mesh-ancestor
25636689|NCT01354444|Protective Agents|protective agents|mesh-ancestor
25636690|NCT01354444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25636691|NCT01354444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25636692|NCT01354444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25636693|NCT01354444|Vasodilator Agents|vasodilator agents|mesh-ancestor
25636694|NCT01354444|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25636695|NCT01354444|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25636696|NCT01354652|Lamivudine|lamivudine|mesh-list
25636697|NCT01354652|Entecavir|entecavir|mesh-list
25636698|NCT01354652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25636699|NCT01354652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25636700|NCT01354652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636701|NCT01354652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636702|NCT01354652|Antiviral Agents|antiviral agents|mesh-ancestor
25636703|NCT01354652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25636704|NCT01354652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25636705|NCT01354652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25636706|NCT01354938|Clarithromycin|clarithromycin|mesh-list
25636707|NCT01354938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25636708|NCT01354938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25636709|NCT01354938|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25636710|NCT01354938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636711|NCT01354938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636712|NCT01354938|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25636713|NCT01354938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25636714|NCT01354964|Vitamin D|vitamin d|mesh-list
25636715|NCT01354964|Ergocalciferols|ergocalciferols|mesh-list
25636716|NCT01354964|Cholecalciferol|cholecalciferol|mesh-list
25636717|NCT01354964|Vitamins|vitamins|mesh-list
25636718|NCT01354964|Micronutrients|micronutrients|mesh-ancestor
25636719|NCT01354964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636720|NCT01354964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25636721|NCT01354964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25636722|NCT01354990|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25636723|NCT01354990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25636724|NCT01354990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636725|NCT01354990|Incretins|incretins|mesh-ancestor
25636726|NCT01354990|Hormones|hormones|mesh-ancestor
25636727|NCT01354990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25636728|NCT01354990|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25636729|NCT01354990|Protease Inhibitors|protease inhibitors|mesh-ancestor
25636730|NCT01354990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636731|NCT01354990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636732|NCT01355068|Phenytoin|phenytoin|mesh-list
25636733|NCT01355068|Anticonvulsants|anticonvulsants|mesh-ancestor
25636734|NCT01355068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25636735|NCT01355068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25636736|NCT01355068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25636737|NCT01355068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636738|NCT01355068|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25636739|NCT01355068|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25636740|NCT01355081|Vortioxetine|vortioxetine|mesh-list
25636741|NCT01355081|Antidepressive Agents|antidepressive agents|mesh-ancestor
25636742|NCT01355081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25636743|NCT01355081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25636744|NCT01355081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25636745|NCT01355081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25636746|NCT01355081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636747|NCT01355081|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25636748|NCT01355081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25636749|NCT01355081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25636750|NCT01355081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636751|NCT01355081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25636752|NCT01355081|Serotonin Agents|serotonin agents|mesh-ancestor
25636753|NCT01355081|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25636754|NCT01355081|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25636755|NCT01355081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25636756|NCT01355081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25636757|NCT01355159|Folic Acid|folic acid|mesh-list
25636758|NCT01355159|Hematinics|hematinics|mesh-ancestor
25636759|NCT01355159|Vitamin B Complex|vitamin b complex|mesh-ancestor
25636760|NCT01355159|Vitamins|vitamins|mesh-ancestor
25636761|NCT01355159|Micronutrients|micronutrients|mesh-ancestor
25636762|NCT01355159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636763|NCT01355289|Interferons|interferons|mesh-list
25636764|NCT01355289|Ribavirin|ribavirin|mesh-list
25636765|NCT01355289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25636766|NCT01355289|Antiviral Agents|antiviral agents|mesh-ancestor
25636767|NCT01355289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25636768|NCT01355289|Antimetabolites|antimetabolites|mesh-ancestor
25636769|NCT01355289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636770|NCT01355302|Cisplatin|cisplatin|mesh-list
25636771|NCT01355302|Capecitabine|capecitabine|mesh-list
25636772|NCT01355302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25636773|NCT01355302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25636774|NCT01355302|Antimetabolites|antimetabolites|mesh-ancestor
25636775|NCT01355302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636776|NCT01355523|Melatonin|melatonin|mesh-list
25636777|NCT01355523|Antioxidants|antioxidants|mesh-ancestor
25636778|NCT01355523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636779|NCT01355523|Protective Agents|protective agents|mesh-ancestor
25636780|NCT01355523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636781|NCT01355523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25636782|NCT01355575|Rifaximin|rifaximin|mesh-list
25636783|NCT01355575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25636784|NCT01355575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25636785|NCT01355575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25636786|NCT01355588|Ketorolac|ketorolac|mesh-list
25636787|NCT01355588|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25636788|NCT01355588|Lidocaine|lidocaine|mesh-list
25636789|NCT01355588|Anesthetics, Local|anesthetics, local|mesh-ancestor
25636790|NCT01355588|Anesthetics|anesthetics|mesh-ancestor
25636791|NCT01355588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25636792|NCT01355588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636793|NCT01355588|Sensory System Agents|sensory system agents|mesh-ancestor
25636794|NCT01355588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25636795|NCT01355588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25636796|NCT01355588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25636797|NCT01355588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25636798|NCT01355588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25636799|NCT01355588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636800|NCT01355588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25636801|NCT01355588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25636802|NCT01355588|Analgesics|analgesics|mesh-ancestor
25636803|NCT01355588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25636804|NCT01355588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25636805|NCT01355588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25636806|NCT01355588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636807|NCT01355705|Aspirin|aspirin|mesh-list
25636808|NCT01355705|Dexamethasone|dexamethasone|mesh-list
25636809|NCT01355705|Dexamethasone acetate|dexamethasone acetate|mesh-list
25636810|NCT01355705|Lenalidomide|lenalidomide|mesh-list
25636811|NCT01355705|Amrubicin|amrubicin|mesh-list
25636812|NCT01355705|BB 1101|bb 1101|mesh-list
25636813|NCT01355705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25636814|NCT01355705|Antiemetics|antiemetics|mesh-ancestor
25636815|NCT01355705|Autonomic Agents|autonomic agents|mesh-ancestor
25636816|NCT01355705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25636817|NCT01355705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636818|NCT01355705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25636819|NCT01355705|Glucocorticoids|glucocorticoids|mesh-ancestor
25636820|NCT01355705|Hormones|hormones|mesh-ancestor
25636821|NCT01355705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25531753|NCT00536510|Vitamins|vitamins|mesh-ancestor
25531754|NCT00536510|Micronutrients|micronutrients|mesh-ancestor
25531755|NCT00536510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531756|NCT00536575|Bortezomib|bortezomib|mesh-list
25531757|NCT00536575|Sorafenib|sorafenib|mesh-list
25531758|NCT00536575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531759|NCT00536575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25531760|NCT00536575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531761|NCT00536575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531762|NCT00536601|Cyclophosphamide|cyclophosphamide|mesh-list
25531763|NCT00536601|Melphalan|melphalan|mesh-list
25531764|NCT00536601|Busulfan|busulfan|mesh-list
25531765|NCT00536601|Thiotepa|thiotepa|mesh-list
25531766|NCT00536601|Carmustine|carmustine|mesh-list
25531767|NCT00536601|Carboplatin|carboplatin|mesh-list
25531768|NCT00536601|Etoposide|etoposide|mesh-list
25531769|NCT00536601|Etoposide phosphate|etoposide phosphate|mesh-list
25531770|NCT00536601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25531771|NCT00536601|Immunologic Factors|immunologic factors|mesh-ancestor
25531772|NCT00536601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531773|NCT00536601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25531774|NCT00536601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25531775|NCT00536601|Alkylating Agents|alkylating agents|mesh-ancestor
25531776|NCT00536601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531777|NCT00536601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531778|NCT00536601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25531779|NCT00536601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25531780|NCT00536601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25531781|NCT00536601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25531782|NCT00536601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822743|NCT00004637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040988|NCT02706795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040989|NCT02706795|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25040990|NCT02706795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25040991|NCT02706795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040992|NCT02706795|Cholinergic Agents|cholinergic agents|mesh-ancestor
25040993|NCT02706795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24954700|NCT03872661|Growth Inhibitors|growth inhibitors|mesh-ancestor
24954701|NCT03872661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124511|NCT03075579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124512|NCT03075579|Adrenergic Agents|adrenergic agents|mesh-ancestor
25124513|NCT03075579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25124514|NCT03075579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124515|NCT03075358|Lidocaine|lidocaine|mesh-list
25124516|NCT03075358|Anesthetics, Local|anesthetics, local|mesh-ancestor
25124517|NCT03075358|Anesthetics|anesthetics|mesh-ancestor
25124518|NCT03075358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25636822|NCT01355705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25636823|NCT01355705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25636824|NCT01355705|Protease Inhibitors|protease inhibitors|mesh-ancestor
25636825|NCT01355705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636826|NCT01355705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636827|NCT01355705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25636828|NCT01355705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25636829|NCT01355705|Analgesics|analgesics|mesh-ancestor
25636830|NCT01355705|Sensory System Agents|sensory system agents|mesh-ancestor
25636831|NCT01355705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25636832|NCT01355705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25636833|NCT01355705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25636834|NCT01355705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25636835|NCT01355705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25636836|NCT01355705|Antipyretics|antipyretics|mesh-ancestor
25636837|NCT01355705|Immunologic Factors|immunologic factors|mesh-ancestor
25636838|NCT01355705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25636839|NCT01355705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25636840|NCT01355705|Growth Substances|growth substances|mesh-ancestor
25636841|NCT01355705|Growth Inhibitors|growth inhibitors|mesh-ancestor
25636842|NCT01356407|Picosulfate sodium|picosulfate sodium|mesh-list
25636843|NCT01356407|Cathartics|cathartics|mesh-ancestor
25636844|NCT01356407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25636845|NCT01356602|Triamcinolone|triamcinolone|mesh-list
25636846|NCT01356602|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25636847|NCT01356602|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25636848|NCT01356602|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25636849|NCT01356602|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25636850|NCT01356602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25636851|NCT01356602|Glucocorticoids|glucocorticoids|mesh-ancestor
25636852|NCT01356602|Hormones|hormones|mesh-ancestor
25636853|NCT01356602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25636854|NCT01356602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636855|NCT01356602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25636856|NCT01356602|Immunologic Factors|immunologic factors|mesh-ancestor
25636857|NCT01356602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636858|NCT01356602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636859|NCT01356628|Palbociclib|palbociclib|mesh-list
25636860|NCT01356628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25636861|NCT01356628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25636862|NCT01356628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636863|NCT01356628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636864|NCT01356940|4-Aminopyridine|4-aminopyridine|mesh-list
25636865|NCT01356940|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25636866|NCT01356940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25636867|NCT01356940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636868|NCT01356966|Folic Acid|folic acid|mesh-list
25636869|NCT01356966|Hematinics|hematinics|mesh-ancestor
25636870|NCT01356966|Vitamin B Complex|vitamin b complex|mesh-ancestor
25636871|NCT01356966|Vitamins|vitamins|mesh-ancestor
25636872|NCT01356966|Micronutrients|micronutrients|mesh-ancestor
25636873|NCT01356966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636874|NCT01357135|Metformin|metformin|mesh-list
25636875|NCT01357135|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25636876|NCT01357135|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25636877|NCT01357135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636878|NCT01357135|Incretins|incretins|mesh-ancestor
25636879|NCT01357135|Hormones|hormones|mesh-ancestor
25636880|NCT01357135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25636881|NCT01357135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25636882|NCT01357135|Protease Inhibitors|protease inhibitors|mesh-ancestor
25636883|NCT01357135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636884|NCT01357135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636885|NCT01357148|Metformin|metformin|mesh-list
25636886|NCT01357148|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25636887|NCT01357148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25636888|NCT01357148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636889|NCT01357148|Incretins|incretins|mesh-ancestor
25636890|NCT01357148|Hormones|hormones|mesh-ancestor
25636891|NCT01357148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25636892|NCT01357148|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25636893|NCT01357148|Protease Inhibitors|protease inhibitors|mesh-ancestor
25636894|NCT01357148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636895|NCT01357148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636896|NCT01357161|Paclitaxel|paclitaxel|mesh-list
25636897|NCT01357161|Carboplatin|carboplatin|mesh-list
25636898|NCT01357161|Adavosertib|adavosertib|mesh-list
25636899|NCT01357161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25636900|NCT01357161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25636901|NCT01357161|Tubulin Modulators|tubulin modulators|mesh-ancestor
25636902|NCT01357161|Antimitotic Agents|antimitotic agents|mesh-ancestor
25636903|NCT01357161|Mitosis Modulators|mitosis modulators|mesh-ancestor
25636904|NCT01357161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636905|NCT01357161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636906|NCT01357616|Timolol|timolol|mesh-list
25636907|NCT01357616|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25636908|NCT01357616|Brinzolamide|brinzolamide|mesh-list
25636909|NCT01357616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25636910|NCT01357616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25636911|NCT01357616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25636912|NCT01357616|Adrenergic Agents|adrenergic agents|mesh-ancestor
25636913|NCT01357616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25636914|NCT01357616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636915|NCT01357616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636916|NCT01357616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25636917|NCT01357616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25636918|NCT01357616|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25636919|NCT01357616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636920|NCT01357655|Dasatinib|dasatinib|mesh-list
25636921|NCT01357655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25636922|NCT01357655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25531783|NCT00536731|Budesonide|budesonide|mesh-list
25636923|NCT01357655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25636924|NCT01357655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656400|NCT01574651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25656401|NCT01574651|Cholinergic Agents|cholinergic agents|mesh-ancestor
25656402|NCT01574651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25656403|NCT01574651|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25656404|NCT01574703|Bupropion|bupropion|mesh-list
25656405|NCT01574703|Nicotine|nicotine|mesh-list
25656406|NCT01574703|Varenicline|varenicline|mesh-list
25656407|NCT01574703|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25656408|NCT01574703|Autonomic Agents|autonomic agents|mesh-ancestor
25656409|NCT01574703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25656410|NCT01574703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656411|NCT01574703|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25656412|NCT01574703|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25656413|NCT01574703|Cholinergic Agents|cholinergic agents|mesh-ancestor
25656414|NCT01574703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25656415|NCT01574703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656416|NCT01574703|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25656417|NCT01574703|Antidepressive Agents|antidepressive agents|mesh-ancestor
25656418|NCT01574703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25656419|NCT01574703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25656420|NCT01574703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25656421|NCT01574703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25656422|NCT01574703|Dopamine Agents|dopamine agents|mesh-ancestor
25656423|NCT01574703|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25656424|NCT01574703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25656425|NCT01574703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25656426|NCT01574716|Gemcitabine|gemcitabine|mesh-list
25656427|NCT01574716|Docetaxel|docetaxel|mesh-list
25656428|NCT01574716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25656429|NCT01574716|Antimetabolites|antimetabolites|mesh-ancestor
25656430|NCT01574716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656431|NCT01574716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656432|NCT01574716|Antiviral Agents|antiviral agents|mesh-ancestor
25656433|NCT01574716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25656434|NCT01574716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25656435|NCT01574716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25656436|NCT01574716|Immunologic Factors|immunologic factors|mesh-ancestor
25656437|NCT01574716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656438|NCT01574716|Tubulin Modulators|tubulin modulators|mesh-ancestor
25656439|NCT01574716|Antimitotic Agents|antimitotic agents|mesh-ancestor
25656440|NCT01574716|Mitosis Modulators|mitosis modulators|mesh-ancestor
25656441|NCT01574807|Lidocaine|lidocaine|mesh-list
25656442|NCT01574807|Mepivacaine|mepivacaine|mesh-list
25656443|NCT01574807|Anesthetics, Local|anesthetics, local|mesh-ancestor
25656444|NCT01574807|Anesthetics|anesthetics|mesh-ancestor
25656445|NCT01574807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25656446|NCT01574807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656447|NCT01574807|Sensory System Agents|sensory system agents|mesh-ancestor
25656448|NCT01574807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25656449|NCT01574807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25656450|NCT01574807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25656451|NCT01574807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25656452|NCT01574807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25656453|NCT01574807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656454|NCT01575054|Botulinum Toxins|botulinum toxins|mesh-list
25656455|NCT01575054|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25656456|NCT01575054|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25656457|NCT01575054|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25656458|NCT01575054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25656459|NCT01575054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656460|NCT01575054|Cholinergic Agents|cholinergic agents|mesh-ancestor
25656461|NCT01575054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25656462|NCT01575054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656463|NCT01575054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25656464|NCT01575054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25656465|NCT01575275|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25656466|NCT01575275|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25656467|NCT01575275|Dermatologic Agents|dermatologic agents|mesh-ancestor
25656468|NCT01575561|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25656469|NCT01575561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25656470|NCT01575561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25656471|NCT01575561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25822744|NCT00004637|Protective Agents|protective agents|mesh-ancestor
25636925|NCT01357889|rGLP-1 protein|rglp-1 protein|mesh-list
25636926|NCT01357889|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25636927|NCT01357889|Incretins|incretins|mesh-ancestor
25636928|NCT01357889|Hormones|hormones|mesh-ancestor
25636929|NCT01357889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25636930|NCT01357889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636931|NCT01358175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25636932|NCT01358175|Immunologic Factors|immunologic factors|mesh-ancestor
25636933|NCT01358175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636934|NCT01358266|Sirolimus|sirolimus|mesh-list
25636935|NCT01358266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25636936|NCT01358266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25636937|NCT01358266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25636938|NCT01358266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25636939|NCT01358266|Antifungal Agents|antifungal agents|mesh-ancestor
25636940|NCT01358266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25636941|NCT01358266|Immunologic Factors|immunologic factors|mesh-ancestor
25636942|NCT01358266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636943|NCT01358357|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25636944|NCT01358357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25636945|NCT01358357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25636946|NCT01358357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25636947|NCT01358357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636948|NCT01358357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25636949|NCT01358357|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25636950|NCT01358357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25636951|NCT01358357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25636952|NCT01358357|Adrenergic Agents|adrenergic agents|mesh-ancestor
25636953|NCT01358357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25636954|NCT01358357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636955|NCT01358357|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25636956|NCT01358357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25636957|NCT01358357|Serotonin Agents|serotonin agents|mesh-ancestor
25636958|NCT01358357|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25636959|NCT01358357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25636960|NCT01358357|Dopamine Agents|dopamine agents|mesh-ancestor
25636961|NCT01358526|Oxycodone|oxycodone|mesh-list
25636962|NCT01358526|Naloxone|naloxone|mesh-list
25636963|NCT01358526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25636964|NCT01358526|Narcotics|narcotics|mesh-ancestor
25636965|NCT01358526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25636966|NCT01358526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636967|NCT01358526|Analgesics|analgesics|mesh-ancestor
25636968|NCT01358526|Sensory System Agents|sensory system agents|mesh-ancestor
25636969|NCT01358526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25636970|NCT01358526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25636971|NCT01358578|Etanercept|etanercept|mesh-list
25636972|NCT01358578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25636973|NCT01358578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25636974|NCT01358578|Analgesics|analgesics|mesh-ancestor
25636975|NCT01358578|Sensory System Agents|sensory system agents|mesh-ancestor
25636976|NCT01358578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25636977|NCT01358578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636978|NCT01358578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25636979|NCT01358578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25636980|NCT01358578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25636981|NCT01358578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25636982|NCT01358578|Immunologic Factors|immunologic factors|mesh-ancestor
25636983|NCT01358721|Nivolumab|nivolumab|mesh-list
25636984|NCT01358721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25636985|NCT01358721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25636986|NCT01358721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25636987|NCT01358721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25636988|NCT01358734|Lenalidomide|lenalidomide|mesh-list
25636989|NCT01358734|Azacitidine|azacitidine|mesh-list
25636990|NCT01358734|Immunologic Factors|immunologic factors|mesh-ancestor
25636991|NCT01358734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25636992|NCT01358734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25636993|NCT01358734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25636994|NCT01358734|Growth Substances|growth substances|mesh-ancestor
25636995|NCT01358734|Growth Inhibitors|growth inhibitors|mesh-ancestor
25636996|NCT01358734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25636997|NCT01358734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25636998|NCT01358734|Antimetabolites|antimetabolites|mesh-ancestor
25531928|NCT00537290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25636999|NCT01358734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637000|NCT01358734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25637001|NCT01358760|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25637002|NCT01358760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25637003|NCT01358760|Immunologic Factors|immunologic factors|mesh-ancestor
25637004|NCT01358760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637005|NCT01358864|Interferons|interferons|mesh-list
25637006|NCT01358864|Ribavirin|ribavirin|mesh-list
25637007|NCT01358864|Interferon-alpha|interferon-alpha|mesh-list
25637008|NCT01358864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25637009|NCT01358864|Antiviral Agents|antiviral agents|mesh-ancestor
25637010|NCT01358864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25637011|NCT01358864|Antimetabolites|antimetabolites|mesh-ancestor
25637012|NCT01358864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637013|NCT01358864|Immunologic Factors|immunologic factors|mesh-ancestor
25637014|NCT01358864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637015|NCT01358968|Gemcitabine|gemcitabine|mesh-list
25637016|NCT01358968|Pemetrexed|pemetrexed|mesh-list
25637017|NCT01358968|Desipramine|desipramine|mesh-list
25637018|NCT01358968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25637019|NCT01358968|Antimetabolites|antimetabolites|mesh-ancestor
25637020|NCT01358968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637021|NCT01358968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25637022|NCT01358968|Antiviral Agents|antiviral agents|mesh-ancestor
25637023|NCT01358968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25637024|NCT01358968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25637025|NCT01358968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25637026|NCT01358968|Immunologic Factors|immunologic factors|mesh-ancestor
25637027|NCT01358968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637028|NCT01358968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25637029|NCT01358968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25637030|NCT01358968|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25637031|NCT01358968|Antidepressive Agents|antidepressive agents|mesh-ancestor
25637032|NCT01358968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25637033|NCT01358968|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25637034|NCT01358968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25637035|NCT01358968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25637036|NCT01358968|Adrenergic Agents|adrenergic agents|mesh-ancestor
25637037|NCT01358968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25637038|NCT01359007|Leucovorin|leucovorin|mesh-list
25637039|NCT01359007|Oxaliplatin|oxaliplatin|mesh-list
25637040|NCT01359007|Irinotecan|irinotecan|mesh-list
25637041|NCT01359007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25637042|NCT01359007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25637043|NCT01359007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25637044|NCT01359007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25637045|NCT01359007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637046|NCT01359007|Antidotes|antidotes|mesh-ancestor
25637047|NCT01359007|Protective Agents|protective agents|mesh-ancestor
25637048|NCT01359007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637049|NCT01359007|Vitamin B Complex|vitamin b complex|mesh-ancestor
25637050|NCT01359007|Vitamins|vitamins|mesh-ancestor
25637051|NCT01359007|Micronutrients|micronutrients|mesh-ancestor
25637052|NCT01359150|Tofacitinib|tofacitinib|mesh-list
25637053|NCT01359150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25637054|NCT01359150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25637055|NCT01359150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637056|NCT01359644|Ribavirin|ribavirin|mesh-list
25637057|NCT01359644|Sofosbuvir|sofosbuvir|mesh-list
25637058|NCT01359644|Antimetabolites|antimetabolites|mesh-ancestor
25637059|NCT01359644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637060|NCT01359644|Antiviral Agents|antiviral agents|mesh-ancestor
25637061|NCT01359644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25637062|NCT01359735|Bacitracin|bacitracin|mesh-list
25637063|NCT01359735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25637064|NCT01359735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25637065|NCT01359735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25637066|NCT01359904|Dialysis Solutions|dialysis solutions|mesh-list
25637067|NCT01359904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25637068|NCT01359956|Interferons|interferons|mesh-list
25637069|NCT01359956|Interferon-alpha|interferon-alpha|mesh-list
25637070|NCT01359956|Interferon alpha-2|interferon alpha-2|mesh-list
25637071|NCT01359956|Dacarbazine|dacarbazine|mesh-list
25637072|NCT01359956|Fotemustine|fotemustine|mesh-list
25637073|NCT01359956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25637074|NCT01359956|Antiviral Agents|antiviral agents|mesh-ancestor
25637075|NCT01359956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25637076|NCT01359956|Immunologic Factors|immunologic factors|mesh-ancestor
25637077|NCT01359956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637078|NCT01359956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25637079|NCT01359956|Alkylating Agents|alkylating agents|mesh-ancestor
25637080|NCT01359956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637081|NCT01360021|Budesonide|budesonide|mesh-list
25637082|NCT01360021|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25637083|NCT01360021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25637084|NCT01360021|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25637085|NCT01360021|Autonomic Agents|autonomic agents|mesh-ancestor
25637086|NCT01360021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25637087|NCT01360021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637088|NCT01360021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25637089|NCT01360021|Respiratory System Agents|respiratory system agents|mesh-ancestor
25637090|NCT01360021|Glucocorticoids|glucocorticoids|mesh-ancestor
25637091|NCT01360021|Hormones|hormones|mesh-ancestor
25637092|NCT01360021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25637093|NCT01360450|Clonidine|clonidine|mesh-list
25637094|NCT01360450|Analgesics|analgesics|mesh-ancestor
25637095|NCT01360450|Sensory System Agents|sensory system agents|mesh-ancestor
25637096|NCT01360450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25637097|NCT01360450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718433|NCT02430389|Analgesics|analgesics|mesh-ancestor
25637098|NCT01360450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25637099|NCT01360450|Sympatholytics|sympatholytics|mesh-ancestor
25637100|NCT01360450|Autonomic Agents|autonomic agents|mesh-ancestor
25637101|NCT01360450|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25637102|NCT01360450|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25637103|NCT01360450|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25637104|NCT01360450|Adrenergic Agents|adrenergic agents|mesh-ancestor
25637105|NCT01360450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25637106|NCT01360450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637107|NCT01360554|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25637108|NCT01360554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25637109|NCT01360554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25637110|NCT01360554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25637111|NCT01360554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637112|NCT01360762|Pentamidine|pentamidine|mesh-list
25637113|NCT01360762|Antifungal Agents|antifungal agents|mesh-ancestor
25637114|NCT01360762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25637115|NCT01360762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25637116|NCT01360762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25637117|NCT01360762|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25637118|NCT01360866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25637119|NCT01360866|Citalopram|citalopram|mesh-list
25637120|NCT01360866|Fluoxetine|fluoxetine|mesh-list
25637121|NCT01360866|Paroxetine|paroxetine|mesh-list
25637122|NCT01360866|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25637123|NCT01360866|Sertraline|sertraline|mesh-list
25637124|NCT01360866|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25637125|NCT01360866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25637126|NCT01360866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25637127|NCT01360866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637128|NCT01360866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25637129|NCT01360866|Serotonin Agents|serotonin agents|mesh-ancestor
25637130|NCT01360866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637131|NCT01360866|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25637132|NCT01360866|Antidepressive Agents|antidepressive agents|mesh-ancestor
25637133|NCT01360866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25637134|NCT01360866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25637135|NCT01360866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25637136|NCT01360866|Analgesics|analgesics|mesh-ancestor
25637137|NCT01360866|Sensory System Agents|sensory system agents|mesh-ancestor
25637138|NCT01360866|Dopamine Agents|dopamine agents|mesh-ancestor
25637139|NCT01360866|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25637140|NCT01360866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25637141|NCT01360866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25637142|NCT01360996|Contraceptive Agents|contraceptive agents|mesh-list
25637143|NCT01360996|Contraceptives, Oral|contraceptives, oral|mesh-list
25637144|NCT01360996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25637145|NCT01360996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637146|NCT01360996|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25637147|NCT01361009|Pramipexole|pramipexole|mesh-list
25637148|NCT01361009|Antioxidants|antioxidants|mesh-ancestor
25637149|NCT01361009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718442|NCT02430818|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25718443|NCT02430818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25718444|NCT02430818|Anesthetics, General|anesthetics, general|mesh-ancestor
25718445|NCT02430818|Anesthetics|anesthetics|mesh-ancestor
25718446|NCT02430818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25718447|NCT02430818|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25718448|NCT02430818|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25718449|NCT02430818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25637150|NCT01361009|Protective Agents|protective agents|mesh-ancestor
25637151|NCT01361009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637152|NCT01361009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25637153|NCT01361009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25637154|NCT01361009|Dopamine Agonists|dopamine agonists|mesh-ancestor
25637155|NCT01361009|Dopamine Agents|dopamine agents|mesh-ancestor
25637156|NCT01361009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25637157|NCT01361048|Metronidazole|metronidazole|mesh-list
25637158|NCT01361048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25637159|NCT01361048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25637160|NCT01361048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25637161|NCT01361048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25637162|NCT01361217|Midazolam|midazolam|mesh-list
25637163|NCT01361217|Dextromethorphan|dextromethorphan|mesh-list
25637164|NCT01361217|Caffeine|caffeine|mesh-list
25637165|NCT01361217|Fluoxetine|fluoxetine|mesh-list
25637166|NCT01361217|Omeprazole|omeprazole|mesh-list
25637167|NCT01361217|Lovastatin|lovastatin|mesh-list
25637168|NCT01361217|L 647318|l 647318|mesh-list
25637169|NCT01361217|Dihydromevinolin|dihydromevinolin|mesh-list
25637170|NCT01361217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25637171|NCT01361217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25637172|NCT01361217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25637173|NCT01361217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637174|NCT01361217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25637175|NCT01361217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25637176|NCT01361217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25637177|NCT01361217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25637178|NCT01361217|Anesthetics, General|anesthetics, general|mesh-ancestor
25637179|NCT01361217|Anesthetics|anesthetics|mesh-ancestor
25637180|NCT01361217|GABA Modulators|gaba modulators|mesh-ancestor
25637181|NCT01361217|GABA Agents|gaba agents|mesh-ancestor
25637182|NCT01361217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25637183|NCT01361217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637184|NCT01361217|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25637185|NCT01361217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25637186|NCT01361217|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25637187|NCT01361217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25637188|NCT01361217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25637189|NCT01361217|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25637190|NCT01361217|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25637191|NCT01361217|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25637192|NCT01361217|Purinergic Agents|purinergic agents|mesh-ancestor
25637193|NCT01361217|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25637194|NCT01361217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25637195|NCT01361217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25637196|NCT01361217|Serotonin Agents|serotonin agents|mesh-ancestor
25637197|NCT01361217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25637198|NCT01361217|Antidepressive Agents|antidepressive agents|mesh-ancestor
25637199|NCT01361217|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25637200|NCT01361217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25637201|NCT01361217|Antitussive Agents|antitussive agents|mesh-ancestor
25637202|NCT01361217|Respiratory System Agents|respiratory system agents|mesh-ancestor
25637203|NCT01361217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25637204|NCT01361217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25637205|NCT01361217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25637206|NCT01361217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25637207|NCT01361217|Antimetabolites|antimetabolites|mesh-ancestor
25637208|NCT01361217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25637209|NCT01361217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25637210|NCT01361308|Paroxetine|paroxetine|mesh-list
25637211|NCT01361308|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25637212|NCT01361308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25637213|NCT01361308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25637214|NCT01361308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637215|NCT01361308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25637216|NCT01361308|Serotonin Agents|serotonin agents|mesh-ancestor
25777894|NCT03031340|Pregabalin|pregabalin|mesh-list
25637217|NCT01361308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637218|NCT01361308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25637219|NCT01361308|Antidepressive Agents|antidepressive agents|mesh-ancestor
25637220|NCT01361308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25637221|NCT01361308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25637222|NCT01361308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25637223|NCT01361308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25637224|NCT01361464|Tipifarnib|tipifarnib|mesh-list
25637225|NCT01361464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25637226|NCT01361594|Insulin|insulin|mesh-list
25637227|NCT01361594|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25637228|NCT01361594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25637229|NCT01361594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637230|NCT01361607|Nabiximols|nabiximols|mesh-list
25637231|NCT01361607|Analgesics|analgesics|mesh-ancestor
25637232|NCT01361607|Sensory System Agents|sensory system agents|mesh-ancestor
25637233|NCT01361607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25637234|NCT01361607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637235|NCT01361620|Aspirin|aspirin|mesh-list
25637236|NCT01361620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25637237|NCT01361620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25637238|NCT01361620|Analgesics|analgesics|mesh-ancestor
25637239|NCT01361620|Sensory System Agents|sensory system agents|mesh-ancestor
25637240|NCT01361620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25637241|NCT01361620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637242|NCT01361620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25637243|NCT01361620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25637244|NCT01361620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25637245|NCT01361620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25637246|NCT01361620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637247|NCT01361620|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25637248|NCT01361620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25637249|NCT01361620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25637250|NCT01361620|Antipyretics|antipyretics|mesh-ancestor
25637251|NCT01361633|Cycloserine|cycloserine|mesh-list
25637252|NCT01361633|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25637253|NCT01361633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25637254|NCT01361633|Renal Agents|renal agents|mesh-ancestor
25637255|NCT01361633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25637256|NCT01361633|Antitubercular Agents|antitubercular agents|mesh-ancestor
25637257|NCT01361633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25637258|NCT01361633|Antimetabolites|antimetabolites|mesh-ancestor
25637259|NCT01361633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637260|NCT01361711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25637261|NCT01361711|Alemtuzumab|alemtuzumab|mesh-list
25637262|NCT01361711|Ofatumumab|ofatumumab|mesh-list
25637263|NCT01361711|Antibodies|antibodies|mesh-list
25637264|NCT01361711|Immunoglobulins|immunoglobulins|mesh-list
25637265|NCT01361711|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25637266|NCT01361711|Immunologic Factors|immunologic factors|mesh-ancestor
25637267|NCT01361711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637268|NCT01361711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25637269|NCT01362127|Cisplatin|cisplatin|mesh-list
25637270|NCT01362127|Carboplatin|carboplatin|mesh-list
25637271|NCT01362127|Oxaliplatin|oxaliplatin|mesh-list
25637272|NCT01362127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25637273|NCT01362140|Darbepoetin alfa|darbepoetin alfa|mesh-list
25637274|NCT01362140|Hematinics|hematinics|mesh-ancestor
25637275|NCT01362192|Chlorhexidine|chlorhexidine|mesh-list
25637276|NCT01362192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25637277|NCT01362192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25637278|NCT01362192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25637279|NCT01362192|Disinfectants|disinfectants|mesh-ancestor
25637280|NCT01362192|Dermatologic Agents|dermatologic agents|mesh-ancestor
25637281|NCT01362205|Dexmedetomidine|dexmedetomidine|mesh-list
25637282|NCT01362205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25637283|NCT01362205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25637284|NCT01362205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637285|NCT01362205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25637286|NCT01362205|Analgesics|analgesics|mesh-ancestor
25637287|NCT01362205|Sensory System Agents|sensory system agents|mesh-ancestor
25637288|NCT01362205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25637289|NCT01362205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25637290|NCT01362205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25637291|NCT01362205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25637292|NCT01362205|Adrenergic Agents|adrenergic agents|mesh-ancestor
25637293|NCT01362205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25637294|NCT01362205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637295|NCT01362296|Docetaxel|docetaxel|mesh-list
25637296|NCT01362296|Trametinib|trametinib|mesh-list
25637297|NCT01362296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25637298|NCT01362296|Tubulin Modulators|tubulin modulators|mesh-ancestor
25637299|NCT01362296|Antimitotic Agents|antimitotic agents|mesh-ancestor
25637300|NCT01362296|Mitosis Modulators|mitosis modulators|mesh-ancestor
25656472|NCT01575561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532240|NCT00539006|Xhance|xhance|mesh-list
25637301|NCT01362296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637302|NCT01362296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25637303|NCT01362296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25637304|NCT01362348|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25637305|NCT01362348|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25637306|NCT01362439|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25637307|NCT01362439|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25637308|NCT01362439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25637309|NCT01362439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25637310|NCT01362439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637311|NCT01362439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25637312|NCT01362439|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25637313|NCT01362439|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25637314|NCT01362439|Serotonin Agents|serotonin agents|mesh-ancestor
25637315|NCT01362439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25637316|NCT01362439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637317|NCT01362439|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25637318|NCT01362439|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25637319|NCT01362439|Dopamine Agents|dopamine agents|mesh-ancestor
25637321|NCT01362491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25637322|NCT01362491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25637323|NCT01362491|Analgesics|analgesics|mesh-ancestor
25637324|NCT01362491|Sensory System Agents|sensory system agents|mesh-ancestor
25637325|NCT01362491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25637326|NCT01362491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637327|NCT01362491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25637328|NCT01362491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25637329|NCT01362491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25637330|NCT01362491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25637331|NCT01362491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637332|NCT01362530|Ondansetron|ondansetron|mesh-list
25637333|NCT01362530|Aprepitant|aprepitant|mesh-list
25637334|NCT01362530|Fosaprepitant|fosaprepitant|mesh-list
25637335|NCT01362530|Antiemetics|antiemetics|mesh-ancestor
25637336|NCT01362530|Autonomic Agents|autonomic agents|mesh-ancestor
25637337|NCT01362530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25637338|NCT01362530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637339|NCT01362530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25637340|NCT01362530|Antipruritics|antipruritics|mesh-ancestor
25637341|NCT01362530|Dermatologic Agents|dermatologic agents|mesh-ancestor
25637342|NCT01362530|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25637343|NCT01362530|Serotonin Agents|serotonin agents|mesh-ancestor
25637344|NCT01362530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25637345|NCT01362530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637346|NCT01362530|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25637347|NCT01362530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25637348|NCT01362530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25637349|NCT01362530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25637350|NCT01362530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25637351|NCT01362530|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25637352|NCT01362608|Triamcinolone|triamcinolone|mesh-list
25637353|NCT01362608|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25637354|NCT01362608|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25637355|NCT01362608|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25718453|NCT02431260|INCB054329|incb054329|mesh-list
25637356|NCT01362608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25637357|NCT01362608|Glucocorticoids|glucocorticoids|mesh-ancestor
25637358|NCT01362608|Hormones|hormones|mesh-ancestor
25637359|NCT01362608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25637360|NCT01362608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637361|NCT01362608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25637362|NCT01362608|Immunologic Factors|immunologic factors|mesh-ancestor
25637363|NCT01362608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25637364|NCT01362608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637365|NCT01362686|Rivastigmine|rivastigmine|mesh-list
25637366|NCT01362686|Donepezil|donepezil|mesh-list
25637367|NCT01362686|Galantamine|galantamine|mesh-list
25637368|NCT01362686|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25637369|NCT01362686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25637370|NCT01362686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637371|NCT01362686|Cholinergic Agents|cholinergic agents|mesh-ancestor
25637372|NCT01362686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25637373|NCT01362686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637374|NCT01362686|Nootropic Agents|nootropic agents|mesh-ancestor
25637375|NCT01362686|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25637376|NCT01362686|Autonomic Agents|autonomic agents|mesh-ancestor
25637377|NCT01362686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25637378|NCT01362686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25637379|NCT01362686|Protective Agents|protective agents|mesh-ancestor
25637380|NCT01362790|Cyclophosphamide|cyclophosphamide|mesh-list
25637381|NCT01362790|Pentostatin|pentostatin|mesh-list
25637382|NCT01362790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25637383|NCT01362790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25637384|NCT01362790|Immunologic Factors|immunologic factors|mesh-ancestor
25637385|NCT01362790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637386|NCT01362790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25637387|NCT01362790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25637388|NCT01362790|Alkylating Agents|alkylating agents|mesh-ancestor
25637389|NCT01362790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637390|NCT01362790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25637391|NCT01362790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25637392|NCT01362790|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25637393|NCT01362790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25637394|NCT01362959|Nicotine|nicotine|mesh-list
25637395|NCT01362959|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25637396|NCT01362959|Autonomic Agents|autonomic agents|mesh-ancestor
25637397|NCT01362959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25637398|NCT01362959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637399|NCT01362959|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25637400|NCT01362959|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25637401|NCT01362959|Cholinergic Agents|cholinergic agents|mesh-ancestor
25637402|NCT01362959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25637403|NCT01362959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637404|NCT01363011|Darunavir|darunavir|mesh-list
25637405|NCT01363011|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25637406|NCT01363011|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24450114|NCT00317798|Sirolimus|sirolimus|mesh-list
25637407|NCT01363011|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25637408|NCT01363011|Protease Inhibitors|protease inhibitors|mesh-ancestor
25637409|NCT01363011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25637410|NCT01363011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637411|NCT01363011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25637412|NCT01363011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25637413|NCT01363011|Antiviral Agents|antiviral agents|mesh-ancestor
25637414|NCT01363011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25637415|NCT01363050|Ketorolac|ketorolac|mesh-list
25637416|NCT01363050|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25637417|NCT01363050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25637418|NCT01363050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25637419|NCT01363050|Analgesics|analgesics|mesh-ancestor
25637420|NCT01363050|Sensory System Agents|sensory system agents|mesh-ancestor
25637421|NCT01363050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25637422|NCT01363050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637423|NCT01363050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25637424|NCT01363050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25637425|NCT01363050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25637426|NCT01363050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25637427|NCT01363050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637428|NCT01363076|Ketorolac|ketorolac|mesh-list
25637429|NCT01363076|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25637430|NCT01363076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25637431|NCT01363076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25637432|NCT01363076|Analgesics|analgesics|mesh-ancestor
25637433|NCT01363076|Sensory System Agents|sensory system agents|mesh-ancestor
25637434|NCT01363076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25637435|NCT01363076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637436|NCT01363076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25637437|NCT01363076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25637438|NCT01363076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25637439|NCT01363076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25637440|NCT01363076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637441|NCT01363128|Cytarabine|cytarabine|mesh-list
25637442|NCT01363128|Dexamethasone|dexamethasone|mesh-list
25637443|NCT01363128|Dexamethasone acetate|dexamethasone acetate|mesh-list
25637444|NCT01363128|Cyclophosphamide|cyclophosphamide|mesh-list
25637445|NCT01363128|Doxorubicin|doxorubicin|mesh-list
25637446|NCT01363128|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25637447|NCT01363128|Methotrexate|methotrexate|mesh-list
25637448|NCT01363128|Vincristine|vincristine|mesh-list
25637449|NCT01363128|Ofatumumab|ofatumumab|mesh-list
25637450|NCT01363128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25637451|NCT01363128|BB 1101|bb 1101|mesh-list
25637452|NCT01363128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25637453|NCT01363128|Immunologic Factors|immunologic factors|mesh-ancestor
25637454|NCT01363128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637455|NCT01363128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25637456|NCT01363128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25637457|NCT01363128|Alkylating Agents|alkylating agents|mesh-ancestor
25637458|NCT01363128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637459|NCT01363128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25637460|NCT01363128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25637461|NCT01363128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25637462|NCT01363128|Antiemetics|antiemetics|mesh-ancestor
25637463|NCT01363128|Autonomic Agents|autonomic agents|mesh-ancestor
25637464|NCT01363128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25637465|NCT01363128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25637466|NCT01363128|Glucocorticoids|glucocorticoids|mesh-ancestor
25637467|NCT01363128|Hormones|hormones|mesh-ancestor
25637468|NCT01363128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25637469|NCT01363128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25637470|NCT01363128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25637471|NCT01363128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25637472|NCT01363128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25637473|NCT01363128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25637474|NCT01363128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25637475|NCT01363128|Abortifacient Agents|abortifacient agents|mesh-ancestor
25637476|NCT01363128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25637477|NCT01363128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25637478|NCT01363128|Antimetabolites|antimetabolites|mesh-ancestor
25637479|NCT01363128|Dermatologic Agents|dermatologic agents|mesh-ancestor
25637480|NCT01363128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25637481|NCT01363128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25637482|NCT01363128|Antiviral Agents|antiviral agents|mesh-ancestor
25637483|NCT01363128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25637484|NCT01363128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25637485|NCT01363128|Tubulin Modulators|tubulin modulators|mesh-ancestor
25637486|NCT01363128|Antimitotic Agents|antimitotic agents|mesh-ancestor
25637487|NCT01363128|Mitosis Modulators|mitosis modulators|mesh-ancestor
25637488|NCT01363128|Protease Inhibitors|protease inhibitors|mesh-ancestor
25637489|NCT01363297|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25637490|NCT01363297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25637491|NCT01363297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25637492|NCT01363297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25637493|NCT01363349|Risperidone|risperidone|mesh-list
25637494|NCT01363349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25637495|NCT01363349|Serotonin Agents|serotonin agents|mesh-ancestor
25637496|NCT01363349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25637497|NCT01363349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637498|NCT01363349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637499|NCT01363349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25637500|NCT01363349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25637501|NCT01363349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25637502|NCT01363349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25637503|NCT01363349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25637504|NCT01363349|Dopamine Agents|dopamine agents|mesh-ancestor
25637505|NCT01363440|Aflibercept|aflibercept|mesh-list
25637506|NCT01363440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25637507|NCT01363440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25637508|NCT01363440|Growth Substances|growth substances|mesh-ancestor
25637509|NCT01363440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637510|NCT01363440|Growth Inhibitors|growth inhibitors|mesh-ancestor
25637511|NCT01363440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25637512|NCT01363479|Dexamethasone|dexamethasone|mesh-list
25637513|NCT01363479|Palonosetron|palonosetron|mesh-list
25637514|NCT01363479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25637515|NCT01363479|Antiemetics|antiemetics|mesh-ancestor
25637516|NCT01363479|Autonomic Agents|autonomic agents|mesh-ancestor
25637517|NCT01363479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25637518|NCT01363479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637519|NCT01363479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25637520|NCT01363479|Glucocorticoids|glucocorticoids|mesh-ancestor
25637521|NCT01363479|Hormones|hormones|mesh-ancestor
25637522|NCT01363479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25532461|NCT00540722|Acetic Acid|acetic acid|mesh-list
25532464|NCT00540722|Gossypol|gossypol|mesh-list
25637523|NCT01363479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25637524|NCT01363479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25637525|NCT01363479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25637526|NCT01363479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25637527|NCT01363479|Serotonin Agents|serotonin agents|mesh-ancestor
25637528|NCT01363479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25637529|NCT01363479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637530|NCT01363661|Molsidomine|molsidomine|mesh-list
25637531|NCT01363661|Vasodilator Agents|vasodilator agents|mesh-ancestor
25637532|NCT01363661|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25637533|NCT01363661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637534|NCT01363700|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25637535|NCT01363700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25637536|NCT01363700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25637537|NCT01363700|Epinastine|epinastine|mesh-list
25637538|NCT01363700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25637539|NCT01363700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25637540|NCT01363700|Analgesics|analgesics|mesh-ancestor
25637541|NCT01363700|Sensory System Agents|sensory system agents|mesh-ancestor
25637542|NCT01363700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25637543|NCT01363700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637544|NCT01363700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25637545|NCT01363700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25637546|NCT01363700|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25637547|NCT01363700|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25637548|NCT01363700|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25637549|NCT01363700|Histamine Antagonists|histamine antagonists|mesh-ancestor
25637550|NCT01363700|Histamine Agents|histamine agents|mesh-ancestor
25637551|NCT01363700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25637552|NCT01363700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637553|NCT01363713|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25637554|NCT01363713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25637555|NCT01363843|Leucovorin|leucovorin|mesh-list
25637556|NCT01363843|Oxaliplatin|oxaliplatin|mesh-list
25637557|NCT01363843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25637558|NCT01363843|Antidotes|antidotes|mesh-ancestor
25637559|NCT01363843|Protective Agents|protective agents|mesh-ancestor
25637560|NCT01363843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637561|NCT01363843|Vitamin B Complex|vitamin b complex|mesh-ancestor
25637562|NCT01363843|Vitamins|vitamins|mesh-ancestor
25637563|NCT01363843|Micronutrients|micronutrients|mesh-ancestor
25637564|NCT01363986|Trastuzumab|trastuzumab|mesh-list
25637565|NCT01363986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25637566|NCT01363986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25637567|NCT01363999|Atorvastatin|atorvastatin|mesh-list
25637568|NCT01363999|Dalcetrapib|dalcetrapib|mesh-list
25637569|NCT01363999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25637570|NCT01363999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25637571|NCT01363999|Antimetabolites|antimetabolites|mesh-ancestor
25637572|NCT01363999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637573|NCT01363999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25637574|NCT01363999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25637575|NCT01363999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25656473|NCT01575561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25656474|NCT01575561|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25656475|NCT01575561|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25656476|NCT01575561|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25656477|NCT01575561|Adrenergic Agents|adrenergic agents|mesh-ancestor
25656478|NCT01575561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25656479|NCT01575561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656480|NCT01575561|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25656481|NCT01575561|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25656482|NCT01575561|Serotonin Agents|serotonin agents|mesh-ancestor
25656483|NCT01575561|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25656484|NCT01575561|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25656485|NCT01575561|Dopamine Agents|dopamine agents|mesh-ancestor
25656486|NCT01575873|Denosumab|denosumab|mesh-list
25656487|NCT01575873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25656488|NCT01575873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656489|NCT01575899|Amoxicillin|amoxicillin|mesh-list
25656490|NCT01575899|Clarithromycin|clarithromycin|mesh-list
25656491|NCT01575899|Levofloxacin|levofloxacin|mesh-list
25656492|NCT01575899|Ofloxacin|ofloxacin|mesh-list
25656493|NCT01575899|Clavulanic Acid|clavulanic acid|mesh-list
25656494|NCT01575899|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25718491|NCT02431676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25718492|NCT02431676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718493|NCT02431754|Tadalafil|tadalafil|mesh-list
25718494|NCT02431754|Vasodilator Agents|vasodilator agents|mesh-ancestor
25718495|NCT02431754|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25637576|NCT01364090|Interferons|interferons|mesh-list
25637577|NCT01364090|Ribavirin|ribavirin|mesh-list
25637578|NCT01364090|Interferon-alpha|interferon-alpha|mesh-list
25637579|NCT01364090|Interferon alpha-2|interferon alpha-2|mesh-list
25637580|NCT01364090|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25637581|NCT01364090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25637582|NCT01364090|Antiviral Agents|antiviral agents|mesh-ancestor
25637583|NCT01364090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25637584|NCT01364090|Antimetabolites|antimetabolites|mesh-ancestor
25637585|NCT01364090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637586|NCT01364090|Immunologic Factors|immunologic factors|mesh-ancestor
25637587|NCT01364090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637588|NCT01364259|Amifostine|amifostine|mesh-list
25637589|NCT01364259|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25637590|NCT01364259|Protective Agents|protective agents|mesh-ancestor
25637591|NCT01364259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637592|NCT01364298|Pregabalin|pregabalin|mesh-list
25637593|NCT01364298|Gabapentin|gabapentin|mesh-list
25637594|NCT01364298|Analgesics|analgesics|mesh-ancestor
25637595|NCT01364298|Sensory System Agents|sensory system agents|mesh-ancestor
25637596|NCT01364298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25637597|NCT01364298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637598|NCT01364298|Anticonvulsants|anticonvulsants|mesh-ancestor
25637599|NCT01364298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25637600|NCT01364298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25637601|NCT01364298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637602|NCT01364298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25637603|NCT01364298|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25637604|NCT01364298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25637605|NCT01364298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25637606|NCT01364298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25637607|NCT01364298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25637608|NCT01364298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25637609|NCT01364298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25637610|NCT01364298|Antimanic Agents|antimanic agents|mesh-ancestor
25637611|NCT01364389|Prednisone|prednisone|mesh-list
25637612|NCT01364389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25637613|NCT01364389|Glucocorticoids|glucocorticoids|mesh-ancestor
25637614|NCT01364389|Hormones|hormones|mesh-ancestor
25637615|NCT01364389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25637616|NCT01364389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637617|NCT01364389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25637618|NCT01364389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25637619|NCT01364428|Insulin|insulin|mesh-list
25637620|NCT01364428|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25637621|NCT01364428|Insulin, Long-Acting|insulin, long-acting|mesh-list
25637622|NCT01364428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25637623|NCT01364428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637624|NCT01364467|Phenylpropanolamine|phenylpropanolamine|mesh-list
25637625|NCT01364467|Guaifenesin|guaifenesin|mesh-list
25637626|NCT01364467|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
25637627|NCT01364467|Expectorants|expectorants|mesh-ancestor
25637628|NCT01364467|Respiratory System Agents|respiratory system agents|mesh-ancestor
25637629|NCT01364467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25637630|NCT01364467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25637631|NCT01364467|Adrenergic Agents|adrenergic agents|mesh-ancestor
25637632|NCT01364467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25637633|NCT01364467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637634|NCT01364467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637635|NCT01364467|Appetite Depressants|appetite depressants|mesh-ancestor
25532598|NCT00541775|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25532599|NCT00541775|Rosiglitazone|rosiglitazone|mesh-list
25532600|NCT00541775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25532601|NCT00541775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532602|NCT00541775|Incretins|incretins|mesh-ancestor
25532603|NCT00541775|Hormones|hormones|mesh-ancestor
25532604|NCT00541775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25637636|NCT01364467|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25637637|NCT01364467|Sympathomimetics|sympathomimetics|mesh-ancestor
25637638|NCT01364467|Autonomic Agents|autonomic agents|mesh-ancestor
25637639|NCT01364467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25637640|NCT01364467|Nasal Decongestants|nasal decongestants|mesh-ancestor
25637641|NCT01364467|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25532605|NCT00541775|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25532606|NCT00541775|Protease Inhibitors|protease inhibitors|mesh-ancestor
25637642|NCT01364558|Diazepam|diazepam|mesh-list
25637643|NCT01364558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25637644|NCT01364558|Anticonvulsants|anticonvulsants|mesh-ancestor
25637645|NCT01364558|Antiemetics|antiemetics|mesh-ancestor
25637646|NCT01364558|Autonomic Agents|autonomic agents|mesh-ancestor
25637647|NCT01364558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25637648|NCT01364558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637649|NCT01364558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25637650|NCT01364558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25637651|NCT01364558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25637652|NCT01364558|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25637653|NCT01364558|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25637654|NCT01364558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25637655|NCT01364558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25637656|NCT01364558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25637657|NCT01364558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25637658|NCT01364558|Anesthetics, General|anesthetics, general|mesh-ancestor
25637659|NCT01364558|Anesthetics|anesthetics|mesh-ancestor
25637660|NCT01364558|GABA Modulators|gaba modulators|mesh-ancestor
25637661|NCT01364558|GABA Agents|gaba agents|mesh-ancestor
25637662|NCT01364558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25637663|NCT01364558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637664|NCT01364584|Exenatide|exenatide|mesh-list
25637665|NCT01364584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25637666|NCT01364584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637667|NCT01364584|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25637668|NCT01364584|Incretins|incretins|mesh-ancestor
25637669|NCT01364584|Hormones|hormones|mesh-ancestor
25637670|NCT01364584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25637671|NCT01364623|Methyltestosterone|methyltestosterone|mesh-list
25637672|NCT01364623|Testosterone|testosterone|mesh-list
25637673|NCT01364623|Testosterone undecanoate|testosterone undecanoate|mesh-list
25637674|NCT01364623|Testosterone enanthate|testosterone enanthate|mesh-list
25637675|NCT01364623|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25637676|NCT01364623|Androgens|androgens|mesh-ancestor
25637677|NCT01364623|Hormones|hormones|mesh-ancestor
25637678|NCT01364623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25637679|NCT01364623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637680|NCT01364623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25637681|NCT01364623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25637682|NCT01364623|Anabolic Agents|anabolic agents|mesh-ancestor
25637683|NCT01364649|Vortioxetine|vortioxetine|mesh-list
25637684|NCT01364649|Citalopram|citalopram|mesh-list
25637685|NCT01364649|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25637686|NCT01364649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25637687|NCT01364649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25637688|NCT01364649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637689|NCT01364649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25637690|NCT01364649|Serotonin Agents|serotonin agents|mesh-ancestor
25637691|NCT01364649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637692|NCT01364649|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25637693|NCT01364649|Antidepressive Agents|antidepressive agents|mesh-ancestor
25637694|NCT01364649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25637695|NCT01364649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25637696|NCT01364649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25637697|NCT01364649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25637698|NCT01364649|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25637699|NCT01364649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25637700|NCT01364649|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25637701|NCT01364649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25637702|NCT01364727|Amrubicin|amrubicin|mesh-list
25637703|NCT01364727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25637704|NCT01364922|Acetaminophen|acetaminophen|mesh-list
25637705|NCT01364922|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25637706|NCT01364922|Hydrocodone|hydrocodone|mesh-list
25637707|NCT01364922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25637708|NCT01364922|Analgesics|analgesics|mesh-ancestor
25637709|NCT01364922|Sensory System Agents|sensory system agents|mesh-ancestor
25637710|NCT01364922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25637711|NCT01364922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637712|NCT01364922|Antipyretics|antipyretics|mesh-ancestor
25637713|NCT01364922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25637714|NCT01364922|Narcotics|narcotics|mesh-ancestor
25637715|NCT01364922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25637716|NCT01364922|Antitussive Agents|antitussive agents|mesh-ancestor
25637717|NCT01364922|Respiratory System Agents|respiratory system agents|mesh-ancestor
25637718|NCT01364922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25637719|NCT01364922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25637720|NCT01364922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25637721|NCT01365052|Naproxen|naproxen|mesh-list
25637722|NCT01365052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25637723|NCT01365052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25637724|NCT01365052|Analgesics|analgesics|mesh-ancestor
25637725|NCT01365052|Sensory System Agents|sensory system agents|mesh-ancestor
25637726|NCT01365052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25637727|NCT01365052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637728|NCT01365052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25637729|NCT01365052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25637730|NCT01365052|Gout Suppressants|gout suppressants|mesh-ancestor
25637731|NCT01365052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25637732|NCT01365052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25637733|NCT01365052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637734|NCT01365091|Metformin|metformin|mesh-list
25637735|NCT01365091|Saxagliptin|saxagliptin|mesh-list
25637736|NCT01365091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25637737|NCT01365091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637738|NCT01365091|Incretins|incretins|mesh-ancestor
25637739|NCT01365091|Hormones|hormones|mesh-ancestor
25637740|NCT01365091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25637741|NCT01365091|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25637742|NCT01365091|Protease Inhibitors|protease inhibitors|mesh-ancestor
25637743|NCT01365091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25637744|NCT01365091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637745|NCT01365455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25637746|NCT01365455|Immunologic Factors|immunologic factors|mesh-ancestor
25637747|NCT01365455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637748|NCT01365468|Everolimus|everolimus|mesh-list
25637749|NCT01365468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25637750|NCT01365468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25637751|NCT01365468|Immunologic Factors|immunologic factors|mesh-ancestor
25637752|NCT01365468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637753|NCT01365481|Amlodipine|amlodipine|mesh-list
25637754|NCT01365481|Valsartan|valsartan|mesh-list
25637755|NCT01365481|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25637756|NCT01365481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25637757|NCT01365481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25718523|NCT02432040|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25718524|NCT02432040|Antimetabolites|antimetabolites|mesh-ancestor
25718525|NCT02432040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718526|NCT02432040|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25718528|NCT02432040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25637758|NCT01365481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25637759|NCT01365481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637760|NCT01365481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25637761|NCT01365481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637762|NCT01365481|Vasodilator Agents|vasodilator agents|mesh-ancestor
25637763|NCT01365481|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25637764|NCT01365481|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25637765|NCT01365481|Diuretics|diuretics|mesh-ancestor
25637766|NCT01365481|Natriuretic Agents|natriuretic agents|mesh-ancestor
25637767|NCT01365481|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25637768|NCT01365507|Insulin|insulin|mesh-list
25637769|NCT01365507|Insulin Aspart|insulin aspart|mesh-list
25637770|NCT01365507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25637771|NCT01365507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637772|NCT01365585|Sildenafil Citrate|sildenafil citrate|mesh-list
25637773|NCT01365585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637774|NCT01365585|Vasodilator Agents|vasodilator agents|mesh-ancestor
25637775|NCT01365585|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25637776|NCT01365585|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25637777|NCT01365585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25637778|NCT01365585|Urological Agents|urological agents|mesh-ancestor
25637779|NCT01365611|Fluticasone|fluticasone|mesh-list
25637781|NCT01365611|Ketorolac|ketorolac|mesh-list
25637782|NCT01365611|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25637783|NCT01365611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25637784|NCT01365611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25637785|NCT01365611|Autonomic Agents|autonomic agents|mesh-ancestor
25637786|NCT01365611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25637787|NCT01365611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637788|NCT01365611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25637789|NCT01365611|Respiratory System Agents|respiratory system agents|mesh-ancestor
25637790|NCT01365611|Dermatologic Agents|dermatologic agents|mesh-ancestor
25637791|NCT01365611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25532736|NCT00542971|Cytarabine|cytarabine|mesh-list
25637792|NCT01365611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25637793|NCT01365611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25637794|NCT01365611|Analgesics|analgesics|mesh-ancestor
25637795|NCT01365611|Sensory System Agents|sensory system agents|mesh-ancestor
25637796|NCT01365611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25637797|NCT01365611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25637798|NCT01365611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25637799|NCT01365611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637800|NCT01365624|Ketorolac|ketorolac|mesh-list
25637801|NCT01365624|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25637802|NCT01365624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25637803|NCT01365624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25637804|NCT01365624|Analgesics|analgesics|mesh-ancestor
25637805|NCT01365624|Sensory System Agents|sensory system agents|mesh-ancestor
25637806|NCT01365624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25637807|NCT01365624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637808|NCT01365624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25637809|NCT01365624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25637810|NCT01365624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25637811|NCT01365624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25637812|NCT01365624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637813|NCT01365650|Fluticasone|fluticasone|mesh-list
25637814|NCT01365650|Xhance|xhance|mesh-list
25637815|NCT01365650|Ketorolac|ketorolac|mesh-list
25637816|NCT01365650|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25637817|NCT01365650|Phenylephrine|phenylephrine|mesh-list
25637818|NCT01365650|Oxymetazoline|oxymetazoline|mesh-list
25637819|NCT01365650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25718531|NCT02432287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637820|NCT01365650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25637821|NCT01365650|Autonomic Agents|autonomic agents|mesh-ancestor
25637822|NCT01365650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25637823|NCT01365650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637824|NCT01365650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25637825|NCT01365650|Respiratory System Agents|respiratory system agents|mesh-ancestor
25637826|NCT01365650|Dermatologic Agents|dermatologic agents|mesh-ancestor
25637827|NCT01365650|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25637828|NCT01365650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25637829|NCT01365650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25637830|NCT01365650|Analgesics|analgesics|mesh-ancestor
25637831|NCT01365650|Sensory System Agents|sensory system agents|mesh-ancestor
25637832|NCT01365650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25637833|NCT01365650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25637834|NCT01365650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25637835|NCT01365650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637836|NCT01365650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25637837|NCT01365650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25637838|NCT01365650|Adrenergic Agents|adrenergic agents|mesh-ancestor
25637839|NCT01365650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25637840|NCT01365650|Sympathomimetics|sympathomimetics|mesh-ancestor
25637841|NCT01365650|Nasal Decongestants|nasal decongestants|mesh-ancestor
25637842|NCT01365650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25637843|NCT01365650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25637844|NCT01365650|Mydriatics|mydriatics|mesh-ancestor
25637845|NCT01365650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25637846|NCT01365650|Protective Agents|protective agents|mesh-ancestor
25637847|NCT01365819|Varenicline|varenicline|mesh-list
25637848|NCT01365819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25637849|NCT01365819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25637850|NCT01365819|Cholinergic Agents|cholinergic agents|mesh-ancestor
25637851|NCT01365819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25637852|NCT01365819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637853|NCT01365819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637854|NCT01366196|Pregabalin|pregabalin|mesh-list
25637855|NCT01366196|Analgesics|analgesics|mesh-ancestor
25637856|NCT01366196|Sensory System Agents|sensory system agents|mesh-ancestor
25637857|NCT01366196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25637858|NCT01366196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637859|NCT01366196|Anticonvulsants|anticonvulsants|mesh-ancestor
25637860|NCT01366196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25637861|NCT01366196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25637862|NCT01366196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637863|NCT01366196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25637864|NCT01366196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25637865|NCT01366196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25637866|NCT01366196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25637867|NCT01366196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25637868|NCT01366209|Pirfenidone|pirfenidone|mesh-list
25637869|NCT01366209|Analgesics|analgesics|mesh-ancestor
25637870|NCT01366209|Sensory System Agents|sensory system agents|mesh-ancestor
25637871|NCT01366209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25637872|NCT01366209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637873|NCT01366209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25637874|NCT01366209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25637875|NCT01366209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25637876|NCT01366209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25637877|NCT01366209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25637878|NCT01366534|Vaccines|vaccines|mesh-list
25637879|NCT01366534|Immunologic Factors|immunologic factors|mesh-ancestor
25637880|NCT01366534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637881|NCT01366638|Ribavirin|ribavirin|mesh-list
25637882|NCT01366638|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25637883|NCT01366638|Simeprevir|simeprevir|mesh-list
25637884|NCT01366638|Antimetabolites|antimetabolites|mesh-ancestor
25637885|NCT01366638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637886|NCT01366638|Antiviral Agents|antiviral agents|mesh-ancestor
25637887|NCT01366638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25637888|NCT01366638|Protease Inhibitors|protease inhibitors|mesh-ancestor
25637889|NCT01366638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25637890|NCT01366885|Vitamin D|vitamin d|mesh-list
25637891|NCT01366885|Cholecalciferol|cholecalciferol|mesh-list
25637892|NCT01366885|Vitamins|vitamins|mesh-ancestor
25637893|NCT01366885|Micronutrients|micronutrients|mesh-ancestor
25637894|NCT01366885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637895|NCT01366885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25637896|NCT01366885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25637897|NCT01366976|Acetaminophen|acetaminophen|mesh-list
25637898|NCT01366976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25637899|NCT01366976|Analgesics|analgesics|mesh-ancestor
25637900|NCT01366976|Sensory System Agents|sensory system agents|mesh-ancestor
25637901|NCT01366976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25637902|NCT01366976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637903|NCT01366976|Antipyretics|antipyretics|mesh-ancestor
25637904|NCT01367119|Ketamine|ketamine|mesh-list
25637905|NCT01367119|Methohexital|methohexital|mesh-list
25637906|NCT01367119|Analgesics|analgesics|mesh-ancestor
25637907|NCT01367119|Sensory System Agents|sensory system agents|mesh-ancestor
25637908|NCT01367119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25637909|NCT01367119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637910|NCT01367119|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25637911|NCT01367119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25637912|NCT01367119|Anesthetics, General|anesthetics, general|mesh-ancestor
25637913|NCT01367119|Anesthetics|anesthetics|mesh-ancestor
25637914|NCT01367119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25637915|NCT01367119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25637916|NCT01367119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25637917|NCT01367119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25637918|NCT01367119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637919|NCT01367158|Vaccines|vaccines|mesh-list
25637920|NCT01367158|Immunologic Factors|immunologic factors|mesh-ancestor
25637921|NCT01367158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637922|NCT01367249|Bromfenac|bromfenac|mesh-list
25637923|NCT01367249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25637924|NCT01367249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25637925|NCT01367249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25637926|NCT01367249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25637927|NCT01367249|Analgesics|analgesics|mesh-ancestor
25637928|NCT01367249|Sensory System Agents|sensory system agents|mesh-ancestor
25637929|NCT01367249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25637930|NCT01367249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637931|NCT01367249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25637932|NCT01367249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25637933|NCT01367275|Irinotecan|irinotecan|mesh-list
25637934|NCT01367275|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25637935|NCT01367275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25637936|NCT01367275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25637937|NCT01367275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637938|NCT01367275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25637939|NCT01367457|Sirolimus|sirolimus|mesh-list
25637940|NCT01367457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25637941|NCT01367457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25532885|NCT00544167|Paclitaxel|paclitaxel|mesh-list
25637942|NCT01367457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25637943|NCT01367457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25637944|NCT01367457|Antifungal Agents|antifungal agents|mesh-ancestor
25637945|NCT01367457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25637946|NCT01367457|Immunologic Factors|immunologic factors|mesh-ancestor
25637947|NCT01367457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637948|NCT01367834|Hormones|hormones|mesh-list
25637949|NCT01367834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25637950|NCT01367834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637951|NCT01367886|Fesoterodine|fesoterodine|mesh-list
25637952|NCT01367886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25637953|NCT01367886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25637954|NCT01367886|Cholinergic Agents|cholinergic agents|mesh-ancestor
25637955|NCT01367886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25637956|NCT01367886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637957|NCT01367886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637958|NCT01367886|Urological Agents|urological agents|mesh-ancestor
25637959|NCT01368081|Metformin|metformin|mesh-list
25637960|NCT01368081|Empagliflozin|empagliflozin|mesh-list
25637961|NCT01368081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25637962|NCT01368081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637963|NCT01368081|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25637964|NCT01368081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637965|NCT01368263|Letrozole|letrozole|mesh-list
25637966|NCT01368263|Anastrozole|anastrozole|mesh-list
25637967|NCT01368263|Goserelin|goserelin|mesh-list
25637968|NCT01368263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25637969|NCT01368263|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25637970|NCT01368263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25637971|NCT01368263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25637972|NCT01368263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637973|NCT01368263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25637974|NCT01368263|Hormone Antagonists|hormone antagonists|mesh-ancestor
25637975|NCT01368263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25637976|NCT01368263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637977|NCT01368263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25637978|NCT01368276|Molgramostim|molgramostim|mesh-list
25637979|NCT01368276|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25637980|NCT01368276|Sargramostim|sargramostim|mesh-list
25637981|NCT01368276|Immunologic Factors|immunologic factors|mesh-ancestor
25637982|NCT01368276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637983|NCT01368276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25637984|NCT01368276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25637985|NCT01368432|Citalopram|citalopram|mesh-list
25637986|NCT01368432|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25637987|NCT01368432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25637988|NCT01368432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25637989|NCT01368432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25637990|NCT01368432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25637991|NCT01368432|Serotonin Agents|serotonin agents|mesh-ancestor
25637992|NCT01368432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25637993|NCT01368432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25637994|NCT01368432|Antidepressive Agents|antidepressive agents|mesh-ancestor
25637995|NCT01368432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25637996|NCT01368536|Amlodipine|amlodipine|mesh-list
25637997|NCT01368536|Chlorthalidone|chlorthalidone|mesh-list
25637998|NCT01368536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25637999|NCT01368536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25638000|NCT01368536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25638001|NCT01368536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638002|NCT01368536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25718571|NCT02433483|Cytarabine|cytarabine|mesh-list
25638003|NCT01368536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638004|NCT01368536|Vasodilator Agents|vasodilator agents|mesh-ancestor
25638005|NCT01368536|Diuretics|diuretics|mesh-ancestor
25638006|NCT01368536|Natriuretic Agents|natriuretic agents|mesh-ancestor
25638007|NCT01368536|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25638008|NCT01368562|Methylnaltrexone|methylnaltrexone|mesh-list
25638009|NCT01368562|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25638010|NCT01368562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638011|NCT01368562|Sensory System Agents|sensory system agents|mesh-ancestor
25638012|NCT01368562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25638013|NCT01368653|Nicotine|nicotine|mesh-list
25638014|NCT01368653|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25638015|NCT01368653|Autonomic Agents|autonomic agents|mesh-ancestor
25638016|NCT01368653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25638017|NCT01368653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638018|NCT01368653|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25638019|NCT01368653|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25638020|NCT01368653|Cholinergic Agents|cholinergic agents|mesh-ancestor
25638021|NCT01368653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25638022|NCT01368653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638023|NCT01368809|Fentanyl|fentanyl|mesh-list
25638024|NCT01368809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25638025|NCT01368809|Narcotics|narcotics|mesh-ancestor
25638026|NCT01368809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25638027|NCT01368809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638028|NCT01368809|Analgesics|analgesics|mesh-ancestor
25638029|NCT01368809|Sensory System Agents|sensory system agents|mesh-ancestor
25638030|NCT01368809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25638031|NCT01368809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25638032|NCT01368809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25638033|NCT01368809|Anesthetics, General|anesthetics, general|mesh-ancestor
25638034|NCT01368809|Anesthetics|anesthetics|mesh-ancestor
25638035|NCT01369069|Insulin|insulin|mesh-list
25638036|NCT01369069|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25638037|NCT01369069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25638038|NCT01369069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638039|NCT01369329|Ustekinumab|ustekinumab|mesh-list
25638040|NCT01369329|Dermatologic Agents|dermatologic agents|mesh-ancestor
25638041|NCT01369342|Ustekinumab|ustekinumab|mesh-list
25638042|NCT01369342|Dermatologic Agents|dermatologic agents|mesh-ancestor
25638043|NCT01369355|Ustekinumab|ustekinumab|mesh-list
25638044|NCT01369355|Dermatologic Agents|dermatologic agents|mesh-ancestor
25638045|NCT01369433|Sirolimus|sirolimus|mesh-list
25638046|NCT01369433|Paclitaxel|paclitaxel|mesh-list
25638047|NCT01369433|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25638048|NCT01369433|Capecitabine|capecitabine|mesh-list
25638049|NCT01369433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25638050|NCT01369433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25638051|NCT01369433|Tubulin Modulators|tubulin modulators|mesh-ancestor
25638052|NCT01369433|Antimitotic Agents|antimitotic agents|mesh-ancestor
25638053|NCT01369433|Mitosis Modulators|mitosis modulators|mesh-ancestor
25638054|NCT01369433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638055|NCT01369433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25638056|NCT01369433|Antimetabolites|antimetabolites|mesh-ancestor
25638057|NCT01369433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25638058|NCT01369433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25638059|NCT01369433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25638060|NCT01369433|Antifungal Agents|antifungal agents|mesh-ancestor
25638061|NCT01369433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25638062|NCT01369433|Immunologic Factors|immunologic factors|mesh-ancestor
25638063|NCT01369433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638064|NCT01369485|Caffeine|caffeine|mesh-list
25638065|NCT01369485|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25638066|NCT01369485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638067|NCT01369485|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25638068|NCT01369485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718581|NCT02433483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25638069|NCT01369485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638070|NCT01369485|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25638071|NCT01369485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25638072|NCT01369485|Purinergic Agents|purinergic agents|mesh-ancestor
25638073|NCT01369485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25638074|NCT01369615|Oxycodone|oxycodone|mesh-list
25638075|NCT01369615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25638076|NCT01369615|Narcotics|narcotics|mesh-ancestor
25638077|NCT01369615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25638078|NCT01369615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638079|NCT01369615|Analgesics|analgesics|mesh-ancestor
25638080|NCT01369615|Sensory System Agents|sensory system agents|mesh-ancestor
25638081|NCT01369615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25638082|NCT01369680|Ketamine|ketamine|mesh-list
25638083|NCT01369680|Analgesics|analgesics|mesh-ancestor
25638084|NCT01369680|Sensory System Agents|sensory system agents|mesh-ancestor
25638085|NCT01369680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25638086|NCT01369680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638087|NCT01369680|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25638088|NCT01369680|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25638089|NCT01369680|Anesthetics, General|anesthetics, general|mesh-ancestor
25638090|NCT01369680|Anesthetics|anesthetics|mesh-ancestor
25638091|NCT01369680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25656495|NCT01575899|Rabeprazole|rabeprazole|mesh-list
25638092|NCT01369680|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25638093|NCT01369680|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25638094|NCT01369680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25638095|NCT01369680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638096|NCT01369732|Epoetin Alfa|epoetin alfa|mesh-list
25638097|NCT01369732|Hematinics|hematinics|mesh-ancestor
25638098|NCT01369745|Prednisone|prednisone|mesh-list
25638099|NCT01369745|Prednisolone|prednisolone|mesh-list
25638100|NCT01369745|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25638101|NCT01369745|Methylprednisolone|methylprednisolone|mesh-list
25638102|NCT01369745|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25638103|NCT01369745|Prednisolone acetate|prednisolone acetate|mesh-list
25638104|NCT01369745|Dipyridamole|dipyridamole|mesh-list
25638105|NCT01369745|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25638106|NCT01369745|Prednisolone phosphate|prednisolone phosphate|mesh-list
25638107|NCT01369745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25638108|NCT01369745|Glucocorticoids|glucocorticoids|mesh-ancestor
25638109|NCT01369745|Hormones|hormones|mesh-ancestor
25638110|NCT01369745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25638111|NCT01369745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638112|NCT01369745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25638113|NCT01369745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25638114|NCT01369745|Antiemetics|antiemetics|mesh-ancestor
25638115|NCT01369745|Autonomic Agents|autonomic agents|mesh-ancestor
25638116|NCT01369745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25638117|NCT01369745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25638118|NCT01369745|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25638119|NCT01369745|Protective Agents|protective agents|mesh-ancestor
25638120|NCT01369745|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25638121|NCT01369745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25638122|NCT01369745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638123|NCT01369745|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25638124|NCT01369745|Vasodilator Agents|vasodilator agents|mesh-ancestor
25638125|NCT01369849|Rituximab|rituximab|mesh-list
25638126|NCT01369849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25638127|NCT01369849|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25638128|NCT01369849|Antibodies|antibodies|mesh-list
25638129|NCT01369849|Immunoglobulins|immunoglobulins|mesh-list
25638130|NCT01369849|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25638131|NCT01369849|Immunologic Factors|immunologic factors|mesh-ancestor
25718592|NCT02433678|Dapagliflozin|dapagliflozin|mesh-list
25638132|NCT01369849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638133|NCT01369849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25638134|NCT01369849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25638135|NCT01369849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25638136|NCT01369849|Alkylating Agents|alkylating agents|mesh-ancestor
25638137|NCT01369849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638138|NCT01369875|Aldesleukin|aldesleukin|mesh-list
25638139|NCT01369875|Cyclophosphamide|cyclophosphamide|mesh-list
25638140|NCT01369875|Fludarabine|fludarabine|mesh-list
25638141|NCT01369875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25638142|NCT01369875|Immunologic Factors|immunologic factors|mesh-ancestor
25638143|NCT01369875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638144|NCT01369875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25638145|NCT01369875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25638146|NCT01369875|Alkylating Agents|alkylating agents|mesh-ancestor
25638147|NCT01369875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638148|NCT01369875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25638149|NCT01369875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25638150|NCT01369875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25638151|NCT01369875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25638152|NCT01369875|Antiviral Agents|antiviral agents|mesh-ancestor
25638153|NCT01369875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25638154|NCT01369888|Cyclophosphamide|cyclophosphamide|mesh-list
25638155|NCT01369888|Fludarabine|fludarabine|mesh-list
25638156|NCT01369888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25638157|NCT01369888|Immunologic Factors|immunologic factors|mesh-ancestor
25638158|NCT01369888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638159|NCT01369888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25638160|NCT01369888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25638161|NCT01369888|Alkylating Agents|alkylating agents|mesh-ancestor
25638162|NCT01369888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638163|NCT01369888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25638164|NCT01369888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25656496|NCT01575899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25656497|NCT01575899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25638165|NCT01370005|Empagliflozin|empagliflozin|mesh-list
25638166|NCT01370005|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25638167|NCT01370005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638168|NCT01370005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25638169|NCT01370005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638170|NCT01370018|Protease Inhibitors|protease inhibitors|mesh-list
25638171|NCT01370018|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25638172|NCT01370018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25638173|NCT01370018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638174|NCT01370018|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25638175|NCT01370018|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25638176|NCT01370213|Interleukin-2|interleukin-2|mesh-list
25638177|NCT01370213|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25638178|NCT01370213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25638179|NCT01370213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25638180|NCT01370213|Analgesics|analgesics|mesh-ancestor
25638181|NCT01370213|Sensory System Agents|sensory system agents|mesh-ancestor
25638182|NCT01370213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25638183|NCT01370213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638184|NCT01370213|Immunologic Factors|immunologic factors|mesh-ancestor
25638185|NCT01370213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25638186|NCT01370265|Adenosine|adenosine|mesh-list
25638187|NCT01370265|Regadenoson|regadenoson|mesh-list
25638188|NCT01370265|Analgesics|analgesics|mesh-ancestor
25638189|NCT01370265|Sensory System Agents|sensory system agents|mesh-ancestor
25638190|NCT01370265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25638191|NCT01370265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638192|NCT01370265|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25638193|NCT01370265|Vasodilator Agents|vasodilator agents|mesh-ancestor
25638194|NCT01370265|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25638195|NCT01370265|Purinergic Agonists|purinergic agonists|mesh-ancestor
25638196|NCT01370265|Purinergic Agents|purinergic agents|mesh-ancestor
25638197|NCT01370265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25638198|NCT01370265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638199|NCT01370265|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25638200|NCT01370356|Varenicline|varenicline|mesh-list
25638201|NCT01370356|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25638202|NCT01370356|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25638203|NCT01370356|Cholinergic Agents|cholinergic agents|mesh-ancestor
25638204|NCT01370356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25638205|NCT01370356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638206|NCT01370356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638207|NCT01370369|Testosterone|testosterone|mesh-list
25638208|NCT01370369|Androgens|androgens|mesh-ancestor
25638209|NCT01370369|Hormones|hormones|mesh-ancestor
25638210|NCT01370369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25638211|NCT01370369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638212|NCT01370408|Dexamethasone|dexamethasone|mesh-list
25638213|NCT01370408|Ondansetron|ondansetron|mesh-list
25638214|NCT01370408|Palonosetron|palonosetron|mesh-list
25638215|NCT01370408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25638216|NCT01370408|Antiemetics|antiemetics|mesh-ancestor
25638217|NCT01370408|Autonomic Agents|autonomic agents|mesh-ancestor
25638218|NCT01370408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25638219|NCT01370408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638220|NCT01370408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25638221|NCT01370408|Glucocorticoids|glucocorticoids|mesh-ancestor
25638222|NCT01370408|Hormones|hormones|mesh-ancestor
25638223|NCT01370408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25638224|NCT01370408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25638225|NCT01370408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25638226|NCT01370408|Antipruritics|antipruritics|mesh-ancestor
25638227|NCT01370408|Dermatologic Agents|dermatologic agents|mesh-ancestor
25638228|NCT01370408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25638229|NCT01370408|Serotonin Agents|serotonin agents|mesh-ancestor
25638230|NCT01370408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25638231|NCT01370408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638232|NCT01370408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25638233|NCT01370408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25638234|NCT01370408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25638235|NCT01370408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25638236|NCT01370408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25638237|NCT01370408|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25638238|NCT01370460|Tranexamic Acid|tranexamic acid|mesh-list
25638239|NCT01370460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25638240|NCT01370460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25638241|NCT01370460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638242|NCT01370460|Hemostatics|hemostatics|mesh-ancestor
25638243|NCT01370460|Coagulants|coagulants|mesh-ancestor
25638244|NCT01370499|Serotonin|serotonin|mesh-list
25638245|NCT01370499|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25638246|NCT01370499|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25638247|NCT01370499|Serotonin Agents|serotonin agents|mesh-ancestor
25638248|NCT01370499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25638249|NCT01370499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638250|NCT01370499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638251|NCT01370499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25638252|NCT01370499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25638253|NCT01370525|Esomeprazole|esomeprazole|mesh-list
25638254|NCT01370525|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25638255|NCT01370525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25638256|NCT01370525|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25638257|NCT01370525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25638258|NCT01370525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638259|NCT01370538|Esomeprazole|esomeprazole|mesh-list
25638260|NCT01370538|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25638261|NCT01370538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25638262|NCT01370538|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25638263|NCT01370538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25638264|NCT01370538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638265|NCT01370564|Diuretics|diuretics|mesh-list
25638266|NCT01370564|Natriuretic Agents|natriuretic agents|mesh-ancestor
25638267|NCT01370564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638268|NCT01370616|Amoxicillin|amoxicillin|mesh-list
25638269|NCT01370616|Tazobactam|tazobactam|mesh-list
25638270|NCT01370616|Piperacillin|piperacillin|mesh-list
25638271|NCT01370616|Ertapenem|ertapenem|mesh-list
25638272|NCT01370616|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25638273|NCT01370616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25638274|NCT01370616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25638275|NCT01370616|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25638276|NCT01370616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25638277|NCT01370616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638278|NCT01370642|Ribavirin|ribavirin|mesh-list
25638279|NCT01370642|Antimetabolites|antimetabolites|mesh-ancestor
25638280|NCT01370642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638281|NCT01370642|Antiviral Agents|antiviral agents|mesh-ancestor
25638282|NCT01370642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25638283|NCT01370655|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25638284|NCT01370655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25638285|NCT01370655|Diuretics|diuretics|mesh-ancestor
25638286|NCT01370655|Natriuretic Agents|natriuretic agents|mesh-ancestor
25638287|NCT01370655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638288|NCT01370655|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25638289|NCT01370655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25638290|NCT01370655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638291|NCT01370694|Prednisolone|prednisolone|mesh-list
25638292|NCT01370694|Cyclophosphamide|cyclophosphamide|mesh-list
25638293|NCT01370694|Vincristine|vincristine|mesh-list
25638294|NCT01370694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25638295|NCT01370694|Immunologic Factors|immunologic factors|mesh-ancestor
25638296|NCT01370694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638297|NCT01370694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25638298|NCT01370694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25638299|NCT01370694|Alkylating Agents|alkylating agents|mesh-ancestor
25638300|NCT01370694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638301|NCT01370694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25638302|NCT01370694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25638303|NCT01370694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25638304|NCT01370694|Tubulin Modulators|tubulin modulators|mesh-ancestor
25638305|NCT01370694|Antimitotic Agents|antimitotic agents|mesh-ancestor
25638306|NCT01370694|Mitosis Modulators|mitosis modulators|mesh-ancestor
25638307|NCT01370694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25638308|NCT01370694|Glucocorticoids|glucocorticoids|mesh-ancestor
25638309|NCT01370694|Hormones|hormones|mesh-ancestor
25638310|NCT01370694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25638311|NCT01370694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25638312|NCT01371110|Midazolam|midazolam|mesh-list
25638313|NCT01371110|Ketamine|ketamine|mesh-list
25638314|NCT01371110|Analgesics|analgesics|mesh-ancestor
25638315|NCT01371110|Sensory System Agents|sensory system agents|mesh-ancestor
25638316|NCT01371110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25638317|NCT01371110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638318|NCT01371110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25638319|NCT01371110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25638320|NCT01371110|Anesthetics, General|anesthetics, general|mesh-ancestor
25638321|NCT01371110|Anesthetics|anesthetics|mesh-ancestor
25638322|NCT01371110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25638323|NCT01371110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25638324|NCT01371110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25638325|NCT01371110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25638326|NCT01371110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638327|NCT01371110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25638328|NCT01371110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25638329|NCT01371110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25638330|NCT01371110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25638331|NCT01371110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25638332|NCT01371110|GABA Modulators|gaba modulators|mesh-ancestor
25638333|NCT01371110|GABA Agents|gaba agents|mesh-ancestor
25638334|NCT01371565|Mifepristone|mifepristone|mesh-list
25638335|NCT01371565|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25638336|NCT01371565|Abortifacient Agents|abortifacient agents|mesh-ancestor
25638337|NCT01371565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25638338|NCT01371565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638339|NCT01371565|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25638340|NCT01371565|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25638341|NCT01371565|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25638342|NCT01371565|Contraceptive Agents|contraceptive agents|mesh-ancestor
25638343|NCT01371565|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25638344|NCT01371565|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25638345|NCT01371565|Hormone Antagonists|hormone antagonists|mesh-ancestor
25638346|NCT01371565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25638347|NCT01371565|Luteolytic Agents|luteolytic agents|mesh-ancestor
25638348|NCT01371565|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25638349|NCT01371565|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25638350|NCT01371643|Octreotide|octreotide|mesh-list
25638351|NCT01371643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25638352|NCT01371643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25638353|NCT01371643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25638354|NCT01371656|Levofloxacin|levofloxacin|mesh-list
25638355|NCT01371656|Ofloxacin|ofloxacin|mesh-list
25638356|NCT01371656|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25638357|NCT01371656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25638358|NCT01371656|Renal Agents|renal agents|mesh-ancestor
25638359|NCT01371656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25638360|NCT01371656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25638361|NCT01371656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25638362|NCT01371656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25638363|NCT01371656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533325|NCT00546637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533326|NCT00546637|Urological Agents|urological agents|mesh-ancestor
25533327|NCT00546728|Metformin|metformin|mesh-list
25533328|NCT00546728|Exenatide|exenatide|mesh-list
25533329|NCT00546728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25533330|NCT00546728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533331|NCT00546728|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25533332|NCT00546728|Incretins|incretins|mesh-ancestor
25533333|NCT00546728|Hormones|hormones|mesh-ancestor
25533334|NCT00546728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25533335|NCT00546871|Immunoglobulins|immunoglobulins|mesh-list
25533336|NCT00546871|Antibodies|antibodies|mesh-list
25533337|NCT00546871|gamma-Globulins|gamma-globulins|mesh-list
25638364|NCT01371656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25638365|NCT01371656|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25638366|NCT01371656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25638367|NCT01371734|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25638368|NCT01371734|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25638369|NCT01371734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25638370|NCT01371734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25638371|NCT01371734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638372|NCT01371734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25638373|NCT01371734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638374|NCT01371734|Antidepressive Agents|antidepressive agents|mesh-ancestor
25638375|NCT01371734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25638376|NCT01371747|Losartan|losartan|mesh-list
25638377|NCT01371747|Spironolactone|spironolactone|mesh-list
25718626|NCT02434497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25718627|NCT02434497|Antimetabolites|antimetabolites|mesh-ancestor
25718628|NCT02434497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638378|NCT01371747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25638379|NCT01371747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25638380|NCT01371747|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25638381|NCT01371747|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25638382|NCT01371747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638383|NCT01371747|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25638384|NCT01371747|Hormone Antagonists|hormone antagonists|mesh-ancestor
25638385|NCT01371747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25638386|NCT01371747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638387|NCT01371747|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25638388|NCT01371747|Diuretics|diuretics|mesh-ancestor
25638389|NCT01371747|Natriuretic Agents|natriuretic agents|mesh-ancestor
25638390|NCT01371786|Mometasone Furoate|mometasone furoate|mesh-list
25638391|NCT01371786|Ciclesonide|ciclesonide|mesh-list
25638392|NCT01371786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25638393|NCT01371786|Dermatologic Agents|dermatologic agents|mesh-ancestor
25638394|NCT01371786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25638395|NCT01371786|Glucocorticoids|glucocorticoids|mesh-ancestor
25638396|NCT01371786|Hormones|hormones|mesh-ancestor
25638397|NCT01371786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25638398|NCT01371786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638399|NCT01371838|Ceftriaxone|ceftriaxone|mesh-list
25638400|NCT01371838|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
25638401|NCT01371838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25638402|NCT01371838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25638403|NCT01371851|Doxazosin|doxazosin|mesh-list
25638404|NCT01371851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25638405|NCT01371851|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25638406|NCT01371851|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25638407|NCT01371851|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25638408|NCT01371851|Adrenergic Agents|adrenergic agents|mesh-ancestor
25638409|NCT01371851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25638410|NCT01371851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638411|NCT01371851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638412|NCT01371877|Vitamin D|vitamin d|mesh-list
25638413|NCT01371877|Ergocalciferols|ergocalciferols|mesh-list
25638414|NCT01371877|Cholecalciferol|cholecalciferol|mesh-list
25638415|NCT01371877|Vitamins|vitamins|mesh-list
25638416|NCT01371877|Micronutrients|micronutrients|mesh-ancestor
25638417|NCT01371877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638418|NCT01371877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25638419|NCT01371877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25638420|NCT01371994|Solifenacin Succinate|solifenacin succinate|mesh-list
25638421|NCT01371994|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25638422|NCT01371994|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25638423|NCT01371994|Cholinergic Agents|cholinergic agents|mesh-ancestor
25638424|NCT01371994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25638425|NCT01371994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638426|NCT01371994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638427|NCT01371994|Urological Agents|urological agents|mesh-ancestor
25638428|NCT01372150|Fluoxetine|fluoxetine|mesh-list
25638429|NCT01372150|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25638430|NCT01372150|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25638431|NCT01372150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25638432|NCT01372150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25638433|NCT01372150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638434|NCT01372150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25638435|NCT01372150|Serotonin Agents|serotonin agents|mesh-ancestor
25638436|NCT01372150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638437|NCT01372150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25638438|NCT01372150|Antidepressive Agents|antidepressive agents|mesh-ancestor
25638439|NCT01372150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25638440|NCT01372150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25638441|NCT01372150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25638442|NCT01372150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25638443|NCT01372150|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25638444|NCT01372202|Paclitaxel|paclitaxel|mesh-list
25638445|NCT01372202|Cisplatin|cisplatin|mesh-list
25638446|NCT01372202|Fluorouracil|fluorouracil|mesh-list
25533387|NCT00547521|Methotrexate|methotrexate|mesh-list
25638447|NCT01372202|Oxaliplatin|oxaliplatin|mesh-list
25638448|NCT01372202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25638449|NCT01372202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25638450|NCT01372202|Tubulin Modulators|tubulin modulators|mesh-ancestor
25638451|NCT01372202|Antimitotic Agents|antimitotic agents|mesh-ancestor
25638452|NCT01372202|Mitosis Modulators|mitosis modulators|mesh-ancestor
25638453|NCT01372202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638454|NCT01372202|Antimetabolites|antimetabolites|mesh-ancestor
25638455|NCT01372202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25638456|NCT01372202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25638457|NCT01372202|Immunologic Factors|immunologic factors|mesh-ancestor
25638458|NCT01372202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638459|NCT01372384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25638460|NCT01372384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25638461|NCT01372384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25638462|NCT01372384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25638463|NCT01372384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638464|NCT01372410|Tiotropium Bromide|tiotropium bromide|mesh-list
25638465|NCT01372410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25638466|NCT01372410|Autonomic Agents|autonomic agents|mesh-ancestor
25638467|NCT01372410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25638468|NCT01372410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638469|NCT01372410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25638470|NCT01372410|Respiratory System Agents|respiratory system agents|mesh-ancestor
25638471|NCT01372410|Parasympatholytics|parasympatholytics|mesh-ancestor
25638472|NCT01372410|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25638473|NCT01372410|Cholinergic Agents|cholinergic agents|mesh-ancestor
25638474|NCT01372410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25638475|NCT01372410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638476|NCT01372995|Vitamin D|vitamin d|mesh-list
25638477|NCT01372995|Ergocalciferols|ergocalciferols|mesh-list
25638478|NCT01372995|Cholecalciferol|cholecalciferol|mesh-list
25638479|NCT01372995|Vitamins|vitamins|mesh-list
25638480|NCT01372995|Micronutrients|micronutrients|mesh-ancestor
25638481|NCT01372995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638482|NCT01372995|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25638483|NCT01372995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25638484|NCT01373164|Gemcitabine|gemcitabine|mesh-list
25638485|NCT01373164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25638486|NCT01373164|Antimetabolites|antimetabolites|mesh-ancestor
25638487|NCT01373164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638488|NCT01373164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25638489|NCT01373164|Antiviral Agents|antiviral agents|mesh-ancestor
25638490|NCT01373164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25718647|NCT02434770|Vaccines|vaccines|mesh-list
25638491|NCT01373164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25638492|NCT01373164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25638493|NCT01373164|Immunologic Factors|immunologic factors|mesh-ancestor
25638494|NCT01373164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638495|NCT01373229|Plerixafor|plerixafor|mesh-list
25638496|NCT01373229|Rituximab|rituximab|mesh-list
25638497|NCT01373229|Lenalidomide|lenalidomide|mesh-list
25638498|NCT01373229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25638499|NCT01373229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25638500|NCT01373229|Immunologic Factors|immunologic factors|mesh-ancestor
25638501|NCT01373229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638502|NCT01373229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25638503|NCT01373229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25638504|NCT01373229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25638505|NCT01373229|Growth Substances|growth substances|mesh-ancestor
25638506|NCT01373229|Growth Inhibitors|growth inhibitors|mesh-ancestor
25638507|NCT01373229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25638508|NCT01373229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25638509|NCT01373229|Antiviral Agents|antiviral agents|mesh-ancestor
25638510|NCT01373229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25638511|NCT01373294|Lenalidomide|lenalidomide|mesh-list
25638512|NCT01373294|BCG Vaccine|bcg vaccine|mesh-list
25638513|NCT01373294|Immunologic Factors|immunologic factors|mesh-ancestor
25638514|NCT01373294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638515|NCT01373294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25638516|NCT01373294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25638517|NCT01373294|Growth Substances|growth substances|mesh-ancestor
25638518|NCT01373294|Growth Inhibitors|growth inhibitors|mesh-ancestor
25638519|NCT01373294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533459|NCT00548184|Trastuzumab|trastuzumab|mesh-list
25638520|NCT01373294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25638521|NCT01373450|Liraglutide|liraglutide|mesh-list
25638522|NCT01373450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25638523|NCT01373450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638524|NCT01373450|Incretins|incretins|mesh-ancestor
25638525|NCT01373450|Hormones|hormones|mesh-ancestor
25638526|NCT01373450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25638527|NCT01373918|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25638528|NCT01373918|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25638529|NCT01373918|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25638530|NCT01373918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25638531|NCT01373931|Moxifloxacin|moxifloxacin|mesh-list
25638532|NCT01373931|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25638533|NCT01373931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25638534|NCT01373931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25638535|NCT01373931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25638536|NCT01373931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25638537|NCT01373931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25638538|NCT01373931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638539|NCT01373931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25638540|NCT01373931|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25638541|NCT01373931|Contraceptive Agents|contraceptive agents|mesh-ancestor
25638542|NCT01373931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25638543|NCT01373931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638544|NCT01373931|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25638545|NCT01373931|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25638546|NCT01373931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25638547|NCT01374087|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25638548|NCT01374087|Luteolytic Agents|luteolytic agents|mesh-ancestor
25638549|NCT01374087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25638550|NCT01374087|Contraceptive Agents|contraceptive agents|mesh-ancestor
25638551|NCT01374087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25638552|NCT01374087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638553|NCT01374087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25638554|NCT01374087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25638555|NCT01374087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25638556|NCT01374178|Insulin Glargine|insulin glargine|mesh-list
25718659|NCT02434939|Anesthetics|anesthetics|mesh-ancestor
25638557|NCT01374178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25638558|NCT01374178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638559|NCT01374217|Clarithromycin|clarithromycin|mesh-list
25638560|NCT01374217|Dexamethasone|dexamethasone|mesh-list
25638561|NCT01374217|Lenalidomide|lenalidomide|mesh-list
25638562|NCT01374217|Tadalafil|tadalafil|mesh-list
25638563|NCT01374217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25638564|NCT01374217|Antiemetics|antiemetics|mesh-ancestor
25638565|NCT01374217|Autonomic Agents|autonomic agents|mesh-ancestor
25638566|NCT01374217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25638567|NCT01374217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638568|NCT01374217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25638569|NCT01374217|Glucocorticoids|glucocorticoids|mesh-ancestor
25638570|NCT01374217|Hormones|hormones|mesh-ancestor
25638571|NCT01374217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25638572|NCT01374217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25638573|NCT01374217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25638574|NCT01374217|Immunologic Factors|immunologic factors|mesh-ancestor
25638575|NCT01374217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25638576|NCT01374217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25638577|NCT01374217|Growth Substances|growth substances|mesh-ancestor
25638578|NCT01374217|Growth Inhibitors|growth inhibitors|mesh-ancestor
25638579|NCT01374217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25638580|NCT01374217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25638581|NCT01374217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25638582|NCT01374217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25638583|NCT01374217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638584|NCT01374217|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25638585|NCT01374217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25638586|NCT01374217|Vasodilator Agents|vasodilator agents|mesh-ancestor
25638587|NCT01374217|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25638588|NCT01374217|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25638589|NCT01374217|Urological Agents|urological agents|mesh-ancestor
25638590|NCT01374269|Acetaminophen|acetaminophen|mesh-list
25638591|NCT01374269|Celecoxib|celecoxib|mesh-list
25638592|NCT01374269|Naproxen|naproxen|mesh-list
25638593|NCT01374269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25638594|NCT01374269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25822745|NCT00004640|Chlorhexidine|chlorhexidine|mesh-list
25638595|NCT01374269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25638596|NCT01374269|Analgesics|analgesics|mesh-ancestor
25638597|NCT01374269|Sensory System Agents|sensory system agents|mesh-ancestor
25638598|NCT01374269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25638599|NCT01374269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638600|NCT01374269|Antipyretics|antipyretics|mesh-ancestor
25638601|NCT01374269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25638602|NCT01374269|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25638603|NCT01374269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25638604|NCT01374269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25638605|NCT01374269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638606|NCT01374269|Gout Suppressants|gout suppressants|mesh-ancestor
25638607|NCT01374425|Leucovorin|leucovorin|mesh-list
25638608|NCT01374425|Bevacizumab|bevacizumab|mesh-list
25638609|NCT01374425|Fluorouracil|fluorouracil|mesh-list
25638610|NCT01374425|Capecitabine|capecitabine|mesh-list
25638611|NCT01374425|Oxaliplatin|oxaliplatin|mesh-list
25638612|NCT01374425|Irinotecan|irinotecan|mesh-list
25638613|NCT01374425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25638614|NCT01374425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25638615|NCT01374425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25638616|NCT01374425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25638617|NCT01374425|Growth Substances|growth substances|mesh-ancestor
25638618|NCT01374425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638619|NCT01374425|Growth Inhibitors|growth inhibitors|mesh-ancestor
25718662|NCT02434939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25718663|NCT02434939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25718664|NCT02434939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638620|NCT01374425|Antimetabolites|antimetabolites|mesh-ancestor
25638621|NCT01374425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638622|NCT01374425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25638623|NCT01374425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25638624|NCT01374425|Immunologic Factors|immunologic factors|mesh-ancestor
25638625|NCT01374425|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25638626|NCT01374425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25638627|NCT01374425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25638628|NCT01374425|Antidotes|antidotes|mesh-ancestor
25638629|NCT01374425|Protective Agents|protective agents|mesh-ancestor
25638630|NCT01374425|Vitamin B Complex|vitamin b complex|mesh-ancestor
25638631|NCT01374425|Vitamins|vitamins|mesh-ancestor
25638632|NCT01374425|Micronutrients|micronutrients|mesh-ancestor
25638633|NCT01374451|Everolimus|everolimus|mesh-list
25638634|NCT01374451|Pasireotide|pasireotide|mesh-list
25638635|NCT01374451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25638636|NCT01374451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25638637|NCT01374451|Immunologic Factors|immunologic factors|mesh-ancestor
25638638|NCT01374451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638639|NCT01374451|Hormones|hormones|mesh-ancestor
25638640|NCT01374451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25638641|NCT01374568|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25638642|NCT01374568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25638643|NCT01374568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638644|NCT01374568|Incretins|incretins|mesh-ancestor
25638645|NCT01374568|Hormones|hormones|mesh-ancestor
25638646|NCT01374568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25638647|NCT01374568|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25638648|NCT01374568|Protease Inhibitors|protease inhibitors|mesh-ancestor
25638649|NCT01374568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25638650|NCT01374568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638651|NCT01374802|Ritonavir|ritonavir|mesh-list
25638652|NCT01374802|Darunavir|darunavir|mesh-list
25638653|NCT01374802|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25638654|NCT01374802|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25638655|NCT01374802|Protease Inhibitors|protease inhibitors|mesh-ancestor
25638656|NCT01374802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25638657|NCT01374802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638658|NCT01374802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25638659|NCT01374802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25638660|NCT01374802|Antiviral Agents|antiviral agents|mesh-ancestor
25638661|NCT01374802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25638662|NCT01374802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25638663|NCT01374802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25638664|NCT01374906|Pasireotide|pasireotide|mesh-list
25638665|NCT01374906|Hormones|hormones|mesh-ancestor
25638666|NCT01374906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25638667|NCT01374906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638668|NCT01374919|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25638669|NCT01374919|Hematinics|hematinics|mesh-ancestor
25638670|NCT01374919|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25638671|NCT01374919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25638672|NCT01374971|Certolizumab Pegol|certolizumab pegol|mesh-list
25638673|NCT01374971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25638674|NCT01374971|Immunologic Factors|immunologic factors|mesh-ancestor
25638675|NCT01374971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638676|NCT01374971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25638677|NCT01375010|Vitamin D|vitamin d|mesh-list
25638678|NCT01375010|Cholecalciferol|cholecalciferol|mesh-list
25638679|NCT01375010|Vitamins|vitamins|mesh-list
25638680|NCT01375010|Micronutrients|micronutrients|mesh-ancestor
25638681|NCT01375010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638682|NCT01375010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25638683|NCT01375010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25638684|NCT01375049|Aztreonam|aztreonam|mesh-list
25638685|NCT01375049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25638686|NCT01375049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25638687|NCT01375075|Atorvastatin|atorvastatin|mesh-list
25638688|NCT01375075|Evacetrapib|evacetrapib|mesh-list
25638689|NCT01375075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25638690|NCT01375075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25638691|NCT01375075|Antimetabolites|antimetabolites|mesh-ancestor
25638692|NCT01375075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638693|NCT01375075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25638694|NCT01375075|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25638695|NCT01375075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25638696|NCT01375127|Tofacitinib|tofacitinib|mesh-list
25638697|NCT01375127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25638698|NCT01375127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25638699|NCT01375127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638700|NCT01375140|Prednisone|prednisone|mesh-list
25638701|NCT01375140|Lenalidomide|lenalidomide|mesh-list
25638702|NCT01375140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25638703|NCT01375140|Glucocorticoids|glucocorticoids|mesh-ancestor
25638704|NCT01375140|Hormones|hormones|mesh-ancestor
25638705|NCT01375140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25638706|NCT01375140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638707|NCT01375140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25638708|NCT01375140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25638709|NCT01375140|Immunologic Factors|immunologic factors|mesh-ancestor
25638710|NCT01375140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25638711|NCT01375140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25638712|NCT01375140|Growth Substances|growth substances|mesh-ancestor
25638713|NCT01375140|Growth Inhibitors|growth inhibitors|mesh-ancestor
25638714|NCT01375374|Lacosamide|lacosamide|mesh-list
25638715|NCT01375374|Levetiracetam|levetiracetam|mesh-list
25638716|NCT01375374|Anticonvulsants|anticonvulsants|mesh-ancestor
25638717|NCT01375374|Nootropic Agents|nootropic agents|mesh-ancestor
25638718|NCT01375374|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25638719|NCT01375374|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25638720|NCT01375374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25638721|NCT01375374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638722|NCT01375491|Doxycycline|doxycycline|mesh-list
25638723|NCT01375491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25638724|NCT01375491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25638725|NCT01375491|Antimalarials|antimalarials|mesh-ancestor
25638726|NCT01375491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25638727|NCT01375491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25638728|NCT01375608|Decitabine|decitabine|mesh-list
25638729|NCT01375608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25638730|NCT01375608|Antimetabolites|antimetabolites|mesh-ancestor
25638731|NCT01375608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638732|NCT01375608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25638733|NCT01375608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25638734|NCT01375660|Vitamin D|vitamin d|mesh-list
25638735|NCT01375660|Ergocalciferols|ergocalciferols|mesh-list
25638736|NCT01375660|Vitamins|vitamins|mesh-ancestor
25638737|NCT01375660|Micronutrients|micronutrients|mesh-ancestor
25638738|NCT01375660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638739|NCT01375660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25638740|NCT01375660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25638741|NCT01375751|Evolocumab|evolocumab|mesh-list
25638742|NCT01375751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25638743|NCT01375751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25638744|NCT01375751|Antimetabolites|antimetabolites|mesh-ancestor
25638745|NCT01375751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638746|NCT01375751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25638747|NCT01375764|Ezetimibe|ezetimibe|mesh-list
25638748|NCT01375764|Evolocumab|evolocumab|mesh-list
25638749|NCT01375764|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25638750|NCT01375764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25638751|NCT01375764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25638752|NCT01375764|Antimetabolites|antimetabolites|mesh-ancestor
25638753|NCT01375764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638754|NCT01375764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25638755|NCT01375764|Immunologic Factors|immunologic factors|mesh-ancestor
25638756|NCT01375764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638757|NCT01375777|Ezetimibe|ezetimibe|mesh-list
25638758|NCT01375777|Evolocumab|evolocumab|mesh-list
25638759|NCT01375777|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25638760|NCT01375777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25638761|NCT01375777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25638762|NCT01375777|Antimetabolites|antimetabolites|mesh-ancestor
25638763|NCT01375777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638764|NCT01375777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25638765|NCT01375777|Immunologic Factors|immunologic factors|mesh-ancestor
25638766|NCT01375777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638767|NCT01375946|Contraceptive Agents|contraceptive agents|mesh-list
25638768|NCT01375946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25638769|NCT01375946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638770|NCT01376167|Chloroquine|chloroquine|mesh-list
25638771|NCT01376167|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
25638772|NCT01376167|Primaquine|primaquine|mesh-list
25638773|NCT01376167|Tafenoquine|tafenoquine|mesh-list
25638774|NCT01376167|Amebicides|amebicides|mesh-ancestor
25638775|NCT01376167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25638776|NCT01376167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25638777|NCT01376167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25638778|NCT01376167|Antimalarials|antimalarials|mesh-ancestor
25638779|NCT01376167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25638780|NCT01376167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25638781|NCT01376167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25638782|NCT01376167|Analgesics|analgesics|mesh-ancestor
25638783|NCT01376167|Sensory System Agents|sensory system agents|mesh-ancestor
25638784|NCT01376167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25638785|NCT01376167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638786|NCT01376167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25638787|NCT01376167|Filaricides|filaricides|mesh-ancestor
25638788|NCT01376167|Antinematodal Agents|antinematodal agents|mesh-ancestor
25638789|NCT01376167|Anthelmintics|anthelmintics|mesh-ancestor
25638790|NCT01376245|Fluticasone|fluticasone|mesh-list
25638791|NCT01376245|Xhance|xhance|mesh-list
25638792|NCT01376245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25638793|NCT01376245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25638794|NCT01376245|Autonomic Agents|autonomic agents|mesh-ancestor
25638795|NCT01376245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25638796|NCT01376245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638797|NCT01376245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25638798|NCT01376245|Respiratory System Agents|respiratory system agents|mesh-ancestor
25638799|NCT01376245|Dermatologic Agents|dermatologic agents|mesh-ancestor
25638800|NCT01376245|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25638801|NCT01376297|Dexamethasone|dexamethasone|mesh-list
25638802|NCT01376297|Aprepitant|aprepitant|mesh-list
25638803|NCT01376297|Palonosetron|palonosetron|mesh-list
25638804|NCT01376297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25638805|NCT01376297|Antiemetics|antiemetics|mesh-ancestor
25638806|NCT01376297|Autonomic Agents|autonomic agents|mesh-ancestor
25638807|NCT01376297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25638808|NCT01376297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638809|NCT01376297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25638810|NCT01376297|Glucocorticoids|glucocorticoids|mesh-ancestor
25638811|NCT01376297|Hormones|hormones|mesh-ancestor
25638812|NCT01376297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25638813|NCT01376297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25638814|NCT01376297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25638815|NCT01376297|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25638816|NCT01376297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25638817|NCT01376297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638818|NCT01376297|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25638819|NCT01376297|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25638820|NCT01376297|Serotonin Agents|serotonin agents|mesh-ancestor
25638821|NCT01376310|Gemcitabine|gemcitabine|mesh-list
25638822|NCT01376310|Paclitaxel|paclitaxel|mesh-list
25638823|NCT01376310|Docetaxel|docetaxel|mesh-list
25638824|NCT01376310|Carboplatin|carboplatin|mesh-list
25638825|NCT01376310|Pemetrexed|pemetrexed|mesh-list
25638826|NCT01376310|Everolimus|everolimus|mesh-list
25638827|NCT01376310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25638829|NCT01376310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25638830|NCT01376310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25638831|NCT01376310|Tubulin Modulators|tubulin modulators|mesh-ancestor
25638832|NCT01376310|Antimitotic Agents|antimitotic agents|mesh-ancestor
25718682|NCT02435680|Antimetabolites|antimetabolites|mesh-ancestor
25638833|NCT01376310|Mitosis Modulators|mitosis modulators|mesh-ancestor
25638834|NCT01376310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638835|NCT01376310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25638836|NCT01376310|Antimetabolites|antimetabolites|mesh-ancestor
25638837|NCT01376310|Antiviral Agents|antiviral agents|mesh-ancestor
25638838|NCT01376310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25638839|NCT01376310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25638840|NCT01376310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25638841|NCT01376310|Immunologic Factors|immunologic factors|mesh-ancestor
25638842|NCT01376310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638843|NCT01376310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25638844|NCT01376310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25638845|NCT01376310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25656498|NCT01575899|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25656499|NCT01575899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25656500|NCT01575899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656501|NCT01575899|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25656502|NCT01575899|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25656503|NCT01575899|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25656504|NCT01575899|Renal Agents|renal agents|mesh-ancestor
25656505|NCT01575899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25656506|NCT01575899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25656507|NCT01575899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656508|NCT01575899|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25656509|NCT01575899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25656510|NCT01575899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25656511|NCT01575899|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25656512|NCT01575899|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25656513|NCT01576042|Amiodarone|amiodarone|mesh-list
25656514|NCT01576042|Sotalol|sotalol|mesh-list
25656515|NCT01576042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25656516|NCT01576042|Vasodilator Agents|vasodilator agents|mesh-ancestor
25656517|NCT01576042|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25656518|NCT01576042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25656519|NCT01576042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656520|NCT01576042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25656521|NCT01576042|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25656522|NCT01576042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25656523|NCT01576042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25656524|NCT01576042|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25656525|NCT01576042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25656526|NCT01576042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25656527|NCT01576042|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25656528|NCT01576042|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25656529|NCT01576042|Adrenergic Agents|adrenergic agents|mesh-ancestor
25656530|NCT01576042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25656531|NCT01576042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656532|NCT01576042|Sympatholytics|sympatholytics|mesh-ancestor
25656533|NCT01576042|Autonomic Agents|autonomic agents|mesh-ancestor
25656534|NCT01576042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25656535|NCT01576172|Prednisone|prednisone|mesh-list
25656536|NCT01576172|Cortisone|cortisone|mesh-list
25656537|NCT01576172|Abiraterone Acetate|abiraterone acetate|mesh-list
25656538|NCT01576172|Veliparib|veliparib|mesh-list
25656539|NCT01576172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25656540|NCT01576172|Glucocorticoids|glucocorticoids|mesh-ancestor
25656541|NCT01576172|Hormones|hormones|mesh-ancestor
25656542|NCT01576172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25656543|NCT01576172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656544|NCT01576172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25656545|NCT01576172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656546|NCT01576172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25656547|NCT01576172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25656548|NCT01576172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656549|NCT01576172|Hormone Antagonists|hormone antagonists|mesh-ancestor
25656550|NCT01576172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25638847|NCT01376349|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25638848|NCT01376349|Immunologic Factors|immunologic factors|mesh-ancestor
25638849|NCT01376349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638850|NCT01376362|Interferons|interferons|mesh-list
25638851|NCT01376362|Interferon-gamma|interferon-gamma|mesh-list
25638852|NCT01376362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25638853|NCT01376362|Antiviral Agents|antiviral agents|mesh-ancestor
25638854|NCT01376362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25638855|NCT01376557|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25638856|NCT01376557|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25638857|NCT01376557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638858|NCT01376557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25638859|NCT01376557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638860|NCT01376700|Factor VIII|factor viii|mesh-list
25638861|NCT01376700|Coagulants|coagulants|mesh-ancestor
25638862|NCT01376804|Valganciclovir|valganciclovir|mesh-list
25638863|NCT01376804|Antiviral Agents|antiviral agents|mesh-ancestor
25638864|NCT01376804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25638865|NCT01377194|Milnacipran|milnacipran|mesh-list
25638866|NCT01377194|Levomilnacipran|levomilnacipran|mesh-list
25638867|NCT01377194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25638868|NCT01377194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25638869|NCT01377194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25638870|NCT01377194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638871|NCT01377194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25638872|NCT01377194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638873|NCT01377194|Antidepressive Agents|antidepressive agents|mesh-ancestor
25638874|NCT01377194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25638875|NCT01377194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25638876|NCT01377194|Analgesics|analgesics|mesh-ancestor
25638877|NCT01377194|Sensory System Agents|sensory system agents|mesh-ancestor
25638878|NCT01377194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25638879|NCT01377389|Ipilimumab|ipilimumab|mesh-list
25638880|NCT01377389|Leuprolide|leuprolide|mesh-list
25638881|NCT01377389|Goserelin|goserelin|mesh-list
25638882|NCT01377389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25638883|NCT01377389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25638884|NCT01377389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25638885|NCT01377389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638886|NCT01377389|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25638887|NCT01377389|Fertility Agents|fertility agents|mesh-ancestor
25638888|NCT01377389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25638889|NCT01377389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638890|NCT01377389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25638891|NCT01377467|Denosumab|denosumab|mesh-list
25638892|NCT01377467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25638893|NCT01377467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638894|NCT01377480|Posaconazole|posaconazole|mesh-list
25638895|NCT01377480|Benzonidazole|benzonidazole|mesh-list
25638896|NCT01377480|Antifungal Agents|antifungal agents|mesh-ancestor
25638897|NCT01377480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25638898|NCT01377480|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25638899|NCT01377480|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25638900|NCT01377480|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25638901|NCT01377480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25638902|NCT01377480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25638903|NCT01377480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25638904|NCT01377480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638905|NCT01377480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25638906|NCT01377480|Hormone Antagonists|hormone antagonists|mesh-ancestor
25638907|NCT01377480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25638908|NCT01377480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638909|NCT01377480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25638910|NCT01377480|Immunologic Factors|immunologic factors|mesh-ancestor
25638911|NCT01377623|Dexmedetomidine|dexmedetomidine|mesh-list
25638912|NCT01377623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25638913|NCT01377623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25638914|NCT01377623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638915|NCT01377623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25718687|NCT02435680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25718688|NCT02435680|Immunologic Factors|immunologic factors|mesh-ancestor
25638916|NCT01377623|Analgesics|analgesics|mesh-ancestor
25533900|NCT00550771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25638917|NCT01377623|Sensory System Agents|sensory system agents|mesh-ancestor
25638918|NCT01377623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25638919|NCT01377623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25638920|NCT01377623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25638921|NCT01377623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25638922|NCT01377623|Adrenergic Agents|adrenergic agents|mesh-ancestor
25638923|NCT01377623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25638924|NCT01377623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638925|NCT01377636|Isoproterenol|isoproterenol|mesh-list
25638926|NCT01377636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25638927|NCT01377636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25638928|NCT01377636|Adrenergic Agents|adrenergic agents|mesh-ancestor
25638929|NCT01377636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25638930|NCT01377636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638931|NCT01377636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638932|NCT01377636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25638933|NCT01377636|Autonomic Agents|autonomic agents|mesh-ancestor
25638934|NCT01377636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25638935|NCT01377636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25638936|NCT01377636|Respiratory System Agents|respiratory system agents|mesh-ancestor
25638937|NCT01377636|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25638938|NCT01377636|Sympathomimetics|sympathomimetics|mesh-ancestor
25638939|NCT01377636|Protective Agents|protective agents|mesh-ancestor
25638940|NCT01377844|Bexagliflozin|bexagliflozin|mesh-list
25638941|NCT01377844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25638942|NCT01377844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638943|NCT01377922|Amifampridine|amifampridine|mesh-list
25638944|NCT01377922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25638945|NCT01377922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25638946|NCT01377922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638947|NCT01377922|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25638948|NCT01377922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25638949|NCT01377922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638950|NCT01377987|Acetazolamide|acetazolamide|mesh-list
25638951|NCT01377987|Anticonvulsants|anticonvulsants|mesh-ancestor
25638952|NCT01377987|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25638953|NCT01377987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25638954|NCT01377987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638955|NCT01377987|Diuretics|diuretics|mesh-ancestor
25638956|NCT01377987|Natriuretic Agents|natriuretic agents|mesh-ancestor
25638957|NCT01377987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638958|NCT01378104|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25638959|NCT01378104|Interferon-alpha|interferon-alpha|mesh-list
25638960|NCT01378104|Antiviral Agents|antiviral agents|mesh-ancestor
25638961|NCT01378104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25638962|NCT01378104|Immunologic Factors|immunologic factors|mesh-ancestor
25638963|NCT01378104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638964|NCT01378117|Insulin Glargine|insulin glargine|mesh-list
25638965|NCT01378117|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25638966|NCT01378117|Insulin Lispro|insulin lispro|mesh-list
25638967|NCT01378117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25638968|NCT01378117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638969|NCT01378117|Incretins|incretins|mesh-ancestor
25638970|NCT01378117|Hormones|hormones|mesh-ancestor
25638971|NCT01378117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25638972|NCT01378117|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25638973|NCT01378117|Protease Inhibitors|protease inhibitors|mesh-ancestor
25638974|NCT01378117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25638975|NCT01378117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25638976|NCT01378273|Epoetin Alfa|epoetin alfa|mesh-list
25638977|NCT01378273|Hematinics|hematinics|mesh-ancestor
25638978|NCT01378299|Methyltestosterone|methyltestosterone|mesh-list
25638979|NCT01378299|Testosterone|testosterone|mesh-list
25638980|NCT01378299|Testosterone undecanoate|testosterone undecanoate|mesh-list
25638981|NCT01378299|Testosterone enanthate|testosterone enanthate|mesh-list
25638982|NCT01378299|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25638983|NCT01378299|Androgens|androgens|mesh-ancestor
25638984|NCT01378299|Hormones|hormones|mesh-ancestor
25638985|NCT01378299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25638986|NCT01378299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638987|NCT01378299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25638988|NCT01378299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25638989|NCT01378299|Anabolic Agents|anabolic agents|mesh-ancestor
25638990|NCT01378325|Phenylephrine|phenylephrine|mesh-list
25533979|NCT00551213|Irinotecan|irinotecan|mesh-list
25638991|NCT01378325|Oxymetazoline|oxymetazoline|mesh-list
25638992|NCT01378325|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25638993|NCT01378325|Mydriatics|mydriatics|mesh-ancestor
25638994|NCT01378325|Autonomic Agents|autonomic agents|mesh-ancestor
25638995|NCT01378325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25638996|NCT01378325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25638997|NCT01378325|Sympathomimetics|sympathomimetics|mesh-ancestor
25638998|NCT01378325|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25638999|NCT01378325|Nasal Decongestants|nasal decongestants|mesh-ancestor
25639000|NCT01378325|Respiratory System Agents|respiratory system agents|mesh-ancestor
25639001|NCT01378325|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25639002|NCT01378325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25639003|NCT01378325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25639004|NCT01378325|Adrenergic Agents|adrenergic agents|mesh-ancestor
25639005|NCT01378325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25639006|NCT01378325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639007|NCT01378325|Protective Agents|protective agents|mesh-ancestor
25639008|NCT01378377|Niacinamide|niacinamide|mesh-list
25639009|NCT01378377|Sirolimus|sirolimus|mesh-list
25639010|NCT01378377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25639011|NCT01378377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25639012|NCT01378377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25639013|NCT01378377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25639014|NCT01378377|Antifungal Agents|antifungal agents|mesh-ancestor
25639015|NCT01378377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25639016|NCT01378377|Immunologic Factors|immunologic factors|mesh-ancestor
25639017|NCT01378377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639018|NCT01378377|Vitamin B Complex|vitamin b complex|mesh-ancestor
25639019|NCT01378377|Vitamins|vitamins|mesh-ancestor
25639020|NCT01378377|Micronutrients|micronutrients|mesh-ancestor
25639021|NCT01378416|Decitabine|decitabine|mesh-list
25639022|NCT01378416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25639023|NCT01378416|Antimetabolites|antimetabolites|mesh-ancestor
25639024|NCT01378416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639025|NCT01378416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25639026|NCT01378416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639027|NCT01378429|Ciclesonide|ciclesonide|mesh-list
25639028|NCT01378429|Glucocorticoids|glucocorticoids|mesh-ancestor
25639029|NCT01378429|Hormones|hormones|mesh-ancestor
25639030|NCT01378429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25639031|NCT01378429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639032|NCT01378429|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25639033|NCT01378520|Ketoconazole|ketoconazole|mesh-list
25639034|NCT01378520|Antifungal Agents|antifungal agents|mesh-ancestor
25639035|NCT01378520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25639036|NCT01378520|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25639037|NCT01378520|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25639038|NCT01378520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639039|NCT01378520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639040|NCT01378520|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25639041|NCT01378520|Hormone Antagonists|hormone antagonists|mesh-ancestor
25639042|NCT01378520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25639043|NCT01378520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639044|NCT01378520|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25639045|NCT01378858|Varenicline|varenicline|mesh-list
25639046|NCT01378858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25639047|NCT01378858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25639048|NCT01378858|Cholinergic Agents|cholinergic agents|mesh-ancestor
25639049|NCT01378858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25639050|NCT01378858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639051|NCT01378858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639052|NCT01378962|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25639053|NCT01378962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25639054|NCT01378962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25639055|NCT01378962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639056|NCT01378962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639057|NCT01378975|Vemurafenib|vemurafenib|mesh-list
25639058|NCT01378975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25639059|NCT01378975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25639060|NCT01378975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639061|NCT01378975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639062|NCT01378988|Dexmedetomidine|dexmedetomidine|mesh-list
25639063|NCT01378988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25639064|NCT01378988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25639065|NCT01378988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639066|NCT01378988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25639067|NCT01378988|Analgesics|analgesics|mesh-ancestor
25639068|NCT01378988|Sensory System Agents|sensory system agents|mesh-ancestor
25639069|NCT01378988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25639070|NCT01378988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25639071|NCT01378988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25639072|NCT01378988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25639073|NCT01378988|Adrenergic Agents|adrenergic agents|mesh-ancestor
25639074|NCT01378988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25639075|NCT01378988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639076|NCT01379183|Erythromycin|erythromycin|mesh-list
25639077|NCT01379183|Erythromycin Estolate|erythromycin estolate|mesh-list
25639078|NCT01379183|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25639079|NCT01379183|Erythromycin stearate|erythromycin stearate|mesh-list
25639080|NCT01379183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25639081|NCT01379183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25639082|NCT01379183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25639083|NCT01379183|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25639084|NCT01379183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639085|NCT01379183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639087|NCT01379508|Telbivudine|telbivudine|mesh-list
25639088|NCT01379508|Antiviral Agents|antiviral agents|mesh-ancestor
25639089|NCT01379508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25639090|NCT01379508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25639091|NCT01379508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25639092|NCT01379508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639093|NCT01379508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639094|NCT01379508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25639095|NCT01379508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25639096|NCT01379521|Everolimus|everolimus|mesh-list
25639097|NCT01379521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25639098|NCT01379521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25639099|NCT01379521|Immunologic Factors|immunologic factors|mesh-ancestor
25639100|NCT01379521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639101|NCT01379573|Hydroxychloroquine|hydroxychloroquine|mesh-list
25639102|NCT01379573|Antimalarials|antimalarials|mesh-ancestor
25639103|NCT01379573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25639104|NCT01379573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25639105|NCT01379573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25639106|NCT01379573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639107|NCT01379573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639108|NCT01379573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25639109|NCT01379664|Sevoflurane|sevoflurane|mesh-list
25639110|NCT01379664|Isoflurane|isoflurane|mesh-list
25639111|NCT01379664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25639112|NCT01379664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25639113|NCT01379664|Anesthetics, General|anesthetics, general|mesh-ancestor
25639114|NCT01379664|Anesthetics|anesthetics|mesh-ancestor
25639115|NCT01379664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25639116|NCT01379664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639117|NCT01379937|Vaccines|vaccines|mesh-list
25639118|NCT01379937|Immunologic Factors|immunologic factors|mesh-ancestor
25639119|NCT01379937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639120|NCT01380080|Efavirenz|efavirenz|mesh-list
25639121|NCT01380080|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25639122|NCT01380080|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25639123|NCT01380080|Rifampin|rifampin|mesh-list
25639124|NCT01380080|Isoniazid|isoniazid|mesh-list
25639125|NCT01380080|Pyrazinamide|pyrazinamide|mesh-list
25639126|NCT01380080|Ethambutol|ethambutol|mesh-list
25639127|NCT01380080|Isoniazid, pyrazinamide, rifampin drug combination|isoniazid, pyrazinamide, rifampin drug combination|mesh-list
25639128|NCT01380080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25639129|NCT01380080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25639130|NCT01380080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639131|NCT01380080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639132|NCT01380080|Antiviral Agents|antiviral agents|mesh-ancestor
25639133|NCT01380080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25639134|NCT01380080|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25639135|NCT01380080|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25639136|NCT01380080|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25639137|NCT01380080|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25534195|NCT00552422|Antiemetics|antiemetics|mesh-ancestor
25534196|NCT00552422|Autonomic Agents|autonomic agents|mesh-ancestor
25534197|NCT00552422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25534198|NCT00552422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534199|NCT00552422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25534200|NCT00552422|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25534201|NCT00552422|Dopamine Agents|dopamine agents|mesh-ancestor
25534202|NCT00552422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25534203|NCT00552422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124519|NCT03075358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124520|NCT03075358|Sensory System Agents|sensory system agents|mesh-ancestor
25040997|NCT02700529|Ubenimex|ubenimex|mesh-list
25040998|NCT02700529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25162121|NCT02908035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25162122|NCT02908035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25162123|NCT02908035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25162124|NCT02908035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162125|NCT02908035|Antifungal Agents|antifungal agents|mesh-ancestor
25162126|NCT02908035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25162127|NCT02908035|Immunologic Factors|immunologic factors|mesh-ancestor
25162128|NCT02908035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162129|NCT02907749|Carvedilol|carvedilol|mesh-list
25162130|NCT02907749|Spironolactone|spironolactone|mesh-list
25162135|NCT02907749|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25162136|NCT02907749|Diuretics|diuretics|mesh-ancestor
25162137|NCT02907749|Natriuretic Agents|natriuretic agents|mesh-ancestor
25162138|NCT02907749|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25162139|NCT02907749|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25162140|NCT02907749|Adrenergic Agents|adrenergic agents|mesh-ancestor
25162141|NCT02907749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25162142|NCT02907749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162143|NCT02907749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25162144|NCT02907749|Antioxidants|antioxidants|mesh-ancestor
25162145|NCT02907749|Protective Agents|protective agents|mesh-ancestor
25162146|NCT02907749|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25162147|NCT02907749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24437522|NCT00273962|Tocolytic Agents|tocolytic agents|mesh-ancestor
25162154|NCT02907593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25124541|NCT03074994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162155|NCT02907593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25162156|NCT02907593|Autonomic Agents|autonomic agents|mesh-ancestor
25162157|NCT02907593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25822746|NCT00004640|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25822747|NCT00004640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25822748|NCT00004640|Disinfectants|disinfectants|mesh-ancestor
25822749|NCT00004643|Cytarabine|cytarabine|mesh-list
24843311|NCT02226913|Mydriatics|mydriatics|mesh-ancestor
25124561|NCT03074825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25124562|NCT03074825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124564|NCT03074773|Dexamethasone|dexamethasone|mesh-list
24437449|NCT00273689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24437451|NCT00273689|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24437452|NCT00273689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24437453|NCT00273689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437454|NCT00273689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24437455|NCT00273689|Autonomic Agents|autonomic agents|mesh-ancestor
24437456|NCT00273689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24437457|NCT00273689|Tocolytic Agents|tocolytic agents|mesh-ancestor
24437458|NCT00273689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24437459|NCT00273689|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24437460|NCT00273689|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24437461|NCT00273689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24979918|NCT04971954|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24979919|NCT04971954|Cholinergic Agents|cholinergic agents|mesh-ancestor
24979920|NCT04971954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25404094|NCT03684980|Vitamin B Complex|vitamin b complex|mesh-ancestor
25639138|NCT01380080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25639139|NCT01380080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25639140|NCT01380080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25639141|NCT01380080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25639142|NCT01380080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25639143|NCT01380080|Antitubercular Agents|antitubercular agents|mesh-ancestor
25639144|NCT01380080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25639145|NCT01380080|Leprostatic Agents|leprostatic agents|mesh-ancestor
25822750|NCT00004643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25639146|NCT01380080|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25639147|NCT01380080|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25639148|NCT01380080|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25639149|NCT01380080|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25639150|NCT01380080|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25639151|NCT01380080|Antimetabolites|antimetabolites|mesh-ancestor
25639152|NCT01380080|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25639153|NCT01380093|Naltrexone|naltrexone|mesh-list
25639154|NCT01380093|Morphine|morphine|mesh-list
25639155|NCT01380093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25639156|NCT01380093|Narcotics|narcotics|mesh-ancestor
25639157|NCT01380093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25639158|NCT01380093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639159|NCT01380093|Analgesics|analgesics|mesh-ancestor
25639160|NCT01380093|Sensory System Agents|sensory system agents|mesh-ancestor
25639161|NCT01380093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25639162|NCT01380093|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25639163|NCT01380093|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25639164|NCT01380106|Lenalidomide|lenalidomide|mesh-list
25639165|NCT01380106|Immunologic Factors|immunologic factors|mesh-ancestor
25639166|NCT01380106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639167|NCT01380106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25639168|NCT01380106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25639169|NCT01380106|Growth Substances|growth substances|mesh-ancestor
25639170|NCT01380106|Growth Inhibitors|growth inhibitors|mesh-ancestor
25639171|NCT01380106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25639172|NCT01380184|Sirolimus|sirolimus|mesh-list
25639173|NCT01380184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25639174|NCT01380184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25639175|NCT01380184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25639176|NCT01380184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25639177|NCT01380184|Antifungal Agents|antifungal agents|mesh-ancestor
25639178|NCT01380184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25639179|NCT01380184|Immunologic Factors|immunologic factors|mesh-ancestor
25639180|NCT01380184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639181|NCT01380197|Morphine|morphine|mesh-list
25639182|NCT01380197|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25639183|NCT01380197|Narcotics|narcotics|mesh-ancestor
25639184|NCT01380197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25639185|NCT01380197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639186|NCT01380197|Analgesics|analgesics|mesh-ancestor
25639187|NCT01380197|Sensory System Agents|sensory system agents|mesh-ancestor
25639188|NCT01380197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25639189|NCT01380327|Immunologic Factors|immunologic factors|mesh-list
25639190|NCT01380327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639191|NCT01380366|Hormones|hormones|mesh-list
25639192|NCT01380366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25639193|NCT01380366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639194|NCT01380535|Methoxsalen|methoxsalen|mesh-list
25639195|NCT01380535|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25639196|NCT01380535|Dermatologic Agents|dermatologic agents|mesh-ancestor
25639197|NCT01380691|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
25639198|NCT01380691|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25639199|NCT01380691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25639200|NCT01380691|Disinfectants|disinfectants|mesh-ancestor
25639201|NCT01380730|Evolocumab|evolocumab|mesh-list
25639202|NCT01380730|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25639203|NCT01380730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25639204|NCT01380730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25639205|NCT01380730|Antimetabolites|antimetabolites|mesh-ancestor
25639206|NCT01380730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639207|NCT01380730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25639208|NCT01380730|Immunologic Factors|immunologic factors|mesh-ancestor
25639209|NCT01380730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639210|NCT01380743|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
25639211|NCT01380743|Antiviral Agents|antiviral agents|mesh-ancestor
25639212|NCT01380743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25639213|NCT01380743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639214|NCT01380743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639215|NCT01380782|Nintedanib|nintedanib|mesh-list
25639216|NCT01380782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25639217|NCT01380782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25718754|NCT02436135|Idelalisib|idelalisib|mesh-list
25639218|NCT01380782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639219|NCT01380782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534204|NCT00552578|Buprenorphine|buprenorphine|mesh-list
25639220|NCT01380990|Busulfan|busulfan|mesh-list
25639221|NCT01380990|Alkylating Agents|alkylating agents|mesh-ancestor
25639222|NCT01380990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639223|NCT01380990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25639224|NCT01380990|Immunologic Factors|immunologic factors|mesh-ancestor
25639225|NCT01380990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639226|NCT01380990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25639227|NCT01380990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25639228|NCT01380990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25639229|NCT01381016|Hormones|hormones|mesh-list
25639230|NCT01381016|Estradiol|estradiol|mesh-list
25639231|NCT01381016|Progesterone|progesterone|mesh-list
25639232|NCT01381016|Estrogens|estrogens|mesh-list
25639233|NCT01381016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25639234|NCT01381016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639235|NCT01381016|Progestins|progestins|mesh-ancestor
25639236|NCT01381120|Acetaminophen|acetaminophen|mesh-list
25639237|NCT01381120|Oxycodone|oxycodone|mesh-list
25639238|NCT01381120|Solifenacin Succinate|solifenacin succinate|mesh-list
25639239|NCT01381120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25639240|NCT01381120|Analgesics|analgesics|mesh-ancestor
25639241|NCT01381120|Sensory System Agents|sensory system agents|mesh-ancestor
25639242|NCT01381120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25639243|NCT01381120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639244|NCT01381120|Antipyretics|antipyretics|mesh-ancestor
25639245|NCT01381120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25639246|NCT01381120|Narcotics|narcotics|mesh-ancestor
25639247|NCT01381120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25639248|NCT01381120|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25639249|NCT01381120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25639250|NCT01381120|Cholinergic Agents|cholinergic agents|mesh-ancestor
25639251|NCT01381120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25639252|NCT01381120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639253|NCT01381120|Urological Agents|urological agents|mesh-ancestor
25639254|NCT01381406|Tiotropium Bromide|tiotropium bromide|mesh-list
25639255|NCT01381406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25639256|NCT01381406|Autonomic Agents|autonomic agents|mesh-ancestor
25639257|NCT01381406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25639258|NCT01381406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639259|NCT01381406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25639260|NCT01381406|Respiratory System Agents|respiratory system agents|mesh-ancestor
25639261|NCT01381406|Parasympatholytics|parasympatholytics|mesh-ancestor
25639262|NCT01381406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25639263|NCT01381406|Cholinergic Agents|cholinergic agents|mesh-ancestor
25639264|NCT01381406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25639265|NCT01381406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639266|NCT01381471|Fluticasone|fluticasone|mesh-list
25639267|NCT01381471|Xhance|xhance|mesh-list
25639268|NCT01381471|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25639269|NCT01381471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25639270|NCT01381471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25639271|NCT01381471|Autonomic Agents|autonomic agents|mesh-ancestor
25639272|NCT01381471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25639273|NCT01381471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639274|NCT01381471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25639275|NCT01381471|Respiratory System Agents|respiratory system agents|mesh-ancestor
25639276|NCT01381471|Dermatologic Agents|dermatologic agents|mesh-ancestor
25771384|NCT03605212|Febuxostat|febuxostat|mesh-list
25639277|NCT01381471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25639278|NCT01381471|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25639279|NCT01381471|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25639280|NCT01381471|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25639281|NCT01381471|Adrenergic Agents|adrenergic agents|mesh-ancestor
25639282|NCT01381471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25639283|NCT01381471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639284|NCT01381549|Imipenem|imipenem|mesh-list
25639285|NCT01381549|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
25639286|NCT01381549|Cilastatin|cilastatin|mesh-list
25639287|NCT01381549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25639288|NCT01381549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25639289|NCT01381549|Protease Inhibitors|protease inhibitors|mesh-ancestor
25639290|NCT01381549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639291|NCT01381549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639292|NCT01381562|Meropenem|meropenem|mesh-list
25639293|NCT01381562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25639294|NCT01381562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25639295|NCT01381692|Sirolimus|sirolimus|mesh-list
25639296|NCT01381692|Dexamethasone|dexamethasone|mesh-list
25639297|NCT01381692|Dexamethasone acetate|dexamethasone acetate|mesh-list
25639298|NCT01381692|Rituximab|rituximab|mesh-list
25639299|NCT01381692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25639300|NCT01381692|Bortezomib|bortezomib|mesh-list
25639301|NCT01381692|Antibodies|antibodies|mesh-list
25639302|NCT01381692|Immunoglobulins|immunoglobulins|mesh-list
25639303|NCT01381692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25639304|NCT01381692|BB 1101|bb 1101|mesh-list
25639305|NCT01381692|Immunologic Factors|immunologic factors|mesh-ancestor
25639306|NCT01381692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639307|NCT01381692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25639308|NCT01381692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25639309|NCT01381692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25639310|NCT01381692|Antiemetics|antiemetics|mesh-ancestor
25639311|NCT01381692|Autonomic Agents|autonomic agents|mesh-ancestor
25639312|NCT01381692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25639313|NCT01381692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25639314|NCT01381692|Glucocorticoids|glucocorticoids|mesh-ancestor
25639315|NCT01381692|Hormones|hormones|mesh-ancestor
25639316|NCT01381692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25639317|NCT01381692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25639318|NCT01381692|Protease Inhibitors|protease inhibitors|mesh-ancestor
25639319|NCT01381692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639320|NCT01381692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639321|NCT01381692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25639322|NCT01381692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25639323|NCT01381692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25639324|NCT01381692|Antifungal Agents|antifungal agents|mesh-ancestor
25639325|NCT01381692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25639326|NCT01381718|Modafinil|modafinil|mesh-list
25639327|NCT01381718|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25639328|NCT01381718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639329|NCT01381718|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25639330|NCT01381718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25639331|NCT01381718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25639332|NCT01381718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639333|NCT01381861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25639334|NCT01381861|Immunologic Factors|immunologic factors|mesh-ancestor
25639335|NCT01381861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639336|NCT01381874|Prednisone|prednisone|mesh-list
25639337|NCT01381874|Prednisolone|prednisolone|mesh-list
25639338|NCT01381874|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25639339|NCT01381874|Methylprednisolone|methylprednisolone|mesh-list
25639340|NCT01381874|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25639341|NCT01381874|Prednisolone acetate|prednisolone acetate|mesh-list
25639342|NCT01381874|Exemestane|exemestane|mesh-list
25639343|NCT01381874|Abiraterone Acetate|abiraterone acetate|mesh-list
25639344|NCT01381874|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25639345|NCT01381874|Prednisolone phosphate|prednisolone phosphate|mesh-list
25639346|NCT01381874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25639347|NCT01381874|Glucocorticoids|glucocorticoids|mesh-ancestor
25639348|NCT01381874|Hormones|hormones|mesh-ancestor
25639349|NCT01381874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25639350|NCT01381874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639351|NCT01381874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25639352|NCT01381874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25639353|NCT01381874|Antiemetics|antiemetics|mesh-ancestor
25639354|NCT01381874|Autonomic Agents|autonomic agents|mesh-ancestor
25639355|NCT01381874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25639356|NCT01381874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25639357|NCT01381874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25639358|NCT01381874|Protective Agents|protective agents|mesh-ancestor
25639359|NCT01381874|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25639360|NCT01381874|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25639361|NCT01381874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639362|NCT01381874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639363|NCT01381874|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25639364|NCT01381874|Hormone Antagonists|hormone antagonists|mesh-ancestor
25639365|NCT01381874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25639366|NCT01381900|Metformin|metformin|mesh-list
25639367|NCT01381900|Canagliflozin|canagliflozin|mesh-list
25639368|NCT01381900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25639369|NCT01381900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639370|NCT01381900|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25639371|NCT01381900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639372|NCT01381926|Exenatide|exenatide|mesh-list
25639373|NCT01381926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25639374|NCT01381926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639375|NCT01381926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25639376|NCT01381926|Incretins|incretins|mesh-ancestor
25639377|NCT01381926|Hormones|hormones|mesh-ancestor
25639378|NCT01381926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25639379|NCT01382225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25639380|NCT01382225|Hyaluronic Acid|hyaluronic acid|mesh-list
25639381|NCT01382225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25639382|NCT01382225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25639383|NCT01382225|Immunologic Factors|immunologic factors|mesh-ancestor
25639384|NCT01382225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639385|NCT01382225|Viscosupplements|viscosupplements|mesh-ancestor
25639386|NCT01382225|Protective Agents|protective agents|mesh-ancestor
25639387|NCT01382303|Pentoxifylline|pentoxifylline|mesh-list
25639388|NCT01382303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25639389|NCT01382303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639390|NCT01382303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639391|NCT01382303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25639392|NCT01382303|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25639393|NCT01382303|Protective Agents|protective agents|mesh-ancestor
25639394|NCT01382303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639395|NCT01382303|Vasodilator Agents|vasodilator agents|mesh-ancestor
25639396|NCT01382303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25639397|NCT01382303|Antioxidants|antioxidants|mesh-ancestor
25639398|NCT01382446|Chlorhexidine|chlorhexidine|mesh-list
25639399|NCT01382446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25639400|NCT01382446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25639401|NCT01382446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25639402|NCT01382446|Disinfectants|disinfectants|mesh-ancestor
25639403|NCT01382446|Dermatologic Agents|dermatologic agents|mesh-ancestor
25639404|NCT01382940|Acetaminophen|acetaminophen|mesh-list
25639405|NCT01382940|Methylprednisolone|methylprednisolone|mesh-list
25639406|NCT01382940|Rituximab|rituximab|mesh-list
25639407|NCT01382940|Methotrexate|methotrexate|mesh-list
25639408|NCT01382940|Histamine Antagonists|histamine antagonists|mesh-list
25639409|NCT01382940|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25639410|NCT01382940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25639411|NCT01382940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25639412|NCT01382940|Immunologic Factors|immunologic factors|mesh-ancestor
25639413|NCT01382940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639414|NCT01382940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25639415|NCT01382940|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25639416|NCT01382940|Abortifacient Agents|abortifacient agents|mesh-ancestor
25639417|NCT01382940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25639418|NCT01382940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25639419|NCT01382940|Antimetabolites|antimetabolites|mesh-ancestor
25639420|NCT01382940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639421|NCT01382940|Dermatologic Agents|dermatologic agents|mesh-ancestor
25639422|NCT01382940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639423|NCT01382940|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25639424|NCT01382940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25639425|NCT01382940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25639426|NCT01382940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25639427|NCT01382940|Analgesics|analgesics|mesh-ancestor
25639428|NCT01382940|Sensory System Agents|sensory system agents|mesh-ancestor
25639429|NCT01382940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25639430|NCT01382940|Antipyretics|antipyretics|mesh-ancestor
25639431|NCT01382940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25639432|NCT01382940|Antiemetics|antiemetics|mesh-ancestor
25639433|NCT01382940|Autonomic Agents|autonomic agents|mesh-ancestor
25639434|NCT01382940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25639435|NCT01382940|Glucocorticoids|glucocorticoids|mesh-ancestor
25639436|NCT01382940|Hormones|hormones|mesh-ancestor
25639437|NCT01382940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25639438|NCT01382940|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25639439|NCT01382940|Protective Agents|protective agents|mesh-ancestor
25639440|NCT01382940|Histamine Agents|histamine agents|mesh-ancestor
25639441|NCT01382940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25639442|NCT01383096|Artefenomel|artefenomel|mesh-list
25639443|NCT01383096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25639444|NCT01383096|Antimalarials|antimalarials|mesh-ancestor
25639445|NCT01383096|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25639446|NCT01383096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25639447|NCT01383096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25639448|NCT01383161|Curcumin|curcumin|mesh-list
25639449|NCT01383161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25639450|NCT01383161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25639451|NCT01383161|Analgesics|analgesics|mesh-ancestor
25639452|NCT01383161|Sensory System Agents|sensory system agents|mesh-ancestor
25639453|NCT01383161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25639454|NCT01383161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639455|NCT01383161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25639456|NCT01383161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25639457|NCT01383161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25639458|NCT01383161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639459|NCT01383161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656551|NCT01576172|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25656552|NCT01576276|Ketorolac|ketorolac|mesh-list
25656553|NCT01576276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25656554|NCT01576276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25656555|NCT01576276|Analgesics|analgesics|mesh-ancestor
25656556|NCT01576276|Sensory System Agents|sensory system agents|mesh-ancestor
25656557|NCT01576276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25656558|NCT01576276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656559|NCT01576276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25656560|NCT01576276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25656561|NCT01576276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25656562|NCT01576276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25656563|NCT01576276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656564|NCT01576341|Epoetin Alfa|epoetin alfa|mesh-list
25656565|NCT01576341|Hematinics|hematinics|mesh-ancestor
25656566|NCT01576406|Crizotinib|crizotinib|mesh-list
25656567|NCT01576406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656568|NCT01576406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25656569|NCT01576406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25656570|NCT01576406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656571|NCT01576484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25656572|NCT01576484|Immunologic Factors|immunologic factors|mesh-ancestor
25656573|NCT01576484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656574|NCT01576523|Complement C1s|complement c1s|mesh-list
25656575|NCT01576523|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25656576|NCT01576523|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
25656577|NCT01576523|Immunologic Factors|immunologic factors|mesh-ancestor
25656578|NCT01576523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656579|NCT01576523|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25656580|NCT01576523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25656581|NCT01576588|Rituximab|rituximab|mesh-list
25656582|NCT01576588|Glucocorticoids|glucocorticoids|mesh-list
25656583|NCT01576588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25656584|NCT01576588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656585|NCT01576588|Immunologic Factors|immunologic factors|mesh-ancestor
25656586|NCT01576588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656587|NCT01576588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25656588|NCT01576588|Hormones|hormones|mesh-ancestor
25656589|NCT01576588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25656590|NCT01576705|Leucovorin|leucovorin|mesh-list
25656591|NCT01576705|Folic Acid|folic acid|mesh-list
25656592|NCT01576705|Hormones|hormones|mesh-list
25656593|NCT01576705|Levoleucovorin|levoleucovorin|mesh-list
25656594|NCT01576705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25656595|NCT01576705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656596|NCT01576705|Antidotes|antidotes|mesh-ancestor
25656597|NCT01576705|Protective Agents|protective agents|mesh-ancestor
25656598|NCT01576705|Vitamin B Complex|vitamin b complex|mesh-ancestor
25656599|NCT01576705|Vitamins|vitamins|mesh-ancestor
25656600|NCT01576705|Micronutrients|micronutrients|mesh-ancestor
25656601|NCT01576705|Hematinics|hematinics|mesh-ancestor
25656602|NCT01576718|Fluticasone|fluticasone|mesh-list
25656603|NCT01576718|Xhance|xhance|mesh-list
25656604|NCT01576718|Albuterol|albuterol|mesh-list
25656605|NCT01576718|Adrenergic Agonists|adrenergic agonists|mesh-list
25656606|NCT01576718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25656607|NCT01576718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25656608|NCT01576718|Autonomic Agents|autonomic agents|mesh-ancestor
25656609|NCT01576718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25656610|NCT01576718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656611|NCT01576718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25656612|NCT01576718|Respiratory System Agents|respiratory system agents|mesh-ancestor
25656613|NCT01576718|Dermatologic Agents|dermatologic agents|mesh-ancestor
25534501|NCT00553696|Cisplatin|cisplatin|mesh-list
25534502|NCT00553696|Sunitinib|sunitinib|mesh-list
25656614|NCT01576718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25656615|NCT01576718|Tocolytic Agents|tocolytic agents|mesh-ancestor
25639460|NCT01383200|Lidocaine|lidocaine|mesh-list
25639461|NCT01383200|Tetracaine|tetracaine|mesh-list
25639462|NCT01383200|Anesthetics, Local|anesthetics, local|mesh-ancestor
25639463|NCT01383200|Anesthetics|anesthetics|mesh-ancestor
25639464|NCT01383200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25639465|NCT01383200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639466|NCT01383200|Sensory System Agents|sensory system agents|mesh-ancestor
25639467|NCT01383200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25639468|NCT01383200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25639469|NCT01383200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25639470|NCT01383200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25404055|NCT03685331|Palbociclib|palbociclib|mesh-list
25639471|NCT01383200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25639472|NCT01383200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639473|NCT01383356|Metformin|metformin|mesh-list
25639474|NCT01383356|Linagliptin|linagliptin|mesh-list
25639475|NCT01383356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25639476|NCT01383356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639477|NCT01383356|Incretins|incretins|mesh-ancestor
25639478|NCT01383356|Hormones|hormones|mesh-ancestor
25639479|NCT01383356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25639480|NCT01383356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25639481|NCT01383356|Protease Inhibitors|protease inhibitors|mesh-ancestor
25639482|NCT01383356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639483|NCT01383356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639484|NCT01383486|Naproxen|naproxen|mesh-list
25639485|NCT01383486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25639486|NCT01383486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25639487|NCT01383486|Analgesics|analgesics|mesh-ancestor
25639488|NCT01383486|Sensory System Agents|sensory system agents|mesh-ancestor
25639489|NCT01383486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25639490|NCT01383486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639491|NCT01383486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25639492|NCT01383486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25639493|NCT01383486|Gout Suppressants|gout suppressants|mesh-ancestor
25639494|NCT01383486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25639495|NCT01383486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639496|NCT01383486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639497|NCT01383499|Bromides|bromides|mesh-list
25639498|NCT01383499|Tiotropium Bromide|tiotropium bromide|mesh-list
25639499|NCT01383499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25639500|NCT01383499|Autonomic Agents|autonomic agents|mesh-ancestor
25639501|NCT01383499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25639502|NCT01383499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639503|NCT01383499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25639504|NCT01383499|Respiratory System Agents|respiratory system agents|mesh-ancestor
25639505|NCT01383499|Parasympatholytics|parasympatholytics|mesh-ancestor
25639506|NCT01383499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25639507|NCT01383499|Cholinergic Agents|cholinergic agents|mesh-ancestor
25639508|NCT01383499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25639509|NCT01383499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639510|NCT01383499|Anticonvulsants|anticonvulsants|mesh-ancestor
25639511|NCT01383707|Leucovorin|leucovorin|mesh-list
25639512|NCT01383707|Bevacizumab|bevacizumab|mesh-list
25639513|NCT01383707|Fluorouracil|fluorouracil|mesh-list
25639514|NCT01383707|Oxaliplatin|oxaliplatin|mesh-list
25639515|NCT01383707|Levoleucovorin|levoleucovorin|mesh-list
25639516|NCT01383707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25639517|NCT01383707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25639518|NCT01383707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25639519|NCT01383707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25639520|NCT01383707|Growth Substances|growth substances|mesh-ancestor
25639521|NCT01383707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639522|NCT01383707|Growth Inhibitors|growth inhibitors|mesh-ancestor
25639523|NCT01383707|Antimetabolites|antimetabolites|mesh-ancestor
25639524|NCT01383707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639525|NCT01383707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25639526|NCT01383707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25639527|NCT01383707|Immunologic Factors|immunologic factors|mesh-ancestor
25639528|NCT01383707|Antidotes|antidotes|mesh-ancestor
25639529|NCT01383707|Protective Agents|protective agents|mesh-ancestor
25639530|NCT01383707|Vitamin B Complex|vitamin b complex|mesh-ancestor
25639531|NCT01383707|Vitamins|vitamins|mesh-ancestor
25639532|NCT01383707|Micronutrients|micronutrients|mesh-ancestor
25639533|NCT01383759|Dexamethasone|dexamethasone|mesh-list
25639534|NCT01383759|Dexamethasone acetate|dexamethasone acetate|mesh-list
25639535|NCT01383759|Bortezomib|bortezomib|mesh-list
25639537|NCT01383759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25639538|NCT01383759|Antiemetics|antiemetics|mesh-ancestor
25639539|NCT01383759|Autonomic Agents|autonomic agents|mesh-ancestor
25639540|NCT01383759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25639541|NCT01383759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639542|NCT01383759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25639543|NCT01383759|Glucocorticoids|glucocorticoids|mesh-ancestor
25639544|NCT01383759|Hormones|hormones|mesh-ancestor
25639545|NCT01383759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25639546|NCT01383759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25639547|NCT01383759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25639548|NCT01383759|Protease Inhibitors|protease inhibitors|mesh-ancestor
25639549|NCT01383759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639550|NCT01383759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639551|NCT01383928|Dexamethasone|dexamethasone|mesh-list
25639552|NCT01383928|Lenalidomide|lenalidomide|mesh-list
25639553|NCT01383928|Ixazomib|ixazomib|mesh-list
25639554|NCT01383928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25639555|NCT01383928|Antiemetics|antiemetics|mesh-ancestor
25639556|NCT01383928|Autonomic Agents|autonomic agents|mesh-ancestor
25639557|NCT01383928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25639558|NCT01383928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639559|NCT01383928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25639560|NCT01383928|Glucocorticoids|glucocorticoids|mesh-ancestor
25639561|NCT01383928|Hormones|hormones|mesh-ancestor
25639562|NCT01383928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25639563|NCT01383928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25639564|NCT01383928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25639565|NCT01383928|Immunologic Factors|immunologic factors|mesh-ancestor
25639566|NCT01383928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25639567|NCT01383928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25639568|NCT01383928|Growth Substances|growth substances|mesh-ancestor
25639569|NCT01383928|Growth Inhibitors|growth inhibitors|mesh-ancestor
25639570|NCT01383928|Protease Inhibitors|protease inhibitors|mesh-ancestor
25639571|NCT01383928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639572|NCT01383928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639573|NCT01383954|Diclofenac|diclofenac|mesh-list
25639574|NCT01383954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25639575|NCT01383954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25639576|NCT01383954|Analgesics|analgesics|mesh-ancestor
25639577|NCT01383954|Sensory System Agents|sensory system agents|mesh-ancestor
25639578|NCT01383954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25639579|NCT01383954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639580|NCT01383954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25639581|NCT01383954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25639582|NCT01383954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25639583|NCT01383954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639584|NCT01383954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639585|NCT01383993|Voriconazole|voriconazole|mesh-list
25639586|NCT01383993|Antifungal Agents|antifungal agents|mesh-ancestor
25639587|NCT01383993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25639588|NCT01383993|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25639589|NCT01383993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25639590|NCT01383993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639591|NCT01383993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639592|NCT01383993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25639593|NCT01383993|Hormone Antagonists|hormone antagonists|mesh-ancestor
25639594|NCT01383993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25639595|NCT01383993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639596|NCT01383993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25639597|NCT01384292|Naloxegol|naloxegol|mesh-list
25639598|NCT01384292|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25639599|NCT01384292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639600|NCT01384292|Sensory System Agents|sensory system agents|mesh-ancestor
25718812|NCT02436759|Mydriatics|mydriatics|mesh-ancestor
25639601|NCT01384292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25639602|NCT01384539|Cholecalciferol|cholecalciferol|mesh-list
25639603|NCT01384539|Vitamin D|vitamin d|mesh-list
25639604|NCT01384539|Calcitriol|calcitriol|mesh-list
25639605|NCT01384539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25639606|NCT01384539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639607|NCT01384539|Vitamins|vitamins|mesh-ancestor
25639608|NCT01384539|Micronutrients|micronutrients|mesh-ancestor
25534638|NCT00555061|Retapamulin|retapamulin|mesh-list
25639609|NCT01384539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25639610|NCT01384539|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25639611|NCT01384539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25639612|NCT01384539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639613|NCT01384539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25639614|NCT01384591|Acetylcysteine|acetylcysteine|mesh-list
25639615|NCT01384591|Losartan|losartan|mesh-list
25639616|NCT01384591|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25639617|NCT01384591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25639618|NCT01384591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25639619|NCT01384591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25639620|NCT01384591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25639621|NCT01384591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639622|NCT01384591|Antiviral Agents|antiviral agents|mesh-ancestor
25639623|NCT01384591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25639624|NCT01384591|Expectorants|expectorants|mesh-ancestor
25639625|NCT01384591|Respiratory System Agents|respiratory system agents|mesh-ancestor
25639626|NCT01384591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25639627|NCT01384591|Antioxidants|antioxidants|mesh-ancestor
25639628|NCT01384591|Protective Agents|protective agents|mesh-ancestor
25639629|NCT01384591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639630|NCT01384591|Antidotes|antidotes|mesh-ancestor
25639631|NCT01384734|Ritonavir|ritonavir|mesh-list
25639632|NCT01384734|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25639633|NCT01384734|Tenofovir|tenofovir|mesh-list
25639634|NCT01384734|Raltegravir Potassium|raltegravir potassium|mesh-list
25639635|NCT01384734|Fostemsavir|fostemsavir|mesh-list
25639636|NCT01384734|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25639637|NCT01384734|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25639638|NCT01384734|Protease Inhibitors|protease inhibitors|mesh-ancestor
25639639|NCT01384734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639640|NCT01384734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639641|NCT01384734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25639642|NCT01384734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25639643|NCT01384734|Antiviral Agents|antiviral agents|mesh-ancestor
25639644|NCT01384734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25639645|NCT01384734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25639646|NCT01384734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25639647|NCT01384734|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25639648|NCT01384734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25639649|NCT01384734|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25639650|NCT01384734|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25639651|NCT01384734|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25639652|NCT01384734|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25639653|NCT01384877|Lidocaine|lidocaine|mesh-list
25639654|NCT01384877|Anesthetics, Local|anesthetics, local|mesh-ancestor
25639655|NCT01384877|Anesthetics|anesthetics|mesh-ancestor
25639656|NCT01384877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25639657|NCT01384877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639658|NCT01384877|Sensory System Agents|sensory system agents|mesh-ancestor
25639659|NCT01384877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25639660|NCT01384877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25639661|NCT01384877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25639662|NCT01384877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25639663|NCT01384877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25639664|NCT01384877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639665|NCT01385098|Calcium, Dietary|calcium, dietary|mesh-list
25639666|NCT01385098|Vitamin D|vitamin d|mesh-list
25639667|NCT01385098|Ergocalciferols|ergocalciferols|mesh-list
25639668|NCT01385098|Cholecalciferol|cholecalciferol|mesh-list
25639669|NCT01385098|Vitamins|vitamins|mesh-list
25639670|NCT01385098|Calcium|calcium|mesh-list
25639671|NCT01385098|Micronutrients|micronutrients|mesh-ancestor
25639672|NCT01385098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639673|NCT01385098|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25639674|NCT01385098|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25639675|NCT01385189|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25639676|NCT01385189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25639677|NCT01385189|Immunologic Factors|immunologic factors|mesh-ancestor
25639678|NCT01385189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639679|NCT01385189|Antacids|antacids|mesh-ancestor
25639680|NCT01385189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639681|NCT01385189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25639682|NCT01385566|Vaccines|vaccines|mesh-list
25639683|NCT01385566|Immunologic Factors|immunologic factors|mesh-ancestor
25639684|NCT01385566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639685|NCT01385748|Clonidine|clonidine|mesh-list
25639686|NCT01385748|Analgesics|analgesics|mesh-ancestor
25639687|NCT01385748|Sensory System Agents|sensory system agents|mesh-ancestor
25639688|NCT01385748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25639689|NCT01385748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639690|NCT01385748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25639691|NCT01385748|Sympatholytics|sympatholytics|mesh-ancestor
25639692|NCT01385748|Autonomic Agents|autonomic agents|mesh-ancestor
25639693|NCT01385748|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25639694|NCT01385748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25639695|NCT01385748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25639696|NCT01385748|Adrenergic Agents|adrenergic agents|mesh-ancestor
25639697|NCT01385748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25639698|NCT01385748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639699|NCT01386554|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25639700|NCT01386554|Hormones|hormones|mesh-ancestor
25639701|NCT01386554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25639702|NCT01386554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639703|NCT01386606|Methyltestosterone|methyltestosterone|mesh-list
25639704|NCT01386606|Enclomiphene|enclomiphene|mesh-list
25639705|NCT01386606|Clomiphene|clomiphene|mesh-list
25639706|NCT01386606|Zuclomiphene|zuclomiphene|mesh-list
25639707|NCT01386606|Testosterone|testosterone|mesh-list
25639708|NCT01386606|Testosterone undecanoate|testosterone undecanoate|mesh-list
25639709|NCT01386606|Testosterone enanthate|testosterone enanthate|mesh-list
25639710|NCT01386606|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25639711|NCT01386606|Androgens|androgens|mesh-ancestor
25639712|NCT01386606|Hormones|hormones|mesh-ancestor
25639713|NCT01386606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25639714|NCT01386606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639715|NCT01386606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25639716|NCT01386606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25639717|NCT01386606|Anabolic Agents|anabolic agents|mesh-ancestor
25639718|NCT01386606|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25639719|NCT01386606|Hormone Antagonists|hormone antagonists|mesh-ancestor
25639720|NCT01386606|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25639721|NCT01386606|Fertility Agents|fertility agents|mesh-ancestor
25639722|NCT01386606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25639723|NCT01386606|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25639724|NCT01386606|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25639725|NCT01386645|Acetylcysteine|acetylcysteine|mesh-list
25639726|NCT01386645|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25639727|NCT01386645|Antiviral Agents|antiviral agents|mesh-ancestor
25639728|NCT01386645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25639729|NCT01386645|Expectorants|expectorants|mesh-ancestor
25639730|NCT01386645|Respiratory System Agents|respiratory system agents|mesh-ancestor
25639731|NCT01386645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25639732|NCT01386645|Antioxidants|antioxidants|mesh-ancestor
25639733|NCT01386645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639734|NCT01386645|Protective Agents|protective agents|mesh-ancestor
25639735|NCT01386645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639736|NCT01386645|Antidotes|antidotes|mesh-ancestor
25639737|NCT01386970|Lamivudine|lamivudine|mesh-list
25639738|NCT01386970|Zidovudine|zidovudine|mesh-list
25639739|NCT01386970|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25639740|NCT01386970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25639741|NCT01386970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25639742|NCT01386970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639743|NCT01386970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639744|NCT01386970|Antiviral Agents|antiviral agents|mesh-ancestor
25639745|NCT01386970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25639746|NCT01386970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25639747|NCT01386970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25639748|NCT01386970|Antimetabolites|antimetabolites|mesh-ancestor
25639749|NCT01386983|Finasteride|finasteride|mesh-list
25639750|NCT01386983|Dutasteride|dutasteride|mesh-list
25639751|NCT01386983|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25639752|NCT01386983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25639753|NCT01386983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639754|NCT01386983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639755|NCT01386983|Hormone Antagonists|hormone antagonists|mesh-ancestor
25639756|NCT01386983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25639757|NCT01386983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639758|NCT01386983|Urological Agents|urological agents|mesh-ancestor
25639760|NCT01387022|Lamivudine|lamivudine|mesh-list
25639761|NCT01387022|Efavirenz|efavirenz|mesh-list
25639762|NCT01387022|Antiviral Agents|antiviral agents|mesh-ancestor
25639763|NCT01387022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25639764|NCT01387022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25639765|NCT01387022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25639766|NCT01387022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639767|NCT01387022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639768|NCT01387022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25639769|NCT01387022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25639770|NCT01387022|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25639771|NCT01387022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25639772|NCT01387022|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25639773|NCT01387022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25639774|NCT01387022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25639775|NCT01387022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25639776|NCT01387074|Botulinum Toxins|botulinum toxins|mesh-list
25639777|NCT01387074|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25639778|NCT01387074|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25639779|NCT01387074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25639780|NCT01387074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25639781|NCT01387074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639782|NCT01387074|Cholinergic Agents|cholinergic agents|mesh-ancestor
25639783|NCT01387074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25639784|NCT01387074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639785|NCT01387074|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25639786|NCT01387074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25639787|NCT01387139|Ketamine|ketamine|mesh-list
25639788|NCT01387139|Propofol|propofol|mesh-list
25639789|NCT01387139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25639790|NCT01387139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25639791|NCT01387139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639792|NCT01387139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25639793|NCT01387139|Anesthetics, General|anesthetics, general|mesh-ancestor
25639794|NCT01387139|Anesthetics|anesthetics|mesh-ancestor
25639795|NCT01387139|Analgesics|analgesics|mesh-ancestor
25639796|NCT01387139|Sensory System Agents|sensory system agents|mesh-ancestor
25639797|NCT01387139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25639798|NCT01387139|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25639799|NCT01387139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25639800|NCT01387139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25639801|NCT01387139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25639802|NCT01387139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639803|NCT01387178|Fluticasone|fluticasone|mesh-list
25639804|NCT01387178|Xhance|xhance|mesh-list
25639805|NCT01387178|Bromides|bromides|mesh-list
25639806|NCT01387178|Tiotropium Bromide|tiotropium bromide|mesh-list
25639807|NCT01387178|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25639808|NCT01387178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25639809|NCT01387178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25639810|NCT01387178|Autonomic Agents|autonomic agents|mesh-ancestor
25639811|NCT01387178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25639812|NCT01387178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639813|NCT01387178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25639814|NCT01387178|Respiratory System Agents|respiratory system agents|mesh-ancestor
25639815|NCT01387178|Dermatologic Agents|dermatologic agents|mesh-ancestor
25639816|NCT01387178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25639817|NCT01387178|Parasympatholytics|parasympatholytics|mesh-ancestor
25639818|NCT01387178|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25639819|NCT01387178|Cholinergic Agents|cholinergic agents|mesh-ancestor
25639820|NCT01387178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25639821|NCT01387178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639822|NCT01387178|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25639823|NCT01387178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25639824|NCT01387178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25639825|NCT01387178|Adrenergic Agents|adrenergic agents|mesh-ancestor
25639826|NCT01387178|Anticonvulsants|anticonvulsants|mesh-ancestor
25639827|NCT01387347|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25639828|NCT01387347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25639829|NCT01387464|Bromfenac|bromfenac|mesh-list
25639830|NCT01387464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25639831|NCT01387464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25639832|NCT01387464|Analgesics|analgesics|mesh-ancestor
25639833|NCT01387464|Sensory System Agents|sensory system agents|mesh-ancestor
25639834|NCT01387464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25639835|NCT01387464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639836|NCT01387464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25639837|NCT01387464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25639838|NCT01387516|Nicotine|nicotine|mesh-list
25639839|NCT01387516|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25639840|NCT01387516|Autonomic Agents|autonomic agents|mesh-ancestor
25639841|NCT01387516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25639842|NCT01387516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639843|NCT01387516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25639844|NCT01387516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25639845|NCT01387516|Cholinergic Agents|cholinergic agents|mesh-ancestor
25639846|NCT01387516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25639847|NCT01387516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639848|NCT01387542|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25639849|NCT01387542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25639850|NCT01387542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25639851|NCT01387542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25639852|NCT01387542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639853|NCT01387542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25639854|NCT01387542|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25639855|NCT01387542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25639856|NCT01387542|Serotonin Agents|serotonin agents|mesh-ancestor
25639857|NCT01387542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25639858|NCT01387542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639859|NCT01387542|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25639860|NCT01387542|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25639861|NCT01387542|Dopamine Agents|dopamine agents|mesh-ancestor
25639862|NCT01387607|Pregabalin|pregabalin|mesh-list
25639863|NCT01387607|Analgesics|analgesics|mesh-ancestor
25639864|NCT01387607|Sensory System Agents|sensory system agents|mesh-ancestor
25639865|NCT01387607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25639866|NCT01387607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639867|NCT01387607|Anticonvulsants|anticonvulsants|mesh-ancestor
25639868|NCT01387607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25639869|NCT01387607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25639870|NCT01387607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639871|NCT01387607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25639872|NCT01387607|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25639873|NCT01387607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25639874|NCT01387607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25639875|NCT01387607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25639876|NCT01387672|Nitroglycerin|nitroglycerin|mesh-list
25639877|NCT01387672|Vasodilator Agents|vasodilator agents|mesh-ancestor
25639878|NCT01387815|Adalimumab|adalimumab|mesh-list
25639879|NCT01387815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25639880|NCT01387815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25639881|NCT01387932|Doxorubicin|doxorubicin|mesh-list
25639882|NCT01387932|Ethiodized Oil|ethiodized oil|mesh-list
25639883|NCT01387932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25639884|NCT01387932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25639885|NCT01387932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25639886|NCT01387932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25639887|NCT01387932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639888|NCT01387932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639889|NCT01388335|Warfarin|warfarin|mesh-list
25639890|NCT01388335|Anticoagulants|anticoagulants|mesh-ancestor
25639891|NCT01388361|Insulin|insulin|mesh-list
25639892|NCT01388361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25639893|NCT01388361|Insulin Aspart|insulin aspart|mesh-list
25639894|NCT01388361|Liraglutide|liraglutide|mesh-list
25639895|NCT01388361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25639896|NCT01388361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639897|NCT01388361|Incretins|incretins|mesh-ancestor
25639898|NCT01388361|Hormones|hormones|mesh-ancestor
25639899|NCT01388361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25639900|NCT01388478|Pramipexole|pramipexole|mesh-list
25639901|NCT01388478|Antioxidants|antioxidants|mesh-ancestor
25639902|NCT01388478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639903|NCT01388478|Protective Agents|protective agents|mesh-ancestor
25639904|NCT01388478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639905|NCT01388478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25639906|NCT01388478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25639907|NCT01388478|Dopamine Agonists|dopamine agonists|mesh-ancestor
25639908|NCT01388478|Dopamine Agents|dopamine agents|mesh-ancestor
25639909|NCT01388478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25639910|NCT01388543|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25639911|NCT01388543|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25639912|NCT01388543|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25639913|NCT01388543|Protease Inhibitors|protease inhibitors|mesh-ancestor
25639914|NCT01388543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639915|NCT01388543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639916|NCT01388543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25639917|NCT01388543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25639918|NCT01388543|Antiviral Agents|antiviral agents|mesh-ancestor
25639919|NCT01388543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25639920|NCT01388647|Carboplatin|carboplatin|mesh-list
25639921|NCT01388647|Trastuzumab|trastuzumab|mesh-list
25639922|NCT01388647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25639923|NCT01388647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25639924|NCT01388790|Cisplatin|cisplatin|mesh-list
25639925|NCT01388790|Cetuximab|cetuximab|mesh-list
25639926|NCT01388790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25639927|NCT01388790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25639928|NCT01388946|Ropivacaine|ropivacaine|mesh-list
25639929|NCT01388946|Anesthetics, Local|anesthetics, local|mesh-ancestor
25639930|NCT01388946|Anesthetics|anesthetics|mesh-ancestor
25639931|NCT01388946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25639932|NCT01388946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639933|NCT01388946|Sensory System Agents|sensory system agents|mesh-ancestor
25639934|NCT01388946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25639935|NCT01388985|Vaccines|vaccines|mesh-list
25639936|NCT01388985|Immunologic Factors|immunologic factors|mesh-ancestor
25639937|NCT01388985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639938|NCT01389076|Methotrexate|methotrexate|mesh-list
25639939|NCT01389076|Tositumomab I-131|tositumomab i-131|mesh-list
25639940|NCT01389076|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25639941|NCT01389076|Abortifacient Agents|abortifacient agents|mesh-ancestor
25639942|NCT01389076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25639943|NCT01389076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639944|NCT01389076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25639945|NCT01389076|Antimetabolites|antimetabolites|mesh-ancestor
25639946|NCT01389076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639947|NCT01389076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25639948|NCT01389076|Dermatologic Agents|dermatologic agents|mesh-ancestor
25639949|NCT01389076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639950|NCT01389076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25639951|NCT01389076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25639952|NCT01389076|Immunologic Factors|immunologic factors|mesh-ancestor
25639953|NCT01389076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25639954|NCT01389076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25639955|NCT01389102|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25639956|NCT01389102|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25639957|NCT01389102|Estradiol|estradiol|mesh-list
25639958|NCT01389102|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25639959|NCT01389102|Estrogens|estrogens|mesh-ancestor
25639960|NCT01389102|Hormones|hormones|mesh-ancestor
25639961|NCT01389102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25639962|NCT01389102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639963|NCT01389102|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25639964|NCT01389102|Contraceptive Agents|contraceptive agents|mesh-ancestor
25639965|NCT01389102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25639966|NCT01389102|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25639967|NCT01389284|Naproxen|naproxen|mesh-list
25639968|NCT01389284|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25639969|NCT01389284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25639970|NCT01389284|Analgesics|analgesics|mesh-ancestor
25718854|NCT02437383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25718855|NCT02437383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25639971|NCT01389284|Sensory System Agents|sensory system agents|mesh-ancestor
25639972|NCT01389284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25639973|NCT01389284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639974|NCT01389284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25639975|NCT01389284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25639976|NCT01389284|Gout Suppressants|gout suppressants|mesh-ancestor
25639977|NCT01389284|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25639978|NCT01389284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25639979|NCT01389284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639980|NCT01389323|Interferons|interferons|mesh-list
25639981|NCT01389323|Ribavirin|ribavirin|mesh-list
25639982|NCT01389323|Interferon-alpha|interferon-alpha|mesh-list
25639983|NCT01389323|Interferon alpha-2|interferon alpha-2|mesh-list
25639984|NCT01389323|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25535063|NCT00557492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535064|NCT00557492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25535065|NCT00557492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25535066|NCT00557492|Growth Substances|growth substances|mesh-ancestor
25535067|NCT00557492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535068|NCT00557492|Growth Inhibitors|growth inhibitors|mesh-ancestor
25535069|NCT00557492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25535070|NCT00557492|Antimetabolites|antimetabolites|mesh-ancestor
25535071|NCT00557492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535072|NCT00557492|Antiviral Agents|antiviral agents|mesh-ancestor
25535073|NCT00557492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25535074|NCT00557492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535075|NCT00557492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25535076|NCT00557492|Immunologic Factors|immunologic factors|mesh-ancestor
25535077|NCT00557622|Paroxetine|paroxetine|mesh-list
25535078|NCT00557622|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25535079|NCT00557622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25535080|NCT00557622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25535081|NCT00557622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535082|NCT00557622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25535083|NCT00557622|Serotonin Agents|serotonin agents|mesh-ancestor
25535084|NCT00557622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535085|NCT00557622|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25535086|NCT00557622|Antidepressive Agents|antidepressive agents|mesh-ancestor
25535087|NCT00557622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25535088|NCT00557622|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25535089|NCT00557622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25535090|NCT00557622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535091|NCT00557830|Sorafenib|sorafenib|mesh-list
25535092|NCT00557830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535093|NCT00557830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25535094|NCT00557830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535095|NCT00557830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859922|NCT02306577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24859924|NCT02306577|Antiviral Agents|antiviral agents|mesh-ancestor
24540390|NCT00667797|Albuterol|albuterol|mesh-list
25404095|NCT03684980|Vitamins|vitamins|mesh-ancestor
25639985|NCT01389323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25639986|NCT01389323|Antiviral Agents|antiviral agents|mesh-ancestor
25639987|NCT01389323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25639988|NCT01389323|Antimetabolites|antimetabolites|mesh-ancestor
25639989|NCT01389323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25639990|NCT01389323|Immunologic Factors|immunologic factors|mesh-ancestor
25639991|NCT01389323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639992|NCT01389596|Pregabalin|pregabalin|mesh-list
25639993|NCT01389596|Analgesics|analgesics|mesh-ancestor
25639994|NCT01389596|Sensory System Agents|sensory system agents|mesh-ancestor
25639995|NCT01389596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25639996|NCT01389596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25639997|NCT01389596|Anticonvulsants|anticonvulsants|mesh-ancestor
25639998|NCT01389596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25639999|NCT01389596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25640000|NCT01389596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640001|NCT01389596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25640002|NCT01389596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25640003|NCT01389596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25640004|NCT01389596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25640005|NCT01389596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25640006|NCT01389752|Charcoal|charcoal|mesh-list
25640007|NCT01389752|Antidotes|antidotes|mesh-ancestor
25640008|NCT01389752|Protective Agents|protective agents|mesh-ancestor
25640009|NCT01389752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640010|NCT01389856|Bosentan|bosentan|mesh-list
25640011|NCT01389856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25640012|NCT01389856|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25640013|NCT01389856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640014|NCT01389973|Ustekinumab|ustekinumab|mesh-list
25640015|NCT01389973|Dermatologic Agents|dermatologic agents|mesh-ancestor
25640016|NCT01390064|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25640017|NCT01390064|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25640018|NCT01390064|Immunologic Factors|immunologic factors|mesh-ancestor
25640019|NCT01390064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640020|NCT01390077|Nitisinone|nitisinone|mesh-list
25640021|NCT01390077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25640022|NCT01390077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640023|NCT01390220|Midazolam|midazolam|mesh-list
25640024|NCT01390220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25640025|NCT01390220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25640026|NCT01390220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25640027|NCT01390220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640028|NCT01390220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25640029|NCT01390220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25640030|NCT01390220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25640031|NCT01390220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25640032|NCT01390220|Anesthetics, General|anesthetics, general|mesh-ancestor
25640033|NCT01390220|Anesthetics|anesthetics|mesh-ancestor
25640034|NCT01390220|GABA Modulators|gaba modulators|mesh-ancestor
25640035|NCT01390220|GABA Agents|gaba agents|mesh-ancestor
25640036|NCT01390220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25640037|NCT01390220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640038|NCT01390233|Dinoprostone|dinoprostone|mesh-list
25640039|NCT01390233|Oxytocics|oxytocics|mesh-ancestor
25640040|NCT01390233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25640041|NCT01390233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640042|NCT01390246|Bupropion|bupropion|mesh-list
25640043|NCT01390246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25640044|NCT01390246|Antidepressive Agents|antidepressive agents|mesh-ancestor
25640045|NCT01390246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25640046|NCT01390246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25640047|NCT01390246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25640048|NCT01390246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25640049|NCT01390246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640050|NCT01390246|Dopamine Agents|dopamine agents|mesh-ancestor
25640051|NCT01390246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25640052|NCT01390246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640053|NCT01390246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25640054|NCT01390246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25640055|NCT01390246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25656616|NCT01576718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25656617|NCT01576718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25656618|NCT01576718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25656619|NCT01576718|Adrenergic Agents|adrenergic agents|mesh-ancestor
25656620|NCT01576718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25656621|NCT01576718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656622|NCT01576809|Acetaminophen|acetaminophen|mesh-list
25656623|NCT01576809|Phenylpropanolamine|phenylpropanolamine|mesh-list
25656624|NCT01576809|Phenylephrine|phenylephrine|mesh-list
25656625|NCT01576809|Oxymetazoline|oxymetazoline|mesh-list
25656626|NCT01576809|Guaifenesin|guaifenesin|mesh-list
25656627|NCT01576809|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
25656628|NCT01576809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25656629|NCT01576809|Analgesics|analgesics|mesh-ancestor
25656630|NCT01576809|Sensory System Agents|sensory system agents|mesh-ancestor
25656631|NCT01576809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25656632|NCT01576809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656633|NCT01576809|Antipyretics|antipyretics|mesh-ancestor
25656634|NCT01576809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25656635|NCT01576809|Mydriatics|mydriatics|mesh-ancestor
25656636|NCT01576809|Autonomic Agents|autonomic agents|mesh-ancestor
25656637|NCT01576809|Sympathomimetics|sympathomimetics|mesh-ancestor
25656638|NCT01576809|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25656639|NCT01576809|Nasal Decongestants|nasal decongestants|mesh-ancestor
25656640|NCT01576809|Respiratory System Agents|respiratory system agents|mesh-ancestor
25656641|NCT01576809|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25656642|NCT01576809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25656643|NCT01576809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25656644|NCT01576809|Adrenergic Agents|adrenergic agents|mesh-ancestor
25656645|NCT01576809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25656646|NCT01576809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656647|NCT01576809|Protective Agents|protective agents|mesh-ancestor
25656648|NCT01576809|Expectorants|expectorants|mesh-ancestor
25656649|NCT01576809|Appetite Depressants|appetite depressants|mesh-ancestor
25656650|NCT01576809|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25656651|NCT01576874|Oxytocin|oxytocin|mesh-list
25656652|NCT01576874|Oxytocics|oxytocics|mesh-ancestor
25535096|NCT00558012|Vitamin D|vitamin d|mesh-list
25656653|NCT01576874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25656654|NCT01576874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640056|NCT01390389|Ubiquinone|ubiquinone|mesh-list
25640057|NCT01390389|Coenzyme Q10|coenzyme q10|mesh-list
25640058|NCT01390389|Micronutrients|micronutrients|mesh-ancestor
25640059|NCT01390389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640060|NCT01390389|Vitamins|vitamins|mesh-ancestor
25640061|NCT01390402|Aldesleukin|aldesleukin|mesh-list
25640062|NCT01390402|Methotrexate|methotrexate|mesh-list
25640063|NCT01390402|Fludarabine phosphate|fludarabine phosphate|mesh-list
25640064|NCT01390402|Fludarabine|fludarabine|mesh-list
25640065|NCT01390402|Busulfan|busulfan|mesh-list
25640066|NCT01390402|Interleukin-2|interleukin-2|mesh-list
25640067|NCT01390402|Tacrolimus|tacrolimus|mesh-list
25640068|NCT01390402|Thymoglobulin|thymoglobulin|mesh-list
25640069|NCT01390402|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25640070|NCT01390402|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25640071|NCT01390402|Abortifacient Agents|abortifacient agents|mesh-ancestor
25640072|NCT01390402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25640073|NCT01390402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640074|NCT01390402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25640075|NCT01390402|Antimetabolites|antimetabolites|mesh-ancestor
25640076|NCT01390402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640077|NCT01390402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25640078|NCT01390402|Dermatologic Agents|dermatologic agents|mesh-ancestor
25640079|NCT01390402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25640080|NCT01390402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25640081|NCT01390402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25640082|NCT01390402|Immunologic Factors|immunologic factors|mesh-ancestor
25640083|NCT01390402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25640084|NCT01390402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25640085|NCT01390402|Antiviral Agents|antiviral agents|mesh-ancestor
25640086|NCT01390402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25640087|NCT01390402|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25640088|NCT01390402|Alkylating Agents|alkylating agents|mesh-ancestor
25640089|NCT01390402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25640090|NCT01390402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25640091|NCT01390402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25640092|NCT01390402|Analgesics|analgesics|mesh-ancestor
25640093|NCT01390402|Sensory System Agents|sensory system agents|mesh-ancestor
25640094|NCT01390402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25640095|NCT01390402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25640096|NCT01390402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25640097|NCT01390428|Grazoprevir|grazoprevir|mesh-list
25640098|NCT01390428|Antiviral Agents|antiviral agents|mesh-ancestor
25640099|NCT01390428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25640100|NCT01390441|Acetaminophen|acetaminophen|mesh-list
25640101|NCT01390441|Loratadine|loratadine|mesh-list
25640102|NCT01390441|Methylprednisolone|methylprednisolone|mesh-list
25640103|NCT01390441|Rituximab|rituximab|mesh-list
25640104|NCT01390441|Methotrexate|methotrexate|mesh-list
25640105|NCT01390441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25640106|NCT01390441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25640107|NCT01390441|Immunologic Factors|immunologic factors|mesh-ancestor
25640108|NCT01390441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640109|NCT01390441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25640110|NCT01390441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25640111|NCT01390441|Abortifacient Agents|abortifacient agents|mesh-ancestor
25640112|NCT01390441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25640113|NCT01390441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25640114|NCT01390441|Antimetabolites|antimetabolites|mesh-ancestor
25640115|NCT01390441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640116|NCT01390441|Dermatologic Agents|dermatologic agents|mesh-ancestor
25640117|NCT01390441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25640118|NCT01390441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25640119|NCT01390441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25640120|NCT01390441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25640121|NCT01390441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25640122|NCT01390441|Analgesics|analgesics|mesh-ancestor
25640123|NCT01390441|Sensory System Agents|sensory system agents|mesh-ancestor
25640124|NCT01390441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25640125|NCT01390441|Antipyretics|antipyretics|mesh-ancestor
25640126|NCT01390441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25640127|NCT01390441|Antiemetics|antiemetics|mesh-ancestor
25640128|NCT01390441|Autonomic Agents|autonomic agents|mesh-ancestor
25640129|NCT01390441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25640130|NCT01390441|Glucocorticoids|glucocorticoids|mesh-ancestor
25535173|NCT00558467|Pramipexole|pramipexole|mesh-list
25640131|NCT01390441|Hormones|hormones|mesh-ancestor
25640132|NCT01390441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25640133|NCT01390441|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25640134|NCT01390441|Protective Agents|protective agents|mesh-ancestor
25640136|NCT01390441|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25640137|NCT01390441|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25640138|NCT01390441|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25640139|NCT01390441|Histamine Antagonists|histamine antagonists|mesh-ancestor
25640140|NCT01390441|Histamine Agents|histamine agents|mesh-ancestor
25640141|NCT01390441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25640142|NCT01390584|Prednisone|prednisone|mesh-list
25640143|NCT01390584|Cyclophosphamide|cyclophosphamide|mesh-list
25640144|NCT01390584|Dacarbazine|dacarbazine|mesh-list
25640145|NCT01390584|Doxorubicin|doxorubicin|mesh-list
25640146|NCT01390584|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25640147|NCT01390584|Etoposide|etoposide|mesh-list
25640148|NCT01390584|Vincristine|vincristine|mesh-list
25640149|NCT01390584|Etoposide phosphate|etoposide phosphate|mesh-list
25640150|NCT01390584|Bleomycin|bleomycin|mesh-list
25640151|NCT01390584|Vinblastine|vinblastine|mesh-list
25640152|NCT01390584|Podophyllotoxin|podophyllotoxin|mesh-list
25640153|NCT01390584|Procarbazine|procarbazine|mesh-list
25640154|NCT01390584|Imidazole|imidazole|mesh-list
25640155|NCT01390584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25640156|NCT01390584|Immunologic Factors|immunologic factors|mesh-ancestor
25640157|NCT01390584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640158|NCT01390584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25640159|NCT01390584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25640160|NCT01390584|Alkylating Agents|alkylating agents|mesh-ancestor
25640161|NCT01390584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640162|NCT01390584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25640163|NCT01390584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25640164|NCT01390584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25640165|NCT01390584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25640166|NCT01390584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25640167|NCT01390584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25640168|NCT01390584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25640169|NCT01390584|Glucocorticoids|glucocorticoids|mesh-ancestor
25640170|NCT01390584|Hormones|hormones|mesh-ancestor
25640171|NCT01390584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25640172|NCT01390584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25640173|NCT01390584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25640174|NCT01390584|Tubulin Modulators|tubulin modulators|mesh-ancestor
25640175|NCT01390584|Antimitotic Agents|antimitotic agents|mesh-ancestor
25640176|NCT01390584|Mitosis Modulators|mitosis modulators|mesh-ancestor
25640177|NCT01390584|Keratolytic Agents|keratolytic agents|mesh-ancestor
25640178|NCT01390584|Dermatologic Agents|dermatologic agents|mesh-ancestor
25640179|NCT01390649|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25640180|NCT01390649|Immunologic Factors|immunologic factors|mesh-ancestor
25640181|NCT01390649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640182|NCT01390818|Niacinamide|niacinamide|mesh-list
25640183|NCT01390818|Sirolimus|sirolimus|mesh-list
25640184|NCT01390818|Elafin|elafin|mesh-list
25640185|NCT01390818|Protease Inhibitors|protease inhibitors|mesh-ancestor
25640186|NCT01390818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25640187|NCT01390818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640188|NCT01390818|Vitamin B Complex|vitamin b complex|mesh-ancestor
25640189|NCT01390818|Vitamins|vitamins|mesh-ancestor
25640190|NCT01390818|Micronutrients|micronutrients|mesh-ancestor
25640191|NCT01390818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640192|NCT01390818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25640193|NCT01390818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25640194|NCT01390818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25640195|NCT01390818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25640196|NCT01390818|Antifungal Agents|antifungal agents|mesh-ancestor
25640197|NCT01390818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25640198|NCT01390818|Immunologic Factors|immunologic factors|mesh-ancestor
25640199|NCT01390844|Ribavirin|ribavirin|mesh-list
25640200|NCT01390844|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25640201|NCT01390844|Antimetabolites|antimetabolites|mesh-ancestor
25640202|NCT01390844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640203|NCT01390844|Antiviral Agents|antiviral agents|mesh-ancestor
25640204|NCT01390844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25640205|NCT01390857|Valacyclovir|valacyclovir|mesh-list
25640206|NCT01390857|Antiviral Agents|antiviral agents|mesh-ancestor
25640207|NCT01390857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25640208|NCT01390870|Alfuzosin|alfuzosin|mesh-list
25535241|NCT00558636|Tubulin Modulators|tubulin modulators|mesh-ancestor
25640209|NCT01390870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640210|NCT01390870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640211|NCT01390870|Urological Agents|urological agents|mesh-ancestor
25640212|NCT01390870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25640213|NCT01390870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25640214|NCT01390870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25640215|NCT01390870|Adrenergic Agents|adrenergic agents|mesh-ancestor
25640216|NCT01390870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25640217|NCT01390909|Oxcarbazepine|oxcarbazepine|mesh-list
25640218|NCT01390909|Anticonvulsants|anticonvulsants|mesh-list
25640219|NCT01390909|Lactitol|lactitol|mesh-list
25640220|NCT01390909|Cathartics|cathartics|mesh-ancestor
25640221|NCT01390909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25640222|NCT01390909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640223|NCT01390909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25640224|NCT01390909|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25640225|NCT01390909|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25640226|NCT01390909|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25640227|NCT01390909|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25640228|NCT01390948|Bevacizumab|bevacizumab|mesh-list
25640229|NCT01390948|Temozolomide|temozolomide|mesh-list
25640230|NCT01390948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25640231|NCT01390948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25718924|NCT02439164|Anesthetics|anesthetics|mesh-ancestor
25640232|NCT01390948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25640233|NCT01390948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25640234|NCT01390948|Growth Substances|growth substances|mesh-ancestor
25640235|NCT01390948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640236|NCT01390948|Growth Inhibitors|growth inhibitors|mesh-ancestor
25640237|NCT01390948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25640238|NCT01390948|Alkylating Agents|alkylating agents|mesh-ancestor
25640239|NCT01390948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640240|NCT01391013|Ritonavir|ritonavir|mesh-list
25640241|NCT01391013|Darunavir|darunavir|mesh-list
25640242|NCT01391013|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
25640243|NCT01391013|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25640244|NCT01391013|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25640245|NCT01391013|Protease Inhibitors|protease inhibitors|mesh-ancestor
25640246|NCT01391013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25640247|NCT01391013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640248|NCT01391013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25640249|NCT01391013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25640250|NCT01391013|Antiviral Agents|antiviral agents|mesh-ancestor
25640251|NCT01391013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25640252|NCT01391013|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25640253|NCT01391013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25640254|NCT01391013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25640255|NCT01391130|Sunitinib|sunitinib|mesh-list
25640256|NCT01391130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25640257|NCT01391130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25640258|NCT01391130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25640259|NCT01391130|Growth Substances|growth substances|mesh-ancestor
25640260|NCT01391130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640261|NCT01391130|Growth Inhibitors|growth inhibitors|mesh-ancestor
25640262|NCT01391130|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25640263|NCT01391130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25640264|NCT01391130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640265|NCT01391273|Bimatoprost|bimatoprost|mesh-list
25640266|NCT01391273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25640267|NCT01391273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25640268|NCT01391286|Bimatoprost|bimatoprost|mesh-list
25640269|NCT01391286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25640270|NCT01391286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25640271|NCT01391299|Botulinum Toxins|botulinum toxins|mesh-list
25640272|NCT01391299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25640273|NCT01391299|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25640274|NCT01391299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25640275|NCT01391299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25640276|NCT01391299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640277|NCT01391299|Cholinergic Agents|cholinergic agents|mesh-ancestor
25640278|NCT01391299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25640279|NCT01391299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640280|NCT01391299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25640281|NCT01391299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25640282|NCT01391312|Botulinum Toxins|botulinum toxins|mesh-list
25656655|NCT01576952|Bromfenac|bromfenac|mesh-list
25535319|NCT00559468|Anesthetics, General|anesthetics, general|mesh-ancestor
25640283|NCT01391312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25640284|NCT01391312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25640285|NCT01391312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25640286|NCT01391312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25640287|NCT01391312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640288|NCT01391312|Cholinergic Agents|cholinergic agents|mesh-ancestor
25640289|NCT01391312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25640290|NCT01391312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640291|NCT01391312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25640292|NCT01391312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25640293|NCT01391325|Allopurinol|allopurinol|mesh-list
25640294|NCT01391325|Antimetabolites|antimetabolites|mesh-ancestor
25640295|NCT01391325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640296|NCT01391325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25640297|NCT01391325|Gout Suppressants|gout suppressants|mesh-ancestor
25640298|NCT01391325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25640299|NCT01391325|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25640300|NCT01391325|Antioxidants|antioxidants|mesh-ancestor
25640301|NCT01391325|Protective Agents|protective agents|mesh-ancestor
25640302|NCT01391325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640303|NCT01391364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25640304|NCT01391559|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25640305|NCT01391559|Formoterol Fumarate|formoterol fumarate|mesh-list
25640306|NCT01391559|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25640307|NCT01391559|Autonomic Agents|autonomic agents|mesh-ancestor
25640308|NCT01391559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25640309|NCT01391559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640310|NCT01391559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25640311|NCT01391559|Respiratory System Agents|respiratory system agents|mesh-ancestor
25640312|NCT01391559|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25640313|NCT01391559|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25640314|NCT01391559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25640315|NCT01391559|Adrenergic Agents|adrenergic agents|mesh-ancestor
25640316|NCT01391559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25640317|NCT01391559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640318|NCT01391663|Alogliptin|alogliptin|mesh-list
25640319|NCT01391663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25640320|NCT01391663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640321|NCT01391663|Incretins|incretins|mesh-ancestor
25640322|NCT01391663|Hormones|hormones|mesh-ancestor
25640323|NCT01391663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25640324|NCT01391663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25640325|NCT01391663|Protease Inhibitors|protease inhibitors|mesh-ancestor
25640326|NCT01391663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25640327|NCT01391663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640328|NCT01391793|Dexamethasone|dexamethasone|mesh-list
25640329|NCT01391793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25640330|NCT01391793|Antiemetics|antiemetics|mesh-ancestor
25640331|NCT01391793|Autonomic Agents|autonomic agents|mesh-ancestor
25640332|NCT01391793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25640333|NCT01391793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640334|NCT01391793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25640335|NCT01391793|Glucocorticoids|glucocorticoids|mesh-ancestor
25640336|NCT01391793|Hormones|hormones|mesh-ancestor
25640337|NCT01391793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25640338|NCT01391793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25640339|NCT01391793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25640340|NCT01391858|Pregabalin|pregabalin|mesh-list
25640341|NCT01391858|Analgesics|analgesics|mesh-ancestor
25640342|NCT01391858|Sensory System Agents|sensory system agents|mesh-ancestor
25640343|NCT01391858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25640344|NCT01391858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640345|NCT01391858|Anticonvulsants|anticonvulsants|mesh-ancestor
25640346|NCT01391858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25640347|NCT01391858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25640348|NCT01391858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640349|NCT01391858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25640350|NCT01391858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25640351|NCT01391858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25640352|NCT01391858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25640353|NCT01391858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25640354|NCT01392183|Diphenhydramine|diphenhydramine|mesh-list
25640355|NCT01392183|Sirolimus|sirolimus|mesh-list
25822751|NCT00004643|Antimetabolites|antimetabolites|mesh-ancestor
25640356|NCT01392183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25640357|NCT01392183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25640358|NCT01392183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25640359|NCT01392183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25640360|NCT01392183|Antifungal Agents|antifungal agents|mesh-ancestor
25640361|NCT01392183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25640362|NCT01392183|Immunologic Factors|immunologic factors|mesh-ancestor
25640363|NCT01392183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640364|NCT01392183|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25640365|NCT01392183|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25640366|NCT01392183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25640367|NCT01392183|Anesthetics, Local|anesthetics, local|mesh-ancestor
25640368|NCT01392183|Anesthetics|anesthetics|mesh-ancestor
25640369|NCT01392183|Sensory System Agents|sensory system agents|mesh-ancestor
25640370|NCT01392183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25640371|NCT01392183|Antiemetics|antiemetics|mesh-ancestor
25640372|NCT01392183|Autonomic Agents|autonomic agents|mesh-ancestor
25640373|NCT01392183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25640374|NCT01392183|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25640375|NCT01392183|Histamine Antagonists|histamine antagonists|mesh-ancestor
25640376|NCT01392183|Histamine Agents|histamine agents|mesh-ancestor
25640377|NCT01392183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25640378|NCT01392183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640379|NCT01392183|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25640380|NCT01392300|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25640381|NCT01392300|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25640382|NCT01392300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25640383|NCT01392300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640384|NCT01392300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25640385|NCT01392300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25640386|NCT01392300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640387|NCT01392300|Cholinergic Agents|cholinergic agents|mesh-ancestor
25640388|NCT01392300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25640389|NCT01392326|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25640390|NCT01392326|Immunologic Factors|immunologic factors|mesh-ancestor
25640391|NCT01392326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640392|NCT01392378|Acetaminophen|acetaminophen|mesh-list
25640393|NCT01392378|Ibuprofen|ibuprofen|mesh-list
25640394|NCT01392378|Vaccines|vaccines|mesh-list
25640395|NCT01392378|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25640396|NCT01392378|Immunologic Factors|immunologic factors|mesh-ancestor
25640397|NCT01392378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640398|NCT01392378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25640399|NCT01392378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25640400|NCT01392378|Analgesics|analgesics|mesh-ancestor
25640401|NCT01392378|Sensory System Agents|sensory system agents|mesh-ancestor
25640402|NCT01392378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25640403|NCT01392378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25640404|NCT01392378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25640405|NCT01392378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25640406|NCT01392378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25640407|NCT01392378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640408|NCT01392378|Antipyretics|antipyretics|mesh-ancestor
25640409|NCT01392469|Imatinib Mesylate|imatinib mesylate|mesh-list
25640410|NCT01392469|Bosentan|bosentan|mesh-list
25640411|NCT01392469|Sildenafil Citrate|sildenafil citrate|mesh-list
25640412|NCT01392469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25640413|NCT01392469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25640414|NCT01392469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25640415|NCT01392469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640416|NCT01392469|Vasodilator Agents|vasodilator agents|mesh-ancestor
25640417|NCT01392469|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25640418|NCT01392469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25640419|NCT01392469|Urological Agents|urological agents|mesh-ancestor
25640420|NCT01392469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25640421|NCT01392469|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25640422|NCT01392495|Imatinib Mesylate|imatinib mesylate|mesh-list
25640423|NCT01392495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25640424|NCT01392495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25640425|NCT01392495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25640426|NCT01392495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640427|NCT01392560|Empagliflozin|empagliflozin|mesh-list
25640428|NCT01392560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25657144|NCT01583374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640429|NCT01392560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640430|NCT01392560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25640431|NCT01392560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640433|NCT01392573|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25640434|NCT01392573|Liraglutide|liraglutide|mesh-list
25640435|NCT01392573|Insulin, Long-Acting|insulin, long-acting|mesh-list
25640436|NCT01392573|Xultophy|xultophy|mesh-list
25640437|NCT01392573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25640438|NCT01392573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640439|NCT01392573|Incretins|incretins|mesh-ancestor
25640440|NCT01392573|Hormones|hormones|mesh-ancestor
25640441|NCT01392573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25640442|NCT01392677|Dapagliflozin|dapagliflozin|mesh-list
25640443|NCT01392677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25640444|NCT01392677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640445|NCT01392677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25640446|NCT01392677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640447|NCT01392703|Dasatinib|dasatinib|mesh-list
25640448|NCT01392703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25640449|NCT01392703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25640450|NCT01392703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25640451|NCT01392703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640452|NCT01392859|Levocetirizine|levocetirizine|mesh-list
25640453|NCT01392859|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25640454|NCT01392859|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25640455|NCT01392859|Histamine Antagonists|histamine antagonists|mesh-ancestor
25640456|NCT01392859|Histamine Agents|histamine agents|mesh-ancestor
25640457|NCT01392859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25640458|NCT01392859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640459|NCT01392859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640460|NCT01392963|Botulinum Toxins|botulinum toxins|mesh-list
25640461|NCT01392963|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25640462|NCT01392963|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25640463|NCT01392963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25640464|NCT01392963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25640465|NCT01392963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640466|NCT01392963|Cholinergic Agents|cholinergic agents|mesh-ancestor
25640467|NCT01392963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25640468|NCT01392963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640469|NCT01392963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25640470|NCT01392963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25640471|NCT01392989|Cyclosporine|cyclosporine|mesh-list
25640472|NCT01392989|Mycophenolic Acid|mycophenolic acid|mesh-list
25640473|NCT01392989|Cyclosporins|cyclosporins|mesh-list
25640474|NCT01392989|Thymoglobulin|thymoglobulin|mesh-list
25640475|NCT01392989|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25640476|NCT01392989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25640477|NCT01392989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640478|NCT01392989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25640479|NCT01392989|Immunologic Factors|immunologic factors|mesh-ancestor
25640480|NCT01392989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640481|NCT01392989|Antifungal Agents|antifungal agents|mesh-ancestor
25640482|NCT01392989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25640483|NCT01392989|Dermatologic Agents|dermatologic agents|mesh-ancestor
25640484|NCT01392989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25640485|NCT01392989|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25640486|NCT01392989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25640487|NCT01392989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25640488|NCT01392989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25718947|NCT02439320|Lasmiditan|lasmiditan|mesh-list
25640489|NCT01392989|Antitubercular Agents|antitubercular agents|mesh-ancestor
25640490|NCT01392989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25640491|NCT01393106|Idelalisib|idelalisib|mesh-list
25640492|NCT01393106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25640493|NCT01393106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25640494|NCT01393106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640495|NCT01393132|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25640496|NCT01393132|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25640497|NCT01393158|Apremilast|apremilast|mesh-list
25640498|NCT01393158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25640499|NCT01393158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25640500|NCT01393158|Analgesics|analgesics|mesh-ancestor
25640501|NCT01393158|Sensory System Agents|sensory system agents|mesh-ancestor
25535555|NCT00561418|Vorinostat|vorinostat|mesh-list
25640502|NCT01393158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25640503|NCT01393158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640504|NCT01393158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25640505|NCT01393158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25640506|NCT01393158|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25640507|NCT01393158|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25640508|NCT01393158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25640509|NCT01393158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640510|NCT01393392|Methadone|methadone|mesh-list
25640511|NCT01393392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25640512|NCT01393392|Narcotics|narcotics|mesh-ancestor
25640513|NCT01393392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25640514|NCT01393392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640515|NCT01393392|Analgesics|analgesics|mesh-ancestor
25640516|NCT01393392|Sensory System Agents|sensory system agents|mesh-ancestor
25640517|NCT01393392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25640518|NCT01393392|Antitussive Agents|antitussive agents|mesh-ancestor
25640519|NCT01393392|Respiratory System Agents|respiratory system agents|mesh-ancestor
25640520|NCT01393405|Methotrexate|methotrexate|mesh-list
25640521|NCT01393405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25640522|NCT01393405|Abortifacient Agents|abortifacient agents|mesh-ancestor
25640523|NCT01393405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25640524|NCT01393405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640525|NCT01393405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25640526|NCT01393405|Antimetabolites|antimetabolites|mesh-ancestor
25640527|NCT01393405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640528|NCT01393405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25640529|NCT01393405|Dermatologic Agents|dermatologic agents|mesh-ancestor
25640530|NCT01393405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25640531|NCT01393405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25640532|NCT01393405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25640533|NCT01393405|Immunologic Factors|immunologic factors|mesh-ancestor
25640534|NCT01393405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25640535|NCT01393405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25640536|NCT01393457|Levodopa|levodopa|mesh-list
25640537|NCT01393457|Carbidopa|carbidopa|mesh-list
25640538|NCT01393457|Ropinirole|ropinirole|mesh-list
25640539|NCT01393457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25640540|NCT01393457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25640541|NCT01393457|Dopamine Agents|dopamine agents|mesh-ancestor
25640542|NCT01393457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25640543|NCT01393457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640544|NCT01393457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640545|NCT01393457|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25640546|NCT01393457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25640547|NCT01393457|Dopamine Agonists|dopamine agonists|mesh-ancestor
25640548|NCT01393600|Tetrabenazine|tetrabenazine|mesh-list
25640549|NCT01393600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25640550|NCT01393600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25640551|NCT01393600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25640552|NCT01393600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640553|NCT01393600|Adrenergic Agents|adrenergic agents|mesh-ancestor
25640554|NCT01393600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25640555|NCT01393600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640556|NCT01393626|Tofacitinib|tofacitinib|mesh-list
25640557|NCT01393626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25640558|NCT01393626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25640559|NCT01393626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640560|NCT01393704|Vasopressins|vasopressins|mesh-list
25640561|NCT01393704|Arginine Vasopressin|arginine vasopressin|mesh-list
25640562|NCT01393704|Hemostatics|hemostatics|mesh-ancestor
25640563|NCT01393704|Coagulants|coagulants|mesh-ancestor
25640564|NCT01393704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25640565|NCT01393704|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25640566|NCT01393704|Natriuretic Agents|natriuretic agents|mesh-ancestor
25640567|NCT01393704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640568|NCT01393717|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25640569|NCT01393717|Antibodies|antibodies|mesh-list
25640570|NCT01393717|Immunoglobulins|immunoglobulins|mesh-list
25640571|NCT01393717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25640572|NCT01393717|Immunoconjugates|immunoconjugates|mesh-list
25640573|NCT01393717|Immunologic Factors|immunologic factors|mesh-ancestor
25640574|NCT01393717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640575|NCT01393717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25640576|NCT01393717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25640578|NCT01393730|Abiraterone Acetate|abiraterone acetate|mesh-list
25640579|NCT01393730|Dutasteride|dutasteride|mesh-list
25640580|NCT01393730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25640581|NCT01393730|Glucocorticoids|glucocorticoids|mesh-ancestor
25640582|NCT01393730|Hormones|hormones|mesh-ancestor
25640583|NCT01393730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25640584|NCT01393730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640585|NCT01393730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25640586|NCT01393730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25640587|NCT01393730|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25640588|NCT01393730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25640589|NCT01393730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640590|NCT01393730|Hormone Antagonists|hormone antagonists|mesh-ancestor
25640591|NCT01393730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25640592|NCT01393730|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25640593|NCT01393899|Tofacitinib|tofacitinib|mesh-list
25640594|NCT01393899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25640595|NCT01393899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25640596|NCT01393899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640597|NCT01393964|Dexamethasone|dexamethasone|mesh-list
25640598|NCT01393964|Dexamethasone acetate|dexamethasone acetate|mesh-list
25640599|NCT01393964|Lenalidomide|lenalidomide|mesh-list
25640600|NCT01393964|Elotuzumab|elotuzumab|mesh-list
25640601|NCT01393964|BB 1101|bb 1101|mesh-list
25640602|NCT01393964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25640603|NCT01393964|Antiemetics|antiemetics|mesh-ancestor
25640604|NCT01393964|Autonomic Agents|autonomic agents|mesh-ancestor
25640605|NCT01393964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25640606|NCT01393964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640607|NCT01393964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25640608|NCT01393964|Glucocorticoids|glucocorticoids|mesh-ancestor
25640609|NCT01393964|Hormones|hormones|mesh-ancestor
25640610|NCT01393964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25640611|NCT01393964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25640612|NCT01393964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25640613|NCT01393964|Protease Inhibitors|protease inhibitors|mesh-ancestor
25640614|NCT01393964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25640615|NCT01393964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640616|NCT01393964|Immunologic Factors|immunologic factors|mesh-ancestor
25640617|NCT01393964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25640618|NCT01393964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25640619|NCT01393964|Growth Substances|growth substances|mesh-ancestor
25640620|NCT01393964|Growth Inhibitors|growth inhibitors|mesh-ancestor
25640621|NCT01393990|Tamoxifen|tamoxifen|mesh-list
25640622|NCT01393990|Midazolam|midazolam|mesh-list
25640623|NCT01393990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25640624|NCT01393990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25640625|NCT01393990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25640626|NCT01393990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640627|NCT01393990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25640628|NCT01393990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25640629|NCT01393990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25640630|NCT01393990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25640631|NCT01393990|Anesthetics, General|anesthetics, general|mesh-ancestor
25640632|NCT01393990|Anesthetics|anesthetics|mesh-ancestor
25640633|NCT01393990|GABA Modulators|gaba modulators|mesh-ancestor
25640634|NCT01393990|GABA Agents|gaba agents|mesh-ancestor
25640635|NCT01393990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25640636|NCT01393990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640637|NCT01393990|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25640638|NCT01393990|Hormone Antagonists|hormone antagonists|mesh-ancestor
25640639|NCT01393990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25640640|NCT01393990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25640641|NCT01393990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25640642|NCT01393990|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25640643|NCT01393990|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25640644|NCT01393990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25640645|NCT01394185|Dronabinol|dronabinol|mesh-list
25640646|NCT01394185|Hallucinogens|hallucinogens|mesh-ancestor
25640647|NCT01394185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640648|NCT01394185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25640649|NCT01394185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25640650|NCT01394185|Analgesics|analgesics|mesh-ancestor
25535686|NCT00562159|Fluticasone|fluticasone|mesh-list
25640652|NCT01394185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25640653|NCT01394185|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25640654|NCT01394185|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25640655|NCT01394185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25640656|NCT01394185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640657|NCT01394185|Hormones|hormones|mesh-ancestor
25640658|NCT01394185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25640659|NCT01394250|Lidocaine|lidocaine|mesh-list
25640660|NCT01394250|Anesthetics, Local|anesthetics, local|mesh-ancestor
25640661|NCT01394250|Anesthetics|anesthetics|mesh-ancestor
25640662|NCT01394250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25640663|NCT01394250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640664|NCT01394250|Sensory System Agents|sensory system agents|mesh-ancestor
25640665|NCT01394250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25640666|NCT01394250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25640667|NCT01394250|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25640668|NCT01394250|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25640669|NCT01394250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25640670|NCT01394250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640671|NCT01394510|Acetylcysteine|acetylcysteine|mesh-list
25640672|NCT01394510|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25640673|NCT01394510|Antiviral Agents|antiviral agents|mesh-ancestor
25640674|NCT01394510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25640675|NCT01394510|Expectorants|expectorants|mesh-ancestor
25640676|NCT01394510|Respiratory System Agents|respiratory system agents|mesh-ancestor
25640677|NCT01394510|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25640678|NCT01394510|Antioxidants|antioxidants|mesh-ancestor
25640679|NCT01394510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640680|NCT01394510|Protective Agents|protective agents|mesh-ancestor
25640681|NCT01394510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640682|NCT01394510|Antidotes|antidotes|mesh-ancestor
25640683|NCT01394523|Bupivacaine|bupivacaine|mesh-list
25640684|NCT01394523|Anesthetics, Local|anesthetics, local|mesh-ancestor
25640685|NCT01394523|Anesthetics|anesthetics|mesh-ancestor
25640686|NCT01394523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25718981|NCT02440568|Cytarabine|cytarabine|mesh-list
25640687|NCT01394523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640688|NCT01394523|Sensory System Agents|sensory system agents|mesh-ancestor
25640689|NCT01394523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25640690|NCT01394614|Vaccines|vaccines|mesh-list
25640691|NCT01394614|Immunologic Factors|immunologic factors|mesh-ancestor
25640692|NCT01394614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640693|NCT01394627|Eplerenone|eplerenone|mesh-list
25640694|NCT01394627|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25640695|NCT01394627|Hormone Antagonists|hormone antagonists|mesh-ancestor
25640696|NCT01394627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25640697|NCT01394627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640698|NCT01394627|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25640699|NCT01394627|Diuretics|diuretics|mesh-ancestor
25640700|NCT01394627|Natriuretic Agents|natriuretic agents|mesh-ancestor
25640701|NCT01394627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25640702|NCT01394718|Acetaminophen|acetaminophen|mesh-list
25640703|NCT01394718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25640704|NCT01394718|Analgesics|analgesics|mesh-ancestor
25640705|NCT01394718|Sensory System Agents|sensory system agents|mesh-ancestor
25640706|NCT01394718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25640707|NCT01394718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640708|NCT01394718|Antipyretics|antipyretics|mesh-ancestor
25640709|NCT01394939|Irinotecan|irinotecan|mesh-list
25640710|NCT01394939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25640711|NCT01394939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25640712|NCT01394939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25640713|NCT01394939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640714|NCT01394939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25640715|NCT01394952|Dulaglutide|dulaglutide|mesh-list
25640716|NCT01394952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25640717|NCT01394952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640718|NCT01394991|Epoetin Alfa|epoetin alfa|mesh-list
25640719|NCT01394991|Hematinics|hematinics|mesh-ancestor
25640720|NCT01395017|Dasatinib|dasatinib|mesh-list
25640721|NCT01395017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25640722|NCT01395017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25640723|NCT01395017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535770|NCT00562627|Mydriatics|mydriatics|mesh-ancestor
25640724|NCT01395017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640725|NCT01395030|Choline|choline|mesh-list
25640726|NCT01395030|Lipotropic Agents|lipotropic agents|mesh-ancestor
25640727|NCT01395030|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25640728|NCT01395030|Antimetabolites|antimetabolites|mesh-ancestor
25640729|NCT01395030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640730|NCT01395030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25640731|NCT01395030|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25640732|NCT01395030|Nootropic Agents|nootropic agents|mesh-ancestor
25640733|NCT01395043|Epinephrine|epinephrine|mesh-list
25640734|NCT01395043|Bupivacaine|bupivacaine|mesh-list
25640735|NCT01395043|Anesthetics, Local|anesthetics, local|mesh-ancestor
25640736|NCT01395043|Anesthetics|anesthetics|mesh-ancestor
25640737|NCT01395043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25640738|NCT01395043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640739|NCT01395043|Sensory System Agents|sensory system agents|mesh-ancestor
25640740|NCT01395043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25640741|NCT01395043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25640742|NCT01395043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25640743|NCT01395043|Adrenergic Agents|adrenergic agents|mesh-ancestor
25640744|NCT01395043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25640745|NCT01395043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640746|NCT01395043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25640747|NCT01395043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25640748|NCT01395043|Autonomic Agents|autonomic agents|mesh-ancestor
25640749|NCT01395043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25640750|NCT01395043|Respiratory System Agents|respiratory system agents|mesh-ancestor
25640751|NCT01395043|Mydriatics|mydriatics|mesh-ancestor
25640752|NCT01395043|Sympathomimetics|sympathomimetics|mesh-ancestor
25640753|NCT01395043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25640754|NCT01395316|Alemtuzumab|alemtuzumab|mesh-list
25640755|NCT01395316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25640756|NCT01395316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25640757|NCT01395329|Metoprolol|metoprolol|mesh-list
25640758|NCT01395329|Nebivolol|nebivolol|mesh-list
25640759|NCT01395329|Nitroprusside|nitroprusside|mesh-list
25640760|NCT01395329|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
25640762|NCT01395329|Acetylcholine|acetylcholine|mesh-list
25640763|NCT01395329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25640764|NCT01395329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25640765|NCT01395329|Sympatholytics|sympatholytics|mesh-ancestor
25640766|NCT01395329|Autonomic Agents|autonomic agents|mesh-ancestor
25640767|NCT01395329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25640768|NCT01395329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640769|NCT01395329|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25640770|NCT01395329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25640771|NCT01395329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25640772|NCT01395329|Adrenergic Agents|adrenergic agents|mesh-ancestor
25640773|NCT01395329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25640774|NCT01395329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640775|NCT01395329|Vasodilator Agents|vasodilator agents|mesh-ancestor
25640776|NCT01395329|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25640777|NCT01395329|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25640778|NCT01395329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25640779|NCT01395329|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25640780|NCT01395329|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25640781|NCT01395329|Cholinergic Agents|cholinergic agents|mesh-ancestor
25640782|NCT01395329|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25640783|NCT01395329|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25640784|NCT01395524|Naloxegol|naloxegol|mesh-list
25640785|NCT01395524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25640786|NCT01395524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640787|NCT01395524|Sensory System Agents|sensory system agents|mesh-ancestor
25640788|NCT01395524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25640789|NCT01395537|Paclitaxel|paclitaxel|mesh-list
25640790|NCT01395537|Carboplatin|carboplatin|mesh-list
25640791|NCT01395537|Lapatinib|lapatinib|mesh-list
25640792|NCT01395537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25640793|NCT01395537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25640794|NCT01395537|Tubulin Modulators|tubulin modulators|mesh-ancestor
25640795|NCT01395537|Antimitotic Agents|antimitotic agents|mesh-ancestor
25640796|NCT01395537|Mitosis Modulators|mitosis modulators|mesh-ancestor
25640797|NCT01395537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535843|NCT00562965|Tubulin Modulators|tubulin modulators|mesh-ancestor
25640798|NCT01395537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25640800|NCT01395758|Gemcitabine|gemcitabine|mesh-list
25640801|NCT01395758|Docetaxel|docetaxel|mesh-list
25640802|NCT01395758|Pemetrexed|pemetrexed|mesh-list
25640803|NCT01395758|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25535914|NCT00563706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25535915|NCT00563706|Serotonin Agents|serotonin agents|mesh-ancestor
25535916|NCT00563706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25535917|NCT00563706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535918|NCT00563706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535919|NCT00563706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25535920|NCT00563706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25535921|NCT00563706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25535922|NCT00563706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25535923|NCT00563706|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25535924|NCT00563706|Dopamine Agents|dopamine agents|mesh-ancestor
25535925|NCT00563784|Paclitaxel|paclitaxel|mesh-list
25535926|NCT00563784|Carboplatin|carboplatin|mesh-list
25535927|NCT00563784|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25535928|NCT00563784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25535929|NCT00563784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535930|NCT00563784|Tubulin Modulators|tubulin modulators|mesh-ancestor
25535931|NCT00563784|Antimitotic Agents|antimitotic agents|mesh-ancestor
25535932|NCT00563784|Mitosis Modulators|mitosis modulators|mesh-ancestor
25535933|NCT00563784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535934|NCT00563784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25535935|NCT00563784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535936|NCT00563797|Mecamylamine|mecamylamine|mesh-list
24450603|NCT00319800|Irinotecan|irinotecan|mesh-list
25535937|NCT00563797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25535938|NCT00563797|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
25535939|NCT00563797|Autonomic Agents|autonomic agents|mesh-ancestor
25535940|NCT00563797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25535941|NCT00563797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535942|NCT00563797|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25535943|NCT00563797|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25535944|NCT00563797|Cholinergic Agents|cholinergic agents|mesh-ancestor
25535945|NCT00563797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25535946|NCT00563797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535947|NCT00564018|Insulin Detemir|insulin detemir|mesh-list
25535948|NCT00564018|Protamines|protamines|mesh-list
25640804|NCT01395758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25640805|NCT01395758|Antimetabolites|antimetabolites|mesh-ancestor
25640806|NCT01395758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640807|NCT01395758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25640808|NCT01395758|Antiviral Agents|antiviral agents|mesh-ancestor
25640809|NCT01395758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25640810|NCT01395758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25640811|NCT01395758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25640812|NCT01395758|Immunologic Factors|immunologic factors|mesh-ancestor
25640813|NCT01395758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640814|NCT01395758|Tubulin Modulators|tubulin modulators|mesh-ancestor
25640815|NCT01395758|Antimitotic Agents|antimitotic agents|mesh-ancestor
25640816|NCT01395758|Mitosis Modulators|mitosis modulators|mesh-ancestor
25640817|NCT01395758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25640818|NCT01395758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25640819|NCT01395758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25640820|NCT01395784|Pioglitazone|pioglitazone|mesh-list
25640821|NCT01395784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25640822|NCT01395784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640823|NCT01395797|Pioglitazone|pioglitazone|mesh-list
25640824|NCT01395797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25640825|NCT01395797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656656|NCT01576952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25656657|NCT01576952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25656658|NCT01576952|Analgesics|analgesics|mesh-ancestor
25656659|NCT01576952|Sensory System Agents|sensory system agents|mesh-ancestor
25656660|NCT01576952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25656661|NCT01576952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656662|NCT01576952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25656663|NCT01576952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25656664|NCT01577160|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25656665|NCT01577160|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25656666|NCT01577160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25656667|NCT01577160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25640826|NCT01395823|Vitamin D|vitamin d|mesh-list
25640827|NCT01395823|Ergocalciferols|ergocalciferols|mesh-list
25640828|NCT01395823|Vitamins|vitamins|mesh-ancestor
25640829|NCT01395823|Micronutrients|micronutrients|mesh-ancestor
25640830|NCT01395823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640831|NCT01395823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25640832|NCT01395823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25640833|NCT01395888|Fluticasone|fluticasone|mesh-list
25640834|NCT01395888|Xhance|xhance|mesh-list
25640835|NCT01395888|Tiotropium Bromide|tiotropium bromide|mesh-list
25640836|NCT01395888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25640837|NCT01395888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25640838|NCT01395888|Autonomic Agents|autonomic agents|mesh-ancestor
25640839|NCT01395888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25640840|NCT01395888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640841|NCT01395888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25640842|NCT01395888|Respiratory System Agents|respiratory system agents|mesh-ancestor
25640843|NCT01395888|Dermatologic Agents|dermatologic agents|mesh-ancestor
25640844|NCT01395888|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25640845|NCT01395888|Parasympatholytics|parasympatholytics|mesh-ancestor
25640846|NCT01395888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25640847|NCT01395888|Cholinergic Agents|cholinergic agents|mesh-ancestor
25640848|NCT01395888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25640849|NCT01395888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640850|NCT01395901|Ondansetron|ondansetron|mesh-list
25640851|NCT01395901|Palonosetron|palonosetron|mesh-list
25640852|NCT01395901|Antiemetics|antiemetics|mesh-ancestor
25640853|NCT01395901|Autonomic Agents|autonomic agents|mesh-ancestor
25640854|NCT01395901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25640855|NCT01395901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640856|NCT01395901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25640857|NCT01395901|Antipruritics|antipruritics|mesh-ancestor
25640858|NCT01395901|Dermatologic Agents|dermatologic agents|mesh-ancestor
25640859|NCT01395901|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25640860|NCT01395901|Serotonin Agents|serotonin agents|mesh-ancestor
25640861|NCT01395901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25640862|NCT01395901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640863|NCT01395901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25640864|NCT01395901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25640865|NCT01395901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25640866|NCT01395901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25640867|NCT01395901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25640868|NCT01395901|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25640869|NCT01396005|Buprenorphine|buprenorphine|mesh-list
25640870|NCT01396005|Methadone|methadone|mesh-list
25640871|NCT01396005|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25640872|NCT01396005|Naloxone|naloxone|mesh-list
25640873|NCT01396005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25640874|NCT01396005|Narcotics|narcotics|mesh-ancestor
25640875|NCT01396005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25640876|NCT01396005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640877|NCT01396005|Analgesics|analgesics|mesh-ancestor
25640878|NCT01396005|Sensory System Agents|sensory system agents|mesh-ancestor
25640879|NCT01396005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25640880|NCT01396005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25640881|NCT01396005|Antitussive Agents|antitussive agents|mesh-ancestor
25640882|NCT01396005|Respiratory System Agents|respiratory system agents|mesh-ancestor
25640883|NCT01396057|Dexamethasone|dexamethasone|mesh-list
25640884|NCT01396057|Ranibizumab|ranibizumab|mesh-list
25640885|NCT01396057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25640886|NCT01396057|Antiemetics|antiemetics|mesh-ancestor
25640887|NCT01396057|Autonomic Agents|autonomic agents|mesh-ancestor
25640888|NCT01396057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25640889|NCT01396057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640890|NCT01396057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25640891|NCT01396057|Glucocorticoids|glucocorticoids|mesh-ancestor
25640892|NCT01396057|Hormones|hormones|mesh-ancestor
25640893|NCT01396057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25640894|NCT01396057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25640895|NCT01396057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25640896|NCT01396057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25640897|NCT01396057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25640898|NCT01396057|Growth Substances|growth substances|mesh-ancestor
25640899|NCT01396057|Growth Inhibitors|growth inhibitors|mesh-ancestor
25640900|NCT01396070|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25640901|NCT01396070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25640902|NCT01396070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25640904|NCT01396083|Ranibizumab|ranibizumab|mesh-list
25640905|NCT01396083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25640906|NCT01396083|Antiemetics|antiemetics|mesh-ancestor
25640907|NCT01396083|Autonomic Agents|autonomic agents|mesh-ancestor
25640908|NCT01396083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25640909|NCT01396083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640910|NCT01396083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25640911|NCT01396083|Glucocorticoids|glucocorticoids|mesh-ancestor
25640912|NCT01396083|Hormones|hormones|mesh-ancestor
25640913|NCT01396083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25640914|NCT01396083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25640915|NCT01396083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25640916|NCT01396083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25640917|NCT01396083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25640918|NCT01396083|Growth Substances|growth substances|mesh-ancestor
25640919|NCT01396083|Growth Inhibitors|growth inhibitors|mesh-ancestor
25640920|NCT01396148|Sunitinib|sunitinib|mesh-list
25640921|NCT01396148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25640922|NCT01396148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25640923|NCT01396148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25640924|NCT01396148|Growth Substances|growth substances|mesh-ancestor
25640925|NCT01396148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640926|NCT01396148|Growth Inhibitors|growth inhibitors|mesh-ancestor
25640927|NCT01396148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25640928|NCT01396148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25640929|NCT01396148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640930|NCT01396265|Rifampin|rifampin|mesh-list
25640931|NCT01396265|Afatinib|afatinib|mesh-list
25640932|NCT01396265|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25640933|NCT01396265|Antitubercular Agents|antitubercular agents|mesh-ancestor
25640934|NCT01396265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25640935|NCT01396265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25640936|NCT01396265|Leprostatic Agents|leprostatic agents|mesh-ancestor
25640937|NCT01396265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25640938|NCT01396265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25640939|NCT01396265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640940|NCT01396265|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25640941|NCT01396265|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25640942|NCT01396265|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25640943|NCT01396265|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25640944|NCT01396265|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25640945|NCT01396265|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25640946|NCT01396265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25640947|NCT01396265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25640948|NCT01396395|Nicorandil|nicorandil|mesh-list
25640949|NCT01396395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25640950|NCT01396395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25640951|NCT01396395|Vasodilator Agents|vasodilator agents|mesh-ancestor
25640952|NCT01396395|Vitamin B Complex|vitamin b complex|mesh-ancestor
25640953|NCT01396395|Vitamins|vitamins|mesh-ancestor
25640954|NCT01396395|Micronutrients|micronutrients|mesh-ancestor
25640955|NCT01396395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640956|NCT01396421|Brexpiprazole|brexpiprazole|mesh-list
25640957|NCT01396421|Serotonin Agents|serotonin agents|mesh-ancestor
25640958|NCT01396421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25640959|NCT01396421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640960|NCT01396421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640961|NCT01396421|Dopamine Agonists|dopamine agonists|mesh-ancestor
25640962|NCT01396421|Dopamine Agents|dopamine agents|mesh-ancestor
25640963|NCT01396434|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25640964|NCT01396434|Immunologic Factors|immunologic factors|mesh-ancestor
25640965|NCT01396434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640966|NCT01396447|Cariprazine|cariprazine|mesh-list
25640967|NCT01396447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25640968|NCT01396447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25640969|NCT01396447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25640970|NCT01396447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640971|NCT01396447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25640972|NCT01396486|Inositol|inositol|mesh-list
25640973|NCT01396486|Vitamin B Complex|vitamin b complex|mesh-ancestor
25640974|NCT01396486|Vitamins|vitamins|mesh-ancestor
25640975|NCT01396486|Micronutrients|micronutrients|mesh-ancestor
25640976|NCT01396486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640977|NCT01396512|Vaccines|vaccines|mesh-list
25640978|NCT01396512|Immunologic Factors|immunologic factors|mesh-ancestor
25640979|NCT01396512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640980|NCT01397084|Esomeprazole|esomeprazole|mesh-list
25640981|NCT01397084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25640982|NCT01397084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25640983|NCT01397084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25640984|NCT01397084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25640985|NCT01397084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25640986|NCT01397409|Ranibizumab|ranibizumab|mesh-list
25640987|NCT01397409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25640988|NCT01397409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25640989|NCT01397409|Growth Substances|growth substances|mesh-ancestor
25640990|NCT01397409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25640991|NCT01397409|Growth Inhibitors|growth inhibitors|mesh-ancestor
25640992|NCT01397409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25640994|NCT01397422|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25640995|NCT01397422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25640996|NCT01397422|Antiviral Agents|antiviral agents|mesh-ancestor
25640997|NCT01397422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25640998|NCT01397422|Dopamine Agents|dopamine agents|mesh-ancestor
25640999|NCT01397422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25641000|NCT01397422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641001|NCT01397422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641002|NCT01397422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25641003|NCT01397422|Analgesics|analgesics|mesh-ancestor
25641004|NCT01397422|Sensory System Agents|sensory system agents|mesh-ancestor
25641005|NCT01397422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25641006|NCT01397448|Rabeprazole|rabeprazole|mesh-list
25641007|NCT01397448|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25641008|NCT01397448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25641009|NCT01397448|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25641010|NCT01397448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25641011|NCT01397448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641012|NCT01397461|Retapamulin|retapamulin|mesh-list
25641013|NCT01397461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25641014|NCT01397461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25641015|NCT01397591|Bortezomib|bortezomib|mesh-list
25641016|NCT01397591|Ofatumumab|ofatumumab|mesh-list
25641017|NCT01397591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641018|NCT01397825|Rituximab|rituximab|mesh-list
25641019|NCT01397825|Vincristine|vincristine|mesh-list
25641020|NCT01397825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25641021|NCT01397825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641022|NCT01397825|Immunologic Factors|immunologic factors|mesh-ancestor
25641023|NCT01397825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641024|NCT01397825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25641025|NCT01397825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25641026|NCT01397825|Tubulin Modulators|tubulin modulators|mesh-ancestor
25641027|NCT01397825|Antimitotic Agents|antimitotic agents|mesh-ancestor
25641028|NCT01397825|Mitosis Modulators|mitosis modulators|mesh-ancestor
25641029|NCT01397825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641030|NCT01397890|Budesonide|budesonide|mesh-list
25641031|NCT01397890|Formoterol Fumarate|formoterol fumarate|mesh-list
25641032|NCT01397890|Tiotropium Bromide|tiotropium bromide|mesh-list
25641033|NCT01397890|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25641034|NCT01397890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25641035|NCT01397890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25641036|NCT01397890|Autonomic Agents|autonomic agents|mesh-ancestor
25641037|NCT01397890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25641038|NCT01397890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641039|NCT01397890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25641040|NCT01397890|Respiratory System Agents|respiratory system agents|mesh-ancestor
25641041|NCT01397890|Glucocorticoids|glucocorticoids|mesh-ancestor
25641042|NCT01397890|Hormones|hormones|mesh-ancestor
25641043|NCT01397890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25641044|NCT01397890|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25641045|NCT01397890|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25641046|NCT01397890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25641047|NCT01397890|Adrenergic Agents|adrenergic agents|mesh-ancestor
25641048|NCT01397890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25641049|NCT01397890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641050|NCT01397890|Parasympatholytics|parasympatholytics|mesh-ancestor
25641051|NCT01397890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25536111|NCT05559983|Vaccines|vaccines|mesh-list
25641052|NCT01397890|Cholinergic Agents|cholinergic agents|mesh-ancestor
25641053|NCT01398280|Aminocaproic Acid|aminocaproic acid|mesh-list
25641054|NCT01398280|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25641055|NCT01398280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25641056|NCT01398280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641057|NCT01398280|Hemostatics|hemostatics|mesh-ancestor
25641058|NCT01398280|Coagulants|coagulants|mesh-ancestor
25641059|NCT01398410|Rabeprazole|rabeprazole|mesh-list
25641060|NCT01398410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25641061|NCT01398410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25641062|NCT01398410|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25641063|NCT01398410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25641064|NCT01398410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641066|NCT01398514|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25641067|NCT01398514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25641068|NCT01398514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25641069|NCT01398514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641070|NCT01398514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25641071|NCT01398514|Serotonin Agents|serotonin agents|mesh-ancestor
25641072|NCT01398514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641073|NCT01398514|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25641074|NCT01398514|Antidepressive Agents|antidepressive agents|mesh-ancestor
25641075|NCT01398514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25641076|NCT01398943|Antioxidants|antioxidants|mesh-list
25641077|NCT01398943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641078|NCT01398943|Protective Agents|protective agents|mesh-ancestor
25641079|NCT01398943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641080|NCT01398956|Levetiracetam|levetiracetam|mesh-list
25641081|NCT01398956|Anticonvulsants|anticonvulsants|mesh-ancestor
25641082|NCT01398956|Nootropic Agents|nootropic agents|mesh-ancestor
25641083|NCT01398982|Bupivacaine|bupivacaine|mesh-list
25641084|NCT01398982|Anesthetics, Local|anesthetics, local|mesh-ancestor
25641085|NCT01398982|Anesthetics|anesthetics|mesh-ancestor
25641086|NCT01398982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25641087|NCT01398982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641088|NCT01398982|Sensory System Agents|sensory system agents|mesh-ancestor
25641089|NCT01398982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25641090|NCT01399008|Colchicine|colchicine|mesh-list
25641091|NCT01399008|Allopurinol|allopurinol|mesh-list
25641092|NCT01399008|Gout Suppressants|gout suppressants|mesh-ancestor
25641093|NCT01399008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25641094|NCT01399008|Tubulin Modulators|tubulin modulators|mesh-ancestor
25641095|NCT01399008|Antimitotic Agents|antimitotic agents|mesh-ancestor
25641096|NCT01399008|Mitosis Modulators|mitosis modulators|mesh-ancestor
25641097|NCT01399008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641098|NCT01399008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641099|NCT01399008|Antimetabolites|antimetabolites|mesh-ancestor
25641100|NCT01399008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25641101|NCT01399008|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25641102|NCT01399008|Antioxidants|antioxidants|mesh-ancestor
25641103|NCT01399008|Protective Agents|protective agents|mesh-ancestor
25641104|NCT01399008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641105|NCT01399047|Mycophenolic Acid|mycophenolic acid|mesh-list
25641106|NCT01399047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25641107|NCT01399047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641108|NCT01399047|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25641109|NCT01399047|Antitubercular Agents|antitubercular agents|mesh-ancestor
25641110|NCT01399047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25641111|NCT01399047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25641112|NCT01399047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25641113|NCT01399047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641114|NCT01399125|Rivastigmine|rivastigmine|mesh-list
25641115|NCT01399125|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25641116|NCT01399125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25641117|NCT01399125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641118|NCT01399125|Cholinergic Agents|cholinergic agents|mesh-ancestor
25719036|NCT02441114|Sympathomimetics|sympathomimetics|mesh-ancestor
25641119|NCT01399125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25641120|NCT01399125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641121|NCT01399125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25641122|NCT01399125|Protective Agents|protective agents|mesh-ancestor
25641123|NCT01399190|Bevacizumab|bevacizumab|mesh-list
25641124|NCT01399190|Capecitabine|capecitabine|mesh-list
25641125|NCT01399190|Oxaliplatin|oxaliplatin|mesh-list
25641126|NCT01399190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25641127|NCT01399190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641128|NCT01399190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25641129|NCT01399190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25641131|NCT01399190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641132|NCT01399190|Growth Inhibitors|growth inhibitors|mesh-ancestor
25641133|NCT01399190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25641134|NCT01399190|Antimetabolites|antimetabolites|mesh-ancestor
25641135|NCT01399190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641136|NCT01399268|Hydrocortisone|hydrocortisone|mesh-list
25641137|NCT01399268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25641138|NCT01399593|Eculizumab|eculizumab|mesh-list
25641139|NCT01399593|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25641140|NCT01399593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25641141|NCT01399593|Immunologic Factors|immunologic factors|mesh-ancestor
25641142|NCT01399593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641143|NCT01399697|Methotrexate|methotrexate|mesh-list
25641144|NCT01399697|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25641145|NCT01399697|Abortifacient Agents|abortifacient agents|mesh-ancestor
25641146|NCT01399697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25641147|NCT01399697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641148|NCT01399697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25641149|NCT01399697|Antimetabolites|antimetabolites|mesh-ancestor
25641150|NCT01399697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641151|NCT01399697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641152|NCT01399697|Dermatologic Agents|dermatologic agents|mesh-ancestor
25641153|NCT01399697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25641154|NCT01399697|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25641155|NCT01399697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25641156|NCT01399697|Immunologic Factors|immunologic factors|mesh-ancestor
25641157|NCT01399697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25641158|NCT01399697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25641159|NCT01399723|Amoxicillin|amoxicillin|mesh-list
25641160|NCT01399723|Penicillins|penicillins|mesh-list
25641161|NCT01399723|Penicillin G|penicillin g|mesh-list
25641162|NCT01399723|Penicillin G Benzathine|penicillin g benzathine|mesh-list
25641163|NCT01399723|Penicillin G Procaine|penicillin g procaine|mesh-list
25641164|NCT01399723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25641165|NCT01399723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25641166|NCT01399827|Methylphenidate|methylphenidate|mesh-list
25641167|NCT01399827|Amphetamine|amphetamine|mesh-list
25641168|NCT01399827|Adderall|adderall|mesh-list
25641169|NCT01399827|Dextroamphetamine|dextroamphetamine|mesh-list
25641170|NCT01399827|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
25641171|NCT01399827|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25641172|NCT01399827|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25641173|NCT01399827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641174|NCT01399827|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25641175|NCT01399827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25641176|NCT01399827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25641177|NCT01399827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641178|NCT01399827|Dopamine Agents|dopamine agents|mesh-ancestor
25641179|NCT01399827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25641180|NCT01399827|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25641181|NCT01399827|Adrenergic Agents|adrenergic agents|mesh-ancestor
25641182|NCT01399827|Sympathomimetics|sympathomimetics|mesh-ancestor
25641183|NCT01399827|Autonomic Agents|autonomic agents|mesh-ancestor
25641184|NCT01399827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25641185|NCT01399866|Cycloserine|cycloserine|mesh-list
25641186|NCT01399866|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25641187|NCT01399866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25641188|NCT01399866|Renal Agents|renal agents|mesh-ancestor
25641189|NCT01399866|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25641190|NCT01399866|Antitubercular Agents|antitubercular agents|mesh-ancestor
25641191|NCT01399866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25641192|NCT01399866|Antimetabolites|antimetabolites|mesh-ancestor
25641193|NCT01399866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641194|NCT01399905|Carbidopa|carbidopa|mesh-list
25641195|NCT01399905|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25641196|NCT01399905|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25641197|NCT01399905|Dopamine Agents|dopamine agents|mesh-ancestor
25641198|NCT01399905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25641199|NCT01399905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641200|NCT01399905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641201|NCT01399905|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25641202|NCT01399905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25641203|NCT01400113|Asenapine|asenapine|mesh-list
25641204|NCT01400113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25641205|NCT01400113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25641206|NCT01400113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25641207|NCT01400113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641208|NCT01400113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25641209|NCT01400139|Hydrocodone|hydrocodone|mesh-list
25641210|NCT01400139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25641211|NCT01400139|Narcotics|narcotics|mesh-ancestor
25641212|NCT01400139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25641213|NCT01400139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641214|NCT01400139|Analgesics|analgesics|mesh-ancestor
25641215|NCT01400139|Sensory System Agents|sensory system agents|mesh-ancestor
25641216|NCT01400139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25641217|NCT01400139|Antitussive Agents|antitussive agents|mesh-ancestor
25641218|NCT01400139|Respiratory System Agents|respiratory system agents|mesh-ancestor
25641219|NCT01400243|Nicotine|nicotine|mesh-list
25641220|NCT01400243|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25641221|NCT01400243|Autonomic Agents|autonomic agents|mesh-ancestor
25641222|NCT01400243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25641223|NCT01400243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641224|NCT01400243|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25641225|NCT01400243|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25641226|NCT01400243|Cholinergic Agents|cholinergic agents|mesh-ancestor
25641227|NCT01400243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25641228|NCT01400243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641229|NCT01400412|Ritonavir|ritonavir|mesh-list
25641230|NCT01400412|Darunavir|darunavir|mesh-list
25641231|NCT01400412|Tenofovir|tenofovir|mesh-list
25641232|NCT01400412|Emtricitabine|emtricitabine|mesh-list
25641233|NCT01400412|Maraviroc|maraviroc|mesh-list
25641234|NCT01400412|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25641235|NCT01400412|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25641236|NCT01400412|Protease Inhibitors|protease inhibitors|mesh-ancestor
25641237|NCT01400412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25641238|NCT01400412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641239|NCT01400412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25641240|NCT01400412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25641241|NCT01400412|Antiviral Agents|antiviral agents|mesh-ancestor
25641242|NCT01400412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25641243|NCT01400412|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25641244|NCT01400412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25641245|NCT01400412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25641246|NCT01400412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25641247|NCT01400412|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25641248|NCT01400412|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25641249|NCT01400412|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25641250|NCT01400451|Ipilimumab|ipilimumab|mesh-list
25641251|NCT01400451|Vemurafenib|vemurafenib|mesh-list
25641252|NCT01400451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25641253|NCT01400451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641254|NCT01400451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25641255|NCT01400451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641256|NCT01400451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25641257|NCT01400451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25641258|NCT01400503|Siltuximab|siltuximab|mesh-list
25641259|NCT01400503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641260|NCT01400516|Vitamin D|vitamin d|mesh-list
25641261|NCT01400516|Teriparatide|teriparatide|mesh-list
25641262|NCT01400516|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
25641263|NCT01400516|Calcium|calcium|mesh-list
25641264|NCT01400516|Vitamins|vitamins|mesh-ancestor
25641265|NCT01400516|Micronutrients|micronutrients|mesh-ancestor
25641266|NCT01400516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641267|NCT01400516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25641268|NCT01400516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25641269|NCT01400516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25641270|NCT01400906|Fluticasone|fluticasone|mesh-list
25641271|NCT01400906|Xhance|xhance|mesh-list
25641272|NCT01400906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25641273|NCT01400906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25641274|NCT01400906|Autonomic Agents|autonomic agents|mesh-ancestor
25641275|NCT01400906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25641276|NCT01400906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536337|NCT05483491|Aldesleukin|aldesleukin|mesh-list
25641277|NCT01400906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25641278|NCT01400906|Respiratory System Agents|respiratory system agents|mesh-ancestor
25641279|NCT01400906|Dermatologic Agents|dermatologic agents|mesh-ancestor
25641280|NCT01400906|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25641281|NCT01400932|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25641282|NCT01400932|Dermatologic Agents|dermatologic agents|mesh-ancestor
25641283|NCT01400958|Modafinil|modafinil|mesh-list
25641284|NCT01400958|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25641285|NCT01400958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641286|NCT01400958|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25641287|NCT01400958|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25641288|NCT01400958|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25641289|NCT01400958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641290|NCT01401010|Doripenem|doripenem|mesh-list
25641291|NCT01401010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25641292|NCT01401010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25641293|NCT01401023|Tigecycline|tigecycline|mesh-list
25641294|NCT01401023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25641295|NCT01401023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25641296|NCT01401023|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25641297|NCT01401023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25641298|NCT01401023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641299|NCT01401166|Trastuzumab|trastuzumab|mesh-list
25641300|NCT01401166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25641301|NCT01401166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641302|NCT01401322|Lenalidomide|lenalidomide|mesh-list
25641303|NCT01401322|Immunologic Factors|immunologic factors|mesh-ancestor
25641304|NCT01401322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641305|NCT01401322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25641306|NCT01401322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25641307|NCT01401322|Growth Substances|growth substances|mesh-ancestor
25641308|NCT01401322|Growth Inhibitors|growth inhibitors|mesh-ancestor
25641309|NCT01401322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656668|NCT01577160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656669|NCT01577160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25656670|NCT01577160|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25656671|NCT01577160|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25656672|NCT01577160|Serotonin Agents|serotonin agents|mesh-ancestor
25656673|NCT01577160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25656674|NCT01577160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656675|NCT01577160|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25656676|NCT01577160|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25656677|NCT01577160|Dopamine Agents|dopamine agents|mesh-ancestor
25656678|NCT01577186|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25656679|NCT01577186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25656680|NCT01577186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25656681|NCT01577186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25656682|NCT01577186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656683|NCT01577186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25656684|NCT01577186|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25656685|NCT01577186|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25656686|NCT01577186|Serotonin Agents|serotonin agents|mesh-ancestor
25656687|NCT01577186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25656688|NCT01577186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656689|NCT01577186|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25656690|NCT01577186|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25656691|NCT01577186|Dopamine Agents|dopamine agents|mesh-ancestor
25656692|NCT01577706|Alprazolam|alprazolam|mesh-list
25656693|NCT01577706|Dextroamphetamine|dextroamphetamine|mesh-list
25656694|NCT01577706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25656695|NCT01577706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25656696|NCT01577706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656697|NCT01577706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25656698|NCT01577706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25656699|NCT01577706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25656700|NCT01577706|GABA Modulators|gaba modulators|mesh-ancestor
25656701|NCT01577706|GABA Agents|gaba agents|mesh-ancestor
25656702|NCT01577706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25656703|NCT01577706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656704|NCT01577706|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25656705|NCT01577706|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25656706|NCT01577706|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25656707|NCT01577706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25536416|NCT05425732|Vaccines|vaccines|mesh-list
25641310|NCT01401465|Mometasone Furoate|mometasone furoate|mesh-list
25641311|NCT01401465|Ciclesonide|ciclesonide|mesh-list
25641312|NCT01401465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25641313|NCT01401465|Dermatologic Agents|dermatologic agents|mesh-ancestor
25641314|NCT01401465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25641315|NCT01401465|Glucocorticoids|glucocorticoids|mesh-ancestor
25641316|NCT01401465|Hormones|hormones|mesh-ancestor
25641317|NCT01401465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25641318|NCT01401465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641319|NCT01401530|Denileukin diftitox|denileukin diftitox|mesh-list
25641320|NCT01401530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641321|NCT01401543|Tadalafil|tadalafil|mesh-list
25641322|NCT01401543|Vasodilator Agents|vasodilator agents|mesh-ancestor
25641323|NCT01401543|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25641324|NCT01401543|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25641325|NCT01401543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25641326|NCT01401543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641327|NCT01401543|Urological Agents|urological agents|mesh-ancestor
25641328|NCT01401595|Dexetimide|dexetimide|mesh-list
25641329|NCT01401595|Citalopram|citalopram|mesh-list
25641330|NCT01401595|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25641331|NCT01401595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25641332|NCT01401595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25641333|NCT01401595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641334|NCT01401595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25641335|NCT01401595|Serotonin Agents|serotonin agents|mesh-ancestor
25641336|NCT01401595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641337|NCT01401595|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25641338|NCT01401595|Antidepressive Agents|antidepressive agents|mesh-ancestor
25641339|NCT01401595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25641340|NCT01401595|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25641341|NCT01401595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25641342|NCT01401595|Parasympatholytics|parasympatholytics|mesh-ancestor
25641343|NCT01401595|Autonomic Agents|autonomic agents|mesh-ancestor
25641344|NCT01401595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25641345|NCT01401595|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25641346|NCT01401595|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25641347|NCT01401595|Cholinergic Agents|cholinergic agents|mesh-ancestor
25641348|NCT01401647|Lidocaine|lidocaine|mesh-list
25641349|NCT01401647|Amiodarone|amiodarone|mesh-list
25641350|NCT01401647|Anesthetics, Local|anesthetics, local|mesh-ancestor
25641351|NCT01401647|Anesthetics|anesthetics|mesh-ancestor
25641352|NCT01401647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25641353|NCT01401647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641354|NCT01401647|Sensory System Agents|sensory system agents|mesh-ancestor
25641355|NCT01401647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25641356|NCT01401647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25641357|NCT01401647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25641358|NCT01401647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25641359|NCT01401647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25641360|NCT01401647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641361|NCT01401647|Vasodilator Agents|vasodilator agents|mesh-ancestor
25641362|NCT01401647|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25641363|NCT01401647|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25641364|NCT01401647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25641365|NCT01401647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25641366|NCT01401647|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25641367|NCT01401647|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25641368|NCT01401647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25641369|NCT01401959|Trastuzumab|trastuzumab|mesh-list
25641370|NCT01401959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25641371|NCT01401959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641372|NCT01402011|Lidocaine|lidocaine|mesh-list
25641373|NCT01402011|Anesthetics, Local|anesthetics, local|mesh-ancestor
25641374|NCT01402011|Anesthetics|anesthetics|mesh-ancestor
25641375|NCT01402011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25641376|NCT01402011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641377|NCT01402011|Sensory System Agents|sensory system agents|mesh-ancestor
25641378|NCT01402011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25641379|NCT01402011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25641380|NCT01402011|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25641381|NCT01402011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25641382|NCT01402011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25641383|NCT01402011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641384|NCT01402050|Dinoprostone|dinoprostone|mesh-list
25641385|NCT01402050|Oxytocics|oxytocics|mesh-ancestor
25641386|NCT01402050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25641387|NCT01402050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641388|NCT01402063|Temozolomide|temozolomide|mesh-list
25641389|NCT01402063|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
25641390|NCT01402063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25641391|NCT01402063|Alkylating Agents|alkylating agents|mesh-ancestor
25641392|NCT01402063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641393|NCT01402063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641394|NCT01402284|Dexamethasone|dexamethasone|mesh-list
25641395|NCT01402284|Lenalidomide|lenalidomide|mesh-list
25641396|NCT01402284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25641397|NCT01402284|Antiemetics|antiemetics|mesh-ancestor
25641398|NCT01402284|Autonomic Agents|autonomic agents|mesh-ancestor
25641399|NCT01402284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25641400|NCT01402284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641401|NCT01402284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25641402|NCT01402284|Glucocorticoids|glucocorticoids|mesh-ancestor
25641403|NCT01402284|Hormones|hormones|mesh-ancestor
25641404|NCT01402284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25641405|NCT01402284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25641406|NCT01402284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641407|NCT01402284|Immunologic Factors|immunologic factors|mesh-ancestor
25641408|NCT01402284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25641409|NCT01402284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25641410|NCT01402284|Growth Substances|growth substances|mesh-ancestor
25641411|NCT01402284|Growth Inhibitors|growth inhibitors|mesh-ancestor
25641412|NCT01402375|Acetaminophen|acetaminophen|mesh-list
25641413|NCT01402375|Oxycodone|oxycodone|mesh-list
25641414|NCT01402375|Hydrocodone|hydrocodone|mesh-list
25641415|NCT01402375|Codeine|codeine|mesh-list
25641416|NCT01402375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25641417|NCT01402375|Analgesics|analgesics|mesh-ancestor
25641418|NCT01402375|Sensory System Agents|sensory system agents|mesh-ancestor
25641419|NCT01402375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25641420|NCT01402375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641421|NCT01402375|Antipyretics|antipyretics|mesh-ancestor
25641422|NCT01402375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25641423|NCT01402375|Narcotics|narcotics|mesh-ancestor
25641424|NCT01402375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25641425|NCT01402375|Antitussive Agents|antitussive agents|mesh-ancestor
25641426|NCT01402375|Respiratory System Agents|respiratory system agents|mesh-ancestor
25641427|NCT01402427|Verapamil|verapamil|mesh-list
25641428|NCT01402427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25641429|NCT01402427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25641430|NCT01402427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25641431|NCT01402427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641432|NCT01402427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25641433|NCT01402427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641434|NCT01402427|Vasodilator Agents|vasodilator agents|mesh-ancestor
25641435|NCT01402492|Naltrexone|naltrexone|mesh-list
25641436|NCT01402492|Buprenorphine|buprenorphine|mesh-list
25641437|NCT01402492|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25641438|NCT01402492|Naloxone|naloxone|mesh-list
25641439|NCT01402492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25641440|NCT01402492|Narcotics|narcotics|mesh-ancestor
25641441|NCT01402492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25641442|NCT01402492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641443|NCT01402492|Analgesics|analgesics|mesh-ancestor
25641444|NCT01402492|Sensory System Agents|sensory system agents|mesh-ancestor
25641445|NCT01402492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25641446|NCT01402492|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25641447|NCT01402492|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25641448|NCT01402544|Ranibizumab|ranibizumab|mesh-list
25641449|NCT01402544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25641450|NCT01402544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25641451|NCT01402544|Growth Substances|growth substances|mesh-ancestor
25641452|NCT01402544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641453|NCT01402544|Growth Inhibitors|growth inhibitors|mesh-ancestor
25641454|NCT01402544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641455|NCT01402817|Sunitinib|sunitinib|mesh-list
25641456|NCT01402817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641457|NCT01402817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25536559|NCT05382299|Carboplatin|carboplatin|mesh-list
25641458|NCT01402817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25641459|NCT01402817|Growth Substances|growth substances|mesh-ancestor
25641460|NCT01402817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641461|NCT01402817|Growth Inhibitors|growth inhibitors|mesh-ancestor
25641462|NCT01402817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25641463|NCT01402817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25641464|NCT01402817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641465|NCT01402869|Lidocaine|lidocaine|mesh-list
25641466|NCT01402869|Epinephrine|epinephrine|mesh-list
25641467|NCT01402869|Prilocaine|prilocaine|mesh-list
25641468|NCT01402869|Anesthetics, Local|anesthetics, local|mesh-ancestor
25641469|NCT01402869|Anesthetics|anesthetics|mesh-ancestor
25641470|NCT01402869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25641471|NCT01402869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641472|NCT01402869|Sensory System Agents|sensory system agents|mesh-ancestor
25641473|NCT01402869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25641474|NCT01402869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25641475|NCT01402869|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25641476|NCT01402869|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25641477|NCT01402869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25641478|NCT01402869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641479|NCT01402869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25641480|NCT01402869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25641481|NCT01402869|Adrenergic Agents|adrenergic agents|mesh-ancestor
25641482|NCT01402869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25641483|NCT01402869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25641484|NCT01402869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25641485|NCT01402869|Autonomic Agents|autonomic agents|mesh-ancestor
25641486|NCT01402869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25641487|NCT01402869|Respiratory System Agents|respiratory system agents|mesh-ancestor
25641488|NCT01402869|Mydriatics|mydriatics|mesh-ancestor
25641489|NCT01402869|Sympathomimetics|sympathomimetics|mesh-ancestor
25641490|NCT01402869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25641491|NCT01402947|Ciprofloxacin|ciprofloxacin|mesh-list
25641492|NCT01402947|Mesalamine|mesalamine|mesh-list
25641493|NCT01402947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25641494|NCT01402947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25641495|NCT01402947|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25641496|NCT01402947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25641497|NCT01402947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25641498|NCT01402947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641499|NCT01402947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641500|NCT01402947|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25641501|NCT01402947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25641502|NCT01402947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25641503|NCT01402947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25641504|NCT01402947|Analgesics|analgesics|mesh-ancestor
25641505|NCT01402947|Sensory System Agents|sensory system agents|mesh-ancestor
25641506|NCT01402947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25641507|NCT01402947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641508|NCT01402947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25641509|NCT01402947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25641510|NCT01402986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25641511|NCT01402986|Immunologic Factors|immunologic factors|mesh-ancestor
25641512|NCT01402986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641513|NCT01403051|Calcium, Dietary|calcium, dietary|mesh-list
25641514|NCT01403051|Vitamin D|vitamin d|mesh-list
25641515|NCT01403051|Ergocalciferols|ergocalciferols|mesh-list
25641516|NCT01403051|Cholecalciferol|cholecalciferol|mesh-list
25641517|NCT01403051|Vitamins|vitamins|mesh-list
25641518|NCT01403051|Calcium Carbonate|calcium carbonate|mesh-list
25641519|NCT01403051|Calcium|calcium|mesh-list
25641520|NCT01403051|Micronutrients|micronutrients|mesh-ancestor
25641521|NCT01403051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641522|NCT01403051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25641523|NCT01403051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25641524|NCT01403051|Antacids|antacids|mesh-ancestor
25641525|NCT01403051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641526|NCT01403051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25641527|NCT01403116|Methyltestosterone|methyltestosterone|mesh-list
25641528|NCT01403116|Testosterone|testosterone|mesh-list
25641529|NCT01403116|Testosterone undecanoate|testosterone undecanoate|mesh-list
25641530|NCT01403116|Testosterone enanthate|testosterone enanthate|mesh-list
25641531|NCT01403116|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25641532|NCT01403116|Androgens|androgens|mesh-ancestor
25641533|NCT01403116|Hormones|hormones|mesh-ancestor
25656708|NCT01577706|Dopamine Agents|dopamine agents|mesh-ancestor
25641534|NCT01403116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25641535|NCT01403116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641536|NCT01403116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25641537|NCT01403116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641538|NCT01403116|Anabolic Agents|anabolic agents|mesh-ancestor
25641539|NCT01403246|Lenalidomide|lenalidomide|mesh-list
25641540|NCT01403246|Chlorambucil|chlorambucil|mesh-list
25641541|NCT01403246|Immunologic Factors|immunologic factors|mesh-ancestor
25641542|NCT01403246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641543|NCT01403246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25641544|NCT01403246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25641545|NCT01403246|Growth Substances|growth substances|mesh-ancestor
25641546|NCT01403246|Growth Inhibitors|growth inhibitors|mesh-ancestor
25641547|NCT01403246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641548|NCT01403246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25641549|NCT01403246|Alkylating Agents|alkylating agents|mesh-ancestor
25641550|NCT01403246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641551|NCT01403376|Interferons|interferons|mesh-list
25641552|NCT01403376|Interferon-beta|interferon-beta|mesh-list
25641553|NCT01403376|Teriflunomide|teriflunomide|mesh-list
25641554|NCT01403376|Interferon beta-1b|interferon beta-1b|mesh-list
25641555|NCT01403376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641556|NCT01403376|Antiviral Agents|antiviral agents|mesh-ancestor
25641557|NCT01403376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25641558|NCT01403376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25641559|NCT01403376|Immunologic Factors|immunologic factors|mesh-ancestor
25641560|NCT01403376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641561|NCT01403376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25641562|NCT01403376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25641563|NCT01403376|Analgesics|analgesics|mesh-ancestor
25641564|NCT01403376|Sensory System Agents|sensory system agents|mesh-ancestor
25641565|NCT01403376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25641566|NCT01403376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25641567|NCT01403376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25641568|NCT01403376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25641569|NCT01403610|Bevacizumab|bevacizumab|mesh-list
25641570|NCT01403610|Phosphoramide Mustards|phosphoramide mustards|mesh-list
25641571|NCT01403610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25641572|NCT01403610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641573|NCT01403610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25641574|NCT01403610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25641575|NCT01403610|Growth Substances|growth substances|mesh-ancestor
25641576|NCT01403610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641577|NCT01403610|Growth Inhibitors|growth inhibitors|mesh-ancestor
25641578|NCT01403610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25641579|NCT01403610|Alkylating Agents|alkylating agents|mesh-ancestor
25641580|NCT01403610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641581|NCT01403805|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25641582|NCT01403805|Immunologic Factors|immunologic factors|mesh-ancestor
25641583|NCT01403805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641584|NCT01404208|Cycloserine|cycloserine|mesh-list
25641585|NCT01404208|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25641586|NCT01404208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25641587|NCT01404208|Renal Agents|renal agents|mesh-ancestor
25641588|NCT01404208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25641589|NCT01404208|Antitubercular Agents|antitubercular agents|mesh-ancestor
25641590|NCT01404208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25641591|NCT01404208|Antimetabolites|antimetabolites|mesh-ancestor
25641592|NCT01404208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641593|NCT01404260|Gemcitabine|gemcitabine|mesh-list
25641594|NCT01404260|Carboplatin|carboplatin|mesh-list
25641596|NCT01404260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641597|NCT01404260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25641598|NCT01404260|Antimetabolites|antimetabolites|mesh-ancestor
25641599|NCT01404260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641600|NCT01404260|Antiviral Agents|antiviral agents|mesh-ancestor
25641601|NCT01404260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25641602|NCT01404260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25641603|NCT01404260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25641604|NCT01404260|Immunologic Factors|immunologic factors|mesh-ancestor
25641605|NCT01404260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641606|NCT01404260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25641607|NCT01404325|Everolimus|everolimus|mesh-list
25641608|NCT01404325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641609|NCT01404325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25641610|NCT01404325|Immunologic Factors|immunologic factors|mesh-ancestor
25641611|NCT01404325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641612|NCT01404429|Methotrexate|methotrexate|mesh-list
25641613|NCT01404429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25641614|NCT01404429|Abortifacient Agents|abortifacient agents|mesh-ancestor
25641615|NCT01404429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25641616|NCT01404429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641617|NCT01404429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25641618|NCT01404429|Antimetabolites|antimetabolites|mesh-ancestor
25641619|NCT01404429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641620|NCT01404429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641621|NCT01404429|Dermatologic Agents|dermatologic agents|mesh-ancestor
25641622|NCT01404429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25641623|NCT01404429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25641624|NCT01404429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25641625|NCT01404429|Immunologic Factors|immunologic factors|mesh-ancestor
25641626|NCT01404429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25641627|NCT01404429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25641628|NCT01404572|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25641629|NCT01404572|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25641630|NCT01404572|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25641631|NCT01404572|Protease Inhibitors|protease inhibitors|mesh-ancestor
25641632|NCT01404572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25641633|NCT01404572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641634|NCT01404572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25641635|NCT01404572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25641636|NCT01404572|Antiviral Agents|antiviral agents|mesh-ancestor
25641637|NCT01404572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25641638|NCT01404832|Lansoprazole|lansoprazole|mesh-list
25641639|NCT01404832|Dexlansoprazole|dexlansoprazole|mesh-list
25641640|NCT01404832|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25641641|NCT01404832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25641642|NCT01404832|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25641643|NCT01404832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25641644|NCT01404832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641645|NCT01404923|Mebeverine|mebeverine|mesh-list
25641646|NCT01404923|Alverine|alverine|mesh-list
25641647|NCT01404923|Parasympatholytics|parasympatholytics|mesh-list
25641648|NCT01404923|Autonomic Agents|autonomic agents|mesh-ancestor
25641649|NCT01404923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25641650|NCT01404923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641651|NCT01404923|Anticonvulsants|anticonvulsants|mesh-ancestor
25641652|NCT01404936|Interferons|interferons|mesh-list
25641653|NCT01404936|Interferon-alpha|interferon-alpha|mesh-list
25641654|NCT01404936|Interferon alpha-2|interferon alpha-2|mesh-list
25641655|NCT01404936|Doxorubicin|doxorubicin|mesh-list
25641656|NCT01404936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25641657|NCT01404936|Bleomycin|bleomycin|mesh-list
25641658|NCT01404936|Dacarbazine|dacarbazine|mesh-list
25641659|NCT01404936|Vinblastine|vinblastine|mesh-list
25641660|NCT01404936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25641661|NCT01404936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641662|NCT01404936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25641663|NCT01404936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25641664|NCT01404936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25641665|NCT01404936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641666|NCT01404936|Antiviral Agents|antiviral agents|mesh-ancestor
25641667|NCT01404936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25641668|NCT01404936|Immunologic Factors|immunologic factors|mesh-ancestor
25641669|NCT01404936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641670|NCT01404936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25641671|NCT01404936|Alkylating Agents|alkylating agents|mesh-ancestor
25641672|NCT01404936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25641673|NCT01404936|Tubulin Modulators|tubulin modulators|mesh-ancestor
25641674|NCT01404936|Antimitotic Agents|antimitotic agents|mesh-ancestor
25641675|NCT01404936|Mitosis Modulators|mitosis modulators|mesh-ancestor
25641676|NCT01404949|Arsenic Trioxide|arsenic trioxide|mesh-list
25641677|NCT01404949|Tretinoin|tretinoin|mesh-list
25641678|NCT01404949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641679|NCT01404949|Keratolytic Agents|keratolytic agents|mesh-ancestor
25641680|NCT01404949|Dermatologic Agents|dermatologic agents|mesh-ancestor
25641681|NCT01405027|Interferons|interferons|mesh-list
25641682|NCT01405027|Ribavirin|ribavirin|mesh-list
25536783|NCT05255107|Vitamins|vitamins|mesh-ancestor
25641683|NCT01405027|Interferon-alpha|interferon-alpha|mesh-list
25641684|NCT01405027|Interferon alpha-2|interferon alpha-2|mesh-list
25641685|NCT01405027|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25641686|NCT01405027|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25641687|NCT01405027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641688|NCT01405027|Antiviral Agents|antiviral agents|mesh-ancestor
25641689|NCT01405027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25641690|NCT01405027|Antimetabolites|antimetabolites|mesh-ancestor
25641691|NCT01405027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641692|NCT01405027|Immunologic Factors|immunologic factors|mesh-ancestor
25641693|NCT01405027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641694|NCT01405053|Rufinamide|rufinamide|mesh-list
25641695|NCT01405053|Anticonvulsants|anticonvulsants|mesh-list
25641696|NCT01405053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25641697|NCT01405053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25641698|NCT01405053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25641699|NCT01405053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641700|NCT01405456|Eplerenone|eplerenone|mesh-list
25641701|NCT01405456|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25641702|NCT01405456|Hormone Antagonists|hormone antagonists|mesh-ancestor
25641703|NCT01405456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25641704|NCT01405456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641705|NCT01405456|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25641706|NCT01405456|Diuretics|diuretics|mesh-ancestor
25641707|NCT01405456|Natriuretic Agents|natriuretic agents|mesh-ancestor
25641708|NCT01405456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25641709|NCT01405508|Brivaracetam|brivaracetam|mesh-list
25641710|NCT01405508|Anticonvulsants|anticonvulsants|mesh-ancestor
25641711|NCT01405560|Ribavirin|ribavirin|mesh-list
25641712|NCT01405560|Antimetabolites|antimetabolites|mesh-ancestor
25641713|NCT01405560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641714|NCT01405560|Antiviral Agents|antiviral agents|mesh-ancestor
25641715|NCT01405560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25641716|NCT01405742|Factor VIII|factor viii|mesh-list
25641717|NCT01405742|Coagulants|coagulants|mesh-ancestor
25641718|NCT01405768|Lidocaine|lidocaine|mesh-list
25641719|NCT01405768|Anesthetics, Local|anesthetics, local|mesh-ancestor
25641720|NCT01405768|Anesthetics|anesthetics|mesh-ancestor
25641721|NCT01405768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25641722|NCT01405768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641723|NCT01405768|Sensory System Agents|sensory system agents|mesh-ancestor
25641724|NCT01405768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25641725|NCT01405768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25641726|NCT01405768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25641727|NCT01405768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25641728|NCT01405768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25641729|NCT01405768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641730|NCT01405820|Natalizumab|natalizumab|mesh-list
25641731|NCT01405820|Immunologic Factors|immunologic factors|mesh-ancestor
25641732|NCT01405820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641733|NCT01405911|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25641734|NCT01405911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25641735|NCT01405911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641736|NCT01405911|Incretins|incretins|mesh-ancestor
25641737|NCT01405911|Hormones|hormones|mesh-ancestor
25641738|NCT01405911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25641739|NCT01405911|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25641740|NCT01405911|Protease Inhibitors|protease inhibitors|mesh-ancestor
25641741|NCT01405911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25641742|NCT01405911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641743|NCT01405924|Dexamethasone|dexamethasone|mesh-list
25641744|NCT01405924|Fosaprepitant|fosaprepitant|mesh-list
25641745|NCT01405924|Aprepitant|aprepitant|mesh-list
25641746|NCT01405924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25641747|NCT01405924|Antiemetics|antiemetics|mesh-ancestor
25641748|NCT01405924|Autonomic Agents|autonomic agents|mesh-ancestor
25641749|NCT01405924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25641750|NCT01405924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641751|NCT01405924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25641752|NCT01405924|Glucocorticoids|glucocorticoids|mesh-ancestor
25641753|NCT01405924|Hormones|hormones|mesh-ancestor
25641754|NCT01405924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25641755|NCT01405924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25641756|NCT01405924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641757|NCT01405924|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25536860|NCT05222529|Glycopyrrolate|glycopyrrolate|mesh-list
25641758|NCT01405924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25641759|NCT01405924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641760|NCT01405937|Ribavirin|ribavirin|mesh-list
25641761|NCT01405937|Antimetabolites|antimetabolites|mesh-ancestor
25641762|NCT01405937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641763|NCT01405937|Antiviral Agents|antiviral agents|mesh-ancestor
25641764|NCT01405937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25641765|NCT01405950|Clonidine|clonidine|mesh-list
25641766|NCT01405950|Tizanidine|tizanidine|mesh-list
25641767|NCT01405950|Analgesics|analgesics|mesh-ancestor
25641768|NCT01405950|Sensory System Agents|sensory system agents|mesh-ancestor
25641769|NCT01405950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25641770|NCT01405950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641771|NCT01405950|Anticonvulsants|anticonvulsants|mesh-ancestor
25641772|NCT01405950|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25641773|NCT01405950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25641774|NCT01405950|Parasympatholytics|parasympatholytics|mesh-ancestor
25641775|NCT01405950|Autonomic Agents|autonomic agents|mesh-ancestor
25641776|NCT01405950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25641777|NCT01405950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25641778|NCT01405950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25641779|NCT01405950|Adrenergic Agents|adrenergic agents|mesh-ancestor
25641780|NCT01405950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25641781|NCT01405950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641782|NCT01405950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25641783|NCT01405950|Sympatholytics|sympatholytics|mesh-ancestor
25641784|NCT01406015|Spironolactone|spironolactone|mesh-list
25641785|NCT01406015|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25641786|NCT01406015|Hormone Antagonists|hormone antagonists|mesh-ancestor
25641787|NCT01406015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25641788|NCT01406015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641789|NCT01406015|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25641790|NCT01406015|Diuretics|diuretics|mesh-ancestor
25641791|NCT01406015|Natriuretic Agents|natriuretic agents|mesh-ancestor
25641792|NCT01406223|Bupropion|bupropion|mesh-list
25641793|NCT01406223|Nicotine|nicotine|mesh-list
25641794|NCT01406223|Varenicline|varenicline|mesh-list
25641795|NCT01406223|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25641796|NCT01406223|Autonomic Agents|autonomic agents|mesh-ancestor
25641797|NCT01406223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25641798|NCT01406223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641799|NCT01406223|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25641800|NCT01406223|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25641801|NCT01406223|Cholinergic Agents|cholinergic agents|mesh-ancestor
25641802|NCT01406223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25641803|NCT01406223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641804|NCT01406223|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25641805|NCT01406223|Antidepressive Agents|antidepressive agents|mesh-ancestor
25641806|NCT01406223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25641807|NCT01406223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25641808|NCT01406223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25641809|NCT01406223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25641810|NCT01406223|Dopamine Agents|dopamine agents|mesh-ancestor
25641811|NCT01406223|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25641812|NCT01406223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25641813|NCT01406223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25641814|NCT01406444|Risedronic Acid|risedronic acid|mesh-list
25641815|NCT01406444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25641816|NCT01406444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25641817|NCT01406444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641818|NCT01406444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25641819|NCT01406444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641820|NCT01406444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25641821|NCT01406795|Heparin|heparin|mesh-list
25641822|NCT01406795|Anticoagulants|anticoagulants|mesh-ancestor
25641823|NCT01406795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25641824|NCT01406795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25641825|NCT01406795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641826|NCT01406873|Mexiletine|mexiletine|mesh-list
25641827|NCT01406873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25641828|NCT01406873|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25641829|NCT01406873|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25641830|NCT01406873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25641831|NCT01406873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641832|NCT01406938|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25641833|NCT01406938|Immunologic Factors|immunologic factors|mesh-ancestor
25641834|NCT01406938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641836|NCT01407094|Antidepressive Agents|antidepressive agents|mesh-ancestor
25641837|NCT01407094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25641838|NCT01407094|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25641839|NCT01407094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25641840|NCT01407094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25641841|NCT01407094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641842|NCT01407094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25641843|NCT01407094|Serotonin Agents|serotonin agents|mesh-ancestor
25641844|NCT01407094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641845|NCT01407107|Nitroglycerin|nitroglycerin|mesh-list
25641846|NCT01407107|Vasodilator Agents|vasodilator agents|mesh-ancestor
25641847|NCT01407523|Levetiracetam|levetiracetam|mesh-list
25641848|NCT01407523|Anticonvulsants|anticonvulsants|mesh-ancestor
25641849|NCT01407523|Nootropic Agents|nootropic agents|mesh-ancestor
25641850|NCT01407575|Buprenorphine|buprenorphine|mesh-list
25641851|NCT01407575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25641852|NCT01407575|Narcotics|narcotics|mesh-ancestor
25641853|NCT01407575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25641854|NCT01407575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641855|NCT01407575|Analgesics|analgesics|mesh-ancestor
25641856|NCT01407575|Sensory System Agents|sensory system agents|mesh-ancestor
25641857|NCT01407575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25641858|NCT01407575|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25641859|NCT01408030|Bevacizumab|bevacizumab|mesh-list
25641860|NCT01408030|Tranexamic Acid|tranexamic acid|mesh-list
25641861|NCT01408030|Endothelial Growth Factors|endothelial growth factors|mesh-list
25641862|NCT01408030|Estrogens|estrogens|mesh-list
25641863|NCT01408030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25641864|NCT01408030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641865|NCT01408030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25641866|NCT01408030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25641867|NCT01408030|Growth Substances|growth substances|mesh-ancestor
25641868|NCT01408030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641869|NCT01408030|Growth Inhibitors|growth inhibitors|mesh-ancestor
25641870|NCT01408030|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25641871|NCT01408030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25641872|NCT01408030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641873|NCT01408030|Hemostatics|hemostatics|mesh-ancestor
25641874|NCT01408030|Coagulants|coagulants|mesh-ancestor
25641875|NCT01408030|Hormones|hormones|mesh-ancestor
25641876|NCT01408030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25641877|NCT01408043|Plerixafor|plerixafor|mesh-list
25641878|NCT01408043|Etoposide|etoposide|mesh-list
25641879|NCT01408043|Etoposide phosphate|etoposide phosphate|mesh-list
25641880|NCT01408043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25641881|NCT01408043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641882|NCT01408043|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25641883|NCT01408043|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25641884|NCT01408043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25641885|NCT01408043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641886|NCT01408043|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25641887|NCT01408043|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25641888|NCT01408043|Antiviral Agents|antiviral agents|mesh-ancestor
25641889|NCT01408043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25656709|NCT01577966|Sulfasalazine|sulfasalazine|mesh-list
25656710|NCT01577966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25656711|NCT01577966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25656712|NCT01577966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25656713|NCT01577966|Analgesics|analgesics|mesh-ancestor
25656714|NCT01577966|Sensory System Agents|sensory system agents|mesh-ancestor
25656715|NCT01577966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25656716|NCT01577966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656717|NCT01577966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25656718|NCT01577966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25656719|NCT01577966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25656720|NCT01578278|Fluticasone|fluticasone|mesh-list
25656721|NCT01578278|Xhance|xhance|mesh-list
25656722|NCT01578278|Bepotastine besilate|bepotastine besilate|mesh-list
25656723|NCT01578278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25656724|NCT01578278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25656725|NCT01578278|Autonomic Agents|autonomic agents|mesh-ancestor
25641890|NCT01408563|Fludarabine|fludarabine|mesh-list
25641891|NCT01408563|Melphalan|melphalan|mesh-list
25641892|NCT01408563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641893|NCT01408563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641894|NCT01408563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25641895|NCT01408563|Immunologic Factors|immunologic factors|mesh-ancestor
25641896|NCT01408563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641897|NCT01408563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25641898|NCT01408563|Alkylating Agents|alkylating agents|mesh-ancestor
25641899|NCT01408563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25641900|NCT01408576|Epratuzumab|epratuzumab|mesh-list
25641901|NCT01408576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25641902|NCT01408576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641903|NCT01408628|Insulin|insulin|mesh-list
25641904|NCT01408628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25641905|NCT01408628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641906|NCT01408732|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
25641907|NCT01408732|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25641908|NCT01408732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25641909|NCT01408888|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25641910|NCT01408888|Dulaglutide|dulaglutide|mesh-list
25641911|NCT01408888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25641912|NCT01408888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641913|NCT01408888|Incretins|incretins|mesh-ancestor
25641914|NCT01408888|Hormones|hormones|mesh-ancestor
25641915|NCT01408888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25641916|NCT01408888|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25641917|NCT01408888|Protease Inhibitors|protease inhibitors|mesh-ancestor
25641918|NCT01408888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25641919|NCT01408888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641920|NCT01408901|Molgramostim|molgramostim|mesh-list
25641921|NCT01408901|Sargramostim|sargramostim|mesh-list
25641922|NCT01408901|Immunologic Factors|immunologic factors|mesh-ancestor
25641923|NCT01408901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641924|NCT01408901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641925|NCT01408914|Rifampin|rifampin|mesh-list
25641926|NCT01408914|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25641927|NCT01408914|Antitubercular Agents|antitubercular agents|mesh-ancestor
25641928|NCT01408914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25641929|NCT01408914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25641930|NCT01408914|Leprostatic Agents|leprostatic agents|mesh-ancestor
25641931|NCT01408914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25641932|NCT01408914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25641933|NCT01408914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641934|NCT01408914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25641935|NCT01408914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25641936|NCT01408914|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25641937|NCT01408914|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25641938|NCT01408914|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25641939|NCT01408914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25641940|NCT01409239|Insulin|insulin|mesh-list
25641941|NCT01409239|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25641942|NCT01409239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25641943|NCT01409239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641944|NCT01409564|Cilostazol|cilostazol|mesh-list
25641945|NCT01409564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25641946|NCT01409564|Autonomic Agents|autonomic agents|mesh-ancestor
25641947|NCT01409564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25641948|NCT01409564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641949|NCT01409564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25641950|NCT01409564|Respiratory System Agents|respiratory system agents|mesh-ancestor
25641951|NCT01409564|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25641952|NCT01409564|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25641953|NCT01409564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641954|NCT01409564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25641955|NCT01409564|Vasodilator Agents|vasodilator agents|mesh-ancestor
25641956|NCT01409564|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25641957|NCT01409564|Protective Agents|protective agents|mesh-ancestor
25641958|NCT01409564|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25641959|NCT01409564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25641960|NCT01409564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25641961|NCT01409811|Zoledronic Acid|zoledronic acid|mesh-list
25641962|NCT01409811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25641963|NCT01409811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641964|NCT01409837|Lisinopril|lisinopril|mesh-list
25641965|NCT01409837|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25641966|NCT01409837|Protease Inhibitors|protease inhibitors|mesh-ancestor
25641967|NCT01409837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25641968|NCT01409837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641969|NCT01409837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25641970|NCT01409837|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25641971|NCT01409837|Protective Agents|protective agents|mesh-ancestor
25719157|NCT02444793|Mogamulizumab|mogamulizumab|mesh-list
25641972|NCT01409837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641973|NCT01409915|Molgramostim|molgramostim|mesh-list
25641974|NCT01409915|Sargramostim|sargramostim|mesh-list
25641975|NCT01409915|Immunologic Factors|immunologic factors|mesh-ancestor
25641976|NCT01409915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25641977|NCT01409915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25641978|NCT01409993|Sildenafil Citrate|sildenafil citrate|mesh-list
25641979|NCT01409993|Vasodilator Agents|vasodilator agents|mesh-ancestor
25641980|NCT01409993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25641981|NCT01409993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25641982|NCT01409993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25641983|NCT01409993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641984|NCT01409993|Urological Agents|urological agents|mesh-ancestor
25641985|NCT01410058|Efavirenz|efavirenz|mesh-list
25641986|NCT01410058|Nevirapine|nevirapine|mesh-list
25641987|NCT01410058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25641988|NCT01410058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25641989|NCT01410058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25641990|NCT01410058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25641991|NCT01410058|Antiviral Agents|antiviral agents|mesh-ancestor
25641992|NCT01410058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25641993|NCT01410058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25641994|NCT01410058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25641995|NCT01410058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25641996|NCT01410058|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25641997|NCT01410058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25641998|NCT01410058|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25641999|NCT01410058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25642000|NCT01410058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25642001|NCT01410084|Vitamin D|vitamin d|mesh-list
25642002|NCT01410084|Cholecalciferol|cholecalciferol|mesh-list
25642003|NCT01410084|Vitamins|vitamins|mesh-list
25642004|NCT01410084|Vitamin E|vitamin e|mesh-list
25642005|NCT01410084|Micronutrients|micronutrients|mesh-ancestor
25642006|NCT01410084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642007|NCT01410084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25642008|NCT01410084|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25642009|NCT01410084|Antioxidants|antioxidants|mesh-ancestor
25642010|NCT01410084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642011|NCT01410084|Protective Agents|protective agents|mesh-ancestor
25642012|NCT01410227|Factor VIII|factor viii|mesh-list
25642013|NCT01410227|Coagulants|coagulants|mesh-ancestor
25642014|NCT01410240|Hemostatics|hemostatics|mesh-list
25642015|NCT01410240|Coagulants|coagulants|mesh-ancestor
25642016|NCT01410344|Vidarabine|vidarabine|mesh-list
25642017|NCT01410344|Cyclophosphamide|cyclophosphamide|mesh-list
25642018|NCT01410344|Melphalan|melphalan|mesh-list
25642019|NCT01410344|Busulfan|busulfan|mesh-list
25642020|NCT01410344|Fludarabine|fludarabine|mesh-list
25642021|NCT01410344|Fludarabine phosphate|fludarabine phosphate|mesh-list
25642022|NCT01410344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25642023|NCT01410344|Immunologic Factors|immunologic factors|mesh-ancestor
25642024|NCT01410344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642025|NCT01410344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25642026|NCT01410344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25642027|NCT01410344|Alkylating Agents|alkylating agents|mesh-ancestor
25642028|NCT01410344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642029|NCT01410344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642030|NCT01410344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25642031|NCT01410344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25642032|NCT01410344|Antimetabolites|antimetabolites|mesh-ancestor
25642033|NCT01410344|Antiviral Agents|antiviral agents|mesh-ancestor
25642034|NCT01410344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25642035|NCT01410409|Acetaminophen|acetaminophen|mesh-list
25642036|NCT01410409|Pantoprazole|pantoprazole|mesh-list
25642037|NCT01410409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25642038|NCT01410409|Analgesics|analgesics|mesh-ancestor
25642039|NCT01410409|Sensory System Agents|sensory system agents|mesh-ancestor
25642040|NCT01410409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25642041|NCT01410409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642042|NCT01410409|Antipyretics|antipyretics|mesh-ancestor
25642043|NCT01410409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25642044|NCT01410409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25642045|NCT01410409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25642046|NCT01410409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25642047|NCT01410409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642048|NCT01410448|Cyclosporine|cyclosporine|mesh-list
25642049|NCT01410448|Mycophenolic Acid|mycophenolic acid|mesh-list
25642050|NCT01410448|Everolimus|everolimus|mesh-list
25642051|NCT01410448|Cyclosporins|cyclosporins|mesh-list
25642052|NCT01410448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25642053|NCT01410448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642054|NCT01410448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25642055|NCT01410448|Immunologic Factors|immunologic factors|mesh-ancestor
25642056|NCT01410448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642057|NCT01410448|Antifungal Agents|antifungal agents|mesh-ancestor
25642058|NCT01410448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25642059|NCT01410448|Dermatologic Agents|dermatologic agents|mesh-ancestor
25642060|NCT01410448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25642061|NCT01410448|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25642062|NCT01410448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642063|NCT01410448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25642064|NCT01410448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25642065|NCT01410448|Antitubercular Agents|antitubercular agents|mesh-ancestor
25642066|NCT01410448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25642067|NCT01410565|Apaziquone|apaziquone|mesh-list
25642068|NCT01410565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642069|NCT01410604|Metformin|metformin|mesh-list
25642070|NCT01410604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25642071|NCT01410604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642072|NCT01411085|Risperidone|risperidone|mesh-list
25642073|NCT01411085|Desipramine|desipramine|mesh-list
25642074|NCT01411085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25642075|NCT01411085|Serotonin Agents|serotonin agents|mesh-ancestor
25642076|NCT01411085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25642077|NCT01411085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642078|NCT01411085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642079|NCT01411085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25642080|NCT01411085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25642081|NCT01411085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25642082|NCT01411085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25642083|NCT01411085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25642084|NCT01411085|Dopamine Agents|dopamine agents|mesh-ancestor
25642085|NCT01411085|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25642086|NCT01411085|Antidepressive Agents|antidepressive agents|mesh-ancestor
25642087|NCT01411085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25642088|NCT01411085|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25642089|NCT01411085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25642090|NCT01411085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25642091|NCT01411085|Adrenergic Agents|adrenergic agents|mesh-ancestor
25642092|NCT01411137|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25642093|NCT01411137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25642094|NCT01411137|Immunologic Factors|immunologic factors|mesh-ancestor
25642095|NCT01411137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642096|NCT01411137|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25642097|NCT01411137|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25642098|NCT01411137|Dopamine Agonists|dopamine agonists|mesh-ancestor
25642099|NCT01411137|Dopamine Agents|dopamine agents|mesh-ancestor
25642100|NCT01411137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25642101|NCT01411137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642102|NCT01411215|Etanercept|etanercept|mesh-list
25642103|NCT01411215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25642104|NCT01411215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25642105|NCT01411215|Analgesics|analgesics|mesh-ancestor
25642106|NCT01411215|Sensory System Agents|sensory system agents|mesh-ancestor
25642107|NCT01411215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25642108|NCT01411215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642109|NCT01411215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25642110|NCT01411215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25642111|NCT01411215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25642112|NCT01411215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25642113|NCT01411215|Immunologic Factors|immunologic factors|mesh-ancestor
25642114|NCT01411501|Mosapride|mosapride|mesh-list
25537238|NCT04904965|Propofol|propofol|mesh-list
25642115|NCT01411501|Citric Acid|citric acid|mesh-list
25642116|NCT01411501|Sodium Citrate|sodium citrate|mesh-list
25642117|NCT01411501|Anticoagulants|anticoagulants|mesh-ancestor
25642118|NCT01411501|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25642119|NCT01411501|Chelating Agents|chelating agents|mesh-ancestor
25642120|NCT01411501|Sequestering Agents|sequestering agents|mesh-ancestor
25642121|NCT01411501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642122|NCT01411501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25642123|NCT01411501|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25642124|NCT01411501|Serotonin Agents|serotonin agents|mesh-ancestor
25642125|NCT01411501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25642126|NCT01411501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642127|NCT01411696|Dexamethasone|dexamethasone|mesh-list
25642128|NCT01411696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25642129|NCT01411696|Antiemetics|antiemetics|mesh-ancestor
25642130|NCT01411696|Autonomic Agents|autonomic agents|mesh-ancestor
25642131|NCT01411696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25642132|NCT01411696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642133|NCT01411696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25642134|NCT01411696|Glucocorticoids|glucocorticoids|mesh-ancestor
25642135|NCT01411696|Hormones|hormones|mesh-ancestor
25642136|NCT01411696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25642137|NCT01411696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25642138|NCT01411696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642139|NCT01411774|Cycloserine|cycloserine|mesh-list
25642140|NCT01411774|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25642141|NCT01411774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25642142|NCT01411774|Renal Agents|renal agents|mesh-ancestor
25642143|NCT01411774|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25642144|NCT01411774|Antitubercular Agents|antitubercular agents|mesh-ancestor
25642145|NCT01411774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25642146|NCT01411774|Antimetabolites|antimetabolites|mesh-ancestor
25642147|NCT01411774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642148|NCT01411891|Chlorhexidine|chlorhexidine|mesh-list
25642149|NCT01411891|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25642150|NCT01411891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25642151|NCT01411891|Disinfectants|disinfectants|mesh-ancestor
25642152|NCT01411995|Lidocaine|lidocaine|mesh-list
25642153|NCT01411995|Anesthetics, Local|anesthetics, local|mesh-ancestor
25642154|NCT01411995|Anesthetics|anesthetics|mesh-ancestor
25642155|NCT01411995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25642156|NCT01411995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642157|NCT01411995|Sensory System Agents|sensory system agents|mesh-ancestor
25642158|NCT01411995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25642159|NCT01411995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25642160|NCT01411995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25642161|NCT01411995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25642162|NCT01411995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25642163|NCT01411995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642164|NCT01412060|Cariprazine|cariprazine|mesh-list
25642165|NCT01412060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25642166|NCT01412060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25642167|NCT01412060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25642168|NCT01412060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642169|NCT01412060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25642170|NCT01412164|Sirolimus|sirolimus|mesh-list
25642171|NCT01412164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25642172|NCT01412164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25642173|NCT01412164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25642174|NCT01412164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642175|NCT01412164|Antifungal Agents|antifungal agents|mesh-ancestor
25642176|NCT01412164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25642177|NCT01412164|Immunologic Factors|immunologic factors|mesh-ancestor
25642178|NCT01412164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642179|NCT01412229|Paclitaxel|paclitaxel|mesh-list
25642180|NCT01412229|Carboplatin|carboplatin|mesh-list
25642181|NCT01412229|Cetuximab|cetuximab|mesh-list
25642182|NCT01412229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25642183|NCT01412229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642184|NCT01412229|Tubulin Modulators|tubulin modulators|mesh-ancestor
25642185|NCT01412229|Antimitotic Agents|antimitotic agents|mesh-ancestor
25642186|NCT01412229|Mitosis Modulators|mitosis modulators|mesh-ancestor
25642187|NCT01412229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642188|NCT01412229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25642189|NCT01412281|Vaccines|vaccines|mesh-list
25642190|NCT01412281|Immunologic Factors|immunologic factors|mesh-ancestor
25642191|NCT01412281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642192|NCT01412372|Mesalamine|mesalamine|mesh-list
25642193|NCT01412372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25642194|NCT01412372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25642195|NCT01412372|Analgesics|analgesics|mesh-ancestor
25642196|NCT01412372|Sensory System Agents|sensory system agents|mesh-ancestor
25642197|NCT01412372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25642198|NCT01412372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642199|NCT01412372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25642200|NCT01412372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25642201|NCT01412424|Octreotide|octreotide|mesh-list
25642202|NCT01412424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25642203|NCT01412424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25642204|NCT01412424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642205|NCT01412710|Vitamin D|vitamin d|mesh-list
25642206|NCT01412710|Cholecalciferol|cholecalciferol|mesh-list
25642207|NCT01412710|Vitamins|vitamins|mesh-ancestor
25642208|NCT01412710|Micronutrients|micronutrients|mesh-ancestor
25642209|NCT01412710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642210|NCT01412710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25642211|NCT01412710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25642212|NCT01412879|Leucovorin|leucovorin|mesh-list
25642213|NCT01412879|Cytarabine|cytarabine|mesh-list
25642214|NCT01412879|Dexamethasone|dexamethasone|mesh-list
25642215|NCT01412879|Cyclophosphamide|cyclophosphamide|mesh-list
25642216|NCT01412879|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25642217|NCT01412879|Rituximab|rituximab|mesh-list
25642218|NCT01412879|Doxorubicin|doxorubicin|mesh-list
25642219|NCT01412879|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25642220|NCT01412879|Methotrexate|methotrexate|mesh-list
25642221|NCT01412879|Vincristine|vincristine|mesh-list
25642222|NCT01412879|Levoleucovorin|levoleucovorin|mesh-list
25642223|NCT01412879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25642224|NCT01412879|Immunologic Factors|immunologic factors|mesh-ancestor
25642225|NCT01412879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642226|NCT01412879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25642227|NCT01412879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25642228|NCT01412879|Alkylating Agents|alkylating agents|mesh-ancestor
25642229|NCT01412879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642230|NCT01412879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642231|NCT01412879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25642232|NCT01412879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25642233|NCT01412879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25642234|NCT01412879|Antiemetics|antiemetics|mesh-ancestor
25642235|NCT01412879|Autonomic Agents|autonomic agents|mesh-ancestor
25642236|NCT01412879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25642237|NCT01412879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25642238|NCT01412879|Glucocorticoids|glucocorticoids|mesh-ancestor
25642239|NCT01412879|Hormones|hormones|mesh-ancestor
25642240|NCT01412879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25642241|NCT01412879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25642242|NCT01412879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25642243|NCT01412879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25642244|NCT01412879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25642245|NCT01412879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25642246|NCT01412879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25642247|NCT01412879|Abortifacient Agents|abortifacient agents|mesh-ancestor
25642248|NCT01412879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25642249|NCT01412879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25642250|NCT01412879|Antimetabolites|antimetabolites|mesh-ancestor
25642251|NCT01412879|Dermatologic Agents|dermatologic agents|mesh-ancestor
25642252|NCT01412879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25642253|NCT01412879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25642254|NCT01412879|Antiviral Agents|antiviral agents|mesh-ancestor
25642255|NCT01412879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25642256|NCT01412879|Antidotes|antidotes|mesh-ancestor
25642257|NCT01412879|Protective Agents|protective agents|mesh-ancestor
25719165|NCT02445326|Dexamethasone|dexamethasone|mesh-list
25642258|NCT01412879|Vitamin B Complex|vitamin b complex|mesh-ancestor
25642259|NCT01412879|Vitamins|vitamins|mesh-ancestor
25642260|NCT01412879|Micronutrients|micronutrients|mesh-ancestor
25642261|NCT01412879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25642262|NCT01412879|Tubulin Modulators|tubulin modulators|mesh-ancestor
25642263|NCT01412879|Antimitotic Agents|antimitotic agents|mesh-ancestor
25642264|NCT01412879|Mitosis Modulators|mitosis modulators|mesh-ancestor
25642265|NCT01412944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25642266|NCT01412944|Immunologic Factors|immunologic factors|mesh-ancestor
25642267|NCT01412944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642268|NCT01412957|Panitumumab|panitumumab|mesh-list
25642269|NCT01412957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25642270|NCT01412957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642271|NCT01413178|Melphalan|melphalan|mesh-list
25642272|NCT01413178|Busulfan|busulfan|mesh-list
25642273|NCT01413178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25642274|NCT01413178|Alkylating Agents|alkylating agents|mesh-ancestor
25642275|NCT01413178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642276|NCT01413178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642277|NCT01413178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25642278|NCT01413178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25642279|NCT01413178|Immunologic Factors|immunologic factors|mesh-ancestor
25642280|NCT01413178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642281|NCT01413191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25642282|NCT01413191|Immunologic Factors|immunologic factors|mesh-ancestor
25642283|NCT01413191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642284|NCT01413360|Vitamins|vitamins|mesh-list
25642285|NCT01413360|Ascorbic Acid|ascorbic acid|mesh-list
25642286|NCT01413360|Micronutrients|micronutrients|mesh-ancestor
25642287|NCT01413360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642288|NCT01413360|Antioxidants|antioxidants|mesh-ancestor
25642289|NCT01413360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642290|NCT01413360|Protective Agents|protective agents|mesh-ancestor
25642291|NCT01413503|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
25642292|NCT01413503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642293|NCT01413503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25642294|NCT01413503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642295|NCT01413503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25642296|NCT01413516|Varenicline|varenicline|mesh-list
25642297|NCT01413516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25642298|NCT01413516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25642299|NCT01413516|Cholinergic Agents|cholinergic agents|mesh-ancestor
25642300|NCT01413516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25642301|NCT01413516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642302|NCT01413516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642303|NCT01413542|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25642304|NCT01413542|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25642305|NCT01413542|Enalaprilat|enalaprilat|mesh-list
25642306|NCT01413542|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25642307|NCT01413542|Bradykinin|bradykinin|mesh-list
25642308|NCT01413542|Glucagon|glucagon|mesh-list
25642309|NCT01413542|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25642310|NCT01413542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25642311|NCT01413542|Substance P|substance p|mesh-list
25642312|NCT01413542|Neurokinin A|neurokinin a|mesh-list
25642313|NCT01413542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25642314|NCT01413542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642315|NCT01413542|Incretins|incretins|mesh-ancestor
25642316|NCT01413542|Hormones|hormones|mesh-ancestor
25642317|NCT01413542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25642318|NCT01413542|Protease Inhibitors|protease inhibitors|mesh-ancestor
25642319|NCT01413542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25642320|NCT01413542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642321|NCT01413542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25642322|NCT01413542|Natriuretic Agents|natriuretic agents|mesh-ancestor
25642323|NCT01413542|Vasodilator Agents|vasodilator agents|mesh-ancestor
25642324|NCT01413542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25642325|NCT01413542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25642326|NCT01413750|Paclitaxel|paclitaxel|mesh-list
25642327|NCT01413750|Carboplatin|carboplatin|mesh-list
25642328|NCT01413750|Vorinostat|vorinostat|mesh-list
25642329|NCT01413750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25642330|NCT01413750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642331|NCT01413750|Tubulin Modulators|tubulin modulators|mesh-ancestor
25642332|NCT01413750|Antimitotic Agents|antimitotic agents|mesh-ancestor
25642333|NCT01413750|Mitosis Modulators|mitosis modulators|mesh-ancestor
25642334|NCT01413750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642335|NCT01413750|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25642336|NCT01413750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25642337|NCT01413958|Loratadine|loratadine|mesh-list
25642338|NCT01413958|Phenylephrine|phenylephrine|mesh-list
25642339|NCT01413958|Oxymetazoline|oxymetazoline|mesh-list
25642340|NCT01413958|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25642341|NCT01413958|Mydriatics|mydriatics|mesh-ancestor
25642342|NCT01413958|Autonomic Agents|autonomic agents|mesh-ancestor
25642343|NCT01413958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25642344|NCT01413958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642345|NCT01413958|Sympathomimetics|sympathomimetics|mesh-ancestor
25642346|NCT01413958|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25642347|NCT01413958|Nasal Decongestants|nasal decongestants|mesh-ancestor
25642348|NCT01413958|Respiratory System Agents|respiratory system agents|mesh-ancestor
25642349|NCT01413958|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25642350|NCT01413958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25642351|NCT01413958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25642352|NCT01413958|Adrenergic Agents|adrenergic agents|mesh-ancestor
25642353|NCT01413958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25642354|NCT01413958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642355|NCT01413958|Protective Agents|protective agents|mesh-ancestor
25642356|NCT01413958|Antipruritics|antipruritics|mesh-ancestor
25642357|NCT01413958|Dermatologic Agents|dermatologic agents|mesh-ancestor
25642358|NCT01413958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25642359|NCT01413958|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25642360|NCT01413958|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25642361|NCT01413958|Histamine Antagonists|histamine antagonists|mesh-ancestor
25642362|NCT01413958|Histamine Agents|histamine agents|mesh-ancestor
25642364|NCT01414010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25642365|NCT01414010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25642366|NCT01414075|Iron|iron|mesh-list
25642367|NCT01414075|Trace Elements|trace elements|mesh-ancestor
25642368|NCT01414075|Micronutrients|micronutrients|mesh-ancestor
25642369|NCT01414075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642370|NCT01414153|Bevacizumab|bevacizumab|mesh-list
25642371|NCT01414153|Ranibizumab|ranibizumab|mesh-list
25642372|NCT01414153|Aflibercept|aflibercept|mesh-list
25642373|NCT01414153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25642374|NCT01414153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25642375|NCT01414153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642376|NCT01414153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25642377|NCT01414153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25642378|NCT01414153|Growth Substances|growth substances|mesh-ancestor
25642379|NCT01414153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642380|NCT01414153|Growth Inhibitors|growth inhibitors|mesh-ancestor
25642381|NCT01414153|Immunologic Factors|immunologic factors|mesh-ancestor
25642382|NCT01414205|Obinutuzumab|obinutuzumab|mesh-list
25642383|NCT01414205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25642384|NCT01414205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642385|NCT01414257|Methotrexate|methotrexate|mesh-list
25642386|NCT01414257|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25642387|NCT01414257|Abortifacient Agents|abortifacient agents|mesh-ancestor
25642388|NCT01414257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25642389|NCT01414257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642390|NCT01414257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25719186|NCT02445807|Clobetasol|clobetasol|mesh-list
25642391|NCT01414257|Antimetabolites|antimetabolites|mesh-ancestor
25642392|NCT01414257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642393|NCT01414257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642394|NCT01414257|Dermatologic Agents|dermatologic agents|mesh-ancestor
25642395|NCT01414257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25642396|NCT01414257|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25642397|NCT01414257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25642398|NCT01414257|Immunologic Factors|immunologic factors|mesh-ancestor
25642399|NCT01414257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25642400|NCT01414257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25656726|NCT01578278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25656727|NCT01578278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656728|NCT01578278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25656729|NCT01578278|Respiratory System Agents|respiratory system agents|mesh-ancestor
25656730|NCT01578278|Dermatologic Agents|dermatologic agents|mesh-ancestor
25656731|NCT01578278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25656732|NCT01578317|Vaccines|vaccines|mesh-list
25656733|NCT01578317|Immunologic Factors|immunologic factors|mesh-ancestor
25656734|NCT01578317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656735|NCT01578330|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25656736|NCT01578330|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25656737|NCT01578330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656738|NCT01578330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25656739|NCT01578330|Immunologic Factors|immunologic factors|mesh-ancestor
25656740|NCT01578330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656741|NCT01578486|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
25656742|NCT01578486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25656743|NCT01578486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25656744|NCT01578486|Analgesics|analgesics|mesh-ancestor
25642402|NCT01414855|Cyclophosphamide|cyclophosphamide|mesh-list
25642403|NCT01414855|Doxorubicin|doxorubicin|mesh-list
25642404|NCT01414855|Vincristine|vincristine|mesh-list
25642405|NCT01414855|Obinutuzumab|obinutuzumab|mesh-list
25642406|NCT01414855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25642407|NCT01414855|Immunologic Factors|immunologic factors|mesh-ancestor
25642408|NCT01414855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642409|NCT01414855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25642410|NCT01414855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25642411|NCT01414855|Alkylating Agents|alkylating agents|mesh-ancestor
25642412|NCT01414855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642413|NCT01414855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642414|NCT01414855|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25642415|NCT01414855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25642416|NCT01414855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25642417|NCT01414855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25642418|NCT01414855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25642419|NCT01414855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25642420|NCT01414855|Glucocorticoids|glucocorticoids|mesh-ancestor
25642421|NCT01414855|Hormones|hormones|mesh-ancestor
25642422|NCT01414855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25642423|NCT01414855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25642424|NCT01414855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25642425|NCT01414855|Tubulin Modulators|tubulin modulators|mesh-ancestor
25642426|NCT01414855|Antimitotic Agents|antimitotic agents|mesh-ancestor
25642427|NCT01414855|Mitosis Modulators|mitosis modulators|mesh-ancestor
25642428|NCT01414855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25642429|NCT01415349|Omeprazole|omeprazole|mesh-list
25642430|NCT01415349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25642431|NCT01415349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25642432|NCT01415349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25642433|NCT01415349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25642434|NCT01415349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642435|NCT01415401|Timolol|timolol|mesh-list
25642436|NCT01415401|Brinzolamide|brinzolamide|mesh-list
25642437|NCT01415401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25642438|NCT01415401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25642439|NCT01415401|Adrenergic Agents|adrenergic agents|mesh-ancestor
25642440|NCT01415401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25642441|NCT01415401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642442|NCT01415401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642443|NCT01415401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25642444|NCT01415401|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25642445|NCT01415401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25642446|NCT01415401|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25642447|NCT01415518|Budesonide|budesonide|mesh-list
25642448|NCT01415518|Theophylline|theophylline|mesh-list
25642449|NCT01415518|Formoterol Fumarate|formoterol fumarate|mesh-list
25642450|NCT01415518|Ipratropium|ipratropium|mesh-list
25642451|NCT01415518|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25642452|NCT01415518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25642453|NCT01415518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25642454|NCT01415518|Autonomic Agents|autonomic agents|mesh-ancestor
25642455|NCT01415518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25642456|NCT01415518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642457|NCT01415518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25642458|NCT01415518|Respiratory System Agents|respiratory system agents|mesh-ancestor
25642459|NCT01415518|Glucocorticoids|glucocorticoids|mesh-ancestor
25642460|NCT01415518|Hormones|hormones|mesh-ancestor
25642461|NCT01415518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25642462|NCT01415518|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25642463|NCT01415518|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25642464|NCT01415518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25642465|NCT01415518|Adrenergic Agents|adrenergic agents|mesh-ancestor
25642466|NCT01415518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25642467|NCT01415518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642468|NCT01415518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25642469|NCT01415518|Cholinergic Agents|cholinergic agents|mesh-ancestor
25642470|NCT01415518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25642471|NCT01415518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25642472|NCT01415518|Vasodilator Agents|vasodilator agents|mesh-ancestor
25642473|NCT01415518|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25642474|NCT01415518|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25642477|NCT01415531|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25642478|NCT01415531|Vasodilator Agents|vasodilator agents|mesh-ancestor
25642479|NCT01415531|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25642480|NCT01415531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25642481|NCT01415531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25642482|NCT01415531|Adrenergic Agents|adrenergic agents|mesh-ancestor
25642483|NCT01415531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25642484|NCT01415531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642485|NCT01415531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642486|NCT01415583|Dexamethasone|dexamethasone|mesh-list
25642487|NCT01415583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25642488|NCT01415583|Antiemetics|antiemetics|mesh-ancestor
25642489|NCT01415583|Autonomic Agents|autonomic agents|mesh-ancestor
25642490|NCT01415583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25642491|NCT01415583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642492|NCT01415583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25642493|NCT01415583|Glucocorticoids|glucocorticoids|mesh-ancestor
25642494|NCT01415583|Hormones|hormones|mesh-ancestor
25642495|NCT01415583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25642496|NCT01415583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25642497|NCT01415583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642498|NCT01415921|Bromides|bromides|mesh-list
25642499|NCT01415921|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
25642500|NCT01415921|Anticonvulsants|anticonvulsants|mesh-ancestor
25642501|NCT01415921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25642502|NCT01415921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25642503|NCT01415921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642504|NCT01415921|Cholinergic Agents|cholinergic agents|mesh-ancestor
25642505|NCT01415921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25642506|NCT01415921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642507|NCT01415960|Leuprolide|leuprolide|mesh-list
25642508|NCT01415960|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25642509|NCT01415960|Fertility Agents|fertility agents|mesh-ancestor
25642510|NCT01415960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25642511|NCT01415960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642512|NCT01415960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25642513|NCT01415960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642514|NCT01416155|Natalizumab|natalizumab|mesh-list
25642515|NCT01416155|Immunologic Factors|immunologic factors|mesh-ancestor
25642516|NCT01416155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642517|NCT01416181|Natalizumab|natalizumab|mesh-list
25642518|NCT01416181|Immunologic Factors|immunologic factors|mesh-ancestor
25642519|NCT01416181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642520|NCT01416194|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25642521|NCT01416194|Bazedoxifene|bazedoxifene|mesh-list
25642522|NCT01416194|Diphosphonates|diphosphonates|mesh-list
25642523|NCT01416194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25642524|NCT01416194|Hormone Antagonists|hormone antagonists|mesh-ancestor
25642525|NCT01416194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25642526|NCT01416194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642527|NCT01416194|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25642528|NCT01416194|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25642529|NCT01416194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25642530|NCT01416389|Lenograstim|lenograstim|mesh-list
25642531|NCT01416389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25642532|NCT01416389|Immunologic Factors|immunologic factors|mesh-ancestor
25642533|NCT01416389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642534|NCT01416441|Aripiprazole|aripiprazole|mesh-list
25642535|NCT01416441|Antidepressive Agents|antidepressive agents|mesh-ancestor
25642536|NCT01416441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25642537|NCT01416441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25642538|NCT01416441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25642539|NCT01416441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25642540|NCT01416441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642541|NCT01416441|Dopamine Agonists|dopamine agonists|mesh-ancestor
25642542|NCT01416441|Dopamine Agents|dopamine agents|mesh-ancestor
25642543|NCT01416441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25642544|NCT01416441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642545|NCT01416441|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25642546|NCT01416441|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25642547|NCT01416441|Serotonin Agents|serotonin agents|mesh-ancestor
25642548|NCT01416441|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25642549|NCT01416441|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25642550|NCT01416441|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25642552|NCT01416584|Methadone|methadone|mesh-list
25642553|NCT01416584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25642554|NCT01416584|Narcotics|narcotics|mesh-ancestor
25642555|NCT01416584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25642556|NCT01416584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642557|NCT01416584|Analgesics|analgesics|mesh-ancestor
25642558|NCT01416584|Sensory System Agents|sensory system agents|mesh-ancestor
25642559|NCT01416584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25642560|NCT01416584|Antitussive Agents|antitussive agents|mesh-ancestor
25642561|NCT01416584|Respiratory System Agents|respiratory system agents|mesh-ancestor
25642562|NCT01417000|Cyclophosphamide|cyclophosphamide|mesh-list
25642563|NCT01417000|Pancrelipase|pancrelipase|mesh-list
25642564|NCT01417000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25642565|NCT01417000|Immunologic Factors|immunologic factors|mesh-ancestor
25642566|NCT01417000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642567|NCT01417000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25642568|NCT01417000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25642569|NCT01417000|Alkylating Agents|alkylating agents|mesh-ancestor
25642570|NCT01417000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642571|NCT01417000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642572|NCT01417000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25642573|NCT01417000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25642574|NCT01417026|Oxytocin|oxytocin|mesh-list
25642575|NCT01417026|Oxytocics|oxytocics|mesh-ancestor
25642576|NCT01417026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25642577|NCT01417026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642578|NCT01417078|Diazepam|diazepam|mesh-list
25642579|NCT01417078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25642580|NCT01417078|Anticonvulsants|anticonvulsants|mesh-ancestor
25642581|NCT01417078|Antiemetics|antiemetics|mesh-ancestor
25642582|NCT01417078|Autonomic Agents|autonomic agents|mesh-ancestor
25642583|NCT01417078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25642584|NCT01417078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642585|NCT01417078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25642586|NCT01417078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25642587|NCT01417078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25642588|NCT01417078|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25642589|NCT01417078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25642590|NCT01417078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25642591|NCT01417078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25642592|NCT01417078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25642593|NCT01417078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25642594|NCT01417078|Anesthetics, General|anesthetics, general|mesh-ancestor
25642595|NCT01417078|Anesthetics|anesthetics|mesh-ancestor
25642596|NCT01417078|GABA Modulators|gaba modulators|mesh-ancestor
25642597|NCT01417078|GABA Agents|gaba agents|mesh-ancestor
25642598|NCT01417078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25642599|NCT01417078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642600|NCT01417156|Nintedanib|nintedanib|mesh-list
25642601|NCT01417156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642602|NCT01417156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25642603|NCT01417156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25642604|NCT01417156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642605|NCT01417195|Menotropins|menotropins|mesh-list
25642606|NCT01417195|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25642607|NCT01417195|Hormones|hormones|mesh-ancestor
25642608|NCT01417195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25642609|NCT01417195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642610|NCT01417195|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25642611|NCT01417195|Fertility Agents|fertility agents|mesh-ancestor
25642612|NCT01417195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25642613|NCT01417481|Glycine|glycine|mesh-list
25642614|NCT01417481|Glycine Agents|glycine agents|mesh-ancestor
25642615|NCT01417481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25642616|NCT01417481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642617|NCT01417481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642618|NCT01418001|Gemcitabine|gemcitabine|mesh-list
25642619|NCT01418001|Docetaxel|docetaxel|mesh-list
25642620|NCT01418001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25642621|NCT01418001|Antimetabolites|antimetabolites|mesh-ancestor
25642622|NCT01418001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642623|NCT01418001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642624|NCT01418001|Antiviral Agents|antiviral agents|mesh-ancestor
25642625|NCT01418001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25642626|NCT01418001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25642627|NCT01418001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25642628|NCT01418001|Immunologic Factors|immunologic factors|mesh-ancestor
25642629|NCT01418001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642630|NCT01418001|Tubulin Modulators|tubulin modulators|mesh-ancestor
25642631|NCT01418001|Antimitotic Agents|antimitotic agents|mesh-ancestor
25642632|NCT01418001|Mitosis Modulators|mitosis modulators|mesh-ancestor
25642633|NCT01418209|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25642634|NCT01418209|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25642635|NCT01418209|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25642636|NCT01418209|Estradiol|estradiol|mesh-list
25642637|NCT01418209|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25642638|NCT01418209|Progesterone|progesterone|mesh-list
25642639|NCT01418209|Estrogens|estrogens|mesh-ancestor
25642640|NCT01418209|Hormones|hormones|mesh-ancestor
25642641|NCT01418209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25642642|NCT01418209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642643|NCT01418209|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25642644|NCT01418209|Contraceptive Agents|contraceptive agents|mesh-ancestor
25642645|NCT01418209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25642646|NCT01418209|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25642647|NCT01418209|Progestins|progestins|mesh-ancestor
25642648|NCT01418209|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25642649|NCT01418209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25642650|NCT01418209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25642651|NCT01418209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642652|NCT01418209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25642653|NCT01418209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25642654|NCT01418209|Antidepressive Agents|antidepressive agents|mesh-ancestor
25642655|NCT01418209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25642656|NCT01418339|Aripiprazole|aripiprazole|mesh-list
25642657|NCT01418339|Antidepressive Agents|antidepressive agents|mesh-ancestor
25642658|NCT01418339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25642659|NCT01418339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25642660|NCT01418339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25642661|NCT01418339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25642662|NCT01418339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642663|NCT01418339|Dopamine Agonists|dopamine agonists|mesh-ancestor
25642664|NCT01418339|Dopamine Agents|dopamine agents|mesh-ancestor
25642665|NCT01418339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25642666|NCT01418339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642667|NCT01418339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25642668|NCT01418339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25642669|NCT01418339|Serotonin Agents|serotonin agents|mesh-ancestor
25642670|NCT01418339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25642671|NCT01418339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25642672|NCT01418339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25642673|NCT01418339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25642674|NCT01418352|Aripiprazole|aripiprazole|mesh-list
25642675|NCT01418352|Antidepressive Agents|antidepressive agents|mesh-ancestor
25642676|NCT01418352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25642677|NCT01418352|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25642678|NCT01418352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25642679|NCT01418352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25642680|NCT01418352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642681|NCT01418352|Dopamine Agonists|dopamine agonists|mesh-ancestor
25642682|NCT01418352|Dopamine Agents|dopamine agents|mesh-ancestor
25642683|NCT01418352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25642684|NCT01418352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642685|NCT01418352|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25642686|NCT01418352|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25642687|NCT01418352|Serotonin Agents|serotonin agents|mesh-ancestor
25642688|NCT01418352|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25642689|NCT01418352|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25642690|NCT01418352|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25642691|NCT01418352|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25642692|NCT01418365|Metronidazole|metronidazole|mesh-list
25642693|NCT01418365|Mesalamine|mesalamine|mesh-list
25642694|NCT01418365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25537831|NCT03842839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25719221|NCT02446418|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25719222|NCT02446418|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25719223|NCT02446418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25719224|NCT02446418|Adrenergic Agents|adrenergic agents|mesh-ancestor
25719225|NCT02446418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25642695|NCT01418365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25642696|NCT01418365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25642697|NCT01418365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25642698|NCT01418365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25642699|NCT01418365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25642700|NCT01418365|Analgesics|analgesics|mesh-ancestor
25642701|NCT01418365|Sensory System Agents|sensory system agents|mesh-ancestor
25642702|NCT01418365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25642703|NCT01418365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642704|NCT01418365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25642705|NCT01418365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25642706|NCT01419184|Vancomycin|vancomycin|mesh-list
25642707|NCT01419184|Daptomycin|daptomycin|mesh-list
25642708|NCT01419184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25642709|NCT01419184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25642710|NCT01419197|Trastuzumab|trastuzumab|mesh-list
25642711|NCT01419197|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25642712|NCT01419197|Maytansine|maytansine|mesh-list
25642713|NCT01419197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25642714|NCT01419197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642715|NCT01419197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25642716|NCT01419197|Tubulin Modulators|tubulin modulators|mesh-ancestor
25642717|NCT01419197|Antimitotic Agents|antimitotic agents|mesh-ancestor
25642718|NCT01419197|Mitosis Modulators|mitosis modulators|mesh-ancestor
25642719|NCT01419197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642720|NCT01419236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25642721|NCT01419236|Testosterone|testosterone|mesh-list
25642722|NCT01419236|Androgens|androgens|mesh-ancestor
25642723|NCT01419236|Hormones|hormones|mesh-ancestor
25642724|NCT01419236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25642725|NCT01419236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642726|NCT01419275|Xenon|xenon|mesh-list
25642727|NCT01419275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25642728|NCT01419275|Anesthetics, General|anesthetics, general|mesh-ancestor
25642729|NCT01419275|Anesthetics|anesthetics|mesh-ancestor
25642730|NCT01419275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25642731|NCT01419275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642732|NCT01419535|Mifepristone|mifepristone|mesh-list
25642733|NCT01419535|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25642734|NCT01419535|Abortifacient Agents|abortifacient agents|mesh-ancestor
25642735|NCT01419535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25642736|NCT01419535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642737|NCT01419535|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25642738|NCT01419535|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25642739|NCT01419535|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25642740|NCT01419535|Contraceptive Agents|contraceptive agents|mesh-ancestor
25642741|NCT01419535|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25642742|NCT01419535|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25642743|NCT01419535|Hormone Antagonists|hormone antagonists|mesh-ancestor
25642744|NCT01419535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25642745|NCT01419535|Luteolytic Agents|luteolytic agents|mesh-ancestor
25642746|NCT01419535|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25642747|NCT01419535|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25642748|NCT01419639|Everolimus|everolimus|mesh-list
25642749|NCT01419639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642750|NCT01419639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25642751|NCT01419639|Immunologic Factors|immunologic factors|mesh-ancestor
25642752|NCT01419639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642753|NCT01419665|Rituximab|rituximab|mesh-list
25642754|NCT01419665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25642755|NCT01419665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642756|NCT01419665|Immunologic Factors|immunologic factors|mesh-ancestor
25642757|NCT01419665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642758|NCT01419665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25642759|NCT01419717|Denosumab|denosumab|mesh-list
25642760|NCT01419717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25719228|NCT02446483|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25642761|NCT01419717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642762|NCT01419795|Rituximab|rituximab|mesh-list
25642763|NCT01419795|Lenalidomide|lenalidomide|mesh-list
25642764|NCT01419795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25642765|NCT01419795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642766|NCT01419795|Immunologic Factors|immunologic factors|mesh-ancestor
25642767|NCT01419795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642768|NCT01419795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25642769|NCT01419795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25642770|NCT01419795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25642771|NCT01419795|Growth Substances|growth substances|mesh-ancestor
25642772|NCT01419795|Growth Inhibitors|growth inhibitors|mesh-ancestor
25642774|NCT01419977|Tinzaparin|tinzaparin|mesh-list
25642775|NCT01419977|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25642776|NCT01419977|Anticoagulants|anticoagulants|mesh-ancestor
25642777|NCT01419977|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25642778|NCT01419977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25642779|NCT01419977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642780|NCT01420081|Gedatolisib|gedatolisib|mesh-list
25642781|NCT01420081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25642782|NCT01420081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25642783|NCT01420081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642784|NCT01420146|Trastuzumab|trastuzumab|mesh-list
25642785|NCT01420146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25642786|NCT01420146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642787|NCT01420536|Salicylic Acid|salicylic acid|mesh-list
25642788|NCT01420536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25642789|NCT01420536|Antifungal Agents|antifungal agents|mesh-ancestor
25642790|NCT01420536|Keratolytic Agents|keratolytic agents|mesh-ancestor
25642791|NCT01420536|Dermatologic Agents|dermatologic agents|mesh-ancestor
25642792|NCT01420549|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25642793|NCT01420549|Simvastatin|simvastatin|mesh-list
25642794|NCT01420549|Ezetimibe|ezetimibe|mesh-list
25642795|NCT01420549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25642796|NCT01420549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25642797|NCT01420549|Antimetabolites|antimetabolites|mesh-ancestor
25642798|NCT01420549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642799|NCT01420549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25642800|NCT01420549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25642801|NCT01420549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25642802|NCT01420653|Acetaminophen|acetaminophen|mesh-list
25642803|NCT01420653|Ibuprofen|ibuprofen|mesh-list
25642804|NCT01420653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25642805|NCT01420653|Analgesics|analgesics|mesh-ancestor
25642806|NCT01420653|Sensory System Agents|sensory system agents|mesh-ancestor
25642807|NCT01420653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25642808|NCT01420653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642809|NCT01420653|Antipyretics|antipyretics|mesh-ancestor
25642810|NCT01420653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25642811|NCT01420653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25642812|NCT01420653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25642813|NCT01420653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25642814|NCT01420653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25642815|NCT01420653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642816|NCT01420679|10-deazaaminopterin|10-deazaaminopterin|mesh-list
25642817|NCT01420679|Aminopterin|aminopterin|mesh-list
25642818|NCT01420679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25642819|NCT01420679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25642820|NCT01420679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642821|NCT01420679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642822|NCT01421017|Cyclophosphamide|cyclophosphamide|mesh-list
25642823|NCT01421017|Imiquimod|imiquimod|mesh-list
25642824|NCT01421017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25642825|NCT01421017|Immunologic Factors|immunologic factors|mesh-ancestor
25642826|NCT01421017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642827|NCT01421017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25642828|NCT01421017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25642829|NCT01421017|Alkylating Agents|alkylating agents|mesh-ancestor
25642830|NCT01421017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642831|NCT01421017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642832|NCT01421017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25642833|NCT01421017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25642834|NCT01421017|Interferon Inducers|interferon inducers|mesh-ancestor
25642835|NCT01421134|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25642836|NCT01421134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25642837|NCT01421134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25642838|NCT01421134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25642839|NCT01421134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642840|NCT01421134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25642841|NCT01421134|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25642842|NCT01421134|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25642843|NCT01421134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25642844|NCT01421134|Adrenergic Agents|adrenergic agents|mesh-ancestor
25642845|NCT01421134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25642846|NCT01421134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642847|NCT01421134|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25642848|NCT01421134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25642849|NCT01421134|Serotonin Agents|serotonin agents|mesh-ancestor
25642850|NCT01421134|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25642851|NCT01421134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25642852|NCT01421134|Dopamine Agents|dopamine agents|mesh-ancestor
25642853|NCT01421147|Insulin Lispro|insulin lispro|mesh-list
25642854|NCT01421147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25642855|NCT01421147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642856|NCT01421186|Dexamethasone|dexamethasone|mesh-list
25642857|NCT01421186|Lenalidomide|lenalidomide|mesh-list
25642858|NCT01421186|Pomalidomide|pomalidomide|mesh-list
25642859|NCT01421186|Felzartamab|felzartamab|mesh-list
25642860|NCT01421186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25642861|NCT01421186|Antiemetics|antiemetics|mesh-ancestor
25642862|NCT01421186|Autonomic Agents|autonomic agents|mesh-ancestor
25642863|NCT01421186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25642864|NCT01421186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642865|NCT01421186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25642866|NCT01421186|Glucocorticoids|glucocorticoids|mesh-ancestor
25642867|NCT01421186|Hormones|hormones|mesh-ancestor
25642868|NCT01421186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25642869|NCT01421186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25642870|NCT01421186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642871|NCT01421186|Immunologic Factors|immunologic factors|mesh-ancestor
25642872|NCT01421186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25642873|NCT01421186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25642874|NCT01421186|Growth Substances|growth substances|mesh-ancestor
25642875|NCT01421186|Growth Inhibitors|growth inhibitors|mesh-ancestor
25642876|NCT01421225|Insulin|insulin|mesh-list
25642877|NCT01421225|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25642878|NCT01421225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25642879|NCT01421225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642880|NCT01421303|Etanercept|etanercept|mesh-list
25642881|NCT01421303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25642882|NCT01421303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25642883|NCT01421303|Analgesics|analgesics|mesh-ancestor
25642884|NCT01421303|Sensory System Agents|sensory system agents|mesh-ancestor
25642885|NCT01421303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25642886|NCT01421303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642887|NCT01421303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25642888|NCT01421303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25642889|NCT01421303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25642890|NCT01421303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25642891|NCT01421303|Immunologic Factors|immunologic factors|mesh-ancestor
25642892|NCT01421342|Aripiprazole|aripiprazole|mesh-list
25642893|NCT01421342|Bupropion|bupropion|mesh-list
25642894|NCT01421342|Antidepressive Agents|antidepressive agents|mesh-list
25642895|NCT01421342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25642896|NCT01421342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25642897|NCT01421342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25642898|NCT01421342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25642899|NCT01421342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25642900|NCT01421342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642901|NCT01421342|Dopamine Agents|dopamine agents|mesh-ancestor
25642902|NCT01421342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25719236|NCT02446717|Ribavirin|ribavirin|mesh-list
25719237|NCT02446717|Antimetabolites|antimetabolites|mesh-ancestor
25642903|NCT01421342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642904|NCT01421342|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25642905|NCT01421342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25642906|NCT01421342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25642907|NCT01421342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25642908|NCT01421342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25642909|NCT01421342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25642910|NCT01421342|Dopamine Agonists|dopamine agonists|mesh-ancestor
25642911|NCT01421342|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25642912|NCT01421342|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25642913|NCT01421342|Serotonin Agents|serotonin agents|mesh-ancestor
25642914|NCT01421342|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25642915|NCT01421342|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25642916|NCT01421342|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25642917|NCT01421342|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25642918|NCT01421355|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25642919|NCT01421355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25642920|NCT01421355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25642922|NCT01421355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25642923|NCT01421355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642924|NCT01421355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25642925|NCT01421355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25642926|NCT01421355|Antiviral Agents|antiviral agents|mesh-ancestor
25642927|NCT01421355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25642928|NCT01421459|Insulin Glargine|insulin glargine|mesh-list
25642929|NCT01421459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25642930|NCT01421459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642931|NCT01421472|Paclitaxel|paclitaxel|mesh-list
25642932|NCT01421472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25642933|NCT01421472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642934|NCT01421472|Tubulin Modulators|tubulin modulators|mesh-ancestor
25642935|NCT01421472|Antimitotic Agents|antimitotic agents|mesh-ancestor
25642936|NCT01421472|Mitosis Modulators|mitosis modulators|mesh-ancestor
25642937|NCT01421472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642938|NCT01421498|Lifitegrast|lifitegrast|mesh-list
25642939|NCT01421498|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25642940|NCT01421498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25642941|NCT01421511|Linezolid|linezolid|mesh-list
25642942|NCT01421511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25642943|NCT01421511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25642944|NCT01421511|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25642945|NCT01421511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25642946|NCT01421511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642947|NCT01421589|Hormones|hormones|mesh-list
25642948|NCT01421589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25642949|NCT01421589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642950|NCT01421641|Lidocaine|lidocaine|mesh-list
25642951|NCT01421641|Anesthetics, Local|anesthetics, local|mesh-ancestor
25642952|NCT01421641|Anesthetics|anesthetics|mesh-ancestor
25642953|NCT01421641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25642954|NCT01421641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642955|NCT01421641|Sensory System Agents|sensory system agents|mesh-ancestor
25642956|NCT01421641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25642957|NCT01421641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25642958|NCT01421641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25642959|NCT01421641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25642960|NCT01421641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25642961|NCT01421641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642962|NCT01421667|Rituximab|rituximab|mesh-list
25642963|NCT01421667|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25642964|NCT01421667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25642965|NCT01421667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25642966|NCT01421667|Immunologic Factors|immunologic factors|mesh-ancestor
25642967|NCT01421667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642968|NCT01421667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25642969|NCT01421719|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25642970|NCT01421719|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25642971|NCT01421719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25642972|NCT01421719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642973|NCT01421719|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25642974|NCT01421719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25642975|NCT01421719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642976|NCT01421719|Cholinergic Agents|cholinergic agents|mesh-ancestor
25642977|NCT01421719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25642978|NCT01422135|Contraceptive Agents|contraceptive agents|mesh-list
25642979|NCT01422135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25642980|NCT01422135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642981|NCT01422161|Botulinum Toxins|botulinum toxins|mesh-list
25642982|NCT01422161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25642983|NCT01422161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25642984|NCT01422161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25642985|NCT01422161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25642986|NCT01422161|Cholinergic Agents|cholinergic agents|mesh-ancestor
25642987|NCT01422161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25642988|NCT01422161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642989|NCT01422161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25642990|NCT01422161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25642991|NCT01422200|Vaccines|vaccines|mesh-list
25642992|NCT01422200|Immunologic Factors|immunologic factors|mesh-ancestor
25642993|NCT01422200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25642994|NCT01422213|Vortioxetine|vortioxetine|mesh-list
25642995|NCT01422213|Antidepressive Agents|antidepressive agents|mesh-ancestor
25642996|NCT01422213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25642997|NCT01422213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25642998|NCT01422213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25642999|NCT01422213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25643000|NCT01422213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643001|NCT01422213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25643002|NCT01422213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25643003|NCT01422213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25643004|NCT01422213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643005|NCT01422213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25643006|NCT01422213|Serotonin Agents|serotonin agents|mesh-ancestor
25643007|NCT01422213|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25643008|NCT01422213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25643009|NCT01422213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25643010|NCT01422213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25643011|NCT01422226|Alprostadil|alprostadil|mesh-list
25643012|NCT01422226|Misoprostol|misoprostol|mesh-list
25643013|NCT01422226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25643014|NCT01422226|Abortifacient Agents|abortifacient agents|mesh-ancestor
25643015|NCT01422226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25643016|NCT01422226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643017|NCT01422226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25643018|NCT01422226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25643019|NCT01422226|Oxytocics|oxytocics|mesh-ancestor
25643020|NCT01422226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25643021|NCT01422226|Vasodilator Agents|vasodilator agents|mesh-ancestor
25643022|NCT01422226|Urological Agents|urological agents|mesh-ancestor
25656745|NCT01578486|Sensory System Agents|sensory system agents|mesh-ancestor
25656746|NCT01578486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25656747|NCT01578486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656748|NCT01578486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25656749|NCT01578486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25656750|NCT01578499|Methotrexate|methotrexate|mesh-list
25656751|NCT01578499|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25656752|NCT01578499|Bexarotene|bexarotene|mesh-list
25656753|NCT01578499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25656754|NCT01578499|Abortifacient Agents|abortifacient agents|mesh-ancestor
25656755|NCT01578499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25656756|NCT01578499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656757|NCT01578499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25656758|NCT01578499|Antimetabolites|antimetabolites|mesh-ancestor
25656759|NCT01578499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656760|NCT01578499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656761|NCT01578499|Dermatologic Agents|dermatologic agents|mesh-ancestor
25656762|NCT01578499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25656763|NCT01578499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25656764|NCT01578499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25656765|NCT01578499|Immunologic Factors|immunologic factors|mesh-ancestor
25656766|NCT01578499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25656767|NCT01578499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25656768|NCT01578499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25656769|NCT01578551|Metformin|metformin|mesh-list
25656770|NCT01578551|Biguanides|biguanides|mesh-list
25656771|NCT01578551|Paclitaxel|paclitaxel|mesh-list
25656772|NCT01578551|Bevacizumab|bevacizumab|mesh-list
25656773|NCT01578551|Carboplatin|carboplatin|mesh-list
25656774|NCT01578551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25656775|NCT01578551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656776|NCT01578551|Tubulin Modulators|tubulin modulators|mesh-ancestor
25656777|NCT01578551|Antimitotic Agents|antimitotic agents|mesh-ancestor
25656778|NCT01578551|Mitosis Modulators|mitosis modulators|mesh-ancestor
25656779|NCT01578551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656780|NCT01578551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25656781|NCT01578551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25656782|NCT01578551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25656783|NCT01578551|Growth Substances|growth substances|mesh-ancestor
25656784|NCT01578551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656785|NCT01578551|Growth Inhibitors|growth inhibitors|mesh-ancestor
25656786|NCT01578551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25656787|NCT01578707|Ofatumumab|ofatumumab|mesh-list
25656788|NCT01578707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538208|NCT03143270|Nivolumab|nivolumab|mesh-list
25643024|NCT01422304|Glycopyrrolate|glycopyrrolate|mesh-list
25643025|NCT01422304|Neostigmine|neostigmine|mesh-list
25643026|NCT01422304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25643027|NCT01422304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25643028|NCT01422304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25643029|NCT01422304|Autonomic Agents|autonomic agents|mesh-ancestor
25643030|NCT01422304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25643031|NCT01422304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643032|NCT01422304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25643033|NCT01422304|Respiratory System Agents|respiratory system agents|mesh-ancestor
25643034|NCT01422304|Mydriatics|mydriatics|mesh-ancestor
25643035|NCT01422304|Parasympatholytics|parasympatholytics|mesh-ancestor
25643036|NCT01422304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25643037|NCT01422304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25643038|NCT01422304|Cholinergic Agents|cholinergic agents|mesh-ancestor
25643039|NCT01422304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25643040|NCT01422304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643041|NCT01422304|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25643042|NCT01422304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25643043|NCT01422304|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25643044|NCT01422369|Ritonavir|ritonavir|mesh-list
25643045|NCT01422369|Darunavir|darunavir|mesh-list
25643046|NCT01422369|Pitavastatin|pitavastatin|mesh-list
25643047|NCT01422369|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25643048|NCT01422369|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25643049|NCT01422369|Protease Inhibitors|protease inhibitors|mesh-ancestor
25643050|NCT01422369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25643051|NCT01422369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643052|NCT01422369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25643053|NCT01422369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25643054|NCT01422369|Antiviral Agents|antiviral agents|mesh-ancestor
25643055|NCT01422369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25643056|NCT01422369|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25643057|NCT01422369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25643058|NCT01422369|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25643059|NCT01422369|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25643060|NCT01422369|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25643061|NCT01422369|Antimetabolites|antimetabolites|mesh-ancestor
25643062|NCT01422369|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25643063|NCT01422382|Diltiazem|diltiazem|mesh-list
25643064|NCT01422382|Pitavastatin|pitavastatin|mesh-list
25643065|NCT01422382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25643066|NCT01422382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25643067|NCT01422382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25643068|NCT01422382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643069|NCT01422382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25643070|NCT01422382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643071|NCT01422382|Vasodilator Agents|vasodilator agents|mesh-ancestor
25643072|NCT01422382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25643073|NCT01422382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25643074|NCT01422382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25643075|NCT01422382|Antimetabolites|antimetabolites|mesh-ancestor
25643076|NCT01422382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25643077|NCT01422382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25643078|NCT01422408|Fluocinonide|fluocinonide|mesh-list
25643079|NCT01422408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25643080|NCT01422408|Glucocorticoids|glucocorticoids|mesh-ancestor
25643081|NCT01422408|Hormones|hormones|mesh-ancestor
25643082|NCT01422408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25643083|NCT01422408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643084|NCT01422408|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25643085|NCT01422434|Calcitriol|calcitriol|mesh-list
25643086|NCT01422434|Betamethasone|betamethasone|mesh-list
25643087|NCT01422434|Betamethasone Valerate|betamethasone valerate|mesh-list
25643088|NCT01422434|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25643089|NCT01422434|Betamethasone benzoate|betamethasone benzoate|mesh-list
25643090|NCT01422434|Calcipotriene|calcipotriene|mesh-list
25643091|NCT01422434|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25643092|NCT01422434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25643093|NCT01422434|Glucocorticoids|glucocorticoids|mesh-ancestor
25643094|NCT01422434|Hormones|hormones|mesh-ancestor
25643095|NCT01422434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25643096|NCT01422434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643097|NCT01422434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25643098|NCT01422434|Respiratory System Agents|respiratory system agents|mesh-ancestor
25643099|NCT01422434|Dermatologic Agents|dermatologic agents|mesh-ancestor
25643100|NCT01422434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25643101|NCT01422434|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25643102|NCT01422434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25643103|NCT01422434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643104|NCT01422434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25643105|NCT01422434|Vitamins|vitamins|mesh-ancestor
25643106|NCT01422434|Micronutrients|micronutrients|mesh-ancestor
25643107|NCT01422434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25643108|NCT01422538|Mannitol|mannitol|mesh-list
25643109|NCT01422538|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25643110|NCT01422538|Diuretics|diuretics|mesh-ancestor
25643111|NCT01422538|Natriuretic Agents|natriuretic agents|mesh-ancestor
25643112|NCT01422538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643113|NCT01422720|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25643114|NCT01422720|Anticonvulsants|anticonvulsants|mesh-ancestor
25643115|NCT01422720|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25643116|NCT01422720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25643117|NCT01422720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25643118|NCT01422720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643119|NCT01422876|Linagliptin|linagliptin|mesh-list
25643120|NCT01422876|Empagliflozin|empagliflozin|mesh-list
25643121|NCT01422876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25643122|NCT01422876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643123|NCT01422876|Incretins|incretins|mesh-ancestor
25643124|NCT01422876|Hormones|hormones|mesh-ancestor
25643125|NCT01422876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25643126|NCT01422876|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25643127|NCT01422876|Protease Inhibitors|protease inhibitors|mesh-ancestor
25643128|NCT01422876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25643129|NCT01422876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643130|NCT01422876|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25643131|NCT01422915|Colestipol|colestipol|mesh-list
25643132|NCT01422915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25643133|NCT01422915|Antimetabolites|antimetabolites|mesh-ancestor
25643134|NCT01422915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643135|NCT01422915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25643136|NCT01422915|Sequestering Agents|sequestering agents|mesh-ancestor
25643137|NCT01423162|Ascorbic Acid|ascorbic acid|mesh-list
25643138|NCT01423162|Antioxidants|antioxidants|mesh-ancestor
25643139|NCT01423162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643140|NCT01423162|Protective Agents|protective agents|mesh-ancestor
25643141|NCT01423162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643142|NCT01423162|Vitamins|vitamins|mesh-ancestor
25643143|NCT01423162|Micronutrients|micronutrients|mesh-ancestor
25643144|NCT01423253|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25643145|NCT01423253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25643146|NCT01423253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25643147|NCT01423253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25643148|NCT01423253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643149|NCT01423253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25643150|NCT01423253|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25643151|NCT01423253|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25643152|NCT01423253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25643153|NCT01423253|Adrenergic Agents|adrenergic agents|mesh-ancestor
25643154|NCT01423253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25643155|NCT01423253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643156|NCT01423253|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25643157|NCT01423253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25643158|NCT01423253|Serotonin Agents|serotonin agents|mesh-ancestor
25643159|NCT01423253|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25643160|NCT01423253|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25643161|NCT01423253|Dopamine Agents|dopamine agents|mesh-ancestor
25643162|NCT01423604|Capecitabine|capecitabine|mesh-list
25643163|NCT01423604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25643164|NCT01423604|Antimetabolites|antimetabolites|mesh-ancestor
25643165|NCT01423604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643166|NCT01423604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25643167|NCT01423812|Ritonavir|ritonavir|mesh-list
25643168|NCT01423812|Darunavir|darunavir|mesh-list
25643169|NCT01423812|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25643170|NCT01423812|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25643171|NCT01423812|Protease Inhibitors|protease inhibitors|mesh-ancestor
25643172|NCT01423812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25643173|NCT01423812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643174|NCT01423812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25643175|NCT01423812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25643176|NCT01423812|Antiviral Agents|antiviral agents|mesh-ancestor
25643177|NCT01423812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25643178|NCT01423812|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25643179|NCT01423812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25643180|NCT01423916|Moxifloxacin|moxifloxacin|mesh-list
25643181|NCT01423916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25643182|NCT01423916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25643183|NCT01423916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25643184|NCT01423916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25643185|NCT01423916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25643186|NCT01423916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643187|NCT01423916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25643188|NCT01424033|Acetylcysteine|acetylcysteine|mesh-list
25643189|NCT01424033|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25643190|NCT01424033|Antiviral Agents|antiviral agents|mesh-ancestor
25643191|NCT01424033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25643192|NCT01424033|Expectorants|expectorants|mesh-ancestor
25643193|NCT01424033|Respiratory System Agents|respiratory system agents|mesh-ancestor
25643194|NCT01424033|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25643195|NCT01424033|Antioxidants|antioxidants|mesh-ancestor
25643196|NCT01424033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643197|NCT01424033|Protective Agents|protective agents|mesh-ancestor
25643198|NCT01424033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643199|NCT01424033|Antidotes|antidotes|mesh-ancestor
25643200|NCT01424228|Prucalopride|prucalopride|mesh-list
25643201|NCT01424228|Laxatives|laxatives|mesh-ancestor
25643202|NCT01424228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25643203|NCT01424228|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
25643204|NCT01424228|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25643205|NCT01424228|Serotonin Agents|serotonin agents|mesh-ancestor
25643206|NCT01424228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25643207|NCT01424228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643208|NCT01424228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643209|NCT01424566|Nabiximols|nabiximols|mesh-list
25643210|NCT01424566|Analgesics|analgesics|mesh-ancestor
25643211|NCT01424566|Sensory System Agents|sensory system agents|mesh-ancestor
25643212|NCT01424566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25643213|NCT01424566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643214|NCT01424644|Vaccines|vaccines|mesh-list
25643215|NCT01424644|Immunologic Factors|immunologic factors|mesh-ancestor
25643216|NCT01424644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643217|NCT01424813|Albuterol|albuterol|mesh-list
25643218|NCT01424813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25643219|NCT01424813|Autonomic Agents|autonomic agents|mesh-ancestor
25643220|NCT01424813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25643221|NCT01424813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643222|NCT01424813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25643223|NCT01424813|Respiratory System Agents|respiratory system agents|mesh-ancestor
25643224|NCT01424813|Tocolytic Agents|tocolytic agents|mesh-ancestor
25643225|NCT01424813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25643226|NCT01424813|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25643227|NCT01424813|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25643228|NCT01424813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25643229|NCT01424813|Adrenergic Agents|adrenergic agents|mesh-ancestor
25643230|NCT01424813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25643231|NCT01424813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643232|NCT01424930|Prednisone|prednisone|mesh-list
25643233|NCT01424930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25643234|NCT01424930|Glucocorticoids|glucocorticoids|mesh-ancestor
25643235|NCT01424930|Hormones|hormones|mesh-ancestor
25643236|NCT01424930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25643237|NCT01424930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643238|NCT01424930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25643239|NCT01424930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25643240|NCT01425203|Ribavirin|ribavirin|mesh-list
25643241|NCT01425203|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25643242|NCT01425203|Antimetabolites|antimetabolites|mesh-ancestor
25643243|NCT01425203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643244|NCT01425203|Antiviral Agents|antiviral agents|mesh-ancestor
25643245|NCT01425203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25538443|NCT02367040|Rituximab|rituximab|mesh-list
25643246|NCT01425229|Bosentan|bosentan|mesh-list
25643247|NCT01425229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25643248|NCT01425229|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25643249|NCT01425229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643250|NCT01425307|Hydroxyurea|hydroxyurea|mesh-list
25643251|NCT01425307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25643252|NCT01425307|Antisickling Agents|antisickling agents|mesh-ancestor
25643253|NCT01425307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25643254|NCT01425307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643255|NCT01425307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25643256|NCT01425359|Ranolazine|ranolazine|mesh-list
25643257|NCT01425359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25643258|NCT01425359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25643259|NCT01425359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643260|NCT01425463|Glycine|glycine|mesh-list
25643261|NCT01425463|Glycine Agents|glycine agents|mesh-ancestor
25643262|NCT01425463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25643263|NCT01425463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643264|NCT01425463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643265|NCT01425281|Everolimus|everolimus|mesh-list
25643266|NCT01425281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25643267|NCT01425281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25643268|NCT01425281|Immunologic Factors|immunologic factors|mesh-ancestor
25643269|NCT01425281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643270|NCT01425632|Bepotastine besilate|bepotastine besilate|mesh-list
25643271|NCT01425632|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25643272|NCT01425801|Albuterol|albuterol|mesh-list
25643273|NCT01425801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25643274|NCT01425801|Autonomic Agents|autonomic agents|mesh-ancestor
25643275|NCT01425801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25643276|NCT01425801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643277|NCT01425801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25643278|NCT01425801|Respiratory System Agents|respiratory system agents|mesh-ancestor
25643279|NCT01425801|Tocolytic Agents|tocolytic agents|mesh-ancestor
25643280|NCT01425801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25643281|NCT01425801|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25643282|NCT01425801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25643283|NCT01425801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25643284|NCT01425801|Adrenergic Agents|adrenergic agents|mesh-ancestor
25643285|NCT01425801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25643286|NCT01425801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643287|NCT01425853|Celecoxib|celecoxib|mesh-list
25643288|NCT01425853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25643289|NCT01425853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25643290|NCT01425853|Analgesics|analgesics|mesh-ancestor
25643291|NCT01425853|Sensory System Agents|sensory system agents|mesh-ancestor
25643292|NCT01425853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25643293|NCT01425853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643294|NCT01425853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25643295|NCT01425853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25643296|NCT01425853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25643297|NCT01425853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25643298|NCT01425853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25643299|NCT01425853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643300|NCT01426009|Bromides|bromides|mesh-list
25643301|NCT01426009|Tiotropium Bromide|tiotropium bromide|mesh-list
25643302|NCT01426009|Ipratropium|ipratropium|mesh-list
25643303|NCT01426009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25643304|NCT01426009|Autonomic Agents|autonomic agents|mesh-ancestor
25643305|NCT01426009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25643306|NCT01426009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643307|NCT01426009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25643308|NCT01426009|Respiratory System Agents|respiratory system agents|mesh-ancestor
25643309|NCT01426009|Parasympatholytics|parasympatholytics|mesh-ancestor
25643310|NCT01426009|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25643311|NCT01426009|Cholinergic Agents|cholinergic agents|mesh-ancestor
25643312|NCT01426009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25643313|NCT01426009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643314|NCT01426009|Anticonvulsants|anticonvulsants|mesh-ancestor
25643315|NCT01426347|Vitamin D|vitamin d|mesh-list
25643316|NCT01426347|Ergocalciferols|ergocalciferols|mesh-list
25643317|NCT01426347|Vitamins|vitamins|mesh-ancestor
25643318|NCT01426347|Micronutrients|micronutrients|mesh-ancestor
25643319|NCT01426347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656789|NCT01578772|Telmisartan|telmisartan|mesh-list
25643320|NCT01426347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25643321|NCT01426347|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25643322|NCT01426373|Deoxycholic Acid|deoxycholic acid|mesh-list
25643323|NCT01426373|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25643324|NCT01426373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25643325|NCT01426412|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25643326|NCT01426412|Immunologic Factors|immunologic factors|mesh-ancestor
25643327|NCT01426412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643328|NCT01426438|Aspirin|aspirin|mesh-list
25643329|NCT01426438|Niacin|niacin|mesh-list
25643330|NCT01426438|Fenofibrate|fenofibrate|mesh-list
25643331|NCT01426438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25643332|NCT01426438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25643333|NCT01426438|Analgesics|analgesics|mesh-ancestor
25643334|NCT01426438|Sensory System Agents|sensory system agents|mesh-ancestor
25643335|NCT01426438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25643336|NCT01426438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643337|NCT01426438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25643338|NCT01426438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25643339|NCT01426438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25643340|NCT01426438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25643341|NCT01426438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643342|NCT01426438|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25643343|NCT01426438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25643344|NCT01426438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25643345|NCT01426438|Antipyretics|antipyretics|mesh-ancestor
25643346|NCT01426438|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25643347|NCT01426438|Antimetabolites|antimetabolites|mesh-ancestor
25643348|NCT01426438|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25643349|NCT01426438|Vasodilator Agents|vasodilator agents|mesh-ancestor
25643350|NCT01426438|Vitamin B Complex|vitamin b complex|mesh-ancestor
25643351|NCT01426438|Vitamins|vitamins|mesh-ancestor
25643352|NCT01426438|Micronutrients|micronutrients|mesh-ancestor
25643353|NCT01426763|Complement C1s|complement c1s|mesh-list
25643354|NCT01426763|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25643355|NCT01426763|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
25643356|NCT01426763|Immunologic Factors|immunologic factors|mesh-ancestor
25643357|NCT01426763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643358|NCT01426763|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25643359|NCT01426763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25643360|NCT01426854|Nepafenac|nepafenac|mesh-list
25643361|NCT01426854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25643362|NCT01426854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25643363|NCT01426854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25643364|NCT01426854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25643365|NCT01426854|Analgesics|analgesics|mesh-ancestor
25643366|NCT01426854|Sensory System Agents|sensory system agents|mesh-ancestor
25643367|NCT01426854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25643368|NCT01426854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643369|NCT01426854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25643370|NCT01426854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25643371|NCT01426867|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25643372|NCT01426867|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25643373|NCT01426867|Brinzolamide|brinzolamide|mesh-list
25643374|NCT01426867|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25643375|NCT01426867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25643376|NCT01426867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25643377|NCT01426867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25643378|NCT01426867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25643379|NCT01426867|Adrenergic Agents|adrenergic agents|mesh-ancestor
25643380|NCT01426867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25643381|NCT01426867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643382|NCT01426867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643383|NCT01426867|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25643384|NCT01426867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25643385|NCT01426958|Ritonavir|ritonavir|mesh-list
25643386|NCT01426958|Afatinib|afatinib|mesh-list
25643387|NCT01426958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25643388|NCT01426958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25643389|NCT01426958|Protease Inhibitors|protease inhibitors|mesh-ancestor
25643390|NCT01426958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25643391|NCT01426958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643392|NCT01426958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25643393|NCT01426958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25643394|NCT01426958|Antiviral Agents|antiviral agents|mesh-ancestor
25643395|NCT01426958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25643396|NCT01426958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25643397|NCT01426958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25643398|NCT01426958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25643399|NCT01426958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25643401|NCT01427309|Immunologic Factors|immunologic factors|mesh-ancestor
25643402|NCT01427309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643403|NCT01427504|Etravirine|etravirine|mesh-list
25643404|NCT01427504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25643405|NCT01427504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25643406|NCT01427504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25643407|NCT01427504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643408|NCT01427504|Antiviral Agents|antiviral agents|mesh-ancestor
25643409|NCT01427504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25643410|NCT01427517|Acetylcysteine|acetylcysteine|mesh-list
25643411|NCT01427517|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25643412|NCT01427517|Antiviral Agents|antiviral agents|mesh-ancestor
25643413|NCT01427517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25643414|NCT01427517|Expectorants|expectorants|mesh-ancestor
25643415|NCT01427517|Respiratory System Agents|respiratory system agents|mesh-ancestor
25643416|NCT01427517|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25643417|NCT01427517|Antioxidants|antioxidants|mesh-ancestor
25643418|NCT01427517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643419|NCT01427517|Protective Agents|protective agents|mesh-ancestor
25643420|NCT01427517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643421|NCT01427517|Antidotes|antidotes|mesh-ancestor
25643422|NCT01427595|Metformin|metformin|mesh-list
25643423|NCT01427595|Progesterone|progesterone|mesh-list
25643424|NCT01427595|Estradiol|estradiol|mesh-list
25643425|NCT01427595|Estrogens|estrogens|mesh-list
25643426|NCT01427595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25643427|NCT01427595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643428|NCT01427595|Progestins|progestins|mesh-ancestor
25643429|NCT01427595|Hormones|hormones|mesh-ancestor
25643430|NCT01427595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25643431|NCT01427608|Olanzapine|olanzapine|mesh-list
25643432|NCT01427608|Sertraline|sertraline|mesh-list
25643433|NCT01427608|Antiemetics|antiemetics|mesh-ancestor
25643434|NCT01427608|Autonomic Agents|autonomic agents|mesh-ancestor
25643435|NCT01427608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25643436|NCT01427608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643437|NCT01427608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25643438|NCT01427608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25643439|NCT01427608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25643440|NCT01427608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25643441|NCT01427608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25643442|NCT01427608|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25643443|NCT01427608|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25643444|NCT01427608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25643445|NCT01427608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643446|NCT01427608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25643447|NCT01427608|Serotonin Agents|serotonin agents|mesh-ancestor
25643448|NCT01427608|Antidepressive Agents|antidepressive agents|mesh-ancestor
25643449|NCT01427738|Nystatin|nystatin|mesh-list
25643450|NCT01427738|Gentian Violet|gentian violet|mesh-list
25643451|NCT01427738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25643452|NCT01427738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25643453|NCT01427738|Antifungal Agents|antifungal agents|mesh-ancestor
25643454|NCT01427738|Ionophores|ionophores|mesh-ancestor
25643455|NCT01427738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25643456|NCT01427738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643457|NCT01427738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25643458|NCT01427751|Dexamethasone|dexamethasone|mesh-list
25643459|NCT01427751|Ranibizumab|ranibizumab|mesh-list
25643460|NCT01427751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25643461|NCT01427751|Antiemetics|antiemetics|mesh-ancestor
25643462|NCT01427751|Autonomic Agents|autonomic agents|mesh-ancestor
25643463|NCT01427751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25643464|NCT01427751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643465|NCT01427751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25643466|NCT01427751|Glucocorticoids|glucocorticoids|mesh-ancestor
25643467|NCT01427751|Hormones|hormones|mesh-ancestor
25643468|NCT01427751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25643469|NCT01427751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25643470|NCT01427751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25643471|NCT01427751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25643472|NCT01427751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25643473|NCT01427751|Growth Substances|growth substances|mesh-ancestor
25643474|NCT01427751|Growth Inhibitors|growth inhibitors|mesh-ancestor
25643476|NCT01427803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25643477|NCT01427803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25643478|NCT01427803|Analgesics|analgesics|mesh-ancestor
25643479|NCT01427803|Sensory System Agents|sensory system agents|mesh-ancestor
25643480|NCT01427803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25643481|NCT01427803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643482|NCT01427803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25643483|NCT01427803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25643484|NCT01427803|Gout Suppressants|gout suppressants|mesh-ancestor
25643485|NCT01427803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25643486|NCT01427803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25643487|NCT01427803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434860|NCT04784039|Fibrin fragment D|fibrin fragment d|mesh-list
25434861|NCT04784039|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25434862|NCT04784039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25434863|NCT04784039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434864|NCT04784039|Hemostatics|hemostatics|mesh-ancestor
25434865|NCT04784039|Coagulants|coagulants|mesh-ancestor
25434866|NCT04784104|Epinephrine|epinephrine|mesh-list
25434867|NCT04784104|Racepinephrine|racepinephrine|mesh-list
25434868|NCT04784104|Bupivacaine|bupivacaine|mesh-list
25434869|NCT04784104|Prilocaine|prilocaine|mesh-list
25434870|NCT04784104|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25434871|NCT04784104|Epinephryl borate|epinephryl borate|mesh-list
25434872|NCT04784104|Anesthetics, Local|anesthetics, local|mesh-ancestor
25434873|NCT04784104|Anesthetics|anesthetics|mesh-ancestor
25434874|NCT04784104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25434875|NCT04784104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434876|NCT04784104|Sensory System Agents|sensory system agents|mesh-ancestor
25434877|NCT04784104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25434878|NCT04784104|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25434879|NCT04784104|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25434880|NCT04784104|Adrenergic Agents|adrenergic agents|mesh-ancestor
25434881|NCT04784104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25434882|NCT04784104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434883|NCT04784104|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25434884|NCT04784104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25434885|NCT04784104|Autonomic Agents|autonomic agents|mesh-ancestor
25434886|NCT04784104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25434887|NCT04784104|Respiratory System Agents|respiratory system agents|mesh-ancestor
25434888|NCT04784104|Mydriatics|mydriatics|mesh-ancestor
25434889|NCT04784104|Sympathomimetics|sympathomimetics|mesh-ancestor
25434890|NCT04784104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25434891|NCT04784000|Carbamazepine|carbamazepine|mesh-list
25434892|NCT04784000|Anticonvulsants|anticonvulsants|mesh-ancestor
25434893|NCT04784000|Antimanic Agents|antimanic agents|mesh-ancestor
25434894|NCT04784000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25434895|NCT04784000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25434896|NCT04784000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434897|NCT04784000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25434898|NCT04784000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25434899|NCT04784000|Analgesics|analgesics|mesh-ancestor
25434900|NCT04784000|Sensory System Agents|sensory system agents|mesh-ancestor
25434901|NCT04784000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25434902|NCT04784000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25434903|NCT04784000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25434904|NCT04784000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434905|NCT04784000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25434906|NCT04784000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25434907|NCT04783870|Dapagliflozin|dapagliflozin|mesh-list
25434908|NCT04783870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25434909|NCT04783870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434910|NCT04783870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25434911|NCT04783870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434912|NCT04783935|Cladribine|cladribine|mesh-list
25434913|NCT04783935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434914|NCT04783935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25434915|NCT04783935|Immunologic Factors|immunologic factors|mesh-ancestor
25434916|NCT04783935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434917|NCT04783753|Itraconazole|itraconazole|mesh-list
25643488|NCT01427881|Cyclosporine|cyclosporine|mesh-list
25434918|NCT04783753|Quinidine|quinidine|mesh-list
25434919|NCT04783753|Carbamazepine|carbamazepine|mesh-list
25434920|NCT04783753|Antifungal Agents|antifungal agents|mesh-ancestor
25434921|NCT04783753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25434922|NCT04783753|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25434923|NCT04783753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25434924|NCT04783753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25434925|NCT04783753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434926|NCT04783753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25434927|NCT04783753|Hormone Antagonists|hormone antagonists|mesh-ancestor
25434928|NCT04783753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25434929|NCT04783753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434930|NCT04783753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25434931|NCT04783753|Anticonvulsants|anticonvulsants|mesh-ancestor
25822752|NCT00004643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822753|NCT00004643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434933|NCT04783753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25434934|NCT04783753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25434935|NCT04783753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25434936|NCT04783753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25434937|NCT04783753|Analgesics|analgesics|mesh-ancestor
25434938|NCT04783753|Sensory System Agents|sensory system agents|mesh-ancestor
25434939|NCT04783753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25434940|NCT04783753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25434941|NCT04783753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25434942|NCT04783753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25434943|NCT04783753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25434944|NCT04783753|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25434945|NCT04783753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25434946|NCT04783753|Adrenergic Agents|adrenergic agents|mesh-ancestor
25434947|NCT04783753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25434948|NCT04783753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25434949|NCT04783753|Antimalarials|antimalarials|mesh-ancestor
25434950|NCT04783753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25434951|NCT04783753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25434952|NCT04783753|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25434953|NCT04783753|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25434954|NCT04783753|Cholinergic Agents|cholinergic agents|mesh-ancestor
25434955|NCT04783753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25434956|NCT04783753|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25434957|NCT04783636|Leuprolide|leuprolide|mesh-list
25434958|NCT04783636|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25434959|NCT04783636|Fertility Agents|fertility agents|mesh-ancestor
25434960|NCT04783636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25434961|NCT04783636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434962|NCT04783636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25434963|NCT04783636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434964|NCT04783610|Ethanol|ethanol|mesh-list
25434965|NCT04783610|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25434966|NCT04783610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25434967|NCT04783610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25434968|NCT04783610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434969|NCT04782622|Apatinib|apatinib|mesh-list
25434970|NCT04782622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25434971|NCT04782622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25434972|NCT04782622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25434973|NCT04782622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434974|NCT04782960|Bupivacaine|bupivacaine|mesh-list
25434975|NCT04782960|Anesthetics|anesthetics|mesh-list
25434976|NCT04782960|Anesthetics, Local|anesthetics, local|mesh-ancestor
25434977|NCT04782960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25434978|NCT04782960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434979|NCT04782960|Sensory System Agents|sensory system agents|mesh-ancestor
25434980|NCT04782960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25434981|NCT04782388|Alprazolam|alprazolam|mesh-list
25434982|NCT04782388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25434983|NCT04782388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25434984|NCT04782388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25434985|NCT04782388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25434986|NCT04782388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25434987|NCT04782388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25434988|NCT04782388|GABA Modulators|gaba modulators|mesh-ancestor
25643489|NCT01427881|Cyclophosphamide|cyclophosphamide|mesh-list
25434990|NCT04782388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25434991|NCT04782388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434992|NCT04782076|Dabigatran|dabigatran|mesh-list
25434993|NCT04782076|Antithrombins|antithrombins|mesh-ancestor
25434994|NCT04782076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25434995|NCT04782076|Protease Inhibitors|protease inhibitors|mesh-ancestor
25434996|NCT04782076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25434997|NCT04782076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434998|NCT04782076|Anticoagulants|anticoagulants|mesh-ancestor
25434999|NCT04782089|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25435000|NCT04782089|Antibodies|antibodies|mesh-list
25435001|NCT04782089|Immunologic Factors|immunologic factors|mesh-ancestor
25435002|NCT04782089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435003|NCT04782089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25719311|NCT02447991|Serotonin Agents|serotonin agents|mesh-ancestor
25435004|NCT04782089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978865|NCT02652468|Alkylating Agents|alkylating agents|mesh-ancestor
25435008|NCT04782115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25435009|NCT04782115|Growth Substances|growth substances|mesh-ancestor
25435010|NCT04782115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435011|NCT04782115|Growth Inhibitors|growth inhibitors|mesh-ancestor
25435012|NCT04782115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25435013|NCT04782128|RC28-E protein|rc28-e protein|mesh-list
25435014|NCT04782128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25435015|NCT04782128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25435016|NCT04782128|Growth Substances|growth substances|mesh-ancestor
25435017|NCT04782128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435018|NCT04782128|Growth Inhibitors|growth inhibitors|mesh-ancestor
25435019|NCT04782128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25435020|NCT04782310|Pregabalin|pregabalin|mesh-list
25435021|NCT04782310|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25435022|NCT04782310|Analgesics|analgesics|mesh-ancestor
25435023|NCT04782310|Sensory System Agents|sensory system agents|mesh-ancestor
25435024|NCT04782310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25435025|NCT04782310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435026|NCT04782310|Anticonvulsants|anticonvulsants|mesh-ancestor
25435027|NCT04782310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25435028|NCT04782310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25435029|NCT04782310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435030|NCT04782310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25435031|NCT04782310|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25435032|NCT04782310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25435033|NCT04782310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25435034|NCT04782310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25435035|NCT04782310|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25435036|NCT04782310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25435037|NCT04782310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25435038|NCT04782310|Antidepressive Agents|antidepressive agents|mesh-ancestor
25435039|NCT04782310|Dopamine Agents|dopamine agents|mesh-ancestor
25435040|NCT04781998|Liraglutide|liraglutide|mesh-list
25435041|NCT04781998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25435042|NCT04781998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435043|NCT04781998|Incretins|incretins|mesh-ancestor
25435044|NCT04781998|Hormones|hormones|mesh-ancestor
25435045|NCT04781998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25435046|NCT04781803|Cyclosporine|cyclosporine|mesh-list
25435047|NCT04781803|Cyclosporins|cyclosporins|mesh-list
25435048|NCT04781803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25435049|NCT04781803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435050|NCT04781803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25435051|NCT04781803|Immunologic Factors|immunologic factors|mesh-ancestor
25435052|NCT04781803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435053|NCT04781803|Antifungal Agents|antifungal agents|mesh-ancestor
25435054|NCT04781803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25435055|NCT04781803|Dermatologic Agents|dermatologic agents|mesh-ancestor
25435056|NCT04781803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25435057|NCT04781803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25435058|NCT04781686|Docetaxel|docetaxel|mesh-list
25435059|NCT04781686|Apatinib|apatinib|mesh-list
25435060|NCT04781686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25435061|NCT04781686|Tubulin Modulators|tubulin modulators|mesh-ancestor
25435062|NCT04781686|Antimitotic Agents|antimitotic agents|mesh-ancestor
25435063|NCT04781686|Mitosis Modulators|mitosis modulators|mesh-ancestor
25435064|NCT04781686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822754|NCT00004643|Antiviral Agents|antiviral agents|mesh-ancestor
25643490|NCT01427881|Busulfan|busulfan|mesh-list
25435065|NCT04781686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25435066|NCT04781686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25435067|NCT04781777|Insulin|insulin|mesh-list
25435068|NCT04781777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25435069|NCT04781777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435070|NCT04781751|Insulin|insulin|mesh-list
25435071|NCT04781751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25435072|NCT04781751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979247|NCT05064332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24979248|NCT05064332|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24979249|NCT05034029|Metformin|metformin|mesh-list
24979250|NCT05034029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25043498|NCT01253603|Xhance|xhance|mesh-list
25435073|NCT04781270|Bevacizumab|bevacizumab|mesh-list
25435074|NCT04781270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25435075|NCT04781270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25435076|NCT04781270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25435077|NCT04781270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25435078|NCT04781270|Growth Substances|growth substances|mesh-ancestor
25435079|NCT04781270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435080|NCT04781270|Growth Inhibitors|growth inhibitors|mesh-ancestor
25435081|NCT04781439|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25435082|NCT04781439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25435083|NCT04781075|Bupivacaine|bupivacaine|mesh-list
25435084|NCT04781075|Anesthetics, Local|anesthetics, local|mesh-ancestor
25435085|NCT04781075|Anesthetics|anesthetics|mesh-ancestor
25435086|NCT04781075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25435087|NCT04781075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435088|NCT04781075|Sensory System Agents|sensory system agents|mesh-ancestor
25435089|NCT04781075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25435090|NCT04781335|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25435091|NCT04781335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25435092|NCT04781335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25435093|NCT04781335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25435094|NCT04780945|Olaparib|olaparib|mesh-list
25435095|NCT04780945|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25435096|NCT04780945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25435097|NCT04780945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435098|NCT04780945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25435099|NCT04780659|Vaccines|vaccines|mesh-list
25435100|NCT04780659|Immunologic Factors|immunologic factors|mesh-ancestor
25435101|NCT04780659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435102|NCT04780750|Docetaxel|docetaxel|mesh-list
25435103|NCT04780750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25435104|NCT04780750|Tubulin Modulators|tubulin modulators|mesh-ancestor
25435105|NCT04780750|Antimitotic Agents|antimitotic agents|mesh-ancestor
25435106|NCT04780750|Mitosis Modulators|mitosis modulators|mesh-ancestor
25435107|NCT04780750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435108|NCT04780854|Metformin|metformin|mesh-list
25435109|NCT04780854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25435110|NCT04780854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435111|NCT04780958|Vitamin A|vitamin a|mesh-list
25435112|NCT04780958|Vitamins|vitamins|mesh-ancestor
25435113|NCT04780958|Micronutrients|micronutrients|mesh-ancestor
25435114|NCT04780958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435115|NCT04780984|Bromides|bromides|mesh-list
25435116|NCT04780984|Tiotropium Bromide|tiotropium bromide|mesh-list
25435117|NCT04780984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25435118|NCT04780984|Autonomic Agents|autonomic agents|mesh-ancestor
25435119|NCT04780984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25435120|NCT04780984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435121|NCT04780984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25435122|NCT04780984|Respiratory System Agents|respiratory system agents|mesh-ancestor
25435123|NCT04780984|Parasympatholytics|parasympatholytics|mesh-ancestor
25435124|NCT04780984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25435125|NCT04780984|Cholinergic Agents|cholinergic agents|mesh-ancestor
25435126|NCT04780984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25435127|NCT04780984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435128|NCT04780984|Anticonvulsants|anticonvulsants|mesh-ancestor
25435129|NCT04780412|Alprostadil|alprostadil|mesh-list
25435130|NCT04780412|Misoprostol|misoprostol|mesh-list
25435131|NCT04780412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25435132|NCT04780412|Abortifacient Agents|abortifacient agents|mesh-ancestor
25435133|NCT04780412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25643491|NCT01427881|Fludarabine|fludarabine|mesh-list
25643492|NCT01427881|Fludarabine phosphate|fludarabine phosphate|mesh-list
25643494|NCT01427881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25643495|NCT01427881|Immunologic Factors|immunologic factors|mesh-ancestor
25643496|NCT01427881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435134|NCT04780412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435135|NCT04780412|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25435136|NCT04780412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25435137|NCT04780412|Oxytocics|oxytocics|mesh-ancestor
25435138|NCT04780412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25435139|NCT04780412|Vasodilator Agents|vasodilator agents|mesh-ancestor
25435140|NCT04780412|Urological Agents|urological agents|mesh-ancestor
25041000|NCT02700529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438126|NCT00275041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438127|NCT00275041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438128|NCT00275041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980018|NCT04724447|Antiviral Agents|antiviral agents|mesh-ancestor
24439111|NCT00277589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439113|NCT00277602|Anticonvulsants|anticonvulsants|mesh-ancestor
25435143|NCT04780347|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25435144|NCT04780347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25435145|NCT04780347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25435146|NCT04780347|Tubulin Modulators|tubulin modulators|mesh-ancestor
25435147|NCT04780347|Antimitotic Agents|antimitotic agents|mesh-ancestor
25435148|NCT04780347|Mitosis Modulators|mitosis modulators|mesh-ancestor
25435149|NCT04780347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435150|NCT04780347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25435151|NCT04780347|Antimetabolites|antimetabolites|mesh-ancestor
25435152|NCT04780438|Dapagliflozin|dapagliflozin|mesh-list
25435153|NCT04780438|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25435154|NCT04780438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435155|NCT04780438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25435156|NCT04780438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435157|NCT04780217|Pembrolizumab|pembrolizumab|mesh-list
25435158|NCT04780217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25435159|NCT04780217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25435160|NCT04779853|Antibodies|antibodies|mesh-list
25435161|NCT04779853|Immunologic Factors|immunologic factors|mesh-ancestor
25435162|NCT04779853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435163|NCT04779892|Infliximab|infliximab|mesh-list
25435164|NCT04779892|Dermatologic Agents|dermatologic agents|mesh-ancestor
25435165|NCT04779892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25435166|NCT04779892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25435167|NCT04780152|Fluoxetine|fluoxetine|mesh-list
25435168|NCT04780152|Antidepressive Agents|antidepressive agents|mesh-list
25435169|NCT04780152|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25435170|NCT04780152|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25435171|NCT04780152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25435172|NCT04780152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435173|NCT04780152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25435174|NCT04780152|Serotonin Agents|serotonin agents|mesh-ancestor
25435175|NCT04780152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435176|NCT04780152|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25435177|NCT04780152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25435178|NCT04780152|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25435179|NCT04780152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25435180|NCT04780152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25435181|NCT04779762|Ustekinumab|ustekinumab|mesh-list
25435182|NCT04779762|Dermatologic Agents|dermatologic agents|mesh-ancestor
25435183|NCT04779645|Volagidemab|volagidemab|mesh-list
25435184|NCT04779645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25435185|NCT04779645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435186|NCT04779255|Acetaminophen|acetaminophen|mesh-list
25435187|NCT04779255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435188|NCT04779255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25435189|NCT04779255|Analgesics|analgesics|mesh-ancestor
25435190|NCT04779255|Sensory System Agents|sensory system agents|mesh-ancestor
25435191|NCT04779255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25435192|NCT04779255|Antipyretics|antipyretics|mesh-ancestor
25435193|NCT04779567|Acetaminophen|acetaminophen|mesh-list
25435194|NCT04779567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25435195|NCT04779567|Analgesics|analgesics|mesh-ancestor
25435196|NCT04779567|Sensory System Agents|sensory system agents|mesh-ancestor
25435197|NCT04779567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25643497|NCT01427881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25435198|NCT04779567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435199|NCT04779567|Antipyretics|antipyretics|mesh-ancestor
25435200|NCT04779502|Chlorhexidine|chlorhexidine|mesh-list
25435201|NCT04779502|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25435202|NCT04779502|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25435203|NCT04779502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25435204|NCT04779502|Disinfectants|disinfectants|mesh-ancestor
25435205|NCT04779502|Dermatologic Agents|dermatologic agents|mesh-ancestor
25435206|NCT04779580|Anesthetics|anesthetics|mesh-list
25435207|NCT04779580|Anesthetics, Local|anesthetics, local|mesh-list
25435208|NCT04779580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25435209|NCT04779580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435210|NCT04779580|Sensory System Agents|sensory system agents|mesh-ancestor
25435211|NCT04779580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25822756|NCT00004643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25822757|NCT00004643|Immunologic Factors|immunologic factors|mesh-ancestor
25435212|NCT04779060|Dexamethasone|dexamethasone|mesh-list
25435213|NCT04779060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25435214|NCT04779060|Antiemetics|antiemetics|mesh-ancestor
25435215|NCT04779060|Autonomic Agents|autonomic agents|mesh-ancestor
25435216|NCT04779060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25435217|NCT04779060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435218|NCT04779060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25435219|NCT04779060|Glucocorticoids|glucocorticoids|mesh-ancestor
25435220|NCT04779060|Hormones|hormones|mesh-ancestor
25435221|NCT04779060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25435222|NCT04779060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25435223|NCT04779060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25435224|NCT04778917|Heparin|heparin|mesh-list
25435225|NCT04778917|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25435226|NCT04778917|Tinzaparin|tinzaparin|mesh-list
25435227|NCT04778917|Dalteparin|dalteparin|mesh-list
25435228|NCT04778917|Calcium heparin|calcium heparin|mesh-list
25435229|NCT04778917|Calcium|calcium|mesh-list
25435230|NCT04778917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25435231|NCT04778917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435232|NCT04778917|Anticoagulants|anticoagulants|mesh-ancestor
25435233|NCT04778917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25435234|NCT04778917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25435235|NCT04778917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435236|NCT04778865|Vitamin D|vitamin d|mesh-list
25435237|NCT04778865|Ergocalciferols|ergocalciferols|mesh-list
25435238|NCT04778865|Cholecalciferol|cholecalciferol|mesh-list
25435239|NCT04778865|Vitamins|vitamins|mesh-list
25435240|NCT04778865|Micronutrients|micronutrients|mesh-ancestor
25435241|NCT04778865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435242|NCT04778865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25435243|NCT04778865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25435244|NCT04778839|Paclitaxel|paclitaxel|mesh-list
25435245|NCT04778839|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25435246|NCT04778839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25435247|NCT04778839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25435248|NCT04778839|Tubulin Modulators|tubulin modulators|mesh-ancestor
25435249|NCT04778839|Antimitotic Agents|antimitotic agents|mesh-ancestor
25435250|NCT04778839|Mitosis Modulators|mitosis modulators|mesh-ancestor
25435251|NCT04778839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435252|NCT04778813|Artesunate|artesunate|mesh-list
25435253|NCT04778813|Lumefantrine|lumefantrine|mesh-list
25435254|NCT04778813|Artemether|artemether|mesh-list
25435255|NCT04778813|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25435256|NCT04778813|Artenimol|artenimol|mesh-list
25435257|NCT04778813|Pyronaridine|pyronaridine|mesh-list
25435258|NCT04778813|Antimalarials|antimalarials|mesh-ancestor
25435259|NCT04778813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25435260|NCT04778813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25435261|NCT04778813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25435262|NCT04778813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25435263|NCT04778813|Antiviral Agents|antiviral agents|mesh-ancestor
25435264|NCT04778813|Schistosomicides|schistosomicides|mesh-ancestor
25435265|NCT04778813|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25435266|NCT04778813|Anthelmintics|anthelmintics|mesh-ancestor
25435267|NCT04779047|Ritonavir|ritonavir|mesh-list
25435268|NCT04779047|Lopinavir|lopinavir|mesh-list
25435269|NCT04779047|Hydroxychloroquine|hydroxychloroquine|mesh-list
25435270|NCT04779047|Ivermectin|ivermectin|mesh-list
25435271|NCT04779047|Remdesivir|remdesivir|mesh-list
25435272|NCT04779047|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25404096|NCT03684980|Micronutrients|micronutrients|mesh-ancestor
25643498|NCT01427881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25643499|NCT01427881|Alkylating Agents|alkylating agents|mesh-ancestor
25643500|NCT01427881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643501|NCT01427881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25643502|NCT01427881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25643503|NCT01427881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25643504|NCT01427881|Antimetabolites|antimetabolites|mesh-ancestor
25435273|NCT04779047|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25435274|NCT04779047|Protease Inhibitors|protease inhibitors|mesh-ancestor
25435275|NCT04779047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25435276|NCT04779047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435277|NCT04779047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25435278|NCT04779047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25435279|NCT04779047|Antiviral Agents|antiviral agents|mesh-ancestor
24981045|NCT04521114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24981046|NCT04521114|Antiviral Agents|antiviral agents|mesh-ancestor
25822758|NCT00004643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822759|NCT00004644|Acyclovir|acyclovir|mesh-list
25822760|NCT00004644|Antiviral Agents|antiviral agents|mesh-ancestor
25822761|NCT00004644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25822762|NCT00004646|Prednisone|prednisone|mesh-list
25822763|NCT00004646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25822764|NCT00004646|Glucocorticoids|glucocorticoids|mesh-ancestor
25822765|NCT00004646|Hormones|hormones|mesh-ancestor
25822766|NCT00004646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25435280|NCT04779047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25435281|NCT04779047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25435282|NCT04779047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25435283|NCT04779047|Antimalarials|antimalarials|mesh-ancestor
25435284|NCT04779047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25435285|NCT04779047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25435286|NCT04779047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25435287|NCT04779047|Antimetabolites|antimetabolites|mesh-ancestor
25435288|NCT04778514|Contraceptive Agents|contraceptive agents|mesh-list
25435289|NCT04778514|Contraceptives, Oral|contraceptives, oral|mesh-list
25435290|NCT04778514|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25435291|NCT04778514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25435292|NCT04778514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435293|NCT04778514|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25435294|NCT04778072|Iron|iron|mesh-list
25435295|NCT04778072|Trace Elements|trace elements|mesh-ancestor
25435296|NCT04778072|Micronutrients|micronutrients|mesh-ancestor
25435297|NCT04778072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435298|NCT04778137|Omalizumab|omalizumab|mesh-list
25435299|NCT04778137|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25435300|NCT04778137|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25435301|NCT04778137|Respiratory System Agents|respiratory system agents|mesh-ancestor
25435302|NCT04777968|Fluorides|fluorides|mesh-list
25435303|NCT04777968|Cariostatic Agents|cariostatic agents|mesh-ancestor
25435304|NCT04777968|Protective Agents|protective agents|mesh-ancestor
25435305|NCT04777968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435306|NCT04777929|Progesterone|progesterone|mesh-list
25435307|NCT04777929|Estrogens|estrogens|mesh-list
25435308|NCT04777929|Progestins|progestins|mesh-ancestor
25435309|NCT04777929|Hormones|hormones|mesh-ancestor
25435310|NCT04777929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25435311|NCT04777929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435312|NCT04777760|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25435313|NCT04777760|Respiratory System Agents|respiratory system agents|mesh-ancestor
25435314|NCT04777383|Atropine|atropine|mesh-list
25435315|NCT04777383|Phenylephrine|phenylephrine|mesh-list
25435316|NCT04777383|Oxymetazoline|oxymetazoline|mesh-list
25435317|NCT04777383|Norepinephrine|norepinephrine|mesh-list
25435318|NCT04777383|Acetylcholine|acetylcholine|mesh-list
25435319|NCT04777383|Neostigmine|neostigmine|mesh-list
25435320|NCT04777383|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25435321|NCT04777383|Mydriatics|mydriatics|mesh-ancestor
25435322|NCT04777383|Autonomic Agents|autonomic agents|mesh-ancestor
25435323|NCT04777383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25435324|NCT04777383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435325|NCT04777383|Sympathomimetics|sympathomimetics|mesh-ancestor
25435326|NCT04777383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25435327|NCT04777383|Nasal Decongestants|nasal decongestants|mesh-ancestor
25435328|NCT04777383|Respiratory System Agents|respiratory system agents|mesh-ancestor
25435329|NCT04777383|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25435330|NCT04777383|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25435331|NCT04777383|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25435332|NCT04777383|Adrenergic Agents|adrenergic agents|mesh-ancestor
25435333|NCT04777383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25435334|NCT04777383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435335|NCT04777383|Protective Agents|protective agents|mesh-ancestor
25435336|NCT04777383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25435337|NCT04777383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25435338|NCT04777383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25435339|NCT04777383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25435340|NCT04777383|Parasympatholytics|parasympatholytics|mesh-ancestor
25435341|NCT04777383|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25435342|NCT04777383|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25435343|NCT04777383|Cholinergic Agents|cholinergic agents|mesh-ancestor
25435344|NCT04777383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25435345|NCT04777383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25435346|NCT04777383|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25435347|NCT04777383|Vasodilator Agents|vasodilator agents|mesh-ancestor
25435348|NCT04777383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25435349|NCT04777838|Amitriptyline|amitriptyline|mesh-list
25822767|NCT00004646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822768|NCT00004646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25822769|NCT00004646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25822770|NCT00004647|Mexiletine|mexiletine|mesh-list
25822771|NCT00004647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25822772|NCT00004647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25822773|NCT00004647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25047747|NCT00765804|Hormones|hormones|mesh-ancestor
25435350|NCT04777838|Citalopram|citalopram|mesh-list
25435351|NCT04777838|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25435352|NCT04777838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25435353|NCT04777838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25435354|NCT04777838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435355|NCT04777838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25435356|NCT04777838|Serotonin Agents|serotonin agents|mesh-ancestor
25435357|NCT04777838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435358|NCT04777838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25435359|NCT04777838|Antidepressive Agents|antidepressive agents|mesh-ancestor
25435360|NCT04777838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25435361|NCT04777838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25435362|NCT04777838|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25435363|NCT04777838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25435364|NCT04777838|Analgesics|analgesics|mesh-ancestor
25435365|NCT04777838|Sensory System Agents|sensory system agents|mesh-ancestor
25435366|NCT04777838|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25435367|NCT04777838|Adrenergic Agents|adrenergic agents|mesh-ancestor
25435368|NCT04777552|Diazepam|diazepam|mesh-list
25435369|NCT04777552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25435370|NCT04777552|Anticonvulsants|anticonvulsants|mesh-ancestor
25435371|NCT04777552|Antiemetics|antiemetics|mesh-ancestor
25435372|NCT04777552|Autonomic Agents|autonomic agents|mesh-ancestor
25435373|NCT04777552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25435374|NCT04777552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435375|NCT04777552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25435376|NCT04777552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25435377|NCT04777552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25435378|NCT04777552|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25435379|NCT04777552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25435380|NCT04777552|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25435381|NCT04777552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25435382|NCT04777552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25435383|NCT04777552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25435384|NCT04777552|Anesthetics, General|anesthetics, general|mesh-ancestor
25435385|NCT04777552|Anesthetics|anesthetics|mesh-ancestor
25435386|NCT04777552|GABA Modulators|gaba modulators|mesh-ancestor
25435387|NCT04777552|GABA Agents|gaba agents|mesh-ancestor
25435388|NCT04777552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25435389|NCT04777552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435390|NCT04777591|Bupivacaine|bupivacaine|mesh-list
25435391|NCT04777591|Anesthetics, Local|anesthetics, local|mesh-ancestor
25435392|NCT04777591|Anesthetics|anesthetics|mesh-ancestor
25435393|NCT04777591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25435394|NCT04777591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435395|NCT04777591|Sensory System Agents|sensory system agents|mesh-ancestor
25435396|NCT04777591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25435397|NCT04777045|Diltiazem|diltiazem|mesh-list
25435398|NCT04777045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25435399|NCT04777045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25404097|NCT03684811|Gemcitabine|gemcitabine|mesh-list
25435400|NCT04777045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25435401|NCT04777045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435402|NCT04777045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25435403|NCT04777045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435404|NCT04777045|Vasodilator Agents|vasodilator agents|mesh-ancestor
25435405|NCT04777227|Lidocaine|lidocaine|mesh-list
25435406|NCT04777227|Anesthetics, Local|anesthetics, local|mesh-ancestor
25435407|NCT04777227|Anesthetics|anesthetics|mesh-ancestor
25435408|NCT04777227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25435409|NCT04777227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435410|NCT04777227|Sensory System Agents|sensory system agents|mesh-ancestor
25435411|NCT04777227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25435412|NCT04777227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25435413|NCT04777227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25435414|NCT04777227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25435415|NCT04777227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25435416|NCT04777227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982681|NCT00739674|Losartan|losartan|mesh-list
24982682|NCT00739674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24982683|NCT00739674|Calcium Channel Blockers|calcium channel blockers|mesh-list
24982753|NCT00449111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24982754|NCT00449111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24982756|NCT00406783|Desloratadine|desloratadine|mesh-list
25822774|NCT00004647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25435439|NCT04776655|Bevacizumab|bevacizumab|mesh-list
25435440|NCT04776655|Cetuximab|cetuximab|mesh-list
25435441|NCT04776655|Fluorouracil|fluorouracil|mesh-list
25435442|NCT04776655|Irinotecan|irinotecan|mesh-list
25435443|NCT04776655|Calcium|calcium|mesh-list
25435444|NCT04776655|Levoleucovorin|levoleucovorin|mesh-list
25435445|NCT04776655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25435446|NCT04776655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25435447|NCT04776655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25435448|NCT04776655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25435449|NCT04776655|Growth Substances|growth substances|mesh-ancestor
25435450|NCT04776655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435451|NCT04776655|Growth Inhibitors|growth inhibitors|mesh-ancestor
25435452|NCT04776655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25435453|NCT04776655|Antimetabolites|antimetabolites|mesh-ancestor
25435454|NCT04776655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435455|NCT04776655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25435456|NCT04776655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25435457|NCT04776655|Immunologic Factors|immunologic factors|mesh-ancestor
25435458|NCT04776655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25435459|NCT04776655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25435460|NCT04776655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25435461|NCT04776655|Antidotes|antidotes|mesh-ancestor
25435462|NCT04776655|Protective Agents|protective agents|mesh-ancestor
25435463|NCT04776655|Vitamin B Complex|vitamin b complex|mesh-ancestor
25435464|NCT04776655|Vitamins|vitamins|mesh-ancestor
25435465|NCT04776655|Micronutrients|micronutrients|mesh-ancestor
25435466|NCT04776135|Edaravone|edaravone|mesh-list
25435467|NCT04776135|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25435468|NCT04776135|Antioxidants|antioxidants|mesh-ancestor
25435469|NCT04776135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435470|NCT04776135|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25435471|NCT04776135|Protective Agents|protective agents|mesh-ancestor
25435472|NCT04776135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435473|NCT04776226|Citalopram|citalopram|mesh-list
25435474|NCT04776226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25435475|NCT04776226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25435476|NCT04776226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25435477|NCT04776226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435478|NCT04776226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25435479|NCT04776226|Serotonin Agents|serotonin agents|mesh-ancestor
25435480|NCT04776226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435481|NCT04776226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25435482|NCT04776226|Antidepressive Agents|antidepressive agents|mesh-ancestor
25435483|NCT04776226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25435484|NCT04776096|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25435485|NCT04776096|Bepotastine besilate|bepotastine besilate|mesh-list
25435486|NCT04776096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25435487|NCT04776096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25435488|NCT04776096|Analgesics|analgesics|mesh-ancestor
25435489|NCT04776096|Sensory System Agents|sensory system agents|mesh-ancestor
25435490|NCT04776096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25435491|NCT04776096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435492|NCT04776096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25435493|NCT04776096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25435494|NCT04776096|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25435495|NCT04776096|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25435496|NCT04776096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25435497|NCT04776096|Histamine Antagonists|histamine antagonists|mesh-ancestor
25435498|NCT04776096|Histamine Agents|histamine agents|mesh-ancestor
25435499|NCT04776096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25435500|NCT04776096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435501|NCT04775797|Tenofovir|tenofovir|mesh-list
25435502|NCT04775797|Antiviral Agents|antiviral agents|mesh-ancestor
25435503|NCT04775797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25435504|NCT04775797|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25435505|NCT04775797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24847901|NCT05353010|Tacrolimus|tacrolimus|mesh-list
25106748|NCT03145025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25106750|NCT03145025|Hormones|hormones|mesh-ancestor
25106751|NCT03145025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25106752|NCT03145025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106753|NCT03144947|Docetaxel|docetaxel|mesh-list
25106754|NCT03144947|Trastuzumab|trastuzumab|mesh-list
25435506|NCT04775797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25435507|NCT04775797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435508|NCT04775797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25435509|NCT04775797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25435510|NCT04775732|Infliximab|infliximab|mesh-list
25435511|NCT04775732|Dermatologic Agents|dermatologic agents|mesh-ancestor
25435512|NCT04775732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25435513|NCT04775732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25435514|NCT04775563|Vaccines|vaccines|mesh-list
25435515|NCT04775563|Immunologic Factors|immunologic factors|mesh-ancestor
25435516|NCT04775563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435517|NCT04775303|Cyclosporine|cyclosporine|mesh-list
25435518|NCT04775303|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25435519|NCT04775303|Cyclosporins|cyclosporins|mesh-list
25435520|NCT04775303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25435521|NCT04775303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435522|NCT04775303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25435523|NCT04775303|Immunologic Factors|immunologic factors|mesh-ancestor
25435524|NCT04775303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435525|NCT04775303|Antifungal Agents|antifungal agents|mesh-ancestor
25435526|NCT04775303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25435527|NCT04775303|Dermatologic Agents|dermatologic agents|mesh-ancestor
25435528|NCT04775303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25435529|NCT04775303|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25435530|NCT04775303|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25435531|NCT04775576|Anesthetics|anesthetics|mesh-list
25435532|NCT04775576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25435533|NCT04775576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435534|NCT04775459|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25435535|NCT04775459|Respiratory System Agents|respiratory system agents|mesh-ancestor
25435536|NCT04775212|Sevoflurane|sevoflurane|mesh-list
25435537|NCT04775212|Desflurane|desflurane|mesh-list
25435538|NCT04775212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25435539|NCT04775212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25435540|NCT04775212|Anesthetics, General|anesthetics, general|mesh-ancestor
25435541|NCT04775212|Anesthetics|anesthetics|mesh-ancestor
25435542|NCT04775212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25435543|NCT04775212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435544|NCT04775238|Copper|copper|mesh-list
25435545|NCT04775238|Trace Elements|trace elements|mesh-ancestor
25435546|NCT04775238|Micronutrients|micronutrients|mesh-ancestor
25435547|NCT04775238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435548|NCT04774822|Mydriatics|mydriatics|mesh-list
25435549|NCT04774822|Autonomic Agents|autonomic agents|mesh-ancestor
25435550|NCT04774822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25435551|NCT04774822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435552|NCT04775030|Salicylic Acid|salicylic acid|mesh-list
25435553|NCT04775030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25435554|NCT04775030|Antifungal Agents|antifungal agents|mesh-ancestor
25435555|NCT04775030|Keratolytic Agents|keratolytic agents|mesh-ancestor
25435556|NCT04775030|Dermatologic Agents|dermatologic agents|mesh-ancestor
25435557|NCT04774627|Olaparib|olaparib|mesh-list
25435558|NCT04774627|Niraparib|niraparib|mesh-list
25435559|NCT04774627|Veliparib|veliparib|mesh-list
25643507|NCT01427881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25643509|NCT01427881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25435560|NCT04774627|Talazoparib|talazoparib|mesh-list
25435561|NCT04774627|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25435562|NCT04774627|Rucaparib|rucaparib|mesh-list
25435563|NCT04774627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25435564|NCT04774627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435565|NCT04774627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25435566|NCT04775329|Rifaximin|rifaximin|mesh-list
25435567|NCT04775329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25435568|NCT04775329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25435569|NCT04775329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25435570|NCT04774029|Lidocaine|lidocaine|mesh-list
25435571|NCT04774029|Anesthetics, Local|anesthetics, local|mesh-ancestor
25435572|NCT04774029|Anesthetics|anesthetics|mesh-ancestor
25000840|NCT02906332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25000841|NCT02906332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000842|NCT02906332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25000843|NCT02906332|Glucocorticoids|glucocorticoids|mesh-ancestor
25000844|NCT02906332|Hormones|hormones|mesh-ancestor
25000845|NCT02906332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25000846|NCT02906332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24490514|NCT00478699|Antimetabolites|antimetabolites|mesh-ancestor
24985009|NCT03772951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24985010|NCT03772951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24985013|NCT03753087|Empagliflozin|empagliflozin|mesh-list
25435583|NCT04773756|Antiviral Agents|antiviral agents|mesh-ancestor
25435584|NCT04773756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25435585|NCT04773951|Antibodies|antibodies|mesh-list
25435586|NCT04773951|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25435587|NCT04773951|Immunologic Factors|immunologic factors|mesh-ancestor
25435588|NCT04773951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435589|NCT04773873|Lithium Carbonate|lithium carbonate|mesh-list
25435590|NCT04773873|Antidepressive Agents|antidepressive agents|mesh-ancestor
25435591|NCT04773873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25435592|NCT04773873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25435593|NCT04773873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435594|NCT04773873|Antimanic Agents|antimanic agents|mesh-ancestor
25435595|NCT04773873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25435596|NCT04773873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25435597|NCT04773873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435598|NCT04773717|Ascorbic Acid|ascorbic acid|mesh-list
25435599|NCT04773717|Antioxidants|antioxidants|mesh-ancestor
25435600|NCT04773717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435601|NCT04773717|Protective Agents|protective agents|mesh-ancestor
25435602|NCT04773717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435603|NCT04773717|Vitamins|vitamins|mesh-ancestor
25435604|NCT04773717|Micronutrients|micronutrients|mesh-ancestor
25435605|NCT04774159|Colchicine|colchicine|mesh-list
25435606|NCT04774159|Gout Suppressants|gout suppressants|mesh-ancestor
25435607|NCT04774159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25435608|NCT04774159|Tubulin Modulators|tubulin modulators|mesh-ancestor
25435609|NCT04774159|Antimitotic Agents|antimitotic agents|mesh-ancestor
25435610|NCT04774159|Mitosis Modulators|mitosis modulators|mesh-ancestor
25435611|NCT04774159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435612|NCT04774159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25435613|NCT04774406|Olaparib|olaparib|mesh-list
25435614|NCT04774406|Niraparib|niraparib|mesh-list
25435615|NCT04774406|Veliparib|veliparib|mesh-list
25435616|NCT04774406|Talazoparib|talazoparib|mesh-list
25435617|NCT04774406|Rucaparib|rucaparib|mesh-list
25435618|NCT04774406|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25435619|NCT04774406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25435620|NCT04774406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435621|NCT04774406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25435622|NCT04773301|Ropivacaine|ropivacaine|mesh-list
25435623|NCT04773301|Levobupivacaine|levobupivacaine|mesh-list
25435624|NCT04773301|Anesthetics, Local|anesthetics, local|mesh-ancestor
25435625|NCT04773301|Anesthetics|anesthetics|mesh-ancestor
25435626|NCT04773301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25435627|NCT04773301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435628|NCT04773301|Sensory System Agents|sensory system agents|mesh-ancestor
25643510|NCT01427907|Calcium|calcium|mesh-list
25643511|NCT01427907|Sevelamer|sevelamer|mesh-list
25643512|NCT01427907|Calcium acetate|calcium acetate|mesh-list
25643513|NCT01427907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25643514|NCT01427907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643515|NCT01427907|Chelating Agents|chelating agents|mesh-ancestor
25643516|NCT01427907|Sequestering Agents|sequestering agents|mesh-ancestor
25435629|NCT04773301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25435630|NCT04773236|Lidocaine|lidocaine|mesh-list
25435631|NCT04773236|Anesthetics, Local|anesthetics, local|mesh-ancestor
25435632|NCT04773236|Anesthetics|anesthetics|mesh-ancestor
25435633|NCT04773236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25435634|NCT04773236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435635|NCT04773236|Sensory System Agents|sensory system agents|mesh-ancestor
25435636|NCT04773236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25435637|NCT04773236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25435638|NCT04773236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25435639|NCT04773236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25435640|NCT04773236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25435641|NCT04773236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435642|NCT04773093|Lidocaine|lidocaine|mesh-list
25435643|NCT04773093|Anesthetics, Local|anesthetics, local|mesh-ancestor
25435644|NCT04773093|Anesthetics|anesthetics|mesh-ancestor
25435645|NCT04773093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25435646|NCT04773093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435647|NCT04773093|Sensory System Agents|sensory system agents|mesh-ancestor
25435648|NCT04773093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25435649|NCT04773093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25435650|NCT04773093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25435651|NCT04773093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25435652|NCT04773093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24523231|NCT02349906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523232|NCT02349906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799637|NCT01970046|Metformin|metformin|mesh-list
24799906|NCT01971801|Vitamin D|vitamin d|mesh-list
25435653|NCT04773093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435654|NCT04772781|Ibuprofen|ibuprofen|mesh-list
25435655|NCT04772781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25435656|NCT04772781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25435657|NCT04772781|Analgesics|analgesics|mesh-ancestor
25435658|NCT04772781|Sensory System Agents|sensory system agents|mesh-ancestor
25435659|NCT04772781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25435660|NCT04772781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435661|NCT04772781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25435662|NCT04772781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25435663|NCT04772781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25435664|NCT04772781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25435665|NCT04772781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435666|NCT04772729|Insulin|insulin|mesh-list
25435667|NCT04772729|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25435668|NCT04772729|Insulin Aspart|insulin aspart|mesh-list
25435669|NCT04772729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25435670|NCT04772729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435671|NCT04772521|Nicotine|nicotine|mesh-list
25435672|NCT04772521|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25435673|NCT04772521|Autonomic Agents|autonomic agents|mesh-ancestor
25435674|NCT04772521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25435675|NCT04772521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435676|NCT04772521|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25435677|NCT04772521|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25435678|NCT04772521|Cholinergic Agents|cholinergic agents|mesh-ancestor
25435679|NCT04772521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25435680|NCT04772521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435681|NCT04772287|Gemcitabine|gemcitabine|mesh-list
25435682|NCT04772287|Paclitaxel|paclitaxel|mesh-list
25435683|NCT04772287|Vinorelbine|vinorelbine|mesh-list
25435684|NCT04772287|Docetaxel|docetaxel|mesh-list
25435685|NCT04772287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25435686|NCT04772287|Cisplatin|cisplatin|mesh-list
25435687|NCT04772287|Carboplatin|carboplatin|mesh-list
25435688|NCT04772287|Pemetrexed|pemetrexed|mesh-list
25435689|NCT04772287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25435690|NCT04772287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25643517|NCT01427907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435691|NCT04772287|Tubulin Modulators|tubulin modulators|mesh-ancestor
25435693|NCT04772287|Mitosis Modulators|mitosis modulators|mesh-ancestor
25435694|NCT04772287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435695|NCT04772287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25435696|NCT04772287|Antimetabolites|antimetabolites|mesh-ancestor
25435697|NCT04772287|Antiviral Agents|antiviral agents|mesh-ancestor
25435698|NCT04772287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25435699|NCT04772287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25435700|NCT04772287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25435701|NCT04772287|Immunologic Factors|immunologic factors|mesh-ancestor
25435702|NCT04772287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435703|NCT04772287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25435704|NCT04772287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25435705|NCT04772352|Febuxostat|febuxostat|mesh-list
25435706|NCT04772352|Gout Suppressants|gout suppressants|mesh-ancestor
25435707|NCT04772352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25435708|NCT04771715|Pembrolizumab|pembrolizumab|mesh-list
25435709|NCT04771715|Nivolumab|nivolumab|mesh-list
25435710|NCT04771715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25435711|NCT04771715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25435712|NCT04771715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25435713|NCT04771715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435714|NCT04771728|Metronidazole|metronidazole|mesh-list
25435715|NCT04771728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25435716|NCT04771728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25435717|NCT04771728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25435718|NCT04771728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25435719|NCT04771884|Vancomycin|vancomycin|mesh-list
25435720|NCT04771884|Meropenem|meropenem|mesh-list
25435721|NCT04771884|Ceftriaxone|ceftriaxone|mesh-list
25435722|NCT04771884|Linezolid|linezolid|mesh-list
25435723|NCT04771884|Ceftazidime|ceftazidime|mesh-list
25435724|NCT04771884|Ceftizoxime|ceftizoxime|mesh-list
25435725|NCT04771884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25435726|NCT04771884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25822775|NCT00004647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993215|NCT05200260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416992|NCT00204646|Doxorubicin|doxorubicin|mesh-list
25435745|NCT04771026|Dexamethasone|dexamethasone|mesh-list
25435746|NCT04771026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25435747|NCT04771026|Antiemetics|antiemetics|mesh-ancestor
25435748|NCT04771026|Autonomic Agents|autonomic agents|mesh-ancestor
25435749|NCT04771026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25435750|NCT04771026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435751|NCT04771026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25435752|NCT04771026|Glucocorticoids|glucocorticoids|mesh-ancestor
25435753|NCT04771026|Hormones|hormones|mesh-ancestor
25435754|NCT04771026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25435755|NCT04771026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25435756|NCT04771026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25435757|NCT04771000|Ambrisentan|ambrisentan|mesh-list
25435758|NCT04771000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25435759|NCT04770792|Chlorhexidine|chlorhexidine|mesh-list
25435760|NCT04770792|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25435761|NCT04770792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25435762|NCT04770792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25435763|NCT04770792|Disinfectants|disinfectants|mesh-ancestor
25435764|NCT04770792|Dermatologic Agents|dermatologic agents|mesh-ancestor
25435765|NCT04770688|Osimertinib|osimertinib|mesh-list
25435766|NCT04770688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25435767|NCT04770688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25435768|NCT04770688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25435769|NCT04770688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435770|NCT04770961|Ropivacaine|ropivacaine|mesh-list
25435771|NCT04770961|Anesthetics, Local|anesthetics, local|mesh-ancestor
25435772|NCT04770961|Anesthetics|anesthetics|mesh-ancestor
25435773|NCT04770961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25435774|NCT04770961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435775|NCT04770961|Sensory System Agents|sensory system agents|mesh-ancestor
25435776|NCT04770961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25435777|NCT04770389|Ezetimibe|ezetimibe|mesh-list
25435778|NCT04770389|Hypolipidemic Agents|hypolipidemic agents|mesh-list
25435779|NCT04770389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25435780|NCT04770389|Antimetabolites|antimetabolites|mesh-ancestor
25435781|NCT04770389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435782|NCT04770389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25435783|NCT04769908|Lenvatinib|lenvatinib|mesh-list
25435784|NCT04769908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25435785|NCT04769908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25435786|NCT04769908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25435787|NCT04769908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435788|NCT04769557|Acetaminophen|acetaminophen|mesh-list
25435789|NCT04769557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25435790|NCT04769557|Analgesics|analgesics|mesh-ancestor
25435791|NCT04769557|Sensory System Agents|sensory system agents|mesh-ancestor
25435792|NCT04769557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25435793|NCT04769557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435794|NCT04769557|Antipyretics|antipyretics|mesh-ancestor
25435795|NCT04769713|Ropivacaine|ropivacaine|mesh-list
25435796|NCT04769713|Anesthetics, Local|anesthetics, local|mesh-ancestor
25435797|NCT04769713|Anesthetics|anesthetics|mesh-ancestor
25435798|NCT04769713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25435799|NCT04769713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435800|NCT04769713|Sensory System Agents|sensory system agents|mesh-ancestor
25435801|NCT04769713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25435802|NCT04769583|Metronidazole|metronidazole|mesh-list
25435803|NCT04769583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25435804|NCT04769583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25435805|NCT04769583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25435806|NCT04769583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25435807|NCT04769778|Valsartan|valsartan|mesh-list
25435808|NCT04769778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25435809|NCT04769778|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25435810|NCT04769778|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25435811|NCT04769778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869705|NCT00563576|Estrogens|estrogens|mesh-ancestor
24869706|NCT00563576|Hormones|hormones|mesh-ancestor
24869707|NCT00563576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24869708|NCT00563576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869709|NCT00563576|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24625778|NCT01083420|Autonomic Agents|autonomic agents|mesh-ancestor
24625779|NCT01083420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24941554|NCT03989817|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
25435848|NCT04768530|Nitazoxanide|nitazoxanide|mesh-list
25435849|NCT04768530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25435850|NCT04768530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25435851|NCT04768465|Prednisone|prednisone|mesh-list
25435852|NCT04768465|Bromides|bromides|mesh-list
25435853|NCT04768465|Tacrolimus|tacrolimus|mesh-list
25435854|NCT04768465|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
25435855|NCT04768465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25435856|NCT04768465|Glucocorticoids|glucocorticoids|mesh-ancestor
25435857|NCT04768465|Hormones|hormones|mesh-ancestor
25435858|NCT04768465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25435859|NCT04768465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435860|NCT04768465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25435861|NCT04768465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25435862|NCT04768465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25435863|NCT04768465|Immunologic Factors|immunologic factors|mesh-ancestor
25435864|NCT04768465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25435865|NCT04768465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25435866|NCT04768465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435867|NCT04768465|Anticonvulsants|anticonvulsants|mesh-ancestor
25435868|NCT04768465|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25435869|NCT04768465|Cholinergic Agents|cholinergic agents|mesh-ancestor
25435870|NCT04768465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25435871|NCT04768231|Rifampin|rifampin|mesh-list
25435872|NCT04768231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25435873|NCT04768231|Antitubercular Agents|antitubercular agents|mesh-ancestor
25435874|NCT04768231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25435875|NCT04768231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25435876|NCT04768231|Leprostatic Agents|leprostatic agents|mesh-ancestor
25435877|NCT04768231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25435878|NCT04768231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25435879|NCT04768231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435880|NCT04768231|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25435881|NCT04768231|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25435882|NCT04768231|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25435883|NCT04768231|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25435884|NCT04768231|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25435885|NCT04768231|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25643519|NCT01427920|Biphasic Insulins|biphasic insulins|mesh-list
25435886|NCT04768075|Paclitaxel|paclitaxel|mesh-list
25435887|NCT04768075|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25435888|NCT04768075|Cisplatin|cisplatin|mesh-list
25435889|NCT04768075|Carboplatin|carboplatin|mesh-list
25435890|NCT04768075|Pemetrexed|pemetrexed|mesh-list
25435891|NCT04768075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25435892|NCT04768075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25435893|NCT04768075|Tubulin Modulators|tubulin modulators|mesh-ancestor
25435894|NCT04768075|Antimitotic Agents|antimitotic agents|mesh-ancestor
25435895|NCT04768075|Mitosis Modulators|mitosis modulators|mesh-ancestor
25435896|NCT04768075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435897|NCT04768075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25435898|NCT04768075|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25435899|NCT04768075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25435900|NCT04768439|Vitamin D|vitamin d|mesh-list
25435901|NCT04768439|Ergocalciferols|ergocalciferols|mesh-list
25435902|NCT04768439|Cholecalciferol|cholecalciferol|mesh-list
25435903|NCT04768439|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
25435904|NCT04768439|Calcitriol|calcitriol|mesh-list
25435905|NCT04768439|Vitamins|vitamins|mesh-list
25435906|NCT04768439|Micronutrients|micronutrients|mesh-ancestor
25435907|NCT04768439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435908|NCT04768439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25435909|NCT04768439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25435910|NCT04768439|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25435911|NCT04768439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25719381|NCT02448914|Dopamine Agonists|dopamine agonists|mesh-ancestor
25435912|NCT04768439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435913|NCT04768439|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25435914|NCT04768023|Vitamin D|vitamin d|mesh-list
25435915|NCT04768023|Vitamins|vitamins|mesh-ancestor
25435916|NCT04768023|Micronutrients|micronutrients|mesh-ancestor
25435917|NCT04768023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822776|NCT00004650|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25822777|NCT00004650|Medroxyprogesterone|medroxyprogesterone|mesh-list
25822778|NCT00004650|Estrogens|estrogens|mesh-list
25822779|NCT00004650|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25822780|NCT00004650|Hormones|hormones|mesh-ancestor
24961389|NCT03809156|Ambrisentan|ambrisentan|mesh-list
25435918|NCT04768023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25435919|NCT04767828|Capecitabine|capecitabine|mesh-list
25435920|NCT04767828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25435921|NCT04767828|Antimetabolites|antimetabolites|mesh-ancestor
25435922|NCT04767828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435923|NCT04767828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25435924|NCT04767633|Magnesium Sulfate|magnesium sulfate|mesh-list
25435925|NCT04767633|Analgesics|analgesics|mesh-ancestor
25435926|NCT04767633|Sensory System Agents|sensory system agents|mesh-ancestor
25435927|NCT04767633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25435928|NCT04767633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435929|NCT04767633|Anesthetics|anesthetics|mesh-ancestor
25435930|NCT04767633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25435931|NCT04767633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25435932|NCT04767633|Anticonvulsants|anticonvulsants|mesh-ancestor
25435933|NCT04767633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25435934|NCT04767633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25435935|NCT04767633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435936|NCT04767633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25435937|NCT04767633|Tocolytic Agents|tocolytic agents|mesh-ancestor
25435938|NCT04767633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25435939|NCT04767243|Methamphetamine|methamphetamine|mesh-list
25435940|NCT04767243|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25435941|NCT04767243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435942|NCT04767243|Sympathomimetics|sympathomimetics|mesh-ancestor
25435943|NCT04767243|Autonomic Agents|autonomic agents|mesh-ancestor
25435944|NCT04767243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25435945|NCT04767243|Dopamine Agents|dopamine agents|mesh-ancestor
25435946|NCT04767243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25435947|NCT04767243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435948|NCT04767243|Adrenergic Agents|adrenergic agents|mesh-ancestor
25435949|NCT04767243|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25435950|NCT04767243|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25435951|NCT04767243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25435952|NCT04767243|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25435953|NCT04767295|Paclitaxel|paclitaxel|mesh-list
25435954|NCT04767295|Carboplatin|carboplatin|mesh-list
25435955|NCT04767295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25435956|NCT04767295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25435957|NCT04767295|Tubulin Modulators|tubulin modulators|mesh-ancestor
25435958|NCT04767295|Antimitotic Agents|antimitotic agents|mesh-ancestor
25435959|NCT04767295|Mitosis Modulators|mitosis modulators|mesh-ancestor
25435960|NCT04767295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435961|NCT04767308|Cyclophosphamide|cyclophosphamide|mesh-list
25435962|NCT04767308|Fludarabine|fludarabine|mesh-list
25435963|NCT04767308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25435964|NCT04767308|Immunologic Factors|immunologic factors|mesh-ancestor
25435965|NCT04767308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435966|NCT04767308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25435967|NCT04767308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25435968|NCT04767308|Alkylating Agents|alkylating agents|mesh-ancestor
25435969|NCT04767308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25435970|NCT04767308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25435971|NCT04767308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25435972|NCT04767178|Acetaminophen|acetaminophen|mesh-list
25435973|NCT04767178|Ibuprofen|ibuprofen|mesh-list
25435974|NCT04767178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25435975|NCT04767178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25435976|NCT04767178|Analgesics|analgesics|mesh-ancestor
25435977|NCT04767178|Sensory System Agents|sensory system agents|mesh-ancestor
25435978|NCT04767178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25435979|NCT04767178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435980|NCT04767178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25435981|NCT04767178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25435982|NCT04767178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25435983|NCT04767178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25435984|NCT04767178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822781|NCT00004650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25822782|NCT00004650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822783|NCT00004650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25822784|NCT00004650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25822785|NCT00004650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25435985|NCT04767178|Antipyretics|antipyretics|mesh-ancestor
25435986|NCT04767542|Acetaminophen|acetaminophen|mesh-list
25435987|NCT04767542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435988|NCT04767542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25435989|NCT04767542|Analgesics|analgesics|mesh-ancestor
25435990|NCT04767542|Sensory System Agents|sensory system agents|mesh-ancestor
25435991|NCT04767542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25435992|NCT04767542|Antipyretics|antipyretics|mesh-ancestor
25435993|NCT04767035|Midazolam|midazolam|mesh-list
25435994|NCT04767035|Ketamine|ketamine|mesh-list
25435995|NCT04767035|Analgesics|analgesics|mesh-ancestor
25435996|NCT04767035|Sensory System Agents|sensory system agents|mesh-ancestor
25435997|NCT04767035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25435998|NCT04767035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25435999|NCT04767035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25436000|NCT04767035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25436001|NCT04767035|Anesthetics, General|anesthetics, general|mesh-ancestor
25436002|NCT04767035|Anesthetics|anesthetics|mesh-ancestor
25436003|NCT04767035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25436004|NCT04767035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25436005|NCT04767035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25436006|NCT04767035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25436007|NCT04767035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436008|NCT04767035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25436009|NCT04767035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25436010|NCT04767035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25436011|NCT04767035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25436012|NCT04767035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25436013|NCT04767035|GABA Modulators|gaba modulators|mesh-ancestor
25436014|NCT04767035|GABA Agents|gaba agents|mesh-ancestor
25436015|NCT04766827|Paclitaxel|paclitaxel|mesh-list
25436016|NCT04766827|Docetaxel|docetaxel|mesh-list
25436017|NCT04766827|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25436018|NCT04766827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25436019|NCT04766827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436020|NCT04766827|Tubulin Modulators|tubulin modulators|mesh-ancestor
25436021|NCT04766827|Antimitotic Agents|antimitotic agents|mesh-ancestor
25436022|NCT04766827|Mitosis Modulators|mitosis modulators|mesh-ancestor
25404098|NCT03684811|Cisplatin|cisplatin|mesh-list
25436023|NCT04766827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436024|NCT04766775|Fluorides|fluorides|mesh-list
25436025|NCT04766775|Cariostatic Agents|cariostatic agents|mesh-ancestor
25436026|NCT04766775|Protective Agents|protective agents|mesh-ancestor
25436027|NCT04766775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436028|NCT04766736|Antibodies|antibodies|mesh-list
25436029|NCT04766736|Immunologic Factors|immunologic factors|mesh-ancestor
25436030|NCT04766736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436031|NCT04766307|Interleukin-2|interleukin-2|mesh-list
25436032|NCT04766307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436033|NCT04766307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25436034|NCT04766307|Analgesics|analgesics|mesh-ancestor
25436035|NCT04766307|Sensory System Agents|sensory system agents|mesh-ancestor
25436036|NCT04766307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25436037|NCT04766307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436038|NCT04766359|Paclitaxel|paclitaxel|mesh-list
25436039|NCT04766359|Cisplatin|cisplatin|mesh-list
25436040|NCT04766359|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25436041|NCT04766359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25436042|NCT04766359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436043|NCT04766359|Tubulin Modulators|tubulin modulators|mesh-ancestor
25436044|NCT04766359|Antimitotic Agents|antimitotic agents|mesh-ancestor
25436045|NCT04766359|Mitosis Modulators|mitosis modulators|mesh-ancestor
25436046|NCT04766359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436047|NCT04766177|Bumetanide|bumetanide|mesh-list
25436048|NCT04766177|Diuretics|diuretics|mesh-ancestor
25436049|NCT04766177|Natriuretic Agents|natriuretic agents|mesh-ancestor
25436050|NCT04766177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436051|NCT04766177|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25436052|NCT04766177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25436053|NCT04766177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436054|NCT04766151|Nitroglycerin|nitroglycerin|mesh-list
25436055|NCT04766151|Vasodilator Agents|vasodilator agents|mesh-ancestor
25436056|NCT04766684|Lidocaine|lidocaine|mesh-list
25436057|NCT04766684|Anesthetics, Local|anesthetics, local|mesh-ancestor
25822786|NCT00004650|Contraceptive Agents|contraceptive agents|mesh-ancestor
25822787|NCT00004650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25822788|NCT00004650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25436072|NCT04766047|Dexmedetomidine|dexmedetomidine|mesh-list
25436073|NCT04766047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25436074|NCT04766047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25436075|NCT04766047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436076|NCT04766047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25436077|NCT04766047|Analgesics|analgesics|mesh-ancestor
25436078|NCT04766047|Sensory System Agents|sensory system agents|mesh-ancestor
25436079|NCT04766047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25436080|NCT04766047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25436081|NCT04766047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25436082|NCT04766047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25436083|NCT04766047|Adrenergic Agents|adrenergic agents|mesh-ancestor
25436084|NCT04766047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25436085|NCT04766047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436086|NCT04766021|Mirabegron|mirabegron|mesh-list
25436087|NCT04766021|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25436088|NCT04766021|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25436089|NCT04766021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25436090|NCT04766021|Adrenergic Agents|adrenergic agents|mesh-ancestor
25436091|NCT04766021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25436092|NCT04766021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436093|NCT04766021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436094|NCT04766021|Urological Agents|urological agents|mesh-ancestor
25436095|NCT04765267|Vitamin D|vitamin d|mesh-list
25436096|NCT04765267|Cholecalciferol|cholecalciferol|mesh-list
25436097|NCT04765267|Zinc Sulfate|zinc sulfate|mesh-list
25436098|NCT04765267|Vitamins|vitamins|mesh-ancestor
25436099|NCT04765267|Micronutrients|micronutrients|mesh-ancestor
25436100|NCT04765267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436101|NCT04765267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25436102|NCT04765267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25436103|NCT04765267|Astringents|astringents|mesh-ancestor
25436104|NCT04765267|Dermatologic Agents|dermatologic agents|mesh-ancestor
25436105|NCT04765527|Turmeric extract|turmeric extract|mesh-list
25436106|NCT04765527|Antioxidants|antioxidants|mesh-ancestor
25436107|NCT04765527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436108|NCT04765527|Protective Agents|protective agents|mesh-ancestor
25436109|NCT04765527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436110|NCT04765228|Doxorubicin|doxorubicin|mesh-list
25436111|NCT04765228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25436112|NCT04765228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25436113|NCT04765228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436114|NCT04765228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25436115|NCT04765228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25436116|NCT04765228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25436117|NCT04765228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436118|NCT04765085|Aripiprazole|aripiprazole|mesh-list
25436119|NCT04765085|Antidepressive Agents|antidepressive agents|mesh-ancestor
25436120|NCT04765085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25436121|NCT04765085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25436122|NCT04765085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25436123|NCT04765085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25436124|NCT04765085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436125|NCT04765085|Dopamine Agonists|dopamine agonists|mesh-ancestor
25436126|NCT04765085|Dopamine Agents|dopamine agents|mesh-ancestor
25436127|NCT04765085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25436128|NCT04765085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436129|NCT04765085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25436130|NCT04765085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25436131|NCT04765085|Serotonin Agents|serotonin agents|mesh-ancestor
25436132|NCT04765085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25436133|NCT04765085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25436134|NCT04765085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25436135|NCT04765085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25436136|NCT04764955|Vitamin D|vitamin d|mesh-list
25436137|NCT04764955|Cholecalciferol|cholecalciferol|mesh-list
25436138|NCT04764955|Vitamins|vitamins|mesh-ancestor
25436139|NCT04764955|Micronutrients|micronutrients|mesh-ancestor
25436140|NCT04764955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436141|NCT04764955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25436142|NCT04764955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25436143|NCT04764825|Morphine|morphine|mesh-list
25436144|NCT04764825|Methadone|methadone|mesh-list
25436145|NCT04764825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25436146|NCT04764825|Narcotics|narcotics|mesh-ancestor
25436148|NCT04764825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436149|NCT04764825|Analgesics|analgesics|mesh-ancestor
25436150|NCT04764825|Sensory System Agents|sensory system agents|mesh-ancestor
25436151|NCT04764825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25436152|NCT04764825|Antitussive Agents|antitussive agents|mesh-ancestor
25436153|NCT04764825|Respiratory System Agents|respiratory system agents|mesh-ancestor
25436154|NCT04765098|Tamoxifen|tamoxifen|mesh-list
25436155|NCT04765098|Etoposide|etoposide|mesh-list
25436156|NCT04765098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25436157|NCT04765098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436158|NCT04765098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25436159|NCT04765098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25436160|NCT04765098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25436161|NCT04765098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436162|NCT04765098|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25436163|NCT04765098|Hormone Antagonists|hormone antagonists|mesh-ancestor
25436164|NCT04765098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25436165|NCT04765098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436166|NCT04765098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25436167|NCT04765098|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25436168|NCT04765098|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25436169|NCT04765098|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25436170|NCT04764916|Bupivacaine|bupivacaine|mesh-list
25436171|NCT04764916|Anesthetics, Local|anesthetics, local|mesh-ancestor
25436172|NCT04764916|Anesthetics|anesthetics|mesh-ancestor
25436173|NCT04764916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25436174|NCT04764916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436175|NCT04764916|Sensory System Agents|sensory system agents|mesh-ancestor
25436176|NCT04764916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25436177|NCT04764851|Ecopipam|ecopipam|mesh-list
25436178|NCT04764851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25436179|NCT04764851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25436180|NCT04764851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25436181|NCT04764851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436182|NCT04764851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25436183|NCT04764851|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25436185|NCT04764851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25436186|NCT04764851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436187|NCT04764396|Heparin|heparin|mesh-list
25436188|NCT04764396|Calcium heparin|calcium heparin|mesh-list
25436189|NCT04764396|Anticoagulants|anticoagulants|mesh-ancestor
25436190|NCT04764396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25436191|NCT04764396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25436192|NCT04764396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436193|NCT04764227|Paclitaxel|paclitaxel|mesh-list
25436194|NCT04764227|Carboplatin|carboplatin|mesh-list
25436195|NCT04764227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25436196|NCT04764227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436197|NCT04764227|Tubulin Modulators|tubulin modulators|mesh-ancestor
25436198|NCT04764227|Antimitotic Agents|antimitotic agents|mesh-ancestor
25436199|NCT04764227|Mitosis Modulators|mitosis modulators|mesh-ancestor
25436200|NCT04764227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436201|NCT04764344|Haloperidol|haloperidol|mesh-list
25436202|NCT04764344|Ondansetron|ondansetron|mesh-list
25436203|NCT04764344|Haloperidol decanoate|haloperidol decanoate|mesh-list
25436204|NCT04764344|Antiemetics|antiemetics|mesh-ancestor
25436205|NCT04764344|Autonomic Agents|autonomic agents|mesh-ancestor
25436206|NCT04764344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25436207|NCT04764344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436208|NCT04764344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25436209|NCT04764344|Antipruritics|antipruritics|mesh-ancestor
25436210|NCT04764344|Dermatologic Agents|dermatologic agents|mesh-ancestor
25436211|NCT04764344|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25436212|NCT04764344|Serotonin Agents|serotonin agents|mesh-ancestor
25436213|NCT04764344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25436214|NCT04764344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436215|NCT04764344|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25436216|NCT04764344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25436217|NCT04764344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25436218|NCT04764344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25436219|NCT04764344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25436220|NCT04764344|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25436221|NCT04764344|Dopamine Agents|dopamine agents|mesh-ancestor
25436222|NCT04764344|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25436223|NCT04764383|Histamine|histamine|mesh-list
25436224|NCT04764383|Histamine Agonists|histamine agonists|mesh-ancestor
25436225|NCT04764383|Histamine Agents|histamine agents|mesh-ancestor
25436226|NCT04764383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25436227|NCT04764383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436228|NCT04764383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436229|NCT04764084|Niraparib|niraparib|mesh-list
25436230|NCT04764084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25436231|NCT04764084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25436232|NCT04764084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436233|NCT04764084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436234|NCT04764214|Osimertinib|osimertinib|mesh-list
25436235|NCT04764214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436236|NCT04764214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25436237|NCT04764214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25436238|NCT04764214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436239|NCT04764045|Ropivacaine|ropivacaine|mesh-list
25436240|NCT04764045|Anesthetics, Local|anesthetics, local|mesh-ancestor
25436241|NCT04764045|Anesthetics|anesthetics|mesh-ancestor
25436242|NCT04764045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25436243|NCT04764045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436244|NCT04764045|Sensory System Agents|sensory system agents|mesh-ancestor
25436245|NCT04764045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25436246|NCT04763876|Ketorolac|ketorolac|mesh-list
25436247|NCT04763876|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25436248|NCT04763876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25436249|NCT04763876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25436250|NCT04763876|Analgesics|analgesics|mesh-ancestor
25436251|NCT04763876|Sensory System Agents|sensory system agents|mesh-ancestor
25436252|NCT04763876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25436253|NCT04763876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436254|NCT04763876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25436255|NCT04763876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25436256|NCT04763876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25436257|NCT04763876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404099|NCT03684811|Nivolumab|nivolumab|mesh-list
25436258|NCT04763876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436259|NCT04764058|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
25436260|NCT04764058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25436261|NCT04764058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25436262|NCT04764058|Protease Inhibitors|protease inhibitors|mesh-ancestor
25436263|NCT04764058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25436264|NCT04764058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436265|NCT04763434|Dexamethasone|dexamethasone|mesh-list
25436266|NCT04763434|Dexmedetomidine|dexmedetomidine|mesh-list
25436267|NCT04763434|Ropivacaine|ropivacaine|mesh-list
25436268|NCT04763434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25436269|NCT04763434|Antiemetics|antiemetics|mesh-ancestor
25436270|NCT04763434|Autonomic Agents|autonomic agents|mesh-ancestor
25436271|NCT04763434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25436272|NCT04763434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436273|NCT04763434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25436274|NCT04763434|Glucocorticoids|glucocorticoids|mesh-ancestor
25436275|NCT04763434|Hormones|hormones|mesh-ancestor
25436276|NCT04763434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25436277|NCT04763434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25436278|NCT04763434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436279|NCT04763434|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25436280|NCT04763434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25436281|NCT04763434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25436282|NCT04763434|Analgesics|analgesics|mesh-ancestor
25436283|NCT04763434|Sensory System Agents|sensory system agents|mesh-ancestor
25436284|NCT04763434|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25436285|NCT04763434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25436286|NCT04763434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25436287|NCT04763434|Adrenergic Agents|adrenergic agents|mesh-ancestor
25436288|NCT04763434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25436289|NCT04763434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436290|NCT04763434|Anesthetics, Local|anesthetics, local|mesh-ancestor
25436291|NCT04763434|Anesthetics|anesthetics|mesh-ancestor
24447255|NCT00307723|Fluorouracil|fluorouracil|mesh-list
25436292|NCT04763486|Cefazolin|cefazolin|mesh-list
25436293|NCT04763486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25436294|NCT04763486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25436295|NCT04763616|Cemiplimab|cemiplimab|mesh-list
25436296|NCT04763616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25436297|NCT04763616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436298|NCT04763265|Botulinum Toxins|botulinum toxins|mesh-list
25436299|NCT04763265|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25436300|NCT04763265|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25436301|NCT04763265|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25436302|NCT04763265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25436303|NCT04763265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436304|NCT04763265|Cholinergic Agents|cholinergic agents|mesh-ancestor
25436305|NCT04763265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25436306|NCT04763265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436307|NCT04763265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25436308|NCT04763265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25436309|NCT04763070|Ciprofloxacin|ciprofloxacin|mesh-list
25436310|NCT04763070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25436311|NCT04763070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25436312|NCT04763070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25436313|NCT04763070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25436314|NCT04763070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25436315|NCT04763070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436316|NCT04763070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436317|NCT04763070|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25436318|NCT04763070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25436319|NCT04763057|Calcium|calcium|mesh-list
25436320|NCT04763057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25436321|NCT04763057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436322|NCT04763096|Tacrolimus|tacrolimus|mesh-list
25436323|NCT04763096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25436324|NCT04763096|Immunologic Factors|immunologic factors|mesh-ancestor
25436325|NCT04763096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436326|NCT04763096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25436327|NCT04763096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25436328|NCT04763096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436329|NCT04762953|Leucovorin|leucovorin|mesh-list
25436330|NCT04762953|Paclitaxel|paclitaxel|mesh-list
25436331|NCT04762953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25436332|NCT04762953|Fluorouracil|fluorouracil|mesh-list
25436333|NCT04762953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25436334|NCT04762953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436335|NCT04762953|Tubulin Modulators|tubulin modulators|mesh-ancestor
25436336|NCT04762953|Antimitotic Agents|antimitotic agents|mesh-ancestor
25436337|NCT04762953|Mitosis Modulators|mitosis modulators|mesh-ancestor
25436338|NCT04762953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436339|NCT04762953|Antimetabolites|antimetabolites|mesh-ancestor
25436340|NCT04762953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25436341|NCT04762953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25436342|NCT04762953|Immunologic Factors|immunologic factors|mesh-ancestor
25436343|NCT04762953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436344|NCT04762953|Antidotes|antidotes|mesh-ancestor
25436345|NCT04762953|Protective Agents|protective agents|mesh-ancestor
25436346|NCT04762953|Vitamin B Complex|vitamin b complex|mesh-ancestor
25436347|NCT04762953|Vitamins|vitamins|mesh-ancestor
25436348|NCT04762953|Micronutrients|micronutrients|mesh-ancestor
25436349|NCT04762992|Enoxaparin|enoxaparin|mesh-list
25436350|NCT04762992|Anticoagulants|anticoagulants|mesh-ancestor
25436351|NCT04762992|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25436352|NCT04762992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25436353|NCT04762992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436354|NCT04762966|Metformin|metformin|mesh-list
25436355|NCT04762966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25436356|NCT04762966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436357|NCT04762810|Cyclophosphamide|cyclophosphamide|mesh-list
25436358|NCT04762810|Glucocorticoids|glucocorticoids|mesh-list
25436359|NCT04762810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25436360|NCT04762810|Immunologic Factors|immunologic factors|mesh-ancestor
25436361|NCT04762810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807890|NCT02024217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807891|NCT02024256|Magnesium Sulfate|magnesium sulfate|mesh-list
24807892|NCT02024256|Analgesics|analgesics|mesh-ancestor
24667725|NCT05320107|Anesthetics, General|anesthetics, general|mesh-ancestor
24667727|NCT05320107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25436362|NCT04762810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25436363|NCT04762810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25436364|NCT04762810|Alkylating Agents|alkylating agents|mesh-ancestor
25436365|NCT04762810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436366|NCT04762810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436367|NCT04762810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25436368|NCT04762810|Hormones|hormones|mesh-ancestor
25436369|NCT04762810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25436370|NCT04762745|Thalidomide|thalidomide|mesh-list
25436371|NCT04762745|Dexamethasone|dexamethasone|mesh-list
25436372|NCT04762745|Dexamethasone acetate|dexamethasone acetate|mesh-list
25436373|NCT04762745|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25436374|NCT04762745|Pomalidomide|pomalidomide|mesh-list
25436375|NCT04762745|BB 1101|bb 1101|mesh-list
25436376|NCT04762745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25436377|NCT04762745|Antiemetics|antiemetics|mesh-ancestor
25436378|NCT04762745|Autonomic Agents|autonomic agents|mesh-ancestor
25436379|NCT04762745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25436380|NCT04762745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436381|NCT04762745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25436382|NCT04762745|Glucocorticoids|glucocorticoids|mesh-ancestor
25436383|NCT04762745|Hormones|hormones|mesh-ancestor
25436384|NCT04762745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25436385|NCT04762745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25436386|NCT04762745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436387|NCT04762745|Protease Inhibitors|protease inhibitors|mesh-ancestor
25436388|NCT04762745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25436389|NCT04762745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436390|NCT04762745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25436391|NCT04762745|Alkylating Agents|alkylating agents|mesh-ancestor
25436392|NCT04762745|Immunologic Factors|immunologic factors|mesh-ancestor
25436393|NCT04762745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25436394|NCT04762745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25436395|NCT04762745|Growth Substances|growth substances|mesh-ancestor
25436396|NCT04762745|Growth Inhibitors|growth inhibitors|mesh-ancestor
25436397|NCT04762745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25436398|NCT04762745|Leprostatic Agents|leprostatic agents|mesh-ancestor
25436399|NCT04762745|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25436400|NCT04762745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25436401|NCT04762511|Vaccines|vaccines|mesh-list
25436402|NCT04762511|Immunologic Factors|immunologic factors|mesh-ancestor
25436403|NCT04762511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436404|NCT04762784|Glucocorticoids|glucocorticoids|mesh-list
25436406|NCT04762784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25436407|NCT04762784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436408|NCT04762901|Paclitaxel|paclitaxel|mesh-list
25436409|NCT04762901|Cyclophosphamide|cyclophosphamide|mesh-list
25436410|NCT04762901|Carboplatin|carboplatin|mesh-list
25436411|NCT04762901|Doxorubicin|doxorubicin|mesh-list
25436412|NCT04762901|Niraparib|niraparib|mesh-list
25436413|NCT04762901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25436414|NCT04762901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436415|NCT04762901|Tubulin Modulators|tubulin modulators|mesh-ancestor
25436416|NCT04762901|Antimitotic Agents|antimitotic agents|mesh-ancestor
25436417|NCT04762901|Mitosis Modulators|mitosis modulators|mesh-ancestor
25436418|NCT04762901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436419|NCT04762901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25436420|NCT04762901|Immunologic Factors|immunologic factors|mesh-ancestor
25436421|NCT04762901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436422|NCT04762901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25436423|NCT04762901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25436424|NCT04762901|Alkylating Agents|alkylating agents|mesh-ancestor
25436425|NCT04762901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25436426|NCT04762901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25436427|NCT04762901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25436428|NCT04762901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25436429|NCT04762901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25436430|NCT04762901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25436431|NCT04761952|Azathioprine|azathioprine|mesh-list
25436432|NCT04761952|Infliximab|infliximab|mesh-list
25436433|NCT04761952|Dermatologic Agents|dermatologic agents|mesh-ancestor
25436434|NCT04761952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25436435|NCT04761952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24500446|NCT00524251|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24500706|NCT00525551|Antioxidants|antioxidants|mesh-ancestor
25436436|NCT04761952|Antimetabolites|antimetabolites|mesh-ancestor
25436437|NCT04761952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436438|NCT04761952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25436439|NCT04761952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436440|NCT04761952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25436441|NCT04761952|Immunologic Factors|immunologic factors|mesh-ancestor
25436442|NCT04761952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436443|NCT04761757|Antidepressive Agents|antidepressive agents|mesh-list
25436444|NCT04761757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25436445|NCT04762030|Paclitaxel|paclitaxel|mesh-list
25436446|NCT04762030|Carboplatin|carboplatin|mesh-list
25436447|NCT04762030|Durvalumab|durvalumab|mesh-list
25436448|NCT04762030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25436449|NCT04762030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436450|NCT04762030|Tubulin Modulators|tubulin modulators|mesh-ancestor
25436451|NCT04762030|Antimitotic Agents|antimitotic agents|mesh-ancestor
25436452|NCT04762030|Mitosis Modulators|mitosis modulators|mesh-ancestor
25436453|NCT04762030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436454|NCT04762030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25436455|NCT04762134|Doxycycline|doxycycline|mesh-list
25436456|NCT04762134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25436457|NCT04762134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25436458|NCT04762134|Antimalarials|antimalarials|mesh-ancestor
25436459|NCT04762134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25436460|NCT04762134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25436461|NCT04761705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25436462|NCT04761705|Latanoprost|latanoprost|mesh-list
25436463|NCT04761705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25436464|NCT04762147|Acetaminophen|acetaminophen|mesh-list
25436465|NCT04762147|Fentanyl|fentanyl|mesh-list
25436466|NCT04762147|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25436467|NCT04762147|Narcotics|narcotics|mesh-ancestor
25436468|NCT04762147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25436469|NCT04762147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436470|NCT04762147|Analgesics|analgesics|mesh-ancestor
25436471|NCT04762147|Sensory System Agents|sensory system agents|mesh-ancestor
25436472|NCT04762147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25436473|NCT04762147|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25436474|NCT04762147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25436475|NCT04762147|Anesthetics, General|anesthetics, general|mesh-ancestor
25436476|NCT04762147|Anesthetics|anesthetics|mesh-ancestor
25436477|NCT04762147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25436478|NCT04762147|Antipyretics|antipyretics|mesh-ancestor
25436479|NCT04761744|Nivolumab|nivolumab|mesh-list
25436480|NCT04761744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25436481|NCT04761744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436482|NCT04761744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25436483|NCT04761744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436484|NCT04761731|Tacrolimus|tacrolimus|mesh-list
25436485|NCT04761731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25436486|NCT04761731|Immunologic Factors|immunologic factors|mesh-ancestor
25436487|NCT04761731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436488|NCT04761731|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25436489|NCT04761731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25436490|NCT04761731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436491|NCT04761302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25436492|NCT04761185|Raltitrexed|raltitrexed|mesh-list
25436493|NCT04761185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25436494|NCT04761185|Antimetabolites|antimetabolites|mesh-ancestor
25436495|NCT04761185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436496|NCT04761185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436497|NCT04761185|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25436498|NCT04761185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25436499|NCT04761393|Xenon|xenon|mesh-list
25436500|NCT04761393|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25436501|NCT04761393|Anesthetics, General|anesthetics, general|mesh-ancestor
25436502|NCT04761393|Anesthetics|anesthetics|mesh-ancestor
25436503|NCT04761393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25436504|NCT04761393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436505|NCT04761029|Tramadol|tramadol|mesh-list
25436506|NCT04761029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25436507|NCT04761029|Narcotics|narcotics|mesh-ancestor
25436508|NCT04761029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25436509|NCT04761029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436510|NCT04761029|Analgesics|analgesics|mesh-ancestor
25436511|NCT04761029|Sensory System Agents|sensory system agents|mesh-ancestor
25822789|NCT00004650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25436527|NCT04760704|Immunologic Factors|immunologic factors|mesh-ancestor
25436528|NCT04760704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436529|NCT04760574|Testosterone|testosterone|mesh-list
25436530|NCT04760574|Androgens|androgens|mesh-ancestor
25436531|NCT04760574|Hormones|hormones|mesh-ancestor
25436532|NCT04760574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25436533|NCT04760574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436534|NCT04760327|Cisplatin|cisplatin|mesh-list
25436535|NCT04760327|Bleomycin|bleomycin|mesh-list
25436536|NCT04760327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436537|NCT04760327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25436538|NCT04760431|Paclitaxel|paclitaxel|mesh-list
25436539|NCT04760431|Docetaxel|docetaxel|mesh-list
25436540|NCT04760431|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25436541|NCT04760431|Trastuzumab|trastuzumab|mesh-list
25436542|NCT04760431|Pertuzumab|pertuzumab|mesh-list
25436543|NCT04760431|Taxane|taxane|mesh-list
25436544|NCT04760431|Tucatinib|tucatinib|mesh-list
25436545|NCT04760431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25436546|NCT04760431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436547|NCT04760431|Tubulin Modulators|tubulin modulators|mesh-ancestor
25436548|NCT04760431|Antimitotic Agents|antimitotic agents|mesh-ancestor
25436549|NCT04760431|Mitosis Modulators|mitosis modulators|mesh-ancestor
25436550|NCT04760431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436551|NCT04760431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25436552|NCT04760431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25436553|NCT04760431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25436554|NCT04760301|Tranexamic Acid|tranexamic acid|mesh-list
25436555|NCT04760301|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25436556|NCT04760301|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25436557|NCT04760301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436558|NCT04760301|Hemostatics|hemostatics|mesh-ancestor
25436559|NCT04760301|Coagulants|coagulants|mesh-ancestor
25436560|NCT04759703|Pramipexole|pramipexole|mesh-list
25436561|NCT04759703|Antioxidants|antioxidants|mesh-ancestor
25436562|NCT04759703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436563|NCT04759703|Protective Agents|protective agents|mesh-ancestor
25436564|NCT04759703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436565|NCT04759703|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25436566|NCT04759703|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25436567|NCT04759703|Dopamine Agonists|dopamine agonists|mesh-ancestor
25643520|NCT01427920|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
25643521|NCT01427920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25643522|NCT01427920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643523|NCT01427933|Ramucirumab|ramucirumab|mesh-list
25643524|NCT01427933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25643526|NCT01427972|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25436568|NCT04759703|Dopamine Agents|dopamine agents|mesh-ancestor
25436569|NCT04759703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25436570|NCT04759729|Vitamin D|vitamin d|mesh-list
25436571|NCT04759729|Ergocalciferols|ergocalciferols|mesh-list
25436572|NCT04759729|Cholecalciferol|cholecalciferol|mesh-list
25436573|NCT04759729|Vitamins|vitamins|mesh-list
25436574|NCT04759729|Micronutrients|micronutrients|mesh-ancestor
25436575|NCT04759729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436576|NCT04759729|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25436577|NCT04759729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25436578|NCT04759742|Ropivacaine|ropivacaine|mesh-list
25436579|NCT04759742|Anesthetics, Local|anesthetics, local|mesh-ancestor
25436580|NCT04759742|Anesthetics|anesthetics|mesh-ancestor
25436581|NCT04759742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25436582|NCT04759742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436583|NCT04759742|Sensory System Agents|sensory system agents|mesh-ancestor
25436584|NCT04759742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25436585|NCT04759235|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25436586|NCT04759235|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25436587|NCT04759235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436588|NCT04760262|Remifentanil|remifentanil|mesh-list
25436589|NCT04760262|Propofol|propofol|mesh-list
25436590|NCT04760262|Sevoflurane|sevoflurane|mesh-list
25436591|NCT04760262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25436592|NCT04760262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25436593|NCT04760262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436594|NCT04760262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25436595|NCT04760262|Anesthetics, General|anesthetics, general|mesh-ancestor
25436596|NCT04760262|Anesthetics|anesthetics|mesh-ancestor
25436597|NCT04760262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25436598|NCT04760262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25436599|NCT04760262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25436600|NCT04760262|Narcotics|narcotics|mesh-ancestor
25436601|NCT04760262|Analgesics|analgesics|mesh-ancestor
25822790|NCT00004650|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24403121|NCT00159445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25436602|NCT04760262|Sensory System Agents|sensory system agents|mesh-ancestor
25436603|NCT04760262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25436605|NCT04758936|Dexmedetomidine|dexmedetomidine|mesh-list
25436606|NCT04758936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25436607|NCT04758936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25436608|NCT04758936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436609|NCT04758936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25436610|NCT04758936|Analgesics|analgesics|mesh-ancestor
25436611|NCT04758936|Sensory System Agents|sensory system agents|mesh-ancestor
25436612|NCT04758936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25436613|NCT04758936|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25436614|NCT04758936|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25436615|NCT04758936|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25436616|NCT04758936|Adrenergic Agents|adrenergic agents|mesh-ancestor
25436617|NCT04758936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25436618|NCT04758936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436619|NCT04758936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25436620|NCT04758936|Sympatholytics|sympatholytics|mesh-ancestor
25436621|NCT04758936|Autonomic Agents|autonomic agents|mesh-ancestor
25436622|NCT04758871|Progesterone|progesterone|mesh-list
25436623|NCT04758871|Dydrogesterone|dydrogesterone|mesh-list
25436624|NCT04758871|Progestins|progestins|mesh-ancestor
25436625|NCT04758871|Hormones|hormones|mesh-ancestor
25436626|NCT04758871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25436627|NCT04758871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436628|NCT04758858|Glucagon|glucagon|mesh-list
25436629|NCT04758858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436630|NCT04758858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25436631|NCT04758858|Hormones|hormones|mesh-ancestor
25436632|NCT04758858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25436633|NCT04759079|Antiemetics|antiemetics|mesh-list
25436634|NCT04759079|Autonomic Agents|autonomic agents|mesh-ancestor
25436636|NCT04759079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436637|NCT04759079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25436638|NCT04759196|Topiramate|topiramate|mesh-list
25436639|NCT04759196|Levetiracetam|levetiracetam|mesh-list
25436640|NCT04759196|Anticonvulsants|anticonvulsants|mesh-ancestor
25436641|NCT04759196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25436642|NCT04759196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436643|NCT04759196|Nootropic Agents|nootropic agents|mesh-ancestor
25436644|NCT04758689|Methotrexate|methotrexate|mesh-list
25436645|NCT04758689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25436646|NCT04758689|Abortifacient Agents|abortifacient agents|mesh-ancestor
25436647|NCT04758689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25436648|NCT04758689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436649|NCT04758689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25436650|NCT04758689|Antimetabolites|antimetabolites|mesh-ancestor
25436651|NCT04758689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436652|NCT04758689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436653|NCT04758689|Dermatologic Agents|dermatologic agents|mesh-ancestor
25436654|NCT04758689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25436655|NCT04758689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25436656|NCT04758689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25436657|NCT04758689|Immunologic Factors|immunologic factors|mesh-ancestor
25436658|NCT04758689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25436659|NCT04758689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25436660|NCT04758728|Epinephrine|epinephrine|mesh-list
25436661|NCT04758728|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25436662|NCT04758728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25436663|NCT04758728|Adrenergic Agents|adrenergic agents|mesh-ancestor
25436664|NCT04758728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25436665|NCT04758728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436666|NCT04758728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436667|NCT04758728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25436668|NCT04758728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25436669|NCT04758728|Autonomic Agents|autonomic agents|mesh-ancestor
25436670|NCT04758728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25822791|NCT00004650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24405821|NCT00168493|Serotonin|serotonin|mesh-list
24405887|NCT00168714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405888|NCT00168714|Antiviral Agents|antiviral agents|mesh-ancestor
24405931|NCT00168779|Natriuretic Agents|natriuretic agents|mesh-ancestor
25436680|NCT04758286|Anesthetics|anesthetics|mesh-list
25436681|NCT04758286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25436682|NCT04758286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436683|NCT04758273|Vaccines|vaccines|mesh-list
25436684|NCT04758273|Immunologic Factors|immunologic factors|mesh-ancestor
25436685|NCT04758273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436686|NCT04757818|Cetylpyridinium|cetylpyridinium|mesh-list
25436687|NCT04757818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25436688|NCT04757818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25436689|NCT04758000|Metformin|metformin|mesh-list
25436690|NCT04758000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25436691|NCT04758000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436692|NCT04757974|Fostemsavir|fostemsavir|mesh-list
25436693|NCT04757974|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25436694|NCT04757974|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25436695|NCT04757974|Antiviral Agents|antiviral agents|mesh-ancestor
25436696|NCT04757974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25436697|NCT04757974|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25436698|NCT04757974|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25436699|NCT04757974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436700|NCT04757779|Docetaxel|docetaxel|mesh-list
25436701|NCT04757779|Irinotecan|irinotecan|mesh-list
25436702|NCT04757779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436703|NCT04757779|Tubulin Modulators|tubulin modulators|mesh-ancestor
25436704|NCT04757779|Antimitotic Agents|antimitotic agents|mesh-ancestor
25436705|NCT04757779|Mitosis Modulators|mitosis modulators|mesh-ancestor
25436706|NCT04757779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436707|NCT04757779|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25436708|NCT04757779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25436709|NCT04757779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25436710|NCT04757506|Naltrexone|naltrexone|mesh-list
25436711|NCT04757506|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25719486|NCT02451917|Insulin Glargine|insulin glargine|mesh-list
25436712|NCT04757506|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25436713|NCT04757506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436714|NCT04757506|Sensory System Agents|sensory system agents|mesh-ancestor
25436715|NCT04757506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25436716|NCT04757532|Methyltestosterone|methyltestosterone|mesh-list
25436717|NCT04757532|Anastrozole|anastrozole|mesh-list
25436718|NCT04757532|Chlorthalidone|chlorthalidone|mesh-list
25436720|NCT04757532|Testosterone|testosterone|mesh-list
25436721|NCT04757532|Testosterone undecanoate|testosterone undecanoate|mesh-list
25436722|NCT04757532|Testosterone enanthate|testosterone enanthate|mesh-list
25436723|NCT04757532|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25436724|NCT04757532|Danazol|danazol|mesh-list
25436725|NCT04757532|Androgens|androgens|mesh-ancestor
25436726|NCT04757532|Hormones|hormones|mesh-ancestor
25436727|NCT04757532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25436728|NCT04757532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436729|NCT04757532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25436730|NCT04757532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436731|NCT04757532|Anabolic Agents|anabolic agents|mesh-ancestor
25436732|NCT04757532|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25436733|NCT04757532|Antidepressive Agents|antidepressive agents|mesh-ancestor
25436734|NCT04757532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25436735|NCT04757532|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25436736|NCT04757532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25436737|NCT04757532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25436738|NCT04757532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436739|NCT04757532|Dopamine Agents|dopamine agents|mesh-ancestor
25436740|NCT04757532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25436741|NCT04757532|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25436742|NCT04757532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25436743|NCT04757532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25436744|NCT04757532|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25436745|NCT04757532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25436746|NCT04757532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25436747|NCT04757532|Hormone Antagonists|hormone antagonists|mesh-ancestor
25436748|NCT04757532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25436749|NCT04757532|Diuretics|diuretics|mesh-ancestor
25436750|NCT04757532|Natriuretic Agents|natriuretic agents|mesh-ancestor
25436751|NCT04757532|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25436752|NCT04757376|Denosumab|denosumab|mesh-list
24636169|NCT01143584|Dopamine Agonists|dopamine agonists|mesh-list
24636170|NCT01143584|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24636171|NCT01143584|Sympathomimetics|sympathomimetics|mesh-ancestor
24636263|NCT01144312|Fentanyl|fentanyl|mesh-list
25436753|NCT04757376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25436754|NCT04757376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436755|NCT04757337|Cyclophosphamide|cyclophosphamide|mesh-list
25436756|NCT04757337|Doxorubicin|doxorubicin|mesh-list
25436757|NCT04757337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25436758|NCT04757337|Immunologic Factors|immunologic factors|mesh-ancestor
25436759|NCT04757337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436760|NCT04757337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25436761|NCT04757337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25436762|NCT04757337|Alkylating Agents|alkylating agents|mesh-ancestor
25436763|NCT04757337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436764|NCT04757337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436765|NCT04757337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25436766|NCT04757337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25436767|NCT04757337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25436768|NCT04757337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25436769|NCT04757337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25436770|NCT04756882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25436771|NCT04756882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25436772|NCT04756882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25436773|NCT04756882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25436774|NCT04756882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436775|NCT04756882|Cholinergic Agents|cholinergic agents|mesh-ancestor
25436776|NCT04756882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25436777|NCT04756882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436778|NCT04756882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25436779|NCT04756882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25436780|NCT04756895|Vancomycin|vancomycin|mesh-list
25436781|NCT04756895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25436782|NCT04756895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25436783|NCT04756622|Acetylcysteine|acetylcysteine|mesh-list
25436784|NCT04756622|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25436785|NCT04756622|Antiviral Agents|antiviral agents|mesh-ancestor
25436786|NCT04756622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25436787|NCT04756622|Expectorants|expectorants|mesh-ancestor
25436788|NCT04756622|Respiratory System Agents|respiratory system agents|mesh-ancestor
25436789|NCT04756622|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25436790|NCT04756622|Antioxidants|antioxidants|mesh-ancestor
25436791|NCT04756622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436792|NCT04756622|Protective Agents|protective agents|mesh-ancestor
25436793|NCT04756622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436794|NCT04756622|Antidotes|antidotes|mesh-ancestor
25436795|NCT04756492|Cyclosporine|cyclosporine|mesh-list
25436796|NCT04756492|Antifungal Agents|antifungal agents|mesh-ancestor
25436797|NCT04756492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25436798|NCT04756492|Dermatologic Agents|dermatologic agents|mesh-ancestor
25436799|NCT04756492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25436800|NCT04756492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436801|NCT04756492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25436802|NCT04756492|Immunologic Factors|immunologic factors|mesh-ancestor
25436803|NCT04756492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436804|NCT04756492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25436805|NCT04756492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25436806|NCT04756661|Misoprostol|misoprostol|mesh-list
25436807|NCT04756661|Oxytocin|oxytocin|mesh-list
25436808|NCT04756661|Carbetocin|carbetocin|mesh-list
25436809|NCT04756661|Oxytocics|oxytocics|mesh-ancestor
25436810|NCT04756661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25436811|NCT04756661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436812|NCT04756661|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25436813|NCT04756661|Abortifacient Agents|abortifacient agents|mesh-ancestor
25436814|NCT04756661|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25436815|NCT04756661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25436816|NCT04756323|Vaccines|vaccines|mesh-list
25436817|NCT04756323|Immunologic Factors|immunologic factors|mesh-ancestor
25436818|NCT04756323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436819|NCT04756557|Fluorides|fluorides|mesh-list
25436820|NCT04756557|Sodium Fluoride|sodium fluoride|mesh-list
25436821|NCT04756557|Cariostatic Agents|cariostatic agents|mesh-ancestor
25436822|NCT04756557|Protective Agents|protective agents|mesh-ancestor
25436823|NCT04756557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436824|NCT04756206|Dutasteride|dutasteride|mesh-list
25436825|NCT04756206|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25436826|NCT04756206|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25436827|NCT04756206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25436828|NCT04756206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436853|NCT04755868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436854|NCT04755868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436855|NCT04756050|Epinephrine|epinephrine|mesh-list
25436856|NCT04756050|Racepinephrine|racepinephrine|mesh-list
25436857|NCT04756050|Bupivacaine|bupivacaine|mesh-list
25436858|NCT04756050|Prilocaine|prilocaine|mesh-list
25436859|NCT04756050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25436860|NCT04756050|Epinephryl borate|epinephryl borate|mesh-list
25719510|NCT02452047|Imipenem|imipenem|mesh-list
25436861|NCT04756050|Anesthetics, Local|anesthetics, local|mesh-ancestor
25436862|NCT04756050|Anesthetics|anesthetics|mesh-ancestor
25436863|NCT04756050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25436864|NCT04756050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436865|NCT04756050|Sensory System Agents|sensory system agents|mesh-ancestor
25436866|NCT04756050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25436867|NCT04756050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25436868|NCT04756050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25436869|NCT04756050|Adrenergic Agents|adrenergic agents|mesh-ancestor
25436870|NCT04756050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25436871|NCT04756050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436872|NCT04756050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25436873|NCT04756050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25436874|NCT04756050|Autonomic Agents|autonomic agents|mesh-ancestor
25436875|NCT04756050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25436876|NCT04756050|Respiratory System Agents|respiratory system agents|mesh-ancestor
25436877|NCT04756050|Mydriatics|mydriatics|mesh-ancestor
25436878|NCT04756050|Sympathomimetics|sympathomimetics|mesh-ancestor
25436879|NCT04756050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25822792|NCT00004650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436880|NCT04755595|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25436881|NCT04755595|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25436882|NCT04755595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25436883|NCT04755595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25436884|NCT04755595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436885|NCT04755595|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25436886|NCT04755595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25436887|NCT04755595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436888|NCT04755595|Cholinergic Agents|cholinergic agents|mesh-ancestor
25436889|NCT04755595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25436891|NCT04755647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25436892|NCT04755647|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25436893|NCT04755647|Autonomic Agents|autonomic agents|mesh-ancestor
25436894|NCT04755647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25436895|NCT04755647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436896|NCT04755647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25436897|NCT04755647|Respiratory System Agents|respiratory system agents|mesh-ancestor
25436898|NCT04755647|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25436900|NCT04755647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436901|NCT04755647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25436902|NCT04755647|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25436903|NCT04755647|Vasodilator Agents|vasodilator agents|mesh-ancestor
25436904|NCT04755647|Gasotransmitters|gasotransmitters|mesh-ancestor
25436905|NCT04755647|Protective Agents|protective agents|mesh-ancestor
25436906|NCT04755543|Cisplatin|cisplatin|mesh-list
25436907|NCT04755543|Fluorouracil|fluorouracil|mesh-list
25436908|NCT04755543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25436909|NCT04755543|Antimetabolites|antimetabolites|mesh-ancestor
25436910|NCT04755543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436911|NCT04755543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25436912|NCT04755543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25436913|NCT04755543|Immunologic Factors|immunologic factors|mesh-ancestor
25436914|NCT04755543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436915|NCT04755322|Aspirin|aspirin|mesh-list
25436916|NCT04755322|Folic Acid|folic acid|mesh-list
25436917|NCT04755322|Hydroxychloroquine|hydroxychloroquine|mesh-list
25436918|NCT04755322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25436919|NCT04755322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25436920|NCT04755322|Analgesics|analgesics|mesh-ancestor
25436921|NCT04755322|Sensory System Agents|sensory system agents|mesh-ancestor
25436922|NCT04755322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25436923|NCT04755322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436924|NCT04755322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25436925|NCT04755322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25436926|NCT04755322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25436927|NCT04755322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25436928|NCT04755322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436929|NCT04755322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25436930|NCT04755322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25436931|NCT04755322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25436932|NCT04755322|Antipyretics|antipyretics|mesh-ancestor
25436933|NCT04755322|Antimalarials|antimalarials|mesh-ancestor
25436934|NCT04755322|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25436935|NCT04755322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25436936|NCT04755322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25436937|NCT04755322|Hematinics|hematinics|mesh-ancestor
25436938|NCT04755322|Vitamin B Complex|vitamin b complex|mesh-ancestor
25436939|NCT04755322|Vitamins|vitamins|mesh-ancestor
25436940|NCT04755322|Micronutrients|micronutrients|mesh-ancestor
25436941|NCT04755387|Ticagrelor|ticagrelor|mesh-list
25436942|NCT04755387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25436943|NCT04755387|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25436944|NCT04755387|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25436945|NCT04755387|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25436946|NCT04755387|Purinergic Agents|purinergic agents|mesh-ancestor
25436947|NCT04755387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25436948|NCT04755387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436949|NCT04755387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436950|NCT04755062|Micronutrients|micronutrients|mesh-list
25436951|NCT04755062|Trace Elements|trace elements|mesh-list
24486101|NCT00456313|Sympathomimetics|sympathomimetics|mesh-ancestor
24486252|NCT00456937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436952|NCT04755062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436954|NCT04754763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25436955|NCT04754750|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25436956|NCT04754750|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25436957|NCT04754750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25436958|NCT04754750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25436959|NCT04754750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436960|NCT04754750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25436961|NCT04754750|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25436962|NCT04754750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25436963|NCT04754750|Serotonin Agents|serotonin agents|mesh-ancestor
25436964|NCT04754750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25436965|NCT04754750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436966|NCT04754750|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25436967|NCT04754750|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25436968|NCT04754750|Dopamine Agents|dopamine agents|mesh-ancestor
25436969|NCT04754789|Aspirin|aspirin|mesh-list
25436970|NCT04754789|Ticagrelor|ticagrelor|mesh-list
25436971|NCT04754789|Atorvastatin|atorvastatin|mesh-list
25436972|NCT04754789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25436973|NCT04754789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25436974|NCT04754789|Analgesics|analgesics|mesh-ancestor
25436975|NCT04754789|Sensory System Agents|sensory system agents|mesh-ancestor
25436976|NCT04754789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25436977|NCT04754789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25436978|NCT04754789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25436979|NCT04754789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25436980|NCT04754789|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25436981|NCT04754789|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25436982|NCT04754789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25436983|NCT04754789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25436984|NCT04754789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25436985|NCT04754789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25436986|NCT04754789|Antipyretics|antipyretics|mesh-ancestor
25436987|NCT04754789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25436988|NCT04754789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25436989|NCT04754789|Antimetabolites|antimetabolites|mesh-ancestor
25436990|NCT04754789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25436991|NCT04754789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25436992|NCT04754789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25436993|NCT04754789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25436994|NCT04754789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25436995|NCT04754789|Purinergic Agents|purinergic agents|mesh-ancestor
25436996|NCT04754789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25436997|NCT04753918|Ethiodized Oil|ethiodized oil|mesh-list
25436998|NCT04753918|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
25436999|NCT04753918|Trioxsalen|trioxsalen|mesh-list
25437000|NCT04753918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25437001|NCT04753918|Dermatologic Agents|dermatologic agents|mesh-ancestor
25437002|NCT04753918|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25437003|NCT04753723|Gentamicins|gentamicins|mesh-list
25437004|NCT04753723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25437005|NCT04753723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25437006|NCT04753723|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25437007|NCT04753723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437008|NCT04753723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437009|NCT04753515|Midazolam|midazolam|mesh-list
25437010|NCT04753515|Dexmedetomidine|dexmedetomidine|mesh-list
25437011|NCT04753515|Remifentanil|remifentanil|mesh-list
25437012|NCT04753515|Propofol|propofol|mesh-list
25437013|NCT04753515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25437014|NCT04753515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25437015|NCT04753515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437016|NCT04753515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25437017|NCT04753515|Anesthetics, General|anesthetics, general|mesh-ancestor
25437018|NCT04753515|Anesthetics|anesthetics|mesh-ancestor
25437019|NCT04753515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25437020|NCT04753515|Analgesics|analgesics|mesh-ancestor
25437021|NCT04753515|Sensory System Agents|sensory system agents|mesh-ancestor
25437022|NCT04753515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437023|NCT04753515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25437024|NCT04753515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25437025|NCT04753515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25437026|NCT04753515|Adrenergic Agents|adrenergic agents|mesh-ancestor
25437027|NCT04753515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25437028|NCT04753515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437029|NCT04753515|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25437030|NCT04753515|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25437031|NCT04753515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25437032|NCT04753515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25437033|NCT04753515|GABA Modulators|gaba modulators|mesh-ancestor
25437034|NCT04753515|GABA Agents|gaba agents|mesh-ancestor
25437035|NCT04753515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25437036|NCT04753515|Narcotics|narcotics|mesh-ancestor
25437037|NCT04753489|Rivaroxaban|rivaroxaban|mesh-list
25437038|NCT04753489|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25437039|NCT04753489|Antithrombins|antithrombins|mesh-ancestor
25437040|NCT04753489|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25437041|NCT04753489|Protease Inhibitors|protease inhibitors|mesh-ancestor
25437042|NCT04753489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437043|NCT04753489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437044|NCT04753489|Anticoagulants|anticoagulants|mesh-ancestor
25437045|NCT04753619|Niclosamide|niclosamide|mesh-list
25437046|NCT04753619|Anticestodal Agents|anticestodal agents|mesh-ancestor
25437047|NCT04753619|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25437048|NCT04753619|Anthelmintics|anthelmintics|mesh-ancestor
25437049|NCT04753619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25437050|NCT04753619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25437051|NCT04753619|Antinematodal Agents|antinematodal agents|mesh-ancestor
25437052|NCT04753151|Tranexamic Acid|tranexamic acid|mesh-list
25437053|NCT04753151|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25437054|NCT04753151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25437055|NCT04753151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437056|NCT04753151|Hemostatics|hemostatics|mesh-ancestor
25437057|NCT04753151|Coagulants|coagulants|mesh-ancestor
25437058|NCT04753112|Valsartan|valsartan|mesh-list
25437059|NCT04753112|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25437060|NCT04753112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25437061|NCT04753112|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25437062|NCT04753112|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25437063|NCT04753112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437064|NCT04753203|Capecitabine|capecitabine|mesh-list
25437065|NCT04753203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25437066|NCT04753203|Antimetabolites|antimetabolites|mesh-ancestor
25437067|NCT04753203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437068|NCT04753203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25437069|NCT04753177|Paclitaxel|paclitaxel|mesh-list
25437070|NCT04753177|Cyclophosphamide|cyclophosphamide|mesh-list
25437071|NCT04753177|Doxorubicin|doxorubicin|mesh-list
25437072|NCT04753177|Fulvestrant|fulvestrant|mesh-list
25437073|NCT04753177|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25437074|NCT04753177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25437075|NCT04753177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25437076|NCT04753177|Tubulin Modulators|tubulin modulators|mesh-ancestor
25437077|NCT04753177|Antimitotic Agents|antimitotic agents|mesh-ancestor
25437078|NCT04753177|Mitosis Modulators|mitosis modulators|mesh-ancestor
25437079|NCT04753177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437080|NCT04753177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25437081|NCT04753177|Immunologic Factors|immunologic factors|mesh-ancestor
25437082|NCT04753177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437083|NCT04753177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25437084|NCT04753177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25437085|NCT04753177|Alkylating Agents|alkylating agents|mesh-ancestor
25437086|NCT04753177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25437087|NCT04753177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25437088|NCT04753177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25437089|NCT04753177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25437090|NCT04753177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437091|NCT04753177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25437092|NCT04753177|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25437093|NCT04753177|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25437094|NCT04753177|Hormone Antagonists|hormone antagonists|mesh-ancestor
25437095|NCT04753177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25437096|NCT04753177|Luteolytic Agents|luteolytic agents|mesh-ancestor
25437097|NCT04753177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25437098|NCT04753177|Contraceptive Agents|contraceptive agents|mesh-ancestor
25437099|NCT04753177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25437100|NCT04753177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25437103|NCT04753008|Sympathomimetics|sympathomimetics|mesh-ancestor
25437104|NCT04753008|Autonomic Agents|autonomic agents|mesh-ancestor
25437105|NCT04753008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437106|NCT04753008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437107|NCT04753008|Dopamine Agents|dopamine agents|mesh-ancestor
25437108|NCT04753008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25437109|NCT04753008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643527|NCT01427972|Hormone Antagonists|hormone antagonists|mesh-ancestor
25437110|NCT04753008|Protective Agents|protective agents|mesh-ancestor
25437112|NCT04753294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25437113|NCT04753294|Anticonvulsants|anticonvulsants|mesh-ancestor
25437114|NCT04753294|Antiemetics|antiemetics|mesh-ancestor
25437115|NCT04753294|Autonomic Agents|autonomic agents|mesh-ancestor
25437116|NCT04753294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437117|NCT04753294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437118|NCT04753294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25437119|NCT04753294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25437120|NCT04753294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25437121|NCT04753294|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25437122|NCT04753294|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25437123|NCT04753294|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25437124|NCT04753294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25437125|NCT04753294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25437126|NCT04753294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25437127|NCT04753294|Anesthetics, General|anesthetics, general|mesh-ancestor
25437128|NCT04753294|Anesthetics|anesthetics|mesh-ancestor
25437129|NCT04753294|GABA Modulators|gaba modulators|mesh-ancestor
25437130|NCT04753294|GABA Agents|gaba agents|mesh-ancestor
25437131|NCT04753294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25437132|NCT04753294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437133|NCT04752852|Dexamethasone|dexamethasone|mesh-list
25437134|NCT04752852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25437135|NCT04752852|Antiemetics|antiemetics|mesh-ancestor
25437136|NCT04752852|Autonomic Agents|autonomic agents|mesh-ancestor
25437137|NCT04752852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437138|NCT04752852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437139|NCT04752852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25437140|NCT04752852|Glucocorticoids|glucocorticoids|mesh-ancestor
25437141|NCT04752852|Hormones|hormones|mesh-ancestor
25437142|NCT04752852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25437143|NCT04752852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25437144|NCT04752852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25437145|NCT04752111|Esmolol|esmolol|mesh-list
25437146|NCT04752111|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25437147|NCT04752111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25437148|NCT04752111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25437149|NCT04752111|Adrenergic Agents|adrenergic agents|mesh-ancestor
25437150|NCT04752111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25437151|NCT04752111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437152|NCT04752111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437153|NCT04751955|Capecitabine|capecitabine|mesh-list
25437154|NCT04751955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25437155|NCT04751955|Antimetabolites|antimetabolites|mesh-ancestor
25437156|NCT04751955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437157|NCT04751955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25437158|NCT04751669|Trace Elements|trace elements|mesh-list
25437159|NCT04751669|Micronutrients|micronutrients|mesh-list
25437160|NCT04751669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437161|NCT04751344|Bupivacaine|bupivacaine|mesh-list
25437162|NCT04751344|Anesthetics, Local|anesthetics, local|mesh-ancestor
25437163|NCT04751344|Anesthetics|anesthetics|mesh-ancestor
25437164|NCT04751344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25437165|NCT04751344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437166|NCT04751344|Sensory System Agents|sensory system agents|mesh-ancestor
25437167|NCT04751344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437168|NCT04751227|Modafinil|modafinil|mesh-list
25437169|NCT04751227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25437170|NCT04751227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437171|NCT04751227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25437172|NCT04751227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25437173|NCT04751227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25437174|NCT04751227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437175|NCT04751318|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25437176|NCT04751318|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25437177|NCT04751318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25437178|NCT04751318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25437179|NCT04751318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437180|NCT04751318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25437181|NCT04751318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437182|NCT04751318|Analgesics|analgesics|mesh-ancestor
25437183|NCT04751318|Sensory System Agents|sensory system agents|mesh-ancestor
25437184|NCT04751318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437185|NCT04751318|Antidepressive Agents|antidepressive agents|mesh-ancestor
25437186|NCT04751318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25437187|NCT04751318|Dopamine Agents|dopamine agents|mesh-ancestor
25437188|NCT04751604|Niacinamide|niacinamide|mesh-list
25437189|NCT04751604|Niacin|niacin|mesh-list
25437190|NCT04751604|Nicotinic Acids|nicotinic acids|mesh-list
25437191|NCT04751604|Vitamin B Complex|vitamin b complex|mesh-ancestor
25437192|NCT04751604|Vitamins|vitamins|mesh-ancestor
25437193|NCT04751604|Micronutrients|micronutrients|mesh-ancestor
25437194|NCT04751604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437195|NCT04751604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25437196|NCT04751604|Antimetabolites|antimetabolites|mesh-ancestor
25437197|NCT04751604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437198|NCT04751604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25437199|NCT04751604|Vasodilator Agents|vasodilator agents|mesh-ancestor
25437200|NCT04751175|Dexamethasone|dexamethasone|mesh-list
25437201|NCT04751175|Ketamine|ketamine|mesh-list
25437202|NCT04751175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25437203|NCT04751175|Antiemetics|antiemetics|mesh-ancestor
25437204|NCT04751175|Autonomic Agents|autonomic agents|mesh-ancestor
25437205|NCT04751175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437206|NCT04751175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437207|NCT04751175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25437208|NCT04751175|Glucocorticoids|glucocorticoids|mesh-ancestor
25437209|NCT04751175|Hormones|hormones|mesh-ancestor
25437210|NCT04751175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25437211|NCT04751175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25437212|NCT04751175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25437213|NCT04751175|Analgesics|analgesics|mesh-ancestor
25437214|NCT04751175|Sensory System Agents|sensory system agents|mesh-ancestor
25437215|NCT04751175|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25437216|NCT04751175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25437217|NCT04751175|Anesthetics, General|anesthetics, general|mesh-ancestor
25437218|NCT04751175|Anesthetics|anesthetics|mesh-ancestor
25437219|NCT04751175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25437220|NCT04751175|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25437221|NCT04751175|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25437222|NCT04751175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25437223|NCT04751175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437224|NCT04751188|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25437225|NCT04751188|Bezafibrate|bezafibrate|mesh-list
25437226|NCT04751188|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25437227|NCT04751188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25437228|NCT04751188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25437229|NCT04751188|Antimetabolites|antimetabolites|mesh-ancestor
25437230|NCT04751188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437231|NCT04751188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25437232|NCT04751084|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25437233|NCT04751084|Parasympatholytics|parasympatholytics|mesh-ancestor
25437234|NCT04751084|Autonomic Agents|autonomic agents|mesh-ancestor
25437235|NCT04751084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437236|NCT04751084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437237|NCT04751084|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25437238|NCT04751084|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25437239|NCT04751084|Cholinergic Agents|cholinergic agents|mesh-ancestor
25437240|NCT04751084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25437241|NCT04751084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437242|NCT04751136|Cerebrolysin|cerebrolysin|mesh-list
25437243|NCT04751136|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25437244|NCT04751136|Protective Agents|protective agents|mesh-ancestor
25437245|NCT04751136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437246|NCT04751136|Nootropic Agents|nootropic agents|mesh-ancestor
25437247|NCT04750603|Fluticasone|fluticasone|mesh-list
25437248|NCT04750603|Xhance|xhance|mesh-list
25437256|NCT04750603|Respiratory System Agents|respiratory system agents|mesh-ancestor
25437257|NCT04750603|Dermatologic Agents|dermatologic agents|mesh-ancestor
25437258|NCT04750603|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25437259|NCT04750603|Tocolytic Agents|tocolytic agents|mesh-ancestor
25437260|NCT04750603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25437261|NCT04750603|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25437262|NCT04750603|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25437263|NCT04750603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25437264|NCT04750603|Adrenergic Agents|adrenergic agents|mesh-ancestor
25437265|NCT04750603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24807234|NCT02020603|Hemostatics|hemostatics|mesh-list
25822793|NCT00004652|Pimozide|pimozide|mesh-list
25437266|NCT04750603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437267|NCT04750460|Teriparatide|teriparatide|mesh-list
25437268|NCT04750460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25437269|NCT04750460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437270|NCT04750460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25437271|NCT04750317|Tofacitinib|tofacitinib|mesh-list
25437272|NCT04750317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25437273|NCT04750317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437274|NCT04750317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437275|NCT04750382|Gemcitabine|gemcitabine|mesh-list
25437276|NCT04750382|Cisplatin|cisplatin|mesh-list
25437277|NCT04750382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25437278|NCT04750382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25437279|NCT04750382|Antimetabolites|antimetabolites|mesh-ancestor
25437280|NCT04750382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437281|NCT04750382|Antiviral Agents|antiviral agents|mesh-ancestor
25437282|NCT04750382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25437283|NCT04750382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437284|NCT04750382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25437285|NCT04750382|Immunologic Factors|immunologic factors|mesh-ancestor
25437286|NCT04750382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437287|NCT04749940|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25437288|NCT04749940|Laxatives|laxatives|mesh-ancestor
25437289|NCT04749940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25437290|NCT04749979|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25437291|NCT04749979|Luteolytic Agents|luteolytic agents|mesh-ancestor
25437292|NCT04749979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25437293|NCT04749979|Contraceptive Agents|contraceptive agents|mesh-ancestor
25437294|NCT04749979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25437295|NCT04749979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437296|NCT04749979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25437297|NCT04749979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25437298|NCT04749979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25437299|NCT04749914|Dabigatran|dabigatran|mesh-list
25437300|NCT04749914|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25437301|NCT04749914|Lasmiditan|lasmiditan|mesh-list
25437302|NCT04749914|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25437303|NCT04749914|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25437304|NCT04749914|Antimetabolites|antimetabolites|mesh-ancestor
25437305|NCT04749914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437306|NCT04749914|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25437307|NCT04749914|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25437308|NCT04749914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437309|NCT04749914|Antithrombins|antithrombins|mesh-ancestor
25437310|NCT04749914|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25437311|NCT04749914|Protease Inhibitors|protease inhibitors|mesh-ancestor
25437312|NCT04749914|Anticoagulants|anticoagulants|mesh-ancestor
25437313|NCT04749914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25437314|NCT04749914|Serotonin Agents|serotonin agents|mesh-ancestor
25437315|NCT04749914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25437316|NCT04749914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437317|NCT04750122|Carboplatin|carboplatin|mesh-list
25437318|NCT04750122|Docetaxel|docetaxel|mesh-list
25437319|NCT04750122|Trastuzumab|trastuzumab|mesh-list
25437320|NCT04750122|Pertuzumab|pertuzumab|mesh-list
25437321|NCT04750122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25437322|NCT04750122|Tubulin Modulators|tubulin modulators|mesh-ancestor
25437323|NCT04750122|Antimitotic Agents|antimitotic agents|mesh-ancestor
25437324|NCT04750122|Mitosis Modulators|mitosis modulators|mesh-ancestor
25437325|NCT04750122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437326|NCT04750122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25437327|NCT04750135|Metformin|metformin|mesh-list
25437328|NCT04750135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25437329|NCT04750135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437330|NCT04750083|Cisplatin|cisplatin|mesh-list
25437331|NCT04750083|Carboplatin|carboplatin|mesh-list
25437332|NCT04750083|Pembrolizumab|pembrolizumab|mesh-list
25437333|NCT04750083|Pemetrexed|pemetrexed|mesh-list
25437334|NCT04750083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25437335|NCT04750083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25437336|NCT04750083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437337|NCT04750083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437338|NCT04750083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25437339|NCT04750083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25437340|NCT04749797|Bupivacaine|bupivacaine|mesh-list
25437341|NCT04749797|Anesthetics, Local|anesthetics, local|mesh-ancestor
25437342|NCT04749797|Anesthetics|anesthetics|mesh-ancestor
25437343|NCT04749797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25437344|NCT04749797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437345|NCT04749797|Sensory System Agents|sensory system agents|mesh-ancestor
25437346|NCT04749797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437347|NCT04749602|Nivolumab|nivolumab|mesh-list
25437348|NCT04749602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25437349|NCT04749602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25437350|NCT04749602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25437351|NCT04749602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437352|NCT04749043|Nitrous Oxide|nitrous oxide|mesh-list
25437353|NCT04749043|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25437354|NCT04749043|Anesthetics, General|anesthetics, general|mesh-ancestor
25437355|NCT04749043|Anesthetics|anesthetics|mesh-ancestor
25437356|NCT04749043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25437357|NCT04749043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437358|NCT04749043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25437359|NCT04749043|Analgesics|analgesics|mesh-ancestor
25437360|NCT04749043|Sensory System Agents|sensory system agents|mesh-ancestor
25437361|NCT04749043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437362|NCT04749069|Remifentanil|remifentanil|mesh-list
25437363|NCT04749069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25437364|NCT04749069|Narcotics|narcotics|mesh-ancestor
25437365|NCT04749069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25437366|NCT04749069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437367|NCT04749069|Analgesics|analgesics|mesh-ancestor
25437368|NCT04749069|Sensory System Agents|sensory system agents|mesh-ancestor
25437369|NCT04749069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437370|NCT04748887|Superoxide Dismutase|superoxide dismutase|mesh-list
25437371|NCT04748887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25437372|NCT04748887|Antioxidants|antioxidants|mesh-ancestor
25437373|NCT04748887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437374|NCT04748887|Protective Agents|protective agents|mesh-ancestor
25437375|NCT04748887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437376|NCT04748562|Progesterone|progesterone|mesh-list
25437377|NCT04748562|Progestins|progestins|mesh-ancestor
25437378|NCT04748562|Hormones|hormones|mesh-ancestor
25437379|NCT04748562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25437380|NCT04748562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437381|NCT04748757|Annexin A5|annexin a5|mesh-list
25437382|NCT04748757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437383|NCT04748757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437384|NCT04748796|Landiolol|landiolol|mesh-list
25437385|NCT04748796|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25437386|NCT04748796|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25437387|NCT04748796|Adrenergic Agents|adrenergic agents|mesh-ancestor
25437388|NCT04748796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25437389|NCT04748796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437390|NCT04748796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437391|NCT04748796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25437392|NCT04748276|Norepinephrine|norepinephrine|mesh-list
25437422|NCT04747392|Teriparatide|teriparatide|mesh-list
25437423|NCT04747392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25437424|NCT04747392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437425|NCT04747392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25437426|NCT04747015|Oxytocin|oxytocin|mesh-list
25437427|NCT04747015|Oxytocics|oxytocics|mesh-ancestor
25437428|NCT04747015|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25437429|NCT04747015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437430|NCT04746937|Nitazoxanide|nitazoxanide|mesh-list
25437431|NCT04746937|Norfloxacin|norfloxacin|mesh-list
25437432|NCT04746937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25437433|NCT04746937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25437434|NCT04746937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25437435|NCT04746937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25437436|NCT04746937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25437437|NCT04746937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437438|NCT04746937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437439|NCT04746937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25437440|NCT04746937|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25437441|NCT04746937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25437442|NCT04747080|Dexamethasone|dexamethasone|mesh-list
25437443|NCT04747080|Dexamethasone acetate|dexamethasone acetate|mesh-list
25437444|NCT04747080|BB 1101|bb 1101|mesh-list
25437445|NCT04747080|Tacrolimus|tacrolimus|mesh-list
25643528|NCT01427972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25437446|NCT04747080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25437447|NCT04747080|Antiemetics|antiemetics|mesh-ancestor
25437448|NCT04747080|Autonomic Agents|autonomic agents|mesh-ancestor
25437449|NCT04747080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437450|NCT04747080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437451|NCT04747080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25437452|NCT04747080|Glucocorticoids|glucocorticoids|mesh-ancestor
25437453|NCT04747080|Hormones|hormones|mesh-ancestor
25437454|NCT04747080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25437455|NCT04747080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25437456|NCT04747080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25437457|NCT04747080|Protease Inhibitors|protease inhibitors|mesh-ancestor
25437458|NCT04747080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437459|NCT04747080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437460|NCT04747080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25437461|NCT04747080|Immunologic Factors|immunologic factors|mesh-ancestor
25437462|NCT04747080|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25437463|NCT04747171|Dexmedetomidine|dexmedetomidine|mesh-list
25437464|NCT04747171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25437465|NCT04747171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25437466|NCT04747171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437467|NCT04747171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25437468|NCT04747171|Analgesics|analgesics|mesh-ancestor
25437469|NCT04747171|Sensory System Agents|sensory system agents|mesh-ancestor
25437470|NCT04747171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437471|NCT04747171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25437472|NCT04747171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25437473|NCT04747171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25437474|NCT04747171|Adrenergic Agents|adrenergic agents|mesh-ancestor
25437475|NCT04747171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25437476|NCT04747171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437477|NCT04746430|Dexamethasone|dexamethasone|mesh-list
25437478|NCT04746430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25437479|NCT04746430|Antiemetics|antiemetics|mesh-ancestor
25437480|NCT04746430|Autonomic Agents|autonomic agents|mesh-ancestor
25437481|NCT04746430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437482|NCT04746430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437483|NCT04746430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25437484|NCT04746430|Glucocorticoids|glucocorticoids|mesh-ancestor
25437485|NCT04746430|Hormones|hormones|mesh-ancestor
25437486|NCT04746430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25437487|NCT04746430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24441389|NCT00287326|Anesthetics, Local|anesthetics, local|mesh-ancestor
24932682|NCT04077905|Antiemetics|antiemetics|mesh-ancestor
24442345|NCT00290758|Protective Agents|protective agents|mesh-ancestor
24442691|NCT00292123|Antitussive Agents|antitussive agents|mesh-ancestor
24933004|NCT04074473|Propranolol|propranolol|mesh-list
24442930|NCT00293332|Bevacizumab|bevacizumab|mesh-list
25822794|NCT00004652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25822795|NCT00004652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25822796|NCT00004652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25437488|NCT04746430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25437489|NCT04746365|Hydroxychloroquine|hydroxychloroquine|mesh-list
25437490|NCT04746365|Ivermectin|ivermectin|mesh-list
25437491|NCT04746365|Antimalarials|antimalarials|mesh-ancestor
25437492|NCT04746365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25437493|NCT04746365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25437494|NCT04746365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25437495|NCT04746365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437496|NCT04746365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437497|NCT04746365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25437498|NCT04746209|Blinatumomab|blinatumomab|mesh-list
25437499|NCT04746209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25437500|NCT04746040|Fluticasone|fluticasone|mesh-list
25437501|NCT04746040|Xhance|xhance|mesh-list
25437502|NCT04746040|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25437503|NCT04746040|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25437504|NCT04746040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25437505|NCT04746040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25437506|NCT04746040|Autonomic Agents|autonomic agents|mesh-ancestor
25437507|NCT04746040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437508|NCT04746040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437509|NCT04746040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25437510|NCT04746040|Respiratory System Agents|respiratory system agents|mesh-ancestor
25643530|NCT01427972|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25643531|NCT01427972|Diuretics|diuretics|mesh-ancestor
25643532|NCT01427972|Natriuretic Agents|natriuretic agents|mesh-ancestor
25643533|NCT01427972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25643534|NCT01428063|Interferons|interferons|mesh-list
25643535|NCT01428063|Ribavirin|ribavirin|mesh-list
25643536|NCT01428063|Interferon-alpha|interferon-alpha|mesh-list
25643537|NCT01428063|Interferon alpha-2|interferon alpha-2|mesh-list
25643538|NCT01428063|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25643539|NCT01428063|Asunaprevir|asunaprevir|mesh-list
25643540|NCT01428063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25643541|NCT01428063|Antiviral Agents|antiviral agents|mesh-ancestor
25643542|NCT01428063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25643543|NCT01428063|Antimetabolites|antimetabolites|mesh-ancestor
25437511|NCT04746040|Dermatologic Agents|dermatologic agents|mesh-ancestor
25437512|NCT04746040|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25437513|NCT04746040|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25437514|NCT04746040|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25437515|NCT04746040|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25437516|NCT04746040|Adrenergic Agents|adrenergic agents|mesh-ancestor
25437517|NCT04746040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25437518|NCT04746040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437519|NCT04746040|Glucocorticoids|glucocorticoids|mesh-ancestor
25437520|NCT04746040|Hormones|hormones|mesh-ancestor
25437521|NCT04746040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25437522|NCT04746040|Sympathomimetics|sympathomimetics|mesh-ancestor
25437523|NCT04745780|Inositol|inositol|mesh-list
25437524|NCT04745780|Vitamin B Complex|vitamin b complex|mesh-ancestor
25437525|NCT04745780|Vitamins|vitamins|mesh-ancestor
25437526|NCT04745780|Micronutrients|micronutrients|mesh-ancestor
25437527|NCT04745780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437528|NCT04745663|Iodine|iodine|mesh-list
25437529|NCT04745663|Cadexomer iodine|cadexomer iodine|mesh-list
25437530|NCT04745663|Povidone-Iodine|povidone-iodine|mesh-list
25437531|NCT04745663|Povidone|povidone|mesh-list
25437532|NCT04745663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25437533|NCT04745663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25437534|NCT04745663|Trace Elements|trace elements|mesh-ancestor
25437535|NCT04745663|Micronutrients|micronutrients|mesh-ancestor
25437536|NCT04745663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437537|NCT04745663|Plasma Substitutes|plasma substitutes|mesh-ancestor
25437538|NCT04745663|Blood Substitutes|blood substitutes|mesh-ancestor
25437539|NCT04745260|Fentanyl|fentanyl|mesh-list
25437540|NCT04745260|Midazolam|midazolam|mesh-list
25437541|NCT04745260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25437542|NCT04745260|Narcotics|narcotics|mesh-ancestor
25437543|NCT04745260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25437544|NCT04745260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437545|NCT04745260|Analgesics|analgesics|mesh-ancestor
25437546|NCT04745260|Sensory System Agents|sensory system agents|mesh-ancestor
25437547|NCT04745260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437548|NCT04745260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25437549|NCT04745260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25437550|NCT04745260|Anesthetics, General|anesthetics, general|mesh-ancestor
25437551|NCT04745260|Anesthetics|anesthetics|mesh-ancestor
25437552|NCT04745260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25437553|NCT04745260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25437554|NCT04745260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25437555|NCT04745260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25822797|NCT00004652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822798|NCT00004652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25822799|NCT00004652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25822800|NCT00004652|Dopamine Agents|dopamine agents|mesh-ancestor
25822801|NCT00004652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25822802|NCT00004652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822803|NCT00004652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25829451|NCT00006211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437556|NCT04745260|GABA Modulators|gaba modulators|mesh-ancestor
25437570|NCT04745286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25437571|NCT04745286|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25437572|NCT04745286|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25437573|NCT04745286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25643544|NCT01428063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643545|NCT01428063|Immunologic Factors|immunologic factors|mesh-ancestor
25437574|NCT04745286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437575|NCT04745286|Antidepressive Agents|antidepressive agents|mesh-ancestor
25437576|NCT04745286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25437578|NCT04745273|Antiemetics|antiemetics|mesh-ancestor
25437579|NCT04745273|Autonomic Agents|autonomic agents|mesh-ancestor
25437580|NCT04745273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437581|NCT04745273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437582|NCT04745273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25437583|NCT04745273|Antipruritics|antipruritics|mesh-ancestor
25437584|NCT04745273|Dermatologic Agents|dermatologic agents|mesh-ancestor
25437585|NCT04745273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25437586|NCT04745273|Serotonin Agents|serotonin agents|mesh-ancestor
25437587|NCT04745273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25437588|NCT04745273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437589|NCT04745273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25437590|NCT04745273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25719573|NCT02452528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437591|NCT04745273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25437592|NCT04745273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25437593|NCT04745273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25437594|NCT04745442|Antithrombins|antithrombins|mesh-list
25437595|NCT04745442|Antithrombin III|antithrombin iii|mesh-list
25437596|NCT04745442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25437597|NCT04745442|Protease Inhibitors|protease inhibitors|mesh-ancestor
25437598|NCT04745442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437599|NCT04745442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437600|NCT04745442|Anticoagulants|anticoagulants|mesh-ancestor
25437601|NCT04744883|Naloxone|naloxone|mesh-list
25437602|NCT04744883|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25437603|NCT04744883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437604|NCT04744883|Sensory System Agents|sensory system agents|mesh-ancestor
25437605|NCT04744883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437606|NCT04745130|Cetuximab|cetuximab|mesh-list
25437607|NCT04745130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25437608|NCT04745130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25822804|NCT00004662|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25041717|NCT01593228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24826895|NCT02136784|Oxycodone|oxycodone|mesh-list
24826896|NCT02136784|Buprenorphine|buprenorphine|mesh-list
25437610|NCT04744753|Ionophores|ionophores|mesh-list
25437611|NCT04744753|Calcium Ionophores|calcium ionophores|mesh-list
25437612|NCT04744753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25437613|NCT04744753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437614|NCT04744753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25437615|NCT04744753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437616|NCT04744727|Acetaminophen|acetaminophen|mesh-list
25437617|NCT04744727|Meperidine|meperidine|mesh-list
25437618|NCT04744727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25437619|NCT04744727|Analgesics|analgesics|mesh-ancestor
25437620|NCT04744727|Sensory System Agents|sensory system agents|mesh-ancestor
25437621|NCT04744727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437622|NCT04744727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437623|NCT04744727|Antipyretics|antipyretics|mesh-ancestor
25437624|NCT04744727|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25437625|NCT04744727|Narcotics|narcotics|mesh-ancestor
25437626|NCT04744727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25437627|NCT04744727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25437628|NCT04744649|Fluorouracil|fluorouracil|mesh-list
25437629|NCT04744649|Antimetabolites|antimetabolites|mesh-ancestor
25437630|NCT04744649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437631|NCT04744649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25437632|NCT04744649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25437633|NCT04744649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25437634|NCT04744649|Immunologic Factors|immunologic factors|mesh-ancestor
25437635|NCT04744649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437636|NCT04744675|Triamcinolone|triamcinolone|mesh-list
25437637|NCT04744675|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25437638|NCT04744675|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25437639|NCT04744675|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25437640|NCT04744675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25437641|NCT04744675|Glucocorticoids|glucocorticoids|mesh-ancestor
25437642|NCT04744675|Hormones|hormones|mesh-ancestor
25437643|NCT04744675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25437644|NCT04744675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437645|NCT04744675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25437646|NCT04744675|Immunologic Factors|immunologic factors|mesh-ancestor
25437647|NCT04744675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437648|NCT04744675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437649|NCT04744545|Curcumin|curcumin|mesh-list
25437650|NCT04744545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25437651|NCT04744545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25437652|NCT04744545|Analgesics|analgesics|mesh-ancestor
25437653|NCT04744545|Sensory System Agents|sensory system agents|mesh-ancestor
25437654|NCT04744545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437655|NCT04744545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437656|NCT04744545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25437657|NCT04744545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25437658|NCT04744545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25437659|NCT04744545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437660|NCT04744545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437661|NCT04744441|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25437662|NCT04744441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25437663|NCT04744623|Mycophenolic Acid|mycophenolic acid|mesh-list
25437664|NCT04744623|Dapsone|dapsone|mesh-list
25437665|NCT04744623|Prednisolone|prednisolone|mesh-list
25437666|NCT04744623|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25437667|NCT04744623|Methylprednisolone|methylprednisolone|mesh-list
25437668|NCT04744623|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25437669|NCT04744623|Prednisolone acetate|prednisolone acetate|mesh-list
25437670|NCT04744623|Triamcinolone|triamcinolone|mesh-list
25437671|NCT04744623|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25437672|NCT04744623|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25437673|NCT04744623|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25437674|NCT04744623|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25437675|NCT04744623|Prednisolone phosphate|prednisolone phosphate|mesh-list
25822805|NCT00004662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25822806|NCT00004662|Immunologic Factors|immunologic factors|mesh-ancestor
25822807|NCT00004662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822808|NCT00004664|Megestrol|megestrol|mesh-list
24768572|NCT01809171|Vitamin D|vitamin d|mesh-list
25822809|NCT00004664|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25822810|NCT00004664|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25822811|NCT00004664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25437676|NCT04744623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25437677|NCT04744623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25437678|NCT04744623|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25437679|NCT04744623|Antitubercular Agents|antitubercular agents|mesh-ancestor
25437680|NCT04744623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25437681|NCT04744623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25437682|NCT04744623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437683|NCT04744623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437684|NCT04744623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25437686|NCT04744623|Hormones|hormones|mesh-ancestor
25437687|NCT04744623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25437688|NCT04744623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437689|NCT04744623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25437690|NCT04744623|Antiemetics|antiemetics|mesh-ancestor
25437691|NCT04744623|Autonomic Agents|autonomic agents|mesh-ancestor
25437692|NCT04744623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437693|NCT04744623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25437694|NCT04744623|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25437695|NCT04744623|Protective Agents|protective agents|mesh-ancestor
25437696|NCT04744623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25437697|NCT04744623|Immunologic Factors|immunologic factors|mesh-ancestor
25437698|NCT04744623|Antimalarials|antimalarials|mesh-ancestor
25437699|NCT04744623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25437700|NCT04744623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25437701|NCT04744623|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25437702|NCT04744623|Leprostatic Agents|leprostatic agents|mesh-ancestor
25437703|NCT04744662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25437704|NCT04744662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25437705|NCT04744571|Aspirin|aspirin|mesh-list
25437706|NCT04744571|Metoprolol|metoprolol|mesh-list
25437707|NCT04744571|Clopidogrel|clopidogrel|mesh-list
25437708|NCT04744571|Ticagrelor|ticagrelor|mesh-list
25437709|NCT04744571|Atorvastatin|atorvastatin|mesh-list
25437710|NCT04744571|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25437711|NCT04744571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25437712|NCT04744571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25437713|NCT04744571|Analgesics|analgesics|mesh-ancestor
25437714|NCT04744571|Sensory System Agents|sensory system agents|mesh-ancestor
25437715|NCT04744571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437716|NCT04744571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822812|NCT00004664|Contraceptive Agents|contraceptive agents|mesh-ancestor
25643546|NCT01428063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437717|NCT04744571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25437718|NCT04744571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25437719|NCT04744571|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25437720|NCT04744571|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25437721|NCT04744571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437722|NCT04744571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25437723|NCT04744571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25437724|NCT04744571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437726|NCT04744571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25437727|NCT04744571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25437728|NCT04744571|Antimetabolites|antimetabolites|mesh-ancestor
25437729|NCT04744571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25437730|NCT04744571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25437731|NCT04744571|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25437732|NCT04744571|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25437733|NCT04744571|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25437734|NCT04744571|Purinergic Agents|purinergic agents|mesh-ancestor
25437735|NCT04744571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25437736|NCT04744571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25437737|NCT04744571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25437738|NCT04744571|Sympatholytics|sympatholytics|mesh-ancestor
25437739|NCT04744571|Autonomic Agents|autonomic agents|mesh-ancestor
25437740|NCT04744571|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25437741|NCT04744571|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25822813|NCT00004664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25027192|NCT03621995|Catalase|catalase|mesh-list
25027272|NCT03621072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25032686|NCT03579732|Antipyretics|antipyretics|mesh-ancestor
24772710|NCT01835197|Abrocitinib|abrocitinib|mesh-list
24449949|NCT00317434|Lapatinib|lapatinib|mesh-list
24773105|NCT01837446|Antacids|antacids|mesh-ancestor
24806474|NCT02016209|Paclitaxel|paclitaxel|mesh-list
25822814|NCT00004664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437742|NCT04744571|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25437743|NCT04744571|Adrenergic Agents|adrenergic agents|mesh-ancestor
25437745|NCT04743739|Rituximab|rituximab|mesh-list
25437746|NCT04743739|Cyclosporins|cyclosporins|mesh-list
25437747|NCT04743739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25437748|NCT04743739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25437749|NCT04743739|Immunologic Factors|immunologic factors|mesh-ancestor
25437750|NCT04743739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437751|NCT04743739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25437752|NCT04743739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437753|NCT04743739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437754|NCT04743739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25437755|NCT04743739|Antifungal Agents|antifungal agents|mesh-ancestor
25437756|NCT04743739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25437757|NCT04743739|Dermatologic Agents|dermatologic agents|mesh-ancestor
25437758|NCT04743739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25437759|NCT04743687|Zanubrutinib|zanubrutinib|mesh-list
25437760|NCT04743687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25437761|NCT04743687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25437762|NCT04743687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437763|NCT04743687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437764|NCT04743544|Voriconazole|voriconazole|mesh-list
25437765|NCT04743544|Antifungal Agents|antifungal agents|mesh-ancestor
25437766|NCT04743544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25437767|NCT04743544|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25437768|NCT04743544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25437769|NCT04743544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437770|NCT04743544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437771|NCT04743544|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25437772|NCT04743544|Hormone Antagonists|hormone antagonists|mesh-ancestor
25437773|NCT04743544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25437774|NCT04743544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437775|NCT04743544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25437776|NCT04743622|Latanoprost|latanoprost|mesh-list
25437777|NCT04743622|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25437778|NCT04743622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25437779|NCT04743180|Paclitaxel|paclitaxel|mesh-list
25437780|NCT04743180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25437781|NCT04743180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719590|NCT02452528|Histamine Agents|histamine agents|mesh-ancestor
25437782|NCT04743180|Tubulin Modulators|tubulin modulators|mesh-ancestor
25437783|NCT04743180|Antimitotic Agents|antimitotic agents|mesh-ancestor
25437784|NCT04743180|Mitosis Modulators|mitosis modulators|mesh-ancestor
25437785|NCT04743180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437786|NCT04743011|Heparin|heparin|mesh-list
25437787|NCT04743011|Calcium heparin|calcium heparin|mesh-list
25437788|NCT04743011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25437789|NCT04743011|Anticoagulants|anticoagulants|mesh-ancestor
25437790|NCT04743011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25437791|NCT04743011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25437792|NCT04743011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437793|NCT04743297|Dinoprostone|dinoprostone|mesh-list
25437794|NCT04743297|Oxytocics|oxytocics|mesh-ancestor
25437795|NCT04743297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25437796|NCT04743297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437797|NCT04743063|Losartan|losartan|mesh-list
25437798|NCT04743063|Valsartan|valsartan|mesh-list
25437799|NCT04743063|Telmisartan|telmisartan|mesh-list
25437800|NCT04743063|Candesartan|candesartan|mesh-list
25437801|NCT04743063|Olmesartan|olmesartan|mesh-list
25437802|NCT04743063|Irbesartan|irbesartan|mesh-list
25437803|NCT04743063|Eprosartan|eprosartan|mesh-list
25437804|NCT04743063|Angiotensin II|angiotensin ii|mesh-list
25437805|NCT04743063|Giapreza|giapreza|mesh-list
25437806|NCT04743063|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25437807|NCT04743063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
25437808|NCT04743063|Angiotensinogen|angiotensinogen|mesh-list
25437809|NCT04743063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25437810|NCT04743063|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25437811|NCT04743063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437812|NCT04743063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25437813|NCT04743063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25437814|NCT04743063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25437815|NCT04743063|Protease Inhibitors|protease inhibitors|mesh-ancestor
25123913|NCT03080740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437836|NCT04742101|Azacitidine|azacitidine|mesh-list
25437837|NCT04742101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25437838|NCT04742101|Antimetabolites|antimetabolites|mesh-ancestor
25437839|NCT04742101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437840|NCT04742101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25437841|NCT04742101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437842|NCT04742348|Levodopa|levodopa|mesh-list
25437843|NCT04742348|Carbidopa|carbidopa|mesh-list
25437844|NCT04742348|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25437845|NCT04742348|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25437846|NCT04742348|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25437847|NCT04742348|Dopamine Agents|dopamine agents|mesh-ancestor
25437848|NCT04742348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25437849|NCT04742348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437850|NCT04742348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437851|NCT04742348|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25437852|NCT04742348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437853|NCT04742348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25437854|NCT04742348|Immunologic Factors|immunologic factors|mesh-ancestor
25437855|NCT04742348|Dopamine Agonists|dopamine agonists|mesh-ancestor
25437856|NCT04742205|Tranexamic Acid|tranexamic acid|mesh-list
25437857|NCT04742205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25437858|NCT04742205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25437859|NCT04742205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437860|NCT04742205|Hemostatics|hemostatics|mesh-ancestor
25437861|NCT04742205|Coagulants|coagulants|mesh-ancestor
25437862|NCT04741880|Lidocaine|lidocaine|mesh-list
25437863|NCT04741880|Anesthetics, Local|anesthetics, local|mesh-ancestor
25437864|NCT04741880|Anesthetics|anesthetics|mesh-ancestor
25437865|NCT04741880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25437866|NCT04741880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437867|NCT04741880|Sensory System Agents|sensory system agents|mesh-ancestor
25437868|NCT04741880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437869|NCT04741880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25437870|NCT04741880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25437871|NCT04741880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25437872|NCT04741880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25437873|NCT04741880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437874|NCT04741464|Tinzaparin|tinzaparin|mesh-list
25437875|NCT04741464|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25437876|NCT04741464|Dalteparin|dalteparin|mesh-list
25643547|NCT01428063|Protease Inhibitors|protease inhibitors|mesh-ancestor
25643548|NCT01428063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25643549|NCT01428076|Polidocanol|polidocanol|mesh-list
25643550|NCT01428076|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25643551|NCT01428076|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25437877|NCT04741464|Anticoagulants|anticoagulants|mesh-ancestor
25437878|NCT04741464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25437879|NCT04741464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25437880|NCT04741464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437881|NCT04741295|Heparin|heparin|mesh-list
25437882|NCT04741295|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25437883|NCT04741295|Tinzaparin|tinzaparin|mesh-list
25437884|NCT04741295|Dalteparin|dalteparin|mesh-list
25437885|NCT04741295|Anticoagulants|anticoagulants|mesh-ancestor
25437886|NCT04741295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25437887|NCT04741295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25437888|NCT04741295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437889|NCT04741165|Bevacizumab|bevacizumab|mesh-list
25437890|NCT04741165|Lenvatinib|lenvatinib|mesh-list
25437891|NCT04741165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25437892|NCT04741165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25437893|NCT04741165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25437894|NCT04741165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25437895|NCT04741165|Growth Substances|growth substances|mesh-ancestor
25437896|NCT04741165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437897|NCT04741165|Growth Inhibitors|growth inhibitors|mesh-ancestor
25437898|NCT04741165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25437899|NCT04741165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437900|NCT04741165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437901|NCT04740840|Amlodipine|amlodipine|mesh-list
25437902|NCT04740840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25437903|NCT04740840|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25437904|NCT04740840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25437905|NCT04740840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437906|NCT04740840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25437907|NCT04740840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423976|NCT00227656|Interferon alpha-2|interferon alpha-2|mesh-list
24423977|NCT00227656|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25437928|NCT04740021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25437929|NCT04740021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25437930|NCT04740021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25437931|NCT04740021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25437932|NCT04740021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437933|NCT04740021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437934|NCT04740099|Naloxone|naloxone|mesh-list
25437935|NCT04740099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25437936|NCT04740099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437937|NCT04740099|Sensory System Agents|sensory system agents|mesh-ancestor
25437938|NCT04740099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25437939|NCT04739826|HH-GV-678|hh-gv-678|mesh-list
25437940|NCT04739826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25437941|NCT04739826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437942|NCT04739826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437943|NCT04739774|Itraconazole|itraconazole|mesh-list
25437944|NCT04739774|Antifungal Agents|antifungal agents|mesh-ancestor
25437945|NCT04739774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25437946|NCT04739774|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25437947|NCT04739774|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25437948|NCT04739774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437949|NCT04739774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437950|NCT04739774|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25437951|NCT04739774|Hormone Antagonists|hormone antagonists|mesh-ancestor
25437952|NCT04739774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25437953|NCT04739774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437954|NCT04739774|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25437955|NCT04740086|Calcium|calcium|mesh-list
25437956|NCT04740086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25437957|NCT04740086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437958|NCT04739917|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25437959|NCT04739917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25437960|NCT04739917|Immunologic Factors|immunologic factors|mesh-ancestor
25643552|NCT01428128|Arsenic Trioxide|arsenic trioxide|mesh-list
25643553|NCT01428128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25643554|NCT01428193|Flutamide|flutamide|mesh-list
25437961|NCT04739917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437962|NCT04739670|Gemcitabine|gemcitabine|mesh-list
25437963|NCT04739670|Bevacizumab|bevacizumab|mesh-list
25437964|NCT04739670|Carboplatin|carboplatin|mesh-list
25437965|NCT04739670|Atezolizumab|atezolizumab|mesh-list
25437966|NCT04739670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25437967|NCT04739670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25437968|NCT04739670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25437969|NCT04739670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25437970|NCT04739670|Growth Substances|growth substances|mesh-ancestor
25437971|NCT04739670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437972|NCT04739670|Growth Inhibitors|growth inhibitors|mesh-ancestor
25437973|NCT04739670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25437974|NCT04739670|Antimetabolites|antimetabolites|mesh-ancestor
25437975|NCT04739670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437976|NCT04739670|Antiviral Agents|antiviral agents|mesh-ancestor
25437977|NCT04739670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25437978|NCT04739670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437979|NCT04739670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25437980|NCT04739670|Immunologic Factors|immunologic factors|mesh-ancestor
25437981|NCT04739618|Pembrolizumab|pembrolizumab|mesh-list
25437982|NCT04739618|Ipilimumab|ipilimumab|mesh-list
25437983|NCT04739618|Sargramostim|sargramostim|mesh-list
25437984|NCT04739618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25437985|NCT04739618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25437986|NCT04739618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25437987|NCT04739618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437988|NCT04739618|Immunologic Factors|immunologic factors|mesh-ancestor
25437989|NCT04739618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25437990|NCT04739566|Trametinib|trametinib|mesh-list
25437991|NCT04739566|Dabrafenib|dabrafenib|mesh-list
25437992|NCT04739566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25437993|NCT04739566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25437994|NCT04739566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25437995|NCT04739566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25437996|NCT04739410|Ivermectin|ivermectin|mesh-list
25437997|NCT04739410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25437998|NCT04739410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25437999|NCT04739241|Insulin|insulin|mesh-list
25438000|NCT04739241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25438001|NCT04739241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25438002|NCT04739241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438003|NCT04739202|Bevacizumab|bevacizumab|mesh-list
25438004|NCT04739202|Atezolizumab|atezolizumab|mesh-list
25438005|NCT04739202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25438006|NCT04739202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25719616|NCT02453321|Bupivacaine|bupivacaine|mesh-list
25438007|NCT04739202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438008|NCT04739202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25438009|NCT04739202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25438010|NCT04739202|Growth Substances|growth substances|mesh-ancestor
25438011|NCT04739202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438012|NCT04739202|Growth Inhibitors|growth inhibitors|mesh-ancestor
25438013|NCT04739202|Immunologic Factors|immunologic factors|mesh-ancestor
25438014|NCT04739215|Dapagliflozin|dapagliflozin|mesh-list
25438015|NCT04739215|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25438016|NCT04739215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438017|NCT04739215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25438018|NCT04739215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438019|NCT04738955|Micafungin|micafungin|mesh-list
25438020|NCT04738955|Antifungal Agents|antifungal agents|mesh-ancestor
25438021|NCT04738955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25438022|NCT04739111|Antibodies|antibodies|mesh-list
25438023|NCT04739111|Immunoglobulins|immunoglobulins|mesh-list
25438024|NCT04739111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25438025|NCT04739111|Immunologic Factors|immunologic factors|mesh-ancestor
25438026|NCT04739111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438027|NCT04738981|Basiliximab|basiliximab|mesh-list
25438028|NCT04738981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25438029|NCT04738981|Immunologic Factors|immunologic factors|mesh-ancestor
25438030|NCT04738981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438031|NCT04738838|Oxytocin|oxytocin|mesh-list
25438032|NCT04738838|Oxytocics|oxytocics|mesh-ancestor
25438033|NCT04738838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25438034|NCT04738838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444058|NCT00296686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790453|NCT01942551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827035|NCT02137239|Abatacept|abatacept|mesh-list
25829452|NCT00006211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25438035|NCT04738773|Naltrexone|naltrexone|mesh-list
25438036|NCT04738773|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25438037|NCT04738773|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25438038|NCT04738773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438039|NCT04738773|Sensory System Agents|sensory system agents|mesh-ancestor
25438040|NCT04738773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25438041|NCT04738526|Lithium Carbonate|lithium carbonate|mesh-list
25438042|NCT04738526|Antidepressive Agents|antidepressive agents|mesh-ancestor
25438043|NCT04738526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25438044|NCT04738526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25438045|NCT04738526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438046|NCT04738526|Antimanic Agents|antimanic agents|mesh-ancestor
25438047|NCT04738526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25438048|NCT04738526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25438049|NCT04738526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438050|NCT04738058|Lactoferrin|lactoferrin|mesh-list
25438051|NCT04738058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25438052|NCT04738188|Epirubicin|epirubicin|mesh-list
25438053|NCT04738188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25438054|NCT04738188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438055|NCT04738188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25438056|NCT04738188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25438057|NCT04738188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25438058|NCT04738188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438059|NCT04738097|Clopidogrel|clopidogrel|mesh-list
25438060|NCT04738097|Ticagrelor|ticagrelor|mesh-list
25438061|NCT04738097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25438062|NCT04738097|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25438063|NCT04738097|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25438064|NCT04738097|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25438065|NCT04738097|Purinergic Agents|purinergic agents|mesh-ancestor
25438066|NCT04738097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25438067|NCT04738097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438068|NCT04738097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438069|NCT04738045|Ritonavir|ritonavir|mesh-list
25438070|NCT04738045|Lopinavir|lopinavir|mesh-list
25438071|NCT04738045|Remdesivir|remdesivir|mesh-list
25438072|NCT04738045|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25438073|NCT04738045|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25438074|NCT04738045|Protease Inhibitors|protease inhibitors|mesh-ancestor
25438075|NCT04738045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25438076|NCT04738045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438077|NCT04738045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25438078|NCT04738045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25438079|NCT04738045|Antiviral Agents|antiviral agents|mesh-ancestor
25438080|NCT04738045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25438081|NCT04738045|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25438082|NCT04738045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25438083|NCT04738045|Antimetabolites|antimetabolites|mesh-ancestor
25438084|NCT04737889|Rituximab|rituximab|mesh-list
25438085|NCT04737889|Methotrexate|methotrexate|mesh-list
25438086|NCT04737889|Lenalidomide|lenalidomide|mesh-list
25438087|NCT04737889|Temozolomide|temozolomide|mesh-list
25438088|NCT04737889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25438089|NCT04737889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438090|NCT04737889|Immunologic Factors|immunologic factors|mesh-ancestor
25438091|NCT04737889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438092|NCT04737889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25438093|NCT04737889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25438094|NCT04737889|Abortifacient Agents|abortifacient agents|mesh-ancestor
25438095|NCT04737889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25438096|NCT04737889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25438097|NCT04737889|Antimetabolites|antimetabolites|mesh-ancestor
25438098|NCT04737889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438099|NCT04737889|Dermatologic Agents|dermatologic agents|mesh-ancestor
25438100|NCT04737889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25438101|NCT04737889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25438102|NCT04737889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25438103|NCT04737889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25438104|NCT04737889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25438105|NCT04737889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25438106|NCT04737889|Growth Substances|growth substances|mesh-ancestor
25118939|NCT03436862|Nivolumab|nivolumab|mesh-list
24576331|NCT00837954|Coagulants|coagulants|mesh-ancestor
24577706|NCT00845598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577707|NCT00845598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25438112|NCT04737928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25438113|NCT04737980|Dexamethasone|dexamethasone|mesh-list
25438114|NCT04737980|Bupivacaine|bupivacaine|mesh-list
25438115|NCT04737980|Ropivacaine|ropivacaine|mesh-list
25438116|NCT04737980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25438117|NCT04737980|Antiemetics|antiemetics|mesh-ancestor
25438118|NCT04737980|Autonomic Agents|autonomic agents|mesh-ancestor
25438119|NCT04737980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25438120|NCT04737980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438121|NCT04737980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25438122|NCT04737980|Glucocorticoids|glucocorticoids|mesh-ancestor
25438123|NCT04737980|Hormones|hormones|mesh-ancestor
25438124|NCT04737980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25438125|NCT04737980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25438126|NCT04737980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438127|NCT04737980|Anesthetics, Local|anesthetics, local|mesh-ancestor
25438128|NCT04737980|Anesthetics|anesthetics|mesh-ancestor
25438129|NCT04737980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25438130|NCT04737980|Sensory System Agents|sensory system agents|mesh-ancestor
25438131|NCT04737967|Memantine|memantine|mesh-list
25438132|NCT04737967|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25438133|NCT04737967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25438134|NCT04737967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25438135|NCT04737967|Dopamine Agents|dopamine agents|mesh-ancestor
25438136|NCT04737967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25438137|NCT04737967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438138|NCT04737967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438139|NCT04737967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25438140|NCT04737967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25438141|NCT04737967|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25438142|NCT04737967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25438143|NCT04737967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25438144|NCT04737967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25438145|NCT04737967|Antidepressive Agents|antidepressive agents|mesh-ancestor
25438146|NCT04737967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25438147|NCT04737837|Lacosamide|lacosamide|mesh-list
25438148|NCT04737837|Anticonvulsants|anticonvulsants|mesh-ancestor
25438149|NCT04737837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25438150|NCT04737837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25438151|NCT04737837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25438152|NCT04737837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438153|NCT04737655|Beclomethasone|beclomethasone|mesh-list
25438154|NCT04737655|Glycopyrrolate|glycopyrrolate|mesh-list
25438155|NCT04737655|Formoterol Fumarate|formoterol fumarate|mesh-list
25438156|NCT04737655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25438157|NCT04737655|Autonomic Agents|autonomic agents|mesh-ancestor
25438158|NCT04737655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25438159|NCT04737655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438160|NCT04737655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25438161|NCT04737655|Respiratory System Agents|respiratory system agents|mesh-ancestor
25438162|NCT04737655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25438163|NCT04737655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25438164|NCT04737655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25438165|NCT04737655|Adrenergic Agents|adrenergic agents|mesh-ancestor
25438166|NCT04737655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25438167|NCT04737655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438168|NCT04737655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25438169|NCT04737655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25438170|NCT04737655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25438171|NCT04737655|Cholinergic Agents|cholinergic agents|mesh-ancestor
25438172|NCT04737655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25438173|NCT04737655|Glucocorticoids|glucocorticoids|mesh-ancestor
25438174|NCT04737655|Hormones|hormones|mesh-ancestor
25438175|NCT04737655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25438176|NCT04737408|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25438177|NCT04737408|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25438178|NCT04737408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25438179|NCT04737408|Antimetabolites|antimetabolites|mesh-ancestor
25438180|NCT04737408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438181|NCT04737408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25438182|NCT04737408|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25438183|NCT04737408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25438184|NCT04737278|Nicotinic Acids|nicotinic acids|mesh-list
25438186|NCT04737278|Vitamin B Complex|vitamin b complex|mesh-ancestor
25438187|NCT04737278|Vitamins|vitamins|mesh-ancestor
25438188|NCT04737278|Micronutrients|micronutrients|mesh-ancestor
25438189|NCT04737278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438190|NCT04737278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25438191|NCT04737278|Antimetabolites|antimetabolites|mesh-ancestor
25438192|NCT04737278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438193|NCT04737278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25438194|NCT04737278|Vasodilator Agents|vasodilator agents|mesh-ancestor
25438195|NCT04737473|Anesthetics|anesthetics|mesh-list
25438196|NCT04737473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25438197|NCT04737473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438198|NCT04736953|Sirolimus|sirolimus|mesh-list
25438199|NCT04736953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25438200|NCT04736953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25438201|NCT04736953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25438202|NCT04736953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438203|NCT04736953|Antifungal Agents|antifungal agents|mesh-ancestor
25438204|NCT04736953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25438205|NCT04736953|Immunologic Factors|immunologic factors|mesh-ancestor
25438206|NCT04736953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438207|NCT04737057|Fluorides|fluorides|mesh-list
25438208|NCT04737057|Cariostatic Agents|cariostatic agents|mesh-ancestor
25438209|NCT04737057|Protective Agents|protective agents|mesh-ancestor
25438210|NCT04737057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438211|NCT04736836|Rifaximin|rifaximin|mesh-list
25438212|NCT04736836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25438213|NCT04736836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25438214|NCT04736836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25438215|NCT04736823|Paclitaxel|paclitaxel|mesh-list
25438216|NCT04736823|Docetaxel|docetaxel|mesh-list
25438217|NCT04736823|Carboplatin|carboplatin|mesh-list
25438218|NCT04736823|Pemetrexed|pemetrexed|mesh-list
25438219|NCT04736823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25438220|NCT04736823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438221|NCT04736823|Tubulin Modulators|tubulin modulators|mesh-ancestor
25438222|NCT04736823|Antimitotic Agents|antimitotic agents|mesh-ancestor
25438223|NCT04736823|Mitosis Modulators|mitosis modulators|mesh-ancestor
25438224|NCT04736823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438225|NCT04736823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25438226|NCT04736823|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25438227|NCT04736823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25438228|NCT04736914|Zanubrutinib|zanubrutinib|mesh-list
25438229|NCT04736914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438230|NCT04736914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25438231|NCT04736914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25438232|NCT04736914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438233|NCT04736966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25438234|NCT04736966|Immunologic Factors|immunologic factors|mesh-ancestor
25438235|NCT04736966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438236|NCT04736927|Midazolam|midazolam|mesh-list
25438237|NCT04736927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25438238|NCT04736927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25438239|NCT04736927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25438240|NCT04736927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438241|NCT04736927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25438242|NCT04736927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25438243|NCT04736927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25438244|NCT04736927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25438245|NCT04736927|Anesthetics, General|anesthetics, general|mesh-ancestor
25438246|NCT04736927|Anesthetics|anesthetics|mesh-ancestor
25438247|NCT04736927|GABA Modulators|gaba modulators|mesh-ancestor
25438248|NCT04736927|GABA Agents|gaba agents|mesh-ancestor
25438249|NCT04736927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25822815|NCT00004664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24639825|NCT01164345|Plerixafor|plerixafor|mesh-list
24662820|NCT01297023|Vitamin D|vitamin d|mesh-list
25438250|NCT04736927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438251|NCT04736524|Antibodies|antibodies|mesh-list
25438252|NCT04736524|Immunologic Factors|immunologic factors|mesh-ancestor
25438253|NCT04736524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438254|NCT04736810|Gemcitabine|gemcitabine|mesh-list
25438255|NCT04736810|Cisplatin|cisplatin|mesh-list
25438256|NCT04736810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438257|NCT04736810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25438258|NCT04736810|Antimetabolites|antimetabolites|mesh-ancestor
25438259|NCT04736810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438260|NCT04736810|Antiviral Agents|antiviral agents|mesh-ancestor
25438261|NCT04736810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25438262|NCT04736810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25438263|NCT04736810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25438264|NCT04736810|Immunologic Factors|immunologic factors|mesh-ancestor
25438265|NCT04736810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438266|NCT04736693|Zoledronic Acid|zoledronic acid|mesh-list
25438267|NCT04736693|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25438268|NCT04736693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25438269|NCT04736693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438270|NCT04736693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25438271|NCT04736693|Hormone Antagonists|hormone antagonists|mesh-ancestor
25438272|NCT04736693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25438273|NCT04736693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25438274|NCT04736693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25438275|NCT04736719|Warfarin|warfarin|mesh-list
25438276|NCT04736719|Apixaban|apixaban|mesh-list
25438277|NCT04736719|Anticoagulants|anticoagulants|mesh-ancestor
25438278|NCT04736719|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25438279|NCT04736719|Antithrombins|antithrombins|mesh-ancestor
25438280|NCT04736719|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25438281|NCT04736719|Protease Inhibitors|protease inhibitors|mesh-ancestor
25438282|NCT04736719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25438283|NCT04736719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438284|NCT04736433|Valsartan|valsartan|mesh-list
25438285|NCT04736433|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25438286|NCT04736433|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25438287|NCT04736433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25438288|NCT04736433|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25438289|NCT04736433|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25438290|NCT04736433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438291|NCT04736433|Protease Inhibitors|protease inhibitors|mesh-ancestor
25438292|NCT04736433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25438293|NCT04736420|Warfarin|warfarin|mesh-list
25438294|NCT04736420|Rivaroxaban|rivaroxaban|mesh-list
25438295|NCT04736420|Anticoagulants|anticoagulants|mesh-ancestor
25438296|NCT04736420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25438297|NCT04736420|Antithrombins|antithrombins|mesh-ancestor
25438298|NCT04736420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25438299|NCT04736420|Protease Inhibitors|protease inhibitors|mesh-ancestor
25438300|NCT04736420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25438301|NCT04736420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438302|NCT04736589|Sirolimus|sirolimus|mesh-list
25438303|NCT04736589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25438304|NCT04736589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25438305|NCT04736589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25438306|NCT04736589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438307|NCT04736589|Antifungal Agents|antifungal agents|mesh-ancestor
25438308|NCT04736589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25438309|NCT04736589|Immunologic Factors|immunologic factors|mesh-ancestor
25438310|NCT04736589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438311|NCT04736329|Telmisartan|telmisartan|mesh-list
25438312|NCT04736329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25438313|NCT04736329|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25438314|NCT04736329|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25438315|NCT04736329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438316|NCT04736381|Mycophenolic Acid|mycophenolic acid|mesh-list
25438317|NCT04736381|Abatacept|abatacept|mesh-list
25438318|NCT04736381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25438319|NCT04736381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438320|NCT04736381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25438321|NCT04736381|Antitubercular Agents|antitubercular agents|mesh-ancestor
25438322|NCT04736381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25438323|NCT04736381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25438346|NCT04736225|Insulin|insulin|mesh-list
25438347|NCT04736225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25438348|NCT04736225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438349|NCT04736186|Loperamide|loperamide|mesh-list
25438350|NCT04736186|Antidiarrheals|antidiarrheals|mesh-list
25438351|NCT04736186|Bentonite|bentonite|mesh-list
25438352|NCT04736186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25438353|NCT04736186|Antidotes|antidotes|mesh-ancestor
25643555|NCT01428193|Estradiol|estradiol|mesh-list
25438354|NCT04736186|Protective Agents|protective agents|mesh-ancestor
25438355|NCT04736186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438356|NCT04735523|Warfarin|warfarin|mesh-list
25438357|NCT04735523|Dabigatran|dabigatran|mesh-list
25438358|NCT04735523|Anticoagulants|anticoagulants|mesh-ancestor
25438359|NCT04735523|Antithrombins|antithrombins|mesh-ancestor
25438360|NCT04735523|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25438361|NCT04735523|Protease Inhibitors|protease inhibitors|mesh-ancestor
25438362|NCT04735523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25438363|NCT04735523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438364|NCT04735445|Liver Extracts|liver extracts|mesh-list
25438365|NCT04735445|Hematinics|hematinics|mesh-ancestor
25438366|NCT04735510|Cyclosporine|cyclosporine|mesh-list
25438367|NCT04735510|Cyclosporins|cyclosporins|mesh-list
25438368|NCT04735510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25438369|NCT04735510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438370|NCT04735510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25438371|NCT04735510|Immunologic Factors|immunologic factors|mesh-ancestor
25438372|NCT04735510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438373|NCT04735510|Antifungal Agents|antifungal agents|mesh-ancestor
25438374|NCT04735510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25438375|NCT04735510|Dermatologic Agents|dermatologic agents|mesh-ancestor
25438376|NCT04735510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25438377|NCT04735510|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25438380|NCT04735042|Linagliptin|linagliptin|mesh-list
25438381|NCT04735042|Saxagliptin|saxagliptin|mesh-list
25438382|NCT04735042|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25438383|NCT04735042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438384|NCT04735042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25438385|NCT04735042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438386|NCT04735042|Incretins|incretins|mesh-ancestor
25438387|NCT04735042|Hormones|hormones|mesh-ancestor
25438388|NCT04735042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25438389|NCT04735042|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25438390|NCT04735042|Protease Inhibitors|protease inhibitors|mesh-ancestor
25438391|NCT04735042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25438392|NCT04734639|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
25438393|NCT04734639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25438394|NCT04734639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438395|NCT04734782|Antibodies|antibodies|mesh-list
25438396|NCT04734782|Immunologic Factors|immunologic factors|mesh-ancestor
25438397|NCT04734782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438398|NCT04734665|Bevacizumab|bevacizumab|mesh-list
25438399|NCT04734665|Niraparib|niraparib|mesh-list
25438400|NCT04734665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25438401|NCT04734665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438402|NCT04734665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25438403|NCT04734665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25438404|NCT04734665|Growth Substances|growth substances|mesh-ancestor
25438405|NCT04734665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438406|NCT04734665|Growth Inhibitors|growth inhibitors|mesh-ancestor
25438407|NCT04734665|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25438408|NCT04734665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25438409|NCT04734665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438410|NCT05314725|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25438411|NCT05314725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438412|NCT05314725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25438413|NCT05314725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438414|NCT05314673|Bevacizumab|bevacizumab|mesh-list
25438415|NCT05314673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25438416|NCT05314673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438417|NCT05314673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25438418|NCT05314673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25438419|NCT05314673|Growth Substances|growth substances|mesh-ancestor
25438420|NCT05314673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438421|NCT05314673|Growth Inhibitors|growth inhibitors|mesh-ancestor
25438422|NCT05314400|Liver Extracts|liver extracts|mesh-list
25438423|NCT05314400|Hematinics|hematinics|mesh-ancestor
25438424|NCT05314270|Copper|copper|mesh-list
25438425|NCT05314270|Trace Elements|trace elements|mesh-ancestor
25438426|NCT05314270|Micronutrients|micronutrients|mesh-ancestor
25438427|NCT05314270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438428|NCT05314257|Granisetron|granisetron|mesh-list
25438429|NCT05314257|Antiemetics|antiemetics|mesh-ancestor
25438430|NCT05314257|Autonomic Agents|autonomic agents|mesh-ancestor
25438431|NCT05314257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25643556|NCT01428193|Progesterone|progesterone|mesh-list
25643557|NCT01428193|Estrogens|estrogens|mesh-ancestor
25643558|NCT01428193|Hormones|hormones|mesh-ancestor
25643559|NCT01428193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25643560|NCT01428193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643561|NCT01428193|Progestins|progestins|mesh-ancestor
25643562|NCT01428193|Androgen Antagonists|androgen antagonists|mesh-ancestor
25438432|NCT05314257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438433|NCT05314257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25438434|NCT05314257|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25438435|NCT05314257|Serotonin Agents|serotonin agents|mesh-ancestor
25438436|NCT05314257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25438437|NCT05314257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438438|NCT05314153|Brexanolone|brexanolone|mesh-list
25438439|NCT05314153|Neurosteroids|neurosteroids|mesh-ancestor
25438440|NCT05314153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25438441|NCT05314153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438442|NCT05314153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438443|NCT05314153|GABA Modulators|gaba modulators|mesh-ancestor
25438444|NCT05314153|GABA Agents|gaba agents|mesh-ancestor
25438445|NCT05314140|Calcium|calcium|mesh-list
25438446|NCT05314140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24615491|NCT01030042|Cetuximab|cetuximab|mesh-list
24615492|NCT01030042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25132788|NCT03016884|Vaccines|vaccines|mesh-list
24468462|NCT00381654|MP 412|mp 412|mesh-list
24615582|NCT01030601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438447|NCT05314140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438448|NCT05313958|Cytarabine|cytarabine|mesh-list
25438449|NCT05313958|Sorafenib|sorafenib|mesh-list
25438450|NCT05313958|Mitoxantrone|mitoxantrone|mesh-list
25438451|NCT05313958|Idarubicin|idarubicin|mesh-list
25438452|NCT05313958|Cladribine|cladribine|mesh-list
25438453|NCT05313958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25438454|NCT05313958|Antimetabolites|antimetabolites|mesh-ancestor
25438455|NCT05313958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438456|NCT05313958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438457|NCT05313958|Antiviral Agents|antiviral agents|mesh-ancestor
25438458|NCT05313958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25438459|NCT05313958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25438460|NCT05313958|Immunologic Factors|immunologic factors|mesh-ancestor
25438461|NCT05313958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438462|NCT05313958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25438463|NCT05313958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25438464|NCT05313958|Analgesics|analgesics|mesh-ancestor
25438465|NCT05313958|Sensory System Agents|sensory system agents|mesh-ancestor
25438466|NCT05313958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25438467|NCT05313958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25438468|NCT05313958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25438469|NCT05313958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25438470|NCT05313906|Cisplatin|cisplatin|mesh-list
25438471|NCT05313906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438472|NCT05313828|Fluorometholone|fluorometholone|mesh-list
25438473|NCT05313828|Tobramycin|tobramycin|mesh-list
25438474|NCT05313828|Acyclovir|acyclovir|mesh-list
25438475|NCT05313828|Hyaluronic Acid|hyaluronic acid|mesh-list
25438476|NCT05313828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25438477|NCT05313828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25438478|NCT05313828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25438479|NCT05313828|Immunologic Factors|immunologic factors|mesh-ancestor
25438480|NCT05313828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438481|NCT05313828|Viscosupplements|viscosupplements|mesh-ancestor
25438482|NCT05313828|Protective Agents|protective agents|mesh-ancestor
25438483|NCT05313828|Antiviral Agents|antiviral agents|mesh-ancestor
25438484|NCT05313828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25438485|NCT05313828|Glucocorticoids|glucocorticoids|mesh-ancestor
25438486|NCT05313828|Hormones|hormones|mesh-ancestor
25438487|NCT05313828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25438488|NCT05313828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25438489|NCT05313750|Levofloxacin|levofloxacin|mesh-list
25438490|NCT05313750|Ofloxacin|ofloxacin|mesh-list
25438491|NCT05313750|Sitafloxacin|sitafloxacin|mesh-list
25438492|NCT05313750|Anti-Infective Agents|anti-infective agents|mesh-list
25438493|NCT05313750|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25438494|NCT05313750|Renal Agents|renal agents|mesh-ancestor
25438495|NCT05313750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25438496|NCT05313750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25438497|NCT05313750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25438498|NCT05313750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25438499|NCT05313750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438500|NCT05313750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438501|NCT05313750|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25438502|NCT05313750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25438503|NCT05313477|Ergocalciferols|ergocalciferols|mesh-list
25438504|NCT05313477|Vitamin D|vitamin d|mesh-list
25438505|NCT05313477|Calcium Carbonate|calcium carbonate|mesh-list
25438506|NCT05313477|Calcium|calcium|mesh-list
25438507|NCT05313477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25438508|NCT05313477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438509|NCT05313477|Antacids|antacids|mesh-ancestor
25438510|NCT05313477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438511|NCT05313477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25438512|NCT05313477|Vitamins|vitamins|mesh-ancestor
25438513|NCT05313477|Micronutrients|micronutrients|mesh-ancestor
25438514|NCT05313477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25438515|NCT05313425|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25438516|NCT05313425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25438517|NCT05313386|Dexmedetomidine|dexmedetomidine|mesh-list
25438518|NCT05313386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25438519|NCT05313386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25438520|NCT05313386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438521|NCT05313386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25438522|NCT05313386|Analgesics|analgesics|mesh-ancestor
24748052|NCT02978716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748058|NCT02975934|Docetaxel|docetaxel|mesh-list
25438546|NCT05312840|Gemcitabine|gemcitabine|mesh-list
25438548|NCT05312840|Carboplatin|carboplatin|mesh-list
25438549|NCT05312840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438550|NCT05312840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25438551|NCT05312840|Antimetabolites|antimetabolites|mesh-ancestor
25438552|NCT05312840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438553|NCT05312840|Antiviral Agents|antiviral agents|mesh-ancestor
25438554|NCT05312840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25438555|NCT05312840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25438556|NCT05312840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25438557|NCT05312840|Immunologic Factors|immunologic factors|mesh-ancestor
25438558|NCT05312840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438559|NCT05296759|Gabapentin|gabapentin|mesh-list
25438560|NCT05296759|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25438561|NCT05296759|Botulinum Toxins|botulinum toxins|mesh-list
25438562|NCT05296759|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25438563|NCT05296759|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25438564|NCT05296759|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25438565|NCT05296759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25438566|NCT05296759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438567|NCT05296759|Cholinergic Agents|cholinergic agents|mesh-ancestor
25438568|NCT05296759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25438569|NCT05296759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438570|NCT05296759|Analgesics|analgesics|mesh-ancestor
25438571|NCT05296759|Sensory System Agents|sensory system agents|mesh-ancestor
25438572|NCT05296759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25438573|NCT05296759|Anticonvulsants|anticonvulsants|mesh-ancestor
25438574|NCT05296759|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25438575|NCT05296759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25438576|NCT05296759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25438577|NCT05296759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25438578|NCT05296759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25438579|NCT05296759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25438580|NCT05296759|Antimanic Agents|antimanic agents|mesh-ancestor
25438581|NCT05296759|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25438582|NCT05296759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25438583|NCT05296759|Antidepressive Agents|antidepressive agents|mesh-ancestor
25438584|NCT05296759|Dopamine Agents|dopamine agents|mesh-ancestor
25438585|NCT05296759|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25438586|NCT05292976|Albuterol|albuterol|mesh-list
25438587|NCT05292976|Methacholine Chloride|methacholine chloride|mesh-list
25438588|NCT05292976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25438589|NCT05292976|Autonomic Agents|autonomic agents|mesh-ancestor
25438590|NCT05292976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25438591|NCT05292976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438592|NCT05292976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25438593|NCT05292976|Respiratory System Agents|respiratory system agents|mesh-ancestor
25438594|NCT05292976|Tocolytic Agents|tocolytic agents|mesh-ancestor
25643563|NCT01428193|Hormone Antagonists|hormone antagonists|mesh-ancestor
25438595|NCT05292976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25438596|NCT05292976|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25438597|NCT05292976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25438598|NCT05292976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25438599|NCT05292976|Adrenergic Agents|adrenergic agents|mesh-ancestor
25438600|NCT05292976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25438601|NCT05292976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438603|NCT05292976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25438604|NCT05292976|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
25438605|NCT05292976|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25438606|NCT05292976|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25438607|NCT05292976|Cholinergic Agents|cholinergic agents|mesh-ancestor
25438608|NCT05286554|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25438609|NCT05286554|Hormones|hormones|mesh-list
25438610|NCT05286554|Progesterone|progesterone|mesh-list
25438611|NCT05286554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25438612|NCT05286554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438613|NCT05286554|Progestins|progestins|mesh-ancestor
25438614|NCT05286554|Luteolytic Agents|luteolytic agents|mesh-ancestor
24415459|NCT00199576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24415460|NCT00199576|Antiemetics|antiemetics|mesh-ancestor
24415461|NCT00199576|Autonomic Agents|autonomic agents|mesh-ancestor
24415462|NCT00199576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24415463|NCT00199576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142462|NCT02949765|Iron|iron|mesh-list
25438615|NCT05286554|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25438616|NCT05286554|Contraceptive Agents|contraceptive agents|mesh-ancestor
25438617|NCT05286554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25438618|NCT05286554|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25438619|NCT05286554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25438620|NCT05286554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438621|NCT05286190|Bupivacaine|bupivacaine|mesh-list
25438622|NCT05286190|Anesthetics, Local|anesthetics, local|mesh-ancestor
25438623|NCT05286190|Anesthetics|anesthetics|mesh-ancestor
25438624|NCT05286190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25438625|NCT05286190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438626|NCT05286190|Sensory System Agents|sensory system agents|mesh-ancestor
25438627|NCT05286190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25438629|NCT05269537|Fentanyl|fentanyl|mesh-list
25438630|NCT05269537|Bupivacaine|bupivacaine|mesh-list
25438631|NCT05269537|Oxytocin|oxytocin|mesh-list
25438632|NCT05269537|Anesthetics, Local|anesthetics, local|mesh-ancestor
25438633|NCT05269537|Anesthetics|anesthetics|mesh-ancestor
25438634|NCT05269537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25438635|NCT05269537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438636|NCT05269537|Sensory System Agents|sensory system agents|mesh-ancestor
25438637|NCT05269537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25438638|NCT05269537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25438639|NCT05269537|Narcotics|narcotics|mesh-ancestor
25438640|NCT05269537|Analgesics|analgesics|mesh-ancestor
25438641|NCT05269537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25438642|NCT05269537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25438643|NCT05269537|Anesthetics, General|anesthetics, general|mesh-ancestor
25438644|NCT05269537|Oxytocics|oxytocics|mesh-ancestor
25438645|NCT05269537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25438646|NCT05269537|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25438647|NCT05269537|Sympathomimetics|sympathomimetics|mesh-ancestor
25438648|NCT05269537|Autonomic Agents|autonomic agents|mesh-ancestor
25438649|NCT05269537|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25438650|NCT05269537|Adrenergic Agents|adrenergic agents|mesh-ancestor
25438651|NCT05269537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25438652|NCT05269537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438653|NCT05245474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25438654|NCT05245474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438655|NCT05245474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438656|NCT05243628|Insulin|insulin|mesh-list
25438657|NCT05243628|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25438658|NCT05243628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25438659|NCT05243628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438660|NCT05240898|Adenosine|adenosine|mesh-list
25438661|NCT05240898|Analgesics|analgesics|mesh-ancestor
25438662|NCT05240898|Sensory System Agents|sensory system agents|mesh-ancestor
25438663|NCT05240898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25438664|NCT05240898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438665|NCT05240898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25438666|NCT05240898|Vasodilator Agents|vasodilator agents|mesh-ancestor
25438667|NCT05240898|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25438668|NCT05240898|Purinergic Agonists|purinergic agonists|mesh-ancestor
25438669|NCT05240898|Purinergic Agents|purinergic agents|mesh-ancestor
25438670|NCT05240898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25438671|NCT05240898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438672|NCT05239013|Nitroglycerin|nitroglycerin|mesh-list
25438673|NCT05239013|Vasodilator Agents|vasodilator agents|mesh-ancestor
25438674|NCT05222516|Broncho-Vaxom|broncho-vaxom|mesh-list
25438675|NCT05222516|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25438676|NCT05222516|Immunologic Factors|immunologic factors|mesh-ancestor
25438677|NCT05222516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438678|NCT05221151|Pregabalin|pregabalin|mesh-list
25438679|NCT05221151|Ondansetron|ondansetron|mesh-list
25438680|NCT05221151|Melatonin|melatonin|mesh-list
25438681|NCT05221151|Analgesics|analgesics|mesh-ancestor
25438682|NCT05221151|Sensory System Agents|sensory system agents|mesh-ancestor
25438683|NCT05221151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25438684|NCT05221151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438685|NCT05221151|Anticonvulsants|anticonvulsants|mesh-ancestor
25438686|NCT05221151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25438687|NCT05221151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25438688|NCT05221151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438689|NCT05221151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25438690|NCT05221151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25438691|NCT05221151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25438692|NCT05221151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25438693|NCT05221151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25438694|NCT05221151|Antioxidants|antioxidants|mesh-ancestor
25438695|NCT05221151|Protective Agents|protective agents|mesh-ancestor
25438696|NCT05221151|Antiemetics|antiemetics|mesh-ancestor
25438697|NCT05221151|Autonomic Agents|autonomic agents|mesh-ancestor
25438698|NCT05221151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25438699|NCT05221151|Antipruritics|antipruritics|mesh-ancestor
25438700|NCT05221151|Dermatologic Agents|dermatologic agents|mesh-ancestor
25438701|NCT05221151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25438702|NCT05221151|Serotonin Agents|serotonin agents|mesh-ancestor
25438703|NCT05221151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25438704|NCT05221151|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25438705|NCT05218148|Oxaliplatin|oxaliplatin|mesh-list
25438706|NCT05218148|Trastuzumab|trastuzumab|mesh-list
25438707|NCT05218148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438708|NCT05218148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25438709|NCT05195996|Propranolol|propranolol|mesh-list
25438710|NCT05195996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25438711|NCT05195996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25438712|NCT05195996|Adrenergic Agents|adrenergic agents|mesh-ancestor
25438713|NCT05195996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25438714|NCT05195996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438715|NCT05195996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438716|NCT05195996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25438717|NCT05195996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25438718|NCT05195996|Vasodilator Agents|vasodilator agents|mesh-ancestor
25438719|NCT05065424|Atropine|atropine|mesh-list
25438720|NCT05065424|Fentanyl|fentanyl|mesh-list
25438721|NCT05065424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25438722|NCT05065424|Narcotics|narcotics|mesh-ancestor
25438723|NCT05065424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25438724|NCT05065424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438725|NCT05065424|Analgesics|analgesics|mesh-ancestor
25438726|NCT05065424|Sensory System Agents|sensory system agents|mesh-ancestor
25438727|NCT05065424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25438728|NCT05065424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25438729|NCT05065424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25438730|NCT05065424|Anesthetics, General|anesthetics, general|mesh-ancestor
25438731|NCT05065424|Anesthetics|anesthetics|mesh-ancestor
25438732|NCT05065424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438733|NCT05065424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25438734|NCT05065424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25438735|NCT05065424|Autonomic Agents|autonomic agents|mesh-ancestor
25438736|NCT05065424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25438737|NCT05065424|Respiratory System Agents|respiratory system agents|mesh-ancestor
25438738|NCT05065424|Mydriatics|mydriatics|mesh-ancestor
25438739|NCT05065424|Parasympatholytics|parasympatholytics|mesh-ancestor
25438740|NCT05065424|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25438741|NCT05065424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25438742|NCT05065424|Cholinergic Agents|cholinergic agents|mesh-ancestor
25438743|NCT05065424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25438745|NCT05034952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25438746|NCT05034952|Analgesics|analgesics|mesh-ancestor
25438747|NCT05034952|Sensory System Agents|sensory system agents|mesh-ancestor
25438748|NCT05034952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25438749|NCT05034952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438750|NCT05034952|Antipyretics|antipyretics|mesh-ancestor
25438751|NCT05030441|Ivosidenib|ivosidenib|mesh-list
25438752|NCT05030441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438753|NCT05030441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25438754|NCT05030441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438755|NCT04975256|Adagrasib|adagrasib|mesh-list
25438756|NCT04975256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438757|NCT04948892|Anesthetics|anesthetics|mesh-list
25438758|NCT04948892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25822816|NCT00004664|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24948239|NCT03921099|Vitamins|vitamins|mesh-ancestor
25200097|NCT02736032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25051639|NCT00392574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25051640|NCT00392574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24561799|NCT00762918|Vitamins|vitamins|mesh-ancestor
24561800|NCT00762918|Micronutrients|micronutrients|mesh-ancestor
24561801|NCT00762918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438759|NCT04948892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438768|NCT04905407|Azacitidine|azacitidine|mesh-list
25438769|NCT04905407|Venetoclax|venetoclax|mesh-list
25438770|NCT04905407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25438771|NCT04905407|Antimetabolites|antimetabolites|mesh-ancestor
25438772|NCT04905407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438773|NCT04905407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438774|NCT04905407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25438775|NCT04737187|Trifluridine|trifluridine|mesh-list
25438776|NCT04737187|Bevacizumab|bevacizumab|mesh-list
25438777|NCT04737187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25438778|NCT04737187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438779|NCT04737187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25438780|NCT04737187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25438781|NCT04737187|Growth Substances|growth substances|mesh-ancestor
25438782|NCT04737187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438783|NCT04737187|Growth Inhibitors|growth inhibitors|mesh-ancestor
25438784|NCT04737187|Antimetabolites|antimetabolites|mesh-ancestor
25438785|NCT04737187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438786|NCT04737187|Antiviral Agents|antiviral agents|mesh-ancestor
25438787|NCT04737187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25438788|NCT04729205|Mitomycins|mitomycins|mesh-list
25438789|NCT04729205|Mitomycin|mitomycin|mesh-list
25438790|NCT04729205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25438791|NCT04729205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438792|NCT04729205|Alkylating Agents|alkylating agents|mesh-ancestor
25438793|NCT04729205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438794|NCT04729205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25438795|NCT04729205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25438796|NCT04706013|Pyridoxal|pyridoxal|mesh-list
25438797|NCT04706013|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
25438798|NCT04706013|Vitamin B Complex|vitamin b complex|mesh-ancestor
25438799|NCT04706013|Vitamins|vitamins|mesh-ancestor
25438800|NCT04706013|Micronutrients|micronutrients|mesh-ancestor
25438801|NCT04706013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438802|NCT04685421|Bupivacaine|bupivacaine|mesh-list
25438803|NCT04685421|Anesthetics, Local|anesthetics, local|mesh-ancestor
25438804|NCT04685421|Anesthetics|anesthetics|mesh-ancestor
25438805|NCT04685421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25438806|NCT04685421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438807|NCT04685421|Sensory System Agents|sensory system agents|mesh-ancestor
25438808|NCT04685421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25438809|NCT04662684|Rivaroxaban|rivaroxaban|mesh-list
25438810|NCT04662684|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25438811|NCT04662684|Antithrombins|antithrombins|mesh-ancestor
25438812|NCT04662684|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25438813|NCT04662684|Protease Inhibitors|protease inhibitors|mesh-ancestor
25438814|NCT04662684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25438815|NCT04662684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438816|NCT04662684|Anticoagulants|anticoagulants|mesh-ancestor
25438817|NCT04614363|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25438818|NCT04614363|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25404100|NCT03684811|Azacitidine|azacitidine|mesh-list
25643564|NCT01428193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25643565|NCT01428193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25643566|NCT01428245|Estradiol|estradiol|mesh-list
25643567|NCT01428245|Estrogens|estrogens|mesh-list
25643568|NCT01428245|Progesterone|progesterone|mesh-list
25643569|NCT01428245|Hormones|hormones|mesh-ancestor
25643570|NCT01428245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25643571|NCT01428245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643572|NCT01428245|Progestins|progestins|mesh-ancestor
25643573|NCT01428258|Coal Tar|coal tar|mesh-list
25643574|NCT01428258|Keratolytic Agents|keratolytic agents|mesh-ancestor
25643575|NCT01428258|Dermatologic Agents|dermatologic agents|mesh-ancestor
25643576|NCT01428336|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25643577|NCT01428336|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
25438819|NCT04614363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438820|NCT04609423|Vitamin D|vitamin d|mesh-list
25438821|NCT04609423|Cod Liver Oil|cod liver oil|mesh-list
25438822|NCT04609423|Vitamins|vitamins|mesh-ancestor
25438823|NCT04609423|Micronutrients|micronutrients|mesh-ancestor
25438824|NCT04609423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438825|NCT04609423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25438826|NCT04593459|Metformin|metformin|mesh-list
25438827|NCT04593459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25438828|NCT04593459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438829|NCT04579640|Vitamin D|vitamin d|mesh-list
25438830|NCT04579640|Vitamins|vitamins|mesh-ancestor
25438831|NCT04579640|Micronutrients|micronutrients|mesh-ancestor
25438832|NCT04579640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438833|NCT04579640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25438834|NCT04575948|Chlorhexidine|chlorhexidine|mesh-list
25438835|NCT04575948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25438836|NCT04575948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24634352|NCT01132989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634353|NCT01132989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24634354|NCT01132989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24634355|NCT01132989|Growth Substances|growth substances|mesh-ancestor
24634356|NCT01132989|Growth Inhibitors|growth inhibitors|mesh-ancestor
24634357|NCT01132989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25151410|NCT04672382|Sensory System Agents|sensory system agents|mesh-ancestor
25151658|NCT04547153|Mitosis Modulators|mitosis modulators|mesh-ancestor
25438837|NCT04575948|Disinfectants|disinfectants|mesh-ancestor
25438838|NCT04555603|Pembrolizumab|pembrolizumab|mesh-list
25438839|NCT04555603|Avelumab|avelumab|mesh-list
25438840|NCT04555603|Axitinib|axitinib|mesh-list
25438841|NCT04555603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25438842|NCT04555603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438843|NCT04555603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25438844|NCT04555603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25438845|NCT04555603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438846|NCT04542148|Insulin|insulin|mesh-list
25438847|NCT04542148|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25438848|NCT04542148|Insulin Aspart|insulin aspart|mesh-list
25438849|NCT04542148|Insulin Lispro|insulin lispro|mesh-list
25438850|NCT04542148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25438851|NCT04542148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438852|NCT04502433|Poractant alfa|poractant alfa|mesh-list
25438853|NCT04502433|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
25438854|NCT04502433|Respiratory System Agents|respiratory system agents|mesh-ancestor
25438855|NCT04482959|Carbetocin|carbetocin|mesh-list
25438856|NCT04482959|Oxytocics|oxytocics|mesh-ancestor
25438857|NCT04482959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25438858|NCT04482959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438859|NCT04472767|Nivolumab|nivolumab|mesh-list
25438860|NCT04472767|Ipilimumab|ipilimumab|mesh-list
25438861|NCT04472767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25438862|NCT04472767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438863|NCT04472767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25438864|NCT04472767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438865|NCT04438330|Nickel|nickel|mesh-list
25438866|NCT04438330|Trace Elements|trace elements|mesh-ancestor
25438867|NCT04438330|Micronutrients|micronutrients|mesh-ancestor
25438868|NCT04438330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438869|NCT04403516|Dexamethasone|dexamethasone|mesh-list
25438870|NCT04403516|Prednisolone|prednisolone|mesh-list
25438871|NCT04403516|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25643578|NCT01428336|Cosyntropin|cosyntropin|mesh-list
25438872|NCT04403516|Methylprednisolone|methylprednisolone|mesh-list
25438873|NCT04403516|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25438874|NCT04403516|Prednisolone acetate|prednisolone acetate|mesh-list
25438879|NCT04403516|Autonomic Agents|autonomic agents|mesh-ancestor
25438880|NCT04403516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25438881|NCT04403516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438882|NCT04403516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25438883|NCT04403516|Glucocorticoids|glucocorticoids|mesh-ancestor
25438884|NCT04403516|Hormones|hormones|mesh-ancestor
25438885|NCT04403516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25438886|NCT04403516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25438887|NCT04403516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438888|NCT04403516|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25438889|NCT04403516|Protective Agents|protective agents|mesh-ancestor
25438890|NCT04383639|Locust bean gum|locust bean gum|mesh-list
25438891|NCT04383639|Antidiarrheals|antidiarrheals|mesh-ancestor
25438892|NCT04383639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25438893|NCT04349722|Scopolamine|scopolamine|mesh-list
25438894|NCT04349722|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25438895|NCT04349722|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25438896|NCT04349722|Antiemetics|antiemetics|mesh-ancestor
25438897|NCT04349722|Autonomic Agents|autonomic agents|mesh-ancestor
25438898|NCT04349722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25438899|NCT04349722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438900|NCT04349722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25438901|NCT04349722|Mydriatics|mydriatics|mesh-ancestor
25438902|NCT04349722|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25438903|NCT04349722|Cholinergic Agents|cholinergic agents|mesh-ancestor
25438904|NCT04349722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25438905|NCT04349722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438906|NCT04349722|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25438907|NCT04349722|Parasympatholytics|parasympatholytics|mesh-ancestor
25438908|NCT04313972|Naltrexone|naltrexone|mesh-list
25438909|NCT04313972|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25438910|NCT04313972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25438921|NCT04280965|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25438922|NCT04280965|Antidepressive Agents|antidepressive agents|mesh-ancestor
25438923|NCT04280965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25438924|NCT04280965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25438925|NCT04280965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25438926|NCT04280965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25438927|NCT04280965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438928|NCT04275232|Plasminogen|plasminogen|mesh-list
25438929|NCT04275232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25438930|NCT04275232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25438931|NCT04275232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438932|NCT04248712|Loratadine|loratadine|mesh-list
25438933|NCT04248712|Famotidine|famotidine|mesh-list
25438934|NCT04248712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25438935|NCT04248712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25438936|NCT04248712|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25438937|NCT04248712|Histamine Antagonists|histamine antagonists|mesh-ancestor
25438938|NCT04248712|Histamine Agents|histamine agents|mesh-ancestor
25438939|NCT04248712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25438940|NCT04248712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438941|NCT04248712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438942|NCT04248712|Antipruritics|antipruritics|mesh-ancestor
25438943|NCT04248712|Dermatologic Agents|dermatologic agents|mesh-ancestor
25438944|NCT04248712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25438945|NCT04248712|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25438946|NCT04248712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25438947|NCT04225819|Vitamin D|vitamin d|mesh-list
25438948|NCT04225819|Cholecalciferol|cholecalciferol|mesh-list
25438949|NCT04225819|Vitamins|vitamins|mesh-ancestor
25438950|NCT04225819|Micronutrients|micronutrients|mesh-ancestor
25438951|NCT04225819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438952|NCT04225819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25438953|NCT04225819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25438954|NCT04201756|Afatinib|afatinib|mesh-list
25438955|NCT04201756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485248|NCT00452231|Cycloserine|cycloserine|mesh-list
25643579|NCT01428336|beta-Endorphin|beta-endorphin|mesh-list
25438956|NCT04201756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25438957|NCT04201756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25438958|NCT04201756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438959|NCT04199624|Ascorbic Acid|ascorbic acid|mesh-list
25438960|NCT04199624|Omeprazole|omeprazole|mesh-list
25438961|NCT04199624|Vitamins|vitamins|mesh-ancestor
25438962|NCT04199624|Micronutrients|micronutrients|mesh-ancestor
25438963|NCT04199624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438964|NCT04199624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25438965|NCT04199624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25438966|NCT04199624|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25438967|NCT04199624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25438968|NCT04199624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438969|NCT04199624|Antioxidants|antioxidants|mesh-ancestor
25438970|NCT04199624|Protective Agents|protective agents|mesh-ancestor
25438971|NCT04164979|Pembrolizumab|pembrolizumab|mesh-list
25438972|NCT04164979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25438973|NCT04164979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438974|NCT04154943|Cemiplimab|cemiplimab|mesh-list
25438975|NCT04154943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25438976|NCT04154943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438977|NCT04138706|Vancomycin|vancomycin|mesh-list
25438978|NCT04138706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25438979|NCT04138706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25438980|NCT04123470|Atezolizumab|atezolizumab|mesh-list
25438981|NCT04123470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438982|NCT04084769|Vaccines|vaccines|mesh-list
25438983|NCT04084769|Immunologic Factors|immunologic factors|mesh-ancestor
25438984|NCT04084769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438985|NCT04082754|Antibodies|antibodies|mesh-list
25438986|NCT04082754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25438987|NCT04082754|Immunologic Factors|immunologic factors|mesh-ancestor
25438988|NCT04082754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25438989|NCT04074343|Irinotecan|irinotecan|mesh-list
25053174|NCT00095290|Protease Inhibitors|protease inhibitors|mesh-ancestor
25053175|NCT00095290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053176|NCT00095290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053177|NCT00095290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25053178|NCT00095290|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25053179|NCT00095290|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25053180|NCT00093132|Satraplatin|satraplatin|mesh-list
25075090|NCT03383367|TEMPO|tempo|mesh-list
25438990|NCT04074343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25438991|NCT04074343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25438992|NCT04074343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25438993|NCT04074343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25438994|NCT04074343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438996|NCT04069117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25438997|NCT04069117|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25438998|NCT04069117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25438999|NCT04069117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25439000|NCT04069117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439001|NCT04069117|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25439002|NCT04069117|Hormone Antagonists|hormone antagonists|mesh-ancestor
25439003|NCT04069117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25439004|NCT04069117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439005|NCT04061252|Brodalumab|brodalumab|mesh-list
25439006|NCT04061252|Dermatologic Agents|dermatologic agents|mesh-ancestor
25439007|NCT04041232|Glycerol|glycerol|mesh-list
25439008|NCT04041232|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25439009|NCT04041232|Protective Agents|protective agents|mesh-ancestor
25439010|NCT04041232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439011|NCT04040361|Pembrolizumab|pembrolizumab|mesh-list
25439012|NCT04040361|Ramucirumab|ramucirumab|mesh-list
25439013|NCT04040361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25439014|NCT04040361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439015|NCT04024228|Vaccines|vaccines|mesh-list
25439016|NCT04024228|Hemagglutinins|hemagglutinins|mesh-list
25439017|NCT04024228|Immunologic Factors|immunologic factors|mesh-ancestor
25439018|NCT04024228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439019|NCT04024228|Agglutinins|agglutinins|mesh-ancestor
25439020|NCT04007276|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25439021|NCT04007276|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25439022|NCT04007276|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25439023|NCT04007276|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25439024|NCT04007276|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25439025|NCT04007276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25439026|NCT04007276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25439027|NCT04007276|Adrenergic Agents|adrenergic agents|mesh-ancestor
25439028|NCT04007276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25439029|NCT04007276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439030|NCT04007276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439031|NCT03996148|Dexmedetomidine|dexmedetomidine|mesh-list
25439033|NCT03996148|Propofol|propofol|mesh-list
25439034|NCT03996148|Desflurane|desflurane|mesh-list
25439035|NCT03996148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25439036|NCT03996148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25439037|NCT03996148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439038|NCT03996148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25439039|NCT03996148|Anesthetics, General|anesthetics, general|mesh-ancestor
25439040|NCT03996148|Anesthetics|anesthetics|mesh-ancestor
25439041|NCT03996148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25439042|NCT03996148|Analgesics|analgesics|mesh-ancestor
25439043|NCT03996148|Sensory System Agents|sensory system agents|mesh-ancestor
25439044|NCT03996148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25439045|NCT03996148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25439046|NCT03996148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25439047|NCT03996148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25439048|NCT03996148|Adrenergic Agents|adrenergic agents|mesh-ancestor
25439049|NCT03996148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25439050|NCT03996148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439051|NCT03996148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25439052|NCT03996148|Narcotics|narcotics|mesh-ancestor
25439053|NCT03996148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25439054|NCT03940131|Panitumumab|panitumumab|mesh-list
25439055|NCT03940131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25439056|NCT03940131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439057|NCT03926845|Thiamidol|thiamidol|mesh-list
25439058|NCT03926845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25439059|NCT03926845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439060|NCT03912818|Gemcitabine|gemcitabine|mesh-list
25439061|NCT03912818|Cisplatin|cisplatin|mesh-list
25439062|NCT03912818|Carboplatin|carboplatin|mesh-list
25439063|NCT03912818|Doxorubicin|doxorubicin|mesh-list
25053807|NCT00004181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053870|NCT00004166|Amifostine|amifostine|mesh-list
25439083|NCT03912818|Abortifacient Agents|abortifacient agents|mesh-ancestor
25439084|NCT03912818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25439085|NCT03912818|Dermatologic Agents|dermatologic agents|mesh-ancestor
25439086|NCT03912818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25439087|NCT03912818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25439088|NCT03912818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25439089|NCT03912818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25439090|NCT03912818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25439091|NCT03912818|Tubulin Modulators|tubulin modulators|mesh-ancestor
25439092|NCT03912818|Antimitotic Agents|antimitotic agents|mesh-ancestor
25439093|NCT03912818|Mitosis Modulators|mitosis modulators|mesh-ancestor
25439094|NCT03906539|Atorvastatin|atorvastatin|mesh-list
25439095|NCT03906539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25439096|NCT03906539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25439097|NCT03906539|Antimetabolites|antimetabolites|mesh-ancestor
25439098|NCT03906539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439099|NCT03906539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25439100|NCT03906539|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25439101|NCT03906539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25439102|NCT03834909|Tenofovir|tenofovir|mesh-list
25439103|NCT03834909|Emtricitabine|emtricitabine|mesh-list
25439104|NCT03834909|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25439105|NCT03834909|Antiviral Agents|antiviral agents|mesh-ancestor
25439106|NCT03834909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25439107|NCT03834909|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25439108|NCT03834909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25439109|NCT03834909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25439110|NCT03834909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439111|NCT03834909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25439112|NCT03834909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24446223|NCT00304135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822817|NCT00004664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24983089|NCT02765854|Antiemetics|antiemetics|mesh-ancestor
24866313|NCT00548912|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25054710|NCT03528538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439114|NCT03808480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25439115|NCT03808480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439116|NCT03808480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25439117|NCT03808480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643580|NCT01428336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643581|NCT01428336|Hormones|hormones|mesh-ancestor
25643582|NCT01428336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25643583|NCT01428336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25643584|NCT01428336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643585|NCT01428583|Naltrexone|naltrexone|mesh-list
25439118|NCT03802097|Anti-Infective Agents|anti-infective agents|mesh-list
25439119|NCT03802097|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25439120|NCT03780790|Bupivacaine|bupivacaine|mesh-list
25439121|NCT03780790|Anesthetics, Local|anesthetics, local|mesh-ancestor
25439122|NCT03780790|Anesthetics|anesthetics|mesh-ancestor
25439123|NCT03780790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25439124|NCT03780790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439125|NCT03780790|Sensory System Agents|sensory system agents|mesh-ancestor
25439126|NCT03780790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25439127|NCT03769298|Tacrolimus|tacrolimus|mesh-list
25439128|NCT03769298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25439129|NCT03769298|Immunologic Factors|immunologic factors|mesh-ancestor
25439130|NCT03769298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439131|NCT03769298|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25439132|NCT03769298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25439133|NCT03769298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439134|NCT03761953|Oritavancin|oritavancin|mesh-list
25439135|NCT03761953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25439136|NCT03761953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25439137|NCT03751800|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25439138|NCT03751800|Dienogest|dienogest|mesh-list
25439139|NCT03751800|Levonorgestrel|levonorgestrel|mesh-list
25439140|NCT03751800|Medroxyprogesterone|medroxyprogesterone|mesh-list
25439141|NCT03751800|Estradiol|estradiol|mesh-list
25439142|NCT03751800|Estrogens|estrogens|mesh-ancestor
25439143|NCT03751800|Hormones|hormones|mesh-ancestor
25439144|NCT03751800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25439145|NCT03751800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439146|NCT03751800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25439147|NCT03751800|Contraceptive Agents|contraceptive agents|mesh-ancestor
25439148|NCT03751800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25439149|NCT03751800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25439150|NCT03751800|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25439151|NCT03751800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25439152|NCT03751800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25439153|NCT03751800|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25439154|NCT03751800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25439155|NCT03751800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439156|NCT03751800|Hormone Antagonists|hormone antagonists|mesh-ancestor
25439157|NCT03709888|Pregabalin|pregabalin|mesh-list
25439158|NCT03709888|Memantine|memantine|mesh-list
25439159|NCT03709888|Analgesics|analgesics|mesh-ancestor
25439160|NCT03709888|Sensory System Agents|sensory system agents|mesh-ancestor
25439161|NCT03709888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25439162|NCT03709888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439163|NCT03709888|Anticonvulsants|anticonvulsants|mesh-ancestor
25439164|NCT03709888|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25439165|NCT03709888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25439166|NCT03709888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439167|NCT03709888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25439168|NCT03709888|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25439169|NCT03709888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25439170|NCT03709888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25439171|NCT03709888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25439172|NCT03709888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25439173|NCT03709888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25439174|NCT03709888|Dopamine Agents|dopamine agents|mesh-ancestor
25439175|NCT03709888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25439176|NCT03709888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25439177|NCT03709888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25439178|NCT03633305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25439179|NCT03633305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24548019|NCT00707187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548020|NCT00707187|Urological Agents|urological agents|mesh-ancestor
24868153|NCT03230916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24868154|NCT03230916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24868155|NCT03202667|Empagliflozin|empagliflozin|mesh-list
25822818|NCT00004664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25822819|NCT00004665|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25439182|NCT03616717|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25439183|NCT03616717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439184|NCT03616717|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25439185|NCT03616717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25439186|NCT03616717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25439187|NCT03616717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439188|NCT03606213|Vaccines|vaccines|mesh-list
25439189|NCT03606213|Immunologic Factors|immunologic factors|mesh-ancestor
25439190|NCT03606213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439191|NCT03582085|BCG Vaccine|bcg vaccine|mesh-list
25439192|NCT03582085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25439193|NCT03582085|Immunologic Factors|immunologic factors|mesh-ancestor
25439194|NCT03582085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439195|NCT03575208|Interferons|interferons|mesh-list
25439196|NCT03575208|Interferon-alpha|interferon-alpha|mesh-list
25439197|NCT03575208|Immunoglobulins|immunoglobulins|mesh-list
25439198|NCT03575208|Antibodies|antibodies|mesh-list
25439199|NCT03575208|gamma-Globulins|gamma-globulins|mesh-list
25439200|NCT03575208|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25439201|NCT03575208|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25439202|NCT03575208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439203|NCT03575208|Antiviral Agents|antiviral agents|mesh-ancestor
25439204|NCT03575208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25439205|NCT03575208|Immunologic Factors|immunologic factors|mesh-ancestor
25719714|NCT02454296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25439206|NCT03575208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439207|NCT03444376|Pembrolizumab|pembrolizumab|mesh-list
25439208|NCT03444376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25439209|NCT03444376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439210|NCT03423199|Tamoxifen|tamoxifen|mesh-list
25439211|NCT03423199|Goserelin|goserelin|mesh-list
25439212|NCT03423199|Palbociclib|palbociclib|mesh-list
25439213|NCT03423199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25439214|NCT03423199|Hormone Antagonists|hormone antagonists|mesh-ancestor
25439215|NCT03423199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25439216|NCT03423199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439217|NCT03423199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25439218|NCT03423199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439219|NCT03423199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25439220|NCT03423199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25439221|NCT03423199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25439222|NCT03423199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25439223|NCT03423199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25439224|NCT03423199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439225|NCT03388749|Annamycin|annamycin|mesh-list
25439226|NCT03388749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25439227|NCT03388749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439228|NCT03384563|Dexmedetomidine|dexmedetomidine|mesh-list
25439229|NCT03384563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25439230|NCT03384563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25439231|NCT03384563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439232|NCT03384563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25439233|NCT03384563|Analgesics|analgesics|mesh-ancestor
25439234|NCT03384563|Sensory System Agents|sensory system agents|mesh-ancestor
25439235|NCT03384563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25439236|NCT03384563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25439237|NCT03384563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25439238|NCT03384563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25439239|NCT03384563|Adrenergic Agents|adrenergic agents|mesh-ancestor
25439240|NCT03384563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25439241|NCT03384563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439242|NCT03342937|Pembrolizumab|pembrolizumab|mesh-list
25439243|NCT03342937|Capecitabine|capecitabine|mesh-list
25439244|NCT03342937|Oxaliplatin|oxaliplatin|mesh-list
25439245|NCT03342937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25439246|NCT03342937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25822820|NCT00004665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25643586|NCT01428583|Oxycodone|oxycodone|mesh-list
25643587|NCT01428583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25643588|NCT01428583|Narcotics|narcotics|mesh-ancestor
25822821|NCT00004665|Immunologic Factors|immunologic factors|mesh-ancestor
25822822|NCT00004665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822823|NCT00004669|Hydrocortisone|hydrocortisone|mesh-list
25439247|NCT03342937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25439248|NCT03342937|Antimetabolites|antimetabolites|mesh-ancestor
25439249|NCT03342937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439251|NCT03298984|Daunorubicin|daunorubicin|mesh-list
25439252|NCT03298984|Alvocidib|alvocidib|mesh-list
25439253|NCT03298984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25439254|NCT03298984|Antimetabolites|antimetabolites|mesh-ancestor
25439255|NCT03298984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439256|NCT03298984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439257|NCT03298984|Antiviral Agents|antiviral agents|mesh-ancestor
25439258|NCT03298984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25439259|NCT03298984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25439260|NCT03298984|Immunologic Factors|immunologic factors|mesh-ancestor
25439261|NCT03298984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439262|NCT03298984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25439263|NCT03298984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25439264|NCT03298984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25439265|NCT03298984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25439266|NCT03298984|Growth Inhibitors|growth inhibitors|mesh-ancestor
25439267|NCT03298984|Growth Substances|growth substances|mesh-ancestor
25439268|NCT03298984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25439269|NCT03295747|Peppermint oil|peppermint oil|mesh-list
25439270|NCT03295747|Antiemetics|antiemetics|mesh-ancestor
25439271|NCT03295747|Autonomic Agents|autonomic agents|mesh-ancestor
25439272|NCT03295747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25439273|NCT03295747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439274|NCT03295747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25439275|NCT03295747|Parasympatholytics|parasympatholytics|mesh-ancestor
25439276|NCT03295552|Carboplatin|carboplatin|mesh-list
25439277|NCT03295552|Decitabine|decitabine|mesh-list
25439278|NCT03295552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439279|NCT03295552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25439280|NCT03295552|Antimetabolites|antimetabolites|mesh-ancestor
25439281|NCT03295552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439282|NCT03295552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25439283|NCT03262454|Atezolizumab|atezolizumab|mesh-list
25439284|NCT03262454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439285|NCT03216083|Tranexamic Acid|tranexamic acid|mesh-list
25439286|NCT03216083|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25439287|NCT03216083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25439288|NCT03216083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439289|NCT03216083|Hemostatics|hemostatics|mesh-ancestor
25439290|NCT03216083|Coagulants|coagulants|mesh-ancestor
25439291|NCT03192215|Aspirin|aspirin|mesh-list
25439292|NCT03192215|Apixaban|apixaban|mesh-list
25439293|NCT03192215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25439294|NCT03192215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25439295|NCT03192215|Analgesics|analgesics|mesh-ancestor
25439296|NCT03192215|Sensory System Agents|sensory system agents|mesh-ancestor
25439297|NCT03192215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25439298|NCT03192215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439299|NCT03192215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25439300|NCT03192215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25439301|NCT03192215|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25439302|NCT03192215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25439303|NCT03192215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439304|NCT03192215|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25439305|NCT03192215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25439306|NCT03192215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25439307|NCT03192215|Antipyretics|antipyretics|mesh-ancestor
25439308|NCT03192215|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25439309|NCT03192215|Antithrombins|antithrombins|mesh-ancestor
25439310|NCT03192215|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25439311|NCT03192215|Protease Inhibitors|protease inhibitors|mesh-ancestor
25439312|NCT03192215|Anticoagulants|anticoagulants|mesh-ancestor
25439313|NCT03175198|Dabigatran|dabigatran|mesh-list
25439314|NCT03175198|Antithrombins|antithrombins|mesh-ancestor
25439315|NCT03175198|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25439316|NCT03175198|Protease Inhibitors|protease inhibitors|mesh-ancestor
25439317|NCT03175198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24869817|NCT05150431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25643589|NCT01428583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25643590|NCT01428583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643591|NCT01428583|Analgesics|analgesics|mesh-ancestor
25643592|NCT01428583|Sensory System Agents|sensory system agents|mesh-ancestor
25643593|NCT01428583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25643594|NCT01428583|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25643595|NCT01428583|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25643596|NCT01428713|Tranexamic Acid|tranexamic acid|mesh-list
25643597|NCT01428713|Contraceptive Agents|contraceptive agents|mesh-list
25643598|NCT01428713|Contraceptives, Oral|contraceptives, oral|mesh-list
25822824|NCT00004669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24869822|NCT05150431|Analgesics|analgesics|mesh-ancestor
24879463|NCT04752813|Coagulants|coagulants|mesh-ancestor
24879464|NCT04745559|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24879465|NCT04745559|Immunologic Factors|immunologic factors|mesh-ancestor
25055461|NCT03520985|Pomalidomide|pomalidomide|mesh-list
25822825|NCT00004682|Immunoglobulins|immunoglobulins|mesh-list
25439348|NCT03126799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25439349|NCT03126799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25439350|NCT03126799|Growth Substances|growth substances|mesh-ancestor
25439351|NCT03126799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439352|NCT03126799|Growth Inhibitors|growth inhibitors|mesh-ancestor
25439353|NCT03126799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25439354|NCT03126799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25439355|NCT03126799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439356|NCT03075826|Guadecitabine|guadecitabine|mesh-list
25439357|NCT03075826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870099|NCT03945448|Amebicides|amebicides|mesh-ancestor
24870100|NCT03945448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24870101|NCT03945448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25439359|NCT03062280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25439360|NCT03029702|Metformin|metformin|mesh-list
25439361|NCT03029702|Glyburide|glyburide|mesh-list
25439362|NCT03029702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25439363|NCT03029702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439364|NCT03012620|Pembrolizumab|pembrolizumab|mesh-list
25439365|NCT03012620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25439366|NCT03012620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439367|NCT02993731|Gemcitabine|gemcitabine|mesh-list
25439368|NCT02993731|Paclitaxel|paclitaxel|mesh-list
25439369|NCT02993731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25439370|NCT02993731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439371|NCT02993731|Tubulin Modulators|tubulin modulators|mesh-ancestor
25439372|NCT02993731|Antimitotic Agents|antimitotic agents|mesh-ancestor
25439373|NCT02993731|Mitosis Modulators|mitosis modulators|mesh-ancestor
25439374|NCT02993731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439375|NCT02993731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25439376|NCT02993731|Antimetabolites|antimetabolites|mesh-ancestor
25439377|NCT02993731|Antiviral Agents|antiviral agents|mesh-ancestor
25439378|NCT02993731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25439379|NCT02993731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25439380|NCT02993731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25439381|NCT02993731|Immunologic Factors|immunologic factors|mesh-ancestor
25439382|NCT02993731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439383|NCT02992743|Cyclophosphamide|cyclophosphamide|mesh-list
25439384|NCT02992743|Fludarabine|fludarabine|mesh-list
25439385|NCT02992743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25439386|NCT02992743|Immunologic Factors|immunologic factors|mesh-ancestor
25439387|NCT02992743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439388|NCT02992743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25439389|NCT02992743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25439390|NCT02992743|Alkylating Agents|alkylating agents|mesh-ancestor
25439391|NCT02992743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439392|NCT02992743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439393|NCT02992743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25439394|NCT02888067|Bromides|bromides|mesh-list
25439395|NCT02888067|Rocuronium|rocuronium|mesh-list
25439396|NCT02888067|Anticonvulsants|anticonvulsants|mesh-ancestor
25439397|NCT02888067|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25439398|NCT02888067|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25439399|NCT02888067|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25439400|NCT02888067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25439401|NCT02888067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439402|NCT02858921|Pembrolizumab|pembrolizumab|mesh-list
25439403|NCT02858921|Trametinib|trametinib|mesh-list
25439404|NCT02858921|Dabrafenib|dabrafenib|mesh-list
24487008|NCT00460915|Vasodilator Agents|vasodilator agents|mesh-ancestor
25439405|NCT02858921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25439406|NCT02858921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439407|NCT02858921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25439408|NCT02858921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25439409|NCT02858921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439410|NCT02826161|Paclitaxel|paclitaxel|mesh-list
25439411|NCT02826161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25439412|NCT02826161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439413|NCT02826161|Tubulin Modulators|tubulin modulators|mesh-ancestor
25439414|NCT02826161|Antimitotic Agents|antimitotic agents|mesh-ancestor
25439415|NCT02826161|Mitosis Modulators|mitosis modulators|mesh-ancestor
25439416|NCT02826161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439417|NCT02697474|Vaccines|vaccines|mesh-list
25439418|NCT02697474|Immunologic Factors|immunologic factors|mesh-ancestor
25439419|NCT02697474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439420|NCT02632344|Pembrolizumab|pembrolizumab|mesh-list
25439421|NCT02632344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25439422|NCT02632344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439423|NCT02520011|Cytarabine|cytarabine|mesh-list
25439424|NCT02520011|Mitoxantrone|mitoxantrone|mesh-list
25439425|NCT02520011|Alvocidib|alvocidib|mesh-list
25439426|NCT02520011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25439427|NCT02520011|Antimetabolites|antimetabolites|mesh-ancestor
25822826|NCT00004682|Antibodies|antibodies|mesh-list
24512920|NCT00577668|Antiemetics|antiemetics|mesh-ancestor
24871167|NCT04598009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24871183|NCT04578600|Lenalidomide|lenalidomide|mesh-list
24871263|NCT04218786|Colchicine|colchicine|mesh-list
24962689|NCT03795909|Dexamethasone|dexamethasone|mesh-list
24963442|NCT03790670|Sargramostim|sargramostim|mesh-list
25439428|NCT02520011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439429|NCT02520011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439430|NCT02520011|Antiviral Agents|antiviral agents|mesh-ancestor
25439431|NCT02520011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25439432|NCT02520011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25439433|NCT02520011|Immunologic Factors|immunologic factors|mesh-ancestor
25439434|NCT02520011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439436|NCT02520011|Sensory System Agents|sensory system agents|mesh-ancestor
25439437|NCT02520011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25439438|NCT02520011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25439439|NCT02520011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25439440|NCT02520011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25439441|NCT02520011|Growth Inhibitors|growth inhibitors|mesh-ancestor
25439442|NCT02520011|Growth Substances|growth substances|mesh-ancestor
25439443|NCT02520011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25439444|NCT02315534|Temozolomide|temozolomide|mesh-list
25439445|NCT02315534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25439446|NCT02315534|Alkylating Agents|alkylating agents|mesh-ancestor
25439447|NCT02315534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439448|NCT02315534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439449|NCT02311582|Pembrolizumab|pembrolizumab|mesh-list
25439450|NCT02311582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25439451|NCT02311582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439452|NCT02279719|Sorafenib|sorafenib|mesh-list
25439453|NCT02279719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439454|NCT02279719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25439455|NCT02279719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25439456|NCT02279719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439457|NCT02235857|Dextrans|dextrans|mesh-list
25439458|NCT02235857|Anticoagulants|anticoagulants|mesh-ancestor
25439459|NCT02235857|Plasma Substitutes|plasma substitutes|mesh-ancestor
25439460|NCT02235857|Blood Substitutes|blood substitutes|mesh-ancestor
25439461|NCT02192398|Guanfacine|guanfacine|mesh-list
25439462|NCT02192398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25439463|NCT02192398|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25439464|NCT02192398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25439465|NCT02192398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25439466|NCT02192398|Adrenergic Agents|adrenergic agents|mesh-ancestor
25439467|NCT02192398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25439468|NCT02192398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439469|NCT02192398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439470|NCT02178956|Paclitaxel|paclitaxel|mesh-list
25439471|NCT02178956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25439472|NCT02178956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439473|NCT02178956|Tubulin Modulators|tubulin modulators|mesh-ancestor
25439474|NCT02178956|Antimitotic Agents|antimitotic agents|mesh-ancestor
25439475|NCT02178956|Mitosis Modulators|mitosis modulators|mesh-ancestor
25439476|NCT02178956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439477|NCT02152995|Iodine|iodine|mesh-list
25439478|NCT02152995|Cadexomer iodine|cadexomer iodine|mesh-list
25439479|NCT02152995|Trametinib|trametinib|mesh-list
25439480|NCT02152995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25439481|NCT02152995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25439482|NCT02152995|Trace Elements|trace elements|mesh-ancestor
25439483|NCT02152995|Micronutrients|micronutrients|mesh-ancestor
25439484|NCT02152995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439485|NCT02152995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439486|NCT02152995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25439487|NCT02152995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25439488|NCT02152995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439489|NCT02024607|Leucovorin|leucovorin|mesh-list
25439490|NCT02024607|Bevacizumab|bevacizumab|mesh-list
25439491|NCT02024607|Fluorouracil|fluorouracil|mesh-list
25439492|NCT02024607|Capecitabine|capecitabine|mesh-list
25439493|NCT02024607|Oxaliplatin|oxaliplatin|mesh-list
25439494|NCT02024607|Irinotecan|irinotecan|mesh-list
25439495|NCT02024607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24874372|NCT04777994|Growth Substances|growth substances|mesh-ancestor
24874373|NCT04777994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24874379|NCT04774965|Promethazine|promethazine|mesh-list
25056338|NCT03513393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25056339|NCT03513393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25056340|NCT03513393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25056341|NCT03513393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25056345|NCT03513328|Thiotepa|thiotepa|mesh-list
25439497|NCT02024607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25439498|NCT02024607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25439499|NCT02024607|Growth Substances|growth substances|mesh-ancestor
25439500|NCT02024607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439501|NCT02024607|Growth Inhibitors|growth inhibitors|mesh-ancestor
25439502|NCT02024607|Antimetabolites|antimetabolites|mesh-ancestor
25439503|NCT02024607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439504|NCT02024607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25439505|NCT02024607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25439506|NCT02024607|Immunologic Factors|immunologic factors|mesh-ancestor
25439507|NCT02024607|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25439508|NCT02024607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25439509|NCT02024607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25439510|NCT02024607|Antidotes|antidotes|mesh-ancestor
25439511|NCT02024607|Protective Agents|protective agents|mesh-ancestor
25439512|NCT02024607|Vitamin B Complex|vitamin b complex|mesh-ancestor
25439513|NCT02024607|Vitamins|vitamins|mesh-ancestor
25439514|NCT02024607|Micronutrients|micronutrients|mesh-ancestor
25439515|NCT01929811|Metformin|metformin|mesh-list
25439516|NCT01929811|Docetaxel|docetaxel|mesh-list
25439517|NCT01929811|Epirubicin|epirubicin|mesh-list
25439518|NCT01929811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25439519|NCT01929811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439520|NCT01929811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439521|NCT01929811|Tubulin Modulators|tubulin modulators|mesh-ancestor
25439522|NCT01929811|Antimitotic Agents|antimitotic agents|mesh-ancestor
25439523|NCT01929811|Mitosis Modulators|mitosis modulators|mesh-ancestor
25439524|NCT01929811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439525|NCT01929811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25439526|NCT01929811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25439527|NCT01929811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25439528|NCT01929811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25439529|NCT01925131|Prednisone|prednisone|mesh-list
25439530|NCT01925131|Cyclophosphamide|cyclophosphamide|mesh-list
25439531|NCT01925131|Vincristine|vincristine|mesh-list
25439532|NCT01925131|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25439533|NCT01925131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25439534|NCT01925131|Immunologic Factors|immunologic factors|mesh-ancestor
25439535|NCT01925131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439536|NCT01925131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25439537|NCT01925131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25439538|NCT01925131|Alkylating Agents|alkylating agents|mesh-ancestor
25439539|NCT01925131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439540|NCT01925131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439541|NCT01925131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25439542|NCT01925131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25439543|NCT01925131|Glucocorticoids|glucocorticoids|mesh-ancestor
25439544|NCT01925131|Hormones|hormones|mesh-ancestor
25439545|NCT01925131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25643599|NCT01428713|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25439546|NCT01925131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25439547|NCT01925131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25439548|NCT01925131|Tubulin Modulators|tubulin modulators|mesh-ancestor
25439549|NCT01925131|Antimitotic Agents|antimitotic agents|mesh-ancestor
25439550|NCT01925131|Mitosis Modulators|mitosis modulators|mesh-ancestor
25439551|NCT01925131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25439552|NCT01925131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25439553|NCT01803555|Budesonide|budesonide|mesh-list
25439554|NCT01803555|Formoterol Fumarate|formoterol fumarate|mesh-list
25439555|NCT01803555|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25439556|NCT01803555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25439557|NCT01803555|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25439558|NCT01803555|Autonomic Agents|autonomic agents|mesh-ancestor
25439559|NCT01803555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25439560|NCT01803555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439561|NCT01803555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25439562|NCT01803555|Respiratory System Agents|respiratory system agents|mesh-ancestor
25439563|NCT01803555|Glucocorticoids|glucocorticoids|mesh-ancestor
25439564|NCT01803555|Hormones|hormones|mesh-ancestor
25439565|NCT01803555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25439566|NCT01803555|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25439567|NCT01803555|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24878912|NCT00329043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24878913|NCT00329043|Growth Inhibitors|growth inhibitors|mesh-ancestor
25439568|NCT01803555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25439569|NCT01803555|Adrenergic Agents|adrenergic agents|mesh-ancestor
25439570|NCT01803555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25439571|NCT01803555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439573|NCT01791816|Oxymetazoline|oxymetazoline|mesh-list
25439574|NCT01791816|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
25439575|NCT01791816|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25439576|NCT01791816|Mydriatics|mydriatics|mesh-ancestor
25439577|NCT01791816|Autonomic Agents|autonomic agents|mesh-ancestor
25439578|NCT01791816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25439579|NCT01791816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439580|NCT01791816|Sympathomimetics|sympathomimetics|mesh-ancestor
25439581|NCT01791816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25439582|NCT01791816|Nasal Decongestants|nasal decongestants|mesh-ancestor
25439583|NCT01791816|Respiratory System Agents|respiratory system agents|mesh-ancestor
25439584|NCT01791816|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25439585|NCT01791816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25439586|NCT01791816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25439587|NCT01791816|Adrenergic Agents|adrenergic agents|mesh-ancestor
25439588|NCT01791816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25439589|NCT01791816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439590|NCT01791816|Protective Agents|protective agents|mesh-ancestor
25439591|NCT01791816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25439592|NCT01786434|Fentanyl|fentanyl|mesh-list
25439593|NCT01786434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25439594|NCT01786434|Narcotics|narcotics|mesh-ancestor
25439595|NCT01786434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25439596|NCT01786434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439597|NCT01786434|Analgesics|analgesics|mesh-ancestor
25439598|NCT01786434|Sensory System Agents|sensory system agents|mesh-ancestor
25439599|NCT01786434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25439600|NCT01786434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25439601|NCT01786434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25439602|NCT01786434|Anesthetics, General|anesthetics, general|mesh-ancestor
25439603|NCT01786434|Anesthetics|anesthetics|mesh-ancestor
25439604|NCT01784159|Aspirin|aspirin|mesh-list
25439605|NCT01784159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25439606|NCT01784159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25439607|NCT01784159|Analgesics|analgesics|mesh-ancestor
25439608|NCT01784159|Sensory System Agents|sensory system agents|mesh-ancestor
25439609|NCT01784159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25439610|NCT01784159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439611|NCT01784159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25439612|NCT01784159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25439613|NCT01784159|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25439614|NCT01784159|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25439615|NCT01784159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439616|NCT01784159|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25643600|NCT01428713|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25439617|NCT01784159|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25439618|NCT01784159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25439619|NCT01784159|Antipyretics|antipyretics|mesh-ancestor
25439620|NCT01776307|Capecitabine|capecitabine|mesh-list
25439621|NCT01776307|Cetuximab|cetuximab|mesh-list
25439622|NCT01776307|Panitumumab|panitumumab|mesh-list
25439623|NCT01776307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25439624|NCT01776307|Antimetabolites|antimetabolites|mesh-ancestor
25439625|NCT01776307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439626|NCT01776307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439627|NCT01776307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25439628|NCT01681264|Guanfacine|guanfacine|mesh-list
25439629|NCT01681264|Morphine|morphine|mesh-list
25439630|NCT01681264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25439631|NCT01681264|Narcotics|narcotics|mesh-ancestor
25439632|NCT01681264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25439633|NCT01681264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439634|NCT01681264|Analgesics|analgesics|mesh-ancestor
25439635|NCT01681264|Sensory System Agents|sensory system agents|mesh-ancestor
25439636|NCT01681264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25439637|NCT01681264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25439638|NCT01681264|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25439639|NCT01681264|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25439640|NCT01681264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25439641|NCT01681264|Adrenergic Agents|adrenergic agents|mesh-ancestor
25439642|NCT01681264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25291561|NCT05102396|Oxybutynin|oxybutynin|mesh-list
25439643|NCT01681264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439644|NCT01678586|Diphenhydramine|diphenhydramine|mesh-list
25439646|NCT01678586|Analgesics|analgesics|mesh-ancestor
25439647|NCT01678586|Sensory System Agents|sensory system agents|mesh-ancestor
25439648|NCT01678586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719765|NCT02455518|Acetaminophen|acetaminophen|mesh-list
25439649|NCT01678586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439650|NCT01678586|Anticonvulsants|anticonvulsants|mesh-ancestor
25439651|NCT01678586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25439652|NCT01678586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25439653|NCT01678586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25439654|NCT01678586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25439655|NCT01678586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25439656|NCT01678586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25439657|NCT01678586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25439658|NCT01678586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439659|NCT01678586|Antimanic Agents|antimanic agents|mesh-ancestor
25439660|NCT01678586|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25439661|NCT01678586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25439662|NCT01678586|Anesthetics, Local|anesthetics, local|mesh-ancestor
25439663|NCT01678586|Anesthetics|anesthetics|mesh-ancestor
25439664|NCT01678586|Antiemetics|antiemetics|mesh-ancestor
25439665|NCT01678586|Autonomic Agents|autonomic agents|mesh-ancestor
25439666|NCT01678586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25439667|NCT01678586|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25439668|NCT01678586|Histamine Antagonists|histamine antagonists|mesh-ancestor
25439669|NCT01678586|Histamine Agents|histamine agents|mesh-ancestor
25439670|NCT01678586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25439671|NCT01630213|Vitamin D|vitamin d|mesh-list
25439672|NCT01630213|Ergocalciferols|ergocalciferols|mesh-list
25439673|NCT01630213|Cholecalciferol|cholecalciferol|mesh-list
25439674|NCT01630213|Vitamins|vitamins|mesh-list
25439675|NCT01630213|Micronutrients|micronutrients|mesh-ancestor
25439676|NCT01630213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439677|NCT01630213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25439678|NCT01630213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25439679|NCT01623167|Cyclosporine|cyclosporine|mesh-list
25439680|NCT01623167|Cyclosporins|cyclosporins|mesh-list
25439681|NCT01623167|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25439682|NCT01623167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25439683|NCT01623167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439684|NCT01623167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25439685|NCT01623167|Immunologic Factors|immunologic factors|mesh-ancestor
25439686|NCT01623167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439687|NCT01623167|Antifungal Agents|antifungal agents|mesh-ancestor
25439688|NCT01623167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25439689|NCT01623167|Dermatologic Agents|dermatologic agents|mesh-ancestor
25439690|NCT01623167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25439691|NCT01623167|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25439692|NCT01470716|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25439693|NCT01470716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25643601|NCT01428713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25439694|NCT01470716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25439695|NCT01470716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25439696|NCT01470716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439697|NCT01441349|Simvastatin|simvastatin|mesh-list
25439698|NCT01441349|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25439699|NCT01441349|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25439700|NCT01441349|Antimetabolites|antimetabolites|mesh-ancestor
25439701|NCT01441349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439702|NCT01441349|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25439703|NCT01441349|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25439704|NCT01441349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25439705|NCT01156545|Afatinib|afatinib|mesh-list
25439706|NCT01156545|Simvastatin|simvastatin|mesh-list
25439707|NCT01156545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25439708|NCT01156545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25439709|NCT01156545|Antimetabolites|antimetabolites|mesh-ancestor
25291631|NCT05101785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291632|NCT05101785|Sensory System Agents|sensory system agents|mesh-ancestor
25291633|NCT05101785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25291634|NCT05101785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25291635|NCT05101785|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25291636|NCT05101785|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25291637|NCT05101785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25291648|NCT05101785|Mydriatics|mydriatics|mesh-ancestor
25439710|NCT01156545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439712|NCT01156545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25439713|NCT01156545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25439714|NCT01156545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439715|NCT01156545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25439716|NCT01140516|Trimethoprim|trimethoprim|mesh-list
25439717|NCT01140516|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25439718|NCT01140516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25439719|NCT01140516|Renal Agents|renal agents|mesh-ancestor
25439720|NCT01140516|Antimalarials|antimalarials|mesh-ancestor
25439721|NCT01140516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25439722|NCT01140516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25439723|NCT01140516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25439724|NCT01140516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25439725|NCT01140516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439726|NCT01140516|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25439727|NCT01140516|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25439728|NCT01140516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25439729|NCT00957086|Nimotuzumab|nimotuzumab|mesh-list
25439730|NCT00957086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25439731|NCT00957086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439732|NCT00544830|Leuprolide|leuprolide|mesh-list
25439733|NCT00544830|Goserelin|goserelin|mesh-list
25439734|NCT00544830|Bicalutamide|bicalutamide|mesh-list
25439735|NCT00544830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25439736|NCT00544830|Fertility Agents|fertility agents|mesh-ancestor
25439737|NCT00544830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25439738|NCT00544830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439739|NCT00544830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25439740|NCT00544830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439741|NCT00544830|Androgen Antagonists|androgen antagonists|mesh-ancestor
25439742|NCT00544830|Hormone Antagonists|hormone antagonists|mesh-ancestor
25439743|NCT00544830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25439744|NCT00539981|Hemagglutinins|hemagglutinins|mesh-list
25439745|NCT00539981|Immunologic Factors|immunologic factors|mesh-ancestor
25439746|NCT00539981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439747|NCT00539981|Agglutinins|agglutinins|mesh-ancestor
25439748|NCT00371059|Memantine|memantine|mesh-list
25439749|NCT00371059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25439750|NCT00371059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25439751|NCT00371059|Dopamine Agents|dopamine agents|mesh-ancestor
25439752|NCT00371059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25439753|NCT00371059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439754|NCT00371059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439755|NCT00371059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25439756|NCT00371059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25439757|NCT04734418|Dexmedetomidine|dexmedetomidine|mesh-list
25439758|NCT04734418|Remifentanil|remifentanil|mesh-list
25656790|NCT01578772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25439759|NCT04734418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25439760|NCT04734418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25439761|NCT04734418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439762|NCT04734418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25439763|NCT04734418|Analgesics|analgesics|mesh-ancestor
25439764|NCT04734418|Sensory System Agents|sensory system agents|mesh-ancestor
25439765|NCT04734418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25439766|NCT04734418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25439767|NCT04734418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25439768|NCT04734418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25439769|NCT04734418|Adrenergic Agents|adrenergic agents|mesh-ancestor
25439770|NCT04734418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25291701|NCT05037617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25291702|NCT05037617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291703|NCT05036473|Levodopa|levodopa|mesh-list
25291704|NCT05036473|Carbidopa|carbidopa|mesh-list
25291705|NCT05036473|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25291706|NCT05036473|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25291707|NCT05036473|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25291708|NCT05036473|Dopamine Agents|dopamine agents|mesh-ancestor
25291709|NCT05036473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25291710|NCT05036473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291711|NCT05036473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822827|NCT00004682|gamma-Globulins|gamma-globulins|mesh-list
25439774|NCT04734067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25439775|NCT04734067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439776|NCT04734067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439778|NCT04734353|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25439779|NCT04734353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25439780|NCT04734353|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25439781|NCT04734353|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25439782|NCT04734353|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25439783|NCT04734353|Purinergic Agents|purinergic agents|mesh-ancestor
25439784|NCT04734353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25439785|NCT04734353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439786|NCT04734353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439787|NCT04734119|Anesthetics|anesthetics|mesh-list
25439788|NCT04734119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25439789|NCT04734119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439790|NCT04734041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25439791|NCT04733781|Lidocaine|lidocaine|mesh-list
25439792|NCT04733781|Epinephrine|epinephrine|mesh-list
25439793|NCT04733781|Anesthetics, Local|anesthetics, local|mesh-ancestor
25439794|NCT04733781|Anesthetics|anesthetics|mesh-ancestor
25439795|NCT04733781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25439796|NCT04733781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439797|NCT04733781|Sensory System Agents|sensory system agents|mesh-ancestor
25439798|NCT04733781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25439799|NCT04733781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25439800|NCT04733781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25439801|NCT04733781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25439802|NCT04733781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25439803|NCT04733781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439804|NCT04733781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25439805|NCT04733781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25439806|NCT04733781|Adrenergic Agents|adrenergic agents|mesh-ancestor
25439807|NCT04733781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25439808|NCT04733781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25439809|NCT04733781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25439810|NCT04733781|Autonomic Agents|autonomic agents|mesh-ancestor
25439811|NCT04733781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25439812|NCT04733781|Respiratory System Agents|respiratory system agents|mesh-ancestor
25439813|NCT04733781|Mydriatics|mydriatics|mesh-ancestor
25439814|NCT04733781|Sympathomimetics|sympathomimetics|mesh-ancestor
25439815|NCT04733781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25439816|NCT04733625|Vitamin D|vitamin d|mesh-list
25439817|NCT04733625|Cholecalciferol|cholecalciferol|mesh-list
25439818|NCT04733625|Vitamins|vitamins|mesh-ancestor
25439819|NCT04733625|Micronutrients|micronutrients|mesh-ancestor
25439820|NCT04733625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439821|NCT04733625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25439822|NCT04733625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25439823|NCT04733326|Ketorolac|ketorolac|mesh-list
25643602|NCT01428713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439824|NCT04733326|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25719800|NCT02456662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25439825|NCT04733326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25439826|NCT04733326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25439827|NCT04733326|Analgesics|analgesics|mesh-ancestor
25439828|NCT04733326|Sensory System Agents|sensory system agents|mesh-ancestor
25439829|NCT04733326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25439830|NCT04733326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439831|NCT04733326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25439832|NCT04733326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25439833|NCT04733326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25439834|NCT04733326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291843|NCT04565574|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25291844|NCT04565574|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25291845|NCT04565574|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25291846|NCT04565574|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25291847|NCT04565574|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25291848|NCT04560634|Norepinephrine|norepinephrine|mesh-list
25291849|NCT04560634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25291850|NCT04560634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25291851|NCT04560634|Adrenergic Agents|adrenergic agents|mesh-ancestor
25291852|NCT04560634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25291853|NCT04560634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439835|NCT04733326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439836|NCT04733521|Cisplatin|cisplatin|mesh-list
25439837|NCT04733521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439838|NCT04733508|Exenatide|exenatide|mesh-list
25439839|NCT04733508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25439840|NCT04733508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439841|NCT04733508|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25439842|NCT04733508|Incretins|incretins|mesh-ancestor
25439843|NCT04733508|Hormones|hormones|mesh-ancestor
25439844|NCT04733508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25439845|NCT04733235|Progesterone|progesterone|mesh-list
25439846|NCT04733235|Hormones|hormones|mesh-ancestor
25439847|NCT04733235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25439848|NCT04733235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439849|NCT04733235|Progestins|progestins|mesh-ancestor
25439850|NCT04733131|Abatacept|abatacept|mesh-list
25439851|NCT04733131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25439852|NCT04733131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439853|NCT04733131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439854|NCT04733131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25439855|NCT04733131|Immunologic Factors|immunologic factors|mesh-ancestor
25439856|NCT04733131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439857|NCT04733131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25439858|NCT04733066|Teduglutide|teduglutide|mesh-list
25439859|NCT04733066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25439860|NCT04733066|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25439861|NCT04733066|Protective Agents|protective agents|mesh-ancestor
25439862|NCT04733066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439863|NCT04733573|Salicylic Acid|salicylic acid|mesh-list
25439864|NCT04733573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25439865|NCT04733573|Antifungal Agents|antifungal agents|mesh-ancestor
25439866|NCT04733573|Keratolytic Agents|keratolytic agents|mesh-ancestor
25439867|NCT04733573|Dermatologic Agents|dermatologic agents|mesh-ancestor
25439868|NCT04733196|Chlorhexidine|chlorhexidine|mesh-list
25439869|NCT04733196|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25439870|NCT04733196|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25439871|NCT04733196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25439872|NCT04733196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25439873|NCT04733196|Disinfectants|disinfectants|mesh-ancestor
25439874|NCT04733196|Dermatologic Agents|dermatologic agents|mesh-ancestor
25439875|NCT04732390|Magnesium Sulfate|magnesium sulfate|mesh-list
25439876|NCT04732390|Bupivacaine|bupivacaine|mesh-list
25439877|NCT04732390|Anesthetics, Local|anesthetics, local|mesh-ancestor
25439878|NCT04732390|Anesthetics|anesthetics|mesh-ancestor
25439879|NCT04732390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25439880|NCT04732390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439881|NCT04732390|Sensory System Agents|sensory system agents|mesh-ancestor
25439882|NCT04732390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25439883|NCT04732390|Analgesics|analgesics|mesh-ancestor
25439884|NCT04732390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25439885|NCT04732390|Anticonvulsants|anticonvulsants|mesh-ancestor
25439886|NCT04732390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25439887|NCT04732390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25439888|NCT04732390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439889|NCT04732390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25439890|NCT04732390|Tocolytic Agents|tocolytic agents|mesh-ancestor
25439891|NCT04732390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25439892|NCT04732377|Dexmedetomidine|dexmedetomidine|mesh-list
25439893|NCT04732377|Bupivacaine|bupivacaine|mesh-list
25439894|NCT04732377|Anesthetics, Local|anesthetics, local|mesh-ancestor
25439895|NCT04732377|Anesthetics|anesthetics|mesh-ancestor
25439896|NCT04732377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25439897|NCT04732377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439898|NCT04732377|Sensory System Agents|sensory system agents|mesh-ancestor
25439899|NCT04732377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25439900|NCT04732377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25439901|NCT04732377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25291919|NCT04260477|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25291920|NCT04260477|Antitubercular Agents|antitubercular agents|mesh-ancestor
25291921|NCT04260477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25291922|NCT04260477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25291923|NCT04260477|Leprostatic Agents|leprostatic agents|mesh-ancestor
25291924|NCT04260477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25291925|NCT04260477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291927|NCT04260477|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25439902|NCT04732377|Analgesics|analgesics|mesh-ancestor
25439903|NCT04732377|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25439904|NCT04732377|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25439905|NCT04732377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25439906|NCT04732377|Adrenergic Agents|adrenergic agents|mesh-ancestor
25439907|NCT04732377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25439908|NCT04732377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439909|NCT04732364|Bupivacaine|bupivacaine|mesh-list
25439910|NCT04732364|Anesthetics, Local|anesthetics, local|mesh-ancestor
25439911|NCT04732364|Anesthetics|anesthetics|mesh-ancestor
25439912|NCT04732364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25439913|NCT04732364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439914|NCT04732364|Sensory System Agents|sensory system agents|mesh-ancestor
25439915|NCT04732364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25439916|NCT04732598|Paclitaxel|paclitaxel|mesh-list
25439917|NCT04732598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25439918|NCT04732598|Bevacizumab|bevacizumab|mesh-list
25439919|NCT04732598|Atezolizumab|atezolizumab|mesh-list
25439920|NCT04732598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25439921|NCT04732598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25439922|NCT04732598|Tubulin Modulators|tubulin modulators|mesh-ancestor
25439923|NCT04732598|Antimitotic Agents|antimitotic agents|mesh-ancestor
25439924|NCT04732598|Mitosis Modulators|mitosis modulators|mesh-ancestor
25439925|NCT04732598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439926|NCT04732598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25439927|NCT04732598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25439928|NCT04732598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25439929|NCT04732598|Growth Substances|growth substances|mesh-ancestor
25439930|NCT04732598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439931|NCT04732598|Growth Inhibitors|growth inhibitors|mesh-ancestor
25439932|NCT04732507|Lidocaine|lidocaine|mesh-list
25439933|NCT04732507|Bupivacaine|bupivacaine|mesh-list
25439934|NCT04732507|Anesthetics, Local|anesthetics, local|mesh-ancestor
25439935|NCT04732507|Anesthetics|anesthetics|mesh-ancestor
25439936|NCT04732507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25439937|NCT04732507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439938|NCT04732507|Sensory System Agents|sensory system agents|mesh-ancestor
25439939|NCT04732507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25439940|NCT04732507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25439941|NCT04732507|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25439942|NCT04732507|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25439943|NCT04732507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25439944|NCT04732507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25439945|NCT04732247|Oxytocin|oxytocin|mesh-list
25439946|NCT04732247|Oxytocics|oxytocics|mesh-ancestor
25439947|NCT04732247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25439948|NCT04732247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439949|NCT04731961|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25439950|NCT04731961|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25439951|NCT04731961|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25439952|NCT04731961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25643603|NCT01428713|Hemostatics|hemostatics|mesh-ancestor
25643604|NCT01428713|Coagulants|coagulants|mesh-ancestor
25643605|NCT01428713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25643606|NCT01428713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439953|NCT04731961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25439954|NCT04731961|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25439955|NCT04731961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25439956|NCT04731961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643607|NCT01428713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25656791|NCT01578772|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25656792|NCT01578772|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25439957|NCT04731961|Cholinergic Agents|cholinergic agents|mesh-ancestor
25439958|NCT04731961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25439959|NCT04732104|Lidocaine|lidocaine|mesh-list
25439960|NCT04732104|Xylometazoline|xylometazoline|mesh-list
25439961|NCT04732104|Nasal Decongestants|nasal decongestants|mesh-list
25439962|NCT04732104|Anesthetics, Local|anesthetics, local|mesh-ancestor
25439963|NCT04732104|Anesthetics|anesthetics|mesh-ancestor
25292007|NCT03863184|Rituximab|rituximab|mesh-list
25292008|NCT03863184|Lenalidomide|lenalidomide|mesh-list
25292009|NCT03863184|Acalabrutinib|acalabrutinib|mesh-list
25292010|NCT03863184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25292011|NCT03863184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292012|NCT03863184|Immunologic Factors|immunologic factors|mesh-ancestor
25292013|NCT03863184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292014|NCT03863184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25292015|NCT03863184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25292016|NCT03863184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25292017|NCT03863184|Growth Substances|growth substances|mesh-ancestor
25292018|NCT03863184|Growth Inhibitors|growth inhibitors|mesh-ancestor
25292019|NCT03838744|Olaparib|olaparib|mesh-list
25292057|NCT03522753|Hormones|hormones|mesh-ancestor
25439997|NCT04731909|Cisplatin|cisplatin|mesh-list
25439998|NCT04731909|Carboplatin|carboplatin|mesh-list
25439999|NCT04731909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440000|NCT04731766|Listerine|listerine|mesh-list
25440001|NCT04731766|Fluorides|fluorides|mesh-list
25440002|NCT04731766|Sodium Fluoride|sodium fluoride|mesh-list
25440003|NCT04731766|Cariostatic Agents|cariostatic agents|mesh-ancestor
25440004|NCT04731766|Protective Agents|protective agents|mesh-ancestor
25440005|NCT04731766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440006|NCT04731766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25440007|NCT04731766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25440008|NCT04731376|Methyltestosterone|methyltestosterone|mesh-list
25440009|NCT04731376|Testosterone|testosterone|mesh-list
25440010|NCT04731376|Testosterone undecanoate|testosterone undecanoate|mesh-list
25440011|NCT04731376|Testosterone enanthate|testosterone enanthate|mesh-list
25440012|NCT04731376|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25440013|NCT04731376|Androgens|androgens|mesh-ancestor
25440014|NCT04731376|Hormones|hormones|mesh-ancestor
25440015|NCT04731376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25440016|NCT04731376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440017|NCT04731376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25440018|NCT04731376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440019|NCT04731376|Anabolic Agents|anabolic agents|mesh-ancestor
25440020|NCT04731116|Cannabidiol|cannabidiol|mesh-list
25440021|NCT04731116|Anticonvulsants|anticonvulsants|mesh-ancestor
25440022|NCT04731038|Paclitaxel|paclitaxel|mesh-list
25440023|NCT04731038|Cisplatin|cisplatin|mesh-list
25440024|NCT04731038|Carboplatin|carboplatin|mesh-list
25440025|NCT04731038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25440026|NCT04731038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440027|NCT04731038|Tubulin Modulators|tubulin modulators|mesh-ancestor
25440028|NCT04731038|Antimitotic Agents|antimitotic agents|mesh-ancestor
25440029|NCT04731038|Mitosis Modulators|mitosis modulators|mesh-ancestor
25440030|NCT04731038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440031|NCT04731090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25440032|NCT04731090|Fluoroquinolones|fluoroquinolones|mesh-list
25440033|NCT04731090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25440034|NCT04731090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25440035|NCT04731090|Antitubercular Agents|antitubercular agents|mesh-ancestor
25440036|NCT04731090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25440037|NCT04731090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440038|NCT04731090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440039|NCT04730973|Evolocumab|evolocumab|mesh-list
25440040|NCT04730973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25440041|NCT04730973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25440042|NCT04730973|Antimetabolites|antimetabolites|mesh-ancestor
25440043|NCT04730973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440044|NCT04730973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25440045|NCT04730765|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25440046|NCT04730765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25440047|NCT04730895|Tretinoin|tretinoin|mesh-list
25440048|NCT04730895|Isotretinoin|isotretinoin|mesh-list
25440049|NCT04730895|Vaccines|vaccines|mesh-list
25292126|NCT03023124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292127|NCT03023124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25292128|NCT03023124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25292129|NCT03023124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25292130|NCT03023124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292131|NCT03023124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25292132|NCT03023124|Alkylating Agents|alkylating agents|mesh-ancestor
25292159|NCT02733614|SRX246|srx246|mesh-list
25292160|NCT02733614|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25292161|NCT02733614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292162|NCT02733614|Natriuretic Agents|natriuretic agents|mesh-ancestor
25292163|NCT02733614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881706|NCT01720836|Immunologic Factors|immunologic factors|mesh-ancestor
24881707|NCT01720836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703994|NCT01476007|Vitamins|vitamins|mesh-list
24881711|NCT01559363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881712|NCT01559363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24881713|NCT01559363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881714|NCT01559363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881715|NCT01504919|Nicotine|nicotine|mesh-list
24881716|NCT01504919|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24881717|NCT01504919|Autonomic Agents|autonomic agents|mesh-ancestor
25057138|NCT03507244|Pemetrexed|pemetrexed|mesh-list
25292189|NCT02683018|Dronabinol|dronabinol|mesh-list
25440050|NCT04730895|Myeloma Proteins|myeloma proteins|mesh-list
25440051|NCT04730895|Paraproteins|paraproteins|mesh-list
25440052|NCT04730895|Immunologic Factors|immunologic factors|mesh-ancestor
25440053|NCT04730895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440054|NCT04730895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440055|NCT04730895|Keratolytic Agents|keratolytic agents|mesh-ancestor
25440056|NCT04730895|Dermatologic Agents|dermatologic agents|mesh-ancestor
25440057|NCT04730622|Mitogens|mitogens|mesh-list
25440058|NCT04730622|Mitosis Modulators|mitosis modulators|mesh-ancestor
25440059|NCT04730622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440060|NCT04730544|Nivolumab|nivolumab|mesh-list
25440061|NCT04730544|Ipilimumab|ipilimumab|mesh-list
25440062|NCT04730544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25440063|NCT04730544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440064|NCT04730544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25440065|NCT04730544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440066|NCT04730596|Dexmedetomidine|dexmedetomidine|mesh-list
25440067|NCT04730596|Ketamine|ketamine|mesh-list
25440068|NCT04730596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25440069|NCT04730596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25440070|NCT04730596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440071|NCT04730596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25440072|NCT04730596|Analgesics|analgesics|mesh-ancestor
25440073|NCT04730596|Sensory System Agents|sensory system agents|mesh-ancestor
25440074|NCT04730596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25440075|NCT04730596|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25440076|NCT04730596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25440077|NCT04730596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25440078|NCT04730596|Adrenergic Agents|adrenergic agents|mesh-ancestor
25440079|NCT04730596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25440080|NCT04730596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440081|NCT04730596|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25440082|NCT04730596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25440083|NCT04730596|Anesthetics, General|anesthetics, general|mesh-ancestor
25440084|NCT04730596|Anesthetics|anesthetics|mesh-ancestor
25440085|NCT04730596|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25440086|NCT04730596|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25440087|NCT04730674|Tetracycline|tetracycline|mesh-list
25440088|NCT04730674|Lidocaine|lidocaine|mesh-list
25440089|NCT04730674|Anesthetics, Local|anesthetics, local|mesh-ancestor
25440090|NCT04730674|Anesthetics|anesthetics|mesh-ancestor
25440091|NCT04730674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25440092|NCT04730674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440093|NCT04730674|Sensory System Agents|sensory system agents|mesh-ancestor
25643608|NCT01428882|Midazolam|midazolam|mesh-list
25440094|NCT04730674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25440095|NCT04730674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25440096|NCT04730674|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25440097|NCT04730674|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25440098|NCT04730674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25440099|NCT04730674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440100|NCT04730674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25440101|NCT04730674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25440102|NCT04730674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25440103|NCT04730674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440104|NCT04730375|Dexmedetomidine|dexmedetomidine|mesh-list
25440105|NCT04730375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25440106|NCT04730375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25440107|NCT04730375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440108|NCT04730375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25440109|NCT04730375|Analgesics|analgesics|mesh-ancestor
25440110|NCT04730375|Sensory System Agents|sensory system agents|mesh-ancestor
25440111|NCT04730375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25440112|NCT04730375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25440113|NCT04730375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25440114|NCT04730375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25440115|NCT04730375|Adrenergic Agents|adrenergic agents|mesh-ancestor
25440116|NCT04730375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25440117|NCT04730375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440119|NCT04730245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25440120|NCT04730245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25440121|NCT04730245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25440122|NCT04730297|Acetaminophen|acetaminophen|mesh-list
25440123|NCT04730297|Ibuprofen|ibuprofen|mesh-list
25440124|NCT04730297|Codeine|codeine|mesh-list
25440125|NCT04730297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25440126|NCT04730297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25440127|NCT04730297|Analgesics|analgesics|mesh-ancestor
25440128|NCT04730297|Sensory System Agents|sensory system agents|mesh-ancestor
25440129|NCT04730297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25440130|NCT04730297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440131|NCT04730297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25440132|NCT04730297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25440133|NCT04730297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25440134|NCT04730297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440135|NCT04730297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440136|NCT04730297|Antipyretics|antipyretics|mesh-ancestor
25440137|NCT04730297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25440138|NCT04730297|Narcotics|narcotics|mesh-ancestor
25440139|NCT04730297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25440140|NCT04730297|Antitussive Agents|antitussive agents|mesh-ancestor
25440141|NCT04730297|Respiratory System Agents|respiratory system agents|mesh-ancestor
25440142|NCT04729998|Rivaroxaban|rivaroxaban|mesh-list
25440143|NCT04729998|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25440144|NCT04729998|Antithrombins|antithrombins|mesh-ancestor
25440145|NCT04729998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25440146|NCT04729998|Protease Inhibitors|protease inhibitors|mesh-ancestor
25440147|NCT04729998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440148|NCT04729998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440149|NCT04729998|Anticoagulants|anticoagulants|mesh-ancestor
25440150|NCT04729556|Chitosan|chitosan|mesh-list
25440151|NCT04729556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25440152|NCT04729556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25440153|NCT04729556|Antimetabolites|antimetabolites|mesh-ancestor
25440154|NCT04729556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440155|NCT04729556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25440156|NCT04729556|Chelating Agents|chelating agents|mesh-ancestor
25440157|NCT04729556|Sequestering Agents|sequestering agents|mesh-ancestor
25440158|NCT04729556|Hemostatics|hemostatics|mesh-ancestor
25440159|NCT04729556|Coagulants|coagulants|mesh-ancestor
25440160|NCT04729868|Dexmedetomidine|dexmedetomidine|mesh-list
25440161|NCT04729868|Bupivacaine|bupivacaine|mesh-list
25440162|NCT04729868|Levobupivacaine|levobupivacaine|mesh-list
25440163|NCT04729868|Anesthetics, Local|anesthetics, local|mesh-ancestor
25440164|NCT04729868|Anesthetics|anesthetics|mesh-ancestor
25440165|NCT04729868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25440166|NCT04729868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440167|NCT04729868|Sensory System Agents|sensory system agents|mesh-ancestor
25440168|NCT04729868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25440169|NCT04729868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25440170|NCT04729868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25440171|NCT04729868|Analgesics|analgesics|mesh-ancestor
25440172|NCT04729868|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25440173|NCT04729868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25440174|NCT04729868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25440175|NCT04729868|Adrenergic Agents|adrenergic agents|mesh-ancestor
25440176|NCT04729868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25440177|NCT04729868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440179|NCT04729465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25440180|NCT04729465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25440181|NCT04729465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440182|NCT04729465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25440183|NCT04729465|Anesthetics, General|anesthetics, general|mesh-ancestor
25440184|NCT04729465|Anesthetics|anesthetics|mesh-ancestor
25440185|NCT04729491|Azithromycin|azithromycin|mesh-list
25440186|NCT04729491|Nitazoxanide|nitazoxanide|mesh-list
25292257|NCT02574728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292258|NCT02574728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292259|NCT02574728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25292260|NCT02574728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25292261|NCT02574728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25292262|NCT02574728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25292263|NCT02574728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25292264|NCT02574728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25292265|NCT02574728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25292266|NCT02574728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25292267|NCT02574728|Antifungal Agents|antifungal agents|mesh-ancestor
25292268|NCT02574728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25292269|NCT02574728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25440200|NCT04729348|Pembrolizumab|pembrolizumab|mesh-list
25440201|NCT04729348|Lenvatinib|lenvatinib|mesh-list
25440202|NCT04729348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25440203|NCT04729348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440204|NCT04729348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25440205|NCT04729348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440206|NCT04729348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440207|NCT04729101|Lansoprazole|lansoprazole|mesh-list
25440208|NCT04729101|Dexlansoprazole|dexlansoprazole|mesh-list
25440209|NCT04729101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25440210|NCT04729101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25440211|NCT04729101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25440212|NCT04729101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440213|NCT04729101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440214|NCT04728932|Simendan|simendan|mesh-list
25440215|NCT04728932|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25440216|NCT04728932|Vasodilator Agents|vasodilator agents|mesh-ancestor
25440217|NCT04728932|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25440218|NCT04728932|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25440219|NCT04728932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440220|NCT04728932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440221|NCT04728932|Protective Agents|protective agents|mesh-ancestor
25440222|NCT04728932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440223|NCT04728880|Remdesivir|remdesivir|mesh-list
25440224|NCT04728880|Antimetabolites|antimetabolites|mesh-ancestor
25440225|NCT04728880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440226|NCT04728880|Antiviral Agents|antiviral agents|mesh-ancestor
25440227|NCT04728880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25440228|NCT04728750|Pancrelipase|pancrelipase|mesh-list
25440229|NCT04728750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25440230|NCT04728516|Amoxicillin|amoxicillin|mesh-list
25440231|NCT04728516|Pantoprazole|pantoprazole|mesh-list
25440232|NCT04728516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25440233|NCT04728516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25440234|NCT04728516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25440235|NCT04728516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25440236|NCT04728516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25440237|NCT04728516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440238|NCT04728516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440239|NCT04728581|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25440240|NCT04728581|Mirtazapine|mirtazapine|mesh-list
25440241|NCT04728581|Antidepressive Agents|antidepressive agents|mesh-ancestor
25440242|NCT04728581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24491274|NCT00481819|Hormones|hormones|mesh-ancestor
25440243|NCT04728581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25440244|NCT04728581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25440245|NCT04728581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25440246|NCT04728581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440247|NCT04728581|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25440248|NCT04728581|Histamine Antagonists|histamine antagonists|mesh-ancestor
25440249|NCT04728581|Histamine Agents|histamine agents|mesh-ancestor
25440250|NCT04728581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25440251|NCT04728581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440252|NCT04728581|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25440253|NCT04728581|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25440254|NCT04728581|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25440255|NCT04728581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25440256|NCT04728581|Adrenergic Agents|adrenergic agents|mesh-ancestor
25440257|NCT04728581|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25440258|NCT04728581|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25440259|NCT04728581|Serotonin Agents|serotonin agents|mesh-ancestor
25440260|NCT04728581|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25440262|NCT04728659|Ganirelix|ganirelix|mesh-list
25440263|NCT04728659|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25440264|NCT04728659|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25440265|NCT04728659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25440266|NCT04728659|Contraceptive Agents|contraceptive agents|mesh-ancestor
25440267|NCT04728659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25440268|NCT04728659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440269|NCT04728659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25440270|NCT04728659|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25440271|NCT04728659|Progestins|progestins|mesh-ancestor
25440272|NCT04728659|Hormones|hormones|mesh-ancestor
25440273|NCT04728659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25440274|NCT04728659|Hormone Antagonists|hormone antagonists|mesh-ancestor
25440275|NCT04728386|Sodium Hypochlorite|sodium hypochlorite|mesh-list
25440276|NCT04728386|Eusol|eusol|mesh-list
25440277|NCT04728386|Curcumin|curcumin|mesh-list
25440278|NCT04728386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25440279|NCT04728386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25440280|NCT04728386|Analgesics|analgesics|mesh-ancestor
25440281|NCT04728386|Sensory System Agents|sensory system agents|mesh-ancestor
25440282|NCT04728386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25440283|NCT04728386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440284|NCT04728386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25440285|NCT04728386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25440286|NCT04728386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440287|NCT04728386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440288|NCT04728386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440289|NCT04728386|Disinfectants|disinfectants|mesh-ancestor
25440290|NCT04728386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25440291|NCT04729088|Isosorbide|isosorbide|mesh-list
25440292|NCT04729088|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25440293|NCT04729088|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25440294|NCT04729088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25440295|NCT04729088|Diuretics|diuretics|mesh-ancestor
25440296|NCT04729088|Natriuretic Agents|natriuretic agents|mesh-ancestor
25440297|NCT04729088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440298|NCT04729088|Vasodilator Agents|vasodilator agents|mesh-ancestor
25440299|NCT04729088|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25440300|NCT04729088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440301|NCT04729140|Doxycycline|doxycycline|mesh-list
25440302|NCT04729140|Ivermectin|ivermectin|mesh-list
25440303|NCT04729140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25440304|NCT04729140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25440305|NCT04729140|Antimalarials|antimalarials|mesh-ancestor
25440306|NCT04729140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25440307|NCT04729140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25440308|NCT04728425|Immunoglobulins|immunoglobulins|mesh-list
25440309|NCT04728425|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25440310|NCT04728425|Antibodies|antibodies|mesh-list
25440311|NCT04728425|gamma-Globulins|gamma-globulins|mesh-list
25440312|NCT04728425|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25440313|NCT04728425|Immunoglobulin G|immunoglobulin g|mesh-list
25440314|NCT04728425|Immunologic Factors|immunologic factors|mesh-ancestor
25440315|NCT04728425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440316|NCT04728178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25440317|NCT04728321|Lenvatinib|lenvatinib|mesh-list
25440318|NCT04728321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440319|NCT04728321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25440320|NCT04728321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440321|NCT04728321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440323|NCT04728308|Anesthetics, Local|anesthetics, local|mesh-ancestor
25440324|NCT04728308|Anesthetics|anesthetics|mesh-ancestor
25440325|NCT04728308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25440326|NCT04728308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440327|NCT04728308|Sensory System Agents|sensory system agents|mesh-ancestor
25440328|NCT04728308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25440329|NCT04728230|Carboplatin|carboplatin|mesh-list
25440330|NCT04728230|Etoposide|etoposide|mesh-list
25440331|NCT04728230|Etoposide phosphate|etoposide phosphate|mesh-list
25440332|NCT04728230|Durvalumab|durvalumab|mesh-list
25440333|NCT04728230|Olaparib|olaparib|mesh-list
25440334|NCT04728230|Podophyllotoxin|podophyllotoxin|mesh-list
25440335|NCT04728230|Immunoglobulins|immunoglobulins|mesh-list
25440336|NCT04728230|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25440337|NCT04728230|Immunoglobulin G|immunoglobulin g|mesh-list
25440338|NCT04728230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440339|NCT04728230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25440340|NCT04728230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25440341|NCT04728230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25440342|NCT04728230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440343|NCT04728230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440344|NCT04728230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25440345|NCT04728230|Immunologic Factors|immunologic factors|mesh-ancestor
25440346|NCT04728230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440347|NCT04728230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25292455|NCT04874935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292456|NCT04834063|Selenium|selenium|mesh-list
25292457|NCT04834063|Antioxidants|antioxidants|mesh-ancestor
25292459|NCT04834063|Protective Agents|protective agents|mesh-ancestor
25440348|NCT04728230|Keratolytic Agents|keratolytic agents|mesh-ancestor
25440350|NCT04728230|Tubulin Modulators|tubulin modulators|mesh-ancestor
25440351|NCT04728230|Antimitotic Agents|antimitotic agents|mesh-ancestor
25440352|NCT04728230|Mitosis Modulators|mitosis modulators|mesh-ancestor
25440353|NCT04728035|Irinotecan|irinotecan|mesh-list
25440354|NCT04728035|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25440355|NCT04728035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25440356|NCT04728035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440357|NCT04728035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440358|NCT04728035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440359|NCT04727723|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25440360|NCT04727723|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25440361|NCT04727723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440362|NCT04727671|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25440363|NCT04727671|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25440364|NCT04727671|Cetrorelix|cetrorelix|mesh-list
25440365|NCT04727671|Menotropins|menotropins|mesh-list
25440366|NCT04727671|Luteolytic Agents|luteolytic agents|mesh-ancestor
25440367|NCT04727671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25440368|NCT04727671|Contraceptive Agents|contraceptive agents|mesh-ancestor
25440369|NCT04727671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25440370|NCT04727671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440371|NCT04727671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25440372|NCT04727671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25440373|NCT04727671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440374|NCT04727671|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25440375|NCT04727671|Fertility Agents|fertility agents|mesh-ancestor
25440376|NCT04727671|Hormone Antagonists|hormone antagonists|mesh-ancestor
25440377|NCT04727671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25440378|NCT04727684|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25440379|NCT04727684|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25440380|NCT04727684|Cetrorelix|cetrorelix|mesh-list
25440381|NCT04727684|Menotropins|menotropins|mesh-list
25440382|NCT04727684|Luteolytic Agents|luteolytic agents|mesh-ancestor
25440383|NCT04727684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25440384|NCT04727684|Contraceptive Agents|contraceptive agents|mesh-ancestor
25440385|NCT04727684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25440386|NCT04727684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440387|NCT04727684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25440388|NCT04727684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25440389|NCT04727684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163927|NCT05425875|Dimercaprol|dimercaprol|mesh-list
25440390|NCT04727684|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25440391|NCT04727684|Fertility Agents|fertility agents|mesh-ancestor
25440392|NCT04727684|Hormone Antagonists|hormone antagonists|mesh-ancestor
25440393|NCT04727684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25440394|NCT04727515|Fentanyl|fentanyl|mesh-list
25440395|NCT04727515|Isoflurane|isoflurane|mesh-list
25440396|NCT04727515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25440397|NCT04727515|Narcotics|narcotics|mesh-ancestor
25440398|NCT04727515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25440399|NCT04727515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440400|NCT04727515|Analgesics|analgesics|mesh-ancestor
25440401|NCT04727515|Sensory System Agents|sensory system agents|mesh-ancestor
25440402|NCT04727515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25440403|NCT04727515|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25440404|NCT04727515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25440405|NCT04727515|Anesthetics, General|anesthetics, general|mesh-ancestor
25440406|NCT04727515|Anesthetics|anesthetics|mesh-ancestor
25440407|NCT04727515|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25440408|NCT04727853|Irinotecan|irinotecan|mesh-list
25440409|NCT04727853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25440410|NCT04727853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25440411|NCT04727853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440412|NCT04727853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440413|NCT04727853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440414|NCT04727437|Heparin|heparin|mesh-list
25440415|NCT04727437|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25440416|NCT04727437|Tinzaparin|tinzaparin|mesh-list
25440417|NCT04727437|Dalteparin|dalteparin|mesh-list
25440418|NCT04727437|Warfarin|warfarin|mesh-list
25440419|NCT04727437|Anticoagulants|anticoagulants|mesh-list
25440420|NCT04727437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25440421|NCT04727437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25292522|NCT04552327|Diclofenac|diclofenac|mesh-list
25292523|NCT04552327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25292524|NCT04552327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25440432|NCT04727502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440433|NCT04727502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25440434|NCT04727502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440435|NCT04727502|Analgesics|analgesics|mesh-ancestor
25440436|NCT04727502|Sensory System Agents|sensory system agents|mesh-ancestor
25440437|NCT04727502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25440438|NCT04727502|Antidepressive Agents|antidepressive agents|mesh-ancestor
25440439|NCT04727502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25440440|NCT04727502|Dopamine Agents|dopamine agents|mesh-ancestor
25440441|NCT04727476|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25440442|NCT04727476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25440443|NCT04727476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440444|NCT04727476|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25440445|NCT04727476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25440446|NCT04727476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25440447|NCT04727476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440448|NCT04727476|Dopamine Agents|dopamine agents|mesh-ancestor
25440449|NCT04727476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25440450|NCT04727034|Propofol|propofol|mesh-list
25440451|NCT04727034|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25440452|NCT04727034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25440453|NCT04727034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440454|NCT04727034|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25440455|NCT04727034|Anesthetics, General|anesthetics, general|mesh-ancestor
25440456|NCT04727034|Anesthetics|anesthetics|mesh-ancestor
25292610|NCT04150770|Infliximab|infliximab|mesh-list
25292611|NCT04150770|Dermatologic Agents|dermatologic agents|mesh-ancestor
25292612|NCT04150770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25292613|NCT04150770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25292614|NCT04125771|Diclofenac|diclofenac|mesh-list
25292615|NCT04125771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25292616|NCT04125771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25292617|NCT04125771|Analgesics|analgesics|mesh-ancestor
25292618|NCT04125771|Sensory System Agents|sensory system agents|mesh-ancestor
25292619|NCT04125771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25292620|NCT04125771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292621|NCT04125771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25292622|NCT04125771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25292623|NCT04125771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25292624|NCT04125771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25292625|NCT04125771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292626|NCT04026438|Potassium phosphate|potassium phosphate|mesh-list
25292627|NCT04026438|Cariostatic Agents|cariostatic agents|mesh-ancestor
25292628|NCT04026438|Protective Agents|protective agents|mesh-ancestor
25292629|NCT04026438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292630|NCT03983993|Panitumumab|panitumumab|mesh-list
25822828|NCT00004682|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25822829|NCT00004682|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24881939|NCT00389870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881940|NCT00389870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25440457|NCT04726982|Acetazolamide|acetazolamide|mesh-list
25440458|NCT04726982|Anticonvulsants|anticonvulsants|mesh-ancestor
25440459|NCT04726982|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25440460|NCT04726982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440461|NCT04726982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440462|NCT04726982|Diuretics|diuretics|mesh-ancestor
25440463|NCT04726982|Natriuretic Agents|natriuretic agents|mesh-ancestor
25440464|NCT04726982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440465|NCT04726657|Insulin|insulin|mesh-list
25440466|NCT04726657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25440467|NCT04726657|Insulin, Isophane|insulin, isophane|mesh-list
25440468|NCT04726657|Isophane Insulin, Human|isophane insulin, human|mesh-list
25440469|NCT04726657|Isophane insulin, beef|isophane insulin, beef|mesh-list
25440470|NCT04726657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25440471|NCT04726657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440472|NCT04727073|Spironolactone|spironolactone|mesh-list
25440473|NCT04727073|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25440474|NCT04727073|Hormone Antagonists|hormone antagonists|mesh-ancestor
25440475|NCT04727073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25440476|NCT04727073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440477|NCT04727073|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25440478|NCT04727073|Diuretics|diuretics|mesh-ancestor
25440479|NCT04727073|Natriuretic Agents|natriuretic agents|mesh-ancestor
25440480|NCT04726631|Insulin|insulin|mesh-list
25440481|NCT04726631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25440482|NCT04726631|Insulin, Short-Acting|insulin, short-acting|mesh-list
25440483|NCT04726631|Protamines|protamines|mesh-list
25440484|NCT04726631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25440485|NCT04726631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440486|NCT04726631|Heparin Antagonists|heparin antagonists|mesh-ancestor
25440487|NCT04726631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440488|NCT04726631|Coagulants|coagulants|mesh-ancestor
25440489|NCT04727021|Rivaroxaban|rivaroxaban|mesh-list
25440490|NCT04727021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25440491|NCT04727021|Antithrombins|antithrombins|mesh-ancestor
25440492|NCT04727021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25440493|NCT04727021|Protease Inhibitors|protease inhibitors|mesh-ancestor
25440494|NCT04727021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440495|NCT04727021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440496|NCT04727021|Anticoagulants|anticoagulants|mesh-ancestor
25440497|NCT04726332|Prednisone|prednisone|mesh-list
25440498|NCT04726332|Fulvestrant|fulvestrant|mesh-list
25440499|NCT04726332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25440500|NCT04726332|Glucocorticoids|glucocorticoids|mesh-ancestor
25440501|NCT04726332|Hormones|hormones|mesh-ancestor
25440502|NCT04726332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25440503|NCT04726332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440504|NCT04726332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25440505|NCT04726332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440506|NCT04726332|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25440507|NCT04726332|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25440508|NCT04726332|Hormone Antagonists|hormone antagonists|mesh-ancestor
25440509|NCT04726345|Fexofenadine|fexofenadine|mesh-list
25440510|NCT04726345|Terfenadine|terfenadine|mesh-list
25440511|NCT04726345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25440512|NCT04726345|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25440513|NCT04726345|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25440514|NCT04726345|Histamine Antagonists|histamine antagonists|mesh-ancestor
25292650|NCT03645603|Sensory System Agents|sensory system agents|mesh-ancestor
25292651|NCT03645603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25292652|NCT03645603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25292653|NCT03645603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25292654|NCT03645603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25292655|NCT03645603|Adrenergic Agents|adrenergic agents|mesh-ancestor
25292656|NCT03645603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25292657|NCT03645603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292658|NCT03615742|Budesonide|budesonide|mesh-list
25292659|NCT03615742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25292660|NCT03615742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25292661|NCT03615742|Autonomic Agents|autonomic agents|mesh-ancestor
25292662|NCT03615742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25292663|NCT03615742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292664|NCT03615742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25292665|NCT03615742|Respiratory System Agents|respiratory system agents|mesh-ancestor
25292666|NCT03615742|Glucocorticoids|glucocorticoids|mesh-ancestor
25440515|NCT04726345|Histamine Agents|histamine agents|mesh-ancestor
25440516|NCT04726345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25440517|NCT04726345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440518|NCT04726345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440520|NCT04726280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25440521|NCT04726280|Anesthetics, Local|anesthetics, local|mesh-ancestor
25440522|NCT04726280|Anesthetics|anesthetics|mesh-ancestor
25440523|NCT04726280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25440524|NCT04726280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440525|NCT04726280|Sensory System Agents|sensory system agents|mesh-ancestor
25440526|NCT04726280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25440527|NCT04726553|Mycophenolic Acid|mycophenolic acid|mesh-list
25440528|NCT04726553|Antimalarials|antimalarials|mesh-list
25440529|NCT04726553|Methotrexate|methotrexate|mesh-list
25440530|NCT04726553|Azathioprine|azathioprine|mesh-list
25440531|NCT04726553|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25440532|NCT04726553|Abortifacient Agents|abortifacient agents|mesh-ancestor
25440533|NCT04726553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25440534|NCT04726553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440535|NCT04726553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25440536|NCT04726553|Antimetabolites|antimetabolites|mesh-ancestor
25440537|NCT04726553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440538|NCT04726553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440539|NCT04726553|Dermatologic Agents|dermatologic agents|mesh-ancestor
25440540|NCT04726553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25719842|NCT02457520|Isotretinoin|isotretinoin|mesh-list
25440541|NCT04726553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25440542|NCT04726553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25440543|NCT04726553|Immunologic Factors|immunologic factors|mesh-ancestor
25440544|NCT04726553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25440545|NCT04726553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25440546|NCT04726553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25440547|NCT04726553|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25440548|NCT04726553|Antitubercular Agents|antitubercular agents|mesh-ancestor
25440549|NCT04726553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25440550|NCT04726553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25440551|NCT04726553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25440552|NCT04726553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25440553|NCT04726046|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25440554|NCT04726046|Cefotetan|cefotetan|mesh-list
25440555|NCT04726046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25440556|NCT04725747|Midazolam|midazolam|mesh-list
25440557|NCT04725747|Ketamine|ketamine|mesh-list
25440558|NCT04725747|Analgesics|analgesics|mesh-ancestor
25440559|NCT04725747|Sensory System Agents|sensory system agents|mesh-ancestor
25440560|NCT04725747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25440561|NCT04725747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440562|NCT04725747|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25440563|NCT04725747|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25440564|NCT04725747|Anesthetics, General|anesthetics, general|mesh-ancestor
25440565|NCT04725747|Anesthetics|anesthetics|mesh-ancestor
25440566|NCT04725747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25292720|NCT03414502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25292721|NCT03414502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25292722|NCT03414502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25292723|NCT03414502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25292724|NCT03414502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25292725|NCT03414502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25292726|NCT03414502|Analgesics|analgesics|mesh-ancestor
25292727|NCT03414502|Sensory System Agents|sensory system agents|mesh-ancestor
25292728|NCT03414502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25292729|NCT03414502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25292730|NCT03414502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25292731|NCT03414502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25292732|NCT03414502|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25292733|NCT03199612|Sildenafil Citrate|sildenafil citrate|mesh-list
25292734|NCT03199612|Vasodilator Agents|vasodilator agents|mesh-ancestor
25292735|NCT03199612|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25292736|NCT03199612|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25292737|NCT03199612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25292738|NCT03199612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292739|NCT03199612|Urological Agents|urological agents|mesh-ancestor
25292740|NCT03182751|Tranexamic Acid|tranexamic acid|mesh-list
25292741|NCT03182751|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25440567|NCT04725747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25440568|NCT04725747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25440569|NCT04725747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25440570|NCT04725747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440571|NCT04725747|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25440572|NCT04725747|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25440573|NCT04725747|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25440574|NCT04725747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25440575|NCT04725747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25440576|NCT04725747|GABA Modulators|gaba modulators|mesh-ancestor
25440577|NCT04725747|GABA Agents|gaba agents|mesh-ancestor
25440578|NCT04726007|Fibrinolytic Agents|fibrinolytic agents|mesh-list
25440579|NCT04726007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25440580|NCT04726007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440581|NCT04725942|Posaconazole|posaconazole|mesh-list
25440582|NCT04725942|Antifungal Agents|antifungal agents|mesh-ancestor
25440583|NCT04725942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25440584|NCT04725942|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25440585|NCT04725942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25440586|NCT04725942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25440587|NCT04725942|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25440588|NCT04725942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25440589|NCT04725942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440590|NCT04725942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440591|NCT04725942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25440592|NCT04725942|Hormone Antagonists|hormone antagonists|mesh-ancestor
25440593|NCT04725942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25440594|NCT04725942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440595|NCT04725591|Insulin|insulin|mesh-list
25440596|NCT04725591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25440597|NCT04725591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440598|NCT04725682|Tacrolimus|tacrolimus|mesh-list
25440599|NCT04725682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25440600|NCT04725682|Immunologic Factors|immunologic factors|mesh-ancestor
25440601|NCT04725682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440602|NCT04725682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25440603|NCT04725682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440604|NCT04725682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440605|NCT04725617|Varenicline|varenicline|mesh-list
25440606|NCT04725617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25440607|NCT04725617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25440608|NCT04725617|Cholinergic Agents|cholinergic agents|mesh-ancestor
25440609|NCT04725617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25440610|NCT04725617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440611|NCT04725617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440612|NCT04725448|Paclitaxel|paclitaxel|mesh-list
25440613|NCT04725448|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25440614|NCT04725448|Bevacizumab|bevacizumab|mesh-list
25440615|NCT04725448|Carboplatin|carboplatin|mesh-list
25440616|NCT04725448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25440617|NCT04725448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440618|NCT04725448|Tubulin Modulators|tubulin modulators|mesh-ancestor
25440619|NCT04725448|Antimitotic Agents|antimitotic agents|mesh-ancestor
25440620|NCT04725448|Mitosis Modulators|mitosis modulators|mesh-ancestor
25440621|NCT04725448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440622|NCT04725448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25440623|NCT04725448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25440624|NCT04725448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25440625|NCT04725448|Growth Substances|growth substances|mesh-ancestor
25440626|NCT04725448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440627|NCT04725448|Growth Inhibitors|growth inhibitors|mesh-ancestor
25440628|NCT04725253|Niacinamide|niacinamide|mesh-list
25440629|NCT04725253|Niacin|niacin|mesh-list
25440630|NCT04725253|Nicotinic Acids|nicotinic acids|mesh-list
25440631|NCT04725253|Vitamin B Complex|vitamin b complex|mesh-ancestor
25440632|NCT04725253|Vitamins|vitamins|mesh-ancestor
25292791|NCT05106400|Lidocaine|lidocaine|mesh-list
25292792|NCT05106400|Menthol|menthol|mesh-list
25292793|NCT05106400|Anesthetics, Local|anesthetics, local|mesh-ancestor
25292794|NCT05106400|Anesthetics|anesthetics|mesh-ancestor
25292795|NCT05106400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25292796|NCT05106400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292797|NCT05106400|Sensory System Agents|sensory system agents|mesh-ancestor
25292798|NCT05106400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25440633|NCT04725253|Micronutrients|micronutrients|mesh-ancestor
25440634|NCT04725253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440635|NCT04725253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25440636|NCT04725253|Antimetabolites|antimetabolites|mesh-ancestor
25440637|NCT04725253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440638|NCT04725253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25440639|NCT04725253|Vasodilator Agents|vasodilator agents|mesh-ancestor
25440640|NCT04725383|Amitriptyline|amitriptyline|mesh-list
25440641|NCT04725383|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25440642|NCT04725383|Antidepressive Agents|antidepressive agents|mesh-ancestor
25440643|NCT04725383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25440644|NCT04725383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25440645|NCT04725383|Analgesics|analgesics|mesh-ancestor
25440646|NCT04725383|Sensory System Agents|sensory system agents|mesh-ancestor
25440647|NCT04725383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25440648|NCT04725383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440649|NCT04725383|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25440650|NCT04725383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25440651|NCT04725383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25440652|NCT04725383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440653|NCT04725383|Adrenergic Agents|adrenergic agents|mesh-ancestor
25440654|NCT04725383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25440655|NCT04725149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25440656|NCT04725162|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25440657|NCT04725162|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25440658|NCT04725162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440659|NCT04725357|Meloxicam|meloxicam|mesh-list
25440660|NCT04725357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25440661|NCT04725357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25440662|NCT04725357|Analgesics|analgesics|mesh-ancestor
25440663|NCT04725357|Sensory System Agents|sensory system agents|mesh-ancestor
25440664|NCT04725357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25440665|NCT04725357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440666|NCT04725357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25440667|NCT04725357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25440668|NCT04725357|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25440669|NCT04725357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25440670|NCT04725357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440671|NCT04725357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440672|NCT04725422|Zoledronic Acid|zoledronic acid|mesh-list
25440673|NCT04725422|Pamidronate|pamidronate|mesh-list
25440674|NCT04725422|Sulfasalazine|sulfasalazine|mesh-list
25440675|NCT04725422|Adalimumab|adalimumab|mesh-list
25440676|NCT04725422|Etanercept|etanercept|mesh-list
25440677|NCT04725422|Golimumab|golimumab|mesh-list
25440678|NCT04725422|Methotrexate|methotrexate|mesh-list
25440679|NCT04725422|Infliximab|infliximab|mesh-list
25440680|NCT04725422|Certolizumab Pegol|certolizumab pegol|mesh-list
25440681|NCT04725422|Leflunomide|leflunomide|mesh-list
25440682|NCT04725422|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25440683|NCT04725422|Abortifacient Agents|abortifacient agents|mesh-ancestor
25440684|NCT04725422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25440685|NCT04725422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440686|NCT04725422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25440687|NCT04725422|Antimetabolites|antimetabolites|mesh-ancestor
25440688|NCT04725422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440689|NCT04725422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440690|NCT04725422|Dermatologic Agents|dermatologic agents|mesh-ancestor
25440691|NCT04725422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440692|NCT04725422|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25440693|NCT04725422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25440694|NCT04725422|Immunologic Factors|immunologic factors|mesh-ancestor
25440695|NCT04725422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25440696|NCT04725422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25440697|NCT04725422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25440698|NCT04725422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25440699|NCT04725422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25440700|NCT04725422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25440701|NCT04725422|Analgesics|analgesics|mesh-ancestor
25643609|NCT01428882|Propofol|propofol|mesh-list
25643610|NCT01428882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25643611|NCT01428882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25643612|NCT01428882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440702|NCT04725422|Sensory System Agents|sensory system agents|mesh-ancestor
25440703|NCT04725422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25440704|NCT04725422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25292859|NCT05105412|Lenalidomide|lenalidomide|mesh-list
25292860|NCT05105412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25292861|NCT05105412|Antimetabolites|antimetabolites|mesh-ancestor
25292863|NCT05105412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292935|NCT05104762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292936|NCT05104437|Vaccines|vaccines|mesh-list
25292937|NCT05104437|Immunologic Factors|immunologic factors|mesh-ancestor
25292938|NCT05104437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292939|NCT05104424|Insulin Aspart|insulin aspart|mesh-list
25292940|NCT05104424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25292941|NCT05104424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292942|NCT05104333|Vaccines|vaccines|mesh-list
25292943|NCT05104333|Immunologic Factors|immunologic factors|mesh-ancestor
25292944|NCT05104333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292945|NCT05104281|Osimertinib|osimertinib|mesh-list
25292946|NCT05104281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440735|NCT04724187|Misoprostol|misoprostol|mesh-list
25440736|NCT04724187|Oxytocin|oxytocin|mesh-list
25440737|NCT04724187|Oxytocics|oxytocics|mesh-ancestor
25440738|NCT04724187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25440739|NCT04724187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440740|NCT04724187|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25440741|NCT04724187|Abortifacient Agents|abortifacient agents|mesh-ancestor
25440742|NCT04724187|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25440743|NCT04724187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25440744|NCT04724226|Apatinib|apatinib|mesh-list
25440745|NCT04724226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440746|NCT04724226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25440747|NCT04724226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440748|NCT04724226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440749|NCT04724343|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25440750|NCT04724343|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25440751|NCT04724343|Cetrorelix|cetrorelix|mesh-list
25440752|NCT04724343|Menotropins|menotropins|mesh-list
25440753|NCT04724343|Luteolytic Agents|luteolytic agents|mesh-ancestor
25440754|NCT04724343|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25440755|NCT04724343|Contraceptive Agents|contraceptive agents|mesh-ancestor
25440756|NCT04724343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25440757|NCT04724343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440758|NCT04724343|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25440759|NCT04724343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25440760|NCT04724343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440761|NCT04724343|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25440762|NCT04724343|Fertility Agents|fertility agents|mesh-ancestor
25440763|NCT04724343|Hormone Antagonists|hormone antagonists|mesh-ancestor
25440764|NCT04724343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25440765|NCT04724148|Fentanyl|fentanyl|mesh-list
25440766|NCT04724148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25440767|NCT04724148|Narcotics|narcotics|mesh-ancestor
25440768|NCT04724148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25440769|NCT04724148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440770|NCT04724148|Analgesics|analgesics|mesh-ancestor
25440771|NCT04724148|Sensory System Agents|sensory system agents|mesh-ancestor
25440772|NCT04724148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25440773|NCT04724148|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25440774|NCT04724148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25440775|NCT04724148|Anesthetics, General|anesthetics, general|mesh-ancestor
25440776|NCT04724148|Anesthetics|anesthetics|mesh-ancestor
25440777|NCT04724031|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25440778|NCT04724031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440779|NCT04724031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440780|NCT04724031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440781|NCT04723836|Riboflavin|riboflavin|mesh-list
25440782|NCT04723836|Vitamins|vitamins|mesh-ancestor
25440783|NCT04723836|Micronutrients|micronutrients|mesh-ancestor
25440784|NCT04723836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440785|NCT04723836|Vitamin B Complex|vitamin b complex|mesh-ancestor
25440786|NCT04723836|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25440787|NCT04723836|Dermatologic Agents|dermatologic agents|mesh-ancestor
25643613|NCT01428882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25643614|NCT01428882|Anesthetics, General|anesthetics, general|mesh-ancestor
25643615|NCT01428882|Anesthetics|anesthetics|mesh-ancestor
25643616|NCT01428882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25643617|NCT01428882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25643618|NCT01428882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25643619|NCT01428882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25643620|NCT01428882|GABA Modulators|gaba modulators|mesh-ancestor
25643621|NCT01428882|GABA Agents|gaba agents|mesh-ancestor
25643622|NCT01428882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25657145|NCT01583374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25440788|NCT04723940|Doxycycline|doxycycline|mesh-list
25440789|NCT04723940|Clindamycin|clindamycin|mesh-list
25440790|NCT04723940|Clindamycin palmitate|clindamycin palmitate|mesh-list
25440791|NCT04723940|Clindamycin phosphate|clindamycin phosphate|mesh-list
25440792|NCT04723940|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25440793|NCT04723940|Cefadroxil|cefadroxil|mesh-list
25440794|NCT04723940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25440795|NCT04723940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25440796|NCT04723940|Antimalarials|antimalarials|mesh-ancestor
25440797|NCT04723940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25440798|NCT04723940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25440799|NCT04723940|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25440800|NCT04723940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440801|NCT04723940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440802|NCT04723940|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25440803|NCT04723940|Renal Agents|renal agents|mesh-ancestor
25440804|NCT04723732|Chlorhexidine|chlorhexidine|mesh-list
25440805|NCT04723732|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25440806|NCT04723732|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25440807|NCT04723732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25440808|NCT04723732|Disinfectants|disinfectants|mesh-ancestor
25440809|NCT04723732|Dermatologic Agents|dermatologic agents|mesh-ancestor
25440810|NCT04723875|Paclitaxel|paclitaxel|mesh-list
25440811|NCT04723875|Docetaxel|docetaxel|mesh-list
25440812|NCT04723875|Cisplatin|cisplatin|mesh-list
25440813|NCT04723875|Carboplatin|carboplatin|mesh-list
25440814|NCT04723875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25440815|NCT04723875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440816|NCT04723875|Tubulin Modulators|tubulin modulators|mesh-ancestor
25440817|NCT04723875|Antimitotic Agents|antimitotic agents|mesh-ancestor
25440818|NCT04723875|Mitosis Modulators|mitosis modulators|mesh-ancestor
25440819|NCT04723875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440820|NCT04723563|Heparin|heparin|mesh-list
25440821|NCT04723563|Anticoagulants|anticoagulants|mesh-ancestor
25440822|NCT04723563|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25440823|NCT04723563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25440824|NCT04723563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440825|NCT04723472|Cefuroxime|cefuroxime|mesh-list
25440826|NCT04723472|Cefuroxime axetil|cefuroxime axetil|mesh-list
25440827|NCT04723472|Bismuth|bismuth|mesh-list
25440828|NCT04723472|Antacids|antacids|mesh-ancestor
25440829|NCT04723472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440830|NCT04723472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25440831|NCT04723472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25440832|NCT04723472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25440833|NCT04723147|Levodopa|levodopa|mesh-list
25440834|NCT04723147|Carbidopa|carbidopa|mesh-list
25440835|NCT04723147|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25440836|NCT04723147|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25440837|NCT04723147|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25440838|NCT04723147|Dopamine Agents|dopamine agents|mesh-ancestor
25440839|NCT04723147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25440840|NCT04723147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440841|NCT04723147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440842|NCT04723147|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25440843|NCT04723147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440844|NCT04723147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25440845|NCT04723147|Immunologic Factors|immunologic factors|mesh-ancestor
25440846|NCT04723147|Dopamine Agonists|dopamine agonists|mesh-ancestor
25440847|NCT04723342|Blinatumomab|blinatumomab|mesh-list
25440848|NCT04723342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440849|NCT04723459|Ivermectin|ivermectin|mesh-list
25440850|NCT04723459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25440851|NCT04723459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25440852|NCT04723238|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25440853|NCT04723238|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25440854|NCT04723238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24720446|NCT01568450|Oxycodone|oxycodone|mesh-list
25440855|NCT04723238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25440856|NCT04723238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440857|NCT04723238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25440858|NCT04723238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440860|NCT04723238|Sensory System Agents|sensory system agents|mesh-ancestor
25440861|NCT04723238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25440862|NCT04723238|Antidepressive Agents|antidepressive agents|mesh-ancestor
25440863|NCT04723238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25440864|NCT04723238|Dopamine Agents|dopamine agents|mesh-ancestor
25440865|NCT04723069|Metronidazole|metronidazole|mesh-list
25440866|NCT04723069|Doxycycline|doxycycline|mesh-list
25440867|NCT04723069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25440868|NCT04723069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25440869|NCT04723069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25440870|NCT04723069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25440871|NCT04723069|Antimalarials|antimalarials|mesh-ancestor
25440872|NCT04722796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25440873|NCT04723030|Paclitaxel|paclitaxel|mesh-list
25440874|NCT04723030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25440875|NCT04723030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440876|NCT04723030|Tubulin Modulators|tubulin modulators|mesh-ancestor
25440877|NCT04723030|Antimitotic Agents|antimitotic agents|mesh-ancestor
25440878|NCT04723030|Mitosis Modulators|mitosis modulators|mesh-ancestor
25440879|NCT04723030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440880|NCT04722471|Progesterone|progesterone|mesh-list
25440881|NCT04722471|Progestins|progestins|mesh-ancestor
25440882|NCT04722471|Hormones|hormones|mesh-ancestor
25440883|NCT04722471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25440884|NCT04722471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293071|NCT04495257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25293072|NCT04495257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293073|NCT04495257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25440894|NCT04721795|Antitubercular Agents|antitubercular agents|mesh-list
25440895|NCT04721795|Atorvastatin|atorvastatin|mesh-list
25440896|NCT04721795|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25440897|NCT04721795|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25440898|NCT04721795|Antimetabolites|antimetabolites|mesh-ancestor
25440899|NCT04721795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440900|NCT04721795|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25440901|NCT04721795|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25440902|NCT04721795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440903|NCT04721795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25440904|NCT04721795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25440905|NCT04721704|Amoxicillin|amoxicillin|mesh-list
25440906|NCT04721704|Metronidazole|metronidazole|mesh-list
25440907|NCT04721704|Clarithromycin|clarithromycin|mesh-list
25440908|NCT04721704|Omeprazole|omeprazole|mesh-list
25440909|NCT04721704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25440910|NCT04721704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25440911|NCT04721704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25719890|NCT02458690|Dopamine|dopamine|mesh-list
25440912|NCT04721704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25440913|NCT04721704|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25440914|NCT04721704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25440915|NCT04721704|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25440916|NCT04721704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440917|NCT04721704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440918|NCT04721704|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25440919|NCT04721704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25440920|NCT04721704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25440921|NCT04721223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25440922|NCT04721223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440923|NCT04721223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440924|NCT04721054|Lidocaine|lidocaine|mesh-list
25440925|NCT04721054|Bupivacaine|bupivacaine|mesh-list
25440926|NCT04721054|Anesthetics|anesthetics|mesh-list
25440927|NCT04721054|Anesthetics, Local|anesthetics, local|mesh-ancestor
25440928|NCT04721054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25440929|NCT04721054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440930|NCT04721054|Sensory System Agents|sensory system agents|mesh-ancestor
25440931|NCT04721054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25440932|NCT04721054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25440933|NCT04721054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25440934|NCT04721054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25440935|NCT04721054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25440936|NCT04721054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440937|NCT04721119|Anesthetics|anesthetics|mesh-list
25440938|NCT04721119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25440939|NCT04721119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440940|NCT04721301|Maraviroc|maraviroc|mesh-list
25440941|NCT04721301|Nivolumab|nivolumab|mesh-list
25440942|NCT04721301|Ipilimumab|ipilimumab|mesh-list
25440943|NCT04721301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25440944|NCT04721301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440945|NCT04721301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25440946|NCT04721301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440947|NCT04721301|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25440948|NCT04721301|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25440949|NCT04721301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25440950|NCT04721301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25440951|NCT04721301|Antiviral Agents|antiviral agents|mesh-ancestor
25440952|NCT04721301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25440953|NCT04721301|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25440954|NCT04720807|Letrozole|letrozole|mesh-list
25440955|NCT04720807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440956|NCT04720807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25440957|NCT04720807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25440958|NCT04720807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440959|NCT04720807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293202|NCT03349281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25293203|NCT03349281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25293204|NCT03349281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293205|NCT03349281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25293206|NCT03349281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25293207|NCT03349281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25293208|NCT03349281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440960|NCT04720807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25440961|NCT04720807|Hormone Antagonists|hormone antagonists|mesh-ancestor
25440962|NCT04720807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25440963|NCT04720807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440964|NCT04720768|Palbociclib|palbociclib|mesh-list
25440965|NCT04720768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25440966|NCT04720768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25440967|NCT04720768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440968|NCT04720768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440969|NCT04720833|Vitamin D|vitamin d|mesh-list
25440970|NCT04720833|Calcium|calcium|mesh-list
25440971|NCT04720833|Vitamins|vitamins|mesh-ancestor
25440972|NCT04720833|Micronutrients|micronutrients|mesh-ancestor
25440973|NCT04720833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440974|NCT04720833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25440975|NCT04720833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25440976|NCT04720859|Canagliflozin|canagliflozin|mesh-list
25440977|NCT04720859|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25440978|NCT04720859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440979|NCT04720859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25440980|NCT04720859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440981|NCT04720573|Neostigmine|neostigmine|mesh-list
25440982|NCT04720573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25440983|NCT04720573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25440984|NCT04720573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25440985|NCT04720573|Cholinergic Agents|cholinergic agents|mesh-ancestor
25440986|NCT04720573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25440987|NCT04720573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440988|NCT04720573|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25440989|NCT04720573|Autonomic Agents|autonomic agents|mesh-ancestor
25440990|NCT04720573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25440991|NCT04720287|Bupivacaine|bupivacaine|mesh-list
25440992|NCT04720287|Neostigmine|neostigmine|mesh-list
25440993|NCT04720287|Anesthetics, Local|anesthetics, local|mesh-ancestor
25440994|NCT04720287|Anesthetics|anesthetics|mesh-ancestor
25440995|NCT04720287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25440996|NCT04720287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25440997|NCT04720287|Sensory System Agents|sensory system agents|mesh-ancestor
25440998|NCT04720287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25440999|NCT04720287|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25441000|NCT04720287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25643623|NCT01428882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643624|NCT01429051|Fentanyl|fentanyl|mesh-list
25643625|NCT01429051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25643626|NCT01429051|Narcotics|narcotics|mesh-ancestor
25643627|NCT01429051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25643628|NCT01429051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643629|NCT01429051|Analgesics|analgesics|mesh-ancestor
25441001|NCT04720287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441002|NCT04720287|Cholinergic Agents|cholinergic agents|mesh-ancestor
25441003|NCT04720287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25441004|NCT04720287|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25441005|NCT04720287|Autonomic Agents|autonomic agents|mesh-ancestor
25441006|NCT04720248|Dipyrone|dipyrone|mesh-list
25441007|NCT04720248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25441008|NCT04720248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25441009|NCT04720248|Analgesics|analgesics|mesh-ancestor
25441010|NCT04720248|Sensory System Agents|sensory system agents|mesh-ancestor
25441011|NCT04720248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25441012|NCT04720248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441013|NCT04720248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25441014|NCT04720248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25441015|NCT04720248|Antipyretics|antipyretics|mesh-ancestor
25441016|NCT04720183|Sulfasalazine|sulfasalazine|mesh-list
25441017|NCT04720183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25441018|NCT04720183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25441019|NCT04720183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25441020|NCT04720183|Analgesics|analgesics|mesh-ancestor
25441021|NCT04720183|Sensory System Agents|sensory system agents|mesh-ancestor
25441022|NCT04720183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25441023|NCT04720183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441024|NCT04720183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25441025|NCT04720183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25441026|NCT04720183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25441027|NCT04720131|Capecitabine|capecitabine|mesh-list
25441028|NCT04720131|Apatinib|apatinib|mesh-list
25293275|NCT03142568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293276|NCT03142568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293277|NCT03142568|Urological Agents|urological agents|mesh-ancestor
25293278|NCT03100045|Artesunate|artesunate|mesh-list
25293279|NCT03100045|Artemisinins|artemisinins|mesh-list
25293280|NCT03100045|Artemisinin|artemisinin|mesh-list
25441048|NCT04719650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441049|NCT04719507|Meperidine|meperidine|mesh-list
25441050|NCT04719507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25441051|NCT04719507|Narcotics|narcotics|mesh-ancestor
25441052|NCT04719507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25441053|NCT04719507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441054|NCT04719507|Analgesics|analgesics|mesh-ancestor
25441055|NCT04719507|Sensory System Agents|sensory system agents|mesh-ancestor
25441056|NCT04719507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25441057|NCT04719507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25441058|NCT04719715|Antibodies|antibodies|mesh-list
25441059|NCT04719715|Immunologic Factors|immunologic factors|mesh-ancestor
25441060|NCT04719715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441061|NCT04719585|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25441062|NCT04719585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441063|NCT04719585|Analgesics|analgesics|mesh-ancestor
25441064|NCT04719585|Sensory System Agents|sensory system agents|mesh-ancestor
25441065|NCT04719585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25441066|NCT04719585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25441067|NCT04719585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25441068|NCT04719585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25441069|NCT04719585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441070|NCT04719585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25441071|NCT04719585|Antidepressive Agents|antidepressive agents|mesh-ancestor
25441072|NCT04719585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25441073|NCT04719585|Dopamine Agents|dopamine agents|mesh-ancestor
25441074|NCT04719481|Pravastatin|pravastatin|mesh-list
25441075|NCT04719481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25441076|NCT04719481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25441077|NCT04719481|Antimetabolites|antimetabolites|mesh-ancestor
25441078|NCT04719481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441079|NCT04719481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25441080|NCT04719481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25643630|NCT01429051|Sensory System Agents|sensory system agents|mesh-ancestor
25441081|NCT04719481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293348|NCT05107063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25441084|NCT04719104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441085|NCT04719104|Protective Agents|protective agents|mesh-ancestor
25441086|NCT04719104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441088|NCT04718740|Repaglinide|repaglinide|mesh-list
25441089|NCT04718740|Midazolam|midazolam|mesh-list
25441090|NCT04718740|Caffeine|caffeine|mesh-list
25441091|NCT04718740|Bupropion|bupropion|mesh-list
25441092|NCT04718740|Omeprazole|omeprazole|mesh-list
25441093|NCT04718740|Warfarin|warfarin|mesh-list
25441094|NCT04718740|Vitamins|vitamins|mesh-ancestor
25441095|NCT04718740|Micronutrients|micronutrients|mesh-ancestor
25441096|NCT04718740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441097|NCT04718740|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25441098|NCT04718740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25441099|NCT04718740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25441100|NCT04718740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25441101|NCT04718740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25441102|NCT04718740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25441103|NCT04718740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25441104|NCT04718740|Anesthetics, General|anesthetics, general|mesh-ancestor
25441105|NCT04718740|Anesthetics|anesthetics|mesh-ancestor
25441106|NCT04718740|GABA Modulators|gaba modulators|mesh-ancestor
25441107|NCT04718740|GABA Agents|gaba agents|mesh-ancestor
25441108|NCT04718740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25441109|NCT04718740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441110|NCT04718740|Anticoagulants|anticoagulants|mesh-ancestor
25441111|NCT04718740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25441112|NCT04718740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25441113|NCT04718740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25441114|NCT04718740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441115|NCT04718740|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25441116|NCT04718740|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25441117|NCT04718740|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25441118|NCT04718740|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25441119|NCT04718740|Purinergic Agents|purinergic agents|mesh-ancestor
25441120|NCT04718740|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25441121|NCT04718740|Antidepressive Agents|antidepressive agents|mesh-ancestor
25441122|NCT04718740|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25441123|NCT04718740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25441124|NCT04718740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25441125|NCT04718740|Dopamine Agents|dopamine agents|mesh-ancestor
25441126|NCT04718740|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25441127|NCT04718740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25441128|NCT04718740|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25441129|NCT04718740|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25441130|NCT04718740|Hemostatics|hemostatics|mesh-ancestor
25441131|NCT04718740|Coagulants|coagulants|mesh-ancestor
25441132|NCT04718740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25441133|NCT04718701|Paclitaxel|paclitaxel|mesh-list
25441134|NCT04718701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25441135|NCT04718701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25441136|NCT04718701|Tubulin Modulators|tubulin modulators|mesh-ancestor
25441137|NCT04718701|Antimitotic Agents|antimitotic agents|mesh-ancestor
25441138|NCT04718701|Mitosis Modulators|mitosis modulators|mesh-ancestor
25441139|NCT04718701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441140|NCT04718402|Mitoxantrone|mitoxantrone|mesh-list
25441141|NCT04718402|Analgesics|analgesics|mesh-ancestor
25441142|NCT04718402|Sensory System Agents|sensory system agents|mesh-ancestor
25441143|NCT04718402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25441144|NCT04718402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441145|NCT04718402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25441146|NCT04718402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25441147|NCT04718402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25293428|NCT05083000|Topotecan|topotecan|mesh-list
25293429|NCT05083000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25293430|NCT05083000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25293431|NCT05083000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293432|NCT05083000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293433|NCT05083000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293442|NCT05004077|Amiodarone|amiodarone|mesh-list
25293443|NCT05004077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25441148|NCT04718402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441151|NCT04718311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25441152|NCT04718311|Immunologic Factors|immunologic factors|mesh-ancestor
25657146|NCT01583374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25441153|NCT04718311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441154|NCT04718311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25441155|NCT04718311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441156|NCT04718311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441157|NCT04718376|Mitoxantrone|mitoxantrone|mesh-list
25441158|NCT04718376|Analgesics|analgesics|mesh-ancestor
25441159|NCT04718376|Sensory System Agents|sensory system agents|mesh-ancestor
25441160|NCT04718376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25441161|NCT04718376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441162|NCT04718376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25441163|NCT04718376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25441164|NCT04718376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25441165|NCT04718376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441166|NCT04718376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441167|NCT04718584|Antibodies|antibodies|mesh-list
25441168|NCT04718584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25441169|NCT04718584|Immunologic Factors|immunologic factors|mesh-ancestor
25441170|NCT04718584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441171|NCT04718649|Celecoxib|celecoxib|mesh-list
25441172|NCT04718649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25441173|NCT04718649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25441174|NCT04718649|Analgesics|analgesics|mesh-ancestor
25441175|NCT04718649|Sensory System Agents|sensory system agents|mesh-ancestor
25441176|NCT04718649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25441177|NCT04718649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441178|NCT04718649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25441179|NCT04718649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25441180|NCT04718649|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25441181|NCT04718649|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25441182|NCT04718649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441183|NCT04718649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441184|NCT04718714|Midazolam|midazolam|mesh-list
25441185|NCT04718714|Dexmedetomidine|dexmedetomidine|mesh-list
25441186|NCT04718714|Propofol|propofol|mesh-list
25441187|NCT04718714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25441188|NCT04718714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25441189|NCT04718714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441190|NCT04718714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25441191|NCT04718714|Anesthetics, General|anesthetics, general|mesh-ancestor
25441192|NCT04718714|Anesthetics|anesthetics|mesh-ancestor
25441193|NCT04718714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25441194|NCT04718714|Analgesics|analgesics|mesh-ancestor
25441195|NCT04718714|Sensory System Agents|sensory system agents|mesh-ancestor
25441196|NCT04718714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25441197|NCT04718714|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25441198|NCT04718714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25441199|NCT04718714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25441200|NCT04718714|Adrenergic Agents|adrenergic agents|mesh-ancestor
25441201|NCT04718714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25441202|NCT04718714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441203|NCT04718714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25441204|NCT04718714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25293509|NCT04722978|Gemcitabine|gemcitabine|mesh-list
25293510|NCT04722978|Moxifloxacin|moxifloxacin|mesh-list
25293511|NCT04722978|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25293512|NCT04722978|Carboplatin|carboplatin|mesh-list
25293513|NCT04722978|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25293514|NCT04722978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293515|NCT04722978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25293516|NCT04722978|Antimetabolites|antimetabolites|mesh-ancestor
25293517|NCT04722978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293518|NCT04722978|Antiviral Agents|antiviral agents|mesh-ancestor
25293519|NCT04722978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25293520|NCT04722978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293521|NCT04722978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25293522|NCT04722978|Immunologic Factors|immunologic factors|mesh-ancestor
25293523|NCT04722978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293532|NCT04695106|Aspirin|aspirin|mesh-list
25441206|NCT04718714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25441207|NCT04718714|GABA Modulators|gaba modulators|mesh-ancestor
25441208|NCT04718714|GABA Agents|gaba agents|mesh-ancestor
25441209|NCT04718038|Cetuximab|cetuximab|mesh-list
25441210|NCT04718038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25441211|NCT04718038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25441212|NCT04718233|Sildenafil Citrate|sildenafil citrate|mesh-list
25441213|NCT04718233|Vasodilator Agents|vasodilator agents|mesh-ancestor
25441214|NCT04718233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25441215|NCT04718233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25441216|NCT04718233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441217|NCT04718233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441218|NCT04718233|Urological Agents|urological agents|mesh-ancestor
25441219|NCT04718064|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25441220|NCT04718064|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25441221|NCT04718064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441222|NCT04718064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25441223|NCT04718064|Immunologic Factors|immunologic factors|mesh-ancestor
25441224|NCT04718064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441225|NCT04718259|Midazolam|midazolam|mesh-list
25441226|NCT04718259|Bupivacaine|bupivacaine|mesh-list
25441227|NCT04718259|Anesthetics, Local|anesthetics, local|mesh-ancestor
25441228|NCT04718259|Anesthetics|anesthetics|mesh-ancestor
25441229|NCT04718259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25441230|NCT04718259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441231|NCT04718259|Sensory System Agents|sensory system agents|mesh-ancestor
25441232|NCT04718259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25441233|NCT04718259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25441234|NCT04718259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25441235|NCT04718259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25441236|NCT04718259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25441237|NCT04718259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25441238|NCT04718259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25441239|NCT04718259|Anesthetics, General|anesthetics, general|mesh-ancestor
25441240|NCT04718259|GABA Modulators|gaba modulators|mesh-ancestor
25441241|NCT04718259|GABA Agents|gaba agents|mesh-ancestor
25441242|NCT04718259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25441243|NCT04718259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441244|NCT04717908|Linezolid|linezolid|mesh-list
25441245|NCT04717908|Cycloserine|cycloserine|mesh-list
25441246|NCT04717908|Pyrazinamide|pyrazinamide|mesh-list
25441247|NCT04717908|Bedaquiline|bedaquiline|mesh-list
25441248|NCT04717908|Clofazimine|clofazimine|mesh-list
25441249|NCT04717908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25441250|NCT04717908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25441251|NCT04717908|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25441252|NCT04717908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441253|NCT04717908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441254|NCT04717908|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25441255|NCT04717908|Renal Agents|renal agents|mesh-ancestor
25441256|NCT04717908|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25441257|NCT04717908|Antitubercular Agents|antitubercular agents|mesh-ancestor
25441258|NCT04717908|Antimetabolites|antimetabolites|mesh-ancestor
25441259|NCT04717908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25441260|NCT04717908|Leprostatic Agents|leprostatic agents|mesh-ancestor
25441261|NCT04717986|Dapagliflozin|dapagliflozin|mesh-list
25441262|NCT04717986|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25441263|NCT04717986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441264|NCT04717986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25441265|NCT04717986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441266|NCT04717752|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25441267|NCT04717752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25441268|NCT04717752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441269|NCT04717531|Cyclophosphamide|cyclophosphamide|mesh-list
25441270|NCT04717531|Docetaxel|docetaxel|mesh-list
25441271|NCT04717531|Trastuzumab|trastuzumab|mesh-list
25441272|NCT04717531|Epirubicin|epirubicin|mesh-list
25441273|NCT04717531|Pertuzumab|pertuzumab|mesh-list
25441274|NCT04717531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25441275|NCT04717531|Immunologic Factors|immunologic factors|mesh-ancestor
25441276|NCT04717531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441277|NCT04717531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25293565|NCT04614974|Famotidine|famotidine|mesh-list
25441278|NCT04717531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25441279|NCT04717531|Alkylating Agents|alkylating agents|mesh-ancestor
25441311|NCT04716894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25441312|NCT04716894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441313|NCT04716894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441314|NCT04716894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25441315|NCT04716894|Hormone Antagonists|hormone antagonists|mesh-ancestor
25441316|NCT04716894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25822830|NCT00004682|Immunologic Factors|immunologic factors|mesh-ancestor
25643631|NCT01429051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25643632|NCT01429051|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25643633|NCT01429051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25643634|NCT01429051|Anesthetics, General|anesthetics, general|mesh-ancestor
25441317|NCT04716894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441318|NCT04716894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25441319|NCT04717063|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25441320|NCT04717063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25441321|NCT04717063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25441323|NCT04716569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25441324|NCT04716569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25441326|NCT04716868|Psyllium|psyllium|mesh-list
25441327|NCT04716868|Cathartics|cathartics|mesh-ancestor
25441328|NCT04716868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25441329|NCT04716868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25441330|NCT04716751|Paclitaxel|paclitaxel|mesh-list
25441331|NCT04716751|Carboplatin|carboplatin|mesh-list
25441332|NCT04716751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25441333|NCT04716751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25441334|NCT04716751|Tubulin Modulators|tubulin modulators|mesh-ancestor
25441335|NCT04716751|Antimitotic Agents|antimitotic agents|mesh-ancestor
25441336|NCT04716751|Mitosis Modulators|mitosis modulators|mesh-ancestor
25441337|NCT04716751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441338|NCT04716686|Niraparib|niraparib|mesh-list
25441339|NCT04716686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25441340|NCT04716686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441341|NCT04716686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441342|NCT04716686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25441343|NCT04716296|Ketamine|ketamine|mesh-list
25441344|NCT04716296|Analgesics|analgesics|mesh-ancestor
25441345|NCT04716296|Sensory System Agents|sensory system agents|mesh-ancestor
25441346|NCT04716296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25441347|NCT04716296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441348|NCT04716296|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25441349|NCT04716296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25441350|NCT04716296|Anesthetics, General|anesthetics, general|mesh-ancestor
25441351|NCT04716296|Anesthetics|anesthetics|mesh-ancestor
25441352|NCT04716296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25441353|NCT04716296|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25441354|NCT04716296|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25441355|NCT04716296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25441356|NCT04716296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441357|NCT04716426|Tetracycline|tetracycline|mesh-list
25441358|NCT04716426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25441359|NCT04716426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25441360|NCT04716426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25441361|NCT04716426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441362|NCT04716426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441363|NCT04716179|Hormones|hormones|mesh-list
25441364|NCT04716179|Testosterone|testosterone|mesh-list
25441365|NCT04716179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25441366|NCT04716179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441367|NCT04716179|Androgens|androgens|mesh-ancestor
25441368|NCT04715737|Vasopressins|vasopressins|mesh-list
25441369|NCT04715737|Arginine Vasopressin|arginine vasopressin|mesh-list
25441370|NCT04715737|Oxytocin|oxytocin|mesh-list
25441371|NCT04715737|Oxytocics|oxytocics|mesh-ancestor
25441372|NCT04715737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25441373|NCT04715737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441374|NCT04715737|Hemostatics|hemostatics|mesh-ancestor
25441375|NCT04715737|Coagulants|coagulants|mesh-ancestor
25441376|NCT04715737|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25441377|NCT04715737|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25441378|NCT04715737|Natriuretic Agents|natriuretic agents|mesh-ancestor
25441379|NCT04715620|Niraparib|niraparib|mesh-list
25441380|NCT04715620|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25441381|NCT04715620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441382|NCT04715620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441383|NCT04715620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25441384|NCT04715568|Losartan|losartan|mesh-list
25441385|NCT04715568|Antihypertensive Agents|antihypertensive agents|mesh-list
25441386|NCT04715568|Angiotensin II|angiotensin ii|mesh-list
25293723|NCT03596073|Calcipotriene|calcipotriene|mesh-list
25057266|NCT03506542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811488|NCT02046915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25643635|NCT01429051|Anesthetics|anesthetics|mesh-ancestor
25643636|NCT01429077|Levodopa|levodopa|mesh-list
25643637|NCT01429077|Carbidopa|carbidopa|mesh-list
25293724|NCT03596073|Petrolatum|petrolatum|mesh-list
25293725|NCT03596073|Dermatologic Agents|dermatologic agents|mesh-ancestor
25293726|NCT03596073|Emollients|emollients|mesh-ancestor
25293727|NCT03587844|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25293728|NCT03587844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25293729|NCT03587844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25293730|NCT03587844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25643638|NCT01429077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25643639|NCT01429077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25643640|NCT01429077|Dopamine Agents|dopamine agents|mesh-ancestor
25643641|NCT01429077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25293731|NCT03587844|Immunologic Factors|immunologic factors|mesh-ancestor
25293733|NCT03579914|Metoprolol|metoprolol|mesh-list
25441387|NCT04715568|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
25441388|NCT04715568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25441389|NCT04715568|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25441390|NCT04715568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441391|NCT04715568|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25441392|NCT04715217|Cyclophosphamide|cyclophosphamide|mesh-list
25441393|NCT04715217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25441394|NCT04715217|Immunologic Factors|immunologic factors|mesh-ancestor
25441395|NCT04715217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441396|NCT04715217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25441397|NCT04715217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25441398|NCT04715217|Alkylating Agents|alkylating agents|mesh-ancestor
25441399|NCT04715217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441400|NCT04715217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25441401|NCT04715217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25441402|NCT04715269|Alprazolam|alprazolam|mesh-list
25441403|NCT04715269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25441404|NCT04715269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25441405|NCT04715269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441406|NCT04715269|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25441407|NCT04715269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25441408|NCT04715269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25441409|NCT04715269|GABA Modulators|gaba modulators|mesh-ancestor
25441410|NCT04715269|GABA Agents|gaba agents|mesh-ancestor
25441411|NCT04715269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25441412|NCT04715269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441413|NCT04715152|Dexamethasone|dexamethasone|mesh-list
25441414|NCT04715152|Dexamethasone acetate|dexamethasone acetate|mesh-list
25441415|NCT04715152|Levobupivacaine|levobupivacaine|mesh-list
25441416|NCT04715152|BB 1101|bb 1101|mesh-list
25441417|NCT04715152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25441418|NCT04715152|Antiemetics|antiemetics|mesh-ancestor
25441419|NCT04715152|Autonomic Agents|autonomic agents|mesh-ancestor
25441420|NCT04715152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25441421|NCT04715152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441422|NCT04715152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25441423|NCT04715152|Glucocorticoids|glucocorticoids|mesh-ancestor
25441424|NCT04715152|Hormones|hormones|mesh-ancestor
25441425|NCT04715152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25441426|NCT04715152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25441427|NCT04715152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25441428|NCT04715152|Protease Inhibitors|protease inhibitors|mesh-ancestor
25441429|NCT04715152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441430|NCT04715152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441431|NCT04715152|Anesthetics, Local|anesthetics, local|mesh-ancestor
25441432|NCT04715152|Anesthetics|anesthetics|mesh-ancestor
25441433|NCT04715152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25441434|NCT04715152|Sensory System Agents|sensory system agents|mesh-ancestor
25441435|NCT04715360|Favipiravir|favipiravir|mesh-list
25441436|NCT04715360|Antiviral Agents|antiviral agents|mesh-ancestor
25441437|NCT04715360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25441438|NCT04715295|Azithromycin|azithromycin|mesh-list
25441439|NCT04715295|Doxycycline|doxycycline|mesh-list
25441440|NCT04715295|Hydroxychloroquine|hydroxychloroquine|mesh-list
25441441|NCT04715295|Rivaroxaban|rivaroxaban|mesh-list
25441442|NCT04715295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25441443|NCT04715295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25441444|NCT04715295|Antimalarials|antimalarials|mesh-ancestor
25441445|NCT04715295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25441446|NCT04715295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25643642|NCT01429077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441447|NCT04715295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441448|NCT04715295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441449|NCT04715295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25441450|NCT04715295|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25441451|NCT04715295|Antithrombins|antithrombins|mesh-ancestor
25441452|NCT04715295|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25441453|NCT04715295|Protease Inhibitors|protease inhibitors|mesh-ancestor
25441454|NCT04715295|Anticoagulants|anticoagulants|mesh-ancestor
25441455|NCT04715503|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25441456|NCT04715503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25441457|NCT04715503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441458|NCT04715165|Dexmedetomidine|dexmedetomidine|mesh-list
25441460|NCT04715165|Anesthetics, Local|anesthetics, local|mesh-ancestor
25441461|NCT04715165|Anesthetics|anesthetics|mesh-ancestor
25441462|NCT04715165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25441493|NCT04714554|Erythromycin Estolate|erythromycin estolate|mesh-list
25441494|NCT04714554|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25441495|NCT04714554|Erythromycin stearate|erythromycin stearate|mesh-list
25441496|NCT04714554|Relugolix|relugolix|mesh-list
25441497|NCT04714554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25441498|NCT04714554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25441499|NCT04714554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25441500|NCT04714554|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25441501|NCT04714554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441502|NCT04714554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441503|NCT04714554|Androgen Antagonists|androgen antagonists|mesh-ancestor
25441504|NCT04714554|Hormone Antagonists|hormone antagonists|mesh-ancestor
25441505|NCT04714554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25441506|NCT04714554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441507|NCT04714593|Cyclophosphamide|cyclophosphamide|mesh-list
25441508|NCT04714593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25441509|NCT04714593|Immunologic Factors|immunologic factors|mesh-ancestor
25441510|NCT04714593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441511|NCT04714593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25441512|NCT04714593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25441513|NCT04714593|Alkylating Agents|alkylating agents|mesh-ancestor
25441514|NCT04714593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441515|NCT04714593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25441516|NCT04714593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25441517|NCT04714242|Ranibizumab|ranibizumab|mesh-list
25441518|NCT04714242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25441519|NCT04714242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25441520|NCT04714242|Growth Substances|growth substances|mesh-ancestor
25441521|NCT04714242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441522|NCT04714242|Growth Inhibitors|growth inhibitors|mesh-ancestor
25441523|NCT04714242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25441524|NCT04714229|Vaccines|vaccines|mesh-list
25441525|NCT04714229|Immunologic Factors|immunologic factors|mesh-ancestor
25441526|NCT04714229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441527|NCT04714515|Hydroxychloroquine|hydroxychloroquine|mesh-list
25441528|NCT04714515|Ivermectin|ivermectin|mesh-list
25441529|NCT04714515|Montelukast|montelukast|mesh-list
25441530|NCT04714515|Antimalarials|antimalarials|mesh-ancestor
25441531|NCT04714515|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25441532|NCT04714515|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25441533|NCT04714515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25441534|NCT04714515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441535|NCT04714515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441536|NCT04714515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25441537|NCT04714515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25441538|NCT04714515|Respiratory System Agents|respiratory system agents|mesh-ancestor
25441539|NCT04714515|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25441540|NCT04714515|Hormone Antagonists|hormone antagonists|mesh-ancestor
25441541|NCT04714515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25441542|NCT04714515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441543|NCT04714515|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25441544|NCT04714515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25441545|NCT04714541|Ketamine|ketamine|mesh-list
25441546|NCT04714541|Analgesics|analgesics|mesh-ancestor
25441547|NCT04714541|Sensory System Agents|sensory system agents|mesh-ancestor
25441548|NCT04714541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25441549|NCT04714541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441550|NCT04714541|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25643643|NCT01429077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441551|NCT04714541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25441552|NCT04714541|Anesthetics, General|anesthetics, general|mesh-ancestor
25441553|NCT04714541|Anesthetics|anesthetics|mesh-ancestor
25441554|NCT04714541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25441555|NCT04714541|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25441556|NCT04714541|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25441557|NCT04714541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25441558|NCT04714541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441559|NCT04714073|Itraconazole|itraconazole|mesh-list
25441560|NCT04714073|Antifungal Agents|antifungal agents|mesh-ancestor
25441561|NCT04714073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25441562|NCT04714073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25293935|NCT05110118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25293936|NCT05110118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25441563|NCT04714073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25441564|NCT04714073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441565|NCT04714073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441566|NCT04714073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25441567|NCT04714073|Hormone Antagonists|hormone antagonists|mesh-ancestor
25441568|NCT04714073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25441569|NCT04714073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441570|NCT04714073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25441571|NCT04714112|Dexamethasone|dexamethasone|mesh-list
25441572|NCT04714112|Dexamethasone acetate|dexamethasone acetate|mesh-list
25441573|NCT04714112|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25441574|NCT04714112|BB 1101|bb 1101|mesh-list
25441575|NCT04714112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25441576|NCT04714112|Antiemetics|antiemetics|mesh-ancestor
25441577|NCT04714112|Autonomic Agents|autonomic agents|mesh-ancestor
25441578|NCT04714112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25441579|NCT04714112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441580|NCT04714112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25441581|NCT04714112|Glucocorticoids|glucocorticoids|mesh-ancestor
25441582|NCT04714112|Hormones|hormones|mesh-ancestor
25441583|NCT04714112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25441584|NCT04714112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25441585|NCT04714112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25441586|NCT04714112|Protease Inhibitors|protease inhibitors|mesh-ancestor
25441587|NCT04714112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441588|NCT04714112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441589|NCT04714099|Cyclosporine|cyclosporine|mesh-list
25441590|NCT04714099|Cyclosporins|cyclosporins|mesh-list
25441591|NCT04714099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441592|NCT04714099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441593|NCT04714099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25441594|NCT04714099|Immunologic Factors|immunologic factors|mesh-ancestor
25441595|NCT04714099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441596|NCT04714099|Antifungal Agents|antifungal agents|mesh-ancestor
25441597|NCT04714099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25441598|NCT04714099|Dermatologic Agents|dermatologic agents|mesh-ancestor
25441599|NCT04714099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25441600|NCT04714099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25441601|NCT04713956|Cyclophosphamide|cyclophosphamide|mesh-list
25441602|NCT04713956|Busulfan|busulfan|mesh-list
25441603|NCT04713956|Fludarabine|fludarabine|mesh-list
25441604|NCT04713956|Decitabine|decitabine|mesh-list
25441605|NCT04713956|Lenograstim|lenograstim|mesh-list
25441606|NCT04713956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25441607|NCT04713956|Immunologic Factors|immunologic factors|mesh-ancestor
25441608|NCT04713956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441609|NCT04713956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25441610|NCT04713956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25441611|NCT04713956|Alkylating Agents|alkylating agents|mesh-ancestor
25441612|NCT04713956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441613|NCT04713956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25441614|NCT04713956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25441615|NCT04713956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25441616|NCT04713956|Antimetabolites|antimetabolites|mesh-ancestor
25441617|NCT04713956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441618|NCT04713956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25441619|NCT04714177|Edaravone|edaravone|mesh-list
25441620|NCT04714177|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25441621|NCT04714177|Antioxidants|antioxidants|mesh-ancestor
25643644|NCT01429077|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25643645|NCT01429077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441622|NCT04714177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441623|NCT04714177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25441624|NCT04714177|Protective Agents|protective agents|mesh-ancestor
25441625|NCT04714177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441626|NCT04713904|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25441627|NCT04713904|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25441628|NCT04713904|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25441629|NCT04713904|Estradiol|estradiol|mesh-list
25441630|NCT04713904|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25441631|NCT04713904|Estrogens|estrogens|mesh-ancestor
25441632|NCT04713904|Hormones|hormones|mesh-ancestor
25441633|NCT04713904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25441634|NCT04713904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441635|NCT04713904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25441636|NCT04713904|Contraceptive Agents|contraceptive agents|mesh-ancestor
25294003|NCT05108714|Lidocaine|lidocaine|mesh-list
25441637|NCT04713904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25441638|NCT04713904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25441639|NCT04713904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25441640|NCT04713904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25441641|NCT04713891|Atezolizumab|atezolizumab|mesh-list
25441642|NCT04713891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25441643|NCT04713891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25441644|NCT04713891|Immunologic Factors|immunologic factors|mesh-ancestor
25441645|NCT04713891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441646|NCT04713527|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25441647|NCT04713527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25441648|NCT04713787|Albendazole|albendazole|mesh-list
25441649|NCT04713787|Oxfendazole|oxfendazole|mesh-list
25441650|NCT04713787|Anthelmintics|anthelmintics|mesh-ancestor
25441651|NCT04713787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25441652|NCT04713787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25441653|NCT04713787|Anticestodal Agents|anticestodal agents|mesh-ancestor
25441654|NCT04713787|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25441655|NCT04713787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25441656|NCT04713787|Tubulin Modulators|tubulin modulators|mesh-ancestor
25441657|NCT04713787|Antimitotic Agents|antimitotic agents|mesh-ancestor
25441658|NCT04713787|Mitosis Modulators|mitosis modulators|mesh-ancestor
25441659|NCT04713787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441660|NCT04713787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25441661|NCT04713787|Antinematodal Agents|antinematodal agents|mesh-ancestor
25441662|NCT04713644|Propofol|propofol|mesh-list
25441663|NCT04713644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25441664|NCT04713644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25441665|NCT04713644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441666|NCT04713644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25441667|NCT04713644|Anesthetics, General|anesthetics, general|mesh-ancestor
25441668|NCT04713644|Anesthetics|anesthetics|mesh-ancestor
25441669|NCT04713488|Vaccines|vaccines|mesh-list
25441670|NCT04713488|Immunologic Factors|immunologic factors|mesh-ancestor
25441671|NCT04713488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441672|NCT04713735|Lactoferrin|lactoferrin|mesh-list
25441673|NCT04713735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25441674|NCT04713761|Carboplatin|carboplatin|mesh-list
25441675|NCT04713761|Pemetrexed|pemetrexed|mesh-list
25441676|NCT04713761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25441677|NCT04713761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441678|NCT04713761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441679|NCT04713761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25441680|NCT04713761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25441681|NCT04713631|Artesunate|artesunate|mesh-list
25441682|NCT04713631|Curcumin|curcumin|mesh-list
25441683|NCT04713631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25441684|NCT04713631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25441685|NCT04713631|Analgesics|analgesics|mesh-ancestor
25441686|NCT04713631|Sensory System Agents|sensory system agents|mesh-ancestor
25441687|NCT04713631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25441688|NCT04713631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441689|NCT04713631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25441690|NCT04713631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25441691|NCT04713631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25441692|NCT04713631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441693|NCT04713631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498768|NCT00516191|Alkylating Agents|alkylating agents|mesh-ancestor
25441694|NCT04713631|Antimalarials|antimalarials|mesh-ancestor
25441695|NCT04713631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25294076|NCT04772300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294077|NCT04772300|Antifungal Agents|antifungal agents|mesh-ancestor
25294078|NCT04772300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25294079|NCT04772300|Immunologic Factors|immunologic factors|mesh-ancestor
25294080|NCT04772300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294094|NCT04701060|Apatinib|apatinib|mesh-list
25643646|NCT01429259|Meropenem|meropenem|mesh-list
25643647|NCT01429259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25643648|NCT01429259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25643649|NCT01429272|Aspirin|aspirin|mesh-list
25643650|NCT01429272|Minocycline|minocycline|mesh-list
25643651|NCT01429272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25643652|NCT01429272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25294095|NCT04701060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294096|NCT04701060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25294097|NCT04701060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25294098|NCT04701060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294099|NCT04676477|Osimertinib|osimertinib|mesh-list
25294100|NCT04676477|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
25294101|NCT04676477|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25294102|NCT04676477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294103|NCT04676477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25294104|NCT04676477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25294107|NCT04676477|Immunologic Factors|immunologic factors|mesh-ancestor
25441696|NCT04713631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25441697|NCT04713631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25441698|NCT04713631|Antiviral Agents|antiviral agents|mesh-ancestor
25441699|NCT04713631|Schistosomicides|schistosomicides|mesh-ancestor
25441700|NCT04713631|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25441701|NCT04713631|Anthelmintics|anthelmintics|mesh-ancestor
25441703|NCT04713254|Midazolam|midazolam|mesh-list
25441704|NCT04713254|Bupropion|bupropion|mesh-list
25441705|NCT04713254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25441706|NCT04713254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25441707|NCT04713254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25441708|NCT04713254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441709|NCT04713254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25441710|NCT04713254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25441711|NCT04713254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25441712|NCT04713254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25441713|NCT04713254|Anesthetics, General|anesthetics, general|mesh-ancestor
25441714|NCT04713254|Anesthetics|anesthetics|mesh-ancestor
25441715|NCT04713254|GABA Modulators|gaba modulators|mesh-ancestor
25441716|NCT04713254|GABA Agents|gaba agents|mesh-ancestor
25441717|NCT04713254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25441718|NCT04713254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441719|NCT04713254|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25441720|NCT04713254|Antidepressive Agents|antidepressive agents|mesh-ancestor
25441721|NCT04713254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25441722|NCT04713254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25441723|NCT04713254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25441724|NCT04713254|Dopamine Agents|dopamine agents|mesh-ancestor
25441725|NCT04713254|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25441726|NCT04713254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25441727|NCT04713254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441728|NCT04713254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25441729|NCT04713254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25441730|NCT04713254|Sympatholytics|sympatholytics|mesh-ancestor
25441731|NCT04713254|Autonomic Agents|autonomic agents|mesh-ancestor
25441732|NCT04713254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25441733|NCT04713254|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25441734|NCT04713254|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25441735|NCT04713254|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25441736|NCT04713254|Adrenergic Agents|adrenergic agents|mesh-ancestor
25441737|NCT04713176|Remdesivir|remdesivir|mesh-list
25441738|NCT04713176|Antimetabolites|antimetabolites|mesh-ancestor
25441739|NCT04713176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441740|NCT04713176|Antiviral Agents|antiviral agents|mesh-ancestor
25441741|NCT04713176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25441742|NCT04713410|Prednisolone|prednisolone|mesh-list
25643653|NCT01429272|Analgesics|analgesics|mesh-ancestor
25441743|NCT04713410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25441744|NCT04713410|Glucocorticoids|glucocorticoids|mesh-ancestor
25441745|NCT04713410|Hormones|hormones|mesh-ancestor
25203108|NCT02716129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25441746|NCT04713410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25441747|NCT04713410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441748|NCT04713410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25441749|NCT04713410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25441750|NCT04713189|Fentanyl|fentanyl|mesh-list
25441751|NCT04713189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25441752|NCT04713189|Narcotics|narcotics|mesh-ancestor
25441753|NCT04713189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25441754|NCT04713189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441755|NCT04713189|Analgesics|analgesics|mesh-ancestor
25441756|NCT04713189|Sensory System Agents|sensory system agents|mesh-ancestor
25441757|NCT04713189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25441758|NCT04713189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25441759|NCT04713189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25294155|NCT04456322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25294156|NCT04408664|Cromolyn Sodium|cromolyn sodium|mesh-list
25294157|NCT04408664|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
25294158|NCT04408664|Immunologic Factors|immunologic factors|mesh-ancestor
25294159|NCT04408664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294160|NCT04408664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25294161|NCT04408664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25294162|NCT04408664|Respiratory System Agents|respiratory system agents|mesh-ancestor
25294163|NCT04383119|Gemcitabine|gemcitabine|mesh-list
25294164|NCT04383119|Trabectedin|trabectedin|mesh-list
25294165|NCT04383119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25441761|NCT04713189|Anesthetics|anesthetics|mesh-ancestor
25441762|NCT04713163|Vaccines|vaccines|mesh-list
25441763|NCT04713163|Immunologic Factors|immunologic factors|mesh-ancestor
25441764|NCT04713163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441765|NCT04713332|Vitamin E|vitamin e|mesh-list
25441766|NCT04713332|Tocopherols|tocopherols|mesh-list
25441767|NCT04713332|alpha-Tocopherol|alpha-tocopherol|mesh-list
25441768|NCT04713332|Vitamins|vitamins|mesh-ancestor
25441769|NCT04713332|Micronutrients|micronutrients|mesh-ancestor
25441770|NCT04713332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441771|NCT04713332|Antioxidants|antioxidants|mesh-ancestor
25441772|NCT04713332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441773|NCT04713332|Protective Agents|protective agents|mesh-ancestor
25441774|NCT04712929|Fluconazole|fluconazole|mesh-list
25441775|NCT04712929|Antifungal Agents|antifungal agents|mesh-ancestor
25441776|NCT04712929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25441777|NCT04712929|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25441778|NCT04712929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25441779|NCT04712929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441780|NCT04712929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441781|NCT04712929|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25441782|NCT04712929|Hormone Antagonists|hormone antagonists|mesh-ancestor
25441783|NCT04712929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25441784|NCT04712929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441785|NCT04712929|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25441786|NCT04712929|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25441787|NCT04712799|Xylometazoline|xylometazoline|mesh-list
25441788|NCT04712799|Nasal Decongestants|nasal decongestants|mesh-ancestor
25441789|NCT04712799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25441790|NCT04712799|Respiratory System Agents|respiratory system agents|mesh-ancestor
25441791|NCT04712435|Acetylcysteine|acetylcysteine|mesh-list
25441792|NCT04712435|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25441793|NCT04712435|Antiviral Agents|antiviral agents|mesh-ancestor
25441794|NCT04712435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25441795|NCT04712435|Expectorants|expectorants|mesh-ancestor
25441796|NCT04712435|Respiratory System Agents|respiratory system agents|mesh-ancestor
25441797|NCT04712435|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25441798|NCT04712435|Antioxidants|antioxidants|mesh-ancestor
25441799|NCT04712435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441800|NCT04712435|Protective Agents|protective agents|mesh-ancestor
25441801|NCT04712435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441802|NCT04712435|Antidotes|antidotes|mesh-ancestor
25441803|NCT04712357|Ascorbic Acid|ascorbic acid|mesh-list
25441804|NCT04712357|Tenofovir|tenofovir|mesh-list
25441805|NCT04712357|Emtricitabine|emtricitabine|mesh-list
25441806|NCT04712357|Vitamins|vitamins|mesh-ancestor
25441807|NCT04712357|Micronutrients|micronutrients|mesh-ancestor
25441808|NCT04712357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441809|NCT04712357|Antiviral Agents|antiviral agents|mesh-ancestor
25441810|NCT04712357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25441811|NCT04712357|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25643654|NCT01429272|Sensory System Agents|sensory system agents|mesh-ancestor
25441812|NCT04712357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25441813|NCT04712357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441814|NCT04712357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441815|NCT04712357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25441816|NCT04712357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25441817|NCT04712357|Antioxidants|antioxidants|mesh-ancestor
25441818|NCT04712357|Protective Agents|protective agents|mesh-ancestor
25441819|NCT04712396|Itraconazole|itraconazole|mesh-list
25441820|NCT04712396|Antifungal Agents|antifungal agents|mesh-ancestor
25441821|NCT04712396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25441822|NCT04712396|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25441823|NCT04712396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25441824|NCT04712396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600320|NCT01026220|Immunologic Factors|immunologic factors|mesh-ancestor
25822831|NCT00004682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822832|NCT00004685|Albuterol|albuterol|mesh-list
25294248|NCT04121299|Amlodipine|amlodipine|mesh-list
25294249|NCT04121299|Carvedilol|carvedilol|mesh-list
25294250|NCT04121299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25294251|NCT04121299|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25294252|NCT04121299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25294253|NCT04121299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294255|NCT04121299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441848|NCT04711889|Urinastatin|urinastatin|mesh-list
25441849|NCT04711889|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25441850|NCT04711889|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25441851|NCT04711889|Protease Inhibitors|protease inhibitors|mesh-ancestor
25441852|NCT04711889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441853|NCT04711889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441854|NCT04711863|Fluvoxamine|fluvoxamine|mesh-list
25441855|NCT04711863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25441856|NCT04711863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25441857|NCT04711863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25441858|NCT04711863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441859|NCT04711863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25441860|NCT04711863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25441861|NCT04711863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25441862|NCT04711863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25441863|NCT04711863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441864|NCT04711863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25441865|NCT04711863|Serotonin Agents|serotonin agents|mesh-ancestor
25441866|NCT04711863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25441867|NCT04711863|Antidepressive Agents|antidepressive agents|mesh-ancestor
25441868|NCT04711863|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25441869|NCT04711863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25441870|NCT04711863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441871|NCT04711863|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25441872|NCT04712058|Tenofovir|tenofovir|mesh-list
25441873|NCT04712058|Emtricitabine|emtricitabine|mesh-list
25441874|NCT04712058|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25441875|NCT04712058|Antiviral Agents|antiviral agents|mesh-ancestor
25441876|NCT04712058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25441877|NCT04712058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25441878|NCT04712058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25441879|NCT04712058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441880|NCT04712058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441881|NCT04712058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25441882|NCT04712058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25441883|NCT04711668|Lidocaine|lidocaine|mesh-list
25441884|NCT04711668|Ketamine|ketamine|mesh-list
25441885|NCT04711668|Anesthetics, Local|anesthetics, local|mesh-ancestor
25441886|NCT04711668|Anesthetics|anesthetics|mesh-ancestor
25441887|NCT04711668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25441888|NCT04711668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441889|NCT04711668|Sensory System Agents|sensory system agents|mesh-ancestor
25441890|NCT04711668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25441891|NCT04711668|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25441892|NCT04711668|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25441893|NCT04711668|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25441894|NCT04711668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25441895|NCT04711668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822833|NCT00004685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25643655|NCT01429272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25441896|NCT04711668|Analgesics|analgesics|mesh-ancestor
25441897|NCT04711668|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25441898|NCT04711668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25441899|NCT04711668|Anesthetics, General|anesthetics, general|mesh-ancestor
25441900|NCT04711668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25441901|NCT04711668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25441902|NCT04711668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25441903|NCT04711642|Hyaluronic Acid|hyaluronic acid|mesh-list
25441904|NCT04711642|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25441905|NCT04711642|Immunologic Factors|immunologic factors|mesh-ancestor
25441906|NCT04711642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441907|NCT04711642|Viscosupplements|viscosupplements|mesh-ancestor
25441908|NCT04711642|Protective Agents|protective agents|mesh-ancestor
25441909|NCT04711564|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25441910|NCT04711564|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
25441911|NCT04711564|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25441912|NCT04711564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25441913|NCT04711291|Tacrolimus|tacrolimus|mesh-list
25441914|NCT04711291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25441915|NCT04711291|Immunologic Factors|immunologic factors|mesh-ancestor
25441916|NCT04711291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441917|NCT04711291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25441918|NCT04711291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441919|NCT04711291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294374|NCT03540901|Diuretics|diuretics|mesh-ancestor
25441920|NCT04711343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25441921|NCT04711343|Immunologic Factors|immunologic factors|mesh-ancestor
25441922|NCT04711343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441923|NCT04711265|Vaccines|vaccines|mesh-list
25441924|NCT04711265|Immunologic Factors|immunologic factors|mesh-ancestor
25441925|NCT04711265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441926|NCT04711434|Antibodies|antibodies|mesh-list
25441927|NCT04711434|Immunologic Factors|immunologic factors|mesh-ancestor
25441928|NCT04711434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441929|NCT04711213|Dexamethasone|dexamethasone|mesh-list
25441930|NCT04711213|Dexamethasone acetate|dexamethasone acetate|mesh-list
25441931|NCT04711213|BB 1101|bb 1101|mesh-list
25441932|NCT04711213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25441933|NCT04711213|Antiemetics|antiemetics|mesh-ancestor
25441934|NCT04711213|Autonomic Agents|autonomic agents|mesh-ancestor
25441935|NCT04711213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25441936|NCT04711213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441937|NCT04711213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25441938|NCT04711213|Glucocorticoids|glucocorticoids|mesh-ancestor
25441939|NCT04711213|Hormones|hormones|mesh-ancestor
25441940|NCT04711213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25441941|NCT04711213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25441942|NCT04711213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25441943|NCT04711213|Protease Inhibitors|protease inhibitors|mesh-ancestor
25441944|NCT04711213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25441945|NCT04711213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441946|NCT04711161|Paclitaxel|paclitaxel|mesh-list
25441947|NCT04711161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25441948|NCT04711161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25441949|NCT04711161|Tubulin Modulators|tubulin modulators|mesh-ancestor
25441950|NCT04711161|Antimitotic Agents|antimitotic agents|mesh-ancestor
25441951|NCT04711161|Mitosis Modulators|mitosis modulators|mesh-ancestor
25441952|NCT04711161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441953|NCT04711122|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25441954|NCT04711122|Cephalosporins|cephalosporins|mesh-list
25441955|NCT04711122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25441956|NCT04711096|Bupivacaine|bupivacaine|mesh-list
25441957|NCT04711096|Anesthetics, Local|anesthetics, local|mesh-ancestor
25441958|NCT04711096|Anesthetics|anesthetics|mesh-ancestor
25441959|NCT04711096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25441960|NCT04711096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441961|NCT04711096|Sensory System Agents|sensory system agents|mesh-ancestor
25441962|NCT04711096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25441963|NCT04710927|Fluorides|fluorides|mesh-list
25441964|NCT04710927|Cariostatic Agents|cariostatic agents|mesh-ancestor
25441965|NCT04710927|Protective Agents|protective agents|mesh-ancestor
25441966|NCT04710927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441967|NCT04710914|Midazolam|midazolam|mesh-list
25441968|NCT04710914|Isoflurane|isoflurane|mesh-list
25822834|NCT00004685|Autonomic Agents|autonomic agents|mesh-ancestor
25441969|NCT04710914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25643656|NCT01429272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643657|NCT01429272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25643658|NCT01429272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25643659|NCT01429272|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25643660|NCT01429272|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25643661|NCT01429272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441970|NCT04710914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25441971|NCT04710914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25441972|NCT04710914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25441973|NCT04710914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25441974|NCT04710914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25441975|NCT04710914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25441976|NCT04710914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25719990|NCT02461160|Anesthetics|anesthetics|mesh-ancestor
25441977|NCT04710914|Anesthetics, General|anesthetics, general|mesh-ancestor
25441978|NCT04710914|Anesthetics|anesthetics|mesh-ancestor
25441979|NCT04710914|GABA Modulators|gaba modulators|mesh-ancestor
25441980|NCT04710914|GABA Agents|gaba agents|mesh-ancestor
25441981|NCT04710914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25441982|NCT04710914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25441983|NCT04710914|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25441984|NCT04710888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25441985|NCT04711044|Menthol|menthol|mesh-list
25294449|NCT02991807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294450|NCT02944799|Vitamin D|vitamin d|mesh-list
25294451|NCT02944799|Alendronate|alendronate|mesh-list
25294452|NCT02944799|Calcium|calcium|mesh-list
25294453|NCT02944799|Vitamins|vitamins|mesh-ancestor
25294454|NCT02944799|Micronutrients|micronutrients|mesh-ancestor
25294455|NCT02944799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294456|NCT02944799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25294457|NCT02944799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25294458|NCT02784262|Botulinum Toxins|botulinum toxins|mesh-list
25441986|NCT04711044|Histamine|histamine|mesh-list
25441987|NCT04711044|Antipruritics|antipruritics|mesh-ancestor
25442011|NCT04710017|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25442012|NCT04710017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25442013|NCT04710017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25442014|NCT04710017|Contraceptive Agents|contraceptive agents|mesh-ancestor
25442015|NCT04710017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25442016|NCT04710017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442017|NCT04710017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25442018|NCT04710017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25442019|NCT04710017|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25442020|NCT04710017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25442021|NCT04710017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25442023|NCT04710160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25442024|NCT04710160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442025|NCT04709770|Simethicone|simethicone|mesh-list
25442026|NCT04709770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442027|NCT04709770|Antifoaming Agents|antifoaming agents|mesh-ancestor
25442028|NCT04709770|Emollients|emollients|mesh-ancestor
25442029|NCT04709770|Dermatologic Agents|dermatologic agents|mesh-ancestor
25294525|NCT05111444|Paclitaxel|paclitaxel|mesh-list
25294526|NCT05111444|Capecitabine|capecitabine|mesh-list
25294527|NCT05111444|Oxaliplatin|oxaliplatin|mesh-list
25294528|NCT05111444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25294529|NCT05111444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294530|NCT05111444|Tubulin Modulators|tubulin modulators|mesh-ancestor
25294531|NCT05111444|Antimitotic Agents|antimitotic agents|mesh-ancestor
25294532|NCT05111444|Mitosis Modulators|mitosis modulators|mesh-ancestor
25294533|NCT05111444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294535|NCT05111444|Antimetabolites|antimetabolites|mesh-ancestor
25442030|NCT04709731|Ponatinib|ponatinib|mesh-list
25442031|NCT04709731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25442032|NCT04709731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25442033|NCT04709731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25442034|NCT04709731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442035|NCT04709744|Vitamin D|vitamin d|mesh-list
25442036|NCT04709744|Ergocalciferols|ergocalciferols|mesh-list
25442037|NCT04709744|Cholecalciferol|cholecalciferol|mesh-list
25442038|NCT04709744|Vitamins|vitamins|mesh-list
25442039|NCT04709744|Micronutrients|micronutrients|mesh-ancestor
25442040|NCT04709744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442041|NCT04709744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25643662|NCT01429272|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24499770|NCT00521040|Histamine Antagonists|histamine antagonists|mesh-ancestor
25442042|NCT04709744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25442043|NCT04709380|Sorafenib|sorafenib|mesh-list
25442044|NCT04709380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25442045|NCT04709380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25442046|NCT04709380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25442047|NCT04709380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442048|NCT04709185|Dexamethasone|dexamethasone|mesh-list
25442049|NCT04709185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25442050|NCT04709185|Antiemetics|antiemetics|mesh-ancestor
25442051|NCT04709185|Autonomic Agents|autonomic agents|mesh-ancestor
25442052|NCT04709185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25442053|NCT04709185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442054|NCT04709185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25442055|NCT04709185|Glucocorticoids|glucocorticoids|mesh-ancestor
25442056|NCT04709185|Hormones|hormones|mesh-ancestor
25442057|NCT04709185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25442058|NCT04709185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25442059|NCT04709185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25442060|NCT04709172|Cefditoren|cefditoren|mesh-list
25442061|NCT04709172|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
25442062|NCT04709172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25442063|NCT04709172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25442064|NCT04709315|Choline|choline|mesh-list
25442065|NCT04709315|Rocuronium|rocuronium|mesh-list
25442066|NCT04709315|Succinylcholine|succinylcholine|mesh-list
25442067|NCT04709315|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25442068|NCT04709315|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25442069|NCT04709315|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25442070|NCT04709315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25442071|NCT04709315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442072|NCT04709315|Lipotropic Agents|lipotropic agents|mesh-ancestor
25442073|NCT04709315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25442074|NCT04709315|Antimetabolites|antimetabolites|mesh-ancestor
25442075|NCT04709315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442076|NCT04709315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25442077|NCT04709315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25442078|NCT04709315|Nootropic Agents|nootropic agents|mesh-ancestor
25442079|NCT04709315|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
25442080|NCT04709094|Bupropion|bupropion|mesh-list
25442081|NCT04709094|Warfarin|warfarin|mesh-list
25442082|NCT04709094|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25442083|NCT04709094|Norethindrone|norethindrone|mesh-list
25442084|NCT04709094|Norethindrone Acetate|norethindrone acetate|mesh-list
25442085|NCT04709094|Norinyl|norinyl|mesh-list
25442086|NCT04709094|Estradiol|estradiol|mesh-list
25442087|NCT04709094|Estrogens|estrogens|mesh-ancestor
25442088|NCT04709094|Hormones|hormones|mesh-ancestor
25442089|NCT04709094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25442090|NCT04709094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442091|NCT04709094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25442092|NCT04709094|Contraceptive Agents|contraceptive agents|mesh-ancestor
25442093|NCT04709094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25442094|NCT04709094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25442095|NCT04709094|Anticoagulants|anticoagulants|mesh-ancestor
25442096|NCT04709094|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25442097|NCT04709094|Antidepressive Agents|antidepressive agents|mesh-ancestor
25442098|NCT04709094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25442099|NCT04709094|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25442100|NCT04709094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25442101|NCT04709094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25442102|NCT04709094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442103|NCT04709094|Dopamine Agents|dopamine agents|mesh-ancestor
25442104|NCT04709094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25294600|NCT05103735|Narcotics|narcotics|mesh-ancestor
25442105|NCT04709094|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25442106|NCT04709094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25442107|NCT04709094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25442108|NCT04709094|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25442109|NCT04709094|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25442110|NCT04709094|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25442111|NCT04709094|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25442112|NCT04709289|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25442113|NCT04709289|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25442114|NCT04709289|Dermatologic Agents|dermatologic agents|mesh-ancestor
25442115|NCT04709081|Itraconazole|itraconazole|mesh-list
25442116|NCT04709081|Digoxin|digoxin|mesh-list
25442118|NCT04709081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25442119|NCT04709081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25442120|NCT04709081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25442121|NCT04709081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442122|NCT04709081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25442123|NCT04709081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25442124|NCT04709081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25442125|NCT04709081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25442126|NCT04709081|Anesthetics, General|anesthetics, general|mesh-ancestor
25442127|NCT04709081|Anesthetics|anesthetics|mesh-ancestor
25442128|NCT04709081|GABA Modulators|gaba modulators|mesh-ancestor
25442129|NCT04709081|GABA Agents|gaba agents|mesh-ancestor
25442130|NCT04709081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25442131|NCT04709081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442132|NCT04709081|Antifungal Agents|antifungal agents|mesh-ancestor
25442133|NCT04709081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25442134|NCT04709081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25442135|NCT04709081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25442136|NCT04709081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25442137|NCT04709081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25442138|NCT04709081|Hormone Antagonists|hormone antagonists|mesh-ancestor
25442139|NCT04709081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25442140|NCT04709081|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25442141|NCT04709081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25442142|NCT04709081|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25442143|NCT04709081|Protective Agents|protective agents|mesh-ancestor
25442144|NCT04709029|Dexamethasone|dexamethasone|mesh-list
25442145|NCT04709029|Dexamethasone acetate|dexamethasone acetate|mesh-list
25442146|NCT04709029|BB 1101|bb 1101|mesh-list
25442147|NCT04709029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25442148|NCT04709029|Antiemetics|antiemetics|mesh-ancestor
25442149|NCT04709029|Autonomic Agents|autonomic agents|mesh-ancestor
25442150|NCT04709029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25442151|NCT04709029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442152|NCT04709029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25442153|NCT04709029|Glucocorticoids|glucocorticoids|mesh-ancestor
25442154|NCT04709029|Hormones|hormones|mesh-ancestor
25442155|NCT04709029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25442156|NCT04709029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25442157|NCT04709029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25442158|NCT04709029|Protease Inhibitors|protease inhibitors|mesh-ancestor
25442159|NCT04709029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25442160|NCT04709029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442161|NCT04708821|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25442162|NCT04708821|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25442163|NCT04708821|Dexamethasone|dexamethasone|mesh-list
25442164|NCT04708821|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25442165|NCT04708821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25442166|NCT04708821|Antiemetics|antiemetics|mesh-ancestor
25442167|NCT04708821|Autonomic Agents|autonomic agents|mesh-ancestor
25442168|NCT04708821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25294672|NCT04774237|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25294673|NCT04774237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25294674|NCT04774237|Adrenergic Agents|adrenergic agents|mesh-ancestor
25294675|NCT04774237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25294676|NCT04774237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294677|NCT04774237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294678|NCT04774237|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25294679|NCT04774237|Miotics|miotics|mesh-ancestor
25294680|NCT04774237|Autonomic Agents|autonomic agents|mesh-ancestor
25294681|NCT04774237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25294682|NCT04774237|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25442169|NCT04708821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442170|NCT04708821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25442171|NCT04708821|Glucocorticoids|glucocorticoids|mesh-ancestor
25442172|NCT04708821|Hormones|hormones|mesh-ancestor
25442173|NCT04708821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25442174|NCT04708821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25442175|NCT04708821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25442176|NCT04708821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25442177|NCT04708821|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25442178|NCT04708821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25442179|NCT04708821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25442181|NCT04708821|Sensory System Agents|sensory system agents|mesh-ancestor
25442182|NCT04708821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25442183|NCT04708821|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25442184|NCT04708821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25442185|NCT04708821|Histamine Antagonists|histamine antagonists|mesh-ancestor
25442186|NCT04708821|Histamine Agents|histamine agents|mesh-ancestor
25442187|NCT04708821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25442188|NCT04708821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442189|NCT04708964|Flurbiprofen|flurbiprofen|mesh-list
25442190|NCT04708964|Analgesics|analgesics|mesh-ancestor
25442191|NCT04708964|Sensory System Agents|sensory system agents|mesh-ancestor
25442192|NCT04708964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25442193|NCT04708964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442194|NCT04708964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25442195|NCT04708964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25442196|NCT04708964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25442197|NCT04708964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25442198|NCT04708964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25442199|NCT04708964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25442200|NCT04708964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442201|NCT04708496|Efavirenz|efavirenz|mesh-list
25442202|NCT04708496|Dolutegravir|dolutegravir|mesh-list
25442203|NCT04708496|Lumefantrine|lumefantrine|mesh-list
25442204|NCT04708496|Artemether|artemether|mesh-list
25442205|NCT04708496|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25442206|NCT04708496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25442207|NCT04708496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25442208|NCT04708496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25442209|NCT04708496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442210|NCT04708496|Antiviral Agents|antiviral agents|mesh-ancestor
25442211|NCT04708496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25442212|NCT04708496|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25442213|NCT04708496|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25442214|NCT04708496|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25442215|NCT04708496|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25442216|NCT04708496|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25442217|NCT04708496|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25442218|NCT04708496|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25442219|NCT04708496|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25442220|NCT04708496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25442221|NCT04708496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25442222|NCT04708496|Antimalarials|antimalarials|mesh-ancestor
25442223|NCT04708496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25442224|NCT04708496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25442225|NCT04708249|Inositol|inositol|mesh-list
25442226|NCT04708249|Vitamin B Complex|vitamin b complex|mesh-ancestor
25442227|NCT04708249|Vitamins|vitamins|mesh-ancestor
25442228|NCT04708249|Micronutrients|micronutrients|mesh-ancestor
25442229|NCT04708249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442230|NCT04708353|Ascorbic Acid|ascorbic acid|mesh-list
25442231|NCT04708353|Pregabalin|pregabalin|mesh-list
25442232|NCT04708353|Vitamins|vitamins|mesh-ancestor
25442233|NCT04708353|Micronutrients|micronutrients|mesh-ancestor
25442234|NCT04708353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442235|NCT04708353|Analgesics|analgesics|mesh-ancestor
25442236|NCT04708353|Sensory System Agents|sensory system agents|mesh-ancestor
25442237|NCT04708353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25442238|NCT04708353|Anticonvulsants|anticonvulsants|mesh-ancestor
25442239|NCT04708353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25442240|NCT04708353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25442241|NCT04708353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442242|NCT04708353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25442269|NCT04707742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25442271|NCT04707560|Anticoagulants|anticoagulants|mesh-ancestor
25442272|NCT04707560|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25442273|NCT04707560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25442274|NCT04707560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442275|NCT04707547|Nivolumab|nivolumab|mesh-list
25442276|NCT04707547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25442277|NCT04707547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25442278|NCT04707547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25442279|NCT04707547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442280|NCT04707508|Metformin|metformin|mesh-list
25442281|NCT04707508|Valsartan|valsartan|mesh-list
25442282|NCT04707508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25442283|NCT04707508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442284|NCT04707508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25442285|NCT04707508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25442286|NCT04707508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25442287|NCT04707508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720031|NCT02461758|Vaccines|vaccines|mesh-list
25294816|NCT04279574|Antimanic Agents|antimanic agents|mesh-ancestor
25294817|NCT04279574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25294818|NCT04279574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25294819|NCT04279574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294820|NCT04196075|Andrographolide|andrographolide|mesh-list
25294821|NCT04196075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25294823|NCT04196075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25442289|NCT04707209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25442290|NCT04707209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25442291|NCT04707209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25442292|NCT04707209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25442293|NCT04707209|Antifungal Agents|antifungal agents|mesh-ancestor
25442294|NCT04707209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25442295|NCT04707209|Immunologic Factors|immunologic factors|mesh-ancestor
25442296|NCT04707209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442297|NCT04707092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25442298|NCT04707092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25442299|NCT04707352|Dapagliflozin|dapagliflozin|mesh-list
25442300|NCT04707352|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25442301|NCT04707352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442302|NCT04707352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25442303|NCT04707352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442304|NCT04707118|Paclitaxel|paclitaxel|mesh-list
25442305|NCT04707118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25442306|NCT04707118|Cisplatin|cisplatin|mesh-list
25442307|NCT04707118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25442308|NCT04707118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25442309|NCT04707118|Tubulin Modulators|tubulin modulators|mesh-ancestor
25442310|NCT04707118|Antimitotic Agents|antimitotic agents|mesh-ancestor
25442311|NCT04707118|Mitosis Modulators|mitosis modulators|mesh-ancestor
25442312|NCT04707118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442313|NCT04707027|Aflibercept|aflibercept|mesh-list
25442314|NCT04707027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25442315|NCT04707027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25442316|NCT04707027|Growth Substances|growth substances|mesh-ancestor
25442317|NCT04707027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442318|NCT04707027|Growth Inhibitors|growth inhibitors|mesh-ancestor
25442319|NCT04707027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25442320|NCT04706936|Cyclophosphamide|cyclophosphamide|mesh-list
25442321|NCT04706936|Fludarabine|fludarabine|mesh-list
25442322|NCT04706936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25442323|NCT04706936|Immunologic Factors|immunologic factors|mesh-ancestor
25442324|NCT04706936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442325|NCT04706936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25442326|NCT04706936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25442327|NCT04706936|Alkylating Agents|alkylating agents|mesh-ancestor
25442328|NCT04706936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442329|NCT04706936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25442330|NCT04706936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25442331|NCT04706806|Acetic Acid|acetic acid|mesh-list
25442332|NCT04706806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25442333|NCT04706806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25442334|NCT04706637|Dapagliflozin|dapagliflozin|mesh-list
25442335|NCT04706637|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25442336|NCT04706637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442337|NCT04706637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25442338|NCT04706637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442339|NCT04706910|Furosemide|furosemide|mesh-list
25442340|NCT04706910|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
25442341|NCT04706910|Diuretics|diuretics|mesh-ancestor
25442342|NCT04706910|Natriuretic Agents|natriuretic agents|mesh-ancestor
25442343|NCT04706910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442344|NCT04706910|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25442345|NCT04706910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25720038|NCT02462148|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25442346|NCT04706910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442347|NCT04706910|Dopamine Agents|dopamine agents|mesh-ancestor
25643663|NCT01429272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25643665|NCT01429272|Antipyretics|antipyretics|mesh-ancestor
25643666|NCT01429272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25643667|NCT01429272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25643668|NCT01429285|Hydromorphone|hydromorphone|mesh-list
25643669|NCT01429285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25643670|NCT01429285|Narcotics|narcotics|mesh-ancestor
25442348|NCT04706910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25442349|NCT04706949|Carboplatin|carboplatin|mesh-list
25442350|NCT04706949|Pemetrexed|pemetrexed|mesh-list
25442351|NCT04706949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25442352|NCT04706949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25442353|NCT04706949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442354|NCT04706949|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25442355|NCT04706949|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25442356|NCT04706897|Lidocaine|lidocaine|mesh-list
25442357|NCT04706897|Dexmedetomidine|dexmedetomidine|mesh-list
25442358|NCT04706897|Ketamine|ketamine|mesh-list
25442359|NCT04706897|Anesthetics, Local|anesthetics, local|mesh-ancestor
25442360|NCT04706897|Anesthetics|anesthetics|mesh-ancestor
25442361|NCT04706897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25294932|NCT03456882|RNS60|rns60|mesh-list
25442362|NCT04706897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442363|NCT04706897|Sensory System Agents|sensory system agents|mesh-ancestor
25442364|NCT04706897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25442365|NCT04706897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25442366|NCT04706897|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25442367|NCT04706897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25442368|NCT04706897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25442369|NCT04706897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442370|NCT04706897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25442371|NCT04706897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25442372|NCT04706897|Analgesics|analgesics|mesh-ancestor
25442373|NCT04706897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25442374|NCT04706897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25442375|NCT04706897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25442376|NCT04706897|Adrenergic Agents|adrenergic agents|mesh-ancestor
25442377|NCT04706897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25442378|NCT04706897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25442379|NCT04706897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25442380|NCT04706897|Anesthetics, General|anesthetics, general|mesh-ancestor
25442381|NCT04706897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25442382|NCT04706897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25442383|NCT04706455|Hyaluronic Acid|hyaluronic acid|mesh-list
25442384|NCT04706455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25442385|NCT04706455|Immunologic Factors|immunologic factors|mesh-ancestor
25442386|NCT04706455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442387|NCT04706455|Viscosupplements|viscosupplements|mesh-ancestor
25442388|NCT04706455|Protective Agents|protective agents|mesh-ancestor
25442389|NCT04706429|Trientine|trientine|mesh-list
25442390|NCT04706429|Chelating Agents|chelating agents|mesh-ancestor
25442391|NCT04706429|Sequestering Agents|sequestering agents|mesh-ancestor
25442392|NCT04706429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442393|NCT04706247|Anesthetics|anesthetics|mesh-list
25442394|NCT04706247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25442395|NCT04706247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442396|NCT04706546|Sildenafil Citrate|sildenafil citrate|mesh-list
25442397|NCT04706546|Vasodilator Agents|vasodilator agents|mesh-ancestor
25442398|NCT04706546|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25442399|NCT04706546|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25442400|NCT04706546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25442401|NCT04706546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442402|NCT04706546|Urological Agents|urological agents|mesh-ancestor
25442403|NCT04706377|Vitamin B 12|vitamin b 12|mesh-list
25442404|NCT04706377|Vitamins|vitamins|mesh-ancestor
25442405|NCT04706377|Micronutrients|micronutrients|mesh-ancestor
25442406|NCT04706377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442407|NCT04706377|Vitamin B Complex|vitamin b complex|mesh-ancestor
25442408|NCT04706091|Suvorexant|suvorexant|mesh-list
25442409|NCT04706091|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25442410|NCT04706091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25442411|NCT04706091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25442412|NCT04706091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442413|NCT04706091|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25643671|NCT01429285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25643672|NCT01429285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643673|NCT01429285|Analgesics|analgesics|mesh-ancestor
25643674|NCT01429285|Sensory System Agents|sensory system agents|mesh-ancestor
25643675|NCT01429285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25442414|NCT04706091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25442415|NCT04706091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442416|NCT04705948|Magnesium Sulfate|magnesium sulfate|mesh-list
25442417|NCT04705948|Ketamine|ketamine|mesh-list
25442418|NCT04705948|Analgesics|analgesics|mesh-ancestor
25442419|NCT04705948|Sensory System Agents|sensory system agents|mesh-ancestor
25442420|NCT04705948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25442421|NCT04705948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442422|NCT04705948|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25442423|NCT04705948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25442424|NCT04705948|Anesthetics, General|anesthetics, general|mesh-ancestor
25442425|NCT04705948|Anesthetics|anesthetics|mesh-ancestor
25442426|NCT04705948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25442427|NCT04705948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25442428|NCT04705948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25442429|NCT04705948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25442430|NCT04705948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442431|NCT04705948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25294961|NCT03272464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25294962|NCT03272464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25294963|NCT03272464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442432|NCT04705948|Anticonvulsants|anticonvulsants|mesh-ancestor
25442433|NCT04705948|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25442434|NCT04705948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25442435|NCT04705948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25442436|NCT04705948|Tocolytic Agents|tocolytic agents|mesh-ancestor
25442437|NCT04705948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25442438|NCT04705831|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25442439|NCT04705831|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25442440|NCT04705831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25442441|NCT04705831|Immunologic Factors|immunologic factors|mesh-ancestor
25442442|NCT04705831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442443|NCT04705987|Colchicine|colchicine|mesh-list
25442444|NCT04705987|Gout Suppressants|gout suppressants|mesh-ancestor
25442445|NCT04705987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25442446|NCT04705987|Tubulin Modulators|tubulin modulators|mesh-ancestor
25442447|NCT04705987|Antimitotic Agents|antimitotic agents|mesh-ancestor
25442448|NCT04705987|Mitosis Modulators|mitosis modulators|mesh-ancestor
25442449|NCT04705987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442450|NCT04705987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25442451|NCT04705909|Pitavastatin|pitavastatin|mesh-list
25442452|NCT04705909|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
25442453|NCT04705909|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25442454|NCT04705909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25442455|NCT04705909|Antimetabolites|antimetabolites|mesh-ancestor
25442456|NCT04705909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442457|NCT04705909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25442458|NCT04705909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25442459|NCT04705727|Budesonide|budesonide|mesh-list
25442460|NCT04705727|Terbutaline|terbutaline|mesh-list
25442461|NCT04705727|Formoterol Fumarate|formoterol fumarate|mesh-list
25442462|NCT04705727|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25442463|NCT04705727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25442464|NCT04705727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25442465|NCT04705727|Autonomic Agents|autonomic agents|mesh-ancestor
25442466|NCT04705727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25442467|NCT04705727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442468|NCT04705727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25442469|NCT04705727|Respiratory System Agents|respiratory system agents|mesh-ancestor
25442470|NCT04705727|Glucocorticoids|glucocorticoids|mesh-ancestor
25442471|NCT04705727|Hormones|hormones|mesh-ancestor
25442472|NCT04705727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25442473|NCT04705727|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25442474|NCT04705727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25442475|NCT04705727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25442476|NCT04705727|Adrenergic Agents|adrenergic agents|mesh-ancestor
25442477|NCT04705727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24500467|NCT00524498|Cisplatin|cisplatin|mesh-list
25442478|NCT04705727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442479|NCT04705727|Sympathomimetics|sympathomimetics|mesh-ancestor
25442480|NCT04705727|Tocolytic Agents|tocolytic agents|mesh-ancestor
25442481|NCT04705727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25442482|NCT04705584|Cyclosporine|cyclosporine|mesh-list
25442483|NCT04705584|Prednisolone|prednisolone|mesh-list
25442484|NCT04705584|Cyclosporins|cyclosporins|mesh-list
25442485|NCT04705584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25442486|NCT04705584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442487|NCT04705584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25442488|NCT04705584|Immunologic Factors|immunologic factors|mesh-ancestor
25442489|NCT04705584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442490|NCT04705584|Antifungal Agents|antifungal agents|mesh-ancestor
25442491|NCT04705584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25442492|NCT04705584|Dermatologic Agents|dermatologic agents|mesh-ancestor
25442493|NCT04705584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25442494|NCT04705584|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25442495|NCT04705584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25442496|NCT04705584|Glucocorticoids|glucocorticoids|mesh-ancestor
25295035|NCT05115903|Adalimumab|adalimumab|mesh-list
25295036|NCT05115903|Etanercept|etanercept|mesh-list
25295037|NCT05115903|Golimumab|golimumab|mesh-list
25295038|NCT05115903|Infliximab|infliximab|mesh-list
25295039|NCT05115903|Certolizumab Pegol|certolizumab pegol|mesh-list
25295040|NCT05115903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25295041|NCT05115903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25295042|NCT05115903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25295043|NCT05115903|Dermatologic Agents|dermatologic agents|mesh-ancestor
25295044|NCT05115903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25295054|NCT05115578|Midazolam|midazolam|mesh-list
25442503|NCT04705454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25442504|NCT04705337|Simendan|simendan|mesh-list
25442505|NCT04705337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25442506|NCT04705337|Vasodilator Agents|vasodilator agents|mesh-ancestor
25442507|NCT04705337|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25442508|NCT04705337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25442509|NCT04705337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25442510|NCT04705337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442511|NCT04705337|Protective Agents|protective agents|mesh-ancestor
25442512|NCT04705337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442513|NCT04705480|Pregabalin|pregabalin|mesh-list
25442514|NCT04705480|Gabapentin|gabapentin|mesh-list
25442515|NCT04705480|Analgesics|analgesics|mesh-ancestor
25442516|NCT04705480|Sensory System Agents|sensory system agents|mesh-ancestor
25442517|NCT04705480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25442518|NCT04705480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442519|NCT04705480|Anticonvulsants|anticonvulsants|mesh-ancestor
25442520|NCT04705480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25442521|NCT04705480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25442522|NCT04705480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442523|NCT04705480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25442524|NCT04705480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25442525|NCT04705480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25442526|NCT04705480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25442527|NCT04705480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25442528|NCT04705480|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25442529|NCT04705480|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25442530|NCT04705480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25442531|NCT04705480|Antimanic Agents|antimanic agents|mesh-ancestor
25442532|NCT04705402|Mannitol|mannitol|mesh-list
25442533|NCT04705402|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25442534|NCT04705402|Diuretics|diuretics|mesh-ancestor
25442535|NCT04705402|Natriuretic Agents|natriuretic agents|mesh-ancestor
25442536|NCT04705402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442537|NCT04705519|Paclitaxel|paclitaxel|mesh-list
25442538|NCT04705519|Bevacizumab|bevacizumab|mesh-list
25442539|NCT04705519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25442540|NCT04705519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25442541|NCT04705519|Tubulin Modulators|tubulin modulators|mesh-ancestor
25442542|NCT04705519|Antimitotic Agents|antimitotic agents|mesh-ancestor
25442543|NCT04705519|Mitosis Modulators|mitosis modulators|mesh-ancestor
25442544|NCT04705519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442545|NCT04705519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25442546|NCT04705519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25442547|NCT04705519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25442548|NCT04705519|Growth Substances|growth substances|mesh-ancestor
25442549|NCT04705519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643676|NCT01429298|Hydromorphone|hydromorphone|mesh-list
25643677|NCT01429298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25442550|NCT04705519|Growth Inhibitors|growth inhibitors|mesh-ancestor
25442551|NCT04705428|Fluorides|fluorides|mesh-list
25442552|NCT04705428|Cariostatic Agents|cariostatic agents|mesh-ancestor
25442553|NCT04705428|Protective Agents|protective agents|mesh-ancestor
25442554|NCT04705428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442555|NCT04705415|Niclosamide|niclosamide|mesh-list
25442556|NCT04705415|Anticestodal Agents|anticestodal agents|mesh-ancestor
25442557|NCT04705415|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25442558|NCT04705415|Anthelmintics|anthelmintics|mesh-ancestor
25442559|NCT04705415|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25442560|NCT04705415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25442561|NCT04705415|Antinematodal Agents|antinematodal agents|mesh-ancestor
25295113|NCT05113628|Methylene Blue|methylene blue|mesh-list
25295114|NCT05113628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25295115|NCT05113628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442562|NCT04705129|Zanubrutinib|zanubrutinib|mesh-list
25442563|NCT04705129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25442564|NCT04705129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25442565|NCT04705129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25442566|NCT04705129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442567|NCT04704947|Alendronate|alendronate|mesh-list
25442568|NCT04704947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25442569|NCT04704947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-list
25442570|NCT04704947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25442571|NCT04704947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442572|NCT04704947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25442573|NCT04704947|Adrenergic Agents|adrenergic agents|mesh-ancestor
25442574|NCT04704947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25442575|NCT04704947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442576|NCT04704622|Midazolam|midazolam|mesh-list
25442577|NCT04704622|Dexmedetomidine|dexmedetomidine|mesh-list
25442578|NCT04704622|Ketamine|ketamine|mesh-list
25442579|NCT04704622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25442580|NCT04704622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25442581|NCT04704622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442582|NCT04704622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25442583|NCT04704622|Analgesics|analgesics|mesh-ancestor
25442584|NCT04704622|Sensory System Agents|sensory system agents|mesh-ancestor
25442585|NCT04704622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25442586|NCT04704622|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25442587|NCT04704622|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25442588|NCT04704622|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25442589|NCT04704622|Adrenergic Agents|adrenergic agents|mesh-ancestor
25442590|NCT04704622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25442591|NCT04704622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442592|NCT04704622|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25442593|NCT04704622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25442594|NCT04704622|Anesthetics, General|anesthetics, general|mesh-ancestor
25442595|NCT04704622|Anesthetics|anesthetics|mesh-ancestor
25442596|NCT04704622|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25442597|NCT04704622|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25442598|NCT04704622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25442599|NCT04704622|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25442600|NCT04704622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25442601|NCT04704622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25442602|NCT04704622|GABA Modulators|gaba modulators|mesh-ancestor
25442603|NCT04704622|GABA Agents|gaba agents|mesh-ancestor
25442604|NCT04704440|Sildenafil Citrate|sildenafil citrate|mesh-list
25442605|NCT04704440|Vasodilator Agents|vasodilator agents|mesh-ancestor
25442606|NCT04704440|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25442607|NCT04704440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25442608|NCT04704440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25442609|NCT04704440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442610|NCT04704440|Urological Agents|urological agents|mesh-ancestor
25442611|NCT04704713|Afamelanotide|afamelanotide|mesh-list
25442612|NCT04704713|Dermatologic Agents|dermatologic agents|mesh-ancestor
25442613|NCT04704297|Acetaminophen|acetaminophen|mesh-list
25442614|NCT04704297|Ibuprofen|ibuprofen|mesh-list
25295182|NCT05091242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25295183|NCT05091242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25643678|NCT01429298|Narcotics|narcotics|mesh-ancestor
25295184|NCT05091242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25295185|NCT05091242|Adrenergic Agents|adrenergic agents|mesh-ancestor
25295186|NCT05091242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25643679|NCT01429298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25643680|NCT01429298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643682|NCT01429298|Sensory System Agents|sensory system agents|mesh-ancestor
25295187|NCT05091242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295188|NCT05079854|Moxifloxacin|moxifloxacin|mesh-list
25295189|NCT05079854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25295190|NCT05079854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25295191|NCT05079854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25295192|NCT05079854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25295193|NCT05079854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25295194|NCT05079854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295195|NCT05079854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295196|NCT05073822|Mycophenolic Acid|mycophenolic acid|mesh-list
25295197|NCT05073822|Tacrolimus|tacrolimus|mesh-list
25295198|NCT05073822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25295199|NCT05073822|Immunologic Factors|immunologic factors|mesh-ancestor
25295200|NCT05073822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295201|NCT05073822|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25295202|NCT05073822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25442616|NCT04704297|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25442617|NCT04704297|Amitriptyline|amitriptyline|mesh-list
25442618|NCT04704297|Bupivacaine|bupivacaine|mesh-list
25442619|NCT04704297|Cyclobenzaprine|cyclobenzaprine|mesh-list
25442620|NCT04704297|Anesthetics, Local|anesthetics, local|mesh-ancestor
25442621|NCT04704297|Anesthetics|anesthetics|mesh-ancestor
25442622|NCT04704297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25442623|NCT04704297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442624|NCT04704297|Sensory System Agents|sensory system agents|mesh-ancestor
25442625|NCT04704297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25442626|NCT04704297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25442627|NCT04704297|Analgesics|analgesics|mesh-ancestor
25442628|NCT04704297|Antipyretics|antipyretics|mesh-ancestor
25442629|NCT04704297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25442630|NCT04704297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25442631|NCT04704297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25442632|NCT04704297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25442633|NCT04704297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25442634|NCT04704297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442635|NCT04704297|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25442636|NCT04704297|Antidepressive Agents|antidepressive agents|mesh-ancestor
25442637|NCT04704297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25442638|NCT04704297|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25442639|NCT04704297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25442640|NCT04704297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25442641|NCT04704297|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25442642|NCT04704297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25442643|NCT04704297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25442644|NCT04704297|Adrenergic Agents|adrenergic agents|mesh-ancestor
25442645|NCT04704297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25442646|NCT04704245|Petrolatum|petrolatum|mesh-list
25442647|NCT04704245|Mitogens|mitogens|mesh-list
25442648|NCT04704245|Mitosis Modulators|mitosis modulators|mesh-ancestor
25442649|NCT04704245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442650|NCT04704245|Emollients|emollients|mesh-ancestor
25442651|NCT04704245|Dermatologic Agents|dermatologic agents|mesh-ancestor
25442652|NCT04704141|Hormones|hormones|mesh-list
25442653|NCT04704141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25442654|NCT04704141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442655|NCT04703868|Rabeprazole|rabeprazole|mesh-list
25442656|NCT04703868|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25442657|NCT04703868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25442658|NCT04703868|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25442659|NCT04703868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25442660|NCT04703868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442661|NCT04703803|Lidocaine|lidocaine|mesh-list
25442662|NCT04703803|Anesthetics, Local|anesthetics, local|mesh-ancestor
25442663|NCT04703803|Anesthetics|anesthetics|mesh-ancestor
25442664|NCT04703803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25442665|NCT04703803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442666|NCT04703803|Sensory System Agents|sensory system agents|mesh-ancestor
25442667|NCT04703803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25442668|NCT04703803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24500958|NCT00526305|Tubulin Modulators|tubulin modulators|mesh-ancestor
25643683|NCT01429298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25643684|NCT01429350|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25442669|NCT04703803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25442670|NCT04703803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25442671|NCT04703803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25442672|NCT04703803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442673|NCT04704063|Vitamin E|vitamin e|mesh-list
25442674|NCT04704063|Tocopherols|tocopherols|mesh-list
25442675|NCT04704063|Tocotrienols|tocotrienols|mesh-list
25442676|NCT04704063|Tocovid|tocovid|mesh-list
25442677|NCT04704063|Vitamins|vitamins|mesh-ancestor
25442678|NCT04704063|Micronutrients|micronutrients|mesh-ancestor
25295263|NCT05015335|Adalimumab|adalimumab|mesh-list
25295264|NCT05015335|Methotrexate|methotrexate|mesh-list
25295265|NCT05015335|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25295266|NCT05015335|Abortifacient Agents|abortifacient agents|mesh-ancestor
25295267|NCT05015335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25295268|NCT05015335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295269|NCT05015335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25295270|NCT05015335|Antimetabolites|antimetabolites|mesh-ancestor
25295271|NCT05015335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295272|NCT05015335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295273|NCT05015335|Dermatologic Agents|dermatologic agents|mesh-ancestor
25442679|NCT04704063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442680|NCT04704063|Antioxidants|antioxidants|mesh-ancestor
25442681|NCT04704063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442682|NCT04704063|Protective Agents|protective agents|mesh-ancestor
25442683|NCT04703465|Tenofovir|tenofovir|mesh-list
25442684|NCT04703465|Antiviral Agents|antiviral agents|mesh-ancestor
25442685|NCT04703465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25442686|NCT04703465|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25442687|NCT04703465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25442688|NCT04703465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25442689|NCT04703465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442690|NCT04703465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25442691|NCT04703465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25442692|NCT04703608|Ivermectin|ivermectin|mesh-list
25442693|NCT04703608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25442694|NCT04703608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25442695|NCT04703673|Nasal Decongestants|nasal decongestants|mesh-list
25442696|NCT04703673|Pseudoephedrine|pseudoephedrine|mesh-list
25442697|NCT04703673|Ephedrine|ephedrine|mesh-list
25442698|NCT04703673|Sympathomimetics|sympathomimetics|mesh-list
25442699|NCT04703673|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25442700|NCT04703673|Respiratory System Agents|respiratory system agents|mesh-ancestor
25442701|NCT04703673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25442702|NCT04703673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442703|NCT04703673|Autonomic Agents|autonomic agents|mesh-ancestor
25442704|NCT04703673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25442705|NCT04703673|Adrenergic Agents|adrenergic agents|mesh-ancestor
25442706|NCT04703673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25442707|NCT04703673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442708|NCT04703673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25442709|NCT04703673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25442710|NCT04702906|Trimetazidine|trimetazidine|mesh-list
25442711|NCT04702906|Vasodilator Agents|vasodilator agents|mesh-ancestor
25442712|NCT04703127|Lidocaine|lidocaine|mesh-list
25442713|NCT04703127|Tadalafil|tadalafil|mesh-list
25442714|NCT04703127|Anesthetics, Local|anesthetics, local|mesh-ancestor
25442715|NCT04703127|Anesthetics|anesthetics|mesh-ancestor
25442716|NCT04703127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25442717|NCT04703127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442718|NCT04703127|Sensory System Agents|sensory system agents|mesh-ancestor
25442719|NCT04703127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25442720|NCT04703127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25442721|NCT04703127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25442722|NCT04703127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25442723|NCT04703127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25442724|NCT04703127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501086|NCT00526695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24501087|NCT00526695|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25643685|NCT01429350|Plasminogen|plasminogen|mesh-list
25442725|NCT04703127|Vasodilator Agents|vasodilator agents|mesh-ancestor
25442726|NCT04703127|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25442727|NCT04703127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25643686|NCT01429350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25442728|NCT04703127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25442729|NCT04703127|Urological Agents|urological agents|mesh-ancestor
25442730|NCT04702971|Flunarizine|flunarizine|mesh-list
25442731|NCT04702971|Anticonvulsants|anticonvulsants|mesh-ancestor
25442732|NCT04702971|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25442733|NCT04702971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25442734|NCT04702971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442735|NCT04702971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25442736|NCT04702971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442737|NCT04702971|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25295328|NCT04862468|Hormones|hormones|mesh-ancestor
25295329|NCT04862468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25295330|NCT04862468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25295331|NCT04862468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295332|NCT04828486|Pembrolizumab|pembrolizumab|mesh-list
25295333|NCT04828486|Futibatinib|futibatinib|mesh-list
25295334|NCT04828486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25295335|NCT04828486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295336|NCT04819568|Terlipressin|terlipressin|mesh-list
25295337|NCT04819568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25295338|NCT04819568|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25295339|NCT04818489|Colchicine|colchicine|mesh-list
25295340|NCT04818489|Gout Suppressants|gout suppressants|mesh-ancestor
25295341|NCT04818489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25295354|NCT04765787|Acetaminophen|acetaminophen|mesh-list
25442772|NCT04702490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442773|NCT04702490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25442774|NCT04702490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295408|NCT04638803|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
25295409|NCT04638803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295410|NCT04633772|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
25295411|NCT04633772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25442776|NCT04702048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25442777|NCT04702048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25442778|NCT04702048|Growth Substances|growth substances|mesh-ancestor
25442779|NCT04702048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442780|NCT04702048|Growth Inhibitors|growth inhibitors|mesh-ancestor
25442781|NCT04702048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25442782|NCT04702061|Anesthetics|anesthetics|mesh-list
25442783|NCT04702061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25442784|NCT04702061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442785|NCT04702334|Lidocaine|lidocaine|mesh-list
25442786|NCT04702334|Hyaluronic Acid|hyaluronic acid|mesh-list
25442787|NCT04702334|Anesthetics, Local|anesthetics, local|mesh-ancestor
25442788|NCT04702334|Anesthetics|anesthetics|mesh-ancestor
25442789|NCT04702334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25442790|NCT04702334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442791|NCT04702334|Sensory System Agents|sensory system agents|mesh-ancestor
25442792|NCT04702334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25442793|NCT04702334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25442794|NCT04702334|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25442795|NCT04702334|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25442796|NCT04702334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25442797|NCT04702334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442798|NCT04702334|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25442799|NCT04702334|Immunologic Factors|immunologic factors|mesh-ancestor
25442800|NCT04702334|Viscosupplements|viscosupplements|mesh-ancestor
25442801|NCT04702334|Protective Agents|protective agents|mesh-ancestor
25442802|NCT04702360|Ivacaftor|ivacaftor|mesh-list
25442803|NCT04702360|Elexacaftor|elexacaftor|mesh-list
25442804|NCT04702360|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25442805|NCT04702360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25442806|NCT04702360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442807|NCT04702204|Denosumab|denosumab|mesh-list
25442808|NCT04702204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25442809|NCT04702204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442810|NCT04702009|Antibodies|antibodies|mesh-list
25442811|NCT04702009|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25442812|NCT04702009|Immunologic Factors|immunologic factors|mesh-ancestor
25442813|NCT04702009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442814|NCT04701606|Artesunate|artesunate|mesh-list
25442815|NCT04701606|Pyronaridine|pyronaridine|mesh-list
25442816|NCT04701606|Antimalarials|antimalarials|mesh-ancestor
25442817|NCT04701606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25442818|NCT04701606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25442819|NCT04701606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25442820|NCT04701606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25442821|NCT04701606|Antiviral Agents|antiviral agents|mesh-ancestor
25442822|NCT04701606|Schistosomicides|schistosomicides|mesh-ancestor
25442823|NCT04701606|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25442824|NCT04701606|Anthelmintics|anthelmintics|mesh-ancestor
25442825|NCT04701710|Ivermectin|ivermectin|mesh-list
25442826|NCT04701710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25442827|NCT04701710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25442828|NCT04701528|Tacrolimus|tacrolimus|mesh-list
25442829|NCT04701528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25442830|NCT04701528|Immunologic Factors|immunologic factors|mesh-ancestor
25442831|NCT04701528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295479|NCT04526197|Antimetabolites|antimetabolites|mesh-ancestor
25295480|NCT04526197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25295481|NCT04526197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25295482|NCT04526197|Nootropic Agents|nootropic agents|mesh-ancestor
25295483|NCT04526197|Chelating Agents|chelating agents|mesh-ancestor
25295484|NCT04526197|Sequestering Agents|sequestering agents|mesh-ancestor
25295485|NCT04526197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25295486|NCT04526197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25295487|NCT04526197|Growth Substances|growth substances|mesh-ancestor
25295488|NCT04526197|Growth Inhibitors|growth inhibitors|mesh-ancestor
25295489|NCT04526197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295490|NCT04511013|Nivolumab|nivolumab|mesh-list
25295491|NCT04511013|Ipilimumab|ipilimumab|mesh-list
25295492|NCT04511013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25295493|NCT04511013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295494|NCT04511013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25295495|NCT04511013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295496|NCT04468230|Nicotine|nicotine|mesh-list
25295497|NCT04468230|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25442832|NCT04701528|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25442833|NCT04701528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451327|NCT00323206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442834|NCT04701528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442835|NCT04701463|Calcium|calcium|mesh-list
25442836|NCT04701463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25442837|NCT04701463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442838|NCT04701307|Niraparib|niraparib|mesh-list
25442839|NCT04701307|Immunoglobulins|immunoglobulins|mesh-list
25442840|NCT04701307|Immunoglobulin G|immunoglobulin g|mesh-list
25442841|NCT04701307|Immunologic Factors|immunologic factors|mesh-ancestor
25442842|NCT04701307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442843|NCT04701307|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25442844|NCT04701307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25442845|NCT04701307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442846|NCT04701307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25442847|NCT04701242|Ezetimibe|ezetimibe|mesh-list
25442848|NCT04701242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25442849|NCT04701242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25442850|NCT04701242|Antimetabolites|antimetabolites|mesh-ancestor
25442851|NCT04701242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442852|NCT04701242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25442853|NCT04701320|Methamphetamine|methamphetamine|mesh-list
25442854|NCT04701320|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25442855|NCT04701320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442856|NCT04701320|Sympathomimetics|sympathomimetics|mesh-ancestor
25442857|NCT04701320|Autonomic Agents|autonomic agents|mesh-ancestor
25442858|NCT04701320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25442859|NCT04701320|Dopamine Agents|dopamine agents|mesh-ancestor
25442860|NCT04701320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25442861|NCT04701320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442862|NCT04701320|Adrenergic Agents|adrenergic agents|mesh-ancestor
25442863|NCT04701320|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25442864|NCT04701320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25442865|NCT04701320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25442866|NCT04701320|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25442867|NCT04700826|Rivaroxaban|rivaroxaban|mesh-list
25442868|NCT04700826|Apixaban|apixaban|mesh-list
25442869|NCT04700826|Edoxaban|edoxaban|mesh-list
25442870|NCT04700826|Dabigatran|dabigatran|mesh-list
25442871|NCT04700826|Anticoagulants|anticoagulants|mesh-list
25442872|NCT04700826|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25643687|NCT01429350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25442873|NCT04700826|Antithrombins|antithrombins|mesh-ancestor
25442874|NCT04700826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25442875|NCT04700826|Protease Inhibitors|protease inhibitors|mesh-ancestor
25442876|NCT04700826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25442877|NCT04700826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442878|NCT04700670|Platelet Factor 4|platelet factor 4|mesh-list
25442879|NCT04700670|Coagulants|coagulants|mesh-ancestor
25442880|NCT04700592|Ketamine|ketamine|mesh-list
25442881|NCT04700592|Gabapentin|gabapentin|mesh-list
25442882|NCT04700592|Analgesics|analgesics|mesh-ancestor
25442883|NCT04700592|Sensory System Agents|sensory system agents|mesh-ancestor
25442884|NCT04700592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25442885|NCT04700592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442886|NCT04700592|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25442887|NCT04700592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25442888|NCT04700592|Anesthetics, General|anesthetics, general|mesh-ancestor
25442889|NCT04700592|Anesthetics|anesthetics|mesh-ancestor
25442890|NCT04700592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25442891|NCT04700592|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25442892|NCT04700592|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25442893|NCT04700592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25442894|NCT04700592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442895|NCT04700592|Anticonvulsants|anticonvulsants|mesh-ancestor
25442896|NCT04700592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25442897|NCT04700592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25442898|NCT04700592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25442899|NCT04700592|Antimanic Agents|antimanic agents|mesh-ancestor
25442900|NCT04700943|Anesthetics|anesthetics|mesh-list
25442901|NCT04700943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25442902|NCT04700943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442903|NCT04700709|Mycophenolic Acid|mycophenolic acid|mesh-list
25442904|NCT04700709|Sirolimus|sirolimus|mesh-list
25295558|NCT04418895|Micronutrients|micronutrients|mesh-ancestor
25295559|NCT04414631|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25295560|NCT04414631|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25442905|NCT04700709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25442906|NCT04700709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25442907|NCT04700709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25442908|NCT04700709|Antitubercular Agents|antitubercular agents|mesh-ancestor
25442909|NCT04700709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25442910|NCT04700709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25442911|NCT04700709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25442912|NCT04700709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442913|NCT04700709|Antifungal Agents|antifungal agents|mesh-ancestor
25442914|NCT04700709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25442915|NCT04700709|Immunologic Factors|immunologic factors|mesh-ancestor
25442916|NCT04700709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442918|NCT04700475|Sodium Citrate|sodium citrate|mesh-list
25442919|NCT04700475|Anticoagulants|anticoagulants|mesh-ancestor
25442920|NCT04700475|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25442921|NCT04700475|Chelating Agents|chelating agents|mesh-ancestor
25442922|NCT04700475|Sequestering Agents|sequestering agents|mesh-ancestor
25442923|NCT04700475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442924|NCT04700436|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25442925|NCT04700436|Ezetimibe|ezetimibe|mesh-list
25442926|NCT04700436|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25442927|NCT04700436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25442928|NCT04700436|Antimetabolites|antimetabolites|mesh-ancestor
25442929|NCT04700436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442930|NCT04700436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25442931|NCT04700436|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25442932|NCT04700436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25442933|NCT04700228|Dexmedetomidine|dexmedetomidine|mesh-list
25442934|NCT04700228|Bupivacaine|bupivacaine|mesh-list
25442935|NCT04700228|Anesthetics, Local|anesthetics, local|mesh-ancestor
25442936|NCT04700228|Anesthetics|anesthetics|mesh-ancestor
25442937|NCT04700228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25442938|NCT04700228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442939|NCT04700228|Sensory System Agents|sensory system agents|mesh-ancestor
25442940|NCT04700228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25442941|NCT04700228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25442942|NCT04700228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25442943|NCT04700228|Analgesics|analgesics|mesh-ancestor
25442944|NCT04700228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25442945|NCT04700228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25442946|NCT04700228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25442947|NCT04700228|Adrenergic Agents|adrenergic agents|mesh-ancestor
25643688|NCT01429350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643689|NCT01429584|Bupivacaine|bupivacaine|mesh-list
25643690|NCT01429584|Anesthetics, Local|anesthetics, local|mesh-ancestor
25643691|NCT01429584|Anesthetics|anesthetics|mesh-ancestor
25643692|NCT01429584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25442948|NCT04700228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25442949|NCT04700228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442950|NCT04700397|Nitroglycerin|nitroglycerin|mesh-list
25442951|NCT04700397|Vasodilator Agents|vasodilator agents|mesh-ancestor
25442952|NCT04700046|Mexiletine|mexiletine|mesh-list
25442953|NCT04700046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25442954|NCT04700046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25442955|NCT04700046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25720091|NCT02462473|Dopamine Agents|dopamine agents|mesh-ancestor
25442956|NCT04700046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25442957|NCT04700046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25442958|NCT04699643|Pembrolizumab|pembrolizumab|mesh-list
25442959|NCT04699643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25442960|NCT04699643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25442961|NCT04699903|Antibodies|antibodies|mesh-list
25442962|NCT04699903|Immunoglobulin G|immunoglobulin g|mesh-list
25442963|NCT04699903|Immunologic Factors|immunologic factors|mesh-ancestor
25442964|NCT04699903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442965|NCT04699734|Lidocaine|lidocaine|mesh-list
25442966|NCT04699734|Anesthetics, Local|anesthetics, local|mesh-ancestor
25442967|NCT04699734|Anesthetics|anesthetics|mesh-ancestor
25295633|NCT04299490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295634|NCT04299490|Sensory System Agents|sensory system agents|mesh-ancestor
25295635|NCT04299490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25295636|NCT04299373|Ethanol|ethanol|mesh-list
25295637|NCT04299373|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25295638|NCT04299373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25295639|NCT04299373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25295640|NCT04299373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822835|NCT00004685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25822836|NCT00004685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822837|NCT00004685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25442989|NCT04699214|Endostatins|endostatins|mesh-list
25442990|NCT04699214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25442991|NCT04699214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25442992|NCT04699214|Growth Substances|growth substances|mesh-ancestor
25442993|NCT04699214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25442994|NCT04699214|Growth Inhibitors|growth inhibitors|mesh-ancestor
25442995|NCT04699214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25442996|NCT04698941|Paclitaxel|paclitaxel|mesh-list
25442997|NCT04698941|Simvastatin|simvastatin|mesh-list
25442998|NCT04698941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25442999|NCT04698941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443000|NCT04698941|Tubulin Modulators|tubulin modulators|mesh-ancestor
25443001|NCT04698941|Antimitotic Agents|antimitotic agents|mesh-ancestor
25443002|NCT04698941|Mitosis Modulators|mitosis modulators|mesh-ancestor
25443003|NCT04698941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443004|NCT04698941|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25443005|NCT04698941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25443006|NCT04698941|Antimetabolites|antimetabolites|mesh-ancestor
25443007|NCT04698941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25443008|NCT04698941|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25443009|NCT04698941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25443010|NCT04699058|Antibodies|antibodies|mesh-list
25443011|NCT04699058|Immunologic Factors|immunologic factors|mesh-ancestor
25443012|NCT04699058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443013|NCT04699110|Adenosine|adenosine|mesh-list
25443014|NCT04699110|Epinephrine|epinephrine|mesh-list
25443015|NCT04699110|Racepinephrine|racepinephrine|mesh-list
25443016|NCT04699110|Epinephryl borate|epinephryl borate|mesh-list
25443017|NCT04699110|Analgesics|analgesics|mesh-ancestor
25443018|NCT04699110|Sensory System Agents|sensory system agents|mesh-ancestor
25443019|NCT04699110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25443020|NCT04699110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443021|NCT04699110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25443022|NCT04699110|Vasodilator Agents|vasodilator agents|mesh-ancestor
25443023|NCT04699110|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25443024|NCT04699110|Purinergic Agonists|purinergic agonists|mesh-ancestor
25443025|NCT04699110|Purinergic Agents|purinergic agents|mesh-ancestor
25443026|NCT04699110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25443027|NCT04699110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443028|NCT04699110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25443029|NCT04699110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25443030|NCT04699110|Adrenergic Agents|adrenergic agents|mesh-ancestor
25443031|NCT04699110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25643693|NCT01429584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643694|NCT01429584|Sensory System Agents|sensory system agents|mesh-ancestor
25643695|NCT01429584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25643696|NCT01429792|Ribavirin|ribavirin|mesh-list
25643697|NCT01429792|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25643698|NCT01429792|Antimetabolites|antimetabolites|mesh-ancestor
25643699|NCT01429792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643700|NCT01429792|Antiviral Agents|antiviral agents|mesh-ancestor
25643701|NCT01429792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25643702|NCT01429987|Plecanatide|plecanatide|mesh-list
25643703|NCT01429987|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25643704|NCT01429987|Enzyme Activators|enzyme activators|mesh-ancestor
25443032|NCT04699110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25443033|NCT04699110|Autonomic Agents|autonomic agents|mesh-ancestor
25443034|NCT04699110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25443035|NCT04699110|Respiratory System Agents|respiratory system agents|mesh-ancestor
25443036|NCT04699110|Mydriatics|mydriatics|mesh-ancestor
25443037|NCT04699110|Sympathomimetics|sympathomimetics|mesh-ancestor
25443038|NCT04699110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25443039|NCT04699097|Azithromycin|azithromycin|mesh-list
25443040|NCT04699097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25443041|NCT04699097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25443042|NCT04699279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25443043|NCT04699279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25443044|NCT04699279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25443045|NCT04699279|Antimetabolites|antimetabolites|mesh-ancestor
25443046|NCT04699279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443047|NCT04699279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25443048|NCT04699279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25443049|NCT04699279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25443050|NCT04698746|Anesthetics|anesthetics|mesh-list
25443051|NCT04698746|Anesthetics, Local|anesthetics, local|mesh-list
25443052|NCT04698746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25443053|NCT04698746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443054|NCT04698746|Sensory System Agents|sensory system agents|mesh-ancestor
25443055|NCT04698746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25443056|NCT04698772|Ketamine|ketamine|mesh-list
25443057|NCT04698772|Morphine|morphine|mesh-list
25443058|NCT04698772|Analgesics|analgesics|mesh-ancestor
25443059|NCT04698772|Sensory System Agents|sensory system agents|mesh-ancestor
25443060|NCT04698772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25443061|NCT04698772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295781|NCT03943901|Tubulin Modulators|tubulin modulators|mesh-ancestor
25295782|NCT03943901|Antimitotic Agents|antimitotic agents|mesh-ancestor
25443062|NCT04698772|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25443063|NCT04698772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25443064|NCT04698772|Anesthetics, General|anesthetics, general|mesh-ancestor
25443065|NCT04698772|Anesthetics|anesthetics|mesh-ancestor
25443066|NCT04698772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25443067|NCT04698772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25443068|NCT04698772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25443069|NCT04698772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25443070|NCT04698772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443071|NCT04698772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25443072|NCT04698772|Narcotics|narcotics|mesh-ancestor
25443073|NCT04698512|Sirolimus|sirolimus|mesh-list
25443074|NCT04698512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25443075|NCT04698512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25443076|NCT04698512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25443077|NCT04698512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443078|NCT04698512|Antifungal Agents|antifungal agents|mesh-ancestor
25443079|NCT04698512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25443080|NCT04698512|Immunologic Factors|immunologic factors|mesh-ancestor
25443081|NCT04698512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443082|NCT04698213|Avelumab|avelumab|mesh-list
25443083|NCT04698213|Axitinib|axitinib|mesh-list
25164258|NCT05416658|Antipsychotic Agents|antipsychotic agents|mesh-list
25164259|NCT05416658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25164260|NCT05416658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25164261|NCT05416658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164262|NCT05416658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25164276|NCT05414487|Ofatumumab|ofatumumab|mesh-list
25643705|NCT01429987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643706|NCT01429987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25643707|NCT01430091|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25443084|NCT04698213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25643708|NCT01430091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25822838|NCT00004685|Respiratory System Agents|respiratory system agents|mesh-ancestor
25443085|NCT04698213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443086|NCT04698213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25443087|NCT04698213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25443088|NCT04698213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443089|NCT04698317|Mitogens|mitogens|mesh-list
25443090|NCT04698317|Mitosis Modulators|mitosis modulators|mesh-ancestor
25443091|NCT04698317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443092|NCT04697992|Vitamins|vitamins|mesh-list
25443093|NCT04697992|Ascorbic Acid|ascorbic acid|mesh-list
25443094|NCT04697992|Tranexamic Acid|tranexamic acid|mesh-list
25443095|NCT04697992|Micronutrients|micronutrients|mesh-ancestor
25443096|NCT04697992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443097|NCT04697992|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25443098|NCT04697992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25443099|NCT04697992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443100|NCT04697992|Hemostatics|hemostatics|mesh-ancestor
25443101|NCT04697992|Coagulants|coagulants|mesh-ancestor
25443102|NCT04697992|Antioxidants|antioxidants|mesh-ancestor
25443103|NCT04697992|Protective Agents|protective agents|mesh-ancestor
25443104|NCT04697862|Sildenafil Citrate|sildenafil citrate|mesh-list
25443105|NCT04697862|Vasodilator Agents|vasodilator agents|mesh-ancestor
25443106|NCT04697862|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25443107|NCT04697862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25443108|NCT04697862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25443109|NCT04697862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443110|NCT04697862|Urological Agents|urological agents|mesh-ancestor
25443111|NCT04697641|Amoxicillin|amoxicillin|mesh-list
25443112|NCT04697641|Clarithromycin|clarithromycin|mesh-list
25443113|NCT04697641|Pantoprazole|pantoprazole|mesh-list
25443114|NCT04697641|Z 338|z 338|mesh-list
25443115|NCT04697641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25443116|NCT04697641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25443117|NCT04697641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25443118|NCT04697641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25443119|NCT04697641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443120|NCT04697641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25295857|NCT03678025|Fertility Agents|fertility agents|mesh-ancestor
25295858|NCT03678025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25295859|NCT03678025|Androgen Antagonists|androgen antagonists|mesh-ancestor
25295860|NCT03678025|Hormone Antagonists|hormone antagonists|mesh-ancestor
25295861|NCT03678025|Luteolytic Agents|luteolytic agents|mesh-ancestor
25295862|NCT03678025|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25295863|NCT03678025|Contraceptive Agents|contraceptive agents|mesh-ancestor
25093516|NCT03234699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25822839|NCT00004685|Tocolytic Agents|tocolytic agents|mesh-ancestor
25295864|NCT03678025|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25295865|NCT03678025|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25295866|NCT03678025|Antidepressive Agents|antidepressive agents|mesh-ancestor
25295867|NCT03678025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25295868|NCT03631784|Paclitaxel|paclitaxel|mesh-list
25295869|NCT03631784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25295870|NCT03631784|Carboplatin|carboplatin|mesh-list
25443124|NCT04697641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25443125|NCT04697641|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25443126|NCT04697641|Cholinergic Agents|cholinergic agents|mesh-ancestor
25443127|NCT04697641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25720122|NCT02463097|Insulin|insulin|mesh-list
25443128|NCT04697641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443129|NCT04697732|Anesthetics|anesthetics|mesh-list
25443130|NCT04697732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25443131|NCT04697732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443132|NCT04697537|Dexmedetomidine|dexmedetomidine|mesh-list
25443133|NCT04697537|Ropivacaine|ropivacaine|mesh-list
25443134|NCT04697537|Anesthetics|anesthetics|mesh-ancestor
25443135|NCT04697537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25443136|NCT04697537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443137|NCT04697537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25443138|NCT04697537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25443139|NCT04697537|Analgesics|analgesics|mesh-ancestor
25643710|NCT01430104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25643711|NCT01430104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643712|NCT01430104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25643714|NCT01430182|Methadone|methadone|mesh-list
25643715|NCT01430182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25643716|NCT01430182|Narcotics|narcotics|mesh-ancestor
25643717|NCT01430182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25643718|NCT01430182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643719|NCT01430182|Analgesics|analgesics|mesh-ancestor
25643720|NCT01430182|Sensory System Agents|sensory system agents|mesh-ancestor
25643721|NCT01430182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25643722|NCT01430182|Antitussive Agents|antitussive agents|mesh-ancestor
25643723|NCT01430182|Respiratory System Agents|respiratory system agents|mesh-ancestor
25643724|NCT01430403|Fluticasone|fluticasone|mesh-list
25443140|NCT04697537|Sensory System Agents|sensory system agents|mesh-ancestor
25443141|NCT04697537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25443142|NCT04697537|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25443143|NCT04697537|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25443144|NCT04697537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25443145|NCT04697537|Adrenergic Agents|adrenergic agents|mesh-ancestor
25443146|NCT04697537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25443147|NCT04697537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443148|NCT04697537|Anesthetics, Local|anesthetics, local|mesh-ancestor
25443149|NCT04697745|Dexamethasone|dexamethasone|mesh-list
25443150|NCT04697745|Dexmedetomidine|dexmedetomidine|mesh-list
25443151|NCT04697745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25443152|NCT04697745|Antiemetics|antiemetics|mesh-ancestor
25443153|NCT04697745|Autonomic Agents|autonomic agents|mesh-ancestor
25443154|NCT04697745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25443155|NCT04697745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443156|NCT04697745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25443157|NCT04697745|Glucocorticoids|glucocorticoids|mesh-ancestor
25443158|NCT04697745|Hormones|hormones|mesh-ancestor
25443159|NCT04697745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25443160|NCT04697745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25443161|NCT04697745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443162|NCT04697745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25443163|NCT04697745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25443164|NCT04697745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25443165|NCT04697745|Analgesics|analgesics|mesh-ancestor
25443166|NCT04697745|Sensory System Agents|sensory system agents|mesh-ancestor
25443167|NCT04697745|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25443168|NCT04697745|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25443169|NCT04697745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25443170|NCT04697745|Adrenergic Agents|adrenergic agents|mesh-ancestor
25443171|NCT04697745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25443172|NCT04697745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443173|NCT04697511|Midazolam|midazolam|mesh-list
25443174|NCT04697511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25443175|NCT04697511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25720127|NCT02463331|Prednisone|prednisone|mesh-list
25443176|NCT04697511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25443177|NCT04697511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443178|NCT04697511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25443179|NCT04697511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25443180|NCT04697511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25443181|NCT04697511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25443182|NCT04697511|Anesthetics, General|anesthetics, general|mesh-ancestor
25443183|NCT04697511|Anesthetics|anesthetics|mesh-ancestor
25443184|NCT04697511|GABA Modulators|gaba modulators|mesh-ancestor
25443185|NCT04697511|GABA Agents|gaba agents|mesh-ancestor
25295931|NCT03452826|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25295932|NCT03452826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25295933|NCT03452826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25295934|NCT03452826|Antitubercular Agents|antitubercular agents|mesh-ancestor
25295935|NCT03418961|Carvedilol|carvedilol|mesh-list
25295936|NCT03418961|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25443186|NCT04697511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25443205|NCT04696939|Carboplatin|carboplatin|mesh-list
25443206|NCT04696939|Etoposide|etoposide|mesh-list
25443207|NCT04696939|Atezolizumab|atezolizumab|mesh-list
25443208|NCT04696939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443209|NCT04696939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25443210|NCT04696939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25643725|NCT01430403|Xhance|xhance|mesh-list
25443211|NCT04696939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25443212|NCT04696939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25443213|NCT04696939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443214|NCT04697186|Amoxicillin|amoxicillin|mesh-list
25443215|NCT04697186|Clarithromycin|clarithromycin|mesh-list
25443216|NCT04697186|Rabeprazole|rabeprazole|mesh-list
25443217|NCT04697186|Bismuth|bismuth|mesh-list
25443218|NCT04697186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25443219|NCT04697186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25443220|NCT04697186|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25443221|NCT04697186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25443222|NCT04697186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443223|NCT04697186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25443224|NCT04697186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25443225|NCT04697186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25443226|NCT04697186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25443227|NCT04697186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25443228|NCT04697186|Antacids|antacids|mesh-ancestor
25443229|NCT04696848|Durvalumab|durvalumab|mesh-list
25443230|NCT04696848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25443231|NCT04696848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443232|NCT04696666|Hyaluronic Acid|hyaluronic acid|mesh-list
25443233|NCT04696666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25443234|NCT04696666|Immunologic Factors|immunologic factors|mesh-ancestor
25443235|NCT04696666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443236|NCT04696666|Viscosupplements|viscosupplements|mesh-ancestor
25443237|NCT04696666|Protective Agents|protective agents|mesh-ancestor
25443238|NCT04696783|Esomeprazole|esomeprazole|mesh-list
25443239|NCT04696783|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25443240|NCT04696783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25443241|NCT04696783|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25443242|NCT04696783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25443243|NCT04696783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443244|NCT04696523|Xenon|xenon|mesh-list
25443245|NCT04696523|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25443246|NCT04696523|Anesthetics, General|anesthetics, general|mesh-ancestor
25443247|NCT04696523|Anesthetics|anesthetics|mesh-ancestor
25443248|NCT04696523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25443249|NCT04696523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443250|NCT04696224|Tranexamic Acid|tranexamic acid|mesh-list
25443251|NCT04696224|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25443252|NCT04696224|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25443253|NCT04696224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443254|NCT04696224|Hemostatics|hemostatics|mesh-ancestor
25443255|NCT04696224|Coagulants|coagulants|mesh-ancestor
25443256|NCT04696250|Antineoplastic Agents|antineoplastic agents|mesh-list
25443257|NCT04696536|Listerine|listerine|mesh-list
25443258|NCT04696536|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25443259|NCT04696536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25443260|NCT04696185|Dapagliflozin|dapagliflozin|mesh-list
25443261|NCT04696185|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25443262|NCT04696185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443263|NCT04696185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25443264|NCT04696185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443265|NCT04695925|Carboplatin|carboplatin|mesh-list
25443266|NCT04695925|Pemetrexed|pemetrexed|mesh-list
25443267|NCT04695925|Osimertinib|osimertinib|mesh-list
25443268|NCT04695925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443269|NCT04695925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25443270|NCT04695925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443271|NCT04695925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25443272|NCT04695925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25443273|NCT04695925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25443274|NCT04696120|Apixaban|apixaban|mesh-list
25443275|NCT04696120|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25443276|NCT04696120|Antithrombins|antithrombins|mesh-ancestor
25443277|NCT04696120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25443278|NCT04696120|Protease Inhibitors|protease inhibitors|mesh-ancestor
25443279|NCT04696120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25296085|NCT02680561|Hormones|hormones|mesh-ancestor
25443280|NCT04696120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443281|NCT04696120|Anticoagulants|anticoagulants|mesh-ancestor
25443282|NCT04695613|Magnesium Sulfate|magnesium sulfate|mesh-list
25443283|NCT04695613|Analgesics|analgesics|mesh-ancestor
25443284|NCT04695613|Sensory System Agents|sensory system agents|mesh-ancestor
25443285|NCT04695613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25643726|NCT01430403|Omalizumab|omalizumab|mesh-list
25643727|NCT01430403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25643728|NCT01430403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25643729|NCT01430403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25643731|NCT01430403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25643732|NCT01430403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643733|NCT01430403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25443286|NCT04695613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443287|NCT04695613|Anesthetics|anesthetics|mesh-ancestor
25443288|NCT04695613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25443289|NCT04695613|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25443290|NCT04695613|Anticonvulsants|anticonvulsants|mesh-ancestor
25443291|NCT04695613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25720150|NCT02463331|Antimetabolites|antimetabolites|mesh-ancestor
25443292|NCT04695613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25443293|NCT04695613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443294|NCT04695613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25443295|NCT04695613|Tocolytic Agents|tocolytic agents|mesh-ancestor
25443296|NCT04695613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25443297|NCT04695600|Botulinum Toxins|botulinum toxins|mesh-list
25443298|NCT04695600|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25443299|NCT04695600|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25443300|NCT04695600|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25443301|NCT04695600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25443302|NCT04695600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443303|NCT04695600|Cholinergic Agents|cholinergic agents|mesh-ancestor
25443304|NCT04695600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25443305|NCT04695600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443306|NCT04695600|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25443307|NCT04695600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25443308|NCT04695483|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25443309|NCT04695483|Hormones|hormones|mesh-ancestor
25443310|NCT04695483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25443311|NCT04695483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443312|NCT04695509|Propofol|propofol|mesh-list
25443313|NCT04695509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25443314|NCT04695509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25443315|NCT04695509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443316|NCT04695509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25443317|NCT04695509|Anesthetics, General|anesthetics, general|mesh-ancestor
25443318|NCT04695509|Anesthetics|anesthetics|mesh-ancestor
25443319|NCT04695197|Artesunate|artesunate|mesh-list
25443320|NCT04695197|Lumefantrine|lumefantrine|mesh-list
25443321|NCT04695197|Artemether|artemether|mesh-list
25443322|NCT04695197|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25443323|NCT04695197|Pyronaridine|pyronaridine|mesh-list
25443324|NCT04695197|Antimalarials|antimalarials|mesh-ancestor
25443325|NCT04695197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25443326|NCT04695197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25443327|NCT04695197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25443328|NCT04695197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443329|NCT04695197|Antiviral Agents|antiviral agents|mesh-ancestor
25443330|NCT04695197|Schistosomicides|schistosomicides|mesh-ancestor
25443331|NCT04695197|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25443332|NCT04695197|Anthelmintics|anthelmintics|mesh-ancestor
25443333|NCT04695223|Arsenic Trioxide|arsenic trioxide|mesh-list
25443334|NCT04695223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443335|NCT04694612|Remdesivir|remdesivir|mesh-list
25443336|NCT04694612|Favipiravir|favipiravir|mesh-list
25296141|NCT02384577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25296142|NCT02384577|Autonomic Agents|autonomic agents|mesh-ancestor
25296143|NCT02384577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25296144|NCT02384577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296145|NCT02384577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25296146|NCT02384577|Respiratory System Agents|respiratory system agents|mesh-ancestor
25296147|NCT02384577|Glucocorticoids|glucocorticoids|mesh-ancestor
25296148|NCT02384577|Hormones|hormones|mesh-ancestor
25296149|NCT02384577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25296150|NCT02384577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25296151|NCT02384577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25296152|NCT02384577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24502786|NCT04447040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502787|NCT04416984|Cyclophosphamide|cyclophosphamide|mesh-list
24502788|NCT04416984|Fludarabine|fludarabine|mesh-list
24502789|NCT04416984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25643734|NCT01430403|Respiratory System Agents|respiratory system agents|mesh-ancestor
25643735|NCT01430403|Dermatologic Agents|dermatologic agents|mesh-ancestor
25643736|NCT01430403|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25643737|NCT01430403|Immunologic Factors|immunologic factors|mesh-ancestor
25643738|NCT01430442|Sumatriptan|sumatriptan|mesh-list
25643739|NCT01430442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25643740|NCT01430442|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25643741|NCT01430442|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25643742|NCT01430442|Serotonin Agents|serotonin agents|mesh-ancestor
25296153|NCT02384577|Adrenergic Agents|adrenergic agents|mesh-ancestor
25296154|NCT02384577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25296155|NCT02384577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296156|NCT02203474|Tiotropium Bromide|tiotropium bromide|mesh-list
25296157|NCT02203474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25296158|NCT02203474|Autonomic Agents|autonomic agents|mesh-ancestor
25296168|NCT02092571|Progesterone|progesterone|mesh-list
25443341|NCT04694586|Rifampin|rifampin|mesh-list
25443342|NCT04694586|Isoniazid|isoniazid|mesh-list
25443343|NCT04694586|Pyrazinamide|pyrazinamide|mesh-list
25443344|NCT04694586|Ethambutol|ethambutol|mesh-list
25443345|NCT04694586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25443346|NCT04694586|Antitubercular Agents|antitubercular agents|mesh-ancestor
25443347|NCT04694586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25443348|NCT04694586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25443349|NCT04694586|Leprostatic Agents|leprostatic agents|mesh-ancestor
25443350|NCT04694586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25443351|NCT04694586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25443352|NCT04694586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443353|NCT04694586|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25443354|NCT04694586|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25443355|NCT04694586|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25443356|NCT04694586|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25443357|NCT04694586|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25443358|NCT04694586|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25443359|NCT04694586|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25443360|NCT04694586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25443361|NCT04694586|Antimetabolites|antimetabolites|mesh-ancestor
25443362|NCT04694586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25443363|NCT04694677|Misoprostol|misoprostol|mesh-list
25443364|NCT04694677|Tranexamic Acid|tranexamic acid|mesh-list
25443365|NCT04694677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25443366|NCT04694677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25443367|NCT04694677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443368|NCT04694677|Hemostatics|hemostatics|mesh-ancestor
25443369|NCT04694677|Coagulants|coagulants|mesh-ancestor
25443370|NCT04694677|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25443371|NCT04694677|Abortifacient Agents|abortifacient agents|mesh-ancestor
25443372|NCT04694677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25443373|NCT04694677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443374|NCT04694677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25443375|NCT04694677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25443376|NCT04694677|Oxytocics|oxytocics|mesh-ancestor
25443377|NCT04694183|Paclitaxel|paclitaxel|mesh-list
25443378|NCT04694183|Antibodies|antibodies|mesh-list
25443379|NCT04694183|Immunoglobulins|immunoglobulins|mesh-list
25443380|NCT04694183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25443381|NCT04694183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443382|NCT04694183|Tubulin Modulators|tubulin modulators|mesh-ancestor
25443383|NCT04694183|Antimitotic Agents|antimitotic agents|mesh-ancestor
25443384|NCT04694183|Mitosis Modulators|mitosis modulators|mesh-ancestor
25443385|NCT04694183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443386|NCT04694183|Immunologic Factors|immunologic factors|mesh-ancestor
25443387|NCT04694183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443388|NCT04694404|Oxaliplatin|oxaliplatin|mesh-list
25443389|NCT04694404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443390|NCT04694092|Landiolol|landiolol|mesh-list
25443391|NCT04694092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25443392|NCT04694092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25443393|NCT04694092|Adrenergic Agents|adrenergic agents|mesh-ancestor
25443394|NCT04694092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25443395|NCT04694092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443396|NCT04694092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443397|NCT04694092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25443398|NCT04694300|Acetaminophen|acetaminophen|mesh-list
25443399|NCT04694300|Naproxen|naproxen|mesh-list
25443400|NCT04694300|Tramadol|tramadol|mesh-list
25643743|NCT01430442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25643744|NCT01430442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643745|NCT01430442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443401|NCT04694300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25443402|NCT04694300|Analgesics|analgesics|mesh-ancestor
25443403|NCT04694300|Sensory System Agents|sensory system agents|mesh-ancestor
25443404|NCT04694300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25443405|NCT04694300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443406|NCT04694300|Antipyretics|antipyretics|mesh-ancestor
25443407|NCT04694300|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25443408|NCT04694300|Narcotics|narcotics|mesh-ancestor
25443409|NCT04694300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25443410|NCT04694300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25443411|NCT04694300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25296288|NCT05117957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25296289|NCT05117957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25296290|NCT05117957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296291|NCT05117866|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25296298|NCT05117125|Heparin|heparin|mesh-list
25443412|NCT04694300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25443413|NCT04694300|Gout Suppressants|gout suppressants|mesh-ancestor
25443414|NCT04694300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25443415|NCT04694300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25443416|NCT04694300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443417|NCT04694105|Dexamethasone|dexamethasone|mesh-list
25443418|NCT04694105|Dexmedetomidine|dexmedetomidine|mesh-list
25443419|NCT04694105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25443420|NCT04694105|Antiemetics|antiemetics|mesh-ancestor
25443421|NCT04694105|Autonomic Agents|autonomic agents|mesh-ancestor
25443422|NCT04694105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25443423|NCT04694105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443424|NCT04694105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25443425|NCT04694105|Glucocorticoids|glucocorticoids|mesh-ancestor
25443427|NCT04694105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25443428|NCT04694105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25443429|NCT04694105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443430|NCT04694105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25443431|NCT04694105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25443432|NCT04694105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25443433|NCT04694105|Analgesics|analgesics|mesh-ancestor
25443434|NCT04694105|Sensory System Agents|sensory system agents|mesh-ancestor
25443435|NCT04694105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25443436|NCT04694105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25443437|NCT04694105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25443438|NCT04694105|Adrenergic Agents|adrenergic agents|mesh-ancestor
25443439|NCT04694105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25443440|NCT04694105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443441|NCT04693910|Hormones|hormones|mesh-list
25443442|NCT04693910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25443443|NCT04693910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443444|NCT04693897|Solifenacin Succinate|solifenacin succinate|mesh-list
25443445|NCT04693897|Mirabegron|mirabegron|mesh-list
25443446|NCT04693897|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25443447|NCT04693897|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25443448|NCT04693897|Cholinergic Agents|cholinergic agents|mesh-ancestor
25443449|NCT04693897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25443450|NCT04693897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443451|NCT04693897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443452|NCT04693897|Urological Agents|urological agents|mesh-ancestor
25443453|NCT04693897|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25443454|NCT04693897|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25443455|NCT04693897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25443456|NCT04693897|Adrenergic Agents|adrenergic agents|mesh-ancestor
25443457|NCT04693962|Mitogens|mitogens|mesh-list
25443458|NCT04693962|Mitosis Modulators|mitosis modulators|mesh-ancestor
25443459|NCT04693962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443460|NCT04693312|Methylprednisolone|methylprednisolone|mesh-list
25443461|NCT04693312|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25443462|NCT04693312|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25443463|NCT04693312|Prednisolone|prednisolone|mesh-list
24503177|NCT02978391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25643747|NCT01430455|Antidepressive Agents|antidepressive agents|mesh-ancestor
25643748|NCT01430455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25643749|NCT01430455|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25443464|NCT04693312|Prednisolone acetate|prednisolone acetate|mesh-list
25443465|NCT04693312|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25443466|NCT04693312|Prednisolone phosphate|prednisolone phosphate|mesh-list
25443467|NCT04693312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25443468|NCT04693312|Antiemetics|antiemetics|mesh-ancestor
25443469|NCT04693312|Autonomic Agents|autonomic agents|mesh-ancestor
25443470|NCT04693312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25443471|NCT04693312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443472|NCT04693312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25443473|NCT04693312|Glucocorticoids|glucocorticoids|mesh-ancestor
25443474|NCT04693312|Hormones|hormones|mesh-ancestor
25443475|NCT04693312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25443476|NCT04693312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25443477|NCT04693312|Protective Agents|protective agents|mesh-ancestor
25443478|NCT04693312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25443479|NCT04693312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443480|NCT04693026|Remdesivir|remdesivir|mesh-list
25443481|NCT04693026|Antimetabolites|antimetabolites|mesh-ancestor
25443482|NCT04693026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443483|NCT04693026|Antiviral Agents|antiviral agents|mesh-ancestor
25443484|NCT04693026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25443485|NCT04692623|Insulin|insulin|mesh-list
25443512|NCT04692844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25443513|NCT04692844|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25443514|NCT04692844|Vasodilator Agents|vasodilator agents|mesh-ancestor
25443515|NCT04692844|Anticonvulsants|anticonvulsants|mesh-ancestor
25443516|NCT04692844|GABA Modulators|gaba modulators|mesh-ancestor
25443517|NCT04692844|GABA Agents|gaba agents|mesh-ancestor
25443518|NCT04692896|Lidocaine|lidocaine|mesh-list
25443519|NCT04692896|Anesthetics, Local|anesthetics, local|mesh-ancestor
25443520|NCT04692896|Anesthetics|anesthetics|mesh-ancestor
25443521|NCT04692896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25443522|NCT04692896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443523|NCT04692896|Sensory System Agents|sensory system agents|mesh-ancestor
25443524|NCT04692896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25443525|NCT04692896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25443526|NCT04692896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25443527|NCT04692896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25443528|NCT04692896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25443529|NCT04692896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443530|NCT04692740|Chlorambucil|chlorambucil|mesh-list
25443531|NCT04692740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25443532|NCT04692740|Alkylating Agents|alkylating agents|mesh-ancestor
25443533|NCT04692740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443534|NCT04692740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443535|NCT04692285|Zolpidem|zolpidem|mesh-list
25443536|NCT04692285|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25443537|NCT04692285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25443538|NCT04692285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25443539|NCT04692285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443540|NCT04692285|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25443541|NCT04692285|GABA Agonists|gaba agonists|mesh-ancestor
25443542|NCT04692285|GABA Agents|gaba agents|mesh-ancestor
25443543|NCT04692285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25443544|NCT04692285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443545|NCT04692376|Cyclosporine|cyclosporine|mesh-list
25443546|NCT04692376|Cyclosporins|cyclosporins|mesh-list
25443547|NCT04692376|Glucocorticoids|glucocorticoids|mesh-list
25443548|NCT04692376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25443549|NCT04692376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443550|NCT04692376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25443551|NCT04692376|Immunologic Factors|immunologic factors|mesh-ancestor
24451544|NCT00324077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720180|NCT02463409|Respiratory System Agents|respiratory system agents|mesh-ancestor
25720181|NCT02463409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25720182|NCT02463409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720183|NCT02463409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720184|NCT02463409|Vasodilator Agents|vasodilator agents|mesh-ancestor
25720185|NCT02463409|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25720186|NCT02463409|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25443552|NCT04692376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443553|NCT04692376|Antifungal Agents|antifungal agents|mesh-ancestor
25443554|NCT04692376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25443555|NCT04692376|Dermatologic Agents|dermatologic agents|mesh-ancestor
25443556|NCT04692376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25443557|NCT04692376|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25443558|NCT04692376|Hormones|hormones|mesh-ancestor
25443559|NCT04692376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25443560|NCT04692415|Insulin Glargine|insulin glargine|mesh-list
25443561|NCT04692415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25643750|NCT01430455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720187|NCT02463409|Purinergic Agents|purinergic agents|mesh-ancestor
25720188|NCT02463409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25720189|NCT02464033|Vitamin D|vitamin d|mesh-list
24451609|NCT00324467|Promethazine|promethazine|mesh-list
24451610|NCT00324467|Dexamethasone|dexamethasone|mesh-list
24451611|NCT00324467|Dexamethasone acetate|dexamethasone acetate|mesh-list
24451612|NCT00324467|Prednisone|prednisone|mesh-list
25720190|NCT02464033|Cholecalciferol|cholecalciferol|mesh-list
25720191|NCT02464033|Etanercept|etanercept|mesh-list
25720192|NCT02464033|Vitamins|vitamins|mesh-ancestor
25720193|NCT02464033|Micronutrients|micronutrients|mesh-ancestor
24451613|NCT00324467|Cyclophosphamide|cyclophosphamide|mesh-list
24451614|NCT00324467|Ifosfamide|ifosfamide|mesh-list
24451615|NCT00324467|Rituximab|rituximab|mesh-list
24451616|NCT00324467|Carboplatin|carboplatin|mesh-list
24451617|NCT00324467|Doxorubicin|doxorubicin|mesh-list
25720194|NCT02464033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720195|NCT02464033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25643751|NCT01430455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643752|NCT01430455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25643753|NCT01430455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25643754|NCT01430455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25643755|NCT01430455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643756|NCT01430559|Meloxicam|meloxicam|mesh-list
25643757|NCT01430559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25643758|NCT01430559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25643759|NCT01430559|Analgesics|analgesics|mesh-ancestor
25443562|NCT04692415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443563|NCT04692051|Gemcitabine|gemcitabine|mesh-list
25443564|NCT04692051|Paclitaxel|paclitaxel|mesh-list
25443565|NCT04692051|Cisplatin|cisplatin|mesh-list
25443566|NCT04692051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25443567|NCT04692051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443568|NCT04692051|Tubulin Modulators|tubulin modulators|mesh-ancestor
25443569|NCT04692051|Antimitotic Agents|antimitotic agents|mesh-ancestor
25443570|NCT04692051|Mitosis Modulators|mitosis modulators|mesh-ancestor
25443571|NCT04692051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443572|NCT04692051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25443573|NCT04692051|Antimetabolites|antimetabolites|mesh-ancestor
25443574|NCT04692051|Antiviral Agents|antiviral agents|mesh-ancestor
25443575|NCT04692051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25443576|NCT04692051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25443577|NCT04692051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25443578|NCT04692051|Immunologic Factors|immunologic factors|mesh-ancestor
25443579|NCT04692051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443580|NCT04691765|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25443581|NCT04691765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25443582|NCT04691687|Furosemide|furosemide|mesh-list
25443583|NCT04691687|Diuretics|diuretics|mesh-ancestor
25443584|NCT04691687|Natriuretic Agents|natriuretic agents|mesh-ancestor
25443585|NCT04691687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443586|NCT04691687|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25443587|NCT04691687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25443588|NCT04691687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443589|NCT04691726|Dipyrone|dipyrone|mesh-list
25443590|NCT04691726|Lidocaine|lidocaine|mesh-list
25443591|NCT04691726|Morphine|morphine|mesh-list
25443592|NCT04691726|Anesthetics, Local|anesthetics, local|mesh-ancestor
25443593|NCT04691726|Anesthetics|anesthetics|mesh-ancestor
25443594|NCT04691726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25443595|NCT04691726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443596|NCT04691726|Sensory System Agents|sensory system agents|mesh-ancestor
25443597|NCT04691726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25443598|NCT04691726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25443599|NCT04691726|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25443600|NCT04691726|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25443601|NCT04691726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24451667|NCT00324467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24451668|NCT00324467|Anesthetics, Local|anesthetics, local|mesh-ancestor
24451669|NCT00324467|Anesthetics|anesthetics|mesh-ancestor
24451670|NCT00324467|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25443602|NCT04691726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443603|NCT04691726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25443604|NCT04691726|Narcotics|narcotics|mesh-ancestor
25443605|NCT04691726|Analgesics|analgesics|mesh-ancestor
25443606|NCT04691726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25443607|NCT04691726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25296516|NCT04585061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25443608|NCT04691726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25443609|NCT04691726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25443610|NCT04691726|Antipyretics|antipyretics|mesh-ancestor
25443611|NCT04691934|Anesthetics|anesthetics|mesh-list
25443612|NCT04691934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25443613|NCT04691934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443614|NCT04691362|Tranexamic Acid|tranexamic acid|mesh-list
25443615|NCT04691362|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25443616|NCT04691362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25443617|NCT04691362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443618|NCT04691362|Hemostatics|hemostatics|mesh-ancestor
25443619|NCT04691362|Coagulants|coagulants|mesh-ancestor
25443620|NCT04690920|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25443621|NCT04690920|Remdesivir|remdesivir|mesh-list
24503377|NCT01655225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24503378|NCT01655225|Anesthetics, General|anesthetics, general|mesh-ancestor
24503379|NCT01655225|Anesthetics|anesthetics|mesh-ancestor
24503380|NCT01655225|GABA Modulators|gaba modulators|mesh-ancestor
25643760|NCT01430559|Sensory System Agents|sensory system agents|mesh-ancestor
25643761|NCT01430559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25443622|NCT04690920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25720196|NCT02464033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25720197|NCT02464033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25720198|NCT02464033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25720199|NCT02464033|Analgesics|analgesics|mesh-ancestor
25720200|NCT02464033|Sensory System Agents|sensory system agents|mesh-ancestor
25720201|NCT02464033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25720202|NCT02464033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25720203|NCT02464033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25720204|NCT02464033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25443623|NCT04690920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443624|NCT04690920|Antimetabolites|antimetabolites|mesh-ancestor
25822840|NCT00004685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25443625|NCT04690920|Antiviral Agents|antiviral agents|mesh-ancestor
25443627|NCT04691076|Propofol|propofol|mesh-list
25443628|NCT04691076|Esketamine|esketamine|mesh-list
25443629|NCT04691076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25443630|NCT04691076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25443631|NCT04691076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443632|NCT04691076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25443633|NCT04691076|Anesthetics, General|anesthetics, general|mesh-ancestor
25443634|NCT04691076|Anesthetics|anesthetics|mesh-ancestor
25443635|NCT04691076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25443636|NCT04691076|Narcotics|narcotics|mesh-ancestor
25443637|NCT04691076|Analgesics|analgesics|mesh-ancestor
25443638|NCT04691076|Sensory System Agents|sensory system agents|mesh-ancestor
25443639|NCT04691076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25443640|NCT04691076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25443641|NCT04691076|Antidepressive Agents|antidepressive agents|mesh-ancestor
25443642|NCT04691076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25443643|NCT04691063|Carboplatin|carboplatin|mesh-list
25443644|NCT04691063|Etoposide|etoposide|mesh-list
25443645|NCT04691063|Etoposide phosphate|etoposide phosphate|mesh-list
25443646|NCT04691063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443647|NCT04691063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25443648|NCT04691063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25443649|NCT04691063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25443650|NCT04691063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25443651|NCT04691063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443652|NCT04690608|Triamcinolone|triamcinolone|mesh-list
25443653|NCT04690608|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25443654|NCT04690608|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25443655|NCT04690608|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25443656|NCT04690608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25443657|NCT04690608|Glucocorticoids|glucocorticoids|mesh-ancestor
25720205|NCT02464033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25720206|NCT02464033|Immunologic Factors|immunologic factors|mesh-ancestor
25720207|NCT02464059|Vitamin D|vitamin d|mesh-list
25720208|NCT02464059|Cholecalciferol|cholecalciferol|mesh-list
25720209|NCT02464059|Vitamins|vitamins|mesh-ancestor
25720210|NCT02464059|Micronutrients|micronutrients|mesh-ancestor
25720211|NCT02464059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720212|NCT02464059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25443658|NCT04690608|Hormones|hormones|mesh-ancestor
25443659|NCT04690608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25443660|NCT04690608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443661|NCT04690608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25443662|NCT04690608|Immunologic Factors|immunologic factors|mesh-ancestor
25443663|NCT04690608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25443664|NCT04690608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443665|NCT04690647|Dexamethasone|dexamethasone|mesh-list
25443666|NCT04690647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
25443667|NCT04690647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25443668|NCT04690647|Antiemetics|antiemetics|mesh-ancestor
25720213|NCT02464059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25720214|NCT02464163|Hemagglutinins|hemagglutinins|mesh-list
25720215|NCT02464163|Agglutinins|agglutinins|mesh-ancestor
25720216|NCT02464163|Immunologic Factors|immunologic factors|mesh-ancestor
25720217|NCT02464163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720218|NCT02464176|Dexamethasone|dexamethasone|mesh-list
25720219|NCT02464176|Dexamethasone acetate|dexamethasone acetate|mesh-list
25720220|NCT02464176|Epinephrine|epinephrine|mesh-list
25720221|NCT02464176|Bupivacaine|bupivacaine|mesh-list
25720222|NCT02464176|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25720223|NCT02464176|BB 1101|bb 1101|mesh-list
25720224|NCT02464176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25720225|NCT02464176|Antiemetics|antiemetics|mesh-ancestor
25720226|NCT02464176|Autonomic Agents|autonomic agents|mesh-ancestor
25720227|NCT02464176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25720228|NCT02464176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720229|NCT02464176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25720230|NCT02464176|Glucocorticoids|glucocorticoids|mesh-ancestor
25720231|NCT02464176|Hormones|hormones|mesh-ancestor
25720232|NCT02464176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25720233|NCT02464176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25720234|NCT02464176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25720235|NCT02464176|Protease Inhibitors|protease inhibitors|mesh-ancestor
25720236|NCT02464176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720237|NCT02464176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720238|NCT02464176|Anesthetics, Local|anesthetics, local|mesh-ancestor
25720239|NCT02464176|Anesthetics|anesthetics|mesh-ancestor
25443669|NCT04690647|Autonomic Agents|autonomic agents|mesh-ancestor
25443670|NCT04690647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25443671|NCT04690647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443672|NCT04690647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25443673|NCT04690647|Glucocorticoids|glucocorticoids|mesh-ancestor
25443674|NCT04690647|Hormones|hormones|mesh-ancestor
25443675|NCT04690647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25296589|NCT04153604|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25296597|NCT04126278|Dexamethasone|dexamethasone|mesh-list
25296598|NCT04126278|Cortisone|cortisone|mesh-list
25296599|NCT04126278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25296600|NCT04126278|Antiemetics|antiemetics|mesh-ancestor
25296601|NCT04126278|Autonomic Agents|autonomic agents|mesh-ancestor
25296602|NCT04126278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25296603|NCT04126278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443676|NCT04690647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25443677|NCT04690647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443702|NCT04689971|Vitamins|vitamins|mesh-list
25443703|NCT04689971|Vitamin B Complex|vitamin b complex|mesh-list
25443704|NCT04689971|Micronutrients|micronutrients|mesh-ancestor
25443705|NCT04689971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443706|NCT04690309|Insulin|insulin|mesh-list
24503506|NCT00532116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443707|NCT04690309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25443708|NCT04690309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25443709|NCT04690309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643762|NCT01430559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643763|NCT01430559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25643764|NCT01430559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25643765|NCT01430559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25443710|NCT04689815|Arsenic Trioxide|arsenic trioxide|mesh-list
25443711|NCT04689815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443712|NCT04689893|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
25443713|NCT04689893|Chelating Agents|chelating agents|mesh-ancestor
25443714|NCT04689893|Sequestering Agents|sequestering agents|mesh-ancestor
25443715|NCT04689893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443717|NCT04689412|Antioxidants|antioxidants|mesh-ancestor
25443718|NCT04689412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451678|NCT00324480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451679|NCT00324480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451680|NCT00324480|Growth Inhibitors|growth inhibitors|mesh-ancestor
25720251|NCT02464176|Sympathomimetics|sympathomimetics|mesh-ancestor
25720252|NCT02464176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25720253|NCT02464657|Cytarabine|cytarabine|mesh-list
25720254|NCT02464657|Dexamethasone|dexamethasone|mesh-list
25720255|NCT02464657|Methylprednisolone|methylprednisolone|mesh-list
25720256|NCT02464657|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25720257|NCT02464657|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25720258|NCT02464657|Prednisolone|prednisolone|mesh-list
25720259|NCT02464657|Prednisolone acetate|prednisolone acetate|mesh-list
25720260|NCT02464657|Nivolumab|nivolumab|mesh-list
25720261|NCT02464657|Idarubicin|idarubicin|mesh-list
25720262|NCT02464657|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25720263|NCT02464657|Prednisolone phosphate|prednisolone phosphate|mesh-list
25720264|NCT02464657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25720265|NCT02464657|Antiemetics|antiemetics|mesh-ancestor
25720266|NCT02464657|Autonomic Agents|autonomic agents|mesh-ancestor
25443719|NCT04689412|Protective Agents|protective agents|mesh-ancestor
25443720|NCT04689412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443721|NCT04689412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25443722|NCT04689412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25443723|NCT04689191|Vaccines|vaccines|mesh-list
25443724|NCT04689191|Immunologic Factors|immunologic factors|mesh-ancestor
25443725|NCT04689191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443726|NCT04689100|Leucovorin|leucovorin|mesh-list
25443727|NCT04689100|Fluorouracil|fluorouracil|mesh-list
25443728|NCT04689100|Oxaliplatin|oxaliplatin|mesh-list
25443729|NCT04689100|Irinotecan|irinotecan|mesh-list
25443730|NCT04689100|Calcium|calcium|mesh-list
25443731|NCT04689100|Levoleucovorin|levoleucovorin|mesh-list
25443732|NCT04689100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25443733|NCT04689100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443734|NCT04689100|Antimetabolites|antimetabolites|mesh-ancestor
25443735|NCT04689100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443736|NCT04689100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25443737|NCT04689100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25720268|NCT02464657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720269|NCT02464657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25720270|NCT02464657|Glucocorticoids|glucocorticoids|mesh-ancestor
25720271|NCT02464657|Hormones|hormones|mesh-ancestor
25720272|NCT02464657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25720273|NCT02464657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25720274|NCT02464657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25720275|NCT02464657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25443738|NCT04689100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25443739|NCT04689100|Immunologic Factors|immunologic factors|mesh-ancestor
25443740|NCT04689100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25443741|NCT04689100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25443742|NCT04689100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25443743|NCT04689100|Antidotes|antidotes|mesh-ancestor
25443744|NCT04689100|Protective Agents|protective agents|mesh-ancestor
25443745|NCT04689100|Vitamin B Complex|vitamin b complex|mesh-ancestor
25443746|NCT04689100|Vitamins|vitamins|mesh-ancestor
25443747|NCT04689100|Micronutrients|micronutrients|mesh-ancestor
25443748|NCT04689165|Vaccines|vaccines|mesh-list
25443749|NCT04689165|Immunologic Factors|immunologic factors|mesh-ancestor
25443750|NCT04689165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443751|NCT04688983|Imatinib Mesylate|imatinib mesylate|mesh-list
25443752|NCT04688983|Blinatumomab|blinatumomab|mesh-list
25443753|NCT04688983|Ponatinib|ponatinib|mesh-list
25443754|NCT04688983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443755|NCT04688983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25443756|NCT04688983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25443757|NCT04688983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443758|NCT04688801|Antineoplastic Agents|antineoplastic agents|mesh-list
25443759|NCT04688723|Dabigatran|dabigatran|mesh-list
25443760|NCT04688723|Clopidogrel|clopidogrel|mesh-list
25443761|NCT04688723|Ticagrelor|ticagrelor|mesh-list
25443762|NCT04688723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25443763|NCT04688723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25443764|NCT04688723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25443765|NCT04688723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25443766|NCT04688723|Purinergic Agents|purinergic agents|mesh-ancestor
25443767|NCT04688723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25443768|NCT04688723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443769|NCT04688723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443770|NCT04688723|Antithrombins|antithrombins|mesh-ancestor
25443771|NCT04688723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25443772|NCT04688723|Protease Inhibitors|protease inhibitors|mesh-ancestor
25443773|NCT04688723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25443774|NCT04688723|Anticoagulants|anticoagulants|mesh-ancestor
25296736|NCT03717129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25296737|NCT03717129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25296740|NCT03717129|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25443775|NCT04688645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25443776|NCT04688632|Moxifloxacin|moxifloxacin|mesh-list
25443777|NCT04688632|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25443778|NCT04688632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25643766|NCT01430559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25643767|NCT01430559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25643768|NCT01430559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643770|NCT01430585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25643771|NCT01430585|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25643772|NCT01430585|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25443779|NCT04688632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25443780|NCT04688632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25443781|NCT04688632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25443782|NCT04688632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25443783|NCT04688632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443784|NCT04688632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443785|NCT04688632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25443786|NCT04688632|Contraceptive Agents|contraceptive agents|mesh-ancestor
25443787|NCT04688632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25720276|NCT02464657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25720277|NCT02464657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451773|NCT00324766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451774|NCT00324766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451775|NCT00324766|Protective Agents|protective agents|mesh-ancestor
24451819|NCT00324831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24451820|NCT00324831|Glucocorticoids|glucocorticoids|mesh-ancestor
25720278|NCT02464657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25720279|NCT02464657|Antimetabolites|antimetabolites|mesh-ancestor
25720280|NCT02464657|Antiviral Agents|antiviral agents|mesh-ancestor
25720281|NCT02464657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25720282|NCT02464657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25720283|NCT02464657|Immunologic Factors|immunologic factors|mesh-ancestor
25443788|NCT04688632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443789|NCT04688632|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25443790|NCT04688632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25443791|NCT04688632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25443792|NCT04688346|Epinephrine|epinephrine|mesh-list
25443793|NCT04688346|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25443794|NCT04688346|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25443795|NCT04688346|Adrenergic Agents|adrenergic agents|mesh-ancestor
25443796|NCT04688346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25443797|NCT04688346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443798|NCT04688346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443799|NCT04688346|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25443800|NCT04688346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25443801|NCT04688346|Autonomic Agents|autonomic agents|mesh-ancestor
25443802|NCT04688346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25443803|NCT04688346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25443804|NCT04688346|Respiratory System Agents|respiratory system agents|mesh-ancestor
25443805|NCT04688346|Mydriatics|mydriatics|mesh-ancestor
25443806|NCT04688346|Sympathomimetics|sympathomimetics|mesh-ancestor
25443807|NCT04688346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25443808|NCT04688021|Cytarabine|cytarabine|mesh-list
25443809|NCT04688021|Cyclosporine|cyclosporine|mesh-list
25443810|NCT04688021|Mycophenolic Acid|mycophenolic acid|mesh-list
25443811|NCT04688021|Cyclophosphamide|cyclophosphamide|mesh-list
25443812|NCT04688021|Busulfan|busulfan|mesh-list
25443813|NCT04688021|Cyclosporins|cyclosporins|mesh-list
25443814|NCT04688021|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25443815|NCT04688021|Thymoglobulin|thymoglobulin|mesh-list
25443816|NCT04688021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25443817|NCT04688021|Immunologic Factors|immunologic factors|mesh-ancestor
25443818|NCT04688021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443819|NCT04688021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25443820|NCT04688021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25443821|NCT04688021|Alkylating Agents|alkylating agents|mesh-ancestor
25443822|NCT04688021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443823|NCT04688021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443824|NCT04688021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25443825|NCT04688021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25443826|NCT04688021|Antimetabolites|antimetabolites|mesh-ancestor
25443827|NCT04688021|Antiviral Agents|antiviral agents|mesh-ancestor
25443828|NCT04688021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25443829|NCT04688021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25443830|NCT04688021|Antifungal Agents|antifungal agents|mesh-ancestor
25443831|NCT04688021|Dermatologic Agents|dermatologic agents|mesh-ancestor
25443832|NCT04688021|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25443833|NCT04688021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25443834|NCT04688021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25296811|NCT02195947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25296812|NCT02195947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296813|NCT02023905|Everolimus|everolimus|mesh-list
25296814|NCT02023905|Temozolomide|temozolomide|mesh-list
25296815|NCT02023905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296816|NCT02023905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25296817|NCT02023905|Immunologic Factors|immunologic factors|mesh-ancestor
25296818|NCT02023905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296819|NCT02023905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25296820|NCT02023905|Alkylating Agents|alkylating agents|mesh-ancestor
25296821|NCT02023905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296822|NCT01909414|Vaccines|vaccines|mesh-list
25296823|NCT01909414|Immunologic Factors|immunologic factors|mesh-ancestor
25296824|NCT01909414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643773|NCT01430585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25643774|NCT01430585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643775|NCT01430585|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25643776|NCT01430585|Hormone Antagonists|hormone antagonists|mesh-ancestor
25296825|NCT01890252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25296826|NCT01698307|Adalimumab|adalimumab|mesh-list
25443849|NCT04687566|Memantine|memantine|mesh-list
25443850|NCT04687566|Dextromethorphan|dextromethorphan|mesh-list
25720284|NCT02464657|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25720285|NCT02464657|Protective Agents|protective agents|mesh-ancestor
25720286|NCT02464657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25720287|NCT02464657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25720288|NCT02464657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25720289|NCT02464657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720290|NCT02465450|Lenabasum|lenabasum|mesh-list
25720291|NCT02465450|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24451884|NCT00325104|Hormones|hormones|mesh-list
25720292|NCT02465450|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25720293|NCT02465450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25720294|NCT02465450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720295|NCT02465450|Hormones|hormones|mesh-ancestor
25720296|NCT02465450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25720297|NCT02465450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443851|NCT04687566|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25443852|NCT04687566|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25443853|NCT04687566|Dopamine Agents|dopamine agents|mesh-ancestor
25443854|NCT04687566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25443855|NCT04687566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443856|NCT04687566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443857|NCT04687566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25443858|NCT04687566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25443859|NCT04687566|Antitussive Agents|antitussive agents|mesh-ancestor
25443860|NCT04687566|Respiratory System Agents|respiratory system agents|mesh-ancestor
25443861|NCT04687332|Tryptophan|tryptophan|mesh-list
25443862|NCT04687332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25443863|NCT04687332|Antidepressive Agents|antidepressive agents|mesh-ancestor
25443864|NCT04687332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25443865|NCT04687449|Curcumin|curcumin|mesh-list
25443866|NCT04687449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25443867|NCT04687449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25443868|NCT04687449|Analgesics|analgesics|mesh-ancestor
25443869|NCT04687449|Sensory System Agents|sensory system agents|mesh-ancestor
25720300|NCT02465489|Chelating Agents|chelating agents|mesh-ancestor
25720301|NCT02465489|Sequestering Agents|sequestering agents|mesh-ancestor
25720302|NCT02465489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720303|NCT02465515|rGLP-1 protein|rglp-1 protein|mesh-list
25720304|NCT02465515|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25720305|NCT02465515|Incretins|incretins|mesh-ancestor
25720306|NCT02465515|Hormones|hormones|mesh-ancestor
25720307|NCT02465515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25720308|NCT02465515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720309|NCT02465528|Ceritinib|ceritinib|mesh-list
25443870|NCT04687449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25443871|NCT04687449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443872|NCT04687449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25443873|NCT04687449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25443874|NCT04687449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443875|NCT04687449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25443876|NCT04687449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443877|NCT04687111|Valsartan|valsartan|mesh-list
25443878|NCT04687111|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25443879|NCT04687111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25443880|NCT04687111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25443881|NCT04687111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25443882|NCT04687111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443883|NCT04686890|Acetaminophen|acetaminophen|mesh-list
25443884|NCT04686890|Tramadol|tramadol|mesh-list
25720310|NCT02465528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25720311|NCT02465528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25720312|NCT02465528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720313|NCT02465528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720314|NCT02465632|Clindamycin|clindamycin|mesh-list
25720315|NCT02465632|Clindamycin palmitate|clindamycin palmitate|mesh-list
25720316|NCT02465632|Clindamycin phosphate|clindamycin phosphate|mesh-list
25720317|NCT02465632|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25720318|NCT02465632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25720319|NCT02465632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25443885|NCT04686890|Analgesics|analgesics|mesh-list
25443886|NCT04686890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25443887|NCT04686890|Sensory System Agents|sensory system agents|mesh-ancestor
25443888|NCT04686890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25443889|NCT04686890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443890|NCT04686890|Antipyretics|antipyretics|mesh-ancestor
25443891|NCT04686890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25443892|NCT04686890|Narcotics|narcotics|mesh-ancestor
25443893|NCT04686890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25443894|NCT04687176|Arsenic Trioxide|arsenic trioxide|mesh-list
25443895|NCT04687176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443896|NCT04687163|Oxaliplatin|oxaliplatin|mesh-list
25443897|NCT04687163|Fluorouracil|fluorouracil|mesh-list
25443898|NCT04687163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443899|NCT04687163|Antimetabolites|antimetabolites|mesh-ancestor
25443900|NCT04687163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443901|NCT04687163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25443902|NCT04687163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25443903|NCT04687163|Immunologic Factors|immunologic factors|mesh-ancestor
25443904|NCT04687163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443905|NCT04686929|Abatacept|abatacept|mesh-list
25443906|NCT04686929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25296959|NCT04818372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25296960|NCT04818372|Growth Substances|growth substances|mesh-ancestor
25296961|NCT04818372|Growth Inhibitors|growth inhibitors|mesh-ancestor
25296962|NCT04784299|Lidocaine|lidocaine|mesh-list
25296963|NCT04784299|Anesthetics, Local|anesthetics, local|mesh-ancestor
25296964|NCT04784299|Anesthetics|anesthetics|mesh-ancestor
25296965|NCT04784299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25296966|NCT04784299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296967|NCT04784299|Sensory System Agents|sensory system agents|mesh-ancestor
25296968|NCT04784299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25296969|NCT04784299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25296970|NCT04784299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25296971|NCT04784299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25296972|NCT04784299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25296973|NCT04784299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443907|NCT04686929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443908|NCT04686929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443909|NCT04686929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25443910|NCT04686929|Immunologic Factors|immunologic factors|mesh-ancestor
25443911|NCT04686929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443912|NCT04686929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25443914|NCT04687098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25443915|NCT04687098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25443916|NCT04687098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25443917|NCT04687098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25443918|NCT04687098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25443919|NCT04687098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443920|NCT04686448|Fentanyl|fentanyl|mesh-list
25443921|NCT04686448|Ketamine|ketamine|mesh-list
25443922|NCT04686448|Propofol|propofol|mesh-list
25443923|NCT04686448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25443924|NCT04686448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25443925|NCT04686448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443926|NCT04686448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25443927|NCT04686448|Anesthetics, General|anesthetics, general|mesh-ancestor
25443928|NCT04686448|Anesthetics|anesthetics|mesh-ancestor
25443929|NCT04686448|Analgesics|analgesics|mesh-ancestor
25720320|NCT02465632|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25720321|NCT02465632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720322|NCT02465632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443930|NCT04686448|Sensory System Agents|sensory system agents|mesh-ancestor
25443931|NCT04686448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25443932|NCT04686448|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25443933|NCT04686448|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25443934|NCT04686448|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25443935|NCT04686448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25443936|NCT04686448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443937|NCT04686448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25443938|NCT04686448|Narcotics|narcotics|mesh-ancestor
25443939|NCT04686448|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25443940|NCT04686825|DA-8010|da-8010|mesh-list
25443941|NCT04686825|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25443942|NCT04686825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25443943|NCT04686825|Cholinergic Agents|cholinergic agents|mesh-ancestor
25443944|NCT04686825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25443945|NCT04686825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443946|NCT04686825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443948|NCT04686643|Amlodipine|amlodipine|mesh-list
25443949|NCT04686643|Valsartan|valsartan|mesh-list
25443950|NCT04686643|Indapamide|indapamide|mesh-list
25443951|NCT04686643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25443952|NCT04686643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25443953|NCT04686643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25443954|NCT04686643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443955|NCT04686643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25443956|NCT04686643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443957|NCT04686643|Vasodilator Agents|vasodilator agents|mesh-ancestor
25443958|NCT04686643|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25443959|NCT04686643|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25443960|NCT04686643|Diuretics|diuretics|mesh-ancestor
25443961|NCT04686643|Natriuretic Agents|natriuretic agents|mesh-ancestor
25443962|NCT04686643|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25443963|NCT04686643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25443964|NCT04686643|Antimetabolites|antimetabolites|mesh-ancestor
25443965|NCT04686643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25443966|NCT04686643|Vitamin B Complex|vitamin b complex|mesh-ancestor
25443967|NCT04686643|Vitamins|vitamins|mesh-ancestor
25443968|NCT04686643|Micronutrients|micronutrients|mesh-ancestor
25443969|NCT04685980|Morphine|morphine|mesh-list
25443970|NCT04685980|Anesthetics|anesthetics|mesh-list
25443971|NCT04685980|Anesthetics, Local|anesthetics, local|mesh-list
25443972|NCT04685980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25297035|NCT04247750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25297036|NCT04247750|Immunologic Factors|immunologic factors|mesh-ancestor
25643777|NCT01430585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25643778|NCT01430585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643779|NCT01430611|Vaccines|vaccines|mesh-list
25643780|NCT01430611|Immunologic Factors|immunologic factors|mesh-ancestor
25643781|NCT01430611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643782|NCT01430819|Vaccines|vaccines|mesh-list
25643783|NCT01430819|Immunologic Factors|immunologic factors|mesh-ancestor
25643784|NCT01430819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643785|NCT01431014|Dexamethasone|dexamethasone|mesh-list
25643786|NCT01431014|Dexamethasone acetate|dexamethasone acetate|mesh-list
25297037|NCT04247750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297048|NCT04169698|Denosumab|denosumab|mesh-list
25297049|NCT04169698|Alendronate|alendronate|mesh-list
25297050|NCT04169698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25297051|NCT04169698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297052|NCT03906617|Dexamethasone|dexamethasone|mesh-list
25297053|NCT03906617|Epinephrine|epinephrine|mesh-list
25297054|NCT03906617|Bupivacaine|bupivacaine|mesh-list
25443973|NCT04685980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443974|NCT04685980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25443975|NCT04685980|Narcotics|narcotics|mesh-ancestor
25443976|NCT04685980|Analgesics|analgesics|mesh-ancestor
25443977|NCT04685980|Sensory System Agents|sensory system agents|mesh-ancestor
25443978|NCT04685980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25443979|NCT04686058|Midazolam|midazolam|mesh-list
25443980|NCT04686058|Meperidine|meperidine|mesh-list
25443981|NCT04686058|Propofol|propofol|mesh-list
25443982|NCT04686058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25443983|NCT04686058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25443984|NCT04686058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25443985|NCT04686058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25443986|NCT04686058|Anesthetics, General|anesthetics, general|mesh-ancestor
25443987|NCT04686058|Anesthetics|anesthetics|mesh-ancestor
25443988|NCT04686058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25443989|NCT04686058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25443990|NCT04686058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25443991|NCT04686058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25443992|NCT04686058|GABA Modulators|gaba modulators|mesh-ancestor
25443993|NCT04686058|GABA Agents|gaba agents|mesh-ancestor
25443994|NCT04686058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25443995|NCT04686058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25443996|NCT04686058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25443997|NCT04686058|Narcotics|narcotics|mesh-ancestor
25443998|NCT04686058|Analgesics|analgesics|mesh-ancestor
25443999|NCT04686058|Sensory System Agents|sensory system agents|mesh-ancestor
25444000|NCT04686058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25444001|NCT04685512|Tenofovir|tenofovir|mesh-list
25444002|NCT04685512|Emtricitabine|emtricitabine|mesh-list
25444003|NCT04685512|Antiviral Agents|antiviral agents|mesh-ancestor
25444004|NCT04685512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25444005|NCT04685512|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25444006|NCT04685512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25444007|NCT04685512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444008|NCT04685512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444009|NCT04685512|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25444010|NCT04685512|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25444011|NCT04685642|Aspirin|aspirin|mesh-list
25444012|NCT04685642|Atorvastatin|atorvastatin|mesh-list
25444013|NCT04685642|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25444014|NCT04685642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25444015|NCT04685642|Analgesics|analgesics|mesh-ancestor
25444016|NCT04685642|Sensory System Agents|sensory system agents|mesh-ancestor
25444017|NCT04685642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25444018|NCT04685642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444019|NCT04685642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25444020|NCT04685642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25444021|NCT04685642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25444022|NCT04685642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25297111|NCT03807817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297119|NCT03775850|Pembrolizumab|pembrolizumab|mesh-list
25297120|NCT03775850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25297121|NCT03775850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25297122|NCT03683069|Amlodipine|amlodipine|mesh-list
25297123|NCT03683069|Eplerenone|eplerenone|mesh-list
25297124|NCT03683069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24504065|NCT00533936|Tubulin Modulators|tubulin modulators|mesh-ancestor
25297125|NCT03683069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25297126|NCT03683069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25297127|NCT03683069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297128|NCT03683069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25297129|NCT03683069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297130|NCT03683069|Vasodilator Agents|vasodilator agents|mesh-ancestor
25297131|NCT03683069|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25297132|NCT03683069|Hormone Antagonists|hormone antagonists|mesh-ancestor
25297133|NCT03683069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25297134|NCT03683069|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25297136|NCT03683069|Natriuretic Agents|natriuretic agents|mesh-ancestor
25297137|NCT03677115|Dexmedetomidine|dexmedetomidine|mesh-list
25297138|NCT03677115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25297139|NCT03677115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25297142|NCT03677115|Analgesics|analgesics|mesh-ancestor
25444023|NCT04685642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444024|NCT04685642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25444033|NCT04685538|Tetracaine|tetracaine|mesh-list
25444034|NCT04685538|Chloroprocaine|chloroprocaine|mesh-list
25444035|NCT04685538|Anesthetics, Local|anesthetics, local|mesh-ancestor
25444036|NCT04685538|Anesthetics|anesthetics|mesh-ancestor
25444037|NCT04685538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25444038|NCT04685538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444039|NCT04685538|Sensory System Agents|sensory system agents|mesh-ancestor
25444040|NCT04685538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25444041|NCT04685148|Estradiol|estradiol|mesh-list
25444042|NCT04685148|Estrogens|estrogens|mesh-ancestor
25444043|NCT04685148|Hormones|hormones|mesh-ancestor
25444044|NCT04685148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25444045|NCT04685148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444046|NCT04685031|Clobetasol|clobetasol|mesh-list
25444047|NCT04685031|Nitroglycerin|nitroglycerin|mesh-list
25444048|NCT04685031|Vasodilator Agents|vasodilator agents|mesh-ancestor
25444049|NCT04685031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25444050|NCT04685031|Glucocorticoids|glucocorticoids|mesh-ancestor
25444051|NCT04685031|Hormones|hormones|mesh-ancestor
25444052|NCT04685031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25444053|NCT04685031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444054|NCT04685005|Caffeine|caffeine|mesh-list
25444055|NCT04685005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25444056|NCT04685005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444057|NCT04685005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25444058|NCT04685005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444059|NCT04685005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444060|NCT04685005|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25444061|NCT04685005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25444062|NCT04685005|Purinergic Agents|purinergic agents|mesh-ancestor
25444063|NCT04685005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25444064|NCT04684667|Propranolol|propranolol|mesh-list
25444065|NCT04684667|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25444066|NCT04684667|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25444067|NCT04684667|Adrenergic Agents|adrenergic agents|mesh-ancestor
25444068|NCT04684667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25444069|NCT04684667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444070|NCT04684667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444071|NCT04684667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25444072|NCT04684667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25444073|NCT04684667|Vasodilator Agents|vasodilator agents|mesh-ancestor
25444074|NCT04684628|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25444075|NCT04684628|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25444076|NCT04684628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444077|NCT04684199|Melatonin|melatonin|mesh-list
25444078|NCT04684199|Antioxidants|antioxidants|mesh-ancestor
25444079|NCT04684199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444080|NCT04684199|Protective Agents|protective agents|mesh-ancestor
25444081|NCT04684199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444082|NCT04684199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25444083|NCT04684277|Antidepressive Agents|antidepressive agents|mesh-list
25444084|NCT04684277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25444085|NCT04684498|Oseltamivir|oseltamivir|mesh-list
25444086|NCT04684498|Antiviral Agents|antiviral agents|mesh-ancestor
25444087|NCT04684498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25444088|NCT04684498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25643787|NCT01431014|BB 1101|bb 1101|mesh-list
25444089|NCT04684498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444090|NCT04684017|Carboplatin|carboplatin|mesh-list
25444091|NCT04684017|Etoposide|etoposide|mesh-list
25444092|NCT04684017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444093|NCT04684017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25444094|NCT04684017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25297257|NCT01882816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297258|NCT01758614|Aspirin|aspirin|mesh-list
25297259|NCT01758614|Clopidogrel|clopidogrel|mesh-list
25297260|NCT01758614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25297261|NCT01758614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25297262|NCT01758614|Analgesics|analgesics|mesh-ancestor
25297263|NCT01758614|Sensory System Agents|sensory system agents|mesh-ancestor
25297264|NCT01758614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25297265|NCT01758614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297266|NCT01758614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25297267|NCT01758614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25297268|NCT01758614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25444125|NCT04683341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25444126|NCT04683341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444127|NCT04683341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444128|NCT04683341|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25444129|NCT04683341|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25444130|NCT04683198|Carboplatin|carboplatin|mesh-list
25444131|NCT04683198|Etoposide|etoposide|mesh-list
25444132|NCT04683198|Apatinib|apatinib|mesh-list
25444133|NCT04683198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444134|NCT04683198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25444135|NCT04683198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25444136|NCT04683198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25444137|NCT04683198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444138|NCT04683198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444139|NCT04683198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25444140|NCT04683159|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25444141|NCT04683159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25444142|NCT04683159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25444143|NCT04683159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25444144|NCT04683159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25444145|NCT04683159|Adrenergic Agents|adrenergic agents|mesh-ancestor
25444146|NCT04683159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25444147|NCT04683159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444148|NCT04683159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444149|NCT04683146|Chlorhexidine|chlorhexidine|mesh-list
25444150|NCT04683146|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25444151|NCT04683146|Propranolol|propranolol|mesh-list
25444152|NCT04683146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25444153|NCT04683146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25444154|NCT04683146|Disinfectants|disinfectants|mesh-ancestor
25444155|NCT04683146|Dermatologic Agents|dermatologic agents|mesh-ancestor
25444156|NCT04683146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25444157|NCT04683146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25444158|NCT04683146|Adrenergic Agents|adrenergic agents|mesh-ancestor
25444159|NCT04683146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25444160|NCT04683146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444161|NCT04683146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444162|NCT04683146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25444163|NCT04683146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25444164|NCT04683146|Vasodilator Agents|vasodilator agents|mesh-ancestor
25444165|NCT04683237|Liraglutide|liraglutide|mesh-list
25444166|NCT04683237|Megestrol|megestrol|mesh-list
25444167|NCT04683237|Megestrol Acetate|megestrol acetate|mesh-list
25444168|NCT04683237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25444169|NCT04683237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444170|NCT04683237|Incretins|incretins|mesh-ancestor
25444171|NCT04683237|Hormones|hormones|mesh-ancestor
25720363|NCT02467504|Vitamin B Complex|vitamin b complex|mesh-ancestor
25444172|NCT04683237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25444173|NCT04683237|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25444174|NCT04683237|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25444175|NCT04683237|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25444176|NCT04683237|Contraceptive Agents|contraceptive agents|mesh-ancestor
25444177|NCT04683237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25444178|NCT04683237|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25444179|NCT04683237|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25444180|NCT04683237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25643788|NCT01431014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25643789|NCT01431014|Antiemetics|antiemetics|mesh-ancestor
25643790|NCT01431014|Autonomic Agents|autonomic agents|mesh-ancestor
25444181|NCT04683237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444182|NCT04683237|Appetite Stimulants|appetite stimulants|mesh-ancestor
25444183|NCT04683237|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25444184|NCT04682782|Esketamine|esketamine|mesh-list
25444185|NCT04682782|Antidepressive Agents|antidepressive agents|mesh-ancestor
25444186|NCT04682782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25444187|NCT04682665|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
25444188|NCT04682665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25444189|NCT04682665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25444190|NCT04682691|Erythromycin|erythromycin|mesh-list
25444191|NCT04682691|Erythromycin Estolate|erythromycin estolate|mesh-list
25444192|NCT04682691|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25444193|NCT04682691|Erythromycin stearate|erythromycin stearate|mesh-list
25444194|NCT04682691|Metoclopramide|metoclopramide|mesh-list
25444195|NCT04682691|Antiemetics|antiemetics|mesh-ancestor
25444196|NCT04682691|Autonomic Agents|autonomic agents|mesh-ancestor
25444197|NCT04682691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25444198|NCT04682691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444199|NCT04682691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25444200|NCT04682691|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25444201|NCT04682691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25444202|NCT04682691|Dopamine Agents|dopamine agents|mesh-ancestor
25444203|NCT04682691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25444204|NCT04682691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297407|NCT05119257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297408|NCT05108155|Tacrine|tacrine|mesh-list
25297409|NCT05108155|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25297410|NCT05108155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25297411|NCT05108155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297412|NCT05108155|Cholinergic Agents|cholinergic agents|mesh-ancestor
25297413|NCT05108155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25297414|NCT05108155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297415|NCT05108155|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25444205|NCT04682691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25444206|NCT04682691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25444207|NCT04682691|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25444208|NCT04682691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444210|NCT04682795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25444211|NCT04682795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444212|NCT04682899|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25444213|NCT04682899|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25444214|NCT04682899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25444215|NCT04682899|Antitubercular Agents|antitubercular agents|mesh-ancestor
25444216|NCT04681937|Methylprednisolone|methylprednisolone|mesh-list
25444217|NCT04681937|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25444218|NCT04681937|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25444219|NCT04681937|Prednisolone|prednisolone|mesh-list
25444220|NCT04681937|Prednisolone acetate|prednisolone acetate|mesh-list
25444221|NCT04681937|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25444222|NCT04681937|Prednisolone phosphate|prednisolone phosphate|mesh-list
25444223|NCT04681937|Hyaluronic Acid|hyaluronic acid|mesh-list
25444224|NCT04681937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25444225|NCT04681937|Antiemetics|antiemetics|mesh-ancestor
25444226|NCT04681937|Autonomic Agents|autonomic agents|mesh-ancestor
25444227|NCT04681937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25444228|NCT04681937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444229|NCT04681937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25444230|NCT04681937|Glucocorticoids|glucocorticoids|mesh-ancestor
25444231|NCT04681937|Hormones|hormones|mesh-ancestor
25444232|NCT04681937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25444233|NCT04681937|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25444234|NCT04681937|Protective Agents|protective agents|mesh-ancestor
25444235|NCT04681937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25444236|NCT04681937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444237|NCT04681937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25444238|NCT04681937|Immunologic Factors|immunologic factors|mesh-ancestor
25444239|NCT04681937|Viscosupplements|viscosupplements|mesh-ancestor
25444240|NCT04681846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25444241|NCT04681846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25444242|NCT04682249|Apatinib|apatinib|mesh-list
25444243|NCT04682249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444244|NCT04682249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25444245|NCT04682249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444246|NCT04682249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444247|NCT04682184|Propranolol|propranolol|mesh-list
25444248|NCT04682184|Pseudoephedrine|pseudoephedrine|mesh-list
25444249|NCT04682184|Ephedrine|ephedrine|mesh-list
25444250|NCT04682184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25444251|NCT04682184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25444252|NCT04682184|Adrenergic Agents|adrenergic agents|mesh-ancestor
25444253|NCT04682184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25444254|NCT04682184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444255|NCT04682184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444256|NCT04682184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25444257|NCT04682184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25444258|NCT04682184|Vasodilator Agents|vasodilator agents|mesh-ancestor
25444259|NCT04682184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25444260|NCT04682184|Autonomic Agents|autonomic agents|mesh-ancestor
25444261|NCT04682184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25444262|NCT04682184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25444263|NCT04682184|Respiratory System Agents|respiratory system agents|mesh-ancestor
25444264|NCT04682184|Nasal Decongestants|nasal decongestants|mesh-ancestor
25444265|NCT04682184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25444266|NCT04682184|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25444267|NCT04682184|Sympathomimetics|sympathomimetics|mesh-ancestor
25444268|NCT04682210|Bevacizumab|bevacizumab|mesh-list
25444269|NCT04682210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25444270|NCT04682210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444271|NCT04682210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25444272|NCT04682210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25444273|NCT04682210|Growth Substances|growth substances|mesh-ancestor
25444274|NCT04682210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444275|NCT04682210|Growth Inhibitors|growth inhibitors|mesh-ancestor
25444276|NCT04682132|Antibodies|antibodies|mesh-list
25444277|NCT04682132|Immunologic Factors|immunologic factors|mesh-ancestor
25444278|NCT04682132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444279|NCT04681820|HH-GV-678|hh-gv-678|mesh-list
25444280|NCT04681820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25444281|NCT04681820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444282|NCT04681820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444283|NCT04681911|Gemcitabine|gemcitabine|mesh-list
25444284|NCT04681911|Paclitaxel|paclitaxel|mesh-list
25643791|NCT01431014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25643792|NCT01431014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643793|NCT01431014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25643794|NCT01431014|Glucocorticoids|glucocorticoids|mesh-ancestor
25643795|NCT01431014|Hormones|hormones|mesh-ancestor
25643796|NCT01431014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25643797|NCT01431014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25643798|NCT01431014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25643799|NCT01431014|Protease Inhibitors|protease inhibitors|mesh-ancestor
25643800|NCT01431014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25643801|NCT01431014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643802|NCT01431105|Atorvastatin|atorvastatin|mesh-list
25444285|NCT04681911|Vinorelbine|vinorelbine|mesh-list
25444286|NCT04681911|Carboplatin|carboplatin|mesh-list
25444287|NCT04681911|Capecitabine|capecitabine|mesh-list
25444288|NCT04681911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25720373|NCT02467504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25444289|NCT04681911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444290|NCT04681911|Tubulin Modulators|tubulin modulators|mesh-ancestor
25444291|NCT04681911|Antimitotic Agents|antimitotic agents|mesh-ancestor
25444292|NCT04681911|Mitosis Modulators|mitosis modulators|mesh-ancestor
25444293|NCT04681911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444294|NCT04681911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25444295|NCT04681911|Antimetabolites|antimetabolites|mesh-ancestor
25444296|NCT04681911|Antiviral Agents|antiviral agents|mesh-ancestor
25444297|NCT04681911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25444298|NCT04681911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444299|NCT04681911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25444300|NCT04681911|Immunologic Factors|immunologic factors|mesh-ancestor
25444301|NCT04681911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444302|NCT04682041|Immunoglobulins|immunoglobulins|mesh-list
25444303|NCT04682041|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25444304|NCT04682041|Antibodies|antibodies|mesh-list
25444305|NCT04682041|Immunologic Factors|immunologic factors|mesh-ancestor
25444306|NCT04682041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444307|NCT04680884|Antifungal Agents|antifungal agents|mesh-list
25444308|NCT04680884|Clotrimazole|clotrimazole|mesh-list
25444309|NCT04680884|Miconazole|miconazole|mesh-list
25444310|NCT04680884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25444311|NCT04680884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25444312|NCT04680884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25444313|NCT04680884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25444314|NCT04680884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444315|NCT04680884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444316|NCT04680884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25444317|NCT04680884|Hormone Antagonists|hormone antagonists|mesh-ancestor
25444318|NCT04680884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25444319|NCT04680884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444320|NCT04680884|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25444321|NCT04680884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25444322|NCT04680962|Rituximab|rituximab|mesh-list
25444323|NCT04680962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25444324|NCT04680962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444325|NCT04680962|Immunologic Factors|immunologic factors|mesh-ancestor
25444326|NCT04680962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444327|NCT04680962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25444328|NCT04681027|Oxymorphone|oxymorphone|mesh-list
25444329|NCT04681027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25444330|NCT04681027|Narcotics|narcotics|mesh-ancestor
25444331|NCT04681027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25444332|NCT04681027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444333|NCT04681027|Analgesics|analgesics|mesh-ancestor
25444334|NCT04681027|Sensory System Agents|sensory system agents|mesh-ancestor
25444335|NCT04681027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25444336|NCT04681027|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25444337|NCT04681053|Ivermectin|ivermectin|mesh-list
25444338|NCT04681053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25444339|NCT04681053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25444340|NCT04680923|Bupivacaine|bupivacaine|mesh-list
25444341|NCT04680923|Anesthetics, Local|anesthetics, local|mesh-ancestor
25444342|NCT04680923|Anesthetics|anesthetics|mesh-ancestor
25444343|NCT04680923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25444344|NCT04680923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444345|NCT04680923|Sensory System Agents|sensory system agents|mesh-ancestor
25444346|NCT04680923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25444347|NCT04680819|Propolis|propolis|mesh-list
25444348|NCT04680819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25444349|NCT04680650|Anesthetics|anesthetics|mesh-list
25444350|NCT04680650|Propofol|propofol|mesh-list
25444351|NCT04680650|Sevoflurane|sevoflurane|mesh-list
25444352|NCT04680650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25444353|NCT04680650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444354|NCT04680650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25444355|NCT04680650|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25444356|NCT04680650|Anesthetics, General|anesthetics, general|mesh-ancestor
25444360|NCT04680221|Anesthetics, Local|anesthetics, local|mesh-ancestor
25444361|NCT04680221|Anesthetics|anesthetics|mesh-ancestor
25444362|NCT04680221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25444363|NCT04680221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444364|NCT04680221|Sensory System Agents|sensory system agents|mesh-ancestor
25444365|NCT04680221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25444366|NCT04680091|Efavirenz|efavirenz|mesh-list
25444367|NCT04680091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444368|NCT04680091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444369|NCT04680091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25444370|NCT04680091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25444371|NCT04680091|Antiviral Agents|antiviral agents|mesh-ancestor
25444372|NCT04680091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25444373|NCT04680091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25444374|NCT04680091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25444375|NCT04680091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25444376|NCT04680091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25444377|NCT04680091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25444378|NCT04680091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25444379|NCT04680143|Epoetin Alfa|epoetin alfa|mesh-list
25444380|NCT04680143|Hematinics|hematinics|mesh-ancestor
25444381|NCT04680208|Anesthetics|anesthetics|mesh-list
25444382|NCT04680208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25444383|NCT04680208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444384|NCT04679948|Midazolam|midazolam|mesh-list
25444385|NCT04679948|Caffeine|caffeine|mesh-list
25444386|NCT04679948|Omeprazole|omeprazole|mesh-list
25444387|NCT04679948|Warfarin|warfarin|mesh-list
25444388|NCT04679948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25444389|NCT04679948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25444390|NCT04679948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25444391|NCT04679948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444392|NCT04679948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25444393|NCT04679948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25444394|NCT04679948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25444395|NCT04679948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25444396|NCT04679948|Anesthetics, General|anesthetics, general|mesh-ancestor
25444397|NCT04679948|Anesthetics|anesthetics|mesh-ancestor
25444398|NCT04679948|GABA Modulators|gaba modulators|mesh-ancestor
25444399|NCT04679948|GABA Agents|gaba agents|mesh-ancestor
25444400|NCT04679948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25444401|NCT04679948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444402|NCT04679948|Anticoagulants|anticoagulants|mesh-ancestor
25444403|NCT04679948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25444404|NCT04679948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25444405|NCT04679948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25444406|NCT04679948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444407|NCT04679948|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25444408|NCT04679948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25444409|NCT04679948|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25444410|NCT04679948|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25444411|NCT04679948|Purinergic Agents|purinergic agents|mesh-ancestor
25444412|NCT04680286|Methadone|methadone|mesh-list
25444413|NCT04680286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25444414|NCT04680286|Narcotics|narcotics|mesh-ancestor
25444415|NCT04680286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25444416|NCT04680286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444417|NCT04680286|Analgesics|analgesics|mesh-ancestor
25444418|NCT04680286|Sensory System Agents|sensory system agents|mesh-ancestor
25444419|NCT04680286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25444420|NCT04680286|Antitussive Agents|antitussive agents|mesh-ancestor
25444421|NCT04680286|Respiratory System Agents|respiratory system agents|mesh-ancestor
25444422|NCT04679740|Sirolimus|sirolimus|mesh-list
25444423|NCT04679740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25444424|NCT04679740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25297713|NCT03107182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25297714|NCT03107182|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25297715|NCT03107182|Antipruritics|antipruritics|mesh-ancestor
25297716|NCT03107182|Dermatologic Agents|dermatologic agents|mesh-ancestor
25297717|NCT03107182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25297718|NCT03107182|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25297719|NCT02969837|Dexamethasone|dexamethasone|mesh-list
25297720|NCT02969837|Lenalidomide|lenalidomide|mesh-list
25297721|NCT02969837|Elotuzumab|elotuzumab|mesh-list
25297722|NCT02969837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25444425|NCT04679740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25444426|NCT04679740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444427|NCT04679740|Antifungal Agents|antifungal agents|mesh-ancestor
25444428|NCT04679740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25444429|NCT04679740|Immunologic Factors|immunologic factors|mesh-ancestor
25444430|NCT04679740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444431|NCT04679558|Chlorhexidine|chlorhexidine|mesh-list
25444432|NCT04679558|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25444433|NCT04679558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25444434|NCT04679558|Disinfectants|disinfectants|mesh-ancestor
25444435|NCT04679389|Acetazolamide|acetazolamide|mesh-list
25444436|NCT04679389|Anticonvulsants|anticonvulsants|mesh-ancestor
25444437|NCT04679389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25444438|NCT04679389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444439|NCT04679389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444440|NCT04679389|Diuretics|diuretics|mesh-ancestor
25444441|NCT04679389|Natriuretic Agents|natriuretic agents|mesh-ancestor
25444442|NCT04679389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444443|NCT04680195|Thalidomide|thalidomide|mesh-list
25444444|NCT04680195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25444445|NCT04680195|Immunologic Factors|immunologic factors|mesh-ancestor
25444446|NCT04680195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444447|NCT04680195|Leprostatic Agents|leprostatic agents|mesh-ancestor
25444448|NCT04680195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25444449|NCT04680195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25444450|NCT04680195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25444451|NCT04680195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25444452|NCT04680195|Growth Substances|growth substances|mesh-ancestor
25444453|NCT04680195|Growth Inhibitors|growth inhibitors|mesh-ancestor
25643803|NCT01431105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25643804|NCT01431105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25643805|NCT01431105|Antimetabolites|antimetabolites|mesh-ancestor
25643806|NCT01431105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643807|NCT01431105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25643808|NCT01431105|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25444454|NCT04680195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444456|NCT04679597|Oxaliplatin|oxaliplatin|mesh-list
25444457|NCT04679597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25444458|NCT04679597|Antimetabolites|antimetabolites|mesh-ancestor
25444459|NCT04679597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444460|NCT04679597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444461|NCT04679506|Cytarabine|cytarabine|mesh-list
25444462|NCT04679506|Etoposide|etoposide|mesh-list
25444463|NCT04679506|Cladribine|cladribine|mesh-list
25444464|NCT04679506|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25444465|NCT04679506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444466|NCT04679506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25444467|NCT04679506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25444468|NCT04679506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444469|NCT04679506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444470|NCT04679506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25444471|NCT04679506|Antimetabolites|antimetabolites|mesh-ancestor
25444472|NCT04679506|Antiviral Agents|antiviral agents|mesh-ancestor
25444473|NCT04679506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25444474|NCT04679506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25444475|NCT04679506|Immunologic Factors|immunologic factors|mesh-ancestor
25444476|NCT04679506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444477|NCT04679480|Cemiplimab|cemiplimab|mesh-list
25444478|NCT04679480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25444479|NCT04679480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444480|NCT04679142|Baclofen|baclofen|mesh-list
25444481|NCT04679142|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25444482|NCT04679142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444483|NCT04679142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25444484|NCT04679142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25444485|NCT04679142|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25444486|NCT04679142|GABA Agonists|gaba agonists|mesh-ancestor
25444487|NCT04679142|GABA Agents|gaba agents|mesh-ancestor
25444488|NCT04679142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25444489|NCT04679142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444490|NCT04679064|Gemcitabine|gemcitabine|mesh-list
25444491|NCT04679064|Paclitaxel|paclitaxel|mesh-list
25444492|NCT04679064|Bevacizumab|bevacizumab|mesh-list
25444493|NCT04679064|Doxorubicin|doxorubicin|mesh-list
25444494|NCT04679064|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25444495|NCT04679064|Topotecan|topotecan|mesh-list
25444496|NCT04679064|Niraparib|niraparib|mesh-list
25444497|NCT04679064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25297790|NCT02144857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25297791|NCT02144857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25297792|NCT02144857|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25444498|NCT04679064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444499|NCT04679064|Tubulin Modulators|tubulin modulators|mesh-ancestor
25444500|NCT04679064|Antimitotic Agents|antimitotic agents|mesh-ancestor
25444501|NCT04679064|Mitosis Modulators|mitosis modulators|mesh-ancestor
25444502|NCT04679064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444503|NCT04679064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25444504|NCT04679064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25444505|NCT04679064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25444506|NCT04679064|Growth Substances|growth substances|mesh-ancestor
25444507|NCT04679064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444508|NCT04679064|Growth Inhibitors|growth inhibitors|mesh-ancestor
25444509|NCT04679064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25444510|NCT04679064|Antimetabolites|antimetabolites|mesh-ancestor
25444511|NCT04679064|Antiviral Agents|antiviral agents|mesh-ancestor
25444512|NCT04679064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25444513|NCT04679064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444514|NCT04679064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25444515|NCT04679064|Immunologic Factors|immunologic factors|mesh-ancestor
25444516|NCT04679064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25444517|NCT04679064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24504723|NCT00537901|Growth Inhibitors|growth inhibitors|mesh-ancestor
25444518|NCT04679064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25444519|NCT04679064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25444520|NCT04679064|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25444522|NCT04679103|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25444523|NCT04679103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25643809|NCT01431105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25643810|NCT01431170|Trimethoprim|trimethoprim|mesh-list
25643811|NCT01431170|Polymyxins|polymyxins|mesh-list
25643812|NCT01431170|Polymyxin B|polymyxin b|mesh-list
25643813|NCT01431170|Besifloxacin|besifloxacin|mesh-list
25643814|NCT01431170|Fluoroquinolones|fluoroquinolones|mesh-list
25643815|NCT01431170|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25444525|NCT04679103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444526|NCT04678830|Leronlimab|leronlimab|mesh-list
25444527|NCT04678830|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25444528|NCT04678830|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25444529|NCT04678830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444530|NCT04678830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25444531|NCT04678830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25444532|NCT04678830|Antiviral Agents|antiviral agents|mesh-ancestor
25444533|NCT04678830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25444534|NCT04678791|Cisplatin|cisplatin|mesh-list
25444535|NCT04678791|Nimotuzumab|nimotuzumab|mesh-list
25444536|NCT04678791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444537|NCT04678791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25444538|NCT04678739|Remdesivir|remdesivir|mesh-list
25444539|NCT04678739|Antimetabolites|antimetabolites|mesh-ancestor
25444540|NCT04678739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444541|NCT04678739|Antiviral Agents|antiviral agents|mesh-ancestor
25444542|NCT04678739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25444543|NCT04678492|Amoxicillin|amoxicillin|mesh-list
25444544|NCT04678492|Tetracycline|tetracycline|mesh-list
25444545|NCT04678492|Furazolidone|furazolidone|mesh-list
25444546|NCT04678492|Esomeprazole|esomeprazole|mesh-list
25444547|NCT04678492|Bismuth|bismuth|mesh-list
25444548|NCT04678492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25444549|NCT04678492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25444550|NCT04678492|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25444551|NCT04678492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25444552|NCT04678492|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25444553|NCT04678492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444554|NCT04678492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444555|NCT04678492|Antacids|antacids|mesh-ancestor
25444556|NCT04678492|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25444557|NCT04678492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25444558|NCT04678492|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25444559|NCT04678492|Renal Agents|renal agents|mesh-ancestor
25444560|NCT04678492|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25444561|NCT04678492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25444562|NCT04678492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25444563|NCT04678492|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25444564|NCT04678531|Tea Tree Oil|tea tree oil|mesh-list
25444565|NCT04678531|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25444566|NCT04678531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25444567|NCT04678076|Ketoprofen|ketoprofen|mesh-list
25444568|NCT04678076|Ketoprofen lysine|ketoprofen lysine|mesh-list
25444569|NCT04678076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25444570|NCT04678076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25444571|NCT04678076|Analgesics|analgesics|mesh-ancestor
25444572|NCT04678076|Sensory System Agents|sensory system agents|mesh-ancestor
25444573|NCT04678076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25444574|NCT04678076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444582|NCT04677985|Sensory System Agents|sensory system agents|mesh-ancestor
25444583|NCT04677985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25444584|NCT04677985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444585|NCT04677985|Antipruritics|antipruritics|mesh-ancestor
25444586|NCT04677985|Dermatologic Agents|dermatologic agents|mesh-ancestor
25444587|NCT04677868|Methotrexate|methotrexate|mesh-list
25444588|NCT04677868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25444589|NCT04677868|Abortifacient Agents|abortifacient agents|mesh-ancestor
25444590|NCT04677868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25444591|NCT04677868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444592|NCT04677868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25444593|NCT04677868|Antimetabolites|antimetabolites|mesh-ancestor
25444594|NCT04677868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444595|NCT04677868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444596|NCT04677868|Dermatologic Agents|dermatologic agents|mesh-ancestor
25444597|NCT04677868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444598|NCT04677868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25444599|NCT04677868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25444600|NCT04677868|Immunologic Factors|immunologic factors|mesh-ancestor
25444601|NCT04677868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25444602|NCT04677868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25444603|NCT04677855|Prednisone|prednisone|mesh-list
25444604|NCT04677855|Dutasteride|dutasteride|mesh-list
25444605|NCT04677855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25444606|NCT04677855|Glucocorticoids|glucocorticoids|mesh-ancestor
25444607|NCT04677855|Hormones|hormones|mesh-ancestor
25444608|NCT04677855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25444609|NCT04677855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444610|NCT04677855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25444611|NCT04677855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444612|NCT04677855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25444613|NCT04677855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25444614|NCT04677855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444615|NCT04677855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444616|NCT04677855|Hormone Antagonists|hormone antagonists|mesh-ancestor
25444617|NCT04677335|Lovastatin|lovastatin|mesh-list
25444618|NCT04677335|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25444619|NCT04677335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25444620|NCT04677335|Antimetabolites|antimetabolites|mesh-ancestor
25444621|NCT04677335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444622|NCT04677335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25444623|NCT04677335|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25444624|NCT04677335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444625|NCT04677361|Pembrolizumab|pembrolizumab|mesh-list
25444626|NCT04677361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25444627|NCT04677361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444628|NCT04676958|Vitamin K|vitamin k|mesh-list
25444629|NCT04676958|Vitamin K 2|vitamin k 2|mesh-list
25444630|NCT04676958|Vitamins|vitamins|mesh-ancestor
25444631|NCT04676958|Micronutrients|micronutrients|mesh-ancestor
25444632|NCT04676958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444633|NCT04676958|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25444634|NCT04676958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25444635|NCT04676958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444636|NCT04676958|Hemostatics|hemostatics|mesh-ancestor
25444637|NCT04676958|Coagulants|coagulants|mesh-ancestor
25444638|NCT04676867|Dalcetrapib|dalcetrapib|mesh-list
25444639|NCT04676867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25444640|NCT04676867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25444641|NCT04676867|Antimetabolites|antimetabolites|mesh-ancestor
25298014|NCT05229991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25298015|NCT05229991|Antiviral Agents|antiviral agents|mesh-ancestor
25298016|NCT05229991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25298017|NCT05229991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25298018|NCT05229991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25298019|NCT05229913|Esketamine|esketamine|mesh-list
25298020|NCT05229913|Antidepressive Agents|antidepressive agents|mesh-ancestor
25298021|NCT05229913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25298022|NCT05229796|Empagliflozin|empagliflozin|mesh-list
25298023|NCT05229796|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25298024|NCT05229796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298025|NCT05229796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25444642|NCT04676867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444643|NCT04676867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25444644|NCT04676997|Paclitaxel|paclitaxel|mesh-list
25444645|NCT04676997|Cyclophosphamide|cyclophosphamide|mesh-list
25444646|NCT04676997|Epirubicin|epirubicin|mesh-list
25444647|NCT04676997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25444648|NCT04676997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444649|NCT04676997|Tubulin Modulators|tubulin modulators|mesh-ancestor
25444650|NCT04676997|Antimitotic Agents|antimitotic agents|mesh-ancestor
25444651|NCT04676997|Mitosis Modulators|mitosis modulators|mesh-ancestor
25444652|NCT04676997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444653|NCT04676997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25444654|NCT04676997|Immunologic Factors|immunologic factors|mesh-ancestor
25444655|NCT04676997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444656|NCT04676997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25444657|NCT04676997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25444658|NCT04676997|Alkylating Agents|alkylating agents|mesh-ancestor
25444659|NCT04676997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25444660|NCT04676997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25444661|NCT04676997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25444662|NCT04676997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25444663|NCT04676997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444665|NCT04676763|Substance P|substance p|mesh-list
25444666|NCT04676763|Neurokinin A|neurokinin a|mesh-list
25444667|NCT04676763|Histamine Agonists|histamine agonists|mesh-ancestor
25444668|NCT04676763|Histamine Agents|histamine agents|mesh-ancestor
25444669|NCT04676763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25444670|NCT04676763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444671|NCT04676763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444672|NCT04676789|Pegaspargase|pegaspargase|mesh-list
25444673|NCT04676789|Antibodies|antibodies|mesh-list
25444674|NCT04676789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25444675|NCT04676789|Immunologic Factors|immunologic factors|mesh-ancestor
25444676|NCT04676789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444677|NCT04676789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444678|NCT04676659|Tenecteplase|tenecteplase|mesh-list
25444679|NCT04676659|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25444680|NCT04676659|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25444681|NCT04676659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444682|NCT04676516|GSK-3326595|gsk-3326595|mesh-list
25444683|NCT04676516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444684|NCT04676516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444685|NCT04676776|Levonorgestrel|levonorgestrel|mesh-list
25444686|NCT04676776|Mifepristone|mifepristone|mesh-list
25444687|NCT04676776|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25444688|NCT04676776|Contraceptive Agents|contraceptive agents|mesh-ancestor
25444689|NCT04676776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25444690|NCT04676776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444691|NCT04676776|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25444692|NCT04676776|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25444693|NCT04676776|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25444694|NCT04676776|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25444695|NCT04676776|Abortifacient Agents|abortifacient agents|mesh-ancestor
25444696|NCT04676776|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25444697|NCT04676776|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25444698|NCT04676776|Hormone Antagonists|hormone antagonists|mesh-ancestor
25444699|NCT04676776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25444700|NCT04676776|Luteolytic Agents|luteolytic agents|mesh-ancestor
25444701|NCT04676776|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25444702|NCT04676139|Fluoxetine|fluoxetine|mesh-list
25444703|NCT04676139|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25444704|NCT04676139|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25444705|NCT04676139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25444706|NCT04676139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444707|NCT04676139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25444708|NCT04676139|Serotonin Agents|serotonin agents|mesh-ancestor
25444709|NCT04676139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444710|NCT04676139|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25444711|NCT04676139|Antidepressive Agents|antidepressive agents|mesh-ancestor
25444712|NCT04676139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25444713|NCT04676139|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25444714|NCT04676139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25444716|NCT04676061|Norethindrone|norethindrone|mesh-list
25444717|NCT04676061|Norethindrone Acetate|norethindrone acetate|mesh-list
25444718|NCT04676061|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25444719|NCT04676061|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25444720|NCT04676061|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25444721|NCT04676061|Contraceptive Agents|contraceptive agents|mesh-ancestor
25444722|NCT04676061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25444723|NCT04676061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444724|NCT04676061|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25444725|NCT04676061|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25444726|NCT04676035|Vitamin K 1|vitamin k 1|mesh-list
25444727|NCT04676035|Vitamin K|vitamin k|mesh-list
25444728|NCT04676035|Midazolam|midazolam|mesh-list
25444729|NCT04676035|Omeprazole|omeprazole|mesh-list
25444730|NCT04676035|Warfarin|warfarin|mesh-list
25444731|NCT04676035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25444732|NCT04676035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25444733|NCT04676035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25643816|NCT01431170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25643818|NCT01431170|Antimalarials|antimalarials|mesh-ancestor
25643819|NCT01431170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25643820|NCT01431170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25643821|NCT01431170|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25643822|NCT01431170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25643823|NCT01431170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643824|NCT01431170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25643825|NCT01431170|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25643826|NCT01431170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25643827|NCT01431170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25444734|NCT04676035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444735|NCT04676035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25444736|NCT04676035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25444737|NCT04676035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25444738|NCT04676035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25444739|NCT04676035|Anesthetics, General|anesthetics, general|mesh-ancestor
25444740|NCT04676035|Anesthetics|anesthetics|mesh-ancestor
25444741|NCT04676035|GABA Modulators|gaba modulators|mesh-ancestor
25444742|NCT04676035|GABA Agents|gaba agents|mesh-ancestor
25444743|NCT04676035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25444744|NCT04676035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444745|NCT04676035|Anticoagulants|anticoagulants|mesh-ancestor
25444746|NCT04676035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25444747|NCT04676035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25444748|NCT04676035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25444749|NCT04676035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444750|NCT04676035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25444751|NCT04676035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25444752|NCT04676035|Hemostatics|hemostatics|mesh-ancestor
25444753|NCT04676035|Coagulants|coagulants|mesh-ancestor
25444754|NCT04676035|Vitamins|vitamins|mesh-ancestor
25444755|NCT04676035|Micronutrients|micronutrients|mesh-ancestor
25444756|NCT04675944|Treprostinil|treprostinil|mesh-list
25444757|NCT04675944|Zamicastat|zamicastat|mesh-list
25444758|NCT04675944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25444759|NCT04675944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444760|NCT04675944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444761|NCT04675697|Etoposide|etoposide|mesh-list
25444762|NCT04675697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25444763|NCT04675697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444764|NCT04675697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25444765|NCT04675697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25444766|NCT04675697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444767|NCT04675697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444768|NCT04676126|Dorzolamide|dorzolamide|mesh-list
25444769|NCT04676126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25444770|NCT04676126|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25444771|NCT04676126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444772|NCT04676126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444773|NCT04675619|Pirfenidone|pirfenidone|mesh-list
25444774|NCT04675619|Analgesics|analgesics|mesh-ancestor
25444775|NCT04675619|Sensory System Agents|sensory system agents|mesh-ancestor
25444776|NCT04675619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25444777|NCT04675619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444778|NCT04675619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25444779|NCT04675619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25444780|NCT04675619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25444781|NCT04675619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25298164|NCT05183412|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25298165|NCT05183412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298166|NCT05183412|Sympathomimetics|sympathomimetics|mesh-ancestor
25298167|NCT05183412|Autonomic Agents|autonomic agents|mesh-ancestor
25298168|NCT05183412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25298169|NCT05183412|Dopamine Agents|dopamine agents|mesh-ancestor
25298170|NCT05183412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25444782|NCT04675619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444783|NCT04675762|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25444796|NCT04675983|Cisplatin|cisplatin|mesh-list
25444797|NCT04675983|Fluorouracil|fluorouracil|mesh-list
25444798|NCT04675983|Capecitabine|capecitabine|mesh-list
25444799|NCT04675983|Oxaliplatin|oxaliplatin|mesh-list
25444800|NCT04675983|Ramucirumab|ramucirumab|mesh-list
25444801|NCT04675983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444802|NCT04675983|Antimetabolites|antimetabolites|mesh-ancestor
25643828|NCT01431170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25444803|NCT04675983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444804|NCT04675983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25444805|NCT04675983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25444806|NCT04675983|Immunologic Factors|immunologic factors|mesh-ancestor
25444807|NCT04675983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444808|NCT04675177|Polidocanol|polidocanol|mesh-list
25444809|NCT04675177|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25444810|NCT04675177|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25444811|NCT04675385|Hyaluronic Acid|hyaluronic acid|mesh-list
25444812|NCT04675385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25720420|NCT02469077|Analgesics|analgesics|mesh-ancestor
25444813|NCT04675385|Immunologic Factors|immunologic factors|mesh-ancestor
25444814|NCT04675385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444815|NCT04675385|Viscosupplements|viscosupplements|mesh-ancestor
25444816|NCT04675385|Protective Agents|protective agents|mesh-ancestor
25444817|NCT04675086|Antiviral Agents|antiviral agents|mesh-list
25444818|NCT04675086|Remdesivir|remdesivir|mesh-list
25444819|NCT04675086|Protease Inhibitors|protease inhibitors|mesh-list
25444820|NCT04675086|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25444821|NCT04675086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25444822|NCT04675086|Antimetabolites|antimetabolites|mesh-ancestor
25444823|NCT04675086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444824|NCT04675086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444825|NCT04675086|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25444826|NCT04675086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25444827|NCT04675372|Midazolam|midazolam|mesh-list
25444828|NCT04675372|Dexmedetomidine|dexmedetomidine|mesh-list
25444829|NCT04675372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25444830|NCT04675372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25444831|NCT04675372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444832|NCT04675372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25444833|NCT04675372|Analgesics|analgesics|mesh-ancestor
25444834|NCT04675372|Sensory System Agents|sensory system agents|mesh-ancestor
25444835|NCT04675372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25444836|NCT04675372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25444837|NCT04675372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25444838|NCT04675372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25444839|NCT04675372|Adrenergic Agents|adrenergic agents|mesh-ancestor
25444840|NCT04675372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25444841|NCT04675372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444842|NCT04675372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25444843|NCT04675372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25444844|NCT04675372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25444845|NCT04675372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25444846|NCT04675372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25444847|NCT04675372|Anesthetics, General|anesthetics, general|mesh-ancestor
25444848|NCT04675372|Anesthetics|anesthetics|mesh-ancestor
25444849|NCT04675372|GABA Modulators|gaba modulators|mesh-ancestor
25444850|NCT04675372|GABA Agents|gaba agents|mesh-ancestor
25444851|NCT04674956|Gemcitabine|gemcitabine|mesh-list
25444852|NCT04674956|Paclitaxel|paclitaxel|mesh-list
25444853|NCT04674956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25444854|NCT04674956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444855|NCT04674956|Tubulin Modulators|tubulin modulators|mesh-ancestor
25444856|NCT04674956|Antimitotic Agents|antimitotic agents|mesh-ancestor
25444857|NCT04674956|Mitosis Modulators|mitosis modulators|mesh-ancestor
25444858|NCT04674956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444859|NCT04674956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25444860|NCT04674956|Antimetabolites|antimetabolites|mesh-ancestor
25444861|NCT04674956|Antiviral Agents|antiviral agents|mesh-ancestor
25444862|NCT04674956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25444863|NCT04674956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444864|NCT04674956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25444865|NCT04674956|Immunologic Factors|immunologic factors|mesh-ancestor
25444866|NCT04674956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444867|NCT04675021|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25444868|NCT04674423|Tenofovir|tenofovir|mesh-list
25444869|NCT04674423|Antiviral Agents|antiviral agents|mesh-ancestor
25444870|NCT04674423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25444871|NCT04674423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25444872|NCT04674423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25444873|NCT04674423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444874|NCT04674423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444875|NCT04674423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25444876|NCT04674423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25444877|NCT04674332|Insulin, Long-Acting|insulin, long-acting|mesh-list
25444879|NCT04674332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444880|NCT04674176|Rifaximin|rifaximin|mesh-list
25444881|NCT04674176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25444882|NCT04674176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25444883|NCT04674176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25444884|NCT04674527|Temozolomide|temozolomide|mesh-list
25444885|NCT04674527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25444886|NCT04674527|Alkylating Agents|alkylating agents|mesh-ancestor
25444887|NCT04674527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444888|NCT04674527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444889|NCT04673877|Vancomycin|vancomycin|mesh-list
25444890|NCT04673877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25444891|NCT04673877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25444892|NCT04673955|Cetuximab|cetuximab|mesh-list
25444893|NCT04673955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25444894|NCT04673955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444895|NCT04673799|Denosumab|denosumab|mesh-list
25444896|NCT04673799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25444897|NCT04673799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444898|NCT04673812|Fentanyl|fentanyl|mesh-list
25444899|NCT04673812|Bupivacaine|bupivacaine|mesh-list
25444900|NCT04673812|Naloxone|naloxone|mesh-list
25444901|NCT04673812|Anesthetics, Local|anesthetics, local|mesh-ancestor
25444902|NCT04673812|Anesthetics|anesthetics|mesh-ancestor
25444903|NCT04673812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25444904|NCT04673812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444905|NCT04673812|Sensory System Agents|sensory system agents|mesh-ancestor
25444906|NCT04673812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25444907|NCT04673812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25444908|NCT04673812|Narcotics|narcotics|mesh-ancestor
25444909|NCT04673812|Analgesics|analgesics|mesh-ancestor
25444910|NCT04673812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25444911|NCT04673812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25444912|NCT04673812|Anesthetics, General|anesthetics, general|mesh-ancestor
25444913|NCT04673812|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25444914|NCT04674137|Histamine|histamine|mesh-list
25444915|NCT04674137|Glutarimide|glutarimide|mesh-list
25444916|NCT04674137|Histamine Agonists|histamine agonists|mesh-ancestor
25444917|NCT04674137|Histamine Agents|histamine agents|mesh-ancestor
25444918|NCT04674137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25444919|NCT04674137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444920|NCT04674137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444921|NCT04674137|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25444922|NCT04674137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25444923|NCT04673487|Immunoglobulin G|immunoglobulin g|mesh-list
25444924|NCT04673487|Immunoglobulin M|immunoglobulin m|mesh-list
25444925|NCT04673487|Immunologic Factors|immunologic factors|mesh-ancestor
25444926|NCT04673487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444927|NCT04673461|Xylometazoline|xylometazoline|mesh-list
25444928|NCT04673461|Nasal Decongestants|nasal decongestants|mesh-ancestor
25444929|NCT04673461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25444930|NCT04673461|Respiratory System Agents|respiratory system agents|mesh-ancestor
25444931|NCT04673500|Lidocaine|lidocaine|mesh-list
25444932|NCT04673500|Propofol|propofol|mesh-list
25444933|NCT04673500|Anesthetics, Local|anesthetics, local|mesh-ancestor
25444934|NCT04673500|Anesthetics|anesthetics|mesh-ancestor
25444935|NCT04673500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25444936|NCT04673500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444937|NCT04673500|Sensory System Agents|sensory system agents|mesh-ancestor
25444938|NCT04673500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25444939|NCT04673500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25444940|NCT04673500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25444941|NCT04673500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25444942|NCT04673500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25444943|NCT04673500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444944|NCT04673500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25444945|NCT04673500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25444946|NCT04673500|Anesthetics, General|anesthetics, general|mesh-ancestor
25444947|NCT04673396|Norcantharidin|norcantharidin|mesh-list
25444948|NCT04673396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444949|NCT04673396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102757|NCT03166787|Tadalafil|tadalafil|mesh-list
25444958|NCT04673240|Botulinum Toxins|botulinum toxins|mesh-list
25444959|NCT04673240|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25444960|NCT04673240|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25444961|NCT04673240|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25444962|NCT04673240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25444963|NCT04673240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25444964|NCT04673240|Cholinergic Agents|cholinergic agents|mesh-ancestor
25444965|NCT04673240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25444966|NCT04673240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444967|NCT04673240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25444968|NCT04673240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25444969|NCT04673214|Acetaminophen|acetaminophen|mesh-list
25444970|NCT04673214|Azithromycin|azithromycin|mesh-list
25444971|NCT04673214|Ivermectin|ivermectin|mesh-list
25444972|NCT04673214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25444973|NCT04673214|Analgesics|analgesics|mesh-ancestor
25444974|NCT04673214|Sensory System Agents|sensory system agents|mesh-ancestor
25444975|NCT04673214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25444976|NCT04673214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444977|NCT04673214|Antipyretics|antipyretics|mesh-ancestor
25444978|NCT04673214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25444979|NCT04673214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25444980|NCT04673214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25444981|NCT04672759|Durvalumab|durvalumab|mesh-list
25444982|NCT04672759|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25444983|NCT04672759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25444984|NCT04672759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25444985|NCT04672759|Immunologic Factors|immunologic factors|mesh-ancestor
25444986|NCT04672759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444987|NCT04672499|Cortisone|cortisone|mesh-list
25444988|NCT04672499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25444989|NCT04672707|Bromhexine|bromhexine|mesh-list
25444990|NCT04672707|Expectorants|expectorants|mesh-ancestor
25444991|NCT04672707|Respiratory System Agents|respiratory system agents|mesh-ancestor
25444992|NCT04671914|Hyaluronic Acid|hyaluronic acid|mesh-list
25444993|NCT04671914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25444994|NCT04671914|Immunologic Factors|immunologic factors|mesh-ancestor
25444995|NCT04671914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25444996|NCT04671914|Viscosupplements|viscosupplements|mesh-ancestor
25444997|NCT04671914|Protective Agents|protective agents|mesh-ancestor
25444998|NCT04671836|Lorazepam|lorazepam|mesh-list
25444999|NCT04671836|Anticonvulsants|anticonvulsants|mesh-ancestor
25445000|NCT04671836|Antiemetics|antiemetics|mesh-ancestor
25445001|NCT04671836|Autonomic Agents|autonomic agents|mesh-ancestor
25445002|NCT04671836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25445003|NCT04671836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445004|NCT04671836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25445005|NCT04671836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25445006|NCT04671836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25445007|NCT04671836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25445008|NCT04671836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25445009|NCT04671836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25445010|NCT04671836|GABA Modulators|gaba modulators|mesh-ancestor
25445011|NCT04671836|GABA Agents|gaba agents|mesh-ancestor
25445012|NCT04671836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25445013|NCT04671836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445014|NCT04671589|Meropenem|meropenem|mesh-list
25445015|NCT04671589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25445016|NCT04671589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25445017|NCT04671563|Tenofovir|tenofovir|mesh-list
25445018|NCT04671563|Antiviral Agents|antiviral agents|mesh-ancestor
25445019|NCT04671563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25445020|NCT04671563|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25445021|NCT04671563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25445022|NCT04671563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25445023|NCT04671563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445024|NCT04671563|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25720469|NCT02469701|Nivolumab|nivolumab|mesh-list
25298539|NCT03801122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298540|NCT03801122|Hemostatics|hemostatics|mesh-ancestor
25298541|NCT03801122|Coagulants|coagulants|mesh-ancestor
25298542|NCT03788291|Rituximab|rituximab|mesh-list
25298543|NCT03788291|Acalabrutinib|acalabrutinib|mesh-list
25298544|NCT03788291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25298545|NCT03788291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25822841|NCT00004685|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25298546|NCT03788291|Immunologic Factors|immunologic factors|mesh-ancestor
25298547|NCT03788291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445026|NCT04671446|Autoantibodies|autoantibodies|mesh-list
25445027|NCT04671446|Immunologic Factors|immunologic factors|mesh-ancestor
25445028|NCT04671446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445029|NCT04671160|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25643829|NCT01431170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25643830|NCT01431170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25643831|NCT01431170|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25643832|NCT01431274|Tiotropium Bromide|tiotropium bromide|mesh-list
25643834|NCT01431274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25643835|NCT01431274|Autonomic Agents|autonomic agents|mesh-ancestor
25643836|NCT01431274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25643837|NCT01431274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643838|NCT01431274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25643839|NCT01431274|Respiratory System Agents|respiratory system agents|mesh-ancestor
25643840|NCT01431274|Parasympatholytics|parasympatholytics|mesh-ancestor
25643841|NCT01431274|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25643842|NCT01431274|Cholinergic Agents|cholinergic agents|mesh-ancestor
25643843|NCT01431274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25643844|NCT01431274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445030|NCT04671160|Dalteparin|dalteparin|mesh-list
25445031|NCT04671160|Anticoagulants|anticoagulants|mesh-ancestor
25445032|NCT04671160|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25445033|NCT04671160|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25445034|NCT04671160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445035|NCT04671394|Photosensitizing Agents|photosensitizing agents|mesh-list
25445036|NCT04671394|Dermatologic Agents|dermatologic agents|mesh-ancestor
25445037|NCT04671420|Rituximab|rituximab|mesh-list
25445038|NCT04671420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25445039|NCT04671420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445040|NCT04671420|Immunologic Factors|immunologic factors|mesh-ancestor
25445041|NCT04671420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445042|NCT04671420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25445043|NCT04671108|Hyaluronic Acid|hyaluronic acid|mesh-list
25445044|NCT04671108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25445045|NCT04671108|Immunologic Factors|immunologic factors|mesh-ancestor
25445046|NCT04671108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445047|NCT04671108|Viscosupplements|viscosupplements|mesh-ancestor
25445048|NCT04671108|Protective Agents|protective agents|mesh-ancestor
25445049|NCT04670978|Bevacizumab|bevacizumab|mesh-list
25445050|NCT04670978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25445051|NCT04670978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445052|NCT04670978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25445053|NCT04670978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25445054|NCT04670978|Growth Substances|growth substances|mesh-ancestor
25445055|NCT04670978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445056|NCT04670978|Growth Inhibitors|growth inhibitors|mesh-ancestor
25445057|NCT04671056|Pioglitazone|pioglitazone|mesh-list
25445058|NCT04671056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25445059|NCT04671056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445060|NCT04670601|Flurbiprofen|flurbiprofen|mesh-list
25445061|NCT04670601|Analgesics|analgesics|mesh-ancestor
25445062|NCT04670601|Sensory System Agents|sensory system agents|mesh-ancestor
25445063|NCT04670601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25445064|NCT04670601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445065|NCT04670601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25445066|NCT04670601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25445067|NCT04670601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25445068|NCT04670601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25445069|NCT04670601|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25445070|NCT04670601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25445071|NCT04670601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445072|NCT04670913|Apatinib|apatinib|mesh-list
25445073|NCT04670913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445074|NCT04670913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25445075|NCT04670913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25445076|NCT04670913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445077|NCT04671069|Clopidogrel|clopidogrel|mesh-list
25445078|NCT04671069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25445079|NCT04671069|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25445080|NCT04671069|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25445081|NCT04671069|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25445082|NCT04671069|Purinergic Agents|purinergic agents|mesh-ancestor
25445083|NCT04671069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25445084|NCT04671069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445085|NCT04671069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445086|NCT04670809|Clevidipine|clevidipine|mesh-list
25445087|NCT04670809|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25445088|NCT04670809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25445089|NCT04670809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298616|NCT03679780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298617|NCT03679780|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25298618|NCT03679780|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25298619|NCT03679780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298620|NCT03672773|Temozolomide|temozolomide|mesh-list
24731762|NCT01636401|Bromides|bromides|mesh-list
25298621|NCT03672773|Talazoparib|talazoparib|mesh-list
25298623|NCT03672773|Alkylating Agents|alkylating agents|mesh-ancestor
25445092|NCT04670497|Epinephrine|epinephrine|mesh-list
25445093|NCT04670497|Racepinephrine|racepinephrine|mesh-list
25445094|NCT04670497|Bupivacaine|bupivacaine|mesh-list
25445095|NCT04670497|Epinephryl borate|epinephryl borate|mesh-list
25445096|NCT04670497|Anesthetics, Local|anesthetics, local|mesh-ancestor
25445097|NCT04670497|Anesthetics|anesthetics|mesh-ancestor
25445098|NCT04670497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25445099|NCT04670497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445100|NCT04670497|Sensory System Agents|sensory system agents|mesh-ancestor
25445101|NCT04670497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25445102|NCT04670497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25445103|NCT04670497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25445104|NCT04670497|Adrenergic Agents|adrenergic agents|mesh-ancestor
25445105|NCT04670497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25445106|NCT04670497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445107|NCT04670497|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25445108|NCT04670497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25445109|NCT04670497|Autonomic Agents|autonomic agents|mesh-ancestor
25445110|NCT04670497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25445111|NCT04670497|Respiratory System Agents|respiratory system agents|mesh-ancestor
25445112|NCT04670497|Mydriatics|mydriatics|mesh-ancestor
25445113|NCT04670497|Sympathomimetics|sympathomimetics|mesh-ancestor
25445114|NCT04670497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25445115|NCT04670107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25445116|NCT04670107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445117|NCT04670107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445118|NCT04670224|Anesthetics|anesthetics|mesh-list
25445119|NCT04670224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25445120|NCT04670224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445121|NCT04669821|Propofol|propofol|mesh-list
25445122|NCT04669821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25445123|NCT04669821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25445124|NCT04669821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445125|NCT04669821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25445126|NCT04669821|Anesthetics, General|anesthetics, general|mesh-ancestor
25445127|NCT04669821|Anesthetics|anesthetics|mesh-ancestor
25445128|NCT04670081|Niacinamide|niacinamide|mesh-list
25445129|NCT04670081|Niacin|niacin|mesh-list
25445130|NCT04670081|Nicotinic Acids|nicotinic acids|mesh-list
25445131|NCT04670081|Psilocybin|psilocybin|mesh-list
25445132|NCT04670081|Vitamin B Complex|vitamin b complex|mesh-ancestor
25445133|NCT04670081|Vitamins|vitamins|mesh-ancestor
25445134|NCT04670081|Micronutrients|micronutrients|mesh-ancestor
25445135|NCT04670081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445136|NCT04670081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25445137|NCT04670081|Antimetabolites|antimetabolites|mesh-ancestor
25445138|NCT04670081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445139|NCT04670081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25445140|NCT04670081|Vasodilator Agents|vasodilator agents|mesh-ancestor
25445141|NCT04670081|Hallucinogens|hallucinogens|mesh-ancestor
25445142|NCT04670081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25445143|NCT04669717|Amoxicillin|amoxicillin|mesh-list
25445144|NCT04669717|Azithromycin|azithromycin|mesh-list
25445145|NCT04669717|Metronidazole|metronidazole|mesh-list
25445146|NCT04669717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25445147|NCT04669717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25445148|NCT04669717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25445149|NCT04669717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25445150|NCT04669990|Remdesivir|remdesivir|mesh-list
25445151|NCT04669990|Antimetabolites|antimetabolites|mesh-ancestor
25445152|NCT04669990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445153|NCT04669990|Antiviral Agents|antiviral agents|mesh-ancestor
25445154|NCT04669990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25445155|NCT04669392|Ethanol|ethanol|mesh-list
25298762|NCT03317613|Sensory System Agents|sensory system agents|mesh-ancestor
25298763|NCT03317613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25643845|NCT01431287|Tiotropium Bromide|tiotropium bromide|mesh-list
25298764|NCT03317613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298777|NCT03267498|Nivolumab|nivolumab|mesh-list
25298778|NCT03267498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25298779|NCT03267498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25298780|NCT03267498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25298781|NCT03267498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298782|NCT03251729|Progesterone|progesterone|mesh-list
25298783|NCT03251729|Progestins|progestins|mesh-ancestor
25298784|NCT03251729|Hormones|hormones|mesh-ancestor
25298787|NCT03206073|Durvalumab|durvalumab|mesh-list
25445156|NCT04669392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25445157|NCT04669392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25445158|NCT04669392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25445159|NCT04669392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445160|NCT04669158|Idebenone|idebenone|mesh-list
25445161|NCT04669158|Antioxidants|antioxidants|mesh-ancestor
25445162|NCT04669158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445163|NCT04669158|Protective Agents|protective agents|mesh-ancestor
25445164|NCT04669158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445165|NCT04669145|Ropivacaine|ropivacaine|mesh-list
25445166|NCT04669145|Anesthetics, Local|anesthetics, local|mesh-ancestor
25445167|NCT04669145|Anesthetics|anesthetics|mesh-ancestor
25445168|NCT04669145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25445169|NCT04669145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445170|NCT04669145|Sensory System Agents|sensory system agents|mesh-ancestor
25445171|NCT04669145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25445172|NCT04668976|Gemcitabine|gemcitabine|mesh-list
25445173|NCT04668976|Fluorouracil|fluorouracil|mesh-list
25445174|NCT04668976|Floxuridine|floxuridine|mesh-list
25445175|NCT04668976|Oxaliplatin|oxaliplatin|mesh-list
25445176|NCT04668976|Irinotecan|irinotecan|mesh-list
25445177|NCT04668976|Cetuximab|cetuximab|mesh-list
25445178|NCT04668976|Panitumumab|panitumumab|mesh-list
25445179|NCT04668976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25445180|NCT04668976|Antimetabolites|antimetabolites|mesh-ancestor
25445181|NCT04668976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445182|NCT04668976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445183|NCT04668976|Antiviral Agents|antiviral agents|mesh-ancestor
25445184|NCT04668976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25445185|NCT04668976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25445186|NCT04668976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25445187|NCT04668976|Immunologic Factors|immunologic factors|mesh-ancestor
25445188|NCT04668976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445189|NCT04668976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25445190|NCT04668976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25445191|NCT04668976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25445192|NCT04669366|Sunitinib|sunitinib|mesh-list
25445193|NCT04669366|Axitinib|axitinib|mesh-list
25445194|NCT04669366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445195|NCT04669366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25445196|NCT04669366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25445197|NCT04669366|Growth Substances|growth substances|mesh-ancestor
25445198|NCT04669366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445199|NCT04669366|Growth Inhibitors|growth inhibitors|mesh-ancestor
25445200|NCT04669366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25445201|NCT04669366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25445202|NCT04669366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445203|NCT04668456|Lidocaine|lidocaine|mesh-list
25445204|NCT04668456|Dexmedetomidine|dexmedetomidine|mesh-list
25445205|NCT04668456|Anesthetics, Local|anesthetics, local|mesh-ancestor
25445206|NCT04668456|Anesthetics|anesthetics|mesh-ancestor
25445207|NCT04668456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25445208|NCT04668456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445209|NCT04668456|Sensory System Agents|sensory system agents|mesh-ancestor
25445210|NCT04668456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25445211|NCT04668456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25445212|NCT04668456|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25445213|NCT04668456|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25445214|NCT04668456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25445215|NCT04668456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445216|NCT04668456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25445217|NCT04668456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25445218|NCT04668456|Analgesics|analgesics|mesh-ancestor
25445219|NCT04668456|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25445220|NCT04668456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25445221|NCT04668456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25445222|NCT04668456|Adrenergic Agents|adrenergic agents|mesh-ancestor
25445223|NCT04668456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25445224|NCT04668417|Vaccines|vaccines|mesh-list
25445225|NCT04668417|Immunologic Factors|immunologic factors|mesh-ancestor
25445226|NCT04668417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445227|NCT04668690|Mitoxantrone|mitoxantrone|mesh-list
25445228|NCT04668690|Analgesics|analgesics|mesh-ancestor
25445229|NCT04668690|Sensory System Agents|sensory system agents|mesh-ancestor
25445230|NCT04668690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25445231|NCT04668690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445232|NCT04668690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445233|NCT04668690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25445264|NCT04668469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25445265|NCT04668469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25445266|NCT04668469|Hemostatics|hemostatics|mesh-ancestor
25445267|NCT04668469|Coagulants|coagulants|mesh-ancestor
25445268|NCT04668352|Dactolisib|dactolisib|mesh-list
25445269|NCT04668352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445270|NCT04668300|Durvalumab|durvalumab|mesh-list
25445271|NCT04668300|Immunoglobulins|immunoglobulins|mesh-list
25445272|NCT04668300|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25445273|NCT04668300|Immunoglobulin G|immunoglobulin g|mesh-list
25445274|NCT04668300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25445275|NCT04668300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445276|NCT04668300|Immunologic Factors|immunologic factors|mesh-ancestor
25445277|NCT04668300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298913|NCT02673996|Protective Agents|protective agents|mesh-ancestor
25298914|NCT02673996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25298915|NCT02673996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25298916|NCT02673996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25298926|NCT02597062|Dexamethasone|dexamethasone|mesh-list
25298927|NCT02597062|Cyclophosphamide|cyclophosphamide|mesh-list
25298928|NCT02597062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25298929|NCT02597062|Immunologic Factors|immunologic factors|mesh-ancestor
25445278|NCT04668131|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25445279|NCT04668131|Hyaluronic Acid|hyaluronic acid|mesh-list
25445280|NCT04668131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25445281|NCT04668131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25445282|NCT04668131|Immunologic Factors|immunologic factors|mesh-ancestor
25445283|NCT04668131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445284|NCT04668131|Viscosupplements|viscosupplements|mesh-ancestor
25445285|NCT04668131|Protective Agents|protective agents|mesh-ancestor
25445287|NCT04667663|Cyclophosphamide|cyclophosphamide|mesh-list
25445288|NCT04667663|Daratumumab|daratumumab|mesh-list
25445289|NCT04667663|Pomalidomide|pomalidomide|mesh-list
25445290|NCT04667663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25445291|NCT04667663|Immunologic Factors|immunologic factors|mesh-ancestor
25445292|NCT04667663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445293|NCT04667663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25445294|NCT04667663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25445295|NCT04667663|Alkylating Agents|alkylating agents|mesh-ancestor
25445296|NCT04667663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445297|NCT04667663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445298|NCT04667663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25445299|NCT04667663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25445300|NCT04667663|Antiemetics|antiemetics|mesh-ancestor
25445301|NCT04667663|Autonomic Agents|autonomic agents|mesh-ancestor
25445302|NCT04667663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25445303|NCT04667663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25445304|NCT04667663|Glucocorticoids|glucocorticoids|mesh-ancestor
25445305|NCT04667663|Hormones|hormones|mesh-ancestor
25445306|NCT04667663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25445307|NCT04667663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25445308|NCT04667663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25445309|NCT04667663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25445310|NCT04667663|Growth Substances|growth substances|mesh-ancestor
25445311|NCT04667663|Growth Inhibitors|growth inhibitors|mesh-ancestor
25445312|NCT04667910|Ranibizumab|ranibizumab|mesh-list
25445313|NCT04667910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25445314|NCT04667910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25445315|NCT04667910|Growth Substances|growth substances|mesh-ancestor
25445316|NCT04667910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445317|NCT04667910|Growth Inhibitors|growth inhibitors|mesh-ancestor
25445318|NCT04667910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445319|NCT04667897|Ranibizumab|ranibizumab|mesh-list
25445320|NCT04667897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25445321|NCT04667897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25445322|NCT04667897|Growth Substances|growth substances|mesh-ancestor
25643846|NCT01431287|Olodaterol|olodaterol|mesh-list
25445323|NCT04667897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445324|NCT04667897|Growth Inhibitors|growth inhibitors|mesh-ancestor
25445325|NCT04667897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445326|NCT04667819|Hyaluronic Acid|hyaluronic acid|mesh-list
25298989|NCT01827111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298990|NCT01827111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25298991|NCT01827111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25298992|NCT01631292|Vitamin D|vitamin d|mesh-list
25298993|NCT01631292|Ergocalciferols|ergocalciferols|mesh-list
25298994|NCT01631292|Cholecalciferol|cholecalciferol|mesh-list
25298995|NCT01631292|Vitamins|vitamins|mesh-list
25298996|NCT01631292|Micronutrients|micronutrients|mesh-ancestor
25298997|NCT01631292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298998|NCT01631292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25298999|NCT01631292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25299000|NCT01437111|Vitamin D|vitamin d|mesh-list
25299001|NCT01437111|Cholecalciferol|cholecalciferol|mesh-list
25299002|NCT01437111|Alendronate|alendronate|mesh-list
25299003|NCT01437111|Vitamins|vitamins|mesh-ancestor
25299004|NCT01437111|Micronutrients|micronutrients|mesh-ancestor
25299005|NCT01437111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299006|NCT01437111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25299007|NCT01437111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25299036|NCT01057121|Lenalidomide|lenalidomide|mesh-list
25299037|NCT01057121|Immunologic Factors|immunologic factors|mesh-ancestor
25299038|NCT01057121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299039|NCT01057121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25299040|NCT01057121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25299041|NCT01057121|Growth Substances|growth substances|mesh-ancestor
25299042|NCT01057121|Growth Inhibitors|growth inhibitors|mesh-ancestor
25445328|NCT04667819|Immunologic Factors|immunologic factors|mesh-ancestor
25720488|NCT02469961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25445329|NCT04667819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445330|NCT04667819|Viscosupplements|viscosupplements|mesh-ancestor
25445331|NCT04667819|Protective Agents|protective agents|mesh-ancestor
25445332|NCT04667624|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
25445333|NCT04667624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25445334|NCT04667624|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25445335|NCT04667624|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25445336|NCT04667624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445337|NCT04667351|Fluorouracil|fluorouracil|mesh-list
25445338|NCT04667351|Antimetabolites|antimetabolites|mesh-ancestor
25445339|NCT04667351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445340|NCT04667351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25445341|NCT04667351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445342|NCT04667351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25445343|NCT04667351|Immunologic Factors|immunologic factors|mesh-ancestor
25445344|NCT04667351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445345|NCT04667507|Dexamethasone|dexamethasone|mesh-list
25445346|NCT04667507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25445347|NCT04667507|Antiemetics|antiemetics|mesh-ancestor
25445348|NCT04667507|Autonomic Agents|autonomic agents|mesh-ancestor
25445349|NCT04667507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25445350|NCT04667507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445351|NCT04667507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25445352|NCT04667507|Glucocorticoids|glucocorticoids|mesh-ancestor
25445353|NCT04667507|Hormones|hormones|mesh-ancestor
25445354|NCT04667507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25445355|NCT04667507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25445356|NCT04667507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445357|NCT04667299|Amoxicillin|amoxicillin|mesh-list
25445358|NCT04667299|Metronidazole|metronidazole|mesh-list
25445359|NCT04667299|Potassium Citrate|potassium citrate|mesh-list
25445360|NCT04667299|Rabeprazole|rabeprazole|mesh-list
25445361|NCT04667299|Bismuth|bismuth|mesh-list
25445362|NCT04667299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445363|NCT04667299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25445364|NCT04667299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25445365|NCT04667299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25445366|NCT04667299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25445367|NCT04667299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25445368|NCT04667299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25445369|NCT04667299|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25445370|NCT04667299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25445371|NCT04667299|Antacids|antacids|mesh-ancestor
25445372|NCT04667299|Diuretics|diuretics|mesh-ancestor
25643847|NCT01431287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25643848|NCT01431287|Autonomic Agents|autonomic agents|mesh-ancestor
25445373|NCT04667299|Natriuretic Agents|natriuretic agents|mesh-ancestor
25445374|NCT04667299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445375|NCT04667299|Expectorants|expectorants|mesh-ancestor
25445376|NCT04667299|Respiratory System Agents|respiratory system agents|mesh-ancestor
25445377|NCT04667143|Metformin|metformin|mesh-list
25445378|NCT04667143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25445379|NCT04667143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445380|NCT04666987|Liraglutide|liraglutide|mesh-list
25445381|NCT04666987|Xultophy|xultophy|mesh-list
25445382|NCT04666987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25445383|NCT04666987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445384|NCT04666987|Incretins|incretins|mesh-ancestor
25445385|NCT04666987|Hormones|hormones|mesh-ancestor
25445386|NCT04666987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25445387|NCT04666805|Tamoxifen|tamoxifen|mesh-list
25445388|NCT04666805|Toremifene|toremifene|mesh-list
25445389|NCT04666805|Letrozole|letrozole|mesh-list
25445390|NCT04666805|Anastrozole|anastrozole|mesh-list
25445391|NCT04666805|Exemestane|exemestane|mesh-list
25445392|NCT04666805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445393|NCT04666805|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25445394|NCT04666805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25445395|NCT04666805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25445396|NCT04666805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445397|NCT04666805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25445398|NCT04666805|Hormone Antagonists|hormone antagonists|mesh-ancestor
25445399|NCT04666805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25445400|NCT04666805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445401|NCT04666805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25299075|NCT00961792|Anesthetics|anesthetics|mesh-ancestor
25445423|NCT04666168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25445424|NCT04666168|Immunologic Factors|immunologic factors|mesh-ancestor
25445425|NCT04666168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445426|NCT04666168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25445427|NCT04666168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25445428|NCT04666168|Alkylating Agents|alkylating agents|mesh-ancestor
25445429|NCT04666168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445430|NCT04666168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445431|NCT04666168|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25445432|NCT04665895|Fluticasone|fluticasone|mesh-list
25445434|NCT04665895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25445435|NCT04665895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25445436|NCT04665895|Autonomic Agents|autonomic agents|mesh-ancestor
25445437|NCT04665895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25445438|NCT04665895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445439|NCT04665895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25445440|NCT04665895|Respiratory System Agents|respiratory system agents|mesh-ancestor
25445441|NCT04665895|Dermatologic Agents|dermatologic agents|mesh-ancestor
25445442|NCT04665895|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25445443|NCT04665986|Docetaxel|docetaxel|mesh-list
25445444|NCT04665986|Vinorelbine|vinorelbine|mesh-list
25445445|NCT04665986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445446|NCT04665986|Tubulin Modulators|tubulin modulators|mesh-ancestor
25445447|NCT04665986|Antimitotic Agents|antimitotic agents|mesh-ancestor
25445448|NCT04665986|Mitosis Modulators|mitosis modulators|mesh-ancestor
25445449|NCT04665986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445450|NCT04665986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25445451|NCT04665830|Evolocumab|evolocumab|mesh-list
25445452|NCT04665830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25445453|NCT04665830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25445454|NCT04665830|Antimetabolites|antimetabolites|mesh-ancestor
25445455|NCT04665830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445456|NCT04665830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25445457|NCT04665765|Rituximab|rituximab|mesh-list
25445458|NCT04665765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25445459|NCT04665765|Carboplatin|carboplatin|mesh-list
25445460|NCT04665765|Etoposide|etoposide|mesh-list
25445461|NCT04665765|Etoposide phosphate|etoposide phosphate|mesh-list
25445462|NCT04665765|Ifosfamide|ifosfamide|mesh-list
25445463|NCT04665765|Isophosphamide mustard|isophosphamide mustard|mesh-list
25445464|NCT04665765|Podophyllotoxin|podophyllotoxin|mesh-list
25445465|NCT04665765|Antibodies|antibodies|mesh-list
25445466|NCT04665765|Immunoglobulins|immunoglobulins|mesh-list
25445467|NCT04665765|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25445468|NCT04665765|Immunoconjugates|immunoconjugates|mesh-list
25445469|NCT04665765|Immunologic Factors|immunologic factors|mesh-ancestor
25643849|NCT01431287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25445470|NCT04665765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445471|NCT04665765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445472|NCT04665765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25445473|NCT04665765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25445474|NCT04665765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25445475|NCT04665765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25445476|NCT04665765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25445477|NCT04665765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445478|NCT04665765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25445479|NCT04665765|Alkylating Agents|alkylating agents|mesh-ancestor
25445480|NCT04665765|Keratolytic Agents|keratolytic agents|mesh-ancestor
25445481|NCT04665765|Dermatologic Agents|dermatologic agents|mesh-ancestor
25445482|NCT04665765|Tubulin Modulators|tubulin modulators|mesh-ancestor
25445483|NCT04665765|Antimitotic Agents|antimitotic agents|mesh-ancestor
25445484|NCT04665765|Mitosis Modulators|mitosis modulators|mesh-ancestor
25445485|NCT04665609|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25445486|NCT04665453|Dexmedetomidine|dexmedetomidine|mesh-list
25445487|NCT04665453|Melatonin|melatonin|mesh-list
25445488|NCT04665453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25445489|NCT04665453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25445490|NCT04665453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445491|NCT04665453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25445492|NCT04665453|Analgesics|analgesics|mesh-ancestor
25445493|NCT04665453|Sensory System Agents|sensory system agents|mesh-ancestor
25445494|NCT04665453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25445495|NCT04665453|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25445496|NCT04665453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25445497|NCT04665453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25445498|NCT04665453|Adrenergic Agents|adrenergic agents|mesh-ancestor
25445499|NCT04665453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25445500|NCT04665453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445501|NCT04665453|Antioxidants|antioxidants|mesh-ancestor
25445502|NCT04665453|Protective Agents|protective agents|mesh-ancestor
25445503|NCT04665362|Apatinib|apatinib|mesh-list
25445504|NCT04665362|Antibodies|antibodies|mesh-list
25445505|NCT04665362|Immunologic Factors|immunologic factors|mesh-ancestor
25445506|NCT04665362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445507|NCT04665362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445508|NCT04665362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25445509|NCT04665362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25445510|NCT04665362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445511|NCT04665232|Progesterone|progesterone|mesh-list
25445512|NCT04665232|Progestins|progestins|mesh-ancestor
25445513|NCT04665232|Hormones|hormones|mesh-ancestor
25445514|NCT04665232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25445515|NCT04665232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445516|NCT04665141|Omalizumab|omalizumab|mesh-list
25445517|NCT04665141|Benralizumab|benralizumab|mesh-list
25445518|NCT04665141|Reslizumab|reslizumab|mesh-list
25445519|NCT04665141|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25445520|NCT04665141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25445521|NCT04665141|Respiratory System Agents|respiratory system agents|mesh-ancestor
25445522|NCT04665063|Cyclophosphamide|cyclophosphamide|mesh-list
25445523|NCT04665063|Fludarabine|fludarabine|mesh-list
25445524|NCT04665063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25445525|NCT04665063|Immunologic Factors|immunologic factors|mesh-ancestor
25445526|NCT04665063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445527|NCT04665063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25445528|NCT04665063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25445529|NCT04665063|Alkylating Agents|alkylating agents|mesh-ancestor
25445530|NCT04665063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445531|NCT04665063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445532|NCT04665063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25445533|NCT04665076|Cyclophosphamide|cyclophosphamide|mesh-list
25445534|NCT04665076|Fludarabine|fludarabine|mesh-list
25445535|NCT04665076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25445536|NCT04665076|Immunologic Factors|immunologic factors|mesh-ancestor
25445537|NCT04665076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445538|NCT04665076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25445539|NCT04665076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25445540|NCT04665076|Alkylating Agents|alkylating agents|mesh-ancestor
25445541|NCT04665076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445542|NCT04665076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25643850|NCT01431287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445544|NCT04665050|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25445545|NCT04665050|Immunologic Factors|immunologic factors|mesh-ancestor
25445546|NCT04665050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445547|NCT04665284|Empagliflozin|empagliflozin|mesh-list
25445548|NCT04665284|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25445549|NCT04665284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445550|NCT04665284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25445551|NCT04665284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445552|NCT04665310|Tacrolimus|tacrolimus|mesh-list
25445553|NCT04665310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25445554|NCT04665310|Immunologic Factors|immunologic factors|mesh-ancestor
25445555|NCT04665310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445556|NCT04665310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25445557|NCT04665310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720499|NCT02470234|Dopamine Agents|dopamine agents|mesh-ancestor
25445558|NCT04665310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445559|NCT04664894|Ribavirin|ribavirin|mesh-list
25445560|NCT04664894|Sofosbuvir|sofosbuvir|mesh-list
25445561|NCT04664894|Velpatasvir|velpatasvir|mesh-list
25445562|NCT04664894|Antimetabolites|antimetabolites|mesh-ancestor
25445563|NCT04664894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445564|NCT04664894|Antiviral Agents|antiviral agents|mesh-ancestor
25445565|NCT04664894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25445566|NCT04664803|Cefdinir|cefdinir|mesh-list
25445567|NCT04664803|Cefetamet|cefetamet|mesh-list
25445568|NCT04664803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25445569|NCT04664803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25445570|NCT04664725|Repaglinide|repaglinide|mesh-list
25445571|NCT04664725|Bupropion|bupropion|mesh-list
25445572|NCT04664725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25445573|NCT04664725|Antidepressive Agents|antidepressive agents|mesh-ancestor
25445574|NCT04664725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25445575|NCT04664725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25445576|NCT04664725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25445577|NCT04664725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25445578|NCT04664725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445579|NCT04664725|Dopamine Agents|dopamine agents|mesh-ancestor
25445580|NCT04664725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25445581|NCT04664725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445582|NCT04664725|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25445583|NCT04664725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25445584|NCT04664725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25445585|NCT04664725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25445586|NCT04664764|Insulin, Isophane|insulin, isophane|mesh-list
25445587|NCT04664764|Isophane Insulin, Human|isophane insulin, human|mesh-list
25445588|NCT04664764|Isophane insulin, beef|isophane insulin, beef|mesh-list
25445589|NCT04664764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25445590|NCT04664764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445591|NCT04664595|Propofol|propofol|mesh-list
25445592|NCT04664595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25445593|NCT04664595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25445594|NCT04664595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445595|NCT04664595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25445596|NCT04664595|Anesthetics, General|anesthetics, general|mesh-ancestor
25445597|NCT04664595|Anesthetics|anesthetics|mesh-ancestor
25445598|NCT04664530|Esketamine|esketamine|mesh-list
25445599|NCT04664530|Antidepressive Agents|antidepressive agents|mesh-ancestor
25445600|NCT04664530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25445601|NCT04664517|Anesthetics|anesthetics|mesh-list
25445602|NCT04664517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25445603|NCT04664517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445604|NCT04664010|Vitamins|vitamins|mesh-list
25445605|NCT04664010|Ascorbic Acid|ascorbic acid|mesh-list
25445606|NCT04664010|Interferons|interferons|mesh-list
25445607|NCT04664010|Ribavirin|ribavirin|mesh-list
25445608|NCT04664010|Interferon-alpha|interferon-alpha|mesh-list
25445609|NCT04664010|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
25445629|NCT04664088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445630|NCT04664088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25445631|NCT04664088|Antidepressive Agents|antidepressive agents|mesh-ancestor
25445632|NCT04664088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25445633|NCT04663763|Capecitabine|capecitabine|mesh-list
25445634|NCT04663763|Oxaliplatin|oxaliplatin|mesh-list
25445635|NCT04663763|Antibodies|antibodies|mesh-list
25445636|NCT04663763|Immunologic Factors|immunologic factors|mesh-ancestor
25445637|NCT04663763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643851|NCT01431287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25643852|NCT01431287|Respiratory System Agents|respiratory system agents|mesh-ancestor
25445638|NCT04663763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25445640|NCT04663763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445641|NCT04663763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445642|NCT04664244|Nimotuzumab|nimotuzumab|mesh-list
25445643|NCT04664244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25445644|NCT04664244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445645|NCT04663386|Budesonide|budesonide|mesh-list
25445646|NCT04663386|Formoterol Fumarate|formoterol fumarate|mesh-list
25445647|NCT04663386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25445648|NCT04663386|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25445649|NCT04663386|Autonomic Agents|autonomic agents|mesh-ancestor
25445650|NCT04663386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25445651|NCT04663386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445652|NCT04663386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25445653|NCT04663386|Respiratory System Agents|respiratory system agents|mesh-ancestor
25445654|NCT04663386|Glucocorticoids|glucocorticoids|mesh-ancestor
25445655|NCT04663386|Hormones|hormones|mesh-ancestor
25445656|NCT04663386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25445657|NCT04663386|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25445658|NCT04663386|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25445659|NCT04663386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25445660|NCT04663386|Adrenergic Agents|adrenergic agents|mesh-ancestor
25445661|NCT04663386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25445662|NCT04663386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445663|NCT04663438|Antineoplastic Agents|antineoplastic agents|mesh-list
25445664|NCT04663568|Levonorgestrel|levonorgestrel|mesh-list
25445665|NCT04663568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25445666|NCT04663568|Contraceptive Agents|contraceptive agents|mesh-ancestor
25445667|NCT04663568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25643853|NCT01431287|Parasympatholytics|parasympatholytics|mesh-ancestor
25643854|NCT01431287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25643855|NCT01431287|Cholinergic Agents|cholinergic agents|mesh-ancestor
25643856|NCT01431287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25643857|NCT01431287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643858|NCT01431339|Vancomycin|vancomycin|mesh-list
25643859|NCT01431339|Linezolid|linezolid|mesh-list
25643860|NCT01431339|Dalbavancin|dalbavancin|mesh-list
25643861|NCT01431339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25643862|NCT01431339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25643863|NCT01431339|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25643864|NCT01431339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25445668|NCT04663568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643865|NCT01431339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643866|NCT01431391|Leuprolide|leuprolide|mesh-list
25643867|NCT01431391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25643868|NCT01431391|Fertility Agents|fertility agents|mesh-ancestor
25445669|NCT04663568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25445670|NCT04663568|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25445671|NCT04663568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25445672|NCT04663269|Dexamethasone|dexamethasone|mesh-list
25445673|NCT04663269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25445674|NCT04663269|Antiemetics|antiemetics|mesh-ancestor
25445675|NCT04663269|Autonomic Agents|autonomic agents|mesh-ancestor
25445676|NCT04663269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25445677|NCT04663269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445678|NCT04663269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25445679|NCT04663269|Glucocorticoids|glucocorticoids|mesh-ancestor
25445681|NCT04663269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25445682|NCT04663269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25445683|NCT04663269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445684|NCT04662788|Antibodies|antibodies|mesh-list
25445685|NCT04662788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25445686|NCT04662788|Immunologic Factors|immunologic factors|mesh-ancestor
25445687|NCT04662788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445688|NCT04662736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25445689|NCT04662736|Tedizolid|tedizolid|mesh-list
25445690|NCT04662736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25445691|NCT04662840|Anesthetics|anesthetics|mesh-list
25445692|NCT04662840|Anesthetics, Local|anesthetics, local|mesh-list
25445693|NCT04662840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25164645|NCT05289492|Dexamethasone|dexamethasone|mesh-list
25643869|NCT01431391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25445694|NCT04662840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445695|NCT04662840|Sensory System Agents|sensory system agents|mesh-ancestor
25445696|NCT04662840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25445698|NCT04662866|Pioglitazone|pioglitazone|mesh-list
25445699|NCT04662866|Empagliflozin|empagliflozin|mesh-list
25445700|NCT04662866|Linagliptin|linagliptin|mesh-list
25445701|NCT04662866|Biguanides|biguanides|mesh-list
25445702|NCT04662866|Protease Inhibitors|protease inhibitors|mesh-list
25445703|NCT04662866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25445704|NCT04662866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445705|NCT04662866|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25445706|NCT04662866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445707|NCT04662866|Incretins|incretins|mesh-ancestor
25445708|NCT04662866|Hormones|hormones|mesh-ancestor
25445709|NCT04662866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25445710|NCT04662866|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25445711|NCT04662866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25445712|NCT04662476|Vitamin D|vitamin d|mesh-list
25445713|NCT04662476|Cholecalciferol|cholecalciferol|mesh-list
25445714|NCT04662476|Vitamins|vitamins|mesh-ancestor
25445715|NCT04662476|Micronutrients|micronutrients|mesh-ancestor
25445716|NCT04662476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445717|NCT04662476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25445718|NCT04662476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25445719|NCT04662567|Acetaminophen|acetaminophen|mesh-list
25445720|NCT04662567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25445721|NCT04662567|Analgesics|analgesics|mesh-ancestor
25445722|NCT04662567|Sensory System Agents|sensory system agents|mesh-ancestor
25445723|NCT04662567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25445724|NCT04662567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445725|NCT04662567|Antipyretics|antipyretics|mesh-ancestor
25445726|NCT04662658|Xenon|xenon|mesh-list
25445727|NCT04662658|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25445728|NCT04662658|Anesthetics, General|anesthetics, general|mesh-ancestor
25445729|NCT04662658|Anesthetics|anesthetics|mesh-ancestor
25299445|NCT04810910|Sargramostim|sargramostim|mesh-list
25299446|NCT04810910|Immunologic Factors|immunologic factors|mesh-ancestor
25299447|NCT04810910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299448|NCT04810910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25299449|NCT04746989|Allopurinol|allopurinol|mesh-list
25299450|NCT04746989|Probenecid|probenecid|mesh-list
25299451|NCT04746989|Antimetabolites|antimetabolites|mesh-ancestor
25299452|NCT04746989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299453|NCT04746989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25299454|NCT04746989|Gout Suppressants|gout suppressants|mesh-ancestor
25299455|NCT04746989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25445730|NCT04662658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25445731|NCT04662658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445732|NCT04662385|Listerine|listerine|mesh-list
25445733|NCT04662385|Sodium Fluoride|sodium fluoride|mesh-list
25445734|NCT04662385|Cariostatic Agents|cariostatic agents|mesh-ancestor
25445735|NCT04662385|Protective Agents|protective agents|mesh-ancestor
25445736|NCT04662385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445737|NCT04662385|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25445738|NCT04662385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25445739|NCT04662177|Dexmedetomidine|dexmedetomidine|mesh-list
25445740|NCT04662177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25445741|NCT04662177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25445742|NCT04662177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445743|NCT04662177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25445744|NCT04662177|Analgesics|analgesics|mesh-ancestor
25445745|NCT04662177|Sensory System Agents|sensory system agents|mesh-ancestor
25445746|NCT04662177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25445747|NCT04662177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25445748|NCT04662177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25445749|NCT04662177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25445750|NCT04662177|Adrenergic Agents|adrenergic agents|mesh-ancestor
25445751|NCT04662177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25445752|NCT04662177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445753|NCT04662125|Acetaminophen|acetaminophen|mesh-list
25445754|NCT04662125|Prednisolone|prednisolone|mesh-list
25445755|NCT04662125|Pregabalin|pregabalin|mesh-list
25445756|NCT04662125|Caffeine|caffeine|mesh-list
25445757|NCT04662125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25445758|NCT04662125|Glucocorticoids|glucocorticoids|mesh-ancestor
25445760|NCT04662125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25445761|NCT04662125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445762|NCT04662125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25445763|NCT04662125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445764|NCT04662125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25445765|NCT04662125|Analgesics|analgesics|mesh-ancestor
25445766|NCT04662125|Sensory System Agents|sensory system agents|mesh-ancestor
25445767|NCT04662125|Anticonvulsants|anticonvulsants|mesh-ancestor
25445768|NCT04662125|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25445769|NCT04662125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25445770|NCT04662125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445771|NCT04662125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25445772|NCT04662125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25445773|NCT04662125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25445774|NCT04662125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25445775|NCT04662125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25445776|NCT04662125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25445777|NCT04662125|Antipyretics|antipyretics|mesh-ancestor
25445778|NCT04662125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25445779|NCT04662125|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25445780|NCT04662125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25445781|NCT04662125|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25445782|NCT04662125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25445783|NCT04662125|Purinergic Agents|purinergic agents|mesh-ancestor
25445784|NCT04662125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25445785|NCT04662138|Antiviral Agents|antiviral agents|mesh-list
25445786|NCT04662138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25445787|NCT04662242|Selenium|selenium|mesh-list
25445788|NCT04662242|Antioxidants|antioxidants|mesh-ancestor
25445789|NCT04662242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445790|NCT04662242|Protective Agents|protective agents|mesh-ancestor
25445791|NCT04662242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445792|NCT04662242|Trace Elements|trace elements|mesh-ancestor
25445793|NCT04662242|Micronutrients|micronutrients|mesh-ancestor
25445794|NCT04661670|Salicylic Acid|salicylic acid|mesh-list
25445795|NCT04661670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25445796|NCT04661670|Antifungal Agents|antifungal agents|mesh-ancestor
25445797|NCT04661670|Keratolytic Agents|keratolytic agents|mesh-ancestor
25445798|NCT04661670|Dermatologic Agents|dermatologic agents|mesh-ancestor
25445799|NCT04661709|Aspirin|aspirin|mesh-list
25445800|NCT04661709|Metoprolol|metoprolol|mesh-list
25299523|NCT04529876|Tofacitinib|tofacitinib|mesh-list
25445801|NCT04661709|Isosorbide|isosorbide|mesh-list
25445802|NCT04661709|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25445803|NCT04661709|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25445804|NCT04661709|Trimetazidine|trimetazidine|mesh-list
25445805|NCT04661709|Nitroglycerin|nitroglycerin|mesh-list
25445806|NCT04661709|Clopidogrel|clopidogrel|mesh-list
25445807|NCT04661709|Atorvastatin|atorvastatin|mesh-list
25445808|NCT04661709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445809|NCT04661709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25445810|NCT04661709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25445811|NCT04661709|Analgesics|analgesics|mesh-ancestor
25445812|NCT04661709|Sensory System Agents|sensory system agents|mesh-ancestor
25445813|NCT04661709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25445814|NCT04661709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25445815|NCT04661709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25445816|NCT04661709|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25445817|NCT04661709|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25445818|NCT04661709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445819|NCT04661709|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25445820|NCT04661709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25445821|NCT04661709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25445822|NCT04661709|Antipyretics|antipyretics|mesh-ancestor
25445823|NCT04661709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25445824|NCT04661709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25445825|NCT04661709|Antimetabolites|antimetabolites|mesh-ancestor
25445826|NCT04661709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25445827|NCT04661709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25445828|NCT04661709|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25445829|NCT04661709|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25445830|NCT04661709|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25445831|NCT04661709|Purinergic Agents|purinergic agents|mesh-ancestor
25445832|NCT04661709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25720512|NCT02470390|Anesthetics|anesthetics|mesh-ancestor
25643870|NCT01431391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643871|NCT01431391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25643872|NCT01431391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25643873|NCT01431521|Pioglitazone|pioglitazone|mesh-list
25643874|NCT01431521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25643875|NCT01431521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643876|NCT01431573|Lithium Carbonate|lithium carbonate|mesh-list
25643877|NCT01431573|Antidepressive Agents|antidepressive agents|mesh-ancestor
25643878|NCT01431573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25643879|NCT01431573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25445833|NCT04661709|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25445834|NCT04661709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25445835|NCT04661709|Sympatholytics|sympatholytics|mesh-ancestor
25445836|NCT04661709|Autonomic Agents|autonomic agents|mesh-ancestor
25445837|NCT04661709|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25445838|NCT04661709|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25445839|NCT04661709|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25445840|NCT04661709|Adrenergic Agents|adrenergic agents|mesh-ancestor
25445841|NCT04661709|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25445842|NCT04661709|Diuretics|diuretics|mesh-ancestor
25445843|NCT04661709|Natriuretic Agents|natriuretic agents|mesh-ancestor
25445844|NCT04661709|Vasodilator Agents|vasodilator agents|mesh-ancestor
25445845|NCT04661709|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25445846|NCT04661696|Paclitaxel|paclitaxel|mesh-list
25445847|NCT04661696|Carboplatin|carboplatin|mesh-list
25445848|NCT04661696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25445849|NCT04661696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445850|NCT04661696|Tubulin Modulators|tubulin modulators|mesh-ancestor
25445851|NCT04661696|Antimitotic Agents|antimitotic agents|mesh-ancestor
25445852|NCT04661696|Mitosis Modulators|mitosis modulators|mesh-ancestor
25445853|NCT04661696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445854|NCT04661475|Dexmedetomidine|dexmedetomidine|mesh-list
25445855|NCT04661475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25445856|NCT04661475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25445857|NCT04661475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445858|NCT04661475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25445859|NCT04661475|Analgesics|analgesics|mesh-ancestor
25445860|NCT04661475|Sensory System Agents|sensory system agents|mesh-ancestor
25445861|NCT04661475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25445862|NCT04661475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25445863|NCT04661475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25445864|NCT04661475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25445865|NCT04661475|Adrenergic Agents|adrenergic agents|mesh-ancestor
25445866|NCT04661475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25299595|NCT04393103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25299596|NCT04393103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25299597|NCT04393103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25299598|NCT04393103|Autonomic Agents|autonomic agents|mesh-ancestor
25299599|NCT04393103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25299600|NCT04393103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299601|NCT04393103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25299602|NCT04393103|Respiratory System Agents|respiratory system agents|mesh-ancestor
25299603|NCT04393103|Mydriatics|mydriatics|mesh-ancestor
25299604|NCT04393103|Parasympatholytics|parasympatholytics|mesh-ancestor
25299605|NCT04393103|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25299606|NCT04393103|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25299607|NCT04393103|Cholinergic Agents|cholinergic agents|mesh-ancestor
25299668|NCT03874091|Morphine|morphine|mesh-list
25299671|NCT03874091|Anesthetics, Local|anesthetics, local|mesh-ancestor
25299672|NCT03874091|Anesthetics|anesthetics|mesh-ancestor
25299673|NCT03874091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25445904|NCT04660643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25445905|NCT04660643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445906|NCT04660643|Incretins|incretins|mesh-ancestor
25445907|NCT04660643|Hormones|hormones|mesh-ancestor
25445908|NCT04660643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25445909|NCT04660461|Lansoprazole|lansoprazole|mesh-list
25445910|NCT04660461|Dexlansoprazole|dexlansoprazole|mesh-list
25445911|NCT04660461|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25445912|NCT04660461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25445913|NCT04660461|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25445914|NCT04660461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25445915|NCT04660461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445916|NCT04660305|Insulin Aspart|insulin aspart|mesh-list
25657147|NCT01583374|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25445917|NCT04660305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25445918|NCT04660305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445919|NCT04660565|Prednisone|prednisone|mesh-list
25445920|NCT04660565|Belimumab|belimumab|mesh-list
25445921|NCT04660565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25643880|NCT01431573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643881|NCT01431573|Antimanic Agents|antimanic agents|mesh-ancestor
25643882|NCT01431573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25643883|NCT01431573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25643884|NCT01431573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643885|NCT01431716|Epoprostenol|epoprostenol|mesh-list
25643886|NCT01431716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25445922|NCT04660565|Glucocorticoids|glucocorticoids|mesh-ancestor
25445923|NCT04660565|Hormones|hormones|mesh-ancestor
25445924|NCT04660565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25445925|NCT04660565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445926|NCT04660565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25445927|NCT04660565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445928|NCT04660565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25445929|NCT04660565|Immunologic Factors|immunologic factors|mesh-ancestor
25445930|NCT04660110|Piperaquine|piperaquine|mesh-list
25445931|NCT04660110|Artenimol|artenimol|mesh-list
25445932|NCT04660110|Antimalarials|antimalarials|mesh-ancestor
25445933|NCT04660110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25445934|NCT04660110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25445935|NCT04660110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25445936|NCT04659915|Metformin|metformin|mesh-list
25445937|NCT04659915|Prednisone|prednisone|mesh-list
25445938|NCT04659915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25445939|NCT04659915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445940|NCT04659915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25445941|NCT04659915|Glucocorticoids|glucocorticoids|mesh-ancestor
25445942|NCT04659915|Hormones|hormones|mesh-ancestor
25445943|NCT04659915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25445944|NCT04659915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25445945|NCT04659915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445946|NCT04660123|Bismuth|bismuth|mesh-list
25445947|NCT04660123|Antacids|antacids|mesh-ancestor
25445948|NCT04660123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445949|NCT04660123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25445950|NCT04659785|Apatinib|apatinib|mesh-list
25445951|NCT04659785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445952|NCT04659785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25445953|NCT04659785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25445954|NCT04659785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445955|NCT04659525|Ezetimibe|ezetimibe|mesh-list
25445956|NCT04659525|Evolocumab|evolocumab|mesh-list
25445957|NCT04659525|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25445958|NCT04659525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25445959|NCT04659525|Antimetabolites|antimetabolites|mesh-ancestor
25445960|NCT04659525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445961|NCT04659525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25445962|NCT04659551|Cyclophosphamide|cyclophosphamide|mesh-list
25445963|NCT04659551|Nivolumab|nivolumab|mesh-list
25445964|NCT04659551|Epirubicin|epirubicin|mesh-list
25445965|NCT04659551|Exemestane|exemestane|mesh-list
25445966|NCT04659551|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25445967|NCT04659551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25445968|NCT04659551|Immunologic Factors|immunologic factors|mesh-ancestor
25445969|NCT04659551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445970|NCT04659551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25445971|NCT04659551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25299752|NCT03501576|Vaccines|vaccines|mesh-list
25299753|NCT03501576|Immunologic Factors|immunologic factors|mesh-ancestor
25299754|NCT03501576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299755|NCT03490903|Fentanyl|fentanyl|mesh-list
25299756|NCT03490903|Midazolam|midazolam|mesh-list
25299757|NCT03490903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25299758|NCT03490903|Narcotics|narcotics|mesh-ancestor
25299759|NCT03490903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25299760|NCT03490903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25445972|NCT04659551|Alkylating Agents|alkylating agents|mesh-ancestor
25445973|NCT04659551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164683|NCT05260606|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25164684|NCT05260606|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25164685|NCT05260606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25445974|NCT04659551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445975|NCT04659551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25445976|NCT04659551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25445977|NCT04659551|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25445978|NCT04659551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25445979|NCT04659551|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25720519|NCT02470429|Lubricant Eye Drops|lubricant eye drops|mesh-list
25445980|NCT04659551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25445981|NCT04659551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25445982|NCT04659551|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25445983|NCT04659551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25445984|NCT04659551|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25445985|NCT04659551|Hormone Antagonists|hormone antagonists|mesh-ancestor
25445986|NCT04659551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25445987|NCT04659551|Luteolytic Agents|luteolytic agents|mesh-ancestor
25445988|NCT04659551|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25445989|NCT04659551|Contraceptive Agents|contraceptive agents|mesh-ancestor
25445990|NCT04659551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25445991|NCT04659551|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25445992|NCT04659551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25445994|NCT04659499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25445995|NCT04659499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25445996|NCT04659499|Tubulin Modulators|tubulin modulators|mesh-ancestor
25445997|NCT04659499|Antimitotic Agents|antimitotic agents|mesh-ancestor
25445998|NCT04659499|Mitosis Modulators|mitosis modulators|mesh-ancestor
25445999|NCT04659499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446000|NCT04659642|Fentanyl|fentanyl|mesh-list
25446001|NCT04659642|Dexmedetomidine|dexmedetomidine|mesh-list
25446002|NCT04659642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25446003|NCT04659642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25446004|NCT04659642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446005|NCT04659642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25446006|NCT04659642|Analgesics|analgesics|mesh-ancestor
25446007|NCT04659642|Sensory System Agents|sensory system agents|mesh-ancestor
25446008|NCT04659642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446009|NCT04659642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25446010|NCT04659642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25446011|NCT04659642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25446012|NCT04659642|Adrenergic Agents|adrenergic agents|mesh-ancestor
25446013|NCT04659642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25446014|NCT04659642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446015|NCT04659642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25446016|NCT04659642|Narcotics|narcotics|mesh-ancestor
25446017|NCT04659642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25446018|NCT04659642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25446019|NCT04659642|Anesthetics, General|anesthetics, general|mesh-ancestor
25446020|NCT04659642|Anesthetics|anesthetics|mesh-ancestor
25446021|NCT04659109|Glenzocimab|glenzocimab|mesh-list
25446022|NCT04659109|Anticoagulants|anticoagulants|mesh-ancestor
25446023|NCT04659070|Telmisartan|telmisartan|mesh-list
25446024|NCT04659070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25446025|NCT04659070|Ezetimibe|ezetimibe|mesh-list
25446026|NCT04659070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25446027|NCT04659070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25446028|NCT04659070|Antimetabolites|antimetabolites|mesh-ancestor
25446029|NCT04659070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446030|NCT04659070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25446031|NCT04659070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25446032|NCT04659070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25446033|NCT04659070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25446034|NCT04659070|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25446035|NCT04659070|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25446036|NCT04659057|Lidocaine|lidocaine|mesh-list
25299825|NCT02929485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299826|NCT02929485|Dopamine Agonists|dopamine agonists|mesh-ancestor
25299827|NCT02929485|Dopamine Agents|dopamine agents|mesh-ancestor
25299828|NCT02929485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25299829|NCT02929485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299830|NCT02929485|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25299831|NCT02929485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24975599|NCT03440112|Flumazenil|flumazenil|mesh-list
25446037|NCT04659057|Dexmedetomidine|dexmedetomidine|mesh-list
25446038|NCT04659057|Anesthetics, Local|anesthetics, local|mesh-ancestor
25446039|NCT04659057|Anesthetics|anesthetics|mesh-ancestor
25446040|NCT04659057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25446041|NCT04659057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446042|NCT04659057|Sensory System Agents|sensory system agents|mesh-ancestor
25446044|NCT04659057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25446045|NCT04659057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25446046|NCT04659057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25446047|NCT04659057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25446048|NCT04659057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446049|NCT04659057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25446050|NCT04659057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25446051|NCT04659057|Analgesics|analgesics|mesh-ancestor
25446052|NCT04659057|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25446053|NCT04659057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25446054|NCT04659057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25446055|NCT04659057|Adrenergic Agents|adrenergic agents|mesh-ancestor
25446056|NCT04659057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25446057|NCT04658732|Dexmedetomidine|dexmedetomidine|mesh-list
25446058|NCT04658732|Gabapentin|gabapentin|mesh-list
25446059|NCT04658732|Alprazolam|alprazolam|mesh-list
25446060|NCT04658732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25446061|NCT04658732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25446062|NCT04658732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446063|NCT04658732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25446064|NCT04658732|Analgesics|analgesics|mesh-ancestor
25446065|NCT04658732|Sensory System Agents|sensory system agents|mesh-ancestor
25446066|NCT04658732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446067|NCT04658732|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25446068|NCT04658732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25446069|NCT04658732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25446070|NCT04658732|Adrenergic Agents|adrenergic agents|mesh-ancestor
25446071|NCT04658732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25446072|NCT04658732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446073|NCT04658732|Anticonvulsants|anticonvulsants|mesh-ancestor
25446074|NCT04658732|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25446075|NCT04658732|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25446076|NCT04658732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25446077|NCT04658732|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25446078|NCT04658732|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25446079|NCT04658732|Antimanic Agents|antimanic agents|mesh-ancestor
25446080|NCT04658732|GABA Modulators|gaba modulators|mesh-ancestor
25446081|NCT04658732|GABA Agents|gaba agents|mesh-ancestor
25446082|NCT04658420|Ketamine|ketamine|mesh-list
25446083|NCT04658420|Analgesics|analgesics|mesh-ancestor
25446084|NCT04658420|Sensory System Agents|sensory system agents|mesh-ancestor
25446085|NCT04658420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446086|NCT04658420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446087|NCT04658420|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25446088|NCT04658420|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25446089|NCT04658420|Anesthetics, General|anesthetics, general|mesh-ancestor
25446090|NCT04658420|Anesthetics|anesthetics|mesh-ancestor
25446091|NCT04658420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25446092|NCT04658420|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25446093|NCT04658420|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25446094|NCT04658420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25446095|NCT04658420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446096|NCT04658329|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25446097|NCT04658329|Antiviral Agents|antiviral agents|mesh-ancestor
25446098|NCT04658329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25446099|NCT04658355|Chlorhexidine|chlorhexidine|mesh-list
25446100|NCT04658355|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25446101|NCT04658355|Povidone-Iodine|povidone-iodine|mesh-list
25446102|NCT04658355|Povidone|povidone|mesh-list
25446103|NCT04658355|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25446104|NCT04658355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25446105|NCT04658355|Disinfectants|disinfectants|mesh-ancestor
25446106|NCT04658355|Dermatologic Agents|dermatologic agents|mesh-ancestor
25299898|NCT02683265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25299899|NCT02683265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299900|NCT02683265|Dopamine Agents|dopamine agents|mesh-ancestor
25299901|NCT02683265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25299902|NCT02604446|Oxycodone|oxycodone|mesh-list
25446109|NCT04658134|Glycine|glycine|mesh-list
25446110|NCT04658134|Glycine Agents|glycine agents|mesh-ancestor
25446111|NCT04658134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25446112|NCT04658134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446113|NCT04658134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643887|NCT01431716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25643888|NCT01431794|Gemcitabine|gemcitabine|mesh-list
25643889|NCT01431794|Paclitaxel|paclitaxel|mesh-list
25643890|NCT01431794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25643891|NCT01431794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25643892|NCT01431794|Tubulin Modulators|tubulin modulators|mesh-ancestor
25643893|NCT01431794|Antimitotic Agents|antimitotic agents|mesh-ancestor
25643894|NCT01431794|Mitosis Modulators|mitosis modulators|mesh-ancestor
25643895|NCT01431794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822842|NCT00004685|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25446114|NCT04657939|Pioglitazone|pioglitazone|mesh-list
25446115|NCT04657939|Liraglutide|liraglutide|mesh-list
25446116|NCT04657939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25446117|NCT04657939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446118|NCT04657939|Incretins|incretins|mesh-ancestor
25446119|NCT04657939|Hormones|hormones|mesh-ancestor
25446120|NCT04657939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25446121|NCT04658225|Chlorhexidine|chlorhexidine|mesh-list
25446122|NCT04658225|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25446123|NCT04658225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25446124|NCT04658225|Disinfectants|disinfectants|mesh-ancestor
25446125|NCT04657744|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25446126|NCT04657744|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25446127|NCT04657744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446128|NCT04657744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25446129|NCT04657744|Immunologic Factors|immunologic factors|mesh-ancestor
25446130|NCT04657744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446131|NCT04657497|Camostat|camostat|mesh-list
25446132|NCT04657497|Protease Inhibitors|protease inhibitors|mesh-ancestor
25446133|NCT04657497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25446134|NCT04657497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446135|NCT04657497|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25446136|NCT04657497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25446137|NCT04657692|Anesthetics|anesthetics|mesh-list
25446138|NCT04657692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25446139|NCT04657692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446140|NCT04657484|Prednisolone|prednisolone|mesh-list
25446141|NCT04657484|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25446142|NCT04657484|Methylprednisolone|methylprednisolone|mesh-list
25446143|NCT04657484|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25446144|NCT04657484|Prednisolone acetate|prednisolone acetate|mesh-list
25446145|NCT04657484|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25446146|NCT04657484|Prednisolone phosphate|prednisolone phosphate|mesh-list
25446147|NCT04657484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25446148|NCT04657484|Glucocorticoids|glucocorticoids|mesh-ancestor
25446149|NCT04657484|Hormones|hormones|mesh-ancestor
25446150|NCT04657484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25446151|NCT04657484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446152|NCT04657484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25446153|NCT04657484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25446154|NCT04657484|Antiemetics|antiemetics|mesh-ancestor
25446155|NCT04657484|Autonomic Agents|autonomic agents|mesh-ancestor
25446156|NCT04657484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446157|NCT04657484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25446158|NCT04657484|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25446159|NCT04657484|Protective Agents|protective agents|mesh-ancestor
25446160|NCT04657107|Ketamine|ketamine|mesh-list
25446161|NCT04657107|Esketamine|esketamine|mesh-list
25446162|NCT04657107|Analgesics|analgesics|mesh-ancestor
25446163|NCT04657107|Sensory System Agents|sensory system agents|mesh-ancestor
25446164|NCT04657107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446165|NCT04657107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446166|NCT04657107|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25446167|NCT04657107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25300053|NCT05122780|Acetylcholine|acetylcholine|mesh-list
25300054|NCT05122780|Anticoagulants|anticoagulants|mesh-list
25300055|NCT05122780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25300056|NCT05122780|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25300057|NCT05122780|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25300058|NCT05122780|Adrenergic Agents|adrenergic agents|mesh-ancestor
25300059|NCT05122780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24629070|NCT01103115|Calcium|calcium|mesh-list
24629071|NCT01103115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24629072|NCT01103115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629073|NCT01103115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25643896|NCT01431794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25643897|NCT01431794|Antimetabolites|antimetabolites|mesh-ancestor
25643898|NCT01431794|Antiviral Agents|antiviral agents|mesh-ancestor
25300060|NCT05122780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300061|NCT05122780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300062|NCT05122780|Vasodilator Agents|vasodilator agents|mesh-ancestor
25300063|NCT05122780|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25300064|NCT05122780|Cholinergic Agents|cholinergic agents|mesh-ancestor
25300074|NCT05122741|Aspirin|aspirin|mesh-list
25300075|NCT05122741|Clopidogrel|clopidogrel|mesh-list
25300076|NCT05122741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25300115|NCT05069974|Linezolid|linezolid|mesh-list
25446168|NCT04657107|Anesthetics, General|anesthetics, general|mesh-ancestor
25446169|NCT04657107|Anesthetics|anesthetics|mesh-ancestor
25446170|NCT04657107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25446171|NCT04657107|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25446172|NCT04657107|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25446173|NCT04657107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25446174|NCT04657107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446175|NCT04657107|Antidepressive Agents|antidepressive agents|mesh-ancestor
25446176|NCT04657107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25446177|NCT04657172|Pilocarpine|pilocarpine|mesh-list
25446178|NCT04657172|Miotics|miotics|mesh-ancestor
25446179|NCT04657172|Autonomic Agents|autonomic agents|mesh-ancestor
25446180|NCT04657172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446181|NCT04657172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446182|NCT04657172|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25446183|NCT04657172|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25446184|NCT04657172|Cholinergic Agents|cholinergic agents|mesh-ancestor
25446185|NCT04657172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25446186|NCT04657172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446187|NCT04656665|Aspirin|aspirin|mesh-list
25446188|NCT04656665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25446189|NCT04656665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25446190|NCT04656665|Analgesics|analgesics|mesh-ancestor
25446191|NCT04656665|Sensory System Agents|sensory system agents|mesh-ancestor
25446192|NCT04656665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446193|NCT04656665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446194|NCT04656665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25446195|NCT04656665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25446196|NCT04656665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25446197|NCT04656665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25446198|NCT04656665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446199|NCT04656665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25446200|NCT04656665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25446201|NCT04656665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25446202|NCT04656665|Antipyretics|antipyretics|mesh-ancestor
25446203|NCT04656106|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25446204|NCT04656106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25446205|NCT04656106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446206|NCT04656262|Cyclophosphamide|cyclophosphamide|mesh-list
25446207|NCT04656262|Doxorubicin|doxorubicin|mesh-list
25446208|NCT04656262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25446209|NCT04656262|Immunologic Factors|immunologic factors|mesh-ancestor
25446210|NCT04656262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446211|NCT04656262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25446212|NCT04656262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25446213|NCT04656262|Alkylating Agents|alkylating agents|mesh-ancestor
25446214|NCT04656262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446215|NCT04656262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25446216|NCT04656262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25446217|NCT04656262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25446218|NCT04656262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25446219|NCT04656262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25446220|NCT04656262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25446221|NCT04656249|Lenvatinib|lenvatinib|mesh-list
25446222|NCT04656249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25446223|NCT04656249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25300120|NCT05069974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300139|NCT05052099|Bevacizumab|bevacizumab|mesh-list
25300140|NCT05052099|Atezolizumab|atezolizumab|mesh-list
25300141|NCT05052099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25300142|NCT05052099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300143|NCT05052099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25643899|NCT01431794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25643900|NCT01431794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25643901|NCT01431794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25643902|NCT01431794|Immunologic Factors|immunologic factors|mesh-ancestor
25643903|NCT01431794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643904|NCT01431950|Fluticasone|fluticasone|mesh-list
25643905|NCT01431950|Xhance|xhance|mesh-list
25643906|NCT01431950|Albuterol|albuterol|mesh-list
25300144|NCT05052099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25300145|NCT05052099|Growth Substances|growth substances|mesh-ancestor
25300146|NCT05052099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300147|NCT05052099|Growth Inhibitors|growth inhibitors|mesh-ancestor
25300148|NCT05041920|Omeprazole|omeprazole|mesh-list
25300149|NCT05041920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25300150|NCT05041920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25300151|NCT05041920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25300152|NCT05041920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25300153|NCT05041920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300154|NCT05001802|Ropivacaine|ropivacaine|mesh-list
25446226|NCT04655807|Adalimumab|adalimumab|mesh-list
25446227|NCT04655807|Ustekinumab|ustekinumab|mesh-list
25446228|NCT04655807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25446229|NCT04655807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25446230|NCT04655807|Dermatologic Agents|dermatologic agents|mesh-ancestor
25446231|NCT04655664|Vitamin D|vitamin d|mesh-list
25446232|NCT04655664|Ergocalciferols|ergocalciferols|mesh-list
25446233|NCT04655664|Cholecalciferol|cholecalciferol|mesh-list
25446234|NCT04655664|Vitamins|vitamins|mesh-list
25446235|NCT04655664|Micronutrients|micronutrients|mesh-ancestor
25446236|NCT04655664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446237|NCT04655664|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25446238|NCT04655664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25446239|NCT04655417|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
25446240|NCT04655417|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25446241|NCT04655417|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25446242|NCT04655508|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25446243|NCT04655508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25446244|NCT04655508|Autonomic Agents|autonomic agents|mesh-ancestor
25446245|NCT04655508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446246|NCT04655508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446247|NCT04655508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25446248|NCT04655508|Respiratory System Agents|respiratory system agents|mesh-ancestor
25446249|NCT04655508|Glucocorticoids|glucocorticoids|mesh-ancestor
25446250|NCT04655508|Hormones|hormones|mesh-ancestor
25446251|NCT04655508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25446252|NCT04655508|Sympathomimetics|sympathomimetics|mesh-ancestor
25446253|NCT04655729|Infliximab|infliximab|mesh-list
25446254|NCT04655729|Dermatologic Agents|dermatologic agents|mesh-ancestor
25446255|NCT04655729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25446256|NCT04655729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25446257|NCT04655170|Albuterol|albuterol|mesh-list
25446258|NCT04655170|Formoterol Fumarate|formoterol fumarate|mesh-list
25446259|NCT04655170|Ipratropium|ipratropium|mesh-list
25720568|NCT02471651|Antiemetics|antiemetics|mesh-ancestor
25446260|NCT04655170|Cholinergic Antagonists|cholinergic antagonists|mesh-list
25446261|NCT04655170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25446262|NCT04655170|Autonomic Agents|autonomic agents|mesh-ancestor
25446263|NCT04655170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446264|NCT04655170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446265|NCT04655170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25446266|NCT04655170|Respiratory System Agents|respiratory system agents|mesh-ancestor
25446267|NCT04655170|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25446268|NCT04655170|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25446269|NCT04655170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25446270|NCT04655170|Adrenergic Agents|adrenergic agents|mesh-ancestor
25446271|NCT04655170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25446272|NCT04655170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446273|NCT04655170|Tocolytic Agents|tocolytic agents|mesh-ancestor
25446274|NCT04655170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25446275|NCT04655170|Cholinergic Agents|cholinergic agents|mesh-ancestor
25446276|NCT04655183|Niraparib|niraparib|mesh-list
25446277|NCT04655183|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25446278|NCT04655183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25446279|NCT04655183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446280|NCT04655183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25446281|NCT04655040|Caffeine|caffeine|mesh-list
25643907|NCT01431950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25822843|NCT00004685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25446282|NCT04655040|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25446283|NCT04655040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446284|NCT04655040|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25446285|NCT04655040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25446286|NCT04655040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446287|NCT04655040|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25446288|NCT04655040|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25446289|NCT04655040|Purinergic Agents|purinergic agents|mesh-ancestor
25446290|NCT04655040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25446292|NCT04654962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25446293|NCT04654962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446294|NCT04654416|Colchicine|colchicine|mesh-list
25446295|NCT04654416|Gout Suppressants|gout suppressants|mesh-ancestor
25446296|NCT04654416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25446297|NCT04654416|Tubulin Modulators|tubulin modulators|mesh-ancestor
25446298|NCT04654416|Antimitotic Agents|antimitotic agents|mesh-ancestor
25300273|NCT04359017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300281|NCT04353310|Curcumin|curcumin|mesh-list
25446299|NCT04654416|Mitosis Modulators|mitosis modulators|mesh-ancestor
25446300|NCT04654416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446301|NCT04654416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25446302|NCT04654676|Vildagliptin|vildagliptin|mesh-list
25446303|NCT04654676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25446304|NCT04654676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446305|NCT04654676|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25446306|NCT04654676|Protease Inhibitors|protease inhibitors|mesh-ancestor
25446307|NCT04654676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25446308|NCT04654676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446309|NCT04654819|Anesthetics|anesthetics|mesh-list
25446310|NCT04654819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25446311|NCT04654819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446312|NCT04654741|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25446313|NCT04654741|Medroxyprogesterone|medroxyprogesterone|mesh-list
25446314|NCT04654741|Ganirelix|ganirelix|mesh-list
25446315|NCT04654741|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25446316|NCT04654741|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25446317|NCT04654741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25446318|NCT04654741|Contraceptive Agents|contraceptive agents|mesh-ancestor
25446319|NCT04654741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25446320|NCT04654741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446321|NCT04654741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25446322|NCT04654741|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25446323|NCT04654741|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25446324|NCT04654741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25446325|NCT04654741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25446326|NCT04654741|Hormone Antagonists|hormone antagonists|mesh-ancestor
25446327|NCT04654741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25446328|NCT04654195|Cyclophosphamide|cyclophosphamide|mesh-list
25446329|NCT04654195|Doxorubicin|doxorubicin|mesh-list
25446330|NCT04654195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25446331|NCT04654195|Immunologic Factors|immunologic factors|mesh-ancestor
25446332|NCT04654195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446333|NCT04654195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25446334|NCT04654195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25446335|NCT04654195|Alkylating Agents|alkylating agents|mesh-ancestor
25446336|NCT04654195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446337|NCT04654195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25446338|NCT04654195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25446339|NCT04654195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25446340|NCT04654195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25446341|NCT04654195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25446342|NCT04654195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25446343|NCT04654208|Palbociclib|palbociclib|mesh-list
25446344|NCT04654208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25446345|NCT04654208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25446346|NCT04654208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25446347|NCT04654208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446348|NCT04654182|Chlorhexidine|chlorhexidine|mesh-list
25446349|NCT04654182|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25446350|NCT04654182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25446351|NCT04654182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25446352|NCT04654182|Disinfectants|disinfectants|mesh-ancestor
25446353|NCT04654182|Dermatologic Agents|dermatologic agents|mesh-ancestor
25446354|NCT04654026|Aspirin|aspirin|mesh-list
25446355|NCT04654026|Clopidogrel|clopidogrel|mesh-list
25446356|NCT04654026|Ticagrelor|ticagrelor|mesh-list
25446357|NCT04654026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25446358|NCT04654026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25446359|NCT04654026|Analgesics|analgesics|mesh-ancestor
25446360|NCT04654026|Sensory System Agents|sensory system agents|mesh-ancestor
25446361|NCT04654026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446362|NCT04654026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446363|NCT04654026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25446364|NCT04654026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25446365|NCT04654026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25446366|NCT04654026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25446367|NCT04654026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446368|NCT04654026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25446369|NCT04654026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25446370|NCT04654026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25446371|NCT04654026|Antipyretics|antipyretics|mesh-ancestor
25446372|NCT04654026|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25446398|NCT04653662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25446399|NCT04653662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25446400|NCT04653792|Pregabalin|pregabalin|mesh-list
25446401|NCT04653792|Analgesics|analgesics|mesh-ancestor
25446402|NCT04653792|Sensory System Agents|sensory system agents|mesh-ancestor
25446403|NCT04653792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446404|NCT04653792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446405|NCT04653792|Anticonvulsants|anticonvulsants|mesh-ancestor
25446406|NCT04653792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25446407|NCT04653792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25446408|NCT04653792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446409|NCT04653792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25446410|NCT04653792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25446411|NCT04653792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25446412|NCT04653792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25446413|NCT04653792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25446414|NCT04653779|Metformin|metformin|mesh-list
25446415|NCT04653779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25446416|NCT04653779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446417|NCT04653493|Cyclophosphamide|cyclophosphamide|mesh-list
25446418|NCT04653493|Fludarabine|fludarabine|mesh-list
25446419|NCT04653493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25446420|NCT04653493|Immunologic Factors|immunologic factors|mesh-ancestor
25446421|NCT04653493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446422|NCT04653493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25446423|NCT04653493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25446424|NCT04653493|Alkylating Agents|alkylating agents|mesh-ancestor
25446425|NCT04653493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446426|NCT04653493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25446427|NCT04653493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25446428|NCT04653415|Methylprednisolone|methylprednisolone|mesh-list
25446429|NCT04653415|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25446430|NCT04653415|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25446431|NCT04653415|Prednisolone|prednisolone|mesh-list
25446432|NCT04653415|Prednisolone acetate|prednisolone acetate|mesh-list
25446433|NCT04653415|Gabapentin|gabapentin|mesh-list
25446434|NCT04653415|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25446435|NCT04653415|Prednisolone phosphate|prednisolone phosphate|mesh-list
25446436|NCT04653415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25446437|NCT04653415|Antiemetics|antiemetics|mesh-ancestor
25446438|NCT04653415|Autonomic Agents|autonomic agents|mesh-ancestor
25446439|NCT04653415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446440|NCT04653415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446441|NCT04653415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25446442|NCT04653415|Glucocorticoids|glucocorticoids|mesh-ancestor
25446443|NCT04653415|Hormones|hormones|mesh-ancestor
25446444|NCT04653415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25446445|NCT04653415|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25446446|NCT04653415|Protective Agents|protective agents|mesh-ancestor
25446447|NCT04653415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25446448|NCT04653415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25446449|NCT04653415|Analgesics|analgesics|mesh-ancestor
25446450|NCT04653415|Sensory System Agents|sensory system agents|mesh-ancestor
25446451|NCT04653415|Anticonvulsants|anticonvulsants|mesh-ancestor
25446452|NCT04653415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25446453|NCT04653415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25446454|NCT04653415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25446455|NCT04653415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25446456|NCT04653415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25446457|NCT04653415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25446458|NCT04653415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25446459|NCT04653415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446460|NCT04653415|Antimanic Agents|antimanic agents|mesh-ancestor
25446461|NCT04653337|Norepinephrine|norepinephrine|mesh-list
25446462|NCT04653337|Serotonin|serotonin|mesh-list
25446463|NCT04653337|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
25446464|NCT04653337|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25446465|NCT04653337|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25446466|NCT04653337|Adrenergic Agents|adrenergic agents|mesh-ancestor
25446467|NCT04653337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25300484|NCT03430063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300485|NCT03430063|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25300486|NCT03430063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446468|NCT04653337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446469|NCT04653337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446471|NCT04653337|Autonomic Agents|autonomic agents|mesh-ancestor
25446472|NCT04653337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446473|NCT04653337|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25446474|NCT04653337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25446475|NCT04653337|Serotonin Agents|serotonin agents|mesh-ancestor
25446476|NCT04653337|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25446477|NCT04653337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25446478|NCT04652648|Hydroxychloroquine|hydroxychloroquine|mesh-list
25446479|NCT04652648|Antimalarials|antimalarials|mesh-ancestor
25446480|NCT04652648|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25446481|NCT04652648|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25446482|NCT04652648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25446483|NCT04652648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25446484|NCT04652648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446485|NCT04652648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25446486|NCT04652739|Prednisolone|prednisolone|mesh-list
25446487|NCT04652739|Lycopene|lycopene|mesh-list
25446488|NCT04652739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25446489|NCT04652739|Glucocorticoids|glucocorticoids|mesh-ancestor
25446490|NCT04652739|Hormones|hormones|mesh-ancestor
25446491|NCT04652739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25446492|NCT04652739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446493|NCT04652739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25446494|NCT04652739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25446495|NCT04652739|Protective Agents|protective agents|mesh-ancestor
25446496|NCT04652739|Antioxidants|antioxidants|mesh-ancestor
25446497|NCT04652739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446498|NCT04652739|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25446499|NCT04652739|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25446500|NCT04652661|Midazolam|midazolam|mesh-list
25446501|NCT04652661|Dexmedetomidine|dexmedetomidine|mesh-list
25446502|NCT04652661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25446503|NCT04652661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25446504|NCT04652661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446505|NCT04652661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25446506|NCT04652661|Analgesics|analgesics|mesh-ancestor
25446507|NCT04652661|Sensory System Agents|sensory system agents|mesh-ancestor
25446508|NCT04652661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446509|NCT04652661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25446510|NCT04652661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25446511|NCT04652661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25446512|NCT04652661|Adrenergic Agents|adrenergic agents|mesh-ancestor
25446513|NCT04652661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25446514|NCT04652661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446515|NCT04652661|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25446516|NCT04652661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25446517|NCT04652661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25446518|NCT04652661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25446519|NCT04652661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25446520|NCT04652661|Anesthetics, General|anesthetics, general|mesh-ancestor
25446521|NCT04652661|Anesthetics|anesthetics|mesh-ancestor
25446522|NCT04652661|GABA Modulators|gaba modulators|mesh-ancestor
25446523|NCT04652661|GABA Agents|gaba agents|mesh-ancestor
25446524|NCT04652765|Bicalutamide|bicalutamide|mesh-list
25446525|NCT04652765|Camostat|camostat|mesh-list
25446526|NCT04652765|Androgen Antagonists|androgen antagonists|mesh-ancestor
25446527|NCT04652765|Hormone Antagonists|hormone antagonists|mesh-ancestor
25446528|NCT04652765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25446529|NCT04652765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446530|NCT04652765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25446531|NCT04652765|Protease Inhibitors|protease inhibitors|mesh-ancestor
25446532|NCT04652765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25446533|NCT04652765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446534|NCT04652765|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25446535|NCT04652765|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25446536|NCT04652427|Dexmedetomidine|dexmedetomidine|mesh-list
25446537|NCT04652427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25446538|NCT04652427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25446539|NCT04652427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446540|NCT04652427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25446541|NCT04652427|Analgesics|analgesics|mesh-ancestor
25446542|NCT04652427|Sensory System Agents|sensory system agents|mesh-ancestor
25446543|NCT04652427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446544|NCT04652427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25446545|NCT04652427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25446546|NCT04652427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25446547|NCT04652427|Adrenergic Agents|adrenergic agents|mesh-ancestor
25446548|NCT04652427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25446549|NCT04652427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446550|NCT04652284|Amoxicillin|amoxicillin|mesh-list
25446551|NCT04652284|Clarithromycin|clarithromycin|mesh-list
25446552|NCT04652284|Rifabutin|rifabutin|mesh-list
25446553|NCT04652284|Tinidazole|tinidazole|mesh-list
25446554|NCT04652284|Esomeprazole|esomeprazole|mesh-list
25446555|NCT04652284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25446556|NCT04652284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25446557|NCT04652284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25446558|NCT04652284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25446559|NCT04652284|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25446560|NCT04652284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25446561|NCT04652284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446562|NCT04652284|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25446563|NCT04652284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25446564|NCT04652284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25446565|NCT04652284|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25446566|NCT04652284|Antitubercular Agents|antitubercular agents|mesh-ancestor
25446567|NCT04652284|Alkylating Agents|alkylating agents|mesh-ancestor
25446568|NCT04652284|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25446569|NCT04652284|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25446570|NCT04652284|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25446571|NCT04652323|Calcium|calcium|mesh-list
25446572|NCT04652323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25446573|NCT04652323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446574|NCT04651959|Favipiravir|favipiravir|mesh-list
25446575|NCT04651959|Antiviral Agents|antiviral agents|mesh-ancestor
25446576|NCT04651959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25446577|NCT04652011|Analgesics|analgesics|mesh-list
25446578|NCT04652011|Sensory System Agents|sensory system agents|mesh-ancestor
25446579|NCT04652011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446580|NCT04652011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446581|NCT04652128|Zoledronic Acid|zoledronic acid|mesh-list
25446582|NCT04652128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25446583|NCT04652128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446584|NCT04652115|Defibrotide|defibrotide|mesh-list
25446585|NCT04652115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25446586|NCT04652115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25446587|NCT04652115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446588|NCT04652115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25446589|NCT04651842|Insulin|insulin|mesh-list
25446590|NCT04651842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25446591|NCT04651842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446592|NCT04652089|Simvastatin|simvastatin|mesh-list
25446593|NCT04652089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25446594|NCT04652089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25446595|NCT04652089|Antimetabolites|antimetabolites|mesh-ancestor
25446596|NCT04652089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446597|NCT04652089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25446598|NCT04652089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25446599|NCT04652089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25446600|NCT04651595|Morphine|morphine|mesh-list
25446601|NCT04651595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25446602|NCT04651595|Narcotics|narcotics|mesh-ancestor
25446603|NCT04651595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25446604|NCT04651595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446605|NCT04651595|Analgesics|analgesics|mesh-ancestor
25446606|NCT04651595|Sensory System Agents|sensory system agents|mesh-ancestor
25446607|NCT04651595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446608|NCT04651556|Acetaminophen|acetaminophen|mesh-list
25446609|NCT04651556|Ketorolac|ketorolac|mesh-list
25446610|NCT04651556|Magnesium Sulfate|magnesium sulfate|mesh-list
25446611|NCT04651556|Bupivacaine|bupivacaine|mesh-list
25446612|NCT04651556|Anesthetics, Local|anesthetics, local|mesh-ancestor
25446613|NCT04651556|Anesthetics|anesthetics|mesh-ancestor
25446614|NCT04651556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25446615|NCT04651556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446616|NCT04651556|Sensory System Agents|sensory system agents|mesh-ancestor
25300634|NCT01811368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25300712|NCT05127369|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25300713|NCT05127369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25300714|NCT05127369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25300715|NCT05127369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300716|NCT05127369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25300717|NCT05127369|Serotonin Agents|serotonin agents|mesh-ancestor
25300718|NCT05127369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300725|NCT05126901|Ferric maltol|ferric maltol|mesh-list
25446649|NCT04650893|Dexamethasone|dexamethasone|mesh-list
25446650|NCT04650893|Ketorolac|ketorolac|mesh-list
25446651|NCT04650893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25446652|NCT04650893|Antiemetics|antiemetics|mesh-ancestor
25446653|NCT04650893|Autonomic Agents|autonomic agents|mesh-ancestor
25446654|NCT04650893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446655|NCT04650893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446656|NCT04650893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25446657|NCT04650893|Glucocorticoids|glucocorticoids|mesh-ancestor
25446658|NCT04650893|Hormones|hormones|mesh-ancestor
25446659|NCT04650893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25446660|NCT04650893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25446661|NCT04650893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25446662|NCT04650893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25446663|NCT04650893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25446664|NCT04650893|Analgesics|analgesics|mesh-ancestor
25446665|NCT04650893|Sensory System Agents|sensory system agents|mesh-ancestor
25446666|NCT04650893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25446667|NCT04650893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25446668|NCT04650893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25446669|NCT04650893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446670|NCT04650841|Naloxone|naloxone|mesh-list
25446671|NCT04650841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25446672|NCT04650841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446673|NCT04650841|Sensory System Agents|sensory system agents|mesh-ancestor
25446674|NCT04650841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446675|NCT04650880|Vitamin D|vitamin d|mesh-list
25446676|NCT04650880|Vitamins|vitamins|mesh-ancestor
25446677|NCT04650880|Micronutrients|micronutrients|mesh-ancestor
25446678|NCT04650880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446679|NCT04650880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25446680|NCT04650828|Tenofovir|tenofovir|mesh-list
25446681|NCT04650828|Antiviral Agents|antiviral agents|mesh-ancestor
25446682|NCT04650828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25446683|NCT04650828|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25446684|NCT04650828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25446685|NCT04650828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25446686|NCT04650828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446687|NCT04650828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25446688|NCT04650828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25446689|NCT04650555|Genistein|genistein|mesh-list
25446690|NCT04650555|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25446691|NCT04650555|Protective Agents|protective agents|mesh-ancestor
25446692|NCT04650555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446693|NCT04650555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25822844|NCT00004685|Adrenergic Agents|adrenergic agents|mesh-ancestor
25446694|NCT04650555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25446695|NCT04650555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25446696|NCT04650555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446697|NCT04650555|Phytoestrogens|phytoestrogens|mesh-ancestor
25446698|NCT04650555|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25446699|NCT04650555|Estrogens|estrogens|mesh-ancestor
25446700|NCT04650555|Hormones|hormones|mesh-ancestor
25446701|NCT04650555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25446702|NCT04650321|Ocrelizumab|ocrelizumab|mesh-list
25446703|NCT04650321|Immunologic Factors|immunologic factors|mesh-ancestor
25446704|NCT04650321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446705|NCT04649892|Naltrexone|naltrexone|mesh-list
25446706|NCT04649892|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25446707|NCT04649892|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25446708|NCT04649892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446709|NCT04649892|Sensory System Agents|sensory system agents|mesh-ancestor
25446710|NCT04649892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446711|NCT04649723|Rifampin|rifampin|mesh-list
25446712|NCT04649723|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25446713|NCT04649723|Antitubercular Agents|antitubercular agents|mesh-ancestor
25446714|NCT04649723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25446715|NCT04649723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25446716|NCT04649723|Leprostatic Agents|leprostatic agents|mesh-ancestor
25446717|NCT04649723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25446718|NCT04649723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25446719|NCT04649723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446720|NCT04649723|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25446721|NCT04649723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25446722|NCT04649723|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25446723|NCT04649723|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25446745|NCT04649697|Antioxidants|antioxidants|mesh-ancestor
25446746|NCT04649697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446747|NCT04649697|Protective Agents|protective agents|mesh-ancestor
25446748|NCT04649697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25446749|NCT04649502|Metformin|metformin|mesh-list
25446750|NCT04649502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25446751|NCT04649502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446752|NCT04648891|Lidocaine|lidocaine|mesh-list
25446753|NCT04648891|Anesthetics, Local|anesthetics, local|mesh-ancestor
25446754|NCT04648891|Anesthetics|anesthetics|mesh-ancestor
25446755|NCT04648891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25446756|NCT04648891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446757|NCT04648891|Sensory System Agents|sensory system agents|mesh-ancestor
25446758|NCT04648891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446759|NCT04648891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25446760|NCT04648891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25446761|NCT04648891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25446762|NCT04648891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25446763|NCT04648891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446764|NCT04648813|Bromides|bromides|mesh-list
25446765|NCT04648813|Tiotropium Bromide|tiotropium bromide|mesh-list
25446766|NCT04648813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25446767|NCT04648813|Autonomic Agents|autonomic agents|mesh-ancestor
25446768|NCT04648813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446769|NCT04648813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446770|NCT04648813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25446771|NCT04648813|Respiratory System Agents|respiratory system agents|mesh-ancestor
25446772|NCT04648813|Parasympatholytics|parasympatholytics|mesh-ancestor
25446773|NCT04648813|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25446774|NCT04648813|Cholinergic Agents|cholinergic agents|mesh-ancestor
25446775|NCT04648813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25446776|NCT04648813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446777|NCT04648813|Anticonvulsants|anticonvulsants|mesh-ancestor
25446778|NCT04648358|Dexamethasone|dexamethasone|mesh-list
25446779|NCT04648358|Bupivacaine|bupivacaine|mesh-list
25446780|NCT04648358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25446781|NCT04648358|Antiemetics|antiemetics|mesh-ancestor
25446782|NCT04648358|Autonomic Agents|autonomic agents|mesh-ancestor
25446783|NCT04648358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446784|NCT04648358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446785|NCT04648358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25446786|NCT04648358|Glucocorticoids|glucocorticoids|mesh-ancestor
25446787|NCT04648358|Hormones|hormones|mesh-ancestor
25446788|NCT04648358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25446789|NCT04648358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25446790|NCT04648358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25720621|NCT02472522|Analgesics|analgesics|mesh-ancestor
25446791|NCT04648358|Anesthetics, Local|anesthetics, local|mesh-ancestor
25446792|NCT04648358|Anesthetics|anesthetics|mesh-ancestor
25446793|NCT04648358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25446794|NCT04648358|Sensory System Agents|sensory system agents|mesh-ancestor
25446795|NCT04648423|Sodium Oxybate|sodium oxybate|mesh-list
25446796|NCT04648423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25446797|NCT04648423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25446798|NCT04648423|Anesthetics, General|anesthetics, general|mesh-ancestor
25446799|NCT04648423|Anesthetics|anesthetics|mesh-ancestor
25446800|NCT04648423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25446801|NCT04648423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446802|NCT04648917|Caffeic acid|caffeic acid|mesh-list
25446803|NCT04648917|Antioxidants|antioxidants|mesh-ancestor
25446804|NCT04648917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446805|NCT04648917|Protective Agents|protective agents|mesh-ancestor
25446806|NCT04648917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446807|NCT04648137|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25446808|NCT04648137|Hallucinogens|hallucinogens|mesh-ancestor
25446809|NCT04648137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446810|NCT04648137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25446811|NCT04648137|Serotonin Agents|serotonin agents|mesh-ancestor
25446812|NCT04648137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25446813|NCT04648137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446814|NCT04648137|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25446815|NCT04648137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25446816|NCT04648137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25446817|NCT04648137|Adrenergic Agents|adrenergic agents|mesh-ancestor
25446818|NCT04648332|Bupivacaine|bupivacaine|mesh-list
25446819|NCT04648332|Anesthetics, Local|anesthetics, local|mesh-ancestor
25446820|NCT04648332|Anesthetics|anesthetics|mesh-ancestor
25446821|NCT04648332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25446822|NCT04648332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446823|NCT04648332|Sensory System Agents|sensory system agents|mesh-ancestor
25446824|NCT04648332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446825|NCT04648020|Clonidine|clonidine|mesh-list
25446826|NCT04648020|Analgesics|analgesics|mesh-ancestor
25446827|NCT04648020|Sensory System Agents|sensory system agents|mesh-ancestor
25446828|NCT04648020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446829|NCT04648020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446830|NCT04648020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25446831|NCT04648020|Sympatholytics|sympatholytics|mesh-ancestor
25446832|NCT04648020|Autonomic Agents|autonomic agents|mesh-ancestor
25446833|NCT04648020|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25446834|NCT04648020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25446835|NCT04648020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25446836|NCT04648020|Adrenergic Agents|adrenergic agents|mesh-ancestor
25446837|NCT04648020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25446838|NCT04648020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446839|NCT04648280|Fostemsavir|fostemsavir|mesh-list
25446840|NCT04648280|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25446841|NCT04648280|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25446842|NCT04648280|Antiviral Agents|antiviral agents|mesh-ancestor
25446843|NCT04648280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25446844|NCT04648280|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25446845|NCT04648280|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25446846|NCT04648280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446847|NCT04647669|Interferons|interferons|mesh-list
25446848|NCT04647669|Interferon-beta|interferon-beta|mesh-list
25300930|NCT05087914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300931|NCT05087914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25300932|NCT05087914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25300933|NCT05087914|Gout Suppressants|gout suppressants|mesh-ancestor
25446849|NCT04647669|Interferon beta-1a|interferon beta-1a|mesh-list
25446850|NCT04647669|Remdesivir|remdesivir|mesh-list
25446851|NCT04647669|Acalabrutinib|acalabrutinib|mesh-list
25771760|NCT03633487|Guaifenesin|guaifenesin|mesh-list
25446852|NCT04647669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25446853|NCT04647669|Antiviral Agents|antiviral agents|mesh-ancestor
25446854|NCT04647669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25446855|NCT04647669|Immunologic Factors|immunologic factors|mesh-ancestor
25446856|NCT04647669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446857|NCT04647669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25446858|NCT04647669|Antimetabolites|antimetabolites|mesh-ancestor
25446859|NCT04647669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446860|NCT04647877|Phenytoin|phenytoin|mesh-list
25446861|NCT04647877|Anticonvulsants|anticonvulsants|mesh-ancestor
25446862|NCT04647877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25446863|NCT04647877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25446864|NCT04647877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25446865|NCT04647877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446866|NCT04647877|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25446867|NCT04647877|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25446868|NCT04647838|Tepotinib|tepotinib|mesh-list
25446869|NCT04647838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25446870|NCT04647773|Pregabalin|pregabalin|mesh-list
25446871|NCT04647773|Analgesics|analgesics|mesh-ancestor
25446872|NCT04647773|Sensory System Agents|sensory system agents|mesh-ancestor
25446873|NCT04647773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446874|NCT04647773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446875|NCT04647773|Anticonvulsants|anticonvulsants|mesh-ancestor
25446876|NCT04647773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25446877|NCT04647773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25446878|NCT04647773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446879|NCT04647773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25446880|NCT04647773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25446881|NCT04647773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25446882|NCT04647773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25446883|NCT04647773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25446884|NCT04647461|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25446885|NCT04647461|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25446886|NCT04647461|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25446887|NCT04647461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25446888|NCT04647461|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25446889|NCT04647461|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25446890|NCT04647461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25446891|NCT04647461|Adrenergic Agents|adrenergic agents|mesh-ancestor
25446892|NCT04647461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25446893|NCT04647461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446894|NCT04647461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446895|NCT04647695|Interferons|interferons|mesh-list
25446896|NCT04647695|Interferon-beta|interferon-beta|mesh-list
25446897|NCT04647695|Remdesivir|remdesivir|mesh-list
25446898|NCT04647695|Interferon beta-1b|interferon beta-1b|mesh-list
25446899|NCT04647695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25446900|NCT04647695|Antiviral Agents|antiviral agents|mesh-ancestor
25446901|NCT04647695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25446902|NCT04647695|Immunologic Factors|immunologic factors|mesh-ancestor
25446903|NCT04647695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446904|NCT04647695|Antimetabolites|antimetabolites|mesh-ancestor
25446905|NCT04647695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446906|NCT04647695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25446907|NCT04647552|Hydrocortisone|hydrocortisone|mesh-list
25446908|NCT04647552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25446909|NCT04647344|Paclitaxel|paclitaxel|mesh-list
25446910|NCT04647344|Carboplatin|carboplatin|mesh-list
25446911|NCT04647344|Pemetrexed|pemetrexed|mesh-list
25446912|NCT04647344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25446913|NCT04647344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25446914|NCT04647344|Tubulin Modulators|tubulin modulators|mesh-ancestor
25446915|NCT04647344|Antimitotic Agents|antimitotic agents|mesh-ancestor
25720630|NCT02472522|Anesthetics|anesthetics|mesh-ancestor
25446916|NCT04647344|Mitosis Modulators|mitosis modulators|mesh-ancestor
25446917|NCT04647344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446918|NCT04647344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25446919|NCT04647344|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25301006|NCT04941508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25301007|NCT04941508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25301008|NCT04941508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301009|NCT04941508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25446920|NCT04647344|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25446921|NCT04647292|Antihypertensive Agents|antihypertensive agents|mesh-list
25446922|NCT04646876|Magnesium Sulfate|magnesium sulfate|mesh-list
25446923|NCT04646876|Analgesics|analgesics|mesh-ancestor
25446924|NCT04646876|Sensory System Agents|sensory system agents|mesh-ancestor
25446925|NCT04646876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446926|NCT04646876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446927|NCT04646876|Anesthetics|anesthetics|mesh-ancestor
25446928|NCT04646876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25446929|NCT04646876|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25446930|NCT04646876|Anticonvulsants|anticonvulsants|mesh-ancestor
25446931|NCT04646876|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25446932|NCT04646876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25643908|NCT01431950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25643909|NCT01431950|Autonomic Agents|autonomic agents|mesh-ancestor
25643910|NCT01431950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25643911|NCT01431950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643912|NCT01431950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25643913|NCT01431950|Respiratory System Agents|respiratory system agents|mesh-ancestor
25643914|NCT01431950|Dermatologic Agents|dermatologic agents|mesh-ancestor
25446933|NCT04646876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446934|NCT04646876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25446935|NCT04646876|Tocolytic Agents|tocolytic agents|mesh-ancestor
25446936|NCT04646876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25446937|NCT04646824|Cisplatin|cisplatin|mesh-list
25446938|NCT04646824|Pemetrexed|pemetrexed|mesh-list
25446939|NCT04646824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25446940|NCT04646824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25446941|NCT04646824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446942|NCT04646824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25446943|NCT04646824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25446944|NCT04646707|Lidocaine|lidocaine|mesh-list
25446945|NCT04646707|Bupivacaine|bupivacaine|mesh-list
25446946|NCT04646707|Anesthetics, Local|anesthetics, local|mesh-ancestor
25446947|NCT04646707|Anesthetics|anesthetics|mesh-ancestor
25446948|NCT04646707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25446949|NCT04646707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446950|NCT04646707|Sensory System Agents|sensory system agents|mesh-ancestor
25446951|NCT04646707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446952|NCT04646707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25446953|NCT04646707|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25446954|NCT04646707|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25446955|NCT04646707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25446956|NCT04646707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446957|NCT04646759|Capecitabine|capecitabine|mesh-list
25446958|NCT04646759|Fulvestrant|fulvestrant|mesh-list
25446959|NCT04646759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25446960|NCT04646759|Antimetabolites|antimetabolites|mesh-ancestor
25446961|NCT04646759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446962|NCT04646759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25446963|NCT04646759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25446964|NCT04646759|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25446965|NCT04646759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25446966|NCT04646759|Hormone Antagonists|hormone antagonists|mesh-ancestor
25446967|NCT04646759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25446968|NCT04646759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446969|NCT04646694|Ketamine|ketamine|mesh-list
25446970|NCT04646694|Analgesics|analgesics|mesh-ancestor
25446971|NCT04646694|Sensory System Agents|sensory system agents|mesh-ancestor
25446972|NCT04646694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446973|NCT04646694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446974|NCT04646694|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25446975|NCT04646694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25446976|NCT04646694|Anesthetics, General|anesthetics, general|mesh-ancestor
25446977|NCT04646694|Anesthetics|anesthetics|mesh-ancestor
25446978|NCT04646694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25446979|NCT04646694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25446980|NCT04646694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25446981|NCT04646694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25446982|NCT04646694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25446983|NCT04646317|Dexmedetomidine|dexmedetomidine|mesh-list
25446984|NCT04646317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25446985|NCT04646317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25446986|NCT04646317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25446987|NCT04646317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25446988|NCT04646317|Analgesics|analgesics|mesh-ancestor
25446989|NCT04646317|Sensory System Agents|sensory system agents|mesh-ancestor
25446990|NCT04646317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25446991|NCT04646317|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25447022|NCT04645914|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25447023|NCT04645914|Autonomic Agents|autonomic agents|mesh-ancestor
25447024|NCT04645914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25447025|NCT04645914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447026|NCT04645914|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24631307|NCT01116817|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25643916|NCT01431950|Tocolytic Agents|tocolytic agents|mesh-ancestor
25643917|NCT01431950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25643918|NCT01431950|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25643919|NCT01431950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25643920|NCT01431950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25643921|NCT01431950|Adrenergic Agents|adrenergic agents|mesh-ancestor
25643922|NCT01431950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25643923|NCT01431950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643924|NCT01431963|Lamotrigine|lamotrigine|mesh-list
25643925|NCT01431963|Anticonvulsants|anticonvulsants|mesh-ancestor
25447027|NCT04645914|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25447028|NCT04645914|Cholinergic Agents|cholinergic agents|mesh-ancestor
25447029|NCT04645914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25447030|NCT04645914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447031|NCT04646109|Azithromycin|azithromycin|mesh-list
25447032|NCT04646109|Hydroxychloroquine|hydroxychloroquine|mesh-list
25447033|NCT04646109|Ivermectin|ivermectin|mesh-list
25447034|NCT04646109|Favipiravir|favipiravir|mesh-list
25447035|NCT04646109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25447036|NCT04646109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25447037|NCT04646109|Antimalarials|antimalarials|mesh-ancestor
25447038|NCT04646109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25447039|NCT04646109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25447040|NCT04646109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25447041|NCT04646109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447042|NCT04646109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25447043|NCT04646109|Antiviral Agents|antiviral agents|mesh-ancestor
25447044|NCT04645940|Rabeprazole|rabeprazole|mesh-list
25447045|NCT04645940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25447046|NCT04645940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25447047|NCT04645940|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25643926|NCT01431963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25447048|NCT04645940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25447049|NCT04645940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447050|NCT04645745|Folic Acid|folic acid|mesh-list
25447051|NCT04645745|Inositol|inositol|mesh-list
25447052|NCT04645745|Hematinics|hematinics|mesh-ancestor
25447053|NCT04645745|Vitamin B Complex|vitamin b complex|mesh-ancestor
25447054|NCT04645745|Vitamins|vitamins|mesh-ancestor
25447055|NCT04645745|Micronutrients|micronutrients|mesh-ancestor
25447056|NCT04645745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643927|NCT01431963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25643928|NCT01431963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643929|NCT01431963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25643930|NCT01431963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643931|NCT01431963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25447057|NCT04645303|Triamcinolone|triamcinolone|mesh-list
25447058|NCT04645303|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25447059|NCT04645303|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25447060|NCT04645303|Hyaluronic Acid|hyaluronic acid|mesh-list
25643932|NCT01431963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25643933|NCT01431963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25643934|NCT01431963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25643935|NCT01431963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25643936|NCT01431976|Lamotrigine|lamotrigine|mesh-list
25643937|NCT01431976|Anticonvulsants|anticonvulsants|mesh-ancestor
25643938|NCT01431976|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25643939|NCT01431976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25643940|NCT01431976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447061|NCT04645303|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25447062|NCT04645303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25447063|NCT04645303|Glucocorticoids|glucocorticoids|mesh-ancestor
25447064|NCT04645303|Hormones|hormones|mesh-ancestor
25447065|NCT04645303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25447066|NCT04645303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447067|NCT04645303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25447068|NCT04645303|Immunologic Factors|immunologic factors|mesh-ancestor
25447069|NCT04645303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25447070|NCT04645303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447071|NCT04645303|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25447072|NCT04645303|Viscosupplements|viscosupplements|mesh-ancestor
25447073|NCT04645303|Protective Agents|protective agents|mesh-ancestor
25447074|NCT04644341|Respiratory System Agents|respiratory system agents|mesh-list
25447076|NCT04644484|Immunoglobulins|immunoglobulins|mesh-list
25301230|NCT04572828|Sensory System Agents|sensory system agents|mesh-ancestor
25301231|NCT04572828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25301232|NCT04572828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301233|NCT04572828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25301234|NCT04572828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25301235|NCT04572828|Gout Suppressants|gout suppressants|mesh-ancestor
25301236|NCT04572828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25301237|NCT04572828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25301238|NCT04572828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301239|NCT04564625|Vitamin D|vitamin d|mesh-list
25301240|NCT04564625|Vitamins|vitamins|mesh-ancestor
25301241|NCT04564625|Micronutrients|micronutrients|mesh-ancestor
25301242|NCT04564625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301243|NCT04564625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25301244|NCT04558112|Levodopa|levodopa|mesh-list
25301245|NCT04558112|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25301246|NCT04558112|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25301247|NCT04558112|Dopamine Agents|dopamine agents|mesh-ancestor
25301248|NCT04558112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25301250|NCT04558112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447077|NCT04644484|Immunologic Factors|immunologic factors|mesh-ancestor
25447078|NCT04644484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447079|NCT04644354|Nifedipine|nifedipine|mesh-list
25447080|NCT04644354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25447081|NCT04644354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25447082|NCT04644354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447083|NCT04644354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25447084|NCT04644354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447085|NCT04644354|Vasodilator Agents|vasodilator agents|mesh-ancestor
25447086|NCT04644354|Tocolytic Agents|tocolytic agents|mesh-ancestor
25447087|NCT04644354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25447088|NCT04644250|Paclitaxel|paclitaxel|mesh-list
25447089|NCT04644250|Carboplatin|carboplatin|mesh-list
25447090|NCT04644250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25447091|NCT04644250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447092|NCT04644250|Tubulin Modulators|tubulin modulators|mesh-ancestor
25447093|NCT04644250|Antimitotic Agents|antimitotic agents|mesh-ancestor
25447094|NCT04644250|Mitosis Modulators|mitosis modulators|mesh-ancestor
25447095|NCT04644250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447096|NCT04644094|Dexamethasone|dexamethasone|mesh-list
25447097|NCT04644094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25447098|NCT04644094|Antiemetics|antiemetics|mesh-ancestor
25447099|NCT04644094|Autonomic Agents|autonomic agents|mesh-ancestor
25447100|NCT04644094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25447101|NCT04644094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447102|NCT04644094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25447103|NCT04644094|Glucocorticoids|glucocorticoids|mesh-ancestor
25447104|NCT04644094|Hormones|hormones|mesh-ancestor
25447105|NCT04644094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25447106|NCT04644094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25447107|NCT04644094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447108|NCT04644185|Myeloma Proteins|myeloma proteins|mesh-list
25447109|NCT04644185|Paraproteins|paraproteins|mesh-list
25447110|NCT04644185|Immunologic Factors|immunologic factors|mesh-ancestor
25447111|NCT04644185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447112|NCT04644406|Trastuzumab|trastuzumab|mesh-list
25447113|NCT04644406|Pertuzumab|pertuzumab|mesh-list
25447114|NCT04644406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25447115|NCT04644406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447116|NCT04643821|Calcitriol|calcitriol|mesh-list
25447117|NCT04643821|Acetylcysteine|acetylcysteine|mesh-list
25447118|NCT04643821|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25447119|NCT04643821|Antiviral Agents|antiviral agents|mesh-ancestor
25447120|NCT04643821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25447121|NCT04643821|Expectorants|expectorants|mesh-ancestor
25447122|NCT04643821|Respiratory System Agents|respiratory system agents|mesh-ancestor
25447123|NCT04643821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25447124|NCT04643821|Antioxidants|antioxidants|mesh-ancestor
25447125|NCT04643821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447126|NCT04643821|Protective Agents|protective agents|mesh-ancestor
25447127|NCT04643821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447128|NCT04643821|Antidotes|antidotes|mesh-ancestor
25447129|NCT04643821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25447130|NCT04643821|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25447131|NCT04643821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25447132|NCT04643821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25447133|NCT04643821|Vitamins|vitamins|mesh-ancestor
25447134|NCT04643821|Micronutrients|micronutrients|mesh-ancestor
25447135|NCT04643821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25447136|NCT04643691|Losartan|losartan|mesh-list
25447137|NCT04643691|Spironolactone|spironolactone|mesh-list
25447138|NCT04643691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25447139|NCT04643691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25447140|NCT04643691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25447141|NCT04643691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25447142|NCT04643691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447143|NCT04643691|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25447144|NCT04643691|Hormone Antagonists|hormone antagonists|mesh-ancestor
25447145|NCT04643691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25447146|NCT04643691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301306|NCT04373733|Antiviral Agents|antiviral agents|mesh-ancestor
25301307|NCT04373733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25301308|NCT04334070|Clofazimine|clofazimine|mesh-list
25301309|NCT04334070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25301310|NCT04334070|Leprostatic Agents|leprostatic agents|mesh-ancestor
25301313|NCT04266912|Avelumab|avelumab|mesh-list
25447150|NCT04643483|Adalimumab|adalimumab|mesh-list
25447151|NCT04643483|Certolizumab Pegol|certolizumab pegol|mesh-list
25447152|NCT04643483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25447153|NCT04643483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25447154|NCT04643483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25447155|NCT04643483|Immunologic Factors|immunologic factors|mesh-ancestor
25447156|NCT04643483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447157|NCT04643327|Levetiracetam|levetiracetam|mesh-list
25447158|NCT04643327|Anticonvulsants|anticonvulsants|mesh-ancestor
25447159|NCT04643327|Nootropic Agents|nootropic agents|mesh-ancestor
25447160|NCT04643132|Ketamine|ketamine|mesh-list
25447161|NCT04643132|Esketamine|esketamine|mesh-list
25447162|NCT04643132|Analgesics|analgesics|mesh-ancestor
25447163|NCT04643132|Sensory System Agents|sensory system agents|mesh-ancestor
25447164|NCT04643132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25447165|NCT04643132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447166|NCT04643132|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25447167|NCT04643132|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25447168|NCT04643132|Anesthetics, General|anesthetics, general|mesh-ancestor
25447169|NCT04643132|Anesthetics|anesthetics|mesh-ancestor
25447170|NCT04643132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25447171|NCT04643132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25447172|NCT04643132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25447173|NCT04643132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25447174|NCT04643132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447175|NCT04643132|Antidepressive Agents|antidepressive agents|mesh-ancestor
25447176|NCT04643132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25447177|NCT04643301|Liraglutide|liraglutide|mesh-list
25447178|NCT04643301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25447179|NCT04643301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447180|NCT04643301|Incretins|incretins|mesh-ancestor
25447181|NCT04643301|Hormones|hormones|mesh-ancestor
25447182|NCT04643301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25447183|NCT04642989|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25447184|NCT04642989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25447185|NCT04643106|Hemostatics|hemostatics|mesh-list
25447186|NCT04643106|Coagulants|coagulants|mesh-ancestor
25447187|NCT04642846|Fluorides|fluorides|mesh-list
25447188|NCT04642846|Cariostatic Agents|cariostatic agents|mesh-ancestor
25447189|NCT04642846|Protective Agents|protective agents|mesh-ancestor
25447190|NCT04642846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447191|NCT04642664|Apatinib|apatinib|mesh-list
25447192|NCT04642664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447193|NCT04642664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25447194|NCT04642664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25447195|NCT04642664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447196|NCT04642547|Lenvatinib|lenvatinib|mesh-list
25447197|NCT04642547|Gefitinib|gefitinib|mesh-list
25447198|NCT04642547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447199|NCT04642547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25447200|NCT04642547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25447201|NCT04642547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447202|NCT04642391|Cosyntropin|cosyntropin|mesh-list
25447203|NCT04642391|Hormones|hormones|mesh-ancestor
25404101|NCT03684811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447204|NCT04642391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25447205|NCT04642391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447206|NCT04642131|Caffeine|caffeine|mesh-list
25447207|NCT04642131|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25447208|NCT04642131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447209|NCT04642131|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25447210|NCT04642131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25447211|NCT04642131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447212|NCT04642131|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25447213|NCT04642131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25447214|NCT04642131|Purinergic Agents|purinergic agents|mesh-ancestor
25447215|NCT04642131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25447216|NCT04642001|Listerine|listerine|mesh-list
25301459|NCT03828045|Sensory System Agents|sensory system agents|mesh-ancestor
25301460|NCT03828045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25301461|NCT03828045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301462|NCT03828045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25301463|NCT03828045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25301464|NCT03828045|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25301465|NCT03828045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25301466|NCT03828045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25301468|NCT03825874|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25447230|NCT04641104|Thiamine|thiamine|mesh-list
25447231|NCT04641104|Vitamin B Complex|vitamin b complex|mesh-ancestor
25447232|NCT04641104|Vitamins|vitamins|mesh-ancestor
25447233|NCT04641104|Micronutrients|micronutrients|mesh-ancestor
25447234|NCT04641104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447235|NCT04640870|Afatinib|afatinib|mesh-list
25447236|NCT04640870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447237|NCT04640870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25447238|NCT04640870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25447239|NCT04640870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447240|NCT04640896|Lidocaine|lidocaine|mesh-list
25447241|NCT04640896|Bupivacaine|bupivacaine|mesh-list
25447242|NCT04640896|Anesthetics, Local|anesthetics, local|mesh-ancestor
25447243|NCT04640896|Anesthetics|anesthetics|mesh-ancestor
25447244|NCT04640896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25447245|NCT04640896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447246|NCT04640896|Sensory System Agents|sensory system agents|mesh-ancestor
25447247|NCT04640896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25447248|NCT04640896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25447249|NCT04640896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25447250|NCT04640896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25447251|NCT04640896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25447252|NCT04640896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447253|NCT04640883|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
25447254|NCT04640883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447255|NCT04640883|Immunologic Factors|immunologic factors|mesh-ancestor
25447256|NCT04640883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447257|NCT04640831|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
25447258|NCT04640831|Hallucinogens|hallucinogens|mesh-ancestor
25447259|NCT04640831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447260|NCT04640831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25447261|NCT04640831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25447262|NCT04640831|Serotonin Agents|serotonin agents|mesh-ancestor
25447263|NCT04640831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25447264|NCT04640831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447265|NCT04640831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25447266|NCT04640181|Enoxaparin|enoxaparin|mesh-list
25447267|NCT04640181|Rivaroxaban|rivaroxaban|mesh-list
25447268|NCT04640181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25447269|NCT04640181|Antithrombins|antithrombins|mesh-ancestor
25447270|NCT04640181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25447271|NCT04640181|Protease Inhibitors|protease inhibitors|mesh-ancestor
25447272|NCT04640181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25447273|NCT04640181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447274|NCT04640181|Anticoagulants|anticoagulants|mesh-ancestor
25447275|NCT04640181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25447276|NCT04640181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25447277|NCT04640129|Interferons|interferons|mesh-list
25447278|NCT04640129|Tenofovir|tenofovir|mesh-list
25447279|NCT04640129|Interferon-alpha|interferon-alpha|mesh-list
25447280|NCT04640129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447281|NCT04640129|Antiviral Agents|antiviral agents|mesh-ancestor
25301610|NCT03277924|Epirubicin|epirubicin|mesh-list
25643941|NCT01431976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25643942|NCT01431976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643943|NCT01431976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25643944|NCT01431976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25643945|NCT01431976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25301611|NCT03277924|Ifosfamide|ifosfamide|mesh-list
25301612|NCT03277924|Dacarbazine|dacarbazine|mesh-list
25301613|NCT03277924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301614|NCT03277924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25301615|NCT03277924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25301616|NCT03277924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25301617|NCT03277924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25301618|NCT03277924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301619|NCT03277924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25301620|NCT03277924|Abortifacient Agents|abortifacient agents|mesh-ancestor
25301621|NCT03277924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25301622|NCT03277924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301623|NCT03277924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25301624|NCT03277924|Antimetabolites|antimetabolites|mesh-ancestor
25301625|NCT03277924|Dermatologic Agents|dermatologic agents|mesh-ancestor
25301626|NCT03277924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25301627|NCT03277924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25301628|NCT03277924|Immunologic Factors|immunologic factors|mesh-ancestor
25301629|NCT03277924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25301630|NCT03277924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25301631|NCT03277924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25301632|NCT03277924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25447282|NCT04640129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25447283|NCT04640129|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25447284|NCT04640129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25447285|NCT04640129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25447286|NCT04640129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447287|NCT04640129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25447288|NCT04640129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25447289|NCT04640129|Immunologic Factors|immunologic factors|mesh-ancestor
25447290|NCT04640129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447291|NCT04640324|Vitamin D|vitamin d|mesh-list
25447292|NCT04640324|Vitamins|vitamins|mesh-list
25447293|NCT04640324|Vitamin E|vitamin e|mesh-list
25447294|NCT04640324|Silybin|silybin|mesh-list
25447295|NCT04640324|Micronutrients|micronutrients|mesh-ancestor
25447296|NCT04640324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447297|NCT04640324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25447298|NCT04640324|Antioxidants|antioxidants|mesh-ancestor
25447299|NCT04640324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447300|NCT04640324|Protective Agents|protective agents|mesh-ancestor
25447301|NCT04640324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25447302|NCT04640324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447303|NCT04640285|Menthol|menthol|mesh-list
25447304|NCT04640285|Nicotine|nicotine|mesh-list
25447305|NCT04640285|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25447306|NCT04640285|Autonomic Agents|autonomic agents|mesh-ancestor
25447307|NCT04640285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25447308|NCT04640285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447309|NCT04640285|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25447310|NCT04640285|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25447311|NCT04640285|Cholinergic Agents|cholinergic agents|mesh-ancestor
25447312|NCT04640285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25447313|NCT04640285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447314|NCT04640285|Antipruritics|antipruritics|mesh-ancestor
25447315|NCT04640285|Dermatologic Agents|dermatologic agents|mesh-ancestor
25447316|NCT04639817|Levofloxacin|levofloxacin|mesh-list
25447317|NCT04639817|Ofloxacin|ofloxacin|mesh-list
25447318|NCT04639817|Trimethoprim|trimethoprim|mesh-list
25447319|NCT04639817|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25447320|NCT04639817|Sulfamethoxazole|sulfamethoxazole|mesh-list
25447321|NCT04639817|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25447322|NCT04639817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25447323|NCT04639817|Renal Agents|renal agents|mesh-ancestor
25447324|NCT04639817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25447325|NCT04639817|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25447326|NCT04639817|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25447327|NCT04639817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632569|NCT01124539|Camptothecin|camptothecin|mesh-list
25643946|NCT01431976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25447328|NCT04639817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447329|NCT04639817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447330|NCT04639817|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25447331|NCT04639817|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25447332|NCT04639817|Antimalarials|antimalarials|mesh-ancestor
25447333|NCT04639817|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25447334|NCT04639817|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25447335|NCT04639817|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25447336|NCT04639817|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25447337|NCT04639817|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25447339|NCT04639804|Naproxen|naproxen|mesh-list
25447340|NCT04639804|Aceclofenac|aceclofenac|mesh-list
25447341|NCT04639804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25447342|NCT04639804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25447343|NCT04639804|Analgesics|analgesics|mesh-ancestor
25447344|NCT04639804|Sensory System Agents|sensory system agents|mesh-ancestor
25447345|NCT04639804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25447346|NCT04639804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447347|NCT04639804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25447348|NCT04639804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25447349|NCT04639804|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25447350|NCT04639804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25447351|NCT04639804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25447352|NCT04639804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447353|NCT04639804|Gout Suppressants|gout suppressants|mesh-ancestor
25447354|NCT04639362|Venetoclax|venetoclax|mesh-list
25447355|NCT04639362|Obinutuzumab|obinutuzumab|mesh-list
25447356|NCT04639362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447357|NCT04639362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25447359|NCT04639232|Uricosuric Agents|uricosuric agents|mesh-ancestor
25447360|NCT04639232|Gout Suppressants|gout suppressants|mesh-ancestor
25447361|NCT04639232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25447362|NCT04639232|Renal Agents|renal agents|mesh-ancestor
25447363|NCT04639284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
25447364|NCT04639284|Antibodies|antibodies|mesh-list
25447365|NCT04639284|Immunologic Factors|immunologic factors|mesh-ancestor
25447366|NCT04639284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447367|NCT04639284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25447368|NCT04639284|Growth Substances|growth substances|mesh-ancestor
25447369|NCT04639284|Growth Inhibitors|growth inhibitors|mesh-ancestor
25447370|NCT04639284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447371|NCT04639271|Trastuzumab|trastuzumab|mesh-list
25447372|NCT04639271|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25447373|NCT04639271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25447374|NCT04639271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447375|NCT04639180|Apatinib|apatinib|mesh-list
25447376|NCT04639180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447377|NCT04639180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25447378|NCT04639180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25447379|NCT04639180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447380|NCT04638816|Lidocaine|lidocaine|mesh-list
25447381|NCT04638816|Hyaluronic Acid|hyaluronic acid|mesh-list
25447382|NCT04638816|Anesthetics, Local|anesthetics, local|mesh-ancestor
25447383|NCT04638816|Anesthetics|anesthetics|mesh-ancestor
25447384|NCT04638816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25447385|NCT04638816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447386|NCT04638816|Sensory System Agents|sensory system agents|mesh-ancestor
25447387|NCT04638816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25447388|NCT04638816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25447389|NCT04638816|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25447390|NCT04638816|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25447391|NCT04638816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25447392|NCT04638816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447393|NCT04638816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25447394|NCT04638816|Immunologic Factors|immunologic factors|mesh-ancestor
25447395|NCT04638816|Viscosupplements|viscosupplements|mesh-ancestor
25447396|NCT04638816|Protective Agents|protective agents|mesh-ancestor
25447397|NCT04639193|Acetazolamide|acetazolamide|mesh-list
25447398|NCT04639193|Eszopiclone|eszopiclone|mesh-list
25447399|NCT04639193|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25447400|NCT04639193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25447401|NCT04639193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25447402|NCT04639193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25447403|NCT04639193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447404|NCT04639193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25447405|NCT04639193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447406|NCT04639193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25447407|NCT04639193|Antidepressive Agents|antidepressive agents|mesh-ancestor
25447408|NCT04639193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25447409|NCT04639193|Anticonvulsants|anticonvulsants|mesh-ancestor
25447410|NCT04639193|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25447411|NCT04639193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25447412|NCT04639193|Diuretics|diuretics|mesh-ancestor
25301766|NCT02963064|Immunologic Factors|immunologic factors|mesh-ancestor
25301767|NCT02963064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301768|NCT02909686|Curcumin|curcumin|mesh-list
25301769|NCT02909686|Resveratrol|resveratrol|mesh-list
25301770|NCT02909686|Pycnogenols|pycnogenols|mesh-list
25301771|NCT02909686|Turmeric extract|turmeric extract|mesh-list
25301772|NCT02909686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25301773|NCT02909686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25301774|NCT02909686|Analgesics|analgesics|mesh-ancestor
25301775|NCT02909686|Sensory System Agents|sensory system agents|mesh-ancestor
25301776|NCT02909686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25301777|NCT02909686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301778|NCT02909686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25301779|NCT02909686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25301780|NCT02909686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301781|NCT02909686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25301782|NCT02909686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301783|NCT02909686|Antioxidants|antioxidants|mesh-ancestor
25301784|NCT02909686|Protective Agents|protective agents|mesh-ancestor
25447427|NCT04638686|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25447428|NCT04638790|Dexamethasone|dexamethasone|mesh-list
25447429|NCT04638790|Cyclophosphamide|cyclophosphamide|mesh-list
25447430|NCT04638790|Dacarbazine|dacarbazine|mesh-list
25447431|NCT04638790|Doxorubicin|doxorubicin|mesh-list
25447432|NCT04638790|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25447433|NCT04638790|Etoposide|etoposide|mesh-list
25447434|NCT04638790|Vincristine|vincristine|mesh-list
25447435|NCT04638790|Bleomycin|bleomycin|mesh-list
25447436|NCT04638790|Vinblastine|vinblastine|mesh-list
25447437|NCT04638790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25447438|NCT04638790|Immunologic Factors|immunologic factors|mesh-ancestor
25447439|NCT04638790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447440|NCT04638790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25447441|NCT04638790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25447442|NCT04638790|Alkylating Agents|alkylating agents|mesh-ancestor
25447443|NCT04638790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447444|NCT04638790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447445|NCT04638790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25447446|NCT04638790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25447447|NCT04638790|Antiemetics|antiemetics|mesh-ancestor
25447448|NCT04638790|Autonomic Agents|autonomic agents|mesh-ancestor
25447449|NCT04638790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25447450|NCT04638790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25447451|NCT04638790|Glucocorticoids|glucocorticoids|mesh-ancestor
25447452|NCT04638790|Hormones|hormones|mesh-ancestor
25447453|NCT04638790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25447454|NCT04638790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25447455|NCT04638790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25447456|NCT04638790|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25447457|NCT04638790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25447458|NCT04638790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25447459|NCT04638790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25447460|NCT04638790|Tubulin Modulators|tubulin modulators|mesh-ancestor
25447461|NCT04638790|Antimitotic Agents|antimitotic agents|mesh-ancestor
25447462|NCT04638790|Mitosis Modulators|mitosis modulators|mesh-ancestor
25301842|NCT02512692|Antiviral Agents|antiviral agents|mesh-ancestor
25301843|NCT02512692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25301844|NCT02512692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25301845|NCT02512692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25301846|NCT02512692|Immunologic Factors|immunologic factors|mesh-ancestor
25301847|NCT02512692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301865|NCT02432404|NuvaRing|nuvaring|mesh-list
25301866|NCT02432404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25301867|NCT02432404|Contraceptive Agents|contraceptive agents|mesh-ancestor
25301868|NCT02432404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25301869|NCT02432404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823195|NCT02115594|Entinostat|entinostat|mesh-list
25643947|NCT01431976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25643948|NCT01431989|Amoxicillin|amoxicillin|mesh-list
25643949|NCT01431989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25643950|NCT01431989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25643952|NCT01432015|Fosaprepitant|fosaprepitant|mesh-list
25643953|NCT01432015|Antiemetics|antiemetics|mesh-ancestor
25643954|NCT01432015|Autonomic Agents|autonomic agents|mesh-ancestor
25777419|NCT03598140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822845|NCT00004685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25447469|NCT04638582|Tubulin Modulators|tubulin modulators|mesh-ancestor
25447470|NCT04638582|Antimitotic Agents|antimitotic agents|mesh-ancestor
25447471|NCT04638582|Mitosis Modulators|mitosis modulators|mesh-ancestor
25447472|NCT04638582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447473|NCT04638582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25447474|NCT04638582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25447475|NCT04638582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25447476|NCT04638582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25447478|NCT04638751|Nivolumab|nivolumab|mesh-list
25447479|NCT04638751|Ipilimumab|ipilimumab|mesh-list
25447480|NCT04638751|Durvalumab|durvalumab|mesh-list
25447481|NCT04638751|Avelumab|avelumab|mesh-list
25447482|NCT04638751|Cemiplimab|cemiplimab|mesh-list
25447483|NCT04638751|Atezolizumab|atezolizumab|mesh-list
25447484|NCT04638751|Antineoplastic Agents|antineoplastic agents|mesh-list
25447485|NCT04638751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25447486|NCT04638751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25447487|NCT04638751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447488|NCT04638517|Danazol|danazol|mesh-list
25447489|NCT04638517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25447490|NCT04638517|Hormone Antagonists|hormone antagonists|mesh-ancestor
25447491|NCT04638517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25447492|NCT04638517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447493|NCT04638439|Entecavir|entecavir|mesh-list
25447494|NCT04638439|Nivolumab|nivolumab|mesh-list
25447495|NCT04638439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25447496|NCT04638439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447497|NCT04638439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25447498|NCT04638439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447499|NCT04638439|Antiviral Agents|antiviral agents|mesh-ancestor
25447500|NCT04638439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25447501|NCT04638036|Cetuximab|cetuximab|mesh-list
25447502|NCT04638036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25447503|NCT04638036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447504|NCT04637633|Lubricant Eye Drops|lubricant eye drops|mesh-list
25447505|NCT04637633|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25447506|NCT04637633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25447507|NCT04637464|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25447508|NCT04637464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25447509|NCT04637152|Valsartan|valsartan|mesh-list
25447510|NCT04637152|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25447511|NCT04637152|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25447512|NCT04637152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25447513|NCT04637152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25447514|NCT04637152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447515|NCT04636918|Cyclosporine|cyclosporine|mesh-list
25447516|NCT04636918|Cyclosporins|cyclosporins|mesh-list
25447517|NCT04636918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25447518|NCT04636918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447519|NCT04636918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25447520|NCT04636918|Immunologic Factors|immunologic factors|mesh-ancestor
25301943|NCT02214407|Decitabine|decitabine|mesh-list
25301944|NCT02214407|Hydroxyurea|hydroxyurea|mesh-list
25301945|NCT02214407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25301946|NCT02214407|Antimetabolites|antimetabolites|mesh-ancestor
25301947|NCT02214407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301948|NCT02214407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301949|NCT02214407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25301950|NCT02214407|Antisickling Agents|antisickling agents|mesh-ancestor
25301951|NCT02214407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25301952|NCT01899989|Carboplatin|carboplatin|mesh-list
25301953|NCT01899989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301954|NCT01869114|Sirolimus|sirolimus|mesh-list
25447524|NCT04636918|Dermatologic Agents|dermatologic agents|mesh-ancestor
25447525|NCT04636918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25447526|NCT04636918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25447527|NCT04637204|Axitinib|axitinib|mesh-list
25447529|NCT04637204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25447530|NCT04637204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25447531|NCT04637204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447532|NCT04636957|Ciprofloxacin|ciprofloxacin|mesh-list
25447533|NCT04636957|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
25447534|NCT04636957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25447535|NCT04636957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25447536|NCT04636957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25447537|NCT04636957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25447538|NCT04636957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25447539|NCT04636957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25447540|NCT04636957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447541|NCT04636957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447542|NCT04636957|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25447543|NCT04636957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25447544|NCT04636957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25447545|NCT04636957|Glucocorticoids|glucocorticoids|mesh-ancestor
25447546|NCT04636957|Hormones|hormones|mesh-ancestor
25447547|NCT04636957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25447548|NCT04636957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447549|NCT04637282|Gemfibrozil|gemfibrozil|mesh-list
25447550|NCT04637282|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25447551|NCT04637282|Antimetabolites|antimetabolites|mesh-ancestor
25447552|NCT04637282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447553|NCT04637282|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25447554|NCT04637282|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25447555|NCT04637282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25447556|NCT04637282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25447557|NCT04637360|Calcitriol|calcitriol|mesh-list
25447558|NCT04637360|Cinacalcet|cinacalcet|mesh-list
25447559|NCT04637360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25447560|NCT04637360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447561|NCT04637360|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25447562|NCT04637360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25447563|NCT04637360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447564|NCT04637360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25447565|NCT04637360|Vitamins|vitamins|mesh-ancestor
25447566|NCT04637360|Micronutrients|micronutrients|mesh-ancestor
25447567|NCT04637360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25447568|NCT04637360|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25447569|NCT04637360|Hormone Antagonists|hormone antagonists|mesh-ancestor
25447570|NCT04637360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25447571|NCT04636632|Fosaprepitant|fosaprepitant|mesh-list
25447572|NCT04636632|Aprepitant|aprepitant|mesh-list
25447573|NCT04636632|Antiemetics|antiemetics|mesh-ancestor
25447574|NCT04636632|Autonomic Agents|autonomic agents|mesh-ancestor
25447575|NCT04636632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25447576|NCT04636632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447577|NCT04636632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25447578|NCT04636632|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25447579|NCT04636632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25447580|NCT04636632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301990|NCT01573429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301991|NCT01573429|Protective Agents|protective agents|mesh-ancestor
25301992|NCT01478542|Rituximab|rituximab|mesh-list
25301993|NCT01478542|Vincristine|vincristine|mesh-list
25301994|NCT01478542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25301995|NCT01478542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301996|NCT01478542|Immunologic Factors|immunologic factors|mesh-ancestor
25301997|NCT01478542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301998|NCT01478542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25302000|NCT01478542|Tubulin Modulators|tubulin modulators|mesh-ancestor
25447581|NCT04636125|Doxycycline|doxycycline|mesh-list
25447582|NCT04636125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25447583|NCT04636125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25447584|NCT04636125|Antimalarials|antimalarials|mesh-ancestor
25447585|NCT04636125|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25447586|NCT04636125|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25447587|NCT04636242|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25447588|NCT04636242|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25447589|NCT04636242|Dermatologic Agents|dermatologic agents|mesh-ancestor
25447590|NCT04635852|Fentanyl|fentanyl|mesh-list
25447591|NCT04635852|Morphine|morphine|mesh-list
25447592|NCT04635852|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25447593|NCT04635852|Narcotics|narcotics|mesh-ancestor
25447594|NCT04635852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25447595|NCT04635852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447596|NCT04635852|Analgesics|analgesics|mesh-ancestor
25447597|NCT04635852|Sensory System Agents|sensory system agents|mesh-ancestor
25447598|NCT04635852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25447599|NCT04635852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25447600|NCT04635852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25447601|NCT04635852|Anesthetics, General|anesthetics, general|mesh-ancestor
25447602|NCT04635852|Anesthetics|anesthetics|mesh-ancestor
25447603|NCT04635696|Ethyl Chloride|ethyl chloride|mesh-list
25447604|NCT04635696|Anesthetics, Local|anesthetics, local|mesh-ancestor
25447605|NCT04635696|Anesthetics|anesthetics|mesh-ancestor
25447606|NCT04635696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25447607|NCT04635696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447608|NCT04635696|Sensory System Agents|sensory system agents|mesh-ancestor
25447609|NCT04635696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25447610|NCT04635176|Dexamethasone|dexamethasone|mesh-list
25447611|NCT04635176|Epinephrine|epinephrine|mesh-list
25447612|NCT04635176|Bupivacaine|bupivacaine|mesh-list
25447613|NCT04635176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25447614|NCT04635176|Antiemetics|antiemetics|mesh-ancestor
25447615|NCT04635176|Autonomic Agents|autonomic agents|mesh-ancestor
25447616|NCT04635176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25447617|NCT04635176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447618|NCT04635176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25447619|NCT04635176|Glucocorticoids|glucocorticoids|mesh-ancestor
25447620|NCT04635176|Hormones|hormones|mesh-ancestor
25447621|NCT04635176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25447622|NCT04635176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25447623|NCT04635176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447624|NCT04635176|Anesthetics, Local|anesthetics, local|mesh-ancestor
25447625|NCT04635176|Anesthetics|anesthetics|mesh-ancestor
25447626|NCT04635176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25447627|NCT04635176|Sensory System Agents|sensory system agents|mesh-ancestor
25447628|NCT04635176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25447629|NCT04635176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25447630|NCT04635176|Adrenergic Agents|adrenergic agents|mesh-ancestor
25447631|NCT04635176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25447632|NCT04635176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447633|NCT04635176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25447634|NCT04635176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25447635|NCT04635176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25447636|NCT04635176|Respiratory System Agents|respiratory system agents|mesh-ancestor
25447637|NCT04635176|Mydriatics|mydriatics|mesh-ancestor
25447638|NCT04635176|Sympathomimetics|sympathomimetics|mesh-ancestor
25447639|NCT04635176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25447640|NCT04635566|Mebeverine|mebeverine|mesh-list
25447641|NCT04635566|Alverine|alverine|mesh-list
25447642|NCT04635566|Anticonvulsants|anticonvulsants|mesh-ancestor
25447643|NCT04635566|Parasympatholytics|parasympatholytics|mesh-ancestor
25447644|NCT04635566|Autonomic Agents|autonomic agents|mesh-ancestor
25447645|NCT04635566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25447646|NCT04635566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447647|NCT04635293|Simendan|simendan|mesh-list
25447648|NCT04635293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25447649|NCT04635293|Vasodilator Agents|vasodilator agents|mesh-ancestor
25447650|NCT04635293|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25447651|NCT04635293|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25447652|NCT04635293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25447653|NCT04635293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447654|NCT04635293|Protective Agents|protective agents|mesh-ancestor
25447655|NCT04635293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447656|NCT04635553|Praziquantel|praziquantel|mesh-list
25447657|NCT04635553|Anthelmintics|anthelmintics|mesh-ancestor
25447658|NCT04635553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25447666|NCT04634656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25447667|NCT04634656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447669|NCT04634656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25447670|NCT04634656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25447671|NCT04634656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25447672|NCT04634656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25447673|NCT04634656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25643955|NCT01432015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25447674|NCT04634656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447676|NCT04634500|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25447677|NCT04634500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447678|NCT04634500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25447679|NCT04634500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447680|NCT04634721|Bupivacaine|bupivacaine|mesh-list
25447681|NCT04634721|Anesthetics, Local|anesthetics, local|mesh-ancestor
25447682|NCT04634721|Anesthetics|anesthetics|mesh-ancestor
25447683|NCT04634721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25447684|NCT04634721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447685|NCT04634721|Sensory System Agents|sensory system agents|mesh-ancestor
25447686|NCT04634721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25447687|NCT04633967|Alemtuzumab|alemtuzumab|mesh-list
25447688|NCT04633967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25447689|NCT04633967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447690|NCT04633954|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25447691|NCT04633954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25447692|NCT04633954|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25447693|NCT04633954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25447694|NCT04633954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25447695|NCT04633954|Adrenergic Agents|adrenergic agents|mesh-ancestor
25447696|NCT04633954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25447697|NCT04633954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447698|NCT04633954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447699|NCT04634058|Antibodies|antibodies|mesh-list
25447700|NCT04634058|Immunoglobulins|immunoglobulins|mesh-list
25447701|NCT04634058|Immunologic Factors|immunologic factors|mesh-ancestor
25447702|NCT04634058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447703|NCT04633902|Pembrolizumab|pembrolizumab|mesh-list
25447704|NCT04633902|Olaparib|olaparib|mesh-list
25447705|NCT04633902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25447706|NCT04633902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447707|NCT04633902|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25447708|NCT04633902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25447709|NCT04633902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302140|NCT04955938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302141|NCT04930991|Omeprazole|omeprazole|mesh-list
25302142|NCT04930991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25302143|NCT04930991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25302144|NCT04930991|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25302145|NCT04930991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25302146|NCT04930991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302147|NCT04789434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25302148|NCT04789434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302149|NCT04789434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302150|NCT04773184|Capsaicin|capsaicin|mesh-list
25302151|NCT04773184|Antipruritics|antipruritics|mesh-ancestor
25302152|NCT04773184|Dermatologic Agents|dermatologic agents|mesh-ancestor
25302170|NCT04405674|Paclitaxel|paclitaxel|mesh-list
25447711|NCT04633850|Bupivacaine|bupivacaine|mesh-list
25447712|NCT04633850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25447713|NCT04633850|Antiemetics|antiemetics|mesh-ancestor
25447714|NCT04633850|Autonomic Agents|autonomic agents|mesh-ancestor
25447715|NCT04633850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25447716|NCT04633850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447717|NCT04633850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25447718|NCT04633850|Glucocorticoids|glucocorticoids|mesh-ancestor
25447719|NCT04633850|Hormones|hormones|mesh-ancestor
25447720|NCT04633850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25447721|NCT04633850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25447722|NCT04633850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447723|NCT04633850|Anesthetics, Local|anesthetics, local|mesh-ancestor
25447724|NCT04633850|Anesthetics|anesthetics|mesh-ancestor
25447725|NCT04633850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25447726|NCT04633850|Sensory System Agents|sensory system agents|mesh-ancestor
25447727|NCT04633746|Endostatins|endostatins|mesh-list
25447728|NCT04633746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447729|NCT04633746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25447730|NCT04633746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25447731|NCT04633746|Growth Substances|growth substances|mesh-ancestor
25447732|NCT04633746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447733|NCT04633746|Growth Inhibitors|growth inhibitors|mesh-ancestor
25643956|NCT01432015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643957|NCT01432015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25447734|NCT04633733|Tacrolimus|tacrolimus|mesh-list
25447735|NCT04633733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25447736|NCT04633733|Immunologic Factors|immunologic factors|mesh-ancestor
25447737|NCT04633733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447738|NCT04633733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25447739|NCT04633733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25447740|NCT04633733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447741|NCT04633577|Lidocaine|lidocaine|mesh-list
25447742|NCT04633577|Anesthetics, Local|anesthetics, local|mesh-ancestor
25447743|NCT04633577|Anesthetics|anesthetics|mesh-ancestor
25447744|NCT04633577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25447745|NCT04633577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447746|NCT04633577|Sensory System Agents|sensory system agents|mesh-ancestor
25447747|NCT04633577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25447748|NCT04633577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25447749|NCT04633577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25447750|NCT04633577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25447751|NCT04633577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25447752|NCT04633577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447753|NCT04633044|Betaine|betaine|mesh-list
25447754|NCT04633044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25447755|NCT04633044|Lipotropic Agents|lipotropic agents|mesh-ancestor
25447756|NCT04633044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25447757|NCT04633044|Antimetabolites|antimetabolites|mesh-ancestor
25447758|NCT04633044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447759|NCT04633044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25447760|NCT04632693|Ascorbic Acid|ascorbic acid|mesh-list
25447761|NCT04632693|Vitamins|vitamins|mesh-ancestor
25447762|NCT04632693|Micronutrients|micronutrients|mesh-ancestor
25447763|NCT04632693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447764|NCT04632693|Antioxidants|antioxidants|mesh-ancestor
25447765|NCT04632693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447766|NCT04632693|Protective Agents|protective agents|mesh-ancestor
25447767|NCT04632758|Crizotinib|crizotinib|mesh-list
25447768|NCT04632758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447769|NCT04632758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25447770|NCT04632758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25447771|NCT04632758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447772|NCT04632537|BCG Vaccine|bcg vaccine|mesh-list
25447773|NCT04632537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25447774|NCT04632537|Immunologic Factors|immunologic factors|mesh-ancestor
25447775|NCT04632537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447776|NCT04632238|Metronidazole|metronidazole|mesh-list
25447777|NCT04632238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25447778|NCT04632238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25447779|NCT04632238|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25447780|NCT04632238|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25447781|NCT04632121|Nicorandil|nicorandil|mesh-list
25447782|NCT04632121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25302216|NCT04227314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25302217|NCT04227314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447783|NCT04632121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25447784|NCT04632121|Vasodilator Agents|vasodilator agents|mesh-ancestor
25447785|NCT04632121|Vitamin B Complex|vitamin b complex|mesh-ancestor
25447787|NCT04632121|Micronutrients|micronutrients|mesh-ancestor
25447788|NCT04632121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447789|NCT04631874|Varenicline|varenicline|mesh-list
25447790|NCT04631874|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25447791|NCT04631874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25447792|NCT04631874|Cholinergic Agents|cholinergic agents|mesh-ancestor
25447793|NCT04631874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25447794|NCT04631874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447795|NCT04631874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447796|NCT04631822|Dexamethasone|dexamethasone|mesh-list
25447797|NCT04631822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25447798|NCT04631822|Antiemetics|antiemetics|mesh-ancestor
25447799|NCT04631822|Autonomic Agents|autonomic agents|mesh-ancestor
25447800|NCT04631822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25447801|NCT04631822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447802|NCT04631822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25447803|NCT04631822|Glucocorticoids|glucocorticoids|mesh-ancestor
25447804|NCT04631822|Hormones|hormones|mesh-ancestor
25447805|NCT04631822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25643958|NCT01432015|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25643959|NCT01432015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25643960|NCT01432015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643961|NCT01432145|Methotrexate|methotrexate|mesh-list
25643962|NCT01432145|Mercaptopurine|mercaptopurine|mesh-list
25643963|NCT01432145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25643964|NCT01432145|Abortifacient Agents|abortifacient agents|mesh-ancestor
25643965|NCT01432145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25643966|NCT01432145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643967|NCT01432145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25643968|NCT01432145|Antimetabolites|antimetabolites|mesh-ancestor
25447806|NCT04631822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25447807|NCT04631822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447808|NCT04631627|Aspirin|aspirin|mesh-list
25447809|NCT04631627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25447810|NCT04631627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25447811|NCT04631627|Analgesics|analgesics|mesh-ancestor
25447812|NCT04631627|Sensory System Agents|sensory system agents|mesh-ancestor
25447813|NCT04631627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25447814|NCT04631627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447815|NCT04631627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25447816|NCT04631627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25447817|NCT04631627|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25447818|NCT04631627|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25447819|NCT04631627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447820|NCT04631627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25447821|NCT04631627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25447822|NCT04631627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25447823|NCT04631627|Antipyretics|antipyretics|mesh-ancestor
25447824|NCT04631315|Prednisolone|prednisolone|mesh-list
25447825|NCT04631315|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25447826|NCT04631315|Methylprednisolone|methylprednisolone|mesh-list
25447827|NCT04631315|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25447828|NCT04631315|Prednisolone acetate|prednisolone acetate|mesh-list
25447829|NCT04631315|Phenylephrine|phenylephrine|mesh-list
25447830|NCT04631315|Oxymetazoline|oxymetazoline|mesh-list
25447831|NCT04631315|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25447832|NCT04631315|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25447833|NCT04631315|Prednisolone phosphate|prednisolone phosphate|mesh-list
25447834|NCT04631315|Difluprednate|difluprednate|mesh-list
25447835|NCT04631315|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25447836|NCT04631315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25447837|NCT04631315|Glucocorticoids|glucocorticoids|mesh-ancestor
25447838|NCT04631315|Hormones|hormones|mesh-ancestor
25447839|NCT04631315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25447840|NCT04631315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447841|NCT04631315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25447842|NCT04631315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447843|NCT04631315|Antiemetics|antiemetics|mesh-ancestor
25447844|NCT04631315|Autonomic Agents|autonomic agents|mesh-ancestor
25447845|NCT04631315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25447846|NCT04631315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25447847|NCT04631315|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25447848|NCT04631315|Protective Agents|protective agents|mesh-ancestor
25447849|NCT04631315|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25447850|NCT04631315|Mydriatics|mydriatics|mesh-ancestor
25447851|NCT04631315|Sympathomimetics|sympathomimetics|mesh-ancestor
25447852|NCT04631315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25447853|NCT04631315|Nasal Decongestants|nasal decongestants|mesh-ancestor
25447854|NCT04631315|Respiratory System Agents|respiratory system agents|mesh-ancestor
25447855|NCT04631315|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25447856|NCT04631315|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25447857|NCT04631315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25447858|NCT04631315|Adrenergic Agents|adrenergic agents|mesh-ancestor
25447868|NCT04631484|Niacinamide|niacinamide|mesh-list
25447869|NCT04631484|Niacin|niacin|mesh-list
25447870|NCT04631484|Nicotinic Acids|nicotinic acids|mesh-list
25447871|NCT04631484|Vitamin B Complex|vitamin b complex|mesh-ancestor
25447872|NCT04631484|Vitamins|vitamins|mesh-ancestor
25447873|NCT04631484|Micronutrients|micronutrients|mesh-ancestor
25447874|NCT04631484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447875|NCT04631484|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25447876|NCT04631484|Dermatologic Agents|dermatologic agents|mesh-ancestor
25447877|NCT04631484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25447878|NCT04631484|Antimetabolites|antimetabolites|mesh-ancestor
25447879|NCT04631484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643969|NCT01432145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643970|NCT01432145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25643971|NCT01432145|Dermatologic Agents|dermatologic agents|mesh-ancestor
25643972|NCT01432145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25643973|NCT01432145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25643974|NCT01432145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25643975|NCT01432145|Immunologic Factors|immunologic factors|mesh-ancestor
25447880|NCT04631484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25447881|NCT04631484|Vasodilator Agents|vasodilator agents|mesh-ancestor
25447882|NCT04631250|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25447883|NCT04631250|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25447884|NCT04631250|Dermatologic Agents|dermatologic agents|mesh-ancestor
25447886|NCT04630873|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25447887|NCT04630873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25447888|NCT04630873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447889|NCT04630873|Cholinergic Agents|cholinergic agents|mesh-ancestor
25447890|NCT04630873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25447891|NCT04630873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447892|NCT04631185|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25447893|NCT04631185|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25447894|NCT04631185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25447895|NCT04631185|Antitubercular Agents|antitubercular agents|mesh-ancestor
25447896|NCT04630522|Vitamin D|vitamin d|mesh-list
25447897|NCT04630522|Calcium, Dietary|calcium, dietary|mesh-list
25447898|NCT04630522|Calcium|calcium|mesh-list
25447899|NCT04630522|Vitamins|vitamins|mesh-ancestor
25447900|NCT04630522|Micronutrients|micronutrients|mesh-ancestor
25447901|NCT04630522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447902|NCT04630522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25447903|NCT04630522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25447904|NCT04630444|Riluzole|riluzole|mesh-list
25447905|NCT04630444|Anticonvulsants|anticonvulsants|mesh-ancestor
25447906|NCT04630444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25447907|NCT04630444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25447908|NCT04630444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25447909|NCT04630444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447910|NCT04630444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447911|NCT04630444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25447912|NCT04630444|Protective Agents|protective agents|mesh-ancestor
25447913|NCT04630548|Copper|copper|mesh-list
25447914|NCT04630548|Trace Elements|trace elements|mesh-ancestor
25447915|NCT04630548|Micronutrients|micronutrients|mesh-ancestor
25447916|NCT04630548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447917|NCT04630288|Clopidogrel|clopidogrel|mesh-list
25447918|NCT04630288|Ticagrelor|ticagrelor|mesh-list
25447919|NCT04630288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25447920|NCT04630288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25447921|NCT04630288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25447922|NCT04630288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25447923|NCT04630288|Purinergic Agents|purinergic agents|mesh-ancestor
25447924|NCT04630288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25447925|NCT04630288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302440|NCT03344159|Natriuretic Agents|natriuretic agents|mesh-ancestor
25302441|NCT03319459|Trastuzumab|trastuzumab|mesh-list
25302442|NCT03319459|Cetuximab|cetuximab|mesh-list
25302443|NCT03319459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25302444|NCT03319459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302445|NCT03318874|Hyaluronic Acid|hyaluronic acid|mesh-list
25302446|NCT03318874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25302447|NCT03318874|Immunologic Factors|immunologic factors|mesh-ancestor
25302448|NCT03318874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302449|NCT03318874|Viscosupplements|viscosupplements|mesh-ancestor
25302450|NCT03318874|Protective Agents|protective agents|mesh-ancestor
25302451|NCT03259698|Tenofovir|tenofovir|mesh-list
25302452|NCT03259698|Emtricitabine|emtricitabine|mesh-list
25302453|NCT03259698|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25302454|NCT03259698|Antiviral Agents|antiviral agents|mesh-ancestor
25302455|NCT03259698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25302456|NCT03259698|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25447931|NCT04629885|Oxytocics|oxytocics|mesh-ancestor
25447932|NCT04629885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25447933|NCT04629885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447935|NCT04629495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25447936|NCT04629495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25447937|NCT04629495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25447938|NCT04629495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447939|NCT04629495|Antifungal Agents|antifungal agents|mesh-ancestor
25447940|NCT04629495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25447941|NCT04629495|Immunologic Factors|immunologic factors|mesh-ancestor
25447942|NCT04629495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447943|NCT04629846|Docetaxel|docetaxel|mesh-list
25447944|NCT04629846|Trastuzumab|trastuzumab|mesh-list
25447945|NCT04629846|Pertuzumab|pertuzumab|mesh-list
25447946|NCT04629846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447947|NCT04629846|Tubulin Modulators|tubulin modulators|mesh-ancestor
25447948|NCT04629846|Antimitotic Agents|antimitotic agents|mesh-ancestor
25447949|NCT04629846|Mitosis Modulators|mitosis modulators|mesh-ancestor
25447950|NCT04629846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447951|NCT04629846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25447952|NCT04629573|Anesthetics|anesthetics|mesh-list
25447953|NCT04629573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25447954|NCT04629573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447955|NCT04629612|Anesthetics|anesthetics|mesh-list
25720759|NCT02474407|Diazepam|diazepam|mesh-list
25447956|NCT04629612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25447957|NCT04629612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447958|NCT04629144|Belimumab|belimumab|mesh-list
25447959|NCT04629144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25447960|NCT04629144|Immunologic Factors|immunologic factors|mesh-ancestor
25447961|NCT04629144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447962|NCT04629209|TIC10 compound|tic10 compound|mesh-list
25447963|NCT04629209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447964|NCT04628884|Heparin|heparin|mesh-list
25447965|NCT04628884|Anticoagulants|anticoagulants|mesh-ancestor
25447966|NCT04628884|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25447967|NCT04628884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25447968|NCT04628884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447969|NCT04629027|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25447970|NCT04629027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447971|NCT04629027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447972|NCT04629118|Sirolimus|sirolimus|mesh-list
25447973|NCT04629118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25447974|NCT04629118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25447975|NCT04629118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25447976|NCT04629118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25447977|NCT04629118|Antifungal Agents|antifungal agents|mesh-ancestor
25447978|NCT04629118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25447979|NCT04629118|Immunologic Factors|immunologic factors|mesh-ancestor
25447980|NCT04629118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302517|NCT02648581|Dermatologic Agents|dermatologic agents|mesh-ancestor
25302518|NCT02609815|Metformin|metformin|mesh-list
25302519|NCT02609815|Glimepiride|glimepiride|mesh-list
25302520|NCT02609815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25302521|NCT02609815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302522|NCT02609815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25302523|NCT02609815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25302524|NCT02609815|Immunologic Factors|immunologic factors|mesh-ancestor
25302525|NCT02464878|Etanercept|etanercept|mesh-list
25302526|NCT02464878|Thymoglobulin|thymoglobulin|mesh-list
25302527|NCT02464878|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25302528|NCT02464878|Basiliximab|basiliximab|mesh-list
25302529|NCT02464878|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25302530|NCT02464878|Protein C Inhibitor|protein c inhibitor|mesh-list
25302531|NCT02464878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25302532|NCT02464878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25447981|NCT04628559|Dexmedetomidine|dexmedetomidine|mesh-list
25447983|NCT04628559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25447984|NCT04628559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25447985|NCT04628559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25447986|NCT04628559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25447987|NCT04628559|Analgesics|analgesics|mesh-ancestor
25447988|NCT04628559|Sensory System Agents|sensory system agents|mesh-ancestor
25447989|NCT04628559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25447990|NCT04628559|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25447991|NCT04628559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25447992|NCT04628559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25447993|NCT04628559|Adrenergic Agents|adrenergic agents|mesh-ancestor
25447994|NCT04628559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25447995|NCT04628559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25447996|NCT04628559|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25447997|NCT04628559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25447998|NCT04628559|Anesthetics, General|anesthetics, general|mesh-ancestor
25447999|NCT04628559|Anesthetics|anesthetics|mesh-ancestor
25448000|NCT04628559|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25448001|NCT04628559|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25448002|NCT04628676|Epinephrine|epinephrine|mesh-list
25448003|NCT04628676|Tranylcypromine|tranylcypromine|mesh-list
25448004|NCT04628676|Tranexamic Acid|tranexamic acid|mesh-list
25448005|NCT04628676|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25448006|NCT04628676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25448007|NCT04628676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448008|NCT04628676|Hemostatics|hemostatics|mesh-ancestor
25448009|NCT04628676|Coagulants|coagulants|mesh-ancestor
25448010|NCT04628676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25448011|NCT04628676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25448012|NCT04628676|Adrenergic Agents|adrenergic agents|mesh-ancestor
25448013|NCT04628676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25448014|NCT04628676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448015|NCT04628676|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25448016|NCT04628676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25448017|NCT04628676|Autonomic Agents|autonomic agents|mesh-ancestor
25448018|NCT04628676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25448019|NCT04628676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25448020|NCT04628676|Respiratory System Agents|respiratory system agents|mesh-ancestor
25448021|NCT04628676|Mydriatics|mydriatics|mesh-ancestor
25448022|NCT04628676|Sympathomimetics|sympathomimetics|mesh-ancestor
25448023|NCT04628676|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25448024|NCT04628676|Antidepressive Agents|antidepressive agents|mesh-ancestor
25448025|NCT04628676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25448026|NCT04628676|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25448027|NCT04628676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448028|NCT04628676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25448029|NCT04628676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25448030|NCT04628676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25448031|NCT04628325|Furosemide|furosemide|mesh-list
25448032|NCT04628325|Diuretics|diuretics|mesh-ancestor
25302619|NCT00754949|Azithromycin|azithromycin|mesh-list
25302620|NCT00754949|Dexamethasone|dexamethasone|mesh-list
25302621|NCT00754949|Dexamethasone acetate|dexamethasone acetate|mesh-list
25302622|NCT00754949|BB 1101|bb 1101|mesh-list
25302623|NCT00754949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25302624|NCT00754949|Antiemetics|antiemetics|mesh-ancestor
25302625|NCT00754949|Autonomic Agents|autonomic agents|mesh-ancestor
25302626|NCT00754949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25302627|NCT00754949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302628|NCT00754949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25302629|NCT00754949|Glucocorticoids|glucocorticoids|mesh-ancestor
25302630|NCT00754949|Hormones|hormones|mesh-ancestor
25302631|NCT00754949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25302632|NCT00754949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25302633|NCT00754949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829453|NCT00006211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24816775|NCT02078648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24816776|NCT02078648|Laxatives|laxatives|mesh-ancestor
24816777|NCT02078648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25302634|NCT00754949|Protease Inhibitors|protease inhibitors|mesh-ancestor
25302635|NCT00754949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25302636|NCT00754949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302637|NCT00754949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25448033|NCT04628325|Natriuretic Agents|natriuretic agents|mesh-ancestor
25448034|NCT04628325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448035|NCT04628325|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25448036|NCT04628325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25448037|NCT04628325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448038|NCT04628533|Oxymetazoline|oxymetazoline|mesh-list
25448039|NCT04628533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25448040|NCT04628533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25448041|NCT04628533|Adrenergic Agents|adrenergic agents|mesh-ancestor
25448042|NCT04628533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25448043|NCT04628533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448044|NCT04628533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448045|NCT04628533|Sympathomimetics|sympathomimetics|mesh-ancestor
25448046|NCT04628533|Autonomic Agents|autonomic agents|mesh-ancestor
25448047|NCT04628533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25448048|NCT04628533|Nasal Decongestants|nasal decongestants|mesh-ancestor
25448049|NCT04628533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25643976|NCT01432145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25643977|NCT01432145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25448050|NCT04628533|Respiratory System Agents|respiratory system agents|mesh-ancestor
25448051|NCT04628624|Antioxidants|antioxidants|mesh-list
25448052|NCT04628624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448053|NCT04628624|Protective Agents|protective agents|mesh-ancestor
25448054|NCT04628624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448055|NCT04628000|Vitamin D|vitamin d|mesh-list
25448056|NCT04628000|Ergocalciferols|ergocalciferols|mesh-list
25448057|NCT04628000|Cholecalciferol|cholecalciferol|mesh-list
25448058|NCT04628000|Vitamins|vitamins|mesh-list
25448059|NCT04628000|Micronutrients|micronutrients|mesh-ancestor
25448060|NCT04628000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448061|NCT04628000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25448062|NCT04628000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25448063|NCT04628143|Nafamostat|nafamostat|mesh-list
25448064|NCT04628143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25448065|NCT04628143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25448066|NCT04628143|Analgesics|analgesics|mesh-ancestor
25448067|NCT04628143|Sensory System Agents|sensory system agents|mesh-ancestor
25448068|NCT04628143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25448069|NCT04628143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448070|NCT04628143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25448071|NCT04628143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25448072|NCT04628143|Anticoagulants|anticoagulants|mesh-ancestor
25448073|NCT04628143|Protease Inhibitors|protease inhibitors|mesh-ancestor
25448074|NCT04628143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448075|NCT04628143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448076|NCT04628143|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25448077|NCT04628143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25448078|NCT04628143|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25448079|NCT04628143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25448080|NCT04628143|Immunologic Factors|immunologic factors|mesh-ancestor
25448081|NCT04627779|Flurbiprofen|flurbiprofen|mesh-list
25448082|NCT04627779|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
25448083|NCT04627779|Analgesics|analgesics|mesh-ancestor
25448084|NCT04627779|Sensory System Agents|sensory system agents|mesh-ancestor
25448085|NCT04627779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25448086|NCT04627779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448087|NCT04627779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25448088|NCT04627779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25448089|NCT04627779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25448090|NCT04627779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25448091|NCT04627779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25448092|NCT04627779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448093|NCT04627779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448094|NCT04627571|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25448095|NCT04627571|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25448096|NCT04627467|Chloroquine|chloroquine|mesh-list
25302669|NCT05131893|Antimitotic Agents|antimitotic agents|mesh-ancestor
25302670|NCT05131893|Mitosis Modulators|mitosis modulators|mesh-ancestor
25302671|NCT05131893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302672|NCT05131893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25302673|NCT05131893|Immunologic Factors|immunologic factors|mesh-ancestor
25302674|NCT05131893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302675|NCT05131893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25302676|NCT05131893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25302677|NCT05131893|Alkylating Agents|alkylating agents|mesh-ancestor
25448098|NCT04627467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25448099|NCT04627467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25448100|NCT04627467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25448101|NCT04627467|Antimalarials|antimalarials|mesh-ancestor
25448102|NCT04627467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25448103|NCT04627623|Antibodies|antibodies|mesh-list
25448104|NCT04627623|Immunoglobulin G|immunoglobulin g|mesh-list
25448105|NCT04627623|Immunologic Factors|immunologic factors|mesh-ancestor
25448106|NCT04627623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448107|NCT04627363|Bevacizumab|bevacizumab|mesh-list
25448108|NCT04627363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25448109|NCT04627363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25448110|NCT04627363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25448111|NCT04627363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25448112|NCT04627363|Growth Substances|growth substances|mesh-ancestor
25448113|NCT04627363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448114|NCT04627363|Growth Inhibitors|growth inhibitors|mesh-ancestor
25448115|NCT04627181|Hydroxocobalamin|hydroxocobalamin|mesh-list
25643978|NCT01432171|Lacosamide|lacosamide|mesh-list
25448116|NCT04627181|Vitamin B 12|vitamin b 12|mesh-list
25448117|NCT04627181|Hematinics|hematinics|mesh-ancestor
25448118|NCT04627181|Vitamin B Complex|vitamin b complex|mesh-ancestor
25448119|NCT04627181|Vitamins|vitamins|mesh-ancestor
25448120|NCT04627181|Micronutrients|micronutrients|mesh-ancestor
25448121|NCT04627181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448122|NCT04626739|Cyclophosphamide|cyclophosphamide|mesh-list
25448123|NCT04626739|Fludarabine|fludarabine|mesh-list
25448124|NCT04626739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25448125|NCT04626739|Immunologic Factors|immunologic factors|mesh-ancestor
25448126|NCT04626739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448127|NCT04626739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25448128|NCT04626739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25448129|NCT04626739|Alkylating Agents|alkylating agents|mesh-ancestor
25448130|NCT04626739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448131|NCT04626739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25448132|NCT04626739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25448133|NCT04627129|Itraconazole|itraconazole|mesh-list
25448134|NCT04627129|Antifungal Agents|antifungal agents|mesh-ancestor
25448135|NCT04627129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25448136|NCT04627129|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25448137|NCT04627129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25448138|NCT04627129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448139|NCT04627129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448140|NCT04627129|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25448141|NCT04627129|Hormone Antagonists|hormone antagonists|mesh-ancestor
25448142|NCT04627129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25448143|NCT04627129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448144|NCT04627129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25448145|NCT04626778|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25448146|NCT04626778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25448147|NCT04626778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25448148|NCT04626765|Cyclophosphamide|cyclophosphamide|mesh-list
25448149|NCT04626765|Fludarabine|fludarabine|mesh-list
25448150|NCT04626765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25448151|NCT04626765|Immunologic Factors|immunologic factors|mesh-ancestor
25448152|NCT04626765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448153|NCT04626765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25448154|NCT04626765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25302757|NCT05130684|Paclitaxel|paclitaxel|mesh-list
25302758|NCT05130684|Cisplatin|cisplatin|mesh-list
25302759|NCT05130684|Nivolumab|nivolumab|mesh-list
25302760|NCT05130684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25302761|NCT05130684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302762|NCT05130684|Tubulin Modulators|tubulin modulators|mesh-ancestor
25302763|NCT05130684|Antimitotic Agents|antimitotic agents|mesh-ancestor
25302764|NCT05130684|Mitosis Modulators|mitosis modulators|mesh-ancestor
25302765|NCT05130684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302766|NCT05130684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25302767|NCT05130684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25302768|NCT05130619|Ethanol|ethanol|mesh-list
25302769|NCT05130619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25302770|NCT05130619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25302771|NCT05130619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25302773|NCT05130515|Niraparib|niraparib|mesh-list
25448155|NCT04626765|Alkylating Agents|alkylating agents|mesh-ancestor
25448181|NCT04626726|Immunologic Factors|immunologic factors|mesh-ancestor
25448182|NCT04626726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448183|NCT04626726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25448184|NCT04626726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25448185|NCT04626726|Alkylating Agents|alkylating agents|mesh-ancestor
25448186|NCT04626726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448187|NCT04626726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25448188|NCT04626726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25302816|NCT05008536|Fludarabine|fludarabine|mesh-list
25302817|NCT05008536|Cyclophosphamide|cyclophosphamide|mesh-list
25302818|NCT05008536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302819|NCT05008536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302820|NCT05008536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25302821|NCT05008536|Immunologic Factors|immunologic factors|mesh-ancestor
25302822|NCT05008536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302823|NCT05008536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25302824|NCT05008536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25643979|NCT01432171|Anticonvulsants|anticonvulsants|mesh-ancestor
25302825|NCT05008536|Alkylating Agents|alkylating agents|mesh-ancestor
25302826|NCT05008536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25302828|NCT04991571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25302829|NCT04991571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448190|NCT04626414|Ferric Compounds|ferric compounds|mesh-list
25448191|NCT04626414|Hematinics|hematinics|mesh-ancestor
25448192|NCT04626089|Metformin|metformin|mesh-list
25448193|NCT04626089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25448194|NCT04626089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448195|NCT04626193|Amoxicillin|amoxicillin|mesh-list
25448196|NCT04626193|Doxycycline|doxycycline|mesh-list
25448197|NCT04626193|Levofloxacin|levofloxacin|mesh-list
25448198|NCT04626193|Ofloxacin|ofloxacin|mesh-list
25448199|NCT04626193|Esomeprazole|esomeprazole|mesh-list
25448200|NCT04626193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25448201|NCT04626193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25448202|NCT04626193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25448203|NCT04626193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25448204|NCT04626193|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25448205|NCT04626193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448206|NCT04626193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448207|NCT04626193|Antimalarials|antimalarials|mesh-ancestor
25448208|NCT04626193|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25448209|NCT04626193|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25448210|NCT04626193|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25448211|NCT04626193|Renal Agents|renal agents|mesh-ancestor
25448212|NCT04626193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25448213|NCT04626193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25448214|NCT04626193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25448215|NCT04626193|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25448216|NCT04626193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25448217|NCT04626258|Fluconazole|fluconazole|mesh-list
25448218|NCT04626258|Antifungal Agents|antifungal agents|mesh-ancestor
25448219|NCT04626258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25448220|NCT04626258|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25448221|NCT04626258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25448222|NCT04626258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448223|NCT04626258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448224|NCT04626258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25448225|NCT04626258|Hormone Antagonists|hormone antagonists|mesh-ancestor
25448226|NCT04626258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25448227|NCT04626258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448228|NCT04626258|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25448229|NCT04626258|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25448230|NCT04626063|Acetaminophen|acetaminophen|mesh-list
25448231|NCT04626063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25448232|NCT04626063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25448233|NCT04626063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25448234|NCT04626063|Analgesics|analgesics|mesh-ancestor
25448235|NCT04626063|Sensory System Agents|sensory system agents|mesh-ancestor
25448236|NCT04626063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25448237|NCT04626063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448238|NCT04626063|Antipyretics|antipyretics|mesh-ancestor
25448239|NCT04626063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25448240|NCT04625985|Metformin|metformin|mesh-list
25448241|NCT04625985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25448242|NCT04625985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448243|NCT04625907|Dactinomycin|dactinomycin|mesh-list
25448244|NCT04625907|Cyclophosphamide|cyclophosphamide|mesh-list
25448245|NCT04625907|Temozolomide|temozolomide|mesh-list
25448246|NCT04625907|Ifosfamide|ifosfamide|mesh-list
25448247|NCT04625907|Doxorubicin|doxorubicin|mesh-list
25448248|NCT04625907|Irinotecan|irinotecan|mesh-list
25448249|NCT04625907|Vincristine|vincristine|mesh-list
25448250|NCT04625907|Vinorelbine|vinorelbine|mesh-list
25448251|NCT04625907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25448252|NCT04625907|Immunologic Factors|immunologic factors|mesh-ancestor
25448253|NCT04625907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448254|NCT04625907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25302889|NCT04691505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302890|NCT04691505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302891|NCT04691505|Dermatologic Agents|dermatologic agents|mesh-ancestor
25302892|NCT04691505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25302893|NCT04691505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25302894|NCT04691505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25643980|NCT01432171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25643981|NCT01432171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25643982|NCT01432171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25643983|NCT01432171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643984|NCT01432236|Pregabalin|pregabalin|mesh-list
25643985|NCT01432236|Analgesics|analgesics|mesh-ancestor
25643986|NCT01432236|Sensory System Agents|sensory system agents|mesh-ancestor
25643987|NCT01432236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25643988|NCT01432236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25643989|NCT01432236|Anticonvulsants|anticonvulsants|mesh-ancestor
25643990|NCT01432236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25643991|NCT01432236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25829454|NCT00006211|Antiviral Agents|antiviral agents|mesh-ancestor
25302895|NCT04691505|Immunologic Factors|immunologic factors|mesh-ancestor
25302896|NCT04691505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25302897|NCT04691505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25448255|NCT04625907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25448257|NCT04625907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448258|NCT04625907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25448259|NCT04625907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25448260|NCT04625907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25448261|NCT04625907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25448262|NCT04625907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25448263|NCT04625907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448264|NCT04625907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25448265|NCT04625907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25448266|NCT04625907|Tubulin Modulators|tubulin modulators|mesh-ancestor
25448267|NCT04625907|Antimitotic Agents|antimitotic agents|mesh-ancestor
25448268|NCT04625907|Mitosis Modulators|mitosis modulators|mesh-ancestor
25448269|NCT04625907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25448270|NCT04625907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25448271|NCT04625907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25448272|NCT04625907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25448273|NCT04625699|Durvalumab|durvalumab|mesh-list
25448274|NCT04625699|Tremelimumab|tremelimumab|mesh-list
25448275|NCT04625699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25448276|NCT04625699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25448277|NCT04625608|Acetaminophen|acetaminophen|mesh-list
25448278|NCT04625608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25448279|NCT04625608|Analgesics|analgesics|mesh-ancestor
25448280|NCT04625608|Sensory System Agents|sensory system agents|mesh-ancestor
25448281|NCT04625608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25448282|NCT04625608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448283|NCT04625608|Antipyretics|antipyretics|mesh-ancestor
25448284|NCT04625595|Methyldopa|methyldopa|mesh-list
25448285|NCT04625595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25448286|NCT04625595|Sympatholytics|sympatholytics|mesh-ancestor
25448287|NCT04625595|Autonomic Agents|autonomic agents|mesh-ancestor
25448288|NCT04625595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25448289|NCT04625595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448290|NCT04625595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25448291|NCT04625595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25448292|NCT04625595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25448293|NCT04625595|Adrenergic Agents|adrenergic agents|mesh-ancestor
25448294|NCT04625595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25448295|NCT04625595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448296|NCT04625257|Antibodies|antibodies|mesh-list
25448297|NCT04625257|Immunologic Factors|immunologic factors|mesh-ancestor
25448298|NCT04625257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448299|NCT04625543|Paclitaxel|paclitaxel|mesh-list
25448300|NCT04625543|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25448301|NCT04625543|Cisplatin|cisplatin|mesh-list
25448302|NCT04625543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25448303|NCT04625543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25448304|NCT04625543|Tubulin Modulators|tubulin modulators|mesh-ancestor
25448305|NCT04625543|Antimitotic Agents|antimitotic agents|mesh-ancestor
25448306|NCT04625543|Mitosis Modulators|mitosis modulators|mesh-ancestor
25448307|NCT04625543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448308|NCT04625426|Protective Agents|protective agents|mesh-list
25448309|NCT04625426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448310|NCT04625179|Melatonin|melatonin|mesh-list
25448311|NCT04625179|Hyaluronic Acid|hyaluronic acid|mesh-list
25448312|NCT04625179|Antioxidants|antioxidants|mesh-ancestor
25448313|NCT04625179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448314|NCT04625179|Protective Agents|protective agents|mesh-ancestor
25448315|NCT04625179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448316|NCT04625179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25448317|NCT04625179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25448318|NCT04625179|Immunologic Factors|immunologic factors|mesh-ancestor
25448319|NCT04625179|Viscosupplements|viscosupplements|mesh-ancestor
25448320|NCT04624893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25448321|NCT04624893|Immunoconjugates|immunoconjugates|mesh-list
25448322|NCT04624893|Immunologic Factors|immunologic factors|mesh-ancestor
25448323|NCT04624893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448324|NCT04624906|Rituximab|rituximab|mesh-list
25448325|NCT04624906|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25448326|NCT04624906|Acalabrutinib|acalabrutinib|mesh-list
25302963|NCT04529902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302964|NCT04529902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25302965|NCT04529902|Immunologic Factors|immunologic factors|mesh-ancestor
25302966|NCT04529902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448350|NCT04624269|Antimalarials|antimalarials|mesh-ancestor
25448351|NCT04624269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25448352|NCT04624269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25448353|NCT04624269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25448354|NCT04624269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448355|NCT04624269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448356|NCT04624269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25448357|NCT04624360|Dexamethasone|dexamethasone|mesh-list
25448358|NCT04624360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25448359|NCT04624360|Antiemetics|antiemetics|mesh-ancestor
25448360|NCT04624360|Autonomic Agents|autonomic agents|mesh-ancestor
25448361|NCT04624360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25448362|NCT04624360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448363|NCT04624360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25448364|NCT04624360|Glucocorticoids|glucocorticoids|mesh-ancestor
25448365|NCT04624360|Hormones|hormones|mesh-ancestor
25448366|NCT04624360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25448367|NCT04624360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25448368|NCT04624360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303041|NCT03520231|Vitamin D|vitamin d|mesh-list
25303042|NCT03520231|Denosumab|denosumab|mesh-list
25303043|NCT03520231|Gemcitabine|gemcitabine|mesh-list
25303044|NCT03520231|Carboplatin|carboplatin|mesh-list
25303045|NCT03520231|Calcium|calcium|mesh-list
25303046|NCT03520231|Vitamins|vitamins|mesh-ancestor
25303047|NCT03520231|Micronutrients|micronutrients|mesh-ancestor
25448369|NCT04623879|Ivacaftor|ivacaftor|mesh-list
25448370|NCT04623879|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25448371|NCT04623879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25448372|NCT04623879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448373|NCT04624113|Pembrolizumab|pembrolizumab|mesh-list
25448374|NCT04624113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25448375|NCT04624113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25448376|NCT04624217|Gemcitabine|gemcitabine|mesh-list
25448377|NCT04624217|Paclitaxel|paclitaxel|mesh-list
25448378|NCT04624217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25448379|NCT04624217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25448380|NCT04624217|Tubulin Modulators|tubulin modulators|mesh-ancestor
25448381|NCT04624217|Antimitotic Agents|antimitotic agents|mesh-ancestor
25448382|NCT04624217|Mitosis Modulators|mitosis modulators|mesh-ancestor
25448383|NCT04624217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448384|NCT04624217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25448385|NCT04624217|Antimetabolites|antimetabolites|mesh-ancestor
25448386|NCT04624217|Antiviral Agents|antiviral agents|mesh-ancestor
25448387|NCT04624217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25448388|NCT04624217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448389|NCT04624217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25448390|NCT04624217|Immunologic Factors|immunologic factors|mesh-ancestor
25448391|NCT04624217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448392|NCT04623866|Valsartan|valsartan|mesh-list
25448393|NCT04623866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25448394|NCT04623866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25448395|NCT04623866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25448396|NCT04623866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448397|NCT04623619|Acetylcarnitine|acetylcarnitine|mesh-list
25448398|NCT04623619|Vitamin B Complex|vitamin b complex|mesh-ancestor
25448399|NCT04623619|Vitamins|vitamins|mesh-ancestor
25448400|NCT04623619|Micronutrients|micronutrients|mesh-ancestor
25448401|NCT04623619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448402|NCT04623619|Nootropic Agents|nootropic agents|mesh-ancestor
25448403|NCT04623840|Tadalafil|tadalafil|mesh-list
25448404|NCT04623840|Vasodilator Agents|vasodilator agents|mesh-ancestor
25448405|NCT04623840|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25448406|NCT04623840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25448407|NCT04623840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448408|NCT04623840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448409|NCT04623840|Urological Agents|urological agents|mesh-ancestor
25448410|NCT04623086|Insulin|insulin|mesh-list
25448411|NCT04623086|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25448412|NCT04623086|Insulin Glargine|insulin glargine|mesh-list
25448413|NCT04623086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25448414|NCT04623086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448415|NCT04623385|Tretinoin|tretinoin|mesh-list
25448416|NCT04623385|Isotretinoin|isotretinoin|mesh-list
25448417|NCT04623385|Testosterone|testosterone|mesh-list
25448418|NCT04623385|Androgens|androgens|mesh-ancestor
25448419|NCT04623385|Hormones|hormones|mesh-ancestor
25448420|NCT04623385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25448421|NCT04623385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448422|NCT04623385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25448423|NCT04623385|Keratolytic Agents|keratolytic agents|mesh-ancestor
25448424|NCT04623385|Dermatologic Agents|dermatologic agents|mesh-ancestor
25448425|NCT04623021|Nafamostat|nafamostat|mesh-list
25448426|NCT04623021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25448427|NCT04623021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25448428|NCT04623021|Analgesics|analgesics|mesh-ancestor
25448429|NCT04623021|Sensory System Agents|sensory system agents|mesh-ancestor
25448430|NCT04623021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25448431|NCT04623021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448432|NCT04623021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25448433|NCT04623021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25448434|NCT04623021|Anticoagulants|anticoagulants|mesh-ancestor
25448435|NCT04623021|Protease Inhibitors|protease inhibitors|mesh-ancestor
25448436|NCT04623021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448437|NCT04623021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448438|NCT04623021|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25448439|NCT04623021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25448440|NCT04623021|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25303114|NCT02468180|Polidocanol|polidocanol|mesh-list
25303115|NCT02468180|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25448441|NCT04623021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25448442|NCT04623021|Immunologic Factors|immunologic factors|mesh-ancestor
25448443|NCT04622618|Gabapentin|gabapentin|mesh-list
25448444|NCT04622618|Analgesics|analgesics|mesh-ancestor
25448445|NCT04622618|Sensory System Agents|sensory system agents|mesh-ancestor
25448446|NCT04622618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25448447|NCT04622618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448448|NCT04622618|Anticonvulsants|anticonvulsants|mesh-ancestor
25448449|NCT04622618|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25448450|NCT04622618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25448451|NCT04622618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25448452|NCT04622618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25448453|NCT04622618|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25448454|NCT04622618|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25448455|NCT04622618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25448456|NCT04622618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448457|NCT04622618|Antimanic Agents|antimanic agents|mesh-ancestor
25448458|NCT04622995|Diazepam|diazepam|mesh-list
25448459|NCT04622995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25448460|NCT04622995|Anticonvulsants|anticonvulsants|mesh-ancestor
25448461|NCT04622995|Antiemetics|antiemetics|mesh-ancestor
25448462|NCT04622995|Autonomic Agents|autonomic agents|mesh-ancestor
25448463|NCT04622995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25448464|NCT04622995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448465|NCT04622995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25448466|NCT04622995|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25448467|NCT04622995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25448468|NCT04622995|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25448469|NCT04622995|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25448470|NCT04622995|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25448471|NCT04622995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25448472|NCT04622995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25448473|NCT04622995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25448474|NCT04622995|Anesthetics, General|anesthetics, general|mesh-ancestor
25448475|NCT04622995|Anesthetics|anesthetics|mesh-ancestor
25448476|NCT04622995|GABA Modulators|gaba modulators|mesh-ancestor
25448477|NCT04622995|GABA Agents|gaba agents|mesh-ancestor
25448478|NCT04622995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25643992|NCT01432236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25643993|NCT01432236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25643995|NCT01432236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25448479|NCT04622995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448480|NCT04622956|Methotrexate|methotrexate|mesh-list
25448481|NCT04622956|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25448482|NCT04622956|Abortifacient Agents|abortifacient agents|mesh-ancestor
25448483|NCT04622956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25448484|NCT04622956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448485|NCT04622956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25448486|NCT04622956|Antimetabolites|antimetabolites|mesh-ancestor
25448487|NCT04622956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448488|NCT04622956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25720840|NCT02476422|Ibuprofen|ibuprofen|mesh-list
25448489|NCT04622956|Dermatologic Agents|dermatologic agents|mesh-ancestor
25448490|NCT04622956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448491|NCT04622956|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25448492|NCT04622956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25448493|NCT04622956|Immunologic Factors|immunologic factors|mesh-ancestor
25448494|NCT04622956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25448495|NCT04622956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25448496|NCT04622891|Azithromycin|azithromycin|mesh-list
25448497|NCT04622891|Clarithromycin|clarithromycin|mesh-list
25448498|NCT04622891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25448499|NCT04622891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25448500|NCT04622891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25448501|NCT04622891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448502|NCT04622891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448503|NCT04622891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25448504|NCT04622891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25448505|NCT04622566|Pembrolizumab|pembrolizumab|mesh-list
25448506|NCT04622566|Lenvatinib|lenvatinib|mesh-list
25448507|NCT04622566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25448508|NCT04622566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25448509|NCT04622566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25448510|NCT04622566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448511|NCT04622566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448512|NCT04622579|Rituximab|rituximab|mesh-list
25448513|NCT04622579|Lenalidomide|lenalidomide|mesh-list
25448514|NCT04622579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25448515|NCT04622579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25448516|NCT04622579|Immunologic Factors|immunologic factors|mesh-ancestor
25448517|NCT04622579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448521|NCT04622579|Growth Substances|growth substances|mesh-ancestor
25448522|NCT04622579|Growth Inhibitors|growth inhibitors|mesh-ancestor
25448523|NCT04622982|Vitamin D|vitamin d|mesh-list
25448524|NCT04622982|Vitamins|vitamins|mesh-ancestor
25448525|NCT04622982|Micronutrients|micronutrients|mesh-ancestor
25448526|NCT04622982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448527|NCT04622982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25448528|NCT04622488|Diclofenac|diclofenac|mesh-list
25448529|NCT04622488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25448530|NCT04622488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25448531|NCT04622488|Analgesics|analgesics|mesh-ancestor
25448532|NCT04622488|Sensory System Agents|sensory system agents|mesh-ancestor
25448533|NCT04622488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25448534|NCT04622488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448535|NCT04622488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25448536|NCT04622488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25448537|NCT04622488|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25448538|NCT04622488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448539|NCT04622488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448540|NCT04622202|Pregabalin|pregabalin|mesh-list
25448541|NCT04622202|Analgesics|analgesics|mesh-ancestor
25448542|NCT04622202|Sensory System Agents|sensory system agents|mesh-ancestor
25448543|NCT04622202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25448544|NCT04622202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448545|NCT04622202|Anticonvulsants|anticonvulsants|mesh-ancestor
25448546|NCT04622202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25448547|NCT04622202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25448548|NCT04622202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448549|NCT04622202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25643996|NCT01432236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25643997|NCT01432236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25643998|NCT01432262|Vaccines|vaccines|mesh-list
25643999|NCT01432262|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25644000|NCT01432262|Immunologic Factors|immunologic factors|mesh-ancestor
25644001|NCT01432262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644002|NCT01432275|Insulin|insulin|mesh-list
25644003|NCT01432275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25644004|NCT01432275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644005|NCT01432379|Botulinum Toxins|botulinum toxins|mesh-list
25644006|NCT01432379|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25644007|NCT01432379|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25644008|NCT01432379|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25644009|NCT01432379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25448550|NCT04622202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25448551|NCT04622202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25448552|NCT04622202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25448553|NCT04622202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25448554|NCT04622358|Rabeprazole|rabeprazole|mesh-list
25448555|NCT04622358|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25448556|NCT04622358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25448557|NCT04622358|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25448558|NCT04622358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448559|NCT04622358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448560|NCT04622397|Tranexamic Acid|tranexamic acid|mesh-list
25448561|NCT04622397|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25448562|NCT04622397|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25448563|NCT04622397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448564|NCT04622397|Hemostatics|hemostatics|mesh-ancestor
25448565|NCT04622397|Coagulants|coagulants|mesh-ancestor
25448566|NCT04622111|Metformin|metformin|mesh-list
25448567|NCT04622111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25448568|NCT04622111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448569|NCT04621929|Topiramate|topiramate|mesh-list
25448570|NCT04621929|Phentermine|phentermine|mesh-list
25448571|NCT04621929|Allopurinol|allopurinol|mesh-list
25448572|NCT04621929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448573|NCT04621929|Anticonvulsants|anticonvulsants|mesh-ancestor
25448574|NCT04621929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25448575|NCT04621929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448576|NCT04621929|Antimetabolites|antimetabolites|mesh-ancestor
25448577|NCT04621929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448578|NCT04621929|Gout Suppressants|gout suppressants|mesh-ancestor
25448579|NCT04621929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25448580|NCT04621929|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25448581|NCT04621929|Antioxidants|antioxidants|mesh-ancestor
25448582|NCT04621929|Protective Agents|protective agents|mesh-ancestor
25448583|NCT04621929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25448584|NCT04621929|Appetite Depressants|appetite depressants|mesh-ancestor
25448585|NCT04621929|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25448586|NCT04621929|Sympathomimetics|sympathomimetics|mesh-ancestor
25448587|NCT04621929|Autonomic Agents|autonomic agents|mesh-ancestor
25448588|NCT04621929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25448589|NCT04621929|Adrenergic Agents|adrenergic agents|mesh-ancestor
25448590|NCT04621929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25448591|NCT04622033|Brodalumab|brodalumab|mesh-list
25448592|NCT04622033|Dermatologic Agents|dermatologic agents|mesh-ancestor
25448593|NCT04621799|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25448594|NCT04621799|Hemostatics|hemostatics|mesh-ancestor
25448595|NCT04621799|Coagulants|coagulants|mesh-ancestor
25448596|NCT04621370|Capecitabine|capecitabine|mesh-list
25448597|NCT04621370|Durvalumab|durvalumab|mesh-list
25448598|NCT04621370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25448599|NCT04621370|Antimetabolites|antimetabolites|mesh-ancestor
25448600|NCT04621370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448601|NCT04621370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25448602|NCT04621370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25448603|NCT04621461|Zinc Sulfate|zinc sulfate|mesh-list
25448604|NCT04621461|Astringents|astringents|mesh-ancestor
25448605|NCT04621461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448606|NCT04621461|Dermatologic Agents|dermatologic agents|mesh-ancestor
25448607|NCT04621487|Amoxicillin|amoxicillin|mesh-list
25448608|NCT04621487|Metronidazole|metronidazole|mesh-list
25448609|NCT04621487|Clarithromycin|clarithromycin|mesh-list
25448610|NCT04621487|Pantoprazole|pantoprazole|mesh-list
25448611|NCT04621487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25448612|NCT04621487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25448613|NCT04621487|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25644010|NCT01432379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448614|NCT04621487|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25448615|NCT04621487|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25448616|NCT04621487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448617|NCT04621487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448618|NCT04621487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25448619|NCT04621487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25448620|NCT04621487|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25448621|NCT04621487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25448622|NCT04621487|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25448623|NCT04621565|Hydrocortisone|hydrocortisone|mesh-list
25448624|NCT04621565|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25448625|NCT04621565|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25448626|NCT04621565|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25448627|NCT04621565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25448629|NCT04621617|Sympathomimetics|sympathomimetics|mesh-ancestor
25448630|NCT04621617|Autonomic Agents|autonomic agents|mesh-ancestor
25448631|NCT04621617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25448632|NCT04621617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448633|NCT04621617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25448634|NCT04621617|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25448635|NCT04621617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25448636|NCT04621617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25448637|NCT04621617|Adrenergic Agents|adrenergic agents|mesh-ancestor
25448638|NCT04621617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25448639|NCT04621617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448640|NCT04621669|Metformin|metformin|mesh-list
25448641|NCT04621669|Digoxin|digoxin|mesh-list
25448642|NCT04621669|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25448643|NCT04621669|Calcium|calcium|mesh-list
25448644|NCT04621669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25448645|NCT04621669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448646|NCT04621669|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25448647|NCT04621669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25448648|NCT04621669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25448649|NCT04621669|Antimetabolites|antimetabolites|mesh-ancestor
25448650|NCT04621669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448651|NCT04621669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25448652|NCT04621669|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25448653|NCT04621669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448654|NCT04621669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25448655|NCT04621669|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25448656|NCT04621669|Protective Agents|protective agents|mesh-ancestor
25448657|NCT04621409|Anti-Infective Agents|anti-infective agents|mesh-list
25448658|NCT04621409|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25448659|NCT04621318|Denosumab|denosumab|mesh-list
25448660|NCT04621318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25448661|NCT04621318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448662|NCT04621227|Midazolam|midazolam|mesh-list
25303333|NCT05132270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25303334|NCT05129176|Metronidazole|metronidazole|mesh-list
25303335|NCT05129176|Levofloxacin|levofloxacin|mesh-list
25303336|NCT05129176|Ofloxacin|ofloxacin|mesh-list
25303337|NCT05129176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25448663|NCT04621227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25448664|NCT04621227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25448665|NCT04621227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25448666|NCT04621227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25448667|NCT04621227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448668|NCT04621227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25448669|NCT04621227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25448670|NCT04621227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25448671|NCT04621227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25448672|NCT04621227|Anesthetics, General|anesthetics, general|mesh-ancestor
25448673|NCT04621227|Anesthetics|anesthetics|mesh-ancestor
25448674|NCT04621227|GABA Modulators|gaba modulators|mesh-ancestor
25448675|NCT04621227|GABA Agents|gaba agents|mesh-ancestor
25448676|NCT04621227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25448677|NCT04621227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448678|NCT04621227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25448679|NCT04621227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25448680|NCT04621227|Antimetabolites|antimetabolites|mesh-ancestor
25448681|NCT04621227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24811341|NCT02046460|Vitamin K|vitamin k|mesh-list
25448708|NCT04620954|Nivolumab|nivolumab|mesh-list
25448709|NCT04620954|Oregovomab|oregovomab|mesh-list
25448710|NCT04620954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25448711|NCT04620954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25448712|NCT04620954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25448713|NCT04620954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448714|NCT04621253|Dipyrone|dipyrone|mesh-list
25448715|NCT04621253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25448716|NCT04621253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25448717|NCT04621253|Analgesics|analgesics|mesh-ancestor
25448718|NCT04621253|Sensory System Agents|sensory system agents|mesh-ancestor
25448719|NCT04621253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25448720|NCT04621253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448721|NCT04621253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25448722|NCT04621253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25448723|NCT04621253|Antipyretics|antipyretics|mesh-ancestor
25448724|NCT04621110|Fentanyl|fentanyl|mesh-list
25448725|NCT04621110|Midazolam|midazolam|mesh-list
25448726|NCT04621110|Dexmedetomidine|dexmedetomidine|mesh-list
25448727|NCT04621110|Ketamine|ketamine|mesh-list
25303410|NCT05026606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303411|NCT05026606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25303412|NCT05026606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303421|NCT04924374|Pembrolizumab|pembrolizumab|mesh-list
25303422|NCT04924374|Atezolizumab|atezolizumab|mesh-list
25303423|NCT04924374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25303424|NCT04924374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25303425|NCT04924374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303426|NCT04924374|Immunologic Factors|immunologic factors|mesh-ancestor
25303427|NCT04924374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448728|NCT04621110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25448729|NCT04621110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25448730|NCT04621110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448731|NCT04621110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25448732|NCT04621110|Analgesics|analgesics|mesh-ancestor
25448733|NCT04621110|Sensory System Agents|sensory system agents|mesh-ancestor
25448734|NCT04621110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25448735|NCT04621110|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25448736|NCT04621110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25448737|NCT04621110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25448738|NCT04621110|Adrenergic Agents|adrenergic agents|mesh-ancestor
25448739|NCT04621110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25448740|NCT04621110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448741|NCT04621110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25448742|NCT04621110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25448743|NCT04621110|Anesthetics, General|anesthetics, general|mesh-ancestor
25448744|NCT04621110|Anesthetics|anesthetics|mesh-ancestor
25644011|NCT01432379|Cholinergic Agents|cholinergic agents|mesh-ancestor
25448745|NCT04621110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25448746|NCT04621110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25448747|NCT04621110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25448748|NCT04621110|Narcotics|narcotics|mesh-ancestor
25448749|NCT04621110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25448750|NCT04621110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25448751|NCT04621110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25448752|NCT04621110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25448753|NCT04621110|GABA Modulators|gaba modulators|mesh-ancestor
25448754|NCT04621110|GABA Agents|gaba agents|mesh-ancestor
25448755|NCT04621136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25448756|NCT04621136|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25448757|NCT04620967|Insulin|insulin|mesh-list
25448758|NCT04620967|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25448759|NCT04620967|Insulin Aspart|insulin aspart|mesh-list
25448760|NCT04620967|Insulin, Long-Acting|insulin, long-acting|mesh-list
25448761|NCT04620967|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25448762|NCT04620967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25448763|NCT04620967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448764|NCT04620785|Methylene Blue|methylene blue|mesh-list
25448765|NCT04620785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448766|NCT04620785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448767|NCT04620720|Gabapentin|gabapentin|mesh-list
25448768|NCT04620720|Analgesics|analgesics|mesh-ancestor
25448769|NCT04620720|Sensory System Agents|sensory system agents|mesh-ancestor
25448770|NCT04620720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25448771|NCT04620720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448772|NCT04620720|Anticonvulsants|anticonvulsants|mesh-ancestor
25448773|NCT04620720|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25448774|NCT04620720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25448775|NCT04620720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25448776|NCT04620720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25448777|NCT04620720|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25448778|NCT04620720|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25448779|NCT04620720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25448780|NCT04620720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448781|NCT04620720|Antimanic Agents|antimanic agents|mesh-ancestor
25303487|NCT04605796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25303488|NCT04605796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303489|NCT04605796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25303490|NCT04605796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25303491|NCT04605796|Growth Substances|growth substances|mesh-ancestor
25303492|NCT04605796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303493|NCT04605796|Growth Inhibitors|growth inhibitors|mesh-ancestor
25303517|NCT04313608|Gemcitabine|gemcitabine|mesh-list
25303518|NCT04313608|Oxaliplatin|oxaliplatin|mesh-list
25303519|NCT04313608|Obinutuzumab|obinutuzumab|mesh-list
25303520|NCT04313608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25303521|NCT04313608|Antimetabolites|antimetabolites|mesh-ancestor
25303522|NCT04313608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303523|NCT04313608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303524|NCT04313608|Antiviral Agents|antiviral agents|mesh-ancestor
25303525|NCT04313608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25303526|NCT04313608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25303527|NCT04313608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25303528|NCT04313608|Immunologic Factors|immunologic factors|mesh-ancestor
25303529|NCT04313608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448791|NCT04620772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25448792|NCT04620772|Immunologic Factors|immunologic factors|mesh-ancestor
25448793|NCT04620772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448794|NCT04620772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25448795|NCT04620772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25448796|NCT04620772|Alkylating Agents|alkylating agents|mesh-ancestor
25448797|NCT04620772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448798|NCT04620772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25448799|NCT04620772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25448800|NCT04620577|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25448801|NCT04620577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25448802|NCT04620018|Amoxicillin|amoxicillin|mesh-list
25448803|NCT04620018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25448804|NCT04620018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25448805|NCT04620031|Propofol|propofol|mesh-list
25448806|NCT04620031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25448807|NCT04620031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25448808|NCT04620031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448809|NCT04620031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25448810|NCT04620031|Anesthetics, General|anesthetics, general|mesh-ancestor
25448811|NCT04620031|Anesthetics|anesthetics|mesh-ancestor
25448812|NCT04620109|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25448813|NCT04620109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25448814|NCT04620200|Nivolumab|nivolumab|mesh-list
25448815|NCT04620200|Ipilimumab|ipilimumab|mesh-list
25448816|NCT04620200|Immunologic Factors|immunologic factors|mesh-list
25448817|NCT04620200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25448818|NCT04620200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25448819|NCT04620200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25448820|NCT04620200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448821|NCT04620200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448822|NCT04620135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25448823|NCT04620135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25448824|NCT04620213|Phentolamine|phentolamine|mesh-list
25448825|NCT04620213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25448826|NCT04620213|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25448827|NCT04620213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25448828|NCT04620213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25448829|NCT04620213|Adrenergic Agents|adrenergic agents|mesh-ancestor
25448830|NCT04620213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25448831|NCT04620213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448832|NCT04620213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448833|NCT04620213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25448834|NCT04619758|Emollients|emollients|mesh-list
25448835|NCT04619758|Dermatologic Agents|dermatologic agents|mesh-ancestor
25448836|NCT04619914|Letrozole|letrozole|mesh-list
25448837|NCT04619914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25448838|NCT04619914|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25448839|NCT04619914|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25448840|NCT04619914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448841|NCT04619914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448842|NCT04619914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25448843|NCT04619914|Hormone Antagonists|hormone antagonists|mesh-ancestor
25448844|NCT04619914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25448845|NCT04619914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448846|NCT04619875|Lactulose|lactulose|mesh-list
25448847|NCT04619875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25448848|NCT04619862|Gabapentin|gabapentin|mesh-list
25448849|NCT04619862|Analgesics|analgesics|mesh-ancestor
25448850|NCT04619862|Sensory System Agents|sensory system agents|mesh-ancestor
25448851|NCT04619862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25448852|NCT04619862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448853|NCT04619862|Anticonvulsants|anticonvulsants|mesh-ancestor
25448854|NCT04619862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25448855|NCT04619862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25448856|NCT04619862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25448857|NCT04619862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25448858|NCT04619862|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25448859|NCT04619862|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25448860|NCT04619862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25448861|NCT04619862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448862|NCT04619862|Antimanic Agents|antimanic agents|mesh-ancestor
25448863|NCT04619290|Methylene Blue|methylene blue|mesh-list
25448864|NCT04619290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448865|NCT04619290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448866|NCT04619303|Dexamethasone|dexamethasone|mesh-list
25448867|NCT04619303|Bevacizumab|bevacizumab|mesh-list
25448868|NCT04619303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25448869|NCT04619303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25448870|NCT04619303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25448871|NCT04619303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25448872|NCT04619303|Growth Substances|growth substances|mesh-ancestor
25448873|NCT04619303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448874|NCT04619303|Growth Inhibitors|growth inhibitors|mesh-ancestor
25448875|NCT04619303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25448876|NCT04619303|Antiemetics|antiemetics|mesh-ancestor
25448877|NCT04619303|Autonomic Agents|autonomic agents|mesh-ancestor
25448878|NCT04619303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25448879|NCT04619303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25448880|NCT04619303|Glucocorticoids|glucocorticoids|mesh-ancestor
25448881|NCT04619303|Hormones|hormones|mesh-ancestor
25448882|NCT04619303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25448883|NCT04619303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25644012|NCT01432379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25644013|NCT01432379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448884|NCT04619537|Docetaxel|docetaxel|mesh-list
25448885|NCT04619537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25448886|NCT04619537|Tubulin Modulators|tubulin modulators|mesh-ancestor
25448887|NCT04619537|Antimitotic Agents|antimitotic agents|mesh-ancestor
25448888|NCT04619537|Mitosis Modulators|mitosis modulators|mesh-ancestor
25448889|NCT04619537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448890|NCT04619563|Docetaxel|docetaxel|mesh-list
25448891|NCT04619563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25448892|NCT04619563|Tubulin Modulators|tubulin modulators|mesh-ancestor
25448893|NCT04619563|Antimitotic Agents|antimitotic agents|mesh-ancestor
25448894|NCT04619563|Mitosis Modulators|mitosis modulators|mesh-ancestor
25448895|NCT04619563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448896|NCT04619251|Itraconazole|itraconazole|mesh-list
25448897|NCT04619251|Antifungal Agents|antifungal agents|mesh-ancestor
25448898|NCT04619251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25448899|NCT04619251|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25448900|NCT04619251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25448901|NCT04619251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448902|NCT04619251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448903|NCT04619251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25448904|NCT04619251|Hormone Antagonists|hormone antagonists|mesh-ancestor
25303637|NCT03502148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303638|NCT03450772|Pancrelipase|pancrelipase|mesh-list
25303639|NCT03450772|Pancreatin|pancreatin|mesh-list
25303640|NCT03450772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25303641|NCT03445728|Nicorandil|nicorandil|mesh-list
25303642|NCT03445728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25303643|NCT03445728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25303644|NCT03445728|Vasodilator Agents|vasodilator agents|mesh-ancestor
25303645|NCT03445728|Vitamin B Complex|vitamin b complex|mesh-ancestor
25303646|NCT03445728|Vitamins|vitamins|mesh-ancestor
25303647|NCT03445728|Micronutrients|micronutrients|mesh-ancestor
25303648|NCT03445728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303649|NCT03424460|Hemostatics|hemostatics|mesh-list
25303650|NCT03424460|Coagulants|coagulants|mesh-ancestor
25303651|NCT03341143|Pembrolizumab|pembrolizumab|mesh-list
25303652|NCT03341143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25303653|NCT03341143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303654|NCT03278691|Ketorolac|ketorolac|mesh-list
25303656|NCT03278691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25448905|NCT04619251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25448906|NCT04619251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448907|NCT04619251|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25448908|NCT04619381|Clopidogrel|clopidogrel|mesh-list
25448909|NCT04619381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25448910|NCT04619381|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25448911|NCT04619381|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25448912|NCT04619381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25448913|NCT04619381|Purinergic Agents|purinergic agents|mesh-ancestor
25448914|NCT04619381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25448915|NCT04619381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448916|NCT04619381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448917|NCT04618965|Dexmedetomidine|dexmedetomidine|mesh-list
25448918|NCT04618965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25448919|NCT04618965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25448920|NCT04618965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448921|NCT04618965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25448922|NCT04618965|Analgesics|analgesics|mesh-ancestor
25448923|NCT04618965|Sensory System Agents|sensory system agents|mesh-ancestor
25448924|NCT04618965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25448925|NCT04618965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25448926|NCT04618965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25448927|NCT04618965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25448928|NCT04618965|Adrenergic Agents|adrenergic agents|mesh-ancestor
25448929|NCT04618965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25448930|NCT04618965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448931|NCT04618913|Rivaroxaban|rivaroxaban|mesh-list
25448932|NCT04618913|Apixaban|apixaban|mesh-list
25448933|NCT04618913|Edoxaban|edoxaban|mesh-list
25448934|NCT04618913|Dabigatran|dabigatran|mesh-list
25448935|NCT04618913|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25448936|NCT04618913|Antithrombins|antithrombins|mesh-ancestor
25448937|NCT04618913|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24398984|NCT00146380|Lamivudine|lamivudine|mesh-list
25644014|NCT01432379|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25644015|NCT01432379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25644016|NCT01432405|Pioglitazone|pioglitazone|mesh-list
25644017|NCT01432405|Exenatide|exenatide|mesh-list
25644018|NCT01432405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25644019|NCT01432405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644020|NCT01432405|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25644021|NCT01432405|Incretins|incretins|mesh-ancestor
25644022|NCT01432405|Hormones|hormones|mesh-ancestor
25656793|NCT01578772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448938|NCT04618913|Protease Inhibitors|protease inhibitors|mesh-ancestor
25448939|NCT04618913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448940|NCT04618913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448941|NCT04618913|Anticoagulants|anticoagulants|mesh-ancestor
25448942|NCT04618952|Calcium|calcium|mesh-list
25448943|NCT04618952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25448944|NCT04618952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448945|NCT04619433|Carboplatin|carboplatin|mesh-list
25448946|NCT04619433|Pemetrexed|pemetrexed|mesh-list
25448947|NCT04619433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25448948|NCT04619433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448949|NCT04619433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448950|NCT04619433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25448951|NCT04619433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25448952|NCT04619160|Propofol|propofol|mesh-list
25448953|NCT04619160|Sevoflurane|sevoflurane|mesh-list
25448954|NCT04619160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25448955|NCT04619160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25448956|NCT04619160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448957|NCT04619160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25448958|NCT04619160|Anesthetics, General|anesthetics, general|mesh-ancestor
25448959|NCT04619160|Anesthetics|anesthetics|mesh-ancestor
25448960|NCT04619160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25448961|NCT04619160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25448962|NCT04619069|Hormones|hormones|mesh-list
25448963|NCT04619069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25448964|NCT04619069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448965|NCT04618497|Ketorolac|ketorolac|mesh-list
25448966|NCT04618497|Methoxyflurane|methoxyflurane|mesh-list
25448967|NCT04618497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25448968|NCT04618497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25448969|NCT04618497|Analgesics|analgesics|mesh-ancestor
25448970|NCT04618497|Sensory System Agents|sensory system agents|mesh-ancestor
25448971|NCT04618497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25448972|NCT04618497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448973|NCT04618497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25448974|NCT04618497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25448975|NCT04618497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25448976|NCT04618497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448977|NCT04618497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448978|NCT04618497|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25448979|NCT04618497|Anesthetics, General|anesthetics, general|mesh-ancestor
25448980|NCT04618497|Anesthetics|anesthetics|mesh-ancestor
25448981|NCT04618497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25448983|NCT04618367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25448984|NCT04618367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25448985|NCT04618367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25448986|NCT04618367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25448987|NCT04618575|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25448988|NCT04618575|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25448989|NCT04618575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25448990|NCT04618536|Sunscreening Agents|sunscreening agents|mesh-list
25448991|NCT04618536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25448992|NCT04618536|Protective Agents|protective agents|mesh-ancestor
25448993|NCT04618536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25448994|NCT04618536|Dermatologic Agents|dermatologic agents|mesh-ancestor
25448995|NCT04618601|Spironolactone|spironolactone|mesh-list
25448996|NCT04618601|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25448997|NCT04618601|Hormone Antagonists|hormone antagonists|mesh-ancestor
25448998|NCT04618601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25448999|NCT04618601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449000|NCT04618601|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25449001|NCT04618601|Diuretics|diuretics|mesh-ancestor
25449002|NCT04618601|Natriuretic Agents|natriuretic agents|mesh-ancestor
25449003|NCT04618107|Anesthetics|anesthetics|mesh-list
25449004|NCT04618107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25449005|NCT04618107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449006|NCT04618146|Morphine|morphine|mesh-list
25449007|NCT04618146|Bupivacaine|bupivacaine|mesh-list
25449008|NCT04618146|Anesthetics, Local|anesthetics, local|mesh-ancestor
25449009|NCT04618146|Anesthetics|anesthetics|mesh-ancestor
25449010|NCT04618146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25449011|NCT04618146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449012|NCT04618146|Sensory System Agents|sensory system agents|mesh-ancestor
25449013|NCT04618146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449014|NCT04618146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25449015|NCT04618146|Narcotics|narcotics|mesh-ancestor
25449016|NCT04618146|Analgesics|analgesics|mesh-ancestor
25449017|NCT04618289|Vitamin D|vitamin d|mesh-list
25449018|NCT04618289|Cholecalciferol|cholecalciferol|mesh-list
25449019|NCT04618289|Vitamins|vitamins|mesh-ancestor
25449020|NCT04618289|Micronutrients|micronutrients|mesh-ancestor
25449021|NCT04618289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449022|NCT04618289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25449023|NCT04618289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25449024|NCT04618328|Tretinoin|tretinoin|mesh-list
25449025|NCT04618328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449026|NCT04618328|Keratolytic Agents|keratolytic agents|mesh-ancestor
25449027|NCT04618328|Dermatologic Agents|dermatologic agents|mesh-ancestor
25449028|NCT04617782|Donepezil|donepezil|mesh-list
25449029|NCT04617782|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25449030|NCT04617782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25449031|NCT04617782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449032|NCT04617782|Cholinergic Agents|cholinergic agents|mesh-ancestor
25449033|NCT04617782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25449034|NCT04617782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449035|NCT04617782|Nootropic Agents|nootropic agents|mesh-ancestor
25449036|NCT04617938|Analgesics, Opioid|analgesics, opioid|mesh-list
25449037|NCT04617938|Narcotics|narcotics|mesh-ancestor
25449038|NCT04617938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25449039|NCT04617938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449040|NCT04617938|Analgesics|analgesics|mesh-ancestor
25449041|NCT04617938|Sensory System Agents|sensory system agents|mesh-ancestor
25449042|NCT04617938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449043|NCT04617613|Amoxicillin|amoxicillin|mesh-list
25449044|NCT04617613|Metronidazole|metronidazole|mesh-list
25449045|NCT04617613|Clarithromycin|clarithromycin|mesh-list
25449046|NCT04617613|Omeprazole|omeprazole|mesh-list
25449047|NCT04617613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25449048|NCT04617613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25449049|NCT04617613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25449050|NCT04617613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25449051|NCT04617613|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25449052|NCT04617613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25449053|NCT04617613|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25449054|NCT04617613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25449071|NCT04617652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25449072|NCT04617652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25449073|NCT04617652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449074|NCT04617652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25449075|NCT04617652|Tocolytic Agents|tocolytic agents|mesh-ancestor
25449076|NCT04617652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25449077|NCT04617795|Insulin|insulin|mesh-list
25449078|NCT04617795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25449079|NCT04617795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449080|NCT04617561|Methylprednisolone|methylprednisolone|mesh-list
25449081|NCT04617561|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25449082|NCT04617561|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25449083|NCT04617561|Prednisolone|prednisolone|mesh-list
25449084|NCT04617561|Prednisolone acetate|prednisolone acetate|mesh-list
25449085|NCT04617561|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25449086|NCT04617561|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25449087|NCT04617561|Prednisolone phosphate|prednisolone phosphate|mesh-list
25449088|NCT04617561|Glucocorticoids|glucocorticoids|mesh-list
25449089|NCT04617561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25449090|NCT04617561|Antiemetics|antiemetics|mesh-ancestor
25449091|NCT04617561|Autonomic Agents|autonomic agents|mesh-ancestor
25449092|NCT04617561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449093|NCT04617561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449094|NCT04617561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25449095|NCT04617561|Hormones|hormones|mesh-ancestor
25449096|NCT04617561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25449097|NCT04617561|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25449098|NCT04617561|Protective Agents|protective agents|mesh-ancestor
25449099|NCT04617561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25449100|NCT04617561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449101|NCT04617561|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25449102|NCT04617483|Vaccines|vaccines|mesh-list
25449103|NCT04617483|Immunologic Factors|immunologic factors|mesh-ancestor
25449104|NCT04617483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449105|NCT04617249|Anesthetics|anesthetics|mesh-list
25449106|NCT04617249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25449107|NCT04617249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303864|NCT05135013|Estradiol|estradiol|mesh-list
25303865|NCT05135013|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25303866|NCT05135013|Dydrogesterone|dydrogesterone|mesh-list
25303867|NCT05135013|Estrogens|estrogens|mesh-ancestor
25303868|NCT05135013|Hormones|hormones|mesh-ancestor
25303888|NCT05134558|Xenon|xenon|mesh-list
25449108|NCT04617171|Benralizumab|benralizumab|mesh-list
25449109|NCT04617171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25449110|NCT04617171|Respiratory System Agents|respiratory system agents|mesh-ancestor
25449111|NCT04616872|Methotrexate|methotrexate|mesh-list
25449112|NCT04616872|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25449113|NCT04616872|Abortifacient Agents|abortifacient agents|mesh-ancestor
25449114|NCT04616872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25449115|NCT04616872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449116|NCT04616872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25449117|NCT04616872|Antimetabolites|antimetabolites|mesh-ancestor
25449118|NCT04616872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449119|NCT04616872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449120|NCT04616872|Dermatologic Agents|dermatologic agents|mesh-ancestor
25449121|NCT04616872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25449122|NCT04616872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25449123|NCT04616872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25449124|NCT04616872|Immunologic Factors|immunologic factors|mesh-ancestor
25449125|NCT04616872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25449126|NCT04616872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25449127|NCT04616729|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25449128|NCT04616729|Luteolytic Agents|luteolytic agents|mesh-ancestor
25449129|NCT04616729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25449130|NCT04616729|Contraceptive Agents|contraceptive agents|mesh-ancestor
25449131|NCT04616729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25449132|NCT04616729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449133|NCT04616729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25449134|NCT04616729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25449135|NCT04616729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449136|NCT04616807|Mexiletine|mexiletine|mesh-list
25449137|NCT04616807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25449138|NCT04616807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25449139|NCT04616807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25449140|NCT04616807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25449141|NCT04616807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449142|NCT04617015|Bromides|bromides|mesh-list
25449143|NCT04617015|Ipratropium|ipratropium|mesh-list
25449144|NCT04617015|Anticonvulsants|anticonvulsants|mesh-ancestor
25449145|NCT04617015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25449146|NCT04617015|Autonomic Agents|autonomic agents|mesh-ancestor
25449147|NCT04617015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449148|NCT04617015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449149|NCT04617015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25449150|NCT04617015|Respiratory System Agents|respiratory system agents|mesh-ancestor
25449151|NCT04617015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25449152|NCT04617015|Cholinergic Agents|cholinergic agents|mesh-ancestor
25449153|NCT04617015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25449154|NCT04617015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449155|NCT04617028|Hydroxyurea|hydroxyurea|mesh-list
25449156|NCT04617028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449157|NCT04617028|Antisickling Agents|antisickling agents|mesh-ancestor
25449158|NCT04617028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25449159|NCT04617028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449160|NCT04617028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25449161|NCT04616859|Ethanol|ethanol|mesh-list
25449162|NCT04616859|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25449163|NCT04616859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25449164|NCT04616859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25449165|NCT04616859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656794|NCT01578850|Etanercept|etanercept|mesh-list
25449166|NCT04616586|Siltuximab|siltuximab|mesh-list
25449167|NCT04616586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449168|NCT04616261|Formoterol Fumarate|formoterol fumarate|mesh-list
25449169|NCT04616261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25449170|NCT04616261|Autonomic Agents|autonomic agents|mesh-ancestor
25449171|NCT04616261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449172|NCT04616261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449173|NCT04616261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25449174|NCT04616261|Respiratory System Agents|respiratory system agents|mesh-ancestor
25449175|NCT04616261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25449176|NCT04616261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25449177|NCT04616261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25449178|NCT04616261|Adrenergic Agents|adrenergic agents|mesh-ancestor
25449179|NCT04616261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25449180|NCT04616261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449182|NCT04616352|Cefuroxime axetil|cefuroxime axetil|mesh-list
25449183|NCT04616352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25449184|NCT04616352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25449185|NCT04616313|Xenon|xenon|mesh-list
25449186|NCT04616313|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25449187|NCT04616313|Anesthetics, General|anesthetics, general|mesh-ancestor
25449188|NCT04616313|Anesthetics|anesthetics|mesh-ancestor
25449189|NCT04616313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25449190|NCT04616313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449191|NCT04616391|Insulin|insulin|mesh-list
25449192|NCT04616391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25449193|NCT04616391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449194|NCT04615962|Mometasone Furoate|mometasone furoate|mesh-list
25449195|NCT04615962|Hydrocortisone|hydrocortisone|mesh-list
25449196|NCT04615962|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25449197|NCT04615962|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25449198|NCT04615962|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25449199|NCT04615962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25449200|NCT04615962|Dermatologic Agents|dermatologic agents|mesh-ancestor
25449201|NCT04615962|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25449202|NCT04615767|Inositol|inositol|mesh-list
25449203|NCT04615767|Vitamin B Complex|vitamin b complex|mesh-ancestor
25449204|NCT04615767|Vitamins|vitamins|mesh-ancestor
25449205|NCT04615767|Micronutrients|micronutrients|mesh-ancestor
25449206|NCT04615767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449207|NCT04615702|Acetaminophen|acetaminophen|mesh-list
25449208|NCT04615702|Metronidazole|metronidazole|mesh-list
25449209|NCT04615702|Ciprofloxacin|ciprofloxacin|mesh-list
25449210|NCT04615702|Imipenem|imipenem|mesh-list
25449211|NCT04615702|Diclofenac|diclofenac|mesh-list
25449212|NCT04615702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25449213|NCT04615702|Opiate Alkaloids|opiate alkaloids|mesh-list
25449214|NCT04615702|Secretin|secretin|mesh-list
25449215|NCT04615702|Bilirubin|bilirubin|mesh-list
25449216|NCT04615702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449217|NCT04615702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25449218|NCT04615702|Analgesics|analgesics|mesh-ancestor
25449219|NCT04615702|Sensory System Agents|sensory system agents|mesh-ancestor
25449220|NCT04615702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449221|NCT04615702|Antipyretics|antipyretics|mesh-ancestor
25449222|NCT04615702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25449223|NCT04615702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25449224|NCT04615702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25449225|NCT04615702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25449226|NCT04615702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25449227|NCT04615702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25449228|NCT04615702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25449229|NCT04615702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25449230|NCT04615702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449231|NCT04615702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25449232|NCT04615702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25449233|NCT04615702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449234|NCT04615702|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25449235|NCT04615702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25449236|NCT04615702|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25449237|NCT04615702|Narcotics|narcotics|mesh-ancestor
25449238|NCT04615702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25449239|NCT04615702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25449240|NCT04615702|Hormones|hormones|mesh-ancestor
25449241|NCT04615702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25449242|NCT04615702|Antioxidants|antioxidants|mesh-ancestor
25449243|NCT04615702|Protective Agents|protective agents|mesh-ancestor
25644023|NCT01432405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25644024|NCT01432444|Aripiprazole|aripiprazole|mesh-list
25644025|NCT01432444|Antidepressive Agents|antidepressive agents|mesh-ancestor
25644026|NCT01432444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25644027|NCT01432444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25644028|NCT01432444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25644029|NCT01432444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25644030|NCT01432444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449244|NCT04615611|Albuterol|albuterol|mesh-list
25304015|NCT04955249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304016|NCT04955249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25304017|NCT04955249|Analgesics|analgesics|mesh-ancestor
25304018|NCT04955249|Sensory System Agents|sensory system agents|mesh-ancestor
25304019|NCT04955249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25304020|NCT04955249|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25304021|NCT04955249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25304022|NCT04955249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25304023|NCT04955249|Adrenergic Agents|adrenergic agents|mesh-ancestor
25304024|NCT04955249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25304025|NCT04955249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449245|NCT04615611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25449246|NCT04615611|Autonomic Agents|autonomic agents|mesh-ancestor
25449279|NCT04614727|Fluorides|fluorides|mesh-list
25449280|NCT04614727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25449281|NCT04614727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449282|NCT04614727|Cariostatic Agents|cariostatic agents|mesh-ancestor
25449283|NCT04614727|Protective Agents|protective agents|mesh-ancestor
25304089|NCT04702464|Fluconazole|fluconazole|mesh-list
25304090|NCT04702464|Antifungal Agents|antifungal agents|mesh-ancestor
25304091|NCT04702464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25304092|NCT04702464|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25304093|NCT04702464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25304094|NCT04702464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25304096|NCT04702464|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25449284|NCT04614584|Mirtazapine|mirtazapine|mesh-list
25449285|NCT04614584|Methamphetamine|methamphetamine|mesh-list
25449286|NCT04614584|Antidepressive Agents|antidepressive agents|mesh-ancestor
25449287|NCT04614584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25449288|NCT04614584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25449289|NCT04614584|Histamine Antagonists|histamine antagonists|mesh-ancestor
25449290|NCT04614584|Histamine Agents|histamine agents|mesh-ancestor
25449291|NCT04614584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25449292|NCT04614584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449293|NCT04614584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449294|NCT04614584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25449295|NCT04614584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25449296|NCT04614584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25449297|NCT04614584|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25449298|NCT04614584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25449299|NCT04614584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25449300|NCT04614584|Adrenergic Agents|adrenergic agents|mesh-ancestor
25449301|NCT04614584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25449302|NCT04614584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25449303|NCT04614584|Serotonin Agents|serotonin agents|mesh-ancestor
25449304|NCT04614584|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25449305|NCT04614584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25449306|NCT04614584|Sympathomimetics|sympathomimetics|mesh-ancestor
25449307|NCT04614584|Autonomic Agents|autonomic agents|mesh-ancestor
25449308|NCT04614584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449309|NCT04614584|Dopamine Agents|dopamine agents|mesh-ancestor
25449310|NCT04614584|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25720892|NCT02477423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25449311|NCT04614584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25449312|NCT04614584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25449313|NCT04614584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25449314|NCT04614298|Brodalumab|brodalumab|mesh-list
25449315|NCT04614298|Dermatologic Agents|dermatologic agents|mesh-ancestor
25449316|NCT04614259|Bupivacaine|bupivacaine|mesh-list
25449317|NCT04614259|Anesthetics, Local|anesthetics, local|mesh-ancestor
25449318|NCT04614259|Anesthetics|anesthetics|mesh-ancestor
25449319|NCT04614259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25449320|NCT04614259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449321|NCT04614259|Sensory System Agents|sensory system agents|mesh-ancestor
25449322|NCT04614259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449323|NCT04614194|Letrozole|letrozole|mesh-list
25449324|NCT04614194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449325|NCT04614194|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25449326|NCT04614194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25449327|NCT04614194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25449328|NCT04614194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449329|NCT04614194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25449330|NCT04614194|Hormone Antagonists|hormone antagonists|mesh-ancestor
25449331|NCT04614194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25449332|NCT04614194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449333|NCT04613609|Nicotine|nicotine|mesh-list
25449334|NCT04613609|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25449335|NCT04613609|Autonomic Agents|autonomic agents|mesh-ancestor
25449336|NCT04613609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449337|NCT04613609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449338|NCT04613609|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25449339|NCT04613609|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25449340|NCT04613609|Cholinergic Agents|cholinergic agents|mesh-ancestor
25449341|NCT04613609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25449342|NCT04613609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449343|NCT04613700|Secretin|secretin|mesh-list
25449344|NCT04613700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25304161|NCT04556357|Mydriatics|mydriatics|mesh-ancestor
25304162|NCT04556357|Autonomic Agents|autonomic agents|mesh-ancestor
25304163|NCT04556357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25304164|NCT04556357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304165|NCT04556357|Sympathomimetics|sympathomimetics|mesh-ancestor
25304166|NCT04556357|Nasal Decongestants|nasal decongestants|mesh-ancestor
25304167|NCT04556357|Respiratory System Agents|respiratory system agents|mesh-ancestor
25304168|NCT04556357|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25304169|NCT04556357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25304170|NCT04556357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25304171|NCT04556357|Adrenergic Agents|adrenergic agents|mesh-ancestor
25304172|NCT04556357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25304174|NCT04556357|Protective Agents|protective agents|mesh-ancestor
25449345|NCT04613700|Hormones|hormones|mesh-ancestor
25449346|NCT04613700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25449347|NCT04613700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449348|NCT04613869|Hydromorphone|hydromorphone|mesh-list
25449349|NCT04613869|Esketamine|esketamine|mesh-list
25449350|NCT04613869|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25449351|NCT04613869|Narcotics|narcotics|mesh-ancestor
25449352|NCT04613869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25449353|NCT04613869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449354|NCT04613869|Analgesics|analgesics|mesh-ancestor
25449355|NCT04613869|Sensory System Agents|sensory system agents|mesh-ancestor
25449356|NCT04613869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449357|NCT04613869|Antidepressive Agents|antidepressive agents|mesh-ancestor
25449358|NCT04613869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25449359|NCT04613726|Ondansetron|ondansetron|mesh-list
25449360|NCT04613726|Granisetron|granisetron|mesh-list
25449361|NCT04613726|Antiemetics|antiemetics|mesh-ancestor
25449362|NCT04613726|Autonomic Agents|autonomic agents|mesh-ancestor
25449363|NCT04613726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449364|NCT04613726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449365|NCT04613726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25449366|NCT04613726|Antipruritics|antipruritics|mesh-ancestor
25449367|NCT04613726|Dermatologic Agents|dermatologic agents|mesh-ancestor
25449368|NCT04613726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25449369|NCT04613726|Serotonin Agents|serotonin agents|mesh-ancestor
25449370|NCT04613726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25449371|NCT04613726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449372|NCT04613726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25449373|NCT04613726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25449374|NCT04613726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25449375|NCT04613726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25449376|NCT04613726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25449377|NCT04613557|Cyclophosphamide|cyclophosphamide|mesh-list
25449378|NCT04613557|Fludarabine|fludarabine|mesh-list
25449379|NCT04613557|Fludarabine phosphate|fludarabine phosphate|mesh-list
25449380|NCT04613557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25449381|NCT04613557|Immunologic Factors|immunologic factors|mesh-ancestor
25449382|NCT04613557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449383|NCT04613557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25449384|NCT04613557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25449385|NCT04613557|Alkylating Agents|alkylating agents|mesh-ancestor
25644031|NCT01432444|Dopamine Agonists|dopamine agonists|mesh-ancestor
25644032|NCT01432444|Dopamine Agents|dopamine agents|mesh-ancestor
25644033|NCT01432444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25449386|NCT04613557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449387|NCT04613557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449388|NCT04613557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25449389|NCT04613557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25449390|NCT04613557|Antimetabolites|antimetabolites|mesh-ancestor
25449391|NCT04613804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25449392|NCT04613804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449393|NCT04613804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449394|NCT04613102|Cannabidiol|cannabidiol|mesh-list
25449395|NCT04613102|Anticonvulsants|anticonvulsants|mesh-ancestor
25449396|NCT04613219|Tofacitinib|tofacitinib|mesh-list
25449397|NCT04613219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25449398|NCT04613219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25449399|NCT04613219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449400|NCT04613167|Evolocumab|evolocumab|mesh-list
25304241|NCT04287855|Dexamethasone|dexamethasone|mesh-list
25304242|NCT04287855|Pomalidomide|pomalidomide|mesh-list
25304243|NCT04287855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25304244|NCT04287855|Antiemetics|antiemetics|mesh-ancestor
25304245|NCT04287855|Autonomic Agents|autonomic agents|mesh-ancestor
25304246|NCT04287855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25304247|NCT04287855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304248|NCT04287855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25304249|NCT04287855|Glucocorticoids|glucocorticoids|mesh-ancestor
25304250|NCT04287855|Hormones|hormones|mesh-ancestor
25304251|NCT04287855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25304252|NCT04287855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25304253|NCT04287855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25304254|NCT04287855|Immunologic Factors|immunologic factors|mesh-ancestor
25304255|NCT04287855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25304256|NCT04287855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25304257|NCT04287855|Growth Substances|growth substances|mesh-ancestor
25304258|NCT04287855|Growth Inhibitors|growth inhibitors|mesh-ancestor
25304259|NCT04264897|Metformin|metformin|mesh-list
25304262|NCT04246060|Cysteamine|cysteamine|mesh-list
25449401|NCT04613167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25449402|NCT04613167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25449403|NCT04613167|Antimetabolites|antimetabolites|mesh-ancestor
25449404|NCT04613167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449405|NCT04613167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25449406|NCT04613271|Azithromycin|azithromycin|mesh-list
25449407|NCT04613271|Favipiravir|favipiravir|mesh-list
25449408|NCT04613271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25449409|NCT04613271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25449410|NCT04613271|Antiviral Agents|antiviral agents|mesh-ancestor
25449411|NCT04613284|Durvalumab|durvalumab|mesh-list
25449412|NCT04613284|Endostar protein|endostar protein|mesh-list
25449413|NCT04613284|Endostatins|endostatins|mesh-list
25449414|NCT04613284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25449415|NCT04613284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449416|NCT04613284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25449417|NCT04613284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25449418|NCT04613284|Growth Substances|growth substances|mesh-ancestor
25449419|NCT04613284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449420|NCT04613284|Growth Inhibitors|growth inhibitors|mesh-ancestor
25449421|NCT04612998|Atropine|atropine|mesh-list
25449422|NCT04612998|Ephedrine|ephedrine|mesh-list
25449423|NCT04612998|Metoclopramide|metoclopramide|mesh-list
25449424|NCT04612998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25449425|NCT04612998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25449426|NCT04612998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25449427|NCT04612998|Autonomic Agents|autonomic agents|mesh-ancestor
25449428|NCT04612998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449429|NCT04612998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449430|NCT04612998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25449431|NCT04612998|Respiratory System Agents|respiratory system agents|mesh-ancestor
25449432|NCT04612998|Mydriatics|mydriatics|mesh-ancestor
25449433|NCT04612998|Parasympatholytics|parasympatholytics|mesh-ancestor
25449434|NCT04612998|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25449435|NCT04612998|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25644034|NCT01432444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644035|NCT01432444|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25449436|NCT04612998|Cholinergic Agents|cholinergic agents|mesh-ancestor
25449437|NCT04612998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24400266|NCT00150228|Cholinergic Agents|cholinergic agents|mesh-ancestor
25449438|NCT04612998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449439|NCT04612998|Antiemetics|antiemetics|mesh-ancestor
25449440|NCT04612998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25449441|NCT04612998|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25449442|NCT04612998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25449443|NCT04612998|Dopamine Agents|dopamine agents|mesh-ancestor
25449444|NCT04612998|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25449445|NCT04612998|Sympathomimetics|sympathomimetics|mesh-ancestor
25449446|NCT04612998|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25449447|NCT04612998|Adrenergic Agents|adrenergic agents|mesh-ancestor
25449448|NCT04613180|Montelukast|montelukast|mesh-list
25449449|NCT04613180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25449450|NCT04613180|Respiratory System Agents|respiratory system agents|mesh-ancestor
25449451|NCT04613180|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25449452|NCT04613180|Hormone Antagonists|hormone antagonists|mesh-ancestor
25449453|NCT04613180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25449454|NCT04613180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449455|NCT04613180|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25449456|NCT04613180|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25449457|NCT04613180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449458|NCT04612894|Apatinib|apatinib|mesh-list
25449459|NCT04612894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449460|NCT04612894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25449461|NCT04612894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25449462|NCT04612894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449463|NCT04612634|Vaccines|vaccines|mesh-list
25449464|NCT04612634|Immunologic Factors|immunologic factors|mesh-ancestor
25449465|NCT04612634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449466|NCT04612803|Histamine Antagonists|histamine antagonists|mesh-list
25304310|NCT03976934|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25304311|NCT03976934|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25304312|NCT03976934|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25304313|NCT03976934|Adrenergic Agents|adrenergic agents|mesh-ancestor
25304314|NCT03976934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25304315|NCT03976934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304316|NCT03976934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304317|NCT03976934|Urological Agents|urological agents|mesh-ancestor
25304322|NCT03909217|Dexetimide|dexetimide|mesh-list
25449497|NCT04612530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25449498|NCT04612530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449499|NCT04612504|Atezolizumab|atezolizumab|mesh-list
25449500|NCT04612504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449501|NCT04612179|Sirolimus|sirolimus|mesh-list
25449502|NCT04612179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25449503|NCT04612179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25449504|NCT04612179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25449505|NCT04612179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449506|NCT04612179|Antifungal Agents|antifungal agents|mesh-ancestor
25449507|NCT04612179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25449508|NCT04612179|Immunologic Factors|immunologic factors|mesh-ancestor
25449509|NCT04612179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304386|NCT03712202|Imidazole|imidazole|mesh-list
25304387|NCT03712202|Immunologic Factors|immunologic factors|mesh-ancestor
25304402|NCT03659539|Propofol|propofol|mesh-list
25449511|NCT04612257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25449512|NCT04612257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449513|NCT04611958|Bupivacaine|bupivacaine|mesh-list
25449514|NCT04611958|Anesthetics, Local|anesthetics, local|mesh-ancestor
25449515|NCT04611958|Anesthetics|anesthetics|mesh-ancestor
25449516|NCT04611958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25449517|NCT04611958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449518|NCT04611958|Sensory System Agents|sensory system agents|mesh-ancestor
25449519|NCT04611958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449520|NCT04611971|Belimumab|belimumab|mesh-list
25449521|NCT04611971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25449522|NCT04611971|Immunologic Factors|immunologic factors|mesh-ancestor
25449523|NCT04611971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449524|NCT04611724|Folfirinox|folfirinox|mesh-list
25449525|NCT04611724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449526|NCT04611438|Cannabidiol|cannabidiol|mesh-list
25449527|NCT04611438|Anticonvulsants|anticonvulsants|mesh-ancestor
25449528|NCT04611711|Decitabine|decitabine|mesh-list
25449529|NCT04611711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25449530|NCT04611711|Antimetabolites|antimetabolites|mesh-ancestor
25449531|NCT04611711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449532|NCT04611711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449533|NCT04611711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25449534|NCT04611685|Parecoxib|parecoxib|mesh-list
25449535|NCT04611685|Loxoprofen|loxoprofen|mesh-list
25449536|NCT04611685|Tramadol|tramadol|mesh-list
25449537|NCT04611685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25449538|NCT04611685|Narcotics|narcotics|mesh-ancestor
25449539|NCT04611685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25449540|NCT04611685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449541|NCT04611685|Analgesics|analgesics|mesh-ancestor
25449542|NCT04611685|Sensory System Agents|sensory system agents|mesh-ancestor
25449543|NCT04611685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449544|NCT04611685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25449545|NCT04611685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25449546|NCT04611685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25449547|NCT04611685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449548|NCT04611685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25449549|NCT04611685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25449550|NCT04611685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25449551|NCT04611685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25449552|NCT04611373|Levamisole|levamisole|mesh-list
25449553|NCT04611373|Acetazolamide|acetazolamide|mesh-list
25449554|NCT04611373|Anticonvulsants|anticonvulsants|mesh-ancestor
25449555|NCT04611373|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25449556|NCT04611373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25449557|NCT04611373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449558|NCT04611373|Diuretics|diuretics|mesh-ancestor
25449559|NCT04611373|Natriuretic Agents|natriuretic agents|mesh-ancestor
25449560|NCT04611373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449561|NCT04611373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25449562|NCT04611373|Immunologic Factors|immunologic factors|mesh-ancestor
25449563|NCT04611373|Antinematodal Agents|antinematodal agents|mesh-ancestor
25449564|NCT04611373|Anthelmintics|anthelmintics|mesh-ancestor
25449565|NCT04611373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25449566|NCT04611373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25449567|NCT04611373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25449568|NCT04611464|Misoprostol|misoprostol|mesh-list
25449569|NCT04611464|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25449570|NCT04611464|Abortifacient Agents|abortifacient agents|mesh-ancestor
25449571|NCT04611464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25449572|NCT04611464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449573|NCT04611464|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25449574|NCT04611464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25449575|NCT04611464|Oxytocics|oxytocics|mesh-ancestor
25449576|NCT04611776|Gemcitabine|gemcitabine|mesh-list
25449577|NCT04611776|Paclitaxel|paclitaxel|mesh-list
25449578|NCT04611776|Cisplatin|cisplatin|mesh-list
25449579|NCT04611776|Carboplatin|carboplatin|mesh-list
25449580|NCT04611776|Pemetrexed|pemetrexed|mesh-list
25449581|NCT04611776|Atezolizumab|atezolizumab|mesh-list
25449582|NCT04611776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25449583|NCT04611776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449584|NCT04611776|Tubulin Modulators|tubulin modulators|mesh-ancestor
25449585|NCT04611776|Antimitotic Agents|antimitotic agents|mesh-ancestor
25449586|NCT04611776|Mitosis Modulators|mitosis modulators|mesh-ancestor
25449587|NCT04611776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449588|NCT04611776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25449589|NCT04611776|Antimetabolites|antimetabolites|mesh-ancestor
25449590|NCT04611776|Antiviral Agents|antiviral agents|mesh-ancestor
25449591|NCT04611776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25449592|NCT04611776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25449593|NCT04611776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25449594|NCT04611776|Immunologic Factors|immunologic factors|mesh-ancestor
25449595|NCT04611776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449596|NCT04611776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25449597|NCT04611776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25449598|NCT04611126|Cyclophosphamide|cyclophosphamide|mesh-list
25449599|NCT04611126|Nivolumab|nivolumab|mesh-list
25449600|NCT04611126|Fludarabine|fludarabine|mesh-list
25449601|NCT04611126|Fludarabine phosphate|fludarabine phosphate|mesh-list
25449602|NCT04611126|Ipilimumab|ipilimumab|mesh-list
25449603|NCT04611126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25449604|NCT04611126|Immunologic Factors|immunologic factors|mesh-ancestor
25449605|NCT04611126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449606|NCT04611126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25449607|NCT04611126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25449608|NCT04611126|Alkylating Agents|alkylating agents|mesh-ancestor
25449609|NCT04611126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644036|NCT01432444|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25644037|NCT01432444|Serotonin Agents|serotonin agents|mesh-ancestor
25644038|NCT01432444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25644039|NCT01432444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25644040|NCT01432444|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25644041|NCT01432444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25644042|NCT01432457|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25644043|NCT01432457|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25449610|NCT04611126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449611|NCT04611126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25449612|NCT04611126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25449613|NCT04611126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25449614|NCT04611126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25449615|NCT04611126|Antimetabolites|antimetabolites|mesh-ancestor
25449616|NCT04611165|Nivolumab|nivolumab|mesh-list
25449617|NCT04611165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25449618|NCT04611165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449619|NCT04611165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25449620|NCT04611165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449621|NCT04610879|Carbamazepine|carbamazepine|mesh-list
25449622|NCT04610879|Levetiracetam|levetiracetam|mesh-list
25449623|NCT04610879|Anticonvulsants|anticonvulsants|mesh-ancestor
25449624|NCT04610879|Nootropic Agents|nootropic agents|mesh-ancestor
25449625|NCT04610879|Antimanic Agents|antimanic agents|mesh-ancestor
25449626|NCT04610879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25449627|NCT04610879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25449628|NCT04610879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449629|NCT04610879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25449630|NCT04610879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25449631|NCT04610879|Analgesics|analgesics|mesh-ancestor
25449632|NCT04610879|Sensory System Agents|sensory system agents|mesh-ancestor
25449633|NCT04610879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449634|NCT04610879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25449635|NCT04610879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25449636|NCT04610879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449637|NCT04610879|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25449638|NCT04610879|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25449639|NCT04610580|Choline|choline|mesh-list
25449640|NCT04610580|Lipotropic Agents|lipotropic agents|mesh-ancestor
25449641|NCT04610580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25449642|NCT04610580|Antimetabolites|antimetabolites|mesh-ancestor
25449643|NCT04610580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449644|NCT04610580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25449645|NCT04610580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25449646|NCT04610580|Nootropic Agents|nootropic agents|mesh-ancestor
25449647|NCT04611243|Vaccines|vaccines|mesh-list
25449648|NCT04611243|Immunologic Factors|immunologic factors|mesh-ancestor
25449649|NCT04611243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449650|NCT04610567|Methotrexate|methotrexate|mesh-list
25449651|NCT04610567|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25449652|NCT04610567|Abortifacient Agents|abortifacient agents|mesh-ancestor
25449653|NCT04610567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25449654|NCT04610567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449655|NCT04610567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25449656|NCT04610567|Antimetabolites|antimetabolites|mesh-ancestor
25449657|NCT04610567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449658|NCT04610567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449659|NCT04610567|Dermatologic Agents|dermatologic agents|mesh-ancestor
25449660|NCT04610567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25449661|NCT04610567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25449662|NCT04610567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25449689|NCT04610398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25449691|NCT04610398|Autonomic Agents|autonomic agents|mesh-ancestor
25449692|NCT04610398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449693|NCT04610398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449694|NCT04610398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25449695|NCT04610398|Glucocorticoids|glucocorticoids|mesh-ancestor
25449696|NCT04610398|Hormones|hormones|mesh-ancestor
25449697|NCT04610398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25449698|NCT04610398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25449699|NCT04610398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449700|NCT04610125|Cyclophosphamide|cyclophosphamide|mesh-list
25449701|NCT04610125|Fludarabine|fludarabine|mesh-list
25449703|NCT04610125|Immunologic Factors|immunologic factors|mesh-ancestor
25449704|NCT04610125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449705|NCT04610125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25449706|NCT04610125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25449707|NCT04610125|Alkylating Agents|alkylating agents|mesh-ancestor
25449708|NCT04610125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449709|NCT04610125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449710|NCT04610125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25304613|NCT01503489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25304619|NCT01503489|Sympathomimetics|sympathomimetics|mesh-ancestor
25449711|NCT04609748|Nimesulide|nimesulide|mesh-list
25449712|NCT04609748|Cannabidiol|cannabidiol|mesh-list
25449713|NCT04609748|Anticonvulsants|anticonvulsants|mesh-ancestor
25449714|NCT04609748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25449715|NCT04609748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25644044|NCT01432457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25720942|NCT02478398|Tocolytic Agents|tocolytic agents|mesh-ancestor
25644045|NCT01432457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25644046|NCT01432457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644047|NCT01432457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25644048|NCT01432457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644049|NCT01432457|Antidepressive Agents|antidepressive agents|mesh-ancestor
25644050|NCT01432457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25644051|NCT01432535|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25644052|NCT01432535|Antiviral Agents|antiviral agents|mesh-ancestor
25644053|NCT01432535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25644054|NCT01432561|Cysteamine|cysteamine|mesh-list
25644055|NCT01432561|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
25644056|NCT01432561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644057|NCT01432574|Vaccines|vaccines|mesh-list
25644058|NCT01432574|Immunologic Factors|immunologic factors|mesh-ancestor
25449716|NCT04609748|Analgesics|analgesics|mesh-ancestor
25449717|NCT04609748|Sensory System Agents|sensory system agents|mesh-ancestor
25449718|NCT04609748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449719|NCT04609748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449720|NCT04609748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25449721|NCT04609748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25449722|NCT04609748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25449723|NCT04609748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25449724|NCT04609748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449725|NCT04609540|Trastuzumab|trastuzumab|mesh-list
25449726|NCT04609540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25449727|NCT04609540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449728|NCT04609488|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25449729|NCT04609488|Respiratory System Agents|respiratory system agents|mesh-ancestor
25449730|NCT04609306|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25449731|NCT04609306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25449732|NCT04609306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25449733|NCT04609254|Acetaminophen|acetaminophen|mesh-list
25449734|NCT04609254|Ibuprofen|ibuprofen|mesh-list
25449735|NCT04609254|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
25449736|NCT04609254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25449737|NCT04609254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25449738|NCT04609254|Analgesics|analgesics|mesh-ancestor
25449739|NCT04609254|Sensory System Agents|sensory system agents|mesh-ancestor
25449740|NCT04609254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449741|NCT04609254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449742|NCT04609254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25449743|NCT04609254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25449744|NCT04609254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25449745|NCT04609254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25449746|NCT04609254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449747|NCT04609254|Antipyretics|antipyretics|mesh-ancestor
25449748|NCT04609293|Apatinib|apatinib|mesh-list
25449749|NCT04609293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449750|NCT04609293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25449751|NCT04609293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25449752|NCT04609293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449753|NCT04609189|Vitamin D|vitamin d|mesh-list
25449754|NCT04609189|Cholecalciferol|cholecalciferol|mesh-list
25449755|NCT04609189|Calcium Carbonate|calcium carbonate|mesh-list
25449756|NCT04609189|Calcium|calcium|mesh-list
25449757|NCT04609189|Vitamins|vitamins|mesh-ancestor
25449758|NCT04609189|Micronutrients|micronutrients|mesh-ancestor
25449759|NCT04609189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449760|NCT04609189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25449761|NCT04609189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25449763|NCT04609189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449764|NCT04609189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25449765|NCT04609176|Apatinib|apatinib|mesh-list
25449766|NCT04609176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449767|NCT04609176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25449768|NCT04609176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25449769|NCT04609176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449770|NCT04608734|Midazolam|midazolam|mesh-list
25449771|NCT04608734|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25449772|NCT04608734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25449773|NCT04608734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25449774|NCT04608734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449775|NCT04608734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25449776|NCT04608734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25449777|NCT04608734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25449778|NCT04608734|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25449779|NCT04608734|Anesthetics, General|anesthetics, general|mesh-ancestor
25449780|NCT04608734|Anesthetics|anesthetics|mesh-ancestor
25449781|NCT04608734|GABA Modulators|gaba modulators|mesh-ancestor
25449782|NCT04608734|GABA Agents|gaba agents|mesh-ancestor
25449783|NCT04608734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25449784|NCT04608734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449785|NCT04609033|Ketamine|ketamine|mesh-list
25304691|NCT05137288|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25449787|NCT04609033|Bupivacaine|bupivacaine|mesh-list
25449788|NCT04609033|Anesthetics, Local|anesthetics, local|mesh-ancestor
25449789|NCT04609033|Anesthetics|anesthetics|mesh-ancestor
25449790|NCT04609033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25449791|NCT04609033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449792|NCT04609033|Sensory System Agents|sensory system agents|mesh-ancestor
25449793|NCT04609033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449794|NCT04609033|Analgesics|analgesics|mesh-ancestor
25449795|NCT04609033|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25449796|NCT04609033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25449797|NCT04609033|Anesthetics, General|anesthetics, general|mesh-ancestor
25449798|NCT04609033|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25449799|NCT04609033|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25449800|NCT04609033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25449801|NCT04609033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449802|NCT04609033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25449803|NCT04609033|Narcotics|narcotics|mesh-ancestor
25449804|NCT04608981|Prednisolone|prednisolone|mesh-list
25449805|NCT04608981|Diclofenac|diclofenac|mesh-list
25449806|NCT04608981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25449807|NCT04608981|Glucocorticoids|glucocorticoids|mesh-ancestor
25449808|NCT04608981|Hormones|hormones|mesh-ancestor
25449809|NCT04608981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25449810|NCT04608981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449811|NCT04608981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25449812|NCT04608981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449813|NCT04608981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449814|NCT04608981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25449815|NCT04608981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25449816|NCT04608981|Analgesics|analgesics|mesh-ancestor
25449817|NCT04608981|Sensory System Agents|sensory system agents|mesh-ancestor
25449818|NCT04608981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25449819|NCT04608981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25449820|NCT04608981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25449821|NCT04608981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449822|NCT04608669|Acetaminophen|acetaminophen|mesh-list
25449823|NCT04608669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25449824|NCT04608669|Analgesics|analgesics|mesh-ancestor
25449825|NCT04608669|Sensory System Agents|sensory system agents|mesh-ancestor
25449826|NCT04608669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449827|NCT04608669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449828|NCT04608669|Antipyretics|antipyretics|mesh-ancestor
25449829|NCT04608539|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25449830|NCT04608539|Hematinics|hematinics|mesh-ancestor
25449831|NCT04608253|Choline|choline|mesh-list
25449832|NCT04608253|Lipotropic Agents|lipotropic agents|mesh-ancestor
25449833|NCT04608253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25449835|NCT04608253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449836|NCT04608253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25449837|NCT04608253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25449838|NCT04608253|Nootropic Agents|nootropic agents|mesh-ancestor
25449839|NCT04608500|Minocycline|minocycline|mesh-list
25449840|NCT04608500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25449841|NCT04608500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25449842|NCT04608084|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25449843|NCT04608084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25449844|NCT04608006|Fentanyl|fentanyl|mesh-list
25449845|NCT04608006|Bupivacaine|bupivacaine|mesh-list
25449846|NCT04608006|Anesthetics, Local|anesthetics, local|mesh-ancestor
25449847|NCT04608006|Anesthetics|anesthetics|mesh-ancestor
25449848|NCT04608006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25449849|NCT04608006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304765|NCT05133453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25304766|NCT05133453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25304767|NCT05133453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25304768|NCT05133453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25304769|NCT05133453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25304770|NCT05125978|Dipyrone|dipyrone|mesh-list
25304771|NCT05125978|Tramadol|tramadol|mesh-list
25304772|NCT05125978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25304773|NCT05125978|Narcotics|narcotics|mesh-ancestor
25304774|NCT05125978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25304775|NCT05125978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304776|NCT05125978|Analgesics|analgesics|mesh-ancestor
25449850|NCT04608006|Sensory System Agents|sensory system agents|mesh-ancestor
25449851|NCT04608006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449852|NCT04608006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25449854|NCT04608006|Analgesics|analgesics|mesh-ancestor
25449855|NCT04608006|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25449856|NCT04608006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25449857|NCT04608006|Anesthetics, General|anesthetics, general|mesh-ancestor
25449858|NCT04607733|Mirikizumab|mirikizumab|mesh-list
25449859|NCT04607733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25449860|NCT04607733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25449861|NCT04607733|Analgesics|analgesics|mesh-ancestor
25449862|NCT04607733|Sensory System Agents|sensory system agents|mesh-ancestor
25449863|NCT04607733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449864|NCT04607733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449865|NCT04607733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25449866|NCT04607733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25449867|NCT04607733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25449868|NCT04607733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25449869|NCT04607785|Chlorhexidine|chlorhexidine|mesh-list
25449870|NCT04607785|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25449871|NCT04607785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25449872|NCT04607785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25449873|NCT04607785|Disinfectants|disinfectants|mesh-ancestor
25449874|NCT04607785|Dermatologic Agents|dermatologic agents|mesh-ancestor
25449875|NCT04607629|Omalizumab|omalizumab|mesh-list
25449876|NCT04607629|Budesonide|budesonide|mesh-list
25449877|NCT04607629|Formoterol Fumarate|formoterol fumarate|mesh-list
25449878|NCT04607629|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25449879|NCT04607629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25449880|NCT04607629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25449881|NCT04607629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25449882|NCT04607629|Autonomic Agents|autonomic agents|mesh-ancestor
25449883|NCT04607629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449884|NCT04607629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449885|NCT04607629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25449886|NCT04607629|Respiratory System Agents|respiratory system agents|mesh-ancestor
25449887|NCT04607629|Glucocorticoids|glucocorticoids|mesh-ancestor
25449888|NCT04607629|Hormones|hormones|mesh-ancestor
25449889|NCT04607629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25449890|NCT04607629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25449891|NCT04607629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25449892|NCT04607629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25449893|NCT04607629|Adrenergic Agents|adrenergic agents|mesh-ancestor
25720967|NCT02478489|Naltrexone|naltrexone|mesh-list
25449894|NCT04607629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25449895|NCT04607629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449896|NCT04607629|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25449897|NCT04607629|Immunologic Factors|immunologic factors|mesh-ancestor
25449898|NCT04607603|Cannabidiol|cannabidiol|mesh-list
25644059|NCT01432574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644060|NCT01432600|Dexamethasone|dexamethasone|mesh-list
25644061|NCT01432600|Cyclophosphamide|cyclophosphamide|mesh-list
25644062|NCT01432600|Pomalidomide|pomalidomide|mesh-list
25644063|NCT01432600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25644064|NCT01432600|Immunologic Factors|immunologic factors|mesh-ancestor
25644065|NCT01432600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644066|NCT01432600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25644067|NCT01432600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25644068|NCT01432600|Alkylating Agents|alkylating agents|mesh-ancestor
25644069|NCT01432600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644070|NCT01432600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25644071|NCT01432600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25644072|NCT01432600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25449899|NCT04607603|Anticonvulsants|anticonvulsants|mesh-ancestor
25644073|NCT01432600|Antiemetics|antiemetics|mesh-ancestor
25644074|NCT01432600|Autonomic Agents|autonomic agents|mesh-ancestor
25644075|NCT01432600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25644076|NCT01432600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25449900|NCT04607447|Dexamethasone|dexamethasone|mesh-list
25449901|NCT04607447|Atorvastatin|atorvastatin|mesh-list
25449902|NCT04607447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25449903|NCT04607447|Antiemetics|antiemetics|mesh-ancestor
25449904|NCT04607447|Autonomic Agents|autonomic agents|mesh-ancestor
25449905|NCT04607447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449906|NCT04607447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449907|NCT04607447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25449908|NCT04607447|Glucocorticoids|glucocorticoids|mesh-ancestor
25449909|NCT04607447|Hormones|hormones|mesh-ancestor
25449910|NCT04607447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25449911|NCT04607447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25449912|NCT04607447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449913|NCT04607447|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25304853|NCT05305300|Vaccines|vaccines|mesh-list
25304854|NCT05305300|Somatomedin B|somatomedin b|mesh-list
25304855|NCT05305300|Immunologic Factors|immunologic factors|mesh-ancestor
25304856|NCT05305300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304857|NCT05305300|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25304858|NCT05305300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25304859|NCT05305300|Protease Inhibitors|protease inhibitors|mesh-ancestor
25304860|NCT05305300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25304861|NCT05305300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304862|NCT05305287|Pioglitazone|pioglitazone|mesh-list
25304863|NCT05305287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25304865|NCT05305183|Alendronate|alendronate|mesh-list
25449934|NCT04607642|Manganese|manganese|mesh-list
25449935|NCT04607642|Cisplatin|cisplatin|mesh-list
25449936|NCT04607642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449937|NCT04607642|Trace Elements|trace elements|mesh-ancestor
25449938|NCT04607642|Micronutrients|micronutrients|mesh-ancestor
25449939|NCT04607642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449940|NCT04607057|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-list
25449941|NCT04607057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25449942|NCT04606836|Bupivacaine|bupivacaine|mesh-list
25449943|NCT04606836|Anesthetics, Local|anesthetics, local|mesh-ancestor
25449944|NCT04606836|Anesthetics|anesthetics|mesh-ancestor
25449945|NCT04606836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25449946|NCT04606836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449947|NCT04606836|Sensory System Agents|sensory system agents|mesh-ancestor
25449948|NCT04606836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25449949|NCT04606563|Losartan|losartan|mesh-list
25449950|NCT04606563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25449951|NCT04606563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25449952|NCT04606563|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25449953|NCT04606563|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25449954|NCT04606563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449955|NCT04606537|Itraconazole|itraconazole|mesh-list
25449956|NCT04606537|Rifampin|rifampin|mesh-list
25449957|NCT04606537|Antifungal Agents|antifungal agents|mesh-ancestor
25449958|NCT04606537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25449959|NCT04606537|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25449960|NCT04606537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25449961|NCT04606537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25449962|NCT04606537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644077|NCT01432600|Glucocorticoids|glucocorticoids|mesh-ancestor
25644078|NCT01432600|Hormones|hormones|mesh-ancestor
25449963|NCT04606537|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25449965|NCT04606537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25449966|NCT04606537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449967|NCT04606537|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25449968|NCT04606537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25449969|NCT04606537|Antitubercular Agents|antitubercular agents|mesh-ancestor
25449970|NCT04606537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25449971|NCT04606537|Leprostatic Agents|leprostatic agents|mesh-ancestor
25449972|NCT04606537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25644079|NCT01432600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25644080|NCT01432600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25644081|NCT01432600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25644082|NCT01432600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25644083|NCT01432600|Growth Substances|growth substances|mesh-ancestor
25644084|NCT01432600|Growth Inhibitors|growth inhibitors|mesh-ancestor
25644085|NCT01432626|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
25644086|NCT01432626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25644087|NCT01432626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25449973|NCT04606537|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25449974|NCT04606537|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25449975|NCT04606537|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25449976|NCT04606537|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25449977|NCT04606537|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25449978|NCT04606537|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25449979|NCT04606212|Losartan|losartan|mesh-list
25449980|NCT04606212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25449981|NCT04606212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25449982|NCT04606212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25449983|NCT04606212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25449984|NCT04606212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449985|NCT04606225|Losartan|losartan|mesh-list
25449986|NCT04606225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25449987|NCT04606225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25449988|NCT04606225|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25449989|NCT04606225|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24893695|NCT04447105|Propofol|propofol|mesh-list
25305009|NCT05304169|Leuprolide|leuprolide|mesh-list
25305010|NCT05304169|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25305011|NCT05304169|Fertility Agents|fertility agents|mesh-ancestor
25305012|NCT05304169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25305013|NCT05304169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305014|NCT05304169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25305015|NCT05304169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25305031|NCT05303961|Rebamipide|rebamipide|mesh-list
25305032|NCT05303961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25305033|NCT05303961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25305034|NCT05303961|Antioxidants|antioxidants|mesh-ancestor
25305035|NCT05303961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305036|NCT05303961|Protective Agents|protective agents|mesh-ancestor
25305037|NCT05303961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305038|NCT05303961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25449990|NCT04606225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449991|NCT04606082|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25449992|NCT04606082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25449993|NCT04606082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25449994|NCT04606108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25449995|NCT04606108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25449996|NCT04606108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25449997|NCT04606017|Calcium Carbonate|calcium carbonate|mesh-list
25449998|NCT04606017|Antacids|antacids|mesh-ancestor
25449999|NCT04606017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450000|NCT04606017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25450001|NCT04605770|Cisplatin|cisplatin|mesh-list
25450002|NCT04605770|Pemetrexed|pemetrexed|mesh-list
25450003|NCT04605770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25450004|NCT04605770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25450005|NCT04605770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450006|NCT04605770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25450007|NCT04605770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25450008|NCT04605705|Chrysarobin|chrysarobin|mesh-list
25450009|NCT04605705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25450010|NCT04605705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25450011|NCT04605705|Analgesics|analgesics|mesh-ancestor
25450012|NCT04605705|Sensory System Agents|sensory system agents|mesh-ancestor
25450013|NCT04605705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450014|NCT04605705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450015|NCT04605705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25450016|NCT04605705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25450017|NCT04605887|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
25450018|NCT04605887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25450019|NCT04605887|Vasodilator Agents|vasodilator agents|mesh-ancestor
25450021|NCT04605952|Immunoglobulin G|immunoglobulin g|mesh-list
25450022|NCT04605952|Immunologic Factors|immunologic factors|mesh-ancestor
25450023|NCT04605952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450024|NCT04605562|Palbociclib|palbociclib|mesh-list
25450025|NCT04605562|Antibodies|antibodies|mesh-list
25450026|NCT04605562|Antibodies, Blocking|antibodies, blocking|mesh-list
25450027|NCT04605562|Immunologic Factors|immunologic factors|mesh-ancestor
25450028|NCT04605562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450029|NCT04605562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25450030|NCT04605562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25450031|NCT04605562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25450032|NCT04605562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450033|NCT04605419|Calcium|calcium|mesh-list
25450034|NCT04605419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25450035|NCT04605419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450036|NCT04605588|Ribavirin|ribavirin|mesh-list
25450037|NCT04605588|Hydroxychloroquine|hydroxychloroquine|mesh-list
25450038|NCT04605588|Nitazoxanide|nitazoxanide|mesh-list
25450039|NCT04605588|Antimetabolites|antimetabolites|mesh-ancestor
25450040|NCT04605588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450041|NCT04605588|Antiviral Agents|antiviral agents|mesh-ancestor
25450042|NCT04605588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25450043|NCT04605588|Antimalarials|antimalarials|mesh-ancestor
25450044|NCT04605588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25450045|NCT04605588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25450046|NCT04605588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25450047|NCT04605588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25450048|NCT04605575|Vinorelbine|vinorelbine|mesh-list
25450049|NCT04605575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25450050|NCT04605575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25450051|NCT04605575|Tubulin Modulators|tubulin modulators|mesh-ancestor
25450052|NCT04605575|Antimitotic Agents|antimitotic agents|mesh-ancestor
25450053|NCT04605575|Mitosis Modulators|mitosis modulators|mesh-ancestor
25450054|NCT04605575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450055|NCT04605107|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25450056|NCT04605107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25450057|NCT04605107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305066|NCT05303597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25305067|NCT05303597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305068|NCT05303480|Mechlorethamine|mechlorethamine|mesh-list
25305069|NCT05303480|Alkylating Agents|alkylating agents|mesh-ancestor
25305070|NCT05303480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305071|NCT05303480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25450064|NCT04604756|Losartan|losartan|mesh-list
25450065|NCT04604756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25450066|NCT04604756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25450067|NCT04604756|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25450068|NCT04604756|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25450069|NCT04604756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450070|NCT04604886|Dobutamine|dobutamine|mesh-list
25450071|NCT04604886|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25450072|NCT04604886|Sympathomimetics|sympathomimetics|mesh-ancestor
25450073|NCT04604886|Autonomic Agents|autonomic agents|mesh-ancestor
25450074|NCT04604886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450075|NCT04604886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450076|NCT04604886|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25450077|NCT04604886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25450078|NCT04604886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25450079|NCT04604886|Adrenergic Agents|adrenergic agents|mesh-ancestor
25450080|NCT04604886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25450081|NCT04604886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450082|NCT04604886|Protective Agents|protective agents|mesh-ancestor
25450084|NCT04604678|Naltrexone|naltrexone|mesh-list
25450085|NCT04604678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25450086|NCT04604678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450087|NCT04604678|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25450088|NCT04604678|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25450089|NCT04604678|Sensory System Agents|sensory system agents|mesh-ancestor
25450090|NCT04604678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450091|NCT04604795|Itraconazole|itraconazole|mesh-list
25450092|NCT04604795|Antifungal Agents|antifungal agents|mesh-ancestor
25450093|NCT04604795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25450094|NCT04604795|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25450095|NCT04604795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25450096|NCT04604795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25450097|NCT04604795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450098|NCT04604795|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25450099|NCT04604795|Hormone Antagonists|hormone antagonists|mesh-ancestor
25450100|NCT04604795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25450101|NCT04604795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450102|NCT04604795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25450103|NCT04604509|Bupropion|bupropion|mesh-list
25450104|NCT04604509|Nicotine|nicotine|mesh-list
25450105|NCT04604509|Varenicline|varenicline|mesh-list
25450106|NCT04604509|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25450107|NCT04604509|Autonomic Agents|autonomic agents|mesh-ancestor
25450108|NCT04604509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450109|NCT04604509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450110|NCT04604509|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25450111|NCT04604509|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25450112|NCT04604509|Cholinergic Agents|cholinergic agents|mesh-ancestor
25450113|NCT04604509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25450114|NCT04604509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450115|NCT04604509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25450116|NCT04604509|Antidepressive Agents|antidepressive agents|mesh-ancestor
25450117|NCT04604509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25450118|NCT04604509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25450119|NCT04604509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25450120|NCT04604509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25450121|NCT04604509|Dopamine Agents|dopamine agents|mesh-ancestor
25450122|NCT04604509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25450123|NCT04604509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25450124|NCT04604509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25450125|NCT04604327|Bemiparin|bemiparin|mesh-list
25450126|NCT04604327|Anticoagulants|anticoagulants|mesh-ancestor
25450127|NCT04604223|Pioglitazone|pioglitazone|mesh-list
25450128|NCT04604223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25450129|NCT04604223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450130|NCT04604028|Cyclophosphamide|cyclophosphamide|mesh-list
25450131|NCT04604028|Lenalidomide|lenalidomide|mesh-list
25450132|NCT04604028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25450133|NCT04604028|Immunologic Factors|immunologic factors|mesh-ancestor
25450134|NCT04604028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450135|NCT04604028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25450136|NCT04604028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25450137|NCT04604028|Alkylating Agents|alkylating agents|mesh-ancestor
25450143|NCT04604028|Growth Substances|growth substances|mesh-ancestor
25450144|NCT04604028|Growth Inhibitors|growth inhibitors|mesh-ancestor
25450145|NCT04604054|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25450146|NCT04604054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25450147|NCT04604054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450148|NCT04603729|Dexamethasone|dexamethasone|mesh-list
25450149|NCT04603729|Methylprednisolone|methylprednisolone|mesh-list
25450150|NCT04603729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25450151|NCT04603729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25450152|NCT04603729|Prednisolone|prednisolone|mesh-list
25450153|NCT04603729|Prednisolone acetate|prednisolone acetate|mesh-list
25450154|NCT04603729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25450155|NCT04603729|Prednisolone phosphate|prednisolone phosphate|mesh-list
25450156|NCT04603729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25450157|NCT04603729|Antiemetics|antiemetics|mesh-ancestor
25450158|NCT04603729|Autonomic Agents|autonomic agents|mesh-ancestor
25450159|NCT04603729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450160|NCT04603729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450161|NCT04603729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25822846|NCT00004685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822847|NCT00004686|Prednisone|prednisone|mesh-list
25644088|NCT01432626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644089|NCT01432626|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25644090|NCT01432938|Dulaglutide|dulaglutide|mesh-list
25644091|NCT01432938|Warfarin|warfarin|mesh-list
25644092|NCT01432938|Anticoagulants|anticoagulants|mesh-ancestor
25644093|NCT01432938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25644094|NCT01432938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644095|NCT01433055|Minocycline|minocycline|mesh-list
25644096|NCT01433055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25644097|NCT01433055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25450162|NCT04603729|Glucocorticoids|glucocorticoids|mesh-ancestor
25450163|NCT04603729|Hormones|hormones|mesh-ancestor
25450164|NCT04603729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25450165|NCT04603729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25450166|NCT04603729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25450167|NCT04603729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25450168|NCT04603729|Protective Agents|protective agents|mesh-ancestor
25450169|NCT04603976|Erenumab|erenumab|mesh-list
25450170|NCT04603976|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25450171|NCT04603976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450172|NCT04603976|Analgesics|analgesics|mesh-ancestor
25450173|NCT04603976|Sensory System Agents|sensory system agents|mesh-ancestor
25450174|NCT04603976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450175|NCT04603976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450176|NCT04603833|Docetaxel|docetaxel|mesh-list
25450177|NCT04603833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25450178|NCT04603833|Tubulin Modulators|tubulin modulators|mesh-ancestor
25450179|NCT04603833|Antimitotic Agents|antimitotic agents|mesh-ancestor
25450180|NCT04603833|Mitosis Modulators|mitosis modulators|mesh-ancestor
25450181|NCT04603833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450182|NCT04603872|Dasatinib|dasatinib|mesh-list
25450183|NCT04603872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25450184|NCT04603872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25450185|NCT04603872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25450186|NCT04603872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450187|NCT04603924|Niclosamide|niclosamide|mesh-list
25450188|NCT04603924|Anticestodal Agents|anticestodal agents|mesh-ancestor
25450189|NCT04603924|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25450190|NCT04603924|Anthelmintics|anthelmintics|mesh-ancestor
25450191|NCT04603924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25450192|NCT04603924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25450193|NCT04603924|Antinematodal Agents|antinematodal agents|mesh-ancestor
25450194|NCT04603794|Chlorhexidine|chlorhexidine|mesh-list
25450195|NCT04603794|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25450196|NCT04603794|Povidone-Iodine|povidone-iodine|mesh-list
25450197|NCT04603794|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25450198|NCT04603794|Povidone|povidone|mesh-list
25305292|NCT05283356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305293|NCT05283356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305301|NCT05282108|Imatinib Mesylate|imatinib mesylate|mesh-list
25305302|NCT05282108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25305303|NCT05282108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25305304|NCT05282108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25305305|NCT05282108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450199|NCT04603794|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25450200|NCT04603794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25450201|NCT04603794|Disinfectants|disinfectants|mesh-ancestor
25450202|NCT04603794|Dermatologic Agents|dermatologic agents|mesh-ancestor
25450203|NCT04603794|Plasma Substitutes|plasma substitutes|mesh-ancestor
25450204|NCT04603794|Blood Substitutes|blood substitutes|mesh-ancestor
25450205|NCT04603664|Cystatins|cystatins|mesh-list
25450206|NCT04603664|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25450207|NCT04603664|Protease Inhibitors|protease inhibitors|mesh-ancestor
25450208|NCT04603664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25450209|NCT04603664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450210|NCT04603573|Listerine|listerine|mesh-list
25450211|NCT04603573|Fluorides|fluorides|mesh-list
25450212|NCT04603573|Sodium Fluoride|sodium fluoride|mesh-list
25450213|NCT04603573|Fluorides, Topical|fluorides, topical|mesh-list
25450214|NCT04603573|Cariostatic Agents|cariostatic agents|mesh-ancestor
25450215|NCT04603573|Protective Agents|protective agents|mesh-ancestor
25644098|NCT01433081|Magnesium Sulfate|magnesium sulfate|mesh-list
25644099|NCT01433081|Analgesics|analgesics|mesh-ancestor
25450216|NCT04603573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450217|NCT04603573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25450218|NCT04603573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25450219|NCT04603456|Calcium Carbonate|calcium carbonate|mesh-list
25450220|NCT04603456|Antacids|antacids|mesh-ancestor
25450221|NCT04603456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450222|NCT04603456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25450223|NCT04603131|Vaccines|vaccines|mesh-list
25450224|NCT04603131|Immunologic Factors|immunologic factors|mesh-ancestor
25450225|NCT04603131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450226|NCT04603066|Ondansetron|ondansetron|mesh-list
25450227|NCT04603066|Antiemetics|antiemetics|mesh-ancestor
25450228|NCT04603066|Autonomic Agents|autonomic agents|mesh-ancestor
25450229|NCT04603066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450230|NCT04603066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450231|NCT04603066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25450232|NCT04603066|Antipruritics|antipruritics|mesh-ancestor
25450233|NCT04603066|Dermatologic Agents|dermatologic agents|mesh-ancestor
25450234|NCT04603066|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25450235|NCT04603066|Serotonin Agents|serotonin agents|mesh-ancestor
25450236|NCT04603066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25450237|NCT04603066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450238|NCT04603066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25450239|NCT04603066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25450240|NCT04603066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25450241|NCT04603066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25450242|NCT04603066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25644100|NCT01433081|Sensory System Agents|sensory system agents|mesh-ancestor
25644101|NCT01433081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25644102|NCT01433081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644103|NCT01433081|Anesthetics|anesthetics|mesh-ancestor
25644104|NCT01433081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25644105|NCT01433081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25644106|NCT01433081|Anticonvulsants|anticonvulsants|mesh-ancestor
25644107|NCT01433081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25644108|NCT01433081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25450243|NCT04602767|Phenylephrine|phenylephrine|mesh-list
25450244|NCT04602767|Vasopressins|vasopressins|mesh-list
25450245|NCT04602767|Arginine Vasopressin|arginine vasopressin|mesh-list
25450246|NCT04602767|Oxymetazoline|oxymetazoline|mesh-list
25450247|NCT04602767|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25450248|NCT04602767|Mydriatics|mydriatics|mesh-ancestor
25450249|NCT04602767|Autonomic Agents|autonomic agents|mesh-ancestor
25450250|NCT04602767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450251|NCT04602767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450252|NCT04602767|Sympathomimetics|sympathomimetics|mesh-ancestor
25450253|NCT04602767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25450254|NCT04602767|Nasal Decongestants|nasal decongestants|mesh-ancestor
25450255|NCT04602767|Respiratory System Agents|respiratory system agents|mesh-ancestor
25450256|NCT04602767|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25450257|NCT04602767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25450258|NCT04602767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25450259|NCT04602767|Adrenergic Agents|adrenergic agents|mesh-ancestor
25450260|NCT04602767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25450261|NCT04602767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450262|NCT04602767|Protective Agents|protective agents|mesh-ancestor
25450263|NCT04602767|Hemostatics|hemostatics|mesh-ancestor
25450264|NCT04602767|Coagulants|coagulants|mesh-ancestor
25305365|NCT05265507|Glycopyrrolate|glycopyrrolate|mesh-list
25305366|NCT05265507|Ondansetron|ondansetron|mesh-list
25305367|NCT05265507|Antiemetics|antiemetics|mesh-ancestor
25305368|NCT05265507|Autonomic Agents|autonomic agents|mesh-ancestor
25305369|NCT05265507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25305370|NCT05265507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305371|NCT05265507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25305372|NCT05265507|Antipruritics|antipruritics|mesh-ancestor
25305373|NCT05265507|Dermatologic Agents|dermatologic agents|mesh-ancestor
25305374|NCT05265507|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25450265|NCT04602767|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25165278|NCT04934449|Salicylic Acid|salicylic acid|mesh-list
25165279|NCT04934449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25165280|NCT04934449|Antifungal Agents|antifungal agents|mesh-ancestor
24401807|NCT00154037|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24401808|NCT00154037|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25822848|NCT00004686|Methotrexate|methotrexate|mesh-list
25450266|NCT04602767|Natriuretic Agents|natriuretic agents|mesh-ancestor
25450282|NCT04602026|Keratolytic Agents|keratolytic agents|mesh-ancestor
25450283|NCT04602026|Dermatologic Agents|dermatologic agents|mesh-ancestor
25450284|NCT04602143|Testosterone|testosterone|mesh-list
25450285|NCT04602143|Androgens|androgens|mesh-ancestor
25450286|NCT04602143|Hormones|hormones|mesh-ancestor
25450287|NCT04602143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25450288|NCT04602143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450289|NCT04601961|Propofol|propofol|mesh-list
25450290|NCT04601961|Sevoflurane|sevoflurane|mesh-list
25450291|NCT04601961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25450292|NCT04601961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25450293|NCT04601961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450294|NCT04601961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25450295|NCT04601961|Anesthetics, General|anesthetics, general|mesh-ancestor
25450296|NCT04601961|Anesthetics|anesthetics|mesh-ancestor
25450297|NCT04601961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25450298|NCT04601961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25450299|NCT04602065|Antibodies|antibodies|mesh-list
25450300|NCT04602065|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25450301|NCT04602065|Immunologic Factors|immunologic factors|mesh-ancestor
25450302|NCT04602065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450303|NCT04602013|Paclitaxel|paclitaxel|mesh-list
25450304|NCT04602013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25450305|NCT04602013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25450306|NCT04602013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25450307|NCT04602013|Tubulin Modulators|tubulin modulators|mesh-ancestor
25450308|NCT04602013|Antimitotic Agents|antimitotic agents|mesh-ancestor
25450309|NCT04602013|Mitosis Modulators|mitosis modulators|mesh-ancestor
25450310|NCT04602013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721010|NCT02480114|Fentanyl|fentanyl|mesh-list
25450311|NCT04601688|Dexamethasone|dexamethasone|mesh-list
25450312|NCT04601688|Bevacizumab|bevacizumab|mesh-list
25450313|NCT04601688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25450314|NCT04601688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25450315|NCT04601688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25450316|NCT04601688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25450317|NCT04601688|Growth Substances|growth substances|mesh-ancestor
25450318|NCT04601688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450319|NCT04601688|Growth Inhibitors|growth inhibitors|mesh-ancestor
25450320|NCT04601688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25450321|NCT04601688|Antiemetics|antiemetics|mesh-ancestor
25450322|NCT04601688|Autonomic Agents|autonomic agents|mesh-ancestor
25450323|NCT04601688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450324|NCT04601688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25450325|NCT04601688|Glucocorticoids|glucocorticoids|mesh-ancestor
25450326|NCT04601688|Hormones|hormones|mesh-ancestor
25450327|NCT04601688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25450328|NCT04601688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25450329|NCT04601701|Dexamethasone|dexamethasone|mesh-list
25450330|NCT04601701|Bevacizumab|bevacizumab|mesh-list
25450331|NCT04601701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25450332|NCT04601701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25450333|NCT04601701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25450334|NCT04601701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25450335|NCT04601701|Growth Substances|growth substances|mesh-ancestor
25450336|NCT04601701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450337|NCT04601701|Growth Inhibitors|growth inhibitors|mesh-ancestor
25450338|NCT04601701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25450339|NCT04601701|Antiemetics|antiemetics|mesh-ancestor
25450340|NCT04601701|Autonomic Agents|autonomic agents|mesh-ancestor
25450341|NCT04601701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450342|NCT04601701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25450343|NCT04601701|Glucocorticoids|glucocorticoids|mesh-ancestor
25450344|NCT04601701|Hormones|hormones|mesh-ancestor
25305513|NCT05185167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305514|NCT05185167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25305515|NCT05185167|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25305528|NCT05128617|Paclitaxel|paclitaxel|mesh-list
25305529|NCT05128617|Cyclophosphamide|cyclophosphamide|mesh-list
25305530|NCT05128617|Epirubicin|epirubicin|mesh-list
25305531|NCT05128617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25305532|NCT05128617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25305533|NCT05128617|Tubulin Modulators|tubulin modulators|mesh-ancestor
25305534|NCT05128617|Antimitotic Agents|antimitotic agents|mesh-ancestor
24953180|NCT03887650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25305535|NCT05128617|Mitosis Modulators|mitosis modulators|mesh-ancestor
25450345|NCT04601701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25450346|NCT04601701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25450347|NCT04601675|Dexamethasone|dexamethasone|mesh-list
25450349|NCT04601675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25450350|NCT04601675|Antiemetics|antiemetics|mesh-ancestor
25450351|NCT04601675|Autonomic Agents|autonomic agents|mesh-ancestor
25450352|NCT04601675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450353|NCT04601675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450354|NCT04601675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25450355|NCT04601675|Glucocorticoids|glucocorticoids|mesh-ancestor
25450356|NCT04601675|Hormones|hormones|mesh-ancestor
25450357|NCT04601675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25450358|NCT04601675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25450359|NCT04601675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25450360|NCT04601675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25450361|NCT04601675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25450362|NCT04601675|Growth Substances|growth substances|mesh-ancestor
25450363|NCT04601675|Growth Inhibitors|growth inhibitors|mesh-ancestor
25450364|NCT04601324|Fluticasone|fluticasone|mesh-list
25450365|NCT04601324|Xhance|xhance|mesh-list
25450366|NCT04601324|Azelastine|azelastine|mesh-list
25450367|NCT04601324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25450368|NCT04601324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25450369|NCT04601324|Autonomic Agents|autonomic agents|mesh-ancestor
25450370|NCT04601324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450371|NCT04601324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450372|NCT04601324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25450373|NCT04601324|Respiratory System Agents|respiratory system agents|mesh-ancestor
25450374|NCT04601324|Dermatologic Agents|dermatologic agents|mesh-ancestor
25450375|NCT04601324|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25450376|NCT04601324|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25450377|NCT04601324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25450378|NCT04601324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450379|NCT04601324|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25450380|NCT04601324|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25450381|NCT04601324|Histamine Antagonists|histamine antagonists|mesh-ancestor
25450382|NCT04601324|Histamine Agents|histamine agents|mesh-ancestor
25450383|NCT04601324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25450384|NCT04600999|Favipiravir|favipiravir|mesh-list
25450385|NCT04600999|Antiviral Agents|antiviral agents|mesh-ancestor
25450386|NCT04600999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25450387|NCT04601142|Methylprednisolone|methylprednisolone|mesh-list
25450388|NCT04601142|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25450389|NCT04601142|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25450390|NCT04601142|Prednisolone|prednisolone|mesh-list
25450391|NCT04601142|Prednisolone acetate|prednisolone acetate|mesh-list
25450392|NCT04601142|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25450393|NCT04601142|Prednisolone phosphate|prednisolone phosphate|mesh-list
25450394|NCT04601142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25450395|NCT04601142|Antiemetics|antiemetics|mesh-ancestor
25450396|NCT04601142|Autonomic Agents|autonomic agents|mesh-ancestor
25450397|NCT04601142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450398|NCT04601142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450399|NCT04601142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25450400|NCT04601142|Glucocorticoids|glucocorticoids|mesh-ancestor
25450401|NCT04601142|Hormones|hormones|mesh-ancestor
25450402|NCT04601142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25450403|NCT04601142|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25450404|NCT04601142|Protective Agents|protective agents|mesh-ancestor
25450405|NCT04601142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25450406|NCT04601142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25450407|NCT04601259|Salicylic Acid|salicylic acid|mesh-list
25450408|NCT04601259|Salicylates|salicylates|mesh-list
25450409|NCT04601259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25450410|NCT04601259|Antifungal Agents|antifungal agents|mesh-ancestor
25450411|NCT04601259|Keratolytic Agents|keratolytic agents|mesh-ancestor
25450412|NCT04601259|Dermatologic Agents|dermatologic agents|mesh-ancestor
25450413|NCT04601259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25450414|NCT04601259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25450415|NCT04601259|Analgesics|analgesics|mesh-ancestor
25450416|NCT04601259|Sensory System Agents|sensory system agents|mesh-ancestor
25305587|NCT05099913|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25305588|NCT05099913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25450417|NCT04601259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450418|NCT04601259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450419|NCT04601259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25450420|NCT04601259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25450421|NCT04601259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25450423|NCT04601259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450424|NCT04601389|Omalizumab|omalizumab|mesh-list
25450425|NCT04601389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25450426|NCT04601389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25450427|NCT04601389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25450428|NCT04601389|Respiratory System Agents|respiratory system agents|mesh-ancestor
25450429|NCT04601389|Immunologic Factors|immunologic factors|mesh-ancestor
25450430|NCT04601389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450431|NCT04601077|Nitric Oxide|nitric oxide|mesh-list
25450432|NCT04601077|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25450433|NCT04601077|Autonomic Agents|autonomic agents|mesh-ancestor
25450434|NCT04601077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450435|NCT04601077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450436|NCT04601077|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25450437|NCT04601077|Respiratory System Agents|respiratory system agents|mesh-ancestor
25450438|NCT04601077|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25450439|NCT04601077|Antioxidants|antioxidants|mesh-ancestor
25450440|NCT04601077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450441|NCT04601077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25450442|NCT04601077|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25450443|NCT04601077|Vasodilator Agents|vasodilator agents|mesh-ancestor
25450444|NCT04601077|Gasotransmitters|gasotransmitters|mesh-ancestor
25450445|NCT04601077|Protective Agents|protective agents|mesh-ancestor
25450446|NCT04601116|Atorvastatin|atorvastatin|mesh-list
25450447|NCT04601116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25450448|NCT04601116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25450449|NCT04601116|Antimetabolites|antimetabolites|mesh-ancestor
25450450|NCT04601116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450451|NCT04601116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25450452|NCT04601116|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25450453|NCT04601116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25450454|NCT04600648|Insulin|insulin|mesh-list
25450455|NCT04600648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25450456|NCT04600648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450457|NCT04600167|Isoniazid|isoniazid|mesh-list
25450458|NCT04600167|Rifapentine|rifapentine|mesh-list
25450459|NCT04600167|Antitubercular Agents|antitubercular agents|mesh-ancestor
25450460|NCT04600167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25450461|NCT04600167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25450462|NCT04600167|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25450463|NCT04600167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25450464|NCT04600167|Antimetabolites|antimetabolites|mesh-ancestor
25450465|NCT04600167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450466|NCT04600167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25450467|NCT04600167|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25450468|NCT04600167|Leprostatic Agents|leprostatic agents|mesh-ancestor
25450469|NCT04600427|Anesthetics|anesthetics|mesh-list
25450470|NCT04600427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25450471|NCT04600427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450472|NCT04600271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25450473|NCT04600271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25450474|NCT04600271|Norepinephrine|norepinephrine|mesh-list
25450475|NCT04600271|Analgesics|analgesics|mesh-list
25450476|NCT04600271|Diuretics|diuretics|mesh-list
25450477|NCT04600271|Sensory System Agents|sensory system agents|mesh-ancestor
25450478|NCT04600271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450479|NCT04600271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450480|NCT04600271|Natriuretic Agents|natriuretic agents|mesh-ancestor
25450481|NCT04600271|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25450482|NCT04600271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25450483|NCT04600271|Adrenergic Agents|adrenergic agents|mesh-ancestor
25450484|NCT04600271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25450485|NCT04600271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450486|NCT04600271|Sympathomimetics|sympathomimetics|mesh-ancestor
25450487|NCT04600271|Autonomic Agents|autonomic agents|mesh-ancestor
25450488|NCT04600271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25450489|NCT04600271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25305661|NCT05019222|Anesthetics|anesthetics|mesh-list
25305662|NCT05019222|Sevoflurane|sevoflurane|mesh-list
25305663|NCT05019222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25305668|NCT05010148|Lidocaine|lidocaine|mesh-list
25450490|NCT04600271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25450492|NCT04600089|Analgesics|analgesics|mesh-ancestor
25450493|NCT04600089|Sensory System Agents|sensory system agents|mesh-ancestor
25450494|NCT04600089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450495|NCT04600089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450496|NCT04600089|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25450497|NCT04600089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25450498|NCT04600089|Anesthetics, General|anesthetics, general|mesh-ancestor
25450500|NCT04600089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25450501|NCT04600089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25450502|NCT04600089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25450503|NCT04600089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25450504|NCT04600089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450505|NCT04600414|Analgesics, Opioid|analgesics, opioid|mesh-list
25450506|NCT04600414|Narcotics|narcotics|mesh-ancestor
25450507|NCT04600414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25450508|NCT04600414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450509|NCT04600414|Analgesics|analgesics|mesh-ancestor
25450510|NCT04600414|Sensory System Agents|sensory system agents|mesh-ancestor
25450511|NCT04600414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450512|NCT04599959|Hydrocortisone|hydrocortisone|mesh-list
25450513|NCT04599959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25450514|NCT04600115|Adenosine|adenosine|mesh-list
25450515|NCT04600115|Regadenoson|regadenoson|mesh-list
25450516|NCT04600115|Analgesics|analgesics|mesh-ancestor
25450517|NCT04600115|Sensory System Agents|sensory system agents|mesh-ancestor
25450518|NCT04600115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450519|NCT04600115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450520|NCT04600115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25450521|NCT04600115|Vasodilator Agents|vasodilator agents|mesh-ancestor
25450522|NCT04600115|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25450523|NCT04600115|Purinergic Agonists|purinergic agonists|mesh-ancestor
25450524|NCT04600115|Purinergic Agents|purinergic agents|mesh-ancestor
25450525|NCT04600115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25450526|NCT04600115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450527|NCT04600115|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25450528|NCT04600492|Riociguat|riociguat|mesh-list
25450529|NCT04600492|Enzyme Activators|enzyme activators|mesh-ancestor
25450530|NCT04600492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450531|NCT04600037|Pregabalin|pregabalin|mesh-list
25450532|NCT04600037|Analgesics|analgesics|mesh-ancestor
25450533|NCT04600037|Sensory System Agents|sensory system agents|mesh-ancestor
25450534|NCT04600037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450535|NCT04600037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450536|NCT04600037|Anticonvulsants|anticonvulsants|mesh-ancestor
25450537|NCT04600037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25450538|NCT04600037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25450539|NCT04600037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450540|NCT04600037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25450541|NCT04600037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25450542|NCT04600037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25450543|NCT04600037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25450544|NCT04600037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25450545|NCT04599894|Pregabalin|pregabalin|mesh-list
25450546|NCT04599894|Analgesics|analgesics|mesh-ancestor
25450547|NCT04599894|Sensory System Agents|sensory system agents|mesh-ancestor
25450548|NCT04599894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450549|NCT04599894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450550|NCT04599894|Anticonvulsants|anticonvulsants|mesh-ancestor
25305736|NCT04951986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25305737|NCT04951986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25305738|NCT04951986|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25305739|NCT04951986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25305740|NCT04951986|Renal Agents|renal agents|mesh-ancestor
25305741|NCT04951986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25305742|NCT04951986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25305743|NCT04951986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25305744|NCT04951986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25305745|NCT04951986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305746|NCT04951986|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25305747|NCT04951986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25450560|NCT04599712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25450561|NCT04599712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25450562|NCT04599621|Uric Acid|uric acid|mesh-list
25450563|NCT04599621|Antioxidants|antioxidants|mesh-ancestor
25450564|NCT04599621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450565|NCT04599621|Protective Agents|protective agents|mesh-ancestor
25450566|NCT04599621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450567|NCT04599699|Androgens|androgens|mesh-list
25450568|NCT04599699|Hormones|hormones|mesh-ancestor
25450569|NCT04599699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25450570|NCT04599699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450571|NCT04599205|Tranexamic Acid|tranexamic acid|mesh-list
25450572|NCT04599205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25450573|NCT04599205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25450574|NCT04599205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450575|NCT04599205|Hemostatics|hemostatics|mesh-ancestor
25450576|NCT04599205|Coagulants|coagulants|mesh-ancestor
25450577|NCT04598880|Picosulfate sodium|picosulfate sodium|mesh-list
25450578|NCT04598880|Magnesium citrate|magnesium citrate|mesh-list
25450579|NCT04598880|Cathartics|cathartics|mesh-ancestor
25450580|NCT04598880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25450581|NCT04598737|Lithium Carbonate|lithium carbonate|mesh-list
25450582|NCT04598737|Antidepressive Agents|antidepressive agents|mesh-ancestor
25450583|NCT04598737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25450584|NCT04598737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25450585|NCT04598737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450586|NCT04598737|Antimanic Agents|antimanic agents|mesh-ancestor
25450587|NCT04598737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25450588|NCT04598737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25450589|NCT04598737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450590|NCT04598542|Triamcinolone|triamcinolone|mesh-list
25450591|NCT04598542|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25450592|NCT04598542|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25450593|NCT04598542|Lorecivivint|lorecivivint|mesh-list
25450594|NCT04598542|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25450595|NCT04598542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25450596|NCT04598542|Glucocorticoids|glucocorticoids|mesh-ancestor
25450597|NCT04598542|Hormones|hormones|mesh-ancestor
25450598|NCT04598542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25450599|NCT04598542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450600|NCT04598542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25450601|NCT04598542|Immunologic Factors|immunologic factors|mesh-ancestor
25450602|NCT04598542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25450603|NCT04598542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450604|NCT04598594|Nicotine|nicotine|mesh-list
25450605|NCT04598594|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25450606|NCT04598594|Autonomic Agents|autonomic agents|mesh-ancestor
25450607|NCT04598594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450608|NCT04598594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450609|NCT04598594|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25450610|NCT04598594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25450611|NCT04598594|Cholinergic Agents|cholinergic agents|mesh-ancestor
25450612|NCT04598594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25450613|NCT04598594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450614|NCT04598191|Iloprost|iloprost|mesh-list
25450615|NCT04598191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25450616|NCT04598191|Vasodilator Agents|vasodilator agents|mesh-ancestor
25450617|NCT04598061|Dexmedetomidine|dexmedetomidine|mesh-list
25450618|NCT04598061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25305886|NCT04800393|Anesthetics, General|anesthetics, general|mesh-ancestor
25305887|NCT04800393|Anesthetics|anesthetics|mesh-ancestor
25305888|NCT04800393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25305889|NCT04800393|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25305912|NCT04770532|Insulin|insulin|mesh-list
25305913|NCT04770532|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25305914|NCT04770532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25305915|NCT04770532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305916|NCT04750070|Dopamine|dopamine|mesh-list
25305917|NCT04750070|Epinephrine|epinephrine|mesh-list
25305918|NCT04750070|Racepinephrine|racepinephrine|mesh-list
25305919|NCT04750070|Epinephryl borate|epinephryl borate|mesh-list
25305920|NCT04750070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25305921|NCT04750070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25305922|NCT04750070|Adrenergic Agents|adrenergic agents|mesh-ancestor
25305932|NCT04750070|Mydriatics|mydriatics|mesh-ancestor
25450651|NCT04597775|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25450652|NCT04597775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25450653|NCT04597775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25450654|NCT04597775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450655|NCT04597775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25450656|NCT04597424|Doxycycline|doxycycline|mesh-list
25644109|NCT01433081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644110|NCT01433081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25450657|NCT04597424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25721040|NCT02480114|Antimanic Agents|antimanic agents|mesh-ancestor
25450658|NCT04597424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25450659|NCT04597424|Antimalarials|antimalarials|mesh-ancestor
25450660|NCT04597424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25450661|NCT04597424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25450662|NCT04597203|Hydroquinone|hydroquinone|mesh-list
25450663|NCT04597203|Antioxidants|antioxidants|mesh-ancestor
25644112|NCT01433081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25644113|NCT01433107|Terbinafine|terbinafine|mesh-list
25644114|NCT01433107|Antifungal Agents|antifungal agents|mesh-ancestor
25644115|NCT01433107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25450664|NCT04597203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450665|NCT04597203|Protective Agents|protective agents|mesh-ancestor
25450666|NCT04597203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450667|NCT04597203|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25450668|NCT04596826|Dronabinol|dronabinol|mesh-list
25450669|NCT04596826|Hallucinogens|hallucinogens|mesh-ancestor
25450670|NCT04596826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450671|NCT04596826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25450672|NCT04596826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25450673|NCT04596826|Analgesics|analgesics|mesh-ancestor
25450674|NCT04596826|Sensory System Agents|sensory system agents|mesh-ancestor
25450675|NCT04596826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450676|NCT04596826|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25450677|NCT04596826|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25450678|NCT04596826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25450679|NCT04596826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450680|NCT04596826|Hormones|hormones|mesh-ancestor
25450681|NCT04596826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25450682|NCT04596839|Remdesivir|remdesivir|mesh-list
25450683|NCT04596839|Antimetabolites|antimetabolites|mesh-ancestor
25450684|NCT04596839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450685|NCT04596839|Antiviral Agents|antiviral agents|mesh-ancestor
25450686|NCT04596839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25450687|NCT04596488|Efavirenz|efavirenz|mesh-list
25450688|NCT04596488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25450689|NCT04596488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25450690|NCT04596488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25450691|NCT04596488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450692|NCT04596488|Antiviral Agents|antiviral agents|mesh-ancestor
25450693|NCT04596488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25450694|NCT04596488|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25450695|NCT04596488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25450696|NCT04596488|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25450697|NCT04596488|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25450698|NCT04596488|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25450699|NCT04596488|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25450700|NCT04595942|Fludrocortisone|fludrocortisone|mesh-list
25450701|NCT04595942|Midodrine|midodrine|mesh-list
25450702|NCT04595942|Sympathomimetics|sympathomimetics|mesh-ancestor
25450703|NCT04595942|Autonomic Agents|autonomic agents|mesh-ancestor
25450704|NCT04595942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450705|NCT04595942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450706|NCT04595942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25450707|NCT04595942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25450708|NCT04595942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25450709|NCT04595942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25450710|NCT04595942|Adrenergic Agents|adrenergic agents|mesh-ancestor
25450711|NCT04595942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25450712|NCT04595942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306040|NCT04682743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25306041|NCT04682743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25306042|NCT04682743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25306043|NCT04682743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25306044|NCT04682743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25306045|NCT04656470|Dexmedetomidine|dexmedetomidine|mesh-list
25306046|NCT04656470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25306047|NCT04656470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25644116|NCT01433107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25306048|NCT04656470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306049|NCT04656470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25306050|NCT04656470|Analgesics|analgesics|mesh-ancestor
25306051|NCT04656470|Sensory System Agents|sensory system agents|mesh-ancestor
25306052|NCT04656470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25306053|NCT04656470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25306054|NCT04656470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25306055|NCT04656470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25306056|NCT04656470|Adrenergic Agents|adrenergic agents|mesh-ancestor
25306057|NCT04656470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25306058|NCT04656470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306059|NCT04647500|Methylphenidate|methylphenidate|mesh-list
25450713|NCT04595942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25450714|NCT04595916|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
25450715|NCT04595916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25450717|NCT04595916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450718|NCT04595916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25450719|NCT04595929|Leucovorin|leucovorin|mesh-list
25450720|NCT04595929|Docetaxel|docetaxel|mesh-list
25450721|NCT04595929|Fluorouracil|fluorouracil|mesh-list
25450722|NCT04595929|Oxaliplatin|oxaliplatin|mesh-list
25450723|NCT04595929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25450724|NCT04595929|Tubulin Modulators|tubulin modulators|mesh-ancestor
25450725|NCT04595929|Antimitotic Agents|antimitotic agents|mesh-ancestor
25450726|NCT04595929|Mitosis Modulators|mitosis modulators|mesh-ancestor
25450727|NCT04595929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450728|NCT04595929|Antimetabolites|antimetabolites|mesh-ancestor
25450729|NCT04595929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25450730|NCT04595929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25450731|NCT04595929|Immunologic Factors|immunologic factors|mesh-ancestor
25450732|NCT04595929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450733|NCT04595929|Antidotes|antidotes|mesh-ancestor
25450734|NCT04595929|Protective Agents|protective agents|mesh-ancestor
25450735|NCT04595929|Vitamin B Complex|vitamin b complex|mesh-ancestor
25450736|NCT04595929|Vitamins|vitamins|mesh-ancestor
25450737|NCT04595929|Micronutrients|micronutrients|mesh-ancestor
25450738|NCT04595812|Misoprostol|misoprostol|mesh-list
25450739|NCT04595812|Hemostatics|hemostatics|mesh-list
25450740|NCT04595812|Oxytocin|oxytocin|mesh-list
25450741|NCT04595812|Carbetocin|carbetocin|mesh-list
25450742|NCT04595812|Oxytocics|oxytocics|mesh-ancestor
25450743|NCT04595812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25450744|NCT04595812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450745|NCT04595812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25450746|NCT04595812|Abortifacient Agents|abortifacient agents|mesh-ancestor
25450747|NCT04595812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25450748|NCT04595812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25450749|NCT04595812|Coagulants|coagulants|mesh-ancestor
25450750|NCT04595877|Dipyrone|dipyrone|mesh-list
25450751|NCT04595877|Endorphins|endorphins|mesh-list
25450752|NCT04595877|beta-Endorphin|beta-endorphin|mesh-list
25450753|NCT04595877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25450754|NCT04595877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25450755|NCT04595877|Analgesics|analgesics|mesh-ancestor
25450756|NCT04595877|Sensory System Agents|sensory system agents|mesh-ancestor
25450757|NCT04595877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450758|NCT04595877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450759|NCT04595877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25450760|NCT04595877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25450761|NCT04595877|Antipyretics|antipyretics|mesh-ancestor
25450762|NCT04595877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25450763|NCT04595877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450764|NCT04595318|Varenicline|varenicline|mesh-list
25450765|NCT04595318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25450766|NCT04595318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25450767|NCT04595318|Cholinergic Agents|cholinergic agents|mesh-ancestor
25450768|NCT04595318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25450769|NCT04595318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450770|NCT04595318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450771|NCT04595591|Remifentanil|remifentanil|mesh-list
25450772|NCT04595591|Rocuronium|rocuronium|mesh-list
25450773|NCT04595591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25450774|NCT04595591|Narcotics|narcotics|mesh-ancestor
25450775|NCT04595591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25721047|NCT02480166|Antiviral Agents|antiviral agents|mesh-ancestor
25450776|NCT04595591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450777|NCT04595591|Analgesics|analgesics|mesh-ancestor
25450778|NCT04595591|Sensory System Agents|sensory system agents|mesh-ancestor
25306112|NCT04609111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25644117|NCT01433107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644118|NCT01433250|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25306113|NCT04609111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25306114|NCT04609111|Antipyretics|antipyretics|mesh-ancestor
25306119|NCT04566991|Deferoxamine|deferoxamine|mesh-list
25306120|NCT04566991|Siderophores|siderophores|mesh-ancestor
25306121|NCT04566991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25306122|NCT04566991|Chelating Agents|chelating agents|mesh-ancestor
25306123|NCT04566991|Sequestering Agents|sequestering agents|mesh-ancestor
25306124|NCT04566991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306125|NCT04560595|Caffeine|caffeine|mesh-list
25450779|NCT04595591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450780|NCT04595591|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25450785|NCT04594629|Nitroglycerin|nitroglycerin|mesh-list
25450786|NCT04594629|Vasodilator Agents|vasodilator agents|mesh-ancestor
25450787|NCT04594343|Disulfiram|disulfiram|mesh-list
25450788|NCT04594343|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25450789|NCT04594343|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25450790|NCT04594343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25450791|NCT04594343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450792|NCT04593706|Dexamethasone|dexamethasone|mesh-list
25450793|NCT04593706|Methylprednisolone|methylprednisolone|mesh-list
25450794|NCT04593706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25450795|NCT04593706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25450796|NCT04593706|Prednisolone|prednisolone|mesh-list
25450797|NCT04593706|Prednisolone acetate|prednisolone acetate|mesh-list
25450798|NCT04593706|Triamcinolone|triamcinolone|mesh-list
25450799|NCT04593706|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25450800|NCT04593706|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25450801|NCT04593706|Betamethasone|betamethasone|mesh-list
25450802|NCT04593706|Betamethasone Valerate|betamethasone valerate|mesh-list
25450803|NCT04593706|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25450804|NCT04593706|Betamethasone benzoate|betamethasone benzoate|mesh-list
25450805|NCT04593706|Dexamethasone acetate|dexamethasone acetate|mesh-list
25450806|NCT04593706|Betamethasone acetate|betamethasone acetate|mesh-list
25450807|NCT04593706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25450808|NCT04593706|Prednisolone phosphate|prednisolone phosphate|mesh-list
25450809|NCT04593706|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25450810|NCT04593706|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25450811|NCT04593706|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25450812|NCT04593706|BB 1101|bb 1101|mesh-list
25450813|NCT04593706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25450814|NCT04593706|Antiemetics|antiemetics|mesh-ancestor
25450815|NCT04593706|Autonomic Agents|autonomic agents|mesh-ancestor
25450816|NCT04593706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450817|NCT04593706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450818|NCT04593706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25450819|NCT04593706|Glucocorticoids|glucocorticoids|mesh-ancestor
25450820|NCT04593706|Hormones|hormones|mesh-ancestor
25450821|NCT04593706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25450822|NCT04593706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25450823|NCT04593706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25450824|NCT04593706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25450825|NCT04593706|Protective Agents|protective agents|mesh-ancestor
25450826|NCT04593706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25450827|NCT04593706|Immunologic Factors|immunologic factors|mesh-ancestor
25450828|NCT04593706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25450829|NCT04593706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450830|NCT04593706|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25450831|NCT04593706|Respiratory System Agents|respiratory system agents|mesh-ancestor
25450832|NCT04593706|Protease Inhibitors|protease inhibitors|mesh-ancestor
25450833|NCT04593836|Peppermint oil|peppermint oil|mesh-list
25450834|NCT04593836|Menthol|menthol|mesh-list
25450835|NCT04593836|Antipruritics|antipruritics|mesh-ancestor
25450836|NCT04593836|Dermatologic Agents|dermatologic agents|mesh-ancestor
25450837|NCT04593836|Antiemetics|antiemetics|mesh-ancestor
25450838|NCT04593836|Autonomic Agents|autonomic agents|mesh-ancestor
25450839|NCT04593836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450840|NCT04593836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450841|NCT04593836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25450842|NCT04593836|Parasympatholytics|parasympatholytics|mesh-ancestor
25450843|NCT04593654|Dalteparin|dalteparin|mesh-list
25450844|NCT04593654|Tinzaparin|tinzaparin|mesh-list
25450845|NCT04593654|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25450846|NCT04593654|Anticoagulants|anticoagulants|mesh-ancestor
25450847|NCT04593654|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25644119|NCT01433250|Immunologic Factors|immunologic factors|mesh-ancestor
25450848|NCT04593654|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25644120|NCT01433250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644122|NCT01433913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25644123|NCT01433913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644124|NCT01433978|Maleic acid|maleic acid|mesh-list
25644125|NCT01433978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25644126|NCT01433978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644127|NCT01433991|Lenvatinib|lenvatinib|mesh-list
25644128|NCT01433991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25450849|NCT04593654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450850|NCT04593238|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25450851|NCT04593238|Calcium|calcium|mesh-list
25450852|NCT04593238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25450853|NCT04593238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450854|NCT04593238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25306264|NCT04398914|Paclitaxel|paclitaxel|mesh-list
25306265|NCT04398914|Trastuzumab|trastuzumab|mesh-list
25306266|NCT04398914|Pertuzumab|pertuzumab|mesh-list
25306267|NCT04398914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25306268|NCT04398914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306269|NCT04398914|Tubulin Modulators|tubulin modulators|mesh-ancestor
25306277|NCT04390399|Leucovorin|leucovorin|mesh-list
25450855|NCT04593524|Vitamin D|vitamin d|mesh-list
25450856|NCT04593524|Vitamins|vitamins|mesh-ancestor
25450857|NCT04593524|Micronutrients|micronutrients|mesh-ancestor
25450858|NCT04593524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450859|NCT04593524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25450860|NCT04593446|Picosulfate sodium|picosulfate sodium|mesh-list
25450862|NCT04593446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25450863|NCT04593160|Acetaminophen|acetaminophen|mesh-list
25450864|NCT04593160|Diclofenac|diclofenac|mesh-list
25450865|NCT04593160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25450866|NCT04593160|Analgesics|analgesics|mesh-ancestor
25450867|NCT04593160|Sensory System Agents|sensory system agents|mesh-ancestor
25450868|NCT04593160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450869|NCT04593160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450870|NCT04593160|Antipyretics|antipyretics|mesh-ancestor
25450871|NCT04593160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25450872|NCT04593160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25450873|NCT04593160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25450874|NCT04593160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25450875|NCT04593160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25450876|NCT04593160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450877|NCT04593108|Letrozole|letrozole|mesh-list
25450878|NCT04593108|Misoprostol|misoprostol|mesh-list
25450879|NCT04593108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25450880|NCT04593108|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25450881|NCT04593108|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25450882|NCT04593108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25450883|NCT04593108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450884|NCT04593108|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25450885|NCT04593108|Hormone Antagonists|hormone antagonists|mesh-ancestor
25450886|NCT04593108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25450887|NCT04593108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450888|NCT04593108|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25450889|NCT04593108|Abortifacient Agents|abortifacient agents|mesh-ancestor
25450890|NCT04593108|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25450891|NCT04593108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25450892|NCT04593108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25450893|NCT04593108|Oxytocics|oxytocics|mesh-ancestor
25450894|NCT04592952|Calcitonin|calcitonin|mesh-list
25450895|NCT04592952|Salmon calcitonin|salmon calcitonin|mesh-list
25450896|NCT04592952|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
25450897|NCT04592952|Erenumab|erenumab|mesh-list
25450898|NCT04592952|Katacalcin|katacalcin|mesh-list
25450899|NCT04592952|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25450900|NCT04592952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450901|NCT04592952|Analgesics|analgesics|mesh-ancestor
25450902|NCT04592952|Sensory System Agents|sensory system agents|mesh-ancestor
25450903|NCT04592952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450904|NCT04592952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450905|NCT04592952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25450906|NCT04592952|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25450907|NCT04592952|Vasodilator Agents|vasodilator agents|mesh-ancestor
25450908|NCT04593030|Warfarin|warfarin|mesh-list
25450909|NCT04593030|Apixaban|apixaban|mesh-list
25450910|NCT04593030|Anticoagulants|anticoagulants|mesh-ancestor
25450911|NCT04593030|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25450912|NCT04593030|Antithrombins|antithrombins|mesh-ancestor
25450913|NCT04593030|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25450914|NCT04593030|Protease Inhibitors|protease inhibitors|mesh-ancestor
25450915|NCT04593030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25450916|NCT04593030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450917|NCT04592822|Dabigatran|dabigatran|mesh-list
25450918|NCT04592822|Antithrombins|antithrombins|mesh-ancestor
25450919|NCT04592822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25450920|NCT04592822|Protease Inhibitors|protease inhibitors|mesh-ancestor
25450921|NCT04592822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25450922|NCT04592822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306340|NCT04282629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25306341|NCT04282629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25306342|NCT04282629|Vasodilator Agents|vasodilator agents|mesh-ancestor
25306343|NCT04282629|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25306344|NCT04282629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25306345|NCT04282629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25306346|NCT04282629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306347|NCT04282629|Protective Agents|protective agents|mesh-ancestor
25450923|NCT04592822|Anticoagulants|anticoagulants|mesh-ancestor
25450924|NCT04592666|Carboplatin|carboplatin|mesh-list
25450925|NCT04592666|Pemetrexed|pemetrexed|mesh-list
25450926|NCT04592666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25450927|NCT04592666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25450928|NCT04592666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450929|NCT04592666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25450930|NCT04592666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25450931|NCT04593056|Warfarin|warfarin|mesh-list
25450932|NCT04593056|Rivaroxaban|rivaroxaban|mesh-list
25450933|NCT04593056|Anticoagulants|anticoagulants|mesh-ancestor
25450934|NCT04593056|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25450935|NCT04593056|Antithrombins|antithrombins|mesh-ancestor
25450936|NCT04593056|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25450937|NCT04593056|Protease Inhibitors|protease inhibitors|mesh-ancestor
25450938|NCT04593056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25450939|NCT04593056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450940|NCT04593043|Warfarin|warfarin|mesh-list
25450941|NCT04593043|Dabigatran|dabigatran|mesh-list
25450942|NCT04593043|Anticoagulants|anticoagulants|mesh-ancestor
25450943|NCT04593043|Antithrombins|antithrombins|mesh-ancestor
25450944|NCT04593043|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25450945|NCT04593043|Protease Inhibitors|protease inhibitors|mesh-ancestor
25450946|NCT04593043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25450947|NCT04593043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450948|NCT04592211|Paclitaxel|paclitaxel|mesh-list
25450949|NCT04592211|Pembrolizumab|pembrolizumab|mesh-list
25450950|NCT04592211|Olaparib|olaparib|mesh-list
25450951|NCT04592211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25450952|NCT04592211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25450953|NCT04592211|Tubulin Modulators|tubulin modulators|mesh-ancestor
25450954|NCT04592211|Antimitotic Agents|antimitotic agents|mesh-ancestor
25450955|NCT04592211|Mitosis Modulators|mitosis modulators|mesh-ancestor
25450956|NCT04592211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450957|NCT04592211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25450958|NCT04592211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25450959|NCT04592211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25450960|NCT04592380|Clevidipine|clevidipine|mesh-list
25450961|NCT04592380|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25450962|NCT04592380|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25450963|NCT04592380|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25450964|NCT04592380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25450965|NCT04592380|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25450966|NCT04592380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25450967|NCT04592380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450968|NCT04592380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25450969|NCT04592380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450970|NCT04592198|Palonosetron|palonosetron|mesh-list
25450971|NCT04592198|Antiemetics|antiemetics|mesh-ancestor
25450972|NCT04592198|Autonomic Agents|autonomic agents|mesh-ancestor
25450973|NCT04592198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450974|NCT04592198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450975|NCT04592198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25450976|NCT04592198|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25450977|NCT04592198|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25450978|NCT04592198|Serotonin Agents|serotonin agents|mesh-ancestor
25450979|NCT04592198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25450980|NCT04592198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25450981|NCT04591990|Hydrocortisone|hydrocortisone|mesh-list
25450982|NCT04591990|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25450983|NCT04591990|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25450984|NCT04591990|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25450985|NCT04591990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25306414|NCT04227756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306423|NCT04208997|Amiodarone|amiodarone|mesh-list
25306424|NCT04208997|Sotalol|sotalol|mesh-list
25306425|NCT04208997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
25306426|NCT04208997|Vasodilator Agents|vasodilator agents|mesh-ancestor
25306427|NCT04208997|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25306428|NCT04208997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25306429|NCT04208997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306430|NCT04208997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25306431|NCT04208997|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25306445|NCT04201873|Poly I-C|poly i-c|mesh-list
25450987|NCT04592081|Dexamethasone acetate|dexamethasone acetate|mesh-list
25450988|NCT04592081|BB 1101|bb 1101|mesh-list
25450989|NCT04592081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25450990|NCT04592081|Antiemetics|antiemetics|mesh-ancestor
25450991|NCT04592081|Autonomic Agents|autonomic agents|mesh-ancestor
25450992|NCT04592081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25450993|NCT04592081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25450994|NCT04592081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25450995|NCT04592081|Glucocorticoids|glucocorticoids|mesh-ancestor
25450996|NCT04592081|Hormones|hormones|mesh-ancestor
25450997|NCT04592081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25450998|NCT04592081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25450999|NCT04592081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451000|NCT04592081|Protease Inhibitors|protease inhibitors|mesh-ancestor
25451001|NCT04592081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451002|NCT04592081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451003|NCT04591795|Diclofenac|diclofenac|mesh-list
25451004|NCT04591795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25451005|NCT04591795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25451006|NCT04591795|Analgesics|analgesics|mesh-ancestor
25451007|NCT04591795|Sensory System Agents|sensory system agents|mesh-ancestor
25451008|NCT04591795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451009|NCT04591795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451010|NCT04591795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25451011|NCT04591795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25451012|NCT04591795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25451013|NCT04591795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451014|NCT04591795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451015|NCT04591743|Nicotine|nicotine|mesh-list
25451016|NCT04591743|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25451017|NCT04591743|Autonomic Agents|autonomic agents|mesh-ancestor
25451018|NCT04591743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451019|NCT04591743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451020|NCT04591743|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25451021|NCT04591743|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25451022|NCT04591743|Cholinergic Agents|cholinergic agents|mesh-ancestor
25451023|NCT04591743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25451024|NCT04591743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451025|NCT04591639|Dapagliflozin|dapagliflozin|mesh-list
25451026|NCT04591639|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25451027|NCT04591639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451028|NCT04591639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25451029|NCT04591639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451030|NCT04592029|Bevacizumab|bevacizumab|mesh-list
25451031|NCT04592029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25451032|NCT04592029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451033|NCT04592029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25451034|NCT04592029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25451035|NCT04592029|Growth Substances|growth substances|mesh-ancestor
25451036|NCT04592029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451037|NCT04592029|Growth Inhibitors|growth inhibitors|mesh-ancestor
25451038|NCT04591847|Vitamin D|vitamin d|mesh-list
25451039|NCT04591847|Ergocalciferols|ergocalciferols|mesh-list
25451040|NCT04591847|Vitamins|vitamins|mesh-ancestor
25451041|NCT04591847|Micronutrients|micronutrients|mesh-ancestor
25451042|NCT04591847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451043|NCT04591847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25451044|NCT04591847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25451045|NCT04591535|Levodopa|levodopa|mesh-list
25451046|NCT04591535|Carbidopa|carbidopa|mesh-list
25451047|NCT04591535|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25451048|NCT04591535|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25451049|NCT04591535|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25451050|NCT04591535|Dopamine Agents|dopamine agents|mesh-ancestor
25451051|NCT04591535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25451052|NCT04591535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451053|NCT04591535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451054|NCT04591535|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25451055|NCT04591535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451056|NCT04591535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25451057|NCT04591535|Immunologic Factors|immunologic factors|mesh-ancestor
25451058|NCT04591535|Dopamine Agonists|dopamine agonists|mesh-ancestor
25451059|NCT04591444|Fluorides|fluorides|mesh-list
25451061|NCT04591444|Cariostatic Agents|cariostatic agents|mesh-ancestor
25451062|NCT04591444|Protective Agents|protective agents|mesh-ancestor
25451063|NCT04591444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451064|NCT04591457|Insulin|insulin|mesh-list
25451065|NCT04591457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25451066|NCT04591457|Insulin Glargine|insulin glargine|mesh-list
25451067|NCT04591457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25451068|NCT04591457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451069|NCT04591327|Anesthetics|anesthetics|mesh-list
25451070|NCT04591327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25451071|NCT04591327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451072|NCT04591600|Ivermectin|ivermectin|mesh-list
25451073|NCT04591600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25451074|NCT04591600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25451075|NCT04591405|Vaccines|vaccines|mesh-list
25451076|NCT04591405|Immunologic Factors|immunologic factors|mesh-ancestor
25451077|NCT04591405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451078|NCT04590742|Melatonin|melatonin|mesh-list
25451079|NCT04590742|Antioxidants|antioxidants|mesh-ancestor
25451080|NCT04590742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451081|NCT04590742|Protective Agents|protective agents|mesh-ancestor
25451082|NCT04590742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451083|NCT04590742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25451084|NCT04590638|Epinephrine|epinephrine|mesh-list
25451085|NCT04590638|Racepinephrine|racepinephrine|mesh-list
25451086|NCT04590638|Epinephryl borate|epinephryl borate|mesh-list
25451087|NCT04590638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25451088|NCT04590638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25451089|NCT04590638|Adrenergic Agents|adrenergic agents|mesh-ancestor
25451090|NCT04590638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25451091|NCT04590638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451092|NCT04590638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451093|NCT04590638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25451094|NCT04590638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25451095|NCT04590638|Autonomic Agents|autonomic agents|mesh-ancestor
25451096|NCT04590638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451097|NCT04590638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25451098|NCT04590638|Respiratory System Agents|respiratory system agents|mesh-ancestor
25451099|NCT04590638|Mydriatics|mydriatics|mesh-ancestor
25451100|NCT04590638|Sympathomimetics|sympathomimetics|mesh-ancestor
25451101|NCT04590638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25451102|NCT04590937|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25451103|NCT04590937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25451104|NCT04590937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25451105|NCT04590937|Antimetabolites|antimetabolites|mesh-ancestor
25451106|NCT04590937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451107|NCT04590937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25451108|NCT04590937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25451109|NCT04590937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451110|NCT04590612|Levodopa|levodopa|mesh-list
25451111|NCT04590612|Carbidopa|carbidopa|mesh-list
25451112|NCT04590612|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25451113|NCT04590612|Citalopram|citalopram|mesh-list
25451114|NCT04590612|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
25451115|NCT04590612|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25451116|NCT04590612|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25451118|NCT04590612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25451119|NCT04590612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451120|NCT04590612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451121|NCT04590612|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25451122|NCT04590612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451123|NCT04590612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25451124|NCT04590612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25306563|NCT04079738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306564|NCT04079738|Protease Inhibitors|protease inhibitors|mesh-ancestor
25306565|NCT04079738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25306566|NCT04079738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822849|NCT00004686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24472638|NCT00399945|Tobramycin|tobramycin|mesh-list
25822850|NCT00004686|Glucocorticoids|glucocorticoids|mesh-ancestor
25306605|NCT05431413|Phosphocreatine|phosphocreatine|mesh-list
25451125|NCT04590612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25451127|NCT04590612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25451128|NCT04590612|Antidepressive Agents|antidepressive agents|mesh-ancestor
25451129|NCT04590612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25451130|NCT04590612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25451131|NCT04590612|Immunologic Factors|immunologic factors|mesh-ancestor
25451132|NCT04590612|Dopamine Agonists|dopamine agonists|mesh-ancestor
25451133|NCT04590625|Carboplatin|carboplatin|mesh-list
25451134|NCT04590625|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25451135|NCT04590625|Apatinib|apatinib|mesh-list
25451136|NCT04590625|Cisplatin|cisplatin|mesh-list
25451137|NCT04590625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451138|NCT04590625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451139|NCT04590625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25451140|NCT04590625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451141|NCT04590183|Prednisolone|prednisolone|mesh-list
25451142|NCT04590183|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25451143|NCT04590183|Methylprednisolone|methylprednisolone|mesh-list
25451144|NCT04590183|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25451145|NCT04590183|Prednisolone acetate|prednisolone acetate|mesh-list
25451146|NCT04590183|Tacrolimus|tacrolimus|mesh-list
25451147|NCT04590183|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25451148|NCT04590183|Prednisolone phosphate|prednisolone phosphate|mesh-list
25451149|NCT04590183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25451150|NCT04590183|Immunologic Factors|immunologic factors|mesh-ancestor
25451151|NCT04590183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451152|NCT04590183|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25451153|NCT04590183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451154|NCT04590183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451155|NCT04590183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25451156|NCT04590183|Glucocorticoids|glucocorticoids|mesh-ancestor
25451157|NCT04590183|Hormones|hormones|mesh-ancestor
25451158|NCT04590183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25451159|NCT04590183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25451160|NCT04590183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451161|NCT04590183|Antiemetics|antiemetics|mesh-ancestor
25451162|NCT04590183|Autonomic Agents|autonomic agents|mesh-ancestor
25451163|NCT04590183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451164|NCT04590183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25451165|NCT04590183|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25451166|NCT04590183|Protective Agents|protective agents|mesh-ancestor
25451167|NCT04590508|Xanthohumol|xanthohumol|mesh-list
25451168|NCT04590508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451169|NCT04590508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25451170|NCT04590508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25451171|NCT04590508|Growth Substances|growth substances|mesh-ancestor
25451172|NCT04590508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451173|NCT04590508|Growth Inhibitors|growth inhibitors|mesh-ancestor
25451174|NCT04590482|Letrozole|letrozole|mesh-list
25451175|NCT04590482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451176|NCT04590482|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25451177|NCT04590482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25451178|NCT04590482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451179|NCT04590482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451180|NCT04590482|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25451181|NCT04590482|Hormone Antagonists|hormone antagonists|mesh-ancestor
25451182|NCT04590482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25822851|NCT00004686|Hormones|hormones|mesh-ancestor
25644129|NCT01433991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25644130|NCT01433991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657148|NCT01583374|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25451183|NCT04590482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451184|NCT04590196|Curcumin|curcumin|mesh-list
25451185|NCT04590196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25451186|NCT04590196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25451187|NCT04590196|Analgesics|analgesics|mesh-ancestor
25451188|NCT04590196|Sensory System Agents|sensory system agents|mesh-ancestor
25451189|NCT04590196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451190|NCT04590196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451191|NCT04590196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25451192|NCT04590196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25451193|NCT04590196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451194|NCT04590196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451195|NCT04590196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451196|NCT04589819|Teriparatide|teriparatide|mesh-list
25306632|NCT05431322|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25306633|NCT05431322|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25306634|NCT05431322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25451201|NCT04589728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451202|NCT04589429|Morphine|morphine|mesh-list
25451203|NCT04589429|Nalbuphine|nalbuphine|mesh-list
25451204|NCT04589429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25451205|NCT04589429|Narcotics|narcotics|mesh-ancestor
25451206|NCT04589429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25451207|NCT04589429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451208|NCT04589429|Analgesics|analgesics|mesh-ancestor
25451209|NCT04589429|Sensory System Agents|sensory system agents|mesh-ancestor
25451210|NCT04589429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451211|NCT04589390|Selexipag|selexipag|mesh-list
25451212|NCT04589390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25451213|NCT04589546|Niacinamide|niacinamide|mesh-list
25451214|NCT04589546|Niacin|niacin|mesh-list
25451215|NCT04589546|Nicotinic Acids|nicotinic acids|mesh-list
25451216|NCT04589546|Vitamin B Complex|vitamin b complex|mesh-ancestor
25451217|NCT04589546|Vitamins|vitamins|mesh-ancestor
25451218|NCT04589546|Micronutrients|micronutrients|mesh-ancestor
25451219|NCT04589546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451220|NCT04589546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25451221|NCT04589546|Antimetabolites|antimetabolites|mesh-ancestor
25451222|NCT04589546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451223|NCT04589546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25451224|NCT04589546|Vasodilator Agents|vasodilator agents|mesh-ancestor
25451225|NCT04589494|Morphine|morphine|mesh-list
25451226|NCT04589494|Tramadol|tramadol|mesh-list
25451227|NCT04589494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25451228|NCT04589494|Narcotics|narcotics|mesh-ancestor
25451229|NCT04589494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25451230|NCT04589494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451231|NCT04589494|Analgesics|analgesics|mesh-ancestor
25451232|NCT04589494|Sensory System Agents|sensory system agents|mesh-ancestor
25451233|NCT04589494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451234|NCT04589299|Immunoglobulins|immunoglobulins|mesh-list
25451235|NCT04589299|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25451236|NCT04589299|Antibodies|antibodies|mesh-list
25451237|NCT04589299|Immunologic Factors|immunologic factors|mesh-ancestor
25451238|NCT04589299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451239|NCT04589143|S 20098|s 20098|mesh-list
25451240|NCT04589143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25451241|NCT04589143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25451242|NCT04589143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451243|NCT04589130|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
25451244|NCT04589130|Naltrexone|naltrexone|mesh-list
25451245|NCT04589130|Bupropion|bupropion|mesh-list
25451246|NCT04589130|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25451247|NCT04589130|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25451248|NCT04589130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451249|NCT04589130|Sensory System Agents|sensory system agents|mesh-ancestor
25451250|NCT04589130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451251|NCT04589130|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25451252|NCT04589130|Antidepressive Agents|antidepressive agents|mesh-ancestor
25451253|NCT04589130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25451254|NCT04589130|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25451255|NCT04589130|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25165365|NCT04871607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451256|NCT04589130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25451257|NCT04589130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451258|NCT04589130|Dopamine Agents|dopamine agents|mesh-ancestor
25451259|NCT04589130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25451260|NCT04589130|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25451261|NCT04589130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25451262|NCT04589130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451263|NCT04589130|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25451264|NCT04589234|Gemcitabine|gemcitabine|mesh-list
25451265|NCT04589234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25451266|NCT04589234|Folfirinox|folfirinox|mesh-list
25451267|NCT04589234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25451268|NCT04589234|Antimetabolites|antimetabolites|mesh-ancestor
25306779|NCT05430048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306780|NCT05430048|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25306781|NCT05430048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25306782|NCT05430048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25306783|NCT05430048|Adrenergic Agents|adrenergic agents|mesh-ancestor
25306784|NCT05430048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25306786|NCT05430048|Hemostatics|hemostatics|mesh-ancestor
25451269|NCT04589234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451270|NCT04589234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451271|NCT04589234|Antiviral Agents|antiviral agents|mesh-ancestor
25451272|NCT04589234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25451273|NCT04589234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451274|NCT04589234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25451275|NCT04589234|Immunologic Factors|immunologic factors|mesh-ancestor
25451276|NCT04589234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451278|NCT04588935|Perindopril|perindopril|mesh-list
25451279|NCT04588935|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25451280|NCT04588935|Sympatholytics|sympatholytics|mesh-ancestor
25451281|NCT04588935|Autonomic Agents|autonomic agents|mesh-ancestor
25451282|NCT04588935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451283|NCT04588935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451284|NCT04588935|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25451285|NCT04588935|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25451286|NCT04588935|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25451287|NCT04588935|Adrenergic Agents|adrenergic agents|mesh-ancestor
25451288|NCT04588935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25451289|NCT04588935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451290|NCT04588935|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25451291|NCT04588935|Protease Inhibitors|protease inhibitors|mesh-ancestor
25451292|NCT04588935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451293|NCT04588987|Apatinib|apatinib|mesh-list
25451294|NCT04588987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451295|NCT04588987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25451296|NCT04588987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451297|NCT04588987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451298|NCT04588532|Doxepin|doxepin|mesh-list
25451299|NCT04588532|Histamine|histamine|mesh-list
25451300|NCT04588532|Histamine Agonists|histamine agonists|mesh-ancestor
25451301|NCT04588532|Histamine Agents|histamine agents|mesh-ancestor
25451302|NCT04588532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25451303|NCT04588532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451304|NCT04588532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451305|NCT04588532|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25451306|NCT04588532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25451307|NCT04588532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25451308|NCT04588532|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25451309|NCT04588532|Antidepressive Agents|antidepressive agents|mesh-ancestor
25451310|NCT04588532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25451311|NCT04588532|Histamine Antagonists|histamine antagonists|mesh-ancestor
25451312|NCT04588636|Salicylic Acid|salicylic acid|mesh-list
25451313|NCT04588636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25451314|NCT04588636|Antifungal Agents|antifungal agents|mesh-ancestor
25451315|NCT04588636|Keratolytic Agents|keratolytic agents|mesh-ancestor
25451316|NCT04588636|Dermatologic Agents|dermatologic agents|mesh-ancestor
25451317|NCT04588441|Adenosine|adenosine|mesh-list
25451318|NCT04588441|Analgesics|analgesics|mesh-ancestor
25451319|NCT04588441|Sensory System Agents|sensory system agents|mesh-ancestor
25451320|NCT04588441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451321|NCT04588441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451322|NCT04588441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25451323|NCT04588441|Vasodilator Agents|vasodilator agents|mesh-ancestor
25451324|NCT04588441|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25451325|NCT04588441|Purinergic Agonists|purinergic agonists|mesh-ancestor
25306854|NCT05357833|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25306855|NCT05357833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25306856|NCT05353764|Ropivacaine|ropivacaine|mesh-list
25306857|NCT05353764|Anesthetics, Local|anesthetics, local|mesh-ancestor
25306858|NCT05353764|Anesthetics|anesthetics|mesh-ancestor
25306859|NCT05353764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25306860|NCT05353764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306861|NCT05353764|Sensory System Agents|sensory system agents|mesh-ancestor
25306862|NCT05353764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24431175|NCT00250744|Gabapentin|gabapentin|mesh-list
25306880|NCT05342844|Dexmedetomidine|dexmedetomidine|mesh-list
25306881|NCT05342844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25306882|NCT05342844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25306883|NCT05342844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306884|NCT05342844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25306885|NCT05342844|Analgesics|analgesics|mesh-ancestor
25306886|NCT05342844|Sensory System Agents|sensory system agents|mesh-ancestor
25451327|NCT04588441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25451328|NCT04588441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451329|NCT04588389|Lidocaine|lidocaine|mesh-list
25451330|NCT04588389|Ropivacaine|ropivacaine|mesh-list
25451331|NCT04588389|Anesthetics, Local|anesthetics, local|mesh-ancestor
25451332|NCT04588389|Anesthetics|anesthetics|mesh-ancestor
25451333|NCT04588389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25451334|NCT04588389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451335|NCT04588389|Sensory System Agents|sensory system agents|mesh-ancestor
25451336|NCT04588389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451337|NCT04588389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25451338|NCT04588389|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25451339|NCT04588389|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25451340|NCT04588389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25451341|NCT04588389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451342|NCT04588220|Plasminogen|plasminogen|mesh-list
25451343|NCT04588220|Melatonin|melatonin|mesh-list
25451344|NCT04588220|Antioxidants|antioxidants|mesh-ancestor
25451345|NCT04588220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451346|NCT04588220|Protective Agents|protective agents|mesh-ancestor
25451347|NCT04588220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451348|NCT04588220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25451349|NCT04588220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25451350|NCT04588220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25451351|NCT04588194|Dexamethasone|dexamethasone|mesh-list
25451352|NCT04588194|Rituximab|rituximab|mesh-list
25451353|NCT04588194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25451354|NCT04588194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451355|NCT04588194|Immunologic Factors|immunologic factors|mesh-ancestor
25451356|NCT04588194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451357|NCT04588194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25451358|NCT04588194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25451359|NCT04588194|Antiemetics|antiemetics|mesh-ancestor
25451360|NCT04588194|Autonomic Agents|autonomic agents|mesh-ancestor
25451361|NCT04588194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451362|NCT04588194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25451363|NCT04588194|Glucocorticoids|glucocorticoids|mesh-ancestor
25451364|NCT04588194|Hormones|hormones|mesh-ancestor
25451365|NCT04588194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25451366|NCT04588194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25451367|NCT04588090|Cisplatin|cisplatin|mesh-list
25451368|NCT04588090|Paclitaxel|paclitaxel|mesh-list
25451369|NCT04588090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451370|NCT04588090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25451371|NCT04588090|Tubulin Modulators|tubulin modulators|mesh-ancestor
25451372|NCT04588090|Antimitotic Agents|antimitotic agents|mesh-ancestor
25451373|NCT04588090|Mitosis Modulators|mitosis modulators|mesh-ancestor
25451374|NCT04588090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451375|NCT04588285|Ambroxol|ambroxol|mesh-list
25451376|NCT04588285|Expectorants|expectorants|mesh-ancestor
25451377|NCT04588285|Respiratory System Agents|respiratory system agents|mesh-ancestor
25451378|NCT04588324|Antineoplastic Agents|antineoplastic agents|mesh-list
25451379|NCT04587843|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
25451380|NCT04587843|Naltrexone|naltrexone|mesh-list
25451381|NCT04587843|Bupropion|bupropion|mesh-list
25451382|NCT04587843|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25644131|NCT01433991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644133|NCT01434121|Vitamins|vitamins|mesh-ancestor
25644134|NCT01434121|Micronutrients|micronutrients|mesh-ancestor
25644135|NCT01434121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644136|NCT01434121|Antioxidants|antioxidants|mesh-ancestor
25644137|NCT01434121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451383|NCT04587843|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25451384|NCT04587843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451385|NCT04587843|Sensory System Agents|sensory system agents|mesh-ancestor
25451386|NCT04587843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451387|NCT04587843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25451388|NCT04587843|Antidepressive Agents|antidepressive agents|mesh-ancestor
25451389|NCT04587843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25451390|NCT04587843|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25451391|NCT04587843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25451392|NCT04587843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25306930|NCT05245734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306931|NCT05239884|Nicotine|nicotine|mesh-list
25306932|NCT05239884|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25306933|NCT05239884|Autonomic Agents|autonomic agents|mesh-ancestor
25306934|NCT05239884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25306935|NCT05239884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451418|NCT04587505|Tramadol|tramadol|mesh-list
25451419|NCT04587505|Anesthetics|anesthetics|mesh-list
25451420|NCT04587505|Ropivacaine|ropivacaine|mesh-list
25451421|NCT04587505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25451422|NCT04587505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451423|NCT04587505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25451424|NCT04587505|Narcotics|narcotics|mesh-ancestor
25451425|NCT04587505|Analgesics|analgesics|mesh-ancestor
25451426|NCT04587505|Sensory System Agents|sensory system agents|mesh-ancestor
25451427|NCT04587505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451428|NCT04587505|Anesthetics, Local|anesthetics, local|mesh-ancestor
25307005|NCT05188313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25822852|NCT00004686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25307006|NCT05153408|Carboplatin|carboplatin|mesh-list
25307007|NCT05153408|Pemetrexed|pemetrexed|mesh-list
25307008|NCT05153408|Osimertinib|osimertinib|mesh-list
25307009|NCT05153408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307010|NCT05153408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25307011|NCT05153408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307012|NCT05153408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25307013|NCT05153408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25307014|NCT05153408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25451429|NCT04587141|Ferric gluconate|ferric gluconate|mesh-list
25451430|NCT04587141|Hematinics|hematinics|mesh-ancestor
25451431|NCT04587115|Oxycodone|oxycodone|mesh-list
25451432|NCT04587115|Risperidone|risperidone|mesh-list
25451433|NCT04587115|Ziprasidone|ziprasidone|mesh-list
25451434|NCT04587115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25451435|NCT04587115|Narcotics|narcotics|mesh-ancestor
25451436|NCT04587115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25451437|NCT04587115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451438|NCT04587115|Analgesics|analgesics|mesh-ancestor
25451439|NCT04587115|Sensory System Agents|sensory system agents|mesh-ancestor
25451440|NCT04587115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451441|NCT04587115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25451442|NCT04587115|Serotonin Agents|serotonin agents|mesh-ancestor
25451443|NCT04587115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25451444|NCT04587115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451445|NCT04587115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25451446|NCT04587115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25451447|NCT04587115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25451448|NCT04587115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25451449|NCT04587115|Dopamine Agents|dopamine agents|mesh-ancestor
25451450|NCT04586543|Docetaxel|docetaxel|mesh-list
25451451|NCT04586543|Selegiline|selegiline|mesh-list
25451452|NCT04586543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451453|NCT04586543|Tubulin Modulators|tubulin modulators|mesh-ancestor
25451454|NCT04586543|Antimitotic Agents|antimitotic agents|mesh-ancestor
25451455|NCT04586543|Mitosis Modulators|mitosis modulators|mesh-ancestor
25451456|NCT04586543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451457|NCT04586543|Antidepressive Agents|antidepressive agents|mesh-ancestor
25451458|NCT04586543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25644138|NCT01434121|Protective Agents|protective agents|mesh-ancestor
25451459|NCT04586543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25451460|NCT04586543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25451461|NCT04586543|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25451462|NCT04586543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451463|NCT04586543|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25451464|NCT04586543|Protective Agents|protective agents|mesh-ancestor
25451465|NCT04586543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451466|NCT04586504|Midazolam|midazolam|mesh-list
25451467|NCT04586504|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25451468|NCT04586504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25451469|NCT04586504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25451470|NCT04586504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451471|NCT04586504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25451472|NCT04586504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25451473|NCT04586504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25451474|NCT04586504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25451475|NCT04586504|Anesthetics, General|anesthetics, general|mesh-ancestor
25451476|NCT04586504|Anesthetics|anesthetics|mesh-ancestor
25451477|NCT04586504|GABA Modulators|gaba modulators|mesh-ancestor
25451478|NCT04586504|GABA Agents|gaba agents|mesh-ancestor
25451479|NCT04586504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25451480|NCT04586504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451481|NCT04586790|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25451482|NCT04586790|Epinephrine|epinephrine|mesh-list
25451483|NCT04586790|Racepinephrine|racepinephrine|mesh-list
25451484|NCT04586790|Midodrine|midodrine|mesh-list
25451485|NCT04586790|Norepinephrine|norepinephrine|mesh-list
25451486|NCT04586790|Epinephryl borate|epinephryl borate|mesh-list
25451487|NCT04586790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25307077|NCT04971343|Immunoglobulins|immunoglobulins|mesh-list
25307078|NCT04971343|Immunologic Factors|immunologic factors|mesh-ancestor
25307079|NCT04971343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307098|NCT04954599|Carboplatin|carboplatin|mesh-list
25307099|NCT04954599|Pembrolizumab|pembrolizumab|mesh-list
25307100|NCT04954599|Nivolumab|nivolumab|mesh-list
25307101|NCT04954599|Ipilimumab|ipilimumab|mesh-list
25307102|NCT04954599|Atezolizumab|atezolizumab|mesh-list
25307103|NCT04954599|Durvalumab|durvalumab|mesh-list
25307104|NCT04954599|Avelumab|avelumab|mesh-list
25307105|NCT04954599|Cemiplimab|cemiplimab|mesh-list
25307106|NCT04954599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25307107|NCT04954599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307108|NCT04954599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25307109|NCT04954599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307111|NCT04941573|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25307112|NCT04941573|Anesthetics, General|anesthetics, general|mesh-ancestor
25307113|NCT04941573|Anesthetics|anesthetics|mesh-ancestor
25307135|NCT04884139|Tenofovir|tenofovir|mesh-list
25451488|NCT04586790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25451489|NCT04586790|Adrenergic Agents|adrenergic agents|mesh-ancestor
25451490|NCT04586790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25451491|NCT04586790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451492|NCT04586790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451493|NCT04586790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25451494|NCT04586790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25451495|NCT04586790|Autonomic Agents|autonomic agents|mesh-ancestor
25451496|NCT04586790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451497|NCT04586790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25451498|NCT04586790|Respiratory System Agents|respiratory system agents|mesh-ancestor
25451499|NCT04586790|Mydriatics|mydriatics|mesh-ancestor
25451500|NCT04586790|Sympathomimetics|sympathomimetics|mesh-ancestor
25451501|NCT04586790|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25451502|NCT04586790|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25451503|NCT04586790|Hemostatics|hemostatics|mesh-ancestor
25451504|NCT04586790|Coagulants|coagulants|mesh-ancestor
25451505|NCT04586790|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25451506|NCT04586790|Natriuretic Agents|natriuretic agents|mesh-ancestor
25451507|NCT04586491|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25451508|NCT04586465|Gemcitabine|gemcitabine|mesh-list
25451509|NCT04586465|Cisplatin|cisplatin|mesh-list
25451510|NCT04586465|Carboplatin|carboplatin|mesh-list
25451511|NCT04586465|Pembrolizumab|pembrolizumab|mesh-list
25451512|NCT04586465|Pemetrexed|pemetrexed|mesh-list
25451513|NCT04586465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451514|NCT04586465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25451515|NCT04586465|Antimetabolites|antimetabolites|mesh-ancestor
25451516|NCT04586465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451517|NCT04586465|Antiviral Agents|antiviral agents|mesh-ancestor
25451518|NCT04586465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25451519|NCT04586465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451520|NCT04586465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25451521|NCT04586465|Immunologic Factors|immunologic factors|mesh-ancestor
25451522|NCT04586465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451523|NCT04586465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25451524|NCT04586465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25451525|NCT04586465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25451526|NCT04586218|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25451527|NCT04586335|Olaparib|olaparib|mesh-list
25451528|NCT04586335|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25451529|NCT04586335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451530|NCT04586335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451531|NCT04586335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451532|NCT04586088|Apatinib|apatinib|mesh-list
25451533|NCT04586088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451534|NCT04586088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25451535|NCT04586088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451536|NCT04586088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451537|NCT04586348|Iodine|iodine|mesh-list
25451538|NCT04586348|Cadexomer iodine|cadexomer iodine|mesh-list
25451539|NCT04586348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25451540|NCT04586348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25451541|NCT04586348|Trace Elements|trace elements|mesh-ancestor
25451542|NCT04586348|Micronutrients|micronutrients|mesh-ancestor
25451543|NCT04586348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451544|NCT04586361|Hyaluronic Acid|hyaluronic acid|mesh-list
25451545|NCT04586361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25451546|NCT04586361|Immunologic Factors|immunologic factors|mesh-ancestor
25451547|NCT04586361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451548|NCT04586361|Viscosupplements|viscosupplements|mesh-ancestor
25451549|NCT04586361|Protective Agents|protective agents|mesh-ancestor
25451550|NCT04585997|Omalizumab|omalizumab|mesh-list
25451551|NCT04585997|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25451552|NCT04585997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25451553|NCT04585997|Respiratory System Agents|respiratory system agents|mesh-ancestor
25451554|NCT04585867|Bupivacaine|bupivacaine|mesh-list
25451555|NCT04585867|Anesthetics, Local|anesthetics, local|mesh-ancestor
25451556|NCT04585867|Anesthetics|anesthetics|mesh-ancestor
25451557|NCT04585867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25451558|NCT04585867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451559|NCT04585867|Sensory System Agents|sensory system agents|mesh-ancestor
25451560|NCT04585867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451561|NCT04585932|Leuprolide|leuprolide|mesh-list
25307154|NCT04880785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307155|NCT04880785|Antiviral Agents|antiviral agents|mesh-ancestor
25451562|NCT04585932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25451563|NCT04585932|Fertility Agents|fertility agents|mesh-ancestor
25451564|NCT04585932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25451565|NCT04585932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451566|NCT04585932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25451567|NCT04585932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451569|NCT04585490|Cisplatin|cisplatin|mesh-list
25451570|NCT04585490|Carboplatin|carboplatin|mesh-list
25451571|NCT04585490|Pemetrexed|pemetrexed|mesh-list
25451572|NCT04585490|Durvalumab|durvalumab|mesh-list
25451573|NCT04585490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25451574|NCT04585490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25451575|NCT04585490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451576|NCT04585490|Tubulin Modulators|tubulin modulators|mesh-ancestor
25451577|NCT04585490|Antimitotic Agents|antimitotic agents|mesh-ancestor
25451578|NCT04585490|Mitosis Modulators|mitosis modulators|mesh-ancestor
25451579|NCT04585490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451580|NCT04585490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451581|NCT04585490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25451582|NCT04585490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25451583|NCT04585490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25451584|NCT04585490|Immunologic Factors|immunologic factors|mesh-ancestor
25451585|NCT04585490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451586|NCT04585334|Diclofenac|diclofenac|mesh-list
25451587|NCT04585334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25451588|NCT04585334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25451589|NCT04585334|Analgesics|analgesics|mesh-ancestor
25451590|NCT04585334|Sensory System Agents|sensory system agents|mesh-ancestor
25451591|NCT04585334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25644139|NCT01434186|Metformin|metformin|mesh-list
25644141|NCT01434186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25451592|NCT04585334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451593|NCT04585334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25451594|NCT04585334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25721115|NCT02481934|Immunologic Factors|immunologic factors|mesh-ancestor
25451595|NCT04585334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25451596|NCT04585334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451597|NCT04585334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451598|NCT04585542|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25451599|NCT04585542|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
25451600|NCT04585542|Laxatives|laxatives|mesh-ancestor
25451601|NCT04585542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25451602|NCT04585542|Chelating Agents|chelating agents|mesh-ancestor
25451603|NCT04585542|Sequestering Agents|sequestering agents|mesh-ancestor
25451604|NCT04585542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451605|NCT04585412|Palonosetron|palonosetron|mesh-list
25451606|NCT04585412|Antiemetics|antiemetics|mesh-ancestor
25451607|NCT04585412|Autonomic Agents|autonomic agents|mesh-ancestor
25451608|NCT04585412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451609|NCT04585412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451610|NCT04585412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25451611|NCT04585412|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25451612|NCT04585412|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25451613|NCT04585412|Serotonin Agents|serotonin agents|mesh-ancestor
25451614|NCT04585412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25451615|NCT04585412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451616|NCT04585438|Diclofenac|diclofenac|mesh-list
25451617|NCT04585438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25451618|NCT04585438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25451619|NCT04585438|Analgesics|analgesics|mesh-ancestor
25451620|NCT04585438|Sensory System Agents|sensory system agents|mesh-ancestor
25451621|NCT04585438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451622|NCT04585438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451623|NCT04585438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25451624|NCT04585438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25451625|NCT04585438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25451626|NCT04585438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25307235|NCT04688294|Valsartan|valsartan|mesh-list
25307236|NCT04688294|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25307237|NCT04688294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25307238|NCT04688294|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25307239|NCT04688294|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25307240|NCT04688294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307241|NCT04669938|Immunologic Factors|immunologic factors|mesh-list
25307242|NCT04669938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307255|NCT04629976|Tenofovir|tenofovir|mesh-list
25307256|NCT04629976|Antiviral Agents|antiviral agents|mesh-ancestor
25451627|NCT04585438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451628|NCT04585321|Diclofenac|diclofenac|mesh-list
25451629|NCT04585321|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
25451630|NCT04585321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25451631|NCT04585321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25451632|NCT04585321|Analgesics|analgesics|mesh-ancestor
25451633|NCT04585321|Sensory System Agents|sensory system agents|mesh-ancestor
25451634|NCT04585321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451635|NCT04585321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451636|NCT04585321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25451637|NCT04585321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25451638|NCT04585321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25451639|NCT04585321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451640|NCT04585321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451641|NCT04585230|Mineral Oil|mineral oil|mesh-list
25451642|NCT04585230|Emollients|emollients|mesh-ancestor
25451643|NCT04585230|Dermatologic Agents|dermatologic agents|mesh-ancestor
25451644|NCT04585152|Rituximab|rituximab|mesh-list
25451645|NCT04585152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25451646|NCT04585152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451647|NCT04585152|Immunologic Factors|immunologic factors|mesh-ancestor
25451648|NCT04585152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451649|NCT04585152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25721127|NCT02481947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25451650|NCT04584983|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25451651|NCT04584983|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24404176|NCT00162695|Epirubicin|epirubicin|mesh-list
25644142|NCT01434186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644143|NCT01434186|Incretins|incretins|mesh-ancestor
25644144|NCT01434186|Hormones|hormones|mesh-ancestor
25644145|NCT01434186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25644146|NCT01434186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25644147|NCT01434186|Protease Inhibitors|protease inhibitors|mesh-ancestor
25644148|NCT01434186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25644149|NCT01434186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656795|NCT01578850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25656796|NCT01578850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25656797|NCT01578850|Analgesics|analgesics|mesh-ancestor
25656798|NCT01578850|Sensory System Agents|sensory system agents|mesh-ancestor
25656799|NCT01578850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25656800|NCT01578850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656801|NCT01578850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25451652|NCT04584983|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25451653|NCT04584983|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25451654|NCT04585022|Cimetidine|cimetidine|mesh-list
25451655|NCT04585022|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25451656|NCT04585022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25451657|NCT04585022|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25451658|NCT04585022|Histamine Antagonists|histamine antagonists|mesh-ancestor
25451659|NCT04585022|Histamine Agents|histamine agents|mesh-ancestor
25451660|NCT04585022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25451661|NCT04585022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451662|NCT04585022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451663|NCT04585022|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25451664|NCT04585022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25451665|NCT04585022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451666|NCT04584515|Itraconazole|itraconazole|mesh-list
25451667|NCT04584515|Rifampin|rifampin|mesh-list
25451668|NCT04584515|Antifungal Agents|antifungal agents|mesh-ancestor
25451669|NCT04584515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25451670|NCT04584515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25451671|NCT04584515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25451672|NCT04584515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451673|NCT04584515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451674|NCT04584515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25451675|NCT04584515|Hormone Antagonists|hormone antagonists|mesh-ancestor
25451676|NCT04584515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25451677|NCT04584515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451678|NCT04584515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25451679|NCT04584515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25451680|NCT04584515|Antitubercular Agents|antitubercular agents|mesh-ancestor
25451681|NCT04584515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25451682|NCT04584515|Leprostatic Agents|leprostatic agents|mesh-ancestor
25451683|NCT04584515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25451684|NCT04584515|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25451685|NCT04584515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25451686|NCT04584515|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25451687|NCT04584515|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25451688|NCT04584515|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25451689|NCT04584515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25307298|NCT04579523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307299|NCT04579523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307300|NCT04579523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25721132|NCT02482129|Antiemetics|antiemetics|mesh-ancestor
25307301|NCT04579523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25307302|NCT04579523|Antimetabolites|antimetabolites|mesh-ancestor
25307303|NCT04569994|Insulin|insulin|mesh-list
25307304|NCT04569994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25307305|NCT04569994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451700|NCT04584749|Anesthetics, Local|anesthetics, local|mesh-ancestor
25451701|NCT04584749|Anesthetics|anesthetics|mesh-ancestor
25451702|NCT04584749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25451703|NCT04584749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451704|NCT04584749|Sensory System Agents|sensory system agents|mesh-ancestor
25451705|NCT04584749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451706|NCT04584749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25451707|NCT04584749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25451708|NCT04584749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25451709|NCT04584749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25451710|NCT04584749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451711|NCT04584710|Dactolisib|dactolisib|mesh-list
25451712|NCT04584710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451713|NCT04584671|Xenon|xenon|mesh-list
25451714|NCT04584671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25451715|NCT04584671|Anesthetics, General|anesthetics, general|mesh-ancestor
25451716|NCT04584671|Anesthetics|anesthetics|mesh-ancestor
25451717|NCT04584671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25451718|NCT04584671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451719|NCT04584736|Ezetimibe|ezetimibe|mesh-list
25451720|NCT04584736|Pitavastatin|pitavastatin|mesh-list
25451721|NCT04584736|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25451722|NCT04584736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25451723|NCT04584736|Antimetabolites|antimetabolites|mesh-ancestor
25451724|NCT04584736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451725|NCT04584736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25451726|NCT04584736|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25451727|NCT04584736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451728|NCT04584125|Riboflavin|riboflavin|mesh-list
25451729|NCT04584125|Flavin Mononucleotide|flavin mononucleotide|mesh-list
25451730|NCT04584125|Dextrans|dextrans|mesh-list
25451731|NCT04584125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25451732|NCT04584125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25451733|NCT04584125|Vitamin B Complex|vitamin b complex|mesh-ancestor
25451734|NCT04584125|Vitamins|vitamins|mesh-ancestor
25451735|NCT04584125|Micronutrients|micronutrients|mesh-ancestor
25451736|NCT04584125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451737|NCT04584125|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25451738|NCT04584125|Dermatologic Agents|dermatologic agents|mesh-ancestor
25451739|NCT04584125|Anticoagulants|anticoagulants|mesh-ancestor
25451740|NCT04584125|Plasma Substitutes|plasma substitutes|mesh-ancestor
25451741|NCT04584125|Blood Substitutes|blood substitutes|mesh-ancestor
25451742|NCT04584307|Pomalidomide|pomalidomide|mesh-list
25451743|NCT04584307|Elotuzumab|elotuzumab|mesh-list
25451744|NCT04584307|Immunologic Factors|immunologic factors|mesh-ancestor
25451745|NCT04584307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451746|NCT04584307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25451747|NCT04584307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25451748|NCT04584307|Growth Substances|growth substances|mesh-ancestor
25451749|NCT04584307|Growth Inhibitors|growth inhibitors|mesh-ancestor
25451750|NCT04584307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451751|NCT04584034|Albuterol|albuterol|mesh-list
25451752|NCT04584034|Bronchodilator Agents|bronchodilator agents|mesh-list
25451753|NCT04584034|Autonomic Agents|autonomic agents|mesh-ancestor
25451754|NCT04584034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451755|NCT04584034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451756|NCT04584034|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25451757|NCT04584034|Respiratory System Agents|respiratory system agents|mesh-ancestor
25451758|NCT04584034|Tocolytic Agents|tocolytic agents|mesh-ancestor
25451759|NCT04584034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25451760|NCT04584034|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25451761|NCT04584034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25451762|NCT04584034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25451763|NCT04584034|Adrenergic Agents|adrenergic agents|mesh-ancestor
25451764|NCT04584034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25307447|NCT04132791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307448|NCT04132791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25307449|NCT04132791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25307450|NCT04132791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25307451|NCT04132791|Antipyretics|antipyretics|mesh-ancestor
25307452|NCT04129515|Pembrolizumab|pembrolizumab|mesh-list
25307453|NCT04129515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25307454|NCT04129515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307465|NCT04121507|Cyclophosphamide|cyclophosphamide|mesh-list
25307466|NCT04121507|Thiotepa|thiotepa|mesh-list
25451765|NCT04584034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451766|NCT04584008|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25451767|NCT04584008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451768|NCT04584008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451769|NCT04584008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451770|NCT04583813|Empagliflozin|empagliflozin|mesh-list
25451771|NCT04583813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25451772|NCT04583813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451773|NCT04583813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25451774|NCT04583813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644151|NCT01434342|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25644152|NCT01434342|Autonomic Agents|autonomic agents|mesh-ancestor
25644153|NCT01434342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451775|NCT04583410|Nicotine|nicotine|mesh-list
25451776|NCT04583410|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25451777|NCT04583410|Autonomic Agents|autonomic agents|mesh-ancestor
25451778|NCT04583410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451779|NCT04583410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451780|NCT04583410|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25451781|NCT04583410|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25451782|NCT04583410|Cholinergic Agents|cholinergic agents|mesh-ancestor
25451783|NCT04583410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25451784|NCT04583410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451785|NCT04583267|Tenofovir|tenofovir|mesh-list
25451786|NCT04583267|Emtricitabine|emtricitabine|mesh-list
25451787|NCT04583267|Antiviral Agents|antiviral agents|mesh-ancestor
25451788|NCT04583267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25451789|NCT04583267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25451790|NCT04583267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25451791|NCT04583267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451792|NCT04583267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451793|NCT04583267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25451794|NCT04583267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25451795|NCT04583111|Domperidone|domperidone|mesh-list
25451796|NCT04583111|Sulpiride|sulpiride|mesh-list
25451797|NCT04583111|Antiemetics|antiemetics|mesh-ancestor
25451798|NCT04583111|Autonomic Agents|autonomic agents|mesh-ancestor
25451799|NCT04583111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451800|NCT04583111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451801|NCT04583111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25451802|NCT04583111|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25451803|NCT04583111|Dopamine Agents|dopamine agents|mesh-ancestor
25451804|NCT04583111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25451805|NCT04583111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451806|NCT04583111|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25451807|NCT04583111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25451808|NCT04583111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25451809|NCT04583111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25451810|NCT04583111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25451811|NCT04583111|Antidepressive Agents|antidepressive agents|mesh-ancestor
25451812|NCT04582968|Capecitabine|capecitabine|mesh-list
25451813|NCT04582968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25451814|NCT04582968|Antimetabolites|antimetabolites|mesh-ancestor
25451815|NCT04582968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451816|NCT04582968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451817|NCT04583046|Iloprost|iloprost|mesh-list
25451818|NCT04583046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25451819|NCT04583046|Vasodilator Agents|vasodilator agents|mesh-ancestor
25451820|NCT04583137|Lidocaine|lidocaine|mesh-list
25451821|NCT04583137|Anesthetics, Local|anesthetics, local|mesh-ancestor
25451822|NCT04583137|Anesthetics|anesthetics|mesh-ancestor
25451823|NCT04583137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25451824|NCT04583137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451825|NCT04583137|Sensory System Agents|sensory system agents|mesh-ancestor
25451826|NCT04583137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25307523|NCT04030195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307524|NCT04030195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307525|NCT04030195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25307526|NCT03968913|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25307527|NCT03968913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25307531|NCT03915964|Adalimumab|adalimumab|mesh-list
25307532|NCT03915964|Etanercept|etanercept|mesh-list
25307533|NCT03915964|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
25307534|NCT03915964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25307535|NCT03915964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25307536|NCT03915964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25451827|NCT04583137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25451828|NCT04583137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25451829|NCT04583137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25451830|NCT04583137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25451831|NCT04583137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451832|NCT04583020|Temozolomide|temozolomide|mesh-list
24404671|NCT00164411|Immunologic Factors|immunologic factors|mesh-ancestor
25644154|NCT01434342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451833|NCT04583020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25451834|NCT04583020|Alkylating Agents|alkylating agents|mesh-ancestor
25451835|NCT04583020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451836|NCT04583020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451837|NCT04582942|Lactulose|lactulose|mesh-list
25451838|NCT04582942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25451839|NCT04582929|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25451840|NCT04582929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25451841|NCT04582929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451842|NCT04582929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451843|NCT04582929|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25451844|NCT04582929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25451845|NCT04582929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451846|NCT04582929|Cholinergic Agents|cholinergic agents|mesh-ancestor
25451847|NCT04582929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25451848|NCT04582552|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25451849|NCT04582552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451850|NCT04582552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451851|NCT04582552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451852|NCT04582604|Decitabine|decitabine|mesh-list
25451853|NCT04582604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25451854|NCT04582604|Antimetabolites|antimetabolites|mesh-ancestor
25451855|NCT04582604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451856|NCT04582604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451857|NCT04582604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451858|NCT04582786|Morphine|morphine|mesh-list
25451859|NCT04582786|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25451860|NCT04582786|Narcotics|narcotics|mesh-ancestor
25451861|NCT04582786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25451862|NCT04582786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451863|NCT04582786|Analgesics|analgesics|mesh-ancestor
25451864|NCT04582786|Sensory System Agents|sensory system agents|mesh-ancestor
25451865|NCT04582786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451866|NCT04582084|Etanercept|etanercept|mesh-list
25451867|NCT04582084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25451868|NCT04582084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25451869|NCT04582084|Analgesics|analgesics|mesh-ancestor
25451870|NCT04582084|Sensory System Agents|sensory system agents|mesh-ancestor
25307600|NCT03742414|Respiratory System Agents|respiratory system agents|mesh-ancestor
25307601|NCT03742414|Dermatologic Agents|dermatologic agents|mesh-ancestor
25307602|NCT03742414|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25307605|NCT03718559|Edoxaban|edoxaban|mesh-list
25307606|NCT03718559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25307607|NCT03718559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25307608|NCT03718559|Antithrombins|antithrombins|mesh-ancestor
25307609|NCT03718559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25307610|NCT03718559|Protease Inhibitors|protease inhibitors|mesh-ancestor
25307611|NCT03718559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25307612|NCT03718559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307613|NCT03718559|Anticoagulants|anticoagulants|mesh-ancestor
25307617|NCT03694249|Ifetroban|ifetroban|mesh-list
25307618|NCT03694249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25307619|NCT03660813|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25307620|NCT03660813|Luteolytic Agents|luteolytic agents|mesh-ancestor
25307621|NCT03660813|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25307622|NCT03660813|Contraceptive Agents|contraceptive agents|mesh-ancestor
25307623|NCT03660813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25307624|NCT03660813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307625|NCT03660813|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25307626|NCT03660813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25307627|NCT03660813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526243|NCT00302744|Niacin|niacin|mesh-list
25307654|NCT03601078|Lenalidomide|lenalidomide|mesh-list
25307655|NCT03601078|Immunologic Factors|immunologic factors|mesh-ancestor
25307656|NCT03601078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307657|NCT03601078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25451878|NCT04582305|Bleomycin|bleomycin|mesh-list
25451879|NCT04582305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25451880|NCT04582305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451881|NCT04582136|Sirolimus|sirolimus|mesh-list
25451882|NCT04582136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25644156|NCT01434342|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25451883|NCT04582136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25451884|NCT04582136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25451885|NCT04582136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451886|NCT04582136|Antifungal Agents|antifungal agents|mesh-ancestor
25451887|NCT04582136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25451888|NCT04582136|Immunologic Factors|immunologic factors|mesh-ancestor
25451889|NCT04582136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451890|NCT04582032|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
25451891|NCT04582032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25451892|NCT04582032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25451893|NCT04582032|Analgesics|analgesics|mesh-ancestor
25451894|NCT04582032|Sensory System Agents|sensory system agents|mesh-ancestor
25451895|NCT04582032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451896|NCT04582032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451897|NCT04582032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25451898|NCT04582032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25451899|NCT04582097|Ramipril|ramipril|mesh-list
25451900|NCT04582097|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25451901|NCT04582097|Protease Inhibitors|protease inhibitors|mesh-ancestor
25451902|NCT04582097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451903|NCT04582097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451904|NCT04582097|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25451905|NCT04581876|Paclitaxel|paclitaxel|mesh-list
25451906|NCT04581876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25451907|NCT04581876|Raltitrexed|raltitrexed|mesh-list
25451908|NCT04581876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25451909|NCT04581876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451910|NCT04581876|Tubulin Modulators|tubulin modulators|mesh-ancestor
25451911|NCT04581876|Antimitotic Agents|antimitotic agents|mesh-ancestor
25451912|NCT04581876|Mitosis Modulators|mitosis modulators|mesh-ancestor
25451913|NCT04581876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451914|NCT04581876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25451915|NCT04581876|Antimetabolites|antimetabolites|mesh-ancestor
25451916|NCT04581876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25451917|NCT04581876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451918|NCT04581967|Cyclophosphamide|cyclophosphamide|mesh-list
25451919|NCT04581967|Doxorubicin|doxorubicin|mesh-list
25451920|NCT04581967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25451921|NCT04581967|Immunologic Factors|immunologic factors|mesh-ancestor
25451922|NCT04581967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451923|NCT04581967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25451924|NCT04581967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25451925|NCT04581967|Alkylating Agents|alkylating agents|mesh-ancestor
25451926|NCT04581967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451927|NCT04581967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451928|NCT04581967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25451929|NCT04581967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25451930|NCT04581967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25451931|NCT04581967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25451932|NCT04581967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25451933|NCT04581213|Anesthetics|anesthetics|mesh-list
25451934|NCT04581213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25451935|NCT04581213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451936|NCT04581408|Ivacaftor|ivacaftor|mesh-list
25451937|NCT04581408|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25451938|NCT04581408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25451939|NCT04581408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451940|NCT04581265|Paclitaxel|paclitaxel|mesh-list
25451941|NCT04581265|Cisplatin|cisplatin|mesh-list
25451942|NCT04581265|Ifosfamide|ifosfamide|mesh-list
25451943|NCT04581265|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25451944|NCT04581265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25451945|NCT04581265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307752|NCT03263936|Vorinostat|vorinostat|mesh-list
25307753|NCT03263936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307754|NCT03263936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25307755|NCT03263936|Antimetabolites|antimetabolites|mesh-ancestor
25307756|NCT03263936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307757|NCT03263936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25307760|NCT03263936|Antiviral Agents|antiviral agents|mesh-ancestor
25451958|NCT04580355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25451959|NCT04580355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25451960|NCT04580355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25451961|NCT04580355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25451962|NCT04580342|Propranolol|propranolol|mesh-list
25451963|NCT04580342|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25451964|NCT04580342|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25451965|NCT04580342|Adrenergic Agents|adrenergic agents|mesh-ancestor
25451966|NCT04580342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25451967|NCT04580342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451968|NCT04580342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451969|NCT04580342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25451970|NCT04580342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25451971|NCT04580342|Vasodilator Agents|vasodilator agents|mesh-ancestor
25451972|NCT04580394|Oxybutynin|oxybutynin|mesh-list
25451973|NCT04580394|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25451974|NCT04580394|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25451975|NCT04580394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25451976|NCT04580394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25451977|NCT04580394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25451978|NCT04580394|Adrenergic Agents|adrenergic agents|mesh-ancestor
25451979|NCT04580394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25451980|NCT04580394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451981|NCT04580394|Parasympatholytics|parasympatholytics|mesh-ancestor
25451982|NCT04580394|Autonomic Agents|autonomic agents|mesh-ancestor
25451983|NCT04580394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25451984|NCT04580394|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25451985|NCT04580394|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25451986|NCT04580394|Cholinergic Agents|cholinergic agents|mesh-ancestor
25451987|NCT04580394|Urological Agents|urological agents|mesh-ancestor
25451988|NCT04580199|Ethanol|ethanol|mesh-list
25451989|NCT04580199|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25451990|NCT04580199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25451991|NCT04580199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25451992|NCT04580199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25451993|NCT04580498|Paclitaxel|paclitaxel|mesh-list
25451994|NCT04580498|Carboplatin|carboplatin|mesh-list
25451995|NCT04580498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25451996|NCT04580498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25451997|NCT04580498|Tubulin Modulators|tubulin modulators|mesh-ancestor
25721161|NCT02483000|Biotin|biotin|mesh-list
25451998|NCT04580498|Antimitotic Agents|antimitotic agents|mesh-ancestor
25451999|NCT04580498|Mitosis Modulators|mitosis modulators|mesh-ancestor
25452000|NCT04580498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307828|NCT02979522|Antimitotic Agents|antimitotic agents|mesh-ancestor
25307829|NCT02979522|Mitosis Modulators|mitosis modulators|mesh-ancestor
25307830|NCT02915198|Metformin|metformin|mesh-list
25307831|NCT02915198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25307832|NCT02915198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307833|NCT02888041|Dinoprostone|dinoprostone|mesh-list
25307834|NCT02888041|Oxytocics|oxytocics|mesh-ancestor
25307835|NCT02888041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25452002|NCT04579731|Cathartics|cathartics|mesh-ancestor
25452003|NCT04579731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25452004|NCT04579302|Bupivacaine|bupivacaine|mesh-list
25452005|NCT04579302|Anesthetics, Local|anesthetics, local|mesh-ancestor
25452006|NCT04579302|Anesthetics|anesthetics|mesh-ancestor
25452007|NCT04579302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25452008|NCT04579302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452009|NCT04579302|Sensory System Agents|sensory system agents|mesh-ancestor
25452010|NCT04579302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25452011|NCT04578782|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25452012|NCT04578782|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25452013|NCT04578782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25452014|NCT04578782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25452015|NCT04578782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452016|NCT04578782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25452017|NCT04578782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25452018|NCT04578782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452019|NCT04578782|Cholinergic Agents|cholinergic agents|mesh-ancestor
25452020|NCT04578782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25452021|NCT04579133|Durvalumab|durvalumab|mesh-list
25452022|NCT04579133|Olaparib|olaparib|mesh-list
25452023|NCT04579133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25452024|NCT04579133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25452025|NCT04579133|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25452026|NCT04579133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452027|NCT04579133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452028|NCT04578847|Imatinib Mesylate|imatinib mesylate|mesh-list
25452029|NCT04578847|Dasatinib|dasatinib|mesh-list
25644157|NCT01434342|Cholinergic Agents|cholinergic agents|mesh-ancestor
25644158|NCT01434342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25644159|NCT01434342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644160|NCT01434472|Vidarabine|vidarabine|mesh-list
25644161|NCT01434472|Cyclosporine|cyclosporine|mesh-list
25644162|NCT01434472|Mycophenolic Acid|mycophenolic acid|mesh-list
25644163|NCT01434472|Rituximab|rituximab|mesh-list
25644164|NCT01434472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25644165|NCT01434472|Fludarabine|fludarabine|mesh-list
25644166|NCT01434472|Fludarabine phosphate|fludarabine phosphate|mesh-list
25644167|NCT01434472|Antibodies|antibodies|mesh-list
25644168|NCT01434472|Immunoglobulins|immunoglobulins|mesh-list
25644169|NCT01434472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25452030|NCT04578847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25452031|NCT04578847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25452032|NCT04578847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452033|NCT04578847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452034|NCT04578470|Vitamin D|vitamin d|mesh-list
25452035|NCT04578470|Vitamins|vitamins|mesh-ancestor
25452036|NCT04578470|Micronutrients|micronutrients|mesh-ancestor
25452037|NCT04578470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452038|NCT04578470|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25452039|NCT04578496|Afamelanotide|afamelanotide|mesh-list
25452040|NCT04578496|Dermatologic Agents|dermatologic agents|mesh-ancestor
25452041|NCT04578691|Titanium dioxide|titanium dioxide|mesh-list
25452042|NCT04578691|Sunscreening Agents|sunscreening agents|mesh-ancestor
25452043|NCT04578691|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25452044|NCT04578691|Protective Agents|protective agents|mesh-ancestor
25452045|NCT04578691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452046|NCT04578691|Dermatologic Agents|dermatologic agents|mesh-ancestor
25452047|NCT04578691|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25452048|NCT04578236|Tretinoin|tretinoin|mesh-list
25452049|NCT04578236|Captopril|captopril|mesh-list
25452050|NCT04578236|Isotretinoin|isotretinoin|mesh-list
25452051|NCT04578236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25452052|NCT04578236|Keratolytic Agents|keratolytic agents|mesh-ancestor
25452053|NCT04578236|Dermatologic Agents|dermatologic agents|mesh-ancestor
25452054|NCT04578236|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25452055|NCT04578236|Protease Inhibitors|protease inhibitors|mesh-ancestor
25452056|NCT04578236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452057|NCT04578236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452058|NCT04578236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25452059|NCT04578158|Quercetin|quercetin|mesh-list
25307903|NCT02577120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25307904|NCT02576717|Ozanimod|ozanimod|mesh-list
25307905|NCT02576717|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25307906|NCT02576717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307907|NCT02576717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25307908|NCT02576717|Immunologic Factors|immunologic factors|mesh-ancestor
25307909|NCT02576717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307910|NCT02501096|Pembrolizumab|pembrolizumab|mesh-list
25307911|NCT02501096|Lenvatinib|lenvatinib|mesh-list
25307912|NCT02501096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25307913|NCT02501096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307914|NCT02501096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25307915|NCT02501096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25307916|NCT02501096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307917|NCT02447718|Vaccines|vaccines|mesh-list
25307919|NCT02447718|Immunologic Factors|immunologic factors|mesh-ancestor
25452060|NCT04578158|Antioxidants|antioxidants|mesh-ancestor
25452061|NCT04578158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452062|NCT04578158|Protective Agents|protective agents|mesh-ancestor
25452063|NCT04578158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452064|NCT04577846|Cephalexin|cephalexin|mesh-list
25452065|NCT04577846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25452066|NCT04577846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25452067|NCT04577885|Rifampin|rifampin|mesh-list
25452068|NCT04577885|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25452069|NCT04577885|Antitubercular Agents|antitubercular agents|mesh-ancestor
25452070|NCT04577885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25452071|NCT04577885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25452072|NCT04577885|Leprostatic Agents|leprostatic agents|mesh-ancestor
25452073|NCT04577885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25452074|NCT04577885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452075|NCT04577885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811730|NCT02048098|Oxytocics|oxytocics|mesh-ancestor
25644170|NCT01434472|Cyclosporins|cyclosporins|mesh-list
25644171|NCT01434472|Immunologic Factors|immunologic factors|mesh-ancestor
25452076|NCT04577885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25452077|NCT04577885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25452078|NCT04577885|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25452079|NCT04577885|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25452080|NCT04577885|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25452081|NCT04577885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25452083|NCT04577443|Analgesics|analgesics|mesh-ancestor
25452084|NCT04577443|Sensory System Agents|sensory system agents|mesh-ancestor
25452085|NCT04577443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25452086|NCT04577443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452087|NCT04577443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25452088|NCT04577443|Vasodilator Agents|vasodilator agents|mesh-ancestor
25452089|NCT04577443|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25452090|NCT04577443|Purinergic Agonists|purinergic agonists|mesh-ancestor
25452091|NCT04577443|Purinergic Agents|purinergic agents|mesh-ancestor
25452092|NCT04577443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25452093|NCT04577443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452094|NCT04577378|Itraconazole|itraconazole|mesh-list
25452095|NCT04577378|Tretinoin|tretinoin|mesh-list
25452096|NCT04577378|Isotretinoin|isotretinoin|mesh-list
25452097|NCT04577378|Antifungal Agents|antifungal agents|mesh-ancestor
25452098|NCT04577378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25452099|NCT04577378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25452100|NCT04577378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25452101|NCT04577378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452102|NCT04577378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452103|NCT04577378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25452104|NCT04577378|Hormone Antagonists|hormone antagonists|mesh-ancestor
25452105|NCT04577378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25452106|NCT04577378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452107|NCT04577378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25452108|NCT04577378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25452109|NCT04577378|Keratolytic Agents|keratolytic agents|mesh-ancestor
25452110|NCT04577378|Dermatologic Agents|dermatologic agents|mesh-ancestor
25452111|NCT04577417|Methylphenidate|methylphenidate|mesh-list
25452112|NCT04577417|Amphetamine|amphetamine|mesh-list
25452113|NCT04577417|Adderall|adderall|mesh-list
25452114|NCT04577417|Dextroamphetamine|dextroamphetamine|mesh-list
25452115|NCT04577417|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
25452116|NCT04577417|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25452117|NCT04577417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452118|NCT04577417|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25452119|NCT04577417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25452120|NCT04577417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25307987|NCT01484691|Budesonide|budesonide|mesh-list
25307988|NCT01484691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25307989|NCT01484691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25307990|NCT01484691|Autonomic Agents|autonomic agents|mesh-ancestor
25307991|NCT01484691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25307992|NCT01484691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307993|NCT01484691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25307994|NCT01484691|Respiratory System Agents|respiratory system agents|mesh-ancestor
25307995|NCT01484691|Glucocorticoids|glucocorticoids|mesh-ancestor
25307996|NCT01484691|Hormones|hormones|mesh-ancestor
25307997|NCT01484691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25452132|NCT04577040|Vasodilator Agents|vasodilator agents|mesh-ancestor
25452133|NCT04577040|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25452134|NCT04577040|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25452135|NCT04577040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452136|NCT04577040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452137|NCT04577040|Urological Agents|urological agents|mesh-ancestor
25452138|NCT04576975|Dexmedetomidine|dexmedetomidine|mesh-list
25452139|NCT04576975|Ketamine|ketamine|mesh-list
25452140|NCT04576975|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25452141|NCT04576975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25452142|NCT04576975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452143|NCT04576975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25452144|NCT04576975|Analgesics|analgesics|mesh-ancestor
25452145|NCT04576975|Sensory System Agents|sensory system agents|mesh-ancestor
25452146|NCT04576975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25452147|NCT04576975|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25452148|NCT04576975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25452149|NCT04576975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25452150|NCT04576975|Adrenergic Agents|adrenergic agents|mesh-ancestor
25452151|NCT04576975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25452152|NCT04576975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452153|NCT04576975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25452154|NCT04576975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25452155|NCT04576975|Anesthetics, General|anesthetics, general|mesh-ancestor
25452156|NCT04576975|Anesthetics|anesthetics|mesh-ancestor
25452157|NCT04576975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25452158|NCT04576975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25452159|NCT04577430|Dexmedetomidine|dexmedetomidine|mesh-list
25452160|NCT04577430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25452161|NCT04577430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25452162|NCT04577430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452163|NCT04577430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25452164|NCT04577430|Analgesics|analgesics|mesh-ancestor
25452165|NCT04577430|Sensory System Agents|sensory system agents|mesh-ancestor
25452166|NCT04577430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25452167|NCT04577430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25452168|NCT04577430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25452169|NCT04577430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25452170|NCT04577430|Adrenergic Agents|adrenergic agents|mesh-ancestor
25452171|NCT04577430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25452172|NCT04577430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452173|NCT04576364|Magnesium Sulfate|magnesium sulfate|mesh-list
25452174|NCT04576364|Analgesics|analgesics|mesh-ancestor
25452175|NCT04576364|Sensory System Agents|sensory system agents|mesh-ancestor
25452176|NCT04576364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25452177|NCT04576364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452178|NCT04576364|Anesthetics|anesthetics|mesh-ancestor
25452179|NCT04576364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25452180|NCT04576364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25452181|NCT04576364|Anticonvulsants|anticonvulsants|mesh-ancestor
25452182|NCT04576364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25452183|NCT04576364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25452184|NCT04576364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452185|NCT04576364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25452186|NCT04576364|Tocolytic Agents|tocolytic agents|mesh-ancestor
25452187|NCT04576364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25452188|NCT04576208|Antidiarrheals|antidiarrheals|mesh-list
25452189|NCT04576208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25452190|NCT04576143|Paclitaxel|paclitaxel|mesh-list
25452191|NCT04576143|Docetaxel|docetaxel|mesh-list
25452192|NCT04576143|Cyclophosphamide|cyclophosphamide|mesh-list
25452193|NCT04576143|Epirubicin|epirubicin|mesh-list
25452194|NCT04576143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25452195|NCT04576143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25452196|NCT04576143|Tubulin Modulators|tubulin modulators|mesh-ancestor
25452197|NCT04576143|Antimitotic Agents|antimitotic agents|mesh-ancestor
25452198|NCT04576143|Mitosis Modulators|mitosis modulators|mesh-ancestor
25308131|NCT00136435|Mitosis Modulators|mitosis modulators|mesh-ancestor
25308132|NCT04064918|Timolol|timolol|mesh-list
25308133|NCT04064918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25308134|NCT04064918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25308135|NCT04064918|Adrenergic Agents|adrenergic agents|mesh-ancestor
25308136|NCT04064918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25452199|NCT04576143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452201|NCT04576143|Immunologic Factors|immunologic factors|mesh-ancestor
25452202|NCT04576143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452203|NCT04576143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25452204|NCT04576143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25452205|NCT04576143|Alkylating Agents|alkylating agents|mesh-ancestor
25452206|NCT04576143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25452207|NCT04576143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25452208|NCT04576143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25452209|NCT04576143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25452210|NCT04576143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452211|NCT04576390|Ondansetron|ondansetron|mesh-list
25452212|NCT04576390|Palonosetron|palonosetron|mesh-list
25452213|NCT04576390|Antiemetics|antiemetics|mesh-ancestor
25452214|NCT04576390|Autonomic Agents|autonomic agents|mesh-ancestor
25452215|NCT04576390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25452216|NCT04576390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452217|NCT04576390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25644172|NCT01434472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644173|NCT01434472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25644174|NCT01434472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25644175|NCT01434472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25644176|NCT01434472|Antimetabolites|antimetabolites|mesh-ancestor
25644177|NCT01434472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644178|NCT01434472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25452218|NCT04576390|Antipruritics|antipruritics|mesh-ancestor
25452219|NCT04576390|Dermatologic Agents|dermatologic agents|mesh-ancestor
25452220|NCT04576390|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25452221|NCT04576390|Serotonin Agents|serotonin agents|mesh-ancestor
25452222|NCT04576390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25452223|NCT04576390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644179|NCT01434472|Antiviral Agents|antiviral agents|mesh-ancestor
25644180|NCT01434472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25452224|NCT04576390|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25452225|NCT04576390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25452226|NCT04576390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25452227|NCT04576390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25452228|NCT04576390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25452229|NCT04576390|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25452230|NCT04575688|Bupivacaine|bupivacaine|mesh-list
25452231|NCT04575688|Anesthetics, Local|anesthetics, local|mesh-ancestor
25452232|NCT04575688|Anesthetics|anesthetics|mesh-ancestor
25452233|NCT04575688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25452234|NCT04575688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452235|NCT04575688|Sensory System Agents|sensory system agents|mesh-ancestor
25452236|NCT04575688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25452237|NCT04575779|Cyclosporine|cyclosporine|mesh-list
25452238|NCT04575779|Cyclosporins|cyclosporins|mesh-list
25452239|NCT04575779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452240|NCT04575779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452241|NCT04575779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25452242|NCT04575779|Immunologic Factors|immunologic factors|mesh-ancestor
25452243|NCT04575779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452244|NCT04575779|Antifungal Agents|antifungal agents|mesh-ancestor
25452245|NCT04575779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25452246|NCT04575779|Dermatologic Agents|dermatologic agents|mesh-ancestor
25452247|NCT04575779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25452248|NCT04575779|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25452249|NCT04575675|Dapagliflozin|dapagliflozin|mesh-list
25452250|NCT04575675|Valsartan|valsartan|mesh-list
25452251|NCT04575675|Carvedilol|carvedilol|mesh-list
25452252|NCT04575675|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25452253|NCT04575675|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25452254|NCT04575675|Mineralocorticoids|mineralocorticoids|mesh-list
25452255|NCT04575675|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
25452256|NCT04575675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25452257|NCT04575675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25452258|NCT04575675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25452259|NCT04575675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452260|NCT04575675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25452261|NCT04575675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25308216|NCT03954327|Tenofovir|tenofovir|mesh-list
25308217|NCT03954327|Emtricitabine|emtricitabine|mesh-list
25308218|NCT03954327|Raltegravir Potassium|raltegravir potassium|mesh-list
25308219|NCT03954327|Antiviral Agents|antiviral agents|mesh-ancestor
25308220|NCT03954327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25308221|NCT03954327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25308222|NCT03954327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25308223|NCT03954327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25308224|NCT03954327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308225|NCT03954327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25452262|NCT04575675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452263|NCT04575675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25452264|NCT04575675|Adrenergic Agents|adrenergic agents|mesh-ancestor
25452265|NCT04575675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25452266|NCT04575675|Antioxidants|antioxidants|mesh-ancestor
25452267|NCT04575675|Protective Agents|protective agents|mesh-ancestor
25452268|NCT04575675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25452269|NCT04575675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24405752|NCT00168350|Memantine|memantine|mesh-list
24811773|NCT02048319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644181|NCT01434472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452270|NCT04575675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25452271|NCT04575675|Vasodilator Agents|vasodilator agents|mesh-ancestor
25452272|NCT04575675|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25452273|NCT04575675|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25644182|NCT01434472|Antifungal Agents|antifungal agents|mesh-ancestor
25644183|NCT01434472|Dermatologic Agents|dermatologic agents|mesh-ancestor
25644184|NCT01434472|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25721195|NCT02483000|Vitamins|vitamins|mesh-ancestor
25644185|NCT01434472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25452274|NCT04575675|Hormones|hormones|mesh-ancestor
25452275|NCT04575675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25452276|NCT04575675|Hormone Antagonists|hormone antagonists|mesh-ancestor
25452277|NCT04575675|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25452278|NCT04575675|Diuretics|diuretics|mesh-ancestor
25452279|NCT04575675|Natriuretic Agents|natriuretic agents|mesh-ancestor
25452280|NCT04575558|Azithromycin|azithromycin|mesh-list
25452281|NCT04575558|Hydroxychloroquine|hydroxychloroquine|mesh-list
25452282|NCT04575558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25452283|NCT04575558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25452284|NCT04575558|Antimalarials|antimalarials|mesh-ancestor
25452285|NCT04575558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25452286|NCT04575558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25452287|NCT04575558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452288|NCT04575558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452289|NCT04575558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25452290|NCT04575519|Aspirin|aspirin|mesh-list
25452291|NCT04575519|Ibuprofen|ibuprofen|mesh-list
25452292|NCT04575519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25452293|NCT04575519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25452294|NCT04575519|Analgesics|analgesics|mesh-ancestor
25452295|NCT04575519|Sensory System Agents|sensory system agents|mesh-ancestor
25452296|NCT04575519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25452297|NCT04575519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452298|NCT04575519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25452299|NCT04575519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25452300|NCT04575519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25452301|NCT04575519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452302|NCT04575519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452303|NCT04575519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25452304|NCT04575519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25452305|NCT04575519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25452306|NCT04575519|Antipyretics|antipyretics|mesh-ancestor
25452307|NCT04575194|Liraglutide|liraglutide|mesh-list
25452308|NCT04575194|Naltrexone|naltrexone|mesh-list
25452309|NCT04575194|Bupropion|bupropion|mesh-list
25452310|NCT04575194|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25452311|NCT04575194|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25452312|NCT04575194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452313|NCT04575194|Sensory System Agents|sensory system agents|mesh-ancestor
25452314|NCT04575194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25452315|NCT04575194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25452316|NCT04575194|Incretins|incretins|mesh-ancestor
25452317|NCT04575194|Hormones|hormones|mesh-ancestor
25452318|NCT04575194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25452319|NCT04575194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25452320|NCT04575194|Antidepressive Agents|antidepressive agents|mesh-ancestor
25452321|NCT04575194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25452322|NCT04575194|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25452323|NCT04575194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25452324|NCT04575194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25452325|NCT04575194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452326|NCT04575194|Dopamine Agents|dopamine agents|mesh-ancestor
25452327|NCT04575194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25452328|NCT04575194|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25452329|NCT04575194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25452330|NCT04575194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452331|NCT04575415|Bevacizumab|bevacizumab|mesh-list
25452332|NCT04575415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25452333|NCT04575415|Gefitinib|gefitinib|mesh-list
25452334|NCT04575415|Osimertinib|osimertinib|mesh-list
25452335|NCT04575415|Afatinib|afatinib|mesh-list
25452336|NCT04575415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25452337|NCT04575415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25452338|NCT04575415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25721198|NCT02483611|Magnesium Sulfate|magnesium sulfate|mesh-list
25452339|NCT04575415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25452340|NCT04575415|Growth Substances|growth substances|mesh-ancestor
25644186|NCT01434472|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25644187|NCT01434472|Antitubercular Agents|antitubercular agents|mesh-ancestor
25644188|NCT01434472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25644189|NCT01435018|Tenofovir|tenofovir|mesh-list
25644190|NCT01435018|Emtricitabine|emtricitabine|mesh-list
25644191|NCT01435018|Efavirenz|efavirenz|mesh-list
25644192|NCT01435018|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25644193|NCT01435018|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25644194|NCT01435018|Paclitaxel|paclitaxel|mesh-list
25644195|NCT01435018|Etoposide|etoposide|mesh-list
25452341|NCT04575415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452342|NCT04575415|Growth Inhibitors|growth inhibitors|mesh-ancestor
25452343|NCT04575415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25452344|NCT04575415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452345|NCT04575415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452346|NCT04575389|Uric Acid|uric acid|mesh-list
25452347|NCT04575389|Antioxidants|antioxidants|mesh-ancestor
25452348|NCT04575389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452349|NCT04575389|Protective Agents|protective agents|mesh-ancestor
25452350|NCT04575389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452351|NCT04575493|Ciprofloxacin|ciprofloxacin|mesh-list
25452352|NCT04575493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25452353|NCT04575493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25452354|NCT04575493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25452355|NCT04575493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25452356|NCT04575493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452357|NCT04575493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452358|NCT04575493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25452359|NCT04575493|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25452360|NCT04575493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25452361|NCT04575103|Antipsychotic Agents|antipsychotic agents|mesh-list
25452362|NCT04575103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25452363|NCT04575103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25452364|NCT04575103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452365|NCT04575103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25452366|NCT04574960|Gemcitabine|gemcitabine|mesh-list
25452367|NCT04574960|Cisplatin|cisplatin|mesh-list
25452368|NCT04574960|Carboplatin|carboplatin|mesh-list
25452369|NCT04574960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25452370|NCT04574960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25452371|NCT04574960|Antimetabolites|antimetabolites|mesh-ancestor
25452372|NCT04574960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452373|NCT04574960|Antiviral Agents|antiviral agents|mesh-ancestor
25452374|NCT04574960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25452375|NCT04574960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452376|NCT04574960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25452377|NCT04574960|Immunologic Factors|immunologic factors|mesh-ancestor
25452378|NCT04574960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452379|NCT04574778|Acetaminophen|acetaminophen|mesh-list
25452380|NCT04574778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25452381|NCT04574778|Analgesics|analgesics|mesh-ancestor
25452382|NCT04574778|Sensory System Agents|sensory system agents|mesh-ancestor
25452383|NCT04574778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25452384|NCT04574778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452385|NCT04574778|Antipyretics|antipyretics|mesh-ancestor
25452386|NCT04574791|Tizanidine|tizanidine|mesh-list
25452387|NCT04574791|Analgesics|analgesics|mesh-ancestor
25308358|NCT03832049|Vaccines|vaccines|mesh-list
25308359|NCT03832049|Immunologic Factors|immunologic factors|mesh-ancestor
25308360|NCT03832049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308361|NCT03810105|Durvalumab|durvalumab|mesh-list
25308362|NCT03810105|Olaparib|olaparib|mesh-list
25308363|NCT03810105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25308364|NCT03810105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25308365|NCT03810105|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25308366|NCT03810105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25308367|NCT03810105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308368|NCT03806751|Acetazolamide|acetazolamide|mesh-list
25308369|NCT03806751|Anticonvulsants|anticonvulsants|mesh-ancestor
25308370|NCT03806751|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25308371|NCT03806751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25308372|NCT03806751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308373|NCT03806751|Diuretics|diuretics|mesh-ancestor
25308374|NCT03806751|Natriuretic Agents|natriuretic agents|mesh-ancestor
24405923|NCT00168779|Valsartan|valsartan|mesh-list
25822853|NCT00004686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644196|NCT01435018|Vincristine|vincristine|mesh-list
25644197|NCT01435018|Bleomycin|bleomycin|mesh-list
25644198|NCT01435018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25308375|NCT03806751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644199|NCT01435018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25308400|NCT03800979|Tofacitinib|tofacitinib|mesh-list
25308401|NCT03800979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25308402|NCT03800979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25308403|NCT03800979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308404|NCT03780829|Cycloserine|cycloserine|mesh-list
25452402|NCT04575064|Remdesivir|remdesivir|mesh-list
25452403|NCT04575064|Antimetabolites|antimetabolites|mesh-ancestor
25452404|NCT04575064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452405|NCT04575064|Antiviral Agents|antiviral agents|mesh-ancestor
25452406|NCT04575064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25452407|NCT04574141|Melatonin|melatonin|mesh-list
25452408|NCT04574141|Antioxidants|antioxidants|mesh-ancestor
25452409|NCT04574141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452410|NCT04574141|Protective Agents|protective agents|mesh-ancestor
25452411|NCT04574141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452412|NCT04574141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25452413|NCT04573855|Immunoglobulins|immunoglobulins|mesh-list
25452414|NCT04573855|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25452415|NCT04573855|Antibodies|antibodies|mesh-list
25452416|NCT04573855|Immunologic Factors|immunologic factors|mesh-ancestor
25452417|NCT04573855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452418|NCT04573803|Phenytoin|phenytoin|mesh-list
25452419|NCT04573803|Levetiracetam|levetiracetam|mesh-list
25452420|NCT04573803|Anticonvulsants|anticonvulsants|mesh-ancestor
25452421|NCT04573803|Nootropic Agents|nootropic agents|mesh-ancestor
25452422|NCT04573803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25452423|NCT04573803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25452424|NCT04573803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25452425|NCT04573803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452426|NCT04573803|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25452427|NCT04573803|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25452428|NCT04573426|Acetaminophen|acetaminophen|mesh-list
25452429|NCT04573426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25452430|NCT04573426|Analgesics|analgesics|mesh-ancestor
25452431|NCT04573426|Sensory System Agents|sensory system agents|mesh-ancestor
25452432|NCT04573426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25452433|NCT04573426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452434|NCT04573426|Antipyretics|antipyretics|mesh-ancestor
25452435|NCT04573686|Epoetin Alfa|epoetin alfa|mesh-list
25452436|NCT04573686|Hematinics|hematinics|mesh-ancestor
25452437|NCT04573153|Hydroxychloroquine|hydroxychloroquine|mesh-list
25452438|NCT04573153|Sorbitol|sorbitol|mesh-list
25452439|NCT04573153|Antimalarials|antimalarials|mesh-ancestor
25452440|NCT04573153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25452441|NCT04573153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25452442|NCT04573153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25452443|NCT04573153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452444|NCT04573153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452445|NCT04573153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25452446|NCT04573153|Cathartics|cathartics|mesh-ancestor
25452447|NCT04573153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25452448|NCT04573192|Lomustine|lomustine|mesh-list
25644200|NCT01435018|Tubulin Modulators|tubulin modulators|mesh-ancestor
25644201|NCT01435018|Antimitotic Agents|antimitotic agents|mesh-ancestor
25644202|NCT01435018|Mitosis Modulators|mitosis modulators|mesh-ancestor
25644203|NCT01435018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644204|NCT01435018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25644205|NCT01435018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25644206|NCT01435018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25644207|NCT01435018|Antiviral Agents|antiviral agents|mesh-ancestor
25644208|NCT01435018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25644209|NCT01435018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25644210|NCT01435018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25644211|NCT01435018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25644212|NCT01435018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25644213|NCT01435018|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25644214|NCT01435018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25644215|NCT01435018|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25644216|NCT01435018|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25452449|NCT04573192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25452450|NCT04573192|Alkylating Agents|alkylating agents|mesh-ancestor
25452451|NCT04573192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452452|NCT04573192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25452454|NCT04573049|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25452455|NCT04573049|Vasodilator Agents|vasodilator agents|mesh-ancestor
25452456|NCT04573049|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25452457|NCT04573049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25452458|NCT04573049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452459|NCT04573049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452460|NCT04573049|Protective Agents|protective agents|mesh-ancestor
25452461|NCT04573049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452462|NCT04572698|Endothelial Growth Factors|endothelial growth factors|mesh-list
25452463|NCT04572698|Growth Substances|growth substances|mesh-ancestor
25452464|NCT04572698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452465|NCT04572867|Diuretics|diuretics|mesh-list
25452466|NCT04572867|Natriuretic Agents|natriuretic agents|mesh-ancestor
25452467|NCT04572867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308508|NCT03643744|Analgesics|analgesics|mesh-ancestor
25308509|NCT03643744|Sensory System Agents|sensory system agents|mesh-ancestor
25308510|NCT03643744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25308511|NCT03643744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308512|NCT03643744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25308513|NCT03643744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25308514|NCT03643744|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25308515|NCT03643744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25452468|NCT04572685|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25452469|NCT04572685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25452474|NCT04572685|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25452475|NCT04572685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25452476|NCT04572685|Serotonin Agents|serotonin agents|mesh-ancestor
25452477|NCT04572685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25452478|NCT04572685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452479|NCT04572685|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25452480|NCT04572685|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25452481|NCT04572685|Dopamine Agents|dopamine agents|mesh-ancestor
25452482|NCT04572724|Valsartan|valsartan|mesh-list
25452483|NCT04572724|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25452484|NCT04572724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25721223|NCT02483975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25452485|NCT04572724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25452486|NCT04572724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25452487|NCT04572724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452488|NCT04572997|Apremilast|apremilast|mesh-list
25452489|NCT04572997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25452490|NCT04572997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25452491|NCT04572997|Analgesics|analgesics|mesh-ancestor
25452492|NCT04572997|Sensory System Agents|sensory system agents|mesh-ancestor
25452493|NCT04572997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25452494|NCT04572997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452495|NCT04572997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25452496|NCT04572997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25452497|NCT04572997|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25452498|NCT04572997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25452499|NCT04572997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452500|NCT04572997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452501|NCT04572620|Rituximab|rituximab|mesh-list
25452502|NCT04572620|Abatacept|abatacept|mesh-list
25452503|NCT04572620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25452504|NCT04572620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25452505|NCT04572620|Immunologic Factors|immunologic factors|mesh-ancestor
25452506|NCT04572620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452507|NCT04572620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25452508|NCT04572620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25452509|NCT04572620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452510|NCT04572620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25452511|NCT04572542|Paclitaxel|paclitaxel|mesh-list
25452512|NCT04572542|Apatinib|apatinib|mesh-list
25452513|NCT04572542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25452514|NCT04572542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25452515|NCT04572542|Tubulin Modulators|tubulin modulators|mesh-ancestor
25452516|NCT04572542|Antimitotic Agents|antimitotic agents|mesh-ancestor
25452517|NCT04572542|Mitosis Modulators|mitosis modulators|mesh-ancestor
25452518|NCT04572542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452519|NCT04572542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25452520|NCT04572542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452521|NCT04572516|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25452522|NCT04572516|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25452523|NCT04572516|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25452524|NCT04572516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25452525|NCT04572516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452526|NCT04572516|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25452527|NCT04572516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25452528|NCT04572516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452529|NCT04572516|Cholinergic Agents|cholinergic agents|mesh-ancestor
25452530|NCT04572516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25452531|NCT04572373|SMOFlipid|smoflipid|mesh-list
25452532|NCT04572373|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25452533|NCT04572373|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25452534|NCT04572373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25308582|NCT03457896|Trastuzumab|trastuzumab|mesh-list
25308583|NCT03457896|Cetuximab|cetuximab|mesh-list
25308585|NCT03457896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25452535|NCT04571879|Lidocaine|lidocaine|mesh-list
25452536|NCT04571879|Midazolam|midazolam|mesh-list
25452537|NCT04571879|Anesthetics, Local|anesthetics, local|mesh-ancestor
25452538|NCT04571879|Anesthetics|anesthetics|mesh-ancestor
25452539|NCT04571879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25452540|NCT04571879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452541|NCT04571879|Sensory System Agents|sensory system agents|mesh-ancestor
25452542|NCT04571879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25452543|NCT04571879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25452544|NCT04571879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25452545|NCT04571879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25452546|NCT04571879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25721237|NCT02483975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25452547|NCT04571879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452548|NCT04571879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25452549|NCT04571879|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25452550|NCT04571879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25452551|NCT04571879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25452552|NCT04571879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25452553|NCT04571879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25452554|NCT04571879|Anesthetics, General|anesthetics, general|mesh-ancestor
25452555|NCT04571879|GABA Modulators|gaba modulators|mesh-ancestor
25452556|NCT04571879|GABA Agents|gaba agents|mesh-ancestor
25452557|NCT04571879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25452558|NCT04571437|Capecitabine|capecitabine|mesh-list
25452559|NCT04571437|Letrozole|letrozole|mesh-list
25452560|NCT04571437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25452561|NCT04571437|Antimetabolites|antimetabolites|mesh-ancestor
25452562|NCT04571437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452563|NCT04571437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25452564|NCT04571437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25452565|NCT04571437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25452566|NCT04571437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452567|NCT04571437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25452568|NCT04571437|Hormone Antagonists|hormone antagonists|mesh-ancestor
25452569|NCT04571437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25452570|NCT04571437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452571|NCT04571489|Gemcitabine|gemcitabine|mesh-list
25452572|NCT04571489|Tegafur|tegafur|mesh-list
25452573|NCT04571489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25452574|NCT04571489|Antimetabolites|antimetabolites|mesh-ancestor
25452575|NCT04571489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452576|NCT04571489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25452577|NCT04571489|Antiviral Agents|antiviral agents|mesh-ancestor
25452578|NCT04571489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25452579|NCT04571489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452580|NCT04571489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25452581|NCT04571489|Immunologic Factors|immunologic factors|mesh-ancestor
25452582|NCT04571489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452583|NCT04571996|Acetaminophen|acetaminophen|mesh-list
25452584|NCT04571996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25452585|NCT04571996|Analgesics|analgesics|mesh-ancestor
25452586|NCT04571996|Sensory System Agents|sensory system agents|mesh-ancestor
25452587|NCT04571996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25452588|NCT04571996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644217|NCT01435018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25644218|NCT01435018|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25644219|NCT01435018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25644220|NCT01435122|Axitinib|axitinib|mesh-list
25644221|NCT01435122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25644222|NCT01435122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25644223|NCT01435122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25644224|NCT01435122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644225|NCT01435174|Ranolazine|ranolazine|mesh-list
25644226|NCT01435174|Dialysis Solutions|dialysis solutions|mesh-list
25452589|NCT04571996|Antipyretics|antipyretics|mesh-ancestor
25452590|NCT04571606|Bupivacaine|bupivacaine|mesh-list
25452591|NCT04571606|Anesthetics, Local|anesthetics, local|mesh-ancestor
25452592|NCT04571606|Anesthetics|anesthetics|mesh-ancestor
25452593|NCT04571606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25452594|NCT04571606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452595|NCT04571606|Sensory System Agents|sensory system agents|mesh-ancestor
25452596|NCT04571606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25308654|NCT03336528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308655|NCT03334409|Vitamins|vitamins|mesh-list
25308656|NCT03334409|Ascorbic Acid|ascorbic acid|mesh-list
25308657|NCT03334409|Micronutrients|micronutrients|mesh-ancestor
25308658|NCT03334409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308659|NCT03334409|Antioxidants|antioxidants|mesh-ancestor
25308660|NCT03334409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308661|NCT03334409|Protective Agents|protective agents|mesh-ancestor
25644227|NCT01435174|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25644228|NCT01435174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25644229|NCT01435174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25644230|NCT01435174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308674|NCT03324932|Denosumab|denosumab|mesh-list
25308675|NCT03324932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25308676|NCT03324932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308677|NCT03322215|Capecitabine|capecitabine|mesh-list
25452597|NCT04571164|Rotigotine|rotigotine|mesh-list
25452598|NCT04571164|Dopamine Agonists|dopamine agonists|mesh-ancestor
25452599|NCT04571164|Dopamine Agents|dopamine agents|mesh-ancestor
25452600|NCT04571164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25452601|NCT04571164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452602|NCT04571164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452603|NCT04571151|Halobetasol|halobetasol|mesh-list
25452604|NCT04571151|Calcipotriene|calcipotriene|mesh-list
25452605|NCT04571151|Dermatologic Agents|dermatologic agents|mesh-ancestor
25452606|NCT04571151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25452607|NCT04571229|Mifamurtide|mifamurtide|mesh-list
25452608|NCT04571229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25452609|NCT04571229|Immunologic Factors|immunologic factors|mesh-ancestor
25452610|NCT04571229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452611|NCT04570956|Tamoxifen|tamoxifen|mesh-list
25452612|NCT04570956|Afimoxifene|afimoxifene|mesh-list
25452613|NCT04570956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25452614|NCT04570956|Hormone Antagonists|hormone antagonists|mesh-ancestor
25452615|NCT04570956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25452616|NCT04570956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452617|NCT04570956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25452618|NCT04570956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25452619|NCT04570956|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25452620|NCT04570956|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25452621|NCT04570956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25452622|NCT04570865|Dapagliflozin|dapagliflozin|mesh-list
25452623|NCT04570865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25452624|NCT04570865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452625|NCT04570865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25452626|NCT04570865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452627|NCT04570592|Dexamethasone|dexamethasone|mesh-list
25452628|NCT04570592|Granisetron|granisetron|mesh-list
25452629|NCT04570592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25452630|NCT04570592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25452631|NCT04570592|Antiemetics|antiemetics|mesh-ancestor
25452632|NCT04570592|Autonomic Agents|autonomic agents|mesh-ancestor
25452633|NCT04570592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25452634|NCT04570592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452635|NCT04570592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25452636|NCT04570592|Glucocorticoids|glucocorticoids|mesh-ancestor
25644231|NCT01435382|Bococizumab|bococizumab|mesh-list
25452637|NCT04570592|Hormones|hormones|mesh-ancestor
25452638|NCT04570592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25452639|NCT04570592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25452640|NCT04570592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25452641|NCT04570592|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25452642|NCT04570592|Serotonin Agents|serotonin agents|mesh-ancestor
25452643|NCT04570592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25452644|NCT04570592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452645|NCT04570475|Vitamin D|vitamin d|mesh-list
25452646|NCT04570475|Vitamins|vitamins|mesh-ancestor
25452647|NCT04570475|Micronutrients|micronutrients|mesh-ancestor
25452648|NCT04570475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452649|NCT04570475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25452650|NCT04570683|Nivolumab|nivolumab|mesh-list
25452651|NCT04570683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25452652|NCT04570683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25452653|NCT04570683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25452654|NCT04570683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452655|NCT04570449|Fluoxetine|fluoxetine|mesh-list
25452656|NCT04570449|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25452657|NCT04570449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25452658|NCT04570449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25452659|NCT04570449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452660|NCT04570449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25452661|NCT04570449|Serotonin Agents|serotonin agents|mesh-ancestor
25452662|NCT04570449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452663|NCT04570449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25452664|NCT04570449|Antidepressive Agents|antidepressive agents|mesh-ancestor
25452665|NCT04570449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25452666|NCT04570449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25452667|NCT04570449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25452668|NCT04570449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452669|NCT04570410|Gemcitabine|gemcitabine|mesh-list
25452670|NCT04570410|Cisplatin|cisplatin|mesh-list
25452671|NCT04570410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25452672|NCT04570410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25452673|NCT04570410|Antimetabolites|antimetabolites|mesh-ancestor
25452674|NCT04570410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452675|NCT04570410|Antiviral Agents|antiviral agents|mesh-ancestor
25452676|NCT04570410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25452677|NCT04570410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452678|NCT04570410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25452679|NCT04570410|Immunologic Factors|immunologic factors|mesh-ancestor
25452680|NCT04570410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452681|NCT04570345|Aspirin|aspirin|mesh-list
25452682|NCT04570345|Ticagrelor|ticagrelor|mesh-list
25452683|NCT04570345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25452684|NCT04570345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25452685|NCT04570345|Analgesics|analgesics|mesh-ancestor
25452686|NCT04570345|Sensory System Agents|sensory system agents|mesh-ancestor
25452687|NCT04570345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25452688|NCT04570345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452689|NCT04570345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25452690|NCT04570345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25452691|NCT04570345|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25452692|NCT04570345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25452693|NCT04570345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452694|NCT04570345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25452695|NCT04570345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25452696|NCT04570345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452697|NCT04570345|Antipyretics|antipyretics|mesh-ancestor
25452698|NCT04570345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25452699|NCT04570345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25452700|NCT04570345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25452701|NCT04570345|Purinergic Agents|purinergic agents|mesh-ancestor
25452702|NCT04570345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25452703|NCT04570293|Lidocaine|lidocaine|mesh-list
25452704|NCT04570293|Anesthetics, Local|anesthetics, local|mesh-ancestor
25452705|NCT04570293|Anesthetics|anesthetics|mesh-ancestor
25452706|NCT04570293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25452707|NCT04570293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452708|NCT04570293|Sensory System Agents|sensory system agents|mesh-ancestor
25452709|NCT04570293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25644232|NCT01435382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25644233|NCT01435382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25452710|NCT04570293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25452711|NCT04570293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25452712|NCT04570293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25452713|NCT04570293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25452714|NCT04570293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452715|NCT04570254|Vitamins|vitamins|mesh-list
25452716|NCT04570254|Vitamin E|vitamin e|mesh-list
25452717|NCT04570254|Acetylcysteine|acetylcysteine|mesh-list
25452718|NCT04570254|Pentoxifylline|pentoxifylline|mesh-list
25452719|NCT04570254|Melatonin|melatonin|mesh-list
25452720|NCT04570254|Antioxidants|antioxidants|mesh-list
25452721|NCT04570254|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25452722|NCT04570254|Micronutrients|micronutrients|mesh-ancestor
25452723|NCT04570254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452724|NCT04570254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452725|NCT04570254|Protective Agents|protective agents|mesh-ancestor
25452726|NCT04570254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25452727|NCT04570254|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25452728|NCT04570254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452729|NCT04570254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25452730|NCT04570254|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25452731|NCT04570254|Vasodilator Agents|vasodilator agents|mesh-ancestor
25452732|NCT04570254|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25452733|NCT04570254|Antiviral Agents|antiviral agents|mesh-ancestor
25452734|NCT04570254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25452735|NCT04570254|Expectorants|expectorants|mesh-ancestor
25452736|NCT04570254|Respiratory System Agents|respiratory system agents|mesh-ancestor
25452737|NCT04570254|Antidotes|antidotes|mesh-ancestor
25452738|NCT04570150|Neostigmine|neostigmine|mesh-list
25452739|NCT04570150|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25452740|NCT04570150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452741|NCT04570150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452742|NCT04570150|Cholinergic Agents|cholinergic agents|mesh-ancestor
25452743|NCT04570150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25452744|NCT04570150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452745|NCT04570150|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25452746|NCT04570150|Autonomic Agents|autonomic agents|mesh-ancestor
25452772|NCT04569890|Prednisone|prednisone|mesh-list
25452773|NCT04569890|Certolizumab Pegol|certolizumab pegol|mesh-list
25452774|NCT04569890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25452775|NCT04569890|Glucocorticoids|glucocorticoids|mesh-ancestor
25452776|NCT04569890|Hormones|hormones|mesh-ancestor
25452777|NCT04569890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25452778|NCT04569890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452779|NCT04569890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25452780|NCT04569890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25452781|NCT04569890|Antimalarials|antimalarials|mesh-ancestor
25452782|NCT04569890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25452783|NCT04569890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25452784|NCT04569890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25452785|NCT04569890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452786|NCT04569890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452787|NCT04569890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25452788|NCT04569890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25452789|NCT04569890|Immunologic Factors|immunologic factors|mesh-ancestor
25308874|NCT03043807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308875|NCT03043807|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25308876|NCT03043807|Fertility Agents|fertility agents|mesh-ancestor
25308877|NCT03043807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25308878|NCT03043807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308886|NCT03020875|Acetaminophen|acetaminophen|mesh-list
25452790|NCT04569513|Parathyroid Hormone|parathyroid hormone|mesh-list
25452791|NCT04569513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25452792|NCT04569513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452793|NCT04569630|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25452794|NCT04569630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452795|NCT04569214|PAZ320|paz320|mesh-list
25452796|NCT04569214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25452797|NCT04569214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452798|NCT04569279|Warfarin|warfarin|mesh-list
25452799|NCT04569279|Rivaroxaban|rivaroxaban|mesh-list
25452800|NCT04569279|Anticoagulants|anticoagulants|mesh-ancestor
25452801|NCT04569279|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25452802|NCT04569279|Antithrombins|antithrombins|mesh-ancestor
25452803|NCT04569279|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25452804|NCT04569279|Protease Inhibitors|protease inhibitors|mesh-ancestor
25452805|NCT04569279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452806|NCT04569279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452808|NCT04568863|Antioxidants|antioxidants|mesh-ancestor
25452809|NCT04568863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452810|NCT04568863|Protective Agents|protective agents|mesh-ancestor
25452811|NCT04568863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452812|NCT04568863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25452813|NCT04568772|Atovaquone|atovaquone|mesh-list
25452814|NCT04568772|Proguanil|proguanil|mesh-list
25452815|NCT04568772|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
25452816|NCT04568772|Esomeprazole|esomeprazole|mesh-list
25452817|NCT04568772|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25452818|NCT04568772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25452819|NCT04568772|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25452820|NCT04568772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452821|NCT04568772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452822|NCT04568772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25452823|NCT04568772|Antimalarials|antimalarials|mesh-ancestor
25452824|NCT04568772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25452825|NCT04568772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25452826|NCT04568772|Antimetabolites|antimetabolites|mesh-ancestor
25452827|NCT04568603|Islatravir|islatravir|mesh-list
25452828|NCT04568603|Methadone|methadone|mesh-list
25452829|NCT04568603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25452830|NCT04568603|Narcotics|narcotics|mesh-ancestor
25452831|NCT04568603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25452832|NCT04568603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452833|NCT04568603|Analgesics|analgesics|mesh-ancestor
25452834|NCT04568603|Sensory System Agents|sensory system agents|mesh-ancestor
25452835|NCT04568603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25452836|NCT04568603|Antitussive Agents|antitussive agents|mesh-ancestor
25452837|NCT04568603|Respiratory System Agents|respiratory system agents|mesh-ancestor
25452838|NCT04568603|Antiviral Agents|antiviral agents|mesh-ancestor
25452839|NCT04568603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25452840|NCT04568603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452841|NCT04568603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452842|NCT04568603|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25452843|NCT04568603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25452844|NCT04568603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25452845|NCT04568876|Palmidrol|palmidrol|mesh-list
25452846|NCT04568876|Analgesics|analgesics|mesh-ancestor
25452847|NCT04568876|Sensory System Agents|sensory system agents|mesh-ancestor
25452848|NCT04568876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25452849|NCT04568876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452850|NCT04568876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25452851|NCT04568876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25308949|NCT02809820|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25308950|NCT02809820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25308951|NCT02809820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25308952|NCT02809820|Sympatholytics|sympatholytics|mesh-ancestor
25308953|NCT02809820|Autonomic Agents|autonomic agents|mesh-ancestor
25308954|NCT02809820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25308955|NCT02809820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308956|NCT02809820|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25308957|NCT02809820|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25308958|NCT02809820|Adrenergic Agents|adrenergic agents|mesh-ancestor
25308959|NCT02809820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25308960|NCT02809820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452852|NCT04568876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25452853|NCT04568876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25452854|NCT04568876|Antiviral Agents|antiviral agents|mesh-ancestor
25452855|NCT04568876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25452856|NCT04568876|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25452857|NCT04568876|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25452858|NCT04568876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25452859|NCT04568876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452860|NCT04568876|Hormones|hormones|mesh-ancestor
25452861|NCT04568876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25452862|NCT04568837|Dexamethasone|dexamethasone|mesh-list
25452863|NCT04568837|Dexamethasone acetate|dexamethasone acetate|mesh-list
25452864|NCT04568837|Prednisone|prednisone|mesh-list
25452865|NCT04568837|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25452866|NCT04568837|BB 1101|bb 1101|mesh-list
25452867|NCT04568837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25452868|NCT04568837|Antiemetics|antiemetics|mesh-ancestor
25452869|NCT04568837|Autonomic Agents|autonomic agents|mesh-ancestor
25452870|NCT04568837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25452871|NCT04568837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452872|NCT04568837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25452873|NCT04568837|Glucocorticoids|glucocorticoids|mesh-ancestor
25452874|NCT04568837|Hormones|hormones|mesh-ancestor
25452875|NCT04568837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25452876|NCT04568837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25452877|NCT04568837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25452878|NCT04568837|Protease Inhibitors|protease inhibitors|mesh-ancestor
25452879|NCT04568837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452880|NCT04568837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452881|NCT04568265|Entecavir|entecavir|mesh-list
25452882|NCT04568265|Antiviral Agents|antiviral agents|mesh-ancestor
25452883|NCT04568265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25452884|NCT04568421|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25452885|NCT04568421|Immunologic Factors|immunologic factors|mesh-ancestor
25452886|NCT04568421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452887|NCT04568304|Gemcitabine|gemcitabine|mesh-list
25452888|NCT04568304|Cisplatin|cisplatin|mesh-list
25452889|NCT04568304|Carboplatin|carboplatin|mesh-list
25452890|NCT04568304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25452891|NCT04568304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25452892|NCT04568304|Antimetabolites|antimetabolites|mesh-ancestor
25452893|NCT04568304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452894|NCT04568304|Antiviral Agents|antiviral agents|mesh-ancestor
25452895|NCT04568304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25452896|NCT04568304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452897|NCT04568304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25452898|NCT04568304|Immunologic Factors|immunologic factors|mesh-ancestor
25452899|NCT04568304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452900|NCT04568096|Tamoxifen|tamoxifen|mesh-list
25452901|NCT04568096|Tretinoin|tretinoin|mesh-list
25452902|NCT04568096|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25452903|NCT04568096|Hormone Antagonists|hormone antagonists|mesh-ancestor
25452904|NCT04568096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25452905|NCT04568096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452906|NCT04568096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25452907|NCT04568096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25452908|NCT04568096|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25452909|NCT04568096|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25452910|NCT04568096|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25452911|NCT04568096|Keratolytic Agents|keratolytic agents|mesh-ancestor
25452912|NCT04568096|Dermatologic Agents|dermatologic agents|mesh-ancestor
25452913|NCT04568161|Cyclophosphamide|cyclophosphamide|mesh-list
25452914|NCT04568161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25452915|NCT04568161|Immunologic Factors|immunologic factors|mesh-ancestor
25452916|NCT04568161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452917|NCT04568161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25452918|NCT04568161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25452919|NCT04568161|Alkylating Agents|alkylating agents|mesh-ancestor
25452920|NCT04568161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309023|NCT02632448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309024|NCT02632448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309025|NCT02632448|Antiviral Agents|antiviral agents|mesh-ancestor
25309026|NCT02632448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25309027|NCT02632448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25309028|NCT02632448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25452942|NCT04567069|Vaccines|vaccines|mesh-list
25452943|NCT04567069|Immunologic Factors|immunologic factors|mesh-ancestor
25452944|NCT04567069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452945|NCT04566796|Neostigmine|neostigmine|mesh-list
25452946|NCT04566796|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25452947|NCT04566796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452948|NCT04566796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452949|NCT04566796|Cholinergic Agents|cholinergic agents|mesh-ancestor
25452950|NCT04566796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25452951|NCT04566796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452952|NCT04566796|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25452953|NCT04566796|Autonomic Agents|autonomic agents|mesh-ancestor
25644234|NCT01435382|Antimetabolites|antimetabolites|mesh-ancestor
25644235|NCT01435382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452954|NCT04566796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25452955|NCT04566770|Vaccines|vaccines|mesh-list
25452956|NCT04566770|Immunologic Factors|immunologic factors|mesh-ancestor
25452957|NCT04566770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452958|NCT04566718|Metformin|metformin|mesh-list
25452959|NCT04566718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25452960|NCT04566718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452961|NCT04566224|Pyrithione zinc|pyrithione zinc|mesh-list
25452962|NCT04566224|Keratolytic Agents|keratolytic agents|mesh-ancestor
25452963|NCT04566224|Dermatologic Agents|dermatologic agents|mesh-ancestor
25452964|NCT04566211|Amoxicillin|amoxicillin|mesh-list
25452965|NCT04566211|Metronidazole|metronidazole|mesh-list
25452966|NCT04566211|Clarithromycin|clarithromycin|mesh-list
25452967|NCT04566211|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
25452968|NCT04566211|Pantoprazole|pantoprazole|mesh-list
25452969|NCT04566211|Bismuth|bismuth|mesh-list
25452970|NCT04566211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25452971|NCT04566211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25452972|NCT04566211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25452973|NCT04566211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25452974|NCT04566211|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25452975|NCT04566211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25452976|NCT04566211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25452977|NCT04566211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25452978|NCT04566211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25452979|NCT04566211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25452980|NCT04566211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25452981|NCT04566211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25452982|NCT04566211|Antacids|antacids|mesh-ancestor
25452983|NCT04565496|Pembrolizumab|pembrolizumab|mesh-list
25452984|NCT04565496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25452985|NCT04565496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25452986|NCT04565431|Natalizumab|natalizumab|mesh-list
25452987|NCT04565431|Immunologic Factors|immunologic factors|mesh-ancestor
25309167|NCT02349386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25309168|NCT02349386|Estradiol|estradiol|mesh-list
25309169|NCT02349386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25309170|NCT02349386|Estrogens|estrogens|mesh-ancestor
25309171|NCT02349386|Hormones|hormones|mesh-ancestor
25309172|NCT02349386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25309173|NCT02349386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309174|NCT02349386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25309175|NCT02349386|Contraceptive Agents|contraceptive agents|mesh-ancestor
25309176|NCT02349386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25309177|NCT02349386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25309208|NCT02308241|Ribavirin|ribavirin|mesh-list
25309209|NCT02308241|Antimetabolites|antimetabolites|mesh-ancestor
25309210|NCT02308241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309211|NCT02308241|Antiviral Agents|antiviral agents|mesh-ancestor
25309212|NCT02308241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25309213|NCT02257580|Aminocaproic Acid|aminocaproic acid|mesh-list
25309214|NCT02257580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25309215|NCT02257580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25309216|NCT02257580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309217|NCT02257580|Hemostatics|hemostatics|mesh-ancestor
25309218|NCT02257580|Coagulants|coagulants|mesh-ancestor
25309219|NCT02163356|Ketoconazole|ketoconazole|mesh-list
25309220|NCT02163356|Vincristine|vincristine|mesh-list
25309221|NCT02163356|Fenretinide|fenretinide|mesh-list
25309222|NCT02163356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25309223|NCT02163356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309224|NCT02163356|Tubulin Modulators|tubulin modulators|mesh-ancestor
25309225|NCT02163356|Antimitotic Agents|antimitotic agents|mesh-ancestor
25822854|NCT00004686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25452988|NCT04565431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25452989|NCT04565184|Artesunate|artesunate|mesh-list
25452990|NCT04565184|Lumefantrine|lumefantrine|mesh-list
25452991|NCT04565184|Artemether|artemether|mesh-list
25452992|NCT04565184|Amodiaquine|amodiaquine|mesh-list
25452993|NCT04565184|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25452994|NCT04565184|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
25452995|NCT04565184|Antimalarials|antimalarials|mesh-ancestor
25452996|NCT04565184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25452997|NCT04565184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25452998|NCT04565184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25452999|NCT04565184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453000|NCT04565184|Antiviral Agents|antiviral agents|mesh-ancestor
25644236|NCT01435382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25644237|NCT01435460|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25644238|NCT01435460|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25644239|NCT01435460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25644240|NCT01435460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25644241|NCT01435460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25644242|NCT01435460|Analgesics|analgesics|mesh-ancestor
25453001|NCT04565184|Schistosomicides|schistosomicides|mesh-ancestor
25453002|NCT04565184|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25453003|NCT04565184|Anthelmintics|anthelmintics|mesh-ancestor
25453004|NCT04565171|Yimitasvir|yimitasvir|mesh-list
25453005|NCT04565171|Antiviral Agents|antiviral agents|mesh-ancestor
25453006|NCT04565171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25453007|NCT04564872|Linagliptin|linagliptin|mesh-list
25453008|NCT04564872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25453009|NCT04564872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453010|NCT04564872|Incretins|incretins|mesh-ancestor
25453011|NCT04564872|Hormones|hormones|mesh-ancestor
25453012|NCT04564872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25453013|NCT04564872|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25453014|NCT04564872|Protease Inhibitors|protease inhibitors|mesh-ancestor
25453015|NCT04564872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453016|NCT04564872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453017|NCT04564638|Cyclosporine|cyclosporine|mesh-list
25453018|NCT04564638|Cyclosporins|cyclosporins|mesh-list
25453019|NCT04564638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453020|NCT04564638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453021|NCT04564638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25453022|NCT04564638|Immunologic Factors|immunologic factors|mesh-ancestor
25453023|NCT04564638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453024|NCT04564638|Antifungal Agents|antifungal agents|mesh-ancestor
25453025|NCT04564638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25453026|NCT04564638|Dermatologic Agents|dermatologic agents|mesh-ancestor
25453027|NCT04564638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25453028|NCT04564638|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25453029|NCT04564326|Fentanyl|fentanyl|mesh-list
25453030|NCT04564326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25453031|NCT04564326|Narcotics|narcotics|mesh-ancestor
25453032|NCT04564326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25453033|NCT04564326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453034|NCT04564326|Analgesics|analgesics|mesh-ancestor
25453035|NCT04564326|Sensory System Agents|sensory system agents|mesh-ancestor
25453036|NCT04564326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25453037|NCT04564326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25453038|NCT04564326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25453039|NCT04564326|Anesthetics, General|anesthetics, general|mesh-ancestor
25453040|NCT04564326|Anesthetics|anesthetics|mesh-ancestor
25453041|NCT04564690|Vitamin E|vitamin e|mesh-list
25453042|NCT04564690|Selenium|selenium|mesh-list
25453043|NCT04564690|Vitamins|vitamins|mesh-ancestor
25453044|NCT04564690|Micronutrients|micronutrients|mesh-ancestor
25453045|NCT04564690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453046|NCT04564690|Antioxidants|antioxidants|mesh-ancestor
25453047|NCT04564690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453048|NCT04564690|Protective Agents|protective agents|mesh-ancestor
25453049|NCT04564690|Trace Elements|trace elements|mesh-ancestor
25453050|NCT04564469|Furosemide|furosemide|mesh-list
25453051|NCT04564469|Diuretics|diuretics|mesh-ancestor
25453052|NCT04564469|Natriuretic Agents|natriuretic agents|mesh-ancestor
25721296|NCT02484911|Hormones|hormones|mesh-ancestor
25453053|NCT04564469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453054|NCT04564469|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25453055|NCT04564469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25453056|NCT04564469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453057|NCT04564456|Fluticasone|fluticasone|mesh-list
25453058|NCT04564456|Xhance|xhance|mesh-list
25453059|NCT04564456|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25453060|NCT04564456|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25453061|NCT04564456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25453062|NCT04564456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25453063|NCT04564456|Autonomic Agents|autonomic agents|mesh-ancestor
25453064|NCT04564456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25309240|NCT02102477|Androgens|androgens|mesh-list
25656802|NCT01578850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25453065|NCT04564456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453094|NCT04564144|Meclizine|meclizine|mesh-list
25453095|NCT04564144|Antiemetics|antiemetics|mesh-ancestor
25453096|NCT04564144|Autonomic Agents|autonomic agents|mesh-ancestor
24406876|NCT00171496|Dermatologic Agents|dermatologic agents|mesh-ancestor
25644243|NCT01435460|Sensory System Agents|sensory system agents|mesh-ancestor
25644244|NCT01435460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25644245|NCT01435460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453097|NCT04564144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25453098|NCT04564144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453099|NCT04564144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25453100|NCT04564144|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25453101|NCT04564144|Histamine Antagonists|histamine antagonists|mesh-ancestor
25453102|NCT04564144|Histamine Agents|histamine agents|mesh-ancestor
25453103|NCT04564144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25453104|NCT04564144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453105|NCT04564144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25453106|NCT04564040|Acalabrutinib|acalabrutinib|mesh-list
25453107|NCT04564040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25644246|NCT01435460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25644247|NCT01435460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25644248|NCT01435460|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25644249|NCT01435460|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25644250|NCT01435460|Histamine Antagonists|histamine antagonists|mesh-ancestor
25644251|NCT01435460|Histamine Agents|histamine agents|mesh-ancestor
25453108|NCT04564222|Micronutrients|micronutrients|mesh-list
25453109|NCT04564222|Trace Elements|trace elements|mesh-list
25453110|NCT04564222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453111|NCT04563936|Goserelin|goserelin|mesh-list
25453112|NCT04563936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25453113|NCT04563936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453114|NCT04563975|Paclitaxel|paclitaxel|mesh-list
25453115|NCT04563975|Docetaxel|docetaxel|mesh-list
25453116|NCT04563975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25453117|NCT04563975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453118|NCT04563975|Tubulin Modulators|tubulin modulators|mesh-ancestor
25453119|NCT04563975|Antimitotic Agents|antimitotic agents|mesh-ancestor
25453120|NCT04563975|Mitosis Modulators|mitosis modulators|mesh-ancestor
25453121|NCT04563975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453122|NCT04563962|Methamphetamine|methamphetamine|mesh-list
25453123|NCT04563962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25453124|NCT04563962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453125|NCT04563962|Sympathomimetics|sympathomimetics|mesh-ancestor
25453126|NCT04563962|Autonomic Agents|autonomic agents|mesh-ancestor
25453127|NCT04563962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25453128|NCT04563962|Dopamine Agents|dopamine agents|mesh-ancestor
25453129|NCT04563962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25453130|NCT04563962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453131|NCT04563962|Adrenergic Agents|adrenergic agents|mesh-ancestor
25453132|NCT04563962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25453133|NCT04563962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25453134|NCT04563962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25453135|NCT04563962|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25453136|NCT04563871|Osimertinib|osimertinib|mesh-list
25453137|NCT04563871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453138|NCT04563871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25453139|NCT04563871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453140|NCT04563871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453141|NCT04564001|Infliximab|infliximab|mesh-list
25453142|NCT04564001|Dermatologic Agents|dermatologic agents|mesh-ancestor
25453143|NCT04564001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25453144|NCT04564001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25453145|NCT04563780|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
25453146|NCT04563780|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25453147|NCT04563780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453148|NCT04563299|Prednisolone|prednisolone|mesh-list
25453149|NCT04563299|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25453150|NCT04563299|Methylprednisolone|methylprednisolone|mesh-list
25453151|NCT04563299|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25453152|NCT04563299|Prednisolone acetate|prednisolone acetate|mesh-list
25453153|NCT04563299|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25453154|NCT04563299|Prednisolone phosphate|prednisolone phosphate|mesh-list
25453155|NCT04563299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25453156|NCT04563299|Glucocorticoids|glucocorticoids|mesh-ancestor
25453157|NCT04563299|Hormones|hormones|mesh-ancestor
24407016|NCT00171717|Cyclosporine|cyclosporine|mesh-list
25453158|NCT04563299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25453159|NCT04563299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407017|NCT00171717|Cyclosporins|cyclosporins|mesh-list
25453160|NCT04563299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25453161|NCT04563299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453162|NCT04563299|Antiemetics|antiemetics|mesh-ancestor
25453163|NCT04563299|Autonomic Agents|autonomic agents|mesh-ancestor
25453164|NCT04563299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25309388|NCT01187810|Antimetabolites|antimetabolites|mesh-ancestor
25309389|NCT01187810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309390|NCT01187810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309391|NCT01187810|Dermatologic Agents|dermatologic agents|mesh-ancestor
25453165|NCT04563299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25453166|NCT04563299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25453167|NCT04563299|Protective Agents|protective agents|mesh-ancestor
25453168|NCT04563260|Palonosetron|palonosetron|mesh-list
25453169|NCT04563260|Antiemetics|antiemetics|mesh-ancestor
25453170|NCT04563260|Autonomic Agents|autonomic agents|mesh-ancestor
25453171|NCT04563260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25453172|NCT04563260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453173|NCT04563260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25453174|NCT04563260|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25453175|NCT04563260|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25453176|NCT04563260|Serotonin Agents|serotonin agents|mesh-ancestor
25453177|NCT04563260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25453178|NCT04563260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453179|NCT04563494|Dexamethasone|dexamethasone|mesh-list
25453180|NCT04563494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25453181|NCT04563494|Antiemetics|antiemetics|mesh-ancestor
25453182|NCT04563494|Autonomic Agents|autonomic agents|mesh-ancestor
25453183|NCT04563494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25453184|NCT04563494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453185|NCT04563494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25453186|NCT04563494|Glucocorticoids|glucocorticoids|mesh-ancestor
25453188|NCT04563494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25453189|NCT04563494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25453190|NCT04563494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453191|NCT04563351|Anesthetics|anesthetics|mesh-list
25453192|NCT04563351|Anesthetics, Local|anesthetics, local|mesh-list
25453193|NCT04563351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25453194|NCT04563351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453195|NCT04563351|Sensory System Agents|sensory system agents|mesh-ancestor
25453196|NCT04563351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25453197|NCT04563429|Vitamin A|vitamin a|mesh-list
25453198|NCT04563429|Vitamins|vitamins|mesh-ancestor
25453199|NCT04563429|Micronutrients|micronutrients|mesh-ancestor
25453200|NCT04563429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453201|NCT04563000|Ascorbic Acid|ascorbic acid|mesh-list
25453202|NCT04563000|Vitamins|vitamins|mesh-ancestor
25453203|NCT04563000|Micronutrients|micronutrients|mesh-ancestor
25453204|NCT04563000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453205|NCT04563000|Antioxidants|antioxidants|mesh-ancestor
25453206|NCT04563000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453207|NCT04563000|Protective Agents|protective agents|mesh-ancestor
25453208|NCT04561934|Fluorides|fluorides|mesh-list
25453209|NCT04561934|Cariostatic Agents|cariostatic agents|mesh-ancestor
25453210|NCT04561934|Protective Agents|protective agents|mesh-ancestor
25453211|NCT04561934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453212|NCT04561960|Fluorides|fluorides|mesh-list
25453213|NCT04561960|Cariostatic Agents|cariostatic agents|mesh-ancestor
25453214|NCT04561960|Protective Agents|protective agents|mesh-ancestor
25453215|NCT04561960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453216|NCT04562103|Epinephrine|epinephrine|mesh-list
25453217|NCT04562103|Ropivacaine|ropivacaine|mesh-list
25453218|NCT04562103|Anesthetics, Local|anesthetics, local|mesh-ancestor
25453219|NCT04562103|Anesthetics|anesthetics|mesh-ancestor
25453220|NCT04562103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25453221|NCT04562103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453222|NCT04562103|Sensory System Agents|sensory system agents|mesh-ancestor
25453223|NCT04562103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25453224|NCT04562103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25453225|NCT04562103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25453226|NCT04562103|Adrenergic Agents|adrenergic agents|mesh-ancestor
25453227|NCT04562103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25453228|NCT04562103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453229|NCT04562103|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25453230|NCT04562103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25453231|NCT04562103|Autonomic Agents|autonomic agents|mesh-ancestor
25644252|NCT01435460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25644253|NCT01435460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644254|NCT01435577|Tapentadol|tapentadol|mesh-list
25644255|NCT01435577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25644256|NCT01435577|Narcotics|narcotics|mesh-ancestor
25644257|NCT01435577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25644258|NCT01435577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644259|NCT01435577|Analgesics|analgesics|mesh-ancestor
25644260|NCT01435577|Sensory System Agents|sensory system agents|mesh-ancestor
25644261|NCT01435577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25453232|NCT04562103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25453233|NCT04562103|Respiratory System Agents|respiratory system agents|mesh-ancestor
25453234|NCT04562103|Mydriatics|mydriatics|mesh-ancestor
25453235|NCT04562103|Sympathomimetics|sympathomimetics|mesh-ancestor
25453236|NCT04562103|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25453237|NCT04561635|Micronutrients|micronutrients|mesh-list
25453238|NCT04561635|Trace Elements|trace elements|mesh-list
25453239|NCT04561635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453240|NCT04561921|Magnesium Sulfate|magnesium sulfate|mesh-list
25453241|NCT04561921|Nordefrin|nordefrin|mesh-list
25453242|NCT04561921|Mepivacaine|mepivacaine|mesh-list
25309573|NCT04895098|Ezetimibe|ezetimibe|mesh-list
25309574|NCT04895098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
25453259|NCT04561687|Azelastine|azelastine|mesh-list
25453260|NCT04561687|Budesonide|budesonide|mesh-list
25453261|NCT04561687|Montelukast|montelukast|mesh-list
25453262|NCT04561687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25453263|NCT04561687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25453264|NCT04561687|Autonomic Agents|autonomic agents|mesh-ancestor
25453265|NCT04561687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25453266|NCT04561687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453267|NCT04561687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25453268|NCT04561687|Respiratory System Agents|respiratory system agents|mesh-ancestor
25453269|NCT04561687|Glucocorticoids|glucocorticoids|mesh-ancestor
25453270|NCT04561687|Hormones|hormones|mesh-ancestor
25453271|NCT04561687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25453272|NCT04561687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25453273|NCT04561687|Hormone Antagonists|hormone antagonists|mesh-ancestor
25453274|NCT04561687|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25453275|NCT04561687|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25453276|NCT04561687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453277|NCT04561687|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25453278|NCT04561687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453279|NCT04561687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25453280|NCT04561687|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25453281|NCT04561687|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25453282|NCT04561687|Histamine Antagonists|histamine antagonists|mesh-ancestor
25453283|NCT04561687|Histamine Agents|histamine agents|mesh-ancestor
25453284|NCT04561687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25453285|NCT04561947|Mitogens|mitogens|mesh-list
25453286|NCT04561947|Mitosis Modulators|mitosis modulators|mesh-ancestor
25453287|NCT04561947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453288|NCT04561466|Bezafibrate|bezafibrate|mesh-list
25453289|NCT04561466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25453290|NCT04561466|Antimetabolites|antimetabolites|mesh-ancestor
25453291|NCT04561466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453292|NCT04561466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25453293|NCT04561856|Dexamethasone|dexamethasone|mesh-list
25453294|NCT04561856|Dexamethasone acetate|dexamethasone acetate|mesh-list
25453295|NCT04561856|BB 1101|bb 1101|mesh-list
25453296|NCT04561856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25453297|NCT04561856|Antiemetics|antiemetics|mesh-ancestor
25453298|NCT04561856|Autonomic Agents|autonomic agents|mesh-ancestor
25453299|NCT04561856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25453300|NCT04561856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453301|NCT04561856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25453302|NCT04561856|Glucocorticoids|glucocorticoids|mesh-ancestor
25453303|NCT04561856|Hormones|hormones|mesh-ancestor
25453304|NCT04561856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25453305|NCT04561856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25453306|NCT04561856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453307|NCT04561856|Protease Inhibitors|protease inhibitors|mesh-ancestor
25453308|NCT04561856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453309|NCT04561856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453310|NCT04561817|Paclitaxel|paclitaxel|mesh-list
25453311|NCT04561817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25644262|NCT01435577|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25453312|NCT04561817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453313|NCT04561817|Tubulin Modulators|tubulin modulators|mesh-ancestor
25453314|NCT04561817|Antimitotic Agents|antimitotic agents|mesh-ancestor
25453315|NCT04561817|Mitosis Modulators|mitosis modulators|mesh-ancestor
25453316|NCT04561817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453318|NCT04561219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25453319|NCT04561219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25453320|NCT04561336|Cetuximab|cetuximab|mesh-list
25453321|NCT04561336|Avelumab|avelumab|mesh-list
25453322|NCT04561336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25453323|NCT04561336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453324|NCT04561076|Myeloma Proteins|myeloma proteins|mesh-list
25309606|NCT04737343|Antimetabolites|antimetabolites|mesh-ancestor
25309607|NCT04737343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309608|NCT04737343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25309609|NCT04737343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309610|NCT04737343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25309611|NCT04737343|Immunologic Factors|immunologic factors|mesh-ancestor
25309612|NCT04737343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309613|NCT04737343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25309614|NCT04737343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453325|NCT04561076|Paraproteins|paraproteins|mesh-list
25453326|NCT04561076|Immunologic Factors|immunologic factors|mesh-ancestor
25453327|NCT04561076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453328|NCT04560894|Sorafenib|sorafenib|mesh-list
25453329|NCT04560894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453330|NCT04560894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25453331|NCT04560894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453332|NCT04560894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453333|NCT04560465|Tranexamic Acid|tranexamic acid|mesh-list
25453334|NCT04560465|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25453335|NCT04560465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25453336|NCT04560465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453337|NCT04560465|Hemostatics|hemostatics|mesh-ancestor
25453338|NCT04560465|Coagulants|coagulants|mesh-ancestor
25453339|NCT04560322|Venetoclax|venetoclax|mesh-list
25453340|NCT04560322|Obinutuzumab|obinutuzumab|mesh-list
25453341|NCT04560322|Acalabrutinib|acalabrutinib|mesh-list
25453342|NCT04560322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453343|NCT04560322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25453344|NCT04560751|Lenvatinib|lenvatinib|mesh-list
25453345|NCT04560751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453346|NCT04560751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25453347|NCT04560751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453348|NCT04560751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453349|NCT04560816|Moxifloxacin|moxifloxacin|mesh-list
25453350|NCT04560816|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
25453351|NCT04560816|Choline|choline|mesh-list
25453352|NCT04560816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25453353|NCT04560816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25453354|NCT04560816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25453355|NCT04560816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25453356|NCT04560816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453357|NCT04560816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453358|NCT04560816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453359|NCT04560816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453360|NCT04560816|Lipotropic Agents|lipotropic agents|mesh-ancestor
25453361|NCT04560816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25453362|NCT04560816|Antimetabolites|antimetabolites|mesh-ancestor
25453363|NCT04560816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25453364|NCT04560816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25453365|NCT04560816|Nootropic Agents|nootropic agents|mesh-ancestor
25453366|NCT04560816|Chelating Agents|chelating agents|mesh-ancestor
25453367|NCT04560816|Sequestering Agents|sequestering agents|mesh-ancestor
25453368|NCT04560816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25453369|NCT04560816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25453370|NCT04560816|Growth Substances|growth substances|mesh-ancestor
25453371|NCT04560816|Growth Inhibitors|growth inhibitors|mesh-ancestor
25453372|NCT04560569|Antibodies|antibodies|mesh-list
25453373|NCT04560569|Immunologic Factors|immunologic factors|mesh-ancestor
25453374|NCT04560569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453375|NCT04560426|Parathyroid Hormone|parathyroid hormone|mesh-list
25453376|NCT04560426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25453377|NCT04560426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644263|NCT01435577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25644264|NCT01435577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25453378|NCT04560673|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25453379|NCT04560673|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25453380|NCT04560673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25453381|NCT04560673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25453382|NCT04560673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453383|NCT04560673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25453384|NCT04560673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453386|NCT04560673|Sensory System Agents|sensory system agents|mesh-ancestor
25453387|NCT04560673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25453388|NCT04560673|Antidepressive Agents|antidepressive agents|mesh-ancestor
25453389|NCT04560673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25453390|NCT04560673|Dopamine Agents|dopamine agents|mesh-ancestor
25453391|NCT04559880|Tranexamic Acid|tranexamic acid|mesh-list
25453392|NCT04559880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25453393|NCT04559880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25453394|NCT04559880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453395|NCT04559880|Hemostatics|hemostatics|mesh-ancestor
25453396|NCT04559880|Coagulants|coagulants|mesh-ancestor
25453397|NCT04560231|Remdesivir|remdesivir|mesh-list
25453398|NCT04560231|Antimetabolites|antimetabolites|mesh-ancestor
25453399|NCT04560231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453400|NCT04560231|Antiviral Agents|antiviral agents|mesh-ancestor
25453401|NCT04560231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25453402|NCT04560101|Botulinum Toxins|botulinum toxins|mesh-list
25453403|NCT04560101|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25453404|NCT04560101|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25453405|NCT04560101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25453406|NCT04560101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25453407|NCT04560101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453408|NCT04560101|Cholinergic Agents|cholinergic agents|mesh-ancestor
25453409|NCT04560101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25453410|NCT04560101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453411|NCT04560101|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25453412|NCT04560101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25453413|NCT04560218|Misoprostol|misoprostol|mesh-list
25453414|NCT04560218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25453415|NCT04560218|Abortifacient Agents|abortifacient agents|mesh-ancestor
25453416|NCT04560218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25453417|NCT04560218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453418|NCT04560218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25453419|NCT04560218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25453420|NCT04560218|Oxytocics|oxytocics|mesh-ancestor
25453421|NCT04560049|Phenol|phenol|mesh-list
25453422|NCT04560049|Silver Nitrate|silver nitrate|mesh-list
25453423|NCT04560049|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25453424|NCT04560049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25453425|NCT04560049|Disinfectants|disinfectants|mesh-ancestor
25453426|NCT04560049|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25453427|NCT04560049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25453428|NCT04559841|Simvastatin|simvastatin|mesh-list
25453429|NCT04559841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25453430|NCT04559841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25453431|NCT04559841|Antimetabolites|antimetabolites|mesh-ancestor
25453432|NCT04559841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453433|NCT04559841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25453434|NCT04559841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25453435|NCT04559841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453436|NCT04559425|Dexamethasone|dexamethasone|mesh-list
25453437|NCT04559425|Dexamethasone acetate|dexamethasone acetate|mesh-list
25453438|NCT04559425|BB 1101|bb 1101|mesh-list
25453439|NCT04559425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25453440|NCT04559425|Antiemetics|antiemetics|mesh-ancestor
25453441|NCT04559425|Autonomic Agents|autonomic agents|mesh-ancestor
25453442|NCT04559425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25453443|NCT04559425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453444|NCT04559425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25453445|NCT04559425|Glucocorticoids|glucocorticoids|mesh-ancestor
25453446|NCT04559425|Hormones|hormones|mesh-ancestor
25453447|NCT04559425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25453448|NCT04559425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24407761|NCT00175396|Ascorbic Acid|ascorbic acid|mesh-list
25453449|NCT04559425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453450|NCT04559425|Protease Inhibitors|protease inhibitors|mesh-ancestor
25453451|NCT04559425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453452|NCT04559425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453453|NCT04559568|Midazolam|midazolam|mesh-list
25453454|NCT04559568|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25453455|NCT04559568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25453456|NCT04559568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25453457|NCT04559568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453458|NCT04559568|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25453459|NCT04559568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25453460|NCT04559568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25453461|NCT04559568|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25453462|NCT04559568|Anesthetics, General|anesthetics, general|mesh-ancestor
25453463|NCT04559568|Anesthetics|anesthetics|mesh-ancestor
25453464|NCT04559568|GABA Modulators|gaba modulators|mesh-ancestor
25453465|NCT04559568|GABA Agents|gaba agents|mesh-ancestor
25453466|NCT04559568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25453467|NCT04559568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309758|NCT05244694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25309759|NCT05244694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309760|NCT05244577|Olanzapine|olanzapine|mesh-list
25309761|NCT05244577|Antiemetics|antiemetics|mesh-ancestor
25309762|NCT05244577|Autonomic Agents|autonomic agents|mesh-ancestor
25309763|NCT05244577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25309764|NCT05244577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309765|NCT05244577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25453482|NCT04559308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25453483|NCT04559308|Alkylating Agents|alkylating agents|mesh-ancestor
25453484|NCT04559308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25453485|NCT04559308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25453486|NCT04559308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25453487|NCT04559308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25453488|NCT04559308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25453489|NCT04559308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453490|NCT04559165|Chitosan|chitosan|mesh-list
25453491|NCT04559165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25453492|NCT04559165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25453493|NCT04559165|Antimetabolites|antimetabolites|mesh-ancestor
25453494|NCT04559165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453495|NCT04559165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25453496|NCT04559165|Chelating Agents|chelating agents|mesh-ancestor
25453497|NCT04559165|Sequestering Agents|sequestering agents|mesh-ancestor
25453498|NCT04559165|Hemostatics|hemostatics|mesh-ancestor
25453499|NCT04559165|Coagulants|coagulants|mesh-ancestor
25453500|NCT04559113|Methylprednisolone|methylprednisolone|mesh-list
25453501|NCT04559113|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25453502|NCT04559113|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25453503|NCT04559113|Prednisolone|prednisolone|mesh-list
25453504|NCT04559113|Prednisolone acetate|prednisolone acetate|mesh-list
25453505|NCT04559113|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25453506|NCT04559113|Prednisolone phosphate|prednisolone phosphate|mesh-list
25453507|NCT04559113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25453508|NCT04559113|Antiemetics|antiemetics|mesh-ancestor
25453509|NCT04559113|Autonomic Agents|autonomic agents|mesh-ancestor
25453510|NCT04559113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25453511|NCT04559113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453512|NCT04559113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25453513|NCT04559113|Glucocorticoids|glucocorticoids|mesh-ancestor
25453514|NCT04559113|Hormones|hormones|mesh-ancestor
25453515|NCT04559113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25453516|NCT04559113|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25453517|NCT04559113|Protective Agents|protective agents|mesh-ancestor
25453518|NCT04559113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25453519|NCT04559113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309835|NCT05243706|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25309836|NCT05243706|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25309837|NCT05243706|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25309838|NCT05243706|Histamine Antagonists|histamine antagonists|mesh-ancestor
25309839|NCT05243706|Histamine Agents|histamine agents|mesh-ancestor
25309840|NCT05243706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25309841|NCT05243706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309842|NCT05243706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309843|NCT05243693|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25309844|NCT05243693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25657149|NCT01583374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25644265|NCT01435577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644266|NCT01435577|Adrenergic Agents|adrenergic agents|mesh-ancestor
25453521|NCT04559074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25453522|NCT04559074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25453523|NCT04559074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25453524|NCT04559074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453525|NCT04559074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25453526|NCT04559074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453527|NCT04559074|Vasodilator Agents|vasodilator agents|mesh-ancestor
25453528|NCT04559048|Tacrolimus|tacrolimus|mesh-list
25453529|NCT04559048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25453530|NCT04559048|Immunologic Factors|immunologic factors|mesh-ancestor
25453531|NCT04559048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453532|NCT04559048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25453533|NCT04559048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453534|NCT04559048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453535|NCT04558892|Enoxaparin|enoxaparin|mesh-list
25453536|NCT04558892|Anticoagulants|anticoagulants|mesh-ancestor
25453537|NCT04558892|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25453538|NCT04558892|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25453539|NCT04558892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453540|NCT04558697|Tea Tree Oil|tea tree oil|mesh-list
25453541|NCT04558697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25453542|NCT04558697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25453543|NCT04558580|Rufinamide|rufinamide|mesh-list
25453544|NCT04558580|Anticonvulsants|anticonvulsants|mesh-ancestor
25453545|NCT04558580|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25453546|NCT04558580|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25453547|NCT04558580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25453548|NCT04558580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453549|NCT04558463|Oseltamivir|oseltamivir|mesh-list
25453550|NCT04558463|Favipiravir|favipiravir|mesh-list
25453551|NCT04558463|Antiviral Agents|antiviral agents|mesh-ancestor
25453552|NCT04558463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25453553|NCT04558463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453554|NCT04558463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453555|NCT04558268|Folic Acid|folic acid|mesh-list
25453556|NCT04558268|Prednisone|prednisone|mesh-list
25453557|NCT04558268|Progesterone|progesterone|mesh-list
25453558|NCT04558268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25453559|NCT04558268|Glucocorticoids|glucocorticoids|mesh-ancestor
25453560|NCT04558268|Hormones|hormones|mesh-ancestor
25453561|NCT04558268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25453562|NCT04558268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453563|NCT04558268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25453564|NCT04558268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453565|NCT04558268|Progestins|progestins|mesh-ancestor
25453566|NCT04558268|Hematinics|hematinics|mesh-ancestor
25453567|NCT04558268|Vitamin B Complex|vitamin b complex|mesh-ancestor
25453568|NCT04558268|Vitamins|vitamins|mesh-ancestor
25453569|NCT04558268|Micronutrients|micronutrients|mesh-ancestor
25453570|NCT04558424|Ascorbic Acid|ascorbic acid|mesh-list
25453571|NCT04558424|Antioxidants|antioxidants|mesh-ancestor
25453572|NCT04558424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453573|NCT04558424|Protective Agents|protective agents|mesh-ancestor
25453574|NCT04558424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453575|NCT04558424|Vitamins|vitamins|mesh-ancestor
25453576|NCT04558424|Micronutrients|micronutrients|mesh-ancestor
25453577|NCT04558021|Niclosamide|niclosamide|mesh-list
25453578|NCT04558021|Anticestodal Agents|anticestodal agents|mesh-ancestor
25453579|NCT04558021|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25453580|NCT04558021|Anthelmintics|anthelmintics|mesh-ancestor
25453581|NCT04558021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25453582|NCT04558021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25453583|NCT04558021|Antinematodal Agents|antinematodal agents|mesh-ancestor
25309919|NCT05196945|Amoxicillin|amoxicillin|mesh-list
25309920|NCT05196945|Clarithromycin|clarithromycin|mesh-list
25309921|NCT05196945|Potassium Citrate|potassium citrate|mesh-list
25309922|NCT05196945|Esomeprazole|esomeprazole|mesh-list
25309923|NCT05196945|Bismuth|bismuth|mesh-list
25309924|NCT05196945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309925|NCT05196945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25309926|NCT05196945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25309927|NCT05196945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25309928|NCT05196945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25309929|NCT05196945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25309930|NCT05196945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453584|NCT04557878|Mitogens|mitogens|mesh-list
25453602|NCT04557475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25453603|NCT04557475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25453604|NCT04557475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453605|NCT04557475|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25453606|NCT04557475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25453607|NCT04557475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453608|NCT04557475|Antipyretics|antipyretics|mesh-ancestor
25453609|NCT04557397|Itraconazole|itraconazole|mesh-list
25453610|NCT04557397|Rifampin|rifampin|mesh-list
25453611|NCT04557397|Antifungal Agents|antifungal agents|mesh-ancestor
25453612|NCT04557397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25453613|NCT04557397|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25453614|NCT04557397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25453615|NCT04557397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453616|NCT04557397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453617|NCT04557397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25453618|NCT04557397|Hormone Antagonists|hormone antagonists|mesh-ancestor
25453619|NCT04557397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25453620|NCT04557397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453621|NCT04557397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25453622|NCT04557397|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25453623|NCT04557397|Antitubercular Agents|antitubercular agents|mesh-ancestor
25453624|NCT04557397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25453625|NCT04557397|Leprostatic Agents|leprostatic agents|mesh-ancestor
25453626|NCT04557397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25453627|NCT04557397|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25453628|NCT04557397|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25453629|NCT04557397|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25453630|NCT04557397|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25453631|NCT04557397|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25453632|NCT04557397|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25453633|NCT04557384|Ramucirumab|ramucirumab|mesh-list
25453634|NCT04557384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309984|NCT05119296|Pembrolizumab|pembrolizumab|mesh-list
25309985|NCT05119296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25309986|NCT05119296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309990|NCT04920344|Cisplatin|cisplatin|mesh-list
25309991|NCT04920344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453662|NCT04557020|Antibodies|antibodies|mesh-list
25453663|NCT04557020|Immunologic Factors|immunologic factors|mesh-ancestor
25453664|NCT04557020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453665|NCT04557020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25453666|NCT04557020|Antimetabolites|antimetabolites|mesh-ancestor
25453667|NCT04557020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453668|NCT04557020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453669|NCT04557020|Antiviral Agents|antiviral agents|mesh-ancestor
25453670|NCT04557020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25453671|NCT04557020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453672|NCT04557020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25453673|NCT04556929|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25453674|NCT04556929|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25453675|NCT04556929|Dermatologic Agents|dermatologic agents|mesh-ancestor
25453676|NCT04557007|Pembrolizumab|pembrolizumab|mesh-list
25453677|NCT04557007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25453678|NCT04557007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310067|NCT04799015|Hormones|hormones|mesh-ancestor
25453679|NCT04556760|Prednisolone|prednisolone|mesh-list
25453680|NCT04556760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25453681|NCT04556760|Glucocorticoids|glucocorticoids|mesh-ancestor
25453683|NCT04556760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25453684|NCT04556760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453685|NCT04556760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25453686|NCT04556760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453687|NCT04556708|Chlorhexidine|chlorhexidine|mesh-list
25453688|NCT04556708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25453689|NCT04556708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25453690|NCT04556708|Disinfectants|disinfectants|mesh-ancestor
25453691|NCT04556110|Perindopril|perindopril|mesh-list
25453692|NCT04556110|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25453693|NCT04556110|Protease Inhibitors|protease inhibitors|mesh-ancestor
25453694|NCT04556110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453695|NCT04556110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644267|NCT01435577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25644269|NCT01435616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25644270|NCT01435616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644271|NCT01435759|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25644272|NCT01435759|Antidepressive Agents|antidepressive agents|mesh-list
25453696|NCT04556110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25453697|NCT04556136|Vitamin D|vitamin d|mesh-list
25453698|NCT04556136|Vitamins|vitamins|mesh-ancestor
25453699|NCT04556136|Micronutrients|micronutrients|mesh-ancestor
25453700|NCT04556136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644273|NCT01435759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25453701|NCT04556136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25453702|NCT04556058|Perindopril|perindopril|mesh-list
25453703|NCT04556058|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25453704|NCT04556058|Protease Inhibitors|protease inhibitors|mesh-ancestor
25453705|NCT04556058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453706|NCT04556058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453707|NCT04556058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25453708|NCT04556279|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
25453709|NCT04556279|Hormone Antagonists|hormone antagonists|mesh-ancestor
25453710|NCT04556279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25453711|NCT04556279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453712|NCT04556279|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25453713|NCT04556279|Diuretics|diuretics|mesh-ancestor
25453714|NCT04556279|Natriuretic Agents|natriuretic agents|mesh-ancestor
25453715|NCT04556032|Ergothioneine|ergothioneine|mesh-list
25453716|NCT04556032|Antioxidants|antioxidants|mesh-ancestor
25453717|NCT04556032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453718|NCT04556032|Protective Agents|protective agents|mesh-ancestor
25453719|NCT04556032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453720|NCT04556071|Bevacizumab|bevacizumab|mesh-list
25453721|NCT04556071|Niraparib|niraparib|mesh-list
25453722|NCT04556071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25453723|NCT04556071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453724|NCT04556071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25453725|NCT04556071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25453726|NCT04556071|Growth Substances|growth substances|mesh-ancestor
25453727|NCT04556071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453728|NCT04556071|Growth Inhibitors|growth inhibitors|mesh-ancestor
25453729|NCT04556071|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25453730|NCT04556071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453731|NCT04556071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453732|NCT04555694|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25453733|NCT04555694|Cyclosporine|cyclosporine|mesh-list
25453734|NCT04555694|Dexamethasone|dexamethasone|mesh-list
25453735|NCT04555694|Cyclosporins|cyclosporins|mesh-list
25453736|NCT04555694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25453737|NCT04555694|Antiemetics|antiemetics|mesh-ancestor
25453738|NCT04555694|Autonomic Agents|autonomic agents|mesh-ancestor
25453739|NCT04555694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25453740|NCT04555694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453741|NCT04555694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25453742|NCT04555694|Glucocorticoids|glucocorticoids|mesh-ancestor
25453743|NCT04555694|Hormones|hormones|mesh-ancestor
25453744|NCT04555694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25453745|NCT04555694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25453746|NCT04555694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453747|NCT04555694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453748|NCT04555694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453749|NCT04555694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25310132|NCT04537078|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25310133|NCT04537078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25453750|NCT04555694|Immunologic Factors|immunologic factors|mesh-ancestor
25453751|NCT04555694|Antifungal Agents|antifungal agents|mesh-ancestor
25453752|NCT04555694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25453753|NCT04555694|Dermatologic Agents|dermatologic agents|mesh-ancestor
25453754|NCT04555694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25453755|NCT04555694|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25453756|NCT04555694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25453757|NCT04555733|Lemborexant|lemborexant|mesh-list
25453758|NCT04555733|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25453759|NCT04555733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24906219|NCT04341935|Hormones|hormones|mesh-ancestor
25644274|NCT01435759|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25644275|NCT01435759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644276|NCT01435759|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25644277|NCT01435759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25644278|NCT01435759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25644279|NCT01435759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644280|NCT01435759|Dopamine Agents|dopamine agents|mesh-ancestor
25644281|NCT01435759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25644282|NCT01435798|Dextromethorphan|dextromethorphan|mesh-list
25644283|NCT01435798|Antitussive Agents|antitussive agents|mesh-ancestor
25644284|NCT01435798|Respiratory System Agents|respiratory system agents|mesh-ancestor
25644285|NCT01435798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25453760|NCT04555733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453761|NCT04555733|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25453762|NCT04555733|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25453763|NCT04555733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25453764|NCT04555733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453765|NCT04555707|Betamethasone|betamethasone|mesh-list
25453766|NCT04555707|Betamethasone Valerate|betamethasone valerate|mesh-list
25453767|NCT04555707|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25453768|NCT04555707|Betamethasone benzoate|betamethasone benzoate|mesh-list
25453769|NCT04555707|Apremilast|apremilast|mesh-list
25453770|NCT04555707|Calcipotriene|calcipotriene|mesh-list
25453771|NCT04555707|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25453772|NCT04555707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25453773|NCT04555707|Glucocorticoids|glucocorticoids|mesh-ancestor
25453774|NCT04555707|Hormones|hormones|mesh-ancestor
25453775|NCT04555707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25453776|NCT04555707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453777|NCT04555707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25453778|NCT04555707|Respiratory System Agents|respiratory system agents|mesh-ancestor
25453779|NCT04555707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25453780|NCT04555707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25453781|NCT04555707|Analgesics|analgesics|mesh-ancestor
25453782|NCT04555707|Sensory System Agents|sensory system agents|mesh-ancestor
25453783|NCT04555707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25453784|NCT04555707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25453785|NCT04555707|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25453786|NCT04555707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25453787|NCT04555707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25721382|NCT02486211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25453788|NCT04555707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453789|NCT04555707|Dermatologic Agents|dermatologic agents|mesh-ancestor
25453790|NCT04555525|Sarecycline|sarecycline|mesh-list
25453791|NCT04555525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25453792|NCT04555525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25453793|NCT04555525|Dermatologic Agents|dermatologic agents|mesh-ancestor
25453794|NCT04555304|Paclitaxel|paclitaxel|mesh-list
25453795|NCT04555304|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25453796|NCT04555304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25453797|NCT04555304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453798|NCT04555304|Tubulin Modulators|tubulin modulators|mesh-ancestor
25453799|NCT04555304|Antimitotic Agents|antimitotic agents|mesh-ancestor
25453800|NCT04555304|Mitosis Modulators|mitosis modulators|mesh-ancestor
25453801|NCT04555304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453802|NCT04555291|Ropivacaine|ropivacaine|mesh-list
25453803|NCT04555291|Anesthetics, Local|anesthetics, local|mesh-ancestor
25453804|NCT04555291|Anesthetics|anesthetics|mesh-ancestor
25453805|NCT04555291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25453806|NCT04555291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453807|NCT04555291|Sensory System Agents|sensory system agents|mesh-ancestor
25453808|NCT04555291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25453809|NCT04554979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25453810|NCT04554979|Hydroxychloroquine|hydroxychloroquine|mesh-list
25453811|NCT04554979|Anticoagulants|anticoagulants|mesh-list
25453812|NCT04554979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25453813|NCT04554979|Antimalarials|antimalarials|mesh-ancestor
25310207|NCT04298229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25310208|NCT04298229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310209|NCT04298229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25310210|NCT04298229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310211|NCT04298229|Natriuretic Agents|natriuretic agents|mesh-ancestor
25310224|NCT04268849|Ascorbic Acid|ascorbic acid|mesh-list
25644286|NCT01435798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25644287|NCT01435798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25644288|NCT01435798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644289|NCT01435798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644290|NCT01435824|Amoxicillin|amoxicillin|mesh-list
25644291|NCT01435824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25644292|NCT01435824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25644293|NCT01435928|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25644294|NCT01435928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25310225|NCT04268849|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25310226|NCT04268849|Vitamins|vitamins|mesh-ancestor
25310227|NCT04268849|Micronutrients|micronutrients|mesh-ancestor
25310228|NCT04268849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310229|NCT04268849|Antioxidants|antioxidants|mesh-ancestor
25453824|NCT04554680|Trametinib|trametinib|mesh-list
25453825|NCT04554680|Dabrafenib|dabrafenib|mesh-list
25453826|NCT04554680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453827|NCT04554680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25453828|NCT04554680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453829|NCT04554680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453830|NCT04554615|Insulin|insulin|mesh-list
25453831|NCT04554615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25453832|NCT04554615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453833|NCT04554862|Ketorolac|ketorolac|mesh-list
25453834|NCT04554862|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25453835|NCT04554862|Magnesium Sulfate|magnesium sulfate|mesh-list
25453836|NCT04554862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25453837|NCT04554862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25453838|NCT04554862|Analgesics|analgesics|mesh-ancestor
25453839|NCT04554862|Sensory System Agents|sensory system agents|mesh-ancestor
25453840|NCT04554862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25453841|NCT04554862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453842|NCT04554862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25453843|NCT04554862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25453844|NCT04554862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25453845|NCT04554862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453846|NCT04554862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453847|NCT04554862|Anesthetics|anesthetics|mesh-ancestor
25453848|NCT04554862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25453849|NCT04554862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25453850|NCT04554862|Anticonvulsants|anticonvulsants|mesh-ancestor
25453851|NCT04554862|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25453852|NCT04554862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25453853|NCT04554862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25453854|NCT04554862|Tocolytic Agents|tocolytic agents|mesh-ancestor
25453855|NCT04554862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25453856|NCT04554589|Glycopyrrolate|glycopyrrolate|mesh-list
25453857|NCT04554589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25453858|NCT04554589|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25453859|NCT04554589|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25453860|NCT04554589|Cholinergic Agents|cholinergic agents|mesh-ancestor
25453861|NCT04554589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25453862|NCT04554589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453863|NCT04554589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453864|NCT04554433|Ethanol|ethanol|mesh-list
25453865|NCT04554433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25453866|NCT04554433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25453867|NCT04554433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25453868|NCT04554433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453869|NCT04554524|Paclitaxel|paclitaxel|mesh-list
25453870|NCT04554524|Pembrolizumab|pembrolizumab|mesh-list
25453871|NCT04554524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25453872|NCT04554524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453873|NCT04554524|Tubulin Modulators|tubulin modulators|mesh-ancestor
25453874|NCT04554524|Antimitotic Agents|antimitotic agents|mesh-ancestor
25453875|NCT04554524|Mitosis Modulators|mitosis modulators|mesh-ancestor
25453876|NCT04554524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453877|NCT04554524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25453878|NCT04554303|Amlodipine|amlodipine|mesh-list
25453879|NCT04554303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25453880|NCT04554303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25453881|NCT04554303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25453882|NCT04554303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644295|NCT01435928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25644296|NCT01435928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25644297|NCT01435928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644298|NCT01435928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25644299|NCT01435928|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25644300|NCT01435928|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25644301|NCT01435928|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25644302|NCT01435928|Adrenergic Agents|adrenergic agents|mesh-ancestor
25644303|NCT01435928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25644304|NCT01435928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644305|NCT01435928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25644306|NCT01435928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25644307|NCT01435928|Serotonin Agents|serotonin agents|mesh-ancestor
25644308|NCT01435928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25644309|NCT01435928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25453883|NCT04554303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25453884|NCT04554303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453885|NCT04554303|Vasodilator Agents|vasodilator agents|mesh-ancestor
25453886|NCT04554771|Paclitaxel|paclitaxel|mesh-list
25453887|NCT04554771|Carboplatin|carboplatin|mesh-list
25453888|NCT04554771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25453889|NCT04554771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453890|NCT04554771|Tubulin Modulators|tubulin modulators|mesh-ancestor
25453891|NCT04554771|Antimitotic Agents|antimitotic agents|mesh-ancestor
25453892|NCT04554771|Mitosis Modulators|mitosis modulators|mesh-ancestor
25453893|NCT04554771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453894|NCT04553601|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25453895|NCT04553601|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25453896|NCT04553601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453897|NCT04553380|Insulin|insulin|mesh-list
25453898|NCT04553380|Insulin Glargine|insulin glargine|mesh-list
25453899|NCT04553380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25453900|NCT04553380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453901|NCT04553393|Decitabine|decitabine|mesh-list
25721394|NCT02486302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25453902|NCT04553393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25453903|NCT04553393|Antimetabolites|antimetabolites|mesh-ancestor
25453904|NCT04553393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453905|NCT04553393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453906|NCT04553393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453907|NCT04553510|Bevacizumab|bevacizumab|mesh-list
25453908|NCT04553510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25453909|NCT04553510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453910|NCT04553510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25453911|NCT04553510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25453912|NCT04553510|Growth Substances|growth substances|mesh-ancestor
25453913|NCT04553510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453914|NCT04553510|Growth Inhibitors|growth inhibitors|mesh-ancestor
25453915|NCT04553458|Ethanol|ethanol|mesh-list
25453916|NCT04553458|Sorafenib|sorafenib|mesh-list
25453917|NCT04553458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453918|NCT04553458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25453919|NCT04553458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453920|NCT04553458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453921|NCT04553458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25453922|NCT04553458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25453923|NCT04553458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25453924|NCT04553458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453925|NCT04553328|Bupivacaine|bupivacaine|mesh-list
25453926|NCT04553328|Anesthetics, Local|anesthetics, local|mesh-ancestor
25453927|NCT04553328|Anesthetics|anesthetics|mesh-ancestor
25453928|NCT04553328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25453929|NCT04553328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453930|NCT04553328|Sensory System Agents|sensory system agents|mesh-ancestor
25453931|NCT04553328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25453932|NCT04552977|Temozolomide|temozolomide|mesh-list
25453933|NCT04552977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25310357|NCT03867188|Sensory System Agents|sensory system agents|mesh-ancestor
25310358|NCT03867188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25310359|NCT03867110|Atorvastatin|atorvastatin|mesh-list
25310360|NCT03867110|Ezetimibe|ezetimibe|mesh-list
25310361|NCT03867110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25310362|NCT03867110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25310363|NCT03867110|Antimetabolites|antimetabolites|mesh-ancestor
25310364|NCT03867110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310366|NCT03867110|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25644310|NCT01435928|Dopamine Agents|dopamine agents|mesh-ancestor
25644311|NCT01436045|Insulin glulisine|insulin glulisine|mesh-list
25644312|NCT01436045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25644313|NCT01436045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644314|NCT01436071|Fluticasone|fluticasone|mesh-list
25644315|NCT01436071|Xhance|xhance|mesh-list
25644316|NCT01436071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25644317|NCT01436071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25644318|NCT01436071|Autonomic Agents|autonomic agents|mesh-ancestor
25644319|NCT01436071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25310367|NCT03867110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25310368|NCT03865082|Nivolumab|nivolumab|mesh-list
25310369|NCT03865082|Ipilimumab|ipilimumab|mesh-list
25310370|NCT03865082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25310371|NCT03865082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310372|NCT03865082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25310373|NCT03865082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453960|NCT04552431|Ciprofloxacin|ciprofloxacin|mesh-list
25453962|NCT04552431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25453963|NCT04552431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25453964|NCT04552431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25453965|NCT04552431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25453966|NCT04552431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25453967|NCT04552431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453968|NCT04552431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25453969|NCT04552431|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25453970|NCT04552431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25453971|NCT04552431|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25453972|NCT04552431|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25453973|NCT04552431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25453974|NCT04552431|Adrenergic Agents|adrenergic agents|mesh-ancestor
25453975|NCT04552431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25453976|NCT04552431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453977|NCT04552431|Urological Agents|urological agents|mesh-ancestor
25453978|NCT04552093|Floxuridine|floxuridine|mesh-list
25453979|NCT04552093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25453980|NCT04552093|Antimetabolites|antimetabolites|mesh-ancestor
25453981|NCT04552093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453982|NCT04552093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310435|NCT03681561|Nivolumab|nivolumab|mesh-list
25453983|NCT04551924|Ropivacaine|ropivacaine|mesh-list
25453984|NCT04551924|Anesthetics, Local|anesthetics, local|mesh-ancestor
25453985|NCT04551924|Anesthetics|anesthetics|mesh-ancestor
25453986|NCT04551924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25453987|NCT04551924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25453988|NCT04551924|Sensory System Agents|sensory system agents|mesh-ancestor
25453989|NCT04551924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25453990|NCT04552067|Enoxaparin|enoxaparin|mesh-list
25453991|NCT04552067|Anticoagulants|anticoagulants|mesh-ancestor
25453992|NCT04552067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25453993|NCT04552067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25453994|NCT04552067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25453995|NCT04551833|Levobupivacaine|levobupivacaine|mesh-list
25453996|NCT04551833|Anesthetics, Local|anesthetics, local|mesh-ancestor
25453997|NCT04551833|Anesthetics|anesthetics|mesh-ancestor
25453998|NCT04551833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25453999|NCT04551833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454000|NCT04551833|Sensory System Agents|sensory system agents|mesh-ancestor
25454001|NCT04551833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25454002|NCT04551755|Doxycycline|doxycycline|mesh-list
25454003|NCT04551755|Ivermectin|ivermectin|mesh-list
25454004|NCT04551755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25454005|NCT04551755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25454006|NCT04551755|Antimalarials|antimalarials|mesh-ancestor
25454007|NCT04551755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25454008|NCT04551755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25454009|NCT04551703|Epinephrine|epinephrine|mesh-list
25454010|NCT04551703|Racepinephrine|racepinephrine|mesh-list
25454011|NCT04551703|Epinephryl borate|epinephryl borate|mesh-list
25454012|NCT04551703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25454013|NCT04551703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25454014|NCT04551703|Adrenergic Agents|adrenergic agents|mesh-ancestor
25454015|NCT04551703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25454016|NCT04551703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454017|NCT04551703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454018|NCT04551703|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25454019|NCT04551703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25454020|NCT04551703|Autonomic Agents|autonomic agents|mesh-ancestor
25454021|NCT04551703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25454022|NCT04551703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25454023|NCT04551703|Respiratory System Agents|respiratory system agents|mesh-ancestor
25454024|NCT04551703|Mydriatics|mydriatics|mesh-ancestor
25454025|NCT04551703|Sympathomimetics|sympathomimetics|mesh-ancestor
25454026|NCT04551703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25454027|NCT04551768|Ribavirin|ribavirin|mesh-list
25454028|NCT04551768|Antimetabolites|antimetabolites|mesh-ancestor
25454029|NCT04551768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454030|NCT04551768|Antiviral Agents|antiviral agents|mesh-ancestor
25454031|NCT04551768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25454032|NCT04551781|Prednisone|prednisone|mesh-list
25454033|NCT04551781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25454034|NCT04551781|Glucocorticoids|glucocorticoids|mesh-ancestor
25454035|NCT04551781|Hormones|hormones|mesh-ancestor
25454036|NCT04551781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25454037|NCT04551781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454038|NCT04551781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25454039|NCT04551781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25454040|NCT04551573|Rifapentine|rifapentine|mesh-list
25454041|NCT04551573|Rifampin|rifampin|mesh-list
25454042|NCT04551573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25454043|NCT04551573|Antitubercular Agents|antitubercular agents|mesh-ancestor
25454044|NCT04551573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25454045|NCT04551573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25454046|NCT04551573|Leprostatic Agents|leprostatic agents|mesh-ancestor
25454047|NCT04551573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25454048|NCT04551573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454049|NCT04551573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454050|NCT04551573|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25454051|NCT04551573|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25310511|NCT03408873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25310512|NCT03408873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310513|NCT03408873|Dopamine Agonists|dopamine agonists|mesh-ancestor
25310514|NCT03408873|Dopamine Agents|dopamine agents|mesh-ancestor
25310515|NCT03408873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25310516|NCT03408873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454052|NCT04551573|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25454053|NCT04551573|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25454054|NCT04551573|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25454055|NCT04551573|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25454056|NCT04551170|Theophylline|theophylline|mesh-list
25454057|NCT04551170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25454058|NCT04551170|Autonomic Agents|autonomic agents|mesh-ancestor
25454059|NCT04551170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25454060|NCT04551170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454061|NCT04551170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25454062|NCT04551170|Respiratory System Agents|respiratory system agents|mesh-ancestor
25454063|NCT04551170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25454064|NCT04551170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454065|NCT04551170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454066|NCT04551170|Vasodilator Agents|vasodilator agents|mesh-ancestor
25454067|NCT04551170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25454068|NCT04551170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25454069|NCT04551170|Purinergic Agents|purinergic agents|mesh-ancestor
25454070|NCT04551170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25454071|NCT04551248|Vaccines|vaccines|mesh-list
25454072|NCT04551248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25454073|NCT04551248|Immunologic Factors|immunologic factors|mesh-ancestor
25454074|NCT04551248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454075|NCT04550936|Isavuconazole|isavuconazole|mesh-list
25454076|NCT04550936|Antifungal Agents|antifungal agents|mesh-ancestor
25454077|NCT04550936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25454078|NCT04550949|Denosumab|denosumab|mesh-list
25454079|NCT04550949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25454080|NCT04550949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454081|NCT04550793|Botulinum Toxins|botulinum toxins|mesh-list
25644320|NCT01436071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644321|NCT01436071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25644322|NCT01436071|Respiratory System Agents|respiratory system agents|mesh-ancestor
25644323|NCT01436071|Dermatologic Agents|dermatologic agents|mesh-ancestor
25644324|NCT01436071|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25644325|NCT01436110|Fluticasone|fluticasone|mesh-list
25644326|NCT01436110|Xhance|xhance|mesh-list
25454082|NCT04550793|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25454083|NCT04550793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25454084|NCT04550793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454085|NCT04550793|Cholinergic Agents|cholinergic agents|mesh-ancestor
25454086|NCT04550793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25454087|NCT04550793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454088|NCT04550858|Rebamipide|rebamipide|mesh-list
25454089|NCT04550858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25454090|NCT04550858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25454091|NCT04550858|Antioxidants|antioxidants|mesh-ancestor
25454092|NCT04550858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454093|NCT04550858|Protective Agents|protective agents|mesh-ancestor
25454094|NCT04550858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454095|NCT04550858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454096|NCT04551196|Acetaminophen|acetaminophen|mesh-list
25454097|NCT04551196|Ibuprofen|ibuprofen|mesh-list
25454098|NCT04551196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25454099|NCT04551196|Analgesics|analgesics|mesh-ancestor
25454100|NCT04551196|Sensory System Agents|sensory system agents|mesh-ancestor
25454101|NCT04551196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25454102|NCT04551196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454103|NCT04551196|Antipyretics|antipyretics|mesh-ancestor
25454104|NCT04551196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25454105|NCT04551196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25454106|NCT04551196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25454107|NCT04551196|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25454108|NCT04551196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454109|NCT04551196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310587|NCT03251911|Ivacaftor|ivacaftor|mesh-list
25310588|NCT03251911|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25310589|NCT03251911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25310590|NCT03251911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310591|NCT03221400|Leucovorin|leucovorin|mesh-list
25310592|NCT03221400|Folic Acid|folic acid|mesh-list
25310593|NCT03221400|Fluorouracil|fluorouracil|mesh-list
25310594|NCT03221400|Niraparib|niraparib|mesh-list
25310595|NCT03221400|Levoleucovorin|levoleucovorin|mesh-list
25310596|NCT03221400|Antimetabolites|antimetabolites|mesh-ancestor
25310597|NCT03221400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310598|NCT03221400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25310599|NCT03221400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310600|NCT03221400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25310601|NCT03221400|Immunologic Factors|immunologic factors|mesh-ancestor
25310606|NCT03221400|Vitamins|vitamins|mesh-ancestor
25454115|NCT04550702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25454116|NCT04550702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454117|NCT04550702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454118|NCT04550702|Urological Agents|urological agents|mesh-ancestor
25454119|NCT04550351|Vaccines|vaccines|mesh-list
25454120|NCT04550351|Immunologic Factors|immunologic factors|mesh-ancestor
25454121|NCT04550351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454122|NCT04550637|Apixaban|apixaban|mesh-list
25454123|NCT04550637|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25454124|NCT04550637|Antithrombins|antithrombins|mesh-ancestor
25454125|NCT04550637|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25454126|NCT04550637|Protease Inhibitors|protease inhibitors|mesh-ancestor
25454127|NCT04550637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454128|NCT04550637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454129|NCT04550637|Anticoagulants|anticoagulants|mesh-ancestor
25454130|NCT04550338|Tranexamic Acid|tranexamic acid|mesh-list
25454131|NCT04550338|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25454132|NCT04550338|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25454133|NCT04550338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454134|NCT04550338|Hemostatics|hemostatics|mesh-ancestor
25454135|NCT04550338|Coagulants|coagulants|mesh-ancestor
25454136|NCT04550234|Allopurinol|allopurinol|mesh-list
25454137|NCT04550234|Verinurad|verinurad|mesh-list
25454138|NCT04550234|Antimetabolites|antimetabolites|mesh-ancestor
24827624|NCT02140450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25644327|NCT01436110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25644328|NCT01436110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25644330|NCT01436110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25644331|NCT01436110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644332|NCT01436110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25644333|NCT01436110|Respiratory System Agents|respiratory system agents|mesh-ancestor
25644334|NCT01436110|Dermatologic Agents|dermatologic agents|mesh-ancestor
25644335|NCT01436110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25644336|NCT01436149|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25644337|NCT01436149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25644338|NCT01436149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644339|NCT01436149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25644340|NCT01436149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25644341|NCT01436149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25644342|NCT01436149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644343|NCT01436149|Dopamine Agents|dopamine agents|mesh-ancestor
25644344|NCT01436149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25644345|NCT01436162|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25644346|NCT01436162|Antidepressive Agents|antidepressive agents|mesh-list
25644347|NCT01436162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25644348|NCT01436162|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25454139|NCT04550234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454140|NCT04550234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25644349|NCT01436162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644350|NCT01436162|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25454141|NCT04550234|Gout Suppressants|gout suppressants|mesh-ancestor
25454142|NCT04550234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25454143|NCT04550234|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25454144|NCT04550234|Antioxidants|antioxidants|mesh-ancestor
25454145|NCT04550234|Protective Agents|protective agents|mesh-ancestor
25454146|NCT04550234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454147|NCT04550585|Insulin|insulin|mesh-list
25454148|NCT04550585|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25454149|NCT04550585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25454150|NCT04550585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454151|NCT04550611|Immunoglobulins|immunoglobulins|mesh-list
25454152|NCT04550611|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25454153|NCT04550611|Antibodies|antibodies|mesh-list
25454154|NCT04550611|gamma-Globulins|gamma-globulins|mesh-list
25454155|NCT04550611|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25454156|NCT04550611|Immunologic Factors|immunologic factors|mesh-ancestor
25454157|NCT04550611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454158|NCT04549935|Prednisolone|prednisolone|mesh-list
25454159|NCT04549935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25454160|NCT04549935|Glucocorticoids|glucocorticoids|mesh-ancestor
25454161|NCT04549935|Hormones|hormones|mesh-ancestor
25454162|NCT04549935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25454163|NCT04549935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454164|NCT04549935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25454165|NCT04549935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25454166|NCT04550078|Calcium, Dietary|calcium, dietary|mesh-list
25454167|NCT04550078|Calcium Carbonate|calcium carbonate|mesh-list
25454168|NCT04550078|Calcium|calcium|mesh-list
25454169|NCT04550078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25454170|NCT04550078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454171|NCT04550078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25454172|NCT04550078|Antacids|antacids|mesh-ancestor
25454173|NCT04550078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454174|NCT04550078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25454175|NCT04549844|Bupivacaine|bupivacaine|mesh-list
25454176|NCT04549844|Anesthetics, Local|anesthetics, local|mesh-ancestor
25454177|NCT04549844|Anesthetics|anesthetics|mesh-ancestor
25454178|NCT04549844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25454179|NCT04549844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454180|NCT04549844|Sensory System Agents|sensory system agents|mesh-ancestor
25454181|NCT04549844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25454182|NCT04549415|Metformin|metformin|mesh-list
25454183|NCT04549415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25454184|NCT04549415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454185|NCT04549012|Tranexamic Acid|tranexamic acid|mesh-list
25454186|NCT04549012|Oxytocin|oxytocin|mesh-list
25454187|NCT04549012|Oxytocics|oxytocics|mesh-ancestor
25454188|NCT04549012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25454189|NCT04549012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454191|NCT04549012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25454192|NCT04549012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454193|NCT04549012|Hemostatics|hemostatics|mesh-ancestor
25454194|NCT04549012|Coagulants|coagulants|mesh-ancestor
25454195|NCT04548700|Prednisone|prednisone|mesh-list
25454196|NCT04548700|Cyclophosphamide|cyclophosphamide|mesh-list
25454197|NCT04548700|Vincristine|vincristine|mesh-list
25454198|NCT04548700|Mitoxantrone|mitoxantrone|mesh-list
25454199|NCT04548700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25454200|NCT04548700|Immunologic Factors|immunologic factors|mesh-ancestor
25454201|NCT04548700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454202|NCT04548700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25454203|NCT04548700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25454204|NCT04548700|Alkylating Agents|alkylating agents|mesh-ancestor
25454205|NCT04548700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454206|NCT04548700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25454207|NCT04548700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25454208|NCT04548700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25454209|NCT04548700|Glucocorticoids|glucocorticoids|mesh-ancestor
25454210|NCT04548700|Hormones|hormones|mesh-ancestor
25454211|NCT04548700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25454212|NCT04548700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25454213|NCT04548700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25454214|NCT04548700|Tubulin Modulators|tubulin modulators|mesh-ancestor
25454215|NCT04548700|Antimitotic Agents|antimitotic agents|mesh-ancestor
25454216|NCT04548700|Mitosis Modulators|mitosis modulators|mesh-ancestor
25454217|NCT04548700|Analgesics|analgesics|mesh-ancestor
25454218|NCT04548700|Sensory System Agents|sensory system agents|mesh-ancestor
25454219|NCT04548700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25454220|NCT04548700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25454221|NCT04548700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25454222|NCT04548700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454223|NCT04548557|Immunoglobulins|immunoglobulins|mesh-list
25454224|NCT04548557|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25454225|NCT04548557|Antibodies|antibodies|mesh-list
25454226|NCT04548557|gamma-Globulins|gamma-globulins|mesh-list
25454227|NCT04548557|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25454228|NCT04548557|Immunologic Factors|immunologic factors|mesh-ancestor
25454229|NCT04548557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454230|NCT04548440|Paclitaxel|paclitaxel|mesh-list
25454231|NCT04548440|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25454232|NCT04548440|Cisplatin|cisplatin|mesh-list
25454233|NCT04548440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25454234|NCT04548440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25454235|NCT04548440|Tubulin Modulators|tubulin modulators|mesh-ancestor
25454236|NCT04548440|Antimitotic Agents|antimitotic agents|mesh-ancestor
25454237|NCT04548440|Mitosis Modulators|mitosis modulators|mesh-ancestor
25454238|NCT04548440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454239|NCT04548401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25454240|NCT04548284|Glucocorticoids|glucocorticoids|mesh-list
25454241|NCT04548284|Hormones|hormones|mesh-ancestor
25454242|NCT04548284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25454243|NCT04548284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454244|NCT04548271|Apatinib|apatinib|mesh-list
25454245|NCT04548271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25454246|NCT04548271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25454247|NCT04548271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454248|NCT04548271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454249|NCT04548219|Mirikizumab|mirikizumab|mesh-list
25454250|NCT04548219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25454251|NCT04548219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25454252|NCT04548219|Analgesics|analgesics|mesh-ancestor
25454253|NCT04548219|Sensory System Agents|sensory system agents|mesh-ancestor
25454254|NCT04548219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25454255|NCT04548219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454256|NCT04548219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25454257|NCT04548219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25454258|NCT04548219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25454259|NCT04548219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25454260|NCT04547894|TMC-310911|tmc-310911|mesh-list
25454261|NCT04547894|Protease Inhibitors|protease inhibitors|mesh-ancestor
25454262|NCT04547894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25644351|NCT01436162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25644352|NCT01436162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25644353|NCT01436162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644354|NCT01436162|Dopamine Agents|dopamine agents|mesh-ancestor
25644355|NCT01436162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25644356|NCT01436175|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25644357|NCT01436175|Antidepressive Agents|antidepressive agents|mesh-list
25644358|NCT01436175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25644359|NCT01436175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25454263|NCT04547894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454264|NCT04547829|Lenograstim|lenograstim|mesh-list
25454265|NCT04547829|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25454266|NCT04547829|Immunologic Factors|immunologic factors|mesh-ancestor
25454267|NCT04547829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454268|NCT04547764|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25454269|NCT04547764|Calcium|calcium|mesh-list
25454270|NCT04547764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25454271|NCT04547764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454272|NCT04547764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25454273|NCT04547855|Temozolomide|temozolomide|mesh-list
25454274|NCT04547855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25454275|NCT04547855|Alkylating Agents|alkylating agents|mesh-ancestor
25454276|NCT04547855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454277|NCT04547855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25454278|NCT04547621|Temozolomide|temozolomide|mesh-list
25454279|NCT04547621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25454280|NCT04547621|Alkylating Agents|alkylating agents|mesh-ancestor
25454281|NCT04547621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454282|NCT04547621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25454283|NCT04547608|Propofol|propofol|mesh-list
25454284|NCT04547608|Rocuronium|rocuronium|mesh-list
25454285|NCT04547608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25454286|NCT04547608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25454287|NCT04547608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454288|NCT04547608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25454289|NCT04547608|Anesthetics, General|anesthetics, general|mesh-ancestor
25454290|NCT04547608|Anesthetics|anesthetics|mesh-ancestor
25454291|NCT04547608|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25454292|NCT04547608|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25454293|NCT04547608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25454294|NCT04547608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25454295|NCT04547348|Denosumab|denosumab|mesh-list
25454296|NCT04547348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25454297|NCT04547348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454298|NCT04547426|Nicotine|nicotine|mesh-list
25454299|NCT04547426|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25454300|NCT04547426|Autonomic Agents|autonomic agents|mesh-ancestor
25454301|NCT04547426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25454302|NCT04547426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454303|NCT04547426|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25454304|NCT04547426|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25454305|NCT04547426|Cholinergic Agents|cholinergic agents|mesh-ancestor
25454306|NCT04547426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25454307|NCT04547426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454308|NCT04547452|Antibodies|antibodies|mesh-list
25454309|NCT04547452|Immunologic Factors|immunologic factors|mesh-ancestor
25454310|NCT04547452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454311|NCT04547335|Voriconazole|voriconazole|mesh-list
25454312|NCT04547335|Antifungal Agents|antifungal agents|mesh-ancestor
25454313|NCT04547335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25454314|NCT04547335|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25454315|NCT04547335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25454316|NCT04547335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454317|NCT04547335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454318|NCT04547335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25454319|NCT04547335|Hormone Antagonists|hormone antagonists|mesh-ancestor
25454320|NCT04547335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25454321|NCT04547335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454322|NCT04547335|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25454323|NCT04547296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25454324|NCT04547504|Pembrolizumab|pembrolizumab|mesh-list
25454325|NCT04547504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25644360|NCT01436175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644361|NCT01436175|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25644362|NCT01436175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25644363|NCT01436175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25644364|NCT01436175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644365|NCT01436175|Dopamine Agents|dopamine agents|mesh-ancestor
25454326|NCT04547504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25454327|NCT04547530|Vitamin D|vitamin d|mesh-list
25454328|NCT04547530|Vitamins|vitamins|mesh-ancestor
25454329|NCT04547530|Micronutrients|micronutrients|mesh-ancestor
25454330|NCT04547530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454331|NCT04547530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25454351|NCT04547049|Cytarabine|cytarabine|mesh-list
25454352|NCT04547049|Cyclosporine|cyclosporine|mesh-list
25454353|NCT04547049|Mycophenolic Acid|mycophenolic acid|mesh-list
25454354|NCT04547049|Cyclophosphamide|cyclophosphamide|mesh-list
25454355|NCT04547049|Busulfan|busulfan|mesh-list
25454356|NCT04547049|Cyclosporins|cyclosporins|mesh-list
25454357|NCT04547049|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25454358|NCT04547049|Thymoglobulin|thymoglobulin|mesh-list
25454359|NCT04547049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25454360|NCT04547049|Immunologic Factors|immunologic factors|mesh-ancestor
25454361|NCT04547049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454362|NCT04547049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25454363|NCT04547049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25454364|NCT04547049|Alkylating Agents|alkylating agents|mesh-ancestor
25454365|NCT04547049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454366|NCT04547049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25454367|NCT04547049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25454368|NCT04547049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25454369|NCT04547049|Antimetabolites|antimetabolites|mesh-ancestor
25454370|NCT04547049|Antiviral Agents|antiviral agents|mesh-ancestor
25454371|NCT04547049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25454372|NCT04547049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454373|NCT04547049|Antifungal Agents|antifungal agents|mesh-ancestor
25454374|NCT04547049|Dermatologic Agents|dermatologic agents|mesh-ancestor
25454375|NCT04547049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25454376|NCT04547049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25454377|NCT04547049|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25454378|NCT04547049|Antitubercular Agents|antitubercular agents|mesh-ancestor
25454379|NCT04547049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25454380|NCT04546373|Niraparib|niraparib|mesh-list
25454381|NCT04546373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25454382|NCT04546373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454383|NCT04546373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454384|NCT04546373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25454385|NCT04546282|Osimertinib|osimertinib|mesh-list
25454386|NCT04546282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25454387|NCT04546282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25454388|NCT04546282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454389|NCT04546282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454390|NCT04546347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25454391|NCT04546334|Magnesium Sulfate|magnesium sulfate|mesh-list
25454392|NCT04546334|Analgesics|analgesics|mesh-ancestor
25454393|NCT04546334|Sensory System Agents|sensory system agents|mesh-ancestor
25454394|NCT04546334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25454395|NCT04546334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454396|NCT04546334|Anesthetics|anesthetics|mesh-ancestor
25454397|NCT04546334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25454398|NCT04546334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25454399|NCT04546334|Anticonvulsants|anticonvulsants|mesh-ancestor
25454400|NCT04546334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25454401|NCT04546334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25454402|NCT04546334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454403|NCT04546334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25454404|NCT04546334|Tocolytic Agents|tocolytic agents|mesh-ancestor
25454405|NCT04546334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25454406|NCT04546256|Fluticasone|fluticasone|mesh-list
25454407|NCT04546256|Xhance|xhance|mesh-list
25454408|NCT04546256|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25454409|NCT04546256|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25454410|NCT04546256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25454411|NCT04546256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25454412|NCT04546256|Autonomic Agents|autonomic agents|mesh-ancestor
25454413|NCT04546256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25644366|NCT01436175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25454414|NCT04546256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454415|NCT04546256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25454416|NCT04546256|Respiratory System Agents|respiratory system agents|mesh-ancestor
25454417|NCT04546256|Dermatologic Agents|dermatologic agents|mesh-ancestor
25454418|NCT04546256|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25454419|NCT04546256|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25454420|NCT04546256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25454421|NCT04546256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25454422|NCT04546256|Adrenergic Agents|adrenergic agents|mesh-ancestor
25454423|NCT04546256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25454424|NCT04546256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454425|NCT04546256|Glucocorticoids|glucocorticoids|mesh-ancestor
25454426|NCT04546256|Hormones|hormones|mesh-ancestor
25454427|NCT04546256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25454428|NCT04546256|Sympathomimetics|sympathomimetics|mesh-ancestor
25454429|NCT04546022|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25454430|NCT04545970|Sunscreening Agents|sunscreening agents|mesh-list
25454431|NCT04545970|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25454432|NCT04545970|Protective Agents|protective agents|mesh-ancestor
25454433|NCT04545970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454434|NCT04545970|Dermatologic Agents|dermatologic agents|mesh-ancestor
25454435|NCT04545931|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25454436|NCT04545931|Hemostatics|hemostatics|mesh-ancestor
25454437|NCT04545931|Coagulants|coagulants|mesh-ancestor
25454438|NCT04545931|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25454439|NCT04545931|Natriuretic Agents|natriuretic agents|mesh-ancestor
25454440|NCT04545931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454441|NCT04545944|Midazolam|midazolam|mesh-list
25454442|NCT04545944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25454443|NCT04545944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25454444|NCT04545944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25454445|NCT04545944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454446|NCT04545944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25454447|NCT04545944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25454448|NCT04545944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25454449|NCT04545944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25454450|NCT04545944|Anesthetics, General|anesthetics, general|mesh-ancestor
25454451|NCT04545944|Anesthetics|anesthetics|mesh-ancestor
25454452|NCT04545944|GABA Modulators|gaba modulators|mesh-ancestor
25454453|NCT04545944|GABA Agents|gaba agents|mesh-ancestor
25454454|NCT04545944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25454455|NCT04545944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454456|NCT04545879|Allicin|allicin|mesh-list
25454457|NCT04545879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25454458|NCT04545879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25454459|NCT04545879|Antimetabolites|antimetabolites|mesh-ancestor
25454460|NCT04545879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454461|NCT04545879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25454462|NCT04545879|Antioxidants|antioxidants|mesh-ancestor
25454463|NCT04545879|Protective Agents|protective agents|mesh-ancestor
25454464|NCT04545879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454465|NCT04545879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25454466|NCT04545879|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25454467|NCT04545892|Capsaicin|capsaicin|mesh-list
25454468|NCT04545892|Antipruritics|antipruritics|mesh-ancestor
25454469|NCT04545892|Dermatologic Agents|dermatologic agents|mesh-ancestor
25454470|NCT04545892|Sensory System Agents|sensory system agents|mesh-ancestor
25454471|NCT04545892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25454472|NCT04545892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454473|NCT04545801|Ketamine|ketamine|mesh-list
25454474|NCT04545801|Analgesics|analgesics|mesh-ancestor
25454475|NCT04545801|Sensory System Agents|sensory system agents|mesh-ancestor
25454476|NCT04545801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25454477|NCT04545801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454478|NCT04545801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25454479|NCT04545801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25454480|NCT04545801|Anesthetics, General|anesthetics, general|mesh-ancestor
25454481|NCT04545801|Anesthetics|anesthetics|mesh-ancestor
25454482|NCT04545801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25454483|NCT04545801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25454484|NCT04545801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25454485|NCT04545801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25454486|NCT04545801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454487|NCT04545788|Linezolid|linezolid|mesh-list
25454488|NCT04545788|Cycloserine|cycloserine|mesh-list
25644367|NCT01436201|Dulaglutide|dulaglutide|mesh-list
25822856|NCT00004686|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25644368|NCT01436201|Digoxin|digoxin|mesh-list
25454489|NCT04545788|Bedaquiline|bedaquiline|mesh-list
25454490|NCT04545788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25454491|NCT04545788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25454492|NCT04545788|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25454493|NCT04545788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454494|NCT04545788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454495|NCT04545788|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25454496|NCT04545788|Renal Agents|renal agents|mesh-ancestor
25454497|NCT04545788|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25454498|NCT04545788|Antitubercular Agents|antitubercular agents|mesh-ancestor
25454499|NCT04545788|Antimetabolites|antimetabolites|mesh-ancestor
25454500|NCT04545463|Psyllium|psyllium|mesh-list
25454501|NCT04545463|Cathartics|cathartics|mesh-ancestor
25454502|NCT04545463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25454504|NCT04545450|Testosterone|testosterone|mesh-list
25454505|NCT04545450|Testosterone undecanoate|testosterone undecanoate|mesh-list
25454506|NCT04545450|Testosterone enanthate|testosterone enanthate|mesh-list
25454507|NCT04545450|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25454508|NCT04545450|Dutasteride|dutasteride|mesh-list
25454509|NCT04545450|Androgens|androgens|mesh-ancestor
25454510|NCT04545450|Hormones|hormones|mesh-ancestor
25454511|NCT04545450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25454512|NCT04545450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454513|NCT04545450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25454514|NCT04545450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25454515|NCT04545450|Anabolic Agents|anabolic agents|mesh-ancestor
25454516|NCT04545450|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25454517|NCT04545450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25454518|NCT04545450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454519|NCT04545450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454520|NCT04545450|Hormone Antagonists|hormone antagonists|mesh-ancestor
25454521|NCT04545710|Osimertinib|osimertinib|mesh-list
25454522|NCT04545710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25454523|NCT04545710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25454524|NCT04545710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454525|NCT04545710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454526|NCT04545099|Neostigmine|neostigmine|mesh-list
25454527|NCT04545099|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25454528|NCT04545099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454529|NCT04545099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454530|NCT04545099|Cholinergic Agents|cholinergic agents|mesh-ancestor
25454531|NCT04545099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25454532|NCT04545099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454533|NCT04545099|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25454534|NCT04545099|Autonomic Agents|autonomic agents|mesh-ancestor
25454535|NCT04545099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25454536|NCT04544943|Gentamicins|gentamicins|mesh-list
25454537|NCT04544943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25454538|NCT04544943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25454539|NCT04544943|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25454540|NCT04544943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454541|NCT04544943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454542|NCT04544969|Gemcitabine|gemcitabine|mesh-list
25454543|NCT04544969|Cisplatin|cisplatin|mesh-list
25454544|NCT04544969|Docetaxel|docetaxel|mesh-list
25454545|NCT04544969|Fluorouracil|fluorouracil|mesh-list
25454546|NCT04544969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25454547|NCT04544969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25454548|NCT04544969|Antimetabolites|antimetabolites|mesh-ancestor
25454549|NCT04544969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454550|NCT04544969|Antiviral Agents|antiviral agents|mesh-ancestor
25454551|NCT04544969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25454552|NCT04544969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454553|NCT04544969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25454554|NCT04544969|Immunologic Factors|immunologic factors|mesh-ancestor
25454555|NCT04544969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454556|NCT04544969|Tubulin Modulators|tubulin modulators|mesh-ancestor
25454557|NCT04544969|Antimitotic Agents|antimitotic agents|mesh-ancestor
25454558|NCT04544969|Mitosis Modulators|mitosis modulators|mesh-ancestor
25454559|NCT04544813|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25454560|NCT04544813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25454561|NCT04544683|Dexamethasone|dexamethasone|mesh-list
25644369|NCT01436201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25644370|NCT01436201|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25644371|NCT01436201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25644372|NCT01436201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644373|NCT01436201|Protective Agents|protective agents|mesh-ancestor
25644374|NCT01436201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644375|NCT01436201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25644376|NCT01436266|Folic Acid|folic acid|mesh-list
25644377|NCT01436266|Misoprostol|misoprostol|mesh-list
25644378|NCT01436266|Vitamins|vitamins|mesh-ancestor
25644379|NCT01436266|Micronutrients|micronutrients|mesh-ancestor
25644380|NCT01436266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454562|NCT04544683|Dexamethasone acetate|dexamethasone acetate|mesh-list
25454563|NCT04544683|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25454564|NCT04544683|BB 1101|bb 1101|mesh-list
25454565|NCT04544683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25454566|NCT04544683|Antiemetics|antiemetics|mesh-ancestor
25454567|NCT04544683|Autonomic Agents|autonomic agents|mesh-ancestor
25454568|NCT04544683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25454569|NCT04544683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454570|NCT04544683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25454571|NCT04544683|Glucocorticoids|glucocorticoids|mesh-ancestor
25454572|NCT04544683|Hormones|hormones|mesh-ancestor
25454573|NCT04544683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25454574|NCT04544683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25454575|NCT04544683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25454576|NCT04544683|Protease Inhibitors|protease inhibitors|mesh-ancestor
25454577|NCT04544683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454603|NCT04544319|Dapagliflozin|dapagliflozin|mesh-list
25454604|NCT04544319|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25454605|NCT04544319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454606|NCT04544319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25454607|NCT04544319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454608|NCT04544059|Lenalidomide|lenalidomide|mesh-list
25454609|NCT04544059|Immunologic Factors|immunologic factors|mesh-ancestor
25454610|NCT04544059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454611|NCT04544059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25454612|NCT04544059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25454613|NCT04544059|Growth Substances|growth substances|mesh-ancestor
25454614|NCT04544059|Growth Inhibitors|growth inhibitors|mesh-ancestor
25454615|NCT04544059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25454616|NCT04544163|Lidocaine|lidocaine|mesh-list
25454617|NCT04544163|Magnesium Sulfate|magnesium sulfate|mesh-list
25454618|NCT04544163|Fentanyl|fentanyl|mesh-list
25454619|NCT04544163|Anesthetics, Local|anesthetics, local|mesh-ancestor
25454620|NCT04544163|Anesthetics|anesthetics|mesh-ancestor
25454621|NCT04544163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25454622|NCT04544163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454623|NCT04544163|Sensory System Agents|sensory system agents|mesh-ancestor
25454624|NCT04544163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25454625|NCT04544163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25454626|NCT04544163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25454627|NCT04544163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25454628|NCT04544163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25454629|NCT04544163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454630|NCT04544163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25454631|NCT04544163|Narcotics|narcotics|mesh-ancestor
25454632|NCT04544163|Analgesics|analgesics|mesh-ancestor
25454633|NCT04544163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25454634|NCT04544163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25454635|NCT04544163|Anesthetics, General|anesthetics, general|mesh-ancestor
25454636|NCT04544163|Anticonvulsants|anticonvulsants|mesh-ancestor
25454637|NCT04544163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25454638|NCT04544163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25454639|NCT04544163|Tocolytic Agents|tocolytic agents|mesh-ancestor
25454640|NCT04544163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25454641|NCT04543851|Carbon Fiber|carbon fiber|mesh-list
25454642|NCT04543851|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25454643|NCT04543851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25454644|NCT04543916|Irinotecan|irinotecan|mesh-list
25454645|NCT04543916|Venetoclax|venetoclax|mesh-list
25454646|NCT04543916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25454647|NCT04543916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25454648|NCT04543916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454649|NCT04543916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454650|NCT04543916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25454651|NCT04543890|Cisplatin|cisplatin|mesh-list
25822857|NCT00004686|Abortifacient Agents|abortifacient agents|mesh-ancestor
25454652|NCT04543890|Etoposide|etoposide|mesh-list
25454653|NCT04543890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25454654|NCT04543890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25454655|NCT04543890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25454656|NCT04543890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25454657|NCT04543890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454658|NCT04543890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454659|NCT04543565|Tenofovir|tenofovir|mesh-list
25454660|NCT04543565|Pradefovir|pradefovir|mesh-list
25454661|NCT04543565|Antiviral Agents|antiviral agents|mesh-ancestor
25454662|NCT04543565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25454663|NCT04543565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25454664|NCT04543565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25454665|NCT04543565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454666|NCT04543565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454667|NCT04543565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25454668|NCT04543565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25311234|NCT03913845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25311235|NCT03903939|Iloprost|iloprost|mesh-list
25311236|NCT03903939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25311237|NCT03903939|Vasodilator Agents|vasodilator agents|mesh-ancestor
25311247|NCT03834363|Fentanyl|fentanyl|mesh-list
25311248|NCT03834363|Morphine|morphine|mesh-list
25311249|NCT03834363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25311250|NCT03834363|Narcotics|narcotics|mesh-ancestor
25311251|NCT03834363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25311253|NCT03834363|Analgesics|analgesics|mesh-ancestor
25454669|NCT04543370|Deflazacort|deflazacort|mesh-list
25454670|NCT04543370|Midazolam|midazolam|mesh-list
25454671|NCT04543370|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25454672|NCT04543370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25454673|NCT04543370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25454674|NCT04543370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454675|NCT04543370|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25454676|NCT04543370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25454677|NCT04543370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25454678|NCT04543370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25454679|NCT04543370|Anesthetics, General|anesthetics, general|mesh-ancestor
25454680|NCT04543370|Anesthetics|anesthetics|mesh-ancestor
25454681|NCT04543370|GABA Modulators|gaba modulators|mesh-ancestor
25454682|NCT04543370|GABA Agents|gaba agents|mesh-ancestor
25454683|NCT04543370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25454684|NCT04543370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454685|NCT04543370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25454686|NCT04543370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25454687|NCT04543370|Immunologic Factors|immunologic factors|mesh-ancestor
25454688|NCT04543110|Durvalumab|durvalumab|mesh-list
25454689|NCT04543110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25454690|NCT04543110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25454691|NCT04543188|Midazolam|midazolam|mesh-list
25454692|NCT04543188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25454693|NCT04543188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25454694|NCT04543188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25454695|NCT04543188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454696|NCT04543188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25454697|NCT04543188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25454698|NCT04543188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25454699|NCT04543188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25454700|NCT04543188|Anesthetics, General|anesthetics, general|mesh-ancestor
25454701|NCT04543188|Anesthetics|anesthetics|mesh-ancestor
25454702|NCT04543188|GABA Modulators|gaba modulators|mesh-ancestor
25454703|NCT04543188|GABA Agents|gaba agents|mesh-ancestor
25454704|NCT04543188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25454705|NCT04543188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454706|NCT04543123|Citalopram|citalopram|mesh-list
25454707|NCT04543123|Antidepressive Agents|antidepressive agents|mesh-list
25454708|NCT04543123|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25454709|NCT04543123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25454710|NCT04543123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25454711|NCT04543123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454712|NCT04543123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25454713|NCT04543123|Serotonin Agents|serotonin agents|mesh-ancestor
25454714|NCT04543123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454715|NCT04543123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25454716|NCT04543123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25454717|NCT04542694|Favipiravir|favipiravir|mesh-list
25644381|NCT01436266|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25644382|NCT01436266|Abortifacient Agents|abortifacient agents|mesh-ancestor
25644383|NCT01436266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25644384|NCT01436266|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25454718|NCT04542694|Antiviral Agents|antiviral agents|mesh-ancestor
25454719|NCT04542694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25454720|NCT04542629|Trace Elements|trace elements|mesh-list
25454721|NCT04542629|Rituximab|rituximab|mesh-list
25454722|NCT04542629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25454723|NCT04542629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25454724|NCT04542629|Immunologic Factors|immunologic factors|mesh-ancestor
25454725|NCT04542629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454726|NCT04542629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25454727|NCT04542629|Micronutrients|micronutrients|mesh-ancestor
25454728|NCT04542759|Besifloxacin|besifloxacin|mesh-list
25454729|NCT04542759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25454730|NCT04542759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25454731|NCT04542759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25454732|NCT04542759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25454733|NCT04542759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25454734|NCT04542759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25454735|NCT04542759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454736|NCT04542759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454737|NCT04542759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25454738|NCT04542733|Everolimus|everolimus|mesh-list
25454739|NCT04542733|Tacrolimus|tacrolimus|mesh-list
25454740|NCT04542733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25454741|NCT04542733|Immunologic Factors|immunologic factors|mesh-ancestor
25311311|NCT03287778|Pyridoxine|pyridoxine|mesh-list
25454742|NCT04542733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454743|NCT04542733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25454744|NCT04542733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454749|NCT04542473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25454751|NCT04542226|Anticonvulsants|anticonvulsants|mesh-ancestor
25454752|NCT04542213|Insulin|insulin|mesh-list
25454753|NCT04542213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25454754|NCT04542213|Linagliptin|linagliptin|mesh-list
25454755|NCT04542213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25454756|NCT04542213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454757|NCT04542213|Incretins|incretins|mesh-ancestor
25454758|NCT04542213|Hormones|hormones|mesh-ancestor
25454759|NCT04542213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25454760|NCT04542213|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25454761|NCT04542213|Protease Inhibitors|protease inhibitors|mesh-ancestor
25454762|NCT04542213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454763|NCT04542213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454764|NCT04542369|Cisplatin|cisplatin|mesh-list
25454765|NCT04542369|Etoposide|etoposide|mesh-list
25454766|NCT04542369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25454767|NCT04542369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25454768|NCT04542369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25454769|NCT04542369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25454770|NCT04542369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454771|NCT04542369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454772|NCT04542304|Metolazone|metolazone|mesh-list
25454773|NCT04542304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25454774|NCT04542304|Diuretics|diuretics|mesh-ancestor
25454775|NCT04542304|Natriuretic Agents|natriuretic agents|mesh-ancestor
25454776|NCT04542304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454777|NCT04542304|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25454778|NCT04542304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25454779|NCT04542304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454780|NCT04542252|Cyclosporine|cyclosporine|mesh-list
25454781|NCT04542252|Cyclosporins|cyclosporins|mesh-list
25454782|NCT04542252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454783|NCT04542252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454784|NCT04542252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25454785|NCT04542252|Immunologic Factors|immunologic factors|mesh-ancestor
25454786|NCT04542252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454787|NCT04542252|Antifungal Agents|antifungal agents|mesh-ancestor
25454788|NCT04542252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25454789|NCT04542252|Dermatologic Agents|dermatologic agents|mesh-ancestor
25454790|NCT04542252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25454791|NCT04542252|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25454792|NCT04541719|Remifentanil|remifentanil|mesh-list
25454793|NCT04541719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25454794|NCT04541719|Narcotics|narcotics|mesh-ancestor
25644385|NCT01436266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25644387|NCT01436266|Hematinics|hematinics|mesh-ancestor
25644388|NCT01436266|Vitamin B Complex|vitamin b complex|mesh-ancestor
25644389|NCT01436279|Mifepristone|mifepristone|mesh-list
25644390|NCT01436279|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25644391|NCT01436279|Abortifacient Agents|abortifacient agents|mesh-ancestor
25644392|NCT01436279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25644393|NCT01436279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644394|NCT01436279|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25454795|NCT04541719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25454796|NCT04541719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454797|NCT04541719|Analgesics|analgesics|mesh-ancestor
25454798|NCT04541719|Sensory System Agents|sensory system agents|mesh-ancestor
25454799|NCT04541719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25454800|NCT04541732|Anesthetics|anesthetics|mesh-list
25454801|NCT04541732|Propofol|propofol|mesh-list
25454802|NCT04541732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25454803|NCT04541732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454804|NCT04541732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25454805|NCT04541732|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25454806|NCT04541732|Anesthetics, General|anesthetics, general|mesh-ancestor
25644395|NCT01436279|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25454807|NCT04541823|Propofol|propofol|mesh-list
25454808|NCT04541823|Desflurane|desflurane|mesh-list
25454809|NCT04541823|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25454810|NCT04541823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25454811|NCT04541823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454812|NCT04541823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25454813|NCT04541823|Anesthetics, General|anesthetics, general|mesh-ancestor
25454814|NCT04541823|Anesthetics|anesthetics|mesh-ancestor
25454815|NCT04541823|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25454816|NCT04542005|Albuterol|albuterol|mesh-list
25454817|NCT04542005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25454818|NCT04542005|Autonomic Agents|autonomic agents|mesh-ancestor
25454819|NCT04542005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25454820|NCT04542005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454821|NCT04542005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25454822|NCT04542005|Respiratory System Agents|respiratory system agents|mesh-ancestor
25454823|NCT04542005|Tocolytic Agents|tocolytic agents|mesh-ancestor
25454824|NCT04542005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25454825|NCT04542005|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25454826|NCT04542005|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25454827|NCT04542005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25454828|NCT04542005|Adrenergic Agents|adrenergic agents|mesh-ancestor
25454829|NCT04542005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25454830|NCT04542005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454831|NCT04541147|Dexamethasone|dexamethasone|mesh-list
25454832|NCT04541147|Analgesics|analgesics|mesh-list
25454833|NCT04541147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25454834|NCT04541147|Antiemetics|antiemetics|mesh-ancestor
25454835|NCT04541147|Autonomic Agents|autonomic agents|mesh-ancestor
25454836|NCT04541147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25454837|NCT04541147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454838|NCT04541147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25454839|NCT04541147|Glucocorticoids|glucocorticoids|mesh-ancestor
25454840|NCT04541147|Hormones|hormones|mesh-ancestor
25454841|NCT04541147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25454842|NCT04541147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25454843|NCT04541147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25454844|NCT04541147|Sensory System Agents|sensory system agents|mesh-ancestor
25454845|NCT04541303|Tranexamic Acid|tranexamic acid|mesh-list
25454846|NCT04541303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25454847|NCT04541303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25454848|NCT04541303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454849|NCT04541303|Hemostatics|hemostatics|mesh-ancestor
25454850|NCT04541303|Coagulants|coagulants|mesh-ancestor
25454851|NCT04541277|Cytarabine|cytarabine|mesh-list
25454852|NCT04541277|Azacitidine|azacitidine|mesh-list
25454853|NCT04541277|Decitabine|decitabine|mesh-list
25454854|NCT04541277|Idarubicin|idarubicin|mesh-list
25454855|NCT04541277|Lenograstim|lenograstim|mesh-list
25454856|NCT04541277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25454857|NCT04541277|Antimetabolites|antimetabolites|mesh-ancestor
25454858|NCT04541277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644396|NCT01436279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25454859|NCT04541277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25454860|NCT04541277|Antiviral Agents|antiviral agents|mesh-ancestor
25454861|NCT04541277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25454862|NCT04541277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25454863|NCT04541277|Immunologic Factors|immunologic factors|mesh-ancestor
25454864|NCT04541277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454865|NCT04541277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454866|NCT04541277|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25454867|NCT04541277|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25454868|NCT04541277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25454869|NCT04541277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25454870|NCT04540926|Cyclosporine|cyclosporine|mesh-list
25454871|NCT04540926|Cyclosporins|cyclosporins|mesh-list
25454872|NCT04540926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311450|NCT05072938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311451|NCT05072938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311452|NCT05072899|Hyaluronic Acid|hyaluronic acid|mesh-list
25311453|NCT05072899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25311454|NCT05072899|Immunologic Factors|immunologic factors|mesh-ancestor
25311455|NCT05072899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311456|NCT05072899|Viscosupplements|viscosupplements|mesh-ancestor
25311457|NCT05072899|Protective Agents|protective agents|mesh-ancestor
25311458|NCT05072860|Tranexamic Acid|tranexamic acid|mesh-list
25311459|NCT05072860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25311460|NCT05072860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25311461|NCT05072860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311462|NCT05072860|Hemostatics|hemostatics|mesh-ancestor
25311463|NCT05072860|Coagulants|coagulants|mesh-ancestor
25311464|NCT05072873|Tranexamic Acid|tranexamic acid|mesh-list
25311465|NCT05072873|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25311466|NCT05072873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25454873|NCT04540926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454874|NCT04540926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25454875|NCT04540926|Immunologic Factors|immunologic factors|mesh-ancestor
25454876|NCT04540926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454877|NCT04540926|Antifungal Agents|antifungal agents|mesh-ancestor
25454878|NCT04540926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25454879|NCT04540926|Dermatologic Agents|dermatologic agents|mesh-ancestor
25454880|NCT04540926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25454881|NCT04540926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25454882|NCT04541251|Paclitaxel|paclitaxel|mesh-list
25454883|NCT04541251|Carboplatin|carboplatin|mesh-list
25454884|NCT04541251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25454885|NCT04541251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25454886|NCT04541251|Tubulin Modulators|tubulin modulators|mesh-ancestor
25454887|NCT04541251|Antimitotic Agents|antimitotic agents|mesh-ancestor
25454888|NCT04541251|Mitosis Modulators|mitosis modulators|mesh-ancestor
25454889|NCT04541251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454890|NCT04540965|Famotidine|famotidine|mesh-list
25454891|NCT04540965|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25454892|NCT04540965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25454893|NCT04540965|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25454894|NCT04540965|Histamine Antagonists|histamine antagonists|mesh-ancestor
25454895|NCT04540965|Histamine Agents|histamine agents|mesh-ancestor
25454896|NCT04540965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25454897|NCT04540965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454898|NCT04540965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454899|NCT04540666|Propofol|propofol|mesh-list
25454900|NCT04540666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25454901|NCT04540666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25454902|NCT04540666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454903|NCT04540666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25454904|NCT04540666|Anesthetics, General|anesthetics, general|mesh-ancestor
25454905|NCT04540666|Anesthetics|anesthetics|mesh-ancestor
25454906|NCT04540627|Palivizumab|palivizumab|mesh-list
25454907|NCT04540627|Antiviral Agents|antiviral agents|mesh-ancestor
25454908|NCT04540627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25454909|NCT04539977|Cisplatin|cisplatin|mesh-list
25454910|NCT04539977|Etoposide|etoposide|mesh-list
25454911|NCT04539977|Etoposide phosphate|etoposide phosphate|mesh-list
25454912|NCT04539977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25454913|NCT04539977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25454914|NCT04539977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25454915|NCT04539977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25454916|NCT04539977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25721513|NCT02487199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454917|NCT04539977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454918|NCT04540055|Anesthetics|anesthetics|mesh-list
25454919|NCT04540055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25454920|NCT04540055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454921|NCT04540185|Neuroprotective Agents|neuroprotective agents|mesh-list
25454922|NCT04540185|Vaccines|vaccines|mesh-list
25454923|NCT04540185|Immunologic Factors|immunologic factors|mesh-ancestor
25454924|NCT04540185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454925|NCT04540185|Protective Agents|protective agents|mesh-ancestor
25454926|NCT04539301|Anticoagulants|anticoagulants|mesh-list
25454927|NCT04539314|Dexmedetomidine|dexmedetomidine|mesh-list
25454928|NCT04539314|Bupivacaine|bupivacaine|mesh-list
25454929|NCT04539314|Anesthetics, Local|anesthetics, local|mesh-ancestor
25454930|NCT04539314|Anesthetics|anesthetics|mesh-ancestor
25454931|NCT04539314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25454932|NCT04539314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454933|NCT04539314|Sensory System Agents|sensory system agents|mesh-ancestor
25454934|NCT04539314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25454935|NCT04539314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25454936|NCT04539314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25454937|NCT04539314|Analgesics|analgesics|mesh-ancestor
25454938|NCT04539314|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25454939|NCT04539314|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25454940|NCT04539314|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25454941|NCT04539314|Adrenergic Agents|adrenergic agents|mesh-ancestor
25454942|NCT04539314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25454943|NCT04539314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454944|NCT04539405|Sevoflurane|sevoflurane|mesh-list
25454945|NCT04539405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25454946|NCT04539405|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25454947|NCT04539405|Anesthetics, General|anesthetics, general|mesh-ancestor
25454948|NCT04539405|Anesthetics|anesthetics|mesh-ancestor
25454949|NCT04539405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25454950|NCT04539405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454951|NCT04539249|Magnesium Sulfate|magnesium sulfate|mesh-list
25454952|NCT04539249|Pentazocine|pentazocine|mesh-list
25454953|NCT04539249|Analgesics|analgesics|mesh-ancestor
25454954|NCT04539249|Sensory System Agents|sensory system agents|mesh-ancestor
25454955|NCT04539249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25454956|NCT04539249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454957|NCT04539249|Anesthetics|anesthetics|mesh-ancestor
25454958|NCT04539249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25454959|NCT04539249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25454960|NCT04539249|Anticonvulsants|anticonvulsants|mesh-ancestor
25454961|NCT04539249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25454962|NCT04539249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25454963|NCT04539249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454964|NCT04539249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25454965|NCT04539249|Tocolytic Agents|tocolytic agents|mesh-ancestor
25454966|NCT04539249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25454967|NCT04539249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25454968|NCT04539249|Narcotics|narcotics|mesh-ancestor
25454969|NCT04539249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25454970|NCT04539249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25454971|NCT04539119|Tenofovir|tenofovir|mesh-list
25454972|NCT04539119|Entecavir|entecavir|mesh-list
25454973|NCT04539119|Antiviral Agents|antiviral agents|mesh-ancestor
25454974|NCT04539119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25454975|NCT04539119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25454976|NCT04539119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25454977|NCT04539119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25454978|NCT04539119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454979|NCT04539119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25454980|NCT04539119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25454981|NCT04539379|Magnesium Sulfate|magnesium sulfate|mesh-list
25454982|NCT04539379|Analgesics|analgesics|mesh-ancestor
25454983|NCT04539379|Sensory System Agents|sensory system agents|mesh-ancestor
25454984|NCT04539379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25454985|NCT04539379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25454986|NCT04539379|Anesthetics|anesthetics|mesh-ancestor
25454987|NCT04539379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25454988|NCT04539379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25454989|NCT04539379|Anticonvulsants|anticonvulsants|mesh-ancestor
25454990|NCT04539379|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25454991|NCT04539379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25454992|NCT04539379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644397|NCT01436279|Contraceptive Agents|contraceptive agents|mesh-ancestor
25644398|NCT01436279|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25644399|NCT01436279|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25644400|NCT01436279|Hormone Antagonists|hormone antagonists|mesh-ancestor
25644401|NCT01436279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25644402|NCT01436279|Luteolytic Agents|luteolytic agents|mesh-ancestor
25644403|NCT01436279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25644404|NCT01436279|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25644405|NCT01436305|Mycophenolic Acid|mycophenolic acid|mesh-list
25644406|NCT01436305|Methylprednisolone|methylprednisolone|mesh-list
25644407|NCT01436305|Alemtuzumab|alemtuzumab|mesh-list
25644408|NCT01436305|Abatacept|abatacept|mesh-list
25644409|NCT01436305|Tacrolimus|tacrolimus|mesh-list
25644410|NCT01436305|Basiliximab|basiliximab|mesh-list
25644411|NCT01436305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25644412|NCT01436305|Immunologic Factors|immunologic factors|mesh-ancestor
25644413|NCT01436305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644414|NCT01436305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25644415|NCT01436305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25644416|NCT01436305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25454993|NCT04539379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25454994|NCT04539379|Tocolytic Agents|tocolytic agents|mesh-ancestor
25454995|NCT04539379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25454996|NCT04539106|Ranibizumab|ranibizumab|mesh-list
25454997|NCT04539106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25454998|NCT04539106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25454999|NCT04539106|Growth Substances|growth substances|mesh-ancestor
25455000|NCT04539106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455001|NCT04539106|Growth Inhibitors|growth inhibitors|mesh-ancestor
25455002|NCT04539106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25455003|NCT04538820|Dexamethasone|dexamethasone|mesh-list
25455004|NCT04538820|Dexamethasone acetate|dexamethasone acetate|mesh-list
25455005|NCT04538820|BB 1101|bb 1101|mesh-list
25455006|NCT04538820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25455007|NCT04538820|Antiemetics|antiemetics|mesh-ancestor
25455008|NCT04538820|Autonomic Agents|autonomic agents|mesh-ancestor
25455009|NCT04538820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25455010|NCT04538820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455011|NCT04538820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25455012|NCT04538820|Glucocorticoids|glucocorticoids|mesh-ancestor
25455013|NCT04538820|Hormones|hormones|mesh-ancestor
25455014|NCT04538820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25455015|NCT04538820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25455016|NCT04538820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25455017|NCT04538820|Protease Inhibitors|protease inhibitors|mesh-ancestor
25311595|NCT05070598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25311596|NCT05070598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25311597|NCT05070598|Tubulin Modulators|tubulin modulators|mesh-ancestor
25311598|NCT05070598|Antimitotic Agents|antimitotic agents|mesh-ancestor
25311599|NCT05070598|Mitosis Modulators|mitosis modulators|mesh-ancestor
25311600|NCT05070598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311601|NCT05070598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25311605|NCT05070195|Midazolam|midazolam|mesh-list
25455018|NCT04538820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25455019|NCT04538820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455021|NCT04539054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25455022|NCT04539054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455023|NCT04539054|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25455024|NCT04539054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25455025|NCT04539054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455026|NCT04539054|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25455027|NCT04539054|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25455028|NCT04539054|Purinergic Agents|purinergic agents|mesh-ancestor
25455029|NCT04539054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25455030|NCT04539444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25455031|NCT04539444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041590|NCT01621243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25041591|NCT01621243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043255|NCT01283594|Levodopa|levodopa|mesh-list
24829402|NCT02152228|Teriparatide|teriparatide|mesh-list
24829403|NCT02152228|Hormones|hormones|mesh-list
25644417|NCT01436305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24829404|NCT02152228|Parathyroid Hormone|parathyroid hormone|mesh-list
25644418|NCT01436305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25455032|NCT04539444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25455033|NCT04539418|Vitamin K|vitamin k|mesh-list
25455034|NCT04539418|Vitamin K 2|vitamin k 2|mesh-list
25455035|NCT04539418|Vitamins|vitamins|mesh-ancestor
25455036|NCT04539418|Micronutrients|micronutrients|mesh-ancestor
25455037|NCT04539418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455038|NCT04539418|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25455039|NCT04539418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25455040|NCT04539418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455041|NCT04539418|Hemostatics|hemostatics|mesh-ancestor
25455042|NCT04539418|Coagulants|coagulants|mesh-ancestor
25455043|NCT04538521|Niacin|niacin|mesh-list
25455044|NCT04538521|Nicotinic Acids|nicotinic acids|mesh-list
25455045|NCT04538521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25455046|NCT04538521|Antimetabolites|antimetabolites|mesh-ancestor
25455047|NCT04538521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455048|NCT04538521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25455049|NCT04538521|Vasodilator Agents|vasodilator agents|mesh-ancestor
25455050|NCT04538521|Vitamin B Complex|vitamin b complex|mesh-ancestor
25455051|NCT04538521|Vitamins|vitamins|mesh-ancestor
25455052|NCT04538521|Micronutrients|micronutrients|mesh-ancestor
25455053|NCT04538521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455054|NCT04538391|Bupivacaine|bupivacaine|mesh-list
25455055|NCT04538391|Anesthetics, Local|anesthetics, local|mesh-ancestor
25455056|NCT04538391|Anesthetics|anesthetics|mesh-ancestor
25455057|NCT04538391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25455058|NCT04538391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455059|NCT04538391|Sensory System Agents|sensory system agents|mesh-ancestor
25455060|NCT04538391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25455061|NCT04538365|Triclosan|triclosan|mesh-list
25455062|NCT04538365|Propranolol|propranolol|mesh-list
25455063|NCT04538365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25455064|NCT04538365|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25455065|NCT04538365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25455066|NCT04538365|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25455067|NCT04538365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25455068|NCT04538365|Antimetabolites|antimetabolites|mesh-ancestor
25455069|NCT04538365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455070|NCT04538365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25455071|NCT04538365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25455072|NCT04538365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25455073|NCT04538365|Adrenergic Agents|adrenergic agents|mesh-ancestor
25455074|NCT04538365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25455075|NCT04538365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455076|NCT04538365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25455077|NCT04538365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25455078|NCT04538365|Vasodilator Agents|vasodilator agents|mesh-ancestor
25455079|NCT04538976|Sildenafil Citrate|sildenafil citrate|mesh-list
25455080|NCT04538976|Vasodilator Agents|vasodilator agents|mesh-ancestor
25455081|NCT04538976|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25455082|NCT04538976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25455083|NCT04538976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25455084|NCT04538976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455085|NCT04538976|Urological Agents|urological agents|mesh-ancestor
25455086|NCT04537780|Montelukast|montelukast|mesh-list
25455087|NCT04537780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25455088|NCT04537780|Respiratory System Agents|respiratory system agents|mesh-ancestor
25455089|NCT04537780|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25455090|NCT04537780|Hormone Antagonists|hormone antagonists|mesh-ancestor
25455091|NCT04537780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25455101|NCT04537767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25455102|NCT04537767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455103|NCT04537767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455104|NCT04537689|Cyclosporine|cyclosporine|mesh-list
25455105|NCT04537689|Methotrexate|methotrexate|mesh-list
25455106|NCT04537689|Ixekizumab|ixekizumab|mesh-list
25455107|NCT04537689|Acitretin|acitretin|mesh-list
25455108|NCT04537689|Cyclosporins|cyclosporins|mesh-list
25455109|NCT04537689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25455110|NCT04537689|Abortifacient Agents|abortifacient agents|mesh-ancestor
25455111|NCT04537689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25455112|NCT04537689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455113|NCT04537689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25455114|NCT04537689|Antimetabolites|antimetabolites|mesh-ancestor
25455115|NCT04537689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644419|NCT01436305|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25644420|NCT01436305|Antitubercular Agents|antitubercular agents|mesh-ancestor
25644421|NCT01436305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25455116|NCT04537689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25455117|NCT04537689|Dermatologic Agents|dermatologic agents|mesh-ancestor
25455118|NCT04537689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25455119|NCT04537689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25455120|NCT04537689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25455121|NCT04537689|Immunologic Factors|immunologic factors|mesh-ancestor
25455122|NCT04537689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25455123|NCT04537689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25455124|NCT04537689|Antifungal Agents|antifungal agents|mesh-ancestor
25455125|NCT04537689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25455126|NCT04537689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25455127|NCT04537689|Keratolytic Agents|keratolytic agents|mesh-ancestor
25455128|NCT04537533|Tranexamic Acid|tranexamic acid|mesh-list
25455129|NCT04537533|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25455130|NCT04537533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25455131|NCT04537533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455132|NCT04537533|Hemostatics|hemostatics|mesh-ancestor
25455133|NCT04537533|Coagulants|coagulants|mesh-ancestor
25455134|NCT04537403|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
25455135|NCT04537403|Chelating Agents|chelating agents|mesh-ancestor
25455136|NCT04537403|Sequestering Agents|sequestering agents|mesh-ancestor
25455137|NCT04537403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311745|NCT05067153|Tinzaparin|tinzaparin|mesh-list
25311746|NCT05067153|Dalteparin|dalteparin|mesh-list
25311747|NCT05067153|Anticoagulants|anticoagulants|mesh-ancestor
25311748|NCT05067153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25311749|NCT05067153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25311750|NCT05067153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311751|NCT05067309|Letrozole|letrozole|mesh-list
25311752|NCT05067309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25311753|NCT05067309|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25311754|NCT05067309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25311755|NCT05067309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311756|NCT05067309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721549|NCT02487485|Sirolimus|sirolimus|mesh-list
25311757|NCT05067309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25311758|NCT05067309|Hormone Antagonists|hormone antagonists|mesh-ancestor
25311759|NCT05067309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25311760|NCT05067309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311761|NCT05066958|Antiviral Agents|antiviral agents|mesh-list
25455138|NCT04537065|Mydriatics|mydriatics|mesh-list
25455139|NCT04537065|Autonomic Agents|autonomic agents|mesh-ancestor
25455140|NCT04537065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25455141|NCT04537065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455142|NCT04536922|Aldesleukin|aldesleukin|mesh-list
25455143|NCT04536922|Cyclophosphamide|cyclophosphamide|mesh-list
25455144|NCT04536922|Pembrolizumab|pembrolizumab|mesh-list
25455145|NCT04536922|Fludarabine|fludarabine|mesh-list
25455146|NCT04536922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25455147|NCT04536922|Immunologic Factors|immunologic factors|mesh-ancestor
25455148|NCT04536922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455149|NCT04536922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25455150|NCT04536922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25455151|NCT04536922|Alkylating Agents|alkylating agents|mesh-ancestor
25455152|NCT04536922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455153|NCT04536922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25455154|NCT04536922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25455155|NCT04536922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25455156|NCT04536922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25455157|NCT04536922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25455158|NCT04536922|Antiviral Agents|antiviral agents|mesh-ancestor
25455159|NCT04536922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25455160|NCT04536961|BMS-986165|bms-986165|mesh-list
25455161|NCT04536961|Famotidine|famotidine|mesh-list
25455162|NCT04536961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25455163|NCT04536961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25455164|NCT04536961|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25455165|NCT04536961|Histamine Antagonists|histamine antagonists|mesh-ancestor
25455166|NCT04536961|Histamine Agents|histamine agents|mesh-ancestor
25455167|NCT04536961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25455168|NCT04536961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455169|NCT04536961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644422|NCT01436305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25644423|NCT01436305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25644424|NCT01436305|Antiemetics|antiemetics|mesh-ancestor
25644425|NCT01436305|Autonomic Agents|autonomic agents|mesh-ancestor
25644426|NCT01436305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25822858|NCT00004686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25644427|NCT01436305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25822859|NCT00004686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25822860|NCT00004686|Antimetabolites|antimetabolites|mesh-ancestor
25455170|NCT04536961|Dermatologic Agents|dermatologic agents|mesh-ancestor
25455171|NCT04536961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25455172|NCT04536961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25455173|NCT04536948|Methyl salicylate|methyl salicylate|mesh-list
25455174|NCT04536948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25455175|NCT04536831|Vitamin D|vitamin d|mesh-list
25455176|NCT04536831|Ergocalciferols|ergocalciferols|mesh-list
25455177|NCT04536831|Cholecalciferol|cholecalciferol|mesh-list
25455178|NCT04536831|Vitamins|vitamins|mesh-list
25455179|NCT04536831|Micronutrients|micronutrients|mesh-ancestor
25455180|NCT04536831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455181|NCT04536831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25455182|NCT04536831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25455183|NCT04536558|Olanzapine|olanzapine|mesh-list
25455184|NCT04536558|Fosaprepitant|fosaprepitant|mesh-list
25455185|NCT04536558|Aprepitant|aprepitant|mesh-list
25455186|NCT04536558|Antiemetics|antiemetics|mesh-ancestor
25455187|NCT04536558|Autonomic Agents|autonomic agents|mesh-ancestor
25455188|NCT04536558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25455189|NCT04536558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455190|NCT04536558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25455191|NCT04536558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25455192|NCT04536558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25455193|NCT04536558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25455194|NCT04536558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25455195|NCT04536558|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25455196|NCT04536558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25455197|NCT04536558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25455198|NCT04536558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455199|NCT04536558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25455200|NCT04536558|Serotonin Agents|serotonin agents|mesh-ancestor
25455201|NCT04536558|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25455202|NCT04536662|Dexamethasone|dexamethasone|mesh-list
25455203|NCT04536662|Prednisone|prednisone|mesh-list
25455204|NCT04536662|Hydrocortisone|hydrocortisone|mesh-list
25455205|NCT04536662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25455206|NCT04536662|Antiemetics|antiemetics|mesh-ancestor
25455207|NCT04536662|Autonomic Agents|autonomic agents|mesh-ancestor
25311819|NCT05065658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25311820|NCT05065658|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25311821|NCT05065658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25311822|NCT05065658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25455208|NCT04536662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25455209|NCT04536662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455210|NCT04536662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25455212|NCT04536662|Hormones|hormones|mesh-ancestor
25455213|NCT04536662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25455214|NCT04536662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25455215|NCT04536662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25455216|NCT04536675|Bromides|bromides|mesh-list
25455217|NCT04536675|Anticonvulsants|anticonvulsants|mesh-ancestor
25455218|NCT04536363|Alprostadil|alprostadil|mesh-list
25455219|NCT04536363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25455220|NCT04536363|Vasodilator Agents|vasodilator agents|mesh-ancestor
25455221|NCT04536363|Urological Agents|urological agents|mesh-ancestor
25455222|NCT04536532|Entecavir|entecavir|mesh-list
25455223|NCT04536532|Antiviral Agents|antiviral agents|mesh-ancestor
25455224|NCT04536532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25455225|NCT04536415|Oseltamivir|oseltamivir|mesh-list
25455226|NCT04536415|Antiviral Agents|antiviral agents|mesh-ancestor
25455227|NCT04536415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25455228|NCT04536415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25455229|NCT04536415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455230|NCT04536129|Hydrocortisone|hydrocortisone|mesh-list
25455231|NCT04536129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25644428|NCT01436305|Glucocorticoids|glucocorticoids|mesh-ancestor
25644429|NCT01436305|Hormones|hormones|mesh-ancestor
24448220|NCT00310778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24448221|NCT00310778|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25455232|NCT04535973|Hormones|hormones|mesh-list
25656803|NCT01578850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25455233|NCT04535973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25455234|NCT04535973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455235|NCT04536051|Acetaminophen|acetaminophen|mesh-list
25455236|NCT04536051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25455237|NCT04536051|Analgesics|analgesics|mesh-ancestor
25455238|NCT04536051|Sensory System Agents|sensory system agents|mesh-ancestor
25455239|NCT04536051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25455240|NCT04536051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455241|NCT04536051|Antipyretics|antipyretics|mesh-ancestor
25455243|NCT04536493|Epinephrine|epinephrine|mesh-list
25455244|NCT04536493|Racepinephrine|racepinephrine|mesh-list
25455245|NCT04536493|Tetracaine|tetracaine|mesh-list
25455246|NCT04536493|Epinephryl borate|epinephryl borate|mesh-list
25455247|NCT04536493|Anesthetics, Local|anesthetics, local|mesh-ancestor
25455248|NCT04536493|Anesthetics|anesthetics|mesh-ancestor
25455249|NCT04536493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25455250|NCT04536493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455251|NCT04536493|Sensory System Agents|sensory system agents|mesh-ancestor
25455252|NCT04536493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25455253|NCT04536493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25455254|NCT04536493|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25455255|NCT04536493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25455256|NCT04536493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25455257|NCT04536493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455258|NCT04536493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25455259|NCT04536493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25455260|NCT04536493|Adrenergic Agents|adrenergic agents|mesh-ancestor
25455261|NCT04536493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25455262|NCT04536493|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25721568|NCT02487485|Antifungal Agents|antifungal agents|mesh-ancestor
25455263|NCT04536493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25455264|NCT04536493|Autonomic Agents|autonomic agents|mesh-ancestor
25455265|NCT04536493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25455266|NCT04536493|Respiratory System Agents|respiratory system agents|mesh-ancestor
25455267|NCT04536493|Mydriatics|mydriatics|mesh-ancestor
25455268|NCT04536493|Sympathomimetics|sympathomimetics|mesh-ancestor
25455269|NCT04536493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25455270|NCT04535960|Liraglutide|liraglutide|mesh-list
25455271|NCT04535960|Empagliflozin|empagliflozin|mesh-list
25455272|NCT04535960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25455273|NCT04535960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455274|NCT04535960|Incretins|incretins|mesh-ancestor
25455275|NCT04535960|Hormones|hormones|mesh-ancestor
25455276|NCT04535960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25311892|NCT05063513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311893|NCT05063513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311894|NCT05063422|Trimethoprim|trimethoprim|mesh-list
25311895|NCT05063422|Polymyxins|polymyxins|mesh-list
25311896|NCT05063422|Polymyxin B|polymyxin b|mesh-list
25311897|NCT05063422|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25311898|NCT05063422|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25311899|NCT05063422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25311900|NCT05063422|Renal Agents|renal agents|mesh-ancestor
25455277|NCT04535960|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25455278|NCT04535960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455280|NCT04536181|Prednisolone|prednisolone|mesh-list
25455281|NCT04536181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25455282|NCT04536181|Glucocorticoids|glucocorticoids|mesh-ancestor
25455283|NCT04536181|Hormones|hormones|mesh-ancestor
25455284|NCT04536181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25455285|NCT04536181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455286|NCT04536181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25455287|NCT04536181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25455288|NCT04536428|Hemostatics|hemostatics|mesh-list
25455289|NCT04536428|Coagulants|coagulants|mesh-ancestor
25455290|NCT04535869|Sofosbuvir|sofosbuvir|mesh-list
25455291|NCT04535869|Antiviral Agents|antiviral agents|mesh-ancestor
25455292|NCT04535869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25455293|NCT04535817|Omalizumab|omalizumab|mesh-list
25455294|NCT04535817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25455295|NCT04535817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25455296|NCT04535817|Respiratory System Agents|respiratory system agents|mesh-ancestor
25455297|NCT04535804|Aspirin|aspirin|mesh-list
25455298|NCT04535804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25455299|NCT04535804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25644430|NCT01436305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25644431|NCT01436305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25644432|NCT01436305|Protective Agents|protective agents|mesh-ancestor
25644433|NCT01436305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25644434|NCT01436305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25644435|NCT01436305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25455300|NCT04535804|Analgesics|analgesics|mesh-ancestor
25455301|NCT04535804|Sensory System Agents|sensory system agents|mesh-ancestor
25455302|NCT04535804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25644436|NCT01436370|Vaccines|vaccines|mesh-list
25644437|NCT01436370|Immunologic Factors|immunologic factors|mesh-ancestor
25455303|NCT04535804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455304|NCT04535804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25455305|NCT04535804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25455306|NCT04535804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25455307|NCT04535804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25455308|NCT04535804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455309|NCT04535804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25455310|NCT04535804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25455311|NCT04535804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25455312|NCT04535804|Antipyretics|antipyretics|mesh-ancestor
25455313|NCT04535518|Aspirin|aspirin|mesh-list
25455314|NCT04535518|Infliximab|infliximab|mesh-list
25455315|NCT04535518|Immunoglobulins|immunoglobulins|mesh-list
25455316|NCT04535518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25455317|NCT04535518|gamma-Globulins|gamma-globulins|mesh-list
25455318|NCT04535518|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25455319|NCT04535518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25455320|NCT04535518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25455321|NCT04535518|Analgesics|analgesics|mesh-ancestor
25455322|NCT04535518|Sensory System Agents|sensory system agents|mesh-ancestor
25455323|NCT04535518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25455324|NCT04535518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455325|NCT04535518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25455326|NCT04535518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25455327|NCT04535518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25455328|NCT04535518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25455329|NCT04535518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455330|NCT04535518|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25455331|NCT04535518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25455332|NCT04535518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25455333|NCT04535518|Antipyretics|antipyretics|mesh-ancestor
25455334|NCT04535518|Immunologic Factors|immunologic factors|mesh-ancestor
25455335|NCT04535518|Dermatologic Agents|dermatologic agents|mesh-ancestor
25455336|NCT04535518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25455337|NCT04535700|Pioglitazone|pioglitazone|mesh-list
25455338|NCT04535700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25455339|NCT04535700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455340|NCT04535271|Gemcitabine|gemcitabine|mesh-list
25455341|NCT04535271|Dacarbazine|dacarbazine|mesh-list
25455342|NCT04535271|Trabectedin|trabectedin|mesh-list
25455343|NCT04535271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25455344|NCT04535271|Antimetabolites|antimetabolites|mesh-ancestor
25455345|NCT04535271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455346|NCT04535271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25455347|NCT04535271|Antiviral Agents|antiviral agents|mesh-ancestor
25455348|NCT04535271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25455349|NCT04535271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25455350|NCT04535271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25455351|NCT04535271|Immunologic Factors|immunologic factors|mesh-ancestor
25455352|NCT04535271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455353|NCT04535271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25455355|NCT04534803|BCG Vaccine|bcg vaccine|mesh-list
25455356|NCT04534803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25455357|NCT04534803|Immunologic Factors|immunologic factors|mesh-ancestor
25455358|NCT04534803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455359|NCT04534725|Interferons|interferons|mesh-list
25455360|NCT04534725|Interferon-alpha|interferon-alpha|mesh-list
25455361|NCT04534725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25455362|NCT04534725|Antiviral Agents|antiviral agents|mesh-ancestor
25455363|NCT04534725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25455364|NCT04534725|Immunologic Factors|immunologic factors|mesh-ancestor
25455365|NCT04534725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455366|NCT04534491|Oxybutynin|oxybutynin|mesh-list
25455367|NCT04534491|Parasympatholytics|parasympatholytics|mesh-ancestor
25455368|NCT04534491|Autonomic Agents|autonomic agents|mesh-ancestor
25644438|NCT01436370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644439|NCT01436500|Ifetroban|ifetroban|mesh-list
25455369|NCT04534491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25644440|NCT01436500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25455370|NCT04534491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455371|NCT04534491|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25455372|NCT04534491|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25455373|NCT04534491|Cholinergic Agents|cholinergic agents|mesh-ancestor
25644441|NCT01436526|Rivaroxaban|rivaroxaban|mesh-list
25644442|NCT01436526|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25455374|NCT04534491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25455375|NCT04534491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455376|NCT04534491|Urological Agents|urological agents|mesh-ancestor
25455377|NCT04534478|Prednisone|prednisone|mesh-list
25455378|NCT04534478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25455379|NCT04534478|Glucocorticoids|glucocorticoids|mesh-ancestor
25455380|NCT04534478|Hormones|hormones|mesh-ancestor
25455381|NCT04534478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25455382|NCT04534478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455383|NCT04534478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25455384|NCT04534478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25455385|NCT04534465|Mannitol|mannitol|mesh-list
25455386|NCT04534465|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25455387|NCT04534465|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25455388|NCT04534465|Diuretics|diuretics|mesh-ancestor
25455389|NCT04534465|Natriuretic Agents|natriuretic agents|mesh-ancestor
25455390|NCT04534465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455391|NCT04534465|Laxatives|laxatives|mesh-ancestor
25455392|NCT04534465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25455393|NCT04534231|Nicotine|nicotine|mesh-list
25455394|NCT04534231|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25455395|NCT04534231|Autonomic Agents|autonomic agents|mesh-ancestor
25455396|NCT04534231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25455397|NCT04534231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455398|NCT04534231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25455399|NCT04534231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25455400|NCT04534231|Cholinergic Agents|cholinergic agents|mesh-ancestor
25455401|NCT04534231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25455402|NCT04534231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455403|NCT04534452|Phenylephrine|phenylephrine|mesh-list
25455404|NCT04534452|Oxymetazoline|oxymetazoline|mesh-list
25455405|NCT04534452|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25455406|NCT04534452|Mydriatics|mydriatics|mesh-ancestor
25455407|NCT04534452|Autonomic Agents|autonomic agents|mesh-ancestor
25455408|NCT04534452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25455409|NCT04534452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455410|NCT04534452|Sympathomimetics|sympathomimetics|mesh-ancestor
25455411|NCT04534452|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25312120|NCT05059145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25312121|NCT05059145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312122|NCT05059145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312123|NCT05059145|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25312124|NCT05059145|Hormone Antagonists|hormone antagonists|mesh-ancestor
25312125|NCT05059145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25312126|NCT05059145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312127|NCT05059145|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25312128|NCT05059145|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25312137|NCT05058677|Lidocaine|lidocaine|mesh-list
25312138|NCT05058677|Anesthetics, Local|anesthetics, local|mesh-ancestor
25312139|NCT05058677|Anesthetics|anesthetics|mesh-ancestor
25312140|NCT05058677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25312141|NCT05058677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312142|NCT05058677|Sensory System Agents|sensory system agents|mesh-ancestor
25312143|NCT05058677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25312144|NCT05058677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25455412|NCT04534452|Nasal Decongestants|nasal decongestants|mesh-ancestor
25455413|NCT04534452|Respiratory System Agents|respiratory system agents|mesh-ancestor
25455414|NCT04534452|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25455415|NCT04534452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25455416|NCT04534452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25455417|NCT04534452|Adrenergic Agents|adrenergic agents|mesh-ancestor
25455418|NCT04534452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25455419|NCT04534452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644443|NCT01436526|Antithrombins|antithrombins|mesh-ancestor
25644444|NCT01436526|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25455420|NCT04534452|Protective Agents|protective agents|mesh-ancestor
25455421|NCT04534322|Dexamethasone|dexamethasone|mesh-list
25644445|NCT01436526|Protease Inhibitors|protease inhibitors|mesh-ancestor
25644446|NCT01436526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25721588|NCT02488070|Sequestering Agents|sequestering agents|mesh-ancestor
25644447|NCT01436526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644448|NCT01436526|Anticoagulants|anticoagulants|mesh-ancestor
25644449|NCT01436643|Fluoxetine|fluoxetine|mesh-list
25644450|NCT01436643|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25644451|NCT01436643|Citalopram|citalopram|mesh-list
25644452|NCT01436643|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25644453|NCT01436643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25644454|NCT01436643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25644455|NCT01436643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25455422|NCT04534322|Melphalan|melphalan|mesh-list
25455423|NCT04534322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25455424|NCT04534322|Antiemetics|antiemetics|mesh-ancestor
25455425|NCT04534322|Autonomic Agents|autonomic agents|mesh-ancestor
25455426|NCT04534322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25455427|NCT04534322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455428|NCT04534322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25455429|NCT04534322|Glucocorticoids|glucocorticoids|mesh-ancestor
25455430|NCT04534322|Hormones|hormones|mesh-ancestor
25455431|NCT04534322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25455432|NCT04534322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25455433|NCT04534322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25455434|NCT04534322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25455435|NCT04534322|Alkylating Agents|alkylating agents|mesh-ancestor
25455436|NCT04534322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455437|NCT04534322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25455438|NCT04534322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25455439|NCT04534322|Immunologic Factors|immunologic factors|mesh-ancestor
25455440|NCT04533984|Teriparatide|teriparatide|mesh-list
25455441|NCT04533984|Calcium|calcium|mesh-list
25455442|NCT04533984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25455443|NCT04533984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455444|NCT04533984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25455445|NCT04533724|Amisulpride|amisulpride|mesh-list
25455446|NCT04533724|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25455447|NCT04533724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25455448|NCT04533724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25455449|NCT04533724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455450|NCT04533724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25455451|NCT04533724|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25455452|NCT04533724|Dopamine Agents|dopamine agents|mesh-ancestor
25455453|NCT04533724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25455454|NCT04533724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455455|NCT04533724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25455456|NCT04533724|Antidepressive Agents|antidepressive agents|mesh-ancestor
25455457|NCT04533867|Ondansetron|ondansetron|mesh-list
25455458|NCT04533867|Palonosetron|palonosetron|mesh-list
25455459|NCT04533867|Antiemetics|antiemetics|mesh-ancestor
25455460|NCT04533867|Autonomic Agents|autonomic agents|mesh-ancestor
25455461|NCT04533867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25455462|NCT04533867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455463|NCT04533867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25455464|NCT04533867|Antipruritics|antipruritics|mesh-ancestor
25455465|NCT04533867|Dermatologic Agents|dermatologic agents|mesh-ancestor
25455466|NCT04533867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25455467|NCT04533867|Serotonin Agents|serotonin agents|mesh-ancestor
25455468|NCT04533867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25455469|NCT04533867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455470|NCT04533867|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25455471|NCT04533867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25455472|NCT04533867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25312193|NCT05058209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312194|NCT05058209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25312195|NCT05058209|Immunologic Factors|immunologic factors|mesh-ancestor
25312196|NCT05058209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312197|NCT05058209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312198|NCT05058209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25312199|NCT05058209|Respiratory System Agents|respiratory system agents|mesh-ancestor
25312200|NCT05058105|Meropenem|meropenem|mesh-list
25312201|NCT05058105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25312202|NCT05058105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25312218|NCT05057845|Lenvatinib|lenvatinib|mesh-list
25312219|NCT05057845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25644456|NCT01436643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644457|NCT01436643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25644458|NCT01436643|Serotonin Agents|serotonin agents|mesh-ancestor
25644459|NCT01436643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644460|NCT01436643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25312220|NCT05057845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25312221|NCT05057845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25455473|NCT04533867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25644461|NCT01436643|Antidepressive Agents|antidepressive agents|mesh-ancestor
25644462|NCT01436643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25644463|NCT01436643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25644464|NCT01436643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25644465|NCT01436643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25644466|NCT01436643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25644467|NCT01436643|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25644468|NCT01436643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25455474|NCT04533867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25455475|NCT04533867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25455476|NCT04533906|Povidone-Iodine|povidone-iodine|mesh-list
25455477|NCT04533906|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25455478|NCT04533906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25455479|NCT04533347|Tafenoquine|tafenoquine|mesh-list
25455480|NCT04533347|Antimalarials|antimalarials|mesh-ancestor
25455481|NCT04533347|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25455482|NCT04533347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25455483|NCT04533347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25455484|NCT04533243|Fentanyl|fentanyl|mesh-list
25455485|NCT04533243|Morphine|morphine|mesh-list
25455486|NCT04533243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25455487|NCT04533243|Narcotics|narcotics|mesh-ancestor
25455488|NCT04533243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25455489|NCT04533243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455490|NCT04533243|Analgesics|analgesics|mesh-ancestor
25455491|NCT04533243|Sensory System Agents|sensory system agents|mesh-ancestor
25455492|NCT04533243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25455493|NCT04533243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25455494|NCT04533243|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25455495|NCT04533243|Anesthetics, General|anesthetics, general|mesh-ancestor
25455496|NCT04533243|Anesthetics|anesthetics|mesh-ancestor
25455497|NCT04533321|Afatinib|afatinib|mesh-list
25455498|NCT04533321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25455499|NCT04533321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25455500|NCT04533321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25455501|NCT04533321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455502|NCT04532931|Acetaminophen|acetaminophen|mesh-list
25455503|NCT04532931|Sofosbuvir|sofosbuvir|mesh-list
25455504|NCT04532931|Artesunate|artesunate|mesh-list
25455505|NCT04532931|Favipiravir|favipiravir|mesh-list
25455506|NCT04532931|Amodiaquine|amodiaquine|mesh-list
25455507|NCT04532931|Nitazoxanide|nitazoxanide|mesh-list
25455508|NCT04532931|Pyronaridine|pyronaridine|mesh-list
25455509|NCT04532931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25455510|NCT04532931|Analgesics|analgesics|mesh-ancestor
25455511|NCT04532931|Sensory System Agents|sensory system agents|mesh-ancestor
25455512|NCT04532931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25455513|NCT04532931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455514|NCT04532931|Antipyretics|antipyretics|mesh-ancestor
25455515|NCT04532931|Antiviral Agents|antiviral agents|mesh-ancestor
25455516|NCT04532931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25455517|NCT04532931|Antimalarials|antimalarials|mesh-ancestor
25455518|NCT04532931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25455519|NCT04532931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25455520|NCT04532931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25721605|NCT02488980|Mefloquine|mefloquine|mesh-list
25455521|NCT04532931|Schistosomicides|schistosomicides|mesh-ancestor
25455522|NCT04532931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25455523|NCT04532931|Anthelmintics|anthelmintics|mesh-ancestor
25455524|NCT04532918|Cyclosporine|cyclosporine|mesh-list
25455525|NCT04532918|Rifampin|rifampin|mesh-list
25455526|NCT04532918|Allopurinol|allopurinol|mesh-list
25455527|NCT04532918|Verinurad|verinurad|mesh-list
25455528|NCT04532918|Cyclosporins|cyclosporins|mesh-list
25455529|NCT04532918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25455530|NCT04532918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829591|NCT02153177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25455531|NCT04532918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25644469|NCT01436643|Immunologic Factors|immunologic factors|mesh-ancestor
25822861|NCT00004686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644470|NCT01436799|Alfentanil|alfentanil|mesh-list
25644471|NCT01436799|Propofol|propofol|mesh-list
25644472|NCT01436799|Desflurane|desflurane|mesh-list
25644473|NCT01436799|Rocuronium|rocuronium|mesh-list
25644474|NCT01436799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25644475|NCT01436799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25455532|NCT04532918|Immunologic Factors|immunologic factors|mesh-ancestor
25455533|NCT04532918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455534|NCT04532918|Antifungal Agents|antifungal agents|mesh-ancestor
25455535|NCT04532918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25455536|NCT04532918|Dermatologic Agents|dermatologic agents|mesh-ancestor
25455537|NCT04532918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25455538|NCT04532918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25455539|NCT04532918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25455540|NCT04532918|Antitubercular Agents|antitubercular agents|mesh-ancestor
25455541|NCT04532918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25312268|NCT05056896|Dermatologic Agents|dermatologic agents|mesh-ancestor
25312269|NCT05056389|Oxaliplatin|oxaliplatin|mesh-list
25312270|NCT05056389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25312271|NCT05056402|Vaccines|vaccines|mesh-list
25312272|NCT05056402|Immunologic Factors|immunologic factors|mesh-ancestor
25312273|NCT05056402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312274|NCT05056519|Vaccines|vaccines|mesh-list
25312275|NCT05056519|Immunologic Factors|immunologic factors|mesh-ancestor
25312276|NCT05056519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455542|NCT04532918|Leprostatic Agents|leprostatic agents|mesh-ancestor
25455543|NCT04532918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25455544|NCT04532918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25455545|NCT04532918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25455546|NCT04532918|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25455547|NCT04532918|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25455548|NCT04532918|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25455549|NCT04532918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25455550|NCT04532918|Antimetabolites|antimetabolites|mesh-ancestor
25455551|NCT04532918|Gout Suppressants|gout suppressants|mesh-ancestor
25455552|NCT04532918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25455553|NCT04532918|Antioxidants|antioxidants|mesh-ancestor
25455554|NCT04532918|Protective Agents|protective agents|mesh-ancestor
25455555|NCT04532775|Methylprednisolone|methylprednisolone|mesh-list
25455556|NCT04532775|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25455557|NCT04532775|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25455558|NCT04532775|Prednisolone|prednisolone|mesh-list
25455559|NCT04532775|Prednisolone acetate|prednisolone acetate|mesh-list
25455560|NCT04532775|Magnesium Sulfate|magnesium sulfate|mesh-list
25455561|NCT04532775|Bupivacaine|bupivacaine|mesh-list
25455562|NCT04532775|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25455563|NCT04532775|Prednisolone phosphate|prednisolone phosphate|mesh-list
25455564|NCT04532775|Anesthetics, Local|anesthetics, local|mesh-ancestor
25455565|NCT04532775|Anesthetics|anesthetics|mesh-ancestor
25455566|NCT04532775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25455567|NCT04532775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455568|NCT04532775|Sensory System Agents|sensory system agents|mesh-ancestor
25455569|NCT04532775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25455570|NCT04532775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25455571|NCT04532775|Antiemetics|antiemetics|mesh-ancestor
25455572|NCT04532775|Autonomic Agents|autonomic agents|mesh-ancestor
25455573|NCT04532775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25455574|NCT04532775|Glucocorticoids|glucocorticoids|mesh-ancestor
25455575|NCT04532775|Hormones|hormones|mesh-ancestor
25455576|NCT04532775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25455577|NCT04532775|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25455578|NCT04532775|Protective Agents|protective agents|mesh-ancestor
25455579|NCT04532775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25455580|NCT04532775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25455581|NCT04532775|Analgesics|analgesics|mesh-ancestor
25455582|NCT04532775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25455583|NCT04532775|Anticonvulsants|anticonvulsants|mesh-ancestor
25455584|NCT04532775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25455585|NCT04532775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25455586|NCT04532775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455587|NCT04532775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25455588|NCT04532775|Tocolytic Agents|tocolytic agents|mesh-ancestor
25822862|NCT00004686|Dermatologic Agents|dermatologic agents|mesh-ancestor
25644476|NCT01436799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455589|NCT04532775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25455590|NCT04532671|Ether|ether|mesh-list
25455591|NCT04532671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25455592|NCT04532671|Anesthetics, General|anesthetics, general|mesh-ancestor
25455593|NCT04532671|Anesthetics|anesthetics|mesh-ancestor
25455594|NCT04532671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25455595|NCT04532671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455596|NCT04532684|Pregabalin|pregabalin|mesh-list
25455597|NCT04532684|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25455598|NCT04532684|Analgesics|analgesics|mesh-ancestor
25455599|NCT04532684|Sensory System Agents|sensory system agents|mesh-ancestor
25455600|NCT04532684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25455601|NCT04532684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455602|NCT04532684|Anticonvulsants|anticonvulsants|mesh-ancestor
25455603|NCT04532684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25455604|NCT04532684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25455605|NCT04532684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455606|NCT04532684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25455607|NCT04532684|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25455608|NCT04532684|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25455609|NCT04532684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25455610|NCT04532684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25721629|NCT02489630|Ketamine|ketamine|mesh-list
25455611|NCT04532684|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25455612|NCT04532684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25455613|NCT04532684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25455614|NCT04532684|Antidepressive Agents|antidepressive agents|mesh-ancestor
25312349|NCT05053633|Anesthetics|anesthetics|mesh-list
25771969|NCT03650387|Lidocaine|lidocaine|mesh-list
25312350|NCT05053633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25312351|NCT05053633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455634|NCT04532736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25455636|NCT04532736|Autonomic Agents|autonomic agents|mesh-ancestor
25455637|NCT04532736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25455638|NCT04532736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25455639|NCT04532736|Glucocorticoids|glucocorticoids|mesh-ancestor
25455640|NCT04532736|Hormones|hormones|mesh-ancestor
25455641|NCT04532736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25455642|NCT04532736|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25455643|NCT04532736|Protective Agents|protective agents|mesh-ancestor
25455644|NCT04532736|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25455645|NCT04532606|Anesthetics|anesthetics|mesh-list
25455646|NCT04532606|Propofol|propofol|mesh-list
25455647|NCT04532606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25455648|NCT04532606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455649|NCT04532606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25455650|NCT04532606|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25455651|NCT04532606|Anesthetics, General|anesthetics, general|mesh-ancestor
25312421|NCT05052437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312422|NCT05052437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25312423|NCT05052775|Chlorhexidine|chlorhexidine|mesh-list
25312424|NCT05052775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25312425|NCT05052775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25312426|NCT05052775|Disinfectants|disinfectants|mesh-ancestor
25312427|NCT05052814|Chlorhexidine|chlorhexidine|mesh-list
25312428|NCT05052814|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25312429|NCT05052814|Root Canal Irrigants|root canal irrigants|mesh-list
25312430|NCT05052814|Calcium|calcium|mesh-list
25312431|NCT05052814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25312432|NCT05052814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312433|NCT05052814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25312434|NCT05052814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25312435|NCT05052814|Disinfectants|disinfectants|mesh-ancestor
25312436|NCT05052814|Dermatologic Agents|dermatologic agents|mesh-ancestor
25312437|NCT05052814|Dental Disinfectants|dental disinfectants|mesh-ancestor
25312438|NCT05052008|Erenumab|erenumab|mesh-list
25312441|NCT05052008|Analgesics|analgesics|mesh-ancestor
25455652|NCT04532554|Hormones|hormones|mesh-list
25455653|NCT04532554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25455654|NCT04532554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455655|NCT04532229|Nimotuzumab|nimotuzumab|mesh-list
25455656|NCT04532229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25455657|NCT04532229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25455658|NCT04532060|Anti-Infective Agents|anti-infective agents|mesh-list
25455659|NCT04532060|Nystatin|nystatin|mesh-list
25455660|NCT04532060|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25455661|NCT04532060|Antifungal Agents|antifungal agents|mesh-ancestor
25644477|NCT01436799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25644478|NCT01436799|Anesthetics, General|anesthetics, general|mesh-ancestor
25644479|NCT01436799|Anesthetics|anesthetics|mesh-ancestor
25644480|NCT01436799|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25644481|NCT01436799|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25455662|NCT04532060|Ionophores|ionophores|mesh-ancestor
25455663|NCT04532060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25455664|NCT04532060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455665|NCT04532281|Carbamide Peroxide|carbamide peroxide|mesh-list
25455666|NCT04532281|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25455667|NCT04532281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25455668|NCT04532164|Antifungal Agents|antifungal agents|mesh-list
25455669|NCT04532164|Clotrimazole|clotrimazole|mesh-list
25455670|NCT04532164|Miconazole|miconazole|mesh-list
25455671|NCT04532164|Butenafine|butenafine|mesh-list
25455672|NCT04532164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25455673|NCT04532164|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25455674|NCT04532164|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25455675|NCT04532164|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25455676|NCT04532164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25455677|NCT04532164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455678|NCT04532164|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25455679|NCT04532164|Hormone Antagonists|hormone antagonists|mesh-ancestor
25455680|NCT04532164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25455681|NCT04532164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455682|NCT04532164|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25455683|NCT04532164|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25455684|NCT04532333|Heparin|heparin|mesh-list
25455685|NCT04532333|Bivalirudin|bivalirudin|mesh-list
25455686|NCT04532333|Anticoagulants|anticoagulants|mesh-ancestor
25455687|NCT04532333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25455688|NCT04532333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25455689|NCT04532333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455690|NCT04532333|Antithrombins|antithrombins|mesh-ancestor
25455691|NCT04532333|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25455692|NCT04532333|Protease Inhibitors|protease inhibitors|mesh-ancestor
25455693|NCT04532333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25455694|NCT04531865|Mycophenolic Acid|mycophenolic acid|mesh-list
25455695|NCT04531865|Rituximab|rituximab|mesh-list
25455696|NCT04531865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25455697|NCT04531865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25455698|NCT04531865|Immunologic Factors|immunologic factors|mesh-ancestor
25455699|NCT04531865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455700|NCT04531865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25455701|NCT04531865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25455702|NCT04531865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25455703|NCT04531865|Antitubercular Agents|antitubercular agents|mesh-ancestor
25455704|NCT04531865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25455705|NCT04531865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25455706|NCT04531865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25455707|NCT04531865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455708|NCT04531800|Mitogens|mitogens|mesh-list
25455709|NCT04531800|Mitosis Modulators|mitosis modulators|mesh-ancestor
25455710|NCT04531800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455711|NCT04531813|Butenafine|butenafine|mesh-list
25455712|NCT04531813|Antifungal Agents|antifungal agents|mesh-ancestor
25455713|NCT04531813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25455714|NCT04531748|Toremifene|toremifene|mesh-list
25455715|NCT04531748|Melatonin|melatonin|mesh-list
25455716|NCT04531748|Antioxidants|antioxidants|mesh-ancestor
25455717|NCT04531748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455718|NCT04531748|Protective Agents|protective agents|mesh-ancestor
25455719|NCT04531748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455720|NCT04531748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25455721|NCT04531748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25455722|NCT04531748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25455723|NCT04531748|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25312496|NCT05051163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25455724|NCT04531748|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25455726|NCT04531748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25455727|NCT04531748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25455728|NCT04531527|Butenafine|butenafine|mesh-list
25455729|NCT04531527|Antifungal Agents|antifungal agents|mesh-ancestor
25455730|NCT04531527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25455731|NCT04531371|Dexmedetomidine|dexmedetomidine|mesh-list
25455732|NCT04531371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25455733|NCT04531371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25455734|NCT04531371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455735|NCT04531371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25455736|NCT04531371|Analgesics|analgesics|mesh-ancestor
25455737|NCT04531371|Sensory System Agents|sensory system agents|mesh-ancestor
25455738|NCT04531371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25455739|NCT04531371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25455740|NCT04531371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25455741|NCT04531371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25455742|NCT04531371|Adrenergic Agents|adrenergic agents|mesh-ancestor
25455743|NCT04531371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25455744|NCT04531371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455745|NCT04531540|Butenafine|butenafine|mesh-list
25455746|NCT04531540|Antifungal Agents|antifungal agents|mesh-ancestor
25455747|NCT04531540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25455748|NCT04531423|Golimumab|golimumab|mesh-list
25455749|NCT04531423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25455750|NCT04531423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25455751|NCT04531423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25455752|NCT04531423|Immunologic Factors|immunologic factors|mesh-ancestor
25455753|NCT04531423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455754|NCT04531397|Dapagliflozin|dapagliflozin|mesh-list
25455755|NCT04531397|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25455756|NCT04531397|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25455757|NCT04531397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455758|NCT04531397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25455759|NCT04531397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455760|NCT04531397|Protease Inhibitors|protease inhibitors|mesh-ancestor
25455761|NCT04531397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25455762|NCT04531267|Calcium|calcium|mesh-list
25455763|NCT04531267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25455764|NCT04531267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455765|NCT04531475|Lansoprazole|lansoprazole|mesh-list
25455766|NCT04531475|Dexlansoprazole|dexlansoprazole|mesh-list
25455767|NCT04531475|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25455768|NCT04531475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25455769|NCT04531475|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25455770|NCT04531475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25455771|NCT04531475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455772|NCT04531228|Lenvatinib|lenvatinib|mesh-list
25455773|NCT04531228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25455774|NCT04531228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25455775|NCT04531228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25455776|NCT04531228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455777|NCT04531332|Linezolid|linezolid|mesh-list
25455778|NCT04531332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25455779|NCT04531332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25455780|NCT04531332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25455781|NCT04531332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25455782|NCT04531332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455783|NCT04531163|Acetylcysteine|acetylcysteine|mesh-list
25455784|NCT04531163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25455785|NCT04531163|Antiviral Agents|antiviral agents|mesh-ancestor
25455786|NCT04531163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25455787|NCT04531163|Expectorants|expectorants|mesh-ancestor
25455788|NCT04531163|Respiratory System Agents|respiratory system agents|mesh-ancestor
25455789|NCT04531163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25455790|NCT04531163|Antioxidants|antioxidants|mesh-ancestor
25455791|NCT04531163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455792|NCT04531163|Protective Agents|protective agents|mesh-ancestor
25455793|NCT04531163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455794|NCT04531163|Antidotes|antidotes|mesh-ancestor
25455795|NCT04531072|Ritonavir|ritonavir|mesh-list
25455796|NCT04531072|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25455797|NCT04531072|Lumefantrine|lumefantrine|mesh-list
25455798|NCT04531072|Artemether|artemether|mesh-list
25455800|NCT04531072|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25455801|NCT04531072|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25455802|NCT04531072|Protease Inhibitors|protease inhibitors|mesh-ancestor
25455803|NCT04531072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25455804|NCT04531072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455805|NCT04531072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25455806|NCT04531072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25455807|NCT04531072|Antiviral Agents|antiviral agents|mesh-ancestor
25455808|NCT04531072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25455809|NCT04531072|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25455810|NCT04531072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25455811|NCT04531072|Antimalarials|antimalarials|mesh-ancestor
25455812|NCT04531072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25455813|NCT04531072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25455814|NCT04530864|Dexamethasone|dexamethasone|mesh-list
25455815|NCT04530864|Dexamethasone acetate|dexamethasone acetate|mesh-list
25455816|NCT04530864|BB 1101|bb 1101|mesh-list
25455817|NCT04530864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25455818|NCT04530864|Antiemetics|antiemetics|mesh-ancestor
25455819|NCT04530864|Autonomic Agents|autonomic agents|mesh-ancestor
25455820|NCT04530864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25455821|NCT04530864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455822|NCT04530864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25455823|NCT04530864|Glucocorticoids|glucocorticoids|mesh-ancestor
25455824|NCT04530864|Hormones|hormones|mesh-ancestor
25455825|NCT04530864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25455826|NCT04530864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25455827|NCT04530864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25455828|NCT04530864|Protease Inhibitors|protease inhibitors|mesh-ancestor
25455829|NCT04530864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25455830|NCT04530864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455831|NCT04530903|Clonidine|clonidine|mesh-list
25455832|NCT04530903|Levobupivacaine|levobupivacaine|mesh-list
25455833|NCT04530903|Analgesics|analgesics|mesh-ancestor
25455834|NCT04530903|Sensory System Agents|sensory system agents|mesh-ancestor
25455835|NCT04530903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25455836|NCT04530903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455837|NCT04530903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25455838|NCT04530903|Sympatholytics|sympatholytics|mesh-ancestor
25455839|NCT04530903|Autonomic Agents|autonomic agents|mesh-ancestor
25455840|NCT04530903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25455841|NCT04530903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25455842|NCT04530903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25455843|NCT04530903|Adrenergic Agents|adrenergic agents|mesh-ancestor
25455844|NCT04530903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25455845|NCT04530903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455846|NCT04530903|Anesthetics, Local|anesthetics, local|mesh-ancestor
25455847|NCT04530903|Anesthetics|anesthetics|mesh-ancestor
25455848|NCT04530903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25455849|NCT04530474|Ivermectin|ivermectin|mesh-list
25455850|NCT04530474|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25455851|NCT04530474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25455852|NCT04530500|Androgens|androgens|mesh-list
25455853|NCT04530500|Hormones|hormones|mesh-ancestor
25312645|NCT05048615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312646|NCT05048615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25312647|NCT05048615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312648|NCT05048615|Antifungal Agents|antifungal agents|mesh-ancestor
25312649|NCT05048615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25312650|NCT05048615|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25312651|NCT05048615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25312652|NCT05048615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25312653|NCT05048615|Hormone Antagonists|hormone antagonists|mesh-ancestor
25312654|NCT05048615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25312655|NCT05048615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312656|NCT05048615|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25312657|NCT05048511|Vitamin D|vitamin d|mesh-list
25312658|NCT05048511|Vitamins|vitamins|mesh-ancestor
25312659|NCT05048511|Micronutrients|micronutrients|mesh-ancestor
25312660|NCT05048511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312661|NCT05048511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25312683|NCT05048017|Pembrolizumab|pembrolizumab|mesh-list
25455886|NCT04529954|Valproic Acid|valproic acid|mesh-list
25455887|NCT04529954|Anticonvulsants|anticonvulsants|mesh-ancestor
25455888|NCT04529954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25455889|NCT04529954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455890|NCT04529954|GABA Agents|gaba agents|mesh-ancestor
25455891|NCT04529954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25455892|NCT04529954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455893|NCT04529954|Antimanic Agents|antimanic agents|mesh-ancestor
25455894|NCT04529954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25644482|NCT01436799|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25455895|NCT04529954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25455896|NCT04529954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25455897|NCT04530045|Piperacillin|piperacillin|mesh-list
25455898|NCT04530045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25455899|NCT04530045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25312721|NCT05047991|Irinotecan|irinotecan|mesh-list
25455900|NCT04530188|Propofol|propofol|mesh-list
25455901|NCT04530188|Sevoflurane|sevoflurane|mesh-list
25455902|NCT04530188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25455903|NCT04530188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25455904|NCT04530188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455905|NCT04530188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25455906|NCT04530188|Anesthetics, General|anesthetics, general|mesh-ancestor
25455907|NCT04530188|Anesthetics|anesthetics|mesh-ancestor
25455908|NCT04530188|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25455909|NCT04530188|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25455910|NCT04530227|Paclitaxel|paclitaxel|mesh-list
25455911|NCT04530227|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25455912|NCT04530227|Pemetrexed|pemetrexed|mesh-list
25455913|NCT04530227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25455914|NCT04530227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25455915|NCT04530227|Tubulin Modulators|tubulin modulators|mesh-ancestor
25455916|NCT04530227|Antimitotic Agents|antimitotic agents|mesh-ancestor
25455917|NCT04530227|Mitosis Modulators|mitosis modulators|mesh-ancestor
25455918|NCT04530227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455919|NCT04530227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25455920|NCT04530227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25455921|NCT04530227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25455922|NCT04529811|Rifaximin|rifaximin|mesh-list
25455923|NCT04529811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25455924|NCT04529811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25455925|NCT04529811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25455926|NCT04529668|Vitamin D|vitamin d|mesh-list
25455927|NCT04529668|Vitamins|vitamins|mesh-ancestor
25455928|NCT04529668|Micronutrients|micronutrients|mesh-ancestor
25455929|NCT04529668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455930|NCT04529668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25455931|NCT04529525|Ivermectin|ivermectin|mesh-list
25455932|NCT04529525|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25455933|NCT04529525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25455934|NCT04529512|Dexamethasone|dexamethasone|mesh-list
25455935|NCT04529512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25455936|NCT04529512|Antiemetics|antiemetics|mesh-ancestor
25455937|NCT04529512|Autonomic Agents|autonomic agents|mesh-ancestor
25455938|NCT04529512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25455939|NCT04529512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455940|NCT04529512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25455941|NCT04529512|Glucocorticoids|glucocorticoids|mesh-ancestor
25455942|NCT04529512|Hormones|hormones|mesh-ancestor
25455943|NCT04529512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25455944|NCT04529512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25455945|NCT04529512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25455946|NCT04529356|Acetaminophen|acetaminophen|mesh-list
25455947|NCT04529356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25455948|NCT04529356|Analgesics|analgesics|mesh-ancestor
25455949|NCT04529356|Sensory System Agents|sensory system agents|mesh-ancestor
25455950|NCT04529356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25455951|NCT04529356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455952|NCT04529356|Antipyretics|antipyretics|mesh-ancestor
25455953|NCT04529187|Midazolam|midazolam|mesh-list
25455954|NCT04529187|Dexmedetomidine|dexmedetomidine|mesh-list
25455955|NCT04529187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25455956|NCT04529187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25455957|NCT04529187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455958|NCT04529187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25455959|NCT04529187|Analgesics|analgesics|mesh-ancestor
25455960|NCT04529187|Sensory System Agents|sensory system agents|mesh-ancestor
25455961|NCT04529187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25455962|NCT04529187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25455963|NCT04529187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25455964|NCT04529187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25455965|NCT04529187|Adrenergic Agents|adrenergic agents|mesh-ancestor
25455966|NCT04529187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25455967|NCT04529187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455968|NCT04529187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25312803|NCT05046262|Calcium|calcium|mesh-list
25312804|NCT05046262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25644483|NCT01436799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25644484|NCT01436799|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25644485|NCT01436799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25644486|NCT01436799|Narcotics|narcotics|mesh-ancestor
25644487|NCT01436799|Analgesics|analgesics|mesh-ancestor
25312805|NCT05046262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312806|NCT05046457|Beta-Cryptoxanthin|beta-cryptoxanthin|mesh-list
25312807|NCT05046457|Provitamins|provitamins|mesh-ancestor
25312808|NCT05046457|Vitamins|vitamins|mesh-ancestor
25312809|NCT05046457|Micronutrients|micronutrients|mesh-ancestor
25455969|NCT04529187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25455970|NCT04529187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25455971|NCT04529187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25455972|NCT04529187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25455973|NCT04529187|Anesthetics, General|anesthetics, general|mesh-ancestor
25455974|NCT04529187|Anesthetics|anesthetics|mesh-ancestor
25455975|NCT04529187|GABA Modulators|gaba modulators|mesh-ancestor
25455976|NCT04529187|GABA Agents|gaba agents|mesh-ancestor
25455977|NCT04529005|Angiotensin II|angiotensin ii|mesh-list
25455978|NCT04529005|Giapreza|giapreza|mesh-list
25455979|NCT04529005|Angiotensinogen|angiotensinogen|mesh-list
25455980|NCT04529005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25455981|NCT04529005|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25455982|NCT04529005|Protease Inhibitors|protease inhibitors|mesh-ancestor
25455983|NCT04529005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25455984|NCT04529005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455985|NCT04529226|Haloperidol|haloperidol|mesh-list
25455986|NCT04529226|Pimozide|pimozide|mesh-list
25455987|NCT04529226|Olanzapine|olanzapine|mesh-list
25455988|NCT04529226|Risperidone|risperidone|mesh-list
25455989|NCT04529226|Haloperidol decanoate|haloperidol decanoate|mesh-list
25455990|NCT04529226|Clozapine|clozapine|mesh-list
25455991|NCT04529226|Amisulpride|amisulpride|mesh-list
25455992|NCT04529226|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25455993|NCT04529226|Serotonin Agents|serotonin agents|mesh-ancestor
25455994|NCT04529226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25455995|NCT04529226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25455996|NCT04529226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25455997|NCT04529226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25455998|NCT04529226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25455999|NCT04529226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25456000|NCT04529226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25456001|NCT04529226|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25456002|NCT04529226|Dopamine Agents|dopamine agents|mesh-ancestor
25456003|NCT04529226|Antiemetics|antiemetics|mesh-ancestor
25456004|NCT04529226|Autonomic Agents|autonomic agents|mesh-ancestor
25456005|NCT04529226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25456006|NCT04529226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25456007|NCT04529226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25456008|NCT04529226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25456009|NCT04529226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25456010|NCT04529226|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25456011|NCT04529226|GABA Antagonists|gaba antagonists|mesh-ancestor
25456012|NCT04529226|GABA Agents|gaba agents|mesh-ancestor
25456013|NCT04529226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25456014|NCT04529226|Antidepressive Agents|antidepressive agents|mesh-ancestor
25456015|NCT04528628|Norepinephrine|norepinephrine|mesh-list
25456016|NCT04528628|Serotonin|serotonin|mesh-list
25456017|NCT04528628|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25456018|NCT04528628|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
25456019|NCT04528628|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25456020|NCT04528628|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25456021|NCT04528628|Adrenergic Agents|adrenergic agents|mesh-ancestor
25456022|NCT04528628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25456023|NCT04528628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456024|NCT04528628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456025|NCT04528628|Sympathomimetics|sympathomimetics|mesh-ancestor
25456026|NCT04528628|Autonomic Agents|autonomic agents|mesh-ancestor
25456027|NCT04528628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25456028|NCT04528628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25456029|NCT04528628|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25456030|NCT04528628|Serotonin Agents|serotonin agents|mesh-ancestor
25456031|NCT04528628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25456032|NCT04528628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25456033|NCT04528797|Methylprednisolone|methylprednisolone|mesh-list
25456034|NCT04528797|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25456035|NCT04528797|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25456036|NCT04528797|Prednisolone|prednisolone|mesh-list
25644488|NCT01436799|Sensory System Agents|sensory system agents|mesh-ancestor
25644489|NCT01437267|Vaccines|vaccines|mesh-list
25644490|NCT01437267|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25644491|NCT01437267|Immunologic Factors|immunologic factors|mesh-ancestor
25644492|NCT01437267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644493|NCT01437397|Bromides|bromides|mesh-list
25456037|NCT04528797|Prednisolone acetate|prednisolone acetate|mesh-list
25456038|NCT04528797|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25456039|NCT04528797|Prednisolone phosphate|prednisolone phosphate|mesh-list
25456040|NCT04528797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25456041|NCT04528797|Antiemetics|antiemetics|mesh-ancestor
25456042|NCT04528797|Autonomic Agents|autonomic agents|mesh-ancestor
25456043|NCT04528797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25456044|NCT04528797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456045|NCT04528797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25456046|NCT04528797|Glucocorticoids|glucocorticoids|mesh-ancestor
25456047|NCT04528797|Hormones|hormones|mesh-ancestor
25456048|NCT04528797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25456050|NCT04528797|Protective Agents|protective agents|mesh-ancestor
25456051|NCT04528797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25456052|NCT04528797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456053|NCT04528888|Methylprednisolone|methylprednisolone|mesh-list
25456054|NCT04528888|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25456055|NCT04528888|Heparin|heparin|mesh-list
25456056|NCT04528888|Enoxaparin|enoxaparin|mesh-list
25456057|NCT04528888|Calcium heparin|calcium heparin|mesh-list
25456058|NCT04528888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25456059|NCT04528888|Antiemetics|antiemetics|mesh-ancestor
25456060|NCT04528888|Autonomic Agents|autonomic agents|mesh-ancestor
25456061|NCT04528888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25456062|NCT04528888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456063|NCT04528888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25456064|NCT04528888|Glucocorticoids|glucocorticoids|mesh-ancestor
25456065|NCT04528888|Hormones|hormones|mesh-ancestor
25456066|NCT04528888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25456067|NCT04528888|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25456068|NCT04528888|Protective Agents|protective agents|mesh-ancestor
25456069|NCT04528888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25456070|NCT04528888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456071|NCT04528888|Anticoagulants|anticoagulants|mesh-ancestor
25456072|NCT04528888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25456073|NCT04528888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25456074|NCT04528888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456075|NCT04528927|Azithromycin|azithromycin|mesh-list
25456076|NCT04528927|Doxycycline|doxycycline|mesh-list
25456077|NCT04528927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25456078|NCT04528927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456079|NCT04528927|Antimalarials|antimalarials|mesh-ancestor
25456080|NCT04528927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25456081|NCT04528927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25456082|NCT04528277|Isoniazid|isoniazid|mesh-list
25456083|NCT04528277|Rifapentine|rifapentine|mesh-list
25456084|NCT04528277|Antitubercular Agents|antitubercular agents|mesh-ancestor
25456085|NCT04528277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25456086|NCT04528277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456087|NCT04528277|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25456088|NCT04528277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25456089|NCT04528277|Antimetabolites|antimetabolites|mesh-ancestor
25456090|NCT04528277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456091|NCT04528277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25456092|NCT04528277|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25456093|NCT04528277|Leprostatic Agents|leprostatic agents|mesh-ancestor
25456094|NCT04528290|Ozanimod|ozanimod|mesh-list
25456095|NCT04528290|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25456096|NCT04528290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456097|NCT04528290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25456098|NCT04528290|Immunologic Factors|immunologic factors|mesh-ancestor
25456099|NCT04528290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456100|NCT04528095|Clozapine|clozapine|mesh-list
25456101|NCT04528095|Amisulpride|amisulpride|mesh-list
25456102|NCT04528095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25456103|NCT04528095|Serotonin Agents|serotonin agents|mesh-ancestor
25456104|NCT04528095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25456105|NCT04528095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456106|NCT04528095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456107|NCT04528095|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25644494|NCT01437397|Formoterol Fumarate|formoterol fumarate|mesh-list
25456108|NCT04528095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25312945|NCT05044429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25312946|NCT05044429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312947|NCT05044429|Sensory System Agents|sensory system agents|mesh-ancestor
25312948|NCT05044429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25312949|NCT05044429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25312950|NCT05044429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25312951|NCT05044429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25312952|NCT05044429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25312953|NCT05044429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312967|NCT05044364|Clevidipine|clevidipine|mesh-list
25312968|NCT05044364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25312969|NCT05044364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25456141|NCT04528004|Vasodilator Agents|vasodilator agents|mesh-ancestor
25313008|NCT05043506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313009|NCT05043506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25313010|NCT05043506|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25313011|NCT05043506|Hormone Antagonists|hormone antagonists|mesh-ancestor
25313012|NCT05043506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25313013|NCT05043506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313014|NCT05043688|Paclitaxel|paclitaxel|mesh-list
25313015|NCT05043688|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25313016|NCT05043688|Carboplatin|carboplatin|mesh-list
25313017|NCT05043688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25313018|NCT05043688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25313023|NCT05043350|Loratadine|loratadine|mesh-list
25456142|NCT04527562|Colchicine|colchicine|mesh-list
25456143|NCT04527562|Gout Suppressants|gout suppressants|mesh-ancestor
25456144|NCT04527562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25456145|NCT04527562|Tubulin Modulators|tubulin modulators|mesh-ancestor
25456146|NCT04527562|Antimitotic Agents|antimitotic agents|mesh-ancestor
25456147|NCT04527562|Mitosis Modulators|mitosis modulators|mesh-ancestor
25456148|NCT04527562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456149|NCT04527562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456150|NCT04527679|Lenvatinib|lenvatinib|mesh-list
25456151|NCT04527679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456152|NCT04527679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25456153|NCT04527679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25456154|NCT04527679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456155|NCT04527276|Chlorhexidine|chlorhexidine|mesh-list
25456156|NCT04527276|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25456157|NCT04527276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456158|NCT04527276|Disinfectants|disinfectants|mesh-ancestor
25456159|NCT04527666|Anticoagulants|anticoagulants|mesh-list
25456160|NCT04527211|Ivermectin|ivermectin|mesh-list
25456161|NCT04527211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25456162|NCT04527211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456163|NCT05140811|Azacitidine|azacitidine|mesh-list
25456164|NCT05140811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25456165|NCT05140811|Antimetabolites|antimetabolites|mesh-ancestor
25456166|NCT05140811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456167|NCT05140811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456168|NCT05140811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25456169|NCT05140746|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25456170|NCT05140746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25456171|NCT05140746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456172|NCT05140655|Fulvestrant|fulvestrant|mesh-list
25456173|NCT05140655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25456174|NCT05140655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456175|NCT05140655|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25456176|NCT05140655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25456177|NCT05140655|Hormone Antagonists|hormone antagonists|mesh-ancestor
25456178|NCT05140655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25456179|NCT05140655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456180|NCT05140525|Macitentan|macitentan|mesh-list
25456181|NCT05140525|Riociguat|riociguat|mesh-list
25456182|NCT05140525|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25456183|NCT05140525|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25456184|NCT05140525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456185|NCT05140525|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25456186|NCT05140525|Enzyme Activators|enzyme activators|mesh-ancestor
25644495|NCT01437397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25456187|NCT05140512|Goserelin|goserelin|mesh-list
25456188|NCT05140512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25456189|NCT05140512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456190|NCT05140096|Fluconazole|fluconazole|mesh-list
25456191|NCT05140096|Isavuconazole|isavuconazole|mesh-list
25456192|NCT05140096|Acalabrutinib|acalabrutinib|mesh-list
25456193|NCT05140096|Antifungal Agents|antifungal agents|mesh-ancestor
25456194|NCT05140096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456195|NCT05140096|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25456196|NCT05140096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25456197|NCT05140096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25456198|NCT05140096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456199|NCT05140096|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25456200|NCT05140096|Hormone Antagonists|hormone antagonists|mesh-ancestor
25456201|NCT05140096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25456202|NCT05140096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456203|NCT05140096|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25456204|NCT05140096|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25456205|NCT05140096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456206|NCT05139966|Fluorides|fluorides|mesh-list
25456207|NCT05139966|Cariostatic Agents|cariostatic agents|mesh-ancestor
25456208|NCT05139966|Protective Agents|protective agents|mesh-ancestor
25456209|NCT05139966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456210|NCT05139667|Tacrolimus|tacrolimus|mesh-list
25456211|NCT05139667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25456212|NCT05139667|Immunologic Factors|immunologic factors|mesh-ancestor
25313084|NCT05042336|Lenvatinib|lenvatinib|mesh-list
25313085|NCT05042336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25313086|NCT05042336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25313089|NCT05042271|Meropenem|meropenem|mesh-list
25456213|NCT05139667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456214|NCT05139667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25456215|NCT05139667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25456216|NCT05139667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456217|NCT05139524|Immunoglobulin G|immunoglobulin g|mesh-list
25456218|NCT05139524|Immunologic Factors|immunologic factors|mesh-ancestor
25456219|NCT05139524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456221|NCT05139238|Nifedipine|nifedipine|mesh-list
25456222|NCT05139238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25456223|NCT05139238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25456224|NCT05139238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456225|NCT05139238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25456226|NCT05139238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456227|NCT05139238|Vasodilator Agents|vasodilator agents|mesh-ancestor
25456228|NCT05139238|Tocolytic Agents|tocolytic agents|mesh-ancestor
25456229|NCT05139238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25456230|NCT05139238|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25456231|NCT05139238|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25456232|NCT05139238|Adrenergic Agents|adrenergic agents|mesh-ancestor
25456233|NCT05139238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25456234|NCT05139238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25456235|NCT05139238|Sympathomimetics|sympathomimetics|mesh-ancestor
25456236|NCT05139238|Autonomic Agents|autonomic agents|mesh-ancestor
25456237|NCT05139238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25456238|NCT05139238|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25456239|NCT05139238|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25456240|NCT05138978|Listerine|listerine|mesh-list
25456241|NCT05138978|Sodium Fluoride|sodium fluoride|mesh-list
25456242|NCT05138978|Cariostatic Agents|cariostatic agents|mesh-ancestor
25456243|NCT05138978|Protective Agents|protective agents|mesh-ancestor
25456244|NCT05138978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456245|NCT05138978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25456246|NCT05138978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456247|NCT05138861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25456248|NCT05138861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25456249|NCT05138718|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25456250|NCT05138718|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25456251|NCT05138718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456252|NCT05138484|Chlorhexidine|chlorhexidine|mesh-list
25456253|NCT05138484|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25456254|NCT05138484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25456255|NCT05138484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456256|NCT05138484|Disinfectants|disinfectants|mesh-ancestor
25456257|NCT05138484|Dermatologic Agents|dermatologic agents|mesh-ancestor
25644496|NCT01437397|Autonomic Agents|autonomic agents|mesh-ancestor
25644497|NCT01437397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25644498|NCT01437397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644499|NCT01437397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25644500|NCT01437397|Respiratory System Agents|respiratory system agents|mesh-ancestor
25644501|NCT01437397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25644502|NCT01437397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25456258|NCT05126121|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25644503|NCT01437397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25456259|NCT05126121|Amoxicillin|amoxicillin|mesh-list
25456260|NCT05126121|Clarithromycin|clarithromycin|mesh-list
25456261|NCT05126121|Levofloxacin|levofloxacin|mesh-list
25456262|NCT05126121|Ofloxacin|ofloxacin|mesh-list
25456263|NCT05126121|Tetracycline|tetracycline|mesh-list
25456264|NCT05126121|Tinidazole|tinidazole|mesh-list
25456265|NCT05126121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25456266|NCT05126121|Furazolidone|furazolidone|mesh-list
25456267|NCT05126121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456268|NCT05126121|Antitubercular Agents|antitubercular agents|mesh-ancestor
25456269|NCT05126121|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25644504|NCT01437397|Adrenergic Agents|adrenergic agents|mesh-ancestor
25456270|NCT05126121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25456271|NCT05126121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456272|NCT05126121|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25456273|NCT05126121|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25456274|NCT05126121|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25456275|NCT05126121|Renal Agents|renal agents|mesh-ancestor
25456276|NCT05126121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25313155|NCT05041270|Dexmedetomidine|dexmedetomidine|mesh-list
25313156|NCT05041270|Nalbuphine|nalbuphine|mesh-list
25313157|NCT05041270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25313158|NCT05041270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25313159|NCT05041270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313160|NCT05041270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25313161|NCT05041270|Analgesics|analgesics|mesh-ancestor
25313162|NCT05041270|Sensory System Agents|sensory system agents|mesh-ancestor
25313163|NCT05041270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25456277|NCT05126121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25456278|NCT05126121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456310|NCT04918017|Esomeprazole|esomeprazole|mesh-list
25456311|NCT04918017|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25456312|NCT04918017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25456313|NCT04918017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25456314|NCT04918017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25456315|NCT04918017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456317|NCT04459871|Hemostatics|hemostatics|mesh-ancestor
25456318|NCT04459871|Coagulants|coagulants|mesh-ancestor
25456319|NCT04455139|Melphalan|melphalan|mesh-list
25456320|NCT04455139|Topotecan|topotecan|mesh-list
25456321|NCT04455139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25456322|NCT04455139|Alkylating Agents|alkylating agents|mesh-ancestor
25456323|NCT04455139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456324|NCT04455139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456325|NCT04455139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25456326|NCT04455139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25456327|NCT04455139|Immunologic Factors|immunologic factors|mesh-ancestor
25456328|NCT04455139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456329|NCT04455139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25456330|NCT04455139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25456331|NCT04455139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25456332|NCT04447183|Iodine|iodine|mesh-list
25456333|NCT04447183|Hormones|hormones|mesh-list
25456334|NCT04447183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25456335|NCT04447183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456336|NCT04447183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25456337|NCT04447183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456338|NCT04447183|Trace Elements|trace elements|mesh-ancestor
25456339|NCT04447183|Micronutrients|micronutrients|mesh-ancestor
25456340|NCT04417088|Carboplatin|carboplatin|mesh-list
25456341|NCT04417088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456342|NCT04312594|Acetylcysteine|acetylcysteine|mesh-list
25456343|NCT04312594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25456344|NCT04312594|Antiviral Agents|antiviral agents|mesh-ancestor
25456345|NCT04312594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456346|NCT04312594|Expectorants|expectorants|mesh-ancestor
25456347|NCT04312594|Respiratory System Agents|respiratory system agents|mesh-ancestor
25456348|NCT04312594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25456349|NCT04312594|Antioxidants|antioxidants|mesh-ancestor
25456350|NCT04312594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456351|NCT04312594|Protective Agents|protective agents|mesh-ancestor
25456352|NCT04312594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456353|NCT04312594|Antidotes|antidotes|mesh-ancestor
25456354|NCT04129216|Tamoxifen|tamoxifen|mesh-list
25456355|NCT04129216|Letrozole|letrozole|mesh-list
25456356|NCT04129216|Exemestane|exemestane|mesh-list
25456357|NCT04129216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456358|NCT04129216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456359|NCT04129216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25456360|NCT04129216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25456361|NCT04129216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25456362|NCT04129216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25456363|NCT04129216|Hormone Antagonists|hormone antagonists|mesh-ancestor
25456364|NCT04129216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25456365|NCT04129216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456366|NCT04129216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25456367|NCT04129216|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25456368|NCT04129216|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25456369|NCT04129216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25456370|NCT04106414|Nivolumab|nivolumab|mesh-list
25456371|NCT04106414|Linrodostat|linrodostat|mesh-list
25456372|NCT04106414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25456373|NCT04106414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913218|NCT04267913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24913219|NCT04267913|Glucocorticoids|glucocorticoids|mesh-ancestor
24913388|NCT04265274|Disulfiram|disulfiram|mesh-list
25313300|NCT05037695|Empagliflozin|empagliflozin|mesh-list
25313301|NCT05037695|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25313302|NCT05037695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313303|NCT05037695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25313304|NCT05037695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313318|NCT05037253|Vitamin D|vitamin d|mesh-list
25313319|NCT05037253|Vitamins|vitamins|mesh-ancestor
25313320|NCT05037253|Micronutrients|micronutrients|mesh-ancestor
25313321|NCT05037253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456374|NCT04106414|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25456375|NCT04106414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456376|NCT04106414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25456377|NCT04052880|Dexamethasone|dexamethasone|mesh-list
25456378|NCT04052880|Lenalidomide|lenalidomide|mesh-list
25456379|NCT04052880|Bortezomib|bortezomib|mesh-list
25456380|NCT04052880|Daratumumab|daratumumab|mesh-list
25456381|NCT04052880|Ixazomib|ixazomib|mesh-list
25456382|NCT04052880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25456383|NCT04052880|Antiemetics|antiemetics|mesh-ancestor
25456384|NCT04052880|Autonomic Agents|autonomic agents|mesh-ancestor
25456385|NCT04052880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25456386|NCT04052880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456387|NCT04052880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25456388|NCT04052880|Glucocorticoids|glucocorticoids|mesh-ancestor
25456389|NCT04052880|Hormones|hormones|mesh-ancestor
25456390|NCT04052880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25456391|NCT04052880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25456392|NCT04052880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456393|NCT04052880|Immunologic Factors|immunologic factors|mesh-ancestor
25456394|NCT04052880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25456395|NCT04052880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25456396|NCT04052880|Growth Substances|growth substances|mesh-ancestor
25456397|NCT04052880|Growth Inhibitors|growth inhibitors|mesh-ancestor
25456398|NCT04052880|Protease Inhibitors|protease inhibitors|mesh-ancestor
25456399|NCT04052880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25456400|NCT04052880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456401|NCT03993379|Ipilimumab|ipilimumab|mesh-list
25456402|NCT03993379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25456403|NCT03993379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456404|NCT03993379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25456405|NCT03993379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456406|NCT03921866|Palbociclib|palbociclib|mesh-list
25456407|NCT03921866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456408|NCT03921866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25456409|NCT03921866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25456410|NCT03921866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456411|NCT03772158|Cetirizine|cetirizine|mesh-list
25456412|NCT03772158|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25456413|NCT03772158|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25456414|NCT03772158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25456415|NCT03772158|Histamine Antagonists|histamine antagonists|mesh-ancestor
25456416|NCT03772158|Histamine Agents|histamine agents|mesh-ancestor
25456417|NCT03772158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25456418|NCT03772158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456419|NCT03772158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456420|NCT03723590|Hyaluronic Acid|hyaluronic acid|mesh-list
25456421|NCT03723590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25456422|NCT03723590|Immunologic Factors|immunologic factors|mesh-ancestor
25456423|NCT03723590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456424|NCT03723590|Viscosupplements|viscosupplements|mesh-ancestor
25456425|NCT03723590|Protective Agents|protective agents|mesh-ancestor
25456426|NCT03613727|Ascorbic Acid|ascorbic acid|mesh-list
25456427|NCT03613727|Vitamins|vitamins|mesh-ancestor
25456428|NCT03613727|Micronutrients|micronutrients|mesh-ancestor
25456429|NCT03613727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456430|NCT03613727|Antioxidants|antioxidants|mesh-ancestor
25313374|NCT05036174|Sensory System Agents|sensory system agents|mesh-ancestor
25313375|NCT05036174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25313376|NCT05036174|Antiemetics|antiemetics|mesh-ancestor
25313377|NCT05036174|Autonomic Agents|autonomic agents|mesh-ancestor
25313378|NCT05036174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25313379|NCT05036174|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25313380|NCT05036174|Histamine Antagonists|histamine antagonists|mesh-ancestor
25313381|NCT05036174|Histamine Agents|histamine agents|mesh-ancestor
25313382|NCT05036174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25313383|NCT05036174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313384|NCT05036174|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25313385|NCT05036174|Antipruritics|antipruritics|mesh-ancestor
25313386|NCT05036174|Dermatologic Agents|dermatologic agents|mesh-ancestor
25313406|NCT05035745|Talazoparib|talazoparib|mesh-list
25313407|NCT05035745|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25313408|NCT05035745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25313409|NCT05035745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313412|NCT05035849|Acarbose|acarbose|mesh-list
25456431|NCT03613727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456432|NCT03613727|Protective Agents|protective agents|mesh-ancestor
25456433|NCT03558854|Aspirin|aspirin|mesh-list
25456434|NCT03558854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25456435|NCT03558854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25456436|NCT03558854|Analgesics|analgesics|mesh-ancestor
25456437|NCT03558854|Sensory System Agents|sensory system agents|mesh-ancestor
25456438|NCT03558854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25456439|NCT03558854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456440|NCT03558854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25456441|NCT03558854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25456442|NCT03558854|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25456443|NCT03558854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25456444|NCT03558854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456445|NCT03558854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25456446|NCT03558854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25456447|NCT03558854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25456448|NCT03558854|Antipyretics|antipyretics|mesh-ancestor
25456449|NCT03486301|Pembrolizumab|pembrolizumab|mesh-list
25456450|NCT03486301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25456451|NCT03486301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456452|NCT03430895|Durvalumab|durvalumab|mesh-list
25456453|NCT03430895|Tremelimumab|tremelimumab|mesh-list
25456454|NCT03430895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25456455|NCT03430895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456456|NCT03409458|Avelumab|avelumab|mesh-list
25456457|NCT03409458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25456458|NCT03409458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456459|NCT03366272|Gemcitabine|gemcitabine|mesh-list
25456460|NCT03366272|Rituximab|rituximab|mesh-list
25456461|NCT03366272|Nivolumab|nivolumab|mesh-list
25456462|NCT03366272|Oxaliplatin|oxaliplatin|mesh-list
25456463|NCT03366272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25456464|NCT03366272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456465|NCT03366272|Immunologic Factors|immunologic factors|mesh-ancestor
25456466|NCT03366272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456467|NCT03366272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25456468|NCT03366272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25456469|NCT03366272|Antimetabolites|antimetabolites|mesh-ancestor
25456470|NCT03366272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822863|NCT00004686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25644505|NCT01437397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25644506|NCT01437397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644507|NCT01437397|Anticonvulsants|anticonvulsants|mesh-ancestor
25644508|NCT01437449|Cisplatin|cisplatin|mesh-list
25644509|NCT01437449|Carboplatin|carboplatin|mesh-list
25822864|NCT00004686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25822865|NCT00004686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25456471|NCT03366272|Antiviral Agents|antiviral agents|mesh-ancestor
25456472|NCT03366272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456473|NCT03366272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25456474|NCT03366272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25456475|NCT03366272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25456476|NCT03230838|Meropenem|meropenem|mesh-list
25456477|NCT03230838|Tazobactam|tazobactam|mesh-list
25456478|NCT03230838|Ceftolozane|ceftolozane|mesh-list
25456479|NCT03230838|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
25456480|NCT03230838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25456481|NCT03230838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456482|NCT03230838|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25456483|NCT03230838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25456484|NCT03230838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456485|NCT03230838|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25456486|NCT03230838|Renal Agents|renal agents|mesh-ancestor
25456487|NCT03113955|Epirubicin|epirubicin|mesh-list
25456488|NCT03113955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25456489|NCT03113955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456490|NCT03113955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25456491|NCT03113955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25456492|NCT03113955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25456493|NCT03113955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456494|NCT03034096|Propofol|propofol|mesh-list
25456495|NCT03034096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25456496|NCT03034096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25456497|NCT03034096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456498|NCT03034096|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25456499|NCT03034096|Anesthetics, General|anesthetics, general|mesh-ancestor
25456500|NCT03034096|Anesthetics|anesthetics|mesh-ancestor
25456501|NCT03016338|Niraparib|niraparib|mesh-list
25456502|NCT03016338|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25456503|NCT03016338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25456504|NCT03016338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456505|NCT03016338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456518|NCT02257567|Obinutuzumab|obinutuzumab|mesh-list
25456519|NCT02257567|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25456520|NCT02257567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25456521|NCT02257567|Immunoconjugates|immunoconjugates|mesh-list
25456522|NCT02257567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25456523|NCT02257567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456524|NCT02257567|Immunologic Factors|immunologic factors|mesh-ancestor
25456525|NCT02257567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456526|NCT02257567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25456527|NCT02257567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25456528|NCT02257567|Alkylating Agents|alkylating agents|mesh-ancestor
25456529|NCT02257567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456530|NCT02129647|Axitinib|axitinib|mesh-list
25456531|NCT02129647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456532|NCT02129647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25456533|NCT02129647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25456534|NCT02129647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456535|NCT01959139|Leucovorin|leucovorin|mesh-list
25456536|NCT01959139|Fluorouracil|fluorouracil|mesh-list
25456537|NCT01959139|Oxaliplatin|oxaliplatin|mesh-list
25456538|NCT01959139|Irinotecan|irinotecan|mesh-list
25456539|NCT01959139|Levoleucovorin|levoleucovorin|mesh-list
25456540|NCT01959139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456541|NCT01959139|Antimetabolites|antimetabolites|mesh-ancestor
25456542|NCT01959139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456543|NCT01959139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25456544|NCT01959139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456545|NCT01959139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25456546|NCT01959139|Immunologic Factors|immunologic factors|mesh-ancestor
25456547|NCT01959139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25822866|NCT00004686|Immunologic Factors|immunologic factors|mesh-ancestor
24638730|NCT01157819|Ciprofloxacin|ciprofloxacin|mesh-list
25644510|NCT01437449|Docetaxel|docetaxel|mesh-list
25644511|NCT01437449|Cetuximab|cetuximab|mesh-list
25456548|NCT01959139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25456549|NCT01959139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25456550|NCT01959139|Antidotes|antidotes|mesh-ancestor
25456551|NCT01959139|Protective Agents|protective agents|mesh-ancestor
25456552|NCT01959139|Vitamin B Complex|vitamin b complex|mesh-ancestor
25456553|NCT01959139|Vitamins|vitamins|mesh-ancestor
25456554|NCT01959139|Micronutrients|micronutrients|mesh-ancestor
25456555|NCT01870193|Acetylcysteine|acetylcysteine|mesh-list
25456556|NCT01870193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25456557|NCT01870193|Glycine|glycine|mesh-list
25456558|NCT01870193|Antiviral Agents|antiviral agents|mesh-ancestor
25456559|NCT01870193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456560|NCT01870193|Expectorants|expectorants|mesh-ancestor
25456561|NCT01870193|Respiratory System Agents|respiratory system agents|mesh-ancestor
25456562|NCT01870193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25456563|NCT01870193|Antioxidants|antioxidants|mesh-ancestor
25456564|NCT01870193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456565|NCT01870193|Protective Agents|protective agents|mesh-ancestor
25456566|NCT01870193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456567|NCT01870193|Antidotes|antidotes|mesh-ancestor
25456568|NCT01870193|Glycine Agents|glycine agents|mesh-ancestor
25456569|NCT01870193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25456570|NCT01805284|Linezolid|linezolid|mesh-list
25456571|NCT01805284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25456572|NCT01805284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25456573|NCT01805284|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25456574|NCT01805284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25456575|NCT01805284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456576|NCT01134601|Capecitabine|capecitabine|mesh-list
25456577|NCT01134601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25456578|NCT01134601|Antimetabolites|antimetabolites|mesh-ancestor
25456579|NCT01134601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456580|NCT01134601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25313596|NCT05033704|Plasma Substitutes|plasma substitutes|mesh-ancestor
25456834|NCT04221568|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25456835|NCT04221568|Anesthetics, General|anesthetics, general|mesh-ancestor
25456836|NCT04220203|Capecitabine|capecitabine|mesh-list
25456837|NCT04220203|Trastuzumab|trastuzumab|mesh-list
25456838|NCT04220203|Tucatinib|tucatinib|mesh-list
25456839|NCT04220203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25456840|NCT04220203|Antimetabolites|antimetabolites|mesh-ancestor
25456841|NCT04220203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25456842|NCT04220203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25456843|NCT04220203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25456844|NCT04220203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25456845|NCT04220203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25456846|NCT04216303|Chrysarobin|chrysarobin|mesh-list
25456847|NCT04216303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25456848|NCT04216303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25456849|NCT04216303|Analgesics|analgesics|mesh-ancestor
25456850|NCT04216303|Sensory System Agents|sensory system agents|mesh-ancestor
25456851|NCT04216303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25456852|NCT04216303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25456853|NCT04216303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25456854|NCT04216303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25314573|NCT05017272|Analgesics, Opioid|analgesics, opioid|mesh-list
25314574|NCT05017272|Narcotics|narcotics|mesh-ancestor
25314575|NCT05017272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25314576|NCT05017272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314577|NCT05017272|Analgesics|analgesics|mesh-ancestor
25314578|NCT05017272|Sensory System Agents|sensory system agents|mesh-ancestor
25314579|NCT05017272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25314587|NCT05017155|Mexiletine|mexiletine|mesh-list
25314588|NCT05017155|Lamotrigine|lamotrigine|mesh-list
25314589|NCT05017155|Anticonvulsants|anticonvulsants|mesh-ancestor
25314590|NCT05017155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25314591|NCT05017155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25456914|NCT04135092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25314791|NCT05015322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25314792|NCT05015322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25314793|NCT05015322|Protective Agents|protective agents|mesh-ancestor
25314794|NCT05015322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25314795|NCT05015322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25822867|NCT00004686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25314797|NCT05014711|Remifentanil|remifentanil|mesh-list
25314798|NCT05014711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25314799|NCT05014711|Narcotics|narcotics|mesh-ancestor
25456953|NCT04114500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315396|NCT05006287|Antithrombins|antithrombins|mesh-ancestor
25315397|NCT05006287|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25315398|NCT05006287|Protease Inhibitors|protease inhibitors|mesh-ancestor
25644512|NCT01437449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25644513|NCT01437449|Tubulin Modulators|tubulin modulators|mesh-ancestor
25644514|NCT01437449|Antimitotic Agents|antimitotic agents|mesh-ancestor
25644515|NCT01437449|Mitosis Modulators|mitosis modulators|mesh-ancestor
25315399|NCT05006287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25315400|NCT05006287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743056|NCT05022901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24814301|NCT02063802|Metformin|metformin|mesh-list
25457113|NCT03903406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25457114|NCT03903406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25457115|NCT03903406|Growth Substances|growth substances|mesh-ancestor
25457116|NCT03903406|Growth Inhibitors|growth inhibitors|mesh-ancestor
25457117|NCT03903406|Protease Inhibitors|protease inhibitors|mesh-ancestor
25457118|NCT03903406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457119|NCT03903406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457120|NCT03897192|Bevacizumab|bevacizumab|mesh-list
25457121|NCT03897192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25457122|NCT03897192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457123|NCT03897192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25457124|NCT03897192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25457125|NCT03897192|Growth Substances|growth substances|mesh-ancestor
25457126|NCT03897192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457127|NCT03897192|Growth Inhibitors|growth inhibitors|mesh-ancestor
25457128|NCT03896815|INCB054329|incb054329|mesh-list
25457129|NCT03896815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457152|NCT05278793|Ferrous fumarate|ferrous fumarate|mesh-list
25457153|NCT05278793|Trace Elements|trace elements|mesh-ancestor
25457154|NCT05278793|Micronutrients|micronutrients|mesh-ancestor
25457155|NCT05278793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457156|NCT05278728|Irinotecan|irinotecan|mesh-list
25457157|NCT05278728|Nimotuzumab|nimotuzumab|mesh-list
25457158|NCT05278728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25457159|NCT05278728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25457160|NCT05278728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457161|NCT05278728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457162|NCT05278728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457163|NCT05278728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25457164|NCT05278637|Aspirin|aspirin|mesh-list
25457165|NCT05278637|Ticagrelor|ticagrelor|mesh-list
25457166|NCT05278637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25457167|NCT05278637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25457168|NCT05278637|Analgesics|analgesics|mesh-ancestor
25457169|NCT05278637|Sensory System Agents|sensory system agents|mesh-ancestor
25457170|NCT05278637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25457171|NCT05278637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457172|NCT05278637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25457173|NCT05278637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25457174|NCT05278637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25457175|NCT05278637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25457176|NCT05278637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457177|NCT05278637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25457178|NCT05278637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25457179|NCT05278637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457180|NCT05278637|Antipyretics|antipyretics|mesh-ancestor
25457181|NCT05278637|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25457182|NCT05278637|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25457183|NCT05278637|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25457184|NCT05278637|Purinergic Agents|purinergic agents|mesh-ancestor
25457185|NCT05278637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25457186|NCT05277974|Dexamethasone|dexamethasone|mesh-list
25457187|NCT05277974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25457188|NCT05277974|Antiemetics|antiemetics|mesh-ancestor
25457189|NCT05277974|Autonomic Agents|autonomic agents|mesh-ancestor
25457190|NCT05277974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25457191|NCT05277974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457192|NCT05277974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25457193|NCT05277974|Glucocorticoids|glucocorticoids|mesh-ancestor
25457194|NCT05277974|Hormones|hormones|mesh-ancestor
24534895|NCT00648258|Naproxen|naproxen|mesh-list
25644516|NCT01437449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457195|NCT05277974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25457196|NCT05277974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25457197|NCT05277974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457198|NCT05277701|Lazertinib|lazertinib|mesh-list
25457199|NCT05277701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25457200|NCT05277701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457201|NCT05277701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457202|NCT05277675|Bevacizumab|bevacizumab|mesh-list
25457203|NCT05277675|Lenvatinib|lenvatinib|mesh-list
25457204|NCT05277675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25457205|NCT05277675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457206|NCT05277675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25457207|NCT05277675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25457208|NCT05277675|Growth Substances|growth substances|mesh-ancestor
25457209|NCT05277675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457210|NCT05277675|Growth Inhibitors|growth inhibitors|mesh-ancestor
25457211|NCT05277675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25457212|NCT05277675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457213|NCT05277675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457214|NCT05277038|Clonidine|clonidine|mesh-list
25457215|NCT05277038|Zopiclone|zopiclone|mesh-list
25457216|NCT05277038|Analgesics|analgesics|mesh-ancestor
25457217|NCT05277038|Sensory System Agents|sensory system agents|mesh-ancestor
25457218|NCT05277038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25457219|NCT05277038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457220|NCT05277038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25457221|NCT05277038|Sympatholytics|sympatholytics|mesh-ancestor
25457222|NCT05277038|Autonomic Agents|autonomic agents|mesh-ancestor
25457223|NCT05277038|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25457224|NCT05277038|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25457225|NCT05277038|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25457226|NCT05277038|Adrenergic Agents|adrenergic agents|mesh-ancestor
25457227|NCT05277038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25457228|NCT05277038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457229|NCT05277038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25457230|NCT05277038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25457231|NCT05276960|Cholecalciferol|cholecalciferol|mesh-list
25457232|NCT05276960|Vitamin D|vitamin d|mesh-list
25457233|NCT05276960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25457234|NCT05276960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457235|NCT05276960|Vitamins|vitamins|mesh-ancestor
25457236|NCT05276960|Micronutrients|micronutrients|mesh-ancestor
25457237|NCT05276960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25457238|NCT05276908|Bupivacaine|bupivacaine|mesh-list
25457239|NCT05276908|Anesthetics|anesthetics|mesh-list
25457240|NCT05276908|Anesthetics, Local|anesthetics, local|mesh-ancestor
25457241|NCT05276908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25457242|NCT05276908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457243|NCT05276908|Sensory System Agents|sensory system agents|mesh-ancestor
25457244|NCT05276908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25457245|NCT05276895|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
25457246|NCT05276895|Quercetin|quercetin|mesh-list
25457247|NCT05276895|Antioxidants|antioxidants|mesh-ancestor
25457248|NCT05276895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457249|NCT05276895|Protective Agents|protective agents|mesh-ancestor
25457250|NCT05276895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457251|NCT05276895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25457252|NCT05257213|Heparin|heparin|mesh-list
25457253|NCT05257213|Anticoagulants|anticoagulants|mesh-ancestor
25457254|NCT05257213|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25457255|NCT05257213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25457256|NCT05257213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457257|NCT05232851|Pembrolizumab|pembrolizumab|mesh-list
25457258|NCT05232851|Vaccines|vaccines|mesh-list
25457259|NCT05232851|Immunologic Factors|immunologic factors|mesh-ancestor
25457260|NCT05232851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457261|NCT05232851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25457262|NCT05232851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457263|NCT05230368|Decitabine|decitabine|mesh-list
25457264|NCT05230368|Romidepsin|romidepsin|mesh-list
25457265|NCT05230368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25457266|NCT05230368|Antimetabolites|antimetabolites|mesh-ancestor
25457267|NCT05230368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457268|NCT05230368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457269|NCT05230368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25644517|NCT01437449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25644518|NCT01437540|Bromides|bromides|mesh-list
25644519|NCT01437540|Formoterol Fumarate|formoterol fumarate|mesh-list
25644520|NCT01437540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25644521|NCT01437540|Autonomic Agents|autonomic agents|mesh-ancestor
25644522|NCT01437540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25644523|NCT01437540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644524|NCT01437540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25644525|NCT01437540|Respiratory System Agents|respiratory system agents|mesh-ancestor
25644526|NCT01437540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25457270|NCT05230368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25457271|NCT05212454|Capecitabine|capecitabine|mesh-list
25457272|NCT05212454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25457273|NCT05212454|Antimetabolites|antimetabolites|mesh-ancestor
25457274|NCT05212454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457275|NCT05212454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457276|NCT05176223|Edetic Acid|edetic acid|mesh-list
25457277|NCT05176223|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25457278|NCT05176223|Chelating Agents|chelating agents|mesh-ancestor
25457279|NCT05176223|Sequestering Agents|sequestering agents|mesh-ancestor
25457280|NCT05176223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457281|NCT05176223|Anticoagulants|anticoagulants|mesh-ancestor
25457282|NCT05176223|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25457283|NCT05176223|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25457284|NCT05173493|Amoxicillin|amoxicillin|mesh-list
25457285|NCT05173493|Levofloxacin|levofloxacin|mesh-list
25457286|NCT05173493|Ofloxacin|ofloxacin|mesh-list
25457287|NCT05173493|Tetracycline|tetracycline|mesh-list
25457288|NCT05173493|Furazolidone|furazolidone|mesh-list
25457289|NCT05173493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25457290|NCT05173493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25457291|NCT05173493|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25457292|NCT05173493|Renal Agents|renal agents|mesh-ancestor
25457293|NCT05173493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25457294|NCT05173493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25457295|NCT05173493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457296|NCT05173493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457297|NCT05173493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457298|NCT05173493|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25457299|NCT05173493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25457300|NCT05173493|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25457301|NCT05173493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25457302|NCT05173493|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25457311|NCT05326555|Imidacloprid|imidacloprid|mesh-list
25457312|NCT05326555|Cholinergic Agents|cholinergic agents|mesh-ancestor
25457313|NCT05326555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25457314|NCT05326555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457315|NCT05326555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457316|NCT05326269|Terbutaline|terbutaline|mesh-list
25457317|NCT05326269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25457318|NCT05326269|Autonomic Agents|autonomic agents|mesh-ancestor
25457319|NCT05326269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25457320|NCT05326269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457321|NCT05326269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25457322|NCT05326269|Respiratory System Agents|respiratory system agents|mesh-ancestor
25457323|NCT05326269|Sympathomimetics|sympathomimetics|mesh-ancestor
25457324|NCT05326269|Tocolytic Agents|tocolytic agents|mesh-ancestor
25457325|NCT05326269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25457326|NCT05326269|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25457327|NCT05326269|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25457328|NCT05326269|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25457329|NCT05326269|Adrenergic Agents|adrenergic agents|mesh-ancestor
25457330|NCT05326269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25457331|NCT05326269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457332|NCT05326139|Tranexamic Acid|tranexamic acid|mesh-list
25457333|NCT05326139|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25457334|NCT05326139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25457335|NCT05326139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457336|NCT05326139|Hemostatics|hemostatics|mesh-ancestor
25457337|NCT05326139|Coagulants|coagulants|mesh-ancestor
25457338|NCT05326087|Cetrorelix|cetrorelix|mesh-list
25457339|NCT05326087|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25457340|NCT05326087|Fertility Agents|fertility agents|mesh-ancestor
25457341|NCT05326087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25457342|NCT05326087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457343|NCT05326087|Hormone Antagonists|hormone antagonists|mesh-ancestor
25457344|NCT05326087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25457345|NCT05325762|Dexmedetomidine|dexmedetomidine|mesh-list
25457346|NCT05325762|Propofol|propofol|mesh-list
25644527|NCT01437540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25644528|NCT01437540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25644529|NCT01437540|Adrenergic Agents|adrenergic agents|mesh-ancestor
25644530|NCT01437540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25644531|NCT01437540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644532|NCT01437540|Anticonvulsants|anticonvulsants|mesh-ancestor
25457347|NCT05325762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25457348|NCT05325762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25457349|NCT05325762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457350|NCT05325762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25457351|NCT05325762|Anesthetics, General|anesthetics, general|mesh-ancestor
25457352|NCT05325762|Anesthetics|anesthetics|mesh-ancestor
25457353|NCT05325762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25457354|NCT05325762|Analgesics|analgesics|mesh-ancestor
25457355|NCT05325762|Sensory System Agents|sensory system agents|mesh-ancestor
25457356|NCT05325762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25457357|NCT05325762|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25457358|NCT05325762|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25457359|NCT05325762|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25457360|NCT05325762|Adrenergic Agents|adrenergic agents|mesh-ancestor
25457361|NCT05325762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25457362|NCT05325762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457363|NCT05325684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25457364|NCT05325684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457365|NCT05325684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457366|NCT05325632|Paclitaxel|paclitaxel|mesh-list
25457367|NCT05325632|Trastuzumab|trastuzumab|mesh-list
25457368|NCT05325632|Pertuzumab|pertuzumab|mesh-list
25457369|NCT05325632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25457370|NCT05325632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457371|NCT05325632|Tubulin Modulators|tubulin modulators|mesh-ancestor
25457372|NCT05325632|Antimitotic Agents|antimitotic agents|mesh-ancestor
25457373|NCT05325632|Mitosis Modulators|mitosis modulators|mesh-ancestor
25457374|NCT05325632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457375|NCT05325632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25457376|NCT05325593|Dexamethasone|dexamethasone|mesh-list
25457377|NCT05325593|Dexamethasone acetate|dexamethasone acetate|mesh-list
25457378|NCT05325593|BB 1101|bb 1101|mesh-list
25457379|NCT05325593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25457380|NCT05325593|Antiemetics|antiemetics|mesh-ancestor
25457381|NCT05325593|Autonomic Agents|autonomic agents|mesh-ancestor
25457382|NCT05325593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25457383|NCT05325593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457384|NCT05325593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25457385|NCT05325593|Glucocorticoids|glucocorticoids|mesh-ancestor
25457386|NCT05325593|Hormones|hormones|mesh-ancestor
25457387|NCT05325593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25457388|NCT05325593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25457389|NCT05325593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457390|NCT05325593|Protease Inhibitors|protease inhibitors|mesh-ancestor
25457391|NCT05325593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457392|NCT05325593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457393|NCT05325528|Oxaliplatin|oxaliplatin|mesh-list
25457394|NCT05325528|Tegafur|tegafur|mesh-list
25457395|NCT05325528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457396|NCT05325528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25457397|NCT05325528|Antimetabolites|antimetabolites|mesh-ancestor
25457398|NCT05325528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457399|NCT05325515|Alendronate|alendronate|mesh-list
25457400|NCT05325515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25457401|NCT05325515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457402|NCT05325346|Argatroban|argatroban|mesh-list
25457403|NCT05325346|Antithrombins|antithrombins|mesh-ancestor
25457404|NCT05325346|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25457405|NCT05325346|Protease Inhibitors|protease inhibitors|mesh-ancestor
25457406|NCT05325346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457407|NCT05325346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457408|NCT05325346|Anticoagulants|anticoagulants|mesh-ancestor
25457409|NCT05325346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25644533|NCT01437605|Poly I-C|poly i-c|mesh-list
25644534|NCT01437605|Interferon Inducers|interferon inducers|mesh-ancestor
25644535|NCT01437605|Immunologic Factors|immunologic factors|mesh-ancestor
25457411|NCT05325229|Docetaxel|docetaxel|mesh-list
25457412|NCT05325229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25457413|NCT05325229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457414|NCT05325229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25457415|NCT05325229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25457416|NCT05325229|Growth Substances|growth substances|mesh-ancestor
25457417|NCT05325229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457418|NCT05325229|Growth Inhibitors|growth inhibitors|mesh-ancestor
25457419|NCT05325229|Tubulin Modulators|tubulin modulators|mesh-ancestor
25457420|NCT05325229|Antimitotic Agents|antimitotic agents|mesh-ancestor
25457421|NCT05325229|Mitosis Modulators|mitosis modulators|mesh-ancestor
25457422|NCT05325229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457423|NCT05325190|Granisetron|granisetron|mesh-list
25457424|NCT05325190|Antiemetics|antiemetics|mesh-ancestor
25457425|NCT05325190|Autonomic Agents|autonomic agents|mesh-ancestor
25457426|NCT05325190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25457427|NCT05325190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457428|NCT05325190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25457429|NCT05325190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25457430|NCT05325190|Serotonin Agents|serotonin agents|mesh-ancestor
25457431|NCT05325190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25457432|NCT05325190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457433|NCT05325073|Epoetin Alfa|epoetin alfa|mesh-list
25457434|NCT05325073|Hematinics|hematinics|mesh-ancestor
25457435|NCT05325008|Immunoglobulins|immunoglobulins|mesh-list
25457436|NCT05325008|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25457437|NCT05325008|Antibodies|antibodies|mesh-list
25457438|NCT05325008|gamma-Globulins|gamma-globulins|mesh-list
25457439|NCT05325008|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25457440|NCT05325008|Immunologic Factors|immunologic factors|mesh-ancestor
25457441|NCT05325008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457442|NCT05324917|Rituximab|rituximab|mesh-list
25457443|NCT05324917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25457444|NCT05324917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457445|NCT05324917|Immunologic Factors|immunologic factors|mesh-ancestor
25457446|NCT05324917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457447|NCT05324917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25457448|NCT05324904|Vitamin D|vitamin d|mesh-list
25457449|NCT05324904|Acyclovir|acyclovir|mesh-list
25457450|NCT05324904|Vitamins|vitamins|mesh-ancestor
25457451|NCT05324904|Micronutrients|micronutrients|mesh-ancestor
25457452|NCT05324904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457453|NCT05324904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25457454|NCT05324904|Antiviral Agents|antiviral agents|mesh-ancestor
25457455|NCT05324904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25457456|NCT05324891|Fentanyl|fentanyl|mesh-list
25457457|NCT05324891|Dexmedetomidine|dexmedetomidine|mesh-list
25457458|NCT05324891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25457459|NCT05324891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25457460|NCT05324891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457461|NCT05324891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25457462|NCT05324891|Analgesics|analgesics|mesh-ancestor
25457490|NCT05317403|Antiviral Agents|antiviral agents|mesh-ancestor
25457491|NCT05317403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25457492|NCT05317403|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25457493|NCT05317403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457494|NCT05311579|Niraparib|niraparib|mesh-list
25457495|NCT05311579|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25457496|NCT05311579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457497|NCT05311579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457498|NCT05311579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457499|NCT05263492|Pembrolizumab|pembrolizumab|mesh-list
25457500|NCT05263492|Lenvatinib|lenvatinib|mesh-list
25457501|NCT05263492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25457502|NCT05263492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457503|NCT05263492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25457504|NCT05263492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457505|NCT05263492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316052|NCT04997837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25316053|NCT04997837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25316054|NCT04997837|Antimetabolites|antimetabolites|mesh-ancestor
25316055|NCT04997837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316056|NCT04997837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25316057|NCT04997707|Propofol|propofol|mesh-list
25457506|NCT05204160|Pembrolizumab|pembrolizumab|mesh-list
25457507|NCT05204160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25457508|NCT05204160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457509|NCT05165550|Elsulfavirine|elsulfavirine|mesh-list
25457510|NCT05165550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25457511|NCT05165550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25457512|NCT05165550|Antiviral Agents|antiviral agents|mesh-ancestor
25457513|NCT05165550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25457514|NCT05146804|Sulforaphane|sulforaphane|mesh-list
25457515|NCT05146804|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25457516|NCT05146804|Protective Agents|protective agents|mesh-ancestor
25457517|NCT05146804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721824|NCT02493712|Mesalamine|mesalamine|mesh-list
25457518|NCT05146804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457520|NCT05140941|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25457521|NCT05140941|Velpatasvir|velpatasvir|mesh-list
25457522|NCT05140941|Antiviral Agents|antiviral agents|mesh-ancestor
25457523|NCT05140941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25457524|NCT05102734|Nitroglycerin|nitroglycerin|mesh-list
25457525|NCT05102734|Vasodilator Agents|vasodilator agents|mesh-ancestor
25457526|NCT05036980|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
25457527|NCT05036980|Antioxidants|antioxidants|mesh-ancestor
25457528|NCT05036980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457529|NCT05036980|Protective Agents|protective agents|mesh-ancestor
25457530|NCT05036980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457531|NCT05036980|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25457532|NCT05036980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457533|NCT05029622|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25457534|NCT05029622|Luteolytic Agents|luteolytic agents|mesh-ancestor
25457535|NCT05029622|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25457536|NCT05029622|Contraceptive Agents|contraceptive agents|mesh-ancestor
25457537|NCT05029622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25457538|NCT05029622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457539|NCT05029622|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25457540|NCT05029622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25457541|NCT05029622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457542|NCT05014646|Cholestyramine Resin|cholestyramine resin|mesh-list
25457543|NCT05014646|Leflunomide|leflunomide|mesh-list
25457544|NCT05014646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457545|NCT05014646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457546|NCT05014646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25457547|NCT05014646|Immunologic Factors|immunologic factors|mesh-ancestor
25457548|NCT05014646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457549|NCT05014646|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25457550|NCT05014646|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25457551|NCT05014646|Antimetabolites|antimetabolites|mesh-ancestor
25457552|NCT05014646|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25457553|NCT04931615|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25457554|NCT04931615|Thrombin|thrombin|mesh-list
25457555|NCT04931615|Hemostatics|hemostatics|mesh-ancestor
25457556|NCT04931615|Coagulants|coagulants|mesh-ancestor
25457557|NCT04754334|Insulin|insulin|mesh-list
25457558|NCT04754334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25457559|NCT04754334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457560|NCT04722575|Atezolizumab|atezolizumab|mesh-list
25457561|NCT04722575|Vemurafenib|vemurafenib|mesh-list
25457562|NCT04722575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457563|NCT04722575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25457564|NCT04722575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457565|NCT04722575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457566|NCT04717375|Pembrolizumab|pembrolizumab|mesh-list
25457567|NCT04717375|Cetuximab|cetuximab|mesh-list
25457568|NCT04717375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25457569|NCT04717375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457570|NCT04629872|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25457571|NCT04629872|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25457572|NCT04629872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457573|NCT04629872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25457574|NCT04629872|Immunologic Factors|immunologic factors|mesh-ancestor
25457575|NCT04629872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457576|NCT04498923|Dexamethasone|dexamethasone|mesh-list
25457577|NCT04498923|Epinephrine|epinephrine|mesh-list
25457578|NCT04498923|Bupivacaine|bupivacaine|mesh-list
25457579|NCT04498923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25457580|NCT04498923|Antiemetics|antiemetics|mesh-ancestor
25457581|NCT04498923|Autonomic Agents|autonomic agents|mesh-ancestor
25457582|NCT04498923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25457583|NCT04498923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457584|NCT04498923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25457586|NCT04498923|Hormones|hormones|mesh-ancestor
25457587|NCT04498923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25457588|NCT04498923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25457589|NCT04498923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457590|NCT04498923|Anesthetics, Local|anesthetics, local|mesh-ancestor
25457591|NCT04498923|Anesthetics|anesthetics|mesh-ancestor
25457592|NCT04498923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25457593|NCT04498923|Sensory System Agents|sensory system agents|mesh-ancestor
25457594|NCT04498923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25457595|NCT04498923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25457596|NCT04498923|Adrenergic Agents|adrenergic agents|mesh-ancestor
25457597|NCT04498923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25457598|NCT04498923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457599|NCT04498923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25457600|NCT04498923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25457601|NCT04498923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25457602|NCT04498923|Respiratory System Agents|respiratory system agents|mesh-ancestor
25457603|NCT04498923|Mydriatics|mydriatics|mesh-ancestor
25457604|NCT04498923|Sympathomimetics|sympathomimetics|mesh-ancestor
25457605|NCT04498923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25457606|NCT04469556|Leucovorin|leucovorin|mesh-list
25457607|NCT04469556|Gemcitabine|gemcitabine|mesh-list
25457608|NCT04469556|Paclitaxel|paclitaxel|mesh-list
25457609|NCT04469556|Oxaliplatin|oxaliplatin|mesh-list
25457610|NCT04469556|Irinotecan|irinotecan|mesh-list
25457611|NCT04469556|Folfirinox|folfirinox|mesh-list
25457612|NCT04469556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25457613|NCT04469556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457614|NCT04469556|Tubulin Modulators|tubulin modulators|mesh-ancestor
25457615|NCT04469556|Antimitotic Agents|antimitotic agents|mesh-ancestor
25457616|NCT04469556|Mitosis Modulators|mitosis modulators|mesh-ancestor
25457617|NCT04469556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457618|NCT04469556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25457619|NCT04469556|Antimetabolites|antimetabolites|mesh-ancestor
25457620|NCT04469556|Antiviral Agents|antiviral agents|mesh-ancestor
25457621|NCT04469556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25457622|NCT04469556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457623|NCT04469556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25457624|NCT04469556|Immunologic Factors|immunologic factors|mesh-ancestor
25457625|NCT04469556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457626|NCT04469556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25457627|NCT04469556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25457628|NCT04469556|Antidotes|antidotes|mesh-ancestor
25457629|NCT04469556|Protective Agents|protective agents|mesh-ancestor
25457630|NCT04469556|Vitamin B Complex|vitamin b complex|mesh-ancestor
25457631|NCT04469556|Vitamins|vitamins|mesh-ancestor
25457632|NCT04469556|Micronutrients|micronutrients|mesh-ancestor
25457633|NCT04461795|Erenumab|erenumab|mesh-list
25457634|NCT04461795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25457635|NCT04461795|Immunologic Factors|immunologic factors|mesh-ancestor
25457636|NCT04461795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457637|NCT04461795|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25457638|NCT04461795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457639|NCT04461795|Analgesics|analgesics|mesh-ancestor
25457640|NCT04461795|Sensory System Agents|sensory system agents|mesh-ancestor
25457641|NCT04461795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25457642|NCT04421664|Hydroxychloroquine|hydroxychloroquine|mesh-list
25316200|NCT04996160|Palbociclib|palbociclib|mesh-list
25316201|NCT04996160|BB 1101|bb 1101|mesh-list
25316202|NCT04996160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25316203|NCT04996160|Antiemetics|antiemetics|mesh-ancestor
25316204|NCT04996160|Autonomic Agents|autonomic agents|mesh-ancestor
25316205|NCT04996160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25316206|NCT04996160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316207|NCT04996160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25316208|NCT04996160|Glucocorticoids|glucocorticoids|mesh-ancestor
25316209|NCT04996160|Hormones|hormones|mesh-ancestor
25316210|NCT04996160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25316211|NCT04996160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25316212|NCT04996160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457643|NCT04421664|Antimalarials|antimalarials|mesh-ancestor
25457644|NCT04421664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25457645|NCT04421664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25457646|NCT04421664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25457647|NCT04421664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457648|NCT04421664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457649|NCT04421664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25457651|NCT04410965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25457652|NCT04410965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25457653|NCT04410965|Analgesics|analgesics|mesh-ancestor
25457654|NCT04410965|Sensory System Agents|sensory system agents|mesh-ancestor
25457655|NCT04410965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25457656|NCT04410965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457657|NCT04410965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25457658|NCT04410965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25457659|NCT04410965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25457660|NCT04410965|Immunologic Factors|immunologic factors|mesh-ancestor
25457661|NCT04405999|Bromhexine|bromhexine|mesh-list
25457662|NCT04405999|Expectorants|expectorants|mesh-ancestor
25457663|NCT04405999|Respiratory System Agents|respiratory system agents|mesh-ancestor
25457664|NCT04364555|Clobetasol|clobetasol|mesh-list
25457665|NCT04364555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25457666|NCT04364555|Glucocorticoids|glucocorticoids|mesh-ancestor
25457667|NCT04364555|Hormones|hormones|mesh-ancestor
25457668|NCT04364555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25457669|NCT04364555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457670|NCT04353778|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
25457671|NCT04353778|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25457672|NCT04353778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457673|NCT04353778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457674|NCT04353778|Cholinergic Agents|cholinergic agents|mesh-ancestor
25457675|NCT04353778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25457676|NCT04353778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457677|NCT04280536|Trifluridine|trifluridine|mesh-list
25457678|NCT04280536|Antimetabolites|antimetabolites|mesh-ancestor
25457679|NCT04280536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457680|NCT04280536|Antiviral Agents|antiviral agents|mesh-ancestor
25457681|NCT04280536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25457682|NCT04277858|Cisplatin|cisplatin|mesh-list
25457683|NCT04277858|Docetaxel|docetaxel|mesh-list
25457684|NCT04277858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457685|NCT04277858|Tubulin Modulators|tubulin modulators|mesh-ancestor
25457686|NCT04277858|Antimitotic Agents|antimitotic agents|mesh-ancestor
25457687|NCT04277858|Mitosis Modulators|mitosis modulators|mesh-ancestor
25457688|NCT04277858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457689|NCT04232657|Denosumab|denosumab|mesh-list
25457690|NCT04232657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25457691|NCT04232657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457692|NCT04216043|Caseins|caseins|mesh-list
25457693|NCT04216043|Chelating Agents|chelating agents|mesh-ancestor
25457694|NCT04216043|Sequestering Agents|sequestering agents|mesh-ancestor
25457695|NCT04216043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457696|NCT04184622|Tirzepatide|tirzepatide|mesh-list
25457697|NCT04184622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25457698|NCT04184622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457699|NCT04184622|Incretins|incretins|mesh-ancestor
25457700|NCT04184622|Hormones|hormones|mesh-ancestor
25457701|NCT04184622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25457702|NCT04170738|Amphetamine|amphetamine|mesh-list
25457703|NCT04170738|Adderall|adderall|mesh-list
25457704|NCT04170738|Dextroamphetamine|dextroamphetamine|mesh-list
25457705|NCT04170738|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25457706|NCT04170738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457707|NCT04170738|Sympathomimetics|sympathomimetics|mesh-ancestor
25457708|NCT04170738|Autonomic Agents|autonomic agents|mesh-ancestor
25457709|NCT04170738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25457710|NCT04170738|Dopamine Agents|dopamine agents|mesh-ancestor
25457711|NCT04170738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25457712|NCT04170738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457713|NCT04170738|Adrenergic Agents|adrenergic agents|mesh-ancestor
25457714|NCT04170738|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25457715|NCT04170738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25457716|NCT04170738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25457717|NCT04170738|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25457718|NCT04155424|Eculizumab|eculizumab|mesh-list
25457719|NCT04155424|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25316260|NCT04994951|Triamcinolone|triamcinolone|mesh-list
25316353|NCT04993040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25316354|NCT04993040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25316355|NCT04993040|Tubulin Modulators|tubulin modulators|mesh-ancestor
25316356|NCT04993040|Antimitotic Agents|antimitotic agents|mesh-ancestor
25457742|NCT04091867|Cetuximab|cetuximab|mesh-list
25457743|NCT04091867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25457744|NCT04091867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457745|NCT04082910|Etanercept|etanercept|mesh-list
25457746|NCT04082910|Infliximab|infliximab|mesh-list
25457747|NCT04082910|Metoprolol|metoprolol|mesh-list
25457748|NCT04082910|Dermatologic Agents|dermatologic agents|mesh-ancestor
25457749|NCT04082910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25457750|NCT04082910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25457751|NCT04082910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25457752|NCT04082910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25457753|NCT04082910|Analgesics|analgesics|mesh-ancestor
25457754|NCT04082910|Sensory System Agents|sensory system agents|mesh-ancestor
25457755|NCT04082910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25457756|NCT04082910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457757|NCT04082910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25457758|NCT04082910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25457759|NCT04082910|Immunologic Factors|immunologic factors|mesh-ancestor
25457760|NCT04082910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25457761|NCT04082910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25457762|NCT04082910|Sympatholytics|sympatholytics|mesh-ancestor
25457763|NCT04082910|Autonomic Agents|autonomic agents|mesh-ancestor
25457764|NCT04082910|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25457765|NCT04082910|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25457766|NCT04082910|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25457767|NCT04082910|Adrenergic Agents|adrenergic agents|mesh-ancestor
25457768|NCT04082910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25457769|NCT04082910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457770|NCT04035473|Paclitaxel|paclitaxel|mesh-list
25457771|NCT04035473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25457772|NCT04035473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457773|NCT04035473|Tubulin Modulators|tubulin modulators|mesh-ancestor
25457774|NCT04035473|Antimitotic Agents|antimitotic agents|mesh-ancestor
25457775|NCT04035473|Mitosis Modulators|mitosis modulators|mesh-ancestor
25457776|NCT04035473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457777|NCT04035382|Misoprostol|misoprostol|mesh-list
25457778|NCT04035382|Oxytocin|oxytocin|mesh-list
25457779|NCT04035382|Oxytocics|oxytocics|mesh-ancestor
25457780|NCT04035382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25457781|NCT04035382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457782|NCT04035382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25457783|NCT04035382|Abortifacient Agents|abortifacient agents|mesh-ancestor
25457784|NCT04035382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25457785|NCT04035382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25457786|NCT03993457|Citalopram|citalopram|mesh-list
25457787|NCT03993457|Bupropion|bupropion|mesh-list
25457788|NCT03993457|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25457789|NCT03993457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25457790|NCT03993457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25457791|NCT03993457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457792|NCT03993457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25457793|NCT03993457|Serotonin Agents|serotonin agents|mesh-ancestor
25457794|NCT03993457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457795|NCT03993457|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25457796|NCT03993457|Antidepressive Agents|antidepressive agents|mesh-ancestor
25457797|NCT03993457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25457798|NCT03993457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25457799|NCT03993457|Dopamine Agents|dopamine agents|mesh-ancestor
25457800|NCT03993457|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25457801|NCT03993457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25457802|NCT03993457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316423|NCT04991584|Amoxicillin|amoxicillin|mesh-list
25316424|NCT04991584|Levofloxacin|levofloxacin|mesh-list
25316425|NCT04991584|Ofloxacin|ofloxacin|mesh-list
25316426|NCT04991584|Tetracycline|tetracycline|mesh-list
25316427|NCT04991584|Furazolidone|furazolidone|mesh-list
25316428|NCT04991584|Esomeprazole|esomeprazole|mesh-list
25316429|NCT04991584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25316430|NCT04991584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25316431|NCT04991584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25316432|NCT04991584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25316433|NCT04991584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25316434|NCT04991584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316435|NCT04991584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316436|NCT04991584|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25316437|NCT04991584|Renal Agents|renal agents|mesh-ancestor
25457804|NCT03860428|Ibuprofen|ibuprofen|mesh-list
25457805|NCT03860428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
25457806|NCT03860428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25457807|NCT03860428|Analgesics|analgesics|mesh-ancestor
25457808|NCT03860428|Sensory System Agents|sensory system agents|mesh-ancestor
25457809|NCT03860428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25457810|NCT03860428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457811|NCT03860428|Antipyretics|antipyretics|mesh-ancestor
25457812|NCT03860428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25457813|NCT03860428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25457814|NCT03860428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25457815|NCT03860428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457816|NCT03860428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457817|NCT03796676|Abrocitinib|abrocitinib|mesh-list
25457818|NCT03796676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25457819|NCT03796676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457820|NCT03796676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457821|NCT03796273|Ketoconazole|ketoconazole|mesh-list
25457822|NCT03796273|Antifungal Agents|antifungal agents|mesh-ancestor
25457823|NCT03796273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25457824|NCT03796273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25457825|NCT03796273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25457826|NCT03796273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457827|NCT03796273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457828|NCT03796273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25457829|NCT03796273|Hormone Antagonists|hormone antagonists|mesh-ancestor
25457830|NCT03796273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25457831|NCT03796273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457832|NCT03796273|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25457833|NCT03702270|Penicillins|penicillins|mesh-list
25457834|NCT03702270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25457835|NCT03702270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25457836|NCT03667443|Inositol|inositol|mesh-list
25457837|NCT03667443|Vitamin B Complex|vitamin b complex|mesh-ancestor
25457838|NCT03667443|Vitamins|vitamins|mesh-ancestor
25457839|NCT03667443|Micronutrients|micronutrients|mesh-ancestor
25457840|NCT03667443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457841|NCT03622515|Anesthetics|anesthetics|mesh-list
25457842|NCT03622515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25457843|NCT03622515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457844|NCT03544099|Pembrolizumab|pembrolizumab|mesh-list
25457845|NCT03544099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25457846|NCT03544099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457847|NCT03519074|Cisplatin|cisplatin|mesh-list
25457848|NCT03519074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457849|NCT03498612|Pembrolizumab|pembrolizumab|mesh-list
25457850|NCT03498612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25457851|NCT03498612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457852|NCT03441048|Cytarabine|cytarabine|mesh-list
25457853|NCT03441048|Mitoxantrone|mitoxantrone|mesh-list
25457854|NCT03441048|Cladribine|cladribine|mesh-list
25457855|NCT03441048|Lintuzumab|lintuzumab|mesh-list
25457856|NCT03441048|Lenograstim|lenograstim|mesh-list
25457857|NCT03441048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25457858|NCT03441048|Antimetabolites|antimetabolites|mesh-ancestor
25457859|NCT03441048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457860|NCT03441048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457861|NCT03441048|Antiviral Agents|antiviral agents|mesh-ancestor
25457862|NCT03441048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25457863|NCT03441048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25457864|NCT03441048|Immunologic Factors|immunologic factors|mesh-ancestor
25457865|NCT03441048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457866|NCT03441048|Analgesics|analgesics|mesh-ancestor
25457867|NCT03441048|Sensory System Agents|sensory system agents|mesh-ancestor
25316485|NCT04991207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316486|NCT04991207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316487|NCT04991064|Titanium dioxide|titanium dioxide|mesh-list
25316488|NCT04991064|Sunscreening Agents|sunscreening agents|mesh-ancestor
25316489|NCT04991064|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25316490|NCT04991064|Protective Agents|protective agents|mesh-ancestor
25316491|NCT04991064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316492|NCT04991064|Dermatologic Agents|dermatologic agents|mesh-ancestor
25316493|NCT04991064|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25316494|NCT04991155|Zamicastat|zamicastat|mesh-list
25457868|NCT03441048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25644537|NCT01437605|Antiviral Agents|antiviral agents|mesh-ancestor
25644538|NCT01437605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25644539|NCT01437878|Iloprost|iloprost|mesh-list
25644540|NCT01437878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25644541|NCT01437878|Vasodilator Agents|vasodilator agents|mesh-ancestor
25457869|NCT03441048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25457870|NCT03441048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25457871|NCT03441048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457872|NCT03441048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25457873|NCT03441048|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25457874|NCT03345576|Methyltestosterone|methyltestosterone|mesh-list
25457875|NCT03345576|Testosterone|testosterone|mesh-list
25457876|NCT03345576|Testosterone undecanoate|testosterone undecanoate|mesh-list
25457877|NCT03345576|Testosterone enanthate|testosterone enanthate|mesh-list
25457878|NCT03345576|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25457879|NCT03345576|Androgens|androgens|mesh-ancestor
25457880|NCT03345576|Hormones|hormones|mesh-ancestor
25457881|NCT03345576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25457882|NCT03345576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457883|NCT03345576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25457884|NCT03345576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457885|NCT03345576|Anabolic Agents|anabolic agents|mesh-ancestor
25457886|NCT03338959|Pembrolizumab|pembrolizumab|mesh-list
25457887|NCT03338959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25457888|NCT03338959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457889|NCT03310944|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25457890|NCT03310944|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25457891|NCT03310944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457892|NCT03310944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25457893|NCT03310944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457894|NCT03235739|Naloxegol|naloxegol|mesh-list
25457895|NCT03235739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25457896|NCT03235739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457897|NCT03235739|Sensory System Agents|sensory system agents|mesh-ancestor
25457898|NCT03235739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25457899|NCT03179761|Vaccines|vaccines|mesh-list
25457900|NCT03179761|Immunologic Factors|immunologic factors|mesh-ancestor
25457901|NCT03179761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457902|NCT03150004|Cytarabine|cytarabine|mesh-list
25457903|NCT03150004|Mitoxantrone|mitoxantrone|mesh-list
25457904|NCT03150004|Cladribine|cladribine|mesh-list
25457905|NCT03150004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25457906|NCT03150004|Antimetabolites|antimetabolites|mesh-ancestor
25457907|NCT03150004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457908|NCT03150004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25457909|NCT03150004|Antiviral Agents|antiviral agents|mesh-ancestor
25457910|NCT03150004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25457911|NCT03150004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25457912|NCT03150004|Immunologic Factors|immunologic factors|mesh-ancestor
25457913|NCT03150004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457914|NCT03150004|Analgesics|analgesics|mesh-ancestor
25457915|NCT03150004|Sensory System Agents|sensory system agents|mesh-ancestor
25457916|NCT03150004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25457917|NCT03150004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25457918|NCT03150004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25457919|NCT03150004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457920|NCT03125811|Ethanol|ethanol|mesh-list
25457921|NCT03125811|Ondansetron|ondansetron|mesh-list
25457922|NCT03125811|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25457923|NCT03125811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25457924|NCT03125811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25457925|NCT03125811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457926|NCT03125811|Antiemetics|antiemetics|mesh-ancestor
25457927|NCT03125811|Autonomic Agents|autonomic agents|mesh-ancestor
25457928|NCT03125811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25457929|NCT03125811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25457930|NCT03125811|Antipruritics|antipruritics|mesh-ancestor
25457931|NCT03125811|Dermatologic Agents|dermatologic agents|mesh-ancestor
25457932|NCT03125811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25457933|NCT03125811|Serotonin Agents|serotonin agents|mesh-ancestor
25457934|NCT03125811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25457935|NCT03125811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457936|NCT03125811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25457937|NCT03125811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25644542|NCT01437995|Fluticasone|fluticasone|mesh-list
25316565|NCT04990791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25316566|NCT04990791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25316567|NCT04990791|Analgesics|analgesics|mesh-ancestor
25316568|NCT04990791|Sensory System Agents|sensory system agents|mesh-ancestor
25457949|NCT02845271|Acetaminophen|acetaminophen|mesh-list
25457950|NCT02845271|Tramadol|tramadol|mesh-list
25457951|NCT02845271|Codeine|codeine|mesh-list
25457952|NCT02845271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25457953|NCT02845271|Analgesics|analgesics|mesh-ancestor
25457954|NCT02845271|Sensory System Agents|sensory system agents|mesh-ancestor
25457955|NCT02845271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25457956|NCT02845271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457957|NCT02845271|Antipyretics|antipyretics|mesh-ancestor
25457958|NCT02845271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25457959|NCT02845271|Narcotics|narcotics|mesh-ancestor
25457960|NCT02845271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25457961|NCT02845271|Antitussive Agents|antitussive agents|mesh-ancestor
25457962|NCT02845271|Respiratory System Agents|respiratory system agents|mesh-ancestor
25457963|NCT02842359|Irbesartan|irbesartan|mesh-list
25457964|NCT02842359|Atorvastatin|atorvastatin|mesh-list
25457965|NCT02842359|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25457966|NCT02842359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25457967|NCT02842359|Antimetabolites|antimetabolites|mesh-ancestor
25457968|NCT02842359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457969|NCT02842359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25457970|NCT02842359|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25457971|NCT02842359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457972|NCT02842359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25457973|NCT02842359|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25457974|NCT02842359|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25457975|NCT02679508|Lansoprazole|lansoprazole|mesh-list
25457976|NCT02679508|Dexlansoprazole|dexlansoprazole|mesh-list
25457977|NCT02679508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25457978|NCT02679508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25457979|NCT02679508|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25457980|NCT02679508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457981|NCT02679508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457982|NCT02678312|Enalapril|enalapril|mesh-list
25457983|NCT02678312|Enalaprilat|enalaprilat|mesh-list
25457984|NCT02678312|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25457985|NCT02678312|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25457986|NCT02678312|Protease Inhibitors|protease inhibitors|mesh-ancestor
25457987|NCT02678312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25457988|NCT02678312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25457989|NCT02678312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25457990|NCT02678312|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25457991|NCT02631577|Lenalidomide|lenalidomide|mesh-list
25457992|NCT02631577|Atezolizumab|atezolizumab|mesh-list
25457993|NCT02631577|Obinutuzumab|obinutuzumab|mesh-list
25457994|NCT02631577|Immunologic Factors|immunologic factors|mesh-ancestor
25457995|NCT02631577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25457996|NCT02631577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25457997|NCT02631577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25457998|NCT02631577|Growth Substances|growth substances|mesh-ancestor
25457999|NCT02631577|Growth Inhibitors|growth inhibitors|mesh-ancestor
25458000|NCT02631577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458001|NCT02631577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25458002|NCT02408315|Misoprostol|misoprostol|mesh-list
25458003|NCT02408315|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25458004|NCT02408315|Abortifacient Agents|abortifacient agents|mesh-ancestor
25458005|NCT02408315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25458006|NCT02408315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458007|NCT02408315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25458008|NCT02408315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25458009|NCT02408315|Oxytocics|oxytocics|mesh-ancestor
25458010|NCT02022592|Midazolam|midazolam|mesh-list
25458011|NCT02022592|Lormetazepam|lormetazepam|mesh-list
25458012|NCT02022592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25458013|NCT02022592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25458014|NCT02022592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25458015|NCT02022592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458016|NCT02022592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25458017|NCT02022592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25458018|NCT02022592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25458019|NCT02022592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25458020|NCT02022592|Anesthetics, General|anesthetics, general|mesh-ancestor
25458021|NCT02022592|Anesthetics|anesthetics|mesh-ancestor
25458022|NCT02022592|GABA Modulators|gaba modulators|mesh-ancestor
25458023|NCT02022592|GABA Agents|gaba agents|mesh-ancestor
25458024|NCT02022592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25458025|NCT02022592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458026|NCT01837862|Mebendazole|mebendazole|mesh-list
25458027|NCT01837862|Piperazine|piperazine|mesh-list
25458028|NCT01837862|Piperazine citrate|piperazine citrate|mesh-list
25458029|NCT01837862|Bevacizumab|bevacizumab|mesh-list
25458030|NCT01837862|Carboplatin|carboplatin|mesh-list
25458031|NCT01837862|Irinotecan|irinotecan|mesh-list
25458032|NCT01837862|Vincristine|vincristine|mesh-list
25458033|NCT01837862|Temozolomide|temozolomide|mesh-list
25458034|NCT01837862|DMP 777|dmp 777|mesh-list
25458035|NCT01837862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25458036|NCT01837862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458037|NCT01837862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25458038|NCT01837862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25458039|NCT01837862|Growth Substances|growth substances|mesh-ancestor
25458040|NCT01837862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458041|NCT01837862|Growth Inhibitors|growth inhibitors|mesh-ancestor
25458042|NCT01837862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25458043|NCT01837862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25458044|NCT01837862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25458045|NCT01837862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458046|NCT01837862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25458047|NCT01837862|Tubulin Modulators|tubulin modulators|mesh-ancestor
25458048|NCT01837862|Antimitotic Agents|antimitotic agents|mesh-ancestor
25458049|NCT01837862|Mitosis Modulators|mitosis modulators|mesh-ancestor
25458050|NCT01837862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25458051|NCT01837862|Alkylating Agents|alkylating agents|mesh-ancestor
25458052|NCT01837862|Antinematodal Agents|antinematodal agents|mesh-ancestor
25458053|NCT01837862|Anthelmintics|anthelmintics|mesh-ancestor
25458054|NCT01837862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25458055|NCT01837862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25458056|NCT01813227|Dexamethasone|dexamethasone|mesh-list
25458057|NCT01813227|Rituximab|rituximab|mesh-list
25458058|NCT01813227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25458059|NCT01813227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458060|NCT01813227|Immunologic Factors|immunologic factors|mesh-ancestor
25458061|NCT01813227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458062|NCT01813227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25458063|NCT01813227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25458064|NCT01813227|Antiemetics|antiemetics|mesh-ancestor
25458065|NCT01813227|Autonomic Agents|autonomic agents|mesh-ancestor
25458066|NCT01813227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25458067|NCT01813227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25458068|NCT01813227|Glucocorticoids|glucocorticoids|mesh-ancestor
25458069|NCT01813227|Hormones|hormones|mesh-ancestor
25458070|NCT01813227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25458071|NCT01813227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25458072|NCT01791478|Letrozole|letrozole|mesh-list
25458073|NCT01791478|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
25458074|NCT01791478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458075|NCT01791478|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25458076|NCT01791478|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25316722|NCT04989348|Hormones|hormones|mesh-list
25458077|NCT01791478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25458078|NCT01791478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458080|NCT01791478|Hormone Antagonists|hormone antagonists|mesh-ancestor
25458081|NCT01791478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25458082|NCT01791478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458083|NCT01698840|Vitamin D|vitamin d|mesh-list
25458084|NCT01698840|Vitamins|vitamins|mesh-ancestor
25458085|NCT01698840|Micronutrients|micronutrients|mesh-ancestor
25458086|NCT01698840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458087|NCT01698840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25458088|NCT01695317|Acetylcarnitine|acetylcarnitine|mesh-list
25458089|NCT01695317|Vitamin B Complex|vitamin b complex|mesh-ancestor
25458090|NCT01695317|Vitamins|vitamins|mesh-ancestor
25458091|NCT01695317|Micronutrients|micronutrients|mesh-ancestor
25458092|NCT01695317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458093|NCT01695317|Nootropic Agents|nootropic agents|mesh-ancestor
25458094|NCT01652092|Vidarabine|vidarabine|mesh-list
25644545|NCT01437995|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25644546|NCT01437995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25822868|NCT00004686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25458095|NCT01652092|Cyclophosphamide|cyclophosphamide|mesh-list
25458096|NCT01652092|Melphalan|melphalan|mesh-list
25458097|NCT01652092|Busulfan|busulfan|mesh-list
25458098|NCT01652092|Fludarabine|fludarabine|mesh-list
25458099|NCT01652092|Fludarabine phosphate|fludarabine phosphate|mesh-list
25458100|NCT01652092|Alemtuzumab|alemtuzumab|mesh-list
25458101|NCT01652092|Mesna|mesna|mesh-list
25458102|NCT01652092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25458103|NCT01652092|Immunologic Factors|immunologic factors|mesh-ancestor
25458104|NCT01652092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458105|NCT01652092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25458106|NCT01652092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25458107|NCT01652092|Alkylating Agents|alkylating agents|mesh-ancestor
25458108|NCT01652092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458109|NCT01652092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458110|NCT01652092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25458111|NCT01652092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25458112|NCT01652092|Antimetabolites|antimetabolites|mesh-ancestor
25458113|NCT01652092|Antiviral Agents|antiviral agents|mesh-ancestor
25458114|NCT01652092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25458115|NCT01652092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25458116|NCT01652092|Protective Agents|protective agents|mesh-ancestor
25458117|NCT01505569|Etoposide|etoposide|mesh-list
25458118|NCT01505569|Carboplatin|carboplatin|mesh-list
25458119|NCT01505569|Melphalan|melphalan|mesh-list
25458120|NCT01505569|Busulfan|busulfan|mesh-list
25458121|NCT01505569|Ifosfamide|ifosfamide|mesh-list
25458122|NCT01505569|Thiotepa|thiotepa|mesh-list
25458123|NCT01505569|Lenograstim|lenograstim|mesh-list
25458124|NCT01505569|Mesna|mesna|mesh-list
25458125|NCT01505569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25458126|NCT01505569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458127|NCT01505569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458128|NCT01505569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25458129|NCT01505569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25458130|NCT01505569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25458131|NCT01505569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25458132|NCT01505569|Alkylating Agents|alkylating agents|mesh-ancestor
25458133|NCT01505569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25458134|NCT01505569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25458135|NCT01505569|Immunologic Factors|immunologic factors|mesh-ancestor
25458136|NCT01505569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458137|NCT01505569|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25458138|NCT01505569|Protective Agents|protective agents|mesh-ancestor
25316785|NCT04988282|Glucocorticoids|glucocorticoids|mesh-ancestor
25316786|NCT04988282|Hormones|hormones|mesh-ancestor
25316787|NCT04988282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25316788|NCT04988282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25316789|NCT04988282|Protective Agents|protective agents|mesh-ancestor
25316790|NCT04988282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25316791|NCT04988282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24423956|NCT00227513|Vorinostat|vorinostat|mesh-list
24423957|NCT00227513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24423958|NCT00227513|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25316792|NCT04987632|Letrozole|letrozole|mesh-list
25316793|NCT04987632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25316794|NCT04987632|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25316795|NCT04987632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25316796|NCT04987632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25458139|NCT01196936|Tamoxifen|tamoxifen|mesh-list
25458140|NCT01196936|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25458141|NCT01196936|Hormone Antagonists|hormone antagonists|mesh-ancestor
25458142|NCT01196936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25458143|NCT01196936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458144|NCT01196936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25458145|NCT01196936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458146|NCT01196936|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25458147|NCT01196936|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25458148|NCT01196936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25458149|NCT01127451|Denileukin diftitox|denileukin diftitox|mesh-list
25458150|NCT01127451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458152|NCT01068249|Letrozole|letrozole|mesh-list
25458153|NCT01068249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458154|NCT01068249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25458155|NCT01068249|Immunologic Factors|immunologic factors|mesh-ancestor
25458156|NCT01068249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458157|NCT01068249|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25458158|NCT01068249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25458159|NCT01068249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25458160|NCT01068249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458161|NCT01068249|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25458162|NCT01068249|Hormone Antagonists|hormone antagonists|mesh-ancestor
25458163|NCT01068249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25458164|NCT01054196|Lenalidomide|lenalidomide|mesh-list
25458165|NCT01054196|Melphalan|melphalan|mesh-list
25458166|NCT01054196|Immunologic Factors|immunologic factors|mesh-ancestor
25458167|NCT01054196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458168|NCT01054196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25458169|NCT01054196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25458170|NCT01054196|Growth Substances|growth substances|mesh-ancestor
25458171|NCT01054196|Growth Inhibitors|growth inhibitors|mesh-ancestor
25458172|NCT01054196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458173|NCT01054196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25458174|NCT01054196|Alkylating Agents|alkylating agents|mesh-ancestor
25458175|NCT01054196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458176|NCT01054196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25458177|NCT01054196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25458178|NCT01004874|Bevacizumab|bevacizumab|mesh-list
25458179|NCT01004874|Temozolomide|temozolomide|mesh-list
25458180|NCT01004874|Topotecan|topotecan|mesh-list
25458181|NCT01004874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25458182|NCT01004874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458183|NCT01004874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25458184|NCT01004874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25458185|NCT01004874|Growth Substances|growth substances|mesh-ancestor
25458186|NCT01004874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458187|NCT01004874|Growth Inhibitors|growth inhibitors|mesh-ancestor
25458188|NCT01004874|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25458189|NCT01004874|Alkylating Agents|alkylating agents|mesh-ancestor
25458190|NCT01004874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458191|NCT01004874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25458192|NCT01004874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25458193|NCT01004874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25458194|NCT00268476|Zoledronic Acid|zoledronic acid|mesh-list
25458195|NCT00268476|Metformin|metformin|mesh-list
25458196|NCT00268476|Prednisone|prednisone|mesh-list
25458197|NCT00268476|Prednisolone|prednisolone|mesh-list
25458198|NCT00268476|Celecoxib|celecoxib|mesh-list
25458199|NCT00268476|Docetaxel|docetaxel|mesh-list
25458200|NCT00268476|Estradiol|estradiol|mesh-list
25458201|NCT00268476|Androgens|androgens|mesh-list
25458202|NCT00268476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25458203|NCT00268476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458204|NCT00268476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458205|NCT00268476|Tubulin Modulators|tubulin modulators|mesh-ancestor
25458206|NCT00268476|Antimitotic Agents|antimitotic agents|mesh-ancestor
25458207|NCT00268476|Mitosis Modulators|mitosis modulators|mesh-ancestor
25458208|NCT00268476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458209|NCT00268476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25458210|NCT00268476|Glucocorticoids|glucocorticoids|mesh-ancestor
25458211|NCT00268476|Hormones|hormones|mesh-ancestor
25458212|NCT00268476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25316857|NCT04986995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316858|NCT04986995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316859|NCT04986995|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25458213|NCT00268476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25458215|NCT00268476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25458216|NCT00268476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25458217|NCT00268476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25458218|NCT00268476|Analgesics|analgesics|mesh-ancestor
25458219|NCT00268476|Sensory System Agents|sensory system agents|mesh-ancestor
25458220|NCT00268476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25458221|NCT00268476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25458222|NCT00268476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25458223|NCT00268476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25458224|NCT00268476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25644547|NCT01437995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25458226|NCT05127304|Tiotropium Bromide|tiotropium bromide|mesh-list
25458227|NCT05127304|Olodaterol|olodaterol|mesh-list
25458228|NCT05127304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25458229|NCT05127304|Autonomic Agents|autonomic agents|mesh-ancestor
25458230|NCT05127304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25458231|NCT05127304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458232|NCT05127304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25458233|NCT05127304|Respiratory System Agents|respiratory system agents|mesh-ancestor
25458234|NCT05127304|Parasympatholytics|parasympatholytics|mesh-ancestor
25458235|NCT05127304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25458236|NCT05127304|Cholinergic Agents|cholinergic agents|mesh-ancestor
25458237|NCT05127304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25458238|NCT05127304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458239|NCT05127304|Anticonvulsants|anticonvulsants|mesh-ancestor
25458240|NCT05102162|Meropenem|meropenem|mesh-list
25458241|NCT05102162|Tazobactam|tazobactam|mesh-list
25458242|NCT05102162|Piperacillin|piperacillin|mesh-list
25458243|NCT05102162|Cefepime|cefepime|mesh-list
25458244|NCT05102162|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25458245|NCT05102162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25458246|NCT05102162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25458247|NCT05102162|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25458248|NCT05102162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25458249|NCT05102162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458250|NCT05049980|Mifepristone|mifepristone|mesh-list
25458251|NCT05049980|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25458252|NCT05049980|Abortifacient Agents|abortifacient agents|mesh-ancestor
25458253|NCT05049980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25458254|NCT05049980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458255|NCT05049980|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25458256|NCT05049980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25458257|NCT05049980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25458258|NCT05049980|Contraceptive Agents|contraceptive agents|mesh-ancestor
25458259|NCT05049980|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25458260|NCT05049980|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25458261|NCT05049980|Hormone Antagonists|hormone antagonists|mesh-ancestor
25458262|NCT05049980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25458263|NCT05049980|Luteolytic Agents|luteolytic agents|mesh-ancestor
25458264|NCT05049980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25458265|NCT05049980|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25458266|NCT05003258|Dexamethasone|dexamethasone|mesh-list
25458267|NCT05003258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25458268|NCT05003258|Antiemetics|antiemetics|mesh-ancestor
25458269|NCT05003258|Autonomic Agents|autonomic agents|mesh-ancestor
25458270|NCT05003258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25458271|NCT05003258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458272|NCT05003258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25458273|NCT05003258|Glucocorticoids|glucocorticoids|mesh-ancestor
25458274|NCT05003258|Hormones|hormones|mesh-ancestor
25458275|NCT05003258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25458276|NCT05003258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25458277|NCT05003258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458278|NCT04903353|Risperidone|risperidone|mesh-list
25458279|NCT04903353|Aripiprazole|aripiprazole|mesh-list
25458280|NCT04903353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25458281|NCT04903353|Serotonin Agents|serotonin agents|mesh-ancestor
25458282|NCT04903353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25458283|NCT04903353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458284|NCT04903353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458285|NCT04903353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25458286|NCT04903353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25458291|NCT04903353|Antidepressive Agents|antidepressive agents|mesh-ancestor
25458292|NCT04903353|Dopamine Agonists|dopamine agonists|mesh-ancestor
25458293|NCT04903353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25458294|NCT04903353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25458295|NCT04903353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25458296|NCT04903353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25458297|NCT04844762|Menthol|menthol|mesh-list
25458298|NCT04844762|Antipruritics|antipruritics|mesh-ancestor
25458299|NCT04844762|Dermatologic Agents|dermatologic agents|mesh-ancestor
25458300|NCT04829903|Liraglutide|liraglutide|mesh-list
25458301|NCT04829903|Dulaglutide|dulaglutide|mesh-list
25458302|NCT04829903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25644548|NCT01437995|Autonomic Agents|autonomic agents|mesh-ancestor
25458303|NCT04829903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458304|NCT04829903|Incretins|incretins|mesh-ancestor
25458305|NCT04829903|Hormones|hormones|mesh-ancestor
25458306|NCT04829903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25458307|NCT04813822|Miconazole|miconazole|mesh-list
25458308|NCT04813822|Clotrimazole|clotrimazole|mesh-list
25458309|NCT04813822|Bromides|bromides|mesh-list
25458310|NCT04813822|Anticonvulsants|anticonvulsants|mesh-ancestor
25458311|NCT04813822|Antifungal Agents|antifungal agents|mesh-ancestor
25458312|NCT04813822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25458313|NCT04813822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25458314|NCT04813822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25458315|NCT04813822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25458316|NCT04813822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458317|NCT04813822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25458318|NCT04813822|Hormone Antagonists|hormone antagonists|mesh-ancestor
25458319|NCT04813822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25458320|NCT04813822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458321|NCT04813822|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25458322|NCT04813822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25458323|NCT04813822|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25458324|NCT04791228|Doxorubicin|doxorubicin|mesh-list
25458325|NCT04791228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25458326|NCT04791228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25458327|NCT04791228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458328|NCT04791228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25458329|NCT04791228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25458330|NCT04791228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25458331|NCT04791228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458332|NCT04732845|Cyclophosphamide|cyclophosphamide|mesh-list
25458333|NCT04732845|Fludarabine|fludarabine|mesh-list
25458334|NCT04732845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25458335|NCT04732845|Immunologic Factors|immunologic factors|mesh-ancestor
25458336|NCT04732845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458337|NCT04732845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25458338|NCT04732845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25458339|NCT04732845|Alkylating Agents|alkylating agents|mesh-ancestor
25458340|NCT04732845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458341|NCT04732845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458342|NCT04732845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25458343|NCT04715022|Ascorbic Acid|ascorbic acid|mesh-list
25458344|NCT04715022|Antioxidants|antioxidants|mesh-ancestor
25458345|NCT04715022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458346|NCT04715022|Protective Agents|protective agents|mesh-ancestor
25458347|NCT04715022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458348|NCT04715022|Vitamins|vitamins|mesh-ancestor
25458349|NCT04715022|Micronutrients|micronutrients|mesh-ancestor
25317005|NCT04984577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317006|NCT04983836|Anesthetics|anesthetics|mesh-list
25317007|NCT04983836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25317008|NCT04983836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317009|NCT04984070|Metformin|metformin|mesh-list
25317010|NCT04984070|Drospirenone|drospirenone|mesh-list
25317011|NCT04984070|Contraceptive Agents|contraceptive agents|mesh-list
25317012|NCT04984070|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25458351|NCT04693715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25458352|NCT04693715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25458353|NCT04693715|Analgesics|analgesics|mesh-ancestor
25458354|NCT04693715|Sensory System Agents|sensory system agents|mesh-ancestor
25458355|NCT04693715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25458356|NCT04693715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458357|NCT04693715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25458358|NCT04693715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25458359|NCT04693715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25458360|NCT04683575|Selenium|selenium|mesh-list
25458361|NCT04683575|Antioxidants|antioxidants|mesh-ancestor
25458362|NCT04683575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458363|NCT04683575|Protective Agents|protective agents|mesh-ancestor
25458364|NCT04683575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458365|NCT04683575|Trace Elements|trace elements|mesh-ancestor
25458366|NCT04683575|Micronutrients|micronutrients|mesh-ancestor
25458367|NCT04566380|Capecitabine|capecitabine|mesh-list
25458368|NCT04566380|Oxaliplatin|oxaliplatin|mesh-list
25458369|NCT04566380|Nivolumab|nivolumab|mesh-list
25458370|NCT04566380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25458371|NCT04566380|Antimetabolites|antimetabolites|mesh-ancestor
25458372|NCT04566380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458373|NCT04566380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458374|NCT04566380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25458375|NCT04566380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25458376|NCT04492475|Interferons|interferons|mesh-list
25458377|NCT04492475|Interferon-beta|interferon-beta|mesh-list
25458378|NCT04492475|Interferon beta-1a|interferon beta-1a|mesh-list
25458379|NCT04492475|Remdesivir|remdesivir|mesh-list
25458380|NCT04492475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458381|NCT04492475|Antiviral Agents|antiviral agents|mesh-ancestor
25458382|NCT04492475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25458383|NCT04492475|Immunologic Factors|immunologic factors|mesh-ancestor
25458384|NCT04492475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458385|NCT04492475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25458386|NCT04492475|Antimetabolites|antimetabolites|mesh-ancestor
25458387|NCT04492475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458388|NCT04483206|Melphalan|melphalan|mesh-list
25458389|NCT04483206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25458390|NCT04483206|Alkylating Agents|alkylating agents|mesh-ancestor
25458391|NCT04483206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458392|NCT04483206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458393|NCT04483206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25458394|NCT04483206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25458395|NCT04483206|Immunologic Factors|immunologic factors|mesh-ancestor
25458396|NCT04483206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458397|NCT04474483|Melatonin|melatonin|mesh-list
25458398|NCT04474483|Antioxidants|antioxidants|mesh-ancestor
25458399|NCT04474483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458400|NCT04474483|Protective Agents|protective agents|mesh-ancestor
25458401|NCT04474483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458402|NCT04474483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25458403|NCT04452136|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25458404|NCT04452136|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25458405|NCT04452136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458406|NCT04424966|Infigratinib|infigratinib|mesh-list
25317082|NCT04983160|Allopurinol|allopurinol|mesh-list
25317083|NCT04983160|Antimetabolites|antimetabolites|mesh-ancestor
25317084|NCT04983160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317085|NCT04983160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25317086|NCT04983160|Gout Suppressants|gout suppressants|mesh-ancestor
25317087|NCT04983160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25317088|NCT04983160|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25317089|NCT04983160|Antioxidants|antioxidants|mesh-ancestor
25317090|NCT04983160|Protective Agents|protective agents|mesh-ancestor
25317091|NCT04983160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317092|NCT04982861|Cefixime|cefixime|mesh-list
25317093|NCT04982861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25317094|NCT04982861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25317095|NCT04982874|Furosemide|furosemide|mesh-list
25317096|NCT04982874|Diuretics|diuretics|mesh-ancestor
25317097|NCT04982874|Natriuretic Agents|natriuretic agents|mesh-ancestor
25317098|NCT04982874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317099|NCT04982874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25458407|NCT04424966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458409|NCT04401579|Antimetabolites|antimetabolites|mesh-ancestor
25458410|NCT04401579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458411|NCT04401579|Antiviral Agents|antiviral agents|mesh-ancestor
25458412|NCT04401579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25458413|NCT04320628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
25458414|NCT04320628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25458415|NCT04280705|Remdesivir|remdesivir|mesh-list
25458416|NCT04280705|Antimetabolites|antimetabolites|mesh-ancestor
25458417|NCT04280705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458418|NCT04280705|Antiviral Agents|antiviral agents|mesh-ancestor
25458419|NCT04280705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25458420|NCT04258046|Trametinib|trametinib|mesh-list
25458421|NCT04258046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458422|NCT04258046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25458423|NCT04258046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25458424|NCT04258046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458425|NCT04218409|Oxycodone|oxycodone|mesh-list
25458426|NCT04218409|Oxytocin|oxytocin|mesh-list
25458427|NCT04218409|Oxytocics|oxytocics|mesh-ancestor
25458428|NCT04218409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25822869|NCT00004688|Mercaptopurine|mercaptopurine|mesh-list
25644549|NCT01437995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25644550|NCT01437995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644551|NCT01437995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25644552|NCT01437995|Respiratory System Agents|respiratory system agents|mesh-ancestor
25644553|NCT01437995|Dermatologic Agents|dermatologic agents|mesh-ancestor
25644554|NCT01437995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25644555|NCT01437995|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25644556|NCT01437995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25644557|NCT01437995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25644558|NCT01437995|Adrenergic Agents|adrenergic agents|mesh-ancestor
25644559|NCT01437995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25644560|NCT01437995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644561|NCT01437995|Glucocorticoids|glucocorticoids|mesh-ancestor
25644562|NCT01437995|Hormones|hormones|mesh-ancestor
25644563|NCT01437995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25644564|NCT01437995|Sympathomimetics|sympathomimetics|mesh-ancestor
25644565|NCT01438060|Aripiprazole|aripiprazole|mesh-list
25644566|NCT01438060|Antidepressive Agents|antidepressive agents|mesh-ancestor
25644567|NCT01438060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25644568|NCT01438060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25644569|NCT01438060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25644570|NCT01438060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25458429|NCT04218409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458430|NCT04218409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25458431|NCT04218409|Narcotics|narcotics|mesh-ancestor
25458432|NCT04218409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25458433|NCT04218409|Analgesics|analgesics|mesh-ancestor
25458434|NCT04218409|Sensory System Agents|sensory system agents|mesh-ancestor
25458435|NCT04218409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25458436|NCT04151017|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25458437|NCT04151017|Hemostatics|hemostatics|mesh-ancestor
25458438|NCT04151017|Coagulants|coagulants|mesh-ancestor
25458439|NCT04116398|Dexamethasone|dexamethasone|mesh-list
25458440|NCT04116398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25458441|NCT04116398|Antiemetics|antiemetics|mesh-ancestor
25458442|NCT04116398|Autonomic Agents|autonomic agents|mesh-ancestor
25458443|NCT04116398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25458444|NCT04116398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458445|NCT04116398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25458446|NCT04116398|Glucocorticoids|glucocorticoids|mesh-ancestor
25458447|NCT04116398|Hormones|hormones|mesh-ancestor
25458448|NCT04116398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25458449|NCT04116398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25458450|NCT04116398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458451|NCT04112589|Cytarabine|cytarabine|mesh-list
25458452|NCT04112589|Fludarabine|fludarabine|mesh-list
25458453|NCT04112589|Idarubicin|idarubicin|mesh-list
25458454|NCT04112589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458455|NCT04112589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25458456|NCT04112589|Antimetabolites|antimetabolites|mesh-ancestor
25458457|NCT04112589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458458|NCT04112589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25458459|NCT04112589|Immunologic Factors|immunologic factors|mesh-ancestor
25458460|NCT04112589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458461|NCT04112589|Antiviral Agents|antiviral agents|mesh-ancestor
25458462|NCT04112589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25458463|NCT04112589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25458464|NCT04112589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25458465|NCT04112589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25458466|NCT04112589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25458467|NCT04080427|Dronabinol|dronabinol|mesh-list
25458468|NCT04080427|Hallucinogens|hallucinogens|mesh-ancestor
25458469|NCT04080427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458470|NCT04080427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25458471|NCT04080427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25458472|NCT04080427|Analgesics|analgesics|mesh-ancestor
25458473|NCT04080427|Sensory System Agents|sensory system agents|mesh-ancestor
25458474|NCT04080427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25458475|NCT04080427|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25458476|NCT04080427|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25458477|NCT04080427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25317151|NCT04982549|Mitosis Modulators|mitosis modulators|mesh-ancestor
25317152|NCT04982549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317153|NCT04982549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822870|NCT00004688|Carmustine|carmustine|mesh-list
25458478|NCT04080427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458479|NCT04080427|Hormones|hormones|mesh-ancestor
25458499|NCT03971877|Polymyxins|polymyxins|mesh-list
25458500|NCT03971877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25458501|NCT03971877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25458502|NCT03963414|Carboplatin|carboplatin|mesh-list
25458503|NCT03963414|Etoposide|etoposide|mesh-list
25458504|NCT03963414|Etoposide phosphate|etoposide phosphate|mesh-list
25458505|NCT03963414|Durvalumab|durvalumab|mesh-list
25458506|NCT03963414|Tremelimumab|tremelimumab|mesh-list
25458507|NCT03963414|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25458508|NCT03963414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458509|NCT03963414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25458510|NCT03963414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25458511|NCT03963414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25458512|NCT03963414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25458513|NCT03963414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458514|NCT03963414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25458515|NCT03963414|Immunologic Factors|immunologic factors|mesh-ancestor
25458516|NCT03963414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458517|NCT03955211|Acetaminophen|acetaminophen|mesh-list
25458518|NCT03955211|Ibuprofen|ibuprofen|mesh-list
25458519|NCT03955211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25458520|NCT03955211|Analgesics|analgesics|mesh-ancestor
25458521|NCT03955211|Sensory System Agents|sensory system agents|mesh-ancestor
25458522|NCT03955211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25458523|NCT03955211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458524|NCT03955211|Antipyretics|antipyretics|mesh-ancestor
25458525|NCT03955211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25458526|NCT03955211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25458527|NCT03955211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25458528|NCT03955211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25458529|NCT03955211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25458530|NCT03955211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458531|NCT03943927|Metoprolol|metoprolol|mesh-list
25458532|NCT03943927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25458533|NCT03943927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25458534|NCT03943927|Sympatholytics|sympatholytics|mesh-ancestor
25458535|NCT03943927|Autonomic Agents|autonomic agents|mesh-ancestor
25458536|NCT03943927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25458537|NCT03943927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458538|NCT03943927|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25458539|NCT03943927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25458540|NCT03943927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25458541|NCT03943927|Adrenergic Agents|adrenergic agents|mesh-ancestor
25458542|NCT03943927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25458543|NCT03943927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458544|NCT03900884|Letrozole|letrozole|mesh-list
25458545|NCT03900884|Venetoclax|venetoclax|mesh-list
25458546|NCT03900884|Palbociclib|palbociclib|mesh-list
25458547|NCT03900884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458548|NCT03900884|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25458549|NCT03900884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25458550|NCT03900884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25458551|NCT03900884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458552|NCT03900884|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25458553|NCT03900884|Hormone Antagonists|hormone antagonists|mesh-ancestor
25458554|NCT03900884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25458555|NCT03900884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458556|NCT03900884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25458557|NCT03874897|Antibodies|antibodies|mesh-list
25458558|NCT03874897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25458559|NCT03874897|Immunologic Factors|immunologic factors|mesh-ancestor
25458560|NCT03874897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458561|NCT03853330|Bupivacaine|bupivacaine|mesh-list
25458562|NCT03853330|Anesthetics, Local|anesthetics, local|mesh-ancestor
25458563|NCT03853330|Anesthetics|anesthetics|mesh-ancestor
25458564|NCT03853330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25458565|NCT03853330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458566|NCT03853330|Sensory System Agents|sensory system agents|mesh-ancestor
25458567|NCT03853330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25317296|NCT04980885|Antimetabolites|antimetabolites|mesh-ancestor
25317297|NCT04980885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317298|NCT04980885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25317299|NCT04980885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25317300|NCT04980404|Decitabine|decitabine|mesh-list
25317301|NCT04980404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25458568|NCT03850691|Aldesleukin|aldesleukin|mesh-list
25458569|NCT03850691|Nivolumab|nivolumab|mesh-list
25458570|NCT03850691|Ipilimumab|ipilimumab|mesh-list
25458571|NCT03850691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25458572|NCT03850691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458573|NCT03850691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25721906|NCT02494180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25458574|NCT03850691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458575|NCT03850691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25458576|NCT03850691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25458577|NCT03850691|Antiviral Agents|antiviral agents|mesh-ancestor
25458578|NCT03850691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25458579|NCT03834740|Everolimus|everolimus|mesh-list
25458580|NCT03834740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458581|NCT03834740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25458582|NCT03834740|Immunologic Factors|immunologic factors|mesh-ancestor
25458583|NCT03834740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458584|NCT03805100|Ranibizumab|ranibizumab|mesh-list
25458585|NCT03805100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25458586|NCT03805100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25458587|NCT03805100|Growth Substances|growth substances|mesh-ancestor
25458588|NCT03805100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458589|NCT03805100|Growth Inhibitors|growth inhibitors|mesh-ancestor
25458590|NCT03805100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458591|NCT03764098|Guanfacine|guanfacine|mesh-list
25458592|NCT03764098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25458593|NCT03764098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25458594|NCT03764098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25458595|NCT03764098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25458596|NCT03764098|Adrenergic Agents|adrenergic agents|mesh-ancestor
25458597|NCT03764098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25458598|NCT03764098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458599|NCT03764098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458600|NCT03661645|Dexamethasone|dexamethasone|mesh-list
25458601|NCT03661645|Dexamethasone acetate|dexamethasone acetate|mesh-list
25458602|NCT03661645|Methylprednisolone|methylprednisolone|mesh-list
25458603|NCT03661645|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25458604|NCT03661645|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25458605|NCT03661645|BB 1101|bb 1101|mesh-list
25458606|NCT03661645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25458607|NCT03661645|Antiemetics|antiemetics|mesh-ancestor
25458608|NCT03661645|Autonomic Agents|autonomic agents|mesh-ancestor
25458609|NCT03661645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25458610|NCT03661645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458611|NCT03661645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25458612|NCT03661645|Glucocorticoids|glucocorticoids|mesh-ancestor
25458613|NCT03661645|Hormones|hormones|mesh-ancestor
25458614|NCT03661645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25458615|NCT03661645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25458616|NCT03661645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458617|NCT03661645|Protease Inhibitors|protease inhibitors|mesh-ancestor
25458618|NCT03661645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25458619|NCT03661645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458620|NCT03661645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25458621|NCT03661645|Protective Agents|protective agents|mesh-ancestor
25458622|NCT03647566|Listerine|listerine|mesh-list
25458623|NCT03647566|Fluorides|fluorides|mesh-list
25458624|NCT03647566|Sodium Fluoride|sodium fluoride|mesh-list
25458625|NCT03647566|Cariostatic Agents|cariostatic agents|mesh-ancestor
25458626|NCT03647566|Protective Agents|protective agents|mesh-ancestor
25458627|NCT03647566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458628|NCT03647566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25458629|NCT03647566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25458630|NCT03576313|Ivermectin|ivermectin|mesh-list
25458631|NCT03576313|Piperaquine|piperaquine|mesh-list
25458632|NCT03576313|Artenimol|artenimol|mesh-list
25458633|NCT03576313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25458634|NCT03576313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25458635|NCT03576313|Antimalarials|antimalarials|mesh-ancestor
25458636|NCT03576313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25458637|NCT03533010|Vitamin D|vitamin d|mesh-list
25317360|NCT04979650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25317361|NCT04979650|Prednisolone|prednisolone|mesh-list
25317362|NCT04979650|Prednisolone acetate|prednisolone acetate|mesh-list
25317363|NCT04979650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25317364|NCT04979650|Prednisolone phosphate|prednisolone phosphate|mesh-list
25317365|NCT04979650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25317366|NCT04979650|Antiemetics|antiemetics|mesh-ancestor
25458638|NCT03533010|Vitamins|vitamins|mesh-ancestor
25458639|NCT03533010|Micronutrients|micronutrients|mesh-ancestor
25458640|NCT03533010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458641|NCT03533010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25458642|NCT03512275|Antibodies|antibodies|mesh-list
25458643|NCT03512275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25458644|NCT03512275|Immunologic Factors|immunologic factors|mesh-ancestor
25458645|NCT03512275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458646|NCT03485729|TIC10 compound|tic10 compound|mesh-list
25458647|NCT03485729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458648|NCT03435003|Dexamethasone|dexamethasone|mesh-list
25458649|NCT03435003|Fentanyl|fentanyl|mesh-list
25458650|NCT03435003|Scopolamine|scopolamine|mesh-list
25458651|NCT03435003|Dexmedetomidine|dexmedetomidine|mesh-list
25458652|NCT03435003|Ondansetron|ondansetron|mesh-list
25458653|NCT03435003|Aprepitant|aprepitant|mesh-list
25458654|NCT03435003|Metoclopramide|metoclopramide|mesh-list
25458655|NCT03435003|Prochlorperazine|prochlorperazine|mesh-list
25458656|NCT03435003|Propofol|propofol|mesh-list
25458657|NCT03435003|Sevoflurane|sevoflurane|mesh-list
25458658|NCT03435003|Desflurane|desflurane|mesh-list
25458659|NCT03435003|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25458660|NCT03435003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25458661|NCT03435003|Antiemetics|antiemetics|mesh-ancestor
25458662|NCT03435003|Autonomic Agents|autonomic agents|mesh-ancestor
25458663|NCT03435003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25458664|NCT03435003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458665|NCT03435003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25458666|NCT03435003|Glucocorticoids|glucocorticoids|mesh-ancestor
25458667|NCT03435003|Hormones|hormones|mesh-ancestor
25458668|NCT03435003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25458669|NCT03435003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25458670|NCT03435003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458671|NCT03435003|Anesthetics|anesthetics|mesh-ancestor
25458672|NCT03435003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25458673|NCT03435003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25458674|NCT03435003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25458675|NCT03435003|Anesthetics, General|anesthetics, general|mesh-ancestor
25458676|NCT03435003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25458677|NCT03435003|Analgesics|analgesics|mesh-ancestor
25458678|NCT03435003|Sensory System Agents|sensory system agents|mesh-ancestor
25458679|NCT03435003|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25458680|NCT03435003|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25458681|NCT03435003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25458682|NCT03435003|Adrenergic Agents|adrenergic agents|mesh-ancestor
25458683|NCT03435003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25458684|NCT03435003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458685|NCT03435003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25458686|NCT03435003|Narcotics|narcotics|mesh-ancestor
25458687|NCT03435003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25458688|NCT03435003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25458689|NCT03435003|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25458690|NCT03435003|Antipruritics|antipruritics|mesh-ancestor
25458691|NCT03435003|Dermatologic Agents|dermatologic agents|mesh-ancestor
25458692|NCT03435003|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25458693|NCT03435003|Serotonin Agents|serotonin agents|mesh-ancestor
25458694|NCT03435003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25458695|NCT03435003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25458696|NCT03435003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25458697|NCT03435003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25458698|NCT03435003|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25458699|NCT03435003|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25458700|NCT03435003|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25458701|NCT03435003|Dopamine Agents|dopamine agents|mesh-ancestor
25317432|NCT04979923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317433|NCT04979468|Lamivudine|lamivudine|mesh-list
25317434|NCT04979468|Dolutegravir|dolutegravir|mesh-list
25317435|NCT04979468|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25317436|NCT04979468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25317437|NCT04979468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25317438|NCT04979468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317439|NCT04979468|Antiviral Agents|antiviral agents|mesh-ancestor
25317440|NCT04979468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25317441|NCT04979468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25317442|NCT04979468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25317443|NCT04979468|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25317444|NCT04979468|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25458702|NCT03435003|Mydriatics|mydriatics|mesh-ancestor
25644571|NCT01438060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458703|NCT03435003|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25458704|NCT03435003|Cholinergic Agents|cholinergic agents|mesh-ancestor
25458705|NCT03435003|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25458706|NCT03435003|Parasympatholytics|parasympatholytics|mesh-ancestor
25458707|NCT03434769|Cyclophosphamide|cyclophosphamide|mesh-list
25458708|NCT03434769|Fludarabine|fludarabine|mesh-list
25458709|NCT03434769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25458710|NCT03434769|Immunologic Factors|immunologic factors|mesh-ancestor
25458711|NCT03434769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458712|NCT03434769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25458713|NCT03434769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25458714|NCT03434769|Alkylating Agents|alkylating agents|mesh-ancestor
25458715|NCT03434769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458716|NCT03434769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458717|NCT03434769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25458718|NCT03414983|Leucovorin|leucovorin|mesh-list
25458719|NCT03414983|Bevacizumab|bevacizumab|mesh-list
25458720|NCT03414983|Nivolumab|nivolumab|mesh-list
25458721|NCT03414983|Fluorouracil|fluorouracil|mesh-list
25458722|NCT03414983|Oxaliplatin|oxaliplatin|mesh-list
25458723|NCT03414983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25458724|NCT03414983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458725|NCT03414983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25458726|NCT03414983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25458727|NCT03414983|Growth Substances|growth substances|mesh-ancestor
25458728|NCT03414983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458729|NCT03414983|Growth Inhibitors|growth inhibitors|mesh-ancestor
25458730|NCT03414983|Antimetabolites|antimetabolites|mesh-ancestor
25458731|NCT03414983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458732|NCT03414983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25458733|NCT03414983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25458734|NCT03414983|Immunologic Factors|immunologic factors|mesh-ancestor
25458735|NCT03414983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25458736|NCT03414983|Antidotes|antidotes|mesh-ancestor
25458737|NCT03414983|Protective Agents|protective agents|mesh-ancestor
25458738|NCT03414983|Vitamin B Complex|vitamin b complex|mesh-ancestor
25458739|NCT03414983|Vitamins|vitamins|mesh-ancestor
25458740|NCT03414983|Micronutrients|micronutrients|mesh-ancestor
25458741|NCT03383692|Ritonavir|ritonavir|mesh-list
25458742|NCT03383692|Itraconazole|itraconazole|mesh-list
25458743|NCT03383692|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25458744|NCT03383692|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25458745|NCT03383692|Protease Inhibitors|protease inhibitors|mesh-ancestor
25458746|NCT03383692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25458747|NCT03383692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458748|NCT03383692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25458749|NCT03383692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25458750|NCT03383692|Antiviral Agents|antiviral agents|mesh-ancestor
25458751|NCT03383692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25458752|NCT03383692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25458753|NCT03383692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25458754|NCT03383692|Antifungal Agents|antifungal agents|mesh-ancestor
25458755|NCT03383692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25458756|NCT03383692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25458757|NCT03383692|Hormone Antagonists|hormone antagonists|mesh-ancestor
25458758|NCT03383692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25458759|NCT03383692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458760|NCT03349268|Xenon|xenon|mesh-list
25458761|NCT03349268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25458762|NCT03349268|Anesthetics, General|anesthetics, general|mesh-ancestor
25458763|NCT03349268|Anesthetics|anesthetics|mesh-ancestor
25458764|NCT03349268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25721924|NCT02494180|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25458765|NCT03349268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458766|NCT03321656|Tacrolimus|tacrolimus|mesh-list
25458767|NCT03321656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25458768|NCT03321656|Immunologic Factors|immunologic factors|mesh-ancestor
25458769|NCT03321656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458770|NCT03321656|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25458771|NCT03321656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25458772|NCT03321656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458773|NCT03277638|Pembrolizumab|pembrolizumab|mesh-list
25458774|NCT03277638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25458775|NCT03277638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458776|NCT03182166|Golimumab|golimumab|mesh-list
25644572|NCT01438060|Dopamine Agonists|dopamine agonists|mesh-ancestor
25644573|NCT01438060|Dopamine Agents|dopamine agents|mesh-ancestor
25458777|NCT03182166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25458778|NCT03182166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25458779|NCT03182166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25458780|NCT03182166|Immunologic Factors|immunologic factors|mesh-ancestor
25458781|NCT03182166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458782|NCT03161028|Thioctic Acid|thioctic acid|mesh-list
25458783|NCT03161028|Antioxidants|antioxidants|mesh-ancestor
25458784|NCT03161028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458785|NCT03161028|Protective Agents|protective agents|mesh-ancestor
25458786|NCT03161028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458787|NCT03161028|Vitamin B Complex|vitamin b complex|mesh-ancestor
25458788|NCT03161028|Vitamins|vitamins|mesh-ancestor
25458789|NCT03161028|Micronutrients|micronutrients|mesh-ancestor
25458790|NCT03134131|TIC10 compound|tic10 compound|mesh-list
25458791|NCT03134131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458792|NCT03088826|Acetaminophen|acetaminophen|mesh-list
25458793|NCT03088826|Morphine|morphine|mesh-list
25458794|NCT03088826|Oxycodone|oxycodone|mesh-list
25458795|NCT03088826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25458796|NCT03088826|Narcotics|narcotics|mesh-ancestor
25458797|NCT03088826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25458798|NCT03088826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458799|NCT03088826|Analgesics|analgesics|mesh-ancestor
25458800|NCT03088826|Sensory System Agents|sensory system agents|mesh-ancestor
25458801|NCT03088826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25458802|NCT03088826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25458803|NCT03088826|Antipyretics|antipyretics|mesh-ancestor
25458804|NCT03034018|Suvorexant|suvorexant|mesh-list
25458805|NCT03034018|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25458806|NCT03034018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25458807|NCT03034018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25458808|NCT03034018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458809|NCT03034018|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25458810|NCT03034018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25458811|NCT03034018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458812|NCT03024437|Bevacizumab|bevacizumab|mesh-list
25458813|NCT03024437|Atezolizumab|atezolizumab|mesh-list
25458814|NCT03024437|Entinostat|entinostat|mesh-list
25458815|NCT03024437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25458816|NCT03024437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458817|NCT03024437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25458818|NCT03024437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25458819|NCT03024437|Growth Substances|growth substances|mesh-ancestor
25458820|NCT03024437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458821|NCT03024437|Growth Inhibitors|growth inhibitors|mesh-ancestor
25458822|NCT03024437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25458823|NCT03024437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25458824|NCT03024437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458825|NCT03021460|Pembrolizumab|pembrolizumab|mesh-list
25458826|NCT03021460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25458827|NCT03021460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458828|NCT02892123|Paclitaxel|paclitaxel|mesh-list
25458829|NCT02892123|Vinorelbine|vinorelbine|mesh-list
25458830|NCT02892123|Capecitabine|capecitabine|mesh-list
25458831|NCT02892123|Tucatinib|tucatinib|mesh-list
25458832|NCT02892123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25458833|NCT02892123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458834|NCT02892123|Tubulin Modulators|tubulin modulators|mesh-ancestor
25458835|NCT02892123|Antimitotic Agents|antimitotic agents|mesh-ancestor
25458836|NCT02892123|Mitosis Modulators|mitosis modulators|mesh-ancestor
25458837|NCT02892123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458838|NCT02892123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25458839|NCT02892123|Antimetabolites|antimetabolites|mesh-ancestor
25458840|NCT02892123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25317575|NCT04977791|Immunologic Factors|immunologic factors|mesh-ancestor
25317576|NCT04977791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317577|NCT04977791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317578|NCT04977791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007617|NCT03161912|Growth Inhibitors|growth inhibitors|mesh-ancestor
25007618|NCT03161912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007619|NCT03149809|Solifenacin Succinate|solifenacin succinate|mesh-list
25007620|NCT03149809|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25007621|NCT03149809|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25317594|NCT04977427|Prednisolone|prednisolone|mesh-list
25317595|NCT04977427|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25317596|NCT04977427|Methylprednisolone|methylprednisolone|mesh-list
25317597|NCT04977427|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25317598|NCT04977427|Prednisolone acetate|prednisolone acetate|mesh-list
25317599|NCT04977427|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25458858|NCT02596997|Antiviral Agents|antiviral agents|mesh-ancestor
25458859|NCT02596997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25458860|NCT02555254|Methamphetamine|methamphetamine|mesh-list
25458861|NCT02555254|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25458862|NCT02555254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458863|NCT02555254|Sympathomimetics|sympathomimetics|mesh-ancestor
25458864|NCT02555254|Autonomic Agents|autonomic agents|mesh-ancestor
25458865|NCT02555254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25458866|NCT02555254|Dopamine Agents|dopamine agents|mesh-ancestor
25458867|NCT02555254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25458868|NCT02555254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458869|NCT02555254|Adrenergic Agents|adrenergic agents|mesh-ancestor
25458870|NCT02555254|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25458871|NCT02555254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25458872|NCT02555254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25458873|NCT02555254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25458874|NCT02444728|Hydroxychloroquine|hydroxychloroquine|mesh-list
25458875|NCT02444728|Methylprednisolone|methylprednisolone|mesh-list
25458876|NCT02444728|Cyclophosphamide|cyclophosphamide|mesh-list
25458877|NCT02444728|Azathioprine|azathioprine|mesh-list
25458878|NCT02444728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25458879|NCT02444728|Immunologic Factors|immunologic factors|mesh-ancestor
25458880|NCT02444728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458881|NCT02444728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25458882|NCT02444728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25458883|NCT02444728|Alkylating Agents|alkylating agents|mesh-ancestor
25458884|NCT02444728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458885|NCT02444728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458886|NCT02444728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25458887|NCT02444728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25458888|NCT02444728|Antiemetics|antiemetics|mesh-ancestor
25458889|NCT02444728|Autonomic Agents|autonomic agents|mesh-ancestor
25458890|NCT02444728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25458891|NCT02444728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25458892|NCT02444728|Glucocorticoids|glucocorticoids|mesh-ancestor
25458893|NCT02444728|Hormones|hormones|mesh-ancestor
25458894|NCT02444728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25458895|NCT02444728|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25458896|NCT02444728|Protective Agents|protective agents|mesh-ancestor
25458897|NCT02444728|Antimalarials|antimalarials|mesh-ancestor
25458898|NCT02444728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25458899|NCT02444728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25458900|NCT02444728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25458901|NCT02444728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25458902|NCT02444728|Antimetabolites|antimetabolites|mesh-ancestor
25458903|NCT02444728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25458904|NCT02381353|Bupivacaine|bupivacaine|mesh-list
25458905|NCT02381353|Anesthetics, Local|anesthetics, local|mesh-ancestor
25458906|NCT02381353|Anesthetics|anesthetics|mesh-ancestor
25458907|NCT02381353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25458908|NCT02381353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458909|NCT02381353|Sensory System Agents|sensory system agents|mesh-ancestor
25458910|NCT02381353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25458911|NCT02296918|Rituximab|rituximab|mesh-list
25458912|NCT02296918|Obinutuzumab|obinutuzumab|mesh-list
25458913|NCT02296918|Venetoclax|venetoclax|mesh-list
25458914|NCT02296918|Acalabrutinib|acalabrutinib|mesh-list
25458915|NCT02296918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25458916|NCT02296918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458917|NCT02296918|Immunologic Factors|immunologic factors|mesh-ancestor
25458918|NCT02296918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458919|NCT02296918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25458920|NCT01787409|Vitamin D|vitamin d|mesh-list
25458921|NCT01787409|Cholecalciferol|cholecalciferol|mesh-list
25458922|NCT01787409|Vitamins|vitamins|mesh-ancestor
25458923|NCT01787409|Micronutrients|micronutrients|mesh-ancestor
25458924|NCT01787409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458925|NCT01787409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25458926|NCT01787409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25458927|NCT01426529|Norepinephrine|norepinephrine|mesh-list
25458928|NCT01426529|Angiotensin II|angiotensin ii|mesh-list
25458929|NCT01426529|Giapreza|giapreza|mesh-list
25458930|NCT01426529|Angiotensinogen|angiotensinogen|mesh-list
25458931|NCT01426529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25458932|NCT01426529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25458933|NCT01426529|Adrenergic Agents|adrenergic agents|mesh-ancestor
25458934|NCT01426529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25458935|NCT01426529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458936|NCT01426529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458937|NCT01426529|Sympathomimetics|sympathomimetics|mesh-ancestor
25458938|NCT01426529|Autonomic Agents|autonomic agents|mesh-ancestor
25458939|NCT01426529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25458940|NCT01426529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25458941|NCT01426529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25458942|NCT01426529|Protease Inhibitors|protease inhibitors|mesh-ancestor
25458943|NCT01426529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25458944|NCT01252953|Oxazolidinones|oxazolidinones|mesh-list
25458945|NCT01252953|Anacetrapib|anacetrapib|mesh-list
25458946|NCT01252953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25458947|NCT01252953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25458948|NCT01252953|Antimetabolites|antimetabolites|mesh-ancestor
25458949|NCT01252953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458950|NCT01252953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25458951|NCT01252953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25458952|NCT01252953|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25458953|NCT01252953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25458954|NCT01012609|Irinotecan|irinotecan|mesh-list
25458955|NCT01012609|Cetuximab|cetuximab|mesh-list
25458956|NCT01012609|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25458957|NCT01012609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25458958|NCT01012609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25458959|NCT01012609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458960|NCT01012609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25458961|NCT01012609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25458962|NCT00458835|Ciclesonide|ciclesonide|mesh-list
25458963|NCT00458835|Glucocorticoids|glucocorticoids|mesh-ancestor
25458964|NCT00458835|Hormones|hormones|mesh-ancestor
25458965|NCT00458835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25458966|NCT00458835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458967|NCT00458835|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25458968|NCT00403559|Ketoconazole|ketoconazole|mesh-list
25458969|NCT00403559|Pimecrolimus|pimecrolimus|mesh-list
25458970|NCT00403559|Antifungal Agents|antifungal agents|mesh-ancestor
25458971|NCT00403559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25458972|NCT00403559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25458973|NCT00403559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25458974|NCT00403559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25458975|NCT00403559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458976|NCT00403559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25458977|NCT00403559|Hormone Antagonists|hormone antagonists|mesh-ancestor
25458978|NCT00403559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25458979|NCT00403559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458980|NCT00403559|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25458981|NCT00403559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25458982|NCT00403559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25458983|NCT00403559|Analgesics|analgesics|mesh-ancestor
25458984|NCT00403559|Sensory System Agents|sensory system agents|mesh-ancestor
25458985|NCT00403559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25458986|NCT00403559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25458987|NCT00403559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25458988|NCT00403559|Dermatologic Agents|dermatologic agents|mesh-ancestor
25458989|NCT00403559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25458990|NCT00403559|Immunologic Factors|immunologic factors|mesh-ancestor
25458991|NCT00403559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25458992|NCT05283278|Lactoferrin|lactoferrin|mesh-list
25458993|NCT05283278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25458994|NCT05283057|Empagliflozin|empagliflozin|mesh-list
25458995|NCT05283057|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25458996|NCT05283057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25458997|NCT05283057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25458998|NCT05283057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25458999|NCT05282771|Nicotinic Acids|nicotinic acids|mesh-list
25459000|NCT05282771|Clobetasol|clobetasol|mesh-list
25459001|NCT05282771|Halobetasol|halobetasol|mesh-list
25317789|NCT04974580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25317790|NCT04974580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822871|NCT00004688|Streptozocin|streptozocin|mesh-list
25317796|NCT04974294|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25317797|NCT04974294|Immunologic Factors|immunologic factors|mesh-ancestor
25317798|NCT04974294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459003|NCT05282771|Dermatologic Agents|dermatologic agents|mesh-ancestor
25459004|NCT05282771|Keratolytic Agents|keratolytic agents|mesh-ancestor
25459005|NCT05282771|Vitamin B Complex|vitamin b complex|mesh-ancestor
25459007|NCT05282771|Micronutrients|micronutrients|mesh-ancestor
25459008|NCT05282771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459009|NCT05282771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25459010|NCT05282771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25459011|NCT05282771|Glucocorticoids|glucocorticoids|mesh-ancestor
25459012|NCT05282771|Hormones|hormones|mesh-ancestor
25459013|NCT05282771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25459014|NCT05282719|Azacitidine|azacitidine|mesh-list
25459015|NCT05282719|Venetoclax|venetoclax|mesh-list
25459016|NCT05282719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25459017|NCT05282719|Antimetabolites|antimetabolites|mesh-ancestor
25459018|NCT05282719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459019|NCT05282719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459020|NCT05282719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459021|NCT05282420|Ranibizumab|ranibizumab|mesh-list
25459022|NCT05282420|Aflibercept|aflibercept|mesh-list
25459023|NCT05282420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25459024|NCT05282420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25459025|NCT05282420|Growth Substances|growth substances|mesh-ancestor
25459026|NCT05282420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459027|NCT05282420|Growth Inhibitors|growth inhibitors|mesh-ancestor
25459028|NCT05282420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459029|NCT05282407|Tenofovir|tenofovir|mesh-list
25459030|NCT05282407|Antiviral Agents|antiviral agents|mesh-ancestor
25459031|NCT05282407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25459032|NCT05282407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25459033|NCT05282407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25459034|NCT05282407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459035|NCT05282407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459036|NCT05282407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25459037|NCT05282407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25459038|NCT05282251|Bupivacaine|bupivacaine|mesh-list
25459039|NCT05282251|Anesthetics, Local|anesthetics, local|mesh-ancestor
25459040|NCT05282251|Anesthetics|anesthetics|mesh-ancestor
25459041|NCT05282251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25459042|NCT05282251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459043|NCT05282251|Sensory System Agents|sensory system agents|mesh-ancestor
25459044|NCT05282251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25459045|NCT05281965|Tretinoin|tretinoin|mesh-list
25459046|NCT05281965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459047|NCT05281965|Keratolytic Agents|keratolytic agents|mesh-ancestor
25459048|NCT05281965|Dermatologic Agents|dermatologic agents|mesh-ancestor
25459049|NCT05281926|Nivolumab|nivolumab|mesh-list
25459050|NCT05281926|Poly ICLC|poly iclc|mesh-list
25459051|NCT05281926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25459052|NCT05281926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459053|NCT05281926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25459054|NCT05281926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459055|NCT05281926|Interferon Inducers|interferon inducers|mesh-ancestor
25459056|NCT05281926|Immunologic Factors|immunologic factors|mesh-ancestor
25459057|NCT05281926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459058|NCT05281861|Lithium Carbonate|lithium carbonate|mesh-list
25459059|NCT05281861|Antidepressive Agents|antidepressive agents|mesh-ancestor
25459060|NCT05281861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25459061|NCT05281861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25317862|NCT04972383|Hyaluronic Acid|hyaluronic acid|mesh-list
25317863|NCT04972383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25317864|NCT04972383|Immunologic Factors|immunologic factors|mesh-ancestor
25317865|NCT04972383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317866|NCT04972383|Viscosupplements|viscosupplements|mesh-ancestor
25317867|NCT04972383|Protective Agents|protective agents|mesh-ancestor
24880277|NCT03902418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902050|NCT04378283|Epinephrine|epinephrine|mesh-list
25317868|NCT04972617|Furosemide|furosemide|mesh-list
25317869|NCT04972617|Diuretics|diuretics|mesh-ancestor
25317870|NCT04972617|Natriuretic Agents|natriuretic agents|mesh-ancestor
25317871|NCT04972617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317872|NCT04972617|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25317873|NCT04972617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25317874|NCT04972617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317920|NCT04972513|Nitric Oxide|nitric oxide|mesh-list
25459091|NCT05281276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25459092|NCT05281276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25459093|NCT05281276|Analgesics|analgesics|mesh-ancestor
25459094|NCT05281276|Sensory System Agents|sensory system agents|mesh-ancestor
25459095|NCT05281276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25459096|NCT05281276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459097|NCT05281276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25459098|NCT05281276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25459099|NCT05281276|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25459100|NCT05281276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25459101|NCT05281276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459102|NCT05281276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459103|NCT05281107|Calcium, Dietary|calcium, dietary|mesh-list
25459104|NCT05281107|Vitamin D|vitamin d|mesh-list
25459105|NCT05281107|Ergocalciferols|ergocalciferols|mesh-list
25459106|NCT05281107|Cholecalciferol|cholecalciferol|mesh-list
25459107|NCT05281107|Vitamins|vitamins|mesh-list
25459108|NCT05281107|Calcium|calcium|mesh-list
25459109|NCT05281107|Micronutrients|micronutrients|mesh-ancestor
25459110|NCT05281107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459111|NCT05281107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25459112|NCT05281107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25459113|NCT05281081|Morphine|morphine|mesh-list
25459114|NCT05281081|Levobupivacaine|levobupivacaine|mesh-list
25459115|NCT05281081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25459116|NCT05281081|Narcotics|narcotics|mesh-ancestor
25459117|NCT05281081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25459118|NCT05281081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459119|NCT05281081|Analgesics|analgesics|mesh-ancestor
25459120|NCT05281081|Sensory System Agents|sensory system agents|mesh-ancestor
25459121|NCT05281081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25459122|NCT05281081|Anesthetics, Local|anesthetics, local|mesh-ancestor
25459123|NCT05281081|Anesthetics|anesthetics|mesh-ancestor
25459124|NCT05281003|Paclitaxel|paclitaxel|mesh-list
25459125|NCT05281003|Cisplatin|cisplatin|mesh-list
25459126|NCT05281003|Pembrolizumab|pembrolizumab|mesh-list
25459127|NCT05281003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25459128|NCT05281003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459129|NCT05281003|Tubulin Modulators|tubulin modulators|mesh-ancestor
25459130|NCT05281003|Antimitotic Agents|antimitotic agents|mesh-ancestor
25459131|NCT05281003|Mitosis Modulators|mitosis modulators|mesh-ancestor
25459132|NCT05281003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459133|NCT05281003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25459134|NCT05280873|Methylprednisolone|methylprednisolone|mesh-list
25459135|NCT05280873|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25459136|NCT05280873|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25459137|NCT05280873|Prednisolone|prednisolone|mesh-list
25459138|NCT05280873|Prednisolone acetate|prednisolone acetate|mesh-list
25459139|NCT05280873|Pirfenidone|pirfenidone|mesh-list
25459140|NCT05280873|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25459141|NCT05280873|Prednisolone phosphate|prednisolone phosphate|mesh-list
25459142|NCT05280873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25459143|NCT05280873|Antiemetics|antiemetics|mesh-ancestor
25459144|NCT05280873|Autonomic Agents|autonomic agents|mesh-ancestor
25459145|NCT05280873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25459146|NCT05280873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459147|NCT05280873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25459148|NCT05280873|Glucocorticoids|glucocorticoids|mesh-ancestor
25459149|NCT05280873|Hormones|hormones|mesh-ancestor
25459150|NCT05280873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25459151|NCT05280873|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25459152|NCT05280873|Protective Agents|protective agents|mesh-ancestor
25459153|NCT05280873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25459154|NCT05280873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459155|NCT05280873|Analgesics|analgesics|mesh-ancestor
25459156|NCT05280873|Sensory System Agents|sensory system agents|mesh-ancestor
25459157|NCT05280873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25459158|NCT05280873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25459159|NCT05280873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25459160|NCT05280626|Prednisolone|prednisolone|mesh-list
25459161|NCT05280626|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25459162|NCT05280626|Methylprednisolone|methylprednisolone|mesh-list
25644574|NCT01438060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24459080|NCT00343499|Valsartan|valsartan|mesh-list
25459163|NCT05280626|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25459164|NCT05280626|Prednisolone acetate|prednisolone acetate|mesh-list
25459165|NCT05280626|Cyclophosphamide|cyclophosphamide|mesh-list
25459166|NCT05280626|Rituximab|rituximab|mesh-list
25459167|NCT05280626|Doxorubicin|doxorubicin|mesh-list
25459168|NCT05280626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25459169|NCT05280626|Vincristine|vincristine|mesh-list
25459170|NCT05280626|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25459171|NCT05280626|Prednisolone phosphate|prednisolone phosphate|mesh-list
25459172|NCT05280626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25459173|NCT05280626|Immunologic Factors|immunologic factors|mesh-ancestor
25459174|NCT05280626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459175|NCT05280626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25459176|NCT05280626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25459177|NCT05280626|Alkylating Agents|alkylating agents|mesh-ancestor
25459178|NCT05280626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459179|NCT05280626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459180|NCT05280626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25459181|NCT05280626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25459182|NCT05280626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25459183|NCT05280626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25459184|NCT05280626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25459185|NCT05280626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459186|NCT05280626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25459187|NCT05280626|Glucocorticoids|glucocorticoids|mesh-ancestor
25459188|NCT05280626|Hormones|hormones|mesh-ancestor
25459189|NCT05280626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25459190|NCT05280626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25459191|NCT05280626|Antiemetics|antiemetics|mesh-ancestor
25459192|NCT05280626|Autonomic Agents|autonomic agents|mesh-ancestor
25459193|NCT05280626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25459194|NCT05280626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25459195|NCT05280626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25459196|NCT05280626|Protective Agents|protective agents|mesh-ancestor
25459197|NCT05280626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25459198|NCT05280626|Tubulin Modulators|tubulin modulators|mesh-ancestor
25459199|NCT05280626|Antimitotic Agents|antimitotic agents|mesh-ancestor
25459200|NCT05280626|Mitosis Modulators|mitosis modulators|mesh-ancestor
25459201|NCT05280444|Idarubicin|idarubicin|mesh-list
25459202|NCT05280444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25459203|NCT05280444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459204|NCT05280444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25459205|NCT05280444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25459206|NCT05280444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459207|NCT05280444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459208|NCT05280275|Dexamethasone|dexamethasone|mesh-list
25459209|NCT05280275|Lenalidomide|lenalidomide|mesh-list
25459210|NCT05280275|Daratumumab|daratumumab|mesh-list
25459211|NCT05280275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25459212|NCT05280275|Antiemetics|antiemetics|mesh-ancestor
25459213|NCT05280275|Autonomic Agents|autonomic agents|mesh-ancestor
25459214|NCT05280275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25459215|NCT05280275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459216|NCT05280275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25459217|NCT05280275|Glucocorticoids|glucocorticoids|mesh-ancestor
25459218|NCT05280275|Hormones|hormones|mesh-ancestor
25459219|NCT05280275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25459220|NCT05280275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25459221|NCT05280275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459222|NCT05280275|Immunologic Factors|immunologic factors|mesh-ancestor
25459223|NCT05280275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25459224|NCT05280275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25459225|NCT05280275|Growth Substances|growth substances|mesh-ancestor
25459226|NCT05280275|Growth Inhibitors|growth inhibitors|mesh-ancestor
25459227|NCT05280236|Propofol|propofol|mesh-list
25459228|NCT05280236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25459229|NCT05280236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25459230|NCT05280236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459231|NCT05280236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25318084|NCT04970251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318085|NCT04970069|Analgesics|analgesics|mesh-list
25318086|NCT04970069|Sensory System Agents|sensory system agents|mesh-ancestor
25318087|NCT04970069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25318088|NCT04970069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318089|NCT04970303|Methylphenidate|methylphenidate|mesh-list
25822872|NCT00004688|Antimetabolites|antimetabolites|mesh-ancestor
25318090|NCT04970303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25318091|NCT04970303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318092|NCT04970303|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25459232|NCT05280236|Anesthetics, General|anesthetics, general|mesh-ancestor
25459233|NCT05280236|Anesthetics|anesthetics|mesh-ancestor
25459235|NCT05280197|Anesthetics, Local|anesthetics, local|mesh-ancestor
25459236|NCT05280197|Anesthetics|anesthetics|mesh-ancestor
25459237|NCT05280197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25459238|NCT05280197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459239|NCT05280197|Sensory System Agents|sensory system agents|mesh-ancestor
25459240|NCT05280197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25459241|NCT05280132|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25459242|NCT05280132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25459243|NCT05280132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25459244|NCT05280132|Antitubercular Agents|antitubercular agents|mesh-ancestor
25459245|NCT05280054|Probenecid|probenecid|mesh-list
25459246|NCT05280054|Uricosuric Agents|uricosuric agents|mesh-ancestor
25459247|NCT05280054|Gout Suppressants|gout suppressants|mesh-ancestor
25459248|NCT05280054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25459249|NCT05280054|Renal Agents|renal agents|mesh-ancestor
25459250|NCT05280028|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25459251|NCT05280028|Tibolone|tibolone|mesh-list
25459252|NCT05280028|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25459253|NCT05280028|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25459254|NCT05280028|Medroxyprogesterone|medroxyprogesterone|mesh-list
25459255|NCT05280028|Estradiol|estradiol|mesh-list
25459256|NCT05280028|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25459257|NCT05280028|Estrogens|estrogens|mesh-ancestor
25459258|NCT05280028|Hormones|hormones|mesh-ancestor
25459259|NCT05280028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25459260|NCT05280028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459261|NCT05280028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25459262|NCT05280028|Contraceptive Agents|contraceptive agents|mesh-ancestor
25459263|NCT05280028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25459264|NCT05280028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25459265|NCT05280028|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25459266|NCT05280028|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25459267|NCT05280028|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25459268|NCT05280028|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25459269|NCT05280028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25459270|NCT05280028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459271|NCT05280028|Androgen Antagonists|androgen antagonists|mesh-ancestor
25459272|NCT05280028|Hormone Antagonists|hormone antagonists|mesh-ancestor
25459273|NCT05280028|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25459274|NCT05280028|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25459275|NCT05280028|Anabolic Agents|anabolic agents|mesh-ancestor
25459276|NCT05279872|Zanubrutinib|zanubrutinib|mesh-list
25459277|NCT05279872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459278|NCT05279872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25459279|NCT05279872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459280|NCT05279872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459281|NCT05279716|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25459282|NCT05279716|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25459283|NCT05279690|Colchicine|colchicine|mesh-list
25459284|NCT05279690|Gout Suppressants|gout suppressants|mesh-ancestor
25459285|NCT05279690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25459286|NCT05279690|Tubulin Modulators|tubulin modulators|mesh-ancestor
25459287|NCT05279690|Antimitotic Agents|antimitotic agents|mesh-ancestor
25459288|NCT05279690|Mitosis Modulators|mitosis modulators|mesh-ancestor
25459289|NCT05279690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459290|NCT05279690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459291|NCT05279586|Colistin|colistin|mesh-list
25459292|NCT05279586|Lactulose|lactulose|mesh-list
25459293|NCT05279586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25459294|NCT05279586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25459295|NCT05279586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25459296|NCT05279482|Methylprednisolone|methylprednisolone|mesh-list
25459297|NCT05279482|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25459298|NCT05279482|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25459299|NCT05279482|Prednisolone|prednisolone|mesh-list
25459300|NCT05279482|Prednisolone acetate|prednisolone acetate|mesh-list
25459301|NCT05279482|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25459302|NCT05279482|Prednisolone phosphate|prednisolone phosphate|mesh-list
25459303|NCT05279482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25459304|NCT05279482|Antiemetics|antiemetics|mesh-ancestor
25459305|NCT05279482|Autonomic Agents|autonomic agents|mesh-ancestor
25459306|NCT05279482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25459307|NCT05279482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459308|NCT05279482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25459310|NCT05279482|Hormones|hormones|mesh-ancestor
25459311|NCT05279482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25459312|NCT05279482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25459313|NCT05279482|Protective Agents|protective agents|mesh-ancestor
25459314|NCT05279482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25459315|NCT05279482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459316|NCT05279469|Fibrin fragment D|fibrin fragment d|mesh-list
25459317|NCT05279469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25459318|NCT05279469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25459319|NCT05279469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459320|NCT05279469|Hemostatics|hemostatics|mesh-ancestor
25459321|NCT05279469|Coagulants|coagulants|mesh-ancestor
25459322|NCT05279391|Dexamethasone|dexamethasone|mesh-list
25459323|NCT05279391|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25459324|NCT05279391|Heparin|heparin|mesh-list
25459325|NCT05279391|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25459326|NCT05279391|Tinzaparin|tinzaparin|mesh-list
25459327|NCT05279391|Dalteparin|dalteparin|mesh-list
25459328|NCT05279391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25459329|NCT05279391|Antiemetics|antiemetics|mesh-ancestor
25459330|NCT05279391|Autonomic Agents|autonomic agents|mesh-ancestor
25459331|NCT05279391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25459332|NCT05279391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459333|NCT05279391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25459334|NCT05279391|Glucocorticoids|glucocorticoids|mesh-ancestor
25459335|NCT05279391|Hormones|hormones|mesh-ancestor
25459336|NCT05279391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25459337|NCT05279391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25459338|NCT05279391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459339|NCT05279391|Anticoagulants|anticoagulants|mesh-ancestor
25459340|NCT05279391|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25459341|NCT05279391|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25459342|NCT05279391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459343|NCT05279391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25459344|NCT05279235|Favipiravir|favipiravir|mesh-list
25459345|NCT05279235|Antiviral Agents|antiviral agents|mesh-ancestor
25459346|NCT05279235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25459347|NCT05279040|Ivacaftor|ivacaftor|mesh-list
25459348|NCT05279040|Elexacaftor|elexacaftor|mesh-list
25459349|NCT05279040|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25459350|NCT05279040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25459351|NCT05279040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459352|NCT05278975|Thiostrepton|thiostrepton|mesh-list
25459353|NCT05278975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25459354|NCT05278975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25459355|NCT05267886|Dobutamine|dobutamine|mesh-list
25459356|NCT05267886|Milrinone|milrinone|mesh-list
25459357|NCT05267886|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25459358|NCT05267886|Sympathomimetics|sympathomimetics|mesh-ancestor
25459359|NCT05267886|Autonomic Agents|autonomic agents|mesh-ancestor
25459360|NCT05267886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25459361|NCT05267886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459362|NCT05267886|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25459363|NCT05267886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25459364|NCT05267886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25459365|NCT05267886|Adrenergic Agents|adrenergic agents|mesh-ancestor
25459366|NCT05267886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25459367|NCT05267886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459368|NCT05267886|Protective Agents|protective agents|mesh-ancestor
25459369|NCT05267886|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25459370|NCT05267886|Vasodilator Agents|vasodilator agents|mesh-ancestor
25459371|NCT05267886|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25459372|NCT05267886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25459373|NCT05267886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459374|NCT05262257|Metformin|metformin|mesh-list
25459375|NCT05262257|Dapagliflozin|dapagliflozin|mesh-list
25459376|NCT05262257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25459377|NCT05262257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459378|NCT05262257|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25459379|NCT05262257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459380|NCT05260671|Cetuximab|cetuximab|mesh-list
25459381|NCT05260671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25459382|NCT05260671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459384|NCT05254808|Nitrofurantoin|nitrofurantoin|mesh-list
25459385|NCT05254808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25459386|NCT05254808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25459405|NCT05249634|Androgens|androgens|mesh-ancestor
25459406|NCT05249634|Hormones|hormones|mesh-ancestor
25459407|NCT05249634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25459408|NCT05249634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459409|NCT05247970|Midazolam|midazolam|mesh-list
25459410|NCT05247970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25459411|NCT05247970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25459412|NCT05247970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25459413|NCT05247970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459414|NCT05247970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25459415|NCT05247970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25459416|NCT05247970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25459417|NCT05247970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25459418|NCT05247970|Anesthetics, General|anesthetics, general|mesh-ancestor
25459419|NCT05247970|Anesthetics|anesthetics|mesh-ancestor
25459420|NCT05247970|GABA Modulators|gaba modulators|mesh-ancestor
25459421|NCT05247970|GABA Agents|gaba agents|mesh-ancestor
25459422|NCT05247970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25459423|NCT05247970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459424|NCT05241288|Albuterol|albuterol|mesh-list
25459425|NCT05241288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25459426|NCT05241288|Autonomic Agents|autonomic agents|mesh-ancestor
25459427|NCT05241288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25459428|NCT05241288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459429|NCT05241288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25459430|NCT05241288|Respiratory System Agents|respiratory system agents|mesh-ancestor
25459431|NCT05241288|Tocolytic Agents|tocolytic agents|mesh-ancestor
25459432|NCT05241288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25459433|NCT05241288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25459434|NCT05241288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25459435|NCT05241288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25459436|NCT05241288|Adrenergic Agents|adrenergic agents|mesh-ancestor
25459437|NCT05241288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25459438|NCT05241288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459439|NCT05239637|Heparin|heparin|mesh-list
25459440|NCT05239637|Calcium heparin|calcium heparin|mesh-list
25459441|NCT05239637|Anticoagulants|anticoagulants|mesh-ancestor
25459442|NCT05239637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25459443|NCT05239637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25459444|NCT05239637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459445|NCT05232630|Fenfluramine|fenfluramine|mesh-list
25459446|NCT05232630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25459447|NCT05232630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25459448|NCT05232630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25459449|NCT05232630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459450|NCT05232630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25459451|NCT05232630|Serotonin Agents|serotonin agents|mesh-ancestor
25459452|NCT05232630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459453|NCT05232357|Sodium thiosulfate|sodium thiosulfate|mesh-list
25459454|NCT05232357|Methylene Blue|methylene blue|mesh-list
25459455|NCT05232357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459456|NCT05232357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459457|NCT05232357|Antidotes|antidotes|mesh-ancestor
25459458|NCT05232357|Protective Agents|protective agents|mesh-ancestor
25459459|NCT05232357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459460|NCT05232357|Antioxidants|antioxidants|mesh-ancestor
25459461|NCT05232357|Antitubercular Agents|antitubercular agents|mesh-ancestor
25318352|NCT04965532|Sevoflurane|sevoflurane|mesh-list
25318353|NCT04965532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25318354|NCT04965532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318355|NCT04965532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25318356|NCT04965532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25318357|NCT04965532|Anesthetics, General|anesthetics, general|mesh-ancestor
25318358|NCT04965532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25318359|NCT04965532|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25318360|NCT04965766|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
25318361|NCT04965766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25318362|NCT04965766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318368|NCT04965662|Tenofovir|tenofovir|mesh-list
25318369|NCT04965662|Emtricitabine|emtricitabine|mesh-list
25318370|NCT04965662|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25318371|NCT04965662|Maraviroc|maraviroc|mesh-list
25318372|NCT04965662|Antiviral Agents|antiviral agents|mesh-ancestor
25459462|NCT05232357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25459463|NCT05232357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25459464|NCT05232357|Chelating Agents|chelating agents|mesh-ancestor
25459465|NCT05232357|Sequestering Agents|sequestering agents|mesh-ancestor
25459466|NCT05229003|Irinotecan|irinotecan|mesh-list
25459467|NCT05229003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25459468|NCT05229003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25459469|NCT05229003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459470|NCT05229003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459471|NCT05229003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459472|NCT05215405|Venetoclax|venetoclax|mesh-list
25459473|NCT05215405|Navitoclax|navitoclax|mesh-list
25459474|NCT05215405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459475|NCT05213221|Lenvatinib|lenvatinib|mesh-list
25459476|NCT05213221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459477|NCT05213221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25459478|NCT05213221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459479|NCT05213221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459480|NCT05212857|Leuprolide|leuprolide|mesh-list
25459481|NCT05212857|Goserelin|goserelin|mesh-list
25459482|NCT05212857|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25459483|NCT05212857|Abiraterone Acetate|abiraterone acetate|mesh-list
25459484|NCT05212857|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25459485|NCT05212857|Fertility Agents|fertility agents|mesh-ancestor
25459486|NCT05212857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25459487|NCT05212857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459488|NCT05212857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25459489|NCT05212857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459490|NCT05212857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25459491|NCT05212857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459492|NCT05212857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459493|NCT05212857|Hormone Antagonists|hormone antagonists|mesh-ancestor
25459494|NCT05212857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25459495|NCT05212857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25459496|NCT05212857|Luteolytic Agents|luteolytic agents|mesh-ancestor
25459497|NCT05212857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25459498|NCT05212857|Contraceptive Agents|contraceptive agents|mesh-ancestor
25459499|NCT05212857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25459500|NCT05193968|Nitroprusside|nitroprusside|mesh-list
25459501|NCT05193968|Norepinephrine|norepinephrine|mesh-list
25459502|NCT05193968|Acetylcholine|acetylcholine|mesh-list
25459503|NCT05193968|Terbutaline|terbutaline|mesh-list
25459504|NCT05193968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25459505|NCT05193968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25459506|NCT05193968|Adrenergic Agents|adrenergic agents|mesh-ancestor
25459507|NCT05193968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25459508|NCT05193968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459509|NCT05193968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459510|NCT05193968|Sympathomimetics|sympathomimetics|mesh-ancestor
25459511|NCT05193968|Autonomic Agents|autonomic agents|mesh-ancestor
25459512|NCT05193968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25459513|NCT05193968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25459514|NCT05193968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25459515|NCT05193968|Vasodilator Agents|vasodilator agents|mesh-ancestor
25459516|NCT05193968|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25459517|NCT05193968|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25459518|NCT05193968|Cholinergic Agents|cholinergic agents|mesh-ancestor
25459519|NCT05193968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25459520|NCT05193968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25318423|NCT04964869|Autonomic Agents|autonomic agents|mesh-ancestor
25318424|NCT04964869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25318425|NCT04964869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25318426|NCT04964869|Respiratory System Agents|respiratory system agents|mesh-ancestor
25318427|NCT04964869|Mydriatics|mydriatics|mesh-ancestor
25318428|NCT04964869|Sympathomimetics|sympathomimetics|mesh-ancestor
25318429|NCT04964869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25318430|NCT04964583|Azithromycin|azithromycin|mesh-list
25318431|NCT04964583|Hydroxychloroquine|hydroxychloroquine|mesh-list
25318432|NCT04964583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25318433|NCT04964583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25318434|NCT04964583|Antimalarials|antimalarials|mesh-ancestor
25318435|NCT04964583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25318436|NCT04964583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25318437|NCT04964583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25644575|NCT01438060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318438|NCT04964583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318439|NCT04964583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25459521|NCT05193968|Respiratory System Agents|respiratory system agents|mesh-ancestor
25459523|NCT05193968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25459524|NCT05193968|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25459525|NCT05193968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25459526|NCT05193851|Ricolinostat|ricolinostat|mesh-list
25459527|NCT05193851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459528|NCT05193851|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25459529|NCT05193851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459530|NCT05193851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459531|NCT05190705|Dexamethasone|dexamethasone|mesh-list
25459532|NCT05190705|Dexamethasone acetate|dexamethasone acetate|mesh-list
25459533|NCT05190705|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
25459534|NCT05190705|BB 1101|bb 1101|mesh-list
25459535|NCT05190705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25459536|NCT05190705|Antiemetics|antiemetics|mesh-ancestor
25459537|NCT05190705|Autonomic Agents|autonomic agents|mesh-ancestor
25459538|NCT05190705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25459539|NCT05190705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459540|NCT05190705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25459541|NCT05190705|Glucocorticoids|glucocorticoids|mesh-ancestor
25459542|NCT05190705|Hormones|hormones|mesh-ancestor
25459543|NCT05190705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25459544|NCT05190705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25459545|NCT05190705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459546|NCT05190705|Protease Inhibitors|protease inhibitors|mesh-ancestor
25459547|NCT05190705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459548|NCT05190705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459549|NCT05190705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25459550|NCT05187715|Simvastatin|simvastatin|mesh-list
25459551|NCT05187715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25459552|NCT05187715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25459553|NCT05187715|Antimetabolites|antimetabolites|mesh-ancestor
25459554|NCT05187715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459555|NCT05187715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25459556|NCT05187715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25459557|NCT05187715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459558|NCT05177731|Cytarabine|cytarabine|mesh-list
25459559|NCT05177731|Decitabine|decitabine|mesh-list
25459560|NCT05177731|Venetoclax|venetoclax|mesh-list
25459561|NCT05177731|Idarubicin|idarubicin|mesh-list
25459562|NCT05177731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25459563|NCT05177731|Antimetabolites|antimetabolites|mesh-ancestor
25459564|NCT05177731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459565|NCT05177731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459566|NCT05177731|Antiviral Agents|antiviral agents|mesh-ancestor
25459567|NCT05177731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25459568|NCT05177731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25459569|NCT05177731|Immunologic Factors|immunologic factors|mesh-ancestor
25459570|NCT05177731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459571|NCT05177731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459572|NCT05177731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25459573|NCT05177731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25459574|NCT05177731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25459575|NCT05158309|Capsaicin|capsaicin|mesh-list
25459576|NCT05158309|Antipruritics|antipruritics|mesh-ancestor
25459577|NCT05158309|Dermatologic Agents|dermatologic agents|mesh-ancestor
25459578|NCT05158309|Sensory System Agents|sensory system agents|mesh-ancestor
25459579|NCT05158309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25459580|NCT05158309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459581|NCT05147376|Curcumin|curcumin|mesh-list
25459582|NCT05147376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25459583|NCT05147376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25459584|NCT05147376|Analgesics|analgesics|mesh-ancestor
25459585|NCT05147376|Sensory System Agents|sensory system agents|mesh-ancestor
25459586|NCT05147376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25459587|NCT05147376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459588|NCT05147376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25459589|NCT05147376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25459590|NCT05147376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459591|NCT05147376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459592|NCT05147376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459593|NCT05137587|Ketamine|ketamine|mesh-list
25459594|NCT05137587|Propofol|propofol|mesh-list
25459595|NCT05137587|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25459596|NCT05137587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25459597|NCT05137587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459598|NCT05137587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25459599|NCT05137587|Anesthetics, General|anesthetics, general|mesh-ancestor
25459600|NCT05137587|Anesthetics|anesthetics|mesh-ancestor
25459601|NCT05137587|Analgesics|analgesics|mesh-ancestor
25459602|NCT05137587|Sensory System Agents|sensory system agents|mesh-ancestor
25721980|NCT02495168|Budesonide|budesonide|mesh-list
25459603|NCT05137587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25459604|NCT05137587|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25459605|NCT05137587|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25459606|NCT05137587|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25459607|NCT05137587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25459608|NCT05137587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459609|NCT05137574|Ketamine|ketamine|mesh-list
25459610|NCT05137574|Propofol|propofol|mesh-list
25459611|NCT05137574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25459612|NCT05137574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25459613|NCT05137574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459614|NCT05137574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25459615|NCT05137574|Anesthetics, General|anesthetics, general|mesh-ancestor
25459616|NCT05137574|Anesthetics|anesthetics|mesh-ancestor
25459617|NCT05137574|Analgesics|analgesics|mesh-ancestor
25459618|NCT05137574|Sensory System Agents|sensory system agents|mesh-ancestor
25459619|NCT05137574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25459620|NCT05137574|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25459621|NCT05137574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25459622|NCT05137574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25459623|NCT05137574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25459624|NCT05137574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459625|NCT05132829|Azithromycin|azithromycin|mesh-list
25459626|NCT05132829|Cefazolin|cefazolin|mesh-list
25459627|NCT05132829|Indomethacin|indomethacin|mesh-list
25459628|NCT05132829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25459629|NCT05132829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25459630|NCT05132829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25459631|NCT05132829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25459632|NCT05132829|Analgesics|analgesics|mesh-ancestor
25459633|NCT05132829|Sensory System Agents|sensory system agents|mesh-ancestor
25459634|NCT05132829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25459635|NCT05132829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459636|NCT05132829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25459637|NCT05132829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25459638|NCT05132829|Gout Suppressants|gout suppressants|mesh-ancestor
25459639|NCT05132829|Tocolytic Agents|tocolytic agents|mesh-ancestor
25459640|NCT05132829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25459641|NCT05132829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25459642|NCT05132829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459643|NCT05132829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459644|NCT05125224|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25459645|NCT05125224|Calcium Channel Blockers|calcium channel blockers|mesh-list
25459646|NCT05125224|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
25459647|NCT05125224|Calcium|calcium|mesh-list
25459648|NCT05125224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25459649|NCT05125224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459650|NCT05125224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25459651|NCT05125224|Diuretics|diuretics|mesh-ancestor
25459652|NCT05125224|Natriuretic Agents|natriuretic agents|mesh-ancestor
25459653|NCT05125224|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25459654|NCT05125224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25459655|NCT05125224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459656|NCT05122819|Anesthetics|anesthetics|mesh-list
25459657|NCT05122819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25459658|NCT05122819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459659|NCT05116917|Nivolumab|nivolumab|mesh-list
25459660|NCT05116917|Ipilimumab|ipilimumab|mesh-list
25459661|NCT05116917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25459662|NCT05116917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459663|NCT05116917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25459664|NCT05116917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459665|NCT05114941|Immunoglobulins|immunoglobulins|mesh-list
25459666|NCT05114941|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25459667|NCT05114941|Antibodies|antibodies|mesh-list
25459668|NCT05114941|gamma-Globulins|gamma-globulins|mesh-list
25459669|NCT05114941|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25459701|NCT05075200|Tranexamic Acid|tranexamic acid|mesh-list
25459702|NCT05075200|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25459703|NCT05075200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25459704|NCT05075200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459705|NCT05075200|Hemostatics|hemostatics|mesh-ancestor
25459706|NCT05075200|Coagulants|coagulants|mesh-ancestor
25459707|NCT05068440|Zanubrutinib|zanubrutinib|mesh-list
25459708|NCT05068440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459709|NCT05068440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25459710|NCT05068440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459711|NCT05068440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459712|NCT05036317|Empagliflozin|empagliflozin|mesh-list
25459713|NCT05036317|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25459714|NCT05036317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459715|NCT05036317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25459716|NCT05036317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459717|NCT05034367|Mannitol|mannitol|mesh-list
25459718|NCT05034367|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25459719|NCT05034367|Diuretics|diuretics|mesh-ancestor
25459720|NCT05034367|Natriuretic Agents|natriuretic agents|mesh-ancestor
25459721|NCT05034367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459722|NCT05019638|Ketorolac|ketorolac|mesh-list
25459723|NCT05019638|Epinephrine|epinephrine|mesh-list
25459724|NCT05019638|Racepinephrine|racepinephrine|mesh-list
25459725|NCT05019638|Morphine|morphine|mesh-list
25459726|NCT05019638|Bupivacaine|bupivacaine|mesh-list
25459727|NCT05019638|Epinephryl borate|epinephryl borate|mesh-list
25459728|NCT05019638|Anesthetics, Local|anesthetics, local|mesh-ancestor
25459729|NCT05019638|Anesthetics|anesthetics|mesh-ancestor
25459730|NCT05019638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25459731|NCT05019638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459732|NCT05019638|Sensory System Agents|sensory system agents|mesh-ancestor
25459733|NCT05019638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25459734|NCT05019638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25459735|NCT05019638|Narcotics|narcotics|mesh-ancestor
25459736|NCT05019638|Analgesics|analgesics|mesh-ancestor
25459737|NCT05019638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25459738|NCT05019638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25459739|NCT05019638|Adrenergic Agents|adrenergic agents|mesh-ancestor
25459740|NCT05019638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25459741|NCT05019638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459742|NCT05019638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25459743|NCT05019638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25459744|NCT05019638|Autonomic Agents|autonomic agents|mesh-ancestor
25459745|NCT05019638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25459746|NCT05019638|Respiratory System Agents|respiratory system agents|mesh-ancestor
25459747|NCT05019638|Mydriatics|mydriatics|mesh-ancestor
25459748|NCT05019638|Sympathomimetics|sympathomimetics|mesh-ancestor
25459749|NCT05019638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25459750|NCT05019638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25459751|NCT05019638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25459752|NCT05019638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25459753|NCT05019638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25459754|NCT05019638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25459755|NCT05019638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459756|NCT05009927|Imatinib Mesylate|imatinib mesylate|mesh-list
25459757|NCT05009927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459758|NCT05009927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25459759|NCT05009927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459760|NCT05009927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459761|NCT05005559|Myeloma Proteins|myeloma proteins|mesh-list
25459762|NCT05005559|Paraproteins|paraproteins|mesh-list
25459763|NCT05005559|Immunologic Factors|immunologic factors|mesh-ancestor
25459764|NCT05005559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459765|NCT04997941|Tamoxifen|tamoxifen|mesh-list
25459766|NCT04997941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25459767|NCT04997941|Hormone Antagonists|hormone antagonists|mesh-ancestor
25459768|NCT04997941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25459769|NCT04997941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459770|NCT04997941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25459771|NCT04997941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459772|NCT04997941|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25318706|NCT04961138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318707|NCT04960943|Trastuzumab|trastuzumab|mesh-list
25822873|NCT00004688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459773|NCT04997941|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25459774|NCT04997941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25459775|NCT04994444|Nicotine|nicotine|mesh-list
25459776|NCT04994444|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25459777|NCT04994444|Autonomic Agents|autonomic agents|mesh-ancestor
25459778|NCT04994444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25459779|NCT04994444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459780|NCT04994444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25459781|NCT04994444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25459782|NCT04994444|Cholinergic Agents|cholinergic agents|mesh-ancestor
25459783|NCT04994444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25459784|NCT04994444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459785|NCT04979338|Bupivacaine|bupivacaine|mesh-list
25459786|NCT04979338|Anesthetics, Local|anesthetics, local|mesh-list
25459787|NCT04979338|Anesthetics|anesthetics|mesh-list
25459788|NCT04979338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25459789|NCT04979338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459790|NCT04979338|Sensory System Agents|sensory system agents|mesh-ancestor
25459791|NCT04979338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25459792|NCT04979052|Interferons|interferons|mesh-list
25459793|NCT04979052|Interferon-gamma|interferon-gamma|mesh-list
25459794|NCT04979052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459795|NCT04979052|Antiviral Agents|antiviral agents|mesh-ancestor
25459796|NCT04979052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25459797|NCT04973124|Dexmedetomidine|dexmedetomidine|mesh-list
25459798|NCT04973124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25459799|NCT04973124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25459800|NCT04973124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459801|NCT04973124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25459802|NCT04973124|Analgesics|analgesics|mesh-ancestor
25459803|NCT04973124|Sensory System Agents|sensory system agents|mesh-ancestor
25459804|NCT04973124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25459805|NCT04973124|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25459806|NCT04973124|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25459807|NCT04973124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25459808|NCT04973124|Adrenergic Agents|adrenergic agents|mesh-ancestor
25459809|NCT04973124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25459810|NCT04973124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459811|NCT04971005|Alemtuzumab|alemtuzumab|mesh-list
25459812|NCT04971005|Ocrelizumab|ocrelizumab|mesh-list
25459813|NCT04971005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25459814|NCT04971005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459815|NCT04971005|Immunologic Factors|immunologic factors|mesh-ancestor
25459816|NCT04971005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459817|NCT04951947|Lenvatinib|lenvatinib|mesh-list
25459818|NCT04951947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459819|NCT04951947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25459820|NCT04951947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459821|NCT04951947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459822|NCT04912505|Aspirin|aspirin|mesh-list
25459823|NCT04912505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25459824|NCT04912505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25459825|NCT04912505|Analgesics|analgesics|mesh-ancestor
25459826|NCT04912505|Sensory System Agents|sensory system agents|mesh-ancestor
25459827|NCT04912505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25459828|NCT04912505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459829|NCT04912505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25459830|NCT04912505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25459831|NCT04912505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25459832|NCT04912505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25459833|NCT04912505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459834|NCT04912505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25459835|NCT04912505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25459836|NCT04912505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459837|NCT04912505|Antipyretics|antipyretics|mesh-ancestor
25459838|NCT04912492|Ethanol|ethanol|mesh-list
25318765|NCT04959253|Psilocybin|psilocybin|mesh-list
25318766|NCT04959253|Hallucinogens|hallucinogens|mesh-ancestor
25318767|NCT04959253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318768|NCT04959253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25318769|NCT04959500|Temozolomide|temozolomide|mesh-list
25318770|NCT04959500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25318771|NCT04959500|Alkylating Agents|alkylating agents|mesh-ancestor
25644576|NCT01438060|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25318772|NCT04959500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318774|NCT04959409|Tetracaine|tetracaine|mesh-list
25459839|NCT04912492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25459840|NCT04912492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25459841|NCT04912492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25459842|NCT04912492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459844|NCT04910711|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25459845|NCT04910711|Levonorgestrel|levonorgestrel|mesh-list
25459846|NCT04910711|Medroxyprogesterone|medroxyprogesterone|mesh-list
25459847|NCT04910711|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25459848|NCT04910711|Contraceptive Agents|contraceptive agents|mesh-ancestor
25459849|NCT04910711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25459850|NCT04910711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459851|NCT04910711|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25459852|NCT04910711|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25459853|NCT04910711|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25459854|NCT04910711|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25459855|NCT04910711|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25459856|NCT04910711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459857|NCT04910711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459858|NCT04910711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25459859|NCT04910711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25459860|NCT04910711|Antiviral Agents|antiviral agents|mesh-ancestor
25459861|NCT04910711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25459862|NCT04910711|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25459863|NCT04910711|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25459864|NCT04910711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25459865|NCT04910711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459866|NCT04905810|Azacitidine|azacitidine|mesh-list
25459867|NCT04905810|Decitabine|decitabine|mesh-list
25459868|NCT04905810|Venetoclax|venetoclax|mesh-list
25459869|NCT04905810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25459870|NCT04905810|Antimetabolites|antimetabolites|mesh-ancestor
25459871|NCT04905810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459872|NCT04905810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459873|NCT04905810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459874|NCT04880980|Itraconazole|itraconazole|mesh-list
25459875|NCT04880980|Terbinafine|terbinafine|mesh-list
25459876|NCT04880980|Antifungal Agents|antifungal agents|mesh-ancestor
25459877|NCT04880980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25459878|NCT04880980|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25459879|NCT04880980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25459880|NCT04880980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459881|NCT04880980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459882|NCT04880980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25459883|NCT04880980|Hormone Antagonists|hormone antagonists|mesh-ancestor
25459884|NCT04880980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25459885|NCT04880980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459886|NCT04880980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25459887|NCT04872257|Vitamin D|vitamin d|mesh-list
25459888|NCT04872257|Vitamins|vitamins|mesh-ancestor
25459889|NCT04872257|Micronutrients|micronutrients|mesh-ancestor
25459890|NCT04872257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459891|NCT04872257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25459892|NCT04867928|Azacitidine|azacitidine|mesh-list
25459893|NCT04867928|Venetoclax|venetoclax|mesh-list
25459894|NCT04867928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25459895|NCT04867928|Antimetabolites|antimetabolites|mesh-ancestor
25459896|NCT04867928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459897|NCT04867928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459898|NCT04867928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459899|NCT04846348|Diphenhydramine|diphenhydramine|mesh-list
25459900|NCT04846348|Promethazine|promethazine|mesh-list
25459901|NCT04846348|Salicylates|salicylates|mesh-list
25459902|NCT04846348|Cromolyn Sodium|cromolyn sodium|mesh-list
25459903|NCT04846348|Emollients|emollients|mesh-list
25318827|NCT04957212|Trastuzumab|trastuzumab|mesh-list
25318828|NCT04957212|Pertuzumab|pertuzumab|mesh-list
25318829|NCT04957212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318830|NCT04957212|Tubulin Modulators|tubulin modulators|mesh-ancestor
25318831|NCT04957212|Antimitotic Agents|antimitotic agents|mesh-ancestor
25318832|NCT04957212|Mitosis Modulators|mitosis modulators|mesh-ancestor
25318833|NCT04957212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318834|NCT04957212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25318852|NCT04956419|Fluconazole|fluconazole|mesh-list
25459935|NCT04840472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25459936|NCT04840472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318911|NCT04954560|Eprosartan|eprosartan|mesh-list
25318912|NCT04954560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25318913|NCT04954560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25318914|NCT04954560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25318915|NCT04954560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25318916|NCT04954560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318917|NCT04954560|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
25459938|NCT04823091|Fludarabine|fludarabine|mesh-list
25459939|NCT04823091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25459940|NCT04823091|Immunologic Factors|immunologic factors|mesh-ancestor
25459941|NCT04823091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459942|NCT04823091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25459943|NCT04823091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25459944|NCT04823091|Alkylating Agents|alkylating agents|mesh-ancestor
25459945|NCT04823091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459946|NCT04823091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459947|NCT04823091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25459948|NCT04815902|Losartan|losartan|mesh-list
25459949|NCT04815902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25459950|NCT04815902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25459951|NCT04815902|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25459952|NCT04815902|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25459953|NCT04815902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459954|NCT04814602|Proglumide|proglumide|mesh-list
25459955|NCT04814602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25459956|NCT04814602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25459957|NCT04798755|Adalimumab|adalimumab|mesh-list
25459958|NCT04798755|Methotrexate|methotrexate|mesh-list
25459959|NCT04798755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25459960|NCT04798755|Abortifacient Agents|abortifacient agents|mesh-ancestor
25459961|NCT04798755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25459962|NCT04798755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459963|NCT04798755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25459964|NCT04798755|Antimetabolites|antimetabolites|mesh-ancestor
25459965|NCT04798755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459966|NCT04798755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25459967|NCT04798755|Dermatologic Agents|dermatologic agents|mesh-ancestor
25459968|NCT04798755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25459969|NCT04798755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25459970|NCT04798755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25459971|NCT04798755|Immunologic Factors|immunologic factors|mesh-ancestor
25459972|NCT04798755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25459973|NCT04798755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25459974|NCT04798755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25459975|NCT04792801|Choline|choline|mesh-list
25459976|NCT04792801|Lipotropic Agents|lipotropic agents|mesh-ancestor
25459977|NCT04792801|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25459978|NCT04792801|Antimetabolites|antimetabolites|mesh-ancestor
25459979|NCT04792801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25459980|NCT04792801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25459981|NCT04792801|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25459982|NCT04792801|Nootropic Agents|nootropic agents|mesh-ancestor
25459983|NCT04788108|Dydrogesterone|dydrogesterone|mesh-list
25459984|NCT04788108|Progestins|progestins|mesh-ancestor
25459985|NCT04788108|Hormones|hormones|mesh-ancestor
25459986|NCT04788108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25459987|NCT04788108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459988|NCT04774120|Propofol|propofol|mesh-list
25459989|NCT04774120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25459990|NCT04774120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25459991|NCT04774120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459992|NCT04774120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25459993|NCT04774120|Anesthetics, General|anesthetics, general|mesh-ancestor
25459994|NCT04774120|Anesthetics|anesthetics|mesh-ancestor
25459995|NCT04773002|Anesthetics|anesthetics|mesh-list
25459996|NCT04773002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25459997|NCT04773002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25459999|NCT04762472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25460000|NCT04762472|Respiratory System Agents|respiratory system agents|mesh-ancestor
25460001|NCT04762472|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25460002|NCT04762472|Hormone Antagonists|hormone antagonists|mesh-ancestor
25318968|NCT04954040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25318969|NCT04953117|Paclitaxel|paclitaxel|mesh-list
25318970|NCT04953117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25318971|NCT04953117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318972|NCT04953117|Tubulin Modulators|tubulin modulators|mesh-ancestor
25318973|NCT04953117|Antimitotic Agents|antimitotic agents|mesh-ancestor
25318974|NCT04953117|Mitosis Modulators|mitosis modulators|mesh-ancestor
25318975|NCT04953117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460003|NCT04762472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25460004|NCT04762472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460005|NCT04762472|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25460006|NCT04762472|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25460007|NCT04762472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460009|NCT04753879|Paclitaxel|paclitaxel|mesh-list
25460010|NCT04753879|Cisplatin|cisplatin|mesh-list
25460011|NCT04753879|Pembrolizumab|pembrolizumab|mesh-list
25460012|NCT04753879|Capecitabine|capecitabine|mesh-list
25460013|NCT04753879|Irinotecan|irinotecan|mesh-list
25460014|NCT04753879|Olaparib|olaparib|mesh-list
25460015|NCT04753879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25460016|NCT04753879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460017|NCT04753879|Tubulin Modulators|tubulin modulators|mesh-ancestor
25460018|NCT04753879|Antimitotic Agents|antimitotic agents|mesh-ancestor
25460019|NCT04753879|Mitosis Modulators|mitosis modulators|mesh-ancestor
25460020|NCT04753879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460021|NCT04753879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25460022|NCT04753879|Antimetabolites|antimetabolites|mesh-ancestor
25460023|NCT04753879|Antiviral Agents|antiviral agents|mesh-ancestor
25460024|NCT04753879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25460025|NCT04753879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25460026|NCT04753879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25460027|NCT04753879|Immunologic Factors|immunologic factors|mesh-ancestor
25460028|NCT04753879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460029|NCT04753879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25460030|NCT04753879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25460031|NCT04753879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25460032|NCT04753879|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25460033|NCT04752540|Olorofim|olorofim|mesh-list
25460034|NCT04752540|Antifungal Agents|antifungal agents|mesh-ancestor
25460035|NCT04752540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25460036|NCT04749459|Sunscreening Agents|sunscreening agents|mesh-list
25460037|NCT04749459|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25460038|NCT04749459|Protective Agents|protective agents|mesh-ancestor
25460039|NCT04749459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460040|NCT04749459|Dermatologic Agents|dermatologic agents|mesh-ancestor
25460041|NCT04746924|Pembrolizumab|pembrolizumab|mesh-list
25460042|NCT04746924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25460043|NCT04746924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460044|NCT04734652|Tenofovir|tenofovir|mesh-list
25460045|NCT04734652|Lamivudine|lamivudine|mesh-list
25460046|NCT04734652|Dolutegravir|dolutegravir|mesh-list
25460047|NCT04734652|Antiviral Agents|antiviral agents|mesh-ancestor
25460048|NCT04734652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25460049|NCT04734652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25460050|NCT04734652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25460051|NCT04734652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25460052|NCT04734652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460053|NCT04734652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25460054|NCT04734652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25460055|NCT04734652|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25460056|NCT04734652|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25460057|NCT04732260|Letermovir|letermovir|mesh-list
25460058|NCT04732260|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25460059|NCT04732260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25460060|NCT04732260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460061|NCT04732260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460062|NCT04732260|Antiviral Agents|antiviral agents|mesh-ancestor
25460063|NCT04732260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25460064|NCT04716725|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25460065|NCT04716725|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25460066|NCT04716725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460067|NCT04708340|Ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium D-pantothenate drug combination|ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium d-pantothenate drug combination|mesh-list
25460068|NCT04708340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25460069|NCT04708340|Antioxidants|antioxidants|mesh-ancestor
25460070|NCT04708340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460071|NCT04708340|Protective Agents|protective agents|mesh-ancestor
25460072|NCT04708340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460073|NCT04701281|Capecitabine|capecitabine|mesh-list
25460074|NCT04701281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25460076|NCT04701281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460077|NCT04701281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460078|NCT04690231|Etoposide|etoposide|mesh-list
25460079|NCT04690231|Etoposide phosphate|etoposide phosphate|mesh-list
25460080|NCT04690231|Apatinib|apatinib|mesh-list
25460081|NCT04690231|Ifosfamide|ifosfamide|mesh-list
25460082|NCT04690231|Isophosphamide mustard|isophosphamide mustard|mesh-list
25460083|NCT04690231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25460084|NCT04690231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460085|NCT04690231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25460086|NCT04690231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25460087|NCT04690231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25460088|NCT04690231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460089|NCT04690231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25460090|NCT04690231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25460091|NCT04690231|Alkylating Agents|alkylating agents|mesh-ancestor
25460092|NCT04677439|HH-GV-678|hh-gv-678|mesh-list
25460093|NCT04677439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25460094|NCT04677439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25460095|NCT04677439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460096|NCT04675827|Trastuzumab|trastuzumab|mesh-list
25460097|NCT04675827|Pertuzumab|pertuzumab|mesh-list
25722024|NCT02495779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25460098|NCT04675827|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25460099|NCT04675827|Maytansine|maytansine|mesh-list
25460100|NCT04675827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25460101|NCT04675827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460102|NCT04675827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25460103|NCT04675827|Tubulin Modulators|tubulin modulators|mesh-ancestor
25460104|NCT04675827|Antimitotic Agents|antimitotic agents|mesh-ancestor
25460105|NCT04675827|Mitosis Modulators|mitosis modulators|mesh-ancestor
25460106|NCT04675827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460107|NCT04669678|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25460108|NCT04669678|Medroxyprogesterone|medroxyprogesterone|mesh-list
25460109|NCT04669678|Etonogestrel|etonogestrel|mesh-list
25460110|NCT04669678|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25460111|NCT04669678|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25460112|NCT04669678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25460113|NCT04669678|Contraceptive Agents|contraceptive agents|mesh-ancestor
25460114|NCT04669678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25460115|NCT04669678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460116|NCT04669678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25460117|NCT04669678|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25460118|NCT04669678|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25460119|NCT04669678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25460120|NCT04669678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460121|NCT04651439|Lenograstim|lenograstim|mesh-list
25460122|NCT04651439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25460123|NCT04651439|Immunologic Factors|immunologic factors|mesh-ancestor
25460124|NCT04651439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460125|NCT04642430|Rivaroxaban|rivaroxaban|mesh-list
25460126|NCT04642430|Apixaban|apixaban|mesh-list
25460127|NCT04642430|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25460128|NCT04642430|Antithrombins|antithrombins|mesh-ancestor
25460129|NCT04642430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25460130|NCT04642430|Protease Inhibitors|protease inhibitors|mesh-ancestor
25460131|NCT04642430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25460132|NCT04642430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460133|NCT04642430|Anticoagulants|anticoagulants|mesh-ancestor
25460134|NCT04633564|Bevacizumab|bevacizumab|mesh-list
25460135|NCT04633564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25460136|NCT04633564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460137|NCT04633564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25319118|NCT04951726|Autonomic Agents|autonomic agents|mesh-ancestor
25319119|NCT04951726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25319120|NCT04951349|Petrolatum|petrolatum|mesh-list
25319121|NCT04951349|Emollients|emollients|mesh-ancestor
25319122|NCT04951349|Dermatologic Agents|dermatologic agents|mesh-ancestor
25319123|NCT04951167|Norepinephrine|norepinephrine|mesh-list
25319124|NCT04951167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25319125|NCT04951167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25319126|NCT04951167|Adrenergic Agents|adrenergic agents|mesh-ancestor
25319127|NCT04951167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25319134|NCT04950933|Riluzole|riluzole|mesh-list
25460143|NCT04602845|Fentanyl|fentanyl|mesh-list
25460144|NCT04602845|Midazolam|midazolam|mesh-list
25460145|NCT04602845|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25460146|NCT04602845|Narcotics|narcotics|mesh-ancestor
25460147|NCT04602845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25460148|NCT04602845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460149|NCT04602845|Analgesics|analgesics|mesh-ancestor
25460150|NCT04602845|Sensory System Agents|sensory system agents|mesh-ancestor
25460151|NCT04602845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25460152|NCT04602845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25460153|NCT04602845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25460154|NCT04602845|Anesthetics, General|anesthetics, general|mesh-ancestor
25460155|NCT04602845|Anesthetics|anesthetics|mesh-ancestor
25460156|NCT04602845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25460157|NCT04602845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25460158|NCT04602845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25460159|NCT04602845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25460160|NCT04602845|GABA Modulators|gaba modulators|mesh-ancestor
25460161|NCT04602845|GABA Agents|gaba agents|mesh-ancestor
25460162|NCT04602845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25460163|NCT04602845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460164|NCT04602845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25460165|NCT04602845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25460166|NCT04602845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25460167|NCT04602845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25460168|NCT04602845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25460169|NCT04602845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25460170|NCT04597476|Fucoidan|fucoidan|mesh-list
25460171|NCT04597476|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25460172|NCT04597476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25460173|NCT04597476|Anticoagulants|anticoagulants|mesh-ancestor
25460174|NCT04597476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460175|NCT04597320|Fentanyl|fentanyl|mesh-list
25460176|NCT04597320|Midazolam|midazolam|mesh-list
25460177|NCT04597320|Esketamine|esketamine|mesh-list
25460178|NCT04597320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25460179|NCT04597320|Narcotics|narcotics|mesh-ancestor
25460180|NCT04597320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25460181|NCT04597320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460182|NCT04597320|Analgesics|analgesics|mesh-ancestor
25460183|NCT04597320|Sensory System Agents|sensory system agents|mesh-ancestor
25460184|NCT04597320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25460185|NCT04597320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25460186|NCT04597320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25460187|NCT04597320|Anesthetics, General|anesthetics, general|mesh-ancestor
25460188|NCT04597320|Anesthetics|anesthetics|mesh-ancestor
25460189|NCT04597320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25460190|NCT04597320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25460191|NCT04597320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25460192|NCT04597320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25460193|NCT04597320|GABA Modulators|gaba modulators|mesh-ancestor
25460194|NCT04597320|GABA Agents|gaba agents|mesh-ancestor
25460195|NCT04597320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25460196|NCT04597320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460197|NCT04597320|Antidepressive Agents|antidepressive agents|mesh-ancestor
25460198|NCT04596189|Mometasone Furoate|mometasone furoate|mesh-list
25460199|NCT04596189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25460200|NCT04596189|Dermatologic Agents|dermatologic agents|mesh-ancestor
25460201|NCT04596189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25460202|NCT04568200|Paclitaxel|paclitaxel|mesh-list
25460203|NCT04568200|Carboplatin|carboplatin|mesh-list
25460204|NCT04568200|Durvalumab|durvalumab|mesh-list
25460205|NCT04568200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25460206|NCT04568200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319268|NCT04948957|Esmolol|esmolol|mesh-list
25319269|NCT04948957|Vasodilator Agents|vasodilator agents|mesh-ancestor
25319270|NCT04948957|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25319271|NCT04948957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25319272|NCT04948957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25319273|NCT04948957|Adrenergic Agents|adrenergic agents|mesh-ancestor
25319274|NCT04948957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25319275|NCT04948957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319276|NCT04948957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319277|NCT04948801|Sofosbuvir|sofosbuvir|mesh-list
25460207|NCT04568200|Tubulin Modulators|tubulin modulators|mesh-ancestor
25460208|NCT04568200|Antimitotic Agents|antimitotic agents|mesh-ancestor
25460209|NCT04568200|Mitosis Modulators|mitosis modulators|mesh-ancestor
25460210|NCT04568200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460211|NCT04568200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25460212|NCT04559529|Levetiracetam|levetiracetam|mesh-list
25460213|NCT04559529|Anticonvulsants|anticonvulsants|mesh-ancestor
25460214|NCT04559529|Nootropic Agents|nootropic agents|mesh-ancestor
25460215|NCT04532346|Hydroxychloroquine|hydroxychloroquine|mesh-list
25460216|NCT04532346|Antimalarials|antimalarials|mesh-ancestor
25460217|NCT04532346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25460218|NCT04532346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25460219|NCT04532346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25460220|NCT04532346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25460221|NCT04532346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460222|NCT04532346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25460223|NCT04530747|Metformin|metformin|mesh-list
25460224|NCT04530747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25460225|NCT04530747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460226|NCT04524702|Gemcitabine|gemcitabine|mesh-list
25460227|NCT04524702|Hydroxychloroquine|hydroxychloroquine|mesh-list
25460228|NCT04524702|Paclitaxel|paclitaxel|mesh-list
25460229|NCT04524702|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25460230|NCT04524702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25460231|NCT04524702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460232|NCT04524702|Tubulin Modulators|tubulin modulators|mesh-ancestor
25460233|NCT04524702|Antimitotic Agents|antimitotic agents|mesh-ancestor
25460234|NCT04524702|Mitosis Modulators|mitosis modulators|mesh-ancestor
25460235|NCT04524702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460236|NCT04524702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25460237|NCT04524702|Antimetabolites|antimetabolites|mesh-ancestor
25460238|NCT04524702|Antiviral Agents|antiviral agents|mesh-ancestor
25460239|NCT04524702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25460240|NCT04524702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25460241|NCT04524702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25460242|NCT04524702|Immunologic Factors|immunologic factors|mesh-ancestor
25460243|NCT04524702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460244|NCT04524702|Antimalarials|antimalarials|mesh-ancestor
25460245|NCT04524702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25460246|NCT04524702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25460247|NCT04524702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25460248|NCT04509414|Midazolam|midazolam|mesh-list
25460249|NCT04509414|Dexmedetomidine|dexmedetomidine|mesh-list
25460250|NCT04509414|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25460251|NCT04509414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25460252|NCT04509414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460253|NCT04509414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25460254|NCT04509414|Analgesics|analgesics|mesh-ancestor
25460255|NCT04509414|Sensory System Agents|sensory system agents|mesh-ancestor
25460256|NCT04509414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25460257|NCT04509414|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25460258|NCT04509414|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25460259|NCT04509414|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25460260|NCT04509414|Adrenergic Agents|adrenergic agents|mesh-ancestor
25460261|NCT04509414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25460262|NCT04509414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460263|NCT04509414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25460264|NCT04509414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25460265|NCT04509414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25460266|NCT04509414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25460267|NCT04509414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25460268|NCT04509414|Anesthetics, General|anesthetics, general|mesh-ancestor
25460269|NCT04509414|Anesthetics|anesthetics|mesh-ancestor
25460270|NCT04509414|GABA Modulators|gaba modulators|mesh-ancestor
25460271|NCT04509414|GABA Agents|gaba agents|mesh-ancestor
25460272|NCT04505059|Anesthetics|anesthetics|mesh-list
25460273|NCT04505059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25460274|NCT04505059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460275|NCT04500574|Latanoprost|latanoprost|mesh-list
25460276|NCT04500574|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25460277|NCT04500574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25460278|NCT04493151|Imipenem|imipenem|mesh-list
25460279|NCT04493151|Relebactam|relebactam|mesh-list
25460280|NCT04493151|Cilastatin|cilastatin|mesh-list
25460281|NCT04493151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25460282|NCT04493151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25460283|NCT04493151|Protease Inhibitors|protease inhibitors|mesh-ancestor
25460284|NCT04493151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25460285|NCT04493151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460286|NCT04493151|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25460287|NCT04485325|Etanercept|etanercept|mesh-list
25460288|NCT04485325|Tofacitinib|tofacitinib|mesh-list
25460289|NCT04485325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25460290|NCT04485325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25460291|NCT04485325|Analgesics|analgesics|mesh-ancestor
25460292|NCT04485325|Sensory System Agents|sensory system agents|mesh-ancestor
25722050|NCT02495883|Adrenergic Agents|adrenergic agents|mesh-ancestor
25460293|NCT04485325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25460294|NCT04485325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460295|NCT04485325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25460296|NCT04485325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25460297|NCT04485325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25460298|NCT04485325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25460299|NCT04485325|Immunologic Factors|immunologic factors|mesh-ancestor
25460300|NCT04485325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25460301|NCT04485325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25460302|NCT04485325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460303|NCT04484428|Menthol|menthol|mesh-list
25460304|NCT04484428|Antipruritics|antipruritics|mesh-ancestor
25460305|NCT04484428|Dermatologic Agents|dermatologic agents|mesh-ancestor
25460306|NCT04476420|Betamethasone|betamethasone|mesh-list
25460307|NCT04476420|Betamethasone Valerate|betamethasone valerate|mesh-list
25460308|NCT04476420|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25460309|NCT04476420|Betamethasone benzoate|betamethasone benzoate|mesh-list
25460310|NCT04476420|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25460311|NCT04476420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25460312|NCT04476420|Glucocorticoids|glucocorticoids|mesh-ancestor
25460313|NCT04476420|Hormones|hormones|mesh-ancestor
25460314|NCT04476420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25460315|NCT04476420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460316|NCT04476420|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25460317|NCT04476420|Respiratory System Agents|respiratory system agents|mesh-ancestor
25460318|NCT04476030|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25460319|NCT04476030|Citalopram|citalopram|mesh-list
25460320|NCT04476030|Sertraline|sertraline|mesh-list
25460321|NCT04476030|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25460322|NCT04476030|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25460323|NCT04476030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25460324|NCT04476030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25460325|NCT04476030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460326|NCT04476030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25460327|NCT04476030|Serotonin Agents|serotonin agents|mesh-ancestor
25460328|NCT04476030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460329|NCT04476030|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25460330|NCT04476030|Antidepressive Agents|antidepressive agents|mesh-ancestor
25460331|NCT04476030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25460332|NCT04476030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25460333|NCT04476030|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25460334|NCT04476030|Analgesics|analgesics|mesh-ancestor
25460335|NCT04476030|Sensory System Agents|sensory system agents|mesh-ancestor
25460336|NCT04476030|Dopamine Agents|dopamine agents|mesh-ancestor
25319416|NCT04947267|Anesthetics|anesthetics|mesh-ancestor
25319417|NCT04947267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25319418|NCT04947267|Sensory System Agents|sensory system agents|mesh-ancestor
25319419|NCT04947111|Antibodies|antibodies|mesh-list
25319420|NCT04947111|Immunoglobulins|immunoglobulins|mesh-list
25319421|NCT04947111|Antibodies, Blocking|antibodies, blocking|mesh-list
25319422|NCT04947111|Immunologic Factors|immunologic factors|mesh-ancestor
25319423|NCT04947111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319424|NCT04946929|Heparin|heparin|mesh-list
25319425|NCT04946929|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25319426|NCT04946929|Tinzaparin|tinzaparin|mesh-list
25319427|NCT04946929|Dalteparin|dalteparin|mesh-list
25319428|NCT04946929|Ticagrelor|ticagrelor|mesh-list
25319429|NCT04946929|Anticoagulants|anticoagulants|mesh-ancestor
25319430|NCT04946929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25319431|NCT04946929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25319432|NCT04946929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319433|NCT04946929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25319434|NCT04946929|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25319435|NCT04946929|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25319436|NCT04946929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25319437|NCT04946929|Purinergic Agents|purinergic agents|mesh-ancestor
25319438|NCT04946929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25319439|NCT04946929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319440|NCT04947345|Propofol|propofol|mesh-list
25460337|NCT04475705|Propofol|propofol|mesh-list
25460338|NCT04475705|Sevoflurane|sevoflurane|mesh-list
25460339|NCT04475705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25460340|NCT04475705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25460341|NCT04475705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460342|NCT04475705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25460343|NCT04475705|Anesthetics, General|anesthetics, general|mesh-ancestor
25460344|NCT04475705|Anesthetics|anesthetics|mesh-ancestor
25460345|NCT04475705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25460346|NCT04475705|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25460347|NCT04473508|Ropivacaine|ropivacaine|mesh-list
25460348|NCT04473508|Anesthetics, Local|anesthetics, local|mesh-ancestor
25460349|NCT04473508|Anesthetics|anesthetics|mesh-ancestor
25460350|NCT04473508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25460351|NCT04473508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460352|NCT04473508|Sensory System Agents|sensory system agents|mesh-ancestor
25460353|NCT04473508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25460354|NCT04471402|Dexmedetomidine|dexmedetomidine|mesh-list
25460355|NCT04471402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25460356|NCT04471402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25460357|NCT04471402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460358|NCT04471402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25460359|NCT04471402|Analgesics|analgesics|mesh-ancestor
25460360|NCT04471402|Sensory System Agents|sensory system agents|mesh-ancestor
25460361|NCT04471402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25460362|NCT04471402|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25460363|NCT04471402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25460364|NCT04471402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25460365|NCT04471402|Adrenergic Agents|adrenergic agents|mesh-ancestor
25460366|NCT04471402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25460367|NCT04471402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460368|NCT04468061|Pembrolizumab|pembrolizumab|mesh-list
25460369|NCT04468061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25460370|NCT04468061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460371|NCT04459234|Ketamine|ketamine|mesh-list
25460372|NCT04459234|Analgesics|analgesics|mesh-ancestor
25460373|NCT04459234|Sensory System Agents|sensory system agents|mesh-ancestor
25460374|NCT04459234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25460375|NCT04459234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460376|NCT04459234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25460377|NCT04459234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25460378|NCT04459234|Anesthetics, General|anesthetics, general|mesh-ancestor
25460379|NCT04459234|Anesthetics|anesthetics|mesh-ancestor
25460380|NCT04459234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25460381|NCT04459234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25460382|NCT04459234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25460383|NCT04459234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25460384|NCT04459234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460385|NCT04441034|Anticonvulsants|anticonvulsants|mesh-list
25460386|NCT04441034|Convulsants|convulsants|mesh-list
25460387|NCT04441034|Antidepressive Agents|antidepressive agents|mesh-list
25460388|NCT04441034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25460389|NCT04441034|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25460390|NCT04441034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460391|NCT04432376|Miconazole|miconazole|mesh-list
25460392|NCT04432376|Antifungal Agents|antifungal agents|mesh-ancestor
25460393|NCT04432376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25460394|NCT04432376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25460395|NCT04432376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25460396|NCT04432376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25460397|NCT04432376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460398|NCT04432376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25460399|NCT04432376|Hormone Antagonists|hormone antagonists|mesh-ancestor
25460400|NCT04432376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25460401|NCT04432376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319495|NCT04947241|Gemcitabine|gemcitabine|mesh-list
25460403|NCT04432376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25460405|NCT04429321|Ipilimumab|ipilimumab|mesh-list
25460406|NCT04429321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25460407|NCT04429321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460408|NCT04429321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25460409|NCT04429321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460410|NCT04392622|Cisplatin|cisplatin|mesh-list
25460411|NCT04392622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460412|NCT04390958|Paclitaxel|paclitaxel|mesh-list
25460413|NCT04390958|Cisplatin|cisplatin|mesh-list
25460414|NCT04390958|Capecitabine|capecitabine|mesh-list
25460415|NCT04390958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25460416|NCT04390958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460417|NCT04390958|Tubulin Modulators|tubulin modulators|mesh-ancestor
25460418|NCT04390958|Antimitotic Agents|antimitotic agents|mesh-ancestor
25460419|NCT04390958|Mitosis Modulators|mitosis modulators|mesh-ancestor
25460420|NCT04390958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460421|NCT04390958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25460422|NCT04390958|Antimetabolites|antimetabolites|mesh-ancestor
25460423|NCT04367233|Anesthetics|anesthetics|mesh-list
25460424|NCT04367233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25460425|NCT04367233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460426|NCT04359147|Hydrocortisone|hydrocortisone|mesh-list
25460427|NCT04359147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25460428|NCT04359147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25460429|NCT04359147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25460430|NCT04359147|Yohimbine|yohimbine|mesh-list
25460431|NCT04359147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25460432|NCT04359147|Mydriatics|mydriatics|mesh-ancestor
25460433|NCT04359147|Autonomic Agents|autonomic agents|mesh-ancestor
25460434|NCT04359147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25460435|NCT04359147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460436|NCT04359147|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25460437|NCT04359147|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25460438|NCT04359147|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25460439|NCT04359147|Adrenergic Agents|adrenergic agents|mesh-ancestor
25460440|NCT04359147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25460441|NCT04359147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460442|NCT04359147|Urological Agents|urological agents|mesh-ancestor
25460443|NCT04355585|Colchicine|colchicine|mesh-list
25460444|NCT04355585|Gout Suppressants|gout suppressants|mesh-ancestor
25460445|NCT04355585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25460446|NCT04355585|Tubulin Modulators|tubulin modulators|mesh-ancestor
25460447|NCT04355585|Antimitotic Agents|antimitotic agents|mesh-ancestor
25460448|NCT04355585|Mitosis Modulators|mitosis modulators|mesh-ancestor
25460449|NCT04355585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460450|NCT04355585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460460|NCT04345666|Methyltestosterone|methyltestosterone|mesh-list
25460461|NCT04345666|Testosterone|testosterone|mesh-list
25460462|NCT04345666|Testosterone undecanoate|testosterone undecanoate|mesh-list
25460463|NCT04345666|Testosterone enanthate|testosterone enanthate|mesh-list
25460464|NCT04345666|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25460465|NCT04345666|Androgens|androgens|mesh-ancestor
25460466|NCT04345666|Hormones|hormones|mesh-ancestor
25319565|NCT04946383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25319566|NCT04946383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25319567|NCT04946383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319568|NCT04946383|Antioxidants|antioxidants|mesh-ancestor
25319569|NCT04946383|Protective Agents|protective agents|mesh-ancestor
25460479|NCT04338529|Antacids|antacids|mesh-ancestor
25460480|NCT04338529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460481|NCT04338529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25460482|NCT04332367|Paclitaxel|paclitaxel|mesh-list
25460483|NCT04332367|Carboplatin|carboplatin|mesh-list
25460484|NCT04332367|Ramucirumab|ramucirumab|mesh-list
25460485|NCT04332367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25460486|NCT04332367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460487|NCT04332367|Tubulin Modulators|tubulin modulators|mesh-ancestor
25460488|NCT04332367|Antimitotic Agents|antimitotic agents|mesh-ancestor
25460489|NCT04332367|Mitosis Modulators|mitosis modulators|mesh-ancestor
25460490|NCT04332367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460491|NCT04322357|Prednisone|prednisone|mesh-list
25460492|NCT04322357|Glucocorticoids|glucocorticoids|mesh-list
25460493|NCT04322357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25460494|NCT04322357|Hormones|hormones|mesh-ancestor
25460495|NCT04322357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25460496|NCT04322357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460497|NCT04322357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25460498|NCT04322357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460513|NCT04314895|Paclitaxel|paclitaxel|mesh-list
25460514|NCT04314895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25460515|NCT04314895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25460516|NCT04314895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460517|NCT04314895|Tubulin Modulators|tubulin modulators|mesh-ancestor
25460518|NCT04314895|Antimitotic Agents|antimitotic agents|mesh-ancestor
25460519|NCT04314895|Mitosis Modulators|mitosis modulators|mesh-ancestor
25460520|NCT04314895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460521|NCT04301778|Durvalumab|durvalumab|mesh-list
25460522|NCT04301778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25460523|NCT04301778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460524|NCT04300985|Magnesium Sulfate|magnesium sulfate|mesh-list
25460525|NCT04300985|Dexmedetomidine|dexmedetomidine|mesh-list
25460526|NCT04300985|Anesthetics|anesthetics|mesh-list
25460527|NCT04300985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25460528|NCT04300985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460529|NCT04300985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25460530|NCT04300985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25460531|NCT04300985|Analgesics|analgesics|mesh-ancestor
25460532|NCT04300985|Sensory System Agents|sensory system agents|mesh-ancestor
25460533|NCT04300985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25460534|NCT04300985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25460535|NCT04300985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25460536|NCT04300985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25460537|NCT04300985|Adrenergic Agents|adrenergic agents|mesh-ancestor
25460538|NCT04300985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25644580|NCT01438060|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25644581|NCT01438060|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25722060|NCT02495948|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25460539|NCT04300985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460540|NCT04300985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25460541|NCT04300985|Anticonvulsants|anticonvulsants|mesh-ancestor
25319714|NCT04945096|Respiratory System Agents|respiratory system agents|mesh-ancestor
25319715|NCT04945096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25319716|NCT04945096|Antioxidants|antioxidants|mesh-ancestor
25319717|NCT04945096|Protective Agents|protective agents|mesh-ancestor
25460543|NCT04300985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25460544|NCT04300985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25460545|NCT04300985|Tocolytic Agents|tocolytic agents|mesh-ancestor
25460546|NCT04300985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25460547|NCT04296006|Amphetamine|amphetamine|mesh-list
25460548|NCT04296006|Dextroamphetamine|dextroamphetamine|mesh-list
25460549|NCT04296006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25460550|NCT04296006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460551|NCT04296006|Sympathomimetics|sympathomimetics|mesh-ancestor
25460552|NCT04296006|Autonomic Agents|autonomic agents|mesh-ancestor
25460553|NCT04296006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25460554|NCT04296006|Dopamine Agents|dopamine agents|mesh-ancestor
25460555|NCT04296006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25460556|NCT04296006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460557|NCT04296006|Adrenergic Agents|adrenergic agents|mesh-ancestor
25460558|NCT04296006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25460559|NCT04296006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25460560|NCT04296006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25460561|NCT04296006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25460562|NCT04289142|Dexmedetomidine|dexmedetomidine|mesh-list
25460563|NCT04289142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25460564|NCT04289142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25460565|NCT04289142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460566|NCT04289142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25460567|NCT04289142|Analgesics|analgesics|mesh-ancestor
25460568|NCT04289142|Sensory System Agents|sensory system agents|mesh-ancestor
25460569|NCT04289142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25460570|NCT04289142|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25460571|NCT04289142|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25460572|NCT04289142|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25460573|NCT04289142|Adrenergic Agents|adrenergic agents|mesh-ancestor
25460574|NCT04289142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25460575|NCT04289142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460576|NCT04276792|Analgesics, Opioid|analgesics, opioid|mesh-list
25460577|NCT04276792|Narcotics|narcotics|mesh-ancestor
25460578|NCT04276792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25460579|NCT04276792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460580|NCT04276792|Analgesics|analgesics|mesh-ancestor
25460581|NCT04276792|Sensory System Agents|sensory system agents|mesh-ancestor
25460582|NCT04276792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25460583|NCT04275531|Anesthetics|anesthetics|mesh-list
25460584|NCT04275531|Propofol|propofol|mesh-list
25460585|NCT04275531|Sevoflurane|sevoflurane|mesh-list
25460586|NCT04275531|Isoflurane|isoflurane|mesh-list
25460587|NCT04275531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25460588|NCT04275531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460589|NCT04275531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25460590|NCT04275531|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25460591|NCT04275531|Anesthetics, General|anesthetics, general|mesh-ancestor
25460592|NCT04275531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25460593|NCT04275531|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25460594|NCT04263064|Clonidine|clonidine|mesh-list
25460595|NCT04263064|Analgesics|analgesics|mesh-ancestor
25460596|NCT04263064|Sensory System Agents|sensory system agents|mesh-ancestor
25460597|NCT04263064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25460598|NCT04263064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460599|NCT04263064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25460600|NCT04263064|Sympatholytics|sympatholytics|mesh-ancestor
25460601|NCT04263064|Autonomic Agents|autonomic agents|mesh-ancestor
25460602|NCT04263064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25460603|NCT04263064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25460604|NCT04263064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25460605|NCT04263064|Adrenergic Agents|adrenergic agents|mesh-ancestor
25460606|NCT04263064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25644582|NCT01438060|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25319791|NCT04943588|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
25319792|NCT04943588|Immunologic Factors|immunologic factors|mesh-ancestor
25319793|NCT04943588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319794|NCT04943653|Paclitaxel|paclitaxel|mesh-list
25319795|NCT04943653|Capecitabine|capecitabine|mesh-list
25319796|NCT04943653|Oxaliplatin|oxaliplatin|mesh-list
25319797|NCT04943653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25319798|NCT04943653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319799|NCT04943653|Tubulin Modulators|tubulin modulators|mesh-ancestor
25460607|NCT04263064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460608|NCT04252105|Antioxidants|antioxidants|mesh-list
25460609|NCT04252105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460610|NCT04252105|Protective Agents|protective agents|mesh-ancestor
25460611|NCT04252105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460612|NCT04251585|Insulin|insulin|mesh-list
25460613|NCT04251585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25460614|NCT04251585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460615|NCT04240054|Dexamethasone|dexamethasone|mesh-list
25460616|NCT04240054|Cyclophosphamide|cyclophosphamide|mesh-list
25460617|NCT04240054|Bortezomib|bortezomib|mesh-list
25460618|NCT04240054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25460619|NCT04240054|Immunologic Factors|immunologic factors|mesh-ancestor
25460620|NCT04240054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460621|NCT04240054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25460622|NCT04240054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25460623|NCT04240054|Alkylating Agents|alkylating agents|mesh-ancestor
25460624|NCT04240054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460625|NCT04240054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460626|NCT04240054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25460627|NCT04240054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25460628|NCT04240054|Antiemetics|antiemetics|mesh-ancestor
25460629|NCT04240054|Autonomic Agents|autonomic agents|mesh-ancestor
25460630|NCT04240054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25460631|NCT04240054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25460632|NCT04240054|Glucocorticoids|glucocorticoids|mesh-ancestor
25460633|NCT04240054|Hormones|hormones|mesh-ancestor
25460634|NCT04240054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25460635|NCT04240054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25460636|NCT04239716|Anesthetics|anesthetics|mesh-list
25460637|NCT04239716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25460638|NCT04239716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460639|NCT04235634|Alprostadil|alprostadil|mesh-list
25460640|NCT04235634|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25460641|NCT04235634|Vasodilator Agents|vasodilator agents|mesh-ancestor
25460642|NCT04235634|Urological Agents|urological agents|mesh-ancestor
25460643|NCT04234906|Magnesium Sulfate|magnesium sulfate|mesh-list
25460644|NCT04234906|Amiodarone|amiodarone|mesh-list
25460645|NCT04234906|Procainamide|procainamide|mesh-list
25460646|NCT04234906|Dexmedetomidine|dexmedetomidine|mesh-list
25460647|NCT04234906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25460648|NCT04234906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25460649|NCT04234906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460650|NCT04234906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25460651|NCT04234906|Analgesics|analgesics|mesh-ancestor
25460652|NCT04234906|Sensory System Agents|sensory system agents|mesh-ancestor
25460653|NCT04234906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25460654|NCT04234906|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25460655|NCT04234906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25460656|NCT04234906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25460657|NCT04234906|Adrenergic Agents|adrenergic agents|mesh-ancestor
25460658|NCT04234906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25460659|NCT04234906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460660|NCT04234906|Anesthetics|anesthetics|mesh-ancestor
25460661|NCT04234906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25460662|NCT04234906|Anticonvulsants|anticonvulsants|mesh-ancestor
25460663|NCT04234906|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25460664|NCT04234906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25460665|NCT04234906|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25460666|NCT04234906|Tocolytic Agents|tocolytic agents|mesh-ancestor
25460667|NCT04234906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25460668|NCT04234906|Vasodilator Agents|vasodilator agents|mesh-ancestor
25319863|NCT04943146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319864|NCT04943146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25319865|NCT04943146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25319866|NCT04943146|Analgesics|analgesics|mesh-ancestor
25319867|NCT04943146|Sensory System Agents|sensory system agents|mesh-ancestor
25319868|NCT04943146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25319869|NCT04943146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25319870|NCT04943146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25319871|NCT04943146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25319872|NCT04943146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319873|NCT04943146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25319875|NCT04943146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25460669|NCT04234906|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25460670|NCT04234906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25460671|NCT04234906|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25460672|NCT04234906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25460673|NCT04234906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25460674|NCT04234906|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25460675|NCT04234906|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25460676|NCT04234906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25460677|NCT04234906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25460678|NCT04222257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25460679|NCT04222257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25460680|NCT04222257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25460681|NCT04222257|Antitubercular Agents|antitubercular agents|mesh-ancestor
25460682|NCT04207710|Ethyl Chloride|ethyl chloride|mesh-list
25460683|NCT04207710|Anesthetics, Local|anesthetics, local|mesh-ancestor
25460684|NCT04207710|Anesthetics|anesthetics|mesh-ancestor
25460685|NCT04207710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25460686|NCT04207710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460687|NCT04207710|Sensory System Agents|sensory system agents|mesh-ancestor
25460688|NCT04207710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25460689|NCT04195958|Omalizumab|omalizumab|mesh-list
25460690|NCT04195958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25460691|NCT04195958|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25460692|NCT04195958|Respiratory System Agents|respiratory system agents|mesh-ancestor
25460693|NCT04188860|Paclitaxel|paclitaxel|mesh-list
25460694|NCT04188860|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25460695|NCT04188860|Antibodies|antibodies|mesh-list
25460696|NCT04188860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25460697|NCT04188860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460698|NCT04188860|Tubulin Modulators|tubulin modulators|mesh-ancestor
25460699|NCT04188860|Antimitotic Agents|antimitotic agents|mesh-ancestor
25460700|NCT04188860|Mitosis Modulators|mitosis modulators|mesh-ancestor
25460701|NCT04188860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460702|NCT04188860|Immunologic Factors|immunologic factors|mesh-ancestor
25460703|NCT04188860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460704|NCT04188847|Apatinib|apatinib|mesh-list
25460705|NCT04188847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460706|NCT04188847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25460707|NCT04188847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25460708|NCT04188847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460709|NCT04173949|Ramipril|ramipril|mesh-list
25460710|NCT04173949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25460711|NCT04173949|Protease Inhibitors|protease inhibitors|mesh-ancestor
25460712|NCT04173949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25460713|NCT04173949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460714|NCT04173949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25460715|NCT04170556|Nivolumab|nivolumab|mesh-list
25460716|NCT04170556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25460717|NCT04170556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460718|NCT04170556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25460719|NCT04170556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460720|NCT04152473|Proglumide|proglumide|mesh-list
25460721|NCT04152473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25460722|NCT04152473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25460723|NCT04130802|Dexamethasone|dexamethasone|mesh-list
25460724|NCT04130802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25460725|NCT04130802|Antiemetics|antiemetics|mesh-ancestor
25460726|NCT04130802|Autonomic Agents|autonomic agents|mesh-ancestor
25460727|NCT04130802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25460728|NCT04130802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460729|NCT04130802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25460730|NCT04130802|Glucocorticoids|glucocorticoids|mesh-ancestor
25460731|NCT04130802|Hormones|hormones|mesh-ancestor
25460732|NCT04130802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25822875|NCT00004688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460733|NCT04130802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25460734|NCT04130802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460735|NCT04130659|Omeprazole|omeprazole|mesh-list
25460736|NCT04130659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25460737|NCT04130659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25460738|NCT04130659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25460739|NCT04130659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25460740|NCT04130659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460741|NCT04121468|Metformin|metformin|mesh-list
25319936|NCT04942652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25460742|NCT04121468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25460743|NCT04121468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460745|NCT04117932|Dermatologic Agents|dermatologic agents|mesh-ancestor
25460746|NCT04115267|Antineoplastic Agents|antineoplastic agents|mesh-list
25460747|NCT04108104|Cyproheptadine|cyproheptadine|mesh-list
25460748|NCT04108104|Prazosin|prazosin|mesh-list
25460749|NCT04108104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25460750|NCT04108104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25460751|NCT04108104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25460752|NCT04108104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25460753|NCT04108104|Adrenergic Agents|adrenergic agents|mesh-ancestor
25460754|NCT04108104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25460755|NCT04108104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460756|NCT04108104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460757|NCT04108104|Antipruritics|antipruritics|mesh-ancestor
25460758|NCT04108104|Dermatologic Agents|dermatologic agents|mesh-ancestor
25460759|NCT04108104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25460760|NCT04108104|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25460761|NCT04108104|Histamine Antagonists|histamine antagonists|mesh-ancestor
25460762|NCT04108104|Histamine Agents|histamine agents|mesh-ancestor
25460763|NCT04108104|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25460764|NCT04108104|Serotonin Agents|serotonin agents|mesh-ancestor
25460765|NCT04108104|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25460766|NCT04098393|Fludarabine|fludarabine|mesh-list
25460767|NCT04098393|Melphalan|melphalan|mesh-list
25460768|NCT04098393|Busulfan|busulfan|mesh-list
25460769|NCT04098393|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25460770|NCT04098393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460771|NCT04098393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460772|NCT04098393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25460773|NCT04098393|Immunologic Factors|immunologic factors|mesh-ancestor
25460774|NCT04098393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460775|NCT04098393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25460776|NCT04098393|Alkylating Agents|alkylating agents|mesh-ancestor
25460777|NCT04098393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25460778|NCT04098250|Erenumab|erenumab|mesh-list
25460779|NCT04098250|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25460780|NCT04098250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460781|NCT04098250|Analgesics|analgesics|mesh-ancestor
25460782|NCT04098250|Sensory System Agents|sensory system agents|mesh-ancestor
25460783|NCT04098250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25460784|NCT04098250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460785|NCT04088513|Aspirin|aspirin|mesh-list
25460786|NCT04088513|Clopidogrel|clopidogrel|mesh-list
25460787|NCT04088513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25460788|NCT04088513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25460789|NCT04088513|Analgesics|analgesics|mesh-ancestor
25460790|NCT04088513|Sensory System Agents|sensory system agents|mesh-ancestor
25460791|NCT04088513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25460792|NCT04088513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460793|NCT04088513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25460794|NCT04088513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25460795|NCT04088513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25460796|NCT04088513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25460797|NCT04088513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460798|NCT04088513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25460799|NCT04088513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25460800|NCT04088513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25460801|NCT04088513|Antipyretics|antipyretics|mesh-ancestor
25460802|NCT04088513|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25460803|NCT04088513|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25460804|NCT04088513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25460805|NCT04088513|Purinergic Agents|purinergic agents|mesh-ancestor
25460806|NCT04088513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25644583|NCT01438151|Infliximab|infliximab|mesh-list
25460807|NCT04080947|Montelukast|montelukast|mesh-list
25460808|NCT04080947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25460809|NCT04080947|Respiratory System Agents|respiratory system agents|mesh-ancestor
25460810|NCT04080947|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25460811|NCT04080947|Hormone Antagonists|hormone antagonists|mesh-ancestor
25460812|NCT04080947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25460813|NCT04080947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460814|NCT04080947|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25320008|NCT04941833|Hormones|hormones|mesh-ancestor
25460827|NCT04056910|Nivolumab|nivolumab|mesh-list
25460828|NCT04056910|Ivosidenib|ivosidenib|mesh-list
25460829|NCT04056910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25460830|NCT04056910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460831|NCT04056910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25460832|NCT04056910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460833|NCT04056910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25460834|NCT04053478|Phenylephrine|phenylephrine|mesh-list
25460835|NCT04053478|Oxymetazoline|oxymetazoline|mesh-list
25460836|NCT04053478|Norepinephrine|norepinephrine|mesh-list
25460837|NCT04053478|Ephedrine|ephedrine|mesh-list
25460838|NCT04053478|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25460839|NCT04053478|Mydriatics|mydriatics|mesh-ancestor
25460840|NCT04053478|Autonomic Agents|autonomic agents|mesh-ancestor
25460841|NCT04053478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25460842|NCT04053478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460843|NCT04053478|Sympathomimetics|sympathomimetics|mesh-ancestor
25460844|NCT04053478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25460845|NCT04053478|Nasal Decongestants|nasal decongestants|mesh-ancestor
25460846|NCT04053478|Respiratory System Agents|respiratory system agents|mesh-ancestor
25460847|NCT04053478|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25460848|NCT04053478|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25460849|NCT04053478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25460850|NCT04053478|Adrenergic Agents|adrenergic agents|mesh-ancestor
25460851|NCT04053478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25460852|NCT04053478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460853|NCT04053478|Protective Agents|protective agents|mesh-ancestor
25460854|NCT04053478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25460855|NCT04027309|Midostaurin|midostaurin|mesh-list
25460856|NCT04027309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460857|NCT04027309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25460858|NCT04027309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25460859|NCT04027309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460860|NCT04021524|Chlorhexidine|chlorhexidine|mesh-list
25460861|NCT04021524|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25460862|NCT04021524|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25460863|NCT04021524|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25460864|NCT04021524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25460865|NCT04021524|Disinfectants|disinfectants|mesh-ancestor
25460866|NCT04021524|Dermatologic Agents|dermatologic agents|mesh-ancestor
25460867|NCT03985540|Methamphetamine|methamphetamine|mesh-list
25460868|NCT03985540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25460869|NCT03985540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460870|NCT03985540|Sympathomimetics|sympathomimetics|mesh-ancestor
25460871|NCT03985540|Autonomic Agents|autonomic agents|mesh-ancestor
25460872|NCT03985540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25460873|NCT03985540|Dopamine Agents|dopamine agents|mesh-ancestor
25460874|NCT03985540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25460875|NCT03985540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460876|NCT03985540|Adrenergic Agents|adrenergic agents|mesh-ancestor
25460877|NCT03985540|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25460878|NCT03985540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25460879|NCT03985540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25460880|NCT03985540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25460881|NCT03976973|Acetylcysteine|acetylcysteine|mesh-list
25460882|NCT03976973|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25460883|NCT03976973|Antiviral Agents|antiviral agents|mesh-ancestor
25460884|NCT03976973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25460885|NCT03976973|Expectorants|expectorants|mesh-ancestor
25460886|NCT03976973|Respiratory System Agents|respiratory system agents|mesh-ancestor
25460887|NCT03976973|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25460888|NCT03976973|Antioxidants|antioxidants|mesh-ancestor
25460889|NCT03976973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460890|NCT03976973|Protective Agents|protective agents|mesh-ancestor
25460891|NCT03976973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460892|NCT03976973|Antidotes|antidotes|mesh-ancestor
25460893|NCT03964532|Avelumab|avelumab|mesh-list
25460894|NCT03964532|Talazoparib|talazoparib|mesh-list
25460895|NCT03964532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25460896|NCT03964532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460897|NCT03964532|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25460898|NCT03964532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25460899|NCT03964532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460900|NCT03873727|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25460901|NCT03873727|Immunologic Factors|immunologic factors|mesh-ancestor
25460902|NCT03873727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460904|NCT03873311|Azacitidine|azacitidine|mesh-list
25460905|NCT03873311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25460906|NCT03873311|Antimetabolites|antimetabolites|mesh-ancestor
25460907|NCT03873311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460908|NCT03873311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460909|NCT03873311|Antiviral Agents|antiviral agents|mesh-ancestor
25460910|NCT03873311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25460911|NCT03873311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25460912|NCT03873311|Immunologic Factors|immunologic factors|mesh-ancestor
25460913|NCT03873311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460914|NCT03873311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25460915|NCT03841292|Varenicline|varenicline|mesh-list
25460916|NCT03841292|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25460917|NCT03841292|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25460918|NCT03841292|Cholinergic Agents|cholinergic agents|mesh-ancestor
25460919|NCT03841292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25460920|NCT03841292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460921|NCT03841292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460922|NCT03840291|Edoxaban|edoxaban|mesh-list
25460923|NCT03840291|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25460924|NCT03840291|Antithrombins|antithrombins|mesh-ancestor
25460925|NCT03840291|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25460926|NCT03840291|Protease Inhibitors|protease inhibitors|mesh-ancestor
25460927|NCT03840291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25460928|NCT03840291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460929|NCT03840291|Anticoagulants|anticoagulants|mesh-ancestor
25460930|NCT03830359|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25460931|NCT03830359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25460932|NCT03822780|Hydroxychloroquine|hydroxychloroquine|mesh-list
25460933|NCT03822780|Antimalarials|antimalarials|mesh-ancestor
25460934|NCT03822780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25460935|NCT03822780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25460936|NCT03822780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25460937|NCT03822780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25460938|NCT03822780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460939|NCT03822780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25460940|NCT03817515|Sirolimus|sirolimus|mesh-list
25460941|NCT03817515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25460942|NCT03817515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25460943|NCT03817515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25460944|NCT03817515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460945|NCT03817515|Antifungal Agents|antifungal agents|mesh-ancestor
25460946|NCT03817515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25460947|NCT03817515|Immunologic Factors|immunologic factors|mesh-ancestor
25460948|NCT03817515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25460949|NCT03786796|Olaparib|olaparib|mesh-list
25460950|NCT03786796|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25460951|NCT03786796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25460952|NCT03786796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460953|NCT03786796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25460954|NCT03779074|Amoxicillin|amoxicillin|mesh-list
25460955|NCT03779074|Metronidazole|metronidazole|mesh-list
25460956|NCT03779074|Clarithromycin|clarithromycin|mesh-list
25460957|NCT03779074|Tetracycline|tetracycline|mesh-list
25460958|NCT03779074|Rabeprazole|rabeprazole|mesh-list
25460959|NCT03779074|Bismuth|bismuth|mesh-list
25460960|NCT03779074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25460961|NCT03779074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25460962|NCT03779074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25460963|NCT03779074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25460964|NCT03779074|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25460965|NCT03779074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25460966|NCT03779074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25460967|NCT03779074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25460968|NCT03779074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25644584|NCT01438151|Dermatologic Agents|dermatologic agents|mesh-ancestor
25644585|NCT01438151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25644586|NCT01438151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25460969|NCT03779074|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25460970|NCT03779074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25460971|NCT03779074|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25460972|NCT03779074|Antacids|antacids|mesh-ancestor
25460973|NCT03756961|Lidocaine|lidocaine|mesh-list
25460974|NCT03756961|Dexmedetomidine|dexmedetomidine|mesh-list
25460975|NCT03756961|Remifentanil|remifentanil|mesh-list
25460976|NCT03756961|Oxycodone|oxycodone|mesh-list
25460977|NCT03756961|Propofol|propofol|mesh-list
25460978|NCT03756961|Desflurane|desflurane|mesh-list
25460979|NCT03756961|Esketamine|esketamine|mesh-list
25461003|NCT03756961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25461004|NCT03756961|Antidepressive Agents|antidepressive agents|mesh-ancestor
25461005|NCT03756961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25461006|NCT03735537|Zoledronic Acid|zoledronic acid|mesh-list
25461007|NCT03735537|Teriparatide|teriparatide|mesh-list
25461008|NCT03735537|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25461009|NCT03735537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25461010|NCT03735537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461011|NCT03735537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25461012|NCT03735290|Pembrolizumab|pembrolizumab|mesh-list
25461013|NCT03735290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25461014|NCT03735290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461015|NCT03723967|Paclitaxel|paclitaxel|mesh-list
25461016|NCT03723967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25461017|NCT03723967|Carboplatin|carboplatin|mesh-list
25461018|NCT03723967|Durvalumab|durvalumab|mesh-list
25461019|NCT03723967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25461020|NCT03723967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25461021|NCT03723967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461022|NCT03723967|Tubulin Modulators|tubulin modulators|mesh-ancestor
25461023|NCT03723967|Antimitotic Agents|antimitotic agents|mesh-ancestor
25461024|NCT03723967|Mitosis Modulators|mitosis modulators|mesh-ancestor
25461025|NCT03723967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461026|NCT03723967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25461027|NCT03723967|Immunologic Factors|immunologic factors|mesh-ancestor
25461028|NCT03723967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461029|NCT03668392|Asparaginase|asparaginase|mesh-list
25461030|NCT03668392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461031|NCT03661723|Bevacizumab|bevacizumab|mesh-list
25461032|NCT03661723|Pembrolizumab|pembrolizumab|mesh-list
25461033|NCT03661723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25461034|NCT03661723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461035|NCT03661723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25461036|NCT03661723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25461037|NCT03661723|Growth Substances|growth substances|mesh-ancestor
25461038|NCT03661723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461039|NCT03661723|Growth Inhibitors|growth inhibitors|mesh-ancestor
25461040|NCT03659461|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25461041|NCT03659461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25461042|NCT03659461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461043|NCT03659461|Incretins|incretins|mesh-ancestor
25461044|NCT03659461|Hormones|hormones|mesh-ancestor
25461045|NCT03659461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25461046|NCT03659461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25461047|NCT03659461|Protease Inhibitors|protease inhibitors|mesh-ancestor
25461048|NCT03659461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461049|NCT03659461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461050|NCT03643133|Mifamurtide|mifamurtide|mesh-list
25722075|NCT02497040|Bupivacaine|bupivacaine|mesh-list
25461051|NCT03643133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25461052|NCT03643133|Immunologic Factors|immunologic factors|mesh-ancestor
25461053|NCT03643133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461054|NCT03642067|Nivolumab|nivolumab|mesh-list
25461055|NCT03642067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25461056|NCT03642067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461057|NCT03642067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25461058|NCT03642067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461059|NCT03583307|Sirolimus|sirolimus|mesh-list
25461060|NCT03583307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25461061|NCT03583307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25461062|NCT03583307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25461063|NCT03583307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461064|NCT03583307|Antifungal Agents|antifungal agents|mesh-ancestor
25461065|NCT03583307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25461066|NCT03583307|Immunologic Factors|immunologic factors|mesh-ancestor
25461067|NCT03583307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461068|NCT03546894|Ceritinib|ceritinib|mesh-list
25461069|NCT03546894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461070|NCT03546894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25461071|NCT03546894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461072|NCT03546894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461073|NCT03535727|Gemcitabine|gemcitabine|mesh-list
25461074|NCT03535727|Paclitaxel|paclitaxel|mesh-list
25461075|NCT03535727|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25461076|NCT03535727|Cisplatin|cisplatin|mesh-list
25461077|NCT03535727|Capecitabine|capecitabine|mesh-list
25461078|NCT03535727|Irinotecan|irinotecan|mesh-list
25461079|NCT03535727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25461080|NCT03535727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461081|NCT03535727|Tubulin Modulators|tubulin modulators|mesh-ancestor
25461082|NCT03535727|Antimitotic Agents|antimitotic agents|mesh-ancestor
25461083|NCT03535727|Mitosis Modulators|mitosis modulators|mesh-ancestor
25461084|NCT03535727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461085|NCT03535727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25461086|NCT03535727|Antimetabolites|antimetabolites|mesh-ancestor
25461087|NCT03535727|Antiviral Agents|antiviral agents|mesh-ancestor
25461088|NCT03535727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25461089|NCT03535727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461090|NCT03535727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25461091|NCT03535727|Immunologic Factors|immunologic factors|mesh-ancestor
25461092|NCT03535727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461093|NCT03535727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25461094|NCT03535727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25461095|NCT03526874|Lidocaine|lidocaine|mesh-list
25461096|NCT03526874|Anesthetics, Local|anesthetics, local|mesh-ancestor
25461097|NCT03526874|Anesthetics|anesthetics|mesh-ancestor
25461098|NCT03526874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25461099|NCT03526874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461100|NCT03526874|Sensory System Agents|sensory system agents|mesh-ancestor
25461101|NCT03526874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25461102|NCT03526874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25461103|NCT03526874|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25461104|NCT03526874|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25461105|NCT03526874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25461106|NCT03526874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461107|NCT03492918|Pembrolizumab|pembrolizumab|mesh-list
25461108|NCT03492918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25461109|NCT03492918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461110|NCT03487666|Capecitabine|capecitabine|mesh-list
25461111|NCT03487666|Nivolumab|nivolumab|mesh-list
25461112|NCT03487666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25461113|NCT03487666|Antimetabolites|antimetabolites|mesh-ancestor
25461114|NCT03487666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461115|NCT03487666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461116|NCT03487666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25461117|NCT03487666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25461118|NCT03485950|Meropenem|meropenem|mesh-list
25461119|NCT03485950|Tazobactam|tazobactam|mesh-list
25461120|NCT03485950|Piperacillin|piperacillin|mesh-list
25461121|NCT03485950|Cefepime|cefepime|mesh-list
25461122|NCT03485950|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25461123|NCT03485950|Ceftolozane|ceftolozane|mesh-list
25461124|NCT03485950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25461125|NCT03485950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25461126|NCT03485950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25461127|NCT03485950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461128|NCT03485950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461129|NCT03467867|Rituximab|rituximab|mesh-list
25461130|NCT03467867|Venetoclax|venetoclax|mesh-list
25461131|NCT03467867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25461132|NCT03467867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461133|NCT03467867|Immunologic Factors|immunologic factors|mesh-ancestor
25461134|NCT03467867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461135|NCT03467867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25461136|NCT03449485|Chlorprothixene|chlorprothixene|mesh-list
25461137|NCT03449485|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25461138|NCT03449485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25461139|NCT03449485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25461140|NCT03449485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461141|NCT03449485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25461142|NCT03449485|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25644588|NCT01438177|Cyclophosphamide|cyclophosphamide|mesh-list
25644589|NCT01438177|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25644590|NCT01438177|Bortezomib|bortezomib|mesh-list
25644591|NCT01438177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25644592|NCT01438177|Immunologic Factors|immunologic factors|mesh-ancestor
25644593|NCT01438177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644594|NCT01438177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25461143|NCT03449485|Dopamine Agents|dopamine agents|mesh-ancestor
25461144|NCT03449485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25461145|NCT03449485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461146|NCT03448783|Apixaban|apixaban|mesh-list
25461147|NCT03448783|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25461148|NCT03448783|Antithrombins|antithrombins|mesh-ancestor
25461149|NCT03448783|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25461150|NCT03448783|Protease Inhibitors|protease inhibitors|mesh-ancestor
25461151|NCT03448783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461152|NCT03448783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461153|NCT03448783|Anticoagulants|anticoagulants|mesh-ancestor
25461154|NCT03435458|Misoprostol|misoprostol|mesh-list
25461155|NCT03435458|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25461156|NCT03435458|Abortifacient Agents|abortifacient agents|mesh-ancestor
25461157|NCT03435458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25461158|NCT03435458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461159|NCT03435458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25461160|NCT03435458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25461161|NCT03435458|Oxytocics|oxytocics|mesh-ancestor
25461162|NCT03434444|Propranolol|propranolol|mesh-list
25461163|NCT03434444|Oxytocin|oxytocin|mesh-list
25461164|NCT03434444|Oxytocics|oxytocics|mesh-ancestor
25461165|NCT03434444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25461166|NCT03434444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461167|NCT03434444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25461168|NCT03434444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25461169|NCT03434444|Adrenergic Agents|adrenergic agents|mesh-ancestor
25461170|NCT03434444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25461171|NCT03434444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461172|NCT03434444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25461173|NCT03434444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25461174|NCT03434444|Vasodilator Agents|vasodilator agents|mesh-ancestor
25461175|NCT03431948|Nivolumab|nivolumab|mesh-list
25461176|NCT03431948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25461177|NCT03431948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461178|NCT03431948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25461179|NCT03431948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461180|NCT03427463|Morphine|morphine|mesh-list
25320433|NCT04936126|Amantadine|amantadine|mesh-list
25461181|NCT03427463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25461182|NCT03427463|Narcotics|narcotics|mesh-ancestor
25461183|NCT03427463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25461184|NCT03427463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461185|NCT03427463|Analgesics|analgesics|mesh-ancestor
25461186|NCT03427463|Sensory System Agents|sensory system agents|mesh-ancestor
25461187|NCT03427463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25461188|NCT03417544|Trastuzumab|trastuzumab|mesh-list
25461190|NCT03417544|Atezolizumab|atezolizumab|mesh-list
25461191|NCT03417544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25461192|NCT03417544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461193|NCT03404518|Acetaminophen|acetaminophen|mesh-list
25461194|NCT03404518|Ibuprofen|ibuprofen|mesh-list
25461195|NCT03404518|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25461196|NCT03404518|Hydrocodone|hydrocodone|mesh-list
25461197|NCT03404518|Narcotics|narcotics|mesh-list
25461198|NCT03404518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25461199|NCT03404518|Analgesics|analgesics|mesh-ancestor
25461200|NCT03404518|Sensory System Agents|sensory system agents|mesh-ancestor
25461201|NCT03404518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25461202|NCT03404518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461203|NCT03404518|Antipyretics|antipyretics|mesh-ancestor
25461204|NCT03404518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25461205|NCT03404518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25461206|NCT03404518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25461207|NCT03404518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25461208|NCT03404518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203432|NCT02714231|Diclofenac|diclofenac|mesh-list
25461209|NCT03404518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461210|NCT03404518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25461211|NCT03404518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25461212|NCT03404518|Antitussive Agents|antitussive agents|mesh-ancestor
25461213|NCT03404518|Respiratory System Agents|respiratory system agents|mesh-ancestor
25461215|NCT03376672|Lenalidomide|lenalidomide|mesh-list
25461216|NCT03376672|Ixazomib|ixazomib|mesh-list
25461217|NCT03376672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25461218|NCT03376672|Antiemetics|antiemetics|mesh-ancestor
25461219|NCT03376672|Autonomic Agents|autonomic agents|mesh-ancestor
25461220|NCT03376672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25461221|NCT03376672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461222|NCT03376672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25461223|NCT03376672|Glucocorticoids|glucocorticoids|mesh-ancestor
25461224|NCT03376672|Hormones|hormones|mesh-ancestor
25461225|NCT03376672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25461226|NCT03376672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25461227|NCT03376672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461228|NCT03376672|Immunologic Factors|immunologic factors|mesh-ancestor
25461229|NCT03376672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25461230|NCT03376672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25461231|NCT03376672|Growth Substances|growth substances|mesh-ancestor
25461232|NCT03376672|Growth Inhibitors|growth inhibitors|mesh-ancestor
25461233|NCT03376672|Protease Inhibitors|protease inhibitors|mesh-ancestor
25461234|NCT03376672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461235|NCT03376672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461236|NCT03374800|Pantoprazole|pantoprazole|mesh-list
25461237|NCT03374800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25461238|NCT03374800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25461239|NCT03374800|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25461240|NCT03374800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461241|NCT03374800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461242|NCT03367312|Xenon|xenon|mesh-list
25461243|NCT03367312|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25461244|NCT03367312|Anesthetics, General|anesthetics, general|mesh-ancestor
25461245|NCT03367312|Anesthetics|anesthetics|mesh-ancestor
25461246|NCT03367312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25461247|NCT03367312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461248|NCT03361852|Rituximab|rituximab|mesh-list
25461249|NCT03361852|Pembrolizumab|pembrolizumab|mesh-list
25320509|NCT04935034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25320510|NCT04934930|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25320511|NCT04934930|Obinutuzumab|obinutuzumab|mesh-list
25320512|NCT04934930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25320513|NCT04934930|Alkylating Agents|alkylating agents|mesh-ancestor
25320514|NCT04934930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320517|NCT04935073|Cetrorelix|cetrorelix|mesh-list
25461250|NCT03361852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25461251|NCT03361852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461252|NCT03361852|Immunologic Factors|immunologic factors|mesh-ancestor
25461253|NCT03361852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461254|NCT03361852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25461255|NCT03350516|Calcium, Dietary|calcium, dietary|mesh-list
25461256|NCT03350516|Calcium Carbonate|calcium carbonate|mesh-list
25461257|NCT03350516|Calcium|calcium|mesh-list
25461258|NCT03350516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25461259|NCT03350516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461260|NCT03350516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25461261|NCT03350516|Antacids|antacids|mesh-ancestor
25461262|NCT03350516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461263|NCT03350516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25461264|NCT03322865|Obinutuzumab|obinutuzumab|mesh-list
25461265|NCT03322865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25461266|NCT03322865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461267|NCT03314181|Dexamethasone|dexamethasone|mesh-list
25461268|NCT03314181|Bortezomib|bortezomib|mesh-list
25461269|NCT03314181|Venetoclax|venetoclax|mesh-list
25461270|NCT03314181|Daratumumab|daratumumab|mesh-list
25461271|NCT03314181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25461272|NCT03314181|Antiemetics|antiemetics|mesh-ancestor
25461273|NCT03314181|Autonomic Agents|autonomic agents|mesh-ancestor
25461274|NCT03314181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25461275|NCT03314181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461276|NCT03314181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25461277|NCT03314181|Glucocorticoids|glucocorticoids|mesh-ancestor
25461278|NCT03314181|Hormones|hormones|mesh-ancestor
24648812|NCT01216956|Niacin|niacin|mesh-list
25461279|NCT03314181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25461280|NCT03314181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25461281|NCT03314181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461282|NCT03303989|Mycophenolic Acid|mycophenolic acid|mesh-list
25461283|NCT03303989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25461284|NCT03303989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461285|NCT03303989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25461286|NCT03303989|Antitubercular Agents|antitubercular agents|mesh-ancestor
25461287|NCT03303989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25461288|NCT03303989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25461289|NCT03303989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461290|NCT03303989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461291|NCT03301038|Rifampin|rifampin|mesh-list
25461292|NCT03301038|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25461293|NCT03301038|Antitubercular Agents|antitubercular agents|mesh-ancestor
25461294|NCT03301038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25461295|NCT03301038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25461296|NCT03301038|Leprostatic Agents|leprostatic agents|mesh-ancestor
25461297|NCT03301038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25461298|NCT03301038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461299|NCT03301038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461300|NCT03301038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25461301|NCT03301038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25461302|NCT03301038|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25461303|NCT03301038|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25461304|NCT03301038|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25461305|NCT03301038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25320584|NCT04934514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320585|NCT04934514|Antiviral Agents|antiviral agents|mesh-ancestor
25320586|NCT04934514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25320587|NCT04934514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25320588|NCT04934514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25320589|NCT04934514|Immunologic Factors|immunologic factors|mesh-ancestor
25320590|NCT04934514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320610|NCT04934475|Lenalidomide|lenalidomide|mesh-list
25320611|NCT04934475|Immunologic Factors|immunologic factors|mesh-ancestor
25320612|NCT04934475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320613|NCT04934475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25320614|NCT04934475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25320615|NCT04934475|Growth Substances|growth substances|mesh-ancestor
25320616|NCT04934475|Growth Inhibitors|growth inhibitors|mesh-ancestor
25320617|NCT04934475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24564958|NCT00778245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25822876|NCT00004688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25461320|NCT03217097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461321|NCT03187509|Torsemide|torsemide|mesh-list
25461322|NCT03187509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25461323|NCT03187509|Diuretics|diuretics|mesh-ancestor
25461324|NCT03187509|Natriuretic Agents|natriuretic agents|mesh-ancestor
25461325|NCT03187509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461326|NCT03187509|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25461327|NCT03187509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25461328|NCT03187509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461329|NCT03158090|Lanreotide|lanreotide|mesh-list
25461330|NCT03158090|Octreotide|octreotide|mesh-list
25461331|NCT03158090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461332|NCT03158090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25461333|NCT03158090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25461334|NCT03156504|Ketamine|ketamine|mesh-list
25461335|NCT03156504|Analgesics|analgesics|mesh-ancestor
25461336|NCT03156504|Sensory System Agents|sensory system agents|mesh-ancestor
25461337|NCT03156504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25461338|NCT03156504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461339|NCT03156504|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25461340|NCT03156504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25461341|NCT03156504|Anesthetics, General|anesthetics, general|mesh-ancestor
25461342|NCT03156504|Anesthetics|anesthetics|mesh-ancestor
25461343|NCT03156504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25461344|NCT03156504|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25461345|NCT03156504|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25461346|NCT03156504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25461347|NCT03156504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644595|NCT01438177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25461348|NCT03155100|Dexamethasone|dexamethasone|mesh-list
25461349|NCT03155100|Elotuzumab|elotuzumab|mesh-list
25461350|NCT03155100|Proteasome Inhibitors|proteasome inhibitors|mesh-list
25461351|NCT03155100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25461352|NCT03155100|Antiemetics|antiemetics|mesh-ancestor
25461353|NCT03155100|Autonomic Agents|autonomic agents|mesh-ancestor
25461354|NCT03155100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25461355|NCT03155100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461356|NCT03155100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25461357|NCT03155100|Glucocorticoids|glucocorticoids|mesh-ancestor
25461358|NCT03155100|Hormones|hormones|mesh-ancestor
25461359|NCT03155100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25461360|NCT03155100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25461361|NCT03155100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461362|NCT03155100|Protease Inhibitors|protease inhibitors|mesh-ancestor
25461363|NCT03155100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461364|NCT03155100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461365|NCT03142893|Ketoconazole|ketoconazole|mesh-list
25461366|NCT03142893|Dexamethasone|dexamethasone|mesh-list
25461367|NCT03142893|Dexamethasone acetate|dexamethasone acetate|mesh-list
25461368|NCT03142893|Hydrocortisone|hydrocortisone|mesh-list
25461369|NCT03142893|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25461370|NCT03142893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25461371|NCT03142893|Hormones|hormones|mesh-list
25461372|NCT03142893|Cosyntropin|cosyntropin|mesh-list
25461373|NCT03142893|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25461374|NCT03142893|BB 1101|bb 1101|mesh-list
25461375|NCT03142893|Ganirelix|ganirelix|mesh-list
25461376|NCT03142893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25461377|NCT03142893|Antiemetics|antiemetics|mesh-ancestor
25461378|NCT03142893|Autonomic Agents|autonomic agents|mesh-ancestor
25461379|NCT03142893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25461380|NCT03142893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461381|NCT03142893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25461382|NCT03142893|Glucocorticoids|glucocorticoids|mesh-ancestor
25461383|NCT03142893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25461384|NCT03142893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25461385|NCT03142893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25320734|NCT04932187|Capecitabine|capecitabine|mesh-list
25320735|NCT04932187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25320736|NCT04932187|Antimetabolites|antimetabolites|mesh-ancestor
25320737|NCT04932187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320738|NCT04932187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25320739|NCT04931693|Acetaminophen|acetaminophen|mesh-list
25461386|NCT03142893|Protease Inhibitors|protease inhibitors|mesh-ancestor
25461387|NCT03142893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461388|NCT03142893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461389|NCT03142893|Antifungal Agents|antifungal agents|mesh-ancestor
25461390|NCT03142893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25461391|NCT03142893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25461392|NCT03142893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25461393|NCT03142893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25461394|NCT03142893|Hormone Antagonists|hormone antagonists|mesh-ancestor
25461395|NCT03142893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25461396|NCT03104283|Apatinib|apatinib|mesh-list
25461397|NCT03104283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461398|NCT03104283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25461399|NCT03104283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461400|NCT03104283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461401|NCT03086044|Sofosbuvir|sofosbuvir|mesh-list
25461402|NCT03086044|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25461403|NCT03086044|Velpatasvir|velpatasvir|mesh-list
25461404|NCT03086044|Antiviral Agents|antiviral agents|mesh-ancestor
25461405|NCT03086044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25461406|NCT03067571|Daratumumab|daratumumab|mesh-list
25461407|NCT03067571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461408|NCT02993926|Leuprolide|leuprolide|mesh-list
25461409|NCT02993926|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25461410|NCT02993926|Fertility Agents|fertility agents|mesh-ancestor
25461411|NCT02993926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25461412|NCT02993926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461413|NCT02993926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25461414|NCT02993926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461415|NCT02967640|Ketamine|ketamine|mesh-list
25461416|NCT02967640|Analgesics|analgesics|mesh-ancestor
25644596|NCT01438177|Alkylating Agents|alkylating agents|mesh-ancestor
25644597|NCT01438177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461417|NCT02967640|Sensory System Agents|sensory system agents|mesh-ancestor
25461418|NCT02967640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25461419|NCT02967640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461420|NCT02967640|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25461421|NCT02967640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25461422|NCT02967640|Anesthetics, General|anesthetics, general|mesh-ancestor
25461423|NCT02967640|Anesthetics|anesthetics|mesh-ancestor
25461424|NCT02967640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25461425|NCT02967640|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25461426|NCT02967640|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25461427|NCT02967640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25461428|NCT02967640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461429|NCT02948309|Viscum album peptide|viscum album peptide|mesh-list
25461430|NCT02948309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461431|NCT02948309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25461432|NCT02948309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25461433|NCT02948309|Antiviral Agents|antiviral agents|mesh-ancestor
25461434|NCT02948309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25461435|NCT02932579|Acetaminophen|acetaminophen|mesh-list
25461437|NCT02932579|Oxycodone|oxycodone|mesh-list
25461438|NCT02932579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25461439|NCT02932579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25461440|NCT02932579|Analgesics|analgesics|mesh-ancestor
25461441|NCT02932579|Sensory System Agents|sensory system agents|mesh-ancestor
25461442|NCT02932579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25461443|NCT02932579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461444|NCT02932579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25461445|NCT02932579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25461446|NCT02932579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25461447|NCT02932579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461448|NCT02932579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461449|NCT02932579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25461450|NCT02932579|Narcotics|narcotics|mesh-ancestor
25461451|NCT02932579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25461452|NCT02932579|Antipyretics|antipyretics|mesh-ancestor
25461453|NCT02897375|Cisplatin|cisplatin|mesh-list
25461454|NCT02897375|Carboplatin|carboplatin|mesh-list
25461455|NCT02897375|Palbociclib|palbociclib|mesh-list
25461456|NCT02897375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461457|NCT02897375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25461458|NCT02897375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461459|NCT02897375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461460|NCT02856113|Alogliptin|alogliptin|mesh-list
25461461|NCT02856113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25461462|NCT02856113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461463|NCT02856113|Incretins|incretins|mesh-ancestor
25461465|NCT02856113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25461466|NCT02856113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25461467|NCT02856113|Protease Inhibitors|protease inhibitors|mesh-ancestor
25461468|NCT02856113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461469|NCT02856113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461470|NCT02852967|Belumosudil|belumosudil|mesh-list
25461471|NCT02852967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25461472|NCT02852967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461473|NCT02852967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461474|NCT02823821|Dialysis Solutions|dialysis solutions|mesh-list
25461475|NCT02823821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25461476|NCT02810418|Paclitaxel|paclitaxel|mesh-list
25461477|NCT02810418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25461478|NCT02810418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461479|NCT02810418|Tubulin Modulators|tubulin modulators|mesh-ancestor
25461480|NCT02810418|Antimitotic Agents|antimitotic agents|mesh-ancestor
25461481|NCT02810418|Mitosis Modulators|mitosis modulators|mesh-ancestor
25461482|NCT02810418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461483|NCT02788981|Paclitaxel|paclitaxel|mesh-list
25461484|NCT02788981|Mifepristone|mifepristone|mesh-list
25461485|NCT02788981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25461486|NCT02788981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461487|NCT02788981|Tubulin Modulators|tubulin modulators|mesh-ancestor
25461488|NCT02788981|Antimitotic Agents|antimitotic agents|mesh-ancestor
25461489|NCT02788981|Mitosis Modulators|mitosis modulators|mesh-ancestor
25461490|NCT02788981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461491|NCT02788981|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25461492|NCT02788981|Abortifacient Agents|abortifacient agents|mesh-ancestor
25461493|NCT02788981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25461494|NCT02788981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461495|NCT02788981|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25461496|NCT02788981|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25461497|NCT02788981|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25461498|NCT02788981|Contraceptive Agents|contraceptive agents|mesh-ancestor
25461499|NCT02788981|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25461500|NCT02788981|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25461501|NCT02788981|Hormone Antagonists|hormone antagonists|mesh-ancestor
25461502|NCT02788981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25461503|NCT02788981|Luteolytic Agents|luteolytic agents|mesh-ancestor
25461504|NCT02788981|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25461505|NCT02788981|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25461506|NCT02788773|Durvalumab|durvalumab|mesh-list
25461507|NCT02788773|Tremelimumab|tremelimumab|mesh-list
25461508|NCT02788773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25461509|NCT02788773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461510|NCT02781584|Firsocostat|firsocostat|mesh-list
25461511|NCT02781584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461512|NCT02781584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461513|NCT02767557|Gemcitabine|gemcitabine|mesh-list
25461514|NCT02767557|Paclitaxel|paclitaxel|mesh-list
25461515|NCT02767557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25461516|NCT02767557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461517|NCT02767557|Tubulin Modulators|tubulin modulators|mesh-ancestor
25461518|NCT02767557|Antimitotic Agents|antimitotic agents|mesh-ancestor
25461519|NCT02767557|Mitosis Modulators|mitosis modulators|mesh-ancestor
25461520|NCT02767557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461521|NCT02767557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25461522|NCT02767557|Antimetabolites|antimetabolites|mesh-ancestor
25461523|NCT02767557|Antiviral Agents|antiviral agents|mesh-ancestor
25461524|NCT02767557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25461525|NCT02767557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461526|NCT02767557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25461527|NCT02767557|Immunologic Factors|immunologic factors|mesh-ancestor
25461528|NCT02767557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461529|NCT02730130|Pembrolizumab|pembrolizumab|mesh-list
25461530|NCT02730130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25461531|NCT02730130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461532|NCT02682004|Serotonin|serotonin|mesh-list
25461533|NCT02682004|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25320866|NCT04929626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320867|NCT04929626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25461534|NCT02682004|Serotonin Agents|serotonin agents|mesh-ancestor
25461535|NCT02682004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25461536|NCT02682004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461537|NCT02682004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461538|NCT02656797|Amphotericin B|amphotericin b|mesh-list
25461539|NCT02656797|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25461540|NCT02656797|Amebicides|amebicides|mesh-ancestor
25461541|NCT02656797|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25461542|NCT02656797|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25461543|NCT02656797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25461544|NCT02656797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25461545|NCT02656797|Antifungal Agents|antifungal agents|mesh-ancestor
25461546|NCT02652130|Remestemcel-l|remestemcel-l|mesh-list
25461547|NCT02652130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25461548|NCT02652130|Antiviral Agents|antiviral agents|mesh-ancestor
25461549|NCT02652130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25461550|NCT02625441|Trastuzumab|trastuzumab|mesh-list
25461551|NCT02625441|Pertuzumab|pertuzumab|mesh-list
25461552|NCT02625441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25461553|NCT02625441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461554|NCT02617407|Listerine|listerine|mesh-list
25461555|NCT02617407|Sodium Fluoride|sodium fluoride|mesh-list
25461556|NCT02617407|Cariostatic Agents|cariostatic agents|mesh-ancestor
25461557|NCT02617407|Protective Agents|protective agents|mesh-ancestor
25461558|NCT02617407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461559|NCT02617407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25461560|NCT02617407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25461561|NCT02616393|XL647|xl647|mesh-list
25461562|NCT02616393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461563|NCT02616393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25461564|NCT02616393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461565|NCT02616393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461566|NCT02608385|Pembrolizumab|pembrolizumab|mesh-list
25461567|NCT02608385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25461568|NCT02608385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461569|NCT02602288|Nicotine|nicotine|mesh-list
25461570|NCT02602288|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25461571|NCT02602288|Autonomic Agents|autonomic agents|mesh-ancestor
25461572|NCT02602288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25461573|NCT02602288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461574|NCT02602288|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25461575|NCT02602288|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25461576|NCT02602288|Cholinergic Agents|cholinergic agents|mesh-ancestor
25461577|NCT02602288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25461578|NCT02602288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461579|NCT02593786|Nivolumab|nivolumab|mesh-list
25461580|NCT02593786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25461581|NCT02593786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461582|NCT02593786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25461583|NCT02593786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461584|NCT02577523|Levodopa|levodopa|mesh-list
25461585|NCT02577523|Carbidopa|carbidopa|mesh-list
25461586|NCT02577523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25461587|NCT02577523|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25461588|NCT02577523|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25461589|NCT02577523|Dopamine Agents|dopamine agents|mesh-ancestor
25461590|NCT02577523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25461591|NCT02577523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461592|NCT02577523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722108|NCT02497391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25461593|NCT02577523|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25461594|NCT02577523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461595|NCT02542657|Clarithromycin|clarithromycin|mesh-list
25461596|NCT02542657|Dexamethasone|dexamethasone|mesh-list
25461597|NCT02542657|Pomalidomide|pomalidomide|mesh-list
25461598|NCT02542657|Ixazomib|ixazomib|mesh-list
25461599|NCT02542657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25461600|NCT02542657|Antiemetics|antiemetics|mesh-ancestor
25461601|NCT02542657|Autonomic Agents|autonomic agents|mesh-ancestor
25320940|NCT04927949|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25320941|NCT04927949|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25320942|NCT04927949|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25320943|NCT04927949|Purinergic Agents|purinergic agents|mesh-ancestor
25320944|NCT04927949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25320945|NCT04927949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320947|NCT04928586|Pirfenidone|pirfenidone|mesh-list
25461602|NCT02542657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25461603|NCT02542657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461604|NCT02542657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25461605|NCT02542657|Glucocorticoids|glucocorticoids|mesh-ancestor
25461606|NCT02542657|Hormones|hormones|mesh-ancestor
25461607|NCT02542657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25461608|NCT02542657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25461609|NCT02542657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461610|NCT02542657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461611|NCT02542657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25461612|NCT02542657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25461613|NCT02542657|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25461614|NCT02542657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461615|NCT02542657|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25461616|NCT02542657|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25461617|NCT02542657|Immunologic Factors|immunologic factors|mesh-ancestor
25461618|NCT02542657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25461619|NCT02542657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25461620|NCT02542657|Growth Substances|growth substances|mesh-ancestor
25461621|NCT02542657|Growth Inhibitors|growth inhibitors|mesh-ancestor
25461622|NCT02542657|Protease Inhibitors|protease inhibitors|mesh-ancestor
25461623|NCT02427958|Leuprolide|leuprolide|mesh-list
25461624|NCT02427958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25461625|NCT02427958|Fertility Agents|fertility agents|mesh-ancestor
25461626|NCT02427958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25461627|NCT02427958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461628|NCT02427958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25461629|NCT02427958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461630|NCT02425826|Thalidomide|thalidomide|mesh-list
25461631|NCT02425826|Apremilast|apremilast|mesh-list
25461632|NCT02425826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25461633|NCT02425826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25461634|NCT02425826|Analgesics|analgesics|mesh-ancestor
25461635|NCT02425826|Sensory System Agents|sensory system agents|mesh-ancestor
25461636|NCT02425826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25461637|NCT02425826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461638|NCT02425826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25461639|NCT02425826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25461640|NCT02425826|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25461641|NCT02425826|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25461642|NCT02425826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461643|NCT02425826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461644|NCT02425826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25461645|NCT02425826|Immunologic Factors|immunologic factors|mesh-ancestor
25461646|NCT02425826|Leprostatic Agents|leprostatic agents|mesh-ancestor
25461647|NCT02425826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25461648|NCT02425826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25461649|NCT02425826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25461650|NCT02425826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25461651|NCT02425826|Growth Substances|growth substances|mesh-ancestor
25461652|NCT02425826|Growth Inhibitors|growth inhibitors|mesh-ancestor
25461653|NCT02425826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461654|NCT02400567|Cyclophosphamide|cyclophosphamide|mesh-list
25461655|NCT02400567|Letrozole|letrozole|mesh-list
25461656|NCT02400567|Epirubicin|epirubicin|mesh-list
25461657|NCT02400567|Palbociclib|palbociclib|mesh-list
25461658|NCT02400567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25461659|NCT02400567|Immunologic Factors|immunologic factors|mesh-ancestor
25461660|NCT02400567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461661|NCT02400567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25461662|NCT02400567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25461663|NCT02400567|Alkylating Agents|alkylating agents|mesh-ancestor
25321025|NCT04927000|Tofacitinib|tofacitinib|mesh-list
25321026|NCT04927000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25321027|NCT04927000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321028|NCT04927000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321029|NCT04926753|Fluorouracil|fluorouracil|mesh-list
25321030|NCT04926753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321031|NCT04926753|Antimetabolites|antimetabolites|mesh-ancestor
25321032|NCT04926753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321033|NCT04926753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25321034|NCT04926753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25321035|NCT04926753|Immunologic Factors|immunologic factors|mesh-ancestor
25822877|NCT00004688|Immunologic Factors|immunologic factors|mesh-ancestor
25321037|NCT04926480|Anesthetics|anesthetics|mesh-list
25461664|NCT02400567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461665|NCT02400567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461666|NCT02400567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25461667|NCT02400567|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25461668|NCT02400567|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25461669|NCT02400567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461670|NCT02400567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25461671|NCT02400567|Hormone Antagonists|hormone antagonists|mesh-ancestor
25461672|NCT02400567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25461673|NCT02400567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25461674|NCT02400567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25461675|NCT02400567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25461676|NCT02400567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25461677|NCT02384239|Tamoxifen|tamoxifen|mesh-list
25461678|NCT02384239|Fulvestrant|fulvestrant|mesh-list
25461679|NCT02384239|Palbociclib|palbociclib|mesh-list
25461680|NCT02384239|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25461681|NCT02384239|Hormone Antagonists|hormone antagonists|mesh-ancestor
25461682|NCT02384239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25461683|NCT02384239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461684|NCT02384239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25461685|NCT02384239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461686|NCT02384239|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25461687|NCT02384239|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25461688|NCT02384239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25461689|NCT02384239|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25461690|NCT02384239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25644598|NCT01438177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461691|NCT02384239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461692|NCT02384239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461693|NCT02361801|Dobutamine|dobutamine|mesh-list
25461694|NCT02361801|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25461695|NCT02361801|Sympathomimetics|sympathomimetics|mesh-ancestor
25461696|NCT02361801|Autonomic Agents|autonomic agents|mesh-ancestor
25461697|NCT02361801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25461698|NCT02361801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461699|NCT02361801|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25461700|NCT02361801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25461701|NCT02361801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25461702|NCT02361801|Adrenergic Agents|adrenergic agents|mesh-ancestor
25461703|NCT02361801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25461704|NCT02361801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461705|NCT02361801|Protective Agents|protective agents|mesh-ancestor
25461706|NCT02356705|Lidocaine|lidocaine|mesh-list
25461707|NCT02356705|Midazolam|midazolam|mesh-list
25461708|NCT02356705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25461709|NCT02356705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25461710|NCT02356705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25461711|NCT02356705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461712|NCT02356705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25461713|NCT02356705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25461714|NCT02356705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25461715|NCT02356705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25461716|NCT02356705|Anesthetics, General|anesthetics, general|mesh-ancestor
25461717|NCT02356705|Anesthetics|anesthetics|mesh-ancestor
25461718|NCT02356705|GABA Modulators|gaba modulators|mesh-ancestor
25461719|NCT02356705|GABA Agents|gaba agents|mesh-ancestor
25461720|NCT02356705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25461721|NCT02356705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461722|NCT02356705|Anesthetics, Local|anesthetics, local|mesh-ancestor
25461723|NCT02356705|Sensory System Agents|sensory system agents|mesh-ancestor
25461724|NCT02356705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25461725|NCT02356705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25461726|NCT02356705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25321082|NCT04925557|Ocrelizumab|ocrelizumab|mesh-list
25321083|NCT04925557|Siponimod|siponimod|mesh-list
25321084|NCT04925557|Immunologic Factors|immunologic factors|mesh-ancestor
25321085|NCT04925557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321086|NCT04925557|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25321087|NCT04925557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321088|NCT04925557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25321089|NCT04925141|Dasatinib|dasatinib|mesh-list
25321090|NCT04925141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321091|NCT04925141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25461729|NCT02353247|Norethindrone|norethindrone|mesh-list
25461730|NCT02353247|Norethindrone Acetate|norethindrone acetate|mesh-list
25461731|NCT02353247|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25461732|NCT02353247|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25461733|NCT02353247|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25461734|NCT02353247|Contraceptive Agents|contraceptive agents|mesh-ancestor
25461735|NCT02353247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25461736|NCT02353247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461737|NCT02353247|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25461738|NCT02353247|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25461739|NCT02316002|Pembrolizumab|pembrolizumab|mesh-list
25461740|NCT02316002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25461741|NCT02316002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461742|NCT02254941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25461743|NCT02254941|Antibodies|antibodies|mesh-list
25461744|NCT02254941|Immunoglobulins|immunoglobulins|mesh-list
25461745|NCT02254941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25461746|NCT02254941|Immunologic Factors|immunologic factors|mesh-ancestor
25461747|NCT02254941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461748|NCT02254941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461749|NCT02229084|Paclitaxel|paclitaxel|mesh-list
25461750|NCT02229084|Docetaxel|docetaxel|mesh-list
25461751|NCT02229084|Cyclophosphamide|cyclophosphamide|mesh-list
25461752|NCT02229084|Doxorubicin|doxorubicin|mesh-list
25461753|NCT02229084|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25461754|NCT02229084|Freund's Adjuvant|freund's adjuvant|mesh-list
25461755|NCT02229084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25461756|NCT02229084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461757|NCT02229084|Tubulin Modulators|tubulin modulators|mesh-ancestor
25461758|NCT02229084|Antimitotic Agents|antimitotic agents|mesh-ancestor
25461759|NCT02229084|Mitosis Modulators|mitosis modulators|mesh-ancestor
25461760|NCT02229084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461761|NCT02229084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25461762|NCT02229084|Immunologic Factors|immunologic factors|mesh-ancestor
25461763|NCT02229084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461764|NCT02229084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25461765|NCT02229084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25461766|NCT02229084|Alkylating Agents|alkylating agents|mesh-ancestor
25461767|NCT02229084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25722115|NCT02497404|Antimetabolites|antimetabolites|mesh-ancestor
25461768|NCT02229084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25461769|NCT02229084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25461770|NCT02229084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25461771|NCT02229084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461772|NCT02229084|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25461773|NCT02098954|Gemcitabine|gemcitabine|mesh-list
25461774|NCT02098954|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25461775|NCT02098954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25461776|NCT02098954|Antimetabolites|antimetabolites|mesh-ancestor
25461777|NCT02098954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461778|NCT02098954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461779|NCT02098954|Antiviral Agents|antiviral agents|mesh-ancestor
25461780|NCT02098954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25461781|NCT02098954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461782|NCT02098954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25461783|NCT02098954|Immunologic Factors|immunologic factors|mesh-ancestor
25461784|NCT02098954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461785|NCT02098954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25461786|NCT01927068|Paclitaxel|paclitaxel|mesh-list
25461787|NCT01927068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25461788|NCT01927068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461789|NCT01927068|Tubulin Modulators|tubulin modulators|mesh-ancestor
25461790|NCT01927068|Antimitotic Agents|antimitotic agents|mesh-ancestor
25461791|NCT01927068|Mitosis Modulators|mitosis modulators|mesh-ancestor
25461792|NCT01927068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461793|NCT01837277|Efavirenz|efavirenz|mesh-list
25461794|NCT01837277|Dolutegravir|dolutegravir|mesh-list
25461795|NCT01837277|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25461796|NCT01837277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25461797|NCT01837277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461798|NCT01837277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321235|NCT04922723|Daratumumab|daratumumab|mesh-list
25321236|NCT04922723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321237|NCT04922541|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25321238|NCT04922541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321239|NCT04922541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461800|NCT01837277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25461801|NCT01837277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25461802|NCT01837277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25461803|NCT01837277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25461804|NCT01837277|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25461805|NCT01837277|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25461806|NCT01837277|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25461807|NCT01837277|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25461808|NCT01837277|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25461809|NCT01837277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25461810|NCT01837277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25461811|NCT01813435|Aspirin|aspirin|mesh-list
25461812|NCT01813435|Clopidogrel|clopidogrel|mesh-list
25461813|NCT01813435|Ticagrelor|ticagrelor|mesh-list
25461814|NCT01813435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25461815|NCT01813435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25461816|NCT01813435|Analgesics|analgesics|mesh-ancestor
25461817|NCT01813435|Sensory System Agents|sensory system agents|mesh-ancestor
25461818|NCT01813435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25461819|NCT01813435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461820|NCT01813435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25461821|NCT01813435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25461822|NCT01813435|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25461823|NCT01813435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25461824|NCT01813435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461825|NCT01813435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25461826|NCT01813435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25461827|NCT01813435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461828|NCT01813435|Antipyretics|antipyretics|mesh-ancestor
25461829|NCT01813435|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25461830|NCT01813435|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25461831|NCT01813435|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25461832|NCT01813435|Purinergic Agents|purinergic agents|mesh-ancestor
25461833|NCT01813435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25461834|NCT01779050|Paclitaxel|paclitaxel|mesh-list
25461835|NCT01779050|Docetaxel|docetaxel|mesh-list
25461836|NCT01779050|Cyclophosphamide|cyclophosphamide|mesh-list
25461837|NCT01779050|Carboplatin|carboplatin|mesh-list
25461838|NCT01779050|Doxorubicin|doxorubicin|mesh-list
25461839|NCT01779050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25461840|NCT01779050|Fluorouracil|fluorouracil|mesh-list
25461841|NCT01779050|Trastuzumab|trastuzumab|mesh-list
25461842|NCT01779050|Epirubicin|epirubicin|mesh-list
25461843|NCT01779050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25461844|NCT01779050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461845|NCT01779050|Tubulin Modulators|tubulin modulators|mesh-ancestor
25461846|NCT01779050|Antimitotic Agents|antimitotic agents|mesh-ancestor
25461847|NCT01779050|Mitosis Modulators|mitosis modulators|mesh-ancestor
25461848|NCT01779050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461849|NCT01779050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25461850|NCT01779050|Immunologic Factors|immunologic factors|mesh-ancestor
25461851|NCT01779050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461852|NCT01779050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25461853|NCT01779050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25461854|NCT01779050|Alkylating Agents|alkylating agents|mesh-ancestor
25461855|NCT01779050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25461856|NCT01779050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25461857|NCT01779050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25461858|NCT01779050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25461859|NCT01779050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461860|NCT01779050|Antimetabolites|antimetabolites|mesh-ancestor
25461861|NCT01779050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25461862|NCT01779050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25461863|NCT01765218|Topiramate|topiramate|mesh-list
25461864|NCT01765218|Anticonvulsants|anticonvulsants|mesh-ancestor
25461865|NCT01765218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25461866|NCT01765218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461867|NCT01690299|Etanercept|etanercept|mesh-list
25461868|NCT01690299|Apremilast|apremilast|mesh-list
25461869|NCT01690299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25461870|NCT01690299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25461871|NCT01690299|Analgesics|analgesics|mesh-ancestor
25461872|NCT01690299|Sensory System Agents|sensory system agents|mesh-ancestor
25461873|NCT01690299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25321360|NCT04920747|Taxane|taxane|mesh-list
25461874|NCT01690299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461875|NCT01690299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25461876|NCT01690299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25461877|NCT01690299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25461878|NCT01690299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25461879|NCT01690299|Immunologic Factors|immunologic factors|mesh-ancestor
25461880|NCT01690299|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25461881|NCT01690299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25461882|NCT01690299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461883|NCT01690299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461884|NCT01653925|Dutasteride|dutasteride|mesh-list
25461885|NCT01653925|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25461886|NCT01653925|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25461887|NCT01653925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461888|NCT01653925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461889|NCT01653925|Hormone Antagonists|hormone antagonists|mesh-ancestor
25461890|NCT01653925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25461891|NCT01653925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461892|NCT01525329|Fluorouracil|fluorouracil|mesh-list
25461893|NCT01525329|Antimetabolites|antimetabolites|mesh-ancestor
25461894|NCT01525329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461895|NCT01525329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25461896|NCT01525329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461897|NCT01525329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25461898|NCT01525329|Immunologic Factors|immunologic factors|mesh-ancestor
25461899|NCT01525329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461900|NCT01482286|Metformin|metformin|mesh-list
25461901|NCT01482286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25644599|NCT01438177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25644600|NCT01438177|Amebicides|amebicides|mesh-ancestor
25644601|NCT01438177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25644602|NCT01438177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25461902|NCT01482286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461903|NCT01452152|Clopidogrel|clopidogrel|mesh-list
25461904|NCT01452152|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25461905|NCT01452152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25461906|NCT01452152|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25461907|NCT01452152|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25461908|NCT01452152|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25461909|NCT01452152|Purinergic Agents|purinergic agents|mesh-ancestor
25461910|NCT01452152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25461911|NCT01452152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461912|NCT01452152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461914|NCT01232283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25461915|NCT01232283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25461916|NCT01232283|Analgesics|analgesics|mesh-ancestor
25461917|NCT01232283|Sensory System Agents|sensory system agents|mesh-ancestor
25461918|NCT01232283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25461919|NCT01232283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461920|NCT01232283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25461921|NCT01232283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25461922|NCT01232283|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25461923|NCT01232283|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25461924|NCT01232283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461925|NCT01232283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461926|NCT01231516|Raltegravir Potassium|raltegravir potassium|mesh-list
25461927|NCT01231516|Dolutegravir|dolutegravir|mesh-list
25461928|NCT01231516|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25461929|NCT01231516|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25461930|NCT01231516|Antiviral Agents|antiviral agents|mesh-ancestor
25321365|NCT04920760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321366|NCT04920669|Dexmedetomidine|dexmedetomidine|mesh-list
25321367|NCT04920669|Bupivacaine|bupivacaine|mesh-list
25321368|NCT04920669|Anesthetics, Local|anesthetics, local|mesh-ancestor
25321369|NCT04920669|Anesthetics|anesthetics|mesh-ancestor
25321370|NCT04920669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25321371|NCT04920669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321372|NCT04920669|Sensory System Agents|sensory system agents|mesh-ancestor
25321373|NCT04920669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25321374|NCT04920669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25321375|NCT04920669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25321376|NCT04920669|Analgesics|analgesics|mesh-ancestor
25321377|NCT04920669|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25321378|NCT04920669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25321379|NCT04920669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25461931|NCT01231516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25461932|NCT01231516|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25461933|NCT01231516|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25461934|NCT01231516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461935|NCT01231516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461936|NCT01194219|Apremilast|apremilast|mesh-list
25461937|NCT01194219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25461938|NCT01194219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25461939|NCT01194219|Analgesics|analgesics|mesh-ancestor
25461940|NCT01194219|Sensory System Agents|sensory system agents|mesh-ancestor
25461941|NCT01194219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25461942|NCT01194219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461943|NCT01194219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25461944|NCT01194219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25461945|NCT01194219|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25461946|NCT01194219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25461947|NCT01194219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722142|NCT02497976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461948|NCT01194219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461949|NCT01193842|Prednisone|prednisone|mesh-list
25461950|NCT01193842|Cortisone|cortisone|mesh-list
25461951|NCT01193842|Cyclophosphamide|cyclophosphamide|mesh-list
25461952|NCT01193842|Rituximab|rituximab|mesh-list
25461953|NCT01193842|Doxorubicin|doxorubicin|mesh-list
25461954|NCT01193842|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25461955|NCT01193842|Etoposide|etoposide|mesh-list
25461956|NCT01193842|Vincristine|vincristine|mesh-list
25461957|NCT01193842|Etoposide phosphate|etoposide phosphate|mesh-list
25461959|NCT01193842|Podophyllotoxin|podophyllotoxin|mesh-list
25461960|NCT01193842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25461961|NCT01193842|Antibodies|antibodies|mesh-list
25461962|NCT01193842|Immunoglobulins|immunoglobulins|mesh-list
25461963|NCT01193842|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25461964|NCT01193842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25461965|NCT01193842|Immunologic Factors|immunologic factors|mesh-ancestor
25461966|NCT01193842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461967|NCT01193842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25461968|NCT01193842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25461969|NCT01193842|Alkylating Agents|alkylating agents|mesh-ancestor
25461970|NCT01193842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25461971|NCT01193842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461972|NCT01193842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25461973|NCT01193842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25461974|NCT01193842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25461975|NCT01193842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25461976|NCT01193842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25461977|NCT01193842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25461978|NCT01193842|Glucocorticoids|glucocorticoids|mesh-ancestor
25461979|NCT01193842|Hormones|hormones|mesh-ancestor
25461980|NCT01193842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25461981|NCT01193842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25461982|NCT01193842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25461983|NCT01193842|Tubulin Modulators|tubulin modulators|mesh-ancestor
25461984|NCT01193842|Antimitotic Agents|antimitotic agents|mesh-ancestor
25461985|NCT01193842|Mitosis Modulators|mitosis modulators|mesh-ancestor
25461986|NCT01193842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25461987|NCT01193842|Keratolytic Agents|keratolytic agents|mesh-ancestor
25461988|NCT01193842|Dermatologic Agents|dermatologic agents|mesh-ancestor
25461989|NCT01061840|Molgramostim|molgramostim|mesh-list
25461990|NCT01061840|Modafinil|modafinil|mesh-list
25461991|NCT01061840|Vaccines|vaccines|mesh-list
25461992|NCT01061840|Sargramostim|sargramostim|mesh-list
25461993|NCT01061840|Immunologic Factors|immunologic factors|mesh-ancestor
25461994|NCT01061840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25461995|NCT01061840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25461996|NCT01061840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25461997|NCT01061840|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25461998|NCT01061840|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25461999|NCT01061840|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25462000|NCT01061840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462001|NCT00740116|Tranexamic Acid|tranexamic acid|mesh-list
25462002|NCT00740116|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25462003|NCT00740116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25462004|NCT00740116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462005|NCT00740116|Hemostatics|hemostatics|mesh-ancestor
25462006|NCT00740116|Coagulants|coagulants|mesh-ancestor
25462013|NCT00142584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25462014|NCT00142584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462015|NCT00142584|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25462017|NCT00142584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25462018|NCT00142584|Adrenergic Agents|adrenergic agents|mesh-ancestor
25462019|NCT00142584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25462020|NCT00142584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462021|NCT00142584|Vasodilator Agents|vasodilator agents|mesh-ancestor
25722154|NCT02498483|Analgesics|analgesics|mesh-ancestor
25462022|NCT00142584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25462023|NCT00142584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25462024|NCT00142584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25462025|NCT00107250|Paclitaxel|paclitaxel|mesh-list
25462026|NCT00107250|Carboplatin|carboplatin|mesh-list
25462027|NCT00107250|Capecitabine|capecitabine|mesh-list
25462028|NCT00107250|Cediranib|cediranib|mesh-list
25462029|NCT00107250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25462030|NCT00107250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462031|NCT00107250|Tubulin Modulators|tubulin modulators|mesh-ancestor
25462032|NCT00107250|Antimitotic Agents|antimitotic agents|mesh-ancestor
25462033|NCT00107250|Mitosis Modulators|mitosis modulators|mesh-ancestor
25462034|NCT00107250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462035|NCT00107250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25462036|NCT00107250|Antimetabolites|antimetabolites|mesh-ancestor
25462037|NCT00107250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25462038|NCT00107250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25462046|NCT05285449|Anticonvulsants|anticonvulsants|mesh-ancestor
25462047|NCT05285397|Liraglutide|liraglutide|mesh-list
25462048|NCT05285397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25462049|NCT05285397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462050|NCT05285397|Incretins|incretins|mesh-ancestor
25462051|NCT05285397|Hormones|hormones|mesh-ancestor
25462052|NCT05285397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25462053|NCT05285384|Myeloma Proteins|myeloma proteins|mesh-list
25462054|NCT05285384|Paraproteins|paraproteins|mesh-list
25462055|NCT05285384|Immunologic Factors|immunologic factors|mesh-ancestor
25462056|NCT05285384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462057|NCT05285293|Vitamin A|vitamin a|mesh-list
25462058|NCT05285293|Vitamins|vitamins|mesh-ancestor
25462059|NCT05285293|Micronutrients|micronutrients|mesh-ancestor
25462060|NCT05285293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462061|NCT05285228|Fluorides|fluorides|mesh-list
25462062|NCT05285228|Fluorides, Topical|fluorides, topical|mesh-list
25462063|NCT05285228|Cariostatic Agents|cariostatic agents|mesh-ancestor
25462064|NCT05285228|Protective Agents|protective agents|mesh-ancestor
25462065|NCT05285228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462066|NCT05285085|Atorvastatin|atorvastatin|mesh-list
25462067|NCT05285085|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25462068|NCT05285085|Simvastatin|simvastatin|mesh-list
25462069|NCT05285085|Pravastatin|pravastatin|mesh-list
25462070|NCT05285085|Pitavastatin|pitavastatin|mesh-list
25462071|NCT05285085|Lovastatin|lovastatin|mesh-list
25462072|NCT05285085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25462073|NCT05285085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25462074|NCT05285085|Antimetabolites|antimetabolites|mesh-ancestor
25462075|NCT05285085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462076|NCT05285085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25462077|NCT05285085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25462078|NCT05285085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25462079|NCT05284994|Osimertinib|osimertinib|mesh-list
25462080|NCT05284994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462081|NCT05284994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25462082|NCT05284994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25462083|NCT05284994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462084|NCT05284942|Mycophenolic Acid|mycophenolic acid|mesh-list
25462085|NCT05284942|Prednisone|prednisone|mesh-list
25462086|NCT05284942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25462087|NCT05284942|Glucocorticoids|glucocorticoids|mesh-ancestor
25462088|NCT05284942|Hormones|hormones|mesh-ancestor
25462089|NCT05284942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25462090|NCT05284942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462091|NCT05284942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25462092|NCT05284942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462093|NCT05284942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25462094|NCT05284942|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25462095|NCT05284942|Antitubercular Agents|antitubercular agents|mesh-ancestor
25462096|NCT05284942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25462097|NCT05284942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25462098|NCT05284942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25462099|NCT05284942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462100|NCT05284851|Vaccines|vaccines|mesh-list
25462101|NCT05284851|Immunologic Factors|immunologic factors|mesh-ancestor
25462102|NCT05284851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462103|NCT05284734|Anesthetics|anesthetics|mesh-list
25462104|NCT05284734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25462105|NCT05284734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462113|NCT05284448|Pentoxifylline|pentoxifylline|mesh-list
25462114|NCT05284448|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25462115|NCT05284448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25462116|NCT05284448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462117|NCT05284448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25462118|NCT05284448|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25462119|NCT05284448|Protective Agents|protective agents|mesh-ancestor
25462120|NCT05284448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462121|NCT05284448|Vasodilator Agents|vasodilator agents|mesh-ancestor
25462122|NCT05284448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25462123|NCT05284448|Antioxidants|antioxidants|mesh-ancestor
25462124|NCT05284344|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25462125|NCT05284344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462126|NCT05284318|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25462127|NCT05284318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25462128|NCT05284136|Prednisolone|prednisolone|mesh-list
25462129|NCT05284136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25462130|NCT05284136|Glucocorticoids|glucocorticoids|mesh-ancestor
25462131|NCT05284136|Hormones|hormones|mesh-ancestor
25462132|NCT05284136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25462133|NCT05284136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462134|NCT05284136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25462135|NCT05284136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462136|NCT05284084|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
25462137|NCT05284084|Histamine Antagonists|histamine antagonists|mesh-ancestor
25462138|NCT05284084|Histamine Agents|histamine agents|mesh-ancestor
25462139|NCT05284084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25462140|NCT05284084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462141|NCT05284084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462142|NCT05284019|Erenumab|erenumab|mesh-list
25462143|NCT05284019|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25462144|NCT05284019|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25462145|NCT05284019|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25462146|NCT05284019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462147|NCT05284019|Analgesics|analgesics|mesh-ancestor
25462148|NCT05284019|Sensory System Agents|sensory system agents|mesh-ancestor
25462149|NCT05284019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25462150|NCT05284019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462151|NCT05284019|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25321580|NCT04918953|Prednisolone|prednisolone|mesh-list
25462152|NCT05284019|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25462153|NCT05284019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25462154|NCT05284019|Cholinergic Agents|cholinergic agents|mesh-ancestor
25462155|NCT05284019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25462156|NCT05283980|Bupivacaine|bupivacaine|mesh-list
25462157|NCT05283980|Anesthetics, Local|anesthetics, local|mesh-ancestor
25462158|NCT05283980|Anesthetics|anesthetics|mesh-ancestor
25462159|NCT05283980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25462160|NCT05283980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462161|NCT05283980|Sensory System Agents|sensory system agents|mesh-ancestor
25462162|NCT05283980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25462163|NCT05283954|Ascorbic Acid|ascorbic acid|mesh-list
25462164|NCT05283954|Ivermectin|ivermectin|mesh-list
25462165|NCT05283954|Albendazole|albendazole|mesh-list
25462166|NCT05283954|Prednisolone|prednisolone|mesh-list
25462167|NCT05283954|Fluoxetine|fluoxetine|mesh-list
25462168|NCT05283954|Vitamins|vitamins|mesh-ancestor
25462169|NCT05283954|Micronutrients|micronutrients|mesh-ancestor
25722173|NCT02498769|Botulinum Toxins|botulinum toxins|mesh-list
25462170|NCT05283954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462171|NCT05283954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25462172|NCT05283954|Glucocorticoids|glucocorticoids|mesh-ancestor
25462173|NCT05283954|Hormones|hormones|mesh-ancestor
25462174|NCT05283954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25462175|NCT05283954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25462176|NCT05283954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462177|NCT05283954|Protective Agents|protective agents|mesh-ancestor
25462178|NCT05283954|Antioxidants|antioxidants|mesh-ancestor
25462179|NCT05283954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462180|NCT05283954|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25462181|NCT05283954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25462182|NCT05283954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25462183|NCT05283954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25462184|NCT05283954|Serotonin Agents|serotonin agents|mesh-ancestor
25462185|NCT05283954|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25462186|NCT05283954|Antidepressive Agents|antidepressive agents|mesh-ancestor
25462187|NCT05283954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25462188|NCT05283954|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25462189|NCT05283954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25462191|NCT05283954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25462192|NCT05283954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25462193|NCT05283954|Anthelmintics|anthelmintics|mesh-ancestor
25462194|NCT05283954|Anticestodal Agents|anticestodal agents|mesh-ancestor
25462195|NCT05283954|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25462196|NCT05283954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25462197|NCT05283954|Tubulin Modulators|tubulin modulators|mesh-ancestor
25462198|NCT05283954|Antimitotic Agents|antimitotic agents|mesh-ancestor
25462199|NCT05283954|Mitosis Modulators|mitosis modulators|mesh-ancestor
25462200|NCT05283850|Calcium, Dietary|calcium, dietary|mesh-list
25462201|NCT05283850|Calcium|calcium|mesh-list
25462202|NCT05283850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25462203|NCT05283850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462204|NCT05283850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25462205|NCT05283694|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25462206|NCT05283694|Immunologic Factors|immunologic factors|mesh-ancestor
25462207|NCT05283694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462208|NCT05283681|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25462209|NCT05283681|Immunologic Factors|immunologic factors|mesh-ancestor
25462210|NCT05283681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462211|NCT05283551|Famciclovir|famciclovir|mesh-list
25462212|NCT05283551|Antiviral Agents|antiviral agents|mesh-ancestor
25462213|NCT05283551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25462214|NCT05283551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25462215|NCT05283551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25462216|NCT05283551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462217|NCT05283421|Estrogens|estrogens|mesh-list
25462218|NCT05283421|Hormones|hormones|mesh-ancestor
25462219|NCT05283421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25462220|NCT05283421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462221|NCT05265325|Epoetin Alfa|epoetin alfa|mesh-list
25462222|NCT05265325|Hematinics|hematinics|mesh-ancestor
25462223|NCT05262205|Anesthetics|anesthetics|mesh-list
25462224|NCT05262205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25462225|NCT05262205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462226|NCT05252884|Calcium, Dietary|calcium, dietary|mesh-list
25462227|NCT05252884|Calcitriol|calcitriol|mesh-list
25462243|NCT05233163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462244|NCT05233163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25462245|NCT05233163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462246|NCT05216744|Doxycycline|doxycycline|mesh-list
25462247|NCT05216744|Ceftriaxone|ceftriaxone|mesh-list
25462248|NCT05216744|Cefixime|cefixime|mesh-list
25462249|NCT05216744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25462250|NCT05216744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25462251|NCT05216744|Antimalarials|antimalarials|mesh-ancestor
25462252|NCT05216744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25462253|NCT05216744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25462254|NCT05206084|Sirolimus|sirolimus|mesh-list
25462255|NCT05206084|Everolimus|everolimus|mesh-list
25462256|NCT05206084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462257|NCT05206084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25462258|NCT05206084|Immunologic Factors|immunologic factors|mesh-ancestor
25462259|NCT05206084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462260|NCT05206084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25462261|NCT05206084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25462262|NCT05206084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25462263|NCT05206084|Antifungal Agents|antifungal agents|mesh-ancestor
25462264|NCT05183178|Ticagrelor|ticagrelor|mesh-list
25462265|NCT05183178|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25462266|NCT05183178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25462267|NCT05183178|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25462268|NCT05183178|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25462269|NCT05183178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25462270|NCT05183178|Purinergic Agents|purinergic agents|mesh-ancestor
25462271|NCT05183178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25462272|NCT05183178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462273|NCT05183178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462274|NCT05174351|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25462275|NCT05174351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25462276|NCT05174351|Adrenergic Agents|adrenergic agents|mesh-ancestor
25462277|NCT05174351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25462278|NCT05174351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462279|NCT05174351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462280|NCT05171257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25462281|NCT05171257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25462282|NCT05171257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25462283|NCT05171257|Antitubercular Agents|antitubercular agents|mesh-ancestor
25462284|NCT05163834|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25462285|NCT05163834|Immunologic Factors|immunologic factors|mesh-ancestor
25462286|NCT05163834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462287|NCT05161351|Vitamin D|vitamin d|mesh-list
25462288|NCT05161351|Cholecalciferol|cholecalciferol|mesh-list
25462289|NCT05161351|Baclofen|baclofen|mesh-list
25462290|NCT05161351|Vitamins|vitamins|mesh-ancestor
25462291|NCT05161351|Micronutrients|micronutrients|mesh-ancestor
25462292|NCT05161351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462293|NCT05161351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25462294|NCT05161351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25462295|NCT05161351|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25462296|NCT05161351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25462297|NCT05161351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25462298|NCT05161351|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25462299|NCT05161351|GABA Agonists|gaba agonists|mesh-ancestor
25462300|NCT05161351|GABA Agents|gaba agents|mesh-ancestor
25462301|NCT05161351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25462302|NCT05161351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462303|NCT05158166|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25462304|NCT05158166|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25462305|NCT05158166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25462306|NCT05158166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25462307|NCT05158166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462308|NCT05158166|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25462309|NCT05158166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25462310|NCT05158166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462311|NCT05158166|Cholinergic Agents|cholinergic agents|mesh-ancestor
25462312|NCT05158166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25462313|NCT05145283|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25462314|NCT05145283|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25462315|NCT05145283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25462316|NCT05145283|Immunologic Factors|immunologic factors|mesh-ancestor
25462317|NCT05145283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462318|NCT05137496|Methylprednisolone|methylprednisolone|mesh-list
25462319|NCT05137496|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25462320|NCT05137496|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25462321|NCT05137496|Prednisolone|prednisolone|mesh-list
25462322|NCT05137496|Prednisolone acetate|prednisolone acetate|mesh-list
25462323|NCT05137496|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25462324|NCT05137496|Prednisolone phosphate|prednisolone phosphate|mesh-list
25462325|NCT05137496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25462326|NCT05137496|Antiemetics|antiemetics|mesh-ancestor
25462327|NCT05137496|Autonomic Agents|autonomic agents|mesh-ancestor
25462328|NCT05137496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25462329|NCT05137496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462330|NCT05137496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25462331|NCT05137496|Glucocorticoids|glucocorticoids|mesh-ancestor
25462332|NCT05137496|Hormones|hormones|mesh-ancestor
25462333|NCT05137496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25462334|NCT05137496|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25462335|NCT05137496|Protective Agents|protective agents|mesh-ancestor
25462336|NCT05137496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25462337|NCT05137496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462338|NCT05061563|Esomeprazole|esomeprazole|mesh-list
25462339|NCT05061563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25462340|NCT05061563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25462341|NCT05061563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25462342|NCT05061563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25462343|NCT05061563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462344|NCT05053126|Pregabalin|pregabalin|mesh-list
25462345|NCT05053126|Oxycodone|oxycodone|mesh-list
25321780|NCT04916509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321781|NCT04916509|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25321796|NCT04916574|Antibodies|antibodies|mesh-list
25321797|NCT04916574|Immunologic Factors|immunologic factors|mesh-ancestor
25321798|NCT04916574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321799|NCT04916418|Ropivacaine|ropivacaine|mesh-list
25321800|NCT04916418|Anesthetics, Local|anesthetics, local|mesh-ancestor
25321801|NCT04916418|Anesthetics|anesthetics|mesh-ancestor
25321802|NCT04916418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25321803|NCT04916418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321804|NCT04916418|Sensory System Agents|sensory system agents|mesh-ancestor
25321805|NCT04916418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25321806|NCT04916353|Triamcinolone|triamcinolone|mesh-list
25321807|NCT04916353|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25462346|NCT05053126|Analgesics|analgesics|mesh-ancestor
25462347|NCT05053126|Sensory System Agents|sensory system agents|mesh-ancestor
25462348|NCT05053126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25462349|NCT05053126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462350|NCT05053126|Anticonvulsants|anticonvulsants|mesh-ancestor
25462351|NCT05053126|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25462352|NCT05053126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25462353|NCT05053126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462354|NCT05053126|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25462355|NCT05053126|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25462356|NCT05053126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25462357|NCT05053126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25462358|NCT05053126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25462359|NCT05053126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25462360|NCT05053126|Narcotics|narcotics|mesh-ancestor
25462361|NCT05030818|Aspirin|aspirin|mesh-list
25462362|NCT05030818|Ramipril|ramipril|mesh-list
25462363|NCT05030818|Atorvastatin|atorvastatin|mesh-list
25462364|NCT05030818|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25462365|NCT05030818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25462366|NCT05030818|Antimetabolites|antimetabolites|mesh-ancestor
25462367|NCT05030818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462368|NCT05030818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25462369|NCT05030818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25462370|NCT05030818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25462371|NCT05030818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25462372|NCT05030818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25462373|NCT05030818|Analgesics|analgesics|mesh-ancestor
25462374|NCT05030818|Sensory System Agents|sensory system agents|mesh-ancestor
25462375|NCT05030818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25462376|NCT05030818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462377|NCT05030818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25462378|NCT05030818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25462379|NCT05030818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25462380|NCT05030818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25462381|NCT05030818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25462382|NCT05030818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25462383|NCT05030818|Antipyretics|antipyretics|mesh-ancestor
25462384|NCT05030818|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25462385|NCT05030818|Protease Inhibitors|protease inhibitors|mesh-ancestor
25462386|NCT05030818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25462387|NCT05020912|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25462388|NCT05020912|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25462389|NCT05020912|Dermatologic Agents|dermatologic agents|mesh-ancestor
25462390|NCT04987892|Tamsulosin|tamsulosin|mesh-list
25462391|NCT04987892|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25462392|NCT04987892|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25462393|NCT04987892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25462394|NCT04987892|Adrenergic Agents|adrenergic agents|mesh-ancestor
25462395|NCT04987892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25462396|NCT04987892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462397|NCT04987892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462398|NCT04987892|Urological Agents|urological agents|mesh-ancestor
25462399|NCT04977167|Antibodies|antibodies|mesh-list
25462400|NCT04977167|Immunologic Factors|immunologic factors|mesh-ancestor
25462401|NCT04977167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462402|NCT04949503|Nimotuzumab|nimotuzumab|mesh-list
25462403|NCT04949503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25321849|NCT04916080|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25321850|NCT04916080|Antiviral Agents|antiviral agents|mesh-ancestor
25321851|NCT04916080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25321852|NCT04916080|Expectorants|expectorants|mesh-ancestor
25321853|NCT04916080|Respiratory System Agents|respiratory system agents|mesh-ancestor
25321854|NCT04916080|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25321855|NCT04916080|Antioxidants|antioxidants|mesh-ancestor
25321856|NCT04916080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321857|NCT04916080|Protective Agents|protective agents|mesh-ancestor
25321858|NCT04916080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321860|NCT04915963|Vitamin D|vitamin d|mesh-list
25321861|NCT04915963|Vitamins|vitamins|mesh-ancestor
25321862|NCT04915963|Micronutrients|micronutrients|mesh-ancestor
25321863|NCT04915963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321864|NCT04915963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25321865|NCT04915807|Paclitaxel|paclitaxel|mesh-list
25321866|NCT04915807|Irinotecan|irinotecan|mesh-list
25321867|NCT04915807|Ramucirumab|ramucirumab|mesh-list
25462404|NCT04949503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462406|NCT04933721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25462407|NCT04933721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462408|NCT04849325|Sirolimus|sirolimus|mesh-list
25462409|NCT04849325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25462410|NCT04849325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25462411|NCT04849325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25462412|NCT04849325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462413|NCT04849325|Antifungal Agents|antifungal agents|mesh-ancestor
25462414|NCT04849325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25462415|NCT04849325|Immunologic Factors|immunologic factors|mesh-ancestor
25462416|NCT04849325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462417|NCT04837768|Progesterone|progesterone|mesh-list
25462418|NCT04837768|Progestins|progestins|mesh-ancestor
25462419|NCT04837768|Hormones|hormones|mesh-ancestor
25462420|NCT04837768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25462421|NCT04837768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462422|NCT04769388|Carboplatin|carboplatin|mesh-list
25462423|NCT04769388|Pemetrexed|pemetrexed|mesh-list
25462424|NCT04769388|Osimertinib|osimertinib|mesh-list
25462425|NCT04769388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462426|NCT04769388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25462427|NCT04769388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462428|NCT04769388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25462429|NCT04769388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25462430|NCT04769388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25462431|NCT04759248|Trastuzumab|trastuzumab|mesh-list
25462432|NCT04759248|Atezolizumab|atezolizumab|mesh-list
25462433|NCT04759248|Vinorelbine|vinorelbine|mesh-list
25462434|NCT04759248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25462435|NCT04759248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462436|NCT04759248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25462437|NCT04759248|Tubulin Modulators|tubulin modulators|mesh-ancestor
25462438|NCT04759248|Antimitotic Agents|antimitotic agents|mesh-ancestor
25462439|NCT04759248|Mitosis Modulators|mitosis modulators|mesh-ancestor
25462440|NCT04759248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462441|NCT04733183|Dacarbazine|dacarbazine|mesh-list
25462442|NCT04733183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25462443|NCT04733183|Alkylating Agents|alkylating agents|mesh-ancestor
25462444|NCT04733183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462445|NCT04733183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462446|NCT04707430|Progesterone|progesterone|mesh-list
25462447|NCT04707430|Progestins|progestins|mesh-ancestor
25462448|NCT04707430|Hormones|hormones|mesh-ancestor
25462449|NCT04707430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25462450|NCT04707430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462451|NCT04679623|Midazolam|midazolam|mesh-list
25462452|NCT04679623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25462453|NCT04679623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25462454|NCT04679623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25462455|NCT04679623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462456|NCT04679623|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25462457|NCT04679623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25462458|NCT04679623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25462459|NCT04679623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25462460|NCT04679623|Anesthetics, General|anesthetics, general|mesh-ancestor
25462461|NCT04679623|Anesthetics|anesthetics|mesh-ancestor
25462462|NCT04679623|GABA Modulators|gaba modulators|mesh-ancestor
25462463|NCT04679623|GABA Agents|gaba agents|mesh-ancestor
25462464|NCT04679623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25462465|NCT04679623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462466|NCT04667013|Tetramethylpyrazine|tetramethylpyrazine|mesh-list
25462467|NCT04667013|Vasodilator Agents|vasodilator agents|mesh-ancestor
25462468|NCT04656067|Tranexamic Acid|tranexamic acid|mesh-list
25462469|NCT04656067|Ethamsylate|ethamsylate|mesh-list
25462470|NCT04656067|Oxytocin|oxytocin|mesh-list
25462471|NCT04656067|Oxytocics|oxytocics|mesh-ancestor
25462472|NCT04656067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25462473|NCT04656067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462474|NCT04656067|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25462475|NCT04656067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25462476|NCT04656067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462477|NCT04656067|Hemostatics|hemostatics|mesh-ancestor
25321935|NCT04914910|Insulin|insulin|mesh-list
25462478|NCT04656067|Coagulants|coagulants|mesh-ancestor
25462479|NCT04531943|Progesterone|progesterone|mesh-list
25462480|NCT04531943|Estrogens|estrogens|mesh-list
25462481|NCT04531943|Progestins|progestins|mesh-ancestor
25462482|NCT04531943|Hormones|hormones|mesh-ancestor
25462483|NCT04531943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25462484|NCT04531943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462485|NCT04419519|Venetoclax|venetoclax|mesh-list
25462486|NCT04419519|Antibodies|antibodies|mesh-list
25462487|NCT04419519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25462488|NCT04419519|Immunologic Factors|immunologic factors|mesh-ancestor
25462489|NCT04419519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462490|NCT04419519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462491|NCT04394117|Losartan|losartan|mesh-list
25462492|NCT04394117|Valsartan|valsartan|mesh-list
25462493|NCT04394117|Telmisartan|telmisartan|mesh-list
25462494|NCT04394117|Candesartan|candesartan|mesh-list
25462495|NCT04394117|Olmesartan|olmesartan|mesh-list
25462496|NCT04394117|Irbesartan|irbesartan|mesh-list
25462497|NCT04394117|Eprosartan|eprosartan|mesh-list
25462498|NCT04394117|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
25462499|NCT04394117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25462500|NCT04394117|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25462501|NCT04394117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462502|NCT04394117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25462503|NCT04394117|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
25462504|NCT04393753|Avelumab|avelumab|mesh-list
25462505|NCT04393753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25462506|NCT04393753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462507|NCT04335890|Vaccines|vaccines|mesh-list
25462508|NCT04335890|Immunologic Factors|immunologic factors|mesh-ancestor
25462509|NCT04335890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462510|NCT04203290|Bupivacaine|bupivacaine|mesh-list
25462511|NCT04203290|Sevoflurane|sevoflurane|mesh-list
25462512|NCT04203290|Anesthetics, Local|anesthetics, local|mesh-ancestor
25462513|NCT04203290|Anesthetics|anesthetics|mesh-ancestor
25462514|NCT04203290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25462515|NCT04203290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462516|NCT04203290|Sensory System Agents|sensory system agents|mesh-ancestor
25462517|NCT04203290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25462518|NCT04203290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25462519|NCT04203290|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25462520|NCT04203290|Anesthetics, General|anesthetics, general|mesh-ancestor
25462521|NCT04152863|Pembrolizumab|pembrolizumab|mesh-list
25462522|NCT04152863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25462523|NCT04152863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462524|NCT04125550|Propofol|propofol|mesh-list
25462525|NCT04125550|Sevoflurane|sevoflurane|mesh-list
25462526|NCT04125550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25462527|NCT04125550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25462528|NCT04125550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462529|NCT04125550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25462530|NCT04125550|Anesthetics, General|anesthetics, general|mesh-ancestor
25462531|NCT04125550|Anesthetics|anesthetics|mesh-ancestor
25462532|NCT04125550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25462533|NCT04125550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25462534|NCT04106856|Losartan|losartan|mesh-list
25462535|NCT04106856|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25462536|NCT04106856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25462537|NCT04106856|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25462538|NCT04106856|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25462539|NCT04106856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462540|NCT04090190|Solifenacin Succinate|solifenacin succinate|mesh-list
25462541|NCT04090190|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25462542|NCT04090190|Oxybutynin|oxybutynin|mesh-list
25462543|NCT04090190|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25462544|NCT04090190|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25462545|NCT04090190|Cholinergic Agents|cholinergic agents|mesh-ancestor
25462546|NCT04090190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25462547|NCT04090190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462548|NCT04090190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321998|NCT04913831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321999|NCT04913831|Nootropic Agents|nootropic agents|mesh-ancestor
25322000|NCT04913480|Durvalumab|durvalumab|mesh-list
25322001|NCT04913480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25322002|NCT04913480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462550|NCT04090190|Parasympatholytics|parasympatholytics|mesh-ancestor
25462567|NCT03885713|Golimumab|golimumab|mesh-list
25462568|NCT03885713|Infliximab|infliximab|mesh-list
25462569|NCT03885713|Ustekinumab|ustekinumab|mesh-list
25462570|NCT03885713|Vedolizumab|vedolizumab|mesh-list
25462571|NCT03885713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25462572|NCT03885713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25462573|NCT03885713|Dermatologic Agents|dermatologic agents|mesh-ancestor
25462574|NCT03885713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25722218|NCT02499575|Sensory System Agents|sensory system agents|mesh-ancestor
25462575|NCT03885713|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25462576|NCT03885713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25462577|NCT03885713|Immunologic Factors|immunologic factors|mesh-ancestor
25462578|NCT03885713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462579|NCT03862170|Ciprofloxacin|ciprofloxacin|mesh-list
25462580|NCT03862170|Cefazolin|cefazolin|mesh-list
25462581|NCT03862170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25462582|NCT03862170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25462583|NCT03862170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25462584|NCT03862170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25462585|NCT03862170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25462586|NCT03862170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462587|NCT03862170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462588|NCT03862170|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25462589|NCT03862170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25462590|NCT03825302|Mannitol|mannitol|mesh-list
25462591|NCT03825302|Methacholine Chloride|methacholine chloride|mesh-list
25462592|NCT03825302|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25462593|NCT03825302|Diuretics|diuretics|mesh-ancestor
25462594|NCT03825302|Natriuretic Agents|natriuretic agents|mesh-ancestor
25462595|NCT03825302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462596|NCT03825302|Miotics|miotics|mesh-ancestor
25462597|NCT03825302|Autonomic Agents|autonomic agents|mesh-ancestor
25462598|NCT03825302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25462599|NCT03825302|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25462600|NCT03825302|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
25462601|NCT03825302|Respiratory System Agents|respiratory system agents|mesh-ancestor
25462602|NCT03825302|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25462603|NCT03825302|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25462604|NCT03825302|Cholinergic Agents|cholinergic agents|mesh-ancestor
25462605|NCT03825302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25462606|NCT03825302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462607|NCT03537599|Daratumumab|daratumumab|mesh-list
25462608|NCT03537599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462609|NCT03434730|Cyclosporine|cyclosporine|mesh-list
25462610|NCT03434730|Mycophenolic Acid|mycophenolic acid|mesh-list
25462611|NCT03434730|Lenograstim|lenograstim|mesh-list
25462612|NCT03434730|Cyclosporins|cyclosporins|mesh-list
25462613|NCT03434730|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25462614|NCT03434730|Immunologic Factors|immunologic factors|mesh-ancestor
25462615|NCT03434730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462616|NCT03434730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25462617|NCT03434730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462618|NCT03434730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25462619|NCT03434730|Antifungal Agents|antifungal agents|mesh-ancestor
25462620|NCT03434730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25462621|NCT03434730|Dermatologic Agents|dermatologic agents|mesh-ancestor
25462622|NCT03434730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25462623|NCT03434730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25462624|NCT03434730|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25462625|NCT03434730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462626|NCT03434730|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25462627|NCT03434730|Antitubercular Agents|antitubercular agents|mesh-ancestor
25462628|NCT03434730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25462629|NCT03418779|Prednisolone|prednisolone|mesh-list
25462630|NCT03418779|Cyclophosphamide|cyclophosphamide|mesh-list
25462631|NCT03418779|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25462632|NCT03418779|Immunologic Factors|immunologic factors|mesh-ancestor
25462633|NCT03418779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462634|NCT03418779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25462635|NCT03418779|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25462636|NCT03418779|Alkylating Agents|alkylating agents|mesh-ancestor
25462637|NCT03418779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462638|NCT03418779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462639|NCT03418779|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25462640|NCT03418779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25462641|NCT03418779|Glucocorticoids|glucocorticoids|mesh-ancestor
25462642|NCT03418779|Hormones|hormones|mesh-ancestor
25462643|NCT03418779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25462644|NCT03418779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25462645|NCT03388138|Ketotifen|ketotifen|mesh-list
25462646|NCT03388138|Antipruritics|antipruritics|mesh-ancestor
25462647|NCT03388138|Dermatologic Agents|dermatologic agents|mesh-ancestor
25462648|NCT03388138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25462649|NCT03388138|Histamine Antagonists|histamine antagonists|mesh-ancestor
25462650|NCT03388138|Histamine Agents|histamine agents|mesh-ancestor
25462651|NCT03388138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25462652|NCT03388138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462653|NCT03388138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462654|NCT03388138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25462655|NCT03351348|Bupivacaine|bupivacaine|mesh-list
25462656|NCT03351348|Anesthetics, Local|anesthetics, local|mesh-ancestor
25462657|NCT03351348|Anesthetics|anesthetics|mesh-ancestor
25462658|NCT03351348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25462659|NCT03351348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462660|NCT03351348|Sensory System Agents|sensory system agents|mesh-ancestor
25462661|NCT03351348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25462662|NCT03289039|Fulvestrant|fulvestrant|mesh-list
25462663|NCT03289039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25462664|NCT03289039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462665|NCT03289039|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25462666|NCT03289039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25462667|NCT03289039|Hormone Antagonists|hormone antagonists|mesh-ancestor
25462668|NCT03289039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25462669|NCT03289039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462670|NCT03140423|Mupirocin|mupirocin|mesh-list
25462671|NCT03140423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25462672|NCT03140423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25462673|NCT03140423|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25462674|NCT03140423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25462675|NCT03140423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462676|NCT03101722|Huperzine A|huperzine a|mesh-list
25462677|NCT03101722|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
25462678|NCT03101722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25462679|NCT03101722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462680|NCT03101722|Cholinergic Agents|cholinergic agents|mesh-ancestor
25462681|NCT03101722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25462682|NCT03101722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462683|NCT03101722|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25462684|NCT03101722|Protective Agents|protective agents|mesh-ancestor
25462685|NCT03088852|Magnesium citrate|magnesium citrate|mesh-list
25462686|NCT03088852|Cathartics|cathartics|mesh-ancestor
25462687|NCT03088852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25462688|NCT03067610|Paclitaxel|paclitaxel|mesh-list
25462689|NCT03067610|Cisplatin|cisplatin|mesh-list
25462690|NCT03067610|Carboplatin|carboplatin|mesh-list
25462691|NCT03067610|Cetuximab|cetuximab|mesh-list
25462692|NCT03067610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25462693|NCT03067610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462694|NCT03067610|Tubulin Modulators|tubulin modulators|mesh-ancestor
25462695|NCT03067610|Antimitotic Agents|antimitotic agents|mesh-ancestor
25462696|NCT03067610|Mitosis Modulators|mitosis modulators|mesh-ancestor
25462697|NCT03067610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462698|NCT03067610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25462699|NCT03027609|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25462700|NCT03027609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25462701|NCT03015090|Theophylline|theophylline|mesh-list
25462702|NCT03015090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25462703|NCT03015090|Autonomic Agents|autonomic agents|mesh-ancestor
25462704|NCT03015090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25462705|NCT03015090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462706|NCT03015090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25462707|NCT03015090|Respiratory System Agents|respiratory system agents|mesh-ancestor
25462708|NCT03015090|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25462709|NCT03015090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25462710|NCT03015090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462711|NCT03015090|Vasodilator Agents|vasodilator agents|mesh-ancestor
25462712|NCT03015090|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25462713|NCT03015090|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25462714|NCT03015090|Purinergic Agents|purinergic agents|mesh-ancestor
25462715|NCT03015090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25322210|NCT04910477|Mydriatics|mydriatics|mesh-ancestor
25462716|NCT03000374|Leucovorin|leucovorin|mesh-list
25462717|NCT03000374|Fluorouracil|fluorouracil|mesh-list
25462718|NCT03000374|Oxaliplatin|oxaliplatin|mesh-list
25462719|NCT03000374|Panitumumab|panitumumab|mesh-list
25462720|NCT03000374|Antimetabolites|antimetabolites|mesh-ancestor
25462721|NCT03000374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462722|NCT03000374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25462723|NCT03000374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462724|NCT03000374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25462725|NCT03000374|Immunologic Factors|immunologic factors|mesh-ancestor
25462726|NCT03000374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462727|NCT03000374|Antidotes|antidotes|mesh-ancestor
25462728|NCT03000374|Protective Agents|protective agents|mesh-ancestor
25462729|NCT03000374|Vitamin B Complex|vitamin b complex|mesh-ancestor
25462730|NCT03000374|Vitamins|vitamins|mesh-ancestor
25462731|NCT03000374|Micronutrients|micronutrients|mesh-ancestor
25462732|NCT03000374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25462733|NCT02994836|Adalimumab|adalimumab|mesh-list
25462734|NCT02994836|Infliximab|infliximab|mesh-list
25462735|NCT02994836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25462736|NCT02994836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25462737|NCT02994836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25462738|NCT02994836|Dermatologic Agents|dermatologic agents|mesh-ancestor
25462739|NCT02994836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25462740|NCT02981082|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25462741|NCT02981082|Dermatologic Agents|dermatologic agents|mesh-ancestor
25462742|NCT02981082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25462743|NCT02981082|Immunologic Factors|immunologic factors|mesh-ancestor
25462744|NCT02981082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462745|NCT02800941|Warfarin|warfarin|mesh-list
25462746|NCT02800941|Anticoagulants|anticoagulants|mesh-list
25462747|NCT02800941|Acenocoumarol|acenocoumarol|mesh-list
25462748|NCT02800941|Fluindione|fluindione|mesh-list
25462749|NCT02591784|Nimotuzumab|nimotuzumab|mesh-list
25462750|NCT02591784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25462751|NCT02591784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462752|NCT02359994|Hemostatics|hemostatics|mesh-list
25462753|NCT02359994|Coagulants|coagulants|mesh-ancestor
25462754|NCT02359097|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25462755|NCT02359097|Hematinics|hematinics|mesh-ancestor
25462756|NCT02359097|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25462757|NCT02359097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25462758|NCT02336230|Remestemcel-l|remestemcel-l|mesh-list
25462759|NCT02336230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25462760|NCT02336230|Antiviral Agents|antiviral agents|mesh-ancestor
25462761|NCT02336230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25462762|NCT02188745|Letrozole|letrozole|mesh-list
25462763|NCT02188745|Anastrozole|anastrozole|mesh-list
25462764|NCT02188745|Exemestane|exemestane|mesh-list
25462765|NCT02188745|Estradiol|estradiol|mesh-list
25462766|NCT02188745|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25462767|NCT02188745|Estrogens|estrogens|mesh-ancestor
25462768|NCT02188745|Hormones|hormones|mesh-ancestor
25462769|NCT02188745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25462770|NCT02188745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462771|NCT02188745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462772|NCT02188745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25462773|NCT02188745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25462774|NCT02188745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462775|NCT02188745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25462776|NCT02188745|Hormone Antagonists|hormone antagonists|mesh-ancestor
25462777|NCT02188745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25462778|NCT01992861|Deoxyglucose|deoxyglucose|mesh-list
25462779|NCT01992861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25462780|NCT01992861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25462781|NCT01992861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462782|NCT01992861|Antimetabolites|antimetabolites|mesh-ancestor
25322281|NCT04909775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25322282|NCT04909775|Antimetabolites|antimetabolites|mesh-ancestor
25322283|NCT04909775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322284|NCT04909775|Antiviral Agents|antiviral agents|mesh-ancestor
25322285|NCT04909775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25322286|NCT04909775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322287|NCT04909775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25322288|NCT04909775|Immunologic Factors|immunologic factors|mesh-ancestor
25462783|NCT01992861|Antiviral Agents|antiviral agents|mesh-ancestor
25462784|NCT01992861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25462785|NCT01904136|Mycophenolic Acid|mycophenolic acid|mesh-list
25462786|NCT01904136|Cyclophosphamide|cyclophosphamide|mesh-list
25462808|NCT01584466|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25462809|NCT01584466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25462810|NCT01584466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25462811|NCT01584466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25462812|NCT01584466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462813|NCT01584466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25462814|NCT01584466|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25462815|NCT01584466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25462816|NCT01584466|Serotonin Agents|serotonin agents|mesh-ancestor
25462817|NCT01584466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25462818|NCT01584466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462819|NCT01584466|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25462820|NCT01584466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25462821|NCT01584466|Dopamine Agents|dopamine agents|mesh-ancestor
25462822|NCT01310010|Dasatinib|dasatinib|mesh-list
25462823|NCT01310010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462824|NCT01310010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25462825|NCT01310010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25462826|NCT01310010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462827|NCT00503035|Celecoxib|celecoxib|mesh-list
25462828|NCT00503035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25462829|NCT00503035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25462830|NCT00503035|Analgesics|analgesics|mesh-ancestor
25462831|NCT00503035|Sensory System Agents|sensory system agents|mesh-ancestor
25462832|NCT00503035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25462833|NCT00503035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462834|NCT00503035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25462835|NCT00503035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25462836|NCT00503035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25462837|NCT00503035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25462838|NCT00503035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25462839|NCT00503035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462840|NCT00303849|Sodium thiosulfate|sodium thiosulfate|mesh-list
25462841|NCT00303849|Carboplatin|carboplatin|mesh-list
25462842|NCT00303849|Etoposide|etoposide|mesh-list
25462843|NCT00303849|Etoposide phosphate|etoposide phosphate|mesh-list
25462844|NCT00303849|Melphalan|melphalan|mesh-list
25462845|NCT00303849|Mechlorethamine|mechlorethamine|mesh-list
25462846|NCT00303849|Podophyllotoxin|podophyllotoxin|mesh-list
25462847|NCT00303849|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25462848|NCT00303849|Mannitol|mannitol|mesh-list
25462849|NCT00303849|Antidotes|antidotes|mesh-list
25462850|NCT00303849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25462851|NCT00303849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25462852|NCT00303849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25462853|NCT00303849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25462854|NCT00303849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25462855|NCT00303849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462856|NCT00303849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25462857|NCT00303849|Alkylating Agents|alkylating agents|mesh-ancestor
25462858|NCT00303849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25462859|NCT00303849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25462860|NCT00303849|Immunologic Factors|immunologic factors|mesh-ancestor
25462861|NCT00303849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462862|NCT00303849|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25462863|NCT00303849|Diuretics|diuretics|mesh-ancestor
25462864|NCT00303849|Natriuretic Agents|natriuretic agents|mesh-ancestor
25462865|NCT00303849|Keratolytic Agents|keratolytic agents|mesh-ancestor
25462866|NCT00303849|Dermatologic Agents|dermatologic agents|mesh-ancestor
25462867|NCT00303849|Tubulin Modulators|tubulin modulators|mesh-ancestor
25462868|NCT00303849|Antimitotic Agents|antimitotic agents|mesh-ancestor
25462869|NCT00303849|Mitosis Modulators|mitosis modulators|mesh-ancestor
25462870|NCT00303849|Protective Agents|protective agents|mesh-ancestor
25462871|NCT00303849|Antioxidants|antioxidants|mesh-ancestor
25462872|NCT00303849|Antitubercular Agents|antitubercular agents|mesh-ancestor
25462873|NCT00303849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25462874|NCT00303849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25462875|NCT00303849|Chelating Agents|chelating agents|mesh-ancestor
25462876|NCT00303849|Sequestering Agents|sequestering agents|mesh-ancestor
25462877|NCT00161044|Galantamine|galantamine|mesh-list
25462878|NCT00161044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25462879|NCT00161044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25462880|NCT00161044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25462881|NCT00161044|Cholinergic Agents|cholinergic agents|mesh-ancestor
25462882|NCT00161044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25462883|NCT00161044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462991|NCT05142319|Vaccines|vaccines|mesh-list
25462992|NCT05142319|Immunologic Factors|immunologic factors|mesh-ancestor
25462993|NCT05142319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25462994|NCT05142085|Mineral Oil|mineral oil|mesh-list
25462995|NCT05142085|Emollients|emollients|mesh-ancestor
25462996|NCT05142085|Dermatologic Agents|dermatologic agents|mesh-ancestor
25462997|NCT05141968|Vitamin D|vitamin d|mesh-list
25462998|NCT05141968|Vitamins|vitamins|mesh-ancestor
25462999|NCT05141968|Micronutrients|micronutrients|mesh-ancestor
25463000|NCT05141968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463001|NCT05141968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25463002|NCT05141877|Anesthetics|anesthetics|mesh-list
25463003|NCT05141877|Propofol|propofol|mesh-list
25463004|NCT05141877|Sevoflurane|sevoflurane|mesh-list
25463005|NCT05141877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25463006|NCT05141877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463007|NCT05141877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25463008|NCT05141877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25463009|NCT05141877|Anesthetics, General|anesthetics, general|mesh-ancestor
25463010|NCT05141877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25463011|NCT05141877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25463012|NCT05141864|Lidocaine|lidocaine|mesh-list
25463013|NCT05141864|Anesthetics, Local|anesthetics, local|mesh-ancestor
25463014|NCT05141864|Anesthetics|anesthetics|mesh-ancestor
25463015|NCT05141864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25463016|NCT05141864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463017|NCT05141864|Sensory System Agents|sensory system agents|mesh-ancestor
25463018|NCT05141864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25463019|NCT05141864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25463020|NCT05141864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25463021|NCT05141864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25463022|NCT05141864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25463023|NCT05141864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463024|NCT05141474|Aldesleukin|aldesleukin|mesh-list
25463025|NCT05141474|Cyclophosphamide|cyclophosphamide|mesh-list
25463026|NCT05141474|Fludarabine|fludarabine|mesh-list
25463027|NCT05141474|Interleukin-2|interleukin-2|mesh-list
25463028|NCT05141474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25463029|NCT05141474|Immunologic Factors|immunologic factors|mesh-ancestor
25463030|NCT05141474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463031|NCT05141474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25463032|NCT05141474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25463033|NCT05141474|Alkylating Agents|alkylating agents|mesh-ancestor
25463034|NCT05141474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463035|NCT05141474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463036|NCT05141474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25463037|NCT05141474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25463038|NCT05141474|Analgesics|analgesics|mesh-ancestor
25463039|NCT05141474|Sensory System Agents|sensory system agents|mesh-ancestor
25463040|NCT05141474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25463041|NCT05141474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25463042|NCT05141474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25463043|NCT05141474|Antiviral Agents|antiviral agents|mesh-ancestor
25463044|NCT05141474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25463045|NCT05117281|Levobupivacaine|levobupivacaine|mesh-list
25463046|NCT05117281|Anesthetics, Local|anesthetics, local|mesh-ancestor
25463047|NCT05117281|Anesthetics|anesthetics|mesh-ancestor
25463048|NCT05117281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25463049|NCT05117281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463050|NCT05117281|Sensory System Agents|sensory system agents|mesh-ancestor
25463051|NCT05117281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25463052|NCT05114460|Naloxone|naloxone|mesh-list
25463053|NCT05114460|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25463054|NCT05114460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463055|NCT05114460|Sensory System Agents|sensory system agents|mesh-ancestor
25463056|NCT05114460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25463057|NCT05089175|Aspirin|aspirin|mesh-list
25463058|NCT05089175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25463059|NCT05089175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25463060|NCT05089175|Analgesics|analgesics|mesh-ancestor
25463061|NCT05089175|Sensory System Agents|sensory system agents|mesh-ancestor
25644603|NCT01438177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25322868|NCT04902495|Pemetrexed|pemetrexed|mesh-list
25322869|NCT04902495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322870|NCT04902495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322874|NCT04902222|Morphine|morphine|mesh-list
25463062|NCT05089175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25463063|NCT05089175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463073|NCT05066997|Dexamethasone|dexamethasone|mesh-list
25463074|NCT05066997|Dexamethasone acetate|dexamethasone acetate|mesh-list
25463075|NCT05066997|BB 1101|bb 1101|mesh-list
25463076|NCT05066997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25463077|NCT05066997|Antiemetics|antiemetics|mesh-ancestor
25463078|NCT05066997|Autonomic Agents|autonomic agents|mesh-ancestor
25463079|NCT05066997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25463080|NCT05066997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463081|NCT05066997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25463082|NCT05066997|Glucocorticoids|glucocorticoids|mesh-ancestor
25463083|NCT05066997|Hormones|hormones|mesh-ancestor
25463084|NCT05066997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25463085|NCT05066997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25463086|NCT05066997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463087|NCT05066997|Protease Inhibitors|protease inhibitors|mesh-ancestor
25463088|NCT05066997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25463089|NCT05066997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463090|NCT05064449|Itraconazole|itraconazole|mesh-list
25463091|NCT05064449|Mefenamic Acid|mefenamic acid|mesh-list
25463092|NCT05064449|Antifungal Agents|antifungal agents|mesh-ancestor
25463093|NCT05064449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25463094|NCT05064449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25463095|NCT05064449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25463096|NCT05064449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25463097|NCT05064449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463098|NCT05064449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25463099|NCT05064449|Hormone Antagonists|hormone antagonists|mesh-ancestor
25463100|NCT05064449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25463101|NCT05064449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463102|NCT05064449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25463103|NCT05064449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25463104|NCT05064449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25463105|NCT05064449|Analgesics|analgesics|mesh-ancestor
25463106|NCT05064449|Sensory System Agents|sensory system agents|mesh-ancestor
25463107|NCT05064449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25463108|NCT05064449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25463109|NCT05064449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25463110|NCT05064449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25463111|NCT05059951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25463112|NCT05059951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463113|NCT05059951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463114|NCT05046639|Lidocaine|lidocaine|mesh-list
25463115|NCT05046639|Anesthetics, Local|anesthetics, local|mesh-ancestor
25463116|NCT05046639|Anesthetics|anesthetics|mesh-ancestor
25463117|NCT05046639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25463118|NCT05046639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463119|NCT05046639|Sensory System Agents|sensory system agents|mesh-ancestor
25463120|NCT05046639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25463121|NCT05046639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25463122|NCT05046639|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25463123|NCT05046639|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25463124|NCT05046639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25463125|NCT05046639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463126|NCT05045066|Vitamin D|vitamin d|mesh-list
25463127|NCT05045066|Cholecalciferol|cholecalciferol|mesh-list
25463128|NCT05045066|Vitamins|vitamins|mesh-ancestor
25463129|NCT05045066|Micronutrients|micronutrients|mesh-ancestor
25463130|NCT05045066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463131|NCT05045066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25463132|NCT05045066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25463133|NCT05033639|Melatonin|melatonin|mesh-list
25463134|NCT05033639|Antioxidants|antioxidants|mesh-ancestor
25463135|NCT05033639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463136|NCT05033639|Protective Agents|protective agents|mesh-ancestor
25463137|NCT05033639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463138|NCT05033639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25463140|NCT04963283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25463141|NCT04963283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463142|NCT04963283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25463143|NCT04963283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463144|NCT04887935|Dapagliflozin|dapagliflozin|mesh-list
25463145|NCT04887935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25463146|NCT04887935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463147|NCT04887935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25463148|NCT04887935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463149|NCT04870138|Azithromycin|azithromycin|mesh-list
25463150|NCT04870138|Ciprofloxacin|ciprofloxacin|mesh-list
25463151|NCT04870138|Ceftriaxone|ceftriaxone|mesh-list
25463152|NCT04870138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25463153|NCT04870138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25463154|NCT04870138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25463155|NCT04870138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25463156|NCT04870138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25463157|NCT04870138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463158|NCT04870138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463159|NCT04870138|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25463160|NCT04870138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25463161|NCT04794517|Dapagliflozin|dapagliflozin|mesh-list
25463162|NCT04794517|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25463163|NCT04794517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463164|NCT04794517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25463165|NCT04794517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463166|NCT04729296|Golimumab|golimumab|mesh-list
25463167|NCT04729296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25463168|NCT04729296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25463169|NCT04729296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25463170|NCT04729296|Immunologic Factors|immunologic factors|mesh-ancestor
25463171|NCT04729296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463172|NCT04686786|PF-06372865|pf-06372865|mesh-list
25463173|NCT04686786|GABA Modulators|gaba modulators|mesh-ancestor
25463174|NCT04686786|GABA Agents|gaba agents|mesh-ancestor
25463175|NCT04686786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25463176|NCT04686786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463177|NCT04686786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463178|NCT04649060|Dexamethasone|dexamethasone|mesh-list
25463179|NCT04649060|Melphalan|melphalan|mesh-list
25463180|NCT04649060|Daratumumab|daratumumab|mesh-list
25463181|NCT04649060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25463182|NCT04649060|Antiemetics|antiemetics|mesh-ancestor
25463183|NCT04649060|Autonomic Agents|autonomic agents|mesh-ancestor
25463184|NCT04649060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25463185|NCT04649060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463186|NCT04649060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25463187|NCT04649060|Glucocorticoids|glucocorticoids|mesh-ancestor
25463188|NCT04649060|Hormones|hormones|mesh-ancestor
25463189|NCT04649060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25463190|NCT04649060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25463191|NCT04649060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463192|NCT04649060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25463193|NCT04649060|Alkylating Agents|alkylating agents|mesh-ancestor
25463194|NCT04649060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463195|NCT04649060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25463196|NCT04649060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25463197|NCT04649060|Immunologic Factors|immunologic factors|mesh-ancestor
25463198|NCT04633863|Lubricant Eye Drops|lubricant eye drops|mesh-list
25463199|NCT04633863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25463200|NCT04633863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25463201|NCT04566328|Dexamethasone|dexamethasone|mesh-list
25463202|NCT04566328|Dexamethasone acetate|dexamethasone acetate|mesh-list
25463203|NCT04566328|Lenalidomide|lenalidomide|mesh-list
25463204|NCT04566328|Bortezomib|bortezomib|mesh-list
25463205|NCT04566328|Daratumumab|daratumumab|mesh-list
25463206|NCT04566328|Ichthammol|ichthammol|mesh-list
25463207|NCT04566328|BB 1101|bb 1101|mesh-list
25463208|NCT04566328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25463209|NCT04566328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25463210|NCT04566328|Antiemetics|antiemetics|mesh-ancestor
25463211|NCT04566328|Autonomic Agents|autonomic agents|mesh-ancestor
25463212|NCT04566328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25463213|NCT04566328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644604|NCT01438177|Antimalarials|antimalarials|mesh-ancestor
25463214|NCT04566328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25463215|NCT04566328|Glucocorticoids|glucocorticoids|mesh-ancestor
25463216|NCT04566328|Hormones|hormones|mesh-ancestor
25463217|NCT04566328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25463218|NCT04566328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25463219|NCT04566328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463220|NCT04566328|Protease Inhibitors|protease inhibitors|mesh-ancestor
25463221|NCT04566328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25463222|NCT04566328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463223|NCT04566328|Immunologic Factors|immunologic factors|mesh-ancestor
25463224|NCT04566328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25463225|NCT04566328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25463226|NCT04566328|Growth Substances|growth substances|mesh-ancestor
25463227|NCT04566328|Growth Inhibitors|growth inhibitors|mesh-ancestor
25463228|NCT04566328|Dermatologic Agents|dermatologic agents|mesh-ancestor
25463230|NCT04558190|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25463231|NCT04558190|Albuterol|albuterol|mesh-list
25463232|NCT04558190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25463233|NCT04558190|Autonomic Agents|autonomic agents|mesh-ancestor
25463234|NCT04558190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25463235|NCT04558190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463236|NCT04558190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25463237|NCT04558190|Respiratory System Agents|respiratory system agents|mesh-ancestor
25463238|NCT04558190|Tocolytic Agents|tocolytic agents|mesh-ancestor
25463239|NCT04558190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25463240|NCT04558190|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25463241|NCT04558190|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25463242|NCT04558190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25463243|NCT04558190|Adrenergic Agents|adrenergic agents|mesh-ancestor
25463244|NCT04558190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25463245|NCT04558190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463246|NCT04558190|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25463247|NCT04558190|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25463248|NCT04558190|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25463249|NCT04558190|Micronutrients|micronutrients|mesh-ancestor
25463250|NCT04551365|Chitosan|chitosan|mesh-list
25463251|NCT04551365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25463252|NCT04551365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25463253|NCT04551365|Antimetabolites|antimetabolites|mesh-ancestor
25463254|NCT04551365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463255|NCT04551365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25463256|NCT04551365|Chelating Agents|chelating agents|mesh-ancestor
25463257|NCT04551365|Sequestering Agents|sequestering agents|mesh-ancestor
25463258|NCT04551365|Hemostatics|hemostatics|mesh-ancestor
25463259|NCT04551365|Coagulants|coagulants|mesh-ancestor
25463260|NCT04535089|Lidocaine|lidocaine|mesh-list
25463261|NCT04535089|Dexmedetomidine|dexmedetomidine|mesh-list
25463262|NCT04535089|Anesthetics, Local|anesthetics, local|mesh-ancestor
25463263|NCT04535089|Anesthetics|anesthetics|mesh-ancestor
25463264|NCT04535089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25463265|NCT04535089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463266|NCT04535089|Sensory System Agents|sensory system agents|mesh-ancestor
25463267|NCT04535089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25463268|NCT04535089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25463269|NCT04535089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25463270|NCT04535089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25463271|NCT04535089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25463272|NCT04535089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463273|NCT04535089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25463274|NCT04535089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25463275|NCT04535089|Analgesics|analgesics|mesh-ancestor
25463276|NCT04535089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25463277|NCT04535089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25463278|NCT04535089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25463279|NCT04535089|Adrenergic Agents|adrenergic agents|mesh-ancestor
25463280|NCT04535089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25463281|NCT04462471|Vemurafenib|vemurafenib|mesh-list
25463282|NCT04462471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463283|NCT04462471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25463284|NCT04462471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25463285|NCT04462471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644605|NCT01438411|Cholic Acids|cholic acids|mesh-list
25463286|NCT04444869|Cisplatin|cisplatin|mesh-list
25463287|NCT04444869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463288|NCT04431518|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
25463290|NCT04431518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25323171|NCT04899570|Antimitotic Agents|antimitotic agents|mesh-ancestor
25323172|NCT04899570|Mitosis Modulators|mitosis modulators|mesh-ancestor
25323173|NCT04899453|Rituximab|rituximab|mesh-list
25463291|NCT04431518|Antiviral Agents|antiviral agents|mesh-ancestor
25463292|NCT04431518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25463293|NCT04392505|Durvalumab|durvalumab|mesh-list
25463294|NCT04392505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25463295|NCT04392505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463296|NCT04308694|Methadone|methadone|mesh-list
25463297|NCT04308694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25463298|NCT04308694|Narcotics|narcotics|mesh-ancestor
25463299|NCT04308694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25463300|NCT04308694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463301|NCT04308694|Analgesics|analgesics|mesh-ancestor
25463302|NCT04308694|Sensory System Agents|sensory system agents|mesh-ancestor
25463303|NCT04308694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25463304|NCT04308694|Antitussive Agents|antitussive agents|mesh-ancestor
25463305|NCT04308694|Respiratory System Agents|respiratory system agents|mesh-ancestor
25463306|NCT04223765|Cyclophosphamide|cyclophosphamide|mesh-list
25463307|NCT04223765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25463308|NCT04223765|Fludarabine|fludarabine|mesh-list
25463309|NCT04223765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25463310|NCT04223765|Immunologic Factors|immunologic factors|mesh-ancestor
25463311|NCT04223765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463312|NCT04223765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25463313|NCT04223765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25463314|NCT04223765|Alkylating Agents|alkylating agents|mesh-ancestor
25463315|NCT04223765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463316|NCT04223765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463317|NCT04223765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25463318|NCT04187196|Propofol|propofol|mesh-list
25463319|NCT04187196|Methohexital|methohexital|mesh-list
25463320|NCT04187196|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25463321|NCT04187196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25463322|NCT04187196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463323|NCT04187196|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25463324|NCT04187196|Anesthetics, General|anesthetics, general|mesh-ancestor
25463325|NCT04187196|Anesthetics|anesthetics|mesh-ancestor
25463326|NCT04109885|Diphenhydramine|diphenhydramine|mesh-list
25463327|NCT04109885|Promethazine|promethazine|mesh-list
25463328|NCT04109885|Prochlorperazine|prochlorperazine|mesh-list
25463329|NCT04109885|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25463330|NCT04109885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25463331|NCT04109885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25463332|NCT04109885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463333|NCT04109885|Anesthetics, Local|anesthetics, local|mesh-ancestor
25463334|NCT04109885|Anesthetics|anesthetics|mesh-ancestor
25463335|NCT04109885|Sensory System Agents|sensory system agents|mesh-ancestor
25463336|NCT04109885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25463337|NCT04109885|Antiemetics|antiemetics|mesh-ancestor
25463338|NCT04109885|Autonomic Agents|autonomic agents|mesh-ancestor
25463339|NCT04109885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25463340|NCT04109885|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25463341|NCT04109885|Histamine Antagonists|histamine antagonists|mesh-ancestor
25463342|NCT04109885|Histamine Agents|histamine agents|mesh-ancestor
25463343|NCT04109885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25463344|NCT04109885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463345|NCT04109885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25463346|NCT04109885|Antipruritics|antipruritics|mesh-ancestor
25463347|NCT04109885|Dermatologic Agents|dermatologic agents|mesh-ancestor
25463348|NCT04109885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25463349|NCT04109885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25463350|NCT04109885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25463351|NCT04109885|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25463352|NCT04109885|Dopamine Agents|dopamine agents|mesh-ancestor
25463353|NCT04078737|Aspirin|aspirin|mesh-list
25463354|NCT04078737|Clopidogrel|clopidogrel|mesh-list
25463355|NCT04078737|Ticagrelor|ticagrelor|mesh-list
25463356|NCT04078737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25463357|NCT04078737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25463358|NCT04078737|Analgesics|analgesics|mesh-ancestor
25463359|NCT04078737|Sensory System Agents|sensory system agents|mesh-ancestor
25463360|NCT04078737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25463361|NCT04078737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644606|NCT01438411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25644607|NCT01438424|Lamivudine|lamivudine|mesh-list
25463362|NCT04078737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25463363|NCT04078737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25323245|NCT04898946|Immunologic Factors|immunologic factors|mesh-ancestor
25323246|NCT04898946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323247|NCT04899050|Cannabidiol|cannabidiol|mesh-list
25323248|NCT04899050|Anticonvulsants|anticonvulsants|mesh-ancestor
25463364|NCT04078737|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25463365|NCT04078737|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25463382|NCT03999411|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25463383|NCT03999411|Nicotine|nicotine|mesh-list
25463384|NCT03999411|Antiviral Agents|antiviral agents|mesh-ancestor
25463385|NCT03999411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25463386|NCT03999411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25463387|NCT03999411|Autonomic Agents|autonomic agents|mesh-ancestor
25463388|NCT03999411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25463389|NCT03999411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463390|NCT03999411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25463391|NCT03999411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25463392|NCT03999411|Cholinergic Agents|cholinergic agents|mesh-ancestor
25463393|NCT03999411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25463394|NCT03999411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463395|NCT03958981|Castor Oil|castor oil|mesh-list
25463396|NCT03958981|Cathartics|cathartics|mesh-ancestor
25463397|NCT03958981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25463398|NCT03937635|Dexamethasone|dexamethasone|mesh-list
25463399|NCT03937635|Dexamethasone acetate|dexamethasone acetate|mesh-list
25463400|NCT03937635|Lenalidomide|lenalidomide|mesh-list
25463401|NCT03937635|Daratumumab|daratumumab|mesh-list
25463402|NCT03937635|Ichthammol|ichthammol|mesh-list
25463403|NCT03937635|BB 1101|bb 1101|mesh-list
25463404|NCT03937635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25463405|NCT03937635|Antiemetics|antiemetics|mesh-ancestor
25463406|NCT03937635|Autonomic Agents|autonomic agents|mesh-ancestor
25463407|NCT03937635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25463408|NCT03937635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463409|NCT03937635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25463410|NCT03937635|Glucocorticoids|glucocorticoids|mesh-ancestor
25463411|NCT03937635|Hormones|hormones|mesh-ancestor
25463412|NCT03937635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25463413|NCT03937635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25463414|NCT03937635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463415|NCT03937635|Immunologic Factors|immunologic factors|mesh-ancestor
25463416|NCT03937635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25463417|NCT03937635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25463418|NCT03937635|Growth Substances|growth substances|mesh-ancestor
25463419|NCT03937635|Growth Inhibitors|growth inhibitors|mesh-ancestor
25463420|NCT03937635|Protease Inhibitors|protease inhibitors|mesh-ancestor
25463421|NCT03937635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25463422|NCT03937635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463423|NCT03937635|Dermatologic Agents|dermatologic agents|mesh-ancestor
25463424|NCT03892369|Ethanol|ethanol|mesh-list
25463425|NCT03892369|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25463426|NCT03892369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25463427|NCT03892369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25463428|NCT03892369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463429|NCT03803605|Vorinostat|vorinostat|mesh-list
25463430|NCT03803605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463431|NCT03803605|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25463432|NCT03803605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25463433|NCT03803605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463434|NCT03770728|Metformin|metformin|mesh-list
25463435|NCT03770728|Efpeglenatide|efpeglenatide|mesh-list
25463436|NCT03770728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25463437|NCT03770728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463438|NCT03760146|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25463439|NCT03760146|Immunologic Factors|immunologic factors|mesh-ancestor
25463440|NCT03760146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463441|NCT03713684|Efpeglenatide|efpeglenatide|mesh-list
25463442|NCT03713684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25463443|NCT03713684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463444|NCT03644550|Pembrolizumab|pembrolizumab|mesh-list
25463445|NCT03644550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25644608|NCT01438424|Entecavir|entecavir|mesh-list
25463446|NCT03644550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463447|NCT03514901|Pembrolizumab|pembrolizumab|mesh-list
25463448|NCT03514901|Nivolumab|nivolumab|mesh-list
25463449|NCT03514901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25463450|NCT03514901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463451|NCT03514901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25463452|NCT03514901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463454|NCT03471624|Antiviral Agents|antiviral agents|mesh-ancestor
25463455|NCT03471624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25463456|NCT03471624|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25463457|NCT03471624|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25323393|NCT04898231|Hormones|hormones|mesh-ancestor
25463459|NCT03471624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463460|NCT03471624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25463461|NCT03471624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25463462|NCT03462251|Paclitaxel|paclitaxel|mesh-list
25463463|NCT03462251|Bevacizumab|bevacizumab|mesh-list
25463464|NCT03462251|Capecitabine|capecitabine|mesh-list
25463465|NCT03462251|Fulvestrant|fulvestrant|mesh-list
25463466|NCT03462251|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25463467|NCT03462251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25463468|NCT03462251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463469|NCT03462251|Tubulin Modulators|tubulin modulators|mesh-ancestor
25463470|NCT03462251|Antimitotic Agents|antimitotic agents|mesh-ancestor
25463471|NCT03462251|Mitosis Modulators|mitosis modulators|mesh-ancestor
25463472|NCT03462251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463473|NCT03462251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25463474|NCT03462251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25463475|NCT03462251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25463476|NCT03462251|Growth Substances|growth substances|mesh-ancestor
25463477|NCT03462251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463478|NCT03462251|Growth Inhibitors|growth inhibitors|mesh-ancestor
25463479|NCT03462251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25463480|NCT03462251|Antimetabolites|antimetabolites|mesh-ancestor
25463481|NCT03462251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25463482|NCT03462251|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25463483|NCT03462251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25463484|NCT03462251|Hormone Antagonists|hormone antagonists|mesh-ancestor
25463485|NCT03462251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25463486|NCT03462251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25463487|NCT03462251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25463488|NCT03338647|Doxorubicin|doxorubicin|mesh-list
25463489|NCT03338647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25463490|NCT03338647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463491|NCT03338647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25463492|NCT03338647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25463493|NCT03338647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25463494|NCT03338647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463495|NCT03284034|Deoxycholic Acid|deoxycholic acid|mesh-list
25463496|NCT03284034|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25463497|NCT03284034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25463498|NCT03087760|Pembrolizumab|pembrolizumab|mesh-list
25463499|NCT03087760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25463500|NCT03087760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463501|NCT03066843|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25463502|NCT03066843|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25463503|NCT03066843|Dermatologic Agents|dermatologic agents|mesh-ancestor
25463504|NCT03039114|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25463505|NCT03039114|Obinutuzumab|obinutuzumab|mesh-list
25463506|NCT03039114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25463507|NCT03039114|Alkylating Agents|alkylating agents|mesh-ancestor
25463508|NCT03039114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463509|NCT03039114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463510|NCT03039114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25463511|NCT02894398|Letrozole|letrozole|mesh-list
25463512|NCT02894398|Fulvestrant|fulvestrant|mesh-list
25463513|NCT02894398|Palbociclib|palbociclib|mesh-list
25463514|NCT02894398|Anastrozole|anastrozole|mesh-list
25463515|NCT02894398|Exemestane|exemestane|mesh-list
25463516|NCT02894398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463517|NCT02894398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25463518|NCT02894398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25463519|NCT02894398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722312|NCT02500979|Pramlintide|pramlintide|mesh-list
25463520|NCT02894398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463521|NCT02894398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25463522|NCT02894398|Hormone Antagonists|hormone antagonists|mesh-ancestor
25323468|NCT04897269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25323469|NCT04897269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323471|NCT04896359|Vitamins|vitamins|mesh-ancestor
25323472|NCT04896359|Micronutrients|micronutrients|mesh-ancestor
25323473|NCT04896359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323474|NCT04896359|Antioxidants|antioxidants|mesh-ancestor
25323475|NCT04896359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463523|NCT02894398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25463524|NCT02894398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463525|NCT02894398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25463526|NCT02894398|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25463527|NCT02894398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25463528|NCT02852057|Timolol|timolol|mesh-list
25463529|NCT02852057|Dorzolamide|dorzolamide|mesh-list
25463530|NCT02852057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25463531|NCT02852057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25463532|NCT02852057|Adrenergic Agents|adrenergic agents|mesh-ancestor
25463533|NCT02852057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25463534|NCT02852057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463535|NCT02852057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463536|NCT02852057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25463537|NCT02852057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25463538|NCT02852057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25463539|NCT02852057|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25463540|NCT02728388|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25463541|NCT02728388|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25463542|NCT02728388|Dermatologic Agents|dermatologic agents|mesh-ancestor
25463543|NCT02710734|Cisplatin|cisplatin|mesh-list
25463544|NCT02710734|Doxorubicin|doxorubicin|mesh-list
25463545|NCT02710734|Methotrexate|methotrexate|mesh-list
25463546|NCT02710734|Mitomycins|mitomycins|mesh-list
25463547|NCT02710734|Mitomycin|mitomycin|mesh-list
25463548|NCT02710734|Vinblastine|vinblastine|mesh-list
25463549|NCT02710734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463550|NCT02710734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25463551|NCT02710734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25463552|NCT02710734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25463553|NCT02710734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25463554|NCT02710734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463555|NCT02710734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25463556|NCT02710734|Abortifacient Agents|abortifacient agents|mesh-ancestor
25463557|NCT02710734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25463558|NCT02710734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463559|NCT02710734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25463560|NCT02710734|Antimetabolites|antimetabolites|mesh-ancestor
25463561|NCT02710734|Dermatologic Agents|dermatologic agents|mesh-ancestor
25463562|NCT02710734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25463563|NCT02710734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25463564|NCT02710734|Immunologic Factors|immunologic factors|mesh-ancestor
25463565|NCT02710734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25463566|NCT02710734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25463567|NCT02710734|Alkylating Agents|alkylating agents|mesh-ancestor
25463568|NCT02710734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25463569|NCT02710734|Tubulin Modulators|tubulin modulators|mesh-ancestor
25463570|NCT02710734|Antimitotic Agents|antimitotic agents|mesh-ancestor
25463571|NCT02710734|Mitosis Modulators|mitosis modulators|mesh-ancestor
25463572|NCT02611024|Irinotecan|irinotecan|mesh-list
25463573|NCT02611024|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25463574|NCT02611024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25463575|NCT02611024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25463576|NCT02611024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463577|NCT02611024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463578|NCT02564796|Iron|iron|mesh-list
25463579|NCT02564796|Epoetin Alfa|epoetin alfa|mesh-list
25323543|NCT04895423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25323544|NCT04895423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25323545|NCT04895423|Antifungal Agents|antifungal agents|mesh-ancestor
25323546|NCT04895423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25323547|NCT04895423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25323548|NCT04895423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25323549|NCT04895423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25323550|NCT04895423|Antitubercular Agents|antitubercular agents|mesh-ancestor
25323551|NCT04895423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25323553|NCT04895800|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25323554|NCT04895800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323555|NCT04895800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25323556|NCT04895800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25323557|NCT04895800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323558|NCT04895800|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25323559|NCT04895800|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25463580|NCT02564796|Trace Elements|trace elements|mesh-ancestor
25463581|NCT02564796|Micronutrients|micronutrients|mesh-ancestor
25463582|NCT02564796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463583|NCT02564796|Hematinics|hematinics|mesh-ancestor
25463584|NCT02562716|Gemcitabine|gemcitabine|mesh-list
25463585|NCT02562716|Paclitaxel|paclitaxel|mesh-list
25463586|NCT02562716|Camptothecin|camptothecin|mesh-list
25463587|NCT02562716|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25463588|NCT02562716|Fluorouracil|fluorouracil|mesh-list
25463589|NCT02562716|Oxaliplatin|oxaliplatin|mesh-list
25463590|NCT02562716|Irinotecan|irinotecan|mesh-list
25463591|NCT02562716|Pancrelipase|pancrelipase|mesh-list
25463592|NCT02562716|Pancreatin|pancreatin|mesh-list
25463593|NCT02562716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25463594|NCT02562716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463595|NCT02562716|Tubulin Modulators|tubulin modulators|mesh-ancestor
25463596|NCT02562716|Antimitotic Agents|antimitotic agents|mesh-ancestor
25463597|NCT02562716|Mitosis Modulators|mitosis modulators|mesh-ancestor
25463598|NCT02562716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463599|NCT02562716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25463600|NCT02562716|Antimetabolites|antimetabolites|mesh-ancestor
25463601|NCT02562716|Antiviral Agents|antiviral agents|mesh-ancestor
25463602|NCT02562716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25463603|NCT02562716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25463604|NCT02562716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25463605|NCT02562716|Immunologic Factors|immunologic factors|mesh-ancestor
25463606|NCT02562716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463607|NCT02562716|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25463608|NCT02562716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25463609|NCT02562716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25463610|NCT02558010|Morphine|morphine|mesh-list
25463611|NCT02558010|Methadone|methadone|mesh-list
25463612|NCT02558010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25463613|NCT02558010|Narcotics|narcotics|mesh-ancestor
25463614|NCT02558010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25463615|NCT02558010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463616|NCT02558010|Analgesics|analgesics|mesh-ancestor
25463617|NCT02558010|Sensory System Agents|sensory system agents|mesh-ancestor
25463618|NCT02558010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25463619|NCT02558010|Antitussive Agents|antitussive agents|mesh-ancestor
25463620|NCT02558010|Respiratory System Agents|respiratory system agents|mesh-ancestor
25463621|NCT02502006|Celecoxib|celecoxib|mesh-list
25463622|NCT02502006|Naproxen|naproxen|mesh-list
25463623|NCT02502006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25463624|NCT02502006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25463625|NCT02502006|Analgesics|analgesics|mesh-ancestor
25463626|NCT02502006|Sensory System Agents|sensory system agents|mesh-ancestor
25463627|NCT02502006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25463628|NCT02502006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463629|NCT02502006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25463630|NCT02502006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25463631|NCT02502006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25463632|NCT02502006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25463633|NCT02502006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25463634|NCT02502006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463635|NCT02502006|Gout Suppressants|gout suppressants|mesh-ancestor
25463636|NCT02481245|Bezafibrate|bezafibrate|mesh-list
25463637|NCT02481245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25463638|NCT02481245|Antimetabolites|antimetabolites|mesh-ancestor
25463639|NCT02481245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463640|NCT02481245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25463641|NCT02477384|Propranolol|propranolol|mesh-list
25463642|NCT02477384|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25463643|NCT02477384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25463644|NCT02477384|Adrenergic Agents|adrenergic agents|mesh-ancestor
25463645|NCT02477384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25463646|NCT02477384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463647|NCT02477384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463649|NCT02477384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25463650|NCT02477384|Vasodilator Agents|vasodilator agents|mesh-ancestor
25463651|NCT02427724|Lidocaine|lidocaine|mesh-list
25463652|NCT02427724|Tetracaine|tetracaine|mesh-list
25323623|NCT04894630|Anti-Infective Agents|anti-infective agents|mesh-list
25323624|NCT04894630|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25323625|NCT04894617|Amantadine|amantadine|mesh-list
25323626|NCT04894617|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25463668|NCT02393794|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25463669|NCT02393794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463670|NCT02393794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25463671|NCT02393794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25463672|NCT02393794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463673|NCT02393794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25463674|NCT02393794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25463676|NCT02043847|Lenograstim|lenograstim|mesh-list
25463677|NCT02043847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25463678|NCT02043847|Immunologic Factors|immunologic factors|mesh-ancestor
25463679|NCT02043847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463680|NCT02043847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25463681|NCT02043847|Alkylating Agents|alkylating agents|mesh-ancestor
25463682|NCT02043847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463683|NCT02043847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463684|NCT02043847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25463685|NCT02043847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25463686|NCT01976286|Salicylic Acid|salicylic acid|mesh-list
25463687|NCT01976286|Salicylates|salicylates|mesh-list
25463688|NCT01976286|Glycolic acid|glycolic acid|mesh-list
25463689|NCT01976286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25463690|NCT01976286|Antifungal Agents|antifungal agents|mesh-ancestor
25463691|NCT01976286|Keratolytic Agents|keratolytic agents|mesh-ancestor
25463692|NCT01976286|Dermatologic Agents|dermatologic agents|mesh-ancestor
25463693|NCT01976286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25463694|NCT01976286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25463695|NCT01976286|Analgesics|analgesics|mesh-ancestor
25463696|NCT01976286|Sensory System Agents|sensory system agents|mesh-ancestor
25463697|NCT01976286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25463698|NCT01976286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463699|NCT01976286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25463700|NCT01976286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25463701|NCT01976286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25463702|NCT01976286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25463703|NCT01976286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463704|NCT01775644|Bevacizumab|bevacizumab|mesh-list
25463705|NCT01775644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25463706|NCT01775644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463707|NCT01775644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25463708|NCT01775644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25463709|NCT01775644|Growth Substances|growth substances|mesh-ancestor
25463710|NCT01775644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463711|NCT01775644|Growth Inhibitors|growth inhibitors|mesh-ancestor
25463712|NCT01472081|Nivolumab|nivolumab|mesh-list
25463713|NCT01472081|Ipilimumab|ipilimumab|mesh-list
25463714|NCT01472081|Sunitinib|sunitinib|mesh-list
25463715|NCT01472081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25463716|NCT01472081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463717|NCT01472081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25463718|NCT01472081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463719|NCT01472081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25463720|NCT01472081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25463721|NCT01472081|Growth Substances|growth substances|mesh-ancestor
25463722|NCT01472081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463723|NCT01472081|Growth Inhibitors|growth inhibitors|mesh-ancestor
25463724|NCT01472081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25463725|NCT01472081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25463726|NCT01309672|Prednisone|prednisone|mesh-list
25463727|NCT01309672|Abiraterone Acetate|abiraterone acetate|mesh-list
25463728|NCT01309672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25463729|NCT01309672|Glucocorticoids|glucocorticoids|mesh-ancestor
25463730|NCT01309672|Hormones|hormones|mesh-ancestor
25463731|NCT01309672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25463732|NCT01309672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644609|NCT01438424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25463733|NCT01309672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25463734|NCT01309672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463735|NCT01309672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25463736|NCT01309672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25463737|NCT01309672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463738|NCT01309672|Hormone Antagonists|hormone antagonists|mesh-ancestor
25463739|NCT01309672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25463741|NCT01131169|Fludarabine|fludarabine|mesh-list
25463742|NCT01131169|Fludarabine phosphate|fludarabine phosphate|mesh-list
25463743|NCT01131169|Melphalan|melphalan|mesh-list
25463744|NCT01131169|Busulfan|busulfan|mesh-list
25463745|NCT01131169|Lenograstim|lenograstim|mesh-list
25463746|NCT01131169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463747|NCT01131169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25463748|NCT01131169|Antimetabolites|antimetabolites|mesh-ancestor
25463749|NCT01131169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463750|NCT01131169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25463751|NCT01131169|Immunologic Factors|immunologic factors|mesh-ancestor
25463752|NCT01131169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463753|NCT01131169|Antiviral Agents|antiviral agents|mesh-ancestor
25463754|NCT01131169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25463755|NCT01131169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25463756|NCT01131169|Alkylating Agents|alkylating agents|mesh-ancestor
25463757|NCT01131169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25463758|NCT01131169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25463759|NCT00882505|Vitamin D|vitamin d|mesh-list
25463760|NCT00882505|Vitamins|vitamins|mesh-ancestor
25463761|NCT00882505|Micronutrients|micronutrients|mesh-ancestor
25463762|NCT00882505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463763|NCT00882505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25463764|NCT00871013|Thalidomide|thalidomide|mesh-list
25463765|NCT00871013|Dexamethasone|dexamethasone|mesh-list
25463766|NCT00871013|Cyclophosphamide|cyclophosphamide|mesh-list
25463767|NCT00871013|Melphalan|melphalan|mesh-list
25463768|NCT00871013|Cisplatin|cisplatin|mesh-list
25463769|NCT00871013|Doxorubicin|doxorubicin|mesh-list
25463770|NCT00871013|Etoposide|etoposide|mesh-list
25463771|NCT00871013|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25463772|NCT00871013|Bortezomib|bortezomib|mesh-list
25463773|NCT00871013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25463774|NCT00871013|Immunologic Factors|immunologic factors|mesh-ancestor
25463775|NCT00871013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463776|NCT00871013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25463777|NCT00871013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25463778|NCT00871013|Alkylating Agents|alkylating agents|mesh-ancestor
25323770|NCT04892758|Adrenergic Agents|adrenergic agents|mesh-ancestor
25323771|NCT04892758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25323772|NCT04892758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323773|NCT04892758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25323774|NCT04892758|Dermatologic Agents|dermatologic agents|mesh-ancestor
25323775|NCT04892758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25323779|NCT04892511|Nitroprusside|nitroprusside|mesh-list
25323780|NCT04892511|Labetalol|labetalol|mesh-list
25323781|NCT04892511|Urapidil|urapidil|mesh-list
25463779|NCT00871013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463780|NCT00871013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463781|NCT00871013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25463782|NCT00871013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25463783|NCT00871013|Antiemetics|antiemetics|mesh-ancestor
25463784|NCT00871013|Autonomic Agents|autonomic agents|mesh-ancestor
25463785|NCT00871013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25463786|NCT00871013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25463787|NCT00871013|Glucocorticoids|glucocorticoids|mesh-ancestor
25463788|NCT00871013|Hormones|hormones|mesh-ancestor
25463789|NCT00871013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25463790|NCT00871013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25463791|NCT00871013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25463792|NCT00871013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25463793|NCT00871013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25463794|NCT00871013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25463795|NCT00871013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25463796|NCT00871013|Leprostatic Agents|leprostatic agents|mesh-ancestor
25463797|NCT00871013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25463798|NCT00871013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25463799|NCT00871013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25463800|NCT00871013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25644610|NCT01438424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25644611|NCT01438424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25644612|NCT01438424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463801|NCT00871013|Growth Substances|growth substances|mesh-ancestor
25463802|NCT00871013|Growth Inhibitors|growth inhibitors|mesh-ancestor
25463803|NCT00774345|Lenalidomide|lenalidomide|mesh-list
25463804|NCT00774345|Immunologic Factors|immunologic factors|mesh-ancestor
25463805|NCT00774345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463806|NCT00774345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25463807|NCT00774345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25463808|NCT00774345|Growth Substances|growth substances|mesh-ancestor
25463809|NCT00774345|Growth Inhibitors|growth inhibitors|mesh-ancestor
25463810|NCT00774345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463812|NCT00735657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25463813|NCT00735657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25463814|NCT00735657|Trace Elements|trace elements|mesh-ancestor
25463815|NCT00735657|Micronutrients|micronutrients|mesh-ancestor
25463816|NCT00735657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463817|NCT00258427|Methylprednisolone|methylprednisolone|mesh-list
25463818|NCT00258427|Cyclophosphamide|cyclophosphamide|mesh-list
25463819|NCT00258427|Busulfan|busulfan|mesh-list
25463820|NCT00258427|Fludarabine|fludarabine|mesh-list
25463821|NCT00258427|Fludarabine phosphate|fludarabine phosphate|mesh-list
25463822|NCT00258427|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25463823|NCT00258427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25463824|NCT00258427|Immunologic Factors|immunologic factors|mesh-ancestor
25463825|NCT00258427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463826|NCT00258427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25463827|NCT00258427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25463828|NCT00258427|Alkylating Agents|alkylating agents|mesh-ancestor
25463829|NCT00258427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463830|NCT00258427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25463831|NCT00258427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25463832|NCT00258427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25463833|NCT00258427|Antimetabolites|antimetabolites|mesh-ancestor
25463834|NCT00258427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25463835|NCT00258427|Antiemetics|antiemetics|mesh-ancestor
25463836|NCT00258427|Autonomic Agents|autonomic agents|mesh-ancestor
25463837|NCT00258427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25463838|NCT00258427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25463839|NCT00258427|Glucocorticoids|glucocorticoids|mesh-ancestor
25463840|NCT00258427|Hormones|hormones|mesh-ancestor
25463841|NCT00258427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25463842|NCT00258427|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25463843|NCT00258427|Protective Agents|protective agents|mesh-ancestor
25463844|NCT00250341|Beclomethasone|beclomethasone|mesh-list
25463845|NCT00250341|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25463846|NCT00250341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25463847|NCT00250341|Glucocorticoids|glucocorticoids|mesh-ancestor
25463848|NCT00250341|Hormones|hormones|mesh-ancestor
25463849|NCT00250341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25463850|NCT00250341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463851|NCT00250341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25463852|NCT00250341|Respiratory System Agents|respiratory system agents|mesh-ancestor
25463853|NCT00250341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25463854|NCT00250341|Autonomic Agents|autonomic agents|mesh-ancestor
25463855|NCT00250341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25323845|NCT04891861|Rivaroxaban|rivaroxaban|mesh-list
25463856|NCT00250341|Sympathomimetics|sympathomimetics|mesh-ancestor
25463857|NCT03723538|Dexmedetomidine|dexmedetomidine|mesh-list
25463858|NCT03723538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25463859|NCT03723538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25463860|NCT03723538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463861|NCT03723538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25463862|NCT03723538|Analgesics|analgesics|mesh-ancestor
25463863|NCT03723538|Sensory System Agents|sensory system agents|mesh-ancestor
25463864|NCT03723538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25463865|NCT03723538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25463866|NCT03723538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25463867|NCT03723538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25463868|NCT03723538|Adrenergic Agents|adrenergic agents|mesh-ancestor
25463869|NCT03723538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25463870|NCT03723538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463871|NCT00000102|Nifedipine|nifedipine|mesh-list
25644613|NCT01438424|Antiviral Agents|antiviral agents|mesh-ancestor
25463872|NCT00000102|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25463873|NCT00000102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25463874|NCT00000102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463875|NCT00000102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25463876|NCT00000102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463877|NCT00000102|Vasodilator Agents|vasodilator agents|mesh-ancestor
25463878|NCT00000102|Tocolytic Agents|tocolytic agents|mesh-ancestor
25463879|NCT00000102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25463880|NCT00000125|Antihypertensive Agents|antihypertensive agents|mesh-list
25463881|NCT00000125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25463882|NCT00000125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25463883|NCT00000134|Ganciclovir|ganciclovir|mesh-list
25463884|NCT00000134|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25463885|NCT00000134|Foscarnet|foscarnet|mesh-list
25463886|NCT00000134|Antiviral Agents|antiviral agents|mesh-ancestor
25463887|NCT00000134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25463888|NCT00000134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25463889|NCT00000134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25463890|NCT00000134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722372|NCT02501928|Fesoterodine|fesoterodine|mesh-list
25463891|NCT00000134|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25463892|NCT00000136|Ganciclovir|ganciclovir|mesh-list
25463893|NCT00000136|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25463894|NCT00000136|Foscarnet|foscarnet|mesh-list
25463895|NCT00000136|Antiviral Agents|antiviral agents|mesh-ancestor
25463896|NCT00000136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25463897|NCT00000136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25463898|NCT00000136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25463899|NCT00000136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463900|NCT00000136|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25463901|NCT00000142|Cidofovir|cidofovir|mesh-list
25463902|NCT00000142|Antiviral Agents|antiviral agents|mesh-ancestor
25463903|NCT00000142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25463904|NCT00000142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25463905|NCT00000142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463906|NCT00000143|Ganciclovir|ganciclovir|mesh-list
25463907|NCT00000143|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25463908|NCT00000143|Cidofovir|cidofovir|mesh-list
25463909|NCT00000143|Antiviral Agents|antiviral agents|mesh-ancestor
25463910|NCT00000143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25463911|NCT00000143|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25463912|NCT00000143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25463913|NCT00000143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463914|NCT00000371|Cycloserine|cycloserine|mesh-list
25463915|NCT00000371|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25463916|NCT00000371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25463917|NCT00000371|Renal Agents|renal agents|mesh-ancestor
25463918|NCT00000371|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25463919|NCT00000371|Antitubercular Agents|antitubercular agents|mesh-ancestor
25463920|NCT00000371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25463921|NCT00000371|Antimetabolites|antimetabolites|mesh-ancestor
25463922|NCT00000371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463923|NCT00000378|Sertraline|sertraline|mesh-list
25463924|NCT00000378|Nortriptyline|nortriptyline|mesh-list
25463925|NCT00000378|Antidepressive Agents|antidepressive agents|mesh-ancestor
25463926|NCT00000378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25463927|NCT00000378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25463928|NCT00000378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25463929|NCT00000378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25463930|NCT00000378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463931|NCT00000378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25463932|NCT00000378|Serotonin Agents|serotonin agents|mesh-ancestor
25463933|NCT00000378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463934|NCT00000378|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25463935|NCT00000378|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25463936|NCT00000378|Adrenergic Agents|adrenergic agents|mesh-ancestor
25463937|NCT00000479|Aspirin|aspirin|mesh-list
25463938|NCT00000479|Vitamin E|vitamin e|mesh-list
25463939|NCT00000479|Vitamins|vitamins|mesh-ancestor
25463940|NCT00000479|Micronutrients|micronutrients|mesh-ancestor
25463941|NCT00000479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463942|NCT00000479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25463943|NCT00000479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25463944|NCT00000479|Analgesics|analgesics|mesh-ancestor
25644614|NCT01438424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25644615|NCT01438424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25463945|NCT00000479|Sensory System Agents|sensory system agents|mesh-ancestor
25463946|NCT00000479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25463947|NCT00000479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25463948|NCT00000479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25463949|NCT00000479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25463950|NCT00000479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25722379|NCT02501928|Urological Agents|urological agents|mesh-ancestor
25463951|NCT00000479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25463952|NCT00000479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25463953|NCT00000479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25463954|NCT00000479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25463955|NCT00000479|Antipyretics|antipyretics|mesh-ancestor
25463956|NCT00000479|Antioxidants|antioxidants|mesh-ancestor
25463957|NCT00000479|Protective Agents|protective agents|mesh-ancestor
25463958|NCT00000575|Nedocromil|nedocromil|mesh-list
25463959|NCT00000575|Budesonide|budesonide|mesh-list
25463960|NCT00000575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25463961|NCT00000575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25463962|NCT00000575|Autonomic Agents|autonomic agents|mesh-ancestor
25463963|NCT00000575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25463964|NCT00000575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25463965|NCT00000575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25463966|NCT00000575|Respiratory System Agents|respiratory system agents|mesh-ancestor
25463967|NCT00000575|Glucocorticoids|glucocorticoids|mesh-ancestor
25463968|NCT00000575|Hormones|hormones|mesh-ancestor
25463969|NCT00000575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25463970|NCT00000575|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
25463971|NCT00000575|Immunologic Factors|immunologic factors|mesh-ancestor
25463972|NCT00000575|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25463973|NCT00000620|Insulin|insulin|mesh-list
25463974|NCT00000620|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25463975|NCT00000620|Metformin|metformin|mesh-list
25463976|NCT00000620|Insulin Glargine|insulin glargine|mesh-list
25463977|NCT00000620|Pioglitazone|pioglitazone|mesh-list
25463978|NCT00000620|Insulin Aspart|insulin aspart|mesh-list
25463979|NCT00000620|Glimepiride|glimepiride|mesh-list
25463980|NCT00000620|Rosiglitazone|rosiglitazone|mesh-list
25463981|NCT00000620|Insulin Detemir|insulin detemir|mesh-list
25463982|NCT00000620|Acarbose|acarbose|mesh-list
25463983|NCT00000620|Repaglinide|repaglinide|mesh-list
25463984|NCT00000620|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25463985|NCT00000620|Metoprolol|metoprolol|mesh-list
25463986|NCT00000620|Felodipine|felodipine|mesh-list
25463987|NCT00000620|Amlodipine|amlodipine|mesh-list
25463988|NCT00000620|Valsartan|valsartan|mesh-list
25463989|NCT00000620|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25463990|NCT00000620|Carvedilol|carvedilol|mesh-list
25323995|NCT04890379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323996|NCT04890418|Ketamine|ketamine|mesh-list
25323997|NCT04890418|Analgesics|analgesics|mesh-ancestor
25323998|NCT04890418|Sensory System Agents|sensory system agents|mesh-ancestor
25323999|NCT04890418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25324000|NCT04890418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324001|NCT04890418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25324002|NCT04890418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25324003|NCT04890418|Anesthetics, General|anesthetics, general|mesh-ancestor
25324004|NCT04890418|Anesthetics|anesthetics|mesh-ancestor
25324005|NCT04890418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25324006|NCT04890418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25324007|NCT04890418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25324008|NCT04890418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25463991|NCT00000620|Candesartan|candesartan|mesh-list
25463992|NCT00000620|Candesartan cilexetil|candesartan cilexetil|mesh-list
25463993|NCT00000620|Lisinopril|lisinopril|mesh-list
25463994|NCT00000620|Chlorthalidone|chlorthalidone|mesh-list
25463995|NCT00000620|Diltiazem|diltiazem|mesh-list
25463996|NCT00000620|Benazepril|benazepril|mesh-list
25463997|NCT00000620|Hydralazine|hydralazine|mesh-list
25463998|NCT00000620|Antihypertensive Agents|antihypertensive agents|mesh-list
25463999|NCT00000620|Reserpine|reserpine|mesh-list
25464000|NCT00000620|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
25464001|NCT00000620|Hydrochlorothiazide-triamterene|hydrochlorothiazide-triamterene|mesh-list
25464002|NCT00000620|Triamterene|triamterene|mesh-list
25464003|NCT00000620|Furosemide|furosemide|mesh-list
25464004|NCT00000620|Simvastatin|simvastatin|mesh-list
25464005|NCT00000620|Fenofibrate|fenofibrate|mesh-list
25464006|NCT00000620|Terazosin|terazosin|mesh-list
25464007|NCT00000620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464008|NCT00000620|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25722390|NCT02502734|Fluticasone|fluticasone|mesh-list
25464009|NCT00000620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25464010|NCT00000620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464011|NCT00000620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25464013|NCT00000620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25464014|NCT00000620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25464015|NCT00000620|Antimetabolites|antimetabolites|mesh-ancestor
25464016|NCT00000620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25464017|NCT00000620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25464018|NCT00000620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464019|NCT00000620|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25464020|NCT00000620|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25464021|NCT00000620|Diuretics|diuretics|mesh-ancestor
25464022|NCT00000620|Natriuretic Agents|natriuretic agents|mesh-ancestor
25464023|NCT00000620|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25464024|NCT00000620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25464025|NCT00000620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25464026|NCT00000620|Immunologic Factors|immunologic factors|mesh-ancestor
25464027|NCT00000620|Sympatholytics|sympatholytics|mesh-ancestor
25464028|NCT00000620|Autonomic Agents|autonomic agents|mesh-ancestor
25464029|NCT00000620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25464030|NCT00000620|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25464031|NCT00000620|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25464032|NCT00000620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25464033|NCT00000620|Adrenergic Agents|adrenergic agents|mesh-ancestor
25464034|NCT00000620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25464035|NCT00000620|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25464036|NCT00000620|Antioxidants|antioxidants|mesh-ancestor
25464037|NCT00000620|Protective Agents|protective agents|mesh-ancestor
25464038|NCT00000620|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25464039|NCT00000620|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25464040|NCT00000620|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25464041|NCT00000620|Protease Inhibitors|protease inhibitors|mesh-ancestor
25464042|NCT00000620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25464043|NCT00000620|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25464044|NCT00000620|Urological Agents|urological agents|mesh-ancestor
25464045|NCT00000620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25464046|NCT00000620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25464047|NCT00000620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25464048|NCT00000620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25464049|NCT00000620|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25464050|NCT00000620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25464051|NCT00000620|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
25464052|NCT00000620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25464053|NCT00000620|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25464054|NCT00001151|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
25464055|NCT00001151|Calcitriol|calcitriol|mesh-list
25464056|NCT00001151|Vitamins|vitamins|mesh-ancestor
25464057|NCT00001151|Micronutrients|micronutrients|mesh-ancestor
25464058|NCT00001151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464059|NCT00001151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25464060|NCT00001151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25464061|NCT00001151|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25464062|NCT00001151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25464063|NCT00001151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464064|NCT00001151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25464065|NCT00001213|Cysteamine|cysteamine|mesh-list
25464066|NCT00001213|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
25464067|NCT00001213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464068|NCT00001262|Copper|copper|mesh-list
25324078|NCT04888728|Nebivolol|nebivolol|mesh-list
25464070|NCT00001262|Micronutrients|micronutrients|mesh-ancestor
25464071|NCT00001262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464072|NCT00001304|Vitamin D|vitamin d|mesh-list
25464073|NCT00001304|Calcitriol|calcitriol|mesh-list
25464074|NCT00001304|Calcium|calcium|mesh-list
25464075|NCT00001304|Parathyroid Hormone|parathyroid hormone|mesh-list
25464076|NCT00001304|Hormones|hormones|mesh-list
25464077|NCT00001304|Vitamins|vitamins|mesh-ancestor
25464078|NCT00001304|Micronutrients|micronutrients|mesh-ancestor
25464079|NCT00001304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464080|NCT00001304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25464081|NCT00001304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25464082|NCT00001304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25464083|NCT00001304|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25644616|NCT01438424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25644617|NCT01438489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25644618|NCT01438489|Immunologic Factors|immunologic factors|mesh-ancestor
25644619|NCT01438489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644620|NCT01438710|Tacrolimus|tacrolimus|mesh-list
25644621|NCT01438710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25644622|NCT01438710|Immunologic Factors|immunologic factors|mesh-ancestor
25644623|NCT01438710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644624|NCT01438710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25464084|NCT00001304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25464085|NCT00001304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464086|NCT00001304|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25464087|NCT00001566|Indinavir|indinavir|mesh-list
25464088|NCT00001566|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25464089|NCT00001566|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25464090|NCT00001566|Protease Inhibitors|protease inhibitors|mesh-ancestor
25464091|NCT00001566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464092|NCT00001566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464093|NCT00001566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25464094|NCT00001566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25464095|NCT00001566|Antiviral Agents|antiviral agents|mesh-ancestor
25464096|NCT00001566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25464097|NCT00001575|Edetic Acid|edetic acid|mesh-list
25464098|NCT00001575|Calcium|calcium|mesh-list
25464099|NCT00001575|Pentetic Acid|pentetic acid|mesh-list
25464100|NCT00001575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25464101|NCT00001575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464102|NCT00001575|Antidotes|antidotes|mesh-ancestor
25464103|NCT00001575|Protective Agents|protective agents|mesh-ancestor
25464104|NCT00001575|Chelating Agents|chelating agents|mesh-ancestor
25464105|NCT00001575|Sequestering Agents|sequestering agents|mesh-ancestor
25464106|NCT00001575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464107|NCT00001575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25464108|NCT00001575|Anticoagulants|anticoagulants|mesh-ancestor
25464109|NCT00001575|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25464110|NCT00001586|Vidarabine|vidarabine|mesh-list
25464111|NCT00001586|Rituximab|rituximab|mesh-list
25464112|NCT00001586|Fludarabine|fludarabine|mesh-list
25464113|NCT00001586|Fludarabine phosphate|fludarabine phosphate|mesh-list
25464114|NCT00001586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25464115|NCT00001586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464116|NCT00001586|Immunologic Factors|immunologic factors|mesh-ancestor
25464117|NCT00001586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464118|NCT00001586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25464119|NCT00001586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25464120|NCT00001586|Antimetabolites|antimetabolites|mesh-ancestor
25464121|NCT00001586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464122|NCT00001586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25464123|NCT00001586|Antiviral Agents|antiviral agents|mesh-ancestor
25464124|NCT00001586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25464125|NCT00001596|Pirfenidone|pirfenidone|mesh-list
25464126|NCT00001596|Analgesics|analgesics|mesh-ancestor
25464127|NCT00001596|Sensory System Agents|sensory system agents|mesh-ancestor
25464128|NCT00001596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25464129|NCT00001596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464130|NCT00001596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25464131|NCT00001596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25464132|NCT00001596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25464133|NCT00001596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25464134|NCT00001596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25324144|NCT04888403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324145|NCT04887818|Lidocaine|lidocaine|mesh-list
25324146|NCT04887818|Diltiazem|diltiazem|mesh-list
25324147|NCT04887818|Nifedipine|nifedipine|mesh-list
25324148|NCT04887818|Anesthetics, Local|anesthetics, local|mesh-ancestor
25324149|NCT04887818|Anesthetics|anesthetics|mesh-ancestor
25324150|NCT04887818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25464135|NCT00001656|Olanzapine|olanzapine|mesh-list
25464136|NCT00001656|Clozapine|clozapine|mesh-list
25464137|NCT00001656|Antiemetics|antiemetics|mesh-ancestor
25464138|NCT00001656|Autonomic Agents|autonomic agents|mesh-ancestor
25464139|NCT00001656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25464140|NCT00001656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464141|NCT00001656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25464142|NCT00001656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25464143|NCT00001656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25464144|NCT00001656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25644625|NCT01438710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25644626|NCT01438710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644627|NCT01438814|Metformin|metformin|mesh-list
25644628|NCT01438814|Linagliptin|linagliptin|mesh-list
25464145|NCT00001656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25464146|NCT00001656|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25464147|NCT00001656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25464148|NCT00001656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25464149|NCT00001656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464150|NCT00001656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25464151|NCT00001656|Serotonin Agents|serotonin agents|mesh-ancestor
25464152|NCT00001656|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25464153|NCT00001656|GABA Antagonists|gaba antagonists|mesh-ancestor
25464155|NCT00001703|Freund's Adjuvant|freund's adjuvant|mesh-list
25464156|NCT00001703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25464157|NCT00001703|Immunologic Factors|immunologic factors|mesh-ancestor
25464158|NCT00001703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464159|NCT00001723|Orlistat|orlistat|mesh-list
25464160|NCT00001723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464161|NCT00001723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464162|NCT00001723|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25464163|NCT00001723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25464164|NCT00001832|Cyclophosphamide|cyclophosphamide|mesh-list
25464165|NCT00001832|Fludarabine|fludarabine|mesh-list
25464166|NCT00001832|Interleukin-2|interleukin-2|mesh-list
25464167|NCT00001832|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25464168|NCT00001832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25464169|NCT00001832|Immunologic Factors|immunologic factors|mesh-ancestor
25464170|NCT00001832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464171|NCT00001832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25464172|NCT00001832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25464173|NCT00001832|Alkylating Agents|alkylating agents|mesh-ancestor
25464174|NCT00001832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464175|NCT00001832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464176|NCT00001832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25464177|NCT00001832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25464178|NCT00001832|Analgesics|analgesics|mesh-ancestor
25464179|NCT00001832|Sensory System Agents|sensory system agents|mesh-ancestor
25464180|NCT00001832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25464181|NCT00001832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25464182|NCT00001849|Edetic Acid|edetic acid|mesh-list
25464183|NCT00001849|Pentetic Acid|pentetic acid|mesh-list
25464184|NCT00001849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464185|NCT00001849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464186|NCT00001849|Antidotes|antidotes|mesh-ancestor
25464187|NCT00001849|Protective Agents|protective agents|mesh-ancestor
25464188|NCT00001849|Chelating Agents|chelating agents|mesh-ancestor
25464189|NCT00001849|Sequestering Agents|sequestering agents|mesh-ancestor
25464190|NCT00001849|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25464191|NCT00001849|Anticoagulants|anticoagulants|mesh-ancestor
25464192|NCT00001849|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25464193|NCT00001880|Cyclosporine|cyclosporine|mesh-list
25464194|NCT00001880|Methotrexate|methotrexate|mesh-list
25464195|NCT00001880|Cyclosporins|cyclosporins|mesh-list
25464196|NCT00001880|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25464197|NCT00001880|Abortifacient Agents|abortifacient agents|mesh-ancestor
25324217|NCT04887493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722410|NCT02502864|Cyclophosphamide|cyclophosphamide|mesh-list
25324218|NCT04887493|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25324219|NCT04887493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25324220|NCT04887493|Oxytocics|oxytocics|mesh-ancestor
25324221|NCT04887493|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25324222|NCT04887493|Vasodilator Agents|vasodilator agents|mesh-ancestor
25324223|NCT04887493|Urological Agents|urological agents|mesh-ancestor
25324224|NCT04887311|Tempol|tempol|mesh-list
25324225|NCT04887311|Antioxidants|antioxidants|mesh-ancestor
25324226|NCT04887311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324227|NCT04887311|Protective Agents|protective agents|mesh-ancestor
25324228|NCT04887311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324229|NCT04887311|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25324230|NCT04887311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25324231|NCT04887311|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25324232|NCT04887311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25464198|NCT00001880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25464199|NCT00001880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464200|NCT00001880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25464201|NCT00001880|Antimetabolites|antimetabolites|mesh-ancestor
25644629|NCT01438814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25644630|NCT01438814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464202|NCT00001880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464203|NCT00001880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464204|NCT00001880|Dermatologic Agents|dermatologic agents|mesh-ancestor
25464205|NCT00001880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464206|NCT00001880|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25464207|NCT00001880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25464208|NCT00001880|Immunologic Factors|immunologic factors|mesh-ancestor
25464209|NCT00001880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25464210|NCT00001880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25464211|NCT00001880|Antifungal Agents|antifungal agents|mesh-ancestor
25464212|NCT00001880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25464213|NCT00001880|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25464214|NCT00001941|Daclizumab|daclizumab|mesh-list
25464215|NCT00001941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25464216|NCT00001941|Immunologic Factors|immunologic factors|mesh-ancestor
25464217|NCT00001941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464218|NCT00001959|Pirfenidone|pirfenidone|mesh-list
25464219|NCT00001959|Analgesics|analgesics|mesh-ancestor
25464220|NCT00001959|Sensory System Agents|sensory system agents|mesh-ancestor
25464221|NCT00001959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25464222|NCT00001959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464223|NCT00001959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25464224|NCT00001959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25464225|NCT00001959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25464226|NCT00001959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25464227|NCT00001959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464228|NCT00001962|Daclizumab|daclizumab|mesh-list
25464229|NCT00001962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25464230|NCT00001962|Immunologic Factors|immunologic factors|mesh-ancestor
25464231|NCT00001962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464232|NCT00001984|Alemtuzumab|alemtuzumab|mesh-list
25464233|NCT00001984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25464234|NCT00001984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464235|NCT00002525|Leucovorin|leucovorin|mesh-list
25464236|NCT00002525|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
25464237|NCT00002525|Tetrahydrofolates|tetrahydrofolates|mesh-list
25464238|NCT00002525|Fluorouracil|fluorouracil|mesh-list
25464239|NCT00002525|Calcium|calcium|mesh-list
25464240|NCT00002525|Levoleucovorin|levoleucovorin|mesh-list
25464241|NCT00002525|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25464242|NCT00002525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464243|NCT00002525|Antimetabolites|antimetabolites|mesh-ancestor
25464244|NCT00002525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464245|NCT00002525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25464246|NCT00002525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464247|NCT00002525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25464248|NCT00002525|Immunologic Factors|immunologic factors|mesh-ancestor
25464249|NCT00002525|Antidotes|antidotes|mesh-ancestor
25464250|NCT00002525|Protective Agents|protective agents|mesh-ancestor
25464251|NCT00002525|Vitamin B Complex|vitamin b complex|mesh-ancestor
25464252|NCT00002525|Vitamins|vitamins|mesh-ancestor
25464253|NCT00002525|Micronutrients|micronutrients|mesh-ancestor
25464254|NCT00002558|Paclitaxel|paclitaxel|mesh-list
25464255|NCT00002558|Etoposide|etoposide|mesh-list
25464256|NCT00002558|Carboplatin|carboplatin|mesh-list
25464257|NCT00002558|Ifosfamide|ifosfamide|mesh-list
25464258|NCT00002558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25464259|NCT00002558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464260|NCT00002558|Tubulin Modulators|tubulin modulators|mesh-ancestor
25464261|NCT00002558|Antimitotic Agents|antimitotic agents|mesh-ancestor
25464262|NCT00002558|Mitosis Modulators|mitosis modulators|mesh-ancestor
25464263|NCT00002558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464264|NCT00002558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25464265|NCT00002558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25464266|NCT00002558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464267|NCT00002558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25464268|NCT00002558|Alkylating Agents|alkylating agents|mesh-ancestor
25464269|NCT00002597|Leuprolide|leuprolide|mesh-list
25464270|NCT00002597|Goserelin|goserelin|mesh-list
25324292|NCT04886193|Vitamins|vitamins|mesh-ancestor
25324293|NCT04886193|Micronutrients|micronutrients|mesh-ancestor
25324294|NCT04886167|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25464271|NCT00002597|Flutamide|flutamide|mesh-list
25464272|NCT00002597|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25464274|NCT00002597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25464275|NCT00002597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464276|NCT00002597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25464277|NCT00002597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464278|NCT00002597|Androgen Antagonists|androgen antagonists|mesh-ancestor
25464279|NCT00002597|Hormone Antagonists|hormone antagonists|mesh-ancestor
25464280|NCT00002597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25464281|NCT00002601|Cisplatin|cisplatin|mesh-list
25464282|NCT00002601|Doxorubicin|doxorubicin|mesh-list
25464283|NCT00002601|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25464284|NCT00002601|Melphalan|melphalan|mesh-list
25464285|NCT00002601|Ifosfamide|ifosfamide|mesh-list
25464286|NCT00002601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464287|NCT00002601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25464288|NCT00002601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25464289|NCT00002601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25464290|NCT00002601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464291|NCT00002601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464292|NCT00002601|Immunologic Factors|immunologic factors|mesh-ancestor
25464293|NCT00002601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464294|NCT00002601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25464295|NCT00002601|Alkylating Agents|alkylating agents|mesh-ancestor
25464296|NCT00002601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25464297|NCT00002601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25464298|NCT00002651|Goserelin|goserelin|mesh-list
25464299|NCT00002651|Bicalutamide|bicalutamide|mesh-list
25464300|NCT00002651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25464301|NCT00002651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464302|NCT00002651|Androgen Antagonists|androgen antagonists|mesh-ancestor
25464303|NCT00002651|Hormone Antagonists|hormone antagonists|mesh-ancestor
25464304|NCT00002651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25464305|NCT00002651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464306|NCT00002766|Cytarabine|cytarabine|mesh-list
25464307|NCT00002766|Dactinomycin|dactinomycin|mesh-list
25464308|NCT00002766|Prednisone|prednisone|mesh-list
25464309|NCT00002766|Cyclophosphamide|cyclophosphamide|mesh-list
25464310|NCT00002766|Carmustine|carmustine|mesh-list
25464311|NCT00002766|Doxorubicin|doxorubicin|mesh-list
25464312|NCT00002766|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25464313|NCT00002766|Methotrexate|methotrexate|mesh-list
25464314|NCT00002766|Etoposide|etoposide|mesh-list
25464315|NCT00002766|Vincristine|vincristine|mesh-list
25464316|NCT00002766|Daunorubicin|daunorubicin|mesh-list
25464317|NCT00002766|Mitoxantrone|mitoxantrone|mesh-list
25464318|NCT00002766|Mercaptopurine|mercaptopurine|mesh-list
25464319|NCT00002766|Pegaspargase|pegaspargase|mesh-list
25464320|NCT00002766|Sargramostim|sargramostim|mesh-list
25464321|NCT00002766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25464322|NCT00002766|Immunologic Factors|immunologic factors|mesh-ancestor
25464323|NCT00002766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464324|NCT00002766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25464325|NCT00002766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25324368|NCT04884997|Temozolomide|temozolomide|mesh-list
25324369|NCT04884997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25324370|NCT04884997|Alkylating Agents|alkylating agents|mesh-ancestor
25324371|NCT04884997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324372|NCT04884997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25324373|NCT04884906|Paclitaxel|paclitaxel|mesh-list
25324374|NCT04884906|Cisplatin|cisplatin|mesh-list
25324375|NCT04884906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25324376|NCT04884906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25324377|NCT04884906|Tubulin Modulators|tubulin modulators|mesh-ancestor
25324378|NCT04884906|Antimitotic Agents|antimitotic agents|mesh-ancestor
25324379|NCT04884906|Mitosis Modulators|mitosis modulators|mesh-ancestor
25324380|NCT04884906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324381|NCT04885075|Midazolam|midazolam|mesh-list
25324382|NCT04885075|Diazepam|diazepam|mesh-list
25324383|NCT04885075|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25324384|NCT04885075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25324385|NCT04885075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25324386|NCT04885075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324387|NCT04885075|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25324388|NCT04885075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25324389|NCT04885075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25324390|NCT04885075|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25324392|NCT04885075|Anesthetics|anesthetics|mesh-ancestor
25464326|NCT00002766|Alkylating Agents|alkylating agents|mesh-ancestor
25464327|NCT00002766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464328|NCT00002766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464329|NCT00002766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25644632|NCT01438814|Hormones|hormones|mesh-ancestor
25644633|NCT01438814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25644634|NCT01438814|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25644635|NCT01438814|Protease Inhibitors|protease inhibitors|mesh-ancestor
25644636|NCT01438814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464330|NCT00002766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25464331|NCT00002766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25464332|NCT00002766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25464333|NCT00002766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464334|NCT00002766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25464335|NCT00002766|Glucocorticoids|glucocorticoids|mesh-ancestor
25464336|NCT00002766|Hormones|hormones|mesh-ancestor
25464337|NCT00002766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25464338|NCT00002766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25464339|NCT00002766|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25464340|NCT00002766|Abortifacient Agents|abortifacient agents|mesh-ancestor
25464341|NCT00002766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25464342|NCT00002766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25464343|NCT00002766|Antimetabolites|antimetabolites|mesh-ancestor
25464344|NCT00002766|Dermatologic Agents|dermatologic agents|mesh-ancestor
25464345|NCT00002766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25464346|NCT00002766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25464347|NCT00002766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25464348|NCT00002766|Antiviral Agents|antiviral agents|mesh-ancestor
25464349|NCT00002766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25464350|NCT00002766|Tubulin Modulators|tubulin modulators|mesh-ancestor
25464351|NCT00002766|Antimitotic Agents|antimitotic agents|mesh-ancestor
25464352|NCT00002766|Mitosis Modulators|mitosis modulators|mesh-ancestor
25464353|NCT00002766|Analgesics|analgesics|mesh-ancestor
25464354|NCT00002766|Sensory System Agents|sensory system agents|mesh-ancestor
25464355|NCT00002766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25464356|NCT00002766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25464357|NCT00002766|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25464358|NCT00002842|Leucovorin|leucovorin|mesh-list
25464359|NCT00002842|Fluorouracil|fluorouracil|mesh-list
25464360|NCT00002842|Floxuridine|floxuridine|mesh-list
25464361|NCT00002842|Calcium|calcium|mesh-list
25464362|NCT00002842|Levoleucovorin|levoleucovorin|mesh-list
25722424|NCT02503085|Ibuprofen|ibuprofen|mesh-list
25464363|NCT00002842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25464364|NCT00002842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464365|NCT00002842|Antimetabolites|antimetabolites|mesh-ancestor
25464366|NCT00002842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464367|NCT00002842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25464368|NCT00002842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464369|NCT00002842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25464370|NCT00002842|Immunologic Factors|immunologic factors|mesh-ancestor
25464371|NCT00002842|Antidotes|antidotes|mesh-ancestor
25464372|NCT00002842|Protective Agents|protective agents|mesh-ancestor
25464373|NCT00002842|Vitamin B Complex|vitamin b complex|mesh-ancestor
25464374|NCT00002842|Vitamins|vitamins|mesh-ancestor
25464375|NCT00002842|Micronutrients|micronutrients|mesh-ancestor
25464376|NCT00002850|Ciprofloxacin|ciprofloxacin|mesh-list
25464377|NCT00002850|Ofloxacin|ofloxacin|mesh-list
25464378|NCT00002850|Trimethoprim|trimethoprim|mesh-list
25464379|NCT00002850|Sulfamethoxazole|sulfamethoxazole|mesh-list
25464380|NCT00002850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25464381|NCT00002850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25464382|NCT00002850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25464383|NCT00002850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25464384|NCT00002850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464385|NCT00002850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464386|NCT00002850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464387|NCT00002850|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25464388|NCT00002850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25464389|NCT00002850|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25464390|NCT00002850|Renal Agents|renal agents|mesh-ancestor
25464391|NCT00002850|Antimalarials|antimalarials|mesh-ancestor
25464392|NCT00002850|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25464393|NCT00002850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25464394|NCT00002850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25464395|NCT00002850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25464396|NCT00002850|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25464397|NCT05384821|Irinotecan|irinotecan|mesh-list
25464398|NCT05384821|Etoposide|etoposide|mesh-list
25324445|NCT04884503|Clonazepam|clonazepam|mesh-list
25324447|NCT04884503|GABA Modulators|gaba modulators|mesh-ancestor
25324448|NCT04884503|GABA Agents|gaba agents|mesh-ancestor
25464399|NCT05384821|Vincristine|vincristine|mesh-list
25464400|NCT05384821|Temozolomide|temozolomide|mesh-list
25464402|NCT05384821|Isotretinoin|isotretinoin|mesh-list
25464403|NCT05384821|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25464404|NCT05384821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25464405|NCT05384821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464406|NCT05384821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464407|NCT05384821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464408|NCT05384821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25464409|NCT05384821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25464410|NCT05384821|Tubulin Modulators|tubulin modulators|mesh-ancestor
25464411|NCT05384821|Antimitotic Agents|antimitotic agents|mesh-ancestor
25464412|NCT05384821|Mitosis Modulators|mitosis modulators|mesh-ancestor
25464413|NCT05384821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25464414|NCT05384821|Alkylating Agents|alkylating agents|mesh-ancestor
25464415|NCT05384821|Keratolytic Agents|keratolytic agents|mesh-ancestor
25464416|NCT05384821|Dermatologic Agents|dermatologic agents|mesh-ancestor
25464417|NCT05384743|Rituximab|rituximab|mesh-list
25464418|NCT05384743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25464419|NCT05384743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464420|NCT05384743|Immunologic Factors|immunologic factors|mesh-ancestor
25464421|NCT05384743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464422|NCT05384743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25464423|NCT05384678|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
25464424|NCT05384678|Hallucinogens|hallucinogens|mesh-ancestor
25464425|NCT05384678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464426|NCT05384678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25464427|NCT05384678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25464428|NCT05384678|Serotonin Agents|serotonin agents|mesh-ancestor
25464429|NCT05384678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25464430|NCT05384678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464431|NCT05384678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25464432|NCT05384574|Cholecalciferol|cholecalciferol|mesh-list
25464433|NCT05384574|Vitamin D|vitamin d|mesh-list
25464434|NCT05384574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25464435|NCT05384574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464436|NCT05384574|Vitamins|vitamins|mesh-ancestor
25464437|NCT05384574|Micronutrients|micronutrients|mesh-ancestor
25464438|NCT05384574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25464439|NCT05384483|Cariprazine|cariprazine|mesh-list
25464440|NCT05384483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25464441|NCT05384483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25464442|NCT05384483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25464443|NCT05384483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464444|NCT05384483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25464445|NCT05384366|Paclitaxel|paclitaxel|mesh-list
25464446|NCT05384366|Carboplatin|carboplatin|mesh-list
25464447|NCT05384366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25464448|NCT05384366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464449|NCT05384366|Tubulin Modulators|tubulin modulators|mesh-ancestor
25464450|NCT05384366|Antimitotic Agents|antimitotic agents|mesh-ancestor
25464451|NCT05384366|Mitosis Modulators|mitosis modulators|mesh-ancestor
25464452|NCT05384366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464453|NCT05384210|Gabapentin|gabapentin|mesh-list
25464454|NCT05384210|Milnacipran|milnacipran|mesh-list
25464455|NCT05384210|Levomilnacipran|levomilnacipran|mesh-list
25464456|NCT05384210|Analgesics|analgesics|mesh-ancestor
25464457|NCT05384210|Sensory System Agents|sensory system agents|mesh-ancestor
25464458|NCT05384210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25464459|NCT05384210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464460|NCT05384210|Anticonvulsants|anticonvulsants|mesh-ancestor
25464461|NCT05384210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25464462|NCT05384210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25464463|NCT05384210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25464464|NCT05384210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25464465|NCT05384210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25464466|NCT05384210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25464467|NCT05384210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25464468|NCT05384210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464469|NCT05384210|Antimanic Agents|antimanic agents|mesh-ancestor
25464470|NCT05384210|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25464471|NCT05384210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25464472|NCT05384210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25464473|NCT05384210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25464475|NCT05383820|Ketorolac|ketorolac|mesh-list
25464476|NCT05383820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25464477|NCT05383820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25464478|NCT05383820|Analgesics|analgesics|mesh-ancestor
25464479|NCT05383820|Sensory System Agents|sensory system agents|mesh-ancestor
25464480|NCT05383820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25464481|NCT05383820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464482|NCT05383820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25464483|NCT05383820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25464484|NCT05383820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25464485|NCT05383820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464486|NCT05383820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464487|NCT05383716|Pembrolizumab|pembrolizumab|mesh-list
25464488|NCT05383716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25464489|NCT05383716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464490|NCT05383625|Vaccines|vaccines|mesh-list
25464491|NCT05383625|Immunologic Factors|immunologic factors|mesh-ancestor
25464492|NCT05383625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464493|NCT05383560|Vaccines|vaccines|mesh-list
25464494|NCT05383560|Immunologic Factors|immunologic factors|mesh-ancestor
25464495|NCT05383560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464496|NCT05383547|Bortezomib|bortezomib|mesh-list
25464497|NCT05383547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464498|NCT05383534|Propofol|propofol|mesh-list
25464499|NCT05383534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25464500|NCT05383534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25464501|NCT05383534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464502|NCT05383534|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25464503|NCT05383534|Anesthetics, General|anesthetics, general|mesh-ancestor
25464504|NCT05383534|Anesthetics|anesthetics|mesh-ancestor
25464505|NCT05383521|Tinidazole|tinidazole|mesh-list
25464506|NCT05383521|Alkylating Agents|alkylating agents|mesh-ancestor
25464507|NCT05383521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464508|NCT05383521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25464509|NCT05383521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25464510|NCT05383521|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25464511|NCT05383521|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25464512|NCT05383521|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25464513|NCT05383313|Midazolam|midazolam|mesh-list
25464514|NCT05383313|Ketamine|ketamine|mesh-list
25464515|NCT05383313|Psilocybin|psilocybin|mesh-list
25464516|NCT05383313|Analgesics|analgesics|mesh-ancestor
25464517|NCT05383313|Sensory System Agents|sensory system agents|mesh-ancestor
25464518|NCT05383313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25464519|NCT05383313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464520|NCT05383313|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25464521|NCT05383313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25464522|NCT05383313|Anesthetics, General|anesthetics, general|mesh-ancestor
25464523|NCT05383313|Anesthetics|anesthetics|mesh-ancestor
25464524|NCT05383313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25464525|NCT05383313|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25464526|NCT05383313|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25464527|NCT05383313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25464528|NCT05383313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464529|NCT05383313|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25464530|NCT05383313|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25464531|NCT05383313|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25464532|NCT05383313|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25464533|NCT05383313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25464534|NCT05383313|GABA Modulators|gaba modulators|mesh-ancestor
25464535|NCT05383313|GABA Agents|gaba agents|mesh-ancestor
25464536|NCT05383313|Hallucinogens|hallucinogens|mesh-ancestor
25464537|NCT05383300|Oxytocin|oxytocin|mesh-list
25464538|NCT05383300|Oxytocics|oxytocics|mesh-ancestor
25464539|NCT05383300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25464540|NCT05383300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464541|NCT05383196|Paclitaxel|paclitaxel|mesh-list
25464542|NCT05383196|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25464543|NCT05383196|Onvansertib|onvansertib|mesh-list
25464544|NCT05383196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25324671|NCT04880811|Afatinib|afatinib|mesh-list
25324672|NCT04880811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25324673|NCT04880811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25324674|NCT04880811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25324675|NCT04880811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324676|NCT04880499|Folic Acid|folic acid|mesh-list
25324677|NCT04880499|Riboflavin|riboflavin|mesh-list
25324678|NCT04880499|Vitamins|vitamins|mesh-ancestor
25464545|NCT05383196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464546|NCT05383196|Tubulin Modulators|tubulin modulators|mesh-ancestor
25464547|NCT05383196|Antimitotic Agents|antimitotic agents|mesh-ancestor
25464548|NCT05383196|Mitosis Modulators|mitosis modulators|mesh-ancestor
25464549|NCT05383196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464550|NCT05383196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25464551|NCT05383196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464552|NCT05383183|Choline|choline|mesh-list
25464553|NCT05383183|Lipotropic Agents|lipotropic agents|mesh-ancestor
25464554|NCT05383183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25464555|NCT05383183|Antimetabolites|antimetabolites|mesh-ancestor
25464556|NCT05383183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464557|NCT05383183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25464558|NCT05383183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25464559|NCT05383183|Nootropic Agents|nootropic agents|mesh-ancestor
25464560|NCT05383170|Pembrolizumab|pembrolizumab|mesh-list
25464561|NCT05383170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25464562|NCT05383170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464563|NCT05379803|Aflutinib|aflutinib|mesh-list
25464564|NCT05379803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25464565|NCT05379803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464566|NCT05379803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464567|NCT05376111|Azacitidine|azacitidine|mesh-list
25464568|NCT05376111|Venetoclax|venetoclax|mesh-list
25464569|NCT05376111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25464570|NCT05376111|Antimetabolites|antimetabolites|mesh-ancestor
25464571|NCT05376111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464572|NCT05376111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464573|NCT05376111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464574|NCT05364489|Bevacizumab|bevacizumab|mesh-list
25464575|NCT05364489|Oxaliplatin|oxaliplatin|mesh-list
25464576|NCT05364489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25464577|NCT05364489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464578|NCT05364489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25464579|NCT05364489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25464580|NCT05364489|Growth Substances|growth substances|mesh-ancestor
25464581|NCT05364489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464582|NCT05364489|Growth Inhibitors|growth inhibitors|mesh-ancestor
25464583|NCT05356858|Zanubrutinib|zanubrutinib|mesh-list
25464584|NCT05356858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464585|NCT05356858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25464586|NCT05356858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464587|NCT05356858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464588|NCT05310110|Lidocaine|lidocaine|mesh-list
25464589|NCT05310110|Propofol|propofol|mesh-list
25464590|NCT05310110|Cisatracurium|cisatracurium|mesh-list
25464591|NCT05310110|Atracurium|atracurium|mesh-list
25464592|NCT05310110|Anesthetics, Local|anesthetics, local|mesh-ancestor
25464593|NCT05310110|Anesthetics|anesthetics|mesh-ancestor
25464594|NCT05310110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25464595|NCT05310110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464596|NCT05310110|Sensory System Agents|sensory system agents|mesh-ancestor
25464597|NCT05310110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25464598|NCT05310110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25464599|NCT05310110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25464600|NCT05310110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25464601|NCT05310110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25464602|NCT05310110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464603|NCT05310110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25464604|NCT05310110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25464605|NCT05310110|Anesthetics, General|anesthetics, general|mesh-ancestor
25464606|NCT05310110|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25464607|NCT05310110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25464608|NCT05310110|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25464609|NCT05310110|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25464610|NCT05310110|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25464611|NCT05310110|Cholinergic Agents|cholinergic agents|mesh-ancestor
25464612|NCT05310110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25464613|NCT05297032|Quercetin|quercetin|mesh-list
25464614|NCT05297032|Antioxidants|antioxidants|mesh-ancestor
25464615|NCT05297032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464616|NCT05297032|Protective Agents|protective agents|mesh-ancestor
25656804|NCT01578850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25464617|NCT05297032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464618|NCT05294588|Ciprofloxacin|ciprofloxacin|mesh-list
25464619|NCT05294588|Ceftriaxone|ceftriaxone|mesh-list
25464620|NCT05294588|Cefixime|cefixime|mesh-list
25464651|NCT05231460|Analgesics|analgesics|mesh-ancestor
25464652|NCT05231460|Sensory System Agents|sensory system agents|mesh-ancestor
25464653|NCT05231460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25324827|NCT04878497|Warfarin|warfarin|mesh-list
25324828|NCT04878497|Rivaroxaban|rivaroxaban|mesh-list
25324829|NCT04878497|Dabigatran|dabigatran|mesh-list
25324830|NCT04878497|Apixaban|apixaban|mesh-list
25324831|NCT04878497|Edoxaban|edoxaban|mesh-list
25324832|NCT04878497|Anticoagulants|anticoagulants|mesh-ancestor
25324833|NCT04878497|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25324834|NCT04878497|Antithrombins|antithrombins|mesh-ancestor
25324835|NCT04878497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25324836|NCT04878497|Protease Inhibitors|protease inhibitors|mesh-ancestor
25324837|NCT04878497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464654|NCT05212571|Ketamine|ketamine|mesh-list
25464655|NCT05212571|Esketamine|esketamine|mesh-list
25464656|NCT05212571|Analgesics|analgesics|mesh-ancestor
25464657|NCT05212571|Sensory System Agents|sensory system agents|mesh-ancestor
25464658|NCT05212571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25464659|NCT05212571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464660|NCT05212571|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25464661|NCT05212571|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25464662|NCT05212571|Anesthetics, General|anesthetics, general|mesh-ancestor
25464663|NCT05212571|Anesthetics|anesthetics|mesh-ancestor
25464664|NCT05212571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25464665|NCT05212571|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25464666|NCT05212571|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25464667|NCT05212571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25464668|NCT05212571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464669|NCT05212571|Antidepressive Agents|antidepressive agents|mesh-ancestor
25464670|NCT05212571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25464671|NCT05205486|Cefazolin|cefazolin|mesh-list
25464672|NCT05205486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25464673|NCT05205486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25464674|NCT05181735|Luspatercept|luspatercept|mesh-list
25464675|NCT05181735|Hematinics|hematinics|mesh-ancestor
25464676|NCT05144529|Nivolumab|nivolumab|mesh-list
25464677|NCT05144529|Ipilimumab|ipilimumab|mesh-list
25464678|NCT05144529|Evolocumab|evolocumab|mesh-list
25464679|NCT05144529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25464680|NCT05144529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464681|NCT05144529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25464682|NCT05144529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464683|NCT05144529|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25464684|NCT05144529|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25464685|NCT05144529|Antimetabolites|antimetabolites|mesh-ancestor
25464686|NCT05144529|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25464687|NCT05128487|Pembrolizumab|pembrolizumab|mesh-list
25464688|NCT05128487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25464689|NCT05128487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464690|NCT05096169|Citric Acid|citric acid|mesh-list
25464691|NCT05096169|Sodium Citrate|sodium citrate|mesh-list
25464692|NCT05096169|Clomiphene|clomiphene|mesh-list
25464693|NCT05096169|Enclomiphene|enclomiphene|mesh-list
25464694|NCT05096169|Zuclomiphene|zuclomiphene|mesh-list
25464695|NCT05096169|Anticoagulants|anticoagulants|mesh-ancestor
25464696|NCT05096169|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25464697|NCT05096169|Chelating Agents|chelating agents|mesh-ancestor
25464698|NCT05096169|Sequestering Agents|sequestering agents|mesh-ancestor
25464699|NCT05096169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464700|NCT05096169|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25464701|NCT05096169|Hormone Antagonists|hormone antagonists|mesh-ancestor
25464702|NCT05096169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25324903|NCT05257993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25324904|NCT05257993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25324905|NCT05257993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25324906|NCT05257993|Immunologic Factors|immunologic factors|mesh-ancestor
25324907|NCT05257993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324908|NCT05257902|Choline|choline|mesh-list
25324909|NCT05257902|Lipotropic Agents|lipotropic agents|mesh-ancestor
25324910|NCT05257902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25324911|NCT05257902|Antimetabolites|antimetabolites|mesh-ancestor
25324912|NCT05257902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324913|NCT05257902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25324914|NCT05257902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25324915|NCT05257902|Nootropic Agents|nootropic agents|mesh-ancestor
25324926|NCT05257395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25324927|NCT05257395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324928|NCT05257395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25324929|NCT05257395|Hormone Antagonists|hormone antagonists|mesh-ancestor
25464703|NCT05096169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464704|NCT05096169|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25464705|NCT05096169|Fertility Agents|fertility agents|mesh-ancestor
25464706|NCT05096169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25464707|NCT05096169|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25464708|NCT05096169|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25464709|NCT05085054|Osimertinib|osimertinib|mesh-list
25464710|NCT05085054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464711|NCT05085054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25464712|NCT05085054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464713|NCT05085054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464714|NCT04940338|Dexamethasone|dexamethasone|mesh-list
25464715|NCT04940338|Dexamethasone acetate|dexamethasone acetate|mesh-list
25464717|NCT04940338|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25464719|NCT04940338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25464720|NCT04940338|Antiemetics|antiemetics|mesh-ancestor
25464721|NCT04940338|Autonomic Agents|autonomic agents|mesh-ancestor
25464722|NCT04940338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25464723|NCT04940338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464724|NCT04940338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25464725|NCT04940338|Glucocorticoids|glucocorticoids|mesh-ancestor
25464726|NCT04940338|Hormones|hormones|mesh-ancestor
25464727|NCT04940338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25464728|NCT04940338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25464729|NCT04940338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464730|NCT04940338|Protease Inhibitors|protease inhibitors|mesh-ancestor
25464731|NCT04940338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464732|NCT04940338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464733|NCT04940338|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25464734|NCT04940338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25464735|NCT04940338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25464736|NCT04940338|Analgesics|analgesics|mesh-ancestor
25464737|NCT04940338|Sensory System Agents|sensory system agents|mesh-ancestor
25464738|NCT04940338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25464739|NCT04918069|Capsaicin|capsaicin|mesh-list
25464740|NCT04918069|Antipruritics|antipruritics|mesh-ancestor
25464741|NCT04918069|Dermatologic Agents|dermatologic agents|mesh-ancestor
25464742|NCT04918069|Sensory System Agents|sensory system agents|mesh-ancestor
25464743|NCT04918069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25464744|NCT04918069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464745|NCT04779242|Moxifloxacin|moxifloxacin|mesh-list
25464746|NCT04779242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25464747|NCT04779242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25464748|NCT04779242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25464749|NCT04779242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25464750|NCT04779242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464751|NCT04779242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464752|NCT04779242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464753|NCT04755283|Rivaroxaban|rivaroxaban|mesh-list
25464754|NCT04755283|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25464755|NCT04755283|Antithrombins|antithrombins|mesh-ancestor
25464756|NCT04755283|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25464757|NCT04755283|Protease Inhibitors|protease inhibitors|mesh-ancestor
25464758|NCT04755283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464759|NCT04755283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464760|NCT04755283|Anticoagulants|anticoagulants|mesh-ancestor
25464761|NCT04642820|Methamphetamine|methamphetamine|mesh-list
25464762|NCT04642820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25464763|NCT04642820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324978|NCT05256719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25644637|NCT01438814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644638|NCT01438840|Maleic acid|maleic acid|mesh-list
25644639|NCT01438840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25644640|NCT01438840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644641|NCT01438957|Dexmedetomidine|dexmedetomidine|mesh-list
25644642|NCT01438957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25324979|NCT05256719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25333740|NCT05345002|Tretinoin|tretinoin|mesh-list
25324980|NCT05256719|Immunologic Factors|immunologic factors|mesh-ancestor
25324981|NCT05256719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324982|NCT05256719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25324983|NCT05256693|Vancomycin|vancomycin|mesh-list
25324984|NCT05256693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25324985|NCT05256693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25324986|NCT05256472|Axitinib|axitinib|mesh-list
25324987|NCT05256472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25324988|NCT05256472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25324989|NCT05256472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25324990|NCT05256472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324991|NCT05256342|Etoricoxib|etoricoxib|mesh-list
25324999|NCT05256342|Analgesics|analgesics|mesh-ancestor
25464764|NCT04642820|Sympathomimetics|sympathomimetics|mesh-ancestor
25464765|NCT04642820|Autonomic Agents|autonomic agents|mesh-ancestor
25464766|NCT04642820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25464767|NCT04642820|Dopamine Agents|dopamine agents|mesh-ancestor
25464768|NCT04642820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25464769|NCT04642820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464770|NCT04642820|Adrenergic Agents|adrenergic agents|mesh-ancestor
25464771|NCT04642820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25464772|NCT04642820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25464773|NCT04642820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25464774|NCT04642820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25464775|NCT04588727|Aspirin|aspirin|mesh-list
25464776|NCT04588727|Ticagrelor|ticagrelor|mesh-list
25464777|NCT04588727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25464778|NCT04588727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25464779|NCT04588727|Analgesics|analgesics|mesh-ancestor
25464780|NCT04588727|Sensory System Agents|sensory system agents|mesh-ancestor
25464781|NCT04588727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25464782|NCT04588727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464783|NCT04588727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25464784|NCT04588727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25464785|NCT04588727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25464786|NCT04588727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25464787|NCT04588727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464788|NCT04588727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25464789|NCT04588727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25464790|NCT04588727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464791|NCT04588727|Antipyretics|antipyretics|mesh-ancestor
25464792|NCT04588727|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25464793|NCT04588727|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25464794|NCT04588727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25464795|NCT04588727|Purinergic Agents|purinergic agents|mesh-ancestor
25464796|NCT04588727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25464797|NCT04521803|Rifampin|rifampin|mesh-list
25464798|NCT04521803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25464799|NCT04521803|Antitubercular Agents|antitubercular agents|mesh-ancestor
25464800|NCT04521803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25464801|NCT04521803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25464802|NCT04521803|Leprostatic Agents|leprostatic agents|mesh-ancestor
25464803|NCT04521803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25464804|NCT04521803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464805|NCT04521803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464806|NCT04521803|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25464807|NCT04521803|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25464808|NCT04521803|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25464809|NCT04521803|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25333814|NCT05291390|Pyronaridine|pyronaridine|mesh-list
25464810|NCT04521803|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25464811|NCT04521803|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25464812|NCT04502706|Rituximab|rituximab|mesh-list
25464813|NCT04502706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25464814|NCT04502706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464815|NCT04502706|Immunologic Factors|immunologic factors|mesh-ancestor
24477552|NCT00419042|Antiviral Agents|antiviral agents|mesh-ancestor
25644643|NCT01438957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25644644|NCT01438957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644645|NCT01438957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25644646|NCT01438957|Analgesics|analgesics|mesh-ancestor
25644647|NCT01438957|Sensory System Agents|sensory system agents|mesh-ancestor
25464816|NCT04502706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464817|NCT04502706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25464818|NCT04487145|Piperaquine|piperaquine|mesh-list
25464820|NCT04487145|Antimalarials|antimalarials|mesh-ancestor
25464821|NCT04487145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25464822|NCT04487145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25464823|NCT04487145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25464824|NCT04435600|Ustekinumab|ustekinumab|mesh-list
25464825|NCT04435600|Dermatologic Agents|dermatologic agents|mesh-ancestor
25464826|NCT04405102|Ozanimod|ozanimod|mesh-list
25464827|NCT04405102|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25464828|NCT04405102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464829|NCT04405102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25464830|NCT04405102|Immunologic Factors|immunologic factors|mesh-ancestor
25325053|NCT05255848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25325054|NCT05255848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25325055|NCT05255848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325063|NCT05231941|Lidocaine|lidocaine|mesh-list
25325064|NCT05231941|Ropivacaine|ropivacaine|mesh-list
25325065|NCT05231941|Anesthetics, Local|anesthetics, local|mesh-ancestor
25325066|NCT05231941|Anesthetics|anesthetics|mesh-ancestor
25464831|NCT04405102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464832|NCT04341779|Tenofovir|tenofovir|mesh-list
25464833|NCT04341779|Antiviral Agents|antiviral agents|mesh-ancestor
25464834|NCT04341779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25464835|NCT04341779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25464836|NCT04341779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25464837|NCT04341779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464838|NCT04341779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464839|NCT04341779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25464840|NCT04341779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25464841|NCT04328844|Cisplatin|cisplatin|mesh-list
25464842|NCT04328844|Pemetrexed|pemetrexed|mesh-list
25464843|NCT04328844|Avelumab|avelumab|mesh-list
25464844|NCT04328844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464845|NCT04328844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464846|NCT04328844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464847|NCT04328844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25464848|NCT04328844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25464849|NCT04328844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25464850|NCT04310059|Folic Acid|folic acid|mesh-list
25464851|NCT04310059|Hematinics|hematinics|mesh-ancestor
25464852|NCT04310059|Vitamin B Complex|vitamin b complex|mesh-ancestor
25464853|NCT04310059|Vitamins|vitamins|mesh-ancestor
25464854|NCT04310059|Micronutrients|micronutrients|mesh-ancestor
25464855|NCT04310059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464856|NCT04287062|Suvorexant|suvorexant|mesh-list
25464857|NCT04287062|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25464858|NCT04287062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25464859|NCT04287062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25464860|NCT04287062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464861|NCT04287062|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25464862|NCT04287062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25464863|NCT04287062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464864|NCT04264806|Azacitidine|azacitidine|mesh-list
25464865|NCT04264806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25464866|NCT04264806|Antimetabolites|antimetabolites|mesh-ancestor
25464867|NCT04264806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464868|NCT04264806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464869|NCT04264806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464870|NCT04263831|Aldesleukin|aldesleukin|mesh-list
25464871|NCT04263831|Interleukin-2|interleukin-2|mesh-list
25464872|NCT04263831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464873|NCT04263831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25464874|NCT04263831|Analgesics|analgesics|mesh-ancestor
25464875|NCT04263831|Sensory System Agents|sensory system agents|mesh-ancestor
25464876|NCT04263831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25464877|NCT04263831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464878|NCT04263831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25464879|NCT04263831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25464880|NCT04263831|Antiviral Agents|antiviral agents|mesh-ancestor
25464881|NCT04263831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25464882|NCT04261049|Triamcinolone|triamcinolone|mesh-list
25464883|NCT04261049|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25464884|NCT04261049|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25464885|NCT04261049|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25464886|NCT04261049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25464887|NCT04261049|Glucocorticoids|glucocorticoids|mesh-ancestor
25464888|NCT04261049|Hormones|hormones|mesh-ancestor
25464889|NCT04261049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25464890|NCT04261049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464891|NCT04261049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25464892|NCT04261049|Immunologic Factors|immunologic factors|mesh-ancestor
25325129|NCT05197842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25325130|NCT05197842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25325131|NCT05197842|Alkylating Agents|alkylating agents|mesh-ancestor
25325132|NCT05197842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582050|NCT00867672|Anticonvulsants|anticonvulsants|mesh-ancestor
25325133|NCT05197842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325134|NCT05197842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25325135|NCT05197842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25325136|NCT05197842|Hormones|hormones|mesh-ancestor
25325137|NCT05197842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25325138|NCT05197842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25325139|NCT05189730|Paclitaxel|paclitaxel|mesh-list
25464893|NCT04261049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464894|NCT04261049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464895|NCT04235114|Nimotuzumab|nimotuzumab|mesh-list
25464896|NCT04235114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25464897|NCT04235114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464898|NCT04217317|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25464899|NCT04217317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25464900|NCT04217317|Alkylating Agents|alkylating agents|mesh-ancestor
25464901|NCT04217317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464902|NCT04217317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464903|NCT04214288|Fulvestrant|fulvestrant|mesh-list
25464904|NCT04214288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25464905|NCT04214288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464906|NCT04214288|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25464907|NCT04214288|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25464908|NCT04214288|Hormone Antagonists|hormone antagonists|mesh-ancestor
25464909|NCT04214288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25464910|NCT04214288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464911|NCT04192019|Glucagon|glucagon|mesh-list
25464912|NCT04192019|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25464913|NCT04192019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25464914|NCT04192019|Hormones|hormones|mesh-ancestor
25464915|NCT04192019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25464916|NCT04192019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464917|NCT04192019|Incretins|incretins|mesh-ancestor
25464918|NCT04166474|Dolutegravir|dolutegravir|mesh-list
25464919|NCT04166474|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25464920|NCT04166474|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25464921|NCT04166474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25464922|NCT04166474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464923|NCT04166474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25464924|NCT04166474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25464925|NCT04166474|Antiviral Agents|antiviral agents|mesh-ancestor
25464926|NCT04166474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25464927|NCT04163458|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25464928|NCT04163458|Menotropins|menotropins|mesh-list
25464929|NCT04163458|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25464930|NCT04163458|Fertility Agents|fertility agents|mesh-ancestor
25464931|NCT04163458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25464932|NCT04163458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464933|NCT04150042|Vitamins|vitamins|mesh-list
25464934|NCT04150042|Ascorbic Acid|ascorbic acid|mesh-list
25464935|NCT04150042|Vitamin B 12|vitamin b 12|mesh-list
25464936|NCT04150042|Hydroxocobalamin|hydroxocobalamin|mesh-list
25464937|NCT04150042|Ethanol|ethanol|mesh-list
25464938|NCT04150042|Melphalan|melphalan|mesh-list
25464939|NCT04150042|Carmustine|carmustine|mesh-list
25464940|NCT04150042|Micronutrients|micronutrients|mesh-ancestor
25464941|NCT04150042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478039|NCT00421317|Imatinib Mesylate|imatinib mesylate|mesh-list
25656805|NCT01578850|Immunologic Factors|immunologic factors|mesh-ancestor
25464942|NCT04150042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25464943|NCT04150042|Alkylating Agents|alkylating agents|mesh-ancestor
25464944|NCT04150042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464945|NCT04150042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25464946|NCT04150042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25464947|NCT04150042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25464948|NCT04150042|Immunologic Factors|immunologic factors|mesh-ancestor
25464949|NCT04150042|Antioxidants|antioxidants|mesh-ancestor
25464950|NCT04150042|Protective Agents|protective agents|mesh-ancestor
25464951|NCT04150042|Vitamin B Complex|vitamin b complex|mesh-ancestor
25464952|NCT04150042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25464953|NCT04150042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25464954|NCT04150042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25464955|NCT04150042|Hematinics|hematinics|mesh-ancestor
25464956|NCT04141501|Psilocybin|psilocybin|mesh-list
25464957|NCT04141501|Hallucinogens|hallucinogens|mesh-ancestor
25334032|NCT05188339|Heparin|heparin|mesh-list
25464958|NCT04141501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325202|NCT04984317|Cholinergic Agents|cholinergic agents|mesh-ancestor
25325203|NCT04984317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25325204|NCT04873596|Midazolam|midazolam|mesh-list
25325205|NCT04873596|Dexmedetomidine|dexmedetomidine|mesh-list
25325206|NCT04873596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25325207|NCT04873596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25325208|NCT04873596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325209|NCT04873596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25325210|NCT04873596|Analgesics|analgesics|mesh-ancestor
25325211|NCT04873596|Sensory System Agents|sensory system agents|mesh-ancestor
25464959|NCT04141501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25464966|NCT04059458|Calcium, Dietary|calcium, dietary|mesh-list
25464967|NCT04059458|Calcium|calcium|mesh-list
25464968|NCT04059458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25464969|NCT04059458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464970|NCT04059458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25464971|NCT04059445|Calcium, Dietary|calcium, dietary|mesh-list
25464972|NCT04059445|Calcium|calcium|mesh-list
25464973|NCT04059445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25464974|NCT04059445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464975|NCT04059445|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25464976|NCT04051203|Methylprednisolone|methylprednisolone|mesh-list
25464977|NCT04051203|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25464978|NCT04051203|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25464979|NCT04051203|Prednisolone|prednisolone|mesh-list
25464980|NCT04051203|Prednisolone acetate|prednisolone acetate|mesh-list
25464981|NCT04051203|Lidocaine|lidocaine|mesh-list
25464982|NCT04051203|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25464983|NCT04051203|Prednisolone phosphate|prednisolone phosphate|mesh-list
25464984|NCT04051203|Anesthetics, Local|anesthetics, local|mesh-ancestor
25464985|NCT04051203|Anesthetics|anesthetics|mesh-ancestor
25464986|NCT04051203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25464987|NCT04051203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25464988|NCT04051203|Sensory System Agents|sensory system agents|mesh-ancestor
25464989|NCT04051203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25464990|NCT04051203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25464991|NCT04051203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25464992|NCT04051203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25464993|NCT04051203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25464994|NCT04051203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25464995|NCT04051203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25464996|NCT04051203|Antiemetics|antiemetics|mesh-ancestor
25464997|NCT04051203|Autonomic Agents|autonomic agents|mesh-ancestor
25464998|NCT04051203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25464999|NCT04051203|Glucocorticoids|glucocorticoids|mesh-ancestor
25465000|NCT04051203|Hormones|hormones|mesh-ancestor
25465001|NCT04051203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25465002|NCT04051203|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25465003|NCT04051203|Protective Agents|protective agents|mesh-ancestor
25465004|NCT04051203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25465005|NCT04051203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465006|NCT04028986|Ulipristal acetate|ulipristal acetate|mesh-list
25465007|NCT04028986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25465008|NCT04028986|Contraceptive Agents|contraceptive agents|mesh-ancestor
25465009|NCT04028986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25465010|NCT04028986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465011|NCT04028986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25465012|NCT03993535|Serotonin|serotonin|mesh-list
25465013|NCT03993535|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25465014|NCT03993535|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25465015|NCT03993535|Serotonin Agents|serotonin agents|mesh-ancestor
25465016|NCT03993535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25465017|NCT03993535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465018|NCT03993535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465019|NCT03993535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25465020|NCT03993535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25465021|NCT03961516|Pancrelipase|pancrelipase|mesh-list
25465022|NCT03961516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25465023|NCT03942887|Methylprednisolone|methylprednisolone|mesh-list
25465024|NCT03942887|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25465025|NCT03942887|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25465026|NCT03942887|Prednisolone|prednisolone|mesh-list
25465027|NCT03942887|Prednisolone acetate|prednisolone acetate|mesh-list
25465028|NCT03942887|Cyclophosphamide|cyclophosphamide|mesh-list
25465029|NCT03942887|Rituximab|rituximab|mesh-list
25465030|NCT03942887|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25465031|NCT03942887|Prednisolone phosphate|prednisolone phosphate|mesh-list
25465032|NCT03942887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25465033|NCT03942887|Immunologic Factors|immunologic factors|mesh-ancestor
25465034|NCT03942887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465035|NCT03942887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25465036|NCT03942887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25465037|NCT03942887|Alkylating Agents|alkylating agents|mesh-ancestor
25465038|NCT03942887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325343|NCT04389073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465039|NCT03942887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465040|NCT03942887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25465041|NCT03942887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25465042|NCT03942887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25465043|NCT03942887|Antiemetics|antiemetics|mesh-ancestor
25465044|NCT03942887|Autonomic Agents|autonomic agents|mesh-ancestor
25465045|NCT03942887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25465046|NCT03942887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25465047|NCT03942887|Glucocorticoids|glucocorticoids|mesh-ancestor
25465048|NCT03942887|Hormones|hormones|mesh-ancestor
25465049|NCT03942887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25465050|NCT03942887|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25465051|NCT03942887|Protective Agents|protective agents|mesh-ancestor
25465052|NCT03942887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25465053|NCT03887624|Ethosuximide|ethosuximide|mesh-list
25465054|NCT03887624|Citalopram|citalopram|mesh-list
25465055|NCT03887624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25465056|NCT03887624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25465057|NCT03887624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25465058|NCT03887624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465059|NCT03887624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25465060|NCT03887624|Serotonin Agents|serotonin agents|mesh-ancestor
25465061|NCT03887624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465062|NCT03887624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25465063|NCT03887624|Antidepressive Agents|antidepressive agents|mesh-ancestor
25465064|NCT03887624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25465065|NCT03887624|Anticonvulsants|anticonvulsants|mesh-ancestor
25465066|NCT03876119|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25465067|NCT03876119|Plasminogen|plasminogen|mesh-list
25465068|NCT03876119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25465069|NCT03876119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25465070|NCT03876119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465071|NCT03874286|Liver Extracts|liver extracts|mesh-list
25465072|NCT03874286|Hematinics|hematinics|mesh-ancestor
25465073|NCT03857139|Nicotine|nicotine|mesh-list
25465074|NCT03857139|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25465075|NCT03857139|Autonomic Agents|autonomic agents|mesh-ancestor
25465076|NCT03857139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25465077|NCT03857139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465078|NCT03857139|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25465079|NCT03857139|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25465080|NCT03857139|Cholinergic Agents|cholinergic agents|mesh-ancestor
25465081|NCT03857139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25465082|NCT03857139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465083|NCT03834519|Prednisone|prednisone|mesh-list
25465084|NCT03834519|Pembrolizumab|pembrolizumab|mesh-list
25465085|NCT03834519|Olaparib|olaparib|mesh-list
25465086|NCT03834519|Abiraterone Acetate|abiraterone acetate|mesh-list
25465087|NCT03834519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25465088|NCT03834519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465089|NCT03834519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25465090|NCT03834519|Glucocorticoids|glucocorticoids|mesh-ancestor
25334257|NCT05013632|Antiviral Agents|antiviral agents|mesh-list
25465092|NCT03834519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25465093|NCT03834519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465094|NCT03834519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25465095|NCT03834519|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25325412|NCT04309916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325413|NCT04284397|Aspirin|aspirin|mesh-list
25325414|NCT04284397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25325415|NCT04284397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25325416|NCT04284397|Analgesics|analgesics|mesh-ancestor
25325417|NCT04284397|Sensory System Agents|sensory system agents|mesh-ancestor
25325418|NCT04284397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25325419|NCT04284397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325420|NCT04284397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25325421|NCT04284397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25325422|NCT04284397|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25325423|NCT04284397|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25325424|NCT04284397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325425|NCT04284397|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25325426|NCT04284397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25325427|NCT04284397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25465096|NCT03834519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25465097|NCT03834519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465098|NCT03834519|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25465099|NCT03834519|Hormone Antagonists|hormone antagonists|mesh-ancestor
25465100|NCT03834519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25465101|NCT03821545|Lidocaine|lidocaine|mesh-list
25465102|NCT03821545|Ketamine|ketamine|mesh-list
25465103|NCT03821545|Anesthetics, Local|anesthetics, local|mesh-ancestor
25465104|NCT03821545|Anesthetics|anesthetics|mesh-ancestor
25465105|NCT03821545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25465106|NCT03821545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465107|NCT03821545|Sensory System Agents|sensory system agents|mesh-ancestor
25465108|NCT03821545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25465109|NCT03821545|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25465110|NCT03821545|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25465111|NCT03821545|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25465112|NCT03821545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25465113|NCT03821545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465114|NCT03821545|Analgesics|analgesics|mesh-ancestor
25465115|NCT03821545|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25465116|NCT03821545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25465117|NCT03821545|Anesthetics, General|anesthetics, general|mesh-ancestor
25465118|NCT03821545|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25465119|NCT03821545|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25465120|NCT03821545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25465121|NCT03755765|Amoxicillin|amoxicillin|mesh-list
25465122|NCT03755765|Clavulanic Acid|clavulanic acid|mesh-list
25465123|NCT03755765|Clavulanic Acids|clavulanic acids|mesh-list
25465124|NCT03755765|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25465125|NCT03755765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25334347|NCT04988035|Remdesivir|remdesivir|mesh-list
25465126|NCT03755765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25465127|NCT03755765|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25465128|NCT03755765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25465129|NCT03755765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465130|NCT03751709|Blinatumomab|blinatumomab|mesh-list
25465131|NCT03751709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465132|NCT03717987|Botulinum Toxins|botulinum toxins|mesh-list
25465133|NCT03717987|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25465134|NCT03717987|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25465135|NCT03717987|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25465136|NCT03717987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25465137|NCT03717987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465138|NCT03717987|Cholinergic Agents|cholinergic agents|mesh-ancestor
25465139|NCT03717987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25465140|NCT03717987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465141|NCT03717987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25644648|NCT01438957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25644649|NCT01438957|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25644650|NCT01438957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25644651|NCT01438957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25465142|NCT03717987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25465143|NCT03640377|Praziquantel|praziquantel|mesh-list
25465144|NCT03640377|Anthelmintics|anthelmintics|mesh-ancestor
25465145|NCT03640377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25465146|NCT03640377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25465147|NCT03632187|Abatacept|abatacept|mesh-list
25465148|NCT03632187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25465149|NCT03632187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465150|NCT03632187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465151|NCT03632187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25465152|NCT03632187|Immunologic Factors|immunologic factors|mesh-ancestor
25465153|NCT03632187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465154|NCT03632187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25465155|NCT03587142|Buspirone|buspirone|mesh-list
25465156|NCT03587142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25465157|NCT03587142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25465158|NCT03587142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25465159|NCT03587142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465160|NCT03587142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25465161|NCT03587142|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25465162|NCT03587142|Serotonin Agents|serotonin agents|mesh-ancestor
25465163|NCT03587142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25325491|NCT03946891|Furosemide|furosemide|mesh-list
25325492|NCT03946891|Diuretics|diuretics|mesh-ancestor
25325493|NCT03946891|Natriuretic Agents|natriuretic agents|mesh-ancestor
25325494|NCT03946891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325495|NCT03946891|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25325498|NCT03934684|Dexamethasone|dexamethasone|mesh-list
25465164|NCT03587142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465165|NCT03582917|Alfacalcidol|alfacalcidol|mesh-list
25465166|NCT03582917|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
25465167|NCT03582917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25465168|NCT03582917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465169|NCT03582917|Vitamins|vitamins|mesh-ancestor
25465170|NCT03582917|Micronutrients|micronutrients|mesh-ancestor
25465171|NCT03558724|Bevacizumab|bevacizumab|mesh-list
25465172|NCT03558724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25465173|NCT03558724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465174|NCT03558724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25465175|NCT03558724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25465176|NCT03558724|Growth Substances|growth substances|mesh-ancestor
25465177|NCT03558724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465178|NCT03558724|Growth Inhibitors|growth inhibitors|mesh-ancestor
25465179|NCT03506360|Dexamethasone|dexamethasone|mesh-list
25465180|NCT03506360|Dexamethasone acetate|dexamethasone acetate|mesh-list
25465181|NCT03506360|Pembrolizumab|pembrolizumab|mesh-list
25465182|NCT03506360|Ixazomib|ixazomib|mesh-list
25465183|NCT03506360|Ichthammol|ichthammol|mesh-list
25465184|NCT03506360|BB 1101|bb 1101|mesh-list
25465185|NCT03506360|Glycine|glycine|mesh-list
25465186|NCT03506360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25465187|NCT03506360|Antiemetics|antiemetics|mesh-ancestor
25465188|NCT03506360|Autonomic Agents|autonomic agents|mesh-ancestor
25465189|NCT03506360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25465190|NCT03506360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465191|NCT03506360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25465192|NCT03506360|Glucocorticoids|glucocorticoids|mesh-ancestor
25465193|NCT03506360|Hormones|hormones|mesh-ancestor
25465194|NCT03506360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25465195|NCT03506360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25465196|NCT03506360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465197|NCT03506360|Protease Inhibitors|protease inhibitors|mesh-ancestor
25465198|NCT03506360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25465199|NCT03506360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465200|NCT03506360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25465201|NCT03506360|Dermatologic Agents|dermatologic agents|mesh-ancestor
25465202|NCT03506360|Glycine Agents|glycine agents|mesh-ancestor
25465203|NCT03506360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25465204|NCT03452930|Benzimidazole|benzimidazole|mesh-list
25465205|NCT03452930|Anthelmintics|anthelmintics|mesh-ancestor
25465206|NCT03452930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25325558|NCT03849625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25325559|NCT03849625|Antipyretics|antipyretics|mesh-ancestor
25325560|NCT03769844|Molgramostim|molgramostim|mesh-list
25325561|NCT03769844|Sargramostim|sargramostim|mesh-list
25325562|NCT03769844|Immunologic Factors|immunologic factors|mesh-ancestor
25325563|NCT03769844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325564|NCT03769844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325565|NCT03760068|Insulin Aspart|insulin aspart|mesh-list
25325566|NCT03760068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25325567|NCT03760068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325603|NCT03748680|Oxaliplatin|oxaliplatin|mesh-list
25325604|NCT03748680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325605|NCT03742986|Paclitaxel|paclitaxel|mesh-list
25325606|NCT03742986|Docetaxel|docetaxel|mesh-list
25325607|NCT03742986|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25325608|NCT03742986|Cyclophosphamide|cyclophosphamide|mesh-list
25325609|NCT03742986|Doxorubicin|doxorubicin|mesh-list
25325610|NCT03742986|Nivolumab|nivolumab|mesh-list
25325611|NCT03742986|Trastuzumab|trastuzumab|mesh-list
25325612|NCT03742986|Pertuzumab|pertuzumab|mesh-list
25325613|NCT03742986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25325614|NCT03742986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325615|NCT03742986|Tubulin Modulators|tubulin modulators|mesh-ancestor
25325616|NCT03742986|Antimitotic Agents|antimitotic agents|mesh-ancestor
25325617|NCT03742986|Mitosis Modulators|mitosis modulators|mesh-ancestor
25325618|NCT03742986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325619|NCT03742986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25325620|NCT03742986|Immunologic Factors|immunologic factors|mesh-ancestor
25325621|NCT03742986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325622|NCT03742986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25325623|NCT03742986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25325624|NCT03742986|Alkylating Agents|alkylating agents|mesh-ancestor
25325625|NCT03742986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25325626|NCT03742986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25325635|NCT03612973|Insulin|insulin|mesh-list
25465207|NCT03452930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25465208|NCT03418649|Eplerenone|eplerenone|mesh-list
25465209|NCT03418649|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25465210|NCT03418649|Hormone Antagonists|hormone antagonists|mesh-ancestor
25465211|NCT03418649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25465212|NCT03418649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465213|NCT03418649|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25465214|NCT03418649|Diuretics|diuretics|mesh-ancestor
25465215|NCT03418649|Natriuretic Agents|natriuretic agents|mesh-ancestor
25465216|NCT03418649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25465217|NCT03387475|Deferasirox|deferasirox|mesh-list
25465218|NCT03387475|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25465219|NCT03387475|Chelating Agents|chelating agents|mesh-ancestor
25465220|NCT03387475|Sequestering Agents|sequestering agents|mesh-ancestor
25465221|NCT03387475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465222|NCT03365362|Varenicline|varenicline|mesh-list
25465223|NCT03365362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25465224|NCT03365362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25465225|NCT03365362|Cholinergic Agents|cholinergic agents|mesh-ancestor
25465226|NCT03365362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25465227|NCT03365362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465228|NCT03365362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465229|NCT03363503|Fluticasone|fluticasone|mesh-list
25465230|NCT03363503|Xhance|xhance|mesh-list
25465231|NCT03363503|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25465232|NCT03363503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25465233|NCT03363503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25465234|NCT03363503|Autonomic Agents|autonomic agents|mesh-ancestor
25465235|NCT03363503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25465236|NCT03363503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465237|NCT03363503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25465238|NCT03363503|Respiratory System Agents|respiratory system agents|mesh-ancestor
25465239|NCT03363503|Dermatologic Agents|dermatologic agents|mesh-ancestor
25465240|NCT03363503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25465241|NCT03363503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25465242|NCT03363503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25465243|NCT03363503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25465244|NCT03363503|Adrenergic Agents|adrenergic agents|mesh-ancestor
25465245|NCT03363503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25465246|NCT03363503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465247|NCT03332589|Dabrafenib|dabrafenib|mesh-list
25465248|NCT03332589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465249|NCT03332589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25465250|NCT03332589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25465251|NCT03332589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465252|NCT03260322|Pembrolizumab|pembrolizumab|mesh-list
25465253|NCT03260322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25465254|NCT03260322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465255|NCT03249207|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25465256|NCT03249207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25465257|NCT03246906|Cyclosporine|cyclosporine|mesh-list
25465259|NCT03246906|Mycophenolic Acid|mycophenolic acid|mesh-list
25465260|NCT03246906|Cyclophosphamide|cyclophosphamide|mesh-list
25325637|NCT03612973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325638|NCT03589014|Propranolol|propranolol|mesh-list
25325639|NCT03589014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25325640|NCT03589014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25325641|NCT03589014|Adrenergic Agents|adrenergic agents|mesh-ancestor
25325642|NCT03589014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25325643|NCT03589014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325644|NCT03589014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325645|NCT03589014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25325646|NCT03589014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25325647|NCT03589014|Vasodilator Agents|vasodilator agents|mesh-ancestor
25325648|NCT03583255|Dexamethasone|dexamethasone|mesh-list
25325649|NCT03583255|Dexamethasone acetate|dexamethasone acetate|mesh-list
25325650|NCT03583255|Ichthammol|ichthammol|mesh-list
25325651|NCT03583255|BB 1101|bb 1101|mesh-list
25325652|NCT03583255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25325653|NCT03583255|Antiemetics|antiemetics|mesh-ancestor
25325654|NCT03583255|Autonomic Agents|autonomic agents|mesh-ancestor
25325655|NCT03583255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25325656|NCT03583255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325657|NCT03583255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25465277|NCT03246906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25465278|NCT03246906|Antitubercular Agents|antitubercular agents|mesh-ancestor
25465279|NCT03246906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25465280|NCT03233854|Cyclophosphamide|cyclophosphamide|mesh-list
25465281|NCT03233854|Fludarabine|fludarabine|mesh-list
25465282|NCT03233854|Fludarabine phosphate|fludarabine phosphate|mesh-list
25465283|NCT03233854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25465284|NCT03233854|Immunologic Factors|immunologic factors|mesh-ancestor
25465285|NCT03233854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465286|NCT03233854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25465287|NCT03233854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25465288|NCT03233854|Alkylating Agents|alkylating agents|mesh-ancestor
25465289|NCT03233854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465290|NCT03233854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465291|NCT03233854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25465292|NCT03233854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25465293|NCT03233854|Antimetabolites|antimetabolites|mesh-ancestor
25465294|NCT03210688|Alfacalcidol|alfacalcidol|mesh-list
25465295|NCT03210688|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
25465296|NCT03210688|Prednisone|prednisone|mesh-list
25465297|NCT03210688|Prednisolone|prednisolone|mesh-list
25465298|NCT03210688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25465299|NCT03210688|Glucocorticoids|glucocorticoids|mesh-ancestor
25465300|NCT03210688|Hormones|hormones|mesh-ancestor
25465301|NCT03210688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25465302|NCT03210688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465303|NCT03210688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25465304|NCT03210688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25334720|NCT04583969|Remdesivir|remdesivir|mesh-list
25465305|NCT03210688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25465306|NCT03210688|Vitamins|vitamins|mesh-ancestor
25465307|NCT03210688|Micronutrients|micronutrients|mesh-ancestor
25325711|NCT03300817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325712|NCT03257033|Gemcitabine|gemcitabine|mesh-list
25325713|NCT03257033|Paclitaxel|paclitaxel|mesh-list
25325714|NCT03257033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25325715|NCT03257033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325716|NCT03257033|Tubulin Modulators|tubulin modulators|mesh-ancestor
25325717|NCT03257033|Antimitotic Agents|antimitotic agents|mesh-ancestor
25325718|NCT03257033|Mitosis Modulators|mitosis modulators|mesh-ancestor
25325719|NCT03257033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325720|NCT03257033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25325721|NCT03257033|Antimetabolites|antimetabolites|mesh-ancestor
25325783|NCT02178358|Sorafenib|sorafenib|mesh-list
25465308|NCT03174847|Eplerenone|eplerenone|mesh-list
25465309|NCT03174847|Amiloride|amiloride|mesh-list
25465310|NCT03174847|Spironolactone|spironolactone|mesh-list
25465311|NCT03174847|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
25465312|NCT03174847|Mineralocorticoids|mineralocorticoids|mesh-list
25465313|NCT03174847|Hormone Antagonists|hormone antagonists|mesh-ancestor
25465314|NCT03174847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25465315|NCT03174847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465316|NCT03174847|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25465317|NCT03174847|Diuretics|diuretics|mesh-ancestor
25465318|NCT03174847|Natriuretic Agents|natriuretic agents|mesh-ancestor
25465319|NCT03174847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25465320|NCT03174847|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
25465321|NCT03174847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25465322|NCT03174847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25465323|NCT03174847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465324|NCT03174847|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
25465325|NCT03174847|Hormones|hormones|mesh-ancestor
25465326|NCT03089983|Isoniazid|isoniazid|mesh-list
25465327|NCT03089983|Rifapentine|rifapentine|mesh-list
25465328|NCT03089983|Buprenorphine|buprenorphine|mesh-list
25465329|NCT03089983|Methadone|methadone|mesh-list
25465330|NCT03089983|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25465331|NCT03089983|Naloxone|naloxone|mesh-list
25465332|NCT03089983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25465333|NCT03089983|Narcotics|narcotics|mesh-ancestor
25465334|NCT03089983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25465335|NCT03089983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465336|NCT03089983|Analgesics|analgesics|mesh-ancestor
25465337|NCT03089983|Sensory System Agents|sensory system agents|mesh-ancestor
25465338|NCT03089983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25465339|NCT03089983|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25465340|NCT03089983|Antitussive Agents|antitussive agents|mesh-ancestor
25465341|NCT03089983|Respiratory System Agents|respiratory system agents|mesh-ancestor
25465342|NCT03089983|Antitubercular Agents|antitubercular agents|mesh-ancestor
25465343|NCT03089983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25465344|NCT03089983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25334814|NCT04481035|Acetylcysteine|acetylcysteine|mesh-list
25465345|NCT03089983|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25465346|NCT03089983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25465347|NCT03089983|Antimetabolites|antimetabolites|mesh-ancestor
25465348|NCT03089983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465349|NCT03089983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25465350|NCT03089983|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25465351|NCT03089983|Leprostatic Agents|leprostatic agents|mesh-ancestor
25465352|NCT03023566|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
25465353|NCT03023566|Chelating Agents|chelating agents|mesh-ancestor
25465354|NCT03023566|Sequestering Agents|sequestering agents|mesh-ancestor
25465355|NCT03023566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465356|NCT02996773|Cyclophosphamide|cyclophosphamide|mesh-list
25465357|NCT02996773|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25465358|NCT02996773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25465359|NCT02996773|Immunologic Factors|immunologic factors|mesh-ancestor
25465360|NCT02996773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465361|NCT02996773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25465362|NCT02996773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25465363|NCT02996773|Alkylating Agents|alkylating agents|mesh-ancestor
25465364|NCT02996773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465365|NCT02996773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465366|NCT02996773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25465367|NCT02953145|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25465368|NCT02953145|Hemostatics|hemostatics|mesh-ancestor
25465369|NCT02953145|Coagulants|coagulants|mesh-ancestor
25465370|NCT02925195|Vitamin D|vitamin d|mesh-list
25465371|NCT02925195|Cholecalciferol|cholecalciferol|mesh-list
25325787|NCT02178358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325798|NCT01838174|Methylprednisolone|methylprednisolone|mesh-list
25325799|NCT01838174|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25325800|NCT01838174|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25325801|NCT01838174|Prednisolone|prednisolone|mesh-list
25325802|NCT01838174|Prednisolone acetate|prednisolone acetate|mesh-list
25325803|NCT01838174|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25325804|NCT01838174|Prednisolone phosphate|prednisolone phosphate|mesh-list
25325805|NCT01838174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25325806|NCT01838174|Antiemetics|antiemetics|mesh-ancestor
25465372|NCT02925195|Vitamins|vitamins|mesh-ancestor
25465374|NCT02925195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807947|NCT02024555|Rifampin|rifampin|mesh-list
25644652|NCT01438957|Adrenergic Agents|adrenergic agents|mesh-ancestor
25822878|NCT00004688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644653|NCT01438957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25644654|NCT01438957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644655|NCT01439009|Tolvaptan|tolvaptan|mesh-list
25644656|NCT01439009|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25644657|NCT01439009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465375|NCT02925195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25465376|NCT02925195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25465377|NCT02916979|Methotrexate|methotrexate|mesh-list
25465378|NCT02916979|Fludarabine|fludarabine|mesh-list
25465379|NCT02916979|Busulfan|busulfan|mesh-list
25465380|NCT02916979|Thymoglobulin|thymoglobulin|mesh-list
25465381|NCT02916979|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25465382|NCT02916979|Abortifacient Agents|abortifacient agents|mesh-ancestor
25465383|NCT02916979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25465384|NCT02916979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465385|NCT02916979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25465386|NCT02916979|Antimetabolites|antimetabolites|mesh-ancestor
25465387|NCT02916979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465388|NCT02916979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465389|NCT02916979|Dermatologic Agents|dermatologic agents|mesh-ancestor
25465390|NCT02916979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25465391|NCT02916979|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25465392|NCT02916979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25465393|NCT02916979|Immunologic Factors|immunologic factors|mesh-ancestor
25465394|NCT02916979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25465395|NCT02916979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25465396|NCT02916979|Alkylating Agents|alkylating agents|mesh-ancestor
25465397|NCT02916979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25465398|NCT02916979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25465399|NCT02858037|Dapivirine|dapivirine|mesh-list
25465400|NCT02858037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25465401|NCT02858037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25465402|NCT02858037|Antiviral Agents|antiviral agents|mesh-ancestor
25465403|NCT02858037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25465404|NCT02546661|Durvalumab|durvalumab|mesh-list
25465405|NCT02546661|Olaparib|olaparib|mesh-list
25465406|NCT02546661|Adavosertib|adavosertib|mesh-list
25465407|NCT02546661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25465408|NCT02546661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465409|NCT02546661|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25465410|NCT02546661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25465411|NCT02546661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465412|NCT02310269|Pasireotide|pasireotide|mesh-list
25465413|NCT02310269|Hormones|hormones|mesh-ancestor
25465414|NCT02310269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25465415|NCT02310269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465416|NCT02261636|Mesalamine|mesalamine|mesh-list
25465417|NCT02261636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25465418|NCT02261636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25465419|NCT02261636|Analgesics|analgesics|mesh-ancestor
25465420|NCT02261636|Sensory System Agents|sensory system agents|mesh-ancestor
25325858|NCT00117338|Montelukast|montelukast|mesh-list
25325859|NCT00117338|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25325860|NCT00117338|Respiratory System Agents|respiratory system agents|mesh-ancestor
25325861|NCT00117338|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25325862|NCT00117338|Hormone Antagonists|hormone antagonists|mesh-ancestor
25325863|NCT00117338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25325864|NCT00117338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325865|NCT00117338|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25325866|NCT00117338|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25325867|NCT00117338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325868|NCT04877626|Artesunate|artesunate|mesh-list
25325869|NCT04877626|Antimalarials|antimalarials|mesh-ancestor
25325870|NCT04877626|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25325871|NCT04877626|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25325872|NCT04877626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25325873|NCT04877626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325874|NCT04877626|Antiviral Agents|antiviral agents|mesh-ancestor
25325875|NCT04877626|Schistosomicides|schistosomicides|mesh-ancestor
25325876|NCT04877626|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25325877|NCT04877626|Anthelmintics|anthelmintics|mesh-ancestor
25325878|NCT04877509|Vitamin D|vitamin d|mesh-list
25325879|NCT04877509|Vitamin A|vitamin a|mesh-list
25644658|NCT01439009|Natriuretic Agents|natriuretic agents|mesh-ancestor
25644659|NCT01439009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644660|NCT01439074|Sulfadiazine|sulfadiazine|mesh-list
25644661|NCT01439074|Silver Sulfadiazine|silver sulfadiazine|mesh-list
25644662|NCT01439074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25325881|NCT04877509|Copper|copper|mesh-list
25325882|NCT04877509|Vitamins|vitamins|mesh-ancestor
25325883|NCT04877509|Micronutrients|micronutrients|mesh-ancestor
25325884|NCT04877509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465421|NCT02261636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25465422|NCT02261636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465423|NCT02261636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25465424|NCT02261636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25465426|NCT02256696|Rifabutin|rifabutin|mesh-list
25465427|NCT02256696|Isoniazid|isoniazid|mesh-list
25465428|NCT02256696|Pyrazinamide|pyrazinamide|mesh-list
25465429|NCT02256696|Ethambutol|ethambutol|mesh-list
25465430|NCT02256696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25465431|NCT02256696|Antitubercular Agents|antitubercular agents|mesh-ancestor
25465432|NCT02256696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25465433|NCT02256696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25465434|NCT02256696|Leprostatic Agents|leprostatic agents|mesh-ancestor
25465435|NCT02256696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25465436|NCT02256696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25465437|NCT02256696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465438|NCT02256696|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25465439|NCT02256696|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25465440|NCT02256696|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25465441|NCT02256696|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25465442|NCT02256696|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25465443|NCT02256696|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25465444|NCT02256696|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25465445|NCT02256696|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25465446|NCT02256696|Antimetabolites|antimetabolites|mesh-ancestor
25465447|NCT02256696|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25465448|NCT02172651|Vitamin D|vitamin d|mesh-list
25465449|NCT02172651|Ergocalciferols|ergocalciferols|mesh-list
25465450|NCT02172651|Cholecalciferol|cholecalciferol|mesh-list
25465451|NCT02172651|Vitamins|vitamins|mesh-list
25465452|NCT02172651|Micronutrients|micronutrients|mesh-ancestor
25465453|NCT02172651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465454|NCT02172651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25465455|NCT02172651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25465456|NCT02028338|Dapivirine|dapivirine|mesh-list
25465457|NCT02028338|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25465458|NCT02028338|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25465459|NCT02028338|Antiviral Agents|antiviral agents|mesh-ancestor
25465460|NCT02028338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25465461|NCT01918397|Levofloxacin|levofloxacin|mesh-list
25465462|NCT01918397|Ofloxacin|ofloxacin|mesh-list
25465463|NCT01918397|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25465464|NCT01918397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25465465|NCT01918397|Renal Agents|renal agents|mesh-ancestor
25465466|NCT01918397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25465467|NCT01918397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25465468|NCT01918397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25465469|NCT01918397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25465470|NCT01918397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465471|NCT01918397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465472|NCT01918397|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25465473|NCT01918397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25465474|NCT01815359|Leucovorin|leucovorin|mesh-list
25465475|NCT01815359|Mitomycins|mitomycins|mesh-list
25465476|NCT01815359|Mitomycin|mitomycin|mesh-list
25465477|NCT01815359|Antidotes|antidotes|mesh-ancestor
25465478|NCT01815359|Protective Agents|protective agents|mesh-ancestor
25465479|NCT01815359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465480|NCT01815359|Vitamin B Complex|vitamin b complex|mesh-ancestor
25465481|NCT01815359|Vitamins|vitamins|mesh-ancestor
25465482|NCT01815359|Micronutrients|micronutrients|mesh-ancestor
25465483|NCT01815359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25465484|NCT01815359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465485|NCT01815359|Alkylating Agents|alkylating agents|mesh-ancestor
25465486|NCT01815359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465487|NCT01815359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25465488|NCT01815359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25465489|NCT01757782|Sildenafil Citrate|sildenafil citrate|mesh-list
25465490|NCT01757782|Vasodilator Agents|vasodilator agents|mesh-ancestor
25465491|NCT01757782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25465492|NCT01757782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25465493|NCT01757782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25325929|NCT04877106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25325930|NCT04877106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325931|NCT04876716|Voriconazole|voriconazole|mesh-list
25465494|NCT01757782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465495|NCT01757782|Urological Agents|urological agents|mesh-ancestor
25465497|NCT01612351|Cisplatin|cisplatin|mesh-list
25465498|NCT01612351|Carboplatin|carboplatin|mesh-list
25465499|NCT01612351|Lapatinib|lapatinib|mesh-list
25465500|NCT01612351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25465501|NCT01612351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465502|NCT01612351|Tubulin Modulators|tubulin modulators|mesh-ancestor
25465503|NCT01612351|Antimitotic Agents|antimitotic agents|mesh-ancestor
25465504|NCT01612351|Mitosis Modulators|mitosis modulators|mesh-ancestor
25465505|NCT01612351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465506|NCT01612351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25465507|NCT01612351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25465508|NCT00002931|Paclitaxel|paclitaxel|mesh-list
25465509|NCT00002931|Etoposide|etoposide|mesh-list
25465510|NCT00002931|Carboplatin|carboplatin|mesh-list
25465511|NCT00002931|Ifosfamide|ifosfamide|mesh-list
25465512|NCT00002931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25465513|NCT00002931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465514|NCT00002931|Tubulin Modulators|tubulin modulators|mesh-ancestor
25465515|NCT00002931|Antimitotic Agents|antimitotic agents|mesh-ancestor
25465516|NCT00002931|Mitosis Modulators|mitosis modulators|mesh-ancestor
25465517|NCT00002931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465518|NCT00002931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25465519|NCT00002931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25465520|NCT00002931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25465521|NCT00002931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25465522|NCT00002931|Alkylating Agents|alkylating agents|mesh-ancestor
25465523|NCT00003138|Epoetin Alfa|epoetin alfa|mesh-list
25465524|NCT00003138|Lenograstim|lenograstim|mesh-list
25465525|NCT00003138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25465526|NCT00003138|Immunologic Factors|immunologic factors|mesh-ancestor
25465527|NCT00003138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465528|NCT00003138|Hematinics|hematinics|mesh-ancestor
25465529|NCT00003199|Tamoxifen|tamoxifen|mesh-list
25465530|NCT00003199|Aldesleukin|aldesleukin|mesh-list
25465531|NCT00003199|Melphalan|melphalan|mesh-list
25465532|NCT00003199|Busulfan|busulfan|mesh-list
25465533|NCT00003199|Thiotepa|thiotepa|mesh-list
25465534|NCT00003199|Interleukin-2|interleukin-2|mesh-list
25465535|NCT00003199|Sargramostim|sargramostim|mesh-list
25465536|NCT00003199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465537|NCT00003199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25465538|NCT00003199|Alkylating Agents|alkylating agents|mesh-ancestor
25465539|NCT00003199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465540|NCT00003199|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25465541|NCT00003199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25465542|NCT00003199|Immunologic Factors|immunologic factors|mesh-ancestor
25465543|NCT00003199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465544|NCT00003199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25465545|NCT00003199|Analgesics|analgesics|mesh-ancestor
25465546|NCT00003199|Sensory System Agents|sensory system agents|mesh-ancestor
25465547|NCT00003199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25465548|NCT00003199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25326005|NCT04876521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25326006|NCT04876521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25326007|NCT04876521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25326008|NCT04876521|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25326009|NCT04876521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25326010|NCT04876521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25326011|NCT04876521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326012|NCT04876521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25326013|NCT04876521|Serotonin Agents|serotonin agents|mesh-ancestor
25326014|NCT04876521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25335183|NCT03938389|Valsartan|valsartan|mesh-list
25326015|NCT04876521|Antidepressive Agents|antidepressive agents|mesh-ancestor
25326016|NCT04876521|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25326017|NCT04876521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25326018|NCT04876521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25326019|NCT04876521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25326020|NCT04876521|Dopamine Agents|dopamine agents|mesh-ancestor
25326042|NCT04876261|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
25326043|NCT04876261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25326044|NCT04876261|Antioxidants|antioxidants|mesh-ancestor
25465549|NCT00003199|Hormone Antagonists|hormone antagonists|mesh-ancestor
25465550|NCT00003199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25465551|NCT00003199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25465552|NCT00003199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25465553|NCT00003199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25465554|NCT00003199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25465555|NCT00003199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25465556|NCT00003199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25465557|NCT00003199|Antiviral Agents|antiviral agents|mesh-ancestor
25465558|NCT00003199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25465559|NCT00003222|Aldesleukin|aldesleukin|mesh-list
25465560|NCT00003222|Interleukin-2|interleukin-2|mesh-list
25465561|NCT00003222|Sargramostim|sargramostim|mesh-list
25465562|NCT00003222|Freund's Adjuvant|freund's adjuvant|mesh-list
25465563|NCT00003222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465564|NCT00003222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25465565|NCT00003222|Analgesics|analgesics|mesh-ancestor
25465566|NCT00003222|Sensory System Agents|sensory system agents|mesh-ancestor
25465567|NCT00003222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25465568|NCT00003222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465569|NCT00003222|Immunologic Factors|immunologic factors|mesh-ancestor
25465570|NCT00003222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25465571|NCT00003222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25465572|NCT00003222|Antiviral Agents|antiviral agents|mesh-ancestor
25465573|NCT00003222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25465574|NCT00003222|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25465575|NCT00003224|Vaccines|vaccines|mesh-list
25465576|NCT00003224|Freund's Adjuvant|freund's adjuvant|mesh-list
25465577|NCT00003224|Immunologic Factors|immunologic factors|mesh-ancestor
25465578|NCT00003224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465579|NCT00003224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25465580|NCT00003270|Cyclosporine|cyclosporine|mesh-list
25465581|NCT00003270|Methylprednisolone|methylprednisolone|mesh-list
25465582|NCT00003270|Cyclophosphamide|cyclophosphamide|mesh-list
25465583|NCT00003270|Busulfan|busulfan|mesh-list
25465584|NCT00003270|Cyclosporins|cyclosporins|mesh-list
25465585|NCT00003270|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25465586|NCT00003270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25465587|NCT00003270|Immunologic Factors|immunologic factors|mesh-ancestor
25465588|NCT00003270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465589|NCT00003270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25465590|NCT00003270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25465591|NCT00003270|Alkylating Agents|alkylating agents|mesh-ancestor
25465592|NCT00003270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465593|NCT00003270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465594|NCT00003270|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25465595|NCT00003270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25465596|NCT00003270|Antifungal Agents|antifungal agents|mesh-ancestor
25465597|NCT00003270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25465598|NCT00003270|Dermatologic Agents|dermatologic agents|mesh-ancestor
25465599|NCT00003270|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25465600|NCT00003270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25465601|NCT00003270|Antiemetics|antiemetics|mesh-ancestor
25465602|NCT00003270|Autonomic Agents|autonomic agents|mesh-ancestor
25465603|NCT00003270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25465604|NCT00003270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25465605|NCT00003270|Glucocorticoids|glucocorticoids|mesh-ancestor
25465606|NCT00003270|Hormones|hormones|mesh-ancestor
25465607|NCT00003270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25465608|NCT00003270|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25465609|NCT00003270|Protective Agents|protective agents|mesh-ancestor
25465610|NCT05235100|Apatinib|apatinib|mesh-list
25465611|NCT05235100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465612|NCT05235100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25465613|NCT05235100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25465614|NCT05235100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465615|NCT05234840|Triamcinolone|triamcinolone|mesh-list
25465616|NCT05234840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25465617|NCT05234840|Glucocorticoids|glucocorticoids|mesh-ancestor
25465618|NCT05234840|Hormones|hormones|mesh-ancestor
25465619|NCT05234840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25465665|NCT05233735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25465666|NCT05233735|Glucocorticoids|glucocorticoids|mesh-ancestor
25465667|NCT05233735|Hormones|hormones|mesh-ancestor
25465668|NCT05233735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25465669|NCT05233735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465670|NCT05233735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25465671|NCT05233735|Respiratory System Agents|respiratory system agents|mesh-ancestor
25465672|NCT05233605|Dexmedetomidine|dexmedetomidine|mesh-list
25465673|NCT05233605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25465674|NCT05233605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25465675|NCT05233605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465676|NCT05233605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25465677|NCT05233605|Analgesics|analgesics|mesh-ancestor
25465678|NCT05233605|Sensory System Agents|sensory system agents|mesh-ancestor
25465679|NCT05233605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25465680|NCT05233605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25465681|NCT05233605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25465682|NCT05233605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25465683|NCT05233605|Adrenergic Agents|adrenergic agents|mesh-ancestor
25465684|NCT05233605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25465685|NCT05233605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465686|NCT05233579|Sulforaphane|sulforaphane|mesh-list
25465687|NCT05233579|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25465688|NCT05233579|Protective Agents|protective agents|mesh-ancestor
25465689|NCT05233579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465690|NCT05233579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465691|NCT05233514|Metformin|metformin|mesh-list
25465692|NCT05233514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25465693|NCT05233514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465694|NCT05233462|Bupivacaine|bupivacaine|mesh-list
25465695|NCT05233462|Anesthetics, Local|anesthetics, local|mesh-ancestor
25465696|NCT05233462|Anesthetics|anesthetics|mesh-ancestor
25465697|NCT05233462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25465698|NCT05233462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465699|NCT05233462|Sensory System Agents|sensory system agents|mesh-ancestor
25465700|NCT05233462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25465701|NCT05233358|Pembrolizumab|pembrolizumab|mesh-list
25465703|NCT05233358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25465704|NCT05233358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25465705|NCT05233358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465706|NCT05233358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465707|NCT05233332|Vemurafenib|vemurafenib|mesh-list
25465708|NCT05233332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465709|NCT05233332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25465710|NCT05233332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25465711|NCT05233332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465712|NCT05233202|Simendan|simendan|mesh-list
25465713|NCT05233202|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25465714|NCT05233202|Vasodilator Agents|vasodilator agents|mesh-ancestor
25465715|NCT05233202|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25465716|NCT05233202|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25465717|NCT05233202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25326229|NCT04873284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326230|NCT04873284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25326231|NCT04873284|Glucocorticoids|glucocorticoids|mesh-ancestor
25326232|NCT04873284|Hormones|hormones|mesh-ancestor
25326233|NCT04873284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25326234|NCT04873284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25326235|NCT04873284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25326236|NCT04873284|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25326237|NCT04873284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25326238|NCT04873284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326239|NCT04873284|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25326240|NCT04873284|Serotonin Agents|serotonin agents|mesh-ancestor
25326241|NCT04873102|Danazol|danazol|mesh-list
25326242|NCT04873102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25326243|NCT04873102|Hormone Antagonists|hormone antagonists|mesh-ancestor
25326246|NCT04873011|Quinine|quinine|mesh-list
25465723|NCT05233124|Clopidogrel|clopidogrel|mesh-list
25465724|NCT05233124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25465725|NCT05233124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25465726|NCT05233124|Analgesics|analgesics|mesh-ancestor
25465727|NCT05233124|Sensory System Agents|sensory system agents|mesh-ancestor
25465728|NCT05233124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25465729|NCT05233124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465730|NCT05233124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25465731|NCT05233124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25465732|NCT05233124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25465733|NCT05233124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25465734|NCT05233124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465735|NCT05233124|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25465736|NCT05233124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25465737|NCT05233124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25465738|NCT05233124|Antipyretics|antipyretics|mesh-ancestor
25465739|NCT05233124|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25465740|NCT05233124|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25465741|NCT05233124|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25465742|NCT05233124|Purinergic Agents|purinergic agents|mesh-ancestor
25465743|NCT05233124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25465744|NCT05233124|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25465745|NCT05233124|Antithrombins|antithrombins|mesh-ancestor
25465746|NCT05233124|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25465747|NCT05233124|Protease Inhibitors|protease inhibitors|mesh-ancestor
25465748|NCT05233124|Anticoagulants|anticoagulants|mesh-ancestor
25465749|NCT05232409|Pembrolizumab|pembrolizumab|mesh-list
25465750|NCT05232409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25465751|NCT05232409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465752|NCT05232370|Losartan|losartan|mesh-list
25465753|NCT05232370|Enalapril|enalapril|mesh-list
25465754|NCT05232370|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
25465755|NCT05232370|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25465756|NCT05232370|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25465757|NCT05232370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25465758|NCT05232370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25465759|NCT05232370|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25465760|NCT05232370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465761|NCT05232370|Protease Inhibitors|protease inhibitors|mesh-ancestor
25465762|NCT05232227|Primaquine|primaquine|mesh-list
25465763|NCT05232227|Antimalarials|antimalarials|mesh-ancestor
25465764|NCT05232227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25465765|NCT05232227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25465766|NCT05232227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25465768|NCT05232123|Anticonvulsants|anticonvulsants|mesh-ancestor
25465769|NCT05231330|Fluorides|fluorides|mesh-list
25465770|NCT05231330|Cariostatic Agents|cariostatic agents|mesh-ancestor
25465771|NCT05231330|Protective Agents|protective agents|mesh-ancestor
25465772|NCT05231330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465773|NCT05231148|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25465774|NCT05231148|Calcium|calcium|mesh-list
25465775|NCT05231148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25465776|NCT05231148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465777|NCT05231148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25465779|NCT05230797|Propolis|propolis|mesh-list
25465780|NCT05230797|Eugenol|eugenol|mesh-list
25465781|NCT05230797|Zinc Oxide|zinc oxide|mesh-list
25465782|NCT05230797|Trace Elements|trace elements|mesh-ancestor
25465783|NCT05230797|Micronutrients|micronutrients|mesh-ancestor
25465784|NCT05230797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465785|NCT05230797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25465786|NCT05230797|Dermatologic Agents|dermatologic agents|mesh-ancestor
25465787|NCT05230797|Sunscreening Agents|sunscreening agents|mesh-ancestor
25465788|NCT05230797|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25465789|NCT05230797|Protective Agents|protective agents|mesh-ancestor
25465790|NCT05230654|Fosaprepitant|fosaprepitant|mesh-list
25465792|NCT05230654|Antiemetics|antiemetics|mesh-ancestor
25465793|NCT05230654|Autonomic Agents|autonomic agents|mesh-ancestor
25465794|NCT05230654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25465795|NCT05230654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465796|NCT05230654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25465797|NCT05230654|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25465798|NCT05230654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25465799|NCT05230654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465800|NCT05230472|Simvastatin|simvastatin|mesh-list
25465801|NCT05230472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25465802|NCT05230472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25465803|NCT05230472|Antimetabolites|antimetabolites|mesh-ancestor
25465804|NCT05230472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465805|NCT05230472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25465806|NCT05230472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25465807|NCT05230472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25465808|NCT05228327|Salicylic Acid|salicylic acid|mesh-list
25465809|NCT05228327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25465810|NCT05228327|Antifungal Agents|antifungal agents|mesh-ancestor
25465811|NCT05228327|Keratolytic Agents|keratolytic agents|mesh-ancestor
25465812|NCT05228327|Dermatologic Agents|dermatologic agents|mesh-ancestor
25465813|NCT05209555|Pilocarpine|pilocarpine|mesh-list
25465814|NCT05209555|Miotics|miotics|mesh-ancestor
25465815|NCT05209555|Autonomic Agents|autonomic agents|mesh-ancestor
25465816|NCT05209555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25465817|NCT05209555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465818|NCT05209555|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25465819|NCT05209555|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25465820|NCT05209555|Cholinergic Agents|cholinergic agents|mesh-ancestor
25465821|NCT05209555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25465822|NCT05209555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465823|NCT05208034|Methotrexate|methotrexate|mesh-list
25465824|NCT05208034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25465825|NCT05208034|Abortifacient Agents|abortifacient agents|mesh-ancestor
25465826|NCT05208034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25465827|NCT05208034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465828|NCT05208034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25465829|NCT05208034|Antimetabolites|antimetabolites|mesh-ancestor
25465830|NCT05208034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465831|NCT05208034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465832|NCT05208034|Dermatologic Agents|dermatologic agents|mesh-ancestor
25465833|NCT05208034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25465834|NCT05208034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25465835|NCT05208034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25465836|NCT05208034|Immunologic Factors|immunologic factors|mesh-ancestor
25465837|NCT05208034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25465838|NCT05208034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25465839|NCT05203276|Endostar protein|endostar protein|mesh-list
25465840|NCT05203276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25465841|NCT05203276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25465842|NCT05203276|Growth Substances|growth substances|mesh-ancestor
25644663|NCT01439074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25644664|NCT01439074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25465843|NCT05203276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465844|NCT05203276|Growth Inhibitors|growth inhibitors|mesh-ancestor
25465845|NCT05203276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465847|NCT05184777|Progesterone|progesterone|mesh-list
25465848|NCT05184777|Estrogens|estrogens|mesh-ancestor
25465849|NCT05184777|Hormones|hormones|mesh-ancestor
25465850|NCT05184777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25465851|NCT05184777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465852|NCT05184777|Progestins|progestins|mesh-ancestor
25465853|NCT05093296|Naltrexone|naltrexone|mesh-list
25465854|NCT05093296|Oxytocin|oxytocin|mesh-list
25465855|NCT05093296|Oxytocics|oxytocics|mesh-ancestor
25465856|NCT05093296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25465857|NCT05093296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465858|NCT05093296|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25465859|NCT05093296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25465860|NCT05093296|Sensory System Agents|sensory system agents|mesh-ancestor
25465861|NCT05093296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25326378|NCT04872244|Contraceptive Agents|contraceptive agents|mesh-ancestor
25326379|NCT04872244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25326384|NCT04872322|Ropivacaine|ropivacaine|mesh-list
25465862|NCT05075876|Granisetron|granisetron|mesh-list
25465883|NCT05045170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25465884|NCT05045170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25465885|NCT05045170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25465886|NCT05045170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25465887|NCT05045170|Adrenergic Agents|adrenergic agents|mesh-ancestor
25465888|NCT05045170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25465889|NCT05045170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465890|NCT05042934|Irinotecan|irinotecan|mesh-list
25465891|NCT05042934|Camptothecin|camptothecin|mesh-list
25465892|NCT05042934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25465893|NCT05042934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25465894|NCT05042934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25465895|NCT05042934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465896|NCT05042934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465897|NCT05042934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25465898|NCT05027204|Docetaxel|docetaxel|mesh-list
25465899|NCT05027204|Nivolumab|nivolumab|mesh-list
25465900|NCT05027204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465901|NCT05027204|Tubulin Modulators|tubulin modulators|mesh-ancestor
25465902|NCT05027204|Antimitotic Agents|antimitotic agents|mesh-ancestor
25465903|NCT05027204|Mitosis Modulators|mitosis modulators|mesh-ancestor
25465904|NCT05027204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465905|NCT05027204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25465906|NCT05027204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25465907|NCT05014230|Analgesics, Opioid|analgesics, opioid|mesh-list
25465908|NCT05014230|Narcotics|narcotics|mesh-ancestor
25465909|NCT05014230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25465910|NCT05014230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465911|NCT05014230|Analgesics|analgesics|mesh-ancestor
25465912|NCT05014230|Sensory System Agents|sensory system agents|mesh-ancestor
25465913|NCT05014230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25326451|NCT04871646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25326452|NCT04871646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25326453|NCT04871646|Analgesics|analgesics|mesh-ancestor
25326458|NCT04871646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25465914|NCT05006326|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25465915|NCT05006326|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25465916|NCT05006326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465917|NCT05005507|Tenofovir|tenofovir|mesh-list
25465918|NCT05005507|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25465919|NCT05005507|Antiviral Agents|antiviral agents|mesh-ancestor
25465920|NCT05005507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25465921|NCT05005507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25465922|NCT05005507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25465923|NCT05005507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25465924|NCT05005507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484235|NCT00447213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25465925|NCT05005507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25465926|NCT05005507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25465927|NCT05004987|Dexetimide|dexetimide|mesh-list
25465928|NCT05004987|Citalopram|citalopram|mesh-list
25644665|NCT01439074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25644666|NCT01439074|Coccidiostats|coccidiostats|mesh-ancestor
25644667|NCT01439074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25644668|NCT01439126|Clonidine|clonidine|mesh-list
25644669|NCT01439126|Analgesics|analgesics|mesh-ancestor
25465929|NCT05004987|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25465930|NCT05004987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25465931|NCT05004987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25465932|NCT05004987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465933|NCT05004987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25465934|NCT05004987|Serotonin Agents|serotonin agents|mesh-ancestor
25465935|NCT05004987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465936|NCT05004987|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25465937|NCT05004987|Antidepressive Agents|antidepressive agents|mesh-ancestor
25465938|NCT05004987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25465939|NCT05004987|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25465940|NCT05004987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25465941|NCT05004987|Parasympatholytics|parasympatholytics|mesh-ancestor
25465942|NCT05004987|Autonomic Agents|autonomic agents|mesh-ancestor
25465943|NCT05004987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25465944|NCT05004987|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25465945|NCT05004987|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25465946|NCT05004987|Cholinergic Agents|cholinergic agents|mesh-ancestor
25465947|NCT05004805|Methylene Blue|methylene blue|mesh-list
25465948|NCT05004805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25465949|NCT05004805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465950|NCT04968938|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25465951|NCT04968938|Hallucinogens|hallucinogens|mesh-ancestor
25335717|NCT03457701|Iron|iron|mesh-list
25465952|NCT04968938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465953|NCT04968938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25465954|NCT04968938|Serotonin Agents|serotonin agents|mesh-ancestor
25465955|NCT04968938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25465956|NCT04968938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465957|NCT04968938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25465958|NCT04968938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25465959|NCT04968938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25465960|NCT04968938|Adrenergic Agents|adrenergic agents|mesh-ancestor
25465961|NCT04965220|Trametinib|trametinib|mesh-list
25465962|NCT04965220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465963|NCT04965220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25465964|NCT04965220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25465965|NCT04965220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465966|NCT04937166|Azacitidine|azacitidine|mesh-list
25465967|NCT04937166|Venetoclax|venetoclax|mesh-list
25465968|NCT04937166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25465969|NCT04937166|Antimetabolites|antimetabolites|mesh-ancestor
25465970|NCT04937166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326525|NCT04871152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25326526|NCT04870372|Selegiline|selegiline|mesh-list
25326527|NCT04870372|Antidepressive Agents|antidepressive agents|mesh-ancestor
25326528|NCT04870372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25326529|NCT04870372|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25326530|NCT04870372|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25326531|NCT04870372|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25326532|NCT04870372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25326533|NCT04870372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326534|NCT04870372|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25326535|NCT04870372|Protective Agents|protective agents|mesh-ancestor
25326536|NCT04870372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326537|NCT04870671|Tenofovir|tenofovir|mesh-list
25326538|NCT04870671|Antiviral Agents|antiviral agents|mesh-ancestor
25326539|NCT04870671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25326542|NCT04870671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25465971|NCT04937166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25465972|NCT04937166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25465973|NCT04928950|Charcoal|charcoal|mesh-list
25465974|NCT04928950|Antidotes|antidotes|mesh-ancestor
25465975|NCT04928950|Protective Agents|protective agents|mesh-ancestor
25465976|NCT04928950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465977|NCT04924036|Glycopyrrolate|glycopyrrolate|mesh-list
25465978|NCT04924036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25465979|NCT04924036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25465980|NCT04924036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25465981|NCT04924036|Cholinergic Agents|cholinergic agents|mesh-ancestor
25465982|NCT04924036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25465983|NCT04924036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465984|NCT04924036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465985|NCT05370729|Acetylcysteine|acetylcysteine|mesh-list
25465986|NCT05370729|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25465987|NCT05370729|Antiviral Agents|antiviral agents|mesh-ancestor
25465988|NCT05370729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25465989|NCT05370729|Expectorants|expectorants|mesh-ancestor
25465990|NCT05370729|Respiratory System Agents|respiratory system agents|mesh-ancestor
25465991|NCT05370729|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25465992|NCT05370729|Antioxidants|antioxidants|mesh-ancestor
25465993|NCT05370729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25465994|NCT05370729|Protective Agents|protective agents|mesh-ancestor
25465995|NCT05370729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25465996|NCT05370729|Antidotes|antidotes|mesh-ancestor
25465997|NCT05370599|Losartan|losartan|mesh-list
25465998|NCT05370599|Amlodipine|amlodipine|mesh-list
25465999|NCT05370599|Chlorthalidone|chlorthalidone|mesh-list
25466000|NCT05370599|Antihypertensive Agents|antihypertensive agents|mesh-list
25466001|NCT05370599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25466002|NCT05370599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25466003|NCT05370599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466004|NCT05370599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25466005|NCT05370599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466006|NCT05370599|Vasodilator Agents|vasodilator agents|mesh-ancestor
25466007|NCT05370599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25466008|NCT05370599|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25466009|NCT05370599|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25466010|NCT05370599|Diuretics|diuretics|mesh-ancestor
25466011|NCT05370599|Natriuretic Agents|natriuretic agents|mesh-ancestor
25466012|NCT05370599|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25466013|NCT05370313|Nicotine|nicotine|mesh-list
25466014|NCT05370313|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25466015|NCT05370313|Autonomic Agents|autonomic agents|mesh-ancestor
25466016|NCT05370313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25466017|NCT05370313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466018|NCT05370313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25466019|NCT05370313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25466020|NCT05370313|Cholinergic Agents|cholinergic agents|mesh-ancestor
25466021|NCT05370313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25466022|NCT05370313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466023|NCT05370235|Afamelanotide|afamelanotide|mesh-list
25466024|NCT05370235|Dermatologic Agents|dermatologic agents|mesh-ancestor
25466025|NCT05369819|Midazolam|midazolam|mesh-list
25466026|NCT05369819|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25466027|NCT05369819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25466028|NCT05369819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25466029|NCT05369819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466030|NCT05369819|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25466031|NCT05369819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25466032|NCT05369819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25466033|NCT05369819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25466034|NCT05369819|Anesthetics, General|anesthetics, general|mesh-ancestor
25466035|NCT05369819|Anesthetics|anesthetics|mesh-ancestor
25466036|NCT05369819|GABA Modulators|gaba modulators|mesh-ancestor
25326603|NCT04870203|Adalimumab|adalimumab|mesh-list
25326604|NCT04870203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25326605|NCT04870203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24468406|NCT00381368|Ibandronic Acid|ibandronic acid|mesh-list
24468407|NCT00381368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24468408|NCT00381368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468409|NCT00381472|Ropinirole|ropinirole|mesh-list
25326606|NCT04870190|Osimertinib|osimertinib|mesh-list
25326607|NCT04870190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25326611|NCT04870060|Curcumin|curcumin|mesh-list
25466037|NCT05369819|GABA Agents|gaba agents|mesh-ancestor
25466039|NCT05369819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466040|NCT05369650|Lidocaine|lidocaine|mesh-list
25466041|NCT05369650|Anesthetics, Local|anesthetics, local|mesh-ancestor
25466042|NCT05369650|Anesthetics|anesthetics|mesh-ancestor
25466043|NCT05369650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25466044|NCT05369650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466045|NCT05369650|Sensory System Agents|sensory system agents|mesh-ancestor
25466046|NCT05369650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25466047|NCT05369650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25466048|NCT05369650|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25466049|NCT05369650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25466050|NCT05369650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25466051|NCT05369650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466052|NCT05369481|Minoxidil|minoxidil|mesh-list
25466053|NCT05369481|Sildenafil Citrate|sildenafil citrate|mesh-list
25466054|NCT05369481|Vasodilator Agents|vasodilator agents|mesh-ancestor
25466055|NCT05369481|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25466056|NCT05369481|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25466057|NCT05369481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466058|NCT05369481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466059|NCT05369481|Urological Agents|urological agents|mesh-ancestor
25466060|NCT05369481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25466061|NCT05369468|Dexmedetomidine|dexmedetomidine|mesh-list
25466062|NCT05369468|Bupivacaine|bupivacaine|mesh-list
25466063|NCT05369468|Anesthetics, Local|anesthetics, local|mesh-ancestor
25466064|NCT05369468|Anesthetics|anesthetics|mesh-ancestor
25466065|NCT05369468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25466066|NCT05369468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466067|NCT05369468|Sensory System Agents|sensory system agents|mesh-ancestor
25466068|NCT05369468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25466069|NCT05369468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25466070|NCT05369468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25466071|NCT05369468|Analgesics|analgesics|mesh-ancestor
25466072|NCT05369468|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25466073|NCT05369468|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25466074|NCT05369468|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25466075|NCT05369468|Adrenergic Agents|adrenergic agents|mesh-ancestor
25466076|NCT05369468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25466077|NCT05369468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466078|NCT05369377|Zanubrutinib|zanubrutinib|mesh-list
25466079|NCT05369377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466080|NCT05369377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25466081|NCT05369377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466082|NCT05369377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466083|NCT05369364|Dexamethasone|dexamethasone|mesh-list
25466084|NCT05369364|Zanubrutinib|zanubrutinib|mesh-list
25466085|NCT05369364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25466086|NCT05369364|Antiemetics|antiemetics|mesh-ancestor
25466087|NCT05369364|Autonomic Agents|autonomic agents|mesh-ancestor
25466088|NCT05369364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25466089|NCT05369364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466090|NCT05369364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25466091|NCT05369364|Glucocorticoids|glucocorticoids|mesh-ancestor
25466092|NCT05369364|Hormones|hormones|mesh-ancestor
25466093|NCT05369364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25466094|NCT05369364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25466095|NCT05369364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25336038|NCT02885974|Gemcitabine|gemcitabine|mesh-list
25466096|NCT05369364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25466097|NCT05369364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466098|NCT05369364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466099|NCT05369234|Sucralfate|sucralfate|mesh-list
25466100|NCT05369234|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25466101|NCT05369234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25466102|NCT05369091|Simvastatin|simvastatin|mesh-list
25466103|NCT05369091|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25466104|NCT05369091|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25466105|NCT05369091|Antimetabolites|antimetabolites|mesh-ancestor
25326669|NCT04869176|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25326670|NCT04869176|Purinergic Agents|purinergic agents|mesh-ancestor
25326671|NCT04869176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25326672|NCT04869046|Acetaminophen|acetaminophen|mesh-list
25326673|NCT04869046|Ibuprofen|ibuprofen|mesh-list
25326674|NCT04869046|Analgesics|analgesics|mesh-list
25466132|NCT05363514|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25466133|NCT05363514|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25466134|NCT05363514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466135|NCT05363514|Sensory System Agents|sensory system agents|mesh-ancestor
25466136|NCT05363514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25466137|NCT05359263|Dapagliflozin|dapagliflozin|mesh-list
25466138|NCT05359263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25466139|NCT05359263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466140|NCT05359263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25466141|NCT05359263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466142|NCT05355155|Bevacizumab|bevacizumab|mesh-list
25466143|NCT05355155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25466144|NCT05355155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466145|NCT05355155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25466146|NCT05355155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25466147|NCT05355155|Growth Substances|growth substances|mesh-ancestor
25466148|NCT05355155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466149|NCT05355155|Growth Inhibitors|growth inhibitors|mesh-ancestor
25466150|NCT05342376|Dexmedetomidine|dexmedetomidine|mesh-list
25466151|NCT05342376|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25466152|NCT05342376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25466153|NCT05342376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466154|NCT05342376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25466155|NCT05342376|Analgesics|analgesics|mesh-ancestor
25466156|NCT05342376|Sensory System Agents|sensory system agents|mesh-ancestor
25466157|NCT05342376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25466158|NCT05342376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25466159|NCT05342376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25466160|NCT05342376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25466161|NCT05342376|Adrenergic Agents|adrenergic agents|mesh-ancestor
25466162|NCT05342376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25466163|NCT05342376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466164|NCT05334485|Bromides|bromides|mesh-list
25466165|NCT05334485|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
25466166|NCT05334485|Anticonvulsants|anticonvulsants|mesh-ancestor
25466167|NCT05334485|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25466168|NCT05334485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466169|NCT05334485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466170|NCT05334485|Cholinergic Agents|cholinergic agents|mesh-ancestor
25466171|NCT05334485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25466172|NCT05334485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466173|NCT05324163|Celecoxib|celecoxib|mesh-list
25466174|NCT05324163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25466175|NCT05324163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25466176|NCT05324163|Analgesics|analgesics|mesh-ancestor
25466177|NCT05324163|Sensory System Agents|sensory system agents|mesh-ancestor
25466178|NCT05324163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25466179|NCT05324163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466180|NCT05324163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25466181|NCT05324163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25466182|NCT05324163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25466183|NCT05324163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25466184|NCT05324163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466185|NCT05324163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466186|NCT05271240|Bevacizumab|bevacizumab|mesh-list
25466187|NCT05271240|Temozolomide|temozolomide|mesh-list
25466188|NCT05271240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25466189|NCT05271240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466190|NCT05271240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25466191|NCT05271240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25466192|NCT05271240|Growth Substances|growth substances|mesh-ancestor
25466193|NCT05271240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466194|NCT05271240|Growth Inhibitors|growth inhibitors|mesh-ancestor
25466195|NCT05271240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25466196|NCT05271240|Alkylating Agents|alkylating agents|mesh-ancestor
25466197|NCT05271240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466198|NCT05269030|Ivermectin|ivermectin|mesh-list
25466199|NCT05269030|Budesonide|budesonide|mesh-list
25466200|NCT05269030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25466201|NCT05269030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25466202|NCT05269030|Autonomic Agents|autonomic agents|mesh-ancestor
25326813|NCT04867343|Fentanyl|fentanyl|mesh-list
25466203|NCT05269030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25336173|NCT02790515|Sirolimus|sirolimus|mesh-list
25466204|NCT05269030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466205|NCT05269030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25466206|NCT05269030|Respiratory System Agents|respiratory system agents|mesh-ancestor
25466207|NCT05269030|Glucocorticoids|glucocorticoids|mesh-ancestor
25466208|NCT05269030|Hormones|hormones|mesh-ancestor
25466209|NCT05269030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25466210|NCT05269030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25466211|NCT05269030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25466212|NCT05269017|Vitamin D|vitamin d|mesh-list
25466213|NCT05269017|Cholecalciferol|cholecalciferol|mesh-list
25466214|NCT05269017|Budesonide|budesonide|mesh-list
25466215|NCT05269017|Vitamins|vitamins|mesh-ancestor
25466216|NCT05269017|Micronutrients|micronutrients|mesh-ancestor
25466217|NCT05269017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466218|NCT05269017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25466219|NCT05269017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25466220|NCT05269017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25466221|NCT05269017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25466222|NCT05269017|Autonomic Agents|autonomic agents|mesh-ancestor
25466223|NCT05269017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25466224|NCT05269017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25466225|NCT05269017|Respiratory System Agents|respiratory system agents|mesh-ancestor
25466226|NCT05269017|Glucocorticoids|glucocorticoids|mesh-ancestor
25466227|NCT05269017|Hormones|hormones|mesh-ancestor
25466228|NCT05269017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25466229|NCT05178407|Micronutrients|micronutrients|mesh-list
25466230|NCT05178407|Trace Elements|trace elements|mesh-list
25336267|NCT02572791|Mupirocin|mupirocin|mesh-list
25466231|NCT05178407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466232|NCT05169944|Magrolimab|magrolimab|mesh-list
25466233|NCT05169944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25466234|NCT05169944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466235|NCT05077917|Cromolyn Sodium|cromolyn sodium|mesh-list
25466236|NCT05077917|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
25466237|NCT05077917|Immunologic Factors|immunologic factors|mesh-ancestor
25466238|NCT05077917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466239|NCT05077917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25466240|NCT05077917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25466241|NCT05077917|Respiratory System Agents|respiratory system agents|mesh-ancestor
25466242|NCT04968106|Doxorubicin|doxorubicin|mesh-list
25466243|NCT04968106|Ifosfamide|ifosfamide|mesh-list
25466244|NCT04968106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25466245|NCT04968106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466246|NCT04968106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25466247|NCT04968106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25466248|NCT04968106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466249|NCT04968106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466250|NCT04968106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25466251|NCT04968106|Alkylating Agents|alkylating agents|mesh-ancestor
25466252|NCT04896866|Anti-Infective Agents|anti-infective agents|mesh-list
25466253|NCT04896866|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25466254|NCT04848662|Budesonide|budesonide|mesh-list
25466255|NCT04848662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25466256|NCT04848662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25466257|NCT04848662|Autonomic Agents|autonomic agents|mesh-ancestor
25466258|NCT04848662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25466259|NCT04848662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466260|NCT04848662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25466261|NCT04848662|Respiratory System Agents|respiratory system agents|mesh-ancestor
25466262|NCT04848662|Glucocorticoids|glucocorticoids|mesh-ancestor
25466263|NCT04848662|Hormones|hormones|mesh-ancestor
25466264|NCT04848662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25466265|NCT04749628|Cannabidiol|cannabidiol|mesh-list
25466266|NCT04749628|Anticonvulsants|anticonvulsants|mesh-ancestor
25466267|NCT04735822|Belumosudil|belumosudil|mesh-list
25466268|NCT04735822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25466269|NCT04735822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466270|NCT04735822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466271|NCT04726618|Xenon|xenon|mesh-list
25466272|NCT04726618|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25466273|NCT04726618|Anesthetics, General|anesthetics, general|mesh-ancestor
25326881|NCT04866485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25326887|NCT04866056|Azacitidine|azacitidine|mesh-list
25326888|NCT04866056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25326889|NCT04866056|Antimetabolites|antimetabolites|mesh-ancestor
25326890|NCT04866056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466282|NCT04697693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466284|NCT04697693|Serotonin Agents|serotonin agents|mesh-ancestor
25466285|NCT04697693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466286|NCT04697693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25466287|NCT04697693|Antidepressive Agents|antidepressive agents|mesh-ancestor
25466288|NCT04697693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25466289|NCT04697693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25466290|NCT04697693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25466291|NCT04697693|Analgesics|analgesics|mesh-ancestor
25466292|NCT04697693|Sensory System Agents|sensory system agents|mesh-ancestor
25466293|NCT04697693|Dopamine Agents|dopamine agents|mesh-ancestor
25466294|NCT04610736|Temozolomide|temozolomide|mesh-list
25466295|NCT04610736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25466296|NCT04610736|Alkylating Agents|alkylating agents|mesh-ancestor
25656806|NCT01578980|Pancrelipase|pancrelipase|mesh-list
25466297|NCT04610736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466298|NCT04610736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466299|NCT04581382|Pembrolizumab|pembrolizumab|mesh-list
25466300|NCT04581382|Nivolumab|nivolumab|mesh-list
25466301|NCT04581382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25466302|NCT04581382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466303|NCT04581382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25466304|NCT04581382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466305|NCT04551482|Oxytocin|oxytocin|mesh-list
25466306|NCT04551482|Oxytocics|oxytocics|mesh-ancestor
25466307|NCT04551482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25466308|NCT04551482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466309|NCT04444492|Ranibizumab|ranibizumab|mesh-list
25466310|NCT04444492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25466311|NCT04444492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25466312|NCT04444492|Growth Substances|growth substances|mesh-ancestor
25466313|NCT04444492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466314|NCT04444492|Growth Inhibitors|growth inhibitors|mesh-ancestor
25466315|NCT04444492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466316|NCT04429425|Anesthetics|anesthetics|mesh-list
25466317|NCT04429425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25466318|NCT04429425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466319|NCT04420884|Pembrolizumab|pembrolizumab|mesh-list
25466320|NCT04420884|Fluorouracil|fluorouracil|mesh-list
25466321|NCT04420884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25466322|NCT04420884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466323|NCT04420884|Antimetabolites|antimetabolites|mesh-ancestor
25466324|NCT04420884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466325|NCT04420884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25466326|NCT04420884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25466327|NCT04420884|Immunologic Factors|immunologic factors|mesh-ancestor
25466328|NCT04420884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326958|NCT04865224|Sensory System Agents|sensory system agents|mesh-ancestor
25326959|NCT04865224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25326960|NCT04865224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326961|NCT04865224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25326962|NCT04865224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25326963|NCT04865562|Methyltestosterone|methyltestosterone|mesh-list
25326964|NCT04865562|Testosterone|testosterone|mesh-list
25326965|NCT04865562|Testosterone undecanoate|testosterone undecanoate|mesh-list
25326966|NCT04865562|Testosterone enanthate|testosterone enanthate|mesh-list
25466329|NCT04411550|Pertuzumab|pertuzumab|mesh-list
25466330|NCT04411550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25466331|NCT04411550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466332|NCT04347434|Atorvastatin|atorvastatin|mesh-list
25466333|NCT04347434|Ezetimibe|ezetimibe|mesh-list
25466334|NCT04347434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25466335|NCT04347434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25466336|NCT04347434|Antimetabolites|antimetabolites|mesh-ancestor
25466337|NCT04347434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466338|NCT04347434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25466339|NCT04347434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25466340|NCT04347434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466341|NCT04346914|Carboplatin|carboplatin|mesh-list
25466342|NCT04346914|Etoposide|etoposide|mesh-list
25466343|NCT04346914|Antibodies|antibodies|mesh-list
25466344|NCT04346914|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25466345|NCT04346914|Immunologic Factors|immunologic factors|mesh-ancestor
25466346|NCT04346914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466347|NCT04346914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466348|NCT04346914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25466349|NCT04346914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25466350|NCT04346914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25466351|NCT04346914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466352|NCT04346914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466353|NCT04345718|Buprenorphine|buprenorphine|mesh-list
25466354|NCT04345718|Analgesics, Opioid|analgesics, opioid|mesh-list
25466355|NCT04345718|Narcotics|narcotics|mesh-ancestor
25466356|NCT04345718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25466357|NCT04345718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466358|NCT04345718|Analgesics|analgesics|mesh-ancestor
25466359|NCT04345718|Sensory System Agents|sensory system agents|mesh-ancestor
25466360|NCT04345718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25466361|NCT04345718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25466362|NCT04303390|Cefazolin|cefazolin|mesh-list
25466363|NCT04303390|Cefuroxime|cefuroxime|mesh-list
25466365|NCT04303390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25466366|NCT04303390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25466367|NCT04294459|Acetaminophen|acetaminophen|mesh-list
25466368|NCT04294459|Diphenhydramine|diphenhydramine|mesh-list
25466369|NCT04294459|Promethazine|promethazine|mesh-list
25466370|NCT04294459|Methylprednisolone|methylprednisolone|mesh-list
25466371|NCT04294459|Ranitidine|ranitidine|mesh-list
25466372|NCT04294459|Montelukast|montelukast|mesh-list
25466373|NCT04294459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25466374|NCT04294459|Analgesics|analgesics|mesh-ancestor
25466375|NCT04294459|Sensory System Agents|sensory system agents|mesh-ancestor
25466376|NCT04294459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25466377|NCT04294459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466378|NCT04294459|Antipyretics|antipyretics|mesh-ancestor
25466379|NCT04294459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25466380|NCT04294459|Antiemetics|antiemetics|mesh-ancestor
25466381|NCT04294459|Autonomic Agents|autonomic agents|mesh-ancestor
25466382|NCT04294459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25466383|NCT04294459|Glucocorticoids|glucocorticoids|mesh-ancestor
25466384|NCT04294459|Hormones|hormones|mesh-ancestor
25466385|NCT04294459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25466386|NCT04294459|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25466387|NCT04294459|Protective Agents|protective agents|mesh-ancestor
25466388|NCT04294459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25466389|NCT04294459|Respiratory System Agents|respiratory system agents|mesh-ancestor
25466390|NCT04294459|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25466391|NCT04294459|Hormone Antagonists|hormone antagonists|mesh-ancestor
25466392|NCT04294459|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25466393|NCT04294459|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25466394|NCT04294459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466395|NCT04294459|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25466396|NCT04294459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25466397|NCT04294459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25466398|NCT04294459|Anesthetics, Local|anesthetics, local|mesh-ancestor
25466399|NCT04294459|Anesthetics|anesthetics|mesh-ancestor
25466400|NCT04294459|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25327034|NCT04864314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327035|NCT04864314|Protective Agents|protective agents|mesh-ancestor
25327036|NCT04864314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469727|NCT00386841|Antidepressive Agents|antidepressive agents|mesh-ancestor
25327037|NCT04864366|Tenofovir|tenofovir|mesh-list
25466401|NCT04294459|Histamine Antagonists|histamine antagonists|mesh-ancestor
25466403|NCT04294459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25466404|NCT04294459|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25466405|NCT04294459|Antipruritics|antipruritics|mesh-ancestor
25466406|NCT04294459|Dermatologic Agents|dermatologic agents|mesh-ancestor
25466407|NCT04294459|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25466408|NCT04294459|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25466409|NCT04287790|Naltrexone|naltrexone|mesh-list
25466410|NCT04287790|Disulfiram|disulfiram|mesh-list
25466411|NCT04287790|Acamprosate|acamprosate|mesh-list
25466412|NCT04287790|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25466413|NCT04287790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25466414|NCT04287790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466415|NCT04287790|Sensory System Agents|sensory system agents|mesh-ancestor
25466416|NCT04287790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25466417|NCT04287790|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25466418|NCT04287790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466419|NCT04287790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466420|NCT04266977|Dexamethasone|dexamethasone|mesh-list
25466421|NCT04266977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25466422|NCT04266977|Antiemetics|antiemetics|mesh-ancestor
25466423|NCT04266977|Autonomic Agents|autonomic agents|mesh-ancestor
25466424|NCT04266977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25466425|NCT04266977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466426|NCT04266977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25466427|NCT04266977|Glucocorticoids|glucocorticoids|mesh-ancestor
25466428|NCT04266977|Hormones|hormones|mesh-ancestor
25466429|NCT04266977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25466430|NCT04266977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25466431|NCT04266977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466432|NCT04266340|Midazolam|midazolam|mesh-list
25466433|NCT04266340|Dexmedetomidine|dexmedetomidine|mesh-list
25466434|NCT04266340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25466435|NCT04266340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25466436|NCT04266340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466437|NCT04266340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25466439|NCT04266340|Sensory System Agents|sensory system agents|mesh-ancestor
25466440|NCT04266340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25466441|NCT04266340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25466442|NCT04266340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25466443|NCT04266340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25466444|NCT04266340|Adrenergic Agents|adrenergic agents|mesh-ancestor
25466445|NCT04266340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25466446|NCT04266340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466447|NCT04266340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25466448|NCT04266340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25466449|NCT04266340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25466450|NCT04266340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25466451|NCT04266340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25466452|NCT04266340|Anesthetics, General|anesthetics, general|mesh-ancestor
25466453|NCT04266340|Anesthetics|anesthetics|mesh-ancestor
25466454|NCT04266340|GABA Modulators|gaba modulators|mesh-ancestor
25466455|NCT04266340|GABA Agents|gaba agents|mesh-ancestor
25466456|NCT04263051|Nivolumab|nivolumab|mesh-list
25466457|NCT04263051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25466458|NCT04263051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466459|NCT04263051|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25466460|NCT04263051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466461|NCT04255927|Triclosan|triclosan|mesh-list
25466462|NCT04255927|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25466463|NCT04255927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25466464|NCT04255927|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25466465|NCT04255927|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25466466|NCT04255927|Antimetabolites|antimetabolites|mesh-ancestor
25466467|NCT04255927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466468|NCT04255927|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25466469|NCT04028245|Spartalizumab|spartalizumab|mesh-list
25466470|NCT04028245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25466471|NCT04028245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466472|NCT04028245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466473|NCT03976245|Etanercept|etanercept|mesh-list
25466474|NCT03976245|Tofacitinib|tofacitinib|mesh-list
25466475|NCT03976245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25466476|NCT03976245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25466477|NCT03976245|Analgesics|analgesics|mesh-ancestor
25466478|NCT03976245|Sensory System Agents|sensory system agents|mesh-ancestor
25466479|NCT03976245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25466480|NCT03976245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466481|NCT03976245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25466482|NCT03976245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25466483|NCT03976245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25466484|NCT03976245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25466485|NCT03976245|Immunologic Factors|immunologic factors|mesh-ancestor
25466486|NCT03976245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25466487|NCT03976245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466488|NCT03976245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466489|NCT03974854|Gemcitabine|gemcitabine|mesh-list
25466490|NCT03974854|Capecitabine|capecitabine|mesh-list
25466491|NCT03974854|Irinotecan|irinotecan|mesh-list
25466492|NCT03974854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25466493|NCT03974854|Antimetabolites|antimetabolites|mesh-ancestor
25466494|NCT03974854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466495|NCT03974854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466496|NCT03974854|Antiviral Agents|antiviral agents|mesh-ancestor
25466497|NCT03974854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25466498|NCT03974854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466499|NCT03974854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25466500|NCT03974854|Immunologic Factors|immunologic factors|mesh-ancestor
25466501|NCT03974854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466502|NCT03974854|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25466503|NCT03974854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25466504|NCT03929666|Leucovorin|leucovorin|mesh-list
25466505|NCT03929666|Gemcitabine|gemcitabine|mesh-list
25466506|NCT03929666|Bevacizumab|bevacizumab|mesh-list
25466507|NCT03929666|Cisplatin|cisplatin|mesh-list
25466508|NCT03929666|Fluorouracil|fluorouracil|mesh-list
25466509|NCT03929666|Capecitabine|capecitabine|mesh-list
25466510|NCT03929666|Oxaliplatin|oxaliplatin|mesh-list
24473666|NCT00403728|Dermatologic Agents|dermatologic agents|mesh-ancestor
25466511|NCT03929666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25466512|NCT03929666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466513|NCT03929666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25466514|NCT03929666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25466515|NCT03929666|Growth Substances|growth substances|mesh-ancestor
25466516|NCT03929666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466517|NCT03929666|Growth Inhibitors|growth inhibitors|mesh-ancestor
25466518|NCT03929666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25466519|NCT03929666|Antimetabolites|antimetabolites|mesh-ancestor
25466520|NCT03929666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466521|NCT03929666|Antiviral Agents|antiviral agents|mesh-ancestor
25466522|NCT03929666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25466523|NCT03929666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466524|NCT03929666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25466525|NCT03929666|Immunologic Factors|immunologic factors|mesh-ancestor
25466526|NCT03929666|Antidotes|antidotes|mesh-ancestor
25466527|NCT03929666|Protective Agents|protective agents|mesh-ancestor
25466528|NCT03929666|Vitamin B Complex|vitamin b complex|mesh-ancestor
25466529|NCT03929666|Vitamins|vitamins|mesh-ancestor
25466530|NCT03929666|Micronutrients|micronutrients|mesh-ancestor
25466531|NCT03849534|Salicylic Acid|salicylic acid|mesh-list
25466532|NCT03849534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25466533|NCT03849534|Antifungal Agents|antifungal agents|mesh-ancestor
25466534|NCT03849534|Keratolytic Agents|keratolytic agents|mesh-ancestor
25466535|NCT03849534|Dermatologic Agents|dermatologic agents|mesh-ancestor
25466536|NCT03842722|Protoporphyrin IX|protoporphyrin ix|mesh-list
25466537|NCT03842722|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25466538|NCT03842722|Dermatologic Agents|dermatologic agents|mesh-ancestor
25466539|NCT03813108|Lumefantrine|lumefantrine|mesh-list
25466540|NCT03813108|Artemether|artemether|mesh-list
25466541|NCT03813108|Mefloquine|mefloquine|mesh-list
25466542|NCT03813108|Atovaquone|atovaquone|mesh-list
25466543|NCT03813108|Proguanil|proguanil|mesh-list
25466544|NCT03813108|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
25466545|NCT03813108|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25466546|NCT03813108|Antimalarials|antimalarials|mesh-ancestor
25466547|NCT03813108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25466548|NCT03813108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25466549|NCT03813108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25466550|NCT03813108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466551|NCT03813108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466552|NCT03813108|Antimetabolites|antimetabolites|mesh-ancestor
25466553|NCT03809611|Choline|choline|mesh-list
25466554|NCT03809611|Lipotropic Agents|lipotropic agents|mesh-ancestor
25466555|NCT03809611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25466556|NCT03809611|Antimetabolites|antimetabolites|mesh-ancestor
25466557|NCT03809611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466558|NCT03809611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25466559|NCT03809611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25466560|NCT03809611|Nootropic Agents|nootropic agents|mesh-ancestor
25466561|NCT03800602|Metformin|metformin|mesh-list
25466562|NCT03800602|Nivolumab|nivolumab|mesh-list
25466563|NCT03800602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25466564|NCT03800602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466565|NCT03800602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25466566|NCT03800602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466567|NCT03800602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25466568|NCT03800602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466569|NCT03775629|Tramadol|tramadol|mesh-list
25466570|NCT03775629|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25466571|NCT03775629|Narcotics|narcotics|mesh-ancestor
25466572|NCT03775629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25466573|NCT03775629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466574|NCT03775629|Analgesics|analgesics|mesh-ancestor
25466575|NCT03775629|Sensory System Agents|sensory system agents|mesh-ancestor
25466576|NCT03775629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25466577|NCT03763305|Fentanyl|fentanyl|mesh-list
25466578|NCT03763305|Remifentanil|remifentanil|mesh-list
25466579|NCT03763305|Propofol|propofol|mesh-list
25466580|NCT03763305|Sevoflurane|sevoflurane|mesh-list
25466581|NCT03763305|Desflurane|desflurane|mesh-list
25466582|NCT03763305|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25466583|NCT03763305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25466584|NCT03763305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25466585|NCT03763305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466586|NCT03763305|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25466587|NCT03763305|Anesthetics, General|anesthetics, general|mesh-ancestor
25466588|NCT03763305|Anesthetics|anesthetics|mesh-ancestor
25466589|NCT03763305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25466590|NCT03763305|Narcotics|narcotics|mesh-ancestor
25466591|NCT03763305|Analgesics|analgesics|mesh-ancestor
25466592|NCT03763305|Sensory System Agents|sensory system agents|mesh-ancestor
25466593|NCT03763305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25466594|NCT03763305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25466595|NCT03763305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25466596|NCT03763305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25466597|NCT03739996|Cabotegravir|cabotegravir|mesh-list
25466598|NCT03739996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
25466599|NCT03739996|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25466600|NCT03739996|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25466601|NCT03739996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466602|NCT03739996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466603|NCT03739996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25466604|NCT03739996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25466605|NCT03739996|Antiviral Agents|antiviral agents|mesh-ancestor
25466606|NCT03739996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25466607|NCT03739996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25466608|NCT03689699|Nivolumab|nivolumab|mesh-list
25466609|NCT03689699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25466610|NCT03689699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466611|NCT03689699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25466612|NCT03689699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466613|NCT03628391|Haloperidol|haloperidol|mesh-list
25466614|NCT03628391|Haloperidol decanoate|haloperidol decanoate|mesh-list
25466615|NCT03628391|Antiemetics|antiemetics|mesh-ancestor
25466616|NCT03628391|Autonomic Agents|autonomic agents|mesh-ancestor
25466617|NCT03628391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25466618|NCT03628391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466619|NCT03628391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25466620|NCT03628391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25466621|NCT03628391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25466622|NCT03628391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25466623|NCT03628391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25466624|NCT03628391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25327248|NCT04861051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822879|NCT00004688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24903301|NCT04364802|Iodine|iodine|mesh-list
24470853|NCT00392262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24810626|NCT02041143|Caseins|caseins|mesh-list
25327249|NCT04861103|Enoxaparin|enoxaparin|mesh-list
25466625|NCT03628391|Dopamine Agents|dopamine agents|mesh-ancestor
25466637|NCT03571945|Anesthetics|anesthetics|mesh-list
25466638|NCT03571945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25466639|NCT03571945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466640|NCT03569085|Sevoflurane|sevoflurane|mesh-list
25466641|NCT03569085|Isoflurane|isoflurane|mesh-list
25466642|NCT03569085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25466643|NCT03569085|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25466644|NCT03569085|Anesthetics, General|anesthetics, general|mesh-ancestor
25466645|NCT03569085|Anesthetics|anesthetics|mesh-ancestor
25466646|NCT03569085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25466647|NCT03569085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466648|NCT03511963|Bevacizumab|bevacizumab|mesh-list
25466649|NCT03511963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25466650|NCT03511963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466651|NCT03511963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25466652|NCT03511963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25466653|NCT03511963|Growth Substances|growth substances|mesh-ancestor
25466654|NCT03511963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466655|NCT03511963|Growth Inhibitors|growth inhibitors|mesh-ancestor
25466656|NCT03505021|Simendan|simendan|mesh-list
25466657|NCT03505021|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25466658|NCT03505021|Vasodilator Agents|vasodilator agents|mesh-ancestor
25466659|NCT03505021|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25466660|NCT03505021|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25466661|NCT03505021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466662|NCT03505021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466663|NCT03505021|Protective Agents|protective agents|mesh-ancestor
25466664|NCT03505021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466665|NCT03493152|Everolimus|everolimus|mesh-list
25466666|NCT03493152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466667|NCT03493152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25466668|NCT03493152|Immunologic Factors|immunologic factors|mesh-ancestor
25466669|NCT03493152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466670|NCT03483649|Bevacizumab|bevacizumab|mesh-list
25644670|NCT01439126|Sensory System Agents|sensory system agents|mesh-ancestor
25644671|NCT01439126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25644672|NCT01439126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644673|NCT01439126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25644674|NCT01439126|Sympatholytics|sympatholytics|mesh-ancestor
25644675|NCT01439126|Autonomic Agents|autonomic agents|mesh-ancestor
25644676|NCT01439126|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25822880|NCT00004688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466671|NCT03483649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25466672|NCT03483649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466673|NCT03483649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25466674|NCT03483649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25466675|NCT03483649|Growth Substances|growth substances|mesh-ancestor
25466676|NCT03483649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466677|NCT03483649|Growth Inhibitors|growth inhibitors|mesh-ancestor
25466678|NCT03405714|Brivaracetam|brivaracetam|mesh-list
25466679|NCT03405714|Anticonvulsants|anticonvulsants|mesh-ancestor
25466680|NCT03361436|Halichondrin B|halichondrin b|mesh-list
25466681|NCT03361436|Tubulin Modulators|tubulin modulators|mesh-ancestor
25466682|NCT03361436|Antimitotic Agents|antimitotic agents|mesh-ancestor
25466683|NCT03361436|Mitosis Modulators|mitosis modulators|mesh-ancestor
25466684|NCT03361436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466685|NCT03361436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466686|NCT03282344|Nivolumab|nivolumab|mesh-list
25466687|NCT03282344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25466688|NCT03282344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466689|NCT03282344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25466690|NCT03282344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466691|NCT03272139|Bupivacaine|bupivacaine|mesh-list
25466692|NCT03272139|Anesthetics, Local|anesthetics, local|mesh-ancestor
25466693|NCT03272139|Anesthetics|anesthetics|mesh-ancestor
25466694|NCT03272139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25466695|NCT03272139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466696|NCT03272139|Sensory System Agents|sensory system agents|mesh-ancestor
25466697|NCT03272139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25466698|NCT03232918|Oxytocin|oxytocin|mesh-list
25466699|NCT03232918|Oxytocics|oxytocics|mesh-ancestor
25466700|NCT03232918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25466701|NCT03232918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466702|NCT03203473|Nivolumab|nivolumab|mesh-list
25466703|NCT03203473|Ipilimumab|ipilimumab|mesh-list
25466704|NCT03203473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25466705|NCT03203473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466706|NCT03203473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25466707|NCT03203473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466708|NCT03180736|Dexamethasone|dexamethasone|mesh-list
25466709|NCT03180736|Daratumumab|daratumumab|mesh-list
25466710|NCT03180736|Pomalidomide|pomalidomide|mesh-list
25327394|NCT04859283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25466711|NCT03180736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25466712|NCT03180736|Antiemetics|antiemetics|mesh-ancestor
25466713|NCT03180736|Autonomic Agents|autonomic agents|mesh-ancestor
25466714|NCT03180736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25466715|NCT03180736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466716|NCT03180736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25466717|NCT03180736|Glucocorticoids|glucocorticoids|mesh-ancestor
25466718|NCT03180736|Hormones|hormones|mesh-ancestor
25466719|NCT03180736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25466720|NCT03180736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25466721|NCT03180736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466722|NCT03180736|Immunologic Factors|immunologic factors|mesh-ancestor
25466723|NCT03180736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25466724|NCT03180736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25466725|NCT03180736|Growth Substances|growth substances|mesh-ancestor
25466726|NCT03180736|Growth Inhibitors|growth inhibitors|mesh-ancestor
25466727|NCT03096080|XL647|xl647|mesh-list
25466728|NCT03096080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466729|NCT03096080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25466730|NCT03096080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466731|NCT03096080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466732|NCT03051659|Pembrolizumab|pembrolizumab|mesh-list
25466733|NCT03051659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25466734|NCT03051659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466735|NCT02926586|Cytarabine|cytarabine|mesh-list
25466736|NCT02926586|Fludarabine|fludarabine|mesh-list
25466737|NCT02926586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466738|NCT02926586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25466739|NCT02926586|Antimetabolites|antimetabolites|mesh-ancestor
25466740|NCT02926586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466741|NCT02926586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25466742|NCT02926586|Immunologic Factors|immunologic factors|mesh-ancestor
25466743|NCT02926586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466744|NCT02926586|Antiviral Agents|antiviral agents|mesh-ancestor
25466745|NCT02926586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25466746|NCT02845453|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25466747|NCT02845453|Antidepressive Agents|antidepressive agents|mesh-ancestor
25466748|NCT02845453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25466749|NCT02845453|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25466750|NCT02845453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25466751|NCT02845453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25466752|NCT02845453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466753|NCT02739542|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25466754|NCT02739542|Dermatologic Agents|dermatologic agents|mesh-ancestor
25466755|NCT02739542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25466756|NCT02739542|Immunologic Factors|immunologic factors|mesh-ancestor
25466757|NCT02739542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466759|NCT02677324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466760|NCT02553642|Nivolumab|nivolumab|mesh-list
25466761|NCT02553642|Ipilimumab|ipilimumab|mesh-list
25466762|NCT02553642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25466763|NCT02553642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466764|NCT02553642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25466765|NCT02553642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466766|NCT02411448|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25466767|NCT02411448|Gefitinib|gefitinib|mesh-list
25466768|NCT02411448|Osimertinib|osimertinib|mesh-list
25466769|NCT02411448|Ramucirumab|ramucirumab|mesh-list
25466770|NCT02411448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466771|NCT02411448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25466772|NCT02411448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466773|NCT02411448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466774|NCT02215265|Cisplatin|cisplatin|mesh-list
25466775|NCT02215265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466776|NCT02138955|Curcumin|curcumin|mesh-list
25466777|NCT02138955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24471627|NCT00396240|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24471628|NCT00396240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25327463|NCT04858516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25327464|NCT04858516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25327465|NCT04858516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327466|NCT04858516|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25327467|NCT04858516|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25327468|NCT04858516|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25466781|NCT02138955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25466782|NCT02138955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466783|NCT02138955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25466784|NCT02138955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25466785|NCT02138955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466786|NCT02138955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466787|NCT02138955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466788|NCT02121405|Capecitabine|capecitabine|mesh-list
25466789|NCT02121405|Oxaliplatin|oxaliplatin|mesh-list
25466790|NCT02121405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25466791|NCT02121405|Antimetabolites|antimetabolites|mesh-ancestor
25466792|NCT02121405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466793|NCT02121405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466794|NCT01929915|Fentanyl|fentanyl|mesh-list
25466795|NCT01929915|Morphine|morphine|mesh-list
25466796|NCT01929915|Bupivacaine|bupivacaine|mesh-list
25466797|NCT01929915|Anesthetics, Local|anesthetics, local|mesh-ancestor
25466798|NCT01929915|Anesthetics|anesthetics|mesh-ancestor
25466799|NCT01929915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25466800|NCT01929915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466801|NCT01929915|Sensory System Agents|sensory system agents|mesh-ancestor
25466802|NCT01929915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25466803|NCT01929915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25466804|NCT01929915|Narcotics|narcotics|mesh-ancestor
25466805|NCT01929915|Analgesics|analgesics|mesh-ancestor
25466806|NCT01929915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25466807|NCT01929915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25466808|NCT01929915|Anesthetics, General|anesthetics, general|mesh-ancestor
25466809|NCT01849783|Thalidomide|thalidomide|mesh-list
25466810|NCT01849783|Dexamethasone|dexamethasone|mesh-list
25466811|NCT01849783|Cyclophosphamide|cyclophosphamide|mesh-list
25466812|NCT01849783|Melphalan|melphalan|mesh-list
25466813|NCT01849783|Doxorubicin|doxorubicin|mesh-list
25466814|NCT01849783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25466815|NCT01849783|Etoposide|etoposide|mesh-list
25466816|NCT01849783|Bortezomib|bortezomib|mesh-list
25466817|NCT01849783|Etoposide phosphate|etoposide phosphate|mesh-list
25466818|NCT01849783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25466819|NCT01849783|Immunologic Factors|immunologic factors|mesh-ancestor
25466820|NCT01849783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466821|NCT01849783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25466822|NCT01849783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25466823|NCT01849783|Alkylating Agents|alkylating agents|mesh-ancestor
25466824|NCT01849783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466825|NCT01849783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466826|NCT01849783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25466827|NCT01849783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25466828|NCT01849783|Antiemetics|antiemetics|mesh-ancestor
25466829|NCT01849783|Autonomic Agents|autonomic agents|mesh-ancestor
25466830|NCT01849783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25466831|NCT01849783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25466832|NCT01849783|Glucocorticoids|glucocorticoids|mesh-ancestor
25466833|NCT01849783|Hormones|hormones|mesh-ancestor
25466834|NCT01849783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25466835|NCT01849783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25466836|NCT01849783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25466837|NCT01849783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25466838|NCT01849783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25466839|NCT01849783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466840|NCT01849783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25466841|NCT01849783|Leprostatic Agents|leprostatic agents|mesh-ancestor
25466842|NCT01849783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25822881|NCT00004688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25327546|NCT04856852|Temozolomide|temozolomide|mesh-list
25327547|NCT04856852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25327548|NCT04856852|Alkylating Agents|alkylating agents|mesh-ancestor
25327549|NCT04856852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466843|NCT01849783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25466844|NCT01849783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25466845|NCT01849783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25466876|NCT04857164|Pembrolizumab|pembrolizumab|mesh-list
25466877|NCT04857164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25466878|NCT04857164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466879|NCT04852003|Morphine|morphine|mesh-list
25466880|NCT04852003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25466881|NCT04852003|Narcotics|narcotics|mesh-ancestor
25466882|NCT04852003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25466883|NCT04852003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466884|NCT04852003|Analgesics|analgesics|mesh-ancestor
25466885|NCT04852003|Sensory System Agents|sensory system agents|mesh-ancestor
25466886|NCT04852003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25466887|NCT04786210|Triamcinolone|triamcinolone|mesh-list
25466888|NCT04786210|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25466889|NCT04786210|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25466890|NCT04786210|Fluorouracil|fluorouracil|mesh-list
25466891|NCT04786210|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25466892|NCT04786210|Antimetabolites|antimetabolites|mesh-ancestor
25466893|NCT04786210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466894|NCT04786210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25466895|NCT04786210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466896|NCT04786210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25466897|NCT04786210|Immunologic Factors|immunologic factors|mesh-ancestor
25466898|NCT04786210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466899|NCT04786210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25466900|NCT04786210|Glucocorticoids|glucocorticoids|mesh-ancestor
25466901|NCT04786210|Hormones|hormones|mesh-ancestor
25466902|NCT04786210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25466903|NCT04786210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466904|NCT04761861|Vildagliptin|vildagliptin|mesh-list
25466905|NCT04761861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24488090|NCT00466570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25466906|NCT04761861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466907|NCT04761861|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25466908|NCT04761861|Protease Inhibitors|protease inhibitors|mesh-ancestor
25466909|NCT04761861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466910|NCT04761861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466911|NCT04761094|Insulin|insulin|mesh-list
25466912|NCT04761094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25466913|NCT04761094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466914|NCT04756271|Antibodies|antibodies|mesh-list
25466915|NCT04756271|Antibodies, Blocking|antibodies, blocking|mesh-list
25466916|NCT04756271|Immunologic Factors|immunologic factors|mesh-ancestor
25466917|NCT04756271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466918|NCT04739189|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
25466919|NCT04739189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466920|NCT04739189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466921|NCT04735393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25466922|NCT04735393|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25466923|NCT04718350|Simendan|simendan|mesh-list
25466924|NCT04718350|Milrinone|milrinone|mesh-list
25466925|NCT04718350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25466926|NCT04718350|Vasodilator Agents|vasodilator agents|mesh-ancestor
25466927|NCT04718350|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25466928|NCT04718350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25466929|NCT04718350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466930|NCT04718350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466931|NCT04718350|Protective Agents|protective agents|mesh-ancestor
25466932|NCT04718350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466933|NCT04718350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25466934|NCT04714710|Canrenoic Acid|canrenoic acid|mesh-list
25466935|NCT04714710|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25466936|NCT04714710|Hormone Antagonists|hormone antagonists|mesh-ancestor
25466937|NCT04714710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25466938|NCT04714710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466939|NCT04714710|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25327677|NCT04855279|Cariostatic Agents|cariostatic agents|mesh-ancestor
25327678|NCT04855279|Protective Agents|protective agents|mesh-ancestor
25327679|NCT04855279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327680|NCT04855279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25327681|NCT04855279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25327682|NCT04855279|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25327683|NCT04855383|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25327684|NCT04855383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25327685|NCT04855383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327691|NCT04855110|Warfarin|warfarin|mesh-list
25466941|NCT04714710|Natriuretic Agents|natriuretic agents|mesh-ancestor
25466942|NCT04711915|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
25466943|NCT04711915|Hallucinogens|hallucinogens|mesh-ancestor
25466944|NCT04711915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466945|NCT04711915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25466946|NCT04711915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25466947|NCT04711915|Serotonin Agents|serotonin agents|mesh-ancestor
25466948|NCT04711915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25466949|NCT04711915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466950|NCT04711915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25466951|NCT04698434|Esketamine|esketamine|mesh-list
25466952|NCT04698434|Antidepressive Agents|antidepressive agents|mesh-ancestor
25466953|NCT04698434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25466954|NCT04696575|Lamivudine|lamivudine|mesh-list
25466955|NCT04696575|Carboplatin|carboplatin|mesh-list
25466956|NCT04696575|Etoposide|etoposide|mesh-list
25466957|NCT04696575|Etoposide phosphate|etoposide phosphate|mesh-list
25466958|NCT04696575|Atezolizumab|atezolizumab|mesh-list
25466959|NCT04696575|Podophyllotoxin|podophyllotoxin|mesh-list
25466960|NCT04696575|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25466961|NCT04696575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25466962|NCT04696575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25466963|NCT04696575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25466964|NCT04696575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25466965|NCT04696575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466966|NCT04696575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466967|NCT04696575|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25466968|NCT04696575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25466969|NCT04696575|Antiviral Agents|antiviral agents|mesh-ancestor
25466970|NCT04696575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25822882|NCT00004688|Alkylating Agents|alkylating agents|mesh-ancestor
25644677|NCT01439126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25466971|NCT04696575|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25466972|NCT04696575|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25466973|NCT04696575|Immunologic Factors|immunologic factors|mesh-ancestor
25466974|NCT04696575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466975|NCT04696575|Keratolytic Agents|keratolytic agents|mesh-ancestor
25466976|NCT04696575|Dermatologic Agents|dermatologic agents|mesh-ancestor
25466977|NCT04696575|Tubulin Modulators|tubulin modulators|mesh-ancestor
25466978|NCT04696575|Antimitotic Agents|antimitotic agents|mesh-ancestor
25466979|NCT04696575|Mitosis Modulators|mitosis modulators|mesh-ancestor
25466980|NCT04681430|Gabexate|gabexate|mesh-list
25466981|NCT04681430|Camostat|camostat|mesh-list
25466982|NCT04681430|Protease Inhibitors|protease inhibitors|mesh-ancestor
25466983|NCT04681430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25466984|NCT04681430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25466985|NCT04681430|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25466986|NCT04681430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25466987|NCT04681430|Anticoagulants|anticoagulants|mesh-ancestor
25466988|NCT04677816|Vitamin D|vitamin d|mesh-list
25466989|NCT04677816|Cholecalciferol|cholecalciferol|mesh-list
25466990|NCT04677816|Vitamins|vitamins|mesh-ancestor
25466991|NCT04677816|Micronutrients|micronutrients|mesh-ancestor
25466992|NCT04677816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25466993|NCT04677816|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25466994|NCT04677816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25466995|NCT04674774|Lansoprazole|lansoprazole|mesh-list
25466996|NCT04674774|Dexlansoprazole|dexlansoprazole|mesh-list
25466997|NCT04674774|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25466998|NCT04674774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25466999|NCT04674774|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25467000|NCT04674774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467001|NCT04674774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467002|NCT04672512|Prednisone|prednisone|mesh-list
25467003|NCT04672512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25467004|NCT04672512|Glucocorticoids|glucocorticoids|mesh-ancestor
25467005|NCT04672512|Hormones|hormones|mesh-ancestor
25467006|NCT04672512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25467007|NCT04672512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467008|NCT04672512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25467009|NCT04672512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467010|NCT04650217|Levodopa|levodopa|mesh-list
25467011|NCT04650217|Carbidopa|carbidopa|mesh-list
25467012|NCT04650217|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25467013|NCT04650217|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25467014|NCT04650217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25467015|NCT04650217|Dopamine Agents|dopamine agents|mesh-ancestor
25467016|NCT04650217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25467017|NCT04650217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467018|NCT04650217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467019|NCT04650217|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25467020|NCT04650217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467021|NCT04650217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25467022|NCT04650217|Immunologic Factors|immunologic factors|mesh-ancestor
25467023|NCT04650217|Dopamine Agonists|dopamine agonists|mesh-ancestor
25467024|NCT04618523|Artesunate|artesunate|mesh-list
25467025|NCT04618523|Lumefantrine|lumefantrine|mesh-list
25467026|NCT04618523|Artemether|artemether|mesh-list
25467027|NCT04618523|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25467028|NCT04618523|Amodiaquine|amodiaquine|mesh-list
25467029|NCT04618523|Antimalarials|antimalarials|mesh-ancestor
25467030|NCT04618523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25467031|NCT04618523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25467032|NCT04618523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25467033|NCT04618523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467034|NCT04618523|Antiviral Agents|antiviral agents|mesh-ancestor
25467035|NCT04618523|Schistosomicides|schistosomicides|mesh-ancestor
25467036|NCT04618523|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25467037|NCT04618523|Anthelmintics|anthelmintics|mesh-ancestor
25467038|NCT04608266|Camostat|camostat|mesh-list
25467039|NCT04608266|Protease Inhibitors|protease inhibitors|mesh-ancestor
25467040|NCT04608266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467041|NCT04608266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467042|NCT04608266|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25467043|NCT04608266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25467044|NCT04599816|Simendan|simendan|mesh-list
25467045|NCT04599816|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25467046|NCT04599816|Vasodilator Agents|vasodilator agents|mesh-ancestor
25467047|NCT04599816|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25467048|NCT04599816|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25467049|NCT04599816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467050|NCT04599816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467051|NCT04599816|Protective Agents|protective agents|mesh-ancestor
25467052|NCT04599816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467053|NCT04599777|Sorafenib|sorafenib|mesh-list
25467054|NCT04599777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467055|NCT04599777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25467056|NCT04599777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467057|NCT04599777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467058|NCT04582669|Triamcinolone|triamcinolone|mesh-list
25467059|NCT04582669|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25467060|NCT04582669|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25467061|NCT04582669|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25467062|NCT04582669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25467063|NCT04582669|Glucocorticoids|glucocorticoids|mesh-ancestor
25467064|NCT04582669|Hormones|hormones|mesh-ancestor
25467065|NCT04582669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25467066|NCT04582669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467067|NCT04582669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25467068|NCT04582669|Immunologic Factors|immunologic factors|mesh-ancestor
25467069|NCT04582669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467070|NCT04582669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467071|NCT04567407|Ropivacaine|ropivacaine|mesh-list
25467072|NCT04567407|Anesthetics, Local|anesthetics, local|mesh-ancestor
25467073|NCT04567407|Anesthetics|anesthetics|mesh-ancestor
25467074|NCT04567407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25467075|NCT04567407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467076|NCT04567407|Sensory System Agents|sensory system agents|mesh-ancestor
25467077|NCT04567407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25467078|NCT04562285|Antibodies|antibodies|mesh-list
25467079|NCT04562285|Immunologic Factors|immunologic factors|mesh-ancestor
25467080|NCT04562285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467081|NCT04562246|Antibodies|antibodies|mesh-list
25467082|NCT04562246|Immunologic Factors|immunologic factors|mesh-ancestor
25467083|NCT04562246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327815|NCT04853446|Glucocorticoids|glucocorticoids|mesh-ancestor
25327816|NCT04853446|Hormones|hormones|mesh-ancestor
25327817|NCT04853446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25327818|NCT04853446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25327819|NCT04853446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327820|NCT04853446|Protease Inhibitors|protease inhibitors|mesh-ancestor
25327821|NCT04853446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25327822|NCT04853446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467084|NCT04559334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25467085|NCT04541290|Tacrolimus|tacrolimus|mesh-list
25467086|NCT04541290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25467087|NCT04541290|Immunologic Factors|immunologic factors|mesh-ancestor
25467088|NCT04541290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467089|NCT04541290|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25467090|NCT04541290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467091|NCT04541290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467092|NCT04522557|Interferon alpha-2|interferon alpha-2|mesh-list
25467093|NCT04522557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467094|NCT04522557|Antiviral Agents|antiviral agents|mesh-ancestor
25467095|NCT04522557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25467096|NCT04513067|Pembrolizumab|pembrolizumab|mesh-list
25467097|NCT04513067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25467098|NCT04513067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467099|NCT04504864|Aspirin|aspirin|mesh-list
25467100|NCT04504864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25467101|NCT04504864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25467102|NCT04504864|Analgesics|analgesics|mesh-ancestor
25467103|NCT04504864|Sensory System Agents|sensory system agents|mesh-ancestor
25467104|NCT04504864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25467105|NCT04504864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467106|NCT04504864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25467107|NCT04504864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25467108|NCT04504864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25467109|NCT04504864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25467110|NCT04504864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467111|NCT04504864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24489426|NCT00473174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25644678|NCT01439126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25467112|NCT04504864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25467113|NCT04504864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467115|NCT04497155|Norepinephrine|norepinephrine|mesh-list
25467116|NCT04497155|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25467117|NCT04497155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25467118|NCT04497155|Adrenergic Agents|adrenergic agents|mesh-ancestor
25467119|NCT04497155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25467120|NCT04497155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467121|NCT04497155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467122|NCT04497155|Sympathomimetics|sympathomimetics|mesh-ancestor
25467123|NCT04497155|Autonomic Agents|autonomic agents|mesh-ancestor
25467124|NCT04497155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25467125|NCT04497155|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25467126|NCT04496999|Midostaurin|midostaurin|mesh-list
25467127|NCT04496999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467128|NCT04496999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25467129|NCT04496999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467130|NCT04496999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467131|NCT04493320|Levodopa|levodopa|mesh-list
25467132|NCT04493320|Carbidopa|carbidopa|mesh-list
25467133|NCT04493320|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25467134|NCT04493320|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25467135|NCT04493320|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25467136|NCT04493320|Dopamine Agents|dopamine agents|mesh-ancestor
25467137|NCT04493320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25467138|NCT04493320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467139|NCT04493320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467140|NCT04493320|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25467141|NCT04493320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467142|NCT04493320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25467143|NCT04493320|Immunologic Factors|immunologic factors|mesh-ancestor
25467144|NCT04493320|Dopamine Agonists|dopamine agonists|mesh-ancestor
25467145|NCT04483505|Fulvestrant|fulvestrant|mesh-list
25467146|NCT04483505|Palbociclib|palbociclib|mesh-list
25467147|NCT04483505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25337695|NCT05184842|Decitabine|decitabine|mesh-list
25467148|NCT04483505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467149|NCT04483505|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25467150|NCT04483505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25467151|NCT04483505|Hormone Antagonists|hormone antagonists|mesh-ancestor
25467152|NCT04483505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25327883|NCT04853069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25327884|NCT04853069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327885|NCT04853030|Insulin Aspart|insulin aspart|mesh-list
25327886|NCT04853030|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25327891|NCT04852510|Metformin|metformin|mesh-list
25467153|NCT04483505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467154|NCT04483505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25467155|NCT04483505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467156|NCT04483505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467157|NCT04454489|Pembrolizumab|pembrolizumab|mesh-list
25467158|NCT04454489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25467159|NCT04454489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467160|NCT04443348|Paclitaxel|paclitaxel|mesh-list
25467161|NCT04443348|Cyclophosphamide|cyclophosphamide|mesh-list
25467162|NCT04443348|Carboplatin|carboplatin|mesh-list
25467163|NCT04443348|Doxorubicin|doxorubicin|mesh-list
25467164|NCT04443348|Pembrolizumab|pembrolizumab|mesh-list
25467165|NCT04443348|Capecitabine|capecitabine|mesh-list
25467166|NCT04443348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25467167|NCT04443348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467168|NCT04443348|Tubulin Modulators|tubulin modulators|mesh-ancestor
25467169|NCT04443348|Antimitotic Agents|antimitotic agents|mesh-ancestor
25467170|NCT04443348|Mitosis Modulators|mitosis modulators|mesh-ancestor
25467171|NCT04443348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467172|NCT04443348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25467173|NCT04443348|Immunologic Factors|immunologic factors|mesh-ancestor
25467174|NCT04443348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467175|NCT04443348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25467176|NCT04443348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25467177|NCT04443348|Alkylating Agents|alkylating agents|mesh-ancestor
25337801|NCT05151263|Aspirin|aspirin|mesh-list
25467178|NCT04443348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25467179|NCT04443348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25467180|NCT04443348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25467181|NCT04443348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25467182|NCT04443348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467183|NCT04443348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25467184|NCT04443348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25467185|NCT04443348|Antimetabolites|antimetabolites|mesh-ancestor
25467186|NCT04437303|Anticoagulants|anticoagulants|mesh-list
25467187|NCT04413786|Oxytocin|oxytocin|mesh-list
25467188|NCT04413786|Oxytocics|oxytocics|mesh-ancestor
25467189|NCT04413786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25467190|NCT04413786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467191|NCT04401267|Antihypertensive Agents|antihypertensive agents|mesh-list
25467192|NCT04400383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25467193|NCT04400383|Antibodies|antibodies|mesh-list
25467194|NCT04400383|Immunoglobulins|immunoglobulins|mesh-list
25467195|NCT04400383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25467196|NCT04400383|Immunologic Factors|immunologic factors|mesh-ancestor
25467197|NCT04400383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467198|NCT04400383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467199|NCT04378959|Lidocaine|lidocaine|mesh-list
25467200|NCT04378959|Anesthetics, Local|anesthetics, local|mesh-ancestor
25467201|NCT04378959|Anesthetics|anesthetics|mesh-ancestor
25467202|NCT04378959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25467203|NCT04378959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467204|NCT04378959|Sensory System Agents|sensory system agents|mesh-ancestor
25467205|NCT04378959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25467206|NCT04378959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25467207|NCT04378959|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25467208|NCT04378959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25467209|NCT04378959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25467210|NCT04378959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467211|NCT04361851|Pembrolizumab|pembrolizumab|mesh-list
25467212|NCT04361851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25467213|NCT04361851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467214|NCT04347486|Atropine|atropine|mesh-list
25467215|NCT04347486|Neostigmine|neostigmine|mesh-list
25467216|NCT04347486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25467217|NCT04347486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25467218|NCT04347486|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25467219|NCT04347486|Autonomic Agents|autonomic agents|mesh-ancestor
25467220|NCT04347486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25467221|NCT04347486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467222|NCT04347486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25467223|NCT04347486|Respiratory System Agents|respiratory system agents|mesh-ancestor
25467224|NCT04347486|Mydriatics|mydriatics|mesh-ancestor
25467225|NCT04347486|Parasympatholytics|parasympatholytics|mesh-ancestor
25467226|NCT04347486|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25467227|NCT04347486|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25467228|NCT04347486|Cholinergic Agents|cholinergic agents|mesh-ancestor
25467229|NCT04347486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25467230|NCT04347486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467231|NCT04347486|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25467232|NCT04347486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467233|NCT04347486|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25467234|NCT04338698|Azithromycin|azithromycin|mesh-list
25467235|NCT04338698|Hydroxychloroquine|hydroxychloroquine|mesh-list
25467236|NCT04338698|Oseltamivir|oseltamivir|mesh-list
25467237|NCT04338698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25467238|NCT04338698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25467239|NCT04338698|Antimalarials|antimalarials|mesh-ancestor
25467240|NCT04338698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25467241|NCT04338698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25467242|NCT04338698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467243|NCT04338698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467244|NCT04338698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25467245|NCT04338698|Antiviral Agents|antiviral agents|mesh-ancestor
25467246|NCT04331938|Anesthetics|anesthetics|mesh-list
25467247|NCT04331938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25467248|NCT04331938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467249|NCT04326738|Midazolam|midazolam|mesh-list
25467250|NCT04326738|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25467251|NCT04326738|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25467252|NCT04326738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25467253|NCT04326738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467254|NCT04326738|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25467255|NCT04326738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25467256|NCT04326738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25467257|NCT04326738|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25467258|NCT04326738|Anesthetics, General|anesthetics, general|mesh-ancestor
25467260|NCT04326738|GABA Modulators|gaba modulators|mesh-ancestor
25467261|NCT04326738|GABA Agents|gaba agents|mesh-ancestor
25467262|NCT04326738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25467263|NCT04326738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467264|NCT04288427|Finasteride|finasteride|mesh-list
25467265|NCT04288427|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25467266|NCT04288427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25467267|NCT04288427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467268|NCT04288427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467269|NCT04288427|Hormone Antagonists|hormone antagonists|mesh-ancestor
25467270|NCT04288427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25467271|NCT04288427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467272|NCT04288427|Urological Agents|urological agents|mesh-ancestor
25467273|NCT04274894|Testosterone|testosterone|mesh-list
25467274|NCT04274894|Androgens|androgens|mesh-ancestor
25467275|NCT04274894|Hormones|hormones|mesh-ancestor
25467276|NCT04274894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25467277|NCT04274894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467278|NCT04263090|Nivolumab|nivolumab|mesh-list
25467279|NCT04263090|ON 01910|on 01910|mesh-list
25467280|NCT04263090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25467281|NCT04263090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467282|NCT04263090|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25467283|NCT04263090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467284|NCT04263090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25467285|NCT04263090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467286|NCT04258852|Nicotine|nicotine|mesh-list
25467287|NCT04258852|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25467288|NCT04258852|Autonomic Agents|autonomic agents|mesh-ancestor
25467289|NCT04258852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25467290|NCT04258852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467291|NCT04258852|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25467292|NCT04258852|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25467293|NCT04258852|Cholinergic Agents|cholinergic agents|mesh-ancestor
25467294|NCT04258852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25467295|NCT04258852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467296|NCT04203927|Empagliflozin|empagliflozin|mesh-list
25467297|NCT04203927|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25467298|NCT04203927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328024|NCT04850885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25328025|NCT04850885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328026|NCT04850885|Anesthetics, Local|anesthetics, local|mesh-ancestor
25467299|NCT04203927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25467328|NCT03952299|Mandelic Acids|mandelic acids|mesh-list
25467329|NCT03952299|Oxybutynin|oxybutynin|mesh-list
25467330|NCT03952299|Parasympatholytics|parasympatholytics|mesh-ancestor
25467331|NCT03952299|Autonomic Agents|autonomic agents|mesh-ancestor
25467332|NCT03952299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25467333|NCT03952299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467334|NCT03952299|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25467335|NCT03952299|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25467336|NCT03952299|Cholinergic Agents|cholinergic agents|mesh-ancestor
25467337|NCT03952299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25467338|NCT03952299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467339|NCT03952299|Urological Agents|urological agents|mesh-ancestor
25467340|NCT03952299|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25467341|NCT03952299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25467342|NCT03952299|Renal Agents|renal agents|mesh-ancestor
25467343|NCT03948464|Morphine|morphine|mesh-list
25467344|NCT03948464|Methadone|methadone|mesh-list
25467345|NCT03948464|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25467346|NCT03948464|Narcotics|narcotics|mesh-ancestor
25467347|NCT03948464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25467348|NCT03948464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467349|NCT03948464|Analgesics|analgesics|mesh-ancestor
25467350|NCT03948464|Sensory System Agents|sensory system agents|mesh-ancestor
25467351|NCT03948464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25467352|NCT03948464|Antitussive Agents|antitussive agents|mesh-ancestor
25467353|NCT03948464|Respiratory System Agents|respiratory system agents|mesh-ancestor
25467354|NCT03933384|Tenofovir|tenofovir|mesh-list
25467355|NCT03933384|Entecavir|entecavir|mesh-list
24490804|NCT00480194|Bromides|bromides|mesh-list
25467356|NCT03933384|Antiviral Agents|antiviral agents|mesh-ancestor
25467357|NCT03933384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25467358|NCT03933384|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25467359|NCT03933384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25467360|NCT03933384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467361|NCT03933384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467362|NCT03933384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25467363|NCT03933384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25467364|NCT03882047|Fluticasone|fluticasone|mesh-list
25467366|NCT03882047|Mometasone Furoate|mometasone furoate|mesh-list
25467367|NCT03882047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25467368|NCT03882047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25467369|NCT03882047|Autonomic Agents|autonomic agents|mesh-ancestor
25467370|NCT03882047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25467371|NCT03882047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467372|NCT03882047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25467373|NCT03882047|Respiratory System Agents|respiratory system agents|mesh-ancestor
25467374|NCT03882047|Dermatologic Agents|dermatologic agents|mesh-ancestor
25467375|NCT03882047|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25467376|NCT03879772|Mometasone Furoate|mometasone furoate|mesh-list
25467377|NCT03879772|Chlorpheniramine|chlorpheniramine|mesh-list
25467378|NCT03879772|Beclomethasone|beclomethasone|mesh-list
25467379|NCT03879772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467380|NCT03879772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25467381|NCT03879772|Dermatologic Agents|dermatologic agents|mesh-ancestor
25467382|NCT03879772|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25467383|NCT03879772|Glucocorticoids|glucocorticoids|mesh-ancestor
25467384|NCT03879772|Hormones|hormones|mesh-ancestor
25467385|NCT03879772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25467386|NCT03879772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467387|NCT03879772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25467388|NCT03879772|Respiratory System Agents|respiratory system agents|mesh-ancestor
25467389|NCT03879772|Antipruritics|antipruritics|mesh-ancestor
25467390|NCT03879772|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25467391|NCT03879772|Histamine Antagonists|histamine antagonists|mesh-ancestor
25467392|NCT03879772|Histamine Agents|histamine agents|mesh-ancestor
25467393|NCT03879772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25467394|NCT03873402|Nivolumab|nivolumab|mesh-list
25467395|NCT03873402|Ipilimumab|ipilimumab|mesh-list
25467396|NCT03873402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25467397|NCT03873402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467398|NCT03873402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25467399|NCT03873402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467400|NCT03871465|Triamcinolone|triamcinolone|mesh-list
25467401|NCT03871465|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25467402|NCT03871465|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25328158|NCT04849533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25467403|NCT03871465|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25467404|NCT03871465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25467405|NCT03871465|Glucocorticoids|glucocorticoids|mesh-ancestor
25467406|NCT03871465|Hormones|hormones|mesh-ancestor
25467407|NCT03871465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25467408|NCT03871465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467409|NCT03871465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25467410|NCT03871465|Immunologic Factors|immunologic factors|mesh-ancestor
25467411|NCT03871465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467412|NCT03871465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467413|NCT03861559|Mometasone Furoate|mometasone furoate|mesh-list
25467414|NCT03861559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25467415|NCT03861559|Dermatologic Agents|dermatologic agents|mesh-ancestor
25467416|NCT03861559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25467417|NCT03860233|Oxytocin|oxytocin|mesh-list
25467418|NCT03860233|Oxytocics|oxytocics|mesh-ancestor
25467419|NCT03860233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25467420|NCT03860233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467421|NCT03855228|Mometasone Furoate|mometasone furoate|mesh-list
25467422|NCT03855228|Loratadine|loratadine|mesh-list
25467423|NCT03855228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25467424|NCT03855228|Dermatologic Agents|dermatologic agents|mesh-ancestor
25467425|NCT03855228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25467426|NCT03855228|Antipruritics|antipruritics|mesh-ancestor
25467427|NCT03855228|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25467428|NCT03855228|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25467429|NCT03855228|Histamine Antagonists|histamine antagonists|mesh-ancestor
25467430|NCT03855228|Histamine Agents|histamine agents|mesh-ancestor
25467431|NCT03855228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25467432|NCT03855228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467433|NCT03855228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467434|NCT03855189|Mometasone Furoate|mometasone furoate|mesh-list
25467435|NCT03855189|Beclomethasone|beclomethasone|mesh-list
25467436|NCT03855189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25467437|NCT03855189|Dermatologic Agents|dermatologic agents|mesh-ancestor
25467438|NCT03855189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25467439|NCT03855189|Glucocorticoids|glucocorticoids|mesh-ancestor
25467441|NCT03855189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25467442|NCT03855189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467443|NCT03855189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25467444|NCT03855189|Respiratory System Agents|respiratory system agents|mesh-ancestor
25467445|NCT03845543|Paclitaxel|paclitaxel|mesh-list
25467446|NCT03845543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25467447|NCT03845543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467448|NCT03845543|Tubulin Modulators|tubulin modulators|mesh-ancestor
25467449|NCT03845543|Antimitotic Agents|antimitotic agents|mesh-ancestor
25467450|NCT03845543|Mitosis Modulators|mitosis modulators|mesh-ancestor
25467451|NCT03845543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467452|NCT03840200|Rucaparib|rucaparib|mesh-list
25467453|NCT03840200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25467454|NCT03840200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467455|NCT03840200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467456|NCT03840200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467457|NCT03830918|Temozolomide|temozolomide|mesh-list
25467458|NCT03830918|Atezolizumab|atezolizumab|mesh-list
25467459|NCT03830918|Niraparib|niraparib|mesh-list
25467460|NCT03830918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25467461|NCT03830918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25467462|NCT03830918|Alkylating Agents|alkylating agents|mesh-ancestor
25467463|NCT03830918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467464|NCT03830918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467465|NCT03830918|Immunologic Factors|immunologic factors|mesh-ancestor
25467466|NCT03830918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467467|NCT03830918|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25467468|NCT03830918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467469|NCT03828292|Dexamethasone|dexamethasone|mesh-list
25467470|NCT03828292|Bortezomib|bortezomib|mesh-list
25467471|NCT03828292|Pomalidomide|pomalidomide|mesh-list
25328225|NCT04848974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25328226|NCT04848974|Immunologic Factors|immunologic factors|mesh-ancestor
25328227|NCT04848974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012810|NCT04318015|Antimalarials|antimalarials|mesh-ancestor
24473133|NCT00402077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473134|NCT00402077|Antidepressive Agents|antidepressive agents|mesh-ancestor
24473135|NCT00402077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25467472|NCT03828292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25467473|NCT03828292|Antiemetics|antiemetics|mesh-ancestor
25467474|NCT03828292|Autonomic Agents|autonomic agents|mesh-ancestor
25467475|NCT03828292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25467476|NCT03828292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467477|NCT03828292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25467478|NCT03828292|Glucocorticoids|glucocorticoids|mesh-ancestor
25467479|NCT03828292|Hormones|hormones|mesh-ancestor
25467480|NCT03828292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25467481|NCT03828292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25338368|NCT04759274|Diuretics|diuretics|mesh-list
25467482|NCT03828292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467483|NCT03828292|Immunologic Factors|immunologic factors|mesh-ancestor
25467484|NCT03828292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25467485|NCT03828292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25467486|NCT03828292|Growth Substances|growth substances|mesh-ancestor
25467487|NCT03828292|Growth Inhibitors|growth inhibitors|mesh-ancestor
25467488|NCT03769285|Niacinamide|niacinamide|mesh-list
25467489|NCT03769285|Niacin|niacin|mesh-list
25467490|NCT03769285|Nicotinic Acids|nicotinic acids|mesh-list
25467491|NCT03769285|Vitamin B Complex|vitamin b complex|mesh-ancestor
25467492|NCT03769285|Vitamins|vitamins|mesh-ancestor
25467493|NCT03769285|Micronutrients|micronutrients|mesh-ancestor
25467494|NCT03769285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467495|NCT03769285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25467496|NCT03769285|Antimetabolites|antimetabolites|mesh-ancestor
25467497|NCT03769285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467498|NCT03769285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25467499|NCT03769285|Vasodilator Agents|vasodilator agents|mesh-ancestor
25467500|NCT03768492|Caffeine|caffeine|mesh-list
25467501|NCT03768492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25467502|NCT03768492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467503|NCT03768492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25467504|NCT03768492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467505|NCT03768492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467506|NCT03768492|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25467507|NCT03768492|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25467508|NCT03768492|Purinergic Agents|purinergic agents|mesh-ancestor
25467509|NCT03768492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25467510|NCT03764631|Empagliflozin|empagliflozin|mesh-list
25467511|NCT03764631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25467512|NCT03764631|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25467513|NCT03764631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467514|NCT03764631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25467515|NCT03764631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467516|NCT03764631|Protease Inhibitors|protease inhibitors|mesh-ancestor
25467517|NCT03764631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467518|NCT03761030|Levodopa|levodopa|mesh-list
25467519|NCT03761030|Carbidopa|carbidopa|mesh-list
25467520|NCT03761030|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25467521|NCT03761030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25467522|NCT03761030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25467523|NCT03761030|Dopamine Agents|dopamine agents|mesh-ancestor
25467524|NCT03761030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25467525|NCT03761030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467526|NCT03761030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467527|NCT03761030|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25467528|NCT03761030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467529|NCT03761030|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25467530|NCT03761030|Immunologic Factors|immunologic factors|mesh-ancestor
25467531|NCT03761030|Dopamine Agonists|dopamine agonists|mesh-ancestor
25467532|NCT03745144|Cladribine|cladribine|mesh-list
25467533|NCT03745144|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25467534|NCT03745144|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
25467535|NCT03745144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467536|NCT03745144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25467537|NCT03745144|Immunologic Factors|immunologic factors|mesh-ancestor
25467538|NCT03745144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328283|NCT04848181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25328284|NCT04848181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328285|NCT04848181|Urological Agents|urological agents|mesh-ancestor
25328286|NCT04848181|Androgen Antagonists|androgen antagonists|mesh-ancestor
25328287|NCT04848181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328288|NCT04848181|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25467546|NCT03745144|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25467547|NCT03745144|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
25467548|NCT03745144|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25467549|NCT03745144|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25467550|NCT03656081|Itraconazole|itraconazole|mesh-list
25467551|NCT03656081|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25467552|NCT03656081|Amphotericin B|amphotericin b|mesh-list
25467553|NCT03656081|Antifungal Agents|antifungal agents|mesh-ancestor
25467554|NCT03656081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25467555|NCT03656081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25467556|NCT03656081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25467557|NCT03656081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467558|NCT03656081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467559|NCT03656081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25467560|NCT03656081|Hormone Antagonists|hormone antagonists|mesh-ancestor
25467561|NCT03656081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25467562|NCT03656081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467563|NCT03656081|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25467564|NCT03656081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25467565|NCT03656081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25467566|NCT03656081|Amebicides|amebicides|mesh-ancestor
25467567|NCT03656081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25467568|NCT03647657|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25467569|NCT03647657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25644679|NCT01439126|Adrenergic Agents|adrenergic agents|mesh-ancestor
25467570|NCT03647657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467572|NCT03645408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25467573|NCT03645408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467574|NCT03645408|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25467575|NCT03645408|Incretins|incretins|mesh-ancestor
25467576|NCT03645408|Hormones|hormones|mesh-ancestor
25467577|NCT03645408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25467578|NCT03639935|Nivolumab|nivolumab|mesh-list
25467579|NCT03639935|Rucaparib|rucaparib|mesh-list
25467580|NCT03639935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25467581|NCT03639935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467582|NCT03639935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25467583|NCT03639935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467584|NCT03639935|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25467585|NCT03639935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467586|NCT03630055|Rivaroxaban|rivaroxaban|mesh-list
25467587|NCT03630055|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25467588|NCT03630055|Antithrombins|antithrombins|mesh-ancestor
25467589|NCT03630055|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25467590|NCT03630055|Protease Inhibitors|protease inhibitors|mesh-ancestor
25467591|NCT03630055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467592|NCT03630055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467593|NCT03630055|Anticoagulants|anticoagulants|mesh-ancestor
25467594|NCT03623828|Apomorphine|apomorphine|mesh-list
25467595|NCT03623828|Emetics|emetics|mesh-ancestor
25467596|NCT03623828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467597|NCT03623828|Autonomic Agents|autonomic agents|mesh-ancestor
25467598|NCT03623828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25467599|NCT03623828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25467600|NCT03623828|Dopamine Agonists|dopamine agonists|mesh-ancestor
25467601|NCT03623828|Dopamine Agents|dopamine agents|mesh-ancestor
25467602|NCT03623828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25467603|NCT03623828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467604|NCT03573401|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25467605|NCT03573401|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25467606|NCT03573401|Dermatologic Agents|dermatologic agents|mesh-ancestor
25467607|NCT03565913|Calcium, Dietary|calcium, dietary|mesh-list
25467608|NCT03565913|Magnesium citrate|magnesium citrate|mesh-list
25467609|NCT03565913|Calcium|calcium|mesh-list
25467610|NCT03565913|Calcium acetate|calcium acetate|mesh-list
25467611|NCT03565913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25467612|NCT03565913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467613|NCT03565913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25467614|NCT03565913|Chelating Agents|chelating agents|mesh-ancestor
25467615|NCT03565913|Sequestering Agents|sequestering agents|mesh-ancestor
25467616|NCT03565913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467617|NCT03565913|Cathartics|cathartics|mesh-ancestor
25467618|NCT03565913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25467619|NCT03523156|Azithromycin|azithromycin|mesh-list
25467620|NCT03523156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25467621|NCT03523156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25467622|NCT03523091|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25467623|NCT03523091|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25467624|NCT03523091|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25467625|NCT03523091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25467626|NCT03523091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467627|NCT03523091|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25467628|NCT03523091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25467629|NCT03523091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467630|NCT03523091|Cholinergic Agents|cholinergic agents|mesh-ancestor
25467631|NCT03523091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25467632|NCT03476317|Vancomycin|vancomycin|mesh-list
25467633|NCT03476317|Ciprofloxacin|ciprofloxacin|mesh-list
25467634|NCT03476317|Neomycin|neomycin|mesh-list
25467635|NCT03476317|Fluconazole|fluconazole|mesh-list
25467636|NCT03476317|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25467637|NCT03476317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25467638|NCT03476317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25467639|NCT03476317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25467640|NCT03476317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25467641|NCT03476317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467642|NCT03476317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467643|NCT03476317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467644|NCT03476317|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25467645|NCT03476317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25467646|NCT03476317|Antifungal Agents|antifungal agents|mesh-ancestor
25467647|NCT03476317|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25467648|NCT03476317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25467649|NCT03476317|Hormone Antagonists|hormone antagonists|mesh-ancestor
25467650|NCT03476317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25467651|NCT03476317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467652|NCT03476317|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25467653|NCT03476317|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25467654|NCT03476317|Laxatives|laxatives|mesh-ancestor
25467655|NCT03476317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25467656|NCT03476317|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25467657|NCT03434158|Olaparib|olaparib|mesh-list
25467658|NCT03434158|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25467659|NCT03434158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467660|NCT03434158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467661|NCT03434158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467662|NCT03425201|Niraparib|niraparib|mesh-list
25467663|NCT03425201|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25467664|NCT03425201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467665|NCT03425201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467666|NCT03425201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467667|NCT03416153|Paclitaxel|paclitaxel|mesh-list
25467668|NCT03416153|Carboplatin|carboplatin|mesh-list
25467669|NCT03416153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25467670|NCT03416153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467671|NCT03416153|Tubulin Modulators|tubulin modulators|mesh-ancestor
25467672|NCT03416153|Antimitotic Agents|antimitotic agents|mesh-ancestor
25467673|NCT03416153|Mitosis Modulators|mitosis modulators|mesh-ancestor
25467674|NCT03416153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467675|NCT03408340|Fentanyl|fentanyl|mesh-list
25467676|NCT03408340|Ketamine|ketamine|mesh-list
25467677|NCT03408340|Propofol|propofol|mesh-list
25467678|NCT03408340|Sevoflurane|sevoflurane|mesh-list
25467679|NCT03408340|Rocuronium|rocuronium|mesh-list
25467680|NCT03408340|Anesthetics|anesthetics|mesh-ancestor
25467681|NCT03408340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25467682|NCT03408340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467683|NCT03408340|Sensory System Agents|sensory system agents|mesh-ancestor
25467684|NCT03408340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25467685|NCT03408340|Analgesics|analgesics|mesh-ancestor
25467686|NCT03408340|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25467687|NCT03408340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25467688|NCT03408340|Anesthetics, General|anesthetics, general|mesh-ancestor
25467689|NCT03408340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25467690|NCT03408340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25467691|NCT03408340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25467692|NCT03408340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467693|NCT03408340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25467694|NCT03408340|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25338644|NCT04589611|Amobarbital|amobarbital|mesh-list
25467695|NCT03408340|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25467696|NCT03408340|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25467697|NCT03408340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25467698|NCT03408340|Narcotics|narcotics|mesh-ancestor
25467699|NCT03408340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25467700|NCT03408340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25467701|NCT03408340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25467702|NCT03397004|Doxycycline|doxycycline|mesh-list
25467703|NCT03397004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25467704|NCT03397004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25467705|NCT03397004|Antimalarials|antimalarials|mesh-ancestor
25467706|NCT03397004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25467707|NCT03397004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25467708|NCT03383419|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25467709|NCT03383419|Antiviral Agents|antiviral agents|mesh-ancestor
25467710|NCT03383419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25467711|NCT03362190|Ranibizumab|ranibizumab|mesh-list
25467712|NCT03362190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25467713|NCT03362190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25467714|NCT03362190|Growth Substances|growth substances|mesh-ancestor
25467715|NCT03362190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467716|NCT03362190|Growth Inhibitors|growth inhibitors|mesh-ancestor
25467717|NCT03362190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467718|NCT03346668|Gabapentin|gabapentin|mesh-list
25467719|NCT03346668|Analgesics|analgesics|mesh-ancestor
25467720|NCT03346668|Sensory System Agents|sensory system agents|mesh-ancestor
25467721|NCT03346668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25467722|NCT03346668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467723|NCT03346668|Anticonvulsants|anticonvulsants|mesh-ancestor
25467724|NCT03346668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25467725|NCT03346668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25467726|NCT03346668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25467727|NCT03346668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25467728|NCT03346668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25467729|NCT03346668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25467730|NCT03346668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25467731|NCT03346668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467732|NCT03346668|Antimanic Agents|antimanic agents|mesh-ancestor
25467733|NCT03309150|Paclitaxel|paclitaxel|mesh-list
25467734|NCT03309150|Carboplatin|carboplatin|mesh-list
25467735|NCT03309150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25338690|NCT04573920|Atrasentan|atrasentan|mesh-list
25467736|NCT03309150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467737|NCT03309150|Tubulin Modulators|tubulin modulators|mesh-ancestor
25467738|NCT03309150|Antimitotic Agents|antimitotic agents|mesh-ancestor
25467739|NCT03309150|Mitosis Modulators|mitosis modulators|mesh-ancestor
25467740|NCT03309150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467741|NCT03304717|Tenofovir|tenofovir|mesh-list
25467742|NCT03304717|Emtricitabine|emtricitabine|mesh-list
25467743|NCT03304717|Antiviral Agents|antiviral agents|mesh-ancestor
25467744|NCT03304717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25467745|NCT03304717|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25467746|NCT03304717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25467747|NCT03304717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467748|NCT03304717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467749|NCT03304717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25467750|NCT03304717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25328486|NCT04846634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467751|NCT03252522|Micronutrients|micronutrients|mesh-list
25467752|NCT03252522|Trace Elements|trace elements|mesh-list
25467753|NCT03252522|Antioxidants|antioxidants|mesh-list
25467754|NCT03252522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467755|NCT03252522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467756|NCT03252522|Protective Agents|protective agents|mesh-ancestor
25467758|NCT03223155|Ipilimumab|ipilimumab|mesh-list
25467759|NCT03223155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25467760|NCT03223155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467761|NCT03223155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25467762|NCT03223155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467763|NCT03217201|Methamphetamine|methamphetamine|mesh-list
25467764|NCT03217201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25467765|NCT03217201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467766|NCT03217201|Sympathomimetics|sympathomimetics|mesh-ancestor
25467767|NCT03217201|Autonomic Agents|autonomic agents|mesh-ancestor
25467768|NCT03217201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25467769|NCT03217201|Dopamine Agents|dopamine agents|mesh-ancestor
25467770|NCT03217201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25467771|NCT03217201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467772|NCT03217201|Adrenergic Agents|adrenergic agents|mesh-ancestor
25467773|NCT03217201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25467774|NCT03217201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25467775|NCT03217201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25467776|NCT03217201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25467777|NCT03182179|Ondansetron|ondansetron|mesh-list
25467778|NCT03182179|Antiemetics|antiemetics|mesh-ancestor
25467779|NCT03182179|Autonomic Agents|autonomic agents|mesh-ancestor
25467780|NCT03182179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25467781|NCT03182179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467782|NCT03182179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25467783|NCT03182179|Antipruritics|antipruritics|mesh-ancestor
25467784|NCT03182179|Dermatologic Agents|dermatologic agents|mesh-ancestor
25467785|NCT03182179|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25467786|NCT03182179|Serotonin Agents|serotonin agents|mesh-ancestor
25338772|NCT04478292|Sodium thiosulfate|sodium thiosulfate|mesh-list
25467787|NCT03182179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25467788|NCT03182179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467789|NCT03182179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25467790|NCT03182179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25467791|NCT03182179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25467792|NCT03182179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25467793|NCT03182179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25467795|NCT03167242|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25467796|NCT03167242|Antimalarials|antimalarials|mesh-ancestor
25467797|NCT03167242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25467798|NCT03167242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25467799|NCT03167242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25467800|NCT03164473|Rituximab|rituximab|mesh-list
25467801|NCT03164473|Azathioprine|azathioprine|mesh-list
25467802|NCT03164473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25467803|NCT03164473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467804|NCT03164473|Immunologic Factors|immunologic factors|mesh-ancestor
25467805|NCT03164473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467806|NCT03164473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25467807|NCT03164473|Antimetabolites|antimetabolites|mesh-ancestor
25467808|NCT03164473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467809|NCT03164473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25467810|NCT03164473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25467811|NCT03161431|Pembrolizumab|pembrolizumab|mesh-list
25467812|NCT03161431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25328566|NCT04844996|Ezetimibe|ezetimibe|mesh-list
25328567|NCT04844996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25328568|NCT04844996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25328569|NCT04844996|Antimetabolites|antimetabolites|mesh-ancestor
25328570|NCT04844996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328571|NCT04844996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25328572|NCT04845061|Nebivolol|nebivolol|mesh-list
25328573|NCT04845061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25328574|NCT04845061|Vasodilator Agents|vasodilator agents|mesh-ancestor
25328575|NCT04845061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25328576|NCT04845061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25328577|NCT04845061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25328578|NCT04845061|Adrenergic Agents|adrenergic agents|mesh-ancestor
25467813|NCT03161431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467814|NCT03153280|Capecitabine|capecitabine|mesh-list
25467815|NCT03153280|Oxaliplatin|oxaliplatin|mesh-list
25467816|NCT03153280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25467817|NCT03153280|Antimetabolites|antimetabolites|mesh-ancestor
25467818|NCT03153280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467819|NCT03153280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467820|NCT03147612|Cytarabine|cytarabine|mesh-list
25467821|NCT03147612|Cyclophosphamide|cyclophosphamide|mesh-list
25467822|NCT03147612|Rituximab|rituximab|mesh-list
25467823|NCT03147612|Methotrexate|methotrexate|mesh-list
25467824|NCT03147612|Vincristine|vincristine|mesh-list
25467825|NCT03147612|Blinatumomab|blinatumomab|mesh-list
25467826|NCT03147612|Ponatinib|ponatinib|mesh-list
25467827|NCT03147612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25467828|NCT03147612|Muromonab-CD3|muromonab-cd3|mesh-list
25467829|NCT03147612|Antibodies|antibodies|mesh-list
25467830|NCT03147612|Immunoglobulins|immunoglobulins|mesh-list
25467831|NCT03147612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25467832|NCT03147612|Lenograstim|lenograstim|mesh-list
25467833|NCT03147612|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25467834|NCT03147612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25467835|NCT03147612|Immunologic Factors|immunologic factors|mesh-ancestor
25467836|NCT03147612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467837|NCT03147612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25467838|NCT03147612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25467839|NCT03147612|Alkylating Agents|alkylating agents|mesh-ancestor
25467840|NCT03147612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467841|NCT03147612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467842|NCT03147612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25467843|NCT03147612|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25467844|NCT03147612|Abortifacient Agents|abortifacient agents|mesh-ancestor
25467845|NCT03147612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25467846|NCT03147612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25467847|NCT03147612|Antimetabolites|antimetabolites|mesh-ancestor
25467848|NCT03147612|Dermatologic Agents|dermatologic agents|mesh-ancestor
25467849|NCT03147612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467850|NCT03147612|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25467851|NCT03147612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25467852|NCT03147612|Antiviral Agents|antiviral agents|mesh-ancestor
25467853|NCT03147612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25467854|NCT03147612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25467855|NCT03147612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25467856|NCT03147612|Tubulin Modulators|tubulin modulators|mesh-ancestor
25467857|NCT03147612|Antimitotic Agents|antimitotic agents|mesh-ancestor
25467858|NCT03147612|Mitosis Modulators|mitosis modulators|mesh-ancestor
25467859|NCT03147612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25467860|NCT03113253|Tranexamic Acid|tranexamic acid|mesh-list
25467861|NCT03113253|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25467862|NCT03113253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25467863|NCT03113253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467864|NCT03113253|Hemostatics|hemostatics|mesh-ancestor
25467865|NCT03113253|Coagulants|coagulants|mesh-ancestor
25467866|NCT03111992|Spartalizumab|spartalizumab|mesh-list
25467867|NCT03111992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25467868|NCT03111992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467869|NCT03111992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467871|NCT03101046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467872|NCT03101046|Tubulin Modulators|tubulin modulators|mesh-ancestor
25467873|NCT03101046|Antimitotic Agents|antimitotic agents|mesh-ancestor
25467874|NCT03101046|Mitosis Modulators|mitosis modulators|mesh-ancestor
25467875|NCT03101046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467876|NCT03059173|Inositol|inositol|mesh-list
25467877|NCT03059173|Clomiphene|clomiphene|mesh-list
25467878|NCT03059173|Enclomiphene|enclomiphene|mesh-list
25467879|NCT03059173|Zuclomiphene|zuclomiphene|mesh-list
25467880|NCT03059173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25467881|NCT03059173|Hormone Antagonists|hormone antagonists|mesh-ancestor
25467882|NCT03059173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25467883|NCT03059173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467884|NCT03059173|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25467885|NCT03059173|Fertility Agents|fertility agents|mesh-ancestor
25467886|NCT03059173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25328637|NCT04843839|Analgesics|analgesics|mesh-ancestor
25467887|NCT03059173|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25467888|NCT03059173|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25467890|NCT03059173|Vitamins|vitamins|mesh-ancestor
25467891|NCT03059173|Micronutrients|micronutrients|mesh-ancestor
25467892|NCT03015129|Durvalumab|durvalumab|mesh-list
25467893|NCT03015129|Tremelimumab|tremelimumab|mesh-list
25467894|NCT03015129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25467895|NCT03015129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467896|NCT03013491|Ipilimumab|ipilimumab|mesh-list
25467897|NCT03013491|Vemurafenib|vemurafenib|mesh-list
25467898|NCT03013491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25467899|NCT03013491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467900|NCT03013491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25467901|NCT03013491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467902|NCT03013491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25467903|NCT03013491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467904|NCT03008369|Lenvatinib|lenvatinib|mesh-list
25467905|NCT03008369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467906|NCT03008369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25467907|NCT03008369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467908|NCT03008369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467909|NCT02963493|Dexamethasone|dexamethasone|mesh-list
25467910|NCT02963493|Melphalan|melphalan|mesh-list
25467911|NCT02963493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25467912|NCT02963493|Antiemetics|antiemetics|mesh-ancestor
25467913|NCT02963493|Autonomic Agents|autonomic agents|mesh-ancestor
25467914|NCT02963493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25467915|NCT02963493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467916|NCT02963493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25467917|NCT02963493|Glucocorticoids|glucocorticoids|mesh-ancestor
25467918|NCT02963493|Hormones|hormones|mesh-ancestor
25467919|NCT02963493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25467920|NCT02963493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25467921|NCT02963493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467922|NCT02963493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25467923|NCT02963493|Alkylating Agents|alkylating agents|mesh-ancestor
25467924|NCT02963493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467925|NCT02963493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25467926|NCT02963493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25467927|NCT02963493|Immunologic Factors|immunologic factors|mesh-ancestor
25467928|NCT02947503|Metformin|metformin|mesh-list
25467929|NCT02947503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25467930|NCT02947503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467931|NCT02921555|Prednisone|prednisone|mesh-list
25467932|NCT02921555|Methylprednisolone|methylprednisolone|mesh-list
25467933|NCT02921555|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25467934|NCT02921555|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25467935|NCT02921555|Prednisolone|prednisolone|mesh-list
25467936|NCT02921555|Prednisolone acetate|prednisolone acetate|mesh-list
25467937|NCT02921555|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25467938|NCT02921555|Prednisolone phosphate|prednisolone phosphate|mesh-list
25467939|NCT02921555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25467940|NCT02921555|Glucocorticoids|glucocorticoids|mesh-ancestor
25467941|NCT02921555|Hormones|hormones|mesh-ancestor
25467942|NCT02921555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25328706|NCT04843007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25328707|NCT04843007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25328708|NCT04842838|Paclitaxel|paclitaxel|mesh-list
25328709|NCT04842838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25328710|NCT04842838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328711|NCT04842838|Tubulin Modulators|tubulin modulators|mesh-ancestor
25328712|NCT04842838|Antimitotic Agents|antimitotic agents|mesh-ancestor
25328713|NCT04842838|Mitosis Modulators|mitosis modulators|mesh-ancestor
25328714|NCT04842838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328715|NCT04842968|Methylene Blue|methylene blue|mesh-list
25328716|NCT04842968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25328717|NCT04842968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328740|NCT04842435|Immunoglobulins|immunoglobulins|mesh-list
25328741|NCT04842435|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25328742|NCT04842435|Immunologic Factors|immunologic factors|mesh-ancestor
25328743|NCT04842435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328744|NCT04842487|Prednisone|prednisone|mesh-list
25328745|NCT04842487|Cyclophosphamide|cyclophosphamide|mesh-list
25328746|NCT04842487|Rituximab|rituximab|mesh-list
25328747|NCT04842487|Vincristine|vincristine|mesh-list
25822883|NCT00004688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25467967|NCT02861417|Fludarabine phosphate|fludarabine phosphate|mesh-list
25467968|NCT02861417|Tacrolimus|tacrolimus|mesh-list
25467969|NCT02861417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25467970|NCT02861417|Immunologic Factors|immunologic factors|mesh-ancestor
25467971|NCT02861417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25467972|NCT02861417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25467973|NCT02861417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25467974|NCT02861417|Alkylating Agents|alkylating agents|mesh-ancestor
25467975|NCT02861417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467976|NCT02861417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25467977|NCT02861417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25467978|NCT02861417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25467979|NCT02861417|Antimetabolites|antimetabolites|mesh-ancestor
25467980|NCT02861417|Antiviral Agents|antiviral agents|mesh-ancestor
25467981|NCT02861417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25467982|NCT02861417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25467983|NCT02861417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467984|NCT02861417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25467985|NCT02861417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25467986|NCT02861417|Antitubercular Agents|antitubercular agents|mesh-ancestor
25467987|NCT02861417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25328773|NCT04842487|Growth Inhibitors|growth inhibitors|mesh-ancestor
25328774|NCT04842487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25328775|NCT04842487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25328776|NCT04842487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25328777|NCT04842487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25328783|NCT04842383|Peppermint oil|peppermint oil|mesh-list
25328784|NCT04842383|Antiemetics|antiemetics|mesh-ancestor
25328785|NCT04842383|Autonomic Agents|autonomic agents|mesh-ancestor
25328790|NCT04842526|Irinotecan|irinotecan|mesh-list
25467988|NCT02788591|Esomeprazole|esomeprazole|mesh-list
25467989|NCT02788591|Omeprazole|omeprazole|mesh-list
25467990|NCT02788591|Pantoprazole|pantoprazole|mesh-list
25467991|NCT02788591|Lansoprazole|lansoprazole|mesh-list
25467992|NCT02788591|Sucralfate|sucralfate|mesh-list
25467993|NCT02788591|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25467994|NCT02788591|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25467995|NCT02788591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25467996|NCT02788591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25467997|NCT02788591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25467998|NCT02772588|Leuprolide|leuprolide|mesh-list
25467999|NCT02772588|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25468000|NCT02772588|Fertility Agents|fertility agents|mesh-ancestor
25468001|NCT02772588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25468002|NCT02772588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822884|NCT00004689|Clarithromycin|clarithromycin|mesh-list
25468003|NCT02772588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25468004|NCT02772588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25468005|NCT02748057|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25468006|NCT02748057|Ezetimibe|ezetimibe|mesh-list
25468007|NCT02748057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25468008|NCT02748057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25468009|NCT02748057|Antimetabolites|antimetabolites|mesh-ancestor
25468010|NCT02748057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468011|NCT02748057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25468012|NCT02748057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25468013|NCT02748057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468014|NCT02741271|Mometasone Furoate|mometasone furoate|mesh-list
25468015|NCT02741271|Prednisone|prednisone|mesh-list
25468016|NCT02741271|Prednisolone|prednisolone|mesh-list
25468017|NCT02741271|Albuterol|albuterol|mesh-list
25468018|NCT02741271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25468019|NCT02741271|Glucocorticoids|glucocorticoids|mesh-ancestor
25468020|NCT02741271|Hormones|hormones|mesh-ancestor
25468021|NCT02741271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25468022|NCT02741271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468023|NCT02741271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25468024|NCT02741271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25468025|NCT02741271|Autonomic Agents|autonomic agents|mesh-ancestor
25468026|NCT02741271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25468027|NCT02741271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25468028|NCT02741271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25468029|NCT02741271|Respiratory System Agents|respiratory system agents|mesh-ancestor
25468030|NCT02741271|Tocolytic Agents|tocolytic agents|mesh-ancestor
25468031|NCT02741271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25468032|NCT02741271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25468033|NCT02741271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25468034|NCT02741271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25468035|NCT02741271|Adrenergic Agents|adrenergic agents|mesh-ancestor
25468036|NCT02741271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25468037|NCT02741271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468038|NCT02741271|Dermatologic Agents|dermatologic agents|mesh-ancestor
25468039|NCT02741271|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25468040|NCT02741245|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25468041|NCT02741245|Ezetimibe|ezetimibe|mesh-list
25468042|NCT02741245|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25468043|NCT02741245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25468044|NCT02741245|Antimetabolites|antimetabolites|mesh-ancestor
25468045|NCT02741245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468046|NCT02741245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25468047|NCT02741245|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25468048|NCT02741245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468049|NCT02728050|Cytarabine|cytarabine|mesh-list
25468050|NCT02728050|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
25468051|NCT02728050|Sorafenib|sorafenib|mesh-list
25328841|NCT04841369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328868|NCT04841018|Dexamethasone|dexamethasone|mesh-list
25328869|NCT04841018|Dexamethasone acetate|dexamethasone acetate|mesh-list
25328870|NCT04841018|BB 1101|bb 1101|mesh-list
25328871|NCT04841018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25328872|NCT04841018|Antiemetics|antiemetics|mesh-ancestor
25328873|NCT04841018|Autonomic Agents|autonomic agents|mesh-ancestor
25328874|NCT04841018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25328875|NCT04841018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328876|NCT04841018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25328877|NCT04841018|Glucocorticoids|glucocorticoids|mesh-ancestor
25328878|NCT04841018|Hormones|hormones|mesh-ancestor
25328880|NCT04841018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25468052|NCT02728050|Mitoxantrone|mitoxantrone|mesh-list
25468054|NCT02728050|Lenograstim|lenograstim|mesh-list
25468055|NCT02728050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25468056|NCT02728050|Antimetabolites|antimetabolites|mesh-ancestor
25468057|NCT02728050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468058|NCT02728050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25468059|NCT02728050|Antiviral Agents|antiviral agents|mesh-ancestor
25468060|NCT02728050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25468061|NCT02728050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25468062|NCT02728050|Immunologic Factors|immunologic factors|mesh-ancestor
25468063|NCT02728050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468064|NCT02728050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25468065|NCT02728050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25468066|NCT02728050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468067|NCT02728050|Analgesics|analgesics|mesh-ancestor
25468068|NCT02728050|Sensory System Agents|sensory system agents|mesh-ancestor
25468069|NCT02728050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25468070|NCT02728050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25468071|NCT02728050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25468072|NCT02705963|Trametinib|trametinib|mesh-list
25468073|NCT02705963|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25468074|NCT02705963|Norethindrone|norethindrone|mesh-list
25468075|NCT02705963|Norethindrone Acetate|norethindrone acetate|mesh-list
25468076|NCT02705963|Contraceptive Agents|contraceptive agents|mesh-list
25468077|NCT02705963|Contraceptives, Oral|contraceptives, oral|mesh-list
25468078|NCT02705963|Estradiol|estradiol|mesh-list
25468079|NCT02705963|Estrogens|estrogens|mesh-ancestor
25468080|NCT02705963|Hormones|hormones|mesh-ancestor
25468081|NCT02705963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25468082|NCT02705963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468083|NCT02705963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25468084|NCT02705963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25468085|NCT02705963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25468086|NCT02705963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25468087|NCT02705963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25468088|NCT02705963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468089|NCT02705963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468090|NCT02705963|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25468091|NCT02705963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25468092|NCT02688608|Pembrolizumab|pembrolizumab|mesh-list
25468093|NCT02688608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25468094|NCT02688608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25468095|NCT02662257|Propofol|propofol|mesh-list
25468096|NCT02662257|Sevoflurane|sevoflurane|mesh-list
25468097|NCT02662257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25468098|NCT02662257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25468099|NCT02662257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468100|NCT02662257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25468101|NCT02662257|Anesthetics, General|anesthetics, general|mesh-ancestor
25468102|NCT02662257|Anesthetics|anesthetics|mesh-ancestor
25468103|NCT02662257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25468104|NCT02662257|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25468105|NCT02648477|Doxorubicin|doxorubicin|mesh-list
25468106|NCT02648477|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25468107|NCT02648477|Pembrolizumab|pembrolizumab|mesh-list
25468108|NCT02648477|Letrozole|letrozole|mesh-list
25468109|NCT02648477|Anastrozole|anastrozole|mesh-list
25468110|NCT02648477|Exemestane|exemestane|mesh-list
25468111|NCT02648477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25468112|NCT02648477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25468113|NCT02648477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25468114|NCT02648477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25468115|NCT02648477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468116|NCT02648477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468117|NCT02648477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25468118|NCT02648477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25468119|NCT02648477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25468120|NCT02648477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25468121|NCT02648477|Hormone Antagonists|hormone antagonists|mesh-ancestor
25468122|NCT02648477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25468123|NCT02648477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468124|NCT02648477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25468125|NCT02626507|Fulvestrant|fulvestrant|mesh-list
25468126|NCT02626507|Goserelin|goserelin|mesh-list
25468127|NCT02626507|Palbociclib|palbociclib|mesh-list
25468128|NCT02626507|Gedatolisib|gedatolisib|mesh-list
25468129|NCT02626507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25468130|NCT02626507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25468131|NCT02626507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25468132|NCT02626507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25468133|NCT02626507|Hormone Antagonists|hormone antagonists|mesh-ancestor
25468134|NCT02626507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25468135|NCT02626507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468136|NCT02626507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25468137|NCT02626507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468138|NCT02626507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468139|NCT02605967|Spartalizumab|spartalizumab|mesh-list
25468140|NCT02605967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25468141|NCT02605967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468142|NCT02605967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25468143|NCT02570503|Ketorolac|ketorolac|mesh-list
25468144|NCT02570503|Clonidine|clonidine|mesh-list
25468145|NCT02570503|Epinephrine|epinephrine|mesh-list
25468146|NCT02570503|Ropivacaine|ropivacaine|mesh-list
25468147|NCT02570503|Anesthetics, Local|anesthetics, local|mesh-ancestor
25468148|NCT02570503|Anesthetics|anesthetics|mesh-ancestor
25468149|NCT02570503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25468150|NCT02570503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468151|NCT02570503|Sensory System Agents|sensory system agents|mesh-ancestor
25468152|NCT02570503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25468153|NCT02570503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25468154|NCT02570503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25468155|NCT02570503|Adrenergic Agents|adrenergic agents|mesh-ancestor
25468156|NCT02570503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25468157|NCT02570503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468158|NCT02570503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25468159|NCT02570503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25468160|NCT02570503|Autonomic Agents|autonomic agents|mesh-ancestor
25468161|NCT02570503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25468162|NCT02570503|Respiratory System Agents|respiratory system agents|mesh-ancestor
25468163|NCT02570503|Mydriatics|mydriatics|mesh-ancestor
25468164|NCT02570503|Sympathomimetics|sympathomimetics|mesh-ancestor
25468165|NCT02570503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25468166|NCT02570503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25468167|NCT02570503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25468168|NCT02570503|Analgesics|analgesics|mesh-ancestor
25468169|NCT02570503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25468170|NCT02570503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25468171|NCT02570503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25468172|NCT02570503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468173|NCT02570503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25468174|NCT02570503|Sympatholytics|sympatholytics|mesh-ancestor
25468175|NCT02570503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25468176|NCT02564068|Oxytocin|oxytocin|mesh-list
25468177|NCT02564068|Oxytocics|oxytocics|mesh-ancestor
25468178|NCT02564068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25468179|NCT02564068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468180|NCT02553265|Carbidopa|carbidopa|mesh-list
25468181|NCT02553265|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25468182|NCT02553265|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25468183|NCT02553265|Dopamine Agents|dopamine agents|mesh-ancestor
25468184|NCT02553265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25468185|NCT02553265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468186|NCT02553265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468187|NCT02553265|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25468188|NCT02553265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468189|NCT02550288|Atorvastatin|atorvastatin|mesh-list
25468190|NCT02550288|Ezetimibe|ezetimibe|mesh-list
25468191|NCT02550288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25468192|NCT02550288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25468193|NCT02550288|Antimetabolites|antimetabolites|mesh-ancestor
25468194|NCT02550288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468195|NCT02550288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25468196|NCT02550288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25468197|NCT02550288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468198|NCT02510040|Botulinum Toxins|botulinum toxins|mesh-list
25328986|NCT04839627|Hormones|hormones|mesh-ancestor
25328987|NCT04839627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25328988|NCT04839627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468199|NCT02510040|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25468200|NCT02510040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25468201|NCT02510040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468202|NCT02510040|Cholinergic Agents|cholinergic agents|mesh-ancestor
25468203|NCT02510040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25468204|NCT02510040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468205|NCT02492269|Dexmedetomidine|dexmedetomidine|mesh-list
25468206|NCT02492269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25468207|NCT02492269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25468208|NCT02492269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468209|NCT02492269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25468210|NCT02492269|Analgesics|analgesics|mesh-ancestor
25468211|NCT02492269|Sensory System Agents|sensory system agents|mesh-ancestor
25468212|NCT02492269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25822885|NCT00004689|Rifampin|rifampin|mesh-list
25468213|NCT02492269|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25468214|NCT02492269|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25468215|NCT02492269|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25468216|NCT02492269|Adrenergic Agents|adrenergic agents|mesh-ancestor
25468217|NCT02492269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25468218|NCT02492269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468219|NCT02469753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25468220|NCT02469753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25468221|NCT02469753|Analgesics|analgesics|mesh-ancestor
25468222|NCT02469753|Sensory System Agents|sensory system agents|mesh-ancestor
25468223|NCT02469753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25468224|NCT02469753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468225|NCT02469753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25468226|NCT02469753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25468227|NCT02467153|Vitamin D|vitamin d|mesh-list
25468228|NCT02467153|Cholecalciferol|cholecalciferol|mesh-list
25468229|NCT02467153|Vitamins|vitamins|mesh-ancestor
25468230|NCT02467153|Micronutrients|micronutrients|mesh-ancestor
25468231|NCT02467153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468232|NCT02467153|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25468233|NCT02467153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25468234|NCT02460224|Spartalizumab|spartalizumab|mesh-list
25468235|NCT02460224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25468236|NCT02460224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468237|NCT02460224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25468238|NCT02459457|Paclitaxel|paclitaxel|mesh-list
25468239|NCT02459457|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25468240|NCT02459457|Cisplatin|cisplatin|mesh-list
25468241|NCT02459457|Carboplatin|carboplatin|mesh-list
25468242|NCT02459457|Fluorouracil|fluorouracil|mesh-list
25468243|NCT02459457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25468244|NCT02459457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25468245|NCT02459457|Tubulin Modulators|tubulin modulators|mesh-ancestor
25468246|NCT02459457|Antimitotic Agents|antimitotic agents|mesh-ancestor
25468247|NCT02459457|Mitosis Modulators|mitosis modulators|mesh-ancestor
25468248|NCT02459457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468249|NCT02459457|Antimetabolites|antimetabolites|mesh-ancestor
25468250|NCT02459457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25468251|NCT02459457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25468252|NCT02459457|Immunologic Factors|immunologic factors|mesh-ancestor
25329052|NCT04838704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25329053|NCT04838704|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25329054|NCT04838704|Antitubercular Agents|antitubercular agents|mesh-ancestor
25329055|NCT04838704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25329056|NCT04838704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25329057|NCT04838665|Phenylephrine|phenylephrine|mesh-list
25329058|NCT04838665|Oxymetazoline|oxymetazoline|mesh-list
25329059|NCT04838665|Tropicamide|tropicamide|mesh-list
25329060|NCT04838665|Cyclopentolate|cyclopentolate|mesh-list
25329061|NCT04838665|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25329062|NCT04838665|Mydriatics|mydriatics|mesh-ancestor
25329063|NCT04838665|Autonomic Agents|autonomic agents|mesh-ancestor
25329064|NCT04838665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25329065|NCT04838665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329066|NCT04838665|Sympathomimetics|sympathomimetics|mesh-ancestor
25329067|NCT04838665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25329068|NCT04838665|Nasal Decongestants|nasal decongestants|mesh-ancestor
25329069|NCT04838665|Respiratory System Agents|respiratory system agents|mesh-ancestor
25329070|NCT04838665|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25329071|NCT04838665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25468253|NCT02459457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468254|NCT02386774|Benoxinate|benoxinate|mesh-list
25468255|NCT02386774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25468256|NCT02386774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25468257|NCT02386774|Anesthetics, Local|anesthetics, local|mesh-ancestor
25468258|NCT02386774|Anesthetics|anesthetics|mesh-ancestor
25468259|NCT02386774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25468260|NCT02386774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468261|NCT02386774|Sensory System Agents|sensory system agents|mesh-ancestor
25468262|NCT02386774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25468263|NCT02320396|Desloratadine|desloratadine|mesh-list
25468264|NCT02320396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25468265|NCT02320396|Cholinergic Agents|cholinergic agents|mesh-ancestor
25468266|NCT02320396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25468267|NCT02320396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822886|NCT00004689|Ethambutol|ethambutol|mesh-list
25468268|NCT02320396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468269|NCT02320396|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25468270|NCT02320396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25468271|NCT02320396|Histamine Antagonists|histamine antagonists|mesh-ancestor
25468272|NCT02320396|Histamine Agents|histamine agents|mesh-ancestor
25468274|NCT02299505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25468275|NCT02299505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25468276|NCT02299505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468277|NCT02299505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468278|NCT02251262|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25468279|NCT02251262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25468280|NCT02251262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468281|NCT02250014|Sargramostim|sargramostim|mesh-list
25468282|NCT02250014|Immunologic Factors|immunologic factors|mesh-ancestor
25468283|NCT02250014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468284|NCT02235701|Ifosfamide|ifosfamide|mesh-list
25468285|NCT02235701|Doxorubicin|doxorubicin|mesh-list
25468286|NCT02235701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25468287|NCT02235701|Alkylating Agents|alkylating agents|mesh-ancestor
25468288|NCT02235701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468289|NCT02235701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25468290|NCT02235701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25468291|NCT02235701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25468292|NCT02235701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25468293|NCT02235701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468294|NCT02235688|Gemcitabine|gemcitabine|mesh-list
25468295|NCT02235688|Doxorubicin|doxorubicin|mesh-list
25468296|NCT02235688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25468297|NCT02235688|Antimetabolites|antimetabolites|mesh-ancestor
25468298|NCT02235688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468299|NCT02235688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25468300|NCT02235688|Antiviral Agents|antiviral agents|mesh-ancestor
25468301|NCT02235688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25468302|NCT02235688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468303|NCT02235688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25468304|NCT02235688|Immunologic Factors|immunologic factors|mesh-ancestor
25468305|NCT02235688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468306|NCT02235688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25468307|NCT02235688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25468308|NCT02235688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25329130|NCT04837664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329131|NCT04837664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25329132|NCT04837664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25329133|NCT04837664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329134|NCT04837664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25329135|NCT04837664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329136|NCT04837664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25329137|NCT04837664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25329138|NCT04837664|Antifungal Agents|antifungal agents|mesh-ancestor
25329139|NCT04837664|Ionophores|ionophores|mesh-ancestor
25329140|NCT04837664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25329141|NCT04837651|Antibodies|antibodies|mesh-list
25329142|NCT04837651|Immunologic Factors|immunologic factors|mesh-ancestor
25329143|NCT04837651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329144|NCT04837131|Ixazomib|ixazomib|mesh-list
25329145|NCT04837131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329146|NCT04837131|Protease Inhibitors|protease inhibitors|mesh-ancestor
25329147|NCT04837131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468309|NCT02115074|Celecoxib|celecoxib|mesh-list
25468310|NCT02115074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25468311|NCT02115074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25468312|NCT02115074|Analgesics|analgesics|mesh-ancestor
25468313|NCT02115074|Sensory System Agents|sensory system agents|mesh-ancestor
25468314|NCT02115074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25468315|NCT02115074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468316|NCT02115074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25468317|NCT02115074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25468318|NCT02115074|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25468319|NCT02115074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25468320|NCT02115074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468321|NCT02115074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468322|NCT02066636|Nivolumab|nivolumab|mesh-list
25468323|NCT02066636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25644680|NCT01439126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25644681|NCT01439126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468324|NCT02066636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25468325|NCT02066636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25468326|NCT02066636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468327|NCT02053246|Nebivolol|nebivolol|mesh-list
25468328|NCT02053246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25468329|NCT02053246|Vasodilator Agents|vasodilator agents|mesh-ancestor
25468330|NCT02053246|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25468331|NCT02053246|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25468332|NCT02053246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25468333|NCT02053246|Adrenergic Agents|adrenergic agents|mesh-ancestor
25468334|NCT02053246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25468335|NCT02053246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468336|NCT02053246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468337|NCT01980940|Etoricoxib|etoricoxib|mesh-list
25468338|NCT01980940|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
25468339|NCT01980940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25468340|NCT01980940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25468341|NCT01980940|Analgesics|analgesics|mesh-ancestor
25468342|NCT01980940|Sensory System Agents|sensory system agents|mesh-ancestor
25468343|NCT01980940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25468344|NCT01980940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468345|NCT01980940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25468346|NCT01980940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25468347|NCT01980940|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25468348|NCT01980940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25468349|NCT01980940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468350|NCT01980940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468351|NCT01980940|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25468352|NCT01980940|Protective Agents|protective agents|mesh-ancestor
25468353|NCT01980940|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25468354|NCT01980940|Antioxidants|antioxidants|mesh-ancestor
25468355|NCT01923298|Estradiol|estradiol|mesh-list
25468356|NCT01923298|Estrogens|estrogens|mesh-ancestor
25468357|NCT01923298|Hormones|hormones|mesh-ancestor
25468358|NCT01923298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25468359|NCT01923298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468360|NCT01918033|Desloratadine|desloratadine|mesh-list
25468361|NCT01918033|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25468362|NCT01918033|Cholinergic Agents|cholinergic agents|mesh-ancestor
25468363|NCT01918033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25468364|NCT01918033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468365|NCT01918033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468366|NCT01918033|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25468367|NCT01918033|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25468368|NCT01918033|Histamine Antagonists|histamine antagonists|mesh-ancestor
25468369|NCT01918033|Histamine Agents|histamine agents|mesh-ancestor
25329205|NCT04837261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25329206|NCT04837261|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25329219|NCT04836806|Cetirizine|cetirizine|mesh-list
25329220|NCT04836806|Famotidine|famotidine|mesh-list
25329221|NCT04836806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25329222|NCT04836806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25329223|NCT04836806|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25329224|NCT04836806|Histamine Antagonists|histamine antagonists|mesh-ancestor
25329225|NCT04836806|Histamine Agents|histamine agents|mesh-ancestor
25329226|NCT04836806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25329227|NCT04836806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329229|NCT04836806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25468370|NCT01916980|Desloratadine|desloratadine|mesh-list
25468371|NCT01916980|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25468372|NCT01916980|Cholinergic Agents|cholinergic agents|mesh-ancestor
25468373|NCT01916980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25468374|NCT01916980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468375|NCT01916980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468376|NCT01916980|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25468377|NCT01916980|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25468378|NCT01916980|Histamine Antagonists|histamine antagonists|mesh-ancestor
25468379|NCT01916980|Histamine Agents|histamine agents|mesh-ancestor
25468380|NCT01916967|Desloratadine|desloratadine|mesh-list
25468381|NCT01916967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25468382|NCT01916967|Cholinergic Agents|cholinergic agents|mesh-ancestor
25468383|NCT01916967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25468384|NCT01916967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468385|NCT01916967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468386|NCT01916967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25468387|NCT01916967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25468388|NCT01916967|Histamine Antagonists|histamine antagonists|mesh-ancestor
25468391|NCT01893320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25468392|NCT01893320|Antimetabolites|antimetabolites|mesh-ancestor
25468393|NCT01893320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468394|NCT01893320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25468395|NCT01893320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468396|NCT01867606|Immunoglobulins|immunoglobulins|mesh-list
25468397|NCT01867606|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25468398|NCT01867606|Antibodies|antibodies|mesh-list
25468399|NCT01867606|Immunologic Factors|immunologic factors|mesh-ancestor
25468400|NCT01867606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468401|NCT01857063|Montelukast|montelukast|mesh-list
25468402|NCT01857063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25468403|NCT01857063|Respiratory System Agents|respiratory system agents|mesh-ancestor
25468404|NCT01857063|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25468405|NCT01857063|Hormone Antagonists|hormone antagonists|mesh-ancestor
25468406|NCT01857063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25468407|NCT01857063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468408|NCT01857063|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25468409|NCT01857063|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25468410|NCT01857063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468411|NCT01854268|Capsaicin|capsaicin|mesh-list
25468412|NCT01854268|Antipruritics|antipruritics|mesh-ancestor
25468413|NCT01854268|Dermatologic Agents|dermatologic agents|mesh-ancestor
25468414|NCT01854268|Sensory System Agents|sensory system agents|mesh-ancestor
25468415|NCT01854268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25468416|NCT01854268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468417|NCT01852812|Montelukast|montelukast|mesh-list
25468418|NCT01852812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25468419|NCT01852812|Respiratory System Agents|respiratory system agents|mesh-ancestor
25468420|NCT01852812|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25468421|NCT01852812|Hormone Antagonists|hormone antagonists|mesh-ancestor
25468422|NCT01852812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25468423|NCT01852812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468424|NCT01852812|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25468425|NCT01852812|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25468426|NCT01852812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468427|NCT01828021|Margetuximab|margetuximab|mesh-list
25468428|NCT01828021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25468429|NCT01709318|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25329277|NCT04836819|Adrenergic Agents|adrenergic agents|mesh-ancestor
25329278|NCT04836819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25329279|NCT04836819|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25329280|NCT04836819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25329281|NCT04836819|Anesthetics, General|anesthetics, general|mesh-ancestor
25329282|NCT04836819|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25329283|NCT04836819|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25010786|NCT02955394|Fulvestrant|fulvestrant|mesh-list
24761306|NCT01762163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822887|NCT00004689|Streptomycin|streptomycin|mesh-list
25822888|NCT00004689|Thioacetazone|thioacetazone|mesh-list
25468431|NCT01709318|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25468432|NCT01709318|Etonogestrel|etonogestrel|mesh-list
25468434|NCT01709318|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25468435|NCT01709318|Estrogens|estrogens|mesh-ancestor
25468436|NCT01709318|Hormones|hormones|mesh-ancestor
25468437|NCT01709318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25468438|NCT01709318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468439|NCT01709318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25468440|NCT01709318|Contraceptive Agents|contraceptive agents|mesh-ancestor
25468441|NCT01709318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25468442|NCT01709318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25468443|NCT01709318|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25468444|NCT01709318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25468445|NCT01698918|Dexamethasone|dexamethasone|mesh-list
25468446|NCT01698918|Everolimus|everolimus|mesh-list
25644682|NCT01439204|Abatacept|abatacept|mesh-list
25644683|NCT01439204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25644684|NCT01439204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468447|NCT01698918|Letrozole|letrozole|mesh-list
25468448|NCT01698918|Exemestane|exemestane|mesh-list
25468449|NCT01698918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25468450|NCT01698918|Antiemetics|antiemetics|mesh-ancestor
25468451|NCT01698918|Autonomic Agents|autonomic agents|mesh-ancestor
25468452|NCT01698918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25468453|NCT01698918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468454|NCT01698918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25468455|NCT01698918|Glucocorticoids|glucocorticoids|mesh-ancestor
25468456|NCT01698918|Hormones|hormones|mesh-ancestor
25468457|NCT01698918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25468458|NCT01698918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25468459|NCT01698918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25468460|NCT01698918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25468461|NCT01698918|Immunologic Factors|immunologic factors|mesh-ancestor
25468462|NCT01698918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25468463|NCT01698918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25468464|NCT01698918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468465|NCT01698918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468466|NCT01698918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25468467|NCT01698918|Hormone Antagonists|hormone antagonists|mesh-ancestor
25468468|NCT01673620|Loratadine|loratadine|mesh-list
25468469|NCT01673620|Montelukast|montelukast|mesh-list
25468470|NCT01673620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25468471|NCT01673620|Respiratory System Agents|respiratory system agents|mesh-ancestor
25468472|NCT01673620|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25468473|NCT01673620|Hormone Antagonists|hormone antagonists|mesh-ancestor
25468474|NCT01673620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25468475|NCT01673620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329348|NCT04836156|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25329349|NCT04836143|Mitogens|mitogens|mesh-list
25329350|NCT04836143|Endothelial Growth Factors|endothelial growth factors|mesh-list
25329351|NCT04836143|Mitosis Modulators|mitosis modulators|mesh-ancestor
25329352|NCT04836143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329353|NCT04836143|Growth Substances|growth substances|mesh-ancestor
25329354|NCT04836143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329355|NCT04836299|Ivermectin|ivermectin|mesh-list
25329356|NCT04836299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25822889|NCT00004689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25822890|NCT00004689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25329357|NCT04836299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25329388|NCT04835948|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25329389|NCT04835948|Immunologic Factors|immunologic factors|mesh-ancestor
25329390|NCT04835948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329391|NCT04835948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25329392|NCT04835922|Anesthetics|anesthetics|mesh-list
25329393|NCT04835922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25329394|NCT04835922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329395|NCT04835896|Paclitaxel|paclitaxel|mesh-list
25329396|NCT04835896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25329397|NCT04835896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329398|NCT04835896|Tubulin Modulators|tubulin modulators|mesh-ancestor
25329399|NCT04835896|Antimitotic Agents|antimitotic agents|mesh-ancestor
25329400|NCT04835896|Mitosis Modulators|mitosis modulators|mesh-ancestor
25329401|NCT04835896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329402|NCT04835350|Pancrelipase|pancrelipase|mesh-list
25329403|NCT04835350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25468476|NCT01673620|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25468477|NCT01673620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25468478|NCT01673620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468479|NCT01673620|Antipruritics|antipruritics|mesh-ancestor
25468480|NCT01673620|Dermatologic Agents|dermatologic agents|mesh-ancestor
25468481|NCT01673620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25468482|NCT01673620|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25468483|NCT01673620|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25468484|NCT01673620|Histamine Antagonists|histamine antagonists|mesh-ancestor
25468485|NCT01673620|Histamine Agents|histamine agents|mesh-ancestor
25468486|NCT01673620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25468488|NCT01617187|Asenapine|asenapine|mesh-list
25468489|NCT01617187|Antiemetics|antiemetics|mesh-ancestor
25468490|NCT01617187|Autonomic Agents|autonomic agents|mesh-ancestor
25468491|NCT01617187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25644685|NCT01439204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25644686|NCT01439204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25644687|NCT01439204|Immunologic Factors|immunologic factors|mesh-ancestor
25644688|NCT01439204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644689|NCT01439204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25644690|NCT01439282|Capecitabine|capecitabine|mesh-list
25468492|NCT01617187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468493|NCT01617187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25468494|NCT01617187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25468495|NCT01617187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25468496|NCT01617187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25468497|NCT01617187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25468498|NCT01617187|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25468499|NCT01617187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25468500|NCT01617187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25468501|NCT01617187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468502|NCT01617187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25468503|NCT01617187|Serotonin Agents|serotonin agents|mesh-ancestor
25468504|NCT01611883|Ezetimibe|ezetimibe|mesh-list
25468505|NCT01611883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25468506|NCT01611883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25468507|NCT01611883|Antimetabolites|antimetabolites|mesh-ancestor
25468508|NCT01611883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468509|NCT01611883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25468510|NCT01572675|Celecoxib|celecoxib|mesh-list
25468511|NCT01572675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25468512|NCT01572675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25468513|NCT01572675|Analgesics|analgesics|mesh-ancestor
25468514|NCT01572675|Sensory System Agents|sensory system agents|mesh-ancestor
25468515|NCT01572675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25468516|NCT01572675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468517|NCT01572675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25468518|NCT01572675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25468519|NCT01572675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25468520|NCT01572675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25468521|NCT01572675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468522|NCT01572675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468523|NCT01554163|Celecoxib|celecoxib|mesh-list
25468524|NCT01554163|Etoricoxib|etoricoxib|mesh-list
25468525|NCT01554163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25468526|NCT01554163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25468527|NCT01554163|Analgesics|analgesics|mesh-ancestor
25468528|NCT01554163|Sensory System Agents|sensory system agents|mesh-ancestor
25468529|NCT01554163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25468530|NCT01554163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468531|NCT01554163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25468532|NCT01554163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25468533|NCT01554163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25468534|NCT01554163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25468535|NCT01554163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468536|NCT01554163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468537|NCT01502371|Mometasone Furoate|mometasone furoate|mesh-list
25468538|NCT01502371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25468539|NCT01502371|Dermatologic Agents|dermatologic agents|mesh-ancestor
25468540|NCT01502371|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25468541|NCT01490190|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25468542|NCT01490190|Etonogestrel|etonogestrel|mesh-list
25468543|NCT01490190|NuvaRing|nuvaring|mesh-list
25468544|NCT01490190|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25468545|NCT01490190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25468546|NCT01490190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25329421|NCT04835233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25329422|NCT04835233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329423|NCT04834986|Lenvatinib|lenvatinib|mesh-list
25468548|NCT01490190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25468549|NCT01490190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468550|NCT01490190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25468552|NCT01490190|Hormones|hormones|mesh-ancestor
25468553|NCT01490190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25468554|NCT01473108|Eplerenone|eplerenone|mesh-list
25468555|NCT01473108|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25468556|NCT01473108|Hormone Antagonists|hormone antagonists|mesh-ancestor
25468557|NCT01473108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25468558|NCT01473108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468559|NCT01473108|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25468560|NCT01473108|Diuretics|diuretics|mesh-ancestor
25468561|NCT01473108|Natriuretic Agents|natriuretic agents|mesh-ancestor
25468562|NCT01473108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25468563|NCT01471340|Mometasone Furoate|mometasone furoate|mesh-list
25468565|NCT01471340|Prednisolone|prednisolone|mesh-list
25468566|NCT01471340|Albuterol|albuterol|mesh-list
25468567|NCT01471340|Formoterol Fumarate|formoterol fumarate|mesh-list
25468568|NCT01471340|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
25468569|NCT01471340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25468570|NCT01471340|Glucocorticoids|glucocorticoids|mesh-ancestor
25468571|NCT01471340|Hormones|hormones|mesh-ancestor
25468572|NCT01471340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25468573|NCT01471340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468574|NCT01471340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25468575|NCT01471340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25468576|NCT01471340|Autonomic Agents|autonomic agents|mesh-ancestor
25468577|NCT01471340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25468578|NCT01471340|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25468579|NCT01471340|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25468580|NCT01471340|Respiratory System Agents|respiratory system agents|mesh-ancestor
25468581|NCT01471340|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25468582|NCT01471340|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25468583|NCT01471340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25468584|NCT01471340|Adrenergic Agents|adrenergic agents|mesh-ancestor
25468585|NCT01471340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25468586|NCT01471340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468587|NCT01471340|Tocolytic Agents|tocolytic agents|mesh-ancestor
25468588|NCT01471340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25468589|NCT01471340|Dermatologic Agents|dermatologic agents|mesh-ancestor
25468590|NCT01471340|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25468591|NCT01462370|Acetaminophen|acetaminophen|mesh-list
25468592|NCT01462370|Ibuprofen|ibuprofen|mesh-list
25468593|NCT01462370|Etoricoxib|etoricoxib|mesh-list
25468594|NCT01462370|Caffeine|caffeine|mesh-list
25468595|NCT01462370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25468596|NCT01462370|Analgesics|analgesics|mesh-ancestor
25468597|NCT01462370|Sensory System Agents|sensory system agents|mesh-ancestor
25468598|NCT01462370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25468599|NCT01462370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468600|NCT01462370|Antipyretics|antipyretics|mesh-ancestor
25468601|NCT01462370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25468602|NCT01462370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25468603|NCT01462370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25468604|NCT01462370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25468605|NCT01462370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468606|NCT01462370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723573|NCT02524054|Furosemide|furosemide|mesh-list
25468607|NCT01462370|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25468608|NCT01462370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25468609|NCT01462370|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25468610|NCT01462370|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25468611|NCT01462370|Purinergic Agents|purinergic agents|mesh-ancestor
25468612|NCT01462370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25468613|NCT01462370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25329498|NCT04834440|Anesthetics|anesthetics|mesh-ancestor
25329499|NCT04834440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25329500|NCT04834440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329501|NCT04834440|Sensory System Agents|sensory system agents|mesh-ancestor
25329502|NCT04834440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25468614|NCT01381679|Ezetimibe|ezetimibe|mesh-list
25468615|NCT01381679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25468616|NCT01381679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25468617|NCT01381679|Antimetabolites|antimetabolites|mesh-ancestor
25468618|NCT01381679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468619|NCT01381679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25468620|NCT01379989|Carboplatin|carboplatin|mesh-list
25468621|NCT01379989|Doxorubicin|doxorubicin|mesh-list
25468622|NCT01379989|Trabectedin|trabectedin|mesh-list
25468623|NCT01379989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25468624|NCT01379989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25468625|NCT01379989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25468626|NCT01379989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25468627|NCT01379989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468628|NCT01379989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468629|NCT01379989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25468630|NCT01379989|Alkylating Agents|alkylating agents|mesh-ancestor
25468631|NCT01370603|Atorvastatin|atorvastatin|mesh-list
25468632|NCT01370603|Ezetimibe|ezetimibe|mesh-list
25468633|NCT01370603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25468634|NCT01370603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25468635|NCT01370603|Antimetabolites|antimetabolites|mesh-ancestor
25468636|NCT01370603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468637|NCT01370603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25468638|NCT01370603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25468639|NCT01370603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468640|NCT01370590|Atorvastatin|atorvastatin|mesh-list
25468641|NCT01370590|Ezetimibe|ezetimibe|mesh-list
25468642|NCT01370590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25468643|NCT01370590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25468644|NCT01370590|Antimetabolites|antimetabolites|mesh-ancestor
25468645|NCT01370590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468646|NCT01370590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25468647|NCT01370590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25468648|NCT01370590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468649|NCT01349907|Asenapine|asenapine|mesh-list
25468650|NCT01349907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25468651|NCT01349907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25468652|NCT01349907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25468653|NCT01349907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468654|NCT01349907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25468655|NCT01345656|Spironolactone|spironolactone|mesh-list
25468656|NCT01345656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25468657|NCT01345656|Hormone Antagonists|hormone antagonists|mesh-ancestor
25340361|NCT02946788|Minocycline|minocycline|mesh-list
25468658|NCT01345656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25468659|NCT01345656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468660|NCT01345656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25468661|NCT01345656|Diuretics|diuretics|mesh-ancestor
25468662|NCT01345656|Natriuretic Agents|natriuretic agents|mesh-ancestor
25468663|NCT01277822|Losartan|losartan|mesh-list
25468664|NCT01277822|Amlodipine|amlodipine|mesh-list
25468665|NCT01277822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25468666|NCT01277822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25468667|NCT01277822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25468668|NCT01277822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468669|NCT01277822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25468670|NCT01277822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468671|NCT01277822|Vasodilator Agents|vasodilator agents|mesh-ancestor
25468672|NCT01277822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25468673|NCT01277822|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25468674|NCT01277822|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25329579|NCT04834115|Ivermectin|ivermectin|mesh-list
25329580|NCT04834115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25329581|NCT04834115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25329582|NCT04834349|Pembrolizumab|pembrolizumab|mesh-list
25329583|NCT04834349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25329584|NCT04834349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329585|NCT04833608|Carbon Fiber|carbon fiber|mesh-list
25329586|NCT04833608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25329587|NCT04833608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25329588|NCT04833738|Triamcinolone|triamcinolone|mesh-list
25329589|NCT04833738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25329590|NCT04833738|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25329591|NCT04833738|Hyaluronic Acid|hyaluronic acid|mesh-list
25468675|NCT01273259|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25468676|NCT01273259|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25468677|NCT01273259|Immunologic Factors|immunologic factors|mesh-ancestor
25468678|NCT01273259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468680|NCT01208207|Etoricoxib|etoricoxib|mesh-list
25468681|NCT01208207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25468682|NCT01208207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25468683|NCT01208207|Analgesics|analgesics|mesh-ancestor
25468684|NCT01208207|Sensory System Agents|sensory system agents|mesh-ancestor
25468685|NCT01208207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25468686|NCT01208207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468687|NCT01208207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25468688|NCT01208207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25468689|NCT01208207|Gout Suppressants|gout suppressants|mesh-ancestor
25644691|NCT01439282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25644692|NCT01439282|Antimetabolites|antimetabolites|mesh-ancestor
25644693|NCT01439282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468690|NCT01208207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25468691|NCT01208207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468692|NCT01208207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468693|NCT01208207|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25468694|NCT01208181|Etoricoxib|etoricoxib|mesh-list
25468695|NCT01208181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25468696|NCT01208181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25468697|NCT01208181|Analgesics|analgesics|mesh-ancestor
25468698|NCT01208181|Sensory System Agents|sensory system agents|mesh-ancestor
25468699|NCT01208181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25468700|NCT01208181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468701|NCT01208181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25468702|NCT01208181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25468703|NCT01208181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25468704|NCT01208181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25468705|NCT01208181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468706|NCT01208181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468707|NCT01206517|Asenapine|asenapine|mesh-list
25468708|NCT01206517|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25468709|NCT01206517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25468710|NCT01206517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25468711|NCT01206517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468712|NCT01206517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25468713|NCT01190267|Asenapine|asenapine|mesh-list
25468714|NCT01190267|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25468715|NCT01190267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25468716|NCT01190267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25468717|NCT01190267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468718|NCT01190267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25468719|NCT01190254|Asenapine|asenapine|mesh-list
25468720|NCT01190254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25468721|NCT01190254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25468722|NCT01190254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25468723|NCT01190254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468724|NCT01190254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25468725|NCT01154036|Atorvastatin|atorvastatin|mesh-list
25468726|NCT01154036|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25468727|NCT01154036|Ezetimibe|ezetimibe|mesh-list
25468728|NCT01154036|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25468729|NCT01154036|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25468730|NCT01154036|Antimetabolites|antimetabolites|mesh-ancestor
25468731|NCT01154036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468732|NCT01154036|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25468733|NCT01154036|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25468734|NCT01154036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468735|NCT01101464|Asenapine|asenapine|mesh-list
25468736|NCT01101464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25468737|NCT01101464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25468738|NCT01101464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25468739|NCT01101464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329656|NCT04833387|Antibodies|antibodies|mesh-list
25329657|NCT04833387|Immunologic Factors|immunologic factors|mesh-ancestor
25329658|NCT04833387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329659|NCT04833374|Prednisone|prednisone|mesh-list
25329660|NCT04833374|Methylprednisolone|methylprednisolone|mesh-list
25329661|NCT04833374|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25329662|NCT04833374|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25329663|NCT04833374|Prednisolone|prednisolone|mesh-list
25329664|NCT04833374|Prednisolone acetate|prednisolone acetate|mesh-list
25329665|NCT04833374|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25468740|NCT01101464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25468741|NCT01098071|Mometasone Furoate|mometasone furoate|mesh-list
25468742|NCT01098071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25468743|NCT01098071|Dermatologic Agents|dermatologic agents|mesh-ancestor
25468744|NCT01098071|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25468745|NCT01030341|Insulin|insulin|mesh-list
25468746|NCT01030341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25468747|NCT01030341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25468748|NCT01030341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468749|NCT00979901|Loratadine|loratadine|mesh-list
25468750|NCT00979901|Montelukast|montelukast|mesh-list
25468751|NCT00979901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25468752|NCT00979901|Respiratory System Agents|respiratory system agents|mesh-ancestor
25644694|NCT01439282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25644695|NCT01439360|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25644696|NCT01439360|Immunologic Factors|immunologic factors|mesh-ancestor
25644697|NCT01439360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644698|NCT01439373|Interferons|interferons|mesh-list
25644699|NCT01439373|Ribavirin|ribavirin|mesh-list
25644700|NCT01439373|Interferon-alpha|interferon-alpha|mesh-list
25468753|NCT00979901|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25468754|NCT00979901|Hormone Antagonists|hormone antagonists|mesh-ancestor
25468755|NCT00979901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25468756|NCT00979901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468757|NCT00979901|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25468758|NCT00979901|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25468759|NCT00979901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468760|NCT00979901|Antipruritics|antipruritics|mesh-ancestor
25468761|NCT00979901|Dermatologic Agents|dermatologic agents|mesh-ancestor
25468762|NCT00979901|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25468763|NCT00979901|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25468764|NCT00979901|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25468765|NCT00979901|Histamine Antagonists|histamine antagonists|mesh-ancestor
25468766|NCT00979901|Histamine Agents|histamine agents|mesh-ancestor
25468767|NCT00979901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25468768|NCT00963599|Loratadine|loratadine|mesh-list
25468769|NCT00963599|Montelukast|montelukast|mesh-list
25468770|NCT00963599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25468771|NCT00963599|Respiratory System Agents|respiratory system agents|mesh-ancestor
25468772|NCT00963599|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25468773|NCT00963599|Hormone Antagonists|hormone antagonists|mesh-ancestor
25468774|NCT00963599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25468775|NCT00963599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468776|NCT00963599|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25468777|NCT00963599|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25468778|NCT00963599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468779|NCT00963599|Antipruritics|antipruritics|mesh-ancestor
25468780|NCT00963599|Dermatologic Agents|dermatologic agents|mesh-ancestor
25468781|NCT00963599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25468782|NCT00963599|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25468783|NCT00963599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25468784|NCT00963599|Histamine Antagonists|histamine antagonists|mesh-ancestor
25468785|NCT00963599|Histamine Agents|histamine agents|mesh-ancestor
25468786|NCT00963599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25468787|NCT00953680|Losartan|losartan|mesh-list
25468788|NCT00953680|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25468789|NCT00953680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25468790|NCT00953680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25468791|NCT00953680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25468792|NCT00953680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25468793|NCT00953680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329722|NCT04832945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25329723|NCT04832945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25329724|NCT04832776|Bevacizumab|bevacizumab|mesh-list
25329725|NCT04832776|Cetuximab|cetuximab|mesh-list
25329726|NCT04832776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25329727|NCT04832776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329728|NCT04832776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25329729|NCT04832776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25329730|NCT04832776|Growth Substances|growth substances|mesh-ancestor
25329731|NCT04832776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329732|NCT04832776|Growth Inhibitors|growth inhibitors|mesh-ancestor
25329733|NCT04832399|Natalizumab|natalizumab|mesh-list
25329734|NCT04832399|Immunologic Factors|immunologic factors|mesh-ancestor
25329735|NCT04832399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329756|NCT04832035|Psychotropic Drugs|psychotropic drugs|mesh-list
25329778|NCT04832204|Apatinib|apatinib|mesh-list
25329779|NCT04832204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329780|NCT04832204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25329781|NCT04832204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25329783|NCT04831541|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25468794|NCT00953680|Diuretics|diuretics|mesh-ancestor
25468795|NCT00953680|Natriuretic Agents|natriuretic agents|mesh-ancestor
25468796|NCT00953680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468797|NCT00953680|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25468798|NCT00953680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25468799|NCT00945035|Etoricoxib|etoricoxib|mesh-list
25644701|NCT01439373|Interferon alpha-2|interferon alpha-2|mesh-list
25644702|NCT01439373|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25468800|NCT00945035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25468801|NCT00945035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25468803|NCT00945035|Sensory System Agents|sensory system agents|mesh-ancestor
25468804|NCT00945035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25468805|NCT00945035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468806|NCT00945035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25468807|NCT00945035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25468808|NCT00945035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25468809|NCT00945035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25468810|NCT00945035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468811|NCT00945035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468812|NCT00943852|Losartan|losartan|mesh-list
25468813|NCT00943852|Isosorbide|isosorbide|mesh-list
25468814|NCT00943852|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25468815|NCT00943852|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25468816|NCT00943852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25468817|NCT00943852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25468818|NCT00943852|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25468819|NCT00943852|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25468820|NCT00943852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468821|NCT00943852|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25468822|NCT00943852|Diuretics|diuretics|mesh-ancestor
25468823|NCT00943852|Natriuretic Agents|natriuretic agents|mesh-ancestor
25468824|NCT00943852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468825|NCT00943852|Vasodilator Agents|vasodilator agents|mesh-ancestor
25468826|NCT00943852|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25468827|NCT00909389|Simvastatin|simvastatin|mesh-list
25468828|NCT00909389|Ezetimibe|ezetimibe|mesh-list
25468829|NCT00909389|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
25468830|NCT00909389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25468831|NCT00909389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25468832|NCT00909389|Antimetabolites|antimetabolites|mesh-ancestor
25468833|NCT00909389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468834|NCT00909389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25468835|NCT00909389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25468836|NCT00909389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468837|NCT00820027|Ibuprofen|ibuprofen|mesh-list
25468838|NCT00820027|Etoricoxib|etoricoxib|mesh-list
25468839|NCT00820027|Morphine|morphine|mesh-list
25468840|NCT00820027|Oxycodone|oxycodone|mesh-list
25468841|NCT00820027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25468842|NCT00820027|Narcotics|narcotics|mesh-ancestor
25468843|NCT00820027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25468844|NCT00820027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468845|NCT00820027|Analgesics|analgesics|mesh-ancestor
25468846|NCT00820027|Sensory System Agents|sensory system agents|mesh-ancestor
25468847|NCT00820027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25468848|NCT00820027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25468849|NCT00820027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25468850|NCT00820027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25468851|NCT00820027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25468852|NCT00820027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25468853|NCT00820027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468854|NCT00820027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468855|NCT00820027|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25468856|NCT00788710|Etoricoxib|etoricoxib|mesh-list
25468857|NCT00788710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25329798|NCT04831528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25329799|NCT04831528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25329800|NCT04831528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762340|NCT01767623|Vemurafenib|vemurafenib|mesh-list
25329811|NCT04831255|Triamcinolone|triamcinolone|mesh-list
25329812|NCT04831255|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25329813|NCT04831255|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25329814|NCT04831255|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25329815|NCT04831255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25329816|NCT04831255|Glucocorticoids|glucocorticoids|mesh-ancestor
25329817|NCT04831255|Hormones|hormones|mesh-ancestor
25468858|NCT00788710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25468860|NCT00788710|Sensory System Agents|sensory system agents|mesh-ancestor
24496676|NCT00506051|Pemetrexed|pemetrexed|mesh-list
25644703|NCT01439373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25644704|NCT01439373|Antiviral Agents|antiviral agents|mesh-ancestor
25644705|NCT01439373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25644706|NCT01439373|Antimetabolites|antimetabolites|mesh-ancestor
25644707|NCT01439373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644708|NCT01439373|Immunologic Factors|immunologic factors|mesh-ancestor
25644709|NCT01439373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468861|NCT00788710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25468862|NCT00788710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468863|NCT00788710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25468864|NCT00788710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25468865|NCT00788710|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25468866|NCT00788710|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25468867|NCT00788710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468868|NCT00788710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468869|NCT00783224|Fluticasone|fluticasone|mesh-list
25468870|NCT00783224|Mometasone Furoate|mometasone furoate|mesh-list
25468871|NCT00783224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25468872|NCT00783224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25468873|NCT00783224|Autonomic Agents|autonomic agents|mesh-ancestor
25468874|NCT00783224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25468875|NCT00783224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468876|NCT00783224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25468877|NCT00783224|Respiratory System Agents|respiratory system agents|mesh-ancestor
25468878|NCT00783224|Dermatologic Agents|dermatologic agents|mesh-ancestor
25468879|NCT00783224|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25468880|NCT00780403|Cetirizine|cetirizine|mesh-list
25468881|NCT00780403|Desloratadine|desloratadine|mesh-list
25468882|NCT00780403|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25468883|NCT00780403|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25468884|NCT00780403|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25468885|NCT00780403|Histamine Antagonists|histamine antagonists|mesh-ancestor
25468886|NCT00780403|Histamine Agents|histamine agents|mesh-ancestor
25468887|NCT00780403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25468888|NCT00780403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468889|NCT00780403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468890|NCT00780403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25468891|NCT00780403|Cholinergic Agents|cholinergic agents|mesh-ancestor
25468892|NCT00779116|Cetirizine|cetirizine|mesh-list
25468893|NCT00779116|Desloratadine|desloratadine|mesh-list
25468894|NCT00779116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25468895|NCT00779116|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25468896|NCT00779116|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25468897|NCT00779116|Histamine Antagonists|histamine antagonists|mesh-ancestor
25468898|NCT00779116|Histamine Agents|histamine agents|mesh-ancestor
25468899|NCT00779116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25340759|NCT02494882|Dexamethasone|dexamethasone|mesh-list
25468900|NCT00779116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468901|NCT00779116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468902|NCT00779116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25468903|NCT00779116|Cholinergic Agents|cholinergic agents|mesh-ancestor
25468904|NCT00764478|Asenapine|asenapine|mesh-list
25468905|NCT00764478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25468906|NCT00764478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25468907|NCT00764478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25468908|NCT00764478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468909|NCT00764478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25468910|NCT00761527|Desloratadine|desloratadine|mesh-list
25468911|NCT00761527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25468912|NCT00761527|Cholinergic Agents|cholinergic agents|mesh-ancestor
25468913|NCT00761527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25329889|NCT04831099|Testosterone|testosterone|mesh-list
25329890|NCT04831099|Androgens|androgens|mesh-ancestor
25329891|NCT04831099|Hormones|hormones|mesh-ancestor
25329892|NCT04831099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25329893|NCT04831099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329894|NCT04831229|Menthol|menthol|mesh-list
25329895|NCT04831229|Antipruritics|antipruritics|mesh-ancestor
25329896|NCT04831229|Dermatologic Agents|dermatologic agents|mesh-ancestor
25329897|NCT04830358|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25329898|NCT04830358|Immunologic Factors|immunologic factors|mesh-ancestor
25329899|NCT04830358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329900|NCT04830241|Antidepressive Agents|antidepressive agents|mesh-list
25329901|NCT04830241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25329903|NCT04830410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329904|NCT04829916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25329906|NCT04829773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25329907|NCT04829773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25468914|NCT00761527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468915|NCT00761527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468916|NCT00761527|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25468917|NCT00761527|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25468918|NCT00761527|Histamine Antagonists|histamine antagonists|mesh-ancestor
25468920|NCT00757627|Etoricoxib|etoricoxib|mesh-list
25468921|NCT00757627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25468922|NCT00757627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25468923|NCT00757627|Analgesics|analgesics|mesh-ancestor
25468924|NCT00757627|Sensory System Agents|sensory system agents|mesh-ancestor
25468925|NCT00757627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25468926|NCT00757627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468927|NCT00757627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25468928|NCT00757627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25468929|NCT00757627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25468930|NCT00757627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25468931|NCT00757627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468932|NCT00757627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468933|NCT00756938|Losartan|losartan|mesh-list
25468934|NCT00756938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25468935|NCT00756938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25468936|NCT00756938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25468937|NCT00756938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25468938|NCT00756938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468939|NCT00730132|Ezetimibe|ezetimibe|mesh-list
25468940|NCT00730132|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25468941|NCT00730132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25468942|NCT00730132|Antimetabolites|antimetabolites|mesh-ancestor
25468943|NCT00730132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468944|NCT00730132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25468945|NCT00728416|Mometasone Furoate|mometasone furoate|mesh-list
25468946|NCT00728416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25468947|NCT00728416|Dermatologic Agents|dermatologic agents|mesh-ancestor
25468948|NCT00728416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25468949|NCT00723736|Desloratadine|desloratadine|mesh-list
25468950|NCT00723736|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25468951|NCT00723736|Cholinergic Agents|cholinergic agents|mesh-ancestor
25468952|NCT00723736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25468953|NCT00723736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468954|NCT00723736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468955|NCT00723736|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25468956|NCT00723736|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25468957|NCT00723736|Histamine Antagonists|histamine antagonists|mesh-ancestor
25468958|NCT00723736|Histamine Agents|histamine agents|mesh-ancestor
25468959|NCT00705081|Ezetimibe|ezetimibe|mesh-list
25468960|NCT00705081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25468961|NCT00705081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25468962|NCT00705081|Antimetabolites|antimetabolites|mesh-ancestor
25468963|NCT00705081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468964|NCT00705081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25468965|NCT00704769|Desloratadine|desloratadine|mesh-list
25468966|NCT00704769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25468967|NCT00704769|Cholinergic Agents|cholinergic agents|mesh-ancestor
25468968|NCT00704769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25468969|NCT00704769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468970|NCT00704769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468971|NCT00704769|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25468972|NCT00704769|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25468973|NCT00704769|Histamine Antagonists|histamine antagonists|mesh-ancestor
25468974|NCT00704769|Histamine Agents|histamine agents|mesh-ancestor
25468975|NCT00704535|Ezetimibe|ezetimibe|mesh-list
25468976|NCT00704535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25468977|NCT00704535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25468978|NCT00704535|Antimetabolites|antimetabolites|mesh-ancestor
25468979|NCT00704535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468980|NCT00704535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25468981|NCT00694369|Acetaminophen|acetaminophen|mesh-list
25468982|NCT00694369|Ibuprofen|ibuprofen|mesh-list
25468983|NCT00694369|Etoricoxib|etoricoxib|mesh-list
25468984|NCT00694369|Codeine|codeine|mesh-list
25644710|NCT01439555|Simvastatin|simvastatin|mesh-list
25468985|NCT00694369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25468986|NCT00694369|Analgesics|analgesics|mesh-ancestor
25329968|NCT04828824|Estradiol|estradiol|mesh-list
25468987|NCT00694369|Sensory System Agents|sensory system agents|mesh-ancestor
25468988|NCT00694369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25468989|NCT00694369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25468990|NCT00694369|Antipyretics|antipyretics|mesh-ancestor
25468991|NCT00694369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25468992|NCT00694369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25468993|NCT00694369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25468994|NCT00694369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25468995|NCT00694369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25468996|NCT00694369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25468997|NCT00694369|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25468998|NCT00694369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25468999|NCT00694369|Narcotics|narcotics|mesh-ancestor
25469000|NCT00694369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25469001|NCT00694369|Antitussive Agents|antitussive agents|mesh-ancestor
25469002|NCT00694369|Respiratory System Agents|respiratory system agents|mesh-ancestor
25469003|NCT00671528|Gentamicins|gentamicins|mesh-list
25469004|NCT00671528|Clotrimazole|clotrimazole|mesh-list
25469005|NCT00671528|Miconazole|miconazole|mesh-list
25469006|NCT00671528|Betamethasone|betamethasone|mesh-list
25469007|NCT00671528|Betamethasone Valerate|betamethasone valerate|mesh-list
25469008|NCT00671528|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25469009|NCT00671528|Betamethasone benzoate|betamethasone benzoate|mesh-list
25469010|NCT00671528|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25469011|NCT00671528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25469012|NCT00671528|Glucocorticoids|glucocorticoids|mesh-ancestor
25469013|NCT00671528|Hormones|hormones|mesh-ancestor
25469014|NCT00671528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25469015|NCT00671528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469016|NCT00671528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25469017|NCT00671528|Respiratory System Agents|respiratory system agents|mesh-ancestor
25469018|NCT00671528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25469019|NCT00671528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25469020|NCT00671528|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25469021|NCT00671528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25469022|NCT00671528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469023|NCT00671528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25469024|NCT00671528|Antifungal Agents|antifungal agents|mesh-ancestor
25469025|NCT00671528|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25469026|NCT00671528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25469027|NCT00671528|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25469028|NCT00671528|Hormone Antagonists|hormone antagonists|mesh-ancestor
25469029|NCT00671528|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25469030|NCT00671528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25469031|NCT00667823|Macitentan|macitentan|mesh-list
25469032|NCT00667823|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25469033|NCT00667823|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25469034|NCT00667823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469035|NCT00667823|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25469036|NCT00652327|Atorvastatin|atorvastatin|mesh-list
25469037|NCT00652327|Simvastatin|simvastatin|mesh-list
25469038|NCT00652327|Ezetimibe|ezetimibe|mesh-list
25469039|NCT00652327|Pravastatin|pravastatin|mesh-list
25469040|NCT00652327|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
25469041|NCT00652327|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25469042|NCT00652327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25469043|NCT00652327|Antimetabolites|antimetabolites|mesh-ancestor
25469044|NCT00652327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469045|NCT00652327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25469046|NCT00652327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25469047|NCT00604500|Mometasone Furoate|mometasone furoate|mesh-list
25469048|NCT00604500|Formoterol Fumarate|formoterol fumarate|mesh-list
25469049|NCT00604500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25469050|NCT00604500|Autonomic Agents|autonomic agents|mesh-ancestor
25469051|NCT00604500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25469052|NCT00604500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469053|NCT00604500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25469054|NCT00604500|Respiratory System Agents|respiratory system agents|mesh-ancestor
25469055|NCT00604500|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25469056|NCT00604500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25469057|NCT00604500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25469058|NCT00604500|Adrenergic Agents|adrenergic agents|mesh-ancestor
25469059|NCT00604500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25469060|NCT00604500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469061|NCT00604500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25469062|NCT00604500|Dermatologic Agents|dermatologic agents|mesh-ancestor
25469063|NCT00604500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25469065|NCT00568178|Amlodipine|amlodipine|mesh-list
25469066|NCT00568178|Enalapril|enalapril|mesh-list
25469067|NCT00568178|Enalaprilat|enalaprilat|mesh-list
25469068|NCT00568178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25469069|NCT00568178|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25469070|NCT00568178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25469071|NCT00568178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469072|NCT00568178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25469073|NCT00568178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469074|NCT00568178|Vasodilator Agents|vasodilator agents|mesh-ancestor
25469075|NCT00568178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25469076|NCT00568178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25469077|NCT00568178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25469078|NCT00568178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25469079|NCT00568178|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25469080|NCT00568178|Protease Inhibitors|protease inhibitors|mesh-ancestor
25469081|NCT00545844|Montelukast|montelukast|mesh-list
25469082|NCT00545844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25469083|NCT00545844|Respiratory System Agents|respiratory system agents|mesh-ancestor
25469084|NCT00545844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25469085|NCT00545844|Hormone Antagonists|hormone antagonists|mesh-ancestor
25469086|NCT00545844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25469087|NCT00545844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469088|NCT00545844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25469089|NCT00545844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25469090|NCT00545844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469091|NCT00511355|Levonorgestrel|levonorgestrel|mesh-list
25469092|NCT00511355|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25469093|NCT00511355|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25469094|NCT00511355|Estradiol|estradiol|mesh-list
25469095|NCT00511355|Estrogens|estrogens|mesh-ancestor
25469096|NCT00511355|Hormones|hormones|mesh-ancestor
25469097|NCT00511355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25469098|NCT00511355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469099|NCT00511355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25469100|NCT00511355|Contraceptive Agents|contraceptive agents|mesh-ancestor
25469101|NCT00511355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25341057|NCT02153229|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
25469102|NCT00511355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25469103|NCT00511355|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25469104|NCT00511355|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25469105|NCT00511355|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25469106|NCT00511355|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25469107|NCT00491504|Mometasone Furoate|mometasone furoate|mesh-list
25469108|NCT00491504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25469109|NCT00491504|Dermatologic Agents|dermatologic agents|mesh-ancestor
25469110|NCT00491504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25469111|NCT00468312|Mometasone Furoate|mometasone furoate|mesh-list
25469112|NCT00468312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25469113|NCT00468312|Dermatologic Agents|dermatologic agents|mesh-ancestor
25469114|NCT00468312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25469115|NCT00453063|Mometasone Furoate|mometasone furoate|mesh-list
25469116|NCT00453063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25469117|NCT00453063|Dermatologic Agents|dermatologic agents|mesh-ancestor
25330095|NCT04827784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25330110|NCT04827134|Triumeq|triumeq|mesh-list
25330111|NCT04827134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25330112|NCT04827134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25330113|NCT04827134|Antiviral Agents|antiviral agents|mesh-ancestor
25330114|NCT04827134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25330129|NCT04826822|Dexamethasone|dexamethasone|mesh-list
25330130|NCT04826822|Spironolactone|spironolactone|mesh-list
25330131|NCT04826822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25330132|NCT04826822|Antiemetics|antiemetics|mesh-ancestor
25330133|NCT04826822|Autonomic Agents|autonomic agents|mesh-ancestor
25330134|NCT04826822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25330135|NCT04826822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644711|NCT01439555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25644712|NCT01439555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25330136|NCT04826822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25330137|NCT04826822|Glucocorticoids|glucocorticoids|mesh-ancestor
25330138|NCT04826822|Hormones|hormones|mesh-ancestor
25469118|NCT00453063|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25469120|NCT00447603|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25469121|NCT00447603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25469122|NCT00447603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25469123|NCT00447603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25469124|NCT00447603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25469125|NCT00447603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469126|NCT00447603|Diuretics|diuretics|mesh-ancestor
25469127|NCT00447603|Natriuretic Agents|natriuretic agents|mesh-ancestor
25469128|NCT00447603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469129|NCT00447603|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25469130|NCT00447603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25469131|NCT00442351|Mometasone Furoate|mometasone furoate|mesh-list
25469132|NCT00442351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25469133|NCT00442351|Dermatologic Agents|dermatologic agents|mesh-ancestor
25469134|NCT00442351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25469135|NCT00423488|Simvastatin|simvastatin|mesh-list
25469136|NCT00423488|Ezetimibe|ezetimibe|mesh-list
25469137|NCT00423488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25469138|NCT00423488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25469139|NCT00423488|Antimetabolites|antimetabolites|mesh-ancestor
25469140|NCT00423488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469141|NCT00423488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25469142|NCT00423488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25469143|NCT00423488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25469144|NCT00413972|Simvastatin|simvastatin|mesh-list
25469145|NCT00413972|Ezetimibe|ezetimibe|mesh-list
25469146|NCT00413972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25469147|NCT00413972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25469148|NCT00413972|Antimetabolites|antimetabolites|mesh-ancestor
25469149|NCT00413972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469150|NCT00413972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25469151|NCT00413972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25469152|NCT00413972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25469153|NCT00391170|Dexamethasone|dexamethasone|mesh-list
25469154|NCT00391170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25469155|NCT00391170|Antiemetics|antiemetics|mesh-ancestor
25469156|NCT00391170|Autonomic Agents|autonomic agents|mesh-ancestor
25469157|NCT00391170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25469158|NCT00391170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469159|NCT00391170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25469160|NCT00391170|Glucocorticoids|glucocorticoids|mesh-ancestor
25469161|NCT00391170|Hormones|hormones|mesh-ancestor
25469162|NCT00391170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25469163|NCT00391170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25469164|NCT00391170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469165|NCT00359138|Cetirizine|cetirizine|mesh-list
25469166|NCT00359138|Loratadine|loratadine|mesh-list
25469167|NCT00359138|Levocetirizine|levocetirizine|mesh-list
25469168|NCT00359138|Desloratadine|desloratadine|mesh-list
25469169|NCT00359138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25469170|NCT00359138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25469171|NCT00359138|Histamine Antagonists|histamine antagonists|mesh-ancestor
25469172|NCT00359138|Histamine Agents|histamine agents|mesh-ancestor
25469173|NCT00359138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25469174|NCT00359138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469175|NCT00359138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469176|NCT00359138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25469177|NCT00359138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25469178|NCT00359138|Cholinergic Agents|cholinergic agents|mesh-ancestor
25469179|NCT00359138|Antipruritics|antipruritics|mesh-ancestor
25469180|NCT00359138|Dermatologic Agents|dermatologic agents|mesh-ancestor
25469181|NCT00350701|Methyltestosterone|methyltestosterone|mesh-list
25469182|NCT00350701|Testosterone|testosterone|mesh-list
25469183|NCT00350701|Testosterone undecanoate|testosterone undecanoate|mesh-list
25469184|NCT00350701|Testosterone enanthate|testosterone enanthate|mesh-list
25469185|NCT00350701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25469186|NCT00350701|Androgens|androgens|mesh-ancestor
25469187|NCT00350701|Hormones|hormones|mesh-ancestor
25469188|NCT00350701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25469189|NCT00350701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644713|NCT01439555|Antimetabolites|antimetabolites|mesh-ancestor
25644714|NCT01439555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644715|NCT01439555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25469190|NCT00350701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25469191|NCT00350701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330170|NCT04826198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469192|NCT00350701|Anabolic Agents|anabolic agents|mesh-ancestor
25469193|NCT00335816|Leucovorin|leucovorin|mesh-list
25469194|NCT00335816|Fluorouracil|fluorouracil|mesh-list
25469195|NCT00335816|Oxaliplatin|oxaliplatin|mesh-list
25469196|NCT00335816|Calcium|calcium|mesh-list
25469197|NCT00335816|Levoleucovorin|levoleucovorin|mesh-list
25469198|NCT00335816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25469199|NCT00335816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469200|NCT00335816|Antimetabolites|antimetabolites|mesh-ancestor
25469201|NCT00335816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469202|NCT00335816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25469203|NCT00335816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469204|NCT00335816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25469205|NCT00335816|Immunologic Factors|immunologic factors|mesh-ancestor
25469206|NCT00335816|Antidotes|antidotes|mesh-ancestor
25469207|NCT00335816|Protective Agents|protective agents|mesh-ancestor
25469208|NCT00335816|Vitamin B Complex|vitamin b complex|mesh-ancestor
25469209|NCT00335816|Vitamins|vitamins|mesh-ancestor
25469210|NCT00335816|Micronutrients|micronutrients|mesh-ancestor
25469211|NCT00319449|Atorvastatin|atorvastatin|mesh-list
25469212|NCT00319449|Ezetimibe|ezetimibe|mesh-list
25469213|NCT00319449|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25469214|NCT00319449|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25469215|NCT00319449|Antimetabolites|antimetabolites|mesh-ancestor
25469216|NCT00319449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469217|NCT00319449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25469218|NCT00319449|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25469219|NCT00319449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25469220|NCT00305344|Vaccines|vaccines|mesh-list
25469221|NCT00305344|Immunologic Factors|immunologic factors|mesh-ancestor
25469222|NCT00305344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469223|NCT00289887|Losartan|losartan|mesh-list
25469224|NCT00289887|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25469225|NCT00289887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25469226|NCT00289887|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25469227|NCT00289887|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25469228|NCT00289887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469229|NCT00281320|Asenapine|asenapine|mesh-list
25469230|NCT00281320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25469231|NCT00281320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25469232|NCT00281320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25469233|NCT00281320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469234|NCT00281320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25469235|NCT00276016|Phenylephrine|phenylephrine|mesh-list
25469236|NCT00276016|Oxymetazoline|oxymetazoline|mesh-list
25469237|NCT00276016|Pseudoephedrine|pseudoephedrine|mesh-list
25469238|NCT00276016|Ephedrine|ephedrine|mesh-list
25469239|NCT00276016|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25469240|NCT00276016|Mydriatics|mydriatics|mesh-ancestor
25469241|NCT00276016|Autonomic Agents|autonomic agents|mesh-ancestor
25469242|NCT00276016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25469243|NCT00276016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469244|NCT00276016|Sympathomimetics|sympathomimetics|mesh-ancestor
25469245|NCT00276016|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25469246|NCT00276016|Nasal Decongestants|nasal decongestants|mesh-ancestor
25469247|NCT00276016|Respiratory System Agents|respiratory system agents|mesh-ancestor
25469248|NCT00276016|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25469249|NCT00276016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25469250|NCT00276016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25469251|NCT00276016|Adrenergic Agents|adrenergic agents|mesh-ancestor
25469252|NCT00276016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25469253|NCT00276016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469254|NCT00276016|Protective Agents|protective agents|mesh-ancestor
25469255|NCT00276016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25469256|NCT00276016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25469257|NCT00276016|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25469258|NCT00265343|Olanzapine|olanzapine|mesh-list
25469259|NCT00265343|Asenapine|asenapine|mesh-list
25469260|NCT00265343|Antiemetics|antiemetics|mesh-ancestor
25469261|NCT00265343|Autonomic Agents|autonomic agents|mesh-ancestor
25469262|NCT00265343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25330242|NCT04824586|Insulin|insulin|mesh-list
25330243|NCT04824586|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25330244|NCT04824586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25469263|NCT00265343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469264|NCT00265343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25469265|NCT00265343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25469266|NCT00265343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25469267|NCT00265343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25469268|NCT00265343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25469269|NCT00265343|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25469270|NCT00265343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25469271|NCT00265343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25469272|NCT00265343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469273|NCT00265343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25469274|NCT00265343|Serotonin Agents|serotonin agents|mesh-ancestor
25469275|NCT00264147|Diclofenac|diclofenac|mesh-list
25469276|NCT00264147|Etoricoxib|etoricoxib|mesh-list
25469277|NCT00264147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25469278|NCT00264147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25469279|NCT00264147|Analgesics|analgesics|mesh-ancestor
25469280|NCT00264147|Sensory System Agents|sensory system agents|mesh-ancestor
25469281|NCT00264147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25469282|NCT00264147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469283|NCT00264147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25469284|NCT00264147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25469285|NCT00264147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25469286|NCT00264147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25469287|NCT00264147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469288|NCT00264147|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25469289|NCT00202878|Simvastatin|simvastatin|mesh-list
25469290|NCT00202878|Ezetimibe|ezetimibe|mesh-list
25469291|NCT00202878|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
25469292|NCT00202878|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25469293|NCT00202878|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25469294|NCT00202878|Antimetabolites|antimetabolites|mesh-ancestor
25469295|NCT00202878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469296|NCT00202878|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25469297|NCT00202878|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25469298|NCT00202878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25469299|NCT00174265|Olanzapine|olanzapine|mesh-list
25469300|NCT00174265|Asenapine|asenapine|mesh-list
25469301|NCT00174265|Antiemetics|antiemetics|mesh-ancestor
25469302|NCT00174265|Autonomic Agents|autonomic agents|mesh-ancestor
25469303|NCT00174265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25469304|NCT00174265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469305|NCT00174265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25469306|NCT00174265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25469307|NCT00174265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25469308|NCT00174265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25469309|NCT00174265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25469310|NCT00174265|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25469311|NCT00174265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25469312|NCT00174265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25469313|NCT00174265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469314|NCT00174265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25469315|NCT00174265|Serotonin Agents|serotonin agents|mesh-ancestor
25469316|NCT00159783|Olanzapine|olanzapine|mesh-list
25469317|NCT00159783|Asenapine|asenapine|mesh-list
25469318|NCT00159783|Antiemetics|antiemetics|mesh-ancestor
25469319|NCT00159783|Autonomic Agents|autonomic agents|mesh-ancestor
25469320|NCT00159783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25469321|NCT00159783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469322|NCT00159783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25469323|NCT00159783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25469324|NCT00159783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25469325|NCT00159783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25469326|NCT00159783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25469327|NCT00159783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25469328|NCT00159783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25469329|NCT00159783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25469330|NCT00159783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966254|NCT03770013|Bupivacaine|bupivacaine|mesh-list
25330323|NCT04823390|Fentanyl|fentanyl|mesh-list
25330324|NCT04823390|Midazolam|midazolam|mesh-list
25330325|NCT04823390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25330326|NCT04823390|Narcotics|narcotics|mesh-ancestor
25644716|NCT01439555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25644717|NCT01439555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330327|NCT04823390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25330328|NCT04823390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330329|NCT04823390|Analgesics|analgesics|mesh-ancestor
25330330|NCT04823390|Sensory System Agents|sensory system agents|mesh-ancestor
25330335|NCT04823390|Anesthetics|anesthetics|mesh-ancestor
25469331|NCT00159783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25469332|NCT00159783|Serotonin Agents|serotonin agents|mesh-ancestor
25469333|NCT00092677|Simvastatin|simvastatin|mesh-list
25469334|NCT00092677|Ezetimibe|ezetimibe|mesh-list
25469335|NCT00092677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25469336|NCT00092677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25469337|NCT00092677|Antimetabolites|antimetabolites|mesh-ancestor
25469338|NCT00092677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469339|NCT00092677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25469340|NCT00092677|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25469341|NCT00092677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25469342|NCT00090259|Losartan|losartan|mesh-list
25469343|NCT00090259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25469344|NCT00090259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25469345|NCT00090259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25469346|NCT00090259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25469347|NCT00090259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469348|NCT00003298|Leucovorin|leucovorin|mesh-list
25469349|NCT00003298|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
25469350|NCT00003298|Tetrahydrofolates|tetrahydrofolates|mesh-list
25469351|NCT00003298|Paclitaxel|paclitaxel|mesh-list
25469352|NCT00003298|Cisplatin|cisplatin|mesh-list
25469353|NCT00003298|Fluorouracil|fluorouracil|mesh-list
25469354|NCT00003298|Calcium|calcium|mesh-list
25469355|NCT00003298|Levoleucovorin|levoleucovorin|mesh-list
25469356|NCT00003298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25469357|NCT00003298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469358|NCT00003298|Tubulin Modulators|tubulin modulators|mesh-ancestor
25469359|NCT00003298|Antimitotic Agents|antimitotic agents|mesh-ancestor
25469360|NCT00003298|Mitosis Modulators|mitosis modulators|mesh-ancestor
25469361|NCT00003298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469362|NCT00003298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25469363|NCT00003298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469364|NCT00003298|Antimetabolites|antimetabolites|mesh-ancestor
25469365|NCT00003298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25469366|NCT00003298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25469367|NCT00003298|Immunologic Factors|immunologic factors|mesh-ancestor
25469368|NCT00003298|Antidotes|antidotes|mesh-ancestor
25469369|NCT00003298|Protective Agents|protective agents|mesh-ancestor
25469370|NCT00003298|Vitamin B Complex|vitamin b complex|mesh-ancestor
25469371|NCT00003298|Vitamins|vitamins|mesh-ancestor
25469372|NCT00003298|Micronutrients|micronutrients|mesh-ancestor
25469373|NCT00003377|Paclitaxel|paclitaxel|mesh-list
25469374|NCT00003377|Cisplatin|cisplatin|mesh-list
25469375|NCT00003377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25469376|NCT00003377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469377|NCT00003377|Tubulin Modulators|tubulin modulators|mesh-ancestor
25469378|NCT00003377|Antimitotic Agents|antimitotic agents|mesh-ancestor
25469379|NCT00003377|Mitosis Modulators|mitosis modulators|mesh-ancestor
25469380|NCT00003377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469381|NCT00003389|Prednisone|prednisone|mesh-list
25469382|NCT00003389|Cyclophosphamide|cyclophosphamide|mesh-list
25469383|NCT00003389|Dacarbazine|dacarbazine|mesh-list
25469384|NCT00003389|Mechlorethamine|mechlorethamine|mesh-list
25469385|NCT00003389|Doxorubicin|doxorubicin|mesh-list
25469386|NCT00003389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25469387|NCT00003389|Etoposide|etoposide|mesh-list
25469388|NCT00003389|Vincristine|vincristine|mesh-list
25469389|NCT00003389|Etoposide phosphate|etoposide phosphate|mesh-list
25469390|NCT00003389|Bleomycin|bleomycin|mesh-list
25469391|NCT00003389|Vinblastine|vinblastine|mesh-list
25469392|NCT00003389|Podophyllotoxin|podophyllotoxin|mesh-list
25469393|NCT00003389|Imidazole|imidazole|mesh-list
25469394|NCT00003389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25469395|NCT00003389|Immunologic Factors|immunologic factors|mesh-ancestor
25469396|NCT00003389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469397|NCT00003389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25469398|NCT00003389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25469399|NCT00003389|Alkylating Agents|alkylating agents|mesh-ancestor
25469400|NCT00003389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469401|NCT00003389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469402|NCT00003389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25469403|NCT00003389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25469404|NCT00003389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25469405|NCT00003389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25469406|NCT00003389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25469407|NCT00003389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25469408|NCT00003389|Glucocorticoids|glucocorticoids|mesh-ancestor
25469418|NCT00003590|Hydroxyurea|hydroxyurea|mesh-list
25469419|NCT00003590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469420|NCT00003590|Antisickling Agents|antisickling agents|mesh-ancestor
25469421|NCT00003590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25469422|NCT00003590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469423|NCT00003590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25469424|NCT00003631|Cytarabine|cytarabine|mesh-list
25469425|NCT00003631|Cyclophosphamide|cyclophosphamide|mesh-list
25469426|NCT00003631|Melphalan|melphalan|mesh-list
25469427|NCT00003631|Ifosfamide|ifosfamide|mesh-list
25469428|NCT00003631|Carmustine|carmustine|mesh-list
25469429|NCT00003631|Carboplatin|carboplatin|mesh-list
25469430|NCT00003631|Etoposide|etoposide|mesh-list
25469431|NCT00003631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25469432|NCT00003631|Immunologic Factors|immunologic factors|mesh-ancestor
25469433|NCT00003631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469434|NCT00003631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25469435|NCT00003631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25469436|NCT00003631|Alkylating Agents|alkylating agents|mesh-ancestor
25469437|NCT00003631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469438|NCT00003631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469439|NCT00003631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25469440|NCT00003631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25469441|NCT00003631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25469442|NCT00003631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25469443|NCT00003631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25469444|NCT00003631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25469445|NCT00003631|Antimetabolites|antimetabolites|mesh-ancestor
25469446|NCT00003631|Antiviral Agents|antiviral agents|mesh-ancestor
25469447|NCT00003631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25469448|NCT00003644|Paclitaxel|paclitaxel|mesh-list
25469449|NCT00003644|Carboplatin|carboplatin|mesh-list
25469450|NCT00003644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25469451|NCT00003644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469452|NCT00003644|Tubulin Modulators|tubulin modulators|mesh-ancestor
25469453|NCT00003644|Antimitotic Agents|antimitotic agents|mesh-ancestor
25469454|NCT00003644|Mitosis Modulators|mitosis modulators|mesh-ancestor
25469455|NCT00003644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469456|NCT00003645|Leuprolide|leuprolide|mesh-list
25469457|NCT00003645|Goserelin|goserelin|mesh-list
25469458|NCT00003645|Flutamide|flutamide|mesh-list
25469459|NCT00003645|Bicalutamide|bicalutamide|mesh-list
25469460|NCT00003645|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25469461|NCT00003645|Fertility Agents|fertility agents|mesh-ancestor
25469462|NCT00003645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25469463|NCT00003645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469464|NCT00003645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25469465|NCT00003645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469466|NCT00003645|Androgen Antagonists|androgen antagonists|mesh-ancestor
25469467|NCT00003645|Hormone Antagonists|hormone antagonists|mesh-ancestor
25469468|NCT00003645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25469469|NCT00003659|Cyclophosphamide|cyclophosphamide|mesh-list
25469470|NCT00003659|Rituximab|rituximab|mesh-list
25469471|NCT00003659|Fludarabine|fludarabine|mesh-list
25469472|NCT00003659|Fludarabine phosphate|fludarabine phosphate|mesh-list
25469473|NCT00003659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25469474|NCT00003659|Immunologic Factors|immunologic factors|mesh-ancestor
25469475|NCT00003659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469476|NCT00003659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25469477|NCT00003659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25469478|NCT00003659|Alkylating Agents|alkylating agents|mesh-ancestor
25469479|NCT00003659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469480|NCT00003659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25341633|NCT01318317|Plerixafor|plerixafor|mesh-list
25469481|NCT00003659|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25469482|NCT00003659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25469483|NCT00003659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25469484|NCT00003659|Antimetabolites|antimetabolites|mesh-ancestor
25469485|NCT00003702|Dactinomycin|dactinomycin|mesh-list
25469486|NCT00003702|Cactinomycin|cactinomycin|mesh-list
25469487|NCT00003702|Methotrexate|methotrexate|mesh-list
25469488|NCT00003702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25469489|NCT00003702|Abortifacient Agents|abortifacient agents|mesh-ancestor
25469490|NCT00003702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25469491|NCT00003702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469492|NCT00003702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25469493|NCT00003702|Antimetabolites|antimetabolites|mesh-ancestor
25080561|NCT03337503|Dronabinol|dronabinol|mesh-list
25469494|NCT00003702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469495|NCT00003702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469496|NCT00003702|Dermatologic Agents|dermatologic agents|mesh-ancestor
25469497|NCT00003702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25469498|NCT00003702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25469499|NCT00003702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25469500|NCT00003702|Immunologic Factors|immunologic factors|mesh-ancestor
25469501|NCT00003702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25469502|NCT00003702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25469503|NCT00003702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25469504|NCT00003702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25469505|NCT00003702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25469506|NCT00003702|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25469507|NCT00003782|Cyclophosphamide|cyclophosphamide|mesh-list
25469508|NCT00003782|Docetaxel|docetaxel|mesh-list
25469509|NCT00003782|Doxorubicin|doxorubicin|mesh-list
25469510|NCT00003782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25469511|NCT00003782|Immunologic Factors|immunologic factors|mesh-ancestor
25469512|NCT00003782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469513|NCT00003782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25469514|NCT00003782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25469515|NCT00003782|Alkylating Agents|alkylating agents|mesh-ancestor
25469516|NCT00003782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469517|NCT00003782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469518|NCT00003782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25469519|NCT00003782|Tubulin Modulators|tubulin modulators|mesh-ancestor
25469520|NCT00003782|Antimitotic Agents|antimitotic agents|mesh-ancestor
25469521|NCT00003782|Mitosis Modulators|mitosis modulators|mesh-ancestor
25469522|NCT00003782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25469523|NCT00003782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25469524|NCT00003782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25469525|NCT00003782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25469526|NCT00003816|Cyclophosphamide|cyclophosphamide|mesh-list
25469527|NCT00003816|Melphalan|melphalan|mesh-list
25469528|NCT00003816|Busulfan|busulfan|mesh-list
25469529|NCT00003816|Thiotepa|thiotepa|mesh-list
25469530|NCT00003816|Carboplatin|carboplatin|mesh-list
25469531|NCT00003816|Fludarabine|fludarabine|mesh-list
25469532|NCT00003816|Fludarabine phosphate|fludarabine phosphate|mesh-list
25469533|NCT00003816|Etoposide|etoposide|mesh-list
25469534|NCT00003816|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25469535|NCT00003816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25469536|NCT00003816|Immunologic Factors|immunologic factors|mesh-ancestor
25469537|NCT00003816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469538|NCT00003816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25469539|NCT00003816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25469540|NCT00003816|Alkylating Agents|alkylating agents|mesh-ancestor
25469541|NCT00003816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469542|NCT00003816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469543|NCT00003816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25469544|NCT00003816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25469545|NCT00003816|Antimetabolites|antimetabolites|mesh-ancestor
25469546|NCT00003816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25469547|NCT00003816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25469548|NCT00003816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25469549|NCT00003816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25469550|NCT00003820|Rituximab|rituximab|mesh-list
25469551|NCT00003820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25469552|NCT00003820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469553|NCT00003820|Immunologic Factors|immunologic factors|mesh-ancestor
25469554|NCT00003820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469555|NCT00003820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25469556|NCT00003869|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
25469557|NCT00003869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469558|NCT00003869|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25469559|NCT00003869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25469560|NCT00003869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644718|NCT01439568|Carboplatin|carboplatin|mesh-list
25469561|NCT00003869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25469562|NCT00003869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469563|NCT00003875|Aldesleukin|aldesleukin|mesh-list
25469564|NCT00003875|Etoposide|etoposide|mesh-list
25469565|NCT00003875|Etoposide phosphate|etoposide phosphate|mesh-list
25469566|NCT00003875|Busulfan|busulfan|mesh-list
25469567|NCT00003875|Interleukin-2|interleukin-2|mesh-list
25469568|NCT00003875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25469569|NCT00003875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469570|NCT00003875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25469571|NCT00003875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25469572|NCT00003875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25469573|NCT00003875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469574|NCT00003875|Alkylating Agents|alkylating agents|mesh-ancestor
25469575|NCT00003875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25469576|NCT00003875|Immunologic Factors|immunologic factors|mesh-ancestor
25469577|NCT00003875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469578|NCT00003875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25469579|NCT00003875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25469580|NCT00003875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25469581|NCT00003875|Analgesics|analgesics|mesh-ancestor
25469582|NCT00003875|Sensory System Agents|sensory system agents|mesh-ancestor
25469583|NCT00003875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25469584|NCT00003875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25469585|NCT00003875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25469586|NCT00003875|Antiviral Agents|antiviral agents|mesh-ancestor
25469587|NCT00003875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25469588|NCT00003896|Paclitaxel|paclitaxel|mesh-list
25469589|NCT00003896|Cisplatin|cisplatin|mesh-list
25469590|NCT00003896|Doxorubicin|doxorubicin|mesh-list
25469591|NCT00003896|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25469592|NCT00003896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25469593|NCT00003896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469594|NCT00003896|Tubulin Modulators|tubulin modulators|mesh-ancestor
25469595|NCT00003896|Antimitotic Agents|antimitotic agents|mesh-ancestor
25469596|NCT00003896|Mitosis Modulators|mitosis modulators|mesh-ancestor
25469597|NCT00003896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469598|NCT00003896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25469599|NCT00003896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25469600|NCT00003896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25469601|NCT00003896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25469602|NCT00003907|Cisplatin|cisplatin|mesh-list
25469603|NCT00003907|Doxorubicin|doxorubicin|mesh-list
25469604|NCT00003907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25469605|NCT00003907|Mitomycins|mitomycins|mesh-list
25469606|NCT00003907|Mitomycin|mitomycin|mesh-list
25469607|NCT00003907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469608|NCT00003907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25469609|NCT00003907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25469610|NCT00003907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25469611|NCT00003907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25469612|NCT00003907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469613|NCT00003907|Alkylating Agents|alkylating agents|mesh-ancestor
25469614|NCT00003907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25469615|NCT00003910|Prednisone|prednisone|mesh-list
25469616|NCT00003910|Cyclophosphamide|cyclophosphamide|mesh-list
25469617|NCT00003910|Methotrexate|methotrexate|mesh-list
25469618|NCT00003910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25469619|NCT00003910|Immunologic Factors|immunologic factors|mesh-ancestor
25469620|NCT00003910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469621|NCT00003910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25469622|NCT00003910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25469623|NCT00003910|Alkylating Agents|alkylating agents|mesh-ancestor
25469624|NCT00003910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469625|NCT00003910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469626|NCT00003910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25469627|NCT00003910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25469628|NCT00003910|Glucocorticoids|glucocorticoids|mesh-ancestor
25469629|NCT00003910|Hormones|hormones|mesh-ancestor
25469630|NCT00003910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25469631|NCT00003910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25469632|NCT00003910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25469633|NCT00003910|Abortifacient Agents|abortifacient agents|mesh-ancestor
25469634|NCT00003910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25469635|NCT00003910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25644719|NCT01439568|Etoposide|etoposide|mesh-list
25469636|NCT00003910|Antimetabolites|antimetabolites|mesh-ancestor
25469637|NCT00003910|Dermatologic Agents|dermatologic agents|mesh-ancestor
25469638|NCT00003910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25469639|NCT00003910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25469640|NCT00003910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25469641|NCT00004031|Prednisone|prednisone|mesh-list
25330686|NCT04818723|Respiratory System Agents|respiratory system agents|mesh-ancestor
25330687|NCT04818723|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25330688|NCT04818723|Hormone Antagonists|hormone antagonists|mesh-ancestor
25330694|NCT04818736|Vaccines|vaccines|mesh-list
25469643|NCT00004031|Carmustine|carmustine|mesh-list
25469644|NCT00004031|Rituximab|rituximab|mesh-list
25469645|NCT00004031|Doxorubicin|doxorubicin|mesh-list
25469646|NCT00004031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25469647|NCT00004031|Etoposide|etoposide|mesh-list
25469648|NCT00004031|Vincristine|vincristine|mesh-list
25469649|NCT00004031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25469650|NCT00004031|Immunologic Factors|immunologic factors|mesh-ancestor
25469651|NCT00004031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469652|NCT00004031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25469653|NCT00004031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25469654|NCT00004031|Alkylating Agents|alkylating agents|mesh-ancestor
25469655|NCT00004031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469656|NCT00004031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469657|NCT00004031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25469658|NCT00004031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25469659|NCT00004031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25469660|NCT00004031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25469661|NCT00004031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25469662|NCT00004031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25469663|NCT00004031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25469664|NCT00004031|Glucocorticoids|glucocorticoids|mesh-ancestor
25469665|NCT00004031|Hormones|hormones|mesh-ancestor
25469666|NCT00004031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25469667|NCT00004031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25469668|NCT00004031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25469669|NCT00004031|Tubulin Modulators|tubulin modulators|mesh-ancestor
25469670|NCT00004031|Antimitotic Agents|antimitotic agents|mesh-ancestor
25469671|NCT00004031|Mitosis Modulators|mitosis modulators|mesh-ancestor
25469672|NCT00004054|Paclitaxel|paclitaxel|mesh-list
25469673|NCT00004054|Etoposide|etoposide|mesh-list
25469674|NCT00004054|Bicalutamide|bicalutamide|mesh-list
25469675|NCT00004054|Flutamide|flutamide|mesh-list
25469676|NCT00004054|Estramustine|estramustine|mesh-list
25469677|NCT00004054|Warfarin|warfarin|mesh-list
25469678|NCT00004054|Hormones|hormones|mesh-list
25469679|NCT00004054|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25469680|NCT00004054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25469681|NCT00004054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469682|NCT00004054|Tubulin Modulators|tubulin modulators|mesh-ancestor
25469683|NCT00004054|Antimitotic Agents|antimitotic agents|mesh-ancestor
25469684|NCT00004054|Mitosis Modulators|mitosis modulators|mesh-ancestor
25469685|NCT00004054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469686|NCT00004054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25469687|NCT00004054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25469688|NCT00004054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25469689|NCT00004054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25469690|NCT00004054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469691|NCT00004054|Anticoagulants|anticoagulants|mesh-ancestor
25469692|NCT00004054|Androgen Antagonists|androgen antagonists|mesh-ancestor
25469693|NCT00004054|Hormone Antagonists|hormone antagonists|mesh-ancestor
25469694|NCT00004054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25469695|NCT00004054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25469696|NCT00004054|Alkylating Agents|alkylating agents|mesh-ancestor
25469697|NCT00004088|Pamidronate|pamidronate|mesh-list
25469698|NCT00004088|Interferons|interferons|mesh-list
25469699|NCT00004088|Interferon-alpha|interferon-alpha|mesh-list
25469700|NCT00004088|Thalidomide|thalidomide|mesh-list
25469701|NCT00004088|Cyclophosphamide|cyclophosphamide|mesh-list
25469702|NCT00004088|Melphalan|melphalan|mesh-list
25469703|NCT00004088|Busulfan|busulfan|mesh-list
25469704|NCT00004088|Lenograstim|lenograstim|mesh-list
25469705|NCT00004088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25469706|NCT00004088|Immunologic Factors|immunologic factors|mesh-ancestor
25469707|NCT00004088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469708|NCT00004088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25469709|NCT00004088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25644720|NCT01439568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25644721|NCT01439568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25469710|NCT00004088|Alkylating Agents|alkylating agents|mesh-ancestor
25469711|NCT00004088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469712|NCT00004088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469713|NCT00004088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25469714|NCT00004088|Antiviral Agents|antiviral agents|mesh-ancestor
25469715|NCT00004088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25469716|NCT00004088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25469717|NCT00004088|Leprostatic Agents|leprostatic agents|mesh-ancestor
25469718|NCT00004088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25469719|NCT00004088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25469720|NCT00004088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25469721|NCT00004088|Growth Substances|growth substances|mesh-ancestor
25469722|NCT00004088|Growth Inhibitors|growth inhibitors|mesh-ancestor
25469723|NCT00004088|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25469724|NCT00004092|Paclitaxel|paclitaxel|mesh-list
25469725|NCT00004092|Cyclophosphamide|cyclophosphamide|mesh-list
25469726|NCT00004092|Carboplatin|carboplatin|mesh-list
25469727|NCT00004092|Doxorubicin|doxorubicin|mesh-list
25469728|NCT00004092|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25469729|NCT00004092|Thiotepa|thiotepa|mesh-list
25469730|NCT00004092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25469731|NCT00004092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469732|NCT00004092|Tubulin Modulators|tubulin modulators|mesh-ancestor
25469733|NCT00004092|Antimitotic Agents|antimitotic agents|mesh-ancestor
25469734|NCT00004092|Mitosis Modulators|mitosis modulators|mesh-ancestor
25469735|NCT00004092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469736|NCT00004092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25469737|NCT00004092|Immunologic Factors|immunologic factors|mesh-ancestor
25469738|NCT00004092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469739|NCT00004092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25469740|NCT00004092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25469741|NCT00004092|Alkylating Agents|alkylating agents|mesh-ancestor
25469742|NCT00004092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25469743|NCT00004092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25469744|NCT00004092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25469745|NCT00004092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25469746|NCT00004092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25469747|NCT00004124|Prednisone|prednisone|mesh-list
25469748|NCT00004124|Goserelin|goserelin|mesh-list
25469749|NCT00004124|Mitoxantrone|mitoxantrone|mesh-list
25469750|NCT00004124|Bicalutamide|bicalutamide|mesh-list
25469751|NCT00004124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25469752|NCT00004124|Glucocorticoids|glucocorticoids|mesh-ancestor
25469753|NCT00004124|Hormones|hormones|mesh-ancestor
25469754|NCT00004124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25469755|NCT00004124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469756|NCT00004124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25469757|NCT00004124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469758|NCT00004124|Analgesics|analgesics|mesh-ancestor
25469759|NCT00004124|Sensory System Agents|sensory system agents|mesh-ancestor
25469760|NCT00004124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25469761|NCT00004124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25469762|NCT00004124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25469763|NCT00004124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25469764|NCT00004124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469765|NCT00004124|Androgen Antagonists|androgen antagonists|mesh-ancestor
25469766|NCT00004124|Hormone Antagonists|hormone antagonists|mesh-ancestor
25469767|NCT00004143|Alemtuzumab|alemtuzumab|mesh-list
25469768|NCT00004143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25469769|NCT00004143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469770|NCT00004146|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
25469771|NCT00004146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469772|NCT00004146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25469773|NCT00004146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25469774|NCT00004146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469775|NCT00004146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25469776|NCT00004146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469777|NCT00004228|Leucovorin|leucovorin|mesh-list
25469778|NCT00004228|Cytarabine|cytarabine|mesh-list
25469779|NCT00004228|Dexamethasone|dexamethasone|mesh-list
25469780|NCT00004228|Prednisone|prednisone|mesh-list
25469781|NCT00004228|Cyclophosphamide|cyclophosphamide|mesh-list
25469782|NCT00004228|Doxorubicin|doxorubicin|mesh-list
25469783|NCT00004228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25469784|NCT00004228|Methotrexate|methotrexate|mesh-list
25469785|NCT00004228|Vincristine|vincristine|mesh-list
25469787|NCT00004228|Asparaginase|asparaginase|mesh-list
25469788|NCT00004228|Mercaptopurine|mercaptopurine|mesh-list
25469789|NCT00004228|Thioguanine|thioguanine|mesh-list
25469790|NCT00004228|Levoleucovorin|levoleucovorin|mesh-list
25469791|NCT00004228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25017117|NCT02489942|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25330831|NCT04817202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25330832|NCT04817202|Antibodies|antibodies|mesh-list
25330833|NCT04817202|Immunoglobulins|immunoglobulins|mesh-list
25330834|NCT04817202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25469792|NCT00004228|Immunologic Factors|immunologic factors|mesh-ancestor
25469793|NCT00004228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469794|NCT00004228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25469795|NCT00004228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25469796|NCT00004228|Alkylating Agents|alkylating agents|mesh-ancestor
25469797|NCT00004228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469798|NCT00004228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469799|NCT00004228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25469800|NCT00004228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25469802|NCT00004228|Autonomic Agents|autonomic agents|mesh-ancestor
25469803|NCT00004228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25469804|NCT00004228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25469805|NCT00004228|Glucocorticoids|glucocorticoids|mesh-ancestor
25469806|NCT00004228|Hormones|hormones|mesh-ancestor
25469807|NCT00004228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25469808|NCT00004228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25469809|NCT00004228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25469810|NCT00004228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25469811|NCT00004228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25469812|NCT00004228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25469813|NCT00004228|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25469814|NCT00004228|Abortifacient Agents|abortifacient agents|mesh-ancestor
25469815|NCT00004228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25469816|NCT00004228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25469817|NCT00004228|Antimetabolites|antimetabolites|mesh-ancestor
25342002|NCT01062425|Cediranib|cediranib|mesh-list
25469818|NCT00004228|Dermatologic Agents|dermatologic agents|mesh-ancestor
25469819|NCT00004228|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25469820|NCT00004228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25469821|NCT00004228|Antiviral Agents|antiviral agents|mesh-ancestor
25469822|NCT00004228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25469823|NCT00004228|Antidotes|antidotes|mesh-ancestor
25469824|NCT00004228|Protective Agents|protective agents|mesh-ancestor
25469825|NCT00004228|Vitamin B Complex|vitamin b complex|mesh-ancestor
25469826|NCT00004228|Vitamins|vitamins|mesh-ancestor
25469827|NCT00004228|Micronutrients|micronutrients|mesh-ancestor
25469828|NCT00004228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25469829|NCT00004228|Tubulin Modulators|tubulin modulators|mesh-ancestor
25469830|NCT00004228|Antimitotic Agents|antimitotic agents|mesh-ancestor
25469831|NCT00004228|Mitosis Modulators|mitosis modulators|mesh-ancestor
25469832|NCT00004259|Carmustine|carmustine|mesh-list
25469833|NCT00004259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25469834|NCT00004259|Alkylating Agents|alkylating agents|mesh-ancestor
25469835|NCT00004259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469836|NCT00004259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469837|NCT00004412|Arginine butyrate|arginine butyrate|mesh-list
25469838|NCT00004412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469839|NCT00004500|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25469840|NCT00004500|Respiratory System Agents|respiratory system agents|mesh-ancestor
25469841|NCT00004547|Paclitaxel|paclitaxel|mesh-list
25469842|NCT00004547|Cisplatin|cisplatin|mesh-list
25469843|NCT00004547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25469844|NCT00004547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469845|NCT00004547|Tubulin Modulators|tubulin modulators|mesh-ancestor
25469846|NCT00004547|Antimitotic Agents|antimitotic agents|mesh-ancestor
25469847|NCT00004547|Mitosis Modulators|mitosis modulators|mesh-ancestor
25469848|NCT00004547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469849|NCT00004562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25469850|NCT00004562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25469851|NCT00004562|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25469852|NCT00004562|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25469853|NCT00004562|Adrenergic Agents|adrenergic agents|mesh-list
25469854|NCT00004562|Adrenergic Antagonists|adrenergic antagonists|mesh-list
25469855|NCT00004562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25469856|NCT00004562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644722|NCT01439568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25644723|NCT01439568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25644724|NCT01439568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25644725|NCT01439568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644726|NCT01439672|Insulin|insulin|mesh-list
25644727|NCT01439672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25644728|NCT01439672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910227|NCT04301349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24772718|NCT01835236|Pertuzumab|pertuzumab|mesh-list
25330906|NCT04816097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25330907|NCT04816097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25330908|NCT04816097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330909|NCT04816240|Midodrine|midodrine|mesh-list
25330910|NCT04816240|Sympathomimetics|sympathomimetics|mesh-ancestor
25330911|NCT04816240|Autonomic Agents|autonomic agents|mesh-ancestor
25330921|NCT04815265|Dexmedetomidine|dexmedetomidine|mesh-list
25469857|NCT00004562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469858|NCT00004562|Protease Inhibitors|protease inhibitors|mesh-ancestor
25469859|NCT00004563|Cyclophosphamide|cyclophosphamide|mesh-list
25469860|NCT00004563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25469861|NCT00004563|Immunologic Factors|immunologic factors|mesh-ancestor
25469862|NCT00004563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469863|NCT00004563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25469864|NCT00004563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25469865|NCT00004563|Alkylating Agents|alkylating agents|mesh-ancestor
25469866|NCT00004563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469867|NCT00004563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469868|NCT00004563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25469869|NCT00004635|Thalidomide|thalidomide|mesh-list
25469870|NCT00004635|Leuprolide|leuprolide|mesh-list
25469871|NCT00004635|Goserelin|goserelin|mesh-list
25469872|NCT00004635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25469873|NCT00004635|Immunologic Factors|immunologic factors|mesh-ancestor
25469874|NCT00004635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469875|NCT00004635|Leprostatic Agents|leprostatic agents|mesh-ancestor
25469876|NCT00004635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25469877|NCT00004635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25469878|NCT00004635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25469879|NCT00004635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25469880|NCT00004635|Growth Substances|growth substances|mesh-ancestor
25469881|NCT00004635|Growth Inhibitors|growth inhibitors|mesh-ancestor
25469882|NCT00004635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469883|NCT00004635|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25469884|NCT00004635|Fertility Agents|fertility agents|mesh-ancestor
25469885|NCT00004635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25469886|NCT00004635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25469887|NCT00004859|Thalidomide|thalidomide|mesh-list
25469888|NCT00004859|Paclitaxel|paclitaxel|mesh-list
25469889|NCT00004859|Carboplatin|carboplatin|mesh-list
25469890|NCT00004859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25469891|NCT00004859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469892|NCT00004859|Tubulin Modulators|tubulin modulators|mesh-ancestor
25469893|NCT00004859|Antimitotic Agents|antimitotic agents|mesh-ancestor
25469894|NCT00004859|Mitosis Modulators|mitosis modulators|mesh-ancestor
25469895|NCT00004859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469896|NCT00004859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25469897|NCT00004859|Immunologic Factors|immunologic factors|mesh-ancestor
25469898|NCT00004859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469899|NCT00004859|Leprostatic Agents|leprostatic agents|mesh-ancestor
25469900|NCT00004859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25469901|NCT00004859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25469902|NCT00004859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25469903|NCT00004859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25469904|NCT00004859|Growth Substances|growth substances|mesh-ancestor
25469905|NCT00004859|Growth Inhibitors|growth inhibitors|mesh-ancestor
25469906|NCT00004888|Docetaxel|docetaxel|mesh-list
25469907|NCT00004888|Doxorubicin|doxorubicin|mesh-list
25469908|NCT00004888|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25469909|NCT00004888|Trastuzumab|trastuzumab|mesh-list
25469910|NCT00004888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469911|NCT00004888|Tubulin Modulators|tubulin modulators|mesh-ancestor
25469912|NCT00004888|Antimitotic Agents|antimitotic agents|mesh-ancestor
25469913|NCT00004888|Mitosis Modulators|mitosis modulators|mesh-ancestor
25469914|NCT00004888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469915|NCT00004888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25469916|NCT00004888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25469917|NCT00004888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25469918|NCT00004888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25469919|NCT00004888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25469920|NCT00004978|Aldesleukin|aldesleukin|mesh-list
25469921|NCT00004978|Interleukin-2|interleukin-2|mesh-list
25469922|NCT00004978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469923|NCT00004978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25469924|NCT00004978|Analgesics|analgesics|mesh-ancestor
25469925|NCT00004978|Sensory System Agents|sensory system agents|mesh-ancestor
25469926|NCT00004978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25469927|NCT00004978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469928|NCT00004978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25469929|NCT00004978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25469930|NCT00004978|Antiviral Agents|antiviral agents|mesh-ancestor
25469931|NCT00004978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25469932|NCT00005047|Cisplatin|cisplatin|mesh-list
25469933|NCT00005047|Doxorubicin|doxorubicin|mesh-list
25469934|NCT00005047|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25469935|NCT00005047|Methotrexate|methotrexate|mesh-list
25469936|NCT00005047|Vinblastine|vinblastine|mesh-list
25469937|NCT00005047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469938|NCT00005047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25469939|NCT00005047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25469940|NCT00005047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25469941|NCT00005047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25469942|NCT00005047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469943|NCT00005047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25469944|NCT00005047|Abortifacient Agents|abortifacient agents|mesh-ancestor
25469945|NCT00005047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25469946|NCT00005047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469947|NCT00005047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25469948|NCT00005047|Antimetabolites|antimetabolites|mesh-ancestor
25469949|NCT00005047|Dermatologic Agents|dermatologic agents|mesh-ancestor
25469950|NCT00005047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25469951|NCT00005047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25469952|NCT00005047|Immunologic Factors|immunologic factors|mesh-ancestor
25469953|NCT00005047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25469954|NCT00005047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25469955|NCT00005047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25469956|NCT00005047|Tubulin Modulators|tubulin modulators|mesh-ancestor
25469957|NCT00005047|Antimitotic Agents|antimitotic agents|mesh-ancestor
25469958|NCT00005047|Mitosis Modulators|mitosis modulators|mesh-ancestor
25469959|NCT00005669|Metformin|metformin|mesh-list
25469960|NCT00005669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25469961|NCT00005669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469962|NCT00005803|Cytarabine|cytarabine|mesh-list
25469963|NCT00005803|Cyclosporine|cyclosporine|mesh-list
25469964|NCT00005803|Mycophenolic Acid|mycophenolic acid|mesh-list
25469965|NCT00005803|Cyclophosphamide|cyclophosphamide|mesh-list
25469966|NCT00005803|Melphalan|melphalan|mesh-list
25469967|NCT00005803|Mechlorethamine|mechlorethamine|mesh-list
25469968|NCT00005803|Carmustine|carmustine|mesh-list
25469969|NCT00005803|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25469970|NCT00005803|Fludarabine|fludarabine|mesh-list
25469971|NCT00005803|Fludarabine phosphate|fludarabine phosphate|mesh-list
25469972|NCT00005803|Etoposide|etoposide|mesh-list
25469973|NCT00005803|Etoposide phosphate|etoposide phosphate|mesh-list
25469974|NCT00005803|Podophyllotoxin|podophyllotoxin|mesh-list
25469975|NCT00005803|Cyclosporins|cyclosporins|mesh-list
25469976|NCT00005803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25469977|NCT00005803|Immunologic Factors|immunologic factors|mesh-ancestor
25469978|NCT00005803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25469979|NCT00005803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25469980|NCT00005803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25469981|NCT00005803|Alkylating Agents|alkylating agents|mesh-ancestor
25469982|NCT00005803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25469983|NCT00005803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25469984|NCT00005803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25469985|NCT00005803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25469986|NCT00005803|Antimetabolites|antimetabolites|mesh-ancestor
25469987|NCT00005803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25469988|NCT00005803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25469989|NCT00005803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25469990|NCT00005803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25469991|NCT00005803|Antiviral Agents|antiviral agents|mesh-ancestor
25469992|NCT00005803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25469993|NCT00005803|Antifungal Agents|antifungal agents|mesh-ancestor
25469994|NCT00005803|Dermatologic Agents|dermatologic agents|mesh-ancestor
25644729|NCT01439711|Letrozole|letrozole|mesh-list
25644730|NCT01439711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25644731|NCT01439711|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25644732|NCT01439711|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25469995|NCT00005803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25469996|NCT00005803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25644733|NCT01439711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25644734|NCT01439711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644735|NCT01439711|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25644736|NCT01439711|Hormone Antagonists|hormone antagonists|mesh-ancestor
25644737|NCT01439711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25469997|NCT00005803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25469998|NCT00005803|Antitubercular Agents|antitubercular agents|mesh-ancestor
25469999|NCT00005803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25470000|NCT00005803|Keratolytic Agents|keratolytic agents|mesh-ancestor
25470001|NCT00005803|Tubulin Modulators|tubulin modulators|mesh-ancestor
25470002|NCT00005803|Antimitotic Agents|antimitotic agents|mesh-ancestor
25470003|NCT00005803|Mitosis Modulators|mitosis modulators|mesh-ancestor
25470004|NCT00005901|Pamidronate|pamidronate|mesh-list
25470005|NCT00005901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25470006|NCT00005901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470007|NCT00005906|Octreotide|octreotide|mesh-list
25470008|NCT00005906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25470009|NCT00005906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25470010|NCT00005906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470011|NCT00005908|Tamoxifen|tamoxifen|mesh-list
25470012|NCT00005908|Cyclophosphamide|cyclophosphamide|mesh-list
25470013|NCT00005908|Docetaxel|docetaxel|mesh-list
25470014|NCT00005908|Doxorubicin|doxorubicin|mesh-list
25470015|NCT00005908|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25470016|NCT00005908|Capecitabine|capecitabine|mesh-list
25470017|NCT00005908|Anastrozole|anastrozole|mesh-list
25470018|NCT00005908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25470019|NCT00005908|Immunologic Factors|immunologic factors|mesh-ancestor
25470020|NCT00005908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470021|NCT00005908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25470022|NCT00005908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25470023|NCT00005908|Alkylating Agents|alkylating agents|mesh-ancestor
25470024|NCT00005908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470025|NCT00005908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470026|NCT00005908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25470027|NCT00005908|Tubulin Modulators|tubulin modulators|mesh-ancestor
25470028|NCT00005908|Antimitotic Agents|antimitotic agents|mesh-ancestor
25470029|NCT00005908|Mitosis Modulators|mitosis modulators|mesh-ancestor
25470030|NCT00005908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25470031|NCT00005908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25470032|NCT00005908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25470033|NCT00005908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470034|NCT00005908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25470035|NCT00005908|Antimetabolites|antimetabolites|mesh-ancestor
25470036|NCT00005908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25470037|NCT00005908|Hormone Antagonists|hormone antagonists|mesh-ancestor
25470038|NCT00005908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25470039|NCT00005908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25470040|NCT00005908|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25470041|NCT00005908|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25470042|NCT00005908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25470043|NCT00005908|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25470044|NCT00005908|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25470045|NCT00005937|Cyclosporine|cyclosporine|mesh-list
25470046|NCT00005937|Cyclosporins|cyclosporins|mesh-list
25470047|NCT00005937|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25470048|NCT00005937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470049|NCT00005937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470050|NCT00005937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25470051|NCT00005937|Immunologic Factors|immunologic factors|mesh-ancestor
25470052|NCT00005937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470053|NCT00005937|Antifungal Agents|antifungal agents|mesh-ancestor
25470054|NCT00005937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25470055|NCT00005937|Dermatologic Agents|dermatologic agents|mesh-ancestor
25470056|NCT00005937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25470057|NCT00005937|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25470058|NCT00006011|Paclitaxel|paclitaxel|mesh-list
25470059|NCT00006011|Cisplatin|cisplatin|mesh-list
25644738|NCT01439711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644739|NCT01439815|Fluticasone|fluticasone|mesh-list
25644740|NCT01439815|Xhance|xhance|mesh-list
25644741|NCT01439815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25644742|NCT01439815|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25644743|NCT01439815|Autonomic Agents|autonomic agents|mesh-ancestor
25470060|NCT00006011|Doxorubicin|doxorubicin|mesh-list
25470061|NCT00006011|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25470062|NCT00006011|Lenograstim|lenograstim|mesh-list
25470063|NCT00006011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25470064|NCT00006011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470065|NCT00006011|Tubulin Modulators|tubulin modulators|mesh-ancestor
25470066|NCT00006011|Antimitotic Agents|antimitotic agents|mesh-ancestor
25470067|NCT00006011|Mitosis Modulators|mitosis modulators|mesh-ancestor
25470068|NCT00006011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470069|NCT00006011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25470070|NCT00006011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25470071|NCT00006011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25470072|NCT00006011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470073|NCT00006011|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25470074|NCT00006011|Immunologic Factors|immunologic factors|mesh-ancestor
25470075|NCT00006011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470076|NCT00006046|Antibodies|antibodies|mesh-list
25470077|NCT00006046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25470078|NCT00006046|Immunologic Factors|immunologic factors|mesh-ancestor
25470079|NCT00006046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470080|NCT00006099|Antibodies|antibodies|mesh-list
25470081|NCT00006099|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25470082|NCT00006099|Immunologic Factors|immunologic factors|mesh-ancestor
25470083|NCT00006099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470084|NCT00006101|Eflornithine|eflornithine|mesh-list
25470085|NCT00006101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470086|NCT00006101|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25470087|NCT00006101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25470088|NCT00006101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25470093|NCT00006110|Paclitaxel|paclitaxel|mesh-list
25470094|NCT00006110|Cyclophosphamide|cyclophosphamide|mesh-list
25470095|NCT00006110|Doxorubicin|doxorubicin|mesh-list
25470096|NCT00006110|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25470097|NCT00006110|Trastuzumab|trastuzumab|mesh-list
25470098|NCT00006110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25470099|NCT00006110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470100|NCT00006110|Tubulin Modulators|tubulin modulators|mesh-ancestor
25470101|NCT00006110|Antimitotic Agents|antimitotic agents|mesh-ancestor
25470102|NCT00006110|Mitosis Modulators|mitosis modulators|mesh-ancestor
25470103|NCT00006110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470104|NCT00006110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25470105|NCT00006110|Immunologic Factors|immunologic factors|mesh-ancestor
25470106|NCT00006110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470107|NCT00006110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25470108|NCT00006110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25470109|NCT00006110|Alkylating Agents|alkylating agents|mesh-ancestor
25470110|NCT00006110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25470111|NCT00006110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25470112|NCT00006110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25470113|NCT00006110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25470114|NCT00006110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470115|NCT00006110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25470116|NCT00006164|Ribavirin|ribavirin|mesh-list
25470117|NCT00006164|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25470118|NCT00006164|Interferon-alpha|interferon-alpha|mesh-list
25470119|NCT00006164|Antimetabolites|antimetabolites|mesh-ancestor
25470120|NCT00006164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470121|NCT00006164|Antiviral Agents|antiviral agents|mesh-ancestor
25470122|NCT00006164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25470123|NCT00006164|Immunologic Factors|immunologic factors|mesh-ancestor
25470124|NCT00006164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470125|NCT00006170|Bupropion|bupropion|mesh-list
25470126|NCT00006170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25470127|NCT00006170|Antidepressive Agents|antidepressive agents|mesh-ancestor
25470128|NCT00006170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24500990|NCT00526318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24500991|NCT00526318|Alkylating Agents|alkylating agents|mesh-ancestor
25644744|NCT01439815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24500992|NCT00526318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470129|NCT00006170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25470130|NCT00006170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25644745|NCT01439815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470131|NCT00006170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25470132|NCT00006170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470133|NCT00006170|Dopamine Agents|dopamine agents|mesh-ancestor
25470134|NCT00006170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25470135|NCT00006170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470136|NCT00006170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25470137|NCT00006170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25470138|NCT00006170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470139|NCT05347641|Cytarabine|cytarabine|mesh-list
25470140|NCT05347641|Methotrexate|methotrexate|mesh-list
25470141|NCT05347641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470142|NCT05347641|Immunologic Factors|immunologic factors|mesh-ancestor
25470143|NCT05347641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470144|NCT05347641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25470145|NCT05347641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25470146|NCT05347641|Abortifacient Agents|abortifacient agents|mesh-ancestor
25470147|NCT05347641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25470148|NCT05347641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25470149|NCT05347641|Antimetabolites|antimetabolites|mesh-ancestor
25470150|NCT05347641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470151|NCT05347641|Dermatologic Agents|dermatologic agents|mesh-ancestor
25470152|NCT05347641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470153|NCT05347641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25470154|NCT05347641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25470155|NCT05347641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25470156|NCT05347641|Antiviral Agents|antiviral agents|mesh-ancestor
25470157|NCT05347641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25470158|NCT05347498|Febuxostat|febuxostat|mesh-list
25470159|NCT05347498|Gout Suppressants|gout suppressants|mesh-ancestor
25470160|NCT05347498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25470161|NCT05347381|Dexamethasone|dexamethasone|mesh-list
25470162|NCT05347381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25470163|NCT05347381|Antiemetics|antiemetics|mesh-ancestor
25470164|NCT05347381|Autonomic Agents|autonomic agents|mesh-ancestor
25342454|NCT00559182|Omeprazole|omeprazole|mesh-list
25470165|NCT05347381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25470166|NCT05347381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470167|NCT05347381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25470168|NCT05347381|Glucocorticoids|glucocorticoids|mesh-ancestor
25470169|NCT05347381|Hormones|hormones|mesh-ancestor
25470170|NCT05347381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25470171|NCT05347381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25470172|NCT05347381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470173|NCT05347160|Calcium|calcium|mesh-list
25470174|NCT05347160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25470175|NCT05347160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470176|NCT05347134|Gemcitabine|gemcitabine|mesh-list
25470177|NCT05347134|Capecitabine|capecitabine|mesh-list
25470178|NCT05347134|Vinorelbine|vinorelbine|mesh-list
25470179|NCT05347134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25470180|NCT05347134|Antimetabolites|antimetabolites|mesh-ancestor
25470181|NCT05347134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470182|NCT05347134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470183|NCT05347134|Antiviral Agents|antiviral agents|mesh-ancestor
25470184|NCT05347134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25470185|NCT05347134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470186|NCT05347134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25470187|NCT05347134|Immunologic Factors|immunologic factors|mesh-ancestor
25470188|NCT05347134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470189|NCT05347134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25470190|NCT05347134|Tubulin Modulators|tubulin modulators|mesh-ancestor
25470191|NCT05347134|Antimitotic Agents|antimitotic agents|mesh-ancestor
25470192|NCT05347134|Mitosis Modulators|mitosis modulators|mesh-ancestor
25470193|NCT05346952|Carboplatin|carboplatin|mesh-list
25470194|NCT05346952|Pemetrexed|pemetrexed|mesh-list
25470195|NCT05346952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470196|NCT05346952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470197|NCT05346952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470198|NCT05346952|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25470199|NCT05346952|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25470200|NCT05346926|Calpastatin|calpastatin|mesh-list
25470201|NCT05346926|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25470202|NCT05346926|Protease Inhibitors|protease inhibitors|mesh-ancestor
25470203|NCT05346926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25644746|NCT01439815|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25644747|NCT01439815|Respiratory System Agents|respiratory system agents|mesh-ancestor
25644748|NCT01439815|Dermatologic Agents|dermatologic agents|mesh-ancestor
25644749|NCT01439815|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25644750|NCT01439854|Dapagliflozin|dapagliflozin|mesh-list
25644751|NCT01439854|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25644752|NCT01439854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470204|NCT05346926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470205|NCT05346861|Trastuzumab|trastuzumab|mesh-list
25470206|NCT05346861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25470207|NCT05346861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470208|NCT05346562|Cannabidiol|cannabidiol|mesh-list
25470209|NCT05346562|Anticonvulsants|anticonvulsants|mesh-ancestor
25470210|NCT05346419|Vitamin D|vitamin d|mesh-list
25470211|NCT05346419|Risedronic Acid|risedronic acid|mesh-list
25470212|NCT05346419|Vitamins|vitamins|mesh-ancestor
25470213|NCT05346419|Micronutrients|micronutrients|mesh-ancestor
25470214|NCT05346419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470215|NCT05346419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25470216|NCT05346419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25470217|NCT05346419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25470218|NCT05346419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470219|NCT05346419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25470220|NCT05346302|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25470221|NCT05346302|Immunologic Factors|immunologic factors|mesh-ancestor
25470222|NCT05346302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470223|NCT05346211|Curcumin|curcumin|mesh-list
25470224|NCT05346211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25470225|NCT05346211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25470226|NCT05346211|Analgesics|analgesics|mesh-ancestor
25470227|NCT05346211|Sensory System Agents|sensory system agents|mesh-ancestor
25470228|NCT05346211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25331278|NCT04810585|Growth Substances|growth substances|mesh-ancestor
25331279|NCT04810585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331280|NCT04810585|Growth Inhibitors|growth inhibitors|mesh-ancestor
25331281|NCT04810585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470229|NCT05346211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470230|NCT05346211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25470231|NCT05346211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25470232|NCT05346211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470233|NCT05346211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470234|NCT05346211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470235|NCT05346159|Androgens|androgens|mesh-list
25470236|NCT05346159|Hormones|hormones|mesh-ancestor
25470237|NCT05346159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25470238|NCT05346159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470239|NCT05346146|Gemcitabine|gemcitabine|mesh-list
25470240|NCT05346146|Paclitaxel|paclitaxel|mesh-list
25470241|NCT05346146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25470242|NCT05346146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470243|NCT05346146|Tubulin Modulators|tubulin modulators|mesh-ancestor
25470244|NCT05346146|Antimitotic Agents|antimitotic agents|mesh-ancestor
25470245|NCT05346146|Mitosis Modulators|mitosis modulators|mesh-ancestor
25470246|NCT05346146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470247|NCT05346146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25470248|NCT05346146|Antimetabolites|antimetabolites|mesh-ancestor
25470249|NCT05346146|Antiviral Agents|antiviral agents|mesh-ancestor
25470250|NCT05346146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25470251|NCT05346146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470252|NCT05346146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25470253|NCT05346146|Immunologic Factors|immunologic factors|mesh-ancestor
25470254|NCT05346146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470255|NCT05346107|Paclitaxel|paclitaxel|mesh-list
25470256|NCT05346107|Cyclophosphamide|cyclophosphamide|mesh-list
25470257|NCT05346107|Doxorubicin|doxorubicin|mesh-list
25470258|NCT05346107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25470259|NCT05346107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25470260|NCT05346107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470261|NCT05346107|Tubulin Modulators|tubulin modulators|mesh-ancestor
25470262|NCT05346107|Antimitotic Agents|antimitotic agents|mesh-ancestor
25470263|NCT05346107|Mitosis Modulators|mitosis modulators|mesh-ancestor
25470264|NCT05346107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501683|NCT00530413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644753|NCT01439854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25644754|NCT01439854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644755|NCT01439867|Cinacalcet|cinacalcet|mesh-list
25470265|NCT05346107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25470266|NCT05346107|Immunologic Factors|immunologic factors|mesh-ancestor
25470267|NCT05346107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470268|NCT05346107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25470269|NCT05346107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25470270|NCT05346107|Alkylating Agents|alkylating agents|mesh-ancestor
25470271|NCT05346107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25470272|NCT05346107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25470273|NCT05346107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25470274|NCT05346107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25470275|NCT05346107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470276|NCT05345938|Mitoxantrone|mitoxantrone|mesh-list
25470277|NCT05345938|Analgesics|analgesics|mesh-ancestor
25470278|NCT05345938|Sensory System Agents|sensory system agents|mesh-ancestor
25470279|NCT05345938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25470280|NCT05345938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470281|NCT05345938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470282|NCT05345938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25470283|NCT05345938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25470284|NCT05345938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470285|NCT05345938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470286|NCT05345808|Triamcinolone|triamcinolone|mesh-list
25470287|NCT05345808|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25470288|NCT05345808|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25470289|NCT05345808|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25470290|NCT05345808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25470291|NCT05345808|Glucocorticoids|glucocorticoids|mesh-ancestor
25470292|NCT05345808|Hormones|hormones|mesh-ancestor
25470293|NCT05345808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25470294|NCT05345808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331355|NCT04809675|Salicylic Acid|salicylic acid|mesh-list
25331356|NCT04809675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25331357|NCT04809675|Antifungal Agents|antifungal agents|mesh-ancestor
25331358|NCT04809675|Keratolytic Agents|keratolytic agents|mesh-ancestor
25331359|NCT04809675|Dermatologic Agents|dermatologic agents|mesh-ancestor
25331360|NCT04809584|Motexafin gadolinium|motexafin gadolinium|mesh-list
25331361|NCT04809584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331362|NCT04809584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25331364|NCT04809649|Itraconazole|itraconazole|mesh-list
25470308|NCT05345574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25470309|NCT05345574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25470310|NCT05345574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470311|NCT05345574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25470312|NCT05345574|Analgesics|analgesics|mesh-ancestor
25470313|NCT05345574|Sensory System Agents|sensory system agents|mesh-ancestor
25470314|NCT05345574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25470315|NCT05345574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25470316|NCT05345574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25470317|NCT05345574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25470318|NCT05345574|Adrenergic Agents|adrenergic agents|mesh-ancestor
25470319|NCT05345574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25470320|NCT05345574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470321|NCT05345574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25470322|NCT05345574|Narcotics|narcotics|mesh-ancestor
25470323|NCT05343117|Palbociclib|palbociclib|mesh-list
25470324|NCT05343117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470325|NCT05343117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25470326|NCT05343117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470327|NCT05343117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470328|NCT05334433|Anesthetics|anesthetics|mesh-list
25470329|NCT05334433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25470330|NCT05334433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470332|NCT05334056|Anesthetics, Local|anesthetics, local|mesh-ancestor
25470333|NCT05334056|Anesthetics|anesthetics|mesh-ancestor
25470334|NCT05334056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25470335|NCT05334056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470336|NCT05334056|Sensory System Agents|sensory system agents|mesh-ancestor
25470337|NCT05334056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25470338|NCT05334056|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25470339|NCT05334056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24810463|NCT02040402|Immunologic Factors|immunologic factors|mesh-ancestor
25644756|NCT01439867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25644757|NCT01439867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644758|NCT01439867|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25644759|NCT01439867|Hormone Antagonists|hormone antagonists|mesh-ancestor
25644760|NCT01439867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25644761|NCT01439945|Magnesium Oxide|magnesium oxide|mesh-list
25644762|NCT01439945|Antacids|antacids|mesh-ancestor
25644763|NCT01439945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644764|NCT01439945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25656807|NCT01578980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25656808|NCT01579162|Cholic Acids|cholic acids|mesh-list
25470340|NCT05334056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25656809|NCT01579162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25470341|NCT05334056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25470342|NCT05334056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470343|NCT05334056|Dopamine Agents|dopamine agents|mesh-ancestor
25470344|NCT05334056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25470345|NCT05320133|Bismuth|bismuth|mesh-list
25470346|NCT05320133|Antacids|antacids|mesh-ancestor
25470347|NCT05320133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470348|NCT05320133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25470349|NCT05315336|Antibodies|antibodies|mesh-list
25470350|NCT05315336|Immunologic Factors|immunologic factors|mesh-ancestor
25470351|NCT05315336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470352|NCT05237349|Oxaliplatin|oxaliplatin|mesh-list
25470353|NCT05237349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331430|NCT04808856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25331431|NCT04808856|Protective Agents|protective agents|mesh-ancestor
25470354|NCT05185024|Iron|iron|mesh-list
25470355|NCT05185024|Trace Elements|trace elements|mesh-ancestor
25470356|NCT05185024|Micronutrients|micronutrients|mesh-ancestor
25470357|NCT05185024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470358|NCT05168865|Letrozole|letrozole|mesh-list
25470359|NCT05168865|Estradiol|estradiol|mesh-list
25470360|NCT05168865|Progesterone|progesterone|mesh-list
25470361|NCT05168865|Estrogens|estrogens|mesh-ancestor
25470362|NCT05168865|Hormones|hormones|mesh-ancestor
25470363|NCT05168865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25470364|NCT05168865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470365|NCT05168865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470366|NCT05168865|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25470367|NCT05168865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25470368|NCT05168865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470369|NCT05168865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470370|NCT05168865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25470371|NCT05168865|Hormone Antagonists|hormone antagonists|mesh-ancestor
25470372|NCT05168865|Progestins|progestins|mesh-ancestor
25470373|NCT05167734|Dextrans|dextrans|mesh-list
25470374|NCT05167734|Epoetin Alfa|epoetin alfa|mesh-list
25470375|NCT05167734|Iron-Dextran Complex|iron-dextran complex|mesh-list
25470376|NCT05167734|Hematinics|hematinics|mesh-ancestor
25470377|NCT05167734|Anticoagulants|anticoagulants|mesh-ancestor
25470378|NCT05167734|Plasma Substitutes|plasma substitutes|mesh-ancestor
25470379|NCT05167734|Blood Substitutes|blood substitutes|mesh-ancestor
25470380|NCT05158062|Paclitaxel|paclitaxel|mesh-list
25470381|NCT05158062|Docetaxel|docetaxel|mesh-list
25470382|NCT05158062|Bevacizumab|bevacizumab|mesh-list
25470383|NCT05158062|Carboplatin|carboplatin|mesh-list
25470384|NCT05158062|Pembrolizumab|pembrolizumab|mesh-list
25470385|NCT05158062|Olaparib|olaparib|mesh-list
25470386|NCT05158062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25470387|NCT05158062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470388|NCT05158062|Tubulin Modulators|tubulin modulators|mesh-ancestor
25470389|NCT05158062|Antimitotic Agents|antimitotic agents|mesh-ancestor
25470390|NCT05158062|Mitosis Modulators|mitosis modulators|mesh-ancestor
25470391|NCT05158062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470392|NCT05158062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25470393|NCT05158062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25470394|NCT05158062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25470395|NCT05158062|Growth Substances|growth substances|mesh-ancestor
25470396|NCT05158062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470397|NCT05158062|Growth Inhibitors|growth inhibitors|mesh-ancestor
25470398|NCT05158062|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25470399|NCT05158062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470400|NCT05078827|Fluorouracil|fluorouracil|mesh-list
25470401|NCT05078827|Antimetabolites|antimetabolites|mesh-ancestor
25470402|NCT05078827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503200|NCT02712814|Estrogens|estrogens|mesh-list
25656810|NCT01579305|Lidocaine|lidocaine|mesh-list
25470403|NCT05078827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25470404|NCT05078827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470405|NCT05078827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25470406|NCT05078827|Immunologic Factors|immunologic factors|mesh-ancestor
25470407|NCT05078827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470408|NCT05051566|Esomeprazole|esomeprazole|mesh-list
25470409|NCT05051566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25470410|NCT05051566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25470411|NCT05051566|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25470412|NCT05051566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470413|NCT05051566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470414|NCT04935229|Nivolumab|nivolumab|mesh-list
25470415|NCT04935229|Ipilimumab|ipilimumab|mesh-list
25470416|NCT04935229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25470417|NCT04935229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470418|NCT04935229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25470419|NCT04935229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470420|NCT04916197|Dexmedetomidine|dexmedetomidine|mesh-list
25331510|NCT04807829|Nabilone|nabilone|mesh-list
25331511|NCT04807829|Antiemetics|antiemetics|mesh-ancestor
25331512|NCT04807829|Autonomic Agents|autonomic agents|mesh-ancestor
25331513|NCT04807829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25331514|NCT04807829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331515|NCT04807829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25331516|NCT04807829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25331517|NCT04807829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25331520|NCT04807569|Tamsulosin|tamsulosin|mesh-list
25470421|NCT04916197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25470422|NCT04916197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25470423|NCT04916197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470424|NCT04916197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25470425|NCT04916197|Analgesics|analgesics|mesh-ancestor
25470426|NCT04916197|Sensory System Agents|sensory system agents|mesh-ancestor
25470427|NCT04916197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25470428|NCT04916197|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25470429|NCT04916197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25470430|NCT04916197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25470431|NCT04916197|Adrenergic Agents|adrenergic agents|mesh-ancestor
25470432|NCT04916197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25470433|NCT04916197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470434|NCT04828343|Rozanolixizumab|rozanolixizumab|mesh-list
25470435|NCT04828343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25470436|NCT04828343|Immunologic Factors|immunologic factors|mesh-ancestor
25470437|NCT04828343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470438|NCT04797767|Cytarabine|cytarabine|mesh-list
25470439|NCT04797767|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
25470440|NCT04797767|Venetoclax|venetoclax|mesh-list
25470441|NCT04797767|Mitoxantrone|mitoxantrone|mesh-list
25470442|NCT04797767|Cladribine|cladribine|mesh-list
25470443|NCT04797767|Lenograstim|lenograstim|mesh-list
25470444|NCT04797767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25470445|NCT04797767|Antimetabolites|antimetabolites|mesh-ancestor
25470446|NCT04797767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470447|NCT04797767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470448|NCT04797767|Antiviral Agents|antiviral agents|mesh-ancestor
25470449|NCT04797767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25470450|NCT04797767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25470451|NCT04797767|Immunologic Factors|immunologic factors|mesh-ancestor
25470452|NCT04797767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470453|NCT04797767|Analgesics|analgesics|mesh-ancestor
25470454|NCT04797767|Sensory System Agents|sensory system agents|mesh-ancestor
25470455|NCT04797767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25470456|NCT04797767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25470457|NCT04797767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25470458|NCT04797767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470459|NCT04797767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25470460|NCT04658784|Cyclopropane|cyclopropane|mesh-list
25470461|NCT04658784|Anesthetics|anesthetics|mesh-ancestor
25470462|NCT04658784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25470463|NCT04658784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470464|NCT04373785|Temozolomide|temozolomide|mesh-list
25470465|NCT04373785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25470466|NCT04373785|Alkylating Agents|alkylating agents|mesh-ancestor
25470467|NCT04373785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470468|NCT04373785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470469|NCT04218565|Golimumab|golimumab|mesh-list
25470470|NCT04218565|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25470471|NCT04218565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25470472|NCT04218565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25470473|NCT04218565|Immunologic Factors|immunologic factors|mesh-ancestor
25470474|NCT04218565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470475|NCT04161599|Metronidazole|metronidazole|mesh-list
25470476|NCT04161599|Cefuroxime|cefuroxime|mesh-list
25470477|NCT04161599|Cefuroxime axetil|cefuroxime axetil|mesh-list
25470478|NCT04161599|Picosulfate sodium|picosulfate sodium|mesh-list
25470479|NCT04161599|Magnesium Oxide|magnesium oxide|mesh-list
25470480|NCT04161599|Citric Acid|citric acid|mesh-list
25470481|NCT04161599|Sodium Citrate|sodium citrate|mesh-list
25470482|NCT04161599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25470483|NCT04161599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25470484|NCT04161599|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25470485|NCT04161599|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25470486|NCT04161599|Anticoagulants|anticoagulants|mesh-ancestor
25470487|NCT04161599|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25470488|NCT04161599|Chelating Agents|chelating agents|mesh-ancestor
25470489|NCT04161599|Sequestering Agents|sequestering agents|mesh-ancestor
25470490|NCT04161599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470491|NCT04161599|Cathartics|cathartics|mesh-ancestor
25470492|NCT04161599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25470493|NCT04161599|Antacids|antacids|mesh-ancestor
25470494|NCT04134936|Lenalidomide|lenalidomide|mesh-list
25470495|NCT04134936|Immunologic Factors|immunologic factors|mesh-ancestor
25470496|NCT04134936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331577|NCT04807309|Danazol|danazol|mesh-list
25470497|NCT04134936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25470498|NCT04134936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25470499|NCT04134936|Growth Substances|growth substances|mesh-ancestor
25470500|NCT04134936|Growth Inhibitors|growth inhibitors|mesh-ancestor
25470501|NCT04134936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470503|NCT04110145|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25470504|NCT04110145|Enzyme Activators|enzyme activators|mesh-ancestor
25470505|NCT04110145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470506|NCT04110145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25470507|NCT04109391|Trastuzumab|trastuzumab|mesh-list
25470508|NCT04109391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25470509|NCT04109391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470510|NCT04073784|Gemcitabine|gemcitabine|mesh-list
25470511|NCT04073784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25470512|NCT04073784|Antimetabolites|antimetabolites|mesh-ancestor
25470513|NCT04073784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470514|NCT04073784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470515|NCT04073784|Antiviral Agents|antiviral agents|mesh-ancestor
25470516|NCT04073784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25470517|NCT04073784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470518|NCT04073784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25470519|NCT04073784|Immunologic Factors|immunologic factors|mesh-ancestor
25470520|NCT04073784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470521|NCT04008355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25470522|NCT03970330|Naltrexone|naltrexone|mesh-list
25470523|NCT03970330|Norethindrone|norethindrone|mesh-list
25470524|NCT03970330|Norethindrone Acetate|norethindrone acetate|mesh-list
25470525|NCT03970330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25470526|NCT03970330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25470527|NCT03970330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470528|NCT03970330|Sensory System Agents|sensory system agents|mesh-ancestor
25470529|NCT03970330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25470530|NCT03970330|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25470531|NCT03970330|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25470532|NCT03970330|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25470533|NCT03970330|Contraceptive Agents|contraceptive agents|mesh-ancestor
25470534|NCT03970330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25470535|NCT03970330|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25470536|NCT03970330|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25470537|NCT03933306|Dexmedetomidine|dexmedetomidine|mesh-list
25470538|NCT03933306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25470539|NCT03933306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25470540|NCT03933306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470541|NCT03933306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25470542|NCT03933306|Analgesics|analgesics|mesh-ancestor
25470543|NCT03933306|Sensory System Agents|sensory system agents|mesh-ancestor
25470544|NCT03933306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25470545|NCT03933306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25644765|NCT01440101|Natalizumab|natalizumab|mesh-list
25470546|NCT03933306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25470547|NCT03933306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25470548|NCT03933306|Adrenergic Agents|adrenergic agents|mesh-ancestor
25470549|NCT03933306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25470550|NCT03933306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470551|NCT03898934|Vitamin D|vitamin d|mesh-list
25470552|NCT03898934|Vitamins|vitamins|mesh-ancestor
25470553|NCT03898934|Micronutrients|micronutrients|mesh-ancestor
25470554|NCT03898934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470555|NCT03898934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25470556|NCT03884556|Gemcitabine|gemcitabine|mesh-list
25470557|NCT03884556|Paclitaxel|paclitaxel|mesh-list
25470558|NCT03884556|Pembrolizumab|pembrolizumab|mesh-list
25470559|NCT03884556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25470560|NCT03884556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470561|NCT03884556|Tubulin Modulators|tubulin modulators|mesh-ancestor
25470562|NCT03884556|Antimitotic Agents|antimitotic agents|mesh-ancestor
25470563|NCT03884556|Mitosis Modulators|mitosis modulators|mesh-ancestor
25470564|NCT03884556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470565|NCT03884556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25470566|NCT03884556|Antimetabolites|antimetabolites|mesh-ancestor
25331649|NCT04806737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25331650|NCT04806737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25331651|NCT04806737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25331652|NCT04806737|Immunologic Factors|immunologic factors|mesh-ancestor
25331653|NCT04806633|Dapagliflozin|dapagliflozin|mesh-list
25470567|NCT03884556|Antiviral Agents|antiviral agents|mesh-ancestor
25470568|NCT03884556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25470569|NCT03884556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470580|NCT03798639|Nivolumab|nivolumab|mesh-list
25470581|NCT03798639|Ipilimumab|ipilimumab|mesh-list
25470582|NCT03798639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25470583|NCT03798639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470584|NCT03798639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25470585|NCT03798639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470586|NCT03775486|Gemcitabine|gemcitabine|mesh-list
25470587|NCT03775486|Paclitaxel|paclitaxel|mesh-list
25470588|NCT03775486|Cisplatin|cisplatin|mesh-list
25470589|NCT03775486|Carboplatin|carboplatin|mesh-list
25470590|NCT03775486|Pemetrexed|pemetrexed|mesh-list
25470591|NCT03775486|Durvalumab|durvalumab|mesh-list
25470592|NCT03775486|Olaparib|olaparib|mesh-list
25470593|NCT03775486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25470594|NCT03775486|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25470595|NCT03775486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470596|NCT03775486|Tubulin Modulators|tubulin modulators|mesh-ancestor
25470597|NCT03775486|Antimitotic Agents|antimitotic agents|mesh-ancestor
25470598|NCT03775486|Mitosis Modulators|mitosis modulators|mesh-ancestor
25470599|NCT03775486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470600|NCT03775486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25470601|NCT03775486|Antimetabolites|antimetabolites|mesh-ancestor
25470602|NCT03775486|Antiviral Agents|antiviral agents|mesh-ancestor
25470603|NCT03775486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25470604|NCT03775486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470605|NCT03775486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25470606|NCT03775486|Immunologic Factors|immunologic factors|mesh-ancestor
25470607|NCT03775486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470608|NCT03775486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25470609|NCT03775486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25470610|NCT03775486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25470611|NCT03775486|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25470612|NCT03763162|Dexamethasone|dexamethasone|mesh-list
25470613|NCT03763162|Dexamethasone acetate|dexamethasone acetate|mesh-list
25470614|NCT03763162|Bortezomib|bortezomib|mesh-list
25470615|NCT03763162|Daratumumab|daratumumab|mesh-list
25470616|NCT03763162|Ixazomib|ixazomib|mesh-list
25470617|NCT03763162|Ichthammol|ichthammol|mesh-list
25470618|NCT03763162|BB 1101|bb 1101|mesh-list
25470619|NCT03763162|Glycine|glycine|mesh-list
25470620|NCT03763162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25470621|NCT03763162|Antiemetics|antiemetics|mesh-ancestor
25470622|NCT03763162|Autonomic Agents|autonomic agents|mesh-ancestor
25470623|NCT03763162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25470624|NCT03763162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470625|NCT03763162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25470626|NCT03763162|Glucocorticoids|glucocorticoids|mesh-ancestor
25470627|NCT03763162|Hormones|hormones|mesh-ancestor
25470628|NCT03763162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25470629|NCT03763162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25470630|NCT03763162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470631|NCT03763162|Protease Inhibitors|protease inhibitors|mesh-ancestor
25470632|NCT03763162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470633|NCT03763162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470634|NCT03763162|Dermatologic Agents|dermatologic agents|mesh-ancestor
25331795|NCT04805281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331796|NCT04805073|Promethazine|promethazine|mesh-list
25331797|NCT04805073|Diphenhydramine|diphenhydramine|mesh-list
25331798|NCT04805073|Antipruritics|antipruritics|mesh-ancestor
25331799|NCT04805073|Dermatologic Agents|dermatologic agents|mesh-ancestor
25331800|NCT04805073|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25331801|NCT04805073|Histamine Antagonists|histamine antagonists|mesh-ancestor
25331802|NCT04805073|Histamine Agents|histamine agents|mesh-ancestor
25331803|NCT04805073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25331804|NCT04805073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331805|NCT04805073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331806|NCT04805073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25331807|NCT04805073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25331808|NCT04805073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25331809|NCT04805073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25331810|NCT04805073|Anesthetics, Local|anesthetics, local|mesh-ancestor
25331811|NCT04805073|Anesthetics|anesthetics|mesh-ancestor
25331812|NCT04805073|Sensory System Agents|sensory system agents|mesh-ancestor
25331813|NCT04805073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25331814|NCT04805073|Antiemetics|antiemetics|mesh-ancestor
25331815|NCT04805073|Autonomic Agents|autonomic agents|mesh-ancestor
25470635|NCT03763162|Glycine Agents|glycine agents|mesh-ancestor
25470636|NCT03763162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25470637|NCT03751124|Norethindrone|norethindrone|mesh-list
25470638|NCT03751124|Norethindrone Acetate|norethindrone acetate|mesh-list
25470639|NCT03751124|Estradiol|estradiol|mesh-list
25470640|NCT03751124|Relugolix|relugolix|mesh-list
25470641|NCT03751124|Estrogens|estrogens|mesh-ancestor
25470642|NCT03751124|Hormones|hormones|mesh-ancestor
25470643|NCT03751124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25470644|NCT03751124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470645|NCT03751124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25470646|NCT03751124|Contraceptive Agents|contraceptive agents|mesh-ancestor
25470647|NCT03751124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25470648|NCT03751124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25470649|NCT03751124|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25470650|NCT03751124|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25470651|NCT03751124|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25470652|NCT03751124|Androgen Antagonists|androgen antagonists|mesh-ancestor
25470653|NCT03751124|Hormone Antagonists|hormone antagonists|mesh-ancestor
25470654|NCT03629483|Dexmedetomidine|dexmedetomidine|mesh-list
25470655|NCT03629483|Ropivacaine|ropivacaine|mesh-list
25470656|NCT03629483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25470657|NCT03629483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25470658|NCT03629483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470659|NCT03629483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25470660|NCT03629483|Analgesics|analgesics|mesh-ancestor
25470661|NCT03629483|Sensory System Agents|sensory system agents|mesh-ancestor
25470662|NCT03629483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25470663|NCT03629483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25470664|NCT03629483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25470665|NCT03629483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25470666|NCT03629483|Adrenergic Agents|adrenergic agents|mesh-ancestor
25470667|NCT03629483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25470668|NCT03629483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470669|NCT03629483|Anesthetics, Local|anesthetics, local|mesh-ancestor
25470670|NCT03629483|Anesthetics|anesthetics|mesh-ancestor
25470671|NCT03622788|Cyclophosphamide|cyclophosphamide|mesh-list
25470672|NCT03622788|Fludarabine|fludarabine|mesh-list
25470673|NCT03622788|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25470674|NCT03622788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25470675|NCT03622788|Immunologic Factors|immunologic factors|mesh-ancestor
25470676|NCT03622788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470677|NCT03622788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25470678|NCT03622788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25470679|NCT03622788|Alkylating Agents|alkylating agents|mesh-ancestor
25470680|NCT03622788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470681|NCT03622788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470682|NCT03622788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25470683|NCT03553810|Valsartan|valsartan|mesh-list
25644766|NCT01440101|Immunologic Factors|immunologic factors|mesh-ancestor
25470684|NCT03553810|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25470685|NCT03553810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25470686|NCT03553810|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25470687|NCT03553810|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25470688|NCT03553810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470689|NCT03527264|Cisplatin|cisplatin|mesh-list
25470690|NCT03527264|Nivolumab|nivolumab|mesh-list
25470691|NCT03527264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470692|NCT03527264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25470693|NCT03527264|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25470694|NCT03527264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470695|NCT03519308|Gemcitabine|gemcitabine|mesh-list
25470696|NCT03519308|Paclitaxel|paclitaxel|mesh-list
25470697|NCT03519308|Nivolumab|nivolumab|mesh-list
25470698|NCT03519308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25470699|NCT03519308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470700|NCT03519308|Tubulin Modulators|tubulin modulators|mesh-ancestor
25470701|NCT03519308|Antimitotic Agents|antimitotic agents|mesh-ancestor
25470702|NCT03519308|Mitosis Modulators|mitosis modulators|mesh-ancestor
25470703|NCT03519308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470704|NCT03519308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25470705|NCT03519308|Antimetabolites|antimetabolites|mesh-ancestor
25470706|NCT03519308|Antiviral Agents|antiviral agents|mesh-ancestor
25470707|NCT03519308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25470708|NCT03519308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331872|NCT04803500|Simvastatin|simvastatin|mesh-list
25470709|NCT03519308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25470710|NCT03519308|Immunologic Factors|immunologic factors|mesh-ancestor
25470711|NCT03519308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470712|NCT03519308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25470713|NCT03519308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25470714|NCT03447314|Pembrolizumab|pembrolizumab|mesh-list
25470715|NCT03447314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25470716|NCT03447314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470717|NCT03271151|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25470718|NCT03271151|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25470719|NCT03271151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25470720|NCT03271151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25470721|NCT03271151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470722|NCT03271151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25470723|NCT03271151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470724|NCT03271151|Analgesics|analgesics|mesh-ancestor
25470725|NCT03271151|Sensory System Agents|sensory system agents|mesh-ancestor
25470726|NCT03271151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25470727|NCT03271151|Antidepressive Agents|antidepressive agents|mesh-ancestor
25470728|NCT03271151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25470729|NCT03271151|Dopamine Agents|dopamine agents|mesh-ancestor
25470730|NCT03265405|Prednisolone|prednisolone|mesh-list
25470731|NCT03265405|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25470732|NCT03265405|Methylprednisolone|methylprednisolone|mesh-list
25470733|NCT03265405|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25470734|NCT03265405|Prednisolone acetate|prednisolone acetate|mesh-list
25470735|NCT03265405|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25470736|NCT03265405|Prednisolone phosphate|prednisolone phosphate|mesh-list
25470737|NCT03265405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25470738|NCT03265405|Glucocorticoids|glucocorticoids|mesh-ancestor
25470740|NCT03265405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25470741|NCT03265405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470742|NCT03265405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25470743|NCT03265405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470744|NCT03265405|Antiemetics|antiemetics|mesh-ancestor
25470745|NCT03265405|Autonomic Agents|autonomic agents|mesh-ancestor
25470746|NCT03265405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25470747|NCT03265405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25470748|NCT03265405|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25470749|NCT03265405|Protective Agents|protective agents|mesh-ancestor
25470750|NCT03172897|Dexmedetomidine|dexmedetomidine|mesh-list
25470751|NCT03172897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25470752|NCT03172897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25470753|NCT03172897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470754|NCT03172897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25470755|NCT03172897|Analgesics|analgesics|mesh-ancestor
25470756|NCT03172897|Sensory System Agents|sensory system agents|mesh-ancestor
25470757|NCT03172897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25470758|NCT03172897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25470759|NCT03172897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25470760|NCT03172897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25470761|NCT03172897|Adrenergic Agents|adrenergic agents|mesh-ancestor
25470762|NCT03172897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25470763|NCT03172897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470764|NCT03102723|Cangrelor|cangrelor|mesh-list
25470765|NCT03102723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25470766|NCT03102723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25470767|NCT03102723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25470768|NCT03102723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25470769|NCT03102723|Purinergic Agents|purinergic agents|mesh-ancestor
25470770|NCT03102723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25470771|NCT03102723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470772|NCT03102723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470773|NCT03012984|Dexmedetomidine|dexmedetomidine|mesh-list
25470774|NCT03012984|Morphine|morphine|mesh-list
25470775|NCT03012984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25470776|NCT03012984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25470777|NCT03012984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470778|NCT03012984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25470779|NCT03012984|Analgesics|analgesics|mesh-ancestor
25470780|NCT03012984|Sensory System Agents|sensory system agents|mesh-ancestor
25470781|NCT03012984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25470782|NCT03012984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25470783|NCT03012984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25470784|NCT03012984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25470785|NCT03012984|Adrenergic Agents|adrenergic agents|mesh-ancestor
25470786|NCT03012984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25470787|NCT03012984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470788|NCT03012984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25470789|NCT03012984|Narcotics|narcotics|mesh-ancestor
25470790|NCT02993822|Maleic acid|maleic acid|mesh-list
25470791|NCT02993822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470792|NCT02993822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470793|NCT02957019|Rituximab|rituximab|mesh-list
25470794|NCT02957019|Interleukin-2|interleukin-2|mesh-list
25470795|NCT02957019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25470796|NCT02957019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470797|NCT02957019|Immunologic Factors|immunologic factors|mesh-ancestor
25470798|NCT02957019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470799|NCT02957019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25470800|NCT02957019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25470801|NCT02957019|Analgesics|analgesics|mesh-ancestor
25470802|NCT02957019|Sensory System Agents|sensory system agents|mesh-ancestor
25470803|NCT02957019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25470804|NCT02938793|Durvalumab|durvalumab|mesh-list
25470805|NCT02938793|Tremelimumab|tremelimumab|mesh-list
25470806|NCT02938793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25470807|NCT02938793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470808|NCT02924441|Lidocaine|lidocaine|mesh-list
25470809|NCT02924441|Anesthetics, Local|anesthetics, local|mesh-ancestor
25470810|NCT02924441|Anesthetics|anesthetics|mesh-ancestor
25470811|NCT02924441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25470812|NCT02924441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470813|NCT02924441|Sensory System Agents|sensory system agents|mesh-ancestor
25470814|NCT02924441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25470815|NCT02924441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25470816|NCT02924441|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25470817|NCT02924441|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25470818|NCT02924441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25470819|NCT02924441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470820|NCT02924324|Propofol|propofol|mesh-list
25470821|NCT02924324|Ropivacaine|ropivacaine|mesh-list
25470822|NCT02924324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25470823|NCT02924324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25470824|NCT02924324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470825|NCT02924324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25470826|NCT02924324|Anesthetics, General|anesthetics, general|mesh-ancestor
25470827|NCT02924324|Anesthetics|anesthetics|mesh-ancestor
25470828|NCT02924324|Anesthetics, Local|anesthetics, local|mesh-ancestor
25470829|NCT02924324|Sensory System Agents|sensory system agents|mesh-ancestor
25656811|NCT01579305|Anesthetics, Local|anesthetics, local|mesh-ancestor
25470830|NCT02924324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25332024|NCT04802083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332033|NCT04801888|Vaccines|vaccines|mesh-list
25332034|NCT04801888|Immunologic Factors|immunologic factors|mesh-ancestor
25332035|NCT04801888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332036|NCT04801940|Apixaban|apixaban|mesh-list
25332037|NCT04801940|Atorvastatin|atorvastatin|mesh-list
25332038|NCT04801940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25332039|NCT04801940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25332040|NCT04801940|Antimetabolites|antimetabolites|mesh-ancestor
25332041|NCT04801940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332042|NCT04801940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25332043|NCT04801940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25332044|NCT04801940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25332045|NCT04801940|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25332046|NCT04801940|Antithrombins|antithrombins|mesh-ancestor
25332047|NCT04801940|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25332048|NCT04801940|Protease Inhibitors|protease inhibitors|mesh-ancestor
25332049|NCT04801940|Anticoagulants|anticoagulants|mesh-ancestor
25332050|NCT04801966|Pembrolizumab|pembrolizumab|mesh-list
25332051|NCT04801966|Nivolumab|nivolumab|mesh-list
25332052|NCT04801966|Atezolizumab|atezolizumab|mesh-list
25332053|NCT04801966|Olaparib|olaparib|mesh-list
25332054|NCT04801966|Palbociclib|palbociclib|mesh-list
25332055|NCT04801966|Trametinib|trametinib|mesh-list
25332056|NCT04801966|Vemurafenib|vemurafenib|mesh-list
25332057|NCT04801966|Dabrafenib|dabrafenib|mesh-list
25332058|NCT04801966|Talazoparib|talazoparib|mesh-list
25332064|NCT04801966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470831|NCT02901041|Zonisamide|zonisamide|mesh-list
25470832|NCT02901041|Anticonvulsants|anticonvulsants|mesh-ancestor
25470833|NCT02901041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25470834|NCT02901041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25470835|NCT02901041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470836|NCT02901041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25470837|NCT02901041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470838|NCT02753127|Leucovorin|leucovorin|mesh-list
25470839|NCT02753127|Bevacizumab|bevacizumab|mesh-list
25470840|NCT02753127|Fluorouracil|fluorouracil|mesh-list
25470841|NCT02753127|Irinotecan|irinotecan|mesh-list
25470842|NCT02753127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25470843|NCT02753127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470844|NCT02753127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25470845|NCT02753127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25470846|NCT02753127|Growth Substances|growth substances|mesh-ancestor
25470847|NCT02753127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470848|NCT02753127|Growth Inhibitors|growth inhibitors|mesh-ancestor
25470849|NCT02753127|Antimetabolites|antimetabolites|mesh-ancestor
25470850|NCT02753127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470851|NCT02753127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25470852|NCT02753127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25470853|NCT02753127|Immunologic Factors|immunologic factors|mesh-ancestor
25470854|NCT02753127|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25470855|NCT02753127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25470856|NCT02753127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470857|NCT02753127|Antidotes|antidotes|mesh-ancestor
25470858|NCT02753127|Protective Agents|protective agents|mesh-ancestor
25470859|NCT02753127|Vitamin B Complex|vitamin b complex|mesh-ancestor
25470860|NCT02753127|Vitamins|vitamins|mesh-ancestor
25470861|NCT02753127|Micronutrients|micronutrients|mesh-ancestor
25470862|NCT02744430|Mirabegron|mirabegron|mesh-list
25470863|NCT02744430|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25470864|NCT02744430|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25470865|NCT02744430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25470866|NCT02744430|Adrenergic Agents|adrenergic agents|mesh-ancestor
25470867|NCT02744430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25470868|NCT02744430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470869|NCT02744430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470870|NCT02744430|Urological Agents|urological agents|mesh-ancestor
25470871|NCT02674958|Aspirin|aspirin|mesh-list
25470872|NCT02674958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25470873|NCT02674958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25470874|NCT02674958|Analgesics|analgesics|mesh-ancestor
25470875|NCT02674958|Sensory System Agents|sensory system agents|mesh-ancestor
25470876|NCT02674958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25644767|NCT01440101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470877|NCT02674958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470878|NCT02674958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25470879|NCT02674958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25470880|NCT02674958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25470881|NCT02674958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25470882|NCT02674958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470883|NCT02674958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25470884|NCT02674958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25470885|NCT02674958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470886|NCT02674958|Antipyretics|antipyretics|mesh-ancestor
25470887|NCT02668562|Ticagrelor|ticagrelor|mesh-list
25470888|NCT02668562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25470889|NCT02668562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25470890|NCT02668562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25470891|NCT02668562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25470892|NCT02668562|Purinergic Agents|purinergic agents|mesh-ancestor
25470893|NCT02668562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25470894|NCT02668562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470895|NCT02668562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332107|NCT04801485|Inositol|inositol|mesh-list
25332108|NCT04801485|Vitamin B Complex|vitamin b complex|mesh-ancestor
25332109|NCT04801485|Vitamins|vitamins|mesh-ancestor
25332110|NCT04801485|Micronutrients|micronutrients|mesh-ancestor
25332111|NCT04801485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332112|NCT04801342|Memantine|memantine|mesh-list
25332113|NCT04801342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25332114|NCT04801342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25332115|NCT04801342|Dopamine Agents|dopamine agents|mesh-ancestor
25332121|NCT04801264|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25470896|NCT02659241|Adavosertib|adavosertib|mesh-list
25470897|NCT02659241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470898|NCT02659241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470899|NCT02538744|Doxazosin|doxazosin|mesh-list
25470900|NCT02538744|Cocaine|cocaine|mesh-list
25470901|NCT02538744|Modafinil|modafinil|mesh-list
25470902|NCT02538744|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25470903|NCT02538744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470904|NCT02538744|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25470905|NCT02538744|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25470906|NCT02538744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25470907|NCT02538744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470908|NCT02538744|Anesthetics, Local|anesthetics, local|mesh-ancestor
25470909|NCT02538744|Anesthetics|anesthetics|mesh-ancestor
25470910|NCT02538744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25470911|NCT02538744|Sensory System Agents|sensory system agents|mesh-ancestor
25470912|NCT02538744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25470913|NCT02538744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25470914|NCT02538744|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25470915|NCT02538744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25470916|NCT02538744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25470917|NCT02538744|Dopamine Agents|dopamine agents|mesh-ancestor
25470918|NCT02538744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25470919|NCT02538744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25470920|NCT02538744|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25470921|NCT02538744|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25470922|NCT02538744|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25470923|NCT02538744|Adrenergic Agents|adrenergic agents|mesh-ancestor
25470924|NCT02308202|Perindopril|perindopril|mesh-list
25470925|NCT02308202|Doxazosin|doxazosin|mesh-list
25470926|NCT02308202|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25470927|NCT02308202|Protease Inhibitors|protease inhibitors|mesh-ancestor
25470928|NCT02308202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470929|NCT02308202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470930|NCT02308202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25470931|NCT02308202|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25470932|NCT02308202|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25470933|NCT02308202|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25470934|NCT02308202|Adrenergic Agents|adrenergic agents|mesh-ancestor
25470935|NCT02308202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25470936|NCT02308202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470937|NCT02207712|Ranibizumab|ranibizumab|mesh-list
25470938|NCT02207712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25470939|NCT02207712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25470940|NCT02207712|Growth Substances|growth substances|mesh-ancestor
25470941|NCT02207712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470942|NCT02207712|Growth Inhibitors|growth inhibitors|mesh-ancestor
25470943|NCT02207712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470944|NCT02119468|Dexamethasone|dexamethasone|mesh-list
25470945|NCT02119468|Pomalidomide|pomalidomide|mesh-list
25470946|NCT02119468|Ixazomib|ixazomib|mesh-list
25470947|NCT02119468|Glycine|glycine|mesh-list
25470948|NCT02119468|Proteasome Inhibitors|proteasome inhibitors|mesh-list
25470949|NCT02119468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25470950|NCT02119468|Antiemetics|antiemetics|mesh-ancestor
25470951|NCT02119468|Autonomic Agents|autonomic agents|mesh-ancestor
25470952|NCT02119468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25470953|NCT02119468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25470954|NCT02119468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25470955|NCT02119468|Glucocorticoids|glucocorticoids|mesh-ancestor
25470956|NCT02119468|Hormones|hormones|mesh-ancestor
25470957|NCT02119468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25470958|NCT02119468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25470959|NCT02119468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25470960|NCT02119468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25470961|NCT02119468|Immunologic Factors|immunologic factors|mesh-ancestor
25470962|NCT02119468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25470963|NCT02119468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25470964|NCT02119468|Growth Substances|growth substances|mesh-ancestor
25470965|NCT02119468|Growth Inhibitors|growth inhibitors|mesh-ancestor
25470966|NCT02119468|Protease Inhibitors|protease inhibitors|mesh-ancestor
25470967|NCT02119468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25470968|NCT02119468|Glycine Agents|glycine agents|mesh-ancestor
25470969|NCT02119468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25332197|NCT04799639|Paclitaxel|paclitaxel|mesh-list
25470999|NCT01881308|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
25471000|NCT01881308|Antirheumatic Agents|antirheumatic agents|mesh-list
25471001|NCT01881308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25471002|NCT01742299|Imatinib Mesylate|imatinib mesylate|mesh-list
25471003|NCT01742299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471004|NCT01742299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25471005|NCT01742299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471006|NCT01742299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471007|NCT01516216|Vitamin D|vitamin d|mesh-list
25471008|NCT01516216|Leucovorin|leucovorin|mesh-list
25471009|NCT01516216|Bevacizumab|bevacizumab|mesh-list
25471010|NCT01516216|Fluorouracil|fluorouracil|mesh-list
25471011|NCT01516216|Oxaliplatin|oxaliplatin|mesh-list
25471012|NCT01516216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25471013|NCT01516216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471014|NCT01516216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25471015|NCT01516216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25471016|NCT01516216|Growth Substances|growth substances|mesh-ancestor
25471017|NCT01516216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471018|NCT01516216|Growth Inhibitors|growth inhibitors|mesh-ancestor
25471019|NCT01516216|Vitamins|vitamins|mesh-ancestor
25471020|NCT01516216|Micronutrients|micronutrients|mesh-ancestor
25471021|NCT01516216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25471022|NCT01516216|Antimetabolites|antimetabolites|mesh-ancestor
25471023|NCT01516216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471024|NCT01516216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25471025|NCT01516216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25471026|NCT01516216|Immunologic Factors|immunologic factors|mesh-ancestor
25471027|NCT01516216|Antidotes|antidotes|mesh-ancestor
25471028|NCT01516216|Protective Agents|protective agents|mesh-ancestor
25471029|NCT01516216|Vitamin B Complex|vitamin b complex|mesh-ancestor
25471030|NCT01062451|Candesartan|candesartan|mesh-list
25471031|NCT01062451|Perindopril|perindopril|mesh-list
25471032|NCT01062451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25471033|NCT01062451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25471034|NCT01062451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25471035|NCT01062451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471036|NCT01062451|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25471037|NCT01062451|Protease Inhibitors|protease inhibitors|mesh-ancestor
25471038|NCT01062451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471039|NCT00519818|Hydrocortisone|hydrocortisone|mesh-list
25471040|NCT00519818|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25471041|NCT00519818|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25471042|NCT00519818|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25471043|NCT00519818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25471044|NCT00006178|Sirolimus|sirolimus|mesh-list
25471045|NCT00006178|Thymoglobulin|thymoglobulin|mesh-list
25471046|NCT00006178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25471047|NCT00006178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25471048|NCT00006178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25471049|NCT00006178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471050|NCT00006178|Antifungal Agents|antifungal agents|mesh-ancestor
25471051|NCT00006178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25471052|NCT00006178|Immunologic Factors|immunologic factors|mesh-ancestor
25471053|NCT00006178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471054|NCT00006184|Cyclosporine|cyclosporine|mesh-list
25471055|NCT00006184|Prednisone|prednisone|mesh-list
25471056|NCT00006184|Cyclophosphamide|cyclophosphamide|mesh-list
25471057|NCT00006184|Doxorubicin|doxorubicin|mesh-list
25471058|NCT00006184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25471059|NCT00006184|Methotrexate|methotrexate|mesh-list
25471060|NCT00006184|Fludarabine|fludarabine|mesh-list
25471061|NCT00006184|Fludarabine phosphate|fludarabine phosphate|mesh-list
25471062|NCT00006184|Etoposide|etoposide|mesh-list
25471063|NCT00006184|Vincristine|vincristine|mesh-list
25471064|NCT00006184|Bortezomib|bortezomib|mesh-list
25471065|NCT00006184|Molgramostim|molgramostim|mesh-list
25332327|NCT04797338|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
25332328|NCT04797338|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
25332329|NCT04797338|Estradiol|estradiol|mesh-list
25332330|NCT04797338|Progestins|progestins|mesh-ancestor
25332331|NCT04797338|Hormones|hormones|mesh-ancestor
25332332|NCT04797338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25332333|NCT04797338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332353|NCT04796857|Antibodies|antibodies|mesh-list
25471066|NCT00006184|Cyclosporins|cyclosporins|mesh-list
25471067|NCT00006184|Immunoglobulins|immunoglobulins|mesh-list
25471068|NCT00006184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25471069|NCT00006184|Antibodies|antibodies|mesh-list
25471070|NCT00006184|Lenograstim|lenograstim|mesh-list
25471071|NCT00006184|Sargramostim|sargramostim|mesh-list
25471072|NCT00006184|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
25471073|NCT00006184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25471074|NCT00006184|Immunologic Factors|immunologic factors|mesh-ancestor
25471075|NCT00006184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471076|NCT00006184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25471077|NCT00006184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25471078|NCT00006184|Alkylating Agents|alkylating agents|mesh-ancestor
25471079|NCT00006184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471080|NCT00006184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471081|NCT00006184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25471082|NCT00006184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25471083|NCT00006184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25471084|NCT00006184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25471085|NCT00006184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471086|NCT00006184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25471087|NCT00006184|Glucocorticoids|glucocorticoids|mesh-ancestor
25471089|NCT00006184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25471090|NCT00006184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25471091|NCT00006184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25471092|NCT00006184|Abortifacient Agents|abortifacient agents|mesh-ancestor
25471093|NCT00006184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25471094|NCT00006184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25471095|NCT00006184|Antimetabolites|antimetabolites|mesh-ancestor
25471096|NCT00006184|Dermatologic Agents|dermatologic agents|mesh-ancestor
25471097|NCT00006184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25471098|NCT00006184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25471099|NCT00006184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25471100|NCT00006184|Tubulin Modulators|tubulin modulators|mesh-ancestor
25471101|NCT00006184|Antimitotic Agents|antimitotic agents|mesh-ancestor
25471102|NCT00006184|Mitosis Modulators|mitosis modulators|mesh-ancestor
25471103|NCT00006184|Antifungal Agents|antifungal agents|mesh-ancestor
25471104|NCT00006184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25471105|NCT00006184|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25471106|NCT00006184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25471107|NCT00006227|Paclitaxel|paclitaxel|mesh-list
25471108|NCT00006227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25471109|NCT00006227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471110|NCT00006227|Tubulin Modulators|tubulin modulators|mesh-ancestor
25471111|NCT00006227|Antimitotic Agents|antimitotic agents|mesh-ancestor
25644768|NCT01440569|Darunavir|darunavir|mesh-list
25471112|NCT00006227|Mitosis Modulators|mitosis modulators|mesh-ancestor
25471113|NCT00006227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471114|NCT00006237|Interferons|interferons|mesh-list
25471115|NCT00006237|Interferon-alpha|interferon-alpha|mesh-list
25471116|NCT00006237|Aldesleukin|aldesleukin|mesh-list
25471117|NCT00006237|Cisplatin|cisplatin|mesh-list
25644769|NCT01440569|Cobicistat|cobicistat|mesh-list
25471118|NCT00006237|Interleukin-2|interleukin-2|mesh-list
25471119|NCT00006237|Dacarbazine|dacarbazine|mesh-list
25471120|NCT00006237|Vinblastine|vinblastine|mesh-list
25471121|NCT00006237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471122|NCT00006237|Antiviral Agents|antiviral agents|mesh-ancestor
25471123|NCT00006237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25471124|NCT00006237|Immunologic Factors|immunologic factors|mesh-ancestor
25471125|NCT00006237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471126|NCT00006237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25471127|NCT00006237|Analgesics|analgesics|mesh-ancestor
25471128|NCT00006237|Sensory System Agents|sensory system agents|mesh-ancestor
25471129|NCT00006237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25471130|NCT00006237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25471131|NCT00006237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25471132|NCT00006237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25471133|NCT00006237|Alkylating Agents|alkylating agents|mesh-ancestor
25332397|NCT04796714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25332398|NCT04796714|Antipyretics|antipyretics|mesh-ancestor
25332399|NCT04796428|Dapagliflozin|dapagliflozin|mesh-list
25332400|NCT04796428|Empagliflozin|empagliflozin|mesh-list
25332401|NCT04796428|Canagliflozin|canagliflozin|mesh-list
25332402|NCT04796428|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25332403|NCT04796428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332404|NCT04796428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25332405|NCT04796428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332406|NCT04796675|Cyclophosphamide|cyclophosphamide|mesh-list
25332407|NCT04796675|Fludarabine|fludarabine|mesh-list
25013799|NCT05222113|Remdesivir|remdesivir|mesh-list
25471134|NCT00006237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471135|NCT00006237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25471136|NCT00006237|Tubulin Modulators|tubulin modulators|mesh-ancestor
25471137|NCT00006237|Antimitotic Agents|antimitotic agents|mesh-ancestor
25471138|NCT00006237|Mitosis Modulators|mitosis modulators|mesh-ancestor
25471139|NCT00006244|Interferons|interferons|mesh-list
25471140|NCT00006244|Interferon-alpha|interferon-alpha|mesh-list
25471141|NCT00006244|Aldesleukin|aldesleukin|mesh-list
25471142|NCT00006244|Interferon alpha-2|interferon alpha-2|mesh-list
25471143|NCT00006244|Melphalan|melphalan|mesh-list
25471144|NCT00006244|Interleukin-2|interleukin-2|mesh-list
25471145|NCT00006244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471146|NCT00006244|Antiviral Agents|antiviral agents|mesh-ancestor
25471147|NCT00006244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25471148|NCT00006244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25471149|NCT00006244|Alkylating Agents|alkylating agents|mesh-ancestor
25471150|NCT00006244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471151|NCT00006244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25471152|NCT00006244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25471153|NCT00006244|Immunologic Factors|immunologic factors|mesh-ancestor
25471154|NCT00006244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471155|NCT00006244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25471156|NCT00006244|Analgesics|analgesics|mesh-ancestor
25471157|NCT00006244|Sensory System Agents|sensory system agents|mesh-ancestor
25471158|NCT00006244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25471159|NCT00006244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25471160|NCT00006244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25471161|NCT00006289|Neurotropin|neurotropin|mesh-list
25471162|NCT00006289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25471163|NCT00006289|Immunologic Factors|immunologic factors|mesh-ancestor
25471164|NCT00006289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471165|NCT00006289|Analgesics|analgesics|mesh-ancestor
25471166|NCT00006289|Sensory System Agents|sensory system agents|mesh-ancestor
25471167|NCT00006289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25471168|NCT00006289|Anticonvulsants|anticonvulsants|mesh-ancestor
25471169|NCT00006305|Biguanides|biguanides|mesh-list
25471170|NCT00006305|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
25471171|NCT00006305|Calcium Channel Blockers|calcium channel blockers|mesh-list
25471172|NCT00006305|Calcium|calcium|mesh-list
25471173|NCT00006305|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25471174|NCT00006305|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25471175|NCT00006305|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
25471176|NCT00006305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25471177|NCT00006305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471178|NCT00006305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25471179|NCT00006305|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25471180|NCT00006305|Adrenergic Agents|adrenergic agents|mesh-ancestor
25471181|NCT00006305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24461678|NCT00353054|Antacids|antacids|mesh-ancestor
25644770|NCT01440569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25644771|NCT01440569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25471182|NCT00006305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471183|NCT00006305|Protease Inhibitors|protease inhibitors|mesh-ancestor
25471184|NCT00006305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471185|NCT00006305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25471186|NCT00006389|Cisplatin|cisplatin|mesh-list
25471187|NCT00006389|Bryostatin 1|bryostatin 1|mesh-list
25471188|NCT00006389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471189|NCT00006389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25471190|NCT00006389|Immunologic Factors|immunologic factors|mesh-ancestor
25471191|NCT00006389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471192|NCT00006392|Vitamins|vitamins|mesh-list
25471193|NCT00006392|Vitamin E|vitamin e|mesh-list
25471194|NCT00006392|Tocopherols|tocopherols|mesh-list
25471195|NCT00006392|Tocotrienols|tocotrienols|mesh-list
25471196|NCT00006392|alpha-Tocopherol|alpha-tocopherol|mesh-list
25471197|NCT00006392|Selenium|selenium|mesh-list
25471198|NCT00006392|Micronutrients|micronutrients|mesh-ancestor
25471199|NCT00006392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471200|NCT00006392|Antioxidants|antioxidants|mesh-ancestor
25471201|NCT00006392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471202|NCT00006392|Protective Agents|protective agents|mesh-ancestor
25471203|NCT00006392|Trace Elements|trace elements|mesh-ancestor
25471204|NCT00006400|Hydroxyurea|hydroxyurea|mesh-list
25332473|NCT04794231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25332474|NCT04794231|Disinfectants|disinfectants|mesh-ancestor
25332475|NCT04794231|Dermatologic Agents|dermatologic agents|mesh-ancestor
25332476|NCT04794413|Pimavanserin|pimavanserin|mesh-list
25332477|NCT04794413|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25332478|NCT04794413|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25332486|NCT04794413|Serotonin Agents|serotonin agents|mesh-ancestor
25471205|NCT00006400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471206|NCT00006400|Antisickling Agents|antisickling agents|mesh-ancestor
25471207|NCT00006400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471208|NCT00006400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471209|NCT00006400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25471210|NCT00006489|Naltrexone|naltrexone|mesh-list
25471211|NCT00006489|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25471212|NCT00006489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25471213|NCT00006489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471214|NCT00006489|Sensory System Agents|sensory system agents|mesh-ancestor
25471215|NCT00006489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25471216|NCT00006604|Ritonavir|ritonavir|mesh-list
25471217|NCT00006604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25471218|NCT00006604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25471219|NCT00006604|Protease Inhibitors|protease inhibitors|mesh-ancestor
25471220|NCT00006604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471221|NCT00006604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471222|NCT00006604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25471223|NCT00006604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25471224|NCT00006604|Antiviral Agents|antiviral agents|mesh-ancestor
25471225|NCT00006604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25471226|NCT00006604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25471227|NCT00006604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25471228|NCT00006903|Fulvestrant|fulvestrant|mesh-list
25471229|NCT00006903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25471230|NCT00006903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471231|NCT00006903|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25471232|NCT00006903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25471233|NCT00006903|Hormone Antagonists|hormone antagonists|mesh-ancestor
25471234|NCT00006903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25471235|NCT00006903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471236|NCT00007020|Cholic Acids|cholic acids|mesh-list
25471237|NCT00007020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25471238|NCT00007345|Romidepsin|romidepsin|mesh-list
25471239|NCT00007345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25471240|NCT00007345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471241|NCT00007475|Cyclophosphamide|cyclophosphamide|mesh-list
25471242|NCT00007475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25471243|NCT00007475|Immunologic Factors|immunologic factors|mesh-ancestor
25471244|NCT00007475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471245|NCT00007475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25471246|NCT00007475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25471247|NCT00007475|Alkylating Agents|alkylating agents|mesh-ancestor
25471248|NCT00007475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471249|NCT00007475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471250|NCT00007475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25471252|NCT00008138|Carboplatin|carboplatin|mesh-list
25471253|NCT00008138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25471254|NCT00008138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471255|NCT00008138|Tubulin Modulators|tubulin modulators|mesh-ancestor
25471256|NCT00008138|Antimitotic Agents|antimitotic agents|mesh-ancestor
25471257|NCT00008138|Mitosis Modulators|mitosis modulators|mesh-ancestor
25471258|NCT00008138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471259|NCT00008385|Selenium|selenium|mesh-list
25471260|NCT00008385|Antioxidants|antioxidants|mesh-ancestor
25471261|NCT00008385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471262|NCT00008385|Protective Agents|protective agents|mesh-ancestor
25471263|NCT00008385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471264|NCT00008385|Trace Elements|trace elements|mesh-ancestor
25471265|NCT00008385|Micronutrients|micronutrients|mesh-ancestor
25471266|NCT00009737|Leucovorin|leucovorin|mesh-list
25471267|NCT00009737|Fluorouracil|fluorouracil|mesh-list
25471268|NCT00009737|Capecitabine|capecitabine|mesh-list
25471269|NCT00009737|Antimetabolites|antimetabolites|mesh-ancestor
25471270|NCT00009737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471271|NCT00009737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25471272|NCT00009737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471273|NCT00009737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25471274|NCT00009737|Immunologic Factors|immunologic factors|mesh-ancestor
25471275|NCT00009737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471276|NCT00009737|Antidotes|antidotes|mesh-ancestor
25471277|NCT00009737|Protective Agents|protective agents|mesh-ancestor
25471278|NCT00009737|Vitamin B Complex|vitamin b complex|mesh-ancestor
25471279|NCT00009737|Vitamins|vitamins|mesh-ancestor
25471280|NCT00009737|Micronutrients|micronutrients|mesh-ancestor
25471281|NCT00009945|Clodronic Acid|clodronic acid|mesh-list
25471282|NCT00009945|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25471283|NCT00009945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471284|NCT00010257|Paclitaxel|paclitaxel|mesh-list
25471285|NCT00010257|Carboplatin|carboplatin|mesh-list
25471286|NCT00010257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25471287|NCT00010257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471288|NCT00010257|Tubulin Modulators|tubulin modulators|mesh-ancestor
25471289|NCT00010257|Antimitotic Agents|antimitotic agents|mesh-ancestor
25471290|NCT00010257|Mitosis Modulators|mitosis modulators|mesh-ancestor
25471291|NCT00010257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471292|NCT00010439|Alendronate|alendronate|mesh-list
25471293|NCT00010439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25471294|NCT00010439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471295|NCT00011986|Gemcitabine|gemcitabine|mesh-list
25471296|NCT00011986|Paclitaxel|paclitaxel|mesh-list
25471297|NCT00011986|Carboplatin|carboplatin|mesh-list
25471298|NCT00011986|Doxorubicin|doxorubicin|mesh-list
25471299|NCT00011986|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25471300|NCT00011986|Topotecan|topotecan|mesh-list
25471301|NCT00011986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25471302|NCT00011986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471303|NCT00011986|Tubulin Modulators|tubulin modulators|mesh-ancestor
25471304|NCT00011986|Antimitotic Agents|antimitotic agents|mesh-ancestor
25471305|NCT00011986|Mitosis Modulators|mitosis modulators|mesh-ancestor
25471306|NCT00011986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471307|NCT00011986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25471308|NCT00011986|Antimetabolites|antimetabolites|mesh-ancestor
25471309|NCT00011986|Antiviral Agents|antiviral agents|mesh-ancestor
25471310|NCT00011986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25471311|NCT00011986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471312|NCT00011986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25471313|NCT00011986|Immunologic Factors|immunologic factors|mesh-ancestor
25471314|NCT00011986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471315|NCT00011986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25471316|NCT00011986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25471317|NCT00011986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25471318|NCT00011986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25471319|NCT00012012|Cisplatin|cisplatin|mesh-list
25471320|NCT00012012|Amifostine|amifostine|mesh-list
25471321|NCT00012012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471322|NCT00012012|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25471323|NCT00012012|Protective Agents|protective agents|mesh-ancestor
25471324|NCT00012012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471325|NCT00012298|Rituximab|rituximab|mesh-list
25471326|NCT00012298|Oprelvekin|oprelvekin|mesh-list
25471327|NCT00012298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25644772|NCT01440569|Protease Inhibitors|protease inhibitors|mesh-ancestor
25471328|NCT00012298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25471329|NCT00012298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471330|NCT00012298|Immunologic Factors|immunologic factors|mesh-ancestor
25471331|NCT00012298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471332|NCT00012298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25471333|NCT00013611|Aldesleukin|aldesleukin|mesh-list
25471334|NCT00013611|Interleukin-2|interleukin-2|mesh-list
25471335|NCT00013611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471336|NCT00013611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25471337|NCT00013611|Analgesics|analgesics|mesh-ancestor
25471338|NCT00013611|Sensory System Agents|sensory system agents|mesh-ancestor
25471339|NCT00013611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25471340|NCT00013611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471341|NCT00013611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25471342|NCT00013611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25471343|NCT00013611|Antiviral Agents|antiviral agents|mesh-ancestor
25471344|NCT00013611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25471345|NCT00014222|Paclitaxel|paclitaxel|mesh-list
25471346|NCT00014222|Cyclophosphamide|cyclophosphamide|mesh-list
25471347|NCT00014222|Doxorubicin|doxorubicin|mesh-list
25471348|NCT00014222|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25471349|NCT00014222|Fluorouracil|fluorouracil|mesh-list
25471350|NCT00014222|Epirubicin|epirubicin|mesh-list
25471351|NCT00014222|Epoetin Alfa|epoetin alfa|mesh-list
25471352|NCT00014222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25471353|NCT00014222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471354|NCT00014222|Tubulin Modulators|tubulin modulators|mesh-ancestor
25471355|NCT00014222|Antimitotic Agents|antimitotic agents|mesh-ancestor
25471356|NCT00014222|Mitosis Modulators|mitosis modulators|mesh-ancestor
25471357|NCT00014222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471358|NCT00014222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25471360|NCT00014222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471361|NCT00014222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25471362|NCT00014222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25471363|NCT00014222|Alkylating Agents|alkylating agents|mesh-ancestor
25471364|NCT00014222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25471365|NCT00014222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25471366|NCT00014222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25471367|NCT00014222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25471368|NCT00014222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471369|NCT00014222|Antimetabolites|antimetabolites|mesh-ancestor
25471370|NCT00014222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25471371|NCT00014222|Hematinics|hematinics|mesh-ancestor
25471372|NCT00014495|Cytarabine|cytarabine|mesh-list
25471373|NCT00014495|Bismuth|bismuth|mesh-list
25471374|NCT00014495|Antibodies|antibodies|mesh-list
25471375|NCT00014495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25471376|NCT00014495|Immunologic Factors|immunologic factors|mesh-ancestor
25471377|NCT00014495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471378|NCT00014495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25471379|NCT00014495|Antimetabolites|antimetabolites|mesh-ancestor
25471380|NCT00014495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471381|NCT00014495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471382|NCT00014495|Antiviral Agents|antiviral agents|mesh-ancestor
25471383|NCT00014495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25471384|NCT00014495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25471385|NCT00014495|Antacids|antacids|mesh-ancestor
25471386|NCT00014495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25471387|NCT00014911|Sirolimus|sirolimus|mesh-list
25471388|NCT00014911|Pentamidine|pentamidine|mesh-list
25471389|NCT00014911|Trimethoprim|trimethoprim|mesh-list
25471390|NCT00014911|Sulfamethoxazole|sulfamethoxazole|mesh-list
25471391|NCT00014911|Ganciclovir|ganciclovir|mesh-list
25471392|NCT00014911|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25471393|NCT00014911|Tacrolimus|tacrolimus|mesh-list
25471394|NCT00014911|Daclizumab|daclizumab|mesh-list
25471395|NCT00014911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25471396|NCT00014911|Immunologic Factors|immunologic factors|mesh-ancestor
25471397|NCT00014911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471398|NCT00014911|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25471399|NCT00014911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471400|NCT00014911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471401|NCT00014911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25471402|NCT00014911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25471403|NCT00014911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25471404|NCT00014911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471405|NCT00014911|Antifungal Agents|antifungal agents|mesh-ancestor
25471406|NCT00014911|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25471407|NCT00014911|Renal Agents|renal agents|mesh-ancestor
25471408|NCT00014911|Antimalarials|antimalarials|mesh-ancestor
25471409|NCT00014911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25471410|NCT00014911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25471411|NCT00014911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25471412|NCT00014911|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25471413|NCT00014911|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25471414|NCT00014911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25471415|NCT00014911|Antiviral Agents|antiviral agents|mesh-ancestor
25471416|NCT00014911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25471417|NCT00014911|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25471418|NCT00015457|Amlodipine|amlodipine|mesh-list
25471419|NCT00015457|Botulinum Toxins|botulinum toxins|mesh-list
25471420|NCT00015457|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25471421|NCT00015457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25471422|NCT00015457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471423|NCT00015457|Cholinergic Agents|cholinergic agents|mesh-ancestor
25471424|NCT00015457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25471425|NCT00015457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471426|NCT00015457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25471427|NCT00015457|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25471428|NCT00015457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25471429|NCT00015457|Vasodilator Agents|vasodilator agents|mesh-ancestor
25471430|NCT00015847|Interferons|interferons|mesh-list
25471431|NCT00015847|Interferon-alpha|interferon-alpha|mesh-list
25471432|NCT00015847|Imatinib Mesylate|imatinib mesylate|mesh-list
25332699|NCT04791202|Methylprednisolone|methylprednisolone|mesh-list
25471433|NCT00015847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471434|NCT00015847|Antiviral Agents|antiviral agents|mesh-ancestor
25471435|NCT00015847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25471436|NCT00015847|Immunologic Factors|immunologic factors|mesh-ancestor
25471437|NCT00015847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471438|NCT00015847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25471439|NCT00015847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471440|NCT00015847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471441|NCT00016718|Emtricitabine|emtricitabine|mesh-list
25471442|NCT00016718|Efavirenz|efavirenz|mesh-list
25471443|NCT00016718|Didanosine|didanosine|mesh-list
25471444|NCT00016718|Antiviral Agents|antiviral agents|mesh-ancestor
25471445|NCT00016718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25471446|NCT00016718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25471447|NCT00016718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25471448|NCT00016718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471449|NCT00016718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471450|NCT00016718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25471451|NCT00016718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25471452|NCT00016718|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25471453|NCT00016718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25471454|NCT00016718|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25471455|NCT00016718|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25471456|NCT00016718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25471457|NCT00016718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25471458|NCT00016718|Antimetabolites|antimetabolites|mesh-ancestor
25471459|NCT00016913|Paclitaxel|paclitaxel|mesh-list
25471460|NCT00016913|Carboplatin|carboplatin|mesh-list
25471461|NCT00016913|Leuprolide|leuprolide|mesh-list
25471462|NCT00016913|Goserelin|goserelin|mesh-list
25471463|NCT00016913|Estramustine|estramustine|mesh-list
25471464|NCT00016913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25471465|NCT00016913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471466|NCT00016913|Tubulin Modulators|tubulin modulators|mesh-ancestor
25471467|NCT00016913|Antimitotic Agents|antimitotic agents|mesh-ancestor
25471468|NCT00016913|Mitosis Modulators|mitosis modulators|mesh-ancestor
25471469|NCT00016913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471470|NCT00016913|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25471471|NCT00016913|Fertility Agents|fertility agents|mesh-ancestor
25471472|NCT00016913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25471473|NCT00016913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471474|NCT00016913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25471475|NCT00016913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25471476|NCT00016913|Alkylating Agents|alkylating agents|mesh-ancestor
25471477|NCT00017563|Docetaxel|docetaxel|mesh-list
25471478|NCT00017563|Mitoxantrone|mitoxantrone|mesh-list
25471479|NCT00017563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471480|NCT00017563|Tubulin Modulators|tubulin modulators|mesh-ancestor
25471481|NCT00017563|Antimitotic Agents|antimitotic agents|mesh-ancestor
25471482|NCT00017563|Mitosis Modulators|mitosis modulators|mesh-ancestor
25471483|NCT00017563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471484|NCT00017563|Analgesics|analgesics|mesh-ancestor
25471485|NCT00017563|Sensory System Agents|sensory system agents|mesh-ancestor
25471486|NCT00017563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25471487|NCT00017563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471488|NCT00017563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25471489|NCT00017563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25471490|NCT00017563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471491|NCT00018031|Ribavirin|ribavirin|mesh-list
25471492|NCT00018031|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25471493|NCT00018031|Interferon-alpha|interferon-alpha|mesh-list
25471494|NCT00018031|Antimetabolites|antimetabolites|mesh-ancestor
25471495|NCT00018031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471496|NCT00018031|Antiviral Agents|antiviral agents|mesh-ancestor
25471497|NCT00018031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25471498|NCT00018031|Immunologic Factors|immunologic factors|mesh-ancestor
25332770|NCT04790383|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
25332771|NCT04790383|Vasodilator Agents|vasodilator agents|mesh-ancestor
25332772|NCT04790383|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25332773|NCT04790383|Protective Agents|protective agents|mesh-ancestor
25332774|NCT04790383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332775|NCT04790708|Octreotide|octreotide|mesh-list
25332776|NCT04790708|Edotreotide|edotreotide|mesh-list
25332777|NCT04790708|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
25332778|NCT04790708|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25332779|NCT04790708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332780|NCT04790708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25471499|NCT00018031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471500|NCT00019604|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25471501|NCT00019604|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25471502|NCT00019604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471503|NCT00019682|Aldesleukin|aldesleukin|mesh-list
25471504|NCT00019682|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25471505|NCT00019682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471506|NCT00019682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25471507|NCT00019682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25471508|NCT00019682|Antiviral Agents|antiviral agents|mesh-ancestor
25471509|NCT00019682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25471510|NCT00019682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25471511|NCT00019682|Immunologic Factors|immunologic factors|mesh-ancestor
25471512|NCT00019682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471513|NCT00021229|Imatinib Mesylate|imatinib mesylate|mesh-list
25471514|NCT00021229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471515|NCT00021229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25471516|NCT00021229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471517|NCT00021229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471518|NCT00021255|Cyclophosphamide|cyclophosphamide|mesh-list
25471519|NCT00021255|Carboplatin|carboplatin|mesh-list
25471520|NCT00021255|Docetaxel|docetaxel|mesh-list
25471521|NCT00021255|Doxorubicin|doxorubicin|mesh-list
25471522|NCT00021255|Trastuzumab|trastuzumab|mesh-list
25471523|NCT00021255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25471524|NCT00021255|Immunologic Factors|immunologic factors|mesh-ancestor
25471525|NCT00021255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471526|NCT00021255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25471527|NCT00021255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25471528|NCT00021255|Alkylating Agents|alkylating agents|mesh-ancestor
25471529|NCT00021255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471530|NCT00021255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471531|NCT00021255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25471532|NCT00021255|Tubulin Modulators|tubulin modulators|mesh-ancestor
25471533|NCT00021255|Antimitotic Agents|antimitotic agents|mesh-ancestor
25471534|NCT00021255|Mitosis Modulators|mitosis modulators|mesh-ancestor
25471535|NCT00021255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25471536|NCT00021255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25471537|NCT00021255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25471538|NCT00021255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471539|NCT00021255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25471540|NCT00021541|Tipifarnib|tipifarnib|mesh-list
25471541|NCT00021541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471542|NCT00022490|Cytarabine|cytarabine|mesh-list
25471543|NCT00022490|Imatinib Mesylate|imatinib mesylate|mesh-list
25471544|NCT00022490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25471545|NCT00022490|Antimetabolites|antimetabolites|mesh-ancestor
25471546|NCT00022490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471547|NCT00022490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471548|NCT00022490|Antiviral Agents|antiviral agents|mesh-ancestor
25471549|NCT00022490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25471550|NCT00022490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25471551|NCT00022490|Immunologic Factors|immunologic factors|mesh-ancestor
25471552|NCT00022490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471553|NCT00022490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25471554|NCT00022490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471555|NCT00022516|Cyclophosphamide|cyclophosphamide|mesh-list
25471556|NCT00022516|Methotrexate|methotrexate|mesh-list
25471557|NCT00022516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25471558|NCT00022516|Immunologic Factors|immunologic factors|mesh-ancestor
25471559|NCT00022516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471560|NCT00022516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25471561|NCT00022516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25471562|NCT00022516|Alkylating Agents|alkylating agents|mesh-ancestor
25471563|NCT00022516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471564|NCT00022516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332846|NCT04789915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25332847|NCT04789915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25332848|NCT04789915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25332849|NCT04789915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25332850|NCT04789915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25332851|NCT04789915|Antidepressive Agents|antidepressive agents|mesh-ancestor
25822891|NCT00004689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24609490|NCT00996983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25332861|NCT04789005|Phenylephrine|phenylephrine|mesh-list
25471565|NCT00022516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25471566|NCT00022516|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25471567|NCT00022516|Abortifacient Agents|abortifacient agents|mesh-ancestor
25471568|NCT00022516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25471569|NCT00022516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25471570|NCT00022516|Antimetabolites|antimetabolites|mesh-ancestor
25471571|NCT00022516|Dermatologic Agents|dermatologic agents|mesh-ancestor
25471572|NCT00022516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471573|NCT00022516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25471574|NCT00022516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25471575|NCT00022633|Gemcitabine|gemcitabine|mesh-list
25471576|NCT00022633|Paclitaxel|paclitaxel|mesh-list
25471577|NCT00022633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25344071|NCT05550532|Aticaprant|aticaprant|mesh-list
25471578|NCT00022633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471579|NCT00022633|Tubulin Modulators|tubulin modulators|mesh-ancestor
25471580|NCT00022633|Antimitotic Agents|antimitotic agents|mesh-ancestor
25471581|NCT00022633|Mitosis Modulators|mitosis modulators|mesh-ancestor
25471582|NCT00022633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471583|NCT00022633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25471584|NCT00022633|Antimetabolites|antimetabolites|mesh-ancestor
25471585|NCT00022633|Antiviral Agents|antiviral agents|mesh-ancestor
25471586|NCT00022633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25471587|NCT00022633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471588|NCT00022633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25471589|NCT00022633|Immunologic Factors|immunologic factors|mesh-ancestor
25471590|NCT00022633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471591|NCT00022659|Bevacizumab|bevacizumab|mesh-list
25471592|NCT00022659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25471593|NCT00022659|Antibodies|antibodies|mesh-list
25471594|NCT00022659|Immunoglobulins|immunoglobulins|mesh-list
25471595|NCT00022659|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25471596|NCT00022659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471597|NCT00022659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25471598|NCT00022659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25471599|NCT00022659|Growth Substances|growth substances|mesh-ancestor
25471600|NCT00022659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471601|NCT00022659|Growth Inhibitors|growth inhibitors|mesh-ancestor
25471602|NCT00022659|Immunologic Factors|immunologic factors|mesh-ancestor
25471603|NCT00022672|Trastuzumab|trastuzumab|mesh-list
25471604|NCT00022672|Anastrozole|anastrozole|mesh-list
25471605|NCT00022672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25471606|NCT00022672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471607|NCT00022672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25471608|NCT00022672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25471609|NCT00022672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25471610|NCT00022672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471611|NCT00022672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471612|NCT00022672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25471613|NCT00022672|Hormone Antagonists|hormone antagonists|mesh-ancestor
25471614|NCT00022672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25471615|NCT00022672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471617|NCT00022698|Irinotecan|irinotecan|mesh-list
25471618|NCT00022698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25471619|NCT00022698|Antimetabolites|antimetabolites|mesh-ancestor
25471620|NCT00022698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471621|NCT00022698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471622|NCT00022698|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25471623|NCT00022698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25471624|NCT00022698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471625|NCT00022763|Enfuvirtide|enfuvirtide|mesh-list
25471626|NCT00022763|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25471627|NCT00022763|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25471628|NCT00022763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471629|NCT00022763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25332922|NCT04788745|Trimetazidine|trimetazidine|mesh-list
25332923|NCT04788745|Vasodilator Agents|vasodilator agents|mesh-ancestor
25332924|NCT04788355|Hydroxychloroquine|hydroxychloroquine|mesh-list
25332925|NCT04788355|Apixaban|apixaban|mesh-list
25332926|NCT04788355|Antimalarials|antimalarials|mesh-ancestor
25332927|NCT04788355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25332928|NCT04788355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25332929|NCT04788355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25332930|NCT04788355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25332931|NCT04788355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471630|NCT00022763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25471631|NCT00022763|Antiviral Agents|antiviral agents|mesh-ancestor
25471632|NCT00022763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25471633|NCT00023309|Lamivudine|lamivudine|mesh-list
25471634|NCT00023309|Adefovir|adefovir|mesh-list
25471635|NCT00023309|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25471636|NCT00023309|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25471637|NCT00023309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25471638|NCT00023309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471639|NCT00023309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471640|NCT00023309|Antiviral Agents|antiviral agents|mesh-ancestor
25471641|NCT00023309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25471642|NCT00023309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25471643|NCT00023309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25723819|NCT02528253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25471644|NCT00023322|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25471645|NCT00023322|Antiviral Agents|antiviral agents|mesh-ancestor
25471646|NCT00023322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25471647|NCT00023452|Isoniazid|isoniazid|mesh-list
25471648|NCT00023452|Rifapentine|rifapentine|mesh-list
25471649|NCT00023452|Antitubercular Agents|antitubercular agents|mesh-ancestor
25471650|NCT00023452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25471651|NCT00023452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25471652|NCT00023452|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25471653|NCT00023452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25471654|NCT00023452|Antimetabolites|antimetabolites|mesh-ancestor
25471655|NCT00023452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471656|NCT00023452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25471657|NCT00023452|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25471658|NCT00023452|Leprostatic Agents|leprostatic agents|mesh-ancestor
25471659|NCT00023673|Paclitaxel|paclitaxel|mesh-list
25471660|NCT00023673|Carboplatin|carboplatin|mesh-list
25471661|NCT00023673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25471662|NCT00023673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471663|NCT00023673|Tubulin Modulators|tubulin modulators|mesh-ancestor
25471664|NCT00023673|Antimitotic Agents|antimitotic agents|mesh-ancestor
25471665|NCT00023673|Mitosis Modulators|mitosis modulators|mesh-ancestor
25471666|NCT00023673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471667|NCT00023712|Bortezomib|bortezomib|mesh-list
25471668|NCT00023712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471669|NCT00023764|Bortezomib|bortezomib|mesh-list
25471670|NCT00023764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471671|NCT00024102|Doxorubicin|doxorubicin|mesh-list
25471672|NCT00024102|Capecitabine|capecitabine|mesh-list
25471673|NCT00024102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25471674|NCT00024102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471675|NCT00024102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25471676|NCT00024102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25471677|NCT00024102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471678|NCT00024102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471679|NCT00024102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25471680|NCT00024102|Antimetabolites|antimetabolites|mesh-ancestor
25471681|NCT00024167|Ketoconazole|ketoconazole|mesh-list
25471682|NCT00024167|Dexamethasone|dexamethasone|mesh-list
25471684|NCT00024167|Estramustine|estramustine|mesh-list
25471685|NCT00024167|Docetaxel|docetaxel|mesh-list
25471686|NCT00024167|Doxorubicin|doxorubicin|mesh-list
25471687|NCT00024167|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25471688|NCT00024167|Vinblastine|vinblastine|mesh-list
25471689|NCT00024167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25471690|NCT00024167|Antiemetics|antiemetics|mesh-ancestor
25471691|NCT00024167|Autonomic Agents|autonomic agents|mesh-ancestor
25471692|NCT00024167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25471693|NCT00024167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332996|NCT04787731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25332997|NCT04787731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25332998|NCT04787731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332999|NCT04787289|Bevacizumab|bevacizumab|mesh-list
25333000|NCT04787289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25333001|NCT04787289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25333002|NCT04787289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25333003|NCT04787289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25333004|NCT04787289|Growth Substances|growth substances|mesh-ancestor
25333005|NCT04787289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333006|NCT04787289|Growth Inhibitors|growth inhibitors|mesh-ancestor
25333007|NCT04787276|Rifaximin|rifaximin|mesh-list
25333008|NCT04787276|Lactulose|lactulose|mesh-list
25471694|NCT00024167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25471695|NCT00024167|Glucocorticoids|glucocorticoids|mesh-ancestor
25471696|NCT00024167|Hormones|hormones|mesh-ancestor
25471697|NCT00024167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25471698|NCT00024167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25471699|NCT00024167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471700|NCT00024167|Tubulin Modulators|tubulin modulators|mesh-ancestor
25471701|NCT00024167|Antimitotic Agents|antimitotic agents|mesh-ancestor
25471702|NCT00024167|Mitosis Modulators|mitosis modulators|mesh-ancestor
25471703|NCT00024167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471704|NCT00024167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25471705|NCT00024167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25471706|NCT00024167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25471707|NCT00024167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471708|NCT00024167|Antifungal Agents|antifungal agents|mesh-ancestor
25471709|NCT00024167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25471710|NCT00024167|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25471711|NCT00024167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25471712|NCT00024167|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25471713|NCT00024167|Hormone Antagonists|hormone antagonists|mesh-ancestor
25471714|NCT00024167|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25471715|NCT00024167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25471716|NCT00024167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25471717|NCT00024167|Alkylating Agents|alkylating agents|mesh-ancestor
25471718|NCT00024258|Arsenic Trioxide|arsenic trioxide|mesh-list
25471719|NCT00024258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471720|NCT00025155|Epothilones|epothilones|mesh-list
25471721|NCT00025155|Epothilone B|epothilone b|mesh-list
25471722|NCT00025155|Tubulin Modulators|tubulin modulators|mesh-ancestor
25471723|NCT00025155|Antimitotic Agents|antimitotic agents|mesh-ancestor
25471724|NCT00025155|Mitosis Modulators|mitosis modulators|mesh-ancestor
25471725|NCT00025155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471726|NCT00025155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471727|NCT00025233|Bevacizumab|bevacizumab|mesh-list
25471728|NCT00025233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25471729|NCT00025233|Antibodies|antibodies|mesh-list
25471730|NCT00025233|Immunoglobulins|immunoglobulins|mesh-list
25471731|NCT00025233|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25471732|NCT00025233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471733|NCT00025233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25471734|NCT00025233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25471735|NCT00025233|Growth Substances|growth substances|mesh-ancestor
25471736|NCT00025233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471737|NCT00025233|Growth Inhibitors|growth inhibitors|mesh-ancestor
25471738|NCT00025233|Immunologic Factors|immunologic factors|mesh-ancestor
25471739|NCT00025259|Cytarabine|cytarabine|mesh-list
25471740|NCT00025259|Dexamethasone|dexamethasone|mesh-list
25471741|NCT00025259|Prednisone|prednisone|mesh-list
24398496|NCT00144703|Sirolimus|sirolimus|mesh-list
25644773|NCT01440569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471742|NCT00025259|Dexamethasone acetate|dexamethasone acetate|mesh-list
25471743|NCT00025259|Cortisone|cortisone|mesh-list
25471744|NCT00025259|Cyclophosphamide|cyclophosphamide|mesh-list
25471745|NCT00025259|Cisplatin|cisplatin|mesh-list
25471746|NCT00025259|Doxorubicin|doxorubicin|mesh-list
25471747|NCT00025259|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25471748|NCT00025259|Etoposide|etoposide|mesh-list
25471749|NCT00025259|Vincristine|vincristine|mesh-list
25471750|NCT00025259|Etoposide phosphate|etoposide phosphate|mesh-list
25471751|NCT00025259|Bleomycin|bleomycin|mesh-list
25471752|NCT00025259|Podophyllotoxin|podophyllotoxin|mesh-list
25471753|NCT00025259|Lenograstim|lenograstim|mesh-list
25471754|NCT00025259|BB 1101|bb 1101|mesh-list
25471755|NCT00025259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25471756|NCT00025259|Immunologic Factors|immunologic factors|mesh-ancestor
25471757|NCT00025259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471758|NCT00025259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25471759|NCT00025259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25471760|NCT00025259|Alkylating Agents|alkylating agents|mesh-ancestor
25333073|NCT04785755|Furosemide|furosemide|mesh-list
25333074|NCT04785755|Spironolactone|spironolactone|mesh-list
25333075|NCT04785755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25333076|NCT04785755|Diuretics|diuretics|mesh-list
25333077|NCT04785755|Natriuretic Agents|natriuretic agents|mesh-ancestor
25333078|NCT04785755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333079|NCT04785755|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25333080|NCT04785755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25333081|NCT04785755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471761|NCT00025259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471762|NCT00025259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471763|NCT00025259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25471764|NCT00025259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25471765|NCT00025259|Antiemetics|antiemetics|mesh-ancestor
25471766|NCT00025259|Autonomic Agents|autonomic agents|mesh-ancestor
25471767|NCT00025259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25471768|NCT00025259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25471769|NCT00025259|Glucocorticoids|glucocorticoids|mesh-ancestor
25471770|NCT00025259|Hormones|hormones|mesh-ancestor
25471771|NCT00025259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25471772|NCT00025259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25471773|NCT00025259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25471774|NCT00025259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25471775|NCT00025259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25471776|NCT00025259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471777|NCT00025259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25471778|NCT00025259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25471779|NCT00025259|Antimetabolites|antimetabolites|mesh-ancestor
25471780|NCT00025259|Antiviral Agents|antiviral agents|mesh-ancestor
25471781|NCT00025259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25471782|NCT00025259|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25471783|NCT00025259|Tubulin Modulators|tubulin modulators|mesh-ancestor
25471784|NCT00025259|Antimitotic Agents|antimitotic agents|mesh-ancestor
25471785|NCT00025259|Mitosis Modulators|mitosis modulators|mesh-ancestor
25471786|NCT00025259|Protease Inhibitors|protease inhibitors|mesh-ancestor
25471787|NCT00025259|Dermatologic Agents|dermatologic agents|mesh-ancestor
25471788|NCT00025259|Keratolytic Agents|keratolytic agents|mesh-ancestor
25471789|NCT00025506|Thalidomide|thalidomide|mesh-list
25471790|NCT00025506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25471791|NCT00025506|Immunologic Factors|immunologic factors|mesh-ancestor
25471792|NCT00025506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471793|NCT00025506|Leprostatic Agents|leprostatic agents|mesh-ancestor
25471794|NCT00025506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25471795|NCT00025506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25471796|NCT00025506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25471797|NCT00025506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25471798|NCT00025506|Growth Substances|growth substances|mesh-ancestor
25471799|NCT00025506|Growth Inhibitors|growth inhibitors|mesh-ancestor
25471800|NCT00025506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471801|NCT00025662|Interleukin-2|interleukin-2|mesh-list
25471802|NCT00025662|Immunotoxins|immunotoxins|mesh-list
25471803|NCT00025662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471804|NCT00025662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25471805|NCT00025662|Analgesics|analgesics|mesh-ancestor
25471806|NCT00025662|Sensory System Agents|sensory system agents|mesh-ancestor
25471807|NCT00025662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25471808|NCT00025662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471809|NCT00025662|Immunologic Factors|immunologic factors|mesh-ancestor
25471811|NCT00026208|Cyclophosphamide|cyclophosphamide|mesh-list
25471812|NCT00026208|Doxorubicin|doxorubicin|mesh-list
25471813|NCT00026208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25471814|NCT00026208|Etoposide|etoposide|mesh-list
25471815|NCT00026208|Etoposide phosphate|etoposide phosphate|mesh-list
25471816|NCT00026208|Vincristine|vincristine|mesh-list
25471817|NCT00026208|Bleomycin|bleomycin|mesh-list
25471818|NCT00026208|Vinblastine|vinblastine|mesh-list
25471819|NCT00026208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25471820|NCT00026208|Immunologic Factors|immunologic factors|mesh-ancestor
25471821|NCT00026208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471822|NCT00026208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25471823|NCT00026208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25471824|NCT00026208|Alkylating Agents|alkylating agents|mesh-ancestor
25471825|NCT00026208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471826|NCT00026208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471827|NCT00026208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25471828|NCT00026208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25471829|NCT00026208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25333148|NCT04785118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25333149|NCT04785118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333150|NCT04785118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25333151|NCT04785118|Antipruritics|antipruritics|mesh-ancestor
25333152|NCT04785118|Dermatologic Agents|dermatologic agents|mesh-ancestor
25333153|NCT04785118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25333154|NCT04785118|Serotonin Agents|serotonin agents|mesh-ancestor
25333155|NCT04785118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25333157|NCT04785118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25471830|NCT00026208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25471831|NCT00026208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471832|NCT00026208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25471833|NCT00026208|Glucocorticoids|glucocorticoids|mesh-ancestor
25471835|NCT00026208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25471836|NCT00026208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25471837|NCT00026208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25471838|NCT00026208|Tubulin Modulators|tubulin modulators|mesh-ancestor
25471839|NCT00026208|Antimitotic Agents|antimitotic agents|mesh-ancestor
25471840|NCT00026208|Mitosis Modulators|mitosis modulators|mesh-ancestor
25471841|NCT00026221|Interferons|interferons|mesh-list
25471842|NCT00026221|Interferon-alpha|interferon-alpha|mesh-list
25471843|NCT00026221|Bevacizumab|bevacizumab|mesh-list
25471844|NCT00026221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25471845|NCT00026221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471846|NCT00026221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25471847|NCT00026221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25471848|NCT00026221|Growth Substances|growth substances|mesh-ancestor
25471849|NCT00026221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471850|NCT00026221|Growth Inhibitors|growth inhibitors|mesh-ancestor
25471851|NCT00026221|Antiviral Agents|antiviral agents|mesh-ancestor
25471852|NCT00026221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25471853|NCT00026221|Immunologic Factors|immunologic factors|mesh-ancestor
25471854|NCT00026494|Temozolomide|temozolomide|mesh-list
25471855|NCT00026494|Vinorelbine|vinorelbine|mesh-list
25471856|NCT00026494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25471857|NCT00026494|Alkylating Agents|alkylating agents|mesh-ancestor
25471858|NCT00026494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471859|NCT00026494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471860|NCT00026494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25471861|NCT00026494|Tubulin Modulators|tubulin modulators|mesh-ancestor
25471862|NCT00026494|Antimitotic Agents|antimitotic agents|mesh-ancestor
25471863|NCT00026494|Mitosis Modulators|mitosis modulators|mesh-ancestor
25471864|NCT00027027|Pertuzumab|pertuzumab|mesh-list
25471865|NCT00027027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25471866|NCT00027027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471867|NCT00027378|Fluoxetine|fluoxetine|mesh-list
25471868|NCT00027378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25471869|NCT00027378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25471870|NCT00027378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25471871|NCT00027378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471872|NCT00027378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25471873|NCT00027378|Serotonin Agents|serotonin agents|mesh-ancestor
25471874|NCT00027378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471875|NCT00027378|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25471876|NCT00027378|Antidepressive Agents|antidepressive agents|mesh-ancestor
25644774|NCT01440569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471877|NCT00027378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25471878|NCT00027378|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25471879|NCT00027378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25471880|NCT00027378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471881|NCT00027560|Cyclosporine|cyclosporine|mesh-list
25471882|NCT00027560|Fludarabine|fludarabine|mesh-list
25471883|NCT00027560|Fludarabine phosphate|fludarabine phosphate|mesh-list
25471884|NCT00027560|Melphalan|melphalan|mesh-list
25471885|NCT00027560|Alemtuzumab|alemtuzumab|mesh-list
25471886|NCT00027560|Cyclosporins|cyclosporins|mesh-list
25471887|NCT00027560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471888|NCT00027560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25471889|NCT00027560|Antimetabolites|antimetabolites|mesh-ancestor
25471890|NCT00027560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471891|NCT00027560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25471892|NCT00027560|Immunologic Factors|immunologic factors|mesh-ancestor
25471893|NCT00027560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471894|NCT00027560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471895|NCT00027560|Antifungal Agents|antifungal agents|mesh-ancestor
25471896|NCT00027560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25471897|NCT00027560|Dermatologic Agents|dermatologic agents|mesh-ancestor
25471898|NCT00027560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25471899|NCT00027560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25471900|NCT00027560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25471901|NCT00027560|Alkylating Agents|alkylating agents|mesh-ancestor
25471902|NCT00027560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25068484|NCT03433001|Glucocorticoids|glucocorticoids|mesh-ancestor
25021084|NCT03674671|Anesthetics|anesthetics|mesh-ancestor
24611081|NCT01006798|Vaccines|vaccines|mesh-list
25471903|NCT00027560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25471905|NCT00027846|Carboplatin|carboplatin|mesh-list
25471906|NCT00027846|Etoposide|etoposide|mesh-list
25471907|NCT00027846|Vincristine|vincristine|mesh-list
25471908|NCT00027846|Podophyllotoxin|podophyllotoxin|mesh-list
25471909|NCT00027846|Lenograstim|lenograstim|mesh-list
25471910|NCT00027846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25471911|NCT00027846|Immunologic Factors|immunologic factors|mesh-ancestor
25471912|NCT00027846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471913|NCT00027846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25471914|NCT00027846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25471915|NCT00027846|Alkylating Agents|alkylating agents|mesh-ancestor
25471916|NCT00027846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471917|NCT00027846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471918|NCT00027846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25471919|NCT00027846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25471920|NCT00027846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25471921|NCT00027846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25471922|NCT00027846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471923|NCT00027846|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25471924|NCT00027846|Tubulin Modulators|tubulin modulators|mesh-ancestor
25471925|NCT00027846|Antimitotic Agents|antimitotic agents|mesh-ancestor
25471926|NCT00027846|Mitosis Modulators|mitosis modulators|mesh-ancestor
25471927|NCT00027846|Keratolytic Agents|keratolytic agents|mesh-ancestor
25471928|NCT00027846|Dermatologic Agents|dermatologic agents|mesh-ancestor
25471929|NCT00028002|Imatinib Mesylate|imatinib mesylate|mesh-list
25471930|NCT00028002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471931|NCT00028002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25471932|NCT00028002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471933|NCT00028002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471934|NCT00028093|Ribavirin|ribavirin|mesh-list
25471935|NCT00028093|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25471936|NCT00028093|Interferon-alpha|interferon-alpha|mesh-list
25471937|NCT00028093|Antimetabolites|antimetabolites|mesh-ancestor
25471938|NCT00028093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471939|NCT00028093|Antiviral Agents|antiviral agents|mesh-ancestor
25471940|NCT00028093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25471941|NCT00028093|Immunologic Factors|immunologic factors|mesh-ancestor
25471942|NCT00028093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471943|NCT00028262|Cysteamine|cysteamine|mesh-list
25471944|NCT00028262|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
25471945|NCT00028262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471946|NCT00028769|Paclitaxel|paclitaxel|mesh-list
25471947|NCT00028769|Etoposide|etoposide|mesh-list
25471948|NCT00028769|Leuprolide|leuprolide|mesh-list
25471949|NCT00028769|Goserelin|goserelin|mesh-list
25471950|NCT00028769|Bicalutamide|bicalutamide|mesh-list
25471951|NCT00028769|Flutamide|flutamide|mesh-list
25471952|NCT00028769|Estramustine|estramustine|mesh-list
25471953|NCT00028769|Nilutamide|nilutamide|mesh-list
25471954|NCT00028769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25471955|NCT00028769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471956|NCT00028769|Tubulin Modulators|tubulin modulators|mesh-ancestor
25471957|NCT00028769|Antimitotic Agents|antimitotic agents|mesh-ancestor
25471958|NCT00028769|Mitosis Modulators|mitosis modulators|mesh-ancestor
25471959|NCT00028769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25471960|NCT00028769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25471961|NCT00028769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25471962|NCT00028769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25471963|NCT00028769|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25471964|NCT00028769|Fertility Agents|fertility agents|mesh-ancestor
25471965|NCT00028769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25471966|NCT00028769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471967|NCT00028769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25471968|NCT00028769|Androgen Antagonists|androgen antagonists|mesh-ancestor
25471969|NCT00028769|Hormone Antagonists|hormone antagonists|mesh-ancestor
25471970|NCT00028769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25471971|NCT00028769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25471972|NCT00028769|Alkylating Agents|alkylating agents|mesh-ancestor
25471973|NCT00029107|Rituximab|rituximab|mesh-list
25471974|NCT00029107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25344511|NCT05547789|Analgesics|analgesics|mesh-ancestor
25471975|NCT00029107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25471976|NCT00029107|Immunologic Factors|immunologic factors|mesh-ancestor
24695026|NCT04729517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24695027|NCT04729517|Respiratory System Agents|respiratory system agents|mesh-ancestor
25471979|NCT00029536|Progesterone|progesterone|mesh-list
25471980|NCT00029536|Progestins|progestins|mesh-ancestor
25471981|NCT00029536|Hormones|hormones|mesh-ancestor
25471982|NCT00029536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25471983|NCT00029536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471984|NCT00030147|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25471985|NCT00030147|Estradiol|estradiol|mesh-list
25471986|NCT00030147|Estrogens|estrogens|mesh-ancestor
25471987|NCT00030147|Hormones|hormones|mesh-ancestor
25471988|NCT00030147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25471989|NCT00030147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25471990|NCT00030147|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25471991|NCT00030147|Hormone Antagonists|hormone antagonists|mesh-ancestor
25471992|NCT00030147|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25471993|NCT00030147|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25471994|NCT00030147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25471995|NCT00030264|Methotrexate|methotrexate|mesh-list
25471996|NCT00030264|Vinblastine|vinblastine|mesh-list
25471997|NCT00030264|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25471998|NCT00030264|Abortifacient Agents|abortifacient agents|mesh-ancestor
25471999|NCT00030264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25472000|NCT00030264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472001|NCT00030264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25472002|NCT00030264|Antimetabolites|antimetabolites|mesh-ancestor
25472003|NCT00030264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472004|NCT00030264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472005|NCT00030264|Dermatologic Agents|dermatologic agents|mesh-ancestor
25472006|NCT00030264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472007|NCT00030264|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25472008|NCT00030264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25472009|NCT00030264|Immunologic Factors|immunologic factors|mesh-ancestor
25472010|NCT00030264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25472011|NCT00030264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25472012|NCT00030264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25472013|NCT00030264|Tubulin Modulators|tubulin modulators|mesh-ancestor
25472014|NCT00030264|Antimitotic Agents|antimitotic agents|mesh-ancestor
25472015|NCT00030264|Mitosis Modulators|mitosis modulators|mesh-ancestor
25472016|NCT00030901|Selenium|selenium|mesh-list
25472017|NCT00030901|Antioxidants|antioxidants|mesh-ancestor
25472018|NCT00030901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472019|NCT00030901|Protective Agents|protective agents|mesh-ancestor
25472020|NCT00030901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472021|NCT00030901|Trace Elements|trace elements|mesh-ancestor
25472022|NCT00030901|Micronutrients|micronutrients|mesh-ancestor
25472023|NCT00030992|Diphenhydramine|diphenhydramine|mesh-list
25472024|NCT00030992|Promethazine|promethazine|mesh-list
25472025|NCT00030992|Ranitidine|ranitidine|mesh-list
25472026|NCT00030992|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
25472027|NCT00030992|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25472028|NCT00030992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25472029|NCT00030992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25472030|NCT00030992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472031|NCT00030992|Anesthetics, Local|anesthetics, local|mesh-ancestor
25472032|NCT00030992|Anesthetics|anesthetics|mesh-ancestor
25472033|NCT00030992|Sensory System Agents|sensory system agents|mesh-ancestor
25472034|NCT00030992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25472035|NCT00030992|Antiemetics|antiemetics|mesh-ancestor
25472036|NCT00030992|Autonomic Agents|autonomic agents|mesh-ancestor
25472037|NCT00030992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25472038|NCT00030992|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25472039|NCT00030992|Histamine Antagonists|histamine antagonists|mesh-ancestor
25472040|NCT00030992|Histamine Agents|histamine agents|mesh-ancestor
25472041|NCT00030992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25472042|NCT00030992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472043|NCT00030992|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25472044|NCT00030992|Antipruritics|antipruritics|mesh-ancestor
25472045|NCT00030992|Dermatologic Agents|dermatologic agents|mesh-ancestor
25472046|NCT00030992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25472047|NCT00030992|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25472048|NCT00031447|Acyclovir|acyclovir|mesh-list
25472049|NCT00031447|Antiviral Agents|antiviral agents|mesh-ancestor
25344585|NCT05547386|Edetic Acid|edetic acid|mesh-list
25472050|NCT00031447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25472051|NCT00031460|Acyclovir|acyclovir|mesh-list
25472052|NCT00031460|Antiviral Agents|antiviral agents|mesh-ancestor
25472053|NCT00031460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25472054|NCT00031486|Valacyclovir|valacyclovir|mesh-list
25472055|NCT00031486|Antiviral Agents|antiviral agents|mesh-ancestor
25472056|NCT00031486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25472057|NCT00031551|Etanercept|etanercept|mesh-list
25472058|NCT00031551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25472059|NCT00031551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25472060|NCT00031551|Analgesics|analgesics|mesh-ancestor
25472061|NCT00031551|Sensory System Agents|sensory system agents|mesh-ancestor
25472062|NCT00031551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25472063|NCT00031551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472064|NCT00031551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25472065|NCT00031551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25472066|NCT00031551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25472067|NCT00031551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25472068|NCT00031551|Immunologic Factors|immunologic factors|mesh-ancestor
25472069|NCT00031590|Cyclophosphamide|cyclophosphamide|mesh-list
25472070|NCT00031590|Lomustine|lomustine|mesh-list
25472071|NCT00031590|Cisplatin|cisplatin|mesh-list
25472072|NCT00031590|Etoposide|etoposide|mesh-list
25472073|NCT00031590|Vincristine|vincristine|mesh-list
25472074|NCT00031590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25472075|NCT00031590|Immunologic Factors|immunologic factors|mesh-ancestor
25472076|NCT00031590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472077|NCT00031590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25472078|NCT00031590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25472079|NCT00031590|Alkylating Agents|alkylating agents|mesh-ancestor
25472080|NCT00031590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472081|NCT00031590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472082|NCT00031590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25472083|NCT00031590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25472084|NCT00031590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25472085|NCT00031590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25472086|NCT00031590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472087|NCT00031590|Tubulin Modulators|tubulin modulators|mesh-ancestor
25472088|NCT00031590|Antimitotic Agents|antimitotic agents|mesh-ancestor
25472089|NCT00031590|Mitosis Modulators|mitosis modulators|mesh-ancestor
25472090|NCT00031694|Paclitaxel|paclitaxel|mesh-list
25472091|NCT00031694|Bryostatin 1|bryostatin 1|mesh-list
25472092|NCT00031694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25472093|NCT00031694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472094|NCT00031694|Tubulin Modulators|tubulin modulators|mesh-ancestor
25472095|NCT00031694|Antimitotic Agents|antimitotic agents|mesh-ancestor
25472096|NCT00031694|Mitosis Modulators|mitosis modulators|mesh-ancestor
25472097|NCT00031694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472098|NCT00031694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25472099|NCT00031694|Immunologic Factors|immunologic factors|mesh-ancestor
25472100|NCT00031694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472101|NCT00032487|Metformin|metformin|mesh-list
25472102|NCT00032487|Glimepiride|glimepiride|mesh-list
25472103|NCT00032487|Rosiglitazone|rosiglitazone|mesh-list
25472104|NCT00032487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25644775|NCT01440569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25472105|NCT00032487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472106|NCT00032487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25472107|NCT00032487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25472108|NCT00032487|Immunologic Factors|immunologic factors|mesh-ancestor
25472109|NCT00032591|Thrombin|thrombin|mesh-list
25472110|NCT00032591|Hemostatics|hemostatics|mesh-ancestor
25472111|NCT00032591|Coagulants|coagulants|mesh-ancestor
25472112|NCT00033371|Eflornithine|eflornithine|mesh-list
25472113|NCT00033371|Celecoxib|celecoxib|mesh-list
25472114|NCT00033371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25472115|NCT00033371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25472116|NCT00033371|Analgesics|analgesics|mesh-ancestor
25472117|NCT00033371|Sensory System Agents|sensory system agents|mesh-ancestor
25472118|NCT00033371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25472119|NCT00033371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472120|NCT00033371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25472121|NCT00033371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25472122|NCT00033371|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25472123|NCT00033371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25472124|NCT00033371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637561|NCT01151397|Vitamins|vitamins|mesh-ancestor
24637869|NCT01153659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24637871|NCT01153659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25033082|NCT03576456|Alprazolam|alprazolam|mesh-list
25073628|NCT03393988|Dexmedetomidine|dexmedetomidine|mesh-list
25073629|NCT03393988|Sympathomimetics|sympathomimetics|mesh-list
25073630|NCT03393988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25073631|NCT03393988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25073633|NCT03393988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25472125|NCT00033371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472126|NCT00033371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472127|NCT00033371|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25472128|NCT00033371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25472129|NCT00033371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25472130|NCT00033371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25472131|NCT00033371|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
25472132|NCT00033514|Trastuzumab|trastuzumab|mesh-list
25472133|NCT00033514|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25472134|NCT00033514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25472135|NCT00033514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472136|NCT00033514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25472137|NCT00033514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472138|NCT00033514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472139|NCT00033540|Gemcitabine|gemcitabine|mesh-list
25472140|NCT00033540|Capecitabine|capecitabine|mesh-list
25472141|NCT00033540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25472142|NCT00033540|Antimetabolites|antimetabolites|mesh-ancestor
25472143|NCT00033540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472144|NCT00033540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472145|NCT00033540|Antiviral Agents|antiviral agents|mesh-ancestor
25472146|NCT00033540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25472147|NCT00033540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472148|NCT00033540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25472149|NCT00033540|Immunologic Factors|immunologic factors|mesh-ancestor
25472150|NCT00033540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472151|NCT00033657|Paclitaxel|paclitaxel|mesh-list
25472152|NCT00033657|Camptothecin|camptothecin|mesh-list
25472153|NCT00033657|Cisplatin|cisplatin|mesh-list
25472154|NCT00033657|Irinotecan|irinotecan|mesh-list
25472155|NCT00033657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25472156|NCT00033657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472157|NCT00033657|Tubulin Modulators|tubulin modulators|mesh-ancestor
25472158|NCT00033657|Antimitotic Agents|antimitotic agents|mesh-ancestor
25472159|NCT00033657|Mitosis Modulators|mitosis modulators|mesh-ancestor
25472160|NCT00033657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472161|NCT00033657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25472162|NCT00033657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25472163|NCT00033657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472164|NCT00033917|Indomethacin|indomethacin|mesh-list
25472165|NCT00033917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25472166|NCT00033917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25472167|NCT00033917|Analgesics|analgesics|mesh-ancestor
25472168|NCT00033917|Sensory System Agents|sensory system agents|mesh-ancestor
25644776|NCT01440569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25472169|NCT00033917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25472170|NCT00033917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644777|NCT01440569|Antiviral Agents|antiviral agents|mesh-ancestor
25472171|NCT00033917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25472172|NCT00033917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25472173|NCT00033917|Gout Suppressants|gout suppressants|mesh-ancestor
25472174|NCT00033917|Tocolytic Agents|tocolytic agents|mesh-ancestor
25472175|NCT00033917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25472176|NCT00033917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25472177|NCT00033917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472178|NCT00033917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472179|NCT00035555|Cyclosporine|cyclosporine|mesh-list
25472180|NCT00035555|Mycophenolic Acid|mycophenolic acid|mesh-list
25472181|NCT00035555|Abatacept|abatacept|mesh-list
25472182|NCT00035555|Cyclosporins|cyclosporins|mesh-list
25472183|NCT00035555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472184|NCT00035555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472185|NCT00035555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25472186|NCT00035555|Immunologic Factors|immunologic factors|mesh-ancestor
25472187|NCT00035555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472188|NCT00035555|Antifungal Agents|antifungal agents|mesh-ancestor
25472189|NCT00035555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25472190|NCT00035555|Dermatologic Agents|dermatologic agents|mesh-ancestor
25472191|NCT00035555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25472192|NCT00035555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24645029|NCT01194843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24645031|NCT01194882|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24645032|NCT01194882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24645033|NCT01194882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645060|NCT01195298|Antimetabolites|antimetabolites|mesh-ancestor
24645061|NCT01195298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645062|NCT01195324|Canagliflozin|canagliflozin|mesh-list
25472193|NCT00035555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25472194|NCT00035555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472195|NCT00035555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25472196|NCT00035555|Antitubercular Agents|antitubercular agents|mesh-ancestor
25472197|NCT00035555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25472198|NCT00035555|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25472199|NCT00035815|Mitogens|mitogens|mesh-list
25472200|NCT00035815|Mitosis Modulators|mitosis modulators|mesh-ancestor
25472201|NCT00035815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472202|NCT00035932|Ritonavir|ritonavir|mesh-list
25472203|NCT00035932|Lopinavir|lopinavir|mesh-list
25472204|NCT00035932|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25472205|NCT00035932|Saquinavir|saquinavir|mesh-list
25472206|NCT00035932|Tenofovir|tenofovir|mesh-list
25472207|NCT00035932|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25472208|NCT00035932|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25472209|NCT00035932|Protease Inhibitors|protease inhibitors|mesh-ancestor
25472210|NCT00035932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472211|NCT00035932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472212|NCT00035932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25472213|NCT00035932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25472214|NCT00035932|Antiviral Agents|antiviral agents|mesh-ancestor
25472215|NCT00035932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25472216|NCT00035932|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25472217|NCT00035932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25472218|NCT00035932|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25472219|NCT00035932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25472220|NCT00036270|Tamoxifen|tamoxifen|mesh-list
25472221|NCT00036270|Exemestane|exemestane|mesh-list
25472222|NCT00036270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25472223|NCT00036270|Hormone Antagonists|hormone antagonists|mesh-ancestor
25472224|NCT00036270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25472225|NCT00036270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472226|NCT00036270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25472227|NCT00036270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472228|NCT00036270|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25472229|NCT00036270|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25472230|NCT00036270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25472231|NCT00036270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25472232|NCT00036270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25472233|NCT00036270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472234|NCT00036270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472235|NCT00036569|Interferons|interferons|mesh-list
25472236|NCT00036569|Interferon-alpha|interferon-alpha|mesh-list
25472237|NCT00036569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472238|NCT00036569|Antiviral Agents|antiviral agents|mesh-ancestor
25472239|NCT00036569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25472240|NCT00036569|Immunologic Factors|immunologic factors|mesh-ancestor
25472241|NCT00036569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472242|NCT00036738|Cyclosporine|cyclosporine|mesh-list
25472243|NCT00036738|Mycophenolic Acid|mycophenolic acid|mesh-list
25472244|NCT00036738|Fludarabine|fludarabine|mesh-list
25472245|NCT00036738|Fludarabine phosphate|fludarabine phosphate|mesh-list
25472246|NCT00036738|Imatinib Mesylate|imatinib mesylate|mesh-list
25472247|NCT00036738|Dasatinib|dasatinib|mesh-list
25472248|NCT00036738|Cyclosporins|cyclosporins|mesh-list
25472249|NCT00036738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472250|NCT00036738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25472251|NCT00036738|Antimetabolites|antimetabolites|mesh-ancestor
25472252|NCT00036738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472253|NCT00036738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25472254|NCT00036738|Immunologic Factors|immunologic factors|mesh-ancestor
25472255|NCT00036738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472256|NCT00036738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472257|NCT00036738|Antifungal Agents|antifungal agents|mesh-ancestor
25472258|NCT00036738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25472259|NCT00036738|Dermatologic Agents|dermatologic agents|mesh-ancestor
25472260|NCT00036738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25472261|NCT00036738|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25472262|NCT00036738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25472263|NCT00036738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24663869|NCT01303926|Paclitaxel|paclitaxel|mesh-list
24854795|NCT02275663|Cytarabine|cytarabine|mesh-list
24664132|NCT01305226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25032778|NCT03578640|Grazoprevir|grazoprevir|mesh-list
24682602|NCT01387048|Adapalene|adapalene|mesh-list
24800260|NCT01974375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472264|NCT00036738|Antitubercular Agents|antitubercular agents|mesh-ancestor
25472265|NCT00036738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25472266|NCT00036738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25472267|NCT00038103|Celecoxib|celecoxib|mesh-list
25472268|NCT00038103|Exemestane|exemestane|mesh-list
25472269|NCT00038103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25472270|NCT00038103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25472271|NCT00038103|Analgesics|analgesics|mesh-ancestor
25472272|NCT00038103|Sensory System Agents|sensory system agents|mesh-ancestor
25472273|NCT00038103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25472274|NCT00038103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472275|NCT00038103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25472276|NCT00038103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25472277|NCT00038103|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25472278|NCT00038103|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25472279|NCT00038103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472280|NCT00038103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472281|NCT00038103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472282|NCT00038103|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25472283|NCT00038103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25472284|NCT00038103|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25472285|NCT00038103|Hormone Antagonists|hormone antagonists|mesh-ancestor
25472286|NCT00038103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25472287|NCT00038467|Tamoxifen|tamoxifen|mesh-list
25472288|NCT00038467|Exemestane|exemestane|mesh-list
25472289|NCT00038467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25472290|NCT00038467|Hormone Antagonists|hormone antagonists|mesh-ancestor
25472291|NCT00038467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25472292|NCT00038467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472293|NCT00038467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25472294|NCT00038467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472295|NCT00038467|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25472296|NCT00038467|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25472297|NCT00038467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25472298|NCT00038467|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25472299|NCT00038467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25472300|NCT00038467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472301|NCT00038467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472302|NCT00038610|Cytarabine|cytarabine|mesh-list
25472303|NCT00038610|Dexamethasone|dexamethasone|mesh-list
25723856|NCT02530151|Clonidine|clonidine|mesh-list
25472304|NCT00038610|Cyclophosphamide|cyclophosphamide|mesh-list
25472305|NCT00038610|Doxorubicin|doxorubicin|mesh-list
25472306|NCT00038610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25472307|NCT00038610|Methotrexate|methotrexate|mesh-list
25644778|NCT01440569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25822892|NCT00004689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25644779|NCT01440569|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25644780|NCT01440569|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25472308|NCT00038610|Vincristine|vincristine|mesh-list
25472309|NCT00038610|Imatinib Mesylate|imatinib mesylate|mesh-list
25472310|NCT00038610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25472311|NCT00038610|Immunologic Factors|immunologic factors|mesh-ancestor
25472312|NCT00038610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472313|NCT00038610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25472314|NCT00038610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25472315|NCT00038610|Alkylating Agents|alkylating agents|mesh-ancestor
25472316|NCT00038610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472317|NCT00038610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472318|NCT00038610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25472319|NCT00038610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25472320|NCT00038610|Antiemetics|antiemetics|mesh-ancestor
25472321|NCT00038610|Autonomic Agents|autonomic agents|mesh-ancestor
25472322|NCT00038610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25472323|NCT00038610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25472324|NCT00038610|Glucocorticoids|glucocorticoids|mesh-ancestor
25472325|NCT00038610|Hormones|hormones|mesh-ancestor
25472326|NCT00038610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25472327|NCT00038610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25472328|NCT00038610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25472329|NCT00038610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25472330|NCT00038610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25472331|NCT00038610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472332|NCT00038610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25472333|NCT00038610|Abortifacient Agents|abortifacient agents|mesh-ancestor
25472334|NCT00038610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25472335|NCT00038610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25472336|NCT00038610|Antimetabolites|antimetabolites|mesh-ancestor
24850851|NCT02254148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25472338|NCT00038610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25472339|NCT00038610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25472340|NCT00038610|Antiviral Agents|antiviral agents|mesh-ancestor
25472341|NCT00038610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25472342|NCT00038610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25472343|NCT00038610|Tubulin Modulators|tubulin modulators|mesh-ancestor
25472344|NCT00038610|Antimitotic Agents|antimitotic agents|mesh-ancestor
25472345|NCT00038610|Mitosis Modulators|mitosis modulators|mesh-ancestor
25472346|NCT00038610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25472347|NCT00038649|Imatinib Mesylate|imatinib mesylate|mesh-list
25472348|NCT00038649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472349|NCT00038649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25472350|NCT00038649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472351|NCT00038649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472352|NCT00038857|Vidarabine|vidarabine|mesh-list
25472353|NCT00038857|Fludarabine|fludarabine|mesh-list
25472354|NCT00038857|Fludarabine phosphate|fludarabine phosphate|mesh-list
25472355|NCT00038857|Melphalan|melphalan|mesh-list
25472356|NCT00038857|Thiotepa|thiotepa|mesh-list
25472357|NCT00038857|Thymoglobulin|thymoglobulin|mesh-list
25472358|NCT00038857|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25472359|NCT00038857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472360|NCT00038857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25472361|NCT00038857|Antimetabolites|antimetabolites|mesh-ancestor
25472362|NCT00038857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472363|NCT00038857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25472364|NCT00038857|Immunologic Factors|immunologic factors|mesh-ancestor
25472365|NCT00038857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472366|NCT00038857|Antiviral Agents|antiviral agents|mesh-ancestor
25472367|NCT00038857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25472368|NCT00038857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25472369|NCT00038857|Alkylating Agents|alkylating agents|mesh-ancestor
25472370|NCT00038857|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25472371|NCT00038948|Cyclosporine|cyclosporine|mesh-list
25472372|NCT00038948|Sirolimus|sirolimus|mesh-list
25472373|NCT00038948|Tacrolimus|tacrolimus|mesh-list
25472374|NCT00038948|Cyclosporins|cyclosporins|mesh-list
25472375|NCT00038948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25472376|NCT00038948|Immunologic Factors|immunologic factors|mesh-ancestor
25472377|NCT00038948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472378|NCT00038948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25472379|NCT00038948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25644781|NCT01440764|Furosemide|furosemide|mesh-list
25472380|NCT00038948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472381|NCT00038948|Antifungal Agents|antifungal agents|mesh-ancestor
25472382|NCT00038948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25472383|NCT00038948|Dermatologic Agents|dermatologic agents|mesh-ancestor
25472384|NCT00038948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25472385|NCT00038948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25472386|NCT00038948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25472387|NCT00038948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472388|NCT00039130|Leucovorin|leucovorin|mesh-list
25472389|NCT00039130|Cytarabine|cytarabine|mesh-list
25472390|NCT00039130|Dexamethasone|dexamethasone|mesh-list
25472391|NCT00039130|Prednisone|prednisone|mesh-list
25472392|NCT00039130|Cyclophosphamide|cyclophosphamide|mesh-list
25472393|NCT00039130|Ifosfamide|ifosfamide|mesh-list
25472394|NCT00039130|Rituximab|rituximab|mesh-list
25472395|NCT00039130|Doxorubicin|doxorubicin|mesh-list
25472396|NCT00039130|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25472397|NCT00039130|Methotrexate|methotrexate|mesh-list
25472398|NCT00039130|Etoposide|etoposide|mesh-list
25472399|NCT00039130|Vincristine|vincristine|mesh-list
25472400|NCT00039130|Allopurinol|allopurinol|mesh-list
25472401|NCT00039130|Levoleucovorin|levoleucovorin|mesh-list
25472402|NCT00039130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25472403|NCT00039130|Immunologic Factors|immunologic factors|mesh-ancestor
25472404|NCT00039130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472405|NCT00039130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25472406|NCT00039130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25472407|NCT00039130|Alkylating Agents|alkylating agents|mesh-ancestor
25472408|NCT00039130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472409|NCT00039130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472410|NCT00039130|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25472411|NCT00039130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25472412|NCT00039130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25472413|NCT00039130|Antiemetics|antiemetics|mesh-ancestor
25822893|NCT00004689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472414|NCT00039130|Autonomic Agents|autonomic agents|mesh-ancestor
25472415|NCT00039130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25472416|NCT00039130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25472417|NCT00039130|Glucocorticoids|glucocorticoids|mesh-ancestor
25472418|NCT00039130|Hormones|hormones|mesh-ancestor
25472419|NCT00039130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25472420|NCT00039130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25472421|NCT00039130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25472422|NCT00039130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25472423|NCT00039130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25472424|NCT00039130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472425|NCT00039130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25472426|NCT00039130|Abortifacient Agents|abortifacient agents|mesh-ancestor
25472427|NCT00039130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25472428|NCT00039130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25472429|NCT00039130|Antimetabolites|antimetabolites|mesh-ancestor
25472430|NCT00039130|Dermatologic Agents|dermatologic agents|mesh-ancestor
25472431|NCT00039130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25472432|NCT00039130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25472433|NCT00039130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25472434|NCT00039130|Antiviral Agents|antiviral agents|mesh-ancestor
25472435|NCT00039130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25472436|NCT00039130|Antidotes|antidotes|mesh-ancestor
25472437|NCT00039130|Protective Agents|protective agents|mesh-ancestor
25472438|NCT00039130|Vitamin B Complex|vitamin b complex|mesh-ancestor
25472439|NCT00039130|Vitamins|vitamins|mesh-ancestor
25472440|NCT00039130|Micronutrients|micronutrients|mesh-ancestor
25472441|NCT00039130|Tubulin Modulators|tubulin modulators|mesh-ancestor
25472442|NCT00039130|Antimitotic Agents|antimitotic agents|mesh-ancestor
25472443|NCT00039130|Mitosis Modulators|mitosis modulators|mesh-ancestor
25472444|NCT00039130|Gout Suppressants|gout suppressants|mesh-ancestor
25472445|NCT00039130|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25472446|NCT00039130|Antioxidants|antioxidants|mesh-ancestor
25472447|NCT00039195|Prednisone|prednisone|mesh-list
25472448|NCT00039195|Cyclophosphamide|cyclophosphamide|mesh-list
25472449|NCT00039195|Ifosfamide|ifosfamide|mesh-list
25472450|NCT00039195|Rituximab|rituximab|mesh-list
25472451|NCT00039195|Carboplatin|carboplatin|mesh-list
25472452|NCT00039195|Doxorubicin|doxorubicin|mesh-list
25472453|NCT00039195|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25472454|NCT00039195|Etoposide|etoposide|mesh-list
25472455|NCT00039195|Vincristine|vincristine|mesh-list
25472456|NCT00039195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25472457|NCT00039195|Immunologic Factors|immunologic factors|mesh-ancestor
25472458|NCT00039195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472459|NCT00039195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25472460|NCT00039195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25472461|NCT00039195|Alkylating Agents|alkylating agents|mesh-ancestor
25472462|NCT00039195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472463|NCT00039195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472464|NCT00039195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25472465|NCT00039195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25472466|NCT00039195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25472467|NCT00039195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25472468|NCT00039195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25472469|NCT00039195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472470|NCT00039195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25472471|NCT00039195|Glucocorticoids|glucocorticoids|mesh-ancestor
25472472|NCT00039195|Hormones|hormones|mesh-ancestor
25472473|NCT00039195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25472474|NCT00039195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25472475|NCT00039195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25472476|NCT00039195|Tubulin Modulators|tubulin modulators|mesh-ancestor
25472477|NCT00039195|Antimitotic Agents|antimitotic agents|mesh-ancestor
25472478|NCT00039195|Mitosis Modulators|mitosis modulators|mesh-ancestor
25472479|NCT00039377|Leucovorin|leucovorin|mesh-list
25472480|NCT00039377|Cytarabine|cytarabine|mesh-list
25472481|NCT00039377|Cyclophosphamide|cyclophosphamide|mesh-list
25472482|NCT00039377|Methotrexate|methotrexate|mesh-list
25472483|NCT00039377|Etoposide|etoposide|mesh-list
25472484|NCT00039377|Vincristine|vincristine|mesh-list
25472485|NCT00039377|Etoposide phosphate|etoposide phosphate|mesh-list
25472486|NCT00039377|Imatinib Mesylate|imatinib mesylate|mesh-list
25472487|NCT00039377|Tacrolimus|tacrolimus|mesh-list
25472488|NCT00039377|Levoleucovorin|levoleucovorin|mesh-list
25472489|NCT00039377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25472490|NCT00039377|Immunologic Factors|immunologic factors|mesh-ancestor
25472491|NCT00039377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472492|NCT00039377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24938793|NCT04015908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25472496|NCT00039377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472497|NCT00039377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25472498|NCT00039377|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25472499|NCT00039377|Abortifacient Agents|abortifacient agents|mesh-ancestor
25472500|NCT00039377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25472501|NCT00039377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25472502|NCT00039377|Antimetabolites|antimetabolites|mesh-ancestor
25472503|NCT00039377|Dermatologic Agents|dermatologic agents|mesh-ancestor
25472504|NCT00039377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472505|NCT00039377|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25472506|NCT00039377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25472507|NCT00039377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25472508|NCT00039377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25472509|NCT00039377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25472510|NCT00039377|Antiviral Agents|antiviral agents|mesh-ancestor
25472511|NCT00039377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25472512|NCT00039377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25472513|NCT00039377|Antidotes|antidotes|mesh-ancestor
25472514|NCT00039377|Protective Agents|protective agents|mesh-ancestor
25472515|NCT00039377|Vitamin B Complex|vitamin b complex|mesh-ancestor
25472516|NCT00039377|Vitamins|vitamins|mesh-ancestor
25472517|NCT00039377|Micronutrients|micronutrients|mesh-ancestor
25472518|NCT00039377|Tubulin Modulators|tubulin modulators|mesh-ancestor
25472519|NCT00039377|Antimitotic Agents|antimitotic agents|mesh-ancestor
25472520|NCT00039377|Mitosis Modulators|mitosis modulators|mesh-ancestor
25472521|NCT00039377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25472522|NCT00039871|Ribavirin|ribavirin|mesh-list
25472523|NCT00039871|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25472524|NCT00039871|Interferon-alpha|interferon-alpha|mesh-list
25472525|NCT00039871|Antimetabolites|antimetabolites|mesh-ancestor
25472526|NCT00039871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472527|NCT00039871|Antiviral Agents|antiviral agents|mesh-ancestor
25472528|NCT00039871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25472529|NCT00039871|Immunologic Factors|immunologic factors|mesh-ancestor
25472530|NCT00039871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472531|NCT00040365|Amifostine|amifostine|mesh-list
25472532|NCT00040365|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25472533|NCT00040365|Protective Agents|protective agents|mesh-ancestor
25472534|NCT00040365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472535|NCT00040664|Ritonavir|ritonavir|mesh-list
25472536|NCT00040664|Fosamprenavir|fosamprenavir|mesh-list
25472537|NCT00040664|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25472538|NCT00040664|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25472540|NCT00040664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472541|NCT00040664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472542|NCT00040664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25472543|NCT00040664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25472544|NCT00040664|Antiviral Agents|antiviral agents|mesh-ancestor
25472545|NCT00040664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25472546|NCT00040664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25472547|NCT00040664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25472548|NCT00040846|Cyclosporine|cyclosporine|mesh-list
25472549|NCT00040846|Mycophenolic Acid|mycophenolic acid|mesh-list
25472550|NCT00040846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25472551|NCT00040846|Alemtuzumab|alemtuzumab|mesh-list
25472552|NCT00040846|Fludarabine|fludarabine|mesh-list
25472553|NCT00040846|Fludarabine phosphate|fludarabine phosphate|mesh-list
25472554|NCT00040846|Antibodies|antibodies|mesh-list
25472555|NCT00040846|Immunoglobulins|immunoglobulins|mesh-list
25472556|NCT00040846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24939389|NCT04010318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540400|NCT00667797|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24664959|NCT01309490|Antiviral Agents|antiviral agents|mesh-ancestor
24540564|NCT00668499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24540571|NCT00668538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25038716|NCT04624776|Hormones|hormones|mesh-ancestor
25038792|NCT04521335|Copper|copper|mesh-list
25472557|NCT00040846|Cyclosporins|cyclosporins|mesh-list
25472558|NCT00040846|Immunologic Factors|immunologic factors|mesh-ancestor
25472559|NCT00040846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472560|NCT00040846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472561|NCT00040846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25472562|NCT00040846|Antimetabolites|antimetabolites|mesh-ancestor
25472563|NCT00040846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472564|NCT00040846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25472565|NCT00040846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472566|NCT00040846|Antifungal Agents|antifungal agents|mesh-ancestor
25472567|NCT00040846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25472568|NCT00040846|Dermatologic Agents|dermatologic agents|mesh-ancestor
25472569|NCT00040846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25472570|NCT00040846|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25472571|NCT00040846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25472572|NCT00040846|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25472573|NCT00040846|Antitubercular Agents|antitubercular agents|mesh-ancestor
25472574|NCT00040846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25472575|NCT00040937|Thalidomide|thalidomide|mesh-list
25472576|NCT00040937|Dexamethasone|dexamethasone|mesh-list
25472577|NCT00040937|Prednisone|prednisone|mesh-list
25472578|NCT00040937|Cyclophosphamide|cyclophosphamide|mesh-list
25472579|NCT00040937|Melphalan|melphalan|mesh-list
25472580|NCT00040937|Sargramostim|sargramostim|mesh-list
25472581|NCT00040937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25472582|NCT00040937|Immunologic Factors|immunologic factors|mesh-ancestor
25472583|NCT00040937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472584|NCT00040937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25472585|NCT00040937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25472586|NCT00040937|Alkylating Agents|alkylating agents|mesh-ancestor
25472587|NCT00040937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472588|NCT00040937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472589|NCT00040937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25472590|NCT00040937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25472591|NCT00040937|Antiemetics|antiemetics|mesh-ancestor
25472592|NCT00040937|Autonomic Agents|autonomic agents|mesh-ancestor
25472593|NCT00040937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25472594|NCT00040937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25472595|NCT00040937|Glucocorticoids|glucocorticoids|mesh-ancestor
25472596|NCT00040937|Hormones|hormones|mesh-ancestor
25472597|NCT00040937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25472598|NCT00040937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25472599|NCT00040937|Leprostatic Agents|leprostatic agents|mesh-ancestor
25472600|NCT00040937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25472601|NCT00040937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25472602|NCT00040937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25472603|NCT00040937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25472604|NCT00040937|Growth Substances|growth substances|mesh-ancestor
25472605|NCT00040937|Growth Inhibitors|growth inhibitors|mesh-ancestor
25472606|NCT00041067|Docetaxel|docetaxel|mesh-list
25472607|NCT00041067|Trastuzumab|trastuzumab|mesh-list
25472608|NCT00041067|Vinorelbine|vinorelbine|mesh-list
25472609|NCT00041067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472611|NCT00041067|Antimitotic Agents|antimitotic agents|mesh-ancestor
25472612|NCT00041067|Mitosis Modulators|mitosis modulators|mesh-ancestor
25472613|NCT00041067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472614|NCT00041067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25472615|NCT00041067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25472616|NCT00041080|Tamoxifen|tamoxifen|mesh-list
25472617|NCT00041080|Thalidomide|thalidomide|mesh-list
25472618|NCT00041080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25472619|NCT00041080|Hormone Antagonists|hormone antagonists|mesh-ancestor
25472620|NCT00041080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25472621|NCT00041080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472622|NCT00041080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25472623|NCT00041080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472624|NCT00041080|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25472625|NCT00041080|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25472626|NCT00041080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25472627|NCT00041080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24447180|NCT00307645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24447182|NCT00307645|Hormones|hormones|mesh-ancestor
25822894|NCT00004689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25822895|NCT00004689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25822896|NCT00004689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25472629|NCT00041080|Leprostatic Agents|leprostatic agents|mesh-ancestor
25472630|NCT00041080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25472631|NCT00041080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25472632|NCT00041080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25472633|NCT00041080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25472634|NCT00041080|Growth Substances|growth substances|mesh-ancestor
25472635|NCT00041080|Growth Inhibitors|growth inhibitors|mesh-ancestor
25472636|NCT00041119|Paclitaxel|paclitaxel|mesh-list
25472637|NCT00041119|Cyclophosphamide|cyclophosphamide|mesh-list
25472638|NCT00041119|Doxorubicin|doxorubicin|mesh-list
25472639|NCT00041119|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25472640|NCT00041119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25472641|NCT00041119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472642|NCT00041119|Tubulin Modulators|tubulin modulators|mesh-ancestor
25472643|NCT00041119|Antimitotic Agents|antimitotic agents|mesh-ancestor
25472644|NCT00041119|Mitosis Modulators|mitosis modulators|mesh-ancestor
25472645|NCT00041119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472646|NCT00041119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25472647|NCT00041119|Immunologic Factors|immunologic factors|mesh-ancestor
25472648|NCT00041119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472649|NCT00041119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25472650|NCT00041119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25472651|NCT00041119|Alkylating Agents|alkylating agents|mesh-ancestor
25472652|NCT00041119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25472653|NCT00041119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25472654|NCT00041119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25472655|NCT00041119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25472656|NCT00041119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472657|NCT00041132|Leucovorin|leucovorin|mesh-list
25472658|NCT00041132|Cytarabine|cytarabine|mesh-list
25472659|NCT00041132|Dexamethasone|dexamethasone|mesh-list
25472660|NCT00041132|Cyclophosphamide|cyclophosphamide|mesh-list
25472661|NCT00041132|Rituximab|rituximab|mesh-list
25472662|NCT00041132|Doxorubicin|doxorubicin|mesh-list
25472663|NCT00041132|Methotrexate|methotrexate|mesh-list
25472664|NCT00041132|Vincristine|vincristine|mesh-list
25472665|NCT00041132|Levoleucovorin|levoleucovorin|mesh-list
25472666|NCT00041132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25472667|NCT00041132|Immunologic Factors|immunologic factors|mesh-ancestor
25472668|NCT00041132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472669|NCT00041132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25472670|NCT00041132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25472671|NCT00041132|Alkylating Agents|alkylating agents|mesh-ancestor
25472672|NCT00041132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472673|NCT00041132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472674|NCT00041132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25472675|NCT00041132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25472676|NCT00041132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25472677|NCT00041132|Antiemetics|antiemetics|mesh-ancestor
25472678|NCT00041132|Autonomic Agents|autonomic agents|mesh-ancestor
25644782|NCT01440764|Diuretics|diuretics|mesh-ancestor
25644783|NCT01440764|Natriuretic Agents|natriuretic agents|mesh-ancestor
25472679|NCT00041132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25472680|NCT00041132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25472682|NCT00041132|Hormones|hormones|mesh-ancestor
25472683|NCT00041132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25472684|NCT00041132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25472685|NCT00041132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25472686|NCT00041132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25472687|NCT00041132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25472688|NCT00041132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472689|NCT00041132|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25472690|NCT00041132|Abortifacient Agents|abortifacient agents|mesh-ancestor
25472691|NCT00041132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25472692|NCT00041132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25472693|NCT00041132|Antimetabolites|antimetabolites|mesh-ancestor
25472694|NCT00041132|Dermatologic Agents|dermatologic agents|mesh-ancestor
25472695|NCT00041132|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25472696|NCT00041132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25472697|NCT00041132|Antiviral Agents|antiviral agents|mesh-ancestor
25472698|NCT00041132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25472699|NCT00041132|Antidotes|antidotes|mesh-ancestor
25472700|NCT00041132|Protective Agents|protective agents|mesh-ancestor
25472701|NCT00041132|Vitamin B Complex|vitamin b complex|mesh-ancestor
25472702|NCT00041132|Vitamins|vitamins|mesh-ancestor
25472703|NCT00041132|Micronutrients|micronutrients|mesh-ancestor
25472705|NCT00041132|Tubulin Modulators|tubulin modulators|mesh-ancestor
25472706|NCT00041132|Antimitotic Agents|antimitotic agents|mesh-ancestor
25472707|NCT00041132|Mitosis Modulators|mitosis modulators|mesh-ancestor
25472708|NCT00041470|Paclitaxel|paclitaxel|mesh-list
25472709|NCT00041470|Vinorelbine|vinorelbine|mesh-list
25472710|NCT00041470|Trastuzumab|trastuzumab|mesh-list
25472711|NCT00041470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25472712|NCT00041470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472713|NCT00041470|Tubulin Modulators|tubulin modulators|mesh-ancestor
25472714|NCT00041470|Antimitotic Agents|antimitotic agents|mesh-ancestor
25472715|NCT00041470|Mitosis Modulators|mitosis modulators|mesh-ancestor
25472716|NCT00041470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472717|NCT00041470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25472718|NCT00041717|4-Aminopyridine|4-aminopyridine|mesh-list
25472719|NCT00041717|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25472720|NCT00041717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25472721|NCT00041717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472722|NCT00041938|Aspirin|aspirin|mesh-list
25472723|NCT00041938|Warfarin|warfarin|mesh-list
25472724|NCT00041938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25472725|NCT00041938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25472726|NCT00041938|Analgesics|analgesics|mesh-ancestor
25472727|NCT00041938|Sensory System Agents|sensory system agents|mesh-ancestor
25472728|NCT00041938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25472729|NCT00041938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472730|NCT00041938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25472731|NCT00041938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25472732|NCT00041938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25472733|NCT00041938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25472734|NCT00041938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472735|NCT00041938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25472736|NCT00041938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25472737|NCT00041938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472738|NCT00041938|Antipyretics|antipyretics|mesh-ancestor
25472739|NCT00041938|Anticoagulants|anticoagulants|mesh-ancestor
25472740|NCT00042224|Clozapine|clozapine|mesh-list
25472741|NCT00042224|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25472742|NCT00042224|Serotonin Agents|serotonin agents|mesh-ancestor
25472743|NCT00042224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25472744|NCT00042224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472745|NCT00042224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472746|NCT00042224|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25472747|NCT00042224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25472748|NCT00042224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25472749|NCT00042224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25472750|NCT00042224|GABA Antagonists|gaba antagonists|mesh-ancestor
25472751|NCT00042224|GABA Agents|gaba agents|mesh-ancestor
25472752|NCT00042432|Cinacalcet|cinacalcet|mesh-list
25472753|NCT00042432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25644784|NCT01440764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472754|NCT00042432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472755|NCT00042432|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25472756|NCT00042432|Hormone Antagonists|hormone antagonists|mesh-ancestor
25472757|NCT00042432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25472759|NCT00042939|Irinotecan|irinotecan|mesh-list
25472760|NCT00042939|Cetuximab|cetuximab|mesh-list
25472761|NCT00042939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472762|NCT00042939|Tubulin Modulators|tubulin modulators|mesh-ancestor
25472763|NCT00042939|Antimitotic Agents|antimitotic agents|mesh-ancestor
25472764|NCT00042939|Mitosis Modulators|mitosis modulators|mesh-ancestor
25472765|NCT00042939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472766|NCT00042939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25472767|NCT00042939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25472768|NCT00042939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472769|NCT00042939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25472770|NCT00042991|Gefitinib|gefitinib|mesh-list
25472771|NCT00042991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472772|NCT00042991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25822897|NCT00004689|Antitubercular Agents|antitubercular agents|mesh-ancestor
25822898|NCT00004689|Leprostatic Agents|leprostatic agents|mesh-ancestor
25822899|NCT00004689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25472773|NCT00042991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472774|NCT00042991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472775|NCT00043186|Denosumab|denosumab|mesh-list
25472776|NCT00043186|Alendronate|alendronate|mesh-list
25472777|NCT00043186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25472778|NCT00043186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472779|NCT00043550|Sertraline|sertraline|mesh-list
25472780|NCT00043550|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25472781|NCT00043550|Antidepressive Agents|antidepressive agents|mesh-ancestor
25472782|NCT00043550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25472783|NCT00043550|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25472784|NCT00043550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25472785|NCT00043550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25472786|NCT00043550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472787|NCT00043550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25472788|NCT00043550|Serotonin Agents|serotonin agents|mesh-ancestor
25472789|NCT00043550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472790|NCT00043550|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25472791|NCT00043550|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25472792|NCT00043979|Cyclosporine|cyclosporine|mesh-list
25472793|NCT00043979|Sirolimus|sirolimus|mesh-list
25472794|NCT00043979|Prednisone|prednisone|mesh-list
25472795|NCT00043979|Cyclophosphamide|cyclophosphamide|mesh-list
25472796|NCT00043979|Melphalan|melphalan|mesh-list
25472797|NCT00043979|Doxorubicin|doxorubicin|mesh-list
25472798|NCT00043979|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25472799|NCT00043979|Fludarabine|fludarabine|mesh-list
25472800|NCT00043979|Fludarabine phosphate|fludarabine phosphate|mesh-list
25472801|NCT00043979|Etoposide|etoposide|mesh-list
25472802|NCT00043979|Vincristine|vincristine|mesh-list
25472803|NCT00043979|Tacrolimus|tacrolimus|mesh-list
25472804|NCT00043979|Cyclosporins|cyclosporins|mesh-list
25472805|NCT00043979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25472806|NCT00043979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25472807|NCT00043979|Immunologic Factors|immunologic factors|mesh-ancestor
25472808|NCT00043979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472809|NCT00043979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25472810|NCT00043979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25472811|NCT00043979|Alkylating Agents|alkylating agents|mesh-ancestor
25472812|NCT00043979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472813|NCT00043979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472814|NCT00043979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25472815|NCT00043979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25472816|NCT00043979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25472817|NCT00043979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25472818|NCT00043979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472819|NCT00043979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25472820|NCT00043979|Glucocorticoids|glucocorticoids|mesh-ancestor
25472821|NCT00043979|Hormones|hormones|mesh-ancestor
25472822|NCT00043979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25472823|NCT00043979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25472824|NCT00043979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25472825|NCT00043979|Antimetabolites|antimetabolites|mesh-ancestor
25472826|NCT00043979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25472827|NCT00043979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25472828|NCT00043979|Tubulin Modulators|tubulin modulators|mesh-ancestor
25472829|NCT00043979|Antimitotic Agents|antimitotic agents|mesh-ancestor
25472830|NCT00043979|Mitosis Modulators|mitosis modulators|mesh-ancestor
25472831|NCT00043979|Antifungal Agents|antifungal agents|mesh-ancestor
25472832|NCT00043979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25472833|NCT00043979|Dermatologic Agents|dermatologic agents|mesh-ancestor
25472834|NCT00043979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25472835|NCT00043979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25472836|NCT00044005|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25472837|NCT00044005|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25472838|NCT00044005|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25472839|NCT00044005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25472840|NCT00044005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472841|NCT00044005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25472842|NCT00044005|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25472843|NCT00044005|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25472844|NCT00044005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25472845|NCT00044005|Adrenergic Agents|adrenergic agents|mesh-ancestor
25472846|NCT00044005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25472847|NCT00044005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472848|NCT00044005|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25472849|NCT00044005|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25472851|NCT00044005|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25472852|NCT00044005|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25472853|NCT00044005|Dopamine Agents|dopamine agents|mesh-ancestor
25472854|NCT00044044|Haloperidol|haloperidol|mesh-list
25472855|NCT00044044|Haloperidol decanoate|haloperidol decanoate|mesh-list
25472856|NCT00044044|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25472857|NCT00044044|Antiemetics|antiemetics|mesh-ancestor
25472858|NCT00044044|Autonomic Agents|autonomic agents|mesh-ancestor
25472859|NCT00044044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25472860|NCT00044044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472861|NCT00044044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25472862|NCT00044044|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25472863|NCT00044044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25472864|NCT00044044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25472865|NCT00044044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25472866|NCT00044044|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25472867|NCT00044044|Dopamine Agents|dopamine agents|mesh-ancestor
25472868|NCT00044044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25472869|NCT00044044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472870|NCT00044044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25472871|NCT00044044|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25472872|NCT00044044|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25472873|NCT00044044|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25472874|NCT00044044|Adrenergic Agents|adrenergic agents|mesh-ancestor
25472875|NCT00044044|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25472876|NCT00044044|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25472877|NCT00044044|Serotonin Agents|serotonin agents|mesh-ancestor
25472878|NCT00044044|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25472879|NCT00044083|Tolcapone|tolcapone|mesh-list
25472880|NCT00044083|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25472881|NCT00044083|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25472882|NCT00044083|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25472883|NCT00044083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472884|NCT00044083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472885|NCT00044213|Vitamins|vitamins|mesh-list
25472886|NCT00044213|Edetic Acid|edetic acid|mesh-list
25472887|NCT00044213|Pentetic Acid|pentetic acid|mesh-list
25472888|NCT00044213|Micronutrients|micronutrients|mesh-ancestor
25472889|NCT00044213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472890|NCT00044213|Anticoagulants|anticoagulants|mesh-ancestor
25472891|NCT00044213|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25472892|NCT00044213|Chelating Agents|chelating agents|mesh-ancestor
25472893|NCT00044213|Sequestering Agents|sequestering agents|mesh-ancestor
25472894|NCT00044213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472895|NCT00044213|Antidotes|antidotes|mesh-ancestor
25472896|NCT00044213|Protective Agents|protective agents|mesh-ancestor
25472897|NCT00044213|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25472898|NCT00044512|Sorafenib|sorafenib|mesh-list
25472899|NCT00044512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472900|NCT00044512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25644785|NCT01440764|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25644786|NCT01440764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25644787|NCT01440764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644788|NCT01440803|Teriparatide|teriparatide|mesh-list
25644789|NCT01440803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25822900|NCT00004689|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25472901|NCT00044512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472902|NCT00044512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472903|NCT00044655|Olanzapine|olanzapine|mesh-list
25472904|NCT00044655|Risperidone|risperidone|mesh-list
25472905|NCT00044655|Aripiprazole|aripiprazole|mesh-list
25472906|NCT00044655|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25472907|NCT00044655|Ziprasidone|ziprasidone|mesh-list
25472908|NCT00044655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25472909|NCT00044655|Serotonin Agents|serotonin agents|mesh-ancestor
25472910|NCT00044655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25472911|NCT00044655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472912|NCT00044655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472913|NCT00044655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25472914|NCT00044655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25472915|NCT00044655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25472916|NCT00044655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25472917|NCT00044655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25472918|NCT00044655|Dopamine Agents|dopamine agents|mesh-ancestor
25472919|NCT00044655|Antiemetics|antiemetics|mesh-ancestor
25472920|NCT00044655|Autonomic Agents|autonomic agents|mesh-ancestor
25472921|NCT00044655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25472922|NCT00044655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25472923|NCT00044655|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25472924|NCT00044655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25472925|NCT00044655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25472926|NCT00044655|Antidepressive Agents|antidepressive agents|mesh-ancestor
25472927|NCT00044655|Dopamine Agonists|dopamine agonists|mesh-ancestor
25472928|NCT00044655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25472929|NCT00044655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25472930|NCT00044655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25472931|NCT00044655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25472932|NCT00045032|Trastuzumab|trastuzumab|mesh-list
25472933|NCT00045032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25472934|NCT00045032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472935|NCT00045110|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25472936|NCT00045110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472937|NCT00045110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25472938|NCT00045110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472939|NCT00045110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472940|NCT00045162|Cisplatin|cisplatin|mesh-list
25472941|NCT00045162|Irinotecan|irinotecan|mesh-list
25472942|NCT00045162|Etoposide|etoposide|mesh-list
25472943|NCT00045162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472944|NCT00045162|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25472945|NCT00045162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25472946|NCT00045162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472947|NCT00045162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472948|NCT00045162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25472949|NCT00045162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25472950|NCT00045305|Cyclosporine|cyclosporine|mesh-list
25472951|NCT00045305|Mycophenolic Acid|mycophenolic acid|mesh-list
25472952|NCT00045305|Methotrexate|methotrexate|mesh-list
25472953|NCT00045305|Pentostatin|pentostatin|mesh-list
25472954|NCT00045305|Methoxsalen|methoxsalen|mesh-list
25472955|NCT00045305|Cyclosporins|cyclosporins|mesh-list
25472956|NCT00045305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25472957|NCT00045305|Abortifacient Agents|abortifacient agents|mesh-ancestor
25472958|NCT00045305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25472959|NCT00045305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472960|NCT00045305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25472961|NCT00045305|Antimetabolites|antimetabolites|mesh-ancestor
25472962|NCT00045305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472963|NCT00045305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472964|NCT00045305|Dermatologic Agents|dermatologic agents|mesh-ancestor
25472965|NCT00045305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472966|NCT00045305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25472967|NCT00045305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25472968|NCT00045305|Immunologic Factors|immunologic factors|mesh-ancestor
25472970|NCT00045305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25472971|NCT00045305|Antifungal Agents|antifungal agents|mesh-ancestor
25472972|NCT00045305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25472973|NCT00045305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25472974|NCT00045305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25472975|NCT00045305|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25472976|NCT00045305|Antitubercular Agents|antitubercular agents|mesh-ancestor
25472977|NCT00045305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25472978|NCT00045305|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25472979|NCT00045305|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25472980|NCT00045435|Cyclosporine|cyclosporine|mesh-list
25472981|NCT00045435|Mycophenolic Acid|mycophenolic acid|mesh-list
25472982|NCT00045435|Fludarabine|fludarabine|mesh-list
25472983|NCT00045435|Fludarabine phosphate|fludarabine phosphate|mesh-list
25472984|NCT00045435|Cyclosporins|cyclosporins|mesh-list
25472985|NCT00045435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25472986|NCT00045435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25472987|NCT00045435|Antimetabolites|antimetabolites|mesh-ancestor
25472988|NCT00045435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25472989|NCT00045435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25472990|NCT00045435|Immunologic Factors|immunologic factors|mesh-ancestor
25472991|NCT00045435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25472992|NCT00045435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25472993|NCT00045435|Antifungal Agents|antifungal agents|mesh-ancestor
25472994|NCT00045435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25472995|NCT00045435|Dermatologic Agents|dermatologic agents|mesh-ancestor
25472996|NCT00045435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25822901|NCT00004689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25472999|NCT00045435|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25473000|NCT00045435|Antitubercular Agents|antitubercular agents|mesh-ancestor
25473001|NCT00045435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25473002|NCT00045487|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25473003|NCT00045487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473004|NCT00045487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25473005|NCT00045487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473006|NCT00045487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473007|NCT00045630|Gemcitabine|gemcitabine|mesh-list
25473008|NCT00045630|Paclitaxel|paclitaxel|mesh-list
25473009|NCT00045630|Carboplatin|carboplatin|mesh-list
25473010|NCT00045630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25473011|NCT00045630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473012|NCT00045630|Tubulin Modulators|tubulin modulators|mesh-ancestor
25473013|NCT00045630|Antimitotic Agents|antimitotic agents|mesh-ancestor
25473014|NCT00045630|Mitosis Modulators|mitosis modulators|mesh-ancestor
25473015|NCT00045630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473016|NCT00045630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25473017|NCT00045630|Antimetabolites|antimetabolites|mesh-ancestor
25473018|NCT00045630|Antiviral Agents|antiviral agents|mesh-ancestor
25473019|NCT00045630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25473020|NCT00045630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473021|NCT00045630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25473022|NCT00045630|Immunologic Factors|immunologic factors|mesh-ancestor
25473023|NCT00045630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473024|NCT00045708|Epothilones|epothilones|mesh-list
25473025|NCT00045708|Epothilone B|epothilone b|mesh-list
25473026|NCT00045708|Anticonvulsants|anticonvulsants|mesh-list
25473027|NCT00045708|Tubulin Modulators|tubulin modulators|mesh-ancestor
25473028|NCT00045708|Antimitotic Agents|antimitotic agents|mesh-ancestor
25473029|NCT00045708|Mitosis Modulators|mitosis modulators|mesh-ancestor
25473030|NCT00045708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473031|NCT00045708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473032|NCT00045734|Imatinib Mesylate|imatinib mesylate|mesh-list
25473033|NCT00045734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473034|NCT00045734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25473035|NCT00045734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473036|NCT00045734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473037|NCT00045942|Itraconazole|itraconazole|mesh-list
25473038|NCT00045942|Midostaurin|midostaurin|mesh-list
25473039|NCT00045942|Antifungal Agents|antifungal agents|mesh-ancestor
25473040|NCT00045942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25473041|NCT00045942|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25473042|NCT00045942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25473043|NCT00045942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597468|NCT00949494|Hylan|hylan|mesh-list
25473048|NCT00045942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473049|NCT00045942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25473051|NCT00045942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25822902|NCT00004689|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25822903|NCT00004689|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25822904|NCT00004689|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25822905|NCT00004689|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25822906|NCT00004690|Monolaurin|monolaurin|mesh-list
25822907|NCT00004690|Cariostatic Agents|cariostatic agents|mesh-ancestor
25822908|NCT00004690|Protective Agents|protective agents|mesh-ancestor
25473053|NCT00046228|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25473054|NCT00046228|Abciximab|abciximab|mesh-list
25473055|NCT00046228|Anticoagulants|anticoagulants|mesh-ancestor
25473056|NCT00046228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25473057|NCT00046228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25473058|NCT00046228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25473059|NCT00046228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473060|NCT00046475|Midodrine|midodrine|mesh-list
25473061|NCT00046475|Sympathomimetics|sympathomimetics|mesh-ancestor
25473062|NCT00046475|Autonomic Agents|autonomic agents|mesh-ancestor
25473063|NCT00046475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25473064|NCT00046475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473065|NCT00046475|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25473066|NCT00046475|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25473067|NCT00046475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25473068|NCT00046475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25473069|NCT00046475|Adrenergic Agents|adrenergic agents|mesh-ancestor
25473070|NCT00046475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25473071|NCT00046475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473072|NCT00046566|Caseins|caseins|mesh-list
25473073|NCT00046566|Chelating Agents|chelating agents|mesh-ancestor
25473074|NCT00046566|Sequestering Agents|sequestering agents|mesh-ancestor
25473075|NCT00046566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473076|NCT00046839|Celecoxib|celecoxib|mesh-list
25473077|NCT00046839|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
25473078|NCT00046839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25473079|NCT00046839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25473080|NCT00046839|Analgesics|analgesics|mesh-ancestor
25473081|NCT00046839|Sensory System Agents|sensory system agents|mesh-ancestor
25473082|NCT00046839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25473083|NCT00046839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473084|NCT00046839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25473085|NCT00046839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25473086|NCT00046839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25473087|NCT00046839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473088|NCT00046839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473089|NCT00046930|Cytarabine|cytarabine|mesh-list
25473090|NCT00046930|Daunorubicin|daunorubicin|mesh-list
25473091|NCT00046930|Molgramostim|molgramostim|mesh-list
25473092|NCT00046930|Lenograstim|lenograstim|mesh-list
25473093|NCT00046930|Sargramostim|sargramostim|mesh-list
25473094|NCT00046930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25473095|NCT00046930|Antimetabolites|antimetabolites|mesh-ancestor
25473096|NCT00046930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473097|NCT00046930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473098|NCT00046930|Antiviral Agents|antiviral agents|mesh-ancestor
25473099|NCT00046930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25473100|NCT00046930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25473101|NCT00046930|Immunologic Factors|immunologic factors|mesh-ancestor
25473102|NCT00046930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473103|NCT00046930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25473104|NCT00046930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25473105|NCT00046930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25473106|NCT00046930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25473107|NCT00046930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473108|NCT00047060|Cyclosporine|cyclosporine|mesh-list
25473109|NCT00047060|Fludarabine|fludarabine|mesh-list
25473110|NCT00047060|Alemtuzumab|alemtuzumab|mesh-list
25473111|NCT00047060|Cyclosporins|cyclosporins|mesh-list
25473112|NCT00047060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473113|NCT00047060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473114|NCT00047060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25473115|NCT00047060|Immunologic Factors|immunologic factors|mesh-ancestor
25473116|NCT00047060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473117|NCT00047060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473118|NCT00047060|Antifungal Agents|antifungal agents|mesh-ancestor
25473119|NCT00047060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25473120|NCT00047060|Dermatologic Agents|dermatologic agents|mesh-ancestor
25473121|NCT00047060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25473122|NCT00047060|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25473123|NCT00047060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25473124|NCT00047320|Carboplatin|carboplatin|mesh-list
25473125|NCT00047320|Etoposide|etoposide|mesh-list
25822909|NCT00004690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473126|NCT00047320|Ifosfamide|ifosfamide|mesh-list
25473127|NCT00047320|Isophosphamide mustard|isophosphamide mustard|mesh-list
25473128|NCT00047320|Thiotepa|thiotepa|mesh-list
25473129|NCT00047320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473130|NCT00047320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25473131|NCT00047320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25473132|NCT00047320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25473133|NCT00047320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473134|NCT00047320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473135|NCT00047320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25473136|NCT00047320|Alkylating Agents|alkylating agents|mesh-ancestor
25473137|NCT00047320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25473138|NCT00047320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25473139|NCT00047320|Immunologic Factors|immunologic factors|mesh-ancestor
25473140|NCT00047320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473141|NCT00047697|Donepezil|donepezil|mesh-list
25473142|NCT00047697|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25473143|NCT00047697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473144|NCT00047697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473145|NCT00047697|Cholinergic Agents|cholinergic agents|mesh-ancestor
25473146|NCT00047697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25473147|NCT00047697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473148|NCT00047697|Nootropic Agents|nootropic agents|mesh-ancestor
25473149|NCT00047879|Interferons|interferons|mesh-list
25473150|NCT00047879|Interferon-alpha|interferon-alpha|mesh-list
25473151|NCT00047879|Interferon alpha-2|interferon alpha-2|mesh-list
25473152|NCT00047879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25473153|NCT00047879|Thalidomide|thalidomide|mesh-list
25473154|NCT00047879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473155|NCT00047879|Antiviral Agents|antiviral agents|mesh-ancestor
25473156|NCT00047879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25473157|NCT00047879|Immunologic Factors|immunologic factors|mesh-ancestor
25473158|NCT00047879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473159|NCT00047879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25473160|NCT00047879|Leprostatic Agents|leprostatic agents|mesh-ancestor
25473161|NCT00047879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25473162|NCT00047879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25473163|NCT00047879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25473164|NCT00047879|Growth Substances|growth substances|mesh-ancestor
25473165|NCT00047879|Growth Inhibitors|growth inhibitors|mesh-ancestor
25473166|NCT00048035|Epoetin Alfa|epoetin alfa|mesh-list
25473167|NCT00048035|Hematinics|hematinics|mesh-ancestor
25473168|NCT00048048|Epoetin Alfa|epoetin alfa|mesh-list
25473169|NCT00048048|Hematinics|hematinics|mesh-ancestor
25473170|NCT00048061|Vitamin D|vitamin d|mesh-list
25473171|NCT00048061|Ibandronic Acid|ibandronic acid|mesh-list
25473172|NCT00048061|Calcium|calcium|mesh-list
25473173|NCT00048061|Vitamins|vitamins|mesh-ancestor
25473174|NCT00048061|Micronutrients|micronutrients|mesh-ancestor
24820279|NCT02099240|Netilmicin|netilmicin|mesh-list
25656812|NCT01579305|Anesthetics|anesthetics|mesh-ancestor
25644793|NCT01440816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25473175|NCT00048061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473176|NCT00048061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25473177|NCT00048061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25473178|NCT00048074|Ibandronic Acid|ibandronic acid|mesh-list
25473179|NCT00048074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25473180|NCT00048074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473181|NCT00048165|Cyclosporine|cyclosporine|mesh-list
25473182|NCT00048165|Mycophenolic Acid|mycophenolic acid|mesh-list
25473183|NCT00048165|Methylprednisolone|methylprednisolone|mesh-list
25473184|NCT00048165|Cyclosporins|cyclosporins|mesh-list
25473185|NCT00048165|Daclizumab|daclizumab|mesh-list
25473186|NCT00048165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473187|NCT00048165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473188|NCT00048165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25473189|NCT00048165|Immunologic Factors|immunologic factors|mesh-ancestor
25473190|NCT00048165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473191|NCT00048165|Antifungal Agents|antifungal agents|mesh-ancestor
25473192|NCT00048165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25473193|NCT00048165|Dermatologic Agents|dermatologic agents|mesh-ancestor
25473194|NCT00048165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25473195|NCT00048165|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25473196|NCT00048165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25473197|NCT00048165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473198|NCT00048165|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25473199|NCT00048165|Antitubercular Agents|antitubercular agents|mesh-ancestor
25473200|NCT00048165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25473201|NCT00048165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25473202|NCT00048165|Antiemetics|antiemetics|mesh-ancestor
25473203|NCT00048165|Autonomic Agents|autonomic agents|mesh-ancestor
25473204|NCT00048165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25473236|NCT00048568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25473237|NCT00048568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25473238|NCT00048568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25473240|NCT00048581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25473241|NCT00048581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473242|NCT00048581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473243|NCT00048581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25473244|NCT00048581|Immunologic Factors|immunologic factors|mesh-ancestor
25473245|NCT00048581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473246|NCT00048581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24831116|NCT02163213|Immunologic Factors|immunologic factors|mesh-ancestor
24831117|NCT02163213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473247|NCT00048724|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25473248|NCT00048724|Antiviral Agents|antiviral agents|mesh-ancestor
25473249|NCT00048724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25473250|NCT00048737|Vidarabine|vidarabine|mesh-list
25473251|NCT00048737|Cyclophosphamide|cyclophosphamide|mesh-list
25473252|NCT00048737|Rituximab|rituximab|mesh-list
25473253|NCT00048737|Fludarabine|fludarabine|mesh-list
25473254|NCT00048737|Fludarabine phosphate|fludarabine phosphate|mesh-list
25473255|NCT00048737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25473256|NCT00048737|Immunologic Factors|immunologic factors|mesh-ancestor
25473257|NCT00048737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473258|NCT00048737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25473259|NCT00048737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25473260|NCT00048737|Alkylating Agents|alkylating agents|mesh-ancestor
25473261|NCT00048737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473262|NCT00048737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473263|NCT00048737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25473264|NCT00048737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25473265|NCT00048737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25473266|NCT00048737|Antimetabolites|antimetabolites|mesh-ancestor
25473267|NCT00048737|Antiviral Agents|antiviral agents|mesh-ancestor
25473268|NCT00048737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25473269|NCT00048815|Citalopram|citalopram|mesh-list
25473270|NCT00048815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25473271|NCT00048815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25473272|NCT00048815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25473273|NCT00048815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473274|NCT00048815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25473275|NCT00048815|Serotonin Agents|serotonin agents|mesh-ancestor
25473276|NCT00048815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473277|NCT00048815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25473278|NCT00048815|Antidepressive Agents|antidepressive agents|mesh-ancestor
25473279|NCT00048815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25473280|NCT00048893|Metronidazole|metronidazole|mesh-list
25473281|NCT00048893|Paclitaxel|paclitaxel|mesh-list
25473282|NCT00048893|Cyclophosphamide|cyclophosphamide|mesh-list
25473283|NCT00048893|Doxorubicin|doxorubicin|mesh-list
25473284|NCT00048893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25473285|NCT00048893|Fludarabine|fludarabine|mesh-list
25473286|NCT00048893|Fludarabine phosphate|fludarabine phosphate|mesh-list
25473287|NCT00048893|Vaccines|vaccines|mesh-list
25473288|NCT00048893|Sargramostim|sargramostim|mesh-list
25473289|NCT00048893|Immunologic Factors|immunologic factors|mesh-ancestor
25473290|NCT00048893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473291|NCT00048893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25473292|NCT00048893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473293|NCT00048893|Tubulin Modulators|tubulin modulators|mesh-ancestor
25473294|NCT00048893|Antimitotic Agents|antimitotic agents|mesh-ancestor
25473295|NCT00048893|Mitosis Modulators|mitosis modulators|mesh-ancestor
25473296|NCT00048893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473297|NCT00048893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25473298|NCT00048893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25473299|NCT00048893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25473300|NCT00048893|Alkylating Agents|alkylating agents|mesh-ancestor
25473301|NCT00048893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25473302|NCT00048893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25473303|NCT00048893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25473304|NCT00048893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25473305|NCT00048893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473306|NCT00048893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25473307|NCT00048893|Antimetabolites|antimetabolites|mesh-ancestor
25473308|NCT00048893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25473309|NCT00048893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25473310|NCT00048893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25473311|NCT00048893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25473312|NCT00048932|Abatacept|abatacept|mesh-list
25473313|NCT00048932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25473314|NCT00048932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473315|NCT00048932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473316|NCT00048932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25473317|NCT00048932|Immunologic Factors|immunologic factors|mesh-ancestor
25473318|NCT00048932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822910|NCT00004694|Heparin|heparin|mesh-list
25822911|NCT00004694|Anticoagulants|anticoagulants|mesh-ancestor
25822912|NCT00004694|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25822913|NCT00004694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25473319|NCT00048932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25473321|NCT00049036|Cyclophosphamide|cyclophosphamide|mesh-list
25473322|NCT00049036|Rituximab|rituximab|mesh-list
25473323|NCT00049036|Doxorubicin|doxorubicin|mesh-list
25473324|NCT00049036|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25473325|NCT00049036|Etoposide|etoposide|mesh-list
25473326|NCT00049036|Vincristine|vincristine|mesh-list
25473327|NCT00049036|Etoposide phosphate|etoposide phosphate|mesh-list
25473328|NCT00049036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25473329|NCT00049036|Immunologic Factors|immunologic factors|mesh-ancestor
25473330|NCT00049036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473331|NCT00049036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25473332|NCT00049036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25473333|NCT00049036|Alkylating Agents|alkylating agents|mesh-ancestor
25473334|NCT00049036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473335|NCT00049036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473336|NCT00049036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25473337|NCT00049036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25473338|NCT00049036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25473339|NCT00049036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25473340|NCT00049036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25473341|NCT00049036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473342|NCT00049036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25473343|NCT00049036|Glucocorticoids|glucocorticoids|mesh-ancestor
25473344|NCT00049036|Hormones|hormones|mesh-ancestor
25473345|NCT00049036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25473346|NCT00049036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25473347|NCT00049036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25473348|NCT00049036|Tubulin Modulators|tubulin modulators|mesh-ancestor
25473349|NCT00049036|Antimitotic Agents|antimitotic agents|mesh-ancestor
25473350|NCT00049036|Mitosis Modulators|mitosis modulators|mesh-ancestor
25473351|NCT00049127|Imatinib Mesylate|imatinib mesylate|mesh-list
25473352|NCT00049127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473353|NCT00049127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25473354|NCT00049127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473355|NCT00049127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473356|NCT00049257|Paclitaxel|paclitaxel|mesh-list
25473357|NCT00049257|Carboplatin|carboplatin|mesh-list
25473358|NCT00049257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25473359|NCT00049257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473360|NCT00049257|Tubulin Modulators|tubulin modulators|mesh-ancestor
25473361|NCT00049257|Antimitotic Agents|antimitotic agents|mesh-ancestor
25473362|NCT00049257|Mitosis Modulators|mitosis modulators|mesh-ancestor
25473363|NCT00049257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473364|NCT00049322|Bevacizumab|bevacizumab|mesh-list
25473365|NCT00049322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25473366|NCT00049322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473367|NCT00049322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25473368|NCT00049322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25473369|NCT00049322|Growth Substances|growth substances|mesh-ancestor
25473370|NCT00049322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473371|NCT00049322|Growth Inhibitors|growth inhibitors|mesh-ancestor
25473372|NCT00049504|Mycophenolic Acid|mycophenolic acid|mesh-list
25473373|NCT00049504|Cyclophosphamide|cyclophosphamide|mesh-list
25473374|NCT00049504|Fludarabine|fludarabine|mesh-list
25473375|NCT00049504|Fludarabine phosphate|fludarabine phosphate|mesh-list
25473376|NCT00049504|Tacrolimus|tacrolimus|mesh-list
25473377|NCT00049504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25473378|NCT00049504|Immunologic Factors|immunologic factors|mesh-ancestor
25473379|NCT00049504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473380|NCT00049504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25473381|NCT00049504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25473382|NCT00049504|Alkylating Agents|alkylating agents|mesh-ancestor
25473383|NCT00049504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473384|NCT00049504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473385|NCT00049504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25473386|NCT00049504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25473387|NCT00049504|Antimetabolites|antimetabolites|mesh-ancestor
25473388|NCT00049504|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25473389|NCT00049504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473390|NCT00049504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25473391|NCT00049504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25473392|NCT00049504|Antitubercular Agents|antitubercular agents|mesh-ancestor
25473393|NCT00049504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25473394|NCT00049504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25473395|NCT00049517|Cytarabine|cytarabine|mesh-list
25473396|NCT00049517|Cyclophosphamide|cyclophosphamide|mesh-list
25473397|NCT00049517|Busulfan|busulfan|mesh-list
25473398|NCT00049517|Daunorubicin|daunorubicin|mesh-list
25473399|NCT00049517|Gemtuzumab|gemtuzumab|mesh-list
25473400|NCT00049517|Sargramostim|sargramostim|mesh-list
25473401|NCT00049517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25473402|NCT00049517|Immunologic Factors|immunologic factors|mesh-ancestor
25473403|NCT00049517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473404|NCT00049517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25473405|NCT00049517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25473406|NCT00049517|Alkylating Agents|alkylating agents|mesh-ancestor
25473407|NCT00049517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473408|NCT00049517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473409|NCT00049517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25473410|NCT00049517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25473411|NCT00049517|Antimetabolites|antimetabolites|mesh-ancestor
25473412|NCT00049517|Antiviral Agents|antiviral agents|mesh-ancestor
25473413|NCT00049517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25473414|NCT00049517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25473415|NCT00049517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25473416|NCT00049517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25473417|NCT00049517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473418|NCT00049517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25473419|NCT00049530|Interferons|interferons|mesh-list
25473420|NCT00049530|Interferon-alpha|interferon-alpha|mesh-list
25473421|NCT00049530|Interferon alpha-2|interferon alpha-2|mesh-list
25473422|NCT00049530|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25473423|NCT00049530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473424|NCT00049530|Antiviral Agents|antiviral agents|mesh-ancestor
25473425|NCT00049530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25473426|NCT00049530|Immunologic Factors|immunologic factors|mesh-ancestor
24408892|NCT00179920|Carboplatin|carboplatin|mesh-list
25644794|NCT01440816|Immunologic Factors|immunologic factors|mesh-ancestor
25473427|NCT00049530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473428|NCT00049543|Gefitinib|gefitinib|mesh-list
25473429|NCT00049543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473430|NCT00049543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25473431|NCT00049543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473432|NCT00049543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473433|NCT00049673|Thalidomide|thalidomide|mesh-list
25473434|NCT00049673|Prednisone|prednisone|mesh-list
25473435|NCT00049673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25473436|NCT00049673|Glucocorticoids|glucocorticoids|mesh-ancestor
25473437|NCT00049673|Hormones|hormones|mesh-ancestor
25473438|NCT00049673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25473439|NCT00049673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473440|NCT00049673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25473441|NCT00049673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473442|NCT00049673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25473443|NCT00049673|Immunologic Factors|immunologic factors|mesh-ancestor
25473444|NCT00049673|Leprostatic Agents|leprostatic agents|mesh-ancestor
25473445|NCT00049673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25473446|NCT00049673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25473447|NCT00049673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25473448|NCT00049673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25473449|NCT00049673|Growth Substances|growth substances|mesh-ancestor
25473450|NCT00049673|Growth Inhibitors|growth inhibitors|mesh-ancestor
25473451|NCT00049842|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25473452|NCT00049842|Antiviral Agents|antiviral agents|mesh-ancestor
25473453|NCT00049842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25473454|NCT00050011|Zoledronic Acid|zoledronic acid|mesh-list
25473455|NCT00050011|Letrozole|letrozole|mesh-list
25473456|NCT00050011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473457|NCT00050011|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25473458|NCT00050011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25473459|NCT00050011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473460|NCT00050011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473461|NCT00050011|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25473462|NCT00050011|Hormone Antagonists|hormone antagonists|mesh-ancestor
25473463|NCT00050011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25822914|NCT00004694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822915|NCT00004695|Interleukin-2|interleukin-2|mesh-list
25822916|NCT00004695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25822917|NCT00004695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25822918|NCT00004695|Analgesics|analgesics|mesh-ancestor
25473464|NCT00050011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473465|NCT00050011|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25473466|NCT00050089|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25473467|NCT00050089|Antiviral Agents|antiviral agents|mesh-ancestor
25473468|NCT00050089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25473469|NCT00050167|Paclitaxel|paclitaxel|mesh-list
25473470|NCT00050167|Docetaxel|docetaxel|mesh-list
25473471|NCT00050167|Capecitabine|capecitabine|mesh-list
25473472|NCT00050167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25473473|NCT00050167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473474|NCT00050167|Tubulin Modulators|tubulin modulators|mesh-ancestor
25473475|NCT00050167|Antimitotic Agents|antimitotic agents|mesh-ancestor
25473476|NCT00050167|Mitosis Modulators|mitosis modulators|mesh-ancestor
25473477|NCT00050167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473478|NCT00050167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25473479|NCT00050167|Antimetabolites|antimetabolites|mesh-ancestor
25473480|NCT00050622|Methylphenidate|methylphenidate|mesh-list
25473481|NCT00050622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25473482|NCT00050622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473483|NCT00050622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25473484|NCT00050622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25473485|NCT00050622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25473486|NCT00050622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473487|NCT00050622|Dopamine Agents|dopamine agents|mesh-ancestor
25473488|NCT00050622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25473489|NCT00050778|Interferons|interferons|mesh-list
25473490|NCT00050778|Interferon-beta|interferon-beta|mesh-list
25473491|NCT00050778|Interferon beta-1a|interferon beta-1a|mesh-list
25473492|NCT00050778|Alemtuzumab|alemtuzumab|mesh-list
25473493|NCT00050778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473494|NCT00050778|Antiviral Agents|antiviral agents|mesh-ancestor
25473495|NCT00050778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25473496|NCT00050778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25473497|NCT00050778|Immunologic Factors|immunologic factors|mesh-ancestor
25473498|NCT00050778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473499|NCT00050778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25473500|NCT00050960|Paclitaxel|paclitaxel|mesh-list
25473501|NCT00050960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25473502|NCT00050960|Carboplatin|carboplatin|mesh-list
25473503|NCT00050960|Bexarotene|bexarotene|mesh-list
25473504|NCT00050960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25473505|NCT00050960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473506|NCT00050960|Tubulin Modulators|tubulin modulators|mesh-ancestor
25473507|NCT00050960|Antimitotic Agents|antimitotic agents|mesh-ancestor
25473508|NCT00050960|Mitosis Modulators|mitosis modulators|mesh-ancestor
25473509|NCT00050960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473510|NCT00050986|Temozolomide|temozolomide|mesh-list
25473511|NCT00050986|Tipifarnib|tipifarnib|mesh-list
25473512|NCT00050986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25473513|NCT00050986|Alkylating Agents|alkylating agents|mesh-ancestor
25473514|NCT00050986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473515|NCT00050986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473516|NCT00051168|Travoprost|travoprost|mesh-list
25473517|NCT00051168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25473518|NCT00051311|Cyclosporine|cyclosporine|mesh-list
25473519|NCT00051311|Prednisone|prednisone|mesh-list
25473520|NCT00051311|Cyclophosphamide|cyclophosphamide|mesh-list
25473521|NCT00051311|Doxorubicin|doxorubicin|mesh-list
25473522|NCT00051311|Methotrexate|methotrexate|mesh-list
25473523|NCT00051311|Fludarabine|fludarabine|mesh-list
25473524|NCT00051311|Etoposide|etoposide|mesh-list
25473525|NCT00051311|Vincristine|vincristine|mesh-list
25473526|NCT00051311|Cyclosporins|cyclosporins|mesh-list
25473527|NCT00051311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25473528|NCT00051311|Immunologic Factors|immunologic factors|mesh-ancestor
25473529|NCT00051311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473530|NCT00051311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25473531|NCT00051311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25473532|NCT00051311|Alkylating Agents|alkylating agents|mesh-ancestor
25473533|NCT00051311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473534|NCT00051311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473535|NCT00051311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25473536|NCT00051311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25473537|NCT00051311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25473538|NCT00051311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25473539|NCT00051311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473540|NCT00051311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25822919|NCT00004695|Sensory System Agents|sensory system agents|mesh-ancestor
25473541|NCT00051311|Glucocorticoids|glucocorticoids|mesh-ancestor
25473542|NCT00051311|Hormones|hormones|mesh-ancestor
25473543|NCT00051311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25473544|NCT00051311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25473545|NCT00051311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25473546|NCT00051311|Abortifacient Agents|abortifacient agents|mesh-ancestor
25473547|NCT00051311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25473548|NCT00051311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25473549|NCT00051311|Antimetabolites|antimetabolites|mesh-ancestor
25473550|NCT00051311|Dermatologic Agents|dermatologic agents|mesh-ancestor
25473551|NCT00051311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25473552|NCT00051311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25473553|NCT00051311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25473554|NCT00051311|Tubulin Modulators|tubulin modulators|mesh-ancestor
25473555|NCT00051311|Antimitotic Agents|antimitotic agents|mesh-ancestor
25473556|NCT00051311|Mitosis Modulators|mitosis modulators|mesh-ancestor
25473557|NCT00051311|Antifungal Agents|antifungal agents|mesh-ancestor
25473558|NCT00051311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25473559|NCT00051311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25473560|NCT00051558|Alendronate|alendronate|mesh-list
25473561|NCT00051558|Teriparatide|teriparatide|mesh-list
25473562|NCT00051558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25473563|NCT00051558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473564|NCT00051558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25473565|NCT00051636|Vitamin D|vitamin d|mesh-list
25473566|NCT00051636|Zoledronic Acid|zoledronic acid|mesh-list
25473567|NCT00051636|Risedronic Acid|risedronic acid|mesh-list
25473568|NCT00051636|Etidronic Acid|etidronic acid|mesh-list
25473569|NCT00051636|Calcium|calcium|mesh-list
25473570|NCT00051636|Vitamins|vitamins|mesh-ancestor
25473571|NCT00051636|Micronutrients|micronutrients|mesh-ancestor
25473572|NCT00051636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822920|NCT00004695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25473574|NCT00051636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25473575|NCT00051636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25473576|NCT00051636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25473577|NCT00051636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473578|NCT00052078|Sertraline|sertraline|mesh-list
25473579|NCT00052078|Antidepressive Agents|antidepressive agents|mesh-ancestor
25473580|NCT00052078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25473581|NCT00052078|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25473582|NCT00052078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25473583|NCT00052078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25473584|NCT00052078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473585|NCT00052078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25473586|NCT00052078|Serotonin Agents|serotonin agents|mesh-ancestor
25473587|NCT00052078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473588|NCT00052429|Cisplatin|cisplatin|mesh-list
25473589|NCT00052429|Fluorouracil|fluorouracil|mesh-list
25473590|NCT00052429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473591|NCT00052429|Antimetabolites|antimetabolites|mesh-ancestor
25473592|NCT00052429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473593|NCT00052429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25473594|NCT00052429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25473595|NCT00052429|Immunologic Factors|immunologic factors|mesh-ancestor
25473596|NCT00052429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473597|NCT00052442|10-deazaaminopterin|10-deazaaminopterin|mesh-list
25473598|NCT00052442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473599|NCT00052442|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25473600|NCT00052442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473601|NCT00052442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473602|NCT00052715|Poly ICLC|poly iclc|mesh-list
25473603|NCT00052715|Interferon Inducers|interferon inducers|mesh-ancestor
25473604|NCT00052715|Immunologic Factors|immunologic factors|mesh-ancestor
25473605|NCT00052715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473606|NCT00052910|Leucovorin|leucovorin|mesh-list
25473607|NCT00052910|Cisplatin|cisplatin|mesh-list
25822921|NCT00004695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822922|NCT00004696|Morphine|morphine|mesh-list
24471144|NCT00393471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723232|NCT01586169|Ivermectin|ivermectin|mesh-list
24471391|NCT00395070|Temozolomide|temozolomide|mesh-list
24471408|NCT00395213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471450|NCT00395382|Alendronate|alendronate|mesh-list
25473608|NCT00052910|Fluorouracil|fluorouracil|mesh-list
25473609|NCT00052910|Epirubicin|epirubicin|mesh-list
25473610|NCT00052910|Calcium|calcium|mesh-list
25473611|NCT00052910|Levoleucovorin|levoleucovorin|mesh-list
25473612|NCT00052910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473613|NCT00052910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25473614|NCT00052910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473615|NCT00052910|Antimetabolites|antimetabolites|mesh-ancestor
25473616|NCT00052910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473617|NCT00052910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25473618|NCT00052910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25473619|NCT00052910|Immunologic Factors|immunologic factors|mesh-ancestor
25473620|NCT00052910|Antidotes|antidotes|mesh-ancestor
25473621|NCT00052910|Protective Agents|protective agents|mesh-ancestor
25473622|NCT00052910|Vitamin B Complex|vitamin b complex|mesh-ancestor
25473623|NCT00052910|Vitamins|vitamins|mesh-ancestor
25473624|NCT00052910|Micronutrients|micronutrients|mesh-ancestor
25473625|NCT00052910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25473626|NCT00052910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25473627|NCT00052910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25473628|NCT00052910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473629|NCT00053014|Cyclosporine|cyclosporine|mesh-list
25473630|NCT00053014|Mycophenolic Acid|mycophenolic acid|mesh-list
25473631|NCT00053014|Fludarabine|fludarabine|mesh-list
25473632|NCT00053014|Cyclosporins|cyclosporins|mesh-list
25473633|NCT00053014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473634|NCT00053014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473635|NCT00053014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25473636|NCT00053014|Immunologic Factors|immunologic factors|mesh-ancestor
25473637|NCT00053014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473638|NCT00053014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473639|NCT00053014|Antifungal Agents|antifungal agents|mesh-ancestor
25473640|NCT00053014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25473641|NCT00053014|Dermatologic Agents|dermatologic agents|mesh-ancestor
25473642|NCT00053014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25473643|NCT00053014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25473644|NCT00053014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25473645|NCT00053014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25473646|NCT00053014|Antitubercular Agents|antitubercular agents|mesh-ancestor
25473647|NCT00053014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25473648|NCT00053352|Cisplatin|cisplatin|mesh-list
25473649|NCT00053352|Etoposide|etoposide|mesh-list
25473650|NCT00053352|Etoposide phosphate|etoposide phosphate|mesh-list
25473651|NCT00053352|Bleomycin|bleomycin|mesh-list
25473652|NCT00053352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473653|NCT00053352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25473654|NCT00053352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25473655|NCT00053352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25473656|NCT00053352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473657|NCT00053352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473658|NCT00053352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25473659|NCT00053365|Irofulven|irofulven|mesh-list
25473660|NCT00053365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25473661|NCT00053365|Alkylating Agents|alkylating agents|mesh-ancestor
25473662|NCT00053365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473663|NCT00053365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473664|NCT00053417|4-Aminopyridine|4-aminopyridine|mesh-list
25473665|NCT00053417|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25473666|NCT00053417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25473667|NCT00053417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473668|NCT00053482|Vaccines|vaccines|mesh-list
25473669|NCT00053482|Immunologic Factors|immunologic factors|mesh-ancestor
25473670|NCT00053482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473671|NCT00053677|Naltrexone|naltrexone|mesh-list
25473672|NCT00053677|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25473673|NCT00053677|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25473674|NCT00053677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473675|NCT00053677|Sensory System Agents|sensory system agents|mesh-ancestor
25473676|NCT00053677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25473677|NCT00053703|Olanzapine|olanzapine|mesh-list
25473678|NCT00053703|Risperidone|risperidone|mesh-list
25473679|NCT00053703|Molindone|molindone|mesh-list
25473680|NCT00053703|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24476655|NCT00415961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476656|NCT00416039|Midazolam|midazolam|mesh-list
24476657|NCT00416039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24476658|NCT00416039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25473681|NCT00053703|Serotonin Agents|serotonin agents|mesh-ancestor
25473682|NCT00053703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25473683|NCT00053703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473684|NCT00053703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473685|NCT00053703|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25473686|NCT00053703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25473687|NCT00053703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25473688|NCT00053703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25473689|NCT00053703|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25473690|NCT00053703|Dopamine Agents|dopamine agents|mesh-ancestor
25473691|NCT00053703|Antiemetics|antiemetics|mesh-ancestor
25473692|NCT00053703|Autonomic Agents|autonomic agents|mesh-ancestor
25473693|NCT00053703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25473694|NCT00053703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25473695|NCT00053703|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25473696|NCT00053703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25473697|NCT00053703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25473698|NCT00053846|Buspirone|buspirone|mesh-list
25473699|NCT00053846|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25473700|NCT00053846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25473701|NCT00053846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25473702|NCT00053846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473703|NCT00053846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25473704|NCT00053846|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25473705|NCT00053846|Serotonin Agents|serotonin agents|mesh-ancestor
25473706|NCT00053846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25473707|NCT00053846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473708|NCT00053898|Tamoxifen|tamoxifen|mesh-list
25473709|NCT00053898|Anastrozole|anastrozole|mesh-list
25473710|NCT00053898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473711|NCT00053898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25473713|NCT00053898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25473715|NCT00053898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25473716|NCT00053898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473717|NCT00053898|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25473718|NCT00053898|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25473719|NCT00053898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25473720|NCT00053898|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25473721|NCT00053898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25473722|NCT00053898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473723|NCT00053989|Mycophenolic Acid|mycophenolic acid|mesh-list
25473724|NCT00053989|Methylprednisolone|methylprednisolone|mesh-list
25473725|NCT00053989|Cyclophosphamide|cyclophosphamide|mesh-list
25473726|NCT00053989|Fludarabine|fludarabine|mesh-list
25473727|NCT00053989|Fludarabine phosphate|fludarabine phosphate|mesh-list
25473728|NCT00053989|Tacrolimus|tacrolimus|mesh-list
25473729|NCT00053989|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25473730|NCT00053989|Sargramostim|sargramostim|mesh-list
25473731|NCT00053989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25473732|NCT00053989|Immunologic Factors|immunologic factors|mesh-ancestor
25473733|NCT00053989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473734|NCT00053989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25473735|NCT00053989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25473736|NCT00053989|Alkylating Agents|alkylating agents|mesh-ancestor
25473737|NCT00053989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473738|NCT00053989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473739|NCT00053989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25473740|NCT00053989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25473741|NCT00053989|Antimetabolites|antimetabolites|mesh-ancestor
25473742|NCT00053989|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25473743|NCT00053989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473744|NCT00053989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25473745|NCT00053989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25473746|NCT00053989|Antitubercular Agents|antitubercular agents|mesh-ancestor
25473747|NCT00053989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25473748|NCT00053989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25473749|NCT00053989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25473750|NCT00053989|Antiemetics|antiemetics|mesh-ancestor
25473751|NCT00053989|Autonomic Agents|autonomic agents|mesh-ancestor
25473752|NCT00053989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25473753|NCT00053989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25473755|NCT00053989|Hormones|hormones|mesh-ancestor
25473756|NCT00053989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25473757|NCT00053989|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25473758|NCT00053989|Protective Agents|protective agents|mesh-ancestor
25473759|NCT00054028|Suramin|suramin|mesh-list
25473760|NCT00054028|Paclitaxel|paclitaxel|mesh-list
25473761|NCT00054028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25473762|NCT00054028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473763|NCT00054028|Tubulin Modulators|tubulin modulators|mesh-ancestor
25473764|NCT00054028|Antimitotic Agents|antimitotic agents|mesh-ancestor
25473765|NCT00054028|Mitosis Modulators|mitosis modulators|mesh-ancestor
25473766|NCT00054028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473767|NCT00054028|Antinematodal Agents|antinematodal agents|mesh-ancestor
25473768|NCT00054028|Anthelmintics|anthelmintics|mesh-ancestor
25473769|NCT00054028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25473770|NCT00054028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25473771|NCT00054028|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25473772|NCT00054028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25473773|NCT00054132|Bevacizumab|bevacizumab|mesh-list
25473774|NCT00054132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25473775|NCT00054132|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25473776|NCT00054132|Endothelial Growth Factors|endothelial growth factors|mesh-list
25473777|NCT00054132|Antibodies|antibodies|mesh-list
25473778|NCT00054132|Immunoglobulins|immunoglobulins|mesh-list
25473779|NCT00054132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25473780|NCT00054132|Immunoglobulin G|immunoglobulin g|mesh-list
25473781|NCT00054132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473782|NCT00054132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25473783|NCT00054132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25473784|NCT00054132|Growth Substances|growth substances|mesh-ancestor
25473785|NCT00054132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473786|NCT00054132|Growth Inhibitors|growth inhibitors|mesh-ancestor
25473790|NCT00054132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473792|NCT00054275|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25473793|NCT00054275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473794|NCT00054275|Tubulin Modulators|tubulin modulators|mesh-ancestor
25473795|NCT00054275|Antimitotic Agents|antimitotic agents|mesh-ancestor
25473796|NCT00054275|Mitosis Modulators|mitosis modulators|mesh-ancestor
25473797|NCT00054275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473798|NCT00054275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25473799|NCT00054275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473800|NCT00054327|Cytarabine|cytarabine|mesh-list
25473801|NCT00054327|Cyclophosphamide|cyclophosphamide|mesh-list
25473802|NCT00054327|Busulfan|busulfan|mesh-list
25473803|NCT00054327|Etoposide|etoposide|mesh-list
25473804|NCT00054327|Etoposide phosphate|etoposide phosphate|mesh-list
25473805|NCT00054327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25473806|NCT00054327|Immunologic Factors|immunologic factors|mesh-ancestor
25473807|NCT00054327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473808|NCT00054327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25473809|NCT00054327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25473810|NCT00054327|Alkylating Agents|alkylating agents|mesh-ancestor
25473811|NCT00054327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473812|NCT00054327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473813|NCT00054327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25473814|NCT00054327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25473815|NCT00054327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25473816|NCT00054327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25473817|NCT00054327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473818|NCT00054327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25473819|NCT00054327|Antimetabolites|antimetabolites|mesh-ancestor
25473820|NCT00054327|Antiviral Agents|antiviral agents|mesh-ancestor
25473821|NCT00054327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25473822|NCT00054353|Cyclosporine|cyclosporine|mesh-list
25473823|NCT00054353|Mycophenolic Acid|mycophenolic acid|mesh-list
24478761|NCT00424281|PENTA|penta|mesh-list
25473824|NCT00054353|Fludarabine|fludarabine|mesh-list
25473825|NCT00054353|Fludarabine phosphate|fludarabine phosphate|mesh-list
25473826|NCT00054353|Melphalan|melphalan|mesh-list
25473827|NCT00054353|Cyclosporins|cyclosporins|mesh-list
25473828|NCT00054353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473829|NCT00054353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25473830|NCT00054353|Antimetabolites|antimetabolites|mesh-ancestor
25473831|NCT00054353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473832|NCT00054353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25473833|NCT00054353|Immunologic Factors|immunologic factors|mesh-ancestor
25473834|NCT00054353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473835|NCT00054353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473836|NCT00054353|Antifungal Agents|antifungal agents|mesh-ancestor
25473837|NCT00054353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25473838|NCT00054353|Dermatologic Agents|dermatologic agents|mesh-ancestor
25473839|NCT00054353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25473840|NCT00054353|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25473841|NCT00054353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25473842|NCT00054353|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25473843|NCT00054353|Antitubercular Agents|antitubercular agents|mesh-ancestor
25473844|NCT00054353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25473845|NCT00054353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25473846|NCT00054353|Alkylating Agents|alkylating agents|mesh-ancestor
25473847|NCT00054353|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25473848|NCT00054639|Rituximab|rituximab|mesh-list
25473849|NCT00054639|Oblimersen|oblimersen|mesh-list
25473850|NCT00054639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25473851|NCT00054639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473852|NCT00054639|Immunologic Factors|immunologic factors|mesh-ancestor
25473853|NCT00054639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473854|NCT00054639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25473855|NCT00054665|Prednisone|prednisone|mesh-list
25473856|NCT00054665|Cyclophosphamide|cyclophosphamide|mesh-list
25473857|NCT00054665|Doxorubicin|doxorubicin|mesh-list
25473858|NCT00054665|Etoposide|etoposide|mesh-list
25473859|NCT00054665|Vincristine|vincristine|mesh-list
25473861|NCT00054665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25473862|NCT00054665|Immunologic Factors|immunologic factors|mesh-ancestor
25473863|NCT00054665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473864|NCT00054665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25473865|NCT00054665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25473866|NCT00054665|Alkylating Agents|alkylating agents|mesh-ancestor
25473867|NCT00054665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473868|NCT00054665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473869|NCT00054665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25473870|NCT00054665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25473871|NCT00054665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25473872|NCT00054665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25473873|NCT00054665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473874|NCT00054665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25473875|NCT00054665|Glucocorticoids|glucocorticoids|mesh-ancestor
25473876|NCT00054665|Hormones|hormones|mesh-ancestor
25473877|NCT00054665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25473878|NCT00054665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25473879|NCT00054665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25473880|NCT00054665|Tubulin Modulators|tubulin modulators|mesh-ancestor
25473881|NCT00054665|Antimitotic Agents|antimitotic agents|mesh-ancestor
25473882|NCT00054665|Mitosis Modulators|mitosis modulators|mesh-ancestor
25473883|NCT00054691|Gefitinib|gefitinib|mesh-list
25473884|NCT00054691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473885|NCT00054691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25473886|NCT00054691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473887|NCT00054691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473888|NCT00054704|Riluzole|riluzole|mesh-list
25473889|NCT00054704|Anticonvulsants|anticonvulsants|mesh-ancestor
25473890|NCT00054704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25473891|NCT00054704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25473892|NCT00054704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25473893|NCT00054704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473894|NCT00054704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473895|NCT00054704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25473896|NCT00054704|Protective Agents|protective agents|mesh-ancestor
25473897|NCT00054717|Ritonavir|ritonavir|mesh-list
25473898|NCT00054717|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
25473899|NCT00054717|Tipranavir|tipranavir|mesh-list
24479971|NCT00429234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25473900|NCT00054717|Protease Inhibitors|protease inhibitors|mesh-list
25473901|NCT00054717|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25473902|NCT00054717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473903|NCT00054717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473904|NCT00054717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25473905|NCT00054717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25473906|NCT00054717|Antiviral Agents|antiviral agents|mesh-ancestor
25473907|NCT00054717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25473908|NCT00054717|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25473909|NCT00054717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25473911|NCT00054756|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
25473912|NCT00054756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25473913|NCT00054756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473914|NCT00055237|Bevacizumab|bevacizumab|mesh-list
25473915|NCT00055237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25473916|NCT00055237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473917|NCT00055237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25473918|NCT00055237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25473919|NCT00055237|Growth Substances|growth substances|mesh-ancestor
25473920|NCT00055237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473921|NCT00055237|Growth Inhibitors|growth inhibitors|mesh-ancestor
25473922|NCT00055497|Adalimumab|adalimumab|mesh-list
25473923|NCT00055497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25473924|NCT00055497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25473925|NCT00055601|Gemcitabine|gemcitabine|mesh-list
25473926|NCT00055601|Paclitaxel|paclitaxel|mesh-list
25473927|NCT00055601|Cisplatin|cisplatin|mesh-list
25473928|NCT00055601|Fluorouracil|fluorouracil|mesh-list
25473929|NCT00055601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25473930|NCT00055601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473931|NCT00055601|Tubulin Modulators|tubulin modulators|mesh-ancestor
25473932|NCT00055601|Antimitotic Agents|antimitotic agents|mesh-ancestor
25473933|NCT00055601|Mitosis Modulators|mitosis modulators|mesh-ancestor
25644795|NCT01440816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473934|NCT00055601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473935|NCT00055601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25473936|NCT00055601|Antimetabolites|antimetabolites|mesh-ancestor
25473937|NCT00055601|Antiviral Agents|antiviral agents|mesh-ancestor
25473938|NCT00055601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25473939|NCT00055601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473940|NCT00055601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25473941|NCT00055601|Immunologic Factors|immunologic factors|mesh-ancestor
25473942|NCT00055601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473943|NCT00055692|Bevacizumab|bevacizumab|mesh-list
25473944|NCT00055692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25473945|NCT00055692|Antibodies|antibodies|mesh-list
25473946|NCT00055692|Immunoglobulins|immunoglobulins|mesh-list
25473947|NCT00055692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25473948|NCT00055692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473949|NCT00055692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25473950|NCT00055692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25473951|NCT00055692|Growth Substances|growth substances|mesh-ancestor
25473952|NCT00055692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473953|NCT00055692|Growth Inhibitors|growth inhibitors|mesh-ancestor
25473954|NCT00055692|Immunologic Factors|immunologic factors|mesh-ancestor
25473955|NCT00056160|Dexamethasone|dexamethasone|mesh-list
25473956|NCT00056160|Lenalidomide|lenalidomide|mesh-list
25473957|NCT00056160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25473958|NCT00056160|Antiemetics|antiemetics|mesh-ancestor
25473959|NCT00056160|Autonomic Agents|autonomic agents|mesh-ancestor
25473960|NCT00056160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25473961|NCT00056160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473962|NCT00056160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25473963|NCT00056160|Glucocorticoids|glucocorticoids|mesh-ancestor
25473964|NCT00056160|Hormones|hormones|mesh-ancestor
25473965|NCT00056160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25473966|NCT00056160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25473967|NCT00056160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25473968|NCT00056160|Immunologic Factors|immunologic factors|mesh-ancestor
24484240|NCT00447239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24484280|NCT00447473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24457422|NCT00334360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24457480|NCT00334503|Miglitol|miglitol|mesh-list
24486644|NCT00458991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25822923|NCT00004696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25473969|NCT00056160|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25473970|NCT00056160|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25473971|NCT00056160|Growth Substances|growth substances|mesh-ancestor
25473972|NCT00056160|Growth Inhibitors|growth inhibitors|mesh-ancestor
25473973|NCT00056407|Dutasteride|dutasteride|mesh-list
25473974|NCT00056407|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25473975|NCT00056407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25473976|NCT00056407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25473977|NCT00056407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473978|NCT00056407|Hormone Antagonists|hormone antagonists|mesh-ancestor
25473979|NCT00056407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25473980|NCT00056407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473981|NCT00056472|Olanzapine|olanzapine|mesh-list
25473982|NCT00056472|Sertraline|sertraline|mesh-list
25473983|NCT00056472|Antiemetics|antiemetics|mesh-ancestor
25473984|NCT00056472|Autonomic Agents|autonomic agents|mesh-ancestor
25473985|NCT00056472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25473986|NCT00056472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25473987|NCT00056472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25473988|NCT00056472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25473989|NCT00056472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25473990|NCT00056472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25473991|NCT00056472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25473992|NCT00056472|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25473993|NCT00056472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25473994|NCT00056472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25473995|NCT00056472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25473996|NCT00056472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25473997|NCT00056472|Serotonin Agents|serotonin agents|mesh-ancestor
25473998|NCT00056472|Antidepressive Agents|antidepressive agents|mesh-ancestor
25473999|NCT00056498|Risperidone|risperidone|mesh-list
24682722|NCT01388088|Amiloride|amiloride|mesh-list
25644796|NCT01440816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25644797|NCT01440816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25474000|NCT00056498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25474001|NCT00056498|Serotonin Agents|serotonin agents|mesh-ancestor
25474002|NCT00056498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25474003|NCT00056498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474004|NCT00056498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474005|NCT00056498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25474006|NCT00056498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25474007|NCT00056498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25474008|NCT00056498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25474009|NCT00056498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25474010|NCT00056498|Dopamine Agents|dopamine agents|mesh-ancestor
25474011|NCT00056550|Antithrombins|antithrombins|mesh-list
25474012|NCT00056550|Antithrombin III|antithrombin iii|mesh-list
25474013|NCT00056550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25474014|NCT00056550|Protease Inhibitors|protease inhibitors|mesh-ancestor
25474015|NCT00056550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474016|NCT00056550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474017|NCT00056550|Anticoagulants|anticoagulants|mesh-ancestor
25474018|NCT00056862|Ribavirin|ribavirin|mesh-list
25474019|NCT00056862|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25474020|NCT00056862|Interferon-alpha|interferon-alpha|mesh-list
25474021|NCT00056862|Antimetabolites|antimetabolites|mesh-ancestor
25474022|NCT00056862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474023|NCT00056862|Antiviral Agents|antiviral agents|mesh-ancestor
25474024|NCT00056862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25474025|NCT00056862|Immunologic Factors|immunologic factors|mesh-ancestor
25474026|NCT00056862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474027|NCT00057330|polysaccharide-K|polysaccharide-k|mesh-list
25474028|NCT00057330|Vaccines|vaccines|mesh-list
25474029|NCT00057330|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
25474030|NCT00057330|Immunologic Factors|immunologic factors|mesh-ancestor
25474031|NCT00057330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474032|NCT00057330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25474033|NCT00057330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25474034|NCT00057330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474035|NCT00057330|Antiviral Agents|antiviral agents|mesh-ancestor
25474036|NCT00057330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25474037|NCT00057330|Interferon Inducers|interferon inducers|mesh-ancestor
25474038|NCT00057330|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25474039|NCT00057330|Protective Agents|protective agents|mesh-ancestor
25474040|NCT00057551|Antidepressive Agents|antidepressive agents|mesh-list
25474041|NCT00057551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25474042|NCT00057681|Valproic Acid|valproic acid|mesh-list
25474043|NCT00057681|Risperidone|risperidone|mesh-list
25474044|NCT00057681|Lithium Carbonate|lithium carbonate|mesh-list
25474045|NCT00057681|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25474046|NCT00057681|Serotonin Agents|serotonin agents|mesh-ancestor
25474047|NCT00057681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25474048|NCT00057681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474049|NCT00057681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474050|NCT00057681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25474051|NCT00057681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25474052|NCT00057681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25474053|NCT00057681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25474054|NCT00057681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25474055|NCT00057681|Dopamine Agents|dopamine agents|mesh-ancestor
25474056|NCT00057681|Antidepressive Agents|antidepressive agents|mesh-ancestor
25474057|NCT00057681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474058|NCT00057681|Antimanic Agents|antimanic agents|mesh-ancestor
25474059|NCT00057681|Anticonvulsants|anticonvulsants|mesh-ancestor
25474061|NCT00057785|Cisplatin|cisplatin|mesh-list
25474062|NCT00057785|Fluorouracil|fluorouracil|mesh-list
25474063|NCT00057785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474064|NCT00057785|Antimetabolites|antimetabolites|mesh-ancestor
25474065|NCT00057785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474066|NCT00057785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25474067|NCT00057785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25474068|NCT00057785|Immunologic Factors|immunologic factors|mesh-ancestor
25474069|NCT00057785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474070|NCT00057811|Leucovorin|leucovorin|mesh-list
25474071|NCT00057811|Cytarabine|cytarabine|mesh-list
25474072|NCT00057811|Prednisone|prednisone|mesh-list
25474073|NCT00057811|Methylprednisolone|methylprednisolone|mesh-list
25474074|NCT00057811|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25474075|NCT00057811|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25474076|NCT00057811|Prednisolone|prednisolone|mesh-list
25474077|NCT00057811|Prednisolone acetate|prednisolone acetate|mesh-list
25474078|NCT00057811|Hydrocortisone|hydrocortisone|mesh-list
25474079|NCT00057811|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25474080|NCT00057811|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25474081|NCT00057811|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25474082|NCT00057811|Cyclophosphamide|cyclophosphamide|mesh-list
25474083|NCT00057811|Rituximab|rituximab|mesh-list
25474084|NCT00057811|Doxorubicin|doxorubicin|mesh-list
25474085|NCT00057811|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25474086|NCT00057811|Methotrexate|methotrexate|mesh-list
25474087|NCT00057811|Etoposide|etoposide|mesh-list
25474088|NCT00057811|Vincristine|vincristine|mesh-list
25474089|NCT00057811|Etoposide phosphate|etoposide phosphate|mesh-list
25474090|NCT00057811|Rasburicase|rasburicase|mesh-list
25474091|NCT00057811|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25474092|NCT00057811|Prednisolone phosphate|prednisolone phosphate|mesh-list
25474093|NCT00057811|Levoleucovorin|levoleucovorin|mesh-list
25474094|NCT00057811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25474095|NCT00057811|Immunologic Factors|immunologic factors|mesh-ancestor
25474096|NCT00057811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474097|NCT00057811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25474098|NCT00057811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25474099|NCT00057811|Alkylating Agents|alkylating agents|mesh-ancestor
25474100|NCT00057811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474101|NCT00057811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474102|NCT00057811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25474103|NCT00057811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25474104|NCT00057811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25474105|NCT00057811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25474106|NCT00057811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25474107|NCT00057811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474108|NCT00057811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25474109|NCT00057811|Glucocorticoids|glucocorticoids|mesh-ancestor
25474110|NCT00057811|Hormones|hormones|mesh-ancestor
25474111|NCT00057811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25474112|NCT00057811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25474113|NCT00057811|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25474114|NCT00057811|Abortifacient Agents|abortifacient agents|mesh-ancestor
25474115|NCT00057811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25474116|NCT00057811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25474117|NCT00057811|Antimetabolites|antimetabolites|mesh-ancestor
24487623|NCT00464217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487625|NCT00464217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25474118|NCT00057811|Dermatologic Agents|dermatologic agents|mesh-ancestor
25474119|NCT00057811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25474120|NCT00057811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25474121|NCT00057811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25474122|NCT00057811|Antiviral Agents|antiviral agents|mesh-ancestor
25474123|NCT00057811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25474124|NCT00057811|Antidotes|antidotes|mesh-ancestor
25474125|NCT00057811|Protective Agents|protective agents|mesh-ancestor
25474126|NCT00057811|Vitamin B Complex|vitamin b complex|mesh-ancestor
25474127|NCT00057811|Vitamins|vitamins|mesh-ancestor
25474128|NCT00057811|Micronutrients|micronutrients|mesh-ancestor
25474129|NCT00057811|Tubulin Modulators|tubulin modulators|mesh-ancestor
25474130|NCT00057811|Antimitotic Agents|antimitotic agents|mesh-ancestor
25474131|NCT00057811|Mitosis Modulators|mitosis modulators|mesh-ancestor
25474132|NCT00057811|Antiemetics|antiemetics|mesh-ancestor
25474133|NCT00057811|Autonomic Agents|autonomic agents|mesh-ancestor
25474134|NCT00057811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25474135|NCT00057811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25474136|NCT00057811|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25474137|NCT00057811|Gout Suppressants|gout suppressants|mesh-ancestor
25474138|NCT00057837|Cisplatin|cisplatin|mesh-list
25474139|NCT00057837|Irinotecan|irinotecan|mesh-list
25474140|NCT00057837|Etoposide|etoposide|mesh-list
25474141|NCT00057837|Etoposide phosphate|etoposide phosphate|mesh-list
25474142|NCT00057837|Topotecan|topotecan|mesh-list
25474143|NCT00057837|Podophyllotoxin|podophyllotoxin|mesh-list
25474144|NCT00057837|Camptothecin|camptothecin|mesh-list
25474145|NCT00057837|Lenograstim|lenograstim|mesh-list
25474146|NCT00057837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474147|NCT00057837|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25474148|NCT00057837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25474149|NCT00057837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474150|NCT00057837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474151|NCT00057837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25474152|NCT00057837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25474153|NCT00057837|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25474154|NCT00057837|Immunologic Factors|immunologic factors|mesh-ancestor
25474155|NCT00057837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474156|NCT00057837|Keratolytic Agents|keratolytic agents|mesh-ancestor
25474157|NCT00057837|Dermatologic Agents|dermatologic agents|mesh-ancestor
25474158|NCT00057837|Tubulin Modulators|tubulin modulators|mesh-ancestor
25474159|NCT00057837|Antimitotic Agents|antimitotic agents|mesh-ancestor
25474160|NCT00057837|Mitosis Modulators|mitosis modulators|mesh-ancestor
25474161|NCT00057863|Paclitaxel|paclitaxel|mesh-list
25474162|NCT00057863|Oxaliplatin|oxaliplatin|mesh-list
25474163|NCT00057863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25474164|NCT00057863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474165|NCT00057863|Tubulin Modulators|tubulin modulators|mesh-ancestor
25474166|NCT00057863|Antimitotic Agents|antimitotic agents|mesh-ancestor
25474167|NCT00057863|Mitosis Modulators|mitosis modulators|mesh-ancestor
25474168|NCT00057863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474169|NCT00057876|Gemcitabine|gemcitabine|mesh-list
25474170|NCT00057876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25474171|NCT00057876|Antimetabolites|antimetabolites|mesh-ancestor
25474172|NCT00057876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474173|NCT00057876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474174|NCT00057876|Antiviral Agents|antiviral agents|mesh-ancestor
25474175|NCT00057876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25474176|NCT00057876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474177|NCT00057876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25474178|NCT00057876|Immunologic Factors|immunologic factors|mesh-ancestor
25474179|NCT00057876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474180|NCT00057941|Fulvestrant|fulvestrant|mesh-list
25474181|NCT00057941|Anastrozole|anastrozole|mesh-list
25474182|NCT00057941|Gefitinib|gefitinib|mesh-list
25474183|NCT00057941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25474184|NCT00057941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474185|NCT00057941|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25474186|NCT00057941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25474187|NCT00057941|Hormone Antagonists|hormone antagonists|mesh-ancestor
25474188|NCT00057941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25474189|NCT00057941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474190|NCT00057941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25474191|NCT00057941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474192|NCT00057941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474193|NCT00057941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25474194|NCT00057941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25474195|NCT00057954|Cyclosporine|cyclosporine|mesh-list
25822924|NCT00004696|Narcotics|narcotics|mesh-ancestor
25474196|NCT00057954|Mycophenolic Acid|mycophenolic acid|mesh-list
25474197|NCT00057954|Methotrexate|methotrexate|mesh-list
25474198|NCT00057954|Pentostatin|pentostatin|mesh-list
25474199|NCT00057954|Cyclosporins|cyclosporins|mesh-list
25474200|NCT00057954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25474201|NCT00057954|Abortifacient Agents|abortifacient agents|mesh-ancestor
25474202|NCT00057954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25474203|NCT00057954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474204|NCT00057954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25474205|NCT00057954|Antimetabolites|antimetabolites|mesh-ancestor
25474206|NCT00057954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474207|NCT00057954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474208|NCT00057954|Dermatologic Agents|dermatologic agents|mesh-ancestor
25474209|NCT00057954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474210|NCT00057954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25474211|NCT00057954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25474212|NCT00057954|Immunologic Factors|immunologic factors|mesh-ancestor
25474213|NCT00057954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25474214|NCT00057954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25474215|NCT00057954|Antifungal Agents|antifungal agents|mesh-ancestor
25474216|NCT00057954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25474217|NCT00057954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25474218|NCT00057954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25474219|NCT00057954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25474220|NCT00057954|Antitubercular Agents|antitubercular agents|mesh-ancestor
25474221|NCT00057954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25474222|NCT00057954|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25474223|NCT00058019|Epothilones|epothilones|mesh-list
25474224|NCT00058019|Epothilone B|epothilone b|mesh-list
25474225|NCT00058019|Tubulin Modulators|tubulin modulators|mesh-ancestor
25474226|NCT00058019|Antimitotic Agents|antimitotic agents|mesh-ancestor
25474227|NCT00058019|Mitosis Modulators|mitosis modulators|mesh-ancestor
25644798|NCT01440816|Growth Substances|growth substances|mesh-ancestor
25474228|NCT00058019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474229|NCT00058019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474231|NCT00058123|Interferon Inducers|interferon inducers|mesh-ancestor
25474232|NCT00058123|Immunologic Factors|immunologic factors|mesh-ancestor
25474233|NCT00058123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474234|NCT00058240|Alvocidib|alvocidib|mesh-list
25474235|NCT00058240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474236|NCT00058240|Growth Inhibitors|growth inhibitors|mesh-ancestor
25474237|NCT00058240|Growth Substances|growth substances|mesh-ancestor
25474238|NCT00058240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474239|NCT00058240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25474240|NCT00058240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474241|NCT00058240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474242|NCT00058370|Cisplatin|cisplatin|mesh-list
25474243|NCT00058370|Vincristine|vincristine|mesh-list
25474244|NCT00058370|Lomustine|lomustine|mesh-list
25474245|NCT00058370|Antibodies|antibodies|mesh-list
25474246|NCT00058370|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25474247|NCT00058370|Immunologic Factors|immunologic factors|mesh-ancestor
25474248|NCT00058370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474249|NCT00058370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474250|NCT00058370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25474251|NCT00058370|Tubulin Modulators|tubulin modulators|mesh-ancestor
25474252|NCT00058370|Antimitotic Agents|antimitotic agents|mesh-ancestor
25474253|NCT00058370|Mitosis Modulators|mitosis modulators|mesh-ancestor
25474254|NCT00058370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474255|NCT00058370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25474256|NCT00058370|Alkylating Agents|alkylating agents|mesh-ancestor
25474257|NCT00058422|Prednisone|prednisone|mesh-list
25474258|NCT00058422|Cyclophosphamide|cyclophosphamide|mesh-list
25474259|NCT00058422|Rituximab|rituximab|mesh-list
25474260|NCT00058422|Doxorubicin|doxorubicin|mesh-list
25474261|NCT00058422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25474262|NCT00058422|Vincristine|vincristine|mesh-list
25474263|NCT00058422|Darbepoetin alfa|darbepoetin alfa|mesh-list
25474264|NCT00058422|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25474265|NCT00058422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25474266|NCT00058422|Immunologic Factors|immunologic factors|mesh-ancestor
25474267|NCT00058422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474268|NCT00058422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25474269|NCT00058422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25474270|NCT00058422|Alkylating Agents|alkylating agents|mesh-ancestor
25474271|NCT00058422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750817|NCT01700803|Iodine|iodine|mesh-list
25474272|NCT00058422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474273|NCT00058422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25474274|NCT00058422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25474275|NCT00058422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25474276|NCT00058422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25474277|NCT00058422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25474278|NCT00058422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474279|NCT00058422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25474280|NCT00058422|Glucocorticoids|glucocorticoids|mesh-ancestor
25474281|NCT00058422|Hormones|hormones|mesh-ancestor
25474282|NCT00058422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25474283|NCT00058422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25474284|NCT00058422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25474285|NCT00058422|Tubulin Modulators|tubulin modulators|mesh-ancestor
25474286|NCT00058422|Antimitotic Agents|antimitotic agents|mesh-ancestor
25474287|NCT00058422|Mitosis Modulators|mitosis modulators|mesh-ancestor
25474288|NCT00058422|Hematinics|hematinics|mesh-ancestor
25474289|NCT00058539|Pertuzumab|pertuzumab|mesh-list
25474290|NCT00058539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25474291|NCT00058539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474292|NCT00058552|Pertuzumab|pertuzumab|mesh-list
25474293|NCT00058552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25474294|NCT00058552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474295|NCT00058825|Cyclosporine|cyclosporine|mesh-list
25474296|NCT00058825|Fludarabine|fludarabine|mesh-list
25474297|NCT00058825|Alemtuzumab|alemtuzumab|mesh-list
25474298|NCT00058825|Tacrolimus|tacrolimus|mesh-list
25474299|NCT00058825|Cyclosporins|cyclosporins|mesh-list
25474300|NCT00058825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474301|NCT00058825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474302|NCT00058825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25474303|NCT00058825|Immunologic Factors|immunologic factors|mesh-ancestor
25474304|NCT00058825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474305|NCT00058825|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25474306|NCT00058825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474307|NCT00058825|Antifungal Agents|antifungal agents|mesh-ancestor
25474308|NCT00058825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25474309|NCT00058825|Dermatologic Agents|dermatologic agents|mesh-ancestor
25474310|NCT00058825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25474311|NCT00058825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25474312|NCT00059202|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25474313|NCT00059202|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25474314|NCT00059202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25474315|NCT00059215|Clopidogrel|clopidogrel|mesh-list
25474316|NCT00059215|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25474317|NCT00059215|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25474318|NCT00059215|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25474319|NCT00059215|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25474320|NCT00059215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25474321|NCT00059215|Purinergic Agents|purinergic agents|mesh-ancestor
25474322|NCT00059215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25474323|NCT00059215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474324|NCT00059215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474325|NCT00059228|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25474326|NCT00059228|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25474327|NCT00059228|Estradiol|estradiol|mesh-list
25474328|NCT00059228|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25474329|NCT00059228|Estrogens|estrogens|mesh-ancestor
25474330|NCT00059228|Hormones|hormones|mesh-ancestor
25474331|NCT00059228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25474332|NCT00059228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474333|NCT00059228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25474334|NCT00059228|Contraceptive Agents|contraceptive agents|mesh-ancestor
25474335|NCT00059228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25474336|NCT00059228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25474337|NCT00059332|Magnesium Sulfate|magnesium sulfate|mesh-list
25474338|NCT00059332|Analgesics|analgesics|mesh-ancestor
25474339|NCT00059332|Sensory System Agents|sensory system agents|mesh-ancestor
25474340|NCT00059332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25474341|NCT00059332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474342|NCT00059332|Anesthetics|anesthetics|mesh-ancestor
25474343|NCT00059332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25474344|NCT00059332|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25474345|NCT00059332|Anticonvulsants|anticonvulsants|mesh-ancestor
24493129|NCT00489658|Eflornithine|eflornithine|mesh-list
24516897|NCT00604435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516898|NCT00604435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24517020|NCT00605410|Cholinergic Agents|cholinergic agents|mesh-ancestor
24535725|NCT00649623|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24517109|NCT00605995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24517891|NCT00610506|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25474380|NCT00059839|Prednisone|prednisone|mesh-list
25474381|NCT00059839|Doxorubicin|doxorubicin|mesh-list
25474382|NCT00059839|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25474383|NCT00059839|Methotrexate|methotrexate|mesh-list
25474384|NCT00059839|Vincristine|vincristine|mesh-list
25474385|NCT00059839|Mercaptopurine|mercaptopurine|mesh-list
25474386|NCT00059839|Vinblastine|vinblastine|mesh-list
25474387|NCT00059839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25474388|NCT00059839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474389|NCT00059839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25474390|NCT00059839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25474391|NCT00059839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474392|NCT00059839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474393|NCT00059839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25474394|NCT00059839|Glucocorticoids|glucocorticoids|mesh-ancestor
25474395|NCT00059839|Hormones|hormones|mesh-ancestor
25474396|NCT00059839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25474397|NCT00059839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474398|NCT00059839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25474399|NCT00059839|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25474400|NCT00059839|Abortifacient Agents|abortifacient agents|mesh-ancestor
25474401|NCT00059839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25474402|NCT00059839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25474403|NCT00059839|Antimetabolites|antimetabolites|mesh-ancestor
25474404|NCT00059839|Dermatologic Agents|dermatologic agents|mesh-ancestor
25474405|NCT00059839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25474406|NCT00059839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25474407|NCT00059839|Immunologic Factors|immunologic factors|mesh-ancestor
25474408|NCT00059839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25474409|NCT00059839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25474410|NCT00059839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25474411|NCT00059839|Tubulin Modulators|tubulin modulators|mesh-ancestor
25474412|NCT00059839|Antimitotic Agents|antimitotic agents|mesh-ancestor
25474413|NCT00059839|Mitosis Modulators|mitosis modulators|mesh-ancestor
25474414|NCT00060008|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25474415|NCT00060008|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25474416|NCT00060008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474417|NCT00060346|Prednisone|prednisone|mesh-list
25474418|NCT00060346|Cyclophosphamide|cyclophosphamide|mesh-list
25474419|NCT00060346|Rituximab|rituximab|mesh-list
25474420|NCT00060346|Doxorubicin|doxorubicin|mesh-list
25474421|NCT00060346|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25474422|NCT00060346|Vincristine|vincristine|mesh-list
25474423|NCT00060346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25474424|NCT00060346|Immunologic Factors|immunologic factors|mesh-ancestor
25474425|NCT00060346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474426|NCT00060346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25474427|NCT00060346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25474428|NCT00060346|Alkylating Agents|alkylating agents|mesh-ancestor
25474429|NCT00060346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474430|NCT00060346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474431|NCT00060346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25474432|NCT00060346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25474433|NCT00060346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25474434|NCT00060346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25474435|NCT00060346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25474436|NCT00060346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474437|NCT00060346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25474438|NCT00060346|Glucocorticoids|glucocorticoids|mesh-ancestor
25474439|NCT00060346|Hormones|hormones|mesh-ancestor
25474440|NCT00060346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25474441|NCT00060346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25474442|NCT00060346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25474443|NCT00060346|Tubulin Modulators|tubulin modulators|mesh-ancestor
25474444|NCT00060346|Antimitotic Agents|antimitotic agents|mesh-ancestor
25474445|NCT00060346|Mitosis Modulators|mitosis modulators|mesh-ancestor
25474446|NCT00060424|Cyclosporine|cyclosporine|mesh-list
25474447|NCT00060424|Mycophenolic Acid|mycophenolic acid|mesh-list
25474448|NCT00060424|Fludarabine|fludarabine|mesh-list
25474449|NCT00060424|Fludarabine phosphate|fludarabine phosphate|mesh-list
25474450|NCT00060424|Cyclosporins|cyclosporins|mesh-list
25474451|NCT00060424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474452|NCT00060424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25474453|NCT00060424|Antimetabolites|antimetabolites|mesh-ancestor
24525069|NCT04001829|Paclitaxel|paclitaxel|mesh-list
24525128|NCT03933904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474454|NCT00060424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474455|NCT00060424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25474456|NCT00060424|Immunologic Factors|immunologic factors|mesh-ancestor
25474457|NCT00060424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474458|NCT00060424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474459|NCT00060424|Antifungal Agents|antifungal agents|mesh-ancestor
25474460|NCT00060424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25474461|NCT00060424|Dermatologic Agents|dermatologic agents|mesh-ancestor
25474462|NCT00060424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25474463|NCT00060424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25474464|NCT00060424|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25474465|NCT00060424|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25474466|NCT00060424|Antitubercular Agents|antitubercular agents|mesh-ancestor
25474467|NCT00060424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25474468|NCT00060528|Metronidazole|metronidazole|mesh-list
25474469|NCT00060528|Molgramostim|molgramostim|mesh-list
25474470|NCT00060528|Sargramostim|sargramostim|mesh-list
25474471|NCT00060528|Immunologic Factors|immunologic factors|mesh-ancestor
25474472|NCT00060528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474473|NCT00060528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474474|NCT00060528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25474475|NCT00060528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25474476|NCT00060528|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25474477|NCT00060528|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25474478|NCT00060840|Nitric Oxide|nitric oxide|mesh-list
25474479|NCT00060840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25474480|NCT00060840|Autonomic Agents|autonomic agents|mesh-ancestor
25474481|NCT00060840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25474482|NCT00060840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474483|NCT00060840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25474484|NCT00060840|Respiratory System Agents|respiratory system agents|mesh-ancestor
25474485|NCT00060840|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25474486|NCT00060840|Antioxidants|antioxidants|mesh-ancestor
25474487|NCT00060840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474488|NCT00060840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25474489|NCT00060840|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25474490|NCT00060840|Vasodilator Agents|vasodilator agents|mesh-ancestor
25474491|NCT00060840|Gasotransmitters|gasotransmitters|mesh-ancestor
25474492|NCT00060840|Protective Agents|protective agents|mesh-ancestor
25474493|NCT00060944|Dexamethasone|dexamethasone|mesh-list
25474494|NCT00060944|Dexamethasone acetate|dexamethasone acetate|mesh-list
25474495|NCT00060944|Trabectedin|trabectedin|mesh-list
25474496|NCT00060944|BB 1101|bb 1101|mesh-list
25474497|NCT00060944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25474498|NCT00060944|Antiemetics|antiemetics|mesh-ancestor
25474499|NCT00060944|Autonomic Agents|autonomic agents|mesh-ancestor
25474500|NCT00060944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25474501|NCT00060944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474502|NCT00060944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25474503|NCT00060944|Glucocorticoids|glucocorticoids|mesh-ancestor
25474504|NCT00060944|Hormones|hormones|mesh-ancestor
25474505|NCT00060944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25474506|NCT00060944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25474507|NCT00060944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474508|NCT00060944|Protease Inhibitors|protease inhibitors|mesh-ancestor
25474509|NCT00060944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474510|NCT00060944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474511|NCT00060944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25474512|NCT00060944|Alkylating Agents|alkylating agents|mesh-ancestor
25474513|NCT00061048|Alemtuzumab|alemtuzumab|mesh-list
25474514|NCT00061048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25474515|NCT00061048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474516|NCT00061373|Aspirin|aspirin|mesh-list
25474517|NCT00061373|Tinzaparin|tinzaparin|mesh-list
25474518|NCT00061373|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25474519|NCT00061373|Dalteparin|dalteparin|mesh-list
25474520|NCT00061373|Eptifibatide|eptifibatide|mesh-list
25474521|NCT00061373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24528713|NCT00622375|Analgesics|analgesics|mesh-ancestor
24528749|NCT00622622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528751|NCT00622622|Antiviral Agents|antiviral agents|mesh-ancestor
24528752|NCT00622622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24528753|NCT00622622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528754|NCT00622622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24528755|NCT00622622|Immunologic Factors|immunologic factors|mesh-ancestor
24528757|NCT00622648|Enoxaparin|enoxaparin|mesh-list
25474524|NCT00061373|Sensory System Agents|sensory system agents|mesh-ancestor
25474525|NCT00061373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25474526|NCT00061373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474527|NCT00061373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25474528|NCT00061373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25474529|NCT00061373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25474530|NCT00061373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25474531|NCT00061373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474532|NCT00061373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25474533|NCT00061373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25474534|NCT00061373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474536|NCT00061373|Anticoagulants|anticoagulants|mesh-ancestor
25474537|NCT00061633|Vancomycin|vancomycin|mesh-list
25474538|NCT00061633|Penicillins|penicillins|mesh-list
25474539|NCT00061633|Telavancin|telavancin|mesh-list
25474540|NCT00061633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25474541|NCT00061633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25474542|NCT00061893|Celecoxib|celecoxib|mesh-list
25474543|NCT00061893|Cyclophosphamide|cyclophosphamide|mesh-list
25474544|NCT00061893|Ifosfamide|ifosfamide|mesh-list
25474545|NCT00061893|Doxorubicin|doxorubicin|mesh-list
25474546|NCT00061893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25474547|NCT00061893|Etoposide|etoposide|mesh-list
25474548|NCT00061893|Vincristine|vincristine|mesh-list
25474549|NCT00061893|Vinblastine|vinblastine|mesh-list
25474550|NCT00061893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25474551|NCT00061893|Immunologic Factors|immunologic factors|mesh-ancestor
25474552|NCT00061893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474553|NCT00061893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25474554|NCT00061893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25474555|NCT00061893|Alkylating Agents|alkylating agents|mesh-ancestor
25474556|NCT00061893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474557|NCT00061893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474558|NCT00061893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25474559|NCT00061893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25474560|NCT00061893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25474561|NCT00061893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25474562|NCT00061893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474563|NCT00061893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25474564|NCT00061893|Tubulin Modulators|tubulin modulators|mesh-ancestor
25474565|NCT00061893|Antimitotic Agents|antimitotic agents|mesh-ancestor
25474566|NCT00061893|Mitosis Modulators|mitosis modulators|mesh-ancestor
25474567|NCT00061893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25474568|NCT00061893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25474569|NCT00061893|Analgesics|analgesics|mesh-ancestor
25474570|NCT00061893|Sensory System Agents|sensory system agents|mesh-ancestor
25474571|NCT00061893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25474572|NCT00061893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25474573|NCT00061893|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25474574|NCT00061893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25474575|NCT00061932|Irinotecan|irinotecan|mesh-list
25474576|NCT00061932|Bortezomib|bortezomib|mesh-list
25474577|NCT00061932|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25474578|NCT00061932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25474579|NCT00061932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474580|NCT00061932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474581|NCT00061932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474582|NCT00062010|Interferons|interferons|mesh-list
25474583|NCT00062010|Interferon-alpha|interferon-alpha|mesh-list
25474584|NCT00062010|Interferon alpha-2|interferon alpha-2|mesh-list
25474585|NCT00062010|Paclitaxel|paclitaxel|mesh-list
25474586|NCT00062010|Tretinoin|tretinoin|mesh-list
25474587|NCT00062010|Isotretinoin|isotretinoin|mesh-list
25474588|NCT00062010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25474589|NCT00062010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474590|NCT00062010|Tubulin Modulators|tubulin modulators|mesh-ancestor
25474591|NCT00062010|Antimitotic Agents|antimitotic agents|mesh-ancestor
24422153|NCT00221481|Serotonin Agents|serotonin agents|mesh-ancestor
24422154|NCT00221481|Anticonvulsants|anticonvulsants|mesh-ancestor
24422155|NCT00221481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422293|NCT00221962|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25156464|NCT05026567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25156465|NCT05026567|Anesthetics, General|anesthetics, general|mesh-ancestor
25474595|NCT00062010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25474596|NCT00062010|Immunologic Factors|immunologic factors|mesh-ancestor
25474597|NCT00062010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474598|NCT00062010|Keratolytic Agents|keratolytic agents|mesh-ancestor
25474599|NCT00062010|Dermatologic Agents|dermatologic agents|mesh-ancestor
25474600|NCT00062374|Deoxyglucose|deoxyglucose|mesh-list
25474601|NCT00062374|Alovudine|alovudine|mesh-list
25474602|NCT00062374|Cisplatin|cisplatin|mesh-list
25474603|NCT00062374|Irinotecan|irinotecan|mesh-list
25474604|NCT00062374|Camptothecin|camptothecin|mesh-list
25474605|NCT00062374|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25474606|NCT00062374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474607|NCT00062374|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25474608|NCT00062374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25474609|NCT00062374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474610|NCT00062374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474611|NCT00062374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25474612|NCT00062374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25474613|NCT00062374|Antimetabolites|antimetabolites|mesh-ancestor
25474614|NCT00062374|Antiviral Agents|antiviral agents|mesh-ancestor
25474615|NCT00062374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25474616|NCT00062439|Cisplatin|cisplatin|mesh-list
25474617|NCT00062439|Docetaxel|docetaxel|mesh-list
25474618|NCT00062439|Etoposide|etoposide|mesh-list
25474619|NCT00062439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474620|NCT00062439|Tubulin Modulators|tubulin modulators|mesh-ancestor
25474621|NCT00062439|Antimitotic Agents|antimitotic agents|mesh-ancestor
25474622|NCT00062439|Mitosis Modulators|mitosis modulators|mesh-ancestor
25474623|NCT00062439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474624|NCT00062439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25474625|NCT00062439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25644799|NCT01440816|Growth Inhibitors|growth inhibitors|mesh-ancestor
25474626|NCT00062439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25474627|NCT00062439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474628|NCT00062647|Vancomycin|vancomycin|mesh-list
25474629|NCT00062647|Cloxacillin|cloxacillin|mesh-list
25474630|NCT00062647|Oxacillin|oxacillin|mesh-list
25474631|NCT00062647|Nafcillin|nafcillin|mesh-list
25474632|NCT00062647|Telavancin|telavancin|mesh-list
25474633|NCT00062647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25474634|NCT00062647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25474635|NCT00062738|Paroxetine|paroxetine|mesh-list
25474636|NCT00062738|Nortriptyline|nortriptyline|mesh-list
25474637|NCT00062738|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25474638|NCT00062738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25474639|NCT00062738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25474640|NCT00062738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474641|NCT00062738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25474642|NCT00062738|Serotonin Agents|serotonin agents|mesh-ancestor
25474643|NCT00062738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474644|NCT00062738|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25474645|NCT00062738|Antidepressive Agents|antidepressive agents|mesh-ancestor
25474646|NCT00062738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25474647|NCT00062738|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25474648|NCT00062738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25474649|NCT00062738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474650|NCT00062738|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25474651|NCT00062738|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25474652|NCT00062738|Adrenergic Agents|adrenergic agents|mesh-ancestor
25474653|NCT00062764|Pioglitazone|pioglitazone|mesh-list
25474654|NCT00062764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25474655|NCT00062764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474656|NCT00063154|Pertuzumab|pertuzumab|mesh-list
25474657|NCT00063154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24824420|NCT02123355|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24824421|NCT02123355|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24824423|NCT02123355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24824424|NCT02123355|Narcotics|narcotics|mesh-ancestor
25156619|NCT04971356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25156620|NCT04971356|Analgesics|analgesics|mesh-ancestor
25156621|NCT04971356|Sensory System Agents|sensory system agents|mesh-ancestor
24427560|NCT00238368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25474658|NCT00063154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474659|NCT00063232|Metformin|metformin|mesh-list
25474660|NCT00063232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25474661|NCT00063232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474662|NCT00063258|Paclitaxel|paclitaxel|mesh-list
25474663|NCT00063258|Carboplatin|carboplatin|mesh-list
25474664|NCT00063258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25474665|NCT00063258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25474666|NCT00063258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474667|NCT00063258|Tubulin Modulators|tubulin modulators|mesh-ancestor
25474668|NCT00063258|Antimitotic Agents|antimitotic agents|mesh-ancestor
25474669|NCT00063258|Mitosis Modulators|mitosis modulators|mesh-ancestor
25474670|NCT00063258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474671|NCT00063258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25474672|NCT00063258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474673|NCT00063362|Lamotrigine|lamotrigine|mesh-list
25474674|NCT00063362|Valproic Acid|valproic acid|mesh-list
25474675|NCT00063362|Lithium Carbonate|lithium carbonate|mesh-list
25474676|NCT00063362|Antidepressive Agents|antidepressive agents|mesh-ancestor
25474677|NCT00063362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25474678|NCT00063362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474679|NCT00063362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474680|NCT00063362|Antimanic Agents|antimanic agents|mesh-ancestor
25474681|NCT00063362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25474682|NCT00063362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25474683|NCT00063362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474684|NCT00063362|Anticonvulsants|anticonvulsants|mesh-ancestor
25474685|NCT00063362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25474686|NCT00063362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25474687|NCT00063362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25474688|NCT00063362|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25474689|NCT00063362|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25474690|NCT00063362|GABA Agents|gaba agents|mesh-ancestor
25474691|NCT00063362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25474692|NCT00063570|Gemcitabine|gemcitabine|mesh-list
25474693|NCT00063570|Pemetrexed|pemetrexed|mesh-list
25474694|NCT00063570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25474695|NCT00063570|Antimetabolites|antimetabolites|mesh-ancestor
25474696|NCT00063570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644800|NCT01440816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474697|NCT00063570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474698|NCT00063570|Antiviral Agents|antiviral agents|mesh-ancestor
25474699|NCT00063570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25474700|NCT00063570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474701|NCT00063570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25474702|NCT00063570|Immunologic Factors|immunologic factors|mesh-ancestor
25474703|NCT00063570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474704|NCT00063570|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25474705|NCT00063570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25474706|NCT00063622|Vitamin E|vitamin e|mesh-list
25474707|NCT00063622|Pioglitazone|pioglitazone|mesh-list
25474708|NCT00063622|Vitamins|vitamins|mesh-ancestor
25474709|NCT00063622|Micronutrients|micronutrients|mesh-ancestor
25474710|NCT00063622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474711|NCT00063622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25474712|NCT00063622|Antioxidants|antioxidants|mesh-ancestor
25474713|NCT00063622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474714|NCT00063622|Protective Agents|protective agents|mesh-ancestor
25474715|NCT00063635|Vitamin E|vitamin e|mesh-list
25474716|NCT00063635|Metformin|metformin|mesh-list
25474717|NCT00063635|Vitamins|vitamins|mesh-ancestor
25474718|NCT00063635|Micronutrients|micronutrients|mesh-ancestor
25474719|NCT00063635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474720|NCT00063635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25474721|NCT00063635|Antioxidants|antioxidants|mesh-ancestor
25474722|NCT00063635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474723|NCT00063635|Protective Agents|protective agents|mesh-ancestor
25474724|NCT00063934|Docetaxel|docetaxel|mesh-list
25474725|NCT00063934|Doxorubicin|doxorubicin|mesh-list
25474726|NCT00063934|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25474727|NCT00063934|Oblimersen|oblimersen|mesh-list
25157193|NCT04784754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822925|NCT00004696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25051526|NCT00397254|Serotonin Agents|serotonin agents|mesh-ancestor
25157240|NCT04766853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25157243|NCT04766853|Hormones|hormones|mesh-ancestor
24657925|NCT01269528|Miotics|miotics|mesh-ancestor
25116230|NCT03110198|Sensory System Agents|sensory system agents|mesh-ancestor
24627751|NCT01094821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25474728|NCT00063934|Lenograstim|lenograstim|mesh-list
25474729|NCT00063934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474730|NCT00063934|Tubulin Modulators|tubulin modulators|mesh-ancestor
25474731|NCT00063934|Antimitotic Agents|antimitotic agents|mesh-ancestor
25474732|NCT00063934|Mitosis Modulators|mitosis modulators|mesh-ancestor
25474733|NCT00063934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474734|NCT00063934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25474735|NCT00063934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25474736|NCT00063934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25474737|NCT00063934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474738|NCT00063934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25474739|NCT00063934|Immunologic Factors|immunologic factors|mesh-ancestor
25474740|NCT00063934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474741|NCT00063999|Paclitaxel|paclitaxel|mesh-list
25474742|NCT00063999|Cisplatin|cisplatin|mesh-list
25474743|NCT00063999|Carboplatin|carboplatin|mesh-list
25474744|NCT00063999|Doxorubicin|doxorubicin|mesh-list
25474745|NCT00063999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25474746|NCT00063999|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25474747|NCT00063999|Lenograstim|lenograstim|mesh-list
25474748|NCT00063999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25474749|NCT00063999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474750|NCT00063999|Tubulin Modulators|tubulin modulators|mesh-ancestor
25474751|NCT00063999|Antimitotic Agents|antimitotic agents|mesh-ancestor
25474752|NCT00063999|Mitosis Modulators|mitosis modulators|mesh-ancestor
25474753|NCT00063999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474754|NCT00063999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25474755|NCT00063999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25474756|NCT00063999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25474757|NCT00063999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474758|NCT00063999|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25474759|NCT00063999|Immunologic Factors|immunologic factors|mesh-ancestor
25474760|NCT00063999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474761|NCT00064025|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25474762|NCT00064025|Medroxyprogesterone|medroxyprogesterone|mesh-list
25474763|NCT00064025|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25474764|NCT00064025|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25474765|NCT00064025|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25644801|NCT01440881|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25644802|NCT01440881|Natriuretic Agents|natriuretic agents|mesh-ancestor
25644803|NCT01440881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644804|NCT01441037|Danazol|danazol|mesh-list
25644805|NCT01441037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25644806|NCT01441037|Hormone Antagonists|hormone antagonists|mesh-ancestor
25644807|NCT01441037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25644808|NCT01441037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474766|NCT00064025|Contraceptive Agents|contraceptive agents|mesh-ancestor
25474767|NCT00064025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25474768|NCT00064025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474769|NCT00064025|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25474770|NCT00064025|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25474771|NCT00064025|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25474772|NCT00064025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25474773|NCT00064025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474774|NCT00064038|Dexamethasone|dexamethasone|mesh-list
25474775|NCT00064038|Lenalidomide|lenalidomide|mesh-list
25474776|NCT00064038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25474777|NCT00064038|Antiemetics|antiemetics|mesh-ancestor
25474778|NCT00064038|Autonomic Agents|autonomic agents|mesh-ancestor
25474779|NCT00064038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25474780|NCT00064038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474781|NCT00064038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25474782|NCT00064038|Glucocorticoids|glucocorticoids|mesh-ancestor
25474783|NCT00064038|Hormones|hormones|mesh-ancestor
25474784|NCT00064038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25474785|NCT00064038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25474786|NCT00064038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474787|NCT00064038|Immunologic Factors|immunologic factors|mesh-ancestor
25474788|NCT00064038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25474789|NCT00064038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25474790|NCT00064038|Growth Substances|growth substances|mesh-ancestor
25474791|NCT00064038|Growth Inhibitors|growth inhibitors|mesh-ancestor
25474792|NCT00064077|Gemcitabine|gemcitabine|mesh-list
25474793|NCT00064077|Paclitaxel|paclitaxel|mesh-list
25474794|NCT00064077|Vinorelbine|vinorelbine|mesh-list
25474795|NCT00064077|Cisplatin|cisplatin|mesh-list
25474796|NCT00064077|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25474797|NCT00064077|Topotecan|topotecan|mesh-list
25474798|NCT00064077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25474799|NCT00064077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474800|NCT00064077|Tubulin Modulators|tubulin modulators|mesh-ancestor
25474801|NCT00064077|Antimitotic Agents|antimitotic agents|mesh-ancestor
25474802|NCT00064077|Mitosis Modulators|mitosis modulators|mesh-ancestor
25474803|NCT00064077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474804|NCT00064077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25474805|NCT00064077|Antimetabolites|antimetabolites|mesh-ancestor
25474806|NCT00064077|Antiviral Agents|antiviral agents|mesh-ancestor
25474807|NCT00064077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25474808|NCT00064077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474809|NCT00064077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25474810|NCT00064077|Immunologic Factors|immunologic factors|mesh-ancestor
25474811|NCT00064077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474812|NCT00064077|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25474813|NCT00064077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25474814|NCT00064259|Cisplatin|cisplatin|mesh-list
25474815|NCT00064259|Fluorouracil|fluorouracil|mesh-list
25474816|NCT00064259|Oblimersen|oblimersen|mesh-list
25474817|NCT00064259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474818|NCT00064259|Antimetabolites|antimetabolites|mesh-ancestor
25474819|NCT00064259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474820|NCT00064259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25474821|NCT00064259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25474822|NCT00064259|Immunologic Factors|immunologic factors|mesh-ancestor
25474823|NCT00064259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474824|NCT00064337|Thalidomide|thalidomide|mesh-list
25474825|NCT00064337|Dexamethasone|dexamethasone|mesh-list
25474826|NCT00064337|Cyclophosphamide|cyclophosphamide|mesh-list
25474827|NCT00064337|Melphalan|melphalan|mesh-list
25474828|NCT00064337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25474829|NCT00064337|Immunologic Factors|immunologic factors|mesh-ancestor
25474830|NCT00064337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474831|NCT00064337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25474832|NCT00064337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25474833|NCT00064337|Alkylating Agents|alkylating agents|mesh-ancestor
25474834|NCT00064337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474835|NCT00064337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474836|NCT00064337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25474837|NCT00064337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25474838|NCT00064337|Antiemetics|antiemetics|mesh-ancestor
25474839|NCT00064337|Autonomic Agents|autonomic agents|mesh-ancestor
25474840|NCT00064337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25474841|NCT00064337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25474842|NCT00064337|Glucocorticoids|glucocorticoids|mesh-ancestor
25474844|NCT00064337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25474845|NCT00064337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25474846|NCT00064337|Leprostatic Agents|leprostatic agents|mesh-ancestor
25474847|NCT00064337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25474848|NCT00064337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25474849|NCT00064337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25474850|NCT00064337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25474851|NCT00064337|Growth Substances|growth substances|mesh-ancestor
25474852|NCT00064337|Growth Inhibitors|growth inhibitors|mesh-ancestor
25474853|NCT00064350|Sorafenib|sorafenib|mesh-list
25474854|NCT00064350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474855|NCT00064350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25474856|NCT00064350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474857|NCT00064350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474858|NCT00064701|Cyclosporine|cyclosporine|mesh-list
25474859|NCT00064701|Mycophenolic Acid|mycophenolic acid|mesh-list
25474860|NCT00064701|Tacrolimus|tacrolimus|mesh-list
25474861|NCT00064701|Cyclosporins|cyclosporins|mesh-list
25474862|NCT00064701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25474863|NCT00064701|Immunologic Factors|immunologic factors|mesh-ancestor
25474864|NCT00064701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474865|NCT00064701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25474866|NCT00064701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474867|NCT00064701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474868|NCT00064701|Antifungal Agents|antifungal agents|mesh-ancestor
25474869|NCT00064701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25474870|NCT00064701|Dermatologic Agents|dermatologic agents|mesh-ancestor
25474871|NCT00064701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25474872|NCT00064701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25474873|NCT00064701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474874|NCT00064701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25474875|NCT00064701|Antitubercular Agents|antitubercular agents|mesh-ancestor
25474876|NCT00064701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25474877|NCT00064792|Simvastatin|simvastatin|mesh-list
25474878|NCT00064792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25474879|NCT00064792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25474880|NCT00064792|Antimetabolites|antimetabolites|mesh-ancestor
25474881|NCT00064792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474882|NCT00064792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25474883|NCT00064792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25474884|NCT00064792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474885|NCT00064844|Nicotine|nicotine|mesh-list
25474886|NCT00064844|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25474887|NCT00064844|Autonomic Agents|autonomic agents|mesh-ancestor
25474888|NCT00064844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25474889|NCT00064844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474890|NCT00064844|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25474891|NCT00064844|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25474892|NCT00064844|Cholinergic Agents|cholinergic agents|mesh-ancestor
25474893|NCT00064844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25474894|NCT00064844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474895|NCT00064987|Hormones|hormones|mesh-list
25474896|NCT00064987|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25474897|NCT00064987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25474898|NCT00064987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474899|NCT00065065|Rosiglitazone|rosiglitazone|mesh-list
25474900|NCT00065065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25474901|NCT00065065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474902|NCT00065156|Lenalidomide|lenalidomide|mesh-list
25474903|NCT00065156|Immunologic Factors|immunologic factors|mesh-ancestor
25474904|NCT00065156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474905|NCT00065156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25474906|NCT00065156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25474907|NCT00065156|Growth Substances|growth substances|mesh-ancestor
25474908|NCT00065156|Growth Inhibitors|growth inhibitors|mesh-ancestor
25474909|NCT00065156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474910|NCT00065182|Docetaxel|docetaxel|mesh-list
25474911|NCT00065182|Topotecan|topotecan|mesh-list
25474912|NCT00065182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474913|NCT00065182|Tubulin Modulators|tubulin modulators|mesh-ancestor
25474914|NCT00065182|Antimitotic Agents|antimitotic agents|mesh-ancestor
25474915|NCT00065182|Mitosis Modulators|mitosis modulators|mesh-ancestor
25474916|NCT00065182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474917|NCT00065182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25474918|NCT00065182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25474919|NCT00065182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474920|NCT00065260|Cyclosporine|cyclosporine|mesh-list
25474921|NCT00065260|Alemtuzumab|alemtuzumab|mesh-list
25474922|NCT00065260|Cyclosporins|cyclosporins|mesh-list
25474923|NCT00065260|Thymoglobulin|thymoglobulin|mesh-list
25474924|NCT00065260|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25474925|NCT00065260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474926|NCT00065260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474927|NCT00065260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25474928|NCT00065260|Immunologic Factors|immunologic factors|mesh-ancestor
25474929|NCT00065260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474930|NCT00065260|Antifungal Agents|antifungal agents|mesh-ancestor
25474931|NCT00065260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25474932|NCT00065260|Dermatologic Agents|dermatologic agents|mesh-ancestor
25474933|NCT00065260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25474934|NCT00065260|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25474935|NCT00065260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25474936|NCT00065260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474937|NCT00065429|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
25474938|NCT00065429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25474939|NCT00065429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474940|NCT00065429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25474941|NCT00065468|Interferons|interferons|mesh-list
25474942|NCT00065468|Interferon-alpha|interferon-alpha|mesh-list
25474943|NCT00065468|Sirolimus|sirolimus|mesh-list
25474944|NCT00065468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474945|NCT00065468|Antiviral Agents|antiviral agents|mesh-ancestor
25474946|NCT00065468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25474947|NCT00065468|Immunologic Factors|immunologic factors|mesh-ancestor
25474948|NCT00065468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474949|NCT00065468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25474950|NCT00065468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25474951|NCT00065468|Antifungal Agents|antifungal agents|mesh-ancestor
25474952|NCT00065468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25474953|NCT00065507|Entecavir|entecavir|mesh-list
25474954|NCT00065507|Adefovir|adefovir|mesh-list
25474955|NCT00065507|Antiviral Agents|antiviral agents|mesh-ancestor
25474956|NCT00065507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25474958|NCT00065507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25474959|NCT00065507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474960|NCT00065507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474961|NCT00065611|Dexamethasone|dexamethasone|mesh-list
25474962|NCT00065611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25474963|NCT00065611|Antiemetics|antiemetics|mesh-ancestor
25474964|NCT00065611|Autonomic Agents|autonomic agents|mesh-ancestor
25474965|NCT00065611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25474966|NCT00065611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474967|NCT00065611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25474968|NCT00065611|Glucocorticoids|glucocorticoids|mesh-ancestor
25474969|NCT00065611|Hormones|hormones|mesh-ancestor
25474970|NCT00065611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25474971|NCT00065611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25474972|NCT00065611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25474973|NCT00065806|Atorvastatin|atorvastatin|mesh-list
25474974|NCT00065806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25474975|NCT00065806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25474976|NCT00065806|Antimetabolites|antimetabolites|mesh-ancestor
25474977|NCT00065806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474978|NCT00065806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25474979|NCT00065806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25474980|NCT00065806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25474981|NCT00066066|Amoxicillin|amoxicillin|mesh-list
25474982|NCT00066066|Metronidazole|metronidazole|mesh-list
25474983|NCT00066066|Doxycycline|doxycycline|mesh-list
25474984|NCT00066066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25474985|NCT00066066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25644809|NCT01441063|Zidovudine|zidovudine|mesh-list
25644810|NCT01441063|Valganciclovir|valganciclovir|mesh-list
25644811|NCT01441063|Antimetabolites|antimetabolites|mesh-ancestor
25644812|NCT01441063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474986|NCT00066066|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25474987|NCT00066066|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25474988|NCT00066066|Antimalarials|antimalarials|mesh-ancestor
25474989|NCT00066170|Sodium Oxybate|sodium oxybate|mesh-list
25474990|NCT00066170|Modafinil|modafinil|mesh-list
25474991|NCT00066170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25474992|NCT00066170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25474993|NCT00066170|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25474994|NCT00066170|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25474995|NCT00066170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25474996|NCT00066170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25474997|NCT00066170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25474998|NCT00066170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25474999|NCT00066170|Anesthetics, General|anesthetics, general|mesh-ancestor
25475000|NCT00066170|Anesthetics|anesthetics|mesh-ancestor
25475001|NCT00066170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25475002|NCT00066222|Cisplatin|cisplatin|mesh-list
25475003|NCT00066222|Etoposide|etoposide|mesh-list
25475004|NCT00066222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475005|NCT00066222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25475006|NCT00066222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25475007|NCT00066222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25475008|NCT00066222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475009|NCT00066222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475010|NCT00066365|Molgramostim|molgramostim|mesh-list
25475011|NCT00066365|Sargramostim|sargramostim|mesh-list
25475012|NCT00066365|Immunologic Factors|immunologic factors|mesh-ancestor
25475013|NCT00066365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475014|NCT00066365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475015|NCT00066469|Prednisone|prednisone|mesh-list
25475016|NCT00066469|Methylprednisolone|methylprednisolone|mesh-list
25475017|NCT00066469|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25475018|NCT00066469|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25475019|NCT00066469|Prednisolone|prednisolone|mesh-list
25475020|NCT00066469|Prednisolone acetate|prednisolone acetate|mesh-list
25475021|NCT00066469|Cyclophosphamide|cyclophosphamide|mesh-list
25475022|NCT00066469|Rituximab|rituximab|mesh-list
25475023|NCT00066469|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25475024|NCT00066469|Prednisolone phosphate|prednisolone phosphate|mesh-list
25475025|NCT00066469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25475026|NCT00066469|Immunologic Factors|immunologic factors|mesh-ancestor
25475027|NCT00066469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475028|NCT00066469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25822926|NCT00004696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822927|NCT00004696|Analgesics|analgesics|mesh-ancestor
24651795|NCT01233895|Bortezomib|bortezomib|mesh-list
25475029|NCT00066469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25475030|NCT00066469|Alkylating Agents|alkylating agents|mesh-ancestor
25475031|NCT00066469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475032|NCT00066469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475033|NCT00066469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25475034|NCT00066469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25475035|NCT00066469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25475036|NCT00066469|Glucocorticoids|glucocorticoids|mesh-ancestor
25475037|NCT00066469|Hormones|hormones|mesh-ancestor
25475038|NCT00066469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25475039|NCT00066469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25475040|NCT00066469|Antiemetics|antiemetics|mesh-ancestor
25475041|NCT00066469|Autonomic Agents|autonomic agents|mesh-ancestor
25475042|NCT00066469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25475043|NCT00066469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25475044|NCT00066469|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25475045|NCT00066469|Protective Agents|protective agents|mesh-ancestor
25475046|NCT00066573|Anastrozole|anastrozole|mesh-list
25475047|NCT00066573|Exemestane|exemestane|mesh-list
25475048|NCT00066573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25475049|NCT00066573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475050|NCT00066573|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25475051|NCT00066573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25475052|NCT00066573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475053|NCT00066573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822928|NCT00004696|Sensory System Agents|sensory system agents|mesh-ancestor
25475054|NCT00066573|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25475055|NCT00066573|Hormone Antagonists|hormone antagonists|mesh-ancestor
25475056|NCT00066573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25475057|NCT00066573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475058|NCT00066677|Docetaxel|docetaxel|mesh-list
25475059|NCT00066677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475060|NCT00066677|Tubulin Modulators|tubulin modulators|mesh-ancestor
25475061|NCT00066677|Antimitotic Agents|antimitotic agents|mesh-ancestor
25475062|NCT00066677|Mitosis Modulators|mitosis modulators|mesh-ancestor
25475063|NCT00066677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475064|NCT00066690|Tamoxifen|tamoxifen|mesh-list
25475065|NCT00066690|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25475066|NCT00066690|Exemestane|exemestane|mesh-list
25475067|NCT00066690|Tryptophan|tryptophan|mesh-list
25475068|NCT00066690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475069|NCT00066690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25475070|NCT00066690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475071|NCT00066690|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25475072|NCT00066690|Hormone Antagonists|hormone antagonists|mesh-ancestor
25475073|NCT00066690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25475074|NCT00066690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475075|NCT00066690|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25475076|NCT00066690|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25475077|NCT00066690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25475078|NCT00066690|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25475079|NCT00066690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25475080|NCT00066690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475081|NCT00066690|Luteolytic Agents|luteolytic agents|mesh-ancestor
25475082|NCT00066690|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25475083|NCT00066690|Contraceptive Agents|contraceptive agents|mesh-ancestor
25475084|NCT00066690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25475085|NCT00066690|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25475086|NCT00066690|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25475087|NCT00066690|Antidepressive Agents|antidepressive agents|mesh-ancestor
25475088|NCT00066690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25475089|NCT00066703|Tamoxifen|tamoxifen|mesh-list
25475090|NCT00066703|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25475091|NCT00066703|Exemestane|exemestane|mesh-list
25475092|NCT00066703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25475093|NCT00066703|Hormone Antagonists|hormone antagonists|mesh-ancestor
25475094|NCT00066703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25475095|NCT00066703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475096|NCT00066703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25475097|NCT00066703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475098|NCT00066703|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25475099|NCT00066703|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25475100|NCT00066703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25475101|NCT00066703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25475102|NCT00066703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25475103|NCT00066703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475104|NCT00066703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475105|NCT00066703|Luteolytic Agents|luteolytic agents|mesh-ancestor
25475106|NCT00066703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25475107|NCT00066703|Contraceptive Agents|contraceptive agents|mesh-ancestor
25475108|NCT00066703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25475109|NCT00066703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25475110|NCT00066742|Cisplatin|cisplatin|mesh-list
25475111|NCT00066742|Etoposide|etoposide|mesh-list
25475112|NCT00066742|Etoposide phosphate|etoposide phosphate|mesh-list
25475113|NCT00066742|Tirapazamine|tirapazamine|mesh-list
25475114|NCT00066742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475115|NCT00066742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25475116|NCT00066742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25475117|NCT00066742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25475118|NCT00066742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475119|NCT00066742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475120|NCT00066781|Gemcitabine|gemcitabine|mesh-list
25475121|NCT00066781|Irinotecan|irinotecan|mesh-list
25475122|NCT00066781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25475123|NCT00066781|Antimetabolites|antimetabolites|mesh-ancestor
25475124|NCT00066781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475125|NCT00066781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475126|NCT00066781|Antiviral Agents|antiviral agents|mesh-ancestor
25475128|NCT00066781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475129|NCT00066781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25475130|NCT00066781|Immunologic Factors|immunologic factors|mesh-ancestor
25475131|NCT00066781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475132|NCT00066781|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25475133|NCT00066781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25475134|NCT00066937|Benztropine|benztropine|mesh-list
25475135|NCT00066937|Nortriptyline|nortriptyline|mesh-list
25475136|NCT00066937|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25475137|NCT00066937|Antidepressive Agents|antidepressive agents|mesh-ancestor
25475138|NCT00066937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25475139|NCT00066937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25475140|NCT00066937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25475141|NCT00066937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25475142|NCT00066937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475143|NCT00066937|Adrenergic Agents|adrenergic agents|mesh-ancestor
25475144|NCT00066937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25475145|NCT00066937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475146|NCT00066937|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25475147|NCT00066937|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25475148|NCT00066937|Parasympatholytics|parasympatholytics|mesh-ancestor
25475149|NCT00066937|Autonomic Agents|autonomic agents|mesh-ancestor
25475150|NCT00066937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25475151|NCT00066937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25475152|NCT00066937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25475153|NCT00066937|Cholinergic Agents|cholinergic agents|mesh-ancestor
25475154|NCT00066937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25475155|NCT00066937|Dopamine Agents|dopamine agents|mesh-ancestor
25475156|NCT00067002|Vidarabine|vidarabine|mesh-list
25475157|NCT00067002|Cyclophosphamide|cyclophosphamide|mesh-list
25475158|NCT00067002|Melphalan|melphalan|mesh-list
25475159|NCT00067002|Thiotepa|thiotepa|mesh-list
25475160|NCT00067002|Rituximab|rituximab|mesh-list
25475161|NCT00067002|Fludarabine|fludarabine|mesh-list
25475162|NCT00067002|Fludarabine phosphate|fludarabine phosphate|mesh-list
25475163|NCT00067002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25475164|NCT00067002|Immunologic Factors|immunologic factors|mesh-ancestor
25475165|NCT00067002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475166|NCT00067002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25475167|NCT00067002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25475168|NCT00067002|Alkylating Agents|alkylating agents|mesh-ancestor
25475169|NCT00067002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475170|NCT00067002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475171|NCT00067002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25475172|NCT00067002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25475173|NCT00067002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25475174|NCT00067002|Antimetabolites|antimetabolites|mesh-ancestor
25475175|NCT00067002|Antiviral Agents|antiviral agents|mesh-ancestor
24807404|NCT02021851|Aprepitant|aprepitant|mesh-list
25475176|NCT00067002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25475177|NCT00067028|Cytarabine|cytarabine|mesh-list
25475178|NCT00067028|Clofarabine|clofarabine|mesh-list
25475179|NCT00067028|Idarubicin|idarubicin|mesh-list
25475180|NCT00067028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25475181|NCT00067028|Antimetabolites|antimetabolites|mesh-ancestor
25475182|NCT00067028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475183|NCT00067028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475184|NCT00067028|Antiviral Agents|antiviral agents|mesh-ancestor
25475185|NCT00067028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25475186|NCT00067028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25475187|NCT00067028|Immunologic Factors|immunologic factors|mesh-ancestor
25475188|NCT00067028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475189|NCT00067028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25475190|NCT00067028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25475191|NCT00067028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25475192|NCT00067028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475193|NCT00067808|Decitabine|decitabine|mesh-list
25475194|NCT00067808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25475195|NCT00067808|Antimetabolites|antimetabolites|mesh-ancestor
25475196|NCT00067808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475197|NCT00067808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475198|NCT00067808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475199|NCT00067990|Losartan|losartan|mesh-list
25475200|NCT00067990|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25475201|NCT00067990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25475202|NCT00067990|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25475203|NCT00067990|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25475204|NCT00067990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475206|NCT00068250|Methotrexate|methotrexate|mesh-list
25475207|NCT00068250|Temozolomide|temozolomide|mesh-list
25475208|NCT00068250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25475209|NCT00068250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475210|NCT00068250|Immunologic Factors|immunologic factors|mesh-ancestor
25475211|NCT00068250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475212|NCT00068250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25475213|NCT00068250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25475214|NCT00068250|Abortifacient Agents|abortifacient agents|mesh-ancestor
25475215|NCT00068250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25475216|NCT00068250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25475217|NCT00068250|Antimetabolites|antimetabolites|mesh-ancestor
25475218|NCT00068250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475219|NCT00068250|Dermatologic Agents|dermatologic agents|mesh-ancestor
25475220|NCT00068250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475221|NCT00068250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25475222|NCT00068250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25475223|NCT00068250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25475224|NCT00068250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25475225|NCT00068250|Alkylating Agents|alkylating agents|mesh-ancestor
25475226|NCT00068341|Carboplatin|carboplatin|mesh-list
25475227|NCT00068341|Docetaxel|docetaxel|mesh-list
25475228|NCT00068341|Trastuzumab|trastuzumab|mesh-list
25475229|NCT00068341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475230|NCT00068341|Tubulin Modulators|tubulin modulators|mesh-ancestor
25475231|NCT00068341|Antimitotic Agents|antimitotic agents|mesh-ancestor
25475232|NCT00068341|Mitosis Modulators|mitosis modulators|mesh-ancestor
25475233|NCT00068341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475234|NCT00068341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25475235|NCT00068367|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25475236|NCT00068367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475237|NCT00068367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25475238|NCT00068367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475239|NCT00068367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475240|NCT00068380|Imatinib Mesylate|imatinib mesylate|mesh-list
25475241|NCT00068380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475242|NCT00068380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24971620|NCT03723785|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24971631|NCT03723395|Rifampin|rifampin|mesh-list
24832347|NCT02171325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25822929|NCT00004696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25822930|NCT00004697|Choline|choline|mesh-list
25822931|NCT00004697|Lipotropic Agents|lipotropic agents|mesh-ancestor
24832360|NCT02171338|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25475244|NCT00068380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475245|NCT00068393|Gemcitabine|gemcitabine|mesh-list
25475246|NCT00068393|Doxorubicin|doxorubicin|mesh-list
25475247|NCT00068393|Lenograstim|lenograstim|mesh-list
25475248|NCT00068393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25475249|NCT00068393|Antimetabolites|antimetabolites|mesh-ancestor
25475250|NCT00068393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475251|NCT00068393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475252|NCT00068393|Antiviral Agents|antiviral agents|mesh-ancestor
25475253|NCT00068393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25475254|NCT00068393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475255|NCT00068393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25475256|NCT00068393|Immunologic Factors|immunologic factors|mesh-ancestor
25475257|NCT00068393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475258|NCT00068393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25475259|NCT00068393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25475260|NCT00068393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25475261|NCT00068393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25475262|NCT00068406|Cisplatin|cisplatin|mesh-list
25475263|NCT00068406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475264|NCT00068419|Tamoxifen|tamoxifen|mesh-list
25475265|NCT00068419|Sulindac|sulindac|mesh-list
25475266|NCT00068419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475267|NCT00068419|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25475268|NCT00068419|Hormone Antagonists|hormone antagonists|mesh-ancestor
25644813|NCT01441063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25475269|NCT00068419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25475270|NCT00068419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475271|NCT00068419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25475272|NCT00068419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475273|NCT00068419|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25475274|NCT00068419|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25475275|NCT00068419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25475276|NCT00068419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25475277|NCT00068419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25475278|NCT00068419|Analgesics|analgesics|mesh-ancestor
25475279|NCT00068419|Sensory System Agents|sensory system agents|mesh-ancestor
25475280|NCT00068419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25475281|NCT00068419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25475282|NCT00068419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25475283|NCT00068419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25475284|NCT00068419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475285|NCT00068445|Lamotrigine|lamotrigine|mesh-list
25475286|NCT00068445|Anticonvulsants|anticonvulsants|mesh-ancestor
25475287|NCT00068445|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25475288|NCT00068445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25475289|NCT00068445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475290|NCT00068445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25475291|NCT00068445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475292|NCT00068445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25475293|NCT00068445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25475294|NCT00068445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25475295|NCT00068445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25475296|NCT00068445|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25475297|NCT00068575|Interferons|interferons|mesh-list
25475298|NCT00068575|Interferon-alpha|interferon-alpha|mesh-list
25475299|NCT00068575|Interferon alpha-2|interferon alpha-2|mesh-list
25475300|NCT00068575|Cisplatin|cisplatin|mesh-list
25475301|NCT00068575|Fluorouracil|fluorouracil|mesh-list
25475302|NCT00068575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475303|NCT00068575|Antimetabolites|antimetabolites|mesh-ancestor
25475304|NCT00068575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475305|NCT00068575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25475306|NCT00068575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25475307|NCT00068575|Immunologic Factors|immunologic factors|mesh-ancestor
25475308|NCT00068575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475309|NCT00068575|Antiviral Agents|antiviral agents|mesh-ancestor
25475310|NCT00068575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25475311|NCT00068588|Capecitabine|capecitabine|mesh-list
25475312|NCT00068588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25475313|NCT00068588|Antimetabolites|antimetabolites|mesh-ancestor
25822932|NCT00004697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25822933|NCT00004697|Antimetabolites|antimetabolites|mesh-ancestor
24464533|NCT00365313|Celecoxib|celecoxib|mesh-list
25475314|NCT00068588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475315|NCT00068588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475316|NCT00068601|Cyclophosphamide|cyclophosphamide|mesh-list
25475317|NCT00068601|Goserelin|goserelin|mesh-list
25475318|NCT00068601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25475319|NCT00068601|Immunologic Factors|immunologic factors|mesh-ancestor
25475320|NCT00068601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475321|NCT00068601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25475322|NCT00068601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25475323|NCT00068601|Alkylating Agents|alkylating agents|mesh-ancestor
25475324|NCT00068601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475325|NCT00068601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475326|NCT00068601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25475327|NCT00068601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25475328|NCT00068692|Leucovorin|leucovorin|mesh-list
25475329|NCT00068692|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
25475330|NCT00068692|Tetrahydrofolates|tetrahydrofolates|mesh-list
25475331|NCT00068692|Fluorouracil|fluorouracil|mesh-list
25475332|NCT00068692|Oxaliplatin|oxaliplatin|mesh-list
25475333|NCT00068692|Irinotecan|irinotecan|mesh-list
25475334|NCT00068692|Camptothecin|camptothecin|mesh-list
25475335|NCT00068692|Levoleucovorin|levoleucovorin|mesh-list
25475336|NCT00068692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475337|NCT00068692|Antimetabolites|antimetabolites|mesh-ancestor
25475338|NCT00068692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475339|NCT00068692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25475340|NCT00068692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25644814|NCT01441063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25644815|NCT01441063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475341|NCT00068692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25475342|NCT00068692|Immunologic Factors|immunologic factors|mesh-ancestor
25475343|NCT00068692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25475344|NCT00068692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25475345|NCT00068692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475347|NCT00068692|Protective Agents|protective agents|mesh-ancestor
25475348|NCT00068692|Vitamin B Complex|vitamin b complex|mesh-ancestor
25475349|NCT00068692|Vitamins|vitamins|mesh-ancestor
25475350|NCT00068692|Micronutrients|micronutrients|mesh-ancestor
25475351|NCT00068692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25475352|NCT00068770|Celecoxib|celecoxib|mesh-list
25475353|NCT00068770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25475354|NCT00068770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25475355|NCT00068770|Analgesics|analgesics|mesh-ancestor
25475356|NCT00068770|Sensory System Agents|sensory system agents|mesh-ancestor
25475357|NCT00068770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25475358|NCT00068770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475359|NCT00068770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25475360|NCT00068770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25475361|NCT00068770|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25475362|NCT00068770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25475363|NCT00068770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475364|NCT00068770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475365|NCT00069095|Leucovorin|leucovorin|mesh-list
25475366|NCT00069095|Bevacizumab|bevacizumab|mesh-list
25475367|NCT00069095|Fluorouracil|fluorouracil|mesh-list
25475368|NCT00069095|Capecitabine|capecitabine|mesh-list
25475369|NCT00069095|Oxaliplatin|oxaliplatin|mesh-list
25475370|NCT00069095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25475371|NCT00069095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475372|NCT00069095|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25475373|NCT00069095|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25475374|NCT00069095|Growth Substances|growth substances|mesh-ancestor
25475375|NCT00069095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475376|NCT00069095|Growth Inhibitors|growth inhibitors|mesh-ancestor
25475377|NCT00069095|Antimetabolites|antimetabolites|mesh-ancestor
25475378|NCT00069095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475379|NCT00069095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25475380|NCT00069095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25475381|NCT00069095|Immunologic Factors|immunologic factors|mesh-ancestor
25475382|NCT00069095|Antidotes|antidotes|mesh-ancestor
25475383|NCT00069095|Protective Agents|protective agents|mesh-ancestor
25475384|NCT00069095|Vitamin B Complex|vitamin b complex|mesh-ancestor
24864120|NCT00910650|Analgesics|analgesics|mesh-ancestor
24630333|NCT01110941|Protective Agents|protective agents|mesh-ancestor
24748093|NCT02943785|Edoxaban|edoxaban|mesh-list
24832828|NCT02172300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24630500|NCT01111981|Clobetasol|clobetasol|mesh-list
25475424|NCT00069329|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25475425|NCT00069329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25475427|NCT00069784|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25475428|NCT00069784|Insulin Glargine|insulin glargine|mesh-list
25475429|NCT00069784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25475430|NCT00069784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475431|NCT00069823|Esomeprazole|esomeprazole|mesh-list
25475432|NCT00069823|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25475433|NCT00069823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25475434|NCT00069823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25475435|NCT00069823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475436|NCT00069823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475437|NCT00069953|Paclitaxel|paclitaxel|mesh-list
25475438|NCT00069953|Cisplatin|cisplatin|mesh-list
25475439|NCT00069953|Fluorouracil|fluorouracil|mesh-list
25475440|NCT00069953|Lenograstim|lenograstim|mesh-list
25475441|NCT00069953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25475442|NCT00069953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475443|NCT00069953|Tubulin Modulators|tubulin modulators|mesh-ancestor
25475444|NCT00069953|Antimitotic Agents|antimitotic agents|mesh-ancestor
25475445|NCT00069953|Mitosis Modulators|mitosis modulators|mesh-ancestor
25475446|NCT00069953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644816|NCT01441063|Antiviral Agents|antiviral agents|mesh-ancestor
25475447|NCT00069953|Antimetabolites|antimetabolites|mesh-ancestor
25475448|NCT00069953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25475449|NCT00069953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25475450|NCT00069953|Immunologic Factors|immunologic factors|mesh-ancestor
25475451|NCT00069953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475452|NCT00069953|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25475453|NCT00070070|Sargramostim|sargramostim|mesh-list
25475454|NCT00070070|BCG Vaccine|bcg vaccine|mesh-list
25475455|NCT00070070|Immunologic Factors|immunologic factors|mesh-ancestor
25475456|NCT00070070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475457|NCT00070070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25475458|NCT00070109|Trabectedin|trabectedin|mesh-list
25475459|NCT00070109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25475460|NCT00070109|Alkylating Agents|alkylating agents|mesh-ancestor
25475461|NCT00070109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475462|NCT00070109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475463|NCT00070135|Methotrexate|methotrexate|mesh-list
25475464|NCT00070135|Fludarabine phosphate|fludarabine phosphate|mesh-list
25475465|NCT00070135|Fludarabine|fludarabine|mesh-list
25475466|NCT00070135|Busulfan|busulfan|mesh-list
25475467|NCT00070135|Tacrolimus|tacrolimus|mesh-list
25475468|NCT00070135|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25475469|NCT00070135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25475470|NCT00070135|Abortifacient Agents|abortifacient agents|mesh-ancestor
25475471|NCT00070135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25475472|NCT00070135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475473|NCT00070135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25475474|NCT00070135|Antimetabolites|antimetabolites|mesh-ancestor
25475475|NCT00070135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475476|NCT00070135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475477|NCT00070135|Dermatologic Agents|dermatologic agents|mesh-ancestor
25475478|NCT00070135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475479|NCT00070135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25475480|NCT00070135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25475481|NCT00070135|Immunologic Factors|immunologic factors|mesh-ancestor
25475482|NCT00070135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25475483|NCT00070135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25475484|NCT00070135|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25475485|NCT00070135|Alkylating Agents|alkylating agents|mesh-ancestor
25475486|NCT00070135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25475487|NCT00070135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25475488|NCT00070291|Cyclosporine|cyclosporine|mesh-list
25475489|NCT00070291|Cyclosporins|cyclosporins|mesh-list
25475490|NCT00070291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475491|NCT00070291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475492|NCT00070291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25475493|NCT00070291|Immunologic Factors|immunologic factors|mesh-ancestor
25475494|NCT00070291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475495|NCT00070291|Antifungal Agents|antifungal agents|mesh-ancestor
25475496|NCT00070291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25475497|NCT00070291|Dermatologic Agents|dermatologic agents|mesh-ancestor
25475498|NCT00070291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24833549|NCT02174263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833550|NCT02174328|Aspirin|aspirin|mesh-list
24833551|NCT02174328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25475499|NCT00070291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25475500|NCT00070317|Methylene Blue|methylene blue|mesh-list
25475501|NCT00070317|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
25475502|NCT00070317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475503|NCT00070317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475504|NCT00070317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25475505|NCT00070941|Citalopram|citalopram|mesh-list
25475506|NCT00070941|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25475507|NCT00070941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25475508|NCT00070941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25475509|NCT00070941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475510|NCT00070941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25475511|NCT00070941|Serotonin Agents|serotonin agents|mesh-ancestor
25475512|NCT00070941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475513|NCT00070941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25475514|NCT00070941|Antidepressive Agents|antidepressive agents|mesh-ancestor
25475515|NCT00070941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25475516|NCT00071006|Axitinib|axitinib|mesh-list
25475517|NCT00071006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475518|NCT00071006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25475519|NCT00071006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475520|NCT00071006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475521|NCT00071396|Rituximab|rituximab|mesh-list
25644817|NCT01441063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25644818|NCT01441063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25644819|NCT01441063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25644820|NCT01441076|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25644821|NCT01441076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25644822|NCT01441102|Dextromethorphan|dextromethorphan|mesh-list
25644823|NCT01441102|Antitussive Agents|antitussive agents|mesh-ancestor
25822934|NCT00004697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475522|NCT00071396|Alemtuzumab|alemtuzumab|mesh-list
25475523|NCT00071396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25475524|NCT00071396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475525|NCT00071396|Immunologic Factors|immunologic factors|mesh-ancestor
25475526|NCT00071396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475527|NCT00071396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25475528|NCT00071487|Belimumab|belimumab|mesh-list
25475529|NCT00071487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25475530|NCT00071487|Immunologic Factors|immunologic factors|mesh-ancestor
25475531|NCT00071487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475532|NCT00071721|Valproic Acid|valproic acid|mesh-list
25475533|NCT00071721|Anticonvulsants|anticonvulsants|mesh-ancestor
25475534|NCT00071721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475535|NCT00071721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475536|NCT00071721|GABA Agents|gaba agents|mesh-ancestor
25475537|NCT00071721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25475538|NCT00071721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475539|NCT00071721|Antimanic Agents|antimanic agents|mesh-ancestor
25475540|NCT00071721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25475541|NCT00071721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25475542|NCT00071721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25475543|NCT00071760|Ritonavir|ritonavir|mesh-list
25475544|NCT00071760|Fosamprenavir|fosamprenavir|mesh-list
25475545|NCT00071760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25475546|NCT00071760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25475547|NCT00071760|Protease Inhibitors|protease inhibitors|mesh-ancestor
25475548|NCT00071760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475549|NCT00071760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475550|NCT00071760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25475551|NCT00071760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25475552|NCT00071760|Antiviral Agents|antiviral agents|mesh-ancestor
25475553|NCT00071760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25475554|NCT00071760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25475555|NCT00071760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25475556|NCT00071799|Cytarabine|cytarabine|mesh-list
25475557|NCT00071799|Azacitidine|azacitidine|mesh-list
25475558|NCT00071799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25475559|NCT00071799|Antimetabolites|antimetabolites|mesh-ancestor
25475560|NCT00071799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475561|NCT00071799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475562|NCT00071799|Antiviral Agents|antiviral agents|mesh-ancestor
25475563|NCT00071799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25475564|NCT00071799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25475565|NCT00071799|Immunologic Factors|immunologic factors|mesh-ancestor
25475566|NCT00071799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475567|NCT00071799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475568|NCT00071812|Belimumab|belimumab|mesh-list
25475569|NCT00071812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25475570|NCT00071812|Immunologic Factors|immunologic factors|mesh-ancestor
25475571|NCT00071812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475572|NCT00071890|Aldesleukin|aldesleukin|mesh-list
25042960|NCT01345045|Anticonvulsants|anticonvulsants|mesh-ancestor
25475573|NCT00071890|Interleukin-2|interleukin-2|mesh-list
25475574|NCT00071890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475575|NCT00071890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25475576|NCT00071890|Analgesics|analgesics|mesh-ancestor
25475577|NCT00071890|Sensory System Agents|sensory system agents|mesh-ancestor
25475578|NCT00071890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25475579|NCT00071890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475580|NCT00071890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24412117|NCT00190853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412118|NCT00190853|Analgesics|analgesics|mesh-ancestor
24412119|NCT00190853|Sensory System Agents|sensory system agents|mesh-ancestor
25475581|NCT00071890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25475582|NCT00071890|Antiviral Agents|antiviral agents|mesh-ancestor
25475583|NCT00071890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25475584|NCT00071981|Molgramostim|molgramostim|mesh-list
25475585|NCT00071981|Vaccines|vaccines|mesh-list
24412123|NCT00190853|Dopamine Agents|dopamine agents|mesh-ancestor
25644824|NCT01441102|Respiratory System Agents|respiratory system agents|mesh-ancestor
25475586|NCT00071981|Sargramostim|sargramostim|mesh-list
25475587|NCT00071981|Freund's Adjuvant|freund's adjuvant|mesh-list
25475588|NCT00071981|Immunologic Factors|immunologic factors|mesh-ancestor
25475589|NCT00071981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475590|NCT00071981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475591|NCT00071981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25475592|NCT00072176|Sirolimus|sirolimus|mesh-list
25475593|NCT00072176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25475594|NCT00072176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25475595|NCT00072176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25475596|NCT00072176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475597|NCT00072176|Antifungal Agents|antifungal agents|mesh-ancestor
25475598|NCT00072176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25475599|NCT00072176|Immunologic Factors|immunologic factors|mesh-ancestor
25475600|NCT00072176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475601|NCT00072189|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
25475602|NCT00072189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475603|NCT00072189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25475604|NCT00072189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475605|NCT00072189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475606|NCT00072280|Dactinomycin|dactinomycin|mesh-list
25475607|NCT00072280|Cyclophosphamide|cyclophosphamide|mesh-list
25475608|NCT00072280|Ifosfamide|ifosfamide|mesh-list
25475609|NCT00072280|Isophosphamide mustard|isophosphamide mustard|mesh-list
25475610|NCT00072280|Etoposide|etoposide|mesh-list
25475611|NCT00072280|Vincristine|vincristine|mesh-list
25475612|NCT00072280|Lenograstim|lenograstim|mesh-list
25475613|NCT00072280|Mesna|mesna|mesh-list
25475614|NCT00072280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25475615|NCT00072280|Immunologic Factors|immunologic factors|mesh-ancestor
25475616|NCT00072280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475617|NCT00072280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25475618|NCT00072280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25475619|NCT00072280|Alkylating Agents|alkylating agents|mesh-ancestor
25475620|NCT00072280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475621|NCT00072280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475622|NCT00072280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25475623|NCT00072280|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25475624|NCT00072280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25475625|NCT00072280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25475626|NCT00072280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475627|NCT00072280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25475628|NCT00072280|Tubulin Modulators|tubulin modulators|mesh-ancestor
25475629|NCT00072280|Antimitotic Agents|antimitotic agents|mesh-ancestor
25475630|NCT00072280|Mitosis Modulators|mitosis modulators|mesh-ancestor
25475631|NCT00072280|Protective Agents|protective agents|mesh-ancestor
25475632|NCT00072280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25475633|NCT00072280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25475634|NCT00072280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25475635|NCT00072280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25475636|NCT00072280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25475637|NCT00072384|Carboplatin|carboplatin|mesh-list
25475638|NCT00072384|Etoposide|etoposide|mesh-list
25475639|NCT00072384|Vincristine|vincristine|mesh-list
25475640|NCT00072384|Etoposide phosphate|etoposide phosphate|mesh-list
25475641|NCT00072384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348298|NCT05519514|Budesonide|budesonide|mesh-list
25475642|NCT00072384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25475643|NCT00072384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25475644|NCT00072384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25475645|NCT00072384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475646|NCT00072384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475647|NCT00072384|Tubulin Modulators|tubulin modulators|mesh-ancestor
25475648|NCT00072384|Antimitotic Agents|antimitotic agents|mesh-ancestor
24409166|NCT00181142|Daclizumab|daclizumab|mesh-list
24836296|NCT02185066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475649|NCT00072384|Mitosis Modulators|mitosis modulators|mesh-ancestor
25475650|NCT00072449|Rituximab|rituximab|mesh-list
25475651|NCT00072449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25475652|NCT00072449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475653|NCT00072449|Immunologic Factors|immunologic factors|mesh-ancestor
25475654|NCT00072449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475655|NCT00072449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25475656|NCT00072475|Vatalanib|vatalanib|mesh-list
25475657|NCT00072475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25475658|NCT00072475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475659|NCT00072475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475660|NCT00072514|Gemcitabine|gemcitabine|mesh-list
25475661|NCT00072514|Dexamethasone|dexamethasone|mesh-list
25475663|NCT00072514|Carboplatin|carboplatin|mesh-list
25475664|NCT00072514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25475665|NCT00072514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475666|NCT00072514|Immunologic Factors|immunologic factors|mesh-ancestor
25475667|NCT00072514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475668|NCT00072514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25475669|NCT00072514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25475670|NCT00072514|Antiemetics|antiemetics|mesh-ancestor
25475671|NCT00072514|Autonomic Agents|autonomic agents|mesh-ancestor
25475672|NCT00072514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25475673|NCT00072514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25475674|NCT00072514|Glucocorticoids|glucocorticoids|mesh-ancestor
25475675|NCT00072514|Hormones|hormones|mesh-ancestor
25475676|NCT00072514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25475677|NCT00072514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25475678|NCT00072514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25475679|NCT00072514|Antimetabolites|antimetabolites|mesh-ancestor
25475680|NCT00072514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475681|NCT00072514|Antiviral Agents|antiviral agents|mesh-ancestor
25475682|NCT00072514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25475683|NCT00072514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475684|NCT00072514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25475685|NCT00072566|Cyclophosphamide|cyclophosphamide|mesh-list
25475686|NCT00072566|Bevacizumab|bevacizumab|mesh-list
25475687|NCT00072566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25475688|NCT00072566|Antibodies|antibodies|mesh-list
25475689|NCT00072566|Immunoglobulins|immunoglobulins|mesh-list
25475690|NCT00072566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25475691|NCT00072566|Immunoglobulin G|immunoglobulin g|mesh-list
25475692|NCT00072566|Endothelial Growth Factors|endothelial growth factors|mesh-list
25475693|NCT00072566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25475694|NCT00072566|Immunologic Factors|immunologic factors|mesh-ancestor
25475695|NCT00072566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475696|NCT00072566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25475697|NCT00072566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25475698|NCT00072566|Alkylating Agents|alkylating agents|mesh-ancestor
25475699|NCT00072566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475700|NCT00072566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475701|NCT00072566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25475702|NCT00072566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25475703|NCT00072566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25475704|NCT00072566|Growth Substances|growth substances|mesh-ancestor
25475705|NCT00072566|Growth Inhibitors|growth inhibitors|mesh-ancestor
25475706|NCT00073008|Lapatinib|lapatinib|mesh-list
25475707|NCT00073008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475708|NCT00073008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25475709|NCT00073008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475710|NCT00073008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475711|NCT00073021|Mesalamine|mesalamine|mesh-list
25475712|NCT00073021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25475713|NCT00073021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25475714|NCT00073021|Analgesics|analgesics|mesh-ancestor
25475715|NCT00073021|Sensory System Agents|sensory system agents|mesh-ancestor
25475716|NCT00073021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25475717|NCT00073021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475718|NCT00073021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25475719|NCT00073021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25475720|NCT00073073|Vitamin D|vitamin d|mesh-list
25475721|NCT00073073|Exemestane|exemestane|mesh-list
25475722|NCT00073073|Calcium Carbonate|calcium carbonate|mesh-list
25475723|NCT00073073|Calcium|calcium|mesh-list
25475724|NCT00073073|Vitamins|vitamins|mesh-ancestor
24837386|NCT02191176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25475725|NCT00073073|Micronutrients|micronutrients|mesh-ancestor
25475726|NCT00073073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475727|NCT00073073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25475728|NCT00073073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25475729|NCT00073073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475730|NCT00073073|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25475731|NCT00073073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25475732|NCT00073073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475733|NCT00073073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475734|NCT00073073|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25475735|NCT00073073|Hormone Antagonists|hormone antagonists|mesh-ancestor
25475736|NCT00073073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25475738|NCT00073073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25475739|NCT00073307|Sorafenib|sorafenib|mesh-list
25475740|NCT00073307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475741|NCT00073307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25475742|NCT00073307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475743|NCT00073307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475744|NCT00073528|Letrozole|letrozole|mesh-list
25475745|NCT00073528|Lapatinib|lapatinib|mesh-list
25475746|NCT00073528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475747|NCT00073528|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25475748|NCT00073528|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25475749|NCT00073528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475750|NCT00073528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475751|NCT00073528|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25475752|NCT00073528|Hormone Antagonists|hormone antagonists|mesh-ancestor
25475753|NCT00073528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25475754|NCT00073528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475755|NCT00073528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25475756|NCT00073749|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25475757|NCT00073749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25475758|NCT00073749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475759|NCT00073749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25475760|NCT00073918|Iodine|iodine|mesh-list
25475761|NCT00073918|Cadexomer iodine|cadexomer iodine|mesh-list
25475762|NCT00073918|Cyclophosphamide|cyclophosphamide|mesh-list
25475763|NCT00073918|Etoposide|etoposide|mesh-list
25475764|NCT00073918|Etoposide phosphate|etoposide phosphate|mesh-list
25475765|NCT00073918|Tositumomab I-131|tositumomab i-131|mesh-list
25475766|NCT00073918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25475767|NCT00073918|Antibodies|antibodies|mesh-list
25475768|NCT00073918|Immunoglobulins|immunoglobulins|mesh-list
25475769|NCT00073918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25475770|NCT00073918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25475771|NCT00073918|Immunologic Factors|immunologic factors|mesh-ancestor
25475772|NCT00073918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475773|NCT00073918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25475774|NCT00073918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25475775|NCT00073918|Alkylating Agents|alkylating agents|mesh-ancestor
25475776|NCT00073918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475777|NCT00073918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475778|NCT00073918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25475779|NCT00073918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25475780|NCT00073918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25475781|NCT00073918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25475782|NCT00073918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475783|NCT00073918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25475784|NCT00073918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25475785|NCT00073918|Trace Elements|trace elements|mesh-ancestor
25475786|NCT00073918|Micronutrients|micronutrients|mesh-ancestor
25475787|NCT00073957|Cytarabine|cytarabine|mesh-list
25475788|NCT00073957|Rituximab|rituximab|mesh-list
25475789|NCT00073957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25475790|NCT00073957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475791|NCT00073957|Immunologic Factors|immunologic factors|mesh-ancestor
25475792|NCT00073957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475793|NCT00073957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25475794|NCT00073957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25475795|NCT00073957|Antimetabolites|antimetabolites|mesh-ancestor
25475796|NCT00073957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475797|NCT00073957|Antiviral Agents|antiviral agents|mesh-ancestor
25475798|NCT00073957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25475799|NCT00073957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25475800|NCT00073983|Gemcitabine|gemcitabine|mesh-list
25475802|NCT00073983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25475803|NCT00073983|Antimetabolites|antimetabolites|mesh-ancestor
25475804|NCT00073983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475805|NCT00073983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475806|NCT00073983|Antiviral Agents|antiviral agents|mesh-ancestor
25475807|NCT00073983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25475808|NCT00073983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475809|NCT00073983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25475810|NCT00073983|Immunologic Factors|immunologic factors|mesh-ancestor
25644825|NCT01441102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25475812|NCT00073983|Tubulin Modulators|tubulin modulators|mesh-ancestor
25475813|NCT00073983|Antimitotic Agents|antimitotic agents|mesh-ancestor
25475814|NCT00073983|Mitosis Modulators|mitosis modulators|mesh-ancestor
25475815|NCT00074035|Pentostatin|pentostatin|mesh-list
25475816|NCT00074035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475817|NCT00074035|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25475818|NCT00074035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475819|NCT00074035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475820|NCT00074165|Cytarabine|cytarabine|mesh-list
25475821|NCT00074165|Sodium thiosulfate|sodium thiosulfate|mesh-list
25475822|NCT00074165|Cyclophosphamide|cyclophosphamide|mesh-list
25475823|NCT00074165|Rituximab|rituximab|mesh-list
25475824|NCT00074165|Carboplatin|carboplatin|mesh-list
25475825|NCT00074165|Etoposide|etoposide|mesh-list
25475826|NCT00074165|Etoposide phosphate|etoposide phosphate|mesh-list
25475827|NCT00074165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25475828|NCT00074165|Immunologic Factors|immunologic factors|mesh-ancestor
25475829|NCT00074165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475830|NCT00074165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25475831|NCT00074165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25475832|NCT00074165|Alkylating Agents|alkylating agents|mesh-ancestor
25475833|NCT00074165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475834|NCT00074165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475835|NCT00074165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25475836|NCT00074165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25475837|NCT00074165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25475838|NCT00074165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25475839|NCT00074165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25475840|NCT00074165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475841|NCT00074165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25475842|NCT00074165|Antimetabolites|antimetabolites|mesh-ancestor
25475843|NCT00074165|Antiviral Agents|antiviral agents|mesh-ancestor
25475844|NCT00074165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25475845|NCT00074165|Antidotes|antidotes|mesh-ancestor
25475846|NCT00074165|Protective Agents|protective agents|mesh-ancestor
25475847|NCT00074165|Antioxidants|antioxidants|mesh-ancestor
25475848|NCT00074165|Antitubercular Agents|antitubercular agents|mesh-ancestor
25475849|NCT00074165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25475850|NCT00074165|Chelating Agents|chelating agents|mesh-ancestor
25475851|NCT00074165|Sequestering Agents|sequestering agents|mesh-ancestor
25475852|NCT00074269|Cyclosporine|cyclosporine|mesh-list
25475853|NCT00074269|Methotrexate|methotrexate|mesh-list
25475854|NCT00074269|Fludarabine phosphate|fludarabine phosphate|mesh-list
25475855|NCT00074269|Fludarabine|fludarabine|mesh-list
25475856|NCT00074269|Melphalan|melphalan|mesh-list
25475857|NCT00074269|Cyclosporins|cyclosporins|mesh-list
25475858|NCT00074269|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25475859|NCT00074269|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25475860|NCT00074269|Abortifacient Agents|abortifacient agents|mesh-ancestor
25475861|NCT00074269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25475862|NCT00074269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475863|NCT00074269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25475864|NCT00074269|Antimetabolites|antimetabolites|mesh-ancestor
25475865|NCT00074269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475866|NCT00074269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475867|NCT00074269|Dermatologic Agents|dermatologic agents|mesh-ancestor
25475868|NCT00074269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475869|NCT00074269|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25475870|NCT00074269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25475871|NCT00074269|Immunologic Factors|immunologic factors|mesh-ancestor
25475872|NCT00074269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25475873|NCT00074269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25475874|NCT00074269|Antifungal Agents|antifungal agents|mesh-ancestor
25475875|NCT00074269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25475876|NCT00074269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25475877|NCT00074269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25475878|NCT00074269|Alkylating Agents|alkylating agents|mesh-ancestor
25475879|NCT00074269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25475880|NCT00074282|Cyclophosphamide|cyclophosphamide|mesh-list
25475881|NCT00074282|Rituximab|rituximab|mesh-list
25475882|NCT00074282|Alemtuzumab|alemtuzumab|mesh-list
25475883|NCT00074282|Pentostatin|pentostatin|mesh-list
25475884|NCT00074282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25475885|NCT00074282|Immunologic Factors|immunologic factors|mesh-ancestor
25475886|NCT00074282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475887|NCT00074282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25475888|NCT00074282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25475889|NCT00074282|Alkylating Agents|alkylating agents|mesh-ancestor
25475890|NCT00074282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475891|NCT00074282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475892|NCT00074282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25475893|NCT00074282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25475894|NCT00074282|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25475895|NCT00074282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475897|NCT00074308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25475898|NCT00074308|Imatinib Mesylate|imatinib mesylate|mesh-list
25475899|NCT00074308|Antibodies|antibodies|mesh-list
25475900|NCT00074308|Immunoglobulins|immunoglobulins|mesh-list
25475901|NCT00074308|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25475902|NCT00074308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475903|NCT00074308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25475904|NCT00074308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25475905|NCT00074308|Growth Substances|growth substances|mesh-ancestor
25475906|NCT00074308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475907|NCT00074308|Growth Inhibitors|growth inhibitors|mesh-ancestor
25475908|NCT00074308|Immunologic Factors|immunologic factors|mesh-ancestor
25475909|NCT00074308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25475910|NCT00074308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475911|NCT00074308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475912|NCT00074490|Prednisone|prednisone|mesh-list
25475913|NCT00074490|Cyclophosphamide|cyclophosphamide|mesh-list
25475914|NCT00074490|Rituximab|rituximab|mesh-list
25475915|NCT00074490|Doxorubicin|doxorubicin|mesh-list
25475916|NCT00074490|Fludarabine|fludarabine|mesh-list
25475917|NCT00074490|Etoposide|etoposide|mesh-list
25475918|NCT00074490|Vincristine|vincristine|mesh-list
25475919|NCT00074490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25475920|NCT00074490|Immunologic Factors|immunologic factors|mesh-ancestor
25475921|NCT00074490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475922|NCT00074490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25475923|NCT00074490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25475924|NCT00074490|Alkylating Agents|alkylating agents|mesh-ancestor
25475925|NCT00074490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475926|NCT00074490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25475927|NCT00074490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25475928|NCT00074490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25475929|NCT00074490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25475930|NCT00074490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25475931|NCT00074490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25475932|NCT00074490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475933|NCT00074490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25475934|NCT00074490|Glucocorticoids|glucocorticoids|mesh-ancestor
25475935|NCT00074490|Hormones|hormones|mesh-ancestor
25475936|NCT00074490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25475937|NCT00074490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25475938|NCT00074490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25475939|NCT00074490|Tubulin Modulators|tubulin modulators|mesh-ancestor
25475940|NCT00074490|Antimitotic Agents|antimitotic agents|mesh-ancestor
25475941|NCT00074490|Mitosis Modulators|mitosis modulators|mesh-ancestor
25475942|NCT00074581|Ritonavir|ritonavir|mesh-list
25475943|NCT00074581|Lopinavir|lopinavir|mesh-list
25475944|NCT00074581|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25475945|NCT00074581|Tenofovir|tenofovir|mesh-list
24839630|NCT02205502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822935|NCT00004697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25822936|NCT00004697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24839636|NCT02205541|Eculizumab|eculizumab|mesh-list
25043423|NCT01262261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24839637|NCT02205541|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25475946|NCT00074581|Lamivudine|lamivudine|mesh-list
25475947|NCT00074581|Zidovudine|zidovudine|mesh-list
25475948|NCT00074581|Emtricitabine|emtricitabine|mesh-list
25475949|NCT00074581|Nevirapine|nevirapine|mesh-list
25475950|NCT00074581|Stavudine|stavudine|mesh-list
25475951|NCT00074581|Didanosine|didanosine|mesh-list
25475952|NCT00074581|Efavirenz|efavirenz|mesh-list
25475953|NCT00074581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25475954|NCT00074581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25475955|NCT00074581|Protease Inhibitors|protease inhibitors|mesh-ancestor
25475956|NCT00074581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475957|NCT00074581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475958|NCT00074581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25644826|NCT01441102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25644827|NCT01441102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25644828|NCT01441102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644829|NCT01441102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644830|NCT01441180|Sofosbuvir|sofosbuvir|mesh-list
25644831|NCT01441180|Ribavirin|ribavirin|mesh-list
25644832|NCT01441180|Antiviral Agents|antiviral agents|mesh-ancestor
25644833|NCT01441180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25822937|NCT00004697|Nootropic Agents|nootropic agents|mesh-ancestor
25475959|NCT00074581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25475960|NCT00074581|Antiviral Agents|antiviral agents|mesh-ancestor
25475961|NCT00074581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25475962|NCT00074581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25475963|NCT00074581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25475964|NCT00074581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25475965|NCT00074581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25475966|NCT00074581|Antimetabolites|antimetabolites|mesh-ancestor
25475967|NCT00074581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25475968|NCT00074581|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25475969|NCT00074581|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25475970|NCT00074581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25475971|NCT00074581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25475972|NCT00074711|Calcium, Dietary|calcium, dietary|mesh-list
25475973|NCT00074711|Calcium Carbonate|calcium carbonate|mesh-list
25475974|NCT00074711|Calcium|calcium|mesh-list
25475975|NCT00074711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25475976|NCT00074711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475977|NCT00074711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25475978|NCT00074711|Antacids|antacids|mesh-ancestor
25475979|NCT00074711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475980|NCT00074711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25475981|NCT00074802|Paroxetine|paroxetine|mesh-list
25475982|NCT00074802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25475983|NCT00074802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25475984|NCT00074802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25475985|NCT00074802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25475986|NCT00074802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25475987|NCT00074802|Serotonin Agents|serotonin agents|mesh-ancestor
25475988|NCT00074802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25475989|NCT00074802|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25475990|NCT00074802|Antidepressive Agents|antidepressive agents|mesh-ancestor
25475991|NCT00074802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25475992|NCT00074802|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25475993|NCT00074802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25475994|NCT00074802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25475995|NCT00074815|Fluvoxamine|fluvoxamine|mesh-list
25475996|NCT00074815|Citalopram|citalopram|mesh-list
25475997|NCT00074815|Fluoxetine|fluoxetine|mesh-list
25475998|NCT00074815|Paroxetine|paroxetine|mesh-list
25475999|NCT00074815|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25476000|NCT00074815|Sertraline|sertraline|mesh-list
25476001|NCT00074815|Clomipramine|clomipramine|mesh-list
25476002|NCT00074815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25476003|NCT00074815|Serotonin|serotonin|mesh-list
25476004|NCT00074815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25476005|NCT00074815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25476006|NCT00074815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476007|NCT00074815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25476008|NCT00074815|Serotonin Agents|serotonin agents|mesh-ancestor
25476009|NCT00074815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476010|NCT00074815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25476011|NCT00074815|Antidepressive Agents|antidepressive agents|mesh-ancestor
25476012|NCT00074815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25476013|NCT00074815|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25476014|NCT00074815|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25476015|NCT00074815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25476016|NCT00074815|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25822938|NCT00004699|Mitogens|mitogens|mesh-list
25822939|NCT00004699|Mitosis Modulators|mitosis modulators|mesh-ancestor
24534631|NCT00647738|Baclofen|baclofen|mesh-list
25476017|NCT00074815|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25476018|NCT00074815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25476019|NCT00074815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25476020|NCT00074815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25476021|NCT00074815|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25476022|NCT00074815|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25476023|NCT00074815|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25476024|NCT00075023|Thalidomide|thalidomide|mesh-list
25476025|NCT00075023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25476026|NCT00075023|Immunologic Factors|immunologic factors|mesh-ancestor
25476027|NCT00075023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476028|NCT00075023|Leprostatic Agents|leprostatic agents|mesh-ancestor
25476029|NCT00075023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25476030|NCT00075023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25476031|NCT00075023|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25476032|NCT00075023|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25476033|NCT00075023|Growth Substances|growth substances|mesh-ancestor
25476034|NCT00075023|Growth Inhibitors|growth inhibitors|mesh-ancestor
25476035|NCT00075023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476036|NCT00075218|Sunitinib|sunitinib|mesh-list
25476037|NCT00075218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476038|NCT00075218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25476039|NCT00075218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25476040|NCT00075218|Growth Substances|growth substances|mesh-ancestor
25476041|NCT00075218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476042|NCT00075218|Growth Inhibitors|growth inhibitors|mesh-ancestor
25476043|NCT00075218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25476044|NCT00075218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25476045|NCT00075218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476046|NCT00075270|Paclitaxel|paclitaxel|mesh-list
25476047|NCT00075270|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25476048|NCT00075270|Lapatinib|lapatinib|mesh-list
25476049|NCT00075270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25476050|NCT00075270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476051|NCT00075270|Tubulin Modulators|tubulin modulators|mesh-ancestor
25476052|NCT00075270|Antimitotic Agents|antimitotic agents|mesh-ancestor
25476053|NCT00075270|Mitosis Modulators|mitosis modulators|mesh-ancestor
25476054|NCT00075270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476055|NCT00075270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25476056|NCT00075270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25476057|NCT00075335|Plerixafor|plerixafor|mesh-list
25476058|NCT00075335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25476059|NCT00075335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25476060|NCT00075335|Antiviral Agents|antiviral agents|mesh-ancestor
25476061|NCT00075335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25476062|NCT00075400|Imatinib Mesylate|imatinib mesylate|mesh-list
25476063|NCT00075400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476064|NCT00075400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25476065|NCT00075400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25476066|NCT00075400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476067|NCT00075478|Cyclosporine|cyclosporine|mesh-list
25476068|NCT00075478|Mycophenolic Acid|mycophenolic acid|mesh-list
25476069|NCT00075478|Fludarabine|fludarabine|mesh-list
25476070|NCT00075478|Fludarabine phosphate|fludarabine phosphate|mesh-list
25476071|NCT00075478|Cyclosporins|cyclosporins|mesh-list
25476072|NCT00075478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476073|NCT00075478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25476074|NCT00075478|Antimetabolites|antimetabolites|mesh-ancestor
25476075|NCT00075478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476076|NCT00075478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25476077|NCT00075478|Immunologic Factors|immunologic factors|mesh-ancestor
25476078|NCT00075478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476079|NCT00075478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25476080|NCT00075478|Antifungal Agents|antifungal agents|mesh-ancestor
25476081|NCT00075478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25476082|NCT00075478|Dermatologic Agents|dermatologic agents|mesh-ancestor
25476083|NCT00075478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25476084|NCT00075478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25476085|NCT00075478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25476086|NCT00075478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25476087|NCT00075478|Antitubercular Agents|antitubercular agents|mesh-ancestor
25476088|NCT00075478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25476089|NCT00075504|Gemcitabine|gemcitabine|mesh-list
25476090|NCT00075504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25476091|NCT00075504|Antimetabolites|antimetabolites|mesh-ancestor
24839976|NCT02206789|Glucocorticoids|glucocorticoids|mesh-ancestor
25476092|NCT00075504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476093|NCT00075504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476094|NCT00075504|Antiviral Agents|antiviral agents|mesh-ancestor
25476095|NCT00075504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25476096|NCT00075504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25476097|NCT00075504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25476098|NCT00075504|Immunologic Factors|immunologic factors|mesh-ancestor
25476099|NCT00075504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476100|NCT00075582|Dactinomycin|dactinomycin|mesh-list
25476101|NCT00075582|Cactinomycin|cactinomycin|mesh-list
25476102|NCT00075582|Cyclophosphamide|cyclophosphamide|mesh-list
25476103|NCT00075582|Vincristine|vincristine|mesh-list
25476104|NCT00075582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25476105|NCT00075582|Immunologic Factors|immunologic factors|mesh-ancestor
25476106|NCT00075582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476107|NCT00075582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25476108|NCT00075582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25476109|NCT00075582|Alkylating Agents|alkylating agents|mesh-ancestor
25476110|NCT00075582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476111|NCT00075582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476112|NCT00075582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25476113|NCT00075582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25476114|NCT00075582|Tubulin Modulators|tubulin modulators|mesh-ancestor
25476115|NCT00075582|Antimitotic Agents|antimitotic agents|mesh-ancestor
25476116|NCT00075582|Mitosis Modulators|mitosis modulators|mesh-ancestor
25476117|NCT00075582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25476118|NCT00075582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25476119|NCT00075582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25476120|NCT00075582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25476121|NCT00075582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25476122|NCT00075582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25476123|NCT00075725|Calcium, Dietary|calcium, dietary|mesh-list
25476125|NCT00075725|Folic Acid|folic acid|mesh-list
25476126|NCT00075725|Cytarabine|cytarabine|mesh-list
25476127|NCT00075725|Dexamethasone|dexamethasone|mesh-list
25476128|NCT00075725|Dexamethasone acetate|dexamethasone acetate|mesh-list
25476129|NCT00075725|Prednisone|prednisone|mesh-list
25476130|NCT00075725|Cortisone|cortisone|mesh-list
25476131|NCT00075725|Cyclophosphamide|cyclophosphamide|mesh-list
25476132|NCT00075725|Doxorubicin|doxorubicin|mesh-list
25476133|NCT00075725|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25476134|NCT00075725|Methotrexate|methotrexate|mesh-list
25476135|NCT00075725|Vincristine|vincristine|mesh-list
25476136|NCT00075725|Daunorubicin|daunorubicin|mesh-list
25476137|NCT00075725|Asparaginase|asparaginase|mesh-list
25476138|NCT00075725|Mercaptopurine|mercaptopurine|mesh-list
25476139|NCT00075725|Pegaspargase|pegaspargase|mesh-list
25476140|NCT00075725|Thioguanine|thioguanine|mesh-list
25476141|NCT00075725|BB 1101|bb 1101|mesh-list
25476142|NCT00075725|Calcium|calcium|mesh-list
25476143|NCT00075725|2-Aminopurine|2-aminopurine|mesh-list
25476144|NCT00075725|Levoleucovorin|levoleucovorin|mesh-list
25476145|NCT00075725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25476146|NCT00075725|Immunologic Factors|immunologic factors|mesh-ancestor
25476147|NCT00075725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476148|NCT00075725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25476149|NCT00075725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25476150|NCT00075725|Alkylating Agents|alkylating agents|mesh-ancestor
25476151|NCT00075725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476152|NCT00075725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476153|NCT00075725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25476154|NCT00075725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25476155|NCT00075725|Antiemetics|antiemetics|mesh-ancestor
25476156|NCT00075725|Autonomic Agents|autonomic agents|mesh-ancestor
25476157|NCT00075725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25476158|NCT00075725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25476159|NCT00075725|Glucocorticoids|glucocorticoids|mesh-ancestor
25476160|NCT00075725|Hormones|hormones|mesh-ancestor
25476161|NCT00075725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25476162|NCT00075725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25476163|NCT00075725|Protease Inhibitors|protease inhibitors|mesh-ancestor
25476164|NCT00075725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25476165|NCT00075725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25476166|NCT00075725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25476167|NCT00075725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24840379|NCT02209909|Aspirin|aspirin|mesh-list
25476168|NCT00075725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25476169|NCT00075725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25476170|NCT00075725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25476171|NCT00075725|Abortifacient Agents|abortifacient agents|mesh-ancestor
25476172|NCT00075725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25476173|NCT00075725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25476174|NCT00075725|Antimetabolites|antimetabolites|mesh-ancestor
25476175|NCT00075725|Dermatologic Agents|dermatologic agents|mesh-ancestor
25476176|NCT00075725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25476177|NCT00075725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25476178|NCT00075725|Antiviral Agents|antiviral agents|mesh-ancestor
25476179|NCT00075725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25476180|NCT00075725|Antidotes|antidotes|mesh-ancestor
25476181|NCT00075725|Protective Agents|protective agents|mesh-ancestor
25476182|NCT00075725|Vitamin B Complex|vitamin b complex|mesh-ancestor
25476183|NCT00075725|Vitamins|vitamins|mesh-ancestor
25476184|NCT00075725|Micronutrients|micronutrients|mesh-ancestor
25476185|NCT00075725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25476186|NCT00075725|Tubulin Modulators|tubulin modulators|mesh-ancestor
25476187|NCT00075725|Antimitotic Agents|antimitotic agents|mesh-ancestor
25476188|NCT00075725|Mitosis Modulators|mitosis modulators|mesh-ancestor
25476189|NCT00075725|Hematinics|hematinics|mesh-ancestor
25476190|NCT00075764|Fulvestrant|fulvestrant|mesh-list
25476191|NCT00075764|Anastrozole|anastrozole|mesh-list
25476192|NCT00075764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25476193|NCT00075764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476194|NCT00075764|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25476195|NCT00075764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25476196|NCT00075764|Hormone Antagonists|hormone antagonists|mesh-ancestor
25476197|NCT00075764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25476198|NCT00075764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476199|NCT00075764|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25476200|NCT00075764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25476201|NCT00075764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25476202|NCT00075764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476203|NCT00075803|Fluconazole|fluconazole|mesh-list
25476204|NCT00075803|Voriconazole|voriconazole|mesh-list
25476205|NCT00075803|Antifungal Agents|antifungal agents|mesh-ancestor
25476206|NCT00075803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25476207|NCT00075803|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25476208|NCT00075803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25476209|NCT00075803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25476210|NCT00075803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476211|NCT00075803|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25476212|NCT00075803|Hormone Antagonists|hormone antagonists|mesh-ancestor
25476213|NCT00075803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25476214|NCT00075803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476215|NCT00075803|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25476216|NCT00075803|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25476217|NCT00075803|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25476218|NCT00075829|Thalidomide|thalidomide|mesh-list
25476219|NCT00075829|Dexamethasone|dexamethasone|mesh-list
25476220|NCT00075829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25476221|NCT00075829|Antiemetics|antiemetics|mesh-ancestor
25476222|NCT00075829|Autonomic Agents|autonomic agents|mesh-ancestor
25476223|NCT00075829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25476224|NCT00075829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476225|NCT00075829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25476226|NCT00075829|Glucocorticoids|glucocorticoids|mesh-ancestor
25476227|NCT00075829|Hormones|hormones|mesh-ancestor
25476228|NCT00075829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25476229|NCT00075829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25476230|NCT00075829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476231|NCT00075829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25476232|NCT00075829|Immunologic Factors|immunologic factors|mesh-ancestor
25476233|NCT00075829|Leprostatic Agents|leprostatic agents|mesh-ancestor
25476234|NCT00075829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25476235|NCT00075829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25476236|NCT00075829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25476237|NCT00075829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25476238|NCT00075829|Growth Substances|growth substances|mesh-ancestor
25476239|NCT00075829|Growth Inhibitors|growth inhibitors|mesh-ancestor
25476240|NCT00075881|Bortezomib|bortezomib|mesh-list
25476241|NCT00075881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476242|NCT00076011|Mitogens|mitogens|mesh-list
25476243|NCT00076011|Endothelial Growth Factors|endothelial growth factors|mesh-list
25476244|NCT00076011|Mitosis Modulators|mitosis modulators|mesh-ancestor
25476245|NCT00076011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476246|NCT00076011|Growth Substances|growth substances|mesh-ancestor
25476247|NCT00076011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476250|NCT00076024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476251|NCT00076024|Tubulin Modulators|tubulin modulators|mesh-ancestor
25476252|NCT00076024|Antimitotic Agents|antimitotic agents|mesh-ancestor
25476253|NCT00076024|Mitosis Modulators|mitosis modulators|mesh-ancestor
25476254|NCT00076024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476255|NCT00076024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25476256|NCT00076024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25476257|NCT00076102|Pirfenidone|pirfenidone|mesh-list
25476258|NCT00076102|Analgesics|analgesics|mesh-ancestor
25476259|NCT00076102|Sensory System Agents|sensory system agents|mesh-ancestor
25476260|NCT00076102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25476261|NCT00076102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476262|NCT00076102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25476263|NCT00076102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25476264|NCT00076102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25476265|NCT00076102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25476266|NCT00076102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476267|NCT00076336|Lamivudine|lamivudine|mesh-list
25476268|NCT00076336|Telbivudine|telbivudine|mesh-list
25476269|NCT00076336|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25476270|NCT00076336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25476271|NCT00076336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25476272|NCT00076336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476273|NCT00076336|Antiviral Agents|antiviral agents|mesh-ancestor
25476274|NCT00076336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25476275|NCT00076336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25476276|NCT00076336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25476277|NCT00076570|Sirolimus|sirolimus|mesh-list
25476278|NCT00076570|Tacrolimus|tacrolimus|mesh-list
25476279|NCT00076570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25476280|NCT00076570|Immunologic Factors|immunologic factors|mesh-ancestor
25476281|NCT00076570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476282|NCT00076570|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25476283|NCT00076570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25476284|NCT00076570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476285|NCT00076570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25476286|NCT00076570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25476287|NCT00076570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25476288|NCT00076570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476289|NCT00076570|Antifungal Agents|antifungal agents|mesh-ancestor
25476290|NCT00076622|Antidepressive Agents|antidepressive agents|mesh-list
25476291|NCT00076622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25476292|NCT00076687|Botulinum Toxins|botulinum toxins|mesh-list
25476293|NCT00076687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25476294|NCT00076687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25476295|NCT00076687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25476296|NCT00076687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25476297|NCT00076687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476298|NCT00076687|Cholinergic Agents|cholinergic agents|mesh-ancestor
25476299|NCT00076687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25476300|NCT00076687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476301|NCT00076687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25476302|NCT00076687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25476303|NCT00076752|Diphenhydramine|diphenhydramine|mesh-list
25476304|NCT00076752|Promethazine|promethazine|mesh-list
25476305|NCT00076752|Methylprednisolone|methylprednisolone|mesh-list
25476306|NCT00076752|Cyclophosphamide|cyclophosphamide|mesh-list
25476307|NCT00076752|Rituximab|rituximab|mesh-list
25476308|NCT00076752|Fludarabine|fludarabine|mesh-list
25476309|NCT00076752|Fludarabine phosphate|fludarabine phosphate|mesh-list
25476310|NCT00076752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25476311|NCT00076752|Immunologic Factors|immunologic factors|mesh-ancestor
25476312|NCT00076752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476313|NCT00076752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25476314|NCT00076752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25476315|NCT00076752|Alkylating Agents|alkylating agents|mesh-ancestor
25476316|NCT00076752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476317|NCT00076752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476318|NCT00076752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24842156|NCT02219828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25476319|NCT00076752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25476320|NCT00076752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25476322|NCT00076752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25476323|NCT00076752|Antiemetics|antiemetics|mesh-ancestor
25476324|NCT00076752|Autonomic Agents|autonomic agents|mesh-ancestor
25476325|NCT00076752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25476326|NCT00076752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25476327|NCT00076752|Glucocorticoids|glucocorticoids|mesh-ancestor
25476328|NCT00076752|Hormones|hormones|mesh-ancestor
25476329|NCT00076752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25476330|NCT00076752|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25476331|NCT00076752|Protective Agents|protective agents|mesh-ancestor
25476332|NCT00076752|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25476333|NCT00076752|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25476334|NCT00076752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25476335|NCT00076752|Anesthetics, Local|anesthetics, local|mesh-ancestor
25476336|NCT00076752|Anesthetics|anesthetics|mesh-ancestor
25476337|NCT00076752|Sensory System Agents|sensory system agents|mesh-ancestor
25476338|NCT00076752|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25476339|NCT00076752|Histamine Antagonists|histamine antagonists|mesh-ancestor
25476340|NCT00076752|Histamine Agents|histamine agents|mesh-ancestor
25476341|NCT00076752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25476342|NCT00076752|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25476343|NCT00076752|Antipruritics|antipruritics|mesh-ancestor
25476344|NCT00076752|Dermatologic Agents|dermatologic agents|mesh-ancestor
25476345|NCT00076999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25476346|NCT00077064|Captopril|captopril|mesh-list
25476347|NCT00077064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25476348|NCT00077064|Protease Inhibitors|protease inhibitors|mesh-ancestor
25476349|NCT00077064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25476350|NCT00077064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476351|NCT00077064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25476352|NCT00077207|Carboplatin|carboplatin|mesh-list
25476353|NCT00077207|Vincristine|vincristine|mesh-list
25476354|NCT00077207|Temozolomide|temozolomide|mesh-list
25476355|NCT00077207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476356|NCT00077207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25476357|NCT00077207|Tubulin Modulators|tubulin modulators|mesh-ancestor
25476358|NCT00077207|Antimitotic Agents|antimitotic agents|mesh-ancestor
25476359|NCT00077207|Mitosis Modulators|mitosis modulators|mesh-ancestor
25476360|NCT00077207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476361|NCT00077207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25476362|NCT00077207|Alkylating Agents|alkylating agents|mesh-ancestor
25476363|NCT00077376|Carboplatin|carboplatin|mesh-list
25476364|NCT00077376|Trastuzumab|trastuzumab|mesh-list
25476365|NCT00077376|Epothilone B|epothilone b|mesh-list
25476366|NCT00077376|Epothilones|epothilones|mesh-list
25476367|NCT00077376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476368|NCT00077376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25476369|NCT00077376|Tubulin Modulators|tubulin modulators|mesh-ancestor
25476370|NCT00077376|Antimitotic Agents|antimitotic agents|mesh-ancestor
25476371|NCT00077376|Mitosis Modulators|mitosis modulators|mesh-ancestor
25476372|NCT00077376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476373|NCT00077610|Epoetin Alfa|epoetin alfa|mesh-list
25476374|NCT00077610|Hematinics|hematinics|mesh-ancestor
25476375|NCT00077623|Epoetin Alfa|epoetin alfa|mesh-list
25476376|NCT00077623|Hematinics|hematinics|mesh-ancestor
25476377|NCT00077636|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25476378|NCT00077636|Interferon-alpha|interferon-alpha|mesh-list
25476379|NCT00077636|Ribavirin|ribavirin|mesh-list
25476380|NCT00077636|Antiviral Agents|antiviral agents|mesh-ancestor
25476381|NCT00077636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25476382|NCT00077636|Immunologic Factors|immunologic factors|mesh-ancestor
25476383|NCT00077636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476384|NCT00077636|Antimetabolites|antimetabolites|mesh-ancestor
25476385|NCT00077636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476386|NCT00077649|Ribavirin|ribavirin|mesh-list
25476387|NCT00077649|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25476388|NCT00077649|Interferon-alpha|interferon-alpha|mesh-list
25476389|NCT00077649|Interferon alpha-2|interferon alpha-2|mesh-list
25476390|NCT00077649|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
25476391|NCT00077649|Antimetabolites|antimetabolites|mesh-ancestor
25476392|NCT00077649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476393|NCT00077649|Antiviral Agents|antiviral agents|mesh-ancestor
25476394|NCT00077649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25476395|NCT00077649|Immunologic Factors|immunologic factors|mesh-ancestor
25476419|NCT00077974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476420|NCT00077974|Growth Inhibitors|growth inhibitors|mesh-ancestor
25476421|NCT00077974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25476422|NCT00077974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25476423|NCT00077974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476424|NCT00078286|Sertraline|sertraline|mesh-list
25476425|NCT00078286|Antidepressive Agents|antidepressive agents|mesh-ancestor
25476426|NCT00078286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25476427|NCT00078286|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25476428|NCT00078286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25476429|NCT00078286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25476430|NCT00078286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476431|NCT00078286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25476432|NCT00078286|Serotonin Agents|serotonin agents|mesh-ancestor
25476433|NCT00078286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476434|NCT00078312|Modafinil|modafinil|mesh-list
25476435|NCT00078312|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25476436|NCT00078312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476437|NCT00078312|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25476438|NCT00078312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25476439|NCT00078312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25476440|NCT00078312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476441|NCT00078325|Modafinil|modafinil|mesh-list
25476442|NCT00078325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25476443|NCT00078325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476444|NCT00078325|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25476445|NCT00078325|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25476446|NCT00078325|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25476447|NCT00078325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476449|NCT00078338|Interferon-beta|interferon-beta|mesh-list
25476450|NCT00078338|Interferon beta-1a|interferon beta-1a|mesh-list
25476451|NCT00078338|Glatiramer Acetate|glatiramer acetate|mesh-list
25476452|NCT00078338|(T,G)-A-L|(t,g)-a-l|mesh-list
25476453|NCT00078338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476454|NCT00078338|Antiviral Agents|antiviral agents|mesh-ancestor
25476455|NCT00078338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25476456|NCT00078338|Immunologic Factors|immunologic factors|mesh-ancestor
25476457|NCT00078338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476458|NCT00078338|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25476459|NCT00078338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25476460|NCT00078338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25476461|NCT00078377|Modafinil|modafinil|mesh-list
25476462|NCT00078377|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25476463|NCT00078377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476464|NCT00078377|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25476465|NCT00078377|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25476466|NCT00078377|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25476467|NCT00078377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476468|NCT00078403|Ribavirin|ribavirin|mesh-list
25476469|NCT00078403|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25476470|NCT00078403|Antimetabolites|antimetabolites|mesh-ancestor
25476471|NCT00078403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476472|NCT00078403|Antiviral Agents|antiviral agents|mesh-ancestor
25476473|NCT00078403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25476474|NCT00078559|Acetaminophen|acetaminophen|mesh-list
25476475|NCT00078559|Diphenhydramine|diphenhydramine|mesh-list
25476476|NCT00078559|Promethazine|promethazine|mesh-list
25476477|NCT00078559|Sirolimus|sirolimus|mesh-list
25476478|NCT00078559|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25476479|NCT00078559|Nystatin|nystatin|mesh-list
25476480|NCT00078559|Clotrimazole|clotrimazole|mesh-list
25476481|NCT00078559|Miconazole|miconazole|mesh-list
25476482|NCT00078559|Pentamidine|pentamidine|mesh-list
25476483|NCT00078559|Trimethoprim|trimethoprim|mesh-list
25476484|NCT00078559|Acyclovir|acyclovir|mesh-list
25476485|NCT00078559|Valganciclovir|valganciclovir|mesh-list
25476486|NCT00078559|Methylprednisolone|methylprednisolone|mesh-list
25476487|NCT00078559|Alemtuzumab|alemtuzumab|mesh-list
25476488|NCT00078559|Tacrolimus|tacrolimus|mesh-list
25476489|NCT00078559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25476490|NCT00078559|Immunologic Factors|immunologic factors|mesh-ancestor
25476491|NCT00078559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476492|NCT00078559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25476493|NCT00078559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25476494|NCT00078559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476495|NCT00078559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25476496|NCT00078559|Analgesics|analgesics|mesh-ancestor
25476497|NCT00078559|Sensory System Agents|sensory system agents|mesh-ancestor
25476498|NCT00078559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25476500|NCT00078559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25476501|NCT00078559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25476502|NCT00078559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25476503|NCT00078559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476504|NCT00078559|Antifungal Agents|antifungal agents|mesh-ancestor
25476505|NCT00078559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25476506|NCT00078559|Antiemetics|antiemetics|mesh-ancestor
25476507|NCT00078559|Autonomic Agents|autonomic agents|mesh-ancestor
25476508|NCT00078559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25476509|NCT00078559|Glucocorticoids|glucocorticoids|mesh-ancestor
25476510|NCT00078559|Hormones|hormones|mesh-ancestor
25476511|NCT00078559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25476512|NCT00078559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25476513|NCT00078559|Protective Agents|protective agents|mesh-ancestor
25476514|NCT00078559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25476515|NCT00078559|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25476516|NCT00078559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25476517|NCT00078559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25476518|NCT00078559|Anesthetics, Local|anesthetics, local|mesh-ancestor
25476519|NCT00078559|Anesthetics|anesthetics|mesh-ancestor
25476520|NCT00078559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25476521|NCT00078559|Histamine Antagonists|histamine antagonists|mesh-ancestor
25476522|NCT00078559|Histamine Agents|histamine agents|mesh-ancestor
25476523|NCT00078559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25476524|NCT00078559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25476525|NCT00078559|Antipruritics|antipruritics|mesh-ancestor
25476526|NCT00078559|Dermatologic Agents|dermatologic agents|mesh-ancestor
25476527|NCT00078559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25476528|NCT00078559|Renal Agents|renal agents|mesh-ancestor
25476529|NCT00078559|Antimalarials|antimalarials|mesh-ancestor
25476530|NCT00078559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25476531|NCT00078559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25476532|NCT00078559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25476533|NCT00078559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25476534|NCT00078559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25476535|NCT00078559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25476536|NCT00078559|Antiviral Agents|antiviral agents|mesh-ancestor
25476537|NCT00078559|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25476538|NCT00078559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25476539|NCT00078559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25476540|NCT00078559|Hormone Antagonists|hormone antagonists|mesh-ancestor
25476541|NCT00078559|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25476542|NCT00078559|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25476543|NCT00078559|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25476544|NCT00078559|Ionophores|ionophores|mesh-ancestor
25476545|NCT00078559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25476547|NCT00078715|Mydriatics|mydriatics|mesh-ancestor
25476548|NCT00078715|Autonomic Agents|autonomic agents|mesh-ancestor
25476549|NCT00078715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25476550|NCT00078715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476551|NCT00078715|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25476552|NCT00078715|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25476553|NCT00078715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25476554|NCT00078715|Adrenergic Agents|adrenergic agents|mesh-ancestor
25476555|NCT00078715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25476556|NCT00078715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476557|NCT00078715|Urological Agents|urological agents|mesh-ancestor
25476558|NCT00078754|Valproic Acid|valproic acid|mesh-list
25476559|NCT00078754|Fluoxetine|fluoxetine|mesh-list
25476560|NCT00078754|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25476561|NCT00078754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25476562|NCT00078754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25476563|NCT00078754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476564|NCT00078754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25476565|NCT00078754|Serotonin Agents|serotonin agents|mesh-ancestor
25476566|NCT00078754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476567|NCT00078754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25476568|NCT00078754|Antidepressive Agents|antidepressive agents|mesh-ancestor
25476569|NCT00078754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25476570|NCT00078754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25476571|NCT00078754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25644834|NCT01441180|Antimetabolites|antimetabolites|mesh-ancestor
25476576|NCT00078754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25476577|NCT00078754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25476579|NCT00078767|Antidepressive Agents|antidepressive agents|mesh-ancestor
25772281|NCT03675581|Nintedanib|nintedanib|mesh-list
25476580|NCT00078767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25476581|NCT00078767|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25476582|NCT00078767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25476583|NCT00078767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25476584|NCT00078767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476585|NCT00078767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25476586|NCT00078767|Serotonin Agents|serotonin agents|mesh-ancestor
25476587|NCT00078767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476588|NCT00078819|Etanercept|etanercept|mesh-list
25476589|NCT00078819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25476590|NCT00078819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25476591|NCT00078819|Analgesics|analgesics|mesh-ancestor
24892828|NCT04458636|Hormones|hormones|mesh-ancestor
25044302|NCT01116141|Micronutrients|micronutrients|mesh-ancestor
25476592|NCT00078819|Sensory System Agents|sensory system agents|mesh-ancestor
25476593|NCT00078819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25476594|NCT00078819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476595|NCT00078819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25476596|NCT00078819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25476597|NCT00078819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25476598|NCT00078819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25476599|NCT00078819|Immunologic Factors|immunologic factors|mesh-ancestor
25476601|NCT00078897|Antioxidants|antioxidants|mesh-ancestor
25476602|NCT00078897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476603|NCT00078897|Protective Agents|protective agents|mesh-ancestor
25476604|NCT00078897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476605|NCT00078897|Trace Elements|trace elements|mesh-ancestor
25476606|NCT00078897|Micronutrients|micronutrients|mesh-ancestor
25476607|NCT00078949|Gemcitabine|gemcitabine|mesh-list
25476608|NCT00078949|Cytarabine|cytarabine|mesh-list
25476609|NCT00078949|Dexamethasone|dexamethasone|mesh-list
25476610|NCT00078949|Rituximab|rituximab|mesh-list
25476611|NCT00078949|Cisplatin|cisplatin|mesh-list
25476612|NCT00078949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25476613|NCT00078949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476614|NCT00078949|Immunologic Factors|immunologic factors|mesh-ancestor
25476615|NCT00078949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476616|NCT00078949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25476617|NCT00078949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25476618|NCT00078949|Antiemetics|antiemetics|mesh-ancestor
25476619|NCT00078949|Autonomic Agents|autonomic agents|mesh-ancestor
25476620|NCT00078949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25476621|NCT00078949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25476622|NCT00078949|Glucocorticoids|glucocorticoids|mesh-ancestor
25476623|NCT00078949|Hormones|hormones|mesh-ancestor
25476624|NCT00078949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25476625|NCT00078949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25476626|NCT00078949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25476627|NCT00078949|Antimetabolites|antimetabolites|mesh-ancestor
25476628|NCT00078949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476629|NCT00078949|Antiviral Agents|antiviral agents|mesh-ancestor
25476630|NCT00078949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25476631|NCT00078949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25476632|NCT00078949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25476633|NCT00079001|Vitamin D|vitamin d|mesh-list
25476634|NCT00079001|Zoledronic Acid|zoledronic acid|mesh-list
25476635|NCT00079001|Calcium|calcium|mesh-list
25476636|NCT00079001|Androgens|androgens|mesh-list
25476637|NCT00079001|Vitamins|vitamins|mesh-ancestor
25476638|NCT00079001|Micronutrients|micronutrients|mesh-ancestor
25476639|NCT00079001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476640|NCT00079001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25476641|NCT00079001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25476642|NCT00079001|Hormones|hormones|mesh-ancestor
25476643|NCT00079001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25476644|NCT00079040|Bevacizumab|bevacizumab|mesh-list
25476645|NCT00079040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25476646|NCT00079040|Cisplatin|cisplatin|mesh-list
25476647|NCT00079040|Etoposide|etoposide|mesh-list
25476648|NCT00079040|Etoposide phosphate|etoposide phosphate|mesh-list
25476649|NCT00079040|Antibodies|antibodies|mesh-list
25476650|NCT00079040|Immunoglobulins|immunoglobulins|mesh-list
25476651|NCT00079040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25476652|NCT00079040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476653|NCT00079040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25476654|NCT00079040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25476655|NCT00079040|Growth Substances|growth substances|mesh-ancestor
25476656|NCT00079040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476657|NCT00079040|Growth Inhibitors|growth inhibitors|mesh-ancestor
25476658|NCT00079040|Immunologic Factors|immunologic factors|mesh-ancestor
25476659|NCT00079040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25476660|NCT00079040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25476661|NCT00079040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25476662|NCT00079040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25476663|NCT00079040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476664|NCT00079183|Sirolimus|sirolimus|mesh-list
25476665|NCT00079183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25476666|NCT00079183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25476667|NCT00079183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25476668|NCT00079183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476669|NCT00079183|Antifungal Agents|antifungal agents|mesh-ancestor
25476670|NCT00079183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25476671|NCT00079183|Immunologic Factors|immunologic factors|mesh-ancestor
25476672|NCT00079183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476673|NCT00079274|Leucovorin|leucovorin|mesh-list
25476674|NCT00079274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25476675|NCT00079274|Cetuximab|cetuximab|mesh-list
25476676|NCT00079274|Fluorouracil|fluorouracil|mesh-list
25476677|NCT00079274|Oxaliplatin|oxaliplatin|mesh-list
25476678|NCT00079274|Irinotecan|irinotecan|mesh-list
25476679|NCT00079274|Antibodies|antibodies|mesh-list
25476680|NCT00079274|Immunoglobulins|immunoglobulins|mesh-list
25476681|NCT00079274|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25476682|NCT00079274|Levoleucovorin|levoleucovorin|mesh-list
25476683|NCT00079274|Immunologic Factors|immunologic factors|mesh-ancestor
25476684|NCT00079274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476685|NCT00079274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476686|NCT00079274|Antimetabolites|antimetabolites|mesh-ancestor
25476687|NCT00079274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476688|NCT00079274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25476689|NCT00079274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25476690|NCT00079274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25476691|NCT00079274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25476692|NCT00079274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25476693|NCT00079274|Antidotes|antidotes|mesh-ancestor
25476694|NCT00079274|Protective Agents|protective agents|mesh-ancestor
25476695|NCT00079274|Vitamin B Complex|vitamin b complex|mesh-ancestor
25476696|NCT00079274|Vitamins|vitamins|mesh-ancestor
25476697|NCT00079274|Micronutrients|micronutrients|mesh-ancestor
25476698|NCT00079326|Trastuzumab|trastuzumab|mesh-list
25476699|NCT00079326|Epothilone B|epothilone b|mesh-list
25476700|NCT00079326|Epothilones|epothilones|mesh-list
25476701|NCT00079326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25476702|NCT00079326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476703|NCT00079326|Tubulin Modulators|tubulin modulators|mesh-ancestor
25476704|NCT00079326|Antimitotic Agents|antimitotic agents|mesh-ancestor
25476705|NCT00079326|Mitosis Modulators|mitosis modulators|mesh-ancestor
25476706|NCT00079326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476707|NCT00079339|Tipifarnib|tipifarnib|mesh-list
25476708|NCT00079339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476709|NCT00079417|Iodine|iodine|mesh-list
25476710|NCT00079417|Carboplatin|carboplatin|mesh-list
25476711|NCT00079417|Vincristine|vincristine|mesh-list
25476712|NCT00079417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476713|NCT00079417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25476714|NCT00079417|Tubulin Modulators|tubulin modulators|mesh-ancestor
25476715|NCT00079417|Antimitotic Agents|antimitotic agents|mesh-ancestor
25476716|NCT00079417|Mitosis Modulators|mitosis modulators|mesh-ancestor
25476717|NCT00079417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476718|NCT00079417|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25476719|NCT00079417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25476720|NCT00079417|Trace Elements|trace elements|mesh-ancestor
25476721|NCT00079417|Micronutrients|micronutrients|mesh-ancestor
25476722|NCT00079417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656813|NCT01579305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25476723|NCT00079677|Modafinil|modafinil|mesh-list
25476724|NCT00079677|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25476725|NCT00079677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476726|NCT00079677|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25476727|NCT00079677|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25476728|NCT00079677|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25476729|NCT00079677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476730|NCT00079937|Fluticasone|fluticasone|mesh-list
25476731|NCT00079937|Omalizumab|omalizumab|mesh-list
25476732|NCT00079937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25476733|NCT00079937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25476734|NCT00079937|Autonomic Agents|autonomic agents|mesh-ancestor
25476735|NCT00079937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25476736|NCT00079937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476737|NCT00079937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25476738|NCT00079937|Respiratory System Agents|respiratory system agents|mesh-ancestor
25476739|NCT00079937|Dermatologic Agents|dermatologic agents|mesh-ancestor
25476740|NCT00079937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25476741|NCT00080119|Isoniazid|isoniazid|mesh-list
25476742|NCT00080119|Trimethoprim|trimethoprim|mesh-list
25476743|NCT00080119|Sulfamethoxazole|sulfamethoxazole|mesh-list
25476744|NCT00080119|Antitubercular Agents|antitubercular agents|mesh-ancestor
25476745|NCT00080119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25476746|NCT00080119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24846967|NCT02244502|Paclitaxel|paclitaxel|mesh-list
25476747|NCT00080119|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25476748|NCT00080119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25476749|NCT00080119|Antimetabolites|antimetabolites|mesh-ancestor
25476750|NCT00080119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476751|NCT00080119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25476752|NCT00080119|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25476753|NCT00080119|Renal Agents|renal agents|mesh-ancestor
25476754|NCT00080119|Antimalarials|antimalarials|mesh-ancestor
25476755|NCT00080119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25476756|NCT00080119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25476757|NCT00080119|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25476758|NCT00080119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25476759|NCT00080119|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25476760|NCT00080119|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25476761|NCT00080119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25476762|NCT00080223|Pirfenidone|pirfenidone|mesh-list
25476763|NCT00080223|Analgesics|analgesics|mesh-ancestor
25476764|NCT00080223|Sensory System Agents|sensory system agents|mesh-ancestor
25476765|NCT00080223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25476766|NCT00080223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476767|NCT00080223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25476768|NCT00080223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25476769|NCT00080223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25476770|NCT00080223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25476771|NCT00080223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476772|NCT00080288|Modafinil|modafinil|mesh-list
25476773|NCT00080288|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25476774|NCT00080288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476775|NCT00080288|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25476776|NCT00080288|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25476777|NCT00080288|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25476778|NCT00080288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476779|NCT00080301|Capecitabine|capecitabine|mesh-list
25476780|NCT00080301|Epothilones|epothilones|mesh-list
25476781|NCT00080301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25476782|NCT00080301|Antimetabolites|antimetabolites|mesh-ancestor
25476783|NCT00080301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476784|NCT00080301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476785|NCT00080301|Tubulin Modulators|tubulin modulators|mesh-ancestor
25476786|NCT00080301|Antimitotic Agents|antimitotic agents|mesh-ancestor
25476787|NCT00080301|Mitosis Modulators|mitosis modulators|mesh-ancestor
25476788|NCT00080483|Methyltestosterone|methyltestosterone|mesh-list
25476789|NCT00080483|Testosterone|testosterone|mesh-list
25476790|NCT00080483|Testosterone undecanoate|testosterone undecanoate|mesh-list
25476791|NCT00080483|Testosterone enanthate|testosterone enanthate|mesh-list
25476792|NCT00080483|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25476793|NCT00080483|Androgens|androgens|mesh-ancestor
25476794|NCT00080483|Hormones|hormones|mesh-ancestor
25476795|NCT00080483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25644835|NCT01441180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644836|NCT01441245|Furosemide|furosemide|mesh-list
25644837|NCT01441245|Diuretics|diuretics|mesh-ancestor
25644838|NCT01441245|Natriuretic Agents|natriuretic agents|mesh-ancestor
25644839|NCT01441245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644840|NCT01441245|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25644841|NCT01441245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25644842|NCT01441245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644843|NCT01441401|Gabapentin|gabapentin|mesh-list
25644844|NCT01441401|Analgesics|analgesics|mesh-ancestor
25644845|NCT01441401|Sensory System Agents|sensory system agents|mesh-ancestor
25644846|NCT01441401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25644847|NCT01441401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644848|NCT01441401|Anticonvulsants|anticonvulsants|mesh-ancestor
25644849|NCT01441401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25644850|NCT01441401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25476796|NCT00080483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476797|NCT00080483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25476798|NCT00080483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476799|NCT00080483|Anabolic Agents|anabolic agents|mesh-ancestor
25476800|NCT00080899|Fenretinide|fenretinide|mesh-list
25476801|NCT00080899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476802|NCT00080899|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25476803|NCT00080899|Protective Agents|protective agents|mesh-ancestor
25476804|NCT00080899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476805|NCT00080938|Temozolomide|temozolomide|mesh-list
25476806|NCT00080938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25476807|NCT00080938|Alkylating Agents|alkylating agents|mesh-ancestor
25476808|NCT00080938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476809|NCT00080938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476810|NCT00081159|Zoledronic Acid|zoledronic acid|mesh-list
25476811|NCT00081159|Doxorubicin|doxorubicin|mesh-list
25476812|NCT00081159|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25476813|NCT00081159|Leuprolide|leuprolide|mesh-list
25476814|NCT00081159|Goserelin|goserelin|mesh-list
25476815|NCT00081159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25476816|NCT00081159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476817|NCT00081159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25476818|NCT00081159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25476819|NCT00081159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25476820|NCT00081159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721289|NCT01573013|Iron|iron|mesh-list
25476821|NCT00081159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25476822|NCT00081159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476823|NCT00081159|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25476824|NCT00081159|Fertility Agents|fertility agents|mesh-ancestor
25476825|NCT00081159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25476826|NCT00081159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25476827|NCT00081263|Celecoxib|celecoxib|mesh-list
25476828|NCT00081263|Benzenesulfonamide|benzenesulfonamide|mesh-list
25476829|NCT00081263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25476830|NCT00081263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25476831|NCT00081263|Analgesics|analgesics|mesh-ancestor
25476832|NCT00081263|Sensory System Agents|sensory system agents|mesh-ancestor
25476833|NCT00081263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25476834|NCT00081263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476835|NCT00081263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25476836|NCT00081263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25476837|NCT00081263|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25476838|NCT00081263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25476839|NCT00081263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25476840|NCT00081263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476841|NCT00081263|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25476842|NCT00081289|Leucovorin|leucovorin|mesh-list
25476843|NCT00081289|Folic Acid|folic acid|mesh-list
25476844|NCT00081289|Fluorouracil|fluorouracil|mesh-list
25476845|NCT00081289|Capecitabine|capecitabine|mesh-list
25476846|NCT00081289|Oxaliplatin|oxaliplatin|mesh-list
25476847|NCT00081289|Irinotecan|irinotecan|mesh-list
25476848|NCT00081289|Levoleucovorin|levoleucovorin|mesh-list
25476849|NCT00081289|Antimetabolites|antimetabolites|mesh-ancestor
25476850|NCT00081289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476851|NCT00081289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25476852|NCT00081289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24414668|NCT00198380|Gefitinib|gefitinib|mesh-list
25644851|NCT01441401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25644852|NCT01441401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25644853|NCT01441401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25476853|NCT00081289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25476854|NCT00081289|Immunologic Factors|immunologic factors|mesh-ancestor
25476855|NCT00081289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476856|NCT00081289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25476857|NCT00081289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25476858|NCT00081289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25476859|NCT00081289|Antidotes|antidotes|mesh-ancestor
25476860|NCT00081289|Protective Agents|protective agents|mesh-ancestor
25476861|NCT00081289|Vitamin B Complex|vitamin b complex|mesh-ancestor
25476862|NCT00081289|Vitamins|vitamins|mesh-ancestor
25476863|NCT00081289|Micronutrients|micronutrients|mesh-ancestor
25476864|NCT00081289|Hematinics|hematinics|mesh-ancestor
25476865|NCT00081328|Metformin|metformin|mesh-list
25476866|NCT00081328|Rosiglitazone|rosiglitazone|mesh-list
25476867|NCT00081328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25476868|NCT00081328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476869|NCT00081458|Teduglutide|teduglutide|mesh-list
25476870|NCT00081458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25476871|NCT00081458|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25476872|NCT00081458|Protective Agents|protective agents|mesh-ancestor
25476873|NCT00081458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476874|NCT00081653|Ibandronic Acid|ibandronic acid|mesh-list
25476875|NCT00081653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25476876|NCT00081653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476877|NCT00081731|Candesartan cilexetil|candesartan cilexetil|mesh-list
25476878|NCT00081731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25476879|NCT00081731|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25476880|NCT00081731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25476881|NCT00081731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476882|NCT00081770|Ribavirin|ribavirin|mesh-list
25476883|NCT00081770|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25476884|NCT00081770|Interferon-alpha|interferon-alpha|mesh-list
25476885|NCT00081770|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25476886|NCT00081770|Antimetabolites|antimetabolites|mesh-ancestor
25476887|NCT00081770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476888|NCT00081770|Antiviral Agents|antiviral agents|mesh-ancestor
25476889|NCT00081770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25476890|NCT00081770|Immunologic Factors|immunologic factors|mesh-ancestor
25476891|NCT00081770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476892|NCT00081861|Bevacizumab|bevacizumab|mesh-list
25476893|NCT00081861|Rituximab|rituximab|mesh-list
24474100|NCT00404833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474101|NCT00404833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24474102|NCT00404833|Antiemetics|antiemetics|mesh-ancestor
24474103|NCT00404833|Autonomic Agents|autonomic agents|mesh-ancestor
25476894|NCT00081861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25476895|NCT00081861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476896|NCT00081861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25476897|NCT00081861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25476898|NCT00081861|Growth Substances|growth substances|mesh-ancestor
25476899|NCT00081861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476900|NCT00081861|Growth Inhibitors|growth inhibitors|mesh-ancestor
25476901|NCT00081861|Immunologic Factors|immunologic factors|mesh-ancestor
25476902|NCT00081861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25476903|NCT00081939|Thalidomide|thalidomide|mesh-list
25476904|NCT00081939|Bortezomib|bortezomib|mesh-list
25476905|NCT00081939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476906|NCT00081939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25476907|NCT00081939|Immunologic Factors|immunologic factors|mesh-ancestor
25476908|NCT00081939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476909|NCT00081939|Leprostatic Agents|leprostatic agents|mesh-ancestor
25476910|NCT00081939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25476911|NCT00081939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25476912|NCT00081939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25476913|NCT00081939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25476914|NCT00081939|Growth Substances|growth substances|mesh-ancestor
25476915|NCT00081939|Growth Inhibitors|growth inhibitors|mesh-ancestor
25476916|NCT00082017|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
25476917|NCT00082017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476918|NCT00082017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25476919|NCT00082017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25476920|NCT00082017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476921|NCT00082173|Moxifloxacin|moxifloxacin|mesh-list
25644854|NCT01441401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25644855|NCT01441401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25644856|NCT01441401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644857|NCT01441401|Antimanic Agents|antimanic agents|mesh-ancestor
25644858|NCT01441414|Axitinib|axitinib|mesh-list
25476922|NCT00082173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25476923|NCT00082173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25476924|NCT00082173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25476925|NCT00082173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25476926|NCT00082173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25476927|NCT00082173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476928|NCT00082173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476929|NCT00082329|Plerixafor|plerixafor|mesh-list
25476930|NCT00082329|Lenograstim|lenograstim|mesh-list
25476931|NCT00082329|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25476932|NCT00082329|Immunologic Factors|immunologic factors|mesh-ancestor
25476933|NCT00082329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476934|NCT00082329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25476935|NCT00082329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25476936|NCT00082329|Antiviral Agents|antiviral agents|mesh-ancestor
25476937|NCT00082329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25476938|NCT00082355|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25476939|NCT00082355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25476940|NCT00082355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25476941|NCT00082355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476942|NCT00082381|Insulin Glargine|insulin glargine|mesh-list
25476943|NCT00082381|Exenatide|exenatide|mesh-list
25476944|NCT00082381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25476945|NCT00082381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476946|NCT00082381|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25476947|NCT00082381|Incretins|incretins|mesh-ancestor
25476948|NCT00082381|Hormones|hormones|mesh-ancestor
25476949|NCT00082381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25476950|NCT00082407|Insulin Aspart|insulin aspart|mesh-list
25476951|NCT00082407|Exenatide|exenatide|mesh-list
25476952|NCT00082407|Biphasic Insulins|biphasic insulins|mesh-list
25476953|NCT00082407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25476954|NCT00082407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476955|NCT00082407|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25476956|NCT00082407|Incretins|incretins|mesh-ancestor
25476957|NCT00082407|Hormones|hormones|mesh-ancestor
25476958|NCT00082407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25476959|NCT00082433|Capecitabine|capecitabine|mesh-list
25476960|NCT00082433|Epothilones|epothilones|mesh-list
25476961|NCT00082433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25476962|NCT00082433|Antimetabolites|antimetabolites|mesh-ancestor
25476963|NCT00082433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476964|NCT00082433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476965|NCT00082433|Tubulin Modulators|tubulin modulators|mesh-ancestor
25829455|NCT00006211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25044457|NCT01094262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25476966|NCT00082433|Antimitotic Agents|antimitotic agents|mesh-ancestor
25476967|NCT00082433|Mitosis Modulators|mitosis modulators|mesh-ancestor
25476968|NCT00082628|Hormones|hormones|mesh-list
25476969|NCT00082628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25476970|NCT00082628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476971|NCT00082758|Interleukin-2|interleukin-2|mesh-list
25476972|NCT00082758|Denileukin diftitox|denileukin diftitox|mesh-list
25476973|NCT00082758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476974|NCT00082758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25476975|NCT00082758|Analgesics|analgesics|mesh-ancestor
25476976|NCT00082758|Sensory System Agents|sensory system agents|mesh-ancestor
25476977|NCT00082758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25476978|NCT00082758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476979|NCT00082810|Fulvestrant|fulvestrant|mesh-list
25476980|NCT00082810|Tipifarnib|tipifarnib|mesh-list
25476981|NCT00082810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25476982|NCT00082810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476983|NCT00082810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24822546|NCT02112422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24822547|NCT02112422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822549|NCT02112487|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
24822550|NCT02112487|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25476984|NCT00082810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25476985|NCT00082810|Hormone Antagonists|hormone antagonists|mesh-ancestor
25476986|NCT00082810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25476987|NCT00082810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476989|NCT00082888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476990|NCT00083122|Cisplatin|cisplatin|mesh-list
25476991|NCT00083122|Alvocidib|alvocidib|mesh-list
25476992|NCT00083122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25476993|NCT00083122|Growth Inhibitors|growth inhibitors|mesh-ancestor
25476994|NCT00083122|Growth Substances|growth substances|mesh-ancestor
25476995|NCT00083122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25476996|NCT00083122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25476997|NCT00083122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25476998|NCT00083122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25476999|NCT00083174|Exemestane|exemestane|mesh-list
25477000|NCT00083174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477001|NCT00083174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25477002|NCT00083174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25477003|NCT00083174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477004|NCT00083174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477005|NCT00083174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25477006|NCT00083174|Hormone Antagonists|hormone antagonists|mesh-ancestor
25477007|NCT00083174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25477008|NCT00083174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477009|NCT00083226|Doxorubicin|doxorubicin|mesh-list
25477010|NCT00083226|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25477011|NCT00083226|Bortezomib|bortezomib|mesh-list
25477012|NCT00083226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25477013|NCT00083226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477014|NCT00083226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25477015|NCT00083226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25477016|NCT00083226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477017|NCT00083226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477018|NCT00083382|Pamidronate|pamidronate|mesh-list
25477019|NCT00083382|Thalidomide|thalidomide|mesh-list
25477020|NCT00083382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25477021|NCT00083382|Immunologic Factors|immunologic factors|mesh-ancestor
25477022|NCT00083382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477023|NCT00083382|Leprostatic Agents|leprostatic agents|mesh-ancestor
25477024|NCT00083382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25477025|NCT00083382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25477026|NCT00083382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25477027|NCT00083382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25477028|NCT00083382|Growth Substances|growth substances|mesh-ancestor
25477029|NCT00083382|Growth Inhibitors|growth inhibitors|mesh-ancestor
25477030|NCT00083382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477031|NCT00083382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25477032|NCT00083551|Interferons|interferons|mesh-list
25477033|NCT00083551|Cytarabine|cytarabine|mesh-list
25477034|NCT00083551|Interferon-alpha|interferon-alpha|mesh-list
25477035|NCT00083551|Interferon alpha-2|interferon alpha-2|mesh-list
25477036|NCT00083551|Thalidomide|thalidomide|mesh-list
25477037|NCT00083551|Dexamethasone|dexamethasone|mesh-list
25477038|NCT00083551|Cyclophosphamide|cyclophosphamide|mesh-list
25477039|NCT00083551|Melphalan|melphalan|mesh-list
25477040|NCT00083551|Carmustine|carmustine|mesh-list
25477041|NCT00083551|Cisplatin|cisplatin|mesh-list
25477042|NCT00083551|Doxorubicin|doxorubicin|mesh-list
25477043|NCT00083551|Etoposide|etoposide|mesh-list
25822940|NCT00004699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477045|NCT00083551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25477046|NCT00083551|Immunologic Factors|immunologic factors|mesh-ancestor
25477047|NCT00083551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477048|NCT00083551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25477049|NCT00083551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25477050|NCT00083551|Alkylating Agents|alkylating agents|mesh-ancestor
25477051|NCT00083551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477052|NCT00083551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477053|NCT00083551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25477054|NCT00083551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25477055|NCT00083551|Antiemetics|antiemetics|mesh-ancestor
25477056|NCT00083551|Autonomic Agents|autonomic agents|mesh-ancestor
25477057|NCT00083551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25477058|NCT00083551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25477059|NCT00083551|Glucocorticoids|glucocorticoids|mesh-ancestor
25477060|NCT00083551|Hormones|hormones|mesh-ancestor
25477061|NCT00083551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25477062|NCT00083551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25477063|NCT00083551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25477064|NCT00083551|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25477065|NCT00083551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25477066|NCT00083551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477067|NCT00083551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25477068|NCT00083551|Antiviral Agents|antiviral agents|mesh-ancestor
25477069|NCT00083551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25477070|NCT00083551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25477071|NCT00083551|Antimetabolites|antimetabolites|mesh-ancestor
25477072|NCT00083551|Tubulin Modulators|tubulin modulators|mesh-ancestor
25477073|NCT00083551|Antimitotic Agents|antimitotic agents|mesh-ancestor
25477074|NCT00083551|Mitosis Modulators|mitosis modulators|mesh-ancestor
25477075|NCT00083551|Leprostatic Agents|leprostatic agents|mesh-ancestor
25477076|NCT00083551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25477077|NCT00083551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25477078|NCT00083551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25477079|NCT00083551|Growth Substances|growth substances|mesh-ancestor
25477080|NCT00083551|Growth Inhibitors|growth inhibitors|mesh-ancestor
25477081|NCT00083616|Panitumumab|panitumumab|mesh-list
25477082|NCT00083616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25477083|NCT00083616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477084|NCT00083720|Cetuximab|cetuximab|mesh-list
25477085|NCT00083720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25477086|NCT00083720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477087|NCT00083889|Interferons|interferons|mesh-list
25477088|NCT00083889|Interferon-alpha|interferon-alpha|mesh-list
25477089|NCT00083889|Sunitinib|sunitinib|mesh-list
25477090|NCT00083889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477091|NCT00083889|Antiviral Agents|antiviral agents|mesh-ancestor
25477092|NCT00083889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25477093|NCT00083889|Immunologic Factors|immunologic factors|mesh-ancestor
25477094|NCT00083889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477095|NCT00083889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25477096|NCT00083889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25477097|NCT00083889|Growth Substances|growth substances|mesh-ancestor
25477098|NCT00083889|Growth Inhibitors|growth inhibitors|mesh-ancestor
25477099|NCT00083889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25477100|NCT00083889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477101|NCT00083889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477102|NCT00084136|Tenofovir|tenofovir|mesh-list
25477103|NCT00084136|Lamivudine|lamivudine|mesh-list
25477104|NCT00084136|Zidovudine|zidovudine|mesh-list
25477105|NCT00084136|Emtricitabine|emtricitabine|mesh-list
25477106|NCT00084136|Efavirenz|efavirenz|mesh-list
25477107|NCT00084136|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25477108|NCT00084136|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25477109|NCT00084136|Didanosine|didanosine|mesh-list
25477110|NCT00084136|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25477111|NCT00084136|Antiviral Agents|antiviral agents|mesh-ancestor
25477112|NCT00084136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25477113|NCT00084136|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25477114|NCT00084136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25477115|NCT00084136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477116|NCT00084136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822941|NCT00004700|Mitogens|mitogens|mesh-list
25154574|NCT05470647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25477117|NCT00084136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25477118|NCT00084136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25477119|NCT00084136|Antimetabolites|antimetabolites|mesh-ancestor
25477120|NCT00084136|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25477121|NCT00084136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25477122|NCT00084136|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25477123|NCT00084136|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25477124|NCT00084136|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25477125|NCT00084136|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25477126|NCT00084136|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25477127|NCT00084136|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25477128|NCT00084136|Protease Inhibitors|protease inhibitors|mesh-ancestor
25477129|NCT00084149|Ritonavir|ritonavir|mesh-list
25477130|NCT00084149|Lopinavir|lopinavir|mesh-list
25477131|NCT00084149|Lamivudine|lamivudine|mesh-list
25477132|NCT00084149|Zidovudine|zidovudine|mesh-list
25477133|NCT00084149|Abacavir|abacavir|mesh-list
25477134|NCT00084149|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25477135|NCT00084149|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25477136|NCT00084149|Protease Inhibitors|protease inhibitors|mesh-ancestor
25477140|NCT00084149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25477141|NCT00084149|Antiviral Agents|antiviral agents|mesh-ancestor
25477142|NCT00084149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25477143|NCT00084149|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25477144|NCT00084149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25477145|NCT00084149|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25477146|NCT00084149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25477147|NCT00084149|Antimetabolites|antimetabolites|mesh-ancestor
25477148|NCT00084266|Vancomycin|vancomycin|mesh-list
25477149|NCT00084266|Linezolid|linezolid|mesh-list
25477150|NCT00084266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25477151|NCT00084266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25477152|NCT00084266|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25477153|NCT00084266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477154|NCT00084266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477155|NCT00084318|Cisplatin|cisplatin|mesh-list
25477156|NCT00084318|Docetaxel|docetaxel|mesh-list
25477157|NCT00084318|Cetuximab|cetuximab|mesh-list
25477158|NCT00084318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477159|NCT00084318|Tubulin Modulators|tubulin modulators|mesh-ancestor
25477160|NCT00084318|Antimitotic Agents|antimitotic agents|mesh-ancestor
25477161|NCT00084318|Mitosis Modulators|mitosis modulators|mesh-ancestor
25477162|NCT00084318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477163|NCT00084318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25477164|NCT00084409|Iloprost|iloprost|mesh-list
25477165|NCT00084409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25477166|NCT00084409|Vasodilator Agents|vasodilator agents|mesh-ancestor
25477167|NCT00084617|Capecitabine|capecitabine|mesh-list
25477168|NCT00084617|Oxaliplatin|oxaliplatin|mesh-list
25477169|NCT00084617|Irinotecan|irinotecan|mesh-list
25477170|NCT00084617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25477171|NCT00084617|Antimetabolites|antimetabolites|mesh-ancestor
25477172|NCT00084617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477173|NCT00084617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477174|NCT00084617|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25477175|NCT00084617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25477176|NCT00084617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477177|NCT00084682|Romidepsin|romidepsin|mesh-list
25477178|NCT00084682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25477179|NCT00084682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477180|NCT00084747|Bortezomib|bortezomib|mesh-list
25477181|NCT00084747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477182|NCT00084838|Calcium, Dietary|calcium, dietary|mesh-list
25477183|NCT00084838|Leucovorin|leucovorin|mesh-list
25477184|NCT00084838|Cytarabine|cytarabine|mesh-list
25477185|NCT00084838|Dactinomycin|dactinomycin|mesh-list
25477186|NCT00084838|Hydrocortisone|hydrocortisone|mesh-list
25477187|NCT00084838|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25477188|NCT00084838|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25477189|NCT00084838|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25477190|NCT00084838|Cyclophosphamide|cyclophosphamide|mesh-list
25477191|NCT00084838|Temozolomide|temozolomide|mesh-list
25477192|NCT00084838|Cisplatin|cisplatin|mesh-list
25477193|NCT00084838|Doxorubicin|doxorubicin|mesh-list
25477194|NCT00084838|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25477195|NCT00084838|Methotrexate|methotrexate|mesh-list
25477196|NCT00084838|Etoposide|etoposide|mesh-list
25477197|NCT00084838|Vincristine|vincristine|mesh-list
25477198|NCT00084838|Dexrazoxane|dexrazoxane|mesh-list
25477199|NCT00084838|Razoxane|razoxane|mesh-list
25477200|NCT00084838|Lenograstim|lenograstim|mesh-list
25477201|NCT00084838|Calcium|calcium|mesh-list
25477202|NCT00084838|Levoleucovorin|levoleucovorin|mesh-list
25477203|NCT00084838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25477204|NCT00084838|Immunologic Factors|immunologic factors|mesh-ancestor
25477205|NCT00084838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477206|NCT00084838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25477207|NCT00084838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25477208|NCT00084838|Alkylating Agents|alkylating agents|mesh-ancestor
25477209|NCT00084838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477210|NCT00084838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477211|NCT00084838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25822942|NCT00004700|Mitosis Modulators|mitosis modulators|mesh-ancestor
25644859|NCT01441414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477212|NCT00084838|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25477213|NCT00084838|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25477214|NCT00084838|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25477215|NCT00084838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477216|NCT00084838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25477217|NCT00084838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25477218|NCT00084838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25477219|NCT00084838|Abortifacient Agents|abortifacient agents|mesh-ancestor
25477220|NCT00084838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25477221|NCT00084838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25477222|NCT00084838|Antimetabolites|antimetabolites|mesh-ancestor
25477223|NCT00084838|Dermatologic Agents|dermatologic agents|mesh-ancestor
25477224|NCT00084838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25477225|NCT00084838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25477226|NCT00084838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25477227|NCT00084838|Antiviral Agents|antiviral agents|mesh-ancestor
25477228|NCT00084838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25477229|NCT00084838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25477230|NCT00084838|Antidotes|antidotes|mesh-ancestor
25477231|NCT00084838|Protective Agents|protective agents|mesh-ancestor
25477232|NCT00084838|Vitamin B Complex|vitamin b complex|mesh-ancestor
25477233|NCT00084838|Vitamins|vitamins|mesh-ancestor
25477234|NCT00084838|Micronutrients|micronutrients|mesh-ancestor
25477235|NCT00084838|Tubulin Modulators|tubulin modulators|mesh-ancestor
25477236|NCT00084838|Antimitotic Agents|antimitotic agents|mesh-ancestor
25477237|NCT00084838|Mitosis Modulators|mitosis modulators|mesh-ancestor
25477238|NCT00084838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25477239|NCT00084838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25477240|NCT00084838|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25477241|NCT00084838|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25477242|NCT00084864|Calcitriol|calcitriol|mesh-list
25477243|NCT00084864|Dexamethasone|dexamethasone|mesh-list
25477244|NCT00084864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25477245|NCT00084864|Antiemetics|antiemetics|mesh-ancestor
25477246|NCT00084864|Autonomic Agents|autonomic agents|mesh-ancestor
25477247|NCT00084864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25477248|NCT00084864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477249|NCT00084864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25477250|NCT00084864|Glucocorticoids|glucocorticoids|mesh-ancestor
25477251|NCT00084864|Hormones|hormones|mesh-ancestor
25477252|NCT00084864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25477253|NCT00084864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25477254|NCT00084864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477255|NCT00084864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25477256|NCT00084864|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24453463|NCT05008224|Mitosis Modulators|mitosis modulators|mesh-ancestor
24484406|NCT00448214|Warfarin|warfarin|mesh-list
25822943|NCT00004700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822944|NCT00004705|Amiloride|amiloride|mesh-list
25822945|NCT00004705|Diuretics|diuretics|mesh-ancestor
25822946|NCT00004705|Natriuretic Agents|natriuretic agents|mesh-ancestor
25477257|NCT00084864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25477258|NCT00084864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477259|NCT00084864|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25477260|NCT00084864|Vitamins|vitamins|mesh-ancestor
25477261|NCT00084864|Micronutrients|micronutrients|mesh-ancestor
25477262|NCT00084864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25477263|NCT00085098|Cyclophosphamide|cyclophosphamide|mesh-list
25477264|NCT00085098|Cisplatin|cisplatin|mesh-list
25477265|NCT00085098|Carboplatin|carboplatin|mesh-list
25477266|NCT00085098|Etoposide|etoposide|mesh-list
25477267|NCT00085098|Lenograstim|lenograstim|mesh-list
25477268|NCT00085098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25477269|NCT00085098|Immunologic Factors|immunologic factors|mesh-ancestor
25477270|NCT00085098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477271|NCT00085098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25477272|NCT00085098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25477273|NCT00085098|Alkylating Agents|alkylating agents|mesh-ancestor
25477274|NCT00085098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644860|NCT01441414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25644861|NCT01441414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25644862|NCT01441414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644863|NCT01441440|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25644864|NCT01441440|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25644865|NCT01441440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25822947|NCT00004705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644866|NCT01441440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25644867|NCT01441440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644868|NCT01441440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25644869|NCT01441440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644870|NCT01441440|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25644871|NCT01441440|Antidepressive Agents|antidepressive agents|mesh-ancestor
25822948|NCT00004705|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
25477275|NCT00085098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477276|NCT00085098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25477277|NCT00085098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25477278|NCT00085098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25477279|NCT00085098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25477280|NCT00085098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477281|NCT00085098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25477282|NCT00085254|Temozolomide|temozolomide|mesh-list
25477283|NCT00085254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25477284|NCT00085254|Alkylating Agents|alkylating agents|mesh-ancestor
25477285|NCT00085254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477286|NCT00085254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477287|NCT00085293|Decitabine|decitabine|mesh-list
25477288|NCT00085293|Azacitidine|azacitidine|mesh-list
25477289|NCT00085293|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25477290|NCT00085293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25477291|NCT00085293|Antimetabolites|antimetabolites|mesh-ancestor
25477292|NCT00085293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477293|NCT00085293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477294|NCT00085293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477295|NCT00085293|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25477296|NCT00085410|Bortezomib|bortezomib|mesh-list
25477297|NCT00085410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477298|NCT00085423|Aldesleukin|aldesleukin|mesh-list
25477299|NCT00085423|Cyclophosphamide|cyclophosphamide|mesh-list
25477300|NCT00085423|Fludarabine|fludarabine|mesh-list
25477301|NCT00085423|Fludarabine phosphate|fludarabine phosphate|mesh-list
25477302|NCT00085423|Interleukin-2|interleukin-2|mesh-list
25477303|NCT00085423|Molgramostim|molgramostim|mesh-list
25477304|NCT00085423|Sargramostim|sargramostim|mesh-list
25477305|NCT00085423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25477306|NCT00085423|Immunologic Factors|immunologic factors|mesh-ancestor
25477307|NCT00085423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477308|NCT00085423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25477309|NCT00085423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25477310|NCT00085423|Alkylating Agents|alkylating agents|mesh-ancestor
25477311|NCT00085423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477312|NCT00085423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477313|NCT00085423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25477314|NCT00085423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25477315|NCT00085423|Antimetabolites|antimetabolites|mesh-ancestor
25477316|NCT00085423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25477317|NCT00085423|Analgesics|analgesics|mesh-ancestor
25477318|NCT00085423|Sensory System Agents|sensory system agents|mesh-ancestor
25477319|NCT00085423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24749801|NCT00004935|Trastuzumab|trastuzumab|mesh-list
25822949|NCT00004705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24495815|NCT00502099|Interferon alpha-2|interferon alpha-2|mesh-list
24495816|NCT00502099|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24495817|NCT00502099|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24495818|NCT00502099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495880|NCT00502385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154746|NCT05469529|Analgesics|analgesics|mesh-ancestor
24847791|NCT05354076|Doxorubicin|doxorubicin|mesh-list
25477320|NCT00085423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25477321|NCT00085423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25477323|NCT00085423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25477324|NCT00085436|Interferons|interferons|mesh-list
25477325|NCT00085436|Interferon-alpha|interferon-alpha|mesh-list
25477326|NCT00085436|Interferon alpha-2|interferon alpha-2|mesh-list
25477327|NCT00085436|Aldesleukin|aldesleukin|mesh-list
25477328|NCT00085436|Vaccines|vaccines|mesh-list
25477329|NCT00085436|Immunologic Factors|immunologic factors|mesh-ancestor
25477330|NCT00085436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477331|NCT00085436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477332|NCT00085436|Antiviral Agents|antiviral agents|mesh-ancestor
24416688|NCT00203762|Antiviral Agents|antiviral agents|mesh-ancestor
25477334|NCT00085436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25477335|NCT00085436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25477336|NCT00085540|Romidepsin|romidepsin|mesh-list
25477337|NCT00085540|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25477338|NCT00085540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477339|NCT00085566|Everolimus|everolimus|mesh-list
25477340|NCT00085566|Gefitinib|gefitinib|mesh-list
25477341|NCT00085566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477342|NCT00085566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25477343|NCT00085566|Immunologic Factors|immunologic factors|mesh-ancestor
25477344|NCT00085566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477345|NCT00085566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25477346|NCT00085566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477347|NCT00085566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477348|NCT00085644|Adalimumab|adalimumab|mesh-list
25477349|NCT00085644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25477350|NCT00085644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25477351|NCT00085709|Cytarabine|cytarabine|mesh-list
25477352|NCT00085709|Daunorubicin|daunorubicin|mesh-list
25477353|NCT00085709|Gemtuzumab|gemtuzumab|mesh-list
25477354|NCT00085709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25477355|NCT00085709|Antimetabolites|antimetabolites|mesh-ancestor
25477356|NCT00085709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477357|NCT00085709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477358|NCT00085709|Antiviral Agents|antiviral agents|mesh-ancestor
25477359|NCT00085709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25477360|NCT00085709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25477361|NCT00085709|Immunologic Factors|immunologic factors|mesh-ancestor
25477362|NCT00085709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477363|NCT00085709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25477364|NCT00085709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25477365|NCT00085709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25477366|NCT00085709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477367|NCT00085709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25477368|NCT00085839|Paclitaxel|paclitaxel|mesh-list
25477369|NCT00085839|Carboplatin|carboplatin|mesh-list
25477370|NCT00085839|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25477371|NCT00085839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25477372|NCT00085839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477373|NCT00085839|Tubulin Modulators|tubulin modulators|mesh-ancestor
25477374|NCT00085839|Antimitotic Agents|antimitotic agents|mesh-ancestor
25477375|NCT00085839|Mitosis Modulators|mitosis modulators|mesh-ancestor
25477376|NCT00085839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477377|NCT00085839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25477378|NCT00085839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477379|NCT00085917|Interferons|interferons|mesh-list
25477380|NCT00085917|Ribavirin|ribavirin|mesh-list
25477381|NCT00085917|Interferon-alpha|interferon-alpha|mesh-list
25477382|NCT00085917|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25477383|NCT00085917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477384|NCT00085917|Antiviral Agents|antiviral agents|mesh-ancestor
25477385|NCT00085917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25477386|NCT00085917|Antimetabolites|antimetabolites|mesh-ancestor
25477387|NCT00085917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477388|NCT00085917|Immunologic Factors|immunologic factors|mesh-ancestor
25477389|NCT00085917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477390|NCT00086138|Sertraline|sertraline|mesh-list
25477391|NCT00086138|Antidepressive Agents|antidepressive agents|mesh-ancestor
25477392|NCT00086138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25477393|NCT00086138|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24847849|NCT05353205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24847850|NCT05353205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24847851|NCT05353205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477394|NCT00086138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25477395|NCT00086138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25477396|NCT00086138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477397|NCT00086138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25477398|NCT00086138|Serotonin Agents|serotonin agents|mesh-ancestor
25477399|NCT00086138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477400|NCT00086190|Paroxetine|paroxetine|mesh-list
25477401|NCT00086190|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25477402|NCT00086190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25477403|NCT00086190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25477404|NCT00086190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25477411|NCT00086190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25477412|NCT00086190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25477413|NCT00086190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25477414|NCT00086190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477415|NCT00086190|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25477416|NCT00086281|Zolpidem|zolpidem|mesh-list
25477417|NCT00086281|Modafinil|modafinil|mesh-list
25477418|NCT00086281|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25477419|NCT00086281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477420|NCT00086281|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25477421|NCT00086281|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25477422|NCT00086281|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25477423|NCT00086281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477424|NCT00086281|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25477425|NCT00086281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25477426|NCT00086281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25477427|NCT00086281|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25477428|NCT00086281|GABA Agonists|gaba agonists|mesh-ancestor
25477429|NCT00086281|GABA Agents|gaba agents|mesh-ancestor
25477430|NCT00086281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25477431|NCT00086307|Pramipexole|pramipexole|mesh-list
25477432|NCT00086307|Citalopram|citalopram|mesh-list
25477433|NCT00086307|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25477434|NCT00086307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25477435|NCT00086307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25477436|NCT00086307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477437|NCT00086307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25477438|NCT00086307|Serotonin Agents|serotonin agents|mesh-ancestor
25477439|NCT00086307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477440|NCT00086307|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25477441|NCT00086307|Antidepressive Agents|antidepressive agents|mesh-ancestor
25477442|NCT00086307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25477443|NCT00086307|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25477444|NCT00086307|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25477445|NCT00086307|Antioxidants|antioxidants|mesh-ancestor
25477446|NCT00086307|Protective Agents|protective agents|mesh-ancestor
25477447|NCT00086307|Dopamine Agonists|dopamine agonists|mesh-ancestor
25477448|NCT00086307|Dopamine Agents|dopamine agents|mesh-ancestor
25477449|NCT00086346|Cyclosporine|cyclosporine|mesh-list
25477450|NCT00086346|Sirolimus|sirolimus|mesh-list
25477451|NCT00086346|Tacrolimus|tacrolimus|mesh-list
25477452|NCT00086346|Cyclosporins|cyclosporins|mesh-list
25477453|NCT00086346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25477454|NCT00086346|Immunologic Factors|immunologic factors|mesh-ancestor
25477455|NCT00086346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477456|NCT00086346|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25477457|NCT00086346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477458|NCT00086346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154874|NCT05468840|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25154876|NCT05468840|Anesthetics, General|anesthetics, general|mesh-ancestor
25477483|NCT00086385|Dopamine Agents|dopamine agents|mesh-ancestor
25477484|NCT00086385|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25477485|NCT00086385|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25477486|NCT00086385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477487|NCT00086411|Bupropion|bupropion|mesh-list
25477488|NCT00086411|Nicotine|nicotine|mesh-list
25477489|NCT00086411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25477490|NCT00086411|Autonomic Agents|autonomic agents|mesh-ancestor
25477491|NCT00086411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25477492|NCT00086411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477493|NCT00086411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25477495|NCT00086411|Cholinergic Agents|cholinergic agents|mesh-ancestor
25477496|NCT00086411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25477497|NCT00086411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477498|NCT00086411|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25477499|NCT00086411|Antidepressive Agents|antidepressive agents|mesh-ancestor
25477500|NCT00086411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25477501|NCT00086411|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25477502|NCT00086411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25477503|NCT00086411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25477504|NCT00086411|Dopamine Agents|dopamine agents|mesh-ancestor
25477505|NCT00086411|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25477506|NCT00086411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25477507|NCT00086411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477508|NCT00086502|Metformin|metformin|mesh-list
25477509|NCT00086502|Pioglitazone|pioglitazone|mesh-list
25477510|NCT00086502|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25477511|NCT00086502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25477512|NCT00086502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477513|NCT00086502|Incretins|incretins|mesh-ancestor
25477514|NCT00086502|Hormones|hormones|mesh-ancestor
25477515|NCT00086502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25477516|NCT00086502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25477517|NCT00086502|Protease Inhibitors|protease inhibitors|mesh-ancestor
25477518|NCT00086502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477519|NCT00086502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477520|NCT00086515|Metformin|metformin|mesh-list
25477521|NCT00086515|Pioglitazone|pioglitazone|mesh-list
25477522|NCT00086515|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25477523|NCT00086515|Glipizide|glipizide|mesh-list
25477524|NCT00086515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25477525|NCT00086515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477526|NCT00086515|Incretins|incretins|mesh-ancestor
25477527|NCT00086515|Hormones|hormones|mesh-ancestor
25477528|NCT00086515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25477529|NCT00086515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25477530|NCT00086515|Protease Inhibitors|protease inhibitors|mesh-ancestor
25477531|NCT00086515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477532|NCT00086515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477533|NCT00086580|Vidarabine|vidarabine|mesh-list
25477534|NCT00086580|Fludarabine|fludarabine|mesh-list
25477535|NCT00086580|Fludarabine phosphate|fludarabine phosphate|mesh-list
25477536|NCT00086580|Alemtuzumab|alemtuzumab|mesh-list
25477537|NCT00086580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477538|NCT00086580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25477539|NCT00086580|Antimetabolites|antimetabolites|mesh-ancestor
25477540|NCT00086580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477541|NCT00086580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25477542|NCT00086580|Immunologic Factors|immunologic factors|mesh-ancestor
25477543|NCT00086580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477544|NCT00086580|Antiviral Agents|antiviral agents|mesh-ancestor
25477545|NCT00086580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25477546|NCT00086580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25477547|NCT00086619|Parathyroid Hormone|parathyroid hormone|mesh-list
25477548|NCT00086619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477549|NCT00086619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25477550|NCT00086684|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
25477551|NCT00086684|Anticoagulants|anticoagulants|mesh-ancestor
25477552|NCT00086957|Docetaxel|docetaxel|mesh-list
25477553|NCT00086957|Trastuzumab|trastuzumab|mesh-list
25477554|NCT00086957|Gefitinib|gefitinib|mesh-list
25477555|NCT00086957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477556|NCT00086957|Tubulin Modulators|tubulin modulators|mesh-ancestor
25477557|NCT00086957|Antimitotic Agents|antimitotic agents|mesh-ancestor
25477558|NCT00086957|Mitosis Modulators|mitosis modulators|mesh-ancestor
25477559|NCT00086957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477560|NCT00086957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25477561|NCT00086957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25477562|NCT00086957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477563|NCT00086996|Fluorouracil|fluorouracil|mesh-list
25477564|NCT00086996|Oxaliplatin|oxaliplatin|mesh-list
25477565|NCT00086996|Antimetabolites|antimetabolites|mesh-ancestor
25477566|NCT00086996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644872|NCT01441440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25477568|NCT00086996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477569|NCT00086996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25477570|NCT00086996|Immunologic Factors|immunologic factors|mesh-ancestor
25477571|NCT00086996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477572|NCT00087126|Topotecan|topotecan|mesh-list
25477573|NCT00087126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25477574|NCT00087126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25477575|NCT00087126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477576|NCT00087126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477577|NCT00087126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477578|NCT00087139|Epothilones|epothilones|mesh-list
25477579|NCT00087139|Epothilone B|epothilone b|mesh-list
25477580|NCT00087139|Tubulin Modulators|tubulin modulators|mesh-ancestor
24532175|NCT00638326|Purinergic Agents|purinergic agents|mesh-ancestor
24532198|NCT00638534|Telithromycin|telithromycin|mesh-list
25477581|NCT00087139|Antimitotic Agents|antimitotic agents|mesh-ancestor
25477582|NCT00087139|Mitosis Modulators|mitosis modulators|mesh-ancestor
25477583|NCT00087139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477584|NCT00087139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477585|NCT00087152|Capecitabine|capecitabine|mesh-list
25477586|NCT00087152|Imatinib Mesylate|imatinib mesylate|mesh-list
25477587|NCT00087152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25477588|NCT00087152|Antimetabolites|antimetabolites|mesh-ancestor
25477589|NCT00087152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477590|NCT00087152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477591|NCT00087152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25477592|NCT00087152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477593|NCT00087490|Vancomycin|vancomycin|mesh-list
25477594|NCT00087490|Linezolid|linezolid|mesh-list
25477595|NCT00087490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25477596|NCT00087490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25477597|NCT00087490|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25477598|NCT00087490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477599|NCT00087490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477600|NCT00087516|Metformin|metformin|mesh-list
25477601|NCT00087516|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25477602|NCT00087516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25477603|NCT00087516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477604|NCT00087516|Incretins|incretins|mesh-ancestor
25477605|NCT00087516|Hormones|hormones|mesh-ancestor
25477606|NCT00087516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25477607|NCT00087516|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25477608|NCT00087516|Protease Inhibitors|protease inhibitors|mesh-ancestor
25477609|NCT00087516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477610|NCT00087516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477611|NCT00087529|Rituximab|rituximab|mesh-list
25477612|NCT00087529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25477613|NCT00087529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477614|NCT00087529|Immunologic Factors|immunologic factors|mesh-ancestor
25477615|NCT00087529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477616|NCT00087529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25477617|NCT00087555|Sodium Oxybate|sodium oxybate|mesh-list
25477618|NCT00087555|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25477619|NCT00087555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25477620|NCT00087555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25477621|NCT00087555|Anesthetics, General|anesthetics, general|mesh-ancestor
25477622|NCT00087555|Anesthetics|anesthetics|mesh-ancestor
25477623|NCT00087555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25477624|NCT00087555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477625|NCT00087568|Ribavirin|ribavirin|mesh-list
25477626|NCT00087568|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25477627|NCT00087568|Antimetabolites|antimetabolites|mesh-ancestor
25477628|NCT00087568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477629|NCT00087568|Antiviral Agents|antiviral agents|mesh-ancestor
25477630|NCT00087568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25477631|NCT00087594|Ribavirin|ribavirin|mesh-list
25477632|NCT00087594|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25477633|NCT00087594|Antimetabolites|antimetabolites|mesh-ancestor
25477634|NCT00087594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477635|NCT00087594|Antiviral Agents|antiviral agents|mesh-ancestor
25477636|NCT00087594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25477637|NCT00087607|Ribavirin|ribavirin|mesh-list
25477638|NCT00087607|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25477639|NCT00087607|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25477641|NCT00087607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477642|NCT00087607|Antiviral Agents|antiviral agents|mesh-ancestor
25477643|NCT00087607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25477644|NCT00087633|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25477645|NCT00087633|Antiviral Agents|antiviral agents|mesh-ancestor
25477646|NCT00087633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25477647|NCT00087646|Ribavirin|ribavirin|mesh-list
25477648|NCT00087646|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25477649|NCT00087646|Interferon-alpha|interferon-alpha|mesh-list
25477650|NCT00087646|Antimetabolites|antimetabolites|mesh-ancestor
25477651|NCT00087646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477652|NCT00087646|Antiviral Agents|antiviral agents|mesh-ancestor
25477653|NCT00087646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25477654|NCT00087646|Immunologic Factors|immunologic factors|mesh-ancestor
25477655|NCT00087646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477656|NCT00087672|Lenalidomide|lenalidomide|mesh-list
25477657|NCT00087672|Immunologic Factors|immunologic factors|mesh-ancestor
25477658|NCT00087672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477659|NCT00087672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25477660|NCT00087672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25477661|NCT00087672|Growth Substances|growth substances|mesh-ancestor
25477662|NCT00087672|Growth Inhibitors|growth inhibitors|mesh-ancestor
25477663|NCT00087672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477664|NCT00087685|Everolimus|everolimus|mesh-list
25477665|NCT00087685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477666|NCT00087685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25477667|NCT00087685|Immunologic Factors|immunologic factors|mesh-ancestor
25477668|NCT00087685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477669|NCT00087698|Cisplatin|cisplatin|mesh-list
25477670|NCT00087698|Pemetrexed|pemetrexed|mesh-list
25477671|NCT00087698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477672|NCT00087698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477673|NCT00087698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477674|NCT00087698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25477675|NCT00087698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25477676|NCT00088153|Progesterone|progesterone|mesh-list
25477677|NCT00088153|Estrogens|estrogens|mesh-list
25477678|NCT00088153|Progestins|progestins|mesh-ancestor
25477679|NCT00088153|Hormones|hormones|mesh-ancestor
25477680|NCT00088153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25477681|NCT00088153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477682|NCT00088166|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
25477683|NCT00088166|Hormones|hormones|mesh-ancestor
25477684|NCT00088166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25477685|NCT00088166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477686|NCT00088218|Cytarabine|cytarabine|mesh-list
25477687|NCT00088218|Clofarabine|clofarabine|mesh-list
25477688|NCT00088218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25477689|NCT00088218|Antimetabolites|antimetabolites|mesh-ancestor
25477690|NCT00088218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477691|NCT00088218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477692|NCT00088218|Antiviral Agents|antiviral agents|mesh-ancestor
25477693|NCT00088218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25477694|NCT00088218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25477695|NCT00088218|Immunologic Factors|immunologic factors|mesh-ancestor
25477696|NCT00088218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477697|NCT00088374|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25477698|NCT00088374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25477699|NCT00088374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477700|NCT00088413|Molgramostim|molgramostim|mesh-list
25477701|NCT00088413|Sargramostim|sargramostim|mesh-list
25477702|NCT00088413|Immunologic Factors|immunologic factors|mesh-ancestor
25477703|NCT00088413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477704|NCT00088413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477705|NCT00088452|Lamotrigine|lamotrigine|mesh-list
25477706|NCT00088452|Valproic Acid|valproic acid|mesh-list
25477707|NCT00088452|Ethosuximide|ethosuximide|mesh-list
25477708|NCT00088452|Anticonvulsants|anticonvulsants|mesh-ancestor
25477709|NCT00088452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25477710|NCT00088452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25477711|NCT00088452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477712|NCT00088452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25477713|NCT00088452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477714|NCT00088452|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25477715|NCT00088452|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25477716|NCT00088452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25477717|NCT00088452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25477718|NCT00088452|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25477719|NCT00088452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477720|NCT00088452|GABA Agents|gaba agents|mesh-ancestor
25477721|NCT00088452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25477722|NCT00088452|Antimanic Agents|antimanic agents|mesh-ancestor
25477723|NCT00088465|Olanzapine|olanzapine|mesh-list
25477724|NCT00088465|Antiemetics|antiemetics|mesh-ancestor
25477725|NCT00088465|Autonomic Agents|autonomic agents|mesh-ancestor
25477726|NCT00088465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25477727|NCT00088465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477728|NCT00088465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25477729|NCT00088465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25477730|NCT00088465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25005616|NCT03156816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25477731|NCT00088465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25477732|NCT00088465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25477733|NCT00088465|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25477734|NCT00088465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25477735|NCT00088465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25477736|NCT00088465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477737|NCT00088465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25477738|NCT00088465|Serotonin Agents|serotonin agents|mesh-ancestor
25477739|NCT00088530|Gemcitabine|gemcitabine|mesh-list
25477740|NCT00088530|Prednisone|prednisone|mesh-list
25477741|NCT00088530|Cyclophosphamide|cyclophosphamide|mesh-list
25477742|NCT00088530|Rituximab|rituximab|mesh-list
25477743|NCT00088530|Etoposide|etoposide|mesh-list
25477744|NCT00088530|Vincristine|vincristine|mesh-list
25477745|NCT00088530|Vinorelbine|vinorelbine|mesh-list
25477746|NCT00088530|Pixantrone|pixantrone|mesh-list
25477747|NCT00088530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25477748|NCT00088530|Immunologic Factors|immunologic factors|mesh-ancestor
25477749|NCT00088530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477750|NCT00088530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25477751|NCT00088530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25477752|NCT00088530|Alkylating Agents|alkylating agents|mesh-ancestor
25477753|NCT00088530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477754|NCT00088530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477755|NCT00088530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25477756|NCT00088530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25477757|NCT00088530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25477758|NCT00088530|Antimetabolites|antimetabolites|mesh-ancestor
25477759|NCT00088530|Antiviral Agents|antiviral agents|mesh-ancestor
25477760|NCT00088530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25477761|NCT00088530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477762|NCT00088530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25477763|NCT00088530|Glucocorticoids|glucocorticoids|mesh-ancestor
25477764|NCT00088530|Hormones|hormones|mesh-ancestor
25477765|NCT00088530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25477766|NCT00088530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25477767|NCT00088530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25477768|NCT00088530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25477769|NCT00088530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25477770|NCT00088530|Tubulin Modulators|tubulin modulators|mesh-ancestor
25477771|NCT00088530|Antimitotic Agents|antimitotic agents|mesh-ancestor
25477772|NCT00088530|Mitosis Modulators|mitosis modulators|mesh-ancestor
25477773|NCT00088595|Pasireotide|pasireotide|mesh-list
25477774|NCT00088595|Hormones|hormones|mesh-ancestor
25477775|NCT00088595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25477776|NCT00088595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477777|NCT00088621|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25477778|NCT00088621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25477779|NCT00088621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25477780|NCT00088621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25477781|NCT00088621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477782|NCT00088621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25477783|NCT00088621|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25477784|NCT00088621|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25477785|NCT00088621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25477786|NCT00088621|Adrenergic Agents|adrenergic agents|mesh-ancestor
25477787|NCT00088621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24822953|NCT02114463|Anesthetics|anesthetics|mesh-ancestor
25644873|NCT01441570|Metoprolol|metoprolol|mesh-list
25477788|NCT00088621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477789|NCT00088621|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25477790|NCT00088621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25477791|NCT00088621|Serotonin Agents|serotonin agents|mesh-ancestor
25477792|NCT00088621|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25477793|NCT00088621|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25477794|NCT00088621|Dopamine Agents|dopamine agents|mesh-ancestor
25477795|NCT00088634|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25477796|NCT00088634|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25477797|NCT00088634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25477798|NCT00088634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25477799|NCT00088634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477800|NCT00088634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25477801|NCT00088634|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25237402|NCT02550717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237405|NCT02550717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477802|NCT00088634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25477803|NCT00088634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25477804|NCT00088634|Adrenergic Agents|adrenergic agents|mesh-ancestor
25477805|NCT00088634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25477806|NCT00088634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477807|NCT00088634|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25477808|NCT00088634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25477809|NCT00088634|Serotonin Agents|serotonin agents|mesh-ancestor
25477810|NCT00088634|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25477811|NCT00088634|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25477812|NCT00088634|Dopamine Agents|dopamine agents|mesh-ancestor
25477813|NCT00088699|Ketamine|ketamine|mesh-list
25477814|NCT00088699|Analgesics|analgesics|mesh-ancestor
25477815|NCT00088699|Sensory System Agents|sensory system agents|mesh-ancestor
25477816|NCT00088699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25477817|NCT00088699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477818|NCT00088699|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25477819|NCT00088699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25477820|NCT00088699|Anesthetics, General|anesthetics, general|mesh-ancestor
25477821|NCT00088699|Anesthetics|anesthetics|mesh-ancestor
25477822|NCT00088699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25477823|NCT00088699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25477824|NCT00088699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25477825|NCT00088699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25477826|NCT00088699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477827|NCT00088881|Prednisone|prednisone|mesh-list
25477828|NCT00088881|Cyclophosphamide|cyclophosphamide|mesh-list
25477829|NCT00088881|Rituximab|rituximab|mesh-list
25477830|NCT00088881|Doxorubicin|doxorubicin|mesh-list
25477831|NCT00088881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25477832|NCT00088881|Vincristine|vincristine|mesh-list
25477833|NCT00088881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25477834|NCT00088881|Immunologic Factors|immunologic factors|mesh-ancestor
25477835|NCT00088881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477836|NCT00088881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25477837|NCT00088881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25477838|NCT00088881|Alkylating Agents|alkylating agents|mesh-ancestor
25477839|NCT00088881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477840|NCT00088881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477841|NCT00088881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25477842|NCT00088881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25477843|NCT00088881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25477844|NCT00088881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25477845|NCT00088881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25477846|NCT00088881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477847|NCT00088881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25477848|NCT00088881|Glucocorticoids|glucocorticoids|mesh-ancestor
25477849|NCT00088881|Hormones|hormones|mesh-ancestor
25477850|NCT00088881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25477851|NCT00088881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25477852|NCT00088881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25477853|NCT00088881|Tubulin Modulators|tubulin modulators|mesh-ancestor
25477854|NCT00088881|Antimitotic Agents|antimitotic agents|mesh-ancestor
25477855|NCT00088881|Mitosis Modulators|mitosis modulators|mesh-ancestor
25477856|NCT00088907|Docetaxel|docetaxel|mesh-list
25477857|NCT00088907|Gefitinib|gefitinib|mesh-list
25477858|NCT00088907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477859|NCT00088907|Tubulin Modulators|tubulin modulators|mesh-ancestor
25477860|NCT00088907|Antimitotic Agents|antimitotic agents|mesh-ancestor
25477861|NCT00088907|Mitosis Modulators|mitosis modulators|mesh-ancestor
25477862|NCT00088907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477863|NCT00088907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25477864|NCT00088907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477865|NCT00088985|Trastuzumab|trastuzumab|mesh-list
25477866|NCT00088985|Vinorelbine|vinorelbine|mesh-list
25477867|NCT00088985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25477868|NCT00088985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477869|NCT00088985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25477870|NCT00088985|Tubulin Modulators|tubulin modulators|mesh-ancestor
25477871|NCT00088985|Antimitotic Agents|antimitotic agents|mesh-ancestor
25477872|NCT00088985|Mitosis Modulators|mitosis modulators|mesh-ancestor
24848710|NCT03637972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24848711|NCT03637972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848712|NCT03637972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25154934|NCT05468489|Atezolizumab|atezolizumab|mesh-list
25477873|NCT00088985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477874|NCT00089011|Mycophenolic Acid|mycophenolic acid|mesh-list
25477875|NCT00089011|Fludarabine|fludarabine|mesh-list
25477876|NCT00089011|Fludarabine phosphate|fludarabine phosphate|mesh-list
25477877|NCT00089011|Tacrolimus|tacrolimus|mesh-list
25477878|NCT00089011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477879|NCT00089011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25477880|NCT00089011|Antimetabolites|antimetabolites|mesh-ancestor
25477881|NCT00089011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477882|NCT00089011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25477883|NCT00089011|Immunologic Factors|immunologic factors|mesh-ancestor
25477884|NCT00089011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477885|NCT00089011|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25477886|NCT00089011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477887|NCT00089011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25477888|NCT00089011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25477889|NCT00089011|Antitubercular Agents|antitubercular agents|mesh-ancestor
25477890|NCT00089011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25477891|NCT00089011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25477892|NCT00089024|Leucovorin|leucovorin|mesh-list
25477893|NCT00089024|Gemcitabine|gemcitabine|mesh-list
25477894|NCT00089024|Fluorouracil|fluorouracil|mesh-list
25477895|NCT00089024|Oxaliplatin|oxaliplatin|mesh-list
25477896|NCT00089024|Calcium|calcium|mesh-list
25477897|NCT00089024|Levoleucovorin|levoleucovorin|mesh-list
25477898|NCT00089024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25477899|NCT00089024|Antimetabolites|antimetabolites|mesh-ancestor
25477900|NCT00089024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477901|NCT00089024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477902|NCT00089024|Antiviral Agents|antiviral agents|mesh-ancestor
25477903|NCT00089024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25477904|NCT00089024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477905|NCT00089024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25477906|NCT00089024|Immunologic Factors|immunologic factors|mesh-ancestor
25477907|NCT00089024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477908|NCT00089024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25477909|NCT00089024|Antidotes|antidotes|mesh-ancestor
25477910|NCT00089024|Protective Agents|protective agents|mesh-ancestor
25477911|NCT00089024|Vitamin B Complex|vitamin b complex|mesh-ancestor
25477912|NCT00089024|Vitamins|vitamins|mesh-ancestor
25477913|NCT00089024|Micronutrients|micronutrients|mesh-ancestor
25477914|NCT00089076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25477915|NCT00089076|Ipilimumab|ipilimumab|mesh-list
25477916|NCT00089076|Antibodies|antibodies|mesh-list
25477917|NCT00089076|Immunoglobulins|immunoglobulins|mesh-list
25477918|NCT00089076|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25477919|NCT00089076|Immunologic Factors|immunologic factors|mesh-ancestor
25477920|NCT00089076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477921|NCT00089076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477922|NCT00089076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25477923|NCT00089076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477924|NCT00089102|Gemcitabine|gemcitabine|mesh-list
25477925|NCT00089102|Irinotecan|irinotecan|mesh-list
25477926|NCT00089102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25477927|NCT00089102|Antimetabolites|antimetabolites|mesh-ancestor
25477928|NCT00089102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477929|NCT00089102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477930|NCT00089102|Antiviral Agents|antiviral agents|mesh-ancestor
25477931|NCT00089102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25477932|NCT00089102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477937|NCT00089102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25477938|NCT00089284|Rituximab|rituximab|mesh-list
25477939|NCT00089284|Motexafin gadolinium|motexafin gadolinium|mesh-list
25477940|NCT00089284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24453977|NCT04602377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708971|NCT01503593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24708972|NCT01503593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708973|NCT01503658|Aspirin|aspirin|mesh-list
24708974|NCT01503658|Clopidogrel|clopidogrel|mesh-list
25477941|NCT00089284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477942|NCT00089284|Immunologic Factors|immunologic factors|mesh-ancestor
25477943|NCT00089284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25477944|NCT00089284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25477945|NCT00089284|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25477946|NCT00089284|Dermatologic Agents|dermatologic agents|mesh-ancestor
25477947|NCT00089297|Paclitaxel|paclitaxel|mesh-list
25477948|NCT00089297|Carboplatin|carboplatin|mesh-list
25477949|NCT00089297|Cetuximab|cetuximab|mesh-list
25477950|NCT00089297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25477951|NCT00089297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477952|NCT00089297|Tubulin Modulators|tubulin modulators|mesh-ancestor
25477953|NCT00089297|Antimitotic Agents|antimitotic agents|mesh-ancestor
25477954|NCT00089297|Mitosis Modulators|mitosis modulators|mesh-ancestor
25477955|NCT00089297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477956|NCT00089297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25477957|NCT00089479|Capecitabine|capecitabine|mesh-list
25477958|NCT00089479|Docetaxel|docetaxel|mesh-list
25477959|NCT00089479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25477960|NCT00089479|Antimetabolites|antimetabolites|mesh-ancestor
25477961|NCT00089479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477962|NCT00089479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477963|NCT00089479|Tubulin Modulators|tubulin modulators|mesh-ancestor
25477964|NCT00089479|Antimitotic Agents|antimitotic agents|mesh-ancestor
25477965|NCT00089479|Mitosis Modulators|mitosis modulators|mesh-ancestor
25477966|NCT00089505|Ritonavir|ritonavir|mesh-list
25477967|NCT00089505|Lopinavir|lopinavir|mesh-list
25477968|NCT00089505|Tenofovir|tenofovir|mesh-list
25477969|NCT00089505|Emtricitabine|emtricitabine|mesh-list
25477970|NCT00089505|Nevirapine|nevirapine|mesh-list
25477971|NCT00089505|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25477972|NCT00089505|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25477973|NCT00089505|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25477974|NCT00089505|Protease Inhibitors|protease inhibitors|mesh-ancestor
25477975|NCT00089505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25477976|NCT00089505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25477977|NCT00089505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25477978|NCT00089505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25477979|NCT00089505|Antiviral Agents|antiviral agents|mesh-ancestor
25477980|NCT00089505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25477981|NCT00089505|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25477982|NCT00089505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25477983|NCT00089505|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25477984|NCT00089505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25477985|NCT00089505|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25477986|NCT00089505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25477987|NCT00089544|Thalidomide|thalidomide|mesh-list
25477988|NCT00089544|Doxorubicin|doxorubicin|mesh-list
25477989|NCT00089544|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25477990|NCT00089544|Ifosfamide|ifosfamide|mesh-list
25477991|NCT00089544|Isophosphamide mustard|isophosphamide mustard|mesh-list
25477992|NCT00089544|Dacarbazine|dacarbazine|mesh-list
25477993|NCT00089544|Imidazole|imidazole|mesh-list
25477994|NCT00089544|Lenograstim|lenograstim|mesh-list
25644874|NCT01441570|Nebivolol|nebivolol|mesh-list
25477995|NCT00089544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25477996|NCT00089544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25477997|NCT00089544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25477998|NCT00089544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25477999|NCT00089544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478000|NCT00089544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478001|NCT00089544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25478002|NCT00089544|Immunologic Factors|immunologic factors|mesh-ancestor
25478003|NCT00089544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478004|NCT00089544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25478005|NCT00089544|Alkylating Agents|alkylating agents|mesh-ancestor
25478006|NCT00089544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25478007|NCT00089544|Leprostatic Agents|leprostatic agents|mesh-ancestor
25478008|NCT00089544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25478009|NCT00089544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25478010|NCT00089544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25478011|NCT00089544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25478012|NCT00089544|Growth Substances|growth substances|mesh-ancestor
25478013|NCT00089544|Growth Inhibitors|growth inhibitors|mesh-ancestor
25478015|NCT00089583|Fosamprenavir|fosamprenavir|mesh-list
25478016|NCT00089583|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25478017|NCT00089583|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25478018|NCT00089583|Protease Inhibitors|protease inhibitors|mesh-ancestor
25478019|NCT00089583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478020|NCT00089583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478021|NCT00089583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25478022|NCT00089583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25478023|NCT00089583|Antiviral Agents|antiviral agents|mesh-ancestor
25478024|NCT00089583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25478025|NCT00089583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25478026|NCT00089583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25478027|NCT00089609|Thalidomide|thalidomide|mesh-list
25478028|NCT00089609|Prednisone|prednisone|mesh-list
25478029|NCT00089609|Bevacizumab|bevacizumab|mesh-list
25478030|NCT00089609|Docetaxel|docetaxel|mesh-list
25478031|NCT00089609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25478032|NCT00089609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478033|NCT00089609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25478034|NCT00089609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25478035|NCT00089609|Growth Substances|growth substances|mesh-ancestor
25478036|NCT00089609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478037|NCT00089609|Growth Inhibitors|growth inhibitors|mesh-ancestor
25478038|NCT00089609|Tubulin Modulators|tubulin modulators|mesh-ancestor
25478039|NCT00089609|Antimitotic Agents|antimitotic agents|mesh-ancestor
25478040|NCT00089609|Mitosis Modulators|mitosis modulators|mesh-ancestor
25478041|NCT00089609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478042|NCT00089609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25478043|NCT00089609|Glucocorticoids|glucocorticoids|mesh-ancestor
25478044|NCT00089609|Hormones|hormones|mesh-ancestor
25478045|NCT00089609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25478046|NCT00089609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25478047|NCT00089609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25478048|NCT00089609|Immunologic Factors|immunologic factors|mesh-ancestor
25478049|NCT00089609|Leprostatic Agents|leprostatic agents|mesh-ancestor
25478050|NCT00089609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25478051|NCT00089609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25478052|NCT00089635|Panitumumab|panitumumab|mesh-list
25478053|NCT00089635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25478054|NCT00089635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478055|NCT00089648|Sunitinib|sunitinib|mesh-list
25478056|NCT00089648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478057|NCT00089648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25478058|NCT00089648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25478059|NCT00089648|Growth Substances|growth substances|mesh-ancestor
25478060|NCT00089648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478061|NCT00089648|Growth Inhibitors|growth inhibitors|mesh-ancestor
25478062|NCT00089648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25478063|NCT00089648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478064|NCT00089648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478065|NCT00089661|Denosumab|denosumab|mesh-list
25478066|NCT00089661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25478067|NCT00089661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478068|NCT00089674|Denosumab|denosumab|mesh-list
25478069|NCT00089674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25478070|NCT00089674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478071|NCT00089778|Aldesleukin|aldesleukin|mesh-list
25478072|NCT00089778|Interleukin-2|interleukin-2|mesh-list
25478073|NCT00089778|Mitogens|mitogens|mesh-list
25478074|NCT00089778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25644875|NCT01441570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25478075|NCT00089778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25478077|NCT00089778|Sensory System Agents|sensory system agents|mesh-ancestor
25478078|NCT00089778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25478079|NCT00089778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478080|NCT00089778|Mitosis Modulators|mitosis modulators|mesh-ancestor
25478081|NCT00089778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478082|NCT00089778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25478083|NCT00089778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25478084|NCT00089778|Antiviral Agents|antiviral agents|mesh-ancestor
25478085|NCT00089778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25478086|NCT00089843|Risedronic Acid|risedronic acid|mesh-list
25478087|NCT00089843|Etidronic Acid|etidronic acid|mesh-list
25478088|NCT00089843|Methyltestosterone|methyltestosterone|mesh-list
25478089|NCT00089843|Testosterone|testosterone|mesh-list
25478090|NCT00089843|Testosterone undecanoate|testosterone undecanoate|mesh-list
24711109|NCT01513603|Cladribine|cladribine|mesh-list
24711110|NCT01513603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24711111|NCT01513603|Antimetabolites|antimetabolites|mesh-ancestor
25478091|NCT00089843|Testosterone enanthate|testosterone enanthate|mesh-list
25478092|NCT00089843|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25478094|NCT00089843|Hormones|hormones|mesh-ancestor
25478095|NCT00089843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25478096|NCT00089843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478097|NCT00089843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25478098|NCT00089843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478099|NCT00089843|Anabolic Agents|anabolic agents|mesh-ancestor
25478100|NCT00089843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25478101|NCT00089843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25478102|NCT00089843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478103|NCT00089843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25478104|NCT00089843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25478105|NCT00089999|Lapatinib|lapatinib|mesh-list
25478106|NCT00089999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478107|NCT00089999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25478108|NCT00089999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478109|NCT00089999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478110|NCT00090051|Cyclophosphamide|cyclophosphamide|mesh-list
25478111|NCT00090051|Rituximab|rituximab|mesh-list
25478112|NCT00090051|Fludarabine|fludarabine|mesh-list
25478113|NCT00090051|Fludarabine phosphate|fludarabine phosphate|mesh-list
25478114|NCT00090051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25478115|NCT00090051|Immunologic Factors|immunologic factors|mesh-ancestor
25478116|NCT00090051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478117|NCT00090051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25478118|NCT00090051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25478119|NCT00090051|Alkylating Agents|alkylating agents|mesh-ancestor
25478120|NCT00090051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478121|NCT00090051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478122|NCT00090051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25478123|NCT00090051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25478124|NCT00090051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25478125|NCT00090051|Antimetabolites|antimetabolites|mesh-ancestor
25478126|NCT00090103|Tamsulosin|tamsulosin|mesh-list
25478127|NCT00090103|Dutasteride|dutasteride|mesh-list
25478128|NCT00090103|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25478129|NCT00090103|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25478130|NCT00090103|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25478131|NCT00090103|Adrenergic Agents|adrenergic agents|mesh-ancestor
25478132|NCT00090103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25478133|NCT00090103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478134|NCT00090103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478135|NCT00090103|Urological Agents|urological agents|mesh-ancestor
25478136|NCT00090103|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25478137|NCT00090103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25478138|NCT00090103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478139|NCT00090103|Hormone Antagonists|hormone antagonists|mesh-ancestor
25478140|NCT00090103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25478141|NCT00090402|Thioctic Acid|thioctic acid|mesh-list
25478142|NCT00090402|Antioxidants|antioxidants|mesh-ancestor
25478143|NCT00090402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478144|NCT00090402|Protective Agents|protective agents|mesh-ancestor
25478153|NCT00090545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066923|NCT03449173|Sunitinib|sunitinib|mesh-list
25822950|NCT00004705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25478154|NCT00090545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25478155|NCT00090545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478156|NCT00090545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478157|NCT00090584|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25478158|NCT00090584|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25478159|NCT00090584|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25478160|NCT00090584|Cholinergic Agents|cholinergic agents|mesh-ancestor
25478161|NCT00090584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25478162|NCT00090584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478163|NCT00090584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478164|NCT00090584|Urological Agents|urological agents|mesh-ancestor
25478165|NCT00090610|Carboplatin|carboplatin|mesh-list
25478166|NCT00090610|Docetaxel|docetaxel|mesh-list
25478167|NCT00090610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478168|NCT00090610|Tubulin Modulators|tubulin modulators|mesh-ancestor
25478169|NCT00090610|Antimitotic Agents|antimitotic agents|mesh-ancestor
25478170|NCT00090610|Mitosis Modulators|mitosis modulators|mesh-ancestor
25478171|NCT00090610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478172|NCT00090753|Epoetin Alfa|epoetin alfa|mesh-list
25478173|NCT00090753|Darbepoetin alfa|darbepoetin alfa|mesh-list
25478174|NCT00090753|Hematinics|hematinics|mesh-ancestor
25478175|NCT00090766|Valganciclovir|valganciclovir|mesh-list
25478176|NCT00090766|Antiviral Agents|antiviral agents|mesh-ancestor
25478177|NCT00090766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25478178|NCT00090779|Ritonavir|ritonavir|mesh-list
25478179|NCT00090779|Lopinavir|lopinavir|mesh-list
25478180|NCT00090779|Tenofovir|tenofovir|mesh-list
25478181|NCT00090779|Emtricitabine|emtricitabine|mesh-list
25478182|NCT00090779|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25478183|NCT00090779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25478184|NCT00090779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25478185|NCT00090779|Protease Inhibitors|protease inhibitors|mesh-ancestor
25478186|NCT00090779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478187|NCT00090779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478188|NCT00090779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25478189|NCT00090779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25478190|NCT00090779|Antiviral Agents|antiviral agents|mesh-ancestor
25478191|NCT00090779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25478192|NCT00090779|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25478193|NCT00090779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25478194|NCT00090779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25478195|NCT00090779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25478196|NCT00090844|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25478197|NCT00090844|Luteolytic Agents|luteolytic agents|mesh-ancestor
25478198|NCT00090844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25478199|NCT00090844|Contraceptive Agents|contraceptive agents|mesh-ancestor
25478200|NCT00090844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25478201|NCT00090844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478202|NCT00090844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25478203|NCT00090844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25478204|NCT00090844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478205|NCT00090857|Letrozole|letrozole|mesh-list
25478206|NCT00090857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478207|NCT00090857|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25478208|NCT00090857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25478209|NCT00090857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478210|NCT00090857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478211|NCT00090857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25478212|NCT00090857|Hormone Antagonists|hormone antagonists|mesh-ancestor
25478213|NCT00090857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25478214|NCT00090857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478215|NCT00090987|Imatinib Mesylate|imatinib mesylate|mesh-list
25478216|NCT00090987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478217|NCT00090987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25478218|NCT00090987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478219|NCT00090987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478220|NCT00091026|Gemcitabine|gemcitabine|mesh-list
25478221|NCT00091026|Bevacizumab|bevacizumab|mesh-list
25478222|NCT00091026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25478223|NCT00091026|Cetuximab|cetuximab|mesh-list
25006008|NCT05206721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25006009|NCT05206721|Disinfectants|disinfectants|mesh-ancestor
25006010|NCT05206682|Goserelin|goserelin|mesh-list
25006024|NCT05206448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25478224|NCT00091026|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25478225|NCT00091026|Antibodies|antibodies|mesh-list
25478226|NCT00091026|Immunoglobulins|immunoglobulins|mesh-list
25478227|NCT00091026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25478228|NCT00091026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478229|NCT00091026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25478230|NCT00091026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25478231|NCT00091026|Growth Substances|growth substances|mesh-ancestor
25478232|NCT00091026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478233|NCT00091026|Growth Inhibitors|growth inhibitors|mesh-ancestor
25478234|NCT00091026|Immunologic Factors|immunologic factors|mesh-ancestor
25478235|NCT00091026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25478236|NCT00091026|Antimetabolites|antimetabolites|mesh-ancestor
25478237|NCT00091026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478238|NCT00091026|Antiviral Agents|antiviral agents|mesh-ancestor
25478239|NCT00091026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25478240|NCT00091026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478241|NCT00091026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25478242|NCT00091026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25478243|NCT00091260|Dexamethasone|dexamethasone|mesh-list
25478244|NCT00091260|Dexamethasone acetate|dexamethasone acetate|mesh-list
25478245|NCT00091260|Lenalidomide|lenalidomide|mesh-list
25478246|NCT00091260|BB 1101|bb 1101|mesh-list
25478247|NCT00091260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25478248|NCT00091260|Antiemetics|antiemetics|mesh-ancestor
25478249|NCT00091260|Autonomic Agents|autonomic agents|mesh-ancestor
25478250|NCT00091260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25478251|NCT00091260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478252|NCT00091260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25478253|NCT00091260|Glucocorticoids|glucocorticoids|mesh-ancestor
25478254|NCT00091260|Hormones|hormones|mesh-ancestor
25478255|NCT00091260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25478256|NCT00091260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25478257|NCT00091260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478258|NCT00091260|Protease Inhibitors|protease inhibitors|mesh-ancestor
25478259|NCT00091260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478260|NCT00091260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478261|NCT00091260|Immunologic Factors|immunologic factors|mesh-ancestor
25478262|NCT00091260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25478263|NCT00091260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25478264|NCT00091260|Growth Substances|growth substances|mesh-ancestor
25478265|NCT00091260|Growth Inhibitors|growth inhibitors|mesh-ancestor
25478266|NCT00091273|Sargramostim|sargramostim|mesh-list
25478267|NCT00091273|Freund's Adjuvant|freund's adjuvant|mesh-list
25478268|NCT00091273|Immunologic Factors|immunologic factors|mesh-ancestor
25478269|NCT00091273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478270|NCT00091273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25478271|NCT00091442|Docetaxel|docetaxel|mesh-list
25478272|NCT00091442|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25478273|NCT00091442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478274|NCT00091442|Tubulin Modulators|tubulin modulators|mesh-ancestor
25478275|NCT00091442|Antimitotic Agents|antimitotic agents|mesh-ancestor
25478276|NCT00091442|Mitosis Modulators|mitosis modulators|mesh-ancestor
25478277|NCT00091442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478278|NCT00091442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25478279|NCT00091507|Insulin|insulin|mesh-list
25478280|NCT00091507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25478281|NCT00091507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478282|NCT00091572|Temozolomide|temozolomide|mesh-list
25478284|NCT00091572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25478286|NCT00091572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478287|NCT00091572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478288|NCT00091793|Denosumab|denosumab|mesh-list
25478289|NCT00091793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25478290|NCT00091793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478291|NCT00091819|Vancomycin|vancomycin|mesh-list
25478292|NCT00091819|Telavancin|telavancin|mesh-list
25478293|NCT00091819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25478294|NCT00091819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25478295|NCT00091832|Denosumab|denosumab|mesh-list
25478296|NCT00091832|Diphosphonates|diphosphonates|mesh-list
25478297|NCT00091832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25478298|NCT00091832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478299|NCT00091949|Pioglitazone|pioglitazone|mesh-list
25478308|NCT00093145|Paclitaxel|paclitaxel|mesh-list
25478309|NCT00093145|Carboplatin|carboplatin|mesh-list
25478310|NCT00093145|Trastuzumab|trastuzumab|mesh-list
25478311|NCT00093145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25478312|NCT00093145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25478313|NCT00093145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478314|NCT00093145|Tubulin Modulators|tubulin modulators|mesh-ancestor
25478315|NCT00093145|Antimitotic Agents|antimitotic agents|mesh-ancestor
25478316|NCT00093145|Mitosis Modulators|mitosis modulators|mesh-ancestor
25478317|NCT00093145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478318|NCT00093145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25478319|NCT00093379|Capecitabine|capecitabine|mesh-list
25478320|NCT00093379|Oxaliplatin|oxaliplatin|mesh-list
25478321|NCT00093379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25478322|NCT00093379|Antimetabolites|antimetabolites|mesh-ancestor
25478323|NCT00093379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478324|NCT00093379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478325|NCT00093470|Tipifarnib|tipifarnib|mesh-list
25478326|NCT00093470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478327|NCT00093496|Gemcitabine|gemcitabine|mesh-list
25478328|NCT00093496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25478329|NCT00093496|Antimetabolites|antimetabolites|mesh-ancestor
25478330|NCT00093496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478331|NCT00093496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478332|NCT00093496|Antiviral Agents|antiviral agents|mesh-ancestor
25478333|NCT00093496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25478334|NCT00093496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478335|NCT00093496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25478336|NCT00093496|Immunologic Factors|immunologic factors|mesh-ancestor
25478337|NCT00093496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478338|NCT00093756|Paclitaxel|paclitaxel|mesh-list
25478339|NCT00093756|Carboplatin|carboplatin|mesh-list
25478340|NCT00093756|Bortezomib|bortezomib|mesh-list
25478341|NCT00093756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25478342|NCT00093756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478343|NCT00093756|Tubulin Modulators|tubulin modulators|mesh-ancestor
25478344|NCT00093756|Antimitotic Agents|antimitotic agents|mesh-ancestor
25478345|NCT00093756|Mitosis Modulators|mitosis modulators|mesh-ancestor
25478346|NCT00093756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478347|NCT00093782|Sirolimus|sirolimus|mesh-list
25478348|NCT00093782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25478349|NCT00093782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25478350|NCT00093782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25478351|NCT00093782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478352|NCT00093782|Antifungal Agents|antifungal agents|mesh-ancestor
25478353|NCT00093782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25478354|NCT00093782|Immunologic Factors|immunologic factors|mesh-ancestor
25478355|NCT00093782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478356|NCT00093795|Gemcitabine|gemcitabine|mesh-list
25478357|NCT00093795|Paclitaxel|paclitaxel|mesh-list
25478358|NCT00093795|Docetaxel|docetaxel|mesh-list
25478359|NCT00093795|Cyclophosphamide|cyclophosphamide|mesh-list
25478360|NCT00093795|Doxorubicin|doxorubicin|mesh-list
25478361|NCT00093795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25478362|NCT00093795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478363|NCT00093795|Tubulin Modulators|tubulin modulators|mesh-ancestor
25478364|NCT00093795|Antimitotic Agents|antimitotic agents|mesh-ancestor
25478365|NCT00093795|Mitosis Modulators|mitosis modulators|mesh-ancestor
25478366|NCT00093795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478367|NCT00093795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25478368|NCT00093795|Immunologic Factors|immunologic factors|mesh-ancestor
25478369|NCT00093795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478370|NCT00093795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25478371|NCT00093795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25478372|NCT00093795|Alkylating Agents|alkylating agents|mesh-ancestor
25478373|NCT00093795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25478374|NCT00093795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25478375|NCT00093795|Antimetabolites|antimetabolites|mesh-ancestor
25478376|NCT00093795|Antiviral Agents|antiviral agents|mesh-ancestor
25478377|NCT00093795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25478378|NCT00093795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444171|NCT00296868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444172|NCT00296868|Protective Agents|protective agents|mesh-ancestor
25829456|NCT00006211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24444215|NCT00296972|Antimetabolites|antimetabolites|mesh-ancestor
25478379|NCT00093795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25478380|NCT00093795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25478381|NCT00093795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25478382|NCT00093808|Capecitabine|capecitabine|mesh-list
25478383|NCT00093808|Trastuzumab|trastuzumab|mesh-list
25478384|NCT00093808|Vinorelbine|vinorelbine|mesh-list
25478385|NCT00093808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25478386|NCT00093808|Antimetabolites|antimetabolites|mesh-ancestor
25478387|NCT00093808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478388|NCT00093808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478389|NCT00093808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25478390|NCT00093808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25478391|NCT00093808|Tubulin Modulators|tubulin modulators|mesh-ancestor
25478392|NCT00093808|Antimitotic Agents|antimitotic agents|mesh-ancestor
25478393|NCT00093808|Mitosis Modulators|mitosis modulators|mesh-ancestor
25478394|NCT00094055|Axitinib|axitinib|mesh-list
25478395|NCT00094055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478396|NCT00094055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25478397|NCT00094055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478398|NCT00094055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478399|NCT00094094|Axitinib|axitinib|mesh-list
25478400|NCT00094094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478401|NCT00094094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25478402|NCT00094094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478403|NCT00094094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478404|NCT00094107|Axitinib|axitinib|mesh-list
25478405|NCT00094107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478406|NCT00094107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25478407|NCT00094107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478408|NCT00094107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478409|NCT00094172|Atorvastatin|atorvastatin|mesh-list
25478410|NCT00094172|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25478411|NCT00094172|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25478412|NCT00094172|Antimetabolites|antimetabolites|mesh-ancestor
25478413|NCT00094172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478414|NCT00094172|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25478415|NCT00094172|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25478416|NCT00094172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478417|NCT00094302|Spironolactone|spironolactone|mesh-list
25478418|NCT00094302|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
25478419|NCT00094302|Hormone Antagonists|hormone antagonists|mesh-ancestor
25478420|NCT00094302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25478421|NCT00094302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478422|NCT00094302|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25478423|NCT00094302|Diuretics|diuretics|mesh-ancestor
25478424|NCT00094302|Natriuretic Agents|natriuretic agents|mesh-ancestor
25478425|NCT00094328|Anastrozole|anastrozole|mesh-list
25478426|NCT00094328|Bicalutamide|bicalutamide|mesh-list
25478427|NCT00094328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25478428|NCT00094328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478429|NCT00094328|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25478430|NCT00094328|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25478431|NCT00094328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478432|NCT00094328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478433|NCT00094328|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25478434|NCT00094328|Hormone Antagonists|hormone antagonists|mesh-ancestor
25478435|NCT00094328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25478436|NCT00094328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478438|NCT00094445|Curcumin|curcumin|mesh-list
25478439|NCT00094445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25478440|NCT00094445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25478441|NCT00094445|Analgesics|analgesics|mesh-ancestor
25478442|NCT00094445|Sensory System Agents|sensory system agents|mesh-ancestor
25478443|NCT00094445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25478444|NCT00094445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478445|NCT00094445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25478446|NCT00094445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25478447|NCT00094445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478448|NCT00094445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478449|NCT00094445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478450|NCT00094458|Azathioprine|azathioprine|mesh-list
25478451|NCT00094458|Infliximab|infliximab|mesh-list
25478452|NCT00094458|Dermatologic Agents|dermatologic agents|mesh-ancestor
25478453|NCT00094458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25478454|NCT00094458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25478455|NCT00094458|Antimetabolites|antimetabolites|mesh-ancestor
25478456|NCT00094458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478457|NCT00094458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25478458|NCT00094458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478459|NCT00094458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25478460|NCT00094458|Immunologic Factors|immunologic factors|mesh-ancestor
25478461|NCT00094458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478463|NCT00094497|Doxorubicin|doxorubicin|mesh-list
25478464|NCT00094497|Etoposide|etoposide|mesh-list
25478465|NCT00094497|Mitotane|mitotane|mesh-list
25478466|NCT00094497|Streptozocin|streptozocin|mesh-list
25478467|NCT00094497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478468|NCT00094497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25478469|NCT00094497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25478470|NCT00094497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25478471|NCT00094497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478472|NCT00094497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478473|NCT00094497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25478474|NCT00094497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25478475|NCT00094653|Ipilimumab|ipilimumab|mesh-list
25478476|NCT00094653|Vaccines|vaccines|mesh-list
25478477|NCT00094653|Antibodies|antibodies|mesh-list
25478478|NCT00094653|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25478479|NCT00094653|Immunologic Factors|immunologic factors|mesh-ancestor
25478480|NCT00094653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478481|NCT00094653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25478482|NCT00094653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478483|NCT00094653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25478484|NCT00094653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478485|NCT00094757|Pioglitazone|pioglitazone|mesh-list
25478486|NCT00094757|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25478487|NCT00094757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25478488|NCT00094757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478489|NCT00094757|Incretins|incretins|mesh-ancestor
25478490|NCT00094757|Hormones|hormones|mesh-ancestor
25478491|NCT00094757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25478492|NCT00094757|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25478493|NCT00094757|Protease Inhibitors|protease inhibitors|mesh-ancestor
25478494|NCT00094757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478495|NCT00094757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478496|NCT00094770|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25478497|NCT00094770|Glipizide|glipizide|mesh-list
25478498|NCT00094770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25478499|NCT00094770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478500|NCT00094770|Incretins|incretins|mesh-ancestor
25478501|NCT00094770|Hormones|hormones|mesh-ancestor
25478502|NCT00094770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25478503|NCT00094770|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25478504|NCT00094770|Protease Inhibitors|protease inhibitors|mesh-ancestor
25478505|NCT00094770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478506|NCT00094770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478507|NCT00094835|Paclitaxel|paclitaxel|mesh-list
25478508|NCT00094835|Carboplatin|carboplatin|mesh-list
25478509|NCT00094835|Panitumumab|panitumumab|mesh-list
25478510|NCT00094835|Motesanib diphosphate|motesanib diphosphate|mesh-list
25478511|NCT00094835|Imetelstat|imetelstat|mesh-list
25478512|NCT00094835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25478513|NCT00094835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478514|NCT00094835|Tubulin Modulators|tubulin modulators|mesh-ancestor
25478515|NCT00094835|Antimitotic Agents|antimitotic agents|mesh-ancestor
25478516|NCT00094835|Mitosis Modulators|mitosis modulators|mesh-ancestor
25478517|NCT00094835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478518|NCT00094835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25478519|NCT00094835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25478520|NCT00094835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478521|NCT00094861|Paclitaxel|paclitaxel|mesh-list
25478522|NCT00094861|Carboplatin|carboplatin|mesh-list
25478523|NCT00094861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25478524|NCT00094861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730977|NCT01631409|Protease Inhibitors|protease inhibitors|mesh-ancestor
25829457|NCT00006211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24444735|NCT00299013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25478526|NCT00094861|Antimitotic Agents|antimitotic agents|mesh-ancestor
25478527|NCT00094861|Mitosis Modulators|mitosis modulators|mesh-ancestor
25478528|NCT00094861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478529|NCT00094887|Nitric Oxide|nitric oxide|mesh-list
25478530|NCT00094887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25478531|NCT00094887|Autonomic Agents|autonomic agents|mesh-ancestor
25478532|NCT00094887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25478533|NCT00094887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478534|NCT00094887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25478535|NCT00094887|Respiratory System Agents|respiratory system agents|mesh-ancestor
25478536|NCT00094887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25478537|NCT00094887|Antioxidants|antioxidants|mesh-ancestor
25478538|NCT00094887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478539|NCT00094887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25478540|NCT00094887|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25478541|NCT00094887|Vasodilator Agents|vasodilator agents|mesh-ancestor
25478542|NCT00094887|Gasotransmitters|gasotransmitters|mesh-ancestor
25478543|NCT00094887|Protective Agents|protective agents|mesh-ancestor
25478544|NCT00094900|Rilonacept|rilonacept|mesh-list
25478545|NCT00094900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25478546|NCT00095056|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25478547|NCT00095056|Glipizide|glipizide|mesh-list
25478548|NCT00095056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25478549|NCT00095056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478550|NCT00095056|Incretins|incretins|mesh-ancestor
25478551|NCT00095056|Hormones|hormones|mesh-ancestor
25478552|NCT00095056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25478553|NCT00095056|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25478554|NCT00095056|Protease Inhibitors|protease inhibitors|mesh-ancestor
25478555|NCT00095056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478556|NCT00095056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478557|NCT00095121|Lamivudine|lamivudine|mesh-list
25478558|NCT00095121|Adefovir|adefovir|mesh-list
25478559|NCT00095121|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25478560|NCT00095121|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25478561|NCT00095121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25478562|NCT00095121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478563|NCT00095121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478564|NCT00095121|Antiviral Agents|antiviral agents|mesh-ancestor
25478565|NCT00095121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25478566|NCT00095121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25478567|NCT00095121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25478568|NCT00095147|Methotrexate|methotrexate|mesh-list
25478569|NCT00095147|Abatacept|abatacept|mesh-list
25478570|NCT00095147|Infliximab|infliximab|mesh-list
25478571|NCT00095147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25478572|NCT00095147|Abortifacient Agents|abortifacient agents|mesh-ancestor
25478573|NCT00095147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25478574|NCT00095147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478575|NCT00095147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25478576|NCT00095147|Antimetabolites|antimetabolites|mesh-ancestor
25478577|NCT00095147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478578|NCT00095147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478579|NCT00095147|Dermatologic Agents|dermatologic agents|mesh-ancestor
25478580|NCT00095147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478581|NCT00095147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25478582|NCT00095147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25478583|NCT00095147|Immunologic Factors|immunologic factors|mesh-ancestor
25478584|NCT00095147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25644876|NCT01441570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25478585|NCT00095147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25478586|NCT00095147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25478587|NCT00095147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25478588|NCT00095173|Abatacept|abatacept|mesh-list
25478589|NCT00095173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25478590|NCT00095173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240994|NCT04240626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240995|NCT04240626|Antipyretics|antipyretics|mesh-ancestor
24742201|NCT05296317|Epirubicin|epirubicin|mesh-list
24742440|NCT05267431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24742441|NCT05267431|Antioxidants|antioxidants|mesh-ancestor
24742442|NCT05267431|Protective Agents|protective agents|mesh-ancestor
24742728|NCT05189444|Respiratory System Agents|respiratory system agents|mesh-ancestor
24742826|NCT05150795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25478591|NCT00095173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478592|NCT00095173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25478593|NCT00095173|Immunologic Factors|immunologic factors|mesh-ancestor
25478594|NCT00095173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478595|NCT00095173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25478596|NCT00095199|Docetaxel|docetaxel|mesh-list
25478597|NCT00095199|Pemetrexed|pemetrexed|mesh-list
25478598|NCT00095199|Cetuximab|cetuximab|mesh-list
25478599|NCT00095199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478600|NCT00095199|Tubulin Modulators|tubulin modulators|mesh-ancestor
25478601|NCT00095199|Antimitotic Agents|antimitotic agents|mesh-ancestor
25478602|NCT00095199|Mitosis Modulators|mitosis modulators|mesh-ancestor
25478603|NCT00095199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478604|NCT00095199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478605|NCT00095199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25478606|NCT00095199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25478607|NCT00095199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25478608|NCT00095212|Testosterone|testosterone|mesh-list
25478609|NCT00095212|Androgens|androgens|mesh-ancestor
25478610|NCT00095212|Hormones|hormones|mesh-ancestor
25478611|NCT00095212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25478612|NCT00095212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478613|NCT00095238|Irbesartan|irbesartan|mesh-list
25478614|NCT00095238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25478615|NCT00095238|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25478616|NCT00095238|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25478617|NCT00095238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478618|NCT00095498|Denosumab|denosumab|mesh-list
25478619|NCT00095498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25478620|NCT00095498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478621|NCT00095563|Lapatinib|lapatinib|mesh-list
25478622|NCT00095563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478623|NCT00095563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25478624|NCT00095563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478625|NCT00095563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478626|NCT00095836|Gefitinib|gefitinib|mesh-list
25478627|NCT00095836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478628|NCT00095836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25478629|NCT00095836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478630|NCT00095836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478631|NCT00095875|Cisplatin|cisplatin|mesh-list
25478632|NCT00095875|Carboplatin|carboplatin|mesh-list
25478633|NCT00095875|Docetaxel|docetaxel|mesh-list
25478634|NCT00095875|Fluorouracil|fluorouracil|mesh-list
25478635|NCT00095875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478636|NCT00095875|Tubulin Modulators|tubulin modulators|mesh-ancestor
25478637|NCT00095875|Antimitotic Agents|antimitotic agents|mesh-ancestor
25478638|NCT00095875|Mitosis Modulators|mitosis modulators|mesh-ancestor
25478639|NCT00095875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478640|NCT00095875|Antimetabolites|antimetabolites|mesh-ancestor
25478641|NCT00095875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25478642|NCT00095875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25478643|NCT00095875|Immunologic Factors|immunologic factors|mesh-ancestor
25478644|NCT00095875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478645|NCT00095940|Lapatinib|lapatinib|mesh-list
25478646|NCT00095940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478647|NCT00095940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25478648|NCT00095940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478649|NCT00095940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478650|NCT00095979|Epothilones|epothilones|mesh-list
25478651|NCT00095979|Epothilone B|epothilone b|mesh-list
25478652|NCT00095979|Tubulin Modulators|tubulin modulators|mesh-ancestor
25478653|NCT00095979|Antimitotic Agents|antimitotic agents|mesh-ancestor
25478654|NCT00095979|Mitosis Modulators|mitosis modulators|mesh-ancestor
25478655|NCT00095979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478656|NCT00095979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478657|NCT00096018|Thalidomide|thalidomide|mesh-list
24621724|NCT01063621|Autonomic Agents|autonomic agents|mesh-ancestor
24621725|NCT01063621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24621726|NCT01063621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24621727|NCT01063621|Dopamine Agonists|dopamine agonists|mesh-ancestor
24621728|NCT01063621|Dopamine Agents|dopamine agents|mesh-ancestor
24621729|NCT01063621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24747981|NCT03006432|Vitamins|vitamins|mesh-ancestor
24747982|NCT03006432|Micronutrients|micronutrients|mesh-ancestor
25006998|NCT04386811|Vitamins|vitamins|mesh-ancestor
25478658|NCT00096018|Fludarabine|fludarabine|mesh-list
25478659|NCT00096018|Fludarabine phosphate|fludarabine phosphate|mesh-list
25478660|NCT00096018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478661|NCT00096018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25478662|NCT00096018|Antimetabolites|antimetabolites|mesh-ancestor
25478663|NCT00096018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478664|NCT00096018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25478665|NCT00096018|Immunologic Factors|immunologic factors|mesh-ancestor
25478666|NCT00096018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478667|NCT00096018|Leprostatic Agents|leprostatic agents|mesh-ancestor
25478668|NCT00096018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25478669|NCT00096018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25478670|NCT00096018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25478671|NCT00096018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25478672|NCT00096018|Growth Substances|growth substances|mesh-ancestor
25478673|NCT00096018|Growth Inhibitors|growth inhibitors|mesh-ancestor
25478674|NCT00096031|Cetuximab|cetuximab|mesh-list
25478675|NCT00096031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25478676|NCT00096031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478677|NCT00096044|Rituximab|rituximab|mesh-list
25478678|NCT00096044|Lenalidomide|lenalidomide|mesh-list
25478679|NCT00096044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25478680|NCT00096044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478681|NCT00096044|Immunologic Factors|immunologic factors|mesh-ancestor
25478682|NCT00096044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478683|NCT00096044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25478684|NCT00096044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25478685|NCT00096044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25478686|NCT00096044|Growth Substances|growth substances|mesh-ancestor
25478687|NCT00096044|Growth Inhibitors|growth inhibitors|mesh-ancestor
25478688|NCT00096122|Cytarabine|cytarabine|mesh-list
25478689|NCT00096122|Idarubicin|idarubicin|mesh-list
25478690|NCT00096122|Tipifarnib|tipifarnib|mesh-list
25478691|NCT00096122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25478692|NCT00096122|Antimetabolites|antimetabolites|mesh-ancestor
25478693|NCT00096122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478694|NCT00096122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478695|NCT00096122|Antiviral Agents|antiviral agents|mesh-ancestor
25478696|NCT00096122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25478697|NCT00096122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25478698|NCT00096122|Immunologic Factors|immunologic factors|mesh-ancestor
25478699|NCT00096122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478700|NCT00096122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25478701|NCT00096122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25478702|NCT00096122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25478703|NCT00096122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478704|NCT00096135|Leucovorin|leucovorin|mesh-list
25478705|NCT00096135|Cytarabine|cytarabine|mesh-list
25478706|NCT00096135|Dexamethasone|dexamethasone|mesh-list
25478707|NCT00096135|Hydrocortisone|hydrocortisone|mesh-list
25478708|NCT00096135|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25478709|NCT00096135|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25478710|NCT00096135|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25478711|NCT00096135|Cyclophosphamide|cyclophosphamide|mesh-list
25478712|NCT00096135|Methotrexate|methotrexate|mesh-list
25478713|NCT00096135|Etoposide|etoposide|mesh-list
25478714|NCT00096135|Vincristine|vincristine|mesh-list
25478715|NCT00096135|Daunorubicin|daunorubicin|mesh-list
25478716|NCT00096135|Asparaginase|asparaginase|mesh-list
25478717|NCT00096135|Mercaptopurine|mercaptopurine|mesh-list
25478718|NCT00096135|Pegaspargase|pegaspargase|mesh-list
25478719|NCT00096135|Lenograstim|lenograstim|mesh-list
25478720|NCT00096135|Levoleucovorin|levoleucovorin|mesh-list
25478721|NCT00096135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25644877|NCT01441570|Sympatholytics|sympatholytics|mesh-ancestor
25478722|NCT00096135|Immunologic Factors|immunologic factors|mesh-ancestor
25478723|NCT00096135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478724|NCT00096135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25478725|NCT00096135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25478726|NCT00096135|Alkylating Agents|alkylating agents|mesh-ancestor
25478727|NCT00096135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478728|NCT00096135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478729|NCT00096135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25478730|NCT00096135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25478731|NCT00096135|Antiemetics|antiemetics|mesh-ancestor
25478732|NCT00096135|Autonomic Agents|autonomic agents|mesh-ancestor
24750442|NCT01698593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25478733|NCT00096135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25478734|NCT00096135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25478735|NCT00096135|Glucocorticoids|glucocorticoids|mesh-ancestor
25478737|NCT00096135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25478738|NCT00096135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25478739|NCT00096135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25478740|NCT00096135|Abortifacient Agents|abortifacient agents|mesh-ancestor
25478741|NCT00096135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25478742|NCT00096135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25478743|NCT00096135|Antimetabolites|antimetabolites|mesh-ancestor
25478744|NCT00096135|Dermatologic Agents|dermatologic agents|mesh-ancestor
25478745|NCT00096135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478746|NCT00096135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25478747|NCT00096135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25478748|NCT00096135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25478749|NCT00096135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25478750|NCT00096135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25478751|NCT00096135|Antiviral Agents|antiviral agents|mesh-ancestor
25478752|NCT00096135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25478753|NCT00096135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25478754|NCT00096135|Antidotes|antidotes|mesh-ancestor
25478755|NCT00096135|Protective Agents|protective agents|mesh-ancestor
25478756|NCT00096135|Vitamin B Complex|vitamin b complex|mesh-ancestor
25478757|NCT00096135|Vitamins|vitamins|mesh-ancestor
25478758|NCT00096135|Micronutrients|micronutrients|mesh-ancestor
25478759|NCT00096135|Tubulin Modulators|tubulin modulators|mesh-ancestor
25478760|NCT00096135|Antimitotic Agents|antimitotic agents|mesh-ancestor
25478761|NCT00096135|Mitosis Modulators|mitosis modulators|mesh-ancestor
25478762|NCT00096135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25478763|NCT00096161|Cyclosporine|cyclosporine|mesh-list
25478764|NCT00096161|Mycophenolic Acid|mycophenolic acid|mesh-list
25478765|NCT00096161|Vidarabine|vidarabine|mesh-list
25478766|NCT00096161|Pentostatin|pentostatin|mesh-list
25478767|NCT00096161|Cyclosporins|cyclosporins|mesh-list
25478768|NCT00096161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478769|NCT00096161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478770|NCT00096161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25478771|NCT00096161|Immunologic Factors|immunologic factors|mesh-ancestor
25478772|NCT00096161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478773|NCT00096161|Antifungal Agents|antifungal agents|mesh-ancestor
25478774|NCT00096161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25478775|NCT00096161|Dermatologic Agents|dermatologic agents|mesh-ancestor
25478776|NCT00096161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25478777|NCT00096161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25478778|NCT00096161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25478779|NCT00096161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478780|NCT00096161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25478781|NCT00096161|Antitubercular Agents|antitubercular agents|mesh-ancestor
25478782|NCT00096161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25478783|NCT00096161|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25478784|NCT00096161|Antimetabolites|antimetabolites|mesh-ancestor
25478785|NCT00096161|Antiviral Agents|antiviral agents|mesh-ancestor
25478786|NCT00096174|Cisplatin|cisplatin|mesh-list
25478787|NCT00096174|Cetuximab|cetuximab|mesh-list
25478788|NCT00096174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478789|NCT00096174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25478790|NCT00096226|Paclitaxel|paclitaxel|mesh-list
25478791|NCT00096226|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25478792|NCT00096226|Carboplatin|carboplatin|mesh-list
25478793|NCT00096226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25644878|NCT01441570|Autonomic Agents|autonomic agents|mesh-ancestor
25478794|NCT00096226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478795|NCT00096226|Tubulin Modulators|tubulin modulators|mesh-ancestor
25478796|NCT00096226|Antimitotic Agents|antimitotic agents|mesh-ancestor
25478797|NCT00096226|Mitosis Modulators|mitosis modulators|mesh-ancestor
25478798|NCT00096226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478799|NCT00096265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25478800|NCT00096265|Temozolomide|temozolomide|mesh-list
25478801|NCT00096265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478802|NCT00096265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25478803|NCT00096265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478804|NCT00096265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478805|NCT00096265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25478806|NCT00096265|Alkylating Agents|alkylating agents|mesh-ancestor
24494458|NCT00495326|Ethambutol|ethambutol|mesh-list
24494459|NCT00495326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25822951|NCT00004705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822952|NCT00004705|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
25478807|NCT00096278|Calcium, Dietary|calcium, dietary|mesh-list
25478808|NCT00096278|Leucovorin|leucovorin|mesh-list
25478809|NCT00096278|Folic Acid|folic acid|mesh-list
25478810|NCT00096278|Bevacizumab|bevacizumab|mesh-list
25478811|NCT00096278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25478812|NCT00096278|Fluorouracil|fluorouracil|mesh-list
25478813|NCT00096278|Oxaliplatin|oxaliplatin|mesh-list
25478814|NCT00096278|Endothelial Growth Factors|endothelial growth factors|mesh-list
25478815|NCT00096278|Antibodies|antibodies|mesh-list
25478816|NCT00096278|Immunoglobulins|immunoglobulins|mesh-list
25478817|NCT00096278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25478818|NCT00096278|Immunoglobulin G|immunoglobulin g|mesh-list
25478819|NCT00096278|Calcium|calcium|mesh-list
25478820|NCT00096278|Levoleucovorin|levoleucovorin|mesh-list
25478821|NCT00096278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478822|NCT00096278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25478823|NCT00096278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25478824|NCT00096278|Growth Substances|growth substances|mesh-ancestor
25478825|NCT00096278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478826|NCT00096278|Growth Inhibitors|growth inhibitors|mesh-ancestor
25478827|NCT00096278|Immunologic Factors|immunologic factors|mesh-ancestor
25478828|NCT00096278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25478829|NCT00096278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25478830|NCT00096278|Antimetabolites|antimetabolites|mesh-ancestor
25478831|NCT00096278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478832|NCT00096278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25478833|NCT00096278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25478834|NCT00096278|Antidotes|antidotes|mesh-ancestor
25478835|NCT00096278|Protective Agents|protective agents|mesh-ancestor
25478836|NCT00096278|Vitamin B Complex|vitamin b complex|mesh-ancestor
25478837|NCT00096278|Vitamins|vitamins|mesh-ancestor
25478838|NCT00096278|Micronutrients|micronutrients|mesh-ancestor
25478839|NCT00096278|Hematinics|hematinics|mesh-ancestor
25478840|NCT00096356|Vitamins|vitamins|mesh-list
25478841|NCT00096356|Vitamin E|vitamin e|mesh-list
25478842|NCT00096356|Tocopherols|tocopherols|mesh-list
25478843|NCT00096356|Tocotrienols|tocotrienols|mesh-list
25478844|NCT00096356|alpha-Tocopherol|alpha-tocopherol|mesh-list
25478845|NCT00096356|Micronutrients|micronutrients|mesh-ancestor
25478846|NCT00096356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478847|NCT00096356|Antioxidants|antioxidants|mesh-ancestor
25478848|NCT00096356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478849|NCT00096356|Protective Agents|protective agents|mesh-ancestor
25478850|NCT00096382|Aldesleukin|aldesleukin|mesh-list
25478851|NCT00096382|Cyclophosphamide|cyclophosphamide|mesh-list
25478852|NCT00096382|Fludarabine|fludarabine|mesh-list
25478853|NCT00096382|Fludarabine phosphate|fludarabine phosphate|mesh-list
25478854|NCT00096382|Interleukin-2|interleukin-2|mesh-list
25478855|NCT00096382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25478856|NCT00096382|Immunologic Factors|immunologic factors|mesh-ancestor
25478857|NCT00096382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478858|NCT00096382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25478859|NCT00096382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25478860|NCT00096382|Alkylating Agents|alkylating agents|mesh-ancestor
25478861|NCT00096382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478862|NCT00096382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478863|NCT00096382|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25478864|NCT00096382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25478865|NCT00096382|Antimetabolites|antimetabolites|mesh-ancestor
25478866|NCT00096382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25478867|NCT00096382|Analgesics|analgesics|mesh-ancestor
25478868|NCT00096382|Sensory System Agents|sensory system agents|mesh-ancestor
25478869|NCT00096382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25478870|NCT00096382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25478871|NCT00096382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25478872|NCT00096382|Antiviral Agents|antiviral agents|mesh-ancestor
25478873|NCT00096382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25478874|NCT00096447|Lapatinib|lapatinib|mesh-list
25478875|NCT00096447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478876|NCT00096447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25273998|NCT02381275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273999|NCT02381275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274000|NCT02381275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25274001|NCT02381275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25274002|NCT02381184|Clomiphene|clomiphene|mesh-list
25274003|NCT02381184|Enclomiphene|enclomiphene|mesh-list
25274004|NCT02381184|Zuclomiphene|zuclomiphene|mesh-list
25822953|NCT00004705|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24494647|NCT00496275|Cisplatin|cisplatin|mesh-list
24626607|NCT01088009|Lamivudine|lamivudine|mesh-list
25478877|NCT00096447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478880|NCT00096460|Carmustine|carmustine|mesh-list
25478881|NCT00096460|Rituximab|rituximab|mesh-list
25478882|NCT00096460|Methotrexate|methotrexate|mesh-list
25478883|NCT00096460|Fludarabine|fludarabine|mesh-list
25478884|NCT00096460|Etoposide|etoposide|mesh-list
25478885|NCT00096460|Tacrolimus|tacrolimus|mesh-list
25478886|NCT00096460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25478887|NCT00096460|Immunologic Factors|immunologic factors|mesh-ancestor
25478888|NCT00096460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478889|NCT00096460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25478890|NCT00096460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25478891|NCT00096460|Alkylating Agents|alkylating agents|mesh-ancestor
25478892|NCT00096460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478893|NCT00096460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478894|NCT00096460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25478895|NCT00096460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25478896|NCT00096460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25478897|NCT00096460|Abortifacient Agents|abortifacient agents|mesh-ancestor
25478898|NCT00096460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25478899|NCT00096460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25478900|NCT00096460|Antimetabolites|antimetabolites|mesh-ancestor
25478901|NCT00096460|Dermatologic Agents|dermatologic agents|mesh-ancestor
25478902|NCT00096460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478903|NCT00096460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25478904|NCT00096460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25478905|NCT00096460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25478906|NCT00096460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25478907|NCT00096460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25478908|NCT00096460|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25478909|NCT00096486|Everolimus|everolimus|mesh-list
25478910|NCT00096486|Gefitinib|gefitinib|mesh-list
25478911|NCT00096486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478912|NCT00096486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25478913|NCT00096486|Immunologic Factors|immunologic factors|mesh-ancestor
25478914|NCT00096486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478915|NCT00096486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25478916|NCT00096486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478917|NCT00096486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478918|NCT00096538|Valganciclovir|valganciclovir|mesh-list
25478919|NCT00096538|Antiviral Agents|antiviral agents|mesh-ancestor
25478920|NCT00096538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25478921|NCT00096785|Entecavir|entecavir|mesh-list
25478922|NCT00096785|Adefovir|adefovir|mesh-list
25478923|NCT00096785|Antiviral Agents|antiviral agents|mesh-ancestor
25478924|NCT00096785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25478925|NCT00096785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25478926|NCT00096785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25478927|NCT00096785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478928|NCT00096785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478929|NCT00096941|Pertuzumab|pertuzumab|mesh-list
25478930|NCT00096941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25478931|NCT00096941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478932|NCT00096954|Omalizumab|omalizumab|mesh-list
25478933|NCT00096954|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25478934|NCT00096954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25478935|NCT00096954|Respiratory System Agents|respiratory system agents|mesh-ancestor
25478936|NCT00096993|Gemcitabine|gemcitabine|mesh-list
25478937|NCT00096993|Pertuzumab|pertuzumab|mesh-list
25478938|NCT00096993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25478939|NCT00096993|Antimetabolites|antimetabolites|mesh-ancestor
24823250|NCT02116010|Sulfadiazine|sulfadiazine|mesh-list
25822954|NCT00004727|Aspirin|aspirin|mesh-list
25644879|NCT01441570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25644880|NCT01441570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644881|NCT01441570|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25644882|NCT01441570|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25478940|NCT00096993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478941|NCT00096993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478942|NCT00096993|Antiviral Agents|antiviral agents|mesh-ancestor
25478943|NCT00096993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25478944|NCT00096993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25478945|NCT00096993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25478946|NCT00096993|Immunologic Factors|immunologic factors|mesh-ancestor
25478947|NCT00096993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478948|NCT00096993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25478949|NCT00097253|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
25478950|NCT00097253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478951|NCT00097448|Prednisone|prednisone|mesh-list
25478952|NCT00097448|Methylprednisolone|methylprednisolone|mesh-list
25478953|NCT00097448|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25478954|NCT00097448|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25478955|NCT00097448|Prednisolone|prednisolone|mesh-list
25478956|NCT00097448|Prednisolone acetate|prednisolone acetate|mesh-list
25478957|NCT00097448|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25478958|NCT00097448|Prednisolone phosphate|prednisolone phosphate|mesh-list
25478959|NCT00097448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25478960|NCT00097448|Glucocorticoids|glucocorticoids|mesh-ancestor
25478961|NCT00097448|Hormones|hormones|mesh-ancestor
25478962|NCT00097448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25478963|NCT00097448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478964|NCT00097448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25478965|NCT00097448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25478966|NCT00097448|Antiemetics|antiemetics|mesh-ancestor
25478967|NCT00097448|Autonomic Agents|autonomic agents|mesh-ancestor
25478968|NCT00097448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25478969|NCT00097448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25478970|NCT00097448|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25478971|NCT00097448|Protective Agents|protective agents|mesh-ancestor
25478972|NCT00097500|Metformin|metformin|mesh-list
25478973|NCT00097500|Insulin Glargine|insulin glargine|mesh-list
25478974|NCT00097500|Exenatide|exenatide|mesh-list
25478975|NCT00097500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25478976|NCT00097500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478977|NCT00097500|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25478978|NCT00097500|Incretins|incretins|mesh-ancestor
25478979|NCT00097500|Hormones|hormones|mesh-ancestor
25478980|NCT00097500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25478981|NCT00097591|Clopidogrel|clopidogrel|mesh-list
25478982|NCT00097591|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25478983|NCT00097591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25478984|NCT00097591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25478985|NCT00097591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25478986|NCT00097591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25478987|NCT00097591|Purinergic Agents|purinergic agents|mesh-ancestor
25478988|NCT00097591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25478989|NCT00097591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25478990|NCT00097591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478991|NCT00097669|Folic Acid|folic acid|mesh-list
25478992|NCT00097669|Hematinics|hematinics|mesh-ancestor
25478993|NCT00097669|Vitamin B Complex|vitamin b complex|mesh-ancestor
25478994|NCT00097669|Vitamins|vitamins|mesh-ancestor
25478995|NCT00097669|Micronutrients|micronutrients|mesh-ancestor
25478996|NCT00097669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25478997|NCT00097695|Icatibant|icatibant|mesh-list
25478998|NCT00097695|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25478999|NCT00097695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25479000|NCT00097695|Analgesics|analgesics|mesh-ancestor
25479001|NCT00097695|Sensory System Agents|sensory system agents|mesh-ancestor
25479002|NCT00097695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25479003|NCT00097695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479004|NCT00097695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25479005|NCT00097695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25479006|NCT00097695|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
25479007|NCT00097695|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
25479008|NCT00097695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421507|NCT00219388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25644883|NCT01441570|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25644884|NCT01441570|Adrenergic Agents|adrenergic agents|mesh-ancestor
25822955|NCT00004727|Ticlopidine|ticlopidine|mesh-list
25479009|NCT00097695|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25479010|NCT00097695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25479011|NCT00097695|Immunologic Factors|immunologic factors|mesh-ancestor
25479012|NCT00097708|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
25479013|NCT00097708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25479014|NCT00097708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25479015|NCT00097708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479016|NCT00097708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25479017|NCT00097773|Ciprofloxacin|ciprofloxacin|mesh-list
25479018|NCT00097773|Tobramycin|tobramycin|mesh-list
25479019|NCT00097773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25479020|NCT00097773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25479021|NCT00097773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25479022|NCT00097773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25479023|NCT00097773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479024|NCT00097773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851528|NCT02257008|Ritonavir|ritonavir|mesh-list
24437580|NCT00274027|Bromides|bromides|mesh-list
25479025|NCT00097773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479026|NCT00097773|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25479027|NCT00097773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25479028|NCT00097786|Nateglinide|nateglinide|mesh-list
25479029|NCT00097786|Valsartan|valsartan|mesh-list
25479030|NCT00097786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25479031|NCT00097786|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25479032|NCT00097786|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25479033|NCT00097786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479034|NCT00097786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25479035|NCT00097786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479036|NCT00097981|Thalidomide|thalidomide|mesh-list
25479037|NCT00097981|Dexamethasone|dexamethasone|mesh-list
25479038|NCT00097981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25479039|NCT00097981|Antiemetics|antiemetics|mesh-ancestor
25479040|NCT00097981|Autonomic Agents|autonomic agents|mesh-ancestor
25479041|NCT00097981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25479042|NCT00097981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479043|NCT00097981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25479044|NCT00097981|Glucocorticoids|glucocorticoids|mesh-ancestor
25479045|NCT00097981|Hormones|hormones|mesh-ancestor
25479046|NCT00097981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25479047|NCT00097981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25479048|NCT00097981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479049|NCT00097981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25479050|NCT00097981|Immunologic Factors|immunologic factors|mesh-ancestor
25479051|NCT00097981|Leprostatic Agents|leprostatic agents|mesh-ancestor
25479052|NCT00097981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25479053|NCT00097981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25479054|NCT00097981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25479055|NCT00097981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25479056|NCT00097981|Growth Substances|growth substances|mesh-ancestor
25479057|NCT00097981|Growth Inhibitors|growth inhibitors|mesh-ancestor
25479058|NCT00098020|Isotretinoin|isotretinoin|mesh-list
25479059|NCT00098020|Dermatologic Agents|dermatologic agents|mesh-ancestor
25479060|NCT00098059|Famciclovir|famciclovir|mesh-list
25479061|NCT00098059|Antiviral Agents|antiviral agents|mesh-ancestor
25479062|NCT00098059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25479063|NCT00098059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25479064|NCT00098059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479065|NCT00098059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479066|NCT00098254|Sorafenib|sorafenib|mesh-list
25479067|NCT00098254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479068|NCT00098254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25479069|NCT00098254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479070|NCT00098254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479071|NCT00098293|Lamivudine|lamivudine|mesh-list
25479072|NCT00098293|Zidovudine|zidovudine|mesh-list
25479073|NCT00098293|Efavirenz|efavirenz|mesh-list
25479074|NCT00098293|Maraviroc|maraviroc|mesh-list
25479075|NCT00098293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25479076|NCT00098293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25479077|NCT00098293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479078|NCT00098293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479079|NCT00098293|Antiviral Agents|antiviral agents|mesh-ancestor
25644885|NCT01441570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25644886|NCT01441570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479080|NCT00098293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25479081|NCT00098293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25479082|NCT00098293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25479083|NCT00098293|Antimetabolites|antimetabolites|mesh-ancestor
25479084|NCT00098293|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25479085|NCT00098293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25479086|NCT00098293|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25479087|NCT00098293|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25479088|NCT00098293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25479089|NCT00098293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25479090|NCT00098293|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25479091|NCT00098293|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25479092|NCT00098293|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25479093|NCT00098306|Maraviroc|maraviroc|mesh-list
25479094|NCT00098306|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25479095|NCT00098306|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25479096|NCT00098306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479097|NCT00098306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25479098|NCT00098306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25479100|NCT00098306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25479101|NCT00098306|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25479103|NCT00098371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479104|NCT00098371|Growth Inhibitors|growth inhibitors|mesh-ancestor
25479105|NCT00098371|Growth Substances|growth substances|mesh-ancestor
25479106|NCT00098371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479107|NCT00098371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25479108|NCT00098371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479109|NCT00098371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479110|NCT00098670|Rituximab|rituximab|mesh-list
25479111|NCT00098670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25479112|NCT00098670|Alemtuzumab|alemtuzumab|mesh-list
25479113|NCT00098670|Fludarabine|fludarabine|mesh-list
25479114|NCT00098670|Fludarabine phosphate|fludarabine phosphate|mesh-list
25479115|NCT00098670|Antibodies|antibodies|mesh-list
25479116|NCT00098670|Immunoglobulins|immunoglobulins|mesh-list
25479117|NCT00098670|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25479118|NCT00098670|Immunologic Factors|immunologic factors|mesh-ancestor
25479119|NCT00098670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479120|NCT00098670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479121|NCT00098670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25479122|NCT00098670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25479123|NCT00098670|Antimetabolites|antimetabolites|mesh-ancestor
25479124|NCT00098670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479125|NCT00098670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25479126|NCT00098722|Maraviroc|maraviroc|mesh-list
25479127|NCT00098722|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25479128|NCT00098722|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25479129|NCT00098722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479130|NCT00098722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25479131|NCT00098722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25479132|NCT00098722|Antiviral Agents|antiviral agents|mesh-ancestor
25479133|NCT00098722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25479134|NCT00098722|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25479135|NCT00098748|Maraviroc|maraviroc|mesh-list
25479136|NCT00098748|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25479137|NCT00098748|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25479138|NCT00098748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479139|NCT00098748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25479140|NCT00098748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25479141|NCT00098748|Antiviral Agents|antiviral agents|mesh-ancestor
25479142|NCT00098748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25479143|NCT00098748|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25479144|NCT00098774|Leucovorin|leucovorin|mesh-list
25479145|NCT00098774|Cytarabine|cytarabine|mesh-list
25479146|NCT00098774|Rituximab|rituximab|mesh-list
25479147|NCT00098774|Methotrexate|methotrexate|mesh-list
25479148|NCT00098774|Etoposide|etoposide|mesh-list
25479149|NCT00098774|Temozolomide|temozolomide|mesh-list
25479150|NCT00098774|Calcium|calcium|mesh-list
25479151|NCT00098774|Levoleucovorin|levoleucovorin|mesh-list
25479152|NCT00098774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25479153|NCT00098774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479154|NCT00098774|Immunologic Factors|immunologic factors|mesh-ancestor
25644887|NCT01441570|Vasodilator Agents|vasodilator agents|mesh-ancestor
25829458|NCT00006212|Cisplatin|cisplatin|mesh-list
25479155|NCT00098774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479156|NCT00098774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25479157|NCT00098774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25479158|NCT00098774|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25479159|NCT00098774|Abortifacient Agents|abortifacient agents|mesh-ancestor
25479160|NCT00098774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25479161|NCT00098774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25479162|NCT00098774|Antimetabolites|antimetabolites|mesh-ancestor
25479163|NCT00098774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479164|NCT00098774|Dermatologic Agents|dermatologic agents|mesh-ancestor
25479165|NCT00098774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479166|NCT00098774|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25479167|NCT00098774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25479168|NCT00098774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25479169|NCT00098774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25479170|NCT00098774|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25479171|NCT00098774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25479172|NCT00098774|Antiviral Agents|antiviral agents|mesh-ancestor
24444979|NCT00299910|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25479173|NCT00098774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25479175|NCT00098774|Protective Agents|protective agents|mesh-ancestor
25479176|NCT00098774|Vitamin B Complex|vitamin b complex|mesh-ancestor
25479177|NCT00098774|Vitamins|vitamins|mesh-ancestor
25479178|NCT00098774|Micronutrients|micronutrients|mesh-ancestor
25479179|NCT00098774|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25479180|NCT00098774|Alkylating Agents|alkylating agents|mesh-ancestor
25479181|NCT00098787|Leucovorin|leucovorin|mesh-list
25479182|NCT00098787|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
25479183|NCT00098787|Tetrahydrofolates|tetrahydrofolates|mesh-list
25479184|NCT00098787|Bevacizumab|bevacizumab|mesh-list
25479185|NCT00098787|Fluorouracil|fluorouracil|mesh-list
25479186|NCT00098787|Oxaliplatin|oxaliplatin|mesh-list
25479187|NCT00098787|Irinotecan|irinotecan|mesh-list
25479188|NCT00098787|Camptothecin|camptothecin|mesh-list
25479189|NCT00098787|Levoleucovorin|levoleucovorin|mesh-list
25479190|NCT00098787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25479191|NCT00098787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479192|NCT00098787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25479193|NCT00098787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25479194|NCT00098787|Growth Substances|growth substances|mesh-ancestor
25479195|NCT00098787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479196|NCT00098787|Growth Inhibitors|growth inhibitors|mesh-ancestor
25479197|NCT00098787|Antimetabolites|antimetabolites|mesh-ancestor
25479198|NCT00098787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479199|NCT00098787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25479200|NCT00098787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25479201|NCT00098787|Immunologic Factors|immunologic factors|mesh-ancestor
25479202|NCT00098787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25479203|NCT00098787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25479204|NCT00098787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479205|NCT00098787|Antidotes|antidotes|mesh-ancestor
25479206|NCT00098787|Protective Agents|protective agents|mesh-ancestor
25479207|NCT00098787|Vitamin B Complex|vitamin b complex|mesh-ancestor
25479208|NCT00098787|Vitamins|vitamins|mesh-ancestor
25479209|NCT00098787|Micronutrients|micronutrients|mesh-ancestor
25479210|NCT00098787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25479211|NCT00098813|Romidepsin|romidepsin|mesh-list
25479212|NCT00098813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25479213|NCT00098813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479214|NCT00098839|Leucovorin|leucovorin|mesh-list
25479215|NCT00098839|Cytarabine|cytarabine|mesh-list
25479216|NCT00098839|Prednisone|prednisone|mesh-list
25479217|NCT00098839|Hydrocortisone|hydrocortisone|mesh-list
25479218|NCT00098839|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25479219|NCT00098839|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25479220|NCT00098839|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25479221|NCT00098839|Cyclophosphamide|cyclophosphamide|mesh-list
25479222|NCT00098839|Doxorubicin|doxorubicin|mesh-list
25479223|NCT00098839|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25479224|NCT00098839|Methotrexate|methotrexate|mesh-list
25479225|NCT00098839|Etoposide|etoposide|mesh-list
25479226|NCT00098839|Vincristine|vincristine|mesh-list
25479227|NCT00098839|Etoposide phosphate|etoposide phosphate|mesh-list
25479228|NCT00098839|Asparaginase|asparaginase|mesh-list
25479229|NCT00098839|Pegaspargase|pegaspargase|mesh-list
25479230|NCT00098839|Epratuzumab|epratuzumab|mesh-list
25479231|NCT00098839|Dexrazoxane|dexrazoxane|mesh-list
25479232|NCT00098839|Razoxane|razoxane|mesh-list
25479233|NCT00098839|Levoleucovorin|levoleucovorin|mesh-list
25479234|NCT00098839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25479235|NCT00098839|Immunologic Factors|immunologic factors|mesh-ancestor
25479236|NCT00098839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479237|NCT00098839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25479238|NCT00098839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25479239|NCT00098839|Alkylating Agents|alkylating agents|mesh-ancestor
25479240|NCT00098839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479241|NCT00098839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479242|NCT00098839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25479243|NCT00098839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25479244|NCT00098839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25479245|NCT00098839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25479246|NCT00098839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479247|NCT00098839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24445258|NCT00300950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479249|NCT00098839|Hormones|hormones|mesh-ancestor
25479250|NCT00098839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25479251|NCT00098839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25479252|NCT00098839|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25479253|NCT00098839|Abortifacient Agents|abortifacient agents|mesh-ancestor
25479254|NCT00098839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25479255|NCT00098839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25479256|NCT00098839|Antimetabolites|antimetabolites|mesh-ancestor
25479257|NCT00098839|Dermatologic Agents|dermatologic agents|mesh-ancestor
25479258|NCT00098839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25479259|NCT00098839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25479260|NCT00098839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25479261|NCT00098839|Antiviral Agents|antiviral agents|mesh-ancestor
25479262|NCT00098839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25479263|NCT00098839|Antidotes|antidotes|mesh-ancestor
25479264|NCT00098839|Protective Agents|protective agents|mesh-ancestor
25479265|NCT00098839|Vitamin B Complex|vitamin b complex|mesh-ancestor
25479266|NCT00098839|Vitamins|vitamins|mesh-ancestor
25479267|NCT00098839|Micronutrients|micronutrients|mesh-ancestor
25479268|NCT00098839|Tubulin Modulators|tubulin modulators|mesh-ancestor
25479269|NCT00098839|Antimitotic Agents|antimitotic agents|mesh-ancestor
25479270|NCT00098839|Mitosis Modulators|mitosis modulators|mesh-ancestor
25479271|NCT00098839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25479272|NCT00098839|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25479273|NCT00098865|Thalidomide|thalidomide|mesh-list
25479274|NCT00098865|Temozolomide|temozolomide|mesh-list
25479275|NCT00098865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25479276|NCT00098865|Alkylating Agents|alkylating agents|mesh-ancestor
25479277|NCT00098865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479278|NCT00098865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479279|NCT00098865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25479280|NCT00098865|Immunologic Factors|immunologic factors|mesh-ancestor
25479281|NCT00098865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479282|NCT00098865|Leprostatic Agents|leprostatic agents|mesh-ancestor
25479283|NCT00098865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25479284|NCT00098865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25479285|NCT00098865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25479286|NCT00098865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25479287|NCT00098865|Growth Substances|growth substances|mesh-ancestor
25479288|NCT00098865|Growth Inhibitors|growth inhibitors|mesh-ancestor
25479289|NCT00098956|Topotecan|topotecan|mesh-list
25479290|NCT00098956|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
25479291|NCT00098956|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25479292|NCT00098956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25479293|NCT00098956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479294|NCT00098956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479295|NCT00098956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479296|NCT00098956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25479297|NCT00099021|Pioglitazone|pioglitazone|mesh-list
25479298|NCT00099021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25479299|NCT00099021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479300|NCT00099047|Celecoxib|celecoxib|mesh-list
25479301|NCT00099047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25479302|NCT00099047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25479303|NCT00099047|Analgesics|analgesics|mesh-ancestor
25479304|NCT00099047|Sensory System Agents|sensory system agents|mesh-ancestor
25479305|NCT00099047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25479306|NCT00099047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479307|NCT00099047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25479308|NCT00099047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25479309|NCT00099047|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25479310|NCT00099047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25479311|NCT00099047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479312|NCT00099047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479314|NCT00099268|Carbidopa|carbidopa|mesh-list
25479315|NCT00099268|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25479316|NCT00099268|Entacapone|entacapone|mesh-list
25479317|NCT00099268|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25479318|NCT00099268|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25479319|NCT00099268|Dopamine Agents|dopamine agents|mesh-ancestor
25479320|NCT00099268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25479321|NCT00099268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479322|NCT00099268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479323|NCT00099268|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25479324|NCT00099268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565826|NCT00782951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24565827|NCT00783016|Morphine|morphine|mesh-list
25479334|NCT00099359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25479335|NCT00099359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479336|NCT00099359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479338|NCT00099359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25479339|NCT00099359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25479340|NCT00099359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25479341|NCT00099359|Antimetabolites|antimetabolites|mesh-ancestor
25479342|NCT00099359|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25479343|NCT00099359|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25479344|NCT00099359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25479345|NCT00099359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25479346|NCT00099359|Protease Inhibitors|protease inhibitors|mesh-ancestor
25479347|NCT00099632|Ritonavir|ritonavir|mesh-list
25479348|NCT00099632|Lopinavir|lopinavir|mesh-list
25479349|NCT00099632|Tenofovir|tenofovir|mesh-list
25479350|NCT00099632|Lamivudine|lamivudine|mesh-list
25479351|NCT00099632|Zidovudine|zidovudine|mesh-list
25479352|NCT00099632|Emtricitabine|emtricitabine|mesh-list
25479353|NCT00099632|Nevirapine|nevirapine|mesh-list
25479354|NCT00099632|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25479355|NCT00099632|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25479356|NCT00099632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25479357|NCT00099632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25479358|NCT00099632|Protease Inhibitors|protease inhibitors|mesh-ancestor
25479359|NCT00099632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479360|NCT00099632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479361|NCT00099632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25479362|NCT00099632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25479363|NCT00099632|Antiviral Agents|antiviral agents|mesh-ancestor
25479364|NCT00099632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25479365|NCT00099632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25479366|NCT00099632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25479367|NCT00099632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25479368|NCT00099632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25479369|NCT00099632|Antimetabolites|antimetabolites|mesh-ancestor
25479370|NCT00099632|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25479371|NCT00099632|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25479372|NCT00099983|Risperidone|risperidone|mesh-list
25479373|NCT00099983|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25479374|NCT00099983|Serotonin Agents|serotonin agents|mesh-ancestor
25479375|NCT00099983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25479376|NCT00099983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479377|NCT00099983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479378|NCT00099983|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25479379|NCT00099983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25479380|NCT00099983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25479381|NCT00099983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25479382|NCT00099983|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25479383|NCT00099983|Dopamine Agents|dopamine agents|mesh-ancestor
25479384|NCT00100048|Tenofovir|tenofovir|mesh-list
25479385|NCT00100048|Lamivudine|lamivudine|mesh-list
25479386|NCT00100048|Efavirenz|efavirenz|mesh-list
25479387|NCT00100048|Raltegravir Potassium|raltegravir potassium|mesh-list
25479388|NCT00100048|Antiviral Agents|antiviral agents|mesh-ancestor
25479389|NCT00100048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25479390|NCT00100048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25479391|NCT00100048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25479392|NCT00100048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822956|NCT00004727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25822957|NCT00004727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25822958|NCT00004727|Analgesics|analgesics|mesh-ancestor
24851931|NCT02259829|Vasodilator Agents|vasodilator agents|mesh-ancestor
24445855|NCT00302822|Tenofovir|tenofovir|mesh-list
25479393|NCT00100048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479394|NCT00100048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25479395|NCT00100048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25479398|NCT00100048|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25479399|NCT00100048|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25479400|NCT00100048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25479401|NCT00100048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25479402|NCT00100048|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25479403|NCT00100048|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25479404|NCT00100165|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
25479405|NCT00100165|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25479406|NCT00100165|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25479407|NCT00100165|Cholinergic Agents|cholinergic agents|mesh-ancestor
25479408|NCT00100165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25479409|NCT00100165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479410|NCT00100165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479411|NCT00100178|Mycophenolic Acid|mycophenolic acid|mesh-list
25479412|NCT00100178|Daclizumab|daclizumab|mesh-list
25479413|NCT00100178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25479414|NCT00100178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479415|NCT00100178|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25479416|NCT00100178|Antitubercular Agents|antitubercular agents|mesh-ancestor
25479417|NCT00100178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25479418|NCT00100178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25479419|NCT00100178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479420|NCT00100178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479421|NCT00100178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25479422|NCT00100178|Immunologic Factors|immunologic factors|mesh-ancestor
25479423|NCT00100178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479424|NCT00100659|Interferons|interferons|mesh-list
25479425|NCT00100659|Ribavirin|ribavirin|mesh-list
25479426|NCT00100659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479427|NCT00100659|Antiviral Agents|antiviral agents|mesh-ancestor
25479428|NCT00100659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25479429|NCT00100659|Antimetabolites|antimetabolites|mesh-ancestor
25479430|NCT00100659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479431|NCT00100698|Hormones|hormones|mesh-list
25479432|NCT00100698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25479433|NCT00100698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479434|NCT00100789|Gemcitabine|gemcitabine|mesh-list
25479435|NCT00100789|Paclitaxel|paclitaxel|mesh-list
25479436|NCT00100789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25479437|NCT00100789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479438|NCT00100789|Tubulin Modulators|tubulin modulators|mesh-ancestor
25479439|NCT00100789|Antimitotic Agents|antimitotic agents|mesh-ancestor
25479440|NCT00100789|Mitosis Modulators|mitosis modulators|mesh-ancestor
25479441|NCT00100789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479442|NCT00100789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25479443|NCT00100789|Antimetabolites|antimetabolites|mesh-ancestor
25479444|NCT00100789|Antiviral Agents|antiviral agents|mesh-ancestor
25479445|NCT00100789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25479446|NCT00100789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479447|NCT00100789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25479448|NCT00100789|Immunologic Factors|immunologic factors|mesh-ancestor
25479449|NCT00100789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479450|NCT00100802|Temozolomide|temozolomide|mesh-list
25479451|NCT00100802|Lomustine|lomustine|mesh-list
25479452|NCT00100802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25479453|NCT00100802|Alkylating Agents|alkylating agents|mesh-ancestor
25479454|NCT00100802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479455|NCT00100802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479456|NCT00100815|Gemcitabine|gemcitabine|mesh-list
25479457|NCT00100815|Bevacizumab|bevacizumab|mesh-list
25479458|NCT00100815|Capecitabine|capecitabine|mesh-list
25479459|NCT00100815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25479460|NCT00100815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479461|NCT00100815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25479462|NCT00100815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25479463|NCT00100815|Growth Substances|growth substances|mesh-ancestor
24852030|NCT02260011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25479464|NCT00100815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479466|NCT00100815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25479467|NCT00100815|Antimetabolites|antimetabolites|mesh-ancestor
25479468|NCT00100815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479469|NCT00100815|Antiviral Agents|antiviral agents|mesh-ancestor
25479470|NCT00100815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25479471|NCT00100815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479472|NCT00100815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25479473|NCT00100815|Immunologic Factors|immunologic factors|mesh-ancestor
25479474|NCT00100841|Leucovorin|leucovorin|mesh-list
25479475|NCT00100841|Bevacizumab|bevacizumab|mesh-list
25479476|NCT00100841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25479477|NCT00100841|Cetuximab|cetuximab|mesh-list
25479478|NCT00100841|Fluorouracil|fluorouracil|mesh-list
25479479|NCT00100841|Oxaliplatin|oxaliplatin|mesh-list
25479480|NCT00100841|Antibodies|antibodies|mesh-list
25479481|NCT00100841|Immunoglobulins|immunoglobulins|mesh-list
25479482|NCT00100841|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25479483|NCT00100841|Levoleucovorin|levoleucovorin|mesh-list
25479484|NCT00100841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479485|NCT00100841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25479486|NCT00100841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25479487|NCT00100841|Growth Substances|growth substances|mesh-ancestor
25479488|NCT00100841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479489|NCT00100841|Growth Inhibitors|growth inhibitors|mesh-ancestor
25479490|NCT00100841|Immunologic Factors|immunologic factors|mesh-ancestor
25479491|NCT00100841|Antimetabolites|antimetabolites|mesh-ancestor
25479492|NCT00100841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479493|NCT00100841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25479494|NCT00100841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25479495|NCT00100841|Antidotes|antidotes|mesh-ancestor
25479496|NCT00100841|Protective Agents|protective agents|mesh-ancestor
25479497|NCT00100841|Vitamin B Complex|vitamin b complex|mesh-ancestor
25479498|NCT00100841|Vitamins|vitamins|mesh-ancestor
25479499|NCT00100841|Micronutrients|micronutrients|mesh-ancestor
25479500|NCT00101010|Prednisone|prednisone|mesh-list
25479501|NCT00101010|Cyclophosphamide|cyclophosphamide|mesh-list
25479502|NCT00101010|Rituximab|rituximab|mesh-list
25479503|NCT00101010|Doxorubicin|doxorubicin|mesh-list
25479504|NCT00101010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25479505|NCT00101010|Vincristine|vincristine|mesh-list
25479506|NCT00101010|Lenograstim|lenograstim|mesh-list
25479507|NCT00101010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25479508|NCT00101010|Immunologic Factors|immunologic factors|mesh-ancestor
25479509|NCT00101010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479510|NCT00101010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25479511|NCT00101010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25479512|NCT00101010|Alkylating Agents|alkylating agents|mesh-ancestor
25479513|NCT00101010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479514|NCT00101010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479515|NCT00101010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25479516|NCT00101010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25479517|NCT00101010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25479518|NCT00101010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25479519|NCT00101010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25479520|NCT00101010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479521|NCT00101010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25479522|NCT00101010|Glucocorticoids|glucocorticoids|mesh-ancestor
25479523|NCT00101010|Hormones|hormones|mesh-ancestor
25479524|NCT00101010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25479525|NCT00101010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25479526|NCT00101010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25479527|NCT00101010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25479528|NCT00101010|Tubulin Modulators|tubulin modulators|mesh-ancestor
25479529|NCT00101010|Antimitotic Agents|antimitotic agents|mesh-ancestor
25479530|NCT00101010|Mitosis Modulators|mitosis modulators|mesh-ancestor
25479531|NCT00101036|Lapatinib|lapatinib|mesh-list
25479532|NCT00101036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479533|NCT00101036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25479534|NCT00101036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479535|NCT00101036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479536|NCT00101166|Vaccines|vaccines|mesh-list
25644888|NCT01441570|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25479537|NCT00101166|Immunologic Factors|immunologic factors|mesh-ancestor
25479538|NCT00101166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479539|NCT00101192|Cisplatin|cisplatin|mesh-list
25479540|NCT00101192|Cetuximab|cetuximab|mesh-list
25479541|NCT00101192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479542|NCT00101192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25479544|NCT00101283|Carboplatin|carboplatin|mesh-list
25479545|NCT00101283|Pemetrexed|pemetrexed|mesh-list
25479546|NCT00101283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479547|NCT00101283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25479548|NCT00101283|Antimetabolites|antimetabolites|mesh-ancestor
25479549|NCT00101283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479550|NCT00101283|Antiviral Agents|antiviral agents|mesh-ancestor
25479551|NCT00101283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25479552|NCT00101283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479553|NCT00101283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25479554|NCT00101283|Immunologic Factors|immunologic factors|mesh-ancestor
25479555|NCT00101283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479556|NCT00101283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25479557|NCT00101283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25479558|NCT00101361|Oxandrolone|oxandrolone|mesh-list
25479559|NCT00101361|Androgens|androgens|mesh-ancestor
25479560|NCT00101361|Hormones|hormones|mesh-ancestor
25479561|NCT00101361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25479562|NCT00101361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479563|NCT00101361|Anabolic Agents|anabolic agents|mesh-ancestor
25479564|NCT00101400|Sorafenib|sorafenib|mesh-list
25479565|NCT00101400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479566|NCT00101400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25479567|NCT00101400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479568|NCT00101400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479569|NCT00101413|Sorafenib|sorafenib|mesh-list
25479570|NCT00101413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479571|NCT00101413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25479572|NCT00101413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479573|NCT00101413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479574|NCT00101452|Citalopram|citalopram|mesh-list
25479575|NCT00101452|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25479576|NCT00101452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25479577|NCT00101452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25479578|NCT00101452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479579|NCT00101452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25479580|NCT00101452|Serotonin Agents|serotonin agents|mesh-ancestor
25479581|NCT00101452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479582|NCT00101452|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25479583|NCT00101452|Antidepressive Agents|antidepressive agents|mesh-ancestor
25479584|NCT00101452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25479585|NCT00101582|Cisplatin|cisplatin|mesh-list
25479586|NCT00101582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479587|NCT00101647|Dasatinib|dasatinib|mesh-list
25479588|NCT00101647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479589|NCT00101647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25479590|NCT00101647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479591|NCT00101647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479592|NCT00101660|Dasatinib|dasatinib|mesh-list
25479593|NCT00101660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479594|NCT00101660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25479595|NCT00101660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479596|NCT00101660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479597|NCT00101686|Bevacizumab|bevacizumab|mesh-list
25479598|NCT00101686|Capecitabine|capecitabine|mesh-list
25479599|NCT00101686|Irinotecan|irinotecan|mesh-list
25479600|NCT00101686|Fluorouracil|fluorouracil|mesh-list
25479601|NCT00101686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25479602|NCT00101686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479603|NCT00101686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25479604|NCT00101686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25479605|NCT00101686|Growth Substances|growth substances|mesh-ancestor
25479606|NCT00101686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479607|NCT00101686|Growth Inhibitors|growth inhibitors|mesh-ancestor
25644889|NCT01441570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25644890|NCT01441570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25479608|NCT00101686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25479609|NCT00101686|Antimetabolites|antimetabolites|mesh-ancestor
25479610|NCT00101686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590555|NCT00913224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24591012|NCT00914667|Warfarin|warfarin|mesh-list
24591143|NCT00915369|Paclitaxel|paclitaxel|mesh-list
24852535|NCT02262702|Analgesics|analgesics|mesh-ancestor
25479611|NCT00101686|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25479612|NCT00101686|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25479613|NCT00101686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479614|NCT00101686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25479615|NCT00101686|Immunologic Factors|immunologic factors|mesh-ancestor
25479616|NCT00101816|Dasatinib|dasatinib|mesh-list
25479617|NCT00101816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479618|NCT00101816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25479619|NCT00101816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479620|NCT00101816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479621|NCT00101907|Gemcitabine|gemcitabine|mesh-list
25479622|NCT00101907|Cisplatin|cisplatin|mesh-list
25479623|NCT00101907|Panitumumab|panitumumab|mesh-list
25479624|NCT00101907|Motesanib diphosphate|motesanib diphosphate|mesh-list
25479625|NCT00101907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479626|NCT00101907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25479627|NCT00101907|Antimetabolites|antimetabolites|mesh-ancestor
25479628|NCT00101907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479629|NCT00101907|Antiviral Agents|antiviral agents|mesh-ancestor
25479630|NCT00101907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25479631|NCT00101907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479632|NCT00101907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25479633|NCT00101907|Immunologic Factors|immunologic factors|mesh-ancestor
25479634|NCT00101907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479635|NCT00101907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25479636|NCT00101907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25479637|NCT00102063|Aripiprazole|aripiprazole|mesh-list
25479638|NCT00102063|Antidepressive Agents|antidepressive agents|mesh-ancestor
25479639|NCT00102063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25479640|NCT00102063|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25479641|NCT00102063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25479642|NCT00102063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25479643|NCT00102063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479644|NCT00102063|Dopamine Agonists|dopamine agonists|mesh-ancestor
25479645|NCT00102063|Dopamine Agents|dopamine agents|mesh-ancestor
25479646|NCT00102063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25479647|NCT00102063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479648|NCT00102063|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25479649|NCT00102063|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25479650|NCT00102063|Serotonin Agents|serotonin agents|mesh-ancestor
25479651|NCT00102063|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25479652|NCT00102063|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25479653|NCT00102063|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25479654|NCT00102063|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25479655|NCT00102440|Allopurinol|allopurinol|mesh-list
25479656|NCT00102440|Febuxostat|febuxostat|mesh-list
25479657|NCT00102440|Antimetabolites|antimetabolites|mesh-ancestor
25479658|NCT00102440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479659|NCT00102440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479660|NCT00102440|Gout Suppressants|gout suppressants|mesh-ancestor
25479661|NCT00102440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25479662|NCT00102440|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25479663|NCT00102440|Antioxidants|antioxidants|mesh-ancestor
25479664|NCT00102440|Protective Agents|protective agents|mesh-ancestor
25479665|NCT00102440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479666|NCT00102518|Aripiprazole|aripiprazole|mesh-list
25479667|NCT00102518|Antidepressive Agents|antidepressive agents|mesh-ancestor
25479668|NCT00102518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25479669|NCT00102518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25479670|NCT00102518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25479671|NCT00102518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25479672|NCT00102518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479673|NCT00102518|Dopamine Agonists|dopamine agonists|mesh-ancestor
25479674|NCT00102518|Dopamine Agents|dopamine agents|mesh-ancestor
25479675|NCT00102518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25479676|NCT00102518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479677|NCT00102518|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25479678|NCT00102518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25479679|NCT00102518|Serotonin Agents|serotonin agents|mesh-ancestor
25479680|NCT00102518|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24602907|NCT00971659|Incretins|incretins|mesh-ancestor
25822959|NCT00004727|Sensory System Agents|sensory system agents|mesh-ancestor
24671166|NCT01324089|Antioxidants|antioxidants|mesh-ancestor
24604613|NCT00980408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25822960|NCT00004727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25479681|NCT00102518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25479682|NCT00102518|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25479683|NCT00102518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25479684|NCT00102531|Cisplatin|cisplatin|mesh-list
25479685|NCT00102531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479686|NCT00102687|Azacitidine|azacitidine|mesh-list
25479687|NCT00102687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25479688|NCT00102687|Antimetabolites|antimetabolites|mesh-ancestor
25479689|NCT00102687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479690|NCT00102687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479691|NCT00102687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479692|NCT00102804|Pemetrexed|pemetrexed|mesh-list
25479693|NCT00102804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479694|NCT00102804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479695|NCT00102804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479696|NCT00102804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25479697|NCT00102804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25479698|NCT00102960|Ritonavir|ritonavir|mesh-list
25479699|NCT00102960|Lopinavir|lopinavir|mesh-list
25479700|NCT00102960|Lamivudine|lamivudine|mesh-list
25479701|NCT00102960|Zidovudine|zidovudine|mesh-list
25479702|NCT00102960|Nevirapine|nevirapine|mesh-list
25479703|NCT00102960|Abacavir|abacavir|mesh-list
25479704|NCT00102960|Didanosine|didanosine|mesh-list
25479705|NCT00102960|Efavirenz|efavirenz|mesh-list
25479706|NCT00102960|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25479707|NCT00102960|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25479708|NCT00102960|Protease Inhibitors|protease inhibitors|mesh-ancestor
25479709|NCT00102960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479710|NCT00102960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479711|NCT00102960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25479712|NCT00102960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25479713|NCT00102960|Antiviral Agents|antiviral agents|mesh-ancestor
25479714|NCT00102960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25479715|NCT00102960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25479716|NCT00102960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25479717|NCT00102960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25479718|NCT00102960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25479719|NCT00102960|Antimetabolites|antimetabolites|mesh-ancestor
25479720|NCT00102960|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25479721|NCT00102960|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25479722|NCT00102960|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25479723|NCT00102960|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25479724|NCT00102960|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25479725|NCT00103116|Vaccines|vaccines|mesh-list
25479726|NCT00103116|Immunologic Factors|immunologic factors|mesh-ancestor
25479727|NCT00103116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479728|NCT00103142|Sargramostim|sargramostim|mesh-list
25479729|NCT00103142|Immunologic Factors|immunologic factors|mesh-ancestor
25479730|NCT00103142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479731|NCT00103194|Lapatinib|lapatinib|mesh-list
25479732|NCT00103194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479733|NCT00103194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25479734|NCT00103194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479735|NCT00103194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479736|NCT00103207|Cetuximab|cetuximab|mesh-list
25479737|NCT00103207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25479738|NCT00103207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479739|NCT00103259|Irinotecan|irinotecan|mesh-list
25479740|NCT00103259|Bortezomib|bortezomib|mesh-list
25479741|NCT00103259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25479742|NCT00103259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25479743|NCT00103259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479744|NCT00103259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479745|NCT00103259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479746|NCT00103285|Calcium, Dietary|calcium, dietary|mesh-list
25479747|NCT00103285|Leucovorin|leucovorin|mesh-list
25479748|NCT00103285|Folic Acid|folic acid|mesh-list
25479749|NCT00103285|Cytarabine|cytarabine|mesh-list
25479750|NCT00103285|Dexamethasone|dexamethasone|mesh-list
25479751|NCT00103285|Dexamethasone acetate|dexamethasone acetate|mesh-list
25479752|NCT00103285|Cyclophosphamide|cyclophosphamide|mesh-list
25479753|NCT00103285|Doxorubicin|doxorubicin|mesh-list
25479754|NCT00103285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25479755|NCT00103285|Methotrexate|methotrexate|mesh-list
24929093|NCT04115423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24528114|NCT00619840|Methylphenidate|methylphenidate|mesh-list
24929137|NCT04115410|Mitomycin|mitomycin|mesh-list
25479756|NCT00103285|Vincristine|vincristine|mesh-list
25479757|NCT00103285|Asparaginase|asparaginase|mesh-list
25479758|NCT00103285|Mercaptopurine|mercaptopurine|mesh-list
25479759|NCT00103285|Pegaspargase|pegaspargase|mesh-list
25479760|NCT00103285|Thioguanine|thioguanine|mesh-list
25479761|NCT00103285|BB 1101|bb 1101|mesh-list
25479762|NCT00103285|Calcium|calcium|mesh-list
25479763|NCT00103285|2-Aminopurine|2-aminopurine|mesh-list
25479764|NCT00103285|Levoleucovorin|levoleucovorin|mesh-list
25479765|NCT00103285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25479766|NCT00103285|Immunologic Factors|immunologic factors|mesh-ancestor
25479767|NCT00103285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479768|NCT00103285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25479769|NCT00103285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25479770|NCT00103285|Alkylating Agents|alkylating agents|mesh-ancestor
25479771|NCT00103285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479772|NCT00103285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479773|NCT00103285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25479774|NCT00103285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25479775|NCT00103285|Antiemetics|antiemetics|mesh-ancestor
25479776|NCT00103285|Autonomic Agents|autonomic agents|mesh-ancestor
25479777|NCT00103285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25479778|NCT00103285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25479779|NCT00103285|Glucocorticoids|glucocorticoids|mesh-ancestor
25479780|NCT00103285|Hormones|hormones|mesh-ancestor
25479781|NCT00103285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25479782|NCT00103285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25479783|NCT00103285|Protease Inhibitors|protease inhibitors|mesh-ancestor
25479784|NCT00103285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479785|NCT00103285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25479786|NCT00103285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25479787|NCT00103285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25479788|NCT00103285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25479789|NCT00103285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25479790|NCT00103285|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25479791|NCT00103285|Abortifacient Agents|abortifacient agents|mesh-ancestor
25479792|NCT00103285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25479793|NCT00103285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25479794|NCT00103285|Antimetabolites|antimetabolites|mesh-ancestor
25479795|NCT00103285|Dermatologic Agents|dermatologic agents|mesh-ancestor
25479796|NCT00103285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25479797|NCT00103285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25479798|NCT00103285|Antiviral Agents|antiviral agents|mesh-ancestor
25479799|NCT00103285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25479800|NCT00103285|Antidotes|antidotes|mesh-ancestor
25479801|NCT00103285|Protective Agents|protective agents|mesh-ancestor
25479802|NCT00103285|Vitamin B Complex|vitamin b complex|mesh-ancestor
25479803|NCT00103285|Vitamins|vitamins|mesh-ancestor
25479804|NCT00103285|Micronutrients|micronutrients|mesh-ancestor
25479805|NCT00103285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25479806|NCT00103285|Tubulin Modulators|tubulin modulators|mesh-ancestor
25479807|NCT00103285|Antimitotic Agents|antimitotic agents|mesh-ancestor
25479808|NCT00103285|Mitosis Modulators|mitosis modulators|mesh-ancestor
25479809|NCT00103285|Hematinics|hematinics|mesh-ancestor
25479810|NCT00103376|Bortezomib|bortezomib|mesh-list
25479811|NCT00103376|Androgens|androgens|mesh-list
25479812|NCT00103376|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
25479813|NCT00103376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479814|NCT00103376|Hormones|hormones|mesh-ancestor
25479815|NCT00103376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25479816|NCT00103376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479817|NCT00103376|Androgen Antagonists|androgen antagonists|mesh-ancestor
25479818|NCT00103376|Hormone Antagonists|hormone antagonists|mesh-ancestor
25479819|NCT00103402|Alfuzosin|alfuzosin|mesh-list
25479820|NCT00103402|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25479821|NCT00103402|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25479822|NCT00103402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25479823|NCT00103402|Adrenergic Agents|adrenergic agents|mesh-ancestor
25479824|NCT00103402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24932727|NCT04077580|Renal Agents|renal agents|mesh-ancestor
24932854|NCT04076137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24854733|NCT02275039|Vaccines|vaccines|mesh-list
25644891|NCT01441596|Vinorelbine|vinorelbine|mesh-list
24933214|NCT04073056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24634796|NCT01135433|Metformin|metformin|mesh-list
24934111|NCT04063683|Paclitaxel|paclitaxel|mesh-list
24934346|NCT04061772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24934347|NCT04061772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479825|NCT00103402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479826|NCT00103402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479827|NCT00103402|Urological Agents|urological agents|mesh-ancestor
25479828|NCT00103506|Doxorubicin|doxorubicin|mesh-list
25479829|NCT00103506|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25479830|NCT00103506|Bortezomib|bortezomib|mesh-list
25479831|NCT00103506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25479832|NCT00103506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479833|NCT00103506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25479834|NCT00103506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25479835|NCT00103506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479836|NCT00103506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479837|NCT00103610|Plerixafor|plerixafor|mesh-list
25479838|NCT00103610|Lenograstim|lenograstim|mesh-list
25479839|NCT00103610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25479840|NCT00103610|Immunologic Factors|immunologic factors|mesh-ancestor
25479841|NCT00103610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479842|NCT00103610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25479843|NCT00103610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25479844|NCT00103610|Antiviral Agents|antiviral agents|mesh-ancestor
25479845|NCT00103610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25479846|NCT00103662|Plerixafor|plerixafor|mesh-list
25479847|NCT00103662|Lenograstim|lenograstim|mesh-list
25479848|NCT00103662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25479849|NCT00103662|Immunologic Factors|immunologic factors|mesh-ancestor
25479850|NCT00103662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479851|NCT00103662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25479852|NCT00103662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25479853|NCT00103662|Antiviral Agents|antiviral agents|mesh-ancestor
25479854|NCT00103662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25479855|NCT00103740|Vitamin D|vitamin d|mesh-list
25479856|NCT00103740|Zoledronic Acid|zoledronic acid|mesh-list
25479857|NCT00103740|Risedronic Acid|risedronic acid|mesh-list
25479858|NCT00103740|Etidronic Acid|etidronic acid|mesh-list
25479859|NCT00103740|Calcium|calcium|mesh-list
25479860|NCT00103740|Vitamins|vitamins|mesh-ancestor
25479861|NCT00103740|Micronutrients|micronutrients|mesh-ancestor
25479862|NCT00103740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479863|NCT00103740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25479864|NCT00103740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25479865|NCT00103740|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25479866|NCT00103740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25479867|NCT00103740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479868|NCT00103844|Imatinib Mesylate|imatinib mesylate|mesh-list
25479869|NCT00103844|Dasatinib|dasatinib|mesh-list
25479870|NCT00103844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479871|NCT00103844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25479872|NCT00103844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479873|NCT00103844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479874|NCT00103857|Metformin|metformin|mesh-list
25479875|NCT00103857|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25479876|NCT00103857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25479877|NCT00103857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479878|NCT00103857|Incretins|incretins|mesh-ancestor
25479879|NCT00103857|Hormones|hormones|mesh-ancestor
25479880|NCT00103857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25479881|NCT00103857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25479882|NCT00103857|Protease Inhibitors|protease inhibitors|mesh-ancestor
25479883|NCT00103857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479884|NCT00103857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479885|NCT00104052|Ribavirin|ribavirin|mesh-list
25479886|NCT00104052|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25479887|NCT00104052|Interferon-alpha|interferon-alpha|mesh-list
25479888|NCT00104052|Antimetabolites|antimetabolites|mesh-ancestor
25479889|NCT00104052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479890|NCT00104052|Antiviral Agents|antiviral agents|mesh-ancestor
25479891|NCT00104052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25479892|NCT00104052|Immunologic Factors|immunologic factors|mesh-ancestor
25479893|NCT00104052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479894|NCT00104104|Zoledronic Acid|zoledronic acid|mesh-list
25479895|NCT00104104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25479896|NCT00104104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479898|NCT00104247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24456013|NCT00329589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24456014|NCT00329615|Isophane Insulin, Human|isophane insulin, human|mesh-list
24456015|NCT00329615|Insulin, Isophane|insulin, isophane|mesh-list
25479900|NCT00104247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25479901|NCT00104247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479902|NCT00104247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25479903|NCT00104247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479904|NCT00104247|Vasodilator Agents|vasodilator agents|mesh-ancestor
25479905|NCT00104299|Prednisone|prednisone|mesh-list
25479906|NCT00104299|Methylprednisolone|methylprednisolone|mesh-list
25479907|NCT00104299|Cyclophosphamide|cyclophosphamide|mesh-list
25479908|NCT00104299|Rituximab|rituximab|mesh-list
25479909|NCT00104299|Azathioprine|azathioprine|mesh-list
25479910|NCT00104299|Glucocorticoids|glucocorticoids|mesh-list
25479911|NCT00104299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25479912|NCT00104299|Immunologic Factors|immunologic factors|mesh-ancestor
25479913|NCT00104299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479914|NCT00104299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25479915|NCT00104299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25479916|NCT00104299|Alkylating Agents|alkylating agents|mesh-ancestor
25479917|NCT00104299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479918|NCT00104299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479919|NCT00104299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25479920|NCT00104299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25479921|NCT00104299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25479922|NCT00104299|Hormones|hormones|mesh-ancestor
25352753|NCT05489952|Iron|iron|mesh-list
25479923|NCT00104299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25479924|NCT00104299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25479925|NCT00104299|Antiemetics|antiemetics|mesh-ancestor
25479926|NCT00104299|Autonomic Agents|autonomic agents|mesh-ancestor
25479927|NCT00104299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25479928|NCT00104299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25479929|NCT00104299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25479930|NCT00104299|Protective Agents|protective agents|mesh-ancestor
25479931|NCT00104299|Antimetabolites|antimetabolites|mesh-ancestor
25479932|NCT00104299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25479933|NCT00104416|Lamotrigine|lamotrigine|mesh-list
25479934|NCT00104416|Anticonvulsants|anticonvulsants|mesh-ancestor
25479935|NCT00104416|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25479936|NCT00104416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25479937|NCT00104416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479938|NCT00104416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25479939|NCT00104416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479940|NCT00104416|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25479941|NCT00104416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25479942|NCT00104416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25479943|NCT00104416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25479944|NCT00104416|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25479945|NCT00104572|Vitamin D|vitamin d|mesh-list
25479946|NCT00104572|Anastrozole|anastrozole|mesh-list
25479947|NCT00104572|Calcium|calcium|mesh-list
25479948|NCT00104572|Testosterone|testosterone|mesh-list
25479949|NCT00104572|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25479950|NCT00104572|Vitamins|vitamins|mesh-ancestor
25479951|NCT00104572|Micronutrients|micronutrients|mesh-ancestor
25479952|NCT00104572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479953|NCT00104572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25479954|NCT00104572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25479955|NCT00104572|Androgens|androgens|mesh-ancestor
25479956|NCT00104572|Hormones|hormones|mesh-ancestor
25479957|NCT00104572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25479958|NCT00104572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25479959|NCT00104572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479960|NCT00104572|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25479961|NCT00104572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479962|NCT00104572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479963|NCT00104572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25479964|NCT00104572|Hormone Antagonists|hormone antagonists|mesh-ancestor
25479965|NCT00104637|Sildenafil Citrate|sildenafil citrate|mesh-list
25479966|NCT00104637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479967|NCT00104637|Vasodilator Agents|vasodilator agents|mesh-ancestor
25644892|NCT01441596|Afatinib|afatinib|mesh-list
25644893|NCT01441596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25644894|NCT01441596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25644895|NCT01441596|Tubulin Modulators|tubulin modulators|mesh-ancestor
25479968|NCT00104637|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25479969|NCT00104637|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25644896|NCT01441596|Antimitotic Agents|antimitotic agents|mesh-ancestor
25644897|NCT01441596|Mitosis Modulators|mitosis modulators|mesh-ancestor
25479970|NCT00104637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479971|NCT00104637|Urological Agents|urological agents|mesh-ancestor
25479972|NCT00104650|Diphosphonates|diphosphonates|mesh-list
25479973|NCT00104650|Denosumab|denosumab|mesh-list
25479974|NCT00104650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25479975|NCT00104650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479976|NCT00104858|Cyclosporine|cyclosporine|mesh-list
25479977|NCT00104858|Mycophenolic Acid|mycophenolic acid|mesh-list
25479978|NCT00104858|Rituximab|rituximab|mesh-list
25479979|NCT00104858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25479980|NCT00104858|Fludarabine|fludarabine|mesh-list
25479981|NCT00104858|Fludarabine phosphate|fludarabine phosphate|mesh-list
25479982|NCT00104858|Antibodies|antibodies|mesh-list
25479983|NCT00104858|Immunoglobulins|immunoglobulins|mesh-list
25479984|NCT00104858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25479985|NCT00104858|Cyclosporins|cyclosporins|mesh-list
25479986|NCT00104858|Immunologic Factors|immunologic factors|mesh-ancestor
25479987|NCT00104858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25479988|NCT00104858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25479989|NCT00104858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25479990|NCT00104858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25479991|NCT00104858|Antimetabolites|antimetabolites|mesh-ancestor
25479992|NCT00104858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25479993|NCT00104858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25479994|NCT00104858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25479995|NCT00104858|Antifungal Agents|antifungal agents|mesh-ancestor
25479996|NCT00104858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25479997|NCT00104858|Dermatologic Agents|dermatologic agents|mesh-ancestor
25479998|NCT00104858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25479999|NCT00104858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25480000|NCT00104858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25480001|NCT00104858|Antitubercular Agents|antitubercular agents|mesh-ancestor
25480002|NCT00104858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25480003|NCT00104871|Bortezomib|bortezomib|mesh-list
25480004|NCT00104871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480005|NCT00104884|Romidepsin|romidepsin|mesh-list
25480006|NCT00104884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25480007|NCT00104884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480008|NCT00105001|Mycophenolic Acid|mycophenolic acid|mesh-list
25480009|NCT00105001|Sirolimus|sirolimus|mesh-list
25480010|NCT00105001|Fludarabine|fludarabine|mesh-list
25480011|NCT00105001|Fludarabine phosphate|fludarabine phosphate|mesh-list
25480012|NCT00105001|Tacrolimus|tacrolimus|mesh-list
25480013|NCT00105001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480014|NCT00105001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25480015|NCT00105001|Antimetabolites|antimetabolites|mesh-ancestor
25480016|NCT00105001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480017|NCT00105001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25480018|NCT00105001|Immunologic Factors|immunologic factors|mesh-ancestor
25480019|NCT00105001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480020|NCT00105001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25480021|NCT00105001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480022|NCT00105001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25480023|NCT00105001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25480024|NCT00105001|Antitubercular Agents|antitubercular agents|mesh-ancestor
25480025|NCT00105001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25480026|NCT00105001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25480027|NCT00105001|Antifungal Agents|antifungal agents|mesh-ancestor
25480028|NCT00105027|Triamcinolone|triamcinolone|mesh-list
25480029|NCT00105027|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25480030|NCT00105027|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25480031|NCT00105027|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25480032|NCT00105027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25480033|NCT00105027|Glucocorticoids|glucocorticoids|mesh-ancestor
25480034|NCT00105027|Hormones|hormones|mesh-ancestor
25480035|NCT00105027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25480036|NCT00105027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480037|NCT00105027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24423897|NCT00227357|Naloxone|naloxone|mesh-list
25829459|NCT00006212|Vinblastine|vinblastine|mesh-list
25822961|NCT00004727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644898|NCT01441596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822962|NCT00004727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25822963|NCT00004727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24647076|NCT01206049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25822964|NCT00004727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25822965|NCT00004727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25822966|NCT00004727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822967|NCT00004727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25822968|NCT00004727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25822969|NCT00004727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822970|NCT00004727|Antipyretics|antipyretics|mesh-ancestor
25822971|NCT00004727|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25822972|NCT00004727|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25644899|NCT01441596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25644900|NCT01441596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25644901|NCT01441635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25644902|NCT01441635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25644903|NCT01441635|Norethindrone|norethindrone|mesh-list
25644904|NCT01441635|Norethindrone Acetate|norethindrone acetate|mesh-list
25480038|NCT00105027|Immunologic Factors|immunologic factors|mesh-ancestor
25480039|NCT00105027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480040|NCT00105027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480042|NCT00105066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25480043|NCT00105066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480044|NCT00105079|Ritonavir|ritonavir|mesh-list
25480045|NCT00105079|Lopinavir|lopinavir|mesh-list
25480046|NCT00105079|Saquinavir|saquinavir|mesh-list
25480047|NCT00105079|Tenofovir|tenofovir|mesh-list
25480048|NCT00105079|Emtricitabine|emtricitabine|mesh-list
25480049|NCT00105079|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25480050|NCT00105079|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25480051|NCT00105079|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25480052|NCT00105079|Protease Inhibitors|protease inhibitors|mesh-ancestor
25480053|NCT00105079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480054|NCT00105079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480055|NCT00105079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25480056|NCT00105079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25480057|NCT00105079|Antiviral Agents|antiviral agents|mesh-ancestor
25480058|NCT00105079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25480059|NCT00105079|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25480060|NCT00105079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25480061|NCT00105079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25480062|NCT00105079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25480063|NCT00105157|Raltegravir Potassium|raltegravir potassium|mesh-list
25480064|NCT00105157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25480065|NCT00105157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25480066|NCT00105157|Antiviral Agents|antiviral agents|mesh-ancestor
25480067|NCT00105157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25480068|NCT00105157|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25480069|NCT00105157|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25480070|NCT00105157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480071|NCT00105157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480072|NCT00105183|Immunoglobulins|immunoglobulins|mesh-list
25480073|NCT00105183|Antibodies|antibodies|mesh-list
25480074|NCT00105183|gamma-Globulins|gamma-globulins|mesh-list
25480075|NCT00105183|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25480076|NCT00105183|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25480077|NCT00105183|Immunoglobulin G|immunoglobulin g|mesh-list
25480078|NCT00105183|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25480079|NCT00105183|Immunologic Factors|immunologic factors|mesh-ancestor
25480080|NCT00105183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480081|NCT00105183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25480082|NCT00105196|Aripiprazole|aripiprazole|mesh-list
25480083|NCT00105196|Antidepressive Agents|antidepressive agents|mesh-ancestor
25480084|NCT00105196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25480085|NCT00105196|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25480086|NCT00105196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25480087|NCT00105196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25480088|NCT00105196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480089|NCT00105196|Dopamine Agonists|dopamine agonists|mesh-ancestor
25480090|NCT00105196|Dopamine Agents|dopamine agents|mesh-ancestor
25480091|NCT00105196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24424161|NCT00228046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25480092|NCT00105196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480093|NCT00105196|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25480094|NCT00105196|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25480095|NCT00105196|Serotonin Agents|serotonin agents|mesh-ancestor
25480096|NCT00105196|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25480097|NCT00105196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25480098|NCT00105196|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25480099|NCT00105196|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25480100|NCT00105235|Cyclosporine|cyclosporine|mesh-list
25480101|NCT00105235|Mycophenolic Acid|mycophenolic acid|mesh-list
25480102|NCT00105235|Alemtuzumab|alemtuzumab|mesh-list
25480103|NCT00105235|Tacrolimus|tacrolimus|mesh-list
25480104|NCT00105235|Cyclosporins|cyclosporins|mesh-list
25480105|NCT00105235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25480106|NCT00105235|Immunologic Factors|immunologic factors|mesh-ancestor
25480107|NCT00105235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822973|NCT00004727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24856771|NCT02286752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24856772|NCT02286752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856773|NCT02286752|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25822974|NCT00004727|Purinergic Agents|purinergic agents|mesh-ancestor
25480108|NCT00105235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25480110|NCT00105235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480112|NCT00105235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25480113|NCT00105235|Dermatologic Agents|dermatologic agents|mesh-ancestor
25480114|NCT00105235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25480115|NCT00105235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25480116|NCT00105235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480117|NCT00105235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25480118|NCT00105235|Antitubercular Agents|antitubercular agents|mesh-ancestor
25480119|NCT00105235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25480120|NCT00105235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25480121|NCT00105443|Sorafenib|sorafenib|mesh-list
25480122|NCT00105443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480123|NCT00105443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25480124|NCT00105443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480125|NCT00105443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480126|NCT00105469|Tobramycin|tobramycin|mesh-list
25480127|NCT00105469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25480128|NCT00105469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25480129|NCT00105482|Naltrexone|naltrexone|mesh-list
25480130|NCT00105482|Nicotine|nicotine|mesh-list
25480131|NCT00105482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25480132|NCT00105482|Autonomic Agents|autonomic agents|mesh-ancestor
25480133|NCT00105482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25480134|NCT00105482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480135|NCT00105482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25480136|NCT00105482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25480137|NCT00105482|Cholinergic Agents|cholinergic agents|mesh-ancestor
25480138|NCT00105482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25480139|NCT00105482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480140|NCT00105482|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25480141|NCT00105482|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25480142|NCT00105482|Sensory System Agents|sensory system agents|mesh-ancestor
25480143|NCT00105534|Azithromycin|azithromycin|mesh-list
25480144|NCT00105534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25480145|NCT00105534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25480146|NCT00105586|Citalopram|citalopram|mesh-list
25480147|NCT00105586|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25480148|NCT00105586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25480149|NCT00105586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25480150|NCT00105586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480151|NCT00105586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25480152|NCT00105586|Serotonin Agents|serotonin agents|mesh-ancestor
25480153|NCT00105586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480154|NCT00105586|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25480155|NCT00105586|Antidepressive Agents|antidepressive agents|mesh-ancestor
25480156|NCT00105586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25480157|NCT00105989|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25480158|NCT00105989|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25480159|NCT00105989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25480160|NCT00105989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25480161|NCT00105989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644905|NCT01441635|Estradiol|estradiol|mesh-list
25480162|NCT00105989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25480163|NCT00105989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480164|NCT00105989|Analgesics|analgesics|mesh-ancestor
25480165|NCT00105989|Sensory System Agents|sensory system agents|mesh-ancestor
25480166|NCT00105989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25480167|NCT00105989|Antidepressive Agents|antidepressive agents|mesh-ancestor
25480168|NCT00105989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25480169|NCT00105989|Dopamine Agents|dopamine agents|mesh-ancestor
25480171|NCT00106002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480172|NCT00106002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480173|NCT00106002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480174|NCT00106002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25480175|NCT00106002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25480176|NCT00106028|Risedronic Acid|risedronic acid|mesh-list
25480177|NCT00106028|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25480178|NCT00106028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25480179|NCT00106028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480187|NCT00106184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480188|NCT00106184|Immunologic Factors|immunologic factors|mesh-ancestor
25480189|NCT00106184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480190|NCT00106184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25480191|NCT00106353|Sirolimus|sirolimus|mesh-list
25480192|NCT00106353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25480193|NCT00106353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25480194|NCT00106353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25480195|NCT00106353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480196|NCT00106353|Antifungal Agents|antifungal agents|mesh-ancestor
25480197|NCT00106353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25480198|NCT00106353|Immunologic Factors|immunologic factors|mesh-ancestor
25480199|NCT00106353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480200|NCT00106392|Tacrolimus|tacrolimus|mesh-list
25480201|NCT00106392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25480202|NCT00106392|Immunologic Factors|immunologic factors|mesh-ancestor
25480203|NCT00106392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480204|NCT00106392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25480205|NCT00106392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480206|NCT00106392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480207|NCT00106431|Romidepsin|romidepsin|mesh-list
25480208|NCT00106431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25480209|NCT00106431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480210|NCT00106535|Methotrexate|methotrexate|mesh-list
25480211|NCT00106535|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25480212|NCT00106535|Abortifacient Agents|abortifacient agents|mesh-ancestor
25480213|NCT00106535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25480214|NCT00106535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480215|NCT00106535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25480216|NCT00106535|Antimetabolites|antimetabolites|mesh-ancestor
25480217|NCT00106535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480218|NCT00106535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480219|NCT00106535|Dermatologic Agents|dermatologic agents|mesh-ancestor
25480220|NCT00106535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480221|NCT00106535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25480222|NCT00106535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25480223|NCT00106535|Immunologic Factors|immunologic factors|mesh-ancestor
25480224|NCT00106535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25480225|NCT00106535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25480226|NCT00106639|Tacrolimus|tacrolimus|mesh-list
25480227|NCT00106639|Tofacitinib|tofacitinib|mesh-list
25480228|NCT00106639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25480229|NCT00106639|Immunologic Factors|immunologic factors|mesh-ancestor
25480230|NCT00106639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480231|NCT00106639|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25480232|NCT00106639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480233|NCT00106639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480234|NCT00106639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25480235|NCT00106704|Pioglitazone|pioglitazone|mesh-list
25480236|NCT00106704|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25480237|NCT00106704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25480238|NCT00106704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480239|NCT00106704|Incretins|incretins|mesh-ancestor
25480240|NCT00106704|Hormones|hormones|mesh-ancestor
25480241|NCT00106704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25480242|NCT00106704|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25480244|NCT00106704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480245|NCT00106704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648743|NCT01216644|Antimetabolites|antimetabolites|mesh-ancestor
25480247|NCT00107120|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25480248|NCT00107120|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25480249|NCT00107120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25480250|NCT00107120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480251|NCT00107120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25480252|NCT00107120|Serotonin Agents|serotonin agents|mesh-ancestor
25480253|NCT00107120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480254|NCT00107120|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25480255|NCT00107120|Antidepressive Agents|antidepressive agents|mesh-ancestor
25480256|NCT00107120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25480257|NCT00107276|Cyclophosphamide|cyclophosphamide|mesh-list
25480258|NCT00107276|Capecitabine|capecitabine|mesh-list
25480259|NCT00107276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25480260|NCT00107276|Immunologic Factors|immunologic factors|mesh-ancestor
25480261|NCT00107276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480262|NCT00107276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25480263|NCT00107276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25480264|NCT00107276|Alkylating Agents|alkylating agents|mesh-ancestor
25480265|NCT00107276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480266|NCT00107276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480267|NCT00107276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25480268|NCT00107276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25480269|NCT00107276|Antimetabolites|antimetabolites|mesh-ancestor
25480270|NCT00107380|Prednisone|prednisone|mesh-list
25480271|NCT00107380|Cyclophosphamide|cyclophosphamide|mesh-list
25480272|NCT00107380|Rituximab|rituximab|mesh-list
25480273|NCT00107380|Doxorubicin|doxorubicin|mesh-list
25480274|NCT00107380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25480275|NCT00107380|Vincristine|vincristine|mesh-list
25480276|NCT00107380|Tositumomab I-131|tositumomab i-131|mesh-list
25480277|NCT00107380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25480278|NCT00107380|Immunologic Factors|immunologic factors|mesh-ancestor
25480279|NCT00107380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480280|NCT00107380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25480281|NCT00107380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25480282|NCT00107380|Alkylating Agents|alkylating agents|mesh-ancestor
25480283|NCT00107380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480284|NCT00107380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480285|NCT00107380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25480286|NCT00107380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25480287|NCT00107380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25480288|NCT00107380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25480289|NCT00107380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25480290|NCT00107380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480291|NCT00107380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25480292|NCT00107380|Glucocorticoids|glucocorticoids|mesh-ancestor
25480293|NCT00107380|Hormones|hormones|mesh-ancestor
25480294|NCT00107380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25480295|NCT00107380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25480296|NCT00107380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25480297|NCT00107380|Tubulin Modulators|tubulin modulators|mesh-ancestor
25480298|NCT00107380|Antimitotic Agents|antimitotic agents|mesh-ancestor
25480299|NCT00107380|Mitosis Modulators|mitosis modulators|mesh-ancestor
25480300|NCT00107536|Lapatinib|lapatinib|mesh-list
25480301|NCT00107536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480302|NCT00107536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25480303|NCT00107536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480304|NCT00107536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480305|NCT00107653|Ribavirin|ribavirin|mesh-list
25480306|NCT00107653|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25480307|NCT00107653|Interferon-alpha|interferon-alpha|mesh-list
25480308|NCT00107653|Antimetabolites|antimetabolites|mesh-ancestor
25480309|NCT00107653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480310|NCT00107653|Antiviral Agents|antiviral agents|mesh-ancestor
25480311|NCT00107653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25480312|NCT00107653|Immunologic Factors|immunologic factors|mesh-ancestor
25480313|NCT00107653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480314|NCT00107744|Caseins|caseins|mesh-list
25480315|NCT00107744|Chelating Agents|chelating agents|mesh-ancestor
25480316|NCT00107744|Sequestering Agents|sequestering agents|mesh-ancestor
25480317|NCT00107744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480319|NCT00107783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480320|NCT00107783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480321|NCT00107900|Edoxaban|edoxaban|mesh-list
25480322|NCT00107900|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25480323|NCT00107900|Antithrombins|antithrombins|mesh-ancestor
25480324|NCT00107900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25480325|NCT00107900|Protease Inhibitors|protease inhibitors|mesh-ancestor
25480326|NCT00107900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480327|NCT00107900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480328|NCT00107900|Anticoagulants|anticoagulants|mesh-ancestor
25480329|NCT00107952|Vancomycin|vancomycin|mesh-list
25480330|NCT00107952|Telavancin|telavancin|mesh-list
25480331|NCT00107952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25480332|NCT00107952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25480333|NCT00107978|Vancomycin|vancomycin|mesh-list
25480334|NCT00107978|Telavancin|telavancin|mesh-list
25480335|NCT00107978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25480336|NCT00107978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25480337|NCT00107991|Etanercept|etanercept|mesh-list
25480338|NCT00107991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25480339|NCT00107991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25480340|NCT00107991|Analgesics|analgesics|mesh-ancestor
25480341|NCT00107991|Sensory System Agents|sensory system agents|mesh-ancestor
25480342|NCT00107991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25480343|NCT00107991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480344|NCT00107991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25480345|NCT00107991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25480346|NCT00107991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25480347|NCT00107991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25480348|NCT00107991|Immunologic Factors|immunologic factors|mesh-ancestor
25480349|NCT00108069|Tamoxifen|tamoxifen|mesh-list
25480350|NCT00108069|Bortezomib|bortezomib|mesh-list
25480351|NCT00108069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480352|NCT00108069|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25480353|NCT00108069|Hormone Antagonists|hormone antagonists|mesh-ancestor
25480354|NCT00108069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25480355|NCT00108069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480356|NCT00108069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25480357|NCT00108069|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25480358|NCT00108069|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25480359|NCT00108069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25480360|NCT00108082|Atenolol|atenolol|mesh-list
25480361|NCT00108082|Carvedilol|carvedilol|mesh-list
25480362|NCT00108082|Lisinopril|lisinopril|mesh-list
25480363|NCT00108082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25480364|NCT00108082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25480365|NCT00108082|Adrenergic Agents|adrenergic agents|mesh-ancestor
25480366|NCT00108082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25480367|NCT00108082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480368|NCT00108082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480369|NCT00108082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25480370|NCT00108082|Antioxidants|antioxidants|mesh-ancestor
25480371|NCT00108082|Protective Agents|protective agents|mesh-ancestor
25480372|NCT00108082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25480373|NCT00108082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25480374|NCT00108082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25480375|NCT00108082|Vasodilator Agents|vasodilator agents|mesh-ancestor
25480376|NCT00108082|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25480377|NCT00108082|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25480378|NCT00108082|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25480379|NCT00108082|Protease Inhibitors|protease inhibitors|mesh-ancestor
25480380|NCT00108082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480381|NCT00108082|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25480382|NCT00108082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25480383|NCT00108082|Sympatholytics|sympatholytics|mesh-ancestor
25480384|NCT00108082|Autonomic Agents|autonomic agents|mesh-ancestor
25480385|NCT00108082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25480386|NCT00108082|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25480387|NCT00108160|Mupirocin|mupirocin|mesh-list
25480388|NCT00108160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25480389|NCT00108160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25480390|NCT00108160|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25480391|NCT00108160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480392|NCT00108160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480393|NCT00108355|Octreotide|octreotide|mesh-list
24660601|NCT01284725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25480394|NCT00108355|Midodrine|midodrine|mesh-list
25480396|NCT00108355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25480397|NCT00108355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480398|NCT00108355|Sympathomimetics|sympathomimetics|mesh-ancestor
25480399|NCT00108355|Autonomic Agents|autonomic agents|mesh-ancestor
25480400|NCT00108355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25480401|NCT00108355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480402|NCT00108355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25480403|NCT00108355|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25480404|NCT00108355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25480405|NCT00108355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25480406|NCT00108355|Adrenergic Agents|adrenergic agents|mesh-ancestor
25480407|NCT00108355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25480408|NCT00108355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480409|NCT00108485|Niacin|niacin|mesh-list
25480410|NCT00108485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25480411|NCT00108485|Antimetabolites|antimetabolites|mesh-ancestor
25480412|NCT00108485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480413|NCT00108485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25480414|NCT00108485|Vasodilator Agents|vasodilator agents|mesh-ancestor
25480415|NCT00108485|Vitamin B Complex|vitamin b complex|mesh-ancestor
25480416|NCT00108485|Vitamins|vitamins|mesh-ancestor
25480417|NCT00108485|Micronutrients|micronutrients|mesh-ancestor
25480418|NCT00108485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480419|NCT00108524|Orlistat|orlistat|mesh-list
25480420|NCT00108524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480421|NCT00108524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480422|NCT00108524|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25480423|NCT00108524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25480424|NCT00108550|Gabapentin|gabapentin|mesh-list
25480425|NCT00108550|Analgesics|analgesics|mesh-ancestor
25480426|NCT00108550|Sensory System Agents|sensory system agents|mesh-ancestor
25480427|NCT00108550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25480428|NCT00108550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480429|NCT00108550|Anticonvulsants|anticonvulsants|mesh-ancestor
25480430|NCT00108550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25480431|NCT00108550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25480432|NCT00108550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25480433|NCT00108550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25480434|NCT00108550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25480435|NCT00108550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25480436|NCT00108550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25480437|NCT00108550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480438|NCT00108550|Antimanic Agents|antimanic agents|mesh-ancestor
25480439|NCT00108732|Metronidazole|metronidazole|mesh-list
25480440|NCT00108732|Goserelin|goserelin|mesh-list
25480441|NCT00108732|Bicalutamide|bicalutamide|mesh-list
25480442|NCT00108732|Vaccines|vaccines|mesh-list
25480443|NCT00108732|Sargramostim|sargramostim|mesh-list
25480444|NCT00108732|Immunologic Factors|immunologic factors|mesh-ancestor
25480445|NCT00108732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480446|NCT00108732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480447|NCT00108732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25480448|NCT00108732|Androgen Antagonists|androgen antagonists|mesh-ancestor
25480449|NCT00108732|Hormone Antagonists|hormone antagonists|mesh-ancestor
25480450|NCT00108732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25480451|NCT00108732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25480452|NCT00108732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25480453|NCT00108732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25480454|NCT00108732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25480455|NCT00108745|Paclitaxel|paclitaxel|mesh-list
25480456|NCT00108745|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25480457|NCT00108745|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
25480458|NCT00108745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25480459|NCT00108745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480460|NCT00108745|Tubulin Modulators|tubulin modulators|mesh-ancestor
25480461|NCT00108745|Antimitotic Agents|antimitotic agents|mesh-ancestor
25480462|NCT00108745|Mitosis Modulators|mitosis modulators|mesh-ancestor
25822975|NCT00004727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25822976|NCT00004727|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25822977|NCT00004727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25822978|NCT00004728|Aspirin|aspirin|mesh-list
25644906|NCT01441635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25480464|NCT00108953|Doxorubicin|doxorubicin|mesh-list
25480465|NCT00108953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25480466|NCT00108953|Sorafenib|sorafenib|mesh-list
25480467|NCT00108953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25480468|NCT00108953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480469|NCT00108953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25480470|NCT00108953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25480471|NCT00108953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480472|NCT00108953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480473|NCT00108953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25480474|NCT00109005|Lenalidomide|lenalidomide|mesh-list
25480475|NCT00109005|Immunologic Factors|immunologic factors|mesh-ancestor
25480476|NCT00109005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480477|NCT00109005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25480478|NCT00109005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25480479|NCT00109005|Growth Substances|growth substances|mesh-ancestor
25480480|NCT00109005|Growth Inhibitors|growth inhibitors|mesh-ancestor
25480481|NCT00109005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480482|NCT00109031|Cyclophosphamide|cyclophosphamide|mesh-list
25480483|NCT00109031|Etoposide|etoposide|mesh-list
25480484|NCT00109031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25480485|NCT00109031|Immunologic Factors|immunologic factors|mesh-ancestor
25480486|NCT00109031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480487|NCT00109031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25480488|NCT00109031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25480489|NCT00109031|Alkylating Agents|alkylating agents|mesh-ancestor
25480490|NCT00109031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480491|NCT00109031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480492|NCT00109031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25480493|NCT00109031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25480494|NCT00109031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25480495|NCT00109031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25480496|NCT00109031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480497|NCT00109343|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25480498|NCT00109343|Immunologic Factors|immunologic factors|mesh-ancestor
25480499|NCT00109343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480500|NCT00109473|Prednisone|prednisone|mesh-list
25480501|NCT00109473|Hormones|hormones|mesh-list
25480502|NCT00109473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25480503|NCT00109473|Glucocorticoids|glucocorticoids|mesh-ancestor
25480504|NCT00109473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25480505|NCT00109473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480506|NCT00109473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25480507|NCT00109473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480508|NCT00109590|Ritonavir|ritonavir|mesh-list
25480509|NCT00109590|Lopinavir|lopinavir|mesh-list
25480510|NCT00109590|Zidovudine|zidovudine|mesh-list
25480511|NCT00109590|Nevirapine|nevirapine|mesh-list
25480512|NCT00109590|Didanosine|didanosine|mesh-list
25480513|NCT00109590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25480514|NCT00109590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25480515|NCT00109590|Protease Inhibitors|protease inhibitors|mesh-ancestor
25480516|NCT00109590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480517|NCT00109590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480518|NCT00109590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25480519|NCT00109590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25480520|NCT00109590|Antiviral Agents|antiviral agents|mesh-ancestor
25480521|NCT00109590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25480522|NCT00109590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25480523|NCT00109590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25480524|NCT00109590|Antimetabolites|antimetabolites|mesh-ancestor
25480525|NCT00109590|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25480526|NCT00109590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25480527|NCT00109590|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25822982|NCT00004728|Analgesics|analgesics|mesh-ancestor
25822983|NCT00004728|Sensory System Agents|sensory system agents|mesh-ancestor
25822984|NCT00004728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24429047|NCT00242437|Thrombin|thrombin|mesh-list
25480528|NCT00109590|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25480529|NCT00109733|Hormones|hormones|mesh-list
25480530|NCT00109733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25480531|NCT00109733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480532|NCT00109772|Lenalidomide|lenalidomide|mesh-list
25480533|NCT00109772|Immunologic Factors|immunologic factors|mesh-ancestor
25480534|NCT00109772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480535|NCT00109772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25480536|NCT00109772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25480537|NCT00109772|Growth Substances|growth substances|mesh-ancestor
25480538|NCT00109772|Growth Inhibitors|growth inhibitors|mesh-ancestor
25480539|NCT00109772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480540|NCT00109837|Leucovorin|leucovorin|mesh-list
25480541|NCT00109837|Cytarabine|cytarabine|mesh-list
25480542|NCT00109837|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25480543|NCT00109837|Dexamethasone|dexamethasone|mesh-list
25480544|NCT00109837|Prednisone|prednisone|mesh-list
25480545|NCT00109837|Cyclophosphamide|cyclophosphamide|mesh-list
25480546|NCT00109837|Doxorubicin|doxorubicin|mesh-list
25480547|NCT00109837|Methotrexate|methotrexate|mesh-list
25480548|NCT00109837|Vincristine|vincristine|mesh-list
25480549|NCT00109837|Daunorubicin|daunorubicin|mesh-list
25480550|NCT00109837|Asparaginase|asparaginase|mesh-list
25480551|NCT00109837|Mitoxantrone|mitoxantrone|mesh-list
25480552|NCT00109837|Mercaptopurine|mercaptopurine|mesh-list
25480553|NCT00109837|Thioguanine|thioguanine|mesh-list
25480554|NCT00109837|Allopurinol|allopurinol|mesh-list
25480555|NCT00109837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25480556|NCT00109837|Immunologic Factors|immunologic factors|mesh-ancestor
25480557|NCT00109837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480558|NCT00109837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25480559|NCT00109837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25480560|NCT00109837|Alkylating Agents|alkylating agents|mesh-ancestor
25480561|NCT00109837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480562|NCT00109837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480563|NCT00109837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25480564|NCT00109837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25480565|NCT00109837|Antiemetics|antiemetics|mesh-ancestor
25480566|NCT00109837|Autonomic Agents|autonomic agents|mesh-ancestor
25480567|NCT00109837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25480568|NCT00109837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25480569|NCT00109837|Glucocorticoids|glucocorticoids|mesh-ancestor
25480570|NCT00109837|Hormones|hormones|mesh-ancestor
25480571|NCT00109837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25480572|NCT00109837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25480573|NCT00109837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25480574|NCT00109837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25480575|NCT00109837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25480576|NCT00109837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480577|NCT00109837|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25480578|NCT00109837|Abortifacient Agents|abortifacient agents|mesh-ancestor
25480579|NCT00109837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25480580|NCT00109837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25480581|NCT00109837|Antimetabolites|antimetabolites|mesh-ancestor
25480582|NCT00109837|Dermatologic Agents|dermatologic agents|mesh-ancestor
25480583|NCT00109837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25480584|NCT00109837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25480585|NCT00109837|Antiviral Agents|antiviral agents|mesh-ancestor
25480586|NCT00109837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25480587|NCT00109837|Antidotes|antidotes|mesh-ancestor
25480588|NCT00109837|Protective Agents|protective agents|mesh-ancestor
25480589|NCT00109837|Vitamin B Complex|vitamin b complex|mesh-ancestor
25480590|NCT00109837|Vitamins|vitamins|mesh-ancestor
25822985|NCT00004728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826845|NCT02136589|Diclofenac|diclofenac|mesh-list
24825973|NCT02131298|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24825974|NCT02131298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24613665|NCT01020279|Celecoxib|celecoxib|mesh-list
25822986|NCT00004728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25822987|NCT00004728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25822988|NCT00004728|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25822989|NCT00004728|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25011006|NCT02424851|Thalidomide|thalidomide|mesh-list
25480591|NCT00109837|Micronutrients|micronutrients|mesh-ancestor
25480592|NCT00109837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25480593|NCT00109837|Tubulin Modulators|tubulin modulators|mesh-ancestor
25480594|NCT00109837|Antimitotic Agents|antimitotic agents|mesh-ancestor
25480601|NCT00109837|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25644907|NCT01441635|Progesterone|progesterone|mesh-list
25480603|NCT00109837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25480605|NCT00109837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25480606|NCT00109837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25480607|NCT00109850|Cisplatin|cisplatin|mesh-list
25480608|NCT00109850|Irinotecan|irinotecan|mesh-list
25480609|NCT00109850|Cetuximab|cetuximab|mesh-list
25480610|NCT00109850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480611|NCT00109850|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25480612|NCT00109850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25480613|NCT00109850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480614|NCT00109850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480615|NCT00109850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25480616|NCT00109928|Gemcitabine|gemcitabine|mesh-list
25480617|NCT00109928|Methylprednisolone|methylprednisolone|mesh-list
25480618|NCT00109928|Etoposide|etoposide|mesh-list
25480619|NCT00109928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480620|NCT00109928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25480621|NCT00109928|Antimetabolites|antimetabolites|mesh-ancestor
25480622|NCT00109928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480623|NCT00109928|Antiviral Agents|antiviral agents|mesh-ancestor
25480624|NCT00109928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25480625|NCT00109928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480626|NCT00109928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25480627|NCT00109928|Immunologic Factors|immunologic factors|mesh-ancestor
25480628|NCT00109928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480629|NCT00109928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25480630|NCT00109928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25480631|NCT00109928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25480632|NCT00109928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25480633|NCT00109928|Antiemetics|antiemetics|mesh-ancestor
25480634|NCT00109928|Autonomic Agents|autonomic agents|mesh-ancestor
25480635|NCT00109928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25480636|NCT00109928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25480637|NCT00109928|Glucocorticoids|glucocorticoids|mesh-ancestor
25480638|NCT00109928|Hormones|hormones|mesh-ancestor
25480639|NCT00109928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25480640|NCT00109928|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25480641|NCT00109928|Protective Agents|protective agents|mesh-ancestor
25480642|NCT00109967|Sirolimus|sirolimus|mesh-list
25480643|NCT00109967|Rituximab|rituximab|mesh-list
25480644|NCT00109967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25480645|NCT00109967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480646|NCT00109967|Immunologic Factors|immunologic factors|mesh-ancestor
25480647|NCT00109967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480648|NCT00109967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25480649|NCT00109967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25480650|NCT00109967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25480651|NCT00109967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25480652|NCT00109967|Antifungal Agents|antifungal agents|mesh-ancestor
25480653|NCT00109967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25480654|NCT00110019|Paclitaxel|paclitaxel|mesh-list
25480655|NCT00110019|Carboplatin|carboplatin|mesh-list
25203457|NCT02714231|Parasympatholytics|parasympatholytics|mesh-ancestor
25822990|NCT00004728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822991|NCT00004728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25822992|NCT00004728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25822993|NCT00004728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25822994|NCT00004728|Antipyretics|antipyretics|mesh-ancestor
25822995|NCT00004728|Anticoagulants|anticoagulants|mesh-ancestor
25480656|NCT00110019|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25480657|NCT00110019|Sorafenib|sorafenib|mesh-list
25480660|NCT00110019|Tubulin Modulators|tubulin modulators|mesh-ancestor
25480661|NCT00110019|Antimitotic Agents|antimitotic agents|mesh-ancestor
25480662|NCT00110019|Mitosis Modulators|mitosis modulators|mesh-ancestor
25480663|NCT00110019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480664|NCT00110019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25480665|NCT00110019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480667|NCT00110084|Paclitaxel|paclitaxel|mesh-list
25480668|NCT00110084|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25480669|NCT00110084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25480670|NCT00110084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480671|NCT00110084|Tubulin Modulators|tubulin modulators|mesh-ancestor
25480672|NCT00110084|Antimitotic Agents|antimitotic agents|mesh-ancestor
25480673|NCT00110084|Mitosis Modulators|mitosis modulators|mesh-ancestor
25480674|NCT00110084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480675|NCT00110084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25480676|NCT00110084|Antimetabolites|antimetabolites|mesh-ancestor
25480677|NCT00110084|Antiviral Agents|antiviral agents|mesh-ancestor
25480678|NCT00110084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25480679|NCT00110084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480680|NCT00110084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25480681|NCT00110084|Immunologic Factors|immunologic factors|mesh-ancestor
25480682|NCT00110084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480683|NCT00110149|Rituximab|rituximab|mesh-list
25480684|NCT00110149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25480685|NCT00110149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480686|NCT00110149|Immunologic Factors|immunologic factors|mesh-ancestor
25480687|NCT00110149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480688|NCT00110149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25480689|NCT00110214|Prednisone|prednisone|mesh-list
25480690|NCT00110214|Bevacizumab|bevacizumab|mesh-list
25480691|NCT00110214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25480692|NCT00110214|Docetaxel|docetaxel|mesh-list
25480693|NCT00110214|Antibodies|antibodies|mesh-list
25480694|NCT00110214|Immunoglobulins|immunoglobulins|mesh-list
25480695|NCT00110214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25480696|NCT00110214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480697|NCT00110214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25480698|NCT00110214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25480699|NCT00110214|Growth Substances|growth substances|mesh-ancestor
25480700|NCT00110214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480701|NCT00110214|Growth Inhibitors|growth inhibitors|mesh-ancestor
25480702|NCT00110214|Immunologic Factors|immunologic factors|mesh-ancestor
25480703|NCT00110214|Tubulin Modulators|tubulin modulators|mesh-ancestor
25480704|NCT00110214|Antimitotic Agents|antimitotic agents|mesh-ancestor
25480705|NCT00110214|Mitosis Modulators|mitosis modulators|mesh-ancestor
25480706|NCT00110214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480707|NCT00110214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25480708|NCT00110214|Glucocorticoids|glucocorticoids|mesh-ancestor
25480709|NCT00110214|Hormones|hormones|mesh-ancestor
25480710|NCT00110214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25480711|NCT00110214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25480712|NCT00110266|Deferasirox|deferasirox|mesh-list
25480713|NCT00110266|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25480714|NCT00110266|Chelating Agents|chelating agents|mesh-ancestor
25480715|NCT00110266|Sequestering Agents|sequestering agents|mesh-ancestor
25480716|NCT00110266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480717|NCT00110305|Efavirenz|efavirenz|mesh-list
25480718|NCT00110305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
25480719|NCT00110305|Rilpivirine|rilpivirine|mesh-list
25480720|NCT00110305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25480721|NCT00110305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480722|NCT00110305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480723|NCT00110305|Antiviral Agents|antiviral agents|mesh-ancestor
25480724|NCT00110305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25822996|NCT00004730|Magnesium Sulfate|magnesium sulfate|mesh-list
25822997|NCT00004730|Analgesics|analgesics|mesh-ancestor
24456311|NCT00330824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24456312|NCT00330824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24668598|NCT04734080|Hallucinogens|hallucinogens|mesh-ancestor
25822998|NCT00004730|Sensory System Agents|sensory system agents|mesh-ancestor
25480725|NCT00110305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25480726|NCT00110305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25480727|NCT00110305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25480728|NCT00110305|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25480729|NCT00110305|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25480730|NCT00110305|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25480732|NCT00110305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25480733|NCT00110357|Irinotecan|irinotecan|mesh-list
25480734|NCT00110357|Cetuximab|cetuximab|mesh-list
25480735|NCT00110357|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25480736|NCT00110357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25480737|NCT00110357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480738|NCT00110357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480739|NCT00110357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480740|NCT00110357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25480741|NCT00110396|Interferons|interferons|mesh-list
25480742|NCT00110396|Interferon-beta|interferon-beta|mesh-list
25480743|NCT00110396|Interferon beta-1a|interferon beta-1a|mesh-list
25480744|NCT00110396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480745|NCT00110396|Antiviral Agents|antiviral agents|mesh-ancestor
25480746|NCT00110396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25480747|NCT00110396|Immunologic Factors|immunologic factors|mesh-ancestor
25480748|NCT00110396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480749|NCT00110396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25480750|NCT00110461|Aripiprazole|aripiprazole|mesh-list
25480751|NCT00110461|Antidepressive Agents|antidepressive agents|mesh-ancestor
25480752|NCT00110461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25480753|NCT00110461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25480754|NCT00110461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25480755|NCT00110461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25480756|NCT00110461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480757|NCT00110461|Dopamine Agonists|dopamine agonists|mesh-ancestor
25480758|NCT00110461|Dopamine Agents|dopamine agents|mesh-ancestor
25480759|NCT00110461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25480760|NCT00110461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480761|NCT00110461|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25480762|NCT00110461|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25480763|NCT00110461|Serotonin Agents|serotonin agents|mesh-ancestor
25480764|NCT00110461|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25480765|NCT00110461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25480766|NCT00110461|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25480767|NCT00110461|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25480768|NCT00110513|Antithrombins|antithrombins|mesh-list
25480769|NCT00110513|Antithrombin III|antithrombin iii|mesh-list
25480770|NCT00110513|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25480771|NCT00110513|Protease Inhibitors|protease inhibitors|mesh-ancestor
25480772|NCT00110513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480773|NCT00110513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480774|NCT00110513|Anticoagulants|anticoagulants|mesh-ancestor
25480775|NCT00110617|Deferasirox|deferasirox|mesh-list
25480776|NCT00110617|Deferoxamine|deferoxamine|mesh-list
25480777|NCT00110617|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25480778|NCT00110617|Chelating Agents|chelating agents|mesh-ancestor
25480779|NCT00110617|Sequestering Agents|sequestering agents|mesh-ancestor
25480780|NCT00110617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480781|NCT00110617|Siderophores|siderophores|mesh-ancestor
25480782|NCT00110812|Aldesleukin|aldesleukin|mesh-list
25480783|NCT00110812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480784|NCT00110812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25480785|NCT00110812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25480786|NCT00110812|Antiviral Agents|antiviral agents|mesh-ancestor
25480787|NCT00110812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25480789|NCT00110890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25480790|NCT00110890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25822999|NCT00004730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25823000|NCT00004730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823001|NCT00004730|Anesthetics|anesthetics|mesh-ancestor
24668792|NCT04596033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24668793|NCT04596033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24668794|NCT04596033|Alkylating Agents|alkylating agents|mesh-ancestor
24668802|NCT04591353|Lidocaine|lidocaine|mesh-list
25480791|NCT00110890|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25480798|NCT00110994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480799|NCT00110994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480800|NCT00110994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25480801|NCT00110994|Alkylating Agents|alkylating agents|mesh-ancestor
25480802|NCT00111007|Paclitaxel|paclitaxel|mesh-list
25480803|NCT00111007|Carboplatin|carboplatin|mesh-list
25480804|NCT00111007|Sorafenib|sorafenib|mesh-list
25480805|NCT00111007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25480806|NCT00111007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480807|NCT00111007|Tubulin Modulators|tubulin modulators|mesh-ancestor
25480808|NCT00111007|Antimitotic Agents|antimitotic agents|mesh-ancestor
25480809|NCT00111007|Mitosis Modulators|mitosis modulators|mesh-ancestor
25480810|NCT00111007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480811|NCT00111007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25480812|NCT00111007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480813|NCT00111241|Letrozole|letrozole|mesh-list
25480814|NCT00111241|Anastrozole|anastrozole|mesh-list
25480815|NCT00111241|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25480816|NCT00111241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480817|NCT00111241|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25480818|NCT00111241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25644910|NCT01441635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25644911|NCT01441635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644912|NCT01441635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25644913|NCT01441635|Contraceptive Agents|contraceptive agents|mesh-ancestor
25644914|NCT01441635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25644915|NCT01441635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25644916|NCT01441635|Progestins|progestins|mesh-ancestor
25480819|NCT00111241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480820|NCT00111241|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25480821|NCT00111241|Hormone Antagonists|hormone antagonists|mesh-ancestor
25480822|NCT00111241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25480823|NCT00111241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480824|NCT00111241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25480825|NCT00111657|Rasburicase|rasburicase|mesh-list
25480826|NCT00111657|Gout Suppressants|gout suppressants|mesh-ancestor
25480827|NCT00111657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25480828|NCT00111761|Leucovorin|leucovorin|mesh-list
25480829|NCT00111761|Fluorouracil|fluorouracil|mesh-list
25480830|NCT00111761|Irinotecan|irinotecan|mesh-list
25480831|NCT00111761|Panitumumab|panitumumab|mesh-list
25480832|NCT00111761|Antimetabolites|antimetabolites|mesh-ancestor
25480833|NCT00111761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480834|NCT00111761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25480835|NCT00111761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480836|NCT00111761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25480837|NCT00111761|Immunologic Factors|immunologic factors|mesh-ancestor
25480838|NCT00111761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480839|NCT00111761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25480840|NCT00111761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25480841|NCT00111761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480842|NCT00111761|Antidotes|antidotes|mesh-ancestor
25480843|NCT00111761|Protective Agents|protective agents|mesh-ancestor
25480844|NCT00111761|Vitamin B Complex|vitamin b complex|mesh-ancestor
25480845|NCT00111761|Vitamins|vitamins|mesh-ancestor
25480846|NCT00111761|Micronutrients|micronutrients|mesh-ancestor
25480847|NCT00111761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25480848|NCT00111813|Bortezomib|bortezomib|mesh-list
25480849|NCT00111813|Vorinostat|vorinostat|mesh-list
25480850|NCT00111813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480851|NCT00111813|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25480852|NCT00111813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480853|NCT00111813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480854|NCT00111839|Pemetrexed|pemetrexed|mesh-list
25480855|NCT00111839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823002|NCT00004730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25823003|NCT00004730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25011307|NCT00369317|Etoposide|etoposide|mesh-list
25823004|NCT00004730|Anticonvulsants|anticonvulsants|mesh-ancestor
25823005|NCT00004730|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25480856|NCT00111839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480857|NCT00111839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480858|NCT00111839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25480859|NCT00111839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25480860|NCT00111917|Infliximab|infliximab|mesh-list
25480861|NCT00111917|Dermatologic Agents|dermatologic agents|mesh-ancestor
25480862|NCT00111917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25480863|NCT00111917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25480864|NCT00112047|Tenofovir|tenofovir|mesh-list
25480865|NCT00112047|Lamivudine|lamivudine|mesh-list
25480866|NCT00112047|Zidovudine|zidovudine|mesh-list
25480867|NCT00112047|Emtricitabine|emtricitabine|mesh-list
25480868|NCT00112047|Efavirenz|efavirenz|mesh-list
25480869|NCT00112047|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25480870|NCT00112047|Antiviral Agents|antiviral agents|mesh-ancestor
25480871|NCT00112047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25480872|NCT00112047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25480873|NCT00112047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25480874|NCT00112047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480875|NCT00112047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480876|NCT00112047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25480877|NCT00112047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25480878|NCT00112047|Antimetabolites|antimetabolites|mesh-ancestor
25480879|NCT00112047|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25480880|NCT00112047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25644917|NCT01441635|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25644918|NCT01441635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25644919|NCT01441635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25644920|NCT01441765|Pidilizumab|pidilizumab|mesh-list
25644921|NCT01441765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25644922|NCT01441765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25644923|NCT01441843|Lorazepam|lorazepam|mesh-list
25644924|NCT01441843|Anticonvulsants|anticonvulsants|mesh-ancestor
25480881|NCT00112047|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25480882|NCT00112047|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25480883|NCT00112047|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25480884|NCT00112047|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25480885|NCT00112151|Methyltestosterone|methyltestosterone|mesh-list
25480886|NCT00112151|Testosterone|testosterone|mesh-list
25480887|NCT00112151|Testosterone undecanoate|testosterone undecanoate|mesh-list
25480888|NCT00112151|Testosterone enanthate|testosterone enanthate|mesh-list
25480889|NCT00112151|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25480890|NCT00112151|Androgens|androgens|mesh-ancestor
25480891|NCT00112151|Hormones|hormones|mesh-ancestor
25480892|NCT00112151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25480893|NCT00112151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480894|NCT00112151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25480895|NCT00112151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480896|NCT00112151|Anabolic Agents|anabolic agents|mesh-ancestor
25480897|NCT00112242|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25480898|NCT00112242|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25480899|NCT00112242|Immunologic Factors|immunologic factors|mesh-ancestor
25480900|NCT00112242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480901|NCT00112294|Paclitaxel|paclitaxel|mesh-list
25480902|NCT00112294|Docetaxel|docetaxel|mesh-list
25480903|NCT00112294|Carboplatin|carboplatin|mesh-list
25480904|NCT00112294|Cetuximab|cetuximab|mesh-list
25480905|NCT00112294|Taxane|taxane|mesh-list
25480906|NCT00112294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25480907|NCT00112294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480908|NCT00112294|Tubulin Modulators|tubulin modulators|mesh-ancestor
25480909|NCT00112294|Antimitotic Agents|antimitotic agents|mesh-ancestor
25480910|NCT00112294|Mitosis Modulators|mitosis modulators|mesh-ancestor
25480911|NCT00112294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480912|NCT00112294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25480913|NCT00112385|Etanercept|etanercept|mesh-list
25480914|NCT00112385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25480915|NCT00112385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25480916|NCT00112385|Analgesics|analgesics|mesh-ancestor
25480917|NCT00112385|Sensory System Agents|sensory system agents|mesh-ancestor
25480918|NCT00112385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25480919|NCT00112385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480920|NCT00112385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25480921|NCT00112385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25480922|NCT00112385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25823006|NCT00004730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25823007|NCT00004730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823008|NCT00004730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25011382|NCT05215106|Durvalumab|durvalumab|mesh-list
25823009|NCT00004730|Tocolytic Agents|tocolytic agents|mesh-ancestor
25823010|NCT00004730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25823011|NCT00004731|Ubiquinone|ubiquinone|mesh-list
25823012|NCT00004731|Coenzyme Q10|coenzyme q10|mesh-list
25480923|NCT00112385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25480924|NCT00112385|Immunologic Factors|immunologic factors|mesh-ancestor
25480925|NCT00112437|Vitamin D|vitamin d|mesh-list
25480926|NCT00112437|Cholecalciferol|cholecalciferol|mesh-list
25480927|NCT00112437|Calcium Carbonate|calcium carbonate|mesh-list
25480928|NCT00112437|Calcium|calcium|mesh-list
25480929|NCT00112437|Vitamins|vitamins|mesh-ancestor
25480930|NCT00112437|Micronutrients|micronutrients|mesh-ancestor
25480931|NCT00112437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480932|NCT00112437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25480933|NCT00112437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25480934|NCT00112437|Antacids|antacids|mesh-ancestor
25480935|NCT00112437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480936|NCT00112437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25480937|NCT00112463|Romidepsin|romidepsin|mesh-list
25480938|NCT00112463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25480939|NCT00112463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480940|NCT00112489|Paclitaxel|paclitaxel|mesh-list
25480941|NCT00112489|Carboplatin|carboplatin|mesh-list
25480942|NCT00112489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25480943|NCT00112489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480944|NCT00112489|Tubulin Modulators|tubulin modulators|mesh-ancestor
25480945|NCT00112489|Antimitotic Agents|antimitotic agents|mesh-ancestor
25480946|NCT00112489|Mitosis Modulators|mitosis modulators|mesh-ancestor
25480947|NCT00112489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480949|NCT00112502|Celecoxib|celecoxib|mesh-list
25480950|NCT00112502|Temozolomide|temozolomide|mesh-list
25480951|NCT00112502|Isotretinoin|isotretinoin|mesh-list
25480952|NCT00112502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25480953|NCT00112502|Alkylating Agents|alkylating agents|mesh-ancestor
25480954|NCT00112502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480955|NCT00112502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480956|NCT00112502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25480957|NCT00112502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25480958|NCT00112502|Analgesics|analgesics|mesh-ancestor
25480959|NCT00112502|Sensory System Agents|sensory system agents|mesh-ancestor
25480960|NCT00112502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25480961|NCT00112502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480962|NCT00112502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25480963|NCT00112502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25480964|NCT00112502|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25480965|NCT00112502|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25480966|NCT00112502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480967|NCT00112502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25480968|NCT00112502|Immunologic Factors|immunologic factors|mesh-ancestor
25480969|NCT00112502|Leprostatic Agents|leprostatic agents|mesh-ancestor
25480970|NCT00112502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25480971|NCT00112502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25480972|NCT00112502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25480973|NCT00112502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25480974|NCT00112502|Growth Substances|growth substances|mesh-ancestor
25480975|NCT00112502|Growth Inhibitors|growth inhibitors|mesh-ancestor
25480976|NCT00112502|Dermatologic Agents|dermatologic agents|mesh-ancestor
25480977|NCT00112580|Ipilimumab|ipilimumab|mesh-list
25480978|NCT00112580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25480979|NCT00112580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25480980|NCT00112580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25480981|NCT00112580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480982|NCT00112593|Cyclosporine|cyclosporine|mesh-list
25480983|NCT00112593|Mycophenolic Acid|mycophenolic acid|mesh-list
25480984|NCT00112593|Fludarabine|fludarabine|mesh-list
25480985|NCT00112593|Fludarabine phosphate|fludarabine phosphate|mesh-list
25480986|NCT00112593|Cyclosporins|cyclosporins|mesh-list
25480987|NCT00112593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823013|NCT00004731|Micronutrients|micronutrients|mesh-ancestor
25823014|NCT00004731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823015|NCT00004731|Vitamins|vitamins|mesh-ancestor
25011515|NCT04844528|Niacin|niacin|mesh-list
25823016|NCT00004733|Levodopa|levodopa|mesh-list
25823017|NCT00004733|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25823018|NCT00004733|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25823019|NCT00004733|Dopamine Agents|dopamine agents|mesh-ancestor
25480988|NCT00112593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25480989|NCT00112593|Antimetabolites|antimetabolites|mesh-ancestor
25480990|NCT00112593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25480991|NCT00112593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25480992|NCT00112593|Immunologic Factors|immunologic factors|mesh-ancestor
25480993|NCT00112593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25480994|NCT00112593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25480995|NCT00112593|Antifungal Agents|antifungal agents|mesh-ancestor
25480996|NCT00112593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25480997|NCT00112593|Dermatologic Agents|dermatologic agents|mesh-ancestor
25480998|NCT00112593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25480999|NCT00112593|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25481000|NCT00112593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25481001|NCT00112593|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25481002|NCT00112593|Antitubercular Agents|antitubercular agents|mesh-ancestor
25481003|NCT00112593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25481004|NCT00112671|Sorafenib|sorafenib|mesh-list
25481005|NCT00112671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481006|NCT00112671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25481007|NCT00112671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404102|NCT03684811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25823020|NCT00004733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25481008|NCT00112671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481010|NCT00112723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481011|NCT00112723|Growth Inhibitors|growth inhibitors|mesh-ancestor
25481012|NCT00112723|Growth Substances|growth substances|mesh-ancestor
25481013|NCT00112723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481014|NCT00112723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25481015|NCT00112723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481016|NCT00112723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481017|NCT00112736|Sirolimus|sirolimus|mesh-list
25481018|NCT00112736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25481019|NCT00112736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481020|NCT00112736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25481021|NCT00112736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481022|NCT00112736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481023|NCT00112736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25481024|NCT00112736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25481025|NCT00112736|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25481026|NCT00112736|Antifungal Agents|antifungal agents|mesh-ancestor
25481027|NCT00112736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25481028|NCT00112736|Immunologic Factors|immunologic factors|mesh-ancestor
25481029|NCT00112736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481030|NCT00112827|Cyclophosphamide|cyclophosphamide|mesh-list
25481031|NCT00112827|Melphalan|melphalan|mesh-list
25481032|NCT00112827|Lenalidomide|lenalidomide|mesh-list
25481033|NCT00112827|Lenograstim|lenograstim|mesh-list
25481034|NCT00112827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25481035|NCT00112827|Immunologic Factors|immunologic factors|mesh-ancestor
25481036|NCT00112827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481037|NCT00112827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25481038|NCT00112827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25481039|NCT00112827|Alkylating Agents|alkylating agents|mesh-ancestor
25481040|NCT00112827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481041|NCT00112827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481042|NCT00112827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25481043|NCT00112827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25481044|NCT00112827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25481045|NCT00112827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25481046|NCT00112827|Growth Substances|growth substances|mesh-ancestor
25481047|NCT00112827|Growth Inhibitors|growth inhibitors|mesh-ancestor
25481048|NCT00112905|Sorafenib|sorafenib|mesh-list
25481049|NCT00112905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481050|NCT00112905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25481051|NCT00112905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481052|NCT00112905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481053|NCT00112918|Leucovorin|leucovorin|mesh-list
25481054|NCT00112918|Bevacizumab|bevacizumab|mesh-list
25481055|NCT00112918|Fluorouracil|fluorouracil|mesh-list
25481056|NCT00112918|Capecitabine|capecitabine|mesh-list
25481057|NCT00112918|Oxaliplatin|oxaliplatin|mesh-list
25481058|NCT00112918|Calcium|calcium|mesh-list
25481059|NCT00112918|Levoleucovorin|levoleucovorin|mesh-list
25166515|NCT03974100|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25166516|NCT03974100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166517|NCT03971071|Erenumab|erenumab|mesh-list
25166518|NCT03971071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25041716|NCT01593228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826118|NCT02132416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25823021|NCT00004733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481060|NCT00112918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25481061|NCT00112918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481062|NCT00112918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25481063|NCT00112918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25481064|NCT00112918|Growth Substances|growth substances|mesh-ancestor
25481065|NCT00112918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481066|NCT00112918|Growth Inhibitors|growth inhibitors|mesh-ancestor
25481067|NCT00112918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25481068|NCT00112918|Antimetabolites|antimetabolites|mesh-ancestor
25481069|NCT00112918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481070|NCT00112918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25481071|NCT00112918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25481072|NCT00112918|Immunologic Factors|immunologic factors|mesh-ancestor
25481073|NCT00112918|Antidotes|antidotes|mesh-ancestor
25481074|NCT00112918|Protective Agents|protective agents|mesh-ancestor
25481075|NCT00112918|Vitamin B Complex|vitamin b complex|mesh-ancestor
25481078|NCT00112957|Vaccines|vaccines|mesh-list
25481079|NCT00112957|Immunologic Factors|immunologic factors|mesh-ancestor
25481080|NCT00112957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481081|NCT00113087|Enalapril|enalapril|mesh-list
25481082|NCT00113087|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25481083|NCT00113087|Protease Inhibitors|protease inhibitors|mesh-ancestor
25481084|NCT00113087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481085|NCT00113087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481086|NCT00113087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25481087|NCT00113217|Bevacizumab|bevacizumab|mesh-list
25481088|NCT00113217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25481089|NCT00113217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481090|NCT00113217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25481091|NCT00113217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25481092|NCT00113217|Growth Substances|growth substances|mesh-ancestor
25481093|NCT00113217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481094|NCT00113217|Growth Inhibitors|growth inhibitors|mesh-ancestor
25481095|NCT00113230|Bevacizumab|bevacizumab|mesh-list
25481096|NCT00113230|Capecitabine|capecitabine|mesh-list
25481097|NCT00113230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25481098|NCT00113230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481099|NCT00113230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25481100|NCT00113230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25481101|NCT00113230|Growth Substances|growth substances|mesh-ancestor
25481102|NCT00113230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481103|NCT00113230|Growth Inhibitors|growth inhibitors|mesh-ancestor
25481104|NCT00113230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25481105|NCT00113230|Antimetabolites|antimetabolites|mesh-ancestor
25481106|NCT00113230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481107|NCT00113269|Mycophenolic Acid|mycophenolic acid|mesh-list
25481108|NCT00113269|Alemtuzumab|alemtuzumab|mesh-list
25481109|NCT00113269|Tacrolimus|tacrolimus|mesh-list
25481110|NCT00113269|Thymoglobulin|thymoglobulin|mesh-list
25481111|NCT00113269|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25481112|NCT00113269|Basiliximab|basiliximab|mesh-list
25481113|NCT00113269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25481114|NCT00113269|Immunologic Factors|immunologic factors|mesh-ancestor
25481115|NCT00113269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481116|NCT00113269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25481117|NCT00113269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481118|NCT00113269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481119|NCT00113269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25481120|NCT00113269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481121|NCT00113269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25481122|NCT00113269|Antitubercular Agents|antitubercular agents|mesh-ancestor
25481123|NCT00113269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25481124|NCT00113269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25481125|NCT00113269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25481126|NCT00113295|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25481127|NCT00113295|Paroxetine|paroxetine|mesh-list
25166519|NCT03971071|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
24456418|NCT00331084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24669262|NCT04149587|Brodalumab|brodalumab|mesh-list
24669263|NCT04149587|Dermatologic Agents|dermatologic agents|mesh-ancestor
25823022|NCT00004733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823023|NCT00004734|Folic Acid|folic acid|mesh-list
25823024|NCT00004734|Pyridoxine|pyridoxine|mesh-list
25481156|NCT00113360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25481157|NCT00113360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25481158|NCT00113373|Lapatinib|lapatinib|mesh-list
25481159|NCT00113373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481160|NCT00113373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25481161|NCT00113373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481162|NCT00113373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166522|NCT03971071|Sensory System Agents|sensory system agents|mesh-ancestor
25166523|NCT03971071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25166524|NCT03971071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166525|NCT03971071|Immunologic Factors|immunologic factors|mesh-ancestor
25823025|NCT00004734|Vitamin B 12|vitamin b 12|mesh-list
24532193|NCT00638482|Natriuretic Agents|natriuretic agents|mesh-ancestor
25823026|NCT00004734|Hydroxocobalamin|hydroxocobalamin|mesh-list
25404103|NCT03684811|Antimetabolites|antimetabolites|mesh-ancestor
25823027|NCT00004734|Hematinics|hematinics|mesh-ancestor
25823028|NCT00004734|Vitamin B Complex|vitamin b complex|mesh-ancestor
25481163|NCT00113490|Palivizumab|palivizumab|mesh-list
25481164|NCT00113490|Antiviral Agents|antiviral agents|mesh-ancestor
25481165|NCT00113490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25481166|NCT00113516|Paclitaxel|paclitaxel|mesh-list
25481167|NCT00113516|Carboplatin|carboplatin|mesh-list
25481168|NCT00113516|Sunitinib|sunitinib|mesh-list
25481169|NCT00113516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25481170|NCT00113516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481171|NCT00113516|Tubulin Modulators|tubulin modulators|mesh-ancestor
25481172|NCT00113516|Antimitotic Agents|antimitotic agents|mesh-ancestor
25481173|NCT00113516|Mitosis Modulators|mitosis modulators|mesh-ancestor
25481174|NCT00113516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481175|NCT00113516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25481176|NCT00113516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25481177|NCT00113516|Growth Substances|growth substances|mesh-ancestor
25481178|NCT00113516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481179|NCT00113516|Growth Inhibitors|growth inhibitors|mesh-ancestor
25481180|NCT00113516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25481181|NCT00113516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481182|NCT00113529|Sunitinib|sunitinib|mesh-list
25481183|NCT00113529|Gefitinib|gefitinib|mesh-list
25481184|NCT00113529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481185|NCT00113529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25481186|NCT00113529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25481187|NCT00113529|Growth Substances|growth substances|mesh-ancestor
25481188|NCT00113529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481189|NCT00113529|Growth Inhibitors|growth inhibitors|mesh-ancestor
25481190|NCT00113529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25481191|NCT00113529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481192|NCT00113529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481193|NCT00113568|Tranexamic Acid|tranexamic acid|mesh-list
25481194|NCT00113568|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25481195|NCT00113568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25481196|NCT00113568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481197|NCT00113568|Hemostatics|hemostatics|mesh-ancestor
25481198|NCT00113568|Coagulants|coagulants|mesh-ancestor
25481199|NCT00113607|Dexamethasone|dexamethasone|mesh-list
25481200|NCT00113607|Trabectedin|trabectedin|mesh-list
25481201|NCT00113607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25481202|NCT00113607|Antiemetics|antiemetics|mesh-ancestor
25481203|NCT00113607|Autonomic Agents|autonomic agents|mesh-ancestor
25481204|NCT00113607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25481205|NCT00113607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481206|NCT00113607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25481207|NCT00113607|Glucocorticoids|glucocorticoids|mesh-ancestor
25481208|NCT00113607|Hormones|hormones|mesh-ancestor
25481209|NCT00113607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25481210|NCT00113607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25481211|NCT00113607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481212|NCT00113607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25481213|NCT00113607|Alkylating Agents|alkylating agents|mesh-ancestor
25481214|NCT00113607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481215|NCT00113841|Curcumin|curcumin|mesh-list
25481216|NCT00113841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25481217|NCT00113841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25481218|NCT00113841|Analgesics|analgesics|mesh-ancestor
25481219|NCT00113841|Sensory System Agents|sensory system agents|mesh-ancestor
25481220|NCT00113841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25481221|NCT00113841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481222|NCT00113841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25481223|NCT00113841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25481224|NCT00113841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481225|NCT00113841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481226|NCT00113841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481227|NCT00114114|Goserelin|goserelin|mesh-list
25481228|NCT00114114|Testosterone|testosterone|mesh-list
25481229|NCT00114114|Androgens|androgens|mesh-ancestor
25823029|NCT00004734|Vitamins|vitamins|mesh-ancestor
25823030|NCT00004734|Micronutrients|micronutrients|mesh-ancestor
25823031|NCT00004734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823032|NCT00004736|Lamivudine|lamivudine|mesh-list
24826128|NCT02132416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011883|NCT03206463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25011884|NCT03166761|Dexamethasone|dexamethasone|mesh-list
25823033|NCT00004736|Zidovudine|zidovudine|mesh-list
25823034|NCT00004736|Stavudine|stavudine|mesh-list
25481230|NCT00114114|Hormones|hormones|mesh-ancestor
25481231|NCT00114114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25481232|NCT00114114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481233|NCT00114114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25481234|NCT00114114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481235|NCT00114127|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25481236|NCT00114127|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25481237|NCT00114127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25481238|NCT00114127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25481239|NCT00114127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481240|NCT00114127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25481241|NCT00114127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481242|NCT00114127|Analgesics|analgesics|mesh-ancestor
25481243|NCT00114127|Sensory System Agents|sensory system agents|mesh-ancestor
25481244|NCT00114127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25481245|NCT00114127|Antidepressive Agents|antidepressive agents|mesh-ancestor
25481246|NCT00114127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25481247|NCT00114127|Dopamine Agents|dopamine agents|mesh-ancestor
25481248|NCT00114166|Topotecan|topotecan|mesh-list
25481249|NCT00114166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25481250|NCT00114166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25481251|NCT00114166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481252|NCT00114166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481253|NCT00114166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481254|NCT00114218|Gemcitabine|gemcitabine|mesh-list
25481255|NCT00114218|Docetaxel|docetaxel|mesh-list
25481256|NCT00114218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25481257|NCT00114218|Antimetabolites|antimetabolites|mesh-ancestor
25354188|NCT05480280|Antidotes|antidotes|mesh-ancestor
25481258|NCT00114218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481259|NCT00114218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481260|NCT00114218|Antiviral Agents|antiviral agents|mesh-ancestor
25481261|NCT00114218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25481262|NCT00114218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481263|NCT00114218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25481264|NCT00114218|Immunologic Factors|immunologic factors|mesh-ancestor
25481265|NCT00114218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481266|NCT00114218|Tubulin Modulators|tubulin modulators|mesh-ancestor
25481267|NCT00114218|Antimitotic Agents|antimitotic agents|mesh-ancestor
25481268|NCT00114218|Mitosis Modulators|mitosis modulators|mesh-ancestor
25481269|NCT00114231|Capecitabine|capecitabine|mesh-list
25481270|NCT00114231|Oxaliplatin|oxaliplatin|mesh-list
25481271|NCT00114231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25481272|NCT00114231|Antimetabolites|antimetabolites|mesh-ancestor
25481273|NCT00114231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481274|NCT00114231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481275|NCT00114244|Gemcitabine|gemcitabine|mesh-list
25481276|NCT00114244|Sorafenib|sorafenib|mesh-list
25481277|NCT00114244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25481278|NCT00114244|Antimetabolites|antimetabolites|mesh-ancestor
25481279|NCT00114244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481280|NCT00114244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481281|NCT00114244|Antiviral Agents|antiviral agents|mesh-ancestor
25481282|NCT00114244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25481283|NCT00114244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481284|NCT00114244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25481285|NCT00114244|Immunologic Factors|immunologic factors|mesh-ancestor
25481286|NCT00114244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481287|NCT00114244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25481288|NCT00114504|Simvastatin|simvastatin|mesh-list
25481289|NCT00114504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25481290|NCT00114504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25481291|NCT00114504|Antimetabolites|antimetabolites|mesh-ancestor
25481292|NCT00114504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481293|NCT00114504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25481294|NCT00114504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25481295|NCT00114504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823036|NCT00004736|Isoniazid|isoniazid|mesh-list
25823037|NCT00004736|Pyrazinamide|pyrazinamide|mesh-list
25823038|NCT00004736|Ethambutol|ethambutol|mesh-list
25823039|NCT00004736|Rifabutin|rifabutin|mesh-list
25823040|NCT00004736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25823041|NCT00004736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25408469|NCT03438396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25823042|NCT00004736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481296|NCT00114517|Estradiol|estradiol|mesh-list
25481297|NCT00114517|Estrogens|estrogens|mesh-list
25481298|NCT00114517|Hormones|hormones|mesh-ancestor
25481299|NCT00114517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25481300|NCT00114517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481301|NCT00114530|Cyclophosphamide|cyclophosphamide|mesh-list
25481302|NCT00114530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25481303|NCT00114530|Immunologic Factors|immunologic factors|mesh-ancestor
25481304|NCT00114530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481305|NCT00114530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25481306|NCT00114530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25481307|NCT00114530|Alkylating Agents|alkylating agents|mesh-ancestor
25481308|NCT00114530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481309|NCT00114530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481310|NCT00114530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25481311|NCT00114738|Rituximab|rituximab|mesh-list
25481312|NCT00114738|Bortezomib|bortezomib|mesh-list
25481313|NCT00114738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25481314|NCT00114738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481315|NCT00114738|Immunologic Factors|immunologic factors|mesh-ancestor
25481316|NCT00114738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481317|NCT00114738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25481318|NCT00114777|Cyclosporine|cyclosporine|mesh-list
25481319|NCT00114777|Abatacept|abatacept|mesh-list
25481320|NCT00114777|Cyclosporins|cyclosporins|mesh-list
25481321|NCT00114777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481322|NCT00114777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481323|NCT00114777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25481324|NCT00114777|Immunologic Factors|immunologic factors|mesh-ancestor
25481325|NCT00114777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481326|NCT00114777|Antifungal Agents|antifungal agents|mesh-ancestor
25481327|NCT00114777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25481328|NCT00114777|Dermatologic Agents|dermatologic agents|mesh-ancestor
25481329|NCT00114777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25481330|NCT00114777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25481331|NCT00114777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25481332|NCT00114777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481333|NCT00114959|Imatinib Mesylate|imatinib mesylate|mesh-list
25481334|NCT00114959|Homoharringtonine|homoharringtonine|mesh-list
25481335|NCT00114959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481336|NCT00114959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25481337|NCT00114959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481338|NCT00114959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481339|NCT00114959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25481340|NCT00114959|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25481341|NCT00114972|Paclitaxel|paclitaxel|mesh-list
25481342|NCT00114972|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25481343|NCT00114972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25481344|NCT00114972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481345|NCT00114972|Tubulin Modulators|tubulin modulators|mesh-ancestor
25481346|NCT00114972|Antimitotic Agents|antimitotic agents|mesh-ancestor
25481347|NCT00114972|Mitosis Modulators|mitosis modulators|mesh-ancestor
25481348|NCT00114972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481349|NCT00115037|Naltrexone|naltrexone|mesh-list
25481350|NCT00115037|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25481351|NCT00115037|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25481352|NCT00115037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481353|NCT00115037|Sensory System Agents|sensory system agents|mesh-ancestor
25481354|NCT00115037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25481355|NCT00115063|Orlistat|orlistat|mesh-list
25481356|NCT00115063|Sibutramine|sibutramine|mesh-list
25481357|NCT00115063|Diethylpropion|diethylpropion|mesh-list
25481358|NCT00115063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481359|NCT00115063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481360|NCT00115063|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25481361|NCT00115063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25481362|NCT00115063|Antidepressive Agents|antidepressive agents|mesh-ancestor
25481363|NCT00115063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25481364|NCT00115063|Appetite Depressants|appetite depressants|mesh-ancestor
25481365|NCT00115297|Montelukast|montelukast|mesh-list
24826198|NCT02133105|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24826199|NCT02133105|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24826200|NCT02133105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24826201|NCT02133105|Adrenergic Agents|adrenergic agents|mesh-ancestor
24826202|NCT02133105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25481366|NCT00115297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25481367|NCT00115297|Respiratory System Agents|respiratory system agents|mesh-ancestor
25481368|NCT00115297|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25481369|NCT00115297|Hormone Antagonists|hormone antagonists|mesh-ancestor
25481370|NCT00115297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25481371|NCT00115297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481372|NCT00115297|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25481373|NCT00115297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25481374|NCT00115297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481375|NCT00115336|Ibuprofen|ibuprofen|mesh-list
25481376|NCT00115336|Ketorolac|ketorolac|mesh-list
25481377|NCT00115336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25481378|NCT00115336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25481379|NCT00115336|Analgesics|analgesics|mesh-ancestor
25481380|NCT00115336|Sensory System Agents|sensory system agents|mesh-ancestor
25481381|NCT00115336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25481382|NCT00115336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481383|NCT00115336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25481384|NCT00115336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25481385|NCT00115336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25481386|NCT00115336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481387|NCT00115336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481388|NCT00115349|Deferiprone|deferiprone|mesh-list
25481389|NCT00115349|Deferoxamine|deferoxamine|mesh-list
25481390|NCT00115349|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25481391|NCT00115349|Chelating Agents|chelating agents|mesh-ancestor
25481392|NCT00115349|Sequestering Agents|sequestering agents|mesh-ancestor
25481393|NCT00115349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481394|NCT00115349|Siderophores|siderophores|mesh-ancestor
25481395|NCT00115739|Imatinib Mesylate|imatinib mesylate|mesh-list
25481396|NCT00115739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481397|NCT00115739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25481398|NCT00115739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481399|NCT00115739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481400|NCT00115765|Bevacizumab|bevacizumab|mesh-list
25481401|NCT00115765|Panitumumab|panitumumab|mesh-list
25481402|NCT00115765|Oxaliplatin|oxaliplatin|mesh-list
25481403|NCT00115765|Irinotecan|irinotecan|mesh-list
25481404|NCT00115765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25481405|NCT00115765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481406|NCT00115765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25481407|NCT00115765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25481408|NCT00115765|Growth Substances|growth substances|mesh-ancestor
25481409|NCT00115765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481410|NCT00115765|Growth Inhibitors|growth inhibitors|mesh-ancestor
25481411|NCT00115765|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25481412|NCT00115765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25481413|NCT00115765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481414|NCT00115765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481415|NCT00115778|Immunoglobulins|immunoglobulins|mesh-list
25481416|NCT00115778|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25481417|NCT00115778|gamma-Globulins|gamma-globulins|mesh-list
25481418|NCT00115778|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25481419|NCT00115778|Immunologic Factors|immunologic factors|mesh-ancestor
25481420|NCT00115778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481421|NCT00115804|Fluoxetine|fluoxetine|mesh-list
25481422|NCT00115804|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25481423|NCT00115804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25481424|NCT00115804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25481425|NCT00115804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823043|NCT00004736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823044|NCT00004736|Antiviral Agents|antiviral agents|mesh-ancestor
25823045|NCT00004736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25166541|NCT03911414|Inositol|inositol|mesh-list
25166542|NCT03911414|Acetylcysteine|acetylcysteine|mesh-list
25166543|NCT03911414|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25166544|NCT03911414|Antiviral Agents|antiviral agents|mesh-ancestor
25166545|NCT03911414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25823046|NCT00004736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25823047|NCT00004736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24826273|NCT02133755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826275|NCT02133820|Sensory System Agents|sensory system agents|mesh-ancestor
25644925|NCT01441843|Antiemetics|antiemetics|mesh-ancestor
25644926|NCT01441843|Autonomic Agents|autonomic agents|mesh-ancestor
25481426|NCT00115804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25481427|NCT00115804|Serotonin Agents|serotonin agents|mesh-ancestor
25481428|NCT00115804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481429|NCT00115804|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25481430|NCT00115804|Antidepressive Agents|antidepressive agents|mesh-ancestor
25481431|NCT00115804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25481432|NCT00115804|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25481433|NCT00115804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25481434|NCT00115804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481435|NCT00116207|Niacinamide|niacinamide|mesh-list
25481436|NCT00116207|Allopurinol|allopurinol|mesh-list
25481437|NCT00116207|Antioxidants|antioxidants|mesh-list
25481438|NCT00116207|Antimetabolites|antimetabolites|mesh-ancestor
25481439|NCT00116207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481440|NCT00116207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481441|NCT00116207|Gout Suppressants|gout suppressants|mesh-ancestor
25481442|NCT00116207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25481443|NCT00116207|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25481444|NCT00116207|Protective Agents|protective agents|mesh-ancestor
25481445|NCT00116207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481446|NCT00116207|Vitamin B Complex|vitamin b complex|mesh-ancestor
25481447|NCT00116207|Vitamins|vitamins|mesh-ancestor
25481448|NCT00116207|Micronutrients|micronutrients|mesh-ancestor
25481449|NCT00116272|Etanercept|etanercept|mesh-list
25481450|NCT00116272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25481451|NCT00116272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25481452|NCT00116272|Analgesics|analgesics|mesh-ancestor
25481453|NCT00116272|Sensory System Agents|sensory system agents|mesh-ancestor
25481454|NCT00116272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25481455|NCT00116272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481456|NCT00116272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25481457|NCT00116272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25481458|NCT00116272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25481459|NCT00116272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25481460|NCT00116272|Immunologic Factors|immunologic factors|mesh-ancestor
25481461|NCT00116428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
25481462|NCT00116649|Imiquimod|imiquimod|mesh-list
25481463|NCT00116649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25481464|NCT00116649|Immunologic Factors|immunologic factors|mesh-ancestor
25481465|NCT00116649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481466|NCT00116649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481467|NCT00116649|Interferon Inducers|interferon inducers|mesh-ancestor
25481468|NCT00116805|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25481469|NCT00116805|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25481470|NCT00116805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25481471|NCT00116805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25481472|NCT00116805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481473|NCT00116805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481474|NCT00116805|Antiviral Agents|antiviral agents|mesh-ancestor
25481475|NCT00116805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25481476|NCT00116805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25481477|NCT00116805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25481478|NCT00116831|Rosiglitazone|rosiglitazone|mesh-list
25481479|NCT00116831|Glipizide|glipizide|mesh-list
25481480|NCT00116831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25481481|NCT00116831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481482|NCT00116844|Valacyclovir|valacyclovir|mesh-list
25481483|NCT00116844|Antiviral Agents|antiviral agents|mesh-ancestor
25481484|NCT00116844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25481485|NCT00116857|Sertraline|sertraline|mesh-list
25481486|NCT00116857|Antidepressive Agents|antidepressive agents|mesh-ancestor
25481487|NCT00116857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25481488|NCT00116857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25481489|NCT00116857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25481490|NCT00116857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25481491|NCT00116857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826352|NCT02134093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24707890|NCT01498796|Ketorolac|ketorolac|mesh-list
25823048|NCT00004736|Antimetabolites|antimetabolites|mesh-ancestor
25823049|NCT00004736|Antitubercular Agents|antitubercular agents|mesh-ancestor
25823050|NCT00004736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25823051|NCT00004736|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25644927|NCT01441843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25823052|NCT00004736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25823053|NCT00004736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25823054|NCT00004736|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25481492|NCT00116857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25481493|NCT00116857|Serotonin Agents|serotonin agents|mesh-ancestor
25481494|NCT00116857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481495|NCT00117156|Rituximab|rituximab|mesh-list
25481496|NCT00117156|Fludarabine|fludarabine|mesh-list
25481497|NCT00117156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25481498|NCT00117156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481499|NCT00117156|Immunologic Factors|immunologic factors|mesh-ancestor
25481500|NCT00117156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481501|NCT00117156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25481502|NCT00117507|Deferasirox|deferasirox|mesh-list
25481503|NCT00117507|Chelating Agents|chelating agents|mesh-list
25481504|NCT00117507|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25481505|NCT00117507|Sequestering Agents|sequestering agents|mesh-ancestor
25481506|NCT00117507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481507|NCT00117572|Cisplatin|cisplatin|mesh-list
25481508|NCT00117572|Docetaxel|docetaxel|mesh-list
25481509|NCT00117572|Fluorouracil|fluorouracil|mesh-list
25481510|NCT00117572|Hydroxyurea|hydroxyurea|mesh-list
25481511|NCT00117572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481512|NCT00117572|Tubulin Modulators|tubulin modulators|mesh-ancestor
25481513|NCT00117572|Antimitotic Agents|antimitotic agents|mesh-ancestor
25481514|NCT00117572|Mitosis Modulators|mitosis modulators|mesh-ancestor
25481515|NCT00117572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481516|NCT00117572|Antimetabolites|antimetabolites|mesh-ancestor
25481517|NCT00117572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25481518|NCT00117572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25481519|NCT00117572|Immunologic Factors|immunologic factors|mesh-ancestor
25481520|NCT00117572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481521|NCT00117572|Antisickling Agents|antisickling agents|mesh-ancestor
25481522|NCT00117572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481523|NCT00117572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25481524|NCT00117598|Sirolimus|sirolimus|mesh-list
25481525|NCT00117598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25481526|NCT00117598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25481527|NCT00117598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25481528|NCT00117598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481529|NCT00117598|Antifungal Agents|antifungal agents|mesh-ancestor
25481530|NCT00117598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25481531|NCT00117598|Immunologic Factors|immunologic factors|mesh-ancestor
25481532|NCT00117598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481533|NCT00117637|Interferons|interferons|mesh-list
25481534|NCT00117637|Sorafenib|sorafenib|mesh-list
25481535|NCT00117637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481536|NCT00117637|Antiviral Agents|antiviral agents|mesh-ancestor
25481537|NCT00117637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25481538|NCT00117637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25481539|NCT00117637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481540|NCT00117637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481541|NCT00117676|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25481542|NCT00117676|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25481543|NCT00117676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25481544|NCT00117676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25481545|NCT00117676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481546|NCT00117676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481547|NCT00117676|Antiviral Agents|antiviral agents|mesh-ancestor
25481548|NCT00117676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25481549|NCT00117676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25481550|NCT00117676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25481551|NCT00117715|Dextromethorphan|dextromethorphan|mesh-list
25481552|NCT00117715|Caffeine|caffeine|mesh-list
25481553|NCT00117715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25481554|NCT00117715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481555|NCT00117715|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25481556|NCT00117715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481557|NCT00117715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481558|NCT00117715|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25481559|NCT00117715|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25481560|NCT00117715|Purinergic Agents|purinergic agents|mesh-ancestor
25481561|NCT00117715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25481562|NCT00117715|Antitussive Agents|antitussive agents|mesh-ancestor
25481563|NCT00117715|Respiratory System Agents|respiratory system agents|mesh-ancestor
25481564|NCT00117715|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25481565|NCT00117715|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25481566|NCT00117845|Denileukin diftitox|denileukin diftitox|mesh-list
25481567|NCT00117845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481568|NCT00117962|Carboplatin|carboplatin|mesh-list
25481569|NCT00117962|Pemetrexed|pemetrexed|mesh-list
25481570|NCT00117962|Cetuximab|cetuximab|mesh-list
25481571|NCT00117962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481572|NCT00117962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481573|NCT00117962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481574|NCT00117962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25481575|NCT00117962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25481576|NCT00117962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25481577|NCT00118040|Genistein|genistein|mesh-list
25481578|NCT00118040|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25481579|NCT00118040|Protective Agents|protective agents|mesh-ancestor
25481580|NCT00118040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481581|NCT00118040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481582|NCT00118040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25481583|NCT00118040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481584|NCT00118040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481585|NCT00118040|Phytoestrogens|phytoestrogens|mesh-ancestor
25481586|NCT00118040|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25481587|NCT00118040|Estrogens|estrogens|mesh-ancestor
25481588|NCT00118040|Hormones|hormones|mesh-ancestor
25481589|NCT00118040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25481590|NCT00118131|Cisplatin|cisplatin|mesh-list
25481591|NCT00118131|Docetaxel|docetaxel|mesh-list
25481592|NCT00118131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481593|NCT00118131|Tubulin Modulators|tubulin modulators|mesh-ancestor
25481594|NCT00118131|Antimitotic Agents|antimitotic agents|mesh-ancestor
25481595|NCT00118131|Mitosis Modulators|mitosis modulators|mesh-ancestor
25481596|NCT00118131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481597|NCT00118144|Bortezomib|bortezomib|mesh-list
25481598|NCT00118144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481599|NCT00118157|Tamoxifen|tamoxifen|mesh-list
25481600|NCT00118157|Lapatinib|lapatinib|mesh-list
25481601|NCT00118157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481602|NCT00118157|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25481603|NCT00118157|Hormone Antagonists|hormone antagonists|mesh-ancestor
25481604|NCT00118157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25481605|NCT00118157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481606|NCT00118157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25481607|NCT00118157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481608|NCT00118157|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25481609|NCT00118157|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25481610|NCT00118157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25481611|NCT00118157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25481612|NCT00118157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481613|NCT00118209|Prednisone|prednisone|mesh-list
25481614|NCT00118209|Cyclophosphamide|cyclophosphamide|mesh-list
25481615|NCT00118209|Rituximab|rituximab|mesh-list
25481616|NCT00118209|Doxorubicin|doxorubicin|mesh-list
25481617|NCT00118209|Etoposide|etoposide|mesh-list
25481618|NCT00118209|Vincristine|vincristine|mesh-list
25481619|NCT00118209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25481620|NCT00118209|Immunologic Factors|immunologic factors|mesh-ancestor
25481621|NCT00118209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481622|NCT00118209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25481623|NCT00118209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25481624|NCT00118209|Alkylating Agents|alkylating agents|mesh-ancestor
25481625|NCT00118209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481626|NCT00118209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481627|NCT00118209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25481628|NCT00118209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25481629|NCT00118209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25481630|NCT00118209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25481631|NCT00118209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25481632|NCT00118209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481633|NCT00118209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25481634|NCT00118209|Glucocorticoids|glucocorticoids|mesh-ancestor
25481635|NCT00118209|Hormones|hormones|mesh-ancestor
25823055|NCT00004736|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25823056|NCT00004736|Protease Inhibitors|protease inhibitors|mesh-ancestor
25823057|NCT00004736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25823058|NCT00004739|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25823059|NCT00004739|Antiviral Agents|antiviral agents|mesh-ancestor
25823060|NCT00004739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25823061|NCT00004740|Isoniazid|isoniazid|mesh-list
25481636|NCT00118209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25481637|NCT00118209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25481638|NCT00118209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25481640|NCT00118209|Antimitotic Agents|antimitotic agents|mesh-ancestor
25481641|NCT00118209|Mitosis Modulators|mitosis modulators|mesh-ancestor
25481642|NCT00118274|Cyclophosphamide|cyclophosphamide|mesh-list
25481643|NCT00118274|Vaccines|vaccines|mesh-list
25481644|NCT00118274|Freund's Adjuvant|freund's adjuvant|mesh-list
25481645|NCT00118274|Immunologic Factors|immunologic factors|mesh-ancestor
25481646|NCT00118274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481647|NCT00118274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25481648|NCT00118274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25481649|NCT00118274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25481650|NCT00118274|Alkylating Agents|alkylating agents|mesh-ancestor
25481651|NCT00118274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481652|NCT00118274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481653|NCT00118274|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25481654|NCT00118274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25481655|NCT00118287|Etanercept|etanercept|mesh-list
25481656|NCT00118287|Azacitidine|azacitidine|mesh-list
25481657|NCT00118287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25481658|NCT00118287|Antimetabolites|antimetabolites|mesh-ancestor
25481659|NCT00118287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481660|NCT00118287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481661|NCT00118287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481662|NCT00118287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25481663|NCT00118287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25481664|NCT00118287|Analgesics|analgesics|mesh-ancestor
25481665|NCT00118287|Sensory System Agents|sensory system agents|mesh-ancestor
25481666|NCT00118287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25481667|NCT00118287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481668|NCT00118287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25481669|NCT00118287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25481670|NCT00118287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25481671|NCT00118287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25481672|NCT00118287|Immunologic Factors|immunologic factors|mesh-ancestor
25481673|NCT00118352|Cyclosporine|cyclosporine|mesh-list
25481674|NCT00118352|Mycophenolic Acid|mycophenolic acid|mesh-list
25481675|NCT00118352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25481676|NCT00118352|Alemtuzumab|alemtuzumab|mesh-list
25481677|NCT00118352|Fludarabine|fludarabine|mesh-list
25481678|NCT00118352|Fludarabine phosphate|fludarabine phosphate|mesh-list
25481679|NCT00118352|Antibodies|antibodies|mesh-list
25481680|NCT00118352|Immunoglobulins|immunoglobulins|mesh-list
25481681|NCT00118352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25481682|NCT00118352|Cyclosporins|cyclosporins|mesh-list
25481683|NCT00118352|Immunologic Factors|immunologic factors|mesh-ancestor
25481684|NCT00118352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481685|NCT00118352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481686|NCT00118352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25481687|NCT00118352|Antimetabolites|antimetabolites|mesh-ancestor
25481688|NCT00118352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481689|NCT00118352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25481690|NCT00118352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481691|NCT00118352|Antifungal Agents|antifungal agents|mesh-ancestor
25481692|NCT00118352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25481693|NCT00118352|Dermatologic Agents|dermatologic agents|mesh-ancestor
25481694|NCT00118352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25481695|NCT00118352|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25481696|NCT00118352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25481697|NCT00118352|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25481698|NCT00118352|Antitubercular Agents|antitubercular agents|mesh-ancestor
25481699|NCT00118352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25481700|NCT00118365|Eflornithine|eflornithine|mesh-list
25481701|NCT00118365|Sulindac|sulindac|mesh-list
25481702|NCT00118365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481703|NCT00118365|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25481704|NCT00118365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25481705|NCT00118365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25481706|NCT00118365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25481707|NCT00118365|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
25481708|NCT00118365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823062|NCT00004740|Antitubercular Agents|antitubercular agents|mesh-ancestor
25481709|NCT00118365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823063|NCT00004740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25481710|NCT00118365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25481711|NCT00118365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25481713|NCT00118365|Sensory System Agents|sensory system agents|mesh-ancestor
25481714|NCT00118365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25481715|NCT00118365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481716|NCT00118365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25481717|NCT00118365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25481718|NCT00118365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25481719|NCT00118378|Modafinil|modafinil|mesh-list
25481720|NCT00118378|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25481721|NCT00118378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481722|NCT00118378|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25481723|NCT00118378|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25481724|NCT00118378|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25481725|NCT00118378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481726|NCT00118404|Fluoxetine|fluoxetine|mesh-list
25481727|NCT00118404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25481728|NCT00118404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25481729|NCT00118404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25481730|NCT00118404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481731|NCT00118404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25481732|NCT00118404|Serotonin Agents|serotonin agents|mesh-ancestor
25481733|NCT00118404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481734|NCT00118404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25481735|NCT00118404|Antidepressive Agents|antidepressive agents|mesh-ancestor
25481736|NCT00118404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25481737|NCT00118404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25481738|NCT00118404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25481739|NCT00118404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481740|NCT00118417|Clonazepam|clonazepam|mesh-list
25481741|NCT00118417|Sertraline|sertraline|mesh-list
25481742|NCT00118417|Antidepressive Agents|antidepressive agents|mesh-ancestor
25481743|NCT00118417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25481744|NCT00118417|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25481745|NCT00118417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25481746|NCT00118417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25481747|NCT00118417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481748|NCT00118417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25481749|NCT00118417|Serotonin Agents|serotonin agents|mesh-ancestor
25481750|NCT00118417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481751|NCT00118417|Anticonvulsants|anticonvulsants|mesh-ancestor
25481752|NCT00118417|GABA Modulators|gaba modulators|mesh-ancestor
25481753|NCT00118417|GABA Agents|gaba agents|mesh-ancestor
25481754|NCT00118430|Antidepressive Agents|antidepressive agents|mesh-list
25481755|NCT00118430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25481756|NCT00118482|Fludrocortisone|fludrocortisone|mesh-list
25481757|NCT00118482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25481758|NCT00118716|Fluticasone|fluticasone|mesh-list
25481759|NCT00118716|Xhance|xhance|mesh-list
25481760|NCT00118716|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25481761|NCT00118716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25481762|NCT00118716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25481763|NCT00118716|Autonomic Agents|autonomic agents|mesh-ancestor
25481764|NCT00118716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25481765|NCT00118716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481766|NCT00118716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25481767|NCT00118716|Respiratory System Agents|respiratory system agents|mesh-ancestor
25481768|NCT00118716|Dermatologic Agents|dermatologic agents|mesh-ancestor
25481769|NCT00118716|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25481770|NCT00118716|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25481771|NCT00118716|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25481772|NCT00118716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25481773|NCT00118716|Adrenergic Agents|adrenergic agents|mesh-ancestor
25481774|NCT00118716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25481775|NCT00118716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481776|NCT00118742|Cyclosporine|cyclosporine|mesh-list
25481777|NCT00118742|Sirolimus|sirolimus|mesh-list
25481778|NCT00118742|Mycophenolic Acid|mycophenolic acid|mesh-list
25481779|NCT00118742|Tacrolimus|tacrolimus|mesh-list
25481780|NCT00118742|Cyclosporins|cyclosporins|mesh-list
25481781|NCT00118742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25481782|NCT00118742|Immunologic Factors|immunologic factors|mesh-ancestor
25481783|NCT00118742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481784|NCT00118742|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25481785|NCT00118742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481786|NCT00118742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481787|NCT00118742|Antifungal Agents|antifungal agents|mesh-ancestor
25481788|NCT00118742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25481789|NCT00118742|Dermatologic Agents|dermatologic agents|mesh-ancestor
25481790|NCT00118742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25481791|NCT00118742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25481792|NCT00118742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481793|NCT00118742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25481794|NCT00118742|Antitubercular Agents|antitubercular agents|mesh-ancestor
25481795|NCT00118742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25481796|NCT00118755|Bevacizumab|bevacizumab|mesh-list
25481797|NCT00118755|Capecitabine|capecitabine|mesh-list
25481798|NCT00118755|Oxaliplatin|oxaliplatin|mesh-list
25481799|NCT00118755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25481800|NCT00118755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481801|NCT00118755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25481802|NCT00118755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25481803|NCT00118755|Growth Substances|growth substances|mesh-ancestor
25481804|NCT00118755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481805|NCT00118755|Growth Inhibitors|growth inhibitors|mesh-ancestor
25481806|NCT00118755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25481807|NCT00118755|Antimetabolites|antimetabolites|mesh-ancestor
25481808|NCT00118755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481809|NCT00118898|Ritonavir|ritonavir|mesh-list
25481810|NCT00118898|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25481811|NCT00118898|Tenofovir|tenofovir|mesh-list
25481812|NCT00118898|Lamivudine|lamivudine|mesh-list
25481813|NCT00118898|Emtricitabine|emtricitabine|mesh-list
25481814|NCT00118898|Abacavir|abacavir|mesh-list
25481815|NCT00118898|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25481816|NCT00118898|Efavirenz|efavirenz|mesh-list
25481817|NCT00118898|Dideoxynucleosides|dideoxynucleosides|mesh-list
25481818|NCT00118898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25481819|NCT00118898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25481820|NCT00118898|Protease Inhibitors|protease inhibitors|mesh-ancestor
25481821|NCT00118898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481822|NCT00118898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481823|NCT00118898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25481824|NCT00118898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25481825|NCT00118898|Antiviral Agents|antiviral agents|mesh-ancestor
25481826|NCT00118898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25481827|NCT00118898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25481828|NCT00118898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25481829|NCT00118898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25481830|NCT00118898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25481831|NCT00118898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25481832|NCT00118898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25481833|NCT00118898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25481834|NCT00118898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25481835|NCT00118898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25481836|NCT00118898|Antimetabolites|antimetabolites|mesh-ancestor
25481837|NCT00119015|Fluticasone|fluticasone|mesh-list
25481838|NCT00119015|Xhance|xhance|mesh-list
25481839|NCT00119015|Montelukast|montelukast|mesh-list
25481840|NCT00119015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25481841|NCT00119015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25481842|NCT00119015|Autonomic Agents|autonomic agents|mesh-ancestor
25481843|NCT00119015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25481844|NCT00119015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481845|NCT00119015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25481846|NCT00119015|Respiratory System Agents|respiratory system agents|mesh-ancestor
25481847|NCT00119015|Dermatologic Agents|dermatologic agents|mesh-ancestor
25481848|NCT00119015|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25481849|NCT00119015|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25481850|NCT00119015|Hormone Antagonists|hormone antagonists|mesh-ancestor
25481851|NCT00119015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25481852|NCT00119015|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25481853|NCT00119015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25481854|NCT00119015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481855|NCT00119106|Tenofovir|tenofovir|mesh-list
25481856|NCT00119106|Antiviral Agents|antiviral agents|mesh-ancestor
25481859|NCT00119106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25481860|NCT00119106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481861|NCT00119106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481862|NCT00119106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25481863|NCT00119106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25481864|NCT00119158|Fluticasone|fluticasone|mesh-list
25481865|NCT00119158|Xhance|xhance|mesh-list
25481866|NCT00119158|Pimecrolimus|pimecrolimus|mesh-list
25481867|NCT00119158|Tacrolimus|tacrolimus|mesh-list
25481868|NCT00119158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25481869|NCT00119158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25481870|NCT00119158|Autonomic Agents|autonomic agents|mesh-ancestor
25481871|NCT00119158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25481872|NCT00119158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481873|NCT00119158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25481874|NCT00119158|Respiratory System Agents|respiratory system agents|mesh-ancestor
25481875|NCT00119158|Dermatologic Agents|dermatologic agents|mesh-ancestor
25481876|NCT00119158|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25481877|NCT00119158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25481878|NCT00119158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25481879|NCT00119158|Analgesics|analgesics|mesh-ancestor
25481880|NCT00119158|Sensory System Agents|sensory system agents|mesh-ancestor
25481881|NCT00119158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25481882|NCT00119158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25481883|NCT00119158|Immunologic Factors|immunologic factors|mesh-ancestor
25481884|NCT00119158|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25481885|NCT00119158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481886|NCT00119158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481887|NCT00119262|Tamoxifen|tamoxifen|mesh-list
25481888|NCT00119262|Cyclophosphamide|cyclophosphamide|mesh-list
25481889|NCT00119262|Bevacizumab|bevacizumab|mesh-list
25481890|NCT00119262|Doxorubicin|doxorubicin|mesh-list
25481891|NCT00119262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25481892|NCT00119262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25481893|NCT00119262|Antibodies|antibodies|mesh-list
25481894|NCT00119262|Immunoglobulins|immunoglobulins|mesh-list
25481895|NCT00119262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25481896|NCT00119262|Lenograstim|lenograstim|mesh-list
25481897|NCT00119262|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25481898|NCT00119262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481899|NCT00119262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481900|NCT00119262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25481901|NCT00119262|Immunologic Factors|immunologic factors|mesh-ancestor
25481902|NCT00119262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481903|NCT00119262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25481904|NCT00119262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25481905|NCT00119262|Alkylating Agents|alkylating agents|mesh-ancestor
25481906|NCT00119262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25481907|NCT00119262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25481908|NCT00119262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25481909|NCT00119262|Growth Substances|growth substances|mesh-ancestor
25481910|NCT00119262|Growth Inhibitors|growth inhibitors|mesh-ancestor
25481911|NCT00119262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25481912|NCT00119262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25481913|NCT00119262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25481914|NCT00119262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481915|NCT00119262|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25481916|NCT00119262|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25481917|NCT00119262|Hormone Antagonists|hormone antagonists|mesh-ancestor
25481918|NCT00119262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25481919|NCT00119262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25481920|NCT00119262|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25481921|NCT00119262|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25481922|NCT00119262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25481923|NCT00119262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25481924|NCT00119379|Tenofovir|tenofovir|mesh-list
25481925|NCT00119379|Antiviral Agents|antiviral agents|mesh-ancestor
25481926|NCT00119379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25481927|NCT00119379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25481928|NCT00119379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25481929|NCT00119379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826539|NCT02135029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481961|NCT00119678|Glucocorticoids|glucocorticoids|mesh-ancestor
25481962|NCT00119678|Hormones|hormones|mesh-ancestor
25481963|NCT00119678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25481964|NCT00119678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723960|NCT02531633|Glucocorticoids|glucocorticoids|mesh-ancestor
25481965|NCT00119678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25481966|NCT00119678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25481967|NCT00119678|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25481968|NCT00119678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481969|NCT00119678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25481970|NCT00119678|Immunologic Factors|immunologic factors|mesh-ancestor
25481971|NCT00119678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25823064|NCT00004740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25823065|NCT00004740|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25823066|NCT00004740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25481972|NCT00120250|Eszopiclone|eszopiclone|mesh-list
25481973|NCT00120250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25481974|NCT00120250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25481975|NCT00120250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481977|NCT00120289|Simvastatin|simvastatin|mesh-list
25481978|NCT00120289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25481979|NCT00120289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25481980|NCT00120289|Antimetabolites|antimetabolites|mesh-ancestor
25481981|NCT00120289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25481982|NCT00120289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25481983|NCT00120289|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25481984|NCT00120289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25481985|NCT00120289|Vasodilator Agents|vasodilator agents|mesh-ancestor
25481986|NCT00120289|Vitamin B Complex|vitamin b complex|mesh-ancestor
25481987|NCT00120289|Vitamins|vitamins|mesh-ancestor
25481988|NCT00120289|Micronutrients|micronutrients|mesh-ancestor
25481989|NCT00120289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481990|NCT00120523|Pimecrolimus|pimecrolimus|mesh-list
25481991|NCT00120523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25481992|NCT00120523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25481993|NCT00120523|Analgesics|analgesics|mesh-ancestor
25481994|NCT00120523|Sensory System Agents|sensory system agents|mesh-ancestor
25481995|NCT00120523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25481996|NCT00120523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25481997|NCT00120523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25481998|NCT00120523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25481999|NCT00120523|Dermatologic Agents|dermatologic agents|mesh-ancestor
25482000|NCT00120523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25482001|NCT00120523|Immunologic Factors|immunologic factors|mesh-ancestor
25482002|NCT00120523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25482003|NCT00120523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482004|NCT00120523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482005|NCT00120874|Memantine|memantine|mesh-list
25482006|NCT00120874|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25482007|NCT00120874|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25482008|NCT00120874|Dopamine Agents|dopamine agents|mesh-ancestor
25482009|NCT00120874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25482010|NCT00120874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482011|NCT00120874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482012|NCT00120874|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25482013|NCT00120874|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25482014|NCT00121134|Cyclophosphamide|cyclophosphamide|mesh-list
25482015|NCT00121134|Bevacizumab|bevacizumab|mesh-list
25482016|NCT00121134|Capecitabine|capecitabine|mesh-list
25482017|NCT00121134|Methotrexate|methotrexate|mesh-list
25482018|NCT00121134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25482019|NCT00121134|Immunologic Factors|immunologic factors|mesh-ancestor
25482020|NCT00121134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482021|NCT00121134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25482022|NCT00121134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25482023|NCT00121134|Alkylating Agents|alkylating agents|mesh-ancestor
25482024|NCT00121134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482025|NCT00121134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482026|NCT00121134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25482027|NCT00121134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25482028|NCT00121134|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25482029|NCT00121134|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25482030|NCT00121134|Growth Substances|growth substances|mesh-ancestor
25482031|NCT00121134|Growth Inhibitors|growth inhibitors|mesh-ancestor
25482032|NCT00121134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25482033|NCT00121134|Antimetabolites|antimetabolites|mesh-ancestor
25482034|NCT00121134|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25482035|NCT00121134|Abortifacient Agents|abortifacient agents|mesh-ancestor
25482036|NCT00121134|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25482037|NCT00121134|Dermatologic Agents|dermatologic agents|mesh-ancestor
25482038|NCT00121134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482039|NCT00121134|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25482040|NCT00121134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25482041|NCT00121186|Methotrexate|methotrexate|mesh-list
25482042|NCT00121186|Fludarabine phosphate|fludarabine phosphate|mesh-list
25482043|NCT00121186|Fludarabine|fludarabine|mesh-list
25823067|NCT00004740|Antimetabolites|antimetabolites|mesh-ancestor
25823068|NCT00004740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823069|NCT00004740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25482044|NCT00121186|Melphalan|melphalan|mesh-list
25482045|NCT00121186|Tacrolimus|tacrolimus|mesh-list
25482046|NCT00121186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25482047|NCT00121186|Abortifacient Agents|abortifacient agents|mesh-ancestor
25482048|NCT00121186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25482049|NCT00121186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482050|NCT00121186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25482051|NCT00121186|Antimetabolites|antimetabolites|mesh-ancestor
25482052|NCT00121186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482053|NCT00121186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482054|NCT00121186|Dermatologic Agents|dermatologic agents|mesh-ancestor
25482055|NCT00121186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482056|NCT00121186|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25482057|NCT00121186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25482058|NCT00121186|Immunologic Factors|immunologic factors|mesh-ancestor
25482059|NCT00121186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25482060|NCT00121186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25482061|NCT00121186|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25482062|NCT00121186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25482063|NCT00121186|Alkylating Agents|alkylating agents|mesh-ancestor
25482064|NCT00121186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25482065|NCT00121199|Prednisone|prednisone|mesh-list
25482066|NCT00121199|Cyclophosphamide|cyclophosphamide|mesh-list
25482067|NCT00121199|Bevacizumab|bevacizumab|mesh-list
25482068|NCT00121199|Rituximab|rituximab|mesh-list
25482069|NCT00121199|Doxorubicin|doxorubicin|mesh-list
25482070|NCT00121199|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25482071|NCT00121199|Vincristine|vincristine|mesh-list
25482072|NCT00121199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25482073|NCT00121199|Antibodies|antibodies|mesh-list
25482074|NCT00121199|Immunoglobulins|immunoglobulins|mesh-list
25482075|NCT00121199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25482076|NCT00121199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25482077|NCT00121199|Immunologic Factors|immunologic factors|mesh-ancestor
25482078|NCT00121199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482079|NCT00121199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25482080|NCT00121199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25482081|NCT00121199|Alkylating Agents|alkylating agents|mesh-ancestor
25482082|NCT00121199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482083|NCT00121199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482084|NCT00121199|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25482085|NCT00121199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25482086|NCT00121199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25482087|NCT00121199|Growth Substances|growth substances|mesh-ancestor
25482088|NCT00121199|Growth Inhibitors|growth inhibitors|mesh-ancestor
25482089|NCT00121199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25482090|NCT00121199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25482091|NCT00121199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25482092|NCT00121199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482093|NCT00121199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25482094|NCT00121199|Glucocorticoids|glucocorticoids|mesh-ancestor
25482095|NCT00121199|Hormones|hormones|mesh-ancestor
25482096|NCT00121199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25482097|NCT00121199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25482098|NCT00121199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25482099|NCT00121199|Tubulin Modulators|tubulin modulators|mesh-ancestor
25482100|NCT00121199|Antimitotic Agents|antimitotic agents|mesh-ancestor
25482101|NCT00121199|Mitosis Modulators|mitosis modulators|mesh-ancestor
25482102|NCT00121225|Vorinostat|vorinostat|mesh-list
25482103|NCT00121225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482104|NCT00121225|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25482105|NCT00121225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482106|NCT00121225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482108|NCT00121251|Capecitabine|capecitabine|mesh-list
25482109|NCT00121251|Sorafenib|sorafenib|mesh-list
25482110|NCT00121251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25482111|NCT00121251|Antimetabolites|antimetabolites|mesh-ancestor
25482112|NCT00121251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482113|NCT00121251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482114|NCT00121251|Antiviral Agents|antiviral agents|mesh-ancestor
25482115|NCT00121251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25482116|NCT00121251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482117|NCT00121251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25482118|NCT00121251|Immunologic Factors|immunologic factors|mesh-ancestor
25482119|NCT00121251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482120|NCT00121251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25482121|NCT00121641|Metformin|metformin|mesh-list
25482122|NCT00121641|Saxagliptin|saxagliptin|mesh-list
25482123|NCT00121641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25482124|NCT00121641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482125|NCT00121641|Incretins|incretins|mesh-ancestor
25482126|NCT00121641|Hormones|hormones|mesh-ancestor
25482127|NCT00121641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25482128|NCT00121641|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25482129|NCT00121641|Protease Inhibitors|protease inhibitors|mesh-ancestor
25482130|NCT00121641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482131|NCT00121641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482132|NCT00121667|Metformin|metformin|mesh-list
25482133|NCT00121667|Pioglitazone|pioglitazone|mesh-list
25482134|NCT00121667|Saxagliptin|saxagliptin|mesh-list
25482135|NCT00121667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25482136|NCT00121667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482137|NCT00121667|Incretins|incretins|mesh-ancestor
25482138|NCT00121667|Hormones|hormones|mesh-ancestor
25482139|NCT00121667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25482140|NCT00121667|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25482141|NCT00121667|Protease Inhibitors|protease inhibitors|mesh-ancestor
25482142|NCT00121667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482143|NCT00121667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482144|NCT00121719|Lenvatinib|lenvatinib|mesh-list
25482145|NCT00121719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482146|NCT00121719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25482147|NCT00121719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482148|NCT00121719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482149|NCT00121810|Mycophenolic Acid|mycophenolic acid|mesh-list
25482150|NCT00121810|Sirolimus|sirolimus|mesh-list
25482151|NCT00121810|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
25482152|NCT00121810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25482153|NCT00121810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482154|NCT00121810|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25482155|NCT00121810|Antitubercular Agents|antitubercular agents|mesh-ancestor
25482156|NCT00121810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25482157|NCT00121810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25482158|NCT00121810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482159|NCT00121810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482160|NCT00121810|Antifungal Agents|antifungal agents|mesh-ancestor
25482161|NCT00121810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25482162|NCT00121810|Immunologic Factors|immunologic factors|mesh-ancestor
25482163|NCT00121810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482164|NCT00121836|Bevacizumab|bevacizumab|mesh-list
25482165|NCT00121836|Capecitabine|capecitabine|mesh-list
25482166|NCT00121836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25482167|NCT00121836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482168|NCT00121836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25482169|NCT00121836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25482170|NCT00121836|Growth Substances|growth substances|mesh-ancestor
25482171|NCT00121836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482172|NCT00121836|Growth Inhibitors|growth inhibitors|mesh-ancestor
25482173|NCT00121836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25482174|NCT00121836|Antimetabolites|antimetabolites|mesh-ancestor
25482175|NCT00121836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482176|NCT00121992|Cyclophosphamide|cyclophosphamide|mesh-list
25482177|NCT00121992|Docetaxel|docetaxel|mesh-list
25482178|NCT00121992|Doxorubicin|doxorubicin|mesh-list
25482179|NCT00121992|Fluorouracil|fluorouracil|mesh-list
25482180|NCT00121992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25482181|NCT00121992|Immunologic Factors|immunologic factors|mesh-ancestor
25482182|NCT00121992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482183|NCT00121992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25482184|NCT00121992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25482185|NCT00121992|Alkylating Agents|alkylating agents|mesh-ancestor
25482186|NCT00121992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482187|NCT00121992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482188|NCT00121992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25482189|NCT00121992|Tubulin Modulators|tubulin modulators|mesh-ancestor
25482190|NCT00121992|Antimitotic Agents|antimitotic agents|mesh-ancestor
25482191|NCT00121992|Mitosis Modulators|mitosis modulators|mesh-ancestor
25045426|NCT00953420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045428|NCT00953420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25482192|NCT00121992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25482193|NCT00121992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25482194|NCT00121992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25482195|NCT00121992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482196|NCT00121992|Antimetabolites|antimetabolites|mesh-ancestor
25482197|NCT00121992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25482198|NCT00122278|Dexamethasone|dexamethasone|mesh-list
25482199|NCT00122278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25482200|NCT00122278|Antiemetics|antiemetics|mesh-ancestor
25482201|NCT00122278|Autonomic Agents|autonomic agents|mesh-ancestor
25482202|NCT00122278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25482203|NCT00122278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482204|NCT00122278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25482205|NCT00122278|Glucocorticoids|glucocorticoids|mesh-ancestor
25482206|NCT00122278|Hormones|hormones|mesh-ancestor
25482207|NCT00122278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25482208|NCT00122278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25482209|NCT00122278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482210|NCT00122317|Eculizumab|eculizumab|mesh-list
25482211|NCT00122317|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25482212|NCT00122317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25482213|NCT00122317|Immunologic Factors|immunologic factors|mesh-ancestor
25482214|NCT00122317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482215|NCT00122369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25482216|NCT00122369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25482217|NCT00122369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482218|NCT00122382|Methotrexate|methotrexate|mesh-list
25482219|NCT00122382|Abatacept|abatacept|mesh-list
25482220|NCT00122382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25482221|NCT00122382|Abortifacient Agents|abortifacient agents|mesh-ancestor
25482222|NCT00122382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25482223|NCT00122382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482224|NCT00122382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25482225|NCT00122382|Antimetabolites|antimetabolites|mesh-ancestor
25482226|NCT00122382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482227|NCT00122382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482228|NCT00122382|Dermatologic Agents|dermatologic agents|mesh-ancestor
25482229|NCT00122382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482230|NCT00122382|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25482231|NCT00122382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25482232|NCT00122382|Immunologic Factors|immunologic factors|mesh-ancestor
25482233|NCT00122382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25482234|NCT00122382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25482235|NCT00122382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25482236|NCT00122447|Aspirin|aspirin|mesh-list
25482237|NCT00122447|Thioctic Acid|thioctic acid|mesh-list
25482238|NCT00122447|Olmesartan|olmesartan|mesh-list
25482239|NCT00122447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25482240|NCT00122447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25482241|NCT00122447|Analgesics|analgesics|mesh-ancestor
25482242|NCT00122447|Sensory System Agents|sensory system agents|mesh-ancestor
25482243|NCT00122447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25482244|NCT00122447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482245|NCT00122447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25482246|NCT00122447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25482247|NCT00122447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25482248|NCT00122447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25482249|NCT00122447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482250|NCT00122447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25482251|NCT00122447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25482252|NCT00122447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482253|NCT00122447|Antipyretics|antipyretics|mesh-ancestor
25482254|NCT00122447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25482255|NCT00122447|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25482256|NCT00122447|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25482257|NCT00122447|Antioxidants|antioxidants|mesh-ancestor
25482258|NCT00122447|Protective Agents|protective agents|mesh-ancestor
25482259|NCT00122447|Vitamin B Complex|vitamin b complex|mesh-ancestor
25482260|NCT00122447|Vitamins|vitamins|mesh-ancestor
25482261|NCT00122447|Micronutrients|micronutrients|mesh-ancestor
25482262|NCT00122460|Cisplatin|cisplatin|mesh-list
25482263|NCT00122460|Carboplatin|carboplatin|mesh-list
25482264|NCT00122460|Fluorouracil|fluorouracil|mesh-list
25482265|NCT00122460|Cetuximab|cetuximab|mesh-list
25482266|NCT00122460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482267|NCT00122460|Antimetabolites|antimetabolites|mesh-ancestor
25482268|NCT00122460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482269|NCT00122460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25482270|NCT00122460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25482271|NCT00122460|Immunologic Factors|immunologic factors|mesh-ancestor
25482272|NCT00122460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482273|NCT00122460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25482274|NCT00122681|Vaccines|vaccines|mesh-list
25482275|NCT00122681|Immunologic Factors|immunologic factors|mesh-ancestor
25482276|NCT00122681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482277|NCT00122980|Hydroxyurea|hydroxyurea|mesh-list
25482278|NCT00122980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482279|NCT00122980|Antisickling Agents|antisickling agents|mesh-ancestor
25482280|NCT00122980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482281|NCT00122980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482282|NCT00122980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25482283|NCT00123110|Metformin|metformin|mesh-list
25482284|NCT00123110|Leuprolide|leuprolide|mesh-list
25482285|NCT00123110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25482286|NCT00123110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482287|NCT00123110|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25482288|NCT00123110|Fertility Agents|fertility agents|mesh-ancestor
25482289|NCT00123110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25482290|NCT00123110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25482291|NCT00123110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482292|NCT00123123|Chlorhexidine|chlorhexidine|mesh-list
25482293|NCT00123123|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25482294|NCT00123123|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25482295|NCT00123123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25482296|NCT00123123|Disinfectants|disinfectants|mesh-ancestor
25482297|NCT00123123|Dermatologic Agents|dermatologic agents|mesh-ancestor
25482298|NCT00123162|Sildenafil Citrate|sildenafil citrate|mesh-list
25482299|NCT00123162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482300|NCT00123162|Vasodilator Agents|vasodilator agents|mesh-ancestor
25482301|NCT00123162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25482302|NCT00123162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25482303|NCT00123162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482304|NCT00123162|Urological Agents|urological agents|mesh-ancestor
25482305|NCT00123474|Dasatinib|dasatinib|mesh-list
25482306|NCT00123474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482307|NCT00123474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25482308|NCT00123474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482309|NCT00123474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482310|NCT00123487|Dasatinib|dasatinib|mesh-list
25482311|NCT00123487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482312|NCT00123487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25482313|NCT00123487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482314|NCT00123487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482315|NCT00123604|Metoprolol|metoprolol|mesh-list
25482316|NCT00123604|Carvedilol|carvedilol|mesh-list
25482317|NCT00123604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25482318|NCT00123604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25482319|NCT00123604|Sympatholytics|sympatholytics|mesh-ancestor
25482320|NCT00123604|Autonomic Agents|autonomic agents|mesh-ancestor
25482321|NCT00123604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25482322|NCT00123604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482323|NCT00123604|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25482324|NCT00123604|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25482325|NCT00123604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25482326|NCT00123604|Adrenergic Agents|adrenergic agents|mesh-ancestor
25482327|NCT00123604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25482328|NCT00123604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644928|NCT01441843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644929|NCT01441843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25482329|NCT00123604|Antioxidants|antioxidants|mesh-ancestor
25482330|NCT00123604|Protective Agents|protective agents|mesh-ancestor
25482331|NCT00123604|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25482332|NCT00123604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25482333|NCT00123604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25482334|NCT00123604|Vasodilator Agents|vasodilator agents|mesh-ancestor
25482335|NCT00123604|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25482336|NCT00123604|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25482337|NCT00123630|Omalizumab|omalizumab|mesh-list
25482338|NCT00123630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25482339|NCT00123630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25482340|NCT00123630|Respiratory System Agents|respiratory system agents|mesh-ancestor
25482341|NCT00123643|Rosiglitazone|rosiglitazone|mesh-list
25823070|NCT00004744|Immunoglobulins|immunoglobulins|mesh-list
25482342|NCT00123643|Glyburide|glyburide|mesh-list
25482343|NCT00123643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25482344|NCT00123643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482345|NCT00123955|Spironolactone|spironolactone|mesh-list
25482346|NCT00123955|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25482347|NCT00123955|Hormone Antagonists|hormone antagonists|mesh-ancestor
25482348|NCT00123955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25482349|NCT00123955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482350|NCT00123955|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25482351|NCT00123955|Diuretics|diuretics|mesh-ancestor
25482352|NCT00123955|Natriuretic Agents|natriuretic agents|mesh-ancestor
25482353|NCT00124020|Vancomycin|vancomycin|mesh-list
25482354|NCT00124020|Telavancin|telavancin|mesh-list
25482355|NCT00124020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25482356|NCT00124020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25482357|NCT00124072|Folic Acid|folic acid|mesh-list
25482358|NCT00124072|Vitamin B 12|vitamin b 12|mesh-list
25482359|NCT00124072|Hydroxocobalamin|hydroxocobalamin|mesh-list
25482360|NCT00124072|Simvastatin|simvastatin|mesh-list
25482361|NCT00124072|Vitamins|vitamins|mesh-ancestor
25482362|NCT00124072|Micronutrients|micronutrients|mesh-ancestor
25482363|NCT00124072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482364|NCT00124072|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25482365|NCT00124072|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25482366|NCT00124072|Antimetabolites|antimetabolites|mesh-ancestor
25482367|NCT00124072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482368|NCT00124072|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25482369|NCT00124072|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25482370|NCT00124072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482371|NCT00124072|Hematinics|hematinics|mesh-ancestor
25482372|NCT00124072|Vitamin B Complex|vitamin b complex|mesh-ancestor
25482373|NCT00124176|Albuterol|albuterol|mesh-list
25482374|NCT00124176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25482375|NCT00124176|Autonomic Agents|autonomic agents|mesh-ancestor
25482376|NCT00124176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25482377|NCT00124176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482378|NCT00124176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25482379|NCT00124176|Respiratory System Agents|respiratory system agents|mesh-ancestor
25482380|NCT00124176|Tocolytic Agents|tocolytic agents|mesh-ancestor
25482381|NCT00124176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25482382|NCT00124176|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25482383|NCT00124176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25482384|NCT00124176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25482385|NCT00124176|Adrenergic Agents|adrenergic agents|mesh-ancestor
25482386|NCT00124176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25482387|NCT00124176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482388|NCT00124449|Abatacept|abatacept|mesh-list
25482389|NCT00124449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25482390|NCT00124449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482391|NCT00124449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482392|NCT00124449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25482393|NCT00124449|Immunologic Factors|immunologic factors|mesh-ancestor
25482394|NCT00124449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482395|NCT00124449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25482396|NCT00124514|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25482397|NCT00124514|Luteolytic Agents|luteolytic agents|mesh-ancestor
25482398|NCT00124514|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25482399|NCT00124514|Contraceptive Agents|contraceptive agents|mesh-ancestor
25823071|NCT00004744|Antibodies|antibodies|mesh-list
25482400|NCT00124514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25644930|NCT01441843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25644931|NCT01441843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25644932|NCT01441843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25644933|NCT01441843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25644934|NCT01441843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25644935|NCT01441843|GABA Modulators|gaba modulators|mesh-ancestor
25644936|NCT01441843|GABA Agents|gaba agents|mesh-ancestor
25482401|NCT00124514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482402|NCT00124514|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25482403|NCT00124514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25482404|NCT00124514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482405|NCT00124579|Thalidomide|thalidomide|mesh-list
25482406|NCT00124579|Dexamethasone|dexamethasone|mesh-list
25482407|NCT00124579|Bortezomib|bortezomib|mesh-list
25482408|NCT00124579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25482409|NCT00124579|Antiemetics|antiemetics|mesh-ancestor
25482410|NCT00124579|Autonomic Agents|autonomic agents|mesh-ancestor
25823072|NCT00004744|gamma-Globulins|gamma-globulins|mesh-list
25823073|NCT00004744|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25823074|NCT00004744|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25823075|NCT00004744|Immunologic Factors|immunologic factors|mesh-ancestor
25823076|NCT00004744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823077|NCT00004747|Immunoglobulins|immunoglobulins|mesh-list
24443699|NCT00295841|Clofarabine|clofarabine|mesh-list
24443700|NCT00295841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25482411|NCT00124579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25482412|NCT00124579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482413|NCT00124579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25482414|NCT00124579|Glucocorticoids|glucocorticoids|mesh-ancestor
25482416|NCT00124579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25482417|NCT00124579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25482418|NCT00124579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482419|NCT00124579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25482420|NCT00124579|Immunologic Factors|immunologic factors|mesh-ancestor
25482421|NCT00124579|Leprostatic Agents|leprostatic agents|mesh-ancestor
25482422|NCT00124579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25482423|NCT00124579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25482424|NCT00124579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25482425|NCT00124579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25482426|NCT00124579|Growth Substances|growth substances|mesh-ancestor
25482427|NCT00124579|Growth Inhibitors|growth inhibitors|mesh-ancestor
25482428|NCT00124618|Cetuximab|cetuximab|mesh-list
25482429|NCT00124618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25482430|NCT00124618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482431|NCT00124657|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25482432|NCT00124657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482433|NCT00124657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25482434|NCT00124657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482435|NCT00124657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482436|NCT00124709|Pimecrolimus|pimecrolimus|mesh-list
25482437|NCT00124709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25482438|NCT00124709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25482439|NCT00124709|Analgesics|analgesics|mesh-ancestor
25482440|NCT00124709|Sensory System Agents|sensory system agents|mesh-ancestor
25482441|NCT00124709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25482442|NCT00124709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482443|NCT00124709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25482444|NCT00124709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25482445|NCT00124709|Dermatologic Agents|dermatologic agents|mesh-ancestor
25482446|NCT00124709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25482447|NCT00124709|Immunologic Factors|immunologic factors|mesh-ancestor
25482448|NCT00124709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25482449|NCT00124709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482450|NCT00124709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482451|NCT00124735|Rocuronium|rocuronium|mesh-list
25482452|NCT00124735|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25482453|NCT00124735|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25482454|NCT00124735|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25482455|NCT00124735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25482456|NCT00124735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482457|NCT00124748|Imatinib Mesylate|imatinib mesylate|mesh-list
25482458|NCT00124748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482459|NCT00124748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25482460|NCT00124748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823078|NCT00004747|Antibodies|antibodies|mesh-list
25644937|NCT01441843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25644938|NCT01441843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823079|NCT00004747|gamma-Globulins|gamma-globulins|mesh-list
25823080|NCT00004747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25482461|NCT00124748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482463|NCT00124943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25482464|NCT00124943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25482465|NCT00124943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482466|NCT00124943|Tubulin Modulators|tubulin modulators|mesh-ancestor
25482467|NCT00124943|Antimitotic Agents|antimitotic agents|mesh-ancestor
25482468|NCT00124943|Mitosis Modulators|mitosis modulators|mesh-ancestor
25482469|NCT00124943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482470|NCT00124982|Abatacept|abatacept|mesh-list
25482471|NCT00124982|Antirheumatic Agents|antirheumatic agents|mesh-list
25482472|NCT00124982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25482473|NCT00124982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482474|NCT00124982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482475|NCT00124982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25482476|NCT00124982|Immunologic Factors|immunologic factors|mesh-ancestor
25482477|NCT00124982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482478|NCT00125034|Oxaliplatin|oxaliplatin|mesh-list
25482479|NCT00125034|Cetuximab|cetuximab|mesh-list
25823081|NCT00004747|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25823082|NCT00004747|Immunologic Factors|immunologic factors|mesh-ancestor
25482480|NCT00125034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482481|NCT00125034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25482482|NCT00125138|Metylperon|metylperon|mesh-list
25482483|NCT00125138|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25482484|NCT00125138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25482485|NCT00125138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25482486|NCT00125138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482487|NCT00125138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25482488|NCT00125164|Mecasermin|mecasermin|mesh-list
25482489|NCT00125164|Growth Substances|growth substances|mesh-ancestor
25482490|NCT00125164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482491|NCT00125190|Mecasermin|mecasermin|mesh-list
25482492|NCT00125190|Growth Substances|growth substances|mesh-ancestor
25482493|NCT00125190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482494|NCT00125359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25482495|NCT00125359|Bexarotene|bexarotene|mesh-list
25482496|NCT00125359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482497|NCT00125359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25482498|NCT00125359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482499|NCT00125359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482500|NCT00125372|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25482501|NCT00125372|Bexarotene|bexarotene|mesh-list
25482502|NCT00125372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482503|NCT00125372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25482504|NCT00125372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482505|NCT00125372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482506|NCT00125515|Naltrexone|naltrexone|mesh-list
25482507|NCT00125515|Memantine|memantine|mesh-list
25482508|NCT00125515|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25482509|NCT00125515|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25482510|NCT00125515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482511|NCT00125515|Sensory System Agents|sensory system agents|mesh-ancestor
25482512|NCT00125515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25482513|NCT00125515|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25482514|NCT00125515|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25482515|NCT00125515|Dopamine Agents|dopamine agents|mesh-ancestor
25482516|NCT00125515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25482517|NCT00125515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482518|NCT00125515|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25482519|NCT00125515|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25482520|NCT00125528|Cycloserine|cycloserine|mesh-list
25482521|NCT00125528|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25482522|NCT00125528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25482523|NCT00125528|Renal Agents|renal agents|mesh-ancestor
25482524|NCT00125528|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25482525|NCT00125528|Antitubercular Agents|antitubercular agents|mesh-ancestor
25482526|NCT00125528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25482527|NCT00125528|Antimetabolites|antimetabolites|mesh-ancestor
25482528|NCT00125528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482529|NCT00125593|Simvastatin|simvastatin|mesh-list
25482530|NCT00125593|Ezetimibe|ezetimibe|mesh-list
25482531|NCT00125593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25482532|NCT00125593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25482533|NCT00125593|Antimetabolites|antimetabolites|mesh-ancestor
25482534|NCT00125593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482535|NCT00125593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25482536|NCT00125593|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25482537|NCT00125593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482538|NCT00125853|Atenolol|atenolol|mesh-list
25482539|NCT00125853|Nebivolol|nebivolol|mesh-list
25482540|NCT00125853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25482541|NCT00125853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25482542|NCT00125853|Sympatholytics|sympatholytics|mesh-ancestor
25482543|NCT00125853|Autonomic Agents|autonomic agents|mesh-ancestor
25482544|NCT00125853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25482545|NCT00125853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482546|NCT00125853|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25482547|NCT00125853|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25482548|NCT00125853|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25482549|NCT00125853|Adrenergic Agents|adrenergic agents|mesh-ancestor
25482550|NCT00125853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25482551|NCT00125853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482552|NCT00125853|Vasodilator Agents|vasodilator agents|mesh-ancestor
25482553|NCT00125853|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25482554|NCT00125853|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25482555|NCT00125853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25482556|NCT00125931|Pentazocine|pentazocine|mesh-list
25482557|NCT00125931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25482558|NCT00125931|Narcotics|narcotics|mesh-ancestor
25482559|NCT00125931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25482560|NCT00125931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482561|NCT00125931|Analgesics|analgesics|mesh-ancestor
25482562|NCT00125931|Sensory System Agents|sensory system agents|mesh-ancestor
25482563|NCT00125931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25482564|NCT00125931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25482565|NCT00125931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25482566|NCT00125957|Bupropion|bupropion|mesh-list
25482567|NCT00125957|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25482568|NCT00125957|Antidepressive Agents|antidepressive agents|mesh-ancestor
25482569|NCT00125957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25482570|NCT00125957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25482571|NCT00125957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25482572|NCT00125957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25482573|NCT00125957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482574|NCT00125957|Dopamine Agents|dopamine agents|mesh-ancestor
25482575|NCT00125957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25482576|NCT00125957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482577|NCT00125957|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25482578|NCT00125957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25482579|NCT00125957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482580|NCT00126191|Leucovorin|leucovorin|mesh-list
25482581|NCT00126191|Cytarabine|cytarabine|mesh-list
25482582|NCT00126191|Cyclophosphamide|cyclophosphamide|mesh-list
25482583|NCT00126191|Ifosfamide|ifosfamide|mesh-list
25482584|NCT00126191|Rituximab|rituximab|mesh-list
25482585|NCT00126191|Doxorubicin|doxorubicin|mesh-list
25482586|NCT00126191|Methotrexate|methotrexate|mesh-list
25482587|NCT00126191|Etoposide|etoposide|mesh-list
25482588|NCT00126191|Vincristine|vincristine|mesh-list
25482589|NCT00126191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25482590|NCT00126191|Immunologic Factors|immunologic factors|mesh-ancestor
25482591|NCT00126191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482592|NCT00126191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25482593|NCT00126191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25482594|NCT00126191|Alkylating Agents|alkylating agents|mesh-ancestor
25482595|NCT00126191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482596|NCT00126191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482597|NCT00126191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25482598|NCT00126191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25482599|NCT00126191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25482600|NCT00126191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25482601|NCT00126191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25482602|NCT00126191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482603|NCT00126191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25482604|NCT00126191|Abortifacient Agents|abortifacient agents|mesh-ancestor
25482605|NCT00126191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25482606|NCT00126191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25482607|NCT00126191|Antimetabolites|antimetabolites|mesh-ancestor
25482608|NCT00126191|Dermatologic Agents|dermatologic agents|mesh-ancestor
25482609|NCT00126191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25482610|NCT00126191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25482611|NCT00126191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25482612|NCT00126191|Antiviral Agents|antiviral agents|mesh-ancestor
25482613|NCT00126191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25482614|NCT00126191|Antidotes|antidotes|mesh-ancestor
25482615|NCT00126191|Protective Agents|protective agents|mesh-ancestor
25482616|NCT00126191|Vitamin B Complex|vitamin b complex|mesh-ancestor
25482617|NCT00126191|Vitamins|vitamins|mesh-ancestor
25482618|NCT00126191|Micronutrients|micronutrients|mesh-ancestor
25482619|NCT00126191|Tubulin Modulators|tubulin modulators|mesh-ancestor
25482620|NCT00126191|Antimitotic Agents|antimitotic agents|mesh-ancestor
25482621|NCT00126191|Mitosis Modulators|mitosis modulators|mesh-ancestor
25482622|NCT00126425|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
25482623|NCT00126425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482624|NCT00126425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482625|NCT00126425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482626|NCT00126425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25823083|NCT00004747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823084|NCT00004748|Methotrexate|methotrexate|mesh-list
25823085|NCT00004748|Colchicine|colchicine|mesh-list
25823086|NCT00004748|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25482629|NCT00126438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482630|NCT00126438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482631|NCT00126438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25482633|NCT00126490|Bevacizumab|bevacizumab|mesh-list
25482634|NCT00126490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25482635|NCT00126490|Interleukin-2|interleukin-2|mesh-list
25482636|NCT00126490|Endothelial Growth Factors|endothelial growth factors|mesh-list
25482637|NCT00126490|Antibodies|antibodies|mesh-list
25482638|NCT00126490|Immunoglobulins|immunoglobulins|mesh-list
25482639|NCT00126490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25482640|NCT00126490|Immunoglobulin G|immunoglobulin g|mesh-list
25482641|NCT00126490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482642|NCT00126490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25482643|NCT00126490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25482644|NCT00126490|Growth Substances|growth substances|mesh-ancestor
25482645|NCT00126490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482646|NCT00126490|Growth Inhibitors|growth inhibitors|mesh-ancestor
25482647|NCT00126490|Immunologic Factors|immunologic factors|mesh-ancestor
25482648|NCT00126490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25482649|NCT00126490|Analgesics|analgesics|mesh-ancestor
25482650|NCT00126490|Sensory System Agents|sensory system agents|mesh-ancestor
25482651|NCT00126490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25482652|NCT00126490|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25482653|NCT00126490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25482654|NCT00126490|Antiviral Agents|antiviral agents|mesh-ancestor
25482655|NCT00126490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25482656|NCT00126503|Bevacizumab|bevacizumab|mesh-list
25482657|NCT00126503|Sorafenib|sorafenib|mesh-list
25482658|NCT00126503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25482659|NCT00126503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482660|NCT00126503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25482661|NCT00126503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25482662|NCT00126503|Growth Substances|growth substances|mesh-ancestor
25482663|NCT00126503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482664|NCT00126503|Growth Inhibitors|growth inhibitors|mesh-ancestor
25482665|NCT00126503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25482666|NCT00126503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482667|NCT00126503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482668|NCT00126555|Gefitinib|gefitinib|mesh-list
25482669|NCT00126555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482670|NCT00126555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25482671|NCT00126555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482672|NCT00126555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482673|NCT00126568|Sorafenib|sorafenib|mesh-list
25482674|NCT00126568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823087|NCT00004748|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25482675|NCT00126568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25482676|NCT00126568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482677|NCT00126568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482678|NCT00126581|Paclitaxel|paclitaxel|mesh-list
25644939|NCT01441882|Dasatinib|dasatinib|mesh-list
25482679|NCT00126581|Carboplatin|carboplatin|mesh-list
25482680|NCT00126581|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25482681|NCT00126581|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25482682|NCT00126581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25482683|NCT00126581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482684|NCT00126581|Tubulin Modulators|tubulin modulators|mesh-ancestor
25482685|NCT00126581|Antimitotic Agents|antimitotic agents|mesh-ancestor
25482686|NCT00126581|Mitosis Modulators|mitosis modulators|mesh-ancestor
25482687|NCT00126581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482688|NCT00126581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25482689|NCT00126581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482690|NCT00126594|Interferons|interferons|mesh-list
25482691|NCT00126594|Interferon-alpha|interferon-alpha|mesh-list
25482692|NCT00126594|Interferon alpha-2|interferon alpha-2|mesh-list
25482693|NCT00126594|Sorafenib|sorafenib|mesh-list
25482694|NCT00126594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482695|NCT00126594|Antiviral Agents|antiviral agents|mesh-ancestor
25482696|NCT00126594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25482697|NCT00126594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25482698|NCT00126594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482699|NCT00126594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482700|NCT00126594|Immunologic Factors|immunologic factors|mesh-ancestor
25482705|NCT00127036|Irinotecan|irinotecan|mesh-list
25482706|NCT00127036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25482707|NCT00127036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482708|NCT00127036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25482709|NCT00127036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25482710|NCT00127036|Growth Substances|growth substances|mesh-ancestor
25482711|NCT00127036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482712|NCT00127036|Growth Inhibitors|growth inhibitors|mesh-ancestor
25482713|NCT00127036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25482714|NCT00127036|Antimetabolites|antimetabolites|mesh-ancestor
25482715|NCT00127036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482716|NCT00127036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25482717|NCT00127036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25482718|NCT00127036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482719|NCT00127101|Vorinostat|vorinostat|mesh-list
25482720|NCT00127101|Bexarotene|bexarotene|mesh-list
25482721|NCT00127101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482722|NCT00127101|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25482723|NCT00127101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482724|NCT00127101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482725|NCT00127166|Fluticasone|fluticasone|mesh-list
25482726|NCT00127166|Xhance|xhance|mesh-list
25482727|NCT00127166|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25482728|NCT00127166|Montelukast|montelukast|mesh-list
25482729|NCT00127166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25482730|NCT00127166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25482731|NCT00127166|Autonomic Agents|autonomic agents|mesh-ancestor
25482732|NCT00127166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25482733|NCT00127166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482734|NCT00127166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25482735|NCT00127166|Respiratory System Agents|respiratory system agents|mesh-ancestor
25482736|NCT00127166|Dermatologic Agents|dermatologic agents|mesh-ancestor
25482737|NCT00127166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25482738|NCT00127166|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25482739|NCT00127166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25482740|NCT00127166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25482741|NCT00127166|Adrenergic Agents|adrenergic agents|mesh-ancestor
25482742|NCT00127166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25482743|NCT00127166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482744|NCT00127166|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25482745|NCT00127166|Hormone Antagonists|hormone antagonists|mesh-ancestor
25482746|NCT00127166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25482747|NCT00127166|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25482748|NCT00127166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25482749|NCT00127192|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25482750|NCT00127192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25482751|NCT00127192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482752|NCT00127192|Incretins|incretins|mesh-ancestor
25482753|NCT00127192|Hormones|hormones|mesh-ancestor
25482754|NCT00127192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24433202|NCT00257868|Rivastigmine|rivastigmine|mesh-list
25644940|NCT01441882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482755|NCT00127192|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25482756|NCT00127192|Protease Inhibitors|protease inhibitors|mesh-ancestor
25482757|NCT00127192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482758|NCT00127192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482759|NCT00127205|Zoledronic Acid|zoledronic acid|mesh-list
25482760|NCT00127205|Ibandronic Acid|ibandronic acid|mesh-list
25482762|NCT00127205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25482763|NCT00127205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482764|NCT00127218|Niacin|niacin|mesh-list
25482765|NCT00127218|Atorvastatin|atorvastatin|mesh-list
25482766|NCT00127218|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25482767|NCT00127218|Simvastatin|simvastatin|mesh-list
25482768|NCT00127218|Pravastatin|pravastatin|mesh-list
25482769|NCT00127218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25482770|NCT00127218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25482771|NCT00127218|Antimetabolites|antimetabolites|mesh-ancestor
25482772|NCT00127218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482785|NCT00127712|Amiodarone|amiodarone|mesh-list
25482786|NCT00127712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25482787|NCT00127712|Vasodilator Agents|vasodilator agents|mesh-ancestor
25482788|NCT00127712|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25482789|NCT00127712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25482790|NCT00127712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482791|NCT00127712|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25482792|NCT00127712|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25482793|NCT00127712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25482794|NCT00127712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482795|NCT00127712|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25482796|NCT00127712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25482797|NCT00127712|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25482798|NCT00127803|Vaccines|vaccines|mesh-list
25482799|NCT00127803|Immunologic Factors|immunologic factors|mesh-ancestor
25482800|NCT00127803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482801|NCT00127842|Etanercept|etanercept|mesh-list
25482802|NCT00127842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25482803|NCT00127842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25482804|NCT00127842|Analgesics|analgesics|mesh-ancestor
25482805|NCT00127842|Sensory System Agents|sensory system agents|mesh-ancestor
25482806|NCT00127842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25482807|NCT00127842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482808|NCT00127842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25482809|NCT00127842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25482810|NCT00127842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25482811|NCT00127842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25482812|NCT00127842|Immunologic Factors|immunologic factors|mesh-ancestor
25482813|NCT00127855|Vaccines|vaccines|mesh-list
25482814|NCT00127855|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25482815|NCT00127855|Immunologic Factors|immunologic factors|mesh-ancestor
25482816|NCT00127855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482817|NCT00127933|Capecitabine|capecitabine|mesh-list
25482818|NCT00127933|Docetaxel|docetaxel|mesh-list
25482819|NCT00127933|Trastuzumab|trastuzumab|mesh-list
25482820|NCT00127933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25482821|NCT00127933|Antimetabolites|antimetabolites|mesh-ancestor
25482822|NCT00127933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482823|NCT00127933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482824|NCT00127933|Tubulin Modulators|tubulin modulators|mesh-ancestor
25482825|NCT00127933|Antimitotic Agents|antimitotic agents|mesh-ancestor
25482826|NCT00127933|Mitosis Modulators|mitosis modulators|mesh-ancestor
25482827|NCT00127933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25482828|NCT00128102|Vorinostat|vorinostat|mesh-list
25482829|NCT00128102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482830|NCT00128102|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25482831|NCT00128102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482832|NCT00128102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482833|NCT00128180|Methylprednisolone|methylprednisolone|mesh-list
25482834|NCT00128180|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25482835|NCT00128180|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25482836|NCT00128180|Prednisolone|prednisolone|mesh-list
25482837|NCT00128180|Prednisolone acetate|prednisolone acetate|mesh-list
25482838|NCT00128180|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25482839|NCT00128180|Prednisolone phosphate|prednisolone phosphate|mesh-list
25482840|NCT00128180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25482841|NCT00128180|Antiemetics|antiemetics|mesh-ancestor
25482842|NCT00128180|Autonomic Agents|autonomic agents|mesh-ancestor
25482843|NCT00128180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25482844|NCT00128180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482845|NCT00128180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25482846|NCT00128180|Glucocorticoids|glucocorticoids|mesh-ancestor
25482848|NCT00128180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25482849|NCT00128180|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25482850|NCT00128180|Protective Agents|protective agents|mesh-ancestor
25482851|NCT00128180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25482852|NCT00128180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482853|NCT00128206|Rifampin|rifampin|mesh-list
25482854|NCT00128206|Isoniazid|isoniazid|mesh-list
25482855|NCT00128206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25482856|NCT00128206|Antitubercular Agents|antitubercular agents|mesh-ancestor
25482857|NCT00128206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25014337|NCT04717765|Micronutrients|micronutrients|mesh-ancestor
25482858|NCT00128206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25482859|NCT00128206|Leprostatic Agents|leprostatic agents|mesh-ancestor
25482860|NCT00128206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25482861|NCT00128206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482862|NCT00128206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482863|NCT00128206|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25482864|NCT00128206|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25482865|NCT00128206|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25482866|NCT00128206|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25482867|NCT00128206|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25482868|NCT00128206|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25482869|NCT00128206|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25482870|NCT00128206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25482871|NCT00128206|Antimetabolites|antimetabolites|mesh-ancestor
25482872|NCT00128206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25482874|NCT00128401|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25482875|NCT00128401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25482876|NCT00128401|Renal Agents|renal agents|mesh-ancestor
25482877|NCT00128401|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25482878|NCT00128401|Antitubercular Agents|antitubercular agents|mesh-ancestor
25482879|NCT00128401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25482880|NCT00128401|Antimetabolites|antimetabolites|mesh-ancestor
25482881|NCT00128401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482882|NCT00128661|Vaccines|vaccines|mesh-list
25482883|NCT00128661|Immunologic Factors|immunologic factors|mesh-ancestor
25482884|NCT00128661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482885|NCT00128830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
25482886|NCT00128830|Etravirine|etravirine|mesh-list
25482887|NCT00128830|Enfuvirtide|enfuvirtide|mesh-list
25482888|NCT00128830|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
25482889|NCT00128830|Protease Inhibitors|protease inhibitors|mesh-list
25482890|NCT00128830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25482891|NCT00128830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482892|NCT00128830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482893|NCT00128830|Antiviral Agents|antiviral agents|mesh-ancestor
25482894|NCT00128830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25482895|NCT00128830|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25482896|NCT00128830|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25482897|NCT00128830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25482898|NCT00128830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25482899|NCT00128830|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25482900|NCT00128921|Bortezomib|bortezomib|mesh-list
25482901|NCT00128921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482902|NCT00129116|Vaccines|vaccines|mesh-list
25482903|NCT00129116|Immunologic Factors|immunologic factors|mesh-ancestor
25482904|NCT00129116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482905|NCT00129129|Vaccines|vaccines|mesh-list
25482906|NCT00129129|Immunologic Factors|immunologic factors|mesh-ancestor
25482907|NCT00129129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482908|NCT00129220|Haloperidol|haloperidol|mesh-list
25482909|NCT00129220|Olanzapine|olanzapine|mesh-list
25482910|NCT00129220|Haloperidol decanoate|haloperidol decanoate|mesh-list
25482911|NCT00129220|Antiemetics|antiemetics|mesh-ancestor
25482912|NCT00129220|Autonomic Agents|autonomic agents|mesh-ancestor
25482913|NCT00129220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25482914|NCT00129220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482915|NCT00129220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25482916|NCT00129220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25482917|NCT00129220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25482918|NCT00129220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25482919|NCT00129220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25482920|NCT00129220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25482921|NCT00129220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25482922|NCT00129220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25482923|NCT00129220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827016|NCT02137161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24827017|NCT02137161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827018|NCT02137161|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24827019|NCT02137161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24827020|NCT02137161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24827021|NCT02137161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24827030|NCT02137213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25482924|NCT00129220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25482925|NCT00129220|Serotonin Agents|serotonin agents|mesh-ancestor
25482926|NCT00129220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25482927|NCT00129220|Dopamine Agents|dopamine agents|mesh-ancestor
25482928|NCT00129220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25482930|NCT00129246|Bupropion|bupropion|mesh-list
25482931|NCT00129246|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25482932|NCT00129246|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25482933|NCT00129246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482934|NCT00129246|Sensory System Agents|sensory system agents|mesh-ancestor
25482935|NCT00129246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25482936|NCT00129246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25482937|NCT00129246|Antidepressive Agents|antidepressive agents|mesh-ancestor
25482938|NCT00129246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25482939|NCT00129246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25482940|NCT00129246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25482941|NCT00129246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25482942|NCT00129246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482943|NCT00129246|Dopamine Agents|dopamine agents|mesh-ancestor
25482944|NCT00129246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25482945|NCT00129246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25482946|NCT00129246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25482947|NCT00129246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482948|NCT00129259|Iron|iron|mesh-list
25482949|NCT00129259|Trace Elements|trace elements|mesh-ancestor
25482950|NCT00129259|Micronutrients|micronutrients|mesh-ancestor
25482951|NCT00129259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482952|NCT00129272|Bupropion|bupropion|mesh-list
25482953|NCT00129272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25482954|NCT00129272|Antidepressive Agents|antidepressive agents|mesh-ancestor
25482955|NCT00129272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25482956|NCT00129272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25482957|NCT00129272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25482958|NCT00129272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25482959|NCT00129272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482960|NCT00129272|Dopamine Agents|dopamine agents|mesh-ancestor
25482961|NCT00129272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25482962|NCT00129272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482963|NCT00129272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25482964|NCT00129272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25482965|NCT00129272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482966|NCT00129285|Modafinil|modafinil|mesh-list
25482967|NCT00129285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25482968|NCT00129285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482969|NCT00129285|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25482970|NCT00129285|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25482971|NCT00129285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25482972|NCT00129285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482973|NCT00129311|Selegiline|selegiline|mesh-list
25482974|NCT00129311|Antidepressive Agents|antidepressive agents|mesh-ancestor
25482975|NCT00129311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25482976|NCT00129311|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25482977|NCT00129311|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25482978|NCT00129311|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25482979|NCT00129311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25482980|NCT00129311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644941|NCT01441882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25644942|NCT01441882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25644943|NCT01441882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644944|NCT01441960|Rocuronium|rocuronium|mesh-list
25644945|NCT01441960|Succinylcholine|succinylcholine|mesh-list
25644946|NCT01441960|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25644947|NCT01441960|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25644948|NCT01441960|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25482981|NCT00129311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25482982|NCT00129311|Protective Agents|protective agents|mesh-ancestor
25482983|NCT00129311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482984|NCT00129376|Cyclophosphamide|cyclophosphamide|mesh-list
25482985|NCT00129376|Docetaxel|docetaxel|mesh-list
25482986|NCT00129376|Doxorubicin|doxorubicin|mesh-list
25482987|NCT00129376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25482988|NCT00129376|Immunologic Factors|immunologic factors|mesh-ancestor
25482989|NCT00129376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25482990|NCT00129376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25482991|NCT00129376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25482992|NCT00129376|Alkylating Agents|alkylating agents|mesh-ancestor
25482993|NCT00129376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25482994|NCT00129376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25482995|NCT00129376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24468234|NCT00380614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25482997|NCT00129376|Antimitotic Agents|antimitotic agents|mesh-ancestor
25482998|NCT00129376|Mitosis Modulators|mitosis modulators|mesh-ancestor
25482999|NCT00129376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25483000|NCT00129376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25483001|NCT00129376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25483002|NCT00129376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483003|NCT00129389|Paclitaxel|paclitaxel|mesh-list
25483004|NCT00129389|Cyclophosphamide|cyclophosphamide|mesh-list
25483005|NCT00129389|Doxorubicin|doxorubicin|mesh-list
25483006|NCT00129389|Fluorouracil|fluorouracil|mesh-list
25483007|NCT00129389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25483008|NCT00129389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483009|NCT00129389|Tubulin Modulators|tubulin modulators|mesh-ancestor
25483010|NCT00129389|Antimitotic Agents|antimitotic agents|mesh-ancestor
25483011|NCT00129389|Mitosis Modulators|mitosis modulators|mesh-ancestor
25483012|NCT00129389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483013|NCT00129389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25483014|NCT00129389|Immunologic Factors|immunologic factors|mesh-ancestor
25483015|NCT00129389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483016|NCT00129389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25483017|NCT00129389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25483018|NCT00129389|Alkylating Agents|alkylating agents|mesh-ancestor
25483019|NCT00129389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25483020|NCT00129389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25483021|NCT00129389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25483022|NCT00129389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25483023|NCT00129389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483024|NCT00129389|Antimetabolites|antimetabolites|mesh-ancestor
25483025|NCT00129389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25483026|NCT00129467|Methylphenidate|methylphenidate|mesh-list
25483027|NCT00129467|Serotonin|serotonin|mesh-list
25483028|NCT00129467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25483029|NCT00129467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25483030|NCT00129467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483031|NCT00129467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25483032|NCT00129467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25483033|NCT00129467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25483034|NCT00129467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483035|NCT00129467|Dopamine Agents|dopamine agents|mesh-ancestor
25483036|NCT00129467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25483037|NCT00129467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25483038|NCT00129467|Serotonin Agents|serotonin agents|mesh-ancestor
25483039|NCT00129545|Warfarin|warfarin|mesh-list
25483040|NCT00129545|Anticoagulants|anticoagulants|mesh-ancestor
25483041|NCT00129623|Ibandronic Acid|ibandronic acid|mesh-list
25483042|NCT00129623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25483043|NCT00129623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483044|NCT00129727|Paclitaxel|paclitaxel|mesh-list
25483045|NCT00129727|Bevacizumab|bevacizumab|mesh-list
25483046|NCT00129727|Carboplatin|carboplatin|mesh-list
25483047|NCT00129727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25483048|NCT00129727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483049|NCT00129727|Tubulin Modulators|tubulin modulators|mesh-ancestor
25483050|NCT00129727|Antimitotic Agents|antimitotic agents|mesh-ancestor
25483051|NCT00129727|Mitosis Modulators|mitosis modulators|mesh-ancestor
25483052|NCT00129727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483053|NCT00129727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25483054|NCT00129727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25483055|NCT00129727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25483056|NCT00129727|Growth Substances|growth substances|mesh-ancestor
25483057|NCT00129727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483058|NCT00129727|Growth Inhibitors|growth inhibitors|mesh-ancestor
25483059|NCT00129766|Palivizumab|palivizumab|mesh-list
25644949|NCT01441960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25483060|NCT00129766|Antiviral Agents|antiviral agents|mesh-ancestor
25483061|NCT00129766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25644950|NCT01441960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644951|NCT01441960|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
25644952|NCT01441973|Elotuzumab|elotuzumab|mesh-list
25644953|NCT01441973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25644954|NCT01442038|Ranolazine|ranolazine|mesh-list
25644955|NCT01442038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25644956|NCT01442038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25644957|NCT01442038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25644958|NCT01442064|Ranibizumab|ranibizumab|mesh-list
25644959|NCT01442064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25644960|NCT01442064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25644961|NCT01442064|Growth Substances|growth substances|mesh-ancestor
25644962|NCT01442064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644963|NCT01442064|Growth Inhibitors|growth inhibitors|mesh-ancestor
25644964|NCT01442064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25644965|NCT01442155|Capecitabine|capecitabine|mesh-list
25644966|NCT01442155|Oxaliplatin|oxaliplatin|mesh-list
24971131|NCT03728192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24576436|NCT00838656|Paclitaxel|paclitaxel|mesh-list
24971147|NCT03728153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25823088|NCT00004748|Abortifacient Agents|abortifacient agents|mesh-ancestor
25823089|NCT00004748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25823090|NCT00004748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457217|NCT00333476|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24457218|NCT00333476|Protective Agents|protective agents|mesh-ancestor
25483062|NCT00129935|Cyclophosphamide|cyclophosphamide|mesh-list
25483063|NCT00129935|Docetaxel|docetaxel|mesh-list
25483064|NCT00129935|Capecitabine|capecitabine|mesh-list
25483065|NCT00129935|Epirubicin|epirubicin|mesh-list
25483066|NCT00129935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25483067|NCT00129935|Immunologic Factors|immunologic factors|mesh-ancestor
25483068|NCT00129935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483069|NCT00129935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25483070|NCT00129935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25483071|NCT00129935|Alkylating Agents|alkylating agents|mesh-ancestor
25483072|NCT00129935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483073|NCT00129935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483074|NCT00129935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25483075|NCT00129935|Tubulin Modulators|tubulin modulators|mesh-ancestor
25483076|NCT00129935|Antimitotic Agents|antimitotic agents|mesh-ancestor
25483077|NCT00129935|Mitosis Modulators|mitosis modulators|mesh-ancestor
25483078|NCT00129935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25483079|NCT00129935|Antimetabolites|antimetabolites|mesh-ancestor
25483080|NCT00129935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25483081|NCT00129935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25483082|NCT00129935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25483083|NCT00129935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483084|NCT00129961|Cyclosporine|cyclosporine|mesh-list
25483085|NCT00129961|Sirolimus|sirolimus|mesh-list
25483086|NCT00129961|Tacrolimus|tacrolimus|mesh-list
25483087|NCT00129961|Cyclosporins|cyclosporins|mesh-list
25483088|NCT00129961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25483089|NCT00129961|Immunologic Factors|immunologic factors|mesh-ancestor
25483090|NCT00129961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483091|NCT00129961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25483092|NCT00129961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483093|NCT00129961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483094|NCT00129961|Antifungal Agents|antifungal agents|mesh-ancestor
25483095|NCT00129961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25483096|NCT00129961|Dermatologic Agents|dermatologic agents|mesh-ancestor
25483097|NCT00129961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25483098|NCT00129961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25483099|NCT00129961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25483100|NCT00129961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483102|NCT00130039|Clopidogrel|clopidogrel|mesh-list
25483103|NCT00130039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25483104|NCT00130039|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25483105|NCT00130039|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25483106|NCT00130039|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25483107|NCT00130039|Purinergic Agents|purinergic agents|mesh-ancestor
25483108|NCT00130039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25483109|NCT00130039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483110|NCT00130039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483111|NCT00130039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25483112|NCT00130039|Autonomic Agents|autonomic agents|mesh-ancestor
25483113|NCT00130039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25483114|NCT00130039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25483115|NCT00130039|Respiratory System Agents|respiratory system agents|mesh-ancestor
25483116|NCT00130039|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25483117|NCT00130039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25483118|NCT00130039|Vasodilator Agents|vasodilator agents|mesh-ancestor
25483119|NCT00130039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25483120|NCT00130039|Protective Agents|protective agents|mesh-ancestor
25483121|NCT00130039|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25483122|NCT00130039|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25483123|NCT00130039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483124|NCT00130117|Contraceptive Agents|contraceptive agents|mesh-list
25483125|NCT00130117|Contraceptives, Oral|contraceptives, oral|mesh-list
25483126|NCT00130117|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25483127|NCT00130117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25483128|NCT00130117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483129|NCT00130117|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25483130|NCT00130208|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
25483131|NCT00130208|Anticoagulants|anticoagulants|mesh-ancestor
25483132|NCT00130208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25483133|NCT00130208|Antimetabolites|antimetabolites|mesh-ancestor
25483134|NCT00130208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483135|NCT00130208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25483136|NCT00130208|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25483137|NCT00130208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25483138|NCT00130208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25483139|NCT00130208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483140|NCT00130247|Rifampin|rifampin|mesh-list
25483141|NCT00130247|Isoniazid|isoniazid|mesh-list
25483142|NCT00130247|Pyrazinamide|pyrazinamide|mesh-list
25483143|NCT00130247|Ethambutol|ethambutol|mesh-list
25483144|NCT00130247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25483145|NCT00130247|Antitubercular Agents|antitubercular agents|mesh-ancestor
25483146|NCT00130247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25483147|NCT00130247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25483148|NCT00130247|Leprostatic Agents|leprostatic agents|mesh-ancestor
25483149|NCT00130247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25483150|NCT00130247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483151|NCT00130247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483152|NCT00130247|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25483153|NCT00130247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25483154|NCT00130247|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25483155|NCT00130247|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25483156|NCT00130247|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25483157|NCT00130247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25483158|NCT00130247|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25483159|NCT00130247|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25483160|NCT00130247|Antimetabolites|antimetabolites|mesh-ancestor
25483161|NCT00130247|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25483162|NCT00130286|Rosiglitazone|rosiglitazone|mesh-list
25483163|NCT00130286|Hormones|hormones|mesh-list
25483164|NCT00130286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25483165|NCT00130286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483166|NCT00130286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25483167|NCT00130520|Bevacizumab|bevacizumab|mesh-list
25483168|NCT00130520|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25483169|NCT00130520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25483170|NCT00130520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483171|NCT00130520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25483172|NCT00130520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25483173|NCT00130520|Growth Substances|growth substances|mesh-ancestor
25483174|NCT00130520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483175|NCT00130520|Growth Inhibitors|growth inhibitors|mesh-ancestor
25483176|NCT00130520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25483177|NCT00130520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483178|NCT00130520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483179|NCT00130533|Capecitabine|capecitabine|mesh-list
25483180|NCT00130533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25483181|NCT00130533|Antimetabolites|antimetabolites|mesh-ancestor
25483182|NCT00130533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483183|NCT00130533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483184|NCT00130637|Daclizumab|daclizumab|mesh-list
25483185|NCT00130637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25483186|NCT00130637|Immunologic Factors|immunologic factors|mesh-ancestor
25483187|NCT00130637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483188|NCT00130689|Cetuximab|cetuximab|mesh-list
25483189|NCT00130689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25483190|NCT00130689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483191|NCT00130728|Bevacizumab|bevacizumab|mesh-list
25483192|NCT00130728|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25483193|NCT00130728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25483194|NCT00130728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483195|NCT00130728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25483196|NCT00130728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25483197|NCT00130728|Growth Substances|growth substances|mesh-ancestor
25483198|NCT00130728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483199|NCT00130728|Growth Inhibitors|growth inhibitors|mesh-ancestor
25483200|NCT00130728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25483201|NCT00130728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483202|NCT00130728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508324|NCT00555087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24508325|NCT00555087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508326|NCT00555087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24944896|NCT03956212|Doxycycline|doxycycline|mesh-list
24513613|NCT00584090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513614|NCT00584090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513615|NCT00584090|Urological Agents|urological agents|mesh-ancestor
25483203|NCT00130780|Bevacizumab|bevacizumab|mesh-list
25483204|NCT00130780|Cisplatin|cisplatin|mesh-list
25483205|NCT00130780|Docetaxel|docetaxel|mesh-list
25483206|NCT00130780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25483207|NCT00130780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483208|NCT00130780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25483209|NCT00130780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25483210|NCT00130780|Growth Substances|growth substances|mesh-ancestor
25483211|NCT00130780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483212|NCT00130780|Growth Inhibitors|growth inhibitors|mesh-ancestor
25483213|NCT00130780|Tubulin Modulators|tubulin modulators|mesh-ancestor
25483214|NCT00130780|Antimitotic Agents|antimitotic agents|mesh-ancestor
25483215|NCT00130780|Mitosis Modulators|mitosis modulators|mesh-ancestor
25483216|NCT00130780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483217|NCT00130793|Vaccines|vaccines|mesh-list
25483218|NCT00130793|Immunologic Factors|immunologic factors|mesh-ancestor
25483219|NCT00130793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483220|NCT00130832|Vaccines|vaccines|mesh-list
25483221|NCT00130832|Immunologic Factors|immunologic factors|mesh-ancestor
25483222|NCT00130832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483223|NCT00130923|Risperidone|risperidone|mesh-list
25483224|NCT00130923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25483225|NCT00130923|Serotonin Agents|serotonin agents|mesh-ancestor
25483226|NCT00130923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25483227|NCT00130923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483228|NCT00130923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483229|NCT00130923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25483230|NCT00130923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25483231|NCT00130923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25483232|NCT00130923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25483233|NCT00130923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25483234|NCT00130923|Dopamine Agents|dopamine agents|mesh-ancestor
25483235|NCT00131248|Metoclopramide|metoclopramide|mesh-list
25483236|NCT00131248|Ranitidine|ranitidine|mesh-list
25483237|NCT00131248|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
25483239|NCT00131248|Autonomic Agents|autonomic agents|mesh-ancestor
25483240|NCT00131248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25483241|NCT00131248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483242|NCT00131248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25483243|NCT00131248|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25483244|NCT00131248|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25483245|NCT00131248|Dopamine Agents|dopamine agents|mesh-ancestor
25483246|NCT00131248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25483247|NCT00131248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483248|NCT00131248|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25483249|NCT00131248|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25483250|NCT00131248|Histamine Antagonists|histamine antagonists|mesh-ancestor
25483251|NCT00131248|Histamine Agents|histamine agents|mesh-ancestor
25483252|NCT00131352|Hylan|hylan|mesh-list
25483253|NCT00131352|Viscosupplements|viscosupplements|mesh-ancestor
25483254|NCT00131352|Protective Agents|protective agents|mesh-ancestor
25483255|NCT00131352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483256|NCT00131378|Hormones|hormones|mesh-list
25483257|NCT00131378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25483258|NCT00131378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483259|NCT00131456|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25483260|NCT00131456|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25483261|NCT00131456|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25483262|NCT00131456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25483263|NCT00131456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483264|NCT00131456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24521048|NCT05174507|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24521049|NCT05174507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521050|NCT05174507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24521051|NCT05174507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521153|NCT05074355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521154|NCT05074355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24521155|NCT05074355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24521157|NCT05053334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24521158|NCT05053334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24521159|NCT05053334|Respiratory System Agents|respiratory system agents|mesh-ancestor
24521160|NCT05037045|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24521248|NCT04931602|Vitamin D|vitamin d|mesh-list
25483265|NCT00131456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483266|NCT00131456|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25483267|NCT00131456|Antidepressive Agents|antidepressive agents|mesh-ancestor
25483268|NCT00131456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25483269|NCT00131469|Teriparatide|teriparatide|mesh-list
25483270|NCT00131469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25483271|NCT00131469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483272|NCT00131469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25483273|NCT00131664|Metformin|metformin|mesh-list
25483274|NCT00131664|Glimepiride|glimepiride|mesh-list
25483275|NCT00131664|Rosiglitazone|rosiglitazone|mesh-list
25483276|NCT00131664|Maleic acid|maleic acid|mesh-list
25483277|NCT00131664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25483278|NCT00131664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483279|NCT00131664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483280|NCT00131664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483281|NCT00131664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25483282|NCT00131664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25483283|NCT00131664|Immunologic Factors|immunologic factors|mesh-ancestor
25483284|NCT00131677|Tenofovir|tenofovir|mesh-list
25483285|NCT00131677|Antiviral Agents|antiviral agents|mesh-ancestor
25483286|NCT00131677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25483287|NCT00131677|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25483288|NCT00131677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25483289|NCT00131677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483290|NCT00131677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483291|NCT00131677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25483292|NCT00131677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25483293|NCT00131885|Levonorgestrel|levonorgestrel|mesh-list
25483294|NCT00131885|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25483295|NCT00131885|Contraceptive Agents|contraceptive agents|mesh-ancestor
25483296|NCT00131885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25483297|NCT00131885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483298|NCT00131885|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25483299|NCT00131885|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25483300|NCT00131885|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25483301|NCT00131911|Sorafenib|sorafenib|mesh-list
25483302|NCT00131911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483303|NCT00131911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25483304|NCT00131911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483305|NCT00131911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483306|NCT00131937|Sorafenib|sorafenib|mesh-list
25483307|NCT00131937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483308|NCT00131937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25483309|NCT00131937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483310|NCT00131937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483311|NCT00132002|Vorinostat|vorinostat|mesh-list
25483312|NCT00132002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483313|NCT00132002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25483314|NCT00132002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483315|NCT00132002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483316|NCT00132028|Vorinostat|vorinostat|mesh-list
25483317|NCT00132028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483318|NCT00132028|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25483319|NCT00132028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483320|NCT00132028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483321|NCT00132301|Prednisone|prednisone|mesh-list
25483322|NCT00132301|Docetaxel|docetaxel|mesh-list
25483323|NCT00132301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483324|NCT00132301|Tubulin Modulators|tubulin modulators|mesh-ancestor
25483325|NCT00132301|Antimitotic Agents|antimitotic agents|mesh-ancestor
25483326|NCT00132301|Mitosis Modulators|mitosis modulators|mesh-ancestor
25483327|NCT00132301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483328|NCT00132301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25483329|NCT00132301|Glucocorticoids|glucocorticoids|mesh-ancestor
25483330|NCT00132301|Hormones|hormones|mesh-ancestor
25483331|NCT00132301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25483332|NCT00132301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483333|NCT00132301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24527042|NCT00614653|Antimetabolites|antimetabolites|mesh-ancestor
24527043|NCT00614653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483334|NCT00132314|Risperidone|risperidone|mesh-list
25483335|NCT00132314|Antipsychotic Agents|antipsychotic agents|mesh-list
25483336|NCT00132314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25483337|NCT00132314|Serotonin Agents|serotonin agents|mesh-ancestor
25483338|NCT00132314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25483339|NCT00132314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483340|NCT00132314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483341|NCT00132314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25483342|NCT00132314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25483343|NCT00132314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25483344|NCT00132314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25483345|NCT00132314|Dopamine Agents|dopamine agents|mesh-ancestor
25483346|NCT00132496|Rabeprazole|rabeprazole|mesh-list
25483347|NCT00132496|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25483348|NCT00132496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25483349|NCT00132496|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25483350|NCT00132496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483351|NCT00132496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483352|NCT00132678|Risperidone|risperidone|mesh-list
25483353|NCT00132678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25483354|NCT00132678|Serotonin Agents|serotonin agents|mesh-ancestor
25483355|NCT00132678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25356445|NCT05439876|Melatonin|melatonin|mesh-list
25483356|NCT00132678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483357|NCT00132678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483358|NCT00132678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25483359|NCT00132678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25483360|NCT00132678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25483361|NCT00132678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25483362|NCT00132678|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25483363|NCT00132678|Dopamine Agents|dopamine agents|mesh-ancestor
25483364|NCT00132691|Cyclosporine|cyclosporine|mesh-list
25483365|NCT00132691|Mycophenolic Acid|mycophenolic acid|mesh-list
25483366|NCT00132691|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
25483367|NCT00132691|Cyclophosphamide|cyclophosphamide|mesh-list
25483368|NCT00132691|Chlorambucil|chlorambucil|mesh-list
25483369|NCT00132691|Methotrexate|methotrexate|mesh-list
25483370|NCT00132691|Azathioprine|azathioprine|mesh-list
25483372|NCT00132691|Tacrolimus|tacrolimus|mesh-list
25483373|NCT00132691|Cyclosporins|cyclosporins|mesh-list
25483374|NCT00132691|Daclizumab|daclizumab|mesh-list
25483375|NCT00132691|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25483376|NCT00132691|Alkylating Agents|alkylating agents|mesh-list
25483377|NCT00132691|Immunologic Factors|immunologic factors|mesh-ancestor
25483378|NCT00132691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483379|NCT00132691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25483380|NCT00132691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25483381|NCT00132691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483382|NCT00132691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483383|NCT00132691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25483384|NCT00132691|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25483385|NCT00132691|Abortifacient Agents|abortifacient agents|mesh-ancestor
25483386|NCT00132691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25483387|NCT00132691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25483388|NCT00132691|Antimetabolites|antimetabolites|mesh-ancestor
25483389|NCT00132691|Dermatologic Agents|dermatologic agents|mesh-ancestor
25483390|NCT00132691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483391|NCT00132691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25483392|NCT00132691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25483393|NCT00132691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25483394|NCT00132691|Antifungal Agents|antifungal agents|mesh-ancestor
25483395|NCT00132691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25483396|NCT00132691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25483397|NCT00132691|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25483398|NCT00132691|Antitubercular Agents|antitubercular agents|mesh-ancestor
24528407|NCT00621036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24528505|NCT00621400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528506|NCT00621400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24528507|NCT00621400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24528508|NCT00621452|Aldesleukin|aldesleukin|mesh-list
24528509|NCT00621452|Cyclophosphamide|cyclophosphamide|mesh-list
24528510|NCT00621452|Interleukin-2|interleukin-2|mesh-list
24528511|NCT00621452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24528512|NCT00621452|Immunologic Factors|immunologic factors|mesh-ancestor
24528513|NCT00621452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528514|NCT00621452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25483399|NCT00132691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25483400|NCT00132691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25483401|NCT00132691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25483402|NCT00132691|Glucocorticoids|glucocorticoids|mesh-ancestor
25483403|NCT00132691|Hormones|hormones|mesh-ancestor
25483404|NCT00132691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25483405|NCT00132730|MK 0873|mk 0873|mesh-list
25483406|NCT00132730|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25483407|NCT00132730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25483408|NCT00132730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483409|NCT00132730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483410|NCT00132769|MK 0873|mk 0873|mesh-list
25483411|NCT00132769|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25483412|NCT00132769|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25483413|NCT00132769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483414|NCT00132769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483415|NCT00132808|Zoledronic Acid|zoledronic acid|mesh-list
25483416|NCT00132808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25483417|NCT00132808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483418|NCT00132873|Sodium Oxybate|sodium oxybate|mesh-list
25483419|NCT00132873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25483420|NCT00132873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25483421|NCT00132873|Anesthetics, General|anesthetics, general|mesh-ancestor
25483422|NCT00132873|Anesthetics|anesthetics|mesh-ancestor
25483423|NCT00132873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25483424|NCT00132873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483425|NCT00133575|Vaccines|vaccines|mesh-list
25483426|NCT00133575|Immunologic Factors|immunologic factors|mesh-ancestor
25483427|NCT00133575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483428|NCT00133705|Mifepristone|mifepristone|mesh-list
25483429|NCT00133705|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25483430|NCT00133705|Abortifacient Agents|abortifacient agents|mesh-ancestor
25483431|NCT00133705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25483432|NCT00133705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483433|NCT00133705|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25644967|NCT01442155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25483434|NCT00133705|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25483435|NCT00133705|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25483436|NCT00133705|Contraceptive Agents|contraceptive agents|mesh-ancestor
25483437|NCT00133705|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25483438|NCT00133705|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25483439|NCT00133705|Hormone Antagonists|hormone antagonists|mesh-ancestor
25483440|NCT00133705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25483441|NCT00133705|Luteolytic Agents|luteolytic agents|mesh-ancestor
25483442|NCT00133705|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25483443|NCT00133705|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25483444|NCT00133952|Ruboxistaurin|ruboxistaurin|mesh-list
25483445|NCT00133952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483446|NCT00133952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483447|NCT00133978|Selenium|selenium|mesh-list
25483448|NCT00133978|Antioxidants|antioxidants|mesh-list
25483449|NCT00133978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483450|NCT00133978|Protective Agents|protective agents|mesh-ancestor
25483451|NCT00133978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483452|NCT00133978|Trace Elements|trace elements|mesh-ancestor
25483453|NCT00133978|Micronutrients|micronutrients|mesh-ancestor
25483454|NCT00133991|Leucovorin|leucovorin|mesh-list
25483455|NCT00133991|Cytarabine|cytarabine|mesh-list
25483456|NCT00133991|Prednisone|prednisone|mesh-list
25483457|NCT00133991|Hydrocortisone|hydrocortisone|mesh-list
25483458|NCT00133991|Cyclophosphamide|cyclophosphamide|mesh-list
25483459|NCT00133991|Rituximab|rituximab|mesh-list
25483460|NCT00133991|Methotrexate|methotrexate|mesh-list
25483461|NCT00133991|Vincristine|vincristine|mesh-list
25483462|NCT00133991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25483463|NCT00133991|Immunologic Factors|immunologic factors|mesh-ancestor
25483464|NCT00133991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483465|NCT00133991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25483466|NCT00133991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25483467|NCT00133991|Alkylating Agents|alkylating agents|mesh-ancestor
25015223|NCT02950259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25155842|NCT05260541|Pramoxine|pramoxine|mesh-list
25155843|NCT05260541|Anesthetics, Local|anesthetics, local|mesh-ancestor
25155844|NCT05260541|Anesthetics|anesthetics|mesh-ancestor
25155845|NCT05260541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25155846|NCT05260541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155847|NCT05260541|Sensory System Agents|sensory system agents|mesh-ancestor
25155848|NCT05260541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25155855|NCT05256537|Mycophenolic Acid|mycophenolic acid|mesh-list
25155864|NCT05255367|Phenol|phenol|mesh-list
25483468|NCT00133991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483469|NCT00133991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483470|NCT00133991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25483471|NCT00133991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25483472|NCT00133991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25483473|NCT00133991|Glucocorticoids|glucocorticoids|mesh-ancestor
25483474|NCT00133991|Hormones|hormones|mesh-ancestor
25483475|NCT00133991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25483476|NCT00133991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25483477|NCT00133991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25483478|NCT00133991|Abortifacient Agents|abortifacient agents|mesh-ancestor
25483479|NCT00133991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25483480|NCT00133991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25483481|NCT00133991|Antimetabolites|antimetabolites|mesh-ancestor
25483482|NCT00133991|Dermatologic Agents|dermatologic agents|mesh-ancestor
25483483|NCT00133991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483484|NCT00133991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25483485|NCT00133991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25483486|NCT00133991|Antiviral Agents|antiviral agents|mesh-ancestor
25483487|NCT00133991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25483488|NCT00133991|Antidotes|antidotes|mesh-ancestor
25483489|NCT00133991|Protective Agents|protective agents|mesh-ancestor
25483490|NCT00133991|Vitamin B Complex|vitamin b complex|mesh-ancestor
25483491|NCT00133991|Vitamins|vitamins|mesh-ancestor
25483492|NCT00133991|Micronutrients|micronutrients|mesh-ancestor
25483493|NCT00133991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25483494|NCT00133991|Tubulin Modulators|tubulin modulators|mesh-ancestor
25483495|NCT00133991|Antimitotic Agents|antimitotic agents|mesh-ancestor
25483496|NCT00133991|Mitosis Modulators|mitosis modulators|mesh-ancestor
25483497|NCT00134004|Mycophenolic Acid|mycophenolic acid|mesh-list
25483498|NCT00134004|Cyclophosphamide|cyclophosphamide|mesh-list
25483499|NCT00134004|Fludarabine|fludarabine|mesh-list
25483501|NCT00134004|Tacrolimus|tacrolimus|mesh-list
25483502|NCT00134004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25483503|NCT00134004|Immunologic Factors|immunologic factors|mesh-ancestor
25483504|NCT00134004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483505|NCT00134004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25483506|NCT00134004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25483507|NCT00134004|Alkylating Agents|alkylating agents|mesh-ancestor
25483508|NCT00134004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483509|NCT00134004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483510|NCT00134004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25483511|NCT00134004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25483512|NCT00134004|Antimetabolites|antimetabolites|mesh-ancestor
25483513|NCT00134004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25483514|NCT00134004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483515|NCT00134004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25483516|NCT00134004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25483517|NCT00134004|Antitubercular Agents|antitubercular agents|mesh-ancestor
25483518|NCT00134004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25483519|NCT00134004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25483520|NCT00134017|Cyclophosphamide|cyclophosphamide|mesh-list
25483521|NCT00134017|Busulfan|busulfan|mesh-list
25483522|NCT00134017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25483523|NCT00134017|Immunologic Factors|immunologic factors|mesh-ancestor
25483524|NCT00134017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483525|NCT00134017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25483526|NCT00134017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25483527|NCT00134017|Alkylating Agents|alkylating agents|mesh-ancestor
25483528|NCT00134017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483529|NCT00134017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483530|NCT00134017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25483531|NCT00134043|Vorinostat|vorinostat|mesh-list
25483532|NCT00134043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483533|NCT00134043|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25483534|NCT00134043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483535|NCT00134043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483536|NCT00134056|Prednisone|prednisone|mesh-list
25483537|NCT00134056|Docetaxel|docetaxel|mesh-list
25483538|NCT00134056|Atrasentan|atrasentan|mesh-list
25483539|NCT00134056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483540|NCT00134056|Tubulin Modulators|tubulin modulators|mesh-ancestor
25483541|NCT00134056|Antimitotic Agents|antimitotic agents|mesh-ancestor
25483542|NCT00134056|Mitosis Modulators|mitosis modulators|mesh-ancestor
25483549|NCT00134056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25483550|NCT00134056|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25483551|NCT00134056|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25483552|NCT00134082|Cyclophosphamide|cyclophosphamide|mesh-list
25483553|NCT00134082|Rituximab|rituximab|mesh-list
25483554|NCT00134082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25483555|NCT00134082|Immunologic Factors|immunologic factors|mesh-ancestor
25483556|NCT00134082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483557|NCT00134082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25483558|NCT00134082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25483559|NCT00134082|Alkylating Agents|alkylating agents|mesh-ancestor
25483560|NCT00134082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483561|NCT00134082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483562|NCT00134082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25483563|NCT00134082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25483564|NCT00134563|Teriflunomide|teriflunomide|mesh-list
25483565|NCT00134563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25483566|NCT00134563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25483567|NCT00134563|Analgesics|analgesics|mesh-ancestor
25483568|NCT00134563|Sensory System Agents|sensory system agents|mesh-ancestor
25483569|NCT00134563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25483570|NCT00134563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483571|NCT00134563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25483572|NCT00134563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25483573|NCT00134563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25483574|NCT00134563|Immunologic Factors|immunologic factors|mesh-ancestor
25483575|NCT00134719|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25483576|NCT00134719|Immunologic Factors|immunologic factors|mesh-ancestor
25483577|NCT00134719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483578|NCT00134901|Memantine|memantine|mesh-list
25483579|NCT00134901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25483580|NCT00134901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25483581|NCT00134901|Dopamine Agents|dopamine agents|mesh-ancestor
25483582|NCT00134901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25483583|NCT00134901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483584|NCT00134901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483585|NCT00134901|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25483586|NCT00134901|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25483587|NCT00135226|Aspirin|aspirin|mesh-list
25483588|NCT00135226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25483589|NCT00135226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25483590|NCT00135226|Analgesics|analgesics|mesh-ancestor
25483591|NCT00135226|Sensory System Agents|sensory system agents|mesh-ancestor
25483592|NCT00135226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25483593|NCT00135226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483594|NCT00135226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25483595|NCT00135226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25483596|NCT00135226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25483597|NCT00135226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25483598|NCT00135226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483599|NCT00135226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25483600|NCT00135226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25483601|NCT00135226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483602|NCT00135226|Antipyretics|antipyretics|mesh-ancestor
25823091|NCT00004748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25823092|NCT00004748|Antimetabolites|antimetabolites|mesh-ancestor
25823093|NCT00004748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823094|NCT00004748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823095|NCT00004748|Dermatologic Agents|dermatologic agents|mesh-ancestor
25483603|NCT00135330|Exenatide|exenatide|mesh-list
25483604|NCT00135330|Rosiglitazone|rosiglitazone|mesh-list
25483605|NCT00135330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25483606|NCT00135330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483607|NCT00135330|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25483608|NCT00135330|Incretins|incretins|mesh-ancestor
25483609|NCT00135330|Hormones|hormones|mesh-ancestor
25483610|NCT00135330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25483611|NCT00135356|Ritonavir|ritonavir|mesh-list
25483612|NCT00135356|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25483613|NCT00135356|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
25483614|NCT00135356|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
25483615|NCT00135356|Protease Inhibitors|protease inhibitors|mesh-list
25483616|NCT00135356|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25483617|NCT00135356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483618|NCT00135356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483619|NCT00135356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25483620|NCT00135356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25483621|NCT00135356|Antiviral Agents|antiviral agents|mesh-ancestor
25483622|NCT00135356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25483623|NCT00135356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25483624|NCT00135356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25483625|NCT00135356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25483626|NCT00135512|Bupropion|bupropion|mesh-list
25483627|NCT00135512|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25483628|NCT00135512|Antidepressive Agents|antidepressive agents|mesh-ancestor
25483629|NCT00135512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25483630|NCT00135512|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25483631|NCT00135512|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25483632|NCT00135512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25483633|NCT00135512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483634|NCT00135512|Dopamine Agents|dopamine agents|mesh-ancestor
25483635|NCT00135512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25483636|NCT00135512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483637|NCT00135512|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25483638|NCT00135512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25483639|NCT00135512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483640|NCT00135694|Prednisone|prednisone|mesh-list
25483641|NCT00135694|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
25483642|NCT00135694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25483643|NCT00135694|Glucocorticoids|glucocorticoids|mesh-ancestor
25483644|NCT00135694|Hormones|hormones|mesh-ancestor
25483645|NCT00135694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25483646|NCT00135694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823096|NCT00004748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483647|NCT00135694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25483648|NCT00135694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483649|NCT00135694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483650|NCT00135694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483651|NCT00135707|Vitamins|vitamins|mesh-list
25483652|NCT00135707|Ascorbic Acid|ascorbic acid|mesh-list
25483653|NCT00135707|Vitamin E|vitamin e|mesh-list
25483654|NCT00135707|alpha-Tocopherol|alpha-tocopherol|mesh-list
25483655|NCT00135707|Micronutrients|micronutrients|mesh-ancestor
25483656|NCT00135707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483657|NCT00135707|Antioxidants|antioxidants|mesh-ancestor
25483658|NCT00135707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483659|NCT00135707|Protective Agents|protective agents|mesh-ancestor
25483660|NCT00135798|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25483661|NCT00135798|Antiviral Agents|antiviral agents|mesh-ancestor
25483662|NCT00135798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25483663|NCT00136084|Cytarabine|cytarabine|mesh-list
25483664|NCT00136084|Dexamethasone|dexamethasone|mesh-list
25483665|NCT00136084|Prednisone|prednisone|mesh-list
25483666|NCT00136084|Cyclophosphamide|cyclophosphamide|mesh-list
25483667|NCT00136084|Methotrexate|methotrexate|mesh-list
25483668|NCT00136084|Etoposide|etoposide|mesh-list
25483669|NCT00136084|Vincristine|vincristine|mesh-list
25483670|NCT00136084|Daunorubicin|daunorubicin|mesh-list
25483671|NCT00136084|Asparaginase|asparaginase|mesh-list
25483672|NCT00136084|Mitoxantrone|mitoxantrone|mesh-list
25483673|NCT00136084|Mercaptopurine|mercaptopurine|mesh-list
25483674|NCT00136084|Cladribine|cladribine|mesh-list
25483675|NCT00136084|Gemtuzumab|gemtuzumab|mesh-list
25483676|NCT00136084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25483677|NCT00136084|Immunologic Factors|immunologic factors|mesh-ancestor
25483678|NCT00136084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483679|NCT00136084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25483680|NCT00136084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25483682|NCT00136084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483683|NCT00136084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483684|NCT00136084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25483685|NCT00136084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25483686|NCT00136084|Antiemetics|antiemetics|mesh-ancestor
25483687|NCT00136084|Autonomic Agents|autonomic agents|mesh-ancestor
25483688|NCT00136084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25483689|NCT00136084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25483690|NCT00136084|Glucocorticoids|glucocorticoids|mesh-ancestor
25483691|NCT00136084|Hormones|hormones|mesh-ancestor
25483692|NCT00136084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25483693|NCT00136084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25483694|NCT00136084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25483695|NCT00136084|Abortifacient Agents|abortifacient agents|mesh-ancestor
25483696|NCT00136084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25483697|NCT00136084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25483698|NCT00136084|Antimetabolites|antimetabolites|mesh-ancestor
25483699|NCT00136084|Dermatologic Agents|dermatologic agents|mesh-ancestor
25483700|NCT00136084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483701|NCT00136084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25483702|NCT00136084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25483703|NCT00136084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25483704|NCT00136084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25483705|NCT00136084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25483706|NCT00136084|Antiviral Agents|antiviral agents|mesh-ancestor
25483707|NCT00136084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25483708|NCT00136084|Tubulin Modulators|tubulin modulators|mesh-ancestor
25483709|NCT00136084|Antimitotic Agents|antimitotic agents|mesh-ancestor
25483710|NCT00136084|Mitosis Modulators|mitosis modulators|mesh-ancestor
25483711|NCT00136084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25483712|NCT00136084|Analgesics|analgesics|mesh-ancestor
25483713|NCT00136084|Sensory System Agents|sensory system agents|mesh-ancestor
25483714|NCT00136084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25483715|NCT00136318|Ribavirin|ribavirin|mesh-list
25483716|NCT00136318|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25483717|NCT00136318|Citalopram|citalopram|mesh-list
25483718|NCT00136318|Antimetabolites|antimetabolites|mesh-ancestor
25483719|NCT00136318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483720|NCT00136318|Antiviral Agents|antiviral agents|mesh-ancestor
25483721|NCT00136318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25483722|NCT00136318|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25483723|NCT00136318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25483724|NCT00136318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25483725|NCT00136318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25644969|NCT01442155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483726|NCT00136318|Serotonin Agents|serotonin agents|mesh-ancestor
25483727|NCT00136318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483728|NCT00136318|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25483729|NCT00136318|Antidepressive Agents|antidepressive agents|mesh-ancestor
25483730|NCT00136318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25483731|NCT00136760|Bupropion|bupropion|mesh-list
25483732|NCT00136760|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25483733|NCT00136760|Antidepressive Agents|antidepressive agents|mesh-ancestor
25483734|NCT00136760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25483735|NCT00136760|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25483736|NCT00136760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25483737|NCT00136760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25483738|NCT00136760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483739|NCT00136760|Dopamine Agents|dopamine agents|mesh-ancestor
25483740|NCT00136760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25483741|NCT00136760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483742|NCT00136760|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25483743|NCT00136760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25483744|NCT00136760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483745|NCT00136916|Insulin|insulin|mesh-list
25483746|NCT00136916|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25483747|NCT00136916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25483748|NCT00136916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483749|NCT00136955|Irinotecan|irinotecan|mesh-list
25483750|NCT00136955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25483751|NCT00136955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25483752|NCT00136955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483753|NCT00136955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483754|NCT00136955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483755|NCT00137046|Insulin|insulin|mesh-list
25483756|NCT00137046|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25483757|NCT00137046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25483758|NCT00137046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483759|NCT00137111|Cytarabine|cytarabine|mesh-list
25483760|NCT00137111|Dexamethasone|dexamethasone|mesh-list
25483761|NCT00137111|Prednisone|prednisone|mesh-list
25483762|NCT00137111|Cyclophosphamide|cyclophosphamide|mesh-list
25483763|NCT00137111|Doxorubicin|doxorubicin|mesh-list
25483764|NCT00137111|Methotrexate|methotrexate|mesh-list
25483765|NCT00137111|Etoposide|etoposide|mesh-list
25483766|NCT00137111|Vincristine|vincristine|mesh-list
25483767|NCT00137111|Daunorubicin|daunorubicin|mesh-list
25483768|NCT00137111|Asparaginase|asparaginase|mesh-list
25483769|NCT00137111|Mercaptopurine|mercaptopurine|mesh-list
25483770|NCT00137111|Pegaspargase|pegaspargase|mesh-list
25483771|NCT00137111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25483772|NCT00137111|Immunologic Factors|immunologic factors|mesh-ancestor
25483773|NCT00137111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483774|NCT00137111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25483775|NCT00137111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25483776|NCT00137111|Alkylating Agents|alkylating agents|mesh-ancestor
25483777|NCT00137111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483778|NCT00137111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483779|NCT00137111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25483780|NCT00137111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25483781|NCT00137111|Antiemetics|antiemetics|mesh-ancestor
25483782|NCT00137111|Autonomic Agents|autonomic agents|mesh-ancestor
25483783|NCT00137111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25483784|NCT00137111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25483785|NCT00137111|Glucocorticoids|glucocorticoids|mesh-ancestor
25483786|NCT00137111|Hormones|hormones|mesh-ancestor
25483787|NCT00137111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25483788|NCT00137111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25483789|NCT00137111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25483790|NCT00137111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25483791|NCT00137111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25483792|NCT00137111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483793|NCT00137111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25483794|NCT00137111|Abortifacient Agents|abortifacient agents|mesh-ancestor
25483795|NCT00137111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25483796|NCT00137111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25483797|NCT00137111|Antimetabolites|antimetabolites|mesh-ancestor
25483798|NCT00137111|Dermatologic Agents|dermatologic agents|mesh-ancestor
25483799|NCT00137111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25483800|NCT00137111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25483801|NCT00137111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25483802|NCT00137111|Antiviral Agents|antiviral agents|mesh-ancestor
25483803|NCT00137111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25483804|NCT00137111|Tubulin Modulators|tubulin modulators|mesh-ancestor
25483805|NCT00137111|Antimitotic Agents|antimitotic agents|mesh-ancestor
25483806|NCT00137111|Mitosis Modulators|mitosis modulators|mesh-ancestor
25483807|NCT00137423|Sunitinib|sunitinib|mesh-list
25483808|NCT00137423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483809|NCT00137423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25483810|NCT00137423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25483811|NCT00137423|Growth Substances|growth substances|mesh-ancestor
25483812|NCT00137423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483813|NCT00137423|Growth Inhibitors|growth inhibitors|mesh-ancestor
25483814|NCT00137423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25483815|NCT00137423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483816|NCT00137423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483817|NCT00137436|Prednisone|prednisone|mesh-list
25483818|NCT00137436|Docetaxel|docetaxel|mesh-list
25483819|NCT00137436|Sunitinib|sunitinib|mesh-list
25483820|NCT00137436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483821|NCT00137436|Tubulin Modulators|tubulin modulators|mesh-ancestor
25483822|NCT00137436|Antimitotic Agents|antimitotic agents|mesh-ancestor
25483823|NCT00137436|Mitosis Modulators|mitosis modulators|mesh-ancestor
24831539|NCT02166632|Anesthetics|anesthetics|mesh-ancestor
24831540|NCT02166632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24831541|NCT02166632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831542|NCT02166632|Sensory System Agents|sensory system agents|mesh-ancestor
24950825|NCT03911557|Tremelimumab|tremelimumab|mesh-list
25483824|NCT00137436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483825|NCT00137436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25483826|NCT00137436|Glucocorticoids|glucocorticoids|mesh-ancestor
25483827|NCT00137436|Hormones|hormones|mesh-ancestor
25483828|NCT00137436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25483829|NCT00137436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483830|NCT00137436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25483831|NCT00137436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25483832|NCT00137436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25483833|NCT00137436|Growth Substances|growth substances|mesh-ancestor
25483834|NCT00137436|Growth Inhibitors|growth inhibitors|mesh-ancestor
25483835|NCT00137436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25483836|NCT00137436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483837|NCT00137449|Sunitinib|sunitinib|mesh-list
25483838|NCT00137449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483839|NCT00137449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25483840|NCT00137449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25483841|NCT00137449|Growth Substances|growth substances|mesh-ancestor
25483842|NCT00137449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483843|NCT00137449|Growth Inhibitors|growth inhibitors|mesh-ancestor
25483844|NCT00137449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25483845|NCT00137449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483846|NCT00137449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483847|NCT00137839|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25483848|NCT00137839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483849|NCT00137839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25483850|NCT00137839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483851|NCT00137839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483852|NCT00137969|Acetaminophen|acetaminophen|mesh-list
25483853|NCT00137969|Diphenhydramine|diphenhydramine|mesh-list
25483854|NCT00137969|Promethazine|promethazine|mesh-list
25483855|NCT00137969|Prednisone|prednisone|mesh-list
25483856|NCT00137969|Rituximab|rituximab|mesh-list
25483857|NCT00137969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25483858|NCT00137969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483859|NCT00137969|Immunologic Factors|immunologic factors|mesh-ancestor
25483860|NCT00137969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483861|NCT00137969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25483862|NCT00137969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25483863|NCT00137969|Glucocorticoids|glucocorticoids|mesh-ancestor
25483864|NCT00137969|Hormones|hormones|mesh-ancestor
25483865|NCT00137969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25483866|NCT00137969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25483867|NCT00137969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25644970|NCT01442155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483868|NCT00137969|Analgesics|analgesics|mesh-ancestor
25483869|NCT00137969|Sensory System Agents|sensory system agents|mesh-ancestor
25483870|NCT00137969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25483871|NCT00137969|Antipyretics|antipyretics|mesh-ancestor
25483872|NCT00137969|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25483873|NCT00137969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25483874|NCT00137969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25483875|NCT00137969|Anesthetics, Local|anesthetics, local|mesh-ancestor
25483876|NCT00137969|Anesthetics|anesthetics|mesh-ancestor
25483877|NCT00137969|Antiemetics|antiemetics|mesh-ancestor
25483878|NCT00137969|Autonomic Agents|autonomic agents|mesh-ancestor
25483879|NCT00137969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25483880|NCT00137969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25483881|NCT00137969|Histamine Antagonists|histamine antagonists|mesh-ancestor
25483882|NCT00137969|Histamine Agents|histamine agents|mesh-ancestor
25483883|NCT00137969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25483884|NCT00137969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483885|NCT00137969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25483886|NCT00137969|Antipruritics|antipruritics|mesh-ancestor
25483887|NCT00137969|Dermatologic Agents|dermatologic agents|mesh-ancestor
25483888|NCT00138125|Trastuzumab|trastuzumab|mesh-list
25483889|NCT00138125|Fulvestrant|fulvestrant|mesh-list
25483890|NCT00138125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25483891|NCT00138125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483892|NCT00138125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25483893|NCT00138125|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25483894|NCT00138125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25483895|NCT00138125|Hormone Antagonists|hormone antagonists|mesh-ancestor
25823097|NCT00004748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25823098|NCT00004748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25823099|NCT00004748|Immunologic Factors|immunologic factors|mesh-ancestor
25823100|NCT00004748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25483896|NCT00138125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25483897|NCT00138125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483898|NCT00138203|Vorinostat|vorinostat|mesh-list
25483899|NCT00138203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483900|NCT00138203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25483901|NCT00138203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483902|NCT00138203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483903|NCT00138424|Cidofovir|cidofovir|mesh-list
25483904|NCT00138424|Antiviral Agents|antiviral agents|mesh-ancestor
25483905|NCT00138424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25483906|NCT00138424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483907|NCT00138424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483908|NCT00138671|Insulin|insulin|mesh-list
25483909|NCT00138671|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25483910|NCT00138671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25483911|NCT00138671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483912|NCT00139477|Metformin|metformin|mesh-list
25483913|NCT00139477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25483914|NCT00139477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483915|NCT00139659|Insulin|insulin|mesh-list
25483916|NCT00139659|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25483917|NCT00139659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25483918|NCT00139659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483919|NCT00139737|Ziprasidone|ziprasidone|mesh-list
25483920|NCT00139737|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25483921|NCT00139737|Serotonin Agents|serotonin agents|mesh-ancestor
25483922|NCT00139737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25483923|NCT00139737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483924|NCT00139737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483925|NCT00139737|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25483926|NCT00139737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25483927|NCT00139737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25483928|NCT00139737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25483929|NCT00139737|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25483930|NCT00139737|Dopamine Agents|dopamine agents|mesh-ancestor
25483931|NCT00139776|Celecoxib|celecoxib|mesh-list
25483932|NCT00139776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25483933|NCT00139776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25483934|NCT00139776|Analgesics|analgesics|mesh-ancestor
25483935|NCT00139776|Sensory System Agents|sensory system agents|mesh-ancestor
25483936|NCT00139776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25483937|NCT00139776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483938|NCT00139776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25483939|NCT00139776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25483940|NCT00139776|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25483941|NCT00139776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25483942|NCT00139776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483943|NCT00139776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483944|NCT00140140|Paclitaxel|paclitaxel|mesh-list
25483945|NCT00140140|Vinorelbine|vinorelbine|mesh-list
25483946|NCT00140140|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25483947|NCT00140140|Trastuzumab|trastuzumab|mesh-list
25483948|NCT00140140|Lenograstim|lenograstim|mesh-list
25483949|NCT00140140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25483950|NCT00140140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483951|NCT00140140|Tubulin Modulators|tubulin modulators|mesh-ancestor
25483952|NCT00140140|Antimitotic Agents|antimitotic agents|mesh-ancestor
25483953|NCT00140140|Mitosis Modulators|mitosis modulators|mesh-ancestor
25483954|NCT00140140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483955|NCT00140140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25483956|NCT00140140|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25483957|NCT00140140|Immunologic Factors|immunologic factors|mesh-ancestor
25483958|NCT00140140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483959|NCT00140426|Risperidone|risperidone|mesh-list
25483960|NCT00140426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25483961|NCT00140426|Serotonin Agents|serotonin agents|mesh-ancestor
25483962|NCT00140426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25483963|NCT00140426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483964|NCT00140426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483965|NCT00140426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25483966|NCT00140426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25483967|NCT00140426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25483968|NCT00140426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25483969|NCT00140426|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25015906|NCT00724789|Hormone Antagonists|hormone antagonists|mesh-ancestor
25483970|NCT00140426|Dopamine Agents|dopamine agents|mesh-ancestor
25483971|NCT00140556|Bevacizumab|bevacizumab|mesh-list
25483972|NCT00140556|Cisplatin|cisplatin|mesh-list
25483973|NCT00140556|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25483974|NCT00140556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25483975|NCT00140556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483976|NCT00140556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25483977|NCT00140556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25483978|NCT00140556|Growth Substances|growth substances|mesh-ancestor
25483979|NCT00140556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483980|NCT00140556|Growth Inhibitors|growth inhibitors|mesh-ancestor
25483981|NCT00140556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25483982|NCT00140556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25483983|NCT00140556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483984|NCT00140855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25483985|NCT00140855|Ipilimumab|ipilimumab|mesh-list
25483986|NCT00140855|Antibodies|antibodies|mesh-list
25483987|NCT00140855|Immunoglobulins|immunoglobulins|mesh-list
25483988|NCT00140855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25483989|NCT00140855|Immunologic Factors|immunologic factors|mesh-ancestor
25483990|NCT00140855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25483991|NCT00140855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25483992|NCT00140855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25483993|NCT00140855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25483994|NCT00141037|Mycophenolic Acid|mycophenolic acid|mesh-list
25483995|NCT00141037|Trimethoprim|trimethoprim|mesh-list
25483996|NCT00141037|Sulfamethoxazole|sulfamethoxazole|mesh-list
25483997|NCT00141037|Valganciclovir|valganciclovir|mesh-list
25483998|NCT00141037|Ganciclovir|ganciclovir|mesh-list
25483999|NCT00141037|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25484000|NCT00141037|Prednisone|prednisone|mesh-list
25484001|NCT00141037|Tacrolimus|tacrolimus|mesh-list
25484002|NCT00141037|Daclizumab|daclizumab|mesh-list
25484003|NCT00141037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25484004|NCT00141037|Glucocorticoids|glucocorticoids|mesh-ancestor
25484005|NCT00141037|Hormones|hormones|mesh-ancestor
25484006|NCT00141037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25484007|NCT00141037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484008|NCT00141037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25484009|NCT00141037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484010|NCT00141037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25484011|NCT00141037|Immunologic Factors|immunologic factors|mesh-ancestor
25484012|NCT00141037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25484013|NCT00141037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484014|NCT00141037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484016|NCT00141037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25484017|NCT00141037|Antitubercular Agents|antitubercular agents|mesh-ancestor
25484018|NCT00141037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25484019|NCT00141037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25484020|NCT00141037|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25484021|NCT00141037|Renal Agents|renal agents|mesh-ancestor
25484022|NCT00141037|Antimalarials|antimalarials|mesh-ancestor
25484023|NCT00141037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25484024|NCT00141037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25484025|NCT00141037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25484026|NCT00141037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25484027|NCT00141037|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25484028|NCT00141037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25484029|NCT00141037|Antiviral Agents|antiviral agents|mesh-ancestor
25484030|NCT00141037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25484031|NCT00141102|Celecoxib|celecoxib|mesh-list
25484032|NCT00141102|Diclofenac|diclofenac|mesh-list
25484033|NCT00141102|Omeprazole|omeprazole|mesh-list
25484034|NCT00141102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25484035|NCT00141102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25484036|NCT00141102|Analgesics|analgesics|mesh-ancestor
25484037|NCT00141102|Sensory System Agents|sensory system agents|mesh-ancestor
25484038|NCT00141102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25484039|NCT00141102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484040|NCT00141102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25484041|NCT00141102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24845645|NCT02238353|Histamine Agents|histamine agents|mesh-ancestor
24845646|NCT02238353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845647|NCT02238366|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25060379|NCT03480308|Hormones|hormones|mesh-ancestor
25484042|NCT00141102|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25484043|NCT00141102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25484044|NCT00141102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484045|NCT00141102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484046|NCT00141102|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25484047|NCT00141102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25484048|NCT00141102|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25484049|NCT00141115|Levetiracetam|levetiracetam|mesh-list
25484050|NCT00141115|Anticonvulsants|anticonvulsants|mesh-ancestor
25484051|NCT00141115|Nootropic Agents|nootropic agents|mesh-ancestor
25484052|NCT00141219|Pregabalin|pregabalin|mesh-list
25484053|NCT00141219|Analgesics|analgesics|mesh-ancestor
25484054|NCT00141219|Sensory System Agents|sensory system agents|mesh-ancestor
25484055|NCT00141219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25484056|NCT00141219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484057|NCT00141219|Anticonvulsants|anticonvulsants|mesh-ancestor
25484058|NCT00141219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25484059|NCT00141219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25484060|NCT00141219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484061|NCT00141219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25484062|NCT00141219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25484063|NCT00141219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25484064|NCT00141219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25484065|NCT00141219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25484066|NCT00141271|Ziprasidone|ziprasidone|mesh-list
25484067|NCT00141271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25484068|NCT00141271|Serotonin Agents|serotonin agents|mesh-ancestor
25484069|NCT00141271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25484070|NCT00141271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484071|NCT00141271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484072|NCT00141271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25484073|NCT00141271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25484074|NCT00141271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25484075|NCT00141271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25484076|NCT00141271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25484077|NCT00141271|Dopamine Agents|dopamine agents|mesh-ancestor
25484078|NCT00141297|Palbociclib|palbociclib|mesh-list
25484079|NCT00141297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484080|NCT00141297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25484081|NCT00141297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484082|NCT00141297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484083|NCT00141453|Olmesartan|olmesartan|mesh-list
25484084|NCT00141453|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25484085|NCT00141453|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25484096|NCT00141518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484098|NCT00141518|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25484099|NCT00141518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484100|NCT00141518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25484101|NCT00141518|Immunologic Factors|immunologic factors|mesh-ancestor
25484102|NCT00141518|Dopamine Agonists|dopamine agonists|mesh-ancestor
25484103|NCT00141726|Etanercept|etanercept|mesh-list
25484104|NCT00141726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25484105|NCT00141726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25484106|NCT00141726|Analgesics|analgesics|mesh-ancestor
25484107|NCT00141726|Sensory System Agents|sensory system agents|mesh-ancestor
25484108|NCT00141726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25484109|NCT00141726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484110|NCT00141726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25484111|NCT00141726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25484112|NCT00141726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25484113|NCT00141726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25484114|NCT00141726|Immunologic Factors|immunologic factors|mesh-ancestor
25484115|NCT00141739|Etanercept|etanercept|mesh-list
25484116|NCT00141739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25484117|NCT00141739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25484118|NCT00141739|Analgesics|analgesics|mesh-ancestor
25484119|NCT00141739|Sensory System Agents|sensory system agents|mesh-ancestor
25484120|NCT00141739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25484121|NCT00141739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484122|NCT00141739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25484123|NCT00141739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25484124|NCT00141739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25484125|NCT00141739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25484126|NCT00141739|Immunologic Factors|immunologic factors|mesh-ancestor
25484127|NCT00141778|Ramipril|ramipril|mesh-list
25484128|NCT00141778|Spironolactone|spironolactone|mesh-list
25484129|NCT00141778|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
25484130|NCT00141778|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25484131|NCT00141778|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25484132|NCT00141778|Mineralocorticoids|mineralocorticoids|mesh-list
25484133|NCT00141778|Hormone Antagonists|hormone antagonists|mesh-ancestor
25484134|NCT00141778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25484135|NCT00141778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484136|NCT00141778|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25484137|NCT00141778|Diuretics|diuretics|mesh-ancestor
25484138|NCT00141778|Natriuretic Agents|natriuretic agents|mesh-ancestor
25484139|NCT00141778|Protease Inhibitors|protease inhibitors|mesh-ancestor
25484140|NCT00141778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484141|NCT00141778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25484142|NCT00141778|Hormones|hormones|mesh-ancestor
25484143|NCT00141817|Pantoprazole|pantoprazole|mesh-list
25484144|NCT00141817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25484145|NCT00141817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25484146|NCT00141817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25484147|NCT00141817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25644971|NCT01442376|Ondansetron|ondansetron|mesh-list
25484148|NCT00141817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484150|NCT00141921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25484151|NCT00141921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25644975|NCT01442376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25644976|NCT01442376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25644977|NCT01442376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25644978|NCT01442376|Antipruritics|antipruritics|mesh-ancestor
25644979|NCT01442376|Dermatologic Agents|dermatologic agents|mesh-ancestor
25644980|NCT01442376|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25644981|NCT01442376|Serotonin Agents|serotonin agents|mesh-ancestor
25644982|NCT01442376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25484152|NCT00141921|Analgesics|analgesics|mesh-ancestor
25484153|NCT00141921|Sensory System Agents|sensory system agents|mesh-ancestor
25484154|NCT00141921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25484155|NCT00141921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484156|NCT00141921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25484157|NCT00141921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25484158|NCT00141921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25484159|NCT00141921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25484160|NCT00141921|Immunologic Factors|immunologic factors|mesh-ancestor
25484161|NCT00142116|Thalidomide|thalidomide|mesh-list
25484162|NCT00142116|Rituximab|rituximab|mesh-list
25484163|NCT00142116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25484164|NCT00142116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484165|NCT00142116|Immunologic Factors|immunologic factors|mesh-ancestor
25484166|NCT00142116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608476|NCT00992238|Flavoxate|flavoxate|mesh-list
25016248|NCT00095004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016249|NCT00095004|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24637477|NCT01150617|Insulin, Short-Acting|insulin, short-acting|mesh-list
24637478|NCT01150617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637480|NCT01150630|Capecitabine|capecitabine|mesh-list
24637482|NCT01150630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637483|NCT01150630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24637484|NCT01150630|Antimetabolites|antimetabolites|mesh-ancestor
25484167|NCT00142116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25484168|NCT00142116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25484169|NCT00142116|Leprostatic Agents|leprostatic agents|mesh-ancestor
25484170|NCT00142116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25484171|NCT00142116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25484172|NCT00142116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25484173|NCT00142116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25484174|NCT00142116|Growth Substances|growth substances|mesh-ancestor
25484175|NCT00142116|Growth Inhibitors|growth inhibitors|mesh-ancestor
25484177|NCT00142168|Lenalidomide|lenalidomide|mesh-list
25484178|NCT00142168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25484179|NCT00142168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484180|NCT00142168|Immunologic Factors|immunologic factors|mesh-ancestor
25484181|NCT00142168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484182|NCT00142168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25484183|NCT00142168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25484184|NCT00142168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25484185|NCT00142168|Growth Substances|growth substances|mesh-ancestor
25484186|NCT00142168|Growth Inhibitors|growth inhibitors|mesh-ancestor
25484187|NCT00142298|Telbivudine|telbivudine|mesh-list
25484188|NCT00142298|Antiviral Agents|antiviral agents|mesh-ancestor
25484189|NCT00142298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25484190|NCT00142298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25484191|NCT00142298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484192|NCT00142298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484193|NCT00142415|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
25484194|NCT00142415|Chelating Agents|chelating agents|mesh-ancestor
25484195|NCT00142415|Sequestering Agents|sequestering agents|mesh-ancestor
25484196|NCT00142415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484197|NCT00142454|Imiquimod|imiquimod|mesh-list
25484198|NCT00142454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25484199|NCT00142454|Immunologic Factors|immunologic factors|mesh-ancestor
24438679|NCT00276601|Antiviral Agents|antiviral agents|mesh-ancestor
25644983|NCT01442376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484200|NCT00142454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484201|NCT00142454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484202|NCT00142454|Interferon Inducers|interferon inducers|mesh-ancestor
25484203|NCT00142506|Sildenafil Citrate|sildenafil citrate|mesh-list
25484204|NCT00142506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484205|NCT00142506|Vasodilator Agents|vasodilator agents|mesh-ancestor
25484206|NCT00142506|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25484207|NCT00142506|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25484208|NCT00142506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484209|NCT00142506|Urological Agents|urological agents|mesh-ancestor
25484210|NCT00142818|Naltrexone|naltrexone|mesh-list
25484211|NCT00142818|Modafinil|modafinil|mesh-list
25484212|NCT00142818|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25484213|NCT00142818|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25484214|NCT00142818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484215|NCT00142818|Sensory System Agents|sensory system agents|mesh-ancestor
25484216|NCT00142818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25484217|NCT00142818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25484218|NCT00142818|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25484219|NCT00142818|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25484220|NCT00142818|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25484221|NCT00142818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484222|NCT00142909|Lofexidine|lofexidine|mesh-list
25484223|NCT00142909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25484224|NCT00142909|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25484225|NCT00142909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484226|NCT00142909|Sensory System Agents|sensory system agents|mesh-ancestor
25484227|NCT00142909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25484228|NCT00142909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25484229|NCT00142909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25484230|NCT00142909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25484231|NCT00142909|Adrenergic Agents|adrenergic agents|mesh-ancestor
25484232|NCT00142909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25484233|NCT00142909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484234|NCT00143247|Insulin|insulin|mesh-list
25484235|NCT00143247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25484236|NCT00143247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484237|NCT00143312|Voriconazole|voriconazole|mesh-list
25484238|NCT00143312|Antifungal Agents|antifungal agents|mesh-ancestor
24848996|NCT03165994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484239|NCT00143312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25484240|NCT00143312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25484241|NCT00143312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25484242|NCT00143312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484243|NCT00143312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484244|NCT00143312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25484245|NCT00143312|Hormone Antagonists|hormone antagonists|mesh-ancestor
25484246|NCT00143312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25484247|NCT00143312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484248|NCT00143312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25484249|NCT00143390|Anastrozole|anastrozole|mesh-list
25484250|NCT00143390|Exemestane|exemestane|mesh-list
25484251|NCT00143390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25484252|NCT00143390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484253|NCT00143390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25484254|NCT00143390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25484255|NCT00143390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484256|NCT00143390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484257|NCT00143390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25484258|NCT00143390|Hormone Antagonists|hormone antagonists|mesh-ancestor
25484259|NCT00143390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25484260|NCT00143390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484261|NCT00143403|Leucovorin|leucovorin|mesh-list
25484262|NCT00143403|Folic Acid|folic acid|mesh-list
25484263|NCT00143403|Irinotecan|irinotecan|mesh-list
25484264|NCT00143403|Fluorouracil|fluorouracil|mesh-list
25484265|NCT00143403|Levoleucovorin|levoleucovorin|mesh-list
25484266|NCT00143403|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25484267|NCT00143403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25166494|NCT03993132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25644984|NCT01442376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25484268|NCT00143403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484269|NCT00143403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484270|NCT00143403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484271|NCT00143403|Antimetabolites|antimetabolites|mesh-ancestor
25484272|NCT00143403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25484273|NCT00143403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25484274|NCT00143403|Immunologic Factors|immunologic factors|mesh-ancestor
25484275|NCT00143403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484276|NCT00143403|Antidotes|antidotes|mesh-ancestor
25484277|NCT00143403|Protective Agents|protective agents|mesh-ancestor
25484278|NCT00143403|Vitamin B Complex|vitamin b complex|mesh-ancestor
25484279|NCT00143403|Vitamins|vitamins|mesh-ancestor
25484280|NCT00143403|Micronutrients|micronutrients|mesh-ancestor
25484281|NCT00143403|Hematinics|hematinics|mesh-ancestor
25484282|NCT00143455|Cisplatin|cisplatin|mesh-list
25484283|NCT00143455|Irinotecan|irinotecan|mesh-list
25484284|NCT00143455|Etoposide|etoposide|mesh-list
25484285|NCT00143455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484286|NCT00143455|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25484287|NCT00143455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25484288|NCT00143455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484289|NCT00143455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484290|NCT00143455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25484291|NCT00143455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25484292|NCT00143845|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25484293|NCT00143845|Immunologic Factors|immunologic factors|mesh-ancestor
25484294|NCT00143845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484295|NCT00144027|Antipsychotic Agents|antipsychotic agents|mesh-list
25484296|NCT00144027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25484297|NCT00144027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25484298|NCT00144027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484299|NCT00144027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25484300|NCT00144170|Ritonavir|ritonavir|mesh-list
25484301|NCT00144170|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
25484302|NCT00144170|Tipranavir|tipranavir|mesh-list
25484303|NCT00144170|Protease Inhibitors|protease inhibitors|mesh-list
25484304|NCT00144170|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25484305|NCT00144170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484306|NCT00144170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484307|NCT00144170|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25484308|NCT00144170|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25484309|NCT00144170|Antiviral Agents|antiviral agents|mesh-ancestor
25484310|NCT00144170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25484311|NCT00144170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24849598|NCT02249234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25484312|NCT00144170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25484315|NCT00144300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484316|NCT00144300|Protective Agents|protective agents|mesh-ancestor
25484317|NCT00144300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484318|NCT00144300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25484319|NCT00144300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25484320|NCT00144300|Dopamine Agonists|dopamine agonists|mesh-ancestor
25484321|NCT00144300|Dopamine Agents|dopamine agents|mesh-ancestor
25484322|NCT00144300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25484323|NCT00144339|Tiotropium Bromide|tiotropium bromide|mesh-list
25484324|NCT00144339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25484325|NCT00144339|Autonomic Agents|autonomic agents|mesh-ancestor
25484326|NCT00144339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25484327|NCT00144339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484328|NCT00144339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25484329|NCT00144339|Respiratory System Agents|respiratory system agents|mesh-ancestor
25484330|NCT00144339|Parasympatholytics|parasympatholytics|mesh-ancestor
25484331|NCT00144339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25484332|NCT00144339|Cholinergic Agents|cholinergic agents|mesh-ancestor
25484333|NCT00144339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25484334|NCT00144339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484335|NCT00144391|Testosterone|testosterone|mesh-list
25484336|NCT00144391|Androgens|androgens|mesh-ancestor
25484337|NCT00144391|Hormones|hormones|mesh-ancestor
25484338|NCT00144391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25484339|NCT00144391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484340|NCT00144963|Dexamethasone|dexamethasone|mesh-list
25484341|NCT00144963|Vincristine|vincristine|mesh-list
25484342|NCT00144963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25484343|NCT00144963|Antiemetics|antiemetics|mesh-ancestor
25484344|NCT00144963|Autonomic Agents|autonomic agents|mesh-ancestor
25484345|NCT00144963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25484346|NCT00144963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484347|NCT00144963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25484348|NCT00144963|Glucocorticoids|glucocorticoids|mesh-ancestor
25484349|NCT00144963|Hormones|hormones|mesh-ancestor
25484350|NCT00144963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25484351|NCT00144963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25484352|NCT00144963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484353|NCT00144963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25484354|NCT00144963|Tubulin Modulators|tubulin modulators|mesh-ancestor
25484355|NCT00144963|Antimitotic Agents|antimitotic agents|mesh-ancestor
25484356|NCT00144963|Mitosis Modulators|mitosis modulators|mesh-ancestor
25484357|NCT00144963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484358|NCT00145041|Vincristine|vincristine|mesh-list
25484359|NCT00145041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25484360|NCT00145041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484361|NCT00145041|Tubulin Modulators|tubulin modulators|mesh-ancestor
25484362|NCT00145041|Antimitotic Agents|antimitotic agents|mesh-ancestor
25484363|NCT00145041|Mitosis Modulators|mitosis modulators|mesh-ancestor
25484364|NCT00145041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484365|NCT00145249|Fluconazole|fluconazole|mesh-list
25484366|NCT00145249|Amphotericin B|amphotericin b|mesh-list
25484367|NCT00145249|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25484368|NCT00145249|Antifungal Agents|antifungal agents|mesh-ancestor
25484369|NCT00145249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25484370|NCT00145249|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25484371|NCT00145249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25484372|NCT00145249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484373|NCT00145249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484374|NCT00145249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25484375|NCT00145249|Hormone Antagonists|hormone antagonists|mesh-ancestor
25484376|NCT00145249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25484377|NCT00145249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484378|NCT00145249|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25484379|NCT00145249|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25484380|NCT00145249|Amebicides|amebicides|mesh-ancestor
25484381|NCT00145249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25484382|NCT00145249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25484383|NCT00145249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25484384|NCT00145327|Zoledronic Acid|zoledronic acid|mesh-list
25484417|NCT00145977|Vitamin D|vitamin d|mesh-list
25484418|NCT00145977|Alendronate|alendronate|mesh-list
25484419|NCT00145977|Calcium|calcium|mesh-list
25484420|NCT00145977|Vitamins|vitamins|mesh-ancestor
25484421|NCT00145977|Micronutrients|micronutrients|mesh-ancestor
25484422|NCT00145977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484423|NCT00145977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25484424|NCT00145977|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25484425|NCT00146328|Tipranavir|tipranavir|mesh-list
25484426|NCT00146328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25484427|NCT00146328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25484428|NCT00146328|Antiviral Agents|antiviral agents|mesh-ancestor
25484429|NCT00146328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25484430|NCT00146640|Prednisone|prednisone|mesh-list
25484431|NCT00146640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25484432|NCT00146640|Glucocorticoids|glucocorticoids|mesh-ancestor
25484433|NCT00146640|Hormones|hormones|mesh-ancestor
25484434|NCT00146640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25484435|NCT00146640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484436|NCT00146640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25484437|NCT00146640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484438|NCT00147199|Treprostinil|treprostinil|mesh-list
25484439|NCT00147199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25484440|NCT00147212|Trabectedin|trabectedin|mesh-list
25484441|NCT00147212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25484442|NCT00147212|Alkylating Agents|alkylating agents|mesh-ancestor
25484443|NCT00147212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484444|NCT00147212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484445|NCT00147225|Carboplatin|carboplatin|mesh-list
25484446|NCT00147225|Doxorubicin|doxorubicin|mesh-list
25484447|NCT00147225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25484448|NCT00147225|Ifosfamide|ifosfamide|mesh-list
25484449|NCT00147225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484450|NCT00147225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25484451|NCT00147225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25484452|NCT00147225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25484453|NCT00147225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484454|NCT00147225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484455|NCT00147225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25484456|NCT00147225|Alkylating Agents|alkylating agents|mesh-ancestor
25484457|NCT00147316|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25484458|NCT00147316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25484459|NCT00147316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25484460|NCT00147316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484461|NCT00147498|Tofacitinib|tofacitinib|mesh-list
25484462|NCT00147498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25484463|NCT00147498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484464|NCT00147498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484465|NCT00147537|Paclitaxel|paclitaxel|mesh-list
25484466|NCT00147537|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25484467|NCT00147537|Carboplatin|carboplatin|mesh-list
25484468|NCT00147537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25484469|NCT00147537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25484470|NCT00147537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25484471|NCT00147537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484472|NCT00147537|Tubulin Modulators|tubulin modulators|mesh-ancestor
25484473|NCT00147537|Antimitotic Agents|antimitotic agents|mesh-ancestor
25484474|NCT00147537|Mitosis Modulators|mitosis modulators|mesh-ancestor
25484475|NCT00147537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484476|NCT00147537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25484477|NCT00147537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484478|NCT00147537|Immunologic Factors|immunologic factors|mesh-ancestor
25484479|NCT00147537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484480|NCT00147745|Insulin Glargine|insulin glargine|mesh-list
25484481|NCT00147745|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
25484482|NCT00147745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25484483|NCT00147745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484484|NCT00147745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25484485|NCT00147745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25484486|NCT00147745|Antimetabolites|antimetabolites|mesh-ancestor
25484487|NCT00147745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484488|NCT00147745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25484489|NCT00147966|Rituximab|rituximab|mesh-list
25484490|NCT00147966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25484491|NCT00147966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24852200|NCT02261077|Parasympatholytics|parasympatholytics|mesh-ancestor
25484492|NCT00147966|Immunologic Factors|immunologic factors|mesh-ancestor
25484493|NCT00147966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484494|NCT00147966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25484495|NCT00148109|Cetuximab|cetuximab|mesh-list
25484496|NCT00148109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25484497|NCT00148109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484498|NCT00148122|Docetaxel|docetaxel|mesh-list
25484499|NCT00148122|Capecitabine|capecitabine|mesh-list
25484500|NCT00148122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484501|NCT00148122|Tubulin Modulators|tubulin modulators|mesh-ancestor
25484502|NCT00148122|Antimitotic Agents|antimitotic agents|mesh-ancestor
25484503|NCT00148122|Mitosis Modulators|mitosis modulators|mesh-ancestor
25484504|NCT00148122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484505|NCT00148122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25484506|NCT00148122|Antimetabolites|antimetabolites|mesh-ancestor
25484507|NCT00148317|Dexamethasone|dexamethasone|mesh-list
25484508|NCT00148317|Doxorubicin|doxorubicin|mesh-list
25484509|NCT00148317|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25484510|NCT00148317|Bortezomib|bortezomib|mesh-list
25484511|NCT00148317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25484512|NCT00148317|Antiemetics|antiemetics|mesh-ancestor
25484513|NCT00148317|Autonomic Agents|autonomic agents|mesh-ancestor
25484514|NCT00148317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25484515|NCT00148317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484516|NCT00148317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25484517|NCT00148317|Glucocorticoids|glucocorticoids|mesh-ancestor
25484518|NCT00148317|Hormones|hormones|mesh-ancestor
25484519|NCT00148317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25484520|NCT00148317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25484521|NCT00148317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484522|NCT00148317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25484523|NCT00148317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25484524|NCT00148317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25644985|NCT01442376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25484525|NCT00148317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484526|NCT00148317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484527|NCT00148668|Carboplatin|carboplatin|mesh-list
25484528|NCT00148668|Docetaxel|docetaxel|mesh-list
25484529|NCT00148668|Trastuzumab|trastuzumab|mesh-list
25484530|NCT00148668|Vinorelbine|vinorelbine|mesh-list
25484531|NCT00148668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484532|NCT00148668|Tubulin Modulators|tubulin modulators|mesh-ancestor
25484533|NCT00148668|Antimitotic Agents|antimitotic agents|mesh-ancestor
25484534|NCT00148668|Mitosis Modulators|mitosis modulators|mesh-ancestor
25484535|NCT00148668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484536|NCT00148668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25484537|NCT00148668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25484538|NCT00148798|Cisplatin|cisplatin|mesh-list
25484539|NCT00148798|Cetuximab|cetuximab|mesh-list
25484540|NCT00148798|Vinorelbine|vinorelbine|mesh-list
25484541|NCT00148798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484542|NCT00148798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25484543|NCT00148798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25484544|NCT00148798|Tubulin Modulators|tubulin modulators|mesh-ancestor
25484545|NCT00148798|Antimitotic Agents|antimitotic agents|mesh-ancestor
25484546|NCT00148798|Mitosis Modulators|mitosis modulators|mesh-ancestor
25484547|NCT00148798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484548|NCT00148941|Vaccines|vaccines|mesh-list
25484549|NCT00148941|Immunologic Factors|immunologic factors|mesh-ancestor
25484550|NCT00148941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484551|NCT00149214|Cyclophosphamide|cyclophosphamide|mesh-list
25484552|NCT00149214|Docetaxel|docetaxel|mesh-list
25484553|NCT00149214|Doxorubicin|doxorubicin|mesh-list
25484554|NCT00149214|Pemetrexed|pemetrexed|mesh-list
25484555|NCT00149214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25484556|NCT00149214|Immunologic Factors|immunologic factors|mesh-ancestor
25484557|NCT00149214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484558|NCT00149214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25484559|NCT00149214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25484560|NCT00149214|Alkylating Agents|alkylating agents|mesh-ancestor
25484561|NCT00149214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484562|NCT00149214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484563|NCT00149214|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24812407|NCT02052024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25484564|NCT00149214|Tubulin Modulators|tubulin modulators|mesh-ancestor
25484565|NCT00149214|Antimitotic Agents|antimitotic agents|mesh-ancestor
25484566|NCT00149214|Mitosis Modulators|mitosis modulators|mesh-ancestor
25484567|NCT00149214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25484568|NCT00149214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25484569|NCT00149214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25484570|NCT00149214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484571|NCT00149214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25484572|NCT00149214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25484573|NCT00149227|Valsartan|valsartan|mesh-list
25484574|NCT00149227|Antihypertensive Agents|antihypertensive agents|mesh-list
25484575|NCT00149227|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25484576|NCT00149227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25484577|NCT00149227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484578|NCT00149630|Disulfiram|disulfiram|mesh-list
25484579|NCT00149630|Methadone|methadone|mesh-list
25484580|NCT00149630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25484581|NCT00149630|Narcotics|narcotics|mesh-ancestor
25484582|NCT00149630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25484583|NCT00149630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484584|NCT00149630|Analgesics|analgesics|mesh-ancestor
25484585|NCT00149630|Sensory System Agents|sensory system agents|mesh-ancestor
25484586|NCT00149630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25484587|NCT00149630|Antitussive Agents|antitussive agents|mesh-ancestor
25484588|NCT00149630|Respiratory System Agents|respiratory system agents|mesh-ancestor
25484589|NCT00149630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25484590|NCT00149630|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25484591|NCT00149630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484592|NCT00149630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484593|NCT00149643|Fluoxetine|fluoxetine|mesh-list
25484594|NCT00149643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25484595|NCT00149643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25484596|NCT00149643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24440412|NCT00282958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25644986|NCT01442376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25484597|NCT00149643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484598|NCT00149643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25484599|NCT00149643|Serotonin Agents|serotonin agents|mesh-ancestor
25484600|NCT00149643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484601|NCT00149643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25484602|NCT00149643|Antidepressive Agents|antidepressive agents|mesh-ancestor
25484603|NCT00149643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25484604|NCT00149643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25484605|NCT00149643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25484606|NCT00149643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484607|NCT00149734|Ondansetron|ondansetron|mesh-list
25484608|NCT00149734|Antiemetics|antiemetics|mesh-ancestor
25484609|NCT00149734|Autonomic Agents|autonomic agents|mesh-ancestor
25484610|NCT00149734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25484611|NCT00149734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484612|NCT00149734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25484613|NCT00149734|Antipruritics|antipruritics|mesh-ancestor
25484614|NCT00149734|Dermatologic Agents|dermatologic agents|mesh-ancestor
25484615|NCT00149734|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25484616|NCT00149734|Serotonin Agents|serotonin agents|mesh-ancestor
25484617|NCT00149734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25484618|NCT00149734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484619|NCT00149734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25484620|NCT00149734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25484621|NCT00149734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25484622|NCT00149734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25484623|NCT00149734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25484624|NCT00149799|Citalopram|citalopram|mesh-list
25484625|NCT00149799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25484626|NCT00149799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25484627|NCT00149799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25484628|NCT00149799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484629|NCT00149799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25484630|NCT00149799|Serotonin Agents|serotonin agents|mesh-ancestor
25484631|NCT00149799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484632|NCT00149799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25484633|NCT00149799|Antidepressive Agents|antidepressive agents|mesh-ancestor
25484634|NCT00149799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25484635|NCT00149825|Dexetimide|dexetimide|mesh-list
25484636|NCT00149825|Citalopram|citalopram|mesh-list
25484637|NCT00149825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25484638|NCT00149825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24812444|NCT02052180|Sensory System Agents|sensory system agents|mesh-ancestor
24596252|NCT00942565|Acetaminophen|acetaminophen|mesh-list
25484639|NCT00149825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25484640|NCT00149825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484641|NCT00149825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25484642|NCT00149825|Serotonin Agents|serotonin agents|mesh-ancestor
25484643|NCT00149825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484644|NCT00149825|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25484645|NCT00149825|Antidepressive Agents|antidepressive agents|mesh-ancestor
25484646|NCT00149825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25484647|NCT00149825|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25484648|NCT00149825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25484649|NCT00149825|Parasympatholytics|parasympatholytics|mesh-ancestor
25484650|NCT00149825|Autonomic Agents|autonomic agents|mesh-ancestor
25484651|NCT00149825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25484652|NCT00149825|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25484653|NCT00149825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25484654|NCT00149825|Cholinergic Agents|cholinergic agents|mesh-ancestor
25484655|NCT00149838|Antidepressive Agents|antidepressive agents|mesh-list
25484656|NCT00149838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25484657|NCT00149890|Cyclosporine|cyclosporine|mesh-list
25484658|NCT00149890|Cyclosporins|cyclosporins|mesh-list
25484659|NCT00149890|Basiliximab|basiliximab|mesh-list
25484660|NCT00149890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484661|NCT00149890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484662|NCT00149890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25484663|NCT00149890|Immunologic Factors|immunologic factors|mesh-ancestor
25484664|NCT00149890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484665|NCT00149890|Antifungal Agents|antifungal agents|mesh-ancestor
25484666|NCT00149890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25484667|NCT00149890|Dermatologic Agents|dermatologic agents|mesh-ancestor
25484668|NCT00149890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25644987|NCT01442376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25644988|NCT01442376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25644989|NCT01442376|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25644990|NCT01442493|Methadone|methadone|mesh-list
25644991|NCT01442493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25484669|NCT00149890|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25484670|NCT00149994|Cyclosporine|cyclosporine|mesh-list
25484671|NCT00149994|Prednisone|prednisone|mesh-list
25484672|NCT00149994|Methylprednisolone|methylprednisolone|mesh-list
25484673|NCT00149994|Tacrolimus|tacrolimus|mesh-list
25484674|NCT00149994|Cyclosporins|cyclosporins|mesh-list
25484675|NCT00149994|Basiliximab|basiliximab|mesh-list
25484676|NCT00149994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25484677|NCT00149994|Glucocorticoids|glucocorticoids|mesh-ancestor
25484678|NCT00149994|Hormones|hormones|mesh-ancestor
25484679|NCT00149994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25484680|NCT00149994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484681|NCT00149994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25484682|NCT00149994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484683|NCT00149994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25484684|NCT00149994|Immunologic Factors|immunologic factors|mesh-ancestor
25484685|NCT00149994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25484686|NCT00149994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484687|NCT00149994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484688|NCT00149994|Antifungal Agents|antifungal agents|mesh-ancestor
25484689|NCT00149994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25484690|NCT00149994|Dermatologic Agents|dermatologic agents|mesh-ancestor
25484691|NCT00149994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25484692|NCT00149994|Antiemetics|antiemetics|mesh-ancestor
25484693|NCT00149994|Autonomic Agents|autonomic agents|mesh-ancestor
25484694|NCT00149994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25484695|NCT00149994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25484696|NCT00149994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25484697|NCT00149994|Protective Agents|protective agents|mesh-ancestor
25484698|NCT00150345|Voriconazole|voriconazole|mesh-list
25484699|NCT00150345|Antifungal Agents|antifungal agents|mesh-ancestor
25484700|NCT00150345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25484701|NCT00150345|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25484702|NCT00150345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25484703|NCT00150345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484704|NCT00150345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484705|NCT00150345|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25484706|NCT00150345|Hormone Antagonists|hormone antagonists|mesh-ancestor
25484707|NCT00150345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25484708|NCT00150345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484709|NCT00150345|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25484710|NCT00150462|Dexamethasone|dexamethasone|mesh-list
24597841|NCT00952029|Protective Agents|protective agents|mesh-ancestor
24597842|NCT00952029|Vitamin B Complex|vitamin b complex|mesh-ancestor
24597915|NCT00952640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484711|NCT00150462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25484712|NCT00150462|Antiemetics|antiemetics|mesh-ancestor
25484713|NCT00150462|Autonomic Agents|autonomic agents|mesh-ancestor
25484714|NCT00150462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25484715|NCT00150462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484716|NCT00150462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25484717|NCT00150462|Glucocorticoids|glucocorticoids|mesh-ancestor
25484718|NCT00150462|Hormones|hormones|mesh-ancestor
25484719|NCT00150462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25484720|NCT00150462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25484721|NCT00150462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484722|NCT00150592|Guanfacine|guanfacine|mesh-list
25484723|NCT00150592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25484724|NCT00150592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25484725|NCT00150592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25484726|NCT00150592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25484727|NCT00150592|Adrenergic Agents|adrenergic agents|mesh-ancestor
25484728|NCT00150592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25484729|NCT00150592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484730|NCT00150592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484731|NCT00150618|Guanfacine|guanfacine|mesh-list
25484732|NCT00150618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24441436|NCT00287391|Rabeprazole|rabeprazole|mesh-list
25644992|NCT01442493|Narcotics|narcotics|mesh-ancestor
25644993|NCT01442493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25644994|NCT01442493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484733|NCT00150618|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25484734|NCT00150618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25484735|NCT00150618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25484736|NCT00150618|Adrenergic Agents|adrenergic agents|mesh-ancestor
25484737|NCT00150618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25484738|NCT00150618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484739|NCT00150618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484740|NCT00150800|Brivaracetam|brivaracetam|mesh-list
25484741|NCT00150800|Anticonvulsants|anticonvulsants|mesh-ancestor
25484742|NCT00150813|Levetiracetam|levetiracetam|mesh-list
25484743|NCT00150813|Anticonvulsants|anticonvulsants|mesh-ancestor
25484744|NCT00150813|Nootropic Agents|nootropic agents|mesh-ancestor
25484746|NCT00150969|Vitamin K 1|vitamin k 1|mesh-list
25484747|NCT00150969|Vitamins|vitamins|mesh-ancestor
25484748|NCT00150969|Micronutrients|micronutrients|mesh-ancestor
25484749|NCT00150969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484750|NCT00150969|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25484751|NCT00150969|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25484752|NCT00150969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484753|NCT00150969|Hemostatics|hemostatics|mesh-ancestor
25484754|NCT00150969|Coagulants|coagulants|mesh-ancestor
25484755|NCT00151281|Thalidomide|thalidomide|mesh-list
25484756|NCT00151281|Prednisone|prednisone|mesh-list
25484757|NCT00151281|Cyclophosphamide|cyclophosphamide|mesh-list
25484758|NCT00151281|Rituximab|rituximab|mesh-list
25484759|NCT00151281|Etoposide|etoposide|mesh-list
25484760|NCT00151281|Procarbazine|procarbazine|mesh-list
25484761|NCT00151281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25484762|NCT00151281|Immunologic Factors|immunologic factors|mesh-ancestor
25484763|NCT00151281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484764|NCT00151281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25484765|NCT00151281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25484766|NCT00151281|Alkylating Agents|alkylating agents|mesh-ancestor
25484767|NCT00151281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484768|NCT00151281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484769|NCT00151281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25484770|NCT00151281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25484771|NCT00151281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25484772|NCT00151281|Glucocorticoids|glucocorticoids|mesh-ancestor
25484773|NCT00151281|Hormones|hormones|mesh-ancestor
25484774|NCT00151281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25484775|NCT00151281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25484776|NCT00151281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25484777|NCT00151281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25484778|NCT00151281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25484779|NCT00151281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598366|NCT00955695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598367|NCT00955695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598427|NCT00956150|Lactulose|lactulose|mesh-list
24598428|NCT00956150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24598429|NCT00956150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24598430|NCT00956150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24598431|NCT00956163|Diphosphonates|diphosphonates|mesh-list
25484780|NCT00151281|Leprostatic Agents|leprostatic agents|mesh-ancestor
25484781|NCT00151281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25484782|NCT00151281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25484783|NCT00151281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25484784|NCT00151281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25484785|NCT00151281|Growth Substances|growth substances|mesh-ancestor
25484786|NCT00151281|Growth Inhibitors|growth inhibitors|mesh-ancestor
25484787|NCT00151320|Rituximab|rituximab|mesh-list
25484788|NCT00151320|Bortezomib|bortezomib|mesh-list
25484789|NCT00151320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25484790|NCT00151320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484791|NCT00151320|Immunologic Factors|immunologic factors|mesh-ancestor
25484792|NCT00151320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484793|NCT00151320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25484794|NCT00151411|Metformin|metformin|mesh-list
25484795|NCT00151411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25484796|NCT00151411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484797|NCT00151476|Celecoxib|celecoxib|mesh-list
25484798|NCT00151476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25484799|NCT00151476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25484800|NCT00151476|Analgesics|analgesics|mesh-ancestor
24441647|NCT00287963|Vinorelbine|vinorelbine|mesh-list
25644996|NCT01442493|Sensory System Agents|sensory system agents|mesh-ancestor
25484801|NCT00151476|Sensory System Agents|sensory system agents|mesh-ancestor
25484802|NCT00151476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25484803|NCT00151476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484804|NCT00151476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25484805|NCT00151476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25484806|NCT00151476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25484807|NCT00151476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25484808|NCT00151476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484809|NCT00151476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484810|NCT00151775|Olmesartan|olmesartan|mesh-list
25484811|NCT00151775|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25484812|NCT00151775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25484813|NCT00151775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25484814|NCT00151775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25484815|NCT00151775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484816|NCT00151814|Olmesartan|olmesartan|mesh-list
25484817|NCT00151814|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25484818|NCT00151814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25484819|NCT00151814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25484820|NCT00151814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25484821|NCT00151814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484822|NCT00151892|Mesalamine|mesalamine|mesh-list
25484823|NCT00151892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25484824|NCT00151892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25484825|NCT00151892|Analgesics|analgesics|mesh-ancestor
25484826|NCT00151892|Sensory System Agents|sensory system agents|mesh-ancestor
25484827|NCT00151892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25484828|NCT00151892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484829|NCT00151892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25484830|NCT00151892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25484831|NCT00151996|Guanfacine|guanfacine|mesh-list
25484832|NCT00151996|Methylphenidate|methylphenidate|mesh-list
25484833|NCT00151996|Amphetamine|amphetamine|mesh-list
25484834|NCT00151996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25484835|NCT00151996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484836|NCT00151996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25484837|NCT00151996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25484838|NCT00151996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25484839|NCT00151996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484840|NCT00151996|Dopamine Agents|dopamine agents|mesh-ancestor
25484841|NCT00151996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25484842|NCT00151996|Sympathomimetics|sympathomimetics|mesh-ancestor
25484843|NCT00151996|Autonomic Agents|autonomic agents|mesh-ancestor
25484844|NCT00151996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25484845|NCT00151996|Adrenergic Agents|adrenergic agents|mesh-ancestor
25017102|NCT02616146|Contraceptive Agents|contraceptive agents|mesh-ancestor
24599369|NCT04687800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24599370|NCT04687800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599371|NCT04687800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24599372|NCT04687800|Glucocorticoids|glucocorticoids|mesh-ancestor
24853017|NCT02265562|Misoprostol|misoprostol|mesh-list
25075758|NCT03378401|Octenidine|octenidine|mesh-list
24853036|NCT02265718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484846|NCT00151996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25484847|NCT00151996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25484848|NCT00151996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25484849|NCT00151996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25484850|NCT00151996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25484851|NCT00152009|Guanfacine|guanfacine|mesh-list
25484852|NCT00152009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25484853|NCT00152009|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25484854|NCT00152009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25484855|NCT00152009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25484856|NCT00152009|Adrenergic Agents|adrenergic agents|mesh-ancestor
25484857|NCT00152009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25484858|NCT00152009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484859|NCT00152009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484860|NCT00152464|Levocetirizine|levocetirizine|mesh-list
25484861|NCT00152464|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25484862|NCT00152464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25484863|NCT00152464|Histamine Antagonists|histamine antagonists|mesh-ancestor
25484864|NCT00152464|Histamine Agents|histamine agents|mesh-ancestor
25484865|NCT00152464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25484866|NCT00152464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484867|NCT00152464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484868|NCT00152516|Levetiracetam|levetiracetam|mesh-list
25484869|NCT00152516|Anticonvulsants|anticonvulsants|mesh-ancestor
25484870|NCT00152516|Nootropic Agents|nootropic agents|mesh-ancestor
25484871|NCT00152971|Enoxaparin|enoxaparin|mesh-list
25484872|NCT00152971|Dabigatran|dabigatran|mesh-list
25484873|NCT00152971|Anticoagulants|anticoagulants|mesh-ancestor
25484874|NCT00152971|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25484875|NCT00152971|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25484876|NCT00152971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484877|NCT00152971|Antithrombins|antithrombins|mesh-ancestor
25484878|NCT00152971|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25484879|NCT00152971|Protease Inhibitors|protease inhibitors|mesh-ancestor
25484880|NCT00152971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484881|NCT00153062|Telmisartan|telmisartan|mesh-list
25484882|NCT00153062|Clopidogrel|clopidogrel|mesh-list
25484883|NCT00153062|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
25484884|NCT00153062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25484885|NCT00153062|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25484886|NCT00153062|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25484887|NCT00153062|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25484888|NCT00153062|Purinergic Agents|purinergic agents|mesh-ancestor
25484889|NCT00153062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25484890|NCT00153062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484891|NCT00153062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484892|NCT00153062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25484893|NCT00153062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25484894|NCT00153062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25484895|NCT00153101|Telmisartan|telmisartan|mesh-list
25484896|NCT00153101|Ramipril|ramipril|mesh-list
25484897|NCT00153101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25484898|NCT00153101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25484899|NCT00153101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25484900|NCT00153101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484901|NCT00153101|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25484902|NCT00153101|Protease Inhibitors|protease inhibitors|mesh-ancestor
25484903|NCT00153101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484904|NCT00153166|Pioglitazone|pioglitazone|mesh-list
25484905|NCT00153166|Atorvastatin|atorvastatin|mesh-list
25484906|NCT00153166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25484907|NCT00153166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25484908|NCT00153166|Antimetabolites|antimetabolites|mesh-ancestor
25484909|NCT00153166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484910|NCT00153166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25484911|NCT00153166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25484912|NCT00153166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484913|NCT00153166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25484914|NCT00153166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484915|NCT00153179|Acipimox|acipimox|mesh-list
25484916|NCT00153179|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25484917|NCT00153179|Antimetabolites|antimetabolites|mesh-ancestor
25484918|NCT00153179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484919|NCT00153179|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25484920|NCT00153803|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25484921|NCT00153803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484922|NCT00153803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25484923|NCT00153803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484924|NCT00153803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484926|NCT00153816|Cholecalciferol|cholecalciferol|mesh-list
25484927|NCT00153816|Calcium Carbonate|calcium carbonate|mesh-list
25484928|NCT00153816|Calcium|calcium|mesh-list
25484929|NCT00153816|Vitamins|vitamins|mesh-ancestor
25484930|NCT00153816|Micronutrients|micronutrients|mesh-ancestor
25484931|NCT00153816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484932|NCT00153816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25484933|NCT00153816|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25484934|NCT00153816|Antacids|antacids|mesh-ancestor
25484935|NCT00153816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484936|NCT00153816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25484937|NCT00153842|Bexarotene|bexarotene|mesh-list
25484938|NCT00153842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484939|NCT00153920|Bortezomib|bortezomib|mesh-list
25484940|NCT00153920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484941|NCT00153985|Fludarabine|fludarabine|mesh-list
25484942|NCT00153985|Alemtuzumab|alemtuzumab|mesh-list
25484943|NCT00153985|Busulfan|busulfan|mesh-list
25484944|NCT00153985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484945|NCT00153985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484946|NCT00153985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25484947|NCT00153985|Immunologic Factors|immunologic factors|mesh-ancestor
25484948|NCT00153985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484949|NCT00153985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25484950|NCT00153985|Alkylating Agents|alkylating agents|mesh-ancestor
25484951|NCT00153985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25484952|NCT00153985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25484953|NCT00154102|Leucovorin|leucovorin|mesh-list
25484954|NCT00154102|Folic Acid|folic acid|mesh-list
25484955|NCT00154102|Fluorouracil|fluorouracil|mesh-list
25484956|NCT00154102|Irinotecan|irinotecan|mesh-list
25484957|NCT00154102|Cetuximab|cetuximab|mesh-list
25484958|NCT00154102|Levoleucovorin|levoleucovorin|mesh-list
25484959|NCT00154102|Antimetabolites|antimetabolites|mesh-ancestor
25484960|NCT00154102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484961|NCT00154102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25484962|NCT00154102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484963|NCT00154102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25484964|NCT00154102|Immunologic Factors|immunologic factors|mesh-ancestor
25484965|NCT00154102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484966|NCT00154102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25484967|NCT00154102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25484968|NCT00154102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484969|NCT00154102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25484970|NCT00154102|Antidotes|antidotes|mesh-ancestor
25484971|NCT00154102|Protective Agents|protective agents|mesh-ancestor
25484972|NCT00154102|Vitamin B Complex|vitamin b complex|mesh-ancestor
25484973|NCT00154102|Vitamins|vitamins|mesh-ancestor
25484974|NCT00154102|Micronutrients|micronutrients|mesh-ancestor
25484975|NCT00154102|Hematinics|hematinics|mesh-ancestor
25484976|NCT00154284|Cyclosporine|cyclosporine|mesh-list
25484977|NCT00154284|Prednisone|prednisone|mesh-list
25484978|NCT00154284|Everolimus|everolimus|mesh-list
25484979|NCT00154284|Cyclosporins|cyclosporins|mesh-list
25484980|NCT00154284|Basiliximab|basiliximab|mesh-list
25484981|NCT00154284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25484982|NCT00154284|Glucocorticoids|glucocorticoids|mesh-ancestor
25484983|NCT00154284|Hormones|hormones|mesh-ancestor
25484984|NCT00154284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25484985|NCT00154284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25484986|NCT00154284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25484987|NCT00154284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484988|NCT00154284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25484989|NCT00154284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25484990|NCT00154284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25484991|NCT00154284|Immunologic Factors|immunologic factors|mesh-ancestor
25484992|NCT00154284|Antifungal Agents|antifungal agents|mesh-ancestor
25484993|NCT00154284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25045263|NCT00979251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25045264|NCT00979251|Analgesics|analgesics|mesh-ancestor
25045265|NCT00979251|Sensory System Agents|sensory system agents|mesh-ancestor
25484994|NCT00154284|Dermatologic Agents|dermatologic agents|mesh-ancestor
25484995|NCT00154284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25484996|NCT00154284|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25484997|NCT00154297|Everolimus|everolimus|mesh-list
25484998|NCT00154297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25484999|NCT00154297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25485000|NCT00154297|Immunologic Factors|immunologic factors|mesh-ancestor
25485001|NCT00154297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485002|NCT00154310|Cyclosporine|cyclosporine|mesh-list
25485003|NCT00154310|Mycophenolic Acid|mycophenolic acid|mesh-list
25485004|NCT00154310|Everolimus|everolimus|mesh-list
25485005|NCT00154310|Cyclosporins|cyclosporins|mesh-list
25485006|NCT00154310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485007|NCT00154310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485008|NCT00154310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25485009|NCT00154310|Immunologic Factors|immunologic factors|mesh-ancestor
25644997|NCT01442493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25485010|NCT00154310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485011|NCT00154310|Antifungal Agents|antifungal agents|mesh-ancestor
25485012|NCT00154310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25644998|NCT01442493|Antitussive Agents|antitussive agents|mesh-ancestor
25644999|NCT01442493|Respiratory System Agents|respiratory system agents|mesh-ancestor
25645000|NCT01442688|Amoxicillin|amoxicillin|mesh-list
25485013|NCT00154310|Dermatologic Agents|dermatologic agents|mesh-ancestor
25485014|NCT00154310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25485015|NCT00154310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25485016|NCT00154310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485017|NCT00154310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25485018|NCT00154310|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25485019|NCT00154310|Antitubercular Agents|antitubercular agents|mesh-ancestor
25485020|NCT00154310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25485021|NCT00154375|Imatinib Mesylate|imatinib mesylate|mesh-list
25485022|NCT00154375|Hydroxyurea|hydroxyurea|mesh-list
25485023|NCT00154375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485024|NCT00154375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25485025|NCT00154375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485026|NCT00154375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485027|NCT00154375|Antisickling Agents|antisickling agents|mesh-ancestor
25485028|NCT00154375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25485029|NCT00156013|Clofarabine|clofarabine|mesh-list
25485030|NCT00156013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25485031|NCT00156013|Antimetabolites|antimetabolites|mesh-ancestor
25485032|NCT00156013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485033|NCT00156013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485034|NCT00156247|Acitretin|acitretin|mesh-list
25485035|NCT00156247|Keratolytic Agents|keratolytic agents|mesh-ancestor
25485036|NCT00156247|Dermatologic Agents|dermatologic agents|mesh-ancestor
25485037|NCT00156533|Zolpidem|zolpidem|mesh-list
25485038|NCT00156533|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25485039|NCT00156533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25485040|NCT00156533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25485041|NCT00156533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485042|NCT00156533|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25485043|NCT00156533|GABA Agonists|gaba agonists|mesh-ancestor
25485044|NCT00156533|GABA Agents|gaba agents|mesh-ancestor
25485045|NCT00156533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25485046|NCT00156533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485047|NCT00156715|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25485048|NCT00156715|Antidepressive Agents|antidepressive agents|mesh-ancestor
25485049|NCT00156715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25485050|NCT00156715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25485051|NCT00156715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25485052|NCT00156715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25485053|NCT00156715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485054|NCT00156819|Fluticasone|fluticasone|mesh-list
25485055|NCT00156819|Xhance|xhance|mesh-list
25485056|NCT00156819|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25485057|NCT00156819|Montelukast|montelukast|mesh-list
25485058|NCT00156819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25485059|NCT00156819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25485060|NCT00156819|Autonomic Agents|autonomic agents|mesh-ancestor
25485061|NCT00156819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25485062|NCT00156819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485063|NCT00156819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25485064|NCT00156819|Respiratory System Agents|respiratory system agents|mesh-ancestor
25485065|NCT00156819|Dermatologic Agents|dermatologic agents|mesh-ancestor
25485066|NCT00156819|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25485067|NCT00156819|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24603018|NCT00972101|Fludarabine|fludarabine|mesh-list
25485068|NCT00156819|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25485069|NCT00156819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25485071|NCT00156819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25485072|NCT00156819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485073|NCT00156819|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25485074|NCT00156819|Hormone Antagonists|hormone antagonists|mesh-ancestor
25485075|NCT00156819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25485076|NCT00156819|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25485077|NCT00156819|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25485078|NCT00156910|Botulinum Toxins|botulinum toxins|mesh-list
25485079|NCT00156910|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25485080|NCT00156910|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25485081|NCT00156910|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25485082|NCT00156910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25485083|NCT00156910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645001|NCT01442688|Mesalamine|mesalamine|mesh-list
25645002|NCT01442688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25645003|NCT01442688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25645004|NCT01442688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25645005|NCT01442688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25645006|NCT01442688|Analgesics|analgesics|mesh-ancestor
25485084|NCT00156910|Cholinergic Agents|cholinergic agents|mesh-ancestor
25485085|NCT00156910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25485086|NCT00156910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485087|NCT00156910|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25485088|NCT00156910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25485089|NCT00156923|Naltrexone|naltrexone|mesh-list
25485090|NCT00156923|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25485091|NCT00156923|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25485092|NCT00156923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485093|NCT00156923|Sensory System Agents|sensory system agents|mesh-ancestor
25485094|NCT00156923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25485095|NCT00156936|Naltrexone|naltrexone|mesh-list
25485096|NCT00156936|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25485097|NCT00156936|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25485098|NCT00156936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485099|NCT00156936|Sensory System Agents|sensory system agents|mesh-ancestor
25485100|NCT00156936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25485101|NCT00157014|Cyclosporine|cyclosporine|mesh-list
25485102|NCT00157014|Mycophenolic Acid|mycophenolic acid|mesh-list
25485103|NCT00157014|Prednisone|prednisone|mesh-list
25485104|NCT00157014|Methylprednisolone|methylprednisolone|mesh-list
25485105|NCT00157014|Tacrolimus|tacrolimus|mesh-list
25485106|NCT00157014|Cyclosporins|cyclosporins|mesh-list
25485107|NCT00157014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25485108|NCT00157014|Glucocorticoids|glucocorticoids|mesh-ancestor
25485109|NCT00157014|Hormones|hormones|mesh-ancestor
25485110|NCT00157014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25485111|NCT00157014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485112|NCT00157014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25485113|NCT00157014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485114|NCT00157014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25485115|NCT00157014|Immunologic Factors|immunologic factors|mesh-ancestor
25485116|NCT00157014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25485117|NCT00157014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485118|NCT00157014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485119|NCT00157014|Antifungal Agents|antifungal agents|mesh-ancestor
25485120|NCT00157014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25485121|NCT00157014|Dermatologic Agents|dermatologic agents|mesh-ancestor
25485122|NCT00157014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25485123|NCT00157014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25485124|NCT00157014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25485125|NCT00157014|Antitubercular Agents|antitubercular agents|mesh-ancestor
25485126|NCT00157014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25485127|NCT00157014|Antiemetics|antiemetics|mesh-ancestor
25485128|NCT00157014|Autonomic Agents|autonomic agents|mesh-ancestor
25485129|NCT00157014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25485130|NCT00157014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25485131|NCT00157014|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25485132|NCT00157014|Protective Agents|protective agents|mesh-ancestor
25485133|NCT00157157|Factor VIII|factor viii|mesh-list
25485134|NCT00157157|Coagulants|coagulants|mesh-ancestor
25485135|NCT00157196|Cyclophosphamide|cyclophosphamide|mesh-list
25485136|NCT00157196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25485137|NCT00157196|Immunologic Factors|immunologic factors|mesh-ancestor
25485138|NCT00157196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485139|NCT00157196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25485140|NCT00157196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25485141|NCT00157196|Alkylating Agents|alkylating agents|mesh-ancestor
25485142|NCT00157196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485143|NCT00157196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485165|NCT00158184|Oxycodone|oxycodone|mesh-list
25485166|NCT00158184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25485167|NCT00158184|Narcotics|narcotics|mesh-ancestor
25485168|NCT00158184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25485169|NCT00158184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485170|NCT00158184|Analgesics|analgesics|mesh-ancestor
25485171|NCT00158184|Sensory System Agents|sensory system agents|mesh-ancestor
25485172|NCT00158184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25485173|NCT00158223|Pimozide|pimozide|mesh-list
25645007|NCT01442688|Sensory System Agents|sensory system agents|mesh-ancestor
25485174|NCT00158223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25645008|NCT01442688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25485175|NCT00158223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25485176|NCT00158223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25485177|NCT00158223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485178|NCT00158223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25485179|NCT00158223|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25485180|NCT00158223|Dopamine Agents|dopamine agents|mesh-ancestor
25485181|NCT00158223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25485182|NCT00158223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485183|NCT00158223|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25485184|NCT00158249|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
25485185|NCT00158249|Nootropic Agents|nootropic agents|mesh-ancestor
25485186|NCT00158262|Propranolol|propranolol|mesh-list
25485187|NCT00158262|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25485188|NCT00158262|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25485189|NCT00158262|Adrenergic Agents|adrenergic agents|mesh-ancestor
25485190|NCT00158262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25485191|NCT00158262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485192|NCT00158262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485193|NCT00158262|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25485194|NCT00158262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25485195|NCT00158262|Vasodilator Agents|vasodilator agents|mesh-ancestor
25485196|NCT00158379|Paclitaxel|paclitaxel|mesh-list
25485197|NCT00158379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25485198|NCT00158379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485199|NCT00158379|Tubulin Modulators|tubulin modulators|mesh-ancestor
25485200|NCT00158379|Antimitotic Agents|antimitotic agents|mesh-ancestor
25485201|NCT00158379|Mitosis Modulators|mitosis modulators|mesh-ancestor
25485202|NCT00158379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485203|NCT00158743|Digoxin|digoxin|mesh-list
25485204|NCT00158743|Antibodies|antibodies|mesh-list
25485205|NCT00158743|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
25485206|NCT00158743|Immunologic Factors|immunologic factors|mesh-ancestor
25485207|NCT00158743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485208|NCT00158743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25485209|NCT00158743|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25485210|NCT00158743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485211|NCT00158743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485212|NCT00158743|Protective Agents|protective agents|mesh-ancestor
25485213|NCT00158756|Vaccines|vaccines|mesh-list
25485214|NCT00158756|Immunologic Factors|immunologic factors|mesh-ancestor
25485215|NCT00158756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485216|NCT00158860|Valacyclovir|valacyclovir|mesh-list
25485217|NCT00158860|Antiviral Agents|antiviral agents|mesh-ancestor
25485218|NCT00158860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25485219|NCT00159263|Budesonide|budesonide|mesh-list
25485220|NCT00159263|Formoterol Fumarate|formoterol fumarate|mesh-list
25485221|NCT00159263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25485222|NCT00159263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25485223|NCT00159263|Autonomic Agents|autonomic agents|mesh-ancestor
25485224|NCT00159263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25485225|NCT00159263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485226|NCT00159263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25485227|NCT00159263|Respiratory System Agents|respiratory system agents|mesh-ancestor
25485228|NCT00159263|Glucocorticoids|glucocorticoids|mesh-ancestor
25485229|NCT00159263|Hormones|hormones|mesh-ancestor
25485230|NCT00159263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24630866|NCT01114191|Hormone Antagonists|hormone antagonists|mesh-ancestor
25823101|NCT00004748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25823102|NCT00004748|Gout Suppressants|gout suppressants|mesh-ancestor
25823103|NCT00004748|Tubulin Modulators|tubulin modulators|mesh-ancestor
25823104|NCT00004748|Antimitotic Agents|antimitotic agents|mesh-ancestor
25823105|NCT00004748|Mitosis Modulators|mitosis modulators|mesh-ancestor
24784680|NCT01909856|Hormones|hormones|mesh-ancestor
25823106|NCT00004748|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25823107|NCT00004748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25823108|NCT00004754|Epoprostenol|epoprostenol|mesh-list
25485231|NCT00159263|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25485232|NCT00159263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25485233|NCT00159263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25485234|NCT00159263|Adrenergic Agents|adrenergic agents|mesh-ancestor
25485235|NCT00159263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25485236|NCT00159263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485237|NCT00159419|Alendronate|alendronate|mesh-list
25485238|NCT00159419|Pamidronate|pamidronate|mesh-list
25823109|NCT00004754|Tezosentan|tezosentan|mesh-list
25823110|NCT00004754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25485239|NCT00159419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25485240|NCT00159419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485241|NCT00159432|Bevacizumab|bevacizumab|mesh-list
25485242|NCT00159432|Capecitabine|capecitabine|mesh-list
25485243|NCT00159432|Oxaliplatin|oxaliplatin|mesh-list
25485244|NCT00159432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25485245|NCT00159432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485246|NCT00159432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25485247|NCT00159432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25485248|NCT00159432|Growth Substances|growth substances|mesh-ancestor
25485249|NCT00159432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485250|NCT00159432|Growth Inhibitors|growth inhibitors|mesh-ancestor
25485251|NCT00159432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25485252|NCT00159432|Antimetabolites|antimetabolites|mesh-ancestor
25485253|NCT00159432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485254|NCT00159822|Voriconazole|voriconazole|mesh-list
25485255|NCT00159822|Antifungal Agents|antifungal agents|mesh-ancestor
25485256|NCT00159822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25485257|NCT00159822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25485258|NCT00159822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25485259|NCT00159822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485260|NCT00159822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485261|NCT00159822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25485262|NCT00159822|Hormone Antagonists|hormone antagonists|mesh-ancestor
25485263|NCT00159822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25485264|NCT00159822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485265|NCT00159822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25485266|NCT00159861|Sildenafil Citrate|sildenafil citrate|mesh-list
25485267|NCT00159861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485268|NCT00159861|Vasodilator Agents|vasodilator agents|mesh-ancestor
25485269|NCT00159861|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25485270|NCT00159861|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25485271|NCT00159861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485272|NCT00159861|Urological Agents|urological agents|mesh-ancestor
25485273|NCT00159874|Sildenafil Citrate|sildenafil citrate|mesh-list
25485274|NCT00159874|Citric Acid|citric acid|mesh-list
25485275|NCT00159874|Sodium Citrate|sodium citrate|mesh-list
25485276|NCT00159874|Anticoagulants|anticoagulants|mesh-ancestor
25485277|NCT00159874|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25485278|NCT00159874|Chelating Agents|chelating agents|mesh-ancestor
25485279|NCT00159874|Sequestering Agents|sequestering agents|mesh-ancestor
25485280|NCT00159874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485281|NCT00159874|Vasodilator Agents|vasodilator agents|mesh-ancestor
25485282|NCT00159874|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25485283|NCT00159874|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25485284|NCT00159874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485285|NCT00159874|Urological Agents|urological agents|mesh-ancestor
25485286|NCT00159913|Sildenafil Citrate|sildenafil citrate|mesh-list
25485287|NCT00159913|Citric Acid|citric acid|mesh-list
25485288|NCT00159913|Sodium Citrate|sodium citrate|mesh-list
25485289|NCT00159913|Anticoagulants|anticoagulants|mesh-ancestor
25485290|NCT00159913|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25485291|NCT00159913|Chelating Agents|chelating agents|mesh-ancestor
25485292|NCT00159913|Sequestering Agents|sequestering agents|mesh-ancestor
25485293|NCT00159913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485294|NCT00159913|Vasodilator Agents|vasodilator agents|mesh-ancestor
25485295|NCT00159913|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25485296|NCT00159913|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25823111|NCT00004754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25823112|NCT00004754|Vasodilator Agents|vasodilator agents|mesh-ancestor
25823113|NCT00004755|Meglumine Antimoniate|meglumine antimoniate|mesh-list
25823114|NCT00004755|Allopurinol|allopurinol|mesh-list
25823115|NCT00004755|Antimetabolites|antimetabolites|mesh-ancestor
25823116|NCT00004755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823117|NCT00004755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485297|NCT00159913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485298|NCT00159913|Urological Agents|urological agents|mesh-ancestor
25485299|NCT00159965|Sertraline|sertraline|mesh-list
25485300|NCT00159965|Antidepressive Agents|antidepressive agents|mesh-ancestor
25485301|NCT00159965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25485302|NCT00159965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25485303|NCT00159965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25485304|NCT00159965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25485305|NCT00159965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485306|NCT00159965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25485307|NCT00159965|Serotonin Agents|serotonin agents|mesh-ancestor
25485308|NCT00159965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485309|NCT00160199|Progesterone|progesterone|mesh-list
25485310|NCT00160199|Progestins|progestins|mesh-ancestor
25485311|NCT00160199|Hormones|hormones|mesh-ancestor
25485312|NCT00160199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25485313|NCT00160199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485314|NCT00160251|Ribavirin|ribavirin|mesh-list
25485315|NCT00160251|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25485316|NCT00160251|Antimetabolites|antimetabolites|mesh-ancestor
25485317|NCT00160251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485318|NCT00160251|Antiviral Agents|antiviral agents|mesh-ancestor
25485319|NCT00160251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25485320|NCT00160524|Certolizumab Pegol|certolizumab pegol|mesh-list
25485321|NCT00160524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25485322|NCT00160524|Immunologic Factors|immunologic factors|mesh-ancestor
25485323|NCT00160524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485324|NCT00160524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25485325|NCT00160615|Levetiracetam|levetiracetam|mesh-list
25485326|NCT00160615|Anticonvulsants|anticonvulsants|mesh-ancestor
25485327|NCT00160615|Nootropic Agents|nootropic agents|mesh-ancestor
25485328|NCT00160641|Certolizumab Pegol|certolizumab pegol|mesh-list
25485329|NCT00160641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25485330|NCT00160641|Immunologic Factors|immunologic factors|mesh-ancestor
25485331|NCT00160641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485332|NCT00160641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25485333|NCT00160654|Levetiracetam|levetiracetam|mesh-list
25485334|NCT00160654|Anticonvulsants|anticonvulsants|mesh-ancestor
25485335|NCT00160654|Nootropic Agents|nootropic agents|mesh-ancestor
25485336|NCT00160667|Brivaracetam|brivaracetam|mesh-list
25485337|NCT00160667|Anticonvulsants|anticonvulsants|mesh-ancestor
25485338|NCT00160680|Levocetirizine|levocetirizine|mesh-list
25485339|NCT00160680|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25485340|NCT00160680|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25485341|NCT00160680|Histamine Antagonists|histamine antagonists|mesh-ancestor
25485342|NCT00160680|Histamine Agents|histamine agents|mesh-ancestor
25485343|NCT00160680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25485344|NCT00160680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485345|NCT00160680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485346|NCT00160693|Certolizumab Pegol|certolizumab pegol|mesh-list
25485347|NCT00160693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25485348|NCT00160693|Immunologic Factors|immunologic factors|mesh-ancestor
25485349|NCT00160693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485350|NCT00160693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25485351|NCT00160706|Certolizumab Pegol|certolizumab pegol|mesh-list
25485352|NCT00160706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25485353|NCT00160706|Immunologic Factors|immunologic factors|mesh-ancestor
25485354|NCT00160706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485355|NCT00160706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25485356|NCT00161213|Gemcitabine|gemcitabine|mesh-list
25485357|NCT00161213|Imatinib Mesylate|imatinib mesylate|mesh-list
25485358|NCT00161213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25485359|NCT00161213|Antimetabolites|antimetabolites|mesh-ancestor
25485360|NCT00161213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485361|NCT00161213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485362|NCT00161213|Antiviral Agents|antiviral agents|mesh-ancestor
25485363|NCT00161213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25485364|NCT00161213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485365|NCT00161213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25485366|NCT00161213|Immunologic Factors|immunologic factors|mesh-ancestor
25485367|NCT00161213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485368|NCT00161213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25485369|NCT00161473|Prazosin|prazosin|mesh-list
25823118|NCT00004755|Gout Suppressants|gout suppressants|mesh-ancestor
25485370|NCT00161473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25485371|NCT00161473|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25485372|NCT00161473|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25485373|NCT00161473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25485374|NCT00161473|Adrenergic Agents|adrenergic agents|mesh-ancestor
25485375|NCT00161473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25485376|NCT00161473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485377|NCT00161473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485378|NCT00162032|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
25485379|NCT00162032|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25485380|NCT00162032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485382|NCT00162097|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25485383|NCT00162097|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25485384|NCT00162097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25485385|NCT00162097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485386|NCT00162097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485387|NCT00162097|Antiviral Agents|antiviral agents|mesh-ancestor
25485388|NCT00162097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25485389|NCT00162097|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25485390|NCT00162097|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25485391|NCT00162097|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25485392|NCT00162097|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25485393|NCT00162097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25485394|NCT00162097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25485395|NCT00162123|Ipilimumab|ipilimumab|mesh-list
25485396|NCT00162123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25485397|NCT00162123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485398|NCT00162123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25485399|NCT00162123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485400|NCT00162266|Abatacept|abatacept|mesh-list
25485401|NCT00162266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25485402|NCT00162266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485403|NCT00162266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485404|NCT00162266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25485405|NCT00162266|Immunologic Factors|immunologic factors|mesh-ancestor
25485406|NCT00162266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485407|NCT00162266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25485408|NCT00162981|Clobazam|clobazam|mesh-list
25485409|NCT00162981|Anticonvulsants|anticonvulsants|mesh-ancestor
25485410|NCT00162981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25485411|NCT00162981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25485412|NCT00162981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25485413|NCT00162981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485414|NCT00162981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25485415|NCT00162981|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25485416|NCT00162981|GABA Agonists|gaba agonists|mesh-ancestor
25485417|NCT00162981|GABA Agents|gaba agents|mesh-ancestor
25485418|NCT00162981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25485419|NCT00162981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485420|NCT00163020|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
25485421|NCT00163020|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
25485422|NCT00163020|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25485423|NCT00163020|Hormone Antagonists|hormone antagonists|mesh-ancestor
25485424|NCT00163020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25485425|NCT00163020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485426|NCT00163020|Progestins|progestins|mesh-ancestor
25485427|NCT00163020|Hormones|hormones|mesh-ancestor
25485428|NCT00163293|Ciclesonide|ciclesonide|mesh-list
25485429|NCT00163293|Glucocorticoids|glucocorticoids|mesh-ancestor
25485430|NCT00163293|Hormones|hormones|mesh-ancestor
25485431|NCT00163293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25485432|NCT00163293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485433|NCT00163293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25485434|NCT00163657|Cyclosporine|cyclosporine|mesh-list
25485435|NCT00163657|Mycophenolic Acid|mycophenolic acid|mesh-list
25485436|NCT00163657|Tacrolimus|tacrolimus|mesh-list
25485437|NCT00163657|Cyclosporins|cyclosporins|mesh-list
25485438|NCT00163657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25485439|NCT00163657|Immunologic Factors|immunologic factors|mesh-ancestor
25485440|NCT00163657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485441|NCT00163657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24586839|NCT00892346|Growth Inhibitors|growth inhibitors|mesh-ancestor
24586840|NCT00892359|Anidulafungin|anidulafungin|mesh-list
24586841|NCT00892359|Antifungal Agents|antifungal agents|mesh-ancestor
24586843|NCT00892385|Temozolomide|temozolomide|mesh-list
25485442|NCT00163657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485443|NCT00163657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485444|NCT00163657|Antifungal Agents|antifungal agents|mesh-ancestor
25485445|NCT00163657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25485446|NCT00163657|Dermatologic Agents|dermatologic agents|mesh-ancestor
25485447|NCT00163657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25485448|NCT00163657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25485449|NCT00163657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823119|NCT00004755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25485450|NCT00163657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25485451|NCT00163657|Antitubercular Agents|antitubercular agents|mesh-ancestor
25485452|NCT00163657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25485454|NCT00165646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25485455|NCT00165646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25485456|NCT00165646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25485457|NCT00165646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485458|NCT00165646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485459|NCT00165672|Rabeprazole|rabeprazole|mesh-list
25485460|NCT00165672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25485461|NCT00165672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25485462|NCT00165672|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25485463|NCT00165672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485464|NCT00165672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485465|NCT00165698|Alfacalcidol|alfacalcidol|mesh-list
25485466|NCT00165698|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
25485467|NCT00165698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25485468|NCT00165698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485469|NCT00165698|Vitamins|vitamins|mesh-ancestor
25485470|NCT00165698|Micronutrients|micronutrients|mesh-ancestor
25485471|NCT00165776|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
25485472|NCT00165776|Botulinum Toxins|botulinum toxins|mesh-list
25485473|NCT00165776|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25485474|NCT00165776|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25485475|NCT00165776|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25485476|NCT00165776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25485477|NCT00165776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485478|NCT00165776|Cholinergic Agents|cholinergic agents|mesh-ancestor
25485479|NCT00165776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25485480|NCT00165776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485481|NCT00165776|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25485482|NCT00165776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25485483|NCT00165776|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25485484|NCT00165841|Rabeprazole|rabeprazole|mesh-list
25485485|NCT00165841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25485486|NCT00165841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25485487|NCT00165841|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25485488|NCT00165841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485489|NCT00165841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485490|NCT00166036|Atorvastatin|atorvastatin|mesh-list
25485491|NCT00166036|Pravastatin|pravastatin|mesh-list
25485492|NCT00166036|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25485493|NCT00166036|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25485494|NCT00166036|Antimetabolites|antimetabolites|mesh-ancestor
25485495|NCT00166036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485496|NCT00166036|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25485497|NCT00166036|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25485498|NCT00166036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485499|NCT00166114|Citalopram|citalopram|mesh-list
25485500|NCT00166114|Desipramine|desipramine|mesh-list
25485501|NCT00166114|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25485502|NCT00166114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25485503|NCT00166114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25485504|NCT00166114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485505|NCT00166114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25485506|NCT00166114|Serotonin Agents|serotonin agents|mesh-ancestor
25485507|NCT00166114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485508|NCT00166114|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25017872|NCT03703089|Antimitotic Agents|antimitotic agents|mesh-ancestor
25017873|NCT03703089|Mitosis Modulators|mitosis modulators|mesh-ancestor
25111046|NCT05265650|Nivolumab|nivolumab|mesh-list
24924206|NCT04161690|Sensory System Agents|sensory system agents|mesh-ancestor
24924207|NCT04161690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24924208|NCT04161690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25485509|NCT00166114|Antidepressive Agents|antidepressive agents|mesh-ancestor
25485510|NCT00166114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25485511|NCT00166114|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25485512|NCT00166114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485513|NCT00166114|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25485514|NCT00166114|Adrenergic Agents|adrenergic agents|mesh-ancestor
25485516|NCT00166166|Nitroprusside|nitroprusside|mesh-list
25485517|NCT00166166|Tetraethylammonium|tetraethylammonium|mesh-list
25485518|NCT00166166|Acetylcholine|acetylcholine|mesh-list
25485519|NCT00166166|Bradykinin|bradykinin|mesh-list
25485520|NCT00166166|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
25823121|NCT00004755|Antioxidants|antioxidants|mesh-ancestor
25823122|NCT00004755|Protective Agents|protective agents|mesh-ancestor
25645009|NCT01442688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645010|NCT01442688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25645011|NCT01442688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25485521|NCT00166166|Kininogens|kininogens|mesh-list
25645012|NCT01442714|Lenalidomide|lenalidomide|mesh-list
25645013|NCT01442714|Azacitidine|azacitidine|mesh-list
25645014|NCT01442714|Immunologic Factors|immunologic factors|mesh-ancestor
25485522|NCT00166166|Antifungal Agents|antifungal agents|mesh-ancestor
25485523|NCT00166166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25485524|NCT00166166|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25485525|NCT00166166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25485526|NCT00166166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485527|NCT00166166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485528|NCT00166166|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25485529|NCT00166166|Hormone Antagonists|hormone antagonists|mesh-ancestor
25485530|NCT00166166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25485531|NCT00166166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485532|NCT00166166|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25485533|NCT00166166|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25485534|NCT00166166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25485535|NCT00166166|Vasodilator Agents|vasodilator agents|mesh-ancestor
25485536|NCT00166166|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25485537|NCT00166166|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25485538|NCT00166166|Cholinergic Agents|cholinergic agents|mesh-ancestor
25485539|NCT00166166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25485540|NCT00166166|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25485541|NCT00166166|Protease Inhibitors|protease inhibitors|mesh-ancestor
25485542|NCT00166166|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25485543|NCT00166166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25485544|NCT00166296|Citalopram|citalopram|mesh-list
25485545|NCT00166296|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25485546|NCT00166296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25485547|NCT00166296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25485548|NCT00166296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485549|NCT00166296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25485550|NCT00166296|Serotonin Agents|serotonin agents|mesh-ancestor
25485551|NCT00166296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485552|NCT00166296|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25485553|NCT00166296|Antidepressive Agents|antidepressive agents|mesh-ancestor
25485554|NCT00166296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25485555|NCT00166439|Cytarabine|cytarabine|mesh-list
25485556|NCT00166439|Dexamethasone|dexamethasone|mesh-list
25485557|NCT00166439|Oxaliplatin|oxaliplatin|mesh-list
25485558|NCT00166439|Rituximab|rituximab|mesh-list
25485559|NCT00166439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25485560|NCT00166439|Antiemetics|antiemetics|mesh-ancestor
25485561|NCT00166439|Autonomic Agents|autonomic agents|mesh-ancestor
25485562|NCT00166439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25485563|NCT00166439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485564|NCT00166439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25485565|NCT00166439|Glucocorticoids|glucocorticoids|mesh-ancestor
25485566|NCT00166439|Hormones|hormones|mesh-ancestor
25485567|NCT00166439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25485568|NCT00166439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25485569|NCT00166439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485570|NCT00166439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25485571|NCT00166439|Immunologic Factors|immunologic factors|mesh-ancestor
25485572|NCT00166439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25485573|NCT00166439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25485574|NCT00166439|Antimetabolites|antimetabolites|mesh-ancestor
25485575|NCT00166439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485576|NCT00166439|Antiviral Agents|antiviral agents|mesh-ancestor
25485577|NCT00166439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24924624|NCT04158076|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25017931|NCT03702894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25017932|NCT03702894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24924625|NCT04158076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24748574|NCT02367794|Paclitaxel|paclitaxel|mesh-list
25485578|NCT00166439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25645015|NCT01442714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485579|NCT00166712|Mycophenolic Acid|mycophenolic acid|mesh-list
25485581|NCT00166712|Alemtuzumab|alemtuzumab|mesh-list
25485582|NCT00166712|Tacrolimus|tacrolimus|mesh-list
25485583|NCT00166712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25485584|NCT00166712|Immunologic Factors|immunologic factors|mesh-ancestor
25485585|NCT00166712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485586|NCT00166712|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25485587|NCT00166712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485588|NCT00166712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485589|NCT00166712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25485590|NCT00166712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485591|NCT00166712|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25485592|NCT00166712|Antitubercular Agents|antitubercular agents|mesh-ancestor
25485593|NCT00166712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25485594|NCT00166712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25485595|NCT00166712|Antifungal Agents|antifungal agents|mesh-ancestor
25485596|NCT00166712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25485597|NCT00167102|Alefacept|alefacept|mesh-list
25485598|NCT00167102|Dermatologic Agents|dermatologic agents|mesh-ancestor
25485599|NCT00167102|Immunologic Factors|immunologic factors|mesh-ancestor
25485600|NCT00167102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485601|NCT00167180|Cyclophosphamide|cyclophosphamide|mesh-list
25485602|NCT00167180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25485603|NCT00167180|Immunologic Factors|immunologic factors|mesh-ancestor
25485604|NCT00167180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485605|NCT00167180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25485606|NCT00167180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25485607|NCT00167180|Alkylating Agents|alkylating agents|mesh-ancestor
25485608|NCT00167180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485609|NCT00167180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485610|NCT00167180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25485611|NCT00167206|Cyclophosphamide|cyclophosphamide|mesh-list
25485612|NCT00167206|Fludarabine|fludarabine|mesh-list
25485613|NCT00167206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25485614|NCT00167206|Immunologic Factors|immunologic factors|mesh-ancestor
25485615|NCT00167206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485616|NCT00167206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25485617|NCT00167206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25485618|NCT00167206|Alkylating Agents|alkylating agents|mesh-ancestor
25485619|NCT00167206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485620|NCT00167206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485621|NCT00167206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25485622|NCT00167245|Topiramate|topiramate|mesh-list
25485623|NCT00167245|Anticonvulsants|anticonvulsants|mesh-ancestor
25485624|NCT00167245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25485625|NCT00167245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485626|NCT00167544|Hydrocortisone|hydrocortisone|mesh-list
25485627|NCT00167544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25485628|NCT00167661|Alemtuzumab|alemtuzumab|mesh-list
25485629|NCT00167661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25485630|NCT00167661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485631|NCT00167934|Valproic Acid|valproic acid|mesh-list
25485632|NCT00167934|Anticonvulsants|anticonvulsants|mesh-ancestor
25485633|NCT00167934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485634|NCT00167934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485635|NCT00167934|GABA Agents|gaba agents|mesh-ancestor
25485636|NCT00167934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25485637|NCT00167934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485638|NCT00167934|Antimanic Agents|antimanic agents|mesh-ancestor
25485639|NCT00167934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25485640|NCT00167934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25485641|NCT00167934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25485642|NCT00168038|Immunoglobulins|immunoglobulins|mesh-list
25485643|NCT00168038|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25485644|NCT00168038|Antibodies|antibodies|mesh-list
25485645|NCT00168038|Immunologic Factors|immunologic factors|mesh-ancestor
25485646|NCT00168038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485647|NCT00168064|Mechlorethamine|mechlorethamine|mesh-list
25485648|NCT00168064|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25485649|NCT00168064|Alkylating Agents|alkylating agents|mesh-ancestor
25485650|NCT00168064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925063|NCT04154735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925064|NCT04154735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485651|NCT00168064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25485652|NCT00168064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485653|NCT00168103|Complement C1s|complement c1s|mesh-list
25485654|NCT00168103|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25485655|NCT00168103|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
25485656|NCT00168103|Immunologic Factors|immunologic factors|mesh-ancestor
25485657|NCT00168103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485658|NCT00168103|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25485659|NCT00168103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25485660|NCT00168298|Dexamethasone|dexamethasone|mesh-list
25485661|NCT00168298|Dexamethasone acetate|dexamethasone acetate|mesh-list
25485662|NCT00168298|BB 1101|bb 1101|mesh-list
25485663|NCT00168298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25485664|NCT00168298|Antiemetics|antiemetics|mesh-ancestor
25485665|NCT00168298|Autonomic Agents|autonomic agents|mesh-ancestor
25485666|NCT00168298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25485667|NCT00168298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485668|NCT00168298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25485669|NCT00168298|Glucocorticoids|glucocorticoids|mesh-ancestor
25485670|NCT00168298|Hormones|hormones|mesh-ancestor
25485671|NCT00168298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25485672|NCT00168298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25485673|NCT00168298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485674|NCT00168298|Protease Inhibitors|protease inhibitors|mesh-ancestor
25485675|NCT00168298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485676|NCT00168298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485677|NCT00168324|Dexamethasone|dexamethasone|mesh-list
25485678|NCT00168324|Dexamethasone acetate|dexamethasone acetate|mesh-list
25485679|NCT00168324|BB 1101|bb 1101|mesh-list
25485680|NCT00168324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25485681|NCT00168324|Antiemetics|antiemetics|mesh-ancestor
25485682|NCT00168324|Autonomic Agents|autonomic agents|mesh-ancestor
25485683|NCT00168324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25485684|NCT00168324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485685|NCT00168324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25485686|NCT00168324|Glucocorticoids|glucocorticoids|mesh-ancestor
25485687|NCT00168324|Hormones|hormones|mesh-ancestor
25485688|NCT00168324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25485689|NCT00168324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25485690|NCT00168324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485691|NCT00168324|Protease Inhibitors|protease inhibitors|mesh-ancestor
25485692|NCT00168324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485693|NCT00168324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485694|NCT00168337|Dexamethasone|dexamethasone|mesh-list
25485695|NCT00168337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25485696|NCT00168337|Antiemetics|antiemetics|mesh-ancestor
25485697|NCT00168337|Autonomic Agents|autonomic agents|mesh-ancestor
25485698|NCT00168337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25485699|NCT00168337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485700|NCT00168337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25485701|NCT00168337|Glucocorticoids|glucocorticoids|mesh-ancestor
25485702|NCT00168337|Hormones|hormones|mesh-ancestor
25485703|NCT00168337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25485704|NCT00168337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25485705|NCT00168337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485706|NCT00168389|Dexamethasone|dexamethasone|mesh-list
25485707|NCT00168389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25485708|NCT00168389|Antiemetics|antiemetics|mesh-ancestor
25485709|NCT00168389|Autonomic Agents|autonomic agents|mesh-ancestor
25485710|NCT00168389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25485711|NCT00168389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485712|NCT00168389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25485713|NCT00168389|Glucocorticoids|glucocorticoids|mesh-ancestor
25485714|NCT00168389|Hormones|hormones|mesh-ancestor
25485715|NCT00168389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25485716|NCT00168389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25485717|NCT00168389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485718|NCT00168428|Botulinum Toxins|botulinum toxins|mesh-list
25485719|NCT00168428|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25485720|NCT00168428|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25485721|NCT00168428|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25485722|NCT00168428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24524063|NCT05307003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24524064|NCT05307003|Serotonin Agents|serotonin agents|mesh-ancestor
24925995|NCT04145492|Coagulants|coagulants|mesh-ancestor
25485723|NCT00168428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485724|NCT00168428|Cholinergic Agents|cholinergic agents|mesh-ancestor
25645016|NCT01442714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25823123|NCT00004755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645017|NCT01442714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25645018|NCT01442714|Growth Substances|growth substances|mesh-ancestor
25645019|NCT01442714|Growth Inhibitors|growth inhibitors|mesh-ancestor
25645020|NCT01442714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645021|NCT01442714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25485725|NCT00168428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25485726|NCT00168428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485727|NCT00168428|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25485728|NCT00168428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25485730|NCT00168454|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25485731|NCT00168454|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25485732|NCT00168454|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25485733|NCT00168454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25485734|NCT00168454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485735|NCT00168454|Cholinergic Agents|cholinergic agents|mesh-ancestor
25485736|NCT00168454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25485737|NCT00168454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485738|NCT00168454|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25485739|NCT00168454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25485740|NCT00168805|Enoxaparin|enoxaparin|mesh-list
25485741|NCT00168805|Dabigatran|dabigatran|mesh-list
25485742|NCT00168805|Anticoagulants|anticoagulants|mesh-ancestor
25485743|NCT00168805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25485744|NCT00168805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25485745|NCT00168805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485746|NCT00168805|Antithrombins|antithrombins|mesh-ancestor
25485747|NCT00168805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25485748|NCT00168805|Protease Inhibitors|protease inhibitors|mesh-ancestor
25485749|NCT00168805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485750|NCT00168818|Enoxaparin|enoxaparin|mesh-list
25485751|NCT00168818|Dabigatran|dabigatran|mesh-list
25485752|NCT00168818|Anticoagulants|anticoagulants|mesh-ancestor
25485753|NCT00168818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25485754|NCT00168818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25485755|NCT00168818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485756|NCT00168818|Antithrombins|antithrombins|mesh-ancestor
25485757|NCT00168818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25485758|NCT00168818|Protease Inhibitors|protease inhibitors|mesh-ancestor
25485759|NCT00168818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485760|NCT00168831|Tiotropium Bromide|tiotropium bromide|mesh-list
25485761|NCT00168831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25485762|NCT00168831|Autonomic Agents|autonomic agents|mesh-ancestor
25485763|NCT00168831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25485764|NCT00168831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485765|NCT00168831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25485766|NCT00168831|Respiratory System Agents|respiratory system agents|mesh-ancestor
25485767|NCT00168831|Parasympatholytics|parasympatholytics|mesh-ancestor
25485768|NCT00168831|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25485769|NCT00168831|Cholinergic Agents|cholinergic agents|mesh-ancestor
25485770|NCT00168831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25485771|NCT00168831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485772|NCT00168844|Tiotropium Bromide|tiotropium bromide|mesh-list
25485773|NCT00168844|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25485774|NCT00168844|Autonomic Agents|autonomic agents|mesh-ancestor
25485775|NCT00168844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25485776|NCT00168844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485777|NCT00168844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25485778|NCT00168844|Respiratory System Agents|respiratory system agents|mesh-ancestor
25485779|NCT00168844|Parasympatholytics|parasympatholytics|mesh-ancestor
25485780|NCT00168844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25485781|NCT00168844|Cholinergic Agents|cholinergic agents|mesh-ancestor
25485782|NCT00168844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25485783|NCT00168844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485784|NCT00169104|Trastuzumab|trastuzumab|mesh-list
25485785|NCT00169104|Vinorelbine|vinorelbine|mesh-list
25485786|NCT00169104|Lenograstim|lenograstim|mesh-list
25485787|NCT00169104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25485788|NCT00169104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485789|NCT00169104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25485790|NCT00169104|Immunologic Factors|immunologic factors|mesh-ancestor
25485791|NCT00169104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485792|NCT00169104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25645022|NCT01442714|Antimetabolites|antimetabolites|mesh-ancestor
25645023|NCT01442714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645024|NCT01442714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645025|NCT01442779|Interferons|interferons|mesh-list
25645026|NCT01442779|Interferon-alpha|interferon-alpha|mesh-list
25485793|NCT00169104|Tubulin Modulators|tubulin modulators|mesh-ancestor
24926311|NCT04142840|Analgesics|analgesics|mesh-ancestor
24524144|NCT05236985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24524145|NCT05236985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485795|NCT00169104|Mitosis Modulators|mitosis modulators|mesh-ancestor
25485796|NCT00169104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485797|NCT00170157|Ipilimumab|ipilimumab|mesh-list
25485798|NCT00170157|Leuprolide|leuprolide|mesh-list
25485799|NCT00170157|Goserelin|goserelin|mesh-list
25485800|NCT00170157|Bicalutamide|bicalutamide|mesh-list
25485801|NCT00170157|Flutamide|flutamide|mesh-list
25485802|NCT00170157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25485803|NCT00170157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485804|NCT00170157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25485805|NCT00170157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485806|NCT00170157|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25485807|NCT00170157|Fertility Agents|fertility agents|mesh-ancestor
25485808|NCT00170157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25485809|NCT00170157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485810|NCT00170157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25485811|NCT00170157|Androgen Antagonists|androgen antagonists|mesh-ancestor
25485812|NCT00170157|Hormone Antagonists|hormone antagonists|mesh-ancestor
25485813|NCT00170157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25485814|NCT00170625|Topotecan|topotecan|mesh-list
25485815|NCT00170625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25485816|NCT00170625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25485817|NCT00170625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485818|NCT00170625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485819|NCT00170625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485820|NCT00170846|Everolimus|everolimus|mesh-list
25485821|NCT00170846|Azathioprine|azathioprine|mesh-list
25485822|NCT00170846|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
25485823|NCT00170846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485824|NCT00170846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25485825|NCT00170846|Immunologic Factors|immunologic factors|mesh-ancestor
25485826|NCT00170846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485827|NCT00170846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485828|NCT00170846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485829|NCT00170846|Antimetabolites|antimetabolites|mesh-ancestor
25485830|NCT00170846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25485831|NCT00170846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25485832|NCT00170950|Amlodipine|amlodipine|mesh-list
25485833|NCT00170950|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25485834|NCT00170950|Benazepril|benazepril|mesh-list
25485835|NCT00170950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25485836|NCT00170950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25485837|NCT00170950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25485838|NCT00170950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485839|NCT00170950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25485840|NCT00170950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485841|NCT00170950|Vasodilator Agents|vasodilator agents|mesh-ancestor
25485842|NCT00170950|Diuretics|diuretics|mesh-ancestor
25485843|NCT00170950|Natriuretic Agents|natriuretic agents|mesh-ancestor
25485844|NCT00170950|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25485845|NCT00170950|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25485846|NCT00170950|Protease Inhibitors|protease inhibitors|mesh-ancestor
25485847|NCT00170950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485848|NCT00171054|Amlodipine|amlodipine|mesh-list
25485849|NCT00171054|Valsartan|valsartan|mesh-list
25485850|NCT00171054|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25485851|NCT00171054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25485852|NCT00171054|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25485853|NCT00171054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25485854|NCT00171054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485855|NCT00171054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25485856|NCT00171054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485857|NCT00171054|Vasodilator Agents|vasodilator agents|mesh-ancestor
25485858|NCT00171054|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24697628|NCT01435954|Doxazosin|doxazosin|mesh-list
25823124|NCT00004755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25485859|NCT00171054|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25485860|NCT00171054|Diuretics|diuretics|mesh-ancestor
25485861|NCT00171054|Natriuretic Agents|natriuretic agents|mesh-ancestor
25485862|NCT00171054|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25485863|NCT00171158|Imatinib Mesylate|imatinib mesylate|mesh-list
25485864|NCT00171158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926949|NCT04137276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926950|NCT04137276|Protective Agents|protective agents|mesh-ancestor
25485889|NCT00171314|Letrozole|letrozole|mesh-list
25485890|NCT00171314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485891|NCT00171314|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25485892|NCT00171314|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25485893|NCT00171314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485894|NCT00171314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485895|NCT00171314|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25485896|NCT00171314|Hormone Antagonists|hormone antagonists|mesh-ancestor
25485897|NCT00171314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25485898|NCT00171314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485899|NCT00171314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25485900|NCT00171340|Zoledronic Acid|zoledronic acid|mesh-list
25485901|NCT00171340|Letrozole|letrozole|mesh-list
25485902|NCT00171340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485903|NCT00171340|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25485904|NCT00171340|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25485905|NCT00171340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485906|NCT00171340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485907|NCT00171340|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25485908|NCT00171340|Hormone Antagonists|hormone antagonists|mesh-ancestor
25485909|NCT00171340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25485910|NCT00171340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485911|NCT00171340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25485912|NCT00171704|Tamoxifen|tamoxifen|mesh-list
25485913|NCT00171704|Letrozole|letrozole|mesh-list
25485914|NCT00171704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485915|NCT00171704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25485916|NCT00171704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25485917|NCT00171704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485918|NCT00171704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485919|NCT00171704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25485920|NCT00171704|Hormone Antagonists|hormone antagonists|mesh-ancestor
25485921|NCT00171704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25485922|NCT00171704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485923|NCT00171704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25485924|NCT00171704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25485925|NCT00171704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25485926|NCT00171704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25485927|NCT00171730|Pasireotide|pasireotide|mesh-list
25485928|NCT00171730|Hormones|hormones|mesh-ancestor
25485929|NCT00171730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25485930|NCT00171730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485931|NCT00171834|Epothilones|epothilones|mesh-list
25485932|NCT00171834|Epothilone B|epothilone b|mesh-list
25485933|NCT00171834|Tubulin Modulators|tubulin modulators|mesh-ancestor
25485934|NCT00171834|Antimitotic Agents|antimitotic agents|mesh-ancestor
25485935|NCT00171834|Mitosis Modulators|mitosis modulators|mesh-ancestor
25485936|NCT00171834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485937|NCT00171834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485938|NCT00171873|Octreotide|octreotide|mesh-list
25485939|NCT00171873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25485940|NCT00171873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25485941|NCT00171873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25485942|NCT00171925|Vitamin D|vitamin d|mesh-list
25485943|NCT00171925|Zoledronic Acid|zoledronic acid|mesh-list
25485944|NCT00171925|Calcium|calcium|mesh-list
25485945|NCT00171925|Vitamins|vitamins|mesh-ancestor
25485946|NCT00171925|Micronutrients|micronutrients|mesh-ancestor
25485947|NCT00171925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485948|NCT00171925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25485949|NCT00171925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25485950|NCT00171951|Pasireotide|pasireotide|mesh-list
25485951|NCT00171951|Hormones|hormones|mesh-ancestor
25645027|NCT01442779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645028|NCT01442779|Antiviral Agents|antiviral agents|mesh-ancestor
25645029|NCT01442779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25645030|NCT01442779|Immunologic Factors|immunologic factors|mesh-ancestor
25645031|NCT01442779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645032|NCT01443026|Lycopene|lycopene|mesh-list
25645033|NCT01443026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25645034|NCT01443026|Antioxidants|antioxidants|mesh-ancestor
25645035|NCT01443026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645036|NCT01443026|Protective Agents|protective agents|mesh-ancestor
25485952|NCT00171951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25485953|NCT00171951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485954|NCT00172042|Zoledronic Acid|zoledronic acid|mesh-list
25485955|NCT00172042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24525078|NCT03987802|Insulin Aspart|insulin aspart|mesh-list
24525079|NCT03987802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25823125|NCT00004755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25823126|NCT00004755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25823127|NCT00004757|Acyclovir|acyclovir|mesh-list
25485956|NCT00172042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485957|NCT00172185|Teduglutide|teduglutide|mesh-list
25485958|NCT00172185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25485959|NCT00172185|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25485960|NCT00172185|Protective Agents|protective agents|mesh-ancestor
25485961|NCT00172185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485962|NCT00174382|Donepezil|donepezil|mesh-list
25485963|NCT00174382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25485964|NCT00174382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485965|NCT00174382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485966|NCT00174382|Cholinergic Agents|cholinergic agents|mesh-ancestor
25485967|NCT00174382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25485968|NCT00174382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485969|NCT00174382|Nootropic Agents|nootropic agents|mesh-ancestor
25485970|NCT00174447|Ziprasidone|ziprasidone|mesh-list
25485971|NCT00174447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25485972|NCT00174447|Serotonin Agents|serotonin agents|mesh-ancestor
25485973|NCT00174447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25485974|NCT00174447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485975|NCT00174447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485976|NCT00174447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25485977|NCT00174447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25485978|NCT00174447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25485979|NCT00174447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25485980|NCT00174447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25485981|NCT00174447|Dopamine Agents|dopamine agents|mesh-ancestor
25485982|NCT00174785|Dronedarone|dronedarone|mesh-list
25485983|NCT00174785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25485984|NCT00174915|Allopurinol|allopurinol|mesh-list
25485985|NCT00174915|Febuxostat|febuxostat|mesh-list
25485986|NCT00174915|Antimetabolites|antimetabolites|mesh-ancestor
25485987|NCT00174915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25485988|NCT00174915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25485989|NCT00174915|Gout Suppressants|gout suppressants|mesh-ancestor
25485990|NCT00174915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25485991|NCT00174915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25485992|NCT00174915|Antioxidants|antioxidants|mesh-ancestor
25485993|NCT00174915|Protective Agents|protective agents|mesh-ancestor
25485994|NCT00174915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25485995|NCT00174941|Febuxostat|febuxostat|mesh-list
25485996|NCT00174941|Gout Suppressants|gout suppressants|mesh-ancestor
25485997|NCT00174941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25485998|NCT00174967|Febuxostat|febuxostat|mesh-list
25485999|NCT00174967|Gout Suppressants|gout suppressants|mesh-ancestor
25486000|NCT00174967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25486001|NCT00175019|Allopurinol|allopurinol|mesh-list
25486002|NCT00175019|Febuxostat|febuxostat|mesh-list
25486003|NCT00175019|Antimetabolites|antimetabolites|mesh-ancestor
25486004|NCT00175019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486005|NCT00175019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25486006|NCT00175019|Gout Suppressants|gout suppressants|mesh-ancestor
25486007|NCT00175019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25486008|NCT00175019|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25486009|NCT00175019|Antioxidants|antioxidants|mesh-ancestor
25486010|NCT00175019|Protective Agents|protective agents|mesh-ancestor
25486011|NCT00175019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486012|NCT00175825|Brivaracetam|brivaracetam|mesh-list
25823128|NCT00004757|Antiviral Agents|antiviral agents|mesh-ancestor
25823129|NCT00004757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25486013|NCT00175825|Anticonvulsants|anticonvulsants|mesh-ancestor
25486014|NCT00175877|Certolizumab Pegol|certolizumab pegol|mesh-list
25823130|NCT00004758|Pyridoxine|pyridoxine|mesh-list
25486015|NCT00175877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25486016|NCT00175877|Immunologic Factors|immunologic factors|mesh-ancestor
25486017|NCT00175877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486018|NCT00175877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25486019|NCT00175916|Brivaracetam|brivaracetam|mesh-list
25486020|NCT00175916|Anticonvulsants|anticonvulsants|mesh-ancestor
25486021|NCT00176202|Valproic Acid|valproic acid|mesh-list
25486022|NCT00176202|Anticonvulsants|anticonvulsants|mesh-list
25486023|NCT00176202|Risperidone|risperidone|mesh-list
24525333|NCT03655691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24525334|NCT03649438|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24525335|NCT03649438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525336|NCT03649438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525337|NCT03649438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525338|NCT03649438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24525383|NCT03593655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486024|NCT00176202|Antipsychotic Agents|antipsychotic agents|mesh-list
25486025|NCT00176202|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25486026|NCT00176202|Serotonin Agents|serotonin agents|mesh-ancestor
25486027|NCT00176202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25486028|NCT00176202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486029|NCT00176202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486030|NCT00176202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25486031|NCT00176202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25486032|NCT00176202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25486033|NCT00176202|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25486034|NCT00176202|Dopamine Agents|dopamine agents|mesh-ancestor
25486035|NCT00176202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25486036|NCT00176202|GABA Agents|gaba agents|mesh-ancestor
25486037|NCT00176202|Antimanic Agents|antimanic agents|mesh-ancestor
25486038|NCT00176228|Lamotrigine|lamotrigine|mesh-list
25486039|NCT00176228|Anticonvulsants|anticonvulsants|mesh-ancestor
25486040|NCT00176228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25486041|NCT00176228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25486042|NCT00176228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486043|NCT00176228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25486044|NCT00176228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486045|NCT00176228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25486046|NCT00176228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25486047|NCT00176228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25486048|NCT00176228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25486049|NCT00176228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25486050|NCT00176254|Paclitaxel|paclitaxel|mesh-list
25486051|NCT00176254|Carboplatin|carboplatin|mesh-list
25486052|NCT00176254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25486053|NCT00176254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486054|NCT00176254|Tubulin Modulators|tubulin modulators|mesh-ancestor
25486055|NCT00176254|Antimitotic Agents|antimitotic agents|mesh-ancestor
25486056|NCT00176254|Mitosis Modulators|mitosis modulators|mesh-ancestor
25486057|NCT00176254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486058|NCT00176306|Levofloxacin|levofloxacin|mesh-list
25486059|NCT00176306|Ofloxacin|ofloxacin|mesh-list
25486060|NCT00176306|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25486061|NCT00176306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25486062|NCT00176306|Renal Agents|renal agents|mesh-ancestor
25486063|NCT00176306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25486064|NCT00176306|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25486065|NCT00176306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25486066|NCT00176306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25486067|NCT00176306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486068|NCT00176306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486069|NCT00176306|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25486070|NCT00176306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25486071|NCT00176423|Galantamine|galantamine|mesh-list
25486072|NCT00176423|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25486073|NCT00176423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25486074|NCT00176423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486075|NCT00176423|Cholinergic Agents|cholinergic agents|mesh-ancestor
25486076|NCT00176423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25486077|NCT00176423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486078|NCT00176423|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25486079|NCT00176423|Autonomic Agents|autonomic agents|mesh-ancestor
25486080|NCT00176423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24585984|NCT00888784|Propranolol|propranolol|mesh-list
25823131|NCT00004758|Carbamazepine|carbamazepine|mesh-list
25645037|NCT01443026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645038|NCT01443026|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25486081|NCT00176423|Nootropic Agents|nootropic agents|mesh-ancestor
25486082|NCT00176462|Leucovorin|leucovorin|mesh-list
25645039|NCT01443026|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25645040|NCT01443026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645041|NCT01443078|Gemcitabine|gemcitabine|mesh-list
25645042|NCT01443078|Cisplatin|cisplatin|mesh-list
25645043|NCT01443078|Carboplatin|carboplatin|mesh-list
25645044|NCT01443078|Docetaxel|docetaxel|mesh-list
25645045|NCT01443078|Pemetrexed|pemetrexed|mesh-list
25486083|NCT00176462|Cytarabine|cytarabine|mesh-list
25486084|NCT00176462|Dexamethasone|dexamethasone|mesh-list
25486085|NCT00176462|Hydrocortisone|hydrocortisone|mesh-list
25486086|NCT00176462|Cyclophosphamide|cyclophosphamide|mesh-list
25486087|NCT00176462|Methotrexate|methotrexate|mesh-list
25486088|NCT00176462|Vincristine|vincristine|mesh-list
25486089|NCT00176462|Asparaginase|asparaginase|mesh-list
25486090|NCT00176462|Mercaptopurine|mercaptopurine|mesh-list
25486091|NCT00176462|Thioguanine|thioguanine|mesh-list
25486092|NCT00176462|Daunorubicin|daunorubicin|mesh-list
25486093|NCT00176462|Aminopterin|aminopterin|mesh-list
25486094|NCT00176462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25486095|NCT00176462|Immunologic Factors|immunologic factors|mesh-ancestor
25486096|NCT00176462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486097|NCT00176462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25486098|NCT00176462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25486099|NCT00176462|Alkylating Agents|alkylating agents|mesh-ancestor
25486100|NCT00176462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018687|NCT03697746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25486101|NCT00176462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486102|NCT00176462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25486103|NCT00176462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25486104|NCT00176462|Antiemetics|antiemetics|mesh-ancestor
25486105|NCT00176462|Autonomic Agents|autonomic agents|mesh-ancestor
25486106|NCT00176462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25486107|NCT00176462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25486108|NCT00176462|Glucocorticoids|glucocorticoids|mesh-ancestor
25486109|NCT00176462|Hormones|hormones|mesh-ancestor
25486110|NCT00176462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25486111|NCT00176462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25486112|NCT00176462|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25486113|NCT00176462|Abortifacient Agents|abortifacient agents|mesh-ancestor
25486114|NCT00176462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25486115|NCT00176462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25486116|NCT00176462|Antimetabolites|antimetabolites|mesh-ancestor
25486117|NCT00176462|Dermatologic Agents|dermatologic agents|mesh-ancestor
25486118|NCT00176462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25486119|NCT00176462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25486120|NCT00176462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25486121|NCT00176462|Antiviral Agents|antiviral agents|mesh-ancestor
25486122|NCT00176462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25486123|NCT00176462|Antidotes|antidotes|mesh-ancestor
25486124|NCT00176462|Protective Agents|protective agents|mesh-ancestor
25486125|NCT00176462|Vitamin B Complex|vitamin b complex|mesh-ancestor
25486126|NCT00176462|Vitamins|vitamins|mesh-ancestor
25486127|NCT00176462|Micronutrients|micronutrients|mesh-ancestor
25486128|NCT00176462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25486129|NCT00176462|Tubulin Modulators|tubulin modulators|mesh-ancestor
25486130|NCT00176462|Antimitotic Agents|antimitotic agents|mesh-ancestor
25486131|NCT00176462|Mitosis Modulators|mitosis modulators|mesh-ancestor
25486132|NCT00176462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25486133|NCT00176462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25486134|NCT00176462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25486135|NCT00176592|Glatiramer Acetate|glatiramer acetate|mesh-list
25486136|NCT00176592|Interferon beta-1b|interferon beta-1b|mesh-list
25486137|NCT00176592|(T,G)-A-L|(t,g)-a-l|mesh-list
25486138|NCT00176592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25486139|NCT00176592|Immunologic Factors|immunologic factors|mesh-ancestor
25486140|NCT00176592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486141|NCT00176592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25486142|NCT00176592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25486143|NCT00176605|Cyclophosphamide|cyclophosphamide|mesh-list
25486144|NCT00176605|Etoposide|etoposide|mesh-list
25486145|NCT00176605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25486146|NCT00176605|Immunologic Factors|immunologic factors|mesh-ancestor
25645046|NCT01443078|Vinorelbine|vinorelbine|mesh-list
25486147|NCT00176605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486148|NCT00176605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25645047|NCT01443078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645048|NCT01443078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25645049|NCT01443078|Antimetabolites|antimetabolites|mesh-ancestor
25645050|NCT01443078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645051|NCT01443078|Antiviral Agents|antiviral agents|mesh-ancestor
25645052|NCT01443078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25645053|NCT01443078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645054|NCT01443078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25645055|NCT01443078|Immunologic Factors|immunologic factors|mesh-ancestor
25645056|NCT01443078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486149|NCT00176605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25486150|NCT00176605|Alkylating Agents|alkylating agents|mesh-ancestor
25486151|NCT00176605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486152|NCT00176605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486153|NCT00176605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25486154|NCT00176605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25486155|NCT00176605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25486156|NCT00176605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25486157|NCT00176605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25486158|NCT00176644|Estradiol|estradiol|mesh-list
25486159|NCT00176644|Estrogens|estrogens|mesh-ancestor
25486160|NCT00176644|Hormones|hormones|mesh-ancestor
25486161|NCT00176644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25486162|NCT00176644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486163|NCT00176800|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
25486164|NCT00176800|Chelating Agents|chelating agents|mesh-ancestor
25486165|NCT00176800|Sequestering Agents|sequestering agents|mesh-ancestor
25486166|NCT00176800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486167|NCT00176800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25486168|NCT00176800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25486169|NCT00176800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25486170|NCT00176800|Growth Substances|growth substances|mesh-ancestor
25486171|NCT00176800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486172|NCT00176800|Growth Inhibitors|growth inhibitors|mesh-ancestor
25486173|NCT00176800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486174|NCT00176826|Busulfan|busulfan|mesh-list
24928033|NCT04127019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25486175|NCT00176826|Alkylating Agents|alkylating agents|mesh-ancestor
25486176|NCT00176826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486177|NCT00176826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25486178|NCT00176826|Immunologic Factors|immunologic factors|mesh-ancestor
25486179|NCT00176826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486180|NCT00176826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25486181|NCT00176826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486182|NCT00176826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25486183|NCT00176839|Cyclophosphamide|cyclophosphamide|mesh-list
25486184|NCT00176839|Melphalan|melphalan|mesh-list
25486185|NCT00176839|Busulfan|busulfan|mesh-list
25486186|NCT00176839|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25486187|NCT00176839|Lenograstim|lenograstim|mesh-list
25486188|NCT00176839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25486189|NCT00176839|Immunologic Factors|immunologic factors|mesh-ancestor
25486190|NCT00176839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486191|NCT00176839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25486192|NCT00176839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25486193|NCT00176839|Alkylating Agents|alkylating agents|mesh-ancestor
25486194|NCT00176839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486195|NCT00176839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486196|NCT00176839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25486197|NCT00176839|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25486198|NCT00176852|Vidarabine|vidarabine|mesh-list
25486199|NCT00176852|Cyclophosphamide|cyclophosphamide|mesh-list
25486200|NCT00176852|Busulfan|busulfan|mesh-list
25486201|NCT00176852|Fludarabine|fludarabine|mesh-list
25486202|NCT00176852|Fludarabine phosphate|fludarabine phosphate|mesh-list
25486203|NCT00176852|Alemtuzumab|alemtuzumab|mesh-list
25486204|NCT00176852|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25486205|NCT00176852|Lenograstim|lenograstim|mesh-list
25486206|NCT00176852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25486207|NCT00176852|Immunologic Factors|immunologic factors|mesh-ancestor
25486208|NCT00176852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486209|NCT00176852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25486210|NCT00176852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25486211|NCT00176852|Alkylating Agents|alkylating agents|mesh-ancestor
25645057|NCT01443078|Tubulin Modulators|tubulin modulators|mesh-ancestor
25486212|NCT00176852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486213|NCT00176852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486214|NCT00176852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25486215|NCT00176852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25486216|NCT00176852|Antimetabolites|antimetabolites|mesh-ancestor
25486217|NCT00176852|Antiviral Agents|antiviral agents|mesh-ancestor
25486218|NCT00176852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25486219|NCT00176852|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25486220|NCT00176852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25486221|NCT00176865|Cyclosporine|cyclosporine|mesh-list
25645058|NCT01443078|Antimitotic Agents|antimitotic agents|mesh-ancestor
25645059|NCT01443078|Mitosis Modulators|mitosis modulators|mesh-ancestor
25645060|NCT01443078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25486222|NCT00176865|Mycophenolic Acid|mycophenolic acid|mesh-list
25486223|NCT00176865|Fludarabine|fludarabine|mesh-list
25645061|NCT01443078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25645062|NCT01443078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25645063|NCT01443130|Chloroquine|chloroquine|mesh-list
25645064|NCT01443130|Pyrimethamine|pyrimethamine|mesh-list
25486224|NCT00176865|Melphalan|melphalan|mesh-list
25486225|NCT00176865|Alemtuzumab|alemtuzumab|mesh-list
25486226|NCT00176865|Cyclosporins|cyclosporins|mesh-list
25486227|NCT00176865|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25486228|NCT00176865|Immunoglobulins|immunoglobulins|mesh-list
25486229|NCT00176865|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25486230|NCT00176865|Antibodies|antibodies|mesh-list
25486231|NCT00176865|gamma-Globulins|gamma-globulins|mesh-list
25486232|NCT00176865|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25486233|NCT00176865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486234|NCT00176865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486235|NCT00176865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25486236|NCT00176865|Immunologic Factors|immunologic factors|mesh-ancestor
25486237|NCT00176865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486238|NCT00176865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25486239|NCT00176865|Antifungal Agents|antifungal agents|mesh-ancestor
25486240|NCT00176865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25486241|NCT00176865|Dermatologic Agents|dermatologic agents|mesh-ancestor
25486242|NCT00176865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25486243|NCT00176865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25486244|NCT00176865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25486245|NCT00176865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25486246|NCT00176865|Antitubercular Agents|antitubercular agents|mesh-ancestor
25486247|NCT00176865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25018855|NCT03696186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25018856|NCT03696186|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25486248|NCT00176865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25486249|NCT00176865|Alkylating Agents|alkylating agents|mesh-ancestor
25486250|NCT00176865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25486251|NCT00176865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25486253|NCT00176878|Fludarabine phosphate|fludarabine phosphate|mesh-list
25486254|NCT00176878|Busulfan|busulfan|mesh-list
25486255|NCT00176878|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25486256|NCT00176878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486257|NCT00176878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25486258|NCT00176878|Antimetabolites|antimetabolites|mesh-ancestor
25486259|NCT00176878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486260|NCT00176878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25486261|NCT00176878|Immunologic Factors|immunologic factors|mesh-ancestor
25486262|NCT00176878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486263|NCT00176878|Alkylating Agents|alkylating agents|mesh-ancestor
25486264|NCT00176878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25486265|NCT00176878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25486266|NCT00176904|Cyclophosphamide|cyclophosphamide|mesh-list
25486267|NCT00176904|Busulfan|busulfan|mesh-list
25486268|NCT00176904|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25486269|NCT00176904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25486270|NCT00176904|Immunologic Factors|immunologic factors|mesh-ancestor
25486271|NCT00176904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486272|NCT00176904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25486273|NCT00176904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25486274|NCT00176904|Alkylating Agents|alkylating agents|mesh-ancestor
25486275|NCT00176904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486276|NCT00176904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645065|NCT01443130|Sulfadoxine|sulfadoxine|mesh-list
25010983|NCT02444741|Pembrolizumab|pembrolizumab|mesh-list
25823132|NCT00004758|Valproic Acid|valproic acid|mesh-list
25645066|NCT01443130|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25645067|NCT01443130|Amebicides|amebicides|mesh-ancestor
25645068|NCT01443130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25645069|NCT01443130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25645070|NCT01443130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25645071|NCT01443130|Antimalarials|antimalarials|mesh-ancestor
25645072|NCT01443130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25645073|NCT01443130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25486277|NCT00176904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25486278|NCT00176917|Cyclophosphamide|cyclophosphamide|mesh-list
25486279|NCT00176917|Busulfan|busulfan|mesh-list
25486280|NCT00176917|Thymoglobulin|thymoglobulin|mesh-list
25486281|NCT00176917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25486282|NCT00176917|Immunologic Factors|immunologic factors|mesh-ancestor
25486283|NCT00176917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486284|NCT00176917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25486285|NCT00176917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25486286|NCT00176917|Alkylating Agents|alkylating agents|mesh-ancestor
25486287|NCT00176917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486288|NCT00176917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486289|NCT00176917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25486290|NCT00176930|Cyclophosphamide|cyclophosphamide|mesh-list
25486291|NCT00176930|Busulfan|busulfan|mesh-list
25486292|NCT00176930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25486293|NCT00176930|Immunologic Factors|immunologic factors|mesh-ancestor
25486294|NCT00176930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486295|NCT00176930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25486296|NCT00176930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25486297|NCT00176930|Alkylating Agents|alkylating agents|mesh-ancestor
25486298|NCT00176930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486299|NCT00176930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486300|NCT00176930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25486301|NCT00177047|Cyclophosphamide|cyclophosphamide|mesh-list
25486302|NCT00177047|Melphalan|melphalan|mesh-list
25486303|NCT00177047|Lenograstim|lenograstim|mesh-list
25486304|NCT00177047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25486305|NCT00177047|Immunologic Factors|immunologic factors|mesh-ancestor
25486306|NCT00177047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486307|NCT00177047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25486308|NCT00177047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25486309|NCT00177047|Alkylating Agents|alkylating agents|mesh-ancestor
25486310|NCT00177047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486311|NCT00177047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486312|NCT00177047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25486313|NCT00177047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25486314|NCT00177164|Olanzapine|olanzapine|mesh-list
25486315|NCT00177164|Risperidone|risperidone|mesh-list
25486316|NCT00177164|Aripiprazole|aripiprazole|mesh-list
25486317|NCT00177164|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25486318|NCT00177164|Ziprasidone|ziprasidone|mesh-list
25486319|NCT00177164|Antipsychotic Agents|antipsychotic agents|mesh-list
25486320|NCT00177164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24625282|NCT01081535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24625285|NCT01081535|Anesthetics, General|anesthetics, general|mesh-ancestor
24933175|NCT04074122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24933194|NCT04074122|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24933195|NCT04074122|Protective Agents|protective agents|mesh-ancestor
24975476|NCT03593811|Serotonin Agents|serotonin agents|mesh-ancestor
25486321|NCT00177164|Serotonin Agents|serotonin agents|mesh-ancestor
25486322|NCT00177164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25486323|NCT00177164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486324|NCT00177164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486325|NCT00177164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25486326|NCT00177164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25486327|NCT00177164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25486328|NCT00177164|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25486329|NCT00177164|Dopamine Agents|dopamine agents|mesh-ancestor
25486330|NCT00177164|Antiemetics|antiemetics|mesh-ancestor
25486331|NCT00177164|Autonomic Agents|autonomic agents|mesh-ancestor
25486332|NCT00177164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25486333|NCT00177164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25486334|NCT00177164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25486335|NCT00177164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25486336|NCT00177164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25486337|NCT00177164|Antidepressive Agents|antidepressive agents|mesh-ancestor
25645074|NCT01443130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25486338|NCT00177164|Dopamine Agonists|dopamine agonists|mesh-ancestor
25486339|NCT00177164|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25486340|NCT00177164|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25486341|NCT00177164|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25486342|NCT00177164|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25486343|NCT00177216|Zolpidem|zolpidem|mesh-list
25486344|NCT00177216|Citalopram|citalopram|mesh-list
25486345|NCT00177216|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25486346|NCT00177216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25486347|NCT00177216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25486348|NCT00177216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486349|NCT00177216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25486350|NCT00177216|Serotonin Agents|serotonin agents|mesh-ancestor
25486351|NCT00177216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486352|NCT00177216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25486353|NCT00177216|Antidepressive Agents|antidepressive agents|mesh-ancestor
25486354|NCT00177216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25486355|NCT00177216|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25486356|NCT00177216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25486357|NCT00177216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25486358|NCT00177216|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25486359|NCT00177216|GABA Agonists|gaba agonists|mesh-ancestor
25486360|NCT00177216|GABA Agents|gaba agents|mesh-ancestor
25486361|NCT00177255|Docetaxel|docetaxel|mesh-list
25486362|NCT00177255|Capecitabine|capecitabine|mesh-list
25486363|NCT00177255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486364|NCT00177255|Tubulin Modulators|tubulin modulators|mesh-ancestor
25486365|NCT00177255|Antimitotic Agents|antimitotic agents|mesh-ancestor
25486366|NCT00177255|Mitosis Modulators|mitosis modulators|mesh-ancestor
25486367|NCT00177255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486368|NCT00177255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25486369|NCT00177255|Antimetabolites|antimetabolites|mesh-ancestor
25486370|NCT00177294|Citalopram|citalopram|mesh-list
25486371|NCT00177294|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25486372|NCT00177294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25486373|NCT00177294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25486374|NCT00177294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486375|NCT00177294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25486376|NCT00177294|Serotonin Agents|serotonin agents|mesh-ancestor
25486377|NCT00177294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486378|NCT00177294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25486379|NCT00177294|Antidepressive Agents|antidepressive agents|mesh-ancestor
25486380|NCT00177294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25486381|NCT00177307|Bevacizumab|bevacizumab|mesh-list
25486382|NCT00177307|Capecitabine|capecitabine|mesh-list
25486383|NCT00177307|Oxaliplatin|oxaliplatin|mesh-list
25486384|NCT00177307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25486385|NCT00177307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486386|NCT00177307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25486387|NCT00177307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25486388|NCT00177307|Growth Substances|growth substances|mesh-ancestor
25486389|NCT00177307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486390|NCT00177307|Growth Inhibitors|growth inhibitors|mesh-ancestor
25486391|NCT00177307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25486392|NCT00177307|Antimetabolites|antimetabolites|mesh-ancestor
25486393|NCT00177307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530398|NCT00630097|Modafinil|modafinil|mesh-list
25486394|NCT00177671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25486395|NCT00177671|Donepezil|donepezil|mesh-list
25486396|NCT00177671|Citalopram|citalopram|mesh-list
25486397|NCT00177671|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25486398|NCT00177671|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25486399|NCT00177671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25486400|NCT00177671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25486401|NCT00177671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486402|NCT00177671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25486403|NCT00177671|Serotonin Agents|serotonin agents|mesh-ancestor
25486404|NCT00177671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486405|NCT00177671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25486406|NCT00177671|Antidepressive Agents|antidepressive agents|mesh-ancestor
25486407|NCT00177671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25486408|NCT00177671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25656814|NCT01579305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486409|NCT00177671|Cholinergic Agents|cholinergic agents|mesh-ancestor
25645075|NCT01443130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645076|NCT01443130|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25645078|NCT01443364|Certolizumab Pegol|certolizumab pegol|mesh-list
25645079|NCT01443364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25645080|NCT01443364|Immunologic Factors|immunologic factors|mesh-ancestor
25645081|NCT01443364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645082|NCT01443364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25486410|NCT00177671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25486411|NCT00177671|Analgesics|analgesics|mesh-ancestor
25486412|NCT00177671|Sensory System Agents|sensory system agents|mesh-ancestor
25486413|NCT00177671|Dopamine Agents|dopamine agents|mesh-ancestor
25486414|NCT00177671|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25486415|NCT00177671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645083|NCT01443442|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25486416|NCT00177671|Nootropic Agents|nootropic agents|mesh-ancestor
25486417|NCT00178178|Bupivacaine|bupivacaine|mesh-list
25486418|NCT00178178|Anesthetics, Local|anesthetics, local|mesh-ancestor
25486419|NCT00178178|Anesthetics|anesthetics|mesh-ancestor
25486420|NCT00178178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25486421|NCT00178178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486422|NCT00178178|Sensory System Agents|sensory system agents|mesh-ancestor
25486423|NCT00178178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25486424|NCT00178256|Paclitaxel|paclitaxel|mesh-list
25486425|NCT00178256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25486426|NCT00178256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486427|NCT00178256|Tubulin Modulators|tubulin modulators|mesh-ancestor
25486428|NCT00178256|Antimitotic Agents|antimitotic agents|mesh-ancestor
25486429|NCT00178256|Mitosis Modulators|mitosis modulators|mesh-ancestor
25486430|NCT00178256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486431|NCT00178464|Aspirin|aspirin|mesh-list
25486432|NCT00178464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25486433|NCT00178464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25486434|NCT00178464|Analgesics|analgesics|mesh-ancestor
25486435|NCT00178464|Sensory System Agents|sensory system agents|mesh-ancestor
25486436|NCT00178464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25486437|NCT00178464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486438|NCT00178464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25486439|NCT00178464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25486440|NCT00178464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25486441|NCT00178464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25486442|NCT00178464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486443|NCT00178464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25486444|NCT00178464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25486445|NCT00178464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25486446|NCT00178464|Antipyretics|antipyretics|mesh-ancestor
25486447|NCT00178503|Methylphenidate|methylphenidate|mesh-list
25486448|NCT00178503|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25486449|NCT00178503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486450|NCT00178503|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25486451|NCT00178503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25486452|NCT00178503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25486453|NCT00178503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486454|NCT00178503|Dopamine Agents|dopamine agents|mesh-ancestor
25486455|NCT00178503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25486456|NCT00178646|Botulinum Toxins|botulinum toxins|mesh-list
25486457|NCT00178646|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25486458|NCT00178646|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25486459|NCT00178646|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25486460|NCT00178646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25486461|NCT00178646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486462|NCT00178646|Cholinergic Agents|cholinergic agents|mesh-ancestor
25486463|NCT00178646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25486464|NCT00178646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486465|NCT00178646|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24531036|NCT00633672|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
25486468|NCT00178841|Bexarotene|bexarotene|mesh-list
25486469|NCT00178841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25486470|NCT00178841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486471|NCT00178841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486472|NCT00178919|Trimethaphan|trimethaphan|mesh-list
25486473|NCT00178919|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
25645085|NCT01443442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25486474|NCT00178919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486475|NCT00178919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25486476|NCT00178919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25486477|NCT00178919|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
25486479|NCT00178919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25486480|NCT00178919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486481|NCT00178919|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25486482|NCT00178919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25486483|NCT00178919|Cholinergic Agents|cholinergic agents|mesh-ancestor
25486484|NCT00178919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25486485|NCT00178919|Vasodilator Agents|vasodilator agents|mesh-ancestor
25486486|NCT00179010|Adenosine|adenosine|mesh-list
25486487|NCT00179010|Analgesics|analgesics|mesh-ancestor
25486488|NCT00179010|Sensory System Agents|sensory system agents|mesh-ancestor
25486489|NCT00179010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25486490|NCT00179010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486491|NCT00179010|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25486492|NCT00179010|Vasodilator Agents|vasodilator agents|mesh-ancestor
25486493|NCT00179010|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25486494|NCT00179010|Purinergic Agonists|purinergic agonists|mesh-ancestor
25486495|NCT00179010|Purinergic Agents|purinergic agents|mesh-ancestor
25486496|NCT00179010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25486497|NCT00179010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486498|NCT00179309|Docetaxel|docetaxel|mesh-list
25486499|NCT00179309|Sargramostim|sargramostim|mesh-list
25486500|NCT00179309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486501|NCT00179309|Tubulin Modulators|tubulin modulators|mesh-ancestor
25486502|NCT00179309|Antimitotic Agents|antimitotic agents|mesh-ancestor
25486503|NCT00179309|Mitosis Modulators|mitosis modulators|mesh-ancestor
25486504|NCT00179309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486505|NCT00179309|Immunologic Factors|immunologic factors|mesh-ancestor
25486506|NCT00179309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486507|NCT00179413|Interferons|interferons|mesh-list
25486508|NCT00179413|Interferon-alpha|interferon-alpha|mesh-list
25486509|NCT00179413|Interferon alpha-2|interferon alpha-2|mesh-list
25486510|NCT00179413|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25486511|NCT00179413|Colchicine|colchicine|mesh-list
25486512|NCT00179413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486513|NCT00179413|Antiviral Agents|antiviral agents|mesh-ancestor
25486514|NCT00179413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25486515|NCT00179413|Immunologic Factors|immunologic factors|mesh-ancestor
25486516|NCT00179413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486517|NCT00179413|Gout Suppressants|gout suppressants|mesh-ancestor
25486518|NCT00179413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25486519|NCT00179413|Tubulin Modulators|tubulin modulators|mesh-ancestor
25486520|NCT00179413|Antimitotic Agents|antimitotic agents|mesh-ancestor
25486521|NCT00179413|Mitosis Modulators|mitosis modulators|mesh-ancestor
25486522|NCT00179413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486523|NCT00179478|Interferons|interferons|mesh-list
25486524|NCT00179478|Interferon-beta|interferon-beta|mesh-list
25486525|NCT00179478|Interferon beta-1a|interferon beta-1a|mesh-list
25486526|NCT00179478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486527|NCT00179478|Antiviral Agents|antiviral agents|mesh-ancestor
25486528|NCT00179478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24456422|NCT00331097|Cyclophosphamide|cyclophosphamide|mesh-list
24456423|NCT00331097|Docetaxel|docetaxel|mesh-list
24532301|NCT00639119|Dopamine Agents|dopamine agents|mesh-ancestor
24532302|NCT00639119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24532303|NCT00639119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532304|NCT00639119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532318|NCT00639327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823133|NCT00004758|Nitrazepam|nitrazepam|mesh-list
24669507|NCT03884101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24669508|NCT03884101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25486529|NCT00179478|Immunologic Factors|immunologic factors|mesh-ancestor
25486530|NCT00179478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486531|NCT00179478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25486532|NCT00179517|Anastrozole|anastrozole|mesh-list
25486533|NCT00179517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25486534|NCT00179517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486535|NCT00179517|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24903244|NCT04365231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25645086|NCT01443546|Leuprolide|leuprolide|mesh-list
25645087|NCT01443546|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25645088|NCT01443546|Fertility Agents|fertility agents|mesh-ancestor
25486536|NCT00179517|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25486537|NCT00179517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25486538|NCT00179517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486539|NCT00179517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25486540|NCT00179517|Hormone Antagonists|hormone antagonists|mesh-ancestor
25486541|NCT00179517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25486542|NCT00179517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486543|NCT00179621|Lenalidomide|lenalidomide|mesh-list
25486544|NCT00179621|Immunologic Factors|immunologic factors|mesh-ancestor
25486545|NCT00179621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486546|NCT00179621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25486547|NCT00179621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25486548|NCT00179621|Growth Substances|growth substances|mesh-ancestor
25486549|NCT00179621|Growth Inhibitors|growth inhibitors|mesh-ancestor
25486550|NCT00179621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486551|NCT00179647|Dexamethasone|dexamethasone|mesh-list
25486552|NCT00179647|Lenalidomide|lenalidomide|mesh-list
25486553|NCT00179647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25486554|NCT00179647|Antiemetics|antiemetics|mesh-ancestor
25486555|NCT00179647|Autonomic Agents|autonomic agents|mesh-ancestor
25486556|NCT00179647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25486557|NCT00179647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486558|NCT00179647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25486559|NCT00179647|Glucocorticoids|glucocorticoids|mesh-ancestor
25486560|NCT00179647|Hormones|hormones|mesh-ancestor
25486561|NCT00179647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25486562|NCT00179647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25486563|NCT00179647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486564|NCT00179647|Immunologic Factors|immunologic factors|mesh-ancestor
25486565|NCT00179647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25486566|NCT00179647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25486567|NCT00179647|Growth Substances|growth substances|mesh-ancestor
25486568|NCT00179647|Growth Inhibitors|growth inhibitors|mesh-ancestor
25486569|NCT00179660|Lenalidomide|lenalidomide|mesh-list
25486570|NCT00179660|Immunologic Factors|immunologic factors|mesh-ancestor
25486571|NCT00179660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486572|NCT00179660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25486573|NCT00179660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25486574|NCT00179660|Growth Substances|growth substances|mesh-ancestor
25486575|NCT00179660|Growth Inhibitors|growth inhibitors|mesh-ancestor
25486576|NCT00179660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486577|NCT00179673|Lenalidomide|lenalidomide|mesh-list
25486578|NCT00179673|Immunologic Factors|immunologic factors|mesh-ancestor
25486579|NCT00179673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486580|NCT00179673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25486581|NCT00179673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25486582|NCT00179673|Growth Substances|growth substances|mesh-ancestor
25486583|NCT00179673|Growth Inhibitors|growth inhibitors|mesh-ancestor
25486584|NCT00179673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486585|NCT00179959|Mupirocin|mupirocin|mesh-list
25486586|NCT00179959|Sodium Hypochlorite|sodium hypochlorite|mesh-list
25486587|NCT00179959|Eusol|eusol|mesh-list
25486588|NCT00179959|Petrolatum|petrolatum|mesh-list
25486589|NCT00179959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25486590|NCT00179959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25486591|NCT00179959|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25486592|NCT00179959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25486593|NCT00179959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486594|NCT00179959|Disinfectants|disinfectants|mesh-ancestor
25486595|NCT00179959|Emollients|emollients|mesh-ancestor
25486596|NCT00179959|Dermatologic Agents|dermatologic agents|mesh-ancestor
25486597|NCT00180479|Paclitaxel|paclitaxel|mesh-list
25486598|NCT00180479|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25486599|NCT00180479|Everolimus|everolimus|mesh-list
25486600|NCT00180479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25486601|NCT00180479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486602|NCT00180479|Tubulin Modulators|tubulin modulators|mesh-ancestor
25486603|NCT00180479|Antimitotic Agents|antimitotic agents|mesh-ancestor
25019287|NCT03692143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25486604|NCT00180479|Mitosis Modulators|mitosis modulators|mesh-ancestor
25486605|NCT00180479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486606|NCT00180479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25823134|NCT00004758|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25645089|NCT01443546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25823135|NCT00004758|Anticonvulsants|anticonvulsants|mesh-ancestor
25823136|NCT00004758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645090|NCT01443546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829460|NCT00006212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486607|NCT00180479|Immunologic Factors|immunologic factors|mesh-ancestor
25486608|NCT00180479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486610|NCT00180674|Anticoagulants|anticoagulants|mesh-ancestor
25486611|NCT00180687|Bupivacaine|bupivacaine|mesh-list
25486612|NCT00180687|Coal Tar|coal tar|mesh-list
25486613|NCT00180687|Anesthetics, Local|anesthetics, local|mesh-ancestor
25486614|NCT00180687|Anesthetics|anesthetics|mesh-ancestor
25486615|NCT00180687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25486616|NCT00180687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486617|NCT00180687|Sensory System Agents|sensory system agents|mesh-ancestor
25486618|NCT00180687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25486619|NCT00180687|Keratolytic Agents|keratolytic agents|mesh-ancestor
25486620|NCT00180687|Dermatologic Agents|dermatologic agents|mesh-ancestor
25486621|NCT00180713|Simvastatin|simvastatin|mesh-list
25486622|NCT00180713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25486623|NCT00180713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25486624|NCT00180713|Antimetabolites|antimetabolites|mesh-ancestor
25486625|NCT00180713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486626|NCT00180713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25486627|NCT00180713|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25486628|NCT00180713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25486629|NCT00181155|Allopurinol|allopurinol|mesh-list
25486630|NCT00181155|Antimetabolites|antimetabolites|mesh-ancestor
25486631|NCT00181155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486632|NCT00181155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25486633|NCT00181155|Gout Suppressants|gout suppressants|mesh-ancestor
25486634|NCT00181155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25486635|NCT00181155|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25486636|NCT00181155|Antioxidants|antioxidants|mesh-ancestor
25486637|NCT00181155|Protective Agents|protective agents|mesh-ancestor
25486638|NCT00181155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486639|NCT00181714|Methylphenidate|methylphenidate|mesh-list
25486640|NCT00181714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25486641|NCT00181714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486642|NCT00181714|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25486643|NCT00181714|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25486644|NCT00181714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25486645|NCT00181714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486646|NCT00181714|Dopamine Agents|dopamine agents|mesh-ancestor
25486647|NCT00181714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25486648|NCT00181766|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25486649|NCT00181766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25486650|NCT00181766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25486651|NCT00181766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25486652|NCT00181766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486653|NCT00181766|Adrenergic Agents|adrenergic agents|mesh-ancestor
25486654|NCT00181766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25486655|NCT00181766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486656|NCT00181844|Lamotrigine|lamotrigine|mesh-list
25486657|NCT00181844|Anticonvulsants|anticonvulsants|mesh-ancestor
25486658|NCT00181844|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25486659|NCT00181844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25486660|NCT00181844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011324|NCT00369317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110250|NCT05464745|Perindopril|perindopril|mesh-list
25110251|NCT05464745|Indapamide|indapamide|mesh-list
25110252|NCT05464745|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25110253|NCT05464745|Protease Inhibitors|protease inhibitors|mesh-ancestor
25110254|NCT05464745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25110255|NCT05464745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110256|NCT05464745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25110257|NCT05464745|Diuretics|diuretics|mesh-ancestor
25110258|NCT05464745|Natriuretic Agents|natriuretic agents|mesh-ancestor
24572575|NCT00815568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25011345|NCT05216237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011413|NCT05214872|Natriuretic Agents|natriuretic agents|mesh-ancestor
25011414|NCT05214820|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25011580|NCT04703036|Antidotes|antidotes|mesh-ancestor
25011581|NCT04703036|Glycine Agents|glycine agents|mesh-ancestor
25823137|NCT00004758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645091|NCT01443546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25645092|NCT01443546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645093|NCT01443858|Meclizine|meclizine|mesh-list
25645094|NCT01443858|Nicotine|nicotine|mesh-list
25645095|NCT01443858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25645096|NCT01443858|Autonomic Agents|autonomic agents|mesh-ancestor
25645097|NCT01443858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25645098|NCT01443858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645099|NCT01443858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25645100|NCT01443858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25645101|NCT01443858|Cholinergic Agents|cholinergic agents|mesh-ancestor
25486695|NCT00182091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015357|NCT02527200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645102|NCT01443858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25015359|NCT02527200|Hormones|hormones|mesh-ancestor
25486697|NCT00182689|Sorafenib|sorafenib|mesh-list
25486698|NCT00182689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486699|NCT00182689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25486700|NCT00182689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25486701|NCT00182689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486702|NCT00182754|Octreotide|octreotide|mesh-list
25486703|NCT00182754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25486704|NCT00182754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25486705|NCT00182754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486706|NCT00182767|Doxorubicin|doxorubicin|mesh-list
25486707|NCT00182767|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25486708|NCT00182767|Epothilone B|epothilone b|mesh-list
25486709|NCT00182767|Epothilones|epothilones|mesh-list
25486710|NCT00182767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25486711|NCT00182767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486712|NCT00182767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25486713|NCT00182767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25486714|NCT00182767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25486715|NCT00182767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486716|NCT00182767|Tubulin Modulators|tubulin modulators|mesh-ancestor
25486717|NCT00182767|Antimitotic Agents|antimitotic agents|mesh-ancestor
25486718|NCT00182767|Mitosis Modulators|mitosis modulators|mesh-ancestor
25486719|NCT00182793|Cyclophosphamide|cyclophosphamide|mesh-list
25486720|NCT00182793|Melphalan|melphalan|mesh-list
25486721|NCT00182793|Thiotepa|thiotepa|mesh-list
25486722|NCT00182793|Carboplatin|carboplatin|mesh-list
25486723|NCT00182793|Trastuzumab|trastuzumab|mesh-list
25486724|NCT00182793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25486725|NCT00182793|Immunologic Factors|immunologic factors|mesh-ancestor
25486726|NCT00182793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486727|NCT00182793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25486728|NCT00182793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25486729|NCT00182793|Alkylating Agents|alkylating agents|mesh-ancestor
25486730|NCT00182793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486731|NCT00182793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486732|NCT00182793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25486733|NCT00182793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25486734|NCT00183092|Quinacrine|quinacrine|mesh-list
25486735|NCT00183092|Anticestodal Agents|anticestodal agents|mesh-ancestor
25486736|NCT00183092|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25486737|NCT00183092|Anthelmintics|anthelmintics|mesh-ancestor
25486738|NCT00183092|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25486739|NCT00183092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25486740|NCT00183092|Antimalarials|antimalarials|mesh-ancestor
25486741|NCT00183092|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25486742|NCT00183092|Antinematodal Agents|antinematodal agents|mesh-ancestor
25486743|NCT00183092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486744|NCT00183092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25486745|NCT00183092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486746|NCT00183196|Naltrexone|naltrexone|mesh-list
25486747|NCT00183196|Gabapentin|gabapentin|mesh-list
25486748|NCT00183196|Analgesics|analgesics|mesh-ancestor
25486749|NCT00183196|Sensory System Agents|sensory system agents|mesh-ancestor
25486750|NCT00183196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25486751|NCT00183196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486752|NCT00183196|Anticonvulsants|anticonvulsants|mesh-ancestor
25486753|NCT00183196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25486754|NCT00183196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25486755|NCT00183196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25645103|NCT01443858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645104|NCT01443858|Antiemetics|antiemetics|mesh-ancestor
25645105|NCT01443858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25645106|NCT01443858|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25645107|NCT01443858|Histamine Antagonists|histamine antagonists|mesh-ancestor
25486756|NCT00183196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25486757|NCT00183196|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25486758|NCT00183196|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25486759|NCT00183196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25486760|NCT00183196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486761|NCT00183196|Antimanic Agents|antimanic agents|mesh-ancestor
25486762|NCT00183196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25486763|NCT00183196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25486764|NCT00183248|Mycophenolic Acid|mycophenolic acid|mesh-list
25019567|NCT03690414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25019568|NCT03690414|Respiratory System Agents|respiratory system agents|mesh-ancestor
25019569|NCT03690414|Mydriatics|mydriatics|mesh-ancestor
25019593|NCT03690167|Mitogens|mitogens|mesh-list
24974837|NCT05241535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24974838|NCT05241535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24974839|NCT05241535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25486765|NCT00183248|Sirolimus|sirolimus|mesh-list
25486766|NCT00183248|Alemtuzumab|alemtuzumab|mesh-list
25486767|NCT00183248|Tacrolimus|tacrolimus|mesh-list
25486768|NCT00183248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25486769|NCT00183248|Immunologic Factors|immunologic factors|mesh-ancestor
25486770|NCT00183248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486771|NCT00183248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25486772|NCT00183248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25486773|NCT00183248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486774|NCT00183248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25486775|NCT00183248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486776|NCT00183248|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25486777|NCT00183248|Antitubercular Agents|antitubercular agents|mesh-ancestor
25486778|NCT00183248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25486779|NCT00183248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25486780|NCT00183248|Antifungal Agents|antifungal agents|mesh-ancestor
25486781|NCT00183248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25486782|NCT00183274|Norepinephrine|norepinephrine|mesh-list
25486783|NCT00183274|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25486784|NCT00183274|Serotonin|serotonin|mesh-list
25486785|NCT00183274|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
25486786|NCT00183274|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25486787|NCT00183274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25486788|NCT00183274|Adrenergic Agents|adrenergic agents|mesh-ancestor
25486789|NCT00183274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25486790|NCT00183274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486791|NCT00183274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486792|NCT00183274|Sympathomimetics|sympathomimetics|mesh-ancestor
25486793|NCT00183274|Autonomic Agents|autonomic agents|mesh-ancestor
25486794|NCT00183274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25486795|NCT00183274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25486796|NCT00183274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25486797|NCT00183274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25486798|NCT00183274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25486799|NCT00183274|Antidepressive Agents|antidepressive agents|mesh-ancestor
25486800|NCT00183274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25486801|NCT00183274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25486802|NCT00183274|Serotonin Agents|serotonin agents|mesh-ancestor
25486803|NCT00183339|Fluoxetine|fluoxetine|mesh-list
25486804|NCT00183339|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25486805|NCT00183339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25486806|NCT00183339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25486807|NCT00183339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486808|NCT00183339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25486809|NCT00183339|Serotonin Agents|serotonin agents|mesh-ancestor
25486810|NCT00183339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486811|NCT00183339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25486812|NCT00183339|Antidepressive Agents|antidepressive agents|mesh-ancestor
25486813|NCT00183339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25486814|NCT00183339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25486815|NCT00183339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25486816|NCT00183339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645108|NCT01443858|Histamine Agents|histamine agents|mesh-ancestor
25645109|NCT01443858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25645110|NCT01444300|4-Aminopyridine|4-aminopyridine|mesh-list
25486817|NCT00183391|Methylphenidate|methylphenidate|mesh-list
25486818|NCT00183391|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25486819|NCT00183391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25486820|NCT00183391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486821|NCT00183391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25486822|NCT00183391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25486823|NCT00183391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25486824|NCT00183391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486825|NCT00183391|Dopamine Agents|dopamine agents|mesh-ancestor
25486826|NCT00183391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25486827|NCT00183391|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25486828|NCT00183391|Adrenergic Agents|adrenergic agents|mesh-ancestor
25486830|NCT00183430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25018775|NCT03697057|Anesthetics|anesthetics|mesh-list
25111224|NCT05031026|Analgesics|analgesics|mesh-ancestor
25018776|NCT03697057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25019032|NCT03694119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019033|NCT03694119|Antidepressive Agents|antidepressive agents|mesh-ancestor
25019034|NCT03694119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25019035|NCT03694119|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25019036|NCT03694119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25019037|NCT03694119|Sympathomimetics|sympathomimetics|mesh-ancestor
25486831|NCT00183430|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25486832|NCT00183430|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25486833|NCT00183430|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25486834|NCT00183430|Adrenergic Agents|adrenergic agents|mesh-ancestor
25486835|NCT00183430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25486836|NCT00183430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486837|NCT00183430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486838|NCT00183443|Valproic Acid|valproic acid|mesh-list
25486839|NCT00183443|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25486840|NCT00183443|Antidepressive Agents|antidepressive agents|mesh-ancestor
25486841|NCT00183443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25486842|NCT00183443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25486843|NCT00183443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25486844|NCT00183443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25486845|NCT00183443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486846|NCT00183443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25486847|NCT00183443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486848|NCT00183443|Antimanic Agents|antimanic agents|mesh-ancestor
25486849|NCT00183443|Anticonvulsants|anticonvulsants|mesh-ancestor
25486850|NCT00183443|GABA Agents|gaba agents|mesh-ancestor
25486851|NCT00183443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25486852|NCT00183469|Lamotrigine|lamotrigine|mesh-list
25486853|NCT00183469|Valproic Acid|valproic acid|mesh-list
25486854|NCT00183469|Anticonvulsants|anticonvulsants|mesh-ancestor
25486855|NCT00183469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25486856|NCT00183469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25486857|NCT00183469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486858|NCT00183469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25486859|NCT00183469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486860|NCT00183469|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25486861|NCT00183469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25486862|NCT00183469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25486863|NCT00183469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25486864|NCT00183469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25486865|NCT00183469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25486866|NCT00183469|GABA Agents|gaba agents|mesh-ancestor
25486867|NCT00183469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25486868|NCT00183469|Antimanic Agents|antimanic agents|mesh-ancestor
25486870|NCT00183625|Risperidone|risperidone|mesh-list
25486871|NCT00183625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25486872|NCT00183625|Serotonin Agents|serotonin agents|mesh-ancestor
25486873|NCT00183625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25486874|NCT00183625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486875|NCT00183625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486876|NCT00183625|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25486877|NCT00183625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25486878|NCT00183625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25486879|NCT00183625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25486880|NCT00183625|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25486881|NCT00183625|Dopamine Agents|dopamine agents|mesh-ancestor
25645111|NCT01444300|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25823138|NCT00004758|GABA Agents|gaba agents|mesh-ancestor
25823139|NCT00004758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25645112|NCT01444300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25486882|NCT00183625|Antiemetics|antiemetics|mesh-ancestor
25486883|NCT00183625|Autonomic Agents|autonomic agents|mesh-ancestor
25486884|NCT00183625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25486885|NCT00183625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25486886|NCT00183625|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25486887|NCT00183625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25486888|NCT00183625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25486890|NCT00183677|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25486891|NCT00183677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25486892|NCT00183677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25486893|NCT00183677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486894|NCT00183677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25486895|NCT00183677|Serotonin Agents|serotonin agents|mesh-ancestor
25486896|NCT00183677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486897|NCT00183677|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25486898|NCT00183677|Antidepressive Agents|antidepressive agents|mesh-ancestor
25486899|NCT00183677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25486900|NCT00183729|Memantine|memantine|mesh-list
25486901|NCT00183729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25486902|NCT00183729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25486903|NCT00183729|Dopamine Agents|dopamine agents|mesh-ancestor
25486904|NCT00183729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25486905|NCT00183729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486906|NCT00183729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486907|NCT00183729|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25486908|NCT00183729|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25486909|NCT00183794|Gemcitabine|gemcitabine|mesh-list
25486910|NCT00183794|Docetaxel|docetaxel|mesh-list
25486911|NCT00183794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25486912|NCT00183794|Antimetabolites|antimetabolites|mesh-ancestor
25486913|NCT00183794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486914|NCT00183794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486915|NCT00183794|Antiviral Agents|antiviral agents|mesh-ancestor
25486916|NCT00183794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25486917|NCT00183794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25486918|NCT00183794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25486919|NCT00183794|Immunologic Factors|immunologic factors|mesh-ancestor
25486920|NCT00183794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486921|NCT00183794|Tubulin Modulators|tubulin modulators|mesh-ancestor
25486922|NCT00183794|Antimitotic Agents|antimitotic agents|mesh-ancestor
25486923|NCT00183794|Mitosis Modulators|mitosis modulators|mesh-ancestor
25486924|NCT00183872|Docetaxel|docetaxel|mesh-list
25486925|NCT00183872|Irinotecan|irinotecan|mesh-list
25486926|NCT00183872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486927|NCT00183872|Tubulin Modulators|tubulin modulators|mesh-ancestor
25486928|NCT00183872|Antimitotic Agents|antimitotic agents|mesh-ancestor
25486929|NCT00183872|Mitosis Modulators|mitosis modulators|mesh-ancestor
25486930|NCT00183872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486931|NCT00183872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25486932|NCT00183872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25486933|NCT00183872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25486934|NCT00184002|Prednisone|prednisone|mesh-list
25486935|NCT00184002|Cyclophosphamide|cyclophosphamide|mesh-list
25486936|NCT00184002|Doxorubicin|doxorubicin|mesh-list
25486937|NCT00184002|Vincristine|vincristine|mesh-list
25486938|NCT00184002|Rituximab|rituximab|mesh-list
25486939|NCT00184002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25486940|NCT00184002|Immunologic Factors|immunologic factors|mesh-ancestor
25486941|NCT00184002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486942|NCT00184002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25486943|NCT00184002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25486944|NCT00184002|Alkylating Agents|alkylating agents|mesh-ancestor
25486945|NCT00184002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486946|NCT00184002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486947|NCT00184002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25486948|NCT00184002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25486949|NCT00184002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25486950|NCT00184002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25645113|NCT01444300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645114|NCT01444430|Budesonide|budesonide|mesh-list
25486951|NCT00184002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25486952|NCT00184002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25486953|NCT00184002|Glucocorticoids|glucocorticoids|mesh-ancestor
25486954|NCT00184002|Hormones|hormones|mesh-ancestor
25486955|NCT00184002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25486956|NCT00184002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25486957|NCT00184002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25486958|NCT00184002|Tubulin Modulators|tubulin modulators|mesh-ancestor
25486959|NCT00184002|Antimitotic Agents|antimitotic agents|mesh-ancestor
25486960|NCT00184002|Mitosis Modulators|mitosis modulators|mesh-ancestor
25486961|NCT00184002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25486962|NCT00184028|Oxaliplatin|oxaliplatin|mesh-list
25486963|NCT00184028|Docetaxel|docetaxel|mesh-list
25486964|NCT00184028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486965|NCT00184028|Tubulin Modulators|tubulin modulators|mesh-ancestor
25486966|NCT00184028|Antimitotic Agents|antimitotic agents|mesh-ancestor
25486967|NCT00184028|Mitosis Modulators|mitosis modulators|mesh-ancestor
25486968|NCT00184028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486969|NCT00184054|Ascorbic Acid|ascorbic acid|mesh-list
25486970|NCT00184054|Arsenic Trioxide|arsenic trioxide|mesh-list
25486971|NCT00184054|Vitamins|vitamins|mesh-ancestor
25486972|NCT00184054|Micronutrients|micronutrients|mesh-ancestor
25486973|NCT00184054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486974|NCT00184054|Antioxidants|antioxidants|mesh-ancestor
25486975|NCT00184054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486976|NCT00184054|Protective Agents|protective agents|mesh-ancestor
25486977|NCT00184054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486978|NCT00184093|Gemcitabine|gemcitabine|mesh-list
25486979|NCT00184093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25486980|NCT00184093|Antimetabolites|antimetabolites|mesh-ancestor
25486981|NCT00184093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25486982|NCT00184093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25486983|NCT00184093|Antiviral Agents|antiviral agents|mesh-ancestor
25486984|NCT00184093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25486985|NCT00184093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25486986|NCT00184093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25486987|NCT00184093|Immunologic Factors|immunologic factors|mesh-ancestor
25486988|NCT00184093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486989|NCT00184600|Insulin|insulin|mesh-list
25486990|NCT00184600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25486991|NCT00184600|Insulin Aspart|insulin aspart|mesh-list
25486992|NCT00184600|Insulin, Long-Acting|insulin, long-acting|mesh-list
25486993|NCT00184600|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25486994|NCT00184600|Insulin Detemir|insulin detemir|mesh-list
25486995|NCT00184600|Biphasic Insulins|biphasic insulins|mesh-list
25486996|NCT00184600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25486997|NCT00184600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25486998|NCT00185211|Interferons|interferons|mesh-list
25486999|NCT00185211|Interferon-beta|interferon-beta|mesh-list
25487000|NCT00185211|Interferon beta-1b|interferon beta-1b|mesh-list
25487001|NCT00185211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487002|NCT00185211|Antiviral Agents|antiviral agents|mesh-ancestor
25487003|NCT00185211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25487004|NCT00185211|Immunologic Factors|immunologic factors|mesh-ancestor
25487005|NCT00185211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487006|NCT00185211|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25487007|NCT00185380|Levonorgestrel|levonorgestrel|mesh-list
25487008|NCT00185380|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25487009|NCT00185380|Contraceptive Agents|contraceptive agents|mesh-ancestor
25487010|NCT00185380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25487011|NCT00185380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487012|NCT00185380|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25487013|NCT00185380|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25487014|NCT00185380|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25487015|NCT00185588|Gemcitabine|gemcitabine|mesh-list
25487016|NCT00185588|Vatalanib|vatalanib|mesh-list
25487017|NCT00185588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25487018|NCT00185588|Antimetabolites|antimetabolites|mesh-ancestor
25487019|NCT00185588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487020|NCT00185588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487021|NCT00185588|Antiviral Agents|antiviral agents|mesh-ancestor
25487022|NCT00185588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25487023|NCT00185588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487024|NCT00185588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25487025|NCT00185588|Immunologic Factors|immunologic factors|mesh-ancestor
25656815|NCT01579305|Sensory System Agents|sensory system agents|mesh-ancestor
25487026|NCT00185588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487027|NCT00185588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25487029|NCT00185614|Mycophenolic Acid|mycophenolic acid|mesh-list
25487030|NCT00185614|Cyclophosphamide|cyclophosphamide|mesh-list
25487031|NCT00185614|Melphalan|melphalan|mesh-list
25487032|NCT00185614|Cyclosporins|cyclosporins|mesh-list
25487033|NCT00185614|Lenograstim|lenograstim|mesh-list
25487034|NCT00185614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25487035|NCT00185614|Immunologic Factors|immunologic factors|mesh-ancestor
25487036|NCT00185614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487037|NCT00185614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25487038|NCT00185614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25487039|NCT00185614|Alkylating Agents|alkylating agents|mesh-ancestor
25487040|NCT00185614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487041|NCT00185614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487042|NCT00185614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25487043|NCT00185614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25019864|NCT03687021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25019865|NCT03687021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019866|NCT03686878|Lifitegrast|lifitegrast|mesh-list
25019867|NCT03686878|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25019868|NCT03686878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25019912|NCT03686657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019913|NCT03686657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25019923|NCT03686267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25019924|NCT03686267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25019925|NCT03686267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487044|NCT00185614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487045|NCT00185614|Antifungal Agents|antifungal agents|mesh-ancestor
25487046|NCT00185614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25487047|NCT00185614|Dermatologic Agents|dermatologic agents|mesh-ancestor
25487048|NCT00185614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25487049|NCT00185614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25487050|NCT00185614|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25487051|NCT00185614|Antitubercular Agents|antitubercular agents|mesh-ancestor
25487052|NCT00185614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25487053|NCT00185640|Cyclosporine|cyclosporine|mesh-list
25487054|NCT00185640|Mycophenolic Acid|mycophenolic acid|mesh-list
25487055|NCT00185640|Lenograstim|lenograstim|mesh-list
25487056|NCT00185640|Cyclosporins|cyclosporins|mesh-list
25487057|NCT00185640|Thymoglobulin|thymoglobulin|mesh-list
25487058|NCT00185640|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25487059|NCT00185640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25487060|NCT00185640|Immunologic Factors|immunologic factors|mesh-ancestor
25487061|NCT00185640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487062|NCT00185640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487063|NCT00185640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487064|NCT00185640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25487065|NCT00185640|Antifungal Agents|antifungal agents|mesh-ancestor
25487066|NCT00185640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25487067|NCT00185640|Dermatologic Agents|dermatologic agents|mesh-ancestor
25487068|NCT00185640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25487069|NCT00185640|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25487070|NCT00185640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25487071|NCT00185640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487072|NCT00185640|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25487073|NCT00185640|Antitubercular Agents|antitubercular agents|mesh-ancestor
25487074|NCT00185640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25487075|NCT00185692|Acetaminophen|acetaminophen|mesh-list
25487076|NCT00185692|Cyclosporine|cyclosporine|mesh-list
25487077|NCT00185692|Mycophenolic Acid|mycophenolic acid|mesh-list
25487078|NCT00185692|Methylprednisolone|methylprednisolone|mesh-list
25487079|NCT00185692|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25487080|NCT00185692|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25487081|NCT00185692|Prednisolone|prednisolone|mesh-list
25487082|NCT00185692|Prednisolone acetate|prednisolone acetate|mesh-list
25487083|NCT00185692|Hydrocortisone|hydrocortisone|mesh-list
25487084|NCT00185692|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25487085|NCT00185692|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25487086|NCT00185692|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25487087|NCT00185692|Cyclosporins|cyclosporins|mesh-list
25487088|NCT00185692|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25487089|NCT00185692|Lenograstim|lenograstim|mesh-list
25487090|NCT00185692|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25487091|NCT00185692|Prednisolone phosphate|prednisolone phosphate|mesh-list
25645115|NCT01444430|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25487092|NCT00185692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645116|NCT01444430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25487093|NCT00185692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487094|NCT00185692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25487095|NCT00185692|Immunologic Factors|immunologic factors|mesh-ancestor
25487096|NCT00185692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487097|NCT00185692|Antifungal Agents|antifungal agents|mesh-ancestor
25487098|NCT00185692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25487099|NCT00185692|Dermatologic Agents|dermatologic agents|mesh-ancestor
25487100|NCT00185692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25487101|NCT00185692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25487102|NCT00185692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25487103|NCT00185692|Analgesics|analgesics|mesh-ancestor
25487104|NCT00185692|Sensory System Agents|sensory system agents|mesh-ancestor
25487105|NCT00185692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25487106|NCT00185692|Antipyretics|antipyretics|mesh-ancestor
25487107|NCT00185692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25487108|NCT00185692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487109|NCT00185692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25487110|NCT00185692|Antitubercular Agents|antitubercular agents|mesh-ancestor
25487111|NCT00185692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25487112|NCT00185692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25487113|NCT00185692|Antiemetics|antiemetics|mesh-ancestor
25487114|NCT00185692|Autonomic Agents|autonomic agents|mesh-ancestor
25020138|NCT03683108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25020139|NCT03683108|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25020141|NCT03683043|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25020142|NCT03683043|Fertility Agents|fertility agents|mesh-ancestor
25020143|NCT03683043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25020144|NCT03683043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020145|NCT03683043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25021471|NCT03671174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487115|NCT00185692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25487116|NCT00185692|Glucocorticoids|glucocorticoids|mesh-ancestor
25487118|NCT00185692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25487119|NCT00185692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25487120|NCT00185692|Protective Agents|protective agents|mesh-ancestor
25487121|NCT00185692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25487122|NCT00185692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25487123|NCT00185731|Atorvastatin|atorvastatin|mesh-list
25487124|NCT00185731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25487125|NCT00185731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25487126|NCT00185731|Antimetabolites|antimetabolites|mesh-ancestor
25487127|NCT00185731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487128|NCT00185731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25487129|NCT00185731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25487130|NCT00185731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487131|NCT00185900|Magnesium Sulfate|magnesium sulfate|mesh-list
25487132|NCT00185900|Nifedipine|nifedipine|mesh-list
25487133|NCT00185900|Analgesics|analgesics|mesh-ancestor
25487134|NCT00185900|Sensory System Agents|sensory system agents|mesh-ancestor
25487135|NCT00185900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25487136|NCT00185900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487137|NCT00185900|Anesthetics|anesthetics|mesh-ancestor
25487138|NCT00185900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25487139|NCT00185900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25487140|NCT00185900|Anticonvulsants|anticonvulsants|mesh-ancestor
25487141|NCT00185900|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25487142|NCT00185900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25487143|NCT00185900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487144|NCT00185900|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25487145|NCT00185900|Tocolytic Agents|tocolytic agents|mesh-ancestor
25487146|NCT00185900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25487147|NCT00185900|Vasodilator Agents|vasodilator agents|mesh-ancestor
25487148|NCT00186017|Olanzapine|olanzapine|mesh-list
25487149|NCT00186017|Antiemetics|antiemetics|mesh-ancestor
25487150|NCT00186017|Autonomic Agents|autonomic agents|mesh-ancestor
25487151|NCT00186017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25487152|NCT00186017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487153|NCT00186017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25487154|NCT00186017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25487155|NCT00186017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25487156|NCT00186017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25645117|NCT01444430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25487157|NCT00186017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25487158|NCT00186017|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25487159|NCT00186017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25487160|NCT00186017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25487161|NCT00186017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487162|NCT00186017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25487163|NCT00186017|Serotonin Agents|serotonin agents|mesh-ancestor
25487164|NCT00186043|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25487165|NCT00186043|Antidepressive Agents|antidepressive agents|mesh-ancestor
25487166|NCT00186043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25487167|NCT00186043|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25487168|NCT00186043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25487169|NCT00186043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25487170|NCT00186043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487171|NCT00186056|Mifepristone|mifepristone|mesh-list
25487172|NCT00186056|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25487173|NCT00186056|Abortifacient Agents|abortifacient agents|mesh-ancestor
25487174|NCT00186056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25487175|NCT00186056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487176|NCT00186056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25487177|NCT00186056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25487178|NCT00186056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25487179|NCT00186056|Contraceptive Agents|contraceptive agents|mesh-ancestor
25487180|NCT00186056|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25021950|NCT03666884|Cyclosporins|cyclosporins|mesh-list
25021951|NCT03666884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25021952|NCT03666884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25021953|NCT03666884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021954|NCT03666884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25021955|NCT03666884|Immunologic Factors|immunologic factors|mesh-ancestor
25020034|NCT03684772|Digoxin|digoxin|mesh-list
25487181|NCT00186056|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25487182|NCT00186056|Hormone Antagonists|hormone antagonists|mesh-ancestor
25487183|NCT00186056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25487184|NCT00186056|Luteolytic Agents|luteolytic agents|mesh-ancestor
25487185|NCT00186056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25487186|NCT00186056|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25487187|NCT00186069|Magnesium Sulfate|magnesium sulfate|mesh-list
25487188|NCT00186069|Analgesics|analgesics|mesh-ancestor
25487189|NCT00186069|Sensory System Agents|sensory system agents|mesh-ancestor
25487190|NCT00186069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25487191|NCT00186069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487192|NCT00186069|Anesthetics|anesthetics|mesh-ancestor
25487193|NCT00186069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25487194|NCT00186069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25487195|NCT00186069|Anticonvulsants|anticonvulsants|mesh-ancestor
25487196|NCT00186069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25487197|NCT00186069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25487198|NCT00186069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487199|NCT00186069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25487200|NCT00186069|Tocolytic Agents|tocolytic agents|mesh-ancestor
25487201|NCT00186069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25487202|NCT00186121|Anastrozole|anastrozole|mesh-list
25487203|NCT00186121|Goserelin|goserelin|mesh-list
25487204|NCT00186121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25487205|NCT00186121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487206|NCT00186121|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25487207|NCT00186121|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25487208|NCT00186121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487209|NCT00186121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487210|NCT00186121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25487211|NCT00186121|Hormone Antagonists|hormone antagonists|mesh-ancestor
25487212|NCT00186121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25487213|NCT00186121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487214|NCT00186186|Valproic Acid|valproic acid|mesh-list
25487215|NCT00186186|Anticonvulsants|anticonvulsants|mesh-ancestor
25487216|NCT00186186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487217|NCT00186186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487218|NCT00186186|GABA Agents|gaba agents|mesh-ancestor
25487219|NCT00186186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24915913|NCT04246723|Ritonavir|ritonavir|mesh-list
25645118|NCT01444430|Autonomic Agents|autonomic agents|mesh-ancestor
25645119|NCT01444430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25645120|NCT01444430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645121|NCT01444430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25487220|NCT00186186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487221|NCT00186186|Antimanic Agents|antimanic agents|mesh-ancestor
25487222|NCT00186186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25487223|NCT00186186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25487224|NCT00186186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25487225|NCT00186446|Bupropion|bupropion|mesh-list
25487226|NCT00186446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25487227|NCT00186446|Antidepressive Agents|antidepressive agents|mesh-ancestor
25487228|NCT00186446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25487229|NCT00186446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25487230|NCT00186446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25487231|NCT00186446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25487232|NCT00186446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487233|NCT00186446|Dopamine Agents|dopamine agents|mesh-ancestor
25487234|NCT00186446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25487235|NCT00186446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487236|NCT00186446|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25487237|NCT00186446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25487238|NCT00186446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487239|NCT00186498|Memantine|memantine|mesh-list
25487240|NCT00186498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25487241|NCT00186498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25487242|NCT00186498|Dopamine Agents|dopamine agents|mesh-ancestor
25487243|NCT00186498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25487244|NCT00186498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487245|NCT00186498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487246|NCT00186498|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25487247|NCT00186498|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25487248|NCT00186537|Rosiglitazone|rosiglitazone|mesh-list
25487249|NCT00186537|Fenofibrate|fenofibrate|mesh-list
25023400|NCT03655457|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
25023401|NCT03655457|Respiratory System Agents|respiratory system agents|mesh-ancestor
25023402|NCT03655392|Nitric Oxide|nitric oxide|mesh-list
25487250|NCT00186537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25487251|NCT00186537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487252|NCT00186537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25487253|NCT00186537|Antimetabolites|antimetabolites|mesh-ancestor
25487254|NCT00186537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487255|NCT00186537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25487256|NCT00186628|Acetaminophen|acetaminophen|mesh-list
25487257|NCT00186628|Diphenhydramine|diphenhydramine|mesh-list
25487258|NCT00186628|Promethazine|promethazine|mesh-list
25487259|NCT00186628|Cyclosporine|cyclosporine|mesh-list
25487260|NCT00186628|Hydrocortisone|hydrocortisone|mesh-list
25487261|NCT00186628|Methylprednisolone|methylprednisolone|mesh-list
25487262|NCT00186628|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25487263|NCT00186628|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25487264|NCT00186628|Prednisolone|prednisolone|mesh-list
25487265|NCT00186628|Prednisolone acetate|prednisolone acetate|mesh-list
25487266|NCT00186628|Rituximab|rituximab|mesh-list
25487267|NCT00186628|Granisetron|granisetron|mesh-list
25487268|NCT00186628|Lenograstim|lenograstim|mesh-list
25487269|NCT00186628|Cyclosporins|cyclosporins|mesh-list
25487270|NCT00186628|Thymoglobulin|thymoglobulin|mesh-list
25487271|NCT00186628|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25487272|NCT00186628|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25487273|NCT00186628|Prednisolone phosphate|prednisolone phosphate|mesh-list
25487274|NCT00186628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25487275|NCT00186628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487276|NCT00186628|Immunologic Factors|immunologic factors|mesh-ancestor
25487277|NCT00186628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487278|NCT00186628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25487279|NCT00186628|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25487280|NCT00186628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487281|NCT00186628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487282|NCT00186628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25487283|NCT00186628|Antifungal Agents|antifungal agents|mesh-ancestor
25487284|NCT00186628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25487285|NCT00186628|Dermatologic Agents|dermatologic agents|mesh-ancestor
25487286|NCT00186628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25487287|NCT00186628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25487288|NCT00186628|Analgesics|analgesics|mesh-ancestor
25487289|NCT00186628|Sensory System Agents|sensory system agents|mesh-ancestor
25487290|NCT00186628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25487291|NCT00186628|Antipyretics|antipyretics|mesh-ancestor
25487292|NCT00186628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25487293|NCT00186628|Antiemetics|antiemetics|mesh-ancestor
25487294|NCT00186628|Autonomic Agents|autonomic agents|mesh-ancestor
25487295|NCT00186628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25487296|NCT00186628|Glucocorticoids|glucocorticoids|mesh-ancestor
25487297|NCT00186628|Hormones|hormones|mesh-ancestor
25487298|NCT00186628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25487299|NCT00186628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25487300|NCT00186628|Protective Agents|protective agents|mesh-ancestor
25487301|NCT00186628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25487302|NCT00186628|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25487303|NCT00186628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25487304|NCT00186628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25487305|NCT00186628|Anesthetics, Local|anesthetics, local|mesh-ancestor
25487306|NCT00186628|Anesthetics|anesthetics|mesh-ancestor
25487307|NCT00186628|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25487308|NCT00186628|Histamine Antagonists|histamine antagonists|mesh-ancestor
25487309|NCT00186628|Histamine Agents|histamine agents|mesh-ancestor
25487310|NCT00186628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25487311|NCT00186628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25487312|NCT00186628|Antipruritics|antipruritics|mesh-ancestor
25487313|NCT00186628|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25487314|NCT00186628|Serotonin Agents|serotonin agents|mesh-ancestor
25487315|NCT00186875|Cytarabine|cytarabine|mesh-list
25487316|NCT00186875|Dexamethasone|dexamethasone|mesh-list
25487317|NCT00186875|Dexamethasone acetate|dexamethasone acetate|mesh-list
25487318|NCT00186875|Cyclophosphamide|cyclophosphamide|mesh-list
25487319|NCT00186875|Methotrexate|methotrexate|mesh-list
25487320|NCT00186875|Etoposide|etoposide|mesh-list
25487321|NCT00186875|Etoposide phosphate|etoposide phosphate|mesh-list
25487322|NCT00186875|Vincristine|vincristine|mesh-list
25487323|NCT00186875|Asparaginase|asparaginase|mesh-list
25487324|NCT00186875|Mitoxantrone|mitoxantrone|mesh-list
25025417|NCT03637400|Renal Agents|renal agents|mesh-ancestor
25487325|NCT00186875|Mercaptopurine|mercaptopurine|mesh-list
25487326|NCT00186875|Vinblastine|vinblastine|mesh-list
25487327|NCT00186875|Pegaspargase|pegaspargase|mesh-list
25487328|NCT00186875|Teniposide|teniposide|mesh-list
25487329|NCT00186875|BB 1101|bb 1101|mesh-list
25487330|NCT00186875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25487331|NCT00186875|Immunologic Factors|immunologic factors|mesh-ancestor
25487332|NCT00186875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487333|NCT00186875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25487334|NCT00186875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25487335|NCT00186875|Alkylating Agents|alkylating agents|mesh-ancestor
25487336|NCT00186875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487337|NCT00186875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487338|NCT00186875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25487339|NCT00186875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25487340|NCT00186875|Antiemetics|antiemetics|mesh-ancestor
25487341|NCT00186875|Autonomic Agents|autonomic agents|mesh-ancestor
25487342|NCT00186875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25487343|NCT00186875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25487344|NCT00186875|Glucocorticoids|glucocorticoids|mesh-ancestor
25487345|NCT00186875|Hormones|hormones|mesh-ancestor
25487346|NCT00186875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25487347|NCT00186875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25487348|NCT00186875|Protease Inhibitors|protease inhibitors|mesh-ancestor
25487349|NCT00186875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487350|NCT00186875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25487351|NCT00186875|Abortifacient Agents|abortifacient agents|mesh-ancestor
25487352|NCT00186875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25487353|NCT00186875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25487354|NCT00186875|Antimetabolites|antimetabolites|mesh-ancestor
25487355|NCT00186875|Dermatologic Agents|dermatologic agents|mesh-ancestor
25487356|NCT00186875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25487357|NCT00186875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25487358|NCT00186875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25487359|NCT00186875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25487360|NCT00186875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25487361|NCT00186875|Antiviral Agents|antiviral agents|mesh-ancestor
25487362|NCT00186875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25487363|NCT00186875|Tubulin Modulators|tubulin modulators|mesh-ancestor
25487364|NCT00186875|Antimitotic Agents|antimitotic agents|mesh-ancestor
25487365|NCT00186875|Mitosis Modulators|mitosis modulators|mesh-ancestor
25487366|NCT00186875|Analgesics|analgesics|mesh-ancestor
25487367|NCT00186875|Sensory System Agents|sensory system agents|mesh-ancestor
25645122|NCT01444430|Respiratory System Agents|respiratory system agents|mesh-ancestor
25645123|NCT01444430|Glucocorticoids|glucocorticoids|mesh-ancestor
25645124|NCT01444430|Hormones|hormones|mesh-ancestor
25645125|NCT01444430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25645126|NCT01444651|Tadalafil|tadalafil|mesh-list
25645127|NCT01444651|Vasodilator Agents|vasodilator agents|mesh-ancestor
25487368|NCT00186901|Vitamin D|vitamin d|mesh-list
25487369|NCT00186901|Calcium Carbonate|calcium carbonate|mesh-list
25487370|NCT00186901|Calcium|calcium|mesh-list
25487371|NCT00186901|Vitamins|vitamins|mesh-ancestor
25487372|NCT00186901|Micronutrients|micronutrients|mesh-ancestor
25487373|NCT00186901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487374|NCT00186901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25487375|NCT00186901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25487376|NCT00186901|Antacids|antacids|mesh-ancestor
25487377|NCT00186901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487378|NCT00186901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25487379|NCT00187096|Cyclophosphamide|cyclophosphamide|mesh-list
25487380|NCT00187096|Fludarabine|fludarabine|mesh-list
25487381|NCT00187096|Etoposide|etoposide|mesh-list
25487382|NCT00187096|Interleukin-2|interleukin-2|mesh-list
25487383|NCT00187096|Clofarabine|clofarabine|mesh-list
25487384|NCT00187096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25487385|NCT00187096|Immunologic Factors|immunologic factors|mesh-ancestor
25487386|NCT00187096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487387|NCT00187096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25487388|NCT00187096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25487389|NCT00187096|Alkylating Agents|alkylating agents|mesh-ancestor
25026138|NCT03631862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25026139|NCT03631862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25026140|NCT03631862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026141|NCT03631836|Bevacizumab|bevacizumab|mesh-list
25026142|NCT03631836|Antibodies|antibodies|mesh-list
25026143|NCT03631836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25020280|NCT03681574|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
25020281|NCT03681574|GABA Agents|gaba agents|mesh-ancestor
25020282|NCT03681574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25020283|NCT03681574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020284|NCT03681574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020285|NCT03681548|Doxorubicin|doxorubicin|mesh-list
25020286|NCT03681548|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25020287|NCT03681548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25020288|NCT03681548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823140|NCT00004758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487390|NCT00187096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487391|NCT00187096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487392|NCT00187096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25487393|NCT00187096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25487394|NCT00187096|Antimetabolites|antimetabolites|mesh-ancestor
25487395|NCT00187096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25487396|NCT00187096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25487397|NCT00187096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25487398|NCT00187096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487399|NCT00187096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25487400|NCT00187096|Analgesics|analgesics|mesh-ancestor
25487401|NCT00187096|Sensory System Agents|sensory system agents|mesh-ancestor
25487402|NCT00187096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25487403|NCT00187135|Fentanyl|fentanyl|mesh-list
25487404|NCT00187135|Propofol|propofol|mesh-list
25487405|NCT00187135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25487406|NCT00187135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25487407|NCT00187135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487408|NCT00187135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25487409|NCT00187135|Anesthetics, General|anesthetics, general|mesh-ancestor
25487410|NCT00187135|Anesthetics|anesthetics|mesh-ancestor
25487411|NCT00187135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25487412|NCT00187135|Narcotics|narcotics|mesh-ancestor
25487413|NCT00187135|Analgesics|analgesics|mesh-ancestor
25487414|NCT00187135|Sensory System Agents|sensory system agents|mesh-ancestor
25487415|NCT00187135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25487416|NCT00187135|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25487417|NCT00187486|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25487418|NCT00187486|Temozolomide|temozolomide|mesh-list
25487419|NCT00187486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487420|NCT00187486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25645128|NCT01444651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25487421|NCT00187486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487422|NCT00187486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487423|NCT00187486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25487424|NCT00187486|Alkylating Agents|alkylating agents|mesh-ancestor
25487425|NCT00187655|Cefotaxime|cefotaxime|mesh-list
25487426|NCT00187655|Cefoxitin|cefoxitin|mesh-list
25487427|NCT00187655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25487428|NCT00187655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25487429|NCT00187681|Metformin|metformin|mesh-list
25487430|NCT00187681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25487431|NCT00187681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487432|NCT00187720|Metformin|metformin|mesh-list
25487433|NCT00187720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25487434|NCT00187720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487435|NCT00187889|Eplerenone|eplerenone|mesh-list
25487436|NCT00187889|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25487437|NCT00187889|Hormone Antagonists|hormone antagonists|mesh-ancestor
25487438|NCT00187889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25487439|NCT00187889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487440|NCT00187889|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25487441|NCT00187889|Diuretics|diuretics|mesh-ancestor
25487442|NCT00187889|Natriuretic Agents|natriuretic agents|mesh-ancestor
25487443|NCT00187889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25487444|NCT00189098|Trimethoprim|trimethoprim|mesh-list
25487445|NCT00189098|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25487446|NCT00189098|Sulfamethoxazole|sulfamethoxazole|mesh-list
25487447|NCT00189098|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25487448|NCT00189098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25487449|NCT00189098|Renal Agents|renal agents|mesh-ancestor
25487450|NCT00189098|Antimalarials|antimalarials|mesh-ancestor
25487451|NCT00189098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25487452|NCT00189098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25487453|NCT00189098|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25487454|NCT00189098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487455|NCT00189098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487456|NCT00189098|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25487457|NCT00189098|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24587777|NCT00896987|Antimanic Agents|antimanic agents|mesh-ancestor
24541659|NCT00674557|Exemestane|exemestane|mesh-list
25026259|NCT03630341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983127|NCT02207504|Crizotinib|crizotinib|mesh-list
25026260|NCT03630341|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25026261|NCT03630341|Fertility Agents|fertility agents|mesh-ancestor
25026262|NCT03630341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25026330|NCT03629522|Ondansetron|ondansetron|mesh-list
25487458|NCT00189098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25487459|NCT00189098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25487461|NCT00189137|Docetaxel|docetaxel|mesh-list
25487462|NCT00189137|Doxorubicin|doxorubicin|mesh-list
25487463|NCT00189137|Ifosfamide|ifosfamide|mesh-list
25487464|NCT00189137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25487465|NCT00189137|Antimetabolites|antimetabolites|mesh-ancestor
25487466|NCT00189137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487467|NCT00189137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487468|NCT00189137|Antiviral Agents|antiviral agents|mesh-ancestor
25487469|NCT00189137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25487470|NCT00189137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487471|NCT00189137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25487472|NCT00189137|Immunologic Factors|immunologic factors|mesh-ancestor
25487473|NCT00189137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487474|NCT00189137|Tubulin Modulators|tubulin modulators|mesh-ancestor
25487475|NCT00189137|Antimitotic Agents|antimitotic agents|mesh-ancestor
25487476|NCT00189137|Mitosis Modulators|mitosis modulators|mesh-ancestor
25487477|NCT00189137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25487478|NCT00189137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25487479|NCT00189137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25487480|NCT00189137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25487481|NCT00189137|Alkylating Agents|alkylating agents|mesh-ancestor
25487482|NCT00189202|Sirolimus|sirolimus|mesh-list
25487483|NCT00189202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25487484|NCT00189202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25487485|NCT00189202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25487486|NCT00189202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487487|NCT00189202|Antifungal Agents|antifungal agents|mesh-ancestor
25487488|NCT00189202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25487489|NCT00189202|Immunologic Factors|immunologic factors|mesh-ancestor
25487490|NCT00189202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645129|NCT01444651|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25487491|NCT00189228|Omalizumab|omalizumab|mesh-list
25487492|NCT00189228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25487493|NCT00189228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25487494|NCT00189228|Respiratory System Agents|respiratory system agents|mesh-ancestor
25487495|NCT00189306|Imiquimod|imiquimod|mesh-list
25487496|NCT00189306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25487497|NCT00189306|Immunologic Factors|immunologic factors|mesh-ancestor
25487498|NCT00189306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487499|NCT00189306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487500|NCT00189306|Interferon Inducers|interferon inducers|mesh-ancestor
25487501|NCT00189436|Budesonide|budesonide|mesh-list
25487502|NCT00189436|Albuterol|albuterol|mesh-list
25487503|NCT00189436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25487504|NCT00189436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25487505|NCT00189436|Autonomic Agents|autonomic agents|mesh-ancestor
25487506|NCT00189436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25487507|NCT00189436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487508|NCT00189436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25487509|NCT00189436|Respiratory System Agents|respiratory system agents|mesh-ancestor
25487510|NCT00189436|Glucocorticoids|glucocorticoids|mesh-ancestor
25487511|NCT00189436|Hormones|hormones|mesh-ancestor
25487512|NCT00189436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25487513|NCT00189436|Tocolytic Agents|tocolytic agents|mesh-ancestor
25487514|NCT00189436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25487515|NCT00189436|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25487516|NCT00189436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25487517|NCT00189436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25487518|NCT00189436|Adrenergic Agents|adrenergic agents|mesh-ancestor
25487519|NCT00189436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25487520|NCT00189436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487521|NCT00189462|Montelukast|montelukast|mesh-list
25487522|NCT00189462|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25487523|NCT00189462|Respiratory System Agents|respiratory system agents|mesh-ancestor
25487524|NCT00189462|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25487525|NCT00189462|Hormone Antagonists|hormone antagonists|mesh-ancestor
25487526|NCT00189462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25487527|NCT00189462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487528|NCT00189462|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25487529|NCT00189462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25487530|NCT00189462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487531|NCT00189475|Montelukast|montelukast|mesh-list
24786633|NCT01921010|Vitamins|vitamins|mesh-ancestor
25487532|NCT00189475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25487533|NCT00189475|Respiratory System Agents|respiratory system agents|mesh-ancestor
25487534|NCT00189475|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25487535|NCT00189475|Hormone Antagonists|hormone antagonists|mesh-ancestor
25487536|NCT00189475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25487537|NCT00189475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487538|NCT00189475|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25487539|NCT00189475|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25487540|NCT00189475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487542|NCT00189488|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25487543|NCT00189488|Abortifacient Agents|abortifacient agents|mesh-ancestor
25487544|NCT00189488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25487545|NCT00189488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487546|NCT00189488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25487547|NCT00189488|Antimetabolites|antimetabolites|mesh-ancestor
25487548|NCT00189488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487549|NCT00189488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487550|NCT00189488|Dermatologic Agents|dermatologic agents|mesh-ancestor
25487551|NCT00189488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487552|NCT00189488|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25487553|NCT00189488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25487554|NCT00189488|Immunologic Factors|immunologic factors|mesh-ancestor
25487555|NCT00189488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25487556|NCT00189488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25487557|NCT00190671|Cyclophosphamide|cyclophosphamide|mesh-list
25487558|NCT00190671|Pemetrexed|pemetrexed|mesh-list
25487559|NCT00190671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25487560|NCT00190671|Immunologic Factors|immunologic factors|mesh-ancestor
25487561|NCT00190671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487562|NCT00190671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25487563|NCT00190671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25487564|NCT00190671|Alkylating Agents|alkylating agents|mesh-ancestor
25487565|NCT00190671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487566|NCT00190671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487567|NCT00190671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25487568|NCT00190671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487569|NCT00190671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25487570|NCT00190671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25487571|NCT00190684|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25487572|NCT00190684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25487573|NCT00190684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25487574|NCT00190684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25487575|NCT00190684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487576|NCT00190684|Adrenergic Agents|adrenergic agents|mesh-ancestor
25487577|NCT00190684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25487578|NCT00190684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487579|NCT00190749|Olanzapine|olanzapine|mesh-list
25487580|NCT00190749|Risperidone|risperidone|mesh-list
25487581|NCT00190749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25487582|NCT00190749|Serotonin Agents|serotonin agents|mesh-ancestor
25487583|NCT00190749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25487584|NCT00190749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487585|NCT00190749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487586|NCT00190749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25487587|NCT00190749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25487588|NCT00190749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25487589|NCT00190749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25487590|NCT00190749|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25487591|NCT00190749|Dopamine Agents|dopamine agents|mesh-ancestor
25487592|NCT00190749|Antiemetics|antiemetics|mesh-ancestor
25487593|NCT00190749|Autonomic Agents|autonomic agents|mesh-ancestor
25487594|NCT00190749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25487595|NCT00190749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25487596|NCT00190749|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25487597|NCT00190749|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25487598|NCT00190749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25487599|NCT00190775|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25487600|NCT00190775|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25487601|NCT00190775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25487602|NCT00190775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25487603|NCT00190775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487604|NCT00190775|Adrenergic Agents|adrenergic agents|mesh-ancestor
25487605|NCT00190775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25487606|NCT00190775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487607|NCT00190983|Pemetrexed|pemetrexed|mesh-list
25487608|NCT00190983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487609|NCT00190983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487610|NCT00190983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487611|NCT00190983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25487612|NCT00190983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25487613|NCT00191100|Gemcitabine|gemcitabine|mesh-list
25487614|NCT00191100|Cisplatin|cisplatin|mesh-list
25487615|NCT00191100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487616|NCT00191100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25487617|NCT00191100|Antimetabolites|antimetabolites|mesh-ancestor
25487618|NCT00191100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487619|NCT00191100|Antiviral Agents|antiviral agents|mesh-ancestor
25487620|NCT00191100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25487621|NCT00191100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487622|NCT00191100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25487623|NCT00191100|Immunologic Factors|immunologic factors|mesh-ancestor
25487624|NCT00191100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487625|NCT00191113|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25487626|NCT00191113|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25487627|NCT00191113|Medroxyprogesterone|medroxyprogesterone|mesh-list
25487628|NCT00191113|Estradiol|estradiol|mesh-list
25487629|NCT00191113|Hormones|hormones|mesh-ancestor
25487630|NCT00191113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25487631|NCT00191113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487632|NCT00191113|Estrogens|estrogens|mesh-ancestor
25487633|NCT00191113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25487634|NCT00191113|Contraceptive Agents|contraceptive agents|mesh-ancestor
25487635|NCT00191113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25487636|NCT00191113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25487637|NCT00191113|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25487638|NCT00191113|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25487639|NCT00191113|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25487640|NCT00191113|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25487641|NCT00191113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25487642|NCT00191113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487643|NCT00191139|Gemcitabine|gemcitabine|mesh-list
25487644|NCT00191139|Cisplatin|cisplatin|mesh-list
25487645|NCT00191139|Docetaxel|docetaxel|mesh-list
25487646|NCT00191139|Etoposide|etoposide|mesh-list
25487647|NCT00191139|Etoposide phosphate|etoposide phosphate|mesh-list
25487648|NCT00191139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487649|NCT00191139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25487650|NCT00191139|Antimetabolites|antimetabolites|mesh-ancestor
25487651|NCT00191139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487652|NCT00191139|Antiviral Agents|antiviral agents|mesh-ancestor
25487653|NCT00191139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25487654|NCT00191139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487655|NCT00191139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25487656|NCT00191139|Immunologic Factors|immunologic factors|mesh-ancestor
25487657|NCT00191139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487658|NCT00191139|Tubulin Modulators|tubulin modulators|mesh-ancestor
25487659|NCT00191139|Antimitotic Agents|antimitotic agents|mesh-ancestor
25487660|NCT00191139|Mitosis Modulators|mitosis modulators|mesh-ancestor
25487661|NCT00191139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25487662|NCT00191139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25487663|NCT00191139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25487664|NCT00191152|Gemcitabine|gemcitabine|mesh-list
25487665|NCT00191152|Capecitabine|capecitabine|mesh-list
25487666|NCT00191152|Docetaxel|docetaxel|mesh-list
25487667|NCT00191152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25487668|NCT00191152|Antimetabolites|antimetabolites|mesh-ancestor
25487669|NCT00191152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487670|NCT00191152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487671|NCT00191152|Antiviral Agents|antiviral agents|mesh-ancestor
25487672|NCT00191152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25487673|NCT00191152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487674|NCT00191152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25487675|NCT00191152|Immunologic Factors|immunologic factors|mesh-ancestor
25026998|NCT03623711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25027006|NCT03623711|Analgesics|analgesics|mesh-ancestor
25027007|NCT03623711|Sensory System Agents|sensory system agents|mesh-ancestor
25487676|NCT00191152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487677|NCT00191152|Tubulin Modulators|tubulin modulators|mesh-ancestor
25487678|NCT00191152|Antimitotic Agents|antimitotic agents|mesh-ancestor
25487679|NCT00191152|Mitosis Modulators|mitosis modulators|mesh-ancestor
25487680|NCT00191191|Pemetrexed|pemetrexed|mesh-list
25487681|NCT00191191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487682|NCT00191191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487683|NCT00191191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487684|NCT00191191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25487685|NCT00191191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25487686|NCT00191269|Gemcitabine|gemcitabine|mesh-list
25487687|NCT00191269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25487688|NCT00191269|Antimetabolites|antimetabolites|mesh-ancestor
25487689|NCT00191269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487690|NCT00191269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487691|NCT00191269|Antiviral Agents|antiviral agents|mesh-ancestor
25487692|NCT00191269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25487693|NCT00191269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487694|NCT00191269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25487695|NCT00191269|Immunologic Factors|immunologic factors|mesh-ancestor
25487696|NCT00191269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487697|NCT00191282|Insulin|insulin|mesh-list
25487698|NCT00191282|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25487699|NCT00191282|Insulin Glargine|insulin glargine|mesh-list
25487700|NCT00191282|Insulin Lispro|insulin lispro|mesh-list
25487701|NCT00191282|Isophane Insulin, Human|isophane insulin, human|mesh-list
25487702|NCT00191282|Insulin, Isophane|insulin, isophane|mesh-list
25487703|NCT00191282|Isophane insulin, beef|isophane insulin, beef|mesh-list
25487704|NCT00191282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25487705|NCT00191282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487706|NCT00191308|Cisplatin|cisplatin|mesh-list
25487707|NCT00191308|Pemetrexed|pemetrexed|mesh-list
25487708|NCT00191308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487709|NCT00191308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645130|NCT01444651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487710|NCT00191308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487711|NCT00191308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25487712|NCT00191308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25487713|NCT00191334|Gemcitabine|gemcitabine|mesh-list
25487714|NCT00191334|Cisplatin|cisplatin|mesh-list
25487715|NCT00191334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487716|NCT00191334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25487717|NCT00191334|Antimetabolites|antimetabolites|mesh-ancestor
25487718|NCT00191334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487719|NCT00191334|Antiviral Agents|antiviral agents|mesh-ancestor
25487720|NCT00191334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25487721|NCT00191334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487722|NCT00191334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25487723|NCT00191334|Immunologic Factors|immunologic factors|mesh-ancestor
25487724|NCT00191334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487725|NCT00191386|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25487726|NCT00191386|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25487727|NCT00191386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25487728|NCT00191386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25487729|NCT00191386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487730|NCT00191386|Adrenergic Agents|adrenergic agents|mesh-ancestor
25487731|NCT00191386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25487732|NCT00191386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487733|NCT00191451|Gemcitabine|gemcitabine|mesh-list
25487734|NCT00191451|Carboplatin|carboplatin|mesh-list
25487735|NCT00191451|Trastuzumab|trastuzumab|mesh-list
25487736|NCT00191451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487737|NCT00191451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25487738|NCT00191451|Antimetabolites|antimetabolites|mesh-ancestor
25487739|NCT00191451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487740|NCT00191451|Antiviral Agents|antiviral agents|mesh-ancestor
25487741|NCT00191451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25112672|NCT03965962|Vaccines|vaccines|mesh-list
25112673|NCT03965962|Immunoglobulins|immunoglobulins|mesh-list
25112674|NCT03965962|Antibodies|antibodies|mesh-list
25112675|NCT03965962|gamma-Globulins|gamma-globulins|mesh-list
24987197|NCT03470675|Anesthetics, General|anesthetics, general|mesh-ancestor
25112703|NCT03928275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25112704|NCT03928275|Analgesics|analgesics|mesh-ancestor
25112705|NCT03928275|Sensory System Agents|sensory system agents|mesh-ancestor
25112706|NCT03928275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25487742|NCT00191451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487743|NCT00191451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25487744|NCT00191451|Immunologic Factors|immunologic factors|mesh-ancestor
25487745|NCT00191451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487746|NCT00191451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25487748|NCT00191477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25487749|NCT00191477|Antimetabolites|antimetabolites|mesh-ancestor
25487750|NCT00191477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487751|NCT00191477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487752|NCT00191477|Antiviral Agents|antiviral agents|mesh-ancestor
25487753|NCT00191477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25487754|NCT00191477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487755|NCT00191477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25487756|NCT00191477|Immunologic Factors|immunologic factors|mesh-ancestor
25487757|NCT00191477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487758|NCT00191646|Gemcitabine|gemcitabine|mesh-list
25487759|NCT00191646|Paclitaxel|paclitaxel|mesh-list
25487760|NCT00191646|Carboplatin|carboplatin|mesh-list
25487761|NCT00191646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25487762|NCT00191646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487763|NCT00191646|Tubulin Modulators|tubulin modulators|mesh-ancestor
25487764|NCT00191646|Antimitotic Agents|antimitotic agents|mesh-ancestor
25487765|NCT00191646|Mitosis Modulators|mitosis modulators|mesh-ancestor
25487766|NCT00191646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487767|NCT00191646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25487768|NCT00191646|Antimetabolites|antimetabolites|mesh-ancestor
25487769|NCT00191646|Antiviral Agents|antiviral agents|mesh-ancestor
25487770|NCT00191646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25487771|NCT00191646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487772|NCT00191646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25487773|NCT00191646|Immunologic Factors|immunologic factors|mesh-ancestor
25487774|NCT00191646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487775|NCT00191724|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
25487776|NCT00191724|Enoxaparin|enoxaparin|mesh-list
25487777|NCT00191724|Protein C|protein c|mesh-list
25487778|NCT00191724|Anticoagulants|anticoagulants|mesh-ancestor
25487779|NCT00191724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25487780|NCT00191724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25487781|NCT00191724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487782|NCT00191724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25487783|NCT00191789|Gemcitabine|gemcitabine|mesh-list
25487784|NCT00191789|Cisplatin|cisplatin|mesh-list
25487785|NCT00191789|Doxorubicin|doxorubicin|mesh-list
25487786|NCT00191789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487787|NCT00191789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25487788|NCT00191789|Antimetabolites|antimetabolites|mesh-ancestor
25487789|NCT00191789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487790|NCT00191789|Antiviral Agents|antiviral agents|mesh-ancestor
25487791|NCT00191789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25487792|NCT00191789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487793|NCT00191789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25487794|NCT00191789|Immunologic Factors|immunologic factors|mesh-ancestor
25487795|NCT00191789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487796|NCT00191789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25487797|NCT00191789|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25027453|NCT03620253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25027462|NCT03620032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25027491|NCT03619824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027492|NCT03619824|Antiviral Agents|antiviral agents|mesh-ancestor
25027493|NCT03619824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24796610|NCT01951144|Lorazepam|lorazepam|mesh-list
25027511|NCT03619785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027512|NCT03619785|Sensory System Agents|sensory system agents|mesh-ancestor
25027513|NCT03619785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027514|NCT03619785|Analgesics|analgesics|mesh-ancestor
25020698|NCT03678233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25020699|NCT03678233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020700|NCT03678142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25020701|NCT03678142|Vancomycin|vancomycin|mesh-list
25020702|NCT03678142|Imipenem|imipenem|mesh-list
25020703|NCT03678142|Floxacillin|floxacillin|mesh-list
25020705|NCT03678116|Caffeine|caffeine|mesh-list
25027515|NCT03619785|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25027516|NCT03619785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25027517|NCT03619785|Anesthetics, General|anesthetics, general|mesh-ancestor
25487808|NCT00191815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25487809|NCT00191815|Immunologic Factors|immunologic factors|mesh-ancestor
25487810|NCT00191815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487811|NCT00191854|Gemcitabine|gemcitabine|mesh-list
25487812|NCT00191854|Paclitaxel|paclitaxel|mesh-list
25487813|NCT00191854|Cisplatin|cisplatin|mesh-list
25487814|NCT00191854|Carboplatin|carboplatin|mesh-list
25487815|NCT00191854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25487816|NCT00191854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487817|NCT00191854|Tubulin Modulators|tubulin modulators|mesh-ancestor
25487818|NCT00191854|Antimitotic Agents|antimitotic agents|mesh-ancestor
25487819|NCT00191854|Mitosis Modulators|mitosis modulators|mesh-ancestor
25487820|NCT00191854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487821|NCT00191854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25487822|NCT00191854|Antimetabolites|antimetabolites|mesh-ancestor
25487823|NCT00191854|Antiviral Agents|antiviral agents|mesh-ancestor
25487824|NCT00191854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25487825|NCT00191854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487826|NCT00191854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25487827|NCT00191854|Immunologic Factors|immunologic factors|mesh-ancestor
25487828|NCT00191854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487829|NCT00191906|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25487830|NCT00191906|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25487831|NCT00191906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25487832|NCT00191906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25487833|NCT00191906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487834|NCT00191906|Adrenergic Agents|adrenergic agents|mesh-ancestor
25487835|NCT00191906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25487836|NCT00191906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487837|NCT00191945|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25487838|NCT00191945|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25487839|NCT00191945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25487840|NCT00191945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25487841|NCT00191945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487842|NCT00191945|Adrenergic Agents|adrenergic agents|mesh-ancestor
25487843|NCT00191945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25487844|NCT00191945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487845|NCT00191984|Irinotecan|irinotecan|mesh-list
25487846|NCT00191984|Pemetrexed|pemetrexed|mesh-list
25487847|NCT00191984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25487848|NCT00191984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25487849|NCT00191984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487850|NCT00191984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487851|NCT00191984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487852|NCT00191984|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25487853|NCT00191984|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25112832|NCT03910452|Alkylating Agents|alkylating agents|mesh-ancestor
25112833|NCT03910452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112834|NCT03910452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25112835|NCT03910452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25112836|NCT03910452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25112837|NCT03910452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25112838|NCT03910452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25112839|NCT03910452|Antifungal Agents|antifungal agents|mesh-ancestor
25487854|NCT00192023|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25487855|NCT00192023|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25487856|NCT00192023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25487857|NCT00192023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25487858|NCT00192023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487859|NCT00192023|Adrenergic Agents|adrenergic agents|mesh-ancestor
25487860|NCT00192023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25487861|NCT00192023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487862|NCT00192036|Gemcitabine|gemcitabine|mesh-list
25487863|NCT00192036|Cisplatin|cisplatin|mesh-list
25487864|NCT00192036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487865|NCT00192036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25487866|NCT00192036|Antimetabolites|antimetabolites|mesh-ancestor
25487867|NCT00192036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487868|NCT00192036|Antiviral Agents|antiviral agents|mesh-ancestor
25487869|NCT00192036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25487870|NCT00192036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487871|NCT00192036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25487872|NCT00192036|Immunologic Factors|immunologic factors|mesh-ancestor
25487873|NCT00192036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487874|NCT00192075|Leucovorin|leucovorin|mesh-list
25487875|NCT00192075|Folic Acid|folic acid|mesh-list
25487876|NCT00192075|Gemcitabine|gemcitabine|mesh-list
25487877|NCT00192075|Oxaliplatin|oxaliplatin|mesh-list
25487878|NCT00192075|Levoleucovorin|levoleucovorin|mesh-list
25487879|NCT00192075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25487880|NCT00192075|Antimetabolites|antimetabolites|mesh-ancestor
25487881|NCT00192075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487882|NCT00192075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487883|NCT00192075|Antiviral Agents|antiviral agents|mesh-ancestor
25487884|NCT00192075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25487885|NCT00192075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487886|NCT00192075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25487887|NCT00192075|Immunologic Factors|immunologic factors|mesh-ancestor
25487888|NCT00192075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487889|NCT00192075|Antidotes|antidotes|mesh-ancestor
25487890|NCT00192075|Protective Agents|protective agents|mesh-ancestor
25487891|NCT00192075|Vitamin B Complex|vitamin b complex|mesh-ancestor
25487892|NCT00192075|Vitamins|vitamins|mesh-ancestor
25487893|NCT00192075|Micronutrients|micronutrients|mesh-ancestor
25487894|NCT00192075|Hematinics|hematinics|mesh-ancestor
25487895|NCT00192647|Ribavirin|ribavirin|mesh-list
25487896|NCT00192647|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25487897|NCT00192647|Interferon alpha-2|interferon alpha-2|mesh-list
25487898|NCT00192647|Antimetabolites|antimetabolites|mesh-ancestor
25487899|NCT00192647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487900|NCT00192647|Antiviral Agents|antiviral agents|mesh-ancestor
25487901|NCT00192647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25487902|NCT00192647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487903|NCT00193037|Docetaxel|docetaxel|mesh-list
25487904|NCT00193037|Doxorubicin|doxorubicin|mesh-list
25487905|NCT00193037|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25487906|NCT00193037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487907|NCT00193037|Tubulin Modulators|tubulin modulators|mesh-ancestor
25487908|NCT00193037|Antimitotic Agents|antimitotic agents|mesh-ancestor
25487909|NCT00193037|Mitosis Modulators|mitosis modulators|mesh-ancestor
25656816|NCT01579305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25823141|NCT00004758|Antimanic Agents|antimanic agents|mesh-ancestor
25487910|NCT00193037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487911|NCT00193037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25487912|NCT00193037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25487913|NCT00193037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25487914|NCT00193037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487915|NCT00193050|Gemcitabine|gemcitabine|mesh-list
25487916|NCT00193050|Docetaxel|docetaxel|mesh-list
25487917|NCT00193050|Epirubicin|epirubicin|mesh-list
25487918|NCT00193050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25487919|NCT00193050|Antimetabolites|antimetabolites|mesh-ancestor
25487920|NCT00193050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487921|NCT00193050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487922|NCT00193050|Antiviral Agents|antiviral agents|mesh-ancestor
25487923|NCT00193050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25029457|NCT03602547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029458|NCT03602508|Solifenacin Succinate|solifenacin succinate|mesh-list
25029459|NCT03602508|Mirabegron|mirabegron|mesh-list
25029460|NCT03602508|Fesoterodine|fesoterodine|mesh-list
25029461|NCT03602508|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25487924|NCT00193050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487925|NCT00193050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25487926|NCT00193050|Immunologic Factors|immunologic factors|mesh-ancestor
25487927|NCT00193050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487928|NCT00193050|Tubulin Modulators|tubulin modulators|mesh-ancestor
25487929|NCT00193050|Antimitotic Agents|antimitotic agents|mesh-ancestor
25487930|NCT00193050|Mitosis Modulators|mitosis modulators|mesh-ancestor
25487931|NCT00193050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25487932|NCT00193050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25487933|NCT00193050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25487934|NCT00193063|Gemcitabine|gemcitabine|mesh-list
25487935|NCT00193063|Trastuzumab|trastuzumab|mesh-list
25487936|NCT00193063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25487937|NCT00193063|Antimetabolites|antimetabolites|mesh-ancestor
25487938|NCT00193063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487939|NCT00193063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487940|NCT00193063|Antiviral Agents|antiviral agents|mesh-ancestor
25487941|NCT00193063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25487942|NCT00193063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487943|NCT00193063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25487944|NCT00193063|Immunologic Factors|immunologic factors|mesh-ancestor
25487945|NCT00193063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487946|NCT00193063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25487947|NCT00193128|Docetaxel|docetaxel|mesh-list
25487948|NCT00193128|Capecitabine|capecitabine|mesh-list
25487949|NCT00193128|Oxaliplatin|oxaliplatin|mesh-list
25487950|NCT00193128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487951|NCT00193128|Tubulin Modulators|tubulin modulators|mesh-ancestor
25487952|NCT00193128|Antimitotic Agents|antimitotic agents|mesh-ancestor
25487953|NCT00193128|Mitosis Modulators|mitosis modulators|mesh-ancestor
25487954|NCT00193128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487955|NCT00193128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25487956|NCT00193128|Antimetabolites|antimetabolites|mesh-ancestor
25487957|NCT00193180|Docetaxel|docetaxel|mesh-list
25487958|NCT00193180|Imatinib Mesylate|imatinib mesylate|mesh-list
25487959|NCT00193180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487960|NCT00193180|Tubulin Modulators|tubulin modulators|mesh-ancestor
25487961|NCT00193180|Antimitotic Agents|antimitotic agents|mesh-ancestor
25487962|NCT00193180|Mitosis Modulators|mitosis modulators|mesh-ancestor
25487963|NCT00193180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487964|NCT00193180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25487965|NCT00193180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487966|NCT00193206|Gemcitabine|gemcitabine|mesh-list
25487967|NCT00193206|Paclitaxel|paclitaxel|mesh-list
25487968|NCT00193206|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25487969|NCT00193206|Epirubicin|epirubicin|mesh-list
25487970|NCT00193206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25487971|NCT00193206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487972|NCT00193206|Tubulin Modulators|tubulin modulators|mesh-ancestor
25487973|NCT00193206|Antimitotic Agents|antimitotic agents|mesh-ancestor
25487974|NCT00193206|Mitosis Modulators|mitosis modulators|mesh-ancestor
25487975|NCT00193206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25487976|NCT00193206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25487977|NCT00193206|Antimetabolites|antimetabolites|mesh-ancestor
25487978|NCT00193206|Antiviral Agents|antiviral agents|mesh-ancestor
25487979|NCT00193206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25487980|NCT00193206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823142|NCT00004758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25645131|NCT01444651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645132|NCT01444651|Urological Agents|urological agents|mesh-ancestor
25645133|NCT01444716|Ofatumumab|ofatumumab|mesh-list
25645134|NCT01444716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25645135|NCT01444716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645136|NCT01444716|Immunologic Factors|immunologic factors|mesh-ancestor
25645137|NCT01444716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487981|NCT00193206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25487982|NCT00193206|Immunologic Factors|immunologic factors|mesh-ancestor
25487983|NCT00193206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487984|NCT00193206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25487985|NCT00193206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25487986|NCT00193206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25487987|NCT00193258|Bevacizumab|bevacizumab|mesh-list
25487988|NCT00193258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25487989|NCT00193258|Imatinib Mesylate|imatinib mesylate|mesh-list
25487990|NCT00193258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25487991|NCT00193258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25487992|NCT00193258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25487993|NCT00193258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25487994|NCT00193258|Growth Substances|growth substances|mesh-ancestor
25487995|NCT00193258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25487996|NCT00193258|Growth Inhibitors|growth inhibitors|mesh-ancestor
25487997|NCT00193258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25487998|NCT00193258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25487999|NCT00193258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488000|NCT00193375|Bevacizumab|bevacizumab|mesh-list
25032060|NCT03584178|Autonomic Agents|autonomic agents|mesh-ancestor
25032061|NCT03584178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25488001|NCT00193375|Carboplatin|carboplatin|mesh-list
25488002|NCT00193375|Irinotecan|irinotecan|mesh-list
25488003|NCT00193375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25488004|NCT00193375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488005|NCT00193375|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25488006|NCT00193375|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25488007|NCT00193375|Growth Substances|growth substances|mesh-ancestor
25488008|NCT00193375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488009|NCT00193375|Growth Inhibitors|growth inhibitors|mesh-ancestor
25488010|NCT00193375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25488011|NCT00193375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25488012|NCT00193375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25488013|NCT00193375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488014|NCT00193453|Gemcitabine|gemcitabine|mesh-list
25488015|NCT00193453|Docetaxel|docetaxel|mesh-list
25488016|NCT00193453|Cetuximab|cetuximab|mesh-list
25488017|NCT00193453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25488018|NCT00193453|Antimetabolites|antimetabolites|mesh-ancestor
25488019|NCT00193453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488020|NCT00193453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488021|NCT00193453|Antiviral Agents|antiviral agents|mesh-ancestor
25488022|NCT00193453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25488023|NCT00193453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25488024|NCT00193453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25488025|NCT00193453|Immunologic Factors|immunologic factors|mesh-ancestor
25488026|NCT00193453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488027|NCT00193453|Tubulin Modulators|tubulin modulators|mesh-ancestor
25488028|NCT00193453|Antimitotic Agents|antimitotic agents|mesh-ancestor
25488029|NCT00193453|Mitosis Modulators|mitosis modulators|mesh-ancestor
25488030|NCT00193453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25488031|NCT00193492|Bevacizumab|bevacizumab|mesh-list
25488032|NCT00193492|Rituximab|rituximab|mesh-list
25488033|NCT00193492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25488034|NCT00193492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488035|NCT00193492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25488036|NCT00193492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25488037|NCT00193492|Growth Substances|growth substances|mesh-ancestor
25488038|NCT00193492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488039|NCT00193492|Growth Inhibitors|growth inhibitors|mesh-ancestor
25488040|NCT00193492|Immunologic Factors|immunologic factors|mesh-ancestor
25488041|NCT00193492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25645138|NCT01444742|Cytarabine|cytarabine|mesh-list
25488042|NCT00193596|Gemcitabine|gemcitabine|mesh-list
25488043|NCT00193596|Paclitaxel|paclitaxel|mesh-list
25488044|NCT00193596|Etoposide|etoposide|mesh-list
25488045|NCT00193596|Carboplatin|carboplatin|mesh-list
25488046|NCT00193596|Irinotecan|irinotecan|mesh-list
25645139|NCT01444742|Clofarabine|clofarabine|mesh-list
25645140|NCT01444742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25645141|NCT01444742|Antimetabolites|antimetabolites|mesh-ancestor
25645142|NCT01444742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645143|NCT01444742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645144|NCT01444742|Antiviral Agents|antiviral agents|mesh-ancestor
25488047|NCT00193596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25645145|NCT01444742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25645146|NCT01444742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25645147|NCT01444742|Immunologic Factors|immunologic factors|mesh-ancestor
25645148|NCT01444742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488048|NCT00193596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488049|NCT00193596|Tubulin Modulators|tubulin modulators|mesh-ancestor
25488050|NCT00193596|Antimitotic Agents|antimitotic agents|mesh-ancestor
25488051|NCT00193596|Mitosis Modulators|mitosis modulators|mesh-ancestor
25488052|NCT00193596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488053|NCT00193596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25488054|NCT00193596|Antimetabolites|antimetabolites|mesh-ancestor
25488055|NCT00193596|Antiviral Agents|antiviral agents|mesh-ancestor
25488056|NCT00193596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25488057|NCT00193596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25488058|NCT00193596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25488059|NCT00193596|Immunologic Factors|immunologic factors|mesh-ancestor
25488060|NCT00193596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488061|NCT00193596|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25488062|NCT00193596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25488063|NCT00193596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25488064|NCT00193609|Capecitabine|capecitabine|mesh-list
25488065|NCT00193609|Oxaliplatin|oxaliplatin|mesh-list
25488066|NCT00193609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25488067|NCT00193609|Antimetabolites|antimetabolites|mesh-ancestor
25488068|NCT00193609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488069|NCT00193609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488070|NCT00194012|Aripiprazole|aripiprazole|mesh-list
25488071|NCT00194012|Antidepressive Agents|antidepressive agents|mesh-ancestor
25488072|NCT00194012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25488073|NCT00194012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25488074|NCT00194012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25488075|NCT00194012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25032462|NCT03580681|Protective Agents|protective agents|mesh-ancestor
25488076|NCT00194012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488077|NCT00194012|Dopamine Agonists|dopamine agonists|mesh-ancestor
25488078|NCT00194012|Dopamine Agents|dopamine agents|mesh-ancestor
25488079|NCT00194012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25488080|NCT00194012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488081|NCT00194012|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25488082|NCT00194012|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25488083|NCT00194012|Serotonin Agents|serotonin agents|mesh-ancestor
25488084|NCT00194012|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25488085|NCT00194012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25488086|NCT00194012|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25488087|NCT00194012|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25488088|NCT00194025|Valproic Acid|valproic acid|mesh-list
25488089|NCT00194025|Anticonvulsants|anticonvulsants|mesh-ancestor
25488090|NCT00194025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25488091|NCT00194025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488092|NCT00194025|GABA Agents|gaba agents|mesh-ancestor
25488093|NCT00194025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25488094|NCT00194025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488095|NCT00194025|Antimanic Agents|antimanic agents|mesh-ancestor
25488096|NCT00194025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25488097|NCT00194025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25488098|NCT00194025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25488099|NCT00194077|Aripiprazole|aripiprazole|mesh-list
25488100|NCT00194077|Antidepressive Agents|antidepressive agents|mesh-ancestor
25488101|NCT00194077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25488102|NCT00194077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25488103|NCT00194077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25488104|NCT00194077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25488105|NCT00194077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488106|NCT00194077|Dopamine Agonists|dopamine agonists|mesh-ancestor
25488107|NCT00194077|Dopamine Agents|dopamine agents|mesh-ancestor
25488108|NCT00194077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25488109|NCT00194077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488110|NCT00194077|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25488111|NCT00194077|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25488112|NCT00194077|Serotonin Agents|serotonin agents|mesh-ancestor
25488113|NCT00194077|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25488114|NCT00194077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25488115|NCT00194077|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25488116|NCT00194077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25488117|NCT00194116|Valproic Acid|valproic acid|mesh-list
25488118|NCT00194116|Anticonvulsants|anticonvulsants|mesh-ancestor
25488119|NCT00194116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25488120|NCT00194116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488121|NCT00194116|GABA Agents|gaba agents|mesh-ancestor
25488122|NCT00194116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25488123|NCT00194116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488124|NCT00194116|Antimanic Agents|antimanic agents|mesh-ancestor
25488125|NCT00194116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25488126|NCT00194116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25488127|NCT00194116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25488128|NCT00194129|Valproic Acid|valproic acid|mesh-list
25488129|NCT00194129|Lithium Carbonate|lithium carbonate|mesh-list
25488130|NCT00194129|Antidepressive Agents|antidepressive agents|mesh-ancestor
25488131|NCT00194129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25488132|NCT00194129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25488133|NCT00194129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488134|NCT00194129|Antimanic Agents|antimanic agents|mesh-ancestor
25488135|NCT00194129|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25488136|NCT00194129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25488137|NCT00194129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488138|NCT00194129|Anticonvulsants|anticonvulsants|mesh-ancestor
25488139|NCT00194129|GABA Agents|gaba agents|mesh-ancestor
25488140|NCT00194129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24600073|NCT02711137|Antimetabolites|antimetabolites|mesh-ancestor
25033276|NCT03574857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033278|NCT03574701|Vitamins|vitamins|mesh-ancestor
25033279|NCT03574701|Micronutrients|micronutrients|mesh-ancestor
25114012|NCT01552434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25114013|NCT01517100|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25114014|NCT01517100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034247|NCT03566316|Amlodipine|amlodipine|mesh-list
25034248|NCT03566316|Telmisartan|telmisartan|mesh-list
25034249|NCT03566316|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
25034936|NCT03560973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25488141|NCT00194532|Ciprofloxacin|ciprofloxacin|mesh-list
25488142|NCT00194532|Cefpodoxime|cefpodoxime|mesh-list
25488143|NCT00194532|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
25488144|NCT00194532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25488145|NCT00194532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25488146|NCT00194532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25488147|NCT00194532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25488148|NCT00194532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25488149|NCT00194532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488150|NCT00194532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488151|NCT00194532|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25488152|NCT00194532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25488153|NCT00194610|Botulinum Toxins|botulinum toxins|mesh-list
25488154|NCT00194610|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25488155|NCT00194610|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25488156|NCT00194610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25488157|NCT00194610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488158|NCT00194610|Cholinergic Agents|cholinergic agents|mesh-ancestor
25488159|NCT00194610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25488160|NCT00194610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488161|NCT00194610|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25488162|NCT00194610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25488163|NCT00194675|Testosterone|testosterone|mesh-list
25488164|NCT00194675|Dutasteride|dutasteride|mesh-list
25488165|NCT00194675|Androgens|androgens|mesh-ancestor
25488166|NCT00194675|Hormones|hormones|mesh-ancestor
25488167|NCT00194675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25488168|NCT00194675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488169|NCT00194675|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25488170|NCT00194675|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25488171|NCT00194675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823143|NCT00004758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25645149|NCT01444781|Vaccines|vaccines|mesh-list
25645150|NCT01444781|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25488172|NCT00194675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488173|NCT00194675|Hormone Antagonists|hormone antagonists|mesh-ancestor
25488174|NCT00194779|Tamoxifen|tamoxifen|mesh-list
25488175|NCT00194779|Vinorelbine|vinorelbine|mesh-list
25488176|NCT00194779|Cyclophosphamide|cyclophosphamide|mesh-list
25488177|NCT00194779|Doxorubicin|doxorubicin|mesh-list
25488178|NCT00194779|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25488179|NCT00194779|Capecitabine|capecitabine|mesh-list
25488180|NCT00194779|Methotrexate|methotrexate|mesh-list
25488181|NCT00194779|Trastuzumab|trastuzumab|mesh-list
25488182|NCT00194779|Letrozole|letrozole|mesh-list
25488183|NCT00194779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25488184|NCT00194779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488185|NCT00194779|Tubulin Modulators|tubulin modulators|mesh-ancestor
25488186|NCT00194779|Antimitotic Agents|antimitotic agents|mesh-ancestor
25488187|NCT00194779|Mitosis Modulators|mitosis modulators|mesh-ancestor
25488188|NCT00194779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488189|NCT00194779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25488190|NCT00194779|Immunologic Factors|immunologic factors|mesh-ancestor
25488191|NCT00194779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488192|NCT00194779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25488193|NCT00194779|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25488194|NCT00194779|Alkylating Agents|alkylating agents|mesh-ancestor
25488195|NCT00194779|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25488196|NCT00194779|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25488197|NCT00194779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25488198|NCT00194779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25488199|NCT00194779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25488200|NCT00194779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25488201|NCT00194779|Antimetabolites|antimetabolites|mesh-ancestor
25488202|NCT00194779|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25488203|NCT00194779|Abortifacient Agents|abortifacient agents|mesh-ancestor
25488204|NCT00194779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25488205|NCT00194779|Dermatologic Agents|dermatologic agents|mesh-ancestor
25488206|NCT00194779|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25488207|NCT00194779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25488208|NCT00194779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25488209|NCT00194779|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25488210|NCT00194779|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25036282|NCT03549221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25036283|NCT03549208|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25036285|NCT03549208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036286|NCT03549026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25488211|NCT00194779|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25488212|NCT00194779|Hormone Antagonists|hormone antagonists|mesh-ancestor
25488213|NCT00194779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25488214|NCT00194779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25488215|NCT00194779|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25488216|NCT00194779|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25488217|NCT00194779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25488218|NCT00194792|Paclitaxel|paclitaxel|mesh-list
25488219|NCT00194792|Vinorelbine|vinorelbine|mesh-list
25488220|NCT00194792|Capecitabine|capecitabine|mesh-list
25488221|NCT00194792|Methotrexate|methotrexate|mesh-list
25488222|NCT00194792|Exemestane|exemestane|mesh-list
25488223|NCT00194792|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25488224|NCT00194792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25488225|NCT00194792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488226|NCT00194792|Tubulin Modulators|tubulin modulators|mesh-ancestor
25488227|NCT00194792|Antimitotic Agents|antimitotic agents|mesh-ancestor
25488228|NCT00194792|Mitosis Modulators|mitosis modulators|mesh-ancestor
25488229|NCT00194792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488230|NCT00194792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25488231|NCT00194792|Antimetabolites|antimetabolites|mesh-ancestor
25488232|NCT00194792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25488233|NCT00194792|Abortifacient Agents|abortifacient agents|mesh-ancestor
25488234|NCT00194792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25488235|NCT00194792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488236|NCT00194792|Dermatologic Agents|dermatologic agents|mesh-ancestor
25488237|NCT00194792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25488238|NCT00194792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25488239|NCT00194792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25488240|NCT00194792|Immunologic Factors|immunologic factors|mesh-ancestor
25645151|NCT01444781|Immunologic Factors|immunologic factors|mesh-ancestor
25645152|NCT01444781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645153|NCT01444898|Exenatide|exenatide|mesh-list
25645154|NCT01444898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25645155|NCT01444898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645156|NCT01444898|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25645157|NCT01444898|Incretins|incretins|mesh-ancestor
25645158|NCT01444898|Hormones|hormones|mesh-ancestor
25488241|NCT00194792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25488242|NCT00194792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25488243|NCT00194792|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25488244|NCT00194792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25488245|NCT00194792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25488246|NCT00194792|Hormone Antagonists|hormone antagonists|mesh-ancestor
25488247|NCT00194792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25488248|NCT00194792|Luteolytic Agents|luteolytic agents|mesh-ancestor
25488249|NCT00194792|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25488250|NCT00194792|Contraceptive Agents|contraceptive agents|mesh-ancestor
25488251|NCT00194792|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25488252|NCT00194792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25488253|NCT00194896|Rosiglitazone|rosiglitazone|mesh-list
25488254|NCT00194896|Glyburide|glyburide|mesh-list
25488255|NCT00194896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25488256|NCT00194896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488257|NCT00194987|Prednisone|prednisone|mesh-list
25488258|NCT00194987|Immunoglobulins|immunoglobulins|mesh-list
25488259|NCT00194987|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25488260|NCT00194987|Antibodies|antibodies|mesh-list
25488261|NCT00194987|gamma-Globulins|gamma-globulins|mesh-list
25488262|NCT00194987|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25488263|NCT00194987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25488264|NCT00194987|Glucocorticoids|glucocorticoids|mesh-ancestor
25488265|NCT00194987|Hormones|hormones|mesh-ancestor
25488266|NCT00194987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25488267|NCT00194987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488268|NCT00194987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25488269|NCT00194987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488270|NCT00194987|Immunologic Factors|immunologic factors|mesh-ancestor
25488271|NCT00195039|Antibodies|antibodies|mesh-list
25037065|NCT03540979|Hormones|hormones|mesh-ancestor
25037066|NCT03540953|Mitomycins|mitomycins|mesh-list
25037067|NCT03540953|Mitomycin|mitomycin|mesh-list
25037068|NCT03540953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25037114|NCT03540368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037115|NCT03540368|Hemostatics|hemostatics|mesh-ancestor
25037116|NCT03540368|Coagulants|coagulants|mesh-ancestor
25037125|NCT03540225|Progesterone|progesterone|mesh-list
25037173|NCT03539718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25037174|NCT03539718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25037175|NCT03539627|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25037176|NCT03539627|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25037177|NCT03539627|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24994156|NCT04829799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25488273|NCT00195039|Immunologic Factors|immunologic factors|mesh-ancestor
25488274|NCT00195039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488275|NCT00195273|Cyclosporine|cyclosporine|mesh-list
25488276|NCT00195273|Sirolimus|sirolimus|mesh-list
25488277|NCT00195273|Mycophenolic Acid|mycophenolic acid|mesh-list
25488278|NCT00195273|Cyclosporins|cyclosporins|mesh-list
25488279|NCT00195273|Daclizumab|daclizumab|mesh-list
25488280|NCT00195273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25488281|NCT00195273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488282|NCT00195273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25488283|NCT00195273|Immunologic Factors|immunologic factors|mesh-ancestor
25488284|NCT00195273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488285|NCT00195273|Antifungal Agents|antifungal agents|mesh-ancestor
25488286|NCT00195273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25488287|NCT00195273|Dermatologic Agents|dermatologic agents|mesh-ancestor
25488288|NCT00195273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25488289|NCT00195273|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25488290|NCT00195273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25488291|NCT00195273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488292|NCT00195273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25488293|NCT00195273|Antitubercular Agents|antitubercular agents|mesh-ancestor
25645159|NCT01444898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25488294|NCT00195273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25488295|NCT00195338|Etanercept|etanercept|mesh-list
25488296|NCT00195338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25488297|NCT00195338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25488298|NCT00195338|Analgesics|analgesics|mesh-ancestor
25488299|NCT00195338|Sensory System Agents|sensory system agents|mesh-ancestor
25488300|NCT00195338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25488301|NCT00195338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488302|NCT00195338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25488303|NCT00195338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25488304|NCT00195338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25488305|NCT00195338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25488306|NCT00195338|Immunologic Factors|immunologic factors|mesh-ancestor
25488307|NCT00195351|Metronidazole|metronidazole|mesh-list
25488308|NCT00195351|Ceftriaxone|ceftriaxone|mesh-list
25488309|NCT00195351|Tigecycline|tigecycline|mesh-list
25488310|NCT00195351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25488311|NCT00195351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25488312|NCT00195351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25488313|NCT00195351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25488314|NCT00195351|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25488315|NCT00195351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25488316|NCT00195351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488317|NCT00195403|Etanercept|etanercept|mesh-list
25488318|NCT00195403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25488319|NCT00195403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25488320|NCT00195403|Analgesics|analgesics|mesh-ancestor
25488321|NCT00195403|Sensory System Agents|sensory system agents|mesh-ancestor
25488322|NCT00195403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25488323|NCT00195403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488324|NCT00195403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25488325|NCT00195403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25488326|NCT00195403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25488327|NCT00195403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25488328|NCT00195403|Immunologic Factors|immunologic factors|mesh-ancestor
25488329|NCT00195429|Sirolimus|sirolimus|mesh-list
25488330|NCT00195429|Prednisone|prednisone|mesh-list
25488331|NCT00195429|Tacrolimus|tacrolimus|mesh-list
25488332|NCT00195429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25488333|NCT00195429|Glucocorticoids|glucocorticoids|mesh-ancestor
25488334|NCT00195429|Hormones|hormones|mesh-ancestor
25488335|NCT00195429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25488336|NCT00195429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488337|NCT00195429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25488338|NCT00195429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488339|NCT00195429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25488340|NCT00195429|Immunologic Factors|immunologic factors|mesh-ancestor
25488341|NCT00195429|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25488342|NCT00195429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25488343|NCT00195429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488344|NCT00195429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25488345|NCT00195429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25037697|NCT03535701|Mitosis Modulators|mitosis modulators|mesh-ancestor
25037718|NCT03535558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25488346|NCT00195429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25488348|NCT00195442|Factor VIII|factor viii|mesh-list
25488349|NCT00195442|Coagulants|coagulants|mesh-ancestor
25488350|NCT00195494|Etanercept|etanercept|mesh-list
25488351|NCT00195494|Methotrexate|methotrexate|mesh-list
25488352|NCT00195494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25488353|NCT00195494|Abortifacient Agents|abortifacient agents|mesh-ancestor
25488354|NCT00195494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25488355|NCT00195494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488356|NCT00195494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25488357|NCT00195494|Antimetabolites|antimetabolites|mesh-ancestor
25488358|NCT00195494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488359|NCT00195494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488360|NCT00195494|Dermatologic Agents|dermatologic agents|mesh-ancestor
25488361|NCT00195494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25488362|NCT00195494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25488363|NCT00195494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25488364|NCT00195494|Immunologic Factors|immunologic factors|mesh-ancestor
25488365|NCT00195494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25488366|NCT00195494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25488367|NCT00195494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25488368|NCT00195494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25488369|NCT00195494|Analgesics|analgesics|mesh-ancestor
25488370|NCT00195494|Sensory System Agents|sensory system agents|mesh-ancestor
25488371|NCT00195494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25488372|NCT00195494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25488373|NCT00195494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25488374|NCT00195507|Etanercept|etanercept|mesh-list
25488375|NCT00195507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25488376|NCT00195507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25488377|NCT00195507|Analgesics|analgesics|mesh-ancestor
25488378|NCT00195507|Sensory System Agents|sensory system agents|mesh-ancestor
25488379|NCT00195507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25488380|NCT00195507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488381|NCT00195507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25488382|NCT00195507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25488383|NCT00195507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25488384|NCT00195507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25488385|NCT00195507|Immunologic Factors|immunologic factors|mesh-ancestor
25488386|NCT00195624|Cyclosporine|cyclosporine|mesh-list
25488387|NCT00195624|Alemtuzumab|alemtuzumab|mesh-list
25488388|NCT00195624|Cyclosporins|cyclosporins|mesh-list
25488389|NCT00195624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25488390|NCT00195624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488391|NCT00195624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25488392|NCT00195624|Immunologic Factors|immunologic factors|mesh-ancestor
25488393|NCT00195624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488394|NCT00195624|Antifungal Agents|antifungal agents|mesh-ancestor
25488395|NCT00195624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25488396|NCT00195624|Dermatologic Agents|dermatologic agents|mesh-ancestor
25488397|NCT00195624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25488398|NCT00195624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25488399|NCT00195624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25488400|NCT00195624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488401|NCT00195650|Adalimumab|adalimumab|mesh-list
25488402|NCT00195650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25488403|NCT00195650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25488404|NCT00195663|Adalimumab|adalimumab|mesh-list
25488405|NCT00195663|Methotrexate|methotrexate|mesh-list
25488406|NCT00195663|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25488407|NCT00195663|Abortifacient Agents|abortifacient agents|mesh-ancestor
25488408|NCT00195663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25488409|NCT00195663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488410|NCT00195663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25488411|NCT00195663|Antimetabolites|antimetabolites|mesh-ancestor
25488412|NCT00195663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488413|NCT00195663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488414|NCT00195663|Dermatologic Agents|dermatologic agents|mesh-ancestor
25488415|NCT00195663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25488416|NCT00195663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25488417|NCT00195663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25488418|NCT00195663|Immunologic Factors|immunologic factors|mesh-ancestor
25488419|NCT00195663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25038351|NCT05216211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25488420|NCT00195663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25488421|NCT00195663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25488422|NCT00195676|Adalimumab|adalimumab|mesh-list
25488423|NCT00195676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25488424|NCT00195676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25488425|NCT00195702|Adalimumab|adalimumab|mesh-list
25488426|NCT00195702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25488427|NCT00195702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25488428|NCT00195715|Adalimumab|adalimumab|mesh-list
25488429|NCT00195715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25488430|NCT00195715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25488431|NCT00195819|Adalimumab|adalimumab|mesh-list
25488432|NCT00195819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25488433|NCT00195819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25488434|NCT00196313|Levonorgestrel|levonorgestrel|mesh-list
25488435|NCT00196313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25488436|NCT00196313|Contraceptive Agents|contraceptive agents|mesh-ancestor
25488437|NCT00196313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25488438|NCT00196313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488439|NCT00196313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25488440|NCT00196313|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25488441|NCT00196313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25488442|NCT00196326|Levonorgestrel|levonorgestrel|mesh-list
25488443|NCT00196326|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25488444|NCT00196326|Estradiol|estradiol|mesh-list
25488445|NCT00196326|Estrogens|estrogens|mesh-ancestor
25488446|NCT00196326|Hormones|hormones|mesh-ancestor
25645160|NCT01444924|Bupivacaine|bupivacaine|mesh-list
25488447|NCT00196326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25488448|NCT00196326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488449|NCT00196326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25488450|NCT00196326|Contraceptive Agents|contraceptive agents|mesh-ancestor
25488451|NCT00196326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25488452|NCT00196326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25488453|NCT00196326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25488454|NCT00196326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25488455|NCT00196326|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25488456|NCT00196976|Edetic Acid|edetic acid|mesh-list
25488457|NCT00196976|Vaccines|vaccines|mesh-list
25488458|NCT00196976|Pentetic Acid|pentetic acid|mesh-list
25488459|NCT00196976|Immunologic Factors|immunologic factors|mesh-ancestor
25488460|NCT00196976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488461|NCT00196976|Antidotes|antidotes|mesh-ancestor
25488462|NCT00196976|Protective Agents|protective agents|mesh-ancestor
25488463|NCT00196976|Chelating Agents|chelating agents|mesh-ancestor
25488464|NCT00196976|Sequestering Agents|sequestering agents|mesh-ancestor
25488465|NCT00196976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488466|NCT00196976|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25488467|NCT00196976|Anticoagulants|anticoagulants|mesh-ancestor
25488468|NCT00196976|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25488469|NCT00197002|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25488470|NCT00197002|Immunologic Factors|immunologic factors|mesh-ancestor
25488471|NCT00197002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488472|NCT00197106|Fluticasone|fluticasone|mesh-list
25488473|NCT00197106|Xhance|xhance|mesh-list
25488474|NCT00197106|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25488475|NCT00197106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25488476|NCT00197106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25488477|NCT00197106|Autonomic Agents|autonomic agents|mesh-ancestor
25488478|NCT00197106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25488479|NCT00197106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488480|NCT00197106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25488481|NCT00197106|Respiratory System Agents|respiratory system agents|mesh-ancestor
25488482|NCT00197106|Dermatologic Agents|dermatologic agents|mesh-ancestor
25488483|NCT00197106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25488484|NCT00197106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25488485|NCT00197106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25039702|NCT03706521|Lorecivivint|lorecivivint|mesh-list
24994627|NCT03668041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039717|NCT03704584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039718|NCT03704584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25039719|NCT03704584|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25039720|NCT03704584|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25039721|NCT03704584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25039722|NCT03704584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039723|NCT03704584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25039724|NCT03704584|Antiemetics|antiemetics|mesh-ancestor
25488486|NCT00197106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25488487|NCT00197106|Adrenergic Agents|adrenergic agents|mesh-ancestor
25488488|NCT00197106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25488489|NCT00197106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488490|NCT00197145|Aplaviroc|aplaviroc|mesh-list
25488491|NCT00197145|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25488492|NCT00197145|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25488493|NCT00197145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488494|NCT00197145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25488495|NCT00197145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25488496|NCT00197145|Antiviral Agents|antiviral agents|mesh-ancestor
25488497|NCT00197145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25488498|NCT00197184|Vaccines|vaccines|mesh-list
25488499|NCT00197184|Immunologic Factors|immunologic factors|mesh-ancestor
25488500|NCT00197184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488501|NCT00198029|Hylan|hylan|mesh-list
25488502|NCT00198029|Viscosupplements|viscosupplements|mesh-ancestor
25488503|NCT00198029|Protective Agents|protective agents|mesh-ancestor
25488504|NCT00198029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488505|NCT00198081|Celecoxib|celecoxib|mesh-list
25488506|NCT00198081|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
25488507|NCT00198081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25488508|NCT00198081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25488509|NCT00198081|Analgesics|analgesics|mesh-ancestor
25488510|NCT00198081|Sensory System Agents|sensory system agents|mesh-ancestor
25645161|NCT01444924|Anesthetics, Local|anesthetics, local|mesh-ancestor
25645163|NCT01444924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25645164|NCT01444924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645165|NCT01444924|Sensory System Agents|sensory system agents|mesh-ancestor
25645166|NCT01444924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25488511|NCT00198081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25488512|NCT00198081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488513|NCT00198081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25488514|NCT00198081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25488515|NCT00198081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25488516|NCT00198081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25488517|NCT00198081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488518|NCT00198107|Cycloserine|cycloserine|mesh-list
25488519|NCT00198107|Aripiprazole|aripiprazole|mesh-list
25488520|NCT00198107|Antidepressive Agents|antidepressive agents|mesh-ancestor
25488521|NCT00198107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25488522|NCT00198107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25488523|NCT00198107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25488524|NCT00198107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25488525|NCT00198107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488526|NCT00198107|Dopamine Agonists|dopamine agonists|mesh-ancestor
25488527|NCT00198107|Dopamine Agents|dopamine agents|mesh-ancestor
25488528|NCT00198107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25488529|NCT00198107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488530|NCT00198107|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25488531|NCT00198107|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25488532|NCT00198107|Serotonin Agents|serotonin agents|mesh-ancestor
25488533|NCT00198107|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25488534|NCT00198107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25488535|NCT00198107|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25488536|NCT00198107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25488537|NCT00198107|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25488538|NCT00198107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25488539|NCT00198107|Renal Agents|renal agents|mesh-ancestor
25488540|NCT00198107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25488541|NCT00198107|Antitubercular Agents|antitubercular agents|mesh-ancestor
25488542|NCT00198107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25488543|NCT00198107|Antimetabolites|antimetabolites|mesh-ancestor
25488544|NCT00198133|Pemetrexed|pemetrexed|mesh-list
25488545|NCT00198133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488546|NCT00198133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25488547|NCT00198133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488548|NCT00198133|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25488549|NCT00198133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25488550|NCT00198822|Vitamin A|vitamin a|mesh-list
25488551|NCT00198822|Beta Carotene|beta carotene|mesh-list
25488552|NCT00198822|Carotenoids|carotenoids|mesh-list
25488553|NCT00198822|Vitamins|vitamins|mesh-ancestor
25158186|NCT04426825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25158187|NCT04426825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25158188|NCT04426825|Growth Substances|growth substances|mesh-ancestor
25158189|NCT04426825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25158190|NCT04426825|Growth Inhibitors|growth inhibitors|mesh-ancestor
25158191|NCT04418557|Antibodies|antibodies|mesh-list
25158192|NCT04418557|Immunologic Factors|immunologic factors|mesh-ancestor
25488554|NCT00198822|Micronutrients|micronutrients|mesh-ancestor
25488555|NCT00198822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488556|NCT00198822|Antioxidants|antioxidants|mesh-ancestor
25488557|NCT00198822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488558|NCT00198822|Protective Agents|protective agents|mesh-ancestor
25488559|NCT00198822|Provitamins|provitamins|mesh-ancestor
25488560|NCT00199381|Istradefylline|istradefylline|mesh-list
25488561|NCT00199381|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
25488562|NCT00199381|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25488563|NCT00199381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25488564|NCT00199381|Purinergic Agents|purinergic agents|mesh-ancestor
25488565|NCT00199381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25488566|NCT00199381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488567|NCT00199381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488568|NCT00199797|Leucovorin|leucovorin|mesh-list
25488569|NCT00199797|Fluorouracil|fluorouracil|mesh-list
25488570|NCT00199797|Oxaliplatin|oxaliplatin|mesh-list
25488571|NCT00199797|Antimetabolites|antimetabolites|mesh-ancestor
25488572|NCT00199797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488573|NCT00199797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25488574|NCT00199797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488575|NCT00199797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25488576|NCT00199797|Immunologic Factors|immunologic factors|mesh-ancestor
25488577|NCT00199797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488578|NCT00199797|Antidotes|antidotes|mesh-ancestor
25488579|NCT00199797|Protective Agents|protective agents|mesh-ancestor
25488580|NCT00199797|Vitamin B Complex|vitamin b complex|mesh-ancestor
25488581|NCT00199797|Vitamins|vitamins|mesh-ancestor
25488582|NCT00199797|Micronutrients|micronutrients|mesh-ancestor
25488583|NCT00199836|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25488584|NCT00199836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25488585|NCT00199836|Immunologic Factors|immunologic factors|mesh-ancestor
25488586|NCT00199836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488587|NCT00200161|Temozolomide|temozolomide|mesh-list
25488588|NCT00200161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25488589|NCT00200161|Alkylating Agents|alkylating agents|mesh-ancestor
25488590|NCT00200161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488591|NCT00200161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488592|NCT00200343|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25488593|NCT00200343|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25488594|NCT00200343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25488595|NCT00200356|Ozagrel|ozagrel|mesh-list
25488596|NCT00200356|Edaravone|edaravone|mesh-list
25488597|NCT00200356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25488598|NCT00200356|Antioxidants|antioxidants|mesh-ancestor
25488599|NCT00200356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488600|NCT00200356|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25488601|NCT00200356|Protective Agents|protective agents|mesh-ancestor
25488602|NCT00200356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488603|NCT00200356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25488604|NCT00200356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25488605|NCT00200356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25488606|NCT00200356|Histamine Antagonists|histamine antagonists|mesh-ancestor
25488607|NCT00200356|Histamine Agents|histamine agents|mesh-ancestor
25488608|NCT00200356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25488609|NCT00200902|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25488610|NCT00200902|Citalopram|citalopram|mesh-list
25488611|NCT00200902|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25488612|NCT00200902|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25488613|NCT00200902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25488614|NCT00200902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25488615|NCT00200902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488616|NCT00200902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25159778|NCT03642132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25159779|NCT03642132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25159888|NCT03539744|Hormones|hormones|mesh-ancestor
25159889|NCT03539744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25159969|NCT03421639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25159970|NCT03421639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25159990|NCT03413800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25159991|NCT03413800|Growth Substances|growth substances|mesh-ancestor
25159992|NCT03413800|Growth Inhibitors|growth inhibitors|mesh-ancestor
25159993|NCT03412747|Adalimumab|adalimumab|mesh-list
25159994|NCT03412747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25488617|NCT00200902|Serotonin Agents|serotonin agents|mesh-ancestor
25488618|NCT00200902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488619|NCT00200902|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25488620|NCT00200902|Antidepressive Agents|antidepressive agents|mesh-ancestor
25488621|NCT00200902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25488622|NCT00200902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25488623|NCT00200902|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25488624|NCT00200902|Analgesics|analgesics|mesh-ancestor
25488625|NCT00200902|Sensory System Agents|sensory system agents|mesh-ancestor
25488626|NCT00200902|Dopamine Agents|dopamine agents|mesh-ancestor
25488627|NCT00200967|Beclomethasone|beclomethasone|mesh-list
25488628|NCT00200967|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25488629|NCT00200967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25488630|NCT00200967|Autonomic Agents|autonomic agents|mesh-ancestor
25488631|NCT00200967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25488632|NCT00200967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488633|NCT00200967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25488634|NCT00200967|Respiratory System Agents|respiratory system agents|mesh-ancestor
25488635|NCT00200967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25488636|NCT00200967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25488637|NCT00200967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25488638|NCT00200967|Adrenergic Agents|adrenergic agents|mesh-ancestor
25488639|NCT00200967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25488640|NCT00200967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488641|NCT00200967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25488642|NCT00200967|Glucocorticoids|glucocorticoids|mesh-ancestor
25488644|NCT00200967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25488645|NCT00201123|Interferons|interferons|mesh-list
25488646|NCT00201123|Interferon-gamma|interferon-gamma|mesh-list
25488647|NCT00201123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488648|NCT00201123|Antiviral Agents|antiviral agents|mesh-ancestor
25488649|NCT00201123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25488650|NCT00201448|Vaccines|vaccines|mesh-list
25488651|NCT00201448|Immunologic Factors|immunologic factors|mesh-ancestor
25488652|NCT00201448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488653|NCT00201643|Dexamethasone|dexamethasone|mesh-list
25488654|NCT00201643|Betamethasone|betamethasone|mesh-list
25488655|NCT00201643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25488656|NCT00201643|Antiemetics|antiemetics|mesh-ancestor
25488657|NCT00201643|Autonomic Agents|autonomic agents|mesh-ancestor
25488658|NCT00201643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25488659|NCT00201643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488660|NCT00201643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25488661|NCT00201643|Glucocorticoids|glucocorticoids|mesh-ancestor
25488662|NCT00201643|Hormones|hormones|mesh-ancestor
25488663|NCT00201643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25488664|NCT00201643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25488665|NCT00201643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488666|NCT00201643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25488667|NCT00201643|Respiratory System Agents|respiratory system agents|mesh-ancestor
25488668|NCT00201734|Paclitaxel|paclitaxel|mesh-list
25488669|NCT00201734|Carboplatin|carboplatin|mesh-list
25488670|NCT00201734|Capecitabine|capecitabine|mesh-list
25488671|NCT00201734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25488672|NCT00201734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488673|NCT00201734|Tubulin Modulators|tubulin modulators|mesh-ancestor
25488674|NCT00201734|Antimitotic Agents|antimitotic agents|mesh-ancestor
25488675|NCT00201734|Mitosis Modulators|mitosis modulators|mesh-ancestor
25160127|NCT03268382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25160128|NCT03268382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25160129|NCT03268382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25160130|NCT03268382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25160131|NCT03268382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119051|NCT02980276|Metformin|metformin|mesh-list
25119052|NCT02980276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25119053|NCT02980276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160214|NCT03171025|Nivolumab|nivolumab|mesh-list
25160215|NCT03171025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25160216|NCT03171025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25160217|NCT03171025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25160218|NCT03171025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119113|NCT02759380|Phytoestrogens|phytoestrogens|mesh-list
25160229|NCT03151746|Gabapentin|gabapentin|mesh-list
25160230|NCT03151746|Analgesics|analgesics|mesh-ancestor
25488693|NCT00201773|Celecoxib|celecoxib|mesh-list
25488694|NCT00201773|Exemestane|exemestane|mesh-list
25488695|NCT00201773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25488696|NCT00201773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25488697|NCT00201773|Analgesics|analgesics|mesh-ancestor
25488698|NCT00201773|Sensory System Agents|sensory system agents|mesh-ancestor
25488699|NCT00201773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25488700|NCT00201773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488701|NCT00201773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25488702|NCT00201773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25488703|NCT00201773|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25488704|NCT00201773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25488705|NCT00201773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25488706|NCT00201773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488707|NCT00201773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488708|NCT00201773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25488709|NCT00201773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25488710|NCT00201773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25488711|NCT00201773|Hormone Antagonists|hormone antagonists|mesh-ancestor
25408470|NCT03438396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488712|NCT00201773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25488713|NCT00201825|Docetaxel|docetaxel|mesh-list
25488714|NCT00201825|Capecitabine|capecitabine|mesh-list
25488715|NCT00201825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488716|NCT00201825|Tubulin Modulators|tubulin modulators|mesh-ancestor
25488717|NCT00201825|Antimitotic Agents|antimitotic agents|mesh-ancestor
25488718|NCT00201825|Mitosis Modulators|mitosis modulators|mesh-ancestor
25488719|NCT00201825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488720|NCT00201825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25488721|NCT00201825|Antimetabolites|antimetabolites|mesh-ancestor
25160476|NCT02917083|Cyclophosphamide|cyclophosphamide|mesh-list
25160477|NCT02917083|Fludarabine|fludarabine|mesh-list
25160478|NCT02917083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25160479|NCT02917083|Immunologic Factors|immunologic factors|mesh-ancestor
25160480|NCT02917083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160481|NCT02917083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25160482|NCT02917083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25160550|NCT02885272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25160551|NCT02881242|Trametinib|trametinib|mesh-list
25160552|NCT02881242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25160553|NCT02881242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25021858|NCT03667352|Fentanyl|fentanyl|mesh-list
25488722|NCT00201838|Gemcitabine|gemcitabine|mesh-list
25488723|NCT00201838|Etanercept|etanercept|mesh-list
25488724|NCT00201838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25488725|NCT00201838|Antimetabolites|antimetabolites|mesh-ancestor
25488726|NCT00201838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488727|NCT00201838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488728|NCT00201838|Antiviral Agents|antiviral agents|mesh-ancestor
25488729|NCT00201838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25488730|NCT00201838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25488731|NCT00201838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25488732|NCT00201838|Immunologic Factors|immunologic factors|mesh-ancestor
25488733|NCT00201838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488734|NCT00201838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25488735|NCT00201838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25488736|NCT00201838|Analgesics|analgesics|mesh-ancestor
25488737|NCT00201838|Sensory System Agents|sensory system agents|mesh-ancestor
25488738|NCT00201838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25488739|NCT00201838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25488740|NCT00201838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25488741|NCT00201838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25488742|NCT00201851|Tamoxifen|tamoxifen|mesh-list
25488743|NCT00201851|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25488744|NCT00201851|Hormone Antagonists|hormone antagonists|mesh-ancestor
25488745|NCT00201851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25488746|NCT00201851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488747|NCT00201851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25488748|NCT00201851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488749|NCT00201851|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25488750|NCT00201851|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25488751|NCT00201851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25488752|NCT00201864|Fulvestrant|fulvestrant|mesh-list
25488753|NCT00201864|Exemestane|exemestane|mesh-list
25488754|NCT00201864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25488755|NCT00201864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488756|NCT00201864|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25488757|NCT00201864|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25488758|NCT00201864|Hormone Antagonists|hormone antagonists|mesh-ancestor
25488759|NCT00201864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25488760|NCT00201864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488761|NCT00201864|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25488762|NCT00201864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25488763|NCT00201864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25488764|NCT00201864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488765|NCT00201877|Rituximab|rituximab|mesh-list
25488766|NCT00201877|Bortezomib|bortezomib|mesh-list
25488767|NCT00201877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25488768|NCT00201877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488769|NCT00201877|Immunologic Factors|immunologic factors|mesh-ancestor
25488770|NCT00201877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488771|NCT00201877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25488772|NCT00202449|Prazosin|prazosin|mesh-list
25488773|NCT00202449|Paroxetine|paroxetine|mesh-list
25488774|NCT00202449|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25645168|NCT01445028|Dermatologic Agents|dermatologic agents|mesh-ancestor
25645169|NCT01445080|Sorafenib|sorafenib|mesh-list
25488775|NCT00202449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25488776|NCT00202449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25488777|NCT00202449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488778|NCT00202449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25488779|NCT00202449|Serotonin Agents|serotonin agents|mesh-ancestor
25488780|NCT00202449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488781|NCT00202449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25488782|NCT00202449|Antidepressive Agents|antidepressive agents|mesh-ancestor
25488783|NCT00202449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25488784|NCT00202449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24680524|NCT01375322|Amlodipine|amlodipine|mesh-list
25160973|NCT02293980|Nivolumab|nivolumab|mesh-list
25160974|NCT02293980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25160975|NCT02293980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25160976|NCT02293980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25160977|NCT02293980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160978|NCT02236013|Cytarabine|cytarabine|mesh-list
25160979|NCT02236013|Daunorubicin|daunorubicin|mesh-list
25160980|NCT02236013|Idarubicin|idarubicin|mesh-list
25160981|NCT02236013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25488785|NCT00202449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25488787|NCT00202449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25488788|NCT00202449|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25488789|NCT00202449|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25488790|NCT00202449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25488791|NCT00202449|Adrenergic Agents|adrenergic agents|mesh-ancestor
25488792|NCT00202644|Hydroxyurea|hydroxyurea|mesh-list
25488793|NCT00202644|Anagrelide|anagrelide|mesh-list
25488794|NCT00202644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488795|NCT00202644|Antisickling Agents|antisickling agents|mesh-ancestor
25488796|NCT00202644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25488797|NCT00202644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488798|NCT00202644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25488799|NCT00202644|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25488800|NCT00202644|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25488801|NCT00202644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25488802|NCT00202722|Remifentanil|remifentanil|mesh-list
25488803|NCT00202722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25488804|NCT00202722|Narcotics|narcotics|mesh-ancestor
25488805|NCT00202722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25488806|NCT00202722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488807|NCT00202722|Analgesics|analgesics|mesh-ancestor
25488808|NCT00202722|Sensory System Agents|sensory system agents|mesh-ancestor
25488809|NCT00202722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25488810|NCT00202839|Ribavirin|ribavirin|mesh-list
25488811|NCT00202839|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25488812|NCT00202839|Interferon-alpha|interferon-alpha|mesh-list
25488813|NCT00202839|Antimetabolites|antimetabolites|mesh-ancestor
25488814|NCT00202839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488815|NCT00202839|Antiviral Agents|antiviral agents|mesh-ancestor
25488816|NCT00202839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25488817|NCT00202839|Immunologic Factors|immunologic factors|mesh-ancestor
25488818|NCT00202839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488819|NCT00202930|Rituximab|rituximab|mesh-list
25488820|NCT00202930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25488821|NCT00202930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488822|NCT00202930|Immunologic Factors|immunologic factors|mesh-ancestor
25488823|NCT00202930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488824|NCT00202930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25488825|NCT00203021|Glatiramer Acetate|glatiramer acetate|mesh-list
25488826|NCT00203021|(T,G)-A-L|(t,g)-a-l|mesh-list
25488827|NCT00203021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25488828|NCT00203021|Immunologic Factors|immunologic factors|mesh-ancestor
25488829|NCT00203021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488830|NCT00203021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25488831|NCT00203021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25488832|NCT00203047|Prednisone|prednisone|mesh-list
25488833|NCT00203047|Glatiramer Acetate|glatiramer acetate|mesh-list
25488834|NCT00203047|(T,G)-A-L|(t,g)-a-l|mesh-list
25488835|NCT00203047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25488836|NCT00203047|Glucocorticoids|glucocorticoids|mesh-ancestor
25488837|NCT00203047|Hormones|hormones|mesh-ancestor
25488838|NCT00203047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24819848|NCT02097394|Pancreatin|pancreatin|mesh-list
25488839|NCT00203047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488840|NCT00203047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25488841|NCT00203047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488842|NCT00203047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25488843|NCT00203047|Immunologic Factors|immunologic factors|mesh-ancestor
25488844|NCT00203047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25488845|NCT00203047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25488846|NCT00203216|Levetiracetam|levetiracetam|mesh-list
25488847|NCT00203216|Anticonvulsants|anticonvulsants|mesh-ancestor
25488848|NCT00203216|Nootropic Agents|nootropic agents|mesh-ancestor
25488849|NCT00203229|Lamotrigine|lamotrigine|mesh-list
25488850|NCT00203229|Anticonvulsants|anticonvulsants|mesh-ancestor
25488851|NCT00203229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25161273|NCT01568177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120122|NCT04592159|Nabiximols|nabiximols|mesh-list
25161312|NCT01497392|Immunologic Factors|immunologic factors|mesh-ancestor
25161313|NCT01497392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598408|NCT00956098|Oltipraz|oltipraz|mesh-list
25120367|NCT03995004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25120368|NCT03995004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24804457|NCT02002611|Warfarin|warfarin|mesh-list
25161487|NCT00659711|Hormones|hormones|mesh-ancestor
25488852|NCT00203229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25488853|NCT00203229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488854|NCT00203229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25488855|NCT00203229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488857|NCT00203229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25488858|NCT00203229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25488859|NCT00203229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25488860|NCT00203229|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25488861|NCT00203242|Valproic Acid|valproic acid|mesh-list
25488862|NCT00203242|Anticonvulsants|anticonvulsants|mesh-ancestor
25488863|NCT00203242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25488864|NCT00203242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488865|NCT00203242|GABA Agents|gaba agents|mesh-ancestor
25488866|NCT00203242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25488867|NCT00203242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488868|NCT00203242|Antimanic Agents|antimanic agents|mesh-ancestor
25488869|NCT00203242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25488870|NCT00203242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25488871|NCT00203242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25488872|NCT00203268|Dihydroergotamine|dihydroergotamine|mesh-list
25488873|NCT00203268|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25488874|NCT00203268|Dopamine Agonists|dopamine agonists|mesh-ancestor
25488875|NCT00203268|Dopamine Agents|dopamine agents|mesh-ancestor
25488876|NCT00203268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25488877|NCT00203268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488878|NCT00203268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488879|NCT00203268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25488880|NCT00203268|Analgesics|analgesics|mesh-ancestor
25488881|NCT00203268|Sensory System Agents|sensory system agents|mesh-ancestor
25488882|NCT00203268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25488883|NCT00203294|Triamcinolone|triamcinolone|mesh-list
25488884|NCT00203294|Lidocaine|lidocaine|mesh-list
25488885|NCT00203294|Bupivacaine|bupivacaine|mesh-list
25488886|NCT00203294|Anesthetics, Local|anesthetics, local|mesh-ancestor
25488887|NCT00203294|Anesthetics|anesthetics|mesh-ancestor
25488888|NCT00203294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25488889|NCT00203294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488890|NCT00203294|Sensory System Agents|sensory system agents|mesh-ancestor
25488891|NCT00203294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25488892|NCT00203294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25488893|NCT00203294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25488894|NCT00203294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25488895|NCT00203294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25488896|NCT00203294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488897|NCT00203294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25488898|NCT00203294|Glucocorticoids|glucocorticoids|mesh-ancestor
25488899|NCT00203294|Hormones|hormones|mesh-ancestor
25488900|NCT00203294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25488901|NCT00203307|Olanzapine|olanzapine|mesh-list
25488902|NCT00203307|Antiemetics|antiemetics|mesh-ancestor
25488903|NCT00203307|Autonomic Agents|autonomic agents|mesh-ancestor
25488904|NCT00203307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25488905|NCT00203307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488907|NCT00203307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25488908|NCT00203307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25488909|NCT00203307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25488910|NCT00203307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25488911|NCT00203307|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25488912|NCT00203307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25488913|NCT00203307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25488914|NCT00203307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488915|NCT00203307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25488916|NCT00203307|Serotonin Agents|serotonin agents|mesh-ancestor
25488917|NCT00203411|Bevacizumab|bevacizumab|mesh-list
25488918|NCT00203411|Capecitabine|capecitabine|mesh-list
25488919|NCT00203411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25488920|NCT00203411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488921|NCT00203411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25488922|NCT00203411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25488923|NCT00203411|Growth Substances|growth substances|mesh-ancestor
25161628|NCT00042289|Moxifloxacin|moxifloxacin|mesh-list
25488924|NCT00203411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488925|NCT00203411|Growth Inhibitors|growth inhibitors|mesh-ancestor
25488926|NCT00203411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25488927|NCT00203411|Antimetabolites|antimetabolites|mesh-ancestor
25488928|NCT00203411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488929|NCT00203424|Bevacizumab|bevacizumab|mesh-list
25488930|NCT00203424|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25488931|NCT00203424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25488932|NCT00203424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488933|NCT00203424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25488934|NCT00203424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25488935|NCT00203424|Growth Substances|growth substances|mesh-ancestor
25488936|NCT00203424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488937|NCT00203424|Growth Inhibitors|growth inhibitors|mesh-ancestor
25488938|NCT00203424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25488939|NCT00203424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25488940|NCT00203424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488941|NCT00203476|Niacin|niacin|mesh-list
25488942|NCT00203476|Ezetimibe|ezetimibe|mesh-list
25488943|NCT00203476|Colestipol|colestipol|mesh-list
25488944|NCT00203476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25488945|NCT00203476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25488946|NCT00203476|Antimetabolites|antimetabolites|mesh-ancestor
25488947|NCT00203476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488948|NCT00203476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25488949|NCT00203476|Vasodilator Agents|vasodilator agents|mesh-ancestor
25488950|NCT00203476|Vitamin B Complex|vitamin b complex|mesh-ancestor
25488951|NCT00203476|Vitamins|vitamins|mesh-ancestor
25488952|NCT00203476|Micronutrients|micronutrients|mesh-ancestor
25488953|NCT00203476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488954|NCT00203476|Sequestering Agents|sequestering agents|mesh-ancestor
25488955|NCT00203502|Cyclophosphamide|cyclophosphamide|mesh-list
25488956|NCT00203502|Bevacizumab|bevacizumab|mesh-list
25488957|NCT00203502|Docetaxel|docetaxel|mesh-list
25488958|NCT00203502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25488959|NCT00203502|Immunologic Factors|immunologic factors|mesh-ancestor
25488960|NCT00203502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488961|NCT00203502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25488962|NCT00203502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25488963|NCT00203502|Alkylating Agents|alkylating agents|mesh-ancestor
25488964|NCT00203502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488965|NCT00203502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488966|NCT00203502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25488967|NCT00203502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25488968|NCT00203502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25488969|NCT00203502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25488970|NCT00203502|Growth Substances|growth substances|mesh-ancestor
25488971|NCT00203502|Growth Inhibitors|growth inhibitors|mesh-ancestor
25488972|NCT00203502|Tubulin Modulators|tubulin modulators|mesh-ancestor
25488973|NCT00203502|Antimitotic Agents|antimitotic agents|mesh-ancestor
25488974|NCT00203502|Mitosis Modulators|mitosis modulators|mesh-ancestor
25488975|NCT00203931|Pemetrexed|pemetrexed|mesh-list
25488976|NCT00203931|Cetuximab|cetuximab|mesh-list
25488977|NCT00203931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488978|NCT00203931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645170|NCT01445080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645171|NCT01445080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25645172|NCT01445080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25488979|NCT00203931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25488980|NCT00203931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25488981|NCT00203931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25488982|NCT00203931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25488983|NCT00203996|Pioglitazone|pioglitazone|mesh-list
25488984|NCT00203996|Leuprolide|leuprolide|mesh-list
25488985|NCT00203996|Estrogens|estrogens|mesh-list
25488986|NCT00203996|Progestins|progestins|mesh-list
25488987|NCT00203996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25488988|NCT00203996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25488989|NCT00203996|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25488990|NCT00203996|Fertility Agents|fertility agents|mesh-ancestor
25488991|NCT00203996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25488992|NCT00203996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25488993|NCT00203996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25488994|NCT00203996|Hormones|hormones|mesh-ancestor
25488995|NCT00203996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25488996|NCT00204373|Lansoprazole|lansoprazole|mesh-list
25488997|NCT00204373|Dexlansoprazole|dexlansoprazole|mesh-list
25488998|NCT00204373|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25125230|NCT03070405|Tenofovir|tenofovir|mesh-list
25488999|NCT00204373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25489000|NCT00204373|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25489001|NCT00204373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489002|NCT00204373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489003|NCT00205374|Cidofovir|cidofovir|mesh-list
25489004|NCT00205374|Antiviral Agents|antiviral agents|mesh-ancestor
25489005|NCT00205374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25489006|NCT00205374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489007|NCT00205374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489008|NCT00205504|Moxifloxacin|moxifloxacin|mesh-list
25489009|NCT00205504|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25489010|NCT00205504|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25489011|NCT00205504|Contraceptive Agents|contraceptive agents|mesh-ancestor
25489012|NCT00205504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25489013|NCT00205504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489014|NCT00205504|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25489015|NCT00205504|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25489016|NCT00205504|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25489017|NCT00205504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25489018|NCT00205504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25489019|NCT00205504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25489020|NCT00205504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25489021|NCT00205504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489022|NCT00205504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489023|NCT00205504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489024|NCT00205699|Olanzapine|olanzapine|mesh-list
25489025|NCT00205699|Risperidone|risperidone|mesh-list
25489026|NCT00205699|Aripiprazole|aripiprazole|mesh-list
25489027|NCT00205699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25489028|NCT00205699|Serotonin Agents|serotonin agents|mesh-ancestor
25489029|NCT00205699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25489030|NCT00205699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489031|NCT00205699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489032|NCT00205699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25489033|NCT00205699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25489034|NCT00205699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25489035|NCT00205699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25489036|NCT00205699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25489037|NCT00205699|Dopamine Agents|dopamine agents|mesh-ancestor
25489038|NCT00205699|Antiemetics|antiemetics|mesh-ancestor
25489039|NCT00205699|Autonomic Agents|autonomic agents|mesh-ancestor
25489040|NCT00205699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25489041|NCT00205699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25489042|NCT00205699|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25489043|NCT00205699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25489044|NCT00205699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25489045|NCT00205699|Antidepressive Agents|antidepressive agents|mesh-ancestor
25489046|NCT00205699|Dopamine Agonists|dopamine agonists|mesh-ancestor
25489047|NCT00205699|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25489048|NCT00205699|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25489049|NCT00205699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25645173|NCT01445080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645174|NCT01445535|Prednisone|prednisone|mesh-list
25823144|NCT00004758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25489050|NCT00205699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25489051|NCT00205712|Dexmedetomidine|dexmedetomidine|mesh-list
25489052|NCT00205712|Ketamine|ketamine|mesh-list
25489053|NCT00205712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25489054|NCT00205712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25489055|NCT00205712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489056|NCT00205712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25489057|NCT00205712|Analgesics|analgesics|mesh-ancestor
25489058|NCT00205712|Sensory System Agents|sensory system agents|mesh-ancestor
25489059|NCT00205712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25489060|NCT00205712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25489061|NCT00205712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25489062|NCT00205712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25489063|NCT00205712|Adrenergic Agents|adrenergic agents|mesh-ancestor
25489064|NCT00205712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25489065|NCT00205712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489066|NCT00205712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25489067|NCT00205712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25489068|NCT00205712|Anesthetics, General|anesthetics, general|mesh-ancestor
25489069|NCT00205712|Anesthetics|anesthetics|mesh-ancestor
25489070|NCT00205712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25489071|NCT00205712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25127346|NCT03056274|Metformin|metformin|mesh-list
25489073|NCT00205777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25489074|NCT00205777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25489075|NCT00205777|Hormone Antagonists|hormone antagonists|mesh-ancestor
25489076|NCT00205777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25489077|NCT00205777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489078|NCT00205777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25489079|NCT00205803|Vaccines|vaccines|mesh-list
25489080|NCT00205803|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25489081|NCT00205803|Immunologic Factors|immunologic factors|mesh-ancestor
25489082|NCT00205803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489083|NCT00206076|Mycophenolic Acid|mycophenolic acid|mesh-list
25489084|NCT00206076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25489085|NCT00206076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489086|NCT00206076|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25489087|NCT00206076|Antitubercular Agents|antitubercular agents|mesh-ancestor
25489088|NCT00206076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25489089|NCT00206076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25489090|NCT00206076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489091|NCT00206076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489092|NCT00206102|Risperidone|risperidone|mesh-list
25489093|NCT00206102|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25489094|NCT00206102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25489095|NCT00206102|Serotonin Agents|serotonin agents|mesh-ancestor
25489096|NCT00206102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25489097|NCT00206102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489098|NCT00206102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489099|NCT00206102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25489100|NCT00206102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25489101|NCT00206102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25489102|NCT00206102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25489103|NCT00206102|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25489104|NCT00206102|Dopamine Agents|dopamine agents|mesh-ancestor
25489105|NCT00206102|Antidepressive Agents|antidepressive agents|mesh-ancestor
25489106|NCT00206323|Topiramate|topiramate|mesh-list
25489107|NCT00206323|Anticonvulsants|anticonvulsants|mesh-ancestor
25489108|NCT00206323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25489109|NCT00206323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489110|NCT00206336|Topiramate|topiramate|mesh-list
25489111|NCT00206336|Anticonvulsants|anticonvulsants|mesh-ancestor
25489112|NCT00206336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25489113|NCT00206336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489114|NCT00206427|Lapatinib|lapatinib|mesh-list
25489115|NCT00206427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489116|NCT00206427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25489117|NCT00206427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489118|NCT00206427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489119|NCT00206440|Esomeprazole|esomeprazole|mesh-list
25489120|NCT00206440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25489121|NCT00206440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25489122|NCT00206440|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25489123|NCT00206440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489124|NCT00206440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489125|NCT00206518|Docetaxel|docetaxel|mesh-list
25489126|NCT00206518|Doxorubicin|doxorubicin|mesh-list
25489127|NCT00206518|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25489128|NCT00206518|Cyclophosphamide|cyclophosphamide|mesh-list
25489129|NCT00206518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489130|NCT00206518|Tubulin Modulators|tubulin modulators|mesh-ancestor
25489131|NCT00206518|Antimitotic Agents|antimitotic agents|mesh-ancestor
25489132|NCT00206518|Mitosis Modulators|mitosis modulators|mesh-ancestor
25489133|NCT00206518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489134|NCT00206518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25489135|NCT00206518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25489136|NCT00206518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25489137|NCT00206518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489138|NCT00206518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25489139|NCT00206518|Immunologic Factors|immunologic factors|mesh-ancestor
25489140|NCT00206518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489141|NCT00206518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25489142|NCT00206518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25131359|NCT03026478|Respiratory System Agents|respiratory system agents|mesh-ancestor
25131360|NCT03026205|Cetylpyridinium|cetylpyridinium|mesh-list
25131361|NCT03026205|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25489143|NCT00206518|Alkylating Agents|alkylating agents|mesh-ancestor
25489144|NCT00206518|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25489145|NCT00206726|Fludarabine|fludarabine|mesh-list
25489146|NCT00206726|Alemtuzumab|alemtuzumab|mesh-list
25489147|NCT00206726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489148|NCT00206726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25489149|NCT00207090|Rifampin|rifampin|mesh-list
25489150|NCT00207090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25489151|NCT00207090|Antitubercular Agents|antitubercular agents|mesh-ancestor
25489152|NCT00207090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25489153|NCT00207090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25489154|NCT00207090|Leprostatic Agents|leprostatic agents|mesh-ancestor
25489155|NCT00207090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25489156|NCT00207090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489157|NCT00207090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489158|NCT00207090|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25489159|NCT00207090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25489160|NCT00207090|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25489161|NCT00207090|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25489162|NCT00207090|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25489163|NCT00207090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25489164|NCT00207142|Ritonavir|ritonavir|mesh-list
25489165|NCT00207142|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25489166|NCT00207142|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25489167|NCT00207142|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25489168|NCT00207142|Protease Inhibitors|protease inhibitors|mesh-ancestor
25489169|NCT00207142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489170|NCT00207142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489171|NCT00207142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25489172|NCT00207142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25489173|NCT00207142|Antiviral Agents|antiviral agents|mesh-ancestor
25489174|NCT00207142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25489175|NCT00207142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25489176|NCT00207142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25489177|NCT00207714|Golimumab|golimumab|mesh-list
25489178|NCT00207714|Infliximab|infliximab|mesh-list
25489179|NCT00207714|Dermatologic Agents|dermatologic agents|mesh-ancestor
25489180|NCT00207714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25489181|NCT00207714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25489182|NCT00207714|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25489183|NCT00207714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25489184|NCT00207714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25489185|NCT00207714|Immunologic Factors|immunologic factors|mesh-ancestor
25489186|NCT00207714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489187|NCT00207727|Ustekinumab|ustekinumab|mesh-list
25489188|NCT00207727|Dermatologic Agents|dermatologic agents|mesh-ancestor
25489189|NCT00207740|Golimumab|golimumab|mesh-list
25489190|NCT00207740|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25489191|NCT00207740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25823145|NCT00004758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25645177|NCT01445535|Doxorubicin|doxorubicin|mesh-list
25489192|NCT00207740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25645178|NCT01445535|Etoposide|etoposide|mesh-list
25489193|NCT00207740|Immunologic Factors|immunologic factors|mesh-ancestor
25489194|NCT00207740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489195|NCT00208026|Pimecrolimus|pimecrolimus|mesh-list
25489196|NCT00208026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25489197|NCT00208026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25489198|NCT00208026|Analgesics|analgesics|mesh-ancestor
25489199|NCT00208026|Sensory System Agents|sensory system agents|mesh-ancestor
25489200|NCT00208026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25489201|NCT00208026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489202|NCT00208026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25489203|NCT00208026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25489204|NCT00208026|Dermatologic Agents|dermatologic agents|mesh-ancestor
25489205|NCT00208026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25489206|NCT00208026|Immunologic Factors|immunologic factors|mesh-ancestor
25489207|NCT00208026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25489208|NCT00208026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489209|NCT00208026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489210|NCT00208091|Botulinum Toxins|botulinum toxins|mesh-list
25489211|NCT00208091|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25489212|NCT00208091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25489213|NCT00208091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489214|NCT00208091|Cholinergic Agents|cholinergic agents|mesh-ancestor
25489215|NCT00208091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25489216|NCT00208091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489218|NCT00208767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25489219|NCT00208767|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25489220|NCT00208767|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25489221|NCT00208767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489222|NCT00208975|Cyclophosphamide|cyclophosphamide|mesh-list
25489223|NCT00208975|Rituximab|rituximab|mesh-list
25489224|NCT00208975|Fludarabine|fludarabine|mesh-list
25489225|NCT00208975|Mitoxantrone|mitoxantrone|mesh-list
25489226|NCT00208975|Sargramostim|sargramostim|mesh-list
25489227|NCT00208975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25489228|NCT00208975|Immunologic Factors|immunologic factors|mesh-ancestor
25489229|NCT00208975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489230|NCT00208975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25489231|NCT00208975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25489232|NCT00208975|Alkylating Agents|alkylating agents|mesh-ancestor
25489233|NCT00208975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489234|NCT00208975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489235|NCT00208975|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25489236|NCT00208975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25489237|NCT00208975|Analgesics|analgesics|mesh-ancestor
25489238|NCT00208975|Sensory System Agents|sensory system agents|mesh-ancestor
25489239|NCT00208975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25489240|NCT00208975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25489241|NCT00208975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25489242|NCT00208975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489243|NCT00209092|Docetaxel|docetaxel|mesh-list
25489244|NCT00209092|Capecitabine|capecitabine|mesh-list
25489245|NCT00209092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489246|NCT00209092|Tubulin Modulators|tubulin modulators|mesh-ancestor
25489247|NCT00209092|Antimitotic Agents|antimitotic agents|mesh-ancestor
25489248|NCT00209092|Mitosis Modulators|mitosis modulators|mesh-ancestor
25489249|NCT00209092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489250|NCT00209092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25489251|NCT00209092|Antimetabolites|antimetabolites|mesh-ancestor
25489252|NCT00209170|Citalopram|citalopram|mesh-list
25489253|NCT00209170|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25489254|NCT00209170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25489255|NCT00209170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25489256|NCT00209170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489257|NCT00209170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25489258|NCT00209170|Serotonin Agents|serotonin agents|mesh-ancestor
25489259|NCT00209170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645179|NCT01445535|Vincristine|vincristine|mesh-list
25202095|NCT02723838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25645180|NCT01445535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25645181|NCT01445535|Immunologic Factors|immunologic factors|mesh-ancestor
25645182|NCT01445535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489260|NCT00209170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25489261|NCT00209170|Antidepressive Agents|antidepressive agents|mesh-ancestor
25489262|NCT00209170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25489263|NCT00209560|Fospropofol|fospropofol|mesh-list
25489264|NCT00209560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25489265|NCT00209560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25645183|NCT01445535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25645184|NCT01445535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25645185|NCT01445535|Alkylating Agents|alkylating agents|mesh-ancestor
25645186|NCT01445535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645187|NCT01445535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489266|NCT00209560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489267|NCT00210119|Imatinib Mesylate|imatinib mesylate|mesh-list
25489268|NCT00210119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489269|NCT00210119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25489270|NCT00210119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489271|NCT00210119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489272|NCT00210184|Leucovorin|leucovorin|mesh-list
25489273|NCT00210184|Fluorouracil|fluorouracil|mesh-list
25489274|NCT00210184|Irinotecan|irinotecan|mesh-list
25489275|NCT00210184|Antimetabolites|antimetabolites|mesh-ancestor
25489276|NCT00210184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489277|NCT00210184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25489278|NCT00210184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489279|NCT00210184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25489280|NCT00210184|Immunologic Factors|immunologic factors|mesh-ancestor
25489281|NCT00210184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489282|NCT00210184|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25489283|NCT00210184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25489284|NCT00210184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489285|NCT00210184|Antidotes|antidotes|mesh-ancestor
25489286|NCT00210184|Protective Agents|protective agents|mesh-ancestor
25137214|NCT02986321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25137215|NCT02986321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25137216|NCT02986321|Autonomic Agents|autonomic agents|mesh-ancestor
25137217|NCT02986321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25489287|NCT00210184|Vitamin B Complex|vitamin b complex|mesh-ancestor
25489288|NCT00210184|Vitamins|vitamins|mesh-ancestor
25489289|NCT00210184|Micronutrients|micronutrients|mesh-ancestor
25489290|NCT00210353|Rituximab|rituximab|mesh-list
25489291|NCT00210353|Chlorambucil|chlorambucil|mesh-list
25489292|NCT00210353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25489293|NCT00210353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489294|NCT00210353|Immunologic Factors|immunologic factors|mesh-ancestor
25489295|NCT00210353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489296|NCT00210353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25489297|NCT00210353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25489298|NCT00210353|Alkylating Agents|alkylating agents|mesh-ancestor
25489299|NCT00210353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489300|NCT00210470|Zinc|zinc|mesh-list
25489301|NCT00210470|Indomethacin|indomethacin|mesh-list
25489302|NCT00210470|Cyclophosphamide|cyclophosphamide|mesh-list
25489303|NCT00210470|Omeprazole|omeprazole|mesh-list
25489304|NCT00210470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25489305|NCT00210470|Immunologic Factors|immunologic factors|mesh-ancestor
25489306|NCT00210470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489307|NCT00210470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25489308|NCT00210470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25489309|NCT00210470|Alkylating Agents|alkylating agents|mesh-ancestor
25489310|NCT00210470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489311|NCT00210470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489312|NCT00210470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25489313|NCT00210470|Trace Elements|trace elements|mesh-ancestor
25489314|NCT00210470|Micronutrients|micronutrients|mesh-ancestor
25489315|NCT00210470|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25489316|NCT00210470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25489317|NCT00210470|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25489318|NCT00210470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489319|NCT00210470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25202103|NCT02723500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489320|NCT00210470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25489321|NCT00210470|Analgesics|analgesics|mesh-ancestor
25645188|NCT01445535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25645189|NCT01445535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25645190|NCT01445535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25645191|NCT01445535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25645192|NCT01445535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25489322|NCT00210470|Sensory System Agents|sensory system agents|mesh-ancestor
25489323|NCT00210470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25489324|NCT00210470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25489325|NCT00210470|Gout Suppressants|gout suppressants|mesh-ancestor
25489326|NCT00210470|Tocolytic Agents|tocolytic agents|mesh-ancestor
25489327|NCT00210470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25489328|NCT00210470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25489329|NCT00210626|Epoetin Alfa|epoetin alfa|mesh-list
25489330|NCT00210626|Hematinics|hematinics|mesh-ancestor
25489331|NCT00211081|Spironolactone|spironolactone|mesh-list
25489332|NCT00211081|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25489333|NCT00211081|Hormone Antagonists|hormone antagonists|mesh-ancestor
25489334|NCT00211081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25489335|NCT00211081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489336|NCT00211081|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25489337|NCT00211081|Diuretics|diuretics|mesh-ancestor
25489338|NCT00211081|Natriuretic Agents|natriuretic agents|mesh-ancestor
25489339|NCT00211172|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25489340|NCT00211172|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25489341|NCT00211172|Adrenergic Agents|adrenergic agents|mesh-ancestor
25489342|NCT00211172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25489343|NCT00211172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489344|NCT00211172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489345|NCT00211185|Prednisone|prednisone|mesh-list
25489346|NCT00211185|Cyclophosphamide|cyclophosphamide|mesh-list
25489347|NCT00211185|Doxorubicin|doxorubicin|mesh-list
25489348|NCT00211185|Vincristine|vincristine|mesh-list
25489349|NCT00211185|Denileukin diftitox|denileukin diftitox|mesh-list
25489350|NCT00211185|Lenograstim|lenograstim|mesh-list
25489351|NCT00211185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25489352|NCT00211185|Immunologic Factors|immunologic factors|mesh-ancestor
25489353|NCT00211185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489354|NCT00211185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25489355|NCT00211185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25489356|NCT00211185|Alkylating Agents|alkylating agents|mesh-ancestor
25489357|NCT00211185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489358|NCT00211185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485174|NCT00451867|Mycophenolic Acid|mycophenolic acid|mesh-list
25139797|NCT02968693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25139798|NCT02968693|Antitubercular Agents|antitubercular agents|mesh-ancestor
25489359|NCT00211185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25489360|NCT00211185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25489361|NCT00211185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25489362|NCT00211185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25489363|NCT00211185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489364|NCT00211185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25489366|NCT00211185|Hormones|hormones|mesh-ancestor
25489367|NCT00211185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25489368|NCT00211185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25489369|NCT00211185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25489370|NCT00211185|Tubulin Modulators|tubulin modulators|mesh-ancestor
25489371|NCT00211185|Antimitotic Agents|antimitotic agents|mesh-ancestor
25489372|NCT00211185|Mitosis Modulators|mitosis modulators|mesh-ancestor
25489373|NCT00211185|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25489374|NCT00211510|Insulin|insulin|mesh-list
25489375|NCT00211510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25489376|NCT00211510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489377|NCT00211536|Insulin|insulin|mesh-list
25489378|NCT00211536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25489379|NCT00211536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25489380|NCT00211536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489381|NCT00211692|Interferons|interferons|mesh-list
25489382|NCT00211692|Ribavirin|ribavirin|mesh-list
25489383|NCT00211692|Interferon-alpha|interferon-alpha|mesh-list
25489384|NCT00211692|Interferon alfacon-1|interferon alfacon-1|mesh-list
25489385|NCT00211692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066694|NCT02099188|Antidotes|antidotes|mesh-ancestor
24954653|NCT03874000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24954654|NCT03874000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954656|NCT03874026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25489386|NCT00211692|Antiviral Agents|antiviral agents|mesh-ancestor
25489387|NCT00211692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25489388|NCT00211692|Antimetabolites|antimetabolites|mesh-ancestor
25489389|NCT00211692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489390|NCT00211692|Immunologic Factors|immunologic factors|mesh-ancestor
25489391|NCT00211692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489392|NCT00211757|Valproic Acid|valproic acid|mesh-list
25489393|NCT00211757|Anticonvulsants|anticonvulsants|mesh-ancestor
25489394|NCT00211757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489395|NCT00211757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489396|NCT00211757|GABA Agents|gaba agents|mesh-ancestor
25489397|NCT00211757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25489398|NCT00211757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489399|NCT00211757|Antimanic Agents|antimanic agents|mesh-ancestor
25489400|NCT00211757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25489401|NCT00211757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25489402|NCT00211757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25489403|NCT00211809|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25489404|NCT00211809|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25489405|NCT00211809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25489406|NCT00211809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25489407|NCT00211809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489408|NCT00211809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25489409|NCT00211809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489410|NCT00211809|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25489411|NCT00211809|Antidepressive Agents|antidepressive agents|mesh-ancestor
25489412|NCT00211809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25489413|NCT00211887|Interferons|interferons|mesh-list
25489414|NCT00211887|Interferon-beta|interferon-beta|mesh-list
25489415|NCT00211887|Interferon beta-1a|interferon beta-1a|mesh-list
25489416|NCT00211887|Glatiramer Acetate|glatiramer acetate|mesh-list
25489417|NCT00211887|(T,G)-A-L|(t,g)-a-l|mesh-list
25489418|NCT00211887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489419|NCT00211887|Antiviral Agents|antiviral agents|mesh-ancestor
25489420|NCT00211887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25489421|NCT00211887|Immunologic Factors|immunologic factors|mesh-ancestor
25489422|NCT00211887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489423|NCT00211887|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25489424|NCT00211887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25489425|NCT00211887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25489426|NCT00212758|Hormones|hormones|mesh-list
25489427|NCT00212758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25489428|NCT00212758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489429|NCT00213135|Cladribine|cladribine|mesh-list
25489430|NCT00213135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489431|NCT00213135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24486516|NCT00458315|Paclitaxel|paclitaxel|mesh-list
24533255|NCT00642798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25489432|NCT00213135|Immunologic Factors|immunologic factors|mesh-ancestor
25489435|NCT00213148|Citric Acid|citric acid|mesh-list
25489436|NCT00213148|Sodium Citrate|sodium citrate|mesh-list
25489437|NCT00213148|Clomiphene|clomiphene|mesh-list
25489438|NCT00213148|Enclomiphene|enclomiphene|mesh-list
25489439|NCT00213148|Zuclomiphene|zuclomiphene|mesh-list
25489440|NCT00213148|Anticoagulants|anticoagulants|mesh-ancestor
25489441|NCT00213148|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25489442|NCT00213148|Chelating Agents|chelating agents|mesh-ancestor
25489443|NCT00213148|Sequestering Agents|sequestering agents|mesh-ancestor
25489444|NCT00213148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489445|NCT00213148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25489446|NCT00213148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489447|NCT00213148|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25489448|NCT00213148|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25489449|NCT00213148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489450|NCT00213148|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25489451|NCT00213148|Hormone Antagonists|hormone antagonists|mesh-ancestor
25489452|NCT00213148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25489453|NCT00213148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489454|NCT00213148|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25489455|NCT00213148|Fertility Agents|fertility agents|mesh-ancestor
25489456|NCT00213148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25489457|NCT00213148|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25489458|NCT00213148|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25489459|NCT00213239|Remifentanil|remifentanil|mesh-list
25489460|NCT00213239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25489461|NCT00213239|Narcotics|narcotics|mesh-ancestor
25489462|NCT00213239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25489463|NCT00213239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489464|NCT00213239|Analgesics|analgesics|mesh-ancestor
25489465|NCT00213239|Sensory System Agents|sensory system agents|mesh-ancestor
25489466|NCT00213239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25489467|NCT00213980|Zoledronic Acid|zoledronic acid|mesh-list
25489468|NCT00213980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25489469|NCT00213980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489470|NCT00214019|Fluticasone|fluticasone|mesh-list
25489471|NCT00214019|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25489472|NCT00214019|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25489473|NCT00214019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25489474|NCT00214019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25489475|NCT00214019|Autonomic Agents|autonomic agents|mesh-ancestor
25489476|NCT00214019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25489477|NCT00214019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489478|NCT00214019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25489479|NCT00214019|Respiratory System Agents|respiratory system agents|mesh-ancestor
25489480|NCT00214019|Dermatologic Agents|dermatologic agents|mesh-ancestor
25489481|NCT00214019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25489482|NCT00214019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25489483|NCT00214019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25489484|NCT00214019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25489485|NCT00214019|Adrenergic Agents|adrenergic agents|mesh-ancestor
25489486|NCT00214019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25489487|NCT00214019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489488|NCT00214019|Glucocorticoids|glucocorticoids|mesh-ancestor
25489489|NCT00214019|Hormones|hormones|mesh-ancestor
25489490|NCT00214019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25489491|NCT00214019|Sympathomimetics|sympathomimetics|mesh-ancestor
25489492|NCT00214201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
25489493|NCT00214201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489494|NCT00214201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489495|NCT00214461|Vaccines|vaccines|mesh-list
25489496|NCT00214461|Immunologic Factors|immunologic factors|mesh-ancestor
25489497|NCT00214461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823146|NCT00004758|Analgesics|analgesics|mesh-ancestor
25146901|NCT02918708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166616|NCT03834571|Paclitaxel|paclitaxel|mesh-list
25166617|NCT03834571|Cisplatin|cisplatin|mesh-list
25146903|NCT02918591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25146904|NCT02918591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146905|NCT02918591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25147101|NCT02916602|Diuretics|diuretics|mesh-ancestor
25489499|NCT00214890|Abacavir|abacavir|mesh-list
25489500|NCT00214890|Antiviral Agents|antiviral agents|mesh-ancestor
25489501|NCT00214890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25489502|NCT00214890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25489503|NCT00214890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25489504|NCT00214890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489505|NCT00214890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489506|NCT00214890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25489507|NCT00214890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25489508|NCT00215137|Citalopram|citalopram|mesh-list
25489509|NCT00215137|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25489510|NCT00215137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25489511|NCT00215137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25489512|NCT00215137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489513|NCT00215137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25489514|NCT00215137|Serotonin Agents|serotonin agents|mesh-ancestor
25489515|NCT00215137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489516|NCT00215137|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25489517|NCT00215137|Antidepressive Agents|antidepressive agents|mesh-ancestor
25489518|NCT00215137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25489519|NCT00215150|Ziprasidone|ziprasidone|mesh-list
25489520|NCT00215150|Sertraline|sertraline|mesh-list
25489521|NCT00215150|Antidepressive Agents|antidepressive agents|mesh-ancestor
25489522|NCT00215150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25489523|NCT00215150|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25489524|NCT00215150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25823147|NCT00004758|Sensory System Agents|sensory system agents|mesh-ancestor
25489525|NCT00215150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25645193|NCT01445535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645194|NCT01445535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25645195|NCT01445535|Glucocorticoids|glucocorticoids|mesh-ancestor
25645196|NCT01445535|Hormones|hormones|mesh-ancestor
25645197|NCT01445535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25645198|NCT01445535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25645199|NCT01445535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25645200|NCT01445535|Tubulin Modulators|tubulin modulators|mesh-ancestor
25645201|NCT01445535|Antimitotic Agents|antimitotic agents|mesh-ancestor
25823148|NCT00004758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25489526|NCT00215150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489527|NCT00215150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25489528|NCT00215150|Serotonin Agents|serotonin agents|mesh-ancestor
25489529|NCT00215150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489530|NCT00215150|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25489531|NCT00215150|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25489532|NCT00215150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25489533|NCT00215150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25489534|NCT00215150|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25489535|NCT00215150|Dopamine Agents|dopamine agents|mesh-ancestor
25489536|NCT00215540|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25489537|NCT00215540|Respiratory System Agents|respiratory system agents|mesh-ancestor
25489538|NCT00215553|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25489539|NCT00215553|Respiratory System Agents|respiratory system agents|mesh-ancestor
25489540|NCT00215644|Cisplatin|cisplatin|mesh-list
25489541|NCT00215644|Capecitabine|capecitabine|mesh-list
25489542|NCT00215644|Epirubicin|epirubicin|mesh-list
25489543|NCT00215644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489544|NCT00215644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25489545|NCT00215644|Antimetabolites|antimetabolites|mesh-ancestor
25489546|NCT00215644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489547|NCT00215644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25489548|NCT00215644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25489549|NCT00215644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25489550|NCT00215644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489551|NCT00215787|Lansoprazole|lansoprazole|mesh-list
25489552|NCT00215787|Dexlansoprazole|dexlansoprazole|mesh-list
25489553|NCT00215787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25489554|NCT00215787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25489555|NCT00215787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25489556|NCT00215787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489557|NCT00215787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489558|NCT00215930|Gemcitabine|gemcitabine|mesh-list
25489559|NCT00215930|Carboplatin|carboplatin|mesh-list
25489560|NCT00215930|Docetaxel|docetaxel|mesh-list
25489561|NCT00215930|Vinorelbine|vinorelbine|mesh-list
25489562|NCT00215930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489563|NCT00215930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25489564|NCT00215930|Antimetabolites|antimetabolites|mesh-ancestor
25823149|NCT00004758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25823150|NCT00004758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25823151|NCT00004758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25166618|NCT03834571|Carboplatin|carboplatin|mesh-list
25823152|NCT00004758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25823153|NCT00004758|Vitamin B Complex|vitamin b complex|mesh-ancestor
25823154|NCT00004758|Vitamins|vitamins|mesh-ancestor
25489565|NCT00215930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489566|NCT00215930|Antiviral Agents|antiviral agents|mesh-ancestor
25489567|NCT00215930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25489568|NCT00215930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489569|NCT00215930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25489570|NCT00215930|Immunologic Factors|immunologic factors|mesh-ancestor
25489571|NCT00215930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489572|NCT00215930|Tubulin Modulators|tubulin modulators|mesh-ancestor
25489573|NCT00215930|Antimitotic Agents|antimitotic agents|mesh-ancestor
25489574|NCT00215930|Mitosis Modulators|mitosis modulators|mesh-ancestor
25489575|NCT00215930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25489576|NCT00215943|Zoledronic Acid|zoledronic acid|mesh-list
25489577|NCT00215943|Thalidomide|thalidomide|mesh-list
25489578|NCT00215943|Dexamethasone|dexamethasone|mesh-list
25489579|NCT00215943|Doxorubicin|doxorubicin|mesh-list
25489580|NCT00215943|Vincristine|vincristine|mesh-list
25489581|NCT00215943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25489582|NCT00215943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25489583|NCT00215943|Antiemetics|antiemetics|mesh-ancestor
25489584|NCT00215943|Autonomic Agents|autonomic agents|mesh-ancestor
25489585|NCT00215943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25823155|NCT00004758|Micronutrients|micronutrients|mesh-ancestor
25489586|NCT00215943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489587|NCT00215943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25489588|NCT00215943|Glucocorticoids|glucocorticoids|mesh-ancestor
25489590|NCT00215943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25489591|NCT00215943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25489592|NCT00215943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489593|NCT00215943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25489594|NCT00215943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25489595|NCT00215943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25489596|NCT00215943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489597|NCT00215943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489598|NCT00215943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25489599|NCT00215943|Tubulin Modulators|tubulin modulators|mesh-ancestor
25489600|NCT00215943|Antimitotic Agents|antimitotic agents|mesh-ancestor
25489601|NCT00215943|Mitosis Modulators|mitosis modulators|mesh-ancestor
25489602|NCT00215943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25489603|NCT00215943|Immunologic Factors|immunologic factors|mesh-ancestor
25489604|NCT00215943|Leprostatic Agents|leprostatic agents|mesh-ancestor
25489605|NCT00215943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25489606|NCT00215943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25489607|NCT00215943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25489608|NCT00215943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25489609|NCT00215943|Growth Substances|growth substances|mesh-ancestor
25489610|NCT00215943|Growth Inhibitors|growth inhibitors|mesh-ancestor
25489611|NCT00215943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25489612|NCT00216060|Risedronic Acid|risedronic acid|mesh-list
25489613|NCT00216060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25489614|NCT00216060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25489615|NCT00216060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489616|NCT00216060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25489617|NCT00216060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489618|NCT00216060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25489619|NCT00216086|Capecitabine|capecitabine|mesh-list
25489621|NCT00216086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25489622|NCT00216086|Antimetabolites|antimetabolites|mesh-ancestor
25489623|NCT00216086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489624|NCT00216086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489625|NCT00216086|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25489626|NCT00216086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25489627|NCT00216086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489628|NCT00216099|Folic Acid|folic acid|mesh-list
25489629|NCT00216099|Vitamin B 12|vitamin b 12|mesh-list
25489630|NCT00216099|Hydroxocobalamin|hydroxocobalamin|mesh-list
25489631|NCT00216099|Pemetrexed|pemetrexed|mesh-list
25489632|NCT00216099|Vitamins|vitamins|mesh-ancestor
25489633|NCT00216099|Micronutrients|micronutrients|mesh-ancestor
25489634|NCT00216099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489635|NCT00216099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489636|NCT00216099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041600|NCT01619332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25041602|NCT01619332|Protease Inhibitors|protease inhibitors|mesh-ancestor
25041606|NCT01616524|Ribavirin|ribavirin|mesh-list
25489637|NCT00216099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489639|NCT00216099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25489640|NCT00216099|Hematinics|hematinics|mesh-ancestor
25489641|NCT00216099|Vitamin B Complex|vitamin b complex|mesh-ancestor
25489642|NCT00216125|Cisplatin|cisplatin|mesh-list
25489643|NCT00216125|Docetaxel|docetaxel|mesh-list
25489644|NCT00216125|Etoposide|etoposide|mesh-list
25489645|NCT00216125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489646|NCT00216125|Tubulin Modulators|tubulin modulators|mesh-ancestor
25489647|NCT00216125|Antimitotic Agents|antimitotic agents|mesh-ancestor
25489648|NCT00216125|Mitosis Modulators|mitosis modulators|mesh-ancestor
25489649|NCT00216125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489650|NCT00216125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25489651|NCT00216125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25489652|NCT00216125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25489653|NCT00216125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489654|NCT00216203|Pemetrexed|pemetrexed|mesh-list
25489655|NCT00216203|Cetuximab|cetuximab|mesh-list
25489656|NCT00216203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489657|NCT00216203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489658|NCT00216203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489659|NCT00216203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25489660|NCT00216203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25489661|NCT00216203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25489662|NCT00216476|Risperidone|risperidone|mesh-list
25489663|NCT00216476|Aripiprazole|aripiprazole|mesh-list
25489664|NCT00216476|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25489665|NCT00216476|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25489666|NCT00216476|Serotonin Agents|serotonin agents|mesh-ancestor
25489667|NCT00216476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25489668|NCT00216476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489669|NCT00216476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489670|NCT00216476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25489671|NCT00216476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25489672|NCT00216476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25489673|NCT00216476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25489674|NCT00216476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25489675|NCT00216476|Dopamine Agents|dopamine agents|mesh-ancestor
25489676|NCT00216476|Antidepressive Agents|antidepressive agents|mesh-ancestor
25489677|NCT00216476|Dopamine Agonists|dopamine agonists|mesh-ancestor
25489678|NCT00216476|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25489679|NCT00216476|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25489680|NCT00216476|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25489681|NCT00216476|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25489682|NCT00216671|Risperidone|risperidone|mesh-list
25489683|NCT00216671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25489684|NCT00216671|Serotonin Agents|serotonin agents|mesh-ancestor
25489685|NCT00216671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25489686|NCT00216671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489687|NCT00216671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489688|NCT00216671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25489689|NCT00216671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25489690|NCT00216671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25489691|NCT00216671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25489692|NCT00216671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25489693|NCT00216671|Dopamine Agents|dopamine agents|mesh-ancestor
25489694|NCT00216736|Dexamethasone|dexamethasone|mesh-list
25489695|NCT00216736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25489696|NCT00216736|Antiemetics|antiemetics|mesh-ancestor
25489697|NCT00216736|Autonomic Agents|autonomic agents|mesh-ancestor
25489698|NCT00216736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25489699|NCT00216736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489700|NCT00216736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25489701|NCT00216736|Glucocorticoids|glucocorticoids|mesh-ancestor
25489702|NCT00216736|Hormones|hormones|mesh-ancestor
25489703|NCT00216736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25489704|NCT00216736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25489705|NCT00216736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489706|NCT00217022|Budesonide|budesonide|mesh-list
25489707|NCT00217022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25489708|NCT00217022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25489709|NCT00217022|Autonomic Agents|autonomic agents|mesh-ancestor
25042035|NCT01516203|Ethambutol|ethambutol|mesh-list
24876321|NCT03597568|Resveratrol|resveratrol|mesh-list
25489710|NCT00217022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25489711|NCT00217022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489712|NCT00217022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25489713|NCT00217022|Respiratory System Agents|respiratory system agents|mesh-ancestor
25489714|NCT00217022|Glucocorticoids|glucocorticoids|mesh-ancestor
25489715|NCT00217022|Hormones|hormones|mesh-ancestor
25489716|NCT00217022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25489717|NCT00217087|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
25489718|NCT00217087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489719|NCT00217087|Dermatologic Agents|dermatologic agents|mesh-ancestor
25489720|NCT00217087|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25489721|NCT00217399|Sorafenib|sorafenib|mesh-list
25489722|NCT00217399|Anastrozole|anastrozole|mesh-list
25489723|NCT00217399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489724|NCT00217399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25489725|NCT00217399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489726|NCT00217399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489727|NCT00217399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25489728|NCT00217399|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25489729|NCT00217399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25489730|NCT00217399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25489731|NCT00217399|Hormone Antagonists|hormone antagonists|mesh-ancestor
25645202|NCT01445535|Mitosis Modulators|mitosis modulators|mesh-ancestor
25645204|NCT01445548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25645205|NCT01445548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25645206|NCT01445548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25489732|NCT00217399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25489733|NCT00217399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489734|NCT00217425|Prednisone|prednisone|mesh-list
25489735|NCT00217425|Cyclophosphamide|cyclophosphamide|mesh-list
25489736|NCT00217425|Bevacizumab|bevacizumab|mesh-list
25489737|NCT00217425|Doxorubicin|doxorubicin|mesh-list
25489738|NCT00217425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25489739|NCT00217425|Vincristine|vincristine|mesh-list
25489740|NCT00217425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25489741|NCT00217425|Immunologic Factors|immunologic factors|mesh-ancestor
25489742|NCT00217425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489743|NCT00217425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25489744|NCT00217425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25489745|NCT00217425|Alkylating Agents|alkylating agents|mesh-ancestor
25489746|NCT00217425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489747|NCT00217425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489748|NCT00217425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25489749|NCT00217425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25489750|NCT00217425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25489751|NCT00217425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25489752|NCT00217425|Growth Substances|growth substances|mesh-ancestor
25489753|NCT00217425|Growth Inhibitors|growth inhibitors|mesh-ancestor
25489754|NCT00217425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25489755|NCT00217425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25489756|NCT00217425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25489757|NCT00217425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489758|NCT00217425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25489759|NCT00217425|Glucocorticoids|glucocorticoids|mesh-ancestor
25489760|NCT00217425|Hormones|hormones|mesh-ancestor
25489761|NCT00217425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25489762|NCT00217425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25489763|NCT00217425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25489764|NCT00217425|Tubulin Modulators|tubulin modulators|mesh-ancestor
25489765|NCT00217425|Antimitotic Agents|antimitotic agents|mesh-ancestor
25489766|NCT00217425|Mitosis Modulators|mitosis modulators|mesh-ancestor
25489767|NCT00217438|Melphalan|melphalan|mesh-list
25489768|NCT00217438|Amifostine|amifostine|mesh-list
25489769|NCT00217438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25489770|NCT00217438|Alkylating Agents|alkylating agents|mesh-ancestor
25489771|NCT00217438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489772|NCT00217438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489773|NCT00217438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25489774|NCT00217438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25489775|NCT00217438|Immunologic Factors|immunologic factors|mesh-ancestor
25489776|NCT00217438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489777|NCT00217438|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25489778|NCT00217438|Protective Agents|protective agents|mesh-ancestor
25489779|NCT00217464|Fulvestrant|fulvestrant|mesh-list
25489780|NCT00217464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25489781|NCT00217464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489782|NCT00217464|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25042328|NCT01466088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25489783|NCT00217464|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25489784|NCT00217464|Hormone Antagonists|hormone antagonists|mesh-ancestor
25489785|NCT00217464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25489786|NCT00217464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489787|NCT00217581|Bevacizumab|bevacizumab|mesh-list
25489788|NCT00217581|Docetaxel|docetaxel|mesh-list
25489789|NCT00217581|Oxaliplatin|oxaliplatin|mesh-list
25489790|NCT00217581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25489791|NCT00217581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489792|NCT00217581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25489793|NCT00217581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25489794|NCT00217581|Growth Substances|growth substances|mesh-ancestor
25489795|NCT00217581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489796|NCT00217581|Growth Inhibitors|growth inhibitors|mesh-ancestor
25489797|NCT00217581|Tubulin Modulators|tubulin modulators|mesh-ancestor
25489798|NCT00217581|Antimitotic Agents|antimitotic agents|mesh-ancestor
25489799|NCT00217581|Mitosis Modulators|mitosis modulators|mesh-ancestor
25645207|NCT01445548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645208|NCT01445548|Antifungal Agents|antifungal agents|mesh-ancestor
25645209|NCT01445548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25645210|NCT01445548|Immunologic Factors|immunologic factors|mesh-ancestor
25645211|NCT01445548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645212|NCT01445626|Dexamethasone|dexamethasone|mesh-list
25645213|NCT01445626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25645214|NCT01445626|Antiemetics|antiemetics|mesh-ancestor
25645215|NCT01445626|Autonomic Agents|autonomic agents|mesh-ancestor
25489800|NCT00217581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489801|NCT00217594|Alemtuzumab|alemtuzumab|mesh-list
25489802|NCT00217594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25489803|NCT00217594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489804|NCT00217620|Sorafenib|sorafenib|mesh-list
25489805|NCT00217620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489806|NCT00217620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25489807|NCT00217620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489808|NCT00217620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489809|NCT00217672|Bevacizumab|bevacizumab|mesh-list
25489810|NCT00217672|Docetaxel|docetaxel|mesh-list
25489811|NCT00217672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25489812|NCT00217672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489813|NCT00217672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25489814|NCT00217672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25489815|NCT00217672|Growth Substances|growth substances|mesh-ancestor
25489816|NCT00217672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489817|NCT00217672|Growth Inhibitors|growth inhibitors|mesh-ancestor
25489818|NCT00217672|Tubulin Modulators|tubulin modulators|mesh-ancestor
25489819|NCT00217672|Antimitotic Agents|antimitotic agents|mesh-ancestor
25489820|NCT00217672|Mitosis Modulators|mitosis modulators|mesh-ancestor
25489821|NCT00217672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489822|NCT00217971|Dronabinol|dronabinol|mesh-list
25489823|NCT00217971|Hallucinogens|hallucinogens|mesh-ancestor
25489824|NCT00217971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489825|NCT00217971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25489826|NCT00217971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25489827|NCT00217971|Analgesics|analgesics|mesh-ancestor
25489828|NCT00217971|Sensory System Agents|sensory system agents|mesh-ancestor
25489829|NCT00217971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25489830|NCT00217971|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25489831|NCT00217971|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25489832|NCT00217971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25489833|NCT00217971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489834|NCT00217971|Hormones|hormones|mesh-ancestor
25489835|NCT00217971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25489836|NCT00218023|Naltrexone|naltrexone|mesh-list
25489837|NCT00218023|Levodopa|levodopa|mesh-list
25489838|NCT00218023|Carbidopa|carbidopa|mesh-list
25489839|NCT00218023|Modafinil|modafinil|mesh-list
25489840|NCT00218023|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25489841|NCT00218023|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25489842|NCT00218023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489843|NCT00218023|Sensory System Agents|sensory system agents|mesh-ancestor
25489844|NCT00218023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25489845|NCT00218023|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25489846|NCT00218023|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25489847|NCT00218023|Dopamine Agents|dopamine agents|mesh-ancestor
25489848|NCT00218023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25489849|NCT00218023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489850|NCT00218023|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25489851|NCT00218023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489852|NCT00218023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25489853|NCT00218023|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25489854|NCT00218023|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25489855|NCT00218023|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25489856|NCT00218062|Modafinil|modafinil|mesh-list
25489857|NCT00218062|Amphetamine|amphetamine|mesh-list
25489858|NCT00218062|Dextroamphetamine|dextroamphetamine|mesh-list
25489859|NCT00218062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25489860|NCT00218062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489861|NCT00218062|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25489862|NCT00218062|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25489863|NCT00218062|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25645216|NCT01445626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25489864|NCT00218062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489865|NCT00218062|Sympathomimetics|sympathomimetics|mesh-ancestor
25489866|NCT00218062|Autonomic Agents|autonomic agents|mesh-ancestor
25489867|NCT00218062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25489868|NCT00218062|Dopamine Agents|dopamine agents|mesh-ancestor
25489869|NCT00218062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25489870|NCT00218062|Adrenergic Agents|adrenergic agents|mesh-ancestor
25489871|NCT00218062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25489872|NCT00218062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25489873|NCT00218062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25489874|NCT00218062|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25489875|NCT00218257|Progesterone|progesterone|mesh-list
25489876|NCT00218257|Progestins|progestins|mesh-ancestor
25489877|NCT00218257|Hormones|hormones|mesh-ancestor
25489878|NCT00218257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25489879|NCT00218257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489880|NCT00218296|Lobeline|lobeline|mesh-list
25489881|NCT00218296|Nicotine|nicotine|mesh-list
25489882|NCT00218296|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25489883|NCT00218296|Autonomic Agents|autonomic agents|mesh-ancestor
25489884|NCT00218296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25489885|NCT00218296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489886|NCT00218296|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25489887|NCT00218296|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25489888|NCT00218296|Cholinergic Agents|cholinergic agents|mesh-ancestor
25489889|NCT00218296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25489890|NCT00218296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489891|NCT00218296|Respiratory System Agents|respiratory system agents|mesh-ancestor
25489892|NCT00218387|Modafinil|modafinil|mesh-list
25489893|NCT00218387|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25489894|NCT00218387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489895|NCT00218387|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25489896|NCT00218387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25489897|NCT00218387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25489898|NCT00218387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489899|NCT00218426|Naltrexone|naltrexone|mesh-list
25489900|NCT00218426|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25489901|NCT00218426|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25489902|NCT00218426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489903|NCT00218426|Sensory System Agents|sensory system agents|mesh-ancestor
25489904|NCT00218426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25489905|NCT00218439|Paroxetine|paroxetine|mesh-list
25489906|NCT00218439|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25489907|NCT00218439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25489908|NCT00218439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25489909|NCT00218439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489910|NCT00218439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25489911|NCT00218439|Serotonin Agents|serotonin agents|mesh-ancestor
25489912|NCT00218439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489913|NCT00218439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25489914|NCT00218439|Antidepressive Agents|antidepressive agents|mesh-ancestor
25489915|NCT00218439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25489916|NCT00218439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25489917|NCT00218439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25489918|NCT00218439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489919|NCT00218465|Glycine|glycine|mesh-list
25489920|NCT00218465|Glycine Agents|glycine agents|mesh-ancestor
25489921|NCT00218465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25489922|NCT00218465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489923|NCT00218465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489924|NCT00218491|Acetylcysteine|acetylcysteine|mesh-list
25489925|NCT00218491|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24589406|NCT00907270|Micronutrients|micronutrients|mesh-ancestor
25043052|NCT01332812|Glucocorticoids|glucocorticoids|mesh-ancestor
25043053|NCT01332812|Hormones|hormones|mesh-ancestor
25043201|NCT01309932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489926|NCT00218491|Antiviral Agents|antiviral agents|mesh-ancestor
25489927|NCT00218491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25489929|NCT00218491|Respiratory System Agents|respiratory system agents|mesh-ancestor
25489930|NCT00218491|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25489931|NCT00218491|Antioxidants|antioxidants|mesh-ancestor
25489932|NCT00218491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489933|NCT00218491|Protective Agents|protective agents|mesh-ancestor
25408471|NCT03438318|Atezolizumab|atezolizumab|mesh-list
25489934|NCT00218491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489936|NCT00218543|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25489937|NCT00218543|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25489938|NCT00218543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25489939|NCT00218543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25489940|NCT00218543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489941|NCT00218543|Adrenergic Agents|adrenergic agents|mesh-ancestor
25489942|NCT00218543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25489943|NCT00218543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489944|NCT00219141|Losartan|losartan|mesh-list
25489945|NCT00219141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25489946|NCT00219141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25489947|NCT00219141|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25489948|NCT00219141|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25489949|NCT00219141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489950|NCT00219284|Levodopa|levodopa|mesh-list
25489951|NCT00219284|Carbidopa|carbidopa|mesh-list
25489952|NCT00219284|Entacapone|entacapone|mesh-list
25489953|NCT00219284|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25489954|NCT00219284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25489955|NCT00219284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25489956|NCT00219284|Dopamine Agents|dopamine agents|mesh-ancestor
25489957|NCT00219284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25489958|NCT00219284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489959|NCT00219284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489960|NCT00219284|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25489961|NCT00219284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25489962|NCT00219284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25489963|NCT00219284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25489964|NCT00219284|Immunologic Factors|immunologic factors|mesh-ancestor
25489965|NCT00219284|Dopamine Agonists|dopamine agonists|mesh-ancestor
25489966|NCT00219349|Citalopram|citalopram|mesh-list
25489967|NCT00219349|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25489968|NCT00219349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25489969|NCT00219349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25489970|NCT00219349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489971|NCT00219349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25489972|NCT00219349|Serotonin Agents|serotonin agents|mesh-ancestor
25489973|NCT00219349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489974|NCT00219349|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25489975|NCT00219349|Antidepressive Agents|antidepressive agents|mesh-ancestor
25489976|NCT00219349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25489977|NCT00219544|Pregabalin|pregabalin|mesh-list
25489978|NCT00219544|Analgesics|analgesics|mesh-ancestor
25489979|NCT00219544|Sensory System Agents|sensory system agents|mesh-ancestor
25489980|NCT00219544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25489981|NCT00219544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25489982|NCT00219544|Anticonvulsants|anticonvulsants|mesh-ancestor
25489983|NCT00219544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25489984|NCT00219544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25489985|NCT00219544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489986|NCT00219544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25489987|NCT00219544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25489988|NCT00219544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25489989|NCT00219544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25489990|NCT00219544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25489991|NCT00219557|Gemcitabine|gemcitabine|mesh-list
25489992|NCT00219557|Axitinib|axitinib|mesh-list
25489993|NCT00219557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25489994|NCT00219557|Antimetabolites|antimetabolites|mesh-ancestor
25489995|NCT00219557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25489996|NCT00219557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25489997|NCT00219557|Antiviral Agents|antiviral agents|mesh-ancestor
25489998|NCT00219557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25489999|NCT00219557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490000|NCT00219557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25490001|NCT00219557|Immunologic Factors|immunologic factors|mesh-ancestor
25490002|NCT00219557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490003|NCT00219557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25490004|NCT00220636|Aripiprazole|aripiprazole|mesh-list
25490005|NCT00220636|Antidepressive Agents|antidepressive agents|mesh-ancestor
25490006|NCT00220636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25490007|NCT00220636|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25490008|NCT00220636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25490009|NCT00220636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25490010|NCT00220636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490011|NCT00220636|Dopamine Agonists|dopamine agonists|mesh-ancestor
25490012|NCT00220636|Dopamine Agents|dopamine agents|mesh-ancestor
25490013|NCT00220636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25490014|NCT00220636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490015|NCT00220636|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25490016|NCT00220636|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25490017|NCT00220636|Serotonin Agents|serotonin agents|mesh-ancestor
25490018|NCT00220636|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25490019|NCT00220636|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25490020|NCT00220636|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25490021|NCT00220636|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25490022|NCT00220701|Dexetimide|dexetimide|mesh-list
25490023|NCT00220701|Citalopram|citalopram|mesh-list
25490024|NCT00220701|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25490025|NCT00220701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25490026|NCT00220701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25490027|NCT00220701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490028|NCT00220701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25490029|NCT00220701|Serotonin Agents|serotonin agents|mesh-ancestor
25490030|NCT00220701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490031|NCT00220701|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25490032|NCT00220701|Antidepressive Agents|antidepressive agents|mesh-ancestor
25490033|NCT00220701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25490034|NCT00220701|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25490035|NCT00220701|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25490036|NCT00220701|Parasympatholytics|parasympatholytics|mesh-ancestor
25490037|NCT00220701|Autonomic Agents|autonomic agents|mesh-ancestor
25490038|NCT00220701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25490039|NCT00220701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25490040|NCT00220701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25490041|NCT00220701|Cholinergic Agents|cholinergic agents|mesh-ancestor
25490042|NCT00220727|Immunoglobulins|immunoglobulins|mesh-list
25490043|NCT00220727|Antibodies|antibodies|mesh-list
25490044|NCT00220727|gamma-Globulins|gamma-globulins|mesh-list
25490045|NCT00220727|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25490046|NCT00220727|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25490047|NCT00220727|Immunoglobulin G|immunoglobulin g|mesh-list
25490048|NCT00220727|Immunologic Factors|immunologic factors|mesh-ancestor
25490049|NCT00220727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490050|NCT00220740|Immunoglobulins|immunoglobulins|mesh-list
25490051|NCT00220740|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25490052|NCT00220740|Antibodies|antibodies|mesh-list
25490053|NCT00220740|gamma-Globulins|gamma-globulins|mesh-list
25490054|NCT00220740|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25490055|NCT00220740|Immunoglobulin G|immunoglobulin g|mesh-list
25490056|NCT00220740|Immunologic Factors|immunologic factors|mesh-ancestor
25490057|NCT00220740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490058|NCT00220779|Immunoglobulins|immunoglobulins|mesh-list
25490059|NCT00220779|Antibodies|antibodies|mesh-list
25490060|NCT00220779|gamma-Globulins|gamma-globulins|mesh-list
25490061|NCT00220779|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25490062|NCT00220779|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25490063|NCT00220779|Immunoglobulin G|immunoglobulin g|mesh-list
25490064|NCT00220779|Immunologic Factors|immunologic factors|mesh-ancestor
25490065|NCT00220779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490066|NCT00220805|Immunoglobulins|immunoglobulins|mesh-list
25490067|NCT00220805|Antibodies|antibodies|mesh-list
25490068|NCT00220805|gamma-Globulins|gamma-globulins|mesh-list
25490069|NCT00220805|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25490070|NCT00220805|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25490071|NCT00220805|Immunoglobulin G|immunoglobulin g|mesh-list
25043606|NCT01234779|Serotonin Agents|serotonin agents|mesh-ancestor
25490072|NCT00220805|Immunologic Factors|immunologic factors|mesh-ancestor
25490073|NCT00220805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490075|NCT00220961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25490076|NCT00220961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490077|NCT00221104|Pravastatin|pravastatin|mesh-list
25490078|NCT00221104|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25490079|NCT00221104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25490080|NCT00221104|Antimetabolites|antimetabolites|mesh-ancestor
25490081|NCT00221104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490082|NCT00221104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25490083|NCT00221104|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25490084|NCT00221104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490085|NCT00221195|Thrombin|thrombin|mesh-list
25490086|NCT00221195|Hemostatics|hemostatics|mesh-ancestor
25490087|NCT00221195|Coagulants|coagulants|mesh-ancestor
25490088|NCT00221299|Risedronic Acid|risedronic acid|mesh-list
25490089|NCT00221299|Hormones|hormones|mesh-list
25490090|NCT00221299|Parathyroid Hormone|parathyroid hormone|mesh-list
25490091|NCT00221299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25490092|NCT00221299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490093|NCT00221299|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25490094|NCT00221299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25490095|NCT00221299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490096|NCT00221299|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25490097|NCT00221299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25490098|NCT00221338|Gabapentin|gabapentin|mesh-list
25490099|NCT00221338|Analgesics|analgesics|mesh-ancestor
25490100|NCT00221338|Sensory System Agents|sensory system agents|mesh-ancestor
25490101|NCT00221338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25490102|NCT00221338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490103|NCT00221338|Anticonvulsants|anticonvulsants|mesh-ancestor
25490104|NCT00221338|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25490105|NCT00221338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25490106|NCT00221338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25490107|NCT00221338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25490108|NCT00221338|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25490109|NCT00221338|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25490110|NCT00221338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25490111|NCT00221338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490112|NCT00221338|Antimanic Agents|antimanic agents|mesh-ancestor
25490113|NCT00221403|Valproic Acid|valproic acid|mesh-list
25490114|NCT00221403|Risperidone|risperidone|mesh-list
25490115|NCT00221403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25490116|NCT00221403|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25490117|NCT00221403|Serotonin Agents|serotonin agents|mesh-ancestor
25490118|NCT00221403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25490119|NCT00221403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490120|NCT00221403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490121|NCT00221403|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25490122|NCT00221403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25490123|NCT00221403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25490124|NCT00221403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25490125|NCT00221403|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25490126|NCT00221403|Dopamine Agents|dopamine agents|mesh-ancestor
25490127|NCT00221403|Anticonvulsants|anticonvulsants|mesh-ancestor
25490128|NCT00221403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490129|NCT00221403|GABA Agents|gaba agents|mesh-ancestor
25490130|NCT00221403|Antimanic Agents|antimanic agents|mesh-ancestor
25490131|NCT00222105|Thalidomide|thalidomide|mesh-list
25490132|NCT00222105|Dexamethasone|dexamethasone|mesh-list
25490133|NCT00222105|Doxorubicin|doxorubicin|mesh-list
25490134|NCT00222105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25490135|NCT00222105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25490136|NCT00222105|Antiemetics|antiemetics|mesh-ancestor
25490137|NCT00222105|Autonomic Agents|autonomic agents|mesh-ancestor
25490138|NCT00222105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25490139|NCT00222105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490140|NCT00222105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25490141|NCT00222105|Glucocorticoids|glucocorticoids|mesh-ancestor
25490142|NCT00222105|Hormones|hormones|mesh-ancestor
25490143|NCT00222105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25490144|NCT00222105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25043856|NCT01193140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25043857|NCT01193140|Alkylating Agents|alkylating agents|mesh-ancestor
25043859|NCT01193140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490145|NCT00222105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490146|NCT00222105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25490147|NCT00222105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25490148|NCT00222105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25490149|NCT00222105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490150|NCT00222105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490151|NCT00222105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25490152|NCT00222105|Immunologic Factors|immunologic factors|mesh-ancestor
25490153|NCT00222105|Leprostatic Agents|leprostatic agents|mesh-ancestor
25645217|NCT01445626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490154|NCT00222105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25490155|NCT00222105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25490156|NCT00222105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25490157|NCT00222105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25490158|NCT00222105|Growth Substances|growth substances|mesh-ancestor
25490159|NCT00222105|Growth Inhibitors|growth inhibitors|mesh-ancestor
25490160|NCT00222131|Esomeprazole|esomeprazole|mesh-list
25490161|NCT00222131|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25490162|NCT00222131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25490163|NCT00222131|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25490164|NCT00222131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490165|NCT00222131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490166|NCT00222729|Bevacizumab|bevacizumab|mesh-list
25490167|NCT00222729|Pemetrexed|pemetrexed|mesh-list
25490168|NCT00222729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25490169|NCT00222729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490170|NCT00222729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25490171|NCT00222729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25490172|NCT00222729|Growth Substances|growth substances|mesh-ancestor
25490173|NCT00222729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490174|NCT00222729|Growth Inhibitors|growth inhibitors|mesh-ancestor
25490175|NCT00222729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490176|NCT00222729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490177|NCT00222729|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25490178|NCT00222729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25490179|NCT00223080|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25490180|NCT00223080|Immunologic Factors|immunologic factors|mesh-ancestor
25490181|NCT00223080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490182|NCT00223080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25490183|NCT00223080|Antacids|antacids|mesh-ancestor
25490184|NCT00223080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363923|NCT05251948|Atezolizumab|atezolizumab|mesh-list
25490185|NCT00223080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25490186|NCT00223236|Choline|choline|mesh-list
25490187|NCT00223236|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
25490188|NCT00223236|Lipotropic Agents|lipotropic agents|mesh-ancestor
25490189|NCT00223236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25490190|NCT00223236|Antimetabolites|antimetabolites|mesh-ancestor
25490191|NCT00223236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490192|NCT00223236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25490193|NCT00223236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25490194|NCT00223236|Nootropic Agents|nootropic agents|mesh-ancestor
25490195|NCT00223262|Lamotrigine|lamotrigine|mesh-list
25490196|NCT00223262|Anticonvulsants|anticonvulsants|mesh-ancestor
25490197|NCT00223262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25490198|NCT00223262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25490199|NCT00223262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490200|NCT00223262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25490201|NCT00223262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490202|NCT00223262|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25490203|NCT00223262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25490204|NCT00223262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25490205|NCT00223262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25490206|NCT00223262|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25490207|NCT00223496|Aripiprazole|aripiprazole|mesh-list
25490208|NCT00223496|Antidepressive Agents|antidepressive agents|mesh-ancestor
25490209|NCT00223496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25490210|NCT00223496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25490211|NCT00223496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25490212|NCT00223496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25490213|NCT00223496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490214|NCT00223496|Dopamine Agonists|dopamine agonists|mesh-ancestor
25490215|NCT00223496|Dopamine Agents|dopamine agents|mesh-ancestor
25490216|NCT00223496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25490217|NCT00223496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881932|NCT00389870|Irinotecan|irinotecan|mesh-list
25044167|NCT01133990|Immunologic Factors|immunologic factors|mesh-ancestor
25490218|NCT00223496|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25490219|NCT00223496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25490220|NCT00223496|Serotonin Agents|serotonin agents|mesh-ancestor
25490221|NCT00223496|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25490222|NCT00223496|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25490223|NCT00223496|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25490224|NCT00223496|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25645218|NCT01445626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25490226|NCT00223665|Flutamide|flutamide|mesh-list
25490227|NCT00223665|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25490228|NCT00223665|Fertility Agents|fertility agents|mesh-ancestor
25490229|NCT00223665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25490230|NCT00223665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490231|NCT00223665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25490232|NCT00223665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490233|NCT00223665|Androgen Antagonists|androgen antagonists|mesh-ancestor
25490234|NCT00223665|Hormone Antagonists|hormone antagonists|mesh-ancestor
25490235|NCT00223665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25490236|NCT00223678|Sirolimus|sirolimus|mesh-list
25490237|NCT00223678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25490238|NCT00223678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25490239|NCT00223678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25490240|NCT00223678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490241|NCT00223678|Antifungal Agents|antifungal agents|mesh-ancestor
25490242|NCT00223678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25490243|NCT00223678|Immunologic Factors|immunologic factors|mesh-ancestor
25490244|NCT00223678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490245|NCT00223704|Icatibant|icatibant|mesh-list
25490246|NCT00223704|Aminocaproic Acid|aminocaproic acid|mesh-list
25490247|NCT00223704|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25490248|NCT00223704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25490249|NCT00223704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490250|NCT00223704|Hemostatics|hemostatics|mesh-ancestor
25490251|NCT00223704|Coagulants|coagulants|mesh-ancestor
25490252|NCT00223704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25490253|NCT00223704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25490254|NCT00223704|Analgesics|analgesics|mesh-ancestor
25490255|NCT00223704|Sensory System Agents|sensory system agents|mesh-ancestor
25490256|NCT00223704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25490257|NCT00223704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490258|NCT00223704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25490259|NCT00223704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25490260|NCT00223704|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
25490261|NCT00223704|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
25490262|NCT00223704|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25490263|NCT00223704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25490264|NCT00223704|Immunologic Factors|immunologic factors|mesh-ancestor
25490265|NCT00223821|Oxybutynin|oxybutynin|mesh-list
25490266|NCT00223821|Parasympatholytics|parasympatholytics|mesh-ancestor
25490267|NCT00223821|Autonomic Agents|autonomic agents|mesh-ancestor
25490268|NCT00223821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25490269|NCT00223821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490270|NCT00223821|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25490271|NCT00223821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25490272|NCT00223821|Cholinergic Agents|cholinergic agents|mesh-ancestor
25490273|NCT00223821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25490274|NCT00223821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490275|NCT00223821|Urological Agents|urological agents|mesh-ancestor
25490276|NCT00223977|Ferric gluconate|ferric gluconate|mesh-list
25490277|NCT00223977|Ferric Compounds|ferric compounds|mesh-list
25490278|NCT00223977|Hematinics|hematinics|mesh-ancestor
25490279|NCT00224016|Mandelic Acids|mandelic acids|mesh-list
25490280|NCT00224016|Oxybutynin|oxybutynin|mesh-list
25490281|NCT00224016|Parasympatholytics|parasympatholytics|mesh-ancestor
25490282|NCT00224016|Autonomic Agents|autonomic agents|mesh-ancestor
25490283|NCT00224016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25490284|NCT00224016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044786|NCT01037179|Sensory System Agents|sensory system agents|mesh-ancestor
25044787|NCT01037179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25044874|NCT01025648|Sympathomimetics|sympathomimetics|mesh-ancestor
25044875|NCT01025648|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25044876|NCT01024101|Paclitaxel|paclitaxel|mesh-list
25044877|NCT01024101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25044912|NCT01022801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25044914|NCT01020565|Antiviral Agents|antiviral agents|mesh-ancestor
25490286|NCT00224016|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25490287|NCT00224016|Cholinergic Agents|cholinergic agents|mesh-ancestor
25490288|NCT00224016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25490289|NCT00224016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490290|NCT00224016|Urological Agents|urological agents|mesh-ancestor
25490291|NCT00224016|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25490292|NCT00224016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25490293|NCT00224016|Renal Agents|renal agents|mesh-ancestor
25490294|NCT00224029|Oxybutynin|oxybutynin|mesh-list
25490295|NCT00224029|Parasympatholytics|parasympatholytics|mesh-ancestor
25490296|NCT00224029|Autonomic Agents|autonomic agents|mesh-ancestor
25490297|NCT00224029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25490298|NCT00224029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490299|NCT00224029|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25490300|NCT00224029|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25490301|NCT00224029|Cholinergic Agents|cholinergic agents|mesh-ancestor
25490302|NCT00224029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25490303|NCT00224029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490304|NCT00224029|Urological Agents|urological agents|mesh-ancestor
25490305|NCT00224042|Ferric gluconate|ferric gluconate|mesh-list
25490306|NCT00224042|Hematinics|hematinics|mesh-ancestor
25490307|NCT00224055|Ferric gluconate|ferric gluconate|mesh-list
25490308|NCT00224055|Hematinics|hematinics|mesh-ancestor
25490310|NCT00224107|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25490311|NCT00224107|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25490312|NCT00224107|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25490313|NCT00224107|Adrenergic Agents|adrenergic agents|mesh-ancestor
25490314|NCT00224107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25490315|NCT00224107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490316|NCT00224107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490317|NCT00224107|Urological Agents|urological agents|mesh-ancestor
25490318|NCT00224120|Silodosin|silodosin|mesh-list
25490319|NCT00224120|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25490320|NCT00224120|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25490321|NCT00224120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25490322|NCT00224120|Adrenergic Agents|adrenergic agents|mesh-ancestor
25490323|NCT00224120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25490324|NCT00224120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490325|NCT00224120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490326|NCT00224120|Urological Agents|urological agents|mesh-ancestor
25490327|NCT00224133|Silodosin|silodosin|mesh-list
25490328|NCT00224133|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25490329|NCT00224133|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25490330|NCT00224133|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25490331|NCT00224133|Adrenergic Agents|adrenergic agents|mesh-ancestor
25490332|NCT00224133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25490333|NCT00224133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490334|NCT00224133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490335|NCT00224133|Urological Agents|urological agents|mesh-ancestor
25490336|NCT00224289|Latanoprost|latanoprost|mesh-list
25490337|NCT00224289|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25490338|NCT00224289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25490339|NCT00224484|Vaccines|vaccines|mesh-list
25490340|NCT00224484|Immunologic Factors|immunologic factors|mesh-ancestor
25490341|NCT00224484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490342|NCT00224770|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25490343|NCT00224770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25490344|NCT00224770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25490345|NCT00224770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490346|NCT00224874|Mycophenolic Acid|mycophenolic acid|mesh-list
25490347|NCT00224874|Etanercept|etanercept|mesh-list
25490348|NCT00224874|Pentostatin|pentostatin|mesh-list
25490349|NCT00224874|Denileukin diftitox|denileukin diftitox|mesh-list
25490350|NCT00224874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25490351|NCT00224874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490352|NCT00224874|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25490353|NCT00224874|Antitubercular Agents|antitubercular agents|mesh-ancestor
25490354|NCT00224874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25490355|NCT00224874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25490356|NCT00224874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490357|NCT00224874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965711|NCT03774901|Avelumab|avelumab|mesh-list
25490379|NCT00224952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25490380|NCT00224952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25490381|NCT00224952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25490382|NCT00224952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25490383|NCT00224952|Analgesics|analgesics|mesh-ancestor
25490384|NCT00224952|Sensory System Agents|sensory system agents|mesh-ancestor
25490385|NCT00224952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25490386|NCT00224952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25490387|NCT00224952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25490388|NCT00224952|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25490389|NCT00224952|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25490390|NCT00225017|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25490391|NCT00225017|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25490392|NCT00225017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25490393|NCT00225017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25490394|NCT00225017|Protease Inhibitors|protease inhibitors|mesh-ancestor
25490395|NCT00225017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490396|NCT00225017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490397|NCT00225017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25490398|NCT00225017|Antiviral Agents|antiviral agents|mesh-ancestor
25490399|NCT00225017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25490400|NCT00225147|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25490401|NCT00225147|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25490402|NCT00225147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25490403|NCT00225147|Immunologic Factors|immunologic factors|mesh-ancestor
25490404|NCT00225147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490405|NCT00225212|Rituximab|rituximab|mesh-list
25490406|NCT00225212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25490407|NCT00225212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490408|NCT00225212|Immunologic Factors|immunologic factors|mesh-ancestor
25490409|NCT00225212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490410|NCT00225212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25115075|NCT03118479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490412|NCT00225251|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25490413|NCT00225251|Antidepressive Agents|antidepressive agents|mesh-ancestor
25490414|NCT00225251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25490415|NCT00225251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25490416|NCT00225251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25490417|NCT00225251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25490418|NCT00225251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490419|NCT00225251|Dopamine Agents|dopamine agents|mesh-ancestor
25490420|NCT00225251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25490421|NCT00225251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490422|NCT00225251|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25490423|NCT00225251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25490424|NCT00225251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490425|NCT00225277|Pioglitazone|pioglitazone|mesh-list
25490426|NCT00225277|Glimepiride|glimepiride|mesh-list
25490427|NCT00225277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25490428|NCT00225277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490429|NCT00225277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25490430|NCT00225277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25490431|NCT00225277|Immunologic Factors|immunologic factors|mesh-ancestor
25490432|NCT00225420|Docetaxel|docetaxel|mesh-list
25490433|NCT00225420|Leuprolide|leuprolide|mesh-list
25490434|NCT00225420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490435|NCT00225420|Tubulin Modulators|tubulin modulators|mesh-ancestor
25490436|NCT00225420|Antimitotic Agents|antimitotic agents|mesh-ancestor
25490437|NCT00225420|Mitosis Modulators|mitosis modulators|mesh-ancestor
25490438|NCT00225420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490439|NCT00225420|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25490440|NCT00225420|Fertility Agents|fertility agents|mesh-ancestor
25490441|NCT00225420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25490442|NCT00225420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490443|NCT00225420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25490444|NCT00225498|Olanzapine|olanzapine|mesh-list
25490445|NCT00225498|Risperidone|risperidone|mesh-list
25490446|NCT00225498|Ziprasidone|ziprasidone|mesh-list
25490447|NCT00225498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25490448|NCT00225498|Serotonin Agents|serotonin agents|mesh-ancestor
25490449|NCT00225498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25490450|NCT00225498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490451|NCT00225498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490452|NCT00225498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25490453|NCT00225498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25490454|NCT00225498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25490455|NCT00225498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25490456|NCT00225498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25490457|NCT00225498|Dopamine Agents|dopamine agents|mesh-ancestor
25490458|NCT00225498|Antiemetics|antiemetics|mesh-ancestor
25490459|NCT00225498|Autonomic Agents|autonomic agents|mesh-ancestor
25490460|NCT00225498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25490461|NCT00225498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25490462|NCT00225498|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25645219|NCT01445626|Glucocorticoids|glucocorticoids|mesh-ancestor
25490463|NCT00225498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25490464|NCT00225498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25490466|NCT00225732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25490467|NCT00225732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25490468|NCT00225732|Analgesics|analgesics|mesh-ancestor
25490469|NCT00225732|Sensory System Agents|sensory system agents|mesh-ancestor
25490470|NCT00225732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25490471|NCT00225732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115385|NCT03116490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25115386|NCT03116490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115387|NCT03116542|Alovudine|alovudine|mesh-list
25115388|NCT03116542|Antiviral Agents|antiviral agents|mesh-ancestor
25115389|NCT03116542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25115390|NCT03116347|Immunoglobulins|immunoglobulins|mesh-list
25115391|NCT03116347|Antibodies|antibodies|mesh-list
25115392|NCT03116347|gamma-Globulins|gamma-globulins|mesh-list
25115393|NCT03116347|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25115394|NCT03116347|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25115395|NCT03116347|Immunoglobulin G|immunoglobulin g|mesh-list
25115396|NCT03116347|Immunologic Factors|immunologic factors|mesh-ancestor
25115397|NCT03116347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024370|NCT03646526|Analgesics|analgesics|mesh-ancestor
25490472|NCT00225732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25490473|NCT00225732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25490474|NCT00225732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25490475|NCT00225732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490476|NCT00225732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490477|NCT00225758|Lapatinib|lapatinib|mesh-list
25490478|NCT00225758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490479|NCT00225758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25490480|NCT00225758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490481|NCT00225758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490482|NCT00225784|Gemcitabine|gemcitabine|mesh-list
25490483|NCT00225784|Cetuximab|cetuximab|mesh-list
25490484|NCT00225784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25490485|NCT00225784|Antimetabolites|antimetabolites|mesh-ancestor
25490486|NCT00225784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490487|NCT00225784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490488|NCT00225784|Antiviral Agents|antiviral agents|mesh-ancestor
25490489|NCT00225784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25490490|NCT00225784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490491|NCT00225784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25490492|NCT00225784|Immunologic Factors|immunologic factors|mesh-ancestor
25490493|NCT00225784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490494|NCT00225784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25490495|NCT00226239|Cisplatin|cisplatin|mesh-list
25490496|NCT00226239|Docetaxel|docetaxel|mesh-list
25490497|NCT00226239|Cetuximab|cetuximab|mesh-list
25490498|NCT00226239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490499|NCT00226239|Tubulin Modulators|tubulin modulators|mesh-ancestor
25490500|NCT00226239|Antimitotic Agents|antimitotic agents|mesh-ancestor
25490501|NCT00226239|Mitosis Modulators|mitosis modulators|mesh-ancestor
25490502|NCT00226239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490503|NCT00226239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25490504|NCT00226577|Gemcitabine|gemcitabine|mesh-list
25490505|NCT00226577|Pemetrexed|pemetrexed|mesh-list
25490506|NCT00226577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25490507|NCT00226577|Antimetabolites|antimetabolites|mesh-ancestor
25490508|NCT00226577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490509|NCT00226577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490510|NCT00226577|Antiviral Agents|antiviral agents|mesh-ancestor
25490511|NCT00226577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25490512|NCT00226577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490513|NCT00226577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25490514|NCT00226577|Immunologic Factors|immunologic factors|mesh-ancestor
25490515|NCT00226577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490516|NCT00226577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25490517|NCT00226577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25490518|NCT00226590|Gemcitabine|gemcitabine|mesh-list
25490519|NCT00226590|Paclitaxel|paclitaxel|mesh-list
25490520|NCT00226590|Carboplatin|carboplatin|mesh-list
25490521|NCT00226590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25490522|NCT00226590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490523|NCT00226590|Tubulin Modulators|tubulin modulators|mesh-ancestor
25202123|NCT02723461|Oxytocics|oxytocics|mesh-ancestor
25645220|NCT01445626|Hormones|hormones|mesh-ancestor
25645221|NCT01445626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25645222|NCT01445626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25645223|NCT01445626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645224|NCT01445678|Metronidazole|metronidazole|mesh-list
25645225|NCT01445678|Meropenem|meropenem|mesh-list
25490524|NCT00226590|Antimitotic Agents|antimitotic agents|mesh-ancestor
25490525|NCT00226590|Mitosis Modulators|mitosis modulators|mesh-ancestor
25490526|NCT00226590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490527|NCT00226590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25490528|NCT00226590|Antimetabolites|antimetabolites|mesh-ancestor
25490529|NCT00226590|Antiviral Agents|antiviral agents|mesh-ancestor
25490530|NCT00226590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25490531|NCT00226590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490532|NCT00226590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25490533|NCT00226590|Immunologic Factors|immunologic factors|mesh-ancestor
25490534|NCT00226590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490535|NCT00226655|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
25490536|NCT00226655|Hormones|hormones|mesh-ancestor
25490537|NCT00226655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25490538|NCT00226655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490539|NCT00226811|Sunitinib|sunitinib|mesh-list
25490540|NCT00226811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490541|NCT00226811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25490542|NCT00226811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25115609|NCT03115099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25115610|NCT03115099|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25115611|NCT03115099|Protease Inhibitors|protease inhibitors|mesh-ancestor
25490544|NCT00226811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490545|NCT00226811|Growth Inhibitors|growth inhibitors|mesh-ancestor
25490546|NCT00226811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25490547|NCT00226811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490548|NCT00226811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490549|NCT00226941|Diphenhydramine|diphenhydramine|mesh-list
25490550|NCT00226941|Promethazine|promethazine|mesh-list
25490551|NCT00226941|Capecitabine|capecitabine|mesh-list
25490552|NCT00226941|Oxaliplatin|oxaliplatin|mesh-list
25490553|NCT00226941|Cetuximab|cetuximab|mesh-list
25490554|NCT00226941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25490555|NCT00226941|Antimetabolites|antimetabolites|mesh-ancestor
25490556|NCT00226941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490557|NCT00226941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490558|NCT00226941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25490559|NCT00226941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25490560|NCT00226941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25490561|NCT00226941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25490562|NCT00226941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490563|NCT00226941|Anesthetics, Local|anesthetics, local|mesh-ancestor
25490564|NCT00226941|Anesthetics|anesthetics|mesh-ancestor
25490565|NCT00226941|Sensory System Agents|sensory system agents|mesh-ancestor
25490566|NCT00226941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25490567|NCT00226941|Antiemetics|antiemetics|mesh-ancestor
25490568|NCT00226941|Autonomic Agents|autonomic agents|mesh-ancestor
25490569|NCT00226941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25490570|NCT00226941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25490571|NCT00226941|Histamine Antagonists|histamine antagonists|mesh-ancestor
25490572|NCT00226941|Histamine Agents|histamine agents|mesh-ancestor
25490573|NCT00226941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25490574|NCT00226941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25490575|NCT00226941|Antipruritics|antipruritics|mesh-ancestor
25490576|NCT00226941|Dermatologic Agents|dermatologic agents|mesh-ancestor
25490577|NCT00227019|Vitamins|vitamins|mesh-list
25490578|NCT00227019|Folic Acid|folic acid|mesh-list
25490579|NCT00227019|Vitamin B 12|vitamin b 12|mesh-list
25490580|NCT00227019|Hydroxocobalamin|hydroxocobalamin|mesh-list
25490581|NCT00227019|Vitamin B Complex|vitamin b complex|mesh-list
25490582|NCT00227019|Dexamethasone|dexamethasone|mesh-list
25490583|NCT00227019|Bevacizumab|bevacizumab|mesh-list
25490584|NCT00227019|Pemetrexed|pemetrexed|mesh-list
25490585|NCT00227019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25490586|NCT00227019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490587|NCT00227019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25490588|NCT00227019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25202136|NCT02723448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25202137|NCT02723448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25823156|NCT00004758|Hormones|hormones|mesh-ancestor
25490589|NCT00227019|Growth Substances|growth substances|mesh-ancestor
25490590|NCT00227019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490591|NCT00227019|Growth Inhibitors|growth inhibitors|mesh-ancestor
25490592|NCT00227019|Micronutrients|micronutrients|mesh-ancestor
25490593|NCT00227019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25490594|NCT00227019|Antiemetics|antiemetics|mesh-ancestor
25490595|NCT00227019|Autonomic Agents|autonomic agents|mesh-ancestor
25490596|NCT00227019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25490597|NCT00227019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25490598|NCT00227019|Glucocorticoids|glucocorticoids|mesh-ancestor
25490599|NCT00227019|Hormones|hormones|mesh-ancestor
25490600|NCT00227019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25490601|NCT00227019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25490602|NCT00227019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490603|NCT00227019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490604|NCT00227019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25490605|NCT00227019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25490606|NCT00227019|Hematinics|hematinics|mesh-ancestor
25490607|NCT00227266|Valproic Acid|valproic acid|mesh-list
25490608|NCT00227266|Anticonvulsants|anticonvulsants|mesh-ancestor
25490609|NCT00227266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490610|NCT00227266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490611|NCT00227266|GABA Agents|gaba agents|mesh-ancestor
25490612|NCT00227266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25490613|NCT00227266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891962|NCT04466046|GABA Agents|gaba agents|mesh-ancestor
25116065|NCT03111420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116066|NCT03111420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490614|NCT00227266|Antimanic Agents|antimanic agents|mesh-ancestor
25490615|NCT00227266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25490616|NCT00227266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25490617|NCT00227266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25490618|NCT00227305|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25490619|NCT00227305|Antidepressive Agents|antidepressive agents|mesh-ancestor
25490620|NCT00227305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25490621|NCT00227305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25490622|NCT00227305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25490623|NCT00227305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25490624|NCT00227305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490625|NCT00227344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
25490627|NCT00227370|Antiviral Agents|antiviral agents|mesh-ancestor
25490628|NCT00227370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25490629|NCT00227539|Cisplatin|cisplatin|mesh-list
25490630|NCT00227539|Pemetrexed|pemetrexed|mesh-list
25490631|NCT00227539|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25490632|NCT00227539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490633|NCT00227539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490634|NCT00227539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490635|NCT00227539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25490636|NCT00227539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25490637|NCT00227539|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25490638|NCT00227591|Prednisone|prednisone|mesh-list
25490639|NCT00227591|Lenalidomide|lenalidomide|mesh-list
25490640|NCT00227591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25490641|NCT00227591|Glucocorticoids|glucocorticoids|mesh-ancestor
25490642|NCT00227591|Hormones|hormones|mesh-ancestor
25490643|NCT00227591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25490644|NCT00227591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490645|NCT00227591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25490646|NCT00227591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490647|NCT00227591|Immunologic Factors|immunologic factors|mesh-ancestor
25490648|NCT00227591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25490649|NCT00227591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25490650|NCT00227591|Growth Substances|growth substances|mesh-ancestor
25490651|NCT00227591|Growth Inhibitors|growth inhibitors|mesh-ancestor
25490652|NCT00227617|Leucovorin|leucovorin|mesh-list
25490653|NCT00227617|Bevacizumab|bevacizumab|mesh-list
25490654|NCT00227617|Fluorouracil|fluorouracil|mesh-list
25490655|NCT00227617|Oxaliplatin|oxaliplatin|mesh-list
25490656|NCT00227617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25490657|NCT00227617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490658|NCT00227617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25490659|NCT00227617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25490660|NCT00227617|Growth Substances|growth substances|mesh-ancestor
25490661|NCT00227617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490662|NCT00227617|Growth Inhibitors|growth inhibitors|mesh-ancestor
25490663|NCT00227617|Antimetabolites|antimetabolites|mesh-ancestor
25490664|NCT00227617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490665|NCT00227617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25490666|NCT00227617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25490667|NCT00227617|Immunologic Factors|immunologic factors|mesh-ancestor
25490669|NCT00227617|Protective Agents|protective agents|mesh-ancestor
25490670|NCT00227617|Vitamin B Complex|vitamin b complex|mesh-ancestor
25490671|NCT00227617|Vitamins|vitamins|mesh-ancestor
25490672|NCT00227617|Micronutrients|micronutrients|mesh-ancestor
25490673|NCT00227721|Gemcitabine|gemcitabine|mesh-list
25490674|NCT00227721|Docetaxel|docetaxel|mesh-list
25490675|NCT00227721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25490676|NCT00227721|Antimetabolites|antimetabolites|mesh-ancestor
25490677|NCT00227721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490678|NCT00227721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490679|NCT00227721|Antiviral Agents|antiviral agents|mesh-ancestor
25490680|NCT00227721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25490681|NCT00227721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490682|NCT00227721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25116445|NCT03108664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25116541|NCT03108274|Anesthetics, General|anesthetics, general|mesh-ancestor
25116542|NCT03108274|Anesthetics|anesthetics|mesh-ancestor
25116543|NCT03108274|GABA Modulators|gaba modulators|mesh-ancestor
25116544|NCT03108274|GABA Agents|gaba agents|mesh-ancestor
24893388|NCT04450160|Temozolomide|temozolomide|mesh-list
25116667|NCT03107078|Hormones|hormones|mesh-ancestor
25116668|NCT03107078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25116669|NCT03107078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25116671|NCT03106948|Ascorbic Acid|ascorbic acid|mesh-list
25490683|NCT00227721|Immunologic Factors|immunologic factors|mesh-ancestor
25490684|NCT00227721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490685|NCT00227721|Tubulin Modulators|tubulin modulators|mesh-ancestor
25490686|NCT00227721|Antimitotic Agents|antimitotic agents|mesh-ancestor
25490687|NCT00227721|Mitosis Modulators|mitosis modulators|mesh-ancestor
25490688|NCT00227760|Cediranib|cediranib|mesh-list
25490689|NCT00227760|Maleic acid|maleic acid|mesh-list
25490690|NCT00227760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490691|NCT00227760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490692|NCT00227760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490693|NCT00227760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25490694|NCT00227994|Donepezil|donepezil|mesh-list
25490695|NCT00227994|Galantamine|galantamine|mesh-list
25490696|NCT00227994|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25490697|NCT00227994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490698|NCT00227994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490699|NCT00227994|Cholinergic Agents|cholinergic agents|mesh-ancestor
25490700|NCT00227994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25490701|NCT00227994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490702|NCT00227994|Nootropic Agents|nootropic agents|mesh-ancestor
25490703|NCT00227994|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25490704|NCT00227994|Autonomic Agents|autonomic agents|mesh-ancestor
25490705|NCT00227994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25490706|NCT00228423|Clopidogrel|clopidogrel|mesh-list
25490707|NCT00228423|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25490708|NCT00228423|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25490709|NCT00228423|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25490710|NCT00228423|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25490711|NCT00228423|Purinergic Agents|purinergic agents|mesh-ancestor
25490712|NCT00228423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25490713|NCT00228423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490714|NCT00228423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490715|NCT00228553|Modafinil|modafinil|mesh-list
25490716|NCT00228553|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25490717|NCT00228553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490718|NCT00228553|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25490719|NCT00228553|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25490720|NCT00228553|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25490721|NCT00228553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490722|NCT00228566|Modafinil|modafinil|mesh-list
25490723|NCT00228566|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25490724|NCT00228566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490725|NCT00228566|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25490726|NCT00228566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24956205|NCT03856242|Tamsulosin|tamsulosin|mesh-list
25645226|NCT01445678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25645227|NCT01445678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25645228|NCT01445678|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25645229|NCT01445678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25645230|NCT01445821|Methylprednisolone|methylprednisolone|mesh-list
25645231|NCT01445821|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25645232|NCT01445821|Cyclophosphamide|cyclophosphamide|mesh-list
25645233|NCT01445821|Fludarabine|fludarabine|mesh-list
25645234|NCT01445821|Thymoglobulin|thymoglobulin|mesh-list
25645235|NCT01445821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25645236|NCT01445821|Immunologic Factors|immunologic factors|mesh-ancestor
25645237|NCT01445821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645238|NCT01445821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25645239|NCT01445821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25490727|NCT00228566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25490728|NCT00228566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490729|NCT00228813|Lenograstim|lenograstim|mesh-list
25490730|NCT00228813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25490731|NCT00228813|Immunologic Factors|immunologic factors|mesh-ancestor
25490732|NCT00228813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490733|NCT00228943|Tryptophan|tryptophan|mesh-list
25490734|NCT00228943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25490735|NCT00228943|Antidepressive Agents|antidepressive agents|mesh-ancestor
25490736|NCT00228943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25490737|NCT00229619|Rituximab|rituximab|mesh-list
25490738|NCT00229619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25490739|NCT00229619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490740|NCT00229619|Immunologic Factors|immunologic factors|mesh-ancestor
25490741|NCT00229619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490742|NCT00229619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25490743|NCT00229658|Pramlintide|pramlintide|mesh-list
25490744|NCT00229658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25117367|NCT05286996|Anesthetics|anesthetics|mesh-list
25117368|NCT05286996|Anesthetics, Local|anesthetics, local|mesh-list
25117369|NCT05286996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25117370|NCT05286996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117371|NCT05286996|Sensory System Agents|sensory system agents|mesh-ancestor
25117372|NCT05286996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25117431|NCT05261464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25117432|NCT05261464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117433|NCT05261464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25117434|NCT05261464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25117440|NCT05164367|Atropine|atropine|mesh-list
25490745|NCT00229658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490746|NCT00229723|Cisplatin|cisplatin|mesh-list
25490747|NCT00229723|Gefitinib|gefitinib|mesh-list
25490748|NCT00229723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490749|NCT00229723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25490750|NCT00229723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490751|NCT00229723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490752|NCT00230126|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25490753|NCT00230126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490754|NCT00230126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25490755|NCT00230126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490756|NCT00230126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490757|NCT00230178|Allopurinol|allopurinol|mesh-list
25490758|NCT00230178|Rasburicase|rasburicase|mesh-list
25490759|NCT00230178|Antimetabolites|antimetabolites|mesh-ancestor
25490760|NCT00230178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490761|NCT00230178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490762|NCT00230178|Gout Suppressants|gout suppressants|mesh-ancestor
25490763|NCT00230178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25490764|NCT00230178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25490765|NCT00230178|Antioxidants|antioxidants|mesh-ancestor
25490766|NCT00230178|Protective Agents|protective agents|mesh-ancestor
25490767|NCT00230178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490768|NCT00230282|Cyclophosphamide|cyclophosphamide|mesh-list
25490769|NCT00230282|Fludarabine|fludarabine|mesh-list
25490770|NCT00230282|Alemtuzumab|alemtuzumab|mesh-list
25490771|NCT00230282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25490772|NCT00230282|Immunologic Factors|immunologic factors|mesh-ancestor
25490773|NCT00230282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490774|NCT00230282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25490775|NCT00230282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25645240|NCT01445821|Alkylating Agents|alkylating agents|mesh-ancestor
25490776|NCT00230282|Alkylating Agents|alkylating agents|mesh-ancestor
25490777|NCT00230282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490778|NCT00230282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490779|NCT00230282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25490780|NCT00230282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25490781|NCT00230737|Melatonin|melatonin|mesh-list
25490782|NCT00230737|Antioxidants|antioxidants|mesh-ancestor
25490783|NCT00230737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490784|NCT00230737|Protective Agents|protective agents|mesh-ancestor
25490785|NCT00230737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490786|NCT00230737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25490787|NCT00230971|Metronidazole|metronidazole|mesh-list
25490788|NCT00230971|Ceftriaxone|ceftriaxone|mesh-list
25490789|NCT00230971|Tigecycline|tigecycline|mesh-list
25490790|NCT00230971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25490791|NCT00230971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25490792|NCT00230971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25490793|NCT00230971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25490794|NCT00230971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25490795|NCT00230971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490796|NCT00230971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490797|NCT00231309|Lenograstim|lenograstim|mesh-list
25490798|NCT00231309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25490799|NCT00231309|Immunologic Factors|immunologic factors|mesh-ancestor
25490800|NCT00231309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490801|NCT00231465|Docetaxel|docetaxel|mesh-list
25490802|NCT00231465|Gefitinib|gefitinib|mesh-list
25490803|NCT00231465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490804|NCT00231465|Tubulin Modulators|tubulin modulators|mesh-ancestor
25490805|NCT00231465|Antimitotic Agents|antimitotic agents|mesh-ancestor
25490806|NCT00231465|Mitosis Modulators|mitosis modulators|mesh-ancestor
25490807|NCT00231465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490808|NCT00231465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25490809|NCT00231465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024748|NCT03643276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25024749|NCT03643276|Tubulin Modulators|tubulin modulators|mesh-ancestor
25024750|NCT03643276|Antimitotic Agents|antimitotic agents|mesh-ancestor
25024751|NCT03643276|Mitosis Modulators|mitosis modulators|mesh-ancestor
25117572|NCT05020860|Tubulin Modulators|tubulin modulators|mesh-ancestor
25117573|NCT05020860|Antimitotic Agents|antimitotic agents|mesh-ancestor
25117574|NCT05020860|Mitosis Modulators|mitosis modulators|mesh-ancestor
25117613|NCT04990037|Folfirinox|folfirinox|mesh-list
25117614|NCT04990037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25117615|NCT04966676|Nivolumab|nivolumab|mesh-list
25117616|NCT04966676|Ipilimumab|ipilimumab|mesh-list
25117618|NCT04966676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490810|NCT00231478|Granisetron|granisetron|mesh-list
25490811|NCT00231478|Antiemetics|antiemetics|mesh-ancestor
25490812|NCT00231478|Autonomic Agents|autonomic agents|mesh-ancestor
25490813|NCT00231478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25490814|NCT00231478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490815|NCT00231478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25490816|NCT00231478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25490817|NCT00231478|Serotonin Agents|serotonin agents|mesh-ancestor
25490818|NCT00231478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25490819|NCT00231478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490820|NCT00231777|Ondansetron|ondansetron|mesh-list
25490821|NCT00231777|Aprepitant|aprepitant|mesh-list
25490822|NCT00231777|Antiemetics|antiemetics|mesh-ancestor
25490823|NCT00231777|Autonomic Agents|autonomic agents|mesh-ancestor
25490824|NCT00231777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25490825|NCT00231777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490826|NCT00231777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25490827|NCT00231777|Antipruritics|antipruritics|mesh-ancestor
25490828|NCT00231777|Dermatologic Agents|dermatologic agents|mesh-ancestor
25490829|NCT00231777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25490830|NCT00231777|Serotonin Agents|serotonin agents|mesh-ancestor
25490831|NCT00231777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25490832|NCT00231777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490833|NCT00231777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25490834|NCT00231777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25490835|NCT00231777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25490836|NCT00231777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25490837|NCT00231777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25490838|NCT00231777|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25490839|NCT00231842|Cisplatin|cisplatin|mesh-list
25490840|NCT00231842|Ifosfamide|ifosfamide|mesh-list
25490841|NCT00231842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490842|NCT00231842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25490843|NCT00231842|Alkylating Agents|alkylating agents|mesh-ancestor
25490844|NCT00231842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490845|NCT00231868|Paclitaxel|paclitaxel|mesh-list
25490846|NCT00231868|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25490847|NCT00231868|Carboplatin|carboplatin|mesh-list
25490848|NCT00231868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25490849|NCT00231868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490850|NCT00231868|Tubulin Modulators|tubulin modulators|mesh-ancestor
25490851|NCT00231868|Antimitotic Agents|antimitotic agents|mesh-ancestor
25490852|NCT00231868|Mitosis Modulators|mitosis modulators|mesh-ancestor
25490853|NCT00231868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490854|NCT00231894|Pioglitazone|pioglitazone|mesh-list
25490855|NCT00231894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25490856|NCT00231894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490857|NCT00232180|Eplerenone|eplerenone|mesh-list
25490858|NCT00232180|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25490859|NCT00232180|Hormone Antagonists|hormone antagonists|mesh-ancestor
25490860|NCT00232180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25490861|NCT00232180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490862|NCT00232180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25490863|NCT00232180|Diuretics|diuretics|mesh-ancestor
25490864|NCT00232180|Natriuretic Agents|natriuretic agents|mesh-ancestor
25490865|NCT00232180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25490866|NCT00232479|Carboplatin|carboplatin|mesh-list
25490867|NCT00232479|Docetaxel|docetaxel|mesh-list
25490868|NCT00232479|Trastuzumab|trastuzumab|mesh-list
25490869|NCT00232479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490870|NCT00232479|Tubulin Modulators|tubulin modulators|mesh-ancestor
25490871|NCT00232479|Antimitotic Agents|antimitotic agents|mesh-ancestor
25490872|NCT00232479|Mitosis Modulators|mitosis modulators|mesh-ancestor
25490873|NCT00232479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490874|NCT00232479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25118296|NCT04245865|Vitamin E|vitamin e|mesh-list
25118297|NCT04245865|Tocopherols|tocopherols|mesh-list
25118298|NCT04245865|Bevacizumab|bevacizumab|mesh-list
25118299|NCT04245865|Fluorouracil|fluorouracil|mesh-list
25118300|NCT04245865|Capecitabine|capecitabine|mesh-list
25118301|NCT04245865|Oxaliplatin|oxaliplatin|mesh-list
25118302|NCT04245865|Levoleucovorin|levoleucovorin|mesh-list
25118303|NCT04245865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25118432|NCT04175470|Antioxidants|antioxidants|mesh-ancestor
24786891|NCT01922427|Analgesics|analgesics|mesh-ancestor
25118457|NCT04146038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25118459|NCT04146038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25490878|NCT00232505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25490880|NCT00232583|Pioglitazone|pioglitazone|mesh-list
25490881|NCT00232583|Glyburide|glyburide|mesh-list
25490882|NCT00232583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25490883|NCT00232583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490884|NCT00232596|Ezogabine|ezogabine|mesh-list
25490885|NCT00232596|Anticonvulsants|anticonvulsants|mesh-ancestor
25490886|NCT00232596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25490887|NCT00232596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490888|NCT00232739|Sirolimus|sirolimus|mesh-list
25490889|NCT00232739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25490890|NCT00232739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25490891|NCT00232739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25490892|NCT00232739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490893|NCT00232739|Antifungal Agents|antifungal agents|mesh-ancestor
25490894|NCT00232739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25490895|NCT00232739|Immunologic Factors|immunologic factors|mesh-ancestor
25490896|NCT00232739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490897|NCT00233064|Palivizumab|palivizumab|mesh-list
25490898|NCT00233064|Antiviral Agents|antiviral agents|mesh-ancestor
25490899|NCT00233064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25490900|NCT00233103|Sertraline|sertraline|mesh-list
25490901|NCT00233103|Antidepressive Agents|antidepressive agents|mesh-ancestor
25490902|NCT00233103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25490903|NCT00233103|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25490904|NCT00233103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25490905|NCT00233103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25490906|NCT00233103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490907|NCT00233103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25490908|NCT00233103|Serotonin Agents|serotonin agents|mesh-ancestor
25490909|NCT00233103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490910|NCT00233324|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25645241|NCT01445821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490911|NCT00233324|Respiratory System Agents|respiratory system agents|mesh-ancestor
25490912|NCT00233363|Rebamipide|rebamipide|mesh-list
25490913|NCT00233363|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25490914|NCT00233363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25490915|NCT00233363|Antioxidants|antioxidants|mesh-ancestor
25490916|NCT00233363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490917|NCT00233363|Protective Agents|protective agents|mesh-ancestor
25490918|NCT00233363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490919|NCT00233363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490920|NCT00233389|Rebamipide|rebamipide|mesh-list
25490921|NCT00233389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25490922|NCT00233389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25490923|NCT00233389|Antioxidants|antioxidants|mesh-ancestor
25490924|NCT00233389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490925|NCT00233389|Protective Agents|protective agents|mesh-ancestor
25490926|NCT00233389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490927|NCT00233389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490928|NCT00233454|Midostaurin|midostaurin|mesh-list
24900827|NCT04390789|Calcium|calcium|mesh-list
25024875|NCT03641950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25118940|NCT03436862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25118941|NCT03436862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118942|NCT03436862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24478283|NCT00422175|Siponimod|siponimod|mesh-list
25119121|NCT02724410|Clavulanic Acids|clavulanic acids|mesh-list
25119122|NCT02724410|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25119123|NCT02724410|Ertapenem|ertapenem|mesh-list
25119186|NCT02598583|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25119187|NCT02598583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25119188|NCT02598583|Immunologic Factors|immunologic factors|mesh-ancestor
25119189|NCT02598583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119190|NCT02536794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25119192|NCT02536794|Ipilimumab|ipilimumab|mesh-list
25119193|NCT02536794|Tremelimumab|tremelimumab|mesh-list
25119194|NCT02536794|Antibodies|antibodies|mesh-list
25119195|NCT02536794|Immunoglobulins|immunoglobulins|mesh-list
25119202|NCT02506517|Afatinib|afatinib|mesh-list
25490929|NCT00233454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490930|NCT00233454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25490931|NCT00233454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490932|NCT00233454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490933|NCT00233480|Atorvastatin|atorvastatin|mesh-list
25490934|NCT00233480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25490935|NCT00233480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25490936|NCT00233480|Antimetabolites|antimetabolites|mesh-ancestor
25490937|NCT00233480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490938|NCT00233480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25490939|NCT00233480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25490940|NCT00233480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490941|NCT00233948|Nelfinavir|nelfinavir|mesh-list
25490942|NCT00233948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25490943|NCT00233948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25490944|NCT00233948|Protease Inhibitors|protease inhibitors|mesh-ancestor
25490945|NCT00233948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490946|NCT00233948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490947|NCT00233948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25490948|NCT00233948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25490949|NCT00233948|Antiviral Agents|antiviral agents|mesh-ancestor
25490950|NCT00233948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25490951|NCT00233987|Cyclophosphamide|cyclophosphamide|mesh-list
25490952|NCT00233987|Melphalan|melphalan|mesh-list
25490953|NCT00233987|Carmustine|carmustine|mesh-list
25490954|NCT00233987|Etoposide|etoposide|mesh-list
25490955|NCT00233987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25490956|NCT00233987|Immunologic Factors|immunologic factors|mesh-ancestor
25490957|NCT00233987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490958|NCT00233987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25490959|NCT00233987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25490960|NCT00233987|Alkylating Agents|alkylating agents|mesh-ancestor
25490961|NCT00233987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490962|NCT00233987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490963|NCT00233987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25490964|NCT00233987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25490965|NCT00233987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25490966|NCT00233987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25490967|NCT00233987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490968|NCT00234039|Gemcitabine|gemcitabine|mesh-list
25490969|NCT00234039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25490970|NCT00234039|Antimetabolites|antimetabolites|mesh-ancestor
25490971|NCT00234039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490972|NCT00234039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490973|NCT00234039|Antiviral Agents|antiviral agents|mesh-ancestor
25490974|NCT00234039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25490975|NCT00234039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490976|NCT00234039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25490977|NCT00234039|Immunologic Factors|immunologic factors|mesh-ancestor
25490978|NCT00234039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490979|NCT00234052|Bevacizumab|bevacizumab|mesh-list
25490980|NCT00234052|Carboplatin|carboplatin|mesh-list
25490981|NCT00234052|Pemetrexed|pemetrexed|mesh-list
25490982|NCT00234052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25490983|NCT00234052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25490984|NCT00234052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25490985|NCT00234052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25490986|NCT00234052|Growth Substances|growth substances|mesh-ancestor
25490987|NCT00234052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25490988|NCT00234052|Growth Inhibitors|growth inhibitors|mesh-ancestor
25490989|NCT00234052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25490990|NCT00234052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25490991|NCT00234052|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25490992|NCT00234052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25490993|NCT00234065|Aspirin|aspirin|mesh-list
25490994|NCT00234065|Cilostazol|cilostazol|mesh-list
25490995|NCT00234065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25490996|NCT00234065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25490997|NCT00234065|Analgesics|analgesics|mesh-ancestor
25490998|NCT00234065|Sensory System Agents|sensory system agents|mesh-ancestor
25119288|NCT02375295|Nitrofurantoin|nitrofurantoin|mesh-list
25119289|NCT02375295|Trimethoprim|trimethoprim|mesh-list
25119290|NCT02375295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25119291|NCT02375295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25119293|NCT02375295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25490999|NCT00234065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25491001|NCT00234065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25491002|NCT00234065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25491003|NCT00234065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25491004|NCT00234065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25491005|NCT00234065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491006|NCT00234065|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25491007|NCT00234065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25491008|NCT00234065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491010|NCT00234065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25491011|NCT00234065|Autonomic Agents|autonomic agents|mesh-ancestor
25491012|NCT00234065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25491013|NCT00234065|Respiratory System Agents|respiratory system agents|mesh-ancestor
25491014|NCT00234065|Vasodilator Agents|vasodilator agents|mesh-ancestor
25491015|NCT00234065|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25491016|NCT00234065|Protective Agents|protective agents|mesh-ancestor
25491017|NCT00234065|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25491018|NCT00234065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25491019|NCT00234078|Rebamipide|rebamipide|mesh-list
25491020|NCT00234078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25491021|NCT00234078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25491022|NCT00234078|Antioxidants|antioxidants|mesh-ancestor
25491023|NCT00234078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491024|NCT00234078|Protective Agents|protective agents|mesh-ancestor
25491025|NCT00234078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491026|NCT00234078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491027|NCT00234104|Tolvaptan|tolvaptan|mesh-list
25491028|NCT00234104|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25491029|NCT00234104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491030|NCT00234104|Natriuretic Agents|natriuretic agents|mesh-ancestor
25491031|NCT00234104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491032|NCT00234494|Gemcitabine|gemcitabine|mesh-list
25491033|NCT00234494|Bevacizumab|bevacizumab|mesh-list
25491034|NCT00234494|Cisplatin|cisplatin|mesh-list
25491035|NCT00234494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25491036|NCT00234494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491037|NCT00234494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25491038|NCT00234494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25491039|NCT00234494|Growth Substances|growth substances|mesh-ancestor
25491040|NCT00234494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491041|NCT00234494|Growth Inhibitors|growth inhibitors|mesh-ancestor
25491042|NCT00234494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25491043|NCT00234494|Antimetabolites|antimetabolites|mesh-ancestor
25491044|NCT00234494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491045|NCT00234494|Antiviral Agents|antiviral agents|mesh-ancestor
25491046|NCT00234494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25491047|NCT00234494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491048|NCT00234494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25491049|NCT00234494|Immunologic Factors|immunologic factors|mesh-ancestor
25491050|NCT00234832|Sibutramine|sibutramine|mesh-list
25491051|NCT00234832|Antidepressive Agents|antidepressive agents|mesh-ancestor
25491052|NCT00234832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25491053|NCT00234832|Appetite Depressants|appetite depressants|mesh-ancestor
25491054|NCT00234832|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25491055|NCT00234884|Adalimumab|adalimumab|mesh-list
25491056|NCT00234884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25491057|NCT00234884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25491058|NCT00235391|Deferasirox|deferasirox|mesh-list
25491059|NCT00235391|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25491060|NCT00235391|Chelating Agents|chelating agents|mesh-ancestor
25491061|NCT00235391|Sequestering Agents|sequestering agents|mesh-ancestor
25491062|NCT00235391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491063|NCT00235443|Lacosamide|lacosamide|mesh-list
25491064|NCT00235443|Anticonvulsants|anticonvulsants|mesh-ancestor
25119745|NCT05279963|Adrenergic Agents|adrenergic agents|mesh-ancestor
25119746|NCT05279963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25119796|NCT05161754|Hemostatics|hemostatics|mesh-list
25119797|NCT05161754|Coagulants|coagulants|mesh-ancestor
25119798|NCT05147090|Empagliflozin|empagliflozin|mesh-list
25112306|NCT04195139|Alkylating Agents|alkylating agents|mesh-ancestor
25119799|NCT05147090|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25119800|NCT05147090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119801|NCT05147090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25491101|NCT00235872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25491102|NCT00235872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25491103|NCT00235989|Interferons|interferons|mesh-list
25491104|NCT00235989|Interferon-beta|interferon-beta|mesh-list
25491105|NCT00235989|Interferon beta-1b|interferon beta-1b|mesh-list
25491106|NCT00235989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491107|NCT00235989|Antiviral Agents|antiviral agents|mesh-ancestor
25491108|NCT00235989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25491109|NCT00235989|Immunologic Factors|immunologic factors|mesh-ancestor
25491110|NCT00235989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491111|NCT00235989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25491112|NCT00236080|Modafinil|modafinil|mesh-list
25491113|NCT00236080|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25491114|NCT00236080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491115|NCT00236080|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25491116|NCT00236080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25491117|NCT00236080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25491118|NCT00236080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491119|NCT00236184|Rabeprazole|rabeprazole|mesh-list
25491120|NCT00236184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25491121|NCT00236184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25491122|NCT00236184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25491123|NCT00236184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491124|NCT00236184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491125|NCT00236197|Rabeprazole|rabeprazole|mesh-list
25491126|NCT00236197|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25491127|NCT00236197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25491128|NCT00236197|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25491129|NCT00236197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491130|NCT00236197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491131|NCT00236899|Gemcitabine|gemcitabine|mesh-list
25491132|NCT00236899|Paclitaxel|paclitaxel|mesh-list
25491133|NCT00236899|Docetaxel|docetaxel|mesh-list
25491134|NCT00236899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25491135|NCT00236899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491136|NCT00236899|Tubulin Modulators|tubulin modulators|mesh-ancestor
25491137|NCT00236899|Antimitotic Agents|antimitotic agents|mesh-ancestor
25491138|NCT00236899|Mitosis Modulators|mitosis modulators|mesh-ancestor
25491139|NCT00236899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491140|NCT00236899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25491141|NCT00236899|Antimetabolites|antimetabolites|mesh-ancestor
25491142|NCT00236899|Antiviral Agents|antiviral agents|mesh-ancestor
25491144|NCT00236899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491145|NCT00236899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25491146|NCT00236899|Immunologic Factors|immunologic factors|mesh-ancestor
25491147|NCT00236899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491148|NCT00236938|Epoetin Alfa|epoetin alfa|mesh-list
25491149|NCT00236938|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25491150|NCT00236938|Hematinics|hematinics|mesh-ancestor
25491151|NCT00236951|Epoetin Alfa|epoetin alfa|mesh-list
25491152|NCT00236951|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25491153|NCT00236951|Hematinics|hematinics|mesh-ancestor
25491154|NCT00236977|Iron|iron|mesh-list
25491155|NCT00236977|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25491156|NCT00236977|Trace Elements|trace elements|mesh-ancestor
25491157|NCT00236977|Micronutrients|micronutrients|mesh-ancestor
25491158|NCT00236977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491159|NCT00236977|Hematinics|hematinics|mesh-ancestor
25491160|NCT00237042|Levonorgestrel|levonorgestrel|mesh-list
25491161|NCT00237042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25491162|NCT00237042|Estradiol|estradiol|mesh-list
25491163|NCT00237042|Estrogens|estrogens|mesh-ancestor
25491164|NCT00237042|Hormones|hormones|mesh-ancestor
25491165|NCT00237042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25491166|NCT00237042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491167|NCT00237042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25491168|NCT00237042|Contraceptive Agents|contraceptive agents|mesh-ancestor
25491169|NCT00237042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25491170|NCT00237042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25491171|NCT00237042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25491172|NCT00237042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25491173|NCT00237042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25491174|NCT00237185|Imatinib Mesylate|imatinib mesylate|mesh-list
25491175|NCT00237185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587755|NCT00896831|N-Methylaspartate|n-methylaspartate|mesh-list
25491176|NCT00237185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25491177|NCT00237185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491178|NCT00237185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491179|NCT00237458|Lacosamide|lacosamide|mesh-list
25491180|NCT00237458|Anticonvulsants|anticonvulsants|mesh-ancestor
25491181|NCT00237458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25491182|NCT00237458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25491183|NCT00237458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25491184|NCT00237458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491185|NCT00237666|Ziprasidone|ziprasidone|mesh-list
25491186|NCT00237666|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25491187|NCT00237666|Serotonin Agents|serotonin agents|mesh-ancestor
25491188|NCT00237666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25491189|NCT00237666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491190|NCT00237666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491191|NCT00237666|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25491192|NCT00237666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25491193|NCT00237666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25491194|NCT00237666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25491195|NCT00237666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25491196|NCT00237666|Dopamine Agents|dopamine agents|mesh-ancestor
25491197|NCT00237718|Vitamin E|vitamin e|mesh-list
25491198|NCT00237718|Tocopherols|tocopherols|mesh-list
25491199|NCT00237718|Tocotrienols|tocotrienols|mesh-list
25491200|NCT00237718|alpha-Tocopherol|alpha-tocopherol|mesh-list
25491201|NCT00237718|Thioctic Acid|thioctic acid|mesh-list
25491202|NCT00237718|Vitamins|vitamins|mesh-ancestor
25491203|NCT00237718|Micronutrients|micronutrients|mesh-ancestor
25491204|NCT00237718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491205|NCT00237718|Antioxidants|antioxidants|mesh-ancestor
25491206|NCT00237718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491207|NCT00237718|Protective Agents|protective agents|mesh-ancestor
25491208|NCT00237718|Vitamin B Complex|vitamin b complex|mesh-ancestor
25491209|NCT00238108|Melatonin|melatonin|mesh-list
25491210|NCT00238108|Antioxidants|antioxidants|mesh-ancestor
25491211|NCT00238108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491212|NCT00238108|Protective Agents|protective agents|mesh-ancestor
25491213|NCT00238108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491214|NCT00238108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25491215|NCT00238121|Sorafenib|sorafenib|mesh-list
25491216|NCT00238121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491217|NCT00238121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25491218|NCT00238121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823157|NCT00004758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25491219|NCT00238121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491220|NCT00238238|Rituximab|rituximab|mesh-list
25491221|NCT00238238|Lenalidomide|lenalidomide|mesh-list
25491222|NCT00238238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25491223|NCT00238238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491224|NCT00238238|Immunologic Factors|immunologic factors|mesh-ancestor
25491225|NCT00238238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491226|NCT00238238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25491227|NCT00238238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25491228|NCT00238238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25491229|NCT00238238|Growth Substances|growth substances|mesh-ancestor
25491230|NCT00238238|Growth Inhibitors|growth inhibitors|mesh-ancestor
25491231|NCT00238303|Vorinostat|vorinostat|mesh-list
25491232|NCT00238303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491233|NCT00238303|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25491234|NCT00238303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491235|NCT00238303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491236|NCT00238355|Voriconazole|voriconazole|mesh-list
25491237|NCT00238355|Caspofungin|caspofungin|mesh-list
25491238|NCT00238355|Antifungal Agents|antifungal agents|mesh-ancestor
25491239|NCT00238355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25491240|NCT00238355|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25122926|NCT03088670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25122927|NCT03088670|Protease Inhibitors|protease inhibitors|mesh-ancestor
25122928|NCT03088670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24882924|NCT04757090|Trastuzumab|trastuzumab|mesh-list
25125624|NCT03067753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25125625|NCT03067753|Antiemetics|antiemetics|mesh-ancestor
25126203|NCT03063671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25126204|NCT03063671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126205|NCT03063671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25126206|NCT03063671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25491241|NCT00238355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25491242|NCT00238355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491243|NCT00238355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491244|NCT00238355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25491245|NCT00238355|Hormone Antagonists|hormone antagonists|mesh-ancestor
25491246|NCT00238355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25491247|NCT00238355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491248|NCT00238355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25491250|NCT00238433|Busulfan|busulfan|mesh-list
25491251|NCT00238433|Thiotepa|thiotepa|mesh-list
25491252|NCT00238433|Immunologic Factors|immunologic factors|mesh-ancestor
25491253|NCT00238433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491254|NCT00238433|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25491255|NCT00238433|Alkylating Agents|alkylating agents|mesh-ancestor
25491256|NCT00238433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491257|NCT00238433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491258|NCT00238433|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25491259|NCT00238433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25491260|NCT00238615|Carboplatin|carboplatin|mesh-list
25491261|NCT00238615|Docetaxel|docetaxel|mesh-list
25491262|NCT00238615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491263|NCT00238615|Tubulin Modulators|tubulin modulators|mesh-ancestor
25491264|NCT00238615|Antimitotic Agents|antimitotic agents|mesh-ancestor
25491265|NCT00238615|Mitosis Modulators|mitosis modulators|mesh-ancestor
25491266|NCT00238615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491267|NCT00239005|Mycophenolic Acid|mycophenolic acid|mesh-list
25491268|NCT00239005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25491269|NCT00239005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491270|NCT00239005|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25491271|NCT00239005|Antitubercular Agents|antitubercular agents|mesh-ancestor
25491272|NCT00239005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25491273|NCT00239005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25491274|NCT00239005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491275|NCT00239005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491276|NCT00239356|Aripiprazole|aripiprazole|mesh-list
25491277|NCT00239356|Antidepressive Agents|antidepressive agents|mesh-ancestor
25491278|NCT00239356|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25491279|NCT00239356|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25491280|NCT00239356|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25491281|NCT00239356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25491282|NCT00239356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491283|NCT00239356|Dopamine Agonists|dopamine agonists|mesh-ancestor
25491284|NCT00239356|Dopamine Agents|dopamine agents|mesh-ancestor
25491285|NCT00239356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25724064|NCT02533427|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25491286|NCT00239356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491287|NCT00239356|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25491288|NCT00239356|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25491289|NCT00239356|Serotonin Agents|serotonin agents|mesh-ancestor
25491290|NCT00239356|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25491291|NCT00239356|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25491292|NCT00239356|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25491293|NCT00239356|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25491294|NCT00239590|Methyltestosterone|methyltestosterone|mesh-list
25491295|NCT00239590|Testosterone|testosterone|mesh-list
25491296|NCT00239590|Testosterone undecanoate|testosterone undecanoate|mesh-list
25491297|NCT00239590|Testosterone enanthate|testosterone enanthate|mesh-list
25491298|NCT00239590|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25491299|NCT00239590|Androgens|androgens|mesh-ancestor
25491300|NCT00239590|Hormones|hormones|mesh-ancestor
25491301|NCT00239590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25491302|NCT00239590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491303|NCT00239590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25491304|NCT00239590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491305|NCT00239590|Anabolic Agents|anabolic agents|mesh-ancestor
25491306|NCT00239642|Iron|iron|mesh-list
25491307|NCT00239642|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25491308|NCT00239642|Trace Elements|trace elements|mesh-ancestor
25491309|NCT00239642|Micronutrients|micronutrients|mesh-ancestor
25491310|NCT00239642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491311|NCT00239642|Hematinics|hematinics|mesh-ancestor
25491312|NCT00239681|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25491313|NCT00239681|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25127184|NCT03057041|Fentanyl|fentanyl|mesh-list
25491314|NCT00239681|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25491315|NCT00239681|Antimetabolites|antimetabolites|mesh-ancestor
25491316|NCT00239681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491317|NCT00239681|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25491318|NCT00239681|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25491319|NCT00239681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491320|NCT00240071|Tamoxifen|tamoxifen|mesh-list
25491321|NCT00240071|Bevacizumab|bevacizumab|mesh-list
25491322|NCT00240071|Letrozole|letrozole|mesh-list
25491323|NCT00240071|Exemestane|exemestane|mesh-list
25491324|NCT00240071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25491325|NCT00240071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491326|NCT00240071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25491327|NCT00240071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25491328|NCT00240071|Growth Substances|growth substances|mesh-ancestor
25491329|NCT00240071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491330|NCT00240071|Growth Inhibitors|growth inhibitors|mesh-ancestor
25491331|NCT00240071|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25491332|NCT00240071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25491333|NCT00240071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491334|NCT00240071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491335|NCT00240071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25491336|NCT00240071|Hormone Antagonists|hormone antagonists|mesh-ancestor
25491337|NCT00240071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25491338|NCT00240071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25491339|NCT00240071|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25491340|NCT00240071|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25491341|NCT00240071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25491342|NCT00240097|Carboplatin|carboplatin|mesh-list
25491343|NCT00240097|Oxaliplatin|oxaliplatin|mesh-list
25491344|NCT00240097|Irinotecan|irinotecan|mesh-list
25491345|NCT00240097|Etoposide|etoposide|mesh-list
25491346|NCT00240097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491347|NCT00240097|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25491348|NCT00240097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25491349|NCT00240097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491350|NCT00240097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491351|NCT00240097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25491352|NCT00240097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25491353|NCT00240110|Valproic Acid|valproic acid|mesh-list
25491354|NCT00240110|Lithium Carbonate|lithium carbonate|mesh-list
25491355|NCT00240110|Antidepressive Agents|antidepressive agents|mesh-ancestor
25645242|NCT01445821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645243|NCT01445821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25645244|NCT01445821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25645245|NCT01445821|Antiemetics|antiemetics|mesh-ancestor
25491356|NCT00240110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25491357|NCT00240110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491358|NCT00240110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491359|NCT00240110|Antimanic Agents|antimanic agents|mesh-ancestor
25491360|NCT00240110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25491361|NCT00240110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25491362|NCT00240110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491363|NCT00240110|Anticonvulsants|anticonvulsants|mesh-ancestor
25491364|NCT00240110|GABA Agents|gaba agents|mesh-ancestor
25491365|NCT00240110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25491366|NCT00240162|Vatalanib|vatalanib|mesh-list
25491367|NCT00240162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25491368|NCT00240162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491369|NCT00240162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491370|NCT00240331|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25491371|NCT00240331|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25491372|NCT00240331|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25491373|NCT00240331|Antimetabolites|antimetabolites|mesh-ancestor
25491374|NCT00240331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491375|NCT00240331|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25491376|NCT00240331|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25491377|NCT00240331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491378|NCT00240487|Nitric Oxide|nitric oxide|mesh-list
25491379|NCT00240487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25491380|NCT00240487|Autonomic Agents|autonomic agents|mesh-ancestor
25491381|NCT00240487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25491382|NCT00240487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491383|NCT00240487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25491384|NCT00240487|Respiratory System Agents|respiratory system agents|mesh-ancestor
25491385|NCT00240487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25127812|NCT03052673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25127816|NCT03052673|Anesthetics, General|anesthetics, general|mesh-ancestor
25491386|NCT00240487|Antioxidants|antioxidants|mesh-ancestor
25491387|NCT00240487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491388|NCT00240487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25491389|NCT00240487|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25491390|NCT00240487|Vasodilator Agents|vasodilator agents|mesh-ancestor
25491391|NCT00240487|Gasotransmitters|gasotransmitters|mesh-ancestor
25491392|NCT00240487|Protective Agents|protective agents|mesh-ancestor
25491393|NCT00240526|Immunoglobulins|immunoglobulins|mesh-list
25491394|NCT00240526|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25491395|NCT00240526|Antibodies|antibodies|mesh-list
25491396|NCT00240526|Immunologic Factors|immunologic factors|mesh-ancestor
25491397|NCT00240526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491398|NCT00240981|Testosterone|testosterone|mesh-list
25491399|NCT00240981|Androgens|androgens|mesh-ancestor
25491400|NCT00240981|Hormones|hormones|mesh-ancestor
25491401|NCT00240981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25491402|NCT00240981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491403|NCT00240994|Mycophenolic Acid|mycophenolic acid|mesh-list
25491404|NCT00240994|Sirolimus|sirolimus|mesh-list
25491405|NCT00240994|Alemtuzumab|alemtuzumab|mesh-list
25491406|NCT00240994|Tacrolimus|tacrolimus|mesh-list
25491407|NCT00240994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25491408|NCT00240994|Immunologic Factors|immunologic factors|mesh-ancestor
25491409|NCT00240994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491410|NCT00240994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25491411|NCT00240994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491412|NCT00240994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491413|NCT00240994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25491414|NCT00240994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491415|NCT00240994|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25491416|NCT00240994|Antitubercular Agents|antitubercular agents|mesh-ancestor
25491417|NCT00240994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25491418|NCT00240994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25491419|NCT00240994|Antifungal Agents|antifungal agents|mesh-ancestor
25491420|NCT00240994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25491421|NCT00241176|Aripiprazole|aripiprazole|mesh-list
25491422|NCT00241176|Antidepressive Agents|antidepressive agents|mesh-ancestor
25491423|NCT00241176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25491424|NCT00241176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25491425|NCT00241176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25645246|NCT01445821|Autonomic Agents|autonomic agents|mesh-ancestor
25645247|NCT01445821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25645248|NCT01445821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25645249|NCT01445821|Glucocorticoids|glucocorticoids|mesh-ancestor
25645250|NCT01445821|Hormones|hormones|mesh-ancestor
25645251|NCT01445821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25491426|NCT00241176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25491427|NCT00241176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491428|NCT00241176|Dopamine Agonists|dopamine agonists|mesh-ancestor
25491429|NCT00241176|Dopamine Agents|dopamine agents|mesh-ancestor
25491430|NCT00241176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25491431|NCT00241176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645252|NCT01445821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25491432|NCT00241176|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25491433|NCT00241176|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25491434|NCT00241176|Serotonin Agents|serotonin agents|mesh-ancestor
25491435|NCT00241176|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25491436|NCT00241176|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25645253|NCT01445821|Protective Agents|protective agents|mesh-ancestor
25645254|NCT01445821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25645255|NCT01445847|Lidocaine|lidocaine|mesh-list
25645256|NCT01445847|Anesthetics, Local|anesthetics, local|mesh-ancestor
25645257|NCT01445847|Anesthetics|anesthetics|mesh-ancestor
25645258|NCT01445847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25491437|NCT00241176|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25491438|NCT00241176|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25491439|NCT00241358|Plerixafor|plerixafor|mesh-list
25491440|NCT00241358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25491441|NCT00241358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25491442|NCT00241358|Antiviral Agents|antiviral agents|mesh-ancestor
25491443|NCT00241358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25491444|NCT00241631|Fluticasone|fluticasone|mesh-list
25491445|NCT00241631|Xhance|xhance|mesh-list
25491446|NCT00241631|Theophylline|theophylline|mesh-list
25491447|NCT00241631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25128117|NCT03050710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25128118|NCT03050710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128119|NCT03050710|Sensory System Agents|sensory system agents|mesh-ancestor
25128120|NCT03050710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25128121|NCT03050710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25128122|NCT03050710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25128123|NCT03050710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25128124|NCT03050710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25128125|NCT03050710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128126|NCT03050437|Pemetrexed|pemetrexed|mesh-list
25128127|NCT03050437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25128128|NCT03050437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491448|NCT00241631|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25491449|NCT00241631|Autonomic Agents|autonomic agents|mesh-ancestor
25491450|NCT00241631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25491451|NCT00241631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491452|NCT00241631|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25491453|NCT00241631|Respiratory System Agents|respiratory system agents|mesh-ancestor
25491454|NCT00241631|Dermatologic Agents|dermatologic agents|mesh-ancestor
25491455|NCT00241631|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25491456|NCT00241631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25491457|NCT00241631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491458|NCT00241631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491459|NCT00241631|Vasodilator Agents|vasodilator agents|mesh-ancestor
25491460|NCT00241631|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25491461|NCT00241631|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25491462|NCT00241631|Purinergic Agents|purinergic agents|mesh-ancestor
25491463|NCT00241631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25491464|NCT00241644|Vaccines|vaccines|mesh-list
25491465|NCT00241644|Immunologic Factors|immunologic factors|mesh-ancestor
25491466|NCT00241644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491467|NCT00241839|Allopurinol|allopurinol|mesh-list
25491468|NCT00241839|Chlorthalidone|chlorthalidone|mesh-list
25491469|NCT00241839|Antimetabolites|antimetabolites|mesh-ancestor
25491470|NCT00241839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491471|NCT00241839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491472|NCT00241839|Gout Suppressants|gout suppressants|mesh-ancestor
25491473|NCT00241839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25645259|NCT01445847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645260|NCT01445847|Sensory System Agents|sensory system agents|mesh-ancestor
25645261|NCT01445847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25645262|NCT01445847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25645263|NCT01445847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25645264|NCT01445847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25645265|NCT01445847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25645266|NCT01445847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645267|NCT01445873|Sitaxsentan|sitaxsentan|mesh-list
25645268|NCT01445873|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25645269|NCT01445873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645270|NCT01445886|Calcitriol|calcitriol|mesh-list
25491474|NCT00241839|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25491475|NCT00241839|Antioxidants|antioxidants|mesh-ancestor
25491476|NCT00241839|Protective Agents|protective agents|mesh-ancestor
25491477|NCT00241839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491478|NCT00241839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25491479|NCT00241839|Diuretics|diuretics|mesh-ancestor
25645271|NCT01445886|Calcipotriene|calcipotriene|mesh-list
25645272|NCT01445886|Dermatologic Agents|dermatologic agents|mesh-ancestor
25645273|NCT01445886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25645274|NCT01445886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491480|NCT00241839|Natriuretic Agents|natriuretic agents|mesh-ancestor
25491481|NCT00241839|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25491482|NCT00241839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25491483|NCT00241904|Propranolol|propranolol|mesh-list
25491484|NCT00241904|Metoprolol|metoprolol|mesh-list
25491485|NCT00241904|Atenolol|atenolol|mesh-list
25491486|NCT00241904|Lisinopril|lisinopril|mesh-list
25491487|NCT00241904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25491488|NCT00241904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25491489|NCT00241904|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25491490|NCT00241904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25491491|NCT00241904|Adrenergic Agents|adrenergic agents|mesh-ancestor
25491492|NCT00241904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25491493|NCT00241904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491494|NCT00241904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491495|NCT00241904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25491496|NCT00241904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25491497|NCT00241904|Vasodilator Agents|vasodilator agents|mesh-ancestor
25491498|NCT00241904|Sympatholytics|sympatholytics|mesh-ancestor
25491499|NCT00241904|Autonomic Agents|autonomic agents|mesh-ancestor
25491500|NCT00241904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25491501|NCT00241904|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25491502|NCT00241904|Protease Inhibitors|protease inhibitors|mesh-ancestor
25491503|NCT00241904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491504|NCT00241904|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25491505|NCT00241904|Protective Agents|protective agents|mesh-ancestor
25491506|NCT00242216|Ritonavir|ritonavir|mesh-list
25491507|NCT00242216|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25491508|NCT00242216|Fosamprenavir|fosamprenavir|mesh-list
25491509|NCT00242216|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25491510|NCT00242216|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25491511|NCT00242216|Protease Inhibitors|protease inhibitors|mesh-ancestor
25491512|NCT00242216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491513|NCT00242216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491514|NCT00242216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25491515|NCT00242216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25491516|NCT00242216|Antiviral Agents|antiviral agents|mesh-ancestor
25491517|NCT00242216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25491518|NCT00242216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25491519|NCT00242216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25491520|NCT00242385|Protease Inhibitors|protease inhibitors|mesh-list
25491521|NCT00242385|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25491522|NCT00242385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491523|NCT00242385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128666|NCT03045471|Cyclophosphamide|cyclophosphamide|mesh-list
25491524|NCT00242385|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25491525|NCT00242385|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25491527|NCT00242502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25491528|NCT00242502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25491529|NCT00242502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491530|NCT00242502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25491531|NCT00242502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25491532|NCT00242502|Growth Substances|growth substances|mesh-ancestor
25491533|NCT00242502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491534|NCT00242502|Growth Inhibitors|growth inhibitors|mesh-ancestor
25491535|NCT00242502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25491536|NCT00242502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491537|NCT00242502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491538|NCT00242567|Zoledronic Acid|zoledronic acid|mesh-list
25491539|NCT00242567|Androgens|androgens|mesh-list
25491540|NCT00242567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25491541|NCT00242567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491542|NCT00242567|Hormones|hormones|mesh-ancestor
25491543|NCT00242567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25491544|NCT00242580|Triamcinolone|triamcinolone|mesh-list
25491545|NCT00242580|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25491546|NCT00242580|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25491547|NCT00242580|Verteporfin|verteporfin|mesh-list
25491548|NCT00242580|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25491549|NCT00242580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25491550|NCT00242580|Glucocorticoids|glucocorticoids|mesh-ancestor
25491551|NCT00242580|Hormones|hormones|mesh-ancestor
25491552|NCT00242580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25491553|NCT00242580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491554|NCT00242580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25491555|NCT00242580|Immunologic Factors|immunologic factors|mesh-ancestor
25491556|NCT00242580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491557|NCT00242580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491558|NCT00242580|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25491559|NCT00242580|Dermatologic Agents|dermatologic agents|mesh-ancestor
25491560|NCT00242619|Rosiglitazone|rosiglitazone|mesh-list
25491561|NCT00242619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25491562|NCT00242619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491563|NCT00242632|Memantine|memantine|mesh-list
25491564|NCT00242632|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25491565|NCT00242632|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25491566|NCT00242632|Dopamine Agents|dopamine agents|mesh-ancestor
25491567|NCT00242632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25491568|NCT00242632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491569|NCT00242632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491570|NCT00242632|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25491571|NCT00242632|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25491572|NCT00242710|Bazedoxifene|bazedoxifene|mesh-list
25491573|NCT00242710|Estrogens|estrogens|mesh-list
25491574|NCT00242710|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25491575|NCT00242710|Hormones|hormones|mesh-ancestor
25491576|NCT00242710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25491577|NCT00242710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491578|NCT00242710|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25491579|NCT00242710|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25491580|NCT00242710|Hormone Antagonists|hormone antagonists|mesh-ancestor
25491581|NCT00242710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25491582|NCT00243022|Vitamin B 12|vitamin b 12|mesh-list
25491583|NCT00243022|Hydroxocobalamin|hydroxocobalamin|mesh-list
25491584|NCT00243022|Vitamins|vitamins|mesh-ancestor
25491585|NCT00243022|Micronutrients|micronutrients|mesh-ancestor
25491586|NCT00243022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491587|NCT00243022|Vitamin B Complex|vitamin b complex|mesh-ancestor
25491588|NCT00243022|Hematinics|hematinics|mesh-ancestor
25491589|NCT00243061|Cediranib|cediranib|mesh-list
25491590|NCT00243061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491591|NCT00243061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491592|NCT00243061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491593|NCT00243061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25491594|NCT00243074|Cediranib|cediranib|mesh-list
25491595|NCT00243074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491596|NCT00243074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491597|NCT00243074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491598|NCT00243074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25491599|NCT00243152|Lamotrigine|lamotrigine|mesh-list
25491600|NCT00243152|Anticonvulsants|anticonvulsants|mesh-list
25491601|NCT00243152|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25491602|NCT00243152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25491603|NCT00243152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491604|NCT00243152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25645275|NCT01445886|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25645276|NCT01445886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25645277|NCT01445886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645278|NCT01445886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25491605|NCT00243152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491606|NCT00243152|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25491607|NCT00243152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25491608|NCT00243152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25491609|NCT00243152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25491610|NCT00243152|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25491611|NCT00243191|Imatinib Mesylate|imatinib mesylate|mesh-list
25491612|NCT00243191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491613|NCT00243191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25491614|NCT00243191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491615|NCT00243191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491617|NCT00243347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491618|NCT00243347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25491619|NCT00243347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491620|NCT00243347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491621|NCT00243386|Factor VIII|factor viii|mesh-list
25491622|NCT00243386|Coagulants|coagulants|mesh-ancestor
25491623|NCT00243412|Methylprednisolone|methylprednisolone|mesh-list
25491624|NCT00243412|Rituximab|rituximab|mesh-list
25491625|NCT00243412|Methotrexate|methotrexate|mesh-list
25491626|NCT00243412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25491627|NCT00243412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491628|NCT00243412|Immunologic Factors|immunologic factors|mesh-ancestor
25491629|NCT00243412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491630|NCT00243412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25491631|NCT00243412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25491632|NCT00243412|Abortifacient Agents|abortifacient agents|mesh-ancestor
25491633|NCT00243412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25491634|NCT00243412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25491635|NCT00243412|Antimetabolites|antimetabolites|mesh-ancestor
25491636|NCT00243412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491637|NCT00243412|Dermatologic Agents|dermatologic agents|mesh-ancestor
25491638|NCT00243412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491639|NCT00243412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25491640|NCT00243412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25491641|NCT00243412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25491642|NCT00243412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25491643|NCT00243412|Antiemetics|antiemetics|mesh-ancestor
25491644|NCT00243412|Autonomic Agents|autonomic agents|mesh-ancestor
25491645|NCT00243412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25491646|NCT00243412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25491647|NCT00243412|Glucocorticoids|glucocorticoids|mesh-ancestor
25491648|NCT00243412|Hormones|hormones|mesh-ancestor
25491649|NCT00243412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25491650|NCT00243412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25491651|NCT00243412|Protective Agents|protective agents|mesh-ancestor
25491652|NCT00243503|Trastuzumab|trastuzumab|mesh-list
25491653|NCT00243503|Sunitinib|sunitinib|mesh-list
25491654|NCT00243503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25491655|NCT00243503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491656|NCT00243503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25491657|NCT00243503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25491658|NCT00243503|Growth Substances|growth substances|mesh-ancestor
25491659|NCT00243503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491660|NCT00243503|Growth Inhibitors|growth inhibitors|mesh-ancestor
25491661|NCT00243503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25491662|NCT00243503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491663|NCT00243503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491664|NCT00243659|Factor VIII|factor viii|mesh-list
25491665|NCT00243659|Coagulants|coagulants|mesh-ancestor
25491666|NCT00243932|Ubiquinone|ubiquinone|mesh-list
25491667|NCT00243932|Coenzyme Q10|coenzyme q10|mesh-list
25491668|NCT00243932|Micronutrients|micronutrients|mesh-ancestor
25491669|NCT00243932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491670|NCT00243932|Vitamins|vitamins|mesh-ancestor
25491671|NCT00244101|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25491672|NCT00244101|Respiratory System Agents|respiratory system agents|mesh-ancestor
25491673|NCT00244621|Candesartan|candesartan|mesh-list
25491674|NCT00244621|Candesartan cilexetil|candesartan cilexetil|mesh-list
25491675|NCT00244621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25491676|NCT00244621|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25491677|NCT00244621|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25491678|NCT00244621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491679|NCT00244712|Tenofovir|tenofovir|mesh-list
25491680|NCT00244712|Lamivudine|lamivudine|mesh-list
25491681|NCT00244712|Emtricitabine|emtricitabine|mesh-list
25491682|NCT00244712|Abacavir|abacavir|mesh-list
25491683|NCT00244712|Antiviral Agents|antiviral agents|mesh-ancestor
25491684|NCT00244712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25491685|NCT00244712|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25491686|NCT00244712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25491687|NCT00244712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491688|NCT00244712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491689|NCT00244712|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25491690|NCT00244712|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25491691|NCT00244725|Warfarin|warfarin|mesh-list
25491692|NCT00244725|Anticoagulants|anticoagulants|mesh-ancestor
25491693|NCT00244855|Dexamethasone|dexamethasone|mesh-list
25491694|NCT00244855|Rituximab|rituximab|mesh-list
25491695|NCT00244855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25491696|NCT00244855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491697|NCT00244855|Immunologic Factors|immunologic factors|mesh-ancestor
25491698|NCT00244855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491699|NCT00244855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25491700|NCT00244855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25491701|NCT00244855|Antiemetics|antiemetics|mesh-ancestor
25491702|NCT00244855|Autonomic Agents|autonomic agents|mesh-ancestor
25491703|NCT00244855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25491704|NCT00244855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25491705|NCT00244855|Glucocorticoids|glucocorticoids|mesh-ancestor
25491706|NCT00244855|Hormones|hormones|mesh-ancestor
25491707|NCT00244855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25491708|NCT00244855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25491709|NCT00244881|Cediranib|cediranib|mesh-list
25491710|NCT00244881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491711|NCT00244881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491712|NCT00244881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491713|NCT00244881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25491714|NCT00244933|Gemcitabine|gemcitabine|mesh-list
25491715|NCT00244933|Genistein|genistein|mesh-list
25491716|NCT00244933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25491717|NCT00244933|Antimetabolites|antimetabolites|mesh-ancestor
25491718|NCT00244933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491719|NCT00244933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491720|NCT00244933|Antiviral Agents|antiviral agents|mesh-ancestor
25491721|NCT00244933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25491722|NCT00244933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491723|NCT00244933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25491724|NCT00244933|Immunologic Factors|immunologic factors|mesh-ancestor
25491725|NCT00244933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491726|NCT00244933|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25491727|NCT00244933|Protective Agents|protective agents|mesh-ancestor
25491728|NCT00244933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25491729|NCT00244933|Phytoestrogens|phytoestrogens|mesh-ancestor
25491730|NCT00244933|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25491731|NCT00244933|Estrogens|estrogens|mesh-ancestor
25491732|NCT00244933|Hormones|hormones|mesh-ancestor
25491733|NCT00244933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25491734|NCT00244985|Rituximab|rituximab|mesh-list
25491735|NCT00244985|Doxorubicin|doxorubicin|mesh-list
25491736|NCT00244985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25491737|NCT00244985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25491738|NCT00244985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491739|NCT00244985|Immunologic Factors|immunologic factors|mesh-ancestor
25491740|NCT00244985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491741|NCT00244985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25491742|NCT00244985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25491743|NCT00244985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25491744|NCT00244985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25491745|NCT00244985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491746|NCT00244985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491747|NCT00245011|Ifosfamide|ifosfamide|mesh-list
25491748|NCT00245011|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
25491750|NCT00245011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25491751|NCT00245011|Alkylating Agents|alkylating agents|mesh-ancestor
25645280|NCT01445886|Micronutrients|micronutrients|mesh-ancestor
25645281|NCT01445886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25645282|NCT01445951|Insulin|insulin|mesh-list
25645283|NCT01445951|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25491752|NCT00245011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491753|NCT00245011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491754|NCT00245011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25491755|NCT00245011|Analgesics|analgesics|mesh-ancestor
25491756|NCT00245011|Sensory System Agents|sensory system agents|mesh-ancestor
25491757|NCT00245011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25491758|NCT00245037|Cyclosporine|cyclosporine|mesh-list
25491759|NCT00245037|Mycophenolic Acid|mycophenolic acid|mesh-list
25491760|NCT00245037|Methotrexate|methotrexate|mesh-list
25491761|NCT00245037|Fludarabine phosphate|fludarabine phosphate|mesh-list
25491762|NCT00245037|Fludarabine|fludarabine|mesh-list
25491763|NCT00245037|Busulfan|busulfan|mesh-list
25491764|NCT00245037|Phenytoin|phenytoin|mesh-list
25491765|NCT00245037|Cyclosporins|cyclosporins|mesh-list
25491766|NCT00245037|Lenograstim|lenograstim|mesh-list
25491767|NCT00245037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25491768|NCT00245037|Abortifacient Agents|abortifacient agents|mesh-ancestor
25491769|NCT00245037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25491770|NCT00245037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491771|NCT00245037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25491772|NCT00245037|Antimetabolites|antimetabolites|mesh-ancestor
25491773|NCT00245037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491774|NCT00245037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491775|NCT00245037|Dermatologic Agents|dermatologic agents|mesh-ancestor
25491776|NCT00245037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491777|NCT00245037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25491778|NCT00245037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25491779|NCT00245037|Immunologic Factors|immunologic factors|mesh-ancestor
25491780|NCT00245037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25491781|NCT00245037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25491782|NCT00245037|Antifungal Agents|antifungal agents|mesh-ancestor
25491783|NCT00245037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25491784|NCT00245037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25491785|NCT00245037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25491786|NCT00245037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25491787|NCT00245037|Antitubercular Agents|antitubercular agents|mesh-ancestor
25491788|NCT00245037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25491789|NCT00245037|Alkylating Agents|alkylating agents|mesh-ancestor
25491790|NCT00245037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25491791|NCT00245037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25491792|NCT00245037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25491793|NCT00245037|Anticonvulsants|anticonvulsants|mesh-ancestor
25491794|NCT00245037|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25491795|NCT00245037|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25491796|NCT00245037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25491797|NCT00245037|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25491798|NCT00245037|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25491799|NCT00245050|Pyridoxine|pyridoxine|mesh-list
25491800|NCT00245050|Vitamin B 6|vitamin b 6|mesh-list
25491801|NCT00245050|Doxorubicin|doxorubicin|mesh-list
25491802|NCT00245050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25491803|NCT00245050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25491804|NCT00245050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491805|NCT00245050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25491806|NCT00245050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25491807|NCT00245050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491808|NCT00245050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491809|NCT00245050|Vitamin B Complex|vitamin b complex|mesh-ancestor
25491810|NCT00245050|Vitamins|vitamins|mesh-ancestor
25491811|NCT00245050|Micronutrients|micronutrients|mesh-ancestor
25491812|NCT00245050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491813|NCT00245063|Cediranib|cediranib|mesh-list
25129655|NCT03039205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25129656|NCT03039205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129657|NCT03039205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129658|NCT03039257|Vitamin A|vitamin a|mesh-list
25129659|NCT03039257|Vitamins|vitamins|mesh-ancestor
25129660|NCT03039257|Micronutrients|micronutrients|mesh-ancestor
25129661|NCT03039257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129662|NCT03038919|Methyltestosterone|methyltestosterone|mesh-list
25129663|NCT03038919|Testosterone|testosterone|mesh-list
25491814|NCT00245063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491823|NCT00245557|Sertraline|sertraline|mesh-list
25645284|NCT01445951|Insulin Aspart|insulin aspart|mesh-list
25645285|NCT01445951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25491824|NCT00245557|Antidepressive Agents|antidepressive agents|mesh-ancestor
25491825|NCT00245557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25491826|NCT00245557|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25491827|NCT00245557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25491828|NCT00245557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25491829|NCT00245557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491830|NCT00245557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25491831|NCT00245557|Serotonin Agents|serotonin agents|mesh-ancestor
25491832|NCT00245557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491833|NCT00245583|Topiramate|topiramate|mesh-list
25491834|NCT00245583|Anticonvulsants|anticonvulsants|mesh-ancestor
25491835|NCT00245583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25491836|NCT00245583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491837|NCT00245635|Fluoxetine|fluoxetine|mesh-list
25491838|NCT00245635|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25491839|NCT00245635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25491840|NCT00245635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25491841|NCT00245635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491842|NCT00245635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25491843|NCT00245635|Serotonin Agents|serotonin agents|mesh-ancestor
25491844|NCT00245635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491845|NCT00245635|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25491846|NCT00245635|Antidepressive Agents|antidepressive agents|mesh-ancestor
25491847|NCT00245635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25491848|NCT00245635|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25491849|NCT00245635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25491850|NCT00245635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491851|NCT00245765|Certolizumab Pegol|certolizumab pegol|mesh-list
25491852|NCT00245765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25491853|NCT00245765|Immunologic Factors|immunologic factors|mesh-ancestor
25491854|NCT00245765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491855|NCT00245765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25491856|NCT00245856|Dalteparin|dalteparin|mesh-list
25491857|NCT00245856|Tinzaparin|tinzaparin|mesh-list
25491858|NCT00245856|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25491859|NCT00245856|Warfarin|warfarin|mesh-list
25491860|NCT00245856|Anticoagulants|anticoagulants|mesh-ancestor
25491861|NCT00245856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25491862|NCT00245856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25491863|NCT00245856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491864|NCT00246012|Dacarbazine|dacarbazine|mesh-list
25491865|NCT00246012|Intetumumab|intetumumab|mesh-list
25491866|NCT00246012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25491867|NCT00246012|Alkylating Agents|alkylating agents|mesh-ancestor
25491868|NCT00246012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491869|NCT00246012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491870|NCT00246012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25491871|NCT00246025|Dabigatran|dabigatran|mesh-list
25491872|NCT00246025|Antithrombins|antithrombins|mesh-ancestor
25491873|NCT00246025|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25491874|NCT00246025|Protease Inhibitors|protease inhibitors|mesh-ancestor
25491875|NCT00246025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491876|NCT00246025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491877|NCT00246025|Anticoagulants|anticoagulants|mesh-ancestor
25491878|NCT00246129|Alemtuzumab|alemtuzumab|mesh-list
25491879|NCT00246129|Daclizumab|daclizumab|mesh-list
25491880|NCT00246129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25491881|NCT00246129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491882|NCT00246129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25491883|NCT00246129|Immunologic Factors|immunologic factors|mesh-ancestor
25491884|NCT00246129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491885|NCT00246259|Risperidone|risperidone|mesh-list
25491886|NCT00246259|Antipsychotic Agents|antipsychotic agents|mesh-list
25491887|NCT00246259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25491888|NCT00246259|Serotonin Agents|serotonin agents|mesh-ancestor
25026095|NCT03631901|Diazepam|diazepam|mesh-list
25130120|NCT03036202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130121|NCT03036202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130122|NCT03036202|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25130155|NCT03036085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130156|NCT03036085|Sensory System Agents|sensory system agents|mesh-ancestor
25130157|NCT03036085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25823158|NCT00004758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25130158|NCT03036085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25491889|NCT00246259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25491890|NCT00246259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491891|NCT00246259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491892|NCT00246259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25491893|NCT00246259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25491894|NCT00246259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25491895|NCT00246259|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25491896|NCT00246259|Dopamine Agents|dopamine agents|mesh-ancestor
25491897|NCT00246324|Interferons|interferons|mesh-list
25491898|NCT00246324|Interferon-beta|interferon-beta|mesh-list
25491899|NCT00246324|Interferon beta-1a|interferon beta-1a|mesh-list
25491900|NCT00246324|Doxycycline|doxycycline|mesh-list
25491901|NCT00246324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491902|NCT00246324|Antiviral Agents|antiviral agents|mesh-ancestor
25491903|NCT00246324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25491904|NCT00246324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25491905|NCT00246324|Antimalarials|antimalarials|mesh-ancestor
25491906|NCT00246324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25491907|NCT00246324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25491908|NCT00246324|Immunologic Factors|immunologic factors|mesh-ancestor
25491909|NCT00246324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491910|NCT00246324|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25491911|NCT00246337|Rizatriptan|rizatriptan|mesh-list
25491912|NCT00246337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25491913|NCT00246337|Serotonin Agents|serotonin agents|mesh-ancestor
25491914|NCT00246337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25491915|NCT00246337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491916|NCT00246337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491918|NCT00246376|Fenofibrate|fenofibrate|mesh-list
25491919|NCT00246376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25491920|NCT00246376|Antimetabolites|antimetabolites|mesh-ancestor
25491921|NCT00246376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491922|NCT00246376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25491923|NCT00246376|Vasodilator Agents|vasodilator agents|mesh-ancestor
25491924|NCT00246376|Vitamin B Complex|vitamin b complex|mesh-ancestor
25491925|NCT00246376|Vitamins|vitamins|mesh-ancestor
25491926|NCT00246376|Micronutrients|micronutrients|mesh-ancestor
25491927|NCT00246376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491928|NCT00246441|Paroxetine|paroxetine|mesh-list
25491929|NCT00246441|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25491930|NCT00246441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25491931|NCT00246441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25491932|NCT00246441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491933|NCT00246441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25491934|NCT00246441|Serotonin Agents|serotonin agents|mesh-ancestor
25491935|NCT00246441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491936|NCT00246441|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25491937|NCT00246441|Antidepressive Agents|antidepressive agents|mesh-ancestor
25491938|NCT00246441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25491939|NCT00246441|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25491940|NCT00246441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25491941|NCT00246441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491942|NCT00246519|Atenolol|atenolol|mesh-list
25491943|NCT00246519|Metoprolol|metoprolol|mesh-list
25491944|NCT00246519|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25491945|NCT00246519|Trichlormethiazide|trichlormethiazide|mesh-list
25491946|NCT00246519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25491947|NCT00246519|Diuretics|diuretics|mesh-ancestor
25491948|NCT00246519|Natriuretic Agents|natriuretic agents|mesh-ancestor
25491949|NCT00246519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491950|NCT00246519|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25491951|NCT00246519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25491952|NCT00246519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491953|NCT00246519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25491954|NCT00246519|Sympatholytics|sympatholytics|mesh-ancestor
25491955|NCT00246519|Autonomic Agents|autonomic agents|mesh-ancestor
25491956|NCT00246519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25491957|NCT00246519|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25491958|NCT00246519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25491959|NCT00246519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25491960|NCT00246519|Adrenergic Agents|adrenergic agents|mesh-ancestor
25130502|NCT03032978|Calcium|calcium|mesh-list
25130503|NCT03032978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24959578|NCT03823911|Velpatasvir|velpatasvir|mesh-list
25645286|NCT01445951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491961|NCT00246519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25491963|NCT00246571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491964|NCT00246571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25491965|NCT00246571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25491966|NCT00246571|Growth Substances|growth substances|mesh-ancestor
25491967|NCT00246571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491968|NCT00246571|Growth Inhibitors|growth inhibitors|mesh-ancestor
25491969|NCT00246571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25491970|NCT00246571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491971|NCT00246571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491972|NCT00246740|Doxycycline|doxycycline|mesh-list
25491973|NCT00246740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25491974|NCT00246740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25491975|NCT00246740|Antimalarials|antimalarials|mesh-ancestor
25491976|NCT00246740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25491977|NCT00246740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25491978|NCT00246753|Lapatinib|lapatinib|mesh-list
25491979|NCT00246753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25491980|NCT00246753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25491981|NCT00246753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25491982|NCT00246753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491983|NCT00247273|Risedronic Acid|risedronic acid|mesh-list
25491984|NCT00247273|Etidronic Acid|etidronic acid|mesh-list
25491985|NCT00247273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25491986|NCT00247273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25491987|NCT00247273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25491988|NCT00247273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25491989|NCT00247273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491990|NCT00247273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25491991|NCT00247416|Gemcitabine|gemcitabine|mesh-list
25491992|NCT00247416|Dexamethasone|dexamethasone|mesh-list
25491993|NCT00247416|Carboplatin|carboplatin|mesh-list
25491994|NCT00247416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25491995|NCT00247416|Antiemetics|antiemetics|mesh-ancestor
25491996|NCT00247416|Autonomic Agents|autonomic agents|mesh-ancestor
25491997|NCT00247416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25491998|NCT00247416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25491999|NCT00247416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25492000|NCT00247416|Glucocorticoids|glucocorticoids|mesh-ancestor
25492001|NCT00247416|Hormones|hormones|mesh-ancestor
25492002|NCT00247416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25492003|NCT00247416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25492004|NCT00247416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492005|NCT00247416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25492006|NCT00247416|Antimetabolites|antimetabolites|mesh-ancestor
25492007|NCT00247416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492008|NCT00247416|Antiviral Agents|antiviral agents|mesh-ancestor
25492009|NCT00247416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25492010|NCT00247416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492011|NCT00247416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25492012|NCT00247416|Immunologic Factors|immunologic factors|mesh-ancestor
25492013|NCT00247624|Eszopiclone|eszopiclone|mesh-list
25492014|NCT00247624|Fluoxetine|fluoxetine|mesh-list
25492015|NCT00247624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25492016|NCT00247624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25492017|NCT00247624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25492018|NCT00247624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492019|NCT00247624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25492020|NCT00247624|Serotonin Agents|serotonin agents|mesh-ancestor
25131012|NCT03029494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131013|NCT03029494|Antioxidants|antioxidants|mesh-ancestor
25131014|NCT03029494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131015|NCT03029494|Protective Agents|protective agents|mesh-ancestor
25131016|NCT03029845|Propranolol|propranolol|mesh-list
25026275|NCT03630081|Ciprofloxacin|ciprofloxacin|mesh-list
25131221|NCT03027674|Tocolytic Agents|tocolytic agents|mesh-ancestor
25131222|NCT03027674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25131223|NCT03027648|Levonorgestrel|levonorgestrel|mesh-list
25131224|NCT03027648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25131225|NCT03027648|Contraceptive Agents|contraceptive agents|mesh-ancestor
25131226|NCT03027648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25131227|NCT03027648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131230|NCT03027648|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25492021|NCT00247624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492022|NCT00247624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25492023|NCT00247624|Antidepressive Agents|antidepressive agents|mesh-ancestor
25492024|NCT00247624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25492025|NCT00247624|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25492026|NCT00247624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25492027|NCT00247624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492028|NCT00247624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25492029|NCT00247624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25492030|NCT00247676|Sunitinib|sunitinib|mesh-list
25492031|NCT00247676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492032|NCT00247676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25492033|NCT00247676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25492034|NCT00247676|Growth Substances|growth substances|mesh-ancestor
25492035|NCT00247676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492036|NCT00247676|Growth Inhibitors|growth inhibitors|mesh-ancestor
25492037|NCT00247676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25492038|NCT00247676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492039|NCT00247676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492040|NCT00247962|Sulfasalazine|sulfasalazine|mesh-list
25492041|NCT00247962|Etanercept|etanercept|mesh-list
25492042|NCT00247962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25492043|NCT00247962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25492044|NCT00247962|Analgesics|analgesics|mesh-ancestor
25492045|NCT00247962|Sensory System Agents|sensory system agents|mesh-ancestor
25492046|NCT00247962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25492047|NCT00247962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492048|NCT00247962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25492049|NCT00247962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25492050|NCT00247962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25492051|NCT00247962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25492052|NCT00247962|Immunologic Factors|immunologic factors|mesh-ancestor
25492053|NCT00247962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25492054|NCT00248170|Letrozole|letrozole|mesh-list
25492055|NCT00248170|Anastrozole|anastrozole|mesh-list
25492056|NCT00248170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492057|NCT00248170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25492058|NCT00248170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25492059|NCT00248170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492060|NCT00248170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492061|NCT00248170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25492062|NCT00248170|Hormone Antagonists|hormone antagonists|mesh-ancestor
25492063|NCT00248170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25492064|NCT00248170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492065|NCT00248170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25492066|NCT00248495|Cisplatin|cisplatin|mesh-list
25492067|NCT00248495|Pemetrexed|pemetrexed|mesh-list
25492068|NCT00248495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492069|NCT00248495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492070|NCT00248495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492071|NCT00248495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25492072|NCT00248495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25492073|NCT00248534|Methylprednisolone|methylprednisolone|mesh-list
25492074|NCT00248534|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25492075|NCT00248534|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25492076|NCT00248534|Prednisolone|prednisolone|mesh-list
25492077|NCT00248534|Prednisolone acetate|prednisolone acetate|mesh-list
25492078|NCT00248534|Rituximab|rituximab|mesh-list
25492079|NCT00248534|Temozolomide|temozolomide|mesh-list
25492080|NCT00248534|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25492081|NCT00248534|Prednisolone phosphate|prednisolone phosphate|mesh-list
25492082|NCT00248534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25492083|NCT00248534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492084|NCT00248534|Immunologic Factors|immunologic factors|mesh-ancestor
25492085|NCT00248534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492086|NCT00248534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25492087|NCT00248534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25492088|NCT00248534|Alkylating Agents|alkylating agents|mesh-ancestor
25492089|NCT00248534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492090|NCT00248534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25131484|NCT03025477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131485|NCT03025477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25645287|NCT01446042|Methyltestosterone|methyltestosterone|mesh-list
25645288|NCT01446042|Testosterone|testosterone|mesh-list
25645289|NCT01446042|Testosterone undecanoate|testosterone undecanoate|mesh-list
25131487|NCT03025477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25492092|NCT00248534|Autonomic Agents|autonomic agents|mesh-ancestor
25492093|NCT00248534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25492094|NCT00248534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25492095|NCT00248534|Glucocorticoids|glucocorticoids|mesh-ancestor
25492096|NCT00248534|Hormones|hormones|mesh-ancestor
25492097|NCT00248534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25492098|NCT00248534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25492099|NCT00248534|Protective Agents|protective agents|mesh-ancestor
25492100|NCT00248534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25492101|NCT00248547|Dexamethasone|dexamethasone|mesh-list
25492102|NCT00248547|Ondansetron|ondansetron|mesh-list
25492103|NCT00248547|Aprepitant|aprepitant|mesh-list
25492104|NCT00248547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25492105|NCT00248547|Antiemetics|antiemetics|mesh-ancestor
25492106|NCT00248547|Autonomic Agents|autonomic agents|mesh-ancestor
25492107|NCT00248547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25492108|NCT00248547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492109|NCT00248547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25492110|NCT00248547|Glucocorticoids|glucocorticoids|mesh-ancestor
25492111|NCT00248547|Hormones|hormones|mesh-ancestor
25492112|NCT00248547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25492113|NCT00248547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25492114|NCT00248547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492115|NCT00248547|Antipruritics|antipruritics|mesh-ancestor
25492116|NCT00248547|Dermatologic Agents|dermatologic agents|mesh-ancestor
25492117|NCT00248547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25492118|NCT00248547|Serotonin Agents|serotonin agents|mesh-ancestor
25492119|NCT00248547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25492120|NCT00248547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492121|NCT00248547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25492122|NCT00248547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25492123|NCT00248547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25492124|NCT00248547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25492125|NCT00248547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25492126|NCT00248547|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25492127|NCT00248560|Gemcitabine|gemcitabine|mesh-list
25492128|NCT00248560|Docetaxel|docetaxel|mesh-list
25492129|NCT00248560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25492130|NCT00248560|Antimetabolites|antimetabolites|mesh-ancestor
25492131|NCT00248560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492132|NCT00248560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492133|NCT00248560|Antiviral Agents|antiviral agents|mesh-ancestor
25492134|NCT00248560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25492135|NCT00248560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492136|NCT00248560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25492137|NCT00248560|Immunologic Factors|immunologic factors|mesh-ancestor
25492138|NCT00248560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492139|NCT00248560|Tubulin Modulators|tubulin modulators|mesh-ancestor
25492140|NCT00248560|Antimitotic Agents|antimitotic agents|mesh-ancestor
25492141|NCT00248560|Mitosis Modulators|mitosis modulators|mesh-ancestor
25492142|NCT00248612|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25492143|NCT00248612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25492144|NCT00248612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25492145|NCT00248612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25492146|NCT00248612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492147|NCT00248612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25492148|NCT00248612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492149|NCT00248612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25492150|NCT00248612|Antidepressive Agents|antidepressive agents|mesh-ancestor
25492151|NCT00248612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25492152|NCT00248625|Acetylcysteine|acetylcysteine|mesh-list
25492153|NCT00248625|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25492154|NCT00248625|Antiviral Agents|antiviral agents|mesh-ancestor
25492155|NCT00248625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25492156|NCT00248625|Expectorants|expectorants|mesh-ancestor
25492157|NCT00248625|Respiratory System Agents|respiratory system agents|mesh-ancestor
25492158|NCT00248625|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25492159|NCT00248625|Antioxidants|antioxidants|mesh-ancestor
25492160|NCT00248625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492161|NCT00248625|Protective Agents|protective agents|mesh-ancestor
25645290|NCT01446042|Testosterone enanthate|testosterone enanthate|mesh-list
25645291|NCT01446042|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25645292|NCT01446042|Androgens|androgens|mesh-ancestor
25645293|NCT01446042|Hormones|hormones|mesh-ancestor
25645294|NCT01446042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25645295|NCT01446042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645296|NCT01446042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25366134|NCT05179876|Selexipag|selexipag|mesh-list
25645297|NCT01446042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645298|NCT01446042|Anabolic Agents|anabolic agents|mesh-ancestor
25492162|NCT00248625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492163|NCT00248625|Antidotes|antidotes|mesh-ancestor
25492164|NCT00248651|Amitriptyline|amitriptyline|mesh-list
25492165|NCT00248651|Citalopram|citalopram|mesh-list
25492166|NCT00248651|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25492167|NCT00248651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25492168|NCT00248651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25492169|NCT00248651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492170|NCT00248651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25492171|NCT00248651|Serotonin Agents|serotonin agents|mesh-ancestor
25492172|NCT00248651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492173|NCT00248651|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25492174|NCT00248651|Antidepressive Agents|antidepressive agents|mesh-ancestor
25492175|NCT00248651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25492176|NCT00248651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25492177|NCT00248651|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25492178|NCT00248651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25492179|NCT00248651|Analgesics|analgesics|mesh-ancestor
25492180|NCT00248651|Sensory System Agents|sensory system agents|mesh-ancestor
25492181|NCT00248651|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25492182|NCT00248651|Adrenergic Agents|adrenergic agents|mesh-ancestor
25492183|NCT00248807|Enalaprilat|enalaprilat|mesh-list
25492184|NCT00248807|Enalapril|enalapril|mesh-list
25492185|NCT00248807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25492186|NCT00248807|Protease Inhibitors|protease inhibitors|mesh-ancestor
25492187|NCT00248807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492188|NCT00248807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492189|NCT00248807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25492190|NCT00248833|Vaccines|vaccines|mesh-list
25492191|NCT00248833|Immunologic Factors|immunologic factors|mesh-ancestor
25492192|NCT00248833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492193|NCT00249002|Paclitaxel|paclitaxel|mesh-list
25492194|NCT00249002|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25492195|NCT00249002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25492196|NCT00249002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492197|NCT00249002|Tubulin Modulators|tubulin modulators|mesh-ancestor
25492198|NCT00249002|Antimitotic Agents|antimitotic agents|mesh-ancestor
25492199|NCT00249002|Mitosis Modulators|mitosis modulators|mesh-ancestor
25492200|NCT00249002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492201|NCT00249249|Atorvastatin|atorvastatin|mesh-list
25492202|NCT00249249|Pitavastatin|pitavastatin|mesh-list
25492203|NCT00249249|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25492204|NCT00249249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25492205|NCT00249249|Antimetabolites|antimetabolites|mesh-ancestor
25492206|NCT00249249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492207|NCT00249249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25492208|NCT00249249|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25492209|NCT00249249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492210|NCT00249288|Folic Acid|folic acid|mesh-list
25492211|NCT00249288|Vitamin B Complex|vitamin b complex|mesh-list
25492212|NCT00249288|Hematinics|hematinics|mesh-ancestor
25492213|NCT00249288|Vitamins|vitamins|mesh-ancestor
25492214|NCT00249288|Micronutrients|micronutrients|mesh-ancestor
25492215|NCT00249288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492216|NCT00249379|Acamprosate|acamprosate|mesh-list
25492217|NCT00249379|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25492218|NCT00249444|Mirtazapine|mirtazapine|mesh-list
25492219|NCT00249444|Antidepressive Agents|antidepressive agents|mesh-ancestor
25492220|NCT00249444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25492221|NCT00249444|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25492222|NCT00249444|Histamine Antagonists|histamine antagonists|mesh-ancestor
25492223|NCT00249444|Histamine Agents|histamine agents|mesh-ancestor
25492224|NCT00249444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25492225|NCT00249444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492226|NCT00249444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492227|NCT00249444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25492228|NCT00249444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25645300|NCT01446159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25645301|NCT01446159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645302|NCT01446159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645303|NCT01446159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25645304|NCT01446159|Hormone Antagonists|hormone antagonists|mesh-ancestor
25492229|NCT00249444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25492230|NCT00249444|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25492231|NCT00249444|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25492232|NCT00249444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25492233|NCT00249444|Adrenergic Agents|adrenergic agents|mesh-ancestor
25492234|NCT00249444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25492235|NCT00249444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25492236|NCT00249444|Serotonin Agents|serotonin agents|mesh-ancestor
25492237|NCT00249444|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25492238|NCT00249769|Vaccines|vaccines|mesh-list
25492239|NCT00249769|Immunologic Factors|immunologic factors|mesh-ancestor
25132447|NCT03018535|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25492240|NCT00249769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492241|NCT00249795|Irbesartan|irbesartan|mesh-list
25492242|NCT00249795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25492243|NCT00249795|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25492244|NCT00249795|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25492245|NCT00249795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492246|NCT00249808|Antibodies|antibodies|mesh-list
25492247|NCT00249808|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25492248|NCT00249808|Immunologic Factors|immunologic factors|mesh-ancestor
25492249|NCT00249808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492250|NCT00249834|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25492251|NCT00249834|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25492252|NCT00249834|Hormones|hormones|mesh-ancestor
25492253|NCT00249834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25492254|NCT00249834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492255|NCT00249834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25492256|NCT00249873|Clopidogrel|clopidogrel|mesh-list
25492257|NCT00249873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25492258|NCT00249873|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25492259|NCT00249873|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25492260|NCT00249873|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25492261|NCT00249873|Purinergic Agents|purinergic agents|mesh-ancestor
25492262|NCT00249873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25492263|NCT00249873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492264|NCT00249873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492265|NCT00250432|Caspofungin|caspofungin|mesh-list
25492266|NCT00250432|Antifungal Agents|antifungal agents|mesh-ancestor
25492267|NCT00250432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25492268|NCT00250432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492269|NCT00250432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492270|NCT00250679|Formoterol Fumarate|formoterol fumarate|mesh-list
25492271|NCT00250679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25492272|NCT00250679|Autonomic Agents|autonomic agents|mesh-ancestor
25492273|NCT00250679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25492274|NCT00250679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492275|NCT00250679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25492276|NCT00250679|Respiratory System Agents|respiratory system agents|mesh-ancestor
25492277|NCT00250679|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25492278|NCT00250679|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25492279|NCT00250679|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25492280|NCT00250679|Adrenergic Agents|adrenergic agents|mesh-ancestor
25492281|NCT00250679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25492282|NCT00250679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492283|NCT00250705|Aripiprazole|aripiprazole|mesh-list
25492284|NCT00250705|Antidepressive Agents|antidepressive agents|mesh-ancestor
25492285|NCT00250705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25492286|NCT00250705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25492287|NCT00250705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25492288|NCT00250705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25492289|NCT00250705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492290|NCT00250705|Dopamine Agonists|dopamine agonists|mesh-ancestor
25492291|NCT00250705|Dopamine Agents|dopamine agents|mesh-ancestor
25492292|NCT00250705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25492293|NCT00250705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492294|NCT00250705|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25492295|NCT00250705|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25492296|NCT00250705|Serotonin Agents|serotonin agents|mesh-ancestor
25645305|NCT01446159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25645306|NCT01446159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645307|NCT01446237|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25492297|NCT00250705|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25492298|NCT00250705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25492299|NCT00250705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25492300|NCT00250705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25492301|NCT00250835|Celecoxib|celecoxib|mesh-list
25492302|NCT00250835|Capecitabine|capecitabine|mesh-list
25492303|NCT00250835|Oxaliplatin|oxaliplatin|mesh-list
25492304|NCT00250835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25492305|NCT00250835|Antimetabolites|antimetabolites|mesh-ancestor
25492306|NCT00250835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492307|NCT00250835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492308|NCT00250835|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25492309|NCT00250835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25492310|NCT00250835|Analgesics|analgesics|mesh-ancestor
25132781|NCT03017404|Tubulin Modulators|tubulin modulators|mesh-ancestor
25492311|NCT00250835|Sensory System Agents|sensory system agents|mesh-ancestor
25492312|NCT00250835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25492313|NCT00250835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492314|NCT00250835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25492315|NCT00250835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25492316|NCT00250835|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25492317|NCT00250835|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25492318|NCT00250835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492319|NCT00250926|Dexamethasone|dexamethasone|mesh-list
25492320|NCT00250926|Dexamethasone acetate|dexamethasone acetate|mesh-list
25492321|NCT00250926|Rituximab|rituximab|mesh-list
25492322|NCT00250926|Bortezomib|bortezomib|mesh-list
25492323|NCT00250926|BB 1101|bb 1101|mesh-list
25492324|NCT00250926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25492325|NCT00250926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492326|NCT00250926|Immunologic Factors|immunologic factors|mesh-ancestor
25492327|NCT00250926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492328|NCT00250926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25492329|NCT00250926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25492330|NCT00250926|Antiemetics|antiemetics|mesh-ancestor
25492331|NCT00250926|Autonomic Agents|autonomic agents|mesh-ancestor
25492332|NCT00250926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25492333|NCT00250926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25492334|NCT00250926|Glucocorticoids|glucocorticoids|mesh-ancestor
25492335|NCT00250926|Hormones|hormones|mesh-ancestor
25492336|NCT00250926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25492337|NCT00250926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25492338|NCT00250926|Protease Inhibitors|protease inhibitors|mesh-ancestor
25492339|NCT00250926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492340|NCT00250926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492341|NCT00251004|Cyclosporine|cyclosporine|mesh-list
25492342|NCT00251004|Mycophenolic Acid|mycophenolic acid|mesh-list
25492343|NCT00251004|Everolimus|everolimus|mesh-list
25492344|NCT00251004|Cyclosporins|cyclosporins|mesh-list
25492345|NCT00251004|Basiliximab|basiliximab|mesh-list
25492346|NCT00251004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492347|NCT00251004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492348|NCT00251004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25492349|NCT00251004|Immunologic Factors|immunologic factors|mesh-ancestor
25492350|NCT00251004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492351|NCT00251004|Antifungal Agents|antifungal agents|mesh-ancestor
25492352|NCT00251004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25492353|NCT00251004|Dermatologic Agents|dermatologic agents|mesh-ancestor
25492354|NCT00251004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25492355|NCT00251004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25492356|NCT00251004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492357|NCT00251004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25492358|NCT00251004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25492359|NCT00251004|Antitubercular Agents|antitubercular agents|mesh-ancestor
25492360|NCT00251004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25492361|NCT00251225|Docetaxel|docetaxel|mesh-list
25492362|NCT00251225|Imatinib Mesylate|imatinib mesylate|mesh-list
25492363|NCT00251225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645308|NCT01446237|Dermatologic Agents|dermatologic agents|mesh-ancestor
25656817|NCT01579305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25656818|NCT01579305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25656819|NCT01579305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25656820|NCT01579305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25656821|NCT01579305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656822|NCT01579318|Interleukin-12|interleukin-12|mesh-list
25492364|NCT00251225|Tubulin Modulators|tubulin modulators|mesh-ancestor
25492365|NCT00251225|Antimitotic Agents|antimitotic agents|mesh-ancestor
25492366|NCT00251225|Mitosis Modulators|mitosis modulators|mesh-ancestor
25492367|NCT00251225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492368|NCT00251225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25492369|NCT00251225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492370|NCT00251303|Riluzole|riluzole|mesh-list
25492371|NCT00251303|Anticonvulsants|anticonvulsants|mesh-ancestor
25492372|NCT00251303|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25492373|NCT00251303|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25492374|NCT00251303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25492375|NCT00251303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492376|NCT00251303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492377|NCT00251303|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25492378|NCT00251303|Protective Agents|protective agents|mesh-ancestor
25492379|NCT00251316|Lithium Carbonate|lithium carbonate|mesh-list
25492380|NCT00251316|Antidepressive Agents|antidepressive agents|mesh-ancestor
25492381|NCT00251316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25492382|NCT00251316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492383|NCT00251316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492384|NCT00251316|Antimanic Agents|antimanic agents|mesh-ancestor
25492385|NCT00251316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25492386|NCT00251316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25492387|NCT00251316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492388|NCT00251589|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25492390|NCT00251589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492391|NCT00251589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25492392|NCT00251589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492393|NCT00251589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492394|NCT00251589|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25492395|NCT00251641|Methotrexate|methotrexate|mesh-list
25492396|NCT00251641|Infliximab|infliximab|mesh-list
25492397|NCT00251641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25492398|NCT00251641|Abortifacient Agents|abortifacient agents|mesh-ancestor
25492399|NCT00251641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25492400|NCT00251641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492401|NCT00251641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25492402|NCT00251641|Antimetabolites|antimetabolites|mesh-ancestor
25492403|NCT00251641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492404|NCT00251641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492405|NCT00251641|Dermatologic Agents|dermatologic agents|mesh-ancestor
25492406|NCT00251641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492407|NCT00251641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25492408|NCT00251641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25492409|NCT00251641|Immunologic Factors|immunologic factors|mesh-ancestor
25492410|NCT00251641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25492411|NCT00251641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25492412|NCT00251641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25492413|NCT00251693|Lansoprazole|lansoprazole|mesh-list
25492414|NCT00251693|Dexlansoprazole|dexlansoprazole|mesh-list
25492415|NCT00251693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25492416|NCT00251693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25492417|NCT00251693|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25492418|NCT00251693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492419|NCT00251693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492420|NCT00251719|Lansoprazole|lansoprazole|mesh-list
25492421|NCT00251719|Dexlansoprazole|dexlansoprazole|mesh-list
25492422|NCT00251719|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25492423|NCT00251719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25492424|NCT00251719|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25492425|NCT00251719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492426|NCT00251719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492427|NCT00251745|Dexlansoprazole|dexlansoprazole|mesh-list
25492428|NCT00251745|Lansoprazole|lansoprazole|mesh-list
25492429|NCT00251745|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25492430|NCT00251745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25492431|NCT00251745|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25492432|NCT00251745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492433|NCT00251745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492434|NCT00251758|Dexlansoprazole|dexlansoprazole|mesh-list
25492435|NCT00251758|Lansoprazole|lansoprazole|mesh-list
25492436|NCT00251758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25492437|NCT00251758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25492438|NCT00251758|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25492439|NCT00251758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492440|NCT00251758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492441|NCT00251927|Esomeprazole|esomeprazole|mesh-list
25492442|NCT00251927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25492443|NCT00251927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25492444|NCT00251927|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25492445|NCT00251927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492446|NCT00251927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492447|NCT00251979|Esomeprazole|esomeprazole|mesh-list
25492448|NCT00251979|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25492449|NCT00251979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25133357|NCT03013036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25133358|NCT03013036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25133359|NCT03013036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25133360|NCT03013036|GABA Modulators|gaba modulators|mesh-ancestor
25133361|NCT03013036|GABA Agents|gaba agents|mesh-ancestor
25133362|NCT03013036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25133363|NCT03013036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133364|NCT03013036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25133365|NCT03013036|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25026856|NCT03624959|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25026857|NCT03624959|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25492451|NCT00251979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492452|NCT00251979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492453|NCT00252187|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25492454|NCT00252187|Natriuretic Agents|natriuretic agents|mesh-ancestor
25492455|NCT00252187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492456|NCT00252239|Plasminogen|plasminogen|mesh-list
25492457|NCT00252239|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25492458|NCT00252239|Tenecteplase|tenecteplase|mesh-list
25492459|NCT00252239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25492460|NCT00252239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25492461|NCT00252239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492462|NCT00252499|Rosiglitazone|rosiglitazone|mesh-list
25492463|NCT00252499|Fenofibrate|fenofibrate|mesh-list
25492464|NCT00252499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25492465|NCT00252499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492466|NCT00252499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25492467|NCT00252499|Antimetabolites|antimetabolites|mesh-ancestor
25492468|NCT00252499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492469|NCT00252499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25492470|NCT00252564|Leucovorin|leucovorin|mesh-list
25492471|NCT00252564|Bevacizumab|bevacizumab|mesh-list
25492472|NCT00252564|Cetuximab|cetuximab|mesh-list
25492473|NCT00252564|Fluorouracil|fluorouracil|mesh-list
25492474|NCT00252564|Oxaliplatin|oxaliplatin|mesh-list
25492475|NCT00252564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25492476|NCT00252564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492477|NCT00252564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25492478|NCT00252564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25492479|NCT00252564|Growth Substances|growth substances|mesh-ancestor
25492480|NCT00252564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492481|NCT00252564|Growth Inhibitors|growth inhibitors|mesh-ancestor
25492482|NCT00252564|Antimetabolites|antimetabolites|mesh-ancestor
25492483|NCT00252564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492484|NCT00252564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25492485|NCT00252564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25492486|NCT00252564|Immunologic Factors|immunologic factors|mesh-ancestor
25492487|NCT00252564|Antidotes|antidotes|mesh-ancestor
25492488|NCT00252564|Protective Agents|protective agents|mesh-ancestor
25492489|NCT00252564|Vitamin B Complex|vitamin b complex|mesh-ancestor
25492490|NCT00252564|Vitamins|vitamins|mesh-ancestor
25492491|NCT00252564|Micronutrients|micronutrients|mesh-ancestor
25492492|NCT00252577|Lithium Carbonate|lithium carbonate|mesh-list
25492493|NCT00252577|Antidepressive Agents|antidepressive agents|mesh-ancestor
25492494|NCT00252577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25492495|NCT00252577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492496|NCT00252577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492497|NCT00252577|Antimanic Agents|antimanic agents|mesh-ancestor
25492498|NCT00252577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25492499|NCT00252577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25492500|NCT00252577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492501|NCT00252694|Candesartan|candesartan|mesh-list
25492502|NCT00252694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25492503|NCT00252694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25492504|NCT00252694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25492505|NCT00252694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492506|NCT00252720|Candesartan|candesartan|mesh-list
25492507|NCT00252720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25492508|NCT00252720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25492509|NCT00252720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25492510|NCT00252720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492511|NCT00252733|Candesartan|candesartan|mesh-list
25492512|NCT00252733|Candesartan cilexetil|candesartan cilexetil|mesh-list
25492513|NCT00252733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25492514|NCT00252733|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25492515|NCT00252733|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25492516|NCT00252733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492517|NCT00252967|Atorvastatin|atorvastatin|mesh-list
25492518|NCT00252967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25492519|NCT00252967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25492520|NCT00252967|Antimetabolites|antimetabolites|mesh-ancestor
25492521|NCT00252967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492522|NCT00252967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25492551|NCT00253513|Treosulfan|treosulfan|mesh-list
25492552|NCT00253513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492553|NCT00253513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492554|NCT00253513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25492555|NCT00253513|Alkylating Agents|alkylating agents|mesh-ancestor
25492556|NCT00253630|Vorinostat|vorinostat|mesh-list
25492557|NCT00253630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492558|NCT00253630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25492559|NCT00253630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492560|NCT00253630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492561|NCT00253643|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
25492562|NCT00253643|Antioxidants|antioxidants|mesh-ancestor
25492563|NCT00253643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492564|NCT00253643|Protective Agents|protective agents|mesh-ancestor
25492565|NCT00253643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492566|NCT00253643|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25492567|NCT00253643|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25492568|NCT00253643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492569|NCT00253643|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25492570|NCT00253747|Methylphenidate|methylphenidate|mesh-list
25492571|NCT00253747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25492572|NCT00253747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492573|NCT00253747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25492574|NCT00253747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25492575|NCT00253747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25492576|NCT00253747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492577|NCT00253747|Dopamine Agents|dopamine agents|mesh-ancestor
25492578|NCT00253747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25492579|NCT00253890|Trazodone|trazodone|mesh-list
25492580|NCT00253890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25492581|NCT00253890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25492582|NCT00253890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25492583|NCT00253890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492584|NCT00253890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25492585|NCT00253890|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25492586|NCT00253890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25492587|NCT00253890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25492588|NCT00253890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492589|NCT00253890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25492590|NCT00253890|Serotonin Agents|serotonin agents|mesh-ancestor
25492591|NCT00253890|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25492592|NCT00253890|Antidepressive Agents|antidepressive agents|mesh-ancestor
25492593|NCT00254163|Cyclophosphamide|cyclophosphamide|mesh-list
25492594|NCT00254163|Rituximab|rituximab|mesh-list
25645309|NCT01446809|Doxorubicin|doxorubicin|mesh-list
25645310|NCT01446809|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25645311|NCT01446809|Ifosfamide|ifosfamide|mesh-list
25645312|NCT01446809|Isophosphamide mustard|isophosphamide mustard|mesh-list
25645313|NCT01446809|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25645314|NCT01446809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492595|NCT00254163|Fludarabine|fludarabine|mesh-list
25492596|NCT00254163|Pentostatin|pentostatin|mesh-list
25492597|NCT00254163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25492598|NCT00254163|Immunologic Factors|immunologic factors|mesh-ancestor
25492599|NCT00254163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492600|NCT00254163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25492601|NCT00254163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25492602|NCT00254163|Alkylating Agents|alkylating agents|mesh-ancestor
25492603|NCT00254163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492604|NCT00254163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492605|NCT00254163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25492606|NCT00254163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25492607|NCT00254163|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25492608|NCT00254163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492609|NCT00254293|Abatacept|abatacept|mesh-list
25492610|NCT00254293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25492611|NCT00254293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25492612|NCT00254293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492613|NCT00254293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492614|NCT00254293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25492615|NCT00254293|Immunologic Factors|immunologic factors|mesh-ancestor
25492616|NCT00254293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492617|NCT00254293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25492618|NCT00254397|Leuprolide|leuprolide|mesh-list
25492619|NCT00254397|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25492620|NCT00254397|Fertility Agents|fertility agents|mesh-ancestor
25492621|NCT00254397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25492622|NCT00254397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492623|NCT00254397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25492624|NCT00254397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492625|NCT00254410|Cyclophosphamide|cyclophosphamide|mesh-list
25492626|NCT00254410|Rituximab|rituximab|mesh-list
25492627|NCT00254410|Fludarabine|fludarabine|mesh-list
25492628|NCT00254410|Mitoxantrone|mitoxantrone|mesh-list
25492629|NCT00254410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25492630|NCT00254410|Immunologic Factors|immunologic factors|mesh-ancestor
25492631|NCT00254410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492632|NCT00254410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25492633|NCT00254410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25492634|NCT00254410|Alkylating Agents|alkylating agents|mesh-ancestor
25492635|NCT00254410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492636|NCT00254410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492637|NCT00254410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25492638|NCT00254410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25492639|NCT00254410|Analgesics|analgesics|mesh-ancestor
25134482|NCT03006081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25134483|NCT03006081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25134484|NCT03006081|Growth Substances|growth substances|mesh-ancestor
25492640|NCT00254410|Sensory System Agents|sensory system agents|mesh-ancestor
25492641|NCT00254410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25492642|NCT00254410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25492643|NCT00254410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25492644|NCT00254410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492645|NCT00254462|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25492646|NCT00254462|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25492647|NCT00254462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25492648|NCT00254462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25492649|NCT00254462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492650|NCT00254462|Adrenergic Agents|adrenergic agents|mesh-ancestor
25492651|NCT00254462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25492652|NCT00254462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492654|NCT00254488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25492655|NCT00254488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492656|NCT00254488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492657|NCT00254488|Antimanic Agents|antimanic agents|mesh-ancestor
25492658|NCT00254488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25492659|NCT00254488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25645315|NCT01446809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25492660|NCT00254488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492661|NCT00254488|Anticonvulsants|anticonvulsants|mesh-ancestor
25492662|NCT00254488|GABA Agents|gaba agents|mesh-ancestor
25645316|NCT01446809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25645317|NCT01446809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645318|NCT01446809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645319|NCT01446809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25645320|NCT01446809|Alkylating Agents|alkylating agents|mesh-ancestor
25492663|NCT00254488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25492664|NCT00254540|Sunitinib|sunitinib|mesh-list
25492665|NCT00254540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492666|NCT00254540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25492667|NCT00254540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25492668|NCT00254540|Growth Substances|growth substances|mesh-ancestor
25492669|NCT00254540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492670|NCT00254540|Growth Inhibitors|growth inhibitors|mesh-ancestor
25492671|NCT00254540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25492672|NCT00254540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492673|NCT00254540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492674|NCT00254566|Azithromycin|azithromycin|mesh-list
25492675|NCT00254566|Moxifloxacin|moxifloxacin|mesh-list
25492676|NCT00254566|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25492677|NCT00254566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25492678|NCT00254566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25492679|NCT00254566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25492680|NCT00254566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25492681|NCT00254566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492682|NCT00254566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492683|NCT00254566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492684|NCT00254566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25492685|NCT00254566|Contraceptive Agents|contraceptive agents|mesh-ancestor
25492686|NCT00254566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25492687|NCT00254566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492688|NCT00254566|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25492689|NCT00254566|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25492690|NCT00254566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25492691|NCT00254592|Paclitaxel|paclitaxel|mesh-list
25492692|NCT00254592|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25492693|NCT00254592|Cyclophosphamide|cyclophosphamide|mesh-list
25492694|NCT00254592|Bevacizumab|bevacizumab|mesh-list
25492695|NCT00254592|Carboplatin|carboplatin|mesh-list
25492696|NCT00254592|Doxorubicin|doxorubicin|mesh-list
25492697|NCT00254592|Trastuzumab|trastuzumab|mesh-list
25492698|NCT00254592|Sargramostim|sargramostim|mesh-list
25492699|NCT00254592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25492700|NCT00254592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492701|NCT00254592|Tubulin Modulators|tubulin modulators|mesh-ancestor
25492702|NCT00254592|Antimitotic Agents|antimitotic agents|mesh-ancestor
25134891|NCT03004339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134892|NCT03004339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25134893|NCT03004339|Respiratory System Agents|respiratory system agents|mesh-ancestor
25134894|NCT03004339|Dermatologic Agents|dermatologic agents|mesh-ancestor
25134895|NCT03004066|Daptomycin|daptomycin|mesh-list
25134896|NCT03004066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25134897|NCT03004066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25134898|NCT03004118|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25134899|NCT03004118|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25134900|NCT03004118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25134901|NCT03004222|Bupivacaine|bupivacaine|mesh-list
25492703|NCT00254592|Mitosis Modulators|mitosis modulators|mesh-ancestor
25492704|NCT00254592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492705|NCT00254592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25492706|NCT00254592|Immunologic Factors|immunologic factors|mesh-ancestor
25492707|NCT00254592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492708|NCT00254592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25492709|NCT00254592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25492710|NCT00254592|Alkylating Agents|alkylating agents|mesh-ancestor
25492711|NCT00254592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25492712|NCT00254592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25492713|NCT00254592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25492714|NCT00254592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25492715|NCT00254592|Growth Substances|growth substances|mesh-ancestor
25492716|NCT00254592|Growth Inhibitors|growth inhibitors|mesh-ancestor
25492717|NCT00254592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25645321|NCT01446874|Chlorhexidine|chlorhexidine|mesh-list
25492718|NCT00254592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25492719|NCT00254592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25492720|NCT00254592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492721|NCT00254982|Infliximab|infliximab|mesh-list
25492722|NCT00254982|Dermatologic Agents|dermatologic agents|mesh-ancestor
25492723|NCT00254982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25492724|NCT00254982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25492725|NCT00255008|Ribavirin|ribavirin|mesh-list
25492726|NCT00255008|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25492727|NCT00255008|Interferon-alpha|interferon-alpha|mesh-list
25492728|NCT00255008|Antimetabolites|antimetabolites|mesh-ancestor
25492729|NCT00255008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492730|NCT00255008|Antiviral Agents|antiviral agents|mesh-ancestor
25492731|NCT00255008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25492732|NCT00255008|Immunologic Factors|immunologic factors|mesh-ancestor
25492733|NCT00255008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492734|NCT00255034|Ribavirin|ribavirin|mesh-list
25492735|NCT00255034|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25492736|NCT00255034|Interferon-alpha|interferon-alpha|mesh-list
25492737|NCT00255034|Antimetabolites|antimetabolites|mesh-ancestor
25492738|NCT00255034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492739|NCT00255034|Antiviral Agents|antiviral agents|mesh-ancestor
25492740|NCT00255034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25492741|NCT00255034|Immunologic Factors|immunologic factors|mesh-ancestor
25492742|NCT00255034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492743|NCT00255086|Memantine|memantine|mesh-list
25492744|NCT00255086|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25492745|NCT00255086|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25492746|NCT00255086|Dopamine Agents|dopamine agents|mesh-ancestor
25492747|NCT00255086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25492748|NCT00255086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492749|NCT00255086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492750|NCT00255086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25492751|NCT00255086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25492752|NCT00255151|Dexlansoprazole|dexlansoprazole|mesh-list
25492753|NCT00255151|Lansoprazole|lansoprazole|mesh-list
25492754|NCT00255151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25492755|NCT00255151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25492756|NCT00255151|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25492757|NCT00255151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492758|NCT00255151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492759|NCT00255164|Dexlansoprazole|dexlansoprazole|mesh-list
25492760|NCT00255164|Lansoprazole|lansoprazole|mesh-list
25492761|NCT00255164|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25492762|NCT00255164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25492763|NCT00255164|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25492764|NCT00255164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492765|NCT00255164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492766|NCT00255177|Mifepristone|mifepristone|mesh-list
25492767|NCT00255177|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25492768|NCT00255177|Abortifacient Agents|abortifacient agents|mesh-ancestor
25492769|NCT00255177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25492770|NCT00255177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492771|NCT00255177|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25492772|NCT00255177|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25492773|NCT00255177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25135093|NCT03002493|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25135094|NCT03002493|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25135095|NCT03002493|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25492774|NCT00255177|Contraceptive Agents|contraceptive agents|mesh-ancestor
25492775|NCT00255177|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25492776|NCT00255177|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25492777|NCT00255177|Hormone Antagonists|hormone antagonists|mesh-ancestor
25492778|NCT00255177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25492779|NCT00255177|Luteolytic Agents|luteolytic agents|mesh-ancestor
25492780|NCT00255177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25492781|NCT00255177|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25492782|NCT00255190|Dexlansoprazole|dexlansoprazole|mesh-list
25492783|NCT00255190|Lansoprazole|lansoprazole|mesh-list
25492784|NCT00255190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25492785|NCT00255190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25492786|NCT00255190|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25492787|NCT00255190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492788|NCT00255190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492789|NCT00255346|Dasatinib|dasatinib|mesh-list
25492790|NCT00255346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492791|NCT00255346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25492792|NCT00255346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492793|NCT00255346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492794|NCT00255684|Cyclosporine|cyclosporine|mesh-list
25492795|NCT00255684|Mycophenolic Acid|mycophenolic acid|mesh-list
25492796|NCT00255684|Cyclophosphamide|cyclophosphamide|mesh-list
25492797|NCT00255684|Fludarabine|fludarabine|mesh-list
25492798|NCT00255684|Fludarabine phosphate|fludarabine phosphate|mesh-list
25492799|NCT00255684|Cyclosporins|cyclosporins|mesh-list
25492800|NCT00255684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25492801|NCT00255684|Immunologic Factors|immunologic factors|mesh-ancestor
25492802|NCT00255684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492803|NCT00255684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25492804|NCT00255684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25492805|NCT00255684|Alkylating Agents|alkylating agents|mesh-ancestor
25492806|NCT00255684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492807|NCT00255684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492808|NCT00255684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25492809|NCT00255684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25492810|NCT00255684|Antimetabolites|antimetabolites|mesh-ancestor
25492811|NCT00255684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492812|NCT00255684|Antifungal Agents|antifungal agents|mesh-ancestor
25492813|NCT00255684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25492814|NCT00255684|Dermatologic Agents|dermatologic agents|mesh-ancestor
25492815|NCT00255684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25492816|NCT00255684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25492817|NCT00255684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25492818|NCT00255684|Antitubercular Agents|antitubercular agents|mesh-ancestor
25492819|NCT00255684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25492820|NCT00255723|Carboplatin|carboplatin|mesh-list
25492821|NCT00255723|Etoposide|etoposide|mesh-list
25492822|NCT00255723|Ifosfamide|ifosfamide|mesh-list
25492823|NCT00255723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492824|NCT00255723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25492825|NCT00255723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25492826|NCT00255723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25492827|NCT00255723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492828|NCT00255723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492829|NCT00255723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25492830|NCT00255723|Alkylating Agents|alkylating agents|mesh-ancestor
25492831|NCT00255801|Doxorubicin|doxorubicin|mesh-list
25492832|NCT00255801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25492833|NCT00255801|Bexarotene|bexarotene|mesh-list
25492834|NCT00255801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25492835|NCT00255801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492836|NCT00255801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25492837|NCT00255801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25492838|NCT00255801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492839|NCT00255801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492840|NCT00255840|Ritonavir|ritonavir|mesh-list
25492841|NCT00255840|Lopinavir|lopinavir|mesh-list
25492842|NCT00255840|Lamivudine|lamivudine|mesh-list
25492843|NCT00255840|Nevirapine|nevirapine|mesh-list
25492844|NCT00255840|Stavudine|stavudine|mesh-list
25492845|NCT00255840|Efavirenz|efavirenz|mesh-list
25492846|NCT00255840|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25492847|NCT00255840|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25492848|NCT00255840|Protease Inhibitors|protease inhibitors|mesh-ancestor
25492849|NCT00255840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25135381|NCT02999724|Analgesics|analgesics|mesh-ancestor
25492850|NCT00255840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492851|NCT00255840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25492852|NCT00255840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25492853|NCT00255840|Antiviral Agents|antiviral agents|mesh-ancestor
25492854|NCT00255840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25492855|NCT00255840|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25492856|NCT00255840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25492857|NCT00255840|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25492858|NCT00255840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25492859|NCT00255840|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25492860|NCT00255840|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25492861|NCT00255840|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25492862|NCT00255840|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25492863|NCT00255840|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25823159|NCT00004758|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25645322|NCT01446874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25645323|NCT01446874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25645324|NCT01446874|Disinfectants|disinfectants|mesh-ancestor
25645325|NCT01447017|Carbamide Peroxide|carbamide peroxide|mesh-list
25645326|NCT01447017|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25492864|NCT00255840|Antimetabolites|antimetabolites|mesh-ancestor
25492865|NCT00256204|Rasagiline|rasagiline|mesh-list
25492866|NCT00256204|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25492867|NCT00256204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492868|NCT00256204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492869|NCT00256204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25492870|NCT00256204|Protective Agents|protective agents|mesh-ancestor
25492871|NCT00256204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492872|NCT00256217|Anastrozole|anastrozole|mesh-list
25492873|NCT00256217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25492874|NCT00256217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492875|NCT00256217|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25492876|NCT00256217|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25492877|NCT00256217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492878|NCT00256217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492879|NCT00256217|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25492880|NCT00256217|Hormone Antagonists|hormone antagonists|mesh-ancestor
25492881|NCT00256217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25492882|NCT00256217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492883|NCT00256243|Paclitaxel|paclitaxel|mesh-list
25492884|NCT00256243|Cyclophosphamide|cyclophosphamide|mesh-list
25492885|NCT00256243|Carboplatin|carboplatin|mesh-list
25492886|NCT00256243|Doxorubicin|doxorubicin|mesh-list
25492887|NCT00256243|Trastuzumab|trastuzumab|mesh-list
25492888|NCT00256243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25492889|NCT00256243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492890|NCT00256243|Tubulin Modulators|tubulin modulators|mesh-ancestor
25492891|NCT00256243|Antimitotic Agents|antimitotic agents|mesh-ancestor
25492892|NCT00256243|Mitosis Modulators|mitosis modulators|mesh-ancestor
25492893|NCT00256243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492894|NCT00256243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25492895|NCT00256243|Immunologic Factors|immunologic factors|mesh-ancestor
25492896|NCT00256243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492897|NCT00256243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25492898|NCT00256243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25492899|NCT00256243|Alkylating Agents|alkylating agents|mesh-ancestor
25492900|NCT00256243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25492901|NCT00256243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25492902|NCT00256243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25492903|NCT00256243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25492904|NCT00256243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492905|NCT00256243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25492906|NCT00256282|Docetaxel|docetaxel|mesh-list
25492907|NCT00256282|Vinorelbine|vinorelbine|mesh-list
25492908|NCT00256282|Sargramostim|sargramostim|mesh-list
25492909|NCT00256282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492910|NCT00256282|Tubulin Modulators|tubulin modulators|mesh-ancestor
25492911|NCT00256282|Antimitotic Agents|antimitotic agents|mesh-ancestor
25492912|NCT00256282|Mitosis Modulators|mitosis modulators|mesh-ancestor
25492913|NCT00256282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492914|NCT00256282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25492915|NCT00256282|Immunologic Factors|immunologic factors|mesh-ancestor
25492916|NCT00256282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492917|NCT00256308|Oxaliplatin|oxaliplatin|mesh-list
25492918|NCT00256308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045858|NCT00905606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25045859|NCT00905606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045860|NCT00905567|Topiramate|topiramate|mesh-list
25045861|NCT00905567|Anticonvulsants|anticonvulsants|mesh-ancestor
25492920|NCT00256451|Naltrexone|naltrexone|mesh-list
25492921|NCT00256451|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25492922|NCT00256451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25492923|NCT00256451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25492924|NCT00256451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492925|NCT00256451|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25492926|NCT00256451|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25492927|NCT00256451|Sensory System Agents|sensory system agents|mesh-ancestor
25492928|NCT00256451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962697|NCT03795909|Hormones|hormones|mesh-ancestor
25645327|NCT01447017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25492929|NCT00256698|Fulvestrant|fulvestrant|mesh-list
25492930|NCT00256698|Anastrozole|anastrozole|mesh-list
25492931|NCT00256698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25492932|NCT00256698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492933|NCT00256698|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25492934|NCT00256698|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25492935|NCT00256698|Hormone Antagonists|hormone antagonists|mesh-ancestor
25492936|NCT00256698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25492937|NCT00256698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492938|NCT00256698|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25492939|NCT00256698|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25492940|NCT00256698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492941|NCT00256698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492942|NCT00256750|Cyclosporine|cyclosporine|mesh-list
25492943|NCT00256750|Abatacept|abatacept|mesh-list
25492944|NCT00256750|Cyclosporins|cyclosporins|mesh-list
25492945|NCT00256750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25492946|NCT00256750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492947|NCT00256750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25492948|NCT00256750|Immunologic Factors|immunologic factors|mesh-ancestor
25492949|NCT00256750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492950|NCT00256750|Antifungal Agents|antifungal agents|mesh-ancestor
25492951|NCT00256750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25492952|NCT00256750|Dermatologic Agents|dermatologic agents|mesh-ancestor
25492953|NCT00256750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25492954|NCT00256750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25492955|NCT00256750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25492956|NCT00256750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492957|NCT00256776|Thalidomide|thalidomide|mesh-list
25492958|NCT00256776|Dexamethasone|dexamethasone|mesh-list
25492959|NCT00256776|Bortezomib|bortezomib|mesh-list
25492960|NCT00256776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25492961|NCT00256776|Antiemetics|antiemetics|mesh-ancestor
25492962|NCT00256776|Autonomic Agents|autonomic agents|mesh-ancestor
25492963|NCT00256776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25492964|NCT00256776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492965|NCT00256776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25492966|NCT00256776|Glucocorticoids|glucocorticoids|mesh-ancestor
25492967|NCT00256776|Hormones|hormones|mesh-ancestor
25492968|NCT00256776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25492969|NCT00256776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25492970|NCT00256776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25492971|NCT00256776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25492972|NCT00256776|Immunologic Factors|immunologic factors|mesh-ancestor
25492973|NCT00256776|Leprostatic Agents|leprostatic agents|mesh-ancestor
25492974|NCT00256776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25492975|NCT00256776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25492976|NCT00256776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25492977|NCT00256776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25492978|NCT00256776|Growth Substances|growth substances|mesh-ancestor
25492979|NCT00256776|Growth Inhibitors|growth inhibitors|mesh-ancestor
25492980|NCT00256854|Ropinirole|ropinirole|mesh-list
25492981|NCT00256854|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25492982|NCT00256854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25492983|NCT00256854|Dopamine Agonists|dopamine agonists|mesh-ancestor
25492984|NCT00256854|Dopamine Agents|dopamine agents|mesh-ancestor
25492985|NCT00256854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25492986|NCT00256854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136010|NCT02994381|Ozanimod|ozanimod|mesh-list
25136011|NCT02994381|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25027624|NCT03618316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25136012|NCT02994381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136013|NCT02994381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25136014|NCT02994381|Immunologic Factors|immunologic factors|mesh-ancestor
25136016|NCT02994602|ST 1435|st 1435|mesh-list
25492987|NCT00256854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492989|NCT00256997|Antipsychotic Agents|antipsychotic agents|mesh-list
25492990|NCT00256997|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25492991|NCT00256997|Serotonin Agents|serotonin agents|mesh-ancestor
25492992|NCT00256997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25492993|NCT00256997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25492994|NCT00256997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25492995|NCT00256997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25492996|NCT00256997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25492997|NCT00256997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25492998|NCT00256997|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25492999|NCT00256997|Dopamine Agents|dopamine agents|mesh-ancestor
25493000|NCT00257010|Almotriptan|almotriptan|mesh-list
25493001|NCT00257010|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25493002|NCT00257010|Serotonin Agents|serotonin agents|mesh-ancestor
25493003|NCT00257010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25493004|NCT00257010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493005|NCT00257010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493006|NCT00257166|Ziprasidone|ziprasidone|mesh-list
25493007|NCT00257166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25493008|NCT00257166|Serotonin Agents|serotonin agents|mesh-ancestor
25493009|NCT00257166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25493010|NCT00257166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493011|NCT00257166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493012|NCT00257166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25493013|NCT00257166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25493014|NCT00257166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25493015|NCT00257166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25493016|NCT00257166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25493017|NCT00257166|Dopamine Agents|dopamine agents|mesh-ancestor
25493018|NCT00257192|Ziprasidone|ziprasidone|mesh-list
25493019|NCT00257192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25493020|NCT00257192|Serotonin Agents|serotonin agents|mesh-ancestor
25493021|NCT00257192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25493022|NCT00257192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493023|NCT00257192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493024|NCT00257192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25493025|NCT00257192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25493026|NCT00257192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25493027|NCT00257192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25493028|NCT00257192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25493029|NCT00257192|Dopamine Agents|dopamine agents|mesh-ancestor
25493030|NCT00257309|Tenecteplase|tenecteplase|mesh-list
25493031|NCT00257309|Clopidogrel|clopidogrel|mesh-list
25493032|NCT00257309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25493033|NCT00257309|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25493034|NCT00257309|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25493035|NCT00257309|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25493036|NCT00257309|Purinergic Agents|purinergic agents|mesh-ancestor
25493037|NCT00257309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25493038|NCT00257309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493039|NCT00257309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493040|NCT00257309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25493041|NCT00257309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25493042|NCT00257556|Menotropins|menotropins|mesh-list
25493043|NCT00257556|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25493044|NCT00257556|Hormones|hormones|mesh-ancestor
25493045|NCT00257556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25493046|NCT00257556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493047|NCT00257556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25493048|NCT00257556|Fertility Agents|fertility agents|mesh-ancestor
25493049|NCT00257556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25493050|NCT00257608|Bevacizumab|bevacizumab|mesh-list
25493051|NCT00257608|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25493052|NCT00257608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25493053|NCT00257608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493054|NCT00257608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25493055|NCT00257608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25493056|NCT00257608|Growth Substances|growth substances|mesh-ancestor
25493057|NCT00257608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493058|NCT00257608|Growth Inhibitors|growth inhibitors|mesh-ancestor
25136317|NCT02992340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25493059|NCT00257608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25493060|NCT00257608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493061|NCT00257608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493062|NCT00257686|Pravastatin|pravastatin|mesh-list
25493063|NCT00257686|Pitavastatin|pitavastatin|mesh-list
25493064|NCT00257686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25493065|NCT00257686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25493066|NCT00257686|Antimetabolites|antimetabolites|mesh-ancestor
25493067|NCT00257686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493068|NCT00257686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24963119|NCT03792906|Anesthetics|anesthetics|mesh-ancestor
25645328|NCT01447225|Gemcitabine|gemcitabine|mesh-list
25493069|NCT00257686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25493070|NCT00257686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493071|NCT00257725|Methylphenidate|methylphenidate|mesh-list
25493072|NCT00257725|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25493073|NCT00257725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493074|NCT00257725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25493075|NCT00257725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25493076|NCT00257725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25493077|NCT00257725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493078|NCT00257725|Dopamine Agents|dopamine agents|mesh-ancestor
25493079|NCT00257725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25493080|NCT00257894|Baclofen|baclofen|mesh-list
25493081|NCT00257894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493082|NCT00257894|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25493083|NCT00257894|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25493084|NCT00257894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25493085|NCT00257894|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25493086|NCT00257894|GABA Agonists|gaba agonists|mesh-ancestor
25493087|NCT00257894|GABA Agents|gaba agents|mesh-ancestor
25493088|NCT00257894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25493089|NCT00257894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493090|NCT00257920|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
25493091|NCT00257920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493092|NCT00257920|Vitamins|vitamins|mesh-ancestor
25493093|NCT00257920|Micronutrients|micronutrients|mesh-ancestor
25493094|NCT00257920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25493095|NCT00257933|Prednisolone|prednisolone|mesh-list
25493096|NCT00257933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25493097|NCT00257933|Methylprednisolone|methylprednisolone|mesh-list
25493098|NCT00257933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25493099|NCT00257933|Prednisolone acetate|prednisolone acetate|mesh-list
25493100|NCT00257933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25493101|NCT00257933|Prednisolone phosphate|prednisolone phosphate|mesh-list
25493102|NCT00257933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25493103|NCT00257933|Glucocorticoids|glucocorticoids|mesh-ancestor
25493104|NCT00257933|Hormones|hormones|mesh-ancestor
25493105|NCT00257933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25493106|NCT00257933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493107|NCT00257933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25493108|NCT00257933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493109|NCT00257933|Antiemetics|antiemetics|mesh-ancestor
25493110|NCT00257933|Autonomic Agents|autonomic agents|mesh-ancestor
25493111|NCT00257933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25493112|NCT00257933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25493113|NCT00257933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25493114|NCT00257933|Protective Agents|protective agents|mesh-ancestor
25493115|NCT00258128|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
25493116|NCT00258128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25493117|NCT00258128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25493118|NCT00258128|Analgesics|analgesics|mesh-ancestor
25493119|NCT00258128|Sensory System Agents|sensory system agents|mesh-ancestor
25493120|NCT00258128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25493121|NCT00258128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493122|NCT00258128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25493123|NCT00258128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25493124|NCT00258180|Cyclophosphamide|cyclophosphamide|mesh-list
25493125|NCT00258180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25493126|NCT00258180|Immunologic Factors|immunologic factors|mesh-ancestor
25493127|NCT00258180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493128|NCT00258180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25493129|NCT00258180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25136568|NCT02990546|Autonomic Agents|autonomic agents|mesh-ancestor
25136569|NCT02990546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084848|NCT03302650|Giapreza|giapreza|mesh-list
25493130|NCT00258180|Alkylating Agents|alkylating agents|mesh-ancestor
25493131|NCT00258180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493132|NCT00258180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493133|NCT00258180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25493134|NCT00258206|Cyclophosphamide|cyclophosphamide|mesh-list
25493135|NCT00258206|Rituximab|rituximab|mesh-list
25493136|NCT00258206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25493137|NCT00258206|Immunologic Factors|immunologic factors|mesh-ancestor
25493138|NCT00258206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493139|NCT00258206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25645329|NCT01447225|Carboplatin|carboplatin|mesh-list
25645330|NCT01447225|Pemetrexed|pemetrexed|mesh-list
25645331|NCT01447225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493140|NCT00258206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25493141|NCT00258206|Alkylating Agents|alkylating agents|mesh-ancestor
25493142|NCT00258206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493143|NCT00258206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493144|NCT00258206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25493145|NCT00258206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25493146|NCT00258310|Capecitabine|capecitabine|mesh-list
25493147|NCT00258310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25493148|NCT00258310|Antimetabolites|antimetabolites|mesh-ancestor
25493149|NCT00258310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493150|NCT00258310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493151|NCT00258349|Trastuzumab|trastuzumab|mesh-list
25493152|NCT00258349|Vorinostat|vorinostat|mesh-list
25493153|NCT00258349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25493154|NCT00258349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493155|NCT00258349|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25493156|NCT00258349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493157|NCT00258349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493158|NCT00258362|Carboplatin|carboplatin|mesh-list
25493159|NCT00258362|Docetaxel|docetaxel|mesh-list
25493160|NCT00258362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493161|NCT00258362|Tubulin Modulators|tubulin modulators|mesh-ancestor
25493162|NCT00258362|Antimitotic Agents|antimitotic agents|mesh-ancestor
25493163|NCT00258362|Mitosis Modulators|mitosis modulators|mesh-ancestor
25493164|NCT00258362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493165|NCT00258440|Epoetin Alfa|epoetin alfa|mesh-list
25493166|NCT00258440|Hematinics|hematinics|mesh-ancestor
25493167|NCT00258817|Vaccines|vaccines|mesh-list
25493168|NCT00258817|Immunologic Factors|immunologic factors|mesh-ancestor
25493169|NCT00258817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493170|NCT00258830|Vaccines|vaccines|mesh-list
25493171|NCT00258830|Immunologic Factors|immunologic factors|mesh-ancestor
25493172|NCT00258830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493173|NCT00258856|Vaccines|vaccines|mesh-list
25493174|NCT00258856|Immunologic Factors|immunologic factors|mesh-ancestor
25493175|NCT00258856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493176|NCT00258960|Cyclophosphamide|cyclophosphamide|mesh-list
25493177|NCT00258960|Doxorubicin|doxorubicin|mesh-list
25493178|NCT00258960|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25493179|NCT00258960|Trastuzumab|trastuzumab|mesh-list
25493180|NCT00258960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25493181|NCT00258960|Immunologic Factors|immunologic factors|mesh-ancestor
25493182|NCT00258960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493183|NCT00258960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25493184|NCT00258960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25493185|NCT00258960|Alkylating Agents|alkylating agents|mesh-ancestor
25493186|NCT00258960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493187|NCT00258960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493188|NCT00258960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25493189|NCT00258960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25493190|NCT00258960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25493191|NCT00258960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25493192|NCT00258960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493193|NCT00258960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25493194|NCT00259012|Pantoprazole|pantoprazole|mesh-list
25493195|NCT00259012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25493196|NCT00259012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25493197|NCT00259012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25493198|NCT00259012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493199|NCT00259012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493200|NCT00259090|Fulvestrant|fulvestrant|mesh-list
25493201|NCT00259090|Anastrozole|anastrozole|mesh-list
25136795|NCT02988908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136796|NCT02988908|Cholinergic Agents|cholinergic agents|mesh-ancestor
25136797|NCT02988908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25493202|NCT00259090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25493203|NCT00259090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493204|NCT00259090|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25493205|NCT00259090|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25493206|NCT00259090|Hormone Antagonists|hormone antagonists|mesh-ancestor
25493207|NCT00259090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25645332|NCT01447225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25645333|NCT01447225|Antimetabolites|antimetabolites|mesh-ancestor
25645334|NCT01447225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645335|NCT01447225|Antiviral Agents|antiviral agents|mesh-ancestor
25493208|NCT00259090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493209|NCT00259090|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25493210|NCT00259090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25493211|NCT00259090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493212|NCT00259090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493213|NCT00259272|Olanzapine|olanzapine|mesh-list
25493214|NCT00259272|Antiemetics|antiemetics|mesh-ancestor
25493215|NCT00259272|Autonomic Agents|autonomic agents|mesh-ancestor
25493216|NCT00259272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25493217|NCT00259272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493218|NCT00259272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25493219|NCT00259272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25493220|NCT00259272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25493221|NCT00259272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25493222|NCT00259272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25493223|NCT00259272|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25493224|NCT00259272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25493225|NCT00259272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25493226|NCT00259272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493227|NCT00259272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25493228|NCT00259272|Serotonin Agents|serotonin agents|mesh-ancestor
25493229|NCT00259285|Cisplatin|cisplatin|mesh-list
25493230|NCT00259285|Pemetrexed|pemetrexed|mesh-list
25493231|NCT00259285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493232|NCT00259285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493233|NCT00259285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493234|NCT00259285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25493235|NCT00259285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25493236|NCT00259298|Teriparatide|teriparatide|mesh-list
25493237|NCT00259298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25493238|NCT00259298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493239|NCT00259298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25493240|NCT00259610|Hydroxychloroquine|hydroxychloroquine|mesh-list
25493241|NCT00259610|Sulfasalazine|sulfasalazine|mesh-list
25493242|NCT00259610|Etanercept|etanercept|mesh-list
25493243|NCT00259610|Methotrexate|methotrexate|mesh-list
25493244|NCT00259610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25493245|NCT00259610|Abortifacient Agents|abortifacient agents|mesh-ancestor
25493246|NCT00259610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25493247|NCT00259610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493248|NCT00259610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25493249|NCT00259610|Antimetabolites|antimetabolites|mesh-ancestor
25493250|NCT00259610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493251|NCT00259610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493252|NCT00259610|Dermatologic Agents|dermatologic agents|mesh-ancestor
25493253|NCT00259610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493254|NCT00259610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25493255|NCT00259610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25493256|NCT00259610|Immunologic Factors|immunologic factors|mesh-ancestor
25493257|NCT00259610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25493258|NCT00259610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25493259|NCT00259610|Antimalarials|antimalarials|mesh-ancestor
25493260|NCT00259610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25493261|NCT00259610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25493262|NCT00259610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25493263|NCT00259610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25493264|NCT00259610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25493265|NCT00259610|Analgesics|analgesics|mesh-ancestor
25493266|NCT00259610|Sensory System Agents|sensory system agents|mesh-ancestor
25493267|NCT00259610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25493268|NCT00259610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25493269|NCT00259610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25493270|NCT00259649|Eletriptan|eletriptan|mesh-list
25493271|NCT00259649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25493272|NCT00259649|Serotonin Agents|serotonin agents|mesh-ancestor
25136957|NCT02987920|Narcotics|narcotics|mesh-ancestor
25136958|NCT02987920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25136959|NCT02987920|Anticonvulsants|anticonvulsants|mesh-ancestor
25493273|NCT00259649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25493274|NCT00259649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493275|NCT00259649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645336|NCT01447225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25645337|NCT01447225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645338|NCT01447225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25645339|NCT01447225|Immunologic Factors|immunologic factors|mesh-ancestor
25645340|NCT01447225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645341|NCT01447225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25645342|NCT01447225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25493276|NCT00259740|Denosumab|denosumab|mesh-list
25493277|NCT00259740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25493278|NCT00259740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493279|NCT00259857|Alendronate|alendronate|mesh-list
25493280|NCT00259857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25493281|NCT00259857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493282|NCT00260065|Decitabine|decitabine|mesh-list
25493283|NCT00260065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25493284|NCT00260065|Antimetabolites|antimetabolites|mesh-ancestor
25493285|NCT00260065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493286|NCT00260065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493287|NCT00260065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493288|NCT00260208|Cyclosporine|cyclosporine|mesh-list
25493289|NCT00260208|Tacrolimus|tacrolimus|mesh-list
25493290|NCT00260208|Cyclosporins|cyclosporins|mesh-list
25493291|NCT00260208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25493292|NCT00260208|Immunologic Factors|immunologic factors|mesh-ancestor
25493293|NCT00260208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493294|NCT00260208|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25493295|NCT00260208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493296|NCT00260208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493297|NCT00260208|Antifungal Agents|antifungal agents|mesh-ancestor
25493298|NCT00260208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25493299|NCT00260208|Dermatologic Agents|dermatologic agents|mesh-ancestor
25493300|NCT00260208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25493301|NCT00260533|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25493302|NCT00260533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25493303|NCT00260533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25493304|NCT00260533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25493305|NCT00260533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493306|NCT00260533|Adrenergic Agents|adrenergic agents|mesh-ancestor
25493307|NCT00260533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25493308|NCT00260533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493309|NCT00260689|Cyclosporine|cyclosporine|mesh-list
25493310|NCT00260689|Alemtuzumab|alemtuzumab|mesh-list
25493311|NCT00260689|Cyclosporins|cyclosporins|mesh-list
25493312|NCT00260689|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25493313|NCT00260689|Thymoglobulin|thymoglobulin|mesh-list
25493314|NCT00260689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493315|NCT00260689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493316|NCT00260689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25493317|NCT00260689|Immunologic Factors|immunologic factors|mesh-ancestor
25493318|NCT00260689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493319|NCT00260689|Antifungal Agents|antifungal agents|mesh-ancestor
25493320|NCT00260689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25493321|NCT00260689|Dermatologic Agents|dermatologic agents|mesh-ancestor
25493322|NCT00260689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25493323|NCT00260689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25493324|NCT00260689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25493325|NCT00260689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493326|NCT00260832|Cytarabine|cytarabine|mesh-list
25493327|NCT00260832|Decitabine|decitabine|mesh-list
25493328|NCT00260832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25493329|NCT00260832|Antimetabolites|antimetabolites|mesh-ancestor
25493330|NCT00260832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493331|NCT00260832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493332|NCT00260832|Antiviral Agents|antiviral agents|mesh-ancestor
25493333|NCT00260832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25493334|NCT00260832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25493335|NCT00260832|Immunologic Factors|immunologic factors|mesh-ancestor
25493336|NCT00260832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493337|NCT00260832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493338|NCT00260962|Olanzapine|olanzapine|mesh-list
25493339|NCT00260962|Antiemetics|antiemetics|mesh-ancestor
25493340|NCT00260962|Autonomic Agents|autonomic agents|mesh-ancestor
25493341|NCT00260962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25493342|NCT00260962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137354|NCT02985229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25645343|NCT01447407|Vaccines|vaccines|mesh-list
25137355|NCT02985229|Oxytocics|oxytocics|mesh-ancestor
25137356|NCT02985229|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25137357|NCT02985229|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25156078|NCT05163106|Letrozole|letrozole|mesh-list
25493358|NCT00261443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25493359|NCT00261443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25493360|NCT00261443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25493361|NCT00261443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25493362|NCT00261443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493363|NCT00261443|Dopamine Agonists|dopamine agonists|mesh-ancestor
25493364|NCT00261443|Dopamine Agents|dopamine agents|mesh-ancestor
25493365|NCT00261443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25493366|NCT00261443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493367|NCT00261443|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25493368|NCT00261443|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25493369|NCT00261443|Serotonin Agents|serotonin agents|mesh-ancestor
25493370|NCT00261443|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25493371|NCT00261443|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25493372|NCT00261443|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25493373|NCT00261443|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25493374|NCT00261443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493375|NCT00261443|Antimanic Agents|antimanic agents|mesh-ancestor
25493376|NCT00261443|Anticonvulsants|anticonvulsants|mesh-ancestor
25493377|NCT00261443|GABA Agents|gaba agents|mesh-ancestor
25493378|NCT00261495|Oxycodone|oxycodone|mesh-list
25493379|NCT00261495|Hydromorphone|hydromorphone|mesh-list
25493380|NCT00261495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25493381|NCT00261495|Narcotics|narcotics|mesh-ancestor
25493382|NCT00261495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25493383|NCT00261495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493384|NCT00261495|Analgesics|analgesics|mesh-ancestor
25493385|NCT00261495|Sensory System Agents|sensory system agents|mesh-ancestor
25493386|NCT00261495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25493387|NCT00261833|Protease Inhibitors|protease inhibitors|mesh-list
25493388|NCT00261833|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25493389|NCT00261833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493390|NCT00261833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493391|NCT00261833|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25493392|NCT00261833|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25493393|NCT00261950|Cinacalcet|cinacalcet|mesh-list
25493394|NCT00261950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25493395|NCT00261950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493396|NCT00261950|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25493397|NCT00261950|Hormone Antagonists|hormone antagonists|mesh-ancestor
25493398|NCT00261950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25028232|NCT03612492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25028233|NCT03612492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028234|NCT03612492|Sensory System Agents|sensory system agents|mesh-ancestor
25493400|NCT00262002|Immunologic Factors|immunologic factors|mesh-ancestor
25493401|NCT00262002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493402|NCT00262028|Vaccines|vaccines|mesh-list
25493403|NCT00262028|Immunologic Factors|immunologic factors|mesh-ancestor
25493404|NCT00262028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493405|NCT00262041|Vaccines|vaccines|mesh-list
25493406|NCT00262041|Immunologic Factors|immunologic factors|mesh-ancestor
25493407|NCT00262041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493408|NCT00262067|Bevacizumab|bevacizumab|mesh-list
25493409|NCT00262067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25493410|NCT00262067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493411|NCT00262067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25493412|NCT00262067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25493413|NCT00262067|Growth Substances|growth substances|mesh-ancestor
25493414|NCT00262067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493415|NCT00262067|Growth Inhibitors|growth inhibitors|mesh-ancestor
25493416|NCT00262080|Ecallantide|ecallantide|mesh-list
25493417|NCT00262080|Analgesics|analgesics|mesh-ancestor
25493418|NCT00262080|Sensory System Agents|sensory system agents|mesh-ancestor
25493419|NCT00262080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25493420|NCT00262080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493421|NCT00262080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25493422|NCT00262080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25493423|NCT00262080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25493424|NCT00262080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25493425|NCT00262223|Sertraline|sertraline|mesh-list
25645344|NCT01447407|Aluminum sulfate|aluminum sulfate|mesh-list
25493426|NCT00262223|Antidepressive Agents|antidepressive agents|mesh-ancestor
25493427|NCT00262223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25493428|NCT00262223|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25493429|NCT00262223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25493430|NCT00262223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25493431|NCT00262223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493432|NCT00262223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25493433|NCT00262223|Serotonin Agents|serotonin agents|mesh-ancestor
25493434|NCT00262223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493435|NCT00262301|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25493436|NCT00262301|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25493437|NCT00262301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25493438|NCT00262301|Immunologic Factors|immunologic factors|mesh-ancestor
25493439|NCT00262301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493441|NCT00262522|Lopinavir|lopinavir|mesh-list
25493442|NCT00262522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
25493443|NCT00262522|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25493444|NCT00262522|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25493445|NCT00262522|Protease Inhibitors|protease inhibitors|mesh-ancestor
25493446|NCT00262522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493447|NCT00262522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493448|NCT00262522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25493449|NCT00262522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25493450|NCT00262522|Antiviral Agents|antiviral agents|mesh-ancestor
25493451|NCT00262522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25493452|NCT00262522|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25493453|NCT00262522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25493454|NCT00262522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25493455|NCT00262600|Warfarin|warfarin|mesh-list
25493456|NCT00262600|Dabigatran|dabigatran|mesh-list
25493457|NCT00262600|Anticoagulants|anticoagulants|mesh-ancestor
25493458|NCT00262600|Antithrombins|antithrombins|mesh-ancestor
25493459|NCT00262600|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25493460|NCT00262600|Protease Inhibitors|protease inhibitors|mesh-ancestor
25493461|NCT00262600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493462|NCT00262600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493463|NCT00262639|Gabapentin|gabapentin|mesh-list
25493464|NCT00262639|Flumazenil|flumazenil|mesh-list
25493465|NCT00262639|Analgesics|analgesics|mesh-ancestor
25493466|NCT00262639|Sensory System Agents|sensory system agents|mesh-ancestor
25493467|NCT00262639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25493468|NCT00262639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493469|NCT00262639|Anticonvulsants|anticonvulsants|mesh-ancestor
25493470|NCT00262639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25493471|NCT00262639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25493472|NCT00262639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25493473|NCT00262639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25493474|NCT00262639|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25493475|NCT00262639|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25493476|NCT00262639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25493477|NCT00262639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493478|NCT00262639|Antimanic Agents|antimanic agents|mesh-ancestor
25493479|NCT00262639|Antidotes|antidotes|mesh-ancestor
25493480|NCT00262639|Protective Agents|protective agents|mesh-ancestor
25493481|NCT00262639|GABA Modulators|gaba modulators|mesh-ancestor
25493482|NCT00262639|GABA Agents|gaba agents|mesh-ancestor
25493483|NCT00262730|Temozolomide|temozolomide|mesh-list
25493484|NCT00262730|Poly ICLC|poly iclc|mesh-list
25493485|NCT00262730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25493486|NCT00262730|Alkylating Agents|alkylating agents|mesh-ancestor
25493487|NCT00262730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493488|NCT00262730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493489|NCT00262730|Interferon Inducers|interferon inducers|mesh-ancestor
25493490|NCT00262730|Immunologic Factors|immunologic factors|mesh-ancestor
25493491|NCT00262730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493492|NCT00262821|Cisplatin|cisplatin|mesh-list
25493493|NCT00262821|Tirapazamine|tirapazamine|mesh-list
25493494|NCT00262821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493495|NCT00262834|Vorinostat|vorinostat|mesh-list
25493496|NCT00262834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493497|NCT00262834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25493498|NCT00262834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493499|NCT00262834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493501|NCT00262847|Bevacizumab|bevacizumab|mesh-list
25493502|NCT00262847|Carboplatin|carboplatin|mesh-list
25493503|NCT00262847|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25493504|NCT00262847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25493505|NCT00262847|Endothelial Growth Factors|endothelial growth factors|mesh-list
25493506|NCT00262847|Antibodies|antibodies|mesh-list
25493507|NCT00262847|Immunoglobulins|immunoglobulins|mesh-list
25493508|NCT00262847|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25493509|NCT00262847|Immunoglobulin G|immunoglobulin g|mesh-list
25493510|NCT00262847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25493511|NCT00262847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493512|NCT00262847|Tubulin Modulators|tubulin modulators|mesh-ancestor
25493513|NCT00262847|Antimitotic Agents|antimitotic agents|mesh-ancestor
25493514|NCT00262847|Mitosis Modulators|mitosis modulators|mesh-ancestor
25493515|NCT00262847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493516|NCT00262847|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25493517|NCT00262847|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25493518|NCT00262847|Growth Substances|growth substances|mesh-ancestor
25493519|NCT00262847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493520|NCT00262847|Growth Inhibitors|growth inhibitors|mesh-ancestor
25493521|NCT00262847|Immunologic Factors|immunologic factors|mesh-ancestor
25493522|NCT00262860|Gemcitabine|gemcitabine|mesh-list
25493523|NCT00262860|Bortezomib|bortezomib|mesh-list
25493524|NCT00262860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25493525|NCT00262860|Antimetabolites|antimetabolites|mesh-ancestor
25493526|NCT00262860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493527|NCT00262860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493528|NCT00262860|Antiviral Agents|antiviral agents|mesh-ancestor
25493529|NCT00262860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25493530|NCT00262860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493531|NCT00262860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25493532|NCT00262860|Immunologic Factors|immunologic factors|mesh-ancestor
25493533|NCT00262860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493534|NCT00262873|Bortezomib|bortezomib|mesh-list
25493535|NCT00262873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493536|NCT00262925|Leucovorin|leucovorin|mesh-list
25493537|NCT00262925|Dexamethasone|dexamethasone|mesh-list
25493538|NCT00262925|Methotrexate|methotrexate|mesh-list
25493539|NCT00262925|Vincristine|vincristine|mesh-list
25493540|NCT00262925|Asparaginase|asparaginase|mesh-list
25493541|NCT00262925|Mercaptopurine|mercaptopurine|mesh-list
25493542|NCT00262925|Alemtuzumab|alemtuzumab|mesh-list
25141467|NCT02957643|Micronutrients|micronutrients|mesh-ancestor
25141468|NCT02957643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141469|NCT02957604|Evolocumab|evolocumab|mesh-list
25141470|NCT02957604|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25141471|NCT02957604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25141472|NCT02957604|Antimetabolites|antimetabolites|mesh-ancestor
24760107|NCT01756430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25493543|NCT00262925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25493544|NCT00262925|Antibodies|antibodies|mesh-list
25493545|NCT00262925|Immunoglobulins|immunoglobulins|mesh-list
25493546|NCT00262925|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25493547|NCT00262925|Levoleucovorin|levoleucovorin|mesh-list
25493548|NCT00262925|Immunologic Factors|immunologic factors|mesh-ancestor
25493549|NCT00262925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493550|NCT00262925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25493551|NCT00262925|Antiemetics|antiemetics|mesh-ancestor
25493552|NCT00262925|Autonomic Agents|autonomic agents|mesh-ancestor
25493553|NCT00262925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25493554|NCT00262925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25493555|NCT00262925|Glucocorticoids|glucocorticoids|mesh-ancestor
25493556|NCT00262925|Hormones|hormones|mesh-ancestor
25493557|NCT00262925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25493558|NCT00262925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25493559|NCT00262925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493560|NCT00262925|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25493561|NCT00262925|Abortifacient Agents|abortifacient agents|mesh-ancestor
25493562|NCT00262925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25493563|NCT00262925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25493564|NCT00262925|Antimetabolites|antimetabolites|mesh-ancestor
25493565|NCT00262925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493566|NCT00262925|Dermatologic Agents|dermatologic agents|mesh-ancestor
25493567|NCT00262925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493568|NCT00262925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25493569|NCT00262925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25493570|NCT00262925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25645345|NCT01447407|Immunologic Factors|immunologic factors|mesh-ancestor
25645346|NCT01447407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493571|NCT00262925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25493573|NCT00262925|Protective Agents|protective agents|mesh-ancestor
25645347|NCT01447407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25645348|NCT01447420|Ribavirin|ribavirin|mesh-list
25645349|NCT01447420|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25493574|NCT00262925|Vitamin B Complex|vitamin b complex|mesh-ancestor
25493575|NCT00262925|Vitamins|vitamins|mesh-ancestor
25493576|NCT00262925|Micronutrients|micronutrients|mesh-ancestor
25493577|NCT00262925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25493578|NCT00262925|Tubulin Modulators|tubulin modulators|mesh-ancestor
25493579|NCT00262925|Antimitotic Agents|antimitotic agents|mesh-ancestor
25493580|NCT00262925|Mitosis Modulators|mitosis modulators|mesh-ancestor
25493581|NCT00262951|Interferons|interferons|mesh-list
25493582|NCT00262951|Interferon-alpha|interferon-alpha|mesh-list
25645350|NCT01447420|Antimetabolites|antimetabolites|mesh-ancestor
25645351|NCT01447420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645352|NCT01447420|Antiviral Agents|antiviral agents|mesh-ancestor
25645353|NCT01447420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25645354|NCT01447433|Calcium Carbonate|calcium carbonate|mesh-list
25645355|NCT01447433|Calcium|calcium|mesh-list
25645356|NCT01447433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25493583|NCT00262951|Interferon alpha-2|interferon alpha-2|mesh-list
25493584|NCT00262951|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
25493585|NCT00262951|Cisplatin|cisplatin|mesh-list
25493586|NCT00262951|Fluorouracil|fluorouracil|mesh-list
25493587|NCT00262951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493588|NCT00262951|Antimetabolites|antimetabolites|mesh-ancestor
25493589|NCT00262951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493590|NCT00262951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25493591|NCT00262951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25493592|NCT00262951|Immunologic Factors|immunologic factors|mesh-ancestor
25493593|NCT00262951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493594|NCT00262951|Antiviral Agents|antiviral agents|mesh-ancestor
25493595|NCT00262951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25493596|NCT00262964|Niacin|niacin|mesh-list
25493597|NCT00262964|Fenofibrate|fenofibrate|mesh-list
25493598|NCT00262964|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25493599|NCT00262964|Antimetabolites|antimetabolites|mesh-ancestor
25493600|NCT00262964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493601|NCT00262964|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25493602|NCT00262964|Vasodilator Agents|vasodilator agents|mesh-ancestor
25493603|NCT00262964|Vitamin B Complex|vitamin b complex|mesh-ancestor
25493604|NCT00262964|Vitamins|vitamins|mesh-ancestor
25493605|NCT00262964|Micronutrients|micronutrients|mesh-ancestor
25493606|NCT00262964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493607|NCT00263211|Aspirin|aspirin|mesh-list
25493608|NCT00263211|Clopidogrel|clopidogrel|mesh-list
25493609|NCT00263211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25493610|NCT00263211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25493611|NCT00263211|Analgesics|analgesics|mesh-ancestor
25493612|NCT00263211|Sensory System Agents|sensory system agents|mesh-ancestor
25493613|NCT00263211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25493614|NCT00263211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493615|NCT00263211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25493616|NCT00263211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25493617|NCT00263211|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25493618|NCT00263211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25493619|NCT00263211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493620|NCT00263211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25493621|NCT00263211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25493622|NCT00263211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493623|NCT00263211|Antipyretics|antipyretics|mesh-ancestor
25493624|NCT00263211|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25493625|NCT00263211|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25493626|NCT00263211|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25493627|NCT00263211|Purinergic Agents|purinergic agents|mesh-ancestor
25493628|NCT00263211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25493629|NCT00263328|Tacrolimus|tacrolimus|mesh-list
25493630|NCT00263328|Tofacitinib|tofacitinib|mesh-list
25493631|NCT00263328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25493632|NCT00263328|Immunologic Factors|immunologic factors|mesh-ancestor
25493633|NCT00263328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493634|NCT00263328|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25493635|NCT00263328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493636|NCT00263328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493637|NCT00263328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25493638|NCT00263575|Fentanyl|fentanyl|mesh-list
25493639|NCT00263575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25493640|NCT00263575|Narcotics|narcotics|mesh-ancestor
25493641|NCT00263575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25493642|NCT00263575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493643|NCT00263575|Analgesics|analgesics|mesh-ancestor
25493644|NCT00263575|Sensory System Agents|sensory system agents|mesh-ancestor
25493645|NCT00263575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25493646|NCT00263575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25493647|NCT00263575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25493648|NCT00263575|Anesthetics, General|anesthetics, general|mesh-ancestor
25493649|NCT00263575|Anesthetics|anesthetics|mesh-ancestor
25493650|NCT00263588|Lapatinib|lapatinib|mesh-list
25493651|NCT00263588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493652|NCT00263588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25493653|NCT00263588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493654|NCT00263588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493655|NCT00263887|Protease Inhibitors|protease inhibitors|mesh-list
25493656|NCT00263887|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25493657|NCT00263887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493658|NCT00263887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493659|NCT00263887|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25493660|NCT00263887|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25493661|NCT00264004|Cediranib|cediranib|mesh-list
25493662|NCT00264004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493663|NCT00264004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25493664|NCT00264004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493665|NCT00264004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493666|NCT00264238|Memantine|memantine|mesh-list
25493667|NCT00264238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25493668|NCT00264238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25493669|NCT00264238|Dopamine Agents|dopamine agents|mesh-ancestor
25493670|NCT00264238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25493671|NCT00264238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493672|NCT00264238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493673|NCT00264238|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25493674|NCT00264238|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25493675|NCT00264290|Valganciclovir|valganciclovir|mesh-list
25493676|NCT00264290|Antiviral Agents|antiviral agents|mesh-ancestor
25493677|NCT00264290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25493678|NCT00264303|Levocetirizine|levocetirizine|mesh-list
25493679|NCT00264303|Desloratadine|desloratadine|mesh-list
25493680|NCT00264303|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25493681|NCT00264303|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25493682|NCT00264303|Histamine Antagonists|histamine antagonists|mesh-ancestor
25493683|NCT00264303|Histamine Agents|histamine agents|mesh-ancestor
25493684|NCT00264303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25493685|NCT00264303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493686|NCT00264303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493687|NCT00264303|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25493688|NCT00264303|Cholinergic Agents|cholinergic agents|mesh-ancestor
25493689|NCT00264381|Dalteparin|dalteparin|mesh-list
25493690|NCT00264381|Tinzaparin|tinzaparin|mesh-list
25493691|NCT00264381|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25493692|NCT00264381|Anticoagulants|anticoagulants|mesh-ancestor
25493693|NCT00264381|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25493694|NCT00264381|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25493695|NCT00264381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493696|NCT00264498|Gemcitabine|gemcitabine|mesh-list
25142880|NCT02946437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493697|NCT00264498|Carboplatin|carboplatin|mesh-list
25493698|NCT00264498|Gefitinib|gefitinib|mesh-list
25493699|NCT00264498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493700|NCT00264498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25493701|NCT00264498|Antimetabolites|antimetabolites|mesh-ancestor
25493702|NCT00264498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493703|NCT00264498|Antiviral Agents|antiviral agents|mesh-ancestor
25493704|NCT00264498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25493705|NCT00264498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493706|NCT00264498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25493707|NCT00264498|Immunologic Factors|immunologic factors|mesh-ancestor
25493708|NCT00264498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493709|NCT00264498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25645357|NCT01447433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645358|NCT01447433|Antacids|antacids|mesh-ancestor
25645359|NCT01447433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645360|NCT01447433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25493710|NCT00264537|Golimumab|golimumab|mesh-list
25493711|NCT00264537|Methotrexate|methotrexate|mesh-list
25493712|NCT00264537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25493713|NCT00264537|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25493714|NCT00264537|Abortifacient Agents|abortifacient agents|mesh-ancestor
25493715|NCT00264537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25493716|NCT00264537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493717|NCT00264537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25493718|NCT00264537|Antimetabolites|antimetabolites|mesh-ancestor
25493719|NCT00264537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493720|NCT00264537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493721|NCT00264537|Dermatologic Agents|dermatologic agents|mesh-ancestor
25493722|NCT00264537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493723|NCT00264537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25493724|NCT00264537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25493725|NCT00264537|Immunologic Factors|immunologic factors|mesh-ancestor
25493726|NCT00264537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25493727|NCT00264537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25493728|NCT00264537|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25493729|NCT00264537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25493730|NCT00264550|Golimumab|golimumab|mesh-list
25493731|NCT00264550|Methotrexate|methotrexate|mesh-list
25493732|NCT00264550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25493733|NCT00264550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25493734|NCT00264550|Abortifacient Agents|abortifacient agents|mesh-ancestor
25493735|NCT00264550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25493736|NCT00264550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493737|NCT00264550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25493738|NCT00264550|Antimetabolites|antimetabolites|mesh-ancestor
25493739|NCT00264550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493740|NCT00264550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493741|NCT00264550|Dermatologic Agents|dermatologic agents|mesh-ancestor
25493742|NCT00264550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493743|NCT00264550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25493744|NCT00264550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25493745|NCT00264550|Immunologic Factors|immunologic factors|mesh-ancestor
25493746|NCT00264550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25493747|NCT00264550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25493748|NCT00264550|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25493749|NCT00264550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25493750|NCT00264641|Insulin|insulin|mesh-list
25493751|NCT00264641|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25493752|NCT00264641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25493753|NCT00264641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493754|NCT00264797|Methylphenidate|methylphenidate|mesh-list
25493755|NCT00264797|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25493756|NCT00264797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493757|NCT00264797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25493758|NCT00264797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25493759|NCT00264797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25493760|NCT00264797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493761|NCT00264797|Dopamine Agents|dopamine agents|mesh-ancestor
25493762|NCT00264797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25493763|NCT00264849|Omalizumab|omalizumab|mesh-list
25493764|NCT00264849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25493765|NCT00264849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25493766|NCT00264849|Respiratory System Agents|respiratory system agents|mesh-ancestor
25493767|NCT00264875|Pregabalin|pregabalin|mesh-list
25493768|NCT00264875|Analgesics|analgesics|mesh-ancestor
25493769|NCT00264875|Sensory System Agents|sensory system agents|mesh-ancestor
25493770|NCT00264875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25493771|NCT00264875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493773|NCT00264875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25493774|NCT00264875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25493775|NCT00264875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493776|NCT00264875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25493777|NCT00264875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25493778|NCT00264875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25493779|NCT00264875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25493780|NCT00264875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25493782|NCT00265083|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25493783|NCT00265083|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25493784|NCT00265083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25493785|NCT00265083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25493786|NCT00265083|Immunologic Factors|immunologic factors|mesh-ancestor
25493787|NCT00265083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493788|NCT00265096|Golimumab|golimumab|mesh-list
25493789|NCT00265096|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25493790|NCT00265096|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25493791|NCT00265096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25493792|NCT00265096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25493793|NCT00265096|Immunologic Factors|immunologic factors|mesh-ancestor
25493794|NCT00265096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493795|NCT00265109|Levetiracetam|levetiracetam|mesh-list
25493796|NCT00265109|Anticonvulsants|anticonvulsants|mesh-ancestor
25493797|NCT00265109|Nootropic Agents|nootropic agents|mesh-ancestor
25493798|NCT00265122|Ustekinumab|ustekinumab|mesh-list
25493799|NCT00265122|Dermatologic Agents|dermatologic agents|mesh-ancestor
25493800|NCT00265148|Rosiglitazone|rosiglitazone|mesh-list
25493801|NCT00265148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25493802|NCT00265148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493803|NCT00265200|Zoledronic Acid|zoledronic acid|mesh-list
25493804|NCT00265200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25493805|NCT00265200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493806|NCT00265239|Edaravone|edaravone|mesh-list
25493807|NCT00265239|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25493808|NCT00265239|Antioxidants|antioxidants|mesh-ancestor
25493809|NCT00265239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493810|NCT00265239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25493811|NCT00265239|Protective Agents|protective agents|mesh-ancestor
25493812|NCT00265239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493813|NCT00265317|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25493814|NCT00265317|Sunitinib|sunitinib|mesh-list
25493815|NCT00265317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493816|NCT00265317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25493817|NCT00265317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493818|NCT00265317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493819|NCT00265317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25493820|NCT00265317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25493821|NCT00265317|Growth Substances|growth substances|mesh-ancestor
25493822|NCT00265317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493823|NCT00265317|Growth Inhibitors|growth inhibitors|mesh-ancestor
25493824|NCT00265330|Ziprasidone|ziprasidone|mesh-list
25493825|NCT00265330|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25493826|NCT00265330|Serotonin Agents|serotonin agents|mesh-ancestor
25493827|NCT00265330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25493828|NCT00265330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493829|NCT00265330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493830|NCT00265330|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25493831|NCT00265330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25493832|NCT00265330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25493833|NCT00265330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25493834|NCT00265330|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25493835|NCT00265330|Dopamine Agents|dopamine agents|mesh-ancestor
25493836|NCT00265382|Ziprasidone|ziprasidone|mesh-list
25493837|NCT00265382|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25493838|NCT00265382|Serotonin Agents|serotonin agents|mesh-ancestor
25493839|NCT00265382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25493840|NCT00265382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143973|NCT02939430|Atropine|atropine|mesh-list
25143974|NCT02939430|Neostigmine|neostigmine|mesh-list
25143975|NCT02939430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25143976|NCT02939430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25143977|NCT02939430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25028702|NCT03608514|Terlipressin|terlipressin|mesh-list
25493841|NCT00265382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493842|NCT00265382|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25493843|NCT00265382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25493844|NCT00265382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25493845|NCT00265382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25493846|NCT00265382|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25493847|NCT00265382|Dopamine Agents|dopamine agents|mesh-ancestor
25493848|NCT00265395|Interferons|interferons|mesh-list
25493849|NCT00265395|Ribavirin|ribavirin|mesh-list
25493850|NCT00265395|Interferon-alpha|interferon-alpha|mesh-list
25645362|NCT01447446|Interferon-alpha|interferon-alpha|mesh-list
25645363|NCT01447446|Interferon alpha-2|interferon alpha-2|mesh-list
25645364|NCT01447446|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
25645365|NCT01447446|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25645366|NCT01447446|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25645367|NCT01447446|Antimetabolites|antimetabolites|mesh-ancestor
25645368|NCT01447446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645369|NCT01447446|Antiviral Agents|antiviral agents|mesh-ancestor
25645370|NCT01447446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25645371|NCT01447446|Immunologic Factors|immunologic factors|mesh-ancestor
25645372|NCT01447446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493851|NCT00265395|Interferon alpha-2|interferon alpha-2|mesh-list
25493852|NCT00265395|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25645373|NCT01447446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645374|NCT01447511|Rifampin|rifampin|mesh-list
25645375|NCT01447511|Fluconazole|fluconazole|mesh-list
25645376|NCT01447511|Warfarin|warfarin|mesh-list
25645377|NCT01447511|Anticoagulants|anticoagulants|mesh-ancestor
25645378|NCT01447511|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25493853|NCT00265395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493854|NCT00265395|Antiviral Agents|antiviral agents|mesh-ancestor
25493855|NCT00265395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25493856|NCT00265395|Antimetabolites|antimetabolites|mesh-ancestor
25493857|NCT00265395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493858|NCT00265395|Immunologic Factors|immunologic factors|mesh-ancestor
25493859|NCT00265395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493860|NCT00265616|Pentobarbital|pentobarbital|mesh-list
25493861|NCT00265616|Thiopental|thiopental|mesh-list
25493862|NCT00265616|Propofol|propofol|mesh-list
25493863|NCT00265616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25493864|NCT00265616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25493865|NCT00265616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493866|NCT00265616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25493867|NCT00265616|Anesthetics, General|anesthetics, general|mesh-ancestor
25493868|NCT00265616|Anesthetics|anesthetics|mesh-ancestor
25493869|NCT00265616|Anticonvulsants|anticonvulsants|mesh-ancestor
25493870|NCT00265616|GABA Modulators|gaba modulators|mesh-ancestor
25493871|NCT00265616|GABA Agents|gaba agents|mesh-ancestor
25493872|NCT00265616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25493873|NCT00265616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493874|NCT00265616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25493875|NCT00265759|Letrozole|letrozole|mesh-list
25493876|NCT00265759|Anastrozole|anastrozole|mesh-list
25493877|NCT00265759|Exemestane|exemestane|mesh-list
25493878|NCT00265759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493879|NCT00265759|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25493880|NCT00265759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25493881|NCT00265759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493882|NCT00265759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493883|NCT00265759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25493884|NCT00265759|Hormone Antagonists|hormone antagonists|mesh-ancestor
25493885|NCT00265759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25493886|NCT00265759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493887|NCT00265759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25493888|NCT00265785|Pemetrexed|pemetrexed|mesh-list
25493889|NCT00265785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493890|NCT00265785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493891|NCT00265785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493892|NCT00265785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25493893|NCT00265785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25493894|NCT00265850|Leucovorin|leucovorin|mesh-list
25493895|NCT00265850|Folic Acid|folic acid|mesh-list
25493896|NCT00265850|Bevacizumab|bevacizumab|mesh-list
25493897|NCT00265850|Cetuximab|cetuximab|mesh-list
25493898|NCT00265850|Fluorouracil|fluorouracil|mesh-list
25493899|NCT00265850|Oxaliplatin|oxaliplatin|mesh-list
25493900|NCT00265850|Irinotecan|irinotecan|mesh-list
25493901|NCT00265850|Levoleucovorin|levoleucovorin|mesh-list
25493902|NCT00265850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25493903|NCT00265850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493904|NCT00265850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25493905|NCT00265850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25493906|NCT00265850|Growth Substances|growth substances|mesh-ancestor
25493907|NCT00265850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493908|NCT00265850|Growth Inhibitors|growth inhibitors|mesh-ancestor
25493909|NCT00265850|Antimetabolites|antimetabolites|mesh-ancestor
24627019|NCT01090128|Paclitaxel|paclitaxel|mesh-list
25493910|NCT00265850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493911|NCT00265850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25493912|NCT00265850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25493913|NCT00265850|Immunologic Factors|immunologic factors|mesh-ancestor
25493914|NCT00265850|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25493915|NCT00265850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25493916|NCT00265850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493917|NCT00265850|Antidotes|antidotes|mesh-ancestor
25493918|NCT00265850|Protective Agents|protective agents|mesh-ancestor
25493920|NCT00265850|Vitamins|vitamins|mesh-ancestor
25493921|NCT00265850|Micronutrients|micronutrients|mesh-ancestor
25493922|NCT00265850|Hematinics|hematinics|mesh-ancestor
25493923|NCT00265889|Cyclophosphamide|cyclophosphamide|mesh-list
25493924|NCT00265889|Melphalan|melphalan|mesh-list
25493925|NCT00265889|Busulfan|busulfan|mesh-list
25493926|NCT00265889|Etoposide|etoposide|mesh-list
25493927|NCT00265889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25493928|NCT00265889|Immunologic Factors|immunologic factors|mesh-ancestor
25493929|NCT00265889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493930|NCT00265889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25493931|NCT00265889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25493932|NCT00265889|Alkylating Agents|alkylating agents|mesh-ancestor
25493933|NCT00265889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493934|NCT00265889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493935|NCT00265889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25493936|NCT00265889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25493937|NCT00265889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25493938|NCT00265889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25493939|NCT00265889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493940|NCT00266032|Drospirenone|drospirenone|mesh-list
25493941|NCT00266032|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25493942|NCT00266032|Hormone Antagonists|hormone antagonists|mesh-ancestor
25493943|NCT00266032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25493944|NCT00266032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493945|NCT00266032|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25493946|NCT00266032|Diuretics|diuretics|mesh-ancestor
25493947|NCT00266032|Natriuretic Agents|natriuretic agents|mesh-ancestor
25493948|NCT00266110|Trastuzumab|trastuzumab|mesh-list
25493949|NCT00266110|Vinorelbine|vinorelbine|mesh-list
25493950|NCT00266110|Sargramostim|sargramostim|mesh-list
25493951|NCT00266110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25493952|NCT00266110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493953|NCT00266110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25493954|NCT00266110|Tubulin Modulators|tubulin modulators|mesh-ancestor
25493955|NCT00266110|Antimitotic Agents|antimitotic agents|mesh-ancestor
25493956|NCT00266110|Mitosis Modulators|mitosis modulators|mesh-ancestor
25493957|NCT00266110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493958|NCT00266110|Immunologic Factors|immunologic factors|mesh-ancestor
25493959|NCT00266110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493960|NCT00266227|Rituximab|rituximab|mesh-list
25493961|NCT00266227|Methotrexate|methotrexate|mesh-list
25493962|NCT00266227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25493963|NCT00266227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493964|NCT00266227|Immunologic Factors|immunologic factors|mesh-ancestor
25493965|NCT00266227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493966|NCT00266227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25493967|NCT00266227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25493968|NCT00266227|Abortifacient Agents|abortifacient agents|mesh-ancestor
25493969|NCT00266227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25493970|NCT00266227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25493971|NCT00266227|Antimetabolites|antimetabolites|mesh-ancestor
25493972|NCT00266227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493973|NCT00266227|Dermatologic Agents|dermatologic agents|mesh-ancestor
25493974|NCT00266227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25493975|NCT00266227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25493976|NCT00266227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25493977|NCT00266227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25493978|NCT00266279|Capecitabine|capecitabine|mesh-list
25493979|NCT00266279|Oxaliplatin|oxaliplatin|mesh-list
25493980|NCT00266279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25493981|NCT00266279|Antimetabolites|antimetabolites|mesh-ancestor
25493982|NCT00266279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493983|NCT00266279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25493984|NCT00266409|Alprazolam|alprazolam|mesh-list
25493985|NCT00266409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25645379|NCT01447511|Antitubercular Agents|antitubercular agents|mesh-ancestor
25645380|NCT01447511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25645381|NCT01447511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25493986|NCT00266409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25493987|NCT00266409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25493988|NCT00266409|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25493989|NCT00266409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25493990|NCT00266409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25493991|NCT00266409|GABA Modulators|gaba modulators|mesh-ancestor
25493992|NCT00266409|GABA Agents|gaba agents|mesh-ancestor
25493993|NCT00266409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25493994|NCT00266409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25493995|NCT00266630|Carbamazepine|carbamazepine|mesh-list
25493996|NCT00266630|Valproic Acid|valproic acid|mesh-list
25493998|NCT00266630|Antiemetics|antiemetics|mesh-ancestor
25493999|NCT00266630|Autonomic Agents|autonomic agents|mesh-ancestor
25494000|NCT00266630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25494001|NCT00266630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494002|NCT00266630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25494003|NCT00266630|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25494004|NCT00266630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25494005|NCT00266630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25494006|NCT00266630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25494007|NCT00266630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25494008|NCT00266630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25494009|NCT00266630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25494010|NCT00266630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494011|NCT00266630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25494012|NCT00266630|Serotonin Agents|serotonin agents|mesh-ancestor
25494013|NCT00266630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494014|NCT00266630|Antimanic Agents|antimanic agents|mesh-ancestor
25494015|NCT00266630|Anticonvulsants|anticonvulsants|mesh-ancestor
25494016|NCT00266630|GABA Agents|gaba agents|mesh-ancestor
25494017|NCT00266630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25494018|NCT00266630|Analgesics|analgesics|mesh-ancestor
25494019|NCT00266630|Sensory System Agents|sensory system agents|mesh-ancestor
25494020|NCT00266630|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25494021|NCT00266630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25494022|NCT00266630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25494023|NCT00266656|Hormones|hormones|mesh-list
25494024|NCT00266656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25494025|NCT00266656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494026|NCT00266695|Ruboxistaurin|ruboxistaurin|mesh-list
25494027|NCT00266695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494028|NCT00266695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494029|NCT00266708|Risedronic Acid|risedronic acid|mesh-list
25494030|NCT00266708|Etidronic Acid|etidronic acid|mesh-list
25494031|NCT00266708|Diphosphonates|diphosphonates|mesh-list
25494032|NCT00266708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25494033|NCT00266708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25494034|NCT00266708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494035|NCT00266708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25494036|NCT00266708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494037|NCT00266708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25494038|NCT00266799|Doxorubicin|doxorubicin|mesh-list
25494039|NCT00266799|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25494040|NCT00266799|Capecitabine|capecitabine|mesh-list
25494041|NCT00266799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25494042|NCT00266799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494043|NCT00266799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25494044|NCT00266799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25494045|NCT00266799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494046|NCT00266799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494047|NCT00266799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25494048|NCT00266799|Antimetabolites|antimetabolites|mesh-ancestor
25494049|NCT00266812|Temozolomide|temozolomide|mesh-list
25494050|NCT00266812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25494051|NCT00266812|Alkylating Agents|alkylating agents|mesh-ancestor
25494052|NCT00266812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494053|NCT00266812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494054|NCT00266851|Azithromycin|azithromycin|mesh-list
25494055|NCT00266851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25494056|NCT00266851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25494057|NCT00266864|Methyltestosterone|methyltestosterone|mesh-list
25645382|NCT01447511|Leprostatic Agents|leprostatic agents|mesh-ancestor
25645383|NCT01447511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25645384|NCT01447511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645385|NCT01447511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645386|NCT01447511|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25645387|NCT01447511|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25645388|NCT01447511|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25645389|NCT01447511|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25645390|NCT01447511|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25645391|NCT01447511|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25645392|NCT01447511|Antifungal Agents|antifungal agents|mesh-ancestor
25645393|NCT01447511|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25494058|NCT00266864|Testosterone|testosterone|mesh-list
25494059|NCT00266864|Testosterone undecanoate|testosterone undecanoate|mesh-list
25494060|NCT00266864|Testosterone enanthate|testosterone enanthate|mesh-list
25645394|NCT01447511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25645395|NCT01447511|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25494061|NCT00266864|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25494062|NCT00266864|Androgens|androgens|mesh-ancestor
25494063|NCT00266864|Hormones|hormones|mesh-ancestor
25494064|NCT00266864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25494065|NCT00266864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144557|NCT02935972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25144558|NCT02935855|Warfarin|warfarin|mesh-list
25494066|NCT00266864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25494068|NCT00266864|Anabolic Agents|anabolic agents|mesh-ancestor
25494069|NCT00267007|Epoetin Alfa|epoetin alfa|mesh-list
25494070|NCT00267007|Hematinics|hematinics|mesh-ancestor
25494071|NCT00267020|Gemcitabine|gemcitabine|mesh-list
25494072|NCT00267020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25494073|NCT00267020|Antimetabolites|antimetabolites|mesh-ancestor
25494074|NCT00267020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494075|NCT00267020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494076|NCT00267020|Antiviral Agents|antiviral agents|mesh-ancestor
25494077|NCT00267020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25494078|NCT00267020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494079|NCT00267020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25494080|NCT00267020|Immunologic Factors|immunologic factors|mesh-ancestor
25494081|NCT00267020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494082|NCT00267046|Cisplatin|cisplatin|mesh-list
25494083|NCT00267046|Doxorubicin|doxorubicin|mesh-list
25494084|NCT00267046|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25494085|NCT00267046|Vincristine|vincristine|mesh-list
25494086|NCT00267046|Ifosfamide|ifosfamide|mesh-list
25494087|NCT00267046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494088|NCT00267046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25494089|NCT00267046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25494090|NCT00267046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25494091|NCT00267046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494092|NCT00267046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494093|NCT00267046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25494094|NCT00267046|Tubulin Modulators|tubulin modulators|mesh-ancestor
25494095|NCT00267046|Antimitotic Agents|antimitotic agents|mesh-ancestor
25494096|NCT00267046|Mitosis Modulators|mitosis modulators|mesh-ancestor
25494097|NCT00267046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25494098|NCT00267046|Alkylating Agents|alkylating agents|mesh-ancestor
25494099|NCT00267059|Lenalidomide|lenalidomide|mesh-list
25494100|NCT00267059|Immunologic Factors|immunologic factors|mesh-ancestor
25494101|NCT00267059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494102|NCT00267059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25494103|NCT00267059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25494104|NCT00267059|Growth Substances|growth substances|mesh-ancestor
25494105|NCT00267059|Growth Inhibitors|growth inhibitors|mesh-ancestor
25494106|NCT00267059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494107|NCT00267085|Imatinib Mesylate|imatinib mesylate|mesh-list
25494108|NCT00267085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494109|NCT00267085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25494110|NCT00267085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494111|NCT00267085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494112|NCT00267111|Tetracaine|tetracaine|mesh-list
25494113|NCT00267111|Anesthetics, Local|anesthetics, local|mesh-ancestor
25494114|NCT00267111|Anesthetics|anesthetics|mesh-ancestor
25494115|NCT00267111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25494116|NCT00267111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645396|NCT01447511|Hormone Antagonists|hormone antagonists|mesh-ancestor
25645397|NCT01447511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25645398|NCT01447511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645399|NCT01447511|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25645400|NCT01447511|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25645401|NCT01447576|Antidepressive Agents|antidepressive agents|mesh-list
25494117|NCT00267111|Sensory System Agents|sensory system agents|mesh-ancestor
25494118|NCT00267111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25494119|NCT00267150|Mycophenolic Acid|mycophenolic acid|mesh-list
25494120|NCT00267150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25494121|NCT00267150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494122|NCT00267150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25494123|NCT00267150|Antitubercular Agents|antitubercular agents|mesh-ancestor
25494124|NCT00267150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25494125|NCT00267150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25494126|NCT00267150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494127|NCT00267150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494128|NCT00267189|Cyclosporine|cyclosporine|mesh-list
25494129|NCT00267189|Everolimus|everolimus|mesh-list
25494130|NCT00267189|Azathioprine|azathioprine|mesh-list
25494131|NCT00267189|Tacrolimus|tacrolimus|mesh-list
25494132|NCT00267189|Cyclosporins|cyclosporins|mesh-list
25494133|NCT00267189|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
25494134|NCT00267189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494135|NCT00267189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25144834|NCT02934022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25047559|NCT00794677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25047561|NCT00792727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25047562|NCT00792727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25047564|NCT00792727|Sensory System Agents|sensory system agents|mesh-ancestor
25494136|NCT00267189|Immunologic Factors|immunologic factors|mesh-ancestor
25494137|NCT00267189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494138|NCT00267189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25494139|NCT00267189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494140|NCT00267189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494141|NCT00267189|Antimetabolites|antimetabolites|mesh-ancestor
25494142|NCT00267189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25494143|NCT00267189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25494144|NCT00267189|Antifungal Agents|antifungal agents|mesh-ancestor
25494145|NCT00267189|Dermatologic Agents|dermatologic agents|mesh-ancestor
25494146|NCT00267202|Omalizumab|omalizumab|mesh-list
25494147|NCT00267202|Immunologic Factors|immunologic factors|mesh-list
25494148|NCT00267202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494149|NCT00267202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25494150|NCT00267202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25494151|NCT00267202|Respiratory System Agents|respiratory system agents|mesh-ancestor
25494152|NCT00267293|Acetaminophen|acetaminophen|mesh-list
25494153|NCT00267293|Ibuprofen|ibuprofen|mesh-list
25494154|NCT00267293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25494155|NCT00267293|Analgesics|analgesics|mesh-ancestor
25494156|NCT00267293|Sensory System Agents|sensory system agents|mesh-ancestor
25494157|NCT00267293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25494158|NCT00267293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494159|NCT00267293|Antipyretics|antipyretics|mesh-ancestor
25494160|NCT00267293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25494161|NCT00267293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25494162|NCT00267293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25494163|NCT00267293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25494164|NCT00267293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494165|NCT00267293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494166|NCT00267488|Topotecan|topotecan|mesh-list
25494167|NCT00267488|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25494168|NCT00267488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25494169|NCT00267488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494170|NCT00267488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494171|NCT00267488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494172|NCT00267670|Pentoxifylline|pentoxifylline|mesh-list
25494173|NCT00267670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25494174|NCT00267670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494175|NCT00267670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494176|NCT00267670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25494177|NCT00267670|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25494178|NCT00267670|Protective Agents|protective agents|mesh-ancestor
25494179|NCT00267670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645402|NCT01447576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25645404|NCT01447706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25494180|NCT00267670|Vasodilator Agents|vasodilator agents|mesh-ancestor
25494181|NCT00267670|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25494182|NCT00267670|Antioxidants|antioxidants|mesh-ancestor
25494183|NCT00267696|Gemcitabine|gemcitabine|mesh-list
25494184|NCT00267696|Bevacizumab|bevacizumab|mesh-list
25494185|NCT00267696|Carboplatin|carboplatin|mesh-list
25494186|NCT00267696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25494187|NCT00267696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494188|NCT00267696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25494189|NCT00267696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25494190|NCT00267696|Growth Substances|growth substances|mesh-ancestor
25494191|NCT00267696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494192|NCT00267696|Growth Inhibitors|growth inhibitors|mesh-ancestor
25494193|NCT00267696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25494194|NCT00267696|Antimetabolites|antimetabolites|mesh-ancestor
25494195|NCT00267696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494196|NCT00267696|Antiviral Agents|antiviral agents|mesh-ancestor
25494197|NCT00267696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25494198|NCT00267696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494199|NCT00267696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25494200|NCT00267696|Immunologic Factors|immunologic factors|mesh-ancestor
25494201|NCT00267748|Sunitinib|sunitinib|mesh-list
25494202|NCT00267748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494203|NCT00267748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25494204|NCT00267748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25494205|NCT00267748|Growth Substances|growth substances|mesh-ancestor
25494206|NCT00267748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494207|NCT00267748|Growth Inhibitors|growth inhibitors|mesh-ancestor
25494208|NCT00267748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25494209|NCT00267748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494210|NCT00267748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494211|NCT00267865|Leucovorin|leucovorin|mesh-list
25494236|NCT00267956|Dermatologic Agents|dermatologic agents|mesh-ancestor
25494237|NCT00267969|Ustekinumab|ustekinumab|mesh-list
25494238|NCT00267969|Dermatologic Agents|dermatologic agents|mesh-ancestor
25494239|NCT00268203|Tositumomab I-131|tositumomab i-131|mesh-list
25494240|NCT00268203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494241|NCT00268242|Gemcitabine|gemcitabine|mesh-list
25494242|NCT00268242|Mitoxantrone|mitoxantrone|mesh-list
25494243|NCT00268242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25494244|NCT00268242|Antimetabolites|antimetabolites|mesh-ancestor
25494245|NCT00268242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494246|NCT00268242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494247|NCT00268242|Antiviral Agents|antiviral agents|mesh-ancestor
25494248|NCT00268242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25494249|NCT00268242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494250|NCT00268242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25494251|NCT00268242|Immunologic Factors|immunologic factors|mesh-ancestor
25494252|NCT00268242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494253|NCT00268242|Analgesics|analgesics|mesh-ancestor
25494254|NCT00268242|Sensory System Agents|sensory system agents|mesh-ancestor
25494255|NCT00268242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25494256|NCT00268242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25494257|NCT00268242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25494258|NCT00268346|Gefitinib|gefitinib|mesh-list
25494259|NCT00268346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494260|NCT00268346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25494261|NCT00268346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494262|NCT00268346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494263|NCT00268437|Carboplatin|carboplatin|mesh-list
25494264|NCT00268437|Pemetrexed|pemetrexed|mesh-list
25494265|NCT00268437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494266|NCT00268437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494267|NCT00268437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494268|NCT00268437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25494269|NCT00268437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25494270|NCT00268762|Argatroban|argatroban|mesh-list
25494271|NCT00268762|Antithrombins|antithrombins|mesh-ancestor
25494272|NCT00268762|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25494273|NCT00268762|Protease Inhibitors|protease inhibitors|mesh-ancestor
25494274|NCT00268762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494275|NCT00268762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494276|NCT00268762|Anticoagulants|anticoagulants|mesh-ancestor
25823160|NCT00004758|GABA Modulators|gaba modulators|mesh-ancestor
25823161|NCT00004759|Methylprednisolone|methylprednisolone|mesh-list
25645405|NCT01447706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645406|NCT01447706|Tubulin Modulators|tubulin modulators|mesh-ancestor
25494277|NCT00268762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25494278|NCT00268905|Carboplatin|carboplatin|mesh-list
25494279|NCT00268905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494281|NCT00268983|Rituximab|rituximab|mesh-list
25494282|NCT00268983|Tositumomab I-131|tositumomab i-131|mesh-list
25494283|NCT00268983|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25494284|NCT00268983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25494285|NCT00268983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494286|NCT00268983|Immunologic Factors|immunologic factors|mesh-ancestor
25494287|NCT00268983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494288|NCT00268983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25494289|NCT00268983|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25494290|NCT00268983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25494291|NCT00268983|Trace Elements|trace elements|mesh-ancestor
25494292|NCT00268983|Micronutrients|micronutrients|mesh-ancestor
25494293|NCT00269087|Fluticasone|fluticasone|mesh-list
25494294|NCT00269087|Xhance|xhance|mesh-list
25494295|NCT00269087|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25494296|NCT00269087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25494297|NCT00269087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25494298|NCT00269087|Autonomic Agents|autonomic agents|mesh-ancestor
25494299|NCT00269087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25494300|NCT00269087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494301|NCT00269087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25494302|NCT00269087|Respiratory System Agents|respiratory system agents|mesh-ancestor
25494303|NCT00269087|Dermatologic Agents|dermatologic agents|mesh-ancestor
25494304|NCT00269087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25494305|NCT00269087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25494306|NCT00269087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25146171|NCT02923856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24764300|NCT01780519|GABA Agents|gaba agents|mesh-ancestor
25494307|NCT00269087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25494308|NCT00269087|Adrenergic Agents|adrenergic agents|mesh-ancestor
25494309|NCT00269087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25494310|NCT00269087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494312|NCT00269113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25494313|NCT00269113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494314|NCT00269113|Immunologic Factors|immunologic factors|mesh-ancestor
25494315|NCT00269113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494316|NCT00269113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25494317|NCT00269152|Cisplatin|cisplatin|mesh-list
25494318|NCT00269152|Carboplatin|carboplatin|mesh-list
25494319|NCT00269152|Pemetrexed|pemetrexed|mesh-list
25494320|NCT00269152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494321|NCT00269152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494322|NCT00269152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494323|NCT00269152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25494324|NCT00269152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25494325|NCT00269399|Vancomycin|vancomycin|mesh-list
25494326|NCT00269399|Rifaximin|rifaximin|mesh-list
25494327|NCT00269399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25494328|NCT00269399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25494329|NCT00269399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25494330|NCT00269919|Risperidone|risperidone|mesh-list
25494331|NCT00269919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25494332|NCT00269919|Serotonin Agents|serotonin agents|mesh-ancestor
25494333|NCT00269919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25494334|NCT00269919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494335|NCT00269919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494336|NCT00269919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25494337|NCT00269919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25494338|NCT00269919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25494339|NCT00269919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25494340|NCT00269919|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25494341|NCT00269919|Dopamine Agents|dopamine agents|mesh-ancestor
25494342|NCT00270231|Naltrexone|naltrexone|mesh-list
25494343|NCT00270231|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25494344|NCT00270231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25494345|NCT00270231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494346|NCT00270231|Sensory System Agents|sensory system agents|mesh-ancestor
25494347|NCT00270231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25645407|NCT01447706|Antimitotic Agents|antimitotic agents|mesh-ancestor
25494348|NCT00270257|Buprenorphine|buprenorphine|mesh-list
25494349|NCT00270257|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25494350|NCT00270257|Naloxone|naloxone|mesh-list
25645408|NCT01447706|Mitosis Modulators|mitosis modulators|mesh-ancestor
25645409|NCT01447706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494351|NCT00270257|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25494352|NCT00270257|Narcotics|narcotics|mesh-ancestor
25494353|NCT00270257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25494354|NCT00270257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494355|NCT00270257|Analgesics|analgesics|mesh-ancestor
25494356|NCT00270257|Sensory System Agents|sensory system agents|mesh-ancestor
25494357|NCT00270257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25494358|NCT00270257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25494359|NCT00270296|Ritonavir|ritonavir|mesh-list
25494360|NCT00270296|Lopinavir|lopinavir|mesh-list
25494361|NCT00270296|Lamivudine|lamivudine|mesh-list
25494362|NCT00270296|Zidovudine|zidovudine|mesh-list
25494363|NCT00270296|Nevirapine|nevirapine|mesh-list
25494364|NCT00270296|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25494365|NCT00270296|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25494366|NCT00270296|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25494367|NCT00270296|Protease Inhibitors|protease inhibitors|mesh-ancestor
25494368|NCT00270296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494369|NCT00270296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494370|NCT00270296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25494371|NCT00270296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25494372|NCT00270296|Antiviral Agents|antiviral agents|mesh-ancestor
25494373|NCT00270296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25494374|NCT00270296|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25494375|NCT00270296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25494376|NCT00270296|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25494377|NCT00270296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25494378|NCT00270296|Antimetabolites|antimetabolites|mesh-ancestor
25494379|NCT00270296|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25494380|NCT00270296|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25494381|NCT00270634|Tacrolimus|tacrolimus|mesh-list
24772359|NCT01833299|Estrogens|estrogens|mesh-ancestor
25146346|NCT02922426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25146347|NCT02922426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25146352|NCT02922426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25494382|NCT00270634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25494383|NCT00270634|Immunologic Factors|immunologic factors|mesh-ancestor
25494384|NCT00270634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494385|NCT00270634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25494386|NCT00270634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494387|NCT00270634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494388|NCT00270790|Carboplatin|carboplatin|mesh-list
25494389|NCT00270790|Amifostine|amifostine|mesh-list
25494390|NCT00270790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494391|NCT00270790|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25494392|NCT00270790|Protective Agents|protective agents|mesh-ancestor
25494393|NCT00270790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494394|NCT00270894|Cyclophosphamide|cyclophosphamide|mesh-list
25494395|NCT00270894|Docetaxel|docetaxel|mesh-list
25494396|NCT00270894|Trastuzumab|trastuzumab|mesh-list
25494397|NCT00270894|Epirubicin|epirubicin|mesh-list
25494398|NCT00270894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25494399|NCT00270894|Immunologic Factors|immunologic factors|mesh-ancestor
25494400|NCT00270894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494401|NCT00270894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25494402|NCT00270894|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25494403|NCT00270894|Alkylating Agents|alkylating agents|mesh-ancestor
25494404|NCT00270894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494405|NCT00270894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494406|NCT00270894|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25494407|NCT00270894|Tubulin Modulators|tubulin modulators|mesh-ancestor
25494408|NCT00270894|Antimitotic Agents|antimitotic agents|mesh-ancestor
25494409|NCT00270894|Mitosis Modulators|mitosis modulators|mesh-ancestor
25494410|NCT00270894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25494411|NCT00270894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25494412|NCT00270894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25494413|NCT00270894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25494414|NCT00270894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494415|NCT00271024|Naltrexone|naltrexone|mesh-list
25494416|NCT00271024|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25494417|NCT00271024|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25494418|NCT00271024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494419|NCT00271024|Sensory System Agents|sensory system agents|mesh-ancestor
25494420|NCT00271024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25494421|NCT00271219|Buprenorphine|buprenorphine|mesh-list
25494422|NCT00271219|Methadone|methadone|mesh-list
25494423|NCT00271219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25494424|NCT00271219|Narcotics|narcotics|mesh-ancestor
25494425|NCT00271219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25494426|NCT00271219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494427|NCT00271219|Analgesics|analgesics|mesh-ancestor
25494428|NCT00271219|Sensory System Agents|sensory system agents|mesh-ancestor
25494429|NCT00271219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25494430|NCT00271219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25494431|NCT00271219|Antitussive Agents|antitussive agents|mesh-ancestor
25494432|NCT00271219|Respiratory System Agents|respiratory system agents|mesh-ancestor
25494433|NCT00271505|Bevacizumab|bevacizumab|mesh-list
25494434|NCT00271505|Carboplatin|carboplatin|mesh-list
25494435|NCT00271505|Docetaxel|docetaxel|mesh-list
25494436|NCT00271505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25494437|NCT00271505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494438|NCT00271505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25494439|NCT00271505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25494440|NCT00271505|Growth Substances|growth substances|mesh-ancestor
25494441|NCT00271505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494442|NCT00271505|Growth Inhibitors|growth inhibitors|mesh-ancestor
25494443|NCT00271505|Tubulin Modulators|tubulin modulators|mesh-ancestor
25494444|NCT00271505|Antimitotic Agents|antimitotic agents|mesh-ancestor
25494445|NCT00271505|Mitosis Modulators|mitosis modulators|mesh-ancestor
25494446|NCT00271505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494447|NCT00271570|Infliximab|infliximab|mesh-list
25494448|NCT00271570|Immunoglobulins|immunoglobulins|mesh-list
25494449|NCT00271570|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25494450|NCT00271570|Antibodies|antibodies|mesh-list
25494451|NCT00271570|gamma-Globulins|gamma-globulins|mesh-list
25494452|NCT00271570|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25494453|NCT00271570|Immunologic Factors|immunologic factors|mesh-ancestor
25494454|NCT00271570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146753|NCT02919371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146754|NCT02919371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146755|NCT02919202|Listerine|listerine|mesh-list
25494455|NCT00271570|Dermatologic Agents|dermatologic agents|mesh-ancestor
25494456|NCT00271570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25494457|NCT00271570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25494458|NCT00271596|Citalopram|citalopram|mesh-list
25494459|NCT00271596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25494460|NCT00271596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25494461|NCT00271596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25494462|NCT00271596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494463|NCT00271596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25494464|NCT00271596|Serotonin Agents|serotonin agents|mesh-ancestor
25494465|NCT00271596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494466|NCT00271596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25494467|NCT00271596|Antidepressive Agents|antidepressive agents|mesh-ancestor
25494468|NCT00271596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25494469|NCT00271609|Bevacizumab|bevacizumab|mesh-list
25494470|NCT00271609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25494471|NCT00271609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494472|NCT00271609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25494473|NCT00271609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25494474|NCT00271609|Growth Substances|growth substances|mesh-ancestor
25494475|NCT00271609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494476|NCT00271609|Growth Inhibitors|growth inhibitors|mesh-ancestor
25494477|NCT00272038|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25494478|NCT00272038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494479|NCT00272038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25494480|NCT00272038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494481|NCT00272038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494482|NCT00272311|Aspirin|aspirin|mesh-list
25494483|NCT00272311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25494484|NCT00272311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25494485|NCT00272311|Analgesics|analgesics|mesh-ancestor
25494486|NCT00272311|Sensory System Agents|sensory system agents|mesh-ancestor
25494487|NCT00272311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25494488|NCT00272311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494489|NCT00272311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25494490|NCT00272311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25494491|NCT00272311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25494492|NCT00272311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25494493|NCT00272311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494494|NCT00272311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25494495|NCT00272311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25494496|NCT00272311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494497|NCT00272311|Antipyretics|antipyretics|mesh-ancestor
25494498|NCT00272337|Aspirin|aspirin|mesh-list
25494499|NCT00272337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25494500|NCT00272337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25494501|NCT00272337|Analgesics|analgesics|mesh-ancestor
25494502|NCT00272337|Sensory System Agents|sensory system agents|mesh-ancestor
25494503|NCT00272337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25494504|NCT00272337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494505|NCT00272337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25494506|NCT00272337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25494507|NCT00272337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25494508|NCT00272337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25494509|NCT00272337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494510|NCT00272337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25494511|NCT00272337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25494512|NCT00272337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494513|NCT00272337|Antipyretics|antipyretics|mesh-ancestor
25494514|NCT00272779|Emtricitabine|emtricitabine|mesh-list
25494515|NCT00272779|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25494516|NCT00272779|Antiviral Agents|antiviral agents|mesh-ancestor
25494517|NCT00272779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25494518|NCT00272779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25494519|NCT00272779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25494520|NCT00272779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494521|NCT00272779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494522|NCT00272779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25494523|NCT00272779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25494524|NCT00272779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25494525|NCT00272779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25494526|NCT00272779|Protease Inhibitors|protease inhibitors|mesh-ancestor
25494527|NCT00272792|Verapamil|verapamil|mesh-list
25147118|NCT02916173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25494528|NCT00272792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25494529|NCT00272792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25494530|NCT00272792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25494531|NCT00272792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494532|NCT00272792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25494533|NCT00272792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494534|NCT00272792|Vasodilator Agents|vasodilator agents|mesh-ancestor
25494535|NCT00272961|N-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide|n-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide|mesh-list
25494536|NCT00272961|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25494537|NCT00272961|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25494538|NCT00272961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494540|NCT00272987|Trastuzumab|trastuzumab|mesh-list
25494541|NCT00272987|Lapatinib|lapatinib|mesh-list
25494542|NCT00272987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25494543|NCT00272987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494544|NCT00272987|Tubulin Modulators|tubulin modulators|mesh-ancestor
25494545|NCT00272987|Antimitotic Agents|antimitotic agents|mesh-ancestor
25494546|NCT00272987|Mitosis Modulators|mitosis modulators|mesh-ancestor
25494547|NCT00272987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494548|NCT00272987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25494549|NCT00272987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25494550|NCT00272987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494551|NCT00273052|Metoprolol|metoprolol|mesh-list
25494552|NCT00273052|Carvedilol|carvedilol|mesh-list
25408065|NCT03459222|Nivolumab|nivolumab|mesh-list
25494553|NCT00273052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25494554|NCT00273052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25494555|NCT00273052|Sympatholytics|sympatholytics|mesh-ancestor
25494556|NCT00273052|Autonomic Agents|autonomic agents|mesh-ancestor
25494557|NCT00273052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25494558|NCT00273052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494559|NCT00273052|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25494560|NCT00273052|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25494561|NCT00273052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25494562|NCT00273052|Adrenergic Agents|adrenergic agents|mesh-ancestor
25494563|NCT00273052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25494564|NCT00273052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494565|NCT00273052|Antioxidants|antioxidants|mesh-ancestor
25494566|NCT00273052|Protective Agents|protective agents|mesh-ancestor
25494567|NCT00273052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25494568|NCT00273052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25494569|NCT00273052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25494570|NCT00273052|Vasodilator Agents|vasodilator agents|mesh-ancestor
25494571|NCT00273052|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25494572|NCT00273052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25494573|NCT00273754|Caffeine|caffeine|mesh-list
25494574|NCT00273754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25494575|NCT00273754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494576|NCT00273754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25494577|NCT00273754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494578|NCT00273754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494579|NCT00273754|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25494580|NCT00273754|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25494581|NCT00273754|Purinergic Agents|purinergic agents|mesh-ancestor
25494582|NCT00273754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25494583|NCT00273910|Imiquimod|imiquimod|mesh-list
25494584|NCT00273910|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25494585|NCT00273910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25494586|NCT00273910|Immunologic Factors|immunologic factors|mesh-ancestor
25494587|NCT00273910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494588|NCT00273910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494589|NCT00273910|Interferon Inducers|interferon inducers|mesh-ancestor
25494590|NCT00274261|Nonoxynol|nonoxynol|mesh-list
25494591|NCT00274261|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
25494592|NCT00274261|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
25494593|NCT00274261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494594|NCT00274261|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25494595|NCT00274261|Contraceptive Agents|contraceptive agents|mesh-ancestor
25147201|NCT02915289|Plasma Substitutes|plasma substitutes|mesh-ancestor
25147202|NCT02915289|Blood Substitutes|blood substitutes|mesh-ancestor
25147229|NCT02915055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25494596|NCT00274261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25494597|NCT00274261|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25494598|NCT00274287|Sargramostim|sargramostim|mesh-list
25494599|NCT00274287|Immunologic Factors|immunologic factors|mesh-ancestor
25494600|NCT00274287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494601|NCT00274456|Paclitaxel|paclitaxel|mesh-list
25494602|NCT00274456|Docetaxel|docetaxel|mesh-list
25494603|NCT00274456|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25494604|NCT00274456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25494605|NCT00274456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494606|NCT00274456|Tubulin Modulators|tubulin modulators|mesh-ancestor
25494607|NCT00274456|Antimitotic Agents|antimitotic agents|mesh-ancestor
25494608|NCT00274456|Mitosis Modulators|mitosis modulators|mesh-ancestor
25494609|NCT00274456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494610|NCT00274469|Fulvestrant|fulvestrant|mesh-list
25494611|NCT00274469|Anastrozole|anastrozole|mesh-list
25494612|NCT00274469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25494613|NCT00274469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494614|NCT00274469|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25494615|NCT00274469|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25494616|NCT00274469|Hormone Antagonists|hormone antagonists|mesh-ancestor
25494617|NCT00274469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25494618|NCT00274469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494619|NCT00274469|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25494620|NCT00274469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25494621|NCT00274469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494622|NCT00274469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494623|NCT00274651|Belinostat|belinostat|mesh-list
25494624|NCT00274651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494625|NCT00274651|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25494626|NCT00274651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494627|NCT00274651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494628|NCT00274742|Blinatumomab|blinatumomab|mesh-list
25494629|NCT00274742|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25494630|NCT00274742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494631|NCT00274742|Immunologic Factors|immunologic factors|mesh-ancestor
25494632|NCT00274742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494633|NCT00274768|Capecitabine|capecitabine|mesh-list
25494634|NCT00274768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25494635|NCT00274768|Antimetabolites|antimetabolites|mesh-ancestor
25494636|NCT00274768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494637|NCT00274768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494638|NCT00274781|Arsenic Trioxide|arsenic trioxide|mesh-list
25494639|NCT00274781|Gemtuzumab|gemtuzumab|mesh-list
25494640|NCT00274781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494641|NCT00274781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25494642|NCT00274846|Aldesleukin|aldesleukin|mesh-list
25494643|NCT00274846|Cyclophosphamide|cyclophosphamide|mesh-list
25494644|NCT00274846|Fludarabine|fludarabine|mesh-list
25494645|NCT00274846|Fludarabine phosphate|fludarabine phosphate|mesh-list
25494646|NCT00274846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25494647|NCT00274846|Immunologic Factors|immunologic factors|mesh-ancestor
25494648|NCT00274846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494649|NCT00274846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25494650|NCT00274846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25494651|NCT00274846|Alkylating Agents|alkylating agents|mesh-ancestor
25494652|NCT00274846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494653|NCT00274846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494654|NCT00274846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25494655|NCT00274846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25494656|NCT00274846|Antimetabolites|antimetabolites|mesh-ancestor
25494657|NCT00274846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25494658|NCT00274846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25494659|NCT00274846|Antiviral Agents|antiviral agents|mesh-ancestor
25494660|NCT00274846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25147353|NCT02914028|Acetaminophen|acetaminophen|mesh-list
25147354|NCT02914028|Tramadol|tramadol|mesh-list
25147355|NCT02914028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25147356|NCT02914028|Analgesics|analgesics|mesh-ancestor
25147357|NCT02914028|Sensory System Agents|sensory system agents|mesh-ancestor
25147358|NCT02914028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25147359|NCT02914028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147360|NCT02914028|Antipyretics|antipyretics|mesh-ancestor
25147361|NCT02914028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25494661|NCT00274924|Prednisone|prednisone|mesh-list
25494662|NCT00274924|Cyclophosphamide|cyclophosphamide|mesh-list
25494664|NCT00274924|Rituximab|rituximab|mesh-list
25494665|NCT00274924|Carboplatin|carboplatin|mesh-list
25494666|NCT00274924|Doxorubicin|doxorubicin|mesh-list
25494667|NCT00274924|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25494668|NCT00274924|Etoposide|etoposide|mesh-list
25494669|NCT00274924|Vincristine|vincristine|mesh-list
25494670|NCT00274924|Podophyllotoxin|podophyllotoxin|mesh-list
25494671|NCT00274924|Lenograstim|lenograstim|mesh-list
25494672|NCT00274924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25494673|NCT00274924|Immunologic Factors|immunologic factors|mesh-ancestor
25494674|NCT00274924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494675|NCT00274924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25494676|NCT00274924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25494677|NCT00274924|Alkylating Agents|alkylating agents|mesh-ancestor
25494678|NCT00274924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494679|NCT00274924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494680|NCT00274924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25494681|NCT00274924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25494682|NCT00274924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25494683|NCT00274924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25494684|NCT00274924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25494685|NCT00274924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494686|NCT00274924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25494687|NCT00274924|Glucocorticoids|glucocorticoids|mesh-ancestor
25494688|NCT00274924|Hormones|hormones|mesh-ancestor
25494689|NCT00274924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25494690|NCT00274924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25494691|NCT00274924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25494692|NCT00274924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25494693|NCT00274924|Tubulin Modulators|tubulin modulators|mesh-ancestor
25494694|NCT00274924|Antimitotic Agents|antimitotic agents|mesh-ancestor
25494695|NCT00274924|Mitosis Modulators|mitosis modulators|mesh-ancestor
25494696|NCT00274924|Keratolytic Agents|keratolytic agents|mesh-ancestor
25494697|NCT00274924|Dermatologic Agents|dermatologic agents|mesh-ancestor
25494698|NCT00275002|Temozolomide|temozolomide|mesh-list
25494699|NCT00275002|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
25494700|NCT00275002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25645410|NCT01447849|Lubiprostone|lubiprostone|mesh-list
25494701|NCT00275002|Alkylating Agents|alkylating agents|mesh-ancestor
25645412|NCT01447849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25494702|NCT00275002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494703|NCT00275002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494704|NCT00275002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494705|NCT00275028|Cediranib|cediranib|mesh-list
25494706|NCT00275028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494707|NCT00275028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494708|NCT00275028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494709|NCT00275028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25494710|NCT00275262|Leuprolide|leuprolide|mesh-list
25494711|NCT00275262|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25494712|NCT00275262|Fertility Agents|fertility agents|mesh-ancestor
25494713|NCT00275262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25494714|NCT00275262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494715|NCT00275262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25494716|NCT00275262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494717|NCT00275275|Pramipexole|pramipexole|mesh-list
25494718|NCT00275275|Ropinirole|ropinirole|mesh-list
25494719|NCT00275275|Antioxidants|antioxidants|mesh-ancestor
25494720|NCT00275275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494721|NCT00275275|Protective Agents|protective agents|mesh-ancestor
25494722|NCT00275275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494723|NCT00275275|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25494724|NCT00275275|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25494725|NCT00275275|Dopamine Agonists|dopamine agonists|mesh-ancestor
25494726|NCT00275275|Dopamine Agents|dopamine agents|mesh-ancestor
25494727|NCT00275275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25494728|NCT00275301|Olanzapine|olanzapine|mesh-list
25494729|NCT00275301|Antiemetics|antiemetics|mesh-ancestor
25494730|NCT00275301|Autonomic Agents|autonomic agents|mesh-ancestor
25494731|NCT00275301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25494732|NCT00275301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494733|NCT00275301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25494734|NCT00275301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25494735|NCT00275301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25494736|NCT00275301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25494737|NCT00275301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25494738|NCT00275301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25494739|NCT00275301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25494740|NCT00275301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25494741|NCT00275301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494742|NCT00275301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25494743|NCT00275301|Serotonin Agents|serotonin agents|mesh-ancestor
25494744|NCT00275509|Mycophenolic Acid|mycophenolic acid|mesh-list
25494745|NCT00275509|Dexamethasone|dexamethasone|mesh-list
25494746|NCT00275509|Prednisone|prednisone|mesh-list
25494747|NCT00275509|Tacrolimus|tacrolimus|mesh-list
25494748|NCT00275509|Thymoglobulin|thymoglobulin|mesh-list
25494749|NCT00275509|Daclizumab|daclizumab|mesh-list
25494750|NCT00275509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25494751|NCT00275509|Antiemetics|antiemetics|mesh-ancestor
25494752|NCT00275509|Autonomic Agents|autonomic agents|mesh-ancestor
25494753|NCT00275509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25494754|NCT00275509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494755|NCT00275509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25494756|NCT00275509|Glucocorticoids|glucocorticoids|mesh-ancestor
25494757|NCT00275509|Hormones|hormones|mesh-ancestor
25494758|NCT00275509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25494759|NCT00275509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25494760|NCT00275509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494761|NCT00275509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25494762|NCT00275509|Immunologic Factors|immunologic factors|mesh-ancestor
25494763|NCT00275509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25494764|NCT00275509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494765|NCT00275509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494766|NCT00275509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25494767|NCT00275509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25494768|NCT00275509|Antitubercular Agents|antitubercular agents|mesh-ancestor
25494769|NCT00275509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25494770|NCT00275509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25494771|NCT00275561|Fluticasone|fluticasone|mesh-list
25494772|NCT00275561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25494773|NCT00275561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25494774|NCT00275561|Autonomic Agents|autonomic agents|mesh-ancestor
25494775|NCT00275561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25494776|NCT00275561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494778|NCT00275561|Respiratory System Agents|respiratory system agents|mesh-ancestor
25494779|NCT00275561|Dermatologic Agents|dermatologic agents|mesh-ancestor
25494780|NCT00275561|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25494781|NCT00275821|Ranibizumab|ranibizumab|mesh-list
25494782|NCT00275821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25494783|NCT00275821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25494784|NCT00275821|Growth Substances|growth substances|mesh-ancestor
25494785|NCT00275821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494786|NCT00275821|Growth Inhibitors|growth inhibitors|mesh-ancestor
25494787|NCT00275821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494788|NCT00275834|Zonisamide|zonisamide|mesh-list
25494789|NCT00275834|Anticonvulsants|anticonvulsants|mesh-ancestor
25494790|NCT00275834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25494791|NCT00275834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25494792|NCT00275834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494793|NCT00275834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25494794|NCT00275834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494795|NCT00276094|Tamoxifen|tamoxifen|mesh-list
25494796|NCT00276094|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25494797|NCT00276094|Hormone Antagonists|hormone antagonists|mesh-ancestor
25494798|NCT00276094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25494799|NCT00276094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494800|NCT00276094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25494801|NCT00276094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494802|NCT00276094|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25494803|NCT00276094|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25494804|NCT00276094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25494805|NCT00276250|Abatacept|abatacept|mesh-list
25494806|NCT00276250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25029719|NCT03600974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25147637|NCT02912247|Immunologic Factors|immunologic factors|mesh-ancestor
25147638|NCT02912247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147639|NCT02912247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25147640|NCT02912247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25147641|NCT02912234|Clarithromycin|clarithromycin|mesh-list
25494807|NCT00276250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494808|NCT00276250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494809|NCT00276250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25494810|NCT00276250|Immunologic Factors|immunologic factors|mesh-ancestor
25494811|NCT00276250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494812|NCT00276250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25494813|NCT00276380|Aspirin|aspirin|mesh-list
25494814|NCT00276380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25494815|NCT00276380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25494816|NCT00276380|Analgesics|analgesics|mesh-ancestor
25494817|NCT00276380|Sensory System Agents|sensory system agents|mesh-ancestor
25494818|NCT00276380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25494819|NCT00276380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494820|NCT00276380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25494821|NCT00276380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25494822|NCT00276380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25494823|NCT00276380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25494824|NCT00276380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494825|NCT00276380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25494826|NCT00276380|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25494827|NCT00276380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494828|NCT00276380|Antipyretics|antipyretics|mesh-ancestor
25494829|NCT00276406|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
25494830|NCT00276406|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25494831|NCT00276406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494832|NCT00276406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494833|NCT00276406|Cholinergic Agents|cholinergic agents|mesh-ancestor
25494834|NCT00276406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25494835|NCT00276406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494836|NCT00276549|Gemcitabine|gemcitabine|mesh-list
25494837|NCT00276549|Docetaxel|docetaxel|mesh-list
25494838|NCT00276549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25494839|NCT00276549|Antimetabolites|antimetabolites|mesh-ancestor
25494840|NCT00276549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645413|NCT01447849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494841|NCT00276549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494842|NCT00276549|Antiviral Agents|antiviral agents|mesh-ancestor
25494843|NCT00276549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25494844|NCT00276549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494845|NCT00276549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25494846|NCT00276549|Immunologic Factors|immunologic factors|mesh-ancestor
25494847|NCT00276549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494848|NCT00276549|Tubulin Modulators|tubulin modulators|mesh-ancestor
25494849|NCT00276549|Antimitotic Agents|antimitotic agents|mesh-ancestor
25494850|NCT00276549|Mitosis Modulators|mitosis modulators|mesh-ancestor
25494851|NCT00276614|Bortezomib|bortezomib|mesh-list
25494852|NCT00276614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494853|NCT00276744|Gemcitabine|gemcitabine|mesh-list
25494854|NCT00276744|Sirolimus|sirolimus|mesh-list
25494855|NCT00276744|Capecitabine|capecitabine|mesh-list
25494856|NCT00276744|Docetaxel|docetaxel|mesh-list
25494857|NCT00276744|Irinotecan|irinotecan|mesh-list
25494858|NCT00276744|Cetuximab|cetuximab|mesh-list
25494859|NCT00276744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25494860|NCT00276744|Mitomycins|mitomycins|mesh-list
25494861|NCT00276744|Mitomycin|mitomycin|mesh-list
25494862|NCT00276744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25494863|NCT00276744|Antimetabolites|antimetabolites|mesh-ancestor
25494864|NCT00276744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494865|NCT00276744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494866|NCT00276744|Antiviral Agents|antiviral agents|mesh-ancestor
25494867|NCT00276744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25494868|NCT00276744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494869|NCT00276744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25494870|NCT00276744|Immunologic Factors|immunologic factors|mesh-ancestor
25494871|NCT00276744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494872|NCT00276744|Tubulin Modulators|tubulin modulators|mesh-ancestor
25494873|NCT00276744|Antimitotic Agents|antimitotic agents|mesh-ancestor
25494874|NCT00276744|Mitosis Modulators|mitosis modulators|mesh-ancestor
25494875|NCT00276744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25494876|NCT00276744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25494877|NCT00276744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25494878|NCT00276744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25494879|NCT00276744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25494880|NCT00276744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25494881|NCT00276744|Antifungal Agents|antifungal agents|mesh-ancestor
25494882|NCT00276744|Alkylating Agents|alkylating agents|mesh-ancestor
25147771|NCT02910518|Insulin, Isophane|insulin, isophane|mesh-list
25494883|NCT00276744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25494884|NCT00276861|Gemcitabine|gemcitabine|mesh-list
25494885|NCT00276861|Oxaliplatin|oxaliplatin|mesh-list
25494886|NCT00276861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25494887|NCT00276861|Antimetabolites|antimetabolites|mesh-ancestor
25494888|NCT00276861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494889|NCT00276861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494890|NCT00276861|Antiviral Agents|antiviral agents|mesh-ancestor
25494891|NCT00276861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25494892|NCT00276861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494893|NCT00276861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25494894|NCT00276861|Immunologic Factors|immunologic factors|mesh-ancestor
25494895|NCT00276861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494896|NCT00277212|Lamotrigine|lamotrigine|mesh-list
25494897|NCT00277212|Anticonvulsants|anticonvulsants|mesh-list
25494898|NCT00277212|Aripiprazole|aripiprazole|mesh-list
25494899|NCT00277212|Antidepressive Agents|antidepressive agents|mesh-ancestor
25494900|NCT00277212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25494901|NCT00277212|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25494902|NCT00277212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25494903|NCT00277212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25494904|NCT00277212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494905|NCT00277212|Dopamine Agonists|dopamine agonists|mesh-ancestor
25494906|NCT00277212|Dopamine Agents|dopamine agents|mesh-ancestor
25494907|NCT00277212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25494908|NCT00277212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494909|NCT00277212|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25494910|NCT00277212|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25494911|NCT00277212|Serotonin Agents|serotonin agents|mesh-ancestor
25494912|NCT00277212|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25494913|NCT00277212|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25494914|NCT00277212|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25494915|NCT00277212|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25494916|NCT00277212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25494917|NCT00277212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25494918|NCT00277212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25494919|NCT00277212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25494920|NCT00277355|Minocycline|minocycline|mesh-list
25494921|NCT00277355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25494922|NCT00277355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25494923|NCT00277394|Heparin|heparin|mesh-list
25494924|NCT00277394|Tinzaparin|tinzaparin|mesh-list
25494925|NCT00277394|Anticoagulants|anticoagulants|mesh-ancestor
25494926|NCT00277394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25494927|NCT00277394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25494928|NCT00277394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494929|NCT00278109|Cyclophosphamide|cyclophosphamide|mesh-list
25494930|NCT00278109|Doxorubicin|doxorubicin|mesh-list
25494931|NCT00278109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25494932|NCT00278109|Immunologic Factors|immunologic factors|mesh-ancestor
25494933|NCT00278109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25494934|NCT00278109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25494935|NCT00278109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25494936|NCT00278109|Alkylating Agents|alkylating agents|mesh-ancestor
25494937|NCT00278109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494938|NCT00278109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494939|NCT00278109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25494940|NCT00278109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25494941|NCT00278109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25494942|NCT00278109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25494943|NCT00278109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494944|NCT00278148|Paclitaxel|paclitaxel|mesh-list
25494945|NCT00278148|Carboplatin|carboplatin|mesh-list
25494946|NCT00278148|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25494947|NCT00278148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25494948|NCT00278148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25494949|NCT00278148|Tubulin Modulators|tubulin modulators|mesh-ancestor
25494950|NCT00278148|Antimitotic Agents|antimitotic agents|mesh-ancestor
25494951|NCT00278148|Mitosis Modulators|mitosis modulators|mesh-ancestor
25494952|NCT00278148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25494953|NCT00278148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25494954|NCT00278148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25494955|NCT00278161|Cyclophosphamide|cyclophosphamide|mesh-list
25494956|NCT00278161|Rituximab|rituximab|mesh-list
25147970|NCT02909465|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25148113|NCT05312242|Trace Elements|trace elements|mesh-list
25148176|NCT05311722|Tramadol|tramadol|mesh-list
25148177|NCT05311722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25148178|NCT05311722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25113222|NCT03240211|Antimetabolites|antimetabolites|mesh-ancestor
25148179|NCT05311722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148180|NCT05311722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25494989|NCT00278564|Methylprednisolone|methylprednisolone|mesh-list
25494990|NCT00278564|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25494991|NCT00278564|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25494992|NCT00278564|Prednisolone|prednisolone|mesh-list
25494993|NCT00278564|Prednisolone acetate|prednisolone acetate|mesh-list
25494994|NCT00278564|Cyclophosphamide|cyclophosphamide|mesh-list
25494995|NCT00278564|Rituximab|rituximab|mesh-list
25494996|NCT00278564|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25494997|NCT00278564|Prednisolone phosphate|prednisolone phosphate|mesh-list
25494998|NCT00278564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25494999|NCT00278564|Immunologic Factors|immunologic factors|mesh-ancestor
25495000|NCT00278564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495001|NCT00278564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25495002|NCT00278564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25495003|NCT00278564|Alkylating Agents|alkylating agents|mesh-ancestor
25495004|NCT00278564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495005|NCT00278564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495006|NCT00278564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25495007|NCT00278564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25495008|NCT00278564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25495009|NCT00278564|Antiemetics|antiemetics|mesh-ancestor
25495010|NCT00278564|Autonomic Agents|autonomic agents|mesh-ancestor
25495011|NCT00278564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25495012|NCT00278564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25495013|NCT00278564|Glucocorticoids|glucocorticoids|mesh-ancestor
25495014|NCT00278564|Hormones|hormones|mesh-ancestor
25495015|NCT00278564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25495016|NCT00278564|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25495017|NCT00278564|Protective Agents|protective agents|mesh-ancestor
25495018|NCT00278564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25495019|NCT00278863|Capecitabine|capecitabine|mesh-list
25495020|NCT00278863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25495021|NCT00278863|Antimetabolites|antimetabolites|mesh-ancestor
25495022|NCT00278863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495023|NCT00278863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495024|NCT00278876|Imatinib Mesylate|imatinib mesylate|mesh-list
25495025|NCT00278876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495026|NCT00278876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25495027|NCT00278876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495028|NCT00278876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495029|NCT00278889|Leucovorin|leucovorin|mesh-list
25495030|NCT00278889|Bevacizumab|bevacizumab|mesh-list
25495031|NCT00278889|Fluorouracil|fluorouracil|mesh-list
25495032|NCT00278889|Oxaliplatin|oxaliplatin|mesh-list
25495033|NCT00278889|Cediranib|cediranib|mesh-list
25495034|NCT00278889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25495035|NCT00278889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495036|NCT00278889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25495037|NCT00278889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25495038|NCT00278889|Growth Substances|growth substances|mesh-ancestor
25495039|NCT00278889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495040|NCT00278889|Growth Inhibitors|growth inhibitors|mesh-ancestor
25495041|NCT00278889|Antimetabolites|antimetabolites|mesh-ancestor
25495042|NCT00278889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495043|NCT00278889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25495044|NCT00278889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25495045|NCT00278889|Immunologic Factors|immunologic factors|mesh-ancestor
25495046|NCT00278889|Antidotes|antidotes|mesh-ancestor
25495047|NCT00278889|Protective Agents|protective agents|mesh-ancestor
25495048|NCT00278889|Vitamin B Complex|vitamin b complex|mesh-ancestor
25495049|NCT00278889|Vitamins|vitamins|mesh-ancestor
25495050|NCT00278889|Micronutrients|micronutrients|mesh-ancestor
25495051|NCT00278889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25495052|NCT00278889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495053|NCT00278954|Immunoglobulins|immunoglobulins|mesh-list
25495054|NCT00278954|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25495055|NCT00278954|Antibodies|antibodies|mesh-list
25495056|NCT00278954|gamma-Globulins|gamma-globulins|mesh-list
25495057|NCT00278954|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25148303|NCT05247268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25148304|NCT05247268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148305|NCT05247268|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24766297|NCT01794091|Eplerenone|eplerenone|mesh-list
25148333|NCT05194592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148334|NCT05194592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25148335|NCT05194592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495058|NCT00278954|Immunologic Factors|immunologic factors|mesh-ancestor
25495059|NCT00278954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495060|NCT00279201|Insulin Glargine|insulin glargine|mesh-list
25495061|NCT00279201|Insulin Lispro|insulin lispro|mesh-list
25495062|NCT00279201|Insulin, Isophane|insulin, isophane|mesh-list
25495063|NCT00279201|Biphasic Insulins|biphasic insulins|mesh-list
25495064|NCT00279201|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
25495065|NCT00279201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25495066|NCT00279201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495067|NCT00279214|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
25495068|NCT00279214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25495069|NCT00279305|Rituximab|rituximab|mesh-list
25495070|NCT00279305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25495071|NCT00279305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495072|NCT00279305|Immunologic Factors|immunologic factors|mesh-ancestor
25495073|NCT00279305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495074|NCT00279305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25495075|NCT00279708|Atorvastatin|atorvastatin|mesh-list
25495076|NCT00279708|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25495077|NCT00279708|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25495078|NCT00279708|Antimetabolites|antimetabolites|mesh-ancestor
25495079|NCT00279708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495080|NCT00279708|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25495081|NCT00279708|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25495082|NCT00279708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495083|NCT00279812|Selenium|selenium|mesh-list
25495084|NCT00279812|Antioxidants|antioxidants|mesh-ancestor
25645414|NCT01447888|Morphine|morphine|mesh-list
25495085|NCT00279812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495086|NCT00279812|Protective Agents|protective agents|mesh-ancestor
25495087|NCT00279812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495088|NCT00279812|Trace Elements|trace elements|mesh-ancestor
25495089|NCT00279812|Micronutrients|micronutrients|mesh-ancestor
25495090|NCT00279916|Triamcinolone|triamcinolone|mesh-list
25495091|NCT00279916|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25495092|NCT00279916|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25495093|NCT00279916|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25495094|NCT00279916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25495095|NCT00279916|Glucocorticoids|glucocorticoids|mesh-ancestor
25495096|NCT00279916|Hormones|hormones|mesh-ancestor
25495097|NCT00279916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25495098|NCT00279916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495099|NCT00279916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25495100|NCT00279916|Immunologic Factors|immunologic factors|mesh-ancestor
25495101|NCT00279916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495102|NCT00279916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495103|NCT00280059|Pregabalin|pregabalin|mesh-list
25495104|NCT00280059|Lamotrigine|lamotrigine|mesh-list
25495105|NCT00280059|Analgesics|analgesics|mesh-ancestor
25495106|NCT00280059|Sensory System Agents|sensory system agents|mesh-ancestor
25495107|NCT00280059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25495108|NCT00280059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495109|NCT00280059|Anticonvulsants|anticonvulsants|mesh-ancestor
25495110|NCT00280059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25495111|NCT00280059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25495112|NCT00280059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495113|NCT00280059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25495114|NCT00280059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25495115|NCT00280059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25495116|NCT00280059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25495117|NCT00280059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25495118|NCT00280059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25495119|NCT00280059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25495120|NCT00280150|Paclitaxel|paclitaxel|mesh-list
25495121|NCT00280150|Bevacizumab|bevacizumab|mesh-list
25495122|NCT00280150|Carboplatin|carboplatin|mesh-list
25495123|NCT00280150|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25495124|NCT00280150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25148489|NCT05046535|Autonomic Agents|autonomic agents|mesh-ancestor
25148490|NCT05046535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25148491|NCT05046535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148492|NCT05046535|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25148493|NCT05046535|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25148494|NCT05046535|Cholinergic Agents|cholinergic agents|mesh-ancestor
25148495|NCT05046535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25823162|NCT00004759|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25495126|NCT00280150|Tubulin Modulators|tubulin modulators|mesh-ancestor
25495127|NCT00280150|Antimitotic Agents|antimitotic agents|mesh-ancestor
25495128|NCT00280150|Mitosis Modulators|mitosis modulators|mesh-ancestor
25495129|NCT00280150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495130|NCT00280150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25495131|NCT00280150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25495132|NCT00280150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25495133|NCT00280150|Growth Substances|growth substances|mesh-ancestor
25495134|NCT00280150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495135|NCT00280150|Growth Inhibitors|growth inhibitors|mesh-ancestor
25495136|NCT00280150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25495137|NCT00280150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495138|NCT00280241|Cyclophosphamide|cyclophosphamide|mesh-list
25495139|NCT00280241|Rituximab|rituximab|mesh-list
25495140|NCT00280241|Fludarabine|fludarabine|mesh-list
25495141|NCT00280241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25495142|NCT00280241|Immunologic Factors|immunologic factors|mesh-ancestor
25495143|NCT00280241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495144|NCT00280241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25495145|NCT00280241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25495146|NCT00280241|Alkylating Agents|alkylating agents|mesh-ancestor
25495147|NCT00280241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495148|NCT00280241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490240|NCT00477126|Ritonavir|ritonavir|mesh-list
25645415|NCT01447888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25645416|NCT01447888|Narcotics|narcotics|mesh-ancestor
25495149|NCT00280241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25495150|NCT00280241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25495151|NCT00280293|Lamotrigine|lamotrigine|mesh-list
25495152|NCT00280293|Anticonvulsants|anticonvulsants|mesh-ancestor
25495153|NCT00280293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25495154|NCT00280293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25495155|NCT00280293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495156|NCT00280293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25495157|NCT00280293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495158|NCT00280293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25495159|NCT00280293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25495160|NCT00280293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25495161|NCT00280293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25495162|NCT00280293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25495163|NCT00280384|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
25495164|NCT00280384|Botulinum Toxins|botulinum toxins|mesh-list
25495165|NCT00280384|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25495166|NCT00280384|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25495167|NCT00280384|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25495168|NCT00280384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25495169|NCT00280384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495170|NCT00280384|Cholinergic Agents|cholinergic agents|mesh-ancestor
25495171|NCT00280384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25495172|NCT00280384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495173|NCT00280384|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25495174|NCT00280384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25495175|NCT00280384|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25495177|NCT00280397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495178|NCT00280397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25495179|NCT00280397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495180|NCT00280397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495181|NCT00280566|Ziprasidone|ziprasidone|mesh-list
25495182|NCT00280566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25495183|NCT00280566|Serotonin Agents|serotonin agents|mesh-ancestor
25495184|NCT00280566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25495185|NCT00280566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148616|NCT04862143|Hormone Antagonists|hormone antagonists|mesh-ancestor
25148617|NCT04862143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25148618|NCT04862143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148619|NCT04858490|Diazepam|diazepam|mesh-list
25148620|NCT04858490|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25148649|NCT04844957|Ergocalciferols|ergocalciferols|mesh-list
25148650|NCT04844957|Cholecalciferol|cholecalciferol|mesh-list
25148651|NCT04844957|Vitamins|vitamins|mesh-list
25148652|NCT04844957|Micronutrients|micronutrients|mesh-ancestor
25148653|NCT04844957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148654|NCT04844957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25495186|NCT00280566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495188|NCT00280566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25495189|NCT00280566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25495190|NCT00280566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25495191|NCT00280566|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25495192|NCT00280566|Dopamine Agents|dopamine agents|mesh-ancestor
25495193|NCT00280735|Carboplatin|carboplatin|mesh-list
25495194|NCT00280735|Docetaxel|docetaxel|mesh-list
25495195|NCT00280735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495196|NCT00280735|Tubulin Modulators|tubulin modulators|mesh-ancestor
25495197|NCT00280735|Antimitotic Agents|antimitotic agents|mesh-ancestor
25495198|NCT00280735|Mitosis Modulators|mitosis modulators|mesh-ancestor
25495199|NCT00280735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495200|NCT00280748|Pemetrexed|pemetrexed|mesh-list
25495201|NCT00280748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495202|NCT00280748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495203|NCT00280748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495204|NCT00280748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25495205|NCT00280748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25495206|NCT00281021|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25495207|NCT00281021|Digoxin|digoxin|mesh-list
25495208|NCT00281021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495209|NCT00281021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25495210|NCT00281021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495211|NCT00281021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495212|NCT00281021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25495213|NCT00281021|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25495214|NCT00281021|Protective Agents|protective agents|mesh-ancestor
25495215|NCT00281021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495216|NCT00281528|Paclitaxel|paclitaxel|mesh-list
25495217|NCT00281528|Bevacizumab|bevacizumab|mesh-list
25495218|NCT00281528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25495219|NCT00281528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25495220|NCT00281528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495221|NCT00281528|Tubulin Modulators|tubulin modulators|mesh-ancestor
25495222|NCT00281528|Antimitotic Agents|antimitotic agents|mesh-ancestor
25495223|NCT00281528|Mitosis Modulators|mitosis modulators|mesh-ancestor
25495224|NCT00281528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495225|NCT00281528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25495226|NCT00281528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25495227|NCT00281528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25495228|NCT00281528|Growth Substances|growth substances|mesh-ancestor
25495229|NCT00281528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495230|NCT00281528|Growth Inhibitors|growth inhibitors|mesh-ancestor
25495231|NCT00281580|Amlodipine|amlodipine|mesh-list
25495232|NCT00281580|Telmisartan|telmisartan|mesh-list
25495233|NCT00281580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25495234|NCT00281580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25495235|NCT00281580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25495236|NCT00281580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495237|NCT00281580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25495238|NCT00281580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495239|NCT00281580|Vasodilator Agents|vasodilator agents|mesh-ancestor
25495240|NCT00281580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25495241|NCT00281580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25495242|NCT00281671|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25495243|NCT00281671|Natriuretic Agents|natriuretic agents|mesh-ancestor
25495244|NCT00281671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495245|NCT00281697|Bevacizumab|bevacizumab|mesh-list
25148729|NCT04660760|Immunoglobulins|immunoglobulins|mesh-list
25148730|NCT04660760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25148731|NCT04660760|Lexatumumab|lexatumumab|mesh-list
25148732|NCT04660760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25148733|NCT04660760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148734|NCT04660760|Tubulin Modulators|tubulin modulators|mesh-ancestor
25148735|NCT04660760|Antimitotic Agents|antimitotic agents|mesh-ancestor
25148736|NCT04660760|Mitosis Modulators|mitosis modulators|mesh-ancestor
25148737|NCT04660760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148739|NCT04660760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148740|NCT04660760|Antimetabolites|antimetabolites|mesh-ancestor
25148741|NCT04660760|Antiviral Agents|antiviral agents|mesh-ancestor
25148742|NCT04660760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25495246|NCT00281697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25495247|NCT00281697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495248|NCT00281697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25495249|NCT00281697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25495250|NCT00281697|Growth Substances|growth substances|mesh-ancestor
25495251|NCT00281697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495252|NCT00281697|Growth Inhibitors|growth inhibitors|mesh-ancestor
25495253|NCT00281827|Gemcitabine|gemcitabine|mesh-list
25495254|NCT00281827|Thalidomide|thalidomide|mesh-list
25495255|NCT00281827|Carboplatin|carboplatin|mesh-list
25495256|NCT00281827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495257|NCT00281827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25495258|NCT00281827|Antimetabolites|antimetabolites|mesh-ancestor
25495259|NCT00281827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495260|NCT00281827|Antiviral Agents|antiviral agents|mesh-ancestor
25495261|NCT00281827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25495262|NCT00281827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495263|NCT00281827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25495264|NCT00281827|Immunologic Factors|immunologic factors|mesh-ancestor
25495265|NCT00281827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495266|NCT00281827|Leprostatic Agents|leprostatic agents|mesh-ancestor
25495267|NCT00281827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25495268|NCT00281827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25495269|NCT00281827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25495270|NCT00281827|Growth Substances|growth substances|mesh-ancestor
25495271|NCT00281827|Growth Inhibitors|growth inhibitors|mesh-ancestor
25495272|NCT00281840|Bevacizumab|bevacizumab|mesh-list
25495273|NCT00281840|Docetaxel|docetaxel|mesh-list
25495274|NCT00281840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25495275|NCT00281840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495276|NCT00281840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25495277|NCT00281840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25495279|NCT00281840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495280|NCT00281840|Growth Inhibitors|growth inhibitors|mesh-ancestor
25495281|NCT00281840|Tubulin Modulators|tubulin modulators|mesh-ancestor
25495282|NCT00281840|Antimitotic Agents|antimitotic agents|mesh-ancestor
25495283|NCT00281840|Mitosis Modulators|mitosis modulators|mesh-ancestor
25495284|NCT00281840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495285|NCT00281918|Cyclophosphamide|cyclophosphamide|mesh-list
25495286|NCT00281918|Rituximab|rituximab|mesh-list
25495287|NCT00281918|Fludarabine|fludarabine|mesh-list
25495288|NCT00281918|Fludarabine phosphate|fludarabine phosphate|mesh-list
25495289|NCT00281918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25495290|NCT00281918|Immunologic Factors|immunologic factors|mesh-ancestor
25495291|NCT00281918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495292|NCT00281918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25495293|NCT00281918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25495294|NCT00281918|Alkylating Agents|alkylating agents|mesh-ancestor
25495295|NCT00281918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495296|NCT00281918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495297|NCT00281918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25495298|NCT00281918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25495299|NCT00281918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25495300|NCT00281918|Antimetabolites|antimetabolites|mesh-ancestor
25495301|NCT00281957|Sirolimus|sirolimus|mesh-list
25495302|NCT00281957|Sorafenib|sorafenib|mesh-list
25495303|NCT00281957|Tipifarnib|tipifarnib|mesh-list
25495304|NCT00281957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495305|NCT00281957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25495306|NCT00281957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495307|NCT00281957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495308|NCT00281957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25495309|NCT00281957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25495310|NCT00281957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25495311|NCT00281957|Antifungal Agents|antifungal agents|mesh-ancestor
25495312|NCT00281957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25495313|NCT00281957|Immunologic Factors|immunologic factors|mesh-ancestor
25495314|NCT00281957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495315|NCT00282048|Axitinib|axitinib|mesh-list
25495316|NCT00282048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495317|NCT00282048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25495318|NCT00282048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495319|NCT00282048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495320|NCT00282087|Gemcitabine|gemcitabine|mesh-list
25495321|NCT00282087|Docetaxel|docetaxel|mesh-list
25495322|NCT00282087|Doxorubicin|doxorubicin|mesh-list
25495323|NCT00282087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25495324|NCT00282087|Antimetabolites|antimetabolites|mesh-ancestor
25495325|NCT00282087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495326|NCT00282087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495327|NCT00282087|Antiviral Agents|antiviral agents|mesh-ancestor
25495328|NCT00282087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25495329|NCT00282087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495330|NCT00282087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25495331|NCT00282087|Immunologic Factors|immunologic factors|mesh-ancestor
25495332|NCT00282087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495333|NCT00282087|Tubulin Modulators|tubulin modulators|mesh-ancestor
25495334|NCT00282087|Antimitotic Agents|antimitotic agents|mesh-ancestor
25495335|NCT00282087|Mitosis Modulators|mitosis modulators|mesh-ancestor
25495336|NCT00282087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25495337|NCT00282087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25495338|NCT00282087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25495339|NCT00282243|Tacrolimus|tacrolimus|mesh-list
25495340|NCT00282243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25495341|NCT00282243|Immunologic Factors|immunologic factors|mesh-ancestor
25495342|NCT00282243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495343|NCT00282243|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25495344|NCT00282243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495345|NCT00282243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495346|NCT00282256|Tacrolimus|tacrolimus|mesh-list
25495347|NCT00282256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25495348|NCT00282256|Immunologic Factors|immunologic factors|mesh-ancestor
25645417|NCT01447888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25645418|NCT01447888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645419|NCT01447888|Analgesics|analgesics|mesh-ancestor
25495349|NCT00282256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495350|NCT00282256|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25495351|NCT00282256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495352|NCT00282256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495353|NCT00282282|Sirolimus|sirolimus|mesh-list
25495354|NCT00282282|Fludarabine|fludarabine|mesh-list
25495355|NCT00282282|Busulfan|busulfan|mesh-list
25495356|NCT00282282|Tacrolimus|tacrolimus|mesh-list
25495357|NCT00282282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495358|NCT00282282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495359|NCT00282282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25495360|NCT00282282|Immunologic Factors|immunologic factors|mesh-ancestor
25495361|NCT00282282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495362|NCT00282282|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25495363|NCT00282282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495364|NCT00282282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25495365|NCT00282282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25495366|NCT00282282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25495367|NCT00282282|Antifungal Agents|antifungal agents|mesh-ancestor
25495368|NCT00282282|Alkylating Agents|alkylating agents|mesh-ancestor
25495369|NCT00282282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25495370|NCT00282282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25495371|NCT00282308|Rituximab|rituximab|mesh-list
25495372|NCT00282308|Methotrexate|methotrexate|mesh-list
25495373|NCT00282308|Vaccines|vaccines|mesh-list
25495374|NCT00282308|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25495375|NCT00282308|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
25495376|NCT00282308|Immunologic Factors|immunologic factors|mesh-ancestor
25495377|NCT00282308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495378|NCT00282308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25495379|NCT00282308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495380|NCT00282308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25495381|NCT00282308|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25495382|NCT00282308|Abortifacient Agents|abortifacient agents|mesh-ancestor
25495383|NCT00282308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25495384|NCT00282308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25495385|NCT00282308|Antimetabolites|antimetabolites|mesh-ancestor
25495386|NCT00282308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495387|NCT00282308|Dermatologic Agents|dermatologic agents|mesh-ancestor
25495388|NCT00282308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495389|NCT00282308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25495390|NCT00282308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25149080|NCT04167670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25149081|NCT04167670|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25149082|NCT04167670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25149083|NCT04167670|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25149084|NCT04148495|Acetaminophen|acetaminophen|mesh-list
25495391|NCT00282308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25495392|NCT00282308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25495393|NCT00282347|Acetaminophen|acetaminophen|mesh-list
25495394|NCT00282347|Diphenhydramine|diphenhydramine|mesh-list
25495395|NCT00282347|Promethazine|promethazine|mesh-list
25495396|NCT00282347|Mycophenolic Acid|mycophenolic acid|mesh-list
25495397|NCT00282347|Prednisone|prednisone|mesh-list
25495398|NCT00282347|Methylprednisolone|methylprednisolone|mesh-list
25495399|NCT00282347|Rituximab|rituximab|mesh-list
25495400|NCT00282347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25495401|NCT00282347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495402|NCT00282347|Immunologic Factors|immunologic factors|mesh-ancestor
25495403|NCT00282347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495404|NCT00282347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25495405|NCT00282347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25495406|NCT00282347|Glucocorticoids|glucocorticoids|mesh-ancestor
25495407|NCT00282347|Hormones|hormones|mesh-ancestor
25495408|NCT00282347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25495409|NCT00282347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25495410|NCT00282347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25495411|NCT00282347|Analgesics|analgesics|mesh-ancestor
25495412|NCT00282347|Sensory System Agents|sensory system agents|mesh-ancestor
25495413|NCT00282347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25495414|NCT00282347|Antipyretics|antipyretics|mesh-ancestor
25495415|NCT00282347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24772218|NCT01832363|Xenon|xenon|mesh-list
25495416|NCT00282347|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25495418|NCT00282347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25495419|NCT00282347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25495420|NCT00282347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495421|NCT00282347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495422|NCT00282347|Antiemetics|antiemetics|mesh-ancestor
25495423|NCT00282347|Autonomic Agents|autonomic agents|mesh-ancestor
25495424|NCT00282347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25495425|NCT00282347|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25495426|NCT00282347|Protective Agents|protective agents|mesh-ancestor
25495427|NCT00282347|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25495428|NCT00282347|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25495429|NCT00282347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25495430|NCT00282347|Anesthetics, Local|anesthetics, local|mesh-ancestor
25495431|NCT00282347|Anesthetics|anesthetics|mesh-ancestor
25495432|NCT00282347|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25495433|NCT00282347|Histamine Antagonists|histamine antagonists|mesh-ancestor
25495434|NCT00282347|Histamine Agents|histamine agents|mesh-ancestor
25495435|NCT00282347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25495436|NCT00282347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25495437|NCT00282347|Antipruritics|antipruritics|mesh-ancestor
25495438|NCT00282347|Dermatologic Agents|dermatologic agents|mesh-ancestor
25495439|NCT00282412|Cyclosporine|cyclosporine|mesh-list
25495440|NCT00282412|Mycophenolic Acid|mycophenolic acid|mesh-list
25495441|NCT00282412|Cyclophosphamide|cyclophosphamide|mesh-list
25495442|NCT00282412|Fludarabine|fludarabine|mesh-list
25495443|NCT00282412|Alemtuzumab|alemtuzumab|mesh-list
25495444|NCT00282412|Cyclosporins|cyclosporins|mesh-list
25495445|NCT00282412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25495446|NCT00282412|Immunologic Factors|immunologic factors|mesh-ancestor
25495447|NCT00282412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495448|NCT00282412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25495449|NCT00282412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25495450|NCT00282412|Alkylating Agents|alkylating agents|mesh-ancestor
25495451|NCT00282412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495452|NCT00282412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495453|NCT00282412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25495454|NCT00282412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495455|NCT00282412|Antifungal Agents|antifungal agents|mesh-ancestor
25495456|NCT00282412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25149210|NCT03766581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25149211|NCT03732820|Olaparib|olaparib|mesh-list
25149212|NCT03732820|Abiraterone Acetate|abiraterone acetate|mesh-list
25149213|NCT03732820|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25149214|NCT03732820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25149215|NCT03732820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149216|NCT03732820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25149217|NCT03732820|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25149218|NCT03732820|Hormone Antagonists|hormone antagonists|mesh-ancestor
25149220|NCT03732820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495457|NCT00282412|Dermatologic Agents|dermatologic agents|mesh-ancestor
25495458|NCT00282412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25495459|NCT00282412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25495460|NCT00282412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25495461|NCT00282412|Antitubercular Agents|antitubercular agents|mesh-ancestor
25495462|NCT00282412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25495463|NCT00282412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25495464|NCT00282464|Ziprasidone|ziprasidone|mesh-list
25495465|NCT00282464|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25495466|NCT00282464|Serotonin Agents|serotonin agents|mesh-ancestor
25495467|NCT00282464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25495468|NCT00282464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495469|NCT00282464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495470|NCT00282464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25495471|NCT00282464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25495472|NCT00282464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25495473|NCT00282464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25495474|NCT00282464|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25495475|NCT00282464|Dopamine Agents|dopamine agents|mesh-ancestor
25495476|NCT00282568|Tacrolimus|tacrolimus|mesh-list
25495477|NCT00282568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25495478|NCT00282568|Immunologic Factors|immunologic factors|mesh-ancestor
25495479|NCT00282568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495480|NCT00282568|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25495482|NCT00282568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495483|NCT00282828|Clonazepam|clonazepam|mesh-list
25495484|NCT00282828|Sertraline|sertraline|mesh-list
25495485|NCT00282828|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25495486|NCT00282828|Antidepressive Agents|antidepressive agents|mesh-ancestor
25495487|NCT00282828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25495488|NCT00282828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25495489|NCT00282828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25495490|NCT00282828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25495491|NCT00282828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495492|NCT00282828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25495493|NCT00282828|Serotonin Agents|serotonin agents|mesh-ancestor
25495494|NCT00282828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495495|NCT00282828|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25495496|NCT00282828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25495497|NCT00282828|Anticonvulsants|anticonvulsants|mesh-ancestor
25495498|NCT00282828|GABA Modulators|gaba modulators|mesh-ancestor
25495499|NCT00282828|GABA Agents|gaba agents|mesh-ancestor
25495500|NCT00282919|Azithromycin|azithromycin|mesh-list
25495501|NCT00282919|Chloroquine|chloroquine|mesh-list
25495502|NCT00282919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25495503|NCT00282919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25495504|NCT00282919|Amebicides|amebicides|mesh-ancestor
25495505|NCT00282919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25495506|NCT00282919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25495507|NCT00282919|Antimalarials|antimalarials|mesh-ancestor
25495508|NCT00282919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25495509|NCT00282971|Insulin|insulin|mesh-list
25495510|NCT00282971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25495511|NCT00282971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495512|NCT00282984|Varenicline|varenicline|mesh-list
25495513|NCT00282984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25495514|NCT00282984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25495515|NCT00282984|Cholinergic Agents|cholinergic agents|mesh-ancestor
25495516|NCT00282984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25495517|NCT00282984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495518|NCT00282984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495519|NCT00283049|Insulin|insulin|mesh-list
25495520|NCT00283049|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25495521|NCT00283049|Insulin Glargine|insulin glargine|mesh-list
25495522|NCT00283049|Insulin glulisine|insulin glulisine|mesh-list
25495523|NCT00283049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25495524|NCT00283049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495525|NCT00283062|Docetaxel|docetaxel|mesh-list
25495526|NCT00283062|Leuprolide|leuprolide|mesh-list
25495527|NCT00283062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495528|NCT00283062|Tubulin Modulators|tubulin modulators|mesh-ancestor
25495529|NCT00283062|Antimitotic Agents|antimitotic agents|mesh-ancestor
25495530|NCT00283062|Mitosis Modulators|mitosis modulators|mesh-ancestor
25495531|NCT00283062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495532|NCT00283062|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25149469|NCT05467436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149471|NCT05467436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25495537|NCT00283244|Gemcitabine|gemcitabine|mesh-list
25495538|NCT00283244|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25495539|NCT00283244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25495540|NCT00283244|Antimetabolites|antimetabolites|mesh-ancestor
25495541|NCT00283244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495542|NCT00283244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495543|NCT00283244|Antiviral Agents|antiviral agents|mesh-ancestor
25495544|NCT00283244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25495545|NCT00283244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495546|NCT00283244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25495547|NCT00283244|Immunologic Factors|immunologic factors|mesh-ancestor
25495548|NCT00283244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495549|NCT00283244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25495550|NCT00283387|Betaine|betaine|mesh-list
25495551|NCT00283387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25495552|NCT00283387|Lipotropic Agents|lipotropic agents|mesh-ancestor
25495553|NCT00283387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25495554|NCT00283387|Antimetabolites|antimetabolites|mesh-ancestor
25495555|NCT00283387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495556|NCT00283387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25495557|NCT00283504|Omalizumab|omalizumab|mesh-list
25495558|NCT00283504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25495559|NCT00283504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25495560|NCT00283504|Respiratory System Agents|respiratory system agents|mesh-ancestor
25495562|NCT00283595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25495563|NCT00283595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495564|NCT00283686|Telmisartan|telmisartan|mesh-list
25495565|NCT00283686|Lisinopril|lisinopril|mesh-list
25495566|NCT00283686|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25495567|NCT00283686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25495568|NCT00283686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25495569|NCT00283686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25495570|NCT00283686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495571|NCT00283686|Protease Inhibitors|protease inhibitors|mesh-ancestor
25495572|NCT00283686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495573|NCT00283686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25495574|NCT00283686|Protective Agents|protective agents|mesh-ancestor
25495575|NCT00283686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495576|NCT00283712|Infliximab|infliximab|mesh-list
25495577|NCT00283712|Dermatologic Agents|dermatologic agents|mesh-ancestor
25495578|NCT00283712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25495579|NCT00283712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25495580|NCT00283803|Sulindac sulfone|sulindac sulfone|mesh-list
25495581|NCT00283803|Hormones|hormones|mesh-list
25495582|NCT00283803|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25495583|NCT00283803|Androgen Antagonists|androgen antagonists|mesh-list
25495584|NCT00283803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25495585|NCT00283803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495586|NCT00283803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495587|NCT00283803|Hormone Antagonists|hormone antagonists|mesh-ancestor
25495588|NCT00283803|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25495589|NCT00283803|Protective Agents|protective agents|mesh-ancestor
25495590|NCT00283803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25495591|NCT00283803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495592|NCT00283803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495593|NCT00283803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25495594|NCT00283803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25495595|NCT00283803|Analgesics|analgesics|mesh-ancestor
25149691|NCT05466019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149692|NCT05466019|Vitamin B Complex|vitamin b complex|mesh-ancestor
25149693|NCT05466019|Vitamins|vitamins|mesh-ancestor
25149694|NCT05466019|Micronutrients|micronutrients|mesh-ancestor
24767515|NCT01801410|Oxytocics|oxytocics|mesh-ancestor
25149793|NCT05458375|Estradiol|estradiol|mesh-list
25149794|NCT05458375|Estrogens|estrogens|mesh-ancestor
25149795|NCT05458375|Hormones|hormones|mesh-ancestor
25495597|NCT00283803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25495598|NCT00283803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25495599|NCT00283803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25495600|NCT00283816|Metformin|metformin|mesh-list
25495601|NCT00283816|Contraceptive Agents|contraceptive agents|mesh-list
25495602|NCT00283816|Contraceptives, Oral|contraceptives, oral|mesh-list
25495603|NCT00283816|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25495604|NCT00283816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25495605|NCT00283816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495606|NCT00283816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25495607|NCT00283816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25495608|NCT00284050|Ranibizumab|ranibizumab|mesh-list
25495609|NCT00284050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25495610|NCT00284050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25495611|NCT00284050|Growth Substances|growth substances|mesh-ancestor
25495612|NCT00284050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495613|NCT00284050|Growth Inhibitors|growth inhibitors|mesh-ancestor
25495614|NCT00284050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495615|NCT00284089|Ranibizumab|ranibizumab|mesh-list
25495616|NCT00284089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25495617|NCT00284089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25495618|NCT00284089|Growth Substances|growth substances|mesh-ancestor
25495619|NCT00284089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495620|NCT00284089|Growth Inhibitors|growth inhibitors|mesh-ancestor
25495621|NCT00284089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495622|NCT00284141|Aflibercept|aflibercept|mesh-list
25495623|NCT00284141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25495624|NCT00284141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25495625|NCT00284141|Growth Substances|growth substances|mesh-ancestor
25495626|NCT00284141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495627|NCT00284141|Growth Inhibitors|growth inhibitors|mesh-ancestor
25495628|NCT00284141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495629|NCT00284180|Trastuzumab|trastuzumab|mesh-list
25495630|NCT00284180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25495631|NCT00284180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495632|NCT00284518|Botulinum Toxins|botulinum toxins|mesh-list
25495633|NCT00284518|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25495634|NCT00284518|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25495635|NCT00284518|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25495636|NCT00284518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25495637|NCT00284518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495638|NCT00284518|Cholinergic Agents|cholinergic agents|mesh-ancestor
25495639|NCT00284518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25495640|NCT00284518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495641|NCT00284518|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25495642|NCT00284518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25495643|NCT00284739|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25495644|NCT00284739|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25495645|NCT00284739|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25495646|NCT00284739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495647|NCT00284934|Mycophenolic Acid|mycophenolic acid|mesh-list
25495648|NCT00284934|Prednisone|prednisone|mesh-list
25495649|NCT00284934|Tacrolimus|tacrolimus|mesh-list
25495650|NCT00284934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25495651|NCT00284934|Glucocorticoids|glucocorticoids|mesh-ancestor
25495652|NCT00284934|Hormones|hormones|mesh-ancestor
25495653|NCT00284934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25495654|NCT00284934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495655|NCT00284934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25495656|NCT00284934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495657|NCT00284934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25495658|NCT00284934|Immunologic Factors|immunologic factors|mesh-ancestor
25495659|NCT00284934|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25495660|NCT00284934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495661|NCT00284934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048378|NCT00709371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25048379|NCT00709371|Antidepressive Agents|antidepressive agents|mesh-ancestor
25048380|NCT00709371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25048381|NCT00709371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24767667|NCT01802645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25150008|NCT05357482|Sirolimus|sirolimus|mesh-list
25150009|NCT05357482|Plerixafor|plerixafor|mesh-list
25150010|NCT05357482|Alemtuzumab|alemtuzumab|mesh-list
25495662|NCT00284934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25495663|NCT00284934|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25495664|NCT00284934|Antitubercular Agents|antitubercular agents|mesh-ancestor
25495665|NCT00284934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25495666|NCT00284934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25495667|NCT00285012|Varenicline|varenicline|mesh-list
25495668|NCT00285012|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25495669|NCT00285012|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25495670|NCT00285012|Cholinergic Agents|cholinergic agents|mesh-ancestor
25495671|NCT00285012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25495672|NCT00285012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495673|NCT00285012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495674|NCT00285467|Vitamin D|vitamin d|mesh-list
25495675|NCT00285467|Cholecalciferol|cholecalciferol|mesh-list
25495676|NCT00285467|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
25495677|NCT00285467|Vitamins|vitamins|mesh-ancestor
25495678|NCT00285467|Micronutrients|micronutrients|mesh-ancestor
25495679|NCT00285467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495680|NCT00285467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25495681|NCT00285467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25495682|NCT00285584|Bupropion|bupropion|mesh-list
25495683|NCT00285584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25495684|NCT00285584|Antidepressive Agents|antidepressive agents|mesh-ancestor
25495685|NCT00285584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25495686|NCT00285584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25495687|NCT00285584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25495688|NCT00285584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25495689|NCT00285584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495690|NCT00285584|Dopamine Agents|dopamine agents|mesh-ancestor
25495691|NCT00285584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25495692|NCT00285584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645420|NCT01447888|Sensory System Agents|sensory system agents|mesh-ancestor
25495693|NCT00285584|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25495694|NCT00285584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25495695|NCT00285584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495696|NCT00285779|Etanercept|etanercept|mesh-list
25495697|NCT00285779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25495698|NCT00285779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25495699|NCT00285779|Analgesics|analgesics|mesh-ancestor
25495700|NCT00285779|Sensory System Agents|sensory system agents|mesh-ancestor
25495701|NCT00285779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25495702|NCT00285779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495703|NCT00285779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25495704|NCT00285779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25495705|NCT00285779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25495706|NCT00285779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25495707|NCT00285779|Immunologic Factors|immunologic factors|mesh-ancestor
25495708|NCT00285818|Mifepristone|mifepristone|mesh-list
25495709|NCT00285818|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25495710|NCT00285818|Abortifacient Agents|abortifacient agents|mesh-ancestor
25495711|NCT00285818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25495712|NCT00285818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495713|NCT00285818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25495714|NCT00285818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25495715|NCT00285818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25495716|NCT00285818|Contraceptive Agents|contraceptive agents|mesh-ancestor
25495717|NCT00285818|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25495718|NCT00285818|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25495719|NCT00285818|Hormone Antagonists|hormone antagonists|mesh-ancestor
25495720|NCT00285818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25495721|NCT00285818|Luteolytic Agents|luteolytic agents|mesh-ancestor
25495722|NCT00285818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25495723|NCT00285818|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25495724|NCT00285857|Lovastatin|lovastatin|mesh-list
25495725|NCT00285857|L 647318|l 647318|mesh-list
25495726|NCT00285857|Dihydromevinolin|dihydromevinolin|mesh-list
25030830|NCT03592485|Oxycodone|oxycodone|mesh-list
25030834|NCT03592485|Analgesics|analgesics|mesh-ancestor
25150174|NCT05314569|Fentanyl|fentanyl|mesh-list
25150175|NCT05314569|Midazolam|midazolam|mesh-list
25150176|NCT05314569|Dexmedetomidine|dexmedetomidine|mesh-list
25150201|NCT05314569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25150202|NCT05314569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25150203|NCT05314569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25150205|NCT05314569|GABA Agents|gaba agents|mesh-ancestor
24987634|NCT05190120|Ropivacaine|ropivacaine|mesh-list
25495734|NCT00286091|Denosumab|denosumab|mesh-list
25495735|NCT00286091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25495736|NCT00286091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495737|NCT00286156|Sirolimus|sirolimus|mesh-list
25495738|NCT00286156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25495739|NCT00286156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25495740|NCT00286156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25495741|NCT00286156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495742|NCT00286156|Antifungal Agents|antifungal agents|mesh-ancestor
25495743|NCT00286156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25495744|NCT00286156|Immunologic Factors|immunologic factors|mesh-ancestor
25495745|NCT00286156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495746|NCT00286182|Epoetin Alfa|epoetin alfa|mesh-list
25495747|NCT00286182|Hematinics|hematinics|mesh-ancestor
25495748|NCT00286221|Fentanyl|fentanyl|mesh-list
25495749|NCT00286221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25495750|NCT00286221|Narcotics|narcotics|mesh-ancestor
25495751|NCT00286221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25495752|NCT00286221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495753|NCT00286221|Analgesics|analgesics|mesh-ancestor
25495754|NCT00286221|Sensory System Agents|sensory system agents|mesh-ancestor
25495755|NCT00286221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25495756|NCT00286221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25495757|NCT00286221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25495758|NCT00286221|Anesthetics, General|anesthetics, general|mesh-ancestor
25495759|NCT00286221|Anesthetics|anesthetics|mesh-ancestor
25495760|NCT00286234|Niacin|niacin|mesh-list
25495761|NCT00286234|Nicotinic Acids|nicotinic acids|mesh-list
25495762|NCT00286234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25495763|NCT00286234|Antimetabolites|antimetabolites|mesh-ancestor
25645421|NCT01447888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25495764|NCT00286234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495765|NCT00286234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25645422|NCT01447927|Metformin|metformin|mesh-list
25495766|NCT00286234|Vasodilator Agents|vasodilator agents|mesh-ancestor
25495767|NCT00286234|Vitamin B Complex|vitamin b complex|mesh-ancestor
25495768|NCT00286234|Vitamins|vitamins|mesh-ancestor
25495769|NCT00286234|Micronutrients|micronutrients|mesh-ancestor
25495770|NCT00286234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495771|NCT00286325|Rituximab|rituximab|mesh-list
25495772|NCT00286325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25495773|NCT00286325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495774|NCT00286325|Immunologic Factors|immunologic factors|mesh-ancestor
25495775|NCT00286325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495776|NCT00286325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25495777|NCT00286429|Insulin|insulin|mesh-list
25495778|NCT00286429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25495779|NCT00286429|Alogliptin|alogliptin|mesh-list
25495780|NCT00286429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25495781|NCT00286429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495782|NCT00286429|Incretins|incretins|mesh-ancestor
25495783|NCT00286429|Hormones|hormones|mesh-ancestor
25495784|NCT00286429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25495785|NCT00286429|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25495786|NCT00286429|Protease Inhibitors|protease inhibitors|mesh-ancestor
25495787|NCT00286429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495788|NCT00286429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495789|NCT00286442|Metformin|metformin|mesh-list
25495790|NCT00286442|Alogliptin|alogliptin|mesh-list
25495791|NCT00286442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25495792|NCT00286442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495793|NCT00286442|Incretins|incretins|mesh-ancestor
25495794|NCT00286442|Hormones|hormones|mesh-ancestor
25495795|NCT00286442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25150636|NCT05141344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150637|NCT05141344|Protective Agents|protective agents|mesh-ancestor
25150638|NCT05141344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25150639|NCT05141344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25150640|NCT05137067|Cisplatin|cisplatin|mesh-list
25150641|NCT05137067|Docetaxel|docetaxel|mesh-list
25150642|NCT05137067|Antineoplastic Agents|antineoplastic agents|mesh-list
25150643|NCT05137067|Tubulin Modulators|tubulin modulators|mesh-ancestor
25030990|NCT03591471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25030991|NCT03591471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25030992|NCT03591471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25150644|NCT05137067|Antimitotic Agents|antimitotic agents|mesh-ancestor
25150645|NCT05137067|Mitosis Modulators|mitosis modulators|mesh-ancestor
25150646|NCT05137067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495796|NCT00286442|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25495797|NCT00286442|Protease Inhibitors|protease inhibitors|mesh-ancestor
25495798|NCT00286442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495799|NCT00286442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495800|NCT00286455|Alogliptin|alogliptin|mesh-list
25495801|NCT00286455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25495802|NCT00286455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495803|NCT00286455|Incretins|incretins|mesh-ancestor
25495804|NCT00286455|Hormones|hormones|mesh-ancestor
25495805|NCT00286455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25495806|NCT00286455|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25495807|NCT00286455|Protease Inhibitors|protease inhibitors|mesh-ancestor
25495808|NCT00286455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495809|NCT00286455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495810|NCT00286468|Alogliptin|alogliptin|mesh-list
25495811|NCT00286468|Glyburide|glyburide|mesh-list
25495812|NCT00286468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25495813|NCT00286468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495814|NCT00286468|Incretins|incretins|mesh-ancestor
25495815|NCT00286468|Hormones|hormones|mesh-ancestor
25495816|NCT00286468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25495817|NCT00286468|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25495818|NCT00286468|Protease Inhibitors|protease inhibitors|mesh-ancestor
25495819|NCT00286468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495820|NCT00286468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495821|NCT00286494|Pioglitazone|pioglitazone|mesh-list
25495822|NCT00286494|Alogliptin|alogliptin|mesh-list
25495823|NCT00286494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25495824|NCT00286494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495825|NCT00286494|Incretins|incretins|mesh-ancestor
25495826|NCT00286494|Hormones|hormones|mesh-ancestor
25370132|NCT05042128|Paclitaxel|paclitaxel|mesh-list
25495827|NCT00286494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25495828|NCT00286494|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25495829|NCT00286494|Protease Inhibitors|protease inhibitors|mesh-ancestor
25495830|NCT00286494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495831|NCT00286494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495832|NCT00286949|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25495833|NCT00286949|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25495834|NCT00286949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25495835|NCT00286949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25495836|NCT00286949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495837|NCT00286949|Adrenergic Agents|adrenergic agents|mesh-ancestor
25495838|NCT00286949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25495839|NCT00286949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495840|NCT00287053|Valproic Acid|valproic acid|mesh-list
25495841|NCT00287053|Anticonvulsants|anticonvulsants|mesh-ancestor
25495842|NCT00287053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495843|NCT00287053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495844|NCT00287053|GABA Agents|gaba agents|mesh-ancestor
25495845|NCT00287053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25495846|NCT00287053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495847|NCT00287053|Antimanic Agents|antimanic agents|mesh-ancestor
25495848|NCT00287053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25495849|NCT00287053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25495850|NCT00287053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25495851|NCT00287222|Bevacizumab|bevacizumab|mesh-list
25495852|NCT00287222|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25495853|NCT00287222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25495854|NCT00287222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495855|NCT00287222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25495856|NCT00287222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25495857|NCT00287222|Growth Substances|growth substances|mesh-ancestor
25495858|NCT00287222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495859|NCT00287222|Growth Inhibitors|growth inhibitors|mesh-ancestor
25495860|NCT00287222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25151019|NCT04922983|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25151020|NCT04922983|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25151021|NCT04922983|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25151022|NCT04922983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25151023|NCT04922983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25151024|NCT04922983|Cholinergic Agents|cholinergic agents|mesh-ancestor
25151025|NCT04922983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25495861|NCT00287222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495862|NCT00287222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495863|NCT00287287|Lenalidomide|lenalidomide|mesh-list
25495864|NCT00287287|Immunologic Factors|immunologic factors|mesh-ancestor
25495865|NCT00287287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495866|NCT00287287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25495867|NCT00287287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25495868|NCT00287287|Growth Substances|growth substances|mesh-ancestor
25495869|NCT00287287|Growth Inhibitors|growth inhibitors|mesh-ancestor
25495870|NCT00287287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495871|NCT00287339|Esomeprazole|esomeprazole|mesh-list
25495872|NCT00287339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25495873|NCT00287339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25495874|NCT00287339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25495875|NCT00287339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495876|NCT00287339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495877|NCT00287586|Testosterone|testosterone|mesh-list
25495878|NCT00287586|Androgens|androgens|mesh-ancestor
25495880|NCT00287586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25495881|NCT00287586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495882|NCT00287690|Genistein|genistein|mesh-list
25495883|NCT00287690|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25495884|NCT00287690|Protective Agents|protective agents|mesh-ancestor
25495885|NCT00287690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495886|NCT00287690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495887|NCT00287690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25495888|NCT00287690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495889|NCT00287690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495890|NCT00287690|Phytoestrogens|phytoestrogens|mesh-ancestor
25495891|NCT00287690|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25495892|NCT00287690|Estrogens|estrogens|mesh-ancestor
25495893|NCT00287690|Hormones|hormones|mesh-ancestor
25495894|NCT00287690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25495895|NCT00287716|Pirfenidone|pirfenidone|mesh-list
25495896|NCT00287716|Analgesics|analgesics|mesh-ancestor
25495897|NCT00287716|Sensory System Agents|sensory system agents|mesh-ancestor
25495898|NCT00287716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25495899|NCT00287716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495900|NCT00287716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25495901|NCT00287716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25495902|NCT00287716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25495903|NCT00287716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25495904|NCT00287716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495905|NCT00287729|Pirfenidone|pirfenidone|mesh-list
25495906|NCT00287729|Analgesics|analgesics|mesh-ancestor
25495907|NCT00287729|Sensory System Agents|sensory system agents|mesh-ancestor
25495908|NCT00287729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25495909|NCT00287729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495910|NCT00287729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25495911|NCT00287729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25495912|NCT00287729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25495913|NCT00287729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25495914|NCT00287729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495915|NCT00287872|Thalidomide|thalidomide|mesh-list
25495916|NCT00287872|Bortezomib|bortezomib|mesh-list
25495917|NCT00287872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495918|NCT00287872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25495919|NCT00287872|Immunologic Factors|immunologic factors|mesh-ancestor
25495920|NCT00287872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495921|NCT00287872|Leprostatic Agents|leprostatic agents|mesh-ancestor
25495922|NCT00287872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25495923|NCT00287872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25495924|NCT00287872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25495925|NCT00287872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25151208|NCT04842071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25151302|NCT04749641|Vaccines|vaccines|mesh-list
25151303|NCT04749641|Immunologic Factors|immunologic factors|mesh-ancestor
25151366|NCT04734678|Dermatologic Agents|dermatologic agents|mesh-ancestor
25151367|NCT04734678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25151368|NCT04734678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25151369|NCT04727775|Remdesivir|remdesivir|mesh-list
25151370|NCT04727775|Favipiravir|favipiravir|mesh-list
25151371|NCT04727775|Antimetabolites|antimetabolites|mesh-ancestor
25151372|NCT04727775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495926|NCT00287872|Growth Substances|growth substances|mesh-ancestor
25495927|NCT00287872|Growth Inhibitors|growth inhibitors|mesh-ancestor
25495928|NCT00287989|Paclitaxel|paclitaxel|mesh-list
25495929|NCT00287989|Carboplatin|carboplatin|mesh-list
25495930|NCT00287989|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25495931|NCT00287989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25495932|NCT00287989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495933|NCT00287989|Tubulin Modulators|tubulin modulators|mesh-ancestor
25495934|NCT00287989|Antimitotic Agents|antimitotic agents|mesh-ancestor
25495935|NCT00287989|Mitosis Modulators|mitosis modulators|mesh-ancestor
25495936|NCT00287989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495937|NCT00287989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25495938|NCT00287989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495939|NCT00288015|Bevacizumab|bevacizumab|mesh-list
25495940|NCT00288015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25495941|NCT00288015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495942|NCT00288015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25495943|NCT00288015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25495944|NCT00288015|Growth Substances|growth substances|mesh-ancestor
25495945|NCT00288015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495946|NCT00288015|Growth Inhibitors|growth inhibitors|mesh-ancestor
25495947|NCT00288054|Docetaxel|docetaxel|mesh-list
25495948|NCT00288054|Cetuximab|cetuximab|mesh-list
25495949|NCT00288054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495950|NCT00288054|Tubulin Modulators|tubulin modulators|mesh-ancestor
25495951|NCT00288054|Antimitotic Agents|antimitotic agents|mesh-ancestor
25495952|NCT00288054|Mitosis Modulators|mitosis modulators|mesh-ancestor
25495953|NCT00288054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495954|NCT00288054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25495955|NCT00288067|Rituximab|rituximab|mesh-list
25495956|NCT00288067|Fenretinide|fenretinide|mesh-list
25495957|NCT00288067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25495958|NCT00288067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25495959|NCT00288067|Immunologic Factors|immunologic factors|mesh-ancestor
25495960|NCT00288067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495961|NCT00288067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25495962|NCT00288067|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25495963|NCT00288067|Protective Agents|protective agents|mesh-ancestor
25495964|NCT00288366|Aripiprazole|aripiprazole|mesh-list
25495965|NCT00288366|Ziprasidone|ziprasidone|mesh-list
25495966|NCT00288366|Antidepressive Agents|antidepressive agents|mesh-ancestor
25495967|NCT00288366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25495968|NCT00288366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25495969|NCT00288366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25495970|NCT00288366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25495971|NCT00288366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495972|NCT00288366|Dopamine Agonists|dopamine agonists|mesh-ancestor
25495973|NCT00288366|Dopamine Agents|dopamine agents|mesh-ancestor
25495974|NCT00288366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25495975|NCT00288366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495976|NCT00288366|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25495977|NCT00288366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25495978|NCT00288366|Serotonin Agents|serotonin agents|mesh-ancestor
25495979|NCT00288366|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25495980|NCT00288366|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25495981|NCT00288366|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25495982|NCT00288366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25495983|NCT00288574|Fluoxetine|fluoxetine|mesh-list
25495984|NCT00288574|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25495985|NCT00288574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25495986|NCT00288574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25495987|NCT00288574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25495988|NCT00288574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25495989|NCT00288574|Serotonin Agents|serotonin agents|mesh-ancestor
25151596|NCT04562441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768850|NCT01810926|Cyclosporine|cyclosporine|mesh-list
25151620|NCT04551963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25151621|NCT04551963|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25151622|NCT04551963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25151623|NCT04551963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25151624|NCT04551963|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25151625|NCT04551963|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25495990|NCT00288574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25495991|NCT00288574|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25495992|NCT00288574|Antidepressive Agents|antidepressive agents|mesh-ancestor
25495993|NCT00288574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25495994|NCT00288574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25495995|NCT00288574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25495996|NCT00288574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25495998|NCT00288587|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
25495999|NCT00288587|Natriuretic Agents|natriuretic agents|mesh-ancestor
25496000|NCT00288587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496001|NCT00288587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25496002|NCT00288587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496003|NCT00288600|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25496004|NCT00288600|Immunoglobulins|immunoglobulins|mesh-list
25496005|NCT00288600|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25496006|NCT00288600|Antibodies|antibodies|mesh-list
25496007|NCT00288600|gamma-Globulins|gamma-globulins|mesh-list
25496008|NCT00288600|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25496009|NCT00288600|Immunologic Factors|immunologic factors|mesh-ancestor
25496010|NCT00288600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496011|NCT00288626|Cytarabine|cytarabine|mesh-list
25496012|NCT00288626|Prednisone|prednisone|mesh-list
25496013|NCT00288626|Etoposide|etoposide|mesh-list
25496014|NCT00288626|Melphalan|melphalan|mesh-list
25496015|NCT00288626|Carmustine|carmustine|mesh-list
25496016|NCT00288626|Lenograstim|lenograstim|mesh-list
25496017|NCT00288626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25496018|NCT00288626|Glucocorticoids|glucocorticoids|mesh-ancestor
25496019|NCT00288626|Hormones|hormones|mesh-ancestor
25496020|NCT00288626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25496021|NCT00288626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496022|NCT00288626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25496023|NCT00288626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645423|NCT01447927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24808922|NCT02029898|Sensory System Agents|sensory system agents|mesh-ancestor
25496024|NCT00288626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25496025|NCT00288626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25496026|NCT00288626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25496027|NCT00288626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496028|NCT00288626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496029|NCT00288626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25496030|NCT00288626|Antimetabolites|antimetabolites|mesh-ancestor
25496031|NCT00288626|Antiviral Agents|antiviral agents|mesh-ancestor
25496032|NCT00288626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25496033|NCT00288626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25496034|NCT00288626|Immunologic Factors|immunologic factors|mesh-ancestor
25496035|NCT00288626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25496036|NCT00288626|Alkylating Agents|alkylating agents|mesh-ancestor
25496037|NCT00288626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25496038|NCT00288626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25496040|NCT00288639|Analgesics|analgesics|mesh-ancestor
25496041|NCT00288639|Sensory System Agents|sensory system agents|mesh-ancestor
25496042|NCT00288639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25496043|NCT00288639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496044|NCT00288639|Anticonvulsants|anticonvulsants|mesh-ancestor
25496045|NCT00288639|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25496046|NCT00288639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25496047|NCT00288639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496048|NCT00288639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25496049|NCT00288639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25496050|NCT00288639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25496051|NCT00288639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25496052|NCT00288639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25496053|NCT00288704|Rilonacept|rilonacept|mesh-list
25496054|NCT00288704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25496055|NCT00289016|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25496056|NCT00289016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25496057|NCT00289016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25151856|NCT04397484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25151857|NCT04397484|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25151858|NCT04397484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25151859|NCT04397484|Adrenergic Agents|adrenergic agents|mesh-ancestor
25151860|NCT04397484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25151861|NCT04397484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25151862|NCT04397484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25151863|NCT04397484|Autonomic Agents|autonomic agents|mesh-ancestor
25496058|NCT00289211|Complement C1s|complement c1s|mesh-list
25496059|NCT00289211|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25496060|NCT00289211|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
25496061|NCT00289211|Immunologic Factors|immunologic factors|mesh-ancestor
25496062|NCT00289211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496063|NCT00289211|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25496064|NCT00289211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25496065|NCT00289536|Factor VIII|factor viii|mesh-list
25496066|NCT00289536|Coagulants|coagulants|mesh-ancestor
25496067|NCT00289653|Nicotine|nicotine|mesh-list
25496068|NCT00289653|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25496069|NCT00289653|Autonomic Agents|autonomic agents|mesh-ancestor
25496070|NCT00289653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25496071|NCT00289653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496072|NCT00289653|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25496073|NCT00289653|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25496074|NCT00289653|Cholinergic Agents|cholinergic agents|mesh-ancestor
25496075|NCT00289653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25496076|NCT00289653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496077|NCT00289783|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25496078|NCT00289783|Immunologic Factors|immunologic factors|mesh-ancestor
25496079|NCT00289783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496080|NCT00289848|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25496081|NCT00289848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25496082|NCT00289848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496083|NCT00289848|Incretins|incretins|mesh-ancestor
25496084|NCT00289848|Hormones|hormones|mesh-ancestor
25496085|NCT00289848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25496086|NCT00289848|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25496087|NCT00289848|Protease Inhibitors|protease inhibitors|mesh-ancestor
25496088|NCT00289848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496089|NCT00289848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496090|NCT00289900|Atorvastatin|atorvastatin|mesh-list
25496091|NCT00289900|Simvastatin|simvastatin|mesh-list
25496092|NCT00289900|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25496093|NCT00289900|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25496094|NCT00289900|Antimetabolites|antimetabolites|mesh-ancestor
25496095|NCT00289900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496096|NCT00289900|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25496097|NCT00289900|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25496098|NCT00289900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496099|NCT00289978|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25496100|NCT00289978|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25496101|NCT00289978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496102|NCT00289978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25496103|NCT00289978|Immunologic Factors|immunologic factors|mesh-ancestor
25496104|NCT00289978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496105|NCT00289991|Itraconazole|itraconazole|mesh-list
25496106|NCT00289991|Voriconazole|voriconazole|mesh-list
25496107|NCT00289991|Antifungal Agents|antifungal agents|mesh-ancestor
25496108|NCT00289991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25496109|NCT00289991|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25496110|NCT00289991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25496111|NCT00289991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496112|NCT00289991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496113|NCT00289991|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25496114|NCT00289991|Hormone Antagonists|hormone antagonists|mesh-ancestor
25496115|NCT00289991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25496116|NCT00289991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496117|NCT00289991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25496118|NCT00290290|Chlorhexidine|chlorhexidine|mesh-list
25496119|NCT00290290|Povidone-Iodine|povidone-iodine|mesh-list
25113542|NCT02657434|Carboplatin|carboplatin|mesh-list
25113543|NCT02657434|Pemetrexed|pemetrexed|mesh-list
25113544|NCT02657434|Atezolizumab|atezolizumab|mesh-list
25113545|NCT02657434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25113546|NCT02657434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25152033|NCT04273776|Suvorexant|suvorexant|mesh-list
25152034|NCT04273776|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25152035|NCT04273776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25152036|NCT04273776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25152037|NCT04273776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25152040|NCT04273776|GABA Agents|gaba agents|mesh-ancestor
25496120|NCT00290290|Povidone|povidone|mesh-list
25496121|NCT00290290|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25496122|NCT00290290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25496123|NCT00290290|Disinfectants|disinfectants|mesh-ancestor
25496124|NCT00290290|Plasma Substitutes|plasma substitutes|mesh-ancestor
25496125|NCT00290290|Blood Substitutes|blood substitutes|mesh-ancestor
25496126|NCT00290329|Vaccines|vaccines|mesh-list
25496127|NCT00290329|Immunologic Factors|immunologic factors|mesh-ancestor
25496128|NCT00290329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496129|NCT00290342|Edetic Acid|edetic acid|mesh-list
25496130|NCT00290342|Pentetic Acid|pentetic acid|mesh-list
25496131|NCT00290342|Antidotes|antidotes|mesh-ancestor
25496132|NCT00290342|Protective Agents|protective agents|mesh-ancestor
25496133|NCT00290342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496134|NCT00290342|Chelating Agents|chelating agents|mesh-ancestor
25496135|NCT00290342|Sequestering Agents|sequestering agents|mesh-ancestor
25496136|NCT00290342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496137|NCT00290342|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25496138|NCT00290342|Anticoagulants|anticoagulants|mesh-ancestor
25496139|NCT00290342|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25496140|NCT00290433|Cytarabine|cytarabine|mesh-list
25496141|NCT00290433|Dexamethasone|dexamethasone|mesh-list
25496142|NCT00290433|Cyclophosphamide|cyclophosphamide|mesh-list
25496143|NCT00290433|Doxorubicin|doxorubicin|mesh-list
25496144|NCT00290433|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25496145|NCT00290433|Methotrexate|methotrexate|mesh-list
25496146|NCT00290433|Vincristine|vincristine|mesh-list
25496147|NCT00290433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25496148|NCT00290433|Immunologic Factors|immunologic factors|mesh-ancestor
25496149|NCT00290433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496150|NCT00290433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25496151|NCT00290433|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25496152|NCT00290433|Alkylating Agents|alkylating agents|mesh-ancestor
25370507|NCT05029050|Clonidine|clonidine|mesh-list
25496153|NCT00290433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645424|NCT01447927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645425|NCT01448044|Interferons|interferons|mesh-list
25645426|NCT01448044|Ribavirin|ribavirin|mesh-list
25645427|NCT01448044|Interferon-alpha|interferon-alpha|mesh-list
25645428|NCT01448044|Interferon alpha-2|interferon alpha-2|mesh-list
25645429|NCT01448044|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25645430|NCT01448044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645431|NCT01448044|Antiviral Agents|antiviral agents|mesh-ancestor
25645432|NCT01448044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25645433|NCT01448044|Antimetabolites|antimetabolites|mesh-ancestor
25496154|NCT00290433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496155|NCT00290433|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25496156|NCT00290433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25496157|NCT00290433|Antiemetics|antiemetics|mesh-ancestor
25496158|NCT00290433|Autonomic Agents|autonomic agents|mesh-ancestor
25496159|NCT00290433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25496160|NCT00290433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25496161|NCT00290433|Glucocorticoids|glucocorticoids|mesh-ancestor
25496162|NCT00290433|Hormones|hormones|mesh-ancestor
25496163|NCT00290433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25496164|NCT00290433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25496165|NCT00290433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25496166|NCT00290433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25496167|NCT00290433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25496168|NCT00290433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496169|NCT00290433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25496170|NCT00290433|Abortifacient Agents|abortifacient agents|mesh-ancestor
25496171|NCT00290433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25496172|NCT00290433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25496173|NCT00290433|Antimetabolites|antimetabolites|mesh-ancestor
25496174|NCT00290433|Dermatologic Agents|dermatologic agents|mesh-ancestor
25496175|NCT00290433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25496176|NCT00290433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25496177|NCT00290433|Antiviral Agents|antiviral agents|mesh-ancestor
25496178|NCT00290433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25496179|NCT00290433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25496180|NCT00290433|Tubulin Modulators|tubulin modulators|mesh-ancestor
25496181|NCT00290433|Antimitotic Agents|antimitotic agents|mesh-ancestor
25496182|NCT00290433|Mitosis Modulators|mitosis modulators|mesh-ancestor
25496183|NCT00290472|Sirolimus|sirolimus|mesh-list
25496184|NCT00290472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25496185|NCT00290472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25496186|NCT00290472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25031353|NCT03588429|Isoflurane|isoflurane|mesh-list
25152320|NCT04153032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25152321|NCT04153032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25152322|NCT04153032|Vasodilator Agents|vasodilator agents|mesh-ancestor
25152343|NCT04108858|Immunoglobulins|immunoglobulins|mesh-list
25152344|NCT04108858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25152345|NCT04108858|Immunologic Factors|immunologic factors|mesh-ancestor
25152346|NCT04108858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496187|NCT00290472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496188|NCT00290472|Antifungal Agents|antifungal agents|mesh-ancestor
25496189|NCT00290472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25496190|NCT00290472|Immunologic Factors|immunologic factors|mesh-ancestor
25496191|NCT00290472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496192|NCT00290498|Cytarabine|cytarabine|mesh-list
25496193|NCT00290498|Dexamethasone|dexamethasone|mesh-list
25496194|NCT00290498|Prednisone|prednisone|mesh-list
25496195|NCT00290498|Cyclophosphamide|cyclophosphamide|mesh-list
25496196|NCT00290498|Rituximab|rituximab|mesh-list
25496197|NCT00290498|Doxorubicin|doxorubicin|mesh-list
25496198|NCT00290498|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25496199|NCT00290498|Methotrexate|methotrexate|mesh-list
25496200|NCT00290498|Vincristine|vincristine|mesh-list
25496201|NCT00290498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25496202|NCT00290498|Immunologic Factors|immunologic factors|mesh-ancestor
25496203|NCT00290498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496204|NCT00290498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25496205|NCT00290498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25496206|NCT00290498|Alkylating Agents|alkylating agents|mesh-ancestor
25496207|NCT00290498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496208|NCT00290498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496209|NCT00290498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25496210|NCT00290498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25656823|NCT01579318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25496211|NCT00290498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25496212|NCT00290498|Antiemetics|antiemetics|mesh-ancestor
25496213|NCT00290498|Autonomic Agents|autonomic agents|mesh-ancestor
25496214|NCT00290498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25496215|NCT00290498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25496216|NCT00290498|Glucocorticoids|glucocorticoids|mesh-ancestor
25496217|NCT00290498|Hormones|hormones|mesh-ancestor
25496218|NCT00290498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25496219|NCT00290498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25496220|NCT00290498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25496221|NCT00290498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25496222|NCT00290498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25496223|NCT00290498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496224|NCT00290498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25496225|NCT00290498|Abortifacient Agents|abortifacient agents|mesh-ancestor
25496226|NCT00290498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25496227|NCT00290498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25496228|NCT00290498|Antimetabolites|antimetabolites|mesh-ancestor
25496229|NCT00290498|Dermatologic Agents|dermatologic agents|mesh-ancestor
25496230|NCT00290498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25496231|NCT00290498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25496232|NCT00290498|Antiviral Agents|antiviral agents|mesh-ancestor
25496233|NCT00290498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25496234|NCT00290498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25496235|NCT00290498|Tubulin Modulators|tubulin modulators|mesh-ancestor
25496236|NCT00290498|Antimitotic Agents|antimitotic agents|mesh-ancestor
25496237|NCT00290498|Mitosis Modulators|mitosis modulators|mesh-ancestor
25496238|NCT00290537|Paclitaxel|paclitaxel|mesh-list
25496239|NCT00290537|Carboplatin|carboplatin|mesh-list
25496240|NCT00290537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25496241|NCT00290537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496242|NCT00290537|Tubulin Modulators|tubulin modulators|mesh-ancestor
25496243|NCT00290537|Antimitotic Agents|antimitotic agents|mesh-ancestor
25496244|NCT00290537|Mitosis Modulators|mitosis modulators|mesh-ancestor
25496245|NCT00290537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496246|NCT00290589|Methylprednisolone|methylprednisolone|mesh-list
25496247|NCT00290589|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25152393|NCT04101227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25152394|NCT04101227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25152395|NCT04101227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25152396|NCT04101227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25152397|NCT04093570|Decitabine|decitabine|mesh-list
25152398|NCT04093570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25152399|NCT04093570|Antimetabolites|antimetabolites|mesh-ancestor
25152400|NCT04093570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25152401|NCT04093570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25152402|NCT04093570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25152405|NCT04090879|Nicotine|nicotine|mesh-list
25152406|NCT04090879|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25152407|NCT04090879|Autonomic Agents|autonomic agents|mesh-ancestor
25152408|NCT04090879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25152409|NCT04090879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25152410|NCT04090879|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25152411|NCT04090879|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25496248|NCT00290589|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25496249|NCT00290589|Prednisolone|prednisolone|mesh-list
25496250|NCT00290589|Prednisolone acetate|prednisolone acetate|mesh-list
25496251|NCT00290589|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25496252|NCT00290589|Prednisolone phosphate|prednisolone phosphate|mesh-list
25496253|NCT00290589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25496254|NCT00290589|Antiemetics|antiemetics|mesh-ancestor
25496255|NCT00290589|Autonomic Agents|autonomic agents|mesh-ancestor
25496256|NCT00290589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25496257|NCT00290589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496258|NCT00290589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25496259|NCT00290589|Glucocorticoids|glucocorticoids|mesh-ancestor
25496261|NCT00290589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25496262|NCT00290589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25496263|NCT00290589|Protective Agents|protective agents|mesh-ancestor
25496264|NCT00290589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25496265|NCT00290589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496266|NCT00290615|Bevacizumab|bevacizumab|mesh-list
25496267|NCT00290615|Cetuximab|cetuximab|mesh-list
25496268|NCT00290615|Capecitabine|capecitabine|mesh-list
25496269|NCT00290615|Oxaliplatin|oxaliplatin|mesh-list
25496270|NCT00290615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25496271|NCT00290615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496272|NCT00290615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25496273|NCT00290615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25496274|NCT00290615|Growth Substances|growth substances|mesh-ancestor
25496275|NCT00290615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496276|NCT00290615|Growth Inhibitors|growth inhibitors|mesh-ancestor
25496277|NCT00290615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25496278|NCT00290615|Antimetabolites|antimetabolites|mesh-ancestor
25496279|NCT00290615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496280|NCT00290654|Tamoxifen|tamoxifen|mesh-list
25496281|NCT00290654|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25496282|NCT00290654|Hormone Antagonists|hormone antagonists|mesh-ancestor
25496283|NCT00290654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25496284|NCT00290654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496285|NCT00290654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25496286|NCT00290654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496287|NCT00290654|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25496288|NCT00290654|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25496289|NCT00290654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25496290|NCT00290693|Docetaxel|docetaxel|mesh-list
25496291|NCT00290693|Capecitabine|capecitabine|mesh-list
25496292|NCT00290693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496293|NCT00290693|Tubulin Modulators|tubulin modulators|mesh-ancestor
25496294|NCT00290693|Antimitotic Agents|antimitotic agents|mesh-ancestor
25496295|NCT00290693|Mitosis Modulators|mitosis modulators|mesh-ancestor
25496296|NCT00290693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496297|NCT00290693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25496298|NCT00290693|Antimetabolites|antimetabolites|mesh-ancestor
25496299|NCT00290706|Gemcitabine|gemcitabine|mesh-list
25496300|NCT00290706|Bortezomib|bortezomib|mesh-list
25496301|NCT00290706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25496302|NCT00290706|Antimetabolites|antimetabolites|mesh-ancestor
25496303|NCT00290706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496304|NCT00290706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496305|NCT00290706|Antiviral Agents|antiviral agents|mesh-ancestor
25496306|NCT00290706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25496307|NCT00290706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496308|NCT00290706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25496309|NCT00290706|Immunologic Factors|immunologic factors|mesh-ancestor
25496310|NCT00290706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496311|NCT00290732|Doxorubicin|doxorubicin|mesh-list
25496312|NCT00290732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25496313|NCT00290732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25496314|NCT00290732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25152727|NCT03813875|Sensory System Agents|sensory system agents|mesh-ancestor
25152728|NCT03813875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25152729|NCT03813875|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25152730|NCT03813875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25152761|NCT03809442|Ropivacaine|ropivacaine|mesh-list
25152762|NCT03809442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25152763|NCT03809442|Antiemetics|antiemetics|mesh-ancestor
25152772|NCT03809442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496318|NCT00290732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496320|NCT00290745|Letrozole|letrozole|mesh-list
25496321|NCT00290745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496322|NCT00290745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496323|NCT00290745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25496324|NCT00290745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25496325|NCT00290745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496326|NCT00290745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25496327|NCT00290745|Hormone Antagonists|hormone antagonists|mesh-ancestor
25496328|NCT00290745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25496329|NCT00290745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496330|NCT00290745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25496331|NCT00290745|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25496332|NCT00290745|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25496333|NCT00290745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25496334|NCT00290771|Imatinib Mesylate|imatinib mesylate|mesh-list
25496335|NCT00290771|Hydroxyurea|hydroxyurea|mesh-list
25496336|NCT00290771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496337|NCT00290771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25496338|NCT00290771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496339|NCT00290771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408067|NCT03459222|Linrodostat|linrodostat|mesh-list
25496340|NCT00290771|Antisickling Agents|antisickling agents|mesh-ancestor
25496341|NCT00290771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25496342|NCT00290810|Bevacizumab|bevacizumab|mesh-list
25496343|NCT00290810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25496344|NCT00290810|Antibodies|antibodies|mesh-list
25496345|NCT00290810|Immunoglobulins|immunoglobulins|mesh-list
25496346|NCT00290810|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25496347|NCT00290810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496348|NCT00290810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25496349|NCT00290810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25496350|NCT00290810|Growth Substances|growth substances|mesh-ancestor
25496351|NCT00290810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496352|NCT00290810|Growth Inhibitors|growth inhibitors|mesh-ancestor
25496353|NCT00290810|Immunologic Factors|immunologic factors|mesh-ancestor
25496354|NCT00291135|Letrozole|letrozole|mesh-list
25496355|NCT00291135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496356|NCT00291135|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25496357|NCT00291135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25496358|NCT00291135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496359|NCT00291135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496360|NCT00291135|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25496361|NCT00291135|Hormone Antagonists|hormone antagonists|mesh-ancestor
25496362|NCT00291135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25496363|NCT00291135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496364|NCT00291226|Glycine|glycine|mesh-list
25496365|NCT00291226|Glycine Agents|glycine agents|mesh-ancestor
25496366|NCT00291226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25496367|NCT00291226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496368|NCT00291226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496369|NCT00291330|Warfarin|warfarin|mesh-list
25496370|NCT00291330|Dabigatran|dabigatran|mesh-list
25496371|NCT00291330|Anticoagulants|anticoagulants|mesh-ancestor
25496372|NCT00291330|Antithrombins|antithrombins|mesh-ancestor
25496373|NCT00291330|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25496374|NCT00291330|Protease Inhibitors|protease inhibitors|mesh-ancestor
25496375|NCT00291330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496376|NCT00291330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25152995|NCT03583866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25152996|NCT03583866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25152998|NCT03583333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25152999|NCT03583333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24904035|NCT04359095|Antiviral Agents|antiviral agents|mesh-ancestor
25153000|NCT03583333|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25153001|NCT03583333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496377|NCT00291577|Docetaxel|docetaxel|mesh-list
25496378|NCT00291577|Sunitinib|sunitinib|mesh-list
25496379|NCT00291577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496380|NCT00291577|Tubulin Modulators|tubulin modulators|mesh-ancestor
25496381|NCT00291577|Antimitotic Agents|antimitotic agents|mesh-ancestor
25496382|NCT00291577|Mitosis Modulators|mitosis modulators|mesh-ancestor
25496383|NCT00291577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496384|NCT00291577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25496385|NCT00291577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25496386|NCT00291577|Growth Substances|growth substances|mesh-ancestor
25496387|NCT00291577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496388|NCT00291577|Growth Inhibitors|growth inhibitors|mesh-ancestor
25496389|NCT00291577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25496390|NCT00291577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496391|NCT00291642|Cetirizine|cetirizine|mesh-list
25496392|NCT00291642|Levocetirizine|levocetirizine|mesh-list
25496393|NCT00291642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25496394|NCT00291642|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25496395|NCT00291642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25496396|NCT00291642|Histamine Antagonists|histamine antagonists|mesh-ancestor
25496397|NCT00291642|Histamine Agents|histamine agents|mesh-ancestor
25496398|NCT00291642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25496399|NCT00291642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496400|NCT00291642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496401|NCT00291655|Levetiracetam|levetiracetam|mesh-list
25496402|NCT00291655|Anticonvulsants|anticonvulsants|mesh-ancestor
25496403|NCT00291655|Nootropic Agents|nootropic agents|mesh-ancestor
25496404|NCT00291668|Certolizumab Pegol|certolizumab pegol|mesh-list
25496405|NCT00291668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25496406|NCT00291668|Immunologic Factors|immunologic factors|mesh-ancestor
25496407|NCT00291668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496408|NCT00291668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25496409|NCT00291694|Celecoxib|celecoxib|mesh-list
25645434|NCT01448044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645435|NCT01448044|Immunologic Factors|immunologic factors|mesh-ancestor
25496410|NCT00291694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25496411|NCT00291694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25496412|NCT00291694|Analgesics|analgesics|mesh-ancestor
25496413|NCT00291694|Sensory System Agents|sensory system agents|mesh-ancestor
25496414|NCT00291694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25496415|NCT00291694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496416|NCT00291694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25496417|NCT00291694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25496418|NCT00291694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25496419|NCT00291694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25496420|NCT00291694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496421|NCT00291694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496423|NCT00292162|Carvedilol|carvedilol|mesh-list
25496424|NCT00292162|Ramipril|ramipril|mesh-list
25496425|NCT00292162|Enalapril|enalapril|mesh-list
25496426|NCT00292162|Lisinopril|lisinopril|mesh-list
25496427|NCT00292162|Bisoprolol|bisoprolol|mesh-list
25496428|NCT00292162|Perindopril|perindopril|mesh-list
25496429|NCT00292162|Captopril|captopril|mesh-list
25496430|NCT00292162|Spironolactone|spironolactone|mesh-list
25496431|NCT00292162|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25496432|NCT00292162|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
25496433|NCT00292162|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25496434|NCT00292162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25496435|NCT00292162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25496436|NCT00292162|Sympatholytics|sympatholytics|mesh-ancestor
25496437|NCT00292162|Autonomic Agents|autonomic agents|mesh-ancestor
25496438|NCT00292162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25496439|NCT00292162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496440|NCT00292162|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25496441|NCT00292162|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25496442|NCT00292162|Adrenergic Agents|adrenergic agents|mesh-ancestor
25496443|NCT00292162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25496444|NCT00292162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153176|NCT03382938|Ropivacaine|ropivacaine|mesh-list
25031687|NCT03586323|Sensory System Agents|sensory system agents|mesh-ancestor
25031695|NCT03586219|Narcotics|narcotics|mesh-ancestor
25153177|NCT03382938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25153178|NCT03382938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25153179|NCT03382938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153180|NCT03382938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25153181|NCT03382938|Analgesics|analgesics|mesh-ancestor
25496445|NCT00292162|Hormone Antagonists|hormone antagonists|mesh-ancestor
25496446|NCT00292162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25496447|NCT00292162|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25496448|NCT00292162|Diuretics|diuretics|mesh-ancestor
25496449|NCT00292162|Natriuretic Agents|natriuretic agents|mesh-ancestor
25496450|NCT00292162|Antioxidants|antioxidants|mesh-ancestor
25496451|NCT00292162|Protective Agents|protective agents|mesh-ancestor
25496452|NCT00292162|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25496453|NCT00292162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25496454|NCT00292162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25496455|NCT00292162|Vasodilator Agents|vasodilator agents|mesh-ancestor
25496456|NCT00292162|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25496457|NCT00292162|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25496458|NCT00292162|Protease Inhibitors|protease inhibitors|mesh-ancestor
25496459|NCT00292162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496460|NCT00292162|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25496461|NCT00292188|Pregabalin|pregabalin|mesh-list
25496462|NCT00292188|Analgesics|analgesics|mesh-ancestor
25496463|NCT00292188|Sensory System Agents|sensory system agents|mesh-ancestor
25496464|NCT00292188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25496465|NCT00292188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496466|NCT00292188|Anticonvulsants|anticonvulsants|mesh-ancestor
25496467|NCT00292188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25496468|NCT00292188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25496469|NCT00292188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496470|NCT00292188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25496471|NCT00292188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25496472|NCT00292188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25496473|NCT00292188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25496474|NCT00292188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25645436|NCT01448044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496476|NCT00292227|Rotigotine|rotigotine|mesh-list
25496477|NCT00292227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25496478|NCT00292227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25645437|NCT01448057|Acetaminophen|acetaminophen|mesh-list
25645438|NCT01448057|Dimethindene|dimethindene|mesh-list
25645439|NCT01448057|Phenylephrine|phenylephrine|mesh-list
25645440|NCT01448057|Oxymetazoline|oxymetazoline|mesh-list
25645441|NCT01448057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25645442|NCT01448057|Analgesics|analgesics|mesh-ancestor
25645443|NCT01448057|Sensory System Agents|sensory system agents|mesh-ancestor
25645444|NCT01448057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25645445|NCT01448057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645446|NCT01448057|Antipyretics|antipyretics|mesh-ancestor
25645447|NCT01448057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496479|NCT00292227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25496480|NCT00292227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25496481|NCT00292227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496482|NCT00292227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496483|NCT00292227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496484|NCT00292227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496485|NCT00292227|Dopamine Agonists|dopamine agonists|mesh-ancestor
25496486|NCT00292227|Dopamine Agents|dopamine agents|mesh-ancestor
25496487|NCT00292227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25496488|NCT00292370|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25496489|NCT00292370|Paroxetine|paroxetine|mesh-list
25496490|NCT00292370|Antidepressive Agents|antidepressive agents|mesh-ancestor
25496491|NCT00292370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25496492|NCT00292370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25496493|NCT00292370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25496494|NCT00292370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25496495|NCT00292370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496496|NCT00292370|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25496497|NCT00292370|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25496498|NCT00292370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25496499|NCT00292370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496500|NCT00292370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25496501|NCT00292370|Serotonin Agents|serotonin agents|mesh-ancestor
25496502|NCT00292370|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25496503|NCT00292370|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25496504|NCT00292370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25496505|NCT00292370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496506|NCT00292461|Lamotrigine|lamotrigine|mesh-list
25496507|NCT00292461|Zonisamide|zonisamide|mesh-list
25496508|NCT00292461|Anticonvulsants|anticonvulsants|mesh-ancestor
25496509|NCT00292461|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24770010|NCT01817400|Aspirin|aspirin|mesh-list
25153446|NCT03088410|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25153447|NCT03088410|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25153448|NCT03088410|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25153449|NCT03088410|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25153450|NCT03088293|Cyclophosphamide|cyclophosphamide|mesh-list
25153451|NCT03088293|Infliximab|infliximab|mesh-list
25153452|NCT03088293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25153453|NCT03088293|Immunologic Factors|immunologic factors|mesh-ancestor
25153454|NCT03088293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496510|NCT00292461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25496511|NCT00292461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496512|NCT00292461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25496513|NCT00292461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496514|NCT00292461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25496515|NCT00292461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25496516|NCT00292461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25496517|NCT00292461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25496518|NCT00292461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25496520|NCT00292591|Ergocalciferols|ergocalciferols|mesh-list
25496521|NCT00292591|Cholecalciferol|cholecalciferol|mesh-list
25496522|NCT00292591|Vitamins|vitamins|mesh-list
25496523|NCT00292591|Micronutrients|micronutrients|mesh-ancestor
25496524|NCT00292591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496525|NCT00292591|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25496526|NCT00292591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25496527|NCT00292942|Artesunate|artesunate|mesh-list
25496528|NCT00292942|Mannitol|mannitol|mesh-list
25496529|NCT00292942|Antimalarials|antimalarials|mesh-ancestor
25496530|NCT00292942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25496531|NCT00292942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25496532|NCT00292942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25496533|NCT00292942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496534|NCT00292942|Antiviral Agents|antiviral agents|mesh-ancestor
25496535|NCT00292942|Schistosomicides|schistosomicides|mesh-ancestor
25496536|NCT00292942|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25496537|NCT00292942|Anthelmintics|anthelmintics|mesh-ancestor
25496538|NCT00292942|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25496539|NCT00292942|Diuretics|diuretics|mesh-ancestor
25496540|NCT00292942|Natriuretic Agents|natriuretic agents|mesh-ancestor
25496541|NCT00292942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496542|NCT00292981|Complement C1s|complement c1s|mesh-list
25496543|NCT00292981|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25496544|NCT00292981|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
25496545|NCT00292981|Immunologic Factors|immunologic factors|mesh-ancestor
25496546|NCT00292981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496547|NCT00292981|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25496548|NCT00292981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25496549|NCT00293020|Fentanyl|fentanyl|mesh-list
25496550|NCT00293020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25496551|NCT00293020|Narcotics|narcotics|mesh-ancestor
25496552|NCT00293020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25496553|NCT00293020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496554|NCT00293020|Analgesics|analgesics|mesh-ancestor
25496555|NCT00293020|Sensory System Agents|sensory system agents|mesh-ancestor
25496556|NCT00293020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25496557|NCT00293020|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25496558|NCT00293020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25496559|NCT00293020|Anesthetics, General|anesthetics, general|mesh-ancestor
25496560|NCT00293020|Anesthetics|anesthetics|mesh-ancestor
25496561|NCT00293033|Fentanyl|fentanyl|mesh-list
25496562|NCT00293033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25496563|NCT00293033|Narcotics|narcotics|mesh-ancestor
25496564|NCT00293033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25496565|NCT00293033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496566|NCT00293033|Analgesics|analgesics|mesh-ancestor
25496567|NCT00293033|Sensory System Agents|sensory system agents|mesh-ancestor
25496568|NCT00293033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25496569|NCT00293033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25496570|NCT00293033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25496571|NCT00293033|Anesthetics, General|anesthetics, general|mesh-ancestor
25496572|NCT00293033|Anesthetics|anesthetics|mesh-ancestor
25496573|NCT00293059|Dienogest|dienogest|mesh-list
25496574|NCT00293059|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25496575|NCT00293059|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25496576|NCT00293059|Estradiol|estradiol|mesh-list
25496577|NCT00293059|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25153642|NCT02607865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031884|NCT03585374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25031885|NCT03585374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25031886|NCT03585374|Antipyretics|antipyretics|mesh-ancestor
25153686|NCT02503774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25153687|NCT02503774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25153688|NCT02500147|Metformin|metformin|mesh-list
25153689|NCT02500147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24997757|NCT04429685|Analgesics|analgesics|mesh-ancestor
25496578|NCT00293059|Estrogens|estrogens|mesh-ancestor
25496579|NCT00293059|Hormones|hormones|mesh-ancestor
25496580|NCT00293059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25496581|NCT00293059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496582|NCT00293059|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25496583|NCT00293059|Contraceptive Agents|contraceptive agents|mesh-ancestor
25496584|NCT00293059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25496585|NCT00293059|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25496586|NCT00293059|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25496587|NCT00293059|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25496588|NCT00293059|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25496589|NCT00293059|Hormone Antagonists|hormone antagonists|mesh-ancestor
25496590|NCT00293059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25645448|NCT01448057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25496591|NCT00293059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496592|NCT00293202|Etanercept|etanercept|mesh-list
25496593|NCT00293202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24471299|NCT00394407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25496594|NCT00293202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25496595|NCT00293202|Analgesics|analgesics|mesh-ancestor
25496596|NCT00293202|Sensory System Agents|sensory system agents|mesh-ancestor
25496597|NCT00293202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25496598|NCT00293202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496599|NCT00293202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25496600|NCT00293202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25496601|NCT00293202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25496602|NCT00293202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25496603|NCT00293202|Immunologic Factors|immunologic factors|mesh-ancestor
25496604|NCT00293254|Raltegravir Potassium|raltegravir potassium|mesh-list
25496605|NCT00293254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25496606|NCT00293254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25496607|NCT00293254|Antiviral Agents|antiviral agents|mesh-ancestor
25496608|NCT00293254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25496609|NCT00293254|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25496610|NCT00293254|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25496611|NCT00293254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496612|NCT00293254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496613|NCT00293267|Raltegravir Potassium|raltegravir potassium|mesh-list
25496614|NCT00293267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25496615|NCT00293267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25496616|NCT00293267|Antiviral Agents|antiviral agents|mesh-ancestor
25496617|NCT00293267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25496618|NCT00293267|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25496619|NCT00293267|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25496620|NCT00293267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496621|NCT00293267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496623|NCT00293293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496624|NCT00293384|Dexamethasone|dexamethasone|mesh-list
25496625|NCT00293384|Dexamethasone acetate|dexamethasone acetate|mesh-list
25496626|NCT00293384|Cyclophosphamide|cyclophosphamide|mesh-list
25496627|NCT00293384|Aprepitant|aprepitant|mesh-list
25496628|NCT00293384|Granisetron|granisetron|mesh-list
25496629|NCT00293384|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25496630|NCT00293384|BB 1101|bb 1101|mesh-list
25496631|NCT00293384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25496632|NCT00293384|Immunologic Factors|immunologic factors|mesh-ancestor
25496633|NCT00293384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496634|NCT00293384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25496635|NCT00293384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25496636|NCT00293384|Alkylating Agents|alkylating agents|mesh-ancestor
25496637|NCT00293384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496638|NCT00293384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496639|NCT00293384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25496640|NCT00293384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24770305|NCT01819649|Selenium|selenium|mesh-list
25153930|NCT02071862|Everolimus|everolimus|mesh-list
25153931|NCT02071862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25153932|NCT02071862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25153933|NCT02071862|Tubulin Modulators|tubulin modulators|mesh-ancestor
25153934|NCT02071862|Antimitotic Agents|antimitotic agents|mesh-ancestor
25153935|NCT02071862|Mitosis Modulators|mitosis modulators|mesh-ancestor
25153936|NCT02071862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153937|NCT02071862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25153938|NCT02071862|Immunologic Factors|immunologic factors|mesh-ancestor
25153939|NCT02071862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997809|NCT04326439|Calicheamicins|calicheamicins|mesh-list
24942444|NCT03980990|Metformin|metformin|mesh-list
25496641|NCT00293384|Antiemetics|antiemetics|mesh-ancestor
25496642|NCT00293384|Autonomic Agents|autonomic agents|mesh-ancestor
25496643|NCT00293384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25496644|NCT00293384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25496645|NCT00293384|Glucocorticoids|glucocorticoids|mesh-ancestor
25496646|NCT00293384|Hormones|hormones|mesh-ancestor
25496647|NCT00293384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25496648|NCT00293384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25496649|NCT00293384|Protease Inhibitors|protease inhibitors|mesh-ancestor
25496650|NCT00293384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496651|NCT00293384|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25496652|NCT00293384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25496653|NCT00293384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25496654|NCT00293384|Serotonin Agents|serotonin agents|mesh-ancestor
25496655|NCT00293397|Doxorubicin|doxorubicin|mesh-list
25496656|NCT00293397|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25496657|NCT00293397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25645450|NCT01448057|Autonomic Agents|autonomic agents|mesh-ancestor
25496658|NCT00293397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496659|NCT00293397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25496660|NCT00293397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25496661|NCT00293397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496662|NCT00293397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496663|NCT00293423|polysaccharide-K|polysaccharide-k|mesh-list
25496664|NCT00293423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25496665|NCT00293423|Immunologic Factors|immunologic factors|mesh-ancestor
25496666|NCT00293423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496667|NCT00293423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25496668|NCT00293423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496669|NCT00293423|Antiviral Agents|antiviral agents|mesh-ancestor
25496670|NCT00293423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25496671|NCT00293423|Interferon Inducers|interferon inducers|mesh-ancestor
25496672|NCT00293423|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25496673|NCT00293423|Protective Agents|protective agents|mesh-ancestor
25496674|NCT00293462|Sargramostim|sargramostim|mesh-list
25496675|NCT00293462|Immunologic Factors|immunologic factors|mesh-ancestor
25496676|NCT00293462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496677|NCT00293540|Tamoxifen|tamoxifen|mesh-list
25496678|NCT00293540|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25496679|NCT00293540|Hormone Antagonists|hormone antagonists|mesh-ancestor
25496680|NCT00293540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25496681|NCT00293540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496682|NCT00293540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25496683|NCT00293540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496684|NCT00293540|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25496685|NCT00293540|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25496686|NCT00293540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25496687|NCT00293579|Pemetrexed|pemetrexed|mesh-list
25496688|NCT00293579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496689|NCT00293579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496690|NCT00293579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496691|NCT00293579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25496692|NCT00293579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25496693|NCT00293709|Etanercept|etanercept|mesh-list
25496694|NCT00293709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25154098|NCT01480154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154099|NCT01480154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25154100|NCT01468896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25154101|NCT01468896|Cetuximab|cetuximab|mesh-list
25154102|NCT01468896|Interleukin-12|interleukin-12|mesh-list
25154103|NCT01468896|Antibodies|antibodies|mesh-list
25154104|NCT01468896|Immunoglobulins|immunoglobulins|mesh-list
25154105|NCT01468896|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25154106|NCT01468896|Immunologic Factors|immunologic factors|mesh-ancestor
25154107|NCT01468896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154108|NCT01468896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25154109|NCT01468896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25154110|NCT01468896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25154117|NCT01462890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25154137|NCT01413100|Plerixafor|plerixafor|mesh-list
25154138|NCT01413100|Cyclophosphamide|cyclophosphamide|mesh-list
25154139|NCT01413100|Thymoglobulin|thymoglobulin|mesh-list
25154140|NCT01413100|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25154141|NCT01413100|Lenograstim|lenograstim|mesh-list
24997823|NCT04326439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25496695|NCT00293709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25496696|NCT00293709|Analgesics|analgesics|mesh-ancestor
25496697|NCT00293709|Sensory System Agents|sensory system agents|mesh-ancestor
25496698|NCT00293709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25496699|NCT00293709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496700|NCT00293709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25496701|NCT00293709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25496702|NCT00293709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25496703|NCT00293709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25496704|NCT00293709|Immunologic Factors|immunologic factors|mesh-ancestor
25496705|NCT00293722|Etanercept|etanercept|mesh-list
25496706|NCT00293722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25496707|NCT00293722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25496708|NCT00293722|Analgesics|analgesics|mesh-ancestor
25496709|NCT00293722|Sensory System Agents|sensory system agents|mesh-ancestor
25496710|NCT00293722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25496712|NCT00293722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25496713|NCT00293722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25496714|NCT00293722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25496715|NCT00293722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25496716|NCT00293722|Immunologic Factors|immunologic factors|mesh-ancestor
25496717|NCT00293813|Denosumab|denosumab|mesh-list
25496718|NCT00293813|Alendronate|alendronate|mesh-list
25496719|NCT00293813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25496720|NCT00293813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496721|NCT00294398|Fluticasone|fluticasone|mesh-list
25496722|NCT00294398|Xhance|xhance|mesh-list
25496723|NCT00294398|Budesonide|budesonide|mesh-list
25496724|NCT00294398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25496725|NCT00294398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25496726|NCT00294398|Autonomic Agents|autonomic agents|mesh-ancestor
25496727|NCT00294398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25496728|NCT00294398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496729|NCT00294398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25496730|NCT00294398|Respiratory System Agents|respiratory system agents|mesh-ancestor
25496731|NCT00294398|Dermatologic Agents|dermatologic agents|mesh-ancestor
25496732|NCT00294398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25496733|NCT00294398|Glucocorticoids|glucocorticoids|mesh-ancestor
25496734|NCT00294398|Hormones|hormones|mesh-ancestor
25496735|NCT00294398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25496736|NCT00294515|Valganciclovir|valganciclovir|mesh-list
25496737|NCT00294515|Antiviral Agents|antiviral agents|mesh-ancestor
25496738|NCT00294515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25496739|NCT00294554|Memantine|memantine|mesh-list
25496740|NCT00294554|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25496741|NCT00294554|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25496742|NCT00294554|Dopamine Agents|dopamine agents|mesh-ancestor
25496743|NCT00294554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25496744|NCT00294554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496745|NCT00294554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496746|NCT00294554|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25496747|NCT00294554|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25496748|NCT00294632|Rituximab|rituximab|mesh-list
25496749|NCT00294632|Lenalidomide|lenalidomide|mesh-list
25496750|NCT00294632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25496751|NCT00294632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496752|NCT00294632|Immunologic Factors|immunologic factors|mesh-ancestor
25496753|NCT00294632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496754|NCT00294632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25496755|NCT00294632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25496756|NCT00294632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25496757|NCT00294632|Growth Substances|growth substances|mesh-ancestor
25496758|NCT00294632|Growth Inhibitors|growth inhibitors|mesh-ancestor
25496759|NCT00294658|Prednisone|prednisone|mesh-list
25496760|NCT00294658|Prednisolone|prednisolone|mesh-list
25496761|NCT00294658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25032168|NCT03583424|Mechlorethamine|mechlorethamine|mesh-list
25032169|NCT03583424|Carmustine|carmustine|mesh-list
25032170|NCT03583424|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25032185|NCT03583424|Alkylating Agents|alkylating agents|mesh-ancestor
25032186|NCT03583424|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25154441|NCT00464178|Bortezomib|bortezomib|mesh-list
25154442|NCT00464178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25154443|NCT00265798|Sorafenib|sorafenib|mesh-list
25154444|NCT00265798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25154445|NCT00265798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25496762|NCT00294658|Glucocorticoids|glucocorticoids|mesh-ancestor
25496764|NCT00294658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25496765|NCT00294658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496766|NCT00294658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25496767|NCT00294658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496768|NCT00294671|Diflunisal|diflunisal|mesh-list
25496769|NCT00294671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25496770|NCT00294671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25496771|NCT00294671|Analgesics|analgesics|mesh-ancestor
25496772|NCT00294671|Sensory System Agents|sensory system agents|mesh-ancestor
25496773|NCT00294671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25496774|NCT00294671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496775|NCT00294671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25496776|NCT00294671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25496777|NCT00294671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25645452|NCT01448057|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25645453|NCT01448057|Nasal Decongestants|nasal decongestants|mesh-ancestor
25645454|NCT01448057|Respiratory System Agents|respiratory system agents|mesh-ancestor
25496778|NCT00294671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496779|NCT00294671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496780|NCT00294684|Methylprednisolone|methylprednisolone|mesh-list
25496781|NCT00294684|Prednisolone|prednisolone|mesh-list
25496782|NCT00294684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25496783|NCT00294684|Antiemetics|antiemetics|mesh-ancestor
25496784|NCT00294684|Autonomic Agents|autonomic agents|mesh-ancestor
25496785|NCT00294684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25496786|NCT00294684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496787|NCT00294684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25496788|NCT00294684|Glucocorticoids|glucocorticoids|mesh-ancestor
25496789|NCT00294684|Hormones|hormones|mesh-ancestor
25496790|NCT00294684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25496791|NCT00294684|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25496792|NCT00294684|Protective Agents|protective agents|mesh-ancestor
25496793|NCT00294684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25496794|NCT00294684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496795|NCT00294723|Liraglutide|liraglutide|mesh-list
25496796|NCT00294723|Glimepiride|glimepiride|mesh-list
25496797|NCT00294723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25496798|NCT00294723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496799|NCT00294723|Incretins|incretins|mesh-ancestor
25496800|NCT00294723|Hormones|hormones|mesh-ancestor
25496801|NCT00294723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25496802|NCT00294723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25496803|NCT00294723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25496804|NCT00294723|Immunologic Factors|immunologic factors|mesh-ancestor
25496805|NCT00294762|Paclitaxel|paclitaxel|mesh-list
25496806|NCT00294762|Carboplatin|carboplatin|mesh-list
25496807|NCT00294762|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25496808|NCT00294762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25496809|NCT00294762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496810|NCT00294762|Tubulin Modulators|tubulin modulators|mesh-ancestor
25496811|NCT00294762|Antimitotic Agents|antimitotic agents|mesh-ancestor
25496812|NCT00294762|Mitosis Modulators|mitosis modulators|mesh-ancestor
25496813|NCT00294762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496814|NCT00294762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25496815|NCT00294762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496816|NCT00295022|Montelukast|montelukast|mesh-list
24997904|NCT04188730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24997905|NCT04188730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24997906|NCT04188730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24997907|NCT04188730|Adrenergic Agents|adrenergic agents|mesh-ancestor
24997908|NCT04188730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24997909|NCT04188730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997910|NCT04188730|Analgesics|analgesics|mesh-ancestor
24997911|NCT04188730|Sympatholytics|sympatholytics|mesh-ancestor
24997912|NCT04188730|Autonomic Agents|autonomic agents|mesh-ancestor
24997913|NCT04146298|Cyclophosphamide|cyclophosphamide|mesh-list
24997914|NCT04146298|Fludarabine|fludarabine|mesh-list
24997915|NCT04146298|Antibodies|antibodies|mesh-list
25032226|NCT03583021|Neostigmine|neostigmine|mesh-list
25032227|NCT03583021|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25032228|NCT03583021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24997916|NCT04146298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24997917|NCT04146298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24997918|NCT04146298|Immunologic Factors|immunologic factors|mesh-ancestor
25496817|NCT00295022|Levocetirizine|levocetirizine|mesh-list
25496818|NCT00295022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25496819|NCT00295022|Respiratory System Agents|respiratory system agents|mesh-ancestor
25496820|NCT00295022|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25496821|NCT00295022|Hormone Antagonists|hormone antagonists|mesh-ancestor
25496822|NCT00295022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25496823|NCT00295022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496824|NCT00295022|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25496825|NCT00295022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24472206|NCT00398528|Immunologic Factors|immunologic factors|mesh-ancestor
25656824|NCT01579318|Immunologic Factors|immunologic factors|mesh-ancestor
24472207|NCT00398528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472208|NCT00398528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24472209|NCT00398528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25496826|NCT00295022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496827|NCT00295022|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25496828|NCT00295022|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25496829|NCT00295022|Histamine Antagonists|histamine antagonists|mesh-ancestor
25496830|NCT00295022|Histamine Agents|histamine agents|mesh-ancestor
25496831|NCT00295022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25496832|NCT00295061|Protease Inhibitors|protease inhibitors|mesh-list
25496833|NCT00295061|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25496834|NCT00295061|Protein C Inhibitor|protein c inhibitor|mesh-list
25496835|NCT00295061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496836|NCT00295061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496837|NCT00295061|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25496838|NCT00295061|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25496840|NCT00295503|Cisplatin|cisplatin|mesh-list
25496841|NCT00295503|Pemetrexed|pemetrexed|mesh-list
25496842|NCT00295503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25496843|NCT00295503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496844|NCT00295503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25496845|NCT00295503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25496846|NCT00295503|Growth Substances|growth substances|mesh-ancestor
25496847|NCT00295503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496848|NCT00295503|Growth Inhibitors|growth inhibitors|mesh-ancestor
25496849|NCT00295503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496850|NCT00295503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496851|NCT00295503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25496852|NCT00295503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25496853|NCT00295620|Anastrozole|anastrozole|mesh-list
25496854|NCT00295620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25496855|NCT00295620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496856|NCT00295620|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25496857|NCT00295620|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25496858|NCT00295620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496859|NCT00295620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496860|NCT00295620|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25496861|NCT00295620|Hormone Antagonists|hormone antagonists|mesh-ancestor
25496862|NCT00295620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25496863|NCT00295620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496864|NCT00295633|Metformin|metformin|mesh-list
25496865|NCT00295633|Pioglitazone|pioglitazone|mesh-list
25496866|NCT00295633|Rosiglitazone|rosiglitazone|mesh-list
25496867|NCT00295633|Saxagliptin|saxagliptin|mesh-list
25496868|NCT00295633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25496869|NCT00295633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496870|NCT00295633|Incretins|incretins|mesh-ancestor
25496871|NCT00295633|Hormones|hormones|mesh-ancestor
25496872|NCT00295633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25496873|NCT00295633|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25496874|NCT00295633|Protease Inhibitors|protease inhibitors|mesh-ancestor
25496875|NCT00295633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496876|NCT00295633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496877|NCT00295750|Leuprolide|leuprolide|mesh-list
25496878|NCT00295750|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25496879|NCT00295750|Fertility Agents|fertility agents|mesh-ancestor
25496880|NCT00295750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25496881|NCT00295750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998065|NCT03841565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24998067|NCT03841565|Hormones|hormones|mesh-ancestor
24914291|NCT04256057|Magnesium Sulfate|magnesium sulfate|mesh-list
24976476|NCT03557242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783453|NCT01902121|Insulin|insulin|mesh-list
24821700|NCT02107378|Paclitaxel|paclitaxel|mesh-list
24783513|NCT01902446|Chlorhexidine|chlorhexidine|mesh-list
24821970|NCT02109289|Etanercept|etanercept|mesh-list
24783536|NCT01902498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783578|NCT01902641|Rocuronium|rocuronium|mesh-list
24823025|NCT02114528|Sympatholytics|sympatholytics|mesh-ancestor
25496882|NCT00295750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25496883|NCT00295750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496884|NCT00295867|Zoledronic Acid|zoledronic acid|mesh-list
25496885|NCT00295867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25496886|NCT00295867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496887|NCT00295932|Prednisone|prednisone|mesh-list
25496888|NCT00295932|Cyclophosphamide|cyclophosphamide|mesh-list
25496889|NCT00295932|Rituximab|rituximab|mesh-list
25496890|NCT00295932|Bortezomib|bortezomib|mesh-list
25496891|NCT00295932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25496892|NCT00295932|Immunologic Factors|immunologic factors|mesh-ancestor
25645455|NCT01448057|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25645456|NCT01448057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25496893|NCT00295932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496894|NCT00295932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25496895|NCT00295932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25496896|NCT00295932|Alkylating Agents|alkylating agents|mesh-ancestor
25496897|NCT00295932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496898|NCT00295932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496899|NCT00295932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25496900|NCT00295932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25496901|NCT00295932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25496902|NCT00295932|Glucocorticoids|glucocorticoids|mesh-ancestor
25496903|NCT00295932|Hormones|hormones|mesh-ancestor
25496904|NCT00295932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25496905|NCT00295932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25496906|NCT00296036|Pyridoxine|pyridoxine|mesh-list
25496907|NCT00296036|Vitamin B 6|vitamin b 6|mesh-list
25496908|NCT00296036|Vitamin B Complex|vitamin b complex|mesh-ancestor
25496909|NCT00296036|Vitamins|vitamins|mesh-ancestor
25496910|NCT00296036|Micronutrients|micronutrients|mesh-ancestor
25496911|NCT00296036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496912|NCT00296192|Rotigotine|rotigotine|mesh-list
25496913|NCT00296192|Dopamine Agonists|dopamine agonists|mesh-ancestor
25496914|NCT00296192|Dopamine Agents|dopamine agents|mesh-ancestor
25496915|NCT00296192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25496916|NCT00296192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496917|NCT00296192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496918|NCT00296244|Mycophenolic Acid|mycophenolic acid|mesh-list
25496919|NCT00296244|Prednisone|prednisone|mesh-list
25496920|NCT00296244|Methylprednisolone|methylprednisolone|mesh-list
25496921|NCT00296244|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25496922|NCT00296244|Tacrolimus|tacrolimus|mesh-list
25496923|NCT00296244|Basiliximab|basiliximab|mesh-list
25496924|NCT00296244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25496925|NCT00296244|Glucocorticoids|glucocorticoids|mesh-ancestor
25496926|NCT00296244|Hormones|hormones|mesh-ancestor
25496927|NCT00296244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25496928|NCT00296244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496929|NCT00296244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25496930|NCT00296244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496931|NCT00296244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25496932|NCT00296244|Immunologic Factors|immunologic factors|mesh-ancestor
25496933|NCT00296244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25496934|NCT00296244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496935|NCT00296244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496936|NCT00296244|Antiemetics|antiemetics|mesh-ancestor
25496937|NCT00296244|Autonomic Agents|autonomic agents|mesh-ancestor
25496938|NCT00296244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25496939|NCT00296244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25496940|NCT00296244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25496941|NCT00296244|Protective Agents|protective agents|mesh-ancestor
24832014|NCT02170246|Telmisartan|telmisartan|mesh-list
24832167|NCT02170805|Antithrombins|antithrombins|mesh-ancestor
24832244|NCT02170987|Moxifloxacin|moxifloxacin|mesh-list
24832482|NCT02171559|Enoxaparin|enoxaparin|mesh-list
24985926|NCT02545283|Cytarabine|cytarabine|mesh-list
24985927|NCT02545283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24985928|NCT02545283|Antimetabolites|antimetabolites|mesh-ancestor
24985931|NCT02545283|Antiviral Agents|antiviral agents|mesh-ancestor
24784862|NCT01910610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24784864|NCT01910610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784865|NCT01910766|Ubiquinone|ubiquinone|mesh-list
24784866|NCT01910766|Coenzyme Q10|coenzyme q10|mesh-list
24784867|NCT01910766|Clomiphene|clomiphene|mesh-list
24784868|NCT01910766|Enclomiphene|enclomiphene|mesh-list
24784869|NCT01910766|Zuclomiphene|zuclomiphene|mesh-list
24784870|NCT01910766|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24784871|NCT01910766|Hormone Antagonists|hormone antagonists|mesh-ancestor
24784874|NCT01910766|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25496942|NCT00296244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25496943|NCT00296244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25496944|NCT00296244|Antitubercular Agents|antitubercular agents|mesh-ancestor
25496945|NCT00296244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25496946|NCT00296244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25496947|NCT00296296|Cyclosporine|cyclosporine|mesh-list
25496948|NCT00296296|Tacrolimus|tacrolimus|mesh-list
25496949|NCT00296296|Cyclosporins|cyclosporins|mesh-list
25496950|NCT00296296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25496951|NCT00296296|Immunologic Factors|immunologic factors|mesh-ancestor
25496952|NCT00296296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496953|NCT00296296|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25496954|NCT00296296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496955|NCT00296296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496956|NCT00296296|Antifungal Agents|antifungal agents|mesh-ancestor
25496957|NCT00296296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25496958|NCT00296296|Dermatologic Agents|dermatologic agents|mesh-ancestor
25496959|NCT00296296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25496960|NCT00296322|Cisplatin|cisplatin|mesh-list
25496961|NCT00296322|Mitomycins|mitomycins|mesh-list
25496962|NCT00296322|Mitomycin|mitomycin|mesh-list
25496963|NCT00296322|Doxifluridine|doxifluridine|mesh-list
25496964|NCT00296322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496965|NCT00296322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25496966|NCT00296322|Alkylating Agents|alkylating agents|mesh-ancestor
25496967|NCT00296322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496968|NCT00296322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25496969|NCT00296322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496970|NCT00296322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25496971|NCT00296322|Antimetabolites|antimetabolites|mesh-ancestor
25496972|NCT00296322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25496973|NCT00296322|Immunologic Factors|immunologic factors|mesh-ancestor
25496974|NCT00296322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496975|NCT00296322|Appetite Stimulants|appetite stimulants|mesh-ancestor
25496976|NCT00296322|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25496977|NCT00296335|Cisplatin|cisplatin|mesh-list
25496978|NCT00296335|Mitomycins|mitomycins|mesh-list
25496979|NCT00296335|Mitomycin|mitomycin|mesh-list
25496980|NCT00296335|Doxifluridine|doxifluridine|mesh-list
25496981|NCT00296335|Floxuridine|floxuridine|mesh-list
25496982|NCT00296335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25496983|NCT00296335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25496984|NCT00296335|Alkylating Agents|alkylating agents|mesh-ancestor
25496985|NCT00296335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25496986|NCT00296335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25496987|NCT00296335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25496988|NCT00296335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25496989|NCT00296335|Antimetabolites|antimetabolites|mesh-ancestor
25496990|NCT00296335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25496991|NCT00296335|Immunologic Factors|immunologic factors|mesh-ancestor
25496992|NCT00296335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25496993|NCT00296335|Appetite Stimulants|appetite stimulants|mesh-ancestor
25496994|NCT00296335|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25496995|NCT00296374|Atorvastatin|atorvastatin|mesh-list
25496996|NCT00296374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25496997|NCT00296374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25496998|NCT00296374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25496999|NCT00296374|Antimetabolites|antimetabolites|mesh-ancestor
25497000|NCT00296374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497001|NCT00296374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25497002|NCT00296374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25497003|NCT00296374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497004|NCT00296400|Atorvastatin|atorvastatin|mesh-list
25497005|NCT00296400|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25497006|NCT00296400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24998266|NCT03243058|Interleukin-2|interleukin-2|mesh-list
24797968|NCT01959204|Analgesics|analgesics|mesh-ancestor
24843721|NCT02229045|Paclitaxel|paclitaxel|mesh-list
24995601|NCT05026905|Antidotes|antidotes|mesh-ancestor
24995664|NCT04943900|Nivolumab|nivolumab|mesh-list
24995694|NCT04870957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24995695|NCT04870957|Dopamine Agents|dopamine agents|mesh-ancestor
24995696|NCT04869592|Vaccines|vaccines|mesh-list
24995697|NCT04869592|Immunologic Factors|immunologic factors|mesh-ancestor
24995698|NCT04869592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844190|NCT02231632|Vaccines|vaccines|mesh-list
24995928|NCT04482803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24996994|NCT05420285|Dapagliflozin|dapagliflozin|mesh-list
25497007|NCT00296400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25497008|NCT00296400|Antimetabolites|antimetabolites|mesh-ancestor
25497009|NCT00296400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497010|NCT00296400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25497011|NCT00296400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25497012|NCT00296400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497013|NCT00296491|Fluticasone|fluticasone|mesh-list
25645457|NCT01448057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25497015|NCT00296491|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25645458|NCT01448057|Adrenergic Agents|adrenergic agents|mesh-ancestor
25645459|NCT01448057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25645460|NCT01448057|Protective Agents|protective agents|mesh-ancestor
25497016|NCT00296491|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25497017|NCT00296491|Montelukast|montelukast|mesh-list
25497018|NCT00296491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25497019|NCT00296491|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25497020|NCT00296491|Autonomic Agents|autonomic agents|mesh-ancestor
25497021|NCT00296491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25497022|NCT00296491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497023|NCT00296491|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25497024|NCT00296491|Respiratory System Agents|respiratory system agents|mesh-ancestor
25497025|NCT00296491|Dermatologic Agents|dermatologic agents|mesh-ancestor
25497026|NCT00296491|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25497027|NCT00296491|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25497028|NCT00296491|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25497029|NCT00296491|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25497030|NCT00296491|Adrenergic Agents|adrenergic agents|mesh-ancestor
25497031|NCT00296491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25497032|NCT00296491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497033|NCT00296491|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25497034|NCT00296491|Hormone Antagonists|hormone antagonists|mesh-ancestor
25497035|NCT00296491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25497036|NCT00296491|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25497037|NCT00296491|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25497038|NCT00296491|Glucocorticoids|glucocorticoids|mesh-ancestor
25497039|NCT00296491|Hormones|hormones|mesh-ancestor
25497040|NCT00296491|Sympathomimetics|sympathomimetics|mesh-ancestor
25497041|NCT00296504|Ritonavir|ritonavir|mesh-list
25497042|NCT00296504|Fosamprenavir|fosamprenavir|mesh-list
25497043|NCT00296504|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25497044|NCT00296504|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25497045|NCT00296504|Protease Inhibitors|protease inhibitors|mesh-ancestor
25497046|NCT00296504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497047|NCT00296504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497048|NCT00296504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25497049|NCT00296504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25497050|NCT00296504|Antiviral Agents|antiviral agents|mesh-ancestor
25497051|NCT00296504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25497052|NCT00296504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25497053|NCT00296504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25497054|NCT00296517|Bupropion|bupropion|mesh-list
25497055|NCT00296517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25497056|NCT00296517|Antidepressive Agents|antidepressive agents|mesh-ancestor
25497057|NCT00296517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25497058|NCT00296517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25497059|NCT00296517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25497060|NCT00296517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25497061|NCT00296517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497062|NCT00296517|Dopamine Agents|dopamine agents|mesh-ancestor
25497063|NCT00296517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25497064|NCT00296517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497065|NCT00296517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25497066|NCT00296517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25497067|NCT00296517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497068|NCT00296647|Bupropion|bupropion|mesh-list
25497069|NCT00296647|Nicotine|nicotine|mesh-list
25497070|NCT00296647|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25497071|NCT00296647|Autonomic Agents|autonomic agents|mesh-ancestor
25497072|NCT00296647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25497073|NCT00296647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497074|NCT00296647|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25497075|NCT00296647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25497076|NCT00296647|Cholinergic Agents|cholinergic agents|mesh-ancestor
25048551|NCT00691964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25048552|NCT00691964|Immunologic Factors|immunologic factors|mesh-ancestor
25048553|NCT00691717|Hydrocortisone|hydrocortisone|mesh-list
25048554|NCT00691717|Anecortave|anecortave|mesh-list
25497077|NCT00296647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25497078|NCT00296647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497079|NCT00296647|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25497080|NCT00296647|Antidepressive Agents|antidepressive agents|mesh-ancestor
25497081|NCT00296647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25645461|NCT01448057|Antipruritics|antipruritics|mesh-ancestor
25645462|NCT01448057|Dermatologic Agents|dermatologic agents|mesh-ancestor
25497082|NCT00296647|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25497083|NCT00296647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25497084|NCT00296647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25497085|NCT00296647|Dopamine Agents|dopamine agents|mesh-ancestor
25497086|NCT00296647|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25497087|NCT00296647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25497088|NCT00296647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497089|NCT00296725|Fluoxetine|fluoxetine|mesh-list
25497090|NCT00296725|Imipramine|imipramine|mesh-list
25497091|NCT00296725|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25497092|NCT00296725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25497093|NCT00296725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25497094|NCT00296725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497095|NCT00296725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25497096|NCT00296725|Serotonin Agents|serotonin agents|mesh-ancestor
25497097|NCT00296725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497098|NCT00296725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25497099|NCT00296725|Antidepressive Agents|antidepressive agents|mesh-ancestor
25497100|NCT00296725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25497101|NCT00296725|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25497102|NCT00296725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25497103|NCT00296725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497104|NCT00296725|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25497105|NCT00296725|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25497106|NCT00296725|Adrenergic Agents|adrenergic agents|mesh-ancestor
25497107|NCT00296816|Bevacizumab|bevacizumab|mesh-list
25497108|NCT00296816|Docetaxel|docetaxel|mesh-list
25497109|NCT00296816|Oxaliplatin|oxaliplatin|mesh-list
25497110|NCT00296816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25497111|NCT00296816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497112|NCT00296816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25497113|NCT00296816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25497114|NCT00296816|Growth Substances|growth substances|mesh-ancestor
25497115|NCT00296816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497116|NCT00296816|Growth Inhibitors|growth inhibitors|mesh-ancestor
25497117|NCT00296816|Tubulin Modulators|tubulin modulators|mesh-ancestor
25497118|NCT00296816|Antimitotic Agents|antimitotic agents|mesh-ancestor
25497119|NCT00296816|Mitosis Modulators|mitosis modulators|mesh-ancestor
25497120|NCT00296816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497121|NCT00297037|Pimecrolimus|pimecrolimus|mesh-list
25497122|NCT00297037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25497123|NCT00297037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25497124|NCT00297037|Analgesics|analgesics|mesh-ancestor
25497125|NCT00297037|Sensory System Agents|sensory system agents|mesh-ancestor
25497126|NCT00297037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25497127|NCT00297037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497128|NCT00297037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25497129|NCT00297037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25497130|NCT00297037|Dermatologic Agents|dermatologic agents|mesh-ancestor
25497131|NCT00297037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25497132|NCT00297037|Immunologic Factors|immunologic factors|mesh-ancestor
25497133|NCT00297037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25497134|NCT00297037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497135|NCT00297037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497136|NCT00297232|Natalizumab|natalizumab|mesh-list
25497137|NCT00297232|Immunologic Factors|immunologic factors|mesh-ancestor
25497138|NCT00297232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497139|NCT00297479|Nicotine|nicotine|mesh-list
25497140|NCT00297479|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25497141|NCT00297479|Autonomic Agents|autonomic agents|mesh-ancestor
25497142|NCT00297479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25497143|NCT00297479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497144|NCT00297479|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25497145|NCT00297479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25497146|NCT00297479|Cholinergic Agents|cholinergic agents|mesh-ancestor
25497147|NCT00297479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25497148|NCT00297479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943552|NCT03969758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497149|NCT00297492|Nicotine|nicotine|mesh-list
25497150|NCT00297492|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25497151|NCT00297492|Autonomic Agents|autonomic agents|mesh-ancestor
25497152|NCT00297492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25645463|NCT01448057|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25497153|NCT00297492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497154|NCT00297492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25497155|NCT00297492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25497156|NCT00297492|Cholinergic Agents|cholinergic agents|mesh-ancestor
25497157|NCT00297492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25497158|NCT00297492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497159|NCT00297596|Oxaliplatin|oxaliplatin|mesh-list
25497160|NCT00297596|Trastuzumab|trastuzumab|mesh-list
25497161|NCT00297596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497162|NCT00297596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25497163|NCT00297648|Certolizumab Pegol|certolizumab pegol|mesh-list
25497164|NCT00297648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25497165|NCT00297648|Immunologic Factors|immunologic factors|mesh-ancestor
25497166|NCT00297648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497167|NCT00297648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25497168|NCT00297778|Pramipexole|pramipexole|mesh-list
25497169|NCT00297778|Antioxidants|antioxidants|mesh-ancestor
25497170|NCT00297778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497171|NCT00297778|Protective Agents|protective agents|mesh-ancestor
25497172|NCT00297778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497173|NCT00297778|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25497174|NCT00297778|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25497175|NCT00297778|Dopamine Agonists|dopamine agonists|mesh-ancestor
25497176|NCT00297778|Dopamine Agents|dopamine agents|mesh-ancestor
25497177|NCT00297778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25497178|NCT00297830|Zoledronic Acid|zoledronic acid|mesh-list
25497179|NCT00297830|Alendronate|alendronate|mesh-list
25497180|NCT00297830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25497181|NCT00297830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497182|NCT00297882|Artesunate|artesunate|mesh-list
25497183|NCT00297882|Lumefantrine|lumefantrine|mesh-list
25497184|NCT00297882|Artemether|artemether|mesh-list
25497185|NCT00297882|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25497186|NCT00297882|Amodiaquine|amodiaquine|mesh-list
25497187|NCT00297882|Antimalarials|antimalarials|mesh-ancestor
25497188|NCT00297882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25497189|NCT00297882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25497190|NCT00297882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25497191|NCT00297882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497192|NCT00297882|Antiviral Agents|antiviral agents|mesh-ancestor
25497193|NCT00297882|Schistosomicides|schistosomicides|mesh-ancestor
25497194|NCT00297882|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25497195|NCT00297882|Anthelmintics|anthelmintics|mesh-ancestor
25497196|NCT00298038|Rifaximin|rifaximin|mesh-list
25497197|NCT00298038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25497198|NCT00298038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25497199|NCT00298038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25497200|NCT00298155|Ketoconazole|ketoconazole|mesh-list
25497201|NCT00298155|Goserelin|goserelin|mesh-list
25497202|NCT00298155|Bicalutamide|bicalutamide|mesh-list
25497203|NCT00298155|Dutasteride|dutasteride|mesh-list
25497204|NCT00298155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25497205|NCT00298155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497206|NCT00298155|Antifungal Agents|antifungal agents|mesh-ancestor
25497207|NCT00298155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24946328|NCT03940378|Levamisole|levamisole|mesh-list
24946329|NCT03940378|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24946330|NCT03940378|Immunologic Factors|immunologic factors|mesh-ancestor
24946331|NCT03940378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946332|NCT03940378|Antinematodal Agents|antinematodal agents|mesh-ancestor
24946333|NCT03940378|Anthelmintics|anthelmintics|mesh-ancestor
24946334|NCT03940378|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24946335|NCT03940378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24946336|NCT03940378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24946392|NCT03939663|Abortifacient Agents|abortifacient agents|mesh-ancestor
24946393|NCT03939663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24946394|NCT03939663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946395|NCT03939663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24946396|NCT03939663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24946398|NCT03939884|Diclofenac|diclofenac|mesh-list
24946399|NCT03939884|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25497208|NCT00298155|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25497209|NCT00298155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25497210|NCT00298155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497211|NCT00298155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497212|NCT00298155|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25497213|NCT00298155|Hormone Antagonists|hormone antagonists|mesh-ancestor
25408472|NCT03438318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645464|NCT01448057|Histamine Antagonists|histamine antagonists|mesh-ancestor
25497214|NCT00298155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25497215|NCT00298155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497216|NCT00298155|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25497217|NCT00298155|Androgen Antagonists|androgen antagonists|mesh-ancestor
25497218|NCT00298155|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25497220|NCT00298233|Antiviral Agents|antiviral agents|mesh-ancestor
25497221|NCT00298233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25497222|NCT00298233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497223|NCT00298233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497224|NCT00298272|Methylprednisolone|methylprednisolone|mesh-list
25497225|NCT00298272|Adalimumab|adalimumab|mesh-list
25497226|NCT00298272|Etanercept|etanercept|mesh-list
25497227|NCT00298272|Rituximab|rituximab|mesh-list
25497228|NCT00298272|Methotrexate|methotrexate|mesh-list
25497229|NCT00298272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25497230|NCT00298272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497231|NCT00298272|Immunologic Factors|immunologic factors|mesh-ancestor
25497232|NCT00298272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497233|NCT00298272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25497234|NCT00298272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25497235|NCT00298272|Abortifacient Agents|abortifacient agents|mesh-ancestor
25497236|NCT00298272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25497237|NCT00298272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25497238|NCT00298272|Antimetabolites|antimetabolites|mesh-ancestor
25497239|NCT00298272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497240|NCT00298272|Dermatologic Agents|dermatologic agents|mesh-ancestor
25497241|NCT00298272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497242|NCT00298272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25497243|NCT00298272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25497244|NCT00298272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25497245|NCT00298272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25497246|NCT00298272|Antiemetics|antiemetics|mesh-ancestor
25497247|NCT00298272|Autonomic Agents|autonomic agents|mesh-ancestor
25497248|NCT00298272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25497249|NCT00298272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25497250|NCT00298272|Glucocorticoids|glucocorticoids|mesh-ancestor
25497251|NCT00298272|Hormones|hormones|mesh-ancestor
25497252|NCT00298272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25497253|NCT00298272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25497254|NCT00298272|Protective Agents|protective agents|mesh-ancestor
25497255|NCT00298272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25497256|NCT00298272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25497257|NCT00298272|Analgesics|analgesics|mesh-ancestor
25497258|NCT00298272|Sensory System Agents|sensory system agents|mesh-ancestor
25497259|NCT00298363|Tenofovir|tenofovir|mesh-list
25497260|NCT00298363|Emtricitabine|emtricitabine|mesh-list
25497261|NCT00298363|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25497262|NCT00298363|Entecavir|entecavir|mesh-list
25497263|NCT00298363|Antiviral Agents|antiviral agents|mesh-ancestor
25497264|NCT00298363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25497265|NCT00298363|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25497266|NCT00298363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25497267|NCT00298363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497268|NCT00298363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497269|NCT00298363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25497270|NCT00298363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25497271|NCT00298610|Artesunate|artesunate|mesh-list
25497272|NCT00298610|Atovaquone|atovaquone|mesh-list
25497273|NCT00298610|Proguanil|proguanil|mesh-list
25497274|NCT00298610|Quinidine|quinidine|mesh-list
25497275|NCT00298610|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
25497276|NCT00298610|Antimalarials|antimalarials|mesh-ancestor
25497277|NCT00298610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25497278|NCT00298610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24950507|NCT03914755|Tucatinib|tucatinib|mesh-list
24804414|NCT02002377|Aflibercept|aflibercept|mesh-list
24950716|NCT03912740|Dexmedetomidine|dexmedetomidine|mesh-list
24950717|NCT03912740|Remifentanil|remifentanil|mesh-list
24966078|NCT03771677|Antiviral Agents|antiviral agents|mesh-ancestor
24966079|NCT03771677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24966080|NCT03771677|Immunologic Factors|immunologic factors|mesh-ancestor
24772262|NCT01832662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497310|NCT00299104|Methylprednisolone|methylprednisolone|mesh-list
25497311|NCT00299104|Rituximab|rituximab|mesh-list
25497312|NCT00299104|Methotrexate|methotrexate|mesh-list
25497313|NCT00299104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25497314|NCT00299104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497315|NCT00299104|Immunologic Factors|immunologic factors|mesh-ancestor
25497316|NCT00299104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497317|NCT00299104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25497318|NCT00299104|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25497319|NCT00299104|Abortifacient Agents|abortifacient agents|mesh-ancestor
25497320|NCT00299104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25497321|NCT00299104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25497322|NCT00299104|Antimetabolites|antimetabolites|mesh-ancestor
25497323|NCT00299104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497324|NCT00299104|Dermatologic Agents|dermatologic agents|mesh-ancestor
25497325|NCT00299104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497326|NCT00299104|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25497327|NCT00299104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25497328|NCT00299104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25497329|NCT00299104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25497330|NCT00299104|Antiemetics|antiemetics|mesh-ancestor
25497331|NCT00299104|Autonomic Agents|autonomic agents|mesh-ancestor
25497332|NCT00299104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25497333|NCT00299104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25497334|NCT00299104|Glucocorticoids|glucocorticoids|mesh-ancestor
25497335|NCT00299104|Hormones|hormones|mesh-ancestor
25497336|NCT00299104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25497337|NCT00299104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25497338|NCT00299104|Protective Agents|protective agents|mesh-ancestor
25497339|NCT00299130|Methylprednisolone|methylprednisolone|mesh-list
25497340|NCT00299130|Rituximab|rituximab|mesh-list
25497341|NCT00299130|Methotrexate|methotrexate|mesh-list
25497342|NCT00299130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25497343|NCT00299130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497344|NCT00299130|Immunologic Factors|immunologic factors|mesh-ancestor
25497345|NCT00299130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497346|NCT00299130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25497347|NCT00299130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25497348|NCT00299130|Abortifacient Agents|abortifacient agents|mesh-ancestor
25497349|NCT00299130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25497350|NCT00299130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25497351|NCT00299130|Antimetabolites|antimetabolites|mesh-ancestor
25497352|NCT00299130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497353|NCT00299130|Dermatologic Agents|dermatologic agents|mesh-ancestor
25497354|NCT00299130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497355|NCT00299130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25497356|NCT00299130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25497357|NCT00299130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25497358|NCT00299130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25497359|NCT00299130|Antiemetics|antiemetics|mesh-ancestor
25497360|NCT00299130|Autonomic Agents|autonomic agents|mesh-ancestor
25497361|NCT00299130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25497362|NCT00299130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25497363|NCT00299130|Glucocorticoids|glucocorticoids|mesh-ancestor
25497364|NCT00299130|Hormones|hormones|mesh-ancestor
25497365|NCT00299130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25497366|NCT00299130|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25497367|NCT00299130|Protective Agents|protective agents|mesh-ancestor
25497368|NCT00299156|Clofarabine|clofarabine|mesh-list
25497369|NCT00299156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25497370|NCT00299156|Antimetabolites|antimetabolites|mesh-ancestor
25497371|NCT00299156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497372|NCT00299156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497373|NCT00299182|Cytarabine|cytarabine|mesh-list
25497374|NCT00299182|Dexamethasone|dexamethasone|mesh-list
25497375|NCT00299182|Cyclophosphamide|cyclophosphamide|mesh-list
25497376|NCT00299182|Rituximab|rituximab|mesh-list
25497377|NCT00299182|Doxorubicin|doxorubicin|mesh-list
25497378|NCT00299182|Methotrexate|methotrexate|mesh-list
25497379|NCT00299182|Vincristine|vincristine|mesh-list
25497380|NCT00299182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25497381|NCT00299182|Immunologic Factors|immunologic factors|mesh-ancestor
25497382|NCT00299182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497383|NCT00299182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25497384|NCT00299182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25497385|NCT00299182|Alkylating Agents|alkylating agents|mesh-ancestor
25497386|NCT00299182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497387|NCT00299182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645465|NCT01448057|Histamine Agents|histamine agents|mesh-ancestor
25645466|NCT01448057|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25645467|NCT01448213|Fluorometholone|fluorometholone|mesh-list
25645468|NCT01448213|Prednisolone|prednisolone|mesh-list
25645469|NCT01448213|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25645470|NCT01448213|Methylprednisolone|methylprednisolone|mesh-list
25645471|NCT01448213|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25645472|NCT01448213|Prednisolone acetate|prednisolone acetate|mesh-list
25645473|NCT01448213|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25645474|NCT01448213|Prednisolone phosphate|prednisolone phosphate|mesh-list
25645475|NCT01448213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25645476|NCT01448213|Glucocorticoids|glucocorticoids|mesh-ancestor
25497388|NCT00299182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25497389|NCT00299182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25497390|NCT00299182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25497392|NCT00299182|Autonomic Agents|autonomic agents|mesh-ancestor
25497393|NCT00299182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25497394|NCT00299182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25497395|NCT00299182|Glucocorticoids|glucocorticoids|mesh-ancestor
25497396|NCT00299182|Hormones|hormones|mesh-ancestor
25497397|NCT00299182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25497398|NCT00299182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25497399|NCT00299182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25497400|NCT00299182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25497401|NCT00299182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25497402|NCT00299182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497403|NCT00299182|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25497404|NCT00299182|Abortifacient Agents|abortifacient agents|mesh-ancestor
25497405|NCT00299182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25497406|NCT00299182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25497407|NCT00299182|Antimetabolites|antimetabolites|mesh-ancestor
25497408|NCT00299182|Dermatologic Agents|dermatologic agents|mesh-ancestor
25497409|NCT00299182|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25497410|NCT00299182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25497411|NCT00299182|Antiviral Agents|antiviral agents|mesh-ancestor
25497412|NCT00299182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25497413|NCT00299182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25497414|NCT00299182|Tubulin Modulators|tubulin modulators|mesh-ancestor
25497415|NCT00299182|Antimitotic Agents|antimitotic agents|mesh-ancestor
25497416|NCT00299182|Mitosis Modulators|mitosis modulators|mesh-ancestor
25497417|NCT00299221|Mycophenolic Acid|mycophenolic acid|mesh-list
25497418|NCT00299221|Tacrolimus|tacrolimus|mesh-list
25497419|NCT00299221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25497420|NCT00299221|Immunologic Factors|immunologic factors|mesh-ancestor
25497421|NCT00299221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497422|NCT00299221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25497423|NCT00299221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497424|NCT00299221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497425|NCT00299221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25497426|NCT00299221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497427|NCT00299221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25497428|NCT00299221|Antitubercular Agents|antitubercular agents|mesh-ancestor
25497429|NCT00299221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25497430|NCT00299221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25497431|NCT00299494|Rituximab|rituximab|mesh-list
25497432|NCT00299494|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25497433|NCT00299494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25497434|NCT00299494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497435|NCT00299494|Immunologic Factors|immunologic factors|mesh-ancestor
25497436|NCT00299494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497437|NCT00299494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25497438|NCT00299494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25497439|NCT00299546|Golimumab|golimumab|mesh-list
25497440|NCT00299546|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25497441|NCT00299546|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25497442|NCT00299546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25497443|NCT00299546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25497444|NCT00299546|Immunologic Factors|immunologic factors|mesh-ancestor
25497445|NCT00299546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497446|NCT00299689|Denileukin diftitox|denileukin diftitox|mesh-list
25497447|NCT00299689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497448|NCT00299702|Aripiprazole|aripiprazole|mesh-list
25497449|NCT00299702|Risperidone|risperidone|mesh-list
25497450|NCT00299702|Antidepressive Agents|antidepressive agents|mesh-ancestor
24628813|NCT01101568|Antimetabolites|antimetabolites|mesh-ancestor
25645477|NCT01448213|Hormones|hormones|mesh-ancestor
25497451|NCT00299702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25497452|NCT00299702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25048716|NCT00673478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25048717|NCT00673478|Autonomic Agents|autonomic agents|mesh-ancestor
24773273|NCT01838850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24999565|NCT03981614|Trifluridine|trifluridine|mesh-list
24999566|NCT03981614|Palbociclib|palbociclib|mesh-list
24999567|NCT03981614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24798449|NCT01963702|Mitosis Modulators|mitosis modulators|mesh-ancestor
24798450|NCT01963741|Histamine|histamine|mesh-list
25497453|NCT00299702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25497454|NCT00299702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25497455|NCT00299702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497456|NCT00299702|Dopamine Agonists|dopamine agonists|mesh-ancestor
25497457|NCT00299702|Dopamine Agents|dopamine agents|mesh-ancestor
25497458|NCT00299702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25497459|NCT00299702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497460|NCT00299702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25497461|NCT00299702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25497462|NCT00299702|Serotonin Agents|serotonin agents|mesh-ancestor
25497463|NCT00299702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25497464|NCT00299702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25497465|NCT00299702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25497466|NCT00299702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25497467|NCT00299741|Sunitinib|sunitinib|mesh-list
25497468|NCT00299741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497469|NCT00299741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25497470|NCT00299741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25497471|NCT00299741|Growth Substances|growth substances|mesh-ancestor
25497472|NCT00299741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497473|NCT00299741|Growth Inhibitors|growth inhibitors|mesh-ancestor
25497474|NCT00299741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25497475|NCT00299741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497476|NCT00299741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497477|NCT00299988|Immunoglobulins|immunoglobulins|mesh-list
25497478|NCT00299988|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25497479|NCT00299988|Antibodies|antibodies|mesh-list
25497480|NCT00299988|gamma-Globulins|gamma-globulins|mesh-list
25497481|NCT00299988|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25497482|NCT00299988|Immunologic Factors|immunologic factors|mesh-ancestor
25497483|NCT00299988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497484|NCT00300053|Lenograstim|lenograstim|mesh-list
25497485|NCT00300053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25497486|NCT00300053|Immunologic Factors|immunologic factors|mesh-ancestor
25497487|NCT00300053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497488|NCT00300274|Cyclosporine|cyclosporine|mesh-list
25497489|NCT00300274|Mycophenolic Acid|mycophenolic acid|mesh-list
25497490|NCT00300274|Everolimus|everolimus|mesh-list
25497491|NCT00300274|Cyclosporins|cyclosporins|mesh-list
25497492|NCT00300274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497493|NCT00300274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497494|NCT00300274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25497495|NCT00300274|Immunologic Factors|immunologic factors|mesh-ancestor
25497496|NCT00300274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497497|NCT00300274|Antifungal Agents|antifungal agents|mesh-ancestor
25497498|NCT00300274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25497499|NCT00300274|Dermatologic Agents|dermatologic agents|mesh-ancestor
25497500|NCT00300274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25497501|NCT00300274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25497502|NCT00300274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497503|NCT00300274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25497504|NCT00300274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25497505|NCT00300274|Antitubercular Agents|antitubercular agents|mesh-ancestor
25497506|NCT00300274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25497507|NCT00300365|Aspirin|aspirin|mesh-list
25497508|NCT00300365|Niacin|niacin|mesh-list
25497509|NCT00300365|Pioglitazone|pioglitazone|mesh-list
25497510|NCT00300365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25497511|NCT00300365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25497512|NCT00300365|Analgesics|analgesics|mesh-ancestor
25497513|NCT00300365|Sensory System Agents|sensory system agents|mesh-ancestor
25497514|NCT00300365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25497515|NCT00300365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497516|NCT00300365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25497517|NCT00300365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25497518|NCT00300365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25003164|NCT03959085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25645478|NCT01448213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25823163|NCT00004759|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25645479|NCT01448213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25003165|NCT03959085|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24940802|NCT03997500|Adrenergic Agents|adrenergic agents|mesh-ancestor
24940803|NCT03997500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24940804|NCT03997500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940805|NCT03997500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940806|NCT03997500|Sympathomimetics|sympathomimetics|mesh-ancestor
24940807|NCT03997500|Autonomic Agents|autonomic agents|mesh-ancestor
24940808|NCT03997500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25497519|NCT00300365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25497520|NCT00300365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497521|NCT00300365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25497522|NCT00300365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25497523|NCT00300365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497524|NCT00300365|Antipyretics|antipyretics|mesh-ancestor
25497525|NCT00300365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25497526|NCT00300365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25497527|NCT00300365|Antimetabolites|antimetabolites|mesh-ancestor
25497528|NCT00300365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25497529|NCT00300365|Vasodilator Agents|vasodilator agents|mesh-ancestor
25497530|NCT00300365|Vitamin B Complex|vitamin b complex|mesh-ancestor
25497531|NCT00300365|Vitamins|vitamins|mesh-ancestor
25497532|NCT00300365|Micronutrients|micronutrients|mesh-ancestor
25497533|NCT00300391|Haloperidol|haloperidol|mesh-list
25497534|NCT00300391|Haloperidol decanoate|haloperidol decanoate|mesh-list
25497535|NCT00300391|Antiemetics|antiemetics|mesh-ancestor
25497536|NCT00300391|Autonomic Agents|autonomic agents|mesh-ancestor
25497537|NCT00300391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25497538|NCT00300391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497539|NCT00300391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25497540|NCT00300391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25497541|NCT00300391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25497542|NCT00300391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25497543|NCT00300391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25497544|NCT00300391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25497545|NCT00300391|Dopamine Agents|dopamine agents|mesh-ancestor
25497546|NCT00300391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25497547|NCT00300391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497548|NCT00300391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25497549|NCT00300430|Calcium, Dietary|calcium, dietary|mesh-list
25497550|NCT00300430|Atorvastatin|atorvastatin|mesh-list
25497551|NCT00300430|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25497552|NCT00300430|Simvastatin|simvastatin|mesh-list
25497553|NCT00300430|Fenofibrate|fenofibrate|mesh-list
25497554|NCT00300430|Calcium|calcium|mesh-list
25497555|NCT00300430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25497556|NCT00300430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497557|NCT00300430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25497558|NCT00300430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25497559|NCT00300430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25497560|NCT00300430|Antimetabolites|antimetabolites|mesh-ancestor
25497561|NCT00300430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497562|NCT00300430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25497563|NCT00300430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25497564|NCT00300430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497565|NCT00300456|Simvastatin|simvastatin|mesh-list
25497566|NCT00300456|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25497567|NCT00300456|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25497568|NCT00300456|Antimetabolites|antimetabolites|mesh-ancestor
25372188|NCT04979065|Vitamin D|vitamin d|mesh-list
25497569|NCT00300456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497570|NCT00300456|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25497571|NCT00300456|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25497572|NCT00300456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497573|NCT00300469|Atorvastatin|atorvastatin|mesh-list
25497574|NCT00300469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25497575|NCT00300469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25497576|NCT00300469|Antimetabolites|antimetabolites|mesh-ancestor
25497577|NCT00300469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497578|NCT00300469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25497579|NCT00300469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25497580|NCT00300469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24677267|NCT01355354|Digoxin|digoxin|mesh-list
25497581|NCT00300482|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25106095|NCT04469959|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24784007|NCT01905215|Vaccines|vaccines|mesh-list
25106096|NCT04469959|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25106097|NCT04469959|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25645480|NCT01448213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25645481|NCT01448213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645482|NCT01448213|Antiemetics|antiemetics|mesh-ancestor
25645483|NCT01448213|Autonomic Agents|autonomic agents|mesh-ancestor
25645484|NCT01448213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25106098|NCT04469959|Dopamine Agents|dopamine agents|mesh-ancestor
25106099|NCT04469959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24450336|NCT00318773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25081321|NCT03331263|Chlorhexidine|chlorhexidine|mesh-list
24982362|NCT02913664|Angiotensin II|angiotensin ii|mesh-list
24982363|NCT02913664|Giapreza|giapreza|mesh-list
24982364|NCT02913664|Calcium|calcium|mesh-list
25497582|NCT00300482|Calcium|calcium|mesh-list
25497583|NCT00300482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25497584|NCT00300482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497585|NCT00300482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25497586|NCT00300482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25497587|NCT00300482|Antimetabolites|antimetabolites|mesh-ancestor
25497588|NCT00300482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497589|NCT00300482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25497590|NCT00300482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25497591|NCT00300482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497592|NCT00300495|Amiodarone|amiodarone|mesh-list
25497593|NCT00300495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25497594|NCT00300495|Vasodilator Agents|vasodilator agents|mesh-ancestor
25497595|NCT00300495|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25497596|NCT00300495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25497597|NCT00300495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497598|NCT00300495|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25497599|NCT00300495|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25497600|NCT00300495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25497601|NCT00300495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497602|NCT00300495|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25497603|NCT00300495|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25497604|NCT00300495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25497605|NCT00300677|Voriconazole|voriconazole|mesh-list
25497606|NCT00300677|Antifungal Agents|antifungal agents|mesh-ancestor
25497607|NCT00300677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25497608|NCT00300677|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25497609|NCT00300677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25497610|NCT00300677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497611|NCT00300677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497612|NCT00300677|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25497613|NCT00300677|Hormone Antagonists|hormone antagonists|mesh-ancestor
25497614|NCT00300677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25497615|NCT00300677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497616|NCT00300677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25497617|NCT00300742|Topiramate|topiramate|mesh-list
25497618|NCT00300742|Anticonvulsants|anticonvulsants|mesh-ancestor
25497619|NCT00300742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25497620|NCT00300742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497621|NCT00300755|Pantoprazole|pantoprazole|mesh-list
25497622|NCT00300755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25497623|NCT00300755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25497624|NCT00300755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25497625|NCT00300755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497626|NCT00300755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497627|NCT00300885|Paclitaxel|paclitaxel|mesh-list
25497628|NCT00300885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25497629|NCT00300885|Carboplatin|carboplatin|mesh-list
25497630|NCT00300885|Sorafenib|sorafenib|mesh-list
25497631|NCT00300885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25497632|NCT00300885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497633|NCT00300885|Tubulin Modulators|tubulin modulators|mesh-ancestor
25013224|NCT03188705|Aspirin|aspirin|mesh-list
25013253|NCT03173456|Codeine|codeine|mesh-list
25013254|NCT03173456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25645485|NCT01448213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25013255|NCT03173456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25497634|NCT00300885|Antimitotic Agents|antimitotic agents|mesh-ancestor
25497635|NCT00300885|Mitosis Modulators|mitosis modulators|mesh-ancestor
25497636|NCT00300885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497637|NCT00300885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25497638|NCT00300885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497639|NCT00301028|Paclitaxel|paclitaxel|mesh-list
25497640|NCT00301028|Carboplatin|carboplatin|mesh-list
25497641|NCT00301028|Cetuximab|cetuximab|mesh-list
25497642|NCT00301028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25497643|NCT00301028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497644|NCT00301028|Tubulin Modulators|tubulin modulators|mesh-ancestor
25497645|NCT00301028|Antimitotic Agents|antimitotic agents|mesh-ancestor
25497646|NCT00301028|Mitosis Modulators|mitosis modulators|mesh-ancestor
25497647|NCT00301028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497648|NCT00301028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25497649|NCT00301067|Calcitriol|calcitriol|mesh-list
25497650|NCT00301067|Temozolomide|temozolomide|mesh-list
25497651|NCT00301067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25497652|NCT00301067|Alkylating Agents|alkylating agents|mesh-ancestor
25497653|NCT00301067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497654|NCT00301067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497655|NCT00301067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25497656|NCT00301067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497657|NCT00301067|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25497658|NCT00301067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25497659|NCT00301067|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25497660|NCT00301067|Vitamins|vitamins|mesh-ancestor
25497661|NCT00301067|Micronutrients|micronutrients|mesh-ancestor
25497662|NCT00301067|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25497663|NCT00301366|Protease Inhibitors|protease inhibitors|mesh-list
25497664|NCT00301366|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25497665|NCT00301366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497666|NCT00301366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497667|NCT00301366|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25497668|NCT00301366|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25497669|NCT00301418|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25497670|NCT00301418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497671|NCT00301418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25497672|NCT00301418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497673|NCT00301418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497674|NCT00301756|Belinostat|belinostat|mesh-list
25497675|NCT00301756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497676|NCT00301756|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25497677|NCT00301756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497678|NCT00301756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497679|NCT00301808|Cisplatin|cisplatin|mesh-list
25497680|NCT00301808|Docetaxel|docetaxel|mesh-list
25497681|NCT00301808|Pemetrexed|pemetrexed|mesh-list
25497682|NCT00301808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497683|NCT00301808|Tubulin Modulators|tubulin modulators|mesh-ancestor
25372344|NCT04972968|Hormones|hormones|mesh-ancestor
25497684|NCT00301808|Antimitotic Agents|antimitotic agents|mesh-ancestor
25497685|NCT00301808|Mitosis Modulators|mitosis modulators|mesh-ancestor
25497686|NCT00301808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497687|NCT00301808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497688|NCT00301808|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25497689|NCT00301808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25497690|NCT00301821|Prednisone|prednisone|mesh-list
25497691|NCT00301821|Cyclophosphamide|cyclophosphamide|mesh-list
25497692|NCT00301821|Rituximab|rituximab|mesh-list
25497693|NCT00301821|Doxorubicin|doxorubicin|mesh-list
25497694|NCT00301821|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25497695|NCT00301821|Vincristine|vincristine|mesh-list
25497696|NCT00301821|Epratuzumab|epratuzumab|mesh-list
25497697|NCT00301821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25497698|NCT00301821|Immunologic Factors|immunologic factors|mesh-ancestor
25497699|NCT00301821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497700|NCT00301821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25497701|NCT00301821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25497702|NCT00301821|Alkylating Agents|alkylating agents|mesh-ancestor
25497703|NCT00301821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497704|NCT00301821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497705|NCT00301821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25497706|NCT00301821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25497707|NCT00301821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25497708|NCT00301821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25645486|NCT01448213|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25645487|NCT01448213|Protective Agents|protective agents|mesh-ancestor
25645488|NCT01448213|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25497709|NCT00301821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25497710|NCT00301821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497711|NCT00301821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25497712|NCT00301821|Glucocorticoids|glucocorticoids|mesh-ancestor
25497713|NCT00301821|Hormones|hormones|mesh-ancestor
25497714|NCT00301821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25497715|NCT00301821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25497716|NCT00301821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25497717|NCT00301821|Tubulin Modulators|tubulin modulators|mesh-ancestor
25497718|NCT00301821|Antimitotic Agents|antimitotic agents|mesh-ancestor
25497719|NCT00301821|Mitosis Modulators|mitosis modulators|mesh-ancestor
25497720|NCT00301834|Cyclosporine|cyclosporine|mesh-list
25497721|NCT00301834|Methylprednisolone|methylprednisolone|mesh-list
25497722|NCT00301834|Methotrexate|methotrexate|mesh-list
24796545|NCT01950585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24796546|NCT01950611|Bortezomib|bortezomib|mesh-list
25033180|NCT03575637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033181|NCT03575637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25033182|NCT03575637|Serotonin Agents|serotonin agents|mesh-ancestor
25033183|NCT03575598|Nivolumab|nivolumab|mesh-list
25033184|NCT03575598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25033185|NCT03575598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497723|NCT00301834|Fludarabine phosphate|fludarabine phosphate|mesh-list
25497724|NCT00301834|Fludarabine|fludarabine|mesh-list
25497725|NCT00301834|Busulfan|busulfan|mesh-list
25497726|NCT00301834|Alemtuzumab|alemtuzumab|mesh-list
25497727|NCT00301834|Cyclosporins|cyclosporins|mesh-list
25497728|NCT00301834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25497729|NCT00301834|Abortifacient Agents|abortifacient agents|mesh-ancestor
25497730|NCT00301834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25497731|NCT00301834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497732|NCT00301834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25497733|NCT00301834|Antimetabolites|antimetabolites|mesh-ancestor
25497734|NCT00301834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497735|NCT00301834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497736|NCT00301834|Dermatologic Agents|dermatologic agents|mesh-ancestor
25497737|NCT00301834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497738|NCT00301834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25497739|NCT00301834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25497740|NCT00301834|Immunologic Factors|immunologic factors|mesh-ancestor
25497741|NCT00301834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25497742|NCT00301834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25497743|NCT00301834|Antifungal Agents|antifungal agents|mesh-ancestor
25497744|NCT00301834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25497745|NCT00301834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25497746|NCT00301834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25497747|NCT00301834|Antiemetics|antiemetics|mesh-ancestor
25497748|NCT00301834|Autonomic Agents|autonomic agents|mesh-ancestor
25497749|NCT00301834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25497750|NCT00301834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25497751|NCT00301834|Glucocorticoids|glucocorticoids|mesh-ancestor
25497752|NCT00301834|Hormones|hormones|mesh-ancestor
25497753|NCT00301834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25497754|NCT00301834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25497755|NCT00301834|Protective Agents|protective agents|mesh-ancestor
25497756|NCT00301834|Alkylating Agents|alkylating agents|mesh-ancestor
25497757|NCT00301834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25497758|NCT00301834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25497759|NCT00301834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25497760|NCT00301873|Zoledronic Acid|zoledronic acid|mesh-list
25497761|NCT00301873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25497762|NCT00301873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497763|NCT00301964|Bevacizumab|bevacizumab|mesh-list
25497764|NCT00301964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25497765|NCT00301964|Antibodies|antibodies|mesh-list
25497766|NCT00301964|Immunoglobulins|immunoglobulins|mesh-list
25497767|NCT00301964|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25497768|NCT00301964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497769|NCT00301964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25497770|NCT00301964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25497771|NCT00301964|Growth Substances|growth substances|mesh-ancestor
25497772|NCT00301964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497773|NCT00301964|Growth Inhibitors|growth inhibitors|mesh-ancestor
25497774|NCT00301964|Immunologic Factors|immunologic factors|mesh-ancestor
25497775|NCT00302003|Cytarabine|cytarabine|mesh-list
25497776|NCT00302003|Dexamethasone|dexamethasone|mesh-list
25497777|NCT00302003|Prednisone|prednisone|mesh-list
25497778|NCT00302003|Cyclophosphamide|cyclophosphamide|mesh-list
25497779|NCT00302003|Ifosfamide|ifosfamide|mesh-list
25497780|NCT00302003|Doxorubicin|doxorubicin|mesh-list
25497781|NCT00302003|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25497782|NCT00302003|Etoposide|etoposide|mesh-list
25497783|NCT00302003|Vincristine|vincristine|mesh-list
25497784|NCT00302003|Vinorelbine|vinorelbine|mesh-list
25497785|NCT00302003|Etoposide phosphate|etoposide phosphate|mesh-list
25497786|NCT00302003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25497787|NCT00302003|Immunologic Factors|immunologic factors|mesh-ancestor
25497788|NCT00302003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497789|NCT00302003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25497790|NCT00302003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24988635|NCT02143063|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24988636|NCT02143063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24621416|NCT01062282|Iloprost|iloprost|mesh-list
24988637|NCT02143063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24988638|NCT02143063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988639|NCT02143063|Dopamine Agents|dopamine agents|mesh-ancestor
24990429|NCT03038594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24990431|NCT03009838|Letrozole|letrozole|mesh-list
25497791|NCT00302003|Alkylating Agents|alkylating agents|mesh-ancestor
25497792|NCT00302003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497793|NCT00302003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497794|NCT00302003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25497795|NCT00302003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25497796|NCT00302003|Antiemetics|antiemetics|mesh-ancestor
25497797|NCT00302003|Autonomic Agents|autonomic agents|mesh-ancestor
25497798|NCT00302003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25497799|NCT00302003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25497800|NCT00302003|Glucocorticoids|glucocorticoids|mesh-ancestor
25497801|NCT00302003|Hormones|hormones|mesh-ancestor
25497802|NCT00302003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25497803|NCT00302003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25497804|NCT00302003|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25497805|NCT00302003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25497806|NCT00302003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25497807|NCT00302003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497808|NCT00302003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25497809|NCT00302003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25497810|NCT00302003|Antimetabolites|antimetabolites|mesh-ancestor
25497811|NCT00302003|Antiviral Agents|antiviral agents|mesh-ancestor
25497812|NCT00302003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25497813|NCT00302003|Tubulin Modulators|tubulin modulators|mesh-ancestor
25497814|NCT00302003|Antimitotic Agents|antimitotic agents|mesh-ancestor
25497815|NCT00302003|Mitosis Modulators|mitosis modulators|mesh-ancestor
25497816|NCT00302068|Sertraline|sertraline|mesh-list
25497817|NCT00302068|Antidepressive Agents|antidepressive agents|mesh-ancestor
25497818|NCT00302068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25497819|NCT00302068|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25497820|NCT00302068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25497821|NCT00302068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25497822|NCT00302068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497823|NCT00302068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25497824|NCT00302068|Serotonin Agents|serotonin agents|mesh-ancestor
25497825|NCT00302068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497826|NCT00302081|Ribavirin|ribavirin|mesh-list
25497827|NCT00302081|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25497828|NCT00302081|Interferon-alpha|interferon-alpha|mesh-list
25497829|NCT00302081|Antimetabolites|antimetabolites|mesh-ancestor
25497830|NCT00302081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497831|NCT00302081|Antiviral Agents|antiviral agents|mesh-ancestor
25497832|NCT00302081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25497833|NCT00302081|Immunologic Factors|immunologic factors|mesh-ancestor
25497834|NCT00302081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497835|NCT00302107|Mirtazapine|mirtazapine|mesh-list
25497836|NCT00302107|Antidepressive Agents|antidepressive agents|mesh-ancestor
25497837|NCT00302107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25497838|NCT00302107|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25497839|NCT00302107|Histamine Antagonists|histamine antagonists|mesh-ancestor
25497840|NCT00302107|Histamine Agents|histamine agents|mesh-ancestor
25497841|NCT00302107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25408473|NCT03437746|Methylprednisolone|methylprednisolone|mesh-list
25497842|NCT00302107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497843|NCT00302107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497844|NCT00302107|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25497845|NCT00302107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25497846|NCT00302107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25497847|NCT00302107|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25497848|NCT00302107|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25497849|NCT00302107|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25497850|NCT00302107|Adrenergic Agents|adrenergic agents|mesh-ancestor
25497851|NCT00302107|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25497852|NCT00302107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25497853|NCT00302107|Serotonin Agents|serotonin agents|mesh-ancestor
25497854|NCT00302107|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25497855|NCT00302133|Naltrexone|naltrexone|mesh-list
25497856|NCT00302133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25497857|NCT00302133|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25497858|NCT00302133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497859|NCT00302133|Sensory System Agents|sensory system agents|mesh-ancestor
24993374|NCT05077449|Fulvestrant|fulvestrant|mesh-list
24993375|NCT05077449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24993376|NCT05077449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993377|NCT05077449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24993378|NCT05077449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24775729|NCT01854502|Fluorides|fluorides|mesh-list
25497860|NCT00302133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25497861|NCT00302159|Temozolomide|temozolomide|mesh-list
25497862|NCT00302159|Valproic Acid|valproic acid|mesh-list
25497863|NCT00302159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25497864|NCT00302159|Alkylating Agents|alkylating agents|mesh-ancestor
25497865|NCT00302159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497866|NCT00302159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497867|NCT00302159|Anticonvulsants|anticonvulsants|mesh-ancestor
25497868|NCT00302159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497869|NCT00302159|GABA Agents|gaba agents|mesh-ancestor
25497870|NCT00302159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25497871|NCT00302159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497872|NCT00302159|Antimanic Agents|antimanic agents|mesh-ancestor
25497873|NCT00302159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25497874|NCT00302159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25497875|NCT00302159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25497876|NCT00302211|Bosentan|bosentan|mesh-list
25497877|NCT00302211|Sildenafil Citrate|sildenafil citrate|mesh-list
25497878|NCT00302211|Iloprost|iloprost|mesh-list
25497879|NCT00302211|Vasodilator Agents|vasodilator agents|mesh-ancestor
25497880|NCT00302211|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25497881|NCT00302211|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25497882|NCT00302211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497883|NCT00302211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497884|NCT00302211|Urological Agents|urological agents|mesh-ancestor
25497885|NCT00302211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25497886|NCT00302211|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25497887|NCT00302211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25497888|NCT00302458|Methylphenidate|methylphenidate|mesh-list
25497889|NCT00302458|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25497890|NCT00302458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497891|NCT00302458|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25497892|NCT00302458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25497893|NCT00302458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25497894|NCT00302458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497895|NCT00302458|Dopamine Agents|dopamine agents|mesh-ancestor
25497896|NCT00302458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25497897|NCT00302731|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25497898|NCT00302731|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25497899|NCT00302731|Hormones|hormones|mesh-list
25497900|NCT00302731|Estradiol|estradiol|mesh-list
25497901|NCT00302731|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25497902|NCT00302731|Progesterone|progesterone|mesh-list
25497903|NCT00302731|Estrogens|estrogens|mesh-list
25497904|NCT00302731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25497905|NCT00302731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497906|NCT00302731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25497907|NCT00302731|Contraceptive Agents|contraceptive agents|mesh-ancestor
25497908|NCT00302731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25645489|NCT01448486|Raltegravir Potassium|raltegravir potassium|mesh-list
25497909|NCT00302731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25497910|NCT00302731|Progestins|progestins|mesh-ancestor
25497911|NCT00302848|Drospirenone|drospirenone|mesh-list
25497912|NCT00302848|Contraceptive Agents|contraceptive agents|mesh-list
25497913|NCT00302848|Levonorgestrel|levonorgestrel|mesh-list
25497914|NCT00302848|Contraceptives, Oral|contraceptives, oral|mesh-list
25497915|NCT00302848|Progestins|progestins|mesh-list
25497916|NCT00302848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25497917|NCT00302848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497918|NCT00302848|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25497919|NCT00302848|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25497920|NCT00302848|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25497921|NCT00302848|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25497922|NCT00302848|Hormone Antagonists|hormone antagonists|mesh-ancestor
25497923|NCT00302848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25497924|NCT00302848|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25497925|NCT00302848|Diuretics|diuretics|mesh-ancestor
25497926|NCT00302848|Natriuretic Agents|natriuretic agents|mesh-ancestor
24871761|NCT04821830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776127|NCT01856946|Vitamin D|vitamin d|mesh-list
24833472|NCT02174068|Sensory System Agents|sensory system agents|mesh-ancestor
24833473|NCT02174068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24833478|NCT02174094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24834193|NCT02177409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24843987|NCT02230371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497928|NCT00303108|Carboplatin|carboplatin|mesh-list
25497929|NCT00303108|Doxorubicin|doxorubicin|mesh-list
25497930|NCT00303108|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25497931|NCT00303108|Trastuzumab|trastuzumab|mesh-list
25497932|NCT00303108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497933|NCT00303108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25497934|NCT00303108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25497935|NCT00303108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25497936|NCT00303108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497937|NCT00303108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497938|NCT00303108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25497939|NCT00303316|Vaccines|vaccines|mesh-list
25497940|NCT00303316|Immunologic Factors|immunologic factors|mesh-ancestor
25497941|NCT00303316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497942|NCT00303329|Deferasirox|deferasirox|mesh-list
25497943|NCT00303329|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25497944|NCT00303329|Chelating Agents|chelating agents|mesh-ancestor
25497945|NCT00303329|Sequestering Agents|sequestering agents|mesh-ancestor
25497946|NCT00303329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497947|NCT00303446|Dutasteride|dutasteride|mesh-list
25497948|NCT00303446|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25497949|NCT00303446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25497950|NCT00303446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25497951|NCT00303446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497952|NCT00303446|Hormone Antagonists|hormone antagonists|mesh-ancestor
25497953|NCT00303446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25497954|NCT00303446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497955|NCT00303459|Bosentan|bosentan|mesh-list
25497956|NCT00303459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25497957|NCT00303459|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25497958|NCT00303459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497959|NCT00303485|Vitamin D|vitamin d|mesh-list
25497960|NCT00303485|Ibandronic Acid|ibandronic acid|mesh-list
25497961|NCT00303485|Calcium|calcium|mesh-list
25497962|NCT00303485|Vitamins|vitamins|mesh-ancestor
25497963|NCT00303485|Micronutrients|micronutrients|mesh-ancestor
25497964|NCT00303485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497965|NCT00303485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25497966|NCT00303485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25497967|NCT00303602|Olanzapine|olanzapine|mesh-list
25497968|NCT00303602|Antiemetics|antiemetics|mesh-ancestor
25497969|NCT00303602|Autonomic Agents|autonomic agents|mesh-ancestor
25497970|NCT00303602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25497971|NCT00303602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497972|NCT00303602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25497973|NCT00303602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25497974|NCT00303602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25497975|NCT00303602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25497976|NCT00303602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25497977|NCT00303602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25497978|NCT00303602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25497979|NCT00303602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25497980|NCT00303602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25497981|NCT00303602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25497982|NCT00303602|Serotonin Agents|serotonin agents|mesh-ancestor
25497983|NCT00303628|Leucovorin|leucovorin|mesh-list
25497984|NCT00303628|Bevacizumab|bevacizumab|mesh-list
25497985|NCT00303628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25497986|NCT00303628|Fluorouracil|fluorouracil|mesh-list
25497987|NCT00303628|Oxaliplatin|oxaliplatin|mesh-list
25497988|NCT00303628|Antibodies|antibodies|mesh-list
25497989|NCT00303628|Immunoglobulins|immunoglobulins|mesh-list
25497990|NCT00303628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25497991|NCT00303628|Levoleucovorin|levoleucovorin|mesh-list
25497992|NCT00303628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25497993|NCT00303628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25823164|NCT00004759|Prednisolone|prednisolone|mesh-list
25823165|NCT00004759|Prednisolone acetate|prednisolone acetate|mesh-list
25823166|NCT00004759|Tirilazad|tirilazad|mesh-list
25823167|NCT00004759|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25823168|NCT00004759|Prednisolone phosphate|prednisolone phosphate|mesh-list
25823169|NCT00004759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25823170|NCT00004759|Antiemetics|antiemetics|mesh-ancestor
25497994|NCT00303628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25497995|NCT00303628|Growth Substances|growth substances|mesh-ancestor
25497996|NCT00303628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25497997|NCT00303628|Growth Inhibitors|growth inhibitors|mesh-ancestor
25497998|NCT00303628|Immunologic Factors|immunologic factors|mesh-ancestor
25497999|NCT00303628|Antimetabolites|antimetabolites|mesh-ancestor
25498000|NCT00303628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498001|NCT00303628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25498002|NCT00303628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25498003|NCT00303628|Antidotes|antidotes|mesh-ancestor
25498004|NCT00303628|Protective Agents|protective agents|mesh-ancestor
25498005|NCT00303628|Vitamin B Complex|vitamin b complex|mesh-ancestor
25498006|NCT00303628|Vitamins|vitamins|mesh-ancestor
25498007|NCT00303628|Micronutrients|micronutrients|mesh-ancestor
25498008|NCT00303667|Vidarabine|vidarabine|mesh-list
25498009|NCT00303667|Aldesleukin|aldesleukin|mesh-list
25498010|NCT00303667|Cyclosporine|cyclosporine|mesh-list
25498011|NCT00303667|Cyclophosphamide|cyclophosphamide|mesh-list
25498012|NCT00303667|Fludarabine|fludarabine|mesh-list
25498013|NCT00303667|Fludarabine phosphate|fludarabine phosphate|mesh-list
25498014|NCT00303667|Interleukin-2|interleukin-2|mesh-list
25498015|NCT00303667|Cyclosporins|cyclosporins|mesh-list
25498016|NCT00303667|Thymoglobulin|thymoglobulin|mesh-list
25498017|NCT00303667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25498018|NCT00303667|Immunologic Factors|immunologic factors|mesh-ancestor
25498019|NCT00303667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498020|NCT00303667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25498021|NCT00303667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25498022|NCT00303667|Alkylating Agents|alkylating agents|mesh-ancestor
25498023|NCT00303667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498024|NCT00303667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498025|NCT00303667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25498026|NCT00303667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25498027|NCT00303667|Antimetabolites|antimetabolites|mesh-ancestor
25498028|NCT00303667|Antiviral Agents|antiviral agents|mesh-ancestor
25498029|NCT00303667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25498030|NCT00303667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498031|NCT00303667|Antifungal Agents|antifungal agents|mesh-ancestor
25498032|NCT00303667|Dermatologic Agents|dermatologic agents|mesh-ancestor
25498033|NCT00303667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25498034|NCT00303667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25498035|NCT00303667|Analgesics|analgesics|mesh-ancestor
25498036|NCT00303667|Sensory System Agents|sensory system agents|mesh-ancestor
25498037|NCT00303667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25498038|NCT00303667|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25498039|NCT00303667|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25498040|NCT00303719|Cyclosporine|cyclosporine|mesh-list
25498041|NCT00303719|Mycophenolic Acid|mycophenolic acid|mesh-list
25498042|NCT00303719|Cyclophosphamide|cyclophosphamide|mesh-list
25498043|NCT00303719|Fludarabine|fludarabine|mesh-list
25498044|NCT00303719|Cyclosporins|cyclosporins|mesh-list
25498045|NCT00303719|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25498046|NCT00303719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25498047|NCT00303719|Immunologic Factors|immunologic factors|mesh-ancestor
25498048|NCT00303719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498049|NCT00303719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25823171|NCT00004759|Autonomic Agents|autonomic agents|mesh-ancestor
25498052|NCT00303719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498053|NCT00303719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498054|NCT00303719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25498055|NCT00303719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498056|NCT00303719|Antifungal Agents|antifungal agents|mesh-ancestor
25498057|NCT00303719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25498058|NCT00303719|Dermatologic Agents|dermatologic agents|mesh-ancestor
25498059|NCT00303719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25498060|NCT00303719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25498061|NCT00303719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25498062|NCT00303719|Antitubercular Agents|antitubercular agents|mesh-ancestor
25033587|NCT03572257|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24876527|NCT03449238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24875336|NCT04220008|Gemcitabine|gemcitabine|mesh-list
24875337|NCT04220008|Mycophenolic Acid|mycophenolic acid|mesh-list
24875728|NCT03896269|Daunorubicin|daunorubicin|mesh-list
24875729|NCT03896269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24875730|NCT03896269|Antimetabolites|antimetabolites|mesh-ancestor
24875780|NCT03839823|Capecitabine|capecitabine|mesh-list
25498063|NCT00303719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25498064|NCT00303823|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
25498066|NCT00303823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498067|NCT00303823|Protective Agents|protective agents|mesh-ancestor
25498068|NCT00303823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498069|NCT00303823|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25498070|NCT00303823|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25498071|NCT00303823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498072|NCT00303823|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25498074|NCT00303862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498075|NCT00303862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498076|NCT00303862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498077|NCT00303862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25498078|NCT00303953|Belinostat|belinostat|mesh-list
25498079|NCT00303953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498080|NCT00303953|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25498081|NCT00303953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498082|NCT00303953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498083|NCT00303966|Sorafenib|sorafenib|mesh-list
25498084|NCT00303966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498085|NCT00303966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25498086|NCT00303966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498087|NCT00303966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498088|NCT00304031|Temozolomide|temozolomide|mesh-list
25498089|NCT00304031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25498090|NCT00304031|Alkylating Agents|alkylating agents|mesh-ancestor
25498091|NCT00304031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498092|NCT00304031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498093|NCT00304083|Doxorubicin|doxorubicin|mesh-list
25498094|NCT00304083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25498095|NCT00304083|Etoposide|etoposide|mesh-list
25498096|NCT00304083|Ifosfamide|ifosfamide|mesh-list
25498097|NCT00304083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25498098|NCT00304083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498099|NCT00304083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25498100|NCT00304083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25498101|NCT00304083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498102|NCT00304083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498103|NCT00304083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25498104|NCT00304083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25498105|NCT00304083|Alkylating Agents|alkylating agents|mesh-ancestor
25498106|NCT00304096|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25498107|NCT00304096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25498108|NCT00304096|Immunologic Factors|immunologic factors|mesh-ancestor
25498109|NCT00304096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498110|NCT00304161|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25498111|NCT00304161|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25498112|NCT00304161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25498113|NCT00304161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25498114|NCT00304161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645491|NCT01448486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25645492|NCT01448486|Antiviral Agents|antiviral agents|mesh-ancestor
25498115|NCT00304161|Adrenergic Agents|adrenergic agents|mesh-ancestor
25498116|NCT00304161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25498117|NCT00304161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645493|NCT01448486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25498118|NCT00304187|Erythromycin|erythromycin|mesh-list
25498119|NCT00304187|Erythromycin Estolate|erythromycin estolate|mesh-list
25498120|NCT00304187|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25498121|NCT00304187|Erythromycin stearate|erythromycin stearate|mesh-list
25498122|NCT00304187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25498123|NCT00304187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25498124|NCT00304187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25498125|NCT00304187|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25498126|NCT00304187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498127|NCT00304187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498128|NCT00304278|Cisplatin|cisplatin|mesh-list
25498129|NCT00304278|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25498130|NCT00304278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498131|NCT00304278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24878674|NCT01281176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878675|NCT01281176|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24878676|NCT01281176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498151|NCT00304746|Testosterone|testosterone|mesh-list
25498152|NCT00304746|Androgens|androgens|mesh-ancestor
25498153|NCT00304746|Hormones|hormones|mesh-ancestor
25498154|NCT00304746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25498155|NCT00304746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498156|NCT05267847|Anesthetics|anesthetics|mesh-list
25498157|NCT05267847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25498158|NCT05267847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498159|NCT05267457|Vanadium|vanadium|mesh-list
25498160|NCT05267457|Trace Elements|trace elements|mesh-ancestor
25498161|NCT05267457|Micronutrients|micronutrients|mesh-ancestor
25498162|NCT05267457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498163|NCT05267392|Durvalumab|durvalumab|mesh-list
25498164|NCT05267392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25498165|NCT05267392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498166|NCT05267366|Bevacizumab|bevacizumab|mesh-list
25498167|NCT05267366|Cisplatin|cisplatin|mesh-list
25498168|NCT05267366|Carboplatin|carboplatin|mesh-list
25498169|NCT05267366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25498170|NCT05267366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25498171|NCT05267366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498172|NCT05267366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25498173|NCT05267366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25498174|NCT05267366|Growth Substances|growth substances|mesh-ancestor
25498175|NCT05267366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498176|NCT05267366|Growth Inhibitors|growth inhibitors|mesh-ancestor
25498177|NCT05267366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889577|NCT04491786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889578|NCT04491786|Anticonvulsants|anticonvulsants|mesh-ancestor
24889579|NCT04491786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24889580|NCT04491786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24467182|NCT00376480|Hormones|hormones|mesh-ancestor
24863349|NCT05146089|Bosentan|bosentan|mesh-list
24890501|NCT04482985|Histamine Agents|histamine agents|mesh-ancestor
25498178|NCT05267288|Afatinib|afatinib|mesh-list
25498179|NCT05267288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498180|NCT05267288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25498181|NCT05267288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498182|NCT05267288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498183|NCT05266937|Paclitaxel|paclitaxel|mesh-list
25498184|NCT05266937|Carboplatin|carboplatin|mesh-list
25498185|NCT05266937|Atezolizumab|atezolizumab|mesh-list
25498186|NCT05266937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25498187|NCT05266937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498188|NCT05266937|Tubulin Modulators|tubulin modulators|mesh-ancestor
25498189|NCT05266937|Antimitotic Agents|antimitotic agents|mesh-ancestor
25498190|NCT05266937|Mitosis Modulators|mitosis modulators|mesh-ancestor
25498191|NCT05266937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498192|NCT05266820|Thalidomide|thalidomide|mesh-list
25498193|NCT05266820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25645494|NCT01448486|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25645495|NCT01448486|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25645496|NCT01448486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645497|NCT01448486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498194|NCT05266820|Immunologic Factors|immunologic factors|mesh-ancestor
25498195|NCT05266820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498196|NCT05266820|Leprostatic Agents|leprostatic agents|mesh-ancestor
25498197|NCT05266820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25498198|NCT05266820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25498199|NCT05266820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25498200|NCT05266820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25498201|NCT05266820|Growth Substances|growth substances|mesh-ancestor
25498202|NCT05266820|Growth Inhibitors|growth inhibitors|mesh-ancestor
25498203|NCT05266820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498204|NCT05266794|Selenium|selenium|mesh-list
25498205|NCT05266794|Thioctic Acid|thioctic acid|mesh-list
25498206|NCT05266794|Antioxidants|antioxidants|mesh-ancestor
25498207|NCT05266794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498208|NCT05266794|Protective Agents|protective agents|mesh-ancestor
25498209|NCT05266794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498210|NCT05266794|Trace Elements|trace elements|mesh-ancestor
25498211|NCT05266794|Micronutrients|micronutrients|mesh-ancestor
25498212|NCT05266794|Vitamin B Complex|vitamin b complex|mesh-ancestor
25498213|NCT05266794|Vitamins|vitamins|mesh-ancestor
25498214|NCT05266716|Methamphetamine|methamphetamine|mesh-list
25498215|NCT05266716|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25498216|NCT05266716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498217|NCT05266716|Sympathomimetics|sympathomimetics|mesh-ancestor
25498218|NCT05266716|Autonomic Agents|autonomic agents|mesh-ancestor
25498219|NCT05266716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25498220|NCT05266716|Dopamine Agents|dopamine agents|mesh-ancestor
25498221|NCT05266716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25498222|NCT05266716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498223|NCT05266716|Adrenergic Agents|adrenergic agents|mesh-ancestor
25498224|NCT05266716|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25498225|NCT05266716|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25498226|NCT05266716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25498227|NCT05266716|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25498228|NCT05266690|Dextrans|dextrans|mesh-list
25498229|NCT05266690|Anticoagulants|anticoagulants|mesh-ancestor
25498230|NCT05266690|Plasma Substitutes|plasma substitutes|mesh-ancestor
25498231|NCT05266690|Blood Substitutes|blood substitutes|mesh-ancestor
25498232|NCT05266651|Tadalafil|tadalafil|mesh-list
25498233|NCT05266651|Vasodilator Agents|vasodilator agents|mesh-ancestor
25498234|NCT05266651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25498235|NCT05266651|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25498236|NCT05266651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498237|NCT05266651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498238|NCT05266651|Urological Agents|urological agents|mesh-ancestor
25498239|NCT05266560|Propofol|propofol|mesh-list
25498240|NCT05266560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25498241|NCT05266560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25498242|NCT05266560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498243|NCT05266560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25498244|NCT05266560|Anesthetics, General|anesthetics, general|mesh-ancestor
25498245|NCT05266560|Anesthetics|anesthetics|mesh-ancestor
24879149|NCT04985500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24879150|NCT04985500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879151|NCT04985500|Sensory System Agents|sensory system agents|mesh-ancestor
24879152|NCT04985500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489962|NCT00476073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24894798|NCT05387603|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
24894799|NCT05387603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25498246|NCT05266534|Terlipressin|terlipressin|mesh-list
25498247|NCT05266534|Carbetocin|carbetocin|mesh-list
25498248|NCT05266534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25498249|NCT05266534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25498250|NCT05266534|Oxytocics|oxytocics|mesh-ancestor
25498251|NCT05266534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25498252|NCT05266534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498253|NCT05266274|Azacitidine|azacitidine|mesh-list
25498254|NCT05266274|Antibodies|antibodies|mesh-list
25498255|NCT05266274|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25498256|NCT05266274|Immunologic Factors|immunologic factors|mesh-ancestor
25498257|NCT05266274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498258|NCT05266274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25645499|NCT01448525|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25498259|NCT05266274|Antimetabolites|antimetabolites|mesh-ancestor
25498260|NCT05266274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498261|NCT05266274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498262|NCT05266274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498263|NCT05266261|Cholecalciferol|cholecalciferol|mesh-list
25498264|NCT05266261|Ibandronic Acid|ibandronic acid|mesh-list
25498265|NCT05266261|Calcium Carbonate|calcium carbonate|mesh-list
25498266|NCT05266261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25498267|NCT05266261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498268|NCT05266261|Vitamins|vitamins|mesh-ancestor
25498269|NCT05266261|Micronutrients|micronutrients|mesh-ancestor
25498270|NCT05266261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25498271|NCT05266261|Antacids|antacids|mesh-ancestor
25498272|NCT05266261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498273|NCT05266261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25498274|NCT05266196|Cyclophosphamide|cyclophosphamide|mesh-list
25498275|NCT05266196|Topotecan|topotecan|mesh-list
25498276|NCT05266196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25498277|NCT05266196|Immunologic Factors|immunologic factors|mesh-ancestor
25498278|NCT05266196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498279|NCT05266196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25498280|NCT05266196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25498281|NCT05266196|Alkylating Agents|alkylating agents|mesh-ancestor
25498282|NCT05266196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498283|NCT05266196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498284|NCT05266196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25498285|NCT05266196|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25498286|NCT05266196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25498287|NCT05266196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498288|NCT05266105|Palbociclib|palbociclib|mesh-list
25498289|NCT05266105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498290|NCT05266105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25498291|NCT05266105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498292|NCT05266105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498293|NCT05266040|Valacyclovir|valacyclovir|mesh-list
25498294|NCT05266040|Antiviral Agents|antiviral agents|mesh-ancestor
25498295|NCT05266040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25498296|NCT05265962|Decitabine|decitabine|mesh-list
25498297|NCT05265962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25498298|NCT05265962|Antimetabolites|antimetabolites|mesh-ancestor
25498299|NCT05265962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498300|NCT05265962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498301|NCT05265962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498302|NCT05265819|Hormones|hormones|mesh-list
25498303|NCT05265819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25498304|NCT05265819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498305|NCT05265793|Apatinib|apatinib|mesh-list
25498306|NCT05265793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498307|NCT05265793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25498308|NCT05265793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498309|NCT05265793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498310|NCT05240781|Sirolimus|sirolimus|mesh-list
25498311|NCT05240781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25498312|NCT05240781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25498313|NCT05240781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25498314|NCT05240781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498315|NCT05240781|Antifungal Agents|antifungal agents|mesh-ancestor
25498316|NCT05240781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25498317|NCT05240781|Immunologic Factors|immunologic factors|mesh-ancestor
25498318|NCT05240781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498319|NCT05237596|Acetaminophen|acetaminophen|mesh-list
25498320|NCT05237596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25498321|NCT05237596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25498322|NCT05237596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25498323|NCT05237596|Analgesics|analgesics|mesh-ancestor
25498324|NCT05237596|Sensory System Agents|sensory system agents|mesh-ancestor
25498325|NCT05237596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25498326|NCT05237596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498327|NCT05237596|Antipyretics|antipyretics|mesh-ancestor
25498328|NCT05237596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25498329|NCT05211804|Ranibizumab|ranibizumab|mesh-list
25645500|NCT01448525|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25498330|NCT05211804|Aflibercept|aflibercept|mesh-list
25498331|NCT05211804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498332|NCT05211804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25498333|NCT05211804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25498334|NCT05211804|Growth Substances|growth substances|mesh-ancestor
25498335|NCT05211804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498336|NCT05211804|Growth Inhibitors|growth inhibitors|mesh-ancestor
25498337|NCT05201430|Capecitabine|capecitabine|mesh-list
25498338|NCT05201430|Oxaliplatin|oxaliplatin|mesh-list
25498339|NCT05201430|Irinotecan|irinotecan|mesh-list
25498340|NCT05201430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25498341|NCT05201430|Antimetabolites|antimetabolites|mesh-ancestor
25498342|NCT05201430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498343|NCT05201430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498344|NCT05201430|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25498345|NCT05201430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25498346|NCT05201430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498347|NCT05192369|Moxifloxacin|moxifloxacin|mesh-list
25498348|NCT05192369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25498349|NCT05192369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25498350|NCT05192369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25498351|NCT05192369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25498352|NCT05192369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498353|NCT05192369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498354|NCT05192369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498355|NCT05185973|Micronutrients|micronutrients|mesh-list
25498356|NCT05185973|Trace Elements|trace elements|mesh-list
25498357|NCT05185973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498358|NCT05165485|Tiotropium Bromide|tiotropium bromide|mesh-list
25498359|NCT05165485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25498360|NCT05165485|Autonomic Agents|autonomic agents|mesh-ancestor
25498361|NCT05165485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25498362|NCT05165485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498363|NCT05165485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25498364|NCT05165485|Respiratory System Agents|respiratory system agents|mesh-ancestor
25498365|NCT05165485|Parasympatholytics|parasympatholytics|mesh-ancestor
25498366|NCT05165485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25498367|NCT05165485|Cholinergic Agents|cholinergic agents|mesh-ancestor
25498368|NCT05165485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25498369|NCT05165485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498370|NCT05156060|Ketamine|ketamine|mesh-list
25498371|NCT05156060|Gabapentin|gabapentin|mesh-list
25498372|NCT05156060|Analgesics|analgesics|mesh-ancestor
25498373|NCT05156060|Sensory System Agents|sensory system agents|mesh-ancestor
25498374|NCT05156060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25498375|NCT05156060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498376|NCT05156060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25498377|NCT05156060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25498378|NCT05156060|Anesthetics, General|anesthetics, general|mesh-ancestor
25498379|NCT05156060|Anesthetics|anesthetics|mesh-ancestor
25498380|NCT05156060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25498381|NCT05156060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25498382|NCT05156060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25498383|NCT05156060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25498384|NCT05156060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498385|NCT05156060|Anticonvulsants|anticonvulsants|mesh-ancestor
25498386|NCT05156060|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25498387|NCT05156060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25498388|NCT05156060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25498389|NCT05156060|Antimanic Agents|antimanic agents|mesh-ancestor
25161097|NCT01959698|Rituximab|rituximab|mesh-list
24957587|NCT03843541|Antiviral Agents|antiviral agents|mesh-ancestor
24957588|NCT03843541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24957649|NCT03843047|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24783462|NCT01902160|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25033983|NCT03569241|Androgens|androgens|mesh-list
25498390|NCT05117034|Morphine|morphine|mesh-list
25498391|NCT05117034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25498414|NCT04750226|Levodopa|levodopa|mesh-list
25498415|NCT04750226|Carbidopa|carbidopa|mesh-list
25498416|NCT04750226|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25498417|NCT04750226|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25498418|NCT04750226|Dopamine Agents|dopamine agents|mesh-ancestor
25498419|NCT04750226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25645501|NCT01448525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25498420|NCT04750226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498421|NCT04750226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552080|NCT04183062|Antimetabolites|antimetabolites|mesh-ancestor
25645502|NCT01448616|Tenofovir|tenofovir|mesh-list
25645503|NCT01448616|Antiviral Agents|antiviral agents|mesh-ancestor
25498422|NCT04750226|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25498423|NCT04750226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498424|NCT04641507|Tadalafil|tadalafil|mesh-list
25498425|NCT04641507|Tamsulosin|tamsulosin|mesh-list
25498426|NCT04641507|Vasodilator Agents|vasodilator agents|mesh-ancestor
25498427|NCT04641507|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25498428|NCT04641507|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25498429|NCT04641507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498430|NCT04641507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498431|NCT04641507|Urological Agents|urological agents|mesh-ancestor
25498432|NCT04641507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25498433|NCT04641507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25498434|NCT04641507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25498435|NCT04641507|Adrenergic Agents|adrenergic agents|mesh-ancestor
25498436|NCT04641507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25498437|NCT04641507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498438|NCT04617457|Leucovorin|leucovorin|mesh-list
25498439|NCT04617457|Folic Acid|folic acid|mesh-list
25498440|NCT04617457|Oxaliplatin|oxaliplatin|mesh-list
25498441|NCT04617457|Irinotecan|irinotecan|mesh-list
25498442|NCT04617457|Fluorouracil|fluorouracil|mesh-list
25498443|NCT04617457|Levoleucovorin|levoleucovorin|mesh-list
25498444|NCT04617457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498445|NCT04617457|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25498446|NCT04617457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25498447|NCT04617457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498448|NCT04617457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498449|NCT04617457|Antidotes|antidotes|mesh-ancestor
25498450|NCT04617457|Protective Agents|protective agents|mesh-ancestor
25498451|NCT04617457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498452|NCT04617457|Vitamin B Complex|vitamin b complex|mesh-ancestor
25498453|NCT04617457|Vitamins|vitamins|mesh-ancestor
25498454|NCT04617457|Micronutrients|micronutrients|mesh-ancestor
25498455|NCT04617457|Hematinics|hematinics|mesh-ancestor
25498456|NCT04617457|Antimetabolites|antimetabolites|mesh-ancestor
25498457|NCT04617457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25498458|NCT04617457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25498459|NCT04617457|Immunologic Factors|immunologic factors|mesh-ancestor
25498460|NCT04586660|Denosumab|denosumab|mesh-list
25498461|NCT04586660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25498462|NCT04586660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498463|NCT04528212|Glimepiride|glimepiride|mesh-list
25498464|NCT04528212|Curcumin|curcumin|mesh-list
25498465|NCT04528212|Fenofibrate|fenofibrate|mesh-list
25498466|NCT04528212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25498467|NCT04528212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25498468|NCT04528212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498469|NCT04528212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25498470|NCT04528212|Immunologic Factors|immunologic factors|mesh-ancestor
25498471|NCT04528212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25498472|NCT04528212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25498473|NCT04528212|Analgesics|analgesics|mesh-ancestor
25498474|NCT04528212|Sensory System Agents|sensory system agents|mesh-ancestor
25498475|NCT04528212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25498476|NCT04528212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25498477|NCT04528212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25498478|NCT04528212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498479|NCT04528212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498480|NCT04528212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498481|NCT04528212|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25498482|NCT04528212|Antimetabolites|antimetabolites|mesh-ancestor
25498483|NCT04528212|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25498484|NCT04493931|Rifampin|rifampin|mesh-list
25498485|NCT04493931|Digoxin|digoxin|mesh-list
25498486|NCT04493931|Midazolam|midazolam|mesh-list
25498487|NCT04493931|Cimetidine|cimetidine|mesh-list
25034120|NCT03567629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498488|NCT04493931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25498489|NCT04493931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25498490|NCT04493931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25498491|NCT04493931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498492|NCT04493931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25498493|NCT04493931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25645504|NCT01448616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25498494|NCT04493931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25498495|NCT04493931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25498496|NCT04493931|Anesthetics, General|anesthetics, general|mesh-ancestor
25498498|NCT04493931|GABA Modulators|gaba modulators|mesh-ancestor
25498499|NCT04493931|GABA Agents|gaba agents|mesh-ancestor
25498500|NCT04493931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25498501|NCT04493931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498502|NCT04493931|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25498503|NCT04493931|Antitubercular Agents|antitubercular agents|mesh-ancestor
25498504|NCT04493931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25498505|NCT04493931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25498506|NCT04493931|Leprostatic Agents|leprostatic agents|mesh-ancestor
25498507|NCT04493931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25498508|NCT04493931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498509|NCT04493931|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25498510|NCT04493931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25498511|NCT04493931|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25498512|NCT04493931|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25498513|NCT04493931|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25498514|NCT04493931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25498515|NCT04493931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25498516|NCT04493931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25498517|NCT04493931|Protective Agents|protective agents|mesh-ancestor
25498518|NCT04493931|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25498519|NCT04493931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25498520|NCT04493931|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25498521|NCT04493931|Histamine Antagonists|histamine antagonists|mesh-ancestor
25498522|NCT04493931|Histamine Agents|histamine agents|mesh-ancestor
25498523|NCT04493931|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25498524|NCT04493931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25498525|NCT04489173|Trifluridine|trifluridine|mesh-list
25498526|NCT04489173|Antimetabolites|antimetabolites|mesh-ancestor
25498527|NCT04489173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498528|NCT04489173|Antiviral Agents|antiviral agents|mesh-ancestor
25498529|NCT04489173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25498530|NCT04476511|Cholecalciferol|cholecalciferol|mesh-list
25498531|NCT04476511|Vitamin D|vitamin d|mesh-list
25498532|NCT04476511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25498533|NCT04476511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498534|NCT04476511|Vitamins|vitamins|mesh-ancestor
25498535|NCT04476511|Micronutrients|micronutrients|mesh-ancestor
25498536|NCT04476511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25498537|NCT04445662|Varenicline|varenicline|mesh-list
25498538|NCT04445662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25498539|NCT04445662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25498540|NCT04445662|Cholinergic Agents|cholinergic agents|mesh-ancestor
25498541|NCT04445662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25498542|NCT04445662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498543|NCT04445662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498544|NCT04413617|Tofacitinib|tofacitinib|mesh-list
25498545|NCT04413617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25498546|NCT04413617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498547|NCT04413617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498548|NCT04342572|Melphalan|melphalan|mesh-list
25498549|NCT04342572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25498550|NCT04342572|Alkylating Agents|alkylating agents|mesh-ancestor
25498551|NCT04342572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498552|NCT04342572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498553|NCT04342572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25498554|NCT04342572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25498555|NCT04342572|Immunologic Factors|immunologic factors|mesh-ancestor
25498556|NCT04342572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498557|NCT04339426|Azithromycin|azithromycin|mesh-list
25498558|NCT04339426|Atovaquone|atovaquone|mesh-list
25498559|NCT04339426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25498560|NCT04339426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24787188|NCT01923948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24961243|NCT03809897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890199|NCT04485117|Propofol|propofol|mesh-list
24961397|NCT03808844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498562|NCT04339426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25498563|NCT04339426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25498564|NCT04339426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498565|NCT04339426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498566|NCT04338204|Tofacitinib|tofacitinib|mesh-list
25498567|NCT04338204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25498568|NCT04338204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498569|NCT04338204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498570|NCT04298463|Vancomycin|vancomycin|mesh-list
25498571|NCT04298463|Daptomycin|daptomycin|mesh-list
25498572|NCT04298463|Teicoplanin|teicoplanin|mesh-list
25498573|NCT04298463|Dalbavancin|dalbavancin|mesh-list
25498574|NCT04298463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25498575|NCT04298463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25498576|NCT04260854|Bupivacaine|bupivacaine|mesh-list
25498577|NCT04260854|Anesthetics, Local|anesthetics, local|mesh-ancestor
25498578|NCT04260854|Anesthetics|anesthetics|mesh-ancestor
25498579|NCT04260854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25498580|NCT04260854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498581|NCT04260854|Sensory System Agents|sensory system agents|mesh-ancestor
25498582|NCT04260854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25498583|NCT04251351|Acetaminophen|acetaminophen|mesh-list
25498584|NCT04251351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25498585|NCT04251351|Analgesics|analgesics|mesh-ancestor
25498586|NCT04251351|Sensory System Agents|sensory system agents|mesh-ancestor
25498587|NCT04251351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25498588|NCT04251351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498589|NCT04251351|Antipyretics|antipyretics|mesh-ancestor
25498590|NCT04248569|Nivolumab|nivolumab|mesh-list
25498591|NCT04248569|Ipilimumab|ipilimumab|mesh-list
25498592|NCT04248569|Poly ICLC|poly iclc|mesh-list
25498593|NCT04248569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25498594|NCT04248569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498595|NCT04248569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25498596|NCT04248569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498597|NCT04248569|Interferon Inducers|interferon inducers|mesh-ancestor
25498598|NCT04248569|Immunologic Factors|immunologic factors|mesh-ancestor
25498599|NCT04248569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498600|NCT04221750|Metformin|metformin|mesh-list
25498601|NCT04221750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25498602|NCT04221750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498603|NCT04209686|Paclitaxel|paclitaxel|mesh-list
25498604|NCT04209686|Pembrolizumab|pembrolizumab|mesh-list
25498605|NCT04209686|Olaparib|olaparib|mesh-list
25498606|NCT04209686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25498607|NCT04209686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498608|NCT04209686|Tubulin Modulators|tubulin modulators|mesh-ancestor
25498609|NCT04209686|Antimitotic Agents|antimitotic agents|mesh-ancestor
25498610|NCT04209686|Mitosis Modulators|mitosis modulators|mesh-ancestor
25498611|NCT04209686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498612|NCT04209686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25498613|NCT04209686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25498614|NCT04209686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498615|NCT04207944|Sulindac|sulindac|mesh-list
25498616|NCT04207944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25498617|NCT04207944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25498618|NCT04207944|Analgesics|analgesics|mesh-ancestor
25498619|NCT04207944|Sensory System Agents|sensory system agents|mesh-ancestor
25498620|NCT04207944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25498621|NCT04207944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498622|NCT04207944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25498623|NCT04207944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25498624|NCT04207944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498625|NCT04207944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25498626|NCT04207944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498627|NCT04207944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498628|NCT04177758|Vitamin D|vitamin d|mesh-list
25498629|NCT04177758|Vitamins|vitamins|mesh-ancestor
25498630|NCT04177758|Micronutrients|micronutrients|mesh-ancestor
25498631|NCT04177758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498632|NCT04177758|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25498633|NCT04177680|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
24962008|NCT03803254|Antibodies|antibodies|mesh-list
24962009|NCT03803254|Immunologic Factors|immunologic factors|mesh-ancestor
24962010|NCT03803254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498634|NCT04177680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25498635|NCT04177680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25498636|NCT04145700|Gemcitabine|gemcitabine|mesh-list
25498637|NCT04145700|Docetaxel|docetaxel|mesh-list
25645505|NCT01448616|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25498638|NCT04145700|Ramucirumab|ramucirumab|mesh-list
25498639|NCT04145700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25645506|NCT01448616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25645507|NCT01448616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645508|NCT01448616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645509|NCT01448616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25645510|NCT01448616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25498640|NCT04145700|Antimetabolites|antimetabolites|mesh-ancestor
25498641|NCT04145700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498642|NCT04145700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498643|NCT04145700|Antiviral Agents|antiviral agents|mesh-ancestor
25498644|NCT04145700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25498645|NCT04145700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498646|NCT04145700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25498647|NCT04145700|Immunologic Factors|immunologic factors|mesh-ancestor
25498648|NCT04145700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498649|NCT04145700|Tubulin Modulators|tubulin modulators|mesh-ancestor
25498650|NCT04145700|Antimitotic Agents|antimitotic agents|mesh-ancestor
25498651|NCT04145700|Mitosis Modulators|mitosis modulators|mesh-ancestor
25498652|NCT04129619|Ether|ether|mesh-list
25498653|NCT04129619|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25498654|NCT04129619|Anesthetics, General|anesthetics, general|mesh-ancestor
25498655|NCT04129619|Anesthetics|anesthetics|mesh-ancestor
25498656|NCT04129619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25498657|NCT04129619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498658|NCT04128722|Sirolimus|sirolimus|mesh-list
25498659|NCT04128722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25498660|NCT04128722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25498661|NCT04128722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25498662|NCT04128722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498663|NCT04128722|Antifungal Agents|antifungal agents|mesh-ancestor
25498664|NCT04128722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25498665|NCT04128722|Immunologic Factors|immunologic factors|mesh-ancestor
25498666|NCT04128722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498667|NCT04123873|Acetaminophen|acetaminophen|mesh-list
25498668|NCT04123873|Dexamethasone|dexamethasone|mesh-list
25498669|NCT04123873|Ibuprofen|ibuprofen|mesh-list
25498670|NCT04123873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25498671|NCT04123873|Antiemetics|antiemetics|mesh-ancestor
25498672|NCT04123873|Autonomic Agents|autonomic agents|mesh-ancestor
25498673|NCT04123873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25498674|NCT04123873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498675|NCT04123873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25498676|NCT04123873|Glucocorticoids|glucocorticoids|mesh-ancestor
25498677|NCT04123873|Hormones|hormones|mesh-ancestor
25498678|NCT04123873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25498679|NCT04123873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25498680|NCT04123873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498681|NCT04123873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25498682|NCT04123873|Analgesics|analgesics|mesh-ancestor
25498683|NCT04123873|Sensory System Agents|sensory system agents|mesh-ancestor
25498684|NCT04123873|Antipyretics|antipyretics|mesh-ancestor
25498685|NCT04123873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25498686|NCT04123873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25498687|NCT04123873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25498688|NCT04123873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498689|NCT04123873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498690|NCT04098068|Pembrolizumab|pembrolizumab|mesh-list
25498691|NCT04098068|Antibodies|antibodies|mesh-list
25498692|NCT04098068|Immunologic Factors|immunologic factors|mesh-ancestor
25498693|NCT04098068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498694|NCT04098068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25498695|NCT04098068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498696|NCT04061590|Cisplatin|cisplatin|mesh-list
25498697|NCT04061590|Pembrolizumab|pembrolizumab|mesh-list
25498698|NCT04061590|Pemetrexed|pemetrexed|mesh-list
25498699|NCT04061590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498700|NCT04061590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25498701|NCT04061590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498702|NCT04061590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498703|NCT04061590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25498704|NCT04061590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25498705|NCT04016142|Paclitaxel|paclitaxel|mesh-list
25498706|NCT04016142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24963317|NCT03791827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24963318|NCT03791827|Immunologic Factors|immunologic factors|mesh-ancestor
24963319|NCT03791827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498707|NCT04016142|Carboplatin|carboplatin|mesh-list
25498721|NCT04005287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498722|NCT04005287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498724|NCT03999554|Immunologic Factors|immunologic factors|mesh-ancestor
25498725|NCT03999554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498726|NCT03977467|Atezolizumab|atezolizumab|mesh-list
25498727|NCT03977467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498728|NCT03934567|Abexinostat|abexinostat|mesh-list
25498729|NCT03934567|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25498730|NCT03934567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498731|NCT03934567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498732|NCT03917966|Docetaxel|docetaxel|mesh-list
25498733|NCT03917966|Apatinib|apatinib|mesh-list
25498734|NCT03917966|Nedaplatin|nedaplatin|mesh-list
25498735|NCT03917966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498736|NCT03917966|Tubulin Modulators|tubulin modulators|mesh-ancestor
25498737|NCT03917966|Antimitotic Agents|antimitotic agents|mesh-ancestor
25498738|NCT03917966|Mitosis Modulators|mitosis modulators|mesh-ancestor
25498739|NCT03917966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498740|NCT03917966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25498741|NCT03917966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498742|NCT03867487|Empagliflozin|empagliflozin|mesh-list
25498743|NCT03867487|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25498744|NCT03867487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498745|NCT03867487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25498746|NCT03867487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498747|NCT03826199|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25498748|NCT03826199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25498749|NCT03826199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25498750|NCT03826199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498751|NCT03826199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498752|NCT03826199|Antiviral Agents|antiviral agents|mesh-ancestor
25498753|NCT03826199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25498754|NCT03826199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25498755|NCT03826199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25498756|NCT03783416|Ixazomib|ixazomib|mesh-list
25498757|NCT03783416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498758|NCT03783416|Protease Inhibitors|protease inhibitors|mesh-ancestor
25498759|NCT03783416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498760|NCT03783416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761179|NCT01761487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761358|NCT01762332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24761359|NCT01762332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761361|NCT01762332|Sensory System Agents|sensory system agents|mesh-ancestor
24761362|NCT01762332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25498762|NCT03765983|GDC-0084|gdc-0084|mesh-list
25498763|NCT03765983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25498764|NCT03765983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498765|NCT03765983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498766|NCT03765983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498767|NCT03752723|Cyclophosphamide|cyclophosphamide|mesh-list
25498768|NCT03752723|Pembrolizumab|pembrolizumab|mesh-list
25498769|NCT03752723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25498770|NCT03752723|Immunologic Factors|immunologic factors|mesh-ancestor
25498771|NCT03752723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498772|NCT03752723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25498773|NCT03752723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25498774|NCT03752723|Alkylating Agents|alkylating agents|mesh-ancestor
25498775|NCT03752723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498776|NCT03752723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498777|NCT03752723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25498778|NCT03752723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25498779|NCT03734692|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
25498780|NCT03734692|Cisplatin|cisplatin|mesh-list
25498781|NCT03734692|Pembrolizumab|pembrolizumab|mesh-list
25498782|NCT03734692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498783|NCT03734692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25498784|NCT03734692|Antiviral Agents|antiviral agents|mesh-ancestor
25498785|NCT03734692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25498786|NCT03732352|Deoxyglucose|deoxyglucose|mesh-list
25498787|NCT03732352|Osimertinib|osimertinib|mesh-list
25498788|NCT03732352|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25498789|NCT03732352|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25498790|NCT03732352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498791|NCT03732352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498792|NCT03732352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25498793|NCT03732352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498794|NCT03732352|Antimetabolites|antimetabolites|mesh-ancestor
25498795|NCT03732352|Antiviral Agents|antiviral agents|mesh-ancestor
25498796|NCT03732352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25498797|NCT03709914|Fosfomycin|fosfomycin|mesh-list
25498798|NCT03709914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25498799|NCT03709914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25498800|NCT03706053|Midodrine|midodrine|mesh-list
25498801|NCT03706053|Sympathomimetics|sympathomimetics|mesh-ancestor
25498802|NCT03706053|Autonomic Agents|autonomic agents|mesh-ancestor
25498803|NCT03706053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25498804|NCT03706053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498805|NCT03706053|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25498806|NCT03706053|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25498807|NCT03706053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25498808|NCT03706053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25498809|NCT03706053|Adrenergic Agents|adrenergic agents|mesh-ancestor
25498810|NCT03706053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25498811|NCT03706053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373771|NCT04926545|Antimetabolites|antimetabolites|mesh-ancestor
25498812|NCT03638141|Durvalumab|durvalumab|mesh-list
25335119|NCT04067492|Diclofenac|diclofenac|mesh-list
25498813|NCT03638141|Ipilimumab|ipilimumab|mesh-list
25498814|NCT03638141|Tremelimumab|tremelimumab|mesh-list
25336397|NCT02412228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25336398|NCT02412228|Glucocorticoids|glucocorticoids|mesh-ancestor
25336433|NCT02227940|Immunologic Factors|immunologic factors|mesh-ancestor
25336434|NCT02227940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336435|NCT02227940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25336436|NCT02206048|Proflavine|proflavine|mesh-list
25336437|NCT02206048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25336438|NCT02206048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25336487|NCT02072486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25336488|NCT02072486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25336535|NCT01828710|Folic Acid|folic acid|mesh-list
25336917|NCT05474183|Analgesics|analgesics|mesh-ancestor
25338272|NCT04776148|Trifluridine|trifluridine|mesh-list
25338728|NCT04526795|Antiviral Agents|antiviral agents|mesh-ancestor
25338729|NCT04526795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25338785|NCT04478292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25338786|NCT04478292|Antimetabolites|antimetabolites|mesh-ancestor
25338787|NCT04478292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25338788|NCT04478292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25338789|NCT04478292|Immunologic Factors|immunologic factors|mesh-ancestor
25338790|NCT04478292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25340042|NCT03390010|Oxytocin|oxytocin|mesh-list
25340043|NCT03390010|Methylergonovine|methylergonovine|mesh-list
25340044|NCT03390010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25340637|NCT02587247|Antibodies|antibodies|mesh-list
25342761|NCT05558319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25342762|NCT05558319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25342763|NCT05558319|Glucocorticoids|glucocorticoids|mesh-ancestor
25342764|NCT05558319|Hormones|hormones|mesh-ancestor
25342765|NCT05558319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25342946|NCT05557136|Ether|ether|mesh-list
25342987|NCT05556720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25342988|NCT05556681|Sirolimus|sirolimus|mesh-list
25342989|NCT05556681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25342990|NCT05556681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25342991|NCT05556681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25342992|NCT05556681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25342993|NCT05556681|Antifungal Agents|antifungal agents|mesh-ancestor
25343074|NCT05556044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343075|NCT05556044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25343092|NCT05555888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25343093|NCT05555888|Antimetabolites|antimetabolites|mesh-ancestor
25343278|NCT05554939|Antimetabolites|antimetabolites|mesh-ancestor
25498815|NCT03638141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25498816|NCT03638141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25498817|NCT03638141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498818|NCT03638141|Immunologic Factors|immunologic factors|mesh-ancestor
25498819|NCT03638141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498820|NCT03638141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25498821|NCT03638141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498822|NCT03617172|Misoprostol|misoprostol|mesh-list
25498823|NCT03617172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25498824|NCT03617172|Abortifacient Agents|abortifacient agents|mesh-ancestor
25498825|NCT03617172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25498826|NCT03617172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498827|NCT03617172|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25498828|NCT03617172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25498829|NCT03617172|Oxytocics|oxytocics|mesh-ancestor
25498830|NCT03587272|Sirolimus|sirolimus|mesh-list
25498831|NCT03587272|Alemtuzumab|alemtuzumab|mesh-list
25498832|NCT03587272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25498833|NCT03587272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25498834|NCT03587272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25498835|NCT03587272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498836|NCT03587272|Antifungal Agents|antifungal agents|mesh-ancestor
25498837|NCT03587272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25498838|NCT03587272|Immunologic Factors|immunologic factors|mesh-ancestor
25498839|NCT03587272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498840|NCT03587272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25498841|NCT03549650|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
25498842|NCT03549650|Anticoagulants|anticoagulants|mesh-ancestor
25498843|NCT03518034|Testosterone|testosterone|mesh-list
25498844|NCT03518034|Androgens|androgens|mesh-ancestor
25498846|NCT03518034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25498847|NCT03518034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498848|NCT03493789|Deoxyglucose|deoxyglucose|mesh-list
25498849|NCT03493789|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25498850|NCT03493789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25498851|NCT03493789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498852|NCT03493789|Antimetabolites|antimetabolites|mesh-ancestor
25498853|NCT03493789|Antiviral Agents|antiviral agents|mesh-ancestor
25498854|NCT03493789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25498855|NCT03366415|Gemcitabine|gemcitabine|mesh-list
25498856|NCT03366415|Cisplatin|cisplatin|mesh-list
25498857|NCT03366415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498858|NCT03366415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25498859|NCT03366415|Antimetabolites|antimetabolites|mesh-ancestor
25498860|NCT03366415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498861|NCT03366415|Antiviral Agents|antiviral agents|mesh-ancestor
25498862|NCT03366415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25498863|NCT03366415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498864|NCT03366415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25498865|NCT03366415|Immunologic Factors|immunologic factors|mesh-ancestor
25498866|NCT03366415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498867|NCT03267888|Pembrolizumab|pembrolizumab|mesh-list
25498868|NCT03267888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25498869|NCT03267888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498870|NCT03239015|Trastuzumab|trastuzumab|mesh-list
25498871|NCT03239015|Everolimus|everolimus|mesh-list
25498872|NCT03239015|Olaparib|olaparib|mesh-list
25498873|NCT03239015|Gefitinib|gefitinib|mesh-list
25498874|NCT03239015|Palbociclib|palbociclib|mesh-list
25498875|NCT03239015|Afatinib|afatinib|mesh-list
25498876|NCT03239015|Vemurafenib|vemurafenib|mesh-list
25498877|NCT03239015|Dabrafenib|dabrafenib|mesh-list
25498878|NCT03239015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
25498879|NCT03239015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25498880|NCT03239015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498881|NCT03239015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25498882|NCT03239015|Immunologic Factors|immunologic factors|mesh-ancestor
25343435|NCT05554276|Antibodies|antibodies|mesh-list
25343586|NCT05553522|Antimetabolites|antimetabolites|mesh-ancestor
25343587|NCT05553522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344131|NCT05550402|Cholinergic Agents|cholinergic agents|mesh-ancestor
25344134|NCT05550246|Oxybutynin|oxybutynin|mesh-list
25344135|NCT05550246|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25344136|NCT05550246|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25344137|NCT05550246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25344138|NCT05550246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25344139|NCT05550246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344140|NCT05550246|Adrenergic Agents|adrenergic agents|mesh-ancestor
25344141|NCT05550246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25344142|NCT05550246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344143|NCT05550246|Parasympatholytics|parasympatholytics|mesh-ancestor
25344213|NCT05549778|Polaprezinc|polaprezinc|mesh-list
25344214|NCT05549778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25344215|NCT05549778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25344216|NCT05549752|Amiodarone|amiodarone|mesh-list
25344217|NCT05549752|Flecainide|flecainide|mesh-list
25344365|NCT05549154|Vitamin D|vitamin d|mesh-list
25344232|NCT05549726|Cabotegravir|cabotegravir|mesh-list
25344431|NCT05548582|Narcotics|narcotics|mesh-ancestor
25344661|NCT05546853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25344662|NCT05546853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25344663|NCT05546853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25344664|NCT05546853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344665|NCT05546853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344666|NCT05546853|Antidotes|antidotes|mesh-ancestor
25344667|NCT05546853|Protective Agents|protective agents|mesh-ancestor
25344668|NCT05546853|Vitamin B Complex|vitamin b complex|mesh-ancestor
25344669|NCT05546853|Vitamins|vitamins|mesh-ancestor
25344670|NCT05546853|Micronutrients|micronutrients|mesh-ancestor
25344671|NCT05546762|Povidone-Iodine|povidone-iodine|mesh-list
25344672|NCT05546762|Povidone|povidone|mesh-list
25345198|NCT05543122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25345199|NCT05543122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25345200|NCT05543122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25345201|NCT05543122|Immunologic Factors|immunologic factors|mesh-ancestor
25345202|NCT05543122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25345203|NCT05543122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25345204|NCT05543122|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25345205|NCT05543122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25345206|NCT05543122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25345207|NCT05543122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25345209|NCT05543122|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25345210|NCT05543122|Antidepressive Agents|antidepressive agents|mesh-ancestor
25345211|NCT05543122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25345212|NCT05543122|Autonomic Agents|autonomic agents|mesh-ancestor
25345213|NCT05543122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25345214|NCT05543122|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25345215|NCT05543122|Dopamine Agents|dopamine agents|mesh-ancestor
25345216|NCT05543122|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25345217|NCT05543122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25345218|NCT05543122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25378171|NCT04780061|Vitamins|vitamins|mesh-list
25345927|NCT05537272|Tadalafil|tadalafil|mesh-list
25346062|NCT05536362|Sensory System Agents|sensory system agents|mesh-ancestor
25346063|NCT05536362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25346064|NCT05536362|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25346065|NCT05536362|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25346066|NCT05536362|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25346067|NCT05536362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25346068|NCT05536362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346069|NCT05536362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25346070|NCT05536362|Sympatholytics|sympatholytics|mesh-ancestor
25346071|NCT05536362|Autonomic Agents|autonomic agents|mesh-ancestor
25346072|NCT05536362|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25346073|NCT05536362|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25346074|NCT05536362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25346075|NCT05536362|Adrenergic Agents|adrenergic agents|mesh-ancestor
25346093|NCT05536284|Bisoprolol|bisoprolol|mesh-list
25346141|NCT05536154|Cytarabine|cytarabine|mesh-list
25346590|NCT05533229|Sensory System Agents|sensory system agents|mesh-ancestor
25346591|NCT05533229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25346592|NCT05533229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25346593|NCT05533229|Narcotics|narcotics|mesh-ancestor
25346594|NCT05533229|Analgesics|analgesics|mesh-ancestor
25346595|NCT05533229|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25346604|NCT05533125|Rituximab|rituximab|mesh-list
25379245|NCT04743661|Temozolomide|temozolomide|mesh-list
25346961|NCT05531344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347117|NCT05529667|Paclitaxel|paclitaxel|mesh-list
25347188|NCT05529056|Mydriatics|mydriatics|mesh-ancestor
25347189|NCT05529056|Parasympatholytics|parasympatholytics|mesh-ancestor
25347190|NCT05529056|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25347191|NCT05529056|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25347192|NCT05529056|Cholinergic Agents|cholinergic agents|mesh-ancestor
25347193|NCT05529056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25347194|NCT05529056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379923|NCT04722523|Cetuximab|cetuximab|mesh-list
25347605|NCT05525546|Vaccines|vaccines|mesh-list
25380477|NCT04687761|Cytarabine|cytarabine|mesh-list
25380612|NCT04683939|Gemcitabine|gemcitabine|mesh-list
25348208|NCT05520177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25348209|NCT05520177|Growth Substances|growth substances|mesh-ancestor
25348210|NCT05520177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348211|NCT05520177|Growth Inhibitors|growth inhibitors|mesh-ancestor
25348212|NCT05520177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348434|NCT05518877|Ketamine|ketamine|mesh-list
25348587|NCT05518149|Aticaprant|aticaprant|mesh-list
25348663|NCT05517499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348664|NCT05517486|Bupivacaine|bupivacaine|mesh-list
25348740|NCT05516953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25348741|NCT05516953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25348742|NCT05516953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25348743|NCT05516953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25348744|NCT05516953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25348745|NCT05516953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25348746|NCT05516953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25348748|NCT05516953|Antimanic Agents|antimanic agents|mesh-ancestor
25348895|NCT05515601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25348980|NCT05514990|Dexamethasone|dexamethasone|mesh-list
25349047|NCT05514847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25349048|NCT05514847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25381669|NCT04648033|Antimalarials|antimalarials|mesh-ancestor
25349198|NCT05513937|Vasodilator Agents|vasodilator agents|mesh-ancestor
25349268|NCT05513612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25349272|NCT05513560|Pentoxifylline|pentoxifylline|mesh-list
25349273|NCT05513560|Ibudilast|ibudilast|mesh-list
25349283|NCT05513560|Antioxidants|antioxidants|mesh-ancestor
25349344|NCT05512780|Letrozole|letrozole|mesh-list
25381968|NCT04633226|Vaccines|vaccines|mesh-list
25349488|NCT05512013|Analgesics|analgesics|mesh-ancestor
25349565|NCT05511441|Aspirin|aspirin|mesh-list
25382350|NCT04623775|Cisplatin|cisplatin|mesh-list
25349868|NCT05509478|Lenvatinib|lenvatinib|mesh-list
25350470|NCT05505409|Hormones|hormones|mesh-ancestor
25383109|NCT04599465|Elexacaftor|elexacaftor|mesh-list
25350645|NCT05504291|Etoposide|etoposide|mesh-list
25350951|NCT05502211|Narcotics|narcotics|mesh-ancestor
25383718|NCT04577755|Pomalidomide|pomalidomide|mesh-list
25351333|NCT05499390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383932|NCT04565301|Antiemetics|antiemetics|mesh-ancestor
25384009|NCT04559607|Apatinib|apatinib|mesh-list
25352236|NCT05493657|Antipyretics|antipyretics|mesh-ancestor
25385003|NCT04530565|Glucocorticoids|glucocorticoids|mesh-ancestor
25352926|NCT05488925|Narcotics|narcotics|mesh-ancestor
25385536|NCT04517110|Pregabalin|pregabalin|mesh-list
25385686|NCT04513951|Fluorouracil|fluorouracil|mesh-list
25353309|NCT05487235|Atezolizumab|atezolizumab|mesh-list
25353405|NCT05486884|Benzocaine|benzocaine|mesh-list
25385990|NCT04501978|Antiviral Agents|antiviral agents|mesh-ancestor
25353528|NCT05485571|Methotrexate|methotrexate|mesh-list
25353755|NCT05484193|Progesterone|progesterone|mesh-list
25386464|NCT04483960|Nafamostat|nafamostat|mesh-list
25353990|NCT05481970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25386617|NCT04476277|Biotin|biotin|mesh-list
25354366|NCT05479045|Nivolumab|nivolumab|mesh-list
25354439|NCT05478785|Cisplatin|cisplatin|mesh-list
25387128|NCT04450199|Vitamin D|vitamin d|mesh-list
25387221|NCT04447027|Cc-486|cc-486|mesh-list
25355030|NCT05474898|Analgesics|analgesics|mesh-ancestor
25355031|NCT05474898|Sensory System Agents|sensory system agents|mesh-ancestor
25355032|NCT05474898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25355033|NCT05474898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355034|NCT05474898|Anesthetics|anesthetics|mesh-ancestor
25355035|NCT05474898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25387655|NCT04431388|Anesthetics|anesthetics|mesh-ancestor
25355186|NCT05471544|Renal Agents|renal agents|mesh-ancestor
25355277|NCT05469893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355278|NCT05469893|Immunologic Factors|immunologic factors|mesh-ancestor
25355279|NCT05469893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25388193|NCT04407390|Niacin|niacin|mesh-list
25388494|NCT04392102|Niraparib|niraparib|mesh-list
25356059|NCT05451095|Ketamine|ketamine|mesh-list
25388884|NCT04379596|Cisplatin|cisplatin|mesh-list
25356454|NCT05439694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356455|NCT05439694|Hemostatics|hemostatics|mesh-ancestor
25356456|NCT05439694|Coagulants|coagulants|mesh-ancestor
25356463|NCT05439460|Phenylephrine|phenylephrine|mesh-list
25356464|NCT05439460|Vasopressins|vasopressins|mesh-list
25356465|NCT05439460|Arginine Vasopressin|arginine vasopressin|mesh-list
25357061|NCT05423249|Vitamins|vitamins|mesh-ancestor
25357123|NCT05422066|Glucocorticoids|glucocorticoids|mesh-ancestor
25389789|NCT04324840|Temozolomide|temozolomide|mesh-list
25357542|NCT05412082|Oxaliplatin|oxaliplatin|mesh-list
25357474|NCT05413980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25357475|NCT05413980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25357476|NCT05413980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25357477|NCT05413980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25357478|NCT05413980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357481|NCT05413980|Contraceptive Agents|contraceptive agents|mesh-ancestor
25357556|NCT05412030|Immunologic Factors|immunologic factors|mesh-ancestor
25357557|NCT05412030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357558|NCT05412004|Tirzepatide|tirzepatide|mesh-list
25357559|NCT05412004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25357561|NCT05412004|Incretins|incretins|mesh-ancestor
25357714|NCT05406999|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25357937|NCT05401916|Tramadol|tramadol|mesh-list
25358040|NCT05399498|Psilocybin|psilocybin|mesh-list
25358460|NCT05384938|Benralizumab|benralizumab|mesh-list
25358546|NCT05383352|Leucovorin|leucovorin|mesh-list
25390964|NCT04271475|Macitentan|macitentan|mesh-list
25358725|NCT05380635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358875|NCT05377242|Antioxidants|antioxidants|mesh-ancestor
25359003|NCT05372354|Dexamethasone|dexamethasone|mesh-list
25359076|NCT05371093|Rituximab|rituximab|mesh-list
25359167|NCT05368415|Norepinephrine|norepinephrine|mesh-list
25359168|NCT05368415|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25359169|NCT05368415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25359170|NCT05368415|Adrenergic Agents|adrenergic agents|mesh-ancestor
25359171|NCT05368415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25359178|NCT05368376|Metoprolol|metoprolol|mesh-list
25359237|NCT05367440|Abiraterone Acetate|abiraterone acetate|mesh-list
25359238|NCT05367440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359239|NCT05367440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25359240|NCT05367440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359241|NCT05367440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359242|NCT05367440|Hormone Antagonists|hormone antagonists|mesh-ancestor
25359243|NCT05367440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25359246|NCT05367401|Azacitidine|azacitidine|mesh-list
25359331|NCT05365451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359332|NCT05365451|Diuretics|diuretics|mesh-ancestor
25359333|NCT05365451|Natriuretic Agents|natriuretic agents|mesh-ancestor
25359334|NCT05365451|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25359795|NCT05356897|Trastuzumab|trastuzumab|mesh-list
25359868|NCT05354453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359869|NCT05354453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359870|NCT05354102|Nivolumab|nivolumab|mesh-list
25359871|NCT05354102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25360203|NCT05345990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360204|NCT05345782|Bupivacaine|bupivacaine|mesh-list
25360205|NCT05345782|Anesthetics, Local|anesthetics, local|mesh-ancestor
25360206|NCT05345782|Anesthetics|anesthetics|mesh-ancestor
25360358|NCT05341349|Nivolumab|nivolumab|mesh-list
25360684|NCT05331664|Atropine|atropine|mesh-list
25361000|NCT05324735|Antioxidants|antioxidants|mesh-ancestor
25361001|NCT05324501|Lomustine|lomustine|mesh-list
25361002|NCT05324501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25361077|NCT05321940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361078|NCT05321940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361079|NCT05321940|Antiviral Agents|antiviral agents|mesh-ancestor
25361080|NCT05321940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25361081|NCT05321875|Candesartan|candesartan|mesh-list
25361082|NCT05321875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25361083|NCT05321875|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25361084|NCT05321875|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25361085|NCT05321875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361086|NCT05321810|Warfarin|warfarin|mesh-list
25361087|NCT05321810|Apixaban|apixaban|mesh-list
25361160|NCT05318469|Ivermectin|ivermectin|mesh-list
25361302|NCT05314998|Hematinics|hematinics|mesh-ancestor
25361381|NCT05313256|Lidocaine|lidocaine|mesh-list
25361534|NCT05309655|Purinergic Agents|purinergic agents|mesh-ancestor
25361535|NCT05309655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25361536|NCT05309655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361537|NCT05309525|Tranexamic Acid|tranexamic acid|mesh-list
25361538|NCT05309525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25361539|NCT05309525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25361540|NCT05309525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361541|NCT05309525|Hemostatics|hemostatics|mesh-ancestor
25361542|NCT05309525|Coagulants|coagulants|mesh-ancestor
25361543|NCT05309304|Cefazolin|cefazolin|mesh-list
25361544|NCT05309304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25361837|NCT05303792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25361838|NCT05303792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25361839|NCT05303792|Alkylating Agents|alkylating agents|mesh-ancestor
25361840|NCT05303792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361841|NCT05303792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361842|NCT05303792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25361843|NCT05303792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25361844|NCT05303792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25361845|NCT05303792|Antiemetics|antiemetics|mesh-ancestor
25361846|NCT05303792|Autonomic Agents|autonomic agents|mesh-ancestor
25361847|NCT05303792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25361848|NCT05303792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25361849|NCT05303792|Glucocorticoids|glucocorticoids|mesh-ancestor
25361850|NCT05303792|Hormones|hormones|mesh-ancestor
25361851|NCT05303792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25361852|NCT05303792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25361853|NCT05303792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25361892|NCT05302856|Antibodies|antibodies|mesh-list
25361912|NCT05301842|Durvalumab|durvalumab|mesh-list
25362143|NCT05295927|Hormones|hormones|mesh-ancestor
25362213|NCT05294328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25362586|NCT05285683|Methylphenidate|methylphenidate|mesh-list
25362686|NCT05283226|Paclitaxel|paclitaxel|mesh-list
25362746|NCT05281510|Vesatolimod|vesatolimod|mesh-list
25362893|NCT05279092|Prednisolone acetate|prednisolone acetate|mesh-list
25363041|NCT05275010|Pertuzumab|pertuzumab|mesh-list
25363042|NCT05275010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25363043|NCT05275010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363044|NCT05274477|4-Aminopyridine|4-aminopyridine|mesh-list
25363045|NCT05274477|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25363119|NCT05271318|Pembrolizumab|pembrolizumab|mesh-list
25363266|NCT05266807|Fidaxomicin|fidaxomicin|mesh-list
25363267|NCT05266807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25363268|NCT05266807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25363270|NCT05266729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25363492|NCT05260008|Anesthetics|anesthetics|mesh-ancestor
25363817|NCT05253794|Colchicine|colchicine|mesh-list
25363946|NCT05251376|Morphine|morphine|mesh-list
25364169|NCT05246670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25364170|NCT05246670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25364171|NCT05246670|Antiviral Agents|antiviral agents|mesh-ancestor
25364638|NCT05232825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25364639|NCT05232825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25364640|NCT05232825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364641|NCT05232825|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25364642|NCT05232825|Protective Agents|protective agents|mesh-ancestor
25364643|NCT05232825|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25364644|NCT05232825|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25364645|NCT05232825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25364646|NCT05232825|Anesthetics, Local|anesthetics, local|mesh-ancestor
25364653|NCT05232825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364655|NCT05232825|Antipruritics|antipruritics|mesh-ancestor
25364827|NCT05227001|Camphor|camphor|mesh-list
25365039|NCT05218668|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25365040|NCT05218668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25365041|NCT05218668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365042|NCT05218668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25365043|NCT05218668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365044|NCT05218668|Vasodilator Agents|vasodilator agents|mesh-ancestor
25365045|NCT05218668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25365046|NCT05218668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25365047|NCT05218603|Bortezomib|bortezomib|mesh-list
25365048|NCT05218603|Daratumumab|daratumumab|mesh-list
25365050|NCT05218499|Doxorubicin|doxorubicin|mesh-list
25365116|NCT05216055|Antiemetics|antiemetics|mesh-ancestor
25397170|NCT04012996|Meloxicam|meloxicam|mesh-list
25365345|NCT05209308|Immunologic Factors|immunologic factors|mesh-ancestor
25365346|NCT05209308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365347|NCT05209308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25365358|NCT05208840|Ocrelizumab|ocrelizumab|mesh-list
25365359|NCT05208840|Immunologic Factors|immunologic factors|mesh-ancestor
25365360|NCT05208840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365496|NCT05203822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365497|NCT05203822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25365498|NCT05203822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365499|NCT05203510|Treprostinil|treprostinil|mesh-list
25365500|NCT05203510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25365501|NCT05203172|Cetuximab|cetuximab|mesh-list
25365502|NCT05203172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25365503|NCT05203172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365504|NCT05202860|Vaccines|vaccines|mesh-list
25365594|NCT05201066|Azacitidine|azacitidine|mesh-list
25365595|NCT05201066|Decitabine|decitabine|mesh-list
25365596|NCT05201066|Venetoclax|venetoclax|mesh-list
25365597|NCT05201066|Spartalizumab|spartalizumab|mesh-list
25365598|NCT05201066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25365599|NCT05201066|Antimetabolites|antimetabolites|mesh-ancestor
25365600|NCT05201066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365601|NCT05201066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365602|NCT05201066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25365603|NCT05201066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25365604|NCT05201001|Carboplatin|carboplatin|mesh-list
25365605|NCT05201001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365606|NCT05200559|Pembrolizumab|pembrolizumab|mesh-list
25365607|NCT05200559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25365608|NCT05200559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365609|NCT05200481|Carboplatin|carboplatin|mesh-list
25365610|NCT05200481|Pemetrexed|pemetrexed|mesh-list
25365611|NCT05200481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365612|NCT05200481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25365613|NCT05200481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365614|NCT05200481|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25365615|NCT05200481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25365616|NCT05200364|Bevacizumab|bevacizumab|mesh-list
25365617|NCT05200364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25365624|NCT05200286|Olorofim|olorofim|mesh-list
25365888|NCT05190445|Paclitaxel|paclitaxel|mesh-list
25366063|NCT05180942|Atorvastatin|atorvastatin|mesh-list
25366508|NCT05171335|Lenvatinib|lenvatinib|mesh-list
25366744|NCT05162222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25366745|NCT05162222|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25366746|NCT05162222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25366747|NCT05162222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366748|NCT05162222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366749|NCT05162222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25366750|NCT05162222|Hormone Antagonists|hormone antagonists|mesh-ancestor
25366751|NCT05162222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25366752|NCT05162222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366753|NCT05162222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25366754|NCT05162222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25366755|NCT05162222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25366756|NCT05162222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25366757|NCT05162222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25366758|NCT05162222|Vasodilator Agents|vasodilator agents|mesh-ancestor
25366825|NCT05161195|Tamoxifen|tamoxifen|mesh-list
25366826|NCT05161195|Letrozole|letrozole|mesh-list
25366827|NCT05161195|Fulvestrant|fulvestrant|mesh-list
25366828|NCT05161195|Anastrozole|anastrozole|mesh-list
25366829|NCT05161195|Goserelin|goserelin|mesh-list
25366830|NCT05161195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366831|NCT05161195|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25366832|NCT05161195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25366833|NCT05161195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366849|NCT05159830|Cannabidiol|cannabidiol|mesh-list
25398921|NCT03928015|Hormones|hormones|mesh-ancestor
25367053|NCT05155709|Azacitidine|azacitidine|mesh-list
25367197|NCT05150938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25367198|NCT05150938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25367199|NCT05150938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367200|NCT05150938|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25367294|NCT05146739|Vitamins|vitamins|mesh-ancestor
25399458|NCT03907046|Aspirin|aspirin|mesh-list
25367514|NCT05138822|Renal Agents|renal agents|mesh-ancestor
25367515|NCT05138822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25367516|NCT05138614|Analgesics, Opioid|analgesics, opioid|mesh-list
25367517|NCT05138614|Narcotics|narcotics|mesh-ancestor
25367518|NCT05138614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25367519|NCT05138614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367520|NCT05138614|Analgesics|analgesics|mesh-ancestor
25367521|NCT05138614|Sensory System Agents|sensory system agents|mesh-ancestor
25367522|NCT05138614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25367523|NCT05138549|Beta Carotene|beta carotene|mesh-list
25367524|NCT05138549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367525|NCT05138549|Provitamins|provitamins|mesh-ancestor
25367526|NCT05138549|Vitamins|vitamins|mesh-ancestor
25367527|NCT05138549|Micronutrients|micronutrients|mesh-ancestor
25367531|NCT05137080|Dexamethasone|dexamethasone|mesh-list
25367532|NCT05137080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25367533|NCT05137080|Antiemetics|antiemetics|mesh-ancestor
25367534|NCT05137080|Autonomic Agents|autonomic agents|mesh-ancestor
25367535|NCT05137080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25367536|NCT05137080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367537|NCT05137080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25367538|NCT05137080|Glucocorticoids|glucocorticoids|mesh-ancestor
25367590|NCT05135910|Antifungal Agents|antifungal agents|mesh-ancestor
25367591|NCT05135910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25367592|NCT05135910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367593|NCT05135910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367594|NCT05135273|Vaccines|vaccines|mesh-list
25367595|NCT05135273|Immunologic Factors|immunologic factors|mesh-ancestor
25367596|NCT05135273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367672|NCT05130268|Dronedarone|dronedarone|mesh-list
25367673|NCT05130268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25367674|NCT05128773|Tamoxifen|tamoxifen|mesh-list
25367675|NCT05128773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25367676|NCT05128773|Hormone Antagonists|hormone antagonists|mesh-ancestor
25367684|NCT05127876|Ephedrine|ephedrine|mesh-list
25367743|NCT05125016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367744|NCT05124899|Sunscreening Agents|sunscreening agents|mesh-list
25367745|NCT05124899|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25367746|NCT05124899|Protective Agents|protective agents|mesh-ancestor
25367747|NCT05124899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367748|NCT05124899|Dermatologic Agents|dermatologic agents|mesh-ancestor
25367749|NCT05124340|Vaccines|vaccines|mesh-list
25367750|NCT05124340|Immunologic Factors|immunologic factors|mesh-ancestor
25367751|NCT05124340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367817|NCT05122026|Leprostatic Agents|leprostatic agents|mesh-ancestor
25367823|NCT05119920|Pilocarpine|pilocarpine|mesh-list
25367824|NCT05119920|Miotics|miotics|mesh-ancestor
25367825|NCT05119920|Autonomic Agents|autonomic agents|mesh-ancestor
25367826|NCT05119920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25367828|NCT05119920|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25367969|NCT05115110|Risdiplam|risdiplam|mesh-list
25368131|NCT05109728|Sequestering Agents|sequestering agents|mesh-ancestor
25368132|NCT05109728|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25368294|NCT05105542|Cholinergic Agents|cholinergic agents|mesh-list
25368366|NCT05102552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25368376|NCT05101187|Olorofim|olorofim|mesh-list
25368603|NCT05093608|Bevacizumab|bevacizumab|mesh-list
25368604|NCT05093608|Atezolizumab|atezolizumab|mesh-list
25368605|NCT05093608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25368606|NCT05093608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368607|NCT05093608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25368608|NCT05093608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25368612|NCT05093322|Gemcitabine|gemcitabine|mesh-list
25368833|NCT05086250|Anesthetics|anesthetics|mesh-ancestor
25369060|NCT05078671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25369061|NCT05078671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369062|NCT05078671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369063|NCT05078671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25369064|NCT05078671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25369065|NCT05078671|Antiviral Agents|antiviral agents|mesh-ancestor
25369066|NCT05078671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25369067|NCT05078671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25369068|NCT05078671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25369069|NCT05078463|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25369139|NCT05076604|Cardioplegic Solutions|cardioplegic solutions|mesh-list
25369140|NCT05076604|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25369141|NCT05076175|Ozanimod|ozanimod|mesh-list
25369142|NCT05076175|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25369143|NCT05076175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401121|NCT03825198|Anticonvulsants|anticonvulsants|mesh-ancestor
25369208|NCT05072782|Methotrexate|methotrexate|mesh-list
25369290|NCT05069831|Abrocitinib|abrocitinib|mesh-list
25369291|NCT05069831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25369292|NCT05069831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25369293|NCT05069831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369294|NCT05069597|Pancrelipase|pancrelipase|mesh-list
25369295|NCT05069597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25369296|NCT05069350|Bupivacaine|bupivacaine|mesh-list
25369297|NCT05069350|Anesthetics, Local|anesthetics, local|mesh-ancestor
25369298|NCT05069350|Anesthetics|anesthetics|mesh-ancestor
25401269|NCT03817320|Leucovorin|leucovorin|mesh-list
25369376|NCT05065372|Metformin|metformin|mesh-list
25369377|NCT05065372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25369378|NCT05065372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369379|NCT05065216|Kallikreins|kallikreins|mesh-list
25369380|NCT05065216|Coagulants|coagulants|mesh-ancestor
25369381|NCT05065216|Fertility Agents, Male|fertility agents, male|mesh-ancestor
25369382|NCT05065216|Fertility Agents|fertility agents|mesh-ancestor
25369385|NCT05065190|Nintedanib|nintedanib|mesh-list
25401505|NCT03808090|Calcium|calcium|mesh-list
25369644|NCT05058924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369645|NCT05058924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25369685|NCT05058612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25369686|NCT05058612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369687|NCT05058443|Denosumab|denosumab|mesh-list
25369850|NCT05051007|Fentanyl|fentanyl|mesh-list
25370075|NCT05044468|Lidocaine|lidocaine|mesh-list
25370215|NCT05041153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25370425|NCT05033665|Benzocaine|benzocaine|mesh-list
25370796|NCT05020522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25370797|NCT05020522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370798|NCT05020522|GABA Modulators|gaba modulators|mesh-ancestor
25370799|NCT05020522|GABA Agents|gaba agents|mesh-ancestor
25370800|NCT05020522|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25370801|NCT05020522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25370802|NCT05020522|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25370822|NCT05020184|Cimetidine|cimetidine|mesh-list
25370823|NCT05020184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25370824|NCT05020184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25370825|NCT05020184|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25370826|NCT05020184|Histamine Antagonists|histamine antagonists|mesh-ancestor
25370827|NCT05020184|Histamine Agents|histamine agents|mesh-ancestor
25370828|NCT05020184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25370829|NCT05020184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370830|NCT05020184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370831|NCT05020184|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25402564|NCT03757715|Antiemetics|antiemetics|mesh-ancestor
25371048|NCT05012735|Provitamins|provitamins|mesh-list
25371111|NCT05009992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371112|NCT05009992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371113|NCT05009979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25371114|NCT05009979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25371115|NCT05009979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371117|NCT05009862|Rivaroxaban|rivaroxaban|mesh-list
25371118|NCT05009862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25371119|NCT05009862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25371120|NCT05009862|Analgesics|analgesics|mesh-ancestor
25371121|NCT05009862|Sensory System Agents|sensory system agents|mesh-ancestor
25371188|NCT05008809|Micronutrients|micronutrients|mesh-ancestor
25371189|NCT05008484|Vitamin D|vitamin d|mesh-list
25371190|NCT05008484|Vitamins|vitamins|mesh-ancestor
25371191|NCT05008484|Micronutrients|micronutrients|mesh-ancestor
25371192|NCT05008484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371193|NCT05008484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25371194|NCT05007873|Decitabine|decitabine|mesh-list
25371195|NCT05007873|Dasatinib|dasatinib|mesh-list
25371196|NCT05007873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25371197|NCT05007873|Antimetabolites|antimetabolites|mesh-ancestor
25371198|NCT05007873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371199|NCT05007873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25403173|NCT03732677|Durvalumab|durvalumab|mesh-list
25403250|NCT03727061|Trioxsalen|trioxsalen|mesh-list
25371578|NCT04995497|Anesthetics|anesthetics|mesh-ancestor
25371579|NCT04995497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25371580|NCT04995497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371581|NCT04995497|Sensory System Agents|sensory system agents|mesh-ancestor
25371582|NCT04995497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25371583|NCT04995497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25371584|NCT04995497|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25371585|NCT04995497|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25371586|NCT04995497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25371588|NCT04995029|Buprenorphine|buprenorphine|mesh-list
25371650|NCT04994132|Vinorelbine|vinorelbine|mesh-list
25403570|NCT03714620|Ketamine|ketamine|mesh-list
25372125|NCT04981158|Anesthetics|anesthetics|mesh-list
25372204|NCT04978649|Vasodilator Agents|vasodilator agents|mesh-ancestor
25372274|NCT04975308|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25372275|NCT04975308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25372276|NCT04975308|Hormone Antagonists|hormone antagonists|mesh-ancestor
25372277|NCT04975308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25372278|NCT04975308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372279|NCT04975308|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25372280|NCT04975308|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25372281|NCT04975308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372282|NCT04975308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372283|NCT04974528|Insulin|insulin|mesh-list
25372284|NCT04974528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25404011|NCT03689855|Atezolizumab|atezolizumab|mesh-list
25372448|NCT04969887|Nivolumab|nivolumab|mesh-list
25372517|NCT04967495|Estrogens|estrogens|mesh-ancestor
25372896|NCT04956432|Antioxidants|antioxidants|mesh-ancestor
25405075|NCT03630991|Antidotes|antidotes|mesh-ancestor
25373424|NCT04937699|Ticagrelor|ticagrelor|mesh-list
25373425|NCT04937699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25373426|NCT04937699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25373427|NCT04937699|Analgesics|analgesics|mesh-ancestor
25373428|NCT04937699|Sensory System Agents|sensory system agents|mesh-ancestor
25373429|NCT04937699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25373430|NCT04937699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405299|NCT03614741|Dalteparin|dalteparin|mesh-list
25373843|NCT04924062|Cisplatin|cisplatin|mesh-list
25373984|NCT04919629|Immunoglobulins|immunoglobulins|mesh-list
25374065|NCT04916548|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25374067|NCT04916548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25374068|NCT04916548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374069|NCT04916327|Antioxidants|antioxidants|mesh-list
25374070|NCT04916327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374154|NCT04914676|Immunologic Factors|immunologic factors|mesh-ancestor
25374227|NCT04912596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25374228|NCT04912596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25374229|NCT04912596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25374230|NCT04912596|Adrenergic Agents|adrenergic agents|mesh-ancestor
25374231|NCT04912596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25374232|NCT04912596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374233|NCT04912596|Miotics|miotics|mesh-ancestor
25374234|NCT04912596|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25374235|NCT04912596|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
25374236|NCT04912596|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25374237|NCT04912596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25374238|NCT04912596|Cholinergic Agents|cholinergic agents|mesh-ancestor
25374239|NCT04912596|Sympathomimetics|sympathomimetics|mesh-ancestor
25374240|NCT04912427|Dexamethasone|dexamethasone|mesh-list
25374241|NCT04912427|Bortezomib|bortezomib|mesh-list
25374242|NCT04912427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25374243|NCT04912427|Antiemetics|antiemetics|mesh-ancestor
25374244|NCT04912427|Autonomic Agents|autonomic agents|mesh-ancestor
25374245|NCT04912427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25374380|NCT04908176|GABA Agents|gaba agents|mesh-ancestor
25374381|NCT04908176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25374382|NCT04908176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374383|NCT04907968|Carboplatin|carboplatin|mesh-list
25374384|NCT04907968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374385|NCT04907227|Dexamethasone|dexamethasone|mesh-list
25374386|NCT04907227|Prednisone|prednisone|mesh-list
25374387|NCT04907227|Docetaxel|docetaxel|mesh-list
25374388|NCT04907227|Pembrolizumab|pembrolizumab|mesh-list
25374389|NCT04907227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25374390|NCT04907227|Antiemetics|antiemetics|mesh-ancestor
25374391|NCT04907227|Autonomic Agents|autonomic agents|mesh-ancestor
25374392|NCT04907227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25374393|NCT04907227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374394|NCT04907227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25374395|NCT04907227|Glucocorticoids|glucocorticoids|mesh-ancestor
25374396|NCT04907227|Hormones|hormones|mesh-ancestor
25374398|NCT04907227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25406079|NCT03580187|Morphine|morphine|mesh-list
25374609|NCT04901715|Albuterol|albuterol|mesh-list
25374704|NCT04899232|Antithrombins|antithrombins|mesh-list
25374872|NCT04893109|Trastuzumab|trastuzumab|mesh-list
25374947|NCT04891770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374948|NCT04891770|Antiviral Agents|antiviral agents|mesh-ancestor
25374949|NCT04891770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25374950|NCT04891770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25374951|NCT04891770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25374952|NCT04891770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25374953|NCT04891770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25374954|NCT04891770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25374955|NCT04891484|Ondansetron|ondansetron|mesh-list
25374956|NCT04891484|Antiemetics|antiemetics|mesh-ancestor
25374957|NCT04891484|Autonomic Agents|autonomic agents|mesh-ancestor
25374958|NCT04891484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25374959|NCT04891484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374960|NCT04891484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25374961|NCT04891484|Antipruritics|antipruritics|mesh-ancestor
25374962|NCT04891484|Dermatologic Agents|dermatologic agents|mesh-ancestor
25374963|NCT04891484|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25374964|NCT04891484|Serotonin Agents|serotonin agents|mesh-ancestor
25374965|NCT04891484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25374966|NCT04891484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374967|NCT04891484|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25375017|NCT04889664|Ketamine|ketamine|mesh-list
25375041|NCT04887870|Pembrolizumab|pembrolizumab|mesh-list
25375042|NCT04887870|Nivolumab|nivolumab|mesh-list
25375043|NCT04887870|Ipilimumab|ipilimumab|mesh-list
25375044|NCT04887870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25375045|NCT04887870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375046|NCT04887870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25375047|NCT04887870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406748|NCT03534453|Olaparib|olaparib|mesh-list
25375564|NCT04876027|Dulaglutide|dulaglutide|mesh-list
25407135|NCT03516981|Lenvatinib|lenvatinib|mesh-list
25375717|NCT04870112|Cisplatin|cisplatin|mesh-list
25375870|NCT04862975|Tenofovir|tenofovir|mesh-list
25376090|NCT04854551|Naltrexone|naltrexone|mesh-list
25376091|NCT04854551|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25376092|NCT04854551|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25376093|NCT04854551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376094|NCT04854551|Sensory System Agents|sensory system agents|mesh-ancestor
25376095|NCT04854551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25376107|NCT04854434|Trifluridine|trifluridine|mesh-list
25376108|NCT04854434|Pembrolizumab|pembrolizumab|mesh-list
25376109|NCT04854434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25376110|NCT04854434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25407815|NCT03474770|Huperzine A|huperzine a|mesh-list
25376328|NCT04844866|Immunologic Factors|immunologic factors|mesh-ancestor
25376329|NCT04844866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376330|NCT04844866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25376331|NCT04844866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25376332|NCT04844866|Antimetabolites|antimetabolites|mesh-ancestor
25376333|NCT04844866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376334|NCT04844866|Antiviral Agents|antiviral agents|mesh-ancestor
25376335|NCT04844866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25376336|NCT04844866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25376340|NCT04844814|Prednisone|prednisone|mesh-list
25376634|NCT04835870|Vincristine|vincristine|mesh-list
25376635|NCT04835870|Zanubrutinib|zanubrutinib|mesh-list
25376636|NCT04835870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25376637|NCT04835870|Immunologic Factors|immunologic factors|mesh-ancestor
25376710|NCT04833582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25376711|NCT04833582|Immunologic Factors|immunologic factors|mesh-ancestor
25376712|NCT04833582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376713|NCT04833426|Testosterone|testosterone|mesh-list
25376714|NCT04833426|Androgens|androgens|mesh-ancestor
25376715|NCT04833426|Hormones|hormones|mesh-ancestor
25376716|NCT04833426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25376717|NCT04833426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376718|NCT04833114|Carboplatin|carboplatin|mesh-list
25376719|NCT04833114|Etoposide|etoposide|mesh-list
25376720|NCT04833114|Rituximab|rituximab|mesh-list
25376721|NCT04833114|Ifosfamide|ifosfamide|mesh-list
25376722|NCT04833114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376723|NCT04833114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25376724|NCT04833114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25376725|NCT04833114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25376726|NCT04833114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25376727|NCT04833114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376728|NCT04833114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25376729|NCT04833114|Immunologic Factors|immunologic factors|mesh-ancestor
25377052|NCT04820673|Sarecycline|sarecycline|mesh-list
25377312|NCT04807517|Buspirone|buspirone|mesh-list
25408956|NCT03407144|Etoposide|etoposide|mesh-list
25377808|NCT04790903|Hormones|hormones|mesh-ancestor
25377964|NCT04786964|Vitamin B 12|vitamin b 12|mesh-list
25378113|NCT04783675|Rituximab|rituximab|mesh-list
25409640|NCT03364491|Hemostatics|hemostatics|mesh-ancestor
25378282|NCT04776369|Anesthetics, Local|anesthetics, local|mesh-ancestor
25378283|NCT04776369|Anesthetics|anesthetics|mesh-ancestor
25378284|NCT04776369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25378285|NCT04776369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378286|NCT04776369|Sensory System Agents|sensory system agents|mesh-ancestor
25378288|NCT04776369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25409867|NCT03338790|Prednisone|prednisone|mesh-list
25378584|NCT04763343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25378585|NCT04763343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25378586|NCT04763343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378587|NCT04763252|Coal Tar|coal tar|mesh-list
25378723|NCT04757883|Antibodies|antibodies|mesh-list
25378724|NCT04757883|Immunologic Factors|immunologic factors|mesh-ancestor
25378725|NCT04757883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378726|NCT04757857|Rivaroxaban|rivaroxaban|mesh-list
25378727|NCT04757857|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25378728|NCT04757857|Antithrombins|antithrombins|mesh-ancestor
25378729|NCT04757857|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25378730|NCT04757857|Protease Inhibitors|protease inhibitors|mesh-ancestor
25378731|NCT04757857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25378732|NCT04757857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378733|NCT04757857|Anticoagulants|anticoagulants|mesh-ancestor
25378734|NCT04757740|Methylprednisolone|methylprednisolone|mesh-list
25378735|NCT04757740|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25378736|NCT04757740|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25378737|NCT04757740|Prednisolone|prednisolone|mesh-list
25378738|NCT04757740|Prednisolone acetate|prednisolone acetate|mesh-list
25378739|NCT04757740|Lidocaine|lidocaine|mesh-list
25378740|NCT04757740|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25378741|NCT04757740|Prednisolone phosphate|prednisolone phosphate|mesh-list
25378742|NCT04757740|Anesthetics, Local|anesthetics, local|mesh-ancestor
25378743|NCT04757740|Anesthetics|anesthetics|mesh-ancestor
25378744|NCT04757740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25378745|NCT04757740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378746|NCT04757740|Sensory System Agents|sensory system agents|mesh-ancestor
25378747|NCT04757740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25378748|NCT04757740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25408387|NCT03447132|Goserelin|goserelin|mesh-list
25378754|NCT04757740|Antiemetics|antiemetics|mesh-ancestor
25378980|NCT04752163|Tubulin Modulators|tubulin modulators|mesh-ancestor
25378981|NCT04752163|Antimitotic Agents|antimitotic agents|mesh-ancestor
25378982|NCT04752163|Mitosis Modulators|mitosis modulators|mesh-ancestor
25378983|NCT04752163|Antifungal Agents|antifungal agents|mesh-ancestor
25378984|NCT04752163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25378985|NCT04752163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25410500|NCT03317392|Olaparib|olaparib|mesh-list
25379133|NCT04746495|Natriuretic Agents|natriuretic agents|mesh-ancestor
25379134|NCT04746495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25379135|NCT04746339|Apixaban|apixaban|mesh-list
25379136|NCT04746339|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25379137|NCT04746339|Antithrombins|antithrombins|mesh-ancestor
25379138|NCT04746339|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25379139|NCT04746339|Protease Inhibitors|protease inhibitors|mesh-ancestor
25379140|NCT04746339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410843|NCT03290287|Bromides|bromides|mesh-list
25379513|NCT04735471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25379514|NCT04735471|Immunologic Factors|immunologic factors|mesh-ancestor
25379515|NCT04735471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379516|NCT04735471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25379517|NCT04735471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25379518|NCT04735471|Alkylating Agents|alkylating agents|mesh-ancestor
25379519|NCT04735471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379520|NCT04735471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379521|NCT04735471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25379522|NCT04735354|Valsartan|valsartan|mesh-list
25379523|NCT04735354|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25379524|NCT04735354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25379525|NCT04735354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25379526|NCT04735354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25379527|NCT04735354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379528|NCT04734990|Azacitidine|azacitidine|mesh-list
25379529|NCT04734990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25379530|NCT04734990|Antimetabolites|antimetabolites|mesh-ancestor
25379531|NCT04734990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379747|NCT04729595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379748|NCT04729595|Protective Agents|protective agents|mesh-ancestor
25379749|NCT04729595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379750|NCT04729595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25379751|NCT04729595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379752|NCT04729595|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25379753|NCT04729595|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25379769|NCT04729114|Dexamethasone|dexamethasone|mesh-list
25379770|NCT04729114|Prednisone|prednisone|mesh-list
25379771|NCT04729114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25379772|NCT04729114|Antiemetics|antiemetics|mesh-ancestor
25379773|NCT04729114|Autonomic Agents|autonomic agents|mesh-ancestor
25379774|NCT04729114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25379776|NCT04729114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25379982|NCT04720105|Halobetasol|halobetasol|mesh-list
25379983|NCT04720105|Tazarotene|tazarotene|mesh-list
25379984|NCT04720105|Dermatologic Agents|dermatologic agents|mesh-ancestor
25379985|NCT04720105|Keratolytic Agents|keratolytic agents|mesh-ancestor
25379986|NCT04720105|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25379987|NCT04718961|Volixibat|volixibat|mesh-list
25379988|NCT04718961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25379989|NCT04718480|Fluvoxamine|fluvoxamine|mesh-list
25379990|NCT04718480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25379991|NCT04718480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25380060|NCT04712903|Etoposide|etoposide|mesh-list
25380061|NCT04712903|Durvalumab|durvalumab|mesh-list
25380062|NCT04712903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380144|NCT04708418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380600|NCT04683965|Pemetrexed|pemetrexed|mesh-list
25380976|NCT04672395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380977|NCT04672395|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25380978|NCT04672005|Leucovorin|leucovorin|mesh-list
25380979|NCT04672005|Gemcitabine|gemcitabine|mesh-list
25380980|NCT04672005|Paclitaxel|paclitaxel|mesh-list
25381053|NCT04669171|Lenalidomide|lenalidomide|mesh-list
25381054|NCT04669171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25381055|NCT04669171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381056|NCT04669171|Immunologic Factors|immunologic factors|mesh-ancestor
25381058|NCT04669171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25412684|NCT03185819|Anesthetics|anesthetics|mesh-ancestor
25381431|NCT04657289|Ranibizumab|ranibizumab|mesh-list
25381432|NCT04657289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25381585|NCT04652076|Antimitotic Agents|antimitotic agents|mesh-ancestor
25381732|NCT04644029|Tenofovir|tenofovir|mesh-list
25413161|NCT03151811|Melphalan|melphalan|mesh-list
25381981|NCT04632992|Paclitaxel|paclitaxel|mesh-list
25413369|NCT03136055|Paclitaxel|paclitaxel|mesh-list
25382136|NCT04629248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25382137|NCT04629248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25382138|NCT04629248|Anesthetics, Local|anesthetics, local|mesh-ancestor
25382139|NCT04629248|Anesthetics|anesthetics|mesh-ancestor
25382140|NCT04629248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25382141|NCT04629248|Histamine Antagonists|histamine antagonists|mesh-ancestor
25382142|NCT04629248|Histamine Agents|histamine agents|mesh-ancestor
25382143|NCT04629248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25382144|NCT04629248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25382145|NCT04629248|Antipruritics|antipruritics|mesh-ancestor
25382146|NCT04629248|Dermatologic Agents|dermatologic agents|mesh-ancestor
25382147|NCT04629196|Ustekinumab|ustekinumab|mesh-list
25382148|NCT04629196|Dermatologic Agents|dermatologic agents|mesh-ancestor
25382186|NCT04628338|Interferons|interferons|mesh-list
25382187|NCT04628338|Interferon-gamma|interferon-gamma|mesh-list
25382188|NCT04628338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382189|NCT04628338|Antiviral Agents|antiviral agents|mesh-ancestor
25382190|NCT04628338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25382191|NCT04628026|Venetoclax|venetoclax|mesh-list
25382192|NCT04628026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382193|NCT04627922|Acetylcysteine|acetylcysteine|mesh-list
25382194|NCT04627922|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25382195|NCT04627922|Antiviral Agents|antiviral agents|mesh-ancestor
25382196|NCT04627922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25382197|NCT04627922|Expectorants|expectorants|mesh-ancestor
25382198|NCT04627922|Respiratory System Agents|respiratory system agents|mesh-ancestor
25382199|NCT04627922|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25382200|NCT04627922|Antioxidants|antioxidants|mesh-ancestor
25382201|NCT04627922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382202|NCT04627922|Protective Agents|protective agents|mesh-ancestor
25382203|NCT04627922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382204|NCT04627922|Antidotes|antidotes|mesh-ancestor
25382206|NCT04627870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25382207|NCT04627870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382208|NCT04627870|Tubulin Modulators|tubulin modulators|mesh-ancestor
25382209|NCT04627870|Antimitotic Agents|antimitotic agents|mesh-ancestor
25382210|NCT04627870|Mitosis Modulators|mitosis modulators|mesh-ancestor
25382325|NCT04624204|Etoposide|etoposide|mesh-list
25413754|NCT03111485|Dopamine Agents|dopamine agents|mesh-ancestor
25382539|NCT04616560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25382619|NCT04613960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382620|NCT04613960|Anesthetics|anesthetics|mesh-ancestor
25382622|NCT04613960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25382775|NCT04608331|Analgesics|analgesics|mesh-ancestor
25383304|NCT04592016|Coal Tar|coal tar|mesh-list
25414673|NCT03049306|Propranolol|propranolol|mesh-list
25383684|NCT04578938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25383685|NCT04578938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25383686|NCT04578938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25383695|NCT04578639|Rituximab|rituximab|mesh-list
25383832|NCT04570839|Nivolumab|nivolumab|mesh-list
25384304|NCT04548999|Antiemetics|antiemetics|mesh-ancestor
25384305|NCT04548999|Autonomic Agents|autonomic agents|mesh-ancestor
25384306|NCT04548999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25384307|NCT04548999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384308|NCT04548999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25384309|NCT04548999|Glucocorticoids|glucocorticoids|mesh-ancestor
25384310|NCT04548999|Hormones|hormones|mesh-ancestor
25384313|NCT04548999|Protective Agents|protective agents|mesh-ancestor
25384459|NCT04546399|Micronutrients|micronutrients|mesh-ancestor
25384460|NCT04546399|Tubulin Modulators|tubulin modulators|mesh-ancestor
25384461|NCT04546399|Antimitotic Agents|antimitotic agents|mesh-ancestor
25384462|NCT04546399|Mitosis Modulators|mitosis modulators|mesh-ancestor
25384463|NCT04546399|Hematinics|hematinics|mesh-ancestor
25416210|NCT02965768|Naltrexone|naltrexone|mesh-list
25385004|NCT04530565|Hormones|hormones|mesh-ancestor
25385386|NCT04521946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25416879|NCT02914938|Rituximab|rituximab|mesh-list
25385653|NCT04515329|Cyclosporine|cyclosporine|mesh-list
25385654|NCT04515329|Lubricant Eye Drops|lubricant eye drops|mesh-list
25385655|NCT04515329|Cyclosporins|cyclosporins|mesh-list
25385656|NCT04515329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417030|NCT02905591|Vitamins|vitamins|mesh-ancestor
25385881|NCT04507919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25385882|NCT04507919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25385884|NCT04507503|Futibatinib|futibatinib|mesh-list
25386033|NCT04500613|Hormones|hormones|mesh-ancestor
25386108|NCT04497961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25386109|NCT04497844|Prednisone|prednisone|mesh-list
25386110|NCT04497844|Abiraterone Acetate|abiraterone acetate|mesh-list
25386111|NCT04497844|Niraparib|niraparib|mesh-list
25386112|NCT04497844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25386355|NCT04487080|Lazertinib|lazertinib|mesh-list
25386813|NCT04464980|Naltrexone|naltrexone|mesh-list
25386986|NCT04458831|Hormones|hormones|mesh-ancestor
25387040|NCT04456699|Immunologic Factors|immunologic factors|mesh-ancestor
25387041|NCT04456699|Antidotes|antidotes|mesh-ancestor
25387198|NCT04447352|Antimetabolites|antimetabolites|mesh-ancestor
25387270|NCT04446039|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25387271|NCT04446039|Tianeptine|tianeptine|mesh-list
25387272|NCT04446039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25387273|NCT04446039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25387274|NCT04446039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25387275|NCT04446039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387276|NCT04446039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25387277|NCT04446039|Serotonin Agents|serotonin agents|mesh-ancestor
25387278|NCT04446039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387279|NCT04446039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25387280|NCT04446039|Antidepressive Agents|antidepressive agents|mesh-ancestor
25387494|NCT04438512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25387495|NCT04438512|Adrenergic Agents|adrenergic agents|mesh-ancestor
25387496|NCT04438382|Prednisone|prednisone|mesh-list
25387497|NCT04438382|Cortisone|cortisone|mesh-list
25387498|NCT04438382|Infliximab|infliximab|mesh-list
25387499|NCT04438382|Immunoglobulins|immunoglobulins|mesh-list
25387576|NCT04436250|Anesthetics, General|anesthetics, general|mesh-ancestor
25387500|NCT04438382|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25387648|NCT04431453|Remdesivir|remdesivir|mesh-list
25387735|NCT04429334|Nangibotide|nangibotide|mesh-list
25387801|NCT04425070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25387802|NCT04425070|Antiviral Agents|antiviral agents|mesh-ancestor
25387803|NCT04425070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25387804|NCT04425070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25387805|NCT04425070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25387806|NCT04425070|Immunologic Factors|immunologic factors|mesh-ancestor
25387807|NCT04425070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387809|NCT04425070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25419164|NCT02720445|Nicotine|nicotine|mesh-list
25388036|NCT04412876|Analgesics|analgesics|mesh-ancestor
25388114|NCT04410991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25388192|NCT04407390|Niacinamide|niacinamide|mesh-list
25388273|NCT04402346|Pancrelipase|pancrelipase|mesh-list
25388345|NCT04398537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25388346|NCT04398537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25388348|NCT04398524|Cemiplimab|cemiplimab|mesh-list
25388351|NCT04398134|Entecavir|entecavir|mesh-list
25388885|NCT04379596|Pembrolizumab|pembrolizumab|mesh-list
25389228|NCT04356430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25389315|NCT04352439|Antipyretics|antipyretics|mesh-ancestor
25420679|NCT02607722|Nintedanib|nintedanib|mesh-list
25389863|NCT04322318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25389864|NCT04322318|Tubulin Modulators|tubulin modulators|mesh-ancestor
25389865|NCT04322318|Antimitotic Agents|antimitotic agents|mesh-ancestor
25389866|NCT04322318|Mitosis Modulators|mitosis modulators|mesh-ancestor
25389867|NCT04322318|Keratolytic Agents|keratolytic agents|mesh-ancestor
25389868|NCT04322318|Dermatologic Agents|dermatologic agents|mesh-ancestor
25389869|NCT04322006|Antibodies|antibodies|mesh-list
25389870|NCT04322006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25389871|NCT04322006|Immunologic Factors|immunologic factors|mesh-ancestor
25389872|NCT04322006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389887|NCT04320914|Ibuprofen|ibuprofen|mesh-list
25389888|NCT04320914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25389891|NCT04320914|Sensory System Agents|sensory system agents|mesh-ancestor
25389941|NCT04316442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389949|NCT04316013|Lidocaine|lidocaine|mesh-list
25389950|NCT04316013|Propofol|propofol|mesh-list
25389951|NCT04316013|Sevoflurane|sevoflurane|mesh-list
25389952|NCT04316013|Anesthetics, Local|anesthetics, local|mesh-ancestor
25389953|NCT04316013|Anesthetics|anesthetics|mesh-ancestor
25389954|NCT04316013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25389955|NCT04316013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25389956|NCT04316013|Sensory System Agents|sensory system agents|mesh-ancestor
25389957|NCT04316013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25389958|NCT04316013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25389959|NCT04316013|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25389960|NCT04316013|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25389961|NCT04316013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25389965|NCT04316013|Anesthetics, General|anesthetics, general|mesh-ancestor
25390016|NCT04312659|Infliximab|infliximab|mesh-list
25390017|NCT04312659|Dermatologic Agents|dermatologic agents|mesh-ancestor
25390018|NCT04312659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25390019|NCT04312659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25390020|NCT04311723|Anesthetics|anesthetics|mesh-list
25390021|NCT04311723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25390022|NCT04311723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390023|NCT04311671|Ivermectin|ivermectin|mesh-list
25390024|NCT04311671|Moxidectin|moxidectin|mesh-list
25390025|NCT04311671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25390026|NCT04311671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25390027|NCT04311671|Anthelmintics|anthelmintics|mesh-ancestor
25390028|NCT04311671|Antinematodal Agents|antinematodal agents|mesh-ancestor
25390029|NCT04311515|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25390030|NCT04311515|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25390031|NCT04311515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390064|NCT04311411|Liraglutide|liraglutide|mesh-list
25390065|NCT04311411|Tirzepatide|tirzepatide|mesh-list
25390066|NCT04311411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25390067|NCT04311411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390068|NCT04311411|Incretins|incretins|mesh-ancestor
25390069|NCT04311411|Hormones|hormones|mesh-ancestor
25390070|NCT04311411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25390071|NCT04310930|Azithromycin|azithromycin|mesh-list
25390072|NCT04310930|Moxifloxacin|moxifloxacin|mesh-list
25390073|NCT04310930|Clarithromycin|clarithromycin|mesh-list
25390074|NCT04310930|Doxycycline|doxycycline|mesh-list
25390075|NCT04310930|Linezolid|linezolid|mesh-list
25390076|NCT04310930|Imipenem|imipenem|mesh-list
25390077|NCT04310930|Amikacin|amikacin|mesh-list
25390078|NCT04310930|Ethambutol|ethambutol|mesh-list
25390079|NCT04310930|Rifabutin|rifabutin|mesh-list
25390080|NCT04310930|Tigecycline|tigecycline|mesh-list
25421292|NCT02553447|Vitamin D|vitamin d|mesh-list
25421388|NCT02546986|Cc-486|cc-486|mesh-list
25390248|NCT04305054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25390249|NCT04305054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390361|NCT04300920|Acetylcysteine|acetylcysteine|mesh-list
25390362|NCT04300920|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25390363|NCT04300920|Antiviral Agents|antiviral agents|mesh-ancestor
25390364|NCT04300920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25390365|NCT04300920|Expectorants|expectorants|mesh-ancestor
25390366|NCT04300920|Respiratory System Agents|respiratory system agents|mesh-ancestor
25390367|NCT04300920|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25390368|NCT04300920|Antioxidants|antioxidants|mesh-ancestor
25390369|NCT04300920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390370|NCT04300920|Protective Agents|protective agents|mesh-ancestor
25390371|NCT04300920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390372|NCT04300920|Antidotes|antidotes|mesh-ancestor
25390373|NCT04300790|Metformin|metformin|mesh-list
25390374|NCT04300790|Letrozole|letrozole|mesh-list
25390375|NCT04300790|Fulvestrant|fulvestrant|mesh-list
25390376|NCT04300790|Exemestane|exemestane|mesh-list
25390377|NCT04300790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25390378|NCT04300790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390379|NCT04300790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390380|NCT04300790|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25390381|NCT04300790|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25390382|NCT04300790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25390383|NCT04300790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390384|NCT04300790|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25390385|NCT04300790|Hormone Antagonists|hormone antagonists|mesh-ancestor
25390386|NCT04300790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25390387|NCT04300790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25390388|NCT04300790|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25390389|NCT04300647|Atezolizumab|atezolizumab|mesh-list
25390390|NCT04300647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25390391|NCT04300309|Lumefantrine|lumefantrine|mesh-list
25390392|NCT04300309|Artemether|artemether|mesh-list
25390393|NCT04300309|Antimalarials|antimalarials|mesh-ancestor
25390394|NCT04300309|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25390395|NCT04300309|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25390552|NCT04294628|Trastuzumab|trastuzumab|mesh-list
25390701|NCT04285450|Coagulants|coagulants|mesh-ancestor
25390858|NCT04277442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25390859|NCT04277442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390860|NCT04277442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25390861|NCT04277442|Antimetabolites|antimetabolites|mesh-ancestor
25390955|NCT04272021|Methylphenidate|methylphenidate|mesh-list
25390956|NCT04272021|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25390957|NCT04272021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25390958|NCT04272021|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25390959|NCT04272021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25390960|NCT04272021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25390961|NCT04272021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390962|NCT04272021|Dopamine Agents|dopamine agents|mesh-ancestor
25390963|NCT04272021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25390965|NCT04271475|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25390966|NCT04271475|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25390967|NCT04271475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25390968|NCT04271475|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25390969|NCT04271332|Baclofen|baclofen|mesh-list
25390970|NCT04271332|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25390975|NCT04271332|GABA Agonists|gaba agonists|mesh-ancestor
25391012|NCT04268407|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25391013|NCT04268407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25391014|NCT04268407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391015|NCT04268277|Rituximab|rituximab|mesh-list
25391016|NCT04268277|Pembrolizumab|pembrolizumab|mesh-list
25391017|NCT04268277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25391018|NCT04268277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391019|NCT04268277|Immunologic Factors|immunologic factors|mesh-ancestor
25391020|NCT04268277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391021|NCT04268277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25391022|NCT04267939|Niraparib|niraparib|mesh-list
25391023|NCT04267939|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25391024|NCT04267939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25391025|NCT04267939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391026|NCT04267939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391114|NCT04265534|Pembrolizumab|pembrolizumab|mesh-list
25391051|NCT04266301|Azacitidine|azacitidine|mesh-list
25391052|NCT04266301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25391053|NCT04266301|Antimetabolites|antimetabolites|mesh-ancestor
25391054|NCT04266301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391055|NCT04266301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391056|NCT04266301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25391243|NCT04260529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391244|NCT04260347|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25391245|NCT04260347|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25391246|NCT04260347|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25391247|NCT04260347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391248|NCT04260126|Pembrolizumab|pembrolizumab|mesh-list
25391249|NCT04260126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25391250|NCT04260126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391251|NCT04259944|Capecitabine|capecitabine|mesh-list
25391408|NCT04249401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25391409|NCT04249362|Durvalumab|durvalumab|mesh-list
25391410|NCT04249362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25391411|NCT04249362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391412|NCT04249232|Abaloparatide|abaloparatide|mesh-list
25391413|NCT04249232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25422591|NCT02443077|Antiviral Agents|antiviral agents|mesh-ancestor
25391560|NCT04245839|Cyclophosphamide|cyclophosphamide|mesh-list
25391561|NCT04245839|Fludarabine|fludarabine|mesh-list
25391571|NCT04245709|Clenbuterol|clenbuterol|mesh-list
25391786|NCT04232943|Vaccines|vaccines|mesh-list
25391787|NCT04232943|Immunologic Factors|immunologic factors|mesh-ancestor
25391788|NCT04232943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391789|NCT04232761|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25391790|NCT04232761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25391802|NCT04232306|Bupivacaine|bupivacaine|mesh-list
25391803|NCT04232306|Anesthetics, Local|anesthetics, local|mesh-ancestor
25391804|NCT04232306|Anesthetics|anesthetics|mesh-ancestor
25391805|NCT04232306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25391806|NCT04232306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25391807|NCT04232306|Sensory System Agents|sensory system agents|mesh-ancestor
25391865|NCT04230408|Paclitaxel|paclitaxel|mesh-list
25423049|NCT02403986|Lidocaine|lidocaine|mesh-list
25392020|NCT04225715|Antiviral Agents|antiviral agents|mesh-ancestor
25392167|NCT04221477|Autonomic Agents|autonomic agents|mesh-ancestor
25392397|NCT04216524|Abortifacient Agents|abortifacient agents|mesh-ancestor
25392398|NCT04216524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25392399|NCT04216524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25392400|NCT04216524|Antimetabolites|antimetabolites|mesh-ancestor
25392401|NCT04216524|Dermatologic Agents|dermatologic agents|mesh-ancestor
25392402|NCT04216524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25392403|NCT04216524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25392404|NCT04216524|Antiviral Agents|antiviral agents|mesh-ancestor
25392405|NCT04216524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25392406|NCT04216524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25392407|NCT04216524|Tubulin Modulators|tubulin modulators|mesh-ancestor
25392408|NCT04216524|Antimitotic Agents|antimitotic agents|mesh-ancestor
25392409|NCT04216524|Mitosis Modulators|mitosis modulators|mesh-ancestor
25392410|NCT04216524|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25392411|NCT04216524|Protective Agents|protective agents|mesh-ancestor
25392412|NCT04216329|Temozolomide|temozolomide|mesh-list
25392562|NCT04210115|Oxaliplatin|oxaliplatin|mesh-list
25392413|NCT04216329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25392414|NCT04216329|Alkylating Agents|alkylating agents|mesh-ancestor
25392415|NCT04216329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392416|NCT04216329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25392472|NCT04215848|Adrenergic Agents|adrenergic agents|mesh-ancestor
25392473|NCT04215848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25392474|NCT04215848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25392475|NCT04215146|Paclitaxel|paclitaxel|mesh-list
25392476|NCT04215146|Avelumab|avelumab|mesh-list
25392545|NCT04211675|Irinotecan|irinotecan|mesh-list
25392852|NCT04200456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25392853|NCT04200456|Immunologic Factors|immunologic factors|mesh-ancestor
25393391|NCT04184869|Belinostat|belinostat|mesh-list
25393460|NCT04181827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25393461|NCT04181827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25393462|NCT04181827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25393463|NCT04181827|Glucocorticoids|glucocorticoids|mesh-ancestor
25393464|NCT04181827|Hormones|hormones|mesh-ancestor
25393465|NCT04181827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25393466|NCT04181827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25393467|NCT04181827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393468|NCT04181827|Immunologic Factors|immunologic factors|mesh-ancestor
25393469|NCT04181827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25393470|NCT04181827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25393471|NCT04181827|Growth Substances|growth substances|mesh-ancestor
25393472|NCT04181827|Growth Inhibitors|growth inhibitors|mesh-ancestor
25393473|NCT04181359|Nitric Oxide|nitric oxide|mesh-list
25393474|NCT04181359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25393475|NCT04181359|Autonomic Agents|autonomic agents|mesh-ancestor
25393481|NCT04181359|Antioxidants|antioxidants|mesh-ancestor
25393615|NCT04176705|Immunologic Factors|immunologic factors|mesh-ancestor
25393726|NCT04172675|Mitomycins|mitomycins|mesh-list
25393873|NCT04166435|Temozolomide|temozolomide|mesh-list
25393874|NCT04166435|Olaparib|olaparib|mesh-list
25393875|NCT04166435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25393876|NCT04166435|Alkylating Agents|alkylating agents|mesh-ancestor
25393877|NCT04166435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393878|NCT04166435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393879|NCT04166435|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25393948|NCT04165096|Autonomic Agents|autonomic agents|mesh-ancestor
25393949|NCT04165096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25393950|NCT04165096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25393951|NCT04165096|Histamine Antagonists|histamine antagonists|mesh-ancestor
25393952|NCT04165096|Histamine Agents|histamine agents|mesh-ancestor
25393953|NCT04165096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25393954|NCT04165096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25393955|NCT04165096|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25393956|NCT04165096|Antipruritics|antipruritics|mesh-ancestor
25393957|NCT04165096|Dermatologic Agents|dermatologic agents|mesh-ancestor
25393958|NCT04165083|Pembrolizumab|pembrolizumab|mesh-list
25393959|NCT04165083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25393960|NCT04165083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25393961|NCT04165070|Paclitaxel|paclitaxel|mesh-list
25393962|NCT04165070|Carboplatin|carboplatin|mesh-list
25393963|NCT04165070|Pembrolizumab|pembrolizumab|mesh-list
25393964|NCT04165070|Pemetrexed|pemetrexed|mesh-list
25393965|NCT04165070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25394174|NCT04157036|Antiemetics|antiemetics|mesh-ancestor
25394175|NCT04157036|Autonomic Agents|autonomic agents|mesh-ancestor
25394176|NCT04157036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25394177|NCT04157036|Glucocorticoids|glucocorticoids|mesh-ancestor
25394178|NCT04157036|Hormones|hormones|mesh-ancestor
25394179|NCT04157036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25394180|NCT04157036|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25394181|NCT04157036|Protective Agents|protective agents|mesh-ancestor
25394182|NCT04157036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25394183|NCT04157036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394184|NCT04156581|Dexamethasone|dexamethasone|mesh-list
25394185|NCT04156581|Bupivacaine|bupivacaine|mesh-list
25394186|NCT04156581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25394187|NCT04156581|Antiemetics|antiemetics|mesh-ancestor
25394188|NCT04156581|Autonomic Agents|autonomic agents|mesh-ancestor
25394191|NCT04156581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25394327|NCT04146207|Hormones|hormones|mesh-ancestor
25394328|NCT04146207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25394329|NCT04146207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25394330|NCT04146207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25394331|NCT04146207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394408|NCT04141696|Anesthetics|anesthetics|mesh-ancestor
25394481|NCT04139304|Tubulin Modulators|tubulin modulators|mesh-ancestor
25394713|NCT04126031|Ceftazidime|ceftazidime|mesh-list
25394790|NCT04123561|Protease Inhibitors|protease inhibitors|mesh-ancestor
25395025|NCT04108156|Ranibizumab|ranibizumab|mesh-list
25395134|NCT04101721|Aflibercept|aflibercept|mesh-list
25395135|NCT04101721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25395136|NCT04101721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25395137|NCT04101721|Growth Substances|growth substances|mesh-ancestor
25395138|NCT04101721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25395139|NCT04101721|Growth Inhibitors|growth inhibitors|mesh-ancestor
25395140|NCT04101721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25395952|NCT04072822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25395953|NCT04072445|Trifluridine|trifluridine|mesh-list
25395955|NCT04072445|Camptothecin|camptothecin|mesh-list
25396110|NCT04068103|Antidotes|antidotes|mesh-ancestor
25396183|NCT04062448|Rituximab|rituximab|mesh-list
25427233|NCT01912625|Trametinib|trametinib|mesh-list
25396335|NCT04058067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25396336|NCT04058067|Growth Substances|growth substances|mesh-ancestor
25396337|NCT04058067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396338|NCT04058067|Growth Inhibitors|growth inhibitors|mesh-ancestor
25396339|NCT04058067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396502|NCT04046744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25396503|NCT04046744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396504|NCT04046549|Abatacept|abatacept|mesh-list
25396505|NCT04046549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25396506|NCT04046549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396507|NCT04046549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25427545|NCT01871571|Levoleucovorin|levoleucovorin|mesh-list
25396580|NCT04042701|Pembrolizumab|pembrolizumab|mesh-list
25396581|NCT04042701|Trastuzumab|trastuzumab|mesh-list
25396582|NCT04042701|Camptothecin|camptothecin|mesh-list
25396583|NCT04042701|Immunoconjugates|immunoconjugates|mesh-list
25396584|NCT04042701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25396585|NCT04042701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25396586|NCT04042701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25396587|NCT04042701|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25396588|NCT04042701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25396589|NCT04042701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25396590|NCT04042701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25396591|NCT04042701|Immunologic Factors|immunologic factors|mesh-ancestor
25396592|NCT04042701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25396593|NCT04041973|Lumefantrine|lumefantrine|mesh-list
25396730|NCT04034927|Olaparib|olaparib|mesh-list
25396804|NCT04030455|Cisplatin|cisplatin|mesh-list
25396955|NCT04024436|Fulvestrant|fulvestrant|mesh-list
25397108|NCT04017650|Nivolumab|nivolumab|mesh-list
25428230|NCT01748175|Triamcinolone|triamcinolone|mesh-list
25397333|NCT04007029|Vidarabine|vidarabine|mesh-list
25498883|NCT03239015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25397638|NCT03992404|Botulinum Toxins|botulinum toxins|mesh-list
25397803|NCT03984448|Hormones|hormones|mesh-ancestor
25397804|NCT03984448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25397805|NCT03984448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25397806|NCT03984448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25397807|NCT03984448|Tubulin Modulators|tubulin modulators|mesh-ancestor
25397808|NCT03984448|Antimitotic Agents|antimitotic agents|mesh-ancestor
25397812|NCT03984097|Dexamethasone|dexamethasone|mesh-list
25397881|NCT03981796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25398030|NCT03976063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398031|NCT03976063|Vasodilator Agents|vasodilator agents|mesh-ancestor
25398032|NCT03976063|Tocolytic Agents|tocolytic agents|mesh-ancestor
25398033|NCT03976063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25398034|NCT03975647|Tucatinib|tucatinib|mesh-list
25398035|NCT03975647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25398103|NCT03971110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25398105|NCT03970954|Interleukin-2|interleukin-2|mesh-list
25429180|NCT01572506|Biotin|biotin|mesh-list
25398330|NCT03959566|Midazolam|midazolam|mesh-list
25398407|NCT03954483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25398408|NCT03954483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25398409|NCT03954483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25398410|NCT03954483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25398411|NCT03954483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25398712|NCT03940586|Letermovir|letermovir|mesh-list
25398787|NCT03934814|Immunologic Factors|immunologic factors|mesh-ancestor
25398877|NCT03929640|Ibuprofen|ibuprofen|mesh-list
25430078|NCT01371981|Cytarabine|cytarabine|mesh-list
25399162|NCT03916341|Autonomic Agents|autonomic agents|mesh-ancestor
25399163|NCT03916341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25399164|NCT03916341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399165|NCT03916341|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25399166|NCT03916341|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25399167|NCT03916341|Cholinergic Agents|cholinergic agents|mesh-ancestor
25399168|NCT03916341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25399169|NCT03916341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399170|NCT03916263|Metformin|metformin|mesh-list
25399171|NCT03916263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25399172|NCT03916263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399173|NCT03916068|Vitamin E|vitamin e|mesh-list
25399174|NCT03916068|Pentoxifylline|pentoxifylline|mesh-list
25399175|NCT03916068|Vitamins|vitamins|mesh-ancestor
25399176|NCT03916068|Micronutrients|micronutrients|mesh-ancestor
25399177|NCT03916068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399178|NCT03916068|Antioxidants|antioxidants|mesh-ancestor
25399179|NCT03916068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399180|NCT03916068|Protective Agents|protective agents|mesh-ancestor
25399181|NCT03916068|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25399182|NCT03916068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399183|NCT03916068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25399184|NCT03916068|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25399185|NCT03916068|Vasodilator Agents|vasodilator agents|mesh-ancestor
25399186|NCT03916068|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25399187|NCT03916003|Primaquine|primaquine|mesh-list
25399188|NCT03916003|Antimalarials|antimalarials|mesh-ancestor
25399189|NCT03916003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25399190|NCT03916003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25399191|NCT03916003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25399192|NCT03915678|Atezolizumab|atezolizumab|mesh-list
25399193|NCT03915678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25399194|NCT03915678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399195|NCT03915678|Immunologic Factors|immunologic factors|mesh-ancestor
25399372|NCT03909412|Glucocorticoids|glucocorticoids|mesh-ancestor
25399300|NCT03914300|Nivolumab|nivolumab|mesh-list
25399301|NCT03914300|Ipilimumab|ipilimumab|mesh-list
25399302|NCT03914300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25399303|NCT03914300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25399304|NCT03914300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25399305|NCT03914300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399306|NCT03913221|Caffeine|caffeine|mesh-list
25399307|NCT03913221|Caffeine citrate|caffeine citrate|mesh-list
25399308|NCT03913221|Citric Acid|citric acid|mesh-list
25399309|NCT03913221|Sodium Citrate|sodium citrate|mesh-list
25399310|NCT03913221|Anticoagulants|anticoagulants|mesh-ancestor
25399311|NCT03913221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25399312|NCT03913221|Chelating Agents|chelating agents|mesh-ancestor
25399313|NCT03913221|Sequestering Agents|sequestering agents|mesh-ancestor
25399314|NCT03913221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399315|NCT03913221|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25399316|NCT03913221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399317|NCT03913221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25399318|NCT03913221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399319|NCT03913221|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25399320|NCT03913221|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25399321|NCT03913221|Purinergic Agents|purinergic agents|mesh-ancestor
25399322|NCT03913221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25399323|NCT03912805|Botulinum Toxins|botulinum toxins|mesh-list
25399324|NCT03912805|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25399325|NCT03912805|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25399326|NCT03912805|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25399327|NCT03912805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25399328|NCT03912805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399329|NCT03912805|Cholinergic Agents|cholinergic agents|mesh-ancestor
25399330|NCT03912805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25399331|NCT03912805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399332|NCT03912805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25399414|NCT03909152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25399415|NCT03909152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399416|NCT03909152|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25399417|NCT03909152|Fertility Agents|fertility agents|mesh-ancestor
25399418|NCT03909152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25399419|NCT03908892|Tetracycline|tetracycline|mesh-list
25399420|NCT03908892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25399421|NCT03908892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25399422|NCT03908892|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25399423|NCT03908892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399424|NCT03908892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399425|NCT03907969|AZD7648|azd7648|mesh-list
25399426|NCT03907969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25399427|NCT03907969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25399428|NCT03907969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25399459|NCT03907046|Apixaban|apixaban|mesh-list
25399460|NCT03907046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25399461|NCT03907046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25399462|NCT03907046|Analgesics|analgesics|mesh-ancestor
25399463|NCT03907046|Sensory System Agents|sensory system agents|mesh-ancestor
25399464|NCT03907046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25399465|NCT03907046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25399466|NCT03907046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25399467|NCT03907046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25399468|NCT03907046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25399469|NCT03907046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25430447|NCT01327651|Tenofovir|tenofovir|mesh-list
25399806|NCT03891355|Lenalidomide|lenalidomide|mesh-list
25399902|NCT03882177|Vitamin B 6|vitamin b 6|mesh-list
25400050|NCT03873337|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25400051|NCT03873337|Autonomic Agents|autonomic agents|mesh-ancestor
25400052|NCT03873337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25400053|NCT03873337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25400054|NCT03873337|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25400055|NCT03873337|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25400056|NCT03873337|Cholinergic Agents|cholinergic agents|mesh-ancestor
25400057|NCT03873337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25431209|NCT01167712|Paclitaxel|paclitaxel|mesh-list
25400275|NCT03864419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25400276|NCT03864419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25400277|NCT03864419|Antimetabolites|antimetabolites|mesh-ancestor
25400278|NCT03864419|Dermatologic Agents|dermatologic agents|mesh-ancestor
25400279|NCT03864419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25400280|NCT03864419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25400356|NCT03864042|Antitussive Agents|antitussive agents|mesh-ancestor
25400281|NCT03864419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25400282|NCT03864419|Tubulin Modulators|tubulin modulators|mesh-ancestor
25400283|NCT03864419|Antimitotic Agents|antimitotic agents|mesh-ancestor
25400284|NCT03864419|Mitosis Modulators|mitosis modulators|mesh-ancestor
25400285|NCT03864419|Keratolytic Agents|keratolytic agents|mesh-ancestor
25400305|NCT03864042|Losartan|losartan|mesh-list
25400306|NCT03864042|Midazolam|midazolam|mesh-list
25400307|NCT03864042|Dextromethorphan|dextromethorphan|mesh-list
25400308|NCT03864042|Caffeine|caffeine|mesh-list
25400309|NCT03864042|Modafinil|modafinil|mesh-list
25400310|NCT03864042|Bupropion|bupropion|mesh-list
25431435|NCT01081262|Antimetabolites|antimetabolites|mesh-ancestor
25400809|NCT03838159|Nivolumab|nivolumab|mesh-list
25401047|NCT03825796|Cytarabine|cytarabine|mesh-list
25432055|NCT00881868|Clobetasol|clobetasol|mesh-list
25401434|NCT03813121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25401435|NCT03813121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25401436|NCT03813121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25401437|NCT03813121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25401438|NCT03813121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401439|NCT03813121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25401440|NCT03813121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25401441|NCT03813121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25401442|NCT03813121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25401443|NCT03813121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25401444|NCT03813121|GABA Modulators|gaba modulators|mesh-ancestor
25401445|NCT03813121|GABA Agents|gaba agents|mesh-ancestor
25401446|NCT03812380|Magnesium citrate|magnesium citrate|mesh-list
25401447|NCT03812380|Cathartics|cathartics|mesh-ancestor
25401448|NCT03812380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25401449|NCT03812224|Erenumab|erenumab|mesh-list
25401450|NCT03812224|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25401452|NCT03812224|Analgesics|analgesics|mesh-ancestor
25401518|NCT03807479|Ponatinib|ponatinib|mesh-list
25401671|NCT03801369|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25401672|NCT03801369|Immunoglobulins|immunoglobulins|mesh-list
25401673|NCT03801369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25401674|NCT03801369|Immunoglobulin G|immunoglobulin g|mesh-list
25401675|NCT03801369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25401676|NCT03801369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401677|NCT03801369|Immunologic Factors|immunologic factors|mesh-ancestor
25401678|NCT03801369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401679|NCT03801369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401680|NCT03801369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401681|NCT03800134|Gemcitabine|gemcitabine|mesh-list
25401682|NCT03800134|Paclitaxel|paclitaxel|mesh-list
25401683|NCT03800134|Cisplatin|cisplatin|mesh-list
25401684|NCT03800134|Carboplatin|carboplatin|mesh-list
25401685|NCT03800134|Pemetrexed|pemetrexed|mesh-list
25401764|NCT03797326|Pembrolizumab|pembrolizumab|mesh-list
25401765|NCT03797326|Lenvatinib|lenvatinib|mesh-list
25401766|NCT03797326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25401767|NCT03797326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401768|NCT03797326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25401769|NCT03797326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25401770|NCT03797326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25401771|NCT03797001|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25401772|NCT03797001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25401773|NCT03794999|Benralizumab|benralizumab|mesh-list
25401774|NCT03794999|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25401775|NCT03794999|Respiratory System Agents|respiratory system agents|mesh-ancestor
25401776|NCT03794583|Treprostinil|treprostinil|mesh-list
25401777|NCT03794583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25401785|NCT03794349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25401843|NCT03792841|Etanercept|etanercept|mesh-list
25401844|NCT03792841|Pembrolizumab|pembrolizumab|mesh-list
25401845|NCT03792841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25401846|NCT03792841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25401847|NCT03792841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25401848|NCT03792841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25401849|NCT03792841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25402087|NCT03779854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25402088|NCT03779854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25402089|NCT03779854|Antiviral Agents|antiviral agents|mesh-ancestor
25402090|NCT03779854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25432986|NCT00602459|Rituximab|rituximab|mesh-list
25402392|NCT03769090|Budesonide|budesonide|mesh-list
25403333|NCT03725436|Mitosis Modulators|mitosis modulators|mesh-ancestor
25403334|NCT03725436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403341|NCT03725059|Paclitaxel|paclitaxel|mesh-list
25403342|NCT03725059|Cyclophosphamide|cyclophosphamide|mesh-list
25403343|NCT03725059|Doxorubicin|doxorubicin|mesh-list
25403344|NCT03725059|Pembrolizumab|pembrolizumab|mesh-list
25434208|NCT00217737|Calcium, Dietary|calcium, dietary|mesh-list
25403561|NCT03715244|Anesthetics|anesthetics|mesh-list
25434671|NCT00071708|Analgesics|analgesics|mesh-ancestor
24783962|NCT01905137|Botulinum Toxins|botulinum toxins|mesh-list
25498884|NCT03239015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25498885|NCT03239015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498886|NCT03239015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498887|NCT03239015|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25498888|NCT03239015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25498889|NCT03239015|Growth Substances|growth substances|mesh-ancestor
25724295|NCT02536846|Serotonin Agents|serotonin agents|mesh-ancestor
25724436|NCT02540226|Tranexamic Acid|tranexamic acid|mesh-list
25498890|NCT03239015|Growth Inhibitors|growth inhibitors|mesh-ancestor
25498891|NCT03161379|Cyclophosphamide|cyclophosphamide|mesh-list
25498892|NCT03161379|Nivolumab|nivolumab|mesh-list
25498893|NCT03161379|Pancrelipase|pancrelipase|mesh-list
25498894|NCT03161379|Vaccines|vaccines|mesh-list
25498895|NCT03161379|Immunologic Factors|immunologic factors|mesh-ancestor
25724459|NCT02540668|Warfarin|warfarin|mesh-list
25498896|NCT03161379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498897|NCT03161379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25498898|NCT03161379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25498899|NCT03161379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25498900|NCT03161379|Alkylating Agents|alkylating agents|mesh-ancestor
25498901|NCT03161379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498902|NCT03161379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498903|NCT03161379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25498904|NCT03161379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25498905|NCT03161379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25498906|NCT03161379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25498907|NCT03120780|Fentanyl|fentanyl|mesh-list
25498908|NCT03120780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25498909|NCT03120780|Narcotics|narcotics|mesh-ancestor
25498910|NCT03120780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24765135|NCT01786200|Analgesics|analgesics|mesh-ancestor
25498911|NCT03120780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498912|NCT03120780|Analgesics|analgesics|mesh-ancestor
25498913|NCT03120780|Sensory System Agents|sensory system agents|mesh-ancestor
25498914|NCT03120780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25724874|NCT02547623|Hormones|hormones|mesh-ancestor
25498915|NCT03120780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25498916|NCT03120780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25498917|NCT03120780|Anesthetics, General|anesthetics, general|mesh-ancestor
25498919|NCT03079921|Propranolol|propranolol|mesh-list
25498920|NCT03079921|Phentolamine|phentolamine|mesh-list
25498921|NCT03079921|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25498922|NCT03079921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25725125|NCT02552225|Amitriptyline|amitriptyline|mesh-list
25498923|NCT03079921|Adrenergic Agents|adrenergic agents|mesh-ancestor
25498924|NCT03079921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25498925|NCT03079921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498926|NCT03079921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498927|NCT03079921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25498928|NCT03079921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25498929|NCT03079921|Vasodilator Agents|vasodilator agents|mesh-ancestor
25498930|NCT03079921|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25498931|NCT03062358|Pembrolizumab|pembrolizumab|mesh-list
25498932|NCT03062358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25498933|NCT03062358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498934|NCT03017131|Aldesleukin|aldesleukin|mesh-list
25498935|NCT03017131|Cyclophosphamide|cyclophosphamide|mesh-list
25498936|NCT03017131|Decitabine|decitabine|mesh-list
25498937|NCT03017131|Interleukin-2|interleukin-2|mesh-list
25725411|NCT02557646|Ribavirin|ribavirin|mesh-list
25498938|NCT03017131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25498939|NCT03017131|Immunologic Factors|immunologic factors|mesh-ancestor
25498940|NCT03017131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498941|NCT03017131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25498942|NCT03017131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25725790|NCT02564029|Antiemetics|antiemetics|mesh-ancestor
25725791|NCT02564029|Autonomic Agents|autonomic agents|mesh-ancestor
25725792|NCT02564029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25498943|NCT03017131|Alkylating Agents|alkylating agents|mesh-ancestor
25645511|NCT01448707|Ritonavir|ritonavir|mesh-list
25645512|NCT01448707|Darunavir|darunavir|mesh-list
25498944|NCT03017131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25498945|NCT03017131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498946|NCT03017131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25498947|NCT03017131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25725946|NCT02566889|Infliximab|infliximab|mesh-list
25498948|NCT03017131|Antimetabolites|antimetabolites|mesh-ancestor
25498949|NCT03017131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25498950|NCT03017131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25498951|NCT03017131|Analgesics|analgesics|mesh-ancestor
25498952|NCT03017131|Sensory System Agents|sensory system agents|mesh-ancestor
25498953|NCT03017131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25498954|NCT03017131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25498955|NCT03017131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25498956|NCT03017131|Antiviral Agents|antiviral agents|mesh-ancestor
25726449|NCT02576639|CNP520|cnp520|mesh-list
25726668|NCT02579057|Furosemide|furosemide|mesh-list
25498957|NCT03017131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25498958|NCT03013933|Cyclosporine|cyclosporine|mesh-list
25498959|NCT03013933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25498960|NCT03013933|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25498961|NCT03013933|Verapamil|verapamil|mesh-list
25498962|NCT03013933|Antibodies|antibodies|mesh-list
25498963|NCT03013933|Immunoglobulins|immunoglobulins|mesh-list
25726752|NCT02579863|Hormones|hormones|mesh-ancestor
25726793|NCT02580877|Insulin|insulin|mesh-list
25726866|NCT02581839|BB 1101|bb 1101|mesh-list
25498964|NCT03013933|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25498965|NCT03013933|Cyclosporins|cyclosporins|mesh-list
25498966|NCT03013933|Immunoconjugates|immunoconjugates|mesh-list
25727321|NCT05247788|Ethanol|ethanol|mesh-list
25498967|NCT03013933|Immunologic Factors|immunologic factors|mesh-ancestor
25727393|NCT05159193|Doxorubicin|doxorubicin|mesh-list
25727538|NCT04787354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498968|NCT03013933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498969|NCT03013933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24765895|NCT01791296|Dexmedetomidine|dexmedetomidine|mesh-list
25727814|NCT03664830|Plerixafor|plerixafor|mesh-list
25727879|NCT03389620|Hormones|hormones|mesh-ancestor
25727980|NCT03113487|Pembrolizumab|pembrolizumab|mesh-list
24765896|NCT01791296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24765897|NCT01791296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24765898|NCT01791296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765946|NCT01791439|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24765947|NCT01791439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25728320|NCT00534469|Busulfan|busulfan|mesh-list
25034994|NCT03560427|Antidepressive Agents|antidepressive agents|mesh-ancestor
24765948|NCT01791439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24765949|NCT01791439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25728391|NCT02588261|Gefitinib|gefitinib|mesh-list
24765952|NCT01791608|Trace Elements|trace elements|mesh-ancestor
25166658|NCT03828019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24765953|NCT01791608|Micronutrients|micronutrients|mesh-ancestor
24765954|NCT01791608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25728786|NCT05319873|Carboplatin|carboplatin|mesh-list
25729162|NCT04082806|Serotonin Agents|serotonin agents|mesh-ancestor
25729230|NCT03934541|Vaccines|vaccines|mesh-list
25166659|NCT03828019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25729451|NCT03069963|Antacids|antacids|mesh-ancestor
25729519|NCT01750567|Metformin|metformin|mesh-list
25729662|NCT02596711|Nicotine|nicotine|mesh-list
25729735|NCT02597101|Metformin|metformin|mesh-list
25729808|NCT02598193|Analgesics|analgesics|mesh-ancestor
25729884|NCT02600819|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25729929|NCT02601573|Ribavirin|ribavirin|mesh-list
25730174|NCT02605304|Ribavirin|ribavirin|mesh-list
25731174|NCT02629991|Oxytocin|oxytocin|mesh-list
25731318|NCT02631746|Nivolumab|nivolumab|mesh-list
25731390|NCT02633046|Hormones|hormones|mesh-ancestor
25731502|NCT02634801|Ixekizumab|ixekizumab|mesh-list
25731633|NCT02637076|Sodium Oxybate|sodium oxybate|mesh-list
25731854|NCT02641691|Leucovorin|leucovorin|mesh-list
25731965|NCT02643979|Analgesics|analgesics|mesh-ancestor
25732586|NCT02658149|Epinephrine|epinephrine|mesh-list
25732663|NCT02659501|Epinephrine|epinephrine|mesh-list
25733190|NCT02674399|Hylan|hylan|mesh-list
25733702|NCT02690558|Gemcitabine|gemcitabine|mesh-list
25733821|NCT02692755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25734061|NCT02699892|Rituximab|rituximab|mesh-list
25734072|NCT02700412|Cannabidiol|cannabidiol|mesh-list
25734151|NCT02701582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25734426|NCT02709746|Vortioxetine|vortioxetine|mesh-list
25735255|NCT02727322|Renal Agents|renal agents|mesh-ancestor
25735793|NCT05445895|Clopidogrel|clopidogrel|mesh-list
25735944|NCT05444543|Fluticasone|fluticasone|mesh-list
25736012|NCT05443802|Insulin|insulin|mesh-list
25736490|NCT05312255|Propranolol|propranolol|mesh-list
25736866|NCT04898920|Dexamethasone|dexamethasone|mesh-list
25737664|NCT03915769|Ozanimod|ozanimod|mesh-list
25738372|NCT02379806|Enoxaparin|enoxaparin|mesh-list
25166660|NCT03828019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25166661|NCT03828019|Immunologic Factors|immunologic factors|mesh-ancestor
25166662|NCT03828019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25738976|NCT05449899|Alkylating Agents|alkylating agents|mesh-ancestor
25739132|NCT05448365|Vitamin D|vitamin d|mesh-list
25739206|NCT05447702|Alkylating Agents|alkylating agents|mesh-ancestor
25166663|NCT03828019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25739841|NCT05145907|Pembrolizumab|pembrolizumab|mesh-list
25739916|NCT05062577|Buprenorphine|buprenorphine|mesh-list
25739991|NCT05020821|Analgesics|analgesics|mesh-ancestor
25740160|NCT04895410|Hormones|hormones|mesh-ancestor
25740240|NCT04817254|Nivolumab|nivolumab|mesh-list
25740420|NCT04716946|Durvalumab|durvalumab|mesh-list
25498970|NCT03013933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25740565|NCT04539626|Estradiol|estradiol|mesh-list
25740821|NCT04267887|Antioxidants|antioxidants|mesh-ancestor
25741045|NCT03999268|Insulin|insulin|mesh-list
25741213|NCT03886922|Cromakalim|cromakalim|mesh-list
25742132|NCT02697344|Acetic Acid|acetic acid|mesh-list
25742576|NCT01524991|Gemcitabine|gemcitabine|mesh-list
25742975|NCT05259839|Dexamethasone|dexamethasone|mesh-list
25743285|NCT04978584|Glucocorticoids|glucocorticoids|mesh-ancestor
25743460|NCT04527887|Dexamethasone|dexamethasone|mesh-list
25743680|NCT04177355|Antacids|antacids|mesh-ancestor
25743897|NCT03540485|Melatonin|melatonin|mesh-list
25744012|NCT03215927|Abatacept|abatacept|mesh-list
25744300|NCT01614665|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25744706|NCT02741310|Sumatriptan|sumatriptan|mesh-list
25744977|NCT02748785|Methotrexate|methotrexate|mesh-list
25745282|NCT02756572|Alkylating Agents|alkylating agents|mesh-ancestor
25745358|NCT02758171|Empagliflozin|empagliflozin|mesh-list
25745738|NCT02769481|Glimepiride|glimepiride|mesh-list
25746298|NCT05455918|Paclitaxel|paclitaxel|mesh-list
25746447|NCT05418972|Nivolumab|nivolumab|mesh-list
25746455|NCT05323721|Pyrimethamine|pyrimethamine|mesh-list
25774804|NCT04066426|Hormones|hormones|mesh-ancestor
25747032|NCT03568890|Antipyretics|antipyretics|mesh-ancestor
25747099|NCT03289910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25747414|NCT05080322|Xhance|xhance|mesh-list
25747482|NCT05055752|Antipyretics|antipyretics|mesh-ancestor
25747670|NCT04825522|Vancomycin|vancomycin|mesh-list
25747809|NCT04645823|Lidocaine|lidocaine|mesh-list
25747848|NCT04573751|Verapamil|verapamil|mesh-list
25748192|NCT04101877|Bevacizumab|bevacizumab|mesh-list
25748338|NCT03581409|Aspirin|aspirin|mesh-list
25748701|NCT01685814|Bortezomib|bortezomib|mesh-list
25498971|NCT03013933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25748993|NCT02778113|Incretins|incretins|mesh-ancestor
25749150|NCT02783729|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25749299|NCT02788513|BI 425809|bi 425809|mesh-list
25749381|NCT02791308|Tacrolimus|tacrolimus|mesh-list
25749488|NCT02792699|Rituximab|rituximab|mesh-list
25750377|NCT02825212|Sofosbuvir|sofosbuvir|mesh-list
25750461|NCT02828358|Antidotes|antidotes|mesh-ancestor
25750533|NCT02831816|Ethanol|ethanol|mesh-list
25750569|NCT02832037|BI 425809|bi 425809|mesh-list
25751046|NCT02853318|Bevacizumab|bevacizumab|mesh-list
25751264|NCT02861586|Vaccines|vaccines|mesh-list
25775455|NCT03954444|Sympathomimetics|sympathomimetics|mesh-ancestor
25751416|NCT02866175|Ticagrelor|ticagrelor|mesh-list
25751826|NCT02882152|Narcotics|narcotics|mesh-ancestor
25751988|NCT02890992|Niacin|niacin|mesh-list
25752054|NCT02892344|Mometasone Furoate|mometasone furoate|mesh-list
25752266|NCT02901249|Serotonin Agents|serotonin agents|mesh-ancestor
25752420|NCT02903407|GABA Modulators|gaba modulators|mesh-ancestor
25752488|NCT02904902|Adalimumab|adalimumab|mesh-list
25752562|NCT02907489|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25752841|NCT02913521|Diclofenac|diclofenac|mesh-list
25752994|NCT02917941|Dexamethasone|dexamethasone|mesh-list
25753421|NCT02929667|Serotonin Agents|serotonin agents|mesh-ancestor
25753535|NCT02932904|Vortioxetine|vortioxetine|mesh-list
25753843|NCT02942576|Antithrombins|antithrombins|mesh-ancestor
25754091|NCT02951312|Cholinergic Agents|cholinergic agents|mesh-ancestor
25754240|NCT02953873|Prednisone|prednisone|mesh-list
25754315|NCT02954198|Antiemetics|antiemetics|mesh-ancestor
25754459|NCT02956278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25754764|NCT02965924|Phenylephrine|phenylephrine|mesh-list
25754975|NCT02970305|Pimavanserin|pimavanserin|mesh-list
25755671|NCT02991040|Lidocaine|lidocaine|mesh-list
25755971|NCT03000283|Conivaptan|conivaptan|mesh-list
25756044|NCT03001453|Autonomic Agents|autonomic agents|mesh-ancestor
25756264|NCT03008590|Naltrexone|naltrexone|mesh-list
25756839|NCT03027557|Denosumab|denosumab|mesh-list
25757059|NCT03031899|Hemostatics|hemostatics|mesh-ancestor
25757438|NCT03043560|Ezogabine|ezogabine|mesh-list
25757663|NCT03053401|Anesthetics|anesthetics|mesh-list
25757740|NCT03054844|GABA Modulators|gaba modulators|mesh-ancestor
25757877|NCT03060486|Hybenx|hybenx|mesh-list
25758150|NCT03070171|Dabigatran|dabigatran|mesh-list
25498972|NCT03013933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25498973|NCT03013933|Antifungal Agents|antifungal agents|mesh-ancestor
25498974|NCT03013933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25498975|NCT03013933|Dermatologic Agents|dermatologic agents|mesh-ancestor
25498976|NCT03013933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25498977|NCT03013933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25498978|NCT03013933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25498979|NCT03013933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25758968|NCT03096730|Dsuvia|dsuvia|mesh-list
25498980|NCT03013933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25498981|NCT03013933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25498982|NCT03013933|Vasodilator Agents|vasodilator agents|mesh-ancestor
25498983|NCT03007238|Aldesleukin|aldesleukin|mesh-list
25498984|NCT03007238|Interleukin-2|interleukin-2|mesh-list
25498985|NCT03007238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25498986|NCT03007238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25498987|NCT03007238|Analgesics|analgesics|mesh-ancestor
25498988|NCT03007238|Sensory System Agents|sensory system agents|mesh-ancestor
25498989|NCT03007238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25498990|NCT03007238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25498991|NCT03007238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25498992|NCT03007238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25498993|NCT03007238|Antiviral Agents|antiviral agents|mesh-ancestor
25498994|NCT03007238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25498995|NCT02823002|Lidocaine|lidocaine|mesh-list
25498996|NCT02823002|Anesthetics, Local|anesthetics, local|mesh-ancestor
25498997|NCT02823002|Anesthetics|anesthetics|mesh-ancestor
25498998|NCT02823002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25498999|NCT02823002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645513|NCT01448707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25499000|NCT02823002|Sensory System Agents|sensory system agents|mesh-ancestor
25499001|NCT02823002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25499002|NCT02823002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25499003|NCT02823002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25499004|NCT02823002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25759748|NCT03122860|Lorecivivint|lorecivivint|mesh-list
25499005|NCT02823002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25499006|NCT02823002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499007|NCT02779257|Diazoxide|diazoxide|mesh-list
25499008|NCT02779257|Pasireotide|pasireotide|mesh-list
25499009|NCT02779257|Hormones|hormones|mesh-ancestor
25499010|NCT02779257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25760214|NCT03139604|Prednisolone phosphate|prednisolone phosphate|mesh-list
25499011|NCT02779257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499012|NCT02779257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25499013|NCT02779257|Vasodilator Agents|vasodilator agents|mesh-ancestor
25499014|NCT02678351|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25499015|NCT02678351|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25166726|NCT03733210|Panitumumab|panitumumab|mesh-list
25166727|NCT03733210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25166728|NCT03733210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823172|NCT00004759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25166756|NCT03690921|Fluorouracil|fluorouracil|mesh-list
25166757|NCT03690921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166758|NCT03690921|Antimetabolites|antimetabolites|mesh-ancestor
25166759|NCT03690921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25760375|NCT03149991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25166760|NCT03690921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25760525|NCT03160703|Fluorides|fluorides|mesh-list
25760597|NCT03166124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25760602|NCT03167411|Exenatide|exenatide|mesh-list
25760740|NCT03174158|Nicotine|nicotine|mesh-list
25166761|NCT03690921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25166762|NCT03690921|Immunologic Factors|immunologic factors|mesh-ancestor
25166763|NCT03690921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166764|NCT03685500|Emtricitabine|emtricitabine|mesh-list
25166765|NCT03685500|Darunavir|darunavir|mesh-list
25166766|NCT03685500|Cobicistat|cobicistat|mesh-list
25166767|NCT03685500|Antiviral Agents|antiviral agents|mesh-ancestor
25166768|NCT03685500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25166769|NCT03685500|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25166770|NCT03685500|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25166771|NCT03685500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25166772|NCT03685500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035196|NCT03558919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035197|NCT03558919|Urological Agents|urological agents|mesh-ancestor
25035200|NCT03558919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25166773|NCT03685500|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25084479|NCT03306602|Z 350|z 350|mesh-list
25166774|NCT03685500|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25166775|NCT03685500|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25761551|NCT05236738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25761552|NCT05236738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25761553|NCT05236738|Antiviral Agents|antiviral agents|mesh-ancestor
25761616|NCT04928703|Ketamine|ketamine|mesh-list
25761820|NCT04122170|Aspirin|aspirin|mesh-list
25761893|NCT03931551|Trastuzumab|trastuzumab|mesh-list
25761968|NCT03624036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25762130|NCT02582008|Antidepressive Agents|antidepressive agents|mesh-ancestor
25762131|NCT02582008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25762132|NCT02582008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25762204|NCT01667081|Grazoprevir|grazoprevir|mesh-list
25762272|NCT00634504|Antimetabolites|antimetabolites|mesh-ancestor
25762422|NCT04704921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762423|NCT04682574|Ascorbic Acid|ascorbic acid|mesh-list
25762424|NCT04682574|Vitamins|vitamins|mesh-ancestor
25762561|NCT04473482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25762634|NCT04275362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25166776|NCT03685500|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25499016|NCT02678351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499017|NCT02660411|Propofol|propofol|mesh-list
25499018|NCT02660411|Sevoflurane|sevoflurane|mesh-list
25499019|NCT02660411|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25499020|NCT02660411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25762724|NCT03837509|Daratumumab|daratumumab|mesh-list
25762799|NCT03653338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25762800|NCT03653338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25762801|NCT03653338|Immunologic Factors|immunologic factors|mesh-ancestor
25762812|NCT03624062|Insulin|insulin|mesh-list
25762945|NCT03347929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25763088|NCT02400476|Budesonide|budesonide|mesh-list
25763089|NCT02400476|Loperamide|loperamide|mesh-list
25763162|NCT02199184|Tubulin Modulators|tubulin modulators|mesh-ancestor
25763163|NCT02199184|Antimitotic Agents|antimitotic agents|mesh-ancestor
25499021|NCT02660411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499022|NCT02660411|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25763556|NCT03197025|Aldesleukin|aldesleukin|mesh-list
25763816|NCT03208933|Pirfenidone|pirfenidone|mesh-list
25763893|NCT03214367|Insulin Lispro|insulin lispro|mesh-list
25499023|NCT02660411|Anesthetics, General|anesthetics, general|mesh-ancestor
25499024|NCT02660411|Anesthetics|anesthetics|mesh-ancestor
25499025|NCT02660411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25764033|NCT03222349|Autonomic Agents|autonomic agents|mesh-ancestor
25499026|NCT02660411|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25499027|NCT02633137|Cytarabine|cytarabine|mesh-list
25499028|NCT02633137|Lenalidomide|lenalidomide|mesh-list
25764358|NCT03235050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25499029|NCT02633137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25499030|NCT02633137|Antimetabolites|antimetabolites|mesh-ancestor
25499031|NCT02633137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499032|NCT02633137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499033|NCT02633137|Antiviral Agents|antiviral agents|mesh-ancestor
25499034|NCT02633137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25499035|NCT02633137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25499036|NCT02633137|Immunologic Factors|immunologic factors|mesh-ancestor
25499037|NCT02633137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499038|NCT02633137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25499039|NCT02633137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25499040|NCT02633137|Growth Substances|growth substances|mesh-ancestor
25499041|NCT02633137|Growth Inhibitors|growth inhibitors|mesh-ancestor
25499042|NCT02578732|Leucovorin|leucovorin|mesh-list
25499043|NCT02578732|Oxaliplatin|oxaliplatin|mesh-list
25499044|NCT02578732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499045|NCT02578732|Antidotes|antidotes|mesh-ancestor
25764653|NCT03248947|Naloxone|naloxone|mesh-list
25499046|NCT02578732|Protective Agents|protective agents|mesh-ancestor
25499048|NCT02578732|Vitamin B Complex|vitamin b complex|mesh-ancestor
25499049|NCT02578732|Vitamins|vitamins|mesh-ancestor
25499050|NCT02578732|Micronutrients|micronutrients|mesh-ancestor
25499051|NCT02530437|Paclitaxel|paclitaxel|mesh-list
25765183|NCT03270644|Lasmiditan|lasmiditan|mesh-list
25499052|NCT02530437|Carboplatin|carboplatin|mesh-list
25499053|NCT02530437|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25499054|NCT02530437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25499055|NCT02530437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25765271|NCT03276975|Hemostatics|hemostatics|mesh-ancestor
25499056|NCT02530437|Tubulin Modulators|tubulin modulators|mesh-ancestor
25499057|NCT02530437|Antimitotic Agents|antimitotic agents|mesh-ancestor
25499058|NCT02530437|Mitosis Modulators|mitosis modulators|mesh-ancestor
25499059|NCT02530437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499060|NCT02501434|Heparin|heparin|mesh-list
25499061|NCT02501434|Calcium heparin|calcium heparin|mesh-list
25499062|NCT02501434|Anticoagulants|anticoagulants|mesh-ancestor
25499063|NCT02501434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25499064|NCT02501434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25499065|NCT02501434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499066|NCT02478255|Xenon|xenon|mesh-list
25765416|NCT03286218|Serotonin Agents|serotonin agents|mesh-ancestor
25499067|NCT02478255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25499068|NCT02478255|Anesthetics, General|anesthetics, general|mesh-ancestor
25499069|NCT02478255|Anesthetics|anesthetics|mesh-ancestor
25499070|NCT02478255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25499071|NCT02478255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166795|NCT03654053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25166796|NCT03653000|Anesthetics|anesthetics|mesh-list
25166797|NCT03653000|Anesthetics, Local|anesthetics, local|mesh-list
25166798|NCT03653000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25166799|NCT03653000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166800|NCT03653000|Sensory System Agents|sensory system agents|mesh-ancestor
25166801|NCT03653000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25166802|NCT03639389|Morphine|morphine|mesh-list
25035218|NCT03558750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25035255|NCT03557853|Golimumab|golimumab|mesh-list
25166803|NCT03639389|Analgesics|analgesics|mesh-list
25166804|NCT03639389|Bupivacaine|bupivacaine|mesh-list
25166805|NCT03639389|Anesthetics, Local|anesthetics, local|mesh-ancestor
25166806|NCT03639389|Anesthetics|anesthetics|mesh-ancestor
25765691|NCT03296345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25166807|NCT03639389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25166808|NCT03639389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166809|NCT03639389|Sensory System Agents|sensory system agents|mesh-ancestor
25166810|NCT03639389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25166811|NCT03639389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25166812|NCT03639389|Narcotics|narcotics|mesh-ancestor
25499072|NCT01880541|Anesthetics|anesthetics|mesh-list
25499080|NCT01650350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25499081|NCT01595321|Leucovorin|leucovorin|mesh-list
25765759|NCT03297398|Androgens|androgens|mesh-list
25499082|NCT01595321|Cyclophosphamide|cyclophosphamide|mesh-list
25499083|NCT01595321|Fluorouracil|fluorouracil|mesh-list
25499084|NCT01595321|Oxaliplatin|oxaliplatin|mesh-list
25499085|NCT01595321|Irinotecan|irinotecan|mesh-list
25499086|NCT01595321|Folfirinox|folfirinox|mesh-list
25499087|NCT01595321|Vaccines|vaccines|mesh-list
25499088|NCT01595321|Immunologic Factors|immunologic factors|mesh-ancestor
25765827|NCT03301272|Cholinergic Agents|cholinergic agents|mesh-ancestor
25499089|NCT01595321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499090|NCT01595321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25499091|NCT01595321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25499092|NCT01595321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25499093|NCT01595321|Alkylating Agents|alkylating agents|mesh-ancestor
25499094|NCT01595321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499095|NCT01595321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499096|NCT01595321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25499097|NCT01595321|Antimetabolites|antimetabolites|mesh-ancestor
25499098|NCT01595321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25499099|NCT01595321|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25765953|NCT03307174|Fentanyl|fentanyl|mesh-list
25499100|NCT01595321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25499101|NCT01595321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499102|NCT01595321|Antidotes|antidotes|mesh-ancestor
25499103|NCT01595321|Protective Agents|protective agents|mesh-ancestor
25766024|NCT03308669|Serotonin Agents|serotonin agents|mesh-ancestor
25499104|NCT01595321|Vitamin B Complex|vitamin b complex|mesh-ancestor
25499105|NCT01595321|Vitamins|vitamins|mesh-ancestor
25499106|NCT01595321|Micronutrients|micronutrients|mesh-ancestor
25766307|NCT03321006|Serotonin Agents|serotonin agents|mesh-ancestor
25499107|NCT01552590|Tolvaptan|tolvaptan|mesh-list
25499108|NCT01552590|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25499109|NCT01552590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499110|NCT01552590|Natriuretic Agents|natriuretic agents|mesh-ancestor
25499111|NCT01552590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499112|NCT01345136|Everolimus|everolimus|mesh-list
25766442|NCT03329573|Serotonin Agents|serotonin agents|mesh-ancestor
25499113|NCT01345136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499114|NCT01345136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25499115|NCT01345136|Immunologic Factors|immunologic factors|mesh-ancestor
25499116|NCT01345136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499117|NCT01158417|Resveratrol|resveratrol|mesh-list
25499118|NCT01158417|Antioxidants|antioxidants|mesh-ancestor
25766650|NCT03337308|Ezetimibe|ezetimibe|mesh-list
25499119|NCT01158417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499120|NCT01158417|Protective Agents|protective agents|mesh-ancestor
25499121|NCT01158417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499122|NCT01158417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25766705|NCT03338855|Dapagliflozin|dapagliflozin|mesh-list
25766772|NCT03342690|Hormone Antagonists|hormone antagonists|mesh-ancestor
25499123|NCT01158417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25499124|NCT01000467|Probucol|probucol|mesh-list
25499125|NCT01000467|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25499126|NCT01000467|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25499127|NCT01000467|Antimetabolites|antimetabolites|mesh-ancestor
25499128|NCT01000467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499129|NCT01000467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25499130|NCT01000467|Antioxidants|antioxidants|mesh-ancestor
25767293|NCT03367793|Metronidazole|metronidazole|mesh-list
25499131|NCT01000467|Protective Agents|protective agents|mesh-ancestor
25499132|NCT01000467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166855|NCT03617679|Rucaparib|rucaparib|mesh-list
25166856|NCT03617679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25166857|NCT03617679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25166858|NCT03617679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166859|NCT03617679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166860|NCT03615040|Astegolimab|astegolimab|mesh-list
25767363|NCT03371381|Nivolumab|nivolumab|mesh-list
25776890|NCT03771560|Leucovorin|leucovorin|mesh-list
25166861|NCT03615040|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25166862|NCT03615040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25166863|NCT03615040|Antiviral Agents|antiviral agents|mesh-ancestor
25499133|NCT00743197|Aspirin|aspirin|mesh-list
25499134|NCT00743197|Lisinopril|lisinopril|mesh-list
25499135|NCT00743197|Simvastatin|simvastatin|mesh-list
25499136|NCT00743197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25767491|NCT03378076|FX006|fx006|mesh-list
25499137|NCT00743197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25499138|NCT00743197|Analgesics|analgesics|mesh-ancestor
25499139|NCT00743197|Sensory System Agents|sensory system agents|mesh-ancestor
25767668|NCT03383523|Praziquantel|praziquantel|mesh-list
25767741|NCT03386448|Scopolamine|scopolamine|mesh-list
25767814|NCT03388164|Serotonin Agents|serotonin agents|mesh-ancestor
25768110|NCT03407118|Insulin Lispro|insulin lispro|mesh-list
25499140|NCT00743197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25768360|NCT03425396|Nitrofurantoin|nitrofurantoin|mesh-list
25768432|NCT03430856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25768433|NCT03430856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768434|NCT03430986|Lidocaine|lidocaine|mesh-list
25768435|NCT03430986|Anesthetics, Local|anesthetics, local|mesh-ancestor
25499141|NCT00743197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25768775|NCT03448406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25499142|NCT00743197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25769327|NCT03480022|Hormones|hormones|mesh-ancestor
25499143|NCT00743197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25499144|NCT00743197|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25769733|NCT03500302|Evolocumab|evolocumab|mesh-list
25769801|NCT03503578|Anesthetics|anesthetics|mesh-ancestor
25769948|NCT03512353|Hormones|hormones|mesh-ancestor
25777978|NCT02985840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25499156|NCT00743197|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25499157|NCT00743197|Protease Inhibitors|protease inhibitors|mesh-ancestor
25499158|NCT00743197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25499159|NCT00743197|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25499160|NCT00743197|Protective Agents|protective agents|mesh-ancestor
25499161|NCT00549978|Cilostazol|cilostazol|mesh-list
25499162|NCT00549978|Probucol|probucol|mesh-list
25499163|NCT00549978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25499164|NCT00549978|Autonomic Agents|autonomic agents|mesh-ancestor
25499165|NCT00549978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25499166|NCT00549978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499167|NCT00549978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25778187|NCT02826551|Bupivacaine|bupivacaine|mesh-list
25778425|NCT02708849|Ketamine|ketamine|mesh-list
25499168|NCT00549978|Respiratory System Agents|respiratory system agents|mesh-ancestor
25499169|NCT00549978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25499170|NCT00549978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25205317|NCT04931368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25778862|NCT02518750|Cytarabine|cytarabine|mesh-list
25205318|NCT04931368|Immunologic Factors|immunologic factors|mesh-ancestor
25779239|NCT02392377|Calcium|calcium|mesh-list
25779320|NCT02373865|Glimepiride|glimepiride|mesh-list
25499171|NCT00549978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499172|NCT00549978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25499173|NCT00549978|Vasodilator Agents|vasodilator agents|mesh-ancestor
25499174|NCT00549978|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25499175|NCT00549978|Protective Agents|protective agents|mesh-ancestor
25499176|NCT00549978|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25499177|NCT00549978|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25499179|NCT00549978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25499180|NCT00549978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25499181|NCT00549978|Antimetabolites|antimetabolites|mesh-ancestor
25499182|NCT00549978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25499183|NCT00549978|Antioxidants|antioxidants|mesh-ancestor
25499184|NCT00198328|Bleomycin|bleomycin|mesh-list
25499185|NCT00198328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25499186|NCT00198328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499187|NCT00198315|Bleomycin|bleomycin|mesh-list
25499188|NCT00198315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25499189|NCT00198315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499190|NCT00304954|Sirolimus|sirolimus|mesh-list
25499191|NCT00304954|Infliximab|infliximab|mesh-list
25499192|NCT00304954|Daclizumab|daclizumab|mesh-list
25499193|NCT00304954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25499194|NCT00304954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25499195|NCT00304954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25499196|NCT00304954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499197|NCT00304954|Antifungal Agents|antifungal agents|mesh-ancestor
25499198|NCT00304954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25499199|NCT00304954|Immunologic Factors|immunologic factors|mesh-ancestor
25499200|NCT00304954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499201|NCT00304954|Dermatologic Agents|dermatologic agents|mesh-ancestor
25823173|NCT00004759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823174|NCT00004759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25823175|NCT00004759|Glucocorticoids|glucocorticoids|mesh-ancestor
25823176|NCT00004759|Hormones|hormones|mesh-ancestor
24765955|NCT01791608|Astringents|astringents|mesh-ancestor
25779816|NCT02169830|Topiramate|topiramate|mesh-list
25779887|NCT02147834|Ranolazine|ranolazine|mesh-list
24765956|NCT01791608|Dermatologic Agents|dermatologic agents|mesh-ancestor
24765957|NCT01791647|Inositol|inositol|mesh-list
24765958|NCT01791647|Metformin|metformin|mesh-list
25499202|NCT00304954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25780042|NCT02081183|Glucocorticoids|glucocorticoids|mesh-ancestor
25780108|NCT02048904|Hormones|hormones|mesh-ancestor
25499203|NCT00304954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25499204|NCT00305058|Morphine|morphine|mesh-list
25499205|NCT00305058|Hydromorphone|hydromorphone|mesh-list
25499206|NCT00305058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25499207|NCT00305058|Narcotics|narcotics|mesh-ancestor
25499208|NCT00305058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25780244|NCT01984268|Hormones|hormones|mesh-ancestor
25780525|NCT01895959|Viscosupplements|viscosupplements|mesh-ancestor
25499209|NCT00305058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499210|NCT00305058|Analgesics|analgesics|mesh-ancestor
25499211|NCT00305058|Sensory System Agents|sensory system agents|mesh-ancestor
25499212|NCT00305058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25499213|NCT00305084|Doxorubicin|doxorubicin|mesh-list
25499214|NCT00305084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25499215|NCT00305084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499216|NCT00305084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25499217|NCT00305084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25499218|NCT00305084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499219|NCT00305084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499220|NCT00305110|Hydromorphone|hydromorphone|mesh-list
25499221|NCT00305110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25499222|NCT00305110|Narcotics|narcotics|mesh-ancestor
25499223|NCT00305110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25499224|NCT00305110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499225|NCT00305110|Analgesics|analgesics|mesh-ancestor
25499226|NCT00305110|Sensory System Agents|sensory system agents|mesh-ancestor
25499227|NCT00305110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25499228|NCT00305162|Clopidogrel|clopidogrel|mesh-list
25499229|NCT00305162|Cangrelor|cangrelor|mesh-list
25499230|NCT00305162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25499231|NCT00305162|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25499232|NCT00305162|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25499233|NCT00305162|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25499234|NCT00305162|Purinergic Agents|purinergic agents|mesh-ancestor
25499235|NCT00305162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25499236|NCT00305162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499237|NCT00305162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499238|NCT00305448|Fulvestrant|fulvestrant|mesh-list
25499239|NCT00305448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25499240|NCT00305448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499241|NCT00305448|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25499242|NCT00305448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25499243|NCT00305448|Hormone Antagonists|hormone antagonists|mesh-ancestor
25499244|NCT00305448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25780676|NCT01853982|Tazobactam|tazobactam|mesh-list
25780714|NCT01821898|Budesonide|budesonide|mesh-list
25780934|NCT01754987|Micronutrients|micronutrients|mesh-ancestor
25781231|NCT01675960|Anticonvulsants|anticonvulsants|mesh-ancestor
25499245|NCT00305448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499246|NCT00305578|Memantine|memantine|mesh-list
25499247|NCT00305578|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25499248|NCT00305578|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25499249|NCT00305578|Dopamine Agents|dopamine agents|mesh-ancestor
25499250|NCT00305578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25499251|NCT00305578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499252|NCT00305578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499253|NCT00305578|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25499254|NCT00305578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25499255|NCT00305604|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25499256|NCT00305604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25499257|NCT00305604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499258|NCT00305604|Incretins|incretins|mesh-ancestor
25499259|NCT00305604|Hormones|hormones|mesh-ancestor
25499260|NCT00305604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25499261|NCT00305604|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25499262|NCT00305604|Protease Inhibitors|protease inhibitors|mesh-ancestor
25499263|NCT00305604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499264|NCT00305604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166943|NCT03543189|Nivolumab|nivolumab|mesh-list
25166944|NCT03543189|Androgens|androgens|mesh-list
25166945|NCT03543189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25166946|NCT03543189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166947|NCT03543189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25205319|NCT04931368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205320|NCT04931368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25781516|NCT01598025|Melphalan|melphalan|mesh-list
25781880|NCT01509053|Aripiprazole|aripiprazole|mesh-list
25166948|NCT03543189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166949|NCT03543189|Hormones|hormones|mesh-ancestor
25166950|NCT03543189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25166951|NCT03543189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166952|NCT03540758|Niacin|niacin|mesh-list
25499265|NCT00305682|Mycophenolic Acid|mycophenolic acid|mesh-list
25499266|NCT00305682|Sirolimus|sirolimus|mesh-list
25499267|NCT00305682|Cyclophosphamide|cyclophosphamide|mesh-list
25499268|NCT00305682|Fludarabine|fludarabine|mesh-list
25499269|NCT00305682|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25499270|NCT00305682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25499271|NCT00305682|Immunologic Factors|immunologic factors|mesh-ancestor
25499272|NCT00305682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499273|NCT00305682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25499274|NCT00305682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25499275|NCT00305682|Alkylating Agents|alkylating agents|mesh-ancestor
25499276|NCT00305682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499277|NCT00305682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499278|NCT00305682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25499279|NCT00305682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25499280|NCT00305682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25499281|NCT00305682|Antitubercular Agents|antitubercular agents|mesh-ancestor
25499282|NCT00305682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25499283|NCT00305682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25499284|NCT00305682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499285|NCT00305682|Antifungal Agents|antifungal agents|mesh-ancestor
25499286|NCT00305695|Zoledronic Acid|zoledronic acid|mesh-list
25499287|NCT00305695|Imidazole|imidazole|mesh-list
25499288|NCT00305695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25499289|NCT00305695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499290|NCT00305695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499291|NCT00305695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499292|NCT00305760|Cyclophosphamide|cyclophosphamide|mesh-list
25499293|NCT00305760|Cetuximab|cetuximab|mesh-list
25499294|NCT00305760|Vaccines|vaccines|mesh-list
25499295|NCT00305760|Immunologic Factors|immunologic factors|mesh-ancestor
25499296|NCT00305760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499297|NCT00305760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25499298|NCT00305760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25499299|NCT00305760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25499300|NCT00305760|Alkylating Agents|alkylating agents|mesh-ancestor
25499301|NCT00305760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499302|NCT00305760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499303|NCT00305760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25499304|NCT00305760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25499305|NCT00305773|Vorinostat|vorinostat|mesh-list
25499306|NCT00305773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499307|NCT00305773|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25499308|NCT00305773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499309|NCT00305773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499310|NCT00305864|Temozolomide|temozolomide|mesh-list
25499311|NCT00305864|Motexafin gadolinium|motexafin gadolinium|mesh-list
25499312|NCT00305864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25499313|NCT00305864|Alkylating Agents|alkylating agents|mesh-ancestor
25782039|NCT01434745|Simvastatin|simvastatin|mesh-list
25499314|NCT00305864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25782156|NCT01397552|Hormones|hormones|mesh-ancestor
25782348|NCT01335997|Niacin|niacin|mesh-list
25782650|NCT01269034|Insulin|insulin|mesh-list
25499315|NCT00305864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499316|NCT00305864|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25499317|NCT00305864|Dermatologic Agents|dermatologic agents|mesh-ancestor
25499318|NCT00305877|Gemcitabine|gemcitabine|mesh-list
25499319|NCT00305877|Bevacizumab|bevacizumab|mesh-list
25499320|NCT00305877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25499321|NCT00305877|Cetuximab|cetuximab|mesh-list
25499322|NCT00305877|Capecitabine|capecitabine|mesh-list
25499323|NCT00305877|Antibodies|antibodies|mesh-list
25499324|NCT00305877|Immunoglobulins|immunoglobulins|mesh-list
25499325|NCT00305877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25499326|NCT00305877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167013|NCT03430882|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25167014|NCT03430882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25167015|NCT03430882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167016|NCT03430882|Tubulin Modulators|tubulin modulators|mesh-ancestor
25167017|NCT03430882|Antimitotic Agents|antimitotic agents|mesh-ancestor
25167018|NCT03430882|Mitosis Modulators|mitosis modulators|mesh-ancestor
25035658|NCT03554109|Alkylating Agents|alkylating agents|mesh-ancestor
25782718|NCT01266824|Anesthetics|anesthetics|mesh-ancestor
25782772|NCT01253668|Antibodies|antibodies|mesh-list
25782997|NCT01206439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25783144|NCT01181921|Galantamine|galantamine|mesh-list
25783372|NCT01122511|Antiemetics|antiemetics|mesh-ancestor
25167019|NCT03430882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167020|NCT03408119|Vitamin D|vitamin d|mesh-list
25167021|NCT03408119|Calcium|calcium|mesh-list
25167022|NCT03408119|Vitamins|vitamins|mesh-ancestor
25167023|NCT03408119|Micronutrients|micronutrients|mesh-ancestor
25167024|NCT03408119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167025|NCT03408119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25499328|NCT00305877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25499329|NCT00305877|Growth Substances|growth substances|mesh-ancestor
25499330|NCT00305877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499331|NCT00305877|Growth Inhibitors|growth inhibitors|mesh-ancestor
25499332|NCT00305877|Immunologic Factors|immunologic factors|mesh-ancestor
25499333|NCT00305877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25499334|NCT00305877|Antimetabolites|antimetabolites|mesh-ancestor
25499335|NCT00305877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499336|NCT00305877|Antiviral Agents|antiviral agents|mesh-ancestor
25499337|NCT00305877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25499338|NCT00305877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499339|NCT00305877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25499340|NCT00305942|Carboplatin|carboplatin|mesh-list
25499341|NCT00305942|Topotecan|topotecan|mesh-list
25499342|NCT00305942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499343|NCT00305942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25499344|NCT00305942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25499345|NCT00305942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499346|NCT00305942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499347|NCT00306163|Fluticasone|fluticasone|mesh-list
25499348|NCT00306163|Ciclesonide|ciclesonide|mesh-list
25499349|NCT00306163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25499350|NCT00306163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25499351|NCT00306163|Autonomic Agents|autonomic agents|mesh-ancestor
25499352|NCT00306163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25499353|NCT00306163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499354|NCT00306163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25499355|NCT00306163|Respiratory System Agents|respiratory system agents|mesh-ancestor
25499356|NCT00306163|Dermatologic Agents|dermatologic agents|mesh-ancestor
25499357|NCT00306163|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25499358|NCT00306163|Glucocorticoids|glucocorticoids|mesh-ancestor
25499359|NCT00306163|Hormones|hormones|mesh-ancestor
25499360|NCT00306163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25499361|NCT00306189|Denosumab|denosumab|mesh-list
25499362|NCT00306189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25499363|NCT00306189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499364|NCT00306202|Dasatinib|dasatinib|mesh-list
25499365|NCT00306202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499366|NCT00306202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25499367|NCT00306202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499368|NCT00306202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499369|NCT00306293|Valacyclovir|valacyclovir|mesh-list
25499370|NCT00306293|Antiviral Agents|antiviral agents|mesh-ancestor
25499371|NCT00306293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25499372|NCT00306384|Alogliptin|alogliptin|mesh-list
25499373|NCT00306384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25499374|NCT00306384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645514|NCT01448707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25499376|NCT00306384|Hormones|hormones|mesh-ancestor
25499377|NCT00306384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25499378|NCT00306384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25499379|NCT00306384|Protease Inhibitors|protease inhibitors|mesh-ancestor
25499380|NCT00306384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499381|NCT00306384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499382|NCT00306488|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25499383|NCT00306488|Antioxidants|antioxidants|mesh-list
25499384|NCT00306488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25499385|NCT00306488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499386|NCT00306488|Protective Agents|protective agents|mesh-ancestor
25783615|NCT01051921|Ribavirin|ribavirin|mesh-list
25783980|NCT00996333|Docetaxel|docetaxel|mesh-list
25499387|NCT00306488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499388|NCT00306527|Vaccines|vaccines|mesh-list
25499389|NCT00306527|Immunologic Factors|immunologic factors|mesh-ancestor
25499390|NCT00306527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499391|NCT00306592|Natalizumab|natalizumab|mesh-list
25499392|NCT00306592|Immunologic Factors|immunologic factors|mesh-ancestor
25499393|NCT00306592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499394|NCT00306670|Prednisone|prednisone|mesh-list
25499395|NCT00306670|Rituximab|rituximab|mesh-list
25499396|NCT00306670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25499397|NCT00306670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499398|NCT00306670|Immunologic Factors|immunologic factors|mesh-ancestor
24992437|NCT03770676|Micronutrients|micronutrients|mesh-ancestor
24992438|NCT03764735|Benzalkonium Compounds|benzalkonium compounds|mesh-list
24992439|NCT03764735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25499399|NCT00306670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499400|NCT00306670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25499401|NCT00306670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25499402|NCT00306670|Glucocorticoids|glucocorticoids|mesh-ancestor
25499404|NCT00306670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25499405|NCT00306670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25499406|NCT00306787|Valacyclovir|valacyclovir|mesh-list
25499407|NCT00306787|Famciclovir|famciclovir|mesh-list
25499408|NCT00306787|Antiviral Agents|antiviral agents|mesh-ancestor
25499409|NCT00306787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25499410|NCT00306787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25499411|NCT00306787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499412|NCT00306787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499413|NCT00306852|Mitomycins|mitomycins|mesh-list
25499414|NCT00306852|Mitomycin|mitomycin|mesh-list
25499415|NCT00306852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25499416|NCT00306852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499417|NCT00306852|Alkylating Agents|alkylating agents|mesh-ancestor
25499418|NCT00306852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499419|NCT00306852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25499420|NCT00306852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499421|NCT00306891|Cediranib|cediranib|mesh-list
25499422|NCT00306891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499423|NCT00306891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25499424|NCT00306891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499425|NCT00306891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499426|NCT00307034|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25499427|NCT00307034|Immunologic Factors|immunologic factors|mesh-ancestor
25499428|NCT00307034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499429|NCT00307047|Paclitaxel|paclitaxel|mesh-list
25499430|NCT00307047|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25499431|NCT00307047|Everolimus|everolimus|mesh-list
25499432|NCT00307047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25499433|NCT00307047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499434|NCT00307047|Tubulin Modulators|tubulin modulators|mesh-ancestor
25499435|NCT00307047|Antimitotic Agents|antimitotic agents|mesh-ancestor
25784240|NCT00947284|Nalbuphine|nalbuphine|mesh-list
25784840|NCT00847002|Laxatives|laxatives|mesh-ancestor
25784917|NCT00832572|Ranolazine|ranolazine|mesh-list
25499436|NCT00307047|Mitosis Modulators|mitosis modulators|mesh-ancestor
25499437|NCT00307047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499438|NCT00307047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25499439|NCT00307047|Immunologic Factors|immunologic factors|mesh-ancestor
25499440|NCT00307047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499441|NCT00307086|Bortezomib|bortezomib|mesh-list
25499442|NCT00307086|Melphalan|melphalan|mesh-list
25499443|NCT00307086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499444|NCT00307086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25499445|NCT00307086|Alkylating Agents|alkylating agents|mesh-ancestor
25499446|NCT00307086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499447|NCT00307086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25499448|NCT00307086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25499449|NCT00307086|Immunologic Factors|immunologic factors|mesh-ancestor
25499450|NCT00307086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499451|NCT00307125|Rituximab|rituximab|mesh-list
25499452|NCT00307125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25499453|NCT00307125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499454|NCT00307125|Immunologic Factors|immunologic factors|mesh-ancestor
25499455|NCT00307125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499456|NCT00307125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25499457|NCT00307151|Ritonavir|ritonavir|mesh-list
25499458|NCT00307151|Lopinavir|lopinavir|mesh-list
25499459|NCT00307151|Lamivudine|lamivudine|mesh-list
25499460|NCT00307151|Zidovudine|zidovudine|mesh-list
25499461|NCT00307151|Nevirapine|nevirapine|mesh-list
25499462|NCT00307151|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25499463|NCT00307151|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25499464|NCT00307151|Protease Inhibitors|protease inhibitors|mesh-ancestor
25499465|NCT00307151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499466|NCT00307151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499467|NCT00307151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25499468|NCT00307151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25499469|NCT00307151|Antiviral Agents|antiviral agents|mesh-ancestor
25167142|NCT03302234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167143|NCT03299946|Nivolumab|nivolumab|mesh-list
25167144|NCT03299946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25167145|NCT03299946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499470|NCT00307151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25499471|NCT00307151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25499472|NCT00307151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25499473|NCT00307151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25499474|NCT00307151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25499475|NCT00307151|Antimetabolites|antimetabolites|mesh-ancestor
25499476|NCT00307151|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25499477|NCT00307151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25499478|NCT00307294|Thalidomide|thalidomide|mesh-list
25499479|NCT00307294|Doxorubicin|doxorubicin|mesh-list
25499480|NCT00307294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25499481|NCT00307294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499482|NCT00307294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25499483|NCT00307294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25499484|NCT00307294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499485|NCT00307294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499486|NCT00307294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25499487|NCT00307294|Immunologic Factors|immunologic factors|mesh-ancestor
25499488|NCT00307294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499489|NCT00307294|Leprostatic Agents|leprostatic agents|mesh-ancestor
25499490|NCT00307294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25499491|NCT00307294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25499492|NCT00307294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25784991|NCT00822679|Eszopiclone|eszopiclone|mesh-list
25785071|NCT00808899|Alkylating Agents|alkylating agents|mesh-ancestor
25785220|NCT00791076|Hormones|hormones|mesh-ancestor
25785511|NCT00746603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25499493|NCT00307294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25499494|NCT00307294|Growth Substances|growth substances|mesh-ancestor
25499495|NCT00307294|Growth Inhibitors|growth inhibitors|mesh-ancestor
25499496|NCT00307437|Ustekinumab|ustekinumab|mesh-list
25499497|NCT00307437|Dermatologic Agents|dermatologic agents|mesh-ancestor
25499498|NCT00307489|Tenofovir|tenofovir|mesh-list
25499499|NCT00307489|Emtricitabine|emtricitabine|mesh-list
25499500|NCT00307489|Antiviral Agents|antiviral agents|mesh-ancestor
25499501|NCT00307489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25499502|NCT00307489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25499503|NCT00307489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25499504|NCT00307489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499505|NCT00307489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499506|NCT00307489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25499507|NCT00307489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25499508|NCT00307684|Methylphenidate|methylphenidate|mesh-list
25499509|NCT00307684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25499510|NCT00307684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25785794|NCT00703534|Lesogaberan|lesogaberan|mesh-list
25786026|NCT00673309|Androgens|androgens|mesh-ancestor
25786166|NCT00655057|Citalopram|citalopram|mesh-list
25499511|NCT00307684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25499512|NCT00307684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25499513|NCT00307684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25499514|NCT00307684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645515|NCT01448707|Protease Inhibitors|protease inhibitors|mesh-ancestor
25499515|NCT00307684|Dopamine Agents|dopamine agents|mesh-ancestor
25499516|NCT00307684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25499517|NCT00307736|Bevacizumab|bevacizumab|mesh-list
25499518|NCT00307736|Fluorouracil|fluorouracil|mesh-list
25499519|NCT00307736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25499520|NCT00307736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25499521|NCT00307736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499522|NCT00307736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25499523|NCT00307736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25499524|NCT00307736|Growth Substances|growth substances|mesh-ancestor
25499525|NCT00307736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499526|NCT00307736|Growth Inhibitors|growth inhibitors|mesh-ancestor
25499527|NCT00307736|Antimetabolites|antimetabolites|mesh-ancestor
25499528|NCT00307736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499529|NCT00307736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25499530|NCT00307736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25499531|NCT00307736|Immunologic Factors|immunologic factors|mesh-ancestor
25499532|NCT00307736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25499533|NCT00307736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499534|NCT00307801|Dienogest|dienogest|mesh-list
25167191|NCT03252808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25167192|NCT03252808|Immunologic Factors|immunologic factors|mesh-ancestor
25167193|NCT03252808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035936|NCT03551964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035937|NCT03551873|Plecanatide|plecanatide|mesh-list
25035938|NCT03551873|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25035939|NCT03551873|Enzyme Activators|enzyme activators|mesh-ancestor
25035946|NCT03551808|Ketorolac|ketorolac|mesh-list
25167202|NCT03235505|Nicotine|nicotine|mesh-list
25499535|NCT00307801|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25499536|NCT00307801|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25499537|NCT00307801|Estradiol|estradiol|mesh-list
25499538|NCT00307801|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25499539|NCT00307801|Estrogens|estrogens|mesh-ancestor
25499540|NCT00307801|Hormones|hormones|mesh-ancestor
25499541|NCT00307801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25499542|NCT00307801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499543|NCT00307801|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25499544|NCT00307801|Contraceptive Agents|contraceptive agents|mesh-ancestor
25499545|NCT00307801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25499546|NCT00307801|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25499547|NCT00307801|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25499548|NCT00307801|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25499549|NCT00307801|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25499550|NCT00307801|Hormone Antagonists|hormone antagonists|mesh-ancestor
25499551|NCT00307801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25499552|NCT00307801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499553|NCT00307931|Certolizumab Pegol|certolizumab pegol|mesh-list
25499554|NCT00307931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25786566|NCT00609765|Hormones|hormones|mesh-ancestor
25786710|NCT00577772|Rifaximin|rifaximin|mesh-list
25499555|NCT00307931|Immunologic Factors|immunologic factors|mesh-ancestor
25499556|NCT00307931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499557|NCT00307931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25499558|NCT00308074|Aripiprazole|aripiprazole|mesh-list
25499559|NCT00308074|Antidepressive Agents|antidepressive agents|mesh-ancestor
25787391|NCT00523809|Vidarabine|vidarabine|mesh-list
25499560|NCT00308074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25787676|NCT00487461|Antimetabolites|antimetabolites|mesh-ancestor
25499561|NCT00308074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25499562|NCT00308074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25499563|NCT00308074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25499564|NCT00308074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499565|NCT00308074|Dopamine Agonists|dopamine agonists|mesh-ancestor
25499566|NCT00308074|Dopamine Agents|dopamine agents|mesh-ancestor
25499567|NCT00308074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25499568|NCT00308074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499569|NCT00308074|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25499570|NCT00308074|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25499571|NCT00308074|Serotonin Agents|serotonin agents|mesh-ancestor
25499572|NCT00308074|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25499573|NCT00308074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25499574|NCT00308074|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25499575|NCT00308074|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25499576|NCT00308087|Rituximab|rituximab|mesh-list
25499577|NCT00308087|Molgramostim|molgramostim|mesh-list
25499578|NCT00308087|Sargramostim|sargramostim|mesh-list
25499579|NCT00308087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25499580|NCT00308087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499581|NCT00308087|Immunologic Factors|immunologic factors|mesh-ancestor
25645516|NCT01448707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645517|NCT01448707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499582|NCT00308087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499583|NCT00308087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25499584|NCT00308139|Exenatide|exenatide|mesh-list
25499585|NCT00308139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25499586|NCT00308139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499587|NCT00308139|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25499588|NCT00308139|Incretins|incretins|mesh-ancestor
25499589|NCT00308139|Hormones|hormones|mesh-ancestor
25499590|NCT00308139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25499591|NCT00308308|Insulin|insulin|mesh-list
25499592|NCT00308308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25499593|NCT00308308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499594|NCT00308581|Certolizumab Pegol|certolizumab pegol|mesh-list
25499595|NCT00308581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25499596|NCT00308581|Immunologic Factors|immunologic factors|mesh-ancestor
25499597|NCT00308581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499598|NCT00308581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25499599|NCT00308620|Chloroquine|chloroquine|mesh-list
25499600|NCT00308620|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
25499601|NCT00308620|Amebicides|amebicides|mesh-ancestor
25499602|NCT00308620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25167262|NCT03184090|Palbociclib|palbociclib|mesh-list
25167263|NCT03184090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167264|NCT03184090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25167265|NCT03184090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25167266|NCT03184090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167267|NCT03182231|Exenatide|exenatide|mesh-list
25167268|NCT03182231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25167269|NCT03182231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499603|NCT00308620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25499604|NCT00308620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25788054|NCT00384293|Vitamins|vitamins|mesh-ancestor
25499605|NCT00308620|Antimalarials|antimalarials|mesh-ancestor
25788667|NCT00165503|Sodium thiosulfate|sodium thiosulfate|mesh-list
25499606|NCT00308620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25499607|NCT00308620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25499608|NCT00308620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25499609|NCT00308620|Analgesics|analgesics|mesh-ancestor
25499610|NCT00308620|Sensory System Agents|sensory system agents|mesh-ancestor
25499611|NCT00308620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25499612|NCT00308620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499613|NCT00308620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25499614|NCT00308620|Filaricides|filaricides|mesh-ancestor
25499615|NCT00308620|Antinematodal Agents|antinematodal agents|mesh-ancestor
25499616|NCT00308620|Anthelmintics|anthelmintics|mesh-ancestor
25499617|NCT00308711|Misoprostol|misoprostol|mesh-list
25499618|NCT00308711|Dinoprostone|dinoprostone|mesh-list
25499619|NCT00308711|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25499620|NCT00308711|Abortifacient Agents|abortifacient agents|mesh-ancestor
25499621|NCT00308711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25499622|NCT00308711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499623|NCT00308711|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25499624|NCT00308711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25499625|NCT00308711|Oxytocics|oxytocics|mesh-ancestor
25499626|NCT00308737|Insulin|insulin|mesh-list
25499627|NCT00308737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25499628|NCT00308737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499629|NCT00308750|Carboplatin|carboplatin|mesh-list
25499630|NCT00308750|Docetaxel|docetaxel|mesh-list
25499631|NCT00308750|Pemetrexed|pemetrexed|mesh-list
25499632|NCT00308750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499633|NCT00308750|Tubulin Modulators|tubulin modulators|mesh-ancestor
25499634|NCT00308750|Antimitotic Agents|antimitotic agents|mesh-ancestor
25499635|NCT00308750|Mitosis Modulators|mitosis modulators|mesh-ancestor
25499636|NCT00308750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499637|NCT00308750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499638|NCT00308750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25499639|NCT00308750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25499640|NCT00309166|Vaccines|vaccines|mesh-list
25499641|NCT00309166|Immunologic Factors|immunologic factors|mesh-ancestor
25499642|NCT00309166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499643|NCT00309244|Insulin|insulin|mesh-list
25499644|NCT00309244|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25499645|NCT00309244|Insulin Aspart|insulin aspart|mesh-list
25499646|NCT00309244|Protamines|protamines|mesh-list
25499647|NCT00309244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25499648|NCT00309244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499649|NCT00309244|Heparin Antagonists|heparin antagonists|mesh-ancestor
25645519|NCT01448707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25645520|NCT01448707|Antiviral Agents|antiviral agents|mesh-ancestor
25645521|NCT01448707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25499650|NCT00309244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499651|NCT00309244|Coagulants|coagulants|mesh-ancestor
25499652|NCT00309465|Insulin|insulin|mesh-list
25499653|NCT00309465|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25499654|NCT00309465|Insulin Glargine|insulin glargine|mesh-list
25499655|NCT00309465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25499656|NCT00309465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499657|NCT00309608|Glimepiride|glimepiride|mesh-list
25499658|NCT00309608|Linagliptin|linagliptin|mesh-list
25499659|NCT00309608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25499660|NCT00309608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25499661|NCT00309608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499662|NCT00309608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25499663|NCT00309608|Immunologic Factors|immunologic factors|mesh-ancestor
25499664|NCT00309608|Incretins|incretins|mesh-ancestor
25499665|NCT00309608|Hormones|hormones|mesh-ancestor
25499666|NCT00309608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25499667|NCT00309608|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25499668|NCT00309608|Protease Inhibitors|protease inhibitors|mesh-ancestor
25499669|NCT00309608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499670|NCT00309608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499671|NCT00309738|Simvastatin|simvastatin|mesh-list
25499672|NCT00309738|Pitavastatin|pitavastatin|mesh-list
25499673|NCT00309738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25499674|NCT00309738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25499675|NCT00309738|Antimetabolites|antimetabolites|mesh-ancestor
25499676|NCT00309738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499677|NCT00309738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24766789|NCT01796808|Lidocaine|lidocaine|mesh-list
25499678|NCT00309738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25499679|NCT00309738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499680|NCT00309751|Atorvastatin|atorvastatin|mesh-list
25499681|NCT00309751|Pitavastatin|pitavastatin|mesh-list
25499682|NCT00309751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25499683|NCT00309751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25499684|NCT00309751|Antimetabolites|antimetabolites|mesh-ancestor
25499685|NCT00309751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499686|NCT00309751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25499687|NCT00309751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25499688|NCT00309751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499689|NCT00309777|Simvastatin|simvastatin|mesh-list
25499690|NCT00309777|Pitavastatin|pitavastatin|mesh-list
25499691|NCT00309777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25499692|NCT00309777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25499693|NCT00309777|Antimetabolites|antimetabolites|mesh-ancestor
25499694|NCT00309777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499695|NCT00309777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25499696|NCT00309777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25499697|NCT00309777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499698|NCT00309842|Cyclosporine|cyclosporine|mesh-list
25499699|NCT00309842|Mycophenolic Acid|mycophenolic acid|mesh-list
25499700|NCT00309842|Cyclophosphamide|cyclophosphamide|mesh-list
25499701|NCT00309842|Fludarabine|fludarabine|mesh-list
25499702|NCT00309842|Fludarabine phosphate|fludarabine phosphate|mesh-list
25499703|NCT00309842|Cyclosporins|cyclosporins|mesh-list
25499704|NCT00309842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25499705|NCT00309842|Immunologic Factors|immunologic factors|mesh-ancestor
25499706|NCT00309842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499707|NCT00309842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25789456|NCT00000152|Carotenoids|carotenoids|mesh-list
25789477|NCT00000157|Aspirin|aspirin|mesh-list
25789640|NCT00000188|Selegiline|selegiline|mesh-list
25789778|NCT00000204|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25790079|NCT00000236|Naloxone|naloxone|mesh-list
25790233|NCT00000253|Analgesics|analgesics|mesh-ancestor
25499708|NCT00309842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25499709|NCT00309842|Alkylating Agents|alkylating agents|mesh-ancestor
25499710|NCT00309842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499711|NCT00309842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499712|NCT00309842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25499713|NCT00309842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25499714|NCT00309842|Antimetabolites|antimetabolites|mesh-ancestor
25499715|NCT00309842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499716|NCT00309842|Antifungal Agents|antifungal agents|mesh-ancestor
25499717|NCT00309842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25499718|NCT00309842|Dermatologic Agents|dermatologic agents|mesh-ancestor
25645522|NCT01448707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25790307|NCT00000260|Sensory System Agents|sensory system agents|mesh-ancestor
25790575|NCT00000290|Cocaine|cocaine|mesh-list
25790748|NCT00000307|Naltrexone|naltrexone|mesh-list
25790857|NCT00000318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25790934|NCT00000330|Analgesics|analgesics|mesh-ancestor
25791080|NCT00000347|Dopamine Agents|dopamine agents|mesh-ancestor
25645523|NCT01448707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25645524|NCT01448824|Ketoconazole|ketoconazole|mesh-list
25645525|NCT01448824|Evacetrapib|evacetrapib|mesh-list
25645526|NCT01448824|Antifungal Agents|antifungal agents|mesh-ancestor
25645527|NCT01448824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25645528|NCT01448824|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25499719|NCT00309842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25499720|NCT00309842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25499721|NCT00309842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25499722|NCT00309842|Antitubercular Agents|antitubercular agents|mesh-ancestor
25499723|NCT00309842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25499724|NCT00309907|Methylprednisolone|methylprednisolone|mesh-list
25499725|NCT00309907|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25499726|NCT00309907|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25499727|NCT00309907|Prednisolone|prednisolone|mesh-list
25499728|NCT00309907|Prednisolone acetate|prednisolone acetate|mesh-list
25499729|NCT00309907|Etanercept|etanercept|mesh-list
25499730|NCT00309907|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25499731|NCT00309907|Prednisolone phosphate|prednisolone phosphate|mesh-list
25499732|NCT00309907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25499733|NCT00309907|Antiemetics|antiemetics|mesh-ancestor
25499734|NCT00309907|Autonomic Agents|autonomic agents|mesh-ancestor
25499735|NCT00309907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25499736|NCT00309907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499737|NCT00309907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25499738|NCT00309907|Glucocorticoids|glucocorticoids|mesh-ancestor
25499739|NCT00309907|Hormones|hormones|mesh-ancestor
25499740|NCT00309907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25499741|NCT00309907|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25499742|NCT00309907|Protective Agents|protective agents|mesh-ancestor
25499743|NCT00309907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25167333|NCT03026517|Dabrafenib|dabrafenib|mesh-list
25167334|NCT03026517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167335|NCT03026517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25167336|NCT03026517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25167337|NCT03026517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167338|NCT03026517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25167339|NCT03026517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167340|NCT02996656|Cefazolin|cefazolin|mesh-list
25167341|NCT02996656|Ceftriaxone|ceftriaxone|mesh-list
25167342|NCT02996656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25167343|NCT02996656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25167344|NCT02964884|Lovastatin|lovastatin|mesh-list
25499744|NCT00309907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499745|NCT00309907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25499746|NCT00309907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25499748|NCT00309907|Sensory System Agents|sensory system agents|mesh-ancestor
25499749|NCT00309907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25499750|NCT00309907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25499751|NCT00309907|Immunologic Factors|immunologic factors|mesh-ancestor
25499752|NCT00309946|Cediranib|cediranib|mesh-list
25499753|NCT00309946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25791248|NCT00000374|Olanzapine|olanzapine|mesh-list
25791397|NCT00000395|Hematinics|hematinics|mesh-ancestor
25499754|NCT00309946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499755|NCT00309946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499756|NCT00309946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25499757|NCT00309959|Paclitaxel|paclitaxel|mesh-list
25499758|NCT00309959|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25499759|NCT00309959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25499760|NCT00309959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499761|NCT00309959|Tubulin Modulators|tubulin modulators|mesh-ancestor
25499762|NCT00309959|Antimitotic Agents|antimitotic agents|mesh-ancestor
25499763|NCT00309959|Mitosis Modulators|mitosis modulators|mesh-ancestor
25499764|NCT00309959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499765|NCT00310037|Bortezomib|bortezomib|mesh-list
25499766|NCT00310037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499767|NCT00310050|Pemetrexed|pemetrexed|mesh-list
25499768|NCT00310050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499769|NCT00310050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499770|NCT00310050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499771|NCT00310050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25499772|NCT00310050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25499773|NCT00310076|Thalidomide|thalidomide|mesh-list
25499774|NCT00310076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25499775|NCT00310076|Immunologic Factors|immunologic factors|mesh-ancestor
25499776|NCT00310076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499777|NCT00310076|Leprostatic Agents|leprostatic agents|mesh-ancestor
25499778|NCT00310076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25499779|NCT00310076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25499780|NCT00310076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25499781|NCT00310076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25499782|NCT00310076|Growth Substances|growth substances|mesh-ancestor
25499783|NCT00310076|Growth Inhibitors|growth inhibitors|mesh-ancestor
25499784|NCT00310076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499785|NCT00310375|Ezogabine|ezogabine|mesh-list
25499786|NCT00310375|Anticonvulsants|anticonvulsants|mesh-ancestor
25499787|NCT00310375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25499788|NCT00310375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499789|NCT00310401|Albuterol|albuterol|mesh-list
25499790|NCT00310401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25499791|NCT00310401|Autonomic Agents|autonomic agents|mesh-ancestor
25499792|NCT00310401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25499793|NCT00310401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25791842|NCT00000469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25499794|NCT00310401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25791953|NCT00000491|Aspirin|aspirin|mesh-list
25792093|NCT00000505|Plasminogen|plasminogen|mesh-list
25499795|NCT00310401|Respiratory System Agents|respiratory system agents|mesh-ancestor
25499796|NCT00310401|Tocolytic Agents|tocolytic agents|mesh-ancestor
25499797|NCT00310401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25167394|NCT02830360|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25167395|NCT02830360|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25792292|NCT00000524|Cyclosporine|cyclosporine|mesh-list
25792361|NCT00000530|Nifedipine|nifedipine|mesh-list
25167396|NCT02830360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25792573|NCT00000559|Hormones|hormones|mesh-list
25167397|NCT02830360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25167398|NCT02830360|Adrenergic Agents|adrenergic agents|mesh-ancestor
25167399|NCT02830360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25167400|NCT02830360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167401|NCT02830360|Sympatholytics|sympatholytics|mesh-ancestor
25167402|NCT02830360|Autonomic Agents|autonomic agents|mesh-ancestor
25167403|NCT02830360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25167404|NCT02827435|Bromides|bromides|mesh-list
25167405|NCT02827435|Rocuronium|rocuronium|mesh-list
25167406|NCT02827435|Anticonvulsants|anticonvulsants|mesh-ancestor
25167407|NCT02827435|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25167408|NCT02827435|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25167409|NCT02827435|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25167410|NCT02827435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25167411|NCT02827435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167412|NCT02814916|Dalbavancin|dalbavancin|mesh-list
25167413|NCT02814916|Teicoplanin|teicoplanin|mesh-list
25499803|NCT00310401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499805|NCT00310791|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25499806|NCT00310791|Hormones|hormones|mesh-list
25499807|NCT00310791|Estradiol|estradiol|mesh-list
25499808|NCT00310791|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25499809|NCT00310791|Estrogens|estrogens|mesh-list
25499810|NCT00310791|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25792770|NCT00000596|Glucocorticoids|glucocorticoids|mesh-ancestor
25499811|NCT00310791|Progestins|progestins|mesh-list
25499812|NCT00310791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25499813|NCT00310791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499814|NCT00310791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25499815|NCT00310791|Contraceptive Agents|contraceptive agents|mesh-ancestor
25499816|NCT00310791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25499817|NCT00310791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25792833|NCT00000605|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25792899|NCT00000623|Antimetabolites|antimetabolites|mesh-ancestor
25499818|NCT00310791|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25499819|NCT00310791|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25499820|NCT00310791|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25499821|NCT00310791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25499822|NCT00310791|Immunologic Factors|immunologic factors|mesh-ancestor
25499823|NCT00310804|Vaccines|vaccines|mesh-list
25499824|NCT00310804|Immunologic Factors|immunologic factors|mesh-ancestor
25499825|NCT00310804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499826|NCT00310817|Vaccines|vaccines|mesh-list
25499827|NCT00310817|Immunologic Factors|immunologic factors|mesh-ancestor
25499828|NCT00310817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499829|NCT00310856|Vaccines|vaccines|mesh-list
25499830|NCT00310856|Immunologic Factors|immunologic factors|mesh-ancestor
25499831|NCT00310856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499832|NCT00311155|Amlodipine|amlodipine|mesh-list
25499833|NCT00311155|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25499834|NCT00311155|Olmesartan|olmesartan|mesh-list
25499835|NCT00311155|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25499836|NCT00311155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25499837|NCT00311155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25499838|NCT00311155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25499839|NCT00311155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645529|NCT01448824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25645530|NCT01448824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645531|NCT01448824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645532|NCT01448824|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25499840|NCT00311155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25499841|NCT00311155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499842|NCT00311155|Vasodilator Agents|vasodilator agents|mesh-ancestor
25499843|NCT00311155|Diuretics|diuretics|mesh-ancestor
25499844|NCT00311155|Natriuretic Agents|natriuretic agents|mesh-ancestor
25499845|NCT00311155|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25499846|NCT00311155|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25499847|NCT00311155|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25499849|NCT00311246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25499850|NCT00311246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25167445|NCT02797119|Tranexamic Acid|tranexamic acid|mesh-list
25167446|NCT02797119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25167447|NCT02797119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25167448|NCT02797119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167449|NCT02797119|Hemostatics|hemostatics|mesh-ancestor
25167450|NCT02797119|Coagulants|coagulants|mesh-ancestor
25167461|NCT02770391|Leuprolide|leuprolide|mesh-list
25167462|NCT02770391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25167463|NCT02770391|Fertility Agents|fertility agents|mesh-ancestor
25167464|NCT02770391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25793607|NCT00000681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25793784|NCT00000695|Zidovudine|zidovudine|mesh-list
25793924|NCT00000703|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25793994|NCT00000708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167465|NCT02770391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25794364|NCT00000733|Ribavirin|ribavirin|mesh-list
25167466|NCT02770391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25167467|NCT02770391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167468|NCT02743897|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25167469|NCT02743897|Antiviral Agents|antiviral agents|mesh-ancestor
25167470|NCT02743897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25499851|NCT00311311|Mycophenolic Acid|mycophenolic acid|mesh-list
25499853|NCT00311311|Prednisone|prednisone|mesh-list
25499854|NCT00311311|Tacrolimus|tacrolimus|mesh-list
25499855|NCT00311311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25499856|NCT00311311|Glucocorticoids|glucocorticoids|mesh-ancestor
25499857|NCT00311311|Hormones|hormones|mesh-ancestor
25499858|NCT00311311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25499859|NCT00311311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499860|NCT00311311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25499861|NCT00311311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499862|NCT00311311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25499863|NCT00311311|Immunologic Factors|immunologic factors|mesh-ancestor
25499864|NCT00311311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25499865|NCT00311311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499866|NCT00311311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499867|NCT00311311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25499868|NCT00311311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25499869|NCT00311311|Antitubercular Agents|antitubercular agents|mesh-ancestor
25499870|NCT00311311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25499871|NCT00311311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25795135|NCT00000810|Didanosine|didanosine|mesh-list
25499872|NCT00311311|Antifungal Agents|antifungal agents|mesh-ancestor
25499873|NCT00311363|Gabapentin|gabapentin|mesh-list
25795659|NCT00000875|Promethazine|promethazine|mesh-list
25795739|NCT00000881|Cidofovir|cidofovir|mesh-list
25499874|NCT00311363|Analgesics|analgesics|mesh-ancestor
25499875|NCT00311363|Sensory System Agents|sensory system agents|mesh-ancestor
25796020|NCT00000901|Antiviral Agents|antiviral agents|mesh-ancestor
25499876|NCT00311363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25499877|NCT00311363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499878|NCT00311363|Anticonvulsants|anticonvulsants|mesh-ancestor
25499879|NCT00311363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25499880|NCT00311363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25499881|NCT00311363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25499882|NCT00311363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25499883|NCT00311363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25499884|NCT00311363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25499885|NCT00311363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25499886|NCT00311363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499887|NCT00311363|Antimanic Agents|antimanic agents|mesh-ancestor
25499888|NCT00311376|Botulinum Toxins|botulinum toxins|mesh-list
25499889|NCT00311376|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25499890|NCT00311376|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25499891|NCT00311376|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25499892|NCT00311376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25499893|NCT00311376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499894|NCT00311376|Cholinergic Agents|cholinergic agents|mesh-ancestor
25499895|NCT00311376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25499896|NCT00311376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499897|NCT00311376|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25796828|NCT00000976|Zidovudine|zidovudine|mesh-list
25499898|NCT00311376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25499899|NCT00311402|Aspirin|aspirin|mesh-list
25499900|NCT00311402|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
25499901|NCT00311402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25499902|NCT00311402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25499903|NCT00311402|Analgesics|analgesics|mesh-ancestor
25499904|NCT00311402|Sensory System Agents|sensory system agents|mesh-ancestor
25499905|NCT00311402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25499906|NCT00311402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499907|NCT00311402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25499908|NCT00311402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25499909|NCT00311402|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25499910|NCT00311402|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25499911|NCT00311402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499912|NCT00311402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25499913|NCT00311402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25499914|NCT00311402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25167521|NCT02650986|Cyclophosphamide|cyclophosphamide|mesh-list
25167522|NCT02650986|Decitabine|decitabine|mesh-list
25167523|NCT02650986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25167524|NCT02650986|Immunologic Factors|immunologic factors|mesh-ancestor
25167525|NCT02650986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167526|NCT02650986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25167527|NCT02650986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25167528|NCT02650986|Alkylating Agents|alkylating agents|mesh-ancestor
25167529|NCT02650986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499915|NCT00311402|Antipyretics|antipyretics|mesh-ancestor
25499916|NCT00311584|Irinotecan|irinotecan|mesh-list
25499917|NCT00311584|Temozolomide|temozolomide|mesh-list
25499918|NCT00311584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25499919|NCT00311584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25499920|NCT00311584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499921|NCT00311584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499922|NCT00311584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499923|NCT00311584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25499924|NCT00311584|Alkylating Agents|alkylating agents|mesh-ancestor
25499925|NCT00311623|Sirolimus|sirolimus|mesh-list
25499926|NCT00311623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25499927|NCT00311623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25499928|NCT00311623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25499929|NCT00311623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499930|NCT00311623|Antifungal Agents|antifungal agents|mesh-ancestor
25499931|NCT00311623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25499932|NCT00311623|Immunologic Factors|immunologic factors|mesh-ancestor
25499933|NCT00311623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499934|NCT00312195|Buprenorphine|buprenorphine|mesh-list
25499935|NCT00312195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25499936|NCT00312195|Narcotics|narcotics|mesh-ancestor
25499937|NCT00312195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25499938|NCT00312195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499939|NCT00312195|Analgesics|analgesics|mesh-ancestor
25499940|NCT00312195|Sensory System Agents|sensory system agents|mesh-ancestor
25499941|NCT00312195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25796917|NCT00000987|Zidovudine|zidovudine|mesh-list
25499942|NCT00312195|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25499943|NCT00312208|Cyclophosphamide|cyclophosphamide|mesh-list
25499944|NCT00312208|Docetaxel|docetaxel|mesh-list
25499945|NCT00312208|Doxorubicin|doxorubicin|mesh-list
25499946|NCT00312208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25499947|NCT00312208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25499948|NCT00312208|Immunologic Factors|immunologic factors|mesh-ancestor
25796984|NCT00000991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499949|NCT00312208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499950|NCT00312208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25499951|NCT00312208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25499952|NCT00312208|Alkylating Agents|alkylating agents|mesh-ancestor
25499953|NCT00312208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499954|NCT00312208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499955|NCT00312208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25499956|NCT00312208|Tubulin Modulators|tubulin modulators|mesh-ancestor
25499957|NCT00312208|Antimitotic Agents|antimitotic agents|mesh-ancestor
25499958|NCT00312208|Mitosis Modulators|mitosis modulators|mesh-ancestor
25797337|NCT00001023|Azithromycin|azithromycin|mesh-list
25499959|NCT00312208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25645533|NCT01448824|Hormone Antagonists|hormone antagonists|mesh-ancestor
25645534|NCT01448824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25645535|NCT01448824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645536|NCT01448824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25645537|NCT01448824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25499960|NCT00312208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25499961|NCT00312208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25499962|NCT00312208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499963|NCT00312221|Oxycodone|oxycodone|mesh-list
25499964|NCT00312221|Buprenorphine|buprenorphine|mesh-list
25499965|NCT00312221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25499966|NCT00312221|Narcotics|narcotics|mesh-ancestor
25499967|NCT00312221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25499968|NCT00312221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499969|NCT00312221|Analgesics|analgesics|mesh-ancestor
25499970|NCT00312221|Sensory System Agents|sensory system agents|mesh-ancestor
25499971|NCT00312221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25499972|NCT00312221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25499973|NCT00312338|Moxifloxacin|moxifloxacin|mesh-list
25499974|NCT00312338|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25499975|NCT00312338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25499976|NCT00312338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25499977|NCT00312338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25499978|NCT00312338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25499979|NCT00312338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25499980|NCT00312338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499981|NCT00312338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499982|NCT00312338|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25499983|NCT00312338|Contraceptive Agents|contraceptive agents|mesh-ancestor
25499984|NCT00312338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25499985|NCT00312338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25499986|NCT00312338|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25499987|NCT00312338|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25499988|NCT00312338|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25499989|NCT00312377|Docetaxel|docetaxel|mesh-list
25499990|NCT00312377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25499991|NCT00312377|Tubulin Modulators|tubulin modulators|mesh-ancestor
25499992|NCT00312377|Antimitotic Agents|antimitotic agents|mesh-ancestor
25499993|NCT00312377|Mitosis Modulators|mitosis modulators|mesh-ancestor
25499994|NCT00312377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25499995|NCT00312494|Ziprasidone|ziprasidone|mesh-list
25499996|NCT00312494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25499997|NCT00312494|Serotonin Agents|serotonin agents|mesh-ancestor
25798052|NCT00001101|Doxycycline|doxycycline|mesh-list
25798122|NCT00001110|Dimercaprol|dimercaprol|mesh-list
25798192|NCT00001118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25798195|NCT00001119|Ritonavir|ritonavir|mesh-list
25499998|NCT00312494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25499999|NCT00312494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500000|NCT00312494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500001|NCT00312494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25500002|NCT00312494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25500003|NCT00312494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25500004|NCT00312494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25500005|NCT00312494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25500006|NCT00312494|Dopamine Agents|dopamine agents|mesh-ancestor
25500007|NCT00312572|Buprenorphine|buprenorphine|mesh-list
25500008|NCT00312572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25500009|NCT00312572|Narcotics|narcotics|mesh-ancestor
25500010|NCT00312572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25500011|NCT00312572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500012|NCT00312572|Analgesics|analgesics|mesh-ancestor
25500013|NCT00312572|Sensory System Agents|sensory system agents|mesh-ancestor
25500014|NCT00312572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25500015|NCT00312572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25500016|NCT00312728|Bevacizumab|bevacizumab|mesh-list
25500017|NCT00312728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25500018|NCT00312728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500019|NCT00312728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25500020|NCT00312728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25500021|NCT00312728|Growth Substances|growth substances|mesh-ancestor
25500022|NCT00312728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500023|NCT00312728|Growth Inhibitors|growth inhibitors|mesh-ancestor
25500024|NCT00312845|Rituximab|rituximab|mesh-list
25500025|NCT00312845|Bortezomib|bortezomib|mesh-list
25500026|NCT00312845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25500027|NCT00312845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500028|NCT00312845|Immunologic Factors|immunologic factors|mesh-ancestor
25500029|NCT00312845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500030|NCT00312845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25500031|NCT00312858|Vaccines|vaccines|mesh-list
25500032|NCT00312858|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25500033|NCT00312858|Immunologic Factors|immunologic factors|mesh-ancestor
25645538|NCT01448824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25645539|NCT01448824|Antimetabolites|antimetabolites|mesh-ancestor
25645540|NCT01448824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25645541|NCT01449006|Maraviroc|maraviroc|mesh-list
25645542|NCT01449006|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25500034|NCT00312858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500035|NCT00312923|Policosanol|policosanol|mesh-list
25500036|NCT00312923|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25500037|NCT00312923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25500038|NCT00312923|Antimetabolites|antimetabolites|mesh-ancestor
25500039|NCT00312923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500040|NCT00312923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25500041|NCT00312923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25500042|NCT00313014|Oxycodone|oxycodone|mesh-list
25500043|NCT00313014|Buprenorphine|buprenorphine|mesh-list
25500044|NCT00313014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25500045|NCT00313014|Narcotics|narcotics|mesh-ancestor
25500046|NCT00313014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25500047|NCT00313014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500048|NCT00313014|Analgesics|analgesics|mesh-ancestor
25500049|NCT00313014|Sensory System Agents|sensory system agents|mesh-ancestor
25798415|NCT00001212|Immunologic Factors|immunologic factors|mesh-ancestor
25798433|NCT00001221|Hormones|hormones|mesh-list
25798445|NCT00001249|Antibodies|antibodies|mesh-list
25798510|NCT00001267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25500050|NCT00313014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25500051|NCT00313014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25500052|NCT00313144|Protease Inhibitors|protease inhibitors|mesh-list
25500053|NCT00313144|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25500054|NCT00313144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500055|NCT00313144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25798584|NCT00001303|Gasotransmitters|gasotransmitters|mesh-ancestor
25500056|NCT00313144|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25500057|NCT00313144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25500058|NCT00313170|Fulvestrant|fulvestrant|mesh-list
25500059|NCT00313170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25500060|NCT00313170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500061|NCT00313170|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25500062|NCT00313170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25500063|NCT00313170|Hormone Antagonists|hormone antagonists|mesh-ancestor
25500064|NCT00313170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25500065|NCT00313170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500067|NCT00313300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25500068|NCT00313300|Antithrombins|antithrombins|mesh-ancestor
25500069|NCT00313300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25500070|NCT00313300|Protease Inhibitors|protease inhibitors|mesh-ancestor
25500071|NCT00313300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798651|NCT00001341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25798652|NCT00001341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25798653|NCT00001343|Oxandrolone|oxandrolone|mesh-list
25798654|NCT00001343|Androgens|androgens|mesh-ancestor
25798655|NCT00001343|Hormones|hormones|mesh-ancestor
25798656|NCT00001343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25798657|NCT00001343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25798658|NCT00001343|Anabolic Agents|anabolic agents|mesh-ancestor
25798702|NCT00001378|Fenretinide|fenretinide|mesh-list
25798703|NCT00001378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25798704|NCT00001378|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25798705|NCT00001378|Protective Agents|protective agents|mesh-ancestor
25798771|NCT00001426|Cisplatin|cisplatin|mesh-list
25798844|NCT00001442|Tubulin Modulators|tubulin modulators|mesh-ancestor
25500072|NCT00313300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500073|NCT00313300|Anticoagulants|anticoagulants|mesh-ancestor
25500074|NCT00313313|Metformin|metformin|mesh-list
25500075|NCT00313313|Saxagliptin|saxagliptin|mesh-list
25500076|NCT00313313|Glyburide|glyburide|mesh-list
25500077|NCT00313313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25500078|NCT00313313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500079|NCT00313313|Incretins|incretins|mesh-ancestor
25500080|NCT00313313|Hormones|hormones|mesh-ancestor
25500081|NCT00313313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25500082|NCT00313313|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25500083|NCT00313313|Protease Inhibitors|protease inhibitors|mesh-ancestor
25500084|NCT00313313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500085|NCT00313313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500086|NCT00313560|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25500087|NCT00313560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25799144|NCT00001576|Leucovorin|leucovorin|mesh-list
25500088|NCT00313560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25500089|NCT00313560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500090|NCT00313560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500091|NCT00313586|Azacitidine|azacitidine|mesh-list
25500092|NCT00313586|Entinostat|entinostat|mesh-list
25500093|NCT00313586|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25500094|NCT00313586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25500095|NCT00313586|Antimetabolites|antimetabolites|mesh-ancestor
25500096|NCT00313586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500097|NCT00313586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500098|NCT00313586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500099|NCT00313612|Oxaliplatin|oxaliplatin|mesh-list
25500101|NCT00313612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500102|NCT00313612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25500103|NCT00313612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25500104|NCT00313612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500105|NCT00313612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500106|NCT00313716|Epoetin Alfa|epoetin alfa|mesh-list
25500107|NCT00313716|Hematinics|hematinics|mesh-ancestor
25500108|NCT00313729|Temozolomide|temozolomide|mesh-list
25500109|NCT00313729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25500110|NCT00313729|Alkylating Agents|alkylating agents|mesh-ancestor
25500111|NCT00313729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500112|NCT00313729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500113|NCT00313781|Prednisone|prednisone|mesh-list
25500114|NCT00313781|Docetaxel|docetaxel|mesh-list
25500115|NCT00313781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500116|NCT00313781|Tubulin Modulators|tubulin modulators|mesh-ancestor
25500117|NCT00313781|Antimitotic Agents|antimitotic agents|mesh-ancestor
25500118|NCT00313781|Mitosis Modulators|mitosis modulators|mesh-ancestor
25500119|NCT00313781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500120|NCT00313781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25500121|NCT00313781|Glucocorticoids|glucocorticoids|mesh-ancestor
25500122|NCT00313781|Hormones|hormones|mesh-ancestor
25500123|NCT00313781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25500124|NCT00313781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500125|NCT00313781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25500126|NCT00313820|Pregabalin|pregabalin|mesh-list
25500127|NCT00313820|Analgesics|analgesics|mesh-ancestor
25500128|NCT00313820|Sensory System Agents|sensory system agents|mesh-ancestor
25500129|NCT00313820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25500130|NCT00313820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500131|NCT00313820|Anticonvulsants|anticonvulsants|mesh-ancestor
25500132|NCT00313820|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25500133|NCT00313820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25500134|NCT00313820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500135|NCT00313820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24767619|NCT01802593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24767620|NCT01802593|Abortifacient Agents|abortifacient agents|mesh-ancestor
24620432|NCT01057069|Immunologic Factors|immunologic factors|mesh-ancestor
24620433|NCT01057069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500136|NCT00313820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25500137|NCT00313820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25500138|NCT00313820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25799295|NCT00001666|Methamphetamine|methamphetamine|mesh-list
25500139|NCT00313820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25500140|NCT00313846|Buprenorphine|buprenorphine|mesh-list
25500141|NCT00313846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25500142|NCT00313846|Narcotics|narcotics|mesh-ancestor
25500143|NCT00313846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25500144|NCT00313846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500145|NCT00313846|Analgesics|analgesics|mesh-ancestor
25500146|NCT00313846|Sensory System Agents|sensory system agents|mesh-ancestor
25500147|NCT00313846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25500148|NCT00313846|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25500149|NCT00314106|Aldesleukin|aldesleukin|mesh-list
25500150|NCT00314106|Cyclophosphamide|cyclophosphamide|mesh-list
25500151|NCT00314106|Fludarabine|fludarabine|mesh-list
25500152|NCT00314106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25500153|NCT00314106|Immunologic Factors|immunologic factors|mesh-ancestor
25500154|NCT00314106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500155|NCT00314106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25500156|NCT00314106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25500157|NCT00314106|Alkylating Agents|alkylating agents|mesh-ancestor
25500158|NCT00314106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500159|NCT00314106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500160|NCT00314106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25500161|NCT00314106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25500162|NCT00314106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25500163|NCT00314106|Antiviral Agents|antiviral agents|mesh-ancestor
25500164|NCT00314106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25500165|NCT00314249|Milnacipran|milnacipran|mesh-list
25500166|NCT00314249|Levomilnacipran|levomilnacipran|mesh-list
25500167|NCT00314249|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25500168|NCT00314249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25500169|NCT00314249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25500170|NCT00314249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500171|NCT00314249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25500172|NCT00314249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500173|NCT00314249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25500174|NCT00314249|Analgesics|analgesics|mesh-ancestor
25500175|NCT00314249|Sensory System Agents|sensory system agents|mesh-ancestor
25500176|NCT00314249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25500177|NCT00314249|Antidepressive Agents|antidepressive agents|mesh-ancestor
25500178|NCT00314249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25500179|NCT00314262|Celecoxib|celecoxib|mesh-list
25500180|NCT00314262|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25500181|NCT00314262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500182|NCT00314262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25500183|NCT00314262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500184|NCT00314262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500185|NCT00314262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25500186|NCT00314262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25500187|NCT00314262|Analgesics|analgesics|mesh-ancestor
25500188|NCT00314262|Sensory System Agents|sensory system agents|mesh-ancestor
25500189|NCT00314262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25500190|NCT00314262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500191|NCT00314262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25500192|NCT00314262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25500193|NCT00314262|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25500194|NCT00314262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25500195|NCT00314340|Acetaminophen|acetaminophen|mesh-list
25500196|NCT00314340|Morphine|morphine|mesh-list
25500197|NCT00314340|Hydrocodone|hydrocodone|mesh-list
25500198|NCT00314340|Phenobarbital|phenobarbital|mesh-list
25500199|NCT00314340|Amphetamine|amphetamine|mesh-list
25500200|NCT00314340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25500201|NCT00314340|Narcotics|narcotics|mesh-ancestor
25500202|NCT00314340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25167756|NCT02447276|Fasinumab|fasinumab|mesh-list
25167757|NCT02447276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25167758|NCT02447276|Analgesics|analgesics|mesh-ancestor
25799920|NCT00001954|Etanercept|etanercept|mesh-list
25167759|NCT02447276|Sensory System Agents|sensory system agents|mesh-ancestor
25500203|NCT00314340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500204|NCT00314340|Analgesics|analgesics|mesh-ancestor
25799977|NCT00001964|Cyclosporine|cyclosporine|mesh-list
25500205|NCT00314340|Sensory System Agents|sensory system agents|mesh-ancestor
25500206|NCT00314340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25500207|NCT00314340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25500208|NCT00314340|Antipyretics|antipyretics|mesh-ancestor
25500209|NCT00314340|Antitussive Agents|antitussive agents|mesh-ancestor
25500210|NCT00314340|Respiratory System Agents|respiratory system agents|mesh-ancestor
25500211|NCT00314340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25500212|NCT00314340|Sympathomimetics|sympathomimetics|mesh-ancestor
25800259|NCT00002017|Interleukin-2|interleukin-2|mesh-list
25500213|NCT00314340|Autonomic Agents|autonomic agents|mesh-ancestor
25500214|NCT00314340|Dopamine Agents|dopamine agents|mesh-ancestor
25500215|NCT00314340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25205321|NCT04931368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25800391|NCT00002036|Immune Sera|immune sera|mesh-list
25500216|NCT00314340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500217|NCT00314340|Adrenergic Agents|adrenergic agents|mesh-ancestor
25500218|NCT00314340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25500219|NCT00314340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25500220|NCT00314340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25500221|NCT00314340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25500222|NCT00314340|Anticonvulsants|anticonvulsants|mesh-ancestor
25500223|NCT00314340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25500224|NCT00314340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25800544|NCT00002057|Nystatin|nystatin|mesh-list
25500225|NCT00314340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25500226|NCT00314340|GABA Modulators|gaba modulators|mesh-ancestor
25500227|NCT00314340|GABA Agents|gaba agents|mesh-ancestor
25500228|NCT00314340|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25500229|NCT00314340|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25500230|NCT00314340|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25500231|NCT00314574|Omalizumab|omalizumab|mesh-list
25500232|NCT00314574|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25500233|NCT00314574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25500234|NCT00314574|Respiratory System Agents|respiratory system agents|mesh-ancestor
25500235|NCT00314808|Dronabinol|dronabinol|mesh-list
25500236|NCT00314808|Hallucinogens|hallucinogens|mesh-ancestor
25500237|NCT00314808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500238|NCT00314808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25500239|NCT00314808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25500240|NCT00314808|Analgesics|analgesics|mesh-ancestor
25500241|NCT00314808|Sensory System Agents|sensory system agents|mesh-ancestor
25500242|NCT00314808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25500243|NCT00314808|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25500244|NCT00314808|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25500245|NCT00314808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25500246|NCT00314808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500247|NCT00314808|Hormones|hormones|mesh-ancestor
25500248|NCT00314808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25500249|NCT00314951|Vancomycin|vancomycin|mesh-list
25500250|NCT00314951|Fidaxomicin|fidaxomicin|mesh-list
25500251|NCT00314951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25500252|NCT00314951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25500253|NCT00315055|Vaccines|vaccines|mesh-list
25500254|NCT00315055|Immunologic Factors|immunologic factors|mesh-ancestor
25500255|NCT00315055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500256|NCT00315146|Pioglitazone|pioglitazone|mesh-list
25500257|NCT00315146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25500258|NCT00315146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500259|NCT00315302|Atropine|atropine|mesh-list
25500260|NCT00315302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25500261|NCT00315302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25500262|NCT00315302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25500263|NCT00315302|Autonomic Agents|autonomic agents|mesh-ancestor
25500264|NCT00315302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25500265|NCT00315302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500266|NCT00315302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25500267|NCT00315302|Respiratory System Agents|respiratory system agents|mesh-ancestor
25500268|NCT00315302|Mydriatics|mydriatics|mesh-ancestor
25500269|NCT00315302|Parasympatholytics|parasympatholytics|mesh-ancestor
25500270|NCT00315302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25500271|NCT00315302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25500272|NCT00315302|Cholinergic Agents|cholinergic agents|mesh-ancestor
25500273|NCT00315302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25500274|NCT00315302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500275|NCT00315328|Atropine|atropine|mesh-list
25500276|NCT00315328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25500277|NCT00315328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25500278|NCT00315328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25500279|NCT00315328|Autonomic Agents|autonomic agents|mesh-ancestor
25500280|NCT00315328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25500281|NCT00315328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500282|NCT00315328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25500283|NCT00315328|Respiratory System Agents|respiratory system agents|mesh-ancestor
25500284|NCT00315328|Mydriatics|mydriatics|mesh-ancestor
25500285|NCT00315328|Parasympatholytics|parasympatholytics|mesh-ancestor
25500286|NCT00315328|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25500287|NCT00315328|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25800736|NCT00002078|Interferons|interferons|mesh-list
25500288|NCT00315328|Cholinergic Agents|cholinergic agents|mesh-ancestor
25800878|NCT00002098|Lentinan|lentinan|mesh-list
25801101|NCT00002117|Zidovudine|zidovudine|mesh-list
25500289|NCT00315328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25500290|NCT00315328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500291|NCT00315341|Buprenorphine|buprenorphine|mesh-list
25500292|NCT00315341|Methadone|methadone|mesh-list
25500293|NCT00315341|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25500294|NCT00315341|Naloxone|naloxone|mesh-list
25500295|NCT00315341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25500296|NCT00315341|Narcotics|narcotics|mesh-ancestor
25500297|NCT00315341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25801437|NCT00002155|Antiviral Agents|antiviral agents|mesh-ancestor
25500298|NCT00315341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500299|NCT00315341|Analgesics|analgesics|mesh-ancestor
25500300|NCT00315341|Sensory System Agents|sensory system agents|mesh-ancestor
25500301|NCT00315341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25500302|NCT00315341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25500303|NCT00315341|Antitussive Agents|antitussive agents|mesh-ancestor
25500304|NCT00315341|Respiratory System Agents|respiratory system agents|mesh-ancestor
25500305|NCT00315445|Acetaminophen|acetaminophen|mesh-list
25500306|NCT00315445|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25500307|NCT00315445|Oxycodone|oxycodone|mesh-list
25500308|NCT00315445|Buprenorphine|buprenorphine|mesh-list
25500309|NCT00315445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25500310|NCT00315445|Analgesics|analgesics|mesh-ancestor
25500311|NCT00315445|Sensory System Agents|sensory system agents|mesh-ancestor
25500312|NCT00315445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25500313|NCT00315445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500314|NCT00315445|Antipyretics|antipyretics|mesh-ancestor
25500315|NCT00315445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25500316|NCT00315445|Narcotics|narcotics|mesh-ancestor
25500317|NCT00315445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25500318|NCT00315445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25500319|NCT00315445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25500320|NCT00315445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25500321|NCT00315445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25500323|NCT00315458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25500324|NCT00315458|Narcotics|narcotics|mesh-ancestor
25500325|NCT00315458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25500326|NCT00315458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500327|NCT00315458|Analgesics|analgesics|mesh-ancestor
25500328|NCT00315458|Sensory System Agents|sensory system agents|mesh-ancestor
25500329|NCT00315458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25500330|NCT00315458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25500331|NCT00315705|Cyclophosphamide|cyclophosphamide|mesh-list
25500332|NCT00315705|Etoposide|etoposide|mesh-list
25500333|NCT00315705|Clofarabine|clofarabine|mesh-list
25500334|NCT00315705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25500335|NCT00315705|Immunologic Factors|immunologic factors|mesh-ancestor
25500336|NCT00315705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500337|NCT00315705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25500338|NCT00315705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25500339|NCT00315705|Alkylating Agents|alkylating agents|mesh-ancestor
25500340|NCT00315705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500341|NCT00315705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25801586|NCT00002169|Nelfinavir|nelfinavir|mesh-list
25801628|NCT00002176|Stavudine|stavudine|mesh-list
25500342|NCT00315705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25500343|NCT00315705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25500344|NCT00315705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25205322|NCT04931368|Abortifacient Agents|abortifacient agents|mesh-ancestor
25500345|NCT00315705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25500346|NCT00315705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500347|NCT00315705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25802033|NCT00002212|Bexarotene|bexarotene|mesh-list
25500348|NCT00315705|Antimetabolites|antimetabolites|mesh-ancestor
25500349|NCT00316004|Dextrans|dextrans|mesh-list
25500350|NCT00316004|Anticoagulants|anticoagulants|mesh-ancestor
25500351|NCT00316004|Plasma Substitutes|plasma substitutes|mesh-ancestor
25500352|NCT00316004|Blood Substitutes|blood substitutes|mesh-ancestor
25167855|NCT02405585|Protective Agents|protective agents|mesh-ancestor
25167856|NCT02405585|Vitamin B Complex|vitamin b complex|mesh-ancestor
25167857|NCT02405585|Vitamins|vitamins|mesh-ancestor
25167858|NCT02405585|Micronutrients|micronutrients|mesh-ancestor
25167859|NCT02405260|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25167860|NCT02405260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25167861|NCT02405260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500353|NCT00316017|Dextrans|dextrans|mesh-list
25500354|NCT00316017|Anticoagulants|anticoagulants|mesh-ancestor
25500355|NCT00316017|Plasma Substitutes|plasma substitutes|mesh-ancestor
25500356|NCT00316017|Blood Substitutes|blood substitutes|mesh-ancestor
25500357|NCT00316082|Metformin|metformin|mesh-list
25500358|NCT00316082|Saxagliptin|saxagliptin|mesh-list
25500359|NCT00316082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25500360|NCT00316082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500361|NCT00316082|Incretins|incretins|mesh-ancestor
25500362|NCT00316082|Hormones|hormones|mesh-ancestor
25500363|NCT00316082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25500364|NCT00316082|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25500365|NCT00316082|Protease Inhibitors|protease inhibitors|mesh-ancestor
25500366|NCT00316082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500367|NCT00316082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500368|NCT00316173|Carboplatin|carboplatin|mesh-list
25500369|NCT00316173|Topotecan|topotecan|mesh-list
25500370|NCT00316173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500371|NCT00316173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25500372|NCT00316173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25500373|NCT00316173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500374|NCT00316173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500375|NCT00316186|Carboplatin|carboplatin|mesh-list
25500376|NCT00316186|Topotecan|topotecan|mesh-list
25500377|NCT00316186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500378|NCT00316186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25500379|NCT00316186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25500380|NCT00316186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500381|NCT00316186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500382|NCT00316199|Gemcitabine|gemcitabine|mesh-list
25500383|NCT00316199|Paclitaxel|paclitaxel|mesh-list
25500384|NCT00316199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25500385|NCT00316199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500386|NCT00316199|Tubulin Modulators|tubulin modulators|mesh-ancestor
25500387|NCT00316199|Antimitotic Agents|antimitotic agents|mesh-ancestor
25645543|NCT01449006|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25645544|NCT01449006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645545|NCT01449006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25645546|NCT01449006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25645547|NCT01449006|Antiviral Agents|antiviral agents|mesh-ancestor
25645548|NCT01449006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25645549|NCT01449006|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25205323|NCT04931368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25645550|NCT01449266|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
25645551|NCT01449266|Chelating Agents|chelating agents|mesh-ancestor
25500388|NCT00316199|Mitosis Modulators|mitosis modulators|mesh-ancestor
25500389|NCT00316199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500390|NCT00316199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25500391|NCT00316199|Antimetabolites|antimetabolites|mesh-ancestor
25500392|NCT00316199|Antiviral Agents|antiviral agents|mesh-ancestor
25500393|NCT00316199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25500394|NCT00316199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500395|NCT00316199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25500396|NCT00316199|Immunologic Factors|immunologic factors|mesh-ancestor
25500397|NCT00316199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500398|NCT00316225|Pemetrexed|pemetrexed|mesh-list
25500399|NCT00316225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500400|NCT00316225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500401|NCT00316225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500402|NCT00316225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25500403|NCT00316225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25500404|NCT00316264|Palivizumab|palivizumab|mesh-list
25500405|NCT00316264|Antiviral Agents|antiviral agents|mesh-ancestor
25500406|NCT00316264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25500407|NCT00316277|Opiate Alkaloids|opiate alkaloids|mesh-list
25500408|NCT00316277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25500409|NCT00316277|Narcotics|narcotics|mesh-ancestor
25500410|NCT00316277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25500411|NCT00316277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500412|NCT00316277|Analgesics|analgesics|mesh-ancestor
25500413|NCT00316277|Sensory System Agents|sensory system agents|mesh-ancestor
25500414|NCT00316277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25500415|NCT00316719|Lamivudine|lamivudine|mesh-list
25500416|NCT00316719|Adefovir|adefovir|mesh-list
25500417|NCT00316719|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25500418|NCT00316719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25500419|NCT00316719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25803795|NCT00002398|Adefovir|adefovir|mesh-list
25500420|NCT00316719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25803947|NCT00002413|Emivirine|emivirine|mesh-list
25500421|NCT00316719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500422|NCT00316719|Antiviral Agents|antiviral agents|mesh-ancestor
25500423|NCT00316719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25500424|NCT00316719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25500425|NCT00316719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25500426|NCT00316862|Cisplatin|cisplatin|mesh-list
25500427|NCT00316862|Irinotecan|irinotecan|mesh-list
24771106|NCT01824758|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25500428|NCT00316862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500429|NCT00316862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25804372|NCT00002452|Antiviral Agents|antiviral agents|mesh-ancestor
24407512|NCT00174642|Insulin Glargine|insulin glargine|mesh-list
25500430|NCT00316862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25500431|NCT00316862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205324|NCT04931368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25500432|NCT00316862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25804744|NCT00002481|Antimetabolites|antimetabolites|mesh-ancestor
25500433|NCT00316914|Magnesium Sulfate|magnesium sulfate|mesh-list
25500435|NCT00316914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25500436|NCT00316914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500437|NCT00316914|Analgesics|analgesics|mesh-ancestor
25500438|NCT00316914|Sensory System Agents|sensory system agents|mesh-ancestor
25500439|NCT00316914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25500440|NCT00316914|Anesthetics|anesthetics|mesh-ancestor
25500441|NCT00316914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25500442|NCT00316914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25500443|NCT00316914|Anticonvulsants|anticonvulsants|mesh-ancestor
25500444|NCT00316914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25500445|NCT00316914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25500446|NCT00316914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500447|NCT00316914|Tocolytic Agents|tocolytic agents|mesh-ancestor
25500448|NCT00316914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25500449|NCT00317044|Esomeprazole|esomeprazole|mesh-list
25645552|NCT01449266|Sequestering Agents|sequestering agents|mesh-ancestor
25500450|NCT00317044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25500451|NCT00317044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25645553|NCT01449266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500452|NCT00317044|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25500453|NCT00317044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500454|NCT00317044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500455|NCT00317473|Vaccines|vaccines|mesh-list
25500456|NCT00317473|Immunologic Factors|immunologic factors|mesh-ancestor
25500457|NCT00317473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500458|NCT00317642|Cytarabine|cytarabine|mesh-list
25500459|NCT00317642|Clofarabine|clofarabine|mesh-list
25500460|NCT00317642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25500461|NCT00317642|Antimetabolites|antimetabolites|mesh-ancestor
25500462|NCT00317642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500463|NCT00317642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500464|NCT00317642|Antiviral Agents|antiviral agents|mesh-ancestor
25500465|NCT00317642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25500466|NCT00317642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25500467|NCT00317642|Immunologic Factors|immunologic factors|mesh-ancestor
25500468|NCT00317642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500469|NCT00317720|Trastuzumab|trastuzumab|mesh-list
25500470|NCT00317720|Everolimus|everolimus|mesh-list
25500471|NCT00317720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25500472|NCT00317720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500473|NCT00317720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25500474|NCT00317720|Immunologic Factors|immunologic factors|mesh-ancestor
25500475|NCT00317720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500476|NCT00317941|Interferon beta-1b|interferon beta-1b|mesh-list
25500477|NCT00317941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25500478|NCT00317941|Immunologic Factors|immunologic factors|mesh-ancestor
25500479|NCT00317941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500480|NCT00318136|Paclitaxel|paclitaxel|mesh-list
25500481|NCT00318136|Bevacizumab|bevacizumab|mesh-list
25500482|NCT00318136|Carboplatin|carboplatin|mesh-list
25805519|NCT00002531|Vitamins|vitamins|mesh-ancestor
25805591|NCT00002534|Cytarabine|cytarabine|mesh-list
25205325|NCT04931368|Antimetabolites|antimetabolites|mesh-ancestor
25500483|NCT00318136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25500484|NCT00318136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500485|NCT00318136|Tubulin Modulators|tubulin modulators|mesh-ancestor
25500486|NCT00318136|Antimitotic Agents|antimitotic agents|mesh-ancestor
25500487|NCT00318136|Mitosis Modulators|mitosis modulators|mesh-ancestor
25167939|NCT02382510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167940|NCT02382510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25167941|NCT02382510|Respiratory System Agents|respiratory system agents|mesh-ancestor
25024957|NCT03640468|Lidocaine|lidocaine|mesh-list
25806192|NCT00002571|Antiviral Agents|antiviral agents|mesh-ancestor
25806506|NCT00002590|Hormones|hormones|mesh-ancestor
25806648|NCT00002599|Vincristine|vincristine|mesh-list
25167942|NCT02382510|Parasympatholytics|parasympatholytics|mesh-ancestor
25167943|NCT02382510|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25167944|NCT02382510|Cholinergic Agents|cholinergic agents|mesh-ancestor
25167945|NCT02382510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25167946|NCT02382510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167947|NCT02377895|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25167948|NCT02372578|Pregabalin|pregabalin|mesh-list
25167949|NCT02372578|Analgesics|analgesics|mesh-ancestor
25167950|NCT02372578|Sensory System Agents|sensory system agents|mesh-ancestor
25167951|NCT02372578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25167952|NCT02372578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167953|NCT02372578|Anticonvulsants|anticonvulsants|mesh-ancestor
25500519|NCT00318370|Farletuzumab|farletuzumab|mesh-list
25500520|NCT00318370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500521|NCT00318409|Bupropion|bupropion|mesh-list
25500522|NCT00318409|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25500523|NCT00318409|Antidepressive Agents|antidepressive agents|mesh-ancestor
25500524|NCT00318409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25500525|NCT00318409|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25500526|NCT00318409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25500527|NCT00318409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25500528|NCT00318409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500529|NCT00318409|Dopamine Agents|dopamine agents|mesh-ancestor
25500530|NCT00318409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25500531|NCT00318409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500532|NCT00318409|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25500533|NCT00318409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25500534|NCT00318409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500535|NCT00318461|Metformin|metformin|mesh-list
25500536|NCT00318461|Liraglutide|liraglutide|mesh-list
25500537|NCT00318461|Glimepiride|glimepiride|mesh-list
25500538|NCT00318461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25500539|NCT00318461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500540|NCT00318461|Incretins|incretins|mesh-ancestor
25500541|NCT00318461|Hormones|hormones|mesh-ancestor
25500542|NCT00318461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25500543|NCT00318461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25645554|NCT01449279|Ipilimumab|ipilimumab|mesh-list
25500544|NCT00318461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25500545|NCT00318461|Immunologic Factors|immunologic factors|mesh-ancestor
25500546|NCT00318474|Mycophenolic Acid|mycophenolic acid|mesh-list
25500547|NCT00318474|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25500548|NCT00318474|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25500549|NCT00318474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25500550|NCT00318474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500551|NCT00318474|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25500552|NCT00318474|Antitubercular Agents|antitubercular agents|mesh-ancestor
25500553|NCT00318474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25500554|NCT00318474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25500555|NCT00318474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500556|NCT00318474|Protease Inhibitors|protease inhibitors|mesh-ancestor
25500557|NCT00318643|Mitomycins|mitomycins|mesh-list
25500558|NCT00318643|Mitomycin|mitomycin|mesh-list
25500559|NCT00318643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25500560|NCT00318643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500561|NCT00318643|Alkylating Agents|alkylating agents|mesh-ancestor
24456141|NCT00330239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25806735|NCT00002610|Dactinomycin|dactinomycin|mesh-list
25806819|NCT00002616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25806967|NCT00002633|Leuprolide|leuprolide|mesh-list
25500562|NCT00318643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25807111|NCT00002644|Hormone Antagonists|hormone antagonists|mesh-ancestor
25807277|NCT00002658|Analgesics|analgesics|mesh-ancestor
25807368|NCT00002670|Cobalt|cobalt|mesh-list
25807483|NCT00002678|Immunologic Factors|immunologic factors|mesh-ancestor
25500563|NCT00318643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25500564|NCT00318643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500565|NCT00318708|Fluticasone|fluticasone|mesh-list
25500566|NCT00318708|Xhance|xhance|mesh-list
25500567|NCT00318708|Clarithromycin|clarithromycin|mesh-list
25500568|NCT00318708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25500569|NCT00318708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25500570|NCT00318708|Autonomic Agents|autonomic agents|mesh-ancestor
25500571|NCT00318708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25500572|NCT00318708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500573|NCT00318708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25500574|NCT00318708|Respiratory System Agents|respiratory system agents|mesh-ancestor
25500575|NCT00318708|Dermatologic Agents|dermatologic agents|mesh-ancestor
25500576|NCT00318708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25500577|NCT00318708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25500578|NCT00318708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25500579|NCT00318708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25500580|NCT00318708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500581|NCT00318708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500582|NCT00318708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25500583|NCT00318708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25500584|NCT00318812|Iron|iron|mesh-list
25500585|NCT00318812|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25500586|NCT00318812|Trace Elements|trace elements|mesh-ancestor
25808687|NCT00002772|Tamoxifen|tamoxifen|mesh-list
25808987|NCT00002789|Antimetabolites|antimetabolites|mesh-ancestor
25809058|NCT00002793|Leucovorin|leucovorin|mesh-list
25500587|NCT00318812|Micronutrients|micronutrients|mesh-ancestor
25500588|NCT00318812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500589|NCT00318812|Hematinics|hematinics|mesh-ancestor
25809828|NCT00002837|Paclitaxel|paclitaxel|mesh-list
25500590|NCT00318929|Valproic Acid|valproic acid|mesh-list
25809899|NCT00002846|Aldesleukin|aldesleukin|mesh-list
25500591|NCT00318929|Anticonvulsants|anticonvulsants|mesh-ancestor
25500592|NCT00318929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500593|NCT00318929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500594|NCT00318929|GABA Agents|gaba agents|mesh-ancestor
25500595|NCT00318929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25500596|NCT00318929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500597|NCT00318929|Antimanic Agents|antimanic agents|mesh-ancestor
25500598|NCT00318929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25500599|NCT00318929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25500600|NCT00318929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25500601|NCT00319020|Bosentan|bosentan|mesh-list
25500602|NCT00319020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25500603|NCT00319020|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25500604|NCT00319020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500605|NCT00319046|Miglustat|miglustat|mesh-list
25500606|NCT00319046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500607|NCT00319046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500608|NCT00319046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25500609|NCT00319046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25500610|NCT00319046|Antiviral Agents|antiviral agents|mesh-ancestor
25500611|NCT00319046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25500612|NCT00319046|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25500613|NCT00319046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24793435|NCT03504644|Venetoclax|venetoclax|mesh-list
25645555|NCT01449279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25645557|NCT01449279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25645558|NCT01449279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645559|NCT01449370|Serabelisib|serabelisib|mesh-list
25645560|NCT01449370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500614|NCT00319046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500615|NCT00319111|Bosentan|bosentan|mesh-list
25810246|NCT00002881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500616|NCT00319111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25500617|NCT00319111|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25500618|NCT00319111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500619|NCT00319501|Diazepam|diazepam|mesh-list
25810333|NCT00002889|Leuprolide|leuprolide|mesh-list
25500620|NCT00319501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25500621|NCT00319501|Anticonvulsants|anticonvulsants|mesh-ancestor
25500622|NCT00319501|Antiemetics|antiemetics|mesh-ancestor
25500623|NCT00319501|Autonomic Agents|autonomic agents|mesh-ancestor
25810517|NCT00002911|Marimastat|marimastat|mesh-list
25500624|NCT00319501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25500625|NCT00319501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25810693|NCT00002936|Alkylating Agents|alkylating agents|mesh-ancestor
25500626|NCT00319501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25500627|NCT00319501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25500628|NCT00319501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25500629|NCT00319501|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25500630|NCT00319501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25500631|NCT00319501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25500632|NCT00319501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25500633|NCT00319501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25500634|NCT00319501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25500635|NCT00319501|Anesthetics, General|anesthetics, general|mesh-ancestor
25500636|NCT00319501|Anesthetics|anesthetics|mesh-ancestor
25811358|NCT00003012|Cyclophosphamide|cyclophosphamide|mesh-list
25811432|NCT00003016|Tamoxifen|tamoxifen|mesh-list
25811963|NCT00003072|Paclitaxel|paclitaxel|mesh-list
25812190|NCT00003093|Lenograstim|lenograstim|mesh-list
25500637|NCT00319501|GABA Modulators|gaba modulators|mesh-ancestor
25500638|NCT00319501|GABA Agents|gaba agents|mesh-ancestor
25500639|NCT00319501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25500640|NCT00319501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500641|NCT00319592|Vaccines|vaccines|mesh-list
25500642|NCT00319592|Immunologic Factors|immunologic factors|mesh-ancestor
25500643|NCT00319592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500644|NCT00319644|Dimercaprol|dimercaprol|mesh-list
25500645|NCT00319644|Chelating Agents|chelating agents|mesh-ancestor
25500646|NCT00319644|Sequestering Agents|sequestering agents|mesh-ancestor
25500647|NCT00319644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500648|NCT00319696|Bosentan|bosentan|mesh-list
25500649|NCT00319696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25500650|NCT00319696|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25812266|NCT00003105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25812558|NCT00003139|Pilocarpine|pilocarpine|mesh-list
25812789|NCT00003159|Antiviral Agents|antiviral agents|mesh-ancestor
25813164|NCT00003204|Antimetabolites|antimetabolites|mesh-ancestor
25500651|NCT00319696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500652|NCT00319956|Azithromycin|azithromycin|mesh-list
25500653|NCT00319956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25500654|NCT00319956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25500655|NCT00319982|Diltiazem|diltiazem|mesh-list
25813404|NCT00003217|Hormones|hormones|mesh-ancestor
25500656|NCT00319982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25500657|NCT00319982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25500658|NCT00319982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25500659|NCT00319982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500660|NCT00319982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25500661|NCT00319982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500662|NCT00319982|Vasodilator Agents|vasodilator agents|mesh-ancestor
25500663|NCT00320190|Imatinib Mesylate|imatinib mesylate|mesh-list
25500664|NCT00320190|Dasatinib|dasatinib|mesh-list
25500665|NCT00320190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500666|NCT00320190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25500667|NCT00320190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500668|NCT00320190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500670|NCT00320216|Dermatologic Agents|dermatologic agents|mesh-ancestor
25500671|NCT00320255|Apixaban|apixaban|mesh-list
25500672|NCT00320255|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25500673|NCT00320255|Antithrombins|antithrombins|mesh-ancestor
25500674|NCT00320255|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25500675|NCT00320255|Protease Inhibitors|protease inhibitors|mesh-ancestor
25500676|NCT00320255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500677|NCT00320255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500678|NCT00320255|Anticoagulants|anticoagulants|mesh-ancestor
25500679|NCT00320281|Botulinum Toxins|botulinum toxins|mesh-list
25500680|NCT00320281|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25500681|NCT00320281|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25500682|NCT00320281|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25500683|NCT00320281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25813464|NCT00003231|Cisplatin|cisplatin|mesh-list
25813659|NCT00003254|Eniluracil|eniluracil|mesh-list
25645561|NCT01449370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645562|NCT01449630|Celecoxib|celecoxib|mesh-list
25500684|NCT00320281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500685|NCT00320281|Cholinergic Agents|cholinergic agents|mesh-ancestor
25500686|NCT00320281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25500687|NCT00320281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500688|NCT00320281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25500689|NCT00320281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25500690|NCT00320385|Trastuzumab|trastuzumab|mesh-list
25500691|NCT00320385|Lapatinib|lapatinib|mesh-list
25500692|NCT00320385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25500693|NCT00320385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500694|NCT00320385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25500695|NCT00320385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500696|NCT00320385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500697|NCT00320398|PENTA|penta|mesh-list
25500698|NCT00320398|Fondaparinux|fondaparinux|mesh-list
25500699|NCT00320398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25500700|NCT00320398|Antithrombins|antithrombins|mesh-ancestor
25500701|NCT00320398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25500702|NCT00320398|Protease Inhibitors|protease inhibitors|mesh-ancestor
25500703|NCT00320398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500704|NCT00320398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500705|NCT00320398|Anticoagulants|anticoagulants|mesh-ancestor
25500706|NCT00320398|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25500707|NCT00320398|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25500708|NCT00320411|Lapatinib|lapatinib|mesh-list
25500709|NCT00320411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500710|NCT00320411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25500711|NCT00320411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500712|NCT00320411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500713|NCT00320424|PENTA|penta|mesh-list
25500714|NCT00320424|Fondaparinux|fondaparinux|mesh-list
25500715|NCT00320424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25500716|NCT00320424|Antithrombins|antithrombins|mesh-ancestor
25500717|NCT00320424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25500718|NCT00320424|Protease Inhibitors|protease inhibitors|mesh-ancestor
25500719|NCT00320424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500720|NCT00320424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500721|NCT00320424|Anticoagulants|anticoagulants|mesh-ancestor
25500722|NCT00320424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25500723|NCT00320424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25500724|NCT00320489|Olanzapine|olanzapine|mesh-list
25500725|NCT00320489|Antiemetics|antiemetics|mesh-ancestor
25500726|NCT00320489|Autonomic Agents|autonomic agents|mesh-ancestor
25500727|NCT00320489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25500728|NCT00320489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500729|NCT00320489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25500730|NCT00320489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25500731|NCT00320489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25500732|NCT00320489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25500733|NCT00320489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25500734|NCT00320489|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25500735|NCT00320489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25500736|NCT00320489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25500737|NCT00320489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500738|NCT00320489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25500739|NCT00320489|Serotonin Agents|serotonin agents|mesh-ancestor
25500740|NCT00320515|Cisplatin|cisplatin|mesh-list
25500741|NCT00320515|Pemetrexed|pemetrexed|mesh-list
25500742|NCT00320515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25203551|NCT02713763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25500743|NCT00320515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500744|NCT00320515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500745|NCT00320515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25500746|NCT00320515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25500747|NCT00320528|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25500748|NCT00320528|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25500749|NCT00320528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25500750|NCT00320528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25500751|NCT00320528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500752|NCT00320528|Adrenergic Agents|adrenergic agents|mesh-ancestor
25500753|NCT00320528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25500754|NCT00320528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645563|NCT01449630|LY3031207|ly3031207|mesh-list
25500755|NCT00320541|Gemcitabine|gemcitabine|mesh-list
25645564|NCT01449630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25645565|NCT01449630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25645566|NCT01449630|Analgesics|analgesics|mesh-ancestor
25645567|NCT01449630|Sensory System Agents|sensory system agents|mesh-ancestor
25645568|NCT01449630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25645569|NCT01449630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645570|NCT01449630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25645571|NCT01449630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25500756|NCT00320541|Paclitaxel|paclitaxel|mesh-list
25500757|NCT00320541|Bevacizumab|bevacizumab|mesh-list
25500758|NCT00320541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25500759|NCT00320541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500760|NCT00320541|Tubulin Modulators|tubulin modulators|mesh-ancestor
25500761|NCT00320541|Antimitotic Agents|antimitotic agents|mesh-ancestor
25500762|NCT00320541|Mitosis Modulators|mitosis modulators|mesh-ancestor
25500763|NCT00320541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500764|NCT00320541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25500765|NCT00320541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25500766|NCT00320541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25500767|NCT00320541|Growth Substances|growth substances|mesh-ancestor
25814812|NCT00003396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25814890|NCT00003399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25500768|NCT00320541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500769|NCT00320541|Growth Inhibitors|growth inhibitors|mesh-ancestor
25500770|NCT00320541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25815040|NCT00003408|Aldesleukin|aldesleukin|mesh-list
25500771|NCT00320541|Antimetabolites|antimetabolites|mesh-ancestor
25500772|NCT00320541|Antiviral Agents|antiviral agents|mesh-ancestor
25500773|NCT00320541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25500774|NCT00320541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500775|NCT00320541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25500776|NCT00320541|Immunologic Factors|immunologic factors|mesh-ancestor
25500777|NCT00320671|Risperidone|risperidone|mesh-list
25500778|NCT00320671|Aripiprazole|aripiprazole|mesh-list
25500779|NCT00320671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25500780|NCT00320671|Serotonin Agents|serotonin agents|mesh-ancestor
25815339|NCT00003436|Dermatologic Agents|dermatologic agents|mesh-ancestor
25815500|NCT00003449|Hormones|hormones|mesh-ancestor
25500781|NCT00320671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25500782|NCT00320671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500783|NCT00320671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500784|NCT00320671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25500785|NCT00320671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25500786|NCT00320671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25500787|NCT00320671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25500788|NCT00320671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25500789|NCT00320671|Dopamine Agents|dopamine agents|mesh-ancestor
25500790|NCT00320671|Antidepressive Agents|antidepressive agents|mesh-ancestor
25500791|NCT00320671|Dopamine Agonists|dopamine agonists|mesh-ancestor
25815565|NCT00003478|Antibodies|antibodies|mesh-list
25500792|NCT00320671|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25500793|NCT00320671|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25500794|NCT00320671|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25500795|NCT00320671|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25500796|NCT00320710|Zoledronic Acid|zoledronic acid|mesh-list
25500797|NCT00320710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25500798|NCT00320710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500799|NCT00320749|Gemcitabine|gemcitabine|mesh-list
25500800|NCT00320749|Capecitabine|capecitabine|mesh-list
25500801|NCT00320749|Docetaxel|docetaxel|mesh-list
25500802|NCT00320749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25500803|NCT00320749|Antimetabolites|antimetabolites|mesh-ancestor
25815777|NCT00003544|Irinotecan|irinotecan|mesh-list
25815843|NCT00003554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25500804|NCT00320749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25816073|NCT00003580|Cisplatin|cisplatin|mesh-list
25500805|NCT00320749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500806|NCT00320749|Antiviral Agents|antiviral agents|mesh-ancestor
25500807|NCT00320749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25500808|NCT00320749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500809|NCT00320749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25500810|NCT00320749|Immunologic Factors|immunologic factors|mesh-ancestor
25500811|NCT00320749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500812|NCT00320749|Tubulin Modulators|tubulin modulators|mesh-ancestor
25500813|NCT00320749|Antimitotic Agents|antimitotic agents|mesh-ancestor
25500814|NCT00320749|Mitosis Modulators|mitosis modulators|mesh-ancestor
25500815|NCT00320788|Aflibercept|aflibercept|mesh-list
25500816|NCT00320788|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25500817|NCT00320788|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25500818|NCT00320788|Growth Substances|growth substances|mesh-ancestor
25500819|NCT00320788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500820|NCT00320788|Growth Inhibitors|growth inhibitors|mesh-ancestor
25500821|NCT00320788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500822|NCT00320801|Buprenorphine|buprenorphine|mesh-list
25500823|NCT00320801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25500824|NCT00320801|Narcotics|narcotics|mesh-ancestor
25500825|NCT00320801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25645572|NCT01449630|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25645573|NCT01449630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25645574|NCT01449630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645575|NCT01449630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645576|NCT01449630|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
25645577|NCT01449630|Hormone Antagonists|hormone antagonists|mesh-ancestor
25816732|NCT00003642|Cisplatin|cisplatin|mesh-list
25816882|NCT00003661|Immunologic Factors|immunologic factors|mesh-ancestor
25816959|NCT00003664|Antiviral Agents|antiviral agents|mesh-ancestor
25645578|NCT01449630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25645579|NCT01449682|Dexamethasone|dexamethasone|mesh-list
25645580|NCT01449682|Dexamethasone acetate|dexamethasone acetate|mesh-list
25645581|NCT01449682|BB 1101|bb 1101|mesh-list
25817256|NCT00003691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25645582|NCT01449682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25817335|NCT00003700|Antimetabolites|antimetabolites|mesh-ancestor
25500826|NCT00320801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500827|NCT00320801|Analgesics|analgesics|mesh-ancestor
25500828|NCT00320801|Sensory System Agents|sensory system agents|mesh-ancestor
25500829|NCT00320801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25500830|NCT00320801|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25500831|NCT00321464|Zoledronic Acid|zoledronic acid|mesh-list
25500832|NCT00321464|Denosumab|denosumab|mesh-list
25500833|NCT00321464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25500834|NCT00321464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500835|NCT00321594|Belinostat|belinostat|mesh-list
25500836|NCT00321594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500837|NCT00321594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25500838|NCT00321594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500839|NCT00321594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500840|NCT00321620|Zoledronic Acid|zoledronic acid|mesh-list
25500841|NCT00321620|Denosumab|denosumab|mesh-list
25500842|NCT00321620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25500843|NCT00321620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500844|NCT00321646|Bevacizumab|bevacizumab|mesh-list
25500845|NCT00321646|Docetaxel|docetaxel|mesh-list
25500846|NCT00321646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25500847|NCT00321646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500848|NCT00321646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25500849|NCT00321646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25500850|NCT00321646|Growth Substances|growth substances|mesh-ancestor
25500851|NCT00321646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500852|NCT00321646|Growth Inhibitors|growth inhibitors|mesh-ancestor
25500853|NCT00321646|Tubulin Modulators|tubulin modulators|mesh-ancestor
25500854|NCT00321646|Antimitotic Agents|antimitotic agents|mesh-ancestor
25500855|NCT00321646|Mitosis Modulators|mitosis modulators|mesh-ancestor
25500856|NCT00321646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500857|NCT00321672|Capsaicin|capsaicin|mesh-list
25500858|NCT00321672|Antipruritics|antipruritics|mesh-ancestor
25500859|NCT00321672|Dermatologic Agents|dermatologic agents|mesh-ancestor
25500860|NCT00321672|Sensory System Agents|sensory system agents|mesh-ancestor
25500861|NCT00321672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25500862|NCT00321672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500863|NCT00321685|Calcium, Dietary|calcium, dietary|mesh-list
25500864|NCT00321685|Leucovorin|leucovorin|mesh-list
25500865|NCT00321685|Folic Acid|folic acid|mesh-list
25500866|NCT00321685|Bevacizumab|bevacizumab|mesh-list
25500867|NCT00321685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25500868|NCT00321685|Fluorouracil|fluorouracil|mesh-list
25500869|NCT00321685|Capecitabine|capecitabine|mesh-list
25817823|NCT00003759|Valrubicin|valrubicin|mesh-list
25500870|NCT00321685|Oxaliplatin|oxaliplatin|mesh-list
25500871|NCT00321685|Endothelial Growth Factors|endothelial growth factors|mesh-list
25500872|NCT00321685|Antibodies|antibodies|mesh-list
25500873|NCT00321685|Immunoglobulins|immunoglobulins|mesh-list
25500874|NCT00321685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25500875|NCT00321685|Immunoglobulin G|immunoglobulin g|mesh-list
25500876|NCT00321685|Calcium|calcium|mesh-list
25500877|NCT00321685|Levoleucovorin|levoleucovorin|mesh-list
25500878|NCT00321685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24773918|NCT01842932|Cholinergic Antagonists|cholinergic antagonists|mesh-list
25818435|NCT00003849|Rituximab|rituximab|mesh-list
24773919|NCT01842932|Cimetropium|cimetropium|mesh-list
24773920|NCT01842932|Anticonvulsants|anticonvulsants|mesh-ancestor
24773921|NCT01842932|Cholinergic Agents|cholinergic agents|mesh-ancestor
24773922|NCT01842932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24773923|NCT01842932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774257|NCT01844674|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24774258|NCT01844674|Adrenergic Agents|adrenergic agents|mesh-ancestor
25067778|NCT03439709|Lanreotide|lanreotide|mesh-list
25645583|NCT01449682|Antiemetics|antiemetics|mesh-ancestor
25645584|NCT01449682|Autonomic Agents|autonomic agents|mesh-ancestor
25645585|NCT01449682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25645586|NCT01449682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645587|NCT01449682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24774259|NCT01844674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24774391|NCT01845272|Vasodilator Agents|vasodilator agents|mesh-ancestor
24911783|NCT04284150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24783784|NCT01904097|Pregabalin|pregabalin|mesh-list
25500879|NCT00321685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25500880|NCT00321685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25500881|NCT00321685|Growth Substances|growth substances|mesh-ancestor
25500882|NCT00321685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500883|NCT00321685|Growth Inhibitors|growth inhibitors|mesh-ancestor
25500884|NCT00321685|Immunologic Factors|immunologic factors|mesh-ancestor
25500885|NCT00321685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25500886|NCT00321685|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25500887|NCT00321685|Antimetabolites|antimetabolites|mesh-ancestor
25500888|NCT00321685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500889|NCT00321685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25500890|NCT00321685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25500891|NCT00321685|Antidotes|antidotes|mesh-ancestor
25500892|NCT00321685|Protective Agents|protective agents|mesh-ancestor
25500893|NCT00321685|Vitamin B Complex|vitamin b complex|mesh-ancestor
25500894|NCT00321685|Vitamins|vitamins|mesh-ancestor
25500895|NCT00321685|Micronutrients|micronutrients|mesh-ancestor
25500896|NCT00321685|Hematinics|hematinics|mesh-ancestor
25500897|NCT00321711|Azacitidine|azacitidine|mesh-list
25500898|NCT00321711|Decitabine|decitabine|mesh-list
25500899|NCT00321711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25500900|NCT00321711|Antimetabolites|antimetabolites|mesh-ancestor
25500901|NCT00321711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500902|NCT00321711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500903|NCT00321711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500904|NCT00321737|Dexlansoprazole|dexlansoprazole|mesh-list
25500905|NCT00321737|Lansoprazole|lansoprazole|mesh-list
25500906|NCT00321737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25500907|NCT00321737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25500908|NCT00321737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25500909|NCT00321737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500910|NCT00321737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500911|NCT00321828|Leucovorin|leucovorin|mesh-list
25500912|NCT00321828|Bevacizumab|bevacizumab|mesh-list
25500913|NCT00321828|Fluorouracil|fluorouracil|mesh-list
25500914|NCT00321828|Oxaliplatin|oxaliplatin|mesh-list
25500915|NCT00321828|Levoleucovorin|levoleucovorin|mesh-list
25500916|NCT00321828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25500917|NCT00321828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500918|NCT00321828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25500919|NCT00321828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25500920|NCT00321828|Growth Substances|growth substances|mesh-ancestor
25500921|NCT00321828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500922|NCT00321828|Growth Inhibitors|growth inhibitors|mesh-ancestor
25500923|NCT00321828|Antimetabolites|antimetabolites|mesh-ancestor
25500924|NCT00321828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500925|NCT00321828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25500926|NCT00321828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25500927|NCT00321828|Immunologic Factors|immunologic factors|mesh-ancestor
25500928|NCT00321828|Antidotes|antidotes|mesh-ancestor
25500929|NCT00321828|Protective Agents|protective agents|mesh-ancestor
25500930|NCT00321828|Vitamin B Complex|vitamin b complex|mesh-ancestor
25500931|NCT00321828|Vitamins|vitamins|mesh-ancestor
25500932|NCT00321828|Micronutrients|micronutrients|mesh-ancestor
25500933|NCT00321854|Pramipexole|pramipexole|mesh-list
25500934|NCT00321854|Antioxidants|antioxidants|mesh-ancestor
25500935|NCT00321854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500936|NCT00321854|Protective Agents|protective agents|mesh-ancestor
25500937|NCT00321854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500938|NCT00321854|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25500939|NCT00321854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25500940|NCT00321854|Dopamine Agonists|dopamine agonists|mesh-ancestor
25500941|NCT00321854|Dopamine Agents|dopamine agents|mesh-ancestor
25500942|NCT00321854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25500943|NCT00321893|Budesonide|budesonide|mesh-list
25500944|NCT00321893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25500945|NCT00321893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24921656|NCT04188106|Varenicline|varenicline|mesh-list
25645588|NCT01449682|Glucocorticoids|glucocorticoids|mesh-ancestor
25645589|NCT01449682|Hormones|hormones|mesh-ancestor
25645590|NCT01449682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25818878|NCT00003917|Topotecan|topotecan|mesh-list
25645591|NCT01449682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25645592|NCT01449682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645593|NCT01449682|Protease Inhibitors|protease inhibitors|mesh-ancestor
25645594|NCT01449682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500946|NCT00321893|Autonomic Agents|autonomic agents|mesh-ancestor
25500947|NCT00321893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25500948|NCT00321893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500949|NCT00321893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25500950|NCT00321893|Respiratory System Agents|respiratory system agents|mesh-ancestor
25500951|NCT00321893|Glucocorticoids|glucocorticoids|mesh-ancestor
25500952|NCT00321893|Hormones|hormones|mesh-ancestor
25500953|NCT00321893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25500954|NCT00321906|Sirolimus|sirolimus|mesh-list
25500955|NCT00321906|Azathioprine|azathioprine|mesh-list
25500956|NCT00321906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25500957|NCT00321906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25500958|NCT00321906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25500959|NCT00321906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25500960|NCT00321906|Antifungal Agents|antifungal agents|mesh-ancestor
25500961|NCT00321906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25500962|NCT00321906|Immunologic Factors|immunologic factors|mesh-ancestor
25500963|NCT00321906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500964|NCT00321906|Antimetabolites|antimetabolites|mesh-ancestor
25500965|NCT00321906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500966|NCT00321906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25500967|NCT00321906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25500968|NCT00321919|Epoetin Alfa|epoetin alfa|mesh-list
25500969|NCT00321919|Hematinics|hematinics|mesh-ancestor
25500970|NCT00321932|Calcium, Dietary|calcium, dietary|mesh-list
25500971|NCT00321932|Cholecalciferol|cholecalciferol|mesh-list
25500972|NCT00321932|Zoledronic Acid|zoledronic acid|mesh-list
25500973|NCT00321932|Calcium Carbonate|calcium carbonate|mesh-list
25500974|NCT00321932|Calcium|calcium|mesh-list
25500975|NCT00321932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25819528|NCT00003995|Trastuzumab|trastuzumab|mesh-list
25500976|NCT00321932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500977|NCT00321932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25500978|NCT00321932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500979|NCT00321932|Vitamins|vitamins|mesh-ancestor
25500980|NCT00321932|Micronutrients|micronutrients|mesh-ancestor
25500981|NCT00321932|Antacids|antacids|mesh-ancestor
25500982|NCT00321932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25500983|NCT00321984|Dexlansoprazole|dexlansoprazole|mesh-list
25500984|NCT00321984|Lansoprazole|lansoprazole|mesh-list
25500985|NCT00321984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25500986|NCT00321984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25500987|NCT00321984|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25500988|NCT00321984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25500989|NCT00321984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25500990|NCT00322049|Vaccines|vaccines|mesh-list
25500991|NCT00322049|Immunologic Factors|immunologic factors|mesh-ancestor
25500992|NCT00322049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25500993|NCT00322101|Cyclosporine|cyclosporine|mesh-list
25500994|NCT00322101|Mycophenolic Acid|mycophenolic acid|mesh-list
25500995|NCT00322101|Cyclophosphamide|cyclophosphamide|mesh-list
25500996|NCT00322101|Busulfan|busulfan|mesh-list
25500997|NCT00322101|Methotrexate|methotrexate|mesh-list
25500998|NCT00322101|Fludarabine|fludarabine|mesh-list
25500999|NCT00322101|Fludarabine phosphate|fludarabine phosphate|mesh-list
25501000|NCT00322101|Tacrolimus|tacrolimus|mesh-list
25501001|NCT00322101|Cyclosporins|cyclosporins|mesh-list
25501002|NCT00322101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25501003|NCT00322101|Immunologic Factors|immunologic factors|mesh-ancestor
25501004|NCT00322101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501005|NCT00322101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25501006|NCT00322101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25501007|NCT00322101|Alkylating Agents|alkylating agents|mesh-ancestor
25501008|NCT00322101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501009|NCT00322101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501010|NCT00322101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25501011|NCT00322101|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25501012|NCT00322101|Abortifacient Agents|abortifacient agents|mesh-ancestor
25501013|NCT00322101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25501014|NCT00322101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25501015|NCT00322101|Antimetabolites|antimetabolites|mesh-ancestor
25501016|NCT00322101|Dermatologic Agents|dermatologic agents|mesh-ancestor
25501017|NCT00322101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501018|NCT00322101|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25501019|NCT00322101|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25501020|NCT00322101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25501021|NCT00322101|Antifungal Agents|antifungal agents|mesh-ancestor
25501022|NCT00322101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25501023|NCT00322101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25501024|NCT00322101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25501025|NCT00322101|Antitubercular Agents|antitubercular agents|mesh-ancestor
25168390|NCT02206100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25168391|NCT02206100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168393|NCT02206087|Calcium heparin|calcium heparin|mesh-list
25168394|NCT02206087|Anticoagulants|anticoagulants|mesh-ancestor
25168395|NCT02206087|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25168396|NCT02206087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25168397|NCT02206087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168398|NCT02205528|Metformin|metformin|mesh-list
25168399|NCT02205528|Liraglutide|liraglutide|mesh-list
25168400|NCT02205528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25168401|NCT02205528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168402|NCT02205528|Incretins|incretins|mesh-ancestor
25501026|NCT00322101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25501027|NCT00322153|Memantine|memantine|mesh-list
25501028|NCT00322153|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25501029|NCT00322153|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25501030|NCT00322153|Dopamine Agents|dopamine agents|mesh-ancestor
25501031|NCT00322153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25819841|NCT00004043|Calcitriol|calcitriol|mesh-list
25819914|NCT00004056|Antimetabolites|antimetabolites|mesh-ancestor
25501032|NCT00322153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501033|NCT00322153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25819990|NCT00004064|Oregovomab|oregovomab|mesh-list
25501034|NCT00322153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25501035|NCT00322153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25501036|NCT00322309|Mirtazapine|mirtazapine|mesh-list
25820291|NCT00004102|Calcium|calcium|mesh-list
25820529|NCT00004132|Ifosfamide|ifosfamide|mesh-list
25501037|NCT00322309|Antidepressive Agents|antidepressive agents|mesh-ancestor
25501038|NCT00322309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25501039|NCT00322309|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25501040|NCT00322309|Histamine Antagonists|histamine antagonists|mesh-ancestor
25501041|NCT00322309|Histamine Agents|histamine agents|mesh-ancestor
25501042|NCT00322309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25501043|NCT00322309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501044|NCT00322309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501045|NCT00322309|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25501046|NCT00322309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25501047|NCT00322309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25501048|NCT00322309|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25501049|NCT00322309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25501050|NCT00322309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25501051|NCT00322309|Adrenergic Agents|adrenergic agents|mesh-ancestor
25501052|NCT00322309|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25501053|NCT00322309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25501054|NCT00322309|Serotonin Agents|serotonin agents|mesh-ancestor
25501055|NCT00322309|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25501056|NCT00322335|PENTA|penta|mesh-list
25501057|NCT00322335|Anticoagulants|anticoagulants|mesh-ancestor
25501058|NCT00322335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25501059|NCT00322335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25501060|NCT00322335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501061|NCT00322348|Goserelin|goserelin|mesh-list
25501062|NCT00322348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25501063|NCT00322348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501064|NCT00322374|Epirubicin|epirubicin|mesh-list
25501065|NCT00322374|Epothilones|epothilones|mesh-list
25501066|NCT00322374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25501067|NCT00322374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501068|NCT00322374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25501069|NCT00322374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25501070|NCT00322374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501071|NCT00322374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501072|NCT00322374|Tubulin Modulators|tubulin modulators|mesh-ancestor
25501073|NCT00322374|Antimitotic Agents|antimitotic agents|mesh-ancestor
25501074|NCT00322374|Mitosis Modulators|mitosis modulators|mesh-ancestor
25501075|NCT00322387|Plerixafor|plerixafor|mesh-list
25501076|NCT00322387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25501077|NCT00322387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25501078|NCT00322387|Antiviral Agents|antiviral agents|mesh-ancestor
25645595|NCT01449682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645596|NCT01449747|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25645597|NCT01449747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25645598|NCT01449747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645599|NCT01449747|Incretins|incretins|mesh-ancestor
25645600|NCT01449747|Hormones|hormones|mesh-ancestor
25820790|NCT00004176|Cisplatin|cisplatin|mesh-list
25821524|NCT00004255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25645601|NCT01449747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25645602|NCT01449747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25645603|NCT01449747|Protease Inhibitors|protease inhibitors|mesh-ancestor
25645604|NCT01449747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25656825|NCT01579318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501079|NCT00322387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25501080|NCT00322439|Etanercept|etanercept|mesh-list
25501081|NCT00322439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25501082|NCT00322439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25501083|NCT00322439|Analgesics|analgesics|mesh-ancestor
25501084|NCT00322439|Sensory System Agents|sensory system agents|mesh-ancestor
25501085|NCT00322439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25501086|NCT00322439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501087|NCT00322439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25501088|NCT00322439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25501089|NCT00322439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25501090|NCT00322439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25501091|NCT00322439|Immunologic Factors|immunologic factors|mesh-ancestor
25501092|NCT00322452|Paclitaxel|paclitaxel|mesh-list
25501093|NCT00322452|Carboplatin|carboplatin|mesh-list
25501094|NCT00322452|Gefitinib|gefitinib|mesh-list
25501095|NCT00322452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25501096|NCT00322452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501097|NCT00322452|Tubulin Modulators|tubulin modulators|mesh-ancestor
25501098|NCT00322452|Antimitotic Agents|antimitotic agents|mesh-ancestor
25168435|NCT02187302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168436|NCT02187302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25168438|NCT02187302|Growth Substances|growth substances|mesh-ancestor
25501099|NCT00322452|Mitosis Modulators|mitosis modulators|mesh-ancestor
25501100|NCT00322452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25822100|NCT00004403|Hormones|hormones|mesh-ancestor
25501101|NCT00322452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25501102|NCT00322452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501103|NCT00322465|Azithromycin|azithromycin|mesh-list
25501104|NCT00322465|Doxycycline|doxycycline|mesh-list
25501105|NCT00322465|Tinidazole|tinidazole|mesh-list
25501106|NCT00322465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25501107|NCT00322465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25501108|NCT00322465|Antimalarials|antimalarials|mesh-ancestor
25501109|NCT00322465|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25501110|NCT00322465|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25501111|NCT00322465|Alkylating Agents|alkylating agents|mesh-ancestor
25501112|NCT00322465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501113|NCT00322465|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25501114|NCT00322491|Plerixafor|plerixafor|mesh-list
25501115|NCT00322491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25501116|NCT00322491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25501117|NCT00322491|Antiviral Agents|antiviral agents|mesh-ancestor
25501118|NCT00322491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25501119|NCT00322556|Immunoglobulins|immunoglobulins|mesh-list
25501120|NCT00322556|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25501121|NCT00322556|Antibodies|antibodies|mesh-list
25501122|NCT00322556|Immunologic Factors|immunologic factors|mesh-ancestor
25501123|NCT00322556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501124|NCT00322621|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25501125|NCT00322621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25501126|NCT00322621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25501127|NCT00322621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25501128|NCT00322621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501129|NCT00322621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25501130|NCT00322621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501131|NCT00322621|Analgesics|analgesics|mesh-ancestor
25501132|NCT00322621|Sensory System Agents|sensory system agents|mesh-ancestor
25501133|NCT00322621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25501134|NCT00322621|Antidepressive Agents|antidepressive agents|mesh-ancestor
25501135|NCT00322621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25501136|NCT00322621|Dopamine Agents|dopamine agents|mesh-ancestor
25501137|NCT00322842|Plerixafor|plerixafor|mesh-list
25501138|NCT00322842|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24922090|NCT04183738|Darunavir|darunavir|mesh-list
24922091|NCT04183738|Dolutegravir|dolutegravir|mesh-list
25645605|NCT01449747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645606|NCT01449929|Ritonavir|ritonavir|mesh-list
25501139|NCT00322842|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25501140|NCT00322842|Antiviral Agents|antiviral agents|mesh-ancestor
25501141|NCT00322842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25501142|NCT00322868|Pioglitazone|pioglitazone|mesh-list
25501143|NCT00322868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25501144|NCT00322868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501145|NCT00322881|Paclitaxel|paclitaxel|mesh-list
25501146|NCT00322881|Carboplatin|carboplatin|mesh-list
25501147|NCT00322881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25501148|NCT00322881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501149|NCT00322881|Tubulin Modulators|tubulin modulators|mesh-ancestor
25501150|NCT00322881|Antimitotic Agents|antimitotic agents|mesh-ancestor
25501151|NCT00322881|Mitosis Modulators|mitosis modulators|mesh-ancestor
25501152|NCT00322881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501153|NCT00323115|Temozolomide|temozolomide|mesh-list
25501154|NCT00323115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25501155|NCT00323115|Alkylating Agents|alkylating agents|mesh-ancestor
25501156|NCT00323115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501157|NCT00323115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501158|NCT00323297|Bosentan|bosentan|mesh-list
25501159|NCT00323297|Sildenafil Citrate|sildenafil citrate|mesh-list
25501160|NCT00323297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501161|NCT00323297|Vasodilator Agents|vasodilator agents|mesh-ancestor
25501162|NCT00323297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25501163|NCT00323297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25501164|NCT00323297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501165|NCT00323297|Urological Agents|urological agents|mesh-ancestor
25501166|NCT00323297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25168494|NCT02158585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25168498|NCT02153502|Quinidine|quinidine|mesh-list
25168499|NCT02153502|Quinidine gluconate|quinidine gluconate|mesh-list
25039601|NCT03761225|Tubulin Modulators|tubulin modulators|mesh-ancestor
25039602|NCT03761225|Antimitotic Agents|antimitotic agents|mesh-ancestor
25039603|NCT03761225|Mitosis Modulators|mitosis modulators|mesh-ancestor
25039604|NCT03761225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039823|NCT03646994|Crizotinib|crizotinib|mesh-list
25501182|NCT00323479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25501183|NCT00323479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501184|NCT00323479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25501185|NCT00323479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25501186|NCT00323479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501187|NCT00323479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501188|NCT00323479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25501189|NCT00323479|Hormone Antagonists|hormone antagonists|mesh-ancestor
25501190|NCT00323479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25501191|NCT00323479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501192|NCT00323492|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25501193|NCT00323492|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25501194|NCT00323492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25501195|NCT00323492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501196|NCT00323492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501197|NCT00323492|Antiviral Agents|antiviral agents|mesh-ancestor
25501198|NCT00323492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25501199|NCT00323492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25501200|NCT00323492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25501201|NCT00323557|Molgramostim|molgramostim|mesh-list
25501202|NCT00323557|Sargramostim|sargramostim|mesh-list
25501203|NCT00323557|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25501204|NCT00323557|Immunologic Factors|immunologic factors|mesh-ancestor
25501205|NCT00323557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501206|NCT00323557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501207|NCT00323622|Pyrimethamine|pyrimethamine|mesh-list
25501208|NCT00323622|Sulfadoxine|sulfadoxine|mesh-list
25501209|NCT00323622|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25501210|NCT00323622|Amodiaquine|amodiaquine|mesh-list
25501211|NCT00323622|Vaccines|vaccines|mesh-list
25501212|NCT00323622|Immunologic Factors|immunologic factors|mesh-ancestor
25501213|NCT00323622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501214|NCT00323622|Antimalarials|antimalarials|mesh-ancestor
25501215|NCT00323622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25501216|NCT00323622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25645607|NCT01449929|Darunavir|darunavir|mesh-list
25645608|NCT01449929|Dolutegravir|dolutegravir|mesh-list
25501217|NCT00323622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25501218|NCT00323622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25501219|NCT00323622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501220|NCT00323622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501221|NCT00323622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25501223|NCT00323739|Bevacizumab|bevacizumab|mesh-list
25501224|NCT00323739|Everolimus|everolimus|mesh-list
25501225|NCT00323739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25501226|NCT00323739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501227|NCT00323739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25501228|NCT00323739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25501229|NCT00323739|Growth Substances|growth substances|mesh-ancestor
25501230|NCT00323739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501231|NCT00323739|Growth Inhibitors|growth inhibitors|mesh-ancestor
25501232|NCT00323739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25501233|NCT00323739|Immunologic Factors|immunologic factors|mesh-ancestor
25501234|NCT00323869|Gemcitabine|gemcitabine|mesh-list
25501235|NCT00323869|Bevacizumab|bevacizumab|mesh-list
25501236|NCT00323869|Carboplatin|carboplatin|mesh-list
25501237|NCT00323869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25501238|NCT00323869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501239|NCT00323869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25501240|NCT00323869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25501241|NCT00323869|Growth Substances|growth substances|mesh-ancestor
25501242|NCT00323869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501243|NCT00323869|Growth Inhibitors|growth inhibitors|mesh-ancestor
25501244|NCT00323869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25501245|NCT00323869|Antimetabolites|antimetabolites|mesh-ancestor
25168562|NCT02130687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25168563|NCT02130687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25168564|NCT02130687|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25168565|NCT02130687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25168566|NCT02125266|Methotrexate|methotrexate|mesh-list
25168567|NCT02125266|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25168568|NCT02125266|Abortifacient Agents|abortifacient agents|mesh-ancestor
24995449|NCT05166096|Aspirin|aspirin|mesh-list
25501246|NCT00323869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501247|NCT00323869|Antiviral Agents|antiviral agents|mesh-ancestor
25501248|NCT00323869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25501249|NCT00323869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501250|NCT00323869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25501251|NCT00323869|Immunologic Factors|immunologic factors|mesh-ancestor
25501252|NCT00323882|Ipilimumab|ipilimumab|mesh-list
25501253|NCT00323882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25501254|NCT00323882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501255|NCT00323882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25501256|NCT00323882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501257|NCT00324038|Acetaminophen|acetaminophen|mesh-list
25501258|NCT00324038|Buprenorphine|buprenorphine|mesh-list
25501259|NCT00324038|Codeine|codeine|mesh-list
25501260|NCT00324038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25501261|NCT00324038|Analgesics|analgesics|mesh-ancestor
25501262|NCT00324038|Sensory System Agents|sensory system agents|mesh-ancestor
25501263|NCT00324038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25501264|NCT00324038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501265|NCT00324038|Antipyretics|antipyretics|mesh-ancestor
25501266|NCT00324038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25501267|NCT00324038|Narcotics|narcotics|mesh-ancestor
25501268|NCT00324038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25501269|NCT00324038|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25501270|NCT00324038|Antitussive Agents|antitussive agents|mesh-ancestor
25501271|NCT00324038|Respiratory System Agents|respiratory system agents|mesh-ancestor
25501272|NCT00324155|Ipilimumab|ipilimumab|mesh-list
25501273|NCT00324155|Dacarbazine|dacarbazine|mesh-list
25501274|NCT00324155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25501275|NCT00324155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501276|NCT00324155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25501277|NCT00324155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501278|NCT00324155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25501279|NCT00324155|Alkylating Agents|alkylating agents|mesh-ancestor
25501280|NCT00324168|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25501281|NCT00324168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25501282|NCT00324259|Estradiol|estradiol|mesh-list
25501283|NCT00324259|Estrogens|estrogens|mesh-ancestor
25501284|NCT00324259|Hormones|hormones|mesh-ancestor
25501285|NCT00324259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25501286|NCT00324259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501287|NCT00324272|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25501288|NCT00324272|Hemostatics|hemostatics|mesh-ancestor
25501289|NCT00324272|Coagulants|coagulants|mesh-ancestor
25501290|NCT00324350|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25501291|NCT00324350|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
25501292|NCT00324350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501293|NCT00324350|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25501294|NCT00324350|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25501295|NCT00324350|Antimetabolites|antimetabolites|mesh-ancestor
25501296|NCT00324350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501297|NCT00324350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501298|NCT00324350|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25501299|NCT00324415|Cisplatin|cisplatin|mesh-list
25501300|NCT00324415|Fluorouracil|fluorouracil|mesh-list
25501301|NCT00324415|Cetuximab|cetuximab|mesh-list
25501302|NCT00324415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501303|NCT00324415|Antimetabolites|antimetabolites|mesh-ancestor
25501304|NCT00324415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501305|NCT00324415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25501306|NCT00324415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25501307|NCT00324415|Immunologic Factors|immunologic factors|mesh-ancestor
25501308|NCT00324415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501309|NCT00324415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25501310|NCT00324649|Lamivudine|lamivudine|mesh-list
25501311|NCT00324649|Zidovudine|zidovudine|mesh-list
25501312|NCT00324649|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25168593|NCT02114060|Vaccines|vaccines|mesh-list
25168594|NCT02114060|Immunologic Factors|immunologic factors|mesh-ancestor
25168595|NCT02114060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278225|NCT02352545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278226|NCT02352545|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25278227|NCT02352545|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25278228|NCT02352545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704655|NCT01479556|Pregabalin|pregabalin|mesh-list
25501313|NCT00324649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25501314|NCT00324649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25501315|NCT00324649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501316|NCT00324649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501318|NCT00324649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25501319|NCT00324649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25501320|NCT00324649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25501321|NCT00324649|Antimetabolites|antimetabolites|mesh-ancestor
25501322|NCT00324675|Rosiglitazone|rosiglitazone|mesh-list
25501323|NCT00324675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25501324|NCT00324675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501325|NCT00324740|Vorinostat|vorinostat|mesh-list
25501326|NCT00324740|Isotretinoin|isotretinoin|mesh-list
25501327|NCT00324740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501328|NCT00324740|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25501329|NCT00324740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501330|NCT00324740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501331|NCT00324740|Dermatologic Agents|dermatologic agents|mesh-ancestor
25501332|NCT00324870|Bevacizumab|bevacizumab|mesh-list
25501333|NCT00324870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25501334|NCT00324870|Vorinostat|vorinostat|mesh-list
25501335|NCT00324870|Antibodies|antibodies|mesh-list
25501336|NCT00324870|Immunoglobulins|immunoglobulins|mesh-list
25501337|NCT00324870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25501338|NCT00324870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501339|NCT00324870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25501340|NCT00324870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25501341|NCT00324870|Growth Substances|growth substances|mesh-ancestor
25501342|NCT00324870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501343|NCT00324870|Growth Inhibitors|growth inhibitors|mesh-ancestor
25501344|NCT00324870|Immunologic Factors|immunologic factors|mesh-ancestor
25501345|NCT00324870|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25501346|NCT00324870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501347|NCT00324870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501348|NCT00324896|Eszopiclone|eszopiclone|mesh-list
25501349|NCT00324896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25501350|NCT00324896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25645609|NCT01449929|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25645610|NCT01449929|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25645611|NCT01449929|Protease Inhibitors|protease inhibitors|mesh-ancestor
25645612|NCT01449929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645613|NCT01449929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645614|NCT01449929|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25645615|NCT01449929|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25645616|NCT01449929|Antiviral Agents|antiviral agents|mesh-ancestor
25645617|NCT01449929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25645618|NCT01449929|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25645619|NCT01449929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24860472|NCT02310087|Vitamin E|vitamin e|mesh-list
25645620|NCT01449929|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25645621|NCT01449929|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25645622|NCT01449955|Sirolimus|sirolimus|mesh-list
25645623|NCT01449955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25501351|NCT00324896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501352|NCT00324961|Adefovir|adefovir|mesh-list
25501353|NCT00324961|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25645624|NCT01449955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25645625|NCT01449955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25645626|NCT01449955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645627|NCT01449955|Antifungal Agents|antifungal agents|mesh-ancestor
25501354|NCT00324961|Antiviral Agents|antiviral agents|mesh-ancestor
25501355|NCT00324961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25501356|NCT00324961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25501357|NCT00324961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25501358|NCT00324961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501359|NCT00324961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501360|NCT00324987|Bevacizumab|bevacizumab|mesh-list
25501361|NCT00324987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25501362|NCT00324987|Imatinib Mesylate|imatinib mesylate|mesh-list
25501363|NCT00324987|Endothelial Growth Factors|endothelial growth factors|mesh-list
25501364|NCT00324987|Antibodies|antibodies|mesh-list
25501365|NCT00324987|Immunoglobulins|immunoglobulins|mesh-list
25501366|NCT00324987|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25501367|NCT00324987|Immunoglobulin G|immunoglobulin g|mesh-list
25501368|NCT00324987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501369|NCT00324987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25501370|NCT00324987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25501371|NCT00324987|Growth Substances|growth substances|mesh-ancestor
25501372|NCT00324987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168621|NCT02104245|Ciprofloxacin|ciprofloxacin|mesh-list
25159418|NCT03828006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24529769|NCT00627731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24529770|NCT00627744|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24529771|NCT00627744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24529772|NCT00627744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529773|NCT00627744|Incretins|incretins|mesh-ancestor
24529775|NCT00627744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24529776|NCT00627744|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24529777|NCT00627744|Protease Inhibitors|protease inhibitors|mesh-ancestor
24529778|NCT00627744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529779|NCT00627744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996217|NCT04066023|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24996218|NCT04066023|Serotonin Agents|serotonin agents|mesh-ancestor
25501373|NCT00324987|Growth Inhibitors|growth inhibitors|mesh-ancestor
25501374|NCT00324987|Immunologic Factors|immunologic factors|mesh-ancestor
25501375|NCT00324987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25501376|NCT00324987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501377|NCT00324987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501378|NCT00325078|Infliximab|infliximab|mesh-list
25501379|NCT00325078|Dermatologic Agents|dermatologic agents|mesh-ancestor
25501380|NCT00325078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25501381|NCT00325078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25501382|NCT00325143|Edetic Acid|edetic acid|mesh-list
25501383|NCT00325143|Pentetic Acid|pentetic acid|mesh-list
25501384|NCT00325143|Antidotes|antidotes|mesh-ancestor
25501385|NCT00325143|Protective Agents|protective agents|mesh-ancestor
25501386|NCT00325143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501387|NCT00325143|Chelating Agents|chelating agents|mesh-ancestor
25501388|NCT00325143|Sequestering Agents|sequestering agents|mesh-ancestor
25501389|NCT00325143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501390|NCT00325143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25501391|NCT00325143|Anticoagulants|anticoagulants|mesh-ancestor
25501392|NCT00325143|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25501393|NCT00325234|Gemcitabine|gemcitabine|mesh-list
25501394|NCT00325234|Carboplatin|carboplatin|mesh-list
25501395|NCT00325234|Pemetrexed|pemetrexed|mesh-list
25501396|NCT00325234|Vinorelbine|vinorelbine|mesh-list
25501397|NCT00325234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501398|NCT00325234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25501399|NCT00325234|Antimetabolites|antimetabolites|mesh-ancestor
25501400|NCT00325234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501401|NCT00325234|Antiviral Agents|antiviral agents|mesh-ancestor
25501402|NCT00325234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25501403|NCT00325234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501404|NCT00325234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25501405|NCT00325234|Immunologic Factors|immunologic factors|mesh-ancestor
25501406|NCT00325234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501407|NCT00325234|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25501408|NCT00325234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25501409|NCT00325234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25501410|NCT00325234|Tubulin Modulators|tubulin modulators|mesh-ancestor
25501411|NCT00325234|Antimitotic Agents|antimitotic agents|mesh-ancestor
25501412|NCT00325234|Mitosis Modulators|mitosis modulators|mesh-ancestor
25501413|NCT00325403|Treprostinil|treprostinil|mesh-list
25501414|NCT00325403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25501415|NCT00325416|Melphalan|melphalan|mesh-list
25501416|NCT00325416|Topotecan|topotecan|mesh-list
25501417|NCT00325416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25501418|NCT00325416|Alkylating Agents|alkylating agents|mesh-ancestor
25501419|NCT00325416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501420|NCT00325416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501421|NCT00325416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25501422|NCT00325416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25501423|NCT00325416|Immunologic Factors|immunologic factors|mesh-ancestor
25501424|NCT00325416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501425|NCT00325416|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25501426|NCT00325416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25501427|NCT00325416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501428|NCT00325442|Treprostinil|treprostinil|mesh-list
25501429|NCT00325442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25501430|NCT00325468|Denosumab|denosumab|mesh-list
25501431|NCT00325468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25501432|NCT00325468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501433|NCT00325780|Pitavastatin|pitavastatin|mesh-list
25501434|NCT00325780|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25501435|NCT00325780|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25501436|NCT00325780|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25501437|NCT00325780|Antimetabolites|antimetabolites|mesh-ancestor
25501438|NCT00325780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501439|NCT00325780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501440|NCT00325780|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25501441|NCT00325819|Acetaminophen|acetaminophen|mesh-list
25501442|NCT00325819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25501443|NCT00325819|Analgesics|analgesics|mesh-ancestor
25501444|NCT00325819|Sensory System Agents|sensory system agents|mesh-ancestor
25203579|NCT02713477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203580|NCT02713139|Metronidazole|metronidazole|mesh-list
25203582|NCT02713139|Miconazole|miconazole|mesh-list
25501445|NCT00325819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25501446|NCT00325819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501447|NCT00325819|Antipyretics|antipyretics|mesh-ancestor
25501448|NCT00325897|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25501449|NCT00325897|Azithromycin|azithromycin|mesh-list
25501450|NCT00325897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25501451|NCT00326170|Azacitidine|azacitidine|mesh-list
25501452|NCT00326170|Tretinoin|tretinoin|mesh-list
25501453|NCT00326170|Valproic Acid|valproic acid|mesh-list
25501454|NCT00326170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25501455|NCT00326170|Antimetabolites|antimetabolites|mesh-ancestor
25501456|NCT00326170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501457|NCT00326170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501458|NCT00326170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501459|NCT00326170|Keratolytic Agents|keratolytic agents|mesh-ancestor
25501460|NCT00326170|Dermatologic Agents|dermatologic agents|mesh-ancestor
25501461|NCT00326170|Anticonvulsants|anticonvulsants|mesh-ancestor
25501462|NCT00326170|GABA Agents|gaba agents|mesh-ancestor
25501463|NCT00326170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25501464|NCT00326170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501465|NCT00326170|Antimanic Agents|antimanic agents|mesh-ancestor
25501466|NCT00326170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25501467|NCT00326170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25645628|NCT01449955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25645629|NCT01449955|Immunologic Factors|immunologic factors|mesh-ancestor
25645630|NCT01449955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645631|NCT01450007|Dexamethasone|dexamethasone|mesh-list
25645632|NCT01450007|Dexamethasone acetate|dexamethasone acetate|mesh-list
25645633|NCT01450007|Ropivacaine|ropivacaine|mesh-list
25645634|NCT01450007|BB 1101|bb 1101|mesh-list
25501468|NCT00326170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25501469|NCT00326209|Mesalamine|mesalamine|mesh-list
25501470|NCT00326209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25501471|NCT00326209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25501472|NCT00326209|Analgesics|analgesics|mesh-ancestor
25501473|NCT00326209|Sensory System Agents|sensory system agents|mesh-ancestor
25501474|NCT00326209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25501475|NCT00326209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501476|NCT00326209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25501477|NCT00326209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25501478|NCT00326417|Cyclophosphamide|cyclophosphamide|mesh-list
25501479|NCT00326417|Fludarabine|fludarabine|mesh-list
25645635|NCT01450007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25645636|NCT01450007|Antiemetics|antiemetics|mesh-ancestor
25645637|NCT01450007|Autonomic Agents|autonomic agents|mesh-ancestor
25645638|NCT01450007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25645639|NCT01450007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645640|NCT01450007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25645641|NCT01450007|Glucocorticoids|glucocorticoids|mesh-ancestor
25501480|NCT00326417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25501481|NCT00326417|Immunologic Factors|immunologic factors|mesh-ancestor
25501482|NCT00326417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501483|NCT00326417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25501484|NCT00326417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25501485|NCT00326417|Alkylating Agents|alkylating agents|mesh-ancestor
25501486|NCT00326417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501487|NCT00326417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501488|NCT00326417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25501489|NCT00326495|Cetuximab|cetuximab|mesh-list
25501490|NCT00326495|Sorafenib|sorafenib|mesh-list
25501491|NCT00326495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25501492|NCT00326495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501493|NCT00326495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25501494|NCT00326495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501495|NCT00326495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501496|NCT00326599|Gemcitabine|gemcitabine|mesh-list
25501497|NCT00326599|Carboplatin|carboplatin|mesh-list
25501498|NCT00326599|Cediranib|cediranib|mesh-list
25501499|NCT00326599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501500|NCT00326599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25501501|NCT00326599|Antimetabolites|antimetabolites|mesh-ancestor
25501502|NCT00326599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501503|NCT00326599|Antiviral Agents|antiviral agents|mesh-ancestor
25501504|NCT00326599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25501505|NCT00326599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501506|NCT00326599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25501507|NCT00326599|Immunologic Factors|immunologic factors|mesh-ancestor
25501508|NCT00326599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501509|NCT00326599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25501510|NCT00326612|Midazolam|midazolam|mesh-list
25501511|NCT00326612|Diazepam|diazepam|mesh-list
25501512|NCT00326612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25501513|NCT00326612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25501514|NCT00326612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25168655|NCT02092935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25168656|NCT02092922|Filanesib|filanesib|mesh-list
25168657|NCT02092922|Lenograstim|lenograstim|mesh-list
25168658|NCT02092922|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25168659|NCT02092922|Immunologic Factors|immunologic factors|mesh-ancestor
25168660|NCT02092922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168661|NCT02092922|Antimitotic Agents|antimitotic agents|mesh-ancestor
25168662|NCT02092922|Mitosis Modulators|mitosis modulators|mesh-ancestor
25501515|NCT00326612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501516|NCT00326612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25501517|NCT00326612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25501518|NCT00326612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25501519|NCT00326612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25501520|NCT00326612|Anesthetics, General|anesthetics, general|mesh-ancestor
25645642|NCT01450007|Hormones|hormones|mesh-ancestor
25501522|NCT00326612|GABA Modulators|gaba modulators|mesh-ancestor
25501523|NCT00326612|GABA Agents|gaba agents|mesh-ancestor
25501524|NCT00326612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25501525|NCT00326612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501526|NCT00326612|Anticonvulsants|anticonvulsants|mesh-ancestor
25501527|NCT00326612|Antiemetics|antiemetics|mesh-ancestor
25501528|NCT00326612|Autonomic Agents|autonomic agents|mesh-ancestor
25501529|NCT00326612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25501530|NCT00326612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25501531|NCT00326612|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25501532|NCT00326612|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25501533|NCT00326716|Ritonavir|ritonavir|mesh-list
25501534|NCT00326716|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25501535|NCT00326716|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25501536|NCT00326716|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25501537|NCT00326716|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25501538|NCT00326716|Protease Inhibitors|protease inhibitors|mesh-ancestor
25501539|NCT00326716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501540|NCT00326716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501541|NCT00326716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25501542|NCT00326716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25501543|NCT00326716|Antiviral Agents|antiviral agents|mesh-ancestor
25501544|NCT00326716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25501545|NCT00326716|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25501546|NCT00326716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25501547|NCT00326716|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25501548|NCT00326716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25501549|NCT00326781|Nicotine|nicotine|mesh-list
25501550|NCT00326781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25501551|NCT00326781|Autonomic Agents|autonomic agents|mesh-ancestor
25501552|NCT00326781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25501553|NCT00326781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501554|NCT00326781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25501555|NCT00326781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25501556|NCT00326781|Cholinergic Agents|cholinergic agents|mesh-ancestor
25501557|NCT00326781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25501558|NCT00326781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501559|NCT00326872|Cediranib|cediranib|mesh-list
25501560|NCT00326872|Maleic acid|maleic acid|mesh-list
25501561|NCT00326872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501562|NCT00326872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501563|NCT00326872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501564|NCT00326872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25501565|NCT00326885|Catumaxomab|catumaxomab|mesh-list
25501566|NCT00326885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25501567|NCT00326911|Gemcitabine|gemcitabine|mesh-list
25501568|NCT00326911|Bevacizumab|bevacizumab|mesh-list
25501569|NCT00326911|Cetuximab|cetuximab|mesh-list
25501570|NCT00326911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25501571|NCT00326911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501572|NCT00326911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25501573|NCT00326911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25501574|NCT00326911|Growth Substances|growth substances|mesh-ancestor
25501575|NCT00326911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501576|NCT00326911|Growth Inhibitors|growth inhibitors|mesh-ancestor
25501577|NCT00326911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25501578|NCT00326911|Antimetabolites|antimetabolites|mesh-ancestor
25501579|NCT00326911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501580|NCT00326911|Antiviral Agents|antiviral agents|mesh-ancestor
25501581|NCT00326911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25501582|NCT00326911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501583|NCT00326911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25501584|NCT00326911|Immunologic Factors|immunologic factors|mesh-ancestor
25501585|NCT00326963|Enfuvirtide|enfuvirtide|mesh-list
25501586|NCT00326963|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25501587|NCT00326963|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25501588|NCT00326963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501589|NCT00326963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25168711|NCT02077881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501590|NCT00326963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25501591|NCT00326963|Antiviral Agents|antiviral agents|mesh-ancestor
25501592|NCT00326963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25501593|NCT00327015|Metformin|metformin|mesh-list
25501594|NCT00327015|Pioglitazone|pioglitazone|mesh-list
25501595|NCT00327015|Saxagliptin|saxagliptin|mesh-list
25501596|NCT00327015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25501597|NCT00327015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501598|NCT00327015|Incretins|incretins|mesh-ancestor
25501600|NCT00327015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25501601|NCT00327015|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25501602|NCT00327015|Protease Inhibitors|protease inhibitors|mesh-ancestor
25501603|NCT00327015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501604|NCT00327015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501605|NCT00327171|Aflibercept|aflibercept|mesh-list
25501606|NCT00327171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25501607|NCT00327171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25501608|NCT00327171|Growth Substances|growth substances|mesh-ancestor
25501609|NCT00327171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501610|NCT00327171|Growth Inhibitors|growth inhibitors|mesh-ancestor
25501611|NCT00327171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501612|NCT00327340|Docetaxel|docetaxel|mesh-list
25501613|NCT00327340|Mitoxantrone|mitoxantrone|mesh-list
25501614|NCT00327340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501615|NCT00327340|Tubulin Modulators|tubulin modulators|mesh-ancestor
25501616|NCT00327340|Antimitotic Agents|antimitotic agents|mesh-ancestor
25501617|NCT00327340|Mitosis Modulators|mitosis modulators|mesh-ancestor
25501618|NCT00327340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501619|NCT00327340|Analgesics|analgesics|mesh-ancestor
25501620|NCT00327340|Sensory System Agents|sensory system agents|mesh-ancestor
25501621|NCT00327340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25501622|NCT00327340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501623|NCT00327340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25501624|NCT00327340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25501625|NCT00327340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501626|NCT00327392|Fospropofol|fospropofol|mesh-list
25501627|NCT00327392|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25501628|NCT00327392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25501629|NCT00327392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501630|NCT00327444|Aflibercept|aflibercept|mesh-list
25501631|NCT00327444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25501632|NCT00327444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25501633|NCT00327444|Growth Substances|growth substances|mesh-ancestor
25501634|NCT00327444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501635|NCT00327444|Growth Inhibitors|growth inhibitors|mesh-ancestor
25501636|NCT00327444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501637|NCT00327717|Zonisamide|zonisamide|mesh-list
25501638|NCT00327717|Anticonvulsants|anticonvulsants|mesh-ancestor
25501639|NCT00327717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25501640|NCT00327717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25501641|NCT00327717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501642|NCT00327717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25501643|NCT00327717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501644|NCT00328094|Insulin|insulin|mesh-list
25501645|NCT00328094|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25501646|NCT00328094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25501647|NCT00328094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501648|NCT00328172|Metformin|metformin|mesh-list
25501649|NCT00328172|Linagliptin|linagliptin|mesh-list
25501650|NCT00328172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25501651|NCT00328172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501652|NCT00328172|Incretins|incretins|mesh-ancestor
25501653|NCT00328172|Hormones|hormones|mesh-ancestor
25501654|NCT00328172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25501655|NCT00328172|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25501656|NCT00328172|Protease Inhibitors|protease inhibitors|mesh-ancestor
25501657|NCT00328172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501658|NCT00328172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501659|NCT00328198|Alemtuzumab|alemtuzumab|mesh-list
25501660|NCT00328198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25501661|NCT00328198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501662|NCT00328562|Gefitinib|gefitinib|mesh-list
25501663|NCT00328562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501664|NCT00328562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25121246|NCT03103867|Insulin|insulin|mesh-list
25501665|NCT00328562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501666|NCT00328562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501667|NCT00328614|Ascorbic Acid|ascorbic acid|mesh-list
25501668|NCT00328614|Goserelin|goserelin|mesh-list
25501669|NCT00328614|Methyltestosterone|methyltestosterone|mesh-list
25501670|NCT00328614|Bicalutamide|bicalutamide|mesh-list
25501671|NCT00328614|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
25501672|NCT00328614|Androgens|androgens|mesh-list
25645643|NCT01450007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25501673|NCT00328614|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25501675|NCT00328614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25501676|NCT00328614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501677|NCT00328614|Androgen Antagonists|androgen antagonists|mesh-ancestor
25501678|NCT00328614|Hormone Antagonists|hormone antagonists|mesh-ancestor
25501679|NCT00328614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25501680|NCT00328614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501681|NCT00328614|Hormones|hormones|mesh-ancestor
25501682|NCT00328614|Antioxidants|antioxidants|mesh-ancestor
25501683|NCT00328614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501684|NCT00328614|Protective Agents|protective agents|mesh-ancestor
25501685|NCT00328614|Vitamins|vitamins|mesh-ancestor
25501686|NCT00328614|Micronutrients|micronutrients|mesh-ancestor
25501687|NCT00328614|Estrogens|estrogens|mesh-ancestor
25501688|NCT00328614|Anabolic Agents|anabolic agents|mesh-ancestor
25501689|NCT00328614|Plant Growth Regulators|plant growth regulators|mesh-ancestor
25501690|NCT00328614|Growth Substances|growth substances|mesh-ancestor
25501691|NCT00328614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25501692|NCT00328614|Analgesics|analgesics|mesh-ancestor
25501693|NCT00328614|Sensory System Agents|sensory system agents|mesh-ancestor
25501694|NCT00328614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25501695|NCT00328627|Pioglitazone|pioglitazone|mesh-list
25501696|NCT00328627|Alogliptin|alogliptin|mesh-list
25501697|NCT00328627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25501698|NCT00328627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501699|NCT00328627|Incretins|incretins|mesh-ancestor
25501700|NCT00328627|Hormones|hormones|mesh-ancestor
25501701|NCT00328627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25501702|NCT00328627|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25501703|NCT00328627|Protease Inhibitors|protease inhibitors|mesh-ancestor
25501704|NCT00328627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501705|NCT00328627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501706|NCT00328770|Sirolimus|sirolimus|mesh-list
25501707|NCT00328770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25501708|NCT00328770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25501709|NCT00328770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25501710|NCT00328770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501711|NCT00328770|Antifungal Agents|antifungal agents|mesh-ancestor
25501712|NCT00328770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25501713|NCT00328770|Immunologic Factors|immunologic factors|mesh-ancestor
25501714|NCT00328770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501715|NCT00328861|Aldesleukin|aldesleukin|mesh-list
25501716|NCT00328861|Cyclophosphamide|cyclophosphamide|mesh-list
25501717|NCT00328861|Fludarabine|fludarabine|mesh-list
25501718|NCT00328861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25501719|NCT00328861|Immunologic Factors|immunologic factors|mesh-ancestor
25501720|NCT00328861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501721|NCT00328861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25501722|NCT00328861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25501723|NCT00328861|Alkylating Agents|alkylating agents|mesh-ancestor
25501724|NCT00328861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501725|NCT00328861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501726|NCT00328861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25501727|NCT00328861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25501728|NCT00328861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25501729|NCT00328861|Antiviral Agents|antiviral agents|mesh-ancestor
25501730|NCT00328861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25501731|NCT00328926|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25501732|NCT00328926|Hormones|hormones|mesh-list
25501733|NCT00328926|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25501734|NCT00328926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25501735|NCT00328926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501736|NCT00328926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25501737|NCT00329030|Rituximab|rituximab|mesh-list
25501738|NCT00329030|Tositumomab I-131|tositumomab i-131|mesh-list
25501739|NCT00329030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25501740|NCT00329030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168821|NCT02058420|Vitamins|vitamins|mesh-ancestor
25501741|NCT00329030|Immunologic Factors|immunologic factors|mesh-ancestor
25501742|NCT00329030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501743|NCT00329030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25501744|NCT00329160|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25501745|NCT00329160|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25501746|NCT00329160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25501747|NCT00329160|Antimetabolites|antimetabolites|mesh-ancestor
25501748|NCT00329160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501749|NCT00329160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25501750|NCT00329160|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25501751|NCT00329160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501752|NCT00329238|Warfarin|warfarin|mesh-list
25501753|NCT00329238|Dabigatran|dabigatran|mesh-list
25501754|NCT00329238|Anticoagulants|anticoagulants|mesh-ancestor
25501755|NCT00329238|Antithrombins|antithrombins|mesh-ancestor
25501756|NCT00329238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25501757|NCT00329238|Protease Inhibitors|protease inhibitors|mesh-ancestor
25501758|NCT00329238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501759|NCT00329238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501760|NCT00329303|Certolizumab Pegol|certolizumab pegol|mesh-list
25501761|NCT00329303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25501762|NCT00329303|Immunologic Factors|immunologic factors|mesh-ancestor
25501763|NCT00329303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501764|NCT00329303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25501765|NCT00329407|Topiramate|topiramate|mesh-list
25501766|NCT00329407|Anticonvulsants|anticonvulsants|mesh-ancestor
25501767|NCT00329407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25501768|NCT00329407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501769|NCT00329420|Certolizumab Pegol|certolizumab pegol|mesh-list
25501770|NCT00329420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25501771|NCT00329420|Immunologic Factors|immunologic factors|mesh-ancestor
25501772|NCT00329420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501773|NCT00329420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25501774|NCT00329433|Heparin|heparin|mesh-list
25501775|NCT00329433|Desirudin|desirudin|mesh-list
25501776|NCT00329433|Anticoagulants|anticoagulants|mesh-ancestor
25501777|NCT00329433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25501778|NCT00329433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25501779|NCT00329433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501780|NCT00329550|Certolizumab Pegol|certolizumab pegol|mesh-list
25501781|NCT00329550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25501782|NCT00329550|Immunologic Factors|immunologic factors|mesh-ancestor
25501783|NCT00329550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501784|NCT00329550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25501785|NCT00329602|Ropinirole|ropinirole|mesh-list
25501786|NCT00329602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25501787|NCT00329602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25501788|NCT00329602|Dopamine Agonists|dopamine agonists|mesh-ancestor
25501789|NCT00329602|Dopamine Agents|dopamine agents|mesh-ancestor
25501790|NCT00329602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25501791|NCT00329602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501792|NCT00329602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501793|NCT00329641|Paclitaxel|paclitaxel|mesh-list
25501794|NCT00329641|Carboplatin|carboplatin|mesh-list
25501795|NCT00329641|Sorafenib|sorafenib|mesh-list
25501796|NCT00329641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25501797|NCT00329641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501798|NCT00329641|Tubulin Modulators|tubulin modulators|mesh-ancestor
25501799|NCT00329641|Antimitotic Agents|antimitotic agents|mesh-ancestor
25501800|NCT00329641|Mitosis Modulators|mitosis modulators|mesh-ancestor
25501801|NCT00329641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501802|NCT00329641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25501803|NCT00329641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501804|NCT00329719|Sirolimus|sirolimus|mesh-list
25501805|NCT00329719|Sorafenib|sorafenib|mesh-list
25501806|NCT00329719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501807|NCT00329719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25501808|NCT00329719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501809|NCT00329719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501810|NCT00329719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25501811|NCT00329719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25501812|NCT00329719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25501813|NCT00329719|Antifungal Agents|antifungal agents|mesh-ancestor
25501814|NCT00329719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25501815|NCT00329719|Immunologic Factors|immunologic factors|mesh-ancestor
25501816|NCT00329719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774839|NCT01848132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25501825|NCT00329849|Vaccines|vaccines|mesh-list
25501826|NCT00329849|Immunologic Factors|immunologic factors|mesh-ancestor
25501827|NCT00329849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501828|NCT00329901|Vaccines|vaccines|mesh-list
25501829|NCT00329901|Immunologic Factors|immunologic factors|mesh-ancestor
25645644|NCT01450007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25645645|NCT01450007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501830|NCT00329901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501831|NCT00330161|Vorinostat|vorinostat|mesh-list
25501832|NCT00330161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501833|NCT00330161|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25501834|NCT00330161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501835|NCT00330161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501836|NCT00330174|Acamprosate|acamprosate|mesh-list
25501837|NCT00330174|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25501838|NCT00330187|Bupropion|bupropion|mesh-list
25501839|NCT00330187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25501840|NCT00330187|Antidepressive Agents|antidepressive agents|mesh-ancestor
25501841|NCT00330187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25501842|NCT00330187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25501843|NCT00330187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25501844|NCT00330187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25501845|NCT00330187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501846|NCT00330187|Dopamine Agents|dopamine agents|mesh-ancestor
25501847|NCT00330187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25501848|NCT00330187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501849|NCT00330187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25501850|NCT00330187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25501851|NCT00330187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501852|NCT00330343|Naloxone|naloxone|mesh-list
25501853|NCT00330343|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25501854|NCT00330343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501855|NCT00330343|Sensory System Agents|sensory system agents|mesh-ancestor
25501856|NCT00330343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25501857|NCT00330421|Sorafenib|sorafenib|mesh-list
25501858|NCT00330421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501859|NCT00330421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25501860|NCT00330421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501861|NCT00330421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501862|NCT00330460|Denosumab|denosumab|mesh-list
25501863|NCT00330460|Alendronate|alendronate|mesh-list
25501864|NCT00330460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25501865|NCT00330460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501866|NCT00330551|Risperidone|risperidone|mesh-list
25501867|NCT00330551|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25501868|NCT00330551|Serotonin Agents|serotonin agents|mesh-ancestor
25501869|NCT00330551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25501870|NCT00330551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501871|NCT00330551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501872|NCT00330551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25501873|NCT00330551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25501874|NCT00330551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25501875|NCT00330551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25501876|NCT00330551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25501877|NCT00330551|Dopamine Agents|dopamine agents|mesh-ancestor
25501878|NCT00330564|Sunitinib|sunitinib|mesh-list
25501879|NCT00330564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501880|NCT00330564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25501881|NCT00330564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25501882|NCT00330564|Growth Substances|growth substances|mesh-ancestor
25501883|NCT00330564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501884|NCT00330564|Growth Inhibitors|growth inhibitors|mesh-ancestor
25501885|NCT00330564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25501886|NCT00330564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501887|NCT00330564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501888|NCT00330668|Mecasermin|mecasermin|mesh-list
25501889|NCT00330668|Growth Substances|growth substances|mesh-ancestor
25501890|NCT00330668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501891|NCT00330681|Edaravone|edaravone|mesh-list
25501892|NCT00330681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25501893|NCT00330681|Antioxidants|antioxidants|mesh-ancestor
25501894|NCT00330681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501895|NCT00330681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25501896|NCT00330681|Protective Agents|protective agents|mesh-ancestor
25501897|NCT00330681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501898|NCT00330733|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
25168888|NCT02050828|Growth Inhibitors|growth inhibitors|mesh-ancestor
25501899|NCT00330733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25645646|NCT01450007|Protease Inhibitors|protease inhibitors|mesh-ancestor
25501900|NCT00330733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25501902|NCT00330733|Sensory System Agents|sensory system agents|mesh-ancestor
25501903|NCT00330733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25501904|NCT00330733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501905|NCT00330733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25501906|NCT00330733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25501907|NCT00330759|Zoledronic Acid|zoledronic acid|mesh-list
25501908|NCT00330759|Denosumab|denosumab|mesh-list
25501909|NCT00330759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25501910|NCT00330759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501911|NCT00330863|Olanzapine|olanzapine|mesh-list
25501912|NCT00330863|Risperidone|risperidone|mesh-list
25501913|NCT00330863|Aripiprazole|aripiprazole|mesh-list
25501914|NCT00330863|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25501915|NCT00330863|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25501916|NCT00330863|Ziprasidone|ziprasidone|mesh-list
25501917|NCT00330863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25501918|NCT00330863|Serotonin Agents|serotonin agents|mesh-ancestor
25501919|NCT00330863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25501920|NCT00330863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501921|NCT00330863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501922|NCT00330863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25501923|NCT00330863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25501924|NCT00330863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25501925|NCT00330863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25501926|NCT00330863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25501927|NCT00330863|Dopamine Agents|dopamine agents|mesh-ancestor
25501928|NCT00330863|Antiemetics|antiemetics|mesh-ancestor
25501929|NCT00330863|Autonomic Agents|autonomic agents|mesh-ancestor
25501930|NCT00330863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25501931|NCT00330863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25501932|NCT00330863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25501933|NCT00330863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25501934|NCT00330863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25501935|NCT00330863|Antidepressive Agents|antidepressive agents|mesh-ancestor
25501936|NCT00330863|Dopamine Agonists|dopamine agonists|mesh-ancestor
25501937|NCT00330863|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25501938|NCT00330863|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25501939|NCT00330863|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25501940|NCT00330863|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25501941|NCT00330876|Pitavastatin|pitavastatin|mesh-list
25501942|NCT00330876|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25501943|NCT00330876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25501944|NCT00330876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25501945|NCT00330876|Antimetabolites|antimetabolites|mesh-ancestor
25501946|NCT00330876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501947|NCT00330876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501948|NCT00330876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25501949|NCT00330915|Pemetrexed|pemetrexed|mesh-list
25501950|NCT00330915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501951|NCT00330915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25501952|NCT00330915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25501953|NCT00330915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25501954|NCT00330915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25501955|NCT00330967|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25501956|NCT00330967|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25501957|NCT00330967|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25501958|NCT00330967|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25501959|NCT00331006|Rituximab|rituximab|mesh-list
25501960|NCT00331006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25501961|NCT00331006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501962|NCT00331006|Immunologic Factors|immunologic factors|mesh-ancestor
25501963|NCT00331006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501964|NCT00331006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25501965|NCT00331136|Artesunate|artesunate|mesh-list
25501966|NCT00331136|Pyronaridine|pyronaridine|mesh-list
25501967|NCT00331136|Antimalarials|antimalarials|mesh-ancestor
25501968|NCT00331136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25501969|NCT00331136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25501970|NCT00331136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25501971|NCT00331136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168946|NCT02032277|Doxorubicin|doxorubicin|mesh-list
25168947|NCT02032277|Veliparib|veliparib|mesh-list
25501972|NCT00331136|Antiviral Agents|antiviral agents|mesh-ancestor
25501973|NCT00331136|Schistosomicides|schistosomicides|mesh-ancestor
25501974|NCT00331136|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25645648|NCT01450007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645649|NCT01450007|Anesthetics, Local|anesthetics, local|mesh-ancestor
25645650|NCT01450007|Anesthetics|anesthetics|mesh-ancestor
24861039|NCT02314377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25823177|NCT00004759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25501975|NCT00331136|Anthelmintics|anthelmintics|mesh-ancestor
25501977|NCT00331162|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25501978|NCT00331162|Immunologic Factors|immunologic factors|mesh-ancestor
25501979|NCT00331162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501980|NCT00331162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25501981|NCT00331162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25501982|NCT00331162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501983|NCT00331344|Prednisone|prednisone|mesh-list
25501984|NCT00331344|Mitoxantrone|mitoxantrone|mesh-list
25501985|NCT00331344|Epothilone B|epothilone b|mesh-list
25501986|NCT00331344|Epothilones|epothilones|mesh-list
25501987|NCT00331344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25501988|NCT00331344|Glucocorticoids|glucocorticoids|mesh-ancestor
25501989|NCT00331344|Hormones|hormones|mesh-ancestor
25501990|NCT00331344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25501991|NCT00331344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25501992|NCT00331344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25501993|NCT00331344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25501994|NCT00331344|Analgesics|analgesics|mesh-ancestor
25501995|NCT00331344|Sensory System Agents|sensory system agents|mesh-ancestor
25501996|NCT00331344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25501997|NCT00331344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25501998|NCT00331344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25501999|NCT00331344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502000|NCT00331344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502001|NCT00331344|Tubulin Modulators|tubulin modulators|mesh-ancestor
25502002|NCT00331344|Antimitotic Agents|antimitotic agents|mesh-ancestor
25502003|NCT00331344|Mitosis Modulators|mitosis modulators|mesh-ancestor
25502004|NCT00331409|Everolimus|everolimus|mesh-list
25502005|NCT00331409|Imatinib Mesylate|imatinib mesylate|mesh-list
25502006|NCT00331409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502007|NCT00331409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25502008|NCT00331409|Immunologic Factors|immunologic factors|mesh-ancestor
25502009|NCT00331409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502010|NCT00331409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25502011|NCT00331409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502012|NCT00331409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502013|NCT00331422|Paclitaxel|paclitaxel|mesh-list
25502014|NCT00331422|Carboplatin|carboplatin|mesh-list
25502015|NCT00331422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25502016|NCT00331422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502017|NCT00331422|Tubulin Modulators|tubulin modulators|mesh-ancestor
25502018|NCT00331422|Antimitotic Agents|antimitotic agents|mesh-ancestor
25502019|NCT00331422|Mitosis Modulators|mitosis modulators|mesh-ancestor
25502020|NCT00331422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502021|NCT00331552|Cyclophosphamide|cyclophosphamide|mesh-list
25502022|NCT00331552|Doxorubicin|doxorubicin|mesh-list
25502023|NCT00331552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25502024|NCT00331552|Trastuzumab|trastuzumab|mesh-list
25502025|NCT00331552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25502026|NCT00331552|Antibodies|antibodies|mesh-list
25502027|NCT00331552|Immunoglobulins|immunoglobulins|mesh-list
25502028|NCT00331552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25502029|NCT00331552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25502030|NCT00331552|Immunologic Factors|immunologic factors|mesh-ancestor
25502031|NCT00331552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502032|NCT00331552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25502033|NCT00331552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25502034|NCT00331552|Alkylating Agents|alkylating agents|mesh-ancestor
25502035|NCT00331552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502036|NCT00331552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502037|NCT00331552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25502038|NCT00331552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25823178|NCT00004759|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25823179|NCT00004759|Protective Agents|protective agents|mesh-ancestor
25169011|NCT02014649|Laninamivir|laninamivir|mesh-list
25169012|NCT02014649|Zanamivir|zanamivir|mesh-list
25169013|NCT02014649|Antiviral Agents|antiviral agents|mesh-ancestor
25169014|NCT02014649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25169015|NCT02014649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645651|NCT01450007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25645652|NCT01450007|Sensory System Agents|sensory system agents|mesh-ancestor
25645653|NCT01450098|Evacetrapib|evacetrapib|mesh-list
25645654|NCT01450098|Propyl Gallate|propyl gallate|mesh-list
25645655|NCT01450098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25645656|NCT01450098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25645657|NCT01450098|Antimetabolites|antimetabolites|mesh-ancestor
25645658|NCT01450098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645659|NCT01450098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25645660|NCT01450098|Antioxidants|antioxidants|mesh-ancestor
25645661|NCT01450098|Protective Agents|protective agents|mesh-ancestor
25645662|NCT01450098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169017|NCT02014142|Latanoprost|latanoprost|mesh-list
25502039|NCT00331552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25502040|NCT00331552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25502041|NCT00331552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502043|NCT00331630|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25502044|NCT00331630|Lapatinib|lapatinib|mesh-list
25502045|NCT00331630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25502046|NCT00331630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502047|NCT00331630|Tubulin Modulators|tubulin modulators|mesh-ancestor
25502048|NCT00331630|Antimitotic Agents|antimitotic agents|mesh-ancestor
25502049|NCT00331630|Mitosis Modulators|mitosis modulators|mesh-ancestor
25502050|NCT00331630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502051|NCT00331630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25502052|NCT00331630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502053|NCT00331682|Docetaxel|docetaxel|mesh-list
25502054|NCT00331682|Alvocidib|alvocidib|mesh-list
25502055|NCT00331682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502056|NCT00331682|Tubulin Modulators|tubulin modulators|mesh-ancestor
25502057|NCT00331682|Antimitotic Agents|antimitotic agents|mesh-ancestor
25502058|NCT00331682|Mitosis Modulators|mitosis modulators|mesh-ancestor
25502059|NCT00331682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502060|NCT00331682|Growth Inhibitors|growth inhibitors|mesh-ancestor
25502061|NCT00331682|Growth Substances|growth substances|mesh-ancestor
25502062|NCT00331682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502063|NCT00331682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25502064|NCT00331682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502065|NCT00331760|Cisplatin|cisplatin|mesh-list
25502066|NCT00331760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502067|NCT00331799|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25502068|NCT00331799|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25502069|NCT00331799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25502070|NCT00331799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25502071|NCT00331799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502072|NCT00331799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25502073|NCT00331799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502074|NCT00331799|Analgesics|analgesics|mesh-ancestor
25502075|NCT00331799|Sensory System Agents|sensory system agents|mesh-ancestor
25502076|NCT00331799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25502077|NCT00331799|Antidepressive Agents|antidepressive agents|mesh-ancestor
25502078|NCT00331799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25502079|NCT00331799|Dopamine Agents|dopamine agents|mesh-ancestor
25502080|NCT00331864|Ranibizumab|ranibizumab|mesh-list
25502081|NCT00331864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25502082|NCT00331864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25502083|NCT00331864|Growth Substances|growth substances|mesh-ancestor
25502084|NCT00331864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502085|NCT00331864|Growth Inhibitors|growth inhibitors|mesh-ancestor
25502086|NCT00331864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502087|NCT00332163|Irinotecan|irinotecan|mesh-list
25502088|NCT00332163|Panitumumab|panitumumab|mesh-list
25502089|NCT00332163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25502090|NCT00332163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25502091|NCT00332163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502092|NCT00332163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502093|NCT00332163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502094|NCT00332163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25502095|NCT00332189|Verapamil|verapamil|mesh-list
25502096|NCT00332189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25502097|NCT00332189|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25502098|NCT00332189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25502099|NCT00332189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645663|NCT01450137|Glucocorticoids|glucocorticoids|mesh-list
25645665|NCT01450137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25645666|NCT01450137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645667|NCT01450189|Tenofovir|tenofovir|mesh-list
25502100|NCT00332189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25645668|NCT01450189|Emtricitabine|emtricitabine|mesh-list
25645669|NCT01450189|Raltegravir Potassium|raltegravir potassium|mesh-list
25645670|NCT01450189|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25502101|NCT00332189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502102|NCT00332189|Vasodilator Agents|vasodilator agents|mesh-ancestor
25502103|NCT00332241|Aripiprazole|aripiprazole|mesh-list
25502104|NCT00332241|Antidepressive Agents|antidepressive agents|mesh-ancestor
25502105|NCT00332241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25502106|NCT00332241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25502107|NCT00332241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25502108|NCT00332241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25502109|NCT00332241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502110|NCT00332241|Dopamine Agonists|dopamine agonists|mesh-ancestor
25169062|NCT01998035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25169063|NCT01994382|Rituximab|rituximab|mesh-list
25502112|NCT00332241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25502113|NCT00332241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502114|NCT00332241|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25502115|NCT00332241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25502116|NCT00332241|Serotonin Agents|serotonin agents|mesh-ancestor
25502117|NCT00332241|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25502118|NCT00332241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25502119|NCT00332241|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25502120|NCT00332241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25502121|NCT00332332|Etanercept|etanercept|mesh-list
25502122|NCT00332332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25502123|NCT00332332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25502124|NCT00332332|Analgesics|analgesics|mesh-ancestor
25502125|NCT00332332|Sensory System Agents|sensory system agents|mesh-ancestor
25502126|NCT00332332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25502127|NCT00332332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502128|NCT00332332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25502129|NCT00332332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25502130|NCT00332332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25502131|NCT00332332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25502132|NCT00332332|Immunologic Factors|immunologic factors|mesh-ancestor
25502133|NCT00332462|Cyclosporine|cyclosporine|mesh-list
25502134|NCT00332462|Cyclosporins|cyclosporins|mesh-list
25502135|NCT00332462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502136|NCT00332462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502137|NCT00332462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25502138|NCT00332462|Immunologic Factors|immunologic factors|mesh-ancestor
25502139|NCT00332462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502140|NCT00332462|Antifungal Agents|antifungal agents|mesh-ancestor
25502141|NCT00332462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25502142|NCT00332462|Dermatologic Agents|dermatologic agents|mesh-ancestor
25502143|NCT00332462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25502144|NCT00332462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25502145|NCT00332488|Insulin|insulin|mesh-list
25502146|NCT00332488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25502147|NCT00332488|Metformin|metformin|mesh-list
25502148|NCT00332488|Secretagogues|secretagogues|mesh-list
25502149|NCT00332488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25502150|NCT00332488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502151|NCT00332579|Naltrexone|naltrexone|mesh-list
25502152|NCT00332579|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25502153|NCT00332579|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25502154|NCT00332579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502155|NCT00332579|Sensory System Agents|sensory system agents|mesh-ancestor
25502156|NCT00332579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25502157|NCT00332644|Bupropion|bupropion|mesh-list
25502158|NCT00332644|Nicotine|nicotine|mesh-list
25502159|NCT00332644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25502160|NCT00332644|Autonomic Agents|autonomic agents|mesh-ancestor
25502161|NCT00332644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25502162|NCT00332644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502163|NCT00332644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25502164|NCT00332644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25502165|NCT00332644|Cholinergic Agents|cholinergic agents|mesh-ancestor
25502166|NCT00332644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25645671|NCT01450189|Antiviral Agents|antiviral agents|mesh-ancestor
25502167|NCT00332644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169124|NCT01978366|Growth Inhibitors|growth inhibitors|mesh-ancestor
25169125|NCT01975818|Epoetin Alfa|epoetin alfa|mesh-list
25169126|NCT01975818|Hematinics|hematinics|mesh-ancestor
25169127|NCT01975610|Spebrutinib|spebrutinib|mesh-list
25169128|NCT01975610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25169129|NCT01975610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169130|NCT01975610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169131|NCT01973049|Ribavirin|ribavirin|mesh-list
25169132|NCT01973049|Asunaprevir|asunaprevir|mesh-list
25169133|NCT01973049|Antimetabolites|antimetabolites|mesh-ancestor
25169134|NCT01973049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169135|NCT01973049|Antiviral Agents|antiviral agents|mesh-ancestor
25169136|NCT01973049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25169137|NCT01973049|Protease Inhibitors|protease inhibitors|mesh-ancestor
25169138|NCT01973049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169139|NCT01972854|Riboflavin|riboflavin|mesh-list
25169140|NCT01972854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25169141|NCT01972854|Vitamin B Complex|vitamin b complex|mesh-ancestor
25169142|NCT01972854|Vitamins|vitamins|mesh-ancestor
25502168|NCT00332644|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25502169|NCT00332644|Antidepressive Agents|antidepressive agents|mesh-ancestor
25502170|NCT00332644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25502171|NCT00332644|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25502172|NCT00332644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25502173|NCT00332644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25502175|NCT00332644|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25502176|NCT00332644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25502177|NCT00332644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502178|NCT00332696|Methylprednisolone|methylprednisolone|mesh-list
25502179|NCT00332696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25502180|NCT00332696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25502181|NCT00332696|Prednisolone|prednisolone|mesh-list
25502182|NCT00332696|Prednisolone acetate|prednisolone acetate|mesh-list
25502183|NCT00332696|Octreotide|octreotide|mesh-list
25502184|NCT00332696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25502185|NCT00332696|Prednisolone phosphate|prednisolone phosphate|mesh-list
25502186|NCT00332696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25502187|NCT00332696|Antiemetics|antiemetics|mesh-ancestor
25502188|NCT00332696|Autonomic Agents|autonomic agents|mesh-ancestor
25502189|NCT00332696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25502190|NCT00332696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502191|NCT00332696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25502192|NCT00332696|Glucocorticoids|glucocorticoids|mesh-ancestor
25502193|NCT00332696|Hormones|hormones|mesh-ancestor
25502194|NCT00332696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25502195|NCT00332696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25502196|NCT00332696|Protective Agents|protective agents|mesh-ancestor
25502197|NCT00332696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25502198|NCT00332696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502199|NCT00332709|Zoledronic Acid|zoledronic acid|mesh-list
25502200|NCT00332709|Letrozole|letrozole|mesh-list
25502201|NCT00332709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502202|NCT00332709|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25502203|NCT00332709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25502204|NCT00332709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502205|NCT00332709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502206|NCT00332709|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25502207|NCT00332709|Hormone Antagonists|hormone antagonists|mesh-ancestor
25502208|NCT00332709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25502209|NCT00332709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502210|NCT00332709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25502211|NCT00332839|Cyclosporine|cyclosporine|mesh-list
25502212|NCT00332839|Mycophenolic Acid|mycophenolic acid|mesh-list
25502213|NCT00332839|Everolimus|everolimus|mesh-list
25502214|NCT00332839|Tacrolimus|tacrolimus|mesh-list
25502215|NCT00332839|Cyclosporins|cyclosporins|mesh-list
25502216|NCT00332839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25502217|NCT00332839|Immunologic Factors|immunologic factors|mesh-ancestor
25502218|NCT00332839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502219|NCT00332839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25502220|NCT00332839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502221|NCT00332839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502222|NCT00332839|Antifungal Agents|antifungal agents|mesh-ancestor
25502223|NCT00332839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25502225|NCT00332839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25502226|NCT00332839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502227|NCT00332839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25502228|NCT00332839|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25502229|NCT00332839|Antitubercular Agents|antitubercular agents|mesh-ancestor
25502230|NCT00332839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25502231|NCT00333138|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25502232|NCT00333138|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25502233|NCT00333138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502234|NCT00333138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25502235|NCT00333138|Immunologic Factors|immunologic factors|mesh-ancestor
25502236|NCT00333138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502237|NCT00333177|Risperidone|risperidone|mesh-list
25502238|NCT00333177|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25502239|NCT00333177|Serotonin Agents|serotonin agents|mesh-ancestor
25502240|NCT00333177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25169197|NCT01963208|GABA Modulators|gaba modulators|mesh-ancestor
25502241|NCT00333177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502242|NCT00333177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502244|NCT00333177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25502245|NCT00333177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25502246|NCT00333177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25502247|NCT00333177|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25502248|NCT00333177|Dopamine Agents|dopamine agents|mesh-ancestor
25502249|NCT00333359|Gabapentin|gabapentin|mesh-list
25502250|NCT00333359|Analgesics|analgesics|mesh-ancestor
25502251|NCT00333359|Sensory System Agents|sensory system agents|mesh-ancestor
25502252|NCT00333359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25502253|NCT00333359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502254|NCT00333359|Anticonvulsants|anticonvulsants|mesh-ancestor
25502255|NCT00333359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25502256|NCT00333359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25502257|NCT00333359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25502258|NCT00333359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25502259|NCT00333359|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25502260|NCT00333359|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25502261|NCT00333359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25502262|NCT00333359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502263|NCT00333359|Antimanic Agents|antimanic agents|mesh-ancestor
25502264|NCT00333437|Mycophenolic Acid|mycophenolic acid|mesh-list
25502265|NCT00333437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25502266|NCT00333437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502267|NCT00333437|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25502268|NCT00333437|Antitubercular Agents|antitubercular agents|mesh-ancestor
25502269|NCT00333437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25502270|NCT00333437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25502271|NCT00333437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502272|NCT00333437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502273|NCT00333775|Bevacizumab|bevacizumab|mesh-list
25502274|NCT00333775|Docetaxel|docetaxel|mesh-list
25502275|NCT00333775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25502276|NCT00333775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502277|NCT00333775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25502278|NCT00333775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25502279|NCT00333775|Growth Substances|growth substances|mesh-ancestor
25502280|NCT00333775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502281|NCT00333775|Growth Inhibitors|growth inhibitors|mesh-ancestor
25502282|NCT00333775|Tubulin Modulators|tubulin modulators|mesh-ancestor
25502283|NCT00333775|Antimitotic Agents|antimitotic agents|mesh-ancestor
25502284|NCT00333775|Mitosis Modulators|mitosis modulators|mesh-ancestor
25502285|NCT00333775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502286|NCT00333788|Certolizumab Pegol|certolizumab pegol|mesh-list
25502287|NCT00333788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25502288|NCT00333788|Immunologic Factors|immunologic factors|mesh-ancestor
25502289|NCT00333788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502290|NCT00333788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25502291|NCT00333814|Dexamethasone|dexamethasone|mesh-list
25502292|NCT00333814|Dexamethasone acetate|dexamethasone acetate|mesh-list
25502293|NCT00333814|BB 1101|bb 1101|mesh-list
25502294|NCT00333814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25502295|NCT00333814|Antiemetics|antiemetics|mesh-ancestor
25502296|NCT00333814|Autonomic Agents|autonomic agents|mesh-ancestor
25502297|NCT00333814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25502298|NCT00333814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502299|NCT00333814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25502300|NCT00333814|Glucocorticoids|glucocorticoids|mesh-ancestor
25502302|NCT00333814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25502303|NCT00333814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25502304|NCT00333814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502305|NCT00333814|Protease Inhibitors|protease inhibitors|mesh-ancestor
25502306|NCT00333814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502307|NCT00333814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502308|NCT00333840|Interferons|interferons|mesh-list
25502309|NCT00333840|Cytarabine|cytarabine|mesh-list
25502310|NCT00333840|Interferon-alpha|interferon-alpha|mesh-list
25502311|NCT00333840|Interferon alpha-2|interferon alpha-2|mesh-list
25502312|NCT00333840|Imatinib Mesylate|imatinib mesylate|mesh-list
25502313|NCT00333840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502314|NCT00333840|Antiviral Agents|antiviral agents|mesh-ancestor
25502315|NCT00333840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25502316|NCT00333840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25502317|NCT00333840|Antimetabolites|antimetabolites|mesh-ancestor
25502318|NCT00333840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502319|NCT00333840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25502320|NCT00333840|Immunologic Factors|immunologic factors|mesh-ancestor
25502321|NCT00333840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502322|NCT00333840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25502323|NCT00333840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502324|NCT00333866|Pregabalin|pregabalin|mesh-list
25502325|NCT00333866|Analgesics|analgesics|mesh-ancestor
25502326|NCT00333866|Sensory System Agents|sensory system agents|mesh-ancestor
25502327|NCT00333866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25502328|NCT00333866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502329|NCT00333866|Anticonvulsants|anticonvulsants|mesh-ancestor
25502330|NCT00333866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25502331|NCT00333866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25502332|NCT00333866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502333|NCT00333866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25502334|NCT00333866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25502335|NCT00333866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25502336|NCT00333866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25502337|NCT00333866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25502338|NCT00334074|Cytarabine|cytarabine|mesh-list
25502339|NCT00334074|Clofarabine|clofarabine|mesh-list
25502340|NCT00334074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25502341|NCT00334074|Antimetabolites|antimetabolites|mesh-ancestor
25502342|NCT00334074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502343|NCT00334074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502344|NCT00334074|Antiviral Agents|antiviral agents|mesh-ancestor
25502345|NCT00334074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25502346|NCT00334074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25502347|NCT00334074|Immunologic Factors|immunologic factors|mesh-ancestor
25502348|NCT00334074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502349|NCT00334295|Fulvestrant|fulvestrant|mesh-list
25502350|NCT00334295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25502351|NCT00334295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502352|NCT00334295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25502353|NCT00334295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25502354|NCT00334295|Hormone Antagonists|hormone antagonists|mesh-ancestor
25502355|NCT00334295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25502356|NCT00334295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502357|NCT00334542|Simvastatin|simvastatin|mesh-list
25502358|NCT00334542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25502359|NCT00334542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25502360|NCT00334542|Antimetabolites|antimetabolites|mesh-ancestor
25502361|NCT00334542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502362|NCT00334542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25502363|NCT00334542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25502364|NCT00334542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502365|NCT00334633|Metronidazole|metronidazole|mesh-list
25502366|NCT00334633|Tinidazole|tinidazole|mesh-list
25502367|NCT00334633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25502368|NCT00334633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25502369|NCT00334633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25502370|NCT00334633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25502371|NCT00334633|Alkylating Agents|alkylating agents|mesh-ancestor
24813337|NCT02057887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25502372|NCT00334633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502373|NCT00334633|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25502374|NCT00334737|Epoetin Alfa|epoetin alfa|mesh-list
25502375|NCT00334737|Darbepoetin alfa|darbepoetin alfa|mesh-list
25502376|NCT00334737|Hematinics|hematinics|mesh-ancestor
25502377|NCT00334802|Gemcitabine|gemcitabine|mesh-list
25502378|NCT00334802|Paclitaxel|paclitaxel|mesh-list
25502379|NCT00334802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25502380|NCT00334802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502381|NCT00334802|Tubulin Modulators|tubulin modulators|mesh-ancestor
25502382|NCT00334802|Antimitotic Agents|antimitotic agents|mesh-ancestor
25502383|NCT00334802|Mitosis Modulators|mitosis modulators|mesh-ancestor
25502384|NCT00334802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502385|NCT00334802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25502386|NCT00334802|Antimetabolites|antimetabolites|mesh-ancestor
25169278|NCT01922843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25169279|NCT01922843|Vitamins|vitamins|mesh-ancestor
25169280|NCT01922843|Micronutrients|micronutrients|mesh-ancestor
25169282|NCT01917383|Timolol|timolol|mesh-list
25502387|NCT00334802|Antiviral Agents|antiviral agents|mesh-ancestor
25502388|NCT00334802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25502389|NCT00334802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502390|NCT00334802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25502391|NCT00334802|Immunologic Factors|immunologic factors|mesh-ancestor
25502392|NCT00334802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502393|NCT00334958|Rufinamide|rufinamide|mesh-list
25502394|NCT00334958|Anticonvulsants|anticonvulsants|mesh-ancestor
25502395|NCT00334958|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25502396|NCT00334958|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25502397|NCT00334958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25502398|NCT00334958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502399|NCT00335140|Leucovorin|leucovorin|mesh-list
25502400|NCT00335140|Cytarabine|cytarabine|mesh-list
25502401|NCT00335140|Dexamethasone|dexamethasone|mesh-list
25502402|NCT00335140|Dexamethasone acetate|dexamethasone acetate|mesh-list
25502403|NCT00335140|Rituximab|rituximab|mesh-list
25502404|NCT00335140|Methotrexate|methotrexate|mesh-list
25502405|NCT00335140|Vincristine|vincristine|mesh-list
25502406|NCT00335140|Procarbazine|procarbazine|mesh-list
25502407|NCT00335140|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25502408|NCT00335140|BB 1101|bb 1101|mesh-list
25502409|NCT00335140|Levoleucovorin|levoleucovorin|mesh-list
25502410|NCT00335140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25502411|NCT00335140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502412|NCT00335140|Immunologic Factors|immunologic factors|mesh-ancestor
25502413|NCT00335140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502414|NCT00335140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25502415|NCT00335140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25502416|NCT00335140|Antiemetics|antiemetics|mesh-ancestor
25502417|NCT00335140|Autonomic Agents|autonomic agents|mesh-ancestor
25502418|NCT00335140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25502419|NCT00335140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25502420|NCT00335140|Glucocorticoids|glucocorticoids|mesh-ancestor
25502421|NCT00335140|Hormones|hormones|mesh-ancestor
25502422|NCT00335140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25502423|NCT00335140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25502424|NCT00335140|Protease Inhibitors|protease inhibitors|mesh-ancestor
25502425|NCT00335140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502426|NCT00335140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502427|NCT00335140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25502428|NCT00335140|Abortifacient Agents|abortifacient agents|mesh-ancestor
25502429|NCT00335140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25502430|NCT00335140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25502431|NCT00335140|Antimetabolites|antimetabolites|mesh-ancestor
25502432|NCT00335140|Dermatologic Agents|dermatologic agents|mesh-ancestor
25502433|NCT00335140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25502434|NCT00335140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25502435|NCT00335140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25502436|NCT00335140|Antiviral Agents|antiviral agents|mesh-ancestor
25502437|NCT00335140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25502438|NCT00335140|Antidotes|antidotes|mesh-ancestor
25502439|NCT00335140|Protective Agents|protective agents|mesh-ancestor
25502440|NCT00335140|Vitamin B Complex|vitamin b complex|mesh-ancestor
25502441|NCT00335140|Vitamins|vitamins|mesh-ancestor
25502442|NCT00335140|Micronutrients|micronutrients|mesh-ancestor
25502443|NCT00335140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25502444|NCT00335140|Tubulin Modulators|tubulin modulators|mesh-ancestor
25502445|NCT00335140|Antimitotic Agents|antimitotic agents|mesh-ancestor
25502446|NCT00335140|Mitosis Modulators|mitosis modulators|mesh-ancestor
25502447|NCT00335153|Levodopa|levodopa|mesh-list
25502448|NCT00335153|Carbidopa|carbidopa|mesh-list
25502449|NCT00335153|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25502450|NCT00335153|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25502451|NCT00335153|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25502452|NCT00335153|Dopamine Agents|dopamine agents|mesh-ancestor
25502453|NCT00335153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25502454|NCT00335153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502455|NCT00335153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502456|NCT00335153|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25502457|NCT00335153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502458|NCT00335153|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25502459|NCT00335153|Immunologic Factors|immunologic factors|mesh-ancestor
25502460|NCT00335153|Dopamine Agonists|dopamine agonists|mesh-ancestor
25502461|NCT00335283|Lansoprazole|lansoprazole|mesh-list
25502462|NCT00335283|Dexlansoprazole|dexlansoprazole|mesh-list
25502463|NCT00335283|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25502464|NCT00335283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25502465|NCT00335283|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25502466|NCT00335283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502467|NCT00335283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502468|NCT00335322|Ritonavir|ritonavir|mesh-list
25502469|NCT00335322|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25502470|NCT00335322|Tenofovir|tenofovir|mesh-list
25502471|NCT00335322|Zidovudine|zidovudine|mesh-list
25502472|NCT00335322|Emtricitabine|emtricitabine|mesh-list
25502473|NCT00335322|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25502474|NCT00335322|Abacavir|abacavir|mesh-list
25502475|NCT00335322|Efavirenz|efavirenz|mesh-list
25502476|NCT00335322|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25502477|NCT00335322|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25502478|NCT00335322|Protease Inhibitors|protease inhibitors|mesh-ancestor
25502479|NCT00335322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502480|NCT00335322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502481|NCT00335322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25502482|NCT00335322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25502483|NCT00335322|Antiviral Agents|antiviral agents|mesh-ancestor
25502484|NCT00335322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25502485|NCT00335322|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25502486|NCT00335322|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25502487|NCT00335322|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25502488|NCT00335322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25502489|NCT00335322|Antimetabolites|antimetabolites|mesh-ancestor
25502490|NCT00335322|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25502491|NCT00335322|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25502492|NCT00335322|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25502493|NCT00335322|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25502494|NCT00335322|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25502495|NCT00335452|Clopidogrel|clopidogrel|mesh-list
25502496|NCT00335452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25502497|NCT00335452|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25502498|NCT00335452|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25502499|NCT00335452|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25502500|NCT00335452|Purinergic Agents|purinergic agents|mesh-ancestor
25502501|NCT00335452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25502502|NCT00335452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502503|NCT00335452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502504|NCT00335478|Daptomycin|daptomycin|mesh-list
25502505|NCT00335478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25502506|NCT00335478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25502507|NCT00335504|Sulindac|sulindac|mesh-list
25502508|NCT00335504|Atorvastatin|atorvastatin|mesh-list
25502509|NCT00335504|Calcium|calcium|mesh-list
25502510|NCT00335504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25502511|NCT00335504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502512|NCT00335504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25502513|NCT00335504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25502514|NCT00335504|Antimetabolites|antimetabolites|mesh-ancestor
24542850|NCT00680511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25049072|NCT00637130|Travoprost|travoprost|mesh-list
25502515|NCT00335504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502516|NCT00335504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25502517|NCT00335504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25502518|NCT00335504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645672|NCT01450189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25645673|NCT01450189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25645674|NCT01450189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25645675|NCT01450189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645676|NCT01450189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645677|NCT01450189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25645678|NCT01450189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25645679|NCT01450189|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25645680|NCT01450189|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25645681|NCT01450306|Cycloserine|cycloserine|mesh-list
25645682|NCT01450306|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25502519|NCT00335504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25502520|NCT00335504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25502521|NCT00335504|Analgesics|analgesics|mesh-ancestor
25502522|NCT00335504|Sensory System Agents|sensory system agents|mesh-ancestor
25502523|NCT00335504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25502524|NCT00335504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25502525|NCT00335504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25502526|NCT00335504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502527|NCT00335504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25502528|NCT00335556|Dactinomycin|dactinomycin|mesh-list
25502529|NCT00335556|Cyclophosphamide|cyclophosphamide|mesh-list
25502530|NCT00335556|Carboplatin|carboplatin|mesh-list
25502531|NCT00335556|Doxorubicin|doxorubicin|mesh-list
25502532|NCT00335556|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25502533|NCT00335556|Irinotecan|irinotecan|mesh-list
25502534|NCT00335556|Etoposide|etoposide|mesh-list
25502535|NCT00335556|Vincristine|vincristine|mesh-list
25502536|NCT00335556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25502537|NCT00335556|Immunologic Factors|immunologic factors|mesh-ancestor
24450625|NCT00319865|Glucocorticoids|glucocorticoids|mesh-ancestor
25116945|NCT03105310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25502538|NCT00335556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502539|NCT00335556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25502540|NCT00335556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25502541|NCT00335556|Alkylating Agents|alkylating agents|mesh-ancestor
25502542|NCT00335556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502543|NCT00335556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502544|NCT00335556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25502545|NCT00335556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25502546|NCT00335556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25502547|NCT00335556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25502548|NCT00335556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502549|NCT00335556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25502550|NCT00335556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25502551|NCT00335556|Tubulin Modulators|tubulin modulators|mesh-ancestor
25502552|NCT00335556|Antimitotic Agents|antimitotic agents|mesh-ancestor
25502553|NCT00335556|Mitosis Modulators|mitosis modulators|mesh-ancestor
25502554|NCT00335556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25502555|NCT00335556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25502556|NCT00335556|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25502557|NCT00335556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25502558|NCT00335725|Hormones|hormones|mesh-list
25502559|NCT00335725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25502560|NCT00335725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25502561|NCT00335725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502562|NCT00335738|Carboplatin|carboplatin|mesh-list
25502563|NCT00335738|Etoposide|etoposide|mesh-list
25502564|NCT00335738|Vincristine|vincristine|mesh-list
25502565|NCT00335738|Etoposide phosphate|etoposide phosphate|mesh-list
25502566|NCT00335738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502567|NCT00335738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25502568|NCT00335738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25502569|NCT00335738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25502570|NCT00335738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502571|NCT00335738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502572|NCT00335738|Tubulin Modulators|tubulin modulators|mesh-ancestor
25502573|NCT00335738|Antimitotic Agents|antimitotic agents|mesh-ancestor
25502574|NCT00335738|Mitosis Modulators|mitosis modulators|mesh-ancestor
25502575|NCT00335764|Sirolimus|sirolimus|mesh-list
25502576|NCT00335764|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25502577|NCT00335764|Sorafenib|sorafenib|mesh-list
25502578|NCT00335764|Tipifarnib|tipifarnib|mesh-list
25502579|NCT00335764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502580|NCT00335764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25502581|NCT00335764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673765|NCT01340235|Erythromycin|erythromycin|mesh-list
25502582|NCT00335764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502583|NCT00335764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25502584|NCT00335764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25502585|NCT00335764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25502586|NCT00335764|Antifungal Agents|antifungal agents|mesh-ancestor
25502587|NCT00335764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25502588|NCT00335764|Immunologic Factors|immunologic factors|mesh-ancestor
25502589|NCT00335764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502591|NCT00335829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25502592|NCT00335829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502593|NCT00335829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25502594|NCT00335829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25502595|NCT00335829|Growth Substances|growth substances|mesh-ancestor
25502596|NCT00335829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502597|NCT00335829|Growth Inhibitors|growth inhibitors|mesh-ancestor
25502598|NCT00335959|Capecitabine|capecitabine|mesh-list
25502599|NCT00335959|Oxaliplatin|oxaliplatin|mesh-list
25502600|NCT00335959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25502601|NCT00335959|Antimetabolites|antimetabolites|mesh-ancestor
25502602|NCT00335959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502603|NCT00335959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502604|NCT00335972|Dexmedetomidine|dexmedetomidine|mesh-list
25502605|NCT00335972|Remifentanil|remifentanil|mesh-list
25502606|NCT00335972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25502607|NCT00335972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25502608|NCT00335972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502609|NCT00335972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25169445|NCT01861847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169446|NCT01859962|Ribavirin|ribavirin|mesh-list
25502611|NCT00335972|Sensory System Agents|sensory system agents|mesh-ancestor
25502612|NCT00335972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25502613|NCT00335972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25502614|NCT00335972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25502615|NCT00335972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25502616|NCT00335972|Adrenergic Agents|adrenergic agents|mesh-ancestor
25502617|NCT00335972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25502618|NCT00335972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502619|NCT00335972|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25502620|NCT00335972|Narcotics|narcotics|mesh-ancestor
25502621|NCT00336232|Vitamin K|vitamin k|mesh-list
25502622|NCT00336232|Vitamin K 1|vitamin k 1|mesh-list
25502623|NCT00336232|Vitamins|vitamins|mesh-ancestor
25502624|NCT00336232|Micronutrients|micronutrients|mesh-ancestor
25502625|NCT00336232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502626|NCT00336232|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25502627|NCT00336232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25502628|NCT00336232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502629|NCT00336232|Hemostatics|hemostatics|mesh-ancestor
25502630|NCT00336232|Coagulants|coagulants|mesh-ancestor
25502631|NCT00336323|Bevacizumab|bevacizumab|mesh-list
25502632|NCT00336323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25502633|NCT00336323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502634|NCT00336323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25502635|NCT00336323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25502636|NCT00336323|Growth Substances|growth substances|mesh-ancestor
25502637|NCT00336323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502638|NCT00336323|Growth Inhibitors|growth inhibitors|mesh-ancestor
25502639|NCT00336479|Interferons|interferons|mesh-list
25502640|NCT00336479|Ribavirin|ribavirin|mesh-list
25502641|NCT00336479|Interferon-alpha|interferon-alpha|mesh-list
25502642|NCT00336479|Interferon alpha-2|interferon alpha-2|mesh-list
25502643|NCT00336479|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25502644|NCT00336479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502645|NCT00336479|Antiviral Agents|antiviral agents|mesh-ancestor
25502646|NCT00336479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25502647|NCT00336479|Antimetabolites|antimetabolites|mesh-ancestor
25502648|NCT00336479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502649|NCT00336479|Immunologic Factors|immunologic factors|mesh-ancestor
25502650|NCT00336479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502651|NCT00336492|Infliximab|infliximab|mesh-list
25502652|NCT00336492|Dermatologic Agents|dermatologic agents|mesh-ancestor
25502653|NCT00336492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25502654|NCT00336492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25502655|NCT00336505|Clarithromycin|clarithromycin|mesh-list
25502656|NCT00336505|Cethromycin|cethromycin|mesh-list
25502657|NCT00336505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25502658|NCT00336505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25502659|NCT00336505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25502660|NCT00336505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502661|NCT00336505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502662|NCT00336505|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25502663|NCT00336505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25502664|NCT00336544|Clarithromycin|clarithromycin|mesh-list
25502665|NCT00336544|Cethromycin|cethromycin|mesh-list
25502666|NCT00336544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25502667|NCT00336544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25502668|NCT00336544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25502669|NCT00336544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502670|NCT00336544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502671|NCT00336544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25502672|NCT00336544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25502673|NCT00336583|Cytarabine|cytarabine|mesh-list
25502674|NCT00336583|Methylprednisolone|methylprednisolone|mesh-list
25502675|NCT00336583|Oxaliplatin|oxaliplatin|mesh-list
25502676|NCT00336583|Etoposide|etoposide|mesh-list
25502677|NCT00336583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169513|NCT01836432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25169514|NCT01836432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169515|NCT01836432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25169516|NCT01836432|Immunologic Factors|immunologic factors|mesh-ancestor
25169517|NCT01836432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169518|NCT01836432|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25169519|NCT01836432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25169520|NCT01836432|Antidotes|antidotes|mesh-ancestor
25502692|NCT00336583|Autonomic Agents|autonomic agents|mesh-ancestor
25502693|NCT00336583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25502694|NCT00336583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25502695|NCT00336583|Glucocorticoids|glucocorticoids|mesh-ancestor
25502697|NCT00336583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25502698|NCT00336583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25502699|NCT00336583|Protective Agents|protective agents|mesh-ancestor
25502700|NCT00336700|Gemcitabine|gemcitabine|mesh-list
25502701|NCT00336700|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25502702|NCT00336700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25502703|NCT00336700|Antimetabolites|antimetabolites|mesh-ancestor
25502704|NCT00336700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502705|NCT00336700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502706|NCT00336700|Antiviral Agents|antiviral agents|mesh-ancestor
25502707|NCT00336700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25502708|NCT00336700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502709|NCT00336700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25502710|NCT00336700|Immunologic Factors|immunologic factors|mesh-ancestor
25502711|NCT00336700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502712|NCT00336700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25502713|NCT00336817|Mycophenolic Acid|mycophenolic acid|mesh-list
25502714|NCT00336817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25502715|NCT00336817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502716|NCT00336817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25502717|NCT00336817|Antitubercular Agents|antitubercular agents|mesh-ancestor
25502718|NCT00336817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25502719|NCT00336817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25502720|NCT00336817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502721|NCT00336817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050596|NCT00484419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050597|NCT00484419|Incretins|incretins|mesh-ancestor
25050599|NCT00484419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25050600|NCT00484419|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24541797|NCT00675246|Hormones|hormones|mesh-ancestor
24541798|NCT00675246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25050601|NCT00484419|Protease Inhibitors|protease inhibitors|mesh-ancestor
25050602|NCT00484419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823180|NCT00004759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25823181|NCT00004759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823182|NCT00004759|Antioxidants|antioxidants|mesh-ancestor
25823183|NCT00004759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823184|NCT00004762|Cladribine|cladribine|mesh-list
25823185|NCT00004762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502722|NCT00336856|Irinotecan|irinotecan|mesh-list
25502723|NCT00336856|Cetuximab|cetuximab|mesh-list
25502724|NCT00336856|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25823186|NCT00004762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25502725|NCT00336856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25502726|NCT00336856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502727|NCT00336856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502728|NCT00336856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502729|NCT00336856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25502730|NCT00336895|Mycophenolic Acid|mycophenolic acid|mesh-list
25502731|NCT00336895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25502732|NCT00336895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502733|NCT00336895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25502734|NCT00336895|Antitubercular Agents|antitubercular agents|mesh-ancestor
25502735|NCT00336895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25502736|NCT00336895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25502737|NCT00336895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502738|NCT00336895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502739|NCT00337103|Capecitabine|capecitabine|mesh-list
25502740|NCT00337103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25502741|NCT00337103|Antimetabolites|antimetabolites|mesh-ancestor
25502742|NCT00337103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502743|NCT00337103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502744|NCT00337168|Cytarabine|cytarabine|mesh-list
25502745|NCT00337168|Clofarabine|clofarabine|mesh-list
25502746|NCT00337168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25502747|NCT00337168|Antimetabolites|antimetabolites|mesh-ancestor
25502748|NCT00337168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502749|NCT00337168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502750|NCT00337168|Antiviral Agents|antiviral agents|mesh-ancestor
25502751|NCT00337168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25502752|NCT00337168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25502753|NCT00337168|Immunologic Factors|immunologic factors|mesh-ancestor
25502754|NCT00337168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502755|NCT00337194|Gemcitabine|gemcitabine|mesh-list
25502756|NCT00337194|Doxorubicin|doxorubicin|mesh-list
25502757|NCT00337194|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25502758|NCT00337194|Vinorelbine|vinorelbine|mesh-list
25502759|NCT00337194|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25502760|NCT00337194|Antibodies|antibodies|mesh-list
25502761|NCT00337194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25502762|NCT00337194|Immunologic Factors|immunologic factors|mesh-ancestor
25502763|NCT00337194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502764|NCT00337194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25502765|NCT00337194|Antimetabolites|antimetabolites|mesh-ancestor
25502766|NCT00337194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502767|NCT00337194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502768|NCT00337194|Antiviral Agents|antiviral agents|mesh-ancestor
25502769|NCT00337194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25502770|NCT00337194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502771|NCT00337194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25502772|NCT00337194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25502773|NCT00337194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25502774|NCT00337194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25502775|NCT00337194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25502776|NCT00337194|Tubulin Modulators|tubulin modulators|mesh-ancestor
25502777|NCT00337194|Antimitotic Agents|antimitotic agents|mesh-ancestor
25502778|NCT00337194|Mitosis Modulators|mitosis modulators|mesh-ancestor
25502779|NCT00337194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25502780|NCT00337207|Bevacizumab|bevacizumab|mesh-list
25502781|NCT00337207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25502782|NCT00337207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502783|NCT00337207|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25502784|NCT00337207|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25502785|NCT00337207|Growth Substances|growth substances|mesh-ancestor
25502786|NCT00337207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502787|NCT00337207|Growth Inhibitors|growth inhibitors|mesh-ancestor
25502788|NCT00337285|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25502789|NCT00337285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25502790|NCT00337285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502791|NCT00337285|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25502792|NCT00337285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25502793|NCT00337285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25502794|NCT00337285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783886|NCT01904643|Analgesics|analgesics|mesh-ancestor
25502795|NCT00337285|Dopamine Agents|dopamine agents|mesh-ancestor
25502796|NCT00337285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25502797|NCT00337350|Rosiglitazone|rosiglitazone|mesh-list
25502798|NCT00337350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25502799|NCT00337350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502800|NCT00337428|Vaccines|vaccines|mesh-list
25502801|NCT00337428|Immunologic Factors|immunologic factors|mesh-ancestor
25502802|NCT00337428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502803|NCT00337467|Ritonavir|ritonavir|mesh-list
25502804|NCT00337467|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25502805|NCT00337467|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25502806|NCT00337467|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25502807|NCT00337467|Protease Inhibitors|protease inhibitors|mesh-ancestor
25502808|NCT00337467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502809|NCT00337467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502810|NCT00337467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25502811|NCT00337467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25502812|NCT00337467|Antiviral Agents|antiviral agents|mesh-ancestor
25502813|NCT00337467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25502814|NCT00337467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25502815|NCT00337467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25502816|NCT00337571|Aripiprazole|aripiprazole|mesh-list
25502817|NCT00337571|Antidepressive Agents|antidepressive agents|mesh-ancestor
25502818|NCT00337571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25502819|NCT00337571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25502820|NCT00337571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25502821|NCT00337571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25502822|NCT00337571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502823|NCT00337571|Dopamine Agonists|dopamine agonists|mesh-ancestor
25502824|NCT00337571|Dopamine Agents|dopamine agents|mesh-ancestor
25502825|NCT00337571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25502826|NCT00337571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502827|NCT00337571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25502828|NCT00337571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25502829|NCT00337571|Serotonin Agents|serotonin agents|mesh-ancestor
25502830|NCT00337571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25502831|NCT00337571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25502832|NCT00337571|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25502833|NCT00337571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25502834|NCT00337610|Metformin|metformin|mesh-list
25502835|NCT00337610|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25502836|NCT00337610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25502837|NCT00337610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502838|NCT00337610|Incretins|incretins|mesh-ancestor
25502839|NCT00337610|Hormones|hormones|mesh-ancestor
25502840|NCT00337610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25502841|NCT00337610|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25502842|NCT00337610|Protease Inhibitors|protease inhibitors|mesh-ancestor
25502843|NCT00337610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502844|NCT00337610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502845|NCT00337662|Olanzapine|olanzapine|mesh-list
25502846|NCT00337662|Risperidone|risperidone|mesh-list
25502847|NCT00337662|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25502848|NCT00337662|Serotonin Agents|serotonin agents|mesh-ancestor
25502849|NCT00337662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25502850|NCT00337662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502851|NCT00337662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502852|NCT00337662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25502853|NCT00337662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25502854|NCT00337662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25502855|NCT00337662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25502856|NCT00337662|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25502857|NCT00337662|Dopamine Agents|dopamine agents|mesh-ancestor
25502858|NCT00337662|Antiemetics|antiemetics|mesh-ancestor
25502859|NCT00337662|Autonomic Agents|autonomic agents|mesh-ancestor
25502860|NCT00337662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25502861|NCT00337662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25502862|NCT00337662|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25502863|NCT00337662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25502864|NCT00337662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25502865|NCT00337727|Dexamethasone|dexamethasone|mesh-list
24548523|NCT00710086|Remifentanil|remifentanil|mesh-list
24548579|NCT00710268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502866|NCT00337727|Dexamethasone acetate|dexamethasone acetate|mesh-list
25502867|NCT00337727|Ondansetron|ondansetron|mesh-list
25502868|NCT00337727|Aprepitant|aprepitant|mesh-list
25645683|NCT01450306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25502869|NCT00337727|Fosaprepitant|fosaprepitant|mesh-list
25502870|NCT00337727|BB 1101|bb 1101|mesh-list
25502871|NCT00337727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25502872|NCT00337727|Antiemetics|antiemetics|mesh-ancestor
25502873|NCT00337727|Autonomic Agents|autonomic agents|mesh-ancestor
25502874|NCT00337727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25502875|NCT00337727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502876|NCT00337727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25502877|NCT00337727|Glucocorticoids|glucocorticoids|mesh-ancestor
25502878|NCT00337727|Hormones|hormones|mesh-ancestor
25502879|NCT00337727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25502880|NCT00337727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25502881|NCT00337727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502882|NCT00337727|Protease Inhibitors|protease inhibitors|mesh-ancestor
25502883|NCT00337727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502884|NCT00337727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502885|NCT00337727|Antipruritics|antipruritics|mesh-ancestor
25502886|NCT00337727|Dermatologic Agents|dermatologic agents|mesh-ancestor
25502887|NCT00337727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25502888|NCT00337727|Serotonin Agents|serotonin agents|mesh-ancestor
25502889|NCT00337727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25502890|NCT00337727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25502891|NCT00337727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25502892|NCT00337727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25502893|NCT00337727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25502894|NCT00337727|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25502895|NCT00337727|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25502896|NCT00337779|Glatiramer Acetate|glatiramer acetate|mesh-list
25502897|NCT00337779|(T,G)-A-L|(t,g)-a-l|mesh-list
25502898|NCT00337779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25502899|NCT00337779|Immunologic Factors|immunologic factors|mesh-ancestor
25502900|NCT00337779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502901|NCT00337779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25502902|NCT00337779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25502903|NCT00337935|Epoetin Alfa|epoetin alfa|mesh-list
25502904|NCT00337935|Hematinics|hematinics|mesh-ancestor
25502905|NCT00337987|Prednisone|prednisone|mesh-list
25502906|NCT00337987|Cyclophosphamide|cyclophosphamide|mesh-list
25502907|NCT00337987|Vincristine|vincristine|mesh-list
25502908|NCT00337987|Doxorubicin|doxorubicin|mesh-list
25502909|NCT00337987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25502910|NCT00337987|Denileukin diftitox|denileukin diftitox|mesh-list
25502911|NCT00337987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25502912|NCT00337987|Immunologic Factors|immunologic factors|mesh-ancestor
25502913|NCT00337987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502914|NCT00337987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25502915|NCT00337987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25502916|NCT00337987|Alkylating Agents|alkylating agents|mesh-ancestor
25502917|NCT00337987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502918|NCT00337987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502919|NCT00337987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25502920|NCT00337987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25502921|NCT00337987|Glucocorticoids|glucocorticoids|mesh-ancestor
25502922|NCT00337987|Hormones|hormones|mesh-ancestor
25502923|NCT00337987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25502924|NCT00337987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25502925|NCT00337987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25502926|NCT00337987|Tubulin Modulators|tubulin modulators|mesh-ancestor
25502927|NCT00337987|Antimitotic Agents|antimitotic agents|mesh-ancestor
25502928|NCT00337987|Mitosis Modulators|mitosis modulators|mesh-ancestor
25502929|NCT00337987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25502930|NCT00337987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25502931|NCT00337987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25502932|NCT00337987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502933|NCT00338039|Gemcitabine|gemcitabine|mesh-list
25502934|NCT00338039|Capecitabine|capecitabine|mesh-list
25502935|NCT00338039|Oxaliplatin|oxaliplatin|mesh-list
25502936|NCT00338039|Cetuximab|cetuximab|mesh-list
25502937|NCT00338039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25502938|NCT00338039|Antimetabolites|antimetabolites|mesh-ancestor
25502939|NCT00338039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502940|NCT00338039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502941|NCT00338039|Antiviral Agents|antiviral agents|mesh-ancestor
25502942|NCT00338039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25502943|NCT00338039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502944|NCT00338039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25502945|NCT00338039|Immunologic Factors|immunologic factors|mesh-ancestor
25502946|NCT00338039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645684|NCT01450306|Renal Agents|renal agents|mesh-ancestor
25502947|NCT00338039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25502950|NCT00338598|Glycine|glycine|mesh-list
25502951|NCT00338598|Glycine Agents|glycine agents|mesh-ancestor
25502952|NCT00338598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25502953|NCT00338598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502954|NCT00338598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502955|NCT00338728|Letrozole|letrozole|mesh-list
25502956|NCT00338728|Imatinib Mesylate|imatinib mesylate|mesh-list
25502957|NCT00338728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502958|NCT00338728|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25502959|NCT00338728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25502960|NCT00338728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502961|NCT00338728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502962|NCT00338728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25502963|NCT00338728|Hormone Antagonists|hormone antagonists|mesh-ancestor
25502964|NCT00338728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25502965|NCT00338728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502966|NCT00338728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25502967|NCT00338884|Sunitinib|sunitinib|mesh-list
25502968|NCT00338884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25502969|NCT00338884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25502970|NCT00338884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25502971|NCT00338884|Growth Substances|growth substances|mesh-ancestor
25502972|NCT00338884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502973|NCT00338884|Growth Inhibitors|growth inhibitors|mesh-ancestor
25502974|NCT00338884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25502975|NCT00338884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25502976|NCT00338884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502977|NCT00338949|Olanzapine|olanzapine|mesh-list
25502978|NCT00338949|Risperidone|risperidone|mesh-list
25502979|NCT00338949|Ziprasidone|ziprasidone|mesh-list
25502980|NCT00338949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25502981|NCT00338949|Serotonin Agents|serotonin agents|mesh-ancestor
25502982|NCT00338949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25502983|NCT00338949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25502984|NCT00338949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25502985|NCT00338949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25502986|NCT00338949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25502987|NCT00338949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25502988|NCT00338949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25502989|NCT00338949|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25502990|NCT00338949|Dopamine Agents|dopamine agents|mesh-ancestor
25502991|NCT00338949|Antiemetics|antiemetics|mesh-ancestor
25502992|NCT00338949|Autonomic Agents|autonomic agents|mesh-ancestor
25502993|NCT00338949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25502994|NCT00338949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25502995|NCT00338949|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25502996|NCT00338949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25502997|NCT00338949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25502998|NCT00338962|Naltrexone|naltrexone|mesh-list
25502999|NCT00338962|Paroxetine|paroxetine|mesh-list
25503000|NCT00338962|Desipramine|desipramine|mesh-list
25503001|NCT00338962|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25503002|NCT00338962|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25503003|NCT00338962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503004|NCT00338962|Sensory System Agents|sensory system agents|mesh-ancestor
25503005|NCT00338962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25503006|NCT00338962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25503007|NCT00338962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25503008|NCT00338962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25503009|NCT00338962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503010|NCT00338962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25503011|NCT00338962|Serotonin Agents|serotonin agents|mesh-ancestor
25503012|NCT00338962|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25503013|NCT00338962|Antidepressive Agents|antidepressive agents|mesh-ancestor
25503014|NCT00338962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25503015|NCT00338962|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25503016|NCT00338962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25503017|NCT00338962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25161808|NCT02311998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25503018|NCT00338962|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25503019|NCT00338962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25503020|NCT00338962|Adrenergic Agents|adrenergic agents|mesh-ancestor
25503022|NCT00338988|Oxaliplatin|oxaliplatin|mesh-list
25503023|NCT00338988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25503024|NCT00338988|Antimetabolites|antimetabolites|mesh-ancestor
25503025|NCT00338988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503026|NCT00338988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503027|NCT00339079|Fluoxetine|fluoxetine|mesh-list
25503028|NCT00339079|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25503029|NCT00339079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25503030|NCT00339079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25503031|NCT00339079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503032|NCT00339079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25503033|NCT00339079|Serotonin Agents|serotonin agents|mesh-ancestor
25503034|NCT00339079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503035|NCT00339079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25503036|NCT00339079|Antidepressive Agents|antidepressive agents|mesh-ancestor
25503037|NCT00339079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25503038|NCT00339079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25503039|NCT00339079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25503040|NCT00339079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503041|NCT00339144|Dasatinib|dasatinib|mesh-list
25503042|NCT00339144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503043|NCT00339144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25503044|NCT00339144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503045|NCT00339144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503046|NCT00339833|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
25503047|NCT00339833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25503048|NCT00339833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25503049|NCT00339833|Analgesics|analgesics|mesh-ancestor
25503050|NCT00339833|Sensory System Agents|sensory system agents|mesh-ancestor
25503051|NCT00339833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25503052|NCT00339833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503053|NCT00339833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25503054|NCT00339833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25503055|NCT00340379|Haloperidol|haloperidol|mesh-list
25503056|NCT00340379|Haloperidol decanoate|haloperidol decanoate|mesh-list
25503057|NCT00340379|Ziprasidone|ziprasidone|mesh-list
25503058|NCT00340379|Sertraline|sertraline|mesh-list
25503059|NCT00340379|Antidepressive Agents|antidepressive agents|mesh-ancestor
25503060|NCT00340379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25503061|NCT00340379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25503062|NCT00340379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25503063|NCT00340379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25503064|NCT00340379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503065|NCT00340379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25503066|NCT00340379|Serotonin Agents|serotonin agents|mesh-ancestor
25503067|NCT00340379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503068|NCT00340379|Antiemetics|antiemetics|mesh-ancestor
25503069|NCT00340379|Autonomic Agents|autonomic agents|mesh-ancestor
25503070|NCT00340379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25503071|NCT00340379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25503072|NCT00340379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25503073|NCT00340379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25503074|NCT00340379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25503075|NCT00340379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25503076|NCT00340379|Dopamine Agents|dopamine agents|mesh-ancestor
25503077|NCT00340379|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25503078|NCT00340379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25503079|NCT00340678|Losartan|losartan|mesh-list
25503080|NCT00340678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25503081|NCT00340678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24978229|NCT05035303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25161809|NCT02304302|Memantine|memantine|mesh-list
24978230|NCT05025865|Hyaluronic Acid|hyaluronic acid|mesh-list
24978231|NCT05025865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24978232|NCT05025865|Immunologic Factors|immunologic factors|mesh-ancestor
25161810|NCT02304302|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24419137|NCT00211328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24419138|NCT00211328|Growth Substances|growth substances|mesh-ancestor
24419139|NCT00211328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419142|NCT00211341|Vitamin A|vitamin a|mesh-list
25503082|NCT00340678|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25503083|NCT00340678|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25503084|NCT00340678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503085|NCT00340704|Tamsulosin|tamsulosin|mesh-list
25503086|NCT00340704|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25503087|NCT00340704|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25503088|NCT00340704|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25503089|NCT00340704|Adrenergic Agents|adrenergic agents|mesh-ancestor
25503090|NCT00340704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25503091|NCT00340704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503092|NCT00340704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503093|NCT00340704|Urological Agents|urological agents|mesh-ancestor
25503094|NCT00340834|Interferons|interferons|mesh-list
25503095|NCT00340834|Interferon-beta|interferon-beta|mesh-list
25503096|NCT00340834|Interferon beta-1a|interferon beta-1a|mesh-list
25503097|NCT00340834|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25503098|NCT00340834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503099|NCT00340834|Antiviral Agents|antiviral agents|mesh-ancestor
25503100|NCT00340834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25503101|NCT00340834|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25503102|NCT00340834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503103|NCT00340834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25503104|NCT00340834|Immunologic Factors|immunologic factors|mesh-ancestor
25503105|NCT00340834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503106|NCT00340834|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25503107|NCT00342355|Ritonavir|ritonavir|mesh-list
25503108|NCT00342355|Lopinavir|lopinavir|mesh-list
25503109|NCT00342355|Lamivudine|lamivudine|mesh-list
25503110|NCT00342355|Zidovudine|zidovudine|mesh-list
25503111|NCT00342355|Stavudine|stavudine|mesh-list
25503112|NCT00342355|Didanosine|didanosine|mesh-list
25503113|NCT00342355|Efavirenz|efavirenz|mesh-list
25503114|NCT00342355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25503115|NCT00342355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25503116|NCT00342355|Protease Inhibitors|protease inhibitors|mesh-ancestor
25503117|NCT00342355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503118|NCT00342355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503119|NCT00342355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25503120|NCT00342355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25503121|NCT00342355|Antiviral Agents|antiviral agents|mesh-ancestor
25503122|NCT00342355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25503123|NCT00342355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25503124|NCT00342355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25503125|NCT00342355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25503126|NCT00342355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25503127|NCT00342355|Antimetabolites|antimetabolites|mesh-ancestor
25503128|NCT00342355|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25503129|NCT00342355|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25503130|NCT00342355|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25503131|NCT00342355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25503132|NCT00342355|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25503133|NCT00342563|Mecamylamine|mecamylamine|mesh-list
25503134|NCT00342563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25503135|NCT00342563|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
25503136|NCT00342563|Autonomic Agents|autonomic agents|mesh-ancestor
25503137|NCT00342563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25503138|NCT00342563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503139|NCT00342563|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25503140|NCT00342563|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25503141|NCT00342563|Cholinergic Agents|cholinergic agents|mesh-ancestor
25503142|NCT00342563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25503143|NCT00342563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503144|NCT00342628|Vaccines|vaccines|mesh-list
25503145|NCT00342628|Immunologic Factors|immunologic factors|mesh-ancestor
25503146|NCT00342628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503147|NCT00343044|Bevacizumab|bevacizumab|mesh-list
25503148|NCT00343044|Topotecan|topotecan|mesh-list
25503149|NCT00343044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25503150|NCT00343044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503151|NCT00343044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25503152|NCT00343044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25503153|NCT00343044|Growth Substances|growth substances|mesh-ancestor
25040710|NCT02924389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25503154|NCT00343044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503155|NCT00343044|Growth Inhibitors|growth inhibitors|mesh-ancestor
25503156|NCT00343044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25503157|NCT00343044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25503158|NCT00343044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503159|NCT00343044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503161|NCT00343083|Carboplatin|carboplatin|mesh-list
25503162|NCT00343083|Cetuximab|cetuximab|mesh-list
25503163|NCT00343083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25503164|NCT00343083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503165|NCT00343083|Tubulin Modulators|tubulin modulators|mesh-ancestor
25503166|NCT00343083|Antimitotic Agents|antimitotic agents|mesh-ancestor
25503167|NCT00343083|Mitosis Modulators|mitosis modulators|mesh-ancestor
25503168|NCT00343083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503169|NCT00343083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25503170|NCT00343252|Teriparatide|teriparatide|mesh-list
25503171|NCT00343252|Risedronic Acid|risedronic acid|mesh-list
25503172|NCT00343252|Etidronic Acid|etidronic acid|mesh-list
25503173|NCT00343252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25503174|NCT00343252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503175|NCT00343252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25503176|NCT00343252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25503177|NCT00343252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25503178|NCT00343252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503179|NCT00343291|Paclitaxel|paclitaxel|mesh-list
25503180|NCT00343291|Bevacizumab|bevacizumab|mesh-list
25503181|NCT00343291|Carboplatin|carboplatin|mesh-list
25503182|NCT00343291|Cetuximab|cetuximab|mesh-list
25503183|NCT00343291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25503184|NCT00343291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503185|NCT00343291|Tubulin Modulators|tubulin modulators|mesh-ancestor
25503186|NCT00343291|Antimitotic Agents|antimitotic agents|mesh-ancestor
25503187|NCT00343291|Mitosis Modulators|mitosis modulators|mesh-ancestor
25503188|NCT00343291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503189|NCT00343291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25503190|NCT00343291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25503191|NCT00343291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25503192|NCT00343291|Growth Substances|growth substances|mesh-ancestor
25503193|NCT00343291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503194|NCT00343291|Growth Inhibitors|growth inhibitors|mesh-ancestor
25503195|NCT00343382|Pilocarpine|pilocarpine|mesh-list
25503196|NCT00343382|Miotics|miotics|mesh-ancestor
25503197|NCT00343382|Autonomic Agents|autonomic agents|mesh-ancestor
25503198|NCT00343382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25503199|NCT00343382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503200|NCT00343382|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25503201|NCT00343382|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25503202|NCT00343382|Cholinergic Agents|cholinergic agents|mesh-ancestor
25503203|NCT00343382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25503204|NCT00343382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503205|NCT00343460|Dexamethasone|dexamethasone|mesh-list
25503206|NCT00343460|Palonosetron|palonosetron|mesh-list
25503207|NCT00343460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25503208|NCT00343460|Antiemetics|antiemetics|mesh-ancestor
25503209|NCT00343460|Autonomic Agents|autonomic agents|mesh-ancestor
25503210|NCT00343460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25503211|NCT00343460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503212|NCT00343460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25503213|NCT00343460|Glucocorticoids|glucocorticoids|mesh-ancestor
25503214|NCT00343460|Hormones|hormones|mesh-ancestor
25503215|NCT00343460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25503216|NCT00343460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25503217|NCT00343460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503218|NCT00343460|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25503219|NCT00343460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25503220|NCT00343460|Serotonin Agents|serotonin agents|mesh-ancestor
25503221|NCT00343460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25503222|NCT00343460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503223|NCT00343512|Docetaxel|docetaxel|mesh-list
25503224|NCT00343512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503225|NCT00343512|Tubulin Modulators|tubulin modulators|mesh-ancestor
25503226|NCT00343512|Antimitotic Agents|antimitotic agents|mesh-ancestor
24978332|NCT04728646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24978333|NCT04728646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503227|NCT00343512|Mitosis Modulators|mitosis modulators|mesh-ancestor
25503228|NCT00343512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503229|NCT00343785|Cyclosporine|cyclosporine|mesh-list
25503230|NCT00343785|Cyclophosphamide|cyclophosphamide|mesh-list
25503231|NCT00343785|Methotrexate|methotrexate|mesh-list
25503232|NCT00343785|Cyclosporins|cyclosporins|mesh-list
25503233|NCT00343785|Thymoglobulin|thymoglobulin|mesh-list
25503234|NCT00343785|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25503235|NCT00343785|Immunoglobulins|immunoglobulins|mesh-list
25503236|NCT00343785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25503237|NCT00343785|Immunologic Factors|immunologic factors|mesh-ancestor
25503238|NCT00343785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503239|NCT00343785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25503240|NCT00343785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25503241|NCT00343785|Alkylating Agents|alkylating agents|mesh-ancestor
25503242|NCT00343785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503243|NCT00343785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503244|NCT00343785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25503245|NCT00343785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25503246|NCT00343785|Abortifacient Agents|abortifacient agents|mesh-ancestor
25503247|NCT00343785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25503248|NCT00343785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25503249|NCT00343785|Antimetabolites|antimetabolites|mesh-ancestor
25503250|NCT00343785|Dermatologic Agents|dermatologic agents|mesh-ancestor
25503251|NCT00343785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503252|NCT00343785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25503253|NCT00343785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25503254|NCT00343785|Antifungal Agents|antifungal agents|mesh-ancestor
25503255|NCT00343785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25503256|NCT00343785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25503257|NCT00343863|Dexamethasone|dexamethasone|mesh-list
25503258|NCT00343863|Cyclophosphamide|cyclophosphamide|mesh-list
25503259|NCT00343863|Doxorubicin|doxorubicin|mesh-list
25503260|NCT00343863|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25503261|NCT00343863|Ondansetron|ondansetron|mesh-list
25503262|NCT00343863|Palonosetron|palonosetron|mesh-list
25503263|NCT00343863|Antiemetics|antiemetics|mesh-list
25503264|NCT00343863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25503265|NCT00343863|Immunologic Factors|immunologic factors|mesh-ancestor
25503266|NCT00343863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503267|NCT00343863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25503268|NCT00343863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25503269|NCT00343863|Alkylating Agents|alkylating agents|mesh-ancestor
25503270|NCT00343863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503271|NCT00343863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503272|NCT00343863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25503273|NCT00343863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25503274|NCT00343863|Autonomic Agents|autonomic agents|mesh-ancestor
25503275|NCT00343863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25503276|NCT00343863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25503277|NCT00343863|Glucocorticoids|glucocorticoids|mesh-ancestor
25503278|NCT00343863|Hormones|hormones|mesh-ancestor
25503279|NCT00343863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25503280|NCT00343863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25503281|NCT00343863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25503282|NCT00343863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25503283|NCT00343863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25503284|NCT00343863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503285|NCT00343863|Antipruritics|antipruritics|mesh-ancestor
25503286|NCT00343863|Dermatologic Agents|dermatologic agents|mesh-ancestor
25503287|NCT00343863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25503288|NCT00343863|Serotonin Agents|serotonin agents|mesh-ancestor
25503289|NCT00343863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25503290|NCT00343863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25503291|NCT00343863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25503292|NCT00343863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25503293|NCT00343863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25503294|NCT00343863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25503295|NCT00343863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25503296|NCT00343889|Vaccines|vaccines|mesh-list
25503297|NCT00343889|Immunologic Factors|immunologic factors|mesh-ancestor
25503298|NCT00343889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503299|NCT00344032|Vaccines|vaccines|mesh-list
25503300|NCT00344032|Immunologic Factors|immunologic factors|mesh-ancestor
25503301|NCT00344032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503302|NCT00344175|Simvastatin|simvastatin|mesh-list
25503303|NCT00344175|Pitavastatin|pitavastatin|mesh-list
25503304|NCT00344175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25503305|NCT00344175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25503306|NCT00344175|Antimetabolites|antimetabolites|mesh-ancestor
25503307|NCT00344175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503308|NCT00344175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25503309|NCT00344175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25503310|NCT00344175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503312|NCT00344305|Immunologic Factors|immunologic factors|mesh-ancestor
25503313|NCT00344305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503314|NCT00344318|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25503315|NCT00344318|Immunologic Factors|immunologic factors|mesh-ancestor
25503316|NCT00344318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503317|NCT00344370|Atorvastatin|atorvastatin|mesh-list
25503318|NCT00344370|Pitavastatin|pitavastatin|mesh-list
25503319|NCT00344370|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25503320|NCT00344370|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25503321|NCT00344370|Antimetabolites|antimetabolites|mesh-ancestor
25503322|NCT00344370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503323|NCT00344370|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25503324|NCT00344370|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25503325|NCT00344370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503326|NCT00344461|Tenofovir|tenofovir|mesh-list
25503327|NCT00344461|Nevirapine|nevirapine|mesh-list
25503328|NCT00344461|Antiviral Agents|antiviral agents|mesh-ancestor
25503329|NCT00344461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25503330|NCT00344461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25503331|NCT00344461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25503332|NCT00344461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503333|NCT00344461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503334|NCT00344461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25503335|NCT00344461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25503336|NCT00344461|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25503337|NCT00344461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25503338|NCT00344682|Memantine|memantine|mesh-list
25503339|NCT00344682|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25503340|NCT00344682|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25503341|NCT00344682|Dopamine Agents|dopamine agents|mesh-ancestor
24542130|NCT00677118|Antimetabolites|antimetabolites|mesh-ancestor
24542131|NCT00677118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503342|NCT00344682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25503343|NCT00344682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503344|NCT00344682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503345|NCT00344682|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25503346|NCT00344682|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25503347|NCT00344773|Gefitinib|gefitinib|mesh-list
25503348|NCT00344773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503349|NCT00344773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25503350|NCT00344773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503351|NCT00344773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503352|NCT00344968|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
25503353|NCT00344968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25503354|NCT00344968|Glucocorticoids|glucocorticoids|mesh-ancestor
25503355|NCT00344968|Hormones|hormones|mesh-ancestor
25503356|NCT00344968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25503357|NCT00344968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503358|NCT00345033|Aripiprazole|aripiprazole|mesh-list
25503359|NCT00345033|Antidepressive Agents|antidepressive agents|mesh-ancestor
25503360|NCT00345033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25503361|NCT00345033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25503362|NCT00345033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25503363|NCT00345033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25503364|NCT00345033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503365|NCT00345033|Dopamine Agonists|dopamine agonists|mesh-ancestor
25503366|NCT00345033|Dopamine Agents|dopamine agents|mesh-ancestor
25503367|NCT00345033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25503368|NCT00345033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503369|NCT00345033|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25503370|NCT00345033|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25503371|NCT00345033|Serotonin Agents|serotonin agents|mesh-ancestor
25503372|NCT00345033|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25503373|NCT00345033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25503374|NCT00345033|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25503375|NCT00345033|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25503376|NCT00345046|Prednisolone|prednisolone|mesh-list
25503377|NCT00345046|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25503379|NCT00345046|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25503380|NCT00345046|Prednisolone acetate|prednisolone acetate|mesh-list
25503381|NCT00345046|Prednisone|prednisone|mesh-list
25503382|NCT00345046|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25645685|NCT01450306|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25645686|NCT01450306|Antitubercular Agents|antitubercular agents|mesh-ancestor
25645687|NCT01450306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25645688|NCT01450306|Antimetabolites|antimetabolites|mesh-ancestor
25645689|NCT01450306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645690|NCT01450319|Cetuximab|cetuximab|mesh-list
25503383|NCT00345046|Prednisolone phosphate|prednisolone phosphate|mesh-list
25503384|NCT00345046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25503385|NCT00345046|Glucocorticoids|glucocorticoids|mesh-ancestor
25503386|NCT00345046|Hormones|hormones|mesh-ancestor
25503387|NCT00345046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25503388|NCT00345046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503389|NCT00345046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25503390|NCT00345046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503391|NCT00345046|Antiemetics|antiemetics|mesh-ancestor
25503392|NCT00345046|Autonomic Agents|autonomic agents|mesh-ancestor
25503393|NCT00345046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25503394|NCT00345046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25503395|NCT00345046|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25503396|NCT00345046|Protective Agents|protective agents|mesh-ancestor
25503397|NCT00345371|Topiramate|topiramate|mesh-list
25503398|NCT00345371|Anticonvulsants|anticonvulsants|mesh-ancestor
25503399|NCT00345371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25503400|NCT00345371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503401|NCT00345384|Dexmedetomidine|dexmedetomidine|mesh-list
25503402|NCT00345384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25503403|NCT00345384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25503404|NCT00345384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503405|NCT00345384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25503406|NCT00345384|Analgesics|analgesics|mesh-ancestor
25503407|NCT00345384|Sensory System Agents|sensory system agents|mesh-ancestor
25503408|NCT00345384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25503409|NCT00345384|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25503410|NCT00345384|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25503411|NCT00345384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25503412|NCT00345384|Adrenergic Agents|adrenergic agents|mesh-ancestor
25503413|NCT00345384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25503414|NCT00345384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503415|NCT00345540|Carboplatin|carboplatin|mesh-list
25503416|NCT00345540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503417|NCT00345579|PENTA|penta|mesh-list
25503418|NCT00345579|Anticoagulants|anticoagulants|mesh-ancestor
25503419|NCT00345579|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25503420|NCT00345579|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25503421|NCT00345579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503422|NCT00345605|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25503423|NCT00345605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503424|NCT00345683|Vaccines|vaccines|mesh-list
25503425|NCT00345683|Immunologic Factors|immunologic factors|mesh-ancestor
25503426|NCT00345683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503427|NCT00345865|Cytarabine|cytarabine|mesh-list
25503428|NCT00345865|Cyclophosphamide|cyclophosphamide|mesh-list
25503429|NCT00345865|Carmustine|carmustine|mesh-list
25503430|NCT00345865|Etoposide|etoposide|mesh-list
25503431|NCT00345865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25503432|NCT00345865|Immunologic Factors|immunologic factors|mesh-ancestor
25503433|NCT00345865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503434|NCT00345865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25503435|NCT00345865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25503436|NCT00345865|Alkylating Agents|alkylating agents|mesh-ancestor
25503437|NCT00345865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503438|NCT00345865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503439|NCT00345865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25503440|NCT00345865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25503441|NCT00345865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25503442|NCT00345865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25503443|NCT00345865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503444|NCT00345865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25503445|NCT00345865|Antimetabolites|antimetabolites|mesh-ancestor
25503446|NCT00345865|Antiviral Agents|antiviral agents|mesh-ancestor
25503447|NCT00345865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25503448|NCT00345878|Vaccines|vaccines|mesh-list
25503449|NCT00345878|Immunologic Factors|immunologic factors|mesh-ancestor
24419892|NCT00214331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419893|NCT00214331|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24978558|NCT03948035|Hormones|hormones|mesh-ancestor
25503450|NCT00345878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503451|NCT00345969|Testosterone|testosterone|mesh-list
25503452|NCT00345969|Androgens|androgens|mesh-ancestor
25503453|NCT00345969|Hormones|hormones|mesh-ancestor
25503454|NCT00345969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25503455|NCT00345969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503456|NCT00346034|Pregabalin|pregabalin|mesh-list
25503457|NCT00346034|Analgesics|analgesics|mesh-ancestor
25503458|NCT00346034|Sensory System Agents|sensory system agents|mesh-ancestor
25503459|NCT00346034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25503460|NCT00346034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503461|NCT00346034|Anticonvulsants|anticonvulsants|mesh-ancestor
25503462|NCT00346034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25503463|NCT00346034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25503464|NCT00346034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503465|NCT00346034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25503466|NCT00346034|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25503467|NCT00346034|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25503468|NCT00346034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25503469|NCT00346034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25503470|NCT00346151|Sirolimus|sirolimus|mesh-list
25503471|NCT00346151|Methylprednisolone|methylprednisolone|mesh-list
25503472|NCT00346151|Abatacept|abatacept|mesh-list
25503473|NCT00346151|Thymoglobulin|thymoglobulin|mesh-list
25503474|NCT00346151|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25503475|NCT00346151|Immunoglobulins|immunoglobulins|mesh-list
25503476|NCT00346151|Glucocorticoids|glucocorticoids|mesh-list
25503477|NCT00346151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25503478|NCT00346151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25503479|NCT00346151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25503480|NCT00346151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503481|NCT00346151|Antifungal Agents|antifungal agents|mesh-ancestor
25503482|NCT00346151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25503483|NCT00346151|Immunologic Factors|immunologic factors|mesh-ancestor
25503484|NCT00346151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503485|NCT00346151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25503486|NCT00346151|Antiemetics|antiemetics|mesh-ancestor
25503487|NCT00346151|Autonomic Agents|autonomic agents|mesh-ancestor
25503488|NCT00346151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25503489|NCT00346151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25503490|NCT00346151|Hormones|hormones|mesh-ancestor
25503491|NCT00346151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25503492|NCT00346151|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25503493|NCT00346151|Protective Agents|protective agents|mesh-ancestor
25503494|NCT00346151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25503495|NCT00346151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503496|NCT00346151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25503497|NCT00346216|Ibuprofen|ibuprofen|mesh-list
25503498|NCT00346216|Celecoxib|celecoxib|mesh-list
25503499|NCT00346216|Naproxen|naproxen|mesh-list
25503500|NCT00346216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25503501|NCT00346216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25503502|NCT00346216|Analgesics|analgesics|mesh-ancestor
25503503|NCT00346216|Sensory System Agents|sensory system agents|mesh-ancestor
25503504|NCT00346216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25503505|NCT00346216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503506|NCT00346216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25503507|NCT00346216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25503508|NCT00346216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25503509|NCT00346216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503510|NCT00346216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503511|NCT00346216|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25503512|NCT00346216|Gout Suppressants|gout suppressants|mesh-ancestor
25503513|NCT00346268|Parecoxib|parecoxib|mesh-list
25503514|NCT00346268|Morphine|morphine|mesh-list
25503515|NCT00346268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25503516|NCT00346268|Narcotics|narcotics|mesh-ancestor
25503517|NCT00346268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25503518|NCT00346268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503519|NCT00346268|Analgesics|analgesics|mesh-ancestor
25503520|NCT00346268|Sensory System Agents|sensory system agents|mesh-ancestor
25503521|NCT00346268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25503522|NCT00346268|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25503523|NCT00346268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25105802|NCT04861064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120979|NCT01228331|Amsacrine|amsacrine|mesh-list
25503548|NCT00347360|Carvedilol|carvedilol|mesh-list
25503549|NCT00347360|Lisinopril|lisinopril|mesh-list
25503550|NCT00347360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25503551|NCT00347360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25503552|NCT00347360|Adrenergic Agents|adrenergic agents|mesh-ancestor
25503553|NCT00347360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25503554|NCT00347360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503555|NCT00347360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503556|NCT00347360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25503557|NCT00347360|Antioxidants|antioxidants|mesh-ancestor
25503558|NCT00347360|Protective Agents|protective agents|mesh-ancestor
25503559|NCT00347360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25503560|NCT00347360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25503561|NCT00347360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25503562|NCT00347360|Vasodilator Agents|vasodilator agents|mesh-ancestor
25503563|NCT00347360|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25503564|NCT00347360|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25503565|NCT00347360|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25503566|NCT00347360|Protease Inhibitors|protease inhibitors|mesh-ancestor
25503567|NCT00347360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503568|NCT00347360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25503569|NCT00347438|Capecitabine|capecitabine|mesh-list
25503570|NCT00347438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25503571|NCT00347438|Antimetabolites|antimetabolites|mesh-ancestor
25503572|NCT00347438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503573|NCT00347438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503574|NCT00347776|Azithromycin|azithromycin|mesh-list
25163406|NCT02896582|Antimetabolites|antimetabolites|mesh-ancestor
25503575|NCT00347776|Tetracycline|tetracycline|mesh-list
25503576|NCT00347776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25503577|NCT00347776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25503578|NCT00347776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25503579|NCT00347776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503580|NCT00347776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503581|NCT00347919|Lapatinib|lapatinib|mesh-list
25503582|NCT00347919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503583|NCT00347919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25503584|NCT00347919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503585|NCT00347919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503586|NCT00347932|Besifloxacin|besifloxacin|mesh-list
25503587|NCT00347932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25503588|NCT00347932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25503589|NCT00347932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25503590|NCT00347932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25503591|NCT00347932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503592|NCT00347932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503593|NCT00347932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503594|NCT00348140|Rosiglitazone|rosiglitazone|mesh-list
25503595|NCT00348140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25503596|NCT00348140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503597|NCT00348283|Adalimumab|adalimumab|mesh-list
25503598|NCT00348283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25503599|NCT00348283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25503600|NCT00348309|Rosiglitazone|rosiglitazone|mesh-list
25503601|NCT00348309|Donepezil|donepezil|mesh-list
25503602|NCT00348309|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25503603|NCT00348309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503604|NCT00348309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503605|NCT00348309|Cholinergic Agents|cholinergic agents|mesh-ancestor
25503606|NCT00348309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25503607|NCT00348309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503608|NCT00348309|Nootropic Agents|nootropic agents|mesh-ancestor
25503609|NCT00348309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25503610|NCT00348348|Moxifloxacin|moxifloxacin|mesh-list
25503611|NCT00348348|Besifloxacin|besifloxacin|mesh-list
25503612|NCT00348348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25503613|NCT00348348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25503614|NCT00348348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25503615|NCT00348348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25503616|NCT00348348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503617|NCT00348348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503618|NCT00348348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503619|NCT00348374|Insulin Lispro|insulin lispro|mesh-list
25503620|NCT00348374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24978676|NCT03432741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24978678|NCT03410706|Rivaroxaban|rivaroxaban|mesh-list
25503621|NCT00348374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503622|NCT00348595|Lenalidomide|lenalidomide|mesh-list
25503623|NCT00348595|Immunologic Factors|immunologic factors|mesh-ancestor
25503624|NCT00348595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503625|NCT00348595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25503626|NCT00348595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25503627|NCT00348595|Growth Substances|growth substances|mesh-ancestor
25503628|NCT00348595|Growth Inhibitors|growth inhibitors|mesh-ancestor
25503629|NCT00348595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503630|NCT00348686|Felodipine|felodipine|mesh-list
25503631|NCT00348686|Candesartan|candesartan|mesh-list
25503632|NCT00348686|Candesartan cilexetil|candesartan cilexetil|mesh-list
25503633|NCT00348686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25503634|NCT00348686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25503635|NCT00348686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25503636|NCT00348686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503637|NCT00348686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25503638|NCT00348686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25503639|NCT00348686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25503640|NCT00348686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25503641|NCT00348686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503642|NCT00348686|Vasodilator Agents|vasodilator agents|mesh-ancestor
25503643|NCT00348790|Vatalanib|vatalanib|mesh-list
25503644|NCT00348790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25503645|NCT00348790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503646|NCT00348790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503647|NCT00348816|Prednisone|prednisone|mesh-list
25503648|NCT00348816|Docetaxel|docetaxel|mesh-list
25503649|NCT00348816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503650|NCT00348816|Tubulin Modulators|tubulin modulators|mesh-ancestor
25503651|NCT00348816|Antimitotic Agents|antimitotic agents|mesh-ancestor
25503652|NCT00348816|Mitosis Modulators|mitosis modulators|mesh-ancestor
25503653|NCT00348816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503654|NCT00348816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25503655|NCT00348816|Glucocorticoids|glucocorticoids|mesh-ancestor
25503656|NCT00348816|Hormones|hormones|mesh-ancestor
25503657|NCT00348816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25503658|NCT00348816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503659|NCT00348816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25503660|NCT00348881|Vaccines|vaccines|mesh-list
25503661|NCT00348881|Immunologic Factors|immunologic factors|mesh-ancestor
25503662|NCT00348881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503663|NCT00348933|Vitamin B 12|vitamin b 12|mesh-list
25503664|NCT00348933|Hydroxocobalamin|hydroxocobalamin|mesh-list
25503665|NCT00348933|Betaine|betaine|mesh-list
25503666|NCT00348933|Vitamins|vitamins|mesh-ancestor
25503667|NCT00348933|Micronutrients|micronutrients|mesh-ancestor
25503668|NCT00348933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503669|NCT00348933|Vitamin B Complex|vitamin b complex|mesh-ancestor
25503670|NCT00348933|Hematinics|hematinics|mesh-ancestor
25503671|NCT00348933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25503672|NCT00348933|Lipotropic Agents|lipotropic agents|mesh-ancestor
25503673|NCT00348933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25503674|NCT00348933|Antimetabolites|antimetabolites|mesh-ancestor
25503675|NCT00348933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503676|NCT00348933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25503677|NCT00348946|Androgens|androgens|mesh-list
25503678|NCT00348946|Oxandrolone|oxandrolone|mesh-list
25503679|NCT00348946|Hormones|hormones|mesh-ancestor
25503680|NCT00348946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25503681|NCT00348946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503682|NCT00348946|Anabolic Agents|anabolic agents|mesh-ancestor
25503683|NCT00349336|Bevacizumab|bevacizumab|mesh-list
25503684|NCT00349336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25503685|NCT00349336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503686|NCT00349336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25503687|NCT00349336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25503688|NCT00349336|Growth Substances|growth substances|mesh-ancestor
25503689|NCT00349336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503690|NCT00349336|Growth Inhibitors|growth inhibitors|mesh-ancestor
25503691|NCT00349349|Ofatumumab|ofatumumab|mesh-list
25503692|NCT00349349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503693|NCT00349388|Mesalamine|mesalamine|mesh-list
25503694|NCT00349388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25503695|NCT00349388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25823187|NCT00004762|Immunologic Factors|immunologic factors|mesh-ancestor
25645691|NCT01450319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25645692|NCT01450319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645693|NCT01450683|Itraconazole|itraconazole|mesh-list
25645694|NCT01450683|Antifungal Agents|antifungal agents|mesh-ancestor
25645695|NCT01450683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25645696|NCT01450683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25645697|NCT01450683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25645698|NCT01450683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645699|NCT01450683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645700|NCT01450683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25645701|NCT01450683|Hormone Antagonists|hormone antagonists|mesh-ancestor
25645702|NCT01450683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25645703|NCT01450683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823188|NCT00004762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503696|NCT00349388|Analgesics|analgesics|mesh-ancestor
25503697|NCT00349388|Sensory System Agents|sensory system agents|mesh-ancestor
25503698|NCT00349388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25503699|NCT00349388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503700|NCT00349388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25503701|NCT00349388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25503702|NCT00349622|Ceftriaxone|ceftriaxone|mesh-list
25503703|NCT00349622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25503704|NCT00349622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25503705|NCT00349752|Certolizumab Pegol|certolizumab pegol|mesh-list
25503706|NCT00349752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25503707|NCT00349752|Immunologic Factors|immunologic factors|mesh-ancestor
25503708|NCT00349752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503709|NCT00349752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25503710|NCT00349778|Cyclophosphamide|cyclophosphamide|mesh-list
25503711|NCT00349778|Melphalan|melphalan|mesh-list
25503712|NCT00349778|Carmustine|carmustine|mesh-list
25503713|NCT00349778|Etoposide|etoposide|mesh-list
25503714|NCT00349778|Etoposide phosphate|etoposide phosphate|mesh-list
25503715|NCT00349778|Lenograstim|lenograstim|mesh-list
25503716|NCT00349778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25503717|NCT00349778|Immunologic Factors|immunologic factors|mesh-ancestor
25503718|NCT00349778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503719|NCT00349778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25503720|NCT00349778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25503721|NCT00349778|Alkylating Agents|alkylating agents|mesh-ancestor
25503722|NCT00349778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503723|NCT00349778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503724|NCT00349778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25503725|NCT00349778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25503726|NCT00349778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25503727|NCT00349778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25503728|NCT00349778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503729|NCT00349778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25503730|NCT00349921|Adenosine|adenosine|mesh-list
25503731|NCT00349921|Clonidine|clonidine|mesh-list
25503732|NCT00349921|Analgesics|analgesics|mesh-ancestor
25503733|NCT00349921|Sensory System Agents|sensory system agents|mesh-ancestor
25503734|NCT00349921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25503735|NCT00349921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503736|NCT00349921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25503737|NCT00349921|Sympatholytics|sympatholytics|mesh-ancestor
25503738|NCT00349921|Autonomic Agents|autonomic agents|mesh-ancestor
25503739|NCT00349921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25503740|NCT00349921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25503741|NCT00349921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25503742|NCT00349921|Adrenergic Agents|adrenergic agents|mesh-ancestor
25503743|NCT00349921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25503744|NCT00349921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503745|NCT00349921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25503746|NCT00349921|Vasodilator Agents|vasodilator agents|mesh-ancestor
25503747|NCT00349921|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25503748|NCT00349921|Purinergic Agonists|purinergic agonists|mesh-ancestor
25503749|NCT00349921|Purinergic Agents|purinergic agents|mesh-ancestor
25503750|NCT00349973|Dipyridamole|dipyridamole|mesh-list
25503751|NCT00349973|Olanzapine|olanzapine|mesh-list
25503752|NCT00349973|Antiemetics|antiemetics|mesh-ancestor
25503753|NCT00349973|Autonomic Agents|autonomic agents|mesh-ancestor
25503754|NCT00349973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25503755|NCT00349973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068573|NCT03432767|Chrysarobin|chrysarobin|mesh-list
25503756|NCT00349973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25503757|NCT00349973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25503758|NCT00349973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25503759|NCT00349973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25503760|NCT00349973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25503761|NCT00349973|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25503762|NCT00349973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25503763|NCT00349973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25503764|NCT00349973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503765|NCT00349973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25503766|NCT00349973|Serotonin Agents|serotonin agents|mesh-ancestor
25503767|NCT00349973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25503768|NCT00349973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503769|NCT00349973|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25503770|NCT00349973|Vasodilator Agents|vasodilator agents|mesh-ancestor
25503771|NCT00350025|Paclitaxel|paclitaxel|mesh-list
25503772|NCT00350025|Cetuximab|cetuximab|mesh-list
25503773|NCT00350025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25503774|NCT00350025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503775|NCT00350025|Tubulin Modulators|tubulin modulators|mesh-ancestor
25503776|NCT00350025|Antimitotic Agents|antimitotic agents|mesh-ancestor
25503777|NCT00350025|Mitosis Modulators|mitosis modulators|mesh-ancestor
24862509|NCT02325934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25503778|NCT00350025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503779|NCT00350025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25503780|NCT00350142|Gemcitabine|gemcitabine|mesh-list
25503781|NCT00350142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25503782|NCT00350142|Antimetabolites|antimetabolites|mesh-ancestor
25503783|NCT00350142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503784|NCT00350142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503785|NCT00350142|Antiviral Agents|antiviral agents|mesh-ancestor
25503786|NCT00350142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25503787|NCT00350142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503788|NCT00350142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25503789|NCT00350142|Immunologic Factors|immunologic factors|mesh-ancestor
25503790|NCT00350142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503791|NCT00350207|Bromides|bromides|mesh-list
25503792|NCT00350207|Tiotropium Bromide|tiotropium bromide|mesh-list
25503793|NCT00350207|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25503794|NCT00350207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25503795|NCT00350207|Autonomic Agents|autonomic agents|mesh-ancestor
25503796|NCT00350207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25503797|NCT00350207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503798|NCT00350207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25503799|NCT00350207|Respiratory System Agents|respiratory system agents|mesh-ancestor
25503800|NCT00350207|Parasympatholytics|parasympatholytics|mesh-ancestor
25503801|NCT00350207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25503802|NCT00350207|Cholinergic Agents|cholinergic agents|mesh-ancestor
25503803|NCT00350207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25503804|NCT00350207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503805|NCT00350207|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25503806|NCT00350207|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25503807|NCT00350207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25503808|NCT00350207|Adrenergic Agents|adrenergic agents|mesh-ancestor
25503809|NCT00350207|Anticonvulsants|anticonvulsants|mesh-ancestor
25503810|NCT00350272|Tenofovir|tenofovir|mesh-list
25503811|NCT00350272|Lamivudine|lamivudine|mesh-list
25503812|NCT00350272|Efavirenz|efavirenz|mesh-list
25503813|NCT00350272|Dexelvucitabine|dexelvucitabine|mesh-list
25503814|NCT00350272|Antiviral Agents|antiviral agents|mesh-ancestor
25503815|NCT00350272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25503816|NCT00350272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25503817|NCT00350272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25503818|NCT00350272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503819|NCT00350272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503820|NCT00350272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25503821|NCT00350272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25503822|NCT00350272|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25503823|NCT00350272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25503824|NCT00350272|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25503825|NCT00350272|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25503826|NCT00350272|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25503827|NCT00350272|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25503828|NCT00350363|Gatifloxacin|gatifloxacin|mesh-list
25503829|NCT00350363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25503830|NCT00350363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25503831|NCT00350363|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25503832|NCT00350363|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25503833|NCT00350363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25503834|NCT00350363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25503835|NCT00350363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503836|NCT00350363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503837|NCT00350363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503838|NCT00350519|Epoetin Alfa|epoetin alfa|mesh-list
25503839|NCT00350519|Hematinics|hematinics|mesh-ancestor
25503840|NCT00350532|Clonidine|clonidine|mesh-list
25503841|NCT00350532|Analgesics|analgesics|mesh-ancestor
25503842|NCT00350532|Sensory System Agents|sensory system agents|mesh-ancestor
25503843|NCT00350532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24542338|NCT00678327|Bleomycin|bleomycin|mesh-list
24542339|NCT00678327|Vinblastine|vinblastine|mesh-list
24542340|NCT00678327|Procarbazine|procarbazine|mesh-list
25503844|NCT00350532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503845|NCT00350532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24978760|NCT02991144|Prednisone|prednisone|mesh-list
24978761|NCT02991144|Prednisolone|prednisolone|mesh-list
25503846|NCT00350532|Sympatholytics|sympatholytics|mesh-ancestor
25503847|NCT00350532|Autonomic Agents|autonomic agents|mesh-ancestor
25503848|NCT00350532|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25503849|NCT00350532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25503850|NCT00350532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25503851|NCT00350532|Adrenergic Agents|adrenergic agents|mesh-ancestor
25503852|NCT00350532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25503853|NCT00350532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503854|NCT00350545|Cyclosporine|cyclosporine|mesh-list
25503855|NCT00350545|Prednisone|prednisone|mesh-list
25503856|NCT00350545|Rituximab|rituximab|mesh-list
25503857|NCT00350545|Tacrolimus|tacrolimus|mesh-list
25503858|NCT00350545|Cyclosporins|cyclosporins|mesh-list
25503859|NCT00350545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25503860|NCT00350545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503861|NCT00350545|Immunologic Factors|immunologic factors|mesh-ancestor
25503862|NCT00350545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503863|NCT00350545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25503864|NCT00350545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25503865|NCT00350545|Glucocorticoids|glucocorticoids|mesh-ancestor
25503866|NCT00350545|Hormones|hormones|mesh-ancestor
25503867|NCT00350545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25503868|NCT00350545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25503869|NCT00350545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25503870|NCT00350545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25503871|NCT00350545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503872|NCT00350545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503873|NCT00350545|Antifungal Agents|antifungal agents|mesh-ancestor
25503874|NCT00350545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25503875|NCT00350545|Dermatologic Agents|dermatologic agents|mesh-ancestor
25503876|NCT00350636|Mandelic Acids|mandelic acids|mesh-list
25503877|NCT00350636|Oxybutynin|oxybutynin|mesh-list
25503878|NCT00350636|Parasympatholytics|parasympatholytics|mesh-ancestor
25503879|NCT00350636|Autonomic Agents|autonomic agents|mesh-ancestor
25503880|NCT00350636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25503881|NCT00350636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503882|NCT00350636|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25503883|NCT00350636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25503884|NCT00350636|Cholinergic Agents|cholinergic agents|mesh-ancestor
25503885|NCT00350636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25503886|NCT00350636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503887|NCT00350636|Urological Agents|urological agents|mesh-ancestor
25503888|NCT00350636|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25503889|NCT00350636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25503890|NCT00350636|Renal Agents|renal agents|mesh-ancestor
25503891|NCT00350727|Lapatinib|lapatinib|mesh-list
25503892|NCT00350727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503893|NCT00350727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25503894|NCT00350727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503895|NCT00350727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503896|NCT00350779|Metformin|metformin|mesh-list
25503897|NCT00350779|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25503898|NCT00350779|Rosiglitazone|rosiglitazone|mesh-list
25503899|NCT00350779|Glipizide|glipizide|mesh-list
25503900|NCT00350779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25503901|NCT00350779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503902|NCT00350779|Incretins|incretins|mesh-ancestor
25503903|NCT00350779|Hormones|hormones|mesh-ancestor
25503904|NCT00350779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25645704|NCT01450683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25645705|NCT01450696|Cisplatin|cisplatin|mesh-list
25645706|NCT01450696|Capecitabine|capecitabine|mesh-list
25645707|NCT01450696|Trastuzumab|trastuzumab|mesh-list
24862626|NCT04987931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645708|NCT01450696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645709|NCT01450696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25645710|NCT01450696|Antimetabolites|antimetabolites|mesh-ancestor
25503905|NCT00350779|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25503906|NCT00350779|Protease Inhibitors|protease inhibitors|mesh-ancestor
25503907|NCT00350779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503908|NCT00350779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503909|NCT00350792|Carboplatin|carboplatin|mesh-list
25503910|NCT00350792|Pemetrexed|pemetrexed|mesh-list
25503911|NCT00350792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503912|NCT00350792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503913|NCT00350792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503914|NCT00350792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25503915|NCT00350792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25503916|NCT00350870|Disulfiram|disulfiram|mesh-list
25503917|NCT00350870|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25503918|NCT00350870|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25503919|NCT00350870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503920|NCT00350870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503921|NCT00351000|Ziprasidone|ziprasidone|mesh-list
25503922|NCT00351000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25503923|NCT00351000|Serotonin Agents|serotonin agents|mesh-ancestor
25503924|NCT00351000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25503925|NCT00351000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503926|NCT00351000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503927|NCT00351000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25503928|NCT00351000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25503929|NCT00351000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25503930|NCT00351000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25503931|NCT00351000|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25503932|NCT00351000|Dopamine Agents|dopamine agents|mesh-ancestor
25503934|NCT00351039|Pemetrexed|pemetrexed|mesh-list
25503935|NCT00351039|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25503936|NCT00351039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25503937|NCT00351039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503938|NCT00351039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25503939|NCT00351039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25503940|NCT00351039|Growth Substances|growth substances|mesh-ancestor
25503941|NCT00351039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503942|NCT00351039|Growth Inhibitors|growth inhibitors|mesh-ancestor
25503943|NCT00351039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503944|NCT00351039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503945|NCT00351039|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25503946|NCT00351039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25503947|NCT00351039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25503948|NCT00351273|Azithromycin|azithromycin|mesh-list
25503949|NCT00351273|Doxycycline|doxycycline|mesh-list
25503950|NCT00351273|Rifampin|rifampin|mesh-list
25503951|NCT00351273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25503952|NCT00351273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25503953|NCT00351273|Antimalarials|antimalarials|mesh-ancestor
25503954|NCT00351273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25503955|NCT00351273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25503956|NCT00351273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25503957|NCT00351273|Antitubercular Agents|antitubercular agents|mesh-ancestor
25503958|NCT00351273|Leprostatic Agents|leprostatic agents|mesh-ancestor
25503959|NCT00351273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25503960|NCT00351273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503961|NCT00351273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503962|NCT00351273|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25503963|NCT00351273|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25503964|NCT00351273|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25503965|NCT00351273|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25503966|NCT00351273|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25503967|NCT00351273|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25503968|NCT00351299|Dexmedetomidine|dexmedetomidine|mesh-list
25503969|NCT00351299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25503970|NCT00351299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24683617|NCT01393145|Dermatologic Agents|dermatologic agents|mesh-ancestor
25503971|NCT00351299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25503972|NCT00351299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25503973|NCT00351299|Analgesics|analgesics|mesh-ancestor
25503974|NCT00351299|Sensory System Agents|sensory system agents|mesh-ancestor
25503975|NCT00351299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25823189|NCT00004763|Leuprolide|leuprolide|mesh-list
25645711|NCT01450696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645712|NCT01450696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25645713|NCT01450761|Cisplatin|cisplatin|mesh-list
25645714|NCT01450761|Carboplatin|carboplatin|mesh-list
25645715|NCT01450761|Etoposide|etoposide|mesh-list
25645716|NCT01450761|Ipilimumab|ipilimumab|mesh-list
25645717|NCT01450761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503976|NCT00351299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25503977|NCT00351299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25503978|NCT00351299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25503979|NCT00351299|Adrenergic Agents|adrenergic agents|mesh-ancestor
25503980|NCT00351299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25503981|NCT00351299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503982|NCT00351377|Mycophenolic Acid|mycophenolic acid|mesh-list
25503983|NCT00351377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25503984|NCT00351377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503985|NCT00351377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25503986|NCT00351377|Antitubercular Agents|antitubercular agents|mesh-ancestor
25503987|NCT00351377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25503988|NCT00351377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25503989|NCT00351377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503990|NCT00351377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503991|NCT00351416|Letrozole|letrozole|mesh-list
25503992|NCT00351416|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25503993|NCT00351416|LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-|lhrh, n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-arg(5)-glu(6)-alanh2(10)-|mesh-list
25503994|NCT00351416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25503995|NCT00351416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25503996|NCT00351416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25503997|NCT00351416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25503998|NCT00351416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25503999|NCT00351416|Hormone Antagonists|hormone antagonists|mesh-ancestor
25504000|NCT00351416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25504001|NCT00351416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504002|NCT00351611|Pregabalin|pregabalin|mesh-list
25504003|NCT00351611|Analgesics|analgesics|mesh-ancestor
25504004|NCT00351611|Sensory System Agents|sensory system agents|mesh-ancestor
25504005|NCT00351611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25504006|NCT00351611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504007|NCT00351611|Anticonvulsants|anticonvulsants|mesh-ancestor
25504008|NCT00351611|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25504009|NCT00351611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25504010|NCT00351611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504011|NCT00351611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25504012|NCT00351611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25504013|NCT00351611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25504014|NCT00351611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25504015|NCT00351611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25504016|NCT00351819|Testosterone|testosterone|mesh-list
25504017|NCT00351819|Androgens|androgens|mesh-ancestor
25504018|NCT00351819|Hormones|hormones|mesh-ancestor
25504019|NCT00351819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25504020|NCT00351819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504021|NCT00351936|Aripiprazole|aripiprazole|mesh-list
25504022|NCT00351936|Antidepressive Agents|antidepressive agents|mesh-ancestor
25504023|NCT00351936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25504024|NCT00351936|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25504025|NCT00351936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25504026|NCT00351936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25504027|NCT00351936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504028|NCT00351936|Dopamine Agonists|dopamine agonists|mesh-ancestor
25504029|NCT00351936|Dopamine Agents|dopamine agents|mesh-ancestor
25504030|NCT00351936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25504031|NCT00351936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504032|NCT00351936|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25202999|NCT02717052|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25645718|NCT01450761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25645719|NCT01450761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25504033|NCT00351936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25504034|NCT00351936|Serotonin Agents|serotonin agents|mesh-ancestor
25504035|NCT00351936|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25504036|NCT00351936|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25504037|NCT00351936|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25504038|NCT00351936|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25504039|NCT00352001|Lenalidomide|lenalidomide|mesh-list
25504040|NCT00352001|Azacitidine|azacitidine|mesh-list
25504041|NCT00352001|Immunologic Factors|immunologic factors|mesh-ancestor
25504042|NCT00352001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504043|NCT00352001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25504044|NCT00352001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25504045|NCT00352001|Growth Substances|growth substances|mesh-ancestor
25504046|NCT00352001|Growth Inhibitors|growth inhibitors|mesh-ancestor
25504047|NCT00352001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504048|NCT00352001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25504049|NCT00352001|Antimetabolites|antimetabolites|mesh-ancestor
25504050|NCT00352001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504051|NCT00352001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25504053|NCT00352053|Antiviral Agents|antiviral agents|mesh-ancestor
25504054|NCT00352053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25504055|NCT00352053|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25504056|NCT00352053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25504057|NCT00352053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25504058|NCT00352053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504059|NCT00352053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25504060|NCT00352053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25504061|NCT00352105|Cisplatin|cisplatin|mesh-list
25504062|NCT00352105|Fluorouracil|fluorouracil|mesh-list
25504063|NCT00352105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504064|NCT00352105|Antimetabolites|antimetabolites|mesh-ancestor
25504065|NCT00352105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421421|NCT00218608|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25504066|NCT00352105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25504067|NCT00352105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25504068|NCT00352105|Immunologic Factors|immunologic factors|mesh-ancestor
25504069|NCT00352105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504070|NCT00352365|Lenalidomide|lenalidomide|mesh-list
25504071|NCT00352365|Immunologic Factors|immunologic factors|mesh-ancestor
25504072|NCT00352365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504073|NCT00352365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25504074|NCT00352365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25504075|NCT00352365|Growth Substances|growth substances|mesh-ancestor
25504076|NCT00352365|Growth Inhibitors|growth inhibitors|mesh-ancestor
25504077|NCT00352365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504078|NCT00352417|Atreleuton|atreleuton|mesh-list
25504079|NCT00352417|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25504080|NCT00352417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25504081|NCT00352417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504082|NCT00352612|Clindamycin|clindamycin|mesh-list
25504083|NCT00352612|Clindamycin palmitate|clindamycin palmitate|mesh-list
25504084|NCT00352612|Clindamycin phosphate|clindamycin phosphate|mesh-list
25504085|NCT00352612|Cephalexin|cephalexin|mesh-list
25504086|NCT00352612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25504087|NCT00352612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25504088|NCT00352612|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25504089|NCT00352612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25504090|NCT00352612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504091|NCT00352664|Donepezil|donepezil|mesh-list
25504092|NCT00352664|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25504093|NCT00352664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25504094|NCT00352664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504095|NCT00352664|Cholinergic Agents|cholinergic agents|mesh-ancestor
25504096|NCT00352664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25504097|NCT00352664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504098|NCT00352664|Nootropic Agents|nootropic agents|mesh-ancestor
25504099|NCT00352690|Paclitaxel|paclitaxel|mesh-list
25504100|NCT00352690|Carboplatin|carboplatin|mesh-list
25504101|NCT00352690|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
25504102|NCT00352690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25504103|NCT00352690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504104|NCT00352690|Tubulin Modulators|tubulin modulators|mesh-ancestor
25504105|NCT00352690|Antimitotic Agents|antimitotic agents|mesh-ancestor
25504106|NCT00352690|Mitosis Modulators|mitosis modulators|mesh-ancestor
25645723|NCT01450761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25645724|NCT01450761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25504107|NCT00352690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504108|NCT00352755|Leucovorin|leucovorin|mesh-list
25504109|NCT00352755|Fluorouracil|fluorouracil|mesh-list
25504110|NCT00352755|Oxaliplatin|oxaliplatin|mesh-list
25504111|NCT00352755|Antimetabolites|antimetabolites|mesh-ancestor
25504112|NCT00352755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504113|NCT00352755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25504114|NCT00352755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504115|NCT00352755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25504116|NCT00352755|Immunologic Factors|immunologic factors|mesh-ancestor
25504117|NCT00352755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504118|NCT00352755|Antidotes|antidotes|mesh-ancestor
25504119|NCT00352755|Protective Agents|protective agents|mesh-ancestor
25504120|NCT00352755|Vitamin B Complex|vitamin b complex|mesh-ancestor
25504121|NCT00352755|Vitamins|vitamins|mesh-ancestor
25504122|NCT00352755|Micronutrients|micronutrients|mesh-ancestor
25504123|NCT00352781|Nicotine|nicotine|mesh-list
25504124|NCT00352781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25504125|NCT00352781|Autonomic Agents|autonomic agents|mesh-ancestor
25504126|NCT00352781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25504127|NCT00352781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504128|NCT00352781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25504129|NCT00352781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25504130|NCT00352781|Cholinergic Agents|cholinergic agents|mesh-ancestor
25504131|NCT00352781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25504132|NCT00352781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504133|NCT00352794|Prednisone|prednisone|mesh-list
25504134|NCT00352794|Lenalidomide|lenalidomide|mesh-list
25504135|NCT00352794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25161928|NCT01964495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25161932|NCT01860976|Abatacept|abatacept|mesh-list
25504136|NCT00352794|Glucocorticoids|glucocorticoids|mesh-ancestor
25504144|NCT00352794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25504145|NCT00352794|Growth Substances|growth substances|mesh-ancestor
25504146|NCT00352794|Growth Inhibitors|growth inhibitors|mesh-ancestor
25504147|NCT00352846|Vitamin D|vitamin d|mesh-list
25504148|NCT00352846|Zoledronic Acid|zoledronic acid|mesh-list
25504149|NCT00352846|Calcium Carbonate|calcium carbonate|mesh-list
25504150|NCT00352846|Calcium|calcium|mesh-list
25504151|NCT00352846|Vitamins|vitamins|mesh-ancestor
25504152|NCT00352846|Micronutrients|micronutrients|mesh-ancestor
25504153|NCT00352846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504154|NCT00352846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25504155|NCT00352846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25504156|NCT00352846|Antacids|antacids|mesh-ancestor
25504157|NCT00352846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504158|NCT00352846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25504159|NCT00352885|Citalopram|citalopram|mesh-list
25504160|NCT00352885|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25504161|NCT00352885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25504162|NCT00352885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25504163|NCT00352885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504164|NCT00352885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25504165|NCT00352885|Serotonin Agents|serotonin agents|mesh-ancestor
25504166|NCT00352885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504167|NCT00352885|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25504168|NCT00352885|Antidepressive Agents|antidepressive agents|mesh-ancestor
25504169|NCT00352885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25504170|NCT00352911|Mifepristone|mifepristone|mesh-list
25504171|NCT00352911|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25504172|NCT00352911|Abortifacient Agents|abortifacient agents|mesh-ancestor
25504173|NCT00352911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25823190|NCT00004763|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24451769|NCT00324766|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25504174|NCT00352911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504175|NCT00352911|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25504176|NCT00352911|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25645726|NCT01450800|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25645727|NCT01450800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25504177|NCT00352911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25504178|NCT00352911|Contraceptive Agents|contraceptive agents|mesh-ancestor
25504179|NCT00352911|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25504180|NCT00352911|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25504181|NCT00352911|Hormone Antagonists|hormone antagonists|mesh-ancestor
25504182|NCT00352911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25504183|NCT00352911|Luteolytic Agents|luteolytic agents|mesh-ancestor
25504184|NCT00352911|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25645729|NCT01450800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25645730|NCT01450813|Bromides|bromides|mesh-list
25645731|NCT01450813|Rocuronium|rocuronium|mesh-list
25645732|NCT01450813|Anticonvulsants|anticonvulsants|mesh-ancestor
25645733|NCT01450813|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25504185|NCT00352911|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25504186|NCT00352976|Mycophenolic Acid|mycophenolic acid|mesh-list
25504187|NCT00352976|Sirolimus|sirolimus|mesh-list
25504188|NCT00352976|Cyclophosphamide|cyclophosphamide|mesh-list
25504189|NCT00352976|Fludarabine|fludarabine|mesh-list
25504190|NCT00352976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25504191|NCT00352976|Immunologic Factors|immunologic factors|mesh-ancestor
25504192|NCT00352976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504193|NCT00352976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25504194|NCT00352976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25504195|NCT00352976|Alkylating Agents|alkylating agents|mesh-ancestor
25504196|NCT00352976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504197|NCT00352976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504198|NCT00352976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25504199|NCT00352976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24978885|NCT02525029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24978886|NCT02525029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504200|NCT00352976|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25504201|NCT00352976|Antitubercular Agents|antitubercular agents|mesh-ancestor
25504202|NCT00352976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25504203|NCT00352976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25504204|NCT00352976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25504205|NCT00352976|Antifungal Agents|antifungal agents|mesh-ancestor
25504206|NCT00353119|Etanercept|etanercept|mesh-list
25504207|NCT00353119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25504208|NCT00353119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25504209|NCT00353119|Analgesics|analgesics|mesh-ancestor
25504210|NCT00353119|Sensory System Agents|sensory system agents|mesh-ancestor
25504211|NCT00353119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25504212|NCT00353119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504213|NCT00353119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25504214|NCT00353119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25504215|NCT00353119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25504216|NCT00353119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25504217|NCT00353119|Immunologic Factors|immunologic factors|mesh-ancestor
25504218|NCT00353262|Capecitabine|capecitabine|mesh-list
25504219|NCT00353262|Oxaliplatin|oxaliplatin|mesh-list
25504220|NCT00353262|Bevacizumab|bevacizumab|mesh-list
25504221|NCT00353262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25504222|NCT00353262|Antimetabolites|antimetabolites|mesh-ancestor
25504223|NCT00353262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504224|NCT00353262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504225|NCT00353262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25504226|NCT00353262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25504227|NCT00353262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25504228|NCT00353262|Growth Substances|growth substances|mesh-ancestor
25504229|NCT00353262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504230|NCT00353262|Growth Inhibitors|growth inhibitors|mesh-ancestor
25504231|NCT00353301|Sirolimus|sirolimus|mesh-list
25504232|NCT00353301|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25504233|NCT00353301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504234|NCT00353301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25504235|NCT00353301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25504236|NCT00353301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504237|NCT00353301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25504238|NCT00353301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25504239|NCT00353301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24685149|NCT01798004|Mesna|mesna|mesh-list
25645734|NCT01450813|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25504240|NCT00353301|Antifungal Agents|antifungal agents|mesh-ancestor
25645735|NCT01450813|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25645736|NCT01450813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25645737|NCT01450813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645738|NCT01450826|Ondansetron|ondansetron|mesh-list
25645740|NCT01450826|Antiemetics|antiemetics|mesh-ancestor
25645741|NCT01450826|Autonomic Agents|autonomic agents|mesh-ancestor
25645742|NCT01450826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25504241|NCT00353301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25504242|NCT00353301|Immunologic Factors|immunologic factors|mesh-ancestor
25504243|NCT00353301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504244|NCT00353418|Ribavirin|ribavirin|mesh-list
25504245|NCT00353418|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25504246|NCT00353418|Antimetabolites|antimetabolites|mesh-ancestor
25504247|NCT00353418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504248|NCT00353418|Antiviral Agents|antiviral agents|mesh-ancestor
25504249|NCT00353418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25504250|NCT00353431|Insulin Aspart|insulin aspart|mesh-list
25504251|NCT00353431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25504252|NCT00353431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504253|NCT00353496|Lanreotide|lanreotide|mesh-list
25504254|NCT00353496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504255|NCT00353522|Dalcetrapib|dalcetrapib|mesh-list
25504256|NCT00353522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25504257|NCT00353522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25504258|NCT00353522|Antimetabolites|antimetabolites|mesh-ancestor
25504259|NCT00353522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504260|NCT00353522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25504261|NCT00353652|Chlorthalidone|chlorthalidone|mesh-list
25504262|NCT00353652|Spironolactone|spironolactone|mesh-list
25504263|NCT00353652|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25504264|NCT00353652|Hormone Antagonists|hormone antagonists|mesh-ancestor
25504265|NCT00353652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25504266|NCT00353652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504267|NCT00353652|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25504268|NCT00353652|Diuretics|diuretics|mesh-ancestor
25504269|NCT00353652|Natriuretic Agents|natriuretic agents|mesh-ancestor
25504270|NCT00353652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25504271|NCT00353652|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25504272|NCT00353652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25504273|NCT00353652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823191|NCT00004763|Norethindrone|norethindrone|mesh-list
25504275|NCT00353704|Morphine|morphine|mesh-list
25504276|NCT00353704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25504277|NCT00353704|Narcotics|narcotics|mesh-ancestor
25504278|NCT00353704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25504279|NCT00353704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504280|NCT00353704|Analgesics|analgesics|mesh-ancestor
25504281|NCT00353704|Sensory System Agents|sensory system agents|mesh-ancestor
25504282|NCT00353704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25504283|NCT00353704|Anticonvulsants|anticonvulsants|mesh-ancestor
25504284|NCT00353704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25504285|NCT00353704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25504286|NCT00353704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504287|NCT00353704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25504288|NCT00353704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25504289|NCT00353704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25504290|NCT00353704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25504291|NCT00353834|Insulin|insulin|mesh-list
25504292|NCT00353834|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25504293|NCT00353834|Insulin Glargine|insulin glargine|mesh-list
25504294|NCT00353834|Exenatide|exenatide|mesh-list
25504295|NCT00353834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25504296|NCT00353834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504297|NCT00353834|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25504298|NCT00353834|Incretins|incretins|mesh-ancestor
25504299|NCT00353834|Hormones|hormones|mesh-ancestor
25504300|NCT00353834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25504301|NCT00353873|Fluticasone|fluticasone|mesh-list
25504302|NCT00353873|Xhance|xhance|mesh-list
25504303|NCT00353873|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25504304|NCT00353873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25504305|NCT00353873|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25504306|NCT00353873|Autonomic Agents|autonomic agents|mesh-ancestor
25645743|NCT01450826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645744|NCT01450826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25645745|NCT01450826|Antipruritics|antipruritics|mesh-ancestor
25645746|NCT01450826|Dermatologic Agents|dermatologic agents|mesh-ancestor
25645747|NCT01450826|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25645748|NCT01450826|Serotonin Agents|serotonin agents|mesh-ancestor
25645749|NCT01450826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25656826|NCT01579318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25504307|NCT00353873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25504308|NCT00353873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504309|NCT00353873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25504310|NCT00353873|Respiratory System Agents|respiratory system agents|mesh-ancestor
25504311|NCT00353873|Dermatologic Agents|dermatologic agents|mesh-ancestor
25504312|NCT00353873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25504313|NCT00353873|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25504314|NCT00353873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25504315|NCT00353873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25504316|NCT00353873|Adrenergic Agents|adrenergic agents|mesh-ancestor
25504317|NCT00353873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25504318|NCT00353873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504319|NCT00353977|Vaccines|vaccines|mesh-list
25504320|NCT00353977|Immunologic Factors|immunologic factors|mesh-ancestor
25504321|NCT00353977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504322|NCT00354029|Ketamine|ketamine|mesh-list
25504323|NCT00354029|Analgesics|analgesics|mesh-ancestor
25504324|NCT00354029|Sensory System Agents|sensory system agents|mesh-ancestor
25504325|NCT00354029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25504326|NCT00354029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504327|NCT00354029|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25504328|NCT00354029|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25504329|NCT00354029|Anesthetics, General|anesthetics, general|mesh-ancestor
25504330|NCT00354029|Anesthetics|anesthetics|mesh-ancestor
25504331|NCT00354029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25504332|NCT00354029|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25504333|NCT00354029|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25504334|NCT00354029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25504335|NCT00354029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504336|NCT00354107|Cytarabine|cytarabine|mesh-list
25504337|NCT00354107|Hydrocortisone|hydrocortisone|mesh-list
25504338|NCT00354107|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25504339|NCT00354107|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25504340|NCT00354107|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25504341|NCT00354107|Carboplatin|carboplatin|mesh-list
25504342|NCT00354107|Methotrexate|methotrexate|mesh-list
25504343|NCT00354107|Etoposide|etoposide|mesh-list
25504344|NCT00354107|Etoposide phosphate|etoposide phosphate|mesh-list
25504345|NCT00354107|Ifosfamide|ifosfamide|mesh-list
25504346|NCT00354107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25504347|NCT00354107|Antibodies|antibodies|mesh-list
25504348|NCT00354107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25504349|NCT00354107|Immunologic Factors|immunologic factors|mesh-ancestor
25504350|NCT00354107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504351|NCT00354107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504352|NCT00354107|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25504353|NCT00354107|Abortifacient Agents|abortifacient agents|mesh-ancestor
25504354|NCT00354107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25504355|NCT00354107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25504356|NCT00354107|Antimetabolites|antimetabolites|mesh-ancestor
25504357|NCT00354107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504358|NCT00354107|Dermatologic Agents|dermatologic agents|mesh-ancestor
24475450|NCT00410540|Analgesics|analgesics|mesh-ancestor
25504359|NCT00354107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25504360|NCT00354107|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25504361|NCT00354107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25504362|NCT00354107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25504363|NCT00354107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25504364|NCT00354107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25504365|NCT00354107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25504366|NCT00354107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25504367|NCT00354107|Antiviral Agents|antiviral agents|mesh-ancestor
25504368|NCT00354107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25504369|NCT00354107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25504370|NCT00354107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25504371|NCT00354107|Alkylating Agents|alkylating agents|mesh-ancestor
25504372|NCT00354107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25504373|NCT00354172|Cyclosporine|cyclosporine|mesh-list
25504374|NCT00354172|Mycophenolic Acid|mycophenolic acid|mesh-list
25504375|NCT00354172|Aldesleukin|aldesleukin|mesh-list
25645750|NCT01450826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645751|NCT01450826|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25645752|NCT01450826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25645753|NCT01450826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25645754|NCT01450826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25504376|NCT00354172|Methylprednisolone|methylprednisolone|mesh-list
25504377|NCT00354172|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25504378|NCT00354172|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25645755|NCT01450826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25504379|NCT00354172|Prednisolone|prednisolone|mesh-list
25645756|NCT01450826|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25645757|NCT01451203|Methotrexate|methotrexate|mesh-list
25645758|NCT01451203|Certolizumab Pegol|certolizumab pegol|mesh-list
25645759|NCT01451203|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25645760|NCT01451203|Abortifacient Agents|abortifacient agents|mesh-ancestor
25504380|NCT00354172|Prednisolone acetate|prednisolone acetate|mesh-list
25504381|NCT00354172|Cyclophosphamide|cyclophosphamide|mesh-list
25504382|NCT00354172|Fludarabine|fludarabine|mesh-list
25504383|NCT00354172|Fludarabine phosphate|fludarabine phosphate|mesh-list
25504384|NCT00354172|Interleukin-2|interleukin-2|mesh-list
25504385|NCT00354172|Cyclosporins|cyclosporins|mesh-list
25504386|NCT00354172|Lenograstim|lenograstim|mesh-list
25504387|NCT00354172|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25504388|NCT00354172|Prednisolone phosphate|prednisolone phosphate|mesh-list
25504389|NCT00354172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25504390|NCT00354172|Immunologic Factors|immunologic factors|mesh-ancestor
25504391|NCT00354172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504392|NCT00354172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25504393|NCT00354172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25504394|NCT00354172|Alkylating Agents|alkylating agents|mesh-ancestor
25504395|NCT00354172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504396|NCT00354172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504397|NCT00354172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25504398|NCT00354172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25504399|NCT00354172|Antimetabolites|antimetabolites|mesh-ancestor
25504400|NCT00354172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25504401|NCT00354172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25504402|NCT00354172|Antifungal Agents|antifungal agents|mesh-ancestor
25504403|NCT00354172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25504404|NCT00354172|Dermatologic Agents|dermatologic agents|mesh-ancestor
25504405|NCT00354172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25504406|NCT00354172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25504407|NCT00354172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25504408|NCT00354172|Antitubercular Agents|antitubercular agents|mesh-ancestor
25504409|NCT00354172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25504410|NCT00354172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25504411|NCT00354172|Antiemetics|antiemetics|mesh-ancestor
25504412|NCT00354172|Autonomic Agents|autonomic agents|mesh-ancestor
25504413|NCT00354172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25504414|NCT00354172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25504415|NCT00354172|Glucocorticoids|glucocorticoids|mesh-ancestor
25504416|NCT00354172|Hormones|hormones|mesh-ancestor
25504417|NCT00354172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25504418|NCT00354172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25504419|NCT00354172|Protective Agents|protective agents|mesh-ancestor
25504420|NCT00354172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25504421|NCT00354172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25504422|NCT00354172|Analgesics|analgesics|mesh-ancestor
25504423|NCT00354172|Sensory System Agents|sensory system agents|mesh-ancestor
25504424|NCT00354172|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25504425|NCT00354172|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25504426|NCT00354172|Antiviral Agents|antiviral agents|mesh-ancestor
25504457|NCT00354640|Anastrozole|anastrozole|mesh-list
25504458|NCT00354640|Simvastatin|simvastatin|mesh-list
25504459|NCT00354640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25504460|NCT00354640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25504461|NCT00354640|Antimetabolites|antimetabolites|mesh-ancestor
25504462|NCT00354640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504463|NCT00354640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25504464|NCT00354640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25504465|NCT00354640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25504466|NCT00354640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25504467|NCT00354640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24686233|NCT04968522|Dextroamphetamine|dextroamphetamine|mesh-list
25645761|NCT01451203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25645762|NCT01451203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645763|NCT01451203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25645764|NCT01451203|Antimetabolites|antimetabolites|mesh-ancestor
25645765|NCT01451203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645766|NCT01451203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645767|NCT01451203|Dermatologic Agents|dermatologic agents|mesh-ancestor
25645768|NCT01451203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645769|NCT01451203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25645770|NCT01451203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25645771|NCT01451203|Immunologic Factors|immunologic factors|mesh-ancestor
25645772|NCT01451203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25645773|NCT01451203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25504468|NCT00354640|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25504469|NCT00354640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25504470|NCT00354640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25504471|NCT00354640|Hormone Antagonists|hormone antagonists|mesh-ancestor
25504472|NCT00354640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25504473|NCT00354640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504474|NCT00354679|Bevacizumab|bevacizumab|mesh-list
25504475|NCT00354679|Cisplatin|cisplatin|mesh-list
25504476|NCT00354679|Irinotecan|irinotecan|mesh-list
25504477|NCT00354679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25504478|NCT00354679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504479|NCT00354679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25504480|NCT00354679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25504481|NCT00354679|Growth Substances|growth substances|mesh-ancestor
25504482|NCT00354679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504483|NCT00354679|Growth Inhibitors|growth inhibitors|mesh-ancestor
25504484|NCT00354679|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25504485|NCT00354679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25504486|NCT00354679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25504487|NCT00354679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504488|NCT00354744|Dactinomycin|dactinomycin|mesh-list
25504489|NCT00354744|Cyclophosphamide|cyclophosphamide|mesh-list
25504490|NCT00354744|Ifosfamide|ifosfamide|mesh-list
25504491|NCT00354744|Isophosphamide mustard|isophosphamide mustard|mesh-list
25504492|NCT00354744|Doxorubicin|doxorubicin|mesh-list
25504493|NCT00354744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25504494|NCT00354744|Irinotecan|irinotecan|mesh-list
25504495|NCT00354744|Etoposide|etoposide|mesh-list
25504496|NCT00354744|Vincristine|vincristine|mesh-list
25504497|NCT00354744|Camptothecin|camptothecin|mesh-list
25504498|NCT00354744|Lenograstim|lenograstim|mesh-list
25504499|NCT00354744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25504500|NCT00354744|Immunologic Factors|immunologic factors|mesh-ancestor
25504501|NCT00354744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504502|NCT00354744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25504503|NCT00354744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25504504|NCT00354744|Alkylating Agents|alkylating agents|mesh-ancestor
25504505|NCT00354744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504506|NCT00354744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504507|NCT00354744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25504508|NCT00354744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25504509|NCT00354744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25504510|NCT00354744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25504511|NCT00354744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25504512|NCT00354744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25504513|NCT00354744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25504514|NCT00354744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25504515|NCT00354744|Tubulin Modulators|tubulin modulators|mesh-ancestor
25504516|NCT00354744|Antimitotic Agents|antimitotic agents|mesh-ancestor
25504517|NCT00354744|Mitosis Modulators|mitosis modulators|mesh-ancestor
25504518|NCT00354744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25504519|NCT00354744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25504520|NCT00354744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25504521|NCT00354744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25504522|NCT00354770|Acetylcysteine|acetylcysteine|mesh-list
25504523|NCT00354770|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25504524|NCT00354770|Antiviral Agents|antiviral agents|mesh-ancestor
25504525|NCT00354770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25504526|NCT00354770|Expectorants|expectorants|mesh-ancestor
25504527|NCT00354770|Respiratory System Agents|respiratory system agents|mesh-ancestor
25504528|NCT00354770|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25504529|NCT00354770|Antioxidants|antioxidants|mesh-ancestor
24686513|NCT04760691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645774|NCT01451398|Insulin|insulin|mesh-list
25645775|NCT01451398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25645776|NCT01451398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645777|NCT01451411|Conivaptan|conivaptan|mesh-list
25645778|NCT01451411|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25645779|NCT01451411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645780|NCT01451411|Natriuretic Agents|natriuretic agents|mesh-ancestor
25645781|NCT01451411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504530|NCT00354770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504531|NCT00354770|Protective Agents|protective agents|mesh-ancestor
25040792|NCT02822508|Laxatives|laxatives|mesh-list
25504532|NCT00354770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504533|NCT00354770|Antidotes|antidotes|mesh-ancestor
25504534|NCT00354887|Capecitabine|capecitabine|mesh-list
25504535|NCT00354887|Oxaliplatin|oxaliplatin|mesh-list
25504536|NCT00354887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25504537|NCT00354887|Antimetabolites|antimetabolites|mesh-ancestor
25504538|NCT00354887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504539|NCT00354887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504540|NCT00354913|Imatinib Mesylate|imatinib mesylate|mesh-list
25504541|NCT00354913|Hydroxyurea|hydroxyurea|mesh-list
25504542|NCT00354913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504543|NCT00354913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25504544|NCT00354913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25504545|NCT00354913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504546|NCT00354913|Antisickling Agents|antisickling agents|mesh-ancestor
25504547|NCT00354913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25504548|NCT00354978|Leucovorin|leucovorin|mesh-list
25504549|NCT00354978|Bevacizumab|bevacizumab|mesh-list
25504550|NCT00354978|Fluorouracil|fluorouracil|mesh-list
25504551|NCT00354978|Irinotecan|irinotecan|mesh-list
25504552|NCT00354978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25504553|NCT00354978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504554|NCT00354978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25504555|NCT00354978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25504556|NCT00354978|Growth Substances|growth substances|mesh-ancestor
25504557|NCT00354978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504558|NCT00354978|Growth Inhibitors|growth inhibitors|mesh-ancestor
25504559|NCT00354978|Antimetabolites|antimetabolites|mesh-ancestor
25504560|NCT00354978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504561|NCT00354978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25504562|NCT00354978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25504563|NCT00354978|Immunologic Factors|immunologic factors|mesh-ancestor
25504564|NCT00354978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25504565|NCT00354978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25504566|NCT00354978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25504567|NCT00354978|Antidotes|antidotes|mesh-ancestor
25504568|NCT00354978|Protective Agents|protective agents|mesh-ancestor
25504569|NCT00354978|Vitamin B Complex|vitamin b complex|mesh-ancestor
25504570|NCT00354978|Vitamins|vitamins|mesh-ancestor
25504571|NCT00354978|Micronutrients|micronutrients|mesh-ancestor
25504572|NCT00355030|Leuprolide|leuprolide|mesh-list
25504573|NCT00355030|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25504574|NCT00355030|Fertility Agents|fertility agents|mesh-ancestor
25504575|NCT00355030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25504576|NCT00355030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504577|NCT00355030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25504578|NCT00355030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504579|NCT00355082|Lamotrigine|lamotrigine|mesh-list
25504580|NCT00355082|Anticonvulsants|anticonvulsants|mesh-list
25504581|NCT00355082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25504582|NCT00355082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25504583|NCT00355082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504584|NCT00355082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25504585|NCT00355082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504586|NCT00355082|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25504587|NCT00355082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25504588|NCT00355082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25504589|NCT00355082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25504590|NCT00355082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25504591|NCT00355121|Vaccines|vaccines|mesh-list
25504592|NCT00355121|Immunologic Factors|immunologic factors|mesh-ancestor
25504593|NCT00355121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504594|NCT00355134|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25504595|NCT00355134|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25645782|NCT01451541|Ciclesonide|ciclesonide|mesh-list
25645783|NCT01451541|Glucocorticoids|glucocorticoids|mesh-ancestor
25645784|NCT01451541|Hormones|hormones|mesh-ancestor
25645785|NCT01451541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25645786|NCT01451541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645787|NCT01451541|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25645788|NCT01451606|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25504596|NCT00355134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504597|NCT00355134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25504598|NCT00355134|Immunologic Factors|immunologic factors|mesh-ancestor
25504599|NCT00355134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504600|NCT00355199|Rituximab|rituximab|mesh-list
25504601|NCT00355199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25504602|NCT00355199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504603|NCT00355199|Immunologic Factors|immunologic factors|mesh-ancestor
25645789|NCT01451606|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25645790|NCT01451606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24422999|NCT00224393|Immunologic Factors|immunologic factors|mesh-ancestor
24423000|NCT00224419|Nicotine|nicotine|mesh-list
25504604|NCT00355199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504605|NCT00355199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25504606|NCT00355342|Fluticasone|fluticasone|mesh-list
25645791|NCT01451606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25645792|NCT01451606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645793|NCT01451606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25504607|NCT00355342|Xhance|xhance|mesh-list
25504608|NCT00355342|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25504609|NCT00355342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25504610|NCT00355342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25504611|NCT00355342|Autonomic Agents|autonomic agents|mesh-ancestor
25504612|NCT00355342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25504613|NCT00355342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504614|NCT00355342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25504615|NCT00355342|Respiratory System Agents|respiratory system agents|mesh-ancestor
25504616|NCT00355342|Dermatologic Agents|dermatologic agents|mesh-ancestor
25504617|NCT00355342|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25504618|NCT00355342|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25504619|NCT00355342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25504620|NCT00355342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25504621|NCT00355342|Adrenergic Agents|adrenergic agents|mesh-ancestor
25504622|NCT00355342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25504623|NCT00355342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504624|NCT00355368|Rocuronium|rocuronium|mesh-list
25504625|NCT00355368|Succinylcholine|succinylcholine|mesh-list
25504626|NCT00355368|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25504627|NCT00355368|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25504628|NCT00355368|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25504629|NCT00355368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25504630|NCT00355368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504631|NCT00355368|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
25504632|NCT00355394|Metoclopramide|metoclopramide|mesh-list
25504633|NCT00355394|Antiemetics|antiemetics|mesh-ancestor
25504634|NCT00355394|Autonomic Agents|autonomic agents|mesh-ancestor
25504635|NCT00355394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25504636|NCT00355394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504637|NCT00355394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25504638|NCT00355394|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25504639|NCT00355394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25504640|NCT00355394|Dopamine Agents|dopamine agents|mesh-ancestor
25504641|NCT00355394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25504642|NCT00355394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504643|NCT00355472|Mogamulizumab|mogamulizumab|mesh-list
25504644|NCT00355472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504645|NCT00355615|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25504646|NCT00355615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25504647|NCT00355615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25504648|NCT00355615|Antimetabolites|antimetabolites|mesh-ancestor
25504649|NCT00355615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504650|NCT00355615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25504651|NCT00355615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25504652|NCT00355615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25504653|NCT00355784|Hormones|hormones|mesh-list
24687516|NCT03937219|Nivolumab|nivolumab|mesh-list
25823192|NCT00004763|Norethindrone Acetate|norethindrone acetate|mesh-list
25504654|NCT00355784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25504655|NCT00355784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504656|NCT00356031|Bevacizumab|bevacizumab|mesh-list
25504657|NCT00356031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25504658|NCT00356031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504659|NCT00356031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25504660|NCT00356031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25504661|NCT00356031|Growth Substances|growth substances|mesh-ancestor
25504662|NCT00356031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504663|NCT00356031|Growth Inhibitors|growth inhibitors|mesh-ancestor
25504664|NCT00356122|Bevacizumab|bevacizumab|mesh-list
25504665|NCT00356122|Docetaxel|docetaxel|mesh-list
25504666|NCT00356122|Oxaliplatin|oxaliplatin|mesh-list
25504667|NCT00356122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25504668|NCT00356122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504669|NCT00356122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25504670|NCT00356122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25504671|NCT00356122|Growth Substances|growth substances|mesh-ancestor
25504672|NCT00356122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504673|NCT00356122|Growth Inhibitors|growth inhibitors|mesh-ancestor
25504674|NCT00356122|Tubulin Modulators|tubulin modulators|mesh-ancestor
25504675|NCT00356122|Antimitotic Agents|antimitotic agents|mesh-ancestor
25504676|NCT00356122|Mitosis Modulators|mitosis modulators|mesh-ancestor
25504677|NCT00356122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504678|NCT00356135|Clopidogrel|clopidogrel|mesh-list
25823193|NCT00004763|Norinyl|norinyl|mesh-list
25504679|NCT00356135|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25504680|NCT00356135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25504681|NCT00356135|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25504682|NCT00356135|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25504683|NCT00356135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25504684|NCT00356135|Purinergic Agents|purinergic agents|mesh-ancestor
25504685|NCT00356135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25504686|NCT00356135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504687|NCT00356135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504688|NCT00356148|Ampicillin|ampicillin|mesh-list
25504689|NCT00356148|Sulbactam|sulbactam|mesh-list
25504690|NCT00356148|Sultamicillin|sultamicillin|mesh-list
25504691|NCT00356148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25504692|NCT00356148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25504693|NCT00356148|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25504694|NCT00356148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25504695|NCT00356148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504696|NCT00356200|Fluphenazine|fluphenazine|mesh-list
25504697|NCT00356200|Fluphenazine depot|fluphenazine depot|mesh-list
25504698|NCT00356200|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
25504699|NCT00356200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25504700|NCT00356200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25504701|NCT00356200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25504702|NCT00356200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504703|NCT00356200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25504704|NCT00356200|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25504705|NCT00356200|Dopamine Agents|dopamine agents|mesh-ancestor
25504706|NCT00356200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25504707|NCT00356200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504708|NCT00356265|Phenylephrine|phenylephrine|mesh-list
25504709|NCT00356265|Oxymetazoline|oxymetazoline|mesh-list
25504710|NCT00356265|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25504711|NCT00356265|Mydriatics|mydriatics|mesh-ancestor
25504712|NCT00356265|Autonomic Agents|autonomic agents|mesh-ancestor
25504713|NCT00356265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25504714|NCT00356265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504715|NCT00356265|Sympathomimetics|sympathomimetics|mesh-ancestor
25504716|NCT00356265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25504717|NCT00356265|Nasal Decongestants|nasal decongestants|mesh-ancestor
25504718|NCT00356265|Respiratory System Agents|respiratory system agents|mesh-ancestor
25504719|NCT00356265|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25504720|NCT00356265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25504721|NCT00356265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25504722|NCT00356265|Adrenergic Agents|adrenergic agents|mesh-ancestor
25504723|NCT00356265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25504724|NCT00356265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504725|NCT00356265|Protective Agents|protective agents|mesh-ancestor
25504726|NCT00356278|Cycloserine|cycloserine|mesh-list
25645794|NCT01451606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645795|NCT01451606|Analgesics|analgesics|mesh-ancestor
25645796|NCT01451606|Sensory System Agents|sensory system agents|mesh-ancestor
25645797|NCT01451606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25645798|NCT01451606|Antidepressive Agents|antidepressive agents|mesh-ancestor
25504727|NCT00356278|Alprazolam|alprazolam|mesh-list
25504728|NCT00356278|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25504729|NCT00356278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25504730|NCT00356278|Renal Agents|renal agents|mesh-ancestor
25504731|NCT00356278|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25504732|NCT00356278|Antitubercular Agents|antitubercular agents|mesh-ancestor
25504733|NCT00356278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25504734|NCT00356278|Antimetabolites|antimetabolites|mesh-ancestor
25504735|NCT00356278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504736|NCT00356278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25504737|NCT00356278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25504738|NCT00356278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504739|NCT00356278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25504740|NCT00356278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25504741|NCT00356278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25504742|NCT00356278|GABA Modulators|gaba modulators|mesh-ancestor
25504743|NCT00356278|GABA Agents|gaba agents|mesh-ancestor
25504744|NCT00356278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25504745|NCT00356408|Certolizumab Pegol|certolizumab pegol|mesh-list
25504746|NCT00356408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25504747|NCT00356408|Immunologic Factors|immunologic factors|mesh-ancestor
25504748|NCT00356408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504749|NCT00356408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25504750|NCT00356525|Gemcitabine|gemcitabine|mesh-list
25504751|NCT00356525|Carboplatin|carboplatin|mesh-list
25504752|NCT00356525|Pemetrexed|pemetrexed|mesh-list
25504753|NCT00356525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979059|NCT01556776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504754|NCT00356525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25504756|NCT00356525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504757|NCT00356525|Antiviral Agents|antiviral agents|mesh-ancestor
25504758|NCT00356525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25504759|NCT00356525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25504760|NCT00356525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25504761|NCT00356525|Immunologic Factors|immunologic factors|mesh-ancestor
25504762|NCT00356525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504763|NCT00356525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25504764|NCT00356525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25504765|NCT00356590|Etanercept|etanercept|mesh-list
25504766|NCT00356590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25504767|NCT00356590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25504768|NCT00356590|Analgesics|analgesics|mesh-ancestor
25504769|NCT00356590|Sensory System Agents|sensory system agents|mesh-ancestor
25504770|NCT00356590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25504771|NCT00356590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504772|NCT00356590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25504773|NCT00356590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25504774|NCT00356590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25504775|NCT00356590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25504776|NCT00356590|Immunologic Factors|immunologic factors|mesh-ancestor
25504777|NCT00356603|Sumatriptan|sumatriptan|mesh-list
25504778|NCT00356603|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25504779|NCT00356603|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25504780|NCT00356603|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25504781|NCT00356603|Serotonin Agents|serotonin agents|mesh-ancestor
25504782|NCT00356603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25504783|NCT00356603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504784|NCT00356603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504785|NCT00356759|Warfarin|warfarin|mesh-list
25504786|NCT00356759|Anticoagulants|anticoagulants|mesh-ancestor
25504787|NCT00356811|Paclitaxel|paclitaxel|mesh-list
25504788|NCT00356811|Lapatinib|lapatinib|mesh-list
25504789|NCT00356811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25504790|NCT00356811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504791|NCT00356811|Tubulin Modulators|tubulin modulators|mesh-ancestor
25504792|NCT00356811|Antimitotic Agents|antimitotic agents|mesh-ancestor
25504793|NCT00356811|Mitosis Modulators|mitosis modulators|mesh-ancestor
25504794|NCT00356811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504795|NCT00356811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25504796|NCT00356811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25504797|NCT00356889|Bevacizumab|bevacizumab|mesh-list
25504798|NCT00356889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25504799|NCT00356889|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25504800|NCT00356889|Antibodies|antibodies|mesh-list
25504801|NCT00356889|Immunoglobulins|immunoglobulins|mesh-list
25504802|NCT00356889|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25504803|NCT00356889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504804|NCT00356889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25645799|NCT01451606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25645800|NCT01451606|Dopamine Agents|dopamine agents|mesh-ancestor
25645801|NCT01451632|Irinotecan|irinotecan|mesh-list
25645802|NCT01451632|Cetuximab|cetuximab|mesh-list
25645803|NCT01451632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25645804|NCT01451632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25504805|NCT00356889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25504806|NCT00356889|Growth Substances|growth substances|mesh-ancestor
25504807|NCT00356889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504808|NCT00356889|Growth Inhibitors|growth inhibitors|mesh-ancestor
25504809|NCT00356889|Immunologic Factors|immunologic factors|mesh-ancestor
25645805|NCT01451632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645806|NCT01451632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645807|NCT01451632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504810|NCT00356889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25504811|NCT00356889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25504812|NCT00356889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504813|NCT00356915|Itraconazole|itraconazole|mesh-list
25504814|NCT00356915|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
25504815|NCT00356915|Antifungal Agents|antifungal agents|mesh-ancestor
25504816|NCT00356915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25504817|NCT00356915|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25504818|NCT00356915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25504819|NCT00356915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25504820|NCT00356915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504821|NCT00356915|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25504822|NCT00356915|Hormone Antagonists|hormone antagonists|mesh-ancestor
25504823|NCT00356915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25504824|NCT00356915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979108|NCT00492349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979109|NCT00003102|Antibodies|antibodies|mesh-list
25504825|NCT00356915|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25504826|NCT00356993|Nicotine|nicotine|mesh-list
25504827|NCT00356993|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25504828|NCT00356993|Autonomic Agents|autonomic agents|mesh-ancestor
25504829|NCT00356993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25504830|NCT00356993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504831|NCT00356993|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25504832|NCT00356993|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25504833|NCT00356993|Cholinergic Agents|cholinergic agents|mesh-ancestor
25504834|NCT00356993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25504835|NCT00356993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504836|NCT00357006|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25504837|NCT00357006|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25504838|NCT00357006|Estradiol|estradiol|mesh-list
25504839|NCT00357006|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25504840|NCT00357006|Estrogens|estrogens|mesh-ancestor
25504841|NCT00357006|Hormones|hormones|mesh-ancestor
25504842|NCT00357006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25504843|NCT00357006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504844|NCT00357006|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25504845|NCT00357006|Contraceptive Agents|contraceptive agents|mesh-ancestor
25504846|NCT00357006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25504847|NCT00357006|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25504848|NCT00357032|Belinostat|belinostat|mesh-list
25504849|NCT00357032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504850|NCT00357032|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25504851|NCT00357032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25504852|NCT00357032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504853|NCT00357097|Ropinirole|ropinirole|mesh-list
25504854|NCT00357097|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25504855|NCT00357097|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25504856|NCT00357097|Dopamine Agonists|dopamine agonists|mesh-ancestor
25504857|NCT00357097|Dopamine Agents|dopamine agents|mesh-ancestor
25504858|NCT00357097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25068874|NCT03431142|Aspirin|aspirin|mesh-list
25645808|NCT01451632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25645810|NCT01451645|Allopurinol|allopurinol|mesh-list
25645811|NCT01451645|Gout Suppressants|gout suppressants|mesh-ancestor
25645812|NCT01451645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25645813|NCT01451645|Tubulin Modulators|tubulin modulators|mesh-ancestor
25504859|NCT00357097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504860|NCT00357097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504861|NCT00357110|Fulvestrant|fulvestrant|mesh-list
25504862|NCT00357110|Anastrozole|anastrozole|mesh-list
25504863|NCT00357110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25504864|NCT00357110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504865|NCT00357110|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25504866|NCT00357110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25504867|NCT00357110|Hormone Antagonists|hormone antagonists|mesh-ancestor
25504868|NCT00357110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25504869|NCT00357110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504870|NCT00357110|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25504871|NCT00357110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25504872|NCT00357110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25504873|NCT00357110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504874|NCT00357162|Belinostat|belinostat|mesh-list
25504875|NCT00357162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504876|NCT00357162|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25504877|NCT00357162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25504878|NCT00357162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504879|NCT00357331|Potassium Citrate|potassium citrate|mesh-list
25504880|NCT00357331|Diuretics|diuretics|mesh-ancestor
25504881|NCT00357331|Natriuretic Agents|natriuretic agents|mesh-ancestor
25504882|NCT00357331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504883|NCT00357331|Expectorants|expectorants|mesh-ancestor
25504884|NCT00357331|Respiratory System Agents|respiratory system agents|mesh-ancestor
25504885|NCT00357370|Dapagliflozin|dapagliflozin|mesh-list
25504886|NCT00357370|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25504887|NCT00357370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504888|NCT00357370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24423810|NCT00226915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24423811|NCT00226915|Tubulin Modulators|tubulin modulators|mesh-ancestor
24423812|NCT00226915|Antimitotic Agents|antimitotic agents|mesh-ancestor
24423813|NCT00226915|Mitosis Modulators|mitosis modulators|mesh-ancestor
24423814|NCT00226915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423816|NCT00226954|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24423817|NCT00226954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979145|NCT05181033|Fulvestrant|fulvestrant|mesh-list
24979146|NCT05181033|Lenvatinib|lenvatinib|mesh-list
25504889|NCT00357370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504891|NCT00357396|Busulfan|busulfan|mesh-list
25504892|NCT00357396|Thiotepa|thiotepa|mesh-list
25504893|NCT00357396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25504894|NCT00357396|Alkylating Agents|alkylating agents|mesh-ancestor
25504895|NCT00357396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504896|NCT00357396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504897|NCT00357396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25504898|NCT00357396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25504899|NCT00357396|Immunologic Factors|immunologic factors|mesh-ancestor
25504900|NCT00357396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504901|NCT00357500|Thalidomide|thalidomide|mesh-list
25504902|NCT00357500|Celecoxib|celecoxib|mesh-list
25504903|NCT00357500|Cyclophosphamide|cyclophosphamide|mesh-list
25504904|NCT00357500|Etoposide|etoposide|mesh-list
25504905|NCT00357500|Fenofibrate|fenofibrate|mesh-list
25504906|NCT00357500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25504907|NCT00357500|Immunologic Factors|immunologic factors|mesh-ancestor
25504908|NCT00357500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504909|NCT00357500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25504910|NCT00357500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25504911|NCT00357500|Alkylating Agents|alkylating agents|mesh-ancestor
25504912|NCT00357500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504913|NCT00357500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25504914|NCT00357500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25504915|NCT00357500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25504916|NCT00357500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25504917|NCT00357500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25504918|NCT00357500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645814|NCT01451645|Antimitotic Agents|antimitotic agents|mesh-ancestor
25645815|NCT01451645|Mitosis Modulators|mitosis modulators|mesh-ancestor
25504919|NCT00357500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25504920|NCT00357500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25504921|NCT00357500|Analgesics|analgesics|mesh-ancestor
25504922|NCT00357500|Sensory System Agents|sensory system agents|mesh-ancestor
25504923|NCT00357500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25504924|NCT00357500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25504925|NCT00357500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25504926|NCT00357500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25504927|NCT00357500|Leprostatic Agents|leprostatic agents|mesh-ancestor
25504928|NCT00357500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25504929|NCT00357500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25504930|NCT00357500|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25504931|NCT00357500|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25504932|NCT00357500|Growth Substances|growth substances|mesh-ancestor
25504933|NCT00357500|Growth Inhibitors|growth inhibitors|mesh-ancestor
25504934|NCT00357500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25504935|NCT00357500|Antimetabolites|antimetabolites|mesh-ancestor
25504936|NCT00357500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25504937|NCT00357552|Ritonavir|ritonavir|mesh-list
25504938|NCT00357552|Lopinavir|lopinavir|mesh-list
25504939|NCT00357552|Tenofovir|tenofovir|mesh-list
25504940|NCT00357552|Emtricitabine|emtricitabine|mesh-list
25504941|NCT00357552|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25504942|NCT00357552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25504943|NCT00357552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25504944|NCT00357552|Protease Inhibitors|protease inhibitors|mesh-ancestor
25504945|NCT00357552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24424032|NCT00227695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24424033|NCT00227695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424034|NCT00227695|Immunologic Factors|immunologic factors|mesh-ancestor
25122620|NCT03091894|Anesthetics|anesthetics|mesh-ancestor
25122621|NCT03091894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25122622|NCT03091894|Analgesics|analgesics|mesh-ancestor
25122623|NCT03091894|Sensory System Agents|sensory system agents|mesh-ancestor
25122624|NCT03091894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24979216|NCT05135312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24979217|NCT05135312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979218|NCT05135312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24979219|NCT05135312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24979220|NCT05135312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24979221|NCT05135312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24979222|NCT05135312|Immunologic Factors|immunologic factors|mesh-ancestor
24979224|NCT05116774|Ravulizumab|ravulizumab|mesh-list
24979225|NCT05116774|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24979227|NCT05116774|Immunologic Factors|immunologic factors|mesh-ancestor
25504970|NCT00357877|Chlorhexidine|chlorhexidine|mesh-list
25504971|NCT00357877|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25504972|NCT00357877|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25504973|NCT00357877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25504974|NCT00357877|Disinfectants|disinfectants|mesh-ancestor
25504975|NCT00357877|Dermatologic Agents|dermatologic agents|mesh-ancestor
25504976|NCT00357903|Etanercept|etanercept|mesh-list
25504977|NCT00357903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25504978|NCT00357903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25504979|NCT00357903|Analgesics|analgesics|mesh-ancestor
25504980|NCT00357903|Sensory System Agents|sensory system agents|mesh-ancestor
25504981|NCT00357903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25504982|NCT00357903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25504983|NCT00357903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25504984|NCT00357903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25504985|NCT00357903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25504986|NCT00357903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25504987|NCT00357903|Immunologic Factors|immunologic factors|mesh-ancestor
25504988|NCT00357968|Clopidogrel|clopidogrel|mesh-list
25504989|NCT00357968|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25504990|NCT00357968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25504991|NCT00357968|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25504992|NCT00357968|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25504993|NCT00357968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25504994|NCT00357968|Purinergic Agents|purinergic agents|mesh-ancestor
25504995|NCT00357968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25504996|NCT00357968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25504997|NCT00357968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645816|NCT01451645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645817|NCT01451645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645818|NCT01451645|Antimetabolites|antimetabolites|mesh-ancestor
25504998|NCT00357994|Levodopa|levodopa|mesh-list
25504999|NCT00357994|Carbidopa|carbidopa|mesh-list
25505000|NCT00357994|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25505001|NCT00357994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25505002|NCT00357994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25505003|NCT00357994|Dopamine Agents|dopamine agents|mesh-ancestor
25505004|NCT00357994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25505005|NCT00357994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505006|NCT00357994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505007|NCT00357994|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25505008|NCT00357994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505009|NCT00357994|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25505010|NCT00357994|Immunologic Factors|immunologic factors|mesh-ancestor
25505011|NCT00357994|Dopamine Agonists|dopamine agonists|mesh-ancestor
25505012|NCT00358150|Eliglustat|eliglustat|mesh-list
25505013|NCT00358150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505014|NCT00358150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505015|NCT00358215|Darbepoetin alfa|darbepoetin alfa|mesh-list
25505016|NCT00358215|Hematinics|hematinics|mesh-ancestor
25505017|NCT00358436|Bromides|bromides|mesh-list
25505018|NCT00358436|Anticonvulsants|anticonvulsants|mesh-ancestor
25505019|NCT00358462|Azithromycin|azithromycin|mesh-list
25505020|NCT00358462|Doxycycline|doxycycline|mesh-list
25505021|NCT00358462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25505022|NCT00358462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25505023|NCT00358462|Antimalarials|antimalarials|mesh-ancestor
25505024|NCT00358462|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25505025|NCT00358462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25505026|NCT00358501|Defibrotide|defibrotide|mesh-list
25505027|NCT00358501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25505028|NCT00358501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25505029|NCT00358501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505030|NCT00358501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25505031|NCT00358579|Vasopressins|vasopressins|mesh-list
25505032|NCT00358579|Arginine Vasopressin|arginine vasopressin|mesh-list
25505033|NCT00358579|Epinephrine|epinephrine|mesh-list
25505034|NCT00358579|Racepinephrine|racepinephrine|mesh-list
25505035|NCT00358579|Epinephryl borate|epinephryl borate|mesh-list
25505036|NCT00358579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505037|NCT00358579|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25505038|NCT00358579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25505039|NCT00358579|Adrenergic Agents|adrenergic agents|mesh-ancestor
25505040|NCT00358579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25202826|NCT02718521|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25823194|NCT00004763|Estradiol|estradiol|mesh-list
25202827|NCT02718521|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25202828|NCT02718521|Diuretics|diuretics|mesh-ancestor
25202829|NCT02718521|Natriuretic Agents|natriuretic agents|mesh-ancestor
25202834|NCT02718482|Gemcitabine|gemcitabine|mesh-list
25505041|NCT00358579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505042|NCT00358579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25505043|NCT00358579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25505044|NCT00358579|Autonomic Agents|autonomic agents|mesh-ancestor
25505045|NCT00358579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25505046|NCT00358579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25505047|NCT00358579|Respiratory System Agents|respiratory system agents|mesh-ancestor
25505048|NCT00358579|Mydriatics|mydriatics|mesh-ancestor
25505049|NCT00358579|Sympathomimetics|sympathomimetics|mesh-ancestor
25505050|NCT00358579|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25505051|NCT00358579|Hemostatics|hemostatics|mesh-ancestor
25505052|NCT00358579|Coagulants|coagulants|mesh-ancestor
25505053|NCT00358579|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25505054|NCT00358579|Natriuretic Agents|natriuretic agents|mesh-ancestor
25505055|NCT00358644|Decitabine|decitabine|mesh-list
25505056|NCT00358644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25505057|NCT00358644|Antimetabolites|antimetabolites|mesh-ancestor
25505058|NCT00358644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505059|NCT00358644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505060|NCT00358644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505061|NCT00358657|Mycophenolic Acid|mycophenolic acid|mesh-list
25505062|NCT00358657|Sirolimus|sirolimus|mesh-list
25505063|NCT00358657|Cyclophosphamide|cyclophosphamide|mesh-list
25505064|NCT00358657|Fludarabine|fludarabine|mesh-list
25505065|NCT00358657|Fludarabine phosphate|fludarabine phosphate|mesh-list
25823195|NCT00004763|Estrogens|estrogens|mesh-ancestor
25505066|NCT00358657|Tacrolimus|tacrolimus|mesh-list
25505067|NCT00358657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25505068|NCT00358657|Immunologic Factors|immunologic factors|mesh-ancestor
25505069|NCT00358657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505070|NCT00358657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25505071|NCT00358657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25505072|NCT00358657|Alkylating Agents|alkylating agents|mesh-ancestor
25505073|NCT00358657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505074|NCT00358657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505075|NCT00358657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25505076|NCT00358657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25505077|NCT00358657|Antimetabolites|antimetabolites|mesh-ancestor
25505078|NCT00358657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25505079|NCT00358657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505080|NCT00358657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25505081|NCT00358657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25505082|NCT00358657|Antitubercular Agents|antitubercular agents|mesh-ancestor
25505083|NCT00358657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25505084|NCT00358657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25505085|NCT00358657|Antifungal Agents|antifungal agents|mesh-ancestor
25505086|NCT00358670|Infliximab|infliximab|mesh-list
25505087|NCT00358670|Dermatologic Agents|dermatologic agents|mesh-ancestor
25505088|NCT00358670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25505089|NCT00358670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25505090|NCT00358735|Enoxaparin|enoxaparin|mesh-list
25505091|NCT00358735|Anticoagulants|anticoagulants|mesh-ancestor
25505092|NCT00358735|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25505093|NCT00358735|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25505094|NCT00358735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505095|NCT00358826|Atreleuton|atreleuton|mesh-list
25505096|NCT00358826|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25505097|NCT00358826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505098|NCT00358826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505099|NCT00358917|Ritonavir|ritonavir|mesh-list
25505100|NCT00358917|Lopinavir|lopinavir|mesh-list
25505101|NCT00358917|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
25505102|NCT00358917|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25505103|NCT00358917|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25505104|NCT00358917|Protease Inhibitors|protease inhibitors|mesh-ancestor
25505105|NCT00358917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505106|NCT00358917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505107|NCT00358917|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25505108|NCT00358917|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25505109|NCT00358917|Antiviral Agents|antiviral agents|mesh-ancestor
25505110|NCT00358917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25505111|NCT00358917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25505112|NCT00358917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25505113|NCT00358917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25505114|NCT00359021|Etravirine|etravirine|mesh-list
25505115|NCT00359021|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25505116|NCT00359021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25505117|NCT00359021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505118|NCT00359021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505119|NCT00359021|Antiviral Agents|antiviral agents|mesh-ancestor
25505120|NCT00359021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25505121|NCT00359073|Montelukast|montelukast|mesh-list
25505122|NCT00359073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25505123|NCT00359073|Respiratory System Agents|respiratory system agents|mesh-ancestor
25505124|NCT00359073|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25505125|NCT00359073|Hormone Antagonists|hormone antagonists|mesh-ancestor
25505126|NCT00359073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25505127|NCT00359073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505128|NCT00359073|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25505129|NCT00359073|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25505130|NCT00359073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505131|NCT00359281|Niacin|niacin|mesh-list
25505132|NCT00359281|Dextromethorphan|dextromethorphan|mesh-list
25505133|NCT00359281|Atorvastatin|atorvastatin|mesh-list
25505134|NCT00359281|Simvastatin|simvastatin|mesh-list
25505135|NCT00359281|Ezetimibe|ezetimibe|mesh-list
25505136|NCT00359281|Fenofibrate|fenofibrate|mesh-list
25505137|NCT00359281|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25505138|NCT00359281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25505139|NCT00359281|Antimetabolites|antimetabolites|mesh-ancestor
25505140|NCT00359281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505141|NCT00359281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25505142|NCT00359281|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25645819|NCT01451645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645820|NCT01451645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25505143|NCT00359281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505144|NCT00359281|Vasodilator Agents|vasodilator agents|mesh-ancestor
25505145|NCT00359281|Vitamin B Complex|vitamin b complex|mesh-ancestor
25505146|NCT00359281|Vitamins|vitamins|mesh-ancestor
25505147|NCT00359281|Micronutrients|micronutrients|mesh-ancestor
25505148|NCT00359281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505149|NCT00359281|Antitussive Agents|antitussive agents|mesh-ancestor
25505150|NCT00359281|Respiratory System Agents|respiratory system agents|mesh-ancestor
25505151|NCT00359281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25505152|NCT00359281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25505153|NCT00359281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25505154|NCT00359424|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25505155|NCT00359424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25505156|NCT00359424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25505157|NCT00359424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505158|NCT00359632|Linezolid|linezolid|mesh-list
25505159|NCT00359632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25505160|NCT00359632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25505161|NCT00359632|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25505162|NCT00359632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505163|NCT00359632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505164|NCT00359736|Sildenafil Citrate|sildenafil citrate|mesh-list
25505165|NCT00359736|Vasodilator Agents|vasodilator agents|mesh-ancestor
25505166|NCT00359736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25505167|NCT00359736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25505168|NCT00359736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505169|NCT00359736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505170|NCT00359736|Urological Agents|urological agents|mesh-ancestor
25505171|NCT00359762|Exenatide|exenatide|mesh-list
25505172|NCT00359762|Glimepiride|glimepiride|mesh-list
25505173|NCT00359762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25505174|NCT00359762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505175|NCT00359762|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25505176|NCT00359762|Incretins|incretins|mesh-ancestor
25505177|NCT00359762|Hormones|hormones|mesh-ancestor
25505178|NCT00359762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25505179|NCT00359762|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25505180|NCT00359762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25505181|NCT00359762|Immunologic Factors|immunologic factors|mesh-ancestor
25505182|NCT00359788|Albuterol|albuterol|mesh-list
25505183|NCT00359788|Tiotropium Bromide|tiotropium bromide|mesh-list
25505184|NCT00359788|Ipratropium|ipratropium|mesh-list
25505185|NCT00359788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25505186|NCT00359788|Autonomic Agents|autonomic agents|mesh-ancestor
25505187|NCT00359788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25505188|NCT00359788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505189|NCT00359788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25505190|NCT00359788|Respiratory System Agents|respiratory system agents|mesh-ancestor
25505191|NCT00359788|Parasympatholytics|parasympatholytics|mesh-ancestor
25505220|NCT00360230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505221|NCT00360269|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25505222|NCT00360269|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25505223|NCT00360269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25505224|NCT00360269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25505225|NCT00360269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505226|NCT00360269|Adrenergic Agents|adrenergic agents|mesh-ancestor
25505227|NCT00360269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25505228|NCT00360269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505229|NCT00360282|Rizatriptan|rizatriptan|mesh-list
25505230|NCT00360282|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25505231|NCT00360282|Serotonin Agents|serotonin agents|mesh-ancestor
25505232|NCT00360282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25505233|NCT00360282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505234|NCT00360282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426413|NCT00235963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24426414|NCT00235963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25505238|NCT00360334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505239|NCT00360334|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25505240|NCT00360334|Incretins|incretins|mesh-ancestor
25505242|NCT00360334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25505243|NCT00360360|Paclitaxel|paclitaxel|mesh-list
25645821|NCT01451645|Antioxidants|antioxidants|mesh-ancestor
25505245|NCT00360360|Carboplatin|carboplatin|mesh-list
25505246|NCT00360360|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25505247|NCT00360360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25505248|NCT00360360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505249|NCT00360360|Tubulin Modulators|tubulin modulators|mesh-ancestor
25505250|NCT00360360|Antimitotic Agents|antimitotic agents|mesh-ancestor
25505251|NCT00360360|Mitosis Modulators|mitosis modulators|mesh-ancestor
25505252|NCT00360360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505253|NCT00360360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25505254|NCT00360360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25505255|NCT00360360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25505256|NCT00360360|Growth Substances|growth substances|mesh-ancestor
25505257|NCT00360360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505258|NCT00360360|Growth Inhibitors|growth inhibitors|mesh-ancestor
25505259|NCT00360360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25505260|NCT00360360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505261|NCT00360399|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25505262|NCT00360399|Citalopram|citalopram|mesh-list
25505263|NCT00360399|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25505264|NCT00360399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25505265|NCT00360399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25505266|NCT00360399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505267|NCT00360399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25505268|NCT00360399|Serotonin Agents|serotonin agents|mesh-ancestor
25505269|NCT00360399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505270|NCT00360399|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25505271|NCT00360399|Antidepressive Agents|antidepressive agents|mesh-ancestor
25505272|NCT00360399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25505273|NCT00360399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25505274|NCT00360399|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25505275|NCT00360399|Analgesics|analgesics|mesh-ancestor
25505276|NCT00360399|Sensory System Agents|sensory system agents|mesh-ancestor
25505277|NCT00360399|Dopamine Agents|dopamine agents|mesh-ancestor
25505278|NCT00360490|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25505279|NCT00360490|Levonorgestrel|levonorgestrel|mesh-list
25505280|NCT00360490|Medroxyprogesterone|medroxyprogesterone|mesh-list
25505281|NCT00360490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25505282|NCT00360490|Contraceptive Agents|contraceptive agents|mesh-ancestor
25505283|NCT00360490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25505284|NCT00360490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505285|NCT00360490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25505286|NCT00360490|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25505287|NCT00360490|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25505288|NCT00360490|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25505289|NCT00360490|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25505290|NCT00360490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25505291|NCT00360490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505292|NCT00360568|Levodopa|levodopa|mesh-list
25505293|NCT00360568|Carbidopa|carbidopa|mesh-list
25505294|NCT00360568|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25505295|NCT00360568|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25505296|NCT00360568|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25505297|NCT00360568|Dopamine Agents|dopamine agents|mesh-ancestor
25505298|NCT00360568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25505299|NCT00360568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505300|NCT00360568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427025|NCT00237211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427026|NCT00237211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24427027|NCT00237211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24427028|NCT00237211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823196|NCT00004763|Hormones|hormones|mesh-ancestor
25505301|NCT00360568|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25505303|NCT00360568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25505304|NCT00360568|Immunologic Factors|immunologic factors|mesh-ancestor
25505305|NCT00360568|Dopamine Agonists|dopamine agonists|mesh-ancestor
25505306|NCT00360672|Lenalidomide|lenalidomide|mesh-list
25505307|NCT00360672|Immunologic Factors|immunologic factors|mesh-ancestor
25505308|NCT00360672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505309|NCT00360672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25505310|NCT00360672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25505311|NCT00360672|Growth Substances|growth substances|mesh-ancestor
25505312|NCT00360672|Growth Inhibitors|growth inhibitors|mesh-ancestor
25505313|NCT00360672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505315|NCT00360685|Methotrexate|methotrexate|mesh-list
25505316|NCT00360685|Tacrolimus|tacrolimus|mesh-list
25505317|NCT00360685|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25505318|NCT00360685|Abortifacient Agents|abortifacient agents|mesh-ancestor
25505319|NCT00360685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25505320|NCT00360685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505321|NCT00360685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25505322|NCT00360685|Antimetabolites|antimetabolites|mesh-ancestor
25505323|NCT00360685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505324|NCT00360685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505325|NCT00360685|Dermatologic Agents|dermatologic agents|mesh-ancestor
25505326|NCT00360685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505327|NCT00360685|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25505328|NCT00360685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25505329|NCT00360685|Immunologic Factors|immunologic factors|mesh-ancestor
25505330|NCT00360685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25505331|NCT00360685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25505332|NCT00360685|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25505333|NCT00360685|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25505334|NCT00360685|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25505335|NCT00360685|Antitubercular Agents|antitubercular agents|mesh-ancestor
25505336|NCT00360685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25505337|NCT00360685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25505338|NCT00360698|Insulin|insulin|mesh-list
25505339|NCT00360698|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25505340|NCT00360698|Metformin|metformin|mesh-list
25505341|NCT00360698|Insulin Glargine|insulin glargine|mesh-list
25505342|NCT00360698|Glimepiride|glimepiride|mesh-list
25505343|NCT00360698|Insulin glulisine|insulin glulisine|mesh-list
25505344|NCT00360698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25505345|NCT00360698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505346|NCT00360698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25505347|NCT00360698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25505348|NCT00360698|Immunologic Factors|immunologic factors|mesh-ancestor
25505349|NCT00360724|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25505350|NCT00360724|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25505351|NCT00360724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25505352|NCT00360724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25505353|NCT00360724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505354|NCT00360724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25505355|NCT00360724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505356|NCT00360724|Analgesics|analgesics|mesh-ancestor
25505357|NCT00360724|Sensory System Agents|sensory system agents|mesh-ancestor
25505358|NCT00360724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25505359|NCT00360724|Antidepressive Agents|antidepressive agents|mesh-ancestor
25505360|NCT00360724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25505361|NCT00360724|Dopamine Agents|dopamine agents|mesh-ancestor
25505362|NCT00360828|Irinotecan|irinotecan|mesh-list
25505363|NCT00360828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25505364|NCT00360828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25505365|NCT00360828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505366|NCT00360828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505367|NCT00360828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505368|NCT00360971|Cisplatin|cisplatin|mesh-list
25505369|NCT00360971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505370|NCT00361140|Vidarabine|vidarabine|mesh-list
25505371|NCT00361140|Fludarabine|fludarabine|mesh-list
25505372|NCT00361140|Fludarabine phosphate|fludarabine phosphate|mesh-list
24427884|NCT00239174|Hormones|hormones|mesh-ancestor
24427955|NCT00239382|Meloxicam|meloxicam|mesh-list
25505373|NCT00361140|Busulfan|busulfan|mesh-list
25505374|NCT00361140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505375|NCT00361140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25505376|NCT00361140|Antimetabolites|antimetabolites|mesh-ancestor
25505377|NCT00361140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505378|NCT00361140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25505379|NCT00361140|Immunologic Factors|immunologic factors|mesh-ancestor
25505380|NCT00361140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505381|NCT00361140|Antiviral Agents|antiviral agents|mesh-ancestor
25505382|NCT00361140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25505383|NCT00361140|Alkylating Agents|alkylating agents|mesh-ancestor
25505384|NCT00361140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25505385|NCT00361140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24689848|NCT01397513|Aspirin|aspirin|mesh-list
25505387|NCT00361218|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25505388|NCT00361218|Serotonin|serotonin|mesh-list
25505389|NCT00361218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25505390|NCT00361218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25505391|NCT00361218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505392|NCT00361218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25505393|NCT00361218|Serotonin Agents|serotonin agents|mesh-ancestor
25505394|NCT00361218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505395|NCT00361218|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25505396|NCT00361218|Antidepressive Agents|antidepressive agents|mesh-ancestor
25505397|NCT00361218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25505398|NCT00361218|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25505399|NCT00361231|Gemcitabine|gemcitabine|mesh-list
25505400|NCT00361231|Bevacizumab|bevacizumab|mesh-list
25505401|NCT00361231|Oxaliplatin|oxaliplatin|mesh-list
25505402|NCT00361231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25505403|NCT00361231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505404|NCT00361231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25505405|NCT00361231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25505406|NCT00361231|Growth Substances|growth substances|mesh-ancestor
25505407|NCT00361231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505408|NCT00361231|Growth Inhibitors|growth inhibitors|mesh-ancestor
25505409|NCT00361231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25505410|NCT00361231|Antimetabolites|antimetabolites|mesh-ancestor
25505411|NCT00361231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505412|NCT00361231|Antiviral Agents|antiviral agents|mesh-ancestor
25505413|NCT00361231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25505414|NCT00361231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505415|NCT00361231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25505416|NCT00361231|Immunologic Factors|immunologic factors|mesh-ancestor
25505417|NCT00361257|Minocycline|minocycline|mesh-list
25505418|NCT00361257|Tetracycline|tetracycline|mesh-list
25505419|NCT00361257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25505420|NCT00361257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25505421|NCT00361257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25505422|NCT00361257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505423|NCT00361257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505424|NCT00361270|Complement Factor H|complement factor h|mesh-list
25505425|NCT00361270|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25505426|NCT00361270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25505427|NCT00361270|Immunologic Factors|immunologic factors|mesh-ancestor
25505428|NCT00361270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505429|NCT00361283|Atorvastatin|atorvastatin|mesh-list
25505430|NCT00361283|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25505431|NCT00361283|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25505432|NCT00361283|Antimetabolites|antimetabolites|mesh-ancestor
25505433|NCT00361283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505434|NCT00361283|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25505435|NCT00361283|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25505436|NCT00361283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505437|NCT00361335|Golimumab|golimumab|mesh-list
25505438|NCT00361335|Methotrexate|methotrexate|mesh-list
25505439|NCT00361335|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25505440|NCT00361335|Abortifacient Agents|abortifacient agents|mesh-ancestor
25505441|NCT00361335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25505442|NCT00361335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505443|NCT00361335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25505444|NCT00361335|Antimetabolites|antimetabolites|mesh-ancestor
25505445|NCT00361335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505446|NCT00361335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505447|NCT00361335|Dermatologic Agents|dermatologic agents|mesh-ancestor
25505448|NCT00361335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505449|NCT00361335|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25505450|NCT00361335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25505451|NCT00361335|Immunologic Factors|immunologic factors|mesh-ancestor
25505452|NCT00361335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25505453|NCT00361335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25505454|NCT00361335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25505455|NCT00361335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25505456|NCT00361439|Mometasone Furoate|mometasone furoate|mesh-list
25505457|NCT00361439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25505458|NCT00361439|Dermatologic Agents|dermatologic agents|mesh-ancestor
25505459|NCT00361439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25505460|NCT00361504|Oxycodone|oxycodone|mesh-list
25645822|NCT01451645|Protective Agents|protective agents|mesh-ancestor
25645823|NCT01451645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505461|NCT00361504|Tapentadol|tapentadol|mesh-list
25505462|NCT00361504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25505463|NCT00361504|Narcotics|narcotics|mesh-ancestor
25505464|NCT00361504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25505465|NCT00361504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505466|NCT00361504|Analgesics|analgesics|mesh-ancestor
25505467|NCT00361504|Sensory System Agents|sensory system agents|mesh-ancestor
25505468|NCT00361504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25505469|NCT00361504|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25505470|NCT00361504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25505471|NCT00361504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25505472|NCT00361504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505473|NCT00361504|Adrenergic Agents|adrenergic agents|mesh-ancestor
25505474|NCT00361504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25505475|NCT00361569|Estrogens|estrogens|mesh-list
25505476|NCT00361569|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25505477|NCT00361569|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
25505478|NCT00361569|Hormones|hormones|mesh-ancestor
25505479|NCT00361569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25505480|NCT00361569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505481|NCT00361595|Zoledronic Acid|zoledronic acid|mesh-list
25505482|NCT00361595|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25505483|NCT00361595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505484|NCT00361634|Etanercept|etanercept|mesh-list
25505485|NCT00361634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25505486|NCT00361634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25505487|NCT00361634|Analgesics|analgesics|mesh-ancestor
25505488|NCT00361634|Sensory System Agents|sensory system agents|mesh-ancestor
25505489|NCT00361634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25505490|NCT00361634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505491|NCT00361634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25505492|NCT00361634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25505493|NCT00361634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25505494|NCT00361634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25505495|NCT00361634|Immunologic Factors|immunologic factors|mesh-ancestor
25505496|NCT00361842|Irinotecan|irinotecan|mesh-list
25505497|NCT00361842|Floxuridine|floxuridine|mesh-list
25505498|NCT00361842|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25505499|NCT00361842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25505500|NCT00361842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505501|NCT00361842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505502|NCT00361842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505503|NCT00361842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25505504|NCT00361842|Antimetabolites|antimetabolites|mesh-ancestor
25505505|NCT00361972|Lansoprazole|lansoprazole|mesh-list
25505506|NCT00361972|Dexlansoprazole|dexlansoprazole|mesh-list
25505507|NCT00361972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25505508|NCT00361972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25505509|NCT00361972|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25505510|NCT00361972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505511|NCT00361972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505512|NCT00362115|Olmesartan|olmesartan|mesh-list
25505513|NCT00362115|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25505514|NCT00362115|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25505515|NCT00362115|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25505516|NCT00362115|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25505517|NCT00362115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123288|NCT03086291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25123289|NCT03086291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123290|NCT03086564|Chlorotrianisene|chlorotrianisene|mesh-list
25123292|NCT03086564|Estrogens|estrogens|mesh-ancestor
25505520|NCT00362180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25505522|NCT00362180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505523|NCT00362180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25505524|NCT00362232|Enoxaparin|enoxaparin|mesh-list
25505525|NCT00362232|Rivaroxaban|rivaroxaban|mesh-list
25505526|NCT00362232|Enoxaparin sodium|enoxaparin sodium|mesh-list
25505527|NCT00362232|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25505528|NCT00362232|Antithrombins|antithrombins|mesh-ancestor
25505529|NCT00362232|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25505530|NCT00362232|Protease Inhibitors|protease inhibitors|mesh-ancestor
25505531|NCT00362232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505532|NCT00362232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505534|NCT00362232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25505535|NCT00362232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25505536|NCT00362297|Valacyclovir|valacyclovir|mesh-list
25505537|NCT00362297|Acyclovir|acyclovir|mesh-list
25505538|NCT00362297|Antiviral Agents|antiviral agents|mesh-ancestor
25505539|NCT00362297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25505540|NCT00362414|Mitogens|mitogens|mesh-list
25505541|NCT00362414|Mitosis Modulators|mitosis modulators|mesh-ancestor
25505542|NCT00362414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505543|NCT00362440|Metformin|metformin|mesh-list
25505544|NCT00362440|Pioglitazone|pioglitazone|mesh-list
25505545|NCT00362440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25505546|NCT00362440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505547|NCT00362466|Imatinib Mesylate|imatinib mesylate|mesh-list
25505548|NCT00362466|Dasatinib|dasatinib|mesh-list
25505549|NCT00362466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505550|NCT00362466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25505551|NCT00362466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505552|NCT00362466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505553|NCT00362609|Pantoprazole|pantoprazole|mesh-list
25505554|NCT00362609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25505555|NCT00362609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25505556|NCT00362609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25505557|NCT00362609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505558|NCT00362609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505559|NCT00362817|Carboplatin|carboplatin|mesh-list
25505560|NCT00362817|Temozolomide|temozolomide|mesh-list
25505561|NCT00362817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505562|NCT00362817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25505563|NCT00362817|Alkylating Agents|alkylating agents|mesh-ancestor
25505564|NCT00362817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505565|NCT00362882|Docetaxel|docetaxel|mesh-list
25505566|NCT00362882|Bortezomib|bortezomib|mesh-list
25505567|NCT00362882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505568|NCT00362882|Tubulin Modulators|tubulin modulators|mesh-ancestor
25505569|NCT00362882|Antimitotic Agents|antimitotic agents|mesh-ancestor
25505570|NCT00362882|Mitosis Modulators|mitosis modulators|mesh-ancestor
25505571|NCT00362882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505572|NCT00363051|Everolimus|everolimus|mesh-list
25505573|NCT00363051|Octreotide|octreotide|mesh-list
25505574|NCT00363051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505575|NCT00363051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25505576|NCT00363051|Immunologic Factors|immunologic factors|mesh-ancestor
25505577|NCT00363051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505578|NCT00363051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25505579|NCT00363051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25505580|NCT00363077|Vaccines|vaccines|mesh-list
25505581|NCT00363077|Immunologic Factors|immunologic factors|mesh-ancestor
25505582|NCT00363077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505583|NCT00363129|Vitamin E|vitamin e|mesh-list
25505584|NCT00363129|Vitamins|vitamins|mesh-ancestor
25505585|NCT00363129|Micronutrients|micronutrients|mesh-ancestor
25505586|NCT00363129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505587|NCT00363129|Antioxidants|antioxidants|mesh-ancestor
25505588|NCT00363129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505589|NCT00363129|Protective Agents|protective agents|mesh-ancestor
24428801|NCT00241215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428802|NCT00241215|Cholinergic Agents|cholinergic agents|mesh-ancestor
24428867|NCT00241423|Exenatide|exenatide|mesh-list
25505590|NCT00363142|Ritonavir|ritonavir|mesh-list
25505591|NCT00363142|Fosamprenavir|fosamprenavir|mesh-list
25505592|NCT00363142|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25505593|NCT00363142|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25505594|NCT00363142|Protease Inhibitors|protease inhibitors|mesh-ancestor
25505595|NCT00363142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505596|NCT00363142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505597|NCT00363142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25505598|NCT00363142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25505599|NCT00363142|Antiviral Agents|antiviral agents|mesh-ancestor
25505600|NCT00363142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25505601|NCT00363142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25505602|NCT00363142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25505603|NCT00363168|Ranibizumab|ranibizumab|mesh-list
25505604|NCT00363168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25645824|NCT01451749|Donepezil|donepezil|mesh-list
25505605|NCT00363168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25505606|NCT00363168|Growth Substances|growth substances|mesh-ancestor
25505607|NCT00363168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505608|NCT00363168|Growth Inhibitors|growth inhibitors|mesh-ancestor
25505609|NCT00363168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505610|NCT00363298|Caffeine|caffeine|mesh-list
25505611|NCT00363298|Amphetamine|amphetamine|mesh-list
25505612|NCT00363298|Dextroamphetamine|dextroamphetamine|mesh-list
25505613|NCT00363298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25505614|NCT00363298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505615|NCT00363298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25505616|NCT00363298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505617|NCT00363298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505618|NCT00363298|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25505619|NCT00363298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25505620|NCT00363298|Purinergic Agents|purinergic agents|mesh-ancestor
25505621|NCT00363298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25505622|NCT00363298|Sympathomimetics|sympathomimetics|mesh-ancestor
25505623|NCT00363298|Autonomic Agents|autonomic agents|mesh-ancestor
25505624|NCT00363298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25505625|NCT00363298|Dopamine Agents|dopamine agents|mesh-ancestor
25505626|NCT00363298|Adrenergic Agents|adrenergic agents|mesh-ancestor
25505627|NCT00363298|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25505628|NCT00363298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25505629|NCT00363298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25505630|NCT00363298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25505631|NCT00363311|Dutasteride|dutasteride|mesh-list
25505632|NCT00363311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25505633|NCT00363311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25505634|NCT00363311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505635|NCT00363311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505636|NCT00363311|Hormone Antagonists|hormone antagonists|mesh-ancestor
25505637|NCT00363311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25505638|NCT00363311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505639|NCT00363415|Carboplatin|carboplatin|mesh-list
25505640|NCT00363415|Etoposide|etoposide|mesh-list
25505641|NCT00363415|Pemetrexed|pemetrexed|mesh-list
25505642|NCT00363415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505643|NCT00363415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25505644|NCT00363415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25505645|NCT00363415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25505646|NCT00363415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505647|NCT00363415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505648|NCT00363415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25505649|NCT00363415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25505650|NCT00363467|Busulfan|busulfan|mesh-list
25505651|NCT00363467|Alkylating Agents|alkylating agents|mesh-ancestor
25505652|NCT00363467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505653|NCT00363467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25505654|NCT00363467|Immunologic Factors|immunologic factors|mesh-ancestor
25505655|NCT00363467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505656|NCT00363467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25505657|NCT00363467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505658|NCT00363467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25505659|NCT00363480|Fluticasone|fluticasone|mesh-list
25505660|NCT00363480|Albuterol|albuterol|mesh-list
25505661|NCT00363480|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25505662|NCT00363480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25505663|NCT00363480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25505665|NCT00363480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25505666|NCT00363480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505667|NCT00363480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25505668|NCT00363480|Respiratory System Agents|respiratory system agents|mesh-ancestor
25505669|NCT00363480|Dermatologic Agents|dermatologic agents|mesh-ancestor
25505670|NCT00363480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25505671|NCT00363480|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25505672|NCT00363480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25505673|NCT00363480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25505674|NCT00363480|Adrenergic Agents|adrenergic agents|mesh-ancestor
25505675|NCT00363480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25505676|NCT00363480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505677|NCT00363480|Tocolytic Agents|tocolytic agents|mesh-ancestor
25505678|NCT00363480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25505680|NCT00363545|Immunologic Factors|immunologic factors|mesh-ancestor
25505681|NCT00363545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505682|NCT00363649|Interferons|interferons|mesh-list
25505683|NCT00363649|Interferon-alpha|interferon-alpha|mesh-list
25505684|NCT00363649|Sargramostim|sargramostim|mesh-list
25505685|NCT00363649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505686|NCT00363649|Antiviral Agents|antiviral agents|mesh-ancestor
25505687|NCT00363649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25505688|NCT00363649|Immunologic Factors|immunologic factors|mesh-ancestor
25505689|NCT00363649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505690|NCT00363779|Cyclosporine|cyclosporine|mesh-list
25505691|NCT00363779|Cyclosporins|cyclosporins|mesh-list
25505692|NCT00363779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505693|NCT00363779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505694|NCT00363779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25505695|NCT00363779|Immunologic Factors|immunologic factors|mesh-ancestor
25505696|NCT00363779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505697|NCT00363779|Antifungal Agents|antifungal agents|mesh-ancestor
25505698|NCT00363779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25505699|NCT00363779|Dermatologic Agents|dermatologic agents|mesh-ancestor
25505700|NCT00363779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25505701|NCT00363779|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25505702|NCT00363883|Vorinostat|vorinostat|mesh-list
25505703|NCT00363883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505704|NCT00363883|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25505705|NCT00363883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505706|NCT00363883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505707|NCT00363896|Bromides|bromides|mesh-list
25505708|NCT00363896|Anticonvulsants|anticonvulsants|mesh-ancestor
25505709|NCT00364156|Nicotine|nicotine|mesh-list
25505710|NCT00364156|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25505711|NCT00364156|Autonomic Agents|autonomic agents|mesh-ancestor
25505712|NCT00364156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25163527|NCT02895113|Aspirin|aspirin|mesh-list
25505713|NCT00364156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505714|NCT00364156|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25505715|NCT00364156|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25505716|NCT00364156|Cholinergic Agents|cholinergic agents|mesh-ancestor
25505717|NCT00364156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25505718|NCT00364156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505719|NCT00364286|Dasatinib|dasatinib|mesh-list
25505720|NCT00364286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505721|NCT00364286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25505722|NCT00364286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505723|NCT00364286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505724|NCT00364351|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25505725|NCT00364351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505726|NCT00364351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25505727|NCT00364351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505728|NCT00364351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505729|NCT00364377|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25505730|NCT00364377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25505731|NCT00364377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505732|NCT00364377|Incretins|incretins|mesh-ancestor
25505733|NCT00364377|Hormones|hormones|mesh-ancestor
25505734|NCT00364377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25505735|NCT00364377|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24429896|NCT00245375|Antipyretics|antipyretics|mesh-ancestor
25505736|NCT00364377|Protease Inhibitors|protease inhibitors|mesh-ancestor
25505737|NCT00364377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505738|NCT00364377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505741|NCT00364533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25505742|NCT00364533|Narcotics|narcotics|mesh-ancestor
25505743|NCT00364533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25505744|NCT00364533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505745|NCT00364533|Analgesics|analgesics|mesh-ancestor
25505746|NCT00364533|Sensory System Agents|sensory system agents|mesh-ancestor
25505747|NCT00364533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25505748|NCT00364533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25505749|NCT00364533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25505750|NCT00364533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25505751|NCT00364533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505752|NCT00364533|Adrenergic Agents|adrenergic agents|mesh-ancestor
25505753|NCT00364533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25505755|NCT00364611|Trastuzumab|trastuzumab|mesh-list
25505756|NCT00364611|Docetaxel|docetaxel|mesh-list
25505757|NCT00364611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25505758|NCT00364611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505759|NCT00364611|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25505760|NCT00364611|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25505761|NCT00364611|Growth Substances|growth substances|mesh-ancestor
25505762|NCT00364611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505763|NCT00364611|Growth Inhibitors|growth inhibitors|mesh-ancestor
25505764|NCT00364611|Tubulin Modulators|tubulin modulators|mesh-ancestor
25505765|NCT00364611|Antimitotic Agents|antimitotic agents|mesh-ancestor
25505766|NCT00364611|Mitosis Modulators|mitosis modulators|mesh-ancestor
25505767|NCT00364611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505768|NCT00364793|Emtricitabine|emtricitabine|mesh-list
25505769|NCT00364793|Efavirenz|efavirenz|mesh-list
25505770|NCT00364793|Didanosine|didanosine|mesh-list
25505771|NCT00364793|Antiviral Agents|antiviral agents|mesh-ancestor
25505772|NCT00364793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25505773|NCT00364793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25505774|NCT00364793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25505775|NCT00364793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505776|NCT00364793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505777|NCT00364793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25505778|NCT00364793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25505779|NCT00364793|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25505780|NCT00364793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25505781|NCT00364793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25505782|NCT00364793|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25505783|NCT00364793|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25505784|NCT00364793|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25505785|NCT00364793|Antimetabolites|antimetabolites|mesh-ancestor
25505786|NCT00364819|Rituximab|rituximab|mesh-list
25505787|NCT00364819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25505788|NCT00364819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505789|NCT00364819|Immunologic Factors|immunologic factors|mesh-ancestor
25505790|NCT00364819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505791|NCT00364819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25505792|NCT00364832|Epoetin Alfa|epoetin alfa|mesh-list
25505793|NCT00364832|Hematinics|hematinics|mesh-ancestor
25505794|NCT00364845|Darbepoetin alfa|darbepoetin alfa|mesh-list
25505795|NCT00364845|Hematinics|hematinics|mesh-ancestor
25505796|NCT00364923|10-deazaaminopterin|10-deazaaminopterin|mesh-list
25505797|NCT00364923|Aminopterin|aminopterin|mesh-list
25505798|NCT00364923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25505799|NCT00364923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505800|NCT00364923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505801|NCT00364923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505802|NCT00365053|Belinostat|belinostat|mesh-list
25505803|NCT00365053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505804|NCT00365053|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24431081|NCT00250237|Dopamine Agents|dopamine agents|mesh-ancestor
24431082|NCT00250237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431083|NCT00250237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431084|NCT00250237|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24431192|NCT00250744|Antiemetics|antiemetics|mesh-ancestor
24431193|NCT00250744|Autonomic Agents|autonomic agents|mesh-ancestor
25505805|NCT00365053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505811|NCT00365105|Micronutrients|micronutrients|mesh-ancestor
25505812|NCT00365105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505813|NCT00365105|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25505814|NCT00365105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25505815|NCT00365144|Bevacizumab|bevacizumab|mesh-list
25505816|NCT00365144|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25505817|NCT00365144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25505818|NCT00365144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505819|NCT00365144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25505820|NCT00365144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25505821|NCT00365144|Growth Substances|growth substances|mesh-ancestor
25505822|NCT00365144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505823|NCT00365144|Growth Inhibitors|growth inhibitors|mesh-ancestor
25505824|NCT00365144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25505825|NCT00365144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505826|NCT00365144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505827|NCT00365209|Curcumin|curcumin|mesh-list
25505828|NCT00365209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25505829|NCT00365209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25505830|NCT00365209|Analgesics|analgesics|mesh-ancestor
25505831|NCT00365209|Sensory System Agents|sensory system agents|mesh-ancestor
25505832|NCT00365209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25505833|NCT00365209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505834|NCT00365209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25505835|NCT00365209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25505836|NCT00365209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505837|NCT00365209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505838|NCT00365209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505839|NCT00365261|Eszopiclone|eszopiclone|mesh-list
25505840|NCT00365261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25505841|NCT00365261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25505842|NCT00365261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505843|NCT00365274|Prednisone|prednisone|mesh-list
25505844|NCT00365274|Cyclophosphamide|cyclophosphamide|mesh-list
25505845|NCT00365274|Doxorubicin|doxorubicin|mesh-list
25505846|NCT00365274|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25505847|NCT00365274|Vincristine|vincristine|mesh-list
25505848|NCT00365274|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25505849|NCT00365274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25505850|NCT00365274|Immunologic Factors|immunologic factors|mesh-ancestor
25505851|NCT00365274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505852|NCT00365274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25505853|NCT00365274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25505854|NCT00365274|Alkylating Agents|alkylating agents|mesh-ancestor
25505855|NCT00365274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505856|NCT00365274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505857|NCT00365274|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25505858|NCT00365274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25505859|NCT00365274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25505860|NCT00365274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25505861|NCT00365274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505862|NCT00365274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25505863|NCT00365274|Glucocorticoids|glucocorticoids|mesh-ancestor
25505864|NCT00365274|Hormones|hormones|mesh-ancestor
25505865|NCT00365274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25505866|NCT00365274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25505867|NCT00365274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25505868|NCT00365274|Tubulin Modulators|tubulin modulators|mesh-ancestor
25829461|NCT00006212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24433050|NCT00257387|Antifungal Agents|antifungal agents|mesh-ancestor
24433051|NCT00257387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24433052|NCT00257387|Dermatologic Agents|dermatologic agents|mesh-ancestor
24433053|NCT00257387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24433054|NCT00257387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25505869|NCT00365274|Antimitotic Agents|antimitotic agents|mesh-ancestor
25505870|NCT00365274|Mitosis Modulators|mitosis modulators|mesh-ancestor
25505871|NCT00365274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25505872|NCT00365300|Pantoprazole|pantoprazole|mesh-list
25505873|NCT00365300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25505874|NCT00365300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25505875|NCT00365300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25505876|NCT00365300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505877|NCT00365300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505878|NCT00365352|Gabapentin|gabapentin|mesh-list
25505879|NCT00365352|Analgesics|analgesics|mesh-ancestor
25505880|NCT00365352|Sensory System Agents|sensory system agents|mesh-ancestor
25505881|NCT00365352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25505882|NCT00365352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505883|NCT00365352|Anticonvulsants|anticonvulsants|mesh-ancestor
25505884|NCT00365352|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25505885|NCT00365352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25505886|NCT00365352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25505887|NCT00365352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25505888|NCT00365352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25505889|NCT00365352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25505890|NCT00365352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25505891|NCT00365352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505892|NCT00365352|Antimanic Agents|antimanic agents|mesh-ancestor
25505893|NCT00365365|Cyclophosphamide|cyclophosphamide|mesh-list
25505894|NCT00365365|Bevacizumab|bevacizumab|mesh-list
25505895|NCT00365365|Carboplatin|carboplatin|mesh-list
25505897|NCT00365365|Doxorubicin|doxorubicin|mesh-list
25505898|NCT00365365|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25505899|NCT00365365|Trastuzumab|trastuzumab|mesh-list
25505900|NCT00365365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25505901|NCT00365365|Immunologic Factors|immunologic factors|mesh-ancestor
25505902|NCT00365365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505903|NCT00365365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25505904|NCT00365365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25505905|NCT00365365|Alkylating Agents|alkylating agents|mesh-ancestor
25505906|NCT00365365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505907|NCT00365365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505908|NCT00365365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25505909|NCT00365365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25505910|NCT00365365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25505911|NCT00365365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25505912|NCT00365365|Growth Substances|growth substances|mesh-ancestor
25505913|NCT00365365|Growth Inhibitors|growth inhibitors|mesh-ancestor
25505914|NCT00365365|Tubulin Modulators|tubulin modulators|mesh-ancestor
25505915|NCT00365365|Antimitotic Agents|antimitotic agents|mesh-ancestor
25505916|NCT00365365|Mitosis Modulators|mitosis modulators|mesh-ancestor
25505917|NCT00365365|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25505918|NCT00365365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25505919|NCT00365365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25505920|NCT00365365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505921|NCT00365391|Bevacizumab|bevacizumab|mesh-list
25505922|NCT00365391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25505923|NCT00365391|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25505924|NCT00365391|Antibodies|antibodies|mesh-list
25505925|NCT00365391|Immunoglobulins|immunoglobulins|mesh-list
25505926|NCT00365391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25040928|NCT02736149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040929|NCT02736149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25040930|NCT02736149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25123785|NCT03081728|Ropivacaine|ropivacaine|mesh-list
25040931|NCT02736149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25040932|NCT02736149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25040933|NCT02736149|Protease Inhibitors|protease inhibitors|mesh-ancestor
25040934|NCT02736149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25040935|NCT02736149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040936|NCT02736149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25040937|NCT02736149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25040938|NCT02736149|Antiviral Agents|antiviral agents|mesh-ancestor
25040953|NCT02733432|Fluconazole|fluconazole|mesh-list
25040954|NCT02733432|Rezafungin|rezafungin|mesh-list
25040955|NCT02733432|Antifungal Agents|antifungal agents|mesh-ancestor
25040956|NCT02733432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25040957|NCT02733432|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25505927|NCT00365391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505932|NCT00365391|Growth Inhibitors|growth inhibitors|mesh-ancestor
25505933|NCT00365391|Immunologic Factors|immunologic factors|mesh-ancestor
25505934|NCT00365391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25505935|NCT00365391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505936|NCT00365391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505937|NCT00365417|Cyclophosphamide|cyclophosphamide|mesh-list
25505938|NCT00365417|Bevacizumab|bevacizumab|mesh-list
25505939|NCT00365417|Docetaxel|docetaxel|mesh-list
25505940|NCT00365417|Doxorubicin|doxorubicin|mesh-list
25505941|NCT00365417|Capecitabine|capecitabine|mesh-list
25505942|NCT00365417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25505943|NCT00365417|Immunologic Factors|immunologic factors|mesh-ancestor
25505944|NCT00365417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505945|NCT00365417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25505946|NCT00365417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25505947|NCT00365417|Alkylating Agents|alkylating agents|mesh-ancestor
25505948|NCT00365417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505949|NCT00365417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505950|NCT00365417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25505951|NCT00365417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25505952|NCT00365417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25505953|NCT00365417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25505954|NCT00365417|Growth Substances|growth substances|mesh-ancestor
25505955|NCT00365417|Growth Inhibitors|growth inhibitors|mesh-ancestor
25505956|NCT00365417|Tubulin Modulators|tubulin modulators|mesh-ancestor
25505957|NCT00365417|Antimitotic Agents|antimitotic agents|mesh-ancestor
25505958|NCT00365417|Mitosis Modulators|mitosis modulators|mesh-ancestor
25505959|NCT00365417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25505960|NCT00365417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25505961|NCT00365417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25505962|NCT00365417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25505963|NCT00365417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25505964|NCT00365417|Antimetabolites|antimetabolites|mesh-ancestor
25505965|NCT00365456|Risedronic Acid|risedronic acid|mesh-list
25505967|NCT00365456|Parathyroid Hormone|parathyroid hormone|mesh-list
25505968|NCT00365456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25505969|NCT00365456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505970|NCT00365456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25505971|NCT00365456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25505972|NCT00365456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505973|NCT00365456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25505974|NCT00365456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25505975|NCT00365508|Nicotine|nicotine|mesh-list
25505976|NCT00365508|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25505977|NCT00365508|Autonomic Agents|autonomic agents|mesh-ancestor
25505978|NCT00365508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25505979|NCT00365508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505980|NCT00365508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25505981|NCT00365508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25505982|NCT00365508|Cholinergic Agents|cholinergic agents|mesh-ancestor
25505983|NCT00365508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25505984|NCT00365508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25505985|NCT00365547|Bevacizumab|bevacizumab|mesh-list
25505986|NCT00365547|Topotecan|topotecan|mesh-list
25505987|NCT00365547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25505988|NCT00365547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25505989|NCT00365547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25505990|NCT00365547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25505991|NCT00365547|Growth Substances|growth substances|mesh-ancestor
25505992|NCT00365547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25505993|NCT00365547|Growth Inhibitors|growth inhibitors|mesh-ancestor
25505994|NCT00365547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25505995|NCT00365547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25505996|NCT00365547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433326|NCT00258232|Celecoxib|celecoxib|mesh-list
25506020|NCT00365846|Alemtuzumab|alemtuzumab|mesh-list
25506021|NCT00365846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25506022|NCT00365846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506023|NCT00365859|Aripiprazole|aripiprazole|mesh-list
25506024|NCT00365859|Antidepressive Agents|antidepressive agents|mesh-ancestor
25506025|NCT00365859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25506026|NCT00365859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25506027|NCT00365859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25506028|NCT00365859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25506029|NCT00365859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506030|NCT00365859|Dopamine Agonists|dopamine agonists|mesh-ancestor
25506031|NCT00365859|Dopamine Agents|dopamine agents|mesh-ancestor
25506032|NCT00365859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25506033|NCT00365859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506034|NCT00365859|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25506035|NCT00365859|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25506036|NCT00365859|Serotonin Agents|serotonin agents|mesh-ancestor
25506037|NCT00365859|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25506038|NCT00365859|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25506039|NCT00365859|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25506040|NCT00365859|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25506041|NCT00365976|Eszopiclone|eszopiclone|mesh-list
25506042|NCT00365976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25506043|NCT00365976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25506044|NCT00365976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506045|NCT00366106|Dexamethasone|dexamethasone|mesh-list
25506046|NCT00366106|Doxorubicin|doxorubicin|mesh-list
25506047|NCT00366106|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25506048|NCT00366106|Bortezomib|bortezomib|mesh-list
25506049|NCT00366106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25506050|NCT00366106|Antiemetics|antiemetics|mesh-ancestor
25506051|NCT00366106|Autonomic Agents|autonomic agents|mesh-ancestor
25506052|NCT00366106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25506053|NCT00366106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506054|NCT00366106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25506055|NCT00366106|Glucocorticoids|glucocorticoids|mesh-ancestor
25506056|NCT00366106|Hormones|hormones|mesh-ancestor
25506057|NCT00366106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25506058|NCT00366106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25506059|NCT00366106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506060|NCT00366106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25506061|NCT00366106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25506062|NCT00366106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25506063|NCT00366106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506064|NCT00366106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506065|NCT00366249|Ertapenem|ertapenem|mesh-list
25506066|NCT00366249|Tigecycline|tigecycline|mesh-list
25506067|NCT00366249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25506068|NCT00366249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25506069|NCT00366249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25506070|NCT00366249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506071|NCT00366249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506072|NCT00366301|Metformin|metformin|mesh-list
25506073|NCT00366301|Insulin Glargine|insulin glargine|mesh-list
25506074|NCT00366301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25506075|NCT00366301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506076|NCT00366340|Vaccines|vaccines|mesh-list
25506077|NCT00366340|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25506078|NCT00366340|Immunologic Factors|immunologic factors|mesh-ancestor
25506079|NCT00366340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506080|NCT00366444|Diclofenac|diclofenac|mesh-list
25506081|NCT00366444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25506082|NCT00366444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25506083|NCT00366444|Analgesics|analgesics|mesh-ancestor
25506084|NCT00366444|Sensory System Agents|sensory system agents|mesh-ancestor
25506085|NCT00366444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25506086|NCT00366444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506087|NCT00366444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25506088|NCT00366444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25506089|NCT00366444|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24433919|NCT00260624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24433920|NCT00260624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506090|NCT00366444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506091|NCT00366444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506092|NCT00366457|Gemcitabine|gemcitabine|mesh-list
25506093|NCT00366457|Bevacizumab|bevacizumab|mesh-list
25506094|NCT00366457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25506095|NCT00366457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25506096|NCT00366457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506097|NCT00366457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25506098|NCT00366457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25506099|NCT00366457|Growth Substances|growth substances|mesh-ancestor
25506100|NCT00366457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506101|NCT00366457|Growth Inhibitors|growth inhibitors|mesh-ancestor
25506102|NCT00366457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25506103|NCT00366457|Antimetabolites|antimetabolites|mesh-ancestor
25506104|NCT00366457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506105|NCT00366457|Antiviral Agents|antiviral agents|mesh-ancestor
25506106|NCT00366457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25506107|NCT00366457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506108|NCT00366457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25506109|NCT00366457|Immunologic Factors|immunologic factors|mesh-ancestor
25506110|NCT00366457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25506111|NCT00366535|Neurotropin|neurotropin|mesh-list
25506112|NCT00366535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25506113|NCT00366535|Immunologic Factors|immunologic factors|mesh-ancestor
25506114|NCT00366535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506115|NCT00366535|Analgesics|analgesics|mesh-ancestor
25506116|NCT00366535|Sensory System Agents|sensory system agents|mesh-ancestor
25506117|NCT00366535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25506118|NCT00366535|Anticonvulsants|anticonvulsants|mesh-ancestor
25506119|NCT00366548|Vaccines|vaccines|mesh-list
25506120|NCT00366548|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25506121|NCT00366548|Immunologic Factors|immunologic factors|mesh-ancestor
25506122|NCT00366548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506123|NCT00366626|Naltrexone|naltrexone|mesh-list
25506124|NCT00366626|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25506125|NCT00366626|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25506126|NCT00366626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506127|NCT00366626|Sensory System Agents|sensory system agents|mesh-ancestor
25506128|NCT00366626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25506129|NCT00366678|Vaccines|vaccines|mesh-list
25506130|NCT00366678|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25506131|NCT00366678|Immunologic Factors|immunologic factors|mesh-ancestor
25506132|NCT00366678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506133|NCT00366899|Vaccines|vaccines|mesh-list
25506134|NCT00366899|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25506135|NCT00366899|Immunologic Factors|immunologic factors|mesh-ancestor
25506136|NCT00366899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506137|NCT00367016|Omalizumab|omalizumab|mesh-list
25506138|NCT00367016|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25506139|NCT00367016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25506140|NCT00367016|Respiratory System Agents|respiratory system agents|mesh-ancestor
25506141|NCT00367055|Metformin|metformin|mesh-list
25506142|NCT00367055|Rosiglitazone|rosiglitazone|mesh-list
25506143|NCT00367055|Gliclazide|gliclazide|mesh-list
25506144|NCT00367055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25506145|NCT00367055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506146|NCT00367133|Triamcinolone|triamcinolone|mesh-list
25506147|NCT00367133|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25506148|NCT00367133|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25506149|NCT00367133|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25506150|NCT00367133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25506151|NCT00367133|Glucocorticoids|glucocorticoids|mesh-ancestor
25506152|NCT00367133|Hormones|hormones|mesh-ancestor
25506153|NCT00367133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25506154|NCT00367133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506155|NCT00367133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25506156|NCT00367133|Immunologic Factors|immunologic factors|mesh-ancestor
25506157|NCT00367133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506158|NCT00367133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506159|NCT00367237|Methotrexate|methotrexate|mesh-list
25506160|NCT00367237|Infliximab|infliximab|mesh-list
25506161|NCT00367237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25506162|NCT00367237|Abortifacient Agents|abortifacient agents|mesh-ancestor
25506163|NCT00367237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25506164|NCT00367237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506165|NCT00367237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25506166|NCT00367237|Antimetabolites|antimetabolites|mesh-ancestor
25506167|NCT00367237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506168|NCT00367237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506169|NCT00367237|Dermatologic Agents|dermatologic agents|mesh-ancestor
25506170|NCT00367237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506171|NCT00367237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25506172|NCT00367237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25506173|NCT00367237|Immunologic Factors|immunologic factors|mesh-ancestor
25506174|NCT00367237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25506175|NCT00367237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25506176|NCT00367237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25506177|NCT00367341|Citalopram|citalopram|mesh-list
25506178|NCT00367341|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25506179|NCT00367341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25506180|NCT00367341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25506181|NCT00367341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506182|NCT00367341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25506183|NCT00367341|Serotonin Agents|serotonin agents|mesh-ancestor
25506184|NCT00367341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506185|NCT00367341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25506186|NCT00367341|Antidepressive Agents|antidepressive agents|mesh-ancestor
25506187|NCT00367341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25506188|NCT00367432|Levetiracetam|levetiracetam|mesh-list
25506189|NCT00367432|Anticonvulsants|anticonvulsants|mesh-ancestor
25506190|NCT00367432|Nootropic Agents|nootropic agents|mesh-ancestor
25506191|NCT00367458|Atorvastatin|atorvastatin|mesh-list
25506192|NCT00367458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25506193|NCT00367458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25506194|NCT00367458|Antimetabolites|antimetabolites|mesh-ancestor
25506195|NCT00367458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506196|NCT00367458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25506197|NCT00367458|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25506198|NCT00367458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506199|NCT00367484|Interferons|interferons|mesh-list
25506200|NCT00367484|Interferon-beta|interferon-beta|mesh-list
25506201|NCT00367484|Interferon beta-1a|interferon beta-1a|mesh-list
25506202|NCT00367484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506203|NCT00367484|Antiviral Agents|antiviral agents|mesh-ancestor
25506204|NCT00367484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25506205|NCT00367484|Immunologic Factors|immunologic factors|mesh-ancestor
25506206|NCT00367484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506207|NCT00367484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25506208|NCT00367601|Bevacizumab|bevacizumab|mesh-list
25506209|NCT00367601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25506210|NCT00367601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25506211|NCT00367601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506212|NCT00367601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25506213|NCT00367601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25506214|NCT00367601|Growth Substances|growth substances|mesh-ancestor
25506215|NCT00367601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506216|NCT00367601|Growth Inhibitors|growth inhibitors|mesh-ancestor
25506217|NCT00367601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25506218|NCT00367601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506219|NCT00367601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506220|NCT00367640|Immunologic Factors|immunologic factors|mesh-list
25506221|NCT00367640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506222|NCT00367744|Rosiglitazone|rosiglitazone|mesh-list
25506223|NCT00367744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25506224|NCT00367744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506225|NCT00367770|Bosentan|bosentan|mesh-list
25506226|NCT00367770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25506227|NCT00367770|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25506228|NCT00367770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506229|NCT00367835|Guanfacine|guanfacine|mesh-list
25506230|NCT00367835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25506231|NCT00367835|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25506232|NCT00367835|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25506233|NCT00367835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25506234|NCT00367835|Adrenergic Agents|adrenergic agents|mesh-ancestor
25506235|NCT00367835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25506236|NCT00367835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506237|NCT00367835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506238|NCT00367991|Epoetin Alfa|epoetin alfa|mesh-list
25506239|NCT00367991|Hematinics|hematinics|mesh-ancestor
25506240|NCT00368069|Levetiracetam|levetiracetam|mesh-list
25506241|NCT00368069|Anticonvulsants|anticonvulsants|mesh-ancestor
25506242|NCT00368069|Nootropic Agents|nootropic agents|mesh-ancestor
25506243|NCT00368251|Brivaracetam|brivaracetam|mesh-list
25506244|NCT00368251|Anticonvulsants|anticonvulsants|mesh-ancestor
25506245|NCT00368277|Amlodipine|amlodipine|mesh-list
25506246|NCT00368277|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25506247|NCT00368277|Ramipril|ramipril|mesh-list
25506248|NCT00368277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25506249|NCT00368277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25506250|NCT00368277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25506251|NCT00368277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506252|NCT00368277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25506253|NCT00368277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506254|NCT00368277|Vasodilator Agents|vasodilator agents|mesh-ancestor
25506255|NCT00368277|Diuretics|diuretics|mesh-ancestor
25506256|NCT00368277|Natriuretic Agents|natriuretic agents|mesh-ancestor
25506257|NCT00368277|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25506258|NCT00368277|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25506259|NCT00368277|Protease Inhibitors|protease inhibitors|mesh-ancestor
25506260|NCT00368277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506261|NCT00368290|Modafinil|modafinil|mesh-list
25506262|NCT00368290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25506263|NCT00368290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506264|NCT00368290|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25506265|NCT00368290|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25506266|NCT00368290|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25506267|NCT00368290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506268|NCT00368355|Cytarabine|cytarabine|mesh-list
25506269|NCT00368355|Cyclophosphamide|cyclophosphamide|mesh-list
25506270|NCT00368355|Alemtuzumab|alemtuzumab|mesh-list
25506271|NCT00368355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25506272|NCT00368355|Immunologic Factors|immunologic factors|mesh-ancestor
25506273|NCT00368355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506274|NCT00368355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25506275|NCT00368355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25506276|NCT00368355|Alkylating Agents|alkylating agents|mesh-ancestor
25506277|NCT00368355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506278|NCT00368355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506279|NCT00368355|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25506280|NCT00368355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25506281|NCT00368355|Antimetabolites|antimetabolites|mesh-ancestor
25506282|NCT00368355|Antiviral Agents|antiviral agents|mesh-ancestor
25506283|NCT00368355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25506284|NCT00368355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25506285|NCT00368459|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25506286|NCT00368459|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25506287|NCT00368459|Hormone Antagonists|hormone antagonists|mesh-ancestor
25506288|NCT00368459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25506289|NCT00368459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506290|NCT00368459|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25506291|NCT00368459|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25506292|NCT00368459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25506293|NCT00368537|Ampicillin|ampicillin|mesh-list
25506294|NCT00368537|Tigecycline|tigecycline|mesh-list
25506295|NCT00368537|Sulbactam|sulbactam|mesh-list
25506296|NCT00368537|Sultamicillin|sultamicillin|mesh-list
25506297|NCT00368537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25506298|NCT00368537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25506299|NCT00368537|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25506300|NCT00368537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506301|NCT00368537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506302|NCT00368537|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25506303|NCT00368550|Sertraline|sertraline|mesh-list
25506304|NCT00368550|Antidepressive Agents|antidepressive agents|mesh-ancestor
25506305|NCT00368550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25506306|NCT00368550|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25506307|NCT00368550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25506308|NCT00368550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25506309|NCT00368550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506310|NCT00368550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25506311|NCT00368550|Serotonin Agents|serotonin agents|mesh-ancestor
25506312|NCT00368550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506313|NCT00368641|Icodextrin|icodextrin|mesh-list
25506314|NCT00368641|Dialysis Solutions|dialysis solutions|mesh-ancestor
25506315|NCT00368641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25506316|NCT00368745|Pregabalin|pregabalin|mesh-list
25506317|NCT00368745|Analgesics|analgesics|mesh-ancestor
25506318|NCT00368745|Sensory System Agents|sensory system agents|mesh-ancestor
25506319|NCT00368745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25506320|NCT00368745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506321|NCT00368745|Anticonvulsants|anticonvulsants|mesh-ancestor
25506322|NCT00368745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25506323|NCT00368745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25506324|NCT00368745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506325|NCT00368745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25506326|NCT00368745|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25506327|NCT00368745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25506328|NCT00368745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25506329|NCT00368745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25506330|NCT00368849|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25506331|NCT00368849|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25506332|NCT00368849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25506333|NCT00368849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25506334|NCT00368849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506335|NCT00368849|Adrenergic Agents|adrenergic agents|mesh-ancestor
25506336|NCT00368849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25506337|NCT00368849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506339|NCT00368875|Bevacizumab|bevacizumab|mesh-list
25506340|NCT00368875|Vorinostat|vorinostat|mesh-list
25506341|NCT00368875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25506342|NCT00368875|Antibodies|antibodies|mesh-list
25506343|NCT00368875|Immunoglobulins|immunoglobulins|mesh-list
25506344|NCT00368875|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25506345|NCT00368875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25506346|NCT00368875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506347|NCT00368875|Tubulin Modulators|tubulin modulators|mesh-ancestor
25506348|NCT00368875|Antimitotic Agents|antimitotic agents|mesh-ancestor
25506349|NCT00368875|Mitosis Modulators|mitosis modulators|mesh-ancestor
25506350|NCT00368875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506351|NCT00368875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25506352|NCT00368875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25506353|NCT00368875|Growth Substances|growth substances|mesh-ancestor
25506354|NCT00368875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506355|NCT00368875|Growth Inhibitors|growth inhibitors|mesh-ancestor
25506356|NCT00368875|Immunologic Factors|immunologic factors|mesh-ancestor
25506357|NCT00368875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25506358|NCT00368875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506359|NCT00368927|Sulindac|sulindac|mesh-list
25506360|NCT00368927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25506361|NCT00368927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25506362|NCT00368927|Analgesics|analgesics|mesh-ancestor
25506363|NCT00368927|Sensory System Agents|sensory system agents|mesh-ancestor
25506364|NCT00368927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25506365|NCT00368927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506366|NCT00368927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25506367|NCT00368927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25506368|NCT00368927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506369|NCT00368927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25506370|NCT00368927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506371|NCT00368927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506372|NCT00368966|Vaccines|vaccines|mesh-list
25506373|NCT00368966|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25506374|NCT00368966|Immunologic Factors|immunologic factors|mesh-ancestor
25506375|NCT00368966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506376|NCT00368979|Dutasteride|dutasteride|mesh-list
25506377|NCT00368979|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25506378|NCT00368979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25506379|NCT00368979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506380|NCT00368979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506381|NCT00368979|Hormone Antagonists|hormone antagonists|mesh-ancestor
25506382|NCT00368979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25506383|NCT00368979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506384|NCT00368992|Paclitaxel|paclitaxel|mesh-list
25506385|NCT00368992|Bevacizumab|bevacizumab|mesh-list
25506386|NCT00368992|Cetuximab|cetuximab|mesh-list
25506387|NCT00368992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25506388|NCT00368992|Antibodies|antibodies|mesh-list
24436542|NCT00270413|Growth Substances|growth substances|mesh-ancestor
25506390|NCT00368992|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25506391|NCT00368992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25506392|NCT00368992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506393|NCT00368992|Tubulin Modulators|tubulin modulators|mesh-ancestor
25506394|NCT00368992|Antimitotic Agents|antimitotic agents|mesh-ancestor
25506395|NCT00368992|Mitosis Modulators|mitosis modulators|mesh-ancestor
25506396|NCT00368992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506397|NCT00368992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25506398|NCT00368992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25506399|NCT00368992|Growth Substances|growth substances|mesh-ancestor
25506400|NCT00368992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506401|NCT00368992|Growth Inhibitors|growth inhibitors|mesh-ancestor
25506402|NCT00368992|Immunologic Factors|immunologic factors|mesh-ancestor
25506403|NCT00369122|Bevacizumab|bevacizumab|mesh-list
25506404|NCT00369122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25506405|NCT00369122|Cisplatin|cisplatin|mesh-list
25506406|NCT00369122|Endothelial Growth Factors|endothelial growth factors|mesh-list
25506407|NCT00369122|Antibodies|antibodies|mesh-list
25506408|NCT00369122|Immunoglobulins|immunoglobulins|mesh-list
25506409|NCT00369122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25506410|NCT00369122|Immunoglobulin G|immunoglobulin g|mesh-list
25506411|NCT00369122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506412|NCT00369122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25506413|NCT00369122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25506414|NCT00369122|Growth Substances|growth substances|mesh-ancestor
25506415|NCT00369122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506416|NCT00369122|Growth Inhibitors|growth inhibitors|mesh-ancestor
25506417|NCT00369122|Immunologic Factors|immunologic factors|mesh-ancestor
25506418|NCT00369161|Everolimus|everolimus|mesh-list
25506419|NCT00369161|Tacrolimus|tacrolimus|mesh-list
25506420|NCT00369161|Basiliximab|basiliximab|mesh-list
25506421|NCT00369161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25506422|NCT00369161|Immunologic Factors|immunologic factors|mesh-ancestor
25506423|NCT00369161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506424|NCT00369161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25506425|NCT00369161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408474|NCT03437746|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25506426|NCT00369161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506427|NCT00369161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506428|NCT00369226|Methotrexate|methotrexate|mesh-list
25506429|NCT00369226|Bortezomib|bortezomib|mesh-list
25506430|NCT00369226|Tacrolimus|tacrolimus|mesh-list
25506431|NCT00369226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25506432|NCT00369226|Abortifacient Agents|abortifacient agents|mesh-ancestor
25506433|NCT00369226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25506434|NCT00369226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506435|NCT00369226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25506436|NCT00369226|Antimetabolites|antimetabolites|mesh-ancestor
25506437|NCT00369226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506438|NCT00369226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506439|NCT00369226|Dermatologic Agents|dermatologic agents|mesh-ancestor
25506440|NCT00369226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506441|NCT00369226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25506442|NCT00369226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25506443|NCT00369226|Immunologic Factors|immunologic factors|mesh-ancestor
25506444|NCT00369226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25506445|NCT00369226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25506446|NCT00369226|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25506447|NCT00369278|Mycophenolic Acid|mycophenolic acid|mesh-list
25506448|NCT00369278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25506449|NCT00369278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506450|NCT00369278|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25506451|NCT00369278|Antitubercular Agents|antitubercular agents|mesh-ancestor
25506452|NCT00369278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25506453|NCT00369278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25506454|NCT00369278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506455|NCT00369278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506456|NCT00369343|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25506457|NCT00369343|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25506458|NCT00369343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25506459|NCT00369343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25506460|NCT00369343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506461|NCT00369343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24436979|NCT00272415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506462|NCT00369343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506463|NCT00369343|Antidepressive Agents|antidepressive agents|mesh-ancestor
25506464|NCT00369343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25506465|NCT00369382|Cyclosporine|cyclosporine|mesh-list
25506466|NCT00369382|Sirolimus|sirolimus|mesh-list
25506467|NCT00369382|Tacrolimus|tacrolimus|mesh-list
25506468|NCT00369382|Cyclosporins|cyclosporins|mesh-list
25506469|NCT00369382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25506470|NCT00369382|Immunologic Factors|immunologic factors|mesh-ancestor
25506471|NCT00369382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506472|NCT00369382|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25506473|NCT00369382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506474|NCT00369382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506475|NCT00369382|Antifungal Agents|antifungal agents|mesh-ancestor
25506476|NCT00369382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25506477|NCT00369382|Dermatologic Agents|dermatologic agents|mesh-ancestor
25506478|NCT00369382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25506479|NCT00369382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25506480|NCT00369382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25506481|NCT00369382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506482|NCT00369486|Triamcinolone|triamcinolone|mesh-list
25506483|NCT00369486|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25506484|NCT00369486|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25506485|NCT00369486|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25506486|NCT00369486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25506487|NCT00369486|Glucocorticoids|glucocorticoids|mesh-ancestor
25506488|NCT00369486|Hormones|hormones|mesh-ancestor
25506489|NCT00369486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25506490|NCT00369486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506491|NCT00369486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25506492|NCT00369486|Immunologic Factors|immunologic factors|mesh-ancestor
25506493|NCT00369486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506494|NCT00369486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506495|NCT00369512|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25506496|NCT00369512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506497|NCT00369512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25506498|NCT00369512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506499|NCT00369512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506501|NCT00369577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25506502|NCT00369577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25506503|NCT00369577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25506504|NCT00369577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506505|NCT00369577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25506506|NCT00369577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25506507|NCT00369577|Dopamine Agents|dopamine agents|mesh-ancestor
25506508|NCT00369577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25506509|NCT00369577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506510|NCT00369590|Aflibercept|aflibercept|mesh-list
25506511|NCT00369590|Endothelial Growth Factors|endothelial growth factors|mesh-list
25506512|NCT00369590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25506513|NCT00369590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25506514|NCT00369590|Growth Substances|growth substances|mesh-ancestor
25506515|NCT00369590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506516|NCT00369590|Growth Inhibitors|growth inhibitors|mesh-ancestor
25506517|NCT00369590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506518|NCT00369629|Gemcitabine|gemcitabine|mesh-list
25506519|NCT00369629|Pemetrexed|pemetrexed|mesh-list
25506520|NCT00369629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25506521|NCT00369629|Antimetabolites|antimetabolites|mesh-ancestor
25506522|NCT00369629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506523|NCT00369629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506524|NCT00369629|Antiviral Agents|antiviral agents|mesh-ancestor
25506525|NCT00369629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25506526|NCT00369629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506527|NCT00369629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25506528|NCT00369629|Immunologic Factors|immunologic factors|mesh-ancestor
25506529|NCT00369629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506530|NCT00369629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25506531|NCT00369629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25506532|NCT00369655|Aflibercept|aflibercept|mesh-list
25506533|NCT00369655|Endothelial Growth Factors|endothelial growth factors|mesh-list
25124403|NCT03076762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506534|NCT00369655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25506535|NCT00369655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25506536|NCT00369655|Growth Substances|growth substances|mesh-ancestor
25506537|NCT00369655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506538|NCT00369655|Growth Inhibitors|growth inhibitors|mesh-ancestor
25506539|NCT00369655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506540|NCT00369681|Rituximab|rituximab|mesh-list
25506541|NCT00369681|Doxorubicin|doxorubicin|mesh-list
25506542|NCT00369681|Dacarbazine|dacarbazine|mesh-list
25506543|NCT00369681|Bleomycin|bleomycin|mesh-list
25506544|NCT00369681|Vinblastine|vinblastine|mesh-list
25506545|NCT00369681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25506546|NCT00369681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506547|NCT00369681|Immunologic Factors|immunologic factors|mesh-ancestor
25506548|NCT00369681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506549|NCT00369681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25506550|NCT00369681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25506551|NCT00369681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25506552|NCT00369681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25506553|NCT00369681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506554|NCT00369681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506555|NCT00369681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25506556|NCT00369681|Alkylating Agents|alkylating agents|mesh-ancestor
25506557|NCT00369681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25506558|NCT00369681|Tubulin Modulators|tubulin modulators|mesh-ancestor
25506559|NCT00369681|Antimitotic Agents|antimitotic agents|mesh-ancestor
25506560|NCT00369681|Mitosis Modulators|mitosis modulators|mesh-ancestor
25506561|NCT00369707|Rituximab|rituximab|mesh-list
25506562|NCT00369707|Bortezomib|bortezomib|mesh-list
25506563|NCT00369707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25506564|NCT00369707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506565|NCT00369707|Immunologic Factors|immunologic factors|mesh-ancestor
25506566|NCT00369707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506567|NCT00369707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25506568|NCT00369746|Citalopram|citalopram|mesh-list
25506569|NCT00369746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25506570|NCT00369746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25506571|NCT00369746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25506572|NCT00369746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506573|NCT00369746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25506574|NCT00369746|Serotonin Agents|serotonin agents|mesh-ancestor
25506575|NCT00369746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506576|NCT00369746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25506577|NCT00369746|Antidepressive Agents|antidepressive agents|mesh-ancestor
25506578|NCT00369746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25506579|NCT00369785|Donepezil|donepezil|mesh-list
25506580|NCT00369785|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25506581|NCT00369785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506582|NCT00369785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506583|NCT00369785|Cholinergic Agents|cholinergic agents|mesh-ancestor
25506584|NCT00369785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25506585|NCT00369785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506586|NCT00369785|Nootropic Agents|nootropic agents|mesh-ancestor
25506587|NCT00369915|Scopolamine|scopolamine|mesh-list
25506588|NCT00369915|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25506589|NCT00369915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25506590|NCT00369915|Antiemetics|antiemetics|mesh-ancestor
25506591|NCT00369915|Autonomic Agents|autonomic agents|mesh-ancestor
25506592|NCT00369915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25506593|NCT00369915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506594|NCT00369915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25506595|NCT00369915|Mydriatics|mydriatics|mesh-ancestor
25829462|NCT00006212|Tubulin Modulators|tubulin modulators|mesh-ancestor
24482373|NCT00438828|Hormones|hormones|mesh-ancestor
24437287|NCT00273338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124444|NCT03076320|Adapalene|adapalene|mesh-list
24437288|NCT00273338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24437289|NCT00273338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437305|NCT00273377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24437306|NCT00273377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24437308|NCT00273390|Infliximab|infliximab|mesh-list
24437309|NCT00273390|Dermatologic Agents|dermatologic agents|mesh-ancestor
24437310|NCT00273390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24437311|NCT00273390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24437312|NCT00273416|Sildenafil Citrate|sildenafil citrate|mesh-list
24437313|NCT00273416|Vasodilator Agents|vasodilator agents|mesh-ancestor
25506596|NCT00369915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25506597|NCT00369915|Cholinergic Agents|cholinergic agents|mesh-ancestor
25506610|NCT00369941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25506611|NCT00369941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506612|NCT00369941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506613|NCT00369941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25506614|NCT00369941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25506615|NCT00369941|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25506616|NCT00369941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25506617|NCT00369941|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25506618|NCT00369941|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25506619|NCT00369941|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25506620|NCT00369941|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25506621|NCT00369941|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25506622|NCT00369941|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25506623|NCT00369967|Contraceptive Agents|contraceptive agents|mesh-list
25506624|NCT00369967|NuvaRing|nuvaring|mesh-list
25506625|NCT00369967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25506626|NCT00369967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506627|NCT00369967|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25506628|NCT00370032|Alosetron|alosetron|mesh-list
25506629|NCT00370032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25506630|NCT00370032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25506631|NCT00370032|Serotonin Agents|serotonin agents|mesh-ancestor
25506632|NCT00370032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25506633|NCT00370032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506634|NCT00370032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506635|NCT00370071|Interferons|interferons|mesh-list
25506636|NCT00370071|Interferon-beta|interferon-beta|mesh-list
25506637|NCT00370071|Interferon beta-1b|interferon beta-1b|mesh-list
25506638|NCT00370071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506639|NCT00370071|Antiviral Agents|antiviral agents|mesh-ancestor
25506640|NCT00370071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25506641|NCT00370071|Immunologic Factors|immunologic factors|mesh-ancestor
25506642|NCT00370071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506643|NCT00370071|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25506644|NCT00370149|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25506645|NCT00370149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25506646|NCT00370292|Pemetrexed|pemetrexed|mesh-list
25506647|NCT00370292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506648|NCT00370292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506649|NCT00370292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506650|NCT00370292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25506651|NCT00370292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25124494|NCT03075657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124495|NCT03075657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124496|NCT03075657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25124497|NCT03075657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25124498|NCT03075657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25124499|NCT03075657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25124500|NCT03075657|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25506652|NCT05287633|Esomeprazole|esomeprazole|mesh-list
25506653|NCT05287633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25506654|NCT05287633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25506655|NCT05287633|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25506656|NCT05287633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506657|NCT05287633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506658|NCT05287607|Bilirubin|bilirubin|mesh-list
25506659|NCT05287607|Antioxidants|antioxidants|mesh-ancestor
25506660|NCT05287607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506661|NCT05287607|Protective Agents|protective agents|mesh-ancestor
25506662|NCT05287607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506663|NCT05287542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25506664|NCT05287542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25506665|NCT05287542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506666|NCT05287503|Ambroxol|ambroxol|mesh-list
25506667|NCT05287503|Expectorants|expectorants|mesh-ancestor
25506668|NCT05287503|Respiratory System Agents|respiratory system agents|mesh-ancestor
25506669|NCT05287425|Ciprofloxacin|ciprofloxacin|mesh-list
25506670|NCT05287425|Gentamicins|gentamicins|mesh-list
25506671|NCT05287425|Benzalkonium Compounds|benzalkonium compounds|mesh-list
25506672|NCT05287425|Povidone|povidone|mesh-list
25506673|NCT05287425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25506674|NCT05287425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25506675|NCT05287425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25506676|NCT05287425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25506677|NCT05287425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506678|NCT05287425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506679|NCT05287425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506680|NCT05287425|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25506681|NCT05287425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25506682|NCT05287425|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25506683|NCT05287425|Plasma Substitutes|plasma substitutes|mesh-ancestor
25506684|NCT05287425|Blood Substitutes|blood substitutes|mesh-ancestor
25506685|NCT05287425|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25506686|NCT05287321|Hydroxychloroquine|hydroxychloroquine|mesh-list
25506687|NCT05287321|Antimalarials|antimalarials|mesh-ancestor
25506688|NCT05287321|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25506689|NCT05287321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25506690|NCT05287321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25506691|NCT05287321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506692|NCT05287321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506693|NCT05287321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25506694|NCT05287256|Dronabinol|dronabinol|mesh-list
25506695|NCT05287256|Hallucinogens|hallucinogens|mesh-ancestor
25506696|NCT05287256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506697|NCT05287256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25506698|NCT05287256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25506699|NCT05287256|Analgesics|analgesics|mesh-ancestor
25506700|NCT05287256|Sensory System Agents|sensory system agents|mesh-ancestor
25506701|NCT05287256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25506702|NCT05287256|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25506703|NCT05287256|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25506704|NCT05287256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25506705|NCT05287256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506706|NCT05287256|Hormones|hormones|mesh-ancestor
25506707|NCT05287256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25506708|NCT05287191|Magnesium Sulfate|magnesium sulfate|mesh-list
25506709|NCT05287191|Digoxin|digoxin|mesh-list
25506710|NCT05287191|Amiodarone|amiodarone|mesh-list
25506711|NCT05287191|Analgesics|analgesics|mesh-ancestor
25506712|NCT05287191|Sensory System Agents|sensory system agents|mesh-ancestor
25506713|NCT05287191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25506714|NCT05287191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506715|NCT05287191|Anesthetics|anesthetics|mesh-ancestor
25506716|NCT05287191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25506717|NCT05287191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25506718|NCT05287191|Anticonvulsants|anticonvulsants|mesh-ancestor
25506719|NCT05287191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25506720|NCT05287191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25162148|NCT02907749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25162149|NCT02907749|Vasodilator Agents|vasodilator agents|mesh-ancestor
25162150|NCT02907749|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25162151|NCT02907749|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25162152|NCT02907593|Budesonide|budesonide|mesh-list
25162153|NCT02907593|Calfactant|calfactant|mesh-list
25506721|NCT05287191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506722|NCT05287191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25506723|NCT05287191|Tocolytic Agents|tocolytic agents|mesh-ancestor
24483341|NCT00443105|Tacrolimus|tacrolimus|mesh-list
25506724|NCT05287191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25506725|NCT05287191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25506726|NCT05287191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506727|NCT05287191|Protective Agents|protective agents|mesh-ancestor
25506728|NCT05287191|Vasodilator Agents|vasodilator agents|mesh-ancestor
25506729|NCT05287191|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25506730|NCT05287191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25506731|NCT05287191|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25506732|NCT05287191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25506733|NCT05287191|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25506734|NCT05287191|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25506735|NCT05287191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25506736|NCT05287100|Midodrine|midodrine|mesh-list
25506737|NCT05287100|Sympathomimetics|sympathomimetics|mesh-ancestor
25506738|NCT05287100|Autonomic Agents|autonomic agents|mesh-ancestor
25506739|NCT05287100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25506740|NCT05287100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506741|NCT05287100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25506742|NCT05287100|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25506743|NCT05287100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25506744|NCT05287100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25506745|NCT05287100|Adrenergic Agents|adrenergic agents|mesh-ancestor
25506746|NCT05287100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25506747|NCT05287100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506748|NCT05287035|Dexamethasone|dexamethasone|mesh-list
25506749|NCT05287035|Dexamethasone acetate|dexamethasone acetate|mesh-list
25506750|NCT05287035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25506751|NCT05287035|Antiemetics|antiemetics|mesh-ancestor
25506752|NCT05287035|Autonomic Agents|autonomic agents|mesh-ancestor
25506753|NCT05287035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25506754|NCT05287035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506755|NCT05287035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25506756|NCT05287035|Glucocorticoids|glucocorticoids|mesh-ancestor
25506757|NCT05287035|Hormones|hormones|mesh-ancestor
25506758|NCT05287035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25506759|NCT05287035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25506760|NCT05287035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506761|NCT05286931|Ciprofloxacin|ciprofloxacin|mesh-list
25506762|NCT05286931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25506763|NCT05286931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25506764|NCT05286931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25506765|NCT05286931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25506766|NCT05286931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506767|NCT05286931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506768|NCT05286931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506769|NCT05286931|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25506770|NCT05286931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25506771|NCT05286619|Gemcitabine|gemcitabine|mesh-list
25506772|NCT05286619|Cisplatin|cisplatin|mesh-list
25506773|NCT05286619|Carboplatin|carboplatin|mesh-list
25506774|NCT05286619|Pembrolizumab|pembrolizumab|mesh-list
25506775|NCT05286619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506776|NCT05286619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25506777|NCT05286619|Antimetabolites|antimetabolites|mesh-ancestor
25506778|NCT05286619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506779|NCT05286619|Antiviral Agents|antiviral agents|mesh-ancestor
25506780|NCT05286619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25506781|NCT05286619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506782|NCT05286619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25506783|NCT05286619|Immunologic Factors|immunologic factors|mesh-ancestor
25506784|NCT05286619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506785|NCT05286619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25506786|NCT05286528|Imatinib Mesylate|imatinib mesylate|mesh-list
25506787|NCT05286528|Dasatinib|dasatinib|mesh-list
25506788|NCT05286528|Ponatinib|ponatinib|mesh-list
25506789|NCT05286528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506790|NCT05286528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25506791|NCT05286528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506792|NCT05286528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506793|NCT05286437|Pembrolizumab|pembrolizumab|mesh-list
25124638|NCT03073850|Aspirin|aspirin|mesh-list
25506794|NCT05286437|Letrozole|letrozole|mesh-list
25506795|NCT05286437|Lenvatinib|lenvatinib|mesh-list
25506796|NCT05286437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25506797|NCT05286437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506798|NCT05286437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25506799|NCT05286437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25506800|NCT05286437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506801|NCT05286437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506802|NCT05286437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25506803|NCT05286437|Hormone Antagonists|hormone antagonists|mesh-ancestor
25506804|NCT05286437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25506805|NCT05286437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506806|NCT05286437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25506807|NCT05286346|Tenofovir|tenofovir|mesh-list
25506808|NCT05286346|Antiviral Agents|antiviral agents|mesh-ancestor
25506809|NCT05286346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25506810|NCT05286346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25506811|NCT05286346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25506812|NCT05286346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506813|NCT05286346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506814|NCT05286346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25506815|NCT05286346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25506816|NCT05286268|Plasminogen|plasminogen|mesh-list
25506817|NCT05286268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25506818|NCT05286268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25506819|NCT05286268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506820|NCT05286008|Dexamethasone|dexamethasone|mesh-list
25506821|NCT05286008|Ropivacaine|ropivacaine|mesh-list
25506822|NCT05286008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25506823|NCT05286008|Antiemetics|antiemetics|mesh-ancestor
25506824|NCT05286008|Autonomic Agents|autonomic agents|mesh-ancestor
25506825|NCT05286008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25506826|NCT05286008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506827|NCT05286008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25506828|NCT05286008|Glucocorticoids|glucocorticoids|mesh-ancestor
25506829|NCT05286008|Hormones|hormones|mesh-ancestor
25506830|NCT05286008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25506831|NCT05286008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25506832|NCT05286008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506833|NCT05286008|Anesthetics, Local|anesthetics, local|mesh-ancestor
25506834|NCT05286008|Anesthetics|anesthetics|mesh-ancestor
25506835|NCT05286008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25506836|NCT05286008|Sensory System Agents|sensory system agents|mesh-ancestor
25506837|NCT05285943|Betamethasone|betamethasone|mesh-list
25506838|NCT05285943|Betamethasone Valerate|betamethasone valerate|mesh-list
25506839|NCT05285943|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25506840|NCT05285943|Betamethasone benzoate|betamethasone benzoate|mesh-list
25506841|NCT05285943|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25506842|NCT05285943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25506843|NCT05285943|Glucocorticoids|glucocorticoids|mesh-ancestor
25506844|NCT05285943|Hormones|hormones|mesh-ancestor
25506845|NCT05285943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25506846|NCT05285943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506847|NCT05285943|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25506848|NCT05285943|Respiratory System Agents|respiratory system agents|mesh-ancestor
25506849|NCT05285878|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25506850|NCT05285878|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24693487|NCT01420692|Gliclazide|gliclazide|mesh-list
25645825|NCT01451749|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25645826|NCT01451749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645827|NCT01451749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645828|NCT01451749|Cholinergic Agents|cholinergic agents|mesh-ancestor
25645829|NCT01451749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25506851|NCT05285878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506852|NCT05285878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25506853|NCT05285878|Immunologic Factors|immunologic factors|mesh-ancestor
25506854|NCT05285878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506855|NCT05285787|Vitamin MK 7|vitamin mk 7|mesh-list
25506856|NCT05285787|Hemostatics|hemostatics|mesh-ancestor
25506857|NCT05285787|Coagulants|coagulants|mesh-ancestor
25506858|NCT05250050|Amoxicillin|amoxicillin|mesh-list
25506859|NCT05250050|Metronidazole|metronidazole|mesh-list
25506860|NCT05250050|Clarithromycin|clarithromycin|mesh-list
25506861|NCT05250050|Levofloxacin|levofloxacin|mesh-list
25506862|NCT05250050|Tetracycline|tetracycline|mesh-list
25506863|NCT05250050|Potassium Citrate|potassium citrate|mesh-list
25506864|NCT05250050|Esomeprazole|esomeprazole|mesh-list
25506865|NCT05250050|Bismuth|bismuth|mesh-list
25506866|NCT05250050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506867|NCT05250050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25506868|NCT05250050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25124687|NCT03073408|Anesthetics|anesthetics|mesh-ancestor
25506869|NCT05250050|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25506870|NCT05250050|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25506871|NCT05250050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25506872|NCT05250050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25506873|NCT05250050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25506874|NCT05250050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506875|NCT05250050|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25506876|NCT05250050|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25506877|NCT05250050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25506878|NCT05250050|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25506880|NCT05250050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25506881|NCT05250050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25506882|NCT05250050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25506883|NCT05250050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25506884|NCT05250050|Antacids|antacids|mesh-ancestor
25506885|NCT05250050|Diuretics|diuretics|mesh-ancestor
25506886|NCT05250050|Natriuretic Agents|natriuretic agents|mesh-ancestor
25506887|NCT05250050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506888|NCT05250050|Expectorants|expectorants|mesh-ancestor
25506889|NCT05250050|Respiratory System Agents|respiratory system agents|mesh-ancestor
25506890|NCT05220462|Midazolam|midazolam|mesh-list
25506891|NCT05220462|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25506892|NCT05220462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25506893|NCT05220462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25506894|NCT05220462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506895|NCT05220462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25506896|NCT05220462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25506897|NCT05220462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25506898|NCT05220462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25506899|NCT05220462|Anesthetics, General|anesthetics, general|mesh-ancestor
25506900|NCT05220462|Anesthetics|anesthetics|mesh-ancestor
25506901|NCT05220462|GABA Modulators|gaba modulators|mesh-ancestor
25506902|NCT05220462|GABA Agents|gaba agents|mesh-ancestor
25506903|NCT05220462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25506904|NCT05220462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506905|NCT05219604|Diphenhydramine|diphenhydramine|mesh-list
25506906|NCT05219604|Promethazine|promethazine|mesh-list
25506907|NCT05219604|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25506908|NCT05219604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25506909|NCT05219604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25506910|NCT05219604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506911|NCT05219604|Anesthetics, Local|anesthetics, local|mesh-ancestor
25506912|NCT05219604|Anesthetics|anesthetics|mesh-ancestor
25506913|NCT05219604|Sensory System Agents|sensory system agents|mesh-ancestor
25506914|NCT05219604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25506915|NCT05219604|Antiemetics|antiemetics|mesh-ancestor
25506916|NCT05219604|Autonomic Agents|autonomic agents|mesh-ancestor
25506917|NCT05219604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25506918|NCT05219604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25506919|NCT05219604|Histamine Antagonists|histamine antagonists|mesh-ancestor
25506920|NCT05219604|Histamine Agents|histamine agents|mesh-ancestor
25506921|NCT05219604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25506922|NCT05219604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645830|NCT01451749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506923|NCT05219604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25506924|NCT05219604|Antipruritics|antipruritics|mesh-ancestor
25506925|NCT05219604|Dermatologic Agents|dermatologic agents|mesh-ancestor
25506926|NCT05206955|Tadalafil|tadalafil|mesh-list
25506927|NCT05206955|Vasodilator Agents|vasodilator agents|mesh-ancestor
25506928|NCT05206955|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25506929|NCT05206955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25506930|NCT05206955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506931|NCT05206955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506932|NCT05206955|Urological Agents|urological agents|mesh-ancestor
25506933|NCT05189756|Aprepitant|aprepitant|mesh-list
25506934|NCT05189756|Fosaprepitant|fosaprepitant|mesh-list
25506935|NCT05189756|Antiemetics|antiemetics|mesh-ancestor
25506936|NCT05189756|Autonomic Agents|autonomic agents|mesh-ancestor
25506937|NCT05189756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25506938|NCT05189756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506939|NCT05189756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25506940|NCT05189756|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25506941|NCT05189756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25506942|NCT05189756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506943|NCT05187286|Apixaban|apixaban|mesh-list
24437939|NCT00274807|Antimetabolites|antimetabolites|mesh-ancestor
25506977|NCT05126238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25506978|NCT05126238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25506979|NCT05126238|Antimanic Agents|antimanic agents|mesh-ancestor
25506980|NCT05126238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25506981|NCT05126238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25506982|NCT05126238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506983|NCT05113784|Meplazumab|meplazumab|mesh-list
25506984|NCT05113784|Antiviral Agents|antiviral agents|mesh-ancestor
25506985|NCT05113784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25506986|NCT05109429|Analgesics, Opioid|analgesics, opioid|mesh-list
25506987|NCT05109429|Narcotics|narcotics|mesh-ancestor
25506988|NCT05109429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25506989|NCT05109429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506990|NCT05109429|Analgesics|analgesics|mesh-ancestor
25506991|NCT05109429|Sensory System Agents|sensory system agents|mesh-ancestor
25506992|NCT05109429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25506993|NCT05081492|Antibodies|antibodies|mesh-list
25506994|NCT05081492|Immunoglobulins|immunoglobulins|mesh-list
25506995|NCT05081492|Immunologic Factors|immunologic factors|mesh-ancestor
25506996|NCT05081492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25506997|NCT05075330|Analgesics, Opioid|analgesics, opioid|mesh-list
25506998|NCT05075330|Narcotics|narcotics|mesh-ancestor
25506999|NCT05075330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25507000|NCT05075330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507001|NCT05075330|Analgesics|analgesics|mesh-ancestor
25507002|NCT05075330|Sensory System Agents|sensory system agents|mesh-ancestor
25507003|NCT05075330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25507004|NCT05069038|Palbociclib|palbociclib|mesh-list
25507005|NCT05069038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507006|NCT05069038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25507007|NCT05069038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25507008|NCT05069038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507009|NCT04976283|Pioglitazone|pioglitazone|mesh-list
25507010|NCT04976283|Empagliflozin|empagliflozin|mesh-list
25507011|NCT04976283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25507012|NCT04976283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507013|NCT04976283|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25507014|NCT04976283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507015|NCT04971187|Cisplatin|cisplatin|mesh-list
25507016|NCT04971187|Carboplatin|carboplatin|mesh-list
25507017|NCT04971187|Pemetrexed|pemetrexed|mesh-list
25507018|NCT04971187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507019|NCT04971187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25507020|NCT04971187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507021|NCT04971187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25507022|NCT04971187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25507023|NCT04934696|Contraceptive Agents|contraceptive agents|mesh-list
25507024|NCT04934696|Contraceptives, Oral|contraceptives, oral|mesh-list
25507025|NCT04934696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25507026|NCT04934696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507027|NCT04934696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25507028|NCT04930783|Nivolumab|nivolumab|mesh-list
25507029|NCT04930783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25507030|NCT04930783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507031|NCT04930783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25507032|NCT04930783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507034|NCT04901975|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25507035|NCT04901975|Hormone Antagonists|hormone antagonists|mesh-ancestor
25507036|NCT04901975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25507037|NCT04901975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507038|NCT04901975|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25507039|NCT04901975|Diuretics|diuretics|mesh-ancestor
25124858|NCT03072082|Aspirin|aspirin|mesh-list
24438321|NCT00275522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438322|NCT00275535|Mycophenolic Acid|mycophenolic acid|mesh-list
24438504|NCT00276068|Sensory System Agents|sensory system agents|mesh-ancestor
24438505|NCT00276068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25507046|NCT04899388|Analgesics|analgesics|mesh-ancestor
25507047|NCT04899388|Sensory System Agents|sensory system agents|mesh-ancestor
25507048|NCT04899388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25507049|NCT04899388|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25507050|NCT04899388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25507051|NCT04899388|Anesthetics, General|anesthetics, general|mesh-ancestor
25507052|NCT04899388|Anesthetics|anesthetics|mesh-ancestor
25507053|NCT04892186|Inositol|inositol|mesh-list
25507054|NCT04892186|Metformin|metformin|mesh-list
25507055|NCT04892186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25507056|NCT04892186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507057|NCT04892186|Vitamin B Complex|vitamin b complex|mesh-ancestor
25507058|NCT04892186|Vitamins|vitamins|mesh-ancestor
25507059|NCT04892186|Micronutrients|micronutrients|mesh-ancestor
25507060|NCT04884763|Erenumab|erenumab|mesh-list
25507061|NCT04884763|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25507062|NCT04884763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507063|NCT04884763|Analgesics|analgesics|mesh-ancestor
25507064|NCT04884763|Sensory System Agents|sensory system agents|mesh-ancestor
25507065|NCT04884763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25507066|NCT04884763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507067|NCT04802590|Venetoclax|venetoclax|mesh-list
25507068|NCT04802590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507069|NCT04681443|Phenol|phenol|mesh-list
25507070|NCT04681443|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25507071|NCT04681443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25507072|NCT04681443|Disinfectants|disinfectants|mesh-ancestor
25507073|NCT04681443|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25507074|NCT04681443|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25507075|NCT04666272|Trametinib|trametinib|mesh-list
25507076|NCT04666272|Dabrafenib|dabrafenib|mesh-list
25507077|NCT04666272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507078|NCT04666272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25507079|NCT04666272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25507080|NCT04666272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507081|NCT04656691|Bamlanivimab|bamlanivimab|mesh-list
25507082|NCT04656691|Antiviral Agents|antiviral agents|mesh-ancestor
25507083|NCT04656691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25507084|NCT04600141|Heparin|heparin|mesh-list
25507085|NCT04600141|Calcium heparin|calcium heparin|mesh-list
25507086|NCT04600141|Anticoagulants|anticoagulants|mesh-ancestor
25507087|NCT04600141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25507088|NCT04600141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25507089|NCT04600141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507090|NCT04555096|Avasopasem manganese|avasopasem manganese|mesh-list
25507091|NCT04555096|Antioxidants|antioxidants|mesh-ancestor
25507092|NCT04555096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507093|NCT04555096|Protective Agents|protective agents|mesh-ancestor
25507094|NCT04555096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507095|NCT04517799|Cannabidiol|cannabidiol|mesh-list
25507096|NCT04517799|Anticonvulsants|anticonvulsants|mesh-ancestor
25507097|NCT04504318|Enoxaparin|enoxaparin|mesh-list
25507098|NCT04504318|Apixaban|apixaban|mesh-list
25507099|NCT04504318|Anticoagulants|anticoagulants|mesh-ancestor
25507100|NCT04504318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25507101|NCT04504318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25507102|NCT04504318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507103|NCT04504318|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25507104|NCT04504318|Antithrombins|antithrombins|mesh-ancestor
25507105|NCT04504318|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25507106|NCT04504318|Protease Inhibitors|protease inhibitors|mesh-ancestor
25507107|NCT04504318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25507108|NCT04492553|Testosterone|testosterone|mesh-list
25645831|NCT01451749|Nootropic Agents|nootropic agents|mesh-ancestor
25645832|NCT01451762|Diphenhydramine|diphenhydramine|mesh-list
25645833|NCT01451762|Promethazine|promethazine|mesh-list
25645834|NCT01451762|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25507109|NCT04492553|Androgens|androgens|mesh-ancestor
25507110|NCT04492553|Hormones|hormones|mesh-ancestor
25507111|NCT04492553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25507112|NCT04492553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507113|NCT04417179|Bupivacaine|bupivacaine|mesh-list
25507114|NCT04417179|Anesthetics, Local|anesthetics, local|mesh-ancestor
25507115|NCT04417179|Anesthetics|anesthetics|mesh-ancestor
25507116|NCT04417179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25507117|NCT04417179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507118|NCT04417179|Sensory System Agents|sensory system agents|mesh-ancestor
25507119|NCT04417179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25507120|NCT04316494|Hydroxychloroquine|hydroxychloroquine|mesh-list
25507121|NCT04316494|Antimalarials|antimalarials|mesh-ancestor
25507122|NCT04316494|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25507123|NCT04316494|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25507124|NCT04316494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25507125|NCT04316494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25507126|NCT04316494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507127|NCT04316494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25507128|NCT04294264|Trifluridine|trifluridine|mesh-list
25507129|NCT04294264|Oxaliplatin|oxaliplatin|mesh-list
25507130|NCT04294264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507131|NCT04294264|Antimetabolites|antimetabolites|mesh-ancestor
25507132|NCT04294264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507133|NCT04294264|Antiviral Agents|antiviral agents|mesh-ancestor
25507134|NCT04294264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25507135|NCT04288895|Vortioxetine|vortioxetine|mesh-list
25507136|NCT04288895|Antidepressive Agents|antidepressive agents|mesh-ancestor
25507137|NCT04288895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25507138|NCT04288895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25507139|NCT04288895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25507140|NCT04288895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25507141|NCT04288895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507142|NCT04288895|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25507143|NCT04288895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25507144|NCT04288895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25507145|NCT04288895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507146|NCT04288895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25507147|NCT04288895|Serotonin Agents|serotonin agents|mesh-ancestor
25507148|NCT04288895|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25507149|NCT04288895|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25507150|NCT04288895|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25507151|NCT04288895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25507152|NCT04271202|Erenumab|erenumab|mesh-list
25507153|NCT04271202|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25507154|NCT04271202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507155|NCT04271202|Analgesics|analgesics|mesh-ancestor
25507156|NCT04271202|Sensory System Agents|sensory system agents|mesh-ancestor
25507157|NCT04271202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25507158|NCT04271202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507159|NCT04259060|Hydroxocobalamin|hydroxocobalamin|mesh-list
25507160|NCT04259060|Vitamin B 12|vitamin b 12|mesh-list
25507161|NCT04259060|Hematinics|hematinics|mesh-ancestor
25507162|NCT04259060|Vitamin B Complex|vitamin b complex|mesh-ancestor
25507163|NCT04259060|Vitamins|vitamins|mesh-ancestor
25507164|NCT04259060|Micronutrients|micronutrients|mesh-ancestor
25507165|NCT04259060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507166|NCT04249778|Dapagliflozin|dapagliflozin|mesh-list
25507167|NCT04249778|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25507168|NCT04249778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507169|NCT04249778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25507170|NCT04249778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507171|NCT04163107|Hydroxychloroquine|hydroxychloroquine|mesh-list
25507172|NCT04163107|Dexamethasone|dexamethasone|mesh-list
25507173|NCT04163107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25507174|NCT04163107|Antiemetics|antiemetics|mesh-ancestor
25507175|NCT04163107|Autonomic Agents|autonomic agents|mesh-ancestor
25507176|NCT04163107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25507177|NCT04163107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507178|NCT04163107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25645835|NCT01451762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25507179|NCT04163107|Glucocorticoids|glucocorticoids|mesh-ancestor
25507180|NCT04163107|Hormones|hormones|mesh-ancestor
25507181|NCT04163107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25507182|NCT04163107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25507183|NCT04163107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507184|NCT04163107|Antimalarials|antimalarials|mesh-ancestor
25162196|NCT02907437|Minocycline|minocycline|mesh-list
25162197|NCT02907437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25162200|NCT02907307|Miconazole|miconazole|mesh-list
25507185|NCT04163107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25507186|NCT04163107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25507187|NCT04163107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25507188|NCT04163107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25507189|NCT04163107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507190|NCT04163107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25507191|NCT04080284|Niraparib|niraparib|mesh-list
25507192|NCT04080284|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25507193|NCT04080284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25507194|NCT04080284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507195|NCT04080284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507196|NCT04078126|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25507197|NCT04078126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25507198|NCT04078126|Respiratory System Agents|respiratory system agents|mesh-ancestor
25507199|NCT04072107|Capecitabine|capecitabine|mesh-list
25507200|NCT04072107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25507201|NCT04072107|Antimetabolites|antimetabolites|mesh-ancestor
25507202|NCT04072107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507203|NCT04072107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507204|NCT03984240|Midazolam|midazolam|mesh-list
25507205|NCT03984240|Dexmedetomidine|dexmedetomidine|mesh-list
25507206|NCT03984240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25507207|NCT03984240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25507208|NCT03984240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507209|NCT03984240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25507210|NCT03984240|Analgesics|analgesics|mesh-ancestor
25507211|NCT03984240|Sensory System Agents|sensory system agents|mesh-ancestor
25507212|NCT03984240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25507213|NCT03984240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25507214|NCT03984240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25507215|NCT03984240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25507216|NCT03984240|Adrenergic Agents|adrenergic agents|mesh-ancestor
25507217|NCT03984240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25507218|NCT03984240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507219|NCT03984240|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25507220|NCT03984240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25507221|NCT03984240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25507222|NCT03984240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25507223|NCT03984240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25507224|NCT03984240|Anesthetics, General|anesthetics, general|mesh-ancestor
25507225|NCT03984240|Anesthetics|anesthetics|mesh-ancestor
25507226|NCT03984240|GABA Modulators|gaba modulators|mesh-ancestor
25507227|NCT03984240|GABA Agents|gaba agents|mesh-ancestor
25507228|NCT03983226|Gemcitabine|gemcitabine|mesh-list
25507229|NCT03983226|Cisplatin|cisplatin|mesh-list
25507230|NCT03983226|Carboplatin|carboplatin|mesh-list
25507231|NCT03983226|Doxorubicin|doxorubicin|mesh-list
25507232|NCT03983226|Niraparib|niraparib|mesh-list
25507233|NCT03983226|Taxane|taxane|mesh-list
25507234|NCT03983226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507235|NCT03983226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25507236|NCT03983226|Antimetabolites|antimetabolites|mesh-ancestor
25507237|NCT03983226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507238|NCT03983226|Antiviral Agents|antiviral agents|mesh-ancestor
25507239|NCT03983226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25507240|NCT03983226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25507241|NCT03983226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25507242|NCT03983226|Immunologic Factors|immunologic factors|mesh-ancestor
25507243|NCT03983226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507244|NCT03983226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25507245|NCT03983226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25507246|NCT03983226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25507247|NCT03983226|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25507248|NCT03948347|Liraglutide|liraglutide|mesh-list
25507249|NCT03948347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25507250|NCT03948347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507251|NCT03948347|Incretins|incretins|mesh-ancestor
25507252|NCT03948347|Hormones|hormones|mesh-ancestor
25507253|NCT03948347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25507254|NCT03924401|Abatacept|abatacept|mesh-list
25507255|NCT03924401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25507256|NCT03924401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507257|NCT03924401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507258|NCT03924401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24440704|NCT00284323|Purinergic Agonists|purinergic agonists|mesh-ancestor
25507259|NCT03924401|Immunologic Factors|immunologic factors|mesh-ancestor
25507260|NCT03924401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507261|NCT03924401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25507263|NCT03873805|Cyclophosphamide|cyclophosphamide|mesh-list
25507264|NCT03873805|Fludarabine|fludarabine|mesh-list
25507265|NCT03873805|Fludarabine phosphate|fludarabine phosphate|mesh-list
25507266|NCT03873805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25507267|NCT03873805|Immunologic Factors|immunologic factors|mesh-ancestor
25507268|NCT03873805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507269|NCT03873805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25507270|NCT03873805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25507271|NCT03873805|Alkylating Agents|alkylating agents|mesh-ancestor
25507272|NCT03873805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507273|NCT03873805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507274|NCT03873805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25507275|NCT03873805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25507276|NCT03873805|Antimetabolites|antimetabolites|mesh-ancestor
25507277|NCT03873805|Antiviral Agents|antiviral agents|mesh-ancestor
25507278|NCT03873805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25507279|NCT03871959|Pembrolizumab|pembrolizumab|mesh-list
25507280|NCT03871959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25507281|NCT03871959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507282|NCT03859024|Acetaminophen|acetaminophen|mesh-list
25507283|NCT03859024|Dexamethasone|dexamethasone|mesh-list
25507284|NCT03859024|Ibuprofen|ibuprofen|mesh-list
25507285|NCT03859024|Celecoxib|celecoxib|mesh-list
25507286|NCT03859024|Oxycodone|oxycodone|mesh-list
25507287|NCT03859024|Gabapentin|gabapentin|mesh-list
25507288|NCT03859024|Bupivacaine|bupivacaine|mesh-list
25507289|NCT03859024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25507290|NCT03859024|Antiemetics|antiemetics|mesh-ancestor
25507291|NCT03859024|Autonomic Agents|autonomic agents|mesh-ancestor
25507292|NCT03859024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25507293|NCT03859024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507294|NCT03859024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25507295|NCT03859024|Glucocorticoids|glucocorticoids|mesh-ancestor
25507296|NCT03859024|Hormones|hormones|mesh-ancestor
25507297|NCT03859024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25507298|NCT03859024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25507299|NCT03859024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507300|NCT03859024|Anesthetics, Local|anesthetics, local|mesh-ancestor
25507301|NCT03859024|Anesthetics|anesthetics|mesh-ancestor
25507302|NCT03859024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25507303|NCT03859024|Sensory System Agents|sensory system agents|mesh-ancestor
25507304|NCT03859024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25507305|NCT03859024|Analgesics|analgesics|mesh-ancestor
25507306|NCT03859024|Antipyretics|antipyretics|mesh-ancestor
25507307|NCT03859024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25507308|NCT03859024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25507309|NCT03859024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25507310|NCT03859024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25507311|NCT03859024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507312|NCT03859024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25507313|NCT03859024|Narcotics|narcotics|mesh-ancestor
25507314|NCT03859024|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25507315|NCT03859024|Anticonvulsants|anticonvulsants|mesh-ancestor
25507316|NCT03859024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25507317|NCT03859024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25507318|NCT03859024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25507319|NCT03859024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25507320|NCT03859024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25507321|NCT03859024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25507322|NCT03859024|Antimanic Agents|antimanic agents|mesh-ancestor
25507323|NCT03825341|Hydroxyurea|hydroxyurea|mesh-list
25507324|NCT03825341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507325|NCT03825341|Antisickling Agents|antisickling agents|mesh-ancestor
25507326|NCT03825341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25507327|NCT03825341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829463|NCT00006212|Antimitotic Agents|antimitotic agents|mesh-ancestor
25507328|NCT03825341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25507329|NCT03809000|Leuprolide|leuprolide|mesh-list
25507330|NCT03809000|Goserelin|goserelin|mesh-list
25507331|NCT03809000|Bicalutamide|bicalutamide|mesh-list
25507332|NCT03809000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25507333|NCT03809000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507334|NCT03809000|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25507335|NCT03809000|Fertility Agents|fertility agents|mesh-ancestor
25507336|NCT03809000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25507337|NCT03809000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25507338|NCT03809000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507339|NCT03809000|Androgen Antagonists|androgen antagonists|mesh-ancestor
25507340|NCT03809000|Hormone Antagonists|hormone antagonists|mesh-ancestor
25507341|NCT03796195|Bupivacaine|bupivacaine|mesh-list
25507342|NCT03796195|Anesthetics, Local|anesthetics, local|mesh-ancestor
25507343|NCT03796195|Anesthetics|anesthetics|mesh-ancestor
25507344|NCT03796195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25507345|NCT03796195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507346|NCT03796195|Sensory System Agents|sensory system agents|mesh-ancestor
25507347|NCT03796195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25507348|NCT03751631|Phenylephrine|phenylephrine|mesh-list
25507349|NCT03751631|Oxymetazoline|oxymetazoline|mesh-list
25507350|NCT03751631|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25507351|NCT03751631|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25507352|NCT03751631|Tropicamide|tropicamide|mesh-list
25507353|NCT03751631|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25507354|NCT03751631|Mydriatics|mydriatics|mesh-ancestor
25507355|NCT03751631|Autonomic Agents|autonomic agents|mesh-ancestor
25507356|NCT03751631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25507357|NCT03751631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507358|NCT03751631|Sympathomimetics|sympathomimetics|mesh-ancestor
25507359|NCT03751631|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25507360|NCT03751631|Nasal Decongestants|nasal decongestants|mesh-ancestor
25507361|NCT03751631|Respiratory System Agents|respiratory system agents|mesh-ancestor
25507362|NCT03751631|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25507363|NCT03751631|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25507364|NCT03751631|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25507365|NCT03751631|Adrenergic Agents|adrenergic agents|mesh-ancestor
25507366|NCT03751631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25507367|NCT03751631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507368|NCT03751631|Protective Agents|protective agents|mesh-ancestor
25507369|NCT03751631|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25507370|NCT03751631|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25507371|NCT03751631|Cholinergic Agents|cholinergic agents|mesh-ancestor
25507372|NCT03751098|Phenylephrine|phenylephrine|mesh-list
25507373|NCT03751098|Oxymetazoline|oxymetazoline|mesh-list
25507374|NCT03751098|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25507375|NCT03751098|Tropicamide|tropicamide|mesh-list
25507376|NCT03751098|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25507377|NCT03751098|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25507378|NCT03751098|Mydriatics|mydriatics|mesh-ancestor
25507379|NCT03751098|Autonomic Agents|autonomic agents|mesh-ancestor
25507380|NCT03751098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25507381|NCT03751098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507382|NCT03751098|Sympathomimetics|sympathomimetics|mesh-ancestor
25507383|NCT03751098|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25507384|NCT03751098|Nasal Decongestants|nasal decongestants|mesh-ancestor
25507385|NCT03751098|Respiratory System Agents|respiratory system agents|mesh-ancestor
25507386|NCT03751098|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25507387|NCT03751098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25507388|NCT03751098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25507389|NCT03751098|Adrenergic Agents|adrenergic agents|mesh-ancestor
25507390|NCT03751098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25507391|NCT03751098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507392|NCT03751098|Protective Agents|protective agents|mesh-ancestor
25507393|NCT03751098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25507394|NCT03751098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25507395|NCT03751098|Cholinergic Agents|cholinergic agents|mesh-ancestor
25507396|NCT03729869|Progesterone|progesterone|mesh-list
25507397|NCT03729869|Progestins|progestins|mesh-ancestor
25507398|NCT03729869|Hormones|hormones|mesh-ancestor
25507399|NCT03729869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25507400|NCT03729869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507401|NCT03675412|Caffeine|caffeine|mesh-list
25507402|NCT03675412|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24694256|NCT01424709|Antiviral Agents|antiviral agents|mesh-ancestor
25829464|NCT00006212|Mitosis Modulators|mitosis modulators|mesh-ancestor
25645836|NCT01451762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25645837|NCT01451762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507403|NCT03675412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507404|NCT03675412|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25507405|NCT03675412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25507406|NCT03675412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507407|NCT03675412|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25507408|NCT03675412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25507409|NCT03675412|Purinergic Agents|purinergic agents|mesh-ancestor
25507410|NCT03675412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25507411|NCT03636503|Rituximab|rituximab|mesh-list
25507438|NCT03458117|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25507439|NCT03458117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25507440|NCT03458117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507442|NCT03430700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25507443|NCT03430700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507444|NCT03418675|Brexpiprazole|brexpiprazole|mesh-list
25507445|NCT03418675|Serotonin Agents|serotonin agents|mesh-ancestor
25507446|NCT03418675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25507447|NCT03418675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507448|NCT03418675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507449|NCT03418675|Dopamine Agonists|dopamine agonists|mesh-ancestor
25507450|NCT03418675|Dopamine Agents|dopamine agents|mesh-ancestor
24442803|NCT00292747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24442804|NCT00292747|Analgesics|analgesics|mesh-ancestor
24442805|NCT00292747|Sensory System Agents|sensory system agents|mesh-ancestor
24442806|NCT00292747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24442807|NCT00292747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442808|NCT00292747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25125289|NCT03069950|Leucovorin|leucovorin|mesh-list
25507454|NCT03284723|Letrozole|letrozole|mesh-list
25507455|NCT03284723|Palbociclib|palbociclib|mesh-list
25507456|NCT03284723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507457|NCT03284723|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25507458|NCT03284723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25507459|NCT03284723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25507460|NCT03284723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507461|NCT03284723|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25507462|NCT03284723|Hormone Antagonists|hormone antagonists|mesh-ancestor
25507463|NCT03284723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25507464|NCT03284723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507465|NCT03284723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25507466|NCT03282981|Timolol|timolol|mesh-list
25507467|NCT03282981|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25507468|NCT03282981|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25507469|NCT03282981|Adrenergic Agents|adrenergic agents|mesh-ancestor
25507470|NCT03282981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25507471|NCT03282981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507472|NCT03282981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507473|NCT03282981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25507474|NCT03282981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25507475|NCT03165955|Paclitaxel|paclitaxel|mesh-list
25507476|NCT03165955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25507477|NCT03165955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507478|NCT03165955|Tubulin Modulators|tubulin modulators|mesh-ancestor
25507479|NCT03165955|Antimitotic Agents|antimitotic agents|mesh-ancestor
25507480|NCT03165955|Mitosis Modulators|mitosis modulators|mesh-ancestor
25507481|NCT03165955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507482|NCT03133793|Coenzyme Q10|coenzyme q10|mesh-list
25507483|NCT03133793|Vitamins|vitamins|mesh-ancestor
25507484|NCT03133793|Micronutrients|micronutrients|mesh-ancestor
25507485|NCT03133793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507486|NCT03130127|Terlipressin|terlipressin|mesh-list
25507487|NCT03130127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25507488|NCT03130127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25507489|NCT03127774|Sodium thiosulfate|sodium thiosulfate|mesh-list
25507490|NCT03127774|Cisplatin|cisplatin|mesh-list
25507491|NCT03127774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507492|NCT03127774|Antidotes|antidotes|mesh-ancestor
25507493|NCT03127774|Protective Agents|protective agents|mesh-ancestor
25507494|NCT03127774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507495|NCT03127774|Antioxidants|antioxidants|mesh-ancestor
25507496|NCT03127774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507497|NCT03127774|Antitubercular Agents|antitubercular agents|mesh-ancestor
25645838|NCT01451762|Anesthetics, Local|anesthetics, local|mesh-ancestor
25645839|NCT01451762|Anesthetics|anesthetics|mesh-ancestor
25645840|NCT01451762|Sensory System Agents|sensory system agents|mesh-ancestor
25507498|NCT03127774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25507499|NCT03127774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25507500|NCT03127774|Chelating Agents|chelating agents|mesh-ancestor
25507501|NCT03127774|Sequestering Agents|sequestering agents|mesh-ancestor
25507502|NCT03127267|Riluzole|riluzole|mesh-list
25507503|NCT03127267|Anticonvulsants|anticonvulsants|mesh-ancestor
25507504|NCT03127267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25507505|NCT03127267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25507506|NCT03127267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25507507|NCT03127267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507508|NCT03127267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507509|NCT03127267|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25507510|NCT03127267|Protective Agents|protective agents|mesh-ancestor
25507511|NCT03057795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25507512|NCT03057795|Nivolumab|nivolumab|mesh-list
25507513|NCT03057795|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25507514|NCT03057795|Antibodies|antibodies|mesh-list
25507515|NCT03057795|Immunoglobulins|immunoglobulins|mesh-list
25507516|NCT03057795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25823197|NCT00004763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25823198|NCT00004763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125343|NCT03069768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125345|NCT03069911|Botulinum Toxins|botulinum toxins|mesh-list
25125346|NCT03069911|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25507517|NCT03057795|Immunoconjugates|immunoconjugates|mesh-list
25507518|NCT03057795|Immunologic Factors|immunologic factors|mesh-ancestor
25507519|NCT03057795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507520|NCT03057795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507521|NCT03057795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25507522|NCT03057795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507523|NCT02947685|Trastuzumab|trastuzumab|mesh-list
25507524|NCT02947685|Pertuzumab|pertuzumab|mesh-list
25507525|NCT02947685|Letrozole|letrozole|mesh-list
25507526|NCT02947685|Fulvestrant|fulvestrant|mesh-list
25507527|NCT02947685|Palbociclib|palbociclib|mesh-list
25507528|NCT02947685|Anastrozole|anastrozole|mesh-list
25507529|NCT02947685|Exemestane|exemestane|mesh-list
25507530|NCT02947685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25507531|NCT02947685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507532|NCT02947685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25507533|NCT02947685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25507534|NCT02947685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25507535|NCT02947685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507536|NCT02947685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25507537|NCT02947685|Hormone Antagonists|hormone antagonists|mesh-ancestor
25507538|NCT02947685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25507539|NCT02947685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507540|NCT02947685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25507541|NCT02947685|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25507542|NCT02947685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25507543|NCT02845882|Cytarabine|cytarabine|mesh-list
25507544|NCT02845882|Dexamethasone|dexamethasone|mesh-list
25507545|NCT02845882|Dexamethasone acetate|dexamethasone acetate|mesh-list
25507546|NCT02845882|Prednisone|prednisone|mesh-list
25507547|NCT02845882|Cyclophosphamide|cyclophosphamide|mesh-list
25507548|NCT02845882|Ifosfamide|ifosfamide|mesh-list
25507549|NCT02845882|Doxorubicin|doxorubicin|mesh-list
25507550|NCT02845882|Methotrexate|methotrexate|mesh-list
25507551|NCT02845882|Etoposide|etoposide|mesh-list
25507552|NCT02845882|Vincristine|vincristine|mesh-list
25507553|NCT02845882|Daunorubicin|daunorubicin|mesh-list
25507554|NCT02845882|Asparaginase|asparaginase|mesh-list
25507555|NCT02845882|Mercaptopurine|mercaptopurine|mesh-list
25507556|NCT02845882|Vindesine|vindesine|mesh-list
25507557|NCT02845882|Pegaspargase|pegaspargase|mesh-list
25507558|NCT02845882|BB 1101|bb 1101|mesh-list
25507559|NCT02845882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25507560|NCT02845882|Immunologic Factors|immunologic factors|mesh-ancestor
24694423|NCT01425476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694424|NCT01425476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25645841|NCT01451762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25645842|NCT01451762|Antiemetics|antiemetics|mesh-ancestor
25507561|NCT02845882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507562|NCT02845882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25507563|NCT02845882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25645843|NCT01451762|Autonomic Agents|autonomic agents|mesh-ancestor
25645844|NCT01451762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25645845|NCT01451762|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25645846|NCT01451762|Histamine Antagonists|histamine antagonists|mesh-ancestor
25645847|NCT01451762|Histamine Agents|histamine agents|mesh-ancestor
25645848|NCT01451762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25645849|NCT01451762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507564|NCT02845882|Alkylating Agents|alkylating agents|mesh-ancestor
25507565|NCT02845882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507566|NCT02845882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507567|NCT02845882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25507568|NCT02845882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25823199|NCT00004763|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25507569|NCT02845882|Antiemetics|antiemetics|mesh-ancestor
25507570|NCT02845882|Autonomic Agents|autonomic agents|mesh-ancestor
25507571|NCT02845882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25507572|NCT02845882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25507573|NCT02845882|Glucocorticoids|glucocorticoids|mesh-ancestor
25507574|NCT02845882|Hormones|hormones|mesh-ancestor
25507575|NCT02845882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25507576|NCT02845882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25507577|NCT02845882|Protease Inhibitors|protease inhibitors|mesh-ancestor
25507578|NCT02845882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25507579|NCT02845882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24442974|NCT00293371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442975|NCT00293371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24442976|NCT00293371|Glucocorticoids|glucocorticoids|mesh-ancestor
25823200|NCT00004763|Contraceptive Agents|contraceptive agents|mesh-ancestor
25823201|NCT00004763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25823202|NCT00004763|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25823203|NCT00004763|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25823204|NCT00004763|Fertility Agents|fertility agents|mesh-ancestor
25125386|NCT03069027|Anesthetics|anesthetics|mesh-ancestor
25125387|NCT03069027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25823205|NCT00004763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25507580|NCT02845882|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25507581|NCT02845882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25507582|NCT02845882|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25507583|NCT02845882|Abortifacient Agents|abortifacient agents|mesh-ancestor
25507584|NCT02845882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25507585|NCT02845882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25507587|NCT02845882|Dermatologic Agents|dermatologic agents|mesh-ancestor
25507588|NCT02845882|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25507589|NCT02845882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25507590|NCT02845882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25507591|NCT02845882|Antiviral Agents|antiviral agents|mesh-ancestor
25507592|NCT02845882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25507593|NCT02845882|Tubulin Modulators|tubulin modulators|mesh-ancestor
25507594|NCT02845882|Antimitotic Agents|antimitotic agents|mesh-ancestor
25507595|NCT02845882|Mitosis Modulators|mitosis modulators|mesh-ancestor
25507596|NCT02843451|Silymarin|silymarin|mesh-list
25507597|NCT02843451|Antioxidants|antioxidants|mesh-ancestor
25507598|NCT02843451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507599|NCT02843451|Protective Agents|protective agents|mesh-ancestor
25507600|NCT02843451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507601|NCT02662634|Paclitaxel|paclitaxel|mesh-list
25507602|NCT02662634|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25507603|NCT02662634|Cisplatin|cisplatin|mesh-list
25507604|NCT02662634|Carboplatin|carboplatin|mesh-list
25507605|NCT02662634|Pemetrexed|pemetrexed|mesh-list
25507606|NCT02662634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25507607|NCT02662634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507608|NCT02662634|Tubulin Modulators|tubulin modulators|mesh-ancestor
25507609|NCT02662634|Antimitotic Agents|antimitotic agents|mesh-ancestor
25507610|NCT02662634|Mitosis Modulators|mitosis modulators|mesh-ancestor
25507611|NCT02662634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507612|NCT02662634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25507613|NCT02662634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25507614|NCT02662634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25507615|NCT02658279|Pembrolizumab|pembrolizumab|mesh-list
25507616|NCT02658279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25507617|NCT02658279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507618|NCT02448420|Trastuzumab|trastuzumab|mesh-list
24694562|NCT05386160|Growth Inhibitors|growth inhibitors|mesh-ancestor
25645851|NCT01451762|Antipruritics|antipruritics|mesh-ancestor
25645852|NCT01451762|Dermatologic Agents|dermatologic agents|mesh-ancestor
25645853|NCT01451775|Empagliflozin|empagliflozin|mesh-list
24809067|NCT02030977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645854|NCT01451775|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25645855|NCT01451775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645856|NCT01451775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25645857|NCT01451775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645858|NCT01451814|Nicotine|nicotine|mesh-list
25645859|NCT01451814|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25645860|NCT01451814|Autonomic Agents|autonomic agents|mesh-ancestor
25507619|NCT02448420|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25507620|NCT02448420|Palbociclib|palbociclib|mesh-list
25507621|NCT02448420|Antibodies|antibodies|mesh-list
25507622|NCT02448420|Immunoconjugates|immunoconjugates|mesh-list
25507623|NCT02448420|Immunologic Factors|immunologic factors|mesh-ancestor
25507624|NCT02448420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507625|NCT02448420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25507626|NCT02448420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507627|NCT02448420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25507628|NCT02448420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25507629|NCT02448420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507630|NCT02448420|Tubulin Modulators|tubulin modulators|mesh-ancestor
25507631|NCT02448420|Antimitotic Agents|antimitotic agents|mesh-ancestor
25507632|NCT02448420|Mitosis Modulators|mitosis modulators|mesh-ancestor
25507633|NCT02432963|Pembrolizumab|pembrolizumab|mesh-list
25507634|NCT02432963|Vaccines|vaccines|mesh-list
25507635|NCT02432963|Immunologic Factors|immunologic factors|mesh-ancestor
25507636|NCT02432963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507637|NCT02432963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25507638|NCT02432963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507639|NCT02422446|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
25507640|NCT02422446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25507641|NCT02422446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25507642|NCT02405676|Cytarabine|cytarabine|mesh-list
25507643|NCT02405676|Prednisone|prednisone|mesh-list
25507644|NCT02405676|Cyclophosphamide|cyclophosphamide|mesh-list
25507645|NCT02405676|Ifosfamide|ifosfamide|mesh-list
25507646|NCT02405676|Isophosphamide mustard|isophosphamide mustard|mesh-list
25507647|NCT02405676|Rituximab|rituximab|mesh-list
25507648|NCT02405676|Methotrexate|methotrexate|mesh-list
25507649|NCT02405676|Etoposide|etoposide|mesh-list
25507650|NCT02405676|Etoposide phosphate|etoposide phosphate|mesh-list
25507651|NCT02405676|Vincristine|vincristine|mesh-list
25507652|NCT02405676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25507653|NCT02405676|Immunologic Factors|immunologic factors|mesh-ancestor
25507654|NCT02405676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507655|NCT02405676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25507656|NCT02405676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25507657|NCT02405676|Alkylating Agents|alkylating agents|mesh-ancestor
25507658|NCT02405676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507663|NCT02405676|Glucocorticoids|glucocorticoids|mesh-ancestor
25507664|NCT02405676|Hormones|hormones|mesh-ancestor
25507665|NCT02405676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25507666|NCT02405676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25507667|NCT02405676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25507668|NCT02405676|Abortifacient Agents|abortifacient agents|mesh-ancestor
25507669|NCT02405676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25507670|NCT02405676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25507671|NCT02405676|Antimetabolites|antimetabolites|mesh-ancestor
25507672|NCT02405676|Dermatologic Agents|dermatologic agents|mesh-ancestor
25507673|NCT02405676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25507674|NCT02405676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25507675|NCT02405676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25507676|NCT02405676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25507677|NCT02405676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25507678|NCT02405676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25507679|NCT02405676|Antiviral Agents|antiviral agents|mesh-ancestor
25507680|NCT02405676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25507681|NCT02405676|Tubulin Modulators|tubulin modulators|mesh-ancestor
25507682|NCT02405676|Antimitotic Agents|antimitotic agents|mesh-ancestor
25507683|NCT02405676|Mitosis Modulators|mitosis modulators|mesh-ancestor
25507684|NCT02362451|Vaccines|vaccines|mesh-list
25507685|NCT02362451|Immunologic Factors|immunologic factors|mesh-ancestor
25507686|NCT02362451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507687|NCT02342782|Cytarabine|cytarabine|mesh-list
25823206|NCT00004763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645861|NCT01451814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25645862|NCT01451814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645864|NCT01451814|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25645865|NCT01451814|Cholinergic Agents|cholinergic agents|mesh-ancestor
25507688|NCT02342782|Etoposide|etoposide|mesh-list
25507689|NCT02342782|Melphalan|melphalan|mesh-list
25507690|NCT02342782|Carmustine|carmustine|mesh-list
25507691|NCT02342782|Basiliximab|basiliximab|mesh-list
25507692|NCT02342782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25507693|NCT02342782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507694|NCT02342782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25645866|NCT01451814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25507695|NCT02342782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25507696|NCT02342782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25507697|NCT02342782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507698|NCT02342782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25507699|NCT02342782|Antimetabolites|antimetabolites|mesh-ancestor
25507700|NCT02342782|Antiviral Agents|antiviral agents|mesh-ancestor
25507701|NCT02342782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25507702|NCT02342782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25507703|NCT02342782|Immunologic Factors|immunologic factors|mesh-ancestor
25507704|NCT02342782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507705|NCT02342782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25507706|NCT02342782|Alkylating Agents|alkylating agents|mesh-ancestor
25507707|NCT02342782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25507708|NCT02337634|Silymarin|silymarin|mesh-list
25507709|NCT02337634|Antioxidants|antioxidants|mesh-ancestor
25507710|NCT02337634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507711|NCT02337634|Protective Agents|protective agents|mesh-ancestor
25507712|NCT02337634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507713|NCT02336087|Metformin|metformin|mesh-list
25507714|NCT02336087|Gemcitabine|gemcitabine|mesh-list
25507715|NCT02336087|Paclitaxel|paclitaxel|mesh-list
25507716|NCT02336087|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25507717|NCT02336087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25507718|NCT02336087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507719|NCT02336087|Tubulin Modulators|tubulin modulators|mesh-ancestor
25507720|NCT02336087|Antimitotic Agents|antimitotic agents|mesh-ancestor
25507721|NCT02336087|Mitosis Modulators|mitosis modulators|mesh-ancestor
25507722|NCT02336087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507723|NCT02336087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25507724|NCT02336087|Antimetabolites|antimetabolites|mesh-ancestor
25507725|NCT02336087|Antiviral Agents|antiviral agents|mesh-ancestor
25507726|NCT02336087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25507727|NCT02336087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25507728|NCT02336087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25162220|NCT02906722|Colistin|colistin|mesh-list
25507729|NCT02336087|Immunologic Factors|immunologic factors|mesh-ancestor
25507730|NCT02336087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507731|NCT02336087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25507733|NCT02335580|Hormones|hormones|mesh-ancestor
25507734|NCT02335580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25507735|NCT02335580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507736|NCT02277782|Fentanyl|fentanyl|mesh-list
25507737|NCT02277782|Hydromorphone|hydromorphone|mesh-list
25507738|NCT02277782|Bupivacaine|bupivacaine|mesh-list
25507739|NCT02277782|Anesthetics, Local|anesthetics, local|mesh-ancestor
25507740|NCT02277782|Anesthetics|anesthetics|mesh-ancestor
25507741|NCT02277782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25507742|NCT02277782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507743|NCT02277782|Sensory System Agents|sensory system agents|mesh-ancestor
25507744|NCT02277782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25507745|NCT02277782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25507746|NCT02277782|Narcotics|narcotics|mesh-ancestor
25507747|NCT02277782|Analgesics|analgesics|mesh-ancestor
25507748|NCT02277782|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25507749|NCT02277782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25507750|NCT02277782|Anesthetics, General|anesthetics, general|mesh-ancestor
25507751|NCT02271230|Vitamin D|vitamin d|mesh-list
25507752|NCT02271230|Ergocalciferols|ergocalciferols|mesh-list
25507753|NCT02271230|Cholecalciferol|cholecalciferol|mesh-list
25507754|NCT02271230|Vitamins|vitamins|mesh-list
25645867|NCT01451814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645868|NCT01451827|Tolvaptan|tolvaptan|mesh-list
25507755|NCT02271230|Micronutrients|micronutrients|mesh-ancestor
25645869|NCT01451827|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25645870|NCT01451827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645871|NCT01451827|Natriuretic Agents|natriuretic agents|mesh-ancestor
25645872|NCT01451827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645873|NCT01451996|Loratadine|loratadine|mesh-list
25645874|NCT01451996|Antipruritics|antipruritics|mesh-ancestor
25645875|NCT01451996|Dermatologic Agents|dermatologic agents|mesh-ancestor
25645876|NCT01451996|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25645877|NCT01451996|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25507756|NCT02271230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507757|NCT02271230|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25507758|NCT02271230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25507759|NCT02268448|Clonidine|clonidine|mesh-list
25507760|NCT02268448|Naltrexone|naltrexone|mesh-list
25507761|NCT02268448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25507762|NCT02268448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25507763|NCT02268448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507764|NCT02268448|Sensory System Agents|sensory system agents|mesh-ancestor
25507765|NCT02268448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25507766|NCT02268448|Analgesics|analgesics|mesh-ancestor
25507767|NCT02268448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25507768|NCT02268448|Sympatholytics|sympatholytics|mesh-ancestor
25507769|NCT02268448|Autonomic Agents|autonomic agents|mesh-ancestor
25507770|NCT02268448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25507771|NCT02268448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25507772|NCT02268448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25507773|NCT02268448|Adrenergic Agents|adrenergic agents|mesh-ancestor
25507774|NCT02268448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25507775|NCT02268448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507776|NCT02180724|Acalabrutinib|acalabrutinib|mesh-list
25507777|NCT02180724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507778|NCT02048150|Antibodies|antibodies|mesh-list
25507779|NCT02048150|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25507780|NCT02048150|Immunologic Factors|immunologic factors|mesh-ancestor
25507781|NCT02048150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507782|NCT02038777|Cytarabine|cytarabine|mesh-list
25507783|NCT02038777|Azacitidine|azacitidine|mesh-list
25507784|NCT02038777|Daunorubicin|daunorubicin|mesh-list
25507785|NCT02038777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25507786|NCT02038777|Antimetabolites|antimetabolites|mesh-ancestor
25507787|NCT02038777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507788|NCT02038777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507789|NCT02038777|Antiviral Agents|antiviral agents|mesh-ancestor
25507790|NCT02038777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25507791|NCT02038777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25507792|NCT02038777|Immunologic Factors|immunologic factors|mesh-ancestor
25507793|NCT02038777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507794|NCT02038777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25507795|NCT02038777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25507796|NCT02038777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25507797|NCT02038777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25823207|NCT00004763|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25823208|NCT00004763|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25823209|NCT00004763|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25823210|NCT00004763|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25823211|NCT00004767|Sodium Benzoate|sodium benzoate|mesh-list
25823212|NCT00004767|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25823213|NCT00004767|Phenylacetic acid|phenylacetic acid|mesh-list
25507798|NCT01996449|Amlodipine|amlodipine|mesh-list
25507799|NCT01996449|Eplerenone|eplerenone|mesh-list
25507800|NCT01996449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25507801|NCT01996449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25507802|NCT01996449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25507803|NCT01996449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507804|NCT01996449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25507805|NCT01996449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507806|NCT01996449|Vasodilator Agents|vasodilator agents|mesh-ancestor
25507807|NCT01996449|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25507808|NCT01996449|Hormone Antagonists|hormone antagonists|mesh-ancestor
25507809|NCT01996449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25507810|NCT01996449|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25507811|NCT01996449|Diuretics|diuretics|mesh-ancestor
25507812|NCT01996449|Natriuretic Agents|natriuretic agents|mesh-ancestor
25507813|NCT01958190|Sirolimus|sirolimus|mesh-list
25507814|NCT01958190|Tacrolimus|tacrolimus|mesh-list
25507815|NCT01958190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25507816|NCT01958190|Immunologic Factors|immunologic factors|mesh-ancestor
25507817|NCT01958190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507818|NCT01958190|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25507819|NCT01958190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809265|NCT02032303|Ticagrelor|ticagrelor|mesh-list
25507820|NCT01958190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507821|NCT01958190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25507822|NCT01958190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25507823|NCT01958190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25507824|NCT01958190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507825|NCT01958190|Antifungal Agents|antifungal agents|mesh-ancestor
25507826|NCT01936831|Vitamin B 6|vitamin b 6|mesh-list
25507827|NCT01936831|Pyridoxal|pyridoxal|mesh-list
25507828|NCT01936831|Pyridoxine|pyridoxine|mesh-list
25507829|NCT01936831|Isoniazid|isoniazid|mesh-list
25507830|NCT01936831|Vitamins|vitamins|mesh-ancestor
25507831|NCT01936831|Micronutrients|micronutrients|mesh-ancestor
25507832|NCT01936831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507833|NCT01936831|Vitamin B Complex|vitamin b complex|mesh-ancestor
25507834|NCT01936831|Antitubercular Agents|antitubercular agents|mesh-ancestor
25507835|NCT01936831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25507836|NCT01936831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25507837|NCT01936831|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25507838|NCT01936831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25507839|NCT01936831|Antimetabolites|antimetabolites|mesh-ancestor
25507840|NCT01936831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507841|NCT01936831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25507842|NCT01927419|Nivolumab|nivolumab|mesh-list
25507843|NCT01927419|Ipilimumab|ipilimumab|mesh-list
25507844|NCT01927419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25507845|NCT01927419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507846|NCT01927419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25507847|NCT01927419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507848|NCT01750073|Paclitaxel|paclitaxel|mesh-list
25507849|NCT01750073|Cyclophosphamide|cyclophosphamide|mesh-list
25507850|NCT01750073|Doxorubicin|doxorubicin|mesh-list
25507851|NCT01750073|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25507852|NCT01750073|Trastuzumab|trastuzumab|mesh-list
25507853|NCT01750073|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25507854|NCT01750073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25507855|NCT01750073|Antibodies|antibodies|mesh-list
25507856|NCT01750073|Immunoglobulins|immunoglobulins|mesh-list
25507857|NCT01750073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25507858|NCT01750073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25507859|NCT01750073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507860|NCT01750073|Tubulin Modulators|tubulin modulators|mesh-ancestor
25507861|NCT01750073|Antimitotic Agents|antimitotic agents|mesh-ancestor
25507862|NCT01750073|Mitosis Modulators|mitosis modulators|mesh-ancestor
25507863|NCT01750073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125660|NCT03067688|Amlodipine|amlodipine|mesh-list
25125661|NCT03067688|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
25125662|NCT03067688|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25125663|NCT03067688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25125664|NCT03067688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25125665|NCT03067688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25823214|NCT00004767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823215|NCT00004767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25823216|NCT00004767|Antimetabolites|antimetabolites|mesh-ancestor
25823217|NCT00004767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507864|NCT01750073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25507865|NCT01750073|Immunologic Factors|immunologic factors|mesh-ancestor
25507866|NCT01750073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507867|NCT01750073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25507868|NCT01750073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25507869|NCT01750073|Alkylating Agents|alkylating agents|mesh-ancestor
25507870|NCT01750073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25507871|NCT01750073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25507872|NCT01750073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25507873|NCT01750073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25507874|NCT01750073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25507876|NCT01730833|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25507877|NCT01730833|Trastuzumab|trastuzumab|mesh-list
25507878|NCT01730833|Pertuzumab|pertuzumab|mesh-list
25507879|NCT01730833|Antibodies|antibodies|mesh-list
25507880|NCT01730833|Immunoglobulins|immunoglobulins|mesh-list
25507881|NCT01730833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25645878|NCT01451996|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25645879|NCT01451996|Histamine Antagonists|histamine antagonists|mesh-ancestor
25645880|NCT01451996|Histamine Agents|histamine agents|mesh-ancestor
25645881|NCT01451996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25645882|NCT01451996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823218|NCT00004767|Antifungal Agents|antifungal agents|mesh-ancestor
25507882|NCT01730833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507883|NCT01730833|Tubulin Modulators|tubulin modulators|mesh-ancestor
25507884|NCT01730833|Antimitotic Agents|antimitotic agents|mesh-ancestor
25507885|NCT01730833|Mitosis Modulators|mitosis modulators|mesh-ancestor
25507886|NCT01730833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507887|NCT01730833|Immunologic Factors|immunologic factors|mesh-ancestor
25507888|NCT01730833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507889|NCT01730833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25507890|NCT01723839|Cyclophosphamide|cyclophosphamide|mesh-list
25507891|NCT01723839|Rituximab|rituximab|mesh-list
25507892|NCT01723839|Fludarabine|fludarabine|mesh-list
25507893|NCT01723839|Lenalidomide|lenalidomide|mesh-list
25507894|NCT01723839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25507895|NCT01723839|Immunologic Factors|immunologic factors|mesh-ancestor
25507896|NCT01723839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507897|NCT01723839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25507898|NCT01723839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25507899|NCT01723839|Alkylating Agents|alkylating agents|mesh-ancestor
25507900|NCT01723839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507901|NCT01723839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507902|NCT01723839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25507903|NCT01723839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25507904|NCT01723839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25507905|NCT01723839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25507906|NCT01723839|Growth Substances|growth substances|mesh-ancestor
25507907|NCT01723839|Growth Inhibitors|growth inhibitors|mesh-ancestor
25507908|NCT01711879|Aflibercept|aflibercept|mesh-list
25507909|NCT01711879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25507910|NCT01711879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25507911|NCT01711879|Growth Substances|growth substances|mesh-ancestor
25507912|NCT01711879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507913|NCT01711879|Growth Inhibitors|growth inhibitors|mesh-ancestor
25507914|NCT01711879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507915|NCT01697267|Rituximab|rituximab|mesh-list
25507916|NCT01697267|Azathioprine|azathioprine|mesh-list
25507917|NCT01697267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25507918|NCT01697267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507919|NCT01697267|Immunologic Factors|immunologic factors|mesh-ancestor
25507920|NCT01697267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507921|NCT01697267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25507922|NCT01697267|Antimetabolites|antimetabolites|mesh-ancestor
25507923|NCT01697267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507924|NCT01697267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25507925|NCT01697267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25507926|NCT01653223|Simvastatin|simvastatin|mesh-list
24980204|NCT05440578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24980205|NCT05440578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24980206|NCT05440578|Growth Substances|growth substances|mesh-ancestor
24980207|NCT05440578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980208|NCT05440578|Growth Inhibitors|growth inhibitors|mesh-ancestor
25823219|NCT00004767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25823220|NCT00004770|Thioctic Acid|thioctic acid|mesh-list
24458668|NCT00338780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24458669|NCT00338780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458670|NCT00338780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125739|NCT03066791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25125740|NCT03066791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25507931|NCT01653223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25507932|NCT01653223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25507933|NCT01653223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25507935|NCT01527149|Dexamethasone|dexamethasone|mesh-list
25507936|NCT01527149|Dexamethasone acetate|dexamethasone acetate|mesh-list
25507937|NCT01527149|Cyclophosphamide|cyclophosphamide|mesh-list
25507938|NCT01527149|Doxorubicin|doxorubicin|mesh-list
25507939|NCT01527149|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25507940|NCT01527149|Methotrexate|methotrexate|mesh-list
25507941|NCT01527149|Vincristine|vincristine|mesh-list
25507942|NCT01527149|Ofatumumab|ofatumumab|mesh-list
25507943|NCT01527149|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25645883|NCT01451996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645884|NCT01452126|Ropivacaine|ropivacaine|mesh-list
25645885|NCT01452126|Anesthetics, Local|anesthetics, local|mesh-ancestor
25645886|NCT01452126|Anesthetics|anesthetics|mesh-ancestor
25507944|NCT01527149|BB 1101|bb 1101|mesh-list
25507945|NCT01527149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25507946|NCT01527149|Immunologic Factors|immunologic factors|mesh-ancestor
25507947|NCT01527149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25507948|NCT01527149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25507949|NCT01527149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25507950|NCT01527149|Alkylating Agents|alkylating agents|mesh-ancestor
25507951|NCT01527149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507952|NCT01527149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507953|NCT01527149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25507954|NCT01527149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25507955|NCT01527149|Antiemetics|antiemetics|mesh-ancestor
25507956|NCT01527149|Autonomic Agents|autonomic agents|mesh-ancestor
25507957|NCT01527149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25507958|NCT01527149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25507959|NCT01527149|Glucocorticoids|glucocorticoids|mesh-ancestor
25507960|NCT01527149|Hormones|hormones|mesh-ancestor
25507961|NCT01527149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25507962|NCT01527149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25507963|NCT01527149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25507964|NCT01527149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25507965|NCT01527149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25507966|NCT01527149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25507967|NCT01527149|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25507968|NCT01527149|Abortifacient Agents|abortifacient agents|mesh-ancestor
25507969|NCT01527149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25507970|NCT01527149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25507971|NCT01527149|Antimetabolites|antimetabolites|mesh-ancestor
25507972|NCT01527149|Dermatologic Agents|dermatologic agents|mesh-ancestor
25507973|NCT01527149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25507974|NCT01527149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25507975|NCT01527149|Antiviral Agents|antiviral agents|mesh-ancestor
25507976|NCT01527149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25507977|NCT01527149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25507978|NCT01527149|Tubulin Modulators|tubulin modulators|mesh-ancestor
25507979|NCT01527149|Antimitotic Agents|antimitotic agents|mesh-ancestor
25507980|NCT01527149|Mitosis Modulators|mitosis modulators|mesh-ancestor
25507981|NCT01527149|Protease Inhibitors|protease inhibitors|mesh-ancestor
25507982|NCT01512407|Cisplatin|cisplatin|mesh-list
25507983|NCT01512407|Ethiodized Oil|ethiodized oil|mesh-list
25507984|NCT01512407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507985|NCT01494662|Capecitabine|capecitabine|mesh-list
25507986|NCT01494662|Trastuzumab|trastuzumab|mesh-list
25507987|NCT01494662|Maytansine|maytansine|mesh-list
25507988|NCT01494662|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25507989|NCT01494662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25507990|NCT01494662|Antimetabolites|antimetabolites|mesh-ancestor
25507991|NCT01494662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25507992|NCT01494662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25507993|NCT01494662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24443155|NCT00293800|Travoprost|travoprost|mesh-list
24443156|NCT00293800|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24443157|NCT00293800|Latanoprost|latanoprost|mesh-list
24443158|NCT00293800|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24443159|NCT00293800|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25507994|NCT01494662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25507995|NCT01494662|Tubulin Modulators|tubulin modulators|mesh-ancestor
25507996|NCT01494662|Antimitotic Agents|antimitotic agents|mesh-ancestor
25507997|NCT01494662|Mitosis Modulators|mitosis modulators|mesh-ancestor
25507998|NCT01476839|Cytarabine|cytarabine|mesh-list
25507999|NCT01476839|Etoposide|etoposide|mesh-list
25508000|NCT01476839|Etoposide phosphate|etoposide phosphate|mesh-list
25508001|NCT01476839|Melphalan|melphalan|mesh-list
25508002|NCT01476839|Carmustine|carmustine|mesh-list
25508003|NCT01476839|Basiliximab|basiliximab|mesh-list
25508004|NCT01476839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25508005|NCT01476839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508006|NCT01476839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25508007|NCT01476839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25508008|NCT01476839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612494|NCT01014234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25823221|NCT00004770|Antioxidants|antioxidants|mesh-ancestor
25508009|NCT01476839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645887|NCT01452126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25645888|NCT01452126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645890|NCT01452126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25645891|NCT01452347|Warfarin|warfarin|mesh-list
25645892|NCT01452347|Dabigatran|dabigatran|mesh-list
25645893|NCT01452347|Anticoagulants|anticoagulants|mesh-ancestor
25645894|NCT01452347|Antithrombins|antithrombins|mesh-ancestor
25645895|NCT01452347|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25645896|NCT01452347|Protease Inhibitors|protease inhibitors|mesh-ancestor
25508010|NCT01476839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25508011|NCT01476839|Antimetabolites|antimetabolites|mesh-ancestor
25508012|NCT01476839|Antiviral Agents|antiviral agents|mesh-ancestor
25508013|NCT01476839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25508014|NCT01476839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25508015|NCT01476839|Immunologic Factors|immunologic factors|mesh-ancestor
25508016|NCT01476839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508017|NCT01476839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25508018|NCT01476839|Alkylating Agents|alkylating agents|mesh-ancestor
25508019|NCT01476839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25508020|NCT01388920|Tesamorelin|tesamorelin|mesh-list
25508021|NCT01388920|Growth Substances|growth substances|mesh-ancestor
25508022|NCT01388920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508023|NCT01164202|Sunitinib|sunitinib|mesh-list
25508024|NCT01164202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508025|NCT01164202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25508026|NCT01164202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25508027|NCT01164202|Growth Substances|growth substances|mesh-ancestor
25508028|NCT01164202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508029|NCT01164202|Growth Inhibitors|growth inhibitors|mesh-ancestor
25508030|NCT01164202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25508031|NCT01164202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508032|NCT01164202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508033|NCT01163357|Sirolimus|sirolimus|mesh-list
25508034|NCT01163357|Fludarabine|fludarabine|mesh-list
25508035|NCT01163357|Fludarabine phosphate|fludarabine phosphate|mesh-list
25508036|NCT01163357|Bortezomib|bortezomib|mesh-list
25508037|NCT01163357|Melphalan|melphalan|mesh-list
25508038|NCT01163357|Tacrolimus|tacrolimus|mesh-list
25508039|NCT01163357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508040|NCT01163357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25508041|NCT01163357|Antimetabolites|antimetabolites|mesh-ancestor
25508042|NCT01163357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508043|NCT01163357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25508044|NCT01163357|Immunologic Factors|immunologic factors|mesh-ancestor
25508045|NCT01163357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508046|NCT01163357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25508047|NCT01163357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508048|NCT01163357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25508049|NCT01163357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25508050|NCT01163357|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25508051|NCT01163357|Antifungal Agents|antifungal agents|mesh-ancestor
25508052|NCT01163357|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25508053|NCT01163357|Alkylating Agents|alkylating agents|mesh-ancestor
25508054|NCT01163357|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25508055|NCT01088789|Cyclophosphamide|cyclophosphamide|mesh-list
25508056|NCT01088789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25508057|NCT01088789|Immunologic Factors|immunologic factors|mesh-ancestor
25508058|NCT01088789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508059|NCT01088789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25508060|NCT01088789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25508061|NCT01088789|Alkylating Agents|alkylating agents|mesh-ancestor
25508062|NCT01088789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508063|NCT01088789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508064|NCT01088789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25508065|NCT00638898|Melphalan|melphalan|mesh-list
25508066|NCT00638898|Busulfan|busulfan|mesh-list
24795595|NCT01503632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795596|NCT01503632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24844839|NCT02234869|Interferons|interferons|mesh-list
25508067|NCT00638898|Topotecan|topotecan|mesh-list
25508094|NCT00577278|Antimetabolites|antimetabolites|mesh-ancestor
25508095|NCT00577278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508096|NCT00577278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25508097|NCT00577278|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25508098|NCT00577278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508099|NCT00577278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25508100|NCT00577278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25645897|NCT01452347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645898|NCT01452347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508101|NCT00577278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25508102|NCT00577278|Antifungal Agents|antifungal agents|mesh-ancestor
25508103|NCT00577278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25508104|NCT00577278|Alkylating Agents|alkylating agents|mesh-ancestor
25508105|NCT00577278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25823222|NCT00004770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823223|NCT00004770|Protective Agents|protective agents|mesh-ancestor
25125934|NCT03065998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25823224|NCT00004770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823225|NCT00004770|Vitamin B Complex|vitamin b complex|mesh-ancestor
25645899|NCT01452529|Hydrocodone|hydrocodone|mesh-list
25645900|NCT01452529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25645901|NCT01452529|Narcotics|narcotics|mesh-ancestor
25645902|NCT01452529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25645903|NCT01452529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645904|NCT01452529|Analgesics|analgesics|mesh-ancestor
25645905|NCT01452529|Sensory System Agents|sensory system agents|mesh-ancestor
25645906|NCT01452529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25645907|NCT01452529|Antitussive Agents|antitussive agents|mesh-ancestor
25823226|NCT00004770|Vitamins|vitamins|mesh-ancestor
25823227|NCT00004770|Micronutrients|micronutrients|mesh-ancestor
25823228|NCT00004771|Leuprolide|leuprolide|mesh-list
25823229|NCT00004771|Testosterone|testosterone|mesh-list
25823230|NCT00004771|Androgens|androgens|mesh-ancestor
25508108|NCT00576979|Etoposide phosphate|etoposide phosphate|mesh-list
25508109|NCT00576979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25508110|NCT00576979|Immunologic Factors|immunologic factors|mesh-ancestor
25508111|NCT00576979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508112|NCT00576979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25508113|NCT00576979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25508114|NCT00576979|Alkylating Agents|alkylating agents|mesh-ancestor
25508115|NCT00576979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508116|NCT00576979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508117|NCT00576979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25508118|NCT00576979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25508119|NCT00576979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25508120|NCT00576979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25508121|NCT00576979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508122|NCT00554840|Varenicline|varenicline|mesh-list
25508123|NCT00554840|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25508124|NCT00554840|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25508125|NCT00554840|Cholinergic Agents|cholinergic agents|mesh-ancestor
25508126|NCT00554840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25508127|NCT00554840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508128|NCT00554840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508129|NCT00538031|Celecoxib|celecoxib|mesh-list
25508130|NCT00538031|Cyclophosphamide|cyclophosphamide|mesh-list
25508131|NCT00538031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25508132|NCT00538031|Immunologic Factors|immunologic factors|mesh-ancestor
25508133|NCT00538031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508134|NCT00538031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25508135|NCT00538031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25508136|NCT00538031|Alkylating Agents|alkylating agents|mesh-ancestor
25508137|NCT00538031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508138|NCT00538031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508139|NCT00538031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25508140|NCT00538031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25508141|NCT00538031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25508142|NCT00538031|Analgesics|analgesics|mesh-ancestor
25508143|NCT00538031|Sensory System Agents|sensory system agents|mesh-ancestor
25508144|NCT00538031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25508145|NCT00538031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25508146|NCT00538031|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25508147|NCT00538031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24421914|NCT00220532|Vitamins|vitamins|mesh-ancestor
24695785|NCT01231906|Etoposide|etoposide|mesh-list
25823231|NCT00004771|Hormones|hormones|mesh-ancestor
25508148|NCT00538031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508149|NCT00003656|Interferons|interferons|mesh-list
24695786|NCT01231906|Vincristine|vincristine|mesh-list
25508150|NCT00003656|Interferon-alpha|interferon-alpha|mesh-list
25508151|NCT00003656|Tretinoin|tretinoin|mesh-list
25508152|NCT00003656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508153|NCT00003656|Antiviral Agents|antiviral agents|mesh-ancestor
25508154|NCT00003656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25508155|NCT00003656|Immunologic Factors|immunologic factors|mesh-ancestor
25508156|NCT00003656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508157|NCT00003656|Keratolytic Agents|keratolytic agents|mesh-ancestor
25508158|NCT00003656|Dermatologic Agents|dermatologic agents|mesh-ancestor
25508159|NCT00370396|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25508160|NCT00370396|Immunologic Factors|immunologic factors|mesh-ancestor
25508161|NCT00370396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508162|NCT00370552|Paclitaxel|paclitaxel|mesh-list
25508163|NCT00370552|Epothilones|epothilones|mesh-list
25508164|NCT00370552|Bevacizumab|bevacizumab|mesh-list
25508165|NCT00370552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25508166|NCT00370552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508167|NCT00370552|Tubulin Modulators|tubulin modulators|mesh-ancestor
25508168|NCT00370552|Antimitotic Agents|antimitotic agents|mesh-ancestor
25508169|NCT00370552|Mitosis Modulators|mitosis modulators|mesh-ancestor
25508170|NCT00370552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508171|NCT00370552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25508172|NCT00370552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25508173|NCT00370552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24980357|NCT05352321|Gemcitabine|gemcitabine|mesh-list
25106077|NCT04542135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106078|NCT04542135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25106079|NCT04542135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24980361|NCT05352321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508174|NCT00370552|Growth Substances|growth substances|mesh-ancestor
25508175|NCT00370552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508176|NCT00370552|Growth Inhibitors|growth inhibitors|mesh-ancestor
25508177|NCT00370682|Vaccines|vaccines|mesh-list
25508178|NCT00370682|Immunologic Factors|immunologic factors|mesh-ancestor
25508179|NCT00370682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508180|NCT00370838|Clonidine|clonidine|mesh-list
25508181|NCT00370838|Levetiracetam|levetiracetam|mesh-list
25508182|NCT00370838|Analgesics|analgesics|mesh-ancestor
25508183|NCT00370838|Sensory System Agents|sensory system agents|mesh-ancestor
25508184|NCT00370838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25508185|NCT00370838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508186|NCT00370838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25508187|NCT00370838|Sympatholytics|sympatholytics|mesh-ancestor
25508188|NCT00370838|Autonomic Agents|autonomic agents|mesh-ancestor
25508189|NCT00370838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25508190|NCT00370838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25508191|NCT00370838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25508192|NCT00370838|Adrenergic Agents|adrenergic agents|mesh-ancestor
25508193|NCT00370838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25508194|NCT00370838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508195|NCT00370838|Anticonvulsants|anticonvulsants|mesh-ancestor
25508196|NCT00370838|Nootropic Agents|nootropic agents|mesh-ancestor
25508197|NCT00371150|Entecavir|entecavir|mesh-list
25508198|NCT00371150|Antiviral Agents|antiviral agents|mesh-ancestor
25508199|NCT00371150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25508200|NCT00371176|Cycloserine|cycloserine|mesh-list
25508201|NCT00371176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25508202|NCT00371176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25508203|NCT00371176|Renal Agents|renal agents|mesh-ancestor
25508204|NCT00371176|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25508205|NCT00371176|Antitubercular Agents|antitubercular agents|mesh-ancestor
25508206|NCT00371176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25508207|NCT00371176|Antimetabolites|antimetabolites|mesh-ancestor
25508208|NCT00371176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508209|NCT00371254|Dasatinib|dasatinib|mesh-list
25508210|NCT00371254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508211|NCT00371254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25508212|NCT00371254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508213|NCT00371254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508214|NCT00371345|Dasatinib|dasatinib|mesh-list
25508215|NCT00371345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508216|NCT00371345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25508217|NCT00371345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508218|NCT00371345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508219|NCT00371566|Lapatinib|lapatinib|mesh-list
25508220|NCT00371566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508221|NCT00371566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25508222|NCT00371566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508223|NCT00371566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508224|NCT00371683|Enoxaparin|enoxaparin|mesh-list
25508225|NCT00371683|Apixaban|apixaban|mesh-list
25508226|NCT00371683|Anticoagulants|anticoagulants|mesh-ancestor
25508227|NCT00371683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25508228|NCT00371683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25508229|NCT00371683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508230|NCT00371683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25508231|NCT00371683|Antithrombins|antithrombins|mesh-ancestor
25508232|NCT00371683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25508233|NCT00371683|Protease Inhibitors|protease inhibitors|mesh-ancestor
25508234|NCT00371683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508235|NCT00371761|Interferons|interferons|mesh-list
25508236|NCT00371761|Interferon-alpha|interferon-alpha|mesh-list
25508237|NCT00371761|Interferon alpha-2|interferon alpha-2|mesh-list
25508238|NCT00371761|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25162273|NCT02906176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25162274|NCT02906176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25162275|NCT02906176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162276|NCT02906176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25162277|NCT02906176|Hormone Antagonists|hormone antagonists|mesh-ancestor
25162278|NCT02906176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24461150|NCT00351143|Xhance|xhance|mesh-list
25162279|NCT02906176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162280|NCT02906176|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25508239|NCT00371761|Adefovir|adefovir|mesh-list
25508240|NCT00371761|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25508242|NCT00371761|Antiviral Agents|antiviral agents|mesh-ancestor
25508243|NCT00371761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25508244|NCT00371761|Immunologic Factors|immunologic factors|mesh-ancestor
25508245|NCT00371761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508246|NCT00371761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25508247|NCT00371761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25508248|NCT00371761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508249|NCT00371761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508250|NCT00371826|Cyclosporine|cyclosporine|mesh-list
25508251|NCT00371826|Mycophenolic Acid|mycophenolic acid|mesh-list
25508252|NCT00371826|Prednisone|prednisone|mesh-list
25508253|NCT00371826|Everolimus|everolimus|mesh-list
25508254|NCT00371826|Cyclosporins|cyclosporins|mesh-list
25508255|NCT00371826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
25508256|NCT00371826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25508257|NCT00371826|Glucocorticoids|glucocorticoids|mesh-ancestor
25508258|NCT00371826|Hormones|hormones|mesh-ancestor
25508259|NCT00371826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25508260|NCT00371826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508261|NCT00371826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25508262|NCT00371826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508263|NCT00371826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508264|NCT00371826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508265|NCT00371826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25508266|NCT00371826|Immunologic Factors|immunologic factors|mesh-ancestor
25508267|NCT00371826|Antifungal Agents|antifungal agents|mesh-ancestor
25508268|NCT00371826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25508269|NCT00371826|Dermatologic Agents|dermatologic agents|mesh-ancestor
25508270|NCT00371826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25508271|NCT00371826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25508272|NCT00371826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25508273|NCT00371826|Antitubercular Agents|antitubercular agents|mesh-ancestor
25508274|NCT00371826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25508275|NCT00372060|Pioglitazone|pioglitazone|mesh-list
25508276|NCT00372060|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25508277|NCT00372060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25508278|NCT00372060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508279|NCT00372060|Incretins|incretins|mesh-ancestor
25508280|NCT00372060|Hormones|hormones|mesh-ancestor
25508281|NCT00372060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25508282|NCT00372060|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25508283|NCT00372060|Protease Inhibitors|protease inhibitors|mesh-ancestor
25508284|NCT00372060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508285|NCT00372060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508286|NCT00372385|Interferons|interferons|mesh-list
25508287|NCT00372385|Ribavirin|ribavirin|mesh-list
25645908|NCT01452529|Respiratory System Agents|respiratory system agents|mesh-ancestor
25645909|NCT01452789|Morphine|morphine|mesh-list
25645910|NCT01452789|Buprenorphine|buprenorphine|mesh-list
25645911|NCT01452789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25508288|NCT00372385|Interferon-alpha|interferon-alpha|mesh-list
25508289|NCT00372385|Interferon alpha-2|interferon alpha-2|mesh-list
25508290|NCT00372385|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25508291|NCT00372385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508292|NCT00372385|Antiviral Agents|antiviral agents|mesh-ancestor
25508293|NCT00372385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25508294|NCT00372385|Antimetabolites|antimetabolites|mesh-ancestor
25508295|NCT00372385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508296|NCT00372385|Immunologic Factors|immunologic factors|mesh-ancestor
25508297|NCT00372385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508298|NCT00372424|Docetaxel|docetaxel|mesh-list
25508299|NCT00372424|Trastuzumab|trastuzumab|mesh-list
25508300|NCT00372424|Sunitinib|sunitinib|mesh-list
25508301|NCT00372424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508302|NCT00372424|Tubulin Modulators|tubulin modulators|mesh-ancestor
25508303|NCT00372424|Antimitotic Agents|antimitotic agents|mesh-ancestor
25508304|NCT00372424|Mitosis Modulators|mitosis modulators|mesh-ancestor
25823232|NCT00004771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25823233|NCT00004771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823234|NCT00004771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25823235|NCT00004771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823236|NCT00004771|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25823237|NCT00004771|Fertility Agents|fertility agents|mesh-ancestor
24588980|NCT00905047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588981|NCT00905047|Vitamin B Complex|vitamin b complex|mesh-ancestor
24588982|NCT00905047|Vitamins|vitamins|mesh-ancestor
24588983|NCT00905047|Micronutrients|micronutrients|mesh-ancestor
24588984|NCT00905047|Hematinics|hematinics|mesh-ancestor
24918545|NCT04218500|Vitamins|vitamins|mesh-ancestor
25508305|NCT00372424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508306|NCT00372424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25508308|NCT00372424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25508309|NCT00372424|Growth Substances|growth substances|mesh-ancestor
25508310|NCT00372424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508311|NCT00372424|Growth Inhibitors|growth inhibitors|mesh-ancestor
25508312|NCT00372424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25508313|NCT00372424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508314|NCT00372528|Pregabalin|pregabalin|mesh-list
25508315|NCT00372528|Analgesics|analgesics|mesh-ancestor
25508316|NCT00372528|Sensory System Agents|sensory system agents|mesh-ancestor
25508317|NCT00372528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25508318|NCT00372528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508319|NCT00372528|Anticonvulsants|anticonvulsants|mesh-ancestor
25508320|NCT00372528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25508321|NCT00372528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25508322|NCT00372528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508323|NCT00372528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25508324|NCT00372528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25508325|NCT00372528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25508326|NCT00372528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25508327|NCT00372528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25508328|NCT00372567|Sunitinib|sunitinib|mesh-list
25508329|NCT00372567|Imatinib Mesylate|imatinib mesylate|mesh-list
25508330|NCT00372567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508331|NCT00372567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25508332|NCT00372567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25508333|NCT00372567|Growth Substances|growth substances|mesh-ancestor
25508334|NCT00372567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508335|NCT00372567|Growth Inhibitors|growth inhibitors|mesh-ancestor
25508336|NCT00372567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25508337|NCT00372567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508338|NCT00372567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508339|NCT00372593|Cytarabine|cytarabine|mesh-list
25508340|NCT00372593|Etoposide|etoposide|mesh-list
25508341|NCT00372593|Daunorubicin|daunorubicin|mesh-list
25508342|NCT00372593|Mitoxantrone|mitoxantrone|mesh-list
25508343|NCT00372593|Asparaginase|asparaginase|mesh-list
25508344|NCT00372593|Gemtuzumab|gemtuzumab|mesh-list
25508345|NCT00372593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25508346|NCT00372593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508347|NCT00372593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25508348|NCT00372593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25645912|NCT01452789|Narcotics|narcotics|mesh-ancestor
25508349|NCT00372593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645913|NCT01452789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25508350|NCT00372593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645914|NCT01452789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645915|NCT01452789|Analgesics|analgesics|mesh-ancestor
25508351|NCT00372593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25508352|NCT00372593|Antimetabolites|antimetabolites|mesh-ancestor
25508353|NCT00372593|Antiviral Agents|antiviral agents|mesh-ancestor
25508354|NCT00372593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25823238|NCT00004771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25823239|NCT00004772|Immunoglobulins|immunoglobulins|mesh-list
25823240|NCT00004772|Antibodies|antibodies|mesh-list
25823241|NCT00004772|gamma-Globulins|gamma-globulins|mesh-list
24443264|NCT00294359|Bevacizumab|bevacizumab|mesh-list
24956101|NCT03857581|Clozapine|clozapine|mesh-list
24980553|NCT05182073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980554|NCT05182073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25823242|NCT00004772|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25823243|NCT00004772|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25823244|NCT00004772|Immunologic Factors|immunologic factors|mesh-ancestor
25823245|NCT00004772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823246|NCT00004776|Topiramate|topiramate|mesh-list
25823247|NCT00004776|Anticonvulsants|anticonvulsants|mesh-ancestor
25823248|NCT00004776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25823249|NCT00004776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823250|NCT00004778|Dexamethasone|dexamethasone|mesh-list
25823251|NCT00004778|Betamethasone|betamethasone|mesh-list
25823252|NCT00004778|Hormones|hormones|mesh-list
25126268|NCT03063866|Analgesics|analgesics|mesh-ancestor
24443268|NCT00294359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24443269|NCT00294359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823253|NCT00004778|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
25823254|NCT00004778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25823255|NCT00004778|Antiemetics|antiemetics|mesh-ancestor
25508355|NCT00372593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25508356|NCT00372593|Immunologic Factors|immunologic factors|mesh-ancestor
25508357|NCT00372593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508358|NCT00372593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25508359|NCT00372593|Analgesics|analgesics|mesh-ancestor
25508360|NCT00372593|Sensory System Agents|sensory system agents|mesh-ancestor
25508361|NCT00372593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25508362|NCT00372593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25508364|NCT00372619|Methotrexate|methotrexate|mesh-list
25508365|NCT00372619|Clofarabine|clofarabine|mesh-list
25508366|NCT00372619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25508367|NCT00372619|Abortifacient Agents|abortifacient agents|mesh-ancestor
25508368|NCT00372619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25508369|NCT00372619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508370|NCT00372619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25508371|NCT00372619|Antimetabolites|antimetabolites|mesh-ancestor
25508372|NCT00372619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508373|NCT00372619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508374|NCT00372619|Dermatologic Agents|dermatologic agents|mesh-ancestor
25508375|NCT00372619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508376|NCT00372619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25508377|NCT00372619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25508378|NCT00372619|Immunologic Factors|immunologic factors|mesh-ancestor
25508379|NCT00372619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25508380|NCT00372619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25508381|NCT00372619|Antiviral Agents|antiviral agents|mesh-ancestor
25508382|NCT00372619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25508383|NCT00372697|Octreotide|octreotide|mesh-list
25508384|NCT00372697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25508385|NCT00372697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25508386|NCT00372697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508387|NCT00372775|Sunitinib|sunitinib|mesh-list
25508388|NCT00372775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508389|NCT00372775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25508390|NCT00372775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25508391|NCT00372775|Growth Substances|growth substances|mesh-ancestor
25508392|NCT00372775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508393|NCT00372775|Growth Inhibitors|growth inhibitors|mesh-ancestor
25508394|NCT00372775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25508395|NCT00372775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508396|NCT00372775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508397|NCT00372905|Rituximab|rituximab|mesh-list
25508398|NCT00372905|Bortezomib|bortezomib|mesh-list
25645916|NCT01452789|Sensory System Agents|sensory system agents|mesh-ancestor
25645917|NCT01452789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25645918|NCT01452789|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25645919|NCT01453023|Fluticasone|fluticasone|mesh-list
25645920|NCT01453023|Xhance|xhance|mesh-list
25645921|NCT01453023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25645922|NCT01453023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25645923|NCT01453023|Autonomic Agents|autonomic agents|mesh-ancestor
25508399|NCT00372905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25508400|NCT00372905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25508401|NCT00372905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508402|NCT00372905|Immunologic Factors|immunologic factors|mesh-ancestor
25508403|NCT00372905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508404|NCT00372905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25508405|NCT00372970|Botulinum Toxins|botulinum toxins|mesh-list
25508406|NCT00372970|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25508407|NCT00372970|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25508408|NCT00372970|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25508409|NCT00372970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25508410|NCT00372970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508411|NCT00372970|Cholinergic Agents|cholinergic agents|mesh-ancestor
25508412|NCT00372970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25508413|NCT00372970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508414|NCT00372970|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25508415|NCT00372970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25508416|NCT00372996|Fulvestrant|fulvestrant|mesh-list
25508417|NCT00372996|Exemestane|exemestane|mesh-list
25508418|NCT00372996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25508419|NCT00372996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980659|NCT05030129|Vitamin B 6|vitamin b 6|mesh-list
24980660|NCT05030129|Pyridoxal|pyridoxal|mesh-list
24980661|NCT05030129|Pyridoxine|pyridoxine|mesh-list
24980662|NCT05030129|Ergoloid Mesylates|ergoloid mesylates|mesh-list
24980663|NCT05030129|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
24980664|NCT05030129|Dihydroergotoxine|dihydroergotoxine|mesh-list
24980665|NCT05030129|Vitamins|vitamins|mesh-ancestor
24980666|NCT05030129|Micronutrients|micronutrients|mesh-ancestor
24980667|NCT05030129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980668|NCT05030129|Vitamin B Complex|vitamin b complex|mesh-ancestor
25162298|NCT02905890|Norethindrone Acetate|norethindrone acetate|mesh-list
25508420|NCT00372996|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25508421|NCT00372996|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25508422|NCT00372996|Hormone Antagonists|hormone antagonists|mesh-ancestor
25508423|NCT00372996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25508424|NCT00372996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508425|NCT00372996|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25508426|NCT00372996|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25508427|NCT00372996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508428|NCT00372996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508429|NCT00373113|Capecitabine|capecitabine|mesh-list
25508430|NCT00373113|Sunitinib|sunitinib|mesh-list
25508431|NCT00373113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25508432|NCT00373113|Antimetabolites|antimetabolites|mesh-ancestor
25508433|NCT00373113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508434|NCT00373113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508435|NCT00373113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25508436|NCT00373113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25508437|NCT00373113|Growth Substances|growth substances|mesh-ancestor
25508438|NCT00373113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508439|NCT00373113|Growth Inhibitors|growth inhibitors|mesh-ancestor
25508440|NCT00373113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25508441|NCT00373113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508442|NCT00373256|Paclitaxel|paclitaxel|mesh-list
25508443|NCT00373256|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25508444|NCT00373256|Bevacizumab|bevacizumab|mesh-list
25508445|NCT00373256|Sunitinib|sunitinib|mesh-list
25508446|NCT00373256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25508447|NCT00373256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508448|NCT00373256|Tubulin Modulators|tubulin modulators|mesh-ancestor
25508449|NCT00373256|Antimitotic Agents|antimitotic agents|mesh-ancestor
25508450|NCT00373256|Mitosis Modulators|mitosis modulators|mesh-ancestor
25508451|NCT00373256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508452|NCT00373256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25508453|NCT00373256|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25508454|NCT00373256|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25508455|NCT00373256|Growth Substances|growth substances|mesh-ancestor
25645924|NCT01453023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25823256|NCT00004778|Autonomic Agents|autonomic agents|mesh-ancestor
25508456|NCT00373256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508457|NCT00373256|Growth Inhibitors|growth inhibitors|mesh-ancestor
25508458|NCT00373256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25508459|NCT00373256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508460|NCT00373295|Baclofen|baclofen|mesh-list
25508461|NCT00373295|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25508462|NCT00373295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508463|NCT00373295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25508464|NCT00373295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25508465|NCT00373295|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25508466|NCT00373295|GABA Agonists|gaba agonists|mesh-ancestor
25508467|NCT00373295|GABA Agents|gaba agents|mesh-ancestor
25508468|NCT00373295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25508469|NCT00373295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508470|NCT00373334|Nizatidine|nizatidine|mesh-list
25508471|NCT00373334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25508472|NCT00373334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25508473|NCT00373334|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25508474|NCT00373334|Histamine Antagonists|histamine antagonists|mesh-ancestor
25508475|NCT00373334|Histamine Agents|histamine agents|mesh-ancestor
25508476|NCT00373334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25508477|NCT00373334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508478|NCT00373334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508479|NCT00373360|Treprostinil|treprostinil|mesh-list
25508480|NCT00373360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25508481|NCT00373386|Hormones|hormones|mesh-list
25508482|NCT00373386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25508483|NCT00373386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508484|NCT00373399|Dronabinol|dronabinol|mesh-list
25508485|NCT00373399|Hallucinogens|hallucinogens|mesh-ancestor
25508486|NCT00373399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508487|NCT00373399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25823257|NCT00004778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25823258|NCT00004778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823259|NCT00004778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25823260|NCT00004778|Glucocorticoids|glucocorticoids|mesh-ancestor
25829465|NCT00006212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508488|NCT00373399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25508489|NCT00373399|Analgesics|analgesics|mesh-ancestor
25508490|NCT00373399|Sensory System Agents|sensory system agents|mesh-ancestor
25508491|NCT00373399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25508492|NCT00373399|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25508493|NCT00373399|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25508494|NCT00373399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25508495|NCT00373399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508496|NCT00373399|Hormones|hormones|mesh-ancestor
25508497|NCT00373399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25508498|NCT00373425|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25508499|NCT00373425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508500|NCT00373425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25508501|NCT00373425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508502|NCT00373425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508503|NCT00373490|Vorinostat|vorinostat|mesh-list
25508504|NCT00373490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508505|NCT00373490|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25508506|NCT00373490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508507|NCT00373490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508508|NCT00373529|Clofarabine|clofarabine|mesh-list
25508509|NCT00373529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25508510|NCT00373529|Antimetabolites|antimetabolites|mesh-ancestor
25508511|NCT00373529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508512|NCT00373529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508513|NCT00373685|Celecoxib|celecoxib|mesh-list
25508514|NCT00373685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25508515|NCT00373685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25508516|NCT00373685|Analgesics|analgesics|mesh-ancestor
25508517|NCT00373685|Sensory System Agents|sensory system agents|mesh-ancestor
25508518|NCT00373685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25508519|NCT00373685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508520|NCT00373685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24696680|NCT01431053|Analgesics|analgesics|mesh-ancestor
25508521|NCT00373685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25508522|NCT00373685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25508523|NCT00373685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25508524|NCT00373685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508525|NCT00373685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508526|NCT00373880|Cocaine|cocaine|mesh-list
25508527|NCT00373880|Aripiprazole|aripiprazole|mesh-list
25508528|NCT00373880|Antidepressive Agents|antidepressive agents|mesh-ancestor
25508529|NCT00373880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25508530|NCT00373880|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25508531|NCT00373880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25508532|NCT00373880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25508533|NCT00373880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508534|NCT00373880|Dopamine Agonists|dopamine agonists|mesh-ancestor
25508535|NCT00373880|Dopamine Agents|dopamine agents|mesh-ancestor
25508536|NCT00373880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25508537|NCT00373880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508538|NCT00373880|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25508539|NCT00373880|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25508540|NCT00373880|Serotonin Agents|serotonin agents|mesh-ancestor
25508541|NCT00373880|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25508542|NCT00373880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25508543|NCT00373880|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25508544|NCT00373880|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25508545|NCT00373880|Anesthetics, Local|anesthetics, local|mesh-ancestor
25508546|NCT00373880|Anesthetics|anesthetics|mesh-ancestor
25162300|NCT02905890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25162301|NCT02905890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25823261|NCT00004778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24980721|NCT04992260|Immunologic Factors|immunologic factors|mesh-ancestor
24980722|NCT04992260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980723|NCT04984278|Nabiximols|nabiximols|mesh-list
24980724|NCT04984278|Analgesics|analgesics|mesh-ancestor
25126495|NCT03062163|Vitamins|vitamins|mesh-ancestor
24980725|NCT04984278|Sensory System Agents|sensory system agents|mesh-ancestor
24980726|NCT04984278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24980727|NCT04984278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980728|NCT04969705|Dexmedetomidine|dexmedetomidine|mesh-list
24980729|NCT04969705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24980730|NCT04969705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25508547|NCT00373880|Sensory System Agents|sensory system agents|mesh-ancestor
25508548|NCT00373880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25508549|NCT00373880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25508550|NCT00373880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25508551|NCT00373880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25508552|NCT00373880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25508553|NCT00373958|Vaccines|vaccines|mesh-list
25508554|NCT00373958|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25508555|NCT00373958|Immunologic Factors|immunologic factors|mesh-ancestor
25508556|NCT00373958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508557|NCT00374088|Acetylcysteine|acetylcysteine|mesh-list
25508558|NCT00374088|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25508559|NCT00374088|Antiviral Agents|antiviral agents|mesh-ancestor
25508560|NCT00374088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25508561|NCT00374088|Expectorants|expectorants|mesh-ancestor
25508562|NCT00374088|Respiratory System Agents|respiratory system agents|mesh-ancestor
25508563|NCT00374088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25508564|NCT00374088|Antioxidants|antioxidants|mesh-ancestor
25508565|NCT00374088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508566|NCT00374088|Protective Agents|protective agents|mesh-ancestor
25508567|NCT00374088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508568|NCT00374088|Antidotes|antidotes|mesh-ancestor
25508569|NCT00374140|Everolimus|everolimus|mesh-list
25508570|NCT00374140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508571|NCT00374140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25508572|NCT00374140|Immunologic Factors|immunologic factors|mesh-ancestor
25508573|NCT00374140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508574|NCT00374231|Mycophenolic Acid|mycophenolic acid|mesh-list
25508575|NCT00374231|Prednisone|prednisone|mesh-list
25508576|NCT00374231|Tacrolimus|tacrolimus|mesh-list
25508577|NCT00374231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25508578|NCT00374231|Glucocorticoids|glucocorticoids|mesh-ancestor
25508579|NCT00374231|Hormones|hormones|mesh-ancestor
25508580|NCT00374231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25508581|NCT00374231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508582|NCT00374231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25508583|NCT00374231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508584|NCT00374231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25508585|NCT00374231|Immunologic Factors|immunologic factors|mesh-ancestor
25508586|NCT00374231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25508587|NCT00374231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508588|NCT00374231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508589|NCT00374231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25508590|NCT00374231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25508591|NCT00374231|Antitubercular Agents|antitubercular agents|mesh-ancestor
25508592|NCT00374231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25508593|NCT00374231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25508594|NCT00374244|Pimozide|pimozide|mesh-list
25508595|NCT00374244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25508596|NCT00374244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25508597|NCT00374244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25508598|NCT00374244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508599|NCT00374244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25508600|NCT00374244|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25508601|NCT00374244|Dopamine Agents|dopamine agents|mesh-ancestor
25508602|NCT00374244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25508603|NCT00374244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508604|NCT00374244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25508605|NCT00374322|Lapatinib|lapatinib|mesh-list
25508606|NCT00374322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508607|NCT00374322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25508608|NCT00374322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508609|NCT00374322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508610|NCT00374556|Eszopiclone|eszopiclone|mesh-list
25508611|NCT00374556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25508612|NCT00374556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25508613|NCT00374556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162303|NCT02905890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25041127|NCT02636582|Molgramostim|molgramostim|mesh-list
25041128|NCT02636582|Vaccines|vaccines|mesh-list
25041129|NCT02636582|Sargramostim|sargramostim|mesh-list
25041130|NCT02636582|Immunologic Factors|immunologic factors|mesh-ancestor
25041131|NCT02636582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041132|NCT02636582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25126578|NCT03061006|Dabigatran|dabigatran|mesh-list
25508614|NCT00374803|Mycophenolic Acid|mycophenolic acid|mesh-list
25508615|NCT00374803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25508616|NCT00374803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508617|NCT00374803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25508618|NCT00374803|Antitubercular Agents|antitubercular agents|mesh-ancestor
25508619|NCT00374803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25508620|NCT00374803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25508621|NCT00374803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508622|NCT00374803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508623|NCT00374868|Cisplatin|cisplatin|mesh-list
25508624|NCT00374868|Pemetrexed|pemetrexed|mesh-list
25508625|NCT00374868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508626|NCT00374868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508627|NCT00374868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508628|NCT00374868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25508629|NCT00374868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25508630|NCT00374907|Metformin|metformin|mesh-list
25508631|NCT00374907|Saxagliptin|saxagliptin|mesh-list
25508632|NCT00374907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25508633|NCT00374907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508634|NCT00374907|Incretins|incretins|mesh-ancestor
25508635|NCT00374907|Hormones|hormones|mesh-ancestor
25508636|NCT00374907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25508637|NCT00374907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25508638|NCT00374907|Protease Inhibitors|protease inhibitors|mesh-ancestor
25508639|NCT00374907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508640|NCT00374907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508641|NCT00375219|Homoharringtonine|homoharringtonine|mesh-list
25508642|NCT00375219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25508643|NCT00375219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508644|NCT00375219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25508645|NCT00375219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508646|NCT00375219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645925|NCT01453023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508647|NCT00375427|Zoledronic Acid|zoledronic acid|mesh-list
25508648|NCT00375427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25508649|NCT00375427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508650|NCT00375492|Exenatide|exenatide|mesh-list
25508651|NCT00375492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24964418|NCT03783312|Ibuprofen|ibuprofen|mesh-list
25508652|NCT00375492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508653|NCT00375492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25508654|NCT00375492|Incretins|incretins|mesh-ancestor
25508655|NCT00375492|Hormones|hormones|mesh-ancestor
25508656|NCT00375492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25508657|NCT00375505|Zoledronic Acid|zoledronic acid|mesh-list
25508658|NCT00375505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25508659|NCT00375505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508660|NCT00375518|Atorvastatin|atorvastatin|mesh-list
25508661|NCT00375518|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25508662|NCT00375518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25508663|NCT00375518|Antimetabolites|antimetabolites|mesh-ancestor
25508664|NCT00375518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508665|NCT00375518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25508666|NCT00375518|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25508667|NCT00375518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508668|NCT00375609|Enoxaparin|enoxaparin|mesh-list
25508669|NCT00375609|Betrixaban|betrixaban|mesh-list
25508670|NCT00375609|Anticoagulants|anticoagulants|mesh-ancestor
25508671|NCT00375609|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25508672|NCT00375609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25508673|NCT00375609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508674|NCT00375609|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25508675|NCT00375609|Antithrombins|antithrombins|mesh-ancestor
25508676|NCT00375609|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24980761|NCT04958486|Trastuzumab|trastuzumab|mesh-list
24980762|NCT04958486|Azacitidine|azacitidine|mesh-list
25823262|NCT00004778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24845825|NCT02239484|Tadalafil|tadalafil|mesh-list
24980763|NCT04958486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24980765|NCT04958486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24980766|NCT04958486|Antimetabolites|antimetabolites|mesh-ancestor
24980767|NCT04958486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980768|NCT04958486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24980769|NCT04945616|Aspirin|aspirin|mesh-list
24980770|NCT04945616|Clopidogrel|clopidogrel|mesh-list
25508678|NCT00375609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508679|NCT00375674|Sunitinib|sunitinib|mesh-list
25508680|NCT00375674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508681|NCT00375674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25508682|NCT00375674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25508683|NCT00375674|Growth Substances|growth substances|mesh-ancestor
25508684|NCT00375674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508685|NCT00375674|Growth Inhibitors|growth inhibitors|mesh-ancestor
25508686|NCT00375674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25508687|NCT00375674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508688|NCT00375674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508689|NCT00375713|Cetirizine|cetirizine|mesh-list
25508690|NCT00375713|Hydrocortisone|hydrocortisone|mesh-list
25508691|NCT00375713|Levocetirizine|levocetirizine|mesh-list
25508692|NCT00375713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25508693|NCT00375713|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25508694|NCT00375713|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25508695|NCT00375713|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25508696|NCT00375713|Histamine Antagonists|histamine antagonists|mesh-ancestor
25508697|NCT00375713|Histamine Agents|histamine agents|mesh-ancestor
25508698|NCT00375713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25508699|NCT00375713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508700|NCT00375713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508701|NCT00375752|Letrozole|letrozole|mesh-list
25508702|NCT00375752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508703|NCT00375752|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25508704|NCT00375752|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25508705|NCT00375752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508706|NCT00375752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508707|NCT00375752|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25508708|NCT00375752|Hormone Antagonists|hormone antagonists|mesh-ancestor
25508709|NCT00375752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25508710|NCT00375752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508711|NCT00375830|Diphosphonates|diphosphonates|mesh-list
25508712|NCT00375830|Methylene diphosphonate|methylene diphosphonate|mesh-list
25508714|NCT00375830|Deoxyglucose|deoxyglucose|mesh-list
25508715|NCT00375830|Fluorides|fluorides|mesh-list
25508716|NCT00375830|Sodium Fluoride|sodium fluoride|mesh-list
25508717|NCT00375830|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25508718|NCT00375830|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
25508719|NCT00375830|Cariostatic Agents|cariostatic agents|mesh-ancestor
25508720|NCT00375830|Protective Agents|protective agents|mesh-ancestor
25508721|NCT00375830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508722|NCT00375830|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25508723|NCT00375830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508724|NCT00375830|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25508725|NCT00375830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25508726|NCT00375830|Antimetabolites|antimetabolites|mesh-ancestor
25508727|NCT00375830|Antiviral Agents|antiviral agents|mesh-ancestor
25508728|NCT00375830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25508729|NCT00375934|Diclofenac|diclofenac|mesh-list
25508730|NCT00375934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25508731|NCT00375934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25508732|NCT00375934|Analgesics|analgesics|mesh-ancestor
25508733|NCT00375934|Sensory System Agents|sensory system agents|mesh-ancestor
25508734|NCT00375934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25508735|NCT00375934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508736|NCT00375934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25508737|NCT00375934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25508738|NCT00375934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25508739|NCT00375934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508740|NCT00375934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508741|NCT00375973|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25508742|NCT00375973|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25508743|NCT00375973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25508744|NCT00375973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25508745|NCT00375973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508746|NCT00375973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25508747|NCT00375973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508748|NCT00375973|Analgesics|analgesics|mesh-ancestor
25508749|NCT00375973|Sensory System Agents|sensory system agents|mesh-ancestor
25508773|NCT00376220|Protective Agents|protective agents|mesh-ancestor
25508774|NCT00376246|Ezetimibe|ezetimibe|mesh-list
25508775|NCT00376246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25508776|NCT00376246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25508777|NCT00376246|Antimetabolites|antimetabolites|mesh-ancestor
25508778|NCT00376246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508779|NCT00376246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25508780|NCT00376259|Adefovir|adefovir|mesh-list
25508781|NCT00376259|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25508782|NCT00376259|Telbivudine|telbivudine|mesh-list
25508783|NCT00376259|Antiviral Agents|antiviral agents|mesh-ancestor
25508784|NCT00376259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25508785|NCT00376259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25508786|NCT00376259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25508787|NCT00376259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508788|NCT00376259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823263|NCT00004778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823264|NCT00004778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25823265|NCT00004778|Respiratory System Agents|respiratory system agents|mesh-ancestor
25823266|NCT00004784|Methotrexate|methotrexate|mesh-list
25823267|NCT00004784|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25823268|NCT00004784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25823269|NCT00004784|Abortifacient Agents|abortifacient agents|mesh-ancestor
25823270|NCT00004784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25823271|NCT00004784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783986|NCT01905150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24783988|NCT01905150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783990|NCT01905150|Antiviral Agents|antiviral agents|mesh-ancestor
25508793|NCT00376675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25508794|NCT00376675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25508795|NCT00376675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508796|NCT00376675|Dopamine Agents|dopamine agents|mesh-ancestor
25508797|NCT00376675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25508798|NCT00376688|Sirolimus|sirolimus|mesh-list
25508799|NCT00376688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25508800|NCT00376688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25508801|NCT00376688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25508802|NCT00376688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508803|NCT00376688|Antifungal Agents|antifungal agents|mesh-ancestor
24495712|NCT00501618|GABA Agents|gaba agents|mesh-ancestor
25508804|NCT00376688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25508805|NCT00376688|Immunologic Factors|immunologic factors|mesh-ancestor
25508806|NCT00376688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508807|NCT00376805|Cyclophosphamide|cyclophosphamide|mesh-list
25508808|NCT00376805|Fludarabine|fludarabine|mesh-list
25508809|NCT00376805|Interleukin-2|interleukin-2|mesh-list
25508810|NCT00376805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25508811|NCT00376805|Immunologic Factors|immunologic factors|mesh-ancestor
25508812|NCT00376805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508813|NCT00376805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25508814|NCT00376805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25508815|NCT00376805|Alkylating Agents|alkylating agents|mesh-ancestor
25508816|NCT00376805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508817|NCT00376805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508818|NCT00376805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25508819|NCT00376805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25508820|NCT00376805|Analgesics|analgesics|mesh-ancestor
25508821|NCT00376805|Sensory System Agents|sensory system agents|mesh-ancestor
25508822|NCT00376805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25508823|NCT00376948|Gemcitabine|gemcitabine|mesh-list
25508824|NCT00376948|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25508825|NCT00376948|Genistein|genistein|mesh-list
25508826|NCT00376948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25508827|NCT00376948|Antimetabolites|antimetabolites|mesh-ancestor
25508828|NCT00376948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508829|NCT00376948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508830|NCT00376948|Antiviral Agents|antiviral agents|mesh-ancestor
25508831|NCT00376948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25508832|NCT00376948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508833|NCT00376948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25508834|NCT00376948|Immunologic Factors|immunologic factors|mesh-ancestor
25508835|NCT00376948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508836|NCT00376948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25508837|NCT00376948|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25508838|NCT00376948|Protective Agents|protective agents|mesh-ancestor
25508839|NCT00376948|Phytoestrogens|phytoestrogens|mesh-ancestor
25508840|NCT00376948|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25508841|NCT00376948|Estrogens|estrogens|mesh-ancestor
25508842|NCT00376948|Hormones|hormones|mesh-ancestor
25508843|NCT00376948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25508844|NCT00376961|Prednisone|prednisone|mesh-list
25508845|NCT00376961|Cyclophosphamide|cyclophosphamide|mesh-list
25508846|NCT00376961|Rituximab|rituximab|mesh-list
25508847|NCT00376961|Doxorubicin|doxorubicin|mesh-list
25508848|NCT00376961|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25508849|NCT00376961|Vincristine|vincristine|mesh-list
25508850|NCT00376961|Bortezomib|bortezomib|mesh-list
25508851|NCT00376961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25508852|NCT00376961|Immunologic Factors|immunologic factors|mesh-ancestor
25508853|NCT00376961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508854|NCT00376961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25823272|NCT00004784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25823273|NCT00004784|Antimetabolites|antimetabolites|mesh-ancestor
25823274|NCT00004784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476795|NCT00416533|Docetaxel|docetaxel|mesh-list
24459050|NCT00343408|Antidotes|antidotes|mesh-ancestor
25823275|NCT00004784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508855|NCT00376961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25508856|NCT00376961|Alkylating Agents|alkylating agents|mesh-ancestor
25508857|NCT00376961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508858|NCT00376961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508859|NCT00376961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25508860|NCT00376961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25508861|NCT00376961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25508862|NCT00376961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25508863|NCT00376961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25508864|NCT00376961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508865|NCT00376961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25508866|NCT00376961|Glucocorticoids|glucocorticoids|mesh-ancestor
25508867|NCT00376961|Hormones|hormones|mesh-ancestor
25508868|NCT00376961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25508869|NCT00376961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25508870|NCT00376961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25508871|NCT00376961|Tubulin Modulators|tubulin modulators|mesh-ancestor
25508872|NCT00376961|Antimitotic Agents|antimitotic agents|mesh-ancestor
25508873|NCT00376961|Mitosis Modulators|mitosis modulators|mesh-ancestor
25508874|NCT00377234|Risedronic Acid|risedronic acid|mesh-list
25508875|NCT00377234|Ibandronic Acid|ibandronic acid|mesh-list
25508876|NCT00377234|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25508877|NCT00377234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25508878|NCT00377234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508879|NCT00377234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25508880|NCT00377234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508881|NCT00377234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25508882|NCT00377260|Amoxicillin|amoxicillin|mesh-list
25508883|NCT00377260|Clavulanic Acid|clavulanic acid|mesh-list
25508884|NCT00377260|Clavulanic Acids|clavulanic acids|mesh-list
25508885|NCT00377260|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25508886|NCT00377260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25508887|NCT00377260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25508888|NCT00377260|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25508889|NCT00377260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508890|NCT00377260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508891|NCT00377299|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
25508892|NCT00377299|Nootropic Agents|nootropic agents|mesh-ancestor
25508893|NCT00377312|Hormones|hormones|mesh-list
25508894|NCT00377312|Parathyroid Hormone|parathyroid hormone|mesh-list
25508895|NCT00377312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25508896|NCT00377312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508897|NCT00377312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25508898|NCT00377364|Acetaminophen|acetaminophen|mesh-list
25508899|NCT00377364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25508900|NCT00377364|Analgesics|analgesics|mesh-ancestor
25508901|NCT00377364|Sensory System Agents|sensory system agents|mesh-ancestor
25508902|NCT00377364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25508903|NCT00377364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508904|NCT00377364|Antipyretics|antipyretics|mesh-ancestor
25508905|NCT00377403|Acetaminophen|acetaminophen|mesh-list
25508906|NCT00377403|Amoxicillin|amoxicillin|mesh-list
25508907|NCT00377403|Phenylpropanolamine|phenylpropanolamine|mesh-list
25508908|NCT00377403|Pseudoephedrine|pseudoephedrine|mesh-list
25508909|NCT00377403|Ephedrine|ephedrine|mesh-list
25508910|NCT00377403|Dextromethorphan|dextromethorphan|mesh-list
25508911|NCT00377403|Guaifenesin|guaifenesin|mesh-list
25508912|NCT00377403|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
25508913|NCT00377403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25508914|NCT00377403|Analgesics|analgesics|mesh-ancestor
25508915|NCT00377403|Sensory System Agents|sensory system agents|mesh-ancestor
25508916|NCT00377403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25508917|NCT00377403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508918|NCT00377403|Antipyretics|antipyretics|mesh-ancestor
25508919|NCT00377403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25508920|NCT00377403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24980941|NCT04739358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980942|NCT04729608|Paclitaxel|paclitaxel|mesh-list
24980943|NCT04729608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24980944|NCT04729608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980945|NCT04729608|Tubulin Modulators|tubulin modulators|mesh-ancestor
24980946|NCT04729608|Antimitotic Agents|antimitotic agents|mesh-ancestor
25823276|NCT00004784|Dermatologic Agents|dermatologic agents|mesh-ancestor
25823277|NCT00004784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508921|NCT00377403|Antitussive Agents|antitussive agents|mesh-ancestor
25508922|NCT00377403|Respiratory System Agents|respiratory system agents|mesh-ancestor
25508923|NCT00377403|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25508924|NCT00377403|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25508925|NCT00377403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25508926|NCT00377403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508927|NCT00377403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25508928|NCT00377403|Autonomic Agents|autonomic agents|mesh-ancestor
25508929|NCT00377403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25508930|NCT00377403|Nasal Decongestants|nasal decongestants|mesh-ancestor
25508931|NCT00377403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25508932|NCT00377403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25508933|NCT00377403|Sympathomimetics|sympathomimetics|mesh-ancestor
25508934|NCT00377403|Adrenergic Agents|adrenergic agents|mesh-ancestor
25508936|NCT00377403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25508937|NCT00377403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25645926|NCT01453023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25645927|NCT01453023|Respiratory System Agents|respiratory system agents|mesh-ancestor
25508938|NCT00377403|Appetite Depressants|appetite depressants|mesh-ancestor
25508939|NCT00377403|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25508940|NCT00377429|Catumaxomab|catumaxomab|mesh-list
25508941|NCT00377429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25508943|NCT00377520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508944|NCT00377520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508945|NCT00377520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508946|NCT00377520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25508947|NCT00377520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25508948|NCT00377572|Omalizumab|omalizumab|mesh-list
25508949|NCT00377572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25508950|NCT00377572|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25508951|NCT00377572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25508952|NCT00377572|Respiratory System Agents|respiratory system agents|mesh-ancestor
25508953|NCT00377572|Immunologic Factors|immunologic factors|mesh-ancestor
25508954|NCT00377572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508955|NCT00377637|Mycophenolic Acid|mycophenolic acid|mesh-list
25508956|NCT00377637|Cyclophosphamide|cyclophosphamide|mesh-list
25508957|NCT00377637|Azathioprine|azathioprine|mesh-list
25508958|NCT00377637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25508959|NCT00377637|Immunologic Factors|immunologic factors|mesh-ancestor
25508960|NCT00377637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508961|NCT00377637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25508962|NCT00377637|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25508963|NCT00377637|Alkylating Agents|alkylating agents|mesh-ancestor
25508964|NCT00377637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508965|NCT00377637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25508966|NCT00377637|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25508967|NCT00377637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25508968|NCT00377637|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25508969|NCT00377637|Antitubercular Agents|antitubercular agents|mesh-ancestor
25508970|NCT00377637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25508971|NCT00377637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25508972|NCT00377637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25508973|NCT00377637|Antimetabolites|antimetabolites|mesh-ancestor
25508974|NCT00377637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25508975|NCT00377676|Bromocriptine|bromocriptine|mesh-list
25508976|NCT00377676|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25508977|NCT00377676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25508978|NCT00377676|Hormone Antagonists|hormone antagonists|mesh-ancestor
25508979|NCT00377676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25508980|NCT00377676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508981|NCT00377676|Dopamine Agonists|dopamine agonists|mesh-ancestor
25508982|NCT00377676|Dopamine Agents|dopamine agents|mesh-ancestor
25508983|NCT00377676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24981023|NCT04551144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24981024|NCT04551144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24981025|NCT04551144|Androgens|androgens|mesh-ancestor
24981026|NCT04551144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24981027|NCT04551144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24981028|NCT04551144|Anabolic Agents|anabolic agents|mesh-ancestor
24981029|NCT04534881|Progesterone|progesterone|mesh-list
24981030|NCT04534881|Progestins|progestins|mesh-ancestor
24981031|NCT04534881|Hormones|hormones|mesh-ancestor
25508984|NCT00377676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25508985|NCT00377741|Valganciclovir|valganciclovir|mesh-list
25508986|NCT00377741|Antiviral Agents|antiviral agents|mesh-ancestor
25508988|NCT00377819|Denosumab|denosumab|mesh-list
25508989|NCT00377819|Alendronate|alendronate|mesh-list
25508990|NCT00377819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25508991|NCT00377819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508992|NCT00377832|Acetaminophen|acetaminophen|mesh-list
25508993|NCT00377832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25508994|NCT00377832|Analgesics|analgesics|mesh-ancestor
25508995|NCT00377832|Sensory System Agents|sensory system agents|mesh-ancestor
25508996|NCT00377832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25508997|NCT00377832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25508998|NCT00377832|Antipyretics|antipyretics|mesh-ancestor
25508999|NCT00377858|Insulin|insulin|mesh-list
25509000|NCT00377858|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25509001|NCT00377858|Insulin Glargine|insulin glargine|mesh-list
25509002|NCT00377858|Insulin Lispro|insulin lispro|mesh-list
25509003|NCT00377858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25645928|NCT01453023|Dermatologic Agents|dermatologic agents|mesh-ancestor
25509004|NCT00377858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509005|NCT00377962|Mycophenolic Acid|mycophenolic acid|mesh-list
25509007|NCT00377962|Azathioprine|azathioprine|mesh-list
25509008|NCT00377962|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
25509009|NCT00377962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509010|NCT00377962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25509011|NCT00377962|Immunologic Factors|immunologic factors|mesh-ancestor
25509012|NCT00377962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509013|NCT00377962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509014|NCT00377962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509015|NCT00377962|Antimetabolites|antimetabolites|mesh-ancestor
25509016|NCT00377962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25509017|NCT00377962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25509018|NCT00377962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25509019|NCT00377962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25509020|NCT00377962|Antitubercular Agents|antitubercular agents|mesh-ancestor
25509021|NCT00377962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25509022|NCT00377962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25509023|NCT00378014|Everolimus|everolimus|mesh-list
25509024|NCT00378014|Basiliximab|basiliximab|mesh-list
25509025|NCT00378014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509026|NCT00378014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25509027|NCT00378014|Immunologic Factors|immunologic factors|mesh-ancestor
25509028|NCT00378014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509029|NCT00378079|Methadone|methadone|mesh-list
25509030|NCT00378079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25509031|NCT00378079|Narcotics|narcotics|mesh-ancestor
25509032|NCT00378079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25509033|NCT00378079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509034|NCT00378079|Analgesics|analgesics|mesh-ancestor
25509035|NCT00378079|Sensory System Agents|sensory system agents|mesh-ancestor
25509036|NCT00378079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25509037|NCT00378079|Antitussive Agents|antitussive agents|mesh-ancestor
25509038|NCT00378079|Respiratory System Agents|respiratory system agents|mesh-ancestor
25509039|NCT00378105|Dexamethasone|dexamethasone|mesh-list
25509040|NCT00378105|Lenalidomide|lenalidomide|mesh-list
25509041|NCT00378105|Bortezomib|bortezomib|mesh-list
25509042|NCT00378105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25509043|NCT00378105|Antiemetics|antiemetics|mesh-ancestor
25509044|NCT00378105|Autonomic Agents|autonomic agents|mesh-ancestor
25509045|NCT00378105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25509046|NCT00378105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509047|NCT00378105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24981084|NCT04483115|Tadalafil|tadalafil|mesh-list
24981085|NCT04483115|Vasodilator Agents|vasodilator agents|mesh-ancestor
24981086|NCT04483115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24981087|NCT04483115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24981088|NCT04483115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24981089|NCT04483115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823278|NCT00004784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25823279|NCT00004784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25823280|NCT00004784|Immunologic Factors|immunologic factors|mesh-ancestor
25823281|NCT00004784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25823282|NCT00004784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25823283|NCT00004784|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25823284|NCT00004784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25823285|NCT00004785|Dexamethasone|dexamethasone|mesh-list
25509048|NCT00378105|Glucocorticoids|glucocorticoids|mesh-ancestor
25509049|NCT00378105|Hormones|hormones|mesh-ancestor
25509050|NCT00378105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25509051|NCT00378105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25509052|NCT00378105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509053|NCT00378105|Immunologic Factors|immunologic factors|mesh-ancestor
25509054|NCT00378105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25509055|NCT00378105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25509056|NCT00378105|Growth Substances|growth substances|mesh-ancestor
25509057|NCT00378105|Growth Inhibitors|growth inhibitors|mesh-ancestor
25509058|NCT00378209|Dexamethasone|dexamethasone|mesh-list
25509059|NCT00378209|Lenalidomide|lenalidomide|mesh-list
25509060|NCT00378209|Bortezomib|bortezomib|mesh-list
25509061|NCT00378209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25509062|NCT00378209|Antiemetics|antiemetics|mesh-ancestor
25509063|NCT00378209|Autonomic Agents|autonomic agents|mesh-ancestor
25509064|NCT00378209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25509065|NCT00378209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509066|NCT00378209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25509067|NCT00378209|Glucocorticoids|glucocorticoids|mesh-ancestor
25509068|NCT00378209|Hormones|hormones|mesh-ancestor
25509069|NCT00378209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25509070|NCT00378209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25509071|NCT00378209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509072|NCT00378209|Immunologic Factors|immunologic factors|mesh-ancestor
25509073|NCT00378209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25509074|NCT00378209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25509075|NCT00378209|Growth Substances|growth substances|mesh-ancestor
25509076|NCT00378209|Growth Inhibitors|growth inhibitors|mesh-ancestor
25509077|NCT00378326|Tacrolimus|tacrolimus|mesh-list
25509078|NCT00378326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25509079|NCT00378326|Immunologic Factors|immunologic factors|mesh-ancestor
25509080|NCT00378326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509081|NCT00378326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25509082|NCT00378326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509083|NCT00378326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509084|NCT00378352|Epoetin Alfa|epoetin alfa|mesh-list
25509085|NCT00378352|Hematinics|hematinics|mesh-ancestor
25509086|NCT00378534|Cyclosporine|cyclosporine|mesh-list
25509087|NCT00378534|Cyclophosphamide|cyclophosphamide|mesh-list
25509088|NCT00378534|Fludarabine|fludarabine|mesh-list
25509089|NCT00378534|Cyclosporins|cyclosporins|mesh-list
25509090|NCT00378534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25509091|NCT00378534|Immunologic Factors|immunologic factors|mesh-ancestor
25509092|NCT00378534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509093|NCT00378534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25509094|NCT00378534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25509095|NCT00378534|Alkylating Agents|alkylating agents|mesh-ancestor
25509096|NCT00378534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509097|NCT00378534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509098|NCT00378534|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25509099|NCT00378534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509100|NCT00378534|Antifungal Agents|antifungal agents|mesh-ancestor
25509101|NCT00378534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25509102|NCT00378534|Dermatologic Agents|dermatologic agents|mesh-ancestor
25509103|NCT00378534|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25509104|NCT00378573|Gemcitabine|gemcitabine|mesh-list
25509105|NCT00378573|Bevacizumab|bevacizumab|mesh-list
25509106|NCT00378573|Docetaxel|docetaxel|mesh-list
25509107|NCT00378573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25509108|NCT00378573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509109|NCT00378573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25509110|NCT00378573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25509111|NCT00378573|Growth Substances|growth substances|mesh-ancestor
25509112|NCT00378573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509113|NCT00378573|Growth Inhibitors|growth inhibitors|mesh-ancestor
25509114|NCT00378573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25509115|NCT00378573|Antimetabolites|antimetabolites|mesh-ancestor
25509116|NCT00378573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509117|NCT00378573|Antiviral Agents|antiviral agents|mesh-ancestor
25509118|NCT00378573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25509119|NCT00378573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509120|NCT00378573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25509121|NCT00378573|Immunologic Factors|immunologic factors|mesh-ancestor
25509122|NCT00378573|Tubulin Modulators|tubulin modulators|mesh-ancestor
25509123|NCT00378573|Antimitotic Agents|antimitotic agents|mesh-ancestor
25509124|NCT00378573|Mitosis Modulators|mitosis modulators|mesh-ancestor
24626105|NCT01085617|Antimetabolites|antimetabolites|mesh-ancestor
25823286|NCT00004785|Methylprednisolone|methylprednisolone|mesh-list
25509125|NCT00378599|Interferons|interferons|mesh-list
25509126|NCT00378599|Interferon-alpha|interferon-alpha|mesh-list
25509127|NCT00378599|Interferon alpha-2|interferon alpha-2|mesh-list
25509128|NCT00378599|Ribavirin|ribavirin|mesh-list
25509129|NCT00378599|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25509130|NCT00378599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509131|NCT00378599|Antiviral Agents|antiviral agents|mesh-ancestor
25509132|NCT00378599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25509133|NCT00378599|Immunologic Factors|immunologic factors|mesh-ancestor
25509134|NCT00378599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509135|NCT00378599|Antimetabolites|antimetabolites|mesh-ancestor
25509136|NCT00378599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509137|NCT00378703|Sirolimus|sirolimus|mesh-list
25509138|NCT00378703|Bevacizumab|bevacizumab|mesh-list
25509139|NCT00378703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25509140|NCT00378703|Sorafenib|sorafenib|mesh-list
25509141|NCT00378703|Endothelial Growth Factors|endothelial growth factors|mesh-list
25509142|NCT00378703|Antibodies|antibodies|mesh-list
25509143|NCT00378703|Immunoglobulins|immunoglobulins|mesh-list
25509144|NCT00378703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25509145|NCT00378703|Immunoglobulin G|immunoglobulin g|mesh-list
25509146|NCT00378703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509147|NCT00378703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25509148|NCT00378703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25509149|NCT00378703|Growth Substances|growth substances|mesh-ancestor
25509150|NCT00378703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509151|NCT00378703|Growth Inhibitors|growth inhibitors|mesh-ancestor
25509152|NCT00378703|Immunologic Factors|immunologic factors|mesh-ancestor
25509153|NCT00378703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25509154|NCT00378703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509155|NCT00378703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509156|NCT00378703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25509157|NCT00378703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25509158|NCT00378703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25509159|NCT00378703|Antifungal Agents|antifungal agents|mesh-ancestor
25509160|NCT00378703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25509161|NCT00379145|Trabectedin|trabectedin|mesh-list
25509162|NCT00379145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25509163|NCT00379145|Alkylating Agents|alkylating agents|mesh-ancestor
25509164|NCT00379145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509165|NCT00379145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509166|NCT00379197|Naltrexone|naltrexone|mesh-list
25509167|NCT00379197|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25509168|NCT00379197|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25509169|NCT00379197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509170|NCT00379197|Sensory System Agents|sensory system agents|mesh-ancestor
25509171|NCT00379197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25509172|NCT00379353|Thalidomide|thalidomide|mesh-list
25509173|NCT00379353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25509174|NCT00379353|Immunologic Factors|immunologic factors|mesh-ancestor
25509175|NCT00379353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509176|NCT00379353|Leprostatic Agents|leprostatic agents|mesh-ancestor
25509177|NCT00379353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25509178|NCT00379353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25509179|NCT00379353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25509180|NCT00379353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25509181|NCT00379353|Growth Substances|growth substances|mesh-ancestor
25509182|NCT00379353|Growth Inhibitors|growth inhibitors|mesh-ancestor
25509183|NCT00379353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509184|NCT00379574|Prednisolone|prednisolone|mesh-list
25509185|NCT00379574|Cyclophosphamide|cyclophosphamide|mesh-list
25509186|NCT00379574|Doxorubicin|doxorubicin|mesh-list
25509187|NCT00379574|Vincristine|vincristine|mesh-list
25162329|NCT02905695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25162330|NCT02905682|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25162331|NCT02905682|Hemostatics|hemostatics|mesh-ancestor
25162332|NCT02905682|Coagulants|coagulants|mesh-ancestor
25162333|NCT02905682|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25162334|NCT02905682|Natriuretic Agents|natriuretic agents|mesh-ancestor
25162335|NCT02905682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162336|NCT02905708|Charcoal|charcoal|mesh-list
25162337|NCT02905708|Antidotes|antidotes|mesh-ancestor
25162338|NCT02905708|Protective Agents|protective agents|mesh-ancestor
25162339|NCT02905708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162355|NCT02905539|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25162356|NCT02905539|Hematinics|hematinics|mesh-ancestor
25162357|NCT02905734|Nicotine|nicotine|mesh-list
25162358|NCT02905734|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25509189|NCT00379574|Lenograstim|lenograstim|mesh-list
25509190|NCT00379574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25509191|NCT00379574|Immunologic Factors|immunologic factors|mesh-ancestor
25509192|NCT00379574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509193|NCT00379574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25509194|NCT00379574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25509195|NCT00379574|Alkylating Agents|alkylating agents|mesh-ancestor
25509196|NCT00379574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509197|NCT00379574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509198|NCT00379574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25509199|NCT00379574|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25509200|NCT00379574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25509201|NCT00379574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25509202|NCT00379574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509203|NCT00379574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25509204|NCT00379574|Tubulin Modulators|tubulin modulators|mesh-ancestor
25509205|NCT00379574|Antimitotic Agents|antimitotic agents|mesh-ancestor
25645929|NCT01453023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25509206|NCT00379574|Mitosis Modulators|mitosis modulators|mesh-ancestor
25509207|NCT00379574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25509208|NCT00379574|Glucocorticoids|glucocorticoids|mesh-ancestor
25509209|NCT00379574|Hormones|hormones|mesh-ancestor
25509210|NCT00379574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25509211|NCT00379574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25509212|NCT00379574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25645930|NCT01453049|Glimepiride|glimepiride|mesh-list
25645931|NCT01453049|Rosiglitazone|rosiglitazone|mesh-list
25645932|NCT01453049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25645933|NCT01453049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25645934|NCT01453049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645935|NCT01453049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25645936|NCT01453049|Immunologic Factors|immunologic factors|mesh-ancestor
25656827|NCT01579318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25656828|NCT01579318|Growth Substances|growth substances|mesh-ancestor
25656829|NCT01579318|Growth Inhibitors|growth inhibitors|mesh-ancestor
25656830|NCT01579318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25656831|NCT01579513|Methylprednisolone|methylprednisolone|mesh-list
25656832|NCT01579513|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25656833|NCT01579513|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25509213|NCT00379587|Rituximab|rituximab|mesh-list
25509214|NCT00379587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25509215|NCT00379587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509216|NCT00379587|Immunologic Factors|immunologic factors|mesh-ancestor
25509217|NCT00379587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509218|NCT00379587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25509219|NCT00379639|Gemcitabine|gemcitabine|mesh-list
25509220|NCT00379639|Romidepsin|romidepsin|mesh-list
25509221|NCT00379639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25509222|NCT00379639|Antimetabolites|antimetabolites|mesh-ancestor
25509223|NCT00379639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509224|NCT00379639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509225|NCT00379639|Antiviral Agents|antiviral agents|mesh-ancestor
25509226|NCT00379639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25509227|NCT00379639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509228|NCT00379639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25509229|NCT00379639|Immunologic Factors|immunologic factors|mesh-ancestor
25509230|NCT00379639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509231|NCT00379639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25509232|NCT00379769|Metformin|metformin|mesh-list
25509233|NCT00379769|Rosiglitazone|rosiglitazone|mesh-list
25509234|NCT00379769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25509235|NCT00379769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509236|NCT00379795|Ranibizumab|ranibizumab|mesh-list
25509237|NCT00379795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25509238|NCT00379795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25509239|NCT00379795|Growth Substances|growth substances|mesh-ancestor
25509240|NCT00379795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509241|NCT00379795|Growth Inhibitors|growth inhibitors|mesh-ancestor
25509242|NCT00379795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509243|NCT00379808|Montelukast|montelukast|mesh-list
25509244|NCT00379808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25509245|NCT00379808|Respiratory System Agents|respiratory system agents|mesh-ancestor
25509246|NCT00379808|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25509247|NCT00379808|Hormone Antagonists|hormone antagonists|mesh-ancestor
25509248|NCT00379808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25509249|NCT00379808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509250|NCT00379808|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25509251|NCT00379808|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25509252|NCT00379808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509253|NCT00379821|Azithromycin|azithromycin|mesh-list
25509254|NCT00379821|Artesunate|artesunate|mesh-list
25509255|NCT00379821|Chloroquine|chloroquine|mesh-list
25509256|NCT00379821|Atovaquone|atovaquone|mesh-list
25509257|NCT00379821|Proguanil|proguanil|mesh-list
25823287|NCT00004785|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25509258|NCT00379821|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
25509259|NCT00379821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25509260|NCT00379821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25509261|NCT00379821|Antimalarials|antimalarials|mesh-ancestor
25509262|NCT00379821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25509263|NCT00379821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25656834|NCT01579513|Prednisolone|prednisolone|mesh-list
25656835|NCT01579513|Prednisolone acetate|prednisolone acetate|mesh-list
25509264|NCT00379821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509265|NCT00379821|Antiviral Agents|antiviral agents|mesh-ancestor
25509266|NCT00379821|Schistosomicides|schistosomicides|mesh-ancestor
25509267|NCT00379821|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25509268|NCT00379821|Anthelmintics|anthelmintics|mesh-ancestor
25509270|NCT00379821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25509271|NCT00379821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509272|NCT00379821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509273|NCT00379821|Antimetabolites|antimetabolites|mesh-ancestor
25509275|NCT00379834|Dorzolamide|dorzolamide|mesh-list
25509276|NCT00379834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25509277|NCT00379834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25509278|NCT00379834|Adrenergic Agents|adrenergic agents|mesh-ancestor
25509279|NCT00379834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25509280|NCT00379834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509281|NCT00379834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509282|NCT00379834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25509283|NCT00379834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25509284|NCT00379834|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25509285|NCT00379834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509286|NCT00379899|Vitamin D|vitamin d|mesh-list
25509287|NCT00379899|Cinacalcet|cinacalcet|mesh-list
25509288|NCT00379899|Vitamins|vitamins|mesh-ancestor
25509289|NCT00379899|Micronutrients|micronutrients|mesh-ancestor
25509290|NCT00379899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509291|NCT00379899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25509292|NCT00379899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25509293|NCT00379899|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25509294|NCT00379899|Hormone Antagonists|hormone antagonists|mesh-ancestor
25509295|NCT00379899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25509296|NCT00379912|Azacitidine|azacitidine|mesh-list
25509297|NCT00379912|Epoetin Alfa|epoetin alfa|mesh-list
25509298|NCT00379912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25509299|NCT00379912|Antimetabolites|antimetabolites|mesh-ancestor
25509300|NCT00379912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509301|NCT00379912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509302|NCT00379912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509303|NCT00379912|Hematinics|hematinics|mesh-ancestor
25509304|NCT00380029|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25509305|NCT00380029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509306|NCT00380029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25509307|NCT00380029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509308|NCT00380029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509309|NCT00380068|Ambrisentan|ambrisentan|mesh-list
25509310|NCT00380068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25509311|NCT00380081|Zolpidem|zolpidem|mesh-list
25509312|NCT00380081|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25509313|NCT00380081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25509314|NCT00380081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25509315|NCT00380081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509316|NCT00380081|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25509317|NCT00380081|GABA Agonists|gaba agonists|mesh-ancestor
25509318|NCT00380081|GABA Agents|gaba agents|mesh-ancestor
25509319|NCT00380081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25509320|NCT00380081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509321|NCT00380250|Lubiprostone|lubiprostone|mesh-list
25509322|NCT00380250|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25509323|NCT00380250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25509324|NCT00380250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509325|NCT00380393|Vaccines|vaccines|mesh-list
25127436|NCT03055767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25127437|NCT03055767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127443|NCT03055793|Budesonide|budesonide|mesh-list
24981267|NCT04022876|Carboplatin|carboplatin|mesh-list
24981268|NCT04022876|Pemetrexed|pemetrexed|mesh-list
24981269|NCT04022876|Topotecan|topotecan|mesh-list
25127449|NCT03055793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127450|NCT03055793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25127451|NCT03055793|Respiratory System Agents|respiratory system agents|mesh-ancestor
25127452|NCT03055793|Glucocorticoids|glucocorticoids|mesh-ancestor
25127453|NCT03055793|Hormones|hormones|mesh-ancestor
25509326|NCT00380393|Immunologic Factors|immunologic factors|mesh-ancestor
25509327|NCT00380393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509328|NCT00380588|Gemcitabine|gemcitabine|mesh-list
25509329|NCT00380588|Cisplatin|cisplatin|mesh-list
25645937|NCT01453075|Valacyclovir|valacyclovir|mesh-list
25645938|NCT01453075|Antiviral Agents|antiviral agents|mesh-ancestor
25509330|NCT00380588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509331|NCT00380588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25509332|NCT00380588|Antimetabolites|antimetabolites|mesh-ancestor
25509333|NCT00380588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509334|NCT00380588|Antiviral Agents|antiviral agents|mesh-ancestor
25509335|NCT00380588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25509336|NCT00380588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509337|NCT00380588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25509338|NCT00380588|Immunologic Factors|immunologic factors|mesh-ancestor
25509339|NCT00380588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509340|NCT00380692|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25509341|NCT00380692|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25509342|NCT00380692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25509343|NCT00380692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25509344|NCT00380692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509345|NCT00380692|Adrenergic Agents|adrenergic agents|mesh-ancestor
25509346|NCT00380692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25509347|NCT00380692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509348|NCT00380718|Pemetrexed|pemetrexed|mesh-list
25509349|NCT00380718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509350|NCT00380718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509351|NCT00380718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509352|NCT00380718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25509353|NCT00380718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25509354|NCT00380874|Pregabalin|pregabalin|mesh-list
25509355|NCT00380874|Analgesics|analgesics|mesh-ancestor
25509356|NCT00380874|Sensory System Agents|sensory system agents|mesh-ancestor
25509357|NCT00380874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25509358|NCT00380874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509359|NCT00380874|Anticonvulsants|anticonvulsants|mesh-ancestor
25509360|NCT00380874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25509361|NCT00380874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25509362|NCT00380874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509363|NCT00380874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25509364|NCT00380874|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25509365|NCT00380874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25509366|NCT00380874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25509367|NCT00380874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25509368|NCT00380978|Narcotics|narcotics|mesh-list
25509369|NCT00380978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25509370|NCT00380978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509371|NCT00380978|Analgesics|analgesics|mesh-ancestor
25509372|NCT00380978|Sensory System Agents|sensory system agents|mesh-ancestor
25509373|NCT00380978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25509374|NCT00381004|Vidarabine|vidarabine|mesh-list
25509375|NCT00381004|Cyclophosphamide|cyclophosphamide|mesh-list
25509376|NCT00381004|Rituximab|rituximab|mesh-list
25509377|NCT00381004|Fludarabine|fludarabine|mesh-list
25509378|NCT00381004|Fludarabine phosphate|fludarabine phosphate|mesh-list
25509379|NCT00381004|Sargramostim|sargramostim|mesh-list
25509380|NCT00381004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25509381|NCT00381004|Immunologic Factors|immunologic factors|mesh-ancestor
25509382|NCT00381004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509383|NCT00381004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25509384|NCT00381004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25509385|NCT00381004|Alkylating Agents|alkylating agents|mesh-ancestor
25509386|NCT00381004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509387|NCT00381004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509388|NCT00381004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25509389|NCT00381004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25509390|NCT00381004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25509391|NCT00381004|Antimetabolites|antimetabolites|mesh-ancestor
25509392|NCT00381004|Antiviral Agents|antiviral agents|mesh-ancestor
25509393|NCT00381004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25823288|NCT00004785|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25823289|NCT00004785|Prednisolone|prednisolone|mesh-list
25823290|NCT00004785|Prednisolone acetate|prednisolone acetate|mesh-list
25823291|NCT00004785|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25823292|NCT00004785|Prednisolone phosphate|prednisolone phosphate|mesh-list
25509394|NCT00381043|Acamprosate|acamprosate|mesh-list
25509395|NCT00381043|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25823293|NCT00004785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25823294|NCT00004785|Antiemetics|antiemetics|mesh-ancestor
25509396|NCT00381095|Pregabalin|pregabalin|mesh-list
25509397|NCT00381095|Analgesics|analgesics|mesh-ancestor
25509398|NCT00381095|Sensory System Agents|sensory system agents|mesh-ancestor
25509399|NCT00381095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25509400|NCT00381095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509401|NCT00381095|Anticonvulsants|anticonvulsants|mesh-ancestor
25509402|NCT00381095|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25509403|NCT00381095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25509404|NCT00381095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509405|NCT00381095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25509406|NCT00381095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25509407|NCT00381095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25509408|NCT00381095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25509409|NCT00381095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25509410|NCT00381238|Rosiglitazone|rosiglitazone|mesh-list
25509411|NCT00381238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25509412|NCT00381238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509413|NCT00381303|Ritonavir|ritonavir|mesh-list
25509414|NCT00381303|Darunavir|darunavir|mesh-list
25509415|NCT00381303|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25509416|NCT00381303|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25509417|NCT00381303|Protease Inhibitors|protease inhibitors|mesh-ancestor
25509418|NCT00381303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509419|NCT00381303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509420|NCT00381303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25509421|NCT00381303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25509422|NCT00381303|Antiviral Agents|antiviral agents|mesh-ancestor
25509423|NCT00381303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25509424|NCT00381303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25509425|NCT00381303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25509426|NCT00381550|Fludarabine|fludarabine|mesh-list
25509427|NCT00381550|Fludarabine phosphate|fludarabine phosphate|mesh-list
25509428|NCT00381550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509429|NCT00381550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25509430|NCT00381550|Antimetabolites|antimetabolites|mesh-ancestor
25509431|NCT00381550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509432|NCT00381550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25509433|NCT00381550|Immunologic Factors|immunologic factors|mesh-ancestor
25509434|NCT00381550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509435|NCT00381615|Vaccines|vaccines|mesh-list
25509436|NCT00381615|Immunologic Factors|immunologic factors|mesh-ancestor
25509437|NCT00381615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509438|NCT00381680|Leucovorin|leucovorin|mesh-list
25509439|NCT00381680|Cytarabine|cytarabine|mesh-list
25509440|NCT00381680|Dexamethasone|dexamethasone|mesh-list
25509441|NCT00381680|Prednisone|prednisone|mesh-list
25509442|NCT00381680|Cyclophosphamide|cyclophosphamide|mesh-list
25509443|NCT00381680|Doxorubicin|doxorubicin|mesh-list
25509444|NCT00381680|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25509445|NCT00381680|Methotrexate|methotrexate|mesh-list
25509446|NCT00381680|Etoposide|etoposide|mesh-list
25509447|NCT00381680|Vincristine|vincristine|mesh-list
25509448|NCT00381680|Etoposide phosphate|etoposide phosphate|mesh-list
25509449|NCT00381680|Asparaginase|asparaginase|mesh-list
25509450|NCT00381680|Mercaptopurine|mercaptopurine|mesh-list
25509451|NCT00381680|Pegaspargase|pegaspargase|mesh-list
25509452|NCT00381680|Levoleucovorin|levoleucovorin|mesh-list
25509453|NCT00381680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25509454|NCT00381680|Immunologic Factors|immunologic factors|mesh-ancestor
25509455|NCT00381680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509456|NCT00381680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25509457|NCT00381680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25509458|NCT00381680|Alkylating Agents|alkylating agents|mesh-ancestor
25509459|NCT00381680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509460|NCT00381680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509461|NCT00381680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25162381|NCT02905461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25162382|NCT02905461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162383|NCT02905305|Dexamethasone|dexamethasone|mesh-list
25162384|NCT02905305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25162385|NCT02905305|Antiemetics|antiemetics|mesh-ancestor
25162386|NCT02905305|Autonomic Agents|autonomic agents|mesh-ancestor
25509462|NCT00381680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25509463|NCT00381680|Antiemetics|antiemetics|mesh-ancestor
25509464|NCT00381680|Autonomic Agents|autonomic agents|mesh-ancestor
25509465|NCT00381680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25509468|NCT00381680|Hormones|hormones|mesh-ancestor
25509469|NCT00381680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25509470|NCT00381680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25509471|NCT00381680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25509472|NCT00381680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25509473|NCT00381680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25509474|NCT00381680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509475|NCT00381680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25509476|NCT00381680|Abortifacient Agents|abortifacient agents|mesh-ancestor
25509477|NCT00381680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25509478|NCT00381680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25509479|NCT00381680|Antimetabolites|antimetabolites|mesh-ancestor
25509480|NCT00381680|Dermatologic Agents|dermatologic agents|mesh-ancestor
25509481|NCT00381680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25509482|NCT00381680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25509483|NCT00381680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25509484|NCT00381680|Antiviral Agents|antiviral agents|mesh-ancestor
25509485|NCT00381680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25509486|NCT00381680|Antidotes|antidotes|mesh-ancestor
25509487|NCT00381680|Protective Agents|protective agents|mesh-ancestor
25509488|NCT00381680|Vitamin B Complex|vitamin b complex|mesh-ancestor
25509489|NCT00381680|Vitamins|vitamins|mesh-ancestor
25509490|NCT00381680|Micronutrients|micronutrients|mesh-ancestor
25509491|NCT00381680|Tubulin Modulators|tubulin modulators|mesh-ancestor
25509492|NCT00381680|Antimitotic Agents|antimitotic agents|mesh-ancestor
25509493|NCT00381680|Mitosis Modulators|mitosis modulators|mesh-ancestor
25509494|NCT00381693|Azacitidine|azacitidine|mesh-list
25509495|NCT00381693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25509496|NCT00381693|Antimetabolites|antimetabolites|mesh-ancestor
25509497|NCT00381693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509498|NCT00381693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509499|NCT00381693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509500|NCT00381706|Leucovorin|leucovorin|mesh-list
25509501|NCT00381706|Cisplatin|cisplatin|mesh-list
25509502|NCT00381706|Fluorouracil|fluorouracil|mesh-list
25509503|NCT00381706|Oxaliplatin|oxaliplatin|mesh-list
25509504|NCT00381706|Irinotecan|irinotecan|mesh-list
25509505|NCT00381706|Cetuximab|cetuximab|mesh-list
25509506|NCT00381706|Epirubicin|epirubicin|mesh-list
25509507|NCT00381706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509508|NCT00381706|Antimetabolites|antimetabolites|mesh-ancestor
25509509|NCT00381706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509510|NCT00381706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25509511|NCT00381706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25509512|NCT00381706|Immunologic Factors|immunologic factors|mesh-ancestor
25509513|NCT00381706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509514|NCT00381706|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25509515|NCT00381706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25509516|NCT00381706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509517|NCT00381706|Antidotes|antidotes|mesh-ancestor
25509518|NCT00381706|Protective Agents|protective agents|mesh-ancestor
25509519|NCT00381706|Vitamin B Complex|vitamin b complex|mesh-ancestor
25509520|NCT00381706|Vitamins|vitamins|mesh-ancestor
25509521|NCT00381706|Micronutrients|micronutrients|mesh-ancestor
25509522|NCT00381706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25509523|NCT00381706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25509524|NCT00381706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25509525|NCT00381797|Deoxyglucose|deoxyglucose|mesh-list
25509526|NCT00381797|Bevacizumab|bevacizumab|mesh-list
25509527|NCT00381797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25509528|NCT00381797|Irinotecan|irinotecan|mesh-list
25509529|NCT00381797|Camptothecin|camptothecin|mesh-list
25509530|NCT00381797|Endothelial Growth Factors|endothelial growth factors|mesh-list
25509531|NCT00381797|Antibodies|antibodies|mesh-list
24449344|NCT00315042|Telithromycin|telithromycin|mesh-list
24981466|NCT03132454|Dexamethasone|dexamethasone|mesh-list
24981467|NCT03132454|Dexamethasone acetate|dexamethasone acetate|mesh-list
24981468|NCT03132454|Sorafenib|sorafenib|mesh-list
24981469|NCT03132454|Decitabine|decitabine|mesh-list
24981470|NCT03132454|Palbociclib|palbociclib|mesh-list
24981471|NCT03132454|Ichthammol|ichthammol|mesh-list
24981472|NCT03132454|BB 1101|bb 1101|mesh-list
24981473|NCT03132454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24981474|NCT03132454|Antiemetics|antiemetics|mesh-ancestor
25823295|NCT00004785|Autonomic Agents|autonomic agents|mesh-ancestor
25509532|NCT00381797|Immunoglobulins|immunoglobulins|mesh-list
25509534|NCT00381797|Immunoglobulin G|immunoglobulin g|mesh-list
25509535|NCT00381797|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25509536|NCT00381797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509537|NCT00381797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25509538|NCT00381797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25509539|NCT00381797|Growth Substances|growth substances|mesh-ancestor
25509540|NCT00381797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645939|NCT01453075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25645940|NCT01453153|Gemcitabine|gemcitabine|mesh-list
25645941|NCT01453153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25509541|NCT00381797|Growth Inhibitors|growth inhibitors|mesh-ancestor
25509542|NCT00381797|Immunologic Factors|immunologic factors|mesh-ancestor
25509543|NCT00381797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25509544|NCT00381797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25509545|NCT00381797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509546|NCT00381797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509547|NCT00381797|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25509548|NCT00381797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25509549|NCT00381797|Antimetabolites|antimetabolites|mesh-ancestor
25509550|NCT00381797|Antiviral Agents|antiviral agents|mesh-ancestor
25509551|NCT00381797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25509552|NCT00381810|Acetaminophen|acetaminophen|mesh-list
25509553|NCT00381810|Diphenhydramine|diphenhydramine|mesh-list
25509554|NCT00381810|Promethazine|promethazine|mesh-list
25509555|NCT00381810|Methylprednisolone|methylprednisolone|mesh-list
25509556|NCT00381810|Rituximab|rituximab|mesh-list
25509557|NCT00381810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25509558|NCT00381810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509559|NCT00381810|Immunologic Factors|immunologic factors|mesh-ancestor
25509560|NCT00381810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509561|NCT00381810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25509562|NCT00381810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25509563|NCT00381810|Analgesics|analgesics|mesh-ancestor
25509564|NCT00381810|Sensory System Agents|sensory system agents|mesh-ancestor
25509565|NCT00381810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25509566|NCT00381810|Antipyretics|antipyretics|mesh-ancestor
25509567|NCT00381810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25509568|NCT00381810|Antiemetics|antiemetics|mesh-ancestor
25509569|NCT00381810|Autonomic Agents|autonomic agents|mesh-ancestor
25509570|NCT00381810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25509571|NCT00381810|Glucocorticoids|glucocorticoids|mesh-ancestor
25509572|NCT00381810|Hormones|hormones|mesh-ancestor
25509573|NCT00381810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25509574|NCT00381810|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25509575|NCT00381810|Protective Agents|protective agents|mesh-ancestor
25509576|NCT00381810|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25509577|NCT00381810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25509578|NCT00381810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25509579|NCT00381810|Anesthetics, Local|anesthetics, local|mesh-ancestor
25509580|NCT00381810|Anesthetics|anesthetics|mesh-ancestor
25509581|NCT00381810|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25509582|NCT00381810|Histamine Antagonists|histamine antagonists|mesh-ancestor
25509583|NCT00381810|Histamine Agents|histamine agents|mesh-ancestor
25509584|NCT00381810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25509585|NCT00381810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509586|NCT00381810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25509587|NCT00381810|Antipruritics|antipruritics|mesh-ancestor
25509588|NCT00381810|Dermatologic Agents|dermatologic agents|mesh-ancestor
25509589|NCT00381862|Leucovorin|leucovorin|mesh-list
25509590|NCT00381862|Dexamethasone|dexamethasone|mesh-list
25509591|NCT00381862|Fluorouracil|fluorouracil|mesh-list
25509592|NCT00381862|Oxaliplatin|oxaliplatin|mesh-list
25509593|NCT00381862|Irinotecan|irinotecan|mesh-list
25509594|NCT00381862|Camptothecin|camptothecin|mesh-list
25509595|NCT00381862|Aprepitant|aprepitant|mesh-list
25509596|NCT00381862|Palonosetron|palonosetron|mesh-list
25509597|NCT00381862|Levoleucovorin|levoleucovorin|mesh-list
25509598|NCT00381862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25509599|NCT00381862|Antiemetics|antiemetics|mesh-ancestor
25509600|NCT00381862|Autonomic Agents|autonomic agents|mesh-ancestor
25509601|NCT00381862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25509602|NCT00381862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509603|NCT00381862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25509604|NCT00381862|Glucocorticoids|glucocorticoids|mesh-ancestor
25509605|NCT00381862|Hormones|hormones|mesh-ancestor
25509606|NCT00381862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25509607|NCT00381862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25509608|NCT00381862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24981493|NCT03092817|Antiemetics|antiemetics|mesh-ancestor
25509609|NCT00381862|Antimetabolites|antimetabolites|mesh-ancestor
25645942|NCT01453153|Antimetabolites|antimetabolites|mesh-ancestor
25829466|NCT00006214|Flutamide|flutamide|mesh-list
25509610|NCT00381862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509612|NCT00381862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25509613|NCT00381862|Immunologic Factors|immunologic factors|mesh-ancestor
25509614|NCT00381862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25823296|NCT00004785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25509615|NCT00381862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25509616|NCT00381862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509617|NCT00381862|Antidotes|antidotes|mesh-ancestor
25509618|NCT00381862|Protective Agents|protective agents|mesh-ancestor
25509619|NCT00381862|Vitamin B Complex|vitamin b complex|mesh-ancestor
25509620|NCT00381862|Vitamins|vitamins|mesh-ancestor
25509621|NCT00381862|Micronutrients|micronutrients|mesh-ancestor
25509622|NCT00381862|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25509623|NCT00381862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25509624|NCT00381862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25509625|NCT00381862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25509626|NCT00381862|Serotonin Agents|serotonin agents|mesh-ancestor
25509627|NCT00381862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25509628|NCT00381888|PENTA|penta|mesh-list
25509629|NCT00381888|Fondaparinux|fondaparinux|mesh-list
25509630|NCT00381888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25509631|NCT00381888|Antithrombins|antithrombins|mesh-ancestor
25509632|NCT00381888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25509633|NCT00381888|Protease Inhibitors|protease inhibitors|mesh-ancestor
25509634|NCT00381888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509635|NCT00381888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509636|NCT00381888|Anticoagulants|anticoagulants|mesh-ancestor
25509637|NCT00381888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25509638|NCT00381888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25509639|NCT00381940|Bortezomib|bortezomib|mesh-list
25509640|NCT00381940|Vinorelbine|vinorelbine|mesh-list
25509641|NCT00381940|Ifosfamide|ifosfamide|mesh-list
25509642|NCT00381940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509643|NCT00381940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25509644|NCT00381940|Tubulin Modulators|tubulin modulators|mesh-ancestor
25509645|NCT00381940|Antimitotic Agents|antimitotic agents|mesh-ancestor
25509646|NCT00381940|Mitosis Modulators|mitosis modulators|mesh-ancestor
25509647|NCT00381940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509648|NCT00381940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25509649|NCT00381940|Alkylating Agents|alkylating agents|mesh-ancestor
25509650|NCT00382031|Zalutumumab|zalutumumab|mesh-list
25509651|NCT00382031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25509652|NCT00382031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25509653|NCT00382031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509654|NCT00382031|Immunologic Factors|immunologic factors|mesh-ancestor
25509655|NCT00382031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509656|NCT00382070|Letrozole|letrozole|mesh-list
25509657|NCT00382070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509658|NCT00382070|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25509659|NCT00382070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25509660|NCT00382070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509661|NCT00382070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509662|NCT00382070|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25509663|NCT00382070|Hormone Antagonists|hormone antagonists|mesh-ancestor
25509664|NCT00382070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25509665|NCT00382070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509666|NCT00382109|Sirolimus|sirolimus|mesh-list
25509667|NCT00382109|Cyclophosphamide|cyclophosphamide|mesh-list
25509668|NCT00382109|Thiotepa|thiotepa|mesh-list
25509669|NCT00382109|Methotrexate|methotrexate|mesh-list
25509670|NCT00382109|Tacrolimus|tacrolimus|mesh-list
25509671|NCT00382109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25509672|NCT00382109|Immunologic Factors|immunologic factors|mesh-ancestor
25509673|NCT00382109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509674|NCT00382109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25509675|NCT00382109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25509676|NCT00382109|Alkylating Agents|alkylating agents|mesh-ancestor
25823297|NCT00004785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823298|NCT00004785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25823299|NCT00004785|Glucocorticoids|glucocorticoids|mesh-ancestor
25823300|NCT00004785|Hormones|hormones|mesh-ancestor
25829467|NCT00006214|Androgen Antagonists|androgen antagonists|mesh-ancestor
24981545|NCT02725177|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25169546|NCT01818921|CKD732|ckd732|mesh-list
24981547|NCT02725177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25509680|NCT00382109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25509681|NCT00382109|Abortifacient Agents|abortifacient agents|mesh-ancestor
25509682|NCT00382109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25509683|NCT00382109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25509684|NCT00382109|Antimetabolites|antimetabolites|mesh-ancestor
25509685|NCT00382109|Dermatologic Agents|dermatologic agents|mesh-ancestor
25509686|NCT00382109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509687|NCT00382109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25509688|NCT00382109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25509689|NCT00382109|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25509690|NCT00382109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25509691|NCT00382109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25509692|NCT00382109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25509693|NCT00382109|Antifungal Agents|antifungal agents|mesh-ancestor
25509694|NCT00382148|Omalizumab|omalizumab|mesh-list
25509695|NCT00382148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25509696|NCT00382148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25509697|NCT00382148|Respiratory System Agents|respiratory system agents|mesh-ancestor
25509698|NCT00382265|Tamsulosin|tamsulosin|mesh-list
25509699|NCT00382265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25509700|NCT00382265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25509701|NCT00382265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25509702|NCT00382265|Adrenergic Agents|adrenergic agents|mesh-ancestor
25509703|NCT00382265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25509704|NCT00382265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509705|NCT00382265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509706|NCT00382265|Urological Agents|urological agents|mesh-ancestor
25509707|NCT00382590|Cytarabine|cytarabine|mesh-list
25509708|NCT00382590|Azacitidine|azacitidine|mesh-list
25509709|NCT00382590|Valproic Acid|valproic acid|mesh-list
25509710|NCT00382590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25509711|NCT00382590|Antimetabolites|antimetabolites|mesh-ancestor
25509712|NCT00382590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509713|NCT00382590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509714|NCT00382590|Antiviral Agents|antiviral agents|mesh-ancestor
25509715|NCT00382590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25509716|NCT00382590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25509717|NCT00382590|Immunologic Factors|immunologic factors|mesh-ancestor
25509718|NCT00382590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509719|NCT00382590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509720|NCT00382590|Anticonvulsants|anticonvulsants|mesh-ancestor
25509721|NCT00382590|GABA Agents|gaba agents|mesh-ancestor
25509722|NCT00382590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25509723|NCT00382590|Antimanic Agents|antimanic agents|mesh-ancestor
25509724|NCT00382590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25509725|NCT00382590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25509726|NCT00382590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25509727|NCT00382720|Docetaxel|docetaxel|mesh-list
25509728|NCT00382720|Capecitabine|capecitabine|mesh-list
25509729|NCT00382720|Oxaliplatin|oxaliplatin|mesh-list
25509730|NCT00382720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509731|NCT00382720|Tubulin Modulators|tubulin modulators|mesh-ancestor
25509732|NCT00382720|Antimitotic Agents|antimitotic agents|mesh-ancestor
25509733|NCT00382720|Mitosis Modulators|mitosis modulators|mesh-ancestor
25509734|NCT00382720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509735|NCT00382720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25509736|NCT00382720|Antimetabolites|antimetabolites|mesh-ancestor
25509737|NCT00382733|Topotecan|topotecan|mesh-list
25509738|NCT00382733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25509739|NCT00382733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25509740|NCT00382733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509741|NCT00382733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509742|NCT00382733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509743|NCT00382824|Ubiquinone|ubiquinone|mesh-list
25509744|NCT00382824|Coenzyme Q10|coenzyme q10|mesh-list
25509745|NCT00382824|Micronutrients|micronutrients|mesh-ancestor
25509746|NCT00382824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509747|NCT00382824|Vitamins|vitamins|mesh-ancestor
24981606|NCT02343042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24981608|NCT02343042|Hormones|hormones|mesh-ancestor
25509749|NCT00382993|Sumatriptan|sumatriptan|mesh-list
25509750|NCT00382993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25509751|NCT00382993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25509752|NCT00382993|Analgesics|analgesics|mesh-ancestor
25509753|NCT00382993|Sensory System Agents|sensory system agents|mesh-ancestor
25509754|NCT00382993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24828004|NCT02142634|Hormones|hormones|mesh-ancestor
25509755|NCT00382993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509756|NCT00382993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25509757|NCT00382993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25509758|NCT00382993|Gout Suppressants|gout suppressants|mesh-ancestor
25509759|NCT00382993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25509760|NCT00382993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509761|NCT00382993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509763|NCT00382993|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25509764|NCT00382993|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25509765|NCT00382993|Serotonin Agents|serotonin agents|mesh-ancestor
25509766|NCT00382993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25509767|NCT00383019|Latanoprost|latanoprost|mesh-list
25509768|NCT00383019|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25509769|NCT00383019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25509771|NCT00383149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25509772|NCT00383149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509773|NCT00383162|Naproxen|naproxen|mesh-list
25509774|NCT00383162|Sumatriptan|sumatriptan|mesh-list
25509775|NCT00383162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25509776|NCT00383162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25509777|NCT00383162|Analgesics|analgesics|mesh-ancestor
25509778|NCT00383162|Sensory System Agents|sensory system agents|mesh-ancestor
25509779|NCT00383162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25509780|NCT00383162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509781|NCT00383162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25509782|NCT00383162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25509783|NCT00383162|Gout Suppressants|gout suppressants|mesh-ancestor
25509784|NCT00383162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25509785|NCT00383162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509786|NCT00383162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509787|NCT00383162|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25509788|NCT00383162|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25509789|NCT00383162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25509790|NCT00383162|Serotonin Agents|serotonin agents|mesh-ancestor
25509791|NCT00383162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25509792|NCT00383266|Carboplatin|carboplatin|mesh-list
25509793|NCT00383266|Pemetrexed|pemetrexed|mesh-list
25509794|NCT00383266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509795|NCT00383266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509796|NCT00383266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509797|NCT00383266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25509798|NCT00383266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25509799|NCT00383331|Gemcitabine|gemcitabine|mesh-list
25509800|NCT00383331|Pemetrexed|pemetrexed|mesh-list
25509801|NCT00383331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25509802|NCT00383331|Antimetabolites|antimetabolites|mesh-ancestor
25509803|NCT00383331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509804|NCT00383331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509805|NCT00383331|Antiviral Agents|antiviral agents|mesh-ancestor
25509806|NCT00383331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25509807|NCT00383331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509808|NCT00383331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25509809|NCT00383331|Immunologic Factors|immunologic factors|mesh-ancestor
25509810|NCT00383331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576167|NCT00837239|Antimetabolites|antimetabolites|mesh-ancestor
24576168|NCT00837239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576169|NCT00837239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24576170|NCT00837239|Antiviral Agents|antiviral agents|mesh-ancestor
24576171|NCT00837239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24576172|NCT00837239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24576173|NCT00837239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24576174|NCT00837239|Immunologic Factors|immunologic factors|mesh-ancestor
24576175|NCT00837239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823301|NCT00004785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25509811|NCT00383331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25509812|NCT00383331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25509813|NCT00383448|Cyclosporine|cyclosporine|mesh-list
25509814|NCT00383448|Melphalan|melphalan|mesh-list
25509815|NCT00383448|Alemtuzumab|alemtuzumab|mesh-list
25509816|NCT00383448|Hydroxyurea|hydroxyurea|mesh-list
25509817|NCT00383448|Clofarabine|clofarabine|mesh-list
25509818|NCT00383448|Cyclosporins|cyclosporins|mesh-list
25509819|NCT00383448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509820|NCT00383448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509821|NCT00383448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25509822|NCT00383448|Immunologic Factors|immunologic factors|mesh-ancestor
25509823|NCT00383448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509824|NCT00383448|Antifungal Agents|antifungal agents|mesh-ancestor
25509825|NCT00383448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25509834|NCT00383448|Antisickling Agents|antisickling agents|mesh-ancestor
25509835|NCT00383448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25509836|NCT00383448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25509837|NCT00383448|Antimetabolites|antimetabolites|mesh-ancestor
25509838|NCT00383565|Romidepsin|romidepsin|mesh-list
25509839|NCT00383565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25509840|NCT00383565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509841|NCT00383643|Sodium Oxybate|sodium oxybate|mesh-list
25509842|NCT00383643|Zolpidem|zolpidem|mesh-list
25509843|NCT00383643|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25509844|NCT00383643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25509845|NCT00383643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25509846|NCT00383643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509847|NCT00383643|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25509848|NCT00383643|GABA Agonists|gaba agonists|mesh-ancestor
25509849|NCT00383643|GABA Agents|gaba agents|mesh-ancestor
25509850|NCT00383643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25509851|NCT00383643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509852|NCT00383643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25509853|NCT00383643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25509854|NCT00383643|Anesthetics, General|anesthetics, general|mesh-ancestor
25509855|NCT00383643|Anesthetics|anesthetics|mesh-ancestor
25509856|NCT00383747|Nicotine|nicotine|mesh-list
25509857|NCT00383747|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25509858|NCT00383747|Autonomic Agents|autonomic agents|mesh-ancestor
25509859|NCT00383747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25509860|NCT00383747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509861|NCT00383747|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25509862|NCT00383747|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25509863|NCT00383747|Cholinergic Agents|cholinergic agents|mesh-ancestor
25509864|NCT00383747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25509865|NCT00383747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509866|NCT00383786|Vofopitant|vofopitant|mesh-list
25509867|NCT00383786|Antiemetics|antiemetics|mesh-ancestor
25509868|NCT00383786|Autonomic Agents|autonomic agents|mesh-ancestor
25509869|NCT00383786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25509870|NCT00383786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509871|NCT00383786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25509872|NCT00383786|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25509873|NCT00383786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25509874|NCT00383786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509875|NCT00383942|Misoprostol|misoprostol|mesh-list
25509876|NCT00383942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25509877|NCT00383942|Abortifacient Agents|abortifacient agents|mesh-ancestor
25509878|NCT00383942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25509879|NCT00383942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509880|NCT00383942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25509881|NCT00383942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25509882|NCT00383942|Oxytocics|oxytocics|mesh-ancestor
25509883|NCT00384033|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25509884|NCT00384033|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25509885|NCT00384033|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25509886|NCT00384033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25509887|NCT00384033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25509888|NCT00384033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509889|NCT00384033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25509890|NCT00384033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509891|NCT00384033|Analgesics|analgesics|mesh-ancestor
25509892|NCT00384033|Sensory System Agents|sensory system agents|mesh-ancestor
25509893|NCT00384033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25509894|NCT00384033|Antidepressive Agents|antidepressive agents|mesh-ancestor
25509895|NCT00384033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25509896|NCT00384033|Dopamine Agents|dopamine agents|mesh-ancestor
25509897|NCT00384059|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25509898|NCT00384059|Immunologic Factors|immunologic factors|mesh-ancestor
25509899|NCT00384059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509900|NCT00384085|Insulin|insulin|mesh-list
25509901|NCT00384085|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25509902|NCT00384085|Insulin Glargine|insulin glargine|mesh-list
25509903|NCT00384085|Insulin glulisine|insulin glulisine|mesh-list
25509904|NCT00384085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25509905|NCT00384085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509906|NCT00384176|Leucovorin|leucovorin|mesh-list
25509907|NCT00384176|Bevacizumab|bevacizumab|mesh-list
25509908|NCT00384176|Fluorouracil|fluorouracil|mesh-list
25509909|NCT00384176|Oxaliplatin|oxaliplatin|mesh-list
25509910|NCT00384176|Cediranib|cediranib|mesh-list
25509911|NCT00384176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25509912|NCT00384176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509913|NCT00384176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25509914|NCT00384176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25509915|NCT00384176|Growth Substances|growth substances|mesh-ancestor
25509916|NCT00384176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509917|NCT00384176|Growth Inhibitors|growth inhibitors|mesh-ancestor
25509918|NCT00384176|Antimetabolites|antimetabolites|mesh-ancestor
25509919|NCT00384176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509920|NCT00384176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25509921|NCT00384176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25509922|NCT00384176|Immunologic Factors|immunologic factors|mesh-ancestor
25509923|NCT00384176|Antidotes|antidotes|mesh-ancestor
25509924|NCT00384176|Protective Agents|protective agents|mesh-ancestor
25509925|NCT00384176|Vitamin B Complex|vitamin b complex|mesh-ancestor
25509926|NCT00384176|Vitamins|vitamins|mesh-ancestor
25509927|NCT00384176|Micronutrients|micronutrients|mesh-ancestor
25509928|NCT00384176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25509929|NCT00384176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509930|NCT00384189|Ciclesonide|ciclesonide|mesh-list
25509931|NCT00384189|Albuterol|albuterol|mesh-list
25509932|NCT00384189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25509933|NCT00384189|Autonomic Agents|autonomic agents|mesh-ancestor
25509934|NCT00384189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25509935|NCT00384189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509936|NCT00384189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25509937|NCT00384189|Respiratory System Agents|respiratory system agents|mesh-ancestor
25509938|NCT00384189|Tocolytic Agents|tocolytic agents|mesh-ancestor
25509939|NCT00384189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25509940|NCT00384189|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25509941|NCT00384189|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25509942|NCT00384189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25509943|NCT00384189|Adrenergic Agents|adrenergic agents|mesh-ancestor
25509944|NCT00384189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25509945|NCT00384189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509946|NCT00384189|Glucocorticoids|glucocorticoids|mesh-ancestor
25509947|NCT00384189|Hormones|hormones|mesh-ancestor
25509948|NCT00384189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25509949|NCT00384189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25509950|NCT00384332|Olanzapine|olanzapine|mesh-list
25509951|NCT00384332|Antiemetics|antiemetics|mesh-ancestor
25509952|NCT00384332|Autonomic Agents|autonomic agents|mesh-ancestor
25509953|NCT00384332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25509954|NCT00384332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509955|NCT00384332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25509956|NCT00384332|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25509957|NCT00384332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25509958|NCT00384332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25509959|NCT00384332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25509960|NCT00384332|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25509961|NCT00384332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25509962|NCT00384332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25509963|NCT00384332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509964|NCT00384332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25509965|NCT00384332|Serotonin Agents|serotonin agents|mesh-ancestor
25509966|NCT00384397|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25509967|NCT00384397|Immunologic Factors|immunologic factors|mesh-ancestor
25509968|NCT00384397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509969|NCT00384449|Ranibizumab|ranibizumab|mesh-list
25509970|NCT00384449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25509971|NCT00384449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25509972|NCT00384449|Growth Substances|growth substances|mesh-ancestor
25509973|NCT00384449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509974|NCT00384449|Growth Inhibitors|growth inhibitors|mesh-ancestor
25509975|NCT00384449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509976|NCT00384670|Vaccines|vaccines|mesh-list
25509977|NCT00384670|Immunologic Factors|immunologic factors|mesh-ancestor
25509978|NCT00384670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509979|NCT00384774|Lasmiditan|lasmiditan|mesh-list
25509980|NCT00384774|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25509981|NCT00384774|Serotonin Agents|serotonin agents|mesh-ancestor
25509982|NCT00384774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25509983|NCT00384774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509984|NCT00384774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509985|NCT00384839|Azacitidine|azacitidine|mesh-list
25509986|NCT00384839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25509987|NCT00384839|Antimetabolites|antimetabolites|mesh-ancestor
25509988|NCT00384839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25509989|NCT00384839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25509990|NCT00384839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25509991|NCT00384865|Aspirin|aspirin|mesh-list
25509992|NCT00384865|Simvastatin|simvastatin|mesh-list
25509993|NCT00384865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25509994|NCT00384865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25509995|NCT00384865|Analgesics|analgesics|mesh-ancestor
25509996|NCT00384865|Sensory System Agents|sensory system agents|mesh-ancestor
25509997|NCT00384865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25509998|NCT00384865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25509999|NCT00384865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25510000|NCT00384865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25510001|NCT00384865|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25510002|NCT00384865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25510003|NCT00384865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510004|NCT00384865|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25510005|NCT00384865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25510006|NCT00384865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510007|NCT00384865|Antipyretics|antipyretics|mesh-ancestor
25510008|NCT00384865|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25510009|NCT00384865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25510010|NCT00384865|Antimetabolites|antimetabolites|mesh-ancestor
25510011|NCT00384865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25510012|NCT00384865|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25510013|NCT00384930|Tadalafil|tadalafil|mesh-list
25510014|NCT00384930|Vasodilator Agents|vasodilator agents|mesh-ancestor
25510015|NCT00384930|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25510016|NCT00384930|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25510017|NCT00384930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510018|NCT00384930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510019|NCT00384930|Urological Agents|urological agents|mesh-ancestor
25510021|NCT00384956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25510022|NCT00384956|Antimetabolites|antimetabolites|mesh-ancestor
25510023|NCT00384956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510024|NCT00384956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510025|NCT00384956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510026|NCT00385008|Naproxen|naproxen|mesh-list
25510027|NCT00385008|Sumatriptan|sumatriptan|mesh-list
25510028|NCT00385008|Eletriptan|eletriptan|mesh-list
25510029|NCT00385008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25510030|NCT00385008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25510031|NCT00385008|Analgesics|analgesics|mesh-ancestor
25510032|NCT00385008|Sensory System Agents|sensory system agents|mesh-ancestor
25510033|NCT00385008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25510034|NCT00385008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510035|NCT00385008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25510036|NCT00385008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25510037|NCT00385008|Gout Suppressants|gout suppressants|mesh-ancestor
25510038|NCT00385008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25510039|NCT00385008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510040|NCT00385008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510041|NCT00385008|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25510042|NCT00385008|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25510043|NCT00385008|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25510044|NCT00385008|Serotonin Agents|serotonin agents|mesh-ancestor
25510045|NCT00385008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25510046|NCT00385138|Clopidogrel|clopidogrel|mesh-list
25510047|NCT00385138|Cangrelor|cangrelor|mesh-list
25510048|NCT00385138|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25510049|NCT00385138|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25510050|NCT00385138|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25510051|NCT00385138|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25510052|NCT00385138|Purinergic Agents|purinergic agents|mesh-ancestor
25510053|NCT00385138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25510054|NCT00385138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510055|NCT00385138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510056|NCT00385203|Cediranib|cediranib|mesh-list
25510057|NCT00385203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510058|NCT00385203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25510059|NCT00385203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510060|NCT00385203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510061|NCT00385216|Nicotine|nicotine|mesh-list
25510062|NCT00385216|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25510063|NCT00385216|Autonomic Agents|autonomic agents|mesh-ancestor
25510064|NCT00385216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25510065|NCT00385216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510066|NCT00385216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25510067|NCT00385216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25510068|NCT00385216|Cholinergic Agents|cholinergic agents|mesh-ancestor
25510069|NCT00385216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25510070|NCT00385216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510071|NCT00385268|Acamprosate|acamprosate|mesh-list
25510072|NCT00385268|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25510073|NCT00385541|Morphine|morphine|mesh-list
25510074|NCT00385541|Hydromorphone|hydromorphone|mesh-list
25510075|NCT00385541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25510076|NCT00385541|Narcotics|narcotics|mesh-ancestor
25510077|NCT00385541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25510078|NCT00385541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510079|NCT00385541|Analgesics|analgesics|mesh-ancestor
25510080|NCT00385541|Sensory System Agents|sensory system agents|mesh-ancestor
25510081|NCT00385541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25510082|NCT00385580|Dasatinib|dasatinib|mesh-list
25510083|NCT00385580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510084|NCT00385580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25510085|NCT00385580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510086|NCT00385580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510087|NCT00385593|Budesonide|budesonide|mesh-list
25510088|NCT00385593|Formoterol Fumarate|formoterol fumarate|mesh-list
25510089|NCT00385593|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25510090|NCT00385593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25510091|NCT00385593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25510092|NCT00385593|Autonomic Agents|autonomic agents|mesh-ancestor
25510093|NCT00385593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25510094|NCT00385593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510095|NCT00385593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25510096|NCT00385593|Respiratory System Agents|respiratory system agents|mesh-ancestor
25510097|NCT00385593|Glucocorticoids|glucocorticoids|mesh-ancestor
25510098|NCT00385593|Hormones|hormones|mesh-ancestor
25510099|NCT00385593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25510100|NCT00385593|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25510101|NCT00385593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25510102|NCT00385593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25645948|NCT01453153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25510105|NCT00385593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510106|NCT00385671|Pregabalin|pregabalin|mesh-list
25510107|NCT00385671|Gabapentin|gabapentin|mesh-list
25510108|NCT00385671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25510109|NCT00385671|Analgesics|analgesics|mesh-ancestor
25510110|NCT00385671|Sensory System Agents|sensory system agents|mesh-ancestor
25510111|NCT00385671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25510112|NCT00385671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510113|NCT00385671|Anticonvulsants|anticonvulsants|mesh-ancestor
25510114|NCT00385671|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25510115|NCT00385671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25510116|NCT00385671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510117|NCT00385671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25510118|NCT00385671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25510119|NCT00385671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25510120|NCT00385671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25510121|NCT00385671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25510122|NCT00385671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25510123|NCT00385671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25510124|NCT00385671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25510125|NCT00385671|Antimanic Agents|antimanic agents|mesh-ancestor
25510126|NCT00385671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25510127|NCT00385671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25510128|NCT00385671|Antidepressive Agents|antidepressive agents|mesh-ancestor
25510129|NCT00385671|Dopamine Agents|dopamine agents|mesh-ancestor
25510130|NCT00385684|Acetaminophen|acetaminophen|mesh-list
25510131|NCT00385684|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25510132|NCT00385684|Hydrocodone|hydrocodone|mesh-list
25510133|NCT00385684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25510134|NCT00385684|Narcotics|narcotics|mesh-ancestor
25510135|NCT00385684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25510136|NCT00385684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510137|NCT00385684|Analgesics|analgesics|mesh-ancestor
25510138|NCT00385684|Sensory System Agents|sensory system agents|mesh-ancestor
25510139|NCT00385684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25510140|NCT00385684|Antitussive Agents|antitussive agents|mesh-ancestor
25510141|NCT00385684|Respiratory System Agents|respiratory system agents|mesh-ancestor
25510142|NCT00385684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25510143|NCT00385684|Antipyretics|antipyretics|mesh-ancestor
25510144|NCT00385684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25510145|NCT00385684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25510146|NCT00385684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25510147|NCT00385736|Adalimumab|adalimumab|mesh-list
25510148|NCT00385736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25510149|NCT00385736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25510150|NCT00385762|Paroxetine|paroxetine|mesh-list
25510151|NCT00385762|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25510152|NCT00385762|Serotonin|serotonin|mesh-list
25510153|NCT00385762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25510154|NCT00385762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25510155|NCT00385762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510156|NCT00385762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25128334|NCT03048110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25128335|NCT03048110|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25128336|NCT03048110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25128337|NCT03048110|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25128338|NCT03048110|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25128344|NCT03047837|Aspirin|aspirin|mesh-list
25823302|NCT00004785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24795671|NCT01042379|Metformin|metformin|mesh-list
25510157|NCT00385762|Serotonin Agents|serotonin agents|mesh-ancestor
25510158|NCT00385762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510159|NCT00385762|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25510160|NCT00385762|Antidepressive Agents|antidepressive agents|mesh-ancestor
25510161|NCT00385762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25510162|NCT00385762|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25510163|NCT00385762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25510164|NCT00385762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510165|NCT00385762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25510179|NCT00385788|Antiviral Agents|antiviral agents|mesh-ancestor
25510180|NCT00385788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25510181|NCT00385788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510182|NCT00385788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25510183|NCT00385788|Immunologic Factors|immunologic factors|mesh-ancestor
25510184|NCT00385788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510185|NCT00385788|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25510186|NCT00385788|Abortifacient Agents|abortifacient agents|mesh-ancestor
25510187|NCT00385788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25510188|NCT00385788|Dermatologic Agents|dermatologic agents|mesh-ancestor
25510189|NCT00385788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25510190|NCT00385788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25510191|NCT00385788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25510192|NCT00385788|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25510193|NCT00385788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25510194|NCT00385788|Alkylating Agents|alkylating agents|mesh-ancestor
25510195|NCT00385788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25510196|NCT00385801|Risperidone|risperidone|mesh-list
25510197|NCT00385801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25510198|NCT00385801|Serotonin Agents|serotonin agents|mesh-ancestor
25510199|NCT00385801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25510200|NCT00385801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510201|NCT00385801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510202|NCT00385801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25510203|NCT00385801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25510204|NCT00385801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25510205|NCT00385801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25510206|NCT00385801|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25510207|NCT00385801|Dopamine Agents|dopamine agents|mesh-ancestor
25510208|NCT00385827|Prednisone|prednisone|mesh-list
25510209|NCT00385827|Mitoxantrone|mitoxantrone|mesh-list
25510210|NCT00385827|Siltuximab|siltuximab|mesh-list
25510211|NCT00385827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25510212|NCT00385827|Glucocorticoids|glucocorticoids|mesh-ancestor
25510213|NCT00385827|Hormones|hormones|mesh-ancestor
25829468|NCT00006214|Hormone Antagonists|hormone antagonists|mesh-ancestor
24794067|NCT05414058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981894|NCT01081951|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24981895|NCT01081951|Carboplatin|carboplatin|mesh-list
25510214|NCT00385827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25510215|NCT00385827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510216|NCT00385827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25510217|NCT00385827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510218|NCT00385827|Analgesics|analgesics|mesh-ancestor
25510219|NCT00385827|Sensory System Agents|sensory system agents|mesh-ancestor
25510220|NCT00385827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25510221|NCT00385827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25510223|NCT00385827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510224|NCT00385827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510225|NCT00385944|Clopidogrel|clopidogrel|mesh-list
25510226|NCT00385944|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25510227|NCT00385944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25510228|NCT00385944|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25510229|NCT00385944|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25510230|NCT00385944|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25510231|NCT00385944|Purinergic Agents|purinergic agents|mesh-ancestor
25510232|NCT00385944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25510233|NCT00385944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510234|NCT00385944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510235|NCT00385996|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25510236|NCT00385996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510237|NCT00385996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25510238|NCT00385996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510239|NCT00385996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510240|NCT00386009|Tadalafil|tadalafil|mesh-list
25510241|NCT00386009|Vasodilator Agents|vasodilator agents|mesh-ancestor
25510242|NCT00386009|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25510243|NCT00386009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25510244|NCT00386009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510245|NCT00386009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510246|NCT00386009|Urological Agents|urological agents|mesh-ancestor
25510247|NCT00386022|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25510248|NCT00386022|Estrogens|estrogens|mesh-list
25510249|NCT00386022|LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-|lhrh, n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-arg(5)-glu(6)-alanh2(10)-|mesh-list
25510250|NCT00386022|Hormones|hormones|mesh-ancestor
25510251|NCT00386022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25510252|NCT00386022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510253|NCT00386022|Hormone Antagonists|hormone antagonists|mesh-ancestor
25510254|NCT00386100|Metformin|metformin|mesh-list
25510255|NCT00386100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25510256|NCT00386100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510257|NCT00386152|Epoetin Alfa|epoetin alfa|mesh-list
25510258|NCT00386152|Darbepoetin alfa|darbepoetin alfa|mesh-list
25510259|NCT00386152|Hematinics|hematinics|mesh-ancestor
25510260|NCT00386243|Analgesics, Opioid|analgesics, opioid|mesh-list
25510261|NCT00386243|Analgesics|analgesics|mesh-list
25510262|NCT00386243|Narcotics|narcotics|mesh-ancestor
25510263|NCT00386243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25510264|NCT00386243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510265|NCT00386243|Sensory System Agents|sensory system agents|mesh-ancestor
25510266|NCT00386243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25510267|NCT00386308|Tranexamic Acid|tranexamic acid|mesh-list
25510268|NCT00386308|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25510269|NCT00386308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25510270|NCT00386308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510271|NCT00386308|Hemostatics|hemostatics|mesh-ancestor
25510272|NCT00386308|Coagulants|coagulants|mesh-ancestor
25510273|NCT00386334|Eszopiclone|eszopiclone|mesh-list
25510274|NCT00386334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25510275|NCT00386334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25510276|NCT00386334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510277|NCT00386360|Risedronic Acid|risedronic acid|mesh-list
25510278|NCT00386360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25510279|NCT00386360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24981939|NCT00788671|Levonorgestrel|levonorgestrel|mesh-list
24981940|NCT00788671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24981941|NCT00788671|Contraceptive Agents|contraceptive agents|mesh-ancestor
24981942|NCT00788671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24981943|NCT00788671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510280|NCT00386360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510281|NCT00386360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25510282|NCT00386360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510283|NCT00386360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25510284|NCT00386425|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
25510285|NCT00386425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25510286|NCT00386477|Povidone-Iodine|povidone-iodine|mesh-list
25645952|NCT01453205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25510289|NCT00386607|Valsartan|valsartan|mesh-list
25510290|NCT00386607|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25510291|NCT00386607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25510292|NCT00386607|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25510293|NCT00386607|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25510294|NCT00386607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510295|NCT00386607|Diuretics|diuretics|mesh-ancestor
25510296|NCT00386607|Natriuretic Agents|natriuretic agents|mesh-ancestor
25510297|NCT00386607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510298|NCT00386607|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25510299|NCT00386607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25510300|NCT00387010|Fentanyl|fentanyl|mesh-list
25510301|NCT00387010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25510302|NCT00387010|Narcotics|narcotics|mesh-ancestor
25510303|NCT00387010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25510304|NCT00387010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510305|NCT00387010|Analgesics|analgesics|mesh-ancestor
25510306|NCT00387010|Sensory System Agents|sensory system agents|mesh-ancestor
25510307|NCT00387010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25510308|NCT00387010|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25510309|NCT00387010|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25510310|NCT00387010|Anesthetics, General|anesthetics, general|mesh-ancestor
25510311|NCT00387010|Anesthetics|anesthetics|mesh-ancestor
25510312|NCT00387023|Rituximab|rituximab|mesh-list
25510313|NCT00387023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25510314|NCT00387023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510315|NCT00387023|Immunologic Factors|immunologic factors|mesh-ancestor
25510316|NCT00387023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510317|NCT00387023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25510318|NCT00387036|Fluticasone|fluticasone|mesh-list
25510319|NCT00387036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25510320|NCT00387036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25510321|NCT00387036|Autonomic Agents|autonomic agents|mesh-ancestor
25510322|NCT00387036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25510323|NCT00387036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510324|NCT00387036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25510325|NCT00387036|Respiratory System Agents|respiratory system agents|mesh-ancestor
25510326|NCT00387036|Dermatologic Agents|dermatologic agents|mesh-ancestor
25510327|NCT00387036|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25510328|NCT00387088|Tiotropium Bromide|tiotropium bromide|mesh-list
25510329|NCT00387088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25510330|NCT00387088|Autonomic Agents|autonomic agents|mesh-ancestor
25510331|NCT00387088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25510332|NCT00387088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510333|NCT00387088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25510334|NCT00387088|Respiratory System Agents|respiratory system agents|mesh-ancestor
25510335|NCT00387088|Parasympatholytics|parasympatholytics|mesh-ancestor
25510336|NCT00387088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25510337|NCT00387088|Cholinergic Agents|cholinergic agents|mesh-ancestor
25510338|NCT00387088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25510339|NCT00387088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510340|NCT00387127|Cisplatin|cisplatin|mesh-list
25510341|NCT00387127|Lapatinib|lapatinib|mesh-list
25510342|NCT00387127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510343|NCT00387127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25510344|NCT00387127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510345|NCT00387127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510346|NCT00387335|Sunitinib|sunitinib|mesh-list
25510347|NCT00387335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510348|NCT00387335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25510349|NCT00387335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25510350|NCT00387335|Growth Substances|growth substances|mesh-ancestor
25510351|NCT00387335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510352|NCT00387335|Growth Inhibitors|growth inhibitors|mesh-ancestor
25510353|NCT00387335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25510354|NCT00387335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510355|NCT00387335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510356|NCT00387348|Dexetimide|dexetimide|mesh-list
25510357|NCT00387348|Citalopram|citalopram|mesh-list
25510358|NCT00387348|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25510359|NCT00387348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25645953|NCT01453205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645954|NCT01453205|Immunologic Factors|immunologic factors|mesh-ancestor
25510360|NCT00387348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25510361|NCT00387348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510362|NCT00387348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25510363|NCT00387348|Serotonin Agents|serotonin agents|mesh-ancestor
25510364|NCT00387348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510365|NCT00387348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25510366|NCT00387348|Antidepressive Agents|antidepressive agents|mesh-ancestor
25510367|NCT00387348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25510368|NCT00387348|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25510369|NCT00387348|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25510370|NCT00387348|Parasympatholytics|parasympatholytics|mesh-ancestor
25510371|NCT00387348|Autonomic Agents|autonomic agents|mesh-ancestor
25510372|NCT00387348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25510373|NCT00387348|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25510374|NCT00387348|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25510375|NCT00387348|Cholinergic Agents|cholinergic agents|mesh-ancestor
25510376|NCT00387426|Sunitinib|sunitinib|mesh-list
25510377|NCT00387426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510378|NCT00387426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25510379|NCT00387426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25510380|NCT00387426|Growth Substances|growth substances|mesh-ancestor
25510381|NCT00387426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510382|NCT00387426|Growth Inhibitors|growth inhibitors|mesh-ancestor
25510383|NCT00387426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25510384|NCT00387426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510385|NCT00387426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510386|NCT00387465|Azacitidine|azacitidine|mesh-list
25510387|NCT00387465|Entinostat|entinostat|mesh-list
25510388|NCT00387465|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25510389|NCT00387465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25510390|NCT00387465|Antimetabolites|antimetabolites|mesh-ancestor
25510391|NCT00387465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510392|NCT00387465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510393|NCT00387465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510394|NCT00387621|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25510395|NCT00387621|Natriuretic Agents|natriuretic agents|mesh-ancestor
25510396|NCT00387621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510397|NCT00387647|Azacitidine|azacitidine|mesh-list
25510398|NCT00387647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25510399|NCT00387647|Antimetabolites|antimetabolites|mesh-ancestor
25510400|NCT00387647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510401|NCT00387647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510402|NCT00387647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510403|NCT00387660|Carboplatin|carboplatin|mesh-list
25510404|NCT00387660|Irinotecan|irinotecan|mesh-list
25510405|NCT00387660|Camptothecin|camptothecin|mesh-list
25510406|NCT00387660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510407|NCT00387660|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25510408|NCT00387660|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25510409|NCT00387660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510410|NCT00387660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510411|NCT00387660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25510412|NCT00387751|Bevacizumab|bevacizumab|mesh-list
25510413|NCT00387751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25510414|NCT00387751|Sorafenib|sorafenib|mesh-list
24500876|NCT00526175|Cytarabine|cytarabine|mesh-list
25510415|NCT00387751|Endothelial Growth Factors|endothelial growth factors|mesh-list
25510416|NCT00387751|Antibodies|antibodies|mesh-list
25510417|NCT00387751|Immunoglobulins|immunoglobulins|mesh-list
25510418|NCT00387751|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25510419|NCT00387751|Immunoglobulin G|immunoglobulin g|mesh-list
25510420|NCT00387751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510421|NCT00387751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25510422|NCT00387751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25510423|NCT00387751|Growth Substances|growth substances|mesh-ancestor
25510424|NCT00387751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982043|NCT04391855|Analgesics|analgesics|mesh-ancestor
24982044|NCT04391855|Sensory System Agents|sensory system agents|mesh-ancestor
25510425|NCT00387751|Growth Inhibitors|growth inhibitors|mesh-ancestor
25510426|NCT00387751|Immunologic Factors|immunologic factors|mesh-ancestor
25510427|NCT00387751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25510428|NCT00387751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510429|NCT00387751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510430|NCT00387790|Motexafin gadolinium|motexafin gadolinium|mesh-list
25510440|NCT00387829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25510441|NCT00387829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510442|NCT00387829|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25510443|NCT00387829|Contraceptive Agents|contraceptive agents|mesh-ancestor
25510444|NCT00387829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25510445|NCT00387829|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25510446|NCT00387881|Naproxen|naproxen|mesh-list
25510447|NCT00387881|Sumatriptan|sumatriptan|mesh-list
25510448|NCT00387881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25510449|NCT00387881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25510450|NCT00387881|Analgesics|analgesics|mesh-ancestor
25510451|NCT00387881|Sensory System Agents|sensory system agents|mesh-ancestor
25510452|NCT00387881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25510453|NCT00387881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510454|NCT00387881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25510455|NCT00387881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25510456|NCT00387881|Gout Suppressants|gout suppressants|mesh-ancestor
25510457|NCT00387881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25510458|NCT00387881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510459|NCT00387881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510460|NCT00387881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25510461|NCT00387881|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25510462|NCT00387881|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25510463|NCT00387881|Serotonin Agents|serotonin agents|mesh-ancestor
25510464|NCT00387881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25510465|NCT00387894|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25510466|NCT00387894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510467|NCT00387894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25510468|NCT00387894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510469|NCT00387894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510470|NCT00387959|Cyclosporine|cyclosporine|mesh-list
25510471|NCT00387959|Mycophenolic Acid|mycophenolic acid|mesh-list
25510472|NCT00387959|Cyclophosphamide|cyclophosphamide|mesh-list
25510473|NCT00387959|Rituximab|rituximab|mesh-list
25510474|NCT00387959|Fludarabine|fludarabine|mesh-list
25510475|NCT00387959|Fludarabine phosphate|fludarabine phosphate|mesh-list
25510476|NCT00387959|Cyclosporins|cyclosporins|mesh-list
25510477|NCT00387959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25510478|NCT00387959|Immunologic Factors|immunologic factors|mesh-ancestor
25510479|NCT00387959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510480|NCT00387959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25510481|NCT00387959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25510482|NCT00387959|Alkylating Agents|alkylating agents|mesh-ancestor
25510483|NCT00387959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510484|NCT00387959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24500977|NCT00526318|Doxorubicin|doxorubicin|mesh-list
25510485|NCT00387959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25510486|NCT00387959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25510487|NCT00387959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25510488|NCT00387959|Antimetabolites|antimetabolites|mesh-ancestor
25510498|NCT00388037|Sunitinib|sunitinib|mesh-list
25510499|NCT00388037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510500|NCT00388037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25510501|NCT00388037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25510502|NCT00388037|Growth Substances|growth substances|mesh-ancestor
25510503|NCT00388037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510504|NCT00388037|Growth Inhibitors|growth inhibitors|mesh-ancestor
25510507|NCT00388037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510508|NCT00388154|Gemcitabine|gemcitabine|mesh-list
25510510|NCT00388154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510511|NCT00388154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25510512|NCT00388154|Antimetabolites|antimetabolites|mesh-ancestor
25510513|NCT00388154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510514|NCT00388154|Antiviral Agents|antiviral agents|mesh-ancestor
25510515|NCT00388154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25510516|NCT00388154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510517|NCT00388154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25510518|NCT00388154|Immunologic Factors|immunologic factors|mesh-ancestor
25510519|NCT00388154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510520|NCT00388349|Gemcitabine|gemcitabine|mesh-list
25510521|NCT00388349|Cyclophosphamide|cyclophosphamide|mesh-list
25510522|NCT00388349|Carmustine|carmustine|mesh-list
25510523|NCT00388349|Etoposide|etoposide|mesh-list
25510524|NCT00388349|Vinorelbine|vinorelbine|mesh-list
25510525|NCT00388349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25510526|NCT00388349|Immunologic Factors|immunologic factors|mesh-ancestor
25510527|NCT00388349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510528|NCT00388349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25510529|NCT00388349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25510530|NCT00388349|Alkylating Agents|alkylating agents|mesh-ancestor
25510531|NCT00388349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510532|NCT00388349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510533|NCT00388349|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25510534|NCT00388349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25510535|NCT00388349|Antimetabolites|antimetabolites|mesh-ancestor
25510536|NCT00388349|Antiviral Agents|antiviral agents|mesh-ancestor
25510537|NCT00388349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25510538|NCT00388349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510539|NCT00388349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25510540|NCT00388349|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25510541|NCT00388349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25510542|NCT00388349|Tubulin Modulators|tubulin modulators|mesh-ancestor
25510543|NCT00388349|Antimitotic Agents|antimitotic agents|mesh-ancestor
25510544|NCT00388349|Mitosis Modulators|mitosis modulators|mesh-ancestor
25106298|NCT03117933|Mitosis Modulators|mitosis modulators|mesh-ancestor
25106299|NCT03117933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106300|NCT03117933|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25106301|NCT03117933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25106302|NCT03117933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25106303|NCT03107871|Valganciclovir|valganciclovir|mesh-list
24453064|NCT05339087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510546|NCT00388362|Prednisone|prednisone|mesh-list
25510547|NCT00388362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25510548|NCT00388362|Glucocorticoids|glucocorticoids|mesh-ancestor
25510549|NCT00388362|Hormones|hormones|mesh-ancestor
25510550|NCT00388362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25510551|NCT00388362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510552|NCT00388362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25510553|NCT00388362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510554|NCT00388362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25510555|NCT00388362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25510556|NCT00388362|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25510557|NCT00388362|Antifungal Agents|antifungal agents|mesh-ancestor
25510558|NCT00388362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25510559|NCT00388362|Immunologic Factors|immunologic factors|mesh-ancestor
25510560|NCT00388414|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25510561|NCT00388414|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25510562|NCT00388414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25510563|NCT00388414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25510564|NCT00388414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510565|NCT00388414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25510566|NCT00388414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510567|NCT00388414|Analgesics|analgesics|mesh-ancestor
25510568|NCT00388414|Sensory System Agents|sensory system agents|mesh-ancestor
25510569|NCT00388414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25510570|NCT00388414|Antidepressive Agents|antidepressive agents|mesh-ancestor
25510571|NCT00388414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25510572|NCT00388414|Dopamine Agents|dopamine agents|mesh-ancestor
25510573|NCT00388505|Tobramycin|tobramycin|mesh-list
25510574|NCT00388505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25510575|NCT00388505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25510576|NCT00388583|Vaccines|vaccines|mesh-list
25510577|NCT00388583|Immunologic Factors|immunologic factors|mesh-ancestor
25510578|NCT00388583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510579|NCT00388674|Entecavir|entecavir|mesh-list
25510580|NCT00388674|Antiviral Agents|antiviral agents|mesh-ancestor
25510581|NCT00388674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25510582|NCT00388804|Leuprolide|leuprolide|mesh-list
25510583|NCT00388804|Goserelin|goserelin|mesh-list
25510584|NCT00388804|Flutamide|flutamide|mesh-list
25510585|NCT00388804|Bicalutamide|bicalutamide|mesh-list
25510586|NCT00388804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25510587|NCT00388804|Fertility Agents|fertility agents|mesh-ancestor
25510588|NCT00388804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25510589|NCT00388804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510590|NCT00388804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25510591|NCT00388804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510592|NCT00388804|Androgen Antagonists|androgen antagonists|mesh-ancestor
25510593|NCT00388804|Hormone Antagonists|hormone antagonists|mesh-ancestor
25510594|NCT00388804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25510595|NCT00388973|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25510596|NCT00388973|Antidepressive Agents|antidepressive agents|mesh-ancestor
25510597|NCT00388973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25510598|NCT00388973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25510599|NCT00388973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25510600|NCT00388973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25510601|NCT00388973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510602|NCT00389064|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25510603|NCT00389064|Antidepressive Agents|antidepressive agents|mesh-ancestor
25510604|NCT00389064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25510605|NCT00389064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25510606|NCT00389064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25510607|NCT00389064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25510608|NCT00389064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510609|NCT00389168|Atenolol|atenolol|mesh-list
25510610|NCT00389168|Irbesartan|irbesartan|mesh-list
25510611|NCT00389168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25510612|NCT00389168|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25510613|NCT00389168|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25510614|NCT00389168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510615|NCT00389168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25510616|NCT00389168|Sympatholytics|sympatholytics|mesh-ancestor
25510617|NCT00389168|Autonomic Agents|autonomic agents|mesh-ancestor
25510618|NCT00389168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25510619|NCT00389168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510620|NCT00389168|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25510621|NCT00389168|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25510622|NCT00389168|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25510623|NCT00389168|Adrenergic Agents|adrenergic agents|mesh-ancestor
25510624|NCT00389168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25510625|NCT00389207|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25510626|NCT00389207|Nevirapine|nevirapine|mesh-list
25510627|NCT00389207|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25510628|NCT00389207|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25510629|NCT00389207|Protease Inhibitors|protease inhibitors|mesh-ancestor
25510630|NCT00389207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25164206|NCT05420350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25510631|NCT00389207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510632|NCT00389207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25510633|NCT00389207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25510634|NCT00389207|Antiviral Agents|antiviral agents|mesh-ancestor
25510635|NCT00389207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25510636|NCT00389207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25510637|NCT00389207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25510638|NCT00389207|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25510639|NCT00389207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25510640|NCT00389324|Immunoglobulins|immunoglobulins|mesh-list
25510641|NCT00389324|Antibodies|antibodies|mesh-list
25510642|NCT00389324|gamma-Globulins|gamma-globulins|mesh-list
25510643|NCT00389324|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25510644|NCT00389324|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25510645|NCT00389324|Immunoglobulin G|immunoglobulin g|mesh-list
25510646|NCT00389324|Immunologic Factors|immunologic factors|mesh-ancestor
25645956|NCT01453205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25645957|NCT01453348|Vaccines|vaccines|mesh-list
25645958|NCT01453348|Immunologic Factors|immunologic factors|mesh-ancestor
25510647|NCT00389324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510648|NCT00389441|Axitinib|axitinib|mesh-list
25510649|NCT00389441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510650|NCT00389441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25510651|NCT00389441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510652|NCT00389441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510653|NCT00389493|Risperidone|risperidone|mesh-list
25510654|NCT00389493|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25510655|NCT00389493|Serotonin Agents|serotonin agents|mesh-ancestor
25510656|NCT00389493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25510657|NCT00389493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510658|NCT00389493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510659|NCT00389493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25510660|NCT00389493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25510661|NCT00389493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25510662|NCT00389493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25510663|NCT00389493|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25510664|NCT00389493|Dopamine Agents|dopamine agents|mesh-ancestor
25510665|NCT00389519|Ramipril|ramipril|mesh-list
25510666|NCT00389519|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25510667|NCT00389519|Protease Inhibitors|protease inhibitors|mesh-ancestor
25510668|NCT00389519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510669|NCT00389519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510670|NCT00389519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25510671|NCT00389532|Vaccines|vaccines|mesh-list
25510672|NCT00389532|Immunologic Factors|immunologic factors|mesh-ancestor
25510673|NCT00389532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510674|NCT00389805|Pemetrexed|pemetrexed|mesh-list
25510675|NCT00389805|Bortezomib|bortezomib|mesh-list
25510676|NCT00389805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510677|NCT00389805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510678|NCT00389805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510679|NCT00389805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25510680|NCT00389805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25510681|NCT00389818|Prednisone|prednisone|mesh-list
25510682|NCT00389818|Cyclophosphamide|cyclophosphamide|mesh-list
25510683|NCT00389818|Rituximab|rituximab|mesh-list
25510684|NCT00389818|Doxorubicin|doxorubicin|mesh-list
25510685|NCT00389818|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25510686|NCT00389818|Vincristine|vincristine|mesh-list
25510687|NCT00389818|Sargramostim|sargramostim|mesh-list
25510688|NCT00389818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25510689|NCT00389818|Immunologic Factors|immunologic factors|mesh-ancestor
25510690|NCT00389818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510691|NCT00389818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25510692|NCT00389818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25510693|NCT00389818|Alkylating Agents|alkylating agents|mesh-ancestor
25510694|NCT00389818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510695|NCT00389818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510696|NCT00389818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25510697|NCT00389818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25510698|NCT00389818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25510699|NCT00389818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25510700|NCT00389818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25510701|NCT00389818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510702|NCT00389818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25510703|NCT00389818|Glucocorticoids|glucocorticoids|mesh-ancestor
25510704|NCT00389818|Hormones|hormones|mesh-ancestor
25510705|NCT00389818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25510706|NCT00389818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25510707|NCT00389818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25510708|NCT00389818|Tubulin Modulators|tubulin modulators|mesh-ancestor
25510709|NCT00389818|Antimitotic Agents|antimitotic agents|mesh-ancestor
25510710|NCT00389818|Mitosis Modulators|mitosis modulators|mesh-ancestor
25510711|NCT00389831|Rotigotine|rotigotine|mesh-list
25510712|NCT00389831|Dopamine Agonists|dopamine agonists|mesh-ancestor
25510713|NCT00389831|Dopamine Agents|dopamine agents|mesh-ancestor
25510714|NCT00389831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25510715|NCT00389831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645959|NCT01453348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645960|NCT01453374|Naltrexone|naltrexone|mesh-list
25645961|NCT01453374|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25645962|NCT01453374|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25645963|NCT01453374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645964|NCT01453374|Sensory System Agents|sensory system agents|mesh-ancestor
25645965|NCT01453374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25510716|NCT00389831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510717|NCT00389857|Vaccines|vaccines|mesh-list
25510718|NCT00389857|Immunologic Factors|immunologic factors|mesh-ancestor
25510719|NCT00389857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510720|NCT00389974|Sunitinib|sunitinib|mesh-list
25510721|NCT00389974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510722|NCT00389974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25510723|NCT00389974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25510724|NCT00389974|Growth Substances|growth substances|mesh-ancestor
25510725|NCT00389974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510726|NCT00389974|Growth Inhibitors|growth inhibitors|mesh-ancestor
25510727|NCT00389974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25510728|NCT00389974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510729|NCT00389974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510730|NCT00390013|Gabapentin|gabapentin|mesh-list
25510731|NCT00390013|Analgesics|analgesics|mesh-ancestor
25510732|NCT00390013|Sensory System Agents|sensory system agents|mesh-ancestor
25510733|NCT00390013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25510734|NCT00390013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510735|NCT00390013|Anticonvulsants|anticonvulsants|mesh-ancestor
25510736|NCT00390013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25510737|NCT00390013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25510738|NCT00390013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25510739|NCT00390013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25510740|NCT00390013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25510741|NCT00390013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25510742|NCT00390013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25510743|NCT00390013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510744|NCT00390013|Antimanic Agents|antimanic agents|mesh-ancestor
25510745|NCT00390182|Gemcitabine|gemcitabine|mesh-list
25510746|NCT00390182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25510747|NCT00390182|Antimetabolites|antimetabolites|mesh-ancestor
25510748|NCT00390182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510749|NCT00390182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510750|NCT00390182|Antiviral Agents|antiviral agents|mesh-ancestor
25510751|NCT00390182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25510752|NCT00390182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510753|NCT00390182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25510754|NCT00390182|Immunologic Factors|immunologic factors|mesh-ancestor
25510755|NCT00390182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510756|NCT00390221|Daclizumab|daclizumab|mesh-list
25510757|NCT00390221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25510758|NCT00390221|Immunologic Factors|immunologic factors|mesh-ancestor
25510759|NCT00390221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510760|NCT00390234|Aflibercept|aflibercept|mesh-list
25510761|NCT00390234|Endothelial Growth Factors|endothelial growth factors|mesh-list
25510762|NCT00390234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24810413|NCT02040142|Mitomycins|mitomycins|mesh-list
25510763|NCT00390234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25510764|NCT00390234|Growth Substances|growth substances|mesh-ancestor
25510765|NCT00390234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510766|NCT00390234|Growth Inhibitors|growth inhibitors|mesh-ancestor
25510767|NCT00390234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510768|NCT00390364|Everolimus|everolimus|mesh-list
25510769|NCT00390364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510770|NCT00390364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25510771|NCT00390364|Immunologic Factors|immunologic factors|mesh-ancestor
25510772|NCT00390364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510773|NCT00390416|Leucovorin|leucovorin|mesh-list
25510774|NCT00390416|Bevacizumab|bevacizumab|mesh-list
25510775|NCT00390416|Cisplatin|cisplatin|mesh-list
25510776|NCT00390416|Docetaxel|docetaxel|mesh-list
25510777|NCT00390416|Fluorouracil|fluorouracil|mesh-list
25510778|NCT00390416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25510779|NCT00390416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510780|NCT00390416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25510781|NCT00390416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25510782|NCT00390416|Growth Substances|growth substances|mesh-ancestor
25510783|NCT00390416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510784|NCT00390416|Growth Inhibitors|growth inhibitors|mesh-ancestor
25645966|NCT01453595|Dactolisib|dactolisib|mesh-list
25510785|NCT00390416|Tubulin Modulators|tubulin modulators|mesh-ancestor
25823303|NCT00004785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645967|NCT01453595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25645968|NCT01453725|Golimumab|golimumab|mesh-list
25645969|NCT01453725|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25510786|NCT00390416|Antimitotic Agents|antimitotic agents|mesh-ancestor
25510787|NCT00390416|Mitosis Modulators|mitosis modulators|mesh-ancestor
25510788|NCT00390416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510789|NCT00390416|Antimetabolites|antimetabolites|mesh-ancestor
25510790|NCT00390416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25510791|NCT00390416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25645970|NCT01453725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25645971|NCT01453725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25510792|NCT00390416|Immunologic Factors|immunologic factors|mesh-ancestor
25510793|NCT00390416|Antidotes|antidotes|mesh-ancestor
25510794|NCT00390416|Protective Agents|protective agents|mesh-ancestor
25510795|NCT00390416|Vitamin B Complex|vitamin b complex|mesh-ancestor
25510796|NCT00390416|Vitamins|vitamins|mesh-ancestor
25510797|NCT00390416|Micronutrients|micronutrients|mesh-ancestor
25510798|NCT00390429|Docetaxel|docetaxel|mesh-list
25510799|NCT00390429|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25510800|NCT00390429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510801|NCT00390429|Tubulin Modulators|tubulin modulators|mesh-ancestor
25510802|NCT00390429|Antimitotic Agents|antimitotic agents|mesh-ancestor
25510803|NCT00390429|Mitosis Modulators|mitosis modulators|mesh-ancestor
25510804|NCT00390429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510805|NCT00390429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25510806|NCT00390429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510807|NCT00390455|Fulvestrant|fulvestrant|mesh-list
25510808|NCT00390455|Lapatinib|lapatinib|mesh-list
25510809|NCT00390455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25510810|NCT00390455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510811|NCT00390455|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25510812|NCT00390455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25510813|NCT00390455|Hormone Antagonists|hormone antagonists|mesh-ancestor
25510814|NCT00390455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25510815|NCT00390455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510816|NCT00390455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25510817|NCT00390455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510818|NCT00390455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510819|NCT00390546|Propranolol|propranolol|mesh-list
25510820|NCT00390546|Digoxin|digoxin|mesh-list
25510821|NCT00390546|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25510822|NCT00390546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25510823|NCT00390546|Adrenergic Agents|adrenergic agents|mesh-ancestor
25510824|NCT00390546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25510825|NCT00390546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510826|NCT00390546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510827|NCT00390546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25510828|NCT00390546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25510829|NCT00390546|Vasodilator Agents|vasodilator agents|mesh-ancestor
25510830|NCT00390546|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25510831|NCT00390546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510832|NCT00390546|Protective Agents|protective agents|mesh-ancestor
25510833|NCT00390559|Nicotine|nicotine|mesh-list
25510834|NCT00390559|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25510835|NCT00390559|Autonomic Agents|autonomic agents|mesh-ancestor
25510836|NCT00390559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25510837|NCT00390559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982215|NCT03501381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982216|NCT03495973|Ustekinumab|ustekinumab|mesh-list
24982217|NCT03495973|Dermatologic Agents|dermatologic agents|mesh-ancestor
24982218|NCT03450629|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24982219|NCT03450629|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24982220|NCT03450629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24982221|NCT03450629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25510838|NCT00390559|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25510839|NCT00390559|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25510840|NCT00390559|Cholinergic Agents|cholinergic agents|mesh-ancestor
25510841|NCT00390559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25510842|NCT00390559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510843|NCT00390611|Paclitaxel|paclitaxel|mesh-list
24953999|NCT03880045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779685|NCT01878201|Valsartan|valsartan|mesh-list
25510844|NCT00390611|Carboplatin|carboplatin|mesh-list
25510845|NCT00390611|Sorafenib|sorafenib|mesh-list
25510846|NCT00390611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25510847|NCT00390611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510848|NCT00390611|Tubulin Modulators|tubulin modulators|mesh-ancestor
25510849|NCT00390611|Antimitotic Agents|antimitotic agents|mesh-ancestor
25510850|NCT00390611|Mitosis Modulators|mitosis modulators|mesh-ancestor
25510851|NCT00390611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510852|NCT00390611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25510853|NCT00390611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510854|NCT00390689|Pramipexole|pramipexole|mesh-list
25510855|NCT00390689|Antioxidants|antioxidants|mesh-ancestor
25510856|NCT00390689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510857|NCT00390689|Protective Agents|protective agents|mesh-ancestor
25510858|NCT00390689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510859|NCT00390689|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25510860|NCT00390689|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25510861|NCT00390689|Dopamine Agonists|dopamine agonists|mesh-ancestor
25510862|NCT00390689|Dopamine Agents|dopamine agents|mesh-ancestor
25510863|NCT00390689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25510864|NCT00390780|Clotrimazole|clotrimazole|mesh-list
25510865|NCT00390780|Miconazole|miconazole|mesh-list
25510866|NCT00390780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25510867|NCT00390780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25510868|NCT00390780|Antifungal Agents|antifungal agents|mesh-ancestor
25510869|NCT00390780|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25510870|NCT00390780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25510871|NCT00390780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510872|NCT00390780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510873|NCT00390780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25510874|NCT00390780|Hormone Antagonists|hormone antagonists|mesh-ancestor
25510875|NCT00390780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25510876|NCT00390780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510877|NCT00390780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25510878|NCT00390780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25510879|NCT00390806|Topotecan|topotecan|mesh-list
25510880|NCT00390806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25510881|NCT00390806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25510882|NCT00390806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510883|NCT00390806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510884|NCT00390806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510885|NCT00390858|Deferasirox|deferasirox|mesh-list
25510886|NCT00390858|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25510887|NCT00390858|Chelating Agents|chelating agents|mesh-ancestor
25510888|NCT00390858|Sequestering Agents|sequestering agents|mesh-ancestor
25510889|NCT00390858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510890|NCT00390884|Vaccines|vaccines|mesh-list
25510891|NCT00390884|Immunologic Factors|immunologic factors|mesh-ancestor
25510892|NCT00390884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510893|NCT00390910|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25510894|NCT00390910|Immunologic Factors|immunologic factors|mesh-ancestor
25510895|NCT00390910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510896|NCT00391027|Insulin|insulin|mesh-list
25510897|NCT00391027|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25510898|NCT00391027|Insulin Glargine|insulin glargine|mesh-list
25510899|NCT00391027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25510900|NCT00391027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510901|NCT00391053|Vaccines|vaccines|mesh-list
25510902|NCT00391053|Immunologic Factors|immunologic factors|mesh-ancestor
25510903|NCT00391053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510904|NCT00391079|Nabiximols|nabiximols|mesh-list
25510905|NCT00391079|Analgesics|analgesics|mesh-ancestor
25510906|NCT00391079|Sensory System Agents|sensory system agents|mesh-ancestor
25510907|NCT00391079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25510908|NCT00391079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510909|NCT00391092|Bevacizumab|bevacizumab|mesh-list
25510910|NCT00391092|Trastuzumab|trastuzumab|mesh-list
25510911|NCT00391092|Docetaxel|docetaxel|mesh-list
25510912|NCT00391092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25510913|NCT00391092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510915|NCT00391092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25510916|NCT00391092|Growth Substances|growth substances|mesh-ancestor
25510917|NCT00391092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510918|NCT00391092|Growth Inhibitors|growth inhibitors|mesh-ancestor
25510919|NCT00391092|Tubulin Modulators|tubulin modulators|mesh-ancestor
25510920|NCT00391092|Antimitotic Agents|antimitotic agents|mesh-ancestor
25510921|NCT00391092|Mitosis Modulators|mitosis modulators|mesh-ancestor
25510922|NCT00391092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510924|NCT00391118|Carboplatin|carboplatin|mesh-list
25510925|NCT00391118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25510926|NCT00391118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510927|NCT00391118|Tubulin Modulators|tubulin modulators|mesh-ancestor
25510928|NCT00391118|Antimitotic Agents|antimitotic agents|mesh-ancestor
25510929|NCT00391118|Mitosis Modulators|mitosis modulators|mesh-ancestor
25510930|NCT00391118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510931|NCT00391222|Olanzapine|olanzapine|mesh-list
25510932|NCT00391222|Risperidone|risperidone|mesh-list
25510933|NCT00391222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25510934|NCT00391222|Serotonin Agents|serotonin agents|mesh-ancestor
25510935|NCT00391222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25510936|NCT00391222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510937|NCT00391222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510938|NCT00391222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25510939|NCT00391222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25510940|NCT00391222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25510941|NCT00391222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25510942|NCT00391222|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25510943|NCT00391222|Dopamine Agents|dopamine agents|mesh-ancestor
25510944|NCT00391222|Antiemetics|antiemetics|mesh-ancestor
25510945|NCT00391222|Autonomic Agents|autonomic agents|mesh-ancestor
25510946|NCT00391222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25510947|NCT00391222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25510948|NCT00391222|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25510949|NCT00391222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25510950|NCT00391222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25510951|NCT00391274|Docetaxel|docetaxel|mesh-list
25510952|NCT00391274|Pemetrexed|pemetrexed|mesh-list
25510953|NCT00391274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510954|NCT00391274|Tubulin Modulators|tubulin modulators|mesh-ancestor
25510955|NCT00391274|Antimitotic Agents|antimitotic agents|mesh-ancestor
25510956|NCT00391274|Mitosis Modulators|mitosis modulators|mesh-ancestor
25510957|NCT00391274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510958|NCT00391274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510959|NCT00391274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25510960|NCT00391274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25510961|NCT00391391|Vaccines|vaccines|mesh-list
25510962|NCT00391391|Immunologic Factors|immunologic factors|mesh-ancestor
24502528|NCT04988685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510963|NCT00391391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510964|NCT00391443|Bosentan|bosentan|mesh-list
25510965|NCT00391443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25510966|NCT00391443|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25510967|NCT00391443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510968|NCT00391586|Gemcitabine|gemcitabine|mesh-list
25510969|NCT00391586|Paclitaxel|paclitaxel|mesh-list
25510970|NCT00391586|Etoposide|etoposide|mesh-list
25510971|NCT00391586|Vinorelbine|vinorelbine|mesh-list
25510972|NCT00391586|Docetaxel|docetaxel|mesh-list
25510973|NCT00391586|Irinotecan|irinotecan|mesh-list
25510974|NCT00391586|Pemetrexed|pemetrexed|mesh-list
25510975|NCT00391586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25510976|NCT00391586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25510977|NCT00391586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25510978|NCT00391586|Tubulin Modulators|tubulin modulators|mesh-ancestor
25510979|NCT00391586|Antimitotic Agents|antimitotic agents|mesh-ancestor
25823304|NCT00004785|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25823305|NCT00004785|Protective Agents|protective agents|mesh-ancestor
25823306|NCT00004786|Iloprost|iloprost|mesh-list
25823307|NCT00004786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25823308|NCT00004786|Vasodilator Agents|vasodilator agents|mesh-ancestor
24982396|NCT02703623|Carboplatin|carboplatin|mesh-list
24982397|NCT02703623|Ipilimumab|ipilimumab|mesh-list
24982398|NCT02703623|Abiraterone Acetate|abiraterone acetate|mesh-list
25510980|NCT00391586|Mitosis Modulators|mitosis modulators|mesh-ancestor
25510981|NCT00391586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25510982|NCT00391586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25510983|NCT00391586|Antimetabolites|antimetabolites|mesh-ancestor
25510984|NCT00391586|Antiviral Agents|antiviral agents|mesh-ancestor
25510985|NCT00391586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25510986|NCT00391586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25510987|NCT00391586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25510988|NCT00391586|Immunologic Factors|immunologic factors|mesh-ancestor
25510989|NCT00391586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25510990|NCT00391586|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25510991|NCT00391586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25511000|NCT00391716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511001|NCT00391716|Anticonvulsants|anticonvulsants|mesh-ancestor
25511002|NCT00391716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25511003|NCT00391716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25511004|NCT00391716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25511005|NCT00391716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25511006|NCT00391716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25511007|NCT00391716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25511008|NCT00391716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25511009|NCT00391716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511010|NCT00391716|Antimanic Agents|antimanic agents|mesh-ancestor
25511011|NCT00391768|Oseltamivir|oseltamivir|mesh-list
25511012|NCT00391768|Antiviral Agents|antiviral agents|mesh-ancestor
25511013|NCT00391768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25511014|NCT00391768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25511015|NCT00391768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511016|NCT00391807|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25511017|NCT00391807|Norethindrone|norethindrone|mesh-list
25511018|NCT00391807|Norethindrone Acetate|norethindrone acetate|mesh-list
25511019|NCT00391807|Estradiol|estradiol|mesh-list
25511020|NCT00391807|Estrogens|estrogens|mesh-ancestor
25511021|NCT00391807|Hormones|hormones|mesh-ancestor
25511022|NCT00391807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25511023|NCT00391807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511024|NCT00391807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25511025|NCT00391807|Contraceptive Agents|contraceptive agents|mesh-ancestor
25511026|NCT00391807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25511027|NCT00391807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25511028|NCT00391807|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25203136|NCT02716142|Oxytocics|oxytocics|mesh-ancestor
25511029|NCT00391807|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25511030|NCT00391807|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25511031|NCT00391846|Metoprolol|metoprolol|mesh-list
25511032|NCT00391846|Valsartan|valsartan|mesh-list
25511033|NCT00391846|Carvedilol|carvedilol|mesh-list
25511034|NCT00391846|Candesartan|candesartan|mesh-list
25511035|NCT00391846|Ramipril|ramipril|mesh-list
25511036|NCT00391846|Enalapril|enalapril|mesh-list
25511037|NCT00391846|Lisinopril|lisinopril|mesh-list
25511038|NCT00391846|Eplerenone|eplerenone|mesh-list
25511039|NCT00391846|Bisoprolol|bisoprolol|mesh-list
25511040|NCT00391846|Captopril|captopril|mesh-list
25511041|NCT00391846|Trandolapril|trandolapril|mesh-list
25511042|NCT00391846|Spironolactone|spironolactone|mesh-list
25511043|NCT00391846|Diuretics|diuretics|mesh-list
25511044|NCT00391846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25511045|NCT00391846|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25511046|NCT00391846|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25511047|NCT00391846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511048|NCT00391846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24982552|NCT02308527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823309|NCT00004787|Lenograstim|lenograstim|mesh-list
25511049|NCT00391846|Sympatholytics|sympatholytics|mesh-ancestor
25511050|NCT00391846|Autonomic Agents|autonomic agents|mesh-ancestor
25511051|NCT00391846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25511052|NCT00391846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511053|NCT00391846|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25511054|NCT00391846|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25511055|NCT00391846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25511056|NCT00391846|Adrenergic Agents|adrenergic agents|mesh-ancestor
25511057|NCT00391846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25511058|NCT00391846|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25511063|NCT00391846|Antioxidants|antioxidants|mesh-ancestor
25511064|NCT00391846|Protective Agents|protective agents|mesh-ancestor
25511065|NCT00391846|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25511066|NCT00391846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25511067|NCT00391846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25511068|NCT00391846|Vasodilator Agents|vasodilator agents|mesh-ancestor
25511069|NCT00391846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25511070|NCT00391846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25511071|NCT00391846|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25511072|NCT00391846|Protease Inhibitors|protease inhibitors|mesh-ancestor
25511073|NCT00391846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25511074|NCT00391846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25511075|NCT00391872|Clopidogrel|clopidogrel|mesh-list
25511076|NCT00391872|Ticagrelor|ticagrelor|mesh-list
25511077|NCT00391872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25511078|NCT00391872|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25511079|NCT00391872|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25511080|NCT00391872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25511081|NCT00391872|Purinergic Agents|purinergic agents|mesh-ancestor
25511082|NCT00391872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25511083|NCT00391872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511084|NCT00391872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511085|NCT00391898|Levodopa|levodopa|mesh-list
25511086|NCT00391898|Carbidopa|carbidopa|mesh-list
25511087|NCT00391898|Entacapone|entacapone|mesh-list
25511088|NCT00391898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25511089|NCT00391898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25511090|NCT00391898|Dopamine Agents|dopamine agents|mesh-ancestor
25511091|NCT00391898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25511092|NCT00391898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511093|NCT00391898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511094|NCT00391898|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25511095|NCT00391898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25511096|NCT00391898|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25511097|NCT00391976|Tobramycin|tobramycin|mesh-list
24810486|NCT02040454|Paclitaxel|paclitaxel|mesh-list
25511098|NCT00391976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25511099|NCT00391976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25511100|NCT00391989|Dasatinib|dasatinib|mesh-list
25511101|NCT00391989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25511102|NCT00391989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25511103|NCT00391989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25511104|NCT00391989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511105|NCT00392041|Eszopiclone|eszopiclone|mesh-list
25511106|NCT00392041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25511107|NCT00392041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25511108|NCT00392041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511109|NCT00392054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
25511110|NCT00392171|Temozolomide|temozolomide|mesh-list
25511111|NCT00392171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25511112|NCT00392171|Alkylating Agents|alkylating agents|mesh-ancestor
25511113|NCT00392171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511114|NCT00392171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25511115|NCT00392197|Aripiprazole|aripiprazole|mesh-list
25511116|NCT00392197|Antidepressive Agents|antidepressive agents|mesh-ancestor
25511117|NCT00392197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25511118|NCT00392197|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25511119|NCT00392197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25511120|NCT00392197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25511121|NCT00392197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511122|NCT00392197|Dopamine Agonists|dopamine agonists|mesh-ancestor
25511123|NCT00392197|Dopamine Agents|dopamine agents|mesh-ancestor
25511124|NCT00392197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25511125|NCT00392197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511126|NCT00392197|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25511133|NCT00392223|Azithromycin|azithromycin|mesh-list
25511134|NCT00392223|Minocycline|minocycline|mesh-list
25511135|NCT00392223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25511136|NCT00392223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25511137|NCT00392288|Ciclesonide|ciclesonide|mesh-list
25511138|NCT00392288|Glucocorticoids|glucocorticoids|mesh-ancestor
25511140|NCT00392288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25511141|NCT00392288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511142|NCT00392288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25511143|NCT00392379|Nicotine|nicotine|mesh-list
25511144|NCT00392379|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25511145|NCT00392379|Autonomic Agents|autonomic agents|mesh-ancestor
25511146|NCT00392379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25511147|NCT00392379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511148|NCT00392379|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25511149|NCT00392379|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25511150|NCT00392379|Cholinergic Agents|cholinergic agents|mesh-ancestor
25511151|NCT00392379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25511152|NCT00392379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511153|NCT00392392|Paclitaxel|paclitaxel|mesh-list
25511154|NCT00392392|Bevacizumab|bevacizumab|mesh-list
25511155|NCT00392392|Trastuzumab|trastuzumab|mesh-list
25511156|NCT00392392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25511157|NCT00392392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998265|NCT03243058|Aldesleukin|aldesleukin|mesh-list
25823310|NCT00004787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25823311|NCT00004787|Immunologic Factors|immunologic factors|mesh-ancestor
25823312|NCT00004787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823313|NCT00004789|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
25823314|NCT00004789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823315|NCT00004789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823316|NCT00004794|Cidofovir|cidofovir|mesh-list
25823317|NCT00004794|Antiviral Agents|antiviral agents|mesh-ancestor
24982652|NCT01307046|Losartan|losartan|mesh-list
24982653|NCT01307046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24982654|NCT01307046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24982655|NCT01307046|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25823318|NCT00004794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25823319|NCT00004794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823320|NCT00004794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982671|NCT01041807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982672|NCT01041807|Vasodilator Agents|vasodilator agents|mesh-ancestor
24982673|NCT01041807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24982674|NCT01041807|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24982675|NCT01041807|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25162478|NCT02904499|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25162479|NCT02904499|Protease Inhibitors|protease inhibitors|mesh-ancestor
25162480|NCT02904499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25162481|NCT02904499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162482|NCT02904499|Anticoagulants|anticoagulants|mesh-ancestor
25162483|NCT02904369|Tenofovir|tenofovir|mesh-list
25511158|NCT00392392|Tubulin Modulators|tubulin modulators|mesh-ancestor
25511159|NCT00392392|Antimitotic Agents|antimitotic agents|mesh-ancestor
25511160|NCT00392392|Mitosis Modulators|mitosis modulators|mesh-ancestor
25511161|NCT00392392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511162|NCT00392392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25511163|NCT00392392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25511164|NCT00392392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25511165|NCT00392392|Growth Substances|growth substances|mesh-ancestor
25511166|NCT00392392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511167|NCT00392392|Growth Inhibitors|growth inhibitors|mesh-ancestor
25645972|NCT01453725|Immunologic Factors|immunologic factors|mesh-ancestor
25645973|NCT01453725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25645974|NCT01453855|Travoprost|travoprost|mesh-list
25645975|NCT01453855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25645976|NCT01453855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25511168|NCT00392444|Sunitinib|sunitinib|mesh-list
25511169|NCT00392444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25511170|NCT00392444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25511171|NCT00392444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25511172|NCT00392444|Growth Substances|growth substances|mesh-ancestor
25511173|NCT00392444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511174|NCT00392444|Growth Inhibitors|growth inhibitors|mesh-ancestor
25511175|NCT00392444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25511176|NCT00392444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25511177|NCT00392444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511178|NCT00392496|Sunitinib|sunitinib|mesh-list
25511179|NCT00392496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25511180|NCT00392496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25511181|NCT00392496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25511182|NCT00392496|Growth Substances|growth substances|mesh-ancestor
25511183|NCT00392496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511184|NCT00392496|Growth Inhibitors|growth inhibitors|mesh-ancestor
25511185|NCT00392496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25511186|NCT00392496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25511187|NCT00392496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511188|NCT00392665|Sulindac|sulindac|mesh-list
25511189|NCT00392665|Bevacizumab|bevacizumab|mesh-list
25511190|NCT00392665|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25511191|NCT00392665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25511192|NCT00392665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25511193|NCT00392665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25511194|NCT00392665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25511195|NCT00392665|Growth Substances|growth substances|mesh-ancestor
25511196|NCT00392665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511197|NCT00392665|Growth Inhibitors|growth inhibitors|mesh-ancestor
25511198|NCT00392665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25511199|NCT00392665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25164364|NCT05393505|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25511200|NCT00392665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511201|NCT00392665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25511202|NCT00392665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25511203|NCT00392665|Analgesics|analgesics|mesh-ancestor
25511204|NCT00392665|Sensory System Agents|sensory system agents|mesh-ancestor
25511205|NCT00392665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25511206|NCT00392665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25511207|NCT00392665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25511208|NCT00392665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25511209|NCT00392678|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
25511210|NCT00392678|Sodium Salicylate|sodium salicylate|mesh-list
25511211|NCT00392678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25511212|NCT00392678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25511213|NCT00392678|Analgesics|analgesics|mesh-ancestor
25511214|NCT00392678|Sensory System Agents|sensory system agents|mesh-ancestor
25511215|NCT00392678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25511216|NCT00392678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511217|NCT00392678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25511218|NCT00392678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25511219|NCT00392678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25511220|NCT00392678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25511221|NCT00392678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511222|NCT00392704|Paclitaxel|paclitaxel|mesh-list
25511223|NCT00392704|Bevacizumab|bevacizumab|mesh-list
25511224|NCT00392704|Fluorouracil|fluorouracil|mesh-list
25511225|NCT00392704|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25511226|NCT00392704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25511227|NCT00392704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25511228|NCT00392704|Tubulin Modulators|tubulin modulators|mesh-ancestor
25511229|NCT00392704|Antimitotic Agents|antimitotic agents|mesh-ancestor
25511230|NCT00392704|Mitosis Modulators|mitosis modulators|mesh-ancestor
24982687|NCT00739674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25511231|NCT00392704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511232|NCT00392704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25511233|NCT00392704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25645977|NCT01453855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25823321|NCT00004795|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25511234|NCT00392704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25511235|NCT00392704|Growth Substances|growth substances|mesh-ancestor
25645978|NCT01453998|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25645979|NCT01453998|Immunologic Factors|immunologic factors|mesh-ancestor
25511236|NCT00392704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511237|NCT00392704|Growth Inhibitors|growth inhibitors|mesh-ancestor
25511238|NCT00392704|Antimetabolites|antimetabolites|mesh-ancestor
25511239|NCT00392704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25511240|NCT00392704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25511241|NCT00392704|Immunologic Factors|immunologic factors|mesh-ancestor
25511242|NCT00392704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25511243|NCT00392704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25511245|NCT00392769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25511246|NCT00392769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25511247|NCT00392782|Fludarabine|fludarabine|mesh-list
25511248|NCT00392782|Fludarabine phosphate|fludarabine phosphate|mesh-list
25511249|NCT00392782|Thiotepa|thiotepa|mesh-list
25511250|NCT00392782|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25511251|NCT00392782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25511252|NCT00392782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25511253|NCT00392782|Antimetabolites|antimetabolites|mesh-ancestor
25511254|NCT00392782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511255|NCT00392782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25511256|NCT00392782|Immunologic Factors|immunologic factors|mesh-ancestor
25511257|NCT00392782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511258|NCT00392782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25511259|NCT00392782|Alkylating Agents|alkylating agents|mesh-ancestor
25511260|NCT00392782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25511261|NCT00392834|Leucovorin|leucovorin|mesh-list
25511262|NCT00392834|Cytarabine|cytarabine|mesh-list
25511263|NCT00392834|Hydrocortisone|hydrocortisone|mesh-list
25511264|NCT00392834|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25511265|NCT00392834|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25511266|NCT00392834|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25511267|NCT00392834|Cyclophosphamide|cyclophosphamide|mesh-list
25511268|NCT00392834|Ifosfamide|ifosfamide|mesh-list
25511269|NCT00392834|Rituximab|rituximab|mesh-list
25511270|NCT00392834|Doxorubicin|doxorubicin|mesh-list
25511271|NCT00392834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25511272|NCT00392834|Methotrexate|methotrexate|mesh-list
25511273|NCT00392834|Etoposide|etoposide|mesh-list
25511274|NCT00392834|Vincristine|vincristine|mesh-list
25511275|NCT00392834|Levoleucovorin|levoleucovorin|mesh-list
25511276|NCT00392834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25511277|NCT00392834|Immunologic Factors|immunologic factors|mesh-ancestor
25511278|NCT00392834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511279|NCT00392834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25511280|NCT00392834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25511281|NCT00392834|Alkylating Agents|alkylating agents|mesh-ancestor
25511282|NCT00392834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511283|NCT00392834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25511284|NCT00392834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25511285|NCT00392834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25511286|NCT00392834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25511287|NCT00392834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25511288|NCT00392834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25511289|NCT00392834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25511290|NCT00392834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25511291|NCT00392834|Abortifacient Agents|abortifacient agents|mesh-ancestor
25511292|NCT00392834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25511293|NCT00392834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25511294|NCT00392834|Antimetabolites|antimetabolites|mesh-ancestor
25511295|NCT00392834|Dermatologic Agents|dermatologic agents|mesh-ancestor
25511296|NCT00392834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25511297|NCT00392834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25511298|NCT00392834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25511299|NCT00392834|Antiviral Agents|antiviral agents|mesh-ancestor
25511300|NCT00392834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25511301|NCT00392834|Antidotes|antidotes|mesh-ancestor
25511302|NCT00392834|Protective Agents|protective agents|mesh-ancestor
25511303|NCT00392834|Vitamin B Complex|vitamin b complex|mesh-ancestor
25511304|NCT00392834|Vitamins|vitamins|mesh-ancestor
25511305|NCT00392834|Micronutrients|micronutrients|mesh-ancestor
25106482|NCT02669173|Capecitabine|capecitabine|mesh-list
25511306|NCT00392834|Tubulin Modulators|tubulin modulators|mesh-ancestor
25073296|NCT03395977|Febuxostat|febuxostat|mesh-list
25511307|NCT00392834|Antimitotic Agents|antimitotic agents|mesh-ancestor
25511308|NCT00392834|Mitosis Modulators|mitosis modulators|mesh-ancestor
25511309|NCT00392834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25511311|NCT00392925|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
25511312|NCT00392925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25511313|NCT00392925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511314|NCT00392925|Appetite Depressants|appetite depressants|mesh-ancestor
25511315|NCT00392925|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25511316|NCT00392925|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
25511317|NCT00392925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511318|NCT00392951|Sirolimus|sirolimus|mesh-list
25511319|NCT00392951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25511320|NCT00392951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25511321|NCT00392951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25511322|NCT00392951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25511323|NCT00392951|Antifungal Agents|antifungal agents|mesh-ancestor
25511324|NCT00392951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25511325|NCT00392951|Immunologic Factors|immunologic factors|mesh-ancestor
25511326|NCT00392951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511327|NCT00392990|Cytarabine|cytarabine|mesh-list
25511328|NCT00392990|Cyclophosphamide|cyclophosphamide|mesh-list
25511329|NCT00392990|Ifosfamide|ifosfamide|mesh-list
25511330|NCT00392990|Rituximab|rituximab|mesh-list
25511331|NCT00392990|Doxorubicin|doxorubicin|mesh-list
25511332|NCT00392990|Methotrexate|methotrexate|mesh-list
25511333|NCT00392990|Etoposide|etoposide|mesh-list
25511334|NCT00392990|Etoposide phosphate|etoposide phosphate|mesh-list
25511335|NCT00392990|Vincristine|vincristine|mesh-list
25511336|NCT00392990|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25511337|NCT00392990|Podophyllotoxin|podophyllotoxin|mesh-list
25511338|NCT00392990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25511339|NCT00392990|Immunologic Factors|immunologic factors|mesh-ancestor
25511340|NCT00392990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511341|NCT00392990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25511342|NCT00392990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25511343|NCT00392990|Alkylating Agents|alkylating agents|mesh-ancestor
25511344|NCT00392990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511345|NCT00392990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25511346|NCT00392990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25511347|NCT00392990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25511348|NCT00392990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25511349|NCT00392990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25511350|NCT00392990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25511351|NCT00392990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25511352|NCT00392990|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25511353|NCT00392990|Abortifacient Agents|abortifacient agents|mesh-ancestor
25511354|NCT00392990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25511355|NCT00392990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25511356|NCT00392990|Antimetabolites|antimetabolites|mesh-ancestor
25511357|NCT00392990|Dermatologic Agents|dermatologic agents|mesh-ancestor
25511358|NCT00392990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25511359|NCT00392990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25511360|NCT00392990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25511361|NCT00392990|Antiviral Agents|antiviral agents|mesh-ancestor
25511362|NCT00392990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25511363|NCT00392990|Tubulin Modulators|tubulin modulators|mesh-ancestor
25511364|NCT00392990|Antimitotic Agents|antimitotic agents|mesh-ancestor
25511365|NCT00392990|Mitosis Modulators|mitosis modulators|mesh-ancestor
25511366|NCT00392990|Keratolytic Agents|keratolytic agents|mesh-ancestor
25511367|NCT00393029|Aldesleukin|aldesleukin|mesh-list
25511368|NCT00393029|Cyclophosphamide|cyclophosphamide|mesh-list
25511369|NCT00393029|Fludarabine|fludarabine|mesh-list
25511370|NCT00393029|Fludarabine phosphate|fludarabine phosphate|mesh-list
25511371|NCT00393029|Interleukin-2|interleukin-2|mesh-list
25511372|NCT00393029|Lenograstim|lenograstim|mesh-list
25511373|NCT00393029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25511374|NCT00393029|Immunologic Factors|immunologic factors|mesh-ancestor
25511375|NCT00393029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511376|NCT00393029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25511377|NCT00393029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25511378|NCT00393029|Alkylating Agents|alkylating agents|mesh-ancestor
24982870|NCT00379288|Mometasone Furoate|mometasone furoate|mesh-list
24982871|NCT00379288|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24982873|NCT00379288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25511379|NCT00393029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511380|NCT00393029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25511381|NCT00393029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25511382|NCT00393029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25511384|NCT00393029|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25511385|NCT00393029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25511386|NCT00393029|Analgesics|analgesics|mesh-ancestor
25511387|NCT00393029|Sensory System Agents|sensory system agents|mesh-ancestor
25511388|NCT00393029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25511389|NCT00393029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25511390|NCT00393029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25511391|NCT00393029|Antiviral Agents|antiviral agents|mesh-ancestor
25511392|NCT00393029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25511393|NCT00393042|Amphetamine|amphetamine|mesh-list
25511394|NCT00393042|Adderall|adderall|mesh-list
25511395|NCT00393042|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
25511396|NCT00393042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25511397|NCT00393042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511398|NCT00393042|Sympathomimetics|sympathomimetics|mesh-ancestor
25511399|NCT00393042|Autonomic Agents|autonomic agents|mesh-ancestor
25511400|NCT00393042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25511401|NCT00393042|Dopamine Agents|dopamine agents|mesh-ancestor
25511402|NCT00393042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25511403|NCT00393042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511404|NCT00393042|Adrenergic Agents|adrenergic agents|mesh-ancestor
25511405|NCT00393042|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25511406|NCT00393042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25511407|NCT00393042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25511408|NCT00393042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25511409|NCT00393094|Bevacizumab|bevacizumab|mesh-list
25511410|NCT00393094|Irinotecan|irinotecan|mesh-list
25511411|NCT00393094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25511412|NCT00393094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25511413|NCT00393094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25511414|NCT00393094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25511415|NCT00393094|Growth Substances|growth substances|mesh-ancestor
25511416|NCT00393094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511417|NCT00393094|Growth Inhibitors|growth inhibitors|mesh-ancestor
25511418|NCT00393094|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25511419|NCT00393094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25511420|NCT00393094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25511421|NCT00393094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511422|NCT00393367|Prednisone|prednisone|mesh-list
25511423|NCT00393367|Methylprednisolone|methylprednisolone|mesh-list
25511424|NCT00393367|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25511425|NCT00393367|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25511426|NCT00393367|Prednisolone|prednisolone|mesh-list
25511427|NCT00393367|Prednisolone acetate|prednisolone acetate|mesh-list
25511428|NCT00393367|Budesonide|budesonide|mesh-list
25511429|NCT00393367|Bromides|bromides|mesh-list
25511430|NCT00393367|Albuterol|albuterol|mesh-list
25511431|NCT00393367|Ipratropium|ipratropium|mesh-list
25511432|NCT00393367|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25511433|NCT00393367|Prednisolone phosphate|prednisolone phosphate|mesh-list
25511434|NCT00393367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25511435|NCT00393367|Glucocorticoids|glucocorticoids|mesh-ancestor
25511436|NCT00393367|Hormones|hormones|mesh-ancestor
25511437|NCT00393367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25511438|NCT00393367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511439|NCT00393367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25511440|NCT00393367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25511441|NCT00393367|Antiemetics|antiemetics|mesh-ancestor
25511442|NCT00393367|Autonomic Agents|autonomic agents|mesh-ancestor
25511443|NCT00393367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25511444|NCT00393367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25511445|NCT00393367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25511446|NCT00393367|Protective Agents|protective agents|mesh-ancestor
25511447|NCT00393367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25511448|NCT00393367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25511449|NCT00393367|Respiratory System Agents|respiratory system agents|mesh-ancestor
25511450|NCT00393367|Anticonvulsants|anticonvulsants|mesh-ancestor
25823322|NCT00004795|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25823323|NCT00004795|Immunologic Factors|immunologic factors|mesh-ancestor
25823324|NCT00004795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823325|NCT00004796|Lactulose|lactulose|mesh-list
25511451|NCT00393367|Tocolytic Agents|tocolytic agents|mesh-ancestor
25511475|NCT00393458|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25511476|NCT00393458|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25511478|NCT00393458|Adrenergic Agents|adrenergic agents|mesh-ancestor
25511479|NCT00393458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25511480|NCT00393458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511482|NCT00393484|Entecavir|entecavir|mesh-list
25511483|NCT00393484|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25511484|NCT00393484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25511485|NCT00393484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25511486|NCT00393484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511487|NCT00393484|Antiviral Agents|antiviral agents|mesh-ancestor
25511488|NCT00393484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25511489|NCT00393484|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25511490|NCT00393484|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25511491|NCT00393705|Insulin|insulin|mesh-list
25511492|NCT00393705|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25511493|NCT00393705|Insulin Lispro|insulin lispro|mesh-list
25511494|NCT00393705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25511495|NCT00393705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106543|NCT02574910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106544|NCT02574910|Hormone Antagonists|hormone antagonists|mesh-ancestor
24983025|NCT00092560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24983026|NCT00092560|Antimetabolites|antimetabolites|mesh-ancestor
24983028|NCT00092560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25511497|NCT00393718|Glyburide|glyburide|mesh-list
25511498|NCT00393718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25511499|NCT00393718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511500|NCT00393718|Incretins|incretins|mesh-ancestor
25511501|NCT00393718|Hormones|hormones|mesh-ancestor
25511502|NCT00393718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25511503|NCT00393796|Sunitinib|sunitinib|mesh-list
25511504|NCT00393796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25511505|NCT00393796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25511506|NCT00393796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25511507|NCT00393796|Growth Substances|growth substances|mesh-ancestor
25511508|NCT00393796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511509|NCT00393796|Growth Inhibitors|growth inhibitors|mesh-ancestor
25511510|NCT00393796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25511511|NCT00393796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25511512|NCT00393796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511513|NCT00393848|Ketoconazole|ketoconazole|mesh-list
25511514|NCT00393848|Antifungal Agents|antifungal agents|mesh-ancestor
25511515|NCT00393848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25511516|NCT00393848|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25511517|NCT00393848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25511518|NCT00393848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25511519|NCT00393848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511520|NCT00393848|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25511521|NCT00393848|Hormone Antagonists|hormone antagonists|mesh-ancestor
25511522|NCT00393848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25511523|NCT00393848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511524|NCT00393848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25511525|NCT00393861|Bevacizumab|bevacizumab|mesh-list
25511526|NCT00393861|Oxaliplatin|oxaliplatin|mesh-list
25511527|NCT00393861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25511528|NCT00393861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25511529|NCT00393861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25511530|NCT00393861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25511531|NCT00393861|Growth Substances|growth substances|mesh-ancestor
25511532|NCT00393861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511533|NCT00393861|Growth Inhibitors|growth inhibitors|mesh-ancestor
25511534|NCT00393874|Prazosin|prazosin|mesh-list
25511535|NCT00393874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25511536|NCT00393874|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25511537|NCT00393874|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25511538|NCT00393874|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25511539|NCT00393874|Adrenergic Agents|adrenergic agents|mesh-ancestor
25511540|NCT00393874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25511541|NCT00393874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511542|NCT00393874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511543|NCT00393939|Docetaxel|docetaxel|mesh-list
25511544|NCT00393939|Sunitinib|sunitinib|mesh-list
25511545|NCT00393939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25511546|NCT00393939|Tubulin Modulators|tubulin modulators|mesh-ancestor
25511547|NCT00393939|Antimitotic Agents|antimitotic agents|mesh-ancestor
25511548|NCT00393939|Mitosis Modulators|mitosis modulators|mesh-ancestor
25511549|NCT00393939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511550|NCT00393939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25511551|NCT00393939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25511552|NCT00393939|Growth Substances|growth substances|mesh-ancestor
25511553|NCT00393939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511554|NCT00393939|Growth Inhibitors|growth inhibitors|mesh-ancestor
25511555|NCT00393939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25511556|NCT00393939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25511557|NCT00393978|Topiramate|topiramate|mesh-list
25511558|NCT00393978|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25511559|NCT00393978|Antidepressive Agents|antidepressive agents|mesh-ancestor
25511560|NCT00393978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25511561|NCT00393978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25511562|NCT00393978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25511563|NCT00393978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25511564|NCT00393978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511565|NCT00393978|Anticonvulsants|anticonvulsants|mesh-ancestor
25511566|NCT00393978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25511567|NCT00394082|Paclitaxel|paclitaxel|mesh-list
25511568|NCT00394082|Bevacizumab|bevacizumab|mesh-list
25511569|NCT00394082|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25511570|NCT00394082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25511571|NCT00394082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25511572|NCT00394082|Tubulin Modulators|tubulin modulators|mesh-ancestor
25511573|NCT00394082|Antimitotic Agents|antimitotic agents|mesh-ancestor
25511574|NCT00394082|Mitosis Modulators|mitosis modulators|mesh-ancestor
25511575|NCT00394082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511576|NCT00394082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25511577|NCT00394082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25511578|NCT00394082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25511579|NCT00394082|Growth Substances|growth substances|mesh-ancestor
25511580|NCT00394082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511581|NCT00394082|Growth Inhibitors|growth inhibitors|mesh-ancestor
25511582|NCT00394095|Topiramate|topiramate|mesh-list
25511583|NCT00394095|Anticonvulsants|anticonvulsants|mesh-ancestor
25511584|NCT00394095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25511585|NCT00394095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511586|NCT00394251|Paclitaxel|paclitaxel|mesh-list
25511587|NCT00394251|Cyclophosphamide|cyclophosphamide|mesh-list
25511588|NCT00394251|Bevacizumab|bevacizumab|mesh-list
25511589|NCT00394251|Doxorubicin|doxorubicin|mesh-list
25511590|NCT00394251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25511591|NCT00394251|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25511592|NCT00394251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25511593|NCT00394251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25511594|NCT00394251|Tubulin Modulators|tubulin modulators|mesh-ancestor
25511595|NCT00394251|Antimitotic Agents|antimitotic agents|mesh-ancestor
25511596|NCT00394251|Mitosis Modulators|mitosis modulators|mesh-ancestor
25511597|NCT00394251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511598|NCT00394251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25511599|NCT00394251|Immunologic Factors|immunologic factors|mesh-ancestor
25511600|NCT00394251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511601|NCT00394251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25511602|NCT00394251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25511603|NCT00394251|Alkylating Agents|alkylating agents|mesh-ancestor
25511604|NCT00394251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25511605|NCT00394251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25511606|NCT00394251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25511607|NCT00394251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25511608|NCT00394251|Growth Substances|growth substances|mesh-ancestor
25511609|NCT00394251|Growth Inhibitors|growth inhibitors|mesh-ancestor
25511610|NCT00394251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25511611|NCT00394251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25511612|NCT00394251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25511613|NCT00394251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25511614|NCT00394277|Ribavirin|ribavirin|mesh-list
25511615|NCT00394277|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25511616|NCT00394277|Interferon-alpha|interferon-alpha|mesh-list
25511617|NCT00394277|Antimetabolites|antimetabolites|mesh-ancestor
25511618|NCT00394277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511619|NCT00394277|Antiviral Agents|antiviral agents|mesh-ancestor
25511620|NCT00394277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25511621|NCT00394277|Immunologic Factors|immunologic factors|mesh-ancestor
25511622|NCT00394277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511623|NCT00394329|Beclomethasone|beclomethasone|mesh-list
25511624|NCT00394329|Albuterol|albuterol|mesh-list
25511625|NCT00394329|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25511626|NCT00394329|Autonomic Agents|autonomic agents|mesh-ancestor
25511627|NCT00394329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25511628|NCT00394329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511629|NCT00394329|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25511630|NCT00394329|Respiratory System Agents|respiratory system agents|mesh-ancestor
25511631|NCT00394329|Tocolytic Agents|tocolytic agents|mesh-ancestor
25511632|NCT00394329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25511633|NCT00394329|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25511634|NCT00394329|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25511635|NCT00394329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25511636|NCT00394329|Adrenergic Agents|adrenergic agents|mesh-ancestor
25511637|NCT00394329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25511638|NCT00394329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511639|NCT00394329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25511640|NCT00394329|Glucocorticoids|glucocorticoids|mesh-ancestor
25511641|NCT00394329|Hormones|hormones|mesh-ancestor
24983219|NCT01857934|Antiviral Agents|antiviral agents|mesh-ancestor
24983220|NCT01857934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24983221|NCT01857934|Anticonvulsants|anticonvulsants|mesh-ancestor
24983222|NCT01857934|Nootropic Agents|nootropic agents|mesh-ancestor
25511642|NCT00394329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25511643|NCT00394433|Bevacizumab|bevacizumab|mesh-list
25511644|NCT00394433|Cisplatin|cisplatin|mesh-list
25511645|NCT00394433|Docetaxel|docetaxel|mesh-list
25511646|NCT00394433|Irinotecan|irinotecan|mesh-list
25511647|NCT00394433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25511648|NCT00394433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25511649|NCT00394433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25511650|NCT00394433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25511651|NCT00394433|Growth Substances|growth substances|mesh-ancestor
25511652|NCT00394433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511653|NCT00394433|Growth Inhibitors|growth inhibitors|mesh-ancestor
25511654|NCT00394433|Tubulin Modulators|tubulin modulators|mesh-ancestor
25511655|NCT00394433|Antimitotic Agents|antimitotic agents|mesh-ancestor
25511656|NCT00394433|Mitosis Modulators|mitosis modulators|mesh-ancestor
25511657|NCT00394433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511658|NCT00394433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25511659|NCT00394433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25511660|NCT00394433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25511661|NCT00394472|Lesogaberan|lesogaberan|mesh-list
25511662|NCT00394472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25511663|NCT00394472|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25511664|NCT00394472|GABA Agonists|gaba agonists|mesh-ancestor
25511665|NCT00394472|GABA Agents|gaba agents|mesh-ancestor
25511666|NCT00394472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25511667|NCT00394472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511668|NCT00394472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511669|NCT00394524|Insulin|insulin|mesh-list
25511670|NCT00394524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25511671|NCT00394524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511672|NCT00394589|Infliximab|infliximab|mesh-list
25511673|NCT00394589|Dermatologic Agents|dermatologic agents|mesh-ancestor
25511674|NCT00394589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25511675|NCT00394589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25511676|NCT00394771|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25511677|NCT00394771|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25511678|NCT00394771|Levonorgestrel|levonorgestrel|mesh-list
25511679|NCT00394771|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25511680|NCT00394771|Estradiol|estradiol|mesh-list
25511681|NCT00394771|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25511682|NCT00394771|Estrogens|estrogens|mesh-ancestor
25511683|NCT00394771|Hormones|hormones|mesh-ancestor
25511684|NCT00394771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25511685|NCT00394771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511686|NCT00394771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25511687|NCT00394771|Contraceptive Agents|contraceptive agents|mesh-ancestor
25511688|NCT00394771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25511689|NCT00394771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25511690|NCT00394771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25511691|NCT00394771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25511692|NCT00394771|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25511693|NCT00394836|Ofatumumab|ofatumumab|mesh-list
25511694|NCT00394836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25511695|NCT00394836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25511696|NCT00394836|Immunologic Factors|immunologic factors|mesh-ancestor
25511697|NCT00394836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511698|NCT00394888|Dermatologic Agents|dermatologic agents|mesh-list
25511699|NCT00394901|Pregabalin|pregabalin|mesh-list
25511700|NCT00394901|Analgesics|analgesics|mesh-ancestor
25511701|NCT00394901|Sensory System Agents|sensory system agents|mesh-ancestor
25511702|NCT00394901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25511703|NCT00394901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511704|NCT00394901|Anticonvulsants|anticonvulsants|mesh-ancestor
25511705|NCT00394901|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25511706|NCT00394901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25511707|NCT00394901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511708|NCT00394901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25511709|NCT00394901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25511710|NCT00394901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24983368|NCT00392327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24983369|NCT00392327|Tubulin Modulators|tubulin modulators|mesh-ancestor
24983370|NCT00392327|Antimitotic Agents|antimitotic agents|mesh-ancestor
25511711|NCT00394901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25511712|NCT00394901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25511713|NCT00394914|Pleconaril|pleconaril|mesh-list
25511714|NCT00394914|Antiviral Agents|antiviral agents|mesh-ancestor
25511718|NCT00395018|Entecavir|entecavir|mesh-list
25511719|NCT00395018|Antiviral Agents|antiviral agents|mesh-ancestor
25511720|NCT00395018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25511721|NCT00395044|Gabapentin|gabapentin|mesh-list
25511722|NCT00395044|Analgesics|analgesics|mesh-ancestor
25511723|NCT00395044|Sensory System Agents|sensory system agents|mesh-ancestor
25511724|NCT00395044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25511725|NCT00395044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511726|NCT00395044|Anticonvulsants|anticonvulsants|mesh-ancestor
25511727|NCT00395044|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25511728|NCT00395044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25511729|NCT00395044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25511730|NCT00395044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25511731|NCT00395044|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25511732|NCT00395044|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25511733|NCT00395044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25511734|NCT00395044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511735|NCT00395044|Antimanic Agents|antimanic agents|mesh-ancestor
25511736|NCT00395057|Ranibizumab|ranibizumab|mesh-list
25511737|NCT00395057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25511738|NCT00395057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25511739|NCT00395057|Growth Substances|growth substances|mesh-ancestor
25511740|NCT00395057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511741|NCT00395057|Growth Inhibitors|growth inhibitors|mesh-ancestor
25511742|NCT00395057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25511743|NCT00395161|Selenium|selenium|mesh-list
25511744|NCT00395161|Metoclopramide|metoclopramide|mesh-list
25511745|NCT00395161|Antioxidants|antioxidants|mesh-ancestor
25511746|NCT00395161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511747|NCT00395161|Protective Agents|protective agents|mesh-ancestor
25511748|NCT00395161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511749|NCT00395161|Trace Elements|trace elements|mesh-ancestor
25511750|NCT00395161|Micronutrients|micronutrients|mesh-ancestor
25511751|NCT00395161|Antiemetics|antiemetics|mesh-ancestor
25511752|NCT00395161|Autonomic Agents|autonomic agents|mesh-ancestor
25511753|NCT00395161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25511754|NCT00395161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25511755|NCT00395161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25511756|NCT00395161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25511757|NCT00395161|Dopamine Agents|dopamine agents|mesh-ancestor
25511758|NCT00395161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25511759|NCT00395226|Zinc Sulfate|zinc sulfate|mesh-list
25511760|NCT00395226|Astringents|astringents|mesh-ancestor
25511761|NCT00395226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511762|NCT00395226|Dermatologic Agents|dermatologic agents|mesh-ancestor
25511763|NCT00395304|Fluticasone|fluticasone|mesh-list
25511764|NCT00395304|Xhance|xhance|mesh-list
25511765|NCT00395304|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25511766|NCT00395304|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25511767|NCT00395304|Montelukast|montelukast|mesh-list
25511768|NCT00395304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25511769|NCT00395304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25511770|NCT00395304|Autonomic Agents|autonomic agents|mesh-ancestor
25511771|NCT00395304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25511772|NCT00395304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511773|NCT00395304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25511774|NCT00395304|Respiratory System Agents|respiratory system agents|mesh-ancestor
25511775|NCT00395304|Dermatologic Agents|dermatologic agents|mesh-ancestor
25511776|NCT00395304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25511777|NCT00395304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25511778|NCT00395304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25511779|NCT00395304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25511780|NCT00395304|Adrenergic Agents|adrenergic agents|mesh-ancestor
25511781|NCT00395304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25511782|NCT00395304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511783|NCT00395304|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25511784|NCT00395304|Hormone Antagonists|hormone antagonists|mesh-ancestor
25511785|NCT00395304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25511786|NCT00395304|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25511787|NCT00395304|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25511788|NCT00395304|Glucocorticoids|glucocorticoids|mesh-ancestor
25511790|NCT00395304|Sympathomimetics|sympathomimetics|mesh-ancestor
25511791|NCT00395343|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25511792|NCT00395343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25511793|NCT00395343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511794|NCT00395343|Incretins|incretins|mesh-ancestor
25511795|NCT00395343|Hormones|hormones|mesh-ancestor
25511796|NCT00395343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25511797|NCT00395343|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25511798|NCT00395343|Protease Inhibitors|protease inhibitors|mesh-ancestor
25511799|NCT00395343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25511800|NCT00395343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511801|NCT00395486|Atorvastatin|atorvastatin|mesh-list
25511802|NCT00395486|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25511803|NCT00395486|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25511804|NCT00395486|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25511805|NCT00395486|Antimetabolites|antimetabolites|mesh-ancestor
25511806|NCT00395486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511807|NCT00395486|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25511808|NCT00395486|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25511809|NCT00395486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25511810|NCT00395512|Pioglitazone|pioglitazone|mesh-list
25511811|NCT00395512|Alogliptin|alogliptin|mesh-list
25511812|NCT00395512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25511813|NCT00395512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511814|NCT00395512|Incretins|incretins|mesh-ancestor
25511815|NCT00395512|Hormones|hormones|mesh-ancestor
25511816|NCT00395512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25511817|NCT00395512|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25511818|NCT00395512|Protease Inhibitors|protease inhibitors|mesh-ancestor
25511819|NCT00395512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25511820|NCT00395512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511821|NCT00395629|Deferasirox|deferasirox|mesh-list
25511822|NCT00395629|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25511823|NCT00395629|Chelating Agents|chelating agents|mesh-ancestor
25511824|NCT00395629|Sequestering Agents|sequestering agents|mesh-ancestor
25511825|NCT00395629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511826|NCT00395694|Lamotrigine|lamotrigine|mesh-list
25511827|NCT00395694|Anticonvulsants|anticonvulsants|mesh-ancestor
25511828|NCT00395694|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25511829|NCT00395694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25511830|NCT00395694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511831|NCT00395694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25511832|NCT00395694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511833|NCT00395694|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25511834|NCT00395694|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25511835|NCT00395694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25511836|NCT00395694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25511837|NCT00395694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25511838|NCT00395746|Liraglutide|liraglutide|mesh-list
25511839|NCT00395746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25511840|NCT00395746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511841|NCT00395746|Incretins|incretins|mesh-ancestor
25511842|NCT00395746|Hormones|hormones|mesh-ancestor
25511843|NCT00395746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25511844|NCT00395850|Disulfiram|disulfiram|mesh-list
24432546|NCT00255268|Goserelin|goserelin|mesh-list
25511846|NCT00395850|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25511847|NCT00395850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25511848|NCT00395850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511849|NCT00395876|Tenecteplase|tenecteplase|mesh-list
25511850|NCT00395876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25511851|NCT00395876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25511852|NCT00395876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511853|NCT00395967|Plerixafor|plerixafor|mesh-list
25511854|NCT00395967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25511855|NCT00395967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25511856|NCT00395967|Antiviral Agents|antiviral agents|mesh-ancestor
25511857|NCT00395967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25511858|NCT00396006|Protease Inhibitors|protease inhibitors|mesh-list
25511859|NCT00396006|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25511860|NCT00396006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25511861|NCT00396006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511862|NCT00396006|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25511863|NCT00396006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25511865|NCT00396019|Antiviral Agents|antiviral agents|mesh-ancestor
25511866|NCT00396019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25511867|NCT00396032|Tenecteplase|tenecteplase|mesh-list
25511868|NCT00396032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25511869|NCT00396032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25511870|NCT00396032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511871|NCT00396084|Moxifloxacin|moxifloxacin|mesh-list
25511872|NCT00396084|Levofloxacin|levofloxacin|mesh-list
25511873|NCT00396084|Ofloxacin|ofloxacin|mesh-list
25511874|NCT00396084|Isoniazid|isoniazid|mesh-list
25511875|NCT00396084|Linezolid|linezolid|mesh-list
25511876|NCT00396084|Gatifloxacin|gatifloxacin|mesh-list
25511877|NCT00396084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25511878|NCT00396084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25511879|NCT00396084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25511880|NCT00396084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25511881|NCT00396084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25511882|NCT00396084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511883|NCT00396084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25511884|NCT00396084|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25511885|NCT00396084|Renal Agents|renal agents|mesh-ancestor
25511886|NCT00396084|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25511887|NCT00396084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25511888|NCT00396084|Antitubercular Agents|antitubercular agents|mesh-ancestor
25511889|NCT00396084|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25511890|NCT00396084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25511891|NCT00396084|Antimetabolites|antimetabolites|mesh-ancestor
25511892|NCT00396084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25511893|NCT00396084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25511894|NCT00396084|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25511895|NCT00396084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25511896|NCT00396201|Plerixafor|plerixafor|mesh-list
25511897|NCT00396201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25511898|NCT00396201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25511899|NCT00396201|Antiviral Agents|antiviral agents|mesh-ancestor
25511900|NCT00396201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25511901|NCT00396253|Tenecteplase|tenecteplase|mesh-list
25511902|NCT00396253|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25511903|NCT00396253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25511904|NCT00396253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511905|NCT00396266|Plerixafor|plerixafor|mesh-list
25511906|NCT00396266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25511907|NCT00396266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25511908|NCT00396266|Antiviral Agents|antiviral agents|mesh-ancestor
25511909|NCT00396266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25511910|NCT00396279|Vitamin D|vitamin d|mesh-list
25511911|NCT00396279|Denosumab|denosumab|mesh-list
25511912|NCT00396279|Calcium|calcium|mesh-list
25511913|NCT00396279|Vitamins|vitamins|mesh-ancestor
25511914|NCT00396279|Micronutrients|micronutrients|mesh-ancestor
25511915|NCT00396279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511916|NCT00396279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25511917|NCT00396279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25511918|NCT00396318|Tenecteplase|tenecteplase|mesh-list
25511919|NCT00396318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25511920|NCT00396318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25511921|NCT00396318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511922|NCT00396331|Plerixafor|plerixafor|mesh-list
25511923|NCT00396331|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25511924|NCT00396331|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25511925|NCT00396331|Antiviral Agents|antiviral agents|mesh-ancestor
25511926|NCT00396331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25511928|NCT00396383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25511929|NCT00396383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25511930|NCT00396383|Antiviral Agents|antiviral agents|mesh-ancestor
25511931|NCT00396383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25511932|NCT00396409|Omalizumab|omalizumab|mesh-list
25511933|NCT00396409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25511934|NCT00396409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25511935|NCT00396409|Respiratory System Agents|respiratory system agents|mesh-ancestor
25511936|NCT00396565|Olanzapine|olanzapine|mesh-list
25511937|NCT00396565|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25511938|NCT00396565|Antiemetics|antiemetics|mesh-ancestor
25511939|NCT00396565|Autonomic Agents|autonomic agents|mesh-ancestor
25511940|NCT00396565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25511941|NCT00396565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511943|NCT00396565|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25511944|NCT00396565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25511945|NCT00396565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25511946|NCT00396565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25511947|NCT00396565|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25511948|NCT00396565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25511949|NCT00396565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25511950|NCT00396565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511951|NCT00396565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25511952|NCT00396565|Serotonin Agents|serotonin agents|mesh-ancestor
25511953|NCT00396565|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25511954|NCT00396565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25511955|NCT00396565|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25511956|NCT00396565|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25511957|NCT00396565|Dopamine Agents|dopamine agents|mesh-ancestor
25511958|NCT00396591|Aflibercept|aflibercept|mesh-list
25511959|NCT00396591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25511960|NCT00396591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25511961|NCT00396591|Growth Substances|growth substances|mesh-ancestor
25511962|NCT00396591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511963|NCT00396591|Growth Inhibitors|growth inhibitors|mesh-ancestor
25511964|NCT00396591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25511965|NCT00396656|Atenolol|atenolol|mesh-list
25511966|NCT00396656|Valsartan|valsartan|mesh-list
25511967|NCT00396656|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25511968|NCT00396656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25511969|NCT00396656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25511970|NCT00396656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25511971|NCT00396656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25511972|NCT00396656|Diuretics|diuretics|mesh-ancestor
25511973|NCT00396656|Natriuretic Agents|natriuretic agents|mesh-ancestor
25511974|NCT00396656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511975|NCT00396656|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25511976|NCT00396656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25511977|NCT00396656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25511978|NCT00396656|Sympatholytics|sympatholytics|mesh-ancestor
25511979|NCT00396656|Autonomic Agents|autonomic agents|mesh-ancestor
25511980|NCT00396656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25511981|NCT00396656|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25511982|NCT00396656|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25511983|NCT00396656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25511984|NCT00396656|Adrenergic Agents|adrenergic agents|mesh-ancestor
25511985|NCT00396656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25511986|NCT00396812|Rituximab|rituximab|mesh-list
25511987|NCT00396812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25511988|NCT00396812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25511989|NCT00396812|Immunologic Factors|immunologic factors|mesh-ancestor
25511990|NCT00396812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25511991|NCT00396812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25511992|NCT00396877|Clopidogrel|clopidogrel|mesh-list
25511993|NCT00396877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25511994|NCT00396877|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25511995|NCT00396877|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25511996|NCT00396877|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25511997|NCT00396877|Purinergic Agents|purinergic agents|mesh-ancestor
25073691|NCT03393728|Propranolol|propranolol|mesh-list
25511998|NCT00396877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25511999|NCT00396877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512000|NCT00396877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512001|NCT00397020|Valproic Acid|valproic acid|mesh-list
25512002|NCT00397020|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25512003|NCT00397020|Antidepressive Agents|antidepressive agents|mesh-ancestor
25512004|NCT00397020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25512005|NCT00397020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25512006|NCT00397020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25512007|NCT00397020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25512008|NCT00397020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512009|NCT00397020|Anticonvulsants|anticonvulsants|mesh-ancestor
25512010|NCT00397020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512011|NCT00397020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823326|NCT00004796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25823327|NCT00004799|Vaccines|vaccines|mesh-list
25512012|NCT00397020|GABA Agents|gaba agents|mesh-ancestor
25512013|NCT00397020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25512014|NCT00397020|Antimanic Agents|antimanic agents|mesh-ancestor
25512015|NCT00397033|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25512016|NCT00397033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25512017|NCT00397033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25512018|NCT00397033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25512019|NCT00397033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512020|NCT00397033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25512021|NCT00397033|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25512022|NCT00397033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25512023|NCT00397033|Serotonin Agents|serotonin agents|mesh-ancestor
25512024|NCT00397033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25512025|NCT00397033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512026|NCT00397033|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25512027|NCT00397033|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25512028|NCT00397033|Dopamine Agents|dopamine agents|mesh-ancestor
25512029|NCT00397189|Melatonin|melatonin|mesh-list
25512030|NCT00397189|Antioxidants|antioxidants|mesh-ancestor
25512031|NCT00397189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512032|NCT00397189|Protective Agents|protective agents|mesh-ancestor
25512033|NCT00397189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512034|NCT00397189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25512035|NCT00397488|Sunitinib|sunitinib|mesh-list
25512036|NCT00397488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512037|NCT00397488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25512038|NCT00397488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25512039|NCT00397488|Growth Substances|growth substances|mesh-ancestor
25512040|NCT00397488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512041|NCT00397488|Growth Inhibitors|growth inhibitors|mesh-ancestor
25512042|NCT00397488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25512043|NCT00397488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512044|NCT00397488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512045|NCT00397631|Pioglitazone|pioglitazone|mesh-list
25512046|NCT00397631|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25512047|NCT00397631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25512048|NCT00397631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512049|NCT00397631|Incretins|incretins|mesh-ancestor
25512050|NCT00397631|Hormones|hormones|mesh-ancestor
25512051|NCT00397631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25512052|NCT00397631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25512053|NCT00397631|Protease Inhibitors|protease inhibitors|mesh-ancestor
25512054|NCT00397631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512055|NCT00397631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512056|NCT00397813|Cyclosporine|cyclosporine|mesh-list
25512057|NCT00397813|Mycophenolic Acid|mycophenolic acid|mesh-list
25512058|NCT00397813|Fludarabine|fludarabine|mesh-list
25512059|NCT00397813|Fludarabine phosphate|fludarabine phosphate|mesh-list
25512060|NCT00397813|Cyclosporins|cyclosporins|mesh-list
25512061|NCT00397813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512062|NCT00397813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25512063|NCT00397813|Antimetabolites|antimetabolites|mesh-ancestor
25512064|NCT00397813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512065|NCT00397813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25512066|NCT00397813|Immunologic Factors|immunologic factors|mesh-ancestor
25512067|NCT00397813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512068|NCT00397813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512069|NCT00397813|Antifungal Agents|antifungal agents|mesh-ancestor
25645980|NCT01453998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512070|NCT00397813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25512071|NCT00397813|Dermatologic Agents|dermatologic agents|mesh-ancestor
25512072|NCT00397813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25512073|NCT00397813|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25512074|NCT00397813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25512075|NCT00397813|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25512076|NCT00397813|Antitubercular Agents|antitubercular agents|mesh-ancestor
25512077|NCT00397813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25512078|NCT00397839|Ibandronic Acid|ibandronic acid|mesh-list
25512079|NCT00397839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25512080|NCT00397839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512081|NCT00397878|Saracatinib|saracatinib|mesh-list
25512082|NCT00397878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512083|NCT00397878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512084|NCT00397878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823328|NCT00004799|Immunologic Factors|immunologic factors|mesh-ancestor
25512095|NCT00397943|Immunologic Factors|immunologic factors|mesh-ancestor
25512096|NCT00397943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512097|NCT00397982|Sirolimus|sirolimus|mesh-list
25512098|NCT00397982|Bevacizumab|bevacizumab|mesh-list
25512099|NCT00397982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25512100|NCT00397982|Endothelial Growth Factors|endothelial growth factors|mesh-list
25512101|NCT00397982|Antibodies|antibodies|mesh-list
25512102|NCT00397982|Immunoglobulins|immunoglobulins|mesh-list
25512103|NCT00397982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25512104|NCT00397982|Immunoglobulin G|immunoglobulin g|mesh-list
25512105|NCT00397982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512106|NCT00397982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25512107|NCT00397982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25512108|NCT00397982|Growth Substances|growth substances|mesh-ancestor
25512109|NCT00397982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512110|NCT00397982|Growth Inhibitors|growth inhibitors|mesh-ancestor
25512111|NCT00397982|Immunologic Factors|immunologic factors|mesh-ancestor
25512112|NCT00397982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25512113|NCT00397982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25512114|NCT00397982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25512115|NCT00397982|Antifungal Agents|antifungal agents|mesh-ancestor
25512116|NCT00397982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25512117|NCT00398047|Mitogens|mitogens|mesh-list
25512118|NCT00398047|Mitosis Modulators|mitosis modulators|mesh-ancestor
25512119|NCT00398047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512120|NCT00398086|Gemcitabine|gemcitabine|mesh-list
25512121|NCT00398086|Paclitaxel|paclitaxel|mesh-list
25512122|NCT00398086|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25512123|NCT00398086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25512124|NCT00398086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512125|NCT00398086|Tubulin Modulators|tubulin modulators|mesh-ancestor
25512126|NCT00398086|Antimitotic Agents|antimitotic agents|mesh-ancestor
25512127|NCT00398086|Mitosis Modulators|mitosis modulators|mesh-ancestor
25512128|NCT00398086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512129|NCT00398086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25512130|NCT00398086|Antimetabolites|antimetabolites|mesh-ancestor
25512131|NCT00398086|Antiviral Agents|antiviral agents|mesh-ancestor
25512132|NCT00398086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25512133|NCT00398086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512134|NCT00398086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25512135|NCT00398086|Immunologic Factors|immunologic factors|mesh-ancestor
25512136|NCT00398086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512137|NCT00398112|Sunitinib|sunitinib|mesh-list
25512138|NCT00398112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512139|NCT00398112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25512140|NCT00398112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25512141|NCT00398112|Growth Substances|growth substances|mesh-ancestor
25512142|NCT00398112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512143|NCT00398112|Growth Inhibitors|growth inhibitors|mesh-ancestor
25512144|NCT00398112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25512145|NCT00398112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512146|NCT00398112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512147|NCT00398138|Sargramostim|sargramostim|mesh-list
25512148|NCT00398138|Freund's Adjuvant|freund's adjuvant|mesh-list
25512149|NCT00398138|Immunologic Factors|immunologic factors|mesh-ancestor
25512150|NCT00398138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512151|NCT00398138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25512153|NCT00398216|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
25512154|NCT00398216|Antithrombins|antithrombins|mesh-ancestor
25512155|NCT00398216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25512156|NCT00398216|Protease Inhibitors|protease inhibitors|mesh-ancestor
25512157|NCT00398216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512158|NCT00398216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512159|NCT00398216|Anticoagulants|anticoagulants|mesh-ancestor
25512160|NCT00398320|Bevacizumab|bevacizumab|mesh-list
25512161|NCT00398320|Capecitabine|capecitabine|mesh-list
25512162|NCT00398320|Oxaliplatin|oxaliplatin|mesh-list
25512163|NCT00398320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25512164|NCT00398320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512165|NCT00398320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25512166|NCT00398320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25512167|NCT00398320|Growth Substances|growth substances|mesh-ancestor
25512168|NCT00398320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512169|NCT00398320|Growth Inhibitors|growth inhibitors|mesh-ancestor
25512170|NCT00398320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25512171|NCT00398320|Antimetabolites|antimetabolites|mesh-ancestor
25512172|NCT00398320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512173|NCT00398398|Capecitabine|capecitabine|mesh-list
25512174|NCT00398398|Oxaliplatin|oxaliplatin|mesh-list
25512175|NCT00398398|Cetuximab|cetuximab|mesh-list
25512176|NCT00398398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25512177|NCT00398398|Antimetabolites|antimetabolites|mesh-ancestor
25512178|NCT00398398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512179|NCT00398398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512180|NCT00398398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25512181|NCT00398411|Moxifloxacin|moxifloxacin|mesh-list
25512182|NCT00398411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25512183|NCT00398411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25512184|NCT00398411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25512185|NCT00398411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25512186|NCT00398411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512187|NCT00398411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512188|NCT00398411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512189|NCT00398476|Fluticasone|fluticasone|mesh-list
25512190|NCT00398476|Xhance|xhance|mesh-list
25512191|NCT00398476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25512192|NCT00398476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25512193|NCT00398476|Autonomic Agents|autonomic agents|mesh-ancestor
25512194|NCT00398476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25512195|NCT00398476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512196|NCT00398476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25512197|NCT00398476|Respiratory System Agents|respiratory system agents|mesh-ancestor
25512198|NCT00398476|Dermatologic Agents|dermatologic agents|mesh-ancestor
25512199|NCT00398476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25512200|NCT00398567|Trastuzumab|trastuzumab|mesh-list
25512201|NCT00398567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25512202|NCT00398567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512203|NCT00398632|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25512204|NCT00398632|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25512205|NCT00398632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25512206|NCT00398632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25512207|NCT00398632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512208|NCT00398632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25512209|NCT00398632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512210|NCT00398632|Analgesics|analgesics|mesh-ancestor
25512211|NCT00398632|Sensory System Agents|sensory system agents|mesh-ancestor
25512212|NCT00398632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25512213|NCT00398632|Antidepressive Agents|antidepressive agents|mesh-ancestor
25512214|NCT00398632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25512215|NCT00398632|Dopamine Agents|dopamine agents|mesh-ancestor
25512216|NCT00398866|Triamcinolone|triamcinolone|mesh-list
25512217|NCT00398866|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25512218|NCT00398866|Bupivacaine|bupivacaine|mesh-list
25512219|NCT00398866|Hyaluronic Acid|hyaluronic acid|mesh-list
25512220|NCT00398866|Hylan|hylan|mesh-list
25512221|NCT00398866|Anesthetics, Local|anesthetics, local|mesh-ancestor
25512222|NCT00398866|Anesthetics|anesthetics|mesh-ancestor
25512223|NCT00398866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25512224|NCT00398866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512225|NCT00398866|Sensory System Agents|sensory system agents|mesh-ancestor
25512226|NCT00398866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25512230|NCT00398866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25512231|NCT00398866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25512232|NCT00398866|Immunologic Factors|immunologic factors|mesh-ancestor
25512233|NCT00398866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25512234|NCT00398866|Viscosupplements|viscosupplements|mesh-ancestor
25512235|NCT00398866|Protective Agents|protective agents|mesh-ancestor
25512236|NCT00398918|Zonisamide|zonisamide|mesh-list
25512237|NCT00398918|Anticonvulsants|anticonvulsants|mesh-ancestor
25512238|NCT00398918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25512239|NCT00398918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25512240|NCT00398918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512241|NCT00398918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25512242|NCT00398918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512243|NCT00398983|Decitabine|decitabine|mesh-list
25512244|NCT00398983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25512245|NCT00398983|Antimetabolites|antimetabolites|mesh-ancestor
25512246|NCT00398983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512247|NCT00398983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512248|NCT00398983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512249|NCT00399035|Leucovorin|leucovorin|mesh-list
25512250|NCT00399035|Fluorouracil|fluorouracil|mesh-list
25512251|NCT00399035|Capecitabine|capecitabine|mesh-list
25512252|NCT00399035|Oxaliplatin|oxaliplatin|mesh-list
25512253|NCT00399035|Cediranib|cediranib|mesh-list
25512254|NCT00399035|Levoleucovorin|levoleucovorin|mesh-list
25512255|NCT00399035|Antimetabolites|antimetabolites|mesh-ancestor
25512256|NCT00399035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512257|NCT00399035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25512258|NCT00399035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512259|NCT00399035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25512260|NCT00399035|Immunologic Factors|immunologic factors|mesh-ancestor
25512261|NCT00399035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512262|NCT00399035|Antidotes|antidotes|mesh-ancestor
25512263|NCT00399035|Protective Agents|protective agents|mesh-ancestor
25512264|NCT00399035|Vitamin B Complex|vitamin b complex|mesh-ancestor
25512265|NCT00399035|Vitamins|vitamins|mesh-ancestor
25512266|NCT00399035|Micronutrients|micronutrients|mesh-ancestor
25512267|NCT00399035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25512268|NCT00399035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512269|NCT00399360|Metformin|metformin|mesh-list
25512270|NCT00399360|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25512271|NCT00399360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512272|NCT00399490|Tanezumab|tanezumab|mesh-list
25512273|NCT00399490|Analgesics|analgesics|mesh-ancestor
25512274|NCT00399490|Sensory System Agents|sensory system agents|mesh-ancestor
25512275|NCT00399490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25512276|NCT00399490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512277|NCT00399529|Cyclophosphamide|cyclophosphamide|mesh-list
25512278|NCT00399529|Trastuzumab|trastuzumab|mesh-list
25512279|NCT00399529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25512280|NCT00399529|Immunologic Factors|immunologic factors|mesh-ancestor
25512281|NCT00399529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512282|NCT00399529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25512283|NCT00399529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25512284|NCT00399529|Alkylating Agents|alkylating agents|mesh-ancestor
25512285|NCT00399529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512286|NCT00399529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512287|NCT00399529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25512288|NCT00399529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25512289|NCT00399542|Lubiprostone|lubiprostone|mesh-list
25512290|NCT00399542|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25512291|NCT00399542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25512292|NCT00399542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512293|NCT00399568|Acetaminophen|acetaminophen|mesh-list
25512294|NCT00399568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25512295|NCT00399568|Analgesics|analgesics|mesh-ancestor
25512296|NCT00399568|Sensory System Agents|sensory system agents|mesh-ancestor
25512297|NCT00399568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25512298|NCT00399568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512299|NCT00399568|Antipyretics|antipyretics|mesh-ancestor
25512300|NCT00399763|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25512301|NCT00399763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25512302|NCT00399763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25512303|NCT00399763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25512304|NCT00399763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512305|NCT00399763|Adrenergic Agents|adrenergic agents|mesh-ancestor
25512306|NCT00399763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25512307|NCT00399763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512308|NCT00399893|Octreotide|octreotide|mesh-list
25512309|NCT00399893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25512310|NCT00399893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25512311|NCT00399893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512312|NCT00400153|Ipratropium|ipratropium|mesh-list
25512313|NCT00400153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25512314|NCT00400153|Autonomic Agents|autonomic agents|mesh-ancestor
25512315|NCT00400153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25512316|NCT00400153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512317|NCT00400153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25512318|NCT00400153|Respiratory System Agents|respiratory system agents|mesh-ancestor
25512319|NCT00400153|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25512320|NCT00400153|Cholinergic Agents|cholinergic agents|mesh-ancestor
25512321|NCT00400153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25512322|NCT00400153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512323|NCT00400179|Cisplatin|cisplatin|mesh-list
25512324|NCT00400179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512325|NCT00400205|Cisplatin|cisplatin|mesh-list
25512326|NCT00400205|Docetaxel|docetaxel|mesh-list
25512327|NCT00400205|Fluorouracil|fluorouracil|mesh-list
25512328|NCT00400205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512329|NCT00400205|Tubulin Modulators|tubulin modulators|mesh-ancestor
25512330|NCT00400205|Antimitotic Agents|antimitotic agents|mesh-ancestor
25512331|NCT00400205|Mitosis Modulators|mitosis modulators|mesh-ancestor
25512332|NCT00400205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512333|NCT00400205|Antimetabolites|antimetabolites|mesh-ancestor
25512334|NCT00400205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25512335|NCT00400205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25512336|NCT00400205|Immunologic Factors|immunologic factors|mesh-ancestor
25512337|NCT00400205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512338|NCT00400400|Mycophenolic Acid|mycophenolic acid|mesh-list
25512339|NCT00400400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25512340|NCT00400400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512341|NCT00400400|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25512342|NCT00400400|Antitubercular Agents|antitubercular agents|mesh-ancestor
25512343|NCT00400400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25512344|NCT00400400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25512345|NCT00400400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512346|NCT00400400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512347|NCT00400439|Dalcetrapib|dalcetrapib|mesh-list
25512348|NCT00400439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25512349|NCT00400439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25512350|NCT00400439|Antimetabolites|antimetabolites|mesh-ancestor
25512351|NCT00400439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512352|NCT00400439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25512353|NCT00400517|Thalidomide|thalidomide|mesh-list
25512354|NCT00400517|Sargramostim|sargramostim|mesh-list
25512355|NCT00400517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25512356|NCT00400517|Immunologic Factors|immunologic factors|mesh-ancestor
25512357|NCT00400517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512358|NCT00400517|Leprostatic Agents|leprostatic agents|mesh-ancestor
25512359|NCT00400517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25512360|NCT00400517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25512361|NCT00400517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25512362|NCT00400517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25512363|NCT00400517|Growth Substances|growth substances|mesh-ancestor
25512364|NCT00400517|Growth Inhibitors|growth inhibitors|mesh-ancestor
25512365|NCT00400517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512366|NCT00400569|Sunitinib|sunitinib|mesh-list
25512367|NCT00400569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512368|NCT00400569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25512369|NCT00400569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25512370|NCT00400569|Growth Substances|growth substances|mesh-ancestor
25512371|NCT00400569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512372|NCT00400569|Growth Inhibitors|growth inhibitors|mesh-ancestor
25512373|NCT00400569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24983789|NCT05158608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24983790|NCT05158608|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25512378|NCT00400764|Rituximab|rituximab|mesh-list
25512379|NCT00400764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25512380|NCT00400764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512381|NCT00400764|Immunologic Factors|immunologic factors|mesh-ancestor
25512382|NCT00400764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512383|NCT00400764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25512384|NCT00400803|Gemcitabine|gemcitabine|mesh-list
25512385|NCT00400803|Bevacizumab|bevacizumab|mesh-list
25512386|NCT00400803|Carboplatin|carboplatin|mesh-list
25512387|NCT00400803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25512388|NCT00400803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512389|NCT00400803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25512390|NCT00400803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25512391|NCT00400803|Growth Substances|growth substances|mesh-ancestor
25512392|NCT00400803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512393|NCT00400803|Growth Inhibitors|growth inhibitors|mesh-ancestor
25512394|NCT00400803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25512395|NCT00400803|Antimetabolites|antimetabolites|mesh-ancestor
25512396|NCT00400803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512397|NCT00400803|Antiviral Agents|antiviral agents|mesh-ancestor
25512398|NCT00400803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25512399|NCT00400803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512400|NCT00400803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25512401|NCT00400803|Immunologic Factors|immunologic factors|mesh-ancestor
25512402|NCT00401193|Tranexamic Acid|tranexamic acid|mesh-list
25512403|NCT00401193|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25512404|NCT00401193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25512405|NCT00401193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512406|NCT00401193|Hemostatics|hemostatics|mesh-ancestor
25512407|NCT00401193|Coagulants|coagulants|mesh-ancestor
25512408|NCT00401245|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25512409|NCT00401245|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25512410|NCT00401245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25512411|NCT00401245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25512412|NCT00401245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512413|NCT00401245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25512414|NCT00401245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512415|NCT00401245|Antidepressive Agents|antidepressive agents|mesh-ancestor
25512416|NCT00401245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25512417|NCT00401258|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25512418|NCT00401258|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25512419|NCT00401258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25512420|NCT00401258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25512421|NCT00401258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512422|NCT00401258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25512423|NCT00401258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512424|NCT00401258|Analgesics|analgesics|mesh-ancestor
25512425|NCT00401258|Sensory System Agents|sensory system agents|mesh-ancestor
25512426|NCT00401258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25512427|NCT00401258|Antidepressive Agents|antidepressive agents|mesh-ancestor
25512428|NCT00401258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25512429|NCT00401258|Dopamine Agents|dopamine agents|mesh-ancestor
25512430|NCT00401375|Methylnaltrexone|methylnaltrexone|mesh-list
25512431|NCT00401375|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25512432|NCT00401375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512433|NCT00401375|Sensory System Agents|sensory system agents|mesh-ancestor
25512434|NCT00401375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25823329|NCT00004799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983825|NCT05146635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24983826|NCT05146635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24983827|NCT05146635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24983828|NCT05146635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041279|NCT02589275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25041282|NCT02588677|Riluzole|riluzole|mesh-list
25512435|NCT00401401|Cisplatin|cisplatin|mesh-list
25512436|NCT00401401|Zalutumumab|zalutumumab|mesh-list
25512437|NCT00401401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512438|NCT00401401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25512439|NCT00401414|Warfarin|warfarin|mesh-list
25512440|NCT00401414|Anticoagulants|anticoagulants|mesh-ancestor
25512441|NCT00401531|Vaccines|vaccines|mesh-list
25512442|NCT00401531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25512443|NCT00401531|Immunologic Factors|immunologic factors|mesh-ancestor
25512444|NCT00401531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512445|NCT00401544|Dextrans|dextrans|mesh-list
25512446|NCT00401544|Darbepoetin alfa|darbepoetin alfa|mesh-list
25512447|NCT00401544|Iron-Dextran Complex|iron-dextran complex|mesh-list
25512448|NCT00401544|Hematinics|hematinics|mesh-ancestor
25512449|NCT00401544|Anticoagulants|anticoagulants|mesh-ancestor
25512450|NCT00401544|Plasma Substitutes|plasma substitutes|mesh-ancestor
25512451|NCT00401544|Blood Substitutes|blood substitutes|mesh-ancestor
25512452|NCT00401726|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25823330|NCT00004800|Vaccines|vaccines|mesh-list
25512453|NCT00401726|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25512454|NCT00401726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25512455|NCT00401726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25512456|NCT00401726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512457|NCT00401726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25512458|NCT00401726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512459|NCT00401726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25512460|NCT00401726|Antidepressive Agents|antidepressive agents|mesh-ancestor
25512461|NCT00401726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25512462|NCT00401752|Esomeprazole|esomeprazole|mesh-list
25512463|NCT00401752|Ranitidine|ranitidine|mesh-list
25512464|NCT00401752|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
25512465|NCT00401752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25512466|NCT00401752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25512467|NCT00401752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25512468|NCT00401752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512469|NCT00401752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512470|NCT00401752|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25512471|NCT00401752|Histamine Antagonists|histamine antagonists|mesh-ancestor
25512472|NCT00401752|Histamine Agents|histamine agents|mesh-ancestor
25512473|NCT00401752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25512474|NCT00401752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512475|NCT00401778|Everolimus|everolimus|mesh-list
25512476|NCT00401778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512477|NCT00401778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25512478|NCT00401778|Immunologic Factors|immunologic factors|mesh-ancestor
25512479|NCT00401778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512480|NCT00401817|Bevacizumab|bevacizumab|mesh-list
25512481|NCT00401817|Rituximab|rituximab|mesh-list
25512482|NCT00401817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25512483|NCT00401817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512484|NCT00401817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25512485|NCT00401817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25512486|NCT00401817|Growth Substances|growth substances|mesh-ancestor
25512487|NCT00401817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512488|NCT00401817|Growth Inhibitors|growth inhibitors|mesh-ancestor
25512489|NCT00401817|Immunologic Factors|immunologic factors|mesh-ancestor
25512490|NCT00401817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25512491|NCT00401830|Lacosamide|lacosamide|mesh-list
25512492|NCT00401830|Anticonvulsants|anticonvulsants|mesh-ancestor
25512493|NCT00401830|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25512494|NCT00401830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25512495|NCT00401830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25512496|NCT00401830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512497|NCT00401843|Dexamethasone|dexamethasone|mesh-list
25512498|NCT00401843|Bortezomib|bortezomib|mesh-list
25512499|NCT00401843|Siltuximab|siltuximab|mesh-list
25512500|NCT00401843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25512501|NCT00401843|Antiemetics|antiemetics|mesh-ancestor
25512502|NCT00401843|Autonomic Agents|autonomic agents|mesh-ancestor
25512503|NCT00401843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25512504|NCT00401843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162500|NCT02904304|Sensory System Agents|sensory system agents|mesh-ancestor
25162501|NCT02904304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25162502|NCT02904304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131091|NCT03028701|Budesonide|budesonide|mesh-list
25512505|NCT00401843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25512506|NCT00401843|Glucocorticoids|glucocorticoids|mesh-ancestor
25512507|NCT00401843|Hormones|hormones|mesh-ancestor
25512514|NCT00401882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25512515|NCT00401882|Adrenergic Agents|adrenergic agents|mesh-ancestor
25512516|NCT00401882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25512517|NCT00401882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512518|NCT00401882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512519|NCT00401882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25512520|NCT00401882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25512521|NCT00401882|Autonomic Agents|autonomic agents|mesh-ancestor
25512522|NCT00401882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25512523|NCT00401882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25512524|NCT00401882|Respiratory System Agents|respiratory system agents|mesh-ancestor
25512525|NCT00401882|Mydriatics|mydriatics|mesh-ancestor
25512526|NCT00401882|Sympathomimetics|sympathomimetics|mesh-ancestor
25512527|NCT00401882|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25512528|NCT00401882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25512529|NCT00401882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25512530|NCT00401882|Sympatholytics|sympatholytics|mesh-ancestor
25512531|NCT00401882|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25512532|NCT00401882|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25512533|NCT00401882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25512534|NCT00401960|Daptomycin|daptomycin|mesh-list
25512535|NCT00401960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25512536|NCT00401960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25512537|NCT00401973|Metformin|metformin|mesh-list
25512538|NCT00401973|Amantadine|amantadine|mesh-list
25512539|NCT00401973|Zonisamide|zonisamide|mesh-list
25512540|NCT00401973|Olanzapine|olanzapine|mesh-list
25512541|NCT00401973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25512542|NCT00401973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512543|NCT00401973|Antiemetics|antiemetics|mesh-ancestor
25512544|NCT00401973|Autonomic Agents|autonomic agents|mesh-ancestor
25512545|NCT00401973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25512546|NCT00401973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25512547|NCT00401973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25512548|NCT00401973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25512549|NCT00401973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25512550|NCT00401973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25512551|NCT00401973|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25512552|NCT00401973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25512553|NCT00401973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25512554|NCT00401973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512555|NCT00401973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25512556|NCT00401973|Serotonin Agents|serotonin agents|mesh-ancestor
25512557|NCT00401973|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25512558|NCT00401973|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25512559|NCT00401973|Antiviral Agents|antiviral agents|mesh-ancestor
25512560|NCT00401973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25512561|NCT00401973|Dopamine Agents|dopamine agents|mesh-ancestor
25512562|NCT00401973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25512563|NCT00401973|Analgesics|analgesics|mesh-ancestor
25512564|NCT00401973|Sensory System Agents|sensory system agents|mesh-ancestor
25512565|NCT00401973|Anticonvulsants|anticonvulsants|mesh-ancestor
25512566|NCT00401973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25512567|NCT00401973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25512568|NCT00402025|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25512569|NCT00402025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25512570|NCT00402025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512571|NCT00402051|Cisplatin|cisplatin|mesh-list
24795917|NCT01946620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795918|NCT01946620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24921672|NCT04188249|Immunologic Factors|immunologic factors|mesh-ancestor
24983851|NCT05130060|Trifluridine|trifluridine|mesh-list
24983864|NCT05119075|Dopamine|dopamine|mesh-list
24983865|NCT05119075|Dopamine Agonists|dopamine agonists|mesh-list
25512572|NCT00402051|Carboplatin|carboplatin|mesh-list
25512573|NCT00402051|Pemetrexed|pemetrexed|mesh-list
25512574|NCT00402051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512575|NCT00402051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512576|NCT00402051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512577|NCT00402051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25512578|NCT00402051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25512579|NCT00402103|Amlodipine|amlodipine|mesh-list
25512580|NCT00402103|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25512581|NCT00402103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25512582|NCT00402103|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25512583|NCT00402103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25512584|NCT00402103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512585|NCT00402103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25512586|NCT00402103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512587|NCT00402103|Vasodilator Agents|vasodilator agents|mesh-ancestor
25512588|NCT00402103|Diuretics|diuretics|mesh-ancestor
25512589|NCT00402103|Natriuretic Agents|natriuretic agents|mesh-ancestor
25512590|NCT00402103|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25512591|NCT00402116|Temozolomide|temozolomide|mesh-list
25512592|NCT00402116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25512593|NCT00402116|Alkylating Agents|alkylating agents|mesh-ancestor
25512594|NCT00402116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512595|NCT00402116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512596|NCT00402168|Cyclosporine|cyclosporine|mesh-list
25512597|NCT00402168|Abatacept|abatacept|mesh-list
25512598|NCT00402168|Tacrolimus|tacrolimus|mesh-list
25512599|NCT00402168|Cyclosporins|cyclosporins|mesh-list
25512600|NCT00402168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25512601|NCT00402168|Immunologic Factors|immunologic factors|mesh-ancestor
25512602|NCT00402168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512603|NCT00402168|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25512604|NCT00402168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512605|NCT00402168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512606|NCT00402168|Antifungal Agents|antifungal agents|mesh-ancestor
25512607|NCT00402168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25512608|NCT00402168|Dermatologic Agents|dermatologic agents|mesh-ancestor
25512609|NCT00402168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25512610|NCT00402168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25512611|NCT00402168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512612|NCT00402194|Losartan|losartan|mesh-list
25512613|NCT00402194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25512614|NCT00402194|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25512615|NCT00402194|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25512616|NCT00402194|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25512617|NCT00402194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512618|NCT00402233|Pramipexole|pramipexole|mesh-list
25512619|NCT00402233|Antioxidants|antioxidants|mesh-ancestor
25512620|NCT00402233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512621|NCT00402233|Protective Agents|protective agents|mesh-ancestor
25512622|NCT00402233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512623|NCT00402233|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25512624|NCT00402233|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25512625|NCT00402233|Dopamine Agonists|dopamine agonists|mesh-ancestor
25512626|NCT00402233|Dopamine Agents|dopamine agents|mesh-ancestor
25512627|NCT00402233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25512628|NCT00402285|Lycopene|lycopene|mesh-list
25512629|NCT00402285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25512630|NCT00402285|Antioxidants|antioxidants|mesh-ancestor
25512631|NCT00402285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512632|NCT00402285|Protective Agents|protective agents|mesh-ancestor
25512633|NCT00402285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512634|NCT00402285|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25512635|NCT00402285|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25512636|NCT00402285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512637|NCT00402324|Valproic Acid|valproic acid|mesh-list
25512638|NCT00402324|Olanzapine|olanzapine|mesh-list
25512639|NCT00402324|Antiemetics|antiemetics|mesh-ancestor
25512640|NCT00402324|Autonomic Agents|autonomic agents|mesh-ancestor
25512641|NCT00402324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25512642|NCT00402324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512643|NCT00402324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25512644|NCT00402324|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25512645|NCT00402324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25512646|NCT00402324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25512647|NCT00402324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25512648|NCT00402324|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25512649|NCT00402324|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25512650|NCT00402324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25512651|NCT00402324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512652|NCT00402324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25512653|NCT00402324|Serotonin Agents|serotonin agents|mesh-ancestor
25512654|NCT00402324|Anticonvulsants|anticonvulsants|mesh-ancestor
25512655|NCT00402324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512656|NCT00402324|GABA Agents|gaba agents|mesh-ancestor
25512657|NCT00402324|Antimanic Agents|antimanic agents|mesh-ancestor
25512658|NCT00402337|Linaclotide|linaclotide|mesh-list
25512659|NCT00402337|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25512660|NCT00402337|Enzyme Activators|enzyme activators|mesh-ancestor
25512661|NCT00402337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512662|NCT00402337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25512663|NCT00402597|Rivaroxaban|rivaroxaban|mesh-list
25512664|NCT00402597|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25512665|NCT00402597|Antithrombins|antithrombins|mesh-ancestor
25512666|NCT00402597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25512667|NCT00402597|Protease Inhibitors|protease inhibitors|mesh-ancestor
25512668|NCT00402597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512669|NCT00402597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512670|NCT00402597|Anticoagulants|anticoagulants|mesh-ancestor
25512671|NCT00402688|Levofloxacin|levofloxacin|mesh-list
25512672|NCT00402688|Ofloxacin|ofloxacin|mesh-list
25512673|NCT00402688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25512674|NCT00402688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25645981|NCT01454076|Clarithromycin|clarithromycin|mesh-list
25645982|NCT01454076|Rifampin|rifampin|mesh-list
25645983|NCT01454076|Ketoconazole|ketoconazole|mesh-list
25512675|NCT00402688|Renal Agents|renal agents|mesh-ancestor
25512676|NCT00402688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25512677|NCT00402688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25512678|NCT00402688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25512679|NCT00402688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512680|NCT00402688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512681|NCT00402688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512682|NCT00402688|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25512683|NCT00402688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25512684|NCT00402714|Pentostatin|pentostatin|mesh-list
25512685|NCT00402714|Methoxsalen|methoxsalen|mesh-list
25512686|NCT00402714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512687|NCT00402714|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25512688|NCT00402714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512689|NCT00402714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512690|NCT00402714|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25512691|NCT00402714|Dermatologic Agents|dermatologic agents|mesh-ancestor
25512692|NCT00402727|Amoxicillin|amoxicillin|mesh-list
25512693|NCT00402727|Moxifloxacin|moxifloxacin|mesh-list
25512694|NCT00402727|Tazobactam|tazobactam|mesh-list
25512695|NCT00402727|Piperacillin|piperacillin|mesh-list
25512696|NCT00402727|Clavulanic Acids|clavulanic acids|mesh-list
25512697|NCT00402727|Clavulanic Acid|clavulanic acid|mesh-list
25512698|NCT00402727|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25512699|NCT00402727|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25512700|NCT00402727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25512701|NCT00402727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25512702|NCT00402727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25512703|NCT00402727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25512704|NCT00402727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512705|NCT00402727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512706|NCT00402727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512707|NCT00402727|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25512708|NCT00402727|Contraceptive Agents|contraceptive agents|mesh-ancestor
25512709|NCT00402727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25512710|NCT00402727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512711|NCT00402727|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25512712|NCT00402727|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25512713|NCT00402727|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25512714|NCT00402727|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25512715|NCT00402779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25512716|NCT00402779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512717|NCT00402779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25512718|NCT00402779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512719|NCT00402779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512720|NCT00402896|Mitogens|mitogens|mesh-list
25512721|NCT00402896|Endothelial Growth Factors|endothelial growth factors|mesh-list
25512722|NCT00402896|Mitosis Modulators|mitosis modulators|mesh-ancestor
25512723|NCT00402896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512724|NCT00402896|Growth Substances|growth substances|mesh-ancestor
25512725|NCT00402896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512726|NCT00402987|Celecoxib|celecoxib|mesh-list
25512727|NCT00402987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25512728|NCT00402987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25512729|NCT00402987|Analgesics|analgesics|mesh-ancestor
25512730|NCT00402987|Sensory System Agents|sensory system agents|mesh-ancestor
25512731|NCT00402987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25512732|NCT00402987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512733|NCT00402987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25512734|NCT00402987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25512735|NCT00402987|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25512736|NCT00402987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25512737|NCT00402987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512738|NCT00402987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512739|NCT00403117|Naltrexone|naltrexone|mesh-list
25512740|NCT00403117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25512741|NCT00403117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25512742|NCT00403117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512743|NCT00403117|Sensory System Agents|sensory system agents|mesh-ancestor
25512744|NCT00403117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25645984|NCT01454076|Ixazomib|ixazomib|mesh-list
25645985|NCT01454076|Glycine|glycine|mesh-list
25512745|NCT00403130|Gemcitabine|gemcitabine|mesh-list
25512746|NCT00403130|Paclitaxel|paclitaxel|mesh-list
25512747|NCT00403130|Bevacizumab|bevacizumab|mesh-list
25512748|NCT00403130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25512749|NCT00403130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512750|NCT00403130|Tubulin Modulators|tubulin modulators|mesh-ancestor
25512751|NCT00403130|Antimitotic Agents|antimitotic agents|mesh-ancestor
25512752|NCT00403130|Mitosis Modulators|mitosis modulators|mesh-ancestor
25512753|NCT00403130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512754|NCT00403130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25512755|NCT00403130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25512756|NCT00403130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25512757|NCT00403130|Growth Substances|growth substances|mesh-ancestor
25512758|NCT00403130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512759|NCT00403130|Growth Inhibitors|growth inhibitors|mesh-ancestor
25512760|NCT00403130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25512761|NCT00403130|Antimetabolites|antimetabolites|mesh-ancestor
25512762|NCT00403130|Antiviral Agents|antiviral agents|mesh-ancestor
25512763|NCT00403130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25512764|NCT00403130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512765|NCT00403130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25512766|NCT00403130|Immunologic Factors|immunologic factors|mesh-ancestor
25512767|NCT00403234|Buprenorphine|buprenorphine|mesh-list
25512768|NCT00403234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25512769|NCT00403234|Narcotics|narcotics|mesh-ancestor
25512770|NCT00403234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25512771|NCT00403234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512772|NCT00403234|Analgesics|analgesics|mesh-ancestor
25512773|NCT00403234|Sensory System Agents|sensory system agents|mesh-ancestor
25512774|NCT00403234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25512775|NCT00403234|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25512776|NCT00403260|Artesunate|artesunate|mesh-list
25512777|NCT00403260|Mefloquine|mefloquine|mesh-list
25512778|NCT00403260|Pyronaridine|pyronaridine|mesh-list
25512779|NCT00403260|Antimalarials|antimalarials|mesh-ancestor
25512780|NCT00403260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25512781|NCT00403260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25512782|NCT00403260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25512783|NCT00403260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512784|NCT00403260|Antiviral Agents|antiviral agents|mesh-ancestor
25512785|NCT00403260|Schistosomicides|schistosomicides|mesh-ancestor
25512786|NCT00403260|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25512787|NCT00403260|Anthelmintics|anthelmintics|mesh-ancestor
25512788|NCT00403273|Botulinum Toxins|botulinum toxins|mesh-list
25512789|NCT00403273|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25512790|NCT00403273|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25512791|NCT00403273|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25512792|NCT00403273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25512793|NCT00403273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983934|NCT05064488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24983936|NCT05064488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25512794|NCT00403273|Cholinergic Agents|cholinergic agents|mesh-ancestor
25512796|NCT00403273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512797|NCT00403273|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25512798|NCT00403273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25512799|NCT00403403|Bevacizumab|bevacizumab|mesh-list
25512800|NCT00403403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25512801|NCT00403403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512802|NCT00403403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25512803|NCT00403403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25512804|NCT00403403|Growth Substances|growth substances|mesh-ancestor
25512805|NCT00403403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512806|NCT00403403|Growth Inhibitors|growth inhibitors|mesh-ancestor
25512807|NCT00403455|Paroxetine|paroxetine|mesh-list
25512808|NCT00403455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25512809|NCT00403455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25512810|NCT00403455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25512811|NCT00403455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512812|NCT00403455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25512813|NCT00403455|Serotonin Agents|serotonin agents|mesh-ancestor
25512814|NCT00403455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512815|NCT00403455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25512816|NCT00403455|Antidepressive Agents|antidepressive agents|mesh-ancestor
25512817|NCT00403455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25512818|NCT00403455|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25512819|NCT00403455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25512820|NCT00403455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512821|NCT00403481|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25512822|NCT00403481|Olmesartan|olmesartan|mesh-list
25512823|NCT00403481|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25512824|NCT00403481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25512825|NCT00403481|Diuretics|diuretics|mesh-ancestor
25512826|NCT00403481|Natriuretic Agents|natriuretic agents|mesh-ancestor
25512827|NCT00403481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512828|NCT00403481|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25512829|NCT00403481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25512830|NCT00403481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512831|NCT00403481|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25512832|NCT00403481|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25512833|NCT00403494|Verapamil|verapamil|mesh-list
25512834|NCT00403494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25512835|NCT00403494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25512836|NCT00403494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25512837|NCT00403494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512838|NCT00403494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25512839|NCT00403494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512840|NCT00403494|Vasodilator Agents|vasodilator agents|mesh-ancestor
25512841|NCT00403546|Ziprasidone|ziprasidone|mesh-list
25512842|NCT00403546|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25512843|NCT00403546|Serotonin Agents|serotonin agents|mesh-ancestor
25512844|NCT00403546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25512845|NCT00403546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512846|NCT00403546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512847|NCT00403546|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25512848|NCT00403546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25512849|NCT00403546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25512850|NCT00403546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25512851|NCT00403546|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25512852|NCT00403546|Dopamine Agents|dopamine agents|mesh-ancestor
25512853|NCT00403585|Adefovir|adefovir|mesh-list
25512854|NCT00403585|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25512855|NCT00403585|Antiviral Agents|antiviral agents|mesh-ancestor
25512856|NCT00403585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25512857|NCT00403585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25512858|NCT00403585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25512859|NCT00403585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795953|NCT01946984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24795954|NCT01946984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24795955|NCT01946984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24795956|NCT01946984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795957|NCT01946984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795958|NCT01947010|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25512863|NCT00403754|Autonomic Agents|autonomic agents|mesh-ancestor
25512864|NCT00403754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25512865|NCT00403754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512866|NCT00403754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25512867|NCT00403754|Respiratory System Agents|respiratory system agents|mesh-ancestor
25512868|NCT00403754|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25512869|NCT00403754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25512870|NCT00403754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25512871|NCT00403754|Adrenergic Agents|adrenergic agents|mesh-ancestor
25512872|NCT00403754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25512873|NCT00403754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512874|NCT00403767|Warfarin|warfarin|mesh-list
25512875|NCT00403767|Rivaroxaban|rivaroxaban|mesh-list
25512876|NCT00403767|Anticoagulants|anticoagulants|mesh-ancestor
25512877|NCT00403767|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25512878|NCT00403767|Antithrombins|antithrombins|mesh-ancestor
25512879|NCT00403767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25512880|NCT00403767|Protease Inhibitors|protease inhibitors|mesh-ancestor
25512881|NCT00403767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512882|NCT00403767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512883|NCT00404066|Dexamethasone|dexamethasone|mesh-list
25512884|NCT00404066|Cyclophosphamide|cyclophosphamide|mesh-list
25512885|NCT00404066|Docetaxel|docetaxel|mesh-list
25512886|NCT00404066|Doxorubicin|doxorubicin|mesh-list
25512887|NCT00404066|Trastuzumab|trastuzumab|mesh-list
25512888|NCT00404066|Lapatinib|lapatinib|mesh-list
25512889|NCT00404066|Lenograstim|lenograstim|mesh-list
25512890|NCT00404066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24640778|NCT01170052|Sirolimus|sirolimus|mesh-list
25645986|NCT01454076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25512891|NCT00404066|Immunologic Factors|immunologic factors|mesh-ancestor
25512892|NCT00404066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512893|NCT00404066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25512894|NCT00404066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25512895|NCT00404066|Alkylating Agents|alkylating agents|mesh-ancestor
25512896|NCT00404066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512897|NCT00404066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512898|NCT00404066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25512899|NCT00404066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25512900|NCT00404066|Antiemetics|antiemetics|mesh-ancestor
25512901|NCT00404066|Autonomic Agents|autonomic agents|mesh-ancestor
25512902|NCT00404066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25512903|NCT00404066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25512904|NCT00404066|Glucocorticoids|glucocorticoids|mesh-ancestor
25512905|NCT00404066|Hormones|hormones|mesh-ancestor
25512906|NCT00404066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25512907|NCT00404066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25512908|NCT00404066|Tubulin Modulators|tubulin modulators|mesh-ancestor
25512909|NCT00404066|Antimitotic Agents|antimitotic agents|mesh-ancestor
25512910|NCT00404066|Mitosis Modulators|mitosis modulators|mesh-ancestor
25512911|NCT00404066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25512912|NCT00404066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25512913|NCT00404066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25512914|NCT00404066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512915|NCT00404066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25512916|NCT00404066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25512917|NCT00404066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25512918|NCT00404092|Caspofungin|caspofungin|mesh-list
25512919|NCT00404092|Antifungal Agents|antifungal agents|mesh-ancestor
25512920|NCT00404092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25512921|NCT00404092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512922|NCT00404092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512923|NCT00404235|Paclitaxel|paclitaxel|mesh-list
25512924|NCT00404235|Carboplatin|carboplatin|mesh-list
25512925|NCT00404235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25512926|NCT00404235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25512927|NCT00404235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512928|NCT00404235|Tubulin Modulators|tubulin modulators|mesh-ancestor
25512929|NCT00404235|Antimitotic Agents|antimitotic agents|mesh-ancestor
25512930|NCT00404235|Mitosis Modulators|mitosis modulators|mesh-ancestor
25512931|NCT00404235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512932|NCT00404352|Interferon beta-1a|interferon beta-1a|mesh-list
25512933|NCT00404352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25512934|NCT00404352|Immunologic Factors|immunologic factors|mesh-ancestor
25512935|NCT00404352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512936|NCT00404352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512937|NCT00404352|Antiviral Agents|antiviral agents|mesh-ancestor
25512938|NCT00404352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25512939|NCT00404495|Irinotecan|irinotecan|mesh-list
25512940|NCT00404495|Temozolomide|temozolomide|mesh-list
25512941|NCT00404495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25512942|NCT00404495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25512943|NCT00404495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512944|NCT00404495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512945|NCT00404495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25512946|NCT00404495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25512947|NCT00404495|Alkylating Agents|alkylating agents|mesh-ancestor
25512948|NCT00404547|Ciclesonide|ciclesonide|mesh-list
25512949|NCT00404547|Glucocorticoids|glucocorticoids|mesh-ancestor
25512950|NCT00404547|Hormones|hormones|mesh-ancestor
25512951|NCT00404547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25512952|NCT00404547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512953|NCT00404547|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25512954|NCT00404651|Vaccines|vaccines|mesh-list
25512955|NCT00404651|Immunologic Factors|immunologic factors|mesh-ancestor
25512956|NCT00404651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512957|NCT00404755|Citalopram|citalopram|mesh-list
25512958|NCT00404755|Bupropion|bupropion|mesh-list
25512959|NCT00404755|Imipramine|imipramine|mesh-list
25512960|NCT00404755|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25512961|NCT00404755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25512962|NCT00404755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25512963|NCT00404755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25645987|NCT01454076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25512964|NCT00404755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25512965|NCT00404755|Serotonin Agents|serotonin agents|mesh-ancestor
25512966|NCT00404755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512967|NCT00404755|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25512968|NCT00404755|Antidepressive Agents|antidepressive agents|mesh-ancestor
25512969|NCT00404755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25512970|NCT00404755|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25512971|NCT00404755|Dopamine Agents|dopamine agents|mesh-ancestor
25512972|NCT00404755|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25512973|NCT00404755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25512974|NCT00404755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25512975|NCT00404755|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25512976|NCT00404755|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25512977|NCT00404755|Adrenergic Agents|adrenergic agents|mesh-ancestor
25512978|NCT00404820|Vitamin D|vitamin d|mesh-list
25512979|NCT00404820|Zoledronic Acid|zoledronic acid|mesh-list
25512980|NCT00404820|Alendronate|alendronate|mesh-list
25512981|NCT00404820|Calcium|calcium|mesh-list
25512982|NCT00404820|Vitamins|vitamins|mesh-ancestor
25512983|NCT00404820|Micronutrients|micronutrients|mesh-ancestor
25512984|NCT00404820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25512985|NCT00404820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25512986|NCT00404820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25512987|NCT00405067|Ezetimibe|ezetimibe|mesh-list
25512988|NCT00405067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25512989|NCT00405067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25512990|NCT00405067|Antimetabolites|antimetabolites|mesh-ancestor
25512991|NCT00405067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25512992|NCT00405067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25512993|NCT00405275|Hydroxychloroquine|hydroxychloroquine|mesh-list
25512994|NCT00405275|Sulfasalazine|sulfasalazine|mesh-list
25512995|NCT00405275|Etanercept|etanercept|mesh-list
25512996|NCT00405275|Methotrexate|methotrexate|mesh-list
25512997|NCT00405275|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25512998|NCT00405275|Abortifacient Agents|abortifacient agents|mesh-ancestor
25512999|NCT00405275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25513000|NCT00405275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513001|NCT00405275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25513002|NCT00405275|Antimetabolites|antimetabolites|mesh-ancestor
25513003|NCT00405275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984043|NCT04840641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24984044|NCT04840641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24984045|NCT04840641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25513004|NCT00405275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513005|NCT00405275|Dermatologic Agents|dermatologic agents|mesh-ancestor
25513006|NCT00405275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513007|NCT00405275|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25513008|NCT00405275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25513009|NCT00405275|Immunologic Factors|immunologic factors|mesh-ancestor
25513010|NCT00405275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25513011|NCT00405275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25513012|NCT00405275|Antimalarials|antimalarials|mesh-ancestor
25513013|NCT00405275|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25513014|NCT00405275|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25513015|NCT00405275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25513016|NCT00405275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25513017|NCT00405275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25513018|NCT00405275|Analgesics|analgesics|mesh-ancestor
25513019|NCT00405275|Sensory System Agents|sensory system agents|mesh-ancestor
25513020|NCT00405275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25513021|NCT00405275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25513022|NCT00405275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25513023|NCT00405288|Hydrocortisone|hydrocortisone|mesh-list
25513024|NCT00405288|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25513025|NCT00405288|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25513026|NCT00405288|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25513027|NCT00405288|Pramoxine|pramoxine|mesh-list
25513028|NCT00405288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25513029|NCT00405288|Anesthetics, Local|anesthetics, local|mesh-ancestor
25513030|NCT00405288|Anesthetics|anesthetics|mesh-ancestor
25513031|NCT00405288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25513032|NCT00405288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513033|NCT00405288|Sensory System Agents|sensory system agents|mesh-ancestor
25513034|NCT00405288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25513035|NCT00405353|Methyltestosterone|methyltestosterone|mesh-list
25513036|NCT00405353|Testosterone|testosterone|mesh-list
25513037|NCT00405353|Testosterone undecanoate|testosterone undecanoate|mesh-list
25513038|NCT00405353|Testosterone enanthate|testosterone enanthate|mesh-list
25513039|NCT00405353|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25513040|NCT00405353|Androgens|androgens|mesh-ancestor
25513041|NCT00405353|Hormones|hormones|mesh-ancestor
25513042|NCT00405353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25513043|NCT00405353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513044|NCT00405353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25513045|NCT00405353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513046|NCT00405353|Anabolic Agents|anabolic agents|mesh-ancestor
25513047|NCT00405392|Ibandronic Acid|ibandronic acid|mesh-list
25513048|NCT00405392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25513049|NCT00405392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513050|NCT00405522|Remifentanil|remifentanil|mesh-list
25513051|NCT00405522|Propofol|propofol|mesh-list
25513052|NCT00405522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25513053|NCT00405522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25513054|NCT00405522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513055|NCT00405522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25513056|NCT00405522|Anesthetics, General|anesthetics, general|mesh-ancestor
25513057|NCT00405522|Anesthetics|anesthetics|mesh-ancestor
25513058|NCT00405522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25513059|NCT00405522|Narcotics|narcotics|mesh-ancestor
25513060|NCT00405522|Analgesics|analgesics|mesh-ancestor
25513061|NCT00405522|Sensory System Agents|sensory system agents|mesh-ancestor
25513062|NCT00405522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25513063|NCT00405548|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25513064|NCT00405548|Natriuretic Agents|natriuretic agents|mesh-ancestor
25513065|NCT00405548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513066|NCT00405587|Vemurafenib|vemurafenib|mesh-list
25513067|NCT00405587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513068|NCT00405587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25513069|NCT00405587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513070|NCT00405587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513071|NCT00405639|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25513072|NCT00405639|Natriuretic Agents|natriuretic agents|mesh-ancestor
25513073|NCT00405639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513074|NCT00405652|Mycophenolic Acid|mycophenolic acid|mesh-list
25513075|NCT00405652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25513076|NCT00405652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513077|NCT00405652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25513078|NCT00405652|Antitubercular Agents|antitubercular agents|mesh-ancestor
25513079|NCT00405652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25513080|NCT00405652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25513081|NCT00405652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513082|NCT00405652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513083|NCT00405704|Trimethoprim|trimethoprim|mesh-list
25513084|NCT00405704|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25513085|NCT00405704|Sulfamethoxazole|sulfamethoxazole|mesh-list
25513086|NCT00405704|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25513087|NCT00405704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25513088|NCT00405704|Renal Agents|renal agents|mesh-ancestor
25513089|NCT00405704|Antimalarials|antimalarials|mesh-ancestor
25513090|NCT00405704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25513091|NCT00405704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25513092|NCT00405704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25513093|NCT00405704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513094|NCT00405704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513095|NCT00405704|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25513096|NCT00405704|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25513097|NCT00405704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25513098|NCT00405704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25513099|NCT00405756|Aspirin|aspirin|mesh-list
25513100|NCT00405756|Prednisone|prednisone|mesh-list
25513101|NCT00405756|Lenalidomide|lenalidomide|mesh-list
25513102|NCT00405756|Melphalan|melphalan|mesh-list
25513103|NCT00405756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25513104|NCT00405756|Glucocorticoids|glucocorticoids|mesh-ancestor
25513105|NCT00405756|Hormones|hormones|mesh-ancestor
25513106|NCT00405756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25513107|NCT00405756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513108|NCT00405756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25513109|NCT00405756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513110|NCT00405756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25823331|NCT00004800|Immunologic Factors|immunologic factors|mesh-ancestor
25513111|NCT00405756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25513112|NCT00405756|Analgesics|analgesics|mesh-ancestor
25513113|NCT00405756|Sensory System Agents|sensory system agents|mesh-ancestor
25513114|NCT00405756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25513115|NCT00405756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25513116|NCT00405756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25513117|NCT00405756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25513118|NCT00405756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513119|NCT00405756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25513120|NCT00405756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25513121|NCT00405756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513122|NCT00405756|Antipyretics|antipyretics|mesh-ancestor
25513123|NCT00405756|Immunologic Factors|immunologic factors|mesh-ancestor
25513124|NCT00405756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25513125|NCT00405756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25513126|NCT00405756|Growth Substances|growth substances|mesh-ancestor
25513127|NCT00405756|Growth Inhibitors|growth inhibitors|mesh-ancestor
25513128|NCT00405756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25513129|NCT00405756|Alkylating Agents|alkylating agents|mesh-ancestor
25513130|NCT00405756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25513131|NCT00405756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25513132|NCT00405821|Acyclovir|acyclovir|mesh-list
25513133|NCT00405821|Antiviral Agents|antiviral agents|mesh-ancestor
25513134|NCT00405821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25513135|NCT00405938|Bevacizumab|bevacizumab|mesh-list
25513136|NCT00405938|Fulvestrant|fulvestrant|mesh-list
25513137|NCT00405938|Anastrozole|anastrozole|mesh-list
25513138|NCT00405938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25513139|NCT00405938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513140|NCT00405938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25513141|NCT00405938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25513142|NCT00405938|Growth Substances|growth substances|mesh-ancestor
25513143|NCT00405938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513144|NCT00405938|Growth Inhibitors|growth inhibitors|mesh-ancestor
25513145|NCT00405938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25513146|NCT00405938|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25513147|NCT00405938|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25513148|NCT00405938|Hormone Antagonists|hormone antagonists|mesh-ancestor
25513149|NCT00405938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25513150|NCT00405938|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25513151|NCT00405938|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25513152|NCT00405938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513153|NCT00405938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784661|NCT01909830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25513154|NCT00406029|Levodopa|levodopa|mesh-list
25513155|NCT00406029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25513156|NCT00406029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25513157|NCT00406029|Dopamine Agents|dopamine agents|mesh-ancestor
25513158|NCT00406029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25513159|NCT00406029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513160|NCT00406029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513161|NCT00406276|Docetaxel|docetaxel|mesh-list
25513162|NCT00406276|Everolimus|everolimus|mesh-list
25513163|NCT00406276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513164|NCT00406276|Tubulin Modulators|tubulin modulators|mesh-ancestor
25513165|NCT00406276|Antimitotic Agents|antimitotic agents|mesh-ancestor
25513166|NCT00406276|Mitosis Modulators|mitosis modulators|mesh-ancestor
25513167|NCT00406276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513168|NCT00406276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25513169|NCT00406276|Immunologic Factors|immunologic factors|mesh-ancestor
25513170|NCT00406276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513171|NCT00406315|Ziprasidone|ziprasidone|mesh-list
25513172|NCT00406315|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25513173|NCT00406315|Serotonin Agents|serotonin agents|mesh-ancestor
25513174|NCT00406315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25513175|NCT00406315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513176|NCT00406315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513177|NCT00406315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25513178|NCT00406315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25513179|NCT00406315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25513180|NCT00406315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25513181|NCT00406315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25513182|NCT00406315|Dopamine Agents|dopamine agents|mesh-ancestor
25513183|NCT00406354|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25513184|NCT00406354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25645988|NCT01454076|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25645989|NCT01454076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25645990|NCT01454076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513185|NCT00406354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25513186|NCT00406354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25513187|NCT00406354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513188|NCT00406354|Adrenergic Agents|adrenergic agents|mesh-ancestor
25513189|NCT00406354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25513190|NCT00406354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513191|NCT00406367|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25513192|NCT00406367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25513193|NCT00406367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25513194|NCT00406367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513195|NCT00406367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25513196|NCT00406367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25513197|NCT00406367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513198|NCT00406367|Cholinergic Agents|cholinergic agents|mesh-ancestor
25513199|NCT00406367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25513200|NCT00406393|Sirolimus|sirolimus|mesh-list
25513201|NCT00406393|Methotrexate|methotrexate|mesh-list
25513202|NCT00406393|Tacrolimus|tacrolimus|mesh-list
25513203|NCT00406393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25513204|NCT00406393|Abortifacient Agents|abortifacient agents|mesh-ancestor
25513205|NCT00406393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25513206|NCT00406393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513207|NCT00406393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25513208|NCT00406393|Antimetabolites|antimetabolites|mesh-ancestor
25513209|NCT00406393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513210|NCT00406393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513211|NCT00406393|Dermatologic Agents|dermatologic agents|mesh-ancestor
25513212|NCT00406393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513213|NCT00406393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25513214|NCT00406393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25513215|NCT00406393|Immunologic Factors|immunologic factors|mesh-ancestor
25513216|NCT00406393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25513217|NCT00406393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24462183|NCT00355303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25513218|NCT00406393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25513219|NCT00406393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25513220|NCT00406393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25513221|NCT00406393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25513222|NCT00406393|Antifungal Agents|antifungal agents|mesh-ancestor
25513223|NCT00406419|Methotrexate|methotrexate|mesh-list
25513224|NCT00406419|Ocrelizumab|ocrelizumab|mesh-list
25513225|NCT00406419|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25513226|NCT00406419|Abortifacient Agents|abortifacient agents|mesh-ancestor
24984345|NCT04595266|Leucovorin|leucovorin|mesh-list
25513227|NCT00406419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25513228|NCT00406419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513229|NCT00406419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25513230|NCT00406419|Antimetabolites|antimetabolites|mesh-ancestor
25513231|NCT00406419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513232|NCT00406419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513233|NCT00406419|Dermatologic Agents|dermatologic agents|mesh-ancestor
25513234|NCT00406419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513235|NCT00406419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25513236|NCT00406419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25513237|NCT00406419|Immunologic Factors|immunologic factors|mesh-ancestor
25513238|NCT00406419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25513239|NCT00406419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25513240|NCT00406640|Citalopram|citalopram|mesh-list
25513241|NCT00406640|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25513242|NCT00406640|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25513243|NCT00406640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25513244|NCT00406640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25513245|NCT00406640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513246|NCT00406640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25513247|NCT00406640|Serotonin Agents|serotonin agents|mesh-ancestor
25513248|NCT00406640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513249|NCT00406640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25513250|NCT00406640|Antidepressive Agents|antidepressive agents|mesh-ancestor
25513251|NCT00406640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24642246|NCT01178645|Busulfan|busulfan|mesh-list
25513252|NCT00406640|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25513253|NCT00406653|Abatacept|abatacept|mesh-list
25513254|NCT00406653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25513255|NCT00406653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513256|NCT00406653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513257|NCT00406653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25513258|NCT00406653|Immunologic Factors|immunologic factors|mesh-ancestor
25513259|NCT00406653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513260|NCT00406653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25513261|NCT00406692|Zonisamide|zonisamide|mesh-list
25513262|NCT00406692|Anticonvulsants|anticonvulsants|mesh-ancestor
25513263|NCT00406692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25513264|NCT00406692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25513265|NCT00406692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513266|NCT00406692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25513267|NCT00406692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513268|NCT00406848|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25513269|NCT00406848|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25513270|NCT00406848|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25513271|NCT00406848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25513272|NCT00406848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513273|NCT00406848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25513274|NCT00406848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513275|NCT00406848|Analgesics|analgesics|mesh-ancestor
25513276|NCT00406848|Sensory System Agents|sensory system agents|mesh-ancestor
25513277|NCT00406848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25513278|NCT00406848|Antidepressive Agents|antidepressive agents|mesh-ancestor
25513279|NCT00406848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25513280|NCT00406848|Dopamine Agents|dopamine agents|mesh-ancestor
25513281|NCT00407030|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25513282|NCT00407030|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25513283|NCT00407030|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25513284|NCT00407030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25513285|NCT00407030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513286|NCT00407030|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25513287|NCT00407030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25513288|NCT00407030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513289|NCT00407030|Cholinergic Agents|cholinergic agents|mesh-ancestor
25513290|NCT00407030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25513291|NCT00407355|Ranibizumab|ranibizumab|mesh-list
25513292|NCT00407355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25513293|NCT00407355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25513294|NCT00407355|Growth Substances|growth substances|mesh-ancestor
25513295|NCT00407355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513296|NCT00407355|Growth Inhibitors|growth inhibitors|mesh-ancestor
24984477|NCT04503668|Olanzapine|olanzapine|mesh-list
25513297|NCT00407355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513298|NCT00407381|Ranibizumab|ranibizumab|mesh-list
25513299|NCT00407381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25513300|NCT00407381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25513301|NCT00407381|Growth Substances|growth substances|mesh-ancestor
25513302|NCT00407381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513303|NCT00407381|Growth Inhibitors|growth inhibitors|mesh-ancestor
25513304|NCT00407381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513305|NCT00407485|Aflibercept|aflibercept|mesh-list
25513306|NCT00407485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25513307|NCT00407485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25513308|NCT00407485|Growth Substances|growth substances|mesh-ancestor
25513309|NCT00407485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513310|NCT00407485|Growth Inhibitors|growth inhibitors|mesh-ancestor
25513311|NCT00407485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513312|NCT00407511|Pregabalin|pregabalin|mesh-list
25513313|NCT00407511|Analgesics|analgesics|mesh-ancestor
25513314|NCT00407511|Sensory System Agents|sensory system agents|mesh-ancestor
25513315|NCT00407511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25513316|NCT00407511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513317|NCT00407511|Anticonvulsants|anticonvulsants|mesh-ancestor
25513318|NCT00407511|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25513319|NCT00407511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25513320|NCT00407511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513321|NCT00407511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25645991|NCT01454076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25513322|NCT00407511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25513323|NCT00407511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25513324|NCT00407511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25513325|NCT00407511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25513326|NCT00407537|Amlodipine|amlodipine|mesh-list
25513327|NCT00407537|Atorvastatin|atorvastatin|mesh-list
25513328|NCT00407537|Calcium|calcium|mesh-list
25513329|NCT00407537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25513330|NCT00407537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513331|NCT00407537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25513332|NCT00407537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25513333|NCT00407537|Antimetabolites|antimetabolites|mesh-ancestor
25513334|NCT00407537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513335|NCT00407537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25513336|NCT00407537|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25513337|NCT00407537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513338|NCT00407537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25513339|NCT00407537|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25513340|NCT00407537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25513341|NCT00407537|Vasodilator Agents|vasodilator agents|mesh-ancestor
25513342|NCT00407550|Gemcitabine|gemcitabine|mesh-list
25513343|NCT00407550|Pemetrexed|pemetrexed|mesh-list
25513344|NCT00407550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25513345|NCT00407550|Antimetabolites|antimetabolites|mesh-ancestor
25513346|NCT00407550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513347|NCT00407550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513348|NCT00407550|Antiviral Agents|antiviral agents|mesh-ancestor
25513349|NCT00407550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25513350|NCT00407550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513351|NCT00407550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25513352|NCT00407550|Immunologic Factors|immunologic factors|mesh-ancestor
25513353|NCT00407550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513354|NCT00407550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25513355|NCT00407550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25513356|NCT00407563|Paclitaxel|paclitaxel|mesh-list
25513357|NCT00407563|Bevacizumab|bevacizumab|mesh-list
25513358|NCT00407563|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25513359|NCT00407563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25513360|NCT00407563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513361|NCT00407563|Tubulin Modulators|tubulin modulators|mesh-ancestor
25513362|NCT00407563|Antimitotic Agents|antimitotic agents|mesh-ancestor
25513363|NCT00407563|Mitosis Modulators|mitosis modulators|mesh-ancestor
25513364|NCT00407563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796085|NCT01947933|Sensory System Agents|sensory system agents|mesh-ancestor
24796086|NCT01947933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24796087|NCT01947933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796088|NCT01947933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24796089|NCT01947933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25513365|NCT00407563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25513366|NCT00407563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25513367|NCT00407563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25513368|NCT00407563|Growth Substances|growth substances|mesh-ancestor
25513369|NCT00407563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513370|NCT00407563|Growth Inhibitors|growth inhibitors|mesh-ancestor
25513371|NCT00407654|Aflibercept|aflibercept|mesh-list
25513372|NCT00407654|Endothelial Growth Factors|endothelial growth factors|mesh-list
25513373|NCT00407654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25513374|NCT00407654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25513375|NCT00407654|Growth Substances|growth substances|mesh-ancestor
25513376|NCT00407654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513377|NCT00407654|Growth Inhibitors|growth inhibitors|mesh-ancestor
25513378|NCT00407654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513379|NCT00407745|Pregabalin|pregabalin|mesh-list
25513380|NCT00407745|Analgesics|analgesics|mesh-ancestor
25513381|NCT00407745|Sensory System Agents|sensory system agents|mesh-ancestor
25513382|NCT00407745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25513383|NCT00407745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513384|NCT00407745|Anticonvulsants|anticonvulsants|mesh-ancestor
25513385|NCT00407745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25513386|NCT00407745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25513387|NCT00407745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513388|NCT00407745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25513389|NCT00407745|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25513390|NCT00407745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25513391|NCT00407745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25513392|NCT00407745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25513393|NCT00407797|Pregabalin|pregabalin|mesh-list
25513394|NCT00407797|Analgesics|analgesics|mesh-ancestor
25513395|NCT00407797|Sensory System Agents|sensory system agents|mesh-ancestor
25513396|NCT00407797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25513397|NCT00407797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513398|NCT00407797|Anticonvulsants|anticonvulsants|mesh-ancestor
25513399|NCT00407797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25513400|NCT00407797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25513401|NCT00407797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513402|NCT00407797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25513403|NCT00407797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25513404|NCT00407797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25513405|NCT00407797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25513406|NCT00407797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25513407|NCT00407888|Paclitaxel|paclitaxel|mesh-list
25513408|NCT00407888|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25513409|NCT00407888|Cyclophosphamide|cyclophosphamide|mesh-list
25513410|NCT00407888|Doxorubicin|doxorubicin|mesh-list
25513411|NCT00407888|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25513412|NCT00407888|Trastuzumab|trastuzumab|mesh-list
25513413|NCT00407888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25513414|NCT00407888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513415|NCT00407888|Tubulin Modulators|tubulin modulators|mesh-ancestor
25513416|NCT00407888|Antimitotic Agents|antimitotic agents|mesh-ancestor
25513417|NCT00407888|Mitosis Modulators|mitosis modulators|mesh-ancestor
25513418|NCT00407888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513419|NCT00407888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25513420|NCT00407888|Immunologic Factors|immunologic factors|mesh-ancestor
25513421|NCT00407888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513422|NCT00407888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25513423|NCT00407888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25513424|NCT00407888|Alkylating Agents|alkylating agents|mesh-ancestor
25513425|NCT00407888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25513426|NCT00407888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25513427|NCT00407888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25513428|NCT00407888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25513429|NCT00407888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513430|NCT00407888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25513431|NCT00407966|Cytarabine|cytarabine|mesh-list
25513432|NCT00407966|Mitoxantrone|mitoxantrone|mesh-list
25513433|NCT00407966|Alvocidib|alvocidib|mesh-list
25513434|NCT00407966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25513435|NCT00407966|Antimetabolites|antimetabolites|mesh-ancestor
25513436|NCT00407966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984667|NCT04270669|Growth Substances|growth substances|mesh-ancestor
24984668|NCT04270669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984669|NCT04270669|Growth Inhibitors|growth inhibitors|mesh-ancestor
25513437|NCT00407966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513438|NCT00407966|Antiviral Agents|antiviral agents|mesh-ancestor
25513439|NCT00407966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25513440|NCT00407966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25513441|NCT00407966|Immunologic Factors|immunologic factors|mesh-ancestor
25513442|NCT00407966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513443|NCT00407966|Analgesics|analgesics|mesh-ancestor
25513444|NCT00407966|Sensory System Agents|sensory system agents|mesh-ancestor
25513445|NCT00407966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25513446|NCT00407966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25513447|NCT00407966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25513448|NCT00407966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513449|NCT00407966|Growth Inhibitors|growth inhibitors|mesh-ancestor
25513450|NCT00407966|Growth Substances|growth substances|mesh-ancestor
25513451|NCT00407966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25513453|NCT00408070|Bevacizumab|bevacizumab|mesh-list
25513454|NCT00408070|Carboplatin|carboplatin|mesh-list
25513455|NCT00408070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25513456|NCT00408070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513457|NCT00408070|Tubulin Modulators|tubulin modulators|mesh-ancestor
25513458|NCT00408070|Antimitotic Agents|antimitotic agents|mesh-ancestor
25513459|NCT00408070|Mitosis Modulators|mitosis modulators|mesh-ancestor
25513460|NCT00408070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513461|NCT00408070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25513462|NCT00408070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25513463|NCT00408070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25645992|NCT01454076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25645993|NCT01454076|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25513464|NCT00408070|Growth Substances|growth substances|mesh-ancestor
25513465|NCT00408070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513466|NCT00408070|Growth Inhibitors|growth inhibitors|mesh-ancestor
25513467|NCT00408200|Sotalol|sotalol|mesh-list
25513468|NCT00408200|Flecainide|flecainide|mesh-list
25513469|NCT00408200|Propafenone|propafenone|mesh-list
25513470|NCT00408200|Dofetilide|dofetilide|mesh-list
25513471|NCT00408200|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25513472|NCT00408200|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25513473|NCT00408200|Adrenergic Agents|adrenergic agents|mesh-ancestor
25513474|NCT00408200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25513475|NCT00408200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513476|NCT00408200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513477|NCT00408200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25513478|NCT00408200|Sympatholytics|sympatholytics|mesh-ancestor
25513479|NCT00408200|Autonomic Agents|autonomic agents|mesh-ancestor
25513480|NCT00408200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25513481|NCT00408200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25513482|NCT00408200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25513483|NCT00408200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25513484|NCT00408200|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25513485|NCT00408317|Pancrelipase|pancrelipase|mesh-list
25513486|NCT00408317|Pancreatin|pancreatin|mesh-list
25513487|NCT00408317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25513488|NCT00408408|Gemcitabine|gemcitabine|mesh-list
25513489|NCT00408408|Cyclophosphamide|cyclophosphamide|mesh-list
25513490|NCT00408408|Bevacizumab|bevacizumab|mesh-list
25513491|NCT00408408|Docetaxel|docetaxel|mesh-list
25513492|NCT00408408|Doxorubicin|doxorubicin|mesh-list
25513493|NCT00408408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25513494|NCT00408408|Capecitabine|capecitabine|mesh-list
25513495|NCT00408408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25513496|NCT00408408|Immunologic Factors|immunologic factors|mesh-ancestor
25513497|NCT00408408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513498|NCT00408408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25513499|NCT00408408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25513500|NCT00408408|Alkylating Agents|alkylating agents|mesh-ancestor
25513501|NCT00408408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513502|NCT00408408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513503|NCT00408408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25513504|NCT00408408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25513505|NCT00408408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25513506|NCT00408408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25513507|NCT00408408|Growth Substances|growth substances|mesh-ancestor
24984737|NCT04129996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984738|NCT04125134|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24984739|NCT04125134|Lubricant Eye Drops|lubricant eye drops|mesh-list
24984740|NCT04125134|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24984741|NCT04120766|Nicorandil|nicorandil|mesh-list
25513508|NCT00408408|Growth Inhibitors|growth inhibitors|mesh-ancestor
25513509|NCT00408408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25513510|NCT00408408|Antimetabolites|antimetabolites|mesh-ancestor
25513511|NCT00408408|Antiviral Agents|antiviral agents|mesh-ancestor
25513512|NCT00408408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25513513|NCT00408408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513514|NCT00408408|Tubulin Modulators|tubulin modulators|mesh-ancestor
25513515|NCT00408408|Antimitotic Agents|antimitotic agents|mesh-ancestor
25513516|NCT00408408|Mitosis Modulators|mitosis modulators|mesh-ancestor
25513517|NCT00408408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25513518|NCT00408408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25513519|NCT00408408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25513520|NCT00408421|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25513521|NCT00408421|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25513522|NCT00408421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25513523|NCT00408421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25513524|NCT00408421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513525|NCT00408421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25513526|NCT00408421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513527|NCT00408421|Analgesics|analgesics|mesh-ancestor
25513528|NCT00408421|Sensory System Agents|sensory system agents|mesh-ancestor
25513529|NCT00408421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25513530|NCT00408421|Antidepressive Agents|antidepressive agents|mesh-ancestor
25074404|NCT03388697|Insulin|insulin|mesh-list
25513531|NCT00408421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25513532|NCT00408421|Dopamine Agents|dopamine agents|mesh-ancestor
25513533|NCT00408434|Efatutazone|efatutazone|mesh-list
25513534|NCT00408434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513535|NCT00408460|Paclitaxel|paclitaxel|mesh-list
25513536|NCT00408460|Imatinib Mesylate|imatinib mesylate|mesh-list
25513537|NCT00408460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25513538|NCT00408460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513539|NCT00408460|Tubulin Modulators|tubulin modulators|mesh-ancestor
25513540|NCT00408460|Antimitotic Agents|antimitotic agents|mesh-ancestor
25513541|NCT00408460|Mitosis Modulators|mitosis modulators|mesh-ancestor
25513542|NCT00408460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513543|NCT00408460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25513544|NCT00408460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513545|NCT00408499|Cetuximab|cetuximab|mesh-list
25513546|NCT00408499|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25513547|NCT00408499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25513548|NCT00408499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513549|NCT00408499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25513550|NCT00408499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513551|NCT00408499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513552|NCT00408564|Gemcitabine|gemcitabine|mesh-list
25513553|NCT00408564|Capecitabine|capecitabine|mesh-list
25513554|NCT00408564|Oxaliplatin|oxaliplatin|mesh-list
25513555|NCT00408564|Cetuximab|cetuximab|mesh-list
25513556|NCT00408564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25513557|NCT00408564|Antimetabolites|antimetabolites|mesh-ancestor
25513558|NCT00408564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513559|NCT00408564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513560|NCT00408564|Antiviral Agents|antiviral agents|mesh-ancestor
25513561|NCT00408564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25513562|NCT00408564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513563|NCT00408564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25513564|NCT00408564|Immunologic Factors|immunologic factors|mesh-ancestor
25513565|NCT00408564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513566|NCT00408564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25513567|NCT00408629|Adalimumab|adalimumab|mesh-list
25513568|NCT00408629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25513569|NCT00408629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25513570|NCT00408681|Lithium Carbonate|lithium carbonate|mesh-list
25513571|NCT00408681|Antidepressive Agents|antidepressive agents|mesh-ancestor
25513572|NCT00408681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25513573|NCT00408681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513574|NCT00408681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513575|NCT00408681|Antimanic Agents|antimanic agents|mesh-ancestor
25513576|NCT00408681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25513577|NCT00408681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25513578|NCT00408681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513579|NCT00408694|Bevacizumab|bevacizumab|mesh-list
25513580|NCT00408694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25513581|NCT00408694|Cisplatin|cisplatin|mesh-list
25823332|NCT00004800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513582|NCT00408694|Fluorouracil|fluorouracil|mesh-list
25513583|NCT00408694|Endothelial Growth Factors|endothelial growth factors|mesh-list
25513584|NCT00408694|Antibodies|antibodies|mesh-list
25513585|NCT00408694|Immunoglobulins|immunoglobulins|mesh-list
25513586|NCT00408694|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25513587|NCT00408694|Immunoglobulin G|immunoglobulin g|mesh-list
25513588|NCT00408694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513589|NCT00408694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25513590|NCT00408694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25513591|NCT00408694|Growth Substances|growth substances|mesh-ancestor
25513592|NCT00408694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513593|NCT00408694|Growth Inhibitors|growth inhibitors|mesh-ancestor
25513594|NCT00408694|Immunologic Factors|immunologic factors|mesh-ancestor
25513595|NCT00408694|Antimetabolites|antimetabolites|mesh-ancestor
25513596|NCT00408694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513597|NCT00408694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25513598|NCT00408694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25513599|NCT00408876|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25513600|NCT00408876|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25513601|NCT00408876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25513602|NCT00408876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25513603|NCT00408876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960338|NCT03818334|Thymoglobulin|thymoglobulin|mesh-list
25645994|NCT01454076|Antitubercular Agents|antitubercular agents|mesh-ancestor
25645995|NCT01454076|Leprostatic Agents|leprostatic agents|mesh-ancestor
25645996|NCT01454076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25645997|NCT01454076|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25645998|NCT01454076|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25645999|NCT01454076|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25646000|NCT01454076|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25646001|NCT01454076|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25646002|NCT01454076|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25513604|NCT00408876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25513605|NCT00408876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513606|NCT00408876|Analgesics|analgesics|mesh-ancestor
25513607|NCT00408876|Sensory System Agents|sensory system agents|mesh-ancestor
25513608|NCT00408876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25513609|NCT00408876|Antidepressive Agents|antidepressive agents|mesh-ancestor
25513610|NCT00408876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25513611|NCT00408876|Dopamine Agents|dopamine agents|mesh-ancestor
25513612|NCT00408928|Bortezomib|bortezomib|mesh-list
25513613|NCT00408928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513614|NCT00408993|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25513615|NCT00408993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25513616|NCT00408993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25513617|NCT00408993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25513618|NCT00408993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513619|NCT00408993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25513620|NCT00408993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513621|NCT00408993|Analgesics|analgesics|mesh-ancestor
25513622|NCT00408993|Sensory System Agents|sensory system agents|mesh-ancestor
25513623|NCT00408993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25513624|NCT00408993|Antidepressive Agents|antidepressive agents|mesh-ancestor
25513625|NCT00408993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25513626|NCT00408993|Dopamine Agents|dopamine agents|mesh-ancestor
25513627|NCT00409006|Cisplatin|cisplatin|mesh-list
25513628|NCT00409006|Pemetrexed|pemetrexed|mesh-list
25513629|NCT00409006|Gefitinib|gefitinib|mesh-list
25513630|NCT00409006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513631|NCT00409006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513632|NCT00409006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513633|NCT00409006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25513634|NCT00409006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25513635|NCT00409006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25513636|NCT00409188|Cyclophosphamide|cyclophosphamide|mesh-list
25513637|NCT00409188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25513638|NCT00409188|Immunologic Factors|immunologic factors|mesh-ancestor
25513639|NCT00409188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513640|NCT00409188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25513641|NCT00409188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25513642|NCT00409188|Alkylating Agents|alkylating agents|mesh-ancestor
25513643|NCT00409188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513644|NCT00409188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513645|NCT00409188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25513646|NCT00409292|Everolimus|everolimus|mesh-list
25106826|NCT03144882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106827|NCT03144882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25106828|NCT03144882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25106829|NCT03144882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106830|NCT03144882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25106831|NCT03144882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106832|NCT03144466|Pembrolizumab|pembrolizumab|mesh-list
25106834|NCT03144466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513647|NCT00409292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513648|NCT00409292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25513650|NCT00409292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513651|NCT00409565|Bevacizumab|bevacizumab|mesh-list
25513652|NCT00409565|Cetuximab|cetuximab|mesh-list
25513653|NCT00409565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25513654|NCT00409565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513655|NCT00409565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25513656|NCT00409565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25513657|NCT00409565|Growth Substances|growth substances|mesh-ancestor
25513658|NCT00409565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513659|NCT00409565|Growth Inhibitors|growth inhibitors|mesh-ancestor
25513660|NCT00409578|Valsartan|valsartan|mesh-list
25646003|NCT01454076|Antifungal Agents|antifungal agents|mesh-ancestor
25646004|NCT01454076|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25646005|NCT01454076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25513661|NCT00409578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25513662|NCT00409578|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25513663|NCT00409578|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25513664|NCT00409578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513665|NCT00409617|Adalimumab|adalimumab|mesh-list
25513666|NCT00409617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25513667|NCT00409617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25513668|NCT00409682|Adalimumab|adalimumab|mesh-list
25513669|NCT00409682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25513670|NCT00409682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25513671|NCT00409708|Methylphenidate|methylphenidate|mesh-list
25513672|NCT00409708|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25513673|NCT00409708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513674|NCT00409708|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25646006|NCT01454076|Hormone Antagonists|hormone antagonists|mesh-ancestor
25646007|NCT01454076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25646008|NCT01454076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646009|NCT01454076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646010|NCT01454076|Protease Inhibitors|protease inhibitors|mesh-ancestor
25646011|NCT01454076|Glycine Agents|glycine agents|mesh-ancestor
25646012|NCT01454076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25646013|NCT01454102|Gemcitabine|gemcitabine|mesh-list
25646014|NCT01454102|Paclitaxel|paclitaxel|mesh-list
25513675|NCT00409708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25513676|NCT00409708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25513677|NCT00409708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513678|NCT00409708|Dopamine Agents|dopamine agents|mesh-ancestor
25513679|NCT00409708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25513680|NCT00409747|Minocycline|minocycline|mesh-list
25513681|NCT00409747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25513682|NCT00409747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25513683|NCT00409825|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
25513684|NCT00409825|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
25513685|NCT00409825|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25513686|NCT00409825|Hormone Antagonists|hormone antagonists|mesh-ancestor
25513687|NCT00409825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25513688|NCT00409825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513689|NCT00409825|Progestins|progestins|mesh-ancestor
25513690|NCT00409825|Hormones|hormones|mesh-ancestor
25513691|NCT00409838|Methotrexate|methotrexate|mesh-list
25513692|NCT00409838|Abatacept|abatacept|mesh-list
25513693|NCT00409838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25513694|NCT00409838|Abortifacient Agents|abortifacient agents|mesh-ancestor
25513695|NCT00409838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25513696|NCT00409838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513697|NCT00409838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25513698|NCT00409838|Antimetabolites|antimetabolites|mesh-ancestor
25513699|NCT00409838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513700|NCT00409838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513701|NCT00409838|Dermatologic Agents|dermatologic agents|mesh-ancestor
25513702|NCT00409838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513703|NCT00409838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25513704|NCT00409838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25513705|NCT00409838|Immunologic Factors|immunologic factors|mesh-ancestor
25513706|NCT00409838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25513707|NCT00409838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25513708|NCT00409838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25513709|NCT00410046|Etanercept|etanercept|mesh-list
25513710|NCT00410046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25513711|NCT00410046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25513712|NCT00410046|Analgesics|analgesics|mesh-ancestor
25513713|NCT00410046|Sensory System Agents|sensory system agents|mesh-ancestor
25513714|NCT00410046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25513715|NCT00410046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823333|NCT00004802|Dichlorphenamide|dichlorphenamide|mesh-list
25823334|NCT00004802|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25106869|NCT03144128|Micronutrients|micronutrients|mesh-ancestor
24984801|NCT04040959|Vasodilator Agents|vasodilator agents|mesh-ancestor
24984802|NCT04019262|Temozolomide|temozolomide|mesh-list
25513716|NCT00410046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25513717|NCT00410046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25513718|NCT00410046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25513719|NCT00410046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25513720|NCT00410046|Immunologic Factors|immunologic factors|mesh-ancestor
25513721|NCT00410059|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25513722|NCT00410059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513723|NCT00410059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25513724|NCT00410059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513725|NCT00410059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513726|NCT00410072|Tenofovir|tenofovir|mesh-list
25513727|NCT00410072|Entecavir|entecavir|mesh-list
25513728|NCT00410072|Antiviral Agents|antiviral agents|mesh-ancestor
25513729|NCT00410072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25513730|NCT00410072|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25513731|NCT00410072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25513732|NCT00410072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513733|NCT00410072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513734|NCT00410072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25513735|NCT00410072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25513736|NCT00410124|Everolimus|everolimus|mesh-list
25513737|NCT00410124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513738|NCT00410124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25513739|NCT00410124|Immunologic Factors|immunologic factors|mesh-ancestor
25513740|NCT00410124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513741|NCT00410150|Albuterol|albuterol|mesh-list
25513742|NCT00410150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25513743|NCT00410150|Autonomic Agents|autonomic agents|mesh-ancestor
25513744|NCT00410150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25513745|NCT00410150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513746|NCT00410150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25513747|NCT00410150|Respiratory System Agents|respiratory system agents|mesh-ancestor
25513748|NCT00410150|Tocolytic Agents|tocolytic agents|mesh-ancestor
25513749|NCT00410150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25513750|NCT00410150|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25513751|NCT00410150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25513752|NCT00410150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25513753|NCT00410150|Adrenergic Agents|adrenergic agents|mesh-ancestor
25513754|NCT00410150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25513755|NCT00410150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513756|NCT00410163|Cyclophosphamide|cyclophosphamide|mesh-list
25513757|NCT00410163|Fludarabine|fludarabine|mesh-list
25513758|NCT00410163|Ofatumumab|ofatumumab|mesh-list
25513759|NCT00410163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25513760|NCT00410163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25513761|NCT00410163|Immunologic Factors|immunologic factors|mesh-ancestor
25513762|NCT00410163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513763|NCT00410163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25513764|NCT00410163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25513765|NCT00410163|Alkylating Agents|alkylating agents|mesh-ancestor
25513766|NCT00410163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513767|NCT00410163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513768|NCT00410163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25513769|NCT00410202|Tenofovir|tenofovir|mesh-list
25513770|NCT00410202|Lamivudine|lamivudine|mesh-list
25513771|NCT00410202|Entecavir|entecavir|mesh-list
25513772|NCT00410202|Adefovir|adefovir|mesh-list
25513773|NCT00410202|Antiviral Agents|antiviral agents|mesh-ancestor
25513774|NCT00410202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25513775|NCT00410202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25513776|NCT00410202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25513777|NCT00410202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513778|NCT00410202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513779|NCT00410202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25513780|NCT00410202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25513781|NCT00410384|Belimumab|belimumab|mesh-list
25513782|NCT00410384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25513783|NCT00410384|Immunologic Factors|immunologic factors|mesh-ancestor
25513784|NCT00410384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513785|NCT00410410|Abatacept|abatacept|mesh-list
25513786|NCT00410410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25513787|NCT00410410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513788|NCT00410410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513789|NCT00410410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25106875|NCT03143946|Vitamins|vitamins|mesh-list
25513790|NCT00410410|Immunologic Factors|immunologic factors|mesh-ancestor
25513799|NCT00410423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25513800|NCT00410423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25513801|NCT00410423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513802|NCT00410423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513803|NCT00410423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25513804|NCT00410423|Antimetabolites|antimetabolites|mesh-ancestor
25513805|NCT00410423|Antiviral Agents|antiviral agents|mesh-ancestor
25513806|NCT00410423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25513807|NCT00410423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25513808|NCT00410423|Immunologic Factors|immunologic factors|mesh-ancestor
25513809|NCT00410423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513810|NCT00410423|Analgesics|analgesics|mesh-ancestor
25513811|NCT00410423|Sensory System Agents|sensory system agents|mesh-ancestor
25513812|NCT00410423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25513813|NCT00410488|Dexamethasone|dexamethasone|mesh-list
25513814|NCT00410488|Dexamethasone acetate|dexamethasone acetate|mesh-list
25513815|NCT00410488|Doxorubicin|doxorubicin|mesh-list
25513816|NCT00410488|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25513817|NCT00410488|Vincristine|vincristine|mesh-list
25513818|NCT00410488|Ifosfamide|ifosfamide|mesh-list
25513819|NCT00410488|Dexrazoxane|dexrazoxane|mesh-list
25513820|NCT00410488|Palonosetron|palonosetron|mesh-list
25513821|NCT00410488|BB 1101|bb 1101|mesh-list
25513822|NCT00410488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25513823|NCT00410488|Antiemetics|antiemetics|mesh-ancestor
25513824|NCT00410488|Autonomic Agents|autonomic agents|mesh-ancestor
25513825|NCT00410488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25513826|NCT00410488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513827|NCT00410488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25513828|NCT00410488|Glucocorticoids|glucocorticoids|mesh-ancestor
25513829|NCT00410488|Hormones|hormones|mesh-ancestor
25513830|NCT00410488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25513831|NCT00410488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25513832|NCT00410488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513833|NCT00410488|Protease Inhibitors|protease inhibitors|mesh-ancestor
25513834|NCT00410488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513835|NCT00410488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513836|NCT00410488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25513837|NCT00410488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25513838|NCT00410488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25513839|NCT00410488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25513840|NCT00410488|Tubulin Modulators|tubulin modulators|mesh-ancestor
25513841|NCT00410488|Antimitotic Agents|antimitotic agents|mesh-ancestor
25513842|NCT00410488|Mitosis Modulators|mitosis modulators|mesh-ancestor
25513843|NCT00410488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25513844|NCT00410488|Alkylating Agents|alkylating agents|mesh-ancestor
25513845|NCT00410488|Protective Agents|protective agents|mesh-ancestor
25513846|NCT00410488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25513847|NCT00410488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25513848|NCT00410488|Serotonin Agents|serotonin agents|mesh-ancestor
25513849|NCT00410488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25513850|NCT00410488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24985002|NCT03772951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24985003|NCT03772951|Serotonin Agents|serotonin agents|mesh-ancestor
24985004|NCT03772951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24985005|NCT03772951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985006|NCT03772951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985007|NCT03772951|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24985008|NCT03772951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25162534|NCT02904031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25162542|NCT02904031|Vitamins|vitamins|mesh-ancestor
25513855|NCT00410514|Adrenergic Agents|adrenergic agents|mesh-ancestor
25513856|NCT00410514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25513857|NCT00410514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513858|NCT00410514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513859|NCT00410514|Urological Agents|urological agents|mesh-ancestor
25513860|NCT00410605|Dexamethasone|dexamethasone|mesh-list
25513861|NCT00410605|Bevacizumab|bevacizumab|mesh-list
25513862|NCT00410605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25513863|NCT00410605|Lenalidomide|lenalidomide|mesh-list
25513864|NCT00410605|Antibodies|antibodies|mesh-list
25513865|NCT00410605|Immunoglobulins|immunoglobulins|mesh-list
25513866|NCT00410605|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25513867|NCT00410605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513868|NCT00410605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25513869|NCT00410605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25513870|NCT00410605|Growth Substances|growth substances|mesh-ancestor
25513871|NCT00410605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513872|NCT00410605|Growth Inhibitors|growth inhibitors|mesh-ancestor
25513873|NCT00410605|Immunologic Factors|immunologic factors|mesh-ancestor
25513874|NCT00410605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25513875|NCT00410605|Antiemetics|antiemetics|mesh-ancestor
25513876|NCT00410605|Autonomic Agents|autonomic agents|mesh-ancestor
25513877|NCT00410605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25513878|NCT00410605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25513879|NCT00410605|Glucocorticoids|glucocorticoids|mesh-ancestor
25513881|NCT00410605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25513882|NCT00410605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25513883|NCT00410813|Dasatinib|dasatinib|mesh-list
25513884|NCT00410813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513885|NCT00410813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25513886|NCT00410813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513887|NCT00410813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513888|NCT00410826|Cisplatin|cisplatin|mesh-list
25513889|NCT00410826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25513890|NCT00410826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513891|NCT00410826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25513892|NCT00410826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513893|NCT00410826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513894|NCT00410891|Gatifloxacin|gatifloxacin|mesh-list
25513895|NCT00410891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25513896|NCT00410891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25513897|NCT00410891|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25513898|NCT00410891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25513899|NCT00410891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25513900|NCT00410891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25513901|NCT00410891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513902|NCT00410891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513903|NCT00410891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513904|NCT00410904|Pemetrexed|pemetrexed|mesh-list
25513905|NCT00410904|Cediranib|cediranib|mesh-list
25513906|NCT00410904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513907|NCT00410904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513908|NCT00410904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513909|NCT00410904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25513910|NCT00410904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25513911|NCT00410904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25513912|NCT00411086|Rituximab|rituximab|mesh-list
25513913|NCT00411086|Molgramostim|molgramostim|mesh-list
25513914|NCT00411086|Sargramostim|sargramostim|mesh-list
25513915|NCT00411086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25513916|NCT00411086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513917|NCT00411086|Immunologic Factors|immunologic factors|mesh-ancestor
25513918|NCT00411086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985021|NCT03735420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24860196|NCT02308072|Olaparib|olaparib|mesh-list
25513919|NCT00411086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25513920|NCT00411151|Sunitinib|sunitinib|mesh-list
25513921|NCT00411151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513922|NCT00411151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25513923|NCT00411151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25513924|NCT00411151|Growth Substances|growth substances|mesh-ancestor
25513925|NCT00411151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513926|NCT00411151|Growth Inhibitors|growth inhibitors|mesh-ancestor
25513927|NCT00411151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25513928|NCT00411151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513929|NCT00411151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513931|NCT00411398|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25513932|NCT00411398|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25513933|NCT00411398|Dopamine Agents|dopamine agents|mesh-ancestor
25513934|NCT00411398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25513935|NCT00411398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513936|NCT00411398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513937|NCT00411398|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25513938|NCT00411398|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25513939|NCT00411411|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25513940|NCT00411411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25513941|NCT00411411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513942|NCT00411411|Incretins|incretins|mesh-ancestor
25513943|NCT00411411|Hormones|hormones|mesh-ancestor
25513944|NCT00411411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25513945|NCT00411411|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25513946|NCT00411411|Protease Inhibitors|protease inhibitors|mesh-ancestor
25646015|NCT01454102|Bevacizumab|bevacizumab|mesh-list
25513947|NCT00411411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513948|NCT00411411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513949|NCT00411450|Panitumumab|panitumumab|mesh-list
25513950|NCT00411450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25513951|NCT00411450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513952|NCT00411463|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25513953|NCT00411463|Antidepressive Agents|antidepressive agents|mesh-ancestor
25513954|NCT00411463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25513955|NCT00411463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25513956|NCT00411463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25513957|NCT00411463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25513958|NCT00411463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513959|NCT00411554|Inositol|inositol|mesh-list
25513960|NCT00411554|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25513961|NCT00411554|Voglibose|voglibose|mesh-list
25513962|NCT00411554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25513963|NCT00411554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513964|NCT00411554|Incretins|incretins|mesh-ancestor
25513965|NCT00411554|Hormones|hormones|mesh-ancestor
25513966|NCT00411554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25513967|NCT00411554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25513968|NCT00411554|Protease Inhibitors|protease inhibitors|mesh-ancestor
25513969|NCT00411554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513970|NCT00411554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513971|NCT00411554|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25513972|NCT00411554|Vitamin B Complex|vitamin b complex|mesh-ancestor
25513973|NCT00411554|Vitamins|vitamins|mesh-ancestor
25513974|NCT00411554|Micronutrients|micronutrients|mesh-ancestor
25513975|NCT00411619|Everolimus|everolimus|mesh-list
25513976|NCT00411619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513977|NCT00411619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25513978|NCT00411619|Immunologic Factors|immunologic factors|mesh-ancestor
25513979|NCT00411619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513980|NCT00411632|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25513981|NCT00411632|Bexarotene|bexarotene|mesh-list
25513982|NCT00411632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513983|NCT00411632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25513984|NCT00411632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513985|NCT00411632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513986|NCT00411645|Maribavir|maribavir|mesh-list
25513987|NCT00411645|Antiviral Agents|antiviral agents|mesh-ancestor
25823335|NCT00004802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823336|NCT00004802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823337|NCT00004804|Interferons|interferons|mesh-list
25823338|NCT00004804|Interferon-alpha|interferon-alpha|mesh-list
25823339|NCT00004804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823340|NCT00004804|Antiviral Agents|antiviral agents|mesh-ancestor
25513988|NCT00411645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25513989|NCT00411671|Sorafenib|sorafenib|mesh-list
25513990|NCT00411671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25513991|NCT00411671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25513992|NCT00411671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25513993|NCT00411671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25513994|NCT00411684|Ulipristal acetate|ulipristal acetate|mesh-list
25513995|NCT00411684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25513996|NCT00411684|Contraceptive Agents|contraceptive agents|mesh-ancestor
25513997|NCT00411684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25513998|NCT00411684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25513999|NCT00411684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25514000|NCT00411762|Capecitabine|capecitabine|mesh-list
25514001|NCT00411762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25514002|NCT00411762|Antimetabolites|antimetabolites|mesh-ancestor
25514003|NCT00411762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514004|NCT00411762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514005|NCT00411788|Sirolimus|sirolimus|mesh-list
25514006|NCT00411788|Trastuzumab|trastuzumab|mesh-list
25514007|NCT00411788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25514008|NCT00411788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514009|NCT00411788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25514010|NCT00411788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25514011|NCT00411788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25646016|NCT01454102|Cisplatin|cisplatin|mesh-list
25646017|NCT01454102|Carboplatin|carboplatin|mesh-list
25514012|NCT00411788|Antifungal Agents|antifungal agents|mesh-ancestor
25514013|NCT00411788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25514014|NCT00411788|Immunologic Factors|immunologic factors|mesh-ancestor
25514015|NCT00411788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514016|NCT00412061|Everolimus|everolimus|mesh-list
25514017|NCT00412061|Octreotide|octreotide|mesh-list
25514018|NCT00412061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514019|NCT00412061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25514020|NCT00412061|Immunologic Factors|immunologic factors|mesh-ancestor
25514021|NCT00412061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514022|NCT00412061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25514023|NCT00412061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25514024|NCT00412074|Vitamin D|vitamin d|mesh-list
25514025|NCT00412074|Ergocalciferols|ergocalciferols|mesh-list
25514026|NCT00412074|Cholecalciferol|cholecalciferol|mesh-list
25514027|NCT00412074|Vitamins|vitamins|mesh-list
25514028|NCT00412074|Micronutrients|micronutrients|mesh-ancestor
25514029|NCT00412074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514030|NCT00412074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25514031|NCT00412074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25514032|NCT00412087|Vitamin D|vitamin d|mesh-list
25514033|NCT00412087|Ergocalciferols|ergocalciferols|mesh-list
25514034|NCT00412087|Cholecalciferol|cholecalciferol|mesh-list
25514035|NCT00412087|Vitamins|vitamins|mesh-list
25514036|NCT00412087|Micronutrients|micronutrients|mesh-ancestor
25514037|NCT00412087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514038|NCT00412087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25514039|NCT00412087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25514040|NCT00412113|Calcium, Dietary|calcium, dietary|mesh-list
25514041|NCT00412113|Amlodipine|amlodipine|mesh-list
25514042|NCT00412113|Atorvastatin|atorvastatin|mesh-list
25514043|NCT00412113|Calcium|calcium|mesh-list
25514044|NCT00412113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25514045|NCT00412113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514046|NCT00412113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25514047|NCT00412113|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25514048|NCT00412113|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25514049|NCT00412113|Antimetabolites|antimetabolites|mesh-ancestor
25514050|NCT00412113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514051|NCT00412113|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25514052|NCT00412113|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25823341|NCT00004804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25823342|NCT00004804|Immunologic Factors|immunologic factors|mesh-ancestor
24796163|NCT01948245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25823343|NCT00004804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823344|NCT00004807|Topiramate|topiramate|mesh-list
25823345|NCT00004807|Dextromethorphan|dextromethorphan|mesh-list
25823346|NCT00004807|Donepezil|donepezil|mesh-list
24796164|NCT01948245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796165|NCT01948336|Dexmedetomidine|dexmedetomidine|mesh-list
24796166|NCT01948336|Ketamine|ketamine|mesh-list
24796167|NCT01948336|Propofol|propofol|mesh-list
25514053|NCT00412113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514054|NCT00412113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25514055|NCT00412113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25514056|NCT00412113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25514057|NCT00412113|Vasodilator Agents|vasodilator agents|mesh-ancestor
25514058|NCT00412217|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25514059|NCT00412217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514060|NCT00412217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25514061|NCT00412217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514062|NCT00412217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514063|NCT00412243|Cyclophosphamide|cyclophosphamide|mesh-list
25514064|NCT00412243|Clofarabine|clofarabine|mesh-list
25514065|NCT00412243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25514066|NCT00412243|Immunologic Factors|immunologic factors|mesh-ancestor
25514067|NCT00412243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514068|NCT00412243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25514069|NCT00412243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25514070|NCT00412243|Alkylating Agents|alkylating agents|mesh-ancestor
25514071|NCT00412243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514072|NCT00412243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514073|NCT00412243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25514074|NCT00412243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25514075|NCT00412243|Antimetabolites|antimetabolites|mesh-ancestor
25646018|NCT01454102|Nivolumab|nivolumab|mesh-list
25823347|NCT00004807|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25646019|NCT01454102|Pemetrexed|pemetrexed|mesh-list
25646020|NCT01454102|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25646021|NCT01454102|Ipilimumab|ipilimumab|mesh-list
25646022|NCT01454102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25646023|NCT01454102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646024|NCT01454102|Tubulin Modulators|tubulin modulators|mesh-ancestor
25646025|NCT01454102|Antimitotic Agents|antimitotic agents|mesh-ancestor
25514076|NCT00412360|Cyclosporine|cyclosporine|mesh-list
25514077|NCT00412360|Mycophenolic Acid|mycophenolic acid|mesh-list
25514078|NCT00412360|Cyclophosphamide|cyclophosphamide|mesh-list
25514079|NCT00412360|Fludarabine|fludarabine|mesh-list
25514080|NCT00412360|Cyclosporins|cyclosporins|mesh-list
25514081|NCT00412360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25514082|NCT00412360|Immunologic Factors|immunologic factors|mesh-ancestor
25514083|NCT00412360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514084|NCT00412360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25514085|NCT00412360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25514086|NCT00412360|Alkylating Agents|alkylating agents|mesh-ancestor
25514087|NCT00412360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514088|NCT00412360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514089|NCT00412360|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25514090|NCT00412360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514091|NCT00412360|Antifungal Agents|antifungal agents|mesh-ancestor
25514092|NCT00412360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25514093|NCT00412360|Dermatologic Agents|dermatologic agents|mesh-ancestor
25514094|NCT00412360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25514095|NCT00412360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25514096|NCT00412360|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25514097|NCT00412360|Antitubercular Agents|antitubercular agents|mesh-ancestor
25514098|NCT00412360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25514099|NCT00412373|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25514100|NCT00412373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25514101|NCT00412373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25514102|NCT00412373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25514103|NCT00412373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514104|NCT00412373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25514105|NCT00412373|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25514106|NCT00412373|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25514107|NCT00412373|Serotonin Agents|serotonin agents|mesh-ancestor
25514108|NCT00412373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25514109|NCT00412373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514110|NCT00412373|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25514111|NCT00412373|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25514112|NCT00412373|Dopamine Agents|dopamine agents|mesh-ancestor
25514113|NCT00412425|Palonosetron|palonosetron|mesh-list
25514114|NCT00412425|Antiemetics|antiemetics|mesh-ancestor
25514115|NCT00412425|Autonomic Agents|autonomic agents|mesh-ancestor
25514116|NCT00412425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25162569|NCT02903498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162570|NCT02903498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162571|NCT02903524|Cyclophosphamide|cyclophosphamide|mesh-list
25162572|NCT02903524|Doxorubicin|doxorubicin|mesh-list
25162573|NCT02903524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25162574|NCT02903524|Pirarubicin|pirarubicin|mesh-list
25162575|NCT02903524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25162576|NCT02903524|Immunologic Factors|immunologic factors|mesh-ancestor
25162577|NCT02903524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784799|NCT01910363|Cholinergic Agents|cholinergic agents|mesh-ancestor
25106920|NCT03143738|Anesthetics|anesthetics|mesh-list
25514117|NCT00412425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514118|NCT00412425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25514119|NCT00412425|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25514120|NCT00412425|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25514121|NCT00412425|Serotonin Agents|serotonin agents|mesh-ancestor
25514122|NCT00412425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25514123|NCT00412425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514124|NCT00412451|Plasminogen|plasminogen|mesh-list
25514125|NCT00412451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25514126|NCT00412451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25514127|NCT00412451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514128|NCT00412464|PENTA|penta|mesh-list
25514129|NCT00412464|Fondaparinux|fondaparinux|mesh-list
25514130|NCT00412464|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24705425|NCT01485146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646026|NCT01454102|Mitosis Modulators|mitosis modulators|mesh-ancestor
25514131|NCT00412464|Antithrombins|antithrombins|mesh-ancestor
25514132|NCT00412464|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25514133|NCT00412464|Protease Inhibitors|protease inhibitors|mesh-ancestor
25514134|NCT00412464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514135|NCT00412464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514136|NCT00412464|Anticoagulants|anticoagulants|mesh-ancestor
25514137|NCT00412464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25514138|NCT00412464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25514139|NCT00412529|Entecavir|entecavir|mesh-list
25514140|NCT00412529|Telbivudine|telbivudine|mesh-list
25514141|NCT00412529|Antiviral Agents|antiviral agents|mesh-ancestor
25514142|NCT00412529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25514143|NCT00412529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25514144|NCT00412529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514145|NCT00412529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514146|NCT00412542|Thalidomide|thalidomide|mesh-list
25514147|NCT00412542|Irinotecan|irinotecan|mesh-list
25514148|NCT00412542|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25514149|NCT00412542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25514150|NCT00412542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514151|NCT00412542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514152|NCT00412542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514153|NCT00412542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25514154|NCT00412542|Immunologic Factors|immunologic factors|mesh-ancestor
25514155|NCT00412542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514156|NCT00412542|Leprostatic Agents|leprostatic agents|mesh-ancestor
25514157|NCT00412542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25514158|NCT00412542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25514159|NCT00412542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25514160|NCT00412542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25514161|NCT00412542|Growth Substances|growth substances|mesh-ancestor
25514162|NCT00412542|Growth Inhibitors|growth inhibitors|mesh-ancestor
25514163|NCT00412737|Oseltamivir|oseltamivir|mesh-list
25514164|NCT00412737|Antiviral Agents|antiviral agents|mesh-ancestor
25514165|NCT00412737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25514166|NCT00412737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514167|NCT00412737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514168|NCT00412750|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25514169|NCT00412750|Telbivudine|telbivudine|mesh-list
25514170|NCT00412750|Antiviral Agents|antiviral agents|mesh-ancestor
25514171|NCT00412750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25514172|NCT00412750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25514173|NCT00412750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514174|NCT00412750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514175|NCT00412841|Atorvastatin|atorvastatin|mesh-list
25514176|NCT00412841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25514177|NCT00412841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25514178|NCT00412841|Antimetabolites|antimetabolites|mesh-ancestor
25514179|NCT00412841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514180|NCT00412841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25514181|NCT00412841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25514182|NCT00412841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514183|NCT00412867|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25514184|NCT00412867|Plasminogen|plasminogen|mesh-list
25514185|NCT00412867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25514186|NCT00412867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25514187|NCT00412867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514188|NCT00412893|Voriconazole|voriconazole|mesh-list
24985205|NCT03578081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25162580|NCT02903524|Alkylating Agents|alkylating agents|mesh-ancestor
25514189|NCT00412893|Isavuconazole|isavuconazole|mesh-list
25514190|NCT00412893|Antifungal Agents|antifungal agents|mesh-ancestor
25514191|NCT00412893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25514192|NCT00412893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25514193|NCT00412893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25514194|NCT00412893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514195|NCT00412893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514196|NCT00412893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25514197|NCT00412893|Hormone Antagonists|hormone antagonists|mesh-ancestor
25514198|NCT00412893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25514199|NCT00412893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514200|NCT00412893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25514201|NCT00412958|Plasminogen|plasminogen|mesh-list
25514202|NCT00412958|Fibrinolysin|fibrinolysin|mesh-list
25514203|NCT00412958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25646027|NCT01454102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646028|NCT01454102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25646029|NCT01454102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25646030|NCT01454102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25514204|NCT00412958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25514205|NCT00412958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514207|NCT00412984|Apixaban|apixaban|mesh-list
25514208|NCT00412984|Anticoagulants|anticoagulants|mesh-ancestor
25514209|NCT00412984|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25514210|NCT00412984|Antithrombins|antithrombins|mesh-ancestor
25514211|NCT00412984|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25514212|NCT00412984|Protease Inhibitors|protease inhibitors|mesh-ancestor
25514213|NCT00412984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514214|NCT00412984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514215|NCT00413010|Pregabalin|pregabalin|mesh-list
25514216|NCT00413010|Analgesics|analgesics|mesh-ancestor
25514217|NCT00413010|Sensory System Agents|sensory system agents|mesh-ancestor
25514218|NCT00413010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25514219|NCT00413010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514220|NCT00413010|Anticonvulsants|anticonvulsants|mesh-ancestor
25514221|NCT00413010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25514222|NCT00413010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25514223|NCT00413010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514224|NCT00413010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25514225|NCT00413010|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25514226|NCT00413010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25514227|NCT00413010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25514228|NCT00413010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25514229|NCT00413036|Lenalidomide|lenalidomide|mesh-list
25514230|NCT00413036|Immunologic Factors|immunologic factors|mesh-ancestor
24811218|NCT02045693|Antitussive Agents|antitussive agents|mesh-ancestor
25514231|NCT00413036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514232|NCT00413036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25514233|NCT00413036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25514234|NCT00413036|Growth Substances|growth substances|mesh-ancestor
25514235|NCT00413036|Growth Inhibitors|growth inhibitors|mesh-ancestor
25514236|NCT00413036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514237|NCT00413049|Amlodipine|amlodipine|mesh-list
25514238|NCT00413049|Valsartan|valsartan|mesh-list
25514239|NCT00413049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25514240|NCT00413049|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25514241|NCT00413049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25514242|NCT00413049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514243|NCT00413049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25514244|NCT00413049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514245|NCT00413049|Vasodilator Agents|vasodilator agents|mesh-ancestor
25514246|NCT00413049|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25514247|NCT00413049|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25514248|NCT00413153|Ritonavir|ritonavir|mesh-list
25514249|NCT00413153|Lopinavir|lopinavir|mesh-list
25514250|NCT00413153|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25514251|NCT00413153|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25514252|NCT00413153|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25514253|NCT00413153|Protease Inhibitors|protease inhibitors|mesh-ancestor
25514254|NCT00413153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514255|NCT00413153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514256|NCT00413153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25514257|NCT00413153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25514258|NCT00413153|Antiviral Agents|antiviral agents|mesh-ancestor
25514259|NCT00413153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25514260|NCT00413153|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25514261|NCT00413153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25514262|NCT00413166|Idarubicin|idarubicin|mesh-list
25514263|NCT00413166|Tretinoin|tretinoin|mesh-list
25514270|NCT00413166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514271|NCT00413166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514272|NCT00413166|Keratolytic Agents|keratolytic agents|mesh-ancestor
25514273|NCT00413166|Dermatologic Agents|dermatologic agents|mesh-ancestor
25514274|NCT00413166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25514275|NCT00413218|Voriconazole|voriconazole|mesh-list
25514276|NCT00413218|Caspofungin|caspofungin|mesh-list
25514277|NCT00413218|Isavuconazole|isavuconazole|mesh-list
25514278|NCT00413218|Antifungal Agents|antifungal agents|mesh-ancestor
25514279|NCT00413218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25646032|NCT01454102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646033|NCT01454102|Growth Inhibitors|growth inhibitors|mesh-ancestor
25646034|NCT01454102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25646035|NCT01454102|Antimetabolites|antimetabolites|mesh-ancestor
25646036|NCT01454102|Antiviral Agents|antiviral agents|mesh-ancestor
25646037|NCT01454102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25514280|NCT00413218|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25514281|NCT00413218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25514282|NCT00413218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514283|NCT00413218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514284|NCT00413218|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25514285|NCT00413218|Hormone Antagonists|hormone antagonists|mesh-ancestor
25514286|NCT00413218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25514287|NCT00413218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514288|NCT00413218|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25514289|NCT00413244|Testosterone|testosterone|mesh-list
25514290|NCT00413244|Androgens|androgens|mesh-ancestor
25514291|NCT00413244|Hormones|hormones|mesh-ancestor
25514292|NCT00413244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25514293|NCT00413244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514294|NCT00413283|Gemcitabine|gemcitabine|mesh-list
25514295|NCT00413283|Cisplatin|cisplatin|mesh-list
25514296|NCT00413283|Carboplatin|carboplatin|mesh-list
25514297|NCT00413283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514298|NCT00413283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25514299|NCT00413283|Antimetabolites|antimetabolites|mesh-ancestor
25514300|NCT00413283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514301|NCT00413283|Antiviral Agents|antiviral agents|mesh-ancestor
25514302|NCT00413283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25514303|NCT00413283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811240|NCT02045914|Ionophores|ionophores|mesh-list
25514304|NCT00413283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25514305|NCT00413283|Immunologic Factors|immunologic factors|mesh-ancestor
25514306|NCT00413283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514307|NCT00413335|Rosiglitazone|rosiglitazone|mesh-list
25514308|NCT00413335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25514309|NCT00413335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514310|NCT00413374|Enoxaparin|enoxaparin|mesh-list
25514311|NCT00413374|Anticoagulants|anticoagulants|mesh-ancestor
25514312|NCT00413374|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25514313|NCT00413374|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25514314|NCT00413374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514315|NCT00413400|Etanercept|etanercept|mesh-list
25514316|NCT00413400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25514317|NCT00413400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25514318|NCT00413400|Analgesics|analgesics|mesh-ancestor
25514319|NCT00413400|Sensory System Agents|sensory system agents|mesh-ancestor
25514320|NCT00413400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25514321|NCT00413400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514322|NCT00413400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25514323|NCT00413400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25514324|NCT00413400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25514325|NCT00413400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25514326|NCT00413400|Immunologic Factors|immunologic factors|mesh-ancestor
25514327|NCT00413413|Amlodipine|amlodipine|mesh-list
25514328|NCT00413413|Valsartan|valsartan|mesh-list
25514329|NCT00413413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25823348|NCT00004807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514330|NCT00413413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25514331|NCT00413413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25514332|NCT00413413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514333|NCT00413413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25514334|NCT00413413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514335|NCT00413413|Vasodilator Agents|vasodilator agents|mesh-ancestor
25514336|NCT00413413|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25514337|NCT00413413|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25514338|NCT00413478|Azacitidine|azacitidine|mesh-list
25514339|NCT00413478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25514340|NCT00413478|Antimetabolites|antimetabolites|mesh-ancestor
25514341|NCT00413478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514342|NCT00413478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514343|NCT00413478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514344|NCT00413634|Anagrelide|anagrelide|mesh-list
25646038|NCT01454102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646039|NCT01454102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25646040|NCT01454102|Immunologic Factors|immunologic factors|mesh-ancestor
25646041|NCT01454102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25646042|NCT01454102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25646043|NCT01454102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25646044|NCT01454102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25646045|NCT01454284|Insulin Lispro|insulin lispro|mesh-list
25646046|NCT01454284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25646047|NCT01454284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646048|NCT01454362|Nicotine|nicotine|mesh-list
25646049|NCT01454362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25646050|NCT01454362|Autonomic Agents|autonomic agents|mesh-ancestor
25646051|NCT01454362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25646052|NCT01454362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646053|NCT01454362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25646054|NCT01454362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25514345|NCT00413634|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25514346|NCT00413634|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25514347|NCT00413634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514348|NCT00413634|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25514349|NCT00413660|Tofacitinib|tofacitinib|mesh-list
25514350|NCT00413660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25514351|NCT00413660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514352|NCT00413660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514353|NCT00413777|Tolvaptan|tolvaptan|mesh-list
25514354|NCT00413777|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25514355|NCT00413777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514356|NCT00413777|Natriuretic Agents|natriuretic agents|mesh-ancestor
25514357|NCT00413777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514358|NCT00413894|Epoetin Alfa|epoetin alfa|mesh-list
25514359|NCT00413894|Hematinics|hematinics|mesh-ancestor
25514360|NCT00413920|Mycophenolic Acid|mycophenolic acid|mesh-list
25514361|NCT00413920|Prednisone|prednisone|mesh-list
25514362|NCT00413920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25514363|NCT00413920|Glucocorticoids|glucocorticoids|mesh-ancestor
25514364|NCT00413920|Hormones|hormones|mesh-ancestor
25514365|NCT00413920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25514366|NCT00413920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514367|NCT00413920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25514368|NCT00413920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514369|NCT00413920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25514370|NCT00413920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25514371|NCT00413920|Antitubercular Agents|antitubercular agents|mesh-ancestor
25514372|NCT00413920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25514373|NCT00413920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25514374|NCT00413920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514375|NCT00413920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514376|NCT00413959|Dexamethasone|dexamethasone|mesh-list
25514377|NCT00413959|Cyclophosphamide|cyclophosphamide|mesh-list
25514378|NCT00413959|Rituximab|rituximab|mesh-list
25514379|NCT00413959|Bortezomib|bortezomib|mesh-list
25514380|NCT00413959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25514381|NCT00413959|Immunologic Factors|immunologic factors|mesh-ancestor
25514382|NCT00413959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514383|NCT00413959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25514384|NCT00413959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25514385|NCT00413959|Alkylating Agents|alkylating agents|mesh-ancestor
25514386|NCT00413959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514387|NCT00413959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514388|NCT00413959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25514389|NCT00413959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25514390|NCT00413959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25514391|NCT00413959|Antiemetics|antiemetics|mesh-ancestor
25514392|NCT00413959|Autonomic Agents|autonomic agents|mesh-ancestor
25514393|NCT00413959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25041309|NCT02580305|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
25041310|NCT02580305|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25041311|NCT02580305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041312|NCT02580305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041313|NCT02580305|Cholinergic Agents|cholinergic agents|mesh-ancestor
24998485|NCT02611960|Gemcitabine|gemcitabine|mesh-list
25041314|NCT02580305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25041315|NCT02580305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041316|NCT02580305|Nootropic Agents|nootropic agents|mesh-ancestor
25041317|NCT02580305|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25514394|NCT00413959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25514395|NCT00413959|Glucocorticoids|glucocorticoids|mesh-ancestor
25514396|NCT00413959|Hormones|hormones|mesh-ancestor
25514397|NCT00413959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25514398|NCT00413959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25514399|NCT00414011|Moxifloxacin|moxifloxacin|mesh-list
25514400|NCT00414011|Gatifloxacin|gatifloxacin|mesh-list
25514401|NCT00414011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25514402|NCT00414011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25514403|NCT00414011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25514404|NCT00414011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25514405|NCT00414011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514406|NCT00414011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514407|NCT00414011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514408|NCT00414011|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25514409|NCT00414011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25514410|NCT00414050|Vaccines|vaccines|mesh-list
25514411|NCT00414050|Immunologic Factors|immunologic factors|mesh-ancestor
25514412|NCT00414050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514413|NCT00414076|Letrozole|letrozole|mesh-list
25514414|NCT00414076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514415|NCT00414076|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25514416|NCT00414076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25514417|NCT00414076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514418|NCT00414076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514419|NCT00414076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25514420|NCT00414076|Hormone Antagonists|hormone antagonists|mesh-ancestor
25514421|NCT00414076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25514422|NCT00414076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514423|NCT00414167|Bupropion|bupropion|mesh-list
25514424|NCT00414167|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25514425|NCT00414167|Antidepressive Agents|antidepressive agents|mesh-ancestor
25514426|NCT00414167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25514427|NCT00414167|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25514428|NCT00414167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25514429|NCT00414167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25514430|NCT00414167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514431|NCT00414167|Dopamine Agents|dopamine agents|mesh-ancestor
25514432|NCT00414167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25514433|NCT00414167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514434|NCT00414167|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25514435|NCT00414167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25514436|NCT00414167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514437|NCT00414206|Mecamylamine|mecamylamine|mesh-list
25514438|NCT00414206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25514439|NCT00414206|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
25514440|NCT00414206|Autonomic Agents|autonomic agents|mesh-ancestor
25514441|NCT00414206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25514442|NCT00414206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514443|NCT00414206|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25514444|NCT00414206|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25514445|NCT00414206|Cholinergic Agents|cholinergic agents|mesh-ancestor
25514446|NCT00414206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25514447|NCT00414206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514448|NCT00414271|Docetaxel|docetaxel|mesh-list
25514449|NCT00414271|Capecitabine|capecitabine|mesh-list
25514450|NCT00414271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514451|NCT00414271|Tubulin Modulators|tubulin modulators|mesh-ancestor
25514452|NCT00414271|Antimitotic Agents|antimitotic agents|mesh-ancestor
25514453|NCT00414271|Mitosis Modulators|mitosis modulators|mesh-ancestor
25514454|NCT00414271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514455|NCT00414271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25514456|NCT00414271|Antimetabolites|antimetabolites|mesh-ancestor
25514457|NCT00414310|Decitabine|decitabine|mesh-list
25514458|NCT00414310|Valproic Acid|valproic acid|mesh-list
25514459|NCT00414310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25514460|NCT00414310|Antimetabolites|antimetabolites|mesh-ancestor
25514461|NCT00414310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514462|NCT00414310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514463|NCT00414310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514465|NCT00414310|GABA Agents|gaba agents|mesh-ancestor
25514466|NCT00414310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24488029|NCT00466232|Topotecan|topotecan|mesh-list
25514470|NCT00414310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25514471|NCT00414310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25514472|NCT00414388|Sorafenib|sorafenib|mesh-list
25514473|NCT00414388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514474|NCT00414388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25514475|NCT00414388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514476|NCT00414388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514477|NCT00414440|Everolimus|everolimus|mesh-list
25514478|NCT00414440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514479|NCT00414440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25514480|NCT00414440|Immunologic Factors|immunologic factors|mesh-ancestor
25514481|NCT00414440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514482|NCT00414466|Gabapentin|gabapentin|mesh-list
25514483|NCT00414466|Analgesics|analgesics|mesh-ancestor
25514484|NCT00414466|Sensory System Agents|sensory system agents|mesh-ancestor
25514485|NCT00414466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25514486|NCT00414466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514487|NCT00414466|Anticonvulsants|anticonvulsants|mesh-ancestor
25514488|NCT00414466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25514489|NCT00414466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25514490|NCT00414466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25514491|NCT00414466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25514492|NCT00414466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25514493|NCT00414466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25514494|NCT00414466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25514495|NCT00414466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514496|NCT00414466|Antimanic Agents|antimanic agents|mesh-ancestor
25514497|NCT00414518|Ritonavir|ritonavir|mesh-list
25514498|NCT00414518|Lopinavir|lopinavir|mesh-list
25514499|NCT00414518|Tenofovir|tenofovir|mesh-list
25514500|NCT00414518|Emtricitabine|emtricitabine|mesh-list
25514501|NCT00414518|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25514502|NCT00414518|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25514503|NCT00414518|Protease Inhibitors|protease inhibitors|mesh-ancestor
25514504|NCT00414518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514505|NCT00414518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514506|NCT00414518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25514507|NCT00414518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25514508|NCT00414518|Antiviral Agents|antiviral agents|mesh-ancestor
25514509|NCT00414518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25514510|NCT00414518|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25514511|NCT00414518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25514512|NCT00414518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25514513|NCT00414518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25514514|NCT00414661|Tofacitinib|tofacitinib|mesh-list
25514515|NCT00414661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25514516|NCT00414661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514517|NCT00414661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514518|NCT00414765|Aldesleukin|aldesleukin|mesh-list
25514519|NCT00414765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514520|NCT00414765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25514521|NCT00414765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25514522|NCT00414765|Antiviral Agents|antiviral agents|mesh-ancestor
25514523|NCT00414765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25514524|NCT00414908|Pancrelipase|pancrelipase|mesh-list
25514525|NCT00414908|Pancreatin|pancreatin|mesh-list
25514526|NCT00414908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25514527|NCT00414973|Teriparatide|teriparatide|mesh-list
25514528|NCT00414973|Calcitonin|calcitonin|mesh-list
25514529|NCT00414973|Salmon calcitonin|salmon calcitonin|mesh-list
25514530|NCT00414973|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
25514531|NCT00414973|Katacalcin|katacalcin|mesh-list
25514532|NCT00414973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25514533|NCT00414973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514534|NCT00414973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25514535|NCT00414973|Vasodilator Agents|vasodilator agents|mesh-ancestor
25514536|NCT00415168|Cisplatin|cisplatin|mesh-list
25514537|NCT00415168|Pemetrexed|pemetrexed|mesh-list
24860509|NCT02310347|Analgesics|analgesics|mesh-ancestor
25514538|NCT00415168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514567|NCT00415597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25514568|NCT00415597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514569|NCT00415597|Analgesics|analgesics|mesh-ancestor
25646056|NCT01454362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25646057|NCT01454362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646058|NCT01454414|Permethrin|permethrin|mesh-list
25646059|NCT01454414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646060|NCT01454414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646061|NCT01454596|Aldesleukin|aldesleukin|mesh-list
25514570|NCT00415597|Sensory System Agents|sensory system agents|mesh-ancestor
25514571|NCT00415597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25514572|NCT00415597|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25514573|NCT00415597|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24796212|NCT01948583|Protective Agents|protective agents|mesh-ancestor
24796213|NCT01948648|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
24796214|NCT01948648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24796215|NCT01948648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25823349|NCT00004807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823350|NCT00004807|Cholinergic Agents|cholinergic agents|mesh-ancestor
25823351|NCT00004807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25514580|NCT00415610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514581|NCT00415610|Vasodilator Agents|vasodilator agents|mesh-ancestor
25514582|NCT00415636|Pemetrexed|pemetrexed|mesh-list
25514583|NCT00415636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514584|NCT00415636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514585|NCT00415636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514586|NCT00415636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25514587|NCT00415636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25514588|NCT00415857|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25514589|NCT00415857|Imatinib Mesylate|imatinib mesylate|mesh-list
25514590|NCT00415857|Vaccines|vaccines|mesh-list
25514591|NCT00415857|Sargramostim|sargramostim|mesh-list
25514592|NCT00415857|Immunologic Factors|immunologic factors|mesh-ancestor
25514593|NCT00415857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514594|NCT00415857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514595|NCT00415857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25514596|NCT00415857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514597|NCT00415857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514598|NCT00415857|Antiviral Agents|antiviral agents|mesh-ancestor
25514599|NCT00415857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25514600|NCT00415909|Imatinib Mesylate|imatinib mesylate|mesh-list
25514601|NCT00415909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514602|NCT00415909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25514603|NCT00415909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514604|NCT00415909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514605|NCT00416455|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25514606|NCT00416455|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25514607|NCT00416455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514608|NCT00416494|Bevacizumab|bevacizumab|mesh-list
25514609|NCT00416494|Capecitabine|capecitabine|mesh-list
25514610|NCT00416494|Oxaliplatin|oxaliplatin|mesh-list
25514611|NCT00416494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25514612|NCT00416494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514613|NCT00416494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25514614|NCT00416494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25514615|NCT00416494|Growth Substances|growth substances|mesh-ancestor
25514616|NCT00416494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514617|NCT00416494|Growth Inhibitors|growth inhibitors|mesh-ancestor
25514618|NCT00416494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25514619|NCT00416494|Antimetabolites|antimetabolites|mesh-ancestor
25514620|NCT00416494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514621|NCT00416520|Sevelamer|sevelamer|mesh-list
25514622|NCT00416520|Chelating Agents|chelating agents|mesh-ancestor
25514623|NCT00416520|Sequestering Agents|sequestering agents|mesh-ancestor
25514624|NCT00416520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514625|NCT00416598|Cytarabine|cytarabine|mesh-list
25514626|NCT00416598|Etoposide|etoposide|mesh-list
25514627|NCT00416598|Podophyllotoxin|podophyllotoxin|mesh-list
25514628|NCT00416598|Daunorubicin|daunorubicin|mesh-list
25514629|NCT00416598|Etoposide phosphate|etoposide phosphate|mesh-list
25514630|NCT00416598|Busulfan|busulfan|mesh-list
25514631|NCT00416598|Decitabine|decitabine|mesh-list
25514632|NCT00416598|Lenograstim|lenograstim|mesh-list
25646062|NCT01454596|Cyclophosphamide|cyclophosphamide|mesh-list
25514633|NCT00416598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25514634|NCT00416598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514635|NCT00416598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25646064|NCT01454596|Mitogens|mitogens|mesh-list
25646065|NCT01454596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25646066|NCT01454596|Immunologic Factors|immunologic factors|mesh-ancestor
25646067|NCT01454596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646068|NCT01454596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25646069|NCT01454596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25646070|NCT01454596|Alkylating Agents|alkylating agents|mesh-ancestor
25514636|NCT00416598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25514637|NCT00416598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514638|NCT00416598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823352|NCT00004807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823353|NCT00004807|Nootropic Agents|nootropic agents|mesh-ancestor
25823354|NCT00004807|Anticonvulsants|anticonvulsants|mesh-ancestor
25514639|NCT00416598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25514640|NCT00416598|Antimetabolites|antimetabolites|mesh-ancestor
25514641|NCT00416598|Antiviral Agents|antiviral agents|mesh-ancestor
25514642|NCT00416598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25514643|NCT00416598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25514644|NCT00416598|Immunologic Factors|immunologic factors|mesh-ancestor
25514645|NCT00416598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514646|NCT00416598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25514647|NCT00416598|Alkylating Agents|alkylating agents|mesh-ancestor
25514648|NCT00416598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25514649|NCT00416598|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25514650|NCT00416598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25514651|NCT00416598|Keratolytic Agents|keratolytic agents|mesh-ancestor
25514652|NCT00416598|Dermatologic Agents|dermatologic agents|mesh-ancestor
25514653|NCT00416598|Tubulin Modulators|tubulin modulators|mesh-ancestor
25514654|NCT00416598|Antimitotic Agents|antimitotic agents|mesh-ancestor
25514655|NCT00416598|Mitosis Modulators|mitosis modulators|mesh-ancestor
25514656|NCT00416624|Epoetin Alfa|epoetin alfa|mesh-list
25514657|NCT00416624|Darbepoetin alfa|darbepoetin alfa|mesh-list
25514658|NCT00416624|Hematinics|hematinics|mesh-ancestor
25514659|NCT00416715|Calcium, Dietary|calcium, dietary|mesh-list
25514660|NCT00416715|Vitamin D|vitamin d|mesh-list
25514661|NCT00416715|Cholecalciferol|cholecalciferol|mesh-list
25514662|NCT00416715|Letrozole|letrozole|mesh-list
25514663|NCT00416715|Calcium Carbonate|calcium carbonate|mesh-list
25514664|NCT00416715|Citric Acid|citric acid|mesh-list
25514665|NCT00416715|Sodium Citrate|sodium citrate|mesh-list
25514666|NCT00416715|Calcium|calcium|mesh-list
25514667|NCT00416715|Vitamins|vitamins|mesh-ancestor
25514668|NCT00416715|Micronutrients|micronutrients|mesh-ancestor
25514669|NCT00416715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514670|NCT00416715|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25514671|NCT00416715|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25514672|NCT00416715|Anticoagulants|anticoagulants|mesh-ancestor
25514673|NCT00416715|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25514674|NCT00416715|Chelating Agents|chelating agents|mesh-ancestor
25514675|NCT00416715|Sequestering Agents|sequestering agents|mesh-ancestor
25514676|NCT00416715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514677|NCT00416715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514678|NCT00416715|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25514679|NCT00416715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25514680|NCT00416715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514681|NCT00416715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25514682|NCT00416715|Hormone Antagonists|hormone antagonists|mesh-ancestor
25514683|NCT00416715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25514684|NCT00416715|Antacids|antacids|mesh-ancestor
25514685|NCT00416715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25514686|NCT00416793|Carboplatin|carboplatin|mesh-list
25514687|NCT00416793|Bortezomib|bortezomib|mesh-list
25514688|NCT00416793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514689|NCT00416884|Fludarabine|fludarabine|mesh-list
25514690|NCT00416884|Alemtuzumab|alemtuzumab|mesh-list
25514691|NCT00416884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514692|NCT00416884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25514693|NCT00417079|Prednisone|prednisone|mesh-list
25514694|NCT00417079|Mitoxantrone|mitoxantrone|mesh-list
25514695|NCT00417079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25514696|NCT00417079|Glucocorticoids|glucocorticoids|mesh-ancestor
25514697|NCT00417079|Hormones|hormones|mesh-ancestor
25514698|NCT00417079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25514699|NCT00417079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514700|NCT00417079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25514701|NCT00417079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514702|NCT00417079|Analgesics|analgesics|mesh-ancestor
25646071|NCT01454596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646072|NCT01454596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646073|NCT01454596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25646074|NCT01454596|Mitosis Modulators|mitosis modulators|mesh-ancestor
25646075|NCT01454596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25514703|NCT00417079|Sensory System Agents|sensory system agents|mesh-ancestor
25514704|NCT00417079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25514705|NCT00417079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25514706|NCT00417079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25514707|NCT00417079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514708|NCT00417079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514710|NCT00417170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25514711|NCT00417170|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25514712|NCT00417170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25514713|NCT00417170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514714|NCT00417170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25514715|NCT00417170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514716|NCT00417170|Vasodilator Agents|vasodilator agents|mesh-ancestor
25514717|NCT00417274|Quinacrine|quinacrine|mesh-list
25514718|NCT00417274|Anticestodal Agents|anticestodal agents|mesh-ancestor
25514719|NCT00417274|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25514720|NCT00417274|Anthelmintics|anthelmintics|mesh-ancestor
25514721|NCT00417274|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25514722|NCT00417274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25514723|NCT00417274|Antimalarials|antimalarials|mesh-ancestor
25514724|NCT00417274|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25514725|NCT00417274|Antinematodal Agents|antinematodal agents|mesh-ancestor
25514726|NCT00417274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514727|NCT00417274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514728|NCT00417274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514729|NCT00417417|Rilonacept|rilonacept|mesh-list
25514730|NCT00417417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25514731|NCT00417482|Risperidone|risperidone|mesh-list
25514732|NCT00417482|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25514733|NCT00417482|Serotonin Agents|serotonin agents|mesh-ancestor
25514734|NCT00417482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25514735|NCT00417482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514736|NCT00417482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514737|NCT00417482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25514738|NCT00417482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25514739|NCT00417482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25514740|NCT00417482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25514741|NCT00417482|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25514742|NCT00417482|Dopamine Agents|dopamine agents|mesh-ancestor
25514743|NCT00417885|Sunitinib|sunitinib|mesh-list
25514744|NCT00417885|Exemestane|exemestane|mesh-list
25514745|NCT00417885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514746|NCT00417885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25514747|NCT00417885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25514748|NCT00417885|Growth Substances|growth substances|mesh-ancestor
25514749|NCT00417885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514750|NCT00417885|Growth Inhibitors|growth inhibitors|mesh-ancestor
25514751|NCT00417885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25514752|NCT00417885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514753|NCT00417885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514754|NCT00417885|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25514755|NCT00417885|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25514756|NCT00417885|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25514757|NCT00417885|Hormone Antagonists|hormone antagonists|mesh-ancestor
25514758|NCT00417885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25514759|NCT00417976|Gemcitabine|gemcitabine|mesh-list
25514760|NCT00417976|Bevacizumab|bevacizumab|mesh-list
25514761|NCT00417976|Fluorouracil|fluorouracil|mesh-list
25514762|NCT00417976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25514763|NCT00417976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514764|NCT00417976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25514765|NCT00417976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25514766|NCT00417976|Growth Substances|growth substances|mesh-ancestor
25514767|NCT00417976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514768|NCT00417976|Growth Inhibitors|growth inhibitors|mesh-ancestor
25514769|NCT00417976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25514770|NCT00417976|Antimetabolites|antimetabolites|mesh-ancestor
24998970|NCT05421416|Loratadine|loratadine|mesh-list
25514771|NCT00417976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514772|NCT00417976|Antiviral Agents|antiviral agents|mesh-ancestor
25514773|NCT00417976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25514774|NCT00417976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514775|NCT00417976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25514776|NCT00417976|Immunologic Factors|immunologic factors|mesh-ancestor
25514777|NCT00418028|Capecitabine|capecitabine|mesh-list
25514778|NCT00418028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25514779|NCT00418028|Antimetabolites|antimetabolites|mesh-ancestor
25514780|NCT00418028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514781|NCT00418028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514782|NCT00418093|Gemcitabine|gemcitabine|mesh-list
25514783|NCT00418093|Bevacizumab|bevacizumab|mesh-list
25514784|NCT00418093|Oxaliplatin|oxaliplatin|mesh-list
25514785|NCT00418093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25514786|NCT00418093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514787|NCT00418093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25514788|NCT00418093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25514789|NCT00418093|Growth Substances|growth substances|mesh-ancestor
25514790|NCT00418093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514791|NCT00418093|Growth Inhibitors|growth inhibitors|mesh-ancestor
25514792|NCT00418093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25514793|NCT00418093|Antimetabolites|antimetabolites|mesh-ancestor
25514794|NCT00418093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514795|NCT00418093|Antiviral Agents|antiviral agents|mesh-ancestor
25514796|NCT00418093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25514797|NCT00418093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514798|NCT00418093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25514799|NCT00418093|Immunologic Factors|immunologic factors|mesh-ancestor
25514800|NCT00418262|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25514801|NCT00418262|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25514802|NCT00418262|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25514803|NCT00418262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25514804|NCT00418262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514805|NCT00418262|Adrenergic Agents|adrenergic agents|mesh-ancestor
25514806|NCT00418262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25514807|NCT00418262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514808|NCT00418379|Immunologic Factors|immunologic factors|mesh-list
25514809|NCT00418379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514810|NCT00418457|Anesthetics|anesthetics|mesh-list
25514811|NCT00418457|Propofol|propofol|mesh-list
25514812|NCT00418457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25514813|NCT00418457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514814|NCT00418457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25514815|NCT00418457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25514816|NCT00418457|Anesthetics, General|anesthetics, general|mesh-ancestor
25514817|NCT00418522|Insulin|insulin|mesh-list
25514818|NCT00418522|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25514819|NCT00418522|Insulin Glargine|insulin glargine|mesh-list
25514820|NCT00418522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25514821|NCT00418522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514822|NCT00418574|Abagovomab|abagovomab|mesh-list
25514823|NCT00418574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25514824|NCT00418574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514825|NCT00418691|Methylphenidate|methylphenidate|mesh-list
25514826|NCT00418691|Modafinil|modafinil|mesh-list
25514827|NCT00418691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25514828|NCT00418691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514829|NCT00418691|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25514830|NCT00418691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25514831|NCT00418691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25514832|NCT00418691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514833|NCT00418691|Dopamine Agents|dopamine agents|mesh-ancestor
25514834|NCT00418691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25514835|NCT00418691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25514836|NCT00418691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25514837|NCT00418691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25514838|NCT00418717|Etanercept|etanercept|mesh-list
25514839|NCT00418717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25514840|NCT00418717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25514841|NCT00418717|Analgesics|analgesics|mesh-ancestor
25514842|NCT00418717|Sensory System Agents|sensory system agents|mesh-ancestor
25514843|NCT00418717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25823355|NCT00004807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25646076|NCT01454596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25646077|NCT01454596|Antiviral Agents|antiviral agents|mesh-ancestor
25514844|NCT00418717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514845|NCT00418717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25514846|NCT00418717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25514847|NCT00418717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25646078|NCT01454596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25646079|NCT01454739|Factor VIII|factor viii|mesh-list
25646080|NCT01454739|Coagulants|coagulants|mesh-ancestor
25514848|NCT00418717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25514849|NCT00418717|Immunologic Factors|immunologic factors|mesh-ancestor
25514850|NCT00418886|Pemetrexed|pemetrexed|mesh-list
25514851|NCT00418886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514852|NCT00418886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514853|NCT00418886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514854|NCT00418886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25514855|NCT00418886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25646081|NCT01454778|Paclitaxel|paclitaxel|mesh-list
25646082|NCT01454778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25514856|NCT00418938|Leucovorin|leucovorin|mesh-list
25514857|NCT00418938|Bevacizumab|bevacizumab|mesh-list
25514858|NCT00418938|Panitumumab|panitumumab|mesh-list
25514859|NCT00418938|Fluorouracil|fluorouracil|mesh-list
25823356|NCT00004807|Antitussive Agents|antitussive agents|mesh-ancestor
25823357|NCT00004807|Respiratory System Agents|respiratory system agents|mesh-ancestor
25823358|NCT00004807|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25823359|NCT00004807|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25823360|NCT00004808|Fluconazole|fluconazole|mesh-list
25823361|NCT00004808|Antifungal Agents|antifungal agents|mesh-ancestor
25514860|NCT00418938|Irinotecan|irinotecan|mesh-list
25514861|NCT00418938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25514862|NCT00418938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514863|NCT00418938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25514864|NCT00418938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25646083|NCT01454778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646084|NCT01454778|Tubulin Modulators|tubulin modulators|mesh-ancestor
25646085|NCT01454778|Antimitotic Agents|antimitotic agents|mesh-ancestor
25646086|NCT01454778|Mitosis Modulators|mitosis modulators|mesh-ancestor
25646087|NCT01454778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514865|NCT00418938|Growth Substances|growth substances|mesh-ancestor
25514866|NCT00418938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514867|NCT00418938|Growth Inhibitors|growth inhibitors|mesh-ancestor
25514868|NCT00418938|Antimetabolites|antimetabolites|mesh-ancestor
25514869|NCT00418938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514870|NCT00418938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25514871|NCT00418938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25514872|NCT00418938|Immunologic Factors|immunologic factors|mesh-ancestor
25514873|NCT00418938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25514874|NCT00418938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25514875|NCT00418938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514876|NCT00418938|Antidotes|antidotes|mesh-ancestor
25514877|NCT00418938|Protective Agents|protective agents|mesh-ancestor
25514878|NCT00418938|Vitamin B Complex|vitamin b complex|mesh-ancestor
25514879|NCT00418938|Vitamins|vitamins|mesh-ancestor
25514880|NCT00418938|Micronutrients|micronutrients|mesh-ancestor
25514881|NCT00418951|Voriconazole|voriconazole|mesh-list
25514882|NCT00418951|Amphotericin B|amphotericin b|mesh-list
25514883|NCT00418951|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25514884|NCT00418951|Antifungal Agents|antifungal agents|mesh-ancestor
25514885|NCT00418951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25514886|NCT00418951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25514887|NCT00418951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25514888|NCT00418951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514889|NCT00418951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514890|NCT00418951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25514891|NCT00418951|Hormone Antagonists|hormone antagonists|mesh-ancestor
25514892|NCT00418951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25514893|NCT00418951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514894|NCT00418951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25514895|NCT00418951|Amebicides|amebicides|mesh-ancestor
25514896|NCT00418951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25514897|NCT00418951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25514898|NCT00418951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25514899|NCT00419003|Lamotrigine|lamotrigine|mesh-list
25514900|NCT00419003|Ketamine|ketamine|mesh-list
25514901|NCT00419003|Riluzole|riluzole|mesh-list
25514902|NCT00419003|Analgesics|analgesics|mesh-ancestor
25514903|NCT00419003|Sensory System Agents|sensory system agents|mesh-ancestor
25514904|NCT00419003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25514905|NCT00419003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514906|NCT00419003|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25514907|NCT00419003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25514908|NCT00419003|Anesthetics, General|anesthetics, general|mesh-ancestor
25514909|NCT00419003|Anesthetics|anesthetics|mesh-ancestor
25514910|NCT00419003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25514911|NCT00419003|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25514912|NCT00419003|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25646088|NCT01454791|Diclofenac|diclofenac|mesh-list
25646089|NCT01454791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25646090|NCT01454791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25646091|NCT01454791|Analgesics|analgesics|mesh-ancestor
25646092|NCT01454791|Sensory System Agents|sensory system agents|mesh-ancestor
25646093|NCT01454791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25646094|NCT01454791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646095|NCT01454791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25646096|NCT01454791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25514913|NCT00419003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24395951|NCT00137397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514914|NCT00419003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514915|NCT00419003|Anticonvulsants|anticonvulsants|mesh-ancestor
25514916|NCT00419003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25514917|NCT00419003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25514918|NCT00419003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25514919|NCT00419003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25514920|NCT00419003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25514921|NCT00419003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25514922|NCT00419003|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25514923|NCT00419003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25514924|NCT00419003|Protective Agents|protective agents|mesh-ancestor
25823362|NCT00004808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25823363|NCT00004808|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25823364|NCT00004808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25823365|NCT00004808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823366|NCT00004808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796252|NCT01948895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24796253|NCT01948895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24796254|NCT01948895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514925|NCT00419094|Levetiracetam|levetiracetam|mesh-list
25514926|NCT00419094|Anticonvulsants|anticonvulsants|mesh-ancestor
25514927|NCT00419094|Nootropic Agents|nootropic agents|mesh-ancestor
25514928|NCT00419159|Everolimus|everolimus|mesh-list
25514929|NCT00419159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25514930|NCT00419159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25514931|NCT00419159|Immunologic Factors|immunologic factors|mesh-ancestor
25514932|NCT00419159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514933|NCT00419263|Peramivir|peramivir|mesh-list
25514934|NCT00419263|Antiviral Agents|antiviral agents|mesh-ancestor
25514935|NCT00419263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25514936|NCT00419263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25514937|NCT00419263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514938|NCT00419341|Immunoglobulins|immunoglobulins|mesh-list
25514939|NCT00419341|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25514940|NCT00419341|Antibodies|antibodies|mesh-list
25514941|NCT00419341|Immunologic Factors|immunologic factors|mesh-ancestor
25514942|NCT00419341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514943|NCT00419393|Levetiracetam|levetiracetam|mesh-list
25514944|NCT00419393|Anticonvulsants|anticonvulsants|mesh-ancestor
25514945|NCT00419393|Nootropic Agents|nootropic agents|mesh-ancestor
25514946|NCT00419445|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
25514947|NCT00419445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25514948|NCT00419445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25514949|NCT00419445|Cholinergic Agents|cholinergic agents|mesh-ancestor
25514950|NCT00419445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25514951|NCT00419445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514952|NCT00419445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514953|NCT00419562|Insulin|insulin|mesh-list
25514954|NCT00419562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25514955|NCT00419562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514956|NCT00419666|Calcitriol|calcitriol|mesh-list
25514957|NCT00419666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24999218|NCT04969250|Vaccines|vaccines|mesh-list
25646097|NCT01454791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25646098|NCT01454791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646099|NCT01454791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646100|NCT01454934|Gemcitabine|gemcitabine|mesh-list
25646101|NCT01454934|Docetaxel|docetaxel|mesh-list
25646102|NCT01454934|Pemetrexed|pemetrexed|mesh-list
25646103|NCT01454934|Vinorelbine|vinorelbine|mesh-list
25646104|NCT01454934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25646105|NCT01454934|Antimetabolites|antimetabolites|mesh-ancestor
25646106|NCT01454934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514958|NCT00419666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514959|NCT00419666|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25514960|NCT00419666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25514961|NCT00419666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514962|NCT00419666|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25514963|NCT00419666|Vitamins|vitamins|mesh-ancestor
25514964|NCT00419666|Micronutrients|micronutrients|mesh-ancestor
25514965|NCT00419666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25514966|NCT00419744|Budesonide|budesonide|mesh-list
25514967|NCT00419744|Formoterol Fumarate|formoterol fumarate|mesh-list
24396137|NCT00137852|Analgesics|analgesics|mesh-ancestor
25514968|NCT00419744|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25514969|NCT00419744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25514970|NCT00419744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25514971|NCT00419744|Autonomic Agents|autonomic agents|mesh-ancestor
25514972|NCT00419744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25514973|NCT00419744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514974|NCT00419744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25514975|NCT00419744|Respiratory System Agents|respiratory system agents|mesh-ancestor
25514976|NCT00419744|Glucocorticoids|glucocorticoids|mesh-ancestor
25514977|NCT00419744|Hormones|hormones|mesh-ancestor
25514978|NCT00419744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25514979|NCT00419744|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25514980|NCT00419744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25514981|NCT00419744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25514982|NCT00419744|Adrenergic Agents|adrenergic agents|mesh-ancestor
25514983|NCT00419744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25514984|NCT00419744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25514985|NCT00419757|Budesonide|budesonide|mesh-list
25514986|NCT00419757|Formoterol Fumarate|formoterol fumarate|mesh-list
25514987|NCT00419757|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25514988|NCT00419757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25169555|NCT01818076|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24985797|NCT02730429|Palbociclib|palbociclib|mesh-list
24985798|NCT02730429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985799|NCT02730429|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24985800|NCT02730429|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24985801|NCT02730429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505509|NCT00541281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505510|NCT00541281|Tubulin Modulators|tubulin modulators|mesh-ancestor
25514989|NCT00419757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25514990|NCT00419757|Autonomic Agents|autonomic agents|mesh-ancestor
25514991|NCT00419757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25514992|NCT00419757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25514993|NCT00419757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25514994|NCT00419757|Respiratory System Agents|respiratory system agents|mesh-ancestor
25514996|NCT00419757|Hormones|hormones|mesh-ancestor
25514997|NCT00419757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25514998|NCT00419757|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25514999|NCT00419757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25515000|NCT00419757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25515001|NCT00419757|Adrenergic Agents|adrenergic agents|mesh-ancestor
25515002|NCT00419757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25515003|NCT00419757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515004|NCT00419770|Amphotericin B|amphotericin b|mesh-list
25515005|NCT00419770|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25515006|NCT00419770|Deferasirox|deferasirox|mesh-list
25515007|NCT00419770|Amebicides|amebicides|mesh-ancestor
25515008|NCT00419770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25515009|NCT00419770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25515010|NCT00419770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25515011|NCT00419770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25515012|NCT00419770|Antifungal Agents|antifungal agents|mesh-ancestor
25515013|NCT00419770|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25515014|NCT00419770|Chelating Agents|chelating agents|mesh-ancestor
25646107|NCT01454934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646108|NCT01454934|Antiviral Agents|antiviral agents|mesh-ancestor
25646109|NCT01454934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25646110|NCT01454934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646111|NCT01454934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25646112|NCT01454934|Immunologic Factors|immunologic factors|mesh-ancestor
25646113|NCT01454934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646114|NCT01454934|Tubulin Modulators|tubulin modulators|mesh-ancestor
25646115|NCT01454934|Antimitotic Agents|antimitotic agents|mesh-ancestor
25515015|NCT00419770|Sequestering Agents|sequestering agents|mesh-ancestor
25515016|NCT00419770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515018|NCT00419926|Mycophenolic Acid|mycophenolic acid|mesh-list
25515019|NCT00419926|Prednisone|prednisone|mesh-list
25515020|NCT00419926|Cyclosporins|cyclosporins|mesh-list
25515021|NCT00419926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25515022|NCT00419926|Glucocorticoids|glucocorticoids|mesh-ancestor
25515023|NCT00419926|Hormones|hormones|mesh-ancestor
25515024|NCT00419926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25515025|NCT00419926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515026|NCT00419926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25515027|NCT00419926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515028|NCT00419926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515029|NCT00419926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515030|NCT00419926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25515031|NCT00419926|Immunologic Factors|immunologic factors|mesh-ancestor
25515032|NCT00419926|Antifungal Agents|antifungal agents|mesh-ancestor
25515033|NCT00419926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25515034|NCT00419926|Dermatologic Agents|dermatologic agents|mesh-ancestor
25515035|NCT00419926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25515036|NCT00419926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25515037|NCT00419926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25515038|NCT00419926|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25515039|NCT00419926|Antitubercular Agents|antitubercular agents|mesh-ancestor
25515040|NCT00419926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25515041|NCT00419952|Budesonide|budesonide|mesh-list
25515042|NCT00419952|Formoterol Fumarate|formoterol fumarate|mesh-list
25515043|NCT00419952|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25515044|NCT00419952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25515045|NCT00419952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25515046|NCT00419952|Autonomic Agents|autonomic agents|mesh-ancestor
25515047|NCT00419952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25515048|NCT00419952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515049|NCT00419952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25515050|NCT00419952|Respiratory System Agents|respiratory system agents|mesh-ancestor
25515051|NCT00419952|Glucocorticoids|glucocorticoids|mesh-ancestor
25515052|NCT00419952|Hormones|hormones|mesh-ancestor
25515053|NCT00419952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25515054|NCT00419952|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25515055|NCT00419952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25515056|NCT00419952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25515057|NCT00419952|Adrenergic Agents|adrenergic agents|mesh-ancestor
25515058|NCT00419952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25515059|NCT00419952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515060|NCT00420004|Citalopram|citalopram|mesh-list
25515061|NCT00420004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25515062|NCT00420004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25515063|NCT00420004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25515064|NCT00420004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515065|NCT00420004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25515066|NCT00420004|Serotonin Agents|serotonin agents|mesh-ancestor
25515067|NCT00420004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515068|NCT00420004|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25515069|NCT00420004|Antidepressive Agents|antidepressive agents|mesh-ancestor
25515070|NCT00420004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25515072|NCT00420017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25515073|NCT00420017|Vasodilator Agents|vasodilator agents|mesh-ancestor
25515074|NCT00420017|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25515075|NCT00420017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25515076|NCT00420017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515077|NCT00420017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25515078|NCT00420017|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25646116|NCT01454934|Mitosis Modulators|mitosis modulators|mesh-ancestor
25515079|NCT00420017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25515080|NCT00420017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515081|NCT00420017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25515082|NCT00420017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25515083|NCT00420017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25646117|NCT01454934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25646118|NCT01454934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25646119|NCT01454934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25646120|NCT01455012|Rotigotine|rotigotine|mesh-list
25646121|NCT01455012|Dopamine Agonists|dopamine agonists|mesh-ancestor
25646122|NCT01455012|Dopamine Agents|dopamine agents|mesh-ancestor
25646123|NCT01455012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25646124|NCT01455012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646125|NCT01455012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646126|NCT01455194|Ciclesonide|ciclesonide|mesh-list
25515084|NCT00420056|Palbociclib|palbociclib|mesh-list
25515085|NCT00420056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515086|NCT00420056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25515087|NCT00420056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515088|NCT00420056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515089|NCT00420095|Insulin|insulin|mesh-list
25515090|NCT00420095|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25515091|NCT00420095|Insulin Lispro|insulin lispro|mesh-list
25515092|NCT00420095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25515093|NCT00420095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515094|NCT00420199|Abatacept|abatacept|mesh-list
25515095|NCT00420199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25515096|NCT00420199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515097|NCT00420199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515098|NCT00420199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25515099|NCT00420199|Immunologic Factors|immunologic factors|mesh-ancestor
25515100|NCT00420199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515101|NCT00420199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25515102|NCT00420212|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25515103|NCT00420212|Dermatologic Agents|dermatologic agents|mesh-ancestor
25515104|NCT00420212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25515105|NCT00420212|Immunologic Factors|immunologic factors|mesh-ancestor
25515106|NCT00420212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515107|NCT00420238|Etanercept|etanercept|mesh-list
25515108|NCT00420238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25515109|NCT00420238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25515110|NCT00420238|Analgesics|analgesics|mesh-ancestor
25515111|NCT00420238|Sensory System Agents|sensory system agents|mesh-ancestor
25515112|NCT00420238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25515113|NCT00420238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515114|NCT00420238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25515115|NCT00420238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25515116|NCT00420238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25515117|NCT00420238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25515118|NCT00420238|Immunologic Factors|immunologic factors|mesh-ancestor
25515119|NCT00420290|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25515120|NCT00420290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25515121|NCT00420303|Etanercept|etanercept|mesh-list
25515122|NCT00420303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25515123|NCT00420303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25515124|NCT00420303|Analgesics|analgesics|mesh-ancestor
25515125|NCT00420303|Sensory System Agents|sensory system agents|mesh-ancestor
25515126|NCT00420303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25515127|NCT00420303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515128|NCT00420303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25515129|NCT00420303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25515130|NCT00420303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25515131|NCT00420303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25515132|NCT00420303|Immunologic Factors|immunologic factors|mesh-ancestor
25515133|NCT00420342|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25515134|NCT00420342|Drospirenone|drospirenone|mesh-list
25515135|NCT00420342|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25515136|NCT00420342|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24985894|NCT02556606|Midazolam|midazolam|mesh-list
25515137|NCT00420342|Medroxyprogesterone|medroxyprogesterone|mesh-list
25515138|NCT00420342|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25515139|NCT00420342|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
25515140|NCT00420342|Estradiol|estradiol|mesh-list
24999438|NCT04415944|Carboplatin|carboplatin|mesh-list
25515141|NCT00420342|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25515143|NCT00420342|Hormones|hormones|mesh-ancestor
25646127|NCT01455194|Glucocorticoids|glucocorticoids|mesh-ancestor
25646128|NCT01455194|Hormones|hormones|mesh-ancestor
25646129|NCT01455194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25646130|NCT01455194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646131|NCT01455194|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25646132|NCT01455220|Natalizumab|natalizumab|mesh-list
25646133|NCT01455220|Immunologic Factors|immunologic factors|mesh-ancestor
25646134|NCT01455220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646135|NCT01455415|Pregabalin|pregabalin|mesh-list
25646136|NCT01455415|Analgesics|analgesics|mesh-ancestor
25646137|NCT01455415|Sensory System Agents|sensory system agents|mesh-ancestor
25515144|NCT00420342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25515145|NCT00420342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515146|NCT00420342|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25515147|NCT00420342|Contraceptive Agents|contraceptive agents|mesh-ancestor
25515148|NCT00420342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25515149|NCT00420342|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25515150|NCT00420342|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25515151|NCT00420342|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25515152|NCT00420342|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25515153|NCT00420342|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25515154|NCT00420342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25515155|NCT00420342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515156|NCT00420342|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25515157|NCT00420342|Hormone Antagonists|hormone antagonists|mesh-ancestor
25515158|NCT00420342|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25515159|NCT00420342|Diuretics|diuretics|mesh-ancestor
25515160|NCT00420342|Natriuretic Agents|natriuretic agents|mesh-ancestor
25515161|NCT00420407|Vasopressins|vasopressins|mesh-list
25515162|NCT00420407|Arginine Vasopressin|arginine vasopressin|mesh-list
25515163|NCT00420407|Hemostatics|hemostatics|mesh-ancestor
25515164|NCT00420407|Coagulants|coagulants|mesh-ancestor
25515165|NCT00420407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25515166|NCT00420407|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25515167|NCT00420407|Natriuretic Agents|natriuretic agents|mesh-ancestor
25515168|NCT00420407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515169|NCT00420459|Aripiprazole|aripiprazole|mesh-list
25515170|NCT00420459|Antidepressive Agents|antidepressive agents|mesh-ancestor
25515171|NCT00420459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25515172|NCT00420459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25515173|NCT00420459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25515174|NCT00420459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25515175|NCT00420459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515176|NCT00420459|Dopamine Agonists|dopamine agonists|mesh-ancestor
25515177|NCT00420459|Dopamine Agents|dopamine agents|mesh-ancestor
25515178|NCT00420459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25515179|NCT00420459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515180|NCT00420459|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25515181|NCT00420459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25515182|NCT00420459|Serotonin Agents|serotonin agents|mesh-ancestor
25515183|NCT00420459|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25515184|NCT00420459|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25515185|NCT00420459|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25515186|NCT00420459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25515187|NCT00420511|Metformin|metformin|mesh-list
25515188|NCT00420511|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25515189|NCT00420511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25515190|NCT00420511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515191|NCT00420511|Incretins|incretins|mesh-ancestor
25515192|NCT00420511|Hormones|hormones|mesh-ancestor
25515193|NCT00420511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25515194|NCT00420511|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25515195|NCT00420511|Protease Inhibitors|protease inhibitors|mesh-ancestor
25515196|NCT00420511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515197|NCT00420511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515198|NCT00420628|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25515199|NCT00420628|Tobramycin|tobramycin|mesh-list
25515200|NCT00420628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25515201|NCT00420628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24506691|NCT00546533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24999474|NCT04209855|Paclitaxel|paclitaxel|mesh-list
25646138|NCT01455415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25646139|NCT01455415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646140|NCT01455415|Anticonvulsants|anticonvulsants|mesh-ancestor
25646141|NCT01455415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25646142|NCT01455415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24506692|NCT00546533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24506694|NCT00546533|Sensory System Agents|sensory system agents|mesh-ancestor
24506695|NCT00546533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24506696|NCT00546533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507223|NCT00549146|Glucocorticoids|glucocorticoids|mesh-ancestor
24507225|NCT00549146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24507226|NCT00549146|Sympathomimetics|sympathomimetics|mesh-ancestor
24507227|NCT00549289|Cyclosporine|cyclosporine|mesh-list
25515202|NCT00420628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25515203|NCT00420641|Paroxetine|paroxetine|mesh-list
25515204|NCT00420641|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25515205|NCT00420641|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25515206|NCT00420641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25515207|NCT00420641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515208|NCT00420641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25515209|NCT00420641|Serotonin Agents|serotonin agents|mesh-ancestor
25515210|NCT00420641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515211|NCT00420641|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25515212|NCT00420641|Antidepressive Agents|antidepressive agents|mesh-ancestor
25515213|NCT00420641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25515214|NCT00420641|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25515215|NCT00420641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25515216|NCT00420641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515217|NCT00420771|Gabapentin|gabapentin|mesh-list
25515218|NCT00420771|Analgesics|analgesics|mesh-ancestor
25515219|NCT00420771|Sensory System Agents|sensory system agents|mesh-ancestor
25515220|NCT00420771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25515221|NCT00420771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515222|NCT00420771|Anticonvulsants|anticonvulsants|mesh-ancestor
25515223|NCT00420771|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25515224|NCT00420771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25515225|NCT00420771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25515226|NCT00420771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25515227|NCT00420771|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25515228|NCT00420771|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25515229|NCT00420771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25515230|NCT00420771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515231|NCT00420771|Antimanic Agents|antimanic agents|mesh-ancestor
25515232|NCT00420784|Interferons|interferons|mesh-list
25515233|NCT00420784|Ribavirin|ribavirin|mesh-list
25515234|NCT00420784|Interferon-alpha|interferon-alpha|mesh-list
25515235|NCT00420784|Interferon alpha-2|interferon alpha-2|mesh-list
25515236|NCT00420784|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25515237|NCT00420784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515238|NCT00420784|Antiviral Agents|antiviral agents|mesh-ancestor
25515239|NCT00420784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25515240|NCT00420784|Antimetabolites|antimetabolites|mesh-ancestor
25515241|NCT00420784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515242|NCT00420784|Immunologic Factors|immunologic factors|mesh-ancestor
25515243|NCT00420784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515244|NCT00420849|Dexamethasone|dexamethasone|mesh-list
25515245|NCT00420849|Lenalidomide|lenalidomide|mesh-list
25515246|NCT00420849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25515247|NCT00420849|Antiemetics|antiemetics|mesh-ancestor
25515248|NCT00420849|Autonomic Agents|autonomic agents|mesh-ancestor
25515249|NCT00420849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25515250|NCT00420849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515251|NCT00420849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25515252|NCT00420849|Glucocorticoids|glucocorticoids|mesh-ancestor
25515253|NCT00420849|Hormones|hormones|mesh-ancestor
25515254|NCT00420849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25515255|NCT00420849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25515256|NCT00420849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515257|NCT00420849|Immunologic Factors|immunologic factors|mesh-ancestor
25515258|NCT00420849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25515259|NCT00420849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25515260|NCT00420849|Growth Substances|growth substances|mesh-ancestor
24999588|NCT03912220|Vitamins|vitamins|mesh-ancestor
25515262|NCT00420927|Adalimumab|adalimumab|mesh-list
25515263|NCT00420927|Methotrexate|methotrexate|mesh-list
25515264|NCT00420927|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25515265|NCT00420927|Abortifacient Agents|abortifacient agents|mesh-ancestor
24622077|NCT01065532|Mitosis Modulators|mitosis modulators|mesh-ancestor
24622078|NCT01065532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622079|NCT01065532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24507321|NCT00549874|Glyburide|glyburide|mesh-list
24507322|NCT00549874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24507323|NCT00549874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646143|NCT01455415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646144|NCT01455415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25646145|NCT01455415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25646146|NCT01455415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25646147|NCT01455415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25646148|NCT01455415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25646149|NCT01455428|Pregabalin|pregabalin|mesh-list
25646150|NCT01455428|Analgesics|analgesics|mesh-ancestor
25646151|NCT01455428|Sensory System Agents|sensory system agents|mesh-ancestor
25646152|NCT01455428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25646153|NCT01455428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646154|NCT01455428|Anticonvulsants|anticonvulsants|mesh-ancestor
24507324|NCT00549887|Insulin|insulin|mesh-list
24507325|NCT00549887|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24622097|NCT01065649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24622098|NCT01065649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515266|NCT00420927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25515267|NCT00420927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515268|NCT00420927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25515269|NCT00420927|Antimetabolites|antimetabolites|mesh-ancestor
25515270|NCT00420927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515271|NCT00420927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515272|NCT00420927|Dermatologic Agents|dermatologic agents|mesh-ancestor
25515273|NCT00420927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515274|NCT00420927|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25515275|NCT00420927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25515276|NCT00420927|Immunologic Factors|immunologic factors|mesh-ancestor
25515277|NCT00420927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25515278|NCT00420927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25515279|NCT00420927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25515281|NCT00420992|Morphine|morphine|mesh-list
25515282|NCT00420992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25515283|NCT00420992|Narcotics|narcotics|mesh-ancestor
25515284|NCT00420992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25515285|NCT00420992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515286|NCT00420992|Analgesics|analgesics|mesh-ancestor
25515287|NCT00420992|Sensory System Agents|sensory system agents|mesh-ancestor
25515288|NCT00420992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25515289|NCT00420992|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25515290|NCT00420992|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25515291|NCT00421148|Bromides|bromides|mesh-list
25515292|NCT00421148|Rocuronium|rocuronium|mesh-list
25515293|NCT00421148|Anticonvulsants|anticonvulsants|mesh-ancestor
25515294|NCT00421148|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25515295|NCT00421148|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25515296|NCT00421148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25515297|NCT00421148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25515298|NCT00421148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515299|NCT00421174|Methylprednisolone|methylprednisolone|mesh-list
25515300|NCT00421174|Etanercept|etanercept|mesh-list
25515301|NCT00421174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25515302|NCT00421174|Antiemetics|antiemetics|mesh-ancestor
25515303|NCT00421174|Autonomic Agents|autonomic agents|mesh-ancestor
25515304|NCT00421174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25515305|NCT00421174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515306|NCT00421174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25515307|NCT00421174|Glucocorticoids|glucocorticoids|mesh-ancestor
25515308|NCT00421174|Hormones|hormones|mesh-ancestor
25515309|NCT00421174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25515310|NCT00421174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25515311|NCT00421174|Protective Agents|protective agents|mesh-ancestor
25515312|NCT00421174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24999683|NCT03516214|Nazartinib|nazartinib|mesh-list
25646156|NCT01455428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25646157|NCT01455428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515313|NCT00421174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25515314|NCT00421174|Analgesics|analgesics|mesh-ancestor
25515315|NCT00421174|Sensory System Agents|sensory system agents|mesh-ancestor
25515316|NCT00421174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25515317|NCT00421174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25515318|NCT00421174|Immunologic Factors|immunologic factors|mesh-ancestor
25515319|NCT00421343|Cholecalciferol|cholecalciferol|mesh-list
25646158|NCT01455428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25646159|NCT01455428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25646160|NCT01455428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25646161|NCT01455428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25646162|NCT01455428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25646163|NCT01455519|Hydromorphone|hydromorphone|mesh-list
25646164|NCT01455519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25646165|NCT01455519|Narcotics|narcotics|mesh-ancestor
25646166|NCT01455519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25646167|NCT01455519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646168|NCT01455519|Analgesics|analgesics|mesh-ancestor
25646169|NCT01455519|Sensory System Agents|sensory system agents|mesh-ancestor
25515320|NCT00421343|Vitamin D|vitamin d|mesh-list
25515321|NCT00421343|Alendronate|alendronate|mesh-list
25515322|NCT00421343|Calcium Carbonate|calcium carbonate|mesh-list
25515323|NCT00421343|Calcium|calcium|mesh-list
25515324|NCT00421343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25515325|NCT00421343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515326|NCT00421343|Vitamins|vitamins|mesh-ancestor
25515327|NCT00421343|Micronutrients|micronutrients|mesh-ancestor
25515328|NCT00421343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25515329|NCT00421343|Antacids|antacids|mesh-ancestor
25515330|NCT00421343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515331|NCT00421343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25515332|NCT00421603|Topiramate|topiramate|mesh-list
25515333|NCT00421603|Adderall|adderall|mesh-list
25515334|NCT00421603|Anticonvulsants|anticonvulsants|mesh-ancestor
25515335|NCT00421603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25515336|NCT00421603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515337|NCT00421603|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25515338|NCT00421733|Ergocalciferols|ergocalciferols|mesh-list
25515339|NCT00421733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24986080|NCT02333162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25515340|NCT00421733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515341|NCT00421733|Vitamins|vitamins|mesh-ancestor
25515344|NCT00421889|Paclitaxel|paclitaxel|mesh-list
25515345|NCT00421889|Carboplatin|carboplatin|mesh-list
25515346|NCT00421889|Belinostat|belinostat|mesh-list
25515347|NCT00421889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25515348|NCT00421889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515349|NCT00421889|Tubulin Modulators|tubulin modulators|mesh-ancestor
25515350|NCT00421889|Antimitotic Agents|antimitotic agents|mesh-ancestor
25515351|NCT00421889|Mitosis Modulators|mitosis modulators|mesh-ancestor
25515352|NCT00421889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515353|NCT00421889|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25515354|NCT00421889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515355|NCT00421928|Oxycodone|oxycodone|mesh-list
25515356|NCT00421928|Tapentadol|tapentadol|mesh-list
25515357|NCT00421928|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25515358|NCT00421928|Narcotics|narcotics|mesh-ancestor
25515359|NCT00421928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25515360|NCT00421928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515361|NCT00421928|Analgesics|analgesics|mesh-ancestor
25515362|NCT00421928|Sensory System Agents|sensory system agents|mesh-ancestor
25515363|NCT00421928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25515364|NCT00421928|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25515365|NCT00421928|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25515366|NCT00421928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25515367|NCT00421928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515368|NCT00421928|Adrenergic Agents|adrenergic agents|mesh-ancestor
25515369|NCT00421928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25515370|NCT00421993|Adapalene|adapalene|mesh-list
25515371|NCT00421993|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
25515372|NCT00421993|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25515373|NCT00421993|Dermatologic Agents|dermatologic agents|mesh-ancestor
25646170|NCT01455519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25646172|NCT01456039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25646173|NCT01456039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646174|NCT01456130|Alogliptin|alogliptin|mesh-list
25646175|NCT01456130|Insulin, Short-Acting|insulin, short-acting|mesh-list
25646176|NCT01456130|Secretagogues|secretagogues|mesh-list
25646177|NCT01456130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25515374|NCT00421993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25515375|NCT00421993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25515376|NCT00421993|Analgesics|analgesics|mesh-ancestor
25515377|NCT00421993|Sensory System Agents|sensory system agents|mesh-ancestor
25515378|NCT00421993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25515379|NCT00421993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515380|NCT00421993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25515381|NCT00421993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25515382|NCT00422032|Clofarabine|clofarabine|mesh-list
25515383|NCT00422032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25515384|NCT00422032|Antimetabolites|antimetabolites|mesh-ancestor
25515385|NCT00422032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515386|NCT00422032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515387|NCT00422058|Liraglutide|liraglutide|mesh-list
25515388|NCT00422058|Orlistat|orlistat|mesh-list
25515389|NCT00422058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25515390|NCT00422058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515391|NCT00422058|Incretins|incretins|mesh-ancestor
25515392|NCT00422058|Hormones|hormones|mesh-ancestor
25515393|NCT00422058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25515394|NCT00422058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515395|NCT00422058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515396|NCT00422058|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25515397|NCT00422058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25515398|NCT00422084|Artesunate|artesunate|mesh-list
25515399|NCT00422084|Lumefantrine|lumefantrine|mesh-list
25515400|NCT00422084|Artemether|artemether|mesh-list
25515401|NCT00422084|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25515402|NCT00422084|Pyronaridine|pyronaridine|mesh-list
25515403|NCT00422084|Antimalarials|antimalarials|mesh-ancestor
25515404|NCT00422084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25515405|NCT00422084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25515406|NCT00422084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25515407|NCT00422084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515408|NCT00422084|Antiviral Agents|antiviral agents|mesh-ancestor
25515409|NCT00422084|Schistosomicides|schistosomicides|mesh-ancestor
25515410|NCT00422084|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25515411|NCT00422084|Anthelmintics|anthelmintics|mesh-ancestor
25515412|NCT00422097|Epothilones|epothilones|mesh-list
25515413|NCT00422097|Famotidine|famotidine|mesh-list
25134668|NCT03005483|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25823367|NCT00004808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24986230|NCT02122198|Fertility Agents|fertility agents|mesh-ancestor
24986231|NCT02122198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25515414|NCT00422097|Tubulin Modulators|tubulin modulators|mesh-ancestor
25515415|NCT00422097|Antimitotic Agents|antimitotic agents|mesh-ancestor
25515416|NCT00422097|Mitosis Modulators|mitosis modulators|mesh-ancestor
25515417|NCT00422097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515418|NCT00422097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515419|NCT00422097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25515420|NCT00422097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25515421|NCT00422097|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25515422|NCT00422097|Histamine Antagonists|histamine antagonists|mesh-ancestor
25515423|NCT00422097|Histamine Agents|histamine agents|mesh-ancestor
25515424|NCT00422097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25515425|NCT00422097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515426|NCT00422162|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25515427|NCT00422162|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25515428|NCT00422162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25515429|NCT00422162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25515430|NCT00422162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515431|NCT00422162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25515432|NCT00422162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515433|NCT00422162|Analgesics|analgesics|mesh-ancestor
25515434|NCT00422162|Sensory System Agents|sensory system agents|mesh-ancestor
25515435|NCT00422162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25646178|NCT01456130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646179|NCT01456130|Incretins|incretins|mesh-ancestor
25646180|NCT01456130|Hormones|hormones|mesh-ancestor
25646181|NCT01456130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25646182|NCT01456130|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25646183|NCT01456130|Protease Inhibitors|protease inhibitors|mesh-ancestor
25646184|NCT01456130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646185|NCT01456130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646186|NCT01456143|Proflavine|proflavine|mesh-list
25646187|NCT01456143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25646188|NCT01456143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25646189|NCT01456169|Chlorthalidone|chlorthalidone|mesh-list
25646190|NCT01456169|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25646191|NCT01456169|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25646192|NCT01456169|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24397733|NCT00142480|Bevacizumab|bevacizumab|mesh-list
25646193|NCT01456169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515436|NCT00422162|Antidepressive Agents|antidepressive agents|mesh-ancestor
25515437|NCT00422162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25515438|NCT00422162|Dopamine Agents|dopamine agents|mesh-ancestor
25515439|NCT00422201|Mifepristone|mifepristone|mesh-list
25515440|NCT00422201|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25515441|NCT00422201|Abortifacient Agents|abortifacient agents|mesh-ancestor
25515442|NCT00422201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25515443|NCT00422201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515444|NCT00422201|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25515445|NCT00422201|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25515446|NCT00422201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25515447|NCT00422201|Contraceptive Agents|contraceptive agents|mesh-ancestor
25515448|NCT00422201|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25515449|NCT00422201|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25515450|NCT00422201|Hormone Antagonists|hormone antagonists|mesh-ancestor
25515451|NCT00422201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25515452|NCT00422201|Luteolytic Agents|luteolytic agents|mesh-ancestor
25515453|NCT00422201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25515454|NCT00422201|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25515455|NCT00422227|Hydroxychloroquine|hydroxychloroquine|mesh-list
25515456|NCT00422227|Sulfasalazine|sulfasalazine|mesh-list
25515457|NCT00422227|Etanercept|etanercept|mesh-list
25515458|NCT00422227|Methotrexate|methotrexate|mesh-list
25515459|NCT00422227|Leflunomide|leflunomide|mesh-list
25515460|NCT00422227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25515461|NCT00422227|Abortifacient Agents|abortifacient agents|mesh-ancestor
25515462|NCT00422227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25515463|NCT00422227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515464|NCT00422227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25515465|NCT00422227|Antimetabolites|antimetabolites|mesh-ancestor
25515466|NCT00422227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515467|NCT00422227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515468|NCT00422227|Dermatologic Agents|dermatologic agents|mesh-ancestor
25515469|NCT00422227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515470|NCT00422227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25515471|NCT00422227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25515472|NCT00422227|Immunologic Factors|immunologic factors|mesh-ancestor
25515473|NCT00422227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25515474|NCT00422227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25515475|NCT00422227|Antimalarials|antimalarials|mesh-ancestor
25515476|NCT00422227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25515477|NCT00422227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25515478|NCT00422227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24796382|NCT01949766|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24796383|NCT01949766|Protective Agents|protective agents|mesh-ancestor
24796384|NCT01949766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796385|NCT01949766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796386|NCT01949805|Interferon alpha-2|interferon alpha-2|mesh-list
24796387|NCT01949805|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24796388|NCT01949805|Hydroxyurea|hydroxyurea|mesh-list
24796389|NCT01949805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796390|NCT01949805|Antisickling Agents|antisickling agents|mesh-ancestor
24796391|NCT01949805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796392|NCT01949805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515479|NCT00422227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25515480|NCT00422227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25515482|NCT00422227|Sensory System Agents|sensory system agents|mesh-ancestor
25515483|NCT00422227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25646194|NCT01456169|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25646195|NCT01456169|Diuretics|diuretics|mesh-ancestor
25646196|NCT01456169|Natriuretic Agents|natriuretic agents|mesh-ancestor
25646197|NCT01456169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646198|NCT01456169|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25646199|NCT01456169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25646200|NCT01456299|Remifentanil|remifentanil|mesh-list
25646201|NCT01456299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25646202|NCT01456299|Narcotics|narcotics|mesh-ancestor
25646203|NCT01456299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25646204|NCT01456299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646205|NCT01456299|Analgesics|analgesics|mesh-ancestor
25646206|NCT01456299|Sensory System Agents|sensory system agents|mesh-ancestor
25646207|NCT01456299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25646208|NCT01456780|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25646209|NCT01456780|Tobramycin|tobramycin|mesh-list
25515484|NCT00422227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25515485|NCT00422227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25515486|NCT00422292|Vaccines|vaccines|mesh-list
25515487|NCT00422292|Immunologic Factors|immunologic factors|mesh-ancestor
25515488|NCT00422292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515489|NCT00422383|Rituximab|rituximab|mesh-list
25515490|NCT00422383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25515491|NCT00422383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515492|NCT00422383|Immunologic Factors|immunologic factors|mesh-ancestor
25515493|NCT00422383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515494|NCT00422383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25515495|NCT00422422|Brivaracetam|brivaracetam|mesh-list
25515496|NCT00422422|Anticonvulsants|anticonvulsants|mesh-ancestor
25515497|NCT00422513|Epoetin Alfa|epoetin alfa|mesh-list
25515498|NCT00422513|Hematinics|hematinics|mesh-ancestor
25515499|NCT00422591|Cytarabine|cytarabine|mesh-list
25515500|NCT00422591|Idarubicin|idarubicin|mesh-list
25515501|NCT00422591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25515502|NCT00422591|Antimetabolites|antimetabolites|mesh-ancestor
25515503|NCT00422591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515504|NCT00422591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515505|NCT00422591|Antiviral Agents|antiviral agents|mesh-ancestor
25515506|NCT00422591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25515507|NCT00422591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25515508|NCT00422591|Immunologic Factors|immunologic factors|mesh-ancestor
25515509|NCT00422591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515510|NCT00422591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25515511|NCT00422591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25515512|NCT00422591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25515513|NCT00422591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515514|NCT00422734|Tadalafil|tadalafil|mesh-list
25515515|NCT00422734|Vasodilator Agents|vasodilator agents|mesh-ancestor
25515516|NCT00422734|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25515517|NCT00422734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25515518|NCT00422734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515519|NCT00422734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515520|NCT00422734|Urological Agents|urological agents|mesh-ancestor
25515521|NCT00422799|Rituximab|rituximab|mesh-list
25515522|NCT00422799|Bortezomib|bortezomib|mesh-list
25515523|NCT00422799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25515524|NCT00422799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515525|NCT00422799|Immunologic Factors|immunologic factors|mesh-ancestor
25515526|NCT00422799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515527|NCT00422799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25515528|NCT00422903|Letrozole|letrozole|mesh-list
25515529|NCT00422903|Lapatinib|lapatinib|mesh-list
25515530|NCT00422903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515531|NCT00422903|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25515532|NCT00422903|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25515533|NCT00422903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515534|NCT00422903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515535|NCT00422903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25515536|NCT00422903|Hormone Antagonists|hormone antagonists|mesh-ancestor
25515537|NCT00422903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25515538|NCT00422903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515539|NCT00422903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25515540|NCT00423085|Rivastigmine|rivastigmine|mesh-list
25515541|NCT00423085|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25515542|NCT00423085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515543|NCT00423085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646210|NCT01456780|Lubricant Eye Drops|lubricant eye drops|mesh-list
25646211|NCT01456780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25646212|NCT01456780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25646213|NCT01456780|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25646214|NCT01456780|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25646215|NCT01456780|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25646216|NCT01456936|Bupropion|bupropion|mesh-list
25646217|NCT01456936|Nicotine|nicotine|mesh-list
25515544|NCT00423085|Cholinergic Agents|cholinergic agents|mesh-ancestor
25515545|NCT00423085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25515546|NCT00423085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515547|NCT00423085|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24510123|NCT00563485|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24510124|NCT00563485|Adrenergic Agents|adrenergic agents|mesh-ancestor
24510125|NCT00563485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24796401|NCT01949818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24796402|NCT01949818|Immunologic Factors|immunologic factors|mesh-ancestor
24796403|NCT01949818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515548|NCT00423085|Protective Agents|protective agents|mesh-ancestor
25515549|NCT00423098|Mycophenolic Acid|mycophenolic acid|mesh-list
25515551|NCT00423098|Methylprednisolone|methylprednisolone|mesh-list
25515552|NCT00423098|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25515553|NCT00423098|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25515554|NCT00423098|Prednisolone|prednisolone|mesh-list
25515555|NCT00423098|Prednisolone acetate|prednisolone acetate|mesh-list
25515556|NCT00423098|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25515557|NCT00423098|Prednisolone phosphate|prednisolone phosphate|mesh-list
25515558|NCT00423098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25515559|NCT00423098|Glucocorticoids|glucocorticoids|mesh-ancestor
25515560|NCT00423098|Hormones|hormones|mesh-ancestor
25515561|NCT00423098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25515562|NCT00423098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515563|NCT00423098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25515564|NCT00423098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515565|NCT00423098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25515566|NCT00423098|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25515567|NCT00423098|Antitubercular Agents|antitubercular agents|mesh-ancestor
25515568|NCT00423098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25515569|NCT00423098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25515570|NCT00423098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515571|NCT00423098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515572|NCT00423098|Antiemetics|antiemetics|mesh-ancestor
25515573|NCT00423098|Autonomic Agents|autonomic agents|mesh-ancestor
25515574|NCT00423098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25515575|NCT00423098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25515576|NCT00423098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25515577|NCT00423098|Protective Agents|protective agents|mesh-ancestor
25515578|NCT00423150|Temozolomide|temozolomide|mesh-list
25515579|NCT00423150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25515580|NCT00423150|Alkylating Agents|alkylating agents|mesh-ancestor
25515581|NCT00423150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515582|NCT00423150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515583|NCT00423189|Ranibizumab|ranibizumab|mesh-list
25515584|NCT00423189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25515585|NCT00423189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25515586|NCT00423189|Growth Substances|growth substances|mesh-ancestor
25515587|NCT00423189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515588|NCT00423189|Growth Inhibitors|growth inhibitors|mesh-ancestor
25515589|NCT00423189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515590|NCT00423267|Fluconazole|fluconazole|mesh-list
25515591|NCT00423267|Posaconazole|posaconazole|mesh-list
25515592|NCT00423267|Antifungal Agents|antifungal agents|mesh-ancestor
25515593|NCT00423267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25515594|NCT00423267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25515595|NCT00423267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25515596|NCT00423267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515597|NCT00423267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515598|NCT00423267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25515599|NCT00423267|Hormone Antagonists|hormone antagonists|mesh-ancestor
25515600|NCT00423267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25515601|NCT00423267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515602|NCT00423267|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25515603|NCT00423267|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25646218|NCT01456936|Varenicline|varenicline|mesh-list
25515604|NCT00423267|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25646219|NCT01456936|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25646220|NCT01456936|Autonomic Agents|autonomic agents|mesh-ancestor
25646221|NCT01456936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25646222|NCT01456936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646223|NCT01456936|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25646224|NCT01456936|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25515605|NCT00423267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25515606|NCT00423267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25515608|NCT00423293|Mitomycins|mitomycins|mesh-list
25515609|NCT00423293|Mitomycin|mitomycin|mesh-list
25515610|NCT00423293|Antimetabolites|antimetabolites|mesh-ancestor
25515611|NCT00423293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515612|NCT00423293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25515613|NCT00423293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515614|NCT00423293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25515615|NCT00423293|Immunologic Factors|immunologic factors|mesh-ancestor
25515616|NCT00423293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515617|NCT00423293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25515618|NCT00423293|Alkylating Agents|alkylating agents|mesh-ancestor
25515619|NCT00423293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25515620|NCT00423293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515621|NCT00423319|Enoxaparin|enoxaparin|mesh-list
25515622|NCT00423319|Enoxaparin sodium|enoxaparin sodium|mesh-list
25515623|NCT00423319|Apixaban|apixaban|mesh-list
25515624|NCT00423319|Anticoagulants|anticoagulants|mesh-ancestor
25515625|NCT00423319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25515626|NCT00423319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25515627|NCT00423319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515628|NCT00423319|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25515629|NCT00423319|Antithrombins|antithrombins|mesh-ancestor
25515630|NCT00423319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25515631|NCT00423319|Protease Inhibitors|protease inhibitors|mesh-ancestor
25515632|NCT00423319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515633|NCT00423332|Cediranib|cediranib|mesh-list
25515634|NCT00423332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515635|NCT00423332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25515636|NCT00423332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515637|NCT00423332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515638|NCT00423358|Vitamin D|vitamin d|mesh-list
25515639|NCT00423358|Ergocalciferols|ergocalciferols|mesh-list
25515640|NCT00423358|Vitamins|vitamins|mesh-ancestor
25515641|NCT00423358|Micronutrients|micronutrients|mesh-ancestor
25515642|NCT00423358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515643|NCT00423358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25515644|NCT00423358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25515645|NCT00423449|Gemcitabine|gemcitabine|mesh-list
25515646|NCT00423449|Vorinostat|vorinostat|mesh-list
25515647|NCT00423449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25515648|NCT00423449|Antimetabolites|antimetabolites|mesh-ancestor
25515649|NCT00423449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515650|NCT00423449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515651|NCT00423449|Antiviral Agents|antiviral agents|mesh-ancestor
25515652|NCT00423449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25515653|NCT00423449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515654|NCT00423449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25515655|NCT00423449|Immunologic Factors|immunologic factors|mesh-ancestor
25515656|NCT00423449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515657|NCT00423449|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25515658|NCT00423592|Ambrisentan|ambrisentan|mesh-list
25515659|NCT00423592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25515660|NCT00423657|Vancomycin|vancomycin|mesh-list
25515661|NCT00423657|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
25515662|NCT00423657|Aztreonam|aztreonam|mesh-list
25515663|NCT00423657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25515664|NCT00423657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25515665|NCT00423670|Ribavirin|ribavirin|mesh-list
25515666|NCT00423670|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25515667|NCT00423670|Antimetabolites|antimetabolites|mesh-ancestor
25515668|NCT00423670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515669|NCT00423670|Antiviral Agents|antiviral agents|mesh-ancestor
25515670|NCT00423670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25515671|NCT00423683|PENTA|penta|mesh-list
25515672|NCT00423683|Fondaparinux|fondaparinux|mesh-list
25515673|NCT00423683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25515674|NCT00423683|Antithrombins|antithrombins|mesh-ancestor
25048904|NCT00658372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25515675|NCT00423683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25515676|NCT00423683|Protease Inhibitors|protease inhibitors|mesh-ancestor
25515677|NCT00423683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515678|NCT00423683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515679|NCT00423683|Anticoagulants|anticoagulants|mesh-ancestor
25515680|NCT00423683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25646225|NCT01456936|Cholinergic Agents|cholinergic agents|mesh-ancestor
25646226|NCT01456936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25646227|NCT01456936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646228|NCT01456936|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25646229|NCT01456936|Antidepressive Agents|antidepressive agents|mesh-ancestor
25515681|NCT00423683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25646230|NCT01456936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25515682|NCT00423735|Dasatinib|dasatinib|mesh-list
25515683|NCT00423735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515684|NCT00423735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25515685|NCT00423735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515686|NCT00423735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515687|NCT00423800|Interferons|interferons|mesh-list
25515688|NCT00423800|Ribavirin|ribavirin|mesh-list
25515689|NCT00423800|Interferon-alpha|interferon-alpha|mesh-list
25515690|NCT00423800|Interferon alpha-2|interferon alpha-2|mesh-list
25515691|NCT00423800|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24510946|NCT00566683|Autonomic Agents|autonomic agents|mesh-ancestor
24510947|NCT00566683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24510948|NCT00566683|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24510949|NCT00566683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24510950|NCT00566683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25515692|NCT00423800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515693|NCT00423800|Antiviral Agents|antiviral agents|mesh-ancestor
25646231|NCT01456936|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25646232|NCT01456936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25646233|NCT01456936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25646234|NCT01456936|Dopamine Agents|dopamine agents|mesh-ancestor
25646235|NCT01456936|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25646236|NCT01456936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25646237|NCT01456936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646238|NCT01457118|Etirinotecan pegol|etirinotecan pegol|mesh-list
25646239|NCT01457118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646240|NCT01457118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25646241|NCT01457118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25646242|NCT01457118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646243|NCT01457118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646244|NCT01457339|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25646245|NCT01457339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25515694|NCT00423800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25515695|NCT00423800|Antimetabolites|antimetabolites|mesh-ancestor
25515696|NCT00423800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515697|NCT00423800|Immunologic Factors|immunologic factors|mesh-ancestor
25515698|NCT00423800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515699|NCT00423852|Paclitaxel|paclitaxel|mesh-list
25515700|NCT00423852|Carboplatin|carboplatin|mesh-list
25515701|NCT00423852|Ifosfamide|ifosfamide|mesh-list
25515702|NCT00423852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25515703|NCT00423852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515704|NCT00423852|Tubulin Modulators|tubulin modulators|mesh-ancestor
25515705|NCT00423852|Antimitotic Agents|antimitotic agents|mesh-ancestor
25515706|NCT00423852|Mitosis Modulators|mitosis modulators|mesh-ancestor
25515707|NCT00423852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515708|NCT00423852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25515709|NCT00423852|Alkylating Agents|alkylating agents|mesh-ancestor
25515710|NCT00423878|Olanzapine|olanzapine|mesh-list
25515711|NCT00423878|Risperidone|risperidone|mesh-list
25515712|NCT00423878|Aripiprazole|aripiprazole|mesh-list
25515713|NCT00423878|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25515714|NCT00423878|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25515715|NCT00423878|Serotonin Agents|serotonin agents|mesh-ancestor
25515716|NCT00423878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25515717|NCT00423878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515718|NCT00423878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515719|NCT00423878|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25515720|NCT00423878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25515721|NCT00423878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25515722|NCT00423878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25515723|NCT00423878|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25515724|NCT00423878|Dopamine Agents|dopamine agents|mesh-ancestor
25515725|NCT00423878|Antiemetics|antiemetics|mesh-ancestor
25515726|NCT00423878|Autonomic Agents|autonomic agents|mesh-ancestor
25515727|NCT00423878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25646246|NCT01457339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646247|NCT01457339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25646248|NCT01457339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25646249|NCT01457339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25646250|NCT01457339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515728|NCT00423878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25515729|NCT00423878|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25515730|NCT00423878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25515731|NCT00423878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25515732|NCT00423878|Antidepressive Agents|antidepressive agents|mesh-ancestor
25515733|NCT00423878|Dopamine Agonists|dopamine agonists|mesh-ancestor
25515734|NCT00423878|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25515735|NCT00423878|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25515736|NCT00423878|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25515737|NCT00423878|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25515738|NCT00423891|Entecavir|entecavir|mesh-list
25515739|NCT00423891|Antiviral Agents|antiviral agents|mesh-ancestor
25515740|NCT00423891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25515741|NCT00423917|Bevacizumab|bevacizumab|mesh-list
25515742|NCT00423917|Fulvestrant|fulvestrant|mesh-list
25515743|NCT00423917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25515744|NCT00423917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515745|NCT00423917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25515746|NCT00423917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25515747|NCT00423917|Growth Substances|growth substances|mesh-ancestor
25515748|NCT00423917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515749|NCT00423917|Growth Inhibitors|growth inhibitors|mesh-ancestor
25515750|NCT00423917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25515751|NCT00423917|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25515752|NCT00423917|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25515753|NCT00423917|Hormone Antagonists|hormone antagonists|mesh-ancestor
25515754|NCT00423917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25515755|NCT00423930|Bevacizumab|bevacizumab|mesh-list
25515756|NCT00423930|Cisplatin|cisplatin|mesh-list
25515757|NCT00423930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25515758|NCT00423930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25107032|NCT03143010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24986521|NCT00670358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24986522|NCT00670358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24986523|NCT00670358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24986524|NCT00670358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24986525|NCT00670358|Glucocorticoids|glucocorticoids|mesh-ancestor
24861267|NCT02316379|Xenon|xenon|mesh-list
24986526|NCT00670358|Hormones|hormones|mesh-ancestor
24986527|NCT00670358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24986528|NCT00670358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24986529|NCT00670358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25515759|NCT00423930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25515760|NCT00423930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25515761|NCT00423930|Growth Substances|growth substances|mesh-ancestor
25515762|NCT00423930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515763|NCT00423930|Growth Inhibitors|growth inhibitors|mesh-ancestor
25515765|NCT00423943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25515766|NCT00423943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515767|NCT00423943|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25515768|NCT00423943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25515769|NCT00423943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25515770|NCT00423943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515771|NCT00424021|Ambrisentan|ambrisentan|mesh-list
25515772|NCT00424021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25515773|NCT00424047|Dexamethasone|dexamethasone|mesh-list
25515774|NCT00424047|Dexamethasone acetate|dexamethasone acetate|mesh-list
25515775|NCT00424047|Lenalidomide|lenalidomide|mesh-list
25515776|NCT00424047|BB 1101|bb 1101|mesh-list
25515777|NCT00424047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25515778|NCT00424047|Antiemetics|antiemetics|mesh-ancestor
25515779|NCT00424047|Autonomic Agents|autonomic agents|mesh-ancestor
25515780|NCT00424047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25646251|NCT01457339|Dopamine Agents|dopamine agents|mesh-ancestor
25646252|NCT01457339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25646253|NCT01457430|Icatibant|icatibant|mesh-list
25646254|NCT01457430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25515781|NCT00424047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515782|NCT00424047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25515783|NCT00424047|Glucocorticoids|glucocorticoids|mesh-ancestor
25646255|NCT01457430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25515784|NCT00424047|Hormones|hormones|mesh-ancestor
25646256|NCT01457430|Analgesics|analgesics|mesh-ancestor
25646257|NCT01457430|Sensory System Agents|sensory system agents|mesh-ancestor
25646258|NCT01457430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25646259|NCT01457430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646260|NCT01457430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25646261|NCT01457430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25646262|NCT01457430|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
25515785|NCT00424047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25515786|NCT00424047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25515787|NCT00424047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515788|NCT00424047|Protease Inhibitors|protease inhibitors|mesh-ancestor
25515789|NCT00424047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515790|NCT00424047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515791|NCT00424047|Immunologic Factors|immunologic factors|mesh-ancestor
25515792|NCT00424047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25515793|NCT00424047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25515794|NCT00424047|Growth Substances|growth substances|mesh-ancestor
25515795|NCT00424047|Growth Inhibitors|growth inhibitors|mesh-ancestor
25515796|NCT00424190|Vancomycin|vancomycin|mesh-list
25515797|NCT00424190|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
25515798|NCT00424190|Aztreonam|aztreonam|mesh-list
25515799|NCT00424190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25515800|NCT00424190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25515801|NCT00424255|Lapatinib|lapatinib|mesh-list
25515802|NCT00424255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515803|NCT00424255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25515804|NCT00424255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515805|NCT00424255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515806|NCT00424294|Celecoxib|celecoxib|mesh-list
25515807|NCT00424294|Methotrexate|methotrexate|mesh-list
25515808|NCT00424294|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25515809|NCT00424294|Abortifacient Agents|abortifacient agents|mesh-ancestor
25515810|NCT00424294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25515811|NCT00424294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515812|NCT00424294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25515813|NCT00424294|Antimetabolites|antimetabolites|mesh-ancestor
25515814|NCT00424294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515815|NCT00424294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515816|NCT00424294|Dermatologic Agents|dermatologic agents|mesh-ancestor
25515817|NCT00424294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515818|NCT00424294|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25515819|NCT00424294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24511498|NCT00569088|Natriuretic Agents|natriuretic agents|mesh-ancestor
24511499|NCT00569088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511500|NCT00569101|Tacrolimus|tacrolimus|mesh-list
24511509|NCT00569244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511510|NCT00569296|Aldesleukin|aldesleukin|mesh-list
24511511|NCT00569296|Sargramostim|sargramostim|mesh-list
24511512|NCT00569296|Immunologic Factors|immunologic factors|mesh-ancestor
25162767|NCT02902523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25162768|NCT02902523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25162769|NCT02902432|Endostar protein|endostar protein|mesh-list
24511513|NCT00569296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511514|NCT00569296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511537|NCT00569452|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24511538|NCT00569452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25515820|NCT00424294|Immunologic Factors|immunologic factors|mesh-ancestor
25515821|NCT00424294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25515822|NCT00424294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25515823|NCT00424294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25515824|NCT00424294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25515825|NCT00424294|Analgesics|analgesics|mesh-ancestor
25515826|NCT00424294|Sensory System Agents|sensory system agents|mesh-ancestor
25000522|NCT04311463|Paroxetine|paroxetine|mesh-list
25515827|NCT00424294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25515828|NCT00424294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25646263|NCT01457430|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
25646264|NCT01457430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823368|NCT00004808|Hormone Antagonists|hormone antagonists|mesh-ancestor
25515829|NCT00424294|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25515830|NCT00424294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25515832|NCT00424372|Analgesics|analgesics|mesh-ancestor
25515833|NCT00424372|Sensory System Agents|sensory system agents|mesh-ancestor
25515834|NCT00424372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25203271|NCT02715024|Tamsulosin|tamsulosin|mesh-list
25515835|NCT00424372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515836|NCT00424372|Anticonvulsants|anticonvulsants|mesh-ancestor
25515837|NCT00424372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25515838|NCT00424372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25515839|NCT00424372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515840|NCT00424372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25515841|NCT00424372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25515842|NCT00424372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25515843|NCT00424372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25515844|NCT00424372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25515845|NCT00424385|Sorafenib|sorafenib|mesh-list
25515846|NCT00424385|Imatinib Mesylate|imatinib mesylate|mesh-list
25515847|NCT00424385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515848|NCT00424385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25515849|NCT00424385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515850|NCT00424385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515851|NCT00424398|Bepotastine besilate|bepotastine besilate|mesh-list
25515852|NCT00424398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25515853|NCT00424463|Edaravone|edaravone|mesh-list
25515854|NCT00424463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25515855|NCT00424463|Antioxidants|antioxidants|mesh-ancestor
25515856|NCT00424463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515857|NCT00424463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25515858|NCT00424463|Protective Agents|protective agents|mesh-ancestor
25515859|NCT00424463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515860|NCT00424476|Belimumab|belimumab|mesh-list
25515861|NCT00424476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25515862|NCT00424476|Immunologic Factors|immunologic factors|mesh-ancestor
25515863|NCT00424476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515864|NCT00424489|Methylprednisolone|methylprednisolone|mesh-list
25515865|NCT00424489|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25515866|NCT00424489|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25515867|NCT00424489|Prednisolone|prednisolone|mesh-list
25515868|NCT00424489|Prednisolone acetate|prednisolone acetate|mesh-list
25515869|NCT00424489|Cyclophosphamide|cyclophosphamide|mesh-list
25515870|NCT00424489|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25515871|NCT00424489|Prednisolone phosphate|prednisolone phosphate|mesh-list
25515872|NCT00424489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25515873|NCT00424489|Immunologic Factors|immunologic factors|mesh-ancestor
25515874|NCT00424489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515875|NCT00424489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25515876|NCT00424489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25515877|NCT00424489|Alkylating Agents|alkylating agents|mesh-ancestor
25515878|NCT00424489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515879|NCT00424489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515880|NCT00424489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24986593|NCT00070018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162771|NCT02902432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25162772|NCT02902432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25162773|NCT02902432|Growth Substances|growth substances|mesh-ancestor
25162774|NCT02902432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162775|NCT02902432|Growth Inhibitors|growth inhibitors|mesh-ancestor
25162776|NCT02902432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162782|NCT02902380|Dexmedetomidine|dexmedetomidine|mesh-list
25162783|NCT02902380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25162784|NCT02902380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25162785|NCT02902380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162786|NCT02902380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25162787|NCT02902380|Analgesics|analgesics|mesh-ancestor
25515881|NCT00424489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25515883|NCT00424489|Autonomic Agents|autonomic agents|mesh-ancestor
25515884|NCT00424489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25515885|NCT00424489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25515886|NCT00424489|Glucocorticoids|glucocorticoids|mesh-ancestor
25515887|NCT00424489|Hormones|hormones|mesh-ancestor
25646265|NCT01457430|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25646266|NCT01457430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25646267|NCT01457430|Immunologic Factors|immunologic factors|mesh-ancestor
25646268|NCT01457521|Ibuprofen|ibuprofen|mesh-list
25646269|NCT01457521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25646270|NCT01457521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25646271|NCT01457521|Analgesics|analgesics|mesh-ancestor
25646272|NCT01457521|Sensory System Agents|sensory system agents|mesh-ancestor
25646273|NCT01457521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25646274|NCT01457521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646275|NCT01457521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25515888|NCT00424489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25515889|NCT00424489|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25515890|NCT00424489|Protective Agents|protective agents|mesh-ancestor
25515891|NCT00424489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25515892|NCT00424502|Rituximab|rituximab|mesh-list
25515893|NCT00424502|Methotrexate|methotrexate|mesh-list
25515894|NCT00424502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25515895|NCT00424502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515896|NCT00424502|Immunologic Factors|immunologic factors|mesh-ancestor
25515897|NCT00424502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515898|NCT00424502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25515899|NCT00424502|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25515900|NCT00424502|Abortifacient Agents|abortifacient agents|mesh-ancestor
25515901|NCT00424502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25515902|NCT00424502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25515903|NCT00424502|Antimetabolites|antimetabolites|mesh-ancestor
25515904|NCT00424502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515905|NCT00424502|Dermatologic Agents|dermatologic agents|mesh-ancestor
25515906|NCT00424502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515907|NCT00424502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25515908|NCT00424502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25515909|NCT00424502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25515910|NCT00424515|Imatinib Mesylate|imatinib mesylate|mesh-list
25515911|NCT00424515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515912|NCT00424515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25515913|NCT00424515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515914|NCT00424515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515915|NCT00424528|Tiotropium Bromide|tiotropium bromide|mesh-list
25515916|NCT00424528|Formoterol Fumarate|formoterol fumarate|mesh-list
25515917|NCT00424528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25515918|NCT00424528|Autonomic Agents|autonomic agents|mesh-ancestor
25515919|NCT00424528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25515920|NCT00424528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515921|NCT00424528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25515922|NCT00424528|Respiratory System Agents|respiratory system agents|mesh-ancestor
25515923|NCT00424528|Parasympatholytics|parasympatholytics|mesh-ancestor
25515924|NCT00424528|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25515925|NCT00424528|Cholinergic Agents|cholinergic agents|mesh-ancestor
25515926|NCT00424528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25515927|NCT00424528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515928|NCT00424528|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25515929|NCT00424528|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25515930|NCT00424528|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25515931|NCT00424528|Adrenergic Agents|adrenergic agents|mesh-ancestor
25515932|NCT00424554|Temozolomide|temozolomide|mesh-list
25515933|NCT00424554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25515934|NCT00424554|Alkylating Agents|alkylating agents|mesh-ancestor
25515935|NCT00424554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515936|NCT00424554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515937|NCT00424593|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25515938|NCT00424593|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25515939|NCT00424593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25515940|NCT00424593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25515941|NCT00424593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515942|NCT00424593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25515943|NCT00424593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515944|NCT00424593|Analgesics|analgesics|mesh-ancestor
25515945|NCT00424593|Sensory System Agents|sensory system agents|mesh-ancestor
25515946|NCT00424593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25515947|NCT00424593|Antidepressive Agents|antidepressive agents|mesh-ancestor
25515948|NCT00424593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25823369|NCT00004808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25823370|NCT00004808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823371|NCT00004808|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25515949|NCT00424593|Dopamine Agents|dopamine agents|mesh-ancestor
25515950|NCT00424619|Vitamin D|vitamin d|mesh-list
25515951|NCT00424619|Ergocalciferols|ergocalciferols|mesh-list
25515952|NCT00424619|Cholecalciferol|cholecalciferol|mesh-list
25515953|NCT00424619|Vitamins|vitamins|mesh-list
25515954|NCT00424619|Micronutrients|micronutrients|mesh-ancestor
25515955|NCT00424619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515956|NCT00424619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25515957|NCT00424619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25515958|NCT00424749|Prednisone|prednisone|mesh-list
25515959|NCT00424749|Rituximab|rituximab|mesh-list
25515960|NCT00424749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25515961|NCT00424749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515962|NCT00424749|Immunologic Factors|immunologic factors|mesh-ancestor
25515963|NCT00424749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515964|NCT00424749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25515965|NCT00424749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25515966|NCT00424749|Glucocorticoids|glucocorticoids|mesh-ancestor
25515967|NCT00424749|Hormones|hormones|mesh-ancestor
25515968|NCT00424749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25515969|NCT00424749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25515970|NCT00424762|Rosiglitazone|rosiglitazone|mesh-list
25515971|NCT00424762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25515972|NCT00424762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515973|NCT00424775|Vorinostat|vorinostat|mesh-list
25515974|NCT00424775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515975|NCT00424775|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25515976|NCT00424775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515977|NCT00424775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515978|NCT00424827|Gemcitabine|gemcitabine|mesh-list
25515979|NCT00424827|Fluorouracil|fluorouracil|mesh-list
25515980|NCT00424827|Cetuximab|cetuximab|mesh-list
25515981|NCT00424827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25515982|NCT00424827|Antimetabolites|antimetabolites|mesh-ancestor
25515983|NCT00424827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25515984|NCT00424827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515985|NCT00424827|Antiviral Agents|antiviral agents|mesh-ancestor
25515986|NCT00424827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25515987|NCT00424827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25515988|NCT00424827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25515989|NCT00424827|Immunologic Factors|immunologic factors|mesh-ancestor
25515990|NCT00424827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25515991|NCT00424827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25515992|NCT00424840|Bevacizumab|bevacizumab|mesh-list
25515993|NCT00424840|Carboplatin|carboplatin|mesh-list
25515994|NCT00424840|Bortezomib|bortezomib|mesh-list
25515995|NCT00424840|Docetaxel|docetaxel|mesh-list
25515996|NCT00424840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25515997|NCT00424840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25515998|NCT00424840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25515999|NCT00424840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25516000|NCT00424840|Growth Substances|growth substances|mesh-ancestor
25516001|NCT00424840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516002|NCT00424840|Growth Inhibitors|growth inhibitors|mesh-ancestor
25516003|NCT00424840|Tubulin Modulators|tubulin modulators|mesh-ancestor
25516004|NCT00424840|Antimitotic Agents|antimitotic agents|mesh-ancestor
25516005|NCT00424840|Mitosis Modulators|mitosis modulators|mesh-ancestor
25516006|NCT00424840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516007|NCT00425113|Metronidazole|metronidazole|mesh-list
25516008|NCT00425113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25516009|NCT00425113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25516010|NCT00425113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25516011|NCT00425113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25516012|NCT00425308|Cyclosporine|cyclosporine|mesh-list
25516013|NCT00425308|Mycophenolic Acid|mycophenolic acid|mesh-list
25516014|NCT00425308|Everolimus|everolimus|mesh-list
25516015|NCT00425308|Cyclosporins|cyclosporins|mesh-list
24986639|NCT05189184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986640|NCT05189184|Tubulin Modulators|tubulin modulators|mesh-ancestor
25823372|NCT00004808|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25823373|NCT00004810|Aminosalicylic Acid|aminosalicylic acid|mesh-list
24512592|NCT00575835|Vitamins|vitamins|mesh-list
24512593|NCT00575835|Micronutrients|micronutrients|mesh-ancestor
25646276|NCT01457521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24512594|NCT00575835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516016|NCT00425308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516017|NCT00425308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516018|NCT00425308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25516019|NCT00425308|Immunologic Factors|immunologic factors|mesh-ancestor
25516020|NCT00425308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516021|NCT00425308|Antifungal Agents|antifungal agents|mesh-ancestor
25516022|NCT00425308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25516023|NCT00425308|Dermatologic Agents|dermatologic agents|mesh-ancestor
25516024|NCT00425308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25516025|NCT00425308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25516026|NCT00425308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516027|NCT00425308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25516028|NCT00425308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25516029|NCT00425308|Antitubercular Agents|antitubercular agents|mesh-ancestor
25516030|NCT00425308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25516031|NCT00425373|Amlodipine|amlodipine|mesh-list
25516032|NCT00425373|Valsartan|valsartan|mesh-list
25516033|NCT00425373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25646277|NCT01457521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25646278|NCT01457521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646279|NCT01457521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646280|NCT01457573|Tamsulosin|tamsulosin|mesh-list
25646281|NCT01457573|Solifenacin Succinate|solifenacin succinate|mesh-list
25646282|NCT01457573|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25646283|NCT01457573|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25646284|NCT01457573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25646285|NCT01457573|Adrenergic Agents|adrenergic agents|mesh-ancestor
25646286|NCT01457573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25646287|NCT01457573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646288|NCT01457573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646289|NCT01457573|Urological Agents|urological agents|mesh-ancestor
25646290|NCT01457573|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25646291|NCT01457573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25516034|NCT00425373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25516035|NCT00425373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25516036|NCT00425373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516037|NCT00425373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25516038|NCT00425373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516039|NCT00425373|Vasodilator Agents|vasodilator agents|mesh-ancestor
25516040|NCT00425373|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25516041|NCT00425373|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25516042|NCT00425386|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25516043|NCT00425386|Sunitinib|sunitinib|mesh-list
25516044|NCT00425386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516045|NCT00425386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25516046|NCT00425386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516047|NCT00425386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516048|NCT00425386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25516049|NCT00425386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25516050|NCT00425386|Growth Substances|growth substances|mesh-ancestor
25516051|NCT00425386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516052|NCT00425386|Growth Inhibitors|growth inhibitors|mesh-ancestor
25516053|NCT00425477|Bexarotene|bexarotene|mesh-list
25516054|NCT00425477|Sargramostim|sargramostim|mesh-list
25516055|NCT00425477|Immunologic Factors|immunologic factors|mesh-ancestor
25516056|NCT00425477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516057|NCT00425477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516058|NCT00425503|Bortezomib|bortezomib|mesh-list
25516059|NCT00425503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516060|NCT00425555|Panobinostat|panobinostat|mesh-list
25516061|NCT00425555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516062|NCT00425555|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25516063|NCT00425555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516064|NCT00425555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516065|NCT00425607|Lonafarnib|lonafarnib|mesh-list
25516066|NCT00425607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516067|NCT00425607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516068|NCT00425672|Interleukin-2|interleukin-2|mesh-list
25516069|NCT00425672|Denileukin diftitox|denileukin diftitox|mesh-list
25516070|NCT00425672|Immunotoxins|immunotoxins|mesh-list
25000948|NCT05462548|Hematinics|hematinics|mesh-ancestor
25646292|NCT01457573|Cholinergic Agents|cholinergic agents|mesh-ancestor
25646293|NCT01457703|Letrozole|letrozole|mesh-list
25646294|NCT01457703|Cetrorelix|cetrorelix|mesh-list
25646295|NCT01457703|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25646296|NCT01457703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646297|NCT01457703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25646298|NCT01457703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25646299|NCT01457703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646300|NCT01457703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516071|NCT00425672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516072|NCT00425672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25516073|NCT00425672|Analgesics|analgesics|mesh-ancestor
25516074|NCT00425672|Sensory System Agents|sensory system agents|mesh-ancestor
25516075|NCT00425672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25516076|NCT00425672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516077|NCT00425672|Immunologic Factors|immunologic factors|mesh-ancestor
25516078|NCT00425698|Epoetin Alfa|epoetin alfa|mesh-list
25516079|NCT00425698|Hematinics|hematinics|mesh-ancestor
25516080|NCT00425750|Docetaxel|docetaxel|mesh-list
25516081|NCT00425750|Bortezomib|bortezomib|mesh-list
25516082|NCT00425750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516083|NCT00425750|Tubulin Modulators|tubulin modulators|mesh-ancestor
25516084|NCT00425750|Antimitotic Agents|antimitotic agents|mesh-ancestor
25516085|NCT00425750|Mitosis Modulators|mitosis modulators|mesh-ancestor
25516086|NCT00425750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516087|NCT00425802|Cyclosporine|cyclosporine|mesh-list
25516088|NCT00425802|Mycophenolic Acid|mycophenolic acid|mesh-list
25646301|NCT01457703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25646302|NCT01457703|Hormone Antagonists|hormone antagonists|mesh-ancestor
25646303|NCT01457703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25646304|NCT01457703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516089|NCT00425802|Cyclophosphamide|cyclophosphamide|mesh-list
25516090|NCT00425802|Rituximab|rituximab|mesh-list
25516091|NCT00425802|Fludarabine|fludarabine|mesh-list
25516092|NCT00425802|Fludarabine phosphate|fludarabine phosphate|mesh-list
25516093|NCT00425802|Cyclosporins|cyclosporins|mesh-list
25516094|NCT00425802|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25516095|NCT00425802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25516096|NCT00425802|Immunologic Factors|immunologic factors|mesh-ancestor
25516097|NCT00425802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516098|NCT00425802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25516099|NCT00425802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25516100|NCT00425802|Alkylating Agents|alkylating agents|mesh-ancestor
25516101|NCT00425802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516102|NCT00425802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516103|NCT00425802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25516104|NCT00425802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25516105|NCT00425802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25516106|NCT00425802|Antimetabolites|antimetabolites|mesh-ancestor
25516107|NCT00425802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516108|NCT00425802|Antifungal Agents|antifungal agents|mesh-ancestor
25516109|NCT00425802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25516110|NCT00425802|Dermatologic Agents|dermatologic agents|mesh-ancestor
25516111|NCT00425802|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25516112|NCT00425802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25516113|NCT00425802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25516114|NCT00425802|Antitubercular Agents|antitubercular agents|mesh-ancestor
25516115|NCT00425802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25516116|NCT00425854|Afatinib|afatinib|mesh-list
25516117|NCT00425854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516118|NCT00425854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25516119|NCT00425854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516120|NCT00425854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516121|NCT00425945|Pycnogenols|pycnogenols|mesh-list
25516122|NCT00425945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25516123|NCT00425945|Immunologic Factors|immunologic factors|mesh-ancestor
25516124|NCT00425945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516125|NCT00425945|Antioxidants|antioxidants|mesh-ancestor
25516126|NCT00425945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516127|NCT00425945|Protective Agents|protective agents|mesh-ancestor
25516128|NCT00425945|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25516129|NCT00426127|Docetaxel|docetaxel|mesh-list
25516130|NCT00426127|Doxorubicin|doxorubicin|mesh-list
25516131|NCT00426127|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25516132|NCT00426127|Enoxaparin|enoxaparin|mesh-list
25516133|NCT00426127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646305|NCT01457703|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25646306|NCT01457703|Fertility Agents|fertility agents|mesh-ancestor
25646307|NCT01457703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25646308|NCT01457703|Hormones|hormones|mesh-ancestor
25646309|NCT01457846|Paclitaxel|paclitaxel|mesh-list
25646310|NCT01457846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25646311|NCT01457846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646312|NCT01457846|Tubulin Modulators|tubulin modulators|mesh-ancestor
25646313|NCT01457846|Antimitotic Agents|antimitotic agents|mesh-ancestor
25646314|NCT01457846|Mitosis Modulators|mitosis modulators|mesh-ancestor
25516134|NCT00426127|Tubulin Modulators|tubulin modulators|mesh-ancestor
25516135|NCT00426127|Antimitotic Agents|antimitotic agents|mesh-ancestor
25516136|NCT00426127|Mitosis Modulators|mitosis modulators|mesh-ancestor
25516137|NCT00426127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516138|NCT00426127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25516139|NCT00426127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25516140|NCT00426127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25516141|NCT00426127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516142|NCT00426127|Anticoagulants|anticoagulants|mesh-ancestor
25516143|NCT00426127|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25516144|NCT00426127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25516145|NCT00426153|Octreotide|octreotide|mesh-list
25516146|NCT00426153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25516147|NCT00426153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25516148|NCT00426153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516149|NCT00426270|Immunoglobulins|immunoglobulins|mesh-list
25516150|NCT00426270|Immunologic Factors|immunologic factors|mesh-ancestor
25516151|NCT00426270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516152|NCT00426283|Fluticasone|fluticasone|mesh-list
25516153|NCT00426283|Xhance|xhance|mesh-list
25516154|NCT00426283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25516155|NCT00426283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25516156|NCT00426283|Autonomic Agents|autonomic agents|mesh-ancestor
25516157|NCT00426283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25516158|NCT00426283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516159|NCT00426283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25516160|NCT00426283|Respiratory System Agents|respiratory system agents|mesh-ancestor
25516161|NCT00426283|Dermatologic Agents|dermatologic agents|mesh-ancestor
24513365|NCT00580905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24513366|NCT00580905|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24513367|NCT00580931|Niacinamide|niacinamide|mesh-list
25162822|NCT02902055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162823|NCT02901977|Ramipril|ramipril|mesh-list
25162824|NCT02901977|Doxazosin|doxazosin|mesh-list
25162825|NCT02901977|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25162826|NCT02901977|Protease Inhibitors|protease inhibitors|mesh-ancestor
25162827|NCT02901977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516162|NCT00426283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25516166|NCT00426517|Sirolimus|sirolimus|mesh-list
25516167|NCT00426517|Busulfan|busulfan|mesh-list
25516168|NCT00426517|Alemtuzumab|alemtuzumab|mesh-list
25516169|NCT00426517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25516170|NCT00426517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25516171|NCT00426517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25516172|NCT00426517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516173|NCT00426517|Antifungal Agents|antifungal agents|mesh-ancestor
25516174|NCT00426517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25516175|NCT00426517|Immunologic Factors|immunologic factors|mesh-ancestor
25516176|NCT00426517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516177|NCT00426517|Alkylating Agents|alkylating agents|mesh-ancestor
25516178|NCT00426517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516179|NCT00426517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25516180|NCT00426517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25516181|NCT00426517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25516182|NCT00426556|Paclitaxel|paclitaxel|mesh-list
25516183|NCT00426556|Trastuzumab|trastuzumab|mesh-list
25516184|NCT00426556|Everolimus|everolimus|mesh-list
25516185|NCT00426556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25516186|NCT00426556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516187|NCT00426556|Tubulin Modulators|tubulin modulators|mesh-ancestor
25516188|NCT00426556|Antimitotic Agents|antimitotic agents|mesh-ancestor
25516189|NCT00426556|Mitosis Modulators|mitosis modulators|mesh-ancestor
25516190|NCT00426556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516191|NCT00426556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25516192|NCT00426556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25516193|NCT00426556|Immunologic Factors|immunologic factors|mesh-ancestor
25516194|NCT00426556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646315|NCT01457846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646316|NCT01457885|Busulfan|busulfan|mesh-list
25646317|NCT01457885|Clofarabine|clofarabine|mesh-list
25646318|NCT01457885|Alkylating Agents|alkylating agents|mesh-ancestor
25165104|NCT05051449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25646319|NCT01457885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646320|NCT01457885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25646321|NCT01457885|Immunologic Factors|immunologic factors|mesh-ancestor
25646322|NCT01457885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646323|NCT01457885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25646324|NCT01457885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516195|NCT00426660|Maraviroc|maraviroc|mesh-list
25516196|NCT00426660|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25516197|NCT00426660|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25516198|NCT00426660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516199|NCT00426660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25516200|NCT00426660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25516201|NCT00426660|Antiviral Agents|antiviral agents|mesh-ancestor
25516202|NCT00426660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25516203|NCT00426660|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25516204|NCT00426751|Abciximab|abciximab|mesh-list
25516205|NCT00426751|Eptifibatide|eptifibatide|mesh-list
25516206|NCT00426751|Anticoagulants|anticoagulants|mesh-ancestor
25516207|NCT00426751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25516208|NCT00426764|Romidepsin|romidepsin|mesh-list
25516209|NCT00426764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25516210|NCT00426764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516211|NCT00426842|Midodrine|midodrine|mesh-list
25516212|NCT00426842|Sympathomimetics|sympathomimetics|mesh-ancestor
25516213|NCT00426842|Autonomic Agents|autonomic agents|mesh-ancestor
25516214|NCT00426842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25516215|NCT00426842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516216|NCT00426842|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25516217|NCT00426842|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25516218|NCT00426842|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25516219|NCT00426842|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25516220|NCT00426842|Adrenergic Agents|adrenergic agents|mesh-ancestor
25516221|NCT00426842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25516222|NCT00426842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516223|NCT00426855|Bortezomib|bortezomib|mesh-list
25516224|NCT00426855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25516225|NCT00426855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516226|NCT00426855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25516227|NCT00426855|Alkylating Agents|alkylating agents|mesh-ancestor
25516228|NCT00426855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516229|NCT00427037|Vitamin D|vitamin d|mesh-list
25516230|NCT00427037|Cholecalciferol|cholecalciferol|mesh-list
25516231|NCT00427037|Vitamins|vitamins|mesh-ancestor
25516232|NCT00427037|Micronutrients|micronutrients|mesh-ancestor
25516233|NCT00427037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516234|NCT00427037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25516235|NCT00427037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25516236|NCT00427297|Ritonavir|ritonavir|mesh-list
25516237|NCT00427297|Lopinavir|lopinavir|mesh-list
25516238|NCT00427297|Tenofovir|tenofovir|mesh-list
25516239|NCT00427297|Lamivudine|lamivudine|mesh-list
25516240|NCT00427297|Zidovudine|zidovudine|mesh-list
25516241|NCT00427297|Nevirapine|nevirapine|mesh-list
25516242|NCT00427297|Abacavir|abacavir|mesh-list
25516243|NCT00427297|Stavudine|stavudine|mesh-list
25516245|NCT00427297|Efavirenz|efavirenz|mesh-list
25516246|NCT00427297|Dideoxynucleosides|dideoxynucleosides|mesh-list
25516247|NCT00427297|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25516248|NCT00427297|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25516249|NCT00427297|Protease Inhibitors|protease inhibitors|mesh-ancestor
25516250|NCT00427297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516251|NCT00427297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516252|NCT00427297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25516253|NCT00427297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25516254|NCT00427297|Antiviral Agents|antiviral agents|mesh-ancestor
25516255|NCT00427297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25516256|NCT00427297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25516257|NCT00427297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25516258|NCT00427297|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25516259|NCT00427297|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25516260|NCT00427297|Antimetabolites|antimetabolites|mesh-ancestor
25516261|NCT00427297|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25001395|NCT05342584|Antiviral Agents|antiviral agents|mesh-ancestor
25516262|NCT00427297|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25516263|NCT00427297|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25516264|NCT00427297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25516265|NCT00427297|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25516266|NCT00427336|Vidarabine|vidarabine|mesh-list
25516267|NCT00427336|Cyclophosphamide|cyclophosphamide|mesh-list
25516268|NCT00427336|Fludarabine|fludarabine|mesh-list
25516269|NCT00427336|Fludarabine phosphate|fludarabine phosphate|mesh-list
25646325|NCT01457885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25646326|NCT01457885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25646327|NCT01457885|Antimetabolites|antimetabolites|mesh-ancestor
25646328|NCT01457924|Ofatumumab|ofatumumab|mesh-list
25646329|NCT01457924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25646330|NCT01457924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646331|NCT01457924|Immunologic Factors|immunologic factors|mesh-ancestor
25646332|NCT01457924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516270|NCT00427336|Thymoglobulin|thymoglobulin|mesh-list
25516271|NCT00427336|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25516272|NCT00427336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25516273|NCT00427336|Immunologic Factors|immunologic factors|mesh-ancestor
25516274|NCT00427336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516275|NCT00427336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25516276|NCT00427336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25516277|NCT00427336|Alkylating Agents|alkylating agents|mesh-ancestor
25516278|NCT00427336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516279|NCT00427336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516280|NCT00427336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25516281|NCT00427336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25516282|NCT00427336|Antimetabolites|antimetabolites|mesh-ancestor
25516283|NCT00427336|Antiviral Agents|antiviral agents|mesh-ancestor
25516284|NCT00427336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25516285|NCT00427349|Octreotide|octreotide|mesh-list
25516286|NCT00427349|Motesanib diphosphate|motesanib diphosphate|mesh-list
25516287|NCT00427349|Imetelstat|imetelstat|mesh-list
25516288|NCT00427349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25516289|NCT00427349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25516290|NCT00427349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516291|NCT00427349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25516292|NCT00427349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516293|NCT00427349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516294|NCT00427557|Vidarabine|vidarabine|mesh-list
25516295|NCT00427557|Rituximab|rituximab|mesh-list
25516296|NCT00427557|Fludarabine|fludarabine|mesh-list
25516297|NCT00427557|Fludarabine phosphate|fludarabine phosphate|mesh-list
25516298|NCT00427557|Melphalan|melphalan|mesh-list
25516299|NCT00427557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25516300|NCT00427557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516301|NCT00427557|Immunologic Factors|immunologic factors|mesh-ancestor
25516302|NCT00427557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516303|NCT00427557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25516304|NCT00427557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25516305|NCT00427557|Antimetabolites|antimetabolites|mesh-ancestor
25516306|NCT00427557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516307|NCT00427557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25516308|NCT00427557|Antiviral Agents|antiviral agents|mesh-ancestor
25516309|NCT00427557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25516310|NCT00427557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25516311|NCT00427557|Alkylating Agents|alkylating agents|mesh-ancestor
25516312|NCT00427557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25516313|NCT00427635|Esomeprazole|esomeprazole|mesh-list
25516314|NCT00427635|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25516315|NCT00427635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25516316|NCT00427635|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25516317|NCT00427635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24986990|NCT04681417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25516318|NCT00427635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516319|NCT00427648|Lidocaine|lidocaine|mesh-list
25516320|NCT00427648|Anesthetics, Local|anesthetics, local|mesh-ancestor
25516321|NCT00427648|Anesthetics|anesthetics|mesh-ancestor
25516322|NCT00427648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25516323|NCT00427648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516324|NCT00427648|Sensory System Agents|sensory system agents|mesh-ancestor
25516325|NCT00427648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25516326|NCT00427648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25516327|NCT00427648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25646333|NCT01457950|Denosumab|denosumab|mesh-list
25516328|NCT00427648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25646334|NCT01457950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25646335|NCT01457950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646336|NCT01458106|Factor VIII|factor viii|mesh-list
25646337|NCT01458106|Coagulants|coagulants|mesh-ancestor
25646338|NCT01458171|Immunoglobulins|immunoglobulins|mesh-list
25646339|NCT01458171|Antibodies|antibodies|mesh-list
25646340|NCT01458171|gamma-Globulins|gamma-globulins|mesh-list
25646341|NCT01458171|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25646342|NCT01458171|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25646343|NCT01458171|Immunologic Factors|immunologic factors|mesh-ancestor
25646344|NCT01458171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646345|NCT01458210|Dulaglutide|dulaglutide|mesh-list
25646346|NCT01458210|Moxifloxacin|moxifloxacin|mesh-list
25646347|NCT01458210|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25516329|NCT00427648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25516330|NCT00427648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516331|NCT00427661|Cyclosporine|cyclosporine|mesh-list
25516332|NCT00427661|Fludarabine|fludarabine|mesh-list
25516333|NCT00427661|Busulfan|busulfan|mesh-list
25516334|NCT00427661|Cyclosporins|cyclosporins|mesh-list
25516335|NCT00427661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516336|NCT00427661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516337|NCT00427661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25516338|NCT00427661|Immunologic Factors|immunologic factors|mesh-ancestor
25516339|NCT00427661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516340|NCT00427661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516341|NCT00427661|Antifungal Agents|antifungal agents|mesh-ancestor
25516342|NCT00427661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25516343|NCT00427661|Dermatologic Agents|dermatologic agents|mesh-ancestor
25516344|NCT00427661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25516345|NCT00427661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25516346|NCT00427661|Alkylating Agents|alkylating agents|mesh-ancestor
25516347|NCT00427661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25516348|NCT00427661|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25516349|NCT00427700|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25516350|NCT00427700|Clomiphene|clomiphene|mesh-list
25516351|NCT00427700|Enclomiphene|enclomiphene|mesh-list
25516352|NCT00427700|Zuclomiphene|zuclomiphene|mesh-list
25516353|NCT00427700|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25516354|NCT00427700|Hormone Antagonists|hormone antagonists|mesh-ancestor
25516355|NCT00427700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25516356|NCT00427700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516357|NCT00427700|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25516358|NCT00427700|Fertility Agents|fertility agents|mesh-ancestor
25516359|NCT00427700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25516360|NCT00427700|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25516361|NCT00427700|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25516362|NCT00427700|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25516363|NCT00427765|Melphalan|melphalan|mesh-list
25516364|NCT00427765|Busulfan|busulfan|mesh-list
25516365|NCT00427765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25516366|NCT00427765|Alkylating Agents|alkylating agents|mesh-ancestor
25516367|NCT00427765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516368|NCT00427765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516369|NCT00427765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25516370|NCT00427765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25516371|NCT00427765|Immunologic Factors|immunologic factors|mesh-ancestor
25516372|NCT00427765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516373|NCT00427791|Rituximab|rituximab|mesh-list
25516374|NCT00427791|Etoposide|etoposide|mesh-list
25516375|NCT00427791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25516376|NCT00427791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516377|NCT00427791|Immunologic Factors|immunologic factors|mesh-ancestor
25516378|NCT00427791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516379|NCT00427791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25516380|NCT00427791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25516381|NCT00427791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25516382|NCT00427791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25516383|NCT00427791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516384|NCT00427791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516385|NCT00427804|Calcitriol|calcitriol|mesh-list
25516386|NCT00427804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24709213|NCT01504516|Donepezil|donepezil|mesh-list
25646348|NCT01458210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25516387|NCT00427804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516388|NCT00427804|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25516389|NCT00427804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24513758|NCT00584779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25516390|NCT00427804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516391|NCT00427804|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25646349|NCT01458210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516392|NCT00427804|Vitamins|vitamins|mesh-ancestor
25516393|NCT00427804|Micronutrients|micronutrients|mesh-ancestor
25646350|NCT01458210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25646351|NCT01458210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25646352|NCT01458210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25516394|NCT00427804|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25516395|NCT00427895|Vaccines|vaccines|mesh-list
25516396|NCT00427895|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25516397|NCT00427895|Immunologic Factors|immunologic factors|mesh-ancestor
25516398|NCT00427895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516399|NCT00427921|Adalimumab|adalimumab|mesh-list
25516400|NCT00427921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25516401|NCT00427921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25516402|NCT00427934|Maraviroc|maraviroc|mesh-list
25516403|NCT00427934|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25516404|NCT00427934|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25516405|NCT00427934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516406|NCT00427934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25646353|NCT01458210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25646354|NCT01458210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646355|NCT01458210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516407|NCT00427934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25516408|NCT00427934|Antiviral Agents|antiviral agents|mesh-ancestor
25516409|NCT00427934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25516410|NCT00427934|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25516411|NCT00427960|Atorvastatin|atorvastatin|mesh-list
25516412|NCT00427960|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25516413|NCT00427960|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25516414|NCT00427960|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25516415|NCT00427960|Antimetabolites|antimetabolites|mesh-ancestor
25516416|NCT00427960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516417|NCT00427960|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25516418|NCT00427960|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25516419|NCT00427960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516420|NCT00427973|Cediranib|cediranib|mesh-list
25516421|NCT00427973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516422|NCT00427973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516423|NCT00427973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516424|NCT00427973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25516425|NCT00427999|Pioglitazone|pioglitazone|mesh-list
25516426|NCT00427999|Dexamethasone|dexamethasone|mesh-list
25516427|NCT00427999|Dexamethasone acetate|dexamethasone acetate|mesh-list
25516428|NCT00427999|Etoricoxib|etoricoxib|mesh-list
25516429|NCT00427999|Imatinib Mesylate|imatinib mesylate|mesh-list
25516430|NCT00427999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25516431|NCT00427999|Antiemetics|antiemetics|mesh-ancestor
25516432|NCT00427999|Autonomic Agents|autonomic agents|mesh-ancestor
25516433|NCT00427999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25516434|NCT00427999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516435|NCT00427999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25516436|NCT00427999|Glucocorticoids|glucocorticoids|mesh-ancestor
25516437|NCT00427999|Hormones|hormones|mesh-ancestor
25516438|NCT00427999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25516439|NCT00427999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25516440|NCT00427999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516441|NCT00427999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25516442|NCT00427999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25516443|NCT00427999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516444|NCT00427999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516445|NCT00427999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25516446|NCT00427999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25516447|NCT00427999|Analgesics|analgesics|mesh-ancestor
25516448|NCT00427999|Sensory System Agents|sensory system agents|mesh-ancestor
25516449|NCT00427999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25516450|NCT00427999|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25516451|NCT00427999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25516452|NCT00428090|Rosiglitazone|rosiglitazone|mesh-list
25516453|NCT00428090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25516454|NCT00428090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516456|NCT00428220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577113|NCT00841945|Glucocorticoids|glucocorticoids|mesh-ancestor
25107061|NCT03142646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107062|NCT03142646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25107063|NCT03142646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25202924|NCT02717871|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25202925|NCT02717871|Prednisolone acetate|prednisolone acetate|mesh-list
25162863|NCT02901418|Immunoglobulins|immunoglobulins|mesh-list
25162864|NCT02901418|Immunologic Factors|immunologic factors|mesh-ancestor
25516457|NCT00428220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25516458|NCT00428220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25516459|NCT00428220|Growth Substances|growth substances|mesh-ancestor
25516460|NCT00428220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516461|NCT00428220|Growth Inhibitors|growth inhibitors|mesh-ancestor
25516462|NCT00428220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25516463|NCT00428220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516464|NCT00428220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516465|NCT00428298|Valacyclovir|valacyclovir|mesh-list
25516466|NCT00428298|Antiviral Agents|antiviral agents|mesh-ancestor
25516467|NCT00428298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25516468|NCT00428389|Rivastigmine|rivastigmine|mesh-list
25516469|NCT00428389|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25516470|NCT00428389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516471|NCT00428389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516472|NCT00428389|Cholinergic Agents|cholinergic agents|mesh-ancestor
25516473|NCT00428389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25516474|NCT00428389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516475|NCT00428389|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25516476|NCT00428389|Protective Agents|protective agents|mesh-ancestor
25516478|NCT00428441|Anticoagulants|anticoagulants|mesh-ancestor
25516479|NCT00428584|Interferons|interferons|mesh-list
25516480|NCT00428584|Interferon-beta|interferon-beta|mesh-list
25516481|NCT00428584|Interferon beta-1a|interferon beta-1a|mesh-list
25516482|NCT00428584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516483|NCT00428584|Antiviral Agents|antiviral agents|mesh-ancestor
25516484|NCT00428584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25516485|NCT00428584|Immunologic Factors|immunologic factors|mesh-ancestor
25516486|NCT00428584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516487|NCT00428584|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25516488|NCT00428597|Sunitinib|sunitinib|mesh-list
25516489|NCT00428597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516490|NCT00428597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25516491|NCT00428597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25516492|NCT00428597|Growth Substances|growth substances|mesh-ancestor
25516493|NCT00428597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516494|NCT00428597|Growth Inhibitors|growth inhibitors|mesh-ancestor
25516495|NCT00428597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25516496|NCT00428597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516497|NCT00428597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516498|NCT00428792|Methylphenidate|methylphenidate|mesh-list
25516499|NCT00428792|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25516500|NCT00428792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516501|NCT00428792|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25516502|NCT00428792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25516503|NCT00428792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25516504|NCT00428792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516505|NCT00428792|Dopamine Agents|dopamine agents|mesh-ancestor
25516506|NCT00428792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25516507|NCT00428844|Vancomycin|vancomycin|mesh-list
25516508|NCT00428844|Daptomycin|daptomycin|mesh-list
25516509|NCT00428844|Teicoplanin|teicoplanin|mesh-list
25516510|NCT00428844|Floxacillin|floxacillin|mesh-list
25516511|NCT00428844|Oxacillin|oxacillin|mesh-list
25516512|NCT00428844|Nafcillin|nafcillin|mesh-list
25516513|NCT00428844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25516514|NCT00428844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25516515|NCT00428922|Bevacizumab|bevacizumab|mesh-list
25516516|NCT00428922|Trastuzumab|trastuzumab|mesh-list
25516517|NCT00428922|Docetaxel|docetaxel|mesh-list
25516518|NCT00428922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25516519|NCT00428922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516520|NCT00428922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25516521|NCT00428922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25516522|NCT00428922|Growth Substances|growth substances|mesh-ancestor
25516523|NCT00428922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516524|NCT00428922|Growth Inhibitors|growth inhibitors|mesh-ancestor
25516525|NCT00428922|Tubulin Modulators|tubulin modulators|mesh-ancestor
25516526|NCT00428922|Antimitotic Agents|antimitotic agents|mesh-ancestor
24987213|NCT03467360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987214|NCT03467360|Anticonvulsants|anticonvulsants|mesh-ancestor
24987216|NCT03467360|Diuretics|diuretics|mesh-ancestor
24987252|NCT03412799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24987253|NCT03412799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987254|NCT03412799|Tubulin Modulators|tubulin modulators|mesh-ancestor
25516527|NCT00428922|Mitosis Modulators|mitosis modulators|mesh-ancestor
25516528|NCT00428922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516529|NCT00428948|Tolvaptan|tolvaptan|mesh-list
25516530|NCT00428948|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25516531|NCT00428948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516532|NCT00428948|Natriuretic Agents|natriuretic agents|mesh-ancestor
25516533|NCT00428948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516534|NCT00429104|Trastuzumab|trastuzumab|mesh-list
25646356|NCT01458210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646357|NCT01458210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25646358|NCT01458210|Contraceptive Agents|contraceptive agents|mesh-ancestor
25516535|NCT00429104|Sargramostim|sargramostim|mesh-list
25516536|NCT00429104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25516537|NCT00429104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516538|NCT00429104|Immunologic Factors|immunologic factors|mesh-ancestor
25516539|NCT00429104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516540|NCT00429143|Mycophenolic Acid|mycophenolic acid|mesh-list
25516541|NCT00429143|Cyclophosphamide|cyclophosphamide|mesh-list
25516542|NCT00429143|Tacrolimus|tacrolimus|mesh-list
25516543|NCT00429143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25516544|NCT00429143|Immunologic Factors|immunologic factors|mesh-ancestor
25516545|NCT00429143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516546|NCT00429143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25646359|NCT01458210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25646360|NCT01458210|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25646361|NCT01458210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25646362|NCT01458210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25646363|NCT01458275|Ciclesonide|ciclesonide|mesh-list
25646364|NCT01458275|Glucocorticoids|glucocorticoids|mesh-ancestor
25646365|NCT01458275|Hormones|hormones|mesh-ancestor
25646366|NCT01458275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25646367|NCT01458275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646368|NCT01458275|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25646369|NCT01458418|Montelukast|montelukast|mesh-list
25646370|NCT01458418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25516547|NCT00429143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25516548|NCT00429143|Alkylating Agents|alkylating agents|mesh-ancestor
25516549|NCT00429143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516550|NCT00429143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516551|NCT00429143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25516552|NCT00429143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25516553|NCT00429143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516554|NCT00429143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25516555|NCT00429143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25516556|NCT00429143|Antitubercular Agents|antitubercular agents|mesh-ancestor
25516557|NCT00429143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25516558|NCT00429143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25516559|NCT00429169|Bupropion|bupropion|mesh-list
25516560|NCT00429169|Paroxetine|paroxetine|mesh-list
25516561|NCT00429169|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25516562|NCT00429169|Antidepressive Agents|antidepressive agents|mesh-ancestor
25516563|NCT00429169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25516564|NCT00429169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25516565|NCT00429169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25516566|NCT00429169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25516567|NCT00429169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516568|NCT00429169|Dopamine Agents|dopamine agents|mesh-ancestor
25516569|NCT00429169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25516570|NCT00429169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516571|NCT00429169|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24644795|NCT01193166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25646371|NCT01458418|Respiratory System Agents|respiratory system agents|mesh-ancestor
25646372|NCT01458418|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25646373|NCT01458418|Hormone Antagonists|hormone antagonists|mesh-ancestor
25516572|NCT00429169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25516573|NCT00429169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516574|NCT00429169|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25516575|NCT00429169|Serotonin Agents|serotonin agents|mesh-ancestor
25516576|NCT00429182|Cyclophosphamide|cyclophosphamide|mesh-list
25516577|NCT00429182|Thiotepa|thiotepa|mesh-list
25516578|NCT00429182|Carboplatin|carboplatin|mesh-list
25516579|NCT00429182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25516580|NCT00429182|Immunologic Factors|immunologic factors|mesh-ancestor
25516581|NCT00429182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516582|NCT00429182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25516583|NCT00429182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25516584|NCT00429182|Alkylating Agents|alkylating agents|mesh-ancestor
25516585|NCT00429182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516586|NCT00429182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516587|NCT00429182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25516588|NCT00429273|Guanfacine|guanfacine|mesh-list
25516589|NCT00429273|Methylphenidate|methylphenidate|mesh-list
25516590|NCT00429273|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
25516591|NCT00429273|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25646374|NCT01458418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25516592|NCT00429273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516593|NCT00429273|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25516594|NCT00429273|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25516595|NCT00429273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25516596|NCT00429273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516597|NCT00429273|Dopamine Agents|dopamine agents|mesh-ancestor
25516598|NCT00429273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25516599|NCT00429273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25516600|NCT00429273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25516601|NCT00429273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25516602|NCT00429273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25646375|NCT01458418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646376|NCT01458418|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25646377|NCT01458418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25646378|NCT01458418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646379|NCT01458522|Lacosamide|lacosamide|mesh-list
25646380|NCT01458522|Fosphenytoin|fosphenytoin|mesh-list
25646381|NCT01458522|Anticonvulsants|anticonvulsants|mesh-ancestor
25646382|NCT01458522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25646383|NCT01458522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25646384|NCT01458522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25646385|NCT01458522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646386|NCT01458535|Ritonavir|ritonavir|mesh-list
25646387|NCT01458535|Ribavirin|ribavirin|mesh-list
25646388|NCT01458535|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25646389|NCT01458535|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25516603|NCT00429273|Adrenergic Agents|adrenergic agents|mesh-ancestor
25516604|NCT00429299|Paclitaxel|paclitaxel|mesh-list
25516605|NCT00429299|Cyclophosphamide|cyclophosphamide|mesh-list
25516606|NCT00429299|Fluorouracil|fluorouracil|mesh-list
25516607|NCT00429299|Trastuzumab|trastuzumab|mesh-list
25516608|NCT00429299|Lapatinib|lapatinib|mesh-list
25516609|NCT00429299|Epirubicin|epirubicin|mesh-list
25516610|NCT00429299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25516611|NCT00429299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516612|NCT00429299|Tubulin Modulators|tubulin modulators|mesh-ancestor
25516613|NCT00429299|Antimitotic Agents|antimitotic agents|mesh-ancestor
25516614|NCT00429299|Mitosis Modulators|mitosis modulators|mesh-ancestor
25516615|NCT00429299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516616|NCT00429299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25516617|NCT00429299|Immunologic Factors|immunologic factors|mesh-ancestor
25516618|NCT00429299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516619|NCT00429299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25516620|NCT00429299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25516621|NCT00429299|Alkylating Agents|alkylating agents|mesh-ancestor
25516622|NCT00429299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25516623|NCT00429299|Antimetabolites|antimetabolites|mesh-ancestor
25516624|NCT00429299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25516625|NCT00429299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25516626|NCT00429299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25516627|NCT00429299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516628|NCT00429299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25516629|NCT00429299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25516630|NCT00429299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25516631|NCT00429364|Losartan|losartan|mesh-list
25516632|NCT00429364|Atenolol|atenolol|mesh-list
25516633|NCT00429364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25516634|NCT00429364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25516635|NCT00429364|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25516636|NCT00429364|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25516637|NCT00429364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516638|NCT00429364|Sympatholytics|sympatholytics|mesh-ancestor
25516639|NCT00429364|Autonomic Agents|autonomic agents|mesh-ancestor
25516640|NCT00429364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25516641|NCT00429364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516642|NCT00429364|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25516643|NCT00429364|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25516644|NCT00429364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25516645|NCT00429364|Adrenergic Agents|adrenergic agents|mesh-ancestor
25516646|NCT00429364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25823374|NCT00004810|Antitubercular Agents|antitubercular agents|mesh-ancestor
25516647|NCT00429403|Goserelin|goserelin|mesh-list
25516648|NCT00429403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25516649|NCT00429403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516650|NCT00429416|Cytarabine|cytarabine|mesh-list
25516651|NCT00429416|Cyclophosphamide|cyclophosphamide|mesh-list
25516652|NCT00429416|Fludarabine|fludarabine|mesh-list
25516653|NCT00429416|Fludarabine phosphate|fludarabine phosphate|mesh-list
25516654|NCT00429416|Molgramostim|molgramostim|mesh-list
25516655|NCT00429416|Tacrolimus|tacrolimus|mesh-list
25516656|NCT00429416|Sargramostim|sargramostim|mesh-list
25516657|NCT00429416|Mesna|mesna|mesh-list
25516658|NCT00429416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25516659|NCT00429416|Immunologic Factors|immunologic factors|mesh-ancestor
25646390|NCT01458535|Protease Inhibitors|protease inhibitors|mesh-ancestor
25646391|NCT01458535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646392|NCT01458535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516660|NCT00429416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646393|NCT01458535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25646394|NCT01458535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25646395|NCT01458535|Antiviral Agents|antiviral agents|mesh-ancestor
25646396|NCT01458535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25646397|NCT01458535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25646398|NCT01458535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25646399|NCT01458535|Antimetabolites|antimetabolites|mesh-ancestor
25646400|NCT01458561|Thrombin|thrombin|mesh-list
25646401|NCT01458561|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
25646402|NCT01458561|Hemostatics|hemostatics|mesh-ancestor
25646403|NCT01458561|Coagulants|coagulants|mesh-ancestor
25646404|NCT01458574|Tofacitinib|tofacitinib|mesh-list
25646405|NCT01458574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25646406|NCT01458574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646407|NCT01458574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646408|NCT01458587|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25516661|NCT00429416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25516662|NCT00429416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25516663|NCT00429416|Alkylating Agents|alkylating agents|mesh-ancestor
25516664|NCT00429416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516665|NCT00429416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516666|NCT00429416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25516667|NCT00429416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25516668|NCT00429416|Antimetabolites|antimetabolites|mesh-ancestor
25516669|NCT00429416|Antiviral Agents|antiviral agents|mesh-ancestor
25516670|NCT00429416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25516671|NCT00429416|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25516672|NCT00429416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516673|NCT00429416|Protective Agents|protective agents|mesh-ancestor
25516674|NCT00429494|Leuprolide|leuprolide|mesh-list
25516675|NCT00429494|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25516676|NCT00429494|Fertility Agents|fertility agents|mesh-ancestor
25516677|NCT00429494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25516678|NCT00429494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401738|NCT00153933|Lenalidomide|lenalidomide|mesh-list
25516679|NCT00429494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25202671|NCT02719834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25516680|NCT00429494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25049197|NCT00630201|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25646409|NCT01458587|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25646410|NCT01458587|Dermatologic Agents|dermatologic agents|mesh-ancestor
25646411|NCT01458639|Xenon|xenon|mesh-list
25516681|NCT00429507|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
25516682|NCT00429507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25516683|NCT00429507|Analgesics|analgesics|mesh-ancestor
25516684|NCT00429507|Sensory System Agents|sensory system agents|mesh-ancestor
25516685|NCT00429507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25516686|NCT00429507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516687|NCT00429572|Fludarabine|fludarabine|mesh-list
25516688|NCT00429572|Melphalan|melphalan|mesh-list
25516689|NCT00429572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516690|NCT00429572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516691|NCT00429572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25516692|NCT00429572|Immunologic Factors|immunologic factors|mesh-ancestor
25516693|NCT00429572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516694|NCT00429572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25516695|NCT00429572|Alkylating Agents|alkylating agents|mesh-ancestor
25516696|NCT00429572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25516697|NCT00429702|Diphenhydramine|diphenhydramine|mesh-list
25516698|NCT00429702|Promethazine|promethazine|mesh-list
25516699|NCT00429702|Dexamethasone|dexamethasone|mesh-list
25516700|NCT00429702|Lorazepam|lorazepam|mesh-list
25516701|NCT00429702|Ondansetron|ondansetron|mesh-list
25516702|NCT00429702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25516703|NCT00429702|Antiemetics|antiemetics|mesh-ancestor
25516704|NCT00429702|Autonomic Agents|autonomic agents|mesh-ancestor
25516705|NCT00429702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25516706|NCT00429702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516707|NCT00429702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25516708|NCT00429702|Glucocorticoids|glucocorticoids|mesh-ancestor
25516709|NCT00429702|Hormones|hormones|mesh-ancestor
25516710|NCT00429702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25516711|NCT00429702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25516712|NCT00429702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516713|NCT00429702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516714|NCT00429702|Antipruritics|antipruritics|mesh-ancestor
25516715|NCT00429702|Dermatologic Agents|dermatologic agents|mesh-ancestor
25516716|NCT00429702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25516717|NCT00429702|Serotonin Agents|serotonin agents|mesh-ancestor
25516718|NCT00429702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25516719|NCT00429702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25516720|NCT00429702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25516721|NCT00429702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25516722|NCT00429702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25516723|NCT00429702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25516724|NCT00429702|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25516725|NCT00429702|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25516726|NCT00429702|Anesthetics, Local|anesthetics, local|mesh-ancestor
25516727|NCT00429702|Anesthetics|anesthetics|mesh-ancestor
25516728|NCT00429702|Sensory System Agents|sensory system agents|mesh-ancestor
25516729|NCT00429702|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25516730|NCT00429702|Histamine Antagonists|histamine antagonists|mesh-ancestor
25516731|NCT00429702|Histamine Agents|histamine agents|mesh-ancestor
25516732|NCT00429702|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25516733|NCT00429702|Anticonvulsants|anticonvulsants|mesh-ancestor
25516734|NCT00429702|GABA Modulators|gaba modulators|mesh-ancestor
25516735|NCT00429702|GABA Agents|gaba agents|mesh-ancestor
25516736|NCT00429793|Sirolimus|sirolimus|mesh-list
25516737|NCT00429793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25516738|NCT00429793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25516739|NCT00429793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25516740|NCT00429793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516741|NCT00429793|Antifungal Agents|antifungal agents|mesh-ancestor
25516742|NCT00429793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25516743|NCT00429793|Immunologic Factors|immunologic factors|mesh-ancestor
25516744|NCT00429793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514471|NCT00590785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514472|NCT00590785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24514473|NCT00590785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24514474|NCT00590785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24514475|NCT00590785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24514476|NCT00590785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24514477|NCT00590785|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25516745|NCT00429949|Dasatinib|dasatinib|mesh-list
25516746|NCT00429949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516752|NCT00430183|Goserelin|goserelin|mesh-list
25516753|NCT00430183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646413|NCT01458639|Anesthetics, General|anesthetics, general|mesh-ancestor
25646414|NCT01458639|Anesthetics|anesthetics|mesh-ancestor
25646415|NCT01458639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25646416|NCT01458639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646417|NCT01458951|Tofacitinib|tofacitinib|mesh-list
25646418|NCT01458951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25646419|NCT01458951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646420|NCT01458951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646421|NCT01458990|Omeprazole|omeprazole|mesh-list
25646422|NCT01458990|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25646423|NCT01458990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25646424|NCT01458990|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25646425|NCT01458990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823375|NCT00004810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25516754|NCT00430183|Tubulin Modulators|tubulin modulators|mesh-ancestor
25516755|NCT00430183|Antimitotic Agents|antimitotic agents|mesh-ancestor
25516756|NCT00430183|Mitosis Modulators|mitosis modulators|mesh-ancestor
25516757|NCT00430183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516758|NCT00430183|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25516759|NCT00430183|Fertility Agents|fertility agents|mesh-ancestor
25516760|NCT00430183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25516761|NCT00430183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516762|NCT00430183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25516763|NCT00430248|Allopurinol|allopurinol|mesh-list
25516764|NCT00430248|Febuxostat|febuxostat|mesh-list
25516765|NCT00430248|Antimetabolites|antimetabolites|mesh-ancestor
25516766|NCT00430248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516767|NCT00430248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516768|NCT00430248|Gout Suppressants|gout suppressants|mesh-ancestor
25516769|NCT00430248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25516770|NCT00430248|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25516771|NCT00430248|Antioxidants|antioxidants|mesh-ancestor
25516772|NCT00430248|Protective Agents|protective agents|mesh-ancestor
25516773|NCT00430248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516774|NCT00430352|Rituximab|rituximab|mesh-list
25516775|NCT00430352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25516776|NCT00430352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516777|NCT00430352|Immunologic Factors|immunologic factors|mesh-ancestor
25516778|NCT00430352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516779|NCT00430352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25516780|NCT00430521|Vaccines|vaccines|mesh-list
25516781|NCT00430521|Immunologic Factors|immunologic factors|mesh-ancestor
25516782|NCT00430521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516783|NCT00430573|Cycloserine|cycloserine|mesh-list
25516784|NCT00430573|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25516785|NCT00430573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25516786|NCT00430573|Renal Agents|renal agents|mesh-ancestor
25516787|NCT00430573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25516788|NCT00430573|Antitubercular Agents|antitubercular agents|mesh-ancestor
25516789|NCT00430573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25516790|NCT00430573|Antimetabolites|antimetabolites|mesh-ancestor
25516791|NCT00430573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516792|NCT00430638|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25516793|NCT00430638|Olmesartan|olmesartan|mesh-list
25516794|NCT00430638|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25516795|NCT00430638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25516796|NCT00430638|Diuretics|diuretics|mesh-ancestor
25516797|NCT00430638|Natriuretic Agents|natriuretic agents|mesh-ancestor
25516798|NCT00430638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516799|NCT00430638|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25516800|NCT00430638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25516801|NCT00430638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516802|NCT00430638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25516803|NCT00430638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25516804|NCT00430677|Mycophenolic Acid|mycophenolic acid|mesh-list
25516805|NCT00430677|Prednisone|prednisone|mesh-list
25516806|NCT00430677|Prednisolone|prednisolone|mesh-list
25516807|NCT00430677|Abatacept|abatacept|mesh-list
25823376|NCT00004810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25823377|NCT00004811|Itraconazole|itraconazole|mesh-list
25823378|NCT00004811|Antifungal Agents|antifungal agents|mesh-ancestor
25823379|NCT00004811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25823380|NCT00004811|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24645023|NCT01194843|Ropivacaine|ropivacaine|mesh-list
25823381|NCT00004811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25823382|NCT00004811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516808|NCT00430677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25516809|NCT00430677|Glucocorticoids|glucocorticoids|mesh-ancestor
25516810|NCT00430677|Hormones|hormones|mesh-ancestor
25516811|NCT00430677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25516812|NCT00430677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516813|NCT00430677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25646426|NCT01458990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646427|NCT01459588|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25646428|NCT01459588|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25646429|NCT01459588|Lubricant Eye Drops|lubricant eye drops|mesh-list
25516814|NCT00430677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516815|NCT00430677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25516816|NCT00430677|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25516817|NCT00430677|Antitubercular Agents|antitubercular agents|mesh-ancestor
25516818|NCT00430677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25516819|NCT00430677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25516820|NCT00430677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646430|NCT01459588|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25646431|NCT01459588|Laxatives|laxatives|mesh-ancestor
25646432|NCT01459588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25646433|NCT01459614|Gemcitabine|gemcitabine|mesh-list
25646434|NCT01459614|Cisplatin|cisplatin|mesh-list
25516821|NCT00430677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516822|NCT00430677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25516823|NCT00430677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25516824|NCT00430677|Immunologic Factors|immunologic factors|mesh-ancestor
25516825|NCT00430677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25516826|NCT00430716|Sildenafil Citrate|sildenafil citrate|mesh-list
25516827|NCT00430716|Citric Acid|citric acid|mesh-list
25516828|NCT00430716|Sodium Citrate|sodium citrate|mesh-list
25516829|NCT00430716|Anticoagulants|anticoagulants|mesh-ancestor
25516830|NCT00430716|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25516831|NCT00430716|Chelating Agents|chelating agents|mesh-ancestor
25516832|NCT00430716|Sequestering Agents|sequestering agents|mesh-ancestor
25516833|NCT00430716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516834|NCT00430716|Vasodilator Agents|vasodilator agents|mesh-ancestor
25516835|NCT00430716|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25516836|NCT00430716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25516837|NCT00430716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516838|NCT00430716|Urological Agents|urological agents|mesh-ancestor
25516839|NCT00430781|Lapatinib|lapatinib|mesh-list
25516840|NCT00430781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516841|NCT00430781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25516842|NCT00430781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516843|NCT00430781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516844|NCT00430937|Vancomycin|vancomycin|mesh-list
25516845|NCT00430937|Daptomycin|daptomycin|mesh-list
25516846|NCT00430937|Teicoplanin|teicoplanin|mesh-list
25516847|NCT00430937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25516848|NCT00430937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25516849|NCT00430989|Nitrous Oxide|nitrous oxide|mesh-list
25516850|NCT00430989|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25516851|NCT00430989|Anesthetics, General|anesthetics, general|mesh-ancestor
25516852|NCT00430989|Anesthetics|anesthetics|mesh-ancestor
25516853|NCT00430989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25516854|NCT00430989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516855|NCT00430989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25516856|NCT00430989|Analgesics|analgesics|mesh-ancestor
25516857|NCT00430989|Sensory System Agents|sensory system agents|mesh-ancestor
25516858|NCT00430989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25516859|NCT00431041|Solifenacin Succinate|solifenacin succinate|mesh-list
25516860|NCT00431041|Oxybutynin|oxybutynin|mesh-list
25516861|NCT00431041|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25516862|NCT00431041|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25516863|NCT00431041|Cholinergic Agents|cholinergic agents|mesh-ancestor
25516864|NCT00431041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25516865|NCT00431041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516866|NCT00431041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516867|NCT00431041|Urological Agents|urological agents|mesh-ancestor
25516868|NCT00431041|Parasympatholytics|parasympatholytics|mesh-ancestor
25516869|NCT00431041|Autonomic Agents|autonomic agents|mesh-ancestor
25516870|NCT00431041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25516871|NCT00431067|Afatinib|afatinib|mesh-list
25516872|NCT00431067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646436|NCT01459614|Capecitabine|capecitabine|mesh-list
25646437|NCT01459614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646438|NCT01459614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25646439|NCT01459614|Antimetabolites|antimetabolites|mesh-ancestor
25646440|NCT01459614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646441|NCT01459614|Antiviral Agents|antiviral agents|mesh-ancestor
25516873|NCT00431067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25516874|NCT00431067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516875|NCT00431067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516876|NCT00431132|Estradiol|estradiol|mesh-list
25516877|NCT00431132|Estrogens|estrogens|mesh-ancestor
25516878|NCT00431132|Hormones|hormones|mesh-ancestor
25516879|NCT00431132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25516880|NCT00431132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516881|NCT00431184|Pentazocine|pentazocine|mesh-list
25516882|NCT00431184|Lorazepam|lorazepam|mesh-list
25516883|NCT00431184|Anticonvulsants|anticonvulsants|mesh-ancestor
25516884|NCT00431184|Antiemetics|antiemetics|mesh-ancestor
25516885|NCT00431184|Autonomic Agents|autonomic agents|mesh-ancestor
25516886|NCT00431184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25516887|NCT00431184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516888|NCT00431184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25516889|NCT00431184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25516890|NCT00431184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25516891|NCT00431184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25516892|NCT00431184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25516893|NCT00431184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25516894|NCT00431184|GABA Modulators|gaba modulators|mesh-ancestor
25516895|NCT00431184|GABA Agents|gaba agents|mesh-ancestor
25516896|NCT00431184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25516897|NCT00431184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516898|NCT00431184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25516899|NCT00431184|Narcotics|narcotics|mesh-ancestor
25516900|NCT00431184|Analgesics|analgesics|mesh-ancestor
25516901|NCT00431184|Sensory System Agents|sensory system agents|mesh-ancestor
25516902|NCT00431184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25516903|NCT00431184|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25516904|NCT00431444|Zoledronic Acid|zoledronic acid|mesh-list
25516905|NCT00431444|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25516906|NCT00431444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25516907|NCT00431444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516908|NCT00431444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25516909|NCT00431444|Hormone Antagonists|hormone antagonists|mesh-ancestor
25516910|NCT00431444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25516911|NCT00431444|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25516912|NCT00431444|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25516913|NCT00431496|Cinacalcet|cinacalcet|mesh-list
25516914|NCT00431496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25516915|NCT00431496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516916|NCT00431496|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25516917|NCT00431496|Hormone Antagonists|hormone antagonists|mesh-ancestor
25516918|NCT00431496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25516919|NCT00431626|Dutasteride|dutasteride|mesh-list
25516920|NCT00431626|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25516921|NCT00431626|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25516922|NCT00431626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516923|NCT00431626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516924|NCT00431626|Hormone Antagonists|hormone antagonists|mesh-ancestor
25516925|NCT00431626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25516926|NCT00431626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516927|NCT00431847|Anesthetics|anesthetics|mesh-list
25516928|NCT00431847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25516929|NCT00431847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516930|NCT00431964|Azithromycin|azithromycin|mesh-list
25516931|NCT00431964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25516932|NCT00431964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25516933|NCT00432172|Cyclophosphamide|cyclophosphamide|mesh-list
25516934|NCT00432172|Carboplatin|carboplatin|mesh-list
25516935|NCT00432172|Docetaxel|docetaxel|mesh-list
25516936|NCT00432172|Epirubicin|epirubicin|mesh-list
25516937|NCT00432172|Exemestane|exemestane|mesh-list
25516938|NCT00432172|Goserelin|goserelin|mesh-list
25646442|NCT01459614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24645239|NCT01196767|Anesthetics|anesthetics|mesh-ancestor
25646443|NCT01459614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646444|NCT01459614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25646445|NCT01459614|Immunologic Factors|immunologic factors|mesh-ancestor
25646446|NCT01459614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646447|NCT01459614|Tubulin Modulators|tubulin modulators|mesh-ancestor
25516939|NCT00432172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25516940|NCT00432172|Immunologic Factors|immunologic factors|mesh-ancestor
25516941|NCT00432172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516942|NCT00432172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25516943|NCT00432172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25516944|NCT00432172|Alkylating Agents|alkylating agents|mesh-ancestor
25516945|NCT00432172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516946|NCT00432172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516947|NCT00432172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25516948|NCT00432172|Tubulin Modulators|tubulin modulators|mesh-ancestor
25516949|NCT00432172|Antimitotic Agents|antimitotic agents|mesh-ancestor
25516950|NCT00432172|Mitosis Modulators|mitosis modulators|mesh-ancestor
25516951|NCT00432172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25516952|NCT00432172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25516953|NCT00432172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25516954|NCT00432172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25516955|NCT00432172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24515167|NCT00595140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24515168|NCT00595140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515170|NCT00595140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25516972|NCT00432276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516973|NCT00432341|Botulinum Toxins|botulinum toxins|mesh-list
25516974|NCT00432341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25516975|NCT00432341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25516976|NCT00432341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25516977|NCT00432341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25516978|NCT00432341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25516979|NCT00432341|Cholinergic Agents|cholinergic agents|mesh-ancestor
25516980|NCT00432341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25516981|NCT00432341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516982|NCT00432341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25516983|NCT00432341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25516984|NCT00432458|Zoledronic Acid|zoledronic acid|mesh-list
25516986|NCT00432458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25516987|NCT00432458|Immunologic Factors|immunologic factors|mesh-ancestor
25516988|NCT00432458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25516989|NCT00432458|Leprostatic Agents|leprostatic agents|mesh-ancestor
25516990|NCT00432458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25516991|NCT00432458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25516992|NCT00432458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25516993|NCT00432458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25516994|NCT00432458|Growth Substances|growth substances|mesh-ancestor
25516995|NCT00432458|Growth Inhibitors|growth inhibitors|mesh-ancestor
25516996|NCT00432458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25516997|NCT00432458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25516998|NCT00432562|Vinorelbine|vinorelbine|mesh-list
25516999|NCT00432562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25517000|NCT00432562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517001|NCT00432562|Tubulin Modulators|tubulin modulators|mesh-ancestor
25517002|NCT00432562|Antimitotic Agents|antimitotic agents|mesh-ancestor
25517003|NCT00432562|Mitosis Modulators|mitosis modulators|mesh-ancestor
25517004|NCT00432562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515264|NCT00596115|Antioxidants|antioxidants|mesh-ancestor
24515265|NCT00596115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515350|NCT00596375|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24987668|NCT05189769|Levonorgestrel|levonorgestrel|mesh-list
24987669|NCT05189769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24987670|NCT05189769|Contraceptive Agents|contraceptive agents|mesh-ancestor
24987671|NCT05189769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24987672|NCT05189769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517005|NCT00432666|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25517006|NCT00432666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25517007|NCT00432666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25517008|NCT00432666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517009|NCT00432666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25517010|NCT00432666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25646449|NCT01459614|Mitosis Modulators|mitosis modulators|mesh-ancestor
25656836|NCT01579513|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25656837|NCT01579513|Prednisolone phosphate|prednisolone phosphate|mesh-list
25656838|NCT01579513|Glucocorticoids|glucocorticoids|mesh-list
25656839|NCT01579513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25656840|NCT01579513|Antiemetics|antiemetics|mesh-ancestor
25656841|NCT01579513|Autonomic Agents|autonomic agents|mesh-ancestor
25656842|NCT01579513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25517011|NCT00432666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517012|NCT00432666|Cholinergic Agents|cholinergic agents|mesh-ancestor
25517013|NCT00432666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25517014|NCT00432679|Rosiglitazone|rosiglitazone|mesh-list
25517015|NCT00432679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25517016|NCT00432679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517017|NCT00432991|Ephedrine|ephedrine|mesh-list
25517018|NCT00432991|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25517019|NCT00432991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517020|NCT00432991|Sympathomimetics|sympathomimetics|mesh-ancestor
25517021|NCT00432991|Autonomic Agents|autonomic agents|mesh-ancestor
25517022|NCT00432991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25517023|NCT00432991|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25517024|NCT00432991|Adrenergic Agents|adrenergic agents|mesh-ancestor
25517025|NCT00432991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25517026|NCT00432991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517027|NCT00433004|Levonorgestrel|levonorgestrel|mesh-list
25517028|NCT00433004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25517029|NCT00433004|Contraceptive Agents|contraceptive agents|mesh-ancestor
25517030|NCT00433004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25517031|NCT00433004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517032|NCT00433004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25517033|NCT00433004|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25517034|NCT00433004|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25517035|NCT00433017|Ranibizumab|ranibizumab|mesh-list
25517036|NCT00433017|Verteporfin|verteporfin|mesh-list
25517037|NCT00433017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25517038|NCT00433017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25517039|NCT00433017|Growth Substances|growth substances|mesh-ancestor
25517040|NCT00433017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517041|NCT00433017|Growth Inhibitors|growth inhibitors|mesh-ancestor
25517042|NCT00433017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517043|NCT00433017|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25517044|NCT00433017|Dermatologic Agents|dermatologic agents|mesh-ancestor
25517045|NCT00433160|Teriparatide|teriparatide|mesh-list
25517046|NCT00433160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25517047|NCT00433160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517048|NCT00433160|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25517049|NCT00433199|Testosterone|testosterone|mesh-list
25517050|NCT00433199|Androgens|androgens|mesh-ancestor
25517051|NCT00433199|Hormones|hormones|mesh-ancestor
25517052|NCT00433199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25517053|NCT00433199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517054|NCT00433290|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25517055|NCT00433290|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25517056|NCT00433290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25517057|NCT00433290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25517058|NCT00433290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517059|NCT00433290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25517060|NCT00433290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517061|NCT00433290|Analgesics|analgesics|mesh-ancestor
25517062|NCT00433290|Sensory System Agents|sensory system agents|mesh-ancestor
25517063|NCT00433290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25517064|NCT00433290|Antidepressive Agents|antidepressive agents|mesh-ancestor
25517065|NCT00433290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25517066|NCT00433290|Dopamine Agents|dopamine agents|mesh-ancestor
25517067|NCT00433329|Bosentan|bosentan|mesh-list
25517068|NCT00433329|Sildenafil Citrate|sildenafil citrate|mesh-list
25517069|NCT00433329|Vasodilator Agents|vasodilator agents|mesh-ancestor
25517070|NCT00433329|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25517071|NCT00433329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25517072|NCT00433329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517073|NCT00433329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517074|NCT00433329|Urological Agents|urological agents|mesh-ancestor
25107178|NCT03141970|Prednisone|prednisone|mesh-list
24515480|NCT00597623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24515481|NCT00597662|Icodextrin|icodextrin|mesh-list
25136401|NCT02990975|Ketamine|ketamine|mesh-list
25646450|NCT01459718|Deferasirox|deferasirox|mesh-list
25646451|NCT01459718|Deferoxamine|deferoxamine|mesh-list
25646452|NCT01459718|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25646453|NCT01459718|Chelating Agents|chelating agents|mesh-ancestor
25646454|NCT01459718|Sequestering Agents|sequestering agents|mesh-ancestor
25646455|NCT01459718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646456|NCT01459718|Siderophores|siderophores|mesh-ancestor
25646457|NCT01459796|Rilonacept|rilonacept|mesh-list
25517075|NCT00433329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25517076|NCT00433329|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25517077|NCT00433381|Bevacizumab|bevacizumab|mesh-list
25517078|NCT00433381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25517079|NCT00433381|Irinotecan|irinotecan|mesh-list
25517080|NCT00433381|Temozolomide|temozolomide|mesh-list
25517081|NCT00433381|Camptothecin|camptothecin|mesh-list
25517082|NCT00433381|Endothelial Growth Factors|endothelial growth factors|mesh-list
25517083|NCT00433381|Antibodies|antibodies|mesh-list
25517084|NCT00433381|Immunoglobulins|immunoglobulins|mesh-list
25517085|NCT00433381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25517086|NCT00433381|Immunoglobulin G|immunoglobulin g|mesh-list
25517087|NCT00433381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517088|NCT00433381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25517089|NCT00433381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25517090|NCT00433381|Growth Substances|growth substances|mesh-ancestor
25517091|NCT00433381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517092|NCT00433381|Growth Inhibitors|growth inhibitors|mesh-ancestor
25517093|NCT00433381|Immunologic Factors|immunologic factors|mesh-ancestor
25517094|NCT00433381|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25517095|NCT00433381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25517096|NCT00433381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517097|NCT00433381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517098|NCT00433381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25517099|NCT00433381|Alkylating Agents|alkylating agents|mesh-ancestor
25517100|NCT00433381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25517101|NCT00433446|Siltuximab|siltuximab|mesh-list
25517102|NCT00433446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517103|NCT00433537|Dexamethasone|dexamethasone|mesh-list
25517104|NCT00433537|Cyclophosphamide|cyclophosphamide|mesh-list
25517105|NCT00433537|Rituximab|rituximab|mesh-list
25517106|NCT00433537|Doxorubicin|doxorubicin|mesh-list
25517107|NCT00433537|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25517108|NCT00433537|Vincristine|vincristine|mesh-list
25517109|NCT00433537|Bortezomib|bortezomib|mesh-list
25517110|NCT00433537|Lenograstim|lenograstim|mesh-list
25517111|NCT00433537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25517112|NCT00433537|Immunologic Factors|immunologic factors|mesh-ancestor
25517113|NCT00433537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517114|NCT00433537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25517115|NCT00433537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25517116|NCT00433537|Alkylating Agents|alkylating agents|mesh-ancestor
25517117|NCT00433537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517118|NCT00433537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517119|NCT00433537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25517120|NCT00433537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25517121|NCT00433537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25517122|NCT00433537|Antiemetics|antiemetics|mesh-ancestor
25517123|NCT00433537|Autonomic Agents|autonomic agents|mesh-ancestor
25517124|NCT00433537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25517125|NCT00433537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25517126|NCT00433537|Glucocorticoids|glucocorticoids|mesh-ancestor
25517127|NCT00433537|Hormones|hormones|mesh-ancestor
25517128|NCT00433537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25517129|NCT00433537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25517130|NCT00433537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25517131|NCT00433537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25517132|NCT00433537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25517133|NCT00433537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517134|NCT00433537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25517135|NCT00433537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25517136|NCT00433537|Tubulin Modulators|tubulin modulators|mesh-ancestor
25517137|NCT00433537|Antimitotic Agents|antimitotic agents|mesh-ancestor
25646458|NCT01459796|Allopurinol|allopurinol|mesh-list
25646459|NCT01459796|Antimetabolites|antimetabolites|mesh-ancestor
25517138|NCT00433537|Mitosis Modulators|mitosis modulators|mesh-ancestor
25517139|NCT00433550|Capecitabine|capecitabine|mesh-list
25517140|NCT00433550|Oxaliplatin|oxaliplatin|mesh-list
25517141|NCT00433550|Irinotecan|irinotecan|mesh-list
25517142|NCT00433550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25517143|NCT00433550|Antimetabolites|antimetabolites|mesh-ancestor
25517144|NCT00433550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517145|NCT00433550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517146|NCT00433550|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25646460|NCT01459796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646461|NCT01459796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646462|NCT01459796|Gout Suppressants|gout suppressants|mesh-ancestor
25646463|NCT01459796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25646464|NCT01459796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25646465|NCT01459796|Antioxidants|antioxidants|mesh-ancestor
25646466|NCT01459796|Protective Agents|protective agents|mesh-ancestor
25646467|NCT01459796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646468|NCT01459796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25646469|NCT01459913|Interferons|interferons|mesh-list
25517147|NCT00433550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25517148|NCT00433550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517149|NCT00433745|Vaccines|vaccines|mesh-list
25517150|NCT00433745|Immunologic Factors|immunologic factors|mesh-ancestor
25517151|NCT00433745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517153|NCT00433836|Enalapril|enalapril|mesh-list
25517154|NCT00433836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25517155|NCT00433836|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25517156|NCT00433836|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25517157|NCT00433836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517158|NCT00433836|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25517159|NCT00433836|Protease Inhibitors|protease inhibitors|mesh-ancestor
25517160|NCT00433836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517161|NCT00433914|Vaccines|vaccines|mesh-list
25517162|NCT00433914|Immunologic Factors|immunologic factors|mesh-ancestor
25517163|NCT00433914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517164|NCT00433966|Paclitaxel|paclitaxel|mesh-list
25517165|NCT00433966|Heparin|heparin|mesh-list
25517166|NCT00433966|Calcium heparin|calcium heparin|mesh-list
25517167|NCT00433966|Bivalirudin|bivalirudin|mesh-list
25517168|NCT00433966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25517169|NCT00433966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517170|NCT00433966|Tubulin Modulators|tubulin modulators|mesh-ancestor
25517171|NCT00433966|Antimitotic Agents|antimitotic agents|mesh-ancestor
25517172|NCT00433966|Mitosis Modulators|mitosis modulators|mesh-ancestor
25517173|NCT00433966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517174|NCT00433966|Anticoagulants|anticoagulants|mesh-ancestor
25517175|NCT00433966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25517176|NCT00433966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25517177|NCT00433966|Antithrombins|antithrombins|mesh-ancestor
25517178|NCT00433966|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25517179|NCT00433966|Protease Inhibitors|protease inhibitors|mesh-ancestor
25517180|NCT00433966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517181|NCT00434109|Sunitinib|sunitinib|mesh-list
25517182|NCT00434109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517183|NCT00434109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25517184|NCT00434109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25517185|NCT00434109|Growth Substances|growth substances|mesh-ancestor
25517186|NCT00434109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517187|NCT00434109|Growth Inhibitors|growth inhibitors|mesh-ancestor
25517188|NCT00434109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25517189|NCT00434109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517190|NCT00434109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517191|NCT00434148|Pasireotide|pasireotide|mesh-list
25517192|NCT00434148|Hormones|hormones|mesh-ancestor
25517193|NCT00434148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25517194|NCT00434148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517195|NCT00434213|Methylphenidate|methylphenidate|mesh-list
25517196|NCT00434213|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25517197|NCT00434213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517198|NCT00434213|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25517199|NCT00434213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25517200|NCT00434213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25517201|NCT00434213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517202|NCT00434213|Dopamine Agents|dopamine agents|mesh-ancestor
25517203|NCT00434213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25517204|NCT00434252|Paclitaxel|paclitaxel|mesh-list
25517205|NCT00434252|Bevacizumab|bevacizumab|mesh-list
25646471|NCT01459913|Interferon-alpha|interferon-alpha|mesh-list
25646472|NCT01459913|Interferon alpha-2|interferon alpha-2|mesh-list
25646473|NCT01459913|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25646474|NCT01459913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646475|NCT01459913|Antiviral Agents|antiviral agents|mesh-ancestor
25646476|NCT01459913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25646477|NCT01459913|Antimetabolites|antimetabolites|mesh-ancestor
25646478|NCT01459913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517206|NCT00434252|Carboplatin|carboplatin|mesh-list
25517207|NCT00434252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25517208|NCT00434252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517209|NCT00434252|Tubulin Modulators|tubulin modulators|mesh-ancestor
25517210|NCT00434252|Antimitotic Agents|antimitotic agents|mesh-ancestor
25517211|NCT00434252|Mitosis Modulators|mitosis modulators|mesh-ancestor
25517212|NCT00434252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517213|NCT00434252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25517214|NCT00434252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25517215|NCT00434252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25517216|NCT00434252|Growth Substances|growth substances|mesh-ancestor
25517217|NCT00434252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517218|NCT00434252|Growth Inhibitors|growth inhibitors|mesh-ancestor
25517219|NCT00434304|Ropinirole|ropinirole|mesh-list
25517220|NCT00434304|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25517221|NCT00434304|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25517222|NCT00434304|Dopamine Agonists|dopamine agonists|mesh-ancestor
25517223|NCT00434304|Dopamine Agents|dopamine agents|mesh-ancestor
25517224|NCT00434304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25517225|NCT00434304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517226|NCT00434304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517227|NCT00434356|Paclitaxel|paclitaxel|mesh-list
25517228|NCT00434356|Bevacizumab|bevacizumab|mesh-list
25517229|NCT00434356|Sunitinib|sunitinib|mesh-list
25517230|NCT00434356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25517231|NCT00434356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517232|NCT00434356|Tubulin Modulators|tubulin modulators|mesh-ancestor
25517233|NCT00434356|Antimitotic Agents|antimitotic agents|mesh-ancestor
25517234|NCT00434356|Mitosis Modulators|mitosis modulators|mesh-ancestor
25517235|NCT00434356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517236|NCT00434356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25517237|NCT00434356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25517238|NCT00434356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25517239|NCT00434356|Growth Substances|growth substances|mesh-ancestor
25517240|NCT00434356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517241|NCT00434356|Growth Inhibitors|growth inhibitors|mesh-ancestor
25517242|NCT00434356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25517243|NCT00434356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517244|NCT00434434|Omalizumab|omalizumab|mesh-list
25517245|NCT00434434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25517246|NCT00434434|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25517247|NCT00434434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25517248|NCT00434434|Respiratory System Agents|respiratory system agents|mesh-ancestor
25517249|NCT00434434|Immunologic Factors|immunologic factors|mesh-ancestor
25517250|NCT00434434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517251|NCT00434577|Vaccines|vaccines|mesh-list
25517252|NCT00434577|Immunologic Factors|immunologic factors|mesh-ancestor
25517253|NCT00434577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517254|NCT00434642|Gemcitabine|gemcitabine|mesh-list
25517255|NCT00434642|Bevacizumab|bevacizumab|mesh-list
25517256|NCT00434642|Carboplatin|carboplatin|mesh-list
25517257|NCT00434642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25517258|NCT00434642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517259|NCT00434642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25517260|NCT00434642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25517261|NCT00434642|Growth Substances|growth substances|mesh-ancestor
25517262|NCT00434642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517263|NCT00434642|Growth Inhibitors|growth inhibitors|mesh-ancestor
25517264|NCT00434642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25517265|NCT00434642|Antimetabolites|antimetabolites|mesh-ancestor
25517266|NCT00434642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517267|NCT00434642|Antiviral Agents|antiviral agents|mesh-ancestor
25517268|NCT00434642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25517269|NCT00434642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517270|NCT00434642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25517271|NCT00434642|Immunologic Factors|immunologic factors|mesh-ancestor
25646479|NCT01459913|Immunologic Factors|immunologic factors|mesh-ancestor
25646480|NCT01459913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646481|NCT01460225|Lubiprostone|lubiprostone|mesh-list
25646482|NCT01460225|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25646483|NCT01460225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25646484|NCT01460225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646485|NCT01460290|Asenapine|asenapine|mesh-list
25646486|NCT01460290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25517272|NCT00434876|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25517273|NCT00434876|Antidepressive Agents|antidepressive agents|mesh-ancestor
25517274|NCT00434876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25517275|NCT00434876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25517276|NCT00434876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25517277|NCT00434876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25517278|NCT00434876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517279|NCT00434954|Insulin Aspart|insulin aspart|mesh-list
25517280|NCT00434954|Exenatide|exenatide|mesh-list
25517281|NCT00434954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25517282|NCT00434954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517283|NCT00434954|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25517284|NCT00434954|Incretins|incretins|mesh-ancestor
25517285|NCT00434954|Hormones|hormones|mesh-ancestor
25517286|NCT00434954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25517287|NCT00434967|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25517288|NCT00434967|Candesartan|candesartan|mesh-list
25517289|NCT00434967|Candesartan cilexetil|candesartan cilexetil|mesh-list
25517290|NCT00434967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25517291|NCT00434967|Diuretics|diuretics|mesh-ancestor
25517292|NCT00434967|Natriuretic Agents|natriuretic agents|mesh-ancestor
25517293|NCT00434967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517294|NCT00434967|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25517295|NCT00434967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25517296|NCT00434967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517297|NCT00434967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25517298|NCT00434967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25517299|NCT00434993|Albuterol|albuterol|mesh-list
25823383|NCT00004811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517301|NCT00434993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25517302|NCT00434993|Autonomic Agents|autonomic agents|mesh-ancestor
25517303|NCT00434993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25517304|NCT00434993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517305|NCT00434993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25517306|NCT00434993|Respiratory System Agents|respiratory system agents|mesh-ancestor
25517307|NCT00434993|Tocolytic Agents|tocolytic agents|mesh-ancestor
25517308|NCT00434993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25517309|NCT00434993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25517310|NCT00434993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25517311|NCT00434993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25517312|NCT00434993|Adrenergic Agents|adrenergic agents|mesh-ancestor
25517313|NCT00434993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25517314|NCT00434993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517315|NCT00434993|Chelating Agents|chelating agents|mesh-ancestor
25517316|NCT00434993|Sequestering Agents|sequestering agents|mesh-ancestor
25517317|NCT00435019|Insulin|insulin|mesh-list
25517318|NCT00435019|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25517319|NCT00435019|Insulin Aspart|insulin aspart|mesh-list
25517320|NCT00435019|Insulin Detemir|insulin detemir|mesh-list
25517321|NCT00435019|Isophane Insulin, Human|isophane insulin, human|mesh-list
25517322|NCT00435019|Insulin, Isophane|insulin, isophane|mesh-list
25517323|NCT00435019|Isophane insulin, beef|isophane insulin, beef|mesh-list
25517324|NCT00435019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25517325|NCT00435019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517326|NCT00435045|Atorvastatin|atorvastatin|mesh-list
25517327|NCT00435045|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25517328|NCT00435045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25517329|NCT00435045|Antimetabolites|antimetabolites|mesh-ancestor
25517330|NCT00435045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517331|NCT00435045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25517332|NCT00435045|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25517333|NCT00435045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517334|NCT00435162|Valsartan|valsartan|mesh-list
25517335|NCT00435162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25517336|NCT00435162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25517337|NCT00435162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25646487|NCT01460290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25646488|NCT01460290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25646489|NCT01460290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646490|NCT01460290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25646492|NCT01460342|Vasodilator Agents|vasodilator agents|mesh-ancestor
25646493|NCT01460342|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25646494|NCT01460342|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25646495|NCT01460342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646496|NCT01460342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646497|NCT01460342|Urological Agents|urological agents|mesh-ancestor
25646498|NCT01460368|Moxifloxacin|moxifloxacin|mesh-list
25646499|NCT01460368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25646500|NCT01460368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25646501|NCT01460368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25646502|NCT01460368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25646503|NCT01460368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646504|NCT01460368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517338|NCT00435162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517339|NCT00435370|Tropisetron|tropisetron|mesh-list
25517340|NCT00435370|Risperidone|risperidone|mesh-list
25517341|NCT00435370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25517342|NCT00435370|Serotonin Agents|serotonin agents|mesh-ancestor
25517343|NCT00435370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25517344|NCT00435370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517345|NCT00435370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517346|NCT00435370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25517347|NCT00435370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25517348|NCT00435370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25517349|NCT00435370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25517350|NCT00435370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25517351|NCT00435370|Dopamine Agents|dopamine agents|mesh-ancestor
25517352|NCT00435370|Antiemetics|antiemetics|mesh-ancestor
25517353|NCT00435370|Autonomic Agents|autonomic agents|mesh-ancestor
25517354|NCT00435370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25517355|NCT00435370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25517356|NCT00435370|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25517357|NCT00435409|Capecitabine|capecitabine|mesh-list
25517358|NCT00435409|Sunitinib|sunitinib|mesh-list
25517359|NCT00435409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25517360|NCT00435409|Antimetabolites|antimetabolites|mesh-ancestor
25517361|NCT00435409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517362|NCT00435409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517363|NCT00435409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25517364|NCT00435409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25517365|NCT00435409|Growth Substances|growth substances|mesh-ancestor
25517366|NCT00435409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517367|NCT00435409|Growth Inhibitors|growth inhibitors|mesh-ancestor
25517368|NCT00435409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25517369|NCT00435409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517370|NCT00435461|Fluticasone|fluticasone|mesh-list
25517371|NCT00435461|Xhance|xhance|mesh-list
25517372|NCT00435461|Fexofenadine|fexofenadine|mesh-list
25517373|NCT00435461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24516258|NCT00601276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25517374|NCT00435461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25517375|NCT00435461|Autonomic Agents|autonomic agents|mesh-ancestor
25517376|NCT00435461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25517377|NCT00435461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517378|NCT00435461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25517379|NCT00435461|Respiratory System Agents|respiratory system agents|mesh-ancestor
25517380|NCT00435461|Dermatologic Agents|dermatologic agents|mesh-ancestor
25517381|NCT00435461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25517382|NCT00435461|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25517383|NCT00435461|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25517384|NCT00435461|Histamine Antagonists|histamine antagonists|mesh-ancestor
25517385|NCT00435461|Histamine Agents|histamine agents|mesh-ancestor
25517386|NCT00435461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25517387|NCT00435461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517388|NCT00435487|Heparin|heparin|mesh-list
25517389|NCT00435487|Calcium heparin|calcium heparin|mesh-list
25517390|NCT00435487|Dalteparin|dalteparin|mesh-list
25517391|NCT00435487|Tinzaparin|tinzaparin|mesh-list
25517392|NCT00435487|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25646506|NCT01460381|Quinidine|quinidine|mesh-list
25646507|NCT01460381|Quinidine gluconate|quinidine gluconate|mesh-list
25646508|NCT01460381|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25646509|NCT01460381|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25646510|NCT01460381|Adrenergic Agents|adrenergic agents|mesh-ancestor
25646511|NCT01460381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25517393|NCT00435487|Anticoagulants|anticoagulants|mesh-ancestor
25646512|NCT01460381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646513|NCT01460381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646514|NCT01460381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25646515|NCT01460381|Antimalarials|antimalarials|mesh-ancestor
25646516|NCT01460381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25646517|NCT01460381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25646518|NCT01460381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25646519|NCT01460381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646520|NCT01460381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25646521|NCT01460381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25646522|NCT01460381|Cholinergic Agents|cholinergic agents|mesh-ancestor
25517394|NCT00435487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25517395|NCT00435487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25517396|NCT00435487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517397|NCT00435539|Plasminogen|plasminogen|mesh-list
25517398|NCT00435539|Fibrinolysin|fibrinolysin|mesh-list
25517399|NCT00435539|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25517400|NCT00435539|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25517401|NCT00435539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517402|NCT00435591|Conivaptan|conivaptan|mesh-list
25517403|NCT00435591|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25517404|NCT00435591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517405|NCT00435591|Natriuretic Agents|natriuretic agents|mesh-ancestor
25517406|NCT00435591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517407|NCT00435812|Vaccines|vaccines|mesh-list
25517408|NCT00435812|Immunologic Factors|immunologic factors|mesh-ancestor
25517409|NCT00435812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517410|NCT00435825|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25517411|NCT00435825|Antiviral Agents|antiviral agents|mesh-ancestor
25517412|NCT00435825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25517413|NCT00435929|Ritonavir|ritonavir|mesh-list
25517414|NCT00435929|Saquinavir|saquinavir|mesh-list
25517415|NCT00435929|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25517416|NCT00435929|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25517417|NCT00435929|Protease Inhibitors|protease inhibitors|mesh-ancestor
25517418|NCT00435929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517419|NCT00435929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517420|NCT00435929|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25517421|NCT00435929|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25517422|NCT00435929|Antiviral Agents|antiviral agents|mesh-ancestor
25517423|NCT00435929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25517424|NCT00435929|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25517425|NCT00435929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25517426|NCT00435994|Epinephrine|epinephrine|mesh-list
25517427|NCT00435994|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25517428|NCT00435994|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25517429|NCT00435994|Adrenergic Agents|adrenergic agents|mesh-ancestor
25517430|NCT00435994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25517431|NCT00435994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517432|NCT00435994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517433|NCT00435994|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25517434|NCT00435994|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25517435|NCT00435994|Autonomic Agents|autonomic agents|mesh-ancestor
25517436|NCT00435994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25517437|NCT00435994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25517438|NCT00435994|Respiratory System Agents|respiratory system agents|mesh-ancestor
25823384|NCT00004811|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25823385|NCT00004811|Hormone Antagonists|hormone antagonists|mesh-ancestor
25823386|NCT00004811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25823387|NCT00004811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823388|NCT00004811|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25823389|NCT00004814|Glatiramer Acetate|glatiramer acetate|mesh-list
25823390|NCT00004814|(T,G)-A-L|(t,g)-a-l|mesh-list
25823391|NCT00004814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25823392|NCT00004814|Immunologic Factors|immunologic factors|mesh-ancestor
25517439|NCT00435994|Mydriatics|mydriatics|mesh-ancestor
25517440|NCT00435994|Sympathomimetics|sympathomimetics|mesh-ancestor
25517441|NCT00435994|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25646523|NCT01460381|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25646524|NCT01460381|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25646525|NCT01460381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25646526|NCT01460381|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25646527|NCT01460381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25646528|NCT01460407|Clarithromycin|clarithromycin|mesh-list
25646529|NCT01460407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25646530|NCT01460407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25646531|NCT01460407|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25646532|NCT01460407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646533|NCT01460407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646534|NCT01460407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25646535|NCT01460407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25646536|NCT01460628|Modafinil|modafinil|mesh-list
25517442|NCT00436007|Vaccines|vaccines|mesh-list
25517443|NCT00436007|Immunologic Factors|immunologic factors|mesh-ancestor
25517444|NCT00436007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517445|NCT00436046|Interferons|interferons|mesh-list
25517446|NCT00436046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517447|NCT00436046|Antiviral Agents|antiviral agents|mesh-ancestor
25517448|NCT00436046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25517449|NCT00436163|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25517450|NCT00436163|Antiviral Agents|antiviral agents|mesh-ancestor
25517451|NCT00436163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25517452|NCT00436215|Bevacizumab|bevacizumab|mesh-list
25517453|NCT00436215|Sorafenib|sorafenib|mesh-list
25517454|NCT00436215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25517455|NCT00436215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517456|NCT00436215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25517457|NCT00436215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25517458|NCT00436215|Growth Substances|growth substances|mesh-ancestor
25517459|NCT00436215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517460|NCT00436215|Growth Inhibitors|growth inhibitors|mesh-ancestor
25517461|NCT00436215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25517462|NCT00436215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517463|NCT00436215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517464|NCT00436280|Gemcitabine|gemcitabine|mesh-list
25517465|NCT00436280|Rituximab|rituximab|mesh-list
25517466|NCT00436280|Oxaliplatin|oxaliplatin|mesh-list
25517467|NCT00436280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25517468|NCT00436280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517469|NCT00436280|Immunologic Factors|immunologic factors|mesh-ancestor
25517470|NCT00436280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517471|NCT00436280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25517472|NCT00436280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25517473|NCT00436280|Antimetabolites|antimetabolites|mesh-ancestor
25517474|NCT00436280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517475|NCT00436280|Antiviral Agents|antiviral agents|mesh-ancestor
25517476|NCT00436280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25517477|NCT00436280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517478|NCT00436280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25517479|NCT00436332|Bevacizumab|bevacizumab|mesh-list
25517480|NCT00436332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25517481|NCT00436332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25517482|NCT00436332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517483|NCT00436332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25517484|NCT00436332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25517485|NCT00436332|Growth Substances|growth substances|mesh-ancestor
25517486|NCT00436332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517487|NCT00436332|Growth Inhibitors|growth inhibitors|mesh-ancestor
25517488|NCT00436332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25517489|NCT00436332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517490|NCT00436332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517491|NCT00436345|Remifentanil|remifentanil|mesh-list
25517492|NCT00436345|Propofol|propofol|mesh-list
25517493|NCT00436345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25517494|NCT00436345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24403163|NCT00159484|Analgesics|analgesics|mesh-ancestor
25517495|NCT00436345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517496|NCT00436345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25517497|NCT00436345|Anesthetics, General|anesthetics, general|mesh-ancestor
25002998|NCT04124614|Sertraline|sertraline|mesh-list
25646537|NCT01460628|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25646538|NCT01460628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646539|NCT01460628|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25646540|NCT01460628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25646541|NCT01460628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25646542|NCT01460628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646543|NCT01460719|Vaccines|vaccines|mesh-list
25823393|NCT00004814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517498|NCT00436345|Anesthetics|anesthetics|mesh-ancestor
25517499|NCT00436345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25517500|NCT00436345|Narcotics|narcotics|mesh-ancestor
25517501|NCT00436345|Analgesics|analgesics|mesh-ancestor
25517502|NCT00436345|Sensory System Agents|sensory system agents|mesh-ancestor
25517503|NCT00436345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25517504|NCT00436436|Temozolomide|temozolomide|mesh-list
25517505|NCT00436436|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
25517506|NCT00436436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25517507|NCT00436436|Alkylating Agents|alkylating agents|mesh-ancestor
25517508|NCT00436436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517509|NCT00436436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517510|NCT00436436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517511|NCT00436475|Calcium, Dietary|calcium, dietary|mesh-list
25517512|NCT00436475|Vitamin D|vitamin d|mesh-list
25517513|NCT00436475|Ergocalciferols|ergocalciferols|mesh-list
25517514|NCT00436475|Cholecalciferol|cholecalciferol|mesh-list
25517515|NCT00436475|Vitamins|vitamins|mesh-list
25517517|NCT00436475|Calcium|calcium|mesh-list
25517518|NCT00436475|Micronutrients|micronutrients|mesh-ancestor
25517519|NCT00436475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517520|NCT00436475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25517521|NCT00436475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25517522|NCT00436475|Antacids|antacids|mesh-ancestor
25517523|NCT00436475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517524|NCT00436475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25517525|NCT00436501|Docetaxel|docetaxel|mesh-list
25517526|NCT00436501|Aflibercept|aflibercept|mesh-list
25517527|NCT00436501|Endothelial Growth Factors|endothelial growth factors|mesh-list
25517528|NCT00436501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517529|NCT00436501|Tubulin Modulators|tubulin modulators|mesh-ancestor
25517530|NCT00436501|Antimitotic Agents|antimitotic agents|mesh-ancestor
25517531|NCT00436501|Mitosis Modulators|mitosis modulators|mesh-ancestor
25517532|NCT00436501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517533|NCT00436501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25517534|NCT00436501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25517535|NCT00436501|Growth Substances|growth substances|mesh-ancestor
25517536|NCT00436501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517537|NCT00436501|Growth Inhibitors|growth inhibitors|mesh-ancestor
25517538|NCT00436553|Ranibizumab|ranibizumab|mesh-list
25517539|NCT00436553|Verteporfin|verteporfin|mesh-list
25517540|NCT00436553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25517541|NCT00436553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25517542|NCT00436553|Growth Substances|growth substances|mesh-ancestor
25517543|NCT00436553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517544|NCT00436553|Growth Inhibitors|growth inhibitors|mesh-ancestor
25517545|NCT00436553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517546|NCT00436553|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25517547|NCT00436553|Dermatologic Agents|dermatologic agents|mesh-ancestor
25517548|NCT00436605|Dasatinib|dasatinib|mesh-list
25517549|NCT00436605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517550|NCT00436605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25517551|NCT00436605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517552|NCT00436605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517553|NCT00436618|Everolimus|everolimus|mesh-list
25517554|NCT00436618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517555|NCT00436618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25517556|NCT00436618|Immunologic Factors|immunologic factors|mesh-ancestor
25517557|NCT00436618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517558|NCT00436644|Topotecan|topotecan|mesh-list
25517559|NCT00436644|Lapatinib|lapatinib|mesh-list
25517560|NCT00436644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25517561|NCT00436644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25517562|NCT00436644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517563|NCT00436644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517564|NCT00436644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517565|NCT00436644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25517566|NCT00436748|Darbepoetin alfa|darbepoetin alfa|mesh-list
25646544|NCT01460719|Immunologic Factors|immunologic factors|mesh-ancestor
25646545|NCT01460719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646547|NCT01460875|Interferon-alpha|interferon-alpha|mesh-list
25517567|NCT00436748|Hematinics|hematinics|mesh-ancestor
25517568|NCT00436904|Rituximab|rituximab|mesh-list
25517569|NCT00436904|Alemtuzumab|alemtuzumab|mesh-list
25517570|NCT00436904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25517571|NCT00436904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517572|NCT00436904|Immunologic Factors|immunologic factors|mesh-ancestor
25517573|NCT00436904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517574|NCT00436904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25517575|NCT00436917|Zoledronic Acid|zoledronic acid|mesh-list
25517576|NCT00436917|Letrozole|letrozole|mesh-list
25517577|NCT00436917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517578|NCT00436917|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25517579|NCT00436917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25517580|NCT00436917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517581|NCT00436917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517582|NCT00436917|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25517583|NCT00436917|Hormone Antagonists|hormone antagonists|mesh-ancestor
25517584|NCT00436917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25517585|NCT00436917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517586|NCT00436917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25517587|NCT00436956|Prednisone|prednisone|mesh-list
25517588|NCT00436956|Cediranib|cediranib|mesh-list
25517589|NCT00436956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25517590|NCT00436956|Glucocorticoids|glucocorticoids|mesh-ancestor
25517591|NCT00436956|Hormones|hormones|mesh-ancestor
25517592|NCT00436956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25517593|NCT00436956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517594|NCT00436956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25517595|NCT00436956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517596|NCT00436956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25517597|NCT00436956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517598|NCT00436956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517599|NCT00436969|Hyaluronic Acid|hyaluronic acid|mesh-list
25517600|NCT00436969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25517601|NCT00436969|Immunologic Factors|immunologic factors|mesh-ancestor
25517602|NCT00436969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517603|NCT00436969|Viscosupplements|viscosupplements|mesh-ancestor
25517604|NCT00436969|Protective Agents|protective agents|mesh-ancestor
25517605|NCT00437034|Aflibercept|aflibercept|mesh-list
25517606|NCT00437034|Endothelial Growth Factors|endothelial growth factors|mesh-list
25517607|NCT00437034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25517608|NCT00437034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25517609|NCT00437034|Growth Substances|growth substances|mesh-ancestor
25517610|NCT00437034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517611|NCT00437034|Growth Inhibitors|growth inhibitors|mesh-ancestor
25517612|NCT00437034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517613|NCT00437073|Capecitabine|capecitabine|mesh-list
25517615|NCT00437073|Lapatinib|lapatinib|mesh-list
25517616|NCT00437073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25517617|NCT00437073|Antimetabolites|antimetabolites|mesh-ancestor
25517618|NCT00437073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517619|NCT00437073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517620|NCT00437073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25517621|NCT00437073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25517622|NCT00437073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517623|NCT00437073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25517624|NCT00437125|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25517625|NCT00437125|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25517626|NCT00437125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25517627|NCT00437125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25517628|NCT00437125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517629|NCT00437125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25517630|NCT00437125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517631|NCT00437125|Analgesics|analgesics|mesh-ancestor
25517632|NCT00437125|Sensory System Agents|sensory system agents|mesh-ancestor
25517633|NCT00437125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25517634|NCT00437125|Antidepressive Agents|antidepressive agents|mesh-ancestor
25517635|NCT00437125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25517636|NCT00437125|Dopamine Agents|dopamine agents|mesh-ancestor
25517637|NCT00437203|Gemcitabine|gemcitabine|mesh-list
25646548|NCT01460875|Interferon alpha-2|interferon alpha-2|mesh-list
25517638|NCT00437203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25517639|NCT00437203|Antimetabolites|antimetabolites|mesh-ancestor
25517640|NCT00437203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517641|NCT00437203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517642|NCT00437203|Antiviral Agents|antiviral agents|mesh-ancestor
25517643|NCT00437203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25517644|NCT00437203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517645|NCT00437203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25517646|NCT00437203|Immunologic Factors|immunologic factors|mesh-ancestor
25517647|NCT00437203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517648|NCT00437268|Irinotecan|irinotecan|mesh-list
25517649|NCT00437268|Cetuximab|cetuximab|mesh-list
25517650|NCT00437268|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25517651|NCT00437268|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25517652|NCT00437268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517653|NCT00437268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517654|NCT00437268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517655|NCT00437268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25517656|NCT00437281|Pregabalin|pregabalin|mesh-list
25517657|NCT00437281|Analgesics|analgesics|mesh-ancestor
25517658|NCT00437281|Sensory System Agents|sensory system agents|mesh-ancestor
25517659|NCT00437281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25517660|NCT00437281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517661|NCT00437281|Anticonvulsants|anticonvulsants|mesh-ancestor
25517662|NCT00437281|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25517663|NCT00437281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24862402|NCT02325011|Sensory System Agents|sensory system agents|mesh-ancestor
25517664|NCT00437281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517665|NCT00437281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25517666|NCT00437281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25517667|NCT00437281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25517668|NCT00437281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25517669|NCT00437281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25517670|NCT00437294|Capecitabine|capecitabine|mesh-list
25517671|NCT00437294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25517672|NCT00437294|Antimetabolites|antimetabolites|mesh-ancestor
25517673|NCT00437294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517674|NCT00437294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517675|NCT00437489|Insulin|insulin|mesh-list
25517676|NCT00437489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25517677|NCT00437489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25517678|NCT00437489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517679|NCT00437645|Amlodipine|amlodipine|mesh-list
25517680|NCT00437645|Valsartan|valsartan|mesh-list
25517681|NCT00437645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25517682|NCT00437645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25517683|NCT00437645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25517684|NCT00437645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517685|NCT00437645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25517686|NCT00437645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517687|NCT00437645|Vasodilator Agents|vasodilator agents|mesh-ancestor
25517688|NCT00437645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25517689|NCT00437645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25517690|NCT00437658|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25517691|NCT00437658|Medroxyprogesterone|medroxyprogesterone|mesh-list
25517692|NCT00437658|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25517693|NCT00437658|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25517694|NCT00437658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25517695|NCT00437658|Contraceptive Agents|contraceptive agents|mesh-ancestor
25517696|NCT00437658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25517697|NCT00437658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517698|NCT00437658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25517699|NCT00437658|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25517700|NCT00437658|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24403757|NCT00161447|Acyline|acyline|mesh-list
25517701|NCT00437658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25517702|NCT00437658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517703|NCT00438100|Capecitabine|capecitabine|mesh-list
25517704|NCT00438100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25517705|NCT00438100|Antimetabolites|antimetabolites|mesh-ancestor
25003436|NCT03703271|Immunologic Factors|immunologic factors|mesh-ancestor
25646549|NCT01460875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646550|NCT01460875|Antiviral Agents|antiviral agents|mesh-ancestor
25646551|NCT01460875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25646552|NCT01460875|Immunologic Factors|immunologic factors|mesh-ancestor
25646553|NCT01460875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646554|NCT01460940|Lenalidomide|lenalidomide|mesh-list
25646555|NCT01460940|Panobinostat|panobinostat|mesh-list
25646556|NCT01460940|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25646557|NCT01460940|Immunologic Factors|immunologic factors|mesh-ancestor
25646558|NCT01460940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646559|NCT01460940|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25517706|NCT00438100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517707|NCT00438100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517708|NCT00438204|Gemcitabine|gemcitabine|mesh-list
25517709|NCT00438204|Bevacizumab|bevacizumab|mesh-list
25517710|NCT00438204|Pemetrexed|pemetrexed|mesh-list
25517711|NCT00438204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25517712|NCT00438204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517713|NCT00438204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25517714|NCT00438204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25517715|NCT00438204|Growth Substances|growth substances|mesh-ancestor
25517716|NCT00438204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517717|NCT00438204|Growth Inhibitors|growth inhibitors|mesh-ancestor
25517718|NCT00438204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25517719|NCT00438204|Antimetabolites|antimetabolites|mesh-ancestor
25517720|NCT00438204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517721|NCT00438204|Antiviral Agents|antiviral agents|mesh-ancestor
25517722|NCT00438204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25517723|NCT00438204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517724|NCT00438204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25517725|NCT00438204|Immunologic Factors|immunologic factors|mesh-ancestor
25517726|NCT00438204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25517727|NCT00438204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25517728|NCT00438256|Capecitabine|capecitabine|mesh-list
25517729|NCT00438256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25517730|NCT00438256|Antimetabolites|antimetabolites|mesh-ancestor
25517731|NCT00438256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517732|NCT00438256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987977|NCT04505735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24987978|NCT04479267|Prednisone|prednisone|mesh-list
24987979|NCT04479267|Methylprednisolone|methylprednisolone|mesh-list
24987982|NCT04479267|Prednisolone|prednisolone|mesh-list
25517767|NCT00438464|Finasteride|finasteride|mesh-list
25517768|NCT00438464|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25517769|NCT00438464|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25517770|NCT00438464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517771|NCT00438464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517772|NCT00438464|Hormone Antagonists|hormone antagonists|mesh-ancestor
25517773|NCT00438464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25517774|NCT00438464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517775|NCT00438464|Urological Agents|urological agents|mesh-ancestor
25517776|NCT00438659|Mometasone Furoate|mometasone furoate|mesh-list
25517777|NCT00438659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25517778|NCT00438659|Dermatologic Agents|dermatologic agents|mesh-ancestor
25517779|NCT00438659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25517780|NCT00438672|Dexamethasone|dexamethasone|mesh-list
25517781|NCT00438672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25517782|NCT00438672|Antiemetics|antiemetics|mesh-ancestor
25517783|NCT00438672|Autonomic Agents|autonomic agents|mesh-ancestor
25517784|NCT00438672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25517785|NCT00438672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517786|NCT00438672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25517787|NCT00438672|Glucocorticoids|glucocorticoids|mesh-ancestor
25517788|NCT00438672|Hormones|hormones|mesh-ancestor
25517789|NCT00438672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25517790|NCT00438672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25517791|NCT00438672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517792|NCT00438802|Alefacept|alefacept|mesh-list
25517793|NCT00438802|Dermatologic Agents|dermatologic agents|mesh-ancestor
25517794|NCT00438802|Immunologic Factors|immunologic factors|mesh-ancestor
25517795|NCT00438802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517796|NCT00438815|Complement C1s|complement c1s|mesh-list
25517797|NCT00438815|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25517798|NCT00438815|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
25517799|NCT00438815|Immunologic Factors|immunologic factors|mesh-ancestor
25517800|NCT00438815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798684|NCT01964586|Epinephrine|epinephrine|mesh-list
25517801|NCT00438815|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25517802|NCT00438815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25517804|NCT00438854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517805|NCT00438854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25517806|NCT00438854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517807|NCT00438854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517808|NCT00438880|Rituximab|rituximab|mesh-list
25517809|NCT00438880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25517810|NCT00438880|Antibodies|antibodies|mesh-list
25517811|NCT00438880|Immunoglobulins|immunoglobulins|mesh-list
25517812|NCT00438880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25646560|NCT01460940|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25646561|NCT01460940|Growth Substances|growth substances|mesh-ancestor
25646562|NCT01460940|Growth Inhibitors|growth inhibitors|mesh-ancestor
25646563|NCT01460940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646564|NCT01460940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646565|NCT01460940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646566|NCT01461057|Cisplatin|cisplatin|mesh-list
25646567|NCT01461057|Capecitabine|capecitabine|mesh-list
25646568|NCT01461057|Trastuzumab|trastuzumab|mesh-list
25646569|NCT01461057|Pertuzumab|pertuzumab|mesh-list
25646570|NCT01461057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646571|NCT01461057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25646572|NCT01461057|Antimetabolites|antimetabolites|mesh-ancestor
25646573|NCT01461057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517813|NCT00438880|Immunologic Factors|immunologic factors|mesh-ancestor
25517814|NCT00438880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517815|NCT00438880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517816|NCT00438880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25517817|NCT00438971|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25517818|NCT00438971|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25517819|NCT00438971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25517820|NCT00438971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25517821|NCT00438971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517822|NCT00438971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25517823|NCT00438971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517824|NCT00438971|Analgesics|analgesics|mesh-ancestor
25517825|NCT00438971|Sensory System Agents|sensory system agents|mesh-ancestor
25517826|NCT00438971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25517827|NCT00438971|Antidepressive Agents|antidepressive agents|mesh-ancestor
25517828|NCT00438971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25517829|NCT00438971|Dopamine Agents|dopamine agents|mesh-ancestor
25517830|NCT00439140|Botulinum Toxins|botulinum toxins|mesh-list
25517831|NCT00439140|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25517832|NCT00439140|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25517833|NCT00439140|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25517834|NCT00439140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25517835|NCT00439140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517836|NCT00439140|Cholinergic Agents|cholinergic agents|mesh-ancestor
25517837|NCT00439140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25517838|NCT00439140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517839|NCT00439140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25162973|NCT02900729|Losartan|losartan|mesh-list
25517840|NCT00439140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25517841|NCT00439218|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25517842|NCT00439218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517843|NCT00439231|Lenalidomide|lenalidomide|mesh-list
25517844|NCT00439231|Immunologic Factors|immunologic factors|mesh-ancestor
25517845|NCT00439231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517846|NCT00439231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25517847|NCT00439231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25517848|NCT00439231|Growth Substances|growth substances|mesh-ancestor
25517849|NCT00439231|Growth Inhibitors|growth inhibitors|mesh-ancestor
25517850|NCT00439231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517851|NCT00439244|Zoledronic Acid|zoledronic acid|mesh-list
25517852|NCT00439244|Teriparatide|teriparatide|mesh-list
25517853|NCT00439244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25517854|NCT00439244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517855|NCT00439244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25517856|NCT00439270|Docetaxel|docetaxel|mesh-list
25517857|NCT00439270|Dasatinib|dasatinib|mesh-list
25517858|NCT00439270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517859|NCT00439270|Tubulin Modulators|tubulin modulators|mesh-ancestor
25646574|NCT01461057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25646576|NCT01461096|Immunologic Factors|immunologic factors|mesh-ancestor
25646577|NCT01461096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517860|NCT00439270|Antimitotic Agents|antimitotic agents|mesh-ancestor
25517861|NCT00439270|Mitosis Modulators|mitosis modulators|mesh-ancestor
25646578|NCT01461369|Diclofenac|diclofenac|mesh-list
25646579|NCT01461369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25646580|NCT01461369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25646581|NCT01461369|Analgesics|analgesics|mesh-ancestor
25517862|NCT00439270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517863|NCT00439270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25517864|NCT00439270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517865|NCT00439296|Cytarabine|cytarabine|mesh-list
25517866|NCT00439296|Dexamethasone|dexamethasone|mesh-list
25517867|NCT00439296|Cyclophosphamide|cyclophosphamide|mesh-list
25517868|NCT00439296|Doxorubicin|doxorubicin|mesh-list
25517869|NCT00439296|Methotrexate|methotrexate|mesh-list
25517870|NCT00439296|Asparaginase|asparaginase|mesh-list
25517871|NCT00439296|Mercaptopurine|mercaptopurine|mesh-list
25517872|NCT00439296|Thioguanine|thioguanine|mesh-list
25517873|NCT00439296|Pegaspargase|pegaspargase|mesh-list
25517874|NCT00439296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25517875|NCT00439296|Immunologic Factors|immunologic factors|mesh-ancestor
25517876|NCT00439296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517877|NCT00439296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25517878|NCT00439296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25517879|NCT00439296|Alkylating Agents|alkylating agents|mesh-ancestor
25517880|NCT00439296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517881|NCT00439296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517882|NCT00439296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25517883|NCT00439296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25517884|NCT00439296|Antiemetics|antiemetics|mesh-ancestor
25517885|NCT00439296|Autonomic Agents|autonomic agents|mesh-ancestor
25517886|NCT00439296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25517887|NCT00439296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25517888|NCT00439296|Glucocorticoids|glucocorticoids|mesh-ancestor
25517889|NCT00439296|Hormones|hormones|mesh-ancestor
25517890|NCT00439296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25517891|NCT00439296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25517892|NCT00439296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25517893|NCT00439296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25517894|NCT00439296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25517895|NCT00439296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517896|NCT00439296|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25517897|NCT00439296|Abortifacient Agents|abortifacient agents|mesh-ancestor
25517898|NCT00439296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25517899|NCT00439296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25517900|NCT00439296|Antimetabolites|antimetabolites|mesh-ancestor
24796793|NCT01951911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24796794|NCT01951911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24796795|NCT01951911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24796796|NCT01951911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24796797|NCT01951911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796798|NCT01951924|Immunoglobulins|immunoglobulins|mesh-list
24796799|NCT01951924|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24796800|NCT01951924|Antibodies|antibodies|mesh-list
24796801|NCT01951924|Immunoglobulin G|immunoglobulin g|mesh-list
24796802|NCT01951924|Immunologic Factors|immunologic factors|mesh-ancestor
24796803|NCT01951924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137259|NCT02985697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25137260|NCT02985697|Analgesics|analgesics|mesh-ancestor
24796804|NCT01952314|Naftopidil|naftopidil|mesh-list
25517901|NCT00439296|Dermatologic Agents|dermatologic agents|mesh-ancestor
25517902|NCT00439296|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25517903|NCT00439296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25517904|NCT00439296|Antiviral Agents|antiviral agents|mesh-ancestor
25517905|NCT00439296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25517907|NCT00439309|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
25517908|NCT00439309|Hemostatics|hemostatics|mesh-ancestor
25517909|NCT00439309|Coagulants|coagulants|mesh-ancestor
25517910|NCT00439335|Vaccines|vaccines|mesh-list
25517911|NCT00439335|Immunologic Factors|immunologic factors|mesh-ancestor
25517912|NCT00439335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647526|NCT01209351|Teduglutide|teduglutide|mesh-list
25646582|NCT01461369|Sensory System Agents|sensory system agents|mesh-ancestor
25517913|NCT00439374|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
25517914|NCT00439374|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
25517915|NCT00439374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25517916|NCT00439374|Hormone Antagonists|hormone antagonists|mesh-ancestor
25517917|NCT00439374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25517918|NCT00439374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517919|NCT00439374|Progestins|progestins|mesh-ancestor
25517920|NCT00439374|Hormones|hormones|mesh-ancestor
25646583|NCT01461369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25646584|NCT01461369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646585|NCT01461369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25646586|NCT01461369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25646587|NCT01461369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25646588|NCT01461369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646589|NCT01461369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646590|NCT01461499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
25656843|NCT01579513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517921|NCT00439413|Selegiline|selegiline|mesh-list
25517922|NCT00439413|Antidepressive Agents|antidepressive agents|mesh-ancestor
25517923|NCT00439413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25517924|NCT00439413|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25517925|NCT00439413|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25517926|NCT00439413|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25517927|NCT00439413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517928|NCT00439413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517929|NCT00439413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25517930|NCT00439413|Protective Agents|protective agents|mesh-ancestor
25517931|NCT00439413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517932|NCT00439517|Cetuximab|cetuximab|mesh-list
25517933|NCT00439517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25517934|NCT00439517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517935|NCT00439556|Cytarabine|cytarabine|mesh-list
25517936|NCT00439556|Rituximab|rituximab|mesh-list
25517937|NCT00439556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25517938|NCT00439556|Methotrexate|methotrexate|mesh-list
25517939|NCT00439556|Etoposide|etoposide|mesh-list
25517940|NCT00439556|Bortezomib|bortezomib|mesh-list
25517941|NCT00439556|Etoposide phosphate|etoposide phosphate|mesh-list
25517942|NCT00439556|Melphalan|melphalan|mesh-list
25517943|NCT00439556|Mechlorethamine|mechlorethamine|mesh-list
25517944|NCT00439556|Carmustine|carmustine|mesh-list
25517945|NCT00439556|Podophyllotoxin|podophyllotoxin|mesh-list
25517946|NCT00439556|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25517947|NCT00439556|Antibodies|antibodies|mesh-list
25517948|NCT00439556|Immunoglobulins|immunoglobulins|mesh-list
25517949|NCT00439556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25517950|NCT00439556|Tacrolimus|tacrolimus|mesh-list
25517951|NCT00439556|Lenograstim|lenograstim|mesh-list
25517952|NCT00439556|Thymoglobulin|thymoglobulin|mesh-list
25517953|NCT00439556|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25517954|NCT00439556|Immunologic Factors|immunologic factors|mesh-ancestor
25517955|NCT00439556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517956|NCT00439556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517957|NCT00439556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25517958|NCT00439556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25517959|NCT00439556|Abortifacient Agents|abortifacient agents|mesh-ancestor
25517960|NCT00439556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25517961|NCT00439556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24988109|NCT04234464|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24988110|NCT04234464|Adrenergic Agents|adrenergic agents|mesh-ancestor
24988111|NCT04234464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24988112|NCT04234464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517478|NCT00608101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24517479|NCT00608101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24517481|NCT00608179|Glimepiride|glimepiride|mesh-list
24517483|NCT00608179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24517484|NCT00608179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24517485|NCT00608179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517486|NCT00608179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25162980|NCT02900729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25162981|NCT02900729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162982|NCT02900729|Vasodilator Agents|vasodilator agents|mesh-ancestor
25137335|NCT02985593|KHK4083|khk4083|mesh-list
25162983|NCT02900729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25162985|NCT02900729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25517962|NCT00439556|Antimetabolites|antimetabolites|mesh-ancestor
25646591|NCT01461499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517963|NCT00439556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517964|NCT00439556|Dermatologic Agents|dermatologic agents|mesh-ancestor
25517965|NCT00439556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25517966|NCT00439556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25517967|NCT00439556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25517968|NCT00439556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25517969|NCT00439556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25517970|NCT00439556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25517971|NCT00439556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25517972|NCT00439556|Antiviral Agents|antiviral agents|mesh-ancestor
25517973|NCT00439556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25517974|NCT00439556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25517975|NCT00439556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25517976|NCT00439556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25517977|NCT00439556|Alkylating Agents|alkylating agents|mesh-ancestor
25517978|NCT00439556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25517979|NCT00439556|Keratolytic Agents|keratolytic agents|mesh-ancestor
25517980|NCT00439556|Tubulin Modulators|tubulin modulators|mesh-ancestor
25517981|NCT00439556|Antimitotic Agents|antimitotic agents|mesh-ancestor
25517982|NCT00439556|Mitosis Modulators|mitosis modulators|mesh-ancestor
25517984|NCT00439608|Carboplatin|carboplatin|mesh-list
25517985|NCT00439608|Cetuximab|cetuximab|mesh-list
25517986|NCT00439608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25517987|NCT00439608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25517988|NCT00439608|Tubulin Modulators|tubulin modulators|mesh-ancestor
25517989|NCT00439608|Antimitotic Agents|antimitotic agents|mesh-ancestor
25517990|NCT00439608|Mitosis Modulators|mitosis modulators|mesh-ancestor
25517991|NCT00439608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25517992|NCT00439608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25517993|NCT00439647|Zoledronic Acid|zoledronic acid|mesh-list
25517994|NCT00439647|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25517995|NCT00439647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25517996|NCT00439673|Azacitidine|azacitidine|mesh-list
25517997|NCT00439673|Valproic Acid|valproic acid|mesh-list
25517998|NCT00439673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25517999|NCT00439673|Antimetabolites|antimetabolites|mesh-ancestor
25518000|NCT00439673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518001|NCT00439673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518002|NCT00439673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518003|NCT00439673|Anticonvulsants|anticonvulsants|mesh-ancestor
25518004|NCT00439673|GABA Agents|gaba agents|mesh-ancestor
25518005|NCT00439673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25518006|NCT00439673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518007|NCT00439673|Antimanic Agents|antimanic agents|mesh-ancestor
25518008|NCT00439673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25518009|NCT00439673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25518010|NCT00439673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25518011|NCT00439725|Rivaroxaban|rivaroxaban|mesh-list
25518012|NCT00439725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25518013|NCT00439725|Antithrombins|antithrombins|mesh-ancestor
25518014|NCT00439725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25518015|NCT00439725|Protease Inhibitors|protease inhibitors|mesh-ancestor
25518016|NCT00439725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518017|NCT00439725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518018|NCT00439725|Anticoagulants|anticoagulants|mesh-ancestor
25518019|NCT00439777|Enoxaparin|enoxaparin|mesh-list
25518020|NCT00439777|Rivaroxaban|rivaroxaban|mesh-list
25518021|NCT00439777|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25518022|NCT00439777|Antithrombins|antithrombins|mesh-ancestor
25518023|NCT00439777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25518024|NCT00439777|Protease Inhibitors|protease inhibitors|mesh-ancestor
25518025|NCT00439777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518026|NCT00439777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518027|NCT00439777|Anticoagulants|anticoagulants|mesh-ancestor
25518028|NCT00439777|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25518029|NCT00439777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25518030|NCT00439946|Treprostinil|treprostinil|mesh-list
25518031|NCT00439946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25518032|NCT00440011|Bimatoprost|bimatoprost|mesh-list
25518033|NCT00440011|Travoprost|travoprost|mesh-list
25518034|NCT00440011|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24988187|NCT03941509|Anti-Infective Agents|anti-infective agents|mesh-list
24862568|NCT05118685|Estrogens|estrogens|mesh-list
24517502|NCT00608231|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24988189|NCT03845114|Insulin|insulin|mesh-list
25518035|NCT00440011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25518036|NCT00440011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25518037|NCT00440115|Bupropion|bupropion|mesh-list
25518038|NCT00440115|Nicotine|nicotine|mesh-list
25518039|NCT00440115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25518040|NCT00440115|Autonomic Agents|autonomic agents|mesh-ancestor
25518041|NCT00440115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25518042|NCT00440115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518043|NCT00440115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25518044|NCT00440115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25518045|NCT00440115|Cholinergic Agents|cholinergic agents|mesh-ancestor
25518046|NCT00440115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25518047|NCT00440115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518048|NCT00440115|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25518049|NCT00440115|Antidepressive Agents|antidepressive agents|mesh-ancestor
25518050|NCT00440115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25518051|NCT00440115|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25518052|NCT00440115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25518053|NCT00440115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25518054|NCT00440115|Dopamine Agents|dopamine agents|mesh-ancestor
25518055|NCT00440115|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25518056|NCT00440115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25518057|NCT00440115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518058|NCT00440180|Anastrozole|anastrozole|mesh-list
25518059|NCT00440180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25518060|NCT00440180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518061|NCT00440180|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25518062|NCT00440180|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25518063|NCT00440180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518064|NCT00440180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518065|NCT00440180|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25518066|NCT00440180|Hormone Antagonists|hormone antagonists|mesh-ancestor
25518067|NCT00440180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25518068|NCT00440180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518069|NCT00440193|Enoxaparin|enoxaparin|mesh-list
25518070|NCT00440193|Rivaroxaban|rivaroxaban|mesh-list
25518071|NCT00440193|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25518072|NCT00440193|Antithrombins|antithrombins|mesh-ancestor
25518073|NCT00440193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25518074|NCT00440193|Protease Inhibitors|protease inhibitors|mesh-ancestor
25518075|NCT00440193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518076|NCT00440193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518077|NCT00440193|Anticoagulants|anticoagulants|mesh-ancestor
25518078|NCT00440193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25518079|NCT00440193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25518080|NCT00440232|Frovatriptan|frovatriptan|mesh-list
25518081|NCT00440232|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25518082|NCT00440232|Serotonin Agents|serotonin agents|mesh-ancestor
25518083|NCT00440232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25518084|NCT00440232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518085|NCT00440232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518086|NCT00440310|Talaporfin|talaporfin|mesh-list
25518087|NCT00440310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518088|NCT00440310|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25518089|NCT00440310|Dermatologic Agents|dermatologic agents|mesh-ancestor
25518090|NCT00440401|Thrombin|thrombin|mesh-list
25518091|NCT00440401|Hemostatics|hemostatics|mesh-list
25518092|NCT00440401|Coagulants|coagulants|mesh-ancestor
25518093|NCT00440466|Epoetin Alfa|epoetin alfa|mesh-list
25518094|NCT00440466|Hematinics|hematinics|mesh-ancestor
25518095|NCT00440505|Nicotine|nicotine|mesh-list
25518096|NCT00440505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25518097|NCT00440505|Autonomic Agents|autonomic agents|mesh-ancestor
24404708|NCT00164710|Amodiaquine|amodiaquine|mesh-list
25518098|NCT00440505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25518099|NCT00440505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988249|NCT03631004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24988250|NCT03631004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24988251|NCT03631004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988252|NCT03631004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24988253|NCT03631004|Serotonin Agents|serotonin agents|mesh-ancestor
24988254|NCT03615664|Gemcitabine|gemcitabine|mesh-list
24988255|NCT03615664|Dexamethasone|dexamethasone|mesh-list
24988256|NCT03615664|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25646594|NCT01461538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25646595|NCT01461538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646596|NCT01461538|Immunologic Factors|immunologic factors|mesh-ancestor
25646597|NCT01461538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646598|NCT01461551|Propofol|propofol|mesh-list
25518100|NCT00440505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25518101|NCT00440505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25518102|NCT00440505|Cholinergic Agents|cholinergic agents|mesh-ancestor
25518103|NCT00440505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25518104|NCT00440505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518105|NCT00440518|Lacosamide|lacosamide|mesh-list
25518106|NCT00440518|Anticonvulsants|anticonvulsants|mesh-ancestor
25518107|NCT00440518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25518108|NCT00440518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25518109|NCT00440518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25518110|NCT00440518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518111|NCT00440557|Epoetin Alfa|epoetin alfa|mesh-list
25518112|NCT00440557|Hematinics|hematinics|mesh-ancestor
25518113|NCT00440726|Cytarabine|cytarabine|mesh-list
25518114|NCT00440726|Dexamethasone|dexamethasone|mesh-list
25518115|NCT00440726|Doxorubicin|doxorubicin|mesh-list
25518116|NCT00440726|Methotrexate|methotrexate|mesh-list
25518117|NCT00440726|Vincristine|vincristine|mesh-list
25518118|NCT00440726|Bortezomib|bortezomib|mesh-list
25518119|NCT00440726|Asparaginase|asparaginase|mesh-list
25518120|NCT00440726|Pegaspargase|pegaspargase|mesh-list
25518121|NCT00440726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25518122|NCT00440726|Antiemetics|antiemetics|mesh-ancestor
25518123|NCT00440726|Autonomic Agents|autonomic agents|mesh-ancestor
25518124|NCT00440726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25518125|NCT00440726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518126|NCT00440726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25518127|NCT00440726|Glucocorticoids|glucocorticoids|mesh-ancestor
25518128|NCT00440726|Hormones|hormones|mesh-ancestor
25518129|NCT00440726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25518130|NCT00440726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25518131|NCT00440726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518132|NCT00440726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25518133|NCT00440726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25518134|NCT00440726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25518135|NCT00440726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518136|NCT00440726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518137|NCT00440726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25518138|NCT00440726|Abortifacient Agents|abortifacient agents|mesh-ancestor
25518139|NCT00440726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25518140|NCT00440726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25518141|NCT00440726|Antimetabolites|antimetabolites|mesh-ancestor
25518142|NCT00440726|Dermatologic Agents|dermatologic agents|mesh-ancestor
25518143|NCT00440726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25518144|NCT00440726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25518145|NCT00440726|Immunologic Factors|immunologic factors|mesh-ancestor
25518146|NCT00440726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25518147|NCT00440726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25518148|NCT00440726|Antiviral Agents|antiviral agents|mesh-ancestor
25518149|NCT00440726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25518150|NCT00440726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25518151|NCT00440726|Tubulin Modulators|tubulin modulators|mesh-ancestor
25518152|NCT00440726|Antimitotic Agents|antimitotic agents|mesh-ancestor
25518153|NCT00440726|Mitosis Modulators|mitosis modulators|mesh-ancestor
25518154|NCT00440830|Nicotine|nicotine|mesh-list
25518155|NCT00440830|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25518156|NCT00440830|Autonomic Agents|autonomic agents|mesh-ancestor
25518157|NCT00440830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25518158|NCT00440830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518159|NCT00440830|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25518160|NCT00440830|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25518161|NCT00440830|Cholinergic Agents|cholinergic agents|mesh-ancestor
24988311|NCT03368963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988312|NCT03368963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988313|NCT03368963|Antimetabolites|antimetabolites|mesh-ancestor
24988314|NCT03368963|Antiviral Agents|antiviral agents|mesh-ancestor
24988315|NCT03368963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24988316|NCT03345823|Upadacitinib|upadacitinib|mesh-list
24988348|NCT03130036|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25049527|NCT00595426|Warfarin|warfarin|mesh-list
24988349|NCT03130036|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24988350|NCT03130036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988351|NCT03127215|Olaparib|olaparib|mesh-list
24988352|NCT03127215|Trabectedin|trabectedin|mesh-list
25646599|NCT01461551|Sevoflurane|sevoflurane|mesh-list
25646600|NCT01461551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25646601|NCT01461551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25646602|NCT01461551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646603|NCT01461551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25646604|NCT01461551|Anesthetics, General|anesthetics, general|mesh-ancestor
25646605|NCT01461551|Anesthetics|anesthetics|mesh-ancestor
25646606|NCT01461551|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25646607|NCT01461551|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25646608|NCT01461668|Retapamulin|retapamulin|mesh-list
24988353|NCT03127215|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25518162|NCT00440830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25518163|NCT00440830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518164|NCT00440947|Ritonavir|ritonavir|mesh-list
25518165|NCT00440947|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25518166|NCT00440947|Lamivudine|lamivudine|mesh-list
25518167|NCT00440947|Abacavir|abacavir|mesh-list
25518168|NCT00440947|Dideoxynucleosides|dideoxynucleosides|mesh-list
25518169|NCT00440947|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25518170|NCT00440947|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25518171|NCT00440947|Protease Inhibitors|protease inhibitors|mesh-ancestor
25518172|NCT00440947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518173|NCT00440947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518174|NCT00440947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25518175|NCT00440947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25518176|NCT00440947|Antiviral Agents|antiviral agents|mesh-ancestor
25518177|NCT00440947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25518178|NCT00440947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25518179|NCT00440947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25518180|NCT00440947|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25518181|NCT00440947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25518182|NCT00440947|Antimetabolites|antimetabolites|mesh-ancestor
25518183|NCT00440999|Artesunate|artesunate|mesh-list
25518184|NCT00440999|Chloroquine|chloroquine|mesh-list
25518185|NCT00440999|Pyronaridine|pyronaridine|mesh-list
25518186|NCT00440999|Antimalarials|antimalarials|mesh-ancestor
25518187|NCT00440999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25518188|NCT00440999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25518189|NCT00440999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25518190|NCT00440999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518191|NCT00440999|Antiviral Agents|antiviral agents|mesh-ancestor
25518192|NCT00440999|Schistosomicides|schistosomicides|mesh-ancestor
25518193|NCT00440999|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25518194|NCT00440999|Anthelmintics|anthelmintics|mesh-ancestor
25518195|NCT00440999|Amebicides|amebicides|mesh-ancestor
25518196|NCT00440999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25518197|NCT00441103|Interferon beta-1a|interferon beta-1a|mesh-list
25518198|NCT00441103|Interferon-beta|interferon-beta|mesh-list
25518199|NCT00441103|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25518200|NCT00441103|Immunologic Factors|immunologic factors|mesh-ancestor
25518201|NCT00441103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518202|NCT00441103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518203|NCT00441103|Antiviral Agents|antiviral agents|mesh-ancestor
25518204|NCT00441103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25518205|NCT00441116|Dutasteride|dutasteride|mesh-list
25518206|NCT00441116|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25518207|NCT00441116|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25518208|NCT00441116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518209|NCT00441116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518210|NCT00441116|Hormone Antagonists|hormone antagonists|mesh-ancestor
24811697|NCT02047799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25518211|NCT00441116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25518212|NCT00441116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518213|NCT00441129|Insulin|insulin|mesh-list
25518214|NCT00441129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25518215|NCT00441129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518216|NCT00441142|Temozolomide|temozolomide|mesh-list
25518217|NCT00441142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25518218|NCT00441142|Alkylating Agents|alkylating agents|mesh-ancestor
25518219|NCT00441142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518220|NCT00441142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518221|NCT00441168|Dexamethasone|dexamethasone|mesh-list
25518222|NCT00441168|Vincristine|vincristine|mesh-list
25518223|NCT00441168|Doxorubicin|doxorubicin|mesh-list
25518224|NCT00441168|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25518225|NCT00441168|Bortezomib|bortezomib|mesh-list
25518226|NCT00441168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25518227|NCT00441168|Antiemetics|antiemetics|mesh-ancestor
25518228|NCT00441168|Autonomic Agents|autonomic agents|mesh-ancestor
25518229|NCT00441168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25518230|NCT00441168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646609|NCT01461668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25646610|NCT01461668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25646611|NCT01461733|Amiodarone|amiodarone|mesh-list
25646612|NCT01461733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25646613|NCT01461733|Vasodilator Agents|vasodilator agents|mesh-ancestor
25646614|NCT01461733|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25646615|NCT01461733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25646616|NCT01461733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646617|NCT01461733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25646618|NCT01461733|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25646619|NCT01461733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25646620|NCT01461733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646621|NCT01461733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25646622|NCT01461733|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25518231|NCT00441168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25518232|NCT00441168|Glucocorticoids|glucocorticoids|mesh-ancestor
25518233|NCT00441168|Hormones|hormones|mesh-ancestor
25518234|NCT00441168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25518235|NCT00441168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25518236|NCT00441168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518237|NCT00441168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25518238|NCT00441168|Tubulin Modulators|tubulin modulators|mesh-ancestor
24988420|NCT02849990|Tocolytic Agents|tocolytic agents|mesh-ancestor
25518239|NCT00441168|Antimitotic Agents|antimitotic agents|mesh-ancestor
25518240|NCT00441168|Mitosis Modulators|mitosis modulators|mesh-ancestor
25518241|NCT00441168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518242|NCT00441168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25518243|NCT00441168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25518244|NCT00441168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25518245|NCT00441168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518246|NCT00441285|Albendazole|albendazole|mesh-list
25518247|NCT00441285|Praziquantel|praziquantel|mesh-list
25518248|NCT00441285|Anthelmintics|anthelmintics|mesh-ancestor
25518249|NCT00441285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25518250|NCT00441285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25646623|NCT01461733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25646624|NCT01461824|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25646625|NCT01461824|Medroxyprogesterone|medroxyprogesterone|mesh-list
25518251|NCT00441285|Anticestodal Agents|anticestodal agents|mesh-ancestor
25518252|NCT00441285|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25518253|NCT00441285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25518254|NCT00441285|Tubulin Modulators|tubulin modulators|mesh-ancestor
25518255|NCT00441285|Antimitotic Agents|antimitotic agents|mesh-ancestor
25518256|NCT00441285|Mitosis Modulators|mitosis modulators|mesh-ancestor
25518257|NCT00441285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518258|NCT00441285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518259|NCT00441337|Nivolumab|nivolumab|mesh-list
25518260|NCT00441337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25518261|NCT00441337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518262|NCT00441337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25518263|NCT00441337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518264|NCT00441363|Bromocriptine|bromocriptine|mesh-list
25518265|NCT00441363|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25518266|NCT00441363|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25518267|NCT00441363|Hormone Antagonists|hormone antagonists|mesh-ancestor
25518268|NCT00441363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25518269|NCT00441363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518270|NCT00441363|Dopamine Agonists|dopamine agonists|mesh-ancestor
25518271|NCT00441363|Dopamine Agents|dopamine agents|mesh-ancestor
25518272|NCT00441363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25518273|NCT00441363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518274|NCT00441441|Fluticasone|fluticasone|mesh-list
25518275|NCT00441441|Xhance|xhance|mesh-list
25518276|NCT00441441|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25004283|NCT02187354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646626|NCT01461824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25646627|NCT01461824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25646628|NCT01461824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25646629|NCT01461824|Contraceptive Agents|contraceptive agents|mesh-ancestor
25646630|NCT01461824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25646631|NCT01461824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646632|NCT01461824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25646633|NCT01461824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25518277|NCT00441441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25518278|NCT00441441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25518279|NCT00441441|Autonomic Agents|autonomic agents|mesh-ancestor
25518280|NCT00441441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25518281|NCT00441441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518282|NCT00441441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25518283|NCT00441441|Respiratory System Agents|respiratory system agents|mesh-ancestor
25518284|NCT00441441|Dermatologic Agents|dermatologic agents|mesh-ancestor
25518285|NCT00441441|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25518286|NCT00441441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25518287|NCT00441441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25518288|NCT00441441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25518289|NCT00441441|Adrenergic Agents|adrenergic agents|mesh-ancestor
25518290|NCT00441441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25518291|NCT00441441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518292|NCT00441545|Sevelamer|sevelamer|mesh-list
25518293|NCT00441545|Chelating Agents|chelating agents|mesh-ancestor
25518294|NCT00441545|Sequestering Agents|sequestering agents|mesh-ancestor
25518295|NCT00441545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518296|NCT00441584|Ribavirin|ribavirin|mesh-list
25518297|NCT00441584|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25518298|NCT00441584|Interferon-alpha|interferon-alpha|mesh-list
25518299|NCT00441584|Antimetabolites|antimetabolites|mesh-ancestor
25518300|NCT00441584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518301|NCT00441584|Antiviral Agents|antiviral agents|mesh-ancestor
25518302|NCT00441584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25518303|NCT00441584|Immunologic Factors|immunologic factors|mesh-ancestor
25518304|NCT00441584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518305|NCT00441727|Esomeprazole|esomeprazole|mesh-list
25518306|NCT00441727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25518307|NCT00441727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25518308|NCT00441727|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25518309|NCT00441727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518310|NCT00441727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518311|NCT00441792|Midazolam|midazolam|mesh-list
25518312|NCT00441792|Etomidate|etomidate|mesh-list
25518313|NCT00441792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25518314|NCT00441792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24796871|NCT01952756|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25518315|NCT00441792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25518316|NCT00441792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518317|NCT00441792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25518318|NCT00441792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25518319|NCT00441792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25518320|NCT00441792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25518321|NCT00441792|Anesthetics, General|anesthetics, general|mesh-ancestor
25518322|NCT00441792|Anesthetics|anesthetics|mesh-ancestor
25518323|NCT00441792|GABA Modulators|gaba modulators|mesh-ancestor
25518324|NCT00441792|GABA Agents|gaba agents|mesh-ancestor
25518325|NCT00441792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25165525|NCT04766996|Coagulants|coagulants|mesh-ancestor
25518326|NCT00441792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518327|NCT00441883|Latanoprost|latanoprost|mesh-list
25518328|NCT00441883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25518329|NCT00441883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25518331|NCT00441974|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25518332|NCT00441974|Antiviral Agents|antiviral agents|mesh-ancestor
25518333|NCT00441974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25518334|NCT00441974|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25518335|NCT00441974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25518336|NCT00441974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518337|NCT00441974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518338|NCT00442013|Lansoprazole|lansoprazole|mesh-list
25518339|NCT00442013|Dexlansoprazole|dexlansoprazole|mesh-list
25518340|NCT00442013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25518341|NCT00442013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25518342|NCT00442013|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25518343|NCT00442013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646634|NCT01461824|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25646635|NCT01461824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25646636|NCT01461824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646637|NCT01461928|Rituximab|rituximab|mesh-list
25646638|NCT01461928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25646639|NCT01461928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646640|NCT01461928|Immunologic Factors|immunologic factors|mesh-ancestor
25646641|NCT01461928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646642|NCT01461928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25646643|NCT01462227|Naltrexone|naltrexone|mesh-list
25646644|NCT01462227|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25646645|NCT01462227|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25646646|NCT01462227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518344|NCT00442013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518345|NCT00442169|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25518346|NCT00442364|Polidocanol|polidocanol|mesh-list
25518347|NCT00442364|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25518348|NCT00442364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25518349|NCT00442416|Epoetin Alfa|epoetin alfa|mesh-list
25518350|NCT00442416|Hematinics|hematinics|mesh-ancestor
25518351|NCT00442507|Bevacizumab|bevacizumab|mesh-list
25518352|NCT00442507|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25518353|NCT00442507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25518354|NCT00442507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518355|NCT00442507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25518356|NCT00442507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25518357|NCT00442507|Growth Substances|growth substances|mesh-ancestor
25518358|NCT00442507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518359|NCT00442507|Growth Inhibitors|growth inhibitors|mesh-ancestor
25518360|NCT00442507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25518361|NCT00442507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518362|NCT00442507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518363|NCT00442572|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25518364|NCT00442572|Antiviral Agents|antiviral agents|mesh-ancestor
25518365|NCT00442572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25518366|NCT00442611|Abatacept|abatacept|mesh-list
25518367|NCT00442611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25518368|NCT00442611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518369|NCT00442611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518370|NCT00442611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25518371|NCT00442611|Immunologic Factors|immunologic factors|mesh-ancestor
25518372|NCT00442611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518373|NCT00442611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25518374|NCT00442689|Flutamide|flutamide|mesh-list
25518375|NCT00442689|Drospirenone|drospirenone|mesh-list
25518376|NCT00442689|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25518377|NCT00442689|Estradiol|estradiol|mesh-list
25518378|NCT00442689|Estrogens|estrogens|mesh-ancestor
25518379|NCT00442689|Hormones|hormones|mesh-ancestor
25518380|NCT00442689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25518381|NCT00442689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046163|NCT00871182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25046164|NCT00871182|Cholinergic Agents|cholinergic agents|mesh-ancestor
25046165|NCT00871182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25046166|NCT00871182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046168|NCT00870688|Anticonvulsants|anticonvulsants|mesh-ancestor
25046169|NCT00870688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584433|NCT00880373|Heroin|heroin|mesh-list
25518382|NCT00442689|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25518383|NCT00442689|Contraceptive Agents|contraceptive agents|mesh-ancestor
25518384|NCT00442689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25518385|NCT00442689|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25518386|NCT00442689|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25518387|NCT00442689|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25518388|NCT00442689|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25518389|NCT00442689|Hormone Antagonists|hormone antagonists|mesh-ancestor
25518390|NCT00442689|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25518392|NCT00442689|Natriuretic Agents|natriuretic agents|mesh-ancestor
25518393|NCT00442689|Androgen Antagonists|androgen antagonists|mesh-ancestor
25518394|NCT00442689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25518395|NCT00442689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518396|NCT00442702|Darbepoetin alfa|darbepoetin alfa|mesh-list
25518397|NCT00442702|Hematinics|hematinics|mesh-ancestor
25518398|NCT00442767|Insulin|insulin|mesh-list
25518399|NCT00442767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25518400|NCT00442767|Pramlintide|pramlintide|mesh-list
25518401|NCT00442767|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
25518402|NCT00442767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25518403|NCT00442767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518404|NCT00442767|Appetite Depressants|appetite depressants|mesh-ancestor
25518405|NCT00442767|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25518406|NCT00442767|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
25518407|NCT00442767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518409|NCT00442936|Zolmitriptan|zolmitriptan|mesh-list
25518410|NCT00442936|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25518411|NCT00442936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25518412|NCT00442936|Serotonin Agents|serotonin agents|mesh-ancestor
25518413|NCT00442936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25518414|NCT00442936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518415|NCT00442936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518416|NCT00442936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25518417|NCT00442936|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25518418|NCT00442936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518419|NCT00442962|Tenofovir|tenofovir|mesh-list
25518420|NCT00442962|Emtricitabine|emtricitabine|mesh-list
25518421|NCT00442962|Efavirenz|efavirenz|mesh-list
25518422|NCT00442962|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25518423|NCT00442962|Antiviral Agents|antiviral agents|mesh-ancestor
25518424|NCT00442962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25518425|NCT00442962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25518426|NCT00442962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25518427|NCT00442962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518428|NCT00442962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518429|NCT00442962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25518430|NCT00442962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25518431|NCT00442962|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25518432|NCT00442962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25518433|NCT00442962|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25518434|NCT00442962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25518435|NCT00442962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25518436|NCT00442962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25518437|NCT00443053|PENTA|penta|mesh-list
25518438|NCT00443053|Fondaparinux|fondaparinux|mesh-list
25518439|NCT00443053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25518440|NCT00443053|Antithrombins|antithrombins|mesh-ancestor
25518441|NCT00443053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25518442|NCT00443053|Protease Inhibitors|protease inhibitors|mesh-ancestor
25518443|NCT00443053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518444|NCT00443053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518445|NCT00443053|Anticoagulants|anticoagulants|mesh-ancestor
25518446|NCT00443053|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25518447|NCT00443053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25518448|NCT00443209|Rizatriptan|rizatriptan|mesh-list
25518449|NCT00443209|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25518450|NCT00443209|Serotonin Agents|serotonin agents|mesh-ancestor
25518451|NCT00443209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25518452|NCT00443209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518453|NCT00443209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518454|NCT00443261|Cisplatin|cisplatin|mesh-list
25518455|NCT00443261|Azacitidine|azacitidine|mesh-list
24988591|NCT02323659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24988593|NCT02323659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25518462|NCT00443352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25518464|NCT00443352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25518465|NCT00443352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518466|NCT00443352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25518467|NCT00443352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518468|NCT00443352|Analgesics|analgesics|mesh-ancestor
25518469|NCT00443352|Sensory System Agents|sensory system agents|mesh-ancestor
25518470|NCT00443352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25518471|NCT00443352|Antidepressive Agents|antidepressive agents|mesh-ancestor
25518472|NCT00443352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25518473|NCT00443352|Dopamine Agents|dopamine agents|mesh-ancestor
25518474|NCT00443430|Prednisone|prednisone|mesh-list
25518475|NCT00443430|Prednisolone|prednisolone|mesh-list
25518476|NCT00443430|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25518477|NCT00443430|Methylprednisolone|methylprednisolone|mesh-list
25518478|NCT00443430|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25518479|NCT00443430|Prednisolone acetate|prednisolone acetate|mesh-list
25518481|NCT00443430|Methotrexate|methotrexate|mesh-list
25518482|NCT00443430|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25518483|NCT00443430|Prednisolone phosphate|prednisolone phosphate|mesh-list
25518484|NCT00443430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25518485|NCT00443430|Glucocorticoids|glucocorticoids|mesh-ancestor
25518486|NCT00443430|Hormones|hormones|mesh-ancestor
25518487|NCT00443430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25518488|NCT00443430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518489|NCT00443430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25518490|NCT00443430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518491|NCT00443430|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25518492|NCT00443430|Abortifacient Agents|abortifacient agents|mesh-ancestor
25518493|NCT00443430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25518494|NCT00443430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25518495|NCT00443430|Antimetabolites|antimetabolites|mesh-ancestor
25518496|NCT00443430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518497|NCT00443430|Dermatologic Agents|dermatologic agents|mesh-ancestor
25518498|NCT00443430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518499|NCT00443430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25518500|NCT00443430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25518501|NCT00443430|Immunologic Factors|immunologic factors|mesh-ancestor
25518502|NCT00443430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25518503|NCT00443430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25518504|NCT00443430|Antiemetics|antiemetics|mesh-ancestor
25518505|NCT00443430|Autonomic Agents|autonomic agents|mesh-ancestor
25518506|NCT00443430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25518507|NCT00443430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25518508|NCT00443430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25518509|NCT00443430|Protective Agents|protective agents|mesh-ancestor
25518510|NCT00443430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25518511|NCT00443430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25518512|NCT00443430|Analgesics|analgesics|mesh-ancestor
25518513|NCT00443430|Sensory System Agents|sensory system agents|mesh-ancestor
25518514|NCT00443456|Amlodipine|amlodipine|mesh-list
25518515|NCT00443456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25518516|NCT00443456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25518517|NCT00443456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25518518|NCT00443456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518519|NCT00443456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25518520|NCT00443456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518521|NCT00443456|Vasodilator Agents|vasodilator agents|mesh-ancestor
25518522|NCT00443534|Sunitinib|sunitinib|mesh-list
25518523|NCT00443534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518524|NCT00443534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25518525|NCT00443534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25518526|NCT00443534|Growth Substances|growth substances|mesh-ancestor
25518527|NCT00443534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518528|NCT00443534|Growth Inhibitors|growth inhibitors|mesh-ancestor
25518529|NCT00443534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25518530|NCT00443534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518531|NCT00443534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518532|NCT00443560|Fentanyl|fentanyl|mesh-list
25518533|NCT00443560|Bupivacaine|bupivacaine|mesh-list
25518534|NCT00443560|Anesthetics, Local|anesthetics, local|mesh-ancestor
25518535|NCT00443560|Anesthetics|anesthetics|mesh-ancestor
25518536|NCT00443560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25518537|NCT00443560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518538|NCT00443560|Sensory System Agents|sensory system agents|mesh-ancestor
25518539|NCT00443560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25518540|NCT00443560|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25518541|NCT00443560|Narcotics|narcotics|mesh-ancestor
25518542|NCT00443560|Analgesics|analgesics|mesh-ancestor
25518543|NCT00443560|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25518544|NCT00443560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25518545|NCT00443560|Anesthetics, General|anesthetics, general|mesh-ancestor
25518546|NCT00443651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25518547|NCT00443651|Rituximab|rituximab|mesh-list
25518548|NCT00443651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25518549|NCT00443651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518550|NCT00443651|Immunologic Factors|immunologic factors|mesh-ancestor
25518551|NCT00443651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518552|NCT00443651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25518553|NCT00443703|Ritonavir|ritonavir|mesh-list
25518555|NCT00443703|Raltegravir Potassium|raltegravir potassium|mesh-list
25518556|NCT00443703|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25518557|NCT00443703|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25518558|NCT00443703|Protease Inhibitors|protease inhibitors|mesh-ancestor
25518559|NCT00443703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518560|NCT00443703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518561|NCT00443703|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25518562|NCT00443703|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25518563|NCT00443703|Antiviral Agents|antiviral agents|mesh-ancestor
25518564|NCT00443703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25518565|NCT00443703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25518566|NCT00443703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25518567|NCT00443703|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25518568|NCT00443703|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25518569|NCT00443729|Ritonavir|ritonavir|mesh-list
25518570|NCT00443729|Lopinavir|lopinavir|mesh-list
25518571|NCT00443729|Raltegravir Potassium|raltegravir potassium|mesh-list
25518572|NCT00443729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25518573|NCT00443729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25518574|NCT00443729|Protease Inhibitors|protease inhibitors|mesh-ancestor
25518575|NCT00443729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518576|NCT00443729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518577|NCT00443729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25518578|NCT00443729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25518579|NCT00443729|Antiviral Agents|antiviral agents|mesh-ancestor
25518580|NCT00443729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25518581|NCT00443729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25518582|NCT00443729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25518583|NCT00443729|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25518584|NCT00443729|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25518585|NCT00443755|Metformin|metformin|mesh-list
25518586|NCT00443755|Pioglitazone|pioglitazone|mesh-list
25518587|NCT00443755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25518588|NCT00443755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518589|NCT00443781|Anesthetics|anesthetics|mesh-list
25518590|NCT00443781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25518591|NCT00443781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518592|NCT00443820|Terbinafine|terbinafine|mesh-list
25518593|NCT00443820|Antifungal Agents|antifungal agents|mesh-ancestor
25518594|NCT00443820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25518595|NCT00443820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518596|NCT00443820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988751|NCT00867178|Thiotepa|thiotepa|mesh-list
25518597|NCT00443872|Selegiline|selegiline|mesh-list
25518598|NCT00443872|Antidepressive Agents|antidepressive agents|mesh-ancestor
25518599|NCT00443872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25518600|NCT00443872|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25518601|NCT00443872|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25518602|NCT00443872|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25518603|NCT00443872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518604|NCT00443872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518605|NCT00443872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25518606|NCT00443872|Protective Agents|protective agents|mesh-ancestor
25518607|NCT00443872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518608|NCT00443898|Terbinafine|terbinafine|mesh-list
25518609|NCT00443898|Antifungal Agents|antifungal agents|mesh-ancestor
25518610|NCT00443898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25518611|NCT00443898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518612|NCT00443898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518613|NCT00444028|Loxapine|loxapine|mesh-list
25518614|NCT00444028|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25518615|NCT00444028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25518616|NCT00444028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25518617|NCT00444028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518618|NCT00444028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25518619|NCT00444028|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25518620|NCT00444028|Dopamine Agents|dopamine agents|mesh-ancestor
25518621|NCT00444028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25518622|NCT00444028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518623|NCT00444106|Artesunate|artesunate|mesh-list
25518624|NCT00444106|Lumefantrine|lumefantrine|mesh-list
25518625|NCT00444106|Artemether|artemether|mesh-list
25518626|NCT00444106|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25518627|NCT00444106|Mefloquine|mefloquine|mesh-list
25518628|NCT00444106|Atovaquone|atovaquone|mesh-list
25518629|NCT00444106|Proguanil|proguanil|mesh-list
25518630|NCT00444106|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
25518631|NCT00444106|Antimalarials|antimalarials|mesh-ancestor
25518632|NCT00444106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25518633|NCT00444106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25518634|NCT00444106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25518635|NCT00444106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518636|NCT00444106|Antiviral Agents|antiviral agents|mesh-ancestor
25518637|NCT00444106|Schistosomicides|schistosomicides|mesh-ancestor
25518638|NCT00444106|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25518639|NCT00444106|Anthelmintics|anthelmintics|mesh-ancestor
25518640|NCT00444106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518641|NCT00444106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518642|NCT00444106|Antimetabolites|antimetabolites|mesh-ancestor
25518643|NCT00444145|Lansoprazole|lansoprazole|mesh-list
25518644|NCT00444145|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25518645|NCT00444145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25518646|NCT00444145|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25518647|NCT00444145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518648|NCT00444145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518649|NCT00444275|Esomeprazole|esomeprazole|mesh-list
25518650|NCT00444275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25518651|NCT00444275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25518652|NCT00444275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25518653|NCT00444275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518654|NCT00444275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518655|NCT00444457|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25518656|NCT00444457|Immunologic Factors|immunologic factors|mesh-ancestor
25518657|NCT00444457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518658|NCT00444535|Bevacizumab|bevacizumab|mesh-list
25518659|NCT00444535|Lapatinib|lapatinib|mesh-list
25518660|NCT00444535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25518661|NCT00444535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988796|NCT00352534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988797|NCT00352534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24988798|NCT00352534|Tubulin Modulators|tubulin modulators|mesh-ancestor
24988799|NCT00352534|Antimitotic Agents|antimitotic agents|mesh-ancestor
24988800|NCT00352534|Mitosis Modulators|mitosis modulators|mesh-ancestor
24988801|NCT00352534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24988802|NCT00352534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24988803|NCT00352534|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24988804|NCT00352534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24988806|NCT00033293|Cyclophosphamide|cyclophosphamide|mesh-list
24988807|NCT00033293|Immunoglobulins|immunoglobulins|mesh-list
25518662|NCT00444535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25518663|NCT00444535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25518664|NCT00444535|Growth Substances|growth substances|mesh-ancestor
25518665|NCT00444535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518666|NCT00444535|Growth Inhibitors|growth inhibitors|mesh-ancestor
25518667|NCT00444535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25518668|NCT00444535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518669|NCT00444535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518670|NCT00444587|Trastuzumab|trastuzumab|mesh-list
24406084|NCT00169091|Autonomic Agents|autonomic agents|mesh-ancestor
25518671|NCT00444587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25518672|NCT00444587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518673|NCT00444600|Triamcinolone|triamcinolone|mesh-list
25518674|NCT00444600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25518675|NCT00444600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25518676|NCT00444600|Ranibizumab|ranibizumab|mesh-list
25518677|NCT00444600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25518678|NCT00444600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25518679|NCT00444600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25518680|NCT00444600|Growth Substances|growth substances|mesh-ancestor
25518681|NCT00444600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518682|NCT00444600|Growth Inhibitors|growth inhibitors|mesh-ancestor
25518683|NCT00444600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518684|NCT00444600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25518685|NCT00444600|Glucocorticoids|glucocorticoids|mesh-ancestor
25518686|NCT00444600|Hormones|hormones|mesh-ancestor
25518687|NCT00444600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25518688|NCT00444600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25518689|NCT00444600|Immunologic Factors|immunologic factors|mesh-ancestor
25518690|NCT00444600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518691|NCT00444600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518692|NCT00444626|Lidocaine|lidocaine|mesh-list
25518694|NCT00444626|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25518695|NCT00444626|Hyaluronic Acid|hyaluronic acid|mesh-list
25518696|NCT00444626|Anesthetics, Local|anesthetics, local|mesh-ancestor
25518697|NCT00444626|Anesthetics|anesthetics|mesh-ancestor
25518698|NCT00444626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25518699|NCT00444626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518700|NCT00444626|Sensory System Agents|sensory system agents|mesh-ancestor
25518701|NCT00444626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25518702|NCT00444626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25518703|NCT00444626|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25518704|NCT00444626|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25518705|NCT00444626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25518706|NCT00444626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518707|NCT00444626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25518708|NCT00444626|Immunologic Factors|immunologic factors|mesh-ancestor
25518709|NCT00444626|Viscosupplements|viscosupplements|mesh-ancestor
25518710|NCT00444626|Protective Agents|protective agents|mesh-ancestor
25518711|NCT00444626|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25518712|NCT00444678|Capecitabine|capecitabine|mesh-list
25518713|NCT00444678|Oxaliplatin|oxaliplatin|mesh-list
25518714|NCT00444678|Cetuximab|cetuximab|mesh-list
25518715|NCT00444678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25518716|NCT00444678|Antimetabolites|antimetabolites|mesh-ancestor
25518717|NCT00444678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518718|NCT00444678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518719|NCT00444678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25518720|NCT00444795|Sunitinib|sunitinib|mesh-list
25518721|NCT00444795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518722|NCT00444795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25518723|NCT00444795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25518724|NCT00444795|Growth Substances|growth substances|mesh-ancestor
25518725|NCT00444795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518726|NCT00444795|Growth Inhibitors|growth inhibitors|mesh-ancestor
25518727|NCT00444795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25518728|NCT00444795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518729|NCT00444795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518730|NCT00444912|Plerixafor|plerixafor|mesh-list
25518731|NCT00444912|Rituximab|rituximab|mesh-list
25518732|NCT00444912|Lenograstim|lenograstim|mesh-list
25518733|NCT00444912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24517738|NCT00609752|Prednisolone|prednisolone|mesh-list
24988860|NCT05193292|Trastuzumab|trastuzumab|mesh-list
24988862|NCT05193292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518734|NCT00444912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518735|NCT00444912|Immunologic Factors|immunologic factors|mesh-ancestor
25518736|NCT00444912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518737|NCT00444912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25518738|NCT00444912|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25518739|NCT00444912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25518740|NCT00444912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25518741|NCT00444912|Antiviral Agents|antiviral agents|mesh-ancestor
25518742|NCT00444912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25165647|NCT04725812|Eculizumab|eculizumab|mesh-list
25518743|NCT00444925|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25518745|NCT00444925|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25518746|NCT00444925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25518747|NCT00444925|Cholinergic Agents|cholinergic agents|mesh-ancestor
25518748|NCT00444925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25518749|NCT00444925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518750|NCT00444925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518751|NCT00444925|Urological Agents|urological agents|mesh-ancestor
25518752|NCT00444951|Vaccines|vaccines|mesh-list
25518753|NCT00444951|Immunologic Factors|immunologic factors|mesh-ancestor
25518754|NCT00444951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518755|NCT00444964|Hormones|hormones|mesh-list
25518756|NCT00444964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25518757|NCT00444964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518758|NCT00445003|Triamcinolone|triamcinolone|mesh-list
25518759|NCT00445003|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25518760|NCT00445003|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25518761|NCT00445003|Ranibizumab|ranibizumab|mesh-list
25518762|NCT00445003|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25518763|NCT00445003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25518764|NCT00445003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25518765|NCT00445003|Growth Substances|growth substances|mesh-ancestor
25518766|NCT00445003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518767|NCT00445003|Growth Inhibitors|growth inhibitors|mesh-ancestor
25518768|NCT00445003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518769|NCT00445003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25518770|NCT00445003|Glucocorticoids|glucocorticoids|mesh-ancestor
25518772|NCT00445003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25518773|NCT00445003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25518774|NCT00445003|Immunologic Factors|immunologic factors|mesh-ancestor
25518775|NCT00445003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518776|NCT00445003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518777|NCT00445068|Panobinostat|panobinostat|mesh-list
25518778|NCT00445068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518779|NCT00445068|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25518780|NCT00445068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518781|NCT00445068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518782|NCT00445146|Elvitegravir|elvitegravir|mesh-list
25518783|NCT00445146|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25518784|NCT00445146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25518785|NCT00445146|Antiviral Agents|antiviral agents|mesh-ancestor
25518786|NCT00445146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25518787|NCT00445146|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25518788|NCT00445146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518789|NCT00445146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518790|NCT00445211|Heparin|heparin|mesh-list
25518791|NCT00445211|Calcium heparin|calcium heparin|mesh-list
25518792|NCT00445211|Anticoagulants|anticoagulants|mesh-ancestor
25518793|NCT00445211|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25518794|NCT00445211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25518795|NCT00445211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518796|NCT00445263|Tirofiban|tirofiban|mesh-list
25518797|NCT00445263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25518798|NCT00445263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25518799|NCT00445263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518800|NCT00445263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25518801|NCT00445302|Plerixafor|plerixafor|mesh-list
25518802|NCT00445302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25518803|NCT00445302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25518804|NCT00445302|Antiviral Agents|antiviral agents|mesh-ancestor
24988897|NCT05192213|Hydrocortisone|hydrocortisone|mesh-list
24988898|NCT05192213|Vitamins|vitamins|mesh-ancestor
24988899|NCT05192213|Micronutrients|micronutrients|mesh-ancestor
25518805|NCT00445302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25518806|NCT00445328|Heparin|heparin|mesh-list
25518807|NCT00445328|Calcium heparin|calcium heparin|mesh-list
25518808|NCT00445328|Dalteparin|dalteparin|mesh-list
25518809|NCT00445328|Tinzaparin|tinzaparin|mesh-list
25518810|NCT00445328|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25518811|NCT00445328|Anticoagulants|anticoagulants|mesh-ancestor
25518812|NCT00445328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25518813|NCT00445328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25518814|NCT00445328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518815|NCT00445341|Alvocidib|alvocidib|mesh-list
25518816|NCT00445341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518817|NCT00445341|Growth Inhibitors|growth inhibitors|mesh-ancestor
25518818|NCT00445341|Growth Substances|growth substances|mesh-ancestor
25518819|NCT00445341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518820|NCT00445341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25518821|NCT00445341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518822|NCT00445341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518823|NCT00445432|Adalimumab|adalimumab|mesh-list
25518824|NCT00445432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25518825|NCT00445432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25518826|NCT00445458|Paclitaxel|paclitaxel|mesh-list
25518827|NCT00445458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25518828|NCT00445458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518829|NCT00445458|Tubulin Modulators|tubulin modulators|mesh-ancestor
25518830|NCT00445458|Antimitotic Agents|antimitotic agents|mesh-ancestor
25518831|NCT00445458|Mitosis Modulators|mitosis modulators|mesh-ancestor
25518832|NCT00445458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518833|NCT00445484|Lenalidomide|lenalidomide|mesh-list
25518834|NCT00445484|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25518835|NCT00445484|Immunologic Factors|immunologic factors|mesh-ancestor
25518836|NCT00445484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518837|NCT00445484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25518838|NCT00445484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25518839|NCT00445484|Growth Substances|growth substances|mesh-ancestor
25518840|NCT00445484|Growth Inhibitors|growth inhibitors|mesh-ancestor
25518841|NCT00445484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518842|NCT00445588|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25518843|NCT00445588|Sorafenib|sorafenib|mesh-list
25518844|NCT00445588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518845|NCT00445588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25518846|NCT00445588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518847|NCT00445588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518848|NCT00445601|Gemcitabine|gemcitabine|mesh-list
25518849|NCT00445601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25518850|NCT00445601|Antimetabolites|antimetabolites|mesh-ancestor
25518851|NCT00445601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518852|NCT00445601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518853|NCT00445601|Antiviral Agents|antiviral agents|mesh-ancestor
25518854|NCT00445601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25518855|NCT00445601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518856|NCT00445601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25518857|NCT00445601|Immunologic Factors|immunologic factors|mesh-ancestor
25518858|NCT00445601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518859|NCT00445679|Paroxetine|paroxetine|mesh-list
25518860|NCT00445679|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25518861|NCT00445679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25518862|NCT00445679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25518863|NCT00445679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518864|NCT00445679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25518865|NCT00445679|Serotonin Agents|serotonin agents|mesh-ancestor
25518866|NCT00445679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518867|NCT00445679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25518868|NCT00445679|Antidepressive Agents|antidepressive agents|mesh-ancestor
25518869|NCT00445679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25518870|NCT00445679|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25518871|NCT00445679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25518872|NCT00445679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518873|NCT00445692|Clarithromycin|clarithromycin|mesh-list
25518874|NCT00445692|Dexamethasone|dexamethasone|mesh-list
25518875|NCT00445692|Dexamethasone acetate|dexamethasone acetate|mesh-list
25518876|NCT00445692|Lenalidomide|lenalidomide|mesh-list
25518877|NCT00445692|Ichthammol|ichthammol|mesh-list
25518878|NCT00445692|BB 1101|bb 1101|mesh-list
25518879|NCT00445692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25518880|NCT00445692|Antiemetics|antiemetics|mesh-ancestor
25518881|NCT00445692|Autonomic Agents|autonomic agents|mesh-ancestor
25518882|NCT00445692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25518883|NCT00445692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518884|NCT00445692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25518885|NCT00445692|Glucocorticoids|glucocorticoids|mesh-ancestor
25518886|NCT00445692|Hormones|hormones|mesh-ancestor
25518887|NCT00445692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25518888|NCT00445692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25518889|NCT00445692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518890|NCT00445692|Immunologic Factors|immunologic factors|mesh-ancestor
25518891|NCT00445692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25518892|NCT00445692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25518893|NCT00445692|Growth Substances|growth substances|mesh-ancestor
25518894|NCT00445692|Growth Inhibitors|growth inhibitors|mesh-ancestor
25518895|NCT00445692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25518896|NCT00445692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25518897|NCT00445692|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25518898|NCT00445692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518899|NCT00445692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518900|NCT00445692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25518901|NCT00445692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25518902|NCT00445692|Protease Inhibitors|protease inhibitors|mesh-ancestor
25518903|NCT00445692|Dermatologic Agents|dermatologic agents|mesh-ancestor
25518904|NCT00445744|Cyclophosphamide|cyclophosphamide|mesh-list
25518905|NCT00445744|Busulfan|busulfan|mesh-list
25518906|NCT00445744|Methotrexate|methotrexate|mesh-list
25518907|NCT00445744|Tacrolimus|tacrolimus|mesh-list
25518908|NCT00445744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25518909|NCT00445744|Immunologic Factors|immunologic factors|mesh-ancestor
25518910|NCT00445744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518911|NCT00445744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25518912|NCT00445744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25518913|NCT00445744|Alkylating Agents|alkylating agents|mesh-ancestor
25518914|NCT00445744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518915|NCT00445744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518916|NCT00445744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25518917|NCT00445744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25518918|NCT00445744|Abortifacient Agents|abortifacient agents|mesh-ancestor
25518919|NCT00445744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25518920|NCT00445744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25518921|NCT00445744|Antimetabolites|antimetabolites|mesh-ancestor
25518922|NCT00445744|Dermatologic Agents|dermatologic agents|mesh-ancestor
25518923|NCT00445744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518924|NCT00445744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25518925|NCT00445744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25518926|NCT00445744|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25518927|NCT00445770|Etanercept|etanercept|mesh-list
25518928|NCT00445770|Methotrexate|methotrexate|mesh-list
25518929|NCT00445770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25518930|NCT00445770|Abortifacient Agents|abortifacient agents|mesh-ancestor
25518931|NCT00445770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25518932|NCT00445770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518933|NCT00445770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25518934|NCT00445770|Antimetabolites|antimetabolites|mesh-ancestor
25518935|NCT00445770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518936|NCT00445770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518937|NCT00445770|Dermatologic Agents|dermatologic agents|mesh-ancestor
25518938|NCT00445770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518939|NCT00445770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25518940|NCT00445770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25518941|NCT00445770|Immunologic Factors|immunologic factors|mesh-ancestor
25518942|NCT00445770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25518943|NCT00445770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25518944|NCT00445770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25518945|NCT00445770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25518946|NCT00445770|Analgesics|analgesics|mesh-ancestor
24517865|NCT00610493|Bevacizumab|bevacizumab|mesh-list
24517866|NCT00610493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24517867|NCT00610493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517868|NCT00610493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24517869|NCT00610493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24517911|NCT00610571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517912|NCT00610571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517913|NCT00610571|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25138317|NCT02979132|Iron|iron|mesh-list
25518947|NCT00445770|Sensory System Agents|sensory system agents|mesh-ancestor
25518948|NCT00445770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25518949|NCT00445770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25518950|NCT00445770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25518951|NCT00445848|Bevacizumab|bevacizumab|mesh-list
25518952|NCT00445848|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25518953|NCT00445848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25518954|NCT00445848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518955|NCT00445848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25518956|NCT00445848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25518957|NCT00445848|Growth Substances|growth substances|mesh-ancestor
25518958|NCT00445848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518959|NCT00445848|Growth Inhibitors|growth inhibitors|mesh-ancestor
25518960|NCT00445848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25518961|NCT00445848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25518962|NCT00445848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518963|NCT00445887|Levonorgestrel|levonorgestrel|mesh-list
25518964|NCT00445887|Norgestrel|norgestrel|mesh-list
25518965|NCT00445887|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25518966|NCT00445887|Contraceptive Agents|contraceptive agents|mesh-ancestor
25518967|NCT00445887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25518968|NCT00445887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518969|NCT00445887|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25518970|NCT00445887|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25518971|NCT00445887|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25518972|NCT00445887|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25518973|NCT00445939|Adalimumab|adalimumab|mesh-list
25518974|NCT00445939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25518975|NCT00445939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25518976|NCT00445978|Verapamil|verapamil|mesh-list
25518977|NCT00445978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25518978|NCT00445978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25646647|NCT01462227|Sensory System Agents|sensory system agents|mesh-ancestor
25646648|NCT01462227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25646649|NCT01462253|Cyclophosphamide|cyclophosphamide|mesh-list
25646650|NCT01462253|Clofarabine|clofarabine|mesh-list
25646651|NCT01462253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25518979|NCT00445978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25518980|NCT00445978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518981|NCT00445978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25518982|NCT00445978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518983|NCT00445978|Vasodilator Agents|vasodilator agents|mesh-ancestor
25518984|NCT00446030|Cyclophosphamide|cyclophosphamide|mesh-list
25518985|NCT00446030|Bevacizumab|bevacizumab|mesh-list
25518986|NCT00446030|Carboplatin|carboplatin|mesh-list
25518987|NCT00446030|Docetaxel|docetaxel|mesh-list
25518988|NCT00446030|Doxorubicin|doxorubicin|mesh-list
25518989|NCT00446030|Trastuzumab|trastuzumab|mesh-list
25518990|NCT00446030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25518991|NCT00446030|Immunologic Factors|immunologic factors|mesh-ancestor
25518992|NCT00446030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25518993|NCT00446030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25518994|NCT00446030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25518995|NCT00446030|Alkylating Agents|alkylating agents|mesh-ancestor
25518996|NCT00446030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25518997|NCT00446030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25518998|NCT00446030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25518999|NCT00446030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25519000|NCT00446030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25519001|NCT00446030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25519002|NCT00446030|Growth Substances|growth substances|mesh-ancestor
25519003|NCT00446030|Growth Inhibitors|growth inhibitors|mesh-ancestor
25519004|NCT00446030|Tubulin Modulators|tubulin modulators|mesh-ancestor
25519005|NCT00446030|Antimitotic Agents|antimitotic agents|mesh-ancestor
25519006|NCT00446030|Mitosis Modulators|mitosis modulators|mesh-ancestor
25519007|NCT00446030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25519008|NCT00446030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25519009|NCT00446030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25823394|NCT00004814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25823395|NCT00004814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25823396|NCT00004815|Hormones|hormones|mesh-list
25163010|NCT02900352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25519011|NCT00446134|Ribavirin|ribavirin|mesh-list
25519012|NCT00446134|Taribavirin|taribavirin|mesh-list
25519013|NCT00446134|Antimetabolites|antimetabolites|mesh-ancestor
25519014|NCT00446134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519015|NCT00446134|Antiviral Agents|antiviral agents|mesh-ancestor
25519016|NCT00446134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25519017|NCT00446147|Pyridoxine|pyridoxine|mesh-list
25519018|NCT00446147|Vitamin B Complex|vitamin b complex|mesh-ancestor
25519019|NCT00446147|Vitamins|vitamins|mesh-ancestor
25519020|NCT00446147|Micronutrients|micronutrients|mesh-ancestor
25519021|NCT00446147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519022|NCT00446199|Drospirenone|drospirenone|mesh-list
25102305|NCT03169777|Leucovorin|leucovorin|mesh-list
25519023|NCT00446199|Estradiol|estradiol|mesh-list
25519024|NCT00446199|Estrogens|estrogens|mesh-ancestor
25519025|NCT00446199|Hormones|hormones|mesh-ancestor
25519026|NCT00446199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25519027|NCT00446199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519028|NCT00446199|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25519029|NCT00446199|Hormone Antagonists|hormone antagonists|mesh-ancestor
25519030|NCT00446199|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25519031|NCT00446199|Diuretics|diuretics|mesh-ancestor
25519032|NCT00446199|Natriuretic Agents|natriuretic agents|mesh-ancestor
25519033|NCT00446251|Mycophenolic Acid|mycophenolic acid|mesh-list
25519034|NCT00446251|Rituximab|rituximab|mesh-list
25646652|NCT01462253|Immunologic Factors|immunologic factors|mesh-ancestor
25646653|NCT01462253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646654|NCT01462253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25646655|NCT01462253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25646656|NCT01462253|Alkylating Agents|alkylating agents|mesh-ancestor
25519035|NCT00446251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25519036|NCT00446251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519037|NCT00446251|Immunologic Factors|immunologic factors|mesh-ancestor
25519038|NCT00446251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519039|NCT00446251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25646657|NCT01462253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646658|NCT01462253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646659|NCT01462253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25519040|NCT00446251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25519041|NCT00446251|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25519042|NCT00446251|Antitubercular Agents|antitubercular agents|mesh-ancestor
25519043|NCT00446251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25519044|NCT00446251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25519045|NCT00446251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519046|NCT00446251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519047|NCT00446264|Sirolimus|sirolimus|mesh-list
25519048|NCT00446264|Tacrolimus|tacrolimus|mesh-list
25519049|NCT00446264|Daclizumab|daclizumab|mesh-list
25519050|NCT00446264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25519051|NCT00446264|Immunologic Factors|immunologic factors|mesh-ancestor
25519052|NCT00446264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519053|NCT00446264|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25519054|NCT00446264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519055|NCT00446264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519056|NCT00446264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25519057|NCT00446264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25519058|NCT00446264|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25519059|NCT00446264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519060|NCT00446264|Antifungal Agents|antifungal agents|mesh-ancestor
25519061|NCT00446290|Docetaxel|docetaxel|mesh-list
25519062|NCT00446290|Capecitabine|capecitabine|mesh-list
25519063|NCT00446290|Oxaliplatin|oxaliplatin|mesh-list
25519064|NCT00446290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519065|NCT00446290|Tubulin Modulators|tubulin modulators|mesh-ancestor
25519066|NCT00446290|Antimitotic Agents|antimitotic agents|mesh-ancestor
25519067|NCT00446290|Mitosis Modulators|mitosis modulators|mesh-ancestor
25519068|NCT00446290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519069|NCT00446290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25519070|NCT00446290|Antimetabolites|antimetabolites|mesh-ancestor
25519071|NCT00446446|Panitumumab|panitumumab|mesh-list
25519072|NCT00446446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25519073|NCT00446446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519074|NCT00446459|Mycophenolic Acid|mycophenolic acid|mesh-list
25519075|NCT00446459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25519076|NCT00446459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519077|NCT00446459|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25519078|NCT00446459|Antitubercular Agents|antitubercular agents|mesh-ancestor
25519079|NCT00446459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25519080|NCT00446459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25519081|NCT00446459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519082|NCT00446459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519083|NCT00446511|Valsartan|valsartan|mesh-list
25519084|NCT00446511|Enalapril|enalapril|mesh-list
25519085|NCT00446511|Enalaprilat|enalaprilat|mesh-list
25519086|NCT00446511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25519087|NCT00446511|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25519088|NCT00446511|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25519089|NCT00446511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519090|NCT00446511|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25519091|NCT00446511|Protease Inhibitors|protease inhibitors|mesh-ancestor
25519092|NCT00446511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519093|NCT00446563|Losartan|losartan|mesh-list
25519094|NCT00446563|Amlodipine|amlodipine|mesh-list
25519095|NCT00446563|Valsartan|valsartan|mesh-list
25519096|NCT00446563|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25519097|NCT00446563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25519098|NCT00446563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25519099|NCT00446563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25519100|NCT00446563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519101|NCT00446563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25519102|NCT00446563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519103|NCT00446563|Vasodilator Agents|vasodilator agents|mesh-ancestor
25519104|NCT00446563|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25519105|NCT00446563|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25519106|NCT00446563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25519107|NCT00446563|Diuretics|diuretics|mesh-ancestor
25519108|NCT00446563|Natriuretic Agents|natriuretic agents|mesh-ancestor
25519109|NCT00446563|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25519110|NCT00446641|Cilostazol|cilostazol|mesh-list
25519111|NCT00446641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25519112|NCT00446641|Autonomic Agents|autonomic agents|mesh-ancestor
25519113|NCT00446641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25646660|NCT01462253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25646661|NCT01462253|Antimetabolites|antimetabolites|mesh-ancestor
25519114|NCT00446641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519115|NCT00446641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25519116|NCT00446641|Respiratory System Agents|respiratory system agents|mesh-ancestor
25519117|NCT00446641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25519118|NCT00446641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25519119|NCT00446641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519120|NCT00446641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25519121|NCT00446641|Vasodilator Agents|vasodilator agents|mesh-ancestor
25519122|NCT00446641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25519123|NCT00446641|Protective Agents|protective agents|mesh-ancestor
25519124|NCT00446641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25519125|NCT00446641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25519126|NCT00446641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519127|NCT00446797|Celecoxib|celecoxib|mesh-list
25519128|NCT00446797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25519129|NCT00446797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25519130|NCT00446797|Analgesics|analgesics|mesh-ancestor
25519131|NCT00446797|Sensory System Agents|sensory system agents|mesh-ancestor
25519132|NCT00446797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25519133|NCT00446797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519134|NCT00446797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25519135|NCT00446797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25519136|NCT00446797|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25519137|NCT00446797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25519138|NCT00446797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519139|NCT00446797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519140|NCT00446849|Mesalamine|mesalamine|mesh-list
25519141|NCT00446849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25519142|NCT00446849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25519143|NCT00446849|Analgesics|analgesics|mesh-ancestor
25519144|NCT00446849|Sensory System Agents|sensory system agents|mesh-ancestor
25519145|NCT00446849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25519146|NCT00446849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519147|NCT00446849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25519148|NCT00446849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25519149|NCT00446992|Olanzapine|olanzapine|mesh-list
25519150|NCT00446992|Antiemetics|antiemetics|mesh-ancestor
25519151|NCT00446992|Autonomic Agents|autonomic agents|mesh-ancestor
25519152|NCT00446992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25519153|NCT00446992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519154|NCT00446992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25519155|NCT00446992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24989161|NCT04473807|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24518396|NCT05132595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518397|NCT05132595|Antidepressive Agents|antidepressive agents|mesh-ancestor
24518399|NCT05082909|Probenecid|probenecid|mesh-list
25519156|NCT00446992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25519157|NCT00446992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25519158|NCT00446992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25519159|NCT00446992|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25519160|NCT00446992|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25519161|NCT00446992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25519162|NCT00446992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519163|NCT00446992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25519164|NCT00446992|Serotonin Agents|serotonin agents|mesh-ancestor
25519165|NCT00447005|Axitinib|axitinib|mesh-list
25519166|NCT00447005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519167|NCT00447005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25519168|NCT00447005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519169|NCT00447005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519170|NCT00447057|Pemetrexed|pemetrexed|mesh-list
25519171|NCT00447057|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25519172|NCT00447057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519173|NCT00447057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519174|NCT00447057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519175|NCT00447057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25519176|NCT00447057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25519177|NCT00447057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25519178|NCT00447226|Lapatinib|lapatinib|mesh-list
25519179|NCT00447226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519180|NCT00447226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25519181|NCT00447226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519182|NCT00447226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519183|NCT00447265|Etanercept|etanercept|mesh-list
25519184|NCT00447265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25519185|NCT00447265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25519186|NCT00447265|Analgesics|analgesics|mesh-ancestor
25519187|NCT00447265|Sensory System Agents|sensory system agents|mesh-ancestor
25519188|NCT00447265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25519189|NCT00447265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519190|NCT00447265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25519191|NCT00447265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25519192|NCT00447265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25519193|NCT00447265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25519194|NCT00447265|Immunologic Factors|immunologic factors|mesh-ancestor
25519195|NCT00447278|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25519196|NCT00447278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25519197|NCT00447278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25519198|NCT00447278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25519199|NCT00447278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519200|NCT00447278|Adrenergic Agents|adrenergic agents|mesh-ancestor
25519201|NCT00447278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25519202|NCT00447278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519203|NCT00447330|Bevacizumab|bevacizumab|mesh-list
25519204|NCT00447330|Capecitabine|capecitabine|mesh-list
25519205|NCT00447330|Oxaliplatin|oxaliplatin|mesh-list
25519206|NCT00447330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25519207|NCT00447330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519208|NCT00447330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25519209|NCT00447330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25519210|NCT00447330|Growth Substances|growth substances|mesh-ancestor
25519211|NCT00447330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519212|NCT00447330|Growth Inhibitors|growth inhibitors|mesh-ancestor
25519213|NCT00447330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25519214|NCT00447330|Antimetabolites|antimetabolites|mesh-ancestor
25519215|NCT00447330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519216|NCT00447382|Insulin|insulin|mesh-list
25519217|NCT00447382|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25519218|NCT00447382|Insulin Aspart|insulin aspart|mesh-list
25519219|NCT00447382|Insulin Detemir|insulin detemir|mesh-list
24519374|NCT01773707|Abatacept|abatacept|mesh-list
24519375|NCT01773707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24519376|NCT01773707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519377|NCT01773707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519378|NCT01773707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24989190|NCT04347239|Leronlimab|leronlimab|mesh-list
24989191|NCT04347239|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24989192|NCT04347239|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24989194|NCT04347239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25519220|NCT00447382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25519221|NCT00447382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519222|NCT00447499|Lanreotide|lanreotide|mesh-list
25519223|NCT00447499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519224|NCT00447694|Deferasirox|deferasirox|mesh-list
25519225|NCT00447694|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25519226|NCT00447694|Chelating Agents|chelating agents|mesh-ancestor
25519227|NCT00447694|Sequestering Agents|sequestering agents|mesh-ancestor
25519228|NCT00447694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519229|NCT00447772|Botulinum Toxins|botulinum toxins|mesh-list
25519230|NCT00447772|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25519231|NCT00447772|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25519232|NCT00447772|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25519233|NCT00447772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25519234|NCT00447772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519235|NCT00447772|Cholinergic Agents|cholinergic agents|mesh-ancestor
25519236|NCT00447772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25519237|NCT00447772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519238|NCT00447772|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25519239|NCT00447772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25519240|NCT00447876|Botulinum Toxins|botulinum toxins|mesh-list
25519241|NCT00447876|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25519242|NCT00447876|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25519243|NCT00447876|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25519244|NCT00447876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25519245|NCT00447876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519246|NCT00447876|Cholinergic Agents|cholinergic agents|mesh-ancestor
25519247|NCT00447876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25519248|NCT00447876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519249|NCT00447876|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25519250|NCT00447876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25519251|NCT00447902|Ritonavir|ritonavir|mesh-list
25519252|NCT00447902|Tipranavir|tipranavir|mesh-list
25519253|NCT00447902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25519254|NCT00447902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25519255|NCT00447902|Protease Inhibitors|protease inhibitors|mesh-ancestor
25519256|NCT00447902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519257|NCT00447902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519258|NCT00447902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25519259|NCT00447902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25519260|NCT00447902|Antiviral Agents|antiviral agents|mesh-ancestor
25519261|NCT00447902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25519262|NCT00447902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25519263|NCT00447902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25519264|NCT00448019|Vidarabine|vidarabine|mesh-list
25519265|NCT00448019|Cyclophosphamide|cyclophosphamide|mesh-list
25519266|NCT00448019|Bevacizumab|bevacizumab|mesh-list
25519267|NCT00448019|Rituximab|rituximab|mesh-list
25519268|NCT00448019|Fludarabine|fludarabine|mesh-list
25519269|NCT00448019|Fludarabine phosphate|fludarabine phosphate|mesh-list
25519270|NCT00448019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25519271|NCT00448019|Immunologic Factors|immunologic factors|mesh-ancestor
25519272|NCT00448019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519273|NCT00448019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25519274|NCT00448019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25519275|NCT00448019|Alkylating Agents|alkylating agents|mesh-ancestor
25519276|NCT00448019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519277|NCT00448019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519278|NCT00448019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25519279|NCT00448019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25519280|NCT00448019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25519281|NCT00448019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25519282|NCT00448019|Growth Substances|growth substances|mesh-ancestor
25519283|NCT00448019|Growth Inhibitors|growth inhibitors|mesh-ancestor
24796948|NCT01953419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24519722|NCT05242874|Tropisetron|tropisetron|mesh-list
24519723|NCT05242874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24519724|NCT05242874|Autonomic Agents|autonomic agents|mesh-ancestor
24519725|NCT05242874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24519726|NCT05242874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519727|NCT05242874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24399197|NCT00146900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24519728|NCT05242874|Glucocorticoids|glucocorticoids|mesh-ancestor
24519729|NCT05242874|Hormones|hormones|mesh-ancestor
24519731|NCT05242874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25519287|NCT00448019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25519288|NCT00448123|Tamsulosin|tamsulosin|mesh-list
25519289|NCT00448123|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25519290|NCT00448123|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25519291|NCT00448123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25519292|NCT00448123|Adrenergic Agents|adrenergic agents|mesh-ancestor
25519293|NCT00448123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25519294|NCT00448123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519295|NCT00448123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519296|NCT00448123|Urological Agents|urological agents|mesh-ancestor
25519297|NCT00448136|Bevacizumab|bevacizumab|mesh-list
25519298|NCT00448136|Streptozocin|streptozocin|mesh-list
25519299|NCT00448136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25519300|NCT00448136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519301|NCT00448136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25519302|NCT00448136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25519303|NCT00448136|Growth Substances|growth substances|mesh-ancestor
25519304|NCT00448136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519305|NCT00448136|Growth Inhibitors|growth inhibitors|mesh-ancestor
25519306|NCT00448136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25519307|NCT00448175|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25519308|NCT00448175|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25519309|NCT00448175|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25519310|NCT00448175|Cholinergic Agents|cholinergic agents|mesh-ancestor
25519311|NCT00448175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24651601|NCT01232374|Nimotuzumab|nimotuzumab|mesh-list
25646662|NCT01462266|Metformin|metformin|mesh-list
25519312|NCT00448175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519313|NCT00448175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519314|NCT00448175|Urological Agents|urological agents|mesh-ancestor
25519316|NCT00448201|Fludarabine phosphate|fludarabine phosphate|mesh-list
25519317|NCT00448201|Fludarabine|fludarabine|mesh-list
25519318|NCT00448201|Busulfan|busulfan|mesh-list
25519319|NCT00448201|Tacrolimus|tacrolimus|mesh-list
25519320|NCT00448201|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25519321|NCT00448201|Sargramostim|sargramostim|mesh-list
25519322|NCT00448201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25519323|NCT00448201|Abortifacient Agents|abortifacient agents|mesh-ancestor
25519324|NCT00448201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25519325|NCT00448201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519326|NCT00448201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25519327|NCT00448201|Antimetabolites|antimetabolites|mesh-ancestor
25519328|NCT00448201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519329|NCT00448201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519330|NCT00448201|Dermatologic Agents|dermatologic agents|mesh-ancestor
25519331|NCT00448201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519332|NCT00448201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25519333|NCT00448201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25519334|NCT00448201|Immunologic Factors|immunologic factors|mesh-ancestor
25519335|NCT00448201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25519336|NCT00448201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25519337|NCT00448201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25519338|NCT00448201|Alkylating Agents|alkylating agents|mesh-ancestor
25519339|NCT00448201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25519340|NCT00448201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25519341|NCT00448227|Famciclovir|famciclovir|mesh-list
25519342|NCT00448227|Antiviral Agents|antiviral agents|mesh-ancestor
25519343|NCT00448227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25519344|NCT00448227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24989248|NCT04198363|Bismuth|bismuth|mesh-list
24989249|NCT04198363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989250|NCT04198363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24989251|NCT04198363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24989252|NCT04198363|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25163011|NCT02900352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046378|NCT00850174|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24989253|NCT04198363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24989254|NCT04198363|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24989255|NCT04198363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519349|NCT00448279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519351|NCT00448357|Fludarabine phosphate|fludarabine phosphate|mesh-list
25519352|NCT00448357|Fludarabine|fludarabine|mesh-list
25519353|NCT00448357|Busulfan|busulfan|mesh-list
25519354|NCT00448357|Tacrolimus|tacrolimus|mesh-list
25519355|NCT00448357|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25519356|NCT00448357|Thymoglobulin|thymoglobulin|mesh-list
25519357|NCT00448357|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25519358|NCT00448357|Abortifacient Agents|abortifacient agents|mesh-ancestor
25519359|NCT00448357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25519360|NCT00448357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519361|NCT00448357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25519362|NCT00448357|Antimetabolites|antimetabolites|mesh-ancestor
25519363|NCT00448357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519364|NCT00448357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519365|NCT00448357|Dermatologic Agents|dermatologic agents|mesh-ancestor
25519366|NCT00448357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519367|NCT00448357|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25519368|NCT00448357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25519369|NCT00448357|Immunologic Factors|immunologic factors|mesh-ancestor
25519370|NCT00448357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25519371|NCT00448357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25519372|NCT00448357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25519373|NCT00448357|Alkylating Agents|alkylating agents|mesh-ancestor
25519374|NCT00448357|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25519375|NCT00448357|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25519376|NCT00448435|Fluticasone|fluticasone|mesh-list
25519377|NCT00448435|Xhance|xhance|mesh-list
25519378|NCT00448435|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25519379|NCT00448435|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25519380|NCT00448435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24798924|NCT01966172|Analgesics|analgesics|mesh-ancestor
25646663|NCT01462266|Insulin Glargine|insulin glargine|mesh-list
25519381|NCT00448435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25519382|NCT00448435|Autonomic Agents|autonomic agents|mesh-ancestor
25519383|NCT00448435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25519384|NCT00448435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519385|NCT00448435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25519386|NCT00448435|Respiratory System Agents|respiratory system agents|mesh-ancestor
25519387|NCT00448435|Dermatologic Agents|dermatologic agents|mesh-ancestor
25519388|NCT00448435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25519389|NCT00448435|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25519390|NCT00448435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25519391|NCT00448435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25519392|NCT00448435|Adrenergic Agents|adrenergic agents|mesh-ancestor
25519393|NCT00448435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25519394|NCT00448435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519395|NCT00448435|Glucocorticoids|glucocorticoids|mesh-ancestor
25519396|NCT00448435|Hormones|hormones|mesh-ancestor
25519397|NCT00448435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25519398|NCT00448435|Sympathomimetics|sympathomimetics|mesh-ancestor
25519399|NCT00448539|Rufinamide|rufinamide|mesh-list
25519400|NCT00448539|Anticonvulsants|anticonvulsants|mesh-ancestor
25519401|NCT00448539|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25519402|NCT00448539|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25519403|NCT00448539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25519404|NCT00448539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202927|NCT02717871|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24596937|NCT00946595|Ritonavir|ritonavir|mesh-list
24989292|NCT05366595|Zinc Sulfate|zinc sulfate|mesh-list
24989293|NCT05366595|Astringents|astringents|mesh-ancestor
24989294|NCT05366595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989295|NCT05366595|Dermatologic Agents|dermatologic agents|mesh-ancestor
24989296|NCT05366101|Valsartan|valsartan|mesh-list
24989297|NCT05366101|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24989298|NCT05366101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24989336|NCT05365425|Lipotropic Agents|lipotropic agents|mesh-ancestor
25519405|NCT00448591|Bevacizumab|bevacizumab|mesh-list
25519407|NCT00448591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25519408|NCT00448591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519409|NCT00448591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25519410|NCT00448591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25519411|NCT00448591|Growth Substances|growth substances|mesh-ancestor
25519412|NCT00448591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519413|NCT00448591|Growth Inhibitors|growth inhibitors|mesh-ancestor
25519414|NCT00448669|Tenofovir|tenofovir|mesh-list
25519415|NCT00448669|Emtricitabine|emtricitabine|mesh-list
25519416|NCT00448669|Antiviral Agents|antiviral agents|mesh-ancestor
25519417|NCT00448669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25519418|NCT00448669|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25519419|NCT00448669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25519420|NCT00448669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519421|NCT00448669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519422|NCT00448669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25519423|NCT00448669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25519424|NCT00448708|Paclitaxel|paclitaxel|mesh-list
25519425|NCT00448708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25519426|NCT00448708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25519427|NCT00448708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519428|NCT00448708|Tubulin Modulators|tubulin modulators|mesh-ancestor
25519429|NCT00448708|Antimitotic Agents|antimitotic agents|mesh-ancestor
25519430|NCT00448708|Mitosis Modulators|mitosis modulators|mesh-ancestor
25519431|NCT00448708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519432|NCT00448760|Leucovorin|leucovorin|mesh-list
25519433|NCT00448760|Docetaxel|docetaxel|mesh-list
25519434|NCT00448760|Oxaliplatin|oxaliplatin|mesh-list
25519435|NCT00448760|Floxuridine|floxuridine|mesh-list
25519436|NCT00448760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519437|NCT00448760|Tubulin Modulators|tubulin modulators|mesh-ancestor
25519438|NCT00448760|Antimitotic Agents|antimitotic agents|mesh-ancestor
25519439|NCT00448760|Mitosis Modulators|mitosis modulators|mesh-ancestor
25519440|NCT00448760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519441|NCT00448760|Antidotes|antidotes|mesh-ancestor
25519442|NCT00448760|Protective Agents|protective agents|mesh-ancestor
25519443|NCT00448760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519444|NCT00448760|Vitamin B Complex|vitamin b complex|mesh-ancestor
25519445|NCT00448760|Vitamins|vitamins|mesh-ancestor
25519446|NCT00448760|Micronutrients|micronutrients|mesh-ancestor
25519447|NCT00448760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25519448|NCT00448760|Antimetabolites|antimetabolites|mesh-ancestor
25519449|NCT00448864|Ecallantide|ecallantide|mesh-list
25519450|NCT00448864|Analgesics|analgesics|mesh-ancestor
25519451|NCT00448864|Sensory System Agents|sensory system agents|mesh-ancestor
25519452|NCT00448864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25519453|NCT00448864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519454|NCT00448864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25519455|NCT00448864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25519456|NCT00448864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25519457|NCT00448864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25519458|NCT00448916|Pregabalin|pregabalin|mesh-list
25519459|NCT00448916|Analgesics|analgesics|mesh-ancestor
25519460|NCT00448916|Sensory System Agents|sensory system agents|mesh-ancestor
25519461|NCT00448916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25519462|NCT00448916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519463|NCT00448916|Anticonvulsants|anticonvulsants|mesh-ancestor
25519464|NCT00448916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25519465|NCT00448916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25519466|NCT00448916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519467|NCT00448916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25519468|NCT00448916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25519469|NCT00448916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25519470|NCT00448916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25519471|NCT00448916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25519472|NCT00449007|Bupropion|bupropion|mesh-list
24521132|NCT05104554|Folic Acid|folic acid|mesh-list
24521133|NCT05104554|Micronutrients|micronutrients|mesh-list
24989354|NCT05365165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25202928|NCT02717871|Prednisolone phosphate|prednisolone phosphate|mesh-list
24989355|NCT05365165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989356|NCT05365074|Chloroprocaine|chloroprocaine|mesh-list
24989357|NCT05365074|Anesthetics, Local|anesthetics, local|mesh-ancestor
24989358|NCT05365074|Anesthetics|anesthetics|mesh-ancestor
24989361|NCT05365074|Sensory System Agents|sensory system agents|mesh-ancestor
25519473|NCT00449007|Fluoxetine|fluoxetine|mesh-list
25519474|NCT00449007|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25519475|NCT00449007|Antidepressive Agents|antidepressive agents|mesh-ancestor
25519476|NCT00449007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25519477|NCT00449007|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25519478|NCT00449007|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25519479|NCT00449007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25519480|NCT00449007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519481|NCT00449007|Dopamine Agents|dopamine agents|mesh-ancestor
25519482|NCT00449007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25519483|NCT00449007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519484|NCT00449007|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25519485|NCT00449007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25519486|NCT00449007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519487|NCT00449007|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25519488|NCT00449007|Serotonin Agents|serotonin agents|mesh-ancestor
25519489|NCT00449033|Gemcitabine|gemcitabine|mesh-list
25519490|NCT00449033|Cisplatin|cisplatin|mesh-list
25519491|NCT00449033|Sorafenib|sorafenib|mesh-list
25519492|NCT00449033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519493|NCT00449033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25519494|NCT00449033|Antimetabolites|antimetabolites|mesh-ancestor
25519495|NCT00449033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519496|NCT00449033|Antiviral Agents|antiviral agents|mesh-ancestor
25519497|NCT00449033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25519498|NCT00449033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519499|NCT00449033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25519500|NCT00449033|Immunologic Factors|immunologic factors|mesh-ancestor
25519501|NCT00449033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519502|NCT00449033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25519503|NCT00449046|Fluticasone|fluticasone|mesh-list
25519504|NCT00449046|Xhance|xhance|mesh-list
25519505|NCT00449046|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25519506|NCT00449046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25519507|NCT00449046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25519508|NCT00449046|Autonomic Agents|autonomic agents|mesh-ancestor
25519509|NCT00449046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25519510|NCT00449046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519511|NCT00449046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25646664|NCT01462266|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25519512|NCT00449046|Respiratory System Agents|respiratory system agents|mesh-ancestor
25519513|NCT00449046|Dermatologic Agents|dermatologic agents|mesh-ancestor
25519514|NCT00449046|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25519515|NCT00449046|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25519516|NCT00449046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25519517|NCT00449046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25519518|NCT00449046|Adrenergic Agents|adrenergic agents|mesh-ancestor
25519519|NCT00449046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25519520|NCT00449046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519521|NCT00449072|Loratadine|loratadine|mesh-list
25519522|NCT00449072|Antipruritics|antipruritics|mesh-ancestor
25519523|NCT00449072|Dermatologic Agents|dermatologic agents|mesh-ancestor
25519524|NCT00449072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25519525|NCT00449072|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25519526|NCT00449072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25519527|NCT00449072|Histamine Antagonists|histamine antagonists|mesh-ancestor
25519528|NCT00449072|Histamine Agents|histamine agents|mesh-ancestor
25519529|NCT00449072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25519530|NCT00449072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519531|NCT00449072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519532|NCT00449150|Cetrorelix|cetrorelix|mesh-list
25519533|NCT00449150|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25519534|NCT00449150|Fertility Agents|fertility agents|mesh-ancestor
25519535|NCT00449150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25519536|NCT00449150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519537|NCT00449150|Hormone Antagonists|hormone antagonists|mesh-ancestor
25519538|NCT00449150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25519539|NCT00449163|Leucovorin|leucovorin|mesh-list
25519540|NCT00449163|Bevacizumab|bevacizumab|mesh-list
25519541|NCT00449163|Irinotecan|irinotecan|mesh-list
25519542|NCT00449163|Floxuridine|floxuridine|mesh-list
25519543|NCT00449163|Levoleucovorin|levoleucovorin|mesh-list
25519544|NCT00449163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24521445|NCT04763135|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24521446|NCT04763135|Antidepressive Agents|antidepressive agents|mesh-ancestor
25519545|NCT00449163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519546|NCT00449163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25519547|NCT00449163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25519548|NCT00449163|Growth Substances|growth substances|mesh-ancestor
25519549|NCT00449163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519550|NCT00449163|Growth Inhibitors|growth inhibitors|mesh-ancestor
25519551|NCT00449163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25519552|NCT00449163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25519553|NCT00449163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519554|NCT00449163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519555|NCT00449163|Antidotes|antidotes|mesh-ancestor
25519556|NCT00449163|Protective Agents|protective agents|mesh-ancestor
25519557|NCT00449163|Vitamin B Complex|vitamin b complex|mesh-ancestor
25519558|NCT00449163|Vitamins|vitamins|mesh-ancestor
25519559|NCT00449163|Micronutrients|micronutrients|mesh-ancestor
25519560|NCT00449163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25519561|NCT00449163|Antimetabolites|antimetabolites|mesh-ancestor
25519562|NCT00449176|Oxycodone|oxycodone|mesh-list
25519563|NCT00449176|Tapentadol|tapentadol|mesh-list
25519564|NCT00449176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25519565|NCT00449176|Narcotics|narcotics|mesh-ancestor
25519566|NCT00449176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25519567|NCT00449176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519568|NCT00449176|Analgesics|analgesics|mesh-ancestor
25519569|NCT00449176|Sensory System Agents|sensory system agents|mesh-ancestor
25519570|NCT00449176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25519571|NCT00449176|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25519572|NCT00449176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25519573|NCT00449176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25519574|NCT00449176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519575|NCT00449176|Adrenergic Agents|adrenergic agents|mesh-ancestor
25519576|NCT00449176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25519577|NCT00449644|Bedaquiline|bedaquiline|mesh-list
25519578|NCT00449644|Antitubercular Agents|antitubercular agents|mesh-ancestor
25519579|NCT00449644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25519580|NCT00449644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25519581|NCT00449670|Vaccines|vaccines|mesh-list
25519582|NCT00449670|Immunologic Factors|immunologic factors|mesh-ancestor
25519583|NCT00449670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646665|NCT01462266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25519584|NCT00449748|Everolimus|everolimus|mesh-list
25519585|NCT00449748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519586|NCT00449748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25519587|NCT00449748|Immunologic Factors|immunologic factors|mesh-ancestor
25519588|NCT00449748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519589|NCT00449761|Panobinostat|panobinostat|mesh-list
25519590|NCT00449761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519591|NCT00449761|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25519592|NCT00449761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519593|NCT00449761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519594|NCT00449787|Naproxen|naproxen|mesh-list
25519595|NCT00449787|Sumatriptan|sumatriptan|mesh-list
25519596|NCT00449787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25519597|NCT00449787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25519598|NCT00449787|Analgesics|analgesics|mesh-ancestor
25519599|NCT00449787|Sensory System Agents|sensory system agents|mesh-ancestor
25519600|NCT00449787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25519601|NCT00449787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519602|NCT00449787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25519603|NCT00449787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25519604|NCT00449787|Gout Suppressants|gout suppressants|mesh-ancestor
25519605|NCT00449787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25519606|NCT00449787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519607|NCT00449787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519608|NCT00449787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25519609|NCT00449787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25519610|NCT00449787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25519611|NCT00449787|Serotonin Agents|serotonin agents|mesh-ancestor
25519612|NCT00449787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25519613|NCT00449930|Metformin|metformin|mesh-list
24521702|NCT04595565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829660|NCT00006246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24521798|NCT04519476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24521800|NCT04519476|Protective Agents|protective agents|mesh-ancestor
24521801|NCT04519476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24521802|NCT04500158|Lidocaine|lidocaine|mesh-list
25519614|NCT00449930|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25519615|NCT00449930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25519616|NCT00449930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519617|NCT00449930|Incretins|incretins|mesh-ancestor
25519619|NCT00449930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25519620|NCT00449930|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25519621|NCT00449930|Protease Inhibitors|protease inhibitors|mesh-ancestor
25519622|NCT00449930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519623|NCT00449930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519624|NCT00449956|Timolol|timolol|mesh-list
25519625|NCT00449956|Dorzolamide|dorzolamide|mesh-list
25519626|NCT00449956|Maleic acid|maleic acid|mesh-list
25519627|NCT00449956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25519628|NCT00449956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25519629|NCT00449956|Adrenergic Agents|adrenergic agents|mesh-ancestor
25519630|NCT00449956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25519631|NCT00449956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519632|NCT00449956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519633|NCT00449956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25519634|NCT00449956|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25519635|NCT00449956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519636|NCT00449956|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25519637|NCT00450073|Vitamin D|vitamin d|mesh-list
25519638|NCT00450073|Ergocalciferols|ergocalciferols|mesh-list
25519639|NCT00450073|Cholecalciferol|cholecalciferol|mesh-list
25519640|NCT00450073|Vitamins|vitamins|mesh-list
25519641|NCT00450073|Micronutrients|micronutrients|mesh-ancestor
25519642|NCT00450073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519643|NCT00450073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25519644|NCT00450073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25519645|NCT00450216|Ibuprofen|ibuprofen|mesh-list
25519646|NCT00450216|Famotidine|famotidine|mesh-list
25519647|NCT00450216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25519648|NCT00450216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25519649|NCT00450216|Analgesics|analgesics|mesh-ancestor
25519650|NCT00450216|Sensory System Agents|sensory system agents|mesh-ancestor
25519651|NCT00450216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25519652|NCT00450216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519653|NCT00450216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25823397|NCT00004815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25519654|NCT00450216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25519655|NCT00450216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25519656|NCT00450216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519657|NCT00450216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519658|NCT00450216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25519659|NCT00450216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25519660|NCT00450216|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25519661|NCT00450216|Histamine Antagonists|histamine antagonists|mesh-ancestor
25519662|NCT00450216|Histamine Agents|histamine agents|mesh-ancestor
25519663|NCT00450216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25519664|NCT00450242|Lidocaine|lidocaine|mesh-list
25519665|NCT00450242|Anesthetics, Local|anesthetics, local|mesh-ancestor
25519666|NCT00450242|Anesthetics|anesthetics|mesh-ancestor
25519667|NCT00450242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25519668|NCT00450242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519669|NCT00450242|Sensory System Agents|sensory system agents|mesh-ancestor
25519670|NCT00450242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25519671|NCT00450242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25519672|NCT00450242|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25519673|NCT00450242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25519674|NCT00450242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25519675|NCT00450242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519676|NCT00450255|Aflibercept|aflibercept|mesh-list
25519677|NCT00450255|Endothelial Growth Factors|endothelial growth factors|mesh-list
25519678|NCT00450255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25519679|NCT00450255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25519680|NCT00450255|Growth Substances|growth substances|mesh-ancestor
25519681|NCT00450255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519682|NCT00450255|Growth Inhibitors|growth inhibitors|mesh-ancestor
25519683|NCT00450255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519684|NCT00450385|Prednisone|prednisone|mesh-list
25519685|NCT00450385|Cyclophosphamide|cyclophosphamide|mesh-list
25519686|NCT00450385|Rituximab|rituximab|mesh-list
25519687|NCT00450385|Doxorubicin|doxorubicin|mesh-list
25823398|NCT00004815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519689|NCT00450385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25519690|NCT00450385|Immunologic Factors|immunologic factors|mesh-ancestor
25519691|NCT00450385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519692|NCT00450385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25519693|NCT00450385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25519694|NCT00450385|Alkylating Agents|alkylating agents|mesh-ancestor
25519695|NCT00450385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519696|NCT00450385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519697|NCT00450385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25519698|NCT00450385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25519699|NCT00450385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25519700|NCT00450385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25519701|NCT00450385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25519702|NCT00450385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519703|NCT00450385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25519704|NCT00450385|Glucocorticoids|glucocorticoids|mesh-ancestor
25519705|NCT00450385|Hormones|hormones|mesh-ancestor
25519706|NCT00450385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25519707|NCT00450385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25519708|NCT00450385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25519709|NCT00450385|Tubulin Modulators|tubulin modulators|mesh-ancestor
25519710|NCT00450385|Antimitotic Agents|antimitotic agents|mesh-ancestor
25519711|NCT00450385|Mitosis Modulators|mitosis modulators|mesh-ancestor
25519712|NCT00450463|Metronidazole|metronidazole|mesh-list
25519713|NCT00450463|Molgramostim|molgramostim|mesh-list
25519714|NCT00450463|Flutamide|flutamide|mesh-list
25519715|NCT00450463|Sargramostim|sargramostim|mesh-list
25519716|NCT00450463|Immunologic Factors|immunologic factors|mesh-ancestor
25519717|NCT00450463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519718|NCT00450463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519719|NCT00450463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25519720|NCT00450463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25519721|NCT00450463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25519722|NCT00450463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25519723|NCT00450463|Androgen Antagonists|androgen antagonists|mesh-ancestor
25519724|NCT00450463|Hormone Antagonists|hormone antagonists|mesh-ancestor
25519725|NCT00450463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25519726|NCT00450463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25519727|NCT00450580|Ritonavir|ritonavir|mesh-list
25646666|NCT01462266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519728|NCT00450580|Fosamprenavir|fosamprenavir|mesh-list
25519729|NCT00450580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25519730|NCT00450580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25519731|NCT00450580|Protease Inhibitors|protease inhibitors|mesh-ancestor
25519732|NCT00450580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519733|NCT00450580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519734|NCT00450580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25519735|NCT00450580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25519736|NCT00450580|Antiviral Agents|antiviral agents|mesh-ancestor
25519737|NCT00450580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25519738|NCT00450580|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25519739|NCT00450580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25519740|NCT00450619|Metronidazole|metronidazole|mesh-list
25519741|NCT00450619|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
25519742|NCT00450619|Vaccines|vaccines|mesh-list
25519743|NCT00450619|Sargramostim|sargramostim|mesh-list
25519744|NCT00450619|Immunologic Factors|immunologic factors|mesh-ancestor
25519745|NCT00450619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519746|NCT00450619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25519747|NCT00450619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25519748|NCT00450619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25519749|NCT00450619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25519750|NCT00450619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25519751|NCT00450619|Analgesics|analgesics|mesh-ancestor
25519752|NCT00450619|Sensory System Agents|sensory system agents|mesh-ancestor
25519753|NCT00450619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25519754|NCT00450658|Ibuprofen|ibuprofen|mesh-list
25519755|NCT00450658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25519756|NCT00450658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25519757|NCT00450658|Analgesics|analgesics|mesh-ancestor
25519758|NCT00450658|Sensory System Agents|sensory system agents|mesh-ancestor
25519759|NCT00450658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25519760|NCT00450658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519761|NCT00450658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25519762|NCT00450658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25519763|NCT00450658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25519764|NCT00450658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519765|NCT00450658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519766|NCT00450723|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
25519767|NCT00450723|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25519768|NCT00450723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519769|NCT00450749|Lycopene|lycopene|mesh-list
25519770|NCT00450749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25519771|NCT00450749|Antioxidants|antioxidants|mesh-ancestor
25519772|NCT00450749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519773|NCT00450749|Protective Agents|protective agents|mesh-ancestor
25519774|NCT00450749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519775|NCT00450749|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25519776|NCT00450749|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25519777|NCT00450749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519778|NCT00450801|Leucovorin|leucovorin|mesh-list
25519779|NCT00450801|Cytarabine|cytarabine|mesh-list
25519780|NCT00450801|Thalidomide|thalidomide|mesh-list
25519781|NCT00450801|Cyclophosphamide|cyclophosphamide|mesh-list
25519782|NCT00450801|Ifosfamide|ifosfamide|mesh-list
25519783|NCT00450801|Rituximab|rituximab|mesh-list
25519784|NCT00450801|Doxorubicin|doxorubicin|mesh-list
25519785|NCT00450801|Methotrexate|methotrexate|mesh-list
25519786|NCT00450801|Etoposide|etoposide|mesh-list
25519787|NCT00450801|Vincristine|vincristine|mesh-list
25519788|NCT00450801|Granisetron|granisetron|mesh-list
25519789|NCT00450801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25519790|NCT00450801|Immunologic Factors|immunologic factors|mesh-ancestor
25519791|NCT00450801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519792|NCT00450801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25519793|NCT00450801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25519794|NCT00450801|Alkylating Agents|alkylating agents|mesh-ancestor
25519795|NCT00450801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519796|NCT00450801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519797|NCT00450801|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25519798|NCT00450801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25519799|NCT00450801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25519800|NCT00450801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25519801|NCT00450801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25519802|NCT00450801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646667|NCT01462266|Incretins|incretins|mesh-ancestor
25519803|NCT00450801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25519804|NCT00450801|Abortifacient Agents|abortifacient agents|mesh-ancestor
25519805|NCT00450801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25519806|NCT00450801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25519807|NCT00450801|Antimetabolites|antimetabolites|mesh-ancestor
25519808|NCT00450801|Dermatologic Agents|dermatologic agents|mesh-ancestor
25519809|NCT00450801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25519810|NCT00450801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25519811|NCT00450801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25519812|NCT00450801|Antiviral Agents|antiviral agents|mesh-ancestor
25519813|NCT00450801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25519814|NCT00450801|Antidotes|antidotes|mesh-ancestor
25519815|NCT00450801|Protective Agents|protective agents|mesh-ancestor
25519816|NCT00450801|Vitamin B Complex|vitamin b complex|mesh-ancestor
25519817|NCT00450801|Vitamins|vitamins|mesh-ancestor
25519818|NCT00450801|Micronutrients|micronutrients|mesh-ancestor
25519819|NCT00450801|Tubulin Modulators|tubulin modulators|mesh-ancestor
25519820|NCT00450801|Antimitotic Agents|antimitotic agents|mesh-ancestor
25519821|NCT00450801|Mitosis Modulators|mitosis modulators|mesh-ancestor
25519822|NCT00450801|Antiemetics|antiemetics|mesh-ancestor
25519823|NCT00450801|Autonomic Agents|autonomic agents|mesh-ancestor
25519824|NCT00450801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25519825|NCT00450801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25519826|NCT00450801|Leprostatic Agents|leprostatic agents|mesh-ancestor
25519827|NCT00450801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25519828|NCT00450801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25519829|NCT00450801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25519830|NCT00450801|Growth Substances|growth substances|mesh-ancestor
25519831|NCT00450801|Growth Inhibitors|growth inhibitors|mesh-ancestor
24989488|NCT05148546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24989489|NCT05148546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24989490|NCT05148546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989491|NCT05143762|Acetaminophen|acetaminophen|mesh-list
24989492|NCT05143762|Dexamethasone|dexamethasone|mesh-list
24989493|NCT05143762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24989494|NCT05143762|Antiemetics|antiemetics|mesh-ancestor
25519832|NCT00450801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25519834|NCT00450801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25519835|NCT00450814|Cyclophosphamide|cyclophosphamide|mesh-list
25519836|NCT00450814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25519837|NCT00450814|Immunologic Factors|immunologic factors|mesh-ancestor
25519838|NCT00450814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519839|NCT00450814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25519840|NCT00450814|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25519841|NCT00450814|Alkylating Agents|alkylating agents|mesh-ancestor
25519842|NCT00450814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519843|NCT00450814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519844|NCT00450814|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25519845|NCT00450866|Epothilones|epothilones|mesh-list
25519846|NCT00450866|Epothilone B|epothilone b|mesh-list
25519847|NCT00450866|Tubulin Modulators|tubulin modulators|mesh-ancestor
25519848|NCT00450866|Antimitotic Agents|antimitotic agents|mesh-ancestor
25519849|NCT00450866|Mitosis Modulators|mitosis modulators|mesh-ancestor
25519850|NCT00450866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519851|NCT00450866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519852|NCT00450983|Methotrexate|methotrexate|mesh-list
25519853|NCT00450983|Fludarabine phosphate|fludarabine phosphate|mesh-list
25519854|NCT00450983|Fludarabine|fludarabine|mesh-list
25519855|NCT00450983|Thiotepa|thiotepa|mesh-list
25519856|NCT00450983|Muromonab-CD3|muromonab-cd3|mesh-list
25519857|NCT00450983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25519858|NCT00450983|Abortifacient Agents|abortifacient agents|mesh-ancestor
25519859|NCT00450983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25519860|NCT00450983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519861|NCT00450983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25519862|NCT00450983|Antimetabolites|antimetabolites|mesh-ancestor
25519863|NCT00450983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519864|NCT00450983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519865|NCT00450983|Dermatologic Agents|dermatologic agents|mesh-ancestor
25519866|NCT00450983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519867|NCT00450983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25519868|NCT00450983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25519869|NCT00450983|Immunologic Factors|immunologic factors|mesh-ancestor
25519870|NCT00450983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25646668|NCT01462266|Hormones|hormones|mesh-ancestor
25519871|NCT00450983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25519872|NCT00450983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25519873|NCT00450983|Alkylating Agents|alkylating agents|mesh-ancestor
25519874|NCT00450983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25519875|NCT00451035|Panobinostat|panobinostat|mesh-list
25519876|NCT00451035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519877|NCT00451035|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25519878|NCT00451035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519879|NCT00451035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519880|NCT00451048|Sunitinib|sunitinib|mesh-list
25519881|NCT00451048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519882|NCT00451048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25519883|NCT00451048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25519884|NCT00451048|Growth Substances|growth substances|mesh-ancestor
25519885|NCT00451048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519886|NCT00451048|Growth Inhibitors|growth inhibitors|mesh-ancestor
25519887|NCT00451048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25519888|NCT00451048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519889|NCT00451048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519890|NCT00451178|Prednisone|prednisone|mesh-list
25519891|NCT00451178|Cyclophosphamide|cyclophosphamide|mesh-list
25519892|NCT00451178|Rituximab|rituximab|mesh-list
25519893|NCT00451178|Doxorubicin|doxorubicin|mesh-list
25519894|NCT00451178|Vincristine|vincristine|mesh-list
25519895|NCT00451178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25519896|NCT00451178|Immunologic Factors|immunologic factors|mesh-ancestor
25519897|NCT00451178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989530|NCT05114486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989531|NCT05114486|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24989532|NCT05114486|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24989533|NCT05114486|Cholinergic Agents|cholinergic agents|mesh-ancestor
24989534|NCT05114486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24989535|NCT05114486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989536|NCT05103228|Menotropins|menotropins|mesh-list
24989537|NCT05103228|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24989538|NCT05103228|Hormones|hormones|mesh-ancestor
25519898|NCT00451178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25519899|NCT00451178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25519901|NCT00451178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519902|NCT00451178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519903|NCT00451178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25519904|NCT00451178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25519905|NCT00451178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25519906|NCT00451178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25519907|NCT00451178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25519908|NCT00451178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519909|NCT00451178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25519910|NCT00451178|Glucocorticoids|glucocorticoids|mesh-ancestor
25519911|NCT00451178|Hormones|hormones|mesh-ancestor
25519912|NCT00451178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25519913|NCT00451178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25519914|NCT00451178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25519915|NCT00451178|Tubulin Modulators|tubulin modulators|mesh-ancestor
25519916|NCT00451178|Antimitotic Agents|antimitotic agents|mesh-ancestor
25519917|NCT00451178|Mitosis Modulators|mitosis modulators|mesh-ancestor
25519918|NCT00451191|Botulinum Toxins|botulinum toxins|mesh-list
25519919|NCT00451191|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25519920|NCT00451191|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25519921|NCT00451191|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25519922|NCT00451191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25519923|NCT00451191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519924|NCT00451191|Cholinergic Agents|cholinergic agents|mesh-ancestor
25519925|NCT00451191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25519926|NCT00451191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519927|NCT00451191|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25519928|NCT00451191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25519929|NCT00451204|Glatiramer Acetate|glatiramer acetate|mesh-list
25519930|NCT00451204|Estrogens|estrogens|mesh-list
25519931|NCT00451204|(T,G)-A-L|(t,g)-a-l|mesh-list
25519932|NCT00451204|Hormones|hormones|mesh-ancestor
25519933|NCT00451204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25519934|NCT00451204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519935|NCT00451204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25519936|NCT00451204|Immunologic Factors|immunologic factors|mesh-ancestor
25656844|NCT01579513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25519937|NCT00451204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25519938|NCT00451204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25519939|NCT00451217|Glycopyrrolate|glycopyrrolate|mesh-list
25519940|NCT00451217|Neostigmine|neostigmine|mesh-list
25519941|NCT00451217|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25519942|NCT00451217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25519943|NCT00451217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519944|NCT00451217|Cholinergic Agents|cholinergic agents|mesh-ancestor
25519945|NCT00451217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25519946|NCT00451217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519947|NCT00451217|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25519948|NCT00451217|Autonomic Agents|autonomic agents|mesh-ancestor
25519949|NCT00451217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25519950|NCT00451217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25519951|NCT00451217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25519952|NCT00451217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25519953|NCT00451451|Glatiramer Acetate|glatiramer acetate|mesh-list
25519954|NCT00451451|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25519955|NCT00451451|(T,G)-A-L|(t,g)-a-l|mesh-list
25519956|NCT00451451|Dermatologic Agents|dermatologic agents|mesh-ancestor
25519957|NCT00451451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25519958|NCT00451451|Immunologic Factors|immunologic factors|mesh-ancestor
25519959|NCT00451451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519960|NCT00451451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25519961|NCT00451451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25519962|NCT00451555|Fulvestrant|fulvestrant|mesh-list
25519963|NCT00451555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24524181|NCT05200988|Nivolumab|nivolumab|mesh-list
24524182|NCT05200988|Ipilimumab|ipilimumab|mesh-list
24524183|NCT05200988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24524281|NCT05052229|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24524282|NCT05052229|Vasodilator Agents|vasodilator agents|mesh-ancestor
24524283|NCT05052229|Gasotransmitters|gasotransmitters|mesh-ancestor
24989604|NCT04988425|Methylprednisolone|methylprednisolone|mesh-list
24989605|NCT04988425|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24989606|NCT04988425|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25519964|NCT00451555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519965|NCT00451555|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25519966|NCT00451555|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25519967|NCT00451555|Hormone Antagonists|hormone antagonists|mesh-ancestor
25519968|NCT00451555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25519969|NCT00451555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519970|NCT00451698|Epoetin Alfa|epoetin alfa|mesh-list
25519971|NCT00451698|Hematinics|hematinics|mesh-ancestor
25519972|NCT00451906|Bevacizumab|bevacizumab|mesh-list
25519973|NCT00451906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25519974|NCT00451906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519975|NCT00451906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25519976|NCT00451906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25519977|NCT00451906|Growth Substances|growth substances|mesh-ancestor
25519978|NCT00451906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519979|NCT00451906|Growth Inhibitors|growth inhibitors|mesh-ancestor
25519980|NCT00451958|Leuprolide|leuprolide|mesh-list
25519981|NCT00451958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25519982|NCT00451958|Fertility Agents|fertility agents|mesh-ancestor
25519983|NCT00451958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25519984|NCT00451958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25519985|NCT00451958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25519986|NCT00451958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25519987|NCT00452335|Lubiprostone|lubiprostone|mesh-list
25519988|NCT00452335|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25519989|NCT00452335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25519990|NCT00452335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25519991|NCT00452348|Fluticasone|fluticasone|mesh-list
25519992|NCT00452348|Xhance|xhance|mesh-list
25519993|NCT00452348|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25519994|NCT00452348|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25519995|NCT00452348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25519996|NCT00452348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25519997|NCT00452348|Autonomic Agents|autonomic agents|mesh-ancestor
25519998|NCT00452348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25519999|NCT00452348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520000|NCT00452348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25520001|NCT00452348|Respiratory System Agents|respiratory system agents|mesh-ancestor
25656845|NCT01579513|Hormones|hormones|mesh-ancestor
25520002|NCT00452348|Dermatologic Agents|dermatologic agents|mesh-ancestor
25520003|NCT00452348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25520004|NCT00452348|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25520005|NCT00452348|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25520006|NCT00452348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25520007|NCT00452348|Adrenergic Agents|adrenergic agents|mesh-ancestor
25520008|NCT00452348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25520009|NCT00452348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520010|NCT00452348|Glucocorticoids|glucocorticoids|mesh-ancestor
25520011|NCT00452348|Hormones|hormones|mesh-ancestor
25520012|NCT00452348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25520013|NCT00452348|Sympathomimetics|sympathomimetics|mesh-ancestor
25520014|NCT00452374|Vidarabine|vidarabine|mesh-list
25520015|NCT00452374|Cytarabine|cytarabine|mesh-list
25520016|NCT00452374|Rituximab|rituximab|mesh-list
25520017|NCT00452374|Oxaliplatin|oxaliplatin|mesh-list
25520018|NCT00452374|Fludarabine|fludarabine|mesh-list
25520019|NCT00452374|Fludarabine phosphate|fludarabine phosphate|mesh-list
25520020|NCT00452374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25520021|NCT00452374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520022|NCT00452374|Immunologic Factors|immunologic factors|mesh-ancestor
25520023|NCT00452374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520024|NCT00452374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25520025|NCT00452374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25520026|NCT00452374|Antimetabolites|antimetabolites|mesh-ancestor
25520027|NCT00452374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520028|NCT00452374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25163014|NCT02900469|Denosumab|denosumab|mesh-list
25163015|NCT02900469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25163016|NCT02900469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163017|NCT02900417|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25163018|NCT02900417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25163019|NCT02900417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163020|NCT02900417|Incretins|incretins|mesh-ancestor
25163021|NCT02900417|Hormones|hormones|mesh-ancestor
25163022|NCT02900417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25163027|NCT02900157|Durvalumab|durvalumab|mesh-list
25520029|NCT00452374|Antiviral Agents|antiviral agents|mesh-ancestor
25520030|NCT00452374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25520031|NCT00452387|Prednisone|prednisone|mesh-list
25520032|NCT00452387|Sorafenib|sorafenib|mesh-list
25520033|NCT00452387|Mitoxantrone|mitoxantrone|mesh-list
25520034|NCT00452387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25520035|NCT00452387|Glucocorticoids|glucocorticoids|mesh-ancestor
25520036|NCT00452387|Hormones|hormones|mesh-ancestor
25520037|NCT00452387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25520038|NCT00452387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520039|NCT00452387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25520040|NCT00452387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520041|NCT00452387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25520042|NCT00452387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520043|NCT00452387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520044|NCT00452387|Analgesics|analgesics|mesh-ancestor
25520045|NCT00452387|Sensory System Agents|sensory system agents|mesh-ancestor
25520046|NCT00452387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25520047|NCT00452387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25520048|NCT00452387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25520049|NCT00452400|Olodaterol|olodaterol|mesh-list
25520050|NCT00452400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25520051|NCT00452400|Autonomic Agents|autonomic agents|mesh-ancestor
25520052|NCT00452400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25520053|NCT00452400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520054|NCT00452400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25520055|NCT00452400|Respiratory System Agents|respiratory system agents|mesh-ancestor
25520056|NCT00452413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25520057|NCT00452413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520058|NCT00452413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25520059|NCT00452413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520060|NCT00452413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520061|NCT00452426|Analgesics, Opioid|analgesics, opioid|mesh-list
25520062|NCT00452426|Narcotics|narcotics|mesh-ancestor
25520063|NCT00452426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25520064|NCT00452426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520065|NCT00452426|Analgesics|analgesics|mesh-ancestor
25520066|NCT00452426|Sensory System Agents|sensory system agents|mesh-ancestor
25520067|NCT00452426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25520068|NCT00452439|Vitamin D|vitamin d|mesh-list
25520069|NCT00452439|Risedronic Acid|risedronic acid|mesh-list
25520070|NCT00452439|Etidronic Acid|etidronic acid|mesh-list
25520071|NCT00452439|Calcium|calcium|mesh-list
25520072|NCT00452439|Vitamins|vitamins|mesh-ancestor
25520073|NCT00452439|Micronutrients|micronutrients|mesh-ancestor
25520074|NCT00452439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520075|NCT00452439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25520076|NCT00452439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25520077|NCT00452439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25520078|NCT00452439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25520079|NCT00452439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520080|NCT00452452|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25520081|NCT00452452|Immunologic Factors|immunologic factors|mesh-ancestor
25520082|NCT00452452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520083|NCT00452530|Enoxaparin|enoxaparin|mesh-list
25520084|NCT00452530|Enoxaparin sodium|enoxaparin sodium|mesh-list
25520085|NCT00452530|Apixaban|apixaban|mesh-list
25520086|NCT00452530|Anticoagulants|anticoagulants|mesh-ancestor
25520087|NCT00452530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25520088|NCT00452530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25520089|NCT00452530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520090|NCT00452530|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24524657|NCT04572451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524712|NCT04504734|Analgesics|analgesics|mesh-ancestor
24524713|NCT04504734|Sensory System Agents|sensory system agents|mesh-ancestor
24524714|NCT04504734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24524715|NCT04504734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524716|NCT04504734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24524717|NCT04504734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24524718|NCT04504734|Antioxidants|antioxidants|mesh-ancestor
25139380|NCT02971878|Antidotes|antidotes|mesh-ancestor
25139381|NCT02971644|Cobalt|cobalt|mesh-list
25139382|NCT02971644|Trace Elements|trace elements|mesh-ancestor
25139383|NCT02971644|Micronutrients|micronutrients|mesh-ancestor
25520091|NCT00452530|Antithrombins|antithrombins|mesh-ancestor
25520092|NCT00452530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25520094|NCT00452530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520095|NCT00452543|Acamprosate|acamprosate|mesh-list
25520096|NCT00452543|Dexetimide|dexetimide|mesh-list
25520097|NCT00452543|Citalopram|citalopram|mesh-list
25520098|NCT00452543|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25520099|NCT00452543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25520100|NCT00452543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25520101|NCT00452543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520102|NCT00452543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25520103|NCT00452543|Serotonin Agents|serotonin agents|mesh-ancestor
25520104|NCT00452543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520105|NCT00452543|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25520106|NCT00452543|Antidepressive Agents|antidepressive agents|mesh-ancestor
25520107|NCT00452543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25520108|NCT00452543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25520109|NCT00452543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25520110|NCT00452543|Parasympatholytics|parasympatholytics|mesh-ancestor
25520111|NCT00452543|Autonomic Agents|autonomic agents|mesh-ancestor
25520112|NCT00452543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25520113|NCT00452543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25520114|NCT00452543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25520115|NCT00452543|Cholinergic Agents|cholinergic agents|mesh-ancestor
25520116|NCT00452543|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25520117|NCT00452673|Capecitabine|capecitabine|mesh-list
25520118|NCT00452673|Dasatinib|dasatinib|mesh-list
25520119|NCT00452673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25520120|NCT00452673|Antimetabolites|antimetabolites|mesh-ancestor
25520121|NCT00452673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520122|NCT00452673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520123|NCT00452673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25520124|NCT00452673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520125|NCT00452699|Fluticasone|fluticasone|mesh-list
25520126|NCT00452699|Xhance|xhance|mesh-list
25520127|NCT00452699|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25520128|NCT00452699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25520129|NCT00452699|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25520130|NCT00452699|Autonomic Agents|autonomic agents|mesh-ancestor
25520131|NCT00452699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25520132|NCT00452699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520133|NCT00452699|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25520134|NCT00452699|Respiratory System Agents|respiratory system agents|mesh-ancestor
25646669|NCT01462266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25520135|NCT00452699|Dermatologic Agents|dermatologic agents|mesh-ancestor
25520136|NCT00452699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25520137|NCT00452699|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25520138|NCT00452699|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25520139|NCT00452699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25520140|NCT00452699|Adrenergic Agents|adrenergic agents|mesh-ancestor
25520141|NCT00452699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25520142|NCT00452699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520144|NCT00452790|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25520145|NCT00452790|Immunologic Factors|immunologic factors|mesh-ancestor
25520146|NCT00452790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520147|NCT00452868|Donepezil|donepezil|mesh-list
25520148|NCT00452868|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25520149|NCT00452868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520150|NCT00452868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520151|NCT00452868|Cholinergic Agents|cholinergic agents|mesh-ancestor
25520152|NCT00452868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25520153|NCT00452868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520154|NCT00452868|Nootropic Agents|nootropic agents|mesh-ancestor
25520155|NCT00453102|Rituximab|rituximab|mesh-list
25520156|NCT00453102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25520157|NCT00453102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520158|NCT00453102|Immunologic Factors|immunologic factors|mesh-ancestor
25520159|NCT00453102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525181|NCT03854929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25139448|NCT02971306|Expectorants|expectorants|mesh-ancestor
25139449|NCT02971306|Respiratory System Agents|respiratory system agents|mesh-ancestor
25139450|NCT02971306|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25139451|NCT02971306|Antioxidants|antioxidants|mesh-ancestor
24989687|NCT04878510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24989688|NCT04878510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25520160|NCT00453102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25520161|NCT00453154|Cisplatin|cisplatin|mesh-list
25520162|NCT00453154|Carboplatin|carboplatin|mesh-list
25520163|NCT00453154|Etoposide|etoposide|mesh-list
25520164|NCT00453154|Etoposide phosphate|etoposide phosphate|mesh-list
25520165|NCT00453154|Sunitinib|sunitinib|mesh-list
25520166|NCT00453154|Podophyllotoxin|podophyllotoxin|mesh-list
25520167|NCT00453154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520168|NCT00453154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25520169|NCT00453154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25520170|NCT00453154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25520171|NCT00453154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520172|NCT00453154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520173|NCT00453154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25520174|NCT00453154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25520175|NCT00453154|Growth Substances|growth substances|mesh-ancestor
25520176|NCT00453154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520177|NCT00453154|Growth Inhibitors|growth inhibitors|mesh-ancestor
25520178|NCT00453154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25520179|NCT00453154|Keratolytic Agents|keratolytic agents|mesh-ancestor
25520180|NCT00453154|Dermatologic Agents|dermatologic agents|mesh-ancestor
25520181|NCT00453154|Tubulin Modulators|tubulin modulators|mesh-ancestor
25520182|NCT00453154|Antimitotic Agents|antimitotic agents|mesh-ancestor
25520183|NCT00453154|Mitosis Modulators|mitosis modulators|mesh-ancestor
25520184|NCT00453180|Acetylcysteine|acetylcysteine|mesh-list
25520185|NCT00453180|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25520186|NCT00453180|Antiviral Agents|antiviral agents|mesh-ancestor
25520187|NCT00453180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25520188|NCT00453180|Expectorants|expectorants|mesh-ancestor
25520189|NCT00453180|Respiratory System Agents|respiratory system agents|mesh-ancestor
25520190|NCT00453180|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25520191|NCT00453180|Antioxidants|antioxidants|mesh-ancestor
25520192|NCT00453180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520193|NCT00453180|Protective Agents|protective agents|mesh-ancestor
25520194|NCT00453180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520195|NCT00453180|Antidotes|antidotes|mesh-ancestor
25520196|NCT00453193|Alemtuzumab|alemtuzumab|mesh-list
25520197|NCT00453193|Pentostatin|pentostatin|mesh-list
25520198|NCT00453193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25520199|NCT00453193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520200|NCT00453193|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25520201|NCT00453193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646670|NCT01462266|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25646671|NCT01462266|Protease Inhibitors|protease inhibitors|mesh-ancestor
25646672|NCT01462266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646673|NCT01462266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646674|NCT01462279|Thiamine|thiamine|mesh-list
25646675|NCT01462279|Vitamin B Complex|vitamin b complex|mesh-ancestor
25646676|NCT01462279|Vitamins|vitamins|mesh-ancestor
25646677|NCT01462279|Micronutrients|micronutrients|mesh-ancestor
25520202|NCT00453193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520203|NCT00453310|Sunitinib|sunitinib|mesh-list
25520204|NCT00453310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520205|NCT00453310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25520206|NCT00453310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25520207|NCT00453310|Growth Substances|growth substances|mesh-ancestor
25520208|NCT00453310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520209|NCT00453310|Growth Inhibitors|growth inhibitors|mesh-ancestor
25520210|NCT00453310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25520211|NCT00453310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520212|NCT00453310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520213|NCT00453336|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
25520214|NCT00453336|Trioxsalen|trioxsalen|mesh-list
25520215|NCT00453336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520216|NCT00453336|Dermatologic Agents|dermatologic agents|mesh-ancestor
25520217|NCT00453336|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25520218|NCT00453349|Moxifloxacin|moxifloxacin|mesh-list
25520219|NCT00453349|Metronidazole|metronidazole|mesh-list
25520220|NCT00453349|Levofloxacin|levofloxacin|mesh-list
25520221|NCT00453349|Ofloxacin|ofloxacin|mesh-list
25520222|NCT00453349|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25520223|NCT00453349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25520224|NCT00453349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25520225|NCT00453349|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25520226|NCT00453349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25520227|NCT00453349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520228|NCT00453349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520229|NCT00453349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520230|NCT00453349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25520231|NCT00453349|Contraceptive Agents|contraceptive agents|mesh-ancestor
25520232|NCT00453349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24989693|NCT04878510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989695|NCT04876781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25520233|NCT00453349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520235|NCT00453349|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25520236|NCT00453349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25520237|NCT00453349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25520238|NCT00453349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25520239|NCT00453349|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25520240|NCT00453349|Renal Agents|renal agents|mesh-ancestor
25520241|NCT00453349|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25520242|NCT00453349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25520243|NCT00453362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25520244|NCT00453362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520245|NCT00453362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25520246|NCT00453362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520247|NCT00453362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520248|NCT00453388|Cyclosporine|cyclosporine|mesh-list
25520249|NCT00453388|Mycophenolic Acid|mycophenolic acid|mesh-list
25520250|NCT00453388|Cyclophosphamide|cyclophosphamide|mesh-list
25520251|NCT00453388|Fludarabine|fludarabine|mesh-list
25520252|NCT00453388|Fludarabine phosphate|fludarabine phosphate|mesh-list
25520253|NCT00453388|Cyclosporins|cyclosporins|mesh-list
25520254|NCT00453388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25520255|NCT00453388|Immunologic Factors|immunologic factors|mesh-ancestor
25520256|NCT00453388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520257|NCT00453388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25520258|NCT00453388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25520259|NCT00453388|Alkylating Agents|alkylating agents|mesh-ancestor
25520260|NCT00453388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520261|NCT00453388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520262|NCT00453388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25520263|NCT00453388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25520264|NCT00453388|Antimetabolites|antimetabolites|mesh-ancestor
25520265|NCT00453388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520266|NCT00453388|Antifungal Agents|antifungal agents|mesh-ancestor
25646678|NCT01462279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646679|NCT01462318|Vitamin K|vitamin k|mesh-list
25646680|NCT01462318|Midazolam|midazolam|mesh-list
25520267|NCT00453388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25520268|NCT00453388|Dermatologic Agents|dermatologic agents|mesh-ancestor
25520269|NCT00453388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25520270|NCT00453388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25520271|NCT00453388|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25520272|NCT00453388|Antitubercular Agents|antitubercular agents|mesh-ancestor
25520273|NCT00453388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25520274|NCT00453895|Sunitinib|sunitinib|mesh-list
25520275|NCT00453895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520276|NCT00453895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25520277|NCT00453895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25520278|NCT00453895|Growth Substances|growth substances|mesh-ancestor
25520279|NCT00453895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520280|NCT00453895|Growth Inhibitors|growth inhibitors|mesh-ancestor
25520281|NCT00453895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25520282|NCT00453895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520283|NCT00453895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520284|NCT00453921|Methylphenidate|methylphenidate|mesh-list
24989713|NCT04865289|Antimitotic Agents|antimitotic agents|mesh-ancestor
24989714|NCT04865289|Mitosis Modulators|mitosis modulators|mesh-ancestor
24989715|NCT04865289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989716|NCT04865289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24989717|NCT04865289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24989718|NCT04865289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24989719|NCT04854343|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
24989720|NCT04854343|Protease Inhibitors|protease inhibitors|mesh-list
24989721|NCT04854343|Secretory Leukocyte Peptidase Inhibitor|secretory leukocyte peptidase inhibitor|mesh-list
24989722|NCT04854343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24989723|NCT04854343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989724|NCT04854343|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24989725|NCT04854343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24989726|NCT04854343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24989727|NCT04854343|Antiviral Agents|antiviral agents|mesh-ancestor
24989728|NCT04854343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24989729|NCT04854343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25046531|NCT00840879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25046532|NCT00840879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046533|NCT00840879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24525934|NCT02343549|Growth Substances|growth substances|mesh-ancestor
25520308|NCT00454181|Immunologic Factors|immunologic factors|mesh-ancestor
25520309|NCT00454181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520311|NCT00454194|Sorafenib|sorafenib|mesh-list
25520312|NCT00454194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520313|NCT00454194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520314|NCT00454194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520315|NCT00454194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25520316|NCT00454194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25520317|NCT00454194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25520318|NCT00454207|Sildenafil Citrate|sildenafil citrate|mesh-list
25520319|NCT00454207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520320|NCT00454207|Vasodilator Agents|vasodilator agents|mesh-ancestor
25520321|NCT00454207|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25520322|NCT00454207|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25520323|NCT00454207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520324|NCT00454207|Urological Agents|urological agents|mesh-ancestor
25520325|NCT00454246|Epoetin Alfa|epoetin alfa|mesh-list
25520326|NCT00454246|Darbepoetin alfa|darbepoetin alfa|mesh-list
25520327|NCT00454246|Hematinics|hematinics|mesh-ancestor
25520328|NCT00454324|Paclitaxel|paclitaxel|mesh-list
25520329|NCT00454324|Carboplatin|carboplatin|mesh-list
25520330|NCT00454324|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25520331|NCT00454324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25520332|NCT00454324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520333|NCT00454324|Tubulin Modulators|tubulin modulators|mesh-ancestor
25520334|NCT00454324|Antimitotic Agents|antimitotic agents|mesh-ancestor
25520335|NCT00454324|Mitosis Modulators|mitosis modulators|mesh-ancestor
25520336|NCT00454324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520338|NCT00454584|Ustekinumab|ustekinumab|mesh-list
25520339|NCT00454584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25520340|NCT00454584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25520341|NCT00454584|Analgesics|analgesics|mesh-ancestor
25520342|NCT00454584|Sensory System Agents|sensory system agents|mesh-ancestor
25520343|NCT00454584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25520344|NCT00454584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520345|NCT00454584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25520346|NCT00454584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25520347|NCT00454584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25520348|NCT00454584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25520349|NCT00454584|Immunologic Factors|immunologic factors|mesh-ancestor
25520350|NCT00454584|Dermatologic Agents|dermatologic agents|mesh-ancestor
25520351|NCT00454636|Cisplatin|cisplatin|mesh-list
25520352|NCT00454636|Docetaxel|docetaxel|mesh-list
25520353|NCT00454636|Capecitabine|capecitabine|mesh-list
25520354|NCT00454636|Oxaliplatin|oxaliplatin|mesh-list
25520355|NCT00454636|Epirubicin|epirubicin|mesh-list
25520356|NCT00454636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520357|NCT00454636|Tubulin Modulators|tubulin modulators|mesh-ancestor
25520358|NCT00454636|Antimitotic Agents|antimitotic agents|mesh-ancestor
25520359|NCT00454636|Mitosis Modulators|mitosis modulators|mesh-ancestor
25520360|NCT00454636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520361|NCT00454636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25520362|NCT00454636|Antimetabolites|antimetabolites|mesh-ancestor
25520363|NCT00454636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25520364|NCT00454636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25520365|NCT00454636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25520366|NCT00454636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520367|NCT00454649|Gemcitabine|gemcitabine|mesh-list
25520368|NCT00454649|Paclitaxel|paclitaxel|mesh-list
25520369|NCT00454649|Docetaxel|docetaxel|mesh-list
25520370|NCT00454649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25520371|NCT00454649|Cisplatin|cisplatin|mesh-list
25520372|NCT00454649|Carboplatin|carboplatin|mesh-list
25520373|NCT00454649|Capecitabine|capecitabine|mesh-list
25520374|NCT00454649|Pemetrexed|pemetrexed|mesh-list
25520375|NCT00454649|Axitinib|axitinib|mesh-list
25520376|NCT00454649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25520377|NCT00454649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520378|NCT00454649|Tubulin Modulators|tubulin modulators|mesh-ancestor
25520379|NCT00454649|Antimitotic Agents|antimitotic agents|mesh-ancestor
25520380|NCT00454649|Mitosis Modulators|mitosis modulators|mesh-ancestor
25520381|NCT00454649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520382|NCT00454649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25520383|NCT00454649|Antimetabolites|antimetabolites|mesh-ancestor
25520384|NCT00454649|Antiviral Agents|antiviral agents|mesh-ancestor
25520385|NCT00454649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25520386|NCT00454649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520387|NCT00454649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25520388|NCT00454649|Immunologic Factors|immunologic factors|mesh-ancestor
25520389|NCT00454649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520390|NCT00454649|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25520391|NCT00454649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25520392|NCT00454649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25520393|NCT00454779|Cisplatin|cisplatin|mesh-list
25520394|NCT00454779|Docetaxel|docetaxel|mesh-list
25520395|NCT00454779|Panitumumab|panitumumab|mesh-list
25520396|NCT00454779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520397|NCT00454779|Tubulin Modulators|tubulin modulators|mesh-ancestor
25520398|NCT00454779|Antimitotic Agents|antimitotic agents|mesh-ancestor
25520399|NCT00454779|Mitosis Modulators|mitosis modulators|mesh-ancestor
25520400|NCT00454779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520401|NCT00454779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25520402|NCT00454805|Fulvestrant|fulvestrant|mesh-list
25520403|NCT00454805|Cediranib|cediranib|mesh-list
25520404|NCT00454805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24797080|NCT01953835|Antimetabolites|antimetabolites|mesh-ancestor
24797081|NCT01953835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927506|NCT04132570|Budesonide|budesonide|mesh-list
24989802|NCT04739995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24863793|NCT03305341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25139643|NCT02969733|Analgesics|analgesics|mesh-ancestor
25139644|NCT02969733|Sensory System Agents|sensory system agents|mesh-ancestor
25139645|NCT02969733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25139646|NCT02969733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139650|NCT02969733|Anesthetics|anesthetics|mesh-ancestor
25520405|NCT00454805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520406|NCT00454805|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25520407|NCT00454805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25520408|NCT00454805|Hormone Antagonists|hormone antagonists|mesh-ancestor
25520409|NCT00454805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25520410|NCT00454805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520411|NCT00454805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25520412|NCT00454805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520413|NCT00454805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520414|NCT00455013|Mycophenolic Acid|mycophenolic acid|mesh-list
25520415|NCT00455013|Sirolimus|sirolimus|mesh-list
25520416|NCT00455013|Abatacept|abatacept|mesh-list
25520417|NCT00455013|Tacrolimus|tacrolimus|mesh-list
25520418|NCT00455013|Thymoglobulin|thymoglobulin|mesh-list
25520419|NCT00455013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25520420|NCT00455013|Immunologic Factors|immunologic factors|mesh-ancestor
25520421|NCT00455013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520422|NCT00455013|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25520423|NCT00455013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520424|NCT00455013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520425|NCT00455013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25520426|NCT00455013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520427|NCT00455013|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25520428|NCT00455013|Antitubercular Agents|antitubercular agents|mesh-ancestor
25520429|NCT00455013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25520430|NCT00455013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25520431|NCT00455013|Antifungal Agents|antifungal agents|mesh-ancestor
25520432|NCT00455013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25520433|NCT00455013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25520434|NCT00455312|Methylprednisolone|methylprednisolone|mesh-list
25520435|NCT00455312|Cyclophosphamide|cyclophosphamide|mesh-list
25520436|NCT00455312|Fludarabine|fludarabine|mesh-list
25520437|NCT00455312|Alemtuzumab|alemtuzumab|mesh-list
25520438|NCT00455312|Thymoglobulin|thymoglobulin|mesh-list
25520439|NCT00455312|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25520440|NCT00455312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25520441|NCT00455312|Immunologic Factors|immunologic factors|mesh-ancestor
25520442|NCT00455312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520443|NCT00455312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25520444|NCT00455312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25520445|NCT00455312|Alkylating Agents|alkylating agents|mesh-ancestor
25520446|NCT00455312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520447|NCT00455312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520448|NCT00455312|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25520449|NCT00455312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25520450|NCT00455312|Antiemetics|antiemetics|mesh-ancestor
25520451|NCT00455312|Autonomic Agents|autonomic agents|mesh-ancestor
25520452|NCT00455312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25520453|NCT00455312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25520454|NCT00455312|Glucocorticoids|glucocorticoids|mesh-ancestor
25520455|NCT00455312|Hormones|hormones|mesh-ancestor
25520456|NCT00455312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25520457|NCT00455312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25520458|NCT00455312|Protective Agents|protective agents|mesh-ancestor
25520459|NCT00455312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25520460|NCT00455455|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25520461|NCT00455520|Tapentadol|tapentadol|mesh-list
25520462|NCT00455520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25520463|NCT00455520|Narcotics|narcotics|mesh-ancestor
25520464|NCT00455520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25520465|NCT00455520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520466|NCT00455520|Analgesics|analgesics|mesh-ancestor
25520467|NCT00455520|Sensory System Agents|sensory system agents|mesh-ancestor
25520468|NCT00455520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25520469|NCT00455520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25520470|NCT00455520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25520471|NCT00455520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25520472|NCT00455520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520473|NCT00455520|Adrenergic Agents|adrenergic agents|mesh-ancestor
25520474|NCT00455520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25520475|NCT00455533|Paclitaxel|paclitaxel|mesh-list
25520476|NCT00455533|Epothilones|epothilones|mesh-list
25520477|NCT00455533|Cyclophosphamide|cyclophosphamide|mesh-list
25520478|NCT00455533|Doxorubicin|doxorubicin|mesh-list
25520479|NCT00455533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25520480|NCT00455533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520481|NCT00455533|Tubulin Modulators|tubulin modulators|mesh-ancestor
25520482|NCT00455533|Antimitotic Agents|antimitotic agents|mesh-ancestor
25520483|NCT00455533|Mitosis Modulators|mitosis modulators|mesh-ancestor
25520484|NCT00455533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646681|NCT01462318|Dextromethorphan|dextromethorphan|mesh-list
25520485|NCT00455533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25520486|NCT00455533|Immunologic Factors|immunologic factors|mesh-ancestor
25520487|NCT00455533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520488|NCT00455533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25520489|NCT00455533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25520490|NCT00455533|Alkylating Agents|alkylating agents|mesh-ancestor
25520491|NCT00455533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25520492|NCT00455533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25520493|NCT00455533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25520494|NCT00455533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25520495|NCT00455533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520496|NCT00455650|Mecamylamine|mecamylamine|mesh-list
25520497|NCT00455650|Varenicline|varenicline|mesh-list
25520498|NCT00455650|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25520499|NCT00455650|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25520500|NCT00455650|Cholinergic Agents|cholinergic agents|mesh-ancestor
25520501|NCT00455650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25520502|NCT00455650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520503|NCT00455650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520504|NCT00455650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25520505|NCT00455650|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
25520506|NCT00455650|Autonomic Agents|autonomic agents|mesh-ancestor
25520507|NCT00455650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25520508|NCT00455650|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25520509|NCT00455650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25520510|NCT00455689|Leuprolide|leuprolide|mesh-list
25520511|NCT00455689|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25520512|NCT00455689|Fertility Agents|fertility agents|mesh-ancestor
25520513|NCT00455689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25520514|NCT00455689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520515|NCT00455689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25520516|NCT00455689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520517|NCT00455702|Cycloserine|cycloserine|mesh-list
25520518|NCT00455702|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25520519|NCT00455702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25520520|NCT00455702|Renal Agents|renal agents|mesh-ancestor
25520521|NCT00455702|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25520522|NCT00455702|Antitubercular Agents|antitubercular agents|mesh-ancestor
25520523|NCT00455702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25520524|NCT00455702|Antimetabolites|antimetabolites|mesh-ancestor
25520525|NCT00455702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520526|NCT00455741|Estradiol|estradiol|mesh-list
25520527|NCT00455741|Progesterone|progesterone|mesh-list
25520528|NCT00455741|Estrogens|estrogens|mesh-ancestor
25520529|NCT00455741|Hormones|hormones|mesh-ancestor
25520530|NCT00455741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25520531|NCT00455741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520532|NCT00455741|Progestins|progestins|mesh-ancestor
25520533|NCT00455858|Insulin Detemir|insulin detemir|mesh-list
25520534|NCT00455858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25520535|NCT00455858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520536|NCT00455923|Fluticasone|fluticasone|mesh-list
25520537|NCT00455923|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25520538|NCT00455923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25520539|NCT00455923|Autonomic Agents|autonomic agents|mesh-ancestor
25520540|NCT00455923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25520541|NCT00455923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520542|NCT00455923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25520543|NCT00455923|Respiratory System Agents|respiratory system agents|mesh-ancestor
25520544|NCT00455923|Glucocorticoids|glucocorticoids|mesh-ancestor
25520545|NCT00455923|Hormones|hormones|mesh-ancestor
25520546|NCT00455923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25520547|NCT00455923|Sympathomimetics|sympathomimetics|mesh-ancestor
25520548|NCT00455923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25520549|NCT00455923|Dermatologic Agents|dermatologic agents|mesh-ancestor
25520550|NCT00455923|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25520551|NCT00455962|Estradiol|estradiol|mesh-list
25520552|NCT00455962|Progesterone|progesterone|mesh-list
25520553|NCT00455962|Estrogens|estrogens|mesh-ancestor
25520554|NCT00455962|Hormones|hormones|mesh-ancestor
25520555|NCT00455962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25520556|NCT00455962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520558|NCT00455975|Bevacizumab|bevacizumab|mesh-list
25520559|NCT00455975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25646682|NCT01462318|Caffeine|caffeine|mesh-list
25646683|NCT01462318|Omeprazole|omeprazole|mesh-list
24557480|NCT00752648|Simeprevir|simeprevir|mesh-list
25520560|NCT00455975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520561|NCT00455975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25520562|NCT00455975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25520563|NCT00455975|Growth Substances|growth substances|mesh-ancestor
25520564|NCT00455975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520565|NCT00455975|Growth Inhibitors|growth inhibitors|mesh-ancestor
25520566|NCT00456014|Citalopram|citalopram|mesh-list
25520567|NCT00456014|Desipramine|desipramine|mesh-list
25520568|NCT00456014|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25520569|NCT00456014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25520570|NCT00456014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25520571|NCT00456014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520572|NCT00456014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25520573|NCT00456014|Serotonin Agents|serotonin agents|mesh-ancestor
25520574|NCT00456014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520575|NCT00456014|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25520576|NCT00456014|Antidepressive Agents|antidepressive agents|mesh-ancestor
25520577|NCT00456014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25520578|NCT00456014|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25520579|NCT00456014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520580|NCT00456014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25520581|NCT00456014|Adrenergic Agents|adrenergic agents|mesh-ancestor
25520582|NCT00456092|Apremilast|apremilast|mesh-list
25520583|NCT00456092|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25520584|NCT00456092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25520585|NCT00456092|Analgesics|analgesics|mesh-ancestor
25520586|NCT00456092|Sensory System Agents|sensory system agents|mesh-ancestor
25520587|NCT00456092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25520588|NCT00456092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520589|NCT00456092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25520590|NCT00456092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25520591|NCT00456092|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25520592|NCT00456092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25520593|NCT00456092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520594|NCT00456092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520595|NCT00456300|Exenatide|exenatide|mesh-list
25520596|NCT00456300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25520597|NCT00456300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520598|NCT00456300|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25520599|NCT00456300|Incretins|incretins|mesh-ancestor
25520600|NCT00456300|Hormones|hormones|mesh-ancestor
25520601|NCT00456300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25520602|NCT00456365|Pravastatin|pravastatin|mesh-list
25520603|NCT00456365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25520604|NCT00456365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25520605|NCT00456365|Antimetabolites|antimetabolites|mesh-ancestor
25520606|NCT00456365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520607|NCT00456365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25520608|NCT00456365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25520609|NCT00456365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520610|NCT00456495|Ranibizumab|ranibizumab|mesh-list
25520611|NCT00456495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25520612|NCT00456495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25520613|NCT00456495|Growth Substances|growth substances|mesh-ancestor
25520614|NCT00456495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520615|NCT00456495|Growth Inhibitors|growth inhibitors|mesh-ancestor
25520616|NCT00456495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520617|NCT00456508|Ecallantide|ecallantide|mesh-list
25520618|NCT00456508|Analgesics|analgesics|mesh-ancestor
25520619|NCT00456508|Sensory System Agents|sensory system agents|mesh-ancestor
25520620|NCT00456508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25520621|NCT00456508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520622|NCT00456508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25520623|NCT00456508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25520624|NCT00456508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25520625|NCT00456508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25520626|NCT00456521|Naltrexone|naltrexone|mesh-list
25520627|NCT00456521|Bupropion|bupropion|mesh-list
25520628|NCT00456521|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25520629|NCT00456521|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25520630|NCT00456521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520631|NCT00456521|Sensory System Agents|sensory system agents|mesh-ancestor
25520632|NCT00456521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25646684|NCT01462318|Warfarin|warfarin|mesh-list
25646685|NCT01462318|Daclizumab|daclizumab|mesh-list
25646686|NCT01462318|Vitamins|vitamins|mesh-ancestor
25646687|NCT01462318|Micronutrients|micronutrients|mesh-ancestor
25646688|NCT01462318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646689|NCT01462318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25520633|NCT00456521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25520634|NCT00456521|Antidepressive Agents|antidepressive agents|mesh-ancestor
25520635|NCT00456521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25520636|NCT00456521|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25520637|NCT00456521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25520638|NCT00456521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25520639|NCT00456521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520641|NCT00456521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25520642|NCT00456521|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25520643|NCT00456521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25520644|NCT00456521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520645|NCT00456599|Gemcitabine|gemcitabine|mesh-list
25520646|NCT00456599|Oxaliplatin|oxaliplatin|mesh-list
25520647|NCT00456599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25520648|NCT00456599|Antimetabolites|antimetabolites|mesh-ancestor
25520649|NCT00456599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520650|NCT00456599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520651|NCT00456599|Antiviral Agents|antiviral agents|mesh-ancestor
25520652|NCT00456599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25520653|NCT00456599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520654|NCT00456599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25520655|NCT00456599|Immunologic Factors|immunologic factors|mesh-ancestor
25520656|NCT00456599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520657|NCT00456625|Vaccines|vaccines|mesh-list
25520658|NCT00456625|Immunologic Factors|immunologic factors|mesh-ancestor
25520659|NCT00456625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520660|NCT00456807|Vaccines|vaccines|mesh-list
25520661|NCT00456807|Immunologic Factors|immunologic factors|mesh-ancestor
25520662|NCT00456807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520663|NCT00456846|Paclitaxel|paclitaxel|mesh-list
25520664|NCT00456846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25520665|NCT00456846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25520666|NCT00456846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520667|NCT00456846|Tubulin Modulators|tubulin modulators|mesh-ancestor
25520668|NCT00456846|Antimitotic Agents|antimitotic agents|mesh-ancestor
25520669|NCT00456846|Mitosis Modulators|mitosis modulators|mesh-ancestor
25520670|NCT00456846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520671|NCT00456885|Exenatide|exenatide|mesh-list
25520672|NCT00456885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25520673|NCT00456885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520674|NCT00456885|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25520675|NCT00456885|Incretins|incretins|mesh-ancestor
25520676|NCT00456885|Hormones|hormones|mesh-ancestor
25520677|NCT00456885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25520678|NCT00457002|Enoxaparin|enoxaparin|mesh-list
25520679|NCT00457002|Apixaban|apixaban|mesh-list
25520680|NCT00457002|Anticoagulants|anticoagulants|mesh-ancestor
25520681|NCT00457002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25520682|NCT00457002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25520683|NCT00457002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520684|NCT00457002|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25520685|NCT00457002|Antithrombins|antithrombins|mesh-ancestor
25520686|NCT00457002|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25520687|NCT00457002|Protease Inhibitors|protease inhibitors|mesh-ancestor
25520688|NCT00457002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520689|NCT00457015|Ecallantide|ecallantide|mesh-list
25520690|NCT00457015|Analgesics|analgesics|mesh-ancestor
25520691|NCT00457015|Sensory System Agents|sensory system agents|mesh-ancestor
25520692|NCT00457015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25520693|NCT00457015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520694|NCT00457015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25520695|NCT00457015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25520696|NCT00457015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25520697|NCT00457015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25520698|NCT00457197|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25520699|NCT00457197|Antidepressive Agents|antidepressive agents|mesh-ancestor
25520700|NCT00457197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24529226|NCT00625092|Antidotes|antidotes|mesh-ancestor
24529227|NCT00625092|Protective Agents|protective agents|mesh-ancestor
24529228|NCT00625092|Vitamin B Complex|vitamin b complex|mesh-ancestor
24529229|NCT00625092|Vitamins|vitamins|mesh-ancestor
24654649|NCT01250743|Vitamins|vitamins|mesh-list
25646690|NCT01462318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25520701|NCT00457197|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25520702|NCT00457197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25520703|NCT00457197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25520704|NCT00457197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520707|NCT00457366|Benztropine|benztropine|mesh-list
25520708|NCT00457366|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25520709|NCT00457366|Haloperidol decanoate|haloperidol decanoate|mesh-list
25520710|NCT00457366|Antidepressive Agents|antidepressive agents|mesh-ancestor
25520711|NCT00457366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25520712|NCT00457366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25520713|NCT00457366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25520714|NCT00457366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25520715|NCT00457366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520716|NCT00457366|Antiemetics|antiemetics|mesh-ancestor
25520717|NCT00457366|Autonomic Agents|autonomic agents|mesh-ancestor
25520718|NCT00457366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25520719|NCT00457366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25520720|NCT00457366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25520721|NCT00457366|Dopamine Agents|dopamine agents|mesh-ancestor
25520722|NCT00457366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25520723|NCT00457366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520724|NCT00457366|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25520725|NCT00457366|Anticonvulsants|anticonvulsants|mesh-ancestor
25520726|NCT00457366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25520727|NCT00457366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25520728|NCT00457366|GABA Modulators|gaba modulators|mesh-ancestor
25520729|NCT00457366|GABA Agents|gaba agents|mesh-ancestor
25520730|NCT00457366|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25520731|NCT00457366|Parasympatholytics|parasympatholytics|mesh-ancestor
25520732|NCT00457366|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25520733|NCT00457366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25520734|NCT00457366|Cholinergic Agents|cholinergic agents|mesh-ancestor
25520735|NCT00457366|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25520736|NCT00457366|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25520737|NCT00457366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25520738|NCT00457392|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25520739|NCT00457392|Sunitinib|sunitinib|mesh-list
25520740|NCT00457392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520741|NCT00457392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25520742|NCT00457392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520743|NCT00457392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520744|NCT00457392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25520745|NCT00457392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25520746|NCT00457392|Growth Substances|growth substances|mesh-ancestor
25520747|NCT00457392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520748|NCT00457392|Growth Inhibitors|growth inhibitors|mesh-ancestor
25520749|NCT00457418|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25520750|NCT00457418|Antiviral Agents|antiviral agents|mesh-ancestor
25520751|NCT00457418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25520752|NCT00457626|Valsartan|valsartan|mesh-list
25520753|NCT00457626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25520754|NCT00457626|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25520755|NCT00457626|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25520756|NCT00457626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520757|NCT00457639|Cholic Acids|cholic acids|mesh-list
25520758|NCT00457639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25520759|NCT00457665|Efavirenz|efavirenz|mesh-list
25520760|NCT00457665|Nelfinavir|nelfinavir|mesh-list
25520761|NCT00457665|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25520762|NCT00457665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25520763|NCT00457665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520764|NCT00457665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520765|NCT00457665|Antiviral Agents|antiviral agents|mesh-ancestor
25520766|NCT00457665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25520767|NCT00457665|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25520768|NCT00457665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25520769|NCT00457665|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25520770|NCT00457665|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25520771|NCT00457665|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25520772|NCT00457665|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25520773|NCT00457665|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24799058|NCT01966822|Dolutegravir|dolutegravir|mesh-list
25520774|NCT00457665|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25520775|NCT00457665|Protease Inhibitors|protease inhibitors|mesh-ancestor
25520776|NCT00457665|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25520777|NCT00457665|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25520778|NCT00457691|Leucovorin|leucovorin|mesh-list
25520779|NCT00457691|Fluorouracil|fluorouracil|mesh-list
25520780|NCT00457691|Irinotecan|irinotecan|mesh-list
25520781|NCT00457691|Sunitinib|sunitinib|mesh-list
25520782|NCT00457691|Levoleucovorin|levoleucovorin|mesh-list
25520783|NCT00457691|Antimetabolites|antimetabolites|mesh-ancestor
25520784|NCT00457691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520785|NCT00457691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25520786|NCT00457691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520787|NCT00457691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25520788|NCT00457691|Immunologic Factors|immunologic factors|mesh-ancestor
25520789|NCT00457691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520790|NCT00457691|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25520791|NCT00457691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25520792|NCT00457691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520793|NCT00457691|Antidotes|antidotes|mesh-ancestor
25520794|NCT00457691|Protective Agents|protective agents|mesh-ancestor
25520795|NCT00457691|Vitamin B Complex|vitamin b complex|mesh-ancestor
25520796|NCT00457691|Vitamins|vitamins|mesh-ancestor
25520797|NCT00457691|Micronutrients|micronutrients|mesh-ancestor
25520798|NCT00457691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25520799|NCT00457691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25520800|NCT00457691|Growth Substances|growth substances|mesh-ancestor
25520801|NCT00457691|Growth Inhibitors|growth inhibitors|mesh-ancestor
25520802|NCT00457691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25520803|NCT00457730|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25520804|NCT00457730|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25520805|NCT00457730|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25520806|NCT00457730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25520807|NCT00457730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520808|NCT00457730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25520809|NCT00457730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520810|NCT00457730|Analgesics|analgesics|mesh-ancestor
25520811|NCT00457730|Sensory System Agents|sensory system agents|mesh-ancestor
25520812|NCT00457730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25520813|NCT00457730|Antidepressive Agents|antidepressive agents|mesh-ancestor
25520814|NCT00457730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25520815|NCT00457730|Dopamine Agents|dopamine agents|mesh-ancestor
25520816|NCT00457743|Sunitinib|sunitinib|mesh-list
25520817|NCT00457743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520818|NCT00457743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25520819|NCT00457743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25520820|NCT00457743|Growth Substances|growth substances|mesh-ancestor
25520821|NCT00457743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520822|NCT00457743|Growth Inhibitors|growth inhibitors|mesh-ancestor
25520823|NCT00457743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25520824|NCT00457743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520825|NCT00457743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520826|NCT00457795|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25520827|NCT00457795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25520828|NCT00457795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25520829|NCT00457795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25520830|NCT00457795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25520831|NCT00457795|Adrenergic Agents|adrenergic agents|mesh-ancestor
25520832|NCT00457795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25520833|NCT00457795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520834|NCT00457795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520835|NCT00457821|Ivacaftor|ivacaftor|mesh-list
25520836|NCT00457821|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25520837|NCT00457821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25520838|NCT00457821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520839|NCT00457977|Vaccines|vaccines|mesh-list
25520840|NCT00457977|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25520841|NCT00457977|Immunologic Factors|immunologic factors|mesh-ancestor
24797101|NCT01953887|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24797102|NCT01953887|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24797103|NCT01953887|Adrenergic Agents|adrenergic agents|mesh-ancestor
24797104|NCT01953887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24797105|NCT01953887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797106|NCT01953887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797107|NCT01953887|Urological Agents|urological agents|mesh-ancestor
25520842|NCT00457977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520843|NCT00458211|Ziprasidone|ziprasidone|mesh-list
25520844|NCT00458211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25520845|NCT00458211|Serotonin Agents|serotonin agents|mesh-ancestor
25520846|NCT00458211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25520847|NCT00458211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520848|NCT00458211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520849|NCT00458211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25520850|NCT00458211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25520851|NCT00458211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25520852|NCT00458211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25520853|NCT00458211|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25520854|NCT00458211|Dopamine Agents|dopamine agents|mesh-ancestor
25520855|NCT00458237|Trastuzumab|trastuzumab|mesh-list
25520856|NCT00458237|Everolimus|everolimus|mesh-list
25520857|NCT00458237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25520858|NCT00458237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520859|NCT00458237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25520860|NCT00458237|Immunologic Factors|immunologic factors|mesh-ancestor
25520861|NCT00458237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520862|NCT00458302|Darunavir|darunavir|mesh-list
25520863|NCT00458302|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25520864|NCT00458302|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25520865|NCT00458302|Protease Inhibitors|protease inhibitors|mesh-ancestor
25520866|NCT00458302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520867|NCT00458302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520868|NCT00458302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25520869|NCT00458302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25520870|NCT00458302|Antiviral Agents|antiviral agents|mesh-ancestor
25520871|NCT00458302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25520872|NCT00458393|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25520873|NCT00458393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25520874|NCT00458393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25520875|NCT00458393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520876|NCT00458393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520877|NCT00458393|Antiviral Agents|antiviral agents|mesh-ancestor
25520878|NCT00458393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25520879|NCT00458393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25520880|NCT00458393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25520881|NCT00458705|Thalidomide|thalidomide|mesh-list
25520882|NCT00458705|Dexamethasone|dexamethasone|mesh-list
25520883|NCT00458705|Doxorubicin|doxorubicin|mesh-list
25520884|NCT00458705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25520885|NCT00458705|Bortezomib|bortezomib|mesh-list
25520886|NCT00458705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25520887|NCT00458705|Antiemetics|antiemetics|mesh-ancestor
25520888|NCT00458705|Autonomic Agents|autonomic agents|mesh-ancestor
25520889|NCT00458705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25520890|NCT00458705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520891|NCT00458705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25520892|NCT00458705|Glucocorticoids|glucocorticoids|mesh-ancestor
25520893|NCT00458705|Hormones|hormones|mesh-ancestor
25520894|NCT00458705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25520895|NCT00458705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25520896|NCT00458705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520897|NCT00458705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25520898|NCT00458705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25520899|NCT00458705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25520900|NCT00458705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520901|NCT00458705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520902|NCT00458705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25520903|NCT00458705|Immunologic Factors|immunologic factors|mesh-ancestor
25520904|NCT00458705|Leprostatic Agents|leprostatic agents|mesh-ancestor
25520905|NCT00458705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25520906|NCT00458705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25520907|NCT00458705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25520908|NCT00458705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25520909|NCT00458705|Growth Substances|growth substances|mesh-ancestor
25520910|NCT00458705|Growth Inhibitors|growth inhibitors|mesh-ancestor
25520911|NCT00458822|Dexamethasone|dexamethasone|mesh-list
25520912|NCT00458822|Bortezomib|bortezomib|mesh-list
25520913|NCT00458822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25520914|NCT00458822|Antiemetics|antiemetics|mesh-ancestor
25520915|NCT00458822|Autonomic Agents|autonomic agents|mesh-ancestor
25823399|NCT00004816|Antibodies|antibodies|mesh-list
25520916|NCT00458822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24989955|NCT04490018|Vaccines|vaccines|mesh-list
25520917|NCT00458822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520918|NCT00458822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25520919|NCT00458822|Glucocorticoids|glucocorticoids|mesh-ancestor
25520921|NCT00458822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25520922|NCT00458822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25520923|NCT00458822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520924|NCT00458848|Prednisone|prednisone|mesh-list
25520925|NCT00458848|Methylprednisolone|methylprednisolone|mesh-list
25520926|NCT00458848|Methotrexate|methotrexate|mesh-list
25520927|NCT00458848|Etoposide|etoposide|mesh-list
25520928|NCT00458848|Vincristine|vincristine|mesh-list
25520929|NCT00458848|Imatinib Mesylate|imatinib mesylate|mesh-list
25520930|NCT00458848|Daunorubicin|daunorubicin|mesh-list
25520931|NCT00458848|Asparaginase|asparaginase|mesh-list
25520932|NCT00458848|Mitoxantrone|mitoxantrone|mesh-list
25520933|NCT00458848|Mercaptopurine|mercaptopurine|mesh-list
25520934|NCT00458848|Idarubicin|idarubicin|mesh-list
25520935|NCT00458848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25520936|NCT00458848|Glucocorticoids|glucocorticoids|mesh-ancestor
25520937|NCT00458848|Hormones|hormones|mesh-ancestor
25520938|NCT00458848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25520939|NCT00458848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520940|NCT00458848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25520941|NCT00458848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520942|NCT00458848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25520943|NCT00458848|Abortifacient Agents|abortifacient agents|mesh-ancestor
25520944|NCT00458848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25520945|NCT00458848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25520946|NCT00458848|Antimetabolites|antimetabolites|mesh-ancestor
25520947|NCT00458848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520948|NCT00458848|Dermatologic Agents|dermatologic agents|mesh-ancestor
25520949|NCT00458848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520950|NCT00458848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25520951|NCT00458848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25520952|NCT00458848|Immunologic Factors|immunologic factors|mesh-ancestor
25520953|NCT00458848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25520954|NCT00458848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25520955|NCT00458848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25520956|NCT00458848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25520957|NCT00458848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25520958|NCT00458848|Tubulin Modulators|tubulin modulators|mesh-ancestor
25520959|NCT00458848|Antimitotic Agents|antimitotic agents|mesh-ancestor
25520960|NCT00458848|Mitosis Modulators|mitosis modulators|mesh-ancestor
25520961|NCT00458848|Antiemetics|antiemetics|mesh-ancestor
25520962|NCT00458848|Autonomic Agents|autonomic agents|mesh-ancestor
25520963|NCT00458848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25520964|NCT00458848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25520965|NCT00458848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25520966|NCT00458848|Protective Agents|protective agents|mesh-ancestor
25520967|NCT00458848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25520968|NCT00458848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25520969|NCT00458848|Analgesics|analgesics|mesh-ancestor
25520970|NCT00458848|Sensory System Agents|sensory system agents|mesh-ancestor
25520971|NCT00458952|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
25520972|NCT00458952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520973|NCT00458952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25520974|NCT00458952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520975|NCT00458952|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25520976|NCT00459043|Docetaxel|docetaxel|mesh-list
25520977|NCT00459043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25520978|NCT00459043|Tubulin Modulators|tubulin modulators|mesh-ancestor
25520979|NCT00459043|Antimitotic Agents|antimitotic agents|mesh-ancestor
25520980|NCT00459043|Mitosis Modulators|mitosis modulators|mesh-ancestor
25520981|NCT00459043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25520982|NCT00459056|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25520983|NCT00459056|Carvedilol|carvedilol|mesh-list
25520984|NCT00459056|Lisinopril|lisinopril|mesh-list
25520985|NCT00459056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25520986|NCT00459056|Diuretics|diuretics|mesh-ancestor
25520987|NCT00459056|Natriuretic Agents|natriuretic agents|mesh-ancestor
25520988|NCT00459056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25520989|NCT00459056|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25520990|NCT00459056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25520991|NCT00459056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646691|NCT01462318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25646692|NCT01462318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25520992|NCT00459056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25520993|NCT00459056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25520994|NCT00459056|Adrenergic Agents|adrenergic agents|mesh-ancestor
25520995|NCT00459056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25520996|NCT00459056|Antioxidants|antioxidants|mesh-ancestor
25520997|NCT00459056|Protective Agents|protective agents|mesh-ancestor
25520998|NCT00459056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25520999|NCT00459056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25521000|NCT00459056|Vasodilator Agents|vasodilator agents|mesh-ancestor
25521001|NCT00459056|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25521002|NCT00459056|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25521003|NCT00459056|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25521004|NCT00459056|Protease Inhibitors|protease inhibitors|mesh-ancestor
25521005|NCT00459056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521006|NCT00459056|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25521007|NCT00459108|Dasatinib|dasatinib|mesh-list
25521008|NCT00459108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521009|NCT00459108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25521010|NCT00459108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521011|NCT00459108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521012|NCT00459186|Prednisone|prednisone|mesh-list
25521013|NCT00459186|Docetaxel|docetaxel|mesh-list
25521014|NCT00459186|Everolimus|everolimus|mesh-list
25521015|NCT00459186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521016|NCT00459186|Tubulin Modulators|tubulin modulators|mesh-ancestor
25521017|NCT00459186|Antimitotic Agents|antimitotic agents|mesh-ancestor
25521018|NCT00459186|Mitosis Modulators|mitosis modulators|mesh-ancestor
25521019|NCT00459186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521020|NCT00459186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25521021|NCT00459186|Glucocorticoids|glucocorticoids|mesh-ancestor
25521022|NCT00459186|Hormones|hormones|mesh-ancestor
25521023|NCT00459186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25521024|NCT00459186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521025|NCT00459186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25521026|NCT00459186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25521027|NCT00459186|Immunologic Factors|immunologic factors|mesh-ancestor
25521028|NCT00459290|Mifepristone|mifepristone|mesh-list
25521029|NCT00459290|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25521030|NCT00459290|Abortifacient Agents|abortifacient agents|mesh-ancestor
25521031|NCT00459290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25521032|NCT00459290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521033|NCT00459290|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25521034|NCT00459290|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25521035|NCT00459290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25521036|NCT00459290|Contraceptive Agents|contraceptive agents|mesh-ancestor
25521037|NCT00459290|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25521038|NCT00459290|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25521039|NCT00459290|Hormone Antagonists|hormone antagonists|mesh-ancestor
25521040|NCT00459290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25521041|NCT00459290|Luteolytic Agents|luteolytic agents|mesh-ancestor
25521042|NCT00459290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25521043|NCT00459290|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25521044|NCT00459342|Dasatinib|dasatinib|mesh-list
25521045|NCT00459342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521046|NCT00459342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25521047|NCT00459342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521048|NCT00459342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521049|NCT00459537|Terbinafine|terbinafine|mesh-list
25521050|NCT00459537|Amorolfine|amorolfine|mesh-list
25521051|NCT00459537|Antifungal Agents|antifungal agents|mesh-ancestor
25521052|NCT00459537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25521053|NCT00459537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521054|NCT00459537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521055|NCT00459667|Interferons|interferons|mesh-list
25521056|NCT00459667|Interferon-beta|interferon-beta|mesh-list
25521057|NCT00459667|Interferon beta-1b|interferon beta-1b|mesh-list
25521058|NCT00459667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521059|NCT00459667|Antiviral Agents|antiviral agents|mesh-ancestor
25521060|NCT00459667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25521061|NCT00459667|Immunologic Factors|immunologic factors|mesh-ancestor
25521062|NCT00459667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521063|NCT00459667|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25646693|NCT01462318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25521064|NCT00459706|Etanercept|etanercept|mesh-list
25521065|NCT00459706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25521066|NCT00459706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25521067|NCT00459706|Analgesics|analgesics|mesh-ancestor
25521068|NCT00459706|Sensory System Agents|sensory system agents|mesh-ancestor
25521069|NCT00459706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25521070|NCT00459706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521071|NCT00459706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25521073|NCT00459706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25521074|NCT00459706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25521075|NCT00459706|Immunologic Factors|immunologic factors|mesh-ancestor
25521076|NCT00459732|Zinc|zinc|mesh-list
25521077|NCT00459732|Zinc Sulfate|zinc sulfate|mesh-list
25521078|NCT00459732|Trace Elements|trace elements|mesh-ancestor
25521079|NCT00459732|Micronutrients|micronutrients|mesh-ancestor
25521080|NCT00459732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521081|NCT00459732|Astringents|astringents|mesh-ancestor
25521082|NCT00459732|Dermatologic Agents|dermatologic agents|mesh-ancestor
25521083|NCT00459810|Paclitaxel|paclitaxel|mesh-list
25521084|NCT00459810|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
25521085|NCT00459810|Estradiol|estradiol|mesh-list
25521086|NCT00459810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25521087|NCT00459810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521088|NCT00459810|Tubulin Modulators|tubulin modulators|mesh-ancestor
25521089|NCT00459810|Antimitotic Agents|antimitotic agents|mesh-ancestor
25521090|NCT00459810|Mitosis Modulators|mitosis modulators|mesh-ancestor
25521091|NCT00459810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521092|NCT00459810|Estrogens|estrogens|mesh-ancestor
25521093|NCT00459810|Hormones|hormones|mesh-ancestor
25521094|NCT00459810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25521095|NCT00459810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521096|NCT00459875|Sunitinib|sunitinib|mesh-list
25521097|NCT00459875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521098|NCT00459875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25521099|NCT00459875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25521100|NCT00459875|Growth Substances|growth substances|mesh-ancestor
25521101|NCT00459875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521102|NCT00459875|Growth Inhibitors|growth inhibitors|mesh-ancestor
25521103|NCT00459875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25521104|NCT00459875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521105|NCT00459875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521106|NCT00459953|Nicotine|nicotine|mesh-list
25521107|NCT00459953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25521108|NCT00459953|Autonomic Agents|autonomic agents|mesh-ancestor
25521109|NCT00459953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25521110|NCT00459953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521111|NCT00459953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25521112|NCT00459953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25521113|NCT00459953|Cholinergic Agents|cholinergic agents|mesh-ancestor
25521114|NCT00459953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25521115|NCT00459953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521116|NCT00459979|Sunitinib|sunitinib|mesh-list
25521117|NCT00459979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521118|NCT00459979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25521119|NCT00459979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25521120|NCT00459979|Growth Substances|growth substances|mesh-ancestor
25521121|NCT00459979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521122|NCT00459979|Growth Inhibitors|growth inhibitors|mesh-ancestor
25521123|NCT00459979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25521124|NCT00459979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521125|NCT00459979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521126|NCT00460031|Ketoconazole|ketoconazole|mesh-list
25521127|NCT00460031|Hydrocortisone|hydrocortisone|mesh-list
25521128|NCT00460031|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25521129|NCT00460031|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25521130|NCT00460031|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25521131|NCT00460031|Lenalidomide|lenalidomide|mesh-list
25521132|NCT00460031|Immunologic Factors|immunologic factors|mesh-ancestor
25521133|NCT00460031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521134|NCT00460031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25521135|NCT00460031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25521136|NCT00460031|Growth Substances|growth substances|mesh-ancestor
25521137|NCT00460031|Growth Inhibitors|growth inhibitors|mesh-ancestor
25521138|NCT00460031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521139|NCT00460031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25521140|NCT00460031|Antifungal Agents|antifungal agents|mesh-ancestor
25521141|NCT00460031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25521142|NCT00460031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25521171|NCT00460577|Fenoterol|fenoterol|mesh-list
25521172|NCT00460577|Formoterol Fumarate|formoterol fumarate|mesh-list
25521173|NCT00460577|Ipratropium|ipratropium|mesh-list
25521174|NCT00460577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25646694|NCT01462318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25646695|NCT01462318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25646696|NCT01462318|Anesthetics, General|anesthetics, general|mesh-ancestor
25646697|NCT01462318|Anesthetics|anesthetics|mesh-ancestor
25646698|NCT01462318|GABA Modulators|gaba modulators|mesh-ancestor
25646699|NCT01462318|GABA Agents|gaba agents|mesh-ancestor
25646700|NCT01462318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25646701|NCT01462318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646702|NCT01462318|Anticoagulants|anticoagulants|mesh-ancestor
25646703|NCT01462318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25646704|NCT01462318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25646705|NCT01462318|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25646706|NCT01462318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521175|NCT00460577|Autonomic Agents|autonomic agents|mesh-ancestor
25521176|NCT00460577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25521177|NCT00460577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521178|NCT00460577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25521179|NCT00460577|Respiratory System Agents|respiratory system agents|mesh-ancestor
25521180|NCT00460577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25521181|NCT00460577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25521182|NCT00460577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25521183|NCT00460577|Adrenergic Agents|adrenergic agents|mesh-ancestor
25521184|NCT00460577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25521185|NCT00460577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521186|NCT00460577|Anticonvulsants|anticonvulsants|mesh-ancestor
25521187|NCT00460577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25521188|NCT00460577|Cholinergic Agents|cholinergic agents|mesh-ancestor
25521189|NCT00460577|Sympathomimetics|sympathomimetics|mesh-ancestor
25521190|NCT00460577|Tocolytic Agents|tocolytic agents|mesh-ancestor
25521191|NCT00460577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25521192|NCT00460603|Bevacizumab|bevacizumab|mesh-list
25521193|NCT00460603|Axitinib|axitinib|mesh-list
25521194|NCT00460603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25521195|NCT00460603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521196|NCT00460603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25521197|NCT00460603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25521198|NCT00460603|Growth Substances|growth substances|mesh-ancestor
25521199|NCT00460603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521200|NCT00460603|Growth Inhibitors|growth inhibitors|mesh-ancestor
25521201|NCT00460603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25521202|NCT00460603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521203|NCT00460603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521204|NCT00460746|Ritonavir|ritonavir|mesh-list
25521205|NCT00460746|Darunavir|darunavir|mesh-list
25521206|NCT00460746|Etravirine|etravirine|mesh-list
25521207|NCT00460746|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25521208|NCT00460746|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25521209|NCT00460746|Protease Inhibitors|protease inhibitors|mesh-ancestor
25521210|NCT00460746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521211|NCT00460746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521212|NCT00460746|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25521213|NCT00460746|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25521214|NCT00460746|Antiviral Agents|antiviral agents|mesh-ancestor
25521215|NCT00460746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25521216|NCT00460746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25521217|NCT00460746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25521218|NCT00460746|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25521219|NCT00460746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25521220|NCT00460798|Sunitinib|sunitinib|mesh-list
25521221|NCT00460798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521222|NCT00460798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25521223|NCT00460798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25521224|NCT00460798|Growth Substances|growth substances|mesh-ancestor
25521225|NCT00460798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521226|NCT00460798|Growth Inhibitors|growth inhibitors|mesh-ancestor
25521227|NCT00460798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25521228|NCT00460798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521229|NCT00460798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646707|NCT01462318|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25521230|NCT00460811|Linaclotide|linaclotide|mesh-list
25521231|NCT00460811|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25521232|NCT00460811|Enzyme Activators|enzyme activators|mesh-ancestor
25521233|NCT00460811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521234|NCT00460811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25521235|NCT00460993|Eszopiclone|eszopiclone|mesh-list
25521236|NCT00460993|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25521237|NCT00460993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25521238|NCT00460993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521239|NCT00461123|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
25521240|NCT00461123|Vasodilator Agents|vasodilator agents|mesh-ancestor
25521241|NCT00461123|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25521242|NCT00461123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25521243|NCT00461123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521244|NCT00461123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521246|NCT00461253|Copper|copper|mesh-list
25521247|NCT00461253|Levonorgestrel|levonorgestrel|mesh-list
25521248|NCT00461253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25521249|NCT00461253|Contraceptive Agents|contraceptive agents|mesh-ancestor
25521250|NCT00461253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25521251|NCT00461253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521252|NCT00461253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25521253|NCT00461253|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25521254|NCT00461253|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25521255|NCT00461253|Trace Elements|trace elements|mesh-ancestor
25521256|NCT00461253|Micronutrients|micronutrients|mesh-ancestor
25521257|NCT00461292|Botulinum Toxins|botulinum toxins|mesh-list
25521258|NCT00461292|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25521259|NCT00461292|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25521260|NCT00461292|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25521261|NCT00461292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25521262|NCT00461292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521263|NCT00461292|Cholinergic Agents|cholinergic agents|mesh-ancestor
25521264|NCT00461292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25521265|NCT00461292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521266|NCT00461292|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25521267|NCT00461292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25521268|NCT00461305|Drospirenone|drospirenone|mesh-list
25521269|NCT00461305|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25521270|NCT00461305|Hormone Antagonists|hormone antagonists|mesh-ancestor
25521271|NCT00461305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25521272|NCT00461305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521273|NCT00461305|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25521274|NCT00461305|Diuretics|diuretics|mesh-ancestor
25521275|NCT00461305|Natriuretic Agents|natriuretic agents|mesh-ancestor
25521276|NCT00461331|Insulin|insulin|mesh-list
25521277|NCT00461331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25521278|NCT00461331|Insulin Aspart|insulin aspart|mesh-list
25521279|NCT00461331|Insulin, Long-Acting|insulin, long-acting|mesh-list
25521280|NCT00461331|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25521281|NCT00461331|Insulin Lispro|insulin lispro|mesh-list
25521282|NCT00461331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25521283|NCT00461331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521284|NCT00461500|Fluticasone|fluticasone|mesh-list
25521285|NCT00461500|Xhance|xhance|mesh-list
25521286|NCT00461500|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25521287|NCT00461500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25521288|NCT00461500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25521289|NCT00461500|Autonomic Agents|autonomic agents|mesh-ancestor
25521290|NCT00461500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25521291|NCT00461500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521292|NCT00461500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25521293|NCT00461500|Respiratory System Agents|respiratory system agents|mesh-ancestor
25521294|NCT00461500|Dermatologic Agents|dermatologic agents|mesh-ancestor
25521295|NCT00461500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25521296|NCT00461500|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25521297|NCT00461500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25521298|NCT00461500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25521299|NCT00461500|Adrenergic Agents|adrenergic agents|mesh-ancestor
25521300|NCT00461500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25521301|NCT00461500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521302|NCT00461591|Apaziquone|apaziquone|mesh-list
25521303|NCT00461591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646708|NCT01462318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25521304|NCT00461630|Niacin|niacin|mesh-list
25521305|NCT00461630|Simvastatin|simvastatin|mesh-list
25521306|NCT00461630|Ezetimibe|ezetimibe|mesh-list
25521307|NCT00461630|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
25521308|NCT00461630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25521309|NCT00461630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25521310|NCT00461630|Antimetabolites|antimetabolites|mesh-ancestor
24990114|NCT03678883|Mitosis Modulators|mitosis modulators|mesh-ancestor
25169562|NCT01818076|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25046737|NCT00836056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25046738|NCT00836056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25046739|NCT00836056|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24990115|NCT03678883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990116|NCT03678883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25521311|NCT00461630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521312|NCT00461630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25521313|NCT00461630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25521314|NCT00461630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521315|NCT00461630|Vasodilator Agents|vasodilator agents|mesh-ancestor
25521316|NCT00461630|Vitamin B Complex|vitamin b complex|mesh-ancestor
25521317|NCT00461630|Vitamins|vitamins|mesh-ancestor
25521318|NCT00461630|Micronutrients|micronutrients|mesh-ancestor
25521319|NCT00461630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521320|NCT00461708|Gemcitabine|gemcitabine|mesh-list
25521321|NCT00461708|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25521322|NCT00461708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25521323|NCT00461708|Antimetabolites|antimetabolites|mesh-ancestor
25521324|NCT00461708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521325|NCT00461708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521326|NCT00461708|Antiviral Agents|antiviral agents|mesh-ancestor
25521327|NCT00461708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25521328|NCT00461708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521329|NCT00461708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25521330|NCT00461708|Immunologic Factors|immunologic factors|mesh-ancestor
25521331|NCT00461708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521332|NCT00461708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25521333|NCT00461773|Bevacizumab|bevacizumab|mesh-list
25521334|NCT00461773|Letrozole|letrozole|mesh-list
25521335|NCT00461773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25521336|NCT00461773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521337|NCT00461773|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25521338|NCT00461773|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25521339|NCT00461773|Growth Substances|growth substances|mesh-ancestor
25521340|NCT00461773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521341|NCT00461773|Growth Inhibitors|growth inhibitors|mesh-ancestor
25521342|NCT00461773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25521343|NCT00461773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25521344|NCT00461773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521345|NCT00461773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521346|NCT00461773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25521347|NCT00461773|Hormone Antagonists|hormone antagonists|mesh-ancestor
25521348|NCT00461773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25521349|NCT00461786|Pemetrexed|pemetrexed|mesh-list
25521350|NCT00461786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521351|NCT00461786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521352|NCT00461786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521353|NCT00461786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25521354|NCT00461786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25521355|NCT00461851|Gemcitabine|gemcitabine|mesh-list
25521356|NCT00461851|Carboplatin|carboplatin|mesh-list
25521357|NCT00461851|Sorafenib|sorafenib|mesh-list
25521358|NCT00461851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166045|NCT04447768|Obinutuzumab|obinutuzumab|mesh-list
25521359|NCT00461851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25521360|NCT00461851|Antimetabolites|antimetabolites|mesh-ancestor
25521361|NCT00461851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521362|NCT00461851|Antiviral Agents|antiviral agents|mesh-ancestor
25521363|NCT00461851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25521364|NCT00461851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521365|NCT00461851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25521366|NCT00461851|Immunologic Factors|immunologic factors|mesh-ancestor
25521367|NCT00461851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823400|NCT00004816|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25521368|NCT00461851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25521369|NCT00461981|Vaccines|vaccines|mesh-list
25521370|NCT00461981|Immunologic Factors|immunologic factors|mesh-ancestor
25521371|NCT00461981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521372|NCT00462020|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25521373|NCT00462020|Metronidazole|metronidazole|mesh-list
25521374|NCT00462020|Ceftriaxone|ceftriaxone|mesh-list
25521375|NCT00462020|Ampicillin|ampicillin|mesh-list
25521376|NCT00462020|Clavulanic Acids|clavulanic acids|mesh-list
25521377|NCT00462020|Clavulanic Acid|clavulanic acid|mesh-list
25521378|NCT00462020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25521379|NCT00462020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25521380|NCT00462020|Antitubercular Agents|antitubercular agents|mesh-ancestor
25521381|NCT00462020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25521382|NCT00462020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25521383|NCT00462020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521384|NCT00462020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531864|NCT00637468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25521385|NCT00462020|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25521386|NCT00462072|Infliximab|infliximab|mesh-list
25521387|NCT00462072|Dermatologic Agents|dermatologic agents|mesh-ancestor
25521388|NCT00462072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25521389|NCT00462072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25521390|NCT00462228|Memantine|memantine|mesh-list
25521391|NCT00462228|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25521392|NCT00462228|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25521393|NCT00462228|Dopamine Agents|dopamine agents|mesh-ancestor
25521394|NCT00462228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25521395|NCT00462228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521396|NCT00462228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521397|NCT00462228|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25521398|NCT00462228|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25521399|NCT00462280|Lovastatin|lovastatin|mesh-list
25521400|NCT00462280|L 647318|l 647318|mesh-list
25521401|NCT00462280|Dihydromevinolin|dihydromevinolin|mesh-list
25521402|NCT00462280|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25521403|NCT00462280|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25521404|NCT00462280|Antimetabolites|antimetabolites|mesh-ancestor
25521405|NCT00462280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521406|NCT00462280|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25521407|NCT00462280|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25521408|NCT00462280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521409|NCT00462332|Vidarabine|vidarabine|mesh-list
25521410|NCT00462332|Fludarabine|fludarabine|mesh-list
25521411|NCT00462332|Fludarabine phosphate|fludarabine phosphate|mesh-list
25521412|NCT00462332|Alemtuzumab|alemtuzumab|mesh-list
25521413|NCT00462332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521414|NCT00462332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25521415|NCT00462332|Antimetabolites|antimetabolites|mesh-ancestor
25521416|NCT00462332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521417|NCT00462332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25521418|NCT00462332|Immunologic Factors|immunologic factors|mesh-ancestor
25521419|NCT00462332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521420|NCT00462332|Antiviral Agents|antiviral agents|mesh-ancestor
25521421|NCT00462332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25521422|NCT00462332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25521423|NCT00462345|Rituximab|rituximab|mesh-list
25521424|NCT00462345|Methotrexate|methotrexate|mesh-list
25521425|NCT00462345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25521426|NCT00462345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521427|NCT00462345|Immunologic Factors|immunologic factors|mesh-ancestor
25521428|NCT00462345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521429|NCT00462345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25521430|NCT00462345|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25521431|NCT00462345|Abortifacient Agents|abortifacient agents|mesh-ancestor
25521432|NCT00462345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25521433|NCT00462345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25521434|NCT00462345|Antimetabolites|antimetabolites|mesh-ancestor
25521435|NCT00462345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521436|NCT00462345|Dermatologic Agents|dermatologic agents|mesh-ancestor
25521437|NCT00462345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521438|NCT00462345|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25521439|NCT00462345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25521440|NCT00462345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25521441|NCT00462384|Epoetin Alfa|epoetin alfa|mesh-list
25521442|NCT00462384|Hematinics|hematinics|mesh-ancestor
25521443|NCT00462423|Bevacizumab|bevacizumab|mesh-list
25521444|NCT00462423|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25823401|NCT00004816|Immunologic Factors|immunologic factors|mesh-ancestor
25521445|NCT00462423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25521446|NCT00462423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521447|NCT00462423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25521448|NCT00462423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25521449|NCT00462423|Growth Substances|growth substances|mesh-ancestor
25521450|NCT00462423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521451|NCT00462423|Growth Inhibitors|growth inhibitors|mesh-ancestor
24531982|NCT00637767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531983|NCT00637767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531984|NCT00637767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25823402|NCT00004816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823403|NCT00004817|Phenytoin|phenytoin|mesh-list
25823404|NCT00004817|Valproic Acid|valproic acid|mesh-list
25521453|NCT00462462|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25521454|NCT00462462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25521455|NCT00462462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25521456|NCT00462462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521457|NCT00462501|Leucovorin|leucovorin|mesh-list
25521458|NCT00462501|Bevacizumab|bevacizumab|mesh-list
25521459|NCT00462501|Fluorouracil|fluorouracil|mesh-list
25521460|NCT00462501|Oxaliplatin|oxaliplatin|mesh-list
25521461|NCT00462501|Calcium|calcium|mesh-list
25521462|NCT00462501|Levoleucovorin|levoleucovorin|mesh-list
25521463|NCT00462501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25521464|NCT00462501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521465|NCT00462501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25521466|NCT00462501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25521467|NCT00462501|Growth Substances|growth substances|mesh-ancestor
25521468|NCT00462501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521469|NCT00462501|Growth Inhibitors|growth inhibitors|mesh-ancestor
25521470|NCT00462501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25521471|NCT00462501|Antimetabolites|antimetabolites|mesh-ancestor
25521472|NCT00462501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521473|NCT00462501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25521474|NCT00462501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25521475|NCT00462501|Immunologic Factors|immunologic factors|mesh-ancestor
25521476|NCT00462501|Antidotes|antidotes|mesh-ancestor
25521477|NCT00462501|Protective Agents|protective agents|mesh-ancestor
25521478|NCT00462501|Vitamin B Complex|vitamin b complex|mesh-ancestor
25521479|NCT00462501|Vitamins|vitamins|mesh-ancestor
25521480|NCT00462501|Micronutrients|micronutrients|mesh-ancestor
25521481|NCT00462605|Entinostat|entinostat|mesh-list
25521482|NCT00462605|Sargramostim|sargramostim|mesh-list
25521483|NCT00462605|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25521484|NCT00462605|Immunologic Factors|immunologic factors|mesh-ancestor
25521485|NCT00462605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521486|NCT00462605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521487|NCT00462605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521488|NCT00462605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521489|NCT00462644|Fentanyl|fentanyl|mesh-list
25521490|NCT00462644|Midazolam|midazolam|mesh-list
25521491|NCT00462644|Etomidate|etomidate|mesh-list
25521492|NCT00462644|Succinylcholine|succinylcholine|mesh-list
25521493|NCT00462644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25521494|NCT00462644|Narcotics|narcotics|mesh-ancestor
25521495|NCT00462644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25521496|NCT00462644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521497|NCT00462644|Analgesics|analgesics|mesh-ancestor
25521498|NCT00462644|Sensory System Agents|sensory system agents|mesh-ancestor
25521499|NCT00462644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25521500|NCT00462644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25521501|NCT00462644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25521502|NCT00462644|Anesthetics, General|anesthetics, general|mesh-ancestor
25521503|NCT00462644|Anesthetics|anesthetics|mesh-ancestor
25521504|NCT00462644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25521505|NCT00462644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25521506|NCT00462644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25521507|NCT00462644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25521508|NCT00462644|GABA Modulators|gaba modulators|mesh-ancestor
25521509|NCT00462644|GABA Agents|gaba agents|mesh-ancestor
25521510|NCT00462644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25521511|NCT00462644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521512|NCT00462644|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
25046769|NCT00835705|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25046770|NCT00835705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823405|NCT00004817|Anticonvulsants|anticonvulsants|mesh-ancestor
25046771|NCT00835705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046772|NCT00835692|Clarithromycin|clarithromycin|mesh-list
25046773|NCT00835692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25046774|NCT00835692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25046775|NCT00835692|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25046776|NCT00835692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046777|NCT00835692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869811|NCT05157087|Omalizumab|omalizumab|mesh-list
24990240|NCT03403205|Antimetabolites|antimetabolites|mesh-ancestor
24990241|NCT03403205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990242|NCT03403205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24990243|NCT03403205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24990244|NCT03403205|Nootropic Agents|nootropic agents|mesh-ancestor
25521513|NCT00462644|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25521514|NCT00462644|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25521515|NCT00462670|Tolvaptan|tolvaptan|mesh-list
25521516|NCT00462670|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25521517|NCT00462670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521518|NCT00462670|Natriuretic Agents|natriuretic agents|mesh-ancestor
25521519|NCT00462670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521520|NCT00462709|Complement C1s|complement c1s|mesh-list
25521521|NCT00462709|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25521522|NCT00462709|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
25521523|NCT00462709|Immunologic Factors|immunologic factors|mesh-ancestor
25521524|NCT00462709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521525|NCT00462709|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25521526|NCT00462709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25521527|NCT00462722|Ibuprofen|ibuprofen|mesh-list
25521528|NCT00462722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25521529|NCT00462722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25521530|NCT00462722|Analgesics|analgesics|mesh-ancestor
25521531|NCT00462722|Sensory System Agents|sensory system agents|mesh-ancestor
25521532|NCT00462722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25521533|NCT00462722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521534|NCT00462722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25521535|NCT00462722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25521536|NCT00462722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25521537|NCT00462722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521538|NCT00462722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521539|NCT00462735|Fluorouracil|fluorouracil|mesh-list
25521540|NCT00462735|Cetuximab|cetuximab|mesh-list
25521541|NCT00462735|Hydroxyurea|hydroxyurea|mesh-list
25521542|NCT00462735|Antimetabolites|antimetabolites|mesh-ancestor
25521543|NCT00462735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521544|NCT00462735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25521545|NCT00462735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521546|NCT00462735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25521547|NCT00462735|Immunologic Factors|immunologic factors|mesh-ancestor
25521548|NCT00462735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521549|NCT00462735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25521550|NCT00462735|Antisickling Agents|antisickling agents|mesh-ancestor
25521551|NCT00462735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521552|NCT00462735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25521553|NCT00462826|Aflibercept|aflibercept|mesh-list
25521554|NCT00462826|Endothelial Growth Factors|endothelial growth factors|mesh-list
25521555|NCT00462826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25521556|NCT00462826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25521557|NCT00462826|Growth Substances|growth substances|mesh-ancestor
25521558|NCT00462826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521559|NCT00462826|Growth Inhibitors|growth inhibitors|mesh-ancestor
25521560|NCT00462826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521561|NCT00462865|Gemcitabine|gemcitabine|mesh-list
25521562|NCT00462865|Bevacizumab|bevacizumab|mesh-list
25521563|NCT00462865|Capecitabine|capecitabine|mesh-list
25521564|NCT00462865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25521565|NCT00462865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521566|NCT00462865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25521567|NCT00462865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25521568|NCT00462865|Growth Substances|growth substances|mesh-ancestor
24813867|NCT02060656|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24813868|NCT02060656|Protective Agents|protective agents|mesh-ancestor
24813870|NCT02060669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24813871|NCT02060669|Antimetabolites|antimetabolites|mesh-ancestor
25823406|NCT00004817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813872|NCT02060669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813874|NCT02060734|Lidocaine|lidocaine|mesh-list
24813875|NCT02060734|Anesthetics, Local|anesthetics, local|mesh-ancestor
24813876|NCT02060734|Anesthetics|anesthetics|mesh-ancestor
24813877|NCT02060734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24990298|NCT03316781|Adalimumab|adalimumab|mesh-list
24990299|NCT03316781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24990300|NCT03316781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24990301|NCT03306901|Fluorouracil|fluorouracil|mesh-list
24990302|NCT03306901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990303|NCT03306901|Antimetabolites|antimetabolites|mesh-ancestor
25140466|NCT02964091|Antiviral Agents|antiviral agents|mesh-ancestor
25140467|NCT02964091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25140468|NCT02963779|Apremilast|apremilast|mesh-list
25140471|NCT02963779|Analgesics|analgesics|mesh-ancestor
24990307|NCT03306901|Immunologic Factors|immunologic factors|mesh-ancestor
25521569|NCT00462865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521570|NCT00462865|Growth Inhibitors|growth inhibitors|mesh-ancestor
25521571|NCT00462865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25521572|NCT00462865|Antimetabolites|antimetabolites|mesh-ancestor
25521573|NCT00462865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521574|NCT00462865|Antiviral Agents|antiviral agents|mesh-ancestor
25521575|NCT00462865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25521576|NCT00462865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521577|NCT00462865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25521578|NCT00462865|Immunologic Factors|immunologic factors|mesh-ancestor
25521579|NCT00462982|Sunitinib|sunitinib|mesh-list
25521580|NCT00462982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521581|NCT00462982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25521582|NCT00462982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25521583|NCT00462982|Growth Substances|growth substances|mesh-ancestor
25521584|NCT00462982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521585|NCT00462982|Growth Inhibitors|growth inhibitors|mesh-ancestor
25521586|NCT00462982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25521587|NCT00462982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521588|NCT00462982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521589|NCT00463047|Fentanyl|fentanyl|mesh-list
25521590|NCT00463047|Oxycodone|oxycodone|mesh-list
25521591|NCT00463047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25521592|NCT00463047|Narcotics|narcotics|mesh-ancestor
25521593|NCT00463047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25521594|NCT00463047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521595|NCT00463047|Analgesics|analgesics|mesh-ancestor
25521596|NCT00463047|Sensory System Agents|sensory system agents|mesh-ancestor
25521597|NCT00463047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25521598|NCT00463047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25521599|NCT00463047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25521600|NCT00463047|Anesthetics, General|anesthetics, general|mesh-ancestor
25521601|NCT00463047|Anesthetics|anesthetics|mesh-ancestor
25521602|NCT00463060|Sunitinib|sunitinib|mesh-list
25521603|NCT00463060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521604|NCT00463060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25521605|NCT00463060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25521606|NCT00463060|Growth Substances|growth substances|mesh-ancestor
25521607|NCT00463060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521608|NCT00463060|Growth Inhibitors|growth inhibitors|mesh-ancestor
25521609|NCT00463060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25521610|NCT00463060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521611|NCT00463060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521612|NCT00463151|Rebamipide|rebamipide|mesh-list
25521613|NCT00463151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25521614|NCT00463151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25521615|NCT00463151|Antioxidants|antioxidants|mesh-ancestor
25521616|NCT00463151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521617|NCT00463151|Protective Agents|protective agents|mesh-ancestor
25521618|NCT00463151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521619|NCT00463151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521620|NCT00463346|Acamprosate|acamprosate|mesh-list
25521621|NCT00463346|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25521622|NCT00463385|Thalidomide|thalidomide|mesh-list
25521623|NCT00463385|Prednisone|prednisone|mesh-list
25521624|NCT00463385|Pomalidomide|pomalidomide|mesh-list
25521625|NCT00463385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25521626|NCT00463385|Glucocorticoids|glucocorticoids|mesh-ancestor
25521627|NCT00463385|Hormones|hormones|mesh-ancestor
25521628|NCT00463385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25521629|NCT00463385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521630|NCT00463385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25521631|NCT00463385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521632|NCT00463385|Immunologic Factors|immunologic factors|mesh-ancestor
25521633|NCT00463385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25521634|NCT00463385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25521635|NCT00463385|Growth Substances|growth substances|mesh-ancestor
25521636|NCT00463385|Growth Inhibitors|growth inhibitors|mesh-ancestor
25521637|NCT00463385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25521638|NCT00463385|Leprostatic Agents|leprostatic agents|mesh-ancestor
25521639|NCT00463385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25521640|NCT00463385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25521641|NCT00463437|Vaccines|vaccines|mesh-list
25521642|NCT00463437|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25521643|NCT00463437|Immunologic Factors|immunologic factors|mesh-ancestor
25521644|NCT00463437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521645|NCT00463567|Formoterol Fumarate|formoterol fumarate|mesh-list
25521646|NCT00463567|Tiotropium Bromide|tiotropium bromide|mesh-list
25521647|NCT00463567|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25521648|NCT00463567|Autonomic Agents|autonomic agents|mesh-ancestor
25521649|NCT00463567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25521650|NCT00463567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521651|NCT00463567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25521652|NCT00463567|Respiratory System Agents|respiratory system agents|mesh-ancestor
25521653|NCT00463567|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25521654|NCT00463567|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25521655|NCT00463567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25521656|NCT00463567|Adrenergic Agents|adrenergic agents|mesh-ancestor
25521657|NCT00463567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25521658|NCT00463567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521659|NCT00463567|Parasympatholytics|parasympatholytics|mesh-ancestor
25521660|NCT00463567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25521661|NCT00463567|Cholinergic Agents|cholinergic agents|mesh-ancestor
25521662|NCT00463580|Infliximab|infliximab|mesh-list
25521663|NCT00463580|Dermatologic Agents|dermatologic agents|mesh-ancestor
25521664|NCT00463580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25521665|NCT00463580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25521666|NCT00463606|Calcium, Dietary|calcium, dietary|mesh-list
25521667|NCT00463606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25521668|NCT00463606|Fenofibric acid|fenofibric acid|mesh-list
25521669|NCT00463606|Calcium|calcium|mesh-list
25521670|NCT00463606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25521671|NCT00463606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521672|NCT00463606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25521673|NCT00463606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25521674|NCT00463606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25521675|NCT00463606|Antimetabolites|antimetabolites|mesh-ancestor
25521676|NCT00463606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521677|NCT00463606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25521678|NCT00463606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25521679|NCT00463606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521680|NCT00463684|Vaccines|vaccines|mesh-list
25521681|NCT00463684|Immunologic Factors|immunologic factors|mesh-ancestor
25521682|NCT00463684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521683|NCT00463788|Cisplatin|cisplatin|mesh-list
25521684|NCT00463788|Cetuximab|cetuximab|mesh-list
25521685|NCT00463788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521686|NCT00463788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25521687|NCT00463801|Daptomycin|daptomycin|mesh-list
25521688|NCT00463801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25521689|NCT00463801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25521690|NCT00463840|Fluorouracil|fluorouracil|mesh-list
25521691|NCT00463840|Oxaliplatin|oxaliplatin|mesh-list
25521692|NCT00463840|Antimetabolites|antimetabolites|mesh-ancestor
25521693|NCT00463840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521694|NCT00463840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25521695|NCT00463840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521696|NCT00463840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25521697|NCT00463840|Immunologic Factors|immunologic factors|mesh-ancestor
25521698|NCT00463840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521699|NCT00463866|Budesonide|budesonide|mesh-list
25521700|NCT00463866|Formoterol Fumarate|formoterol fumarate|mesh-list
25521701|NCT00463866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25521702|NCT00463866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25521703|NCT00463866|Autonomic Agents|autonomic agents|mesh-ancestor
25521704|NCT00463866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25521705|NCT00463866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521706|NCT00463866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25521707|NCT00463866|Respiratory System Agents|respiratory system agents|mesh-ancestor
25521709|NCT00463866|Hormones|hormones|mesh-ancestor
25521710|NCT00463866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25521711|NCT00463866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25521712|NCT00463866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25521713|NCT00463866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25521714|NCT00463866|Adrenergic Agents|adrenergic agents|mesh-ancestor
25521715|NCT00463866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25521716|NCT00463866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521717|NCT00464087|Heparin|heparin|mesh-list
25521718|NCT00464087|Calcium heparin|calcium heparin|mesh-list
25521719|NCT00464087|PENTA|penta|mesh-list
25521720|NCT00464087|Bivalirudin|bivalirudin|mesh-list
25521721|NCT00464087|Fondaparinux|fondaparinux|mesh-list
25521722|NCT00464087|Anticoagulants|anticoagulants|mesh-ancestor
25521723|NCT00464087|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25521724|NCT00464087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25521725|NCT00464087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521726|NCT00464087|Antithrombins|antithrombins|mesh-ancestor
25521727|NCT00464087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25521728|NCT00464087|Protease Inhibitors|protease inhibitors|mesh-ancestor
25521729|NCT00464087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521730|NCT00464087|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25521731|NCT00464204|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
25521732|NCT00464204|Plasma Substitutes|plasma substitutes|mesh-ancestor
25521733|NCT00464204|Blood Substitutes|blood substitutes|mesh-ancestor
25521734|NCT00464308|Esomeprazole|esomeprazole|mesh-list
25521735|NCT00464308|Rabeprazole|rabeprazole|mesh-list
25521736|NCT00464308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25521737|NCT00464308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25521738|NCT00464308|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25521739|NCT00464308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521740|NCT00464308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521741|NCT00464438|Moxifloxacin|moxifloxacin|mesh-list
25521742|NCT00464438|Gatifloxacin|gatifloxacin|mesh-list
25521743|NCT00464438|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25521744|NCT00464438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25521745|NCT00464438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25521746|NCT00464438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25521747|NCT00464438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25521748|NCT00464438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521749|NCT00464438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521750|NCT00464438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521751|NCT00464438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25521752|NCT00464490|Dexmedetomidine|dexmedetomidine|mesh-list
25521753|NCT00464490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25521754|NCT00464490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25521755|NCT00464490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521756|NCT00464490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25521757|NCT00464490|Analgesics|analgesics|mesh-ancestor
25521758|NCT00464490|Sensory System Agents|sensory system agents|mesh-ancestor
25521759|NCT00464490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25521760|NCT00464490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25521761|NCT00464490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25521762|NCT00464490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25521763|NCT00464490|Adrenergic Agents|adrenergic agents|mesh-ancestor
25521764|NCT00464490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25521765|NCT00464490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521766|NCT00464542|Metronidazole|metronidazole|mesh-list
25521767|NCT00464542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25521768|NCT00464542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25521769|NCT00464542|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25521770|NCT00464542|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25521771|NCT00464568|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
25521772|NCT00464568|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25521773|NCT00464568|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25521774|NCT00464568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521775|NCT00464568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521776|NCT00464620|Dasatinib|dasatinib|mesh-list
25521777|NCT00464620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521778|NCT00464620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25521780|NCT00464620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521781|NCT00464646|Cyclophosphamide|cyclophosphamide|mesh-list
25521782|NCT00464646|Bevacizumab|bevacizumab|mesh-list
25521783|NCT00464646|Docetaxel|docetaxel|mesh-list
25521784|NCT00464646|Trastuzumab|trastuzumab|mesh-list
25521785|NCT00464646|Epirubicin|epirubicin|mesh-list
25521786|NCT00464646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25521787|NCT00464646|Immunologic Factors|immunologic factors|mesh-ancestor
25521788|NCT00464646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521789|NCT00464646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25521790|NCT00464646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25521791|NCT00464646|Alkylating Agents|alkylating agents|mesh-ancestor
25521792|NCT00464646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521793|NCT00464646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864306|NCT04948463|Vancomycin|vancomycin|mesh-list
25521794|NCT00464646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25521795|NCT00464646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25521796|NCT00464646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25521797|NCT00464646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25521798|NCT00464646|Growth Substances|growth substances|mesh-ancestor
25521799|NCT00464646|Growth Inhibitors|growth inhibitors|mesh-ancestor
25521800|NCT00464646|Tubulin Modulators|tubulin modulators|mesh-ancestor
25521801|NCT00464646|Antimitotic Agents|antimitotic agents|mesh-ancestor
25521802|NCT00464646|Mitosis Modulators|mitosis modulators|mesh-ancestor
25521803|NCT00464646|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25521804|NCT00464646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25521805|NCT00464646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25521806|NCT00464646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521808|NCT00464672|Immunologic Factors|immunologic factors|mesh-ancestor
25521809|NCT00464672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521810|NCT00464685|Dexamethasone|dexamethasone|mesh-list
25521811|NCT00464685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25521812|NCT00464685|Antiemetics|antiemetics|mesh-ancestor
25521813|NCT00464685|Autonomic Agents|autonomic agents|mesh-ancestor
25521814|NCT00464685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25521815|NCT00464685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521816|NCT00464685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25521817|NCT00464685|Glucocorticoids|glucocorticoids|mesh-ancestor
25521818|NCT00464685|Hormones|hormones|mesh-ancestor
25521819|NCT00464685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25521820|NCT00464685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25521821|NCT00464685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521822|NCT00464698|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25521823|NCT00464698|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25521824|NCT00464698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25521825|NCT00464698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25521826|NCT00464698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521827|NCT00464698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25521828|NCT00464698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521829|NCT00464698|Analgesics|analgesics|mesh-ancestor
25521830|NCT00464698|Sensory System Agents|sensory system agents|mesh-ancestor
25521831|NCT00464698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25521832|NCT00464698|Antidepressive Agents|antidepressive agents|mesh-ancestor
25521833|NCT00464698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25521834|NCT00464698|Dopamine Agents|dopamine agents|mesh-ancestor
25521835|NCT00464711|Citalopram|citalopram|mesh-list
25521836|NCT00464711|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25521837|NCT00464711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25521838|NCT00464711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25521839|NCT00464711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521840|NCT00464711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25521841|NCT00464711|Serotonin Agents|serotonin agents|mesh-ancestor
25521842|NCT00464711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521843|NCT00464711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25521844|NCT00464711|Antidepressive Agents|antidepressive agents|mesh-ancestor
25521845|NCT00464711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25521846|NCT00464737|Rotigotine|rotigotine|mesh-list
25521847|NCT00464737|Dopamine Agonists|dopamine agonists|mesh-ancestor
25521848|NCT00464737|Dopamine Agents|dopamine agents|mesh-ancestor
25521849|NCT00464737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25521850|NCT00464737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521851|NCT00464737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521852|NCT00464945|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25521853|NCT00464945|Immunologic Factors|immunologic factors|mesh-ancestor
25521854|NCT00464945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521855|NCT00465088|Niacin|niacin|mesh-list
25521856|NCT00465088|Niacinamide|niacinamide|mesh-list
25521857|NCT00465088|Nicotinic Acids|nicotinic acids|mesh-list
25521858|NCT00465088|Atorvastatin|atorvastatin|mesh-list
25521859|NCT00465088|Simvastatin|simvastatin|mesh-list
25521860|NCT00465088|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25521861|NCT00465088|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25521862|NCT00465088|Antimetabolites|antimetabolites|mesh-ancestor
25521863|NCT00465088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521864|NCT00465088|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25521865|NCT00465088|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25521866|NCT00465088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521867|NCT00465088|Vasodilator Agents|vasodilator agents|mesh-ancestor
25521868|NCT00465088|Vitamin B Complex|vitamin b complex|mesh-ancestor
25521869|NCT00465088|Vitamins|vitamins|mesh-ancestor
25521870|NCT00465088|Micronutrients|micronutrients|mesh-ancestor
25521871|NCT00465088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521872|NCT00465179|Sunitinib|sunitinib|mesh-list
25521873|NCT00465179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521874|NCT00465179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25521875|NCT00465179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25521876|NCT00465179|Growth Substances|growth substances|mesh-ancestor
25521877|NCT00465179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521878|NCT00465179|Growth Inhibitors|growth inhibitors|mesh-ancestor
25521879|NCT00465179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25521880|NCT00465179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521881|NCT00465179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521882|NCT00465530|Gentamicins|gentamicins|mesh-list
25521883|NCT00465530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25521884|NCT00465530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25521885|NCT00465530|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25521886|NCT00465530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25521887|NCT00465530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521888|NCT00465595|Psilocybin|psilocybin|mesh-list
25521889|NCT00465595|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
25521890|NCT00465595|Hallucinogens|hallucinogens|mesh-ancestor
25521891|NCT00465595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521892|NCT00465595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25521893|NCT00465595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25521894|NCT00465595|Serotonin Agents|serotonin agents|mesh-ancestor
25521895|NCT00465595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25521896|NCT00465595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521897|NCT00465595|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25521898|NCT00465647|Hydromorphone|hydromorphone|mesh-list
25521899|NCT00465647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25521900|NCT00465647|Narcotics|narcotics|mesh-ancestor
25521901|NCT00465647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25521902|NCT00465647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521903|NCT00465647|Analgesics|analgesics|mesh-ancestor
25521904|NCT00465647|Sensory System Agents|sensory system agents|mesh-ancestor
25521905|NCT00465647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25521906|NCT00465738|Botulinum Toxins|botulinum toxins|mesh-list
25521907|NCT00465738|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25521908|NCT00465738|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25521909|NCT00465738|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25521910|NCT00465738|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25521911|NCT00465738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25521912|NCT00465738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521913|NCT00465738|Cholinergic Agents|cholinergic agents|mesh-ancestor
25521914|NCT00465738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25521915|NCT00465738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521916|NCT00465738|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25521917|NCT00465738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25521918|NCT00465894|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25521919|NCT00465894|Estradiol|estradiol|mesh-list
25521920|NCT00465894|Estrogens|estrogens|mesh-ancestor
25521921|NCT00465894|Hormones|hormones|mesh-ancestor
25521922|NCT00465894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25521923|NCT00465894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521924|NCT00465894|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25521925|NCT00465894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25521927|NCT00465894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25521928|NCT00465894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990374|NCT03176498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24990375|NCT03176498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24990376|NCT03176498|Antipyretics|antipyretics|mesh-ancestor
24990377|NCT03176498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24990378|NCT03176498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25140712|NCT02962336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140713|NCT02962336|Vasodilator Agents|vasodilator agents|mesh-ancestor
25140714|NCT02962336|Diuretics|diuretics|mesh-ancestor
25140715|NCT02962336|Natriuretic Agents|natriuretic agents|mesh-ancestor
25140716|NCT02962336|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25140717|NCT02962336|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25140718|NCT02962336|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25521947|NCT00466167|Pramipexole|pramipexole|mesh-list
25521948|NCT00466167|Antioxidants|antioxidants|mesh-ancestor
25521949|NCT00466167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521950|NCT00466167|Protective Agents|protective agents|mesh-ancestor
25521951|NCT00466167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521952|NCT00466167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25521953|NCT00466167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25521954|NCT00466167|Dopamine Agonists|dopamine agonists|mesh-ancestor
25521955|NCT00466167|Dopamine Agents|dopamine agents|mesh-ancestor
25521956|NCT00466167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25521957|NCT00466193|Zolpidem|zolpidem|mesh-list
25521958|NCT00466193|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25521959|NCT00466193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25521960|NCT00466193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25521961|NCT00466193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521962|NCT00466193|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25521963|NCT00466193|GABA Agonists|gaba agonists|mesh-ancestor
25521964|NCT00466193|GABA Agents|gaba agents|mesh-ancestor
25521965|NCT00466193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25521966|NCT00466193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521967|NCT00466310|Risperidone|risperidone|mesh-list
25521968|NCT00466310|Aripiprazole|aripiprazole|mesh-list
25521969|NCT00466310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25521970|NCT00466310|Serotonin Agents|serotonin agents|mesh-ancestor
25521971|NCT00466310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25521972|NCT00466310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521973|NCT00466310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521974|NCT00466310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25521975|NCT00466310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25521976|NCT00466310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25521977|NCT00466310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25521978|NCT00466310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25521979|NCT00466310|Dopamine Agents|dopamine agents|mesh-ancestor
25521980|NCT00466310|Antidepressive Agents|antidepressive agents|mesh-ancestor
25521981|NCT00466310|Dopamine Agonists|dopamine agonists|mesh-ancestor
25521982|NCT00466310|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25521983|NCT00466310|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25521984|NCT00466310|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25521985|NCT00466310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25521986|NCT00466440|Prednisone|prednisone|mesh-list
25521987|NCT00466440|Docetaxel|docetaxel|mesh-list
25521988|NCT00466440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25521989|NCT00466440|Tubulin Modulators|tubulin modulators|mesh-ancestor
25521990|NCT00466440|Antimitotic Agents|antimitotic agents|mesh-ancestor
25521991|NCT00466440|Mitosis Modulators|mitosis modulators|mesh-ancestor
25521992|NCT00466440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25521993|NCT00466440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25521994|NCT00466440|Glucocorticoids|glucocorticoids|mesh-ancestor
25521995|NCT00466440|Hormones|hormones|mesh-ancestor
25521996|NCT00466440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25521997|NCT00466440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25521998|NCT00466440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25521999|NCT00466505|Celecoxib|celecoxib|mesh-list
25522000|NCT00466505|Cetuximab|cetuximab|mesh-list
25522001|NCT00466505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25522002|NCT00466505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522003|NCT00466505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25522004|NCT00466505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25522005|NCT00466505|Analgesics|analgesics|mesh-ancestor
25522006|NCT00466505|Sensory System Agents|sensory system agents|mesh-ancestor
25522007|NCT00466505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25522008|NCT00466505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522009|NCT00466505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25522010|NCT00466505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25522011|NCT00466505|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25522012|NCT00466505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25522013|NCT00466505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522014|NCT00466505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522015|NCT00466661|Acamprosate|acamprosate|mesh-list
25522016|NCT00466661|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25522017|NCT00466687|Bevacizumab|bevacizumab|mesh-list
25522018|NCT00466687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25522019|NCT00466687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25522020|NCT00466687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522021|NCT00466687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25522022|NCT00466687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25522023|NCT00466687|Growth Substances|growth substances|mesh-ancestor
25522024|NCT00466687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522025|NCT00466687|Growth Inhibitors|growth inhibitors|mesh-ancestor
25522026|NCT00466687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25522027|NCT00466687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522028|NCT00466687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522029|NCT00466726|Sargramostim|sargramostim|mesh-list
25522030|NCT00466726|Immunologic Factors|immunologic factors|mesh-ancestor
25522031|NCT00466726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522033|NCT00466752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522034|NCT00466752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25522035|NCT00466752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522036|NCT00466752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522037|NCT00466817|Valganciclovir|valganciclovir|mesh-list
25522038|NCT00466817|Antiviral Agents|antiviral agents|mesh-ancestor
25522039|NCT00466817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25522040|NCT00466921|Lenalidomide|lenalidomide|mesh-list
25522041|NCT00466921|Immunologic Factors|immunologic factors|mesh-ancestor
25522042|NCT00466921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522043|NCT00466921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25522044|NCT00466921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25522045|NCT00466921|Growth Substances|growth substances|mesh-ancestor
25522046|NCT00466921|Growth Inhibitors|growth inhibitors|mesh-ancestor
25522047|NCT00466921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522048|NCT00466947|Vaccines|vaccines|mesh-list
25522049|NCT00466947|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25522050|NCT00466947|Immunologic Factors|immunologic factors|mesh-ancestor
25522051|NCT00466947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522052|NCT00466960|Paclitaxel|paclitaxel|mesh-list
25522053|NCT00466960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25522054|NCT00466960|Sargramostim|sargramostim|mesh-list
25522055|NCT00466960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25522056|NCT00466960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522057|NCT00466960|Tubulin Modulators|tubulin modulators|mesh-ancestor
25522058|NCT00466960|Antimitotic Agents|antimitotic agents|mesh-ancestor
25522059|NCT00466960|Mitosis Modulators|mitosis modulators|mesh-ancestor
25522060|NCT00466960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522061|NCT00466960|Immunologic Factors|immunologic factors|mesh-ancestor
25522062|NCT00466960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522063|NCT00467051|Paclitaxel|paclitaxel|mesh-list
25522064|NCT00467051|Carboplatin|carboplatin|mesh-list
25522065|NCT00467051|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25522066|NCT00467051|Ifosfamide|ifosfamide|mesh-list
25522067|NCT00467051|Isophosphamide mustard|isophosphamide mustard|mesh-list
25522068|NCT00467051|Lenograstim|lenograstim|mesh-list
25522069|NCT00467051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25522070|NCT00467051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522071|NCT00467051|Tubulin Modulators|tubulin modulators|mesh-ancestor
25522072|NCT00467051|Antimitotic Agents|antimitotic agents|mesh-ancestor
25522073|NCT00467051|Mitosis Modulators|mitosis modulators|mesh-ancestor
25522074|NCT00467051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522075|NCT00467051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25522076|NCT00467051|Immunologic Factors|immunologic factors|mesh-ancestor
25522077|NCT00467051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522078|NCT00467051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25522079|NCT00467051|Alkylating Agents|alkylating agents|mesh-ancestor
25522080|NCT00467077|Interferons|interferons|mesh-list
25522082|NCT00467077|Interferon alpha-2|interferon alpha-2|mesh-list
25522083|NCT00467077|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25522084|NCT00467077|Gefitinib|gefitinib|mesh-list
25522085|NCT00467077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522086|NCT00467077|Antiviral Agents|antiviral agents|mesh-ancestor
25522087|NCT00467077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25522088|NCT00467077|Immunologic Factors|immunologic factors|mesh-ancestor
24990644|NCT02513186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24990645|NCT02513186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24990646|NCT02513186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24990647|NCT02513186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24990648|NCT02513186|Growth Substances|growth substances|mesh-ancestor
24990649|NCT02513186|Growth Inhibitors|growth inhibitors|mesh-ancestor
24990650|NCT02373241|Losartan|losartan|mesh-list
24990651|NCT02373241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24990656|NCT01941589|Methylprednisolone|methylprednisolone|mesh-list
25522089|NCT00467077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522090|NCT00467077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25522091|NCT00467077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522092|NCT00467077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522093|NCT00467259|Testosterone|testosterone|mesh-list
25522094|NCT00467259|Androgens|androgens|mesh-ancestor
25522095|NCT00467259|Hormones|hormones|mesh-ancestor
25522096|NCT00467259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25522097|NCT00467259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522098|NCT00467272|Daptomycin|daptomycin|mesh-list
25522099|NCT00467272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25522100|NCT00467272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25522101|NCT00467350|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25522102|NCT00467350|Laxatives|laxatives|mesh-ancestor
25522103|NCT00467350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25522104|NCT00467363|Aspirin|aspirin|mesh-list
25522105|NCT00467363|Folic Acid|folic acid|mesh-list
25522106|NCT00467363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25522107|NCT00467363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25522108|NCT00467363|Analgesics|analgesics|mesh-ancestor
25522109|NCT00467363|Sensory System Agents|sensory system agents|mesh-ancestor
25522110|NCT00467363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25522111|NCT00467363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522112|NCT00467363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25522113|NCT00467363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25522114|NCT00467363|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25522115|NCT00467363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25522116|NCT00467363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522117|NCT00467363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25522118|NCT00467363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25522119|NCT00467363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522120|NCT00467363|Antipyretics|antipyretics|mesh-ancestor
25522121|NCT00467363|Hematinics|hematinics|mesh-ancestor
25522122|NCT00467363|Vitamin B Complex|vitamin b complex|mesh-ancestor
25522123|NCT00467363|Vitamins|vitamins|mesh-ancestor
25522124|NCT00467363|Micronutrients|micronutrients|mesh-ancestor
25522125|NCT00467389|Donepezil|donepezil|mesh-list
25522126|NCT00467389|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25522127|NCT00467389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522128|NCT00467389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522129|NCT00467389|Cholinergic Agents|cholinergic agents|mesh-ancestor
25522130|NCT00467389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25522131|NCT00467389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522132|NCT00467389|Nootropic Agents|nootropic agents|mesh-ancestor
25522133|NCT00467558|Naltrexone|naltrexone|mesh-list
25522134|NCT00467558|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25522135|NCT00467558|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25522136|NCT00467558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522137|NCT00467558|Sensory System Agents|sensory system agents|mesh-ancestor
25522138|NCT00467558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25522139|NCT00467584|Aspirin|aspirin|mesh-list
25522140|NCT00467584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25522141|NCT00467584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25522142|NCT00467584|Analgesics|analgesics|mesh-ancestor
25522143|NCT00467584|Sensory System Agents|sensory system agents|mesh-ancestor
25522144|NCT00467584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25522145|NCT00467584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522146|NCT00467584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25522147|NCT00467584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25522149|NCT00467584|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25522150|NCT00467584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522151|NCT00467584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25522152|NCT00467584|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25522153|NCT00467584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522154|NCT00467584|Antipyretics|antipyretics|mesh-ancestor
25522155|NCT00467597|Levodopa|levodopa|mesh-list
25522156|NCT00467597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25522157|NCT00467597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25522158|NCT00467597|Dopamine Agents|dopamine agents|mesh-ancestor
25522159|NCT00467597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25522160|NCT00467597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522161|NCT00467597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990753|NCT00936936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25522162|NCT00467649|Insulin|insulin|mesh-list
25522163|NCT00467649|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25522164|NCT00467649|Insulin Glargine|insulin glargine|mesh-list
25522165|NCT00467649|Insulin Aspart|insulin aspart|mesh-list
25522166|NCT00467649|Insulin Lispro|insulin lispro|mesh-list
25522167|NCT00467649|Insulin Detemir|insulin detemir|mesh-list
25522168|NCT00467649|Insulin glulisine|insulin glulisine|mesh-list
25522169|NCT00467649|Pramlintide|pramlintide|mesh-list
25522170|NCT00467649|Insulin, Short-Acting|insulin, short-acting|mesh-list
25522171|NCT00467649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25522172|NCT00467649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522173|NCT00467740|Olodaterol|olodaterol|mesh-list
25522174|NCT00467740|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25522175|NCT00467740|Autonomic Agents|autonomic agents|mesh-ancestor
25522176|NCT00467740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25522177|NCT00467740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522178|NCT00467740|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25522179|NCT00467740|Respiratory System Agents|respiratory system agents|mesh-ancestor
25522180|NCT00467779|Midazolam|midazolam|mesh-list
25522181|NCT00467779|Dextromethorphan|dextromethorphan|mesh-list
25522182|NCT00467779|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25522183|NCT00467779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25522184|NCT00467779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25522185|NCT00467779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522186|NCT00467779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25522187|NCT00467779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25522188|NCT00467779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25522189|NCT00467779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25522190|NCT00467779|Anesthetics, General|anesthetics, general|mesh-ancestor
25522191|NCT00467779|Anesthetics|anesthetics|mesh-ancestor
25522192|NCT00467779|GABA Modulators|gaba modulators|mesh-ancestor
25522193|NCT00467779|GABA Agents|gaba agents|mesh-ancestor
25522194|NCT00467779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25522195|NCT00467779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522196|NCT00467779|Antitussive Agents|antitussive agents|mesh-ancestor
25522197|NCT00467779|Respiratory System Agents|respiratory system agents|mesh-ancestor
25522198|NCT00467779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25522199|NCT00467779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25522200|NCT00467831|Acetylcysteine|acetylcysteine|mesh-list
25522201|NCT00467831|Erythromycin|erythromycin|mesh-list
25522202|NCT00467831|Erythromycin Estolate|erythromycin estolate|mesh-list
25522203|NCT00467831|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25522204|NCT00467831|Erythromycin stearate|erythromycin stearate|mesh-list
25522205|NCT00467831|Zileuton|zileuton|mesh-list
25522206|NCT00467831|Losartan|losartan|mesh-list
25522207|NCT00467831|Pravastatin|pravastatin|mesh-list
25522208|NCT00467831|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25522209|NCT00467831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25522210|NCT00467831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25522211|NCT00467831|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25522212|NCT00467831|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25522213|NCT00467831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522214|NCT00467831|Antiviral Agents|antiviral agents|mesh-ancestor
25522215|NCT00467831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25522216|NCT00467831|Expectorants|expectorants|mesh-ancestor
25522217|NCT00467831|Respiratory System Agents|respiratory system agents|mesh-ancestor
25522218|NCT00467831|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25522219|NCT00467831|Antioxidants|antioxidants|mesh-ancestor
25522220|NCT00467831|Protective Agents|protective agents|mesh-ancestor
25522221|NCT00467831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522222|NCT00467831|Antidotes|antidotes|mesh-ancestor
25522223|NCT00467831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25646709|NCT01462318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25646710|NCT01462318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25646711|NCT01462318|Purinergic Agents|purinergic agents|mesh-ancestor
25646712|NCT01462318|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25646713|NCT01462318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25646714|NCT01462318|Hemostatics|hemostatics|mesh-ancestor
25522224|NCT00467831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25522225|NCT00467831|Antimetabolites|antimetabolites|mesh-ancestor
25522226|NCT00467831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25522227|NCT00467831|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25522228|NCT00467831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522229|NCT00467831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25522230|NCT00467831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25522231|NCT00467831|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25522232|NCT00467831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25522233|NCT00467831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25522234|NCT00467831|Analgesics|analgesics|mesh-ancestor
25522235|NCT00467831|Sensory System Agents|sensory system agents|mesh-ancestor
25522236|NCT00467831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25522237|NCT00467831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24990797|NCT00511134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990798|NCT00511134|Dopamine Agents|dopamine agents|mesh-ancestor
25522238|NCT00467831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25522239|NCT00467831|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25522240|NCT00467831|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25522241|NCT00467831|Hormone Antagonists|hormone antagonists|mesh-ancestor
25522242|NCT00467831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25522243|NCT00467870|Methyltestosterone|methyltestosterone|mesh-list
25522244|NCT00467870|Testosterone|testosterone|mesh-list
25522245|NCT00467870|Testosterone undecanoate|testosterone undecanoate|mesh-list
25522246|NCT00467870|Testosterone enanthate|testosterone enanthate|mesh-list
25522247|NCT00467870|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25522248|NCT00467870|Androgens|androgens|mesh-ancestor
25522249|NCT00467870|Hormones|hormones|mesh-ancestor
25522250|NCT00467870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25522251|NCT00467870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522252|NCT00467870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25522253|NCT00467870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522254|NCT00467870|Anabolic Agents|anabolic agents|mesh-ancestor
25522255|NCT00467896|Iloprost|iloprost|mesh-list
25522256|NCT00467896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25522257|NCT00467896|Vasodilator Agents|vasodilator agents|mesh-ancestor
25522258|NCT00468052|Fentanyl|fentanyl|mesh-list
25522259|NCT00468052|Dexmedetomidine|dexmedetomidine|mesh-list
25522260|NCT00468052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25522261|NCT00468052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25522262|NCT00468052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522263|NCT00468052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25522264|NCT00468052|Analgesics|analgesics|mesh-ancestor
25522265|NCT00468052|Sensory System Agents|sensory system agents|mesh-ancestor
25522266|NCT00468052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25522267|NCT00468052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25522268|NCT00468052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25522269|NCT00468052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25522270|NCT00468052|Adrenergic Agents|adrenergic agents|mesh-ancestor
25522271|NCT00468052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25522272|NCT00468052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522273|NCT00468052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25522274|NCT00468052|Narcotics|narcotics|mesh-ancestor
25522275|NCT00468052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25522276|NCT00468052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25522277|NCT00468052|Anesthetics, General|anesthetics, general|mesh-ancestor
25522278|NCT00468052|Anesthetics|anesthetics|mesh-ancestor
25522279|NCT00468104|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25522280|NCT00468104|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25522281|NCT00468104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25522282|NCT00468104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522283|NCT00468143|Adderall|adderall|mesh-list
25522284|NCT00468143|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25522285|NCT00468143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522286|NCT00468169|Cisplatin|cisplatin|mesh-list
25522287|NCT00468169|Cetuximab|cetuximab|mesh-list
25522288|NCT00468169|Hydroxyurea|hydroxyurea|mesh-list
25522289|NCT00468169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646715|NCT01462318|Coagulants|coagulants|mesh-ancestor
25522290|NCT00468169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25522292|NCT00468169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522293|NCT00468169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522294|NCT00468169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25522295|NCT00468208|Abatacept|abatacept|mesh-list
25522296|NCT00468208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25522297|NCT00468208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522298|NCT00468208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522299|NCT00468208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24533281|NCT00642863|Retinol palmitate|retinol palmitate|mesh-list
25823407|NCT00004817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823408|NCT00004817|GABA Agents|gaba agents|mesh-ancestor
25823409|NCT00004817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25823410|NCT00004817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823411|NCT00004817|Antimanic Agents|antimanic agents|mesh-ancestor
25823412|NCT00004817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25823413|NCT00004817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25823414|NCT00004817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25823415|NCT00004817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25823416|NCT00004817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24864736|NCT02741388|Antiemetics|antiemetics|mesh-ancestor
25522300|NCT00468208|Immunologic Factors|immunologic factors|mesh-ancestor
25522301|NCT00468208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522302|NCT00468208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25522303|NCT00468299|Misoprostol|misoprostol|mesh-list
25522304|NCT00468299|Mifepristone|mifepristone|mesh-list
25522305|NCT00468299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25522306|NCT00468299|Abortifacient Agents|abortifacient agents|mesh-ancestor
25522307|NCT00468299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25522308|NCT00468299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522309|NCT00468299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25522310|NCT00468299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25522311|NCT00468299|Oxytocics|oxytocics|mesh-ancestor
25522312|NCT00468299|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25522313|NCT00468299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25522314|NCT00468299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25522315|NCT00468299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25522316|NCT00468299|Contraceptive Agents|contraceptive agents|mesh-ancestor
25522317|NCT00468299|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25522318|NCT00468299|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25522319|NCT00468299|Hormone Antagonists|hormone antagonists|mesh-ancestor
25522320|NCT00468299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25522321|NCT00468299|Luteolytic Agents|luteolytic agents|mesh-ancestor
25522322|NCT00468299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25522323|NCT00468299|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25522324|NCT00468481|Drospirenone|drospirenone|mesh-list
25522325|NCT00468481|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25522326|NCT00468481|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
25522327|NCT00468481|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25522328|NCT00468481|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25522329|NCT00468481|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25522330|NCT00468481|Contraceptive Agents|contraceptive agents|mesh-ancestor
25522331|NCT00468481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25522332|NCT00468481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522333|NCT00468481|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25522334|NCT00468481|Estrogens|estrogens|mesh-ancestor
25522335|NCT00468481|Hormones|hormones|mesh-ancestor
25522336|NCT00468481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25522337|NCT00468481|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25522338|NCT00468481|Hormone Antagonists|hormone antagonists|mesh-ancestor
25522339|NCT00468481|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25522340|NCT00468481|Diuretics|diuretics|mesh-ancestor
25522341|NCT00468481|Natriuretic Agents|natriuretic agents|mesh-ancestor
25522342|NCT00468546|Methotrexate|methotrexate|mesh-list
25522343|NCT00468546|Rituximab|rituximab|mesh-list
25522344|NCT00468546|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25522345|NCT00468546|Abortifacient Agents|abortifacient agents|mesh-ancestor
25522346|NCT00468546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25522347|NCT00468546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522348|NCT00468546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25522349|NCT00468546|Antimetabolites|antimetabolites|mesh-ancestor
25522350|NCT00468546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522351|NCT00468546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522352|NCT00468546|Dermatologic Agents|dermatologic agents|mesh-ancestor
25522353|NCT00468546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522354|NCT00468546|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25522355|NCT00468546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25522356|NCT00468546|Immunologic Factors|immunologic factors|mesh-ancestor
25522357|NCT00468546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25522358|NCT00468546|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25522359|NCT00468546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25522360|NCT00468559|Esomeprazole|esomeprazole|mesh-list
25522361|NCT00468559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25522362|NCT00468559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25522363|NCT00468559|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25522364|NCT00468559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522365|NCT00468559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522366|NCT00468585|Bevacizumab|bevacizumab|mesh-list
25522367|NCT00468585|Capecitabine|capecitabine|mesh-list
25522368|NCT00468585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25522369|NCT00468585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522370|NCT00468585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25522371|NCT00468585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24990903|NCT03728179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25522372|NCT00468585|Growth Substances|growth substances|mesh-ancestor
25522373|NCT00468585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522374|NCT00468585|Growth Inhibitors|growth inhibitors|mesh-ancestor
25522375|NCT00468585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25522377|NCT00468585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522378|NCT00468650|Sildenafil Citrate|sildenafil citrate|mesh-list
25522379|NCT00468650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522380|NCT00468650|Vasodilator Agents|vasodilator agents|mesh-ancestor
25522381|NCT00468650|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25522382|NCT00468650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25522383|NCT00468650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522384|NCT00468650|Urological Agents|urological agents|mesh-ancestor
25522386|NCT00468728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25522387|NCT00468728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25522388|NCT00468845|Pregabalin|pregabalin|mesh-list
25522389|NCT00468845|Analgesics|analgesics|mesh-ancestor
25522390|NCT00468845|Sensory System Agents|sensory system agents|mesh-ancestor
25522391|NCT00468845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25522392|NCT00468845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522393|NCT00468845|Anticonvulsants|anticonvulsants|mesh-ancestor
25522394|NCT00468845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25522395|NCT00468845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25522396|NCT00468845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522397|NCT00468845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25522398|NCT00468845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25522399|NCT00468845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25522400|NCT00468845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25522401|NCT00468845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25522402|NCT00468910|Aspirin|aspirin|mesh-list
25522403|NCT00468910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25522404|NCT00468910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25522405|NCT00468910|Analgesics|analgesics|mesh-ancestor
25522406|NCT00468910|Sensory System Agents|sensory system agents|mesh-ancestor
25522407|NCT00468910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25522408|NCT00468910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522409|NCT00468910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25522410|NCT00468910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25522411|NCT00468910|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25522412|NCT00468910|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25522413|NCT00468910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522414|NCT00468910|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25522415|NCT00468910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25522416|NCT00468910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522417|NCT00468910|Antipyretics|antipyretics|mesh-ancestor
25522418|NCT00469014|Vidarabine|vidarabine|mesh-list
25522419|NCT00469014|Fludarabine|fludarabine|mesh-list
25522420|NCT00469014|Fludarabine phosphate|fludarabine phosphate|mesh-list
25522421|NCT00469014|Busulfan|busulfan|mesh-list
25522422|NCT00469014|Clofarabine|clofarabine|mesh-list
25522423|NCT00469014|Thymoglobulin|thymoglobulin|mesh-list
25522424|NCT00469014|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25522425|NCT00469014|Lenograstim|lenograstim|mesh-list
25522426|NCT00469014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522427|NCT00469014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25522428|NCT00469014|Antimetabolites|antimetabolites|mesh-ancestor
25522429|NCT00469014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522430|NCT00469014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25522431|NCT00469014|Immunologic Factors|immunologic factors|mesh-ancestor
25522432|NCT00469014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522433|NCT00469014|Antiviral Agents|antiviral agents|mesh-ancestor
25522434|NCT00469014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25522435|NCT00469014|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25522436|NCT00469014|Alkylating Agents|alkylating agents|mesh-ancestor
25522437|NCT00469014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25522438|NCT00469014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25522439|NCT00469079|Nicotine|nicotine|mesh-list
25522440|NCT00469079|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25522441|NCT00469079|Autonomic Agents|autonomic agents|mesh-ancestor
25522442|NCT00469079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25522443|NCT00469079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522444|NCT00469079|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25522445|NCT00469079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25522446|NCT00469079|Cholinergic Agents|cholinergic agents|mesh-ancestor
25522447|NCT00469079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25522448|NCT00469079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522449|NCT00469092|Insulin|insulin|mesh-list
25522450|NCT00469092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25522451|NCT00469092|Metformin|metformin|mesh-list
25522452|NCT00469092|Insulin Glargine|insulin glargine|mesh-list
25522453|NCT00469092|Insulin Aspart|insulin aspart|mesh-list
25522454|NCT00469092|Glimepiride|glimepiride|mesh-list
25522455|NCT00469092|Biphasic Insulins|biphasic insulins|mesh-list
25522456|NCT00469092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25522457|NCT00469092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522458|NCT00469092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25522459|NCT00469092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25522460|NCT00469092|Immunologic Factors|immunologic factors|mesh-ancestor
25522461|NCT00469144|Fludarabine|fludarabine|mesh-list
25522462|NCT00469144|Busulfan|busulfan|mesh-list
25522463|NCT00469144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522464|NCT00469144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522465|NCT00469144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25522466|NCT00469144|Immunologic Factors|immunologic factors|mesh-ancestor
25522467|NCT00469144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522468|NCT00469144|Alkylating Agents|alkylating agents|mesh-ancestor
25522469|NCT00469144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25522470|NCT00469144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25522471|NCT00469209|Ascorbic Acid|ascorbic acid|mesh-list
25522472|NCT00469209|Bortezomib|bortezomib|mesh-list
25522473|NCT00469209|Melphalan|melphalan|mesh-list
25522474|NCT00469209|Arsenic Trioxide|arsenic trioxide|mesh-list
25522475|NCT00469209|Vitamins|vitamins|mesh-ancestor
25522476|NCT00469209|Micronutrients|micronutrients|mesh-ancestor
25522477|NCT00469209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522478|NCT00469209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522479|NCT00469209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25522480|NCT00469209|Alkylating Agents|alkylating agents|mesh-ancestor
25522481|NCT00469209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522482|NCT00469209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25522483|NCT00469209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25522484|NCT00469209|Immunologic Factors|immunologic factors|mesh-ancestor
25522485|NCT00469209|Antioxidants|antioxidants|mesh-ancestor
25522486|NCT00469209|Protective Agents|protective agents|mesh-ancestor
25522487|NCT00469274|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25522488|NCT00469274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25522489|NCT00469274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25522490|NCT00469274|Antitubercular Agents|antitubercular agents|mesh-ancestor
25522491|NCT00469456|Memantine|memantine|mesh-list
25522492|NCT00469456|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25522493|NCT00469456|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25522494|NCT00469456|Dopamine Agents|dopamine agents|mesh-ancestor
25646716|NCT01462318|Antitussive Agents|antitussive agents|mesh-ancestor
25522495|NCT00469456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25522496|NCT00469456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522497|NCT00469456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522498|NCT00469456|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25522499|NCT00469456|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25522500|NCT00469508|Modafinil|modafinil|mesh-list
25522501|NCT00469508|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25522502|NCT00469508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522503|NCT00469508|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25522504|NCT00469508|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25522505|NCT00469508|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25522506|NCT00469508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522507|NCT00469833|Insulin|insulin|mesh-list
25522508|NCT00469833|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25522509|NCT00469833|Insulin Glargine|insulin glargine|mesh-list
25522510|NCT00469833|Insulin, Long-Acting|insulin, long-acting|mesh-list
25522511|NCT00469833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25522512|NCT00469833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522513|NCT00469859|Cytarabine|cytarabine|mesh-list
25522514|NCT00469859|Idarubicin|idarubicin|mesh-list
25522515|NCT00469859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25522516|NCT00469859|Antimetabolites|antimetabolites|mesh-ancestor
25823417|NCT00004817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25823418|NCT00004817|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25823419|NCT00004817|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25522517|NCT00469859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522518|NCT00469859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522519|NCT00469859|Antiviral Agents|antiviral agents|mesh-ancestor
25522520|NCT00469859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25522521|NCT00469859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25522522|NCT00469859|Immunologic Factors|immunologic factors|mesh-ancestor
25522523|NCT00469859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522524|NCT00469859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25522525|NCT00469859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25522526|NCT00469859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25522527|NCT00469859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522528|NCT00469898|Carboplatin|carboplatin|mesh-list
25522529|NCT00469898|Irinotecan|irinotecan|mesh-list
25522530|NCT00469898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522531|NCT00469898|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25522532|NCT00469898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25522533|NCT00469898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522534|NCT00469898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522535|NCT00470054|Dasatinib|dasatinib|mesh-list
25522536|NCT00470054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522537|NCT00470054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25522538|NCT00470054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522539|NCT00470054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522540|NCT00470093|Interferons|interferons|mesh-list
25522541|NCT00470093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522542|NCT00470093|Antiviral Agents|antiviral agents|mesh-ancestor
25522543|NCT00470093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25522544|NCT00470158|Iron|iron|mesh-list
25522545|NCT00470158|Zinc|zinc|mesh-list
25522546|NCT00470158|Trace Elements|trace elements|mesh-ancestor
25522547|NCT00470158|Micronutrients|micronutrients|mesh-ancestor
25522548|NCT00470158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522549|NCT00470184|Capecitabine|capecitabine|mesh-list
25522550|NCT00470184|Oxaliplatin|oxaliplatin|mesh-list
25522551|NCT00470184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25522552|NCT00470184|Antimetabolites|antimetabolites|mesh-ancestor
25522553|NCT00470184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522554|NCT00470184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522555|NCT00470262|Pioglitazone|pioglitazone|mesh-list
25522556|NCT00470262|Fenofibrate|fenofibrate|mesh-list
25522557|NCT00470262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25522558|NCT00470262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522559|NCT00470262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25522560|NCT00470262|Antimetabolites|antimetabolites|mesh-ancestor
25522561|NCT00470262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522562|NCT00470262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25522563|NCT00470275|Cytarabine|cytarabine|mesh-list
25522564|NCT00470275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25522565|NCT00470275|Antimetabolites|antimetabolites|mesh-ancestor
25522566|NCT00470275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522567|NCT00470275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522568|NCT00470275|Antiviral Agents|antiviral agents|mesh-ancestor
25522569|NCT00470275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25522570|NCT00470275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25522571|NCT00470275|Immunologic Factors|immunologic factors|mesh-ancestor
25522572|NCT00470275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522573|NCT00470301|Paclitaxel|paclitaxel|mesh-list
25522574|NCT00470301|Cyclophosphamide|cyclophosphamide|mesh-list
25522575|NCT00470301|Doxorubicin|doxorubicin|mesh-list
25522576|NCT00470301|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25522577|NCT00470301|Tipifarnib|tipifarnib|mesh-list
25522578|NCT00470301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25522579|NCT00470301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522580|NCT00470301|Tubulin Modulators|tubulin modulators|mesh-ancestor
25522581|NCT00470301|Antimitotic Agents|antimitotic agents|mesh-ancestor
25522582|NCT00470301|Mitosis Modulators|mitosis modulators|mesh-ancestor
25522583|NCT00470301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522584|NCT00470301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25522585|NCT00470301|Immunologic Factors|immunologic factors|mesh-ancestor
25522586|NCT00470301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522587|NCT00470301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25522588|NCT00470301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25522589|NCT00470301|Alkylating Agents|alkylating agents|mesh-ancestor
25522590|NCT00470301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25522591|NCT00470301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25823420|NCT00004825|Insulin|insulin|mesh-list
25823421|NCT00004825|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25823422|NCT00004825|Mitogens|mitogens|mesh-list
25823423|NCT00004825|Mecasermin|mecasermin|mesh-list
25823424|NCT00004825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25522592|NCT00470301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25522593|NCT00470301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25522594|NCT00470301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522595|NCT00470366|Paclitaxel|paclitaxel|mesh-list
25522596|NCT00470366|Cisplatin|cisplatin|mesh-list
25522597|NCT00470366|Ifosfamide|ifosfamide|mesh-list
25522598|NCT00470366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25522599|NCT00470366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522600|NCT00470366|Tubulin Modulators|tubulin modulators|mesh-ancestor
25522601|NCT00470366|Antimitotic Agents|antimitotic agents|mesh-ancestor
25522602|NCT00470366|Mitosis Modulators|mitosis modulators|mesh-ancestor
25522603|NCT00470366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522604|NCT00470366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25522605|NCT00470366|Alkylating Agents|alkylating agents|mesh-ancestor
25522606|NCT00470392|Clobetasol|clobetasol|mesh-list
25522607|NCT00470392|Imiquimod|imiquimod|mesh-list
25522608|NCT00470392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25522609|NCT00470392|Immunologic Factors|immunologic factors|mesh-ancestor
25522610|NCT00470392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522611|NCT00470392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522612|NCT00470392|Interferon Inducers|interferon inducers|mesh-ancestor
25522613|NCT00470392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25522614|NCT00470392|Glucocorticoids|glucocorticoids|mesh-ancestor
25522615|NCT00470392|Hormones|hormones|mesh-ancestor
25522616|NCT00470392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25522617|NCT00470470|Imatinib Mesylate|imatinib mesylate|mesh-list
25522618|NCT00470470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522619|NCT00470470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25522620|NCT00470470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522621|NCT00470470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522622|NCT00470535|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25522623|NCT00470535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522624|NCT00470535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25522625|NCT00470535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522626|NCT00470535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522627|NCT00470548|Paclitaxel|paclitaxel|mesh-list
25522628|NCT00470548|Pemetrexed|pemetrexed|mesh-list
25522629|NCT00470548|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25522630|NCT00470548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25522631|NCT00470548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522632|NCT00470548|Tubulin Modulators|tubulin modulators|mesh-ancestor
25522633|NCT00470548|Antimitotic Agents|antimitotic agents|mesh-ancestor
25522634|NCT00470548|Mitosis Modulators|mitosis modulators|mesh-ancestor
25522635|NCT00470548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522636|NCT00470548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522637|NCT00470548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25522638|NCT00470548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25522639|NCT00470600|Ibuprofen|ibuprofen|mesh-list
25522640|NCT00470600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25522641|NCT00470600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25522642|NCT00470600|Analgesics|analgesics|mesh-ancestor
24799715|NCT01970579|Paclitaxel|paclitaxel|mesh-list
25823425|NCT00004825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522643|NCT00470600|Sensory System Agents|sensory system agents|mesh-ancestor
25522644|NCT00470600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25522645|NCT00470600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522646|NCT00470600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25522647|NCT00470600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25522648|NCT00470600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25522649|NCT00470600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522650|NCT00470600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522651|NCT00470834|Bicalutamide|bicalutamide|mesh-list
25522652|NCT00470834|Dutasteride|dutasteride|mesh-list
25522653|NCT00470834|Androgen Antagonists|androgen antagonists|mesh-ancestor
25522654|NCT00470834|Hormone Antagonists|hormone antagonists|mesh-ancestor
25522655|NCT00470834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25522656|NCT00470834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522657|NCT00470834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522658|NCT00470834|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25522659|NCT00470834|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25522660|NCT00470834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522661|NCT00470834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991024|NCT03082729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24991025|NCT03082729|Analgesics|analgesics|mesh-ancestor
24991026|NCT03082729|Sensory System Agents|sensory system agents|mesh-ancestor
24864894|NCT05148689|Respiratory System Agents|respiratory system agents|mesh-ancestor
25522662|NCT00470847|Trastuzumab|trastuzumab|mesh-list
25522663|NCT00470847|Lapatinib|lapatinib|mesh-list
25522664|NCT00470847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25522665|NCT00470847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522666|NCT00470847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25522667|NCT00470847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522668|NCT00470847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522669|NCT00471068|Timolol|timolol|mesh-list
25522670|NCT00471068|Travoprost|travoprost|mesh-list
25522671|NCT00471068|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25522672|NCT00471068|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25522673|NCT00471068|Adrenergic Agents|adrenergic agents|mesh-ancestor
25522674|NCT00471068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25522675|NCT00471068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522676|NCT00471068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522677|NCT00471068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25522678|NCT00471068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25522679|NCT00471146|Gemcitabine|gemcitabine|mesh-list
25522680|NCT00471146|Axitinib|axitinib|mesh-list
25522681|NCT00471146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25522682|NCT00471146|Antimetabolites|antimetabolites|mesh-ancestor
25522683|NCT00471146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522684|NCT00471146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522685|NCT00471146|Antiviral Agents|antiviral agents|mesh-ancestor
25522686|NCT00471146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25522687|NCT00471146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522688|NCT00471146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25522689|NCT00471146|Immunologic Factors|immunologic factors|mesh-ancestor
25522690|NCT00471146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522691|NCT00471146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25522692|NCT00471237|Alendronate|alendronate|mesh-list
25522693|NCT00471237|Teriparatide|teriparatide|mesh-list
25522694|NCT00471237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25522695|NCT00471237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522696|NCT00471237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25522697|NCT00471276|Sunitinib|sunitinib|mesh-list
25522698|NCT00471276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522699|NCT00471276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25522700|NCT00471276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25522701|NCT00471276|Growth Substances|growth substances|mesh-ancestor
25522702|NCT00471276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522703|NCT00471276|Growth Inhibitors|growth inhibitors|mesh-ancestor
25522704|NCT00471276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25522705|NCT00471276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522706|NCT00471276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522707|NCT00471315|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25522708|NCT00471315|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25522709|NCT00471315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25522710|NCT00471315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25823426|NCT00004825|Mitosis Modulators|mitosis modulators|mesh-ancestor
25522711|NCT00471315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522713|NCT00471315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522714|NCT00471315|Analgesics|analgesics|mesh-ancestor
25522715|NCT00471315|Sensory System Agents|sensory system agents|mesh-ancestor
25522716|NCT00471315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25522717|NCT00471315|Antidepressive Agents|antidepressive agents|mesh-ancestor
25522718|NCT00471315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25522719|NCT00471315|Dopamine Agents|dopamine agents|mesh-ancestor
25522720|NCT00471328|Sunitinib|sunitinib|mesh-list
25522721|NCT00471328|Imatinib Mesylate|imatinib mesylate|mesh-list
25522722|NCT00471328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522723|NCT00471328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25522724|NCT00471328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25522725|NCT00471328|Growth Substances|growth substances|mesh-ancestor
25522726|NCT00471328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522727|NCT00471328|Growth Inhibitors|growth inhibitors|mesh-ancestor
25522728|NCT00471328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25522729|NCT00471328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522730|NCT00471328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991094|NCT02870218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24864938|NCT05136040|Bupivacaine|bupivacaine|mesh-list
24991095|NCT02870218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991096|NCT02859961|Leronlimab|leronlimab|mesh-list
25522731|NCT00471354|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25522732|NCT00471354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25522733|NCT00471354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25522734|NCT00471354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25522735|NCT00471354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522736|NCT00471354|Adrenergic Agents|adrenergic agents|mesh-ancestor
25522737|NCT00471354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25522738|NCT00471354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522739|NCT00471380|Timolol|timolol|mesh-list
25522740|NCT00471380|Travoprost|travoprost|mesh-list
25522741|NCT00471380|Dorzolamide|dorzolamide|mesh-list
25522742|NCT00471380|Brinzolamide|brinzolamide|mesh-list
25522743|NCT00471380|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25522744|NCT00471380|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25522745|NCT00471380|Adrenergic Agents|adrenergic agents|mesh-ancestor
25522746|NCT00471380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25522747|NCT00471380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522748|NCT00471380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522749|NCT00471380|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25522750|NCT00471380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25522751|NCT00471380|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25522752|NCT00471380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522753|NCT00471445|Ketamine|ketamine|mesh-list
25522754|NCT00471445|Amitriptyline|amitriptyline|mesh-list
25522755|NCT00471445|Analgesics|analgesics|mesh-ancestor
25522756|NCT00471445|Sensory System Agents|sensory system agents|mesh-ancestor
25522757|NCT00471445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25522758|NCT00471445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522759|NCT00471445|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25522760|NCT00471445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25522761|NCT00471445|Anesthetics, General|anesthetics, general|mesh-ancestor
25522762|NCT00471445|Anesthetics|anesthetics|mesh-ancestor
25522763|NCT00471445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25522764|NCT00471445|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25522765|NCT00471445|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25522766|NCT00471445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25522767|NCT00471445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522768|NCT00471445|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25522769|NCT00471445|Antidepressive Agents|antidepressive agents|mesh-ancestor
25522770|NCT00471445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25522771|NCT00471445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25522772|NCT00471445|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25522773|NCT00471445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25522774|NCT00471445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25522775|NCT00471445|Adrenergic Agents|adrenergic agents|mesh-ancestor
25522776|NCT00471497|Imatinib Mesylate|imatinib mesylate|mesh-list
25522777|NCT00471497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522778|NCT00471497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25522779|NCT00471497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522780|NCT00471497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522781|NCT00471705|Miltefosine|miltefosine|mesh-list
25646717|NCT01462318|Respiratory System Agents|respiratory system agents|mesh-ancestor
25522782|NCT00471705|Meglumine Antimoniate|meglumine antimoniate|mesh-list
25522783|NCT00471705|Antifungal Agents|antifungal agents|mesh-ancestor
25522784|NCT00471705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25522785|NCT00471705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522786|NCT00471705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25522787|NCT00471705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25522788|NCT00471848|Thymoglobulin|thymoglobulin|mesh-list
25522789|NCT00471848|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25522790|NCT00471848|Immunologic Factors|immunologic factors|mesh-ancestor
25522791|NCT00471848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522792|NCT00471848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25522793|NCT00471887|Tremelimumab|tremelimumab|mesh-list
25522794|NCT00471887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449566|NCT00315965|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24449567|NCT00315965|Vasodilator Agents|vasodilator agents|mesh-ancestor
24449568|NCT00315965|Gasotransmitters|gasotransmitters|mesh-ancestor
24449569|NCT00315965|Protective Agents|protective agents|mesh-ancestor
24449571|NCT00316030|Bexarotene|bexarotene|mesh-list
24449598|NCT00316160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24449599|NCT00316160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449600|NCT00316160|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24449601|NCT00316212|INS 50589|ins 50589|mesh-list
24449602|NCT00316212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25522795|NCT00472030|Omalizumab|omalizumab|mesh-list
25522796|NCT00472030|Prednisone|prednisone|mesh-list
25522797|NCT00472030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25522798|NCT00472030|Glucocorticoids|glucocorticoids|mesh-ancestor
25522799|NCT00472030|Hormones|hormones|mesh-ancestor
25522800|NCT00472030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25522801|NCT00472030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522802|NCT00472030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25522803|NCT00472030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522804|NCT00472030|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25522805|NCT00472030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25522806|NCT00472030|Respiratory System Agents|respiratory system agents|mesh-ancestor
25522807|NCT00472056|Cytarabine|cytarabine|mesh-list
25522808|NCT00472056|Rituximab|rituximab|mesh-list
25522809|NCT00472056|Etoposide|etoposide|mesh-list
25522810|NCT00472056|Melphalan|melphalan|mesh-list
25522811|NCT00472056|Carmustine|carmustine|mesh-list
25522812|NCT00472056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25522813|NCT00472056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522814|NCT00472056|Immunologic Factors|immunologic factors|mesh-ancestor
25522815|NCT00472056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522816|NCT00472056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25522817|NCT00472056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25522818|NCT00472056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25522819|NCT00472056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25522820|NCT00472056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522821|NCT00472056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522822|NCT00472056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25522823|NCT00472056|Antimetabolites|antimetabolites|mesh-ancestor
25522824|NCT00472056|Antiviral Agents|antiviral agents|mesh-ancestor
25522825|NCT00472056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25522826|NCT00472056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25522827|NCT00472056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25522828|NCT00472056|Alkylating Agents|alkylating agents|mesh-ancestor
25522829|NCT00472056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25522830|NCT00472199|Pramipexole|pramipexole|mesh-list
25522831|NCT00472199|Antioxidants|antioxidants|mesh-ancestor
25522832|NCT00472199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522833|NCT00472199|Protective Agents|protective agents|mesh-ancestor
25522834|NCT00472199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522835|NCT00472199|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25522836|NCT00472199|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25522837|NCT00472199|Dopamine Agonists|dopamine agonists|mesh-ancestor
25522838|NCT00472199|Dopamine Agents|dopamine agents|mesh-ancestor
25522839|NCT00472199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25522840|NCT00472303|Morphine|morphine|mesh-list
25522841|NCT00472303|Tapentadol|tapentadol|mesh-list
25522842|NCT00472303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25522843|NCT00472303|Narcotics|narcotics|mesh-ancestor
25522844|NCT00472303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24799920|NCT01972113|Vitamins|vitamins|mesh-list
25522846|NCT00472303|Analgesics|analgesics|mesh-ancestor
25522847|NCT00472303|Sensory System Agents|sensory system agents|mesh-ancestor
25522848|NCT00472303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25522849|NCT00472303|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25522850|NCT00472303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25522851|NCT00472303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25522852|NCT00472303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522853|NCT00472303|Adrenergic Agents|adrenergic agents|mesh-ancestor
25522854|NCT00472303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25522855|NCT00472420|Rituximab|rituximab|mesh-list
25522856|NCT00472420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25522857|NCT00472420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522858|NCT00472420|Immunologic Factors|immunologic factors|mesh-ancestor
25522859|NCT00472420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522860|NCT00472420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25522861|NCT00472641|Ziprasidone|ziprasidone|mesh-list
25522862|NCT00472641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25522863|NCT00472641|Serotonin Agents|serotonin agents|mesh-ancestor
25522864|NCT00472641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25522865|NCT00472641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522866|NCT00472641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522867|NCT00472641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25522868|NCT00472641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25522869|NCT00472641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25522870|NCT00472641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25522872|NCT00472641|Dopamine Agents|dopamine agents|mesh-ancestor
25522873|NCT00472797|Interferon beta-1a|interferon beta-1a|mesh-list
25522874|NCT00472797|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25522875|NCT00472797|Immunologic Factors|immunologic factors|mesh-ancestor
25522876|NCT00472797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522877|NCT00472797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522878|NCT00472797|Antiviral Agents|antiviral agents|mesh-ancestor
25522879|NCT00472797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25522880|NCT00472849|Cytarabine|cytarabine|mesh-list
25522881|NCT00472849|Rituximab|rituximab|mesh-list
25522882|NCT00472849|Oxaliplatin|oxaliplatin|mesh-list
25522883|NCT00472849|Fludarabine|fludarabine|mesh-list
25522884|NCT00472849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25522885|NCT00472849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522886|NCT00472849|Immunologic Factors|immunologic factors|mesh-ancestor
25522887|NCT00472849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522888|NCT00472849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25522889|NCT00472849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25522890|NCT00472849|Antimetabolites|antimetabolites|mesh-ancestor
25522891|NCT00472849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522892|NCT00472849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25522893|NCT00472849|Antiviral Agents|antiviral agents|mesh-ancestor
25522894|NCT00472849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25522895|NCT00473083|Minocycline|minocycline|mesh-list
25522896|NCT00473083|Clindamycin|clindamycin|mesh-list
25522897|NCT00473083|Clindamycin palmitate|clindamycin palmitate|mesh-list
25522898|NCT00473083|Clindamycin phosphate|clindamycin phosphate|mesh-list
25522899|NCT00473083|Triamcinolone|triamcinolone|mesh-list
25522900|NCT00473083|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25522901|NCT00473083|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25522902|NCT00473083|Hydrocortisone|hydrocortisone|mesh-list
25522903|NCT00473083|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25522904|NCT00473083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522905|NCT00473083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522906|NCT00473083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25522907|NCT00473083|Glucocorticoids|glucocorticoids|mesh-ancestor
25522908|NCT00473083|Hormones|hormones|mesh-ancestor
25522909|NCT00473083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25522910|NCT00473083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522911|NCT00473083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25522912|NCT00473083|Immunologic Factors|immunologic factors|mesh-ancestor
25522913|NCT00473083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25522914|NCT00473083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25522915|NCT00473083|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25522916|NCT00473265|Teriparatide|teriparatide|mesh-list
25522917|NCT00473265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25522918|NCT00473265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522919|NCT00473265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25646718|NCT01462318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25522920|NCT00473330|Ranibizumab|ranibizumab|mesh-list
25522921|NCT00473330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25522922|NCT00473330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25522923|NCT00473330|Growth Substances|growth substances|mesh-ancestor
25522924|NCT00473330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522925|NCT00473330|Growth Inhibitors|growth inhibitors|mesh-ancestor
25522926|NCT00473330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522927|NCT00473382|Ranibizumab|ranibizumab|mesh-list
25522928|NCT00473382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25522929|NCT00473382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25522930|NCT00473382|Growth Substances|growth substances|mesh-ancestor
25522931|NCT00473382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522932|NCT00473382|Growth Inhibitors|growth inhibitors|mesh-ancestor
25522933|NCT00473382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522934|NCT00473434|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25522935|NCT00473434|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25522936|NCT00473434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25522937|NCT00473434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25522938|NCT00473434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522939|NCT00473434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25522940|NCT00473434|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25522941|NCT00473434|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25522942|NCT00473434|Serotonin Agents|serotonin agents|mesh-ancestor
25522943|NCT00473434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25522944|NCT00473434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449686|NCT00316498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522945|NCT00473434|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25522946|NCT00473434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25522947|NCT00473434|Dopamine Agents|dopamine agents|mesh-ancestor
25522948|NCT00473512|Dexamethasone|dexamethasone|mesh-list
25522949|NCT00473512|Abiraterone Acetate|abiraterone acetate|mesh-list
25522950|NCT00473512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25522951|NCT00473512|Antiemetics|antiemetics|mesh-ancestor
25522952|NCT00473512|Autonomic Agents|autonomic agents|mesh-ancestor
25522953|NCT00473512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25522954|NCT00473512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522955|NCT00473512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25522956|NCT00473512|Glucocorticoids|glucocorticoids|mesh-ancestor
25522957|NCT00473512|Hormones|hormones|mesh-ancestor
25522958|NCT00473512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25522959|NCT00473512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25522960|NCT00473512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522961|NCT00473512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25522962|NCT00473512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522963|NCT00473512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522964|NCT00473512|Hormone Antagonists|hormone antagonists|mesh-ancestor
25522965|NCT00473512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25522966|NCT00473590|Bevacizumab|bevacizumab|mesh-list
25522967|NCT00473590|Bortezomib|bortezomib|mesh-list
25522968|NCT00473590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25522969|NCT00473590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522970|NCT00473590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25522971|NCT00473590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25522972|NCT00473590|Growth Substances|growth substances|mesh-ancestor
25522973|NCT00473590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522974|NCT00473590|Growth Inhibitors|growth inhibitors|mesh-ancestor
25522975|NCT00473642|Ranibizumab|ranibizumab|mesh-list
25522976|NCT00473642|Verteporfin|verteporfin|mesh-list
25522977|NCT00473642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25522978|NCT00473642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25522979|NCT00473642|Growth Substances|growth substances|mesh-ancestor
25522980|NCT00473642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25522981|NCT00473642|Growth Inhibitors|growth inhibitors|mesh-ancestor
25522982|NCT00473642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25522983|NCT00473642|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25522984|NCT00473642|Dermatologic Agents|dermatologic agents|mesh-ancestor
25522985|NCT00473655|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25522986|NCT00473655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25522987|NCT00473655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25522988|NCT00473655|Antimetabolites|antimetabolites|mesh-ancestor
25522989|NCT00473655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25522990|NCT00473655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25522991|NCT00473655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25522992|NCT00473655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25522993|NCT00473694|Glycopyrrolate|glycopyrrolate|mesh-list
25522994|NCT00473694|Rocuronium|rocuronium|mesh-list
25522995|NCT00473694|Vecuronium Bromide|vecuronium bromide|mesh-list
25522996|NCT00473694|Neostigmine|neostigmine|mesh-list
25522997|NCT00473694|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25522998|NCT00473694|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25522999|NCT00473694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25523000|NCT00473694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25523001|NCT00473694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523002|NCT00473694|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25523003|NCT00473694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523004|NCT00473694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523005|NCT00473694|Cholinergic Agents|cholinergic agents|mesh-ancestor
25523006|NCT00473694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25523007|NCT00473694|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25523008|NCT00473694|Autonomic Agents|autonomic agents|mesh-ancestor
25523009|NCT00473694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25523010|NCT00473694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25523011|NCT00473694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25523012|NCT00473694|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25523013|NCT00473746|Dexamethasone|dexamethasone|mesh-list
25523014|NCT00473746|Prednisone|prednisone|mesh-list
25523015|NCT00473746|Prednisolone|prednisolone|mesh-list
25523016|NCT00473746|Abiraterone Acetate|abiraterone acetate|mesh-list
25523017|NCT00473746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25523018|NCT00473746|Antiemetics|antiemetics|mesh-ancestor
24991228|NCT00468130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523019|NCT00473746|Autonomic Agents|autonomic agents|mesh-ancestor
25523020|NCT00473746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25523021|NCT00473746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523022|NCT00473746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25523023|NCT00473746|Glucocorticoids|glucocorticoids|mesh-ancestor
25523024|NCT00473746|Hormones|hormones|mesh-ancestor
25523025|NCT00473746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25523026|NCT00473746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25523027|NCT00473746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523028|NCT00473746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25523029|NCT00473746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523030|NCT00473746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523031|NCT00473746|Hormone Antagonists|hormone antagonists|mesh-ancestor
25523032|NCT00473746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25523033|NCT00473824|Immunoglobulins|immunoglobulins|mesh-list
25523034|NCT00473824|Antibodies|antibodies|mesh-list
25523035|NCT00473824|gamma-Globulins|gamma-globulins|mesh-list
25523036|NCT00473824|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25523037|NCT00473824|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25523038|NCT00473824|Immunologic Factors|immunologic factors|mesh-ancestor
25523039|NCT00473824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523040|NCT00473837|Chloroquine|chloroquine|mesh-list
25523041|NCT00473837|Amebicides|amebicides|mesh-ancestor
25523042|NCT00473837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25523043|NCT00473837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25523044|NCT00473837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25523045|NCT00473837|Antimalarials|antimalarials|mesh-ancestor
25523046|NCT00473837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25523047|NCT00473876|Metformin|metformin|mesh-list
25523048|NCT00473876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25523049|NCT00473876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523050|NCT00473889|Paclitaxel|paclitaxel|mesh-list
25523051|NCT00473889|Carboplatin|carboplatin|mesh-list
25523052|NCT00473889|Vorinostat|vorinostat|mesh-list
25523053|NCT00473889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25523054|NCT00473889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523055|NCT00473889|Tubulin Modulators|tubulin modulators|mesh-ancestor
25523056|NCT00473889|Antimitotic Agents|antimitotic agents|mesh-ancestor
25523057|NCT00473889|Mitosis Modulators|mitosis modulators|mesh-ancestor
25523058|NCT00473889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523059|NCT00473889|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25523060|NCT00473889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523061|NCT00474045|Insulin|insulin|mesh-list
25523062|NCT00474045|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25523063|NCT00474045|Insulin Aspart|insulin aspart|mesh-list
25523064|NCT00474045|Insulin Detemir|insulin detemir|mesh-list
25523065|NCT00474045|Insulin, Isophane|insulin, isophane|mesh-list
25523066|NCT00474045|Isophane Insulin, Human|isophane insulin, human|mesh-list
25523067|NCT00474045|Isophane insulin, beef|isophane insulin, beef|mesh-list
25523068|NCT00474045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25646719|NCT01462318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25646720|NCT01462318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25646721|NCT01462318|Immunologic Factors|immunologic factors|mesh-ancestor
25646722|NCT01462344|Fluticasone|fluticasone|mesh-list
25646723|NCT01462344|Xhance|xhance|mesh-list
25523069|NCT00474045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523070|NCT00474058|Rotigotine|rotigotine|mesh-list
25523071|NCT00474058|Dopamine Agonists|dopamine agonists|mesh-ancestor
25523072|NCT00474058|Dopamine Agents|dopamine agents|mesh-ancestor
25523073|NCT00474058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25523074|NCT00474058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523075|NCT00474058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523076|NCT00474123|Simvastatin|simvastatin|mesh-list
25523077|NCT00474123|Ezetimibe|ezetimibe|mesh-list
25523078|NCT00474123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25523079|NCT00474123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25523080|NCT00474123|Antimetabolites|antimetabolites|mesh-ancestor
25523081|NCT00474123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523082|NCT00474123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25523083|NCT00474123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25523084|NCT00474123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523085|NCT00474175|Benzocaine|benzocaine|mesh-list
24991325|NCT05195086|Cyclophosphamide|cyclophosphamide|mesh-list
24991326|NCT05195086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24991327|NCT05195086|Immunologic Factors|immunologic factors|mesh-ancestor
24991328|NCT05195086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991329|NCT05195086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25047083|NCT00834197|Mirtazapine|mirtazapine|mesh-list
24991330|NCT05195086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24991331|NCT05195086|Alkylating Agents|alkylating agents|mesh-ancestor
24991332|NCT05195086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523086|NCT00474175|Anesthetics, Local|anesthetics, local|mesh-ancestor
25523087|NCT00474175|Anesthetics|anesthetics|mesh-ancestor
25523088|NCT00474175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25523089|NCT00474175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523090|NCT00474175|Sensory System Agents|sensory system agents|mesh-ancestor
25523091|NCT00474175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25523092|NCT00474201|Ritonavir|ritonavir|mesh-list
25523093|NCT00474201|Lopinavir|lopinavir|mesh-list
25523094|NCT00474201|Gemfibrozil|gemfibrozil|mesh-list
25523095|NCT00474201|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25523096|NCT00474201|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25523097|NCT00474201|Protease Inhibitors|protease inhibitors|mesh-ancestor
25523098|NCT00474201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523099|NCT00474201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523100|NCT00474201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25523101|NCT00474201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25523102|NCT00474201|Antiviral Agents|antiviral agents|mesh-ancestor
25523103|NCT00474201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25523104|NCT00474201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25523105|NCT00474201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25523106|NCT00474201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25523107|NCT00474201|Antimetabolites|antimetabolites|mesh-ancestor
25523108|NCT00474201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25523109|NCT00474201|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25523110|NCT00474240|Atorvastatin|atorvastatin|mesh-list
25523111|NCT00474240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25523112|NCT00474240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25523113|NCT00474240|Antimetabolites|antimetabolites|mesh-ancestor
25523114|NCT00474240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523115|NCT00474240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25523116|NCT00474240|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25523117|NCT00474240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523118|NCT00474253|Rocuronium|rocuronium|mesh-list
25523119|NCT00474253|Succinylcholine|succinylcholine|mesh-list
25523120|NCT00474253|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25523121|NCT00474253|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25523122|NCT00474253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25523123|NCT00474253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25523124|NCT00474253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523125|NCT00474253|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
25523126|NCT00474383|Abiraterone Acetate|abiraterone acetate|mesh-list
25523127|NCT00474383|Glucocorticoids|glucocorticoids|mesh-list
25523128|NCT00474383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523129|NCT00474383|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25523130|NCT00474383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523131|NCT00474383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523132|NCT00474383|Hormone Antagonists|hormone antagonists|mesh-ancestor
25523133|NCT00474383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25523134|NCT00474383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523135|NCT00474383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25523136|NCT00474383|Hormones|hormones|mesh-ancestor
25523137|NCT00474487|Vaccines|vaccines|mesh-list
25523138|NCT00474487|Immunologic Factors|immunologic factors|mesh-ancestor
25523139|NCT00474487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523140|NCT00474526|Vaccines|vaccines|mesh-list
25523141|NCT00474526|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25523142|NCT00474526|Immunologic Factors|immunologic factors|mesh-ancestor
25523143|NCT00474526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523144|NCT00474539|Vaccines|vaccines|mesh-list
25523145|NCT00474539|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25523146|NCT00474539|Immunologic Factors|immunologic factors|mesh-ancestor
25523147|NCT00474539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523148|NCT00474630|Naltrexone|naltrexone|mesh-list
25523149|NCT00474630|Bupropion|bupropion|mesh-list
25523150|NCT00474630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25523151|NCT00474630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25523152|NCT00474630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523153|NCT00474630|Sensory System Agents|sensory system agents|mesh-ancestor
25523154|NCT00474630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25523155|NCT00474630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25523156|NCT00474630|Antidepressive Agents|antidepressive agents|mesh-ancestor
25523157|NCT00474630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25823427|NCT00004825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823428|NCT00004825|Growth Substances|growth substances|mesh-ancestor
25823429|NCT00004826|Clozapine|clozapine|mesh-list
25523158|NCT00474630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25523159|NCT00474630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25523160|NCT00474630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25523161|NCT00474630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523163|NCT00474630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25523164|NCT00474630|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25523165|NCT00474630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25523166|NCT00474630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523167|NCT00474708|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25523168|NCT00474708|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25523169|NCT00474708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25523170|NCT00474708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25523171|NCT00474708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523172|NCT00474708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25523173|NCT00474708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523174|NCT00474708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25523175|NCT00474708|Antidepressive Agents|antidepressive agents|mesh-ancestor
25523176|NCT00474708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25523177|NCT00474786|Sirolimus|sirolimus|mesh-list
25523178|NCT00474786|Sorafenib|sorafenib|mesh-list
25523179|NCT00474786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523180|NCT00474786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25523181|NCT00474786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523182|NCT00474786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523183|NCT00474786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25523184|NCT00474786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25523185|NCT00474786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25523186|NCT00474786|Antifungal Agents|antifungal agents|mesh-ancestor
25523187|NCT00474786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25523188|NCT00474786|Immunologic Factors|immunologic factors|mesh-ancestor
25523189|NCT00474786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523190|NCT00474812|Dasatinib|dasatinib|mesh-list
25523191|NCT00474812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523192|NCT00474812|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25523193|NCT00474812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523194|NCT00474812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523195|NCT00474851|Norethindrone|norethindrone|mesh-list
25523196|NCT00474851|Norethindrone Acetate|norethindrone acetate|mesh-list
25523197|NCT00474851|Estrogens|estrogens|mesh-list
25523198|NCT00474851|Hormones|hormones|mesh-ancestor
25523199|NCT00474851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25646724|NCT01462344|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25646725|NCT01462344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25646726|NCT01462344|Autonomic Agents|autonomic agents|mesh-ancestor
25646727|NCT01462344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25523200|NCT00474851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523201|NCT00474851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25523202|NCT00474851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25523203|NCT00474851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25523204|NCT00474851|Contraceptive Agents|contraceptive agents|mesh-ancestor
25523205|NCT00474851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25523206|NCT00474851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25523207|NCT00474851|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25523208|NCT00474903|Aspirin|aspirin|mesh-list
25523209|NCT00474903|Esomeprazole|esomeprazole|mesh-list
25523210|NCT00474903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25523211|NCT00474903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25523212|NCT00474903|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25523213|NCT00474903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523214|NCT00474903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523215|NCT00474903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25523216|NCT00474903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25523217|NCT00474903|Analgesics|analgesics|mesh-ancestor
25523218|NCT00474903|Sensory System Agents|sensory system agents|mesh-ancestor
25523219|NCT00474903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25523220|NCT00474903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523221|NCT00474903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25523222|NCT00474903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25523223|NCT00474903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25523224|NCT00474903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25523225|NCT00474903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25523226|NCT00474903|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25523227|NCT00474903|Antipyretics|antipyretics|mesh-ancestor
25523228|NCT00474929|Everolimus|everolimus|mesh-list
25523229|NCT00474929|Sorafenib|sorafenib|mesh-list
25523230|NCT00474929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523231|NCT00474929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25523232|NCT00474929|Immunologic Factors|immunologic factors|mesh-ancestor
25523233|NCT00474929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523234|NCT00474929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25523235|NCT00474929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523236|NCT00474929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523237|NCT00474955|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25523238|NCT00474955|Antiviral Agents|antiviral agents|mesh-ancestor
25523239|NCT00474955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25523240|NCT00474994|Sunitinib|sunitinib|mesh-list
25523241|NCT00474994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523242|NCT00474994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25523243|NCT00474994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25523244|NCT00474994|Growth Substances|growth substances|mesh-ancestor
25523245|NCT00474994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523246|NCT00474994|Growth Inhibitors|growth inhibitors|mesh-ancestor
25523247|NCT00474994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25523248|NCT00474994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523249|NCT00474994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523250|NCT00475020|Vidarabine|vidarabine|mesh-list
25523251|NCT00475020|Fludarabine|fludarabine|mesh-list
25523252|NCT00475020|Fludarabine phosphate|fludarabine phosphate|mesh-list
25523253|NCT00475020|Busulfan|busulfan|mesh-list
25523254|NCT00475020|Thymoglobulin|thymoglobulin|mesh-list
25523255|NCT00475020|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25523256|NCT00475020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523257|NCT00475020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25523258|NCT00475020|Antimetabolites|antimetabolites|mesh-ancestor
25523259|NCT00475020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523260|NCT00475020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25523261|NCT00475020|Immunologic Factors|immunologic factors|mesh-ancestor
25523262|NCT00475020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523263|NCT00475020|Antiviral Agents|antiviral agents|mesh-ancestor
25523264|NCT00475020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25523265|NCT00475020|Alkylating Agents|alkylating agents|mesh-ancestor
25523266|NCT00475020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25523267|NCT00475020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25523268|NCT00475033|Vaccines|vaccines|mesh-list
25523269|NCT00475033|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24663637|NCT01302756|Hematinics|hematinics|mesh-ancestor
25646728|NCT01462344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523270|NCT00475033|Immunologic Factors|immunologic factors|mesh-ancestor
25523271|NCT00475033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523272|NCT00475085|Dexamethasone|dexamethasone|mesh-list
25523273|NCT00475085|Aprepitant|aprepitant|mesh-list
25523274|NCT00475085|Palonosetron|palonosetron|mesh-list
25523275|NCT00475085|Granisetron|granisetron|mesh-list
25523276|NCT00475085|Prochlorperazine|prochlorperazine|mesh-list
25523277|NCT00475085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25523278|NCT00475085|Antiemetics|antiemetics|mesh-ancestor
25523279|NCT00475085|Autonomic Agents|autonomic agents|mesh-ancestor
25523280|NCT00475085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25523281|NCT00475085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523282|NCT00475085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25523283|NCT00475085|Glucocorticoids|glucocorticoids|mesh-ancestor
25523284|NCT00475085|Hormones|hormones|mesh-ancestor
25523285|NCT00475085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25523286|NCT00475085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25523287|NCT00475085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523288|NCT00475085|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25523289|NCT00475085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25523290|NCT00475085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523291|NCT00475085|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25523292|NCT00475085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25523293|NCT00475085|Serotonin Agents|serotonin agents|mesh-ancestor
25523294|NCT00475085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25523295|NCT00475085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25523296|NCT00475085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25523297|NCT00475085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25523298|NCT00475085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25523299|NCT00475085|Dopamine Agents|dopamine agents|mesh-ancestor
25523300|NCT00475150|Cediranib|cediranib|mesh-list
25523301|NCT00475150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523302|NCT00475150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523303|NCT00475150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523304|NCT00475150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25523305|NCT00475176|Ribavirin|ribavirin|mesh-list
25523306|NCT00475176|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25523307|NCT00475176|Antimetabolites|antimetabolites|mesh-ancestor
25523308|NCT00475176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523309|NCT00475176|Antiviral Agents|antiviral agents|mesh-ancestor
25523310|NCT00475176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25523311|NCT00475215|Rocuronium|rocuronium|mesh-list
25523312|NCT00475215|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25523313|NCT00475215|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25523314|NCT00475215|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25523315|NCT00475215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25523316|NCT00475215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523317|NCT00475228|Levonorgestrel|levonorgestrel|mesh-list
25523318|NCT00475228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25523319|NCT00475228|Contraceptive Agents|contraceptive agents|mesh-ancestor
25523320|NCT00475228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25523321|NCT00475228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523322|NCT00475228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25523323|NCT00475228|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25523324|NCT00475228|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25523325|NCT00475306|Diphenhydramine|diphenhydramine|mesh-list
25523326|NCT00475306|Promethazine|promethazine|mesh-list
25523327|NCT00475306|Metoclopramide|metoclopramide|mesh-list
25523328|NCT00475306|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25523329|NCT00475306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25523330|NCT00475306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25523331|NCT00475306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523332|NCT00475306|Anesthetics, Local|anesthetics, local|mesh-ancestor
25523333|NCT00475306|Anesthetics|anesthetics|mesh-ancestor
25523334|NCT00475306|Sensory System Agents|sensory system agents|mesh-ancestor
25523335|NCT00475306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25523336|NCT00475306|Antiemetics|antiemetics|mesh-ancestor
25523337|NCT00475306|Autonomic Agents|autonomic agents|mesh-ancestor
25523338|NCT00475306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25523339|NCT00475306|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25523340|NCT00475306|Histamine Antagonists|histamine antagonists|mesh-ancestor
25523341|NCT00475306|Histamine Agents|histamine agents|mesh-ancestor
25523342|NCT00475306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25523343|NCT00475306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523344|NCT00475306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25523346|NCT00475306|Dermatologic Agents|dermatologic agents|mesh-ancestor
25523347|NCT00475306|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25523348|NCT00475306|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25523349|NCT00475306|Dopamine Agents|dopamine agents|mesh-ancestor
25523350|NCT00475319|Rebamipide|rebamipide|mesh-list
25523351|NCT00475319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25523352|NCT00475319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25523353|NCT00475319|Antioxidants|antioxidants|mesh-ancestor
25523354|NCT00475319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523355|NCT00475319|Protective Agents|protective agents|mesh-ancestor
25523356|NCT00475319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523357|NCT00475319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523358|NCT00475423|Rituximab|rituximab|mesh-list
25523359|NCT00475423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25523360|NCT00475423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523361|NCT00475423|Immunologic Factors|immunologic factors|mesh-ancestor
25523362|NCT00475423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523363|NCT00475423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25523364|NCT00475501|Methyltestosterone|methyltestosterone|mesh-list
25523365|NCT00475501|Finasteride|finasteride|mesh-list
25523366|NCT00475501|Testosterone|testosterone|mesh-list
25523367|NCT00475501|Testosterone undecanoate|testosterone undecanoate|mesh-list
25523368|NCT00475501|Testosterone enanthate|testosterone enanthate|mesh-list
25523369|NCT00475501|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25523370|NCT00475501|Androgens|androgens|mesh-ancestor
25523371|NCT00475501|Hormones|hormones|mesh-ancestor
25523372|NCT00475501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25523373|NCT00475501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523374|NCT00475501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25823430|NCT00004826|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25823431|NCT00004826|Serotonin Agents|serotonin agents|mesh-ancestor
25823432|NCT00004826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25823433|NCT00004826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823434|NCT00004826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823435|NCT00004826|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25523375|NCT00475501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523376|NCT00475501|Anabolic Agents|anabolic agents|mesh-ancestor
25523377|NCT00475501|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25523378|NCT00475501|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25523379|NCT00475501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523380|NCT00475501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523381|NCT00475501|Hormone Antagonists|hormone antagonists|mesh-ancestor
25523382|NCT00475501|Urological Agents|urological agents|mesh-ancestor
25523383|NCT00475670|Paclitaxel|paclitaxel|mesh-list
25523384|NCT00475670|Docetaxel|docetaxel|mesh-list
25523385|NCT00475670|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25523386|NCT00475670|Trastuzumab|trastuzumab|mesh-list
25523387|NCT00475670|Taxane|taxane|mesh-list
25523388|NCT00475670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25523389|NCT00475670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523390|NCT00475670|Tubulin Modulators|tubulin modulators|mesh-ancestor
25523391|NCT00475670|Antimitotic Agents|antimitotic agents|mesh-ancestor
25523392|NCT00475670|Mitosis Modulators|mitosis modulators|mesh-ancestor
25523393|NCT00475670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523394|NCT00475670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25523395|NCT00475735|Methylphenidate|methylphenidate|mesh-list
25523396|NCT00475735|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25523397|NCT00475735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523398|NCT00475735|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25523399|NCT00475735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25523400|NCT00475735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25523401|NCT00475735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523402|NCT00475735|Dopamine Agents|dopamine agents|mesh-ancestor
25523403|NCT00475735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25523404|NCT00475852|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25523405|NCT00475852|Natriuretic Agents|natriuretic agents|mesh-ancestor
25523406|NCT00475852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523407|NCT00475865|Teriflunomide|teriflunomide|mesh-list
25523408|NCT00475865|Glatiramer Acetate|glatiramer acetate|mesh-list
25523409|NCT00475865|(T,G)-A-L|(t,g)-a-l|mesh-list
25523410|NCT00475865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25523411|NCT00475865|Immunologic Factors|immunologic factors|mesh-ancestor
25523412|NCT00475865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823436|NCT00004826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25523413|NCT00475865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25523414|NCT00475865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25523415|NCT00475865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25523416|NCT00475865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25523417|NCT00475865|Analgesics|analgesics|mesh-ancestor
25523418|NCT00475865|Sensory System Agents|sensory system agents|mesh-ancestor
25523419|NCT00475865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25523420|NCT00475865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25523421|NCT00475878|Citalopram|citalopram|mesh-list
25523422|NCT00475878|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25523423|NCT00475878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25523424|NCT00475878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25523425|NCT00475878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523426|NCT00475878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25523427|NCT00475878|Serotonin Agents|serotonin agents|mesh-ancestor
25523428|NCT00475878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523429|NCT00475878|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25523430|NCT00475878|Antidepressive Agents|antidepressive agents|mesh-ancestor
25523431|NCT00475878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25523432|NCT00475904|Gabapentin|gabapentin|mesh-list
25523433|NCT00475904|Analgesics|analgesics|mesh-ancestor
25523434|NCT00475904|Sensory System Agents|sensory system agents|mesh-ancestor
25523435|NCT00475904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24991425|NCT05173597|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24991427|NCT05173597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24991428|NCT05173597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991429|NCT05172999|Levonorgestrel|levonorgestrel|mesh-list
24991430|NCT05172999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24991431|NCT05172999|Contraceptive Agents|contraceptive agents|mesh-ancestor
24991432|NCT05172999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24991433|NCT05172999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991434|NCT05172999|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24991435|NCT05172999|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24991436|NCT05172999|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24991437|NCT05170763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25523436|NCT00475904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523437|NCT00475904|Anticonvulsants|anticonvulsants|mesh-ancestor
25523438|NCT00475904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25523439|NCT00475904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25523440|NCT00475904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25523441|NCT00475904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25523442|NCT00475904|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25523443|NCT00475904|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25523444|NCT00475904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25523445|NCT00475904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523446|NCT00475904|Antimanic Agents|antimanic agents|mesh-ancestor
25523447|NCT00476008|Memantine|memantine|mesh-list
25523448|NCT00476008|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25523449|NCT00476008|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25523450|NCT00476008|Dopamine Agents|dopamine agents|mesh-ancestor
25523451|NCT00476008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25523452|NCT00476008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523453|NCT00476008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523454|NCT00476008|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25523455|NCT00476008|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25523456|NCT00476021|Levonorgestrel|levonorgestrel|mesh-list
25523457|NCT00476021|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25523458|NCT00476021|Contraceptive Agents|contraceptive agents|mesh-ancestor
25523459|NCT00476021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25523460|NCT00476021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523461|NCT00476021|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25523462|NCT00476021|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25523463|NCT00476021|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25523464|NCT00476047|Tositumomab I-131|tositumomab i-131|mesh-list
25523465|NCT00476047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523466|NCT00476086|Gemcitabine|gemcitabine|mesh-list
25523467|NCT00476086|Oxaliplatin|oxaliplatin|mesh-list
25523468|NCT00476086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25523469|NCT00476086|Antimetabolites|antimetabolites|mesh-ancestor
25523470|NCT00476086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523471|NCT00476086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523472|NCT00476086|Antiviral Agents|antiviral agents|mesh-ancestor
25523474|NCT00476086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523475|NCT00476086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25523476|NCT00476086|Immunologic Factors|immunologic factors|mesh-ancestor
25523477|NCT00476086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523478|NCT00476151|Ketamine|ketamine|mesh-list
25523479|NCT00476151|Amitriptyline|amitriptyline|mesh-list
25523480|NCT00476151|Analgesics|analgesics|mesh-ancestor
25523481|NCT00476151|Sensory System Agents|sensory system agents|mesh-ancestor
25523482|NCT00476151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25523483|NCT00476151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523484|NCT00476151|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25523485|NCT00476151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25523486|NCT00476151|Anesthetics, General|anesthetics, general|mesh-ancestor
25523487|NCT00476151|Anesthetics|anesthetics|mesh-ancestor
25523488|NCT00476151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25523489|NCT00476151|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25523490|NCT00476151|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25523491|NCT00476151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25523492|NCT00476151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523493|NCT00476151|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25523494|NCT00476151|Antidepressive Agents|antidepressive agents|mesh-ancestor
25523495|NCT00476151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25523496|NCT00476151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25523497|NCT00476151|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25523498|NCT00476151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25523499|NCT00476151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25523500|NCT00476151|Adrenergic Agents|adrenergic agents|mesh-ancestor
25523501|NCT00476229|Rituximab|rituximab|mesh-list
25523502|NCT00476229|Thymoglobulin|thymoglobulin|mesh-list
25523503|NCT00476229|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25523504|NCT00476229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25523505|NCT00476229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523506|NCT00476229|Immunologic Factors|immunologic factors|mesh-ancestor
25523507|NCT00476229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523508|NCT00476229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25523509|NCT00476229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25523510|NCT00476242|Naltrexone|naltrexone|mesh-list
25523511|NCT00476242|Memantine|memantine|mesh-list
25523512|NCT00476242|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25523513|NCT00476242|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25523514|NCT00476242|Dopamine Agents|dopamine agents|mesh-ancestor
25523515|NCT00476242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25523516|NCT00476242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523517|NCT00476242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523518|NCT00476242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25523519|NCT00476242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25523520|NCT00476242|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25523521|NCT00476242|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25523522|NCT00476242|Sensory System Agents|sensory system agents|mesh-ancestor
25523523|NCT00476242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25523524|NCT00476476|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25523525|NCT00476476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523526|NCT00476476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25523527|NCT00476476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523528|NCT00476476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523529|NCT00476593|Dexamethasone|dexamethasone|mesh-list
25523530|NCT00476593|Diclofenac|diclofenac|mesh-list
25523531|NCT00476593|Lactitol|lactitol|mesh-list
25523532|NCT00476593|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25523533|NCT00476593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25523534|NCT00476593|Antiemetics|antiemetics|mesh-ancestor
25523535|NCT00476593|Autonomic Agents|autonomic agents|mesh-ancestor
25523536|NCT00476593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25523537|NCT00476593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523538|NCT00476593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25523539|NCT00476593|Glucocorticoids|glucocorticoids|mesh-ancestor
25523540|NCT00476593|Hormones|hormones|mesh-ancestor
25523541|NCT00476593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25523542|NCT00476593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25523543|NCT00476593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523544|NCT00476593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25523545|NCT00476593|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25523546|NCT00476593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25523547|NCT00476593|Analgesics|analgesics|mesh-ancestor
25523548|NCT00476593|Sensory System Agents|sensory system agents|mesh-ancestor
25523549|NCT00476593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25523550|NCT00476593|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25523551|NCT00476593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523552|NCT00476593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523553|NCT00476593|Cathartics|cathartics|mesh-ancestor
25523554|NCT00476645|Fulvestrant|fulvestrant|mesh-list
25523555|NCT00476645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25523556|NCT00476645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523557|NCT00476645|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25523558|NCT00476645|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25523559|NCT00476645|Hormone Antagonists|hormone antagonists|mesh-ancestor
25523560|NCT00476645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25523561|NCT00476645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523562|NCT00476788|Insulin|insulin|mesh-list
25523563|NCT00476788|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25523564|NCT00476788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25523565|NCT00476788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523566|NCT00476957|Sirolimus|sirolimus|mesh-list
25823437|NCT00004826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25823438|NCT00004826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25823439|NCT00004826|GABA Antagonists|gaba antagonists|mesh-ancestor
24865271|NCT04026191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865272|NCT04026191|Viscosupplements|viscosupplements|mesh-ancestor
24865273|NCT04026191|Protective Agents|protective agents|mesh-ancestor
24865274|NCT04006769|Imatinib Mesylate|imatinib mesylate|mesh-list
24865275|NCT04006769|Entacapone|entacapone|mesh-list
24865276|NCT04006769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865277|NCT04006769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25107515|NCT03139253|Renal Agents|renal agents|mesh-ancestor
25107516|NCT03139253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25107517|NCT03139253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25523567|NCT00476957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25523568|NCT00476957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25523569|NCT00476957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25523570|NCT00476957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523607|NCT00477165|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25523608|NCT00477165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25523609|NCT00477165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25523610|NCT00477165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523611|NCT00477165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25523612|NCT00477165|Serotonin Agents|serotonin agents|mesh-ancestor
25523613|NCT00477165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523614|NCT00477165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25523615|NCT00477165|Antidepressive Agents|antidepressive agents|mesh-ancestor
25523616|NCT00477165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25523617|NCT00477191|Etanercept|etanercept|mesh-list
25523618|NCT00477191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25523619|NCT00477191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25523620|NCT00477191|Analgesics|analgesics|mesh-ancestor
25523621|NCT00477191|Sensory System Agents|sensory system agents|mesh-ancestor
25523622|NCT00477191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25523623|NCT00477191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523624|NCT00477191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25523625|NCT00477191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25523626|NCT00477191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25523627|NCT00477191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25523628|NCT00477191|Immunologic Factors|immunologic factors|mesh-ancestor
25044417|NCT01102660|Naproxen|naproxen|mesh-list
25523629|NCT00477204|Simvastatin|simvastatin|mesh-list
25523630|NCT00477204|Ezetimibe|ezetimibe|mesh-list
25523631|NCT00477204|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
25523632|NCT00477204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25523633|NCT00477204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25523634|NCT00477204|Antimetabolites|antimetabolites|mesh-ancestor
25523635|NCT00477204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523636|NCT00477204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25523637|NCT00477204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25523638|NCT00477204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523639|NCT00477269|Imatinib Mesylate|imatinib mesylate|mesh-list
25523640|NCT00477269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523641|NCT00477269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25523642|NCT00477269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523643|NCT00477269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523646|NCT00477295|Anticonvulsants|anticonvulsants|mesh-ancestor
25523647|NCT00477295|Antimanic Agents|antimanic agents|mesh-ancestor
25523648|NCT00477295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25523649|NCT00477295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25523650|NCT00477295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523651|NCT00477295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25523652|NCT00477295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25523653|NCT00477295|Analgesics|analgesics|mesh-ancestor
25523654|NCT00477295|Sensory System Agents|sensory system agents|mesh-ancestor
25523655|NCT00477295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25523656|NCT00477295|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25523657|NCT00477295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25523658|NCT00477295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523659|NCT00477295|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25523660|NCT00477295|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25523661|NCT00477295|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25523662|NCT00477295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25523663|NCT00477334|Famciclovir|famciclovir|mesh-list
25523664|NCT00477334|Antiviral Agents|antiviral agents|mesh-ancestor
25523665|NCT00477334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25523666|NCT00477334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25523667|NCT00477334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523668|NCT00477334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523669|NCT00477386|Decitabine|decitabine|mesh-list
25823440|NCT00004826|GABA Agents|gaba agents|mesh-ancestor
25823441|NCT00004829|Tobramycin|tobramycin|mesh-list
25142375|NCT02950246|Chlorhexidine|chlorhexidine|mesh-list
25823442|NCT00004829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25823443|NCT00004829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25823444|NCT00004832|Amifampridine|amifampridine|mesh-list
24797382|NCT01955213|Sensory System Agents|sensory system agents|mesh-ancestor
25523670|NCT00477386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25523671|NCT00477386|Antimetabolites|antimetabolites|mesh-ancestor
25523672|NCT00477386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523673|NCT00477386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523674|NCT00477386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523675|NCT00477451|Alprazolam|alprazolam|mesh-list
25523676|NCT00477451|Doxapram|doxapram|mesh-list
25523677|NCT00477451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25523678|NCT00477451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25523679|NCT00477451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523680|NCT00477451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25523681|NCT00477451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25523682|NCT00477451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25523683|NCT00477451|GABA Modulators|gaba modulators|mesh-ancestor
25523684|NCT00477451|GABA Agents|gaba agents|mesh-ancestor
25523685|NCT00477451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25523686|NCT00477451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523687|NCT00477451|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25523688|NCT00477451|Respiratory System Agents|respiratory system agents|mesh-ancestor
25523689|NCT00477464|Capecitabine|capecitabine|mesh-list
25523690|NCT00477464|Lapatinib|lapatinib|mesh-list
25523691|NCT00477464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25523692|NCT00477464|Antimetabolites|antimetabolites|mesh-ancestor
25523693|NCT00477464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523694|NCT00477464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523695|NCT00477464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25523696|NCT00477464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523697|NCT00477490|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25523698|NCT00477490|Hemostatics|hemostatics|mesh-ancestor
25523699|NCT00477490|Coagulants|coagulants|mesh-ancestor
25523700|NCT00477490|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25523701|NCT00477490|Natriuretic Agents|natriuretic agents|mesh-ancestor
25523702|NCT00477490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523703|NCT00477594|Mipomersen|mipomersen|mesh-list
25523704|NCT00477594|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25523705|NCT00477594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25523706|NCT00477594|Antimetabolites|antimetabolites|mesh-ancestor
25523707|NCT00477594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523708|NCT00477594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25523709|NCT00477607|Thioctic Acid|thioctic acid|mesh-list
25523710|NCT00477607|Antioxidants|antioxidants|mesh-ancestor
25823445|NCT00004832|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25646729|NCT01462344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25646730|NCT01462344|Respiratory System Agents|respiratory system agents|mesh-ancestor
25646731|NCT01462344|Glucocorticoids|glucocorticoids|mesh-ancestor
25523711|NCT00477607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523712|NCT00477607|Protective Agents|protective agents|mesh-ancestor
25523713|NCT00477607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523714|NCT00477607|Vitamin B Complex|vitamin b complex|mesh-ancestor
25523715|NCT00477607|Vitamins|vitamins|mesh-ancestor
25523716|NCT00477607|Micronutrients|micronutrients|mesh-ancestor
25523717|NCT00477633|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25523718|NCT00477633|Norethindrone|norethindrone|mesh-list
25523719|NCT00477633|Norethindrone Acetate|norethindrone acetate|mesh-list
25523720|NCT00477633|Estradiol|estradiol|mesh-list
25523721|NCT00477633|Estrogens|estrogens|mesh-ancestor
25523722|NCT00477633|Hormones|hormones|mesh-ancestor
25523723|NCT00477633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25523724|NCT00477633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523725|NCT00477633|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25523726|NCT00477633|Contraceptive Agents|contraceptive agents|mesh-ancestor
25523727|NCT00477633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25523728|NCT00477633|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25523729|NCT00477633|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25523730|NCT00477633|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25523731|NCT00477633|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25523732|NCT00477659|Donepezil|donepezil|mesh-list
25523733|NCT00477659|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25523734|NCT00477659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523735|NCT00477659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523736|NCT00477659|Cholinergic Agents|cholinergic agents|mesh-ancestor
25523737|NCT00477659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25523738|NCT00477659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523739|NCT00477659|Nootropic Agents|nootropic agents|mesh-ancestor
24991727|NCT05041673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24449905|NCT00317408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24449906|NCT00317408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24449907|NCT00317408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449909|NCT00317408|Abortifacient Agents|abortifacient agents|mesh-ancestor
25523740|NCT00477672|Pimavanserin|pimavanserin|mesh-list
25523741|NCT00477672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25523742|NCT00477672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25523743|NCT00477672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25523744|NCT00477672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25523745|NCT00477672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25523746|NCT00477672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523747|NCT00477672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25523748|NCT00477672|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25523749|NCT00477672|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25523750|NCT00477672|Serotonin Agents|serotonin agents|mesh-ancestor
25523751|NCT00477672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25523752|NCT00477672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523754|NCT00477750|Lenalidomide|lenalidomide|mesh-list
25523755|NCT00477750|Melphalan|melphalan|mesh-list
25523756|NCT00477750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25523757|NCT00477750|Glucocorticoids|glucocorticoids|mesh-ancestor
25523758|NCT00477750|Hormones|hormones|mesh-ancestor
25523759|NCT00477750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25523760|NCT00477750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523761|NCT00477750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25523762|NCT00477750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523763|NCT00477750|Immunologic Factors|immunologic factors|mesh-ancestor
25523764|NCT00477750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25523765|NCT00477750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25523766|NCT00477750|Growth Substances|growth substances|mesh-ancestor
25523767|NCT00477750|Growth Inhibitors|growth inhibitors|mesh-ancestor
25523768|NCT00477750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25523769|NCT00477750|Alkylating Agents|alkylating agents|mesh-ancestor
25523770|NCT00477750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523771|NCT00477750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25523772|NCT00477750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25523773|NCT00477971|Dexamethasone|dexamethasone|mesh-list
25523774|NCT00477971|Melphalan|melphalan|mesh-list
25523775|NCT00477971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25523776|NCT00477971|Antiemetics|antiemetics|mesh-ancestor
25646732|NCT01462344|Hormones|hormones|mesh-ancestor
25657200|NCT01584388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523777|NCT00477971|Autonomic Agents|autonomic agents|mesh-ancestor
25523778|NCT00477971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25523779|NCT00477971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523780|NCT00477971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25523781|NCT00477971|Glucocorticoids|glucocorticoids|mesh-ancestor
25523782|NCT00477971|Hormones|hormones|mesh-ancestor
25523783|NCT00477971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25523784|NCT00477971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25523785|NCT00477971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523786|NCT00477971|Immunologic Factors|immunologic factors|mesh-ancestor
25523787|NCT00477971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25523788|NCT00477971|Alkylating Agents|alkylating agents|mesh-ancestor
25523789|NCT00477971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523790|NCT00477971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25523791|NCT00477971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25523792|NCT00478023|Morphine|morphine|mesh-list
25523793|NCT00478023|Tapentadol|tapentadol|mesh-list
25523794|NCT00478023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25523795|NCT00478023|Narcotics|narcotics|mesh-ancestor
25523796|NCT00478023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25523797|NCT00478023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523798|NCT00478023|Analgesics|analgesics|mesh-ancestor
25523799|NCT00478023|Sensory System Agents|sensory system agents|mesh-ancestor
25523800|NCT00478023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25523801|NCT00478023|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25523802|NCT00478023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25523803|NCT00478023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25523804|NCT00478023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523805|NCT00478023|Adrenergic Agents|adrenergic agents|mesh-ancestor
25523806|NCT00478023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25523807|NCT00478036|Prednisolone|prednisolone|mesh-list
25523808|NCT00478036|Prednisolone acetate|prednisolone acetate|mesh-list
25523809|NCT00478036|Ketorolac|ketorolac|mesh-list
25523810|NCT00478036|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25523811|NCT00478036|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25523812|NCT00478036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25523813|NCT00478036|Glucocorticoids|glucocorticoids|mesh-ancestor
25523814|NCT00478036|Hormones|hormones|mesh-ancestor
25523815|NCT00478036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25523816|NCT00478036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523817|NCT00478036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25523818|NCT00478036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523819|NCT00478036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25523820|NCT00478036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25523821|NCT00478036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25523822|NCT00478036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25523823|NCT00478036|Analgesics|analgesics|mesh-ancestor
25523824|NCT00478036|Sensory System Agents|sensory system agents|mesh-ancestor
25523825|NCT00478036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25523826|NCT00478036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25523827|NCT00478036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523828|NCT00478036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523829|NCT00478036|Laxatives|laxatives|mesh-ancestor
25523830|NCT00478140|Trastuzumab|trastuzumab|mesh-list
25523831|NCT00478140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25523832|NCT00478140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523833|NCT00478192|Conivaptan|conivaptan|mesh-list
25523834|NCT00478192|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25523835|NCT00478192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523836|NCT00478192|Natriuretic Agents|natriuretic agents|mesh-ancestor
25523837|NCT00478192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523838|NCT00478205|Donepezil|donepezil|mesh-list
25523839|NCT00478205|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25523840|NCT00478205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523841|NCT00478205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523842|NCT00478205|Cholinergic Agents|cholinergic agents|mesh-ancestor
25523843|NCT00478205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25523844|NCT00478205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523845|NCT00478205|Nootropic Agents|nootropic agents|mesh-ancestor
25523846|NCT00478218|Dexamethasone|dexamethasone|mesh-list
25523847|NCT00478218|Cyclophosphamide|cyclophosphamide|mesh-list
25523848|NCT00478218|Lenalidomide|lenalidomide|mesh-list
25523849|NCT00478218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25523850|NCT00478218|Immunologic Factors|immunologic factors|mesh-ancestor
25646733|NCT01462344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25646734|NCT01462344|Sympathomimetics|sympathomimetics|mesh-ancestor
25646735|NCT01462344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25823446|NCT00004832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25523851|NCT00478218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523852|NCT00478218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25523853|NCT00478218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25523854|NCT00478218|Alkylating Agents|alkylating agents|mesh-ancestor
25523855|NCT00478218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523856|NCT00478218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523857|NCT00478218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25523858|NCT00478218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25523859|NCT00478218|Antiemetics|antiemetics|mesh-ancestor
25523860|NCT00478218|Autonomic Agents|autonomic agents|mesh-ancestor
25523861|NCT00478218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25523862|NCT00478218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25523863|NCT00478218|Glucocorticoids|glucocorticoids|mesh-ancestor
25523864|NCT00478218|Hormones|hormones|mesh-ancestor
25523865|NCT00478218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25523866|NCT00478218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25523867|NCT00478218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25523868|NCT00478218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25523869|NCT00478218|Growth Substances|growth substances|mesh-ancestor
25523870|NCT00478218|Growth Inhibitors|growth inhibitors|mesh-ancestor
25523871|NCT00478231|Maraviroc|maraviroc|mesh-list
25523872|NCT00478231|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25523873|NCT00478231|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25523874|NCT00478231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523875|NCT00478231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25523876|NCT00478231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25523877|NCT00478231|Antiviral Agents|antiviral agents|mesh-ancestor
25523878|NCT00478231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25523879|NCT00478231|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25523880|NCT00478244|Vidarabine|vidarabine|mesh-list
25523881|NCT00478244|Cyclophosphamide|cyclophosphamide|mesh-list
25523882|NCT00478244|Busulfan|busulfan|mesh-list
25523883|NCT00478244|Fludarabine|fludarabine|mesh-list
25523884|NCT00478244|Fludarabine phosphate|fludarabine phosphate|mesh-list
25523885|NCT00478244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25523886|NCT00478244|Immunologic Factors|immunologic factors|mesh-ancestor
25523887|NCT00478244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523888|NCT00478244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25523889|NCT00478244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25523890|NCT00478244|Alkylating Agents|alkylating agents|mesh-ancestor
25523891|NCT00478244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523892|NCT00478244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523893|NCT00478244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25523894|NCT00478244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25523895|NCT00478244|Antimetabolites|antimetabolites|mesh-ancestor
25523896|NCT00478244|Antiviral Agents|antiviral agents|mesh-ancestor
25523897|NCT00478244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25523898|NCT00478335|Calcitonin|calcitonin|mesh-list
25523899|NCT00478335|Salmon calcitonin|salmon calcitonin|mesh-list
25523900|NCT00478335|Indomethacin|indomethacin|mesh-list
25523901|NCT00478335|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25523902|NCT00478335|Amiloride|amiloride|mesh-list
25523903|NCT00478335|Sildenafil Citrate|sildenafil citrate|mesh-list
25523904|NCT00478335|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
25523905|NCT00478335|Katacalcin|katacalcin|mesh-list
25523906|NCT00478335|Vasodilator Agents|vasodilator agents|mesh-ancestor
25523907|NCT00478335|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25523908|NCT00478335|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25523909|NCT00478335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523910|NCT00478335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523911|NCT00478335|Urological Agents|urological agents|mesh-ancestor
25523912|NCT00478335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25523913|NCT00478335|Diuretics|diuretics|mesh-ancestor
25523914|NCT00478335|Natriuretic Agents|natriuretic agents|mesh-ancestor
25523915|NCT00478335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523916|NCT00478335|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25523917|NCT00478335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25523918|NCT00478335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25523919|NCT00478335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25523920|NCT00478335|Analgesics|analgesics|mesh-ancestor
25523921|NCT00478335|Sensory System Agents|sensory system agents|mesh-ancestor
25523922|NCT00478335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25523923|NCT00478335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25523924|NCT00478335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25523925|NCT00478335|Gout Suppressants|gout suppressants|mesh-ancestor
25523926|NCT00478335|Tocolytic Agents|tocolytic agents|mesh-ancestor
25523927|NCT00478335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25523928|NCT00478335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25523929|NCT00478335|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
25523930|NCT00478335|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25523931|NCT00478335|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
25523932|NCT00478335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25523933|NCT00478335|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25523934|NCT00478335|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25523935|NCT00478361|Gemcitabine|gemcitabine|mesh-list
25523936|NCT00478361|Paclitaxel|paclitaxel|mesh-list
25523937|NCT00478361|Doxorubicin|doxorubicin|mesh-list
25523938|NCT00478361|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25523939|NCT00478361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25523940|NCT00478361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523941|NCT00478361|Tubulin Modulators|tubulin modulators|mesh-ancestor
25523942|NCT00478361|Antimitotic Agents|antimitotic agents|mesh-ancestor
25523943|NCT00478361|Mitosis Modulators|mitosis modulators|mesh-ancestor
25523944|NCT00478361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523945|NCT00478361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25523946|NCT00478361|Antimetabolites|antimetabolites|mesh-ancestor
25523947|NCT00478361|Antiviral Agents|antiviral agents|mesh-ancestor
25523948|NCT00478361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25523949|NCT00478361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25523950|NCT00478361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25523951|NCT00478361|Immunologic Factors|immunologic factors|mesh-ancestor
25523952|NCT00478361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523953|NCT00478361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25523954|NCT00478361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25523955|NCT00478361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25523956|NCT00478426|Sunitinib|sunitinib|mesh-list
25523957|NCT00478426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523958|NCT00478426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25523959|NCT00478426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25523960|NCT00478426|Growth Substances|growth substances|mesh-ancestor
25523961|NCT00478426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523962|NCT00478426|Growth Inhibitors|growth inhibitors|mesh-ancestor
25523963|NCT00478426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25523965|NCT00478426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25523966|NCT00478569|Hormones|hormones|mesh-list
25523967|NCT00478569|Parathyroid Hormone|parathyroid hormone|mesh-list
25523968|NCT00478569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25523969|NCT00478569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523970|NCT00478569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25523971|NCT00478608|Sirolimus|sirolimus|mesh-list
25523972|NCT00478608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25523973|NCT00478608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25523974|NCT00478608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25523975|NCT00478608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523976|NCT00478608|Antifungal Agents|antifungal agents|mesh-ancestor
25523977|NCT00478608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25523978|NCT00478608|Immunologic Factors|immunologic factors|mesh-ancestor
25523979|NCT00478608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523980|NCT00478777|Dexamethasone|dexamethasone|mesh-list
25523981|NCT00478777|Lenalidomide|lenalidomide|mesh-list
25523982|NCT00478777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25523983|NCT00478777|Antiemetics|antiemetics|mesh-ancestor
25523984|NCT00478777|Autonomic Agents|autonomic agents|mesh-ancestor
25523985|NCT00478777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25523986|NCT00478777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25523987|NCT00478777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25523988|NCT00478777|Glucocorticoids|glucocorticoids|mesh-ancestor
25523989|NCT00478777|Hormones|hormones|mesh-ancestor
25523990|NCT00478777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25523991|NCT00478777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25523992|NCT00478777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25523993|NCT00478777|Immunologic Factors|immunologic factors|mesh-ancestor
25523994|NCT00478777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25523995|NCT00478777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25523996|NCT00478777|Growth Substances|growth substances|mesh-ancestor
25646737|NCT01462344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25646738|NCT01462435|Celecoxib|celecoxib|mesh-list
25646739|NCT01462435|Diclofenac|diclofenac|mesh-list
25646740|NCT01462435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25646741|NCT01462435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25646742|NCT01462435|Analgesics|analgesics|mesh-ancestor
25646743|NCT01462435|Sensory System Agents|sensory system agents|mesh-ancestor
25646744|NCT01462435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25646745|NCT01462435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646746|NCT01462435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25523997|NCT00478777|Growth Inhibitors|growth inhibitors|mesh-ancestor
25523998|NCT00478881|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
25523999|NCT00478881|Vasodilator Agents|vasodilator agents|mesh-ancestor
25524000|NCT00478881|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25524001|NCT00478881|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25524002|NCT00478881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524003|NCT00478881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524004|NCT00478881|Urological Agents|urological agents|mesh-ancestor
25524005|NCT00479037|Strontium ranelate|strontium ranelate|mesh-list
25524006|NCT00479037|Hormones|hormones|mesh-list
25524007|NCT00479037|Parathyroid Hormone|parathyroid hormone|mesh-list
25524008|NCT00479037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25524009|NCT00479037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524010|NCT00479037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25524011|NCT00479037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25524012|NCT00479089|Dexamethasone|dexamethasone|mesh-list
25524013|NCT00479089|Docetaxel|docetaxel|mesh-list
25524014|NCT00479089|Gefitinib|gefitinib|mesh-list
25524015|NCT00479089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25524016|NCT00479089|Antiemetics|antiemetics|mesh-ancestor
25524017|NCT00479089|Autonomic Agents|autonomic agents|mesh-ancestor
25524018|NCT00479089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25524019|NCT00479089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524020|NCT00479089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25524021|NCT00479089|Glucocorticoids|glucocorticoids|mesh-ancestor
25524022|NCT00479089|Hormones|hormones|mesh-ancestor
25524023|NCT00479089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25524024|NCT00479089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25524025|NCT00479089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524026|NCT00479089|Tubulin Modulators|tubulin modulators|mesh-ancestor
25524027|NCT00479089|Antimitotic Agents|antimitotic agents|mesh-ancestor
25524028|NCT00479089|Mitosis Modulators|mitosis modulators|mesh-ancestor
25524029|NCT00479089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823447|NCT00004832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823448|NCT00004832|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25823449|NCT00004832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24797496|NCT01955759|Sympatholytics|sympatholytics|mesh-ancestor
24797497|NCT01955759|Autonomic Agents|autonomic agents|mesh-ancestor
25524030|NCT00479089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25524031|NCT00479089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524032|NCT00479115|Plerixafor|plerixafor|mesh-list
25524033|NCT00479115|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25524034|NCT00479115|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25524035|NCT00479115|Antiviral Agents|antiviral agents|mesh-ancestor
25524036|NCT00479115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25524037|NCT00479154|Botulinum Toxins|botulinum toxins|mesh-list
25524038|NCT00479154|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25524039|NCT00479154|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25524040|NCT00479154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25524041|NCT00479154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25524042|NCT00479154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524043|NCT00479154|Cholinergic Agents|cholinergic agents|mesh-ancestor
25524044|NCT00479154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25524045|NCT00479154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524046|NCT00479154|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25524047|NCT00479154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25524048|NCT00479232|Decitabine|decitabine|mesh-list
25524049|NCT00479232|Vorinostat|vorinostat|mesh-list
25524050|NCT00479232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25524051|NCT00479232|Antimetabolites|antimetabolites|mesh-ancestor
25524052|NCT00479232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524053|NCT00479232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050032|NCT00544466|Fludarabine|fludarabine|mesh-list
25646747|NCT01462435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25524054|NCT00479232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524055|NCT00479232|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25524056|NCT00479336|Tolvaptan|tolvaptan|mesh-list
25524057|NCT00479336|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25524058|NCT00479336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524059|NCT00479336|Natriuretic Agents|natriuretic agents|mesh-ancestor
25524060|NCT00479336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524062|NCT00479388|Atorvastatin|atorvastatin|mesh-list
25524063|NCT00479388|Simvastatin|simvastatin|mesh-list
25524064|NCT00479388|Calcium|calcium|mesh-list
25524065|NCT00479388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25524066|NCT00479388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524067|NCT00479388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25524068|NCT00479388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25524069|NCT00479388|Antimetabolites|antimetabolites|mesh-ancestor
25524070|NCT00479388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524071|NCT00479388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25524072|NCT00479388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25524073|NCT00479388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524074|NCT00479388|Vasodilator Agents|vasodilator agents|mesh-ancestor
25524075|NCT00479388|Vitamin B Complex|vitamin b complex|mesh-ancestor
25524076|NCT00479388|Vitamins|vitamins|mesh-ancestor
25524077|NCT00479388|Micronutrients|micronutrients|mesh-ancestor
25524078|NCT00479401|Pramipexole|pramipexole|mesh-list
25524079|NCT00479401|Antioxidants|antioxidants|mesh-ancestor
25524080|NCT00479401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524081|NCT00479401|Protective Agents|protective agents|mesh-ancestor
25524082|NCT00479401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524083|NCT00479401|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25524084|NCT00479401|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25524085|NCT00479401|Dopamine Agonists|dopamine agonists|mesh-ancestor
25524086|NCT00479401|Dopamine Agents|dopamine agents|mesh-ancestor
25524087|NCT00479401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25524088|NCT00479466|Metformin|metformin|mesh-list
25524089|NCT00479466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25524090|NCT00479466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524091|NCT00479557|Saponin QA-21V1|saponin qa-21v1|mesh-list
25524092|NCT00479557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25524093|NCT00479557|Immunologic Factors|immunologic factors|mesh-ancestor
25524094|NCT00479557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823450|NCT00004832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823451|NCT00004833|Immunoglobulins|immunoglobulins|mesh-list
24992026|NCT04589351|Antimetabolites|antimetabolites|mesh-ancestor
24992027|NCT04589351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992028|NCT04589351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24992031|NCT04583592|Protease Inhibitors|protease inhibitors|mesh-ancestor
24992032|NCT04583592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24992056|NCT04523961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524095|NCT00479674|Paclitaxel|paclitaxel|mesh-list
25524096|NCT00479674|Bevacizumab|bevacizumab|mesh-list
25524097|NCT00479674|Carboplatin|carboplatin|mesh-list
25524098|NCT00479674|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25524099|NCT00479674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25524100|NCT00479674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524101|NCT00479674|Tubulin Modulators|tubulin modulators|mesh-ancestor
25524102|NCT00479674|Antimitotic Agents|antimitotic agents|mesh-ancestor
25524103|NCT00479674|Mitosis Modulators|mitosis modulators|mesh-ancestor
25524104|NCT00479674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524105|NCT00479674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25524106|NCT00479674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25524107|NCT00479674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25524108|NCT00479674|Growth Substances|growth substances|mesh-ancestor
25524109|NCT00479674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524110|NCT00479674|Growth Inhibitors|growth inhibitors|mesh-ancestor
25524111|NCT00479687|Hyaluronic Acid|hyaluronic acid|mesh-list
25524112|NCT00479687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25524113|NCT00479687|Immunologic Factors|immunologic factors|mesh-ancestor
25524114|NCT00479687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524115|NCT00479687|Viscosupplements|viscosupplements|mesh-ancestor
25524116|NCT00479687|Protective Agents|protective agents|mesh-ancestor
25524117|NCT00479856|Paclitaxel|paclitaxel|mesh-list
25524118|NCT00479856|Docetaxel|docetaxel|mesh-list
25524119|NCT00479856|Capecitabine|capecitabine|mesh-list
25524120|NCT00479856|Lapatinib|lapatinib|mesh-list
25524121|NCT00479856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25524122|NCT00479856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524123|NCT00479856|Tubulin Modulators|tubulin modulators|mesh-ancestor
25524124|NCT00479856|Antimitotic Agents|antimitotic agents|mesh-ancestor
25524125|NCT00479856|Mitosis Modulators|mitosis modulators|mesh-ancestor
25524126|NCT00479856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524127|NCT00479856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25524128|NCT00479856|Antimetabolites|antimetabolites|mesh-ancestor
25524129|NCT00479856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25524130|NCT00479856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524131|NCT00479882|Simvastatin|simvastatin|mesh-list
25524132|NCT00479882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25524133|NCT00479882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25524134|NCT00479882|Antimetabolites|antimetabolites|mesh-ancestor
25524135|NCT00479882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524136|NCT00479882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25524137|NCT00479882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25524138|NCT00479882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524140|NCT00480441|Hallucinogens|hallucinogens|mesh-ancestor
25524141|NCT00480441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524142|NCT00480441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25524143|NCT00480441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25524144|NCT00480441|Analgesics|analgesics|mesh-ancestor
25524145|NCT00480441|Sensory System Agents|sensory system agents|mesh-ancestor
25524146|NCT00480441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25524147|NCT00480441|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25524148|NCT00480441|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25524149|NCT00480441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25524150|NCT00480441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524151|NCT00480441|Hormones|hormones|mesh-ancestor
25524152|NCT00480441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25524153|NCT00480532|Doxycycline|doxycycline|mesh-list
25524154|NCT00480532|Levonorgestrel|levonorgestrel|mesh-list
25524155|NCT00480532|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25524156|NCT00480532|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25524157|NCT00480532|Estradiol|estradiol|mesh-list
25524158|NCT00480532|Estrogens|estrogens|mesh-ancestor
25524159|NCT00480532|Hormones|hormones|mesh-ancestor
25524160|NCT00480532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25524161|NCT00480532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524162|NCT00480532|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25524163|NCT00480532|Contraceptive Agents|contraceptive agents|mesh-ancestor
25524164|NCT00480532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25524165|NCT00480532|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25524166|NCT00480532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25524167|NCT00480532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25524168|NCT00480532|Antimalarials|antimalarials|mesh-ancestor
25524169|NCT00480532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25524170|NCT00480532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25524171|NCT00480532|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25524172|NCT00480532|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25524173|NCT00480532|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25524174|NCT00480532|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25524176|NCT00480636|Tinzaparin|tinzaparin|mesh-list
25524177|NCT00480636|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25524178|NCT00480636|Anticoagulants|anticoagulants|mesh-ancestor
25524179|NCT00480636|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25524180|NCT00480636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25524181|NCT00480636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524182|NCT00480740|Dexmedetomidine|dexmedetomidine|mesh-list
25524183|NCT00480740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25524184|NCT00480740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25524185|NCT00480740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524186|NCT00480740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25524187|NCT00480740|Analgesics|analgesics|mesh-ancestor
25524188|NCT00480740|Sensory System Agents|sensory system agents|mesh-ancestor
25524189|NCT00480740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25524190|NCT00480740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25524191|NCT00480740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25524192|NCT00480740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25524193|NCT00480740|Adrenergic Agents|adrenergic agents|mesh-ancestor
25524194|NCT00480740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25524195|NCT00480740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524196|NCT00480857|Docetaxel|docetaxel|mesh-list
25524197|NCT00480857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524198|NCT00480857|Tubulin Modulators|tubulin modulators|mesh-ancestor
25524199|NCT00480857|Antimitotic Agents|antimitotic agents|mesh-ancestor
25524200|NCT00480857|Mitosis Modulators|mitosis modulators|mesh-ancestor
25524201|NCT00480857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524202|NCT00480987|Vidarabine|vidarabine|mesh-list
25524203|NCT00480987|Cytarabine|cytarabine|mesh-list
25524204|NCT00480987|Oxaliplatin|oxaliplatin|mesh-list
25524205|NCT00480987|Fludarabine|fludarabine|mesh-list
25524206|NCT00480987|Fludarabine phosphate|fludarabine phosphate|mesh-list
25524207|NCT00480987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524208|NCT00480987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25524209|NCT00480987|Antimetabolites|antimetabolites|mesh-ancestor
25524210|NCT00480987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524211|NCT00480987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25524212|NCT00480987|Immunologic Factors|immunologic factors|mesh-ancestor
25524213|NCT00480987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524214|NCT00480987|Antiviral Agents|antiviral agents|mesh-ancestor
25524215|NCT00480987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25524216|NCT00481065|MF59 oil emulsion|mf59 oil emulsion|mesh-list
25524217|NCT00481065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25524218|NCT00481065|Immunologic Factors|immunologic factors|mesh-ancestor
25524219|NCT00481065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524220|NCT00481078|Paclitaxel|paclitaxel|mesh-list
25524221|NCT00481078|Carboplatin|carboplatin|mesh-list
25524222|NCT00481078|Vorinostat|vorinostat|mesh-list
25524223|NCT00481078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25524224|NCT00481078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524225|NCT00481078|Tubulin Modulators|tubulin modulators|mesh-ancestor
25524226|NCT00481078|Antimitotic Agents|antimitotic agents|mesh-ancestor
25524227|NCT00481078|Mitosis Modulators|mitosis modulators|mesh-ancestor
25524228|NCT00481078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524229|NCT00481078|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25524230|NCT00481078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524231|NCT00481195|Modafinil|modafinil|mesh-list
25524232|NCT00481195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25524233|NCT00481195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524234|NCT00481195|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25524235|NCT00481195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25524236|NCT00481195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25524237|NCT00481195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524238|NCT00481247|Imatinib Mesylate|imatinib mesylate|mesh-list
25524239|NCT00481247|Dasatinib|dasatinib|mesh-list
25524240|NCT00481247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524241|NCT00481247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25524242|NCT00481247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524243|NCT00481247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524244|NCT00481351|Simvastatin|simvastatin|mesh-list
25524245|NCT00481351|Ezetimibe|ezetimibe|mesh-list
25524246|NCT00481351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25524248|NCT00481351|Antimetabolites|antimetabolites|mesh-ancestor
25524249|NCT00481351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524250|NCT00481351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25524251|NCT00481351|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25524252|NCT00481351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524253|NCT00481676|Omalizumab|omalizumab|mesh-list
25524254|NCT00481676|Loratadine|loratadine|mesh-list
25524255|NCT00481676|Clemastine|clemastine|mesh-list
25524256|NCT00481676|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25524257|NCT00481676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25524258|NCT00481676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25524259|NCT00481676|Respiratory System Agents|respiratory system agents|mesh-ancestor
25524260|NCT00481676|Immunologic Factors|immunologic factors|mesh-ancestor
25524261|NCT00481676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524262|NCT00481676|Antipruritics|antipruritics|mesh-ancestor
25524263|NCT00481676|Dermatologic Agents|dermatologic agents|mesh-ancestor
25524264|NCT00481676|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25524265|NCT00481676|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25524266|NCT00481676|Histamine Antagonists|histamine antagonists|mesh-ancestor
25524267|NCT00481676|Histamine Agents|histamine agents|mesh-ancestor
25524268|NCT00481676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25524269|NCT00481676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524270|NCT00481767|Vaccines|vaccines|mesh-list
25524271|NCT00481767|Immunologic Factors|immunologic factors|mesh-ancestor
25646748|NCT01462435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25646749|NCT01462435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25646750|NCT01462435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646751|NCT01462435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646752|NCT01462565|Epoprostenol|epoprostenol|mesh-list
25646754|NCT01462565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25646755|NCT01462565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25646756|NCT01462565|Vasodilator Agents|vasodilator agents|mesh-ancestor
25646757|NCT01462695|Sunitinib|sunitinib|mesh-list
25646758|NCT01462695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646759|NCT01462695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25646760|NCT01462695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25646761|NCT01462695|Growth Substances|growth substances|mesh-ancestor
25646762|NCT01462695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646763|NCT01462695|Growth Inhibitors|growth inhibitors|mesh-ancestor
25646764|NCT01462695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25646765|NCT01462695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657201|NCT01584388|Immunologic Factors|immunologic factors|mesh-ancestor
25524272|NCT00481767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524273|NCT00481832|Cyclosporine|cyclosporine|mesh-list
25524274|NCT00481832|Mycophenolic Acid|mycophenolic acid|mesh-list
25524275|NCT00481832|Methylprednisolone|methylprednisolone|mesh-list
25524276|NCT00481832|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25524277|NCT00481832|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25524278|NCT00481832|Prednisolone|prednisolone|mesh-list
25524279|NCT00481832|Prednisolone acetate|prednisolone acetate|mesh-list
25524280|NCT00481832|Cyclophosphamide|cyclophosphamide|mesh-list
25524281|NCT00481832|Carmustine|carmustine|mesh-list
25524282|NCT00481832|Rituximab|rituximab|mesh-list
25524283|NCT00481832|Etoposide|etoposide|mesh-list
25524284|NCT00481832|Cyclosporins|cyclosporins|mesh-list
25524285|NCT00481832|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25524286|NCT00481832|Lenograstim|lenograstim|mesh-list
25524287|NCT00481832|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25524288|NCT00481832|Prednisolone phosphate|prednisolone phosphate|mesh-list
25524289|NCT00481832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25524290|NCT00481832|Immunologic Factors|immunologic factors|mesh-ancestor
25524291|NCT00481832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524292|NCT00481832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25524293|NCT00481832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25524294|NCT00481832|Alkylating Agents|alkylating agents|mesh-ancestor
25524295|NCT00481832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524296|NCT00481832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524297|NCT00481832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25524298|NCT00481832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25524299|NCT00481832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25524300|NCT00481832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25524301|NCT00481832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25524302|NCT00481832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524303|NCT00481832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25524304|NCT00481832|Antifungal Agents|antifungal agents|mesh-ancestor
25524305|NCT00481832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25524306|NCT00481832|Dermatologic Agents|dermatologic agents|mesh-ancestor
25524307|NCT00481832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25524308|NCT00481832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25524309|NCT00481832|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25524310|NCT00481832|Antitubercular Agents|antitubercular agents|mesh-ancestor
25524311|NCT00481832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25524312|NCT00481832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25524313|NCT00481832|Antiemetics|antiemetics|mesh-ancestor
25524314|NCT00481832|Autonomic Agents|autonomic agents|mesh-ancestor
25524315|NCT00481832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25524316|NCT00481832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25524317|NCT00481832|Glucocorticoids|glucocorticoids|mesh-ancestor
25524318|NCT00481832|Hormones|hormones|mesh-ancestor
25524319|NCT00481832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25524320|NCT00481832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25524321|NCT00481832|Protective Agents|protective agents|mesh-ancestor
25823452|NCT00004833|Antibodies|antibodies|mesh-list
25524323|NCT00481845|Anastrozole|anastrozole|mesh-list
25524324|NCT00481845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25524325|NCT00481845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524326|NCT00481845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25524327|NCT00481845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25524328|NCT00481845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524329|NCT00481845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524330|NCT00481845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25524331|NCT00481845|Hormone Antagonists|hormone antagonists|mesh-ancestor
25524332|NCT00481845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25524333|NCT00481845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524334|NCT00481871|Vitamins|vitamins|mesh-list
25524335|NCT00481871|Folic Acid|folic acid|mesh-list
25524336|NCT00481871|Vitamin B 12|vitamin b 12|mesh-list
25524337|NCT00481871|Hydroxocobalamin|hydroxocobalamin|mesh-list
25524338|NCT00481871|Vitamin B Complex|vitamin b complex|mesh-list
25524339|NCT00481871|Gemcitabine|gemcitabine|mesh-list
25524340|NCT00481871|10-deazaaminopterin|10-deazaaminopterin|mesh-list
25524341|NCT00481871|Aminopterin|aminopterin|mesh-list
25524342|NCT00481871|Micronutrients|micronutrients|mesh-ancestor
25524343|NCT00481871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524344|NCT00481871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25524345|NCT00481871|Antimetabolites|antimetabolites|mesh-ancestor
25524346|NCT00481871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524347|NCT00481871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524348|NCT00481871|Antiviral Agents|antiviral agents|mesh-ancestor
25524349|NCT00481871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25524350|NCT00481871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524351|NCT00481871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25524352|NCT00481871|Immunologic Factors|immunologic factors|mesh-ancestor
25524353|NCT00481871|Hematinics|hematinics|mesh-ancestor
25524354|NCT00481871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25524355|NCT00482001|Donepezil|donepezil|mesh-list
25524356|NCT00482001|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25524357|NCT00482001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524358|NCT00482001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524359|NCT00482001|Cholinergic Agents|cholinergic agents|mesh-ancestor
25524360|NCT00482001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25524361|NCT00482001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524362|NCT00482001|Nootropic Agents|nootropic agents|mesh-ancestor
25524363|NCT00482014|Cisplatin|cisplatin|mesh-list
25524364|NCT00482014|Carboplatin|carboplatin|mesh-list
25524365|NCT00482014|Pemetrexed|pemetrexed|mesh-list
25524366|NCT00482014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524367|NCT00482014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524368|NCT00482014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524369|NCT00482014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25524370|NCT00482014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25524371|NCT00482053|Acetaminophen|acetaminophen|mesh-list
25524372|NCT00482053|Diphenhydramine|diphenhydramine|mesh-list
25524373|NCT00482053|Promethazine|promethazine|mesh-list
25524374|NCT00482053|Cyclosporine|cyclosporine|mesh-list
25524375|NCT00482053|Mycophenolic Acid|mycophenolic acid|mesh-list
25524376|NCT00482053|Methylprednisolone|methylprednisolone|mesh-list
25524377|NCT00482053|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25524378|NCT00482053|Hydrocortisone|hydrocortisone|mesh-list
25524379|NCT00482053|Cyclophosphamide|cyclophosphamide|mesh-list
25524380|NCT00482053|Carmustine|carmustine|mesh-list
25524381|NCT00482053|Rituximab|rituximab|mesh-list
25524382|NCT00482053|Etoposide|etoposide|mesh-list
25524383|NCT00482053|Cyclosporins|cyclosporins|mesh-list
25524384|NCT00482053|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25524385|NCT00482053|Lenograstim|lenograstim|mesh-list
25524386|NCT00482053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25524387|NCT00482053|Immunologic Factors|immunologic factors|mesh-ancestor
24450086|NCT00317785|Methotrexate|methotrexate|mesh-list
24450091|NCT00317785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450092|NCT00317785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24450093|NCT00317785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24450094|NCT00317785|Alkylating Agents|alkylating agents|mesh-ancestor
24450095|NCT00317785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450096|NCT00317785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450097|NCT00317785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24450098|NCT00317785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25524388|NCT00482053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524389|NCT00482053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25524390|NCT00482053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25524391|NCT00482053|Alkylating Agents|alkylating agents|mesh-ancestor
25524392|NCT00482053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524393|NCT00482053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524394|NCT00482053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25524395|NCT00482053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25524396|NCT00482053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25524397|NCT00482053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25524398|NCT00482053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25524399|NCT00482053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524400|NCT00482053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25524401|NCT00482053|Antifungal Agents|antifungal agents|mesh-ancestor
25524402|NCT00482053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25524403|NCT00482053|Dermatologic Agents|dermatologic agents|mesh-ancestor
25524404|NCT00482053|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25524405|NCT00482053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25524406|NCT00482053|Analgesics|analgesics|mesh-ancestor
25524407|NCT00482053|Sensory System Agents|sensory system agents|mesh-ancestor
25524408|NCT00482053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25524409|NCT00482053|Antipyretics|antipyretics|mesh-ancestor
25524410|NCT00482053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25524411|NCT00482053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25524412|NCT00482053|Antitubercular Agents|antitubercular agents|mesh-ancestor
25524413|NCT00482053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25524414|NCT00482053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25524415|NCT00482053|Antiemetics|antiemetics|mesh-ancestor
25524416|NCT00482053|Autonomic Agents|autonomic agents|mesh-ancestor
25524417|NCT00482053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25524418|NCT00482053|Glucocorticoids|glucocorticoids|mesh-ancestor
25524419|NCT00482053|Hormones|hormones|mesh-ancestor
25524420|NCT00482053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25524421|NCT00482053|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25524422|NCT00482053|Protective Agents|protective agents|mesh-ancestor
25524423|NCT00482053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25524424|NCT00482053|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25524425|NCT00482053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25524426|NCT00482053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25524427|NCT00482053|Anesthetics, Local|anesthetics, local|mesh-ancestor
25524428|NCT00482053|Anesthetics|anesthetics|mesh-ancestor
25524429|NCT00482053|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25524430|NCT00482053|Histamine Antagonists|histamine antagonists|mesh-ancestor
25524431|NCT00482053|Histamine Agents|histamine agents|mesh-ancestor
25524432|NCT00482053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25524433|NCT00482053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25524434|NCT00482053|Antipruritics|antipruritics|mesh-ancestor
25524435|NCT00482170|Etanercept|etanercept|mesh-list
25524436|NCT00482170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25524437|NCT00482170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25524438|NCT00482170|Analgesics|analgesics|mesh-ancestor
25524439|NCT00482170|Sensory System Agents|sensory system agents|mesh-ancestor
25524440|NCT00482170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25524441|NCT00482170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524442|NCT00482170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25524443|NCT00482170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25524444|NCT00482170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25524445|NCT00482170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25524446|NCT00482170|Immunologic Factors|immunologic factors|mesh-ancestor
25524447|NCT00482274|Docetaxel|docetaxel|mesh-list
25524448|NCT00482274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524449|NCT00482274|Tubulin Modulators|tubulin modulators|mesh-ancestor
25524450|NCT00482274|Antimitotic Agents|antimitotic agents|mesh-ancestor
25524451|NCT00482274|Mitosis Modulators|mitosis modulators|mesh-ancestor
25524452|NCT00482274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524453|NCT00482391|Paclitaxel|paclitaxel|mesh-list
25524454|NCT00482391|Cyclophosphamide|cyclophosphamide|mesh-list
25524455|NCT00482391|Doxorubicin|doxorubicin|mesh-list
25524456|NCT00482391|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24992306|NCT03965130|Glucagon|glucagon|mesh-list
24992307|NCT03965130|Hormones|hormones|mesh-ancestor
24992308|NCT03965130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24992309|NCT03965130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992310|NCT03965130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24866175|NCT03219437|Abortifacient Agents|abortifacient agents|mesh-ancestor
25823453|NCT00004833|gamma-Globulins|gamma-globulins|mesh-list
25524457|NCT00482391|Trastuzumab|trastuzumab|mesh-list
25524458|NCT00482391|Lapatinib|lapatinib|mesh-list
25524459|NCT00482391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25524461|NCT00482391|Tubulin Modulators|tubulin modulators|mesh-ancestor
25524462|NCT00482391|Antimitotic Agents|antimitotic agents|mesh-ancestor
25524463|NCT00482391|Mitosis Modulators|mitosis modulators|mesh-ancestor
25524464|NCT00482391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524465|NCT00482391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25524466|NCT00482391|Immunologic Factors|immunologic factors|mesh-ancestor
25823454|NCT00004833|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25524467|NCT00482391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524468|NCT00482391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25524469|NCT00482391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25524470|NCT00482391|Alkylating Agents|alkylating agents|mesh-ancestor
25524471|NCT00482391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25524472|NCT00482391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25524473|NCT00482391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25646766|NCT01462695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646767|NCT01462773|Interferons|interferons|mesh-list
25646768|NCT01462773|Interferon-alpha|interferon-alpha|mesh-list
25646769|NCT01462773|Interferon alpha-2|interferon alpha-2|mesh-list
25524474|NCT00482391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25524475|NCT00482391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524476|NCT00482391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25524477|NCT00482391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25524478|NCT00482612|Mirtazapine|mirtazapine|mesh-list
25524479|NCT00482612|Antidepressive Agents|antidepressive agents|mesh-ancestor
25524480|NCT00482612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25524481|NCT00482612|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25524482|NCT00482612|Histamine Antagonists|histamine antagonists|mesh-ancestor
25524483|NCT00482612|Histamine Agents|histamine agents|mesh-ancestor
25524484|NCT00482612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25524485|NCT00482612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524486|NCT00482612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524487|NCT00482612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25524488|NCT00482612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25524489|NCT00482612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25524490|NCT00482612|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25524491|NCT00482612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25524492|NCT00482612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25524493|NCT00482612|Adrenergic Agents|adrenergic agents|mesh-ancestor
25524494|NCT00482612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25524495|NCT00482612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25524496|NCT00482612|Serotonin Agents|serotonin agents|mesh-ancestor
25524497|NCT00482612|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25524498|NCT00482625|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25524499|NCT00482625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524500|NCT00482625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25524501|NCT00482625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524502|NCT00482625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524503|NCT00482677|Temozolomide|temozolomide|mesh-list
25524504|NCT00482677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25524505|NCT00482677|Alkylating Agents|alkylating agents|mesh-ancestor
25524506|NCT00482677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524507|NCT00482677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524508|NCT00482703|Dasatinib|dasatinib|mesh-list
25524509|NCT00482703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524510|NCT00482703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25524511|NCT00482703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524512|NCT00482703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524513|NCT00482729|Metformin|metformin|mesh-list
25524514|NCT00482729|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25524515|NCT00482729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25524516|NCT00482729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524517|NCT00482729|Incretins|incretins|mesh-ancestor
25524518|NCT00482729|Hormones|hormones|mesh-ancestor
25524519|NCT00482729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25524520|NCT00482729|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25524521|NCT00482729|Protease Inhibitors|protease inhibitors|mesh-ancestor
25524522|NCT00482729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524523|NCT00482729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524524|NCT00482911|Cyclophosphamide|cyclophosphamide|mesh-list
25524525|NCT00482911|Lenalidomide|lenalidomide|mesh-list
25524526|NCT00482911|Sunitinib|sunitinib|mesh-list
25524527|NCT00482911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25524528|NCT00482911|Immunologic Factors|immunologic factors|mesh-ancestor
25524529|NCT00482911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524530|NCT00482911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25524534|NCT00482911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524535|NCT00482911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25524536|NCT00482911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24666298|NCT01318369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24829880|NCT02155166|Ibuprofen|ibuprofen|mesh-list
25646771|NCT01462773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646772|NCT01462773|Antiviral Agents|antiviral agents|mesh-ancestor
25646773|NCT01462773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25646774|NCT01462773|Immunologic Factors|immunologic factors|mesh-ancestor
25646775|NCT01462773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524537|NCT00482911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25524538|NCT00482911|Growth Substances|growth substances|mesh-ancestor
25524539|NCT00482911|Growth Inhibitors|growth inhibitors|mesh-ancestor
25524540|NCT00482911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25524541|NCT00482911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524542|NCT00483002|Varenicline|varenicline|mesh-list
25646776|NCT01462812|Sumatriptan|sumatriptan|mesh-list
25646777|NCT01462812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25646778|NCT01462812|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25646779|NCT01462812|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25646780|NCT01462812|Serotonin Agents|serotonin agents|mesh-ancestor
25646781|NCT01462812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25646782|NCT01462812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524543|NCT00483002|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25524544|NCT00483002|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25524545|NCT00483002|Cholinergic Agents|cholinergic agents|mesh-ancestor
25524546|NCT00483002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25524547|NCT00483002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524548|NCT00483002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524549|NCT00483223|Cisplatin|cisplatin|mesh-list
25524550|NCT00483223|Carboplatin|carboplatin|mesh-list
25524551|NCT00483223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524552|NCT00483262|Bortezomib|bortezomib|mesh-list
25524553|NCT00483262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524554|NCT00483327|Megestrol|megestrol|mesh-list
25524555|NCT00483327|Megestrol Acetate|megestrol acetate|mesh-list
25524556|NCT00483327|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25524557|NCT00483327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25524558|NCT00483327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25524559|NCT00483327|Contraceptive Agents|contraceptive agents|mesh-ancestor
25524560|NCT00483327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25524561|NCT00483327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524562|NCT00483327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25524563|NCT00483327|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25524564|NCT00483327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25524565|NCT00483327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524566|NCT00483327|Appetite Stimulants|appetite stimulants|mesh-ancestor
25524567|NCT00483327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25524568|NCT00483405|Capecitabine|capecitabine|mesh-list
25524569|NCT00483405|Oxaliplatin|oxaliplatin|mesh-list
25524570|NCT00483405|Cetuximab|cetuximab|mesh-list
25524571|NCT00483405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25524572|NCT00483405|Antimetabolites|antimetabolites|mesh-ancestor
25524573|NCT00483405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524574|NCT00483405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524575|NCT00483405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25524576|NCT00483496|Titanium dioxide|titanium dioxide|mesh-list
25524577|NCT00483496|Sunscreening Agents|sunscreening agents|mesh-ancestor
25524578|NCT00483496|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25524579|NCT00483496|Protective Agents|protective agents|mesh-ancestor
25524580|NCT00483496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524581|NCT00483496|Dermatologic Agents|dermatologic agents|mesh-ancestor
25524582|NCT00483496|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25524583|NCT00483509|Doxorubicin|doxorubicin|mesh-list
25524584|NCT00483509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25524585|NCT00483509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524586|NCT00483509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25524587|NCT00483509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25524588|NCT00483509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524589|NCT00483509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524590|NCT00483548|Ziprasidone|ziprasidone|mesh-list
25524591|NCT00483548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25524592|NCT00483548|Serotonin Agents|serotonin agents|mesh-ancestor
25524593|NCT00483548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25524594|NCT00483548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524595|NCT00483548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666427|NCT01319240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723372|NCT01587196|Sensory System Agents|sensory system agents|mesh-ancestor
25646783|NCT01462812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646785|NCT01462877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25646786|NCT01462877|Antimetabolites|antimetabolites|mesh-ancestor
25646787|NCT01462877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524596|NCT00483548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25524597|NCT00483548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25524598|NCT00483548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25524599|NCT00483548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25524600|NCT00483548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25524601|NCT00483548|Dopamine Agents|dopamine agents|mesh-ancestor
25524602|NCT00483561|Etoposide|etoposide|mesh-list
25524603|NCT00483561|Gefitinib|gefitinib|mesh-list
25524604|NCT00483561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25524605|NCT00483561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524606|NCT00483561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25524607|NCT00483561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25524608|NCT00483561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524609|NCT00483561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524610|NCT00483561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25524611|NCT00483574|Vaccines|vaccines|mesh-list
25524612|NCT00483574|Immunologic Factors|immunologic factors|mesh-ancestor
25524613|NCT00483574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524614|NCT00483652|4-Aminopyridine|4-aminopyridine|mesh-list
25524615|NCT00483652|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25524616|NCT00483652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25524617|NCT00483652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524618|NCT00483717|Ketorolac|ketorolac|mesh-list
25524619|NCT00483717|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25524620|NCT00483717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25524621|NCT00483717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25524622|NCT00483717|Analgesics|analgesics|mesh-ancestor
25524623|NCT00483717|Sensory System Agents|sensory system agents|mesh-ancestor
25524624|NCT00483717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25524625|NCT00483717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524626|NCT00483717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25524627|NCT00483717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25524628|NCT00483717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25524629|NCT00483717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524630|NCT00483717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524631|NCT00483756|Cyclosporine|cyclosporine|mesh-list
25524632|NCT00483756|Cyclosporins|cyclosporins|mesh-list
25524633|NCT00483756|Tofacitinib|tofacitinib|mesh-list
25524634|NCT00483756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524635|NCT00483756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524636|NCT00483756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25524637|NCT00483756|Immunologic Factors|immunologic factors|mesh-ancestor
25524638|NCT00483756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524639|NCT00483756|Antifungal Agents|antifungal agents|mesh-ancestor
25524640|NCT00483756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25524641|NCT00483756|Dermatologic Agents|dermatologic agents|mesh-ancestor
25524642|NCT00483756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25524643|NCT00483756|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25524644|NCT00483756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25524645|NCT00483938|Interferons|interferons|mesh-list
25524646|NCT00483938|Ribavirin|ribavirin|mesh-list
25524647|NCT00483938|Interferon-alpha|interferon-alpha|mesh-list
25524648|NCT00483938|Interferon alpha-2|interferon alpha-2|mesh-list
25524649|NCT00483938|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25524650|NCT00483938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524651|NCT00483938|Antiviral Agents|antiviral agents|mesh-ancestor
25524652|NCT00483938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25524653|NCT00483938|Antimetabolites|antimetabolites|mesh-ancestor
25524654|NCT00483938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524655|NCT00483938|Immunologic Factors|immunologic factors|mesh-ancestor
25524656|NCT00483938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524657|NCT00484094|Sirolimus|sirolimus|mesh-list
25524658|NCT00484094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25524659|NCT00484094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25524660|NCT00484094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25524661|NCT00484094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524662|NCT00484094|Antifungal Agents|antifungal agents|mesh-ancestor
25524663|NCT00484094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25524664|NCT00484094|Immunologic Factors|immunologic factors|mesh-ancestor
25524665|NCT00484094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646788|NCT01462877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25823455|NCT00004833|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25646790|NCT01462929|Tiotropium Bromide|tiotropium bromide|mesh-list
25823456|NCT00004833|Immunologic Factors|immunologic factors|mesh-ancestor
25524666|NCT00484159|Lidocaine|lidocaine|mesh-list
25524667|NCT00484159|Bupivacaine|bupivacaine|mesh-list
25524668|NCT00484159|Anesthetics, Local|anesthetics, local|mesh-ancestor
25524669|NCT00484159|Anesthetics|anesthetics|mesh-ancestor
25524670|NCT00484159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25524671|NCT00484159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992471|NCT03631446|Cathartics|cathartics|mesh-ancestor
24992472|NCT03631446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24992473|NCT03631446|Antacids|antacids|mesh-ancestor
24596212|NCT00942435|Darexaban|darexaban|mesh-list
25524672|NCT00484159|Sensory System Agents|sensory system agents|mesh-ancestor
25524673|NCT00484159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25524674|NCT00484159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25524675|NCT00484159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25524676|NCT00484159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25524677|NCT00484159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25524678|NCT00484159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524679|NCT00484198|Pioglitazone|pioglitazone|mesh-list
25524680|NCT00484198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25524681|NCT00484198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524682|NCT00484289|Abatacept|abatacept|mesh-list
25524683|NCT00484289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25524684|NCT00484289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524685|NCT00484289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524686|NCT00484289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25524687|NCT00484289|Immunologic Factors|immunologic factors|mesh-ancestor
25524688|NCT00484289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524689|NCT00484289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25524690|NCT00484315|Paclitaxel|paclitaxel|mesh-list
25524691|NCT00484315|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25524692|NCT00484315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25524693|NCT00484315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524694|NCT00484315|Tubulin Modulators|tubulin modulators|mesh-ancestor
25524695|NCT00484315|Antimitotic Agents|antimitotic agents|mesh-ancestor
25524696|NCT00484315|Mitosis Modulators|mitosis modulators|mesh-ancestor
25524697|NCT00484315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524698|NCT00484393|Tetracaine|tetracaine|mesh-list
25524699|NCT00484393|Anesthetics, Local|anesthetics, local|mesh-ancestor
25524700|NCT00484393|Anesthetics|anesthetics|mesh-ancestor
25524701|NCT00484393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25524702|NCT00484393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524703|NCT00484393|Sensory System Agents|sensory system agents|mesh-ancestor
25524704|NCT00484393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25524705|NCT00484679|Triamcinolone|triamcinolone|mesh-list
25524706|NCT00484679|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25524707|NCT00484679|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25524708|NCT00484679|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25524709|NCT00484679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25524710|NCT00484679|Glucocorticoids|glucocorticoids|mesh-ancestor
25524711|NCT00484679|Hormones|hormones|mesh-ancestor
25524712|NCT00484679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25524713|NCT00484679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524714|NCT00484679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25524715|NCT00484679|Immunologic Factors|immunologic factors|mesh-ancestor
25524716|NCT00484679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524717|NCT00484679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524718|NCT00484874|Tositumomab I-131|tositumomab i-131|mesh-list
25524719|NCT00484874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524720|NCT00484939|Bevacizumab|bevacizumab|mesh-list
25524721|NCT00484939|Capecitabine|capecitabine|mesh-list
25524722|NCT00484939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25524723|NCT00484939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524724|NCT00484939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25524725|NCT00484939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25524726|NCT00484939|Growth Substances|growth substances|mesh-ancestor
25524727|NCT00484939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524728|NCT00484939|Growth Inhibitors|growth inhibitors|mesh-ancestor
25524729|NCT00484939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24935972|NCT04045678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524730|NCT00484939|Antimetabolites|antimetabolites|mesh-ancestor
25524731|NCT00484939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524732|NCT00485069|Levodopa|levodopa|mesh-list
25646791|NCT01462929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25646792|NCT01462929|Autonomic Agents|autonomic agents|mesh-ancestor
25646793|NCT01462929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25646794|NCT01462929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646795|NCT01462929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25646796|NCT01462929|Respiratory System Agents|respiratory system agents|mesh-ancestor
25646797|NCT01462929|Parasympatholytics|parasympatholytics|mesh-ancestor
25646798|NCT01462929|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25646799|NCT01462929|Cholinergic Agents|cholinergic agents|mesh-ancestor
25646800|NCT01462929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25646801|NCT01462929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524733|NCT00485069|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25524734|NCT00485069|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25524735|NCT00485069|Dopamine Agents|dopamine agents|mesh-ancestor
25524736|NCT00485069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25524737|NCT00485069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524738|NCT00485069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524739|NCT00485134|Vaccines|vaccines|mesh-list
25524740|NCT00485134|Immunologic Factors|immunologic factors|mesh-ancestor
25524741|NCT00485134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524742|NCT00485264|Raltegravir Potassium|raltegravir potassium|mesh-list
25524743|NCT00485264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25524744|NCT00485264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25524745|NCT00485264|Antiviral Agents|antiviral agents|mesh-ancestor
25524746|NCT00485264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25524747|NCT00485264|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25524748|NCT00485264|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25524749|NCT00485264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524750|NCT00485264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524751|NCT00485303|Prednisone|prednisone|mesh-list
25524752|NCT00485303|Abiraterone Acetate|abiraterone acetate|mesh-list
25524753|NCT00485303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25524754|NCT00485303|Glucocorticoids|glucocorticoids|mesh-ancestor
25524755|NCT00485303|Hormones|hormones|mesh-ancestor
25524756|NCT00485303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25524757|NCT00485303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524758|NCT00485303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25524759|NCT00485303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524760|NCT00485303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25524761|NCT00485303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524762|NCT00485303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524763|NCT00485303|Hormone Antagonists|hormone antagonists|mesh-ancestor
25524764|NCT00485303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25524765|NCT00485433|Epinephrine|epinephrine|mesh-list
25524766|NCT00485433|Bupivacaine|bupivacaine|mesh-list
25524767|NCT00485433|Anesthetics, Local|anesthetics, local|mesh-ancestor
25524768|NCT00485433|Anesthetics|anesthetics|mesh-ancestor
25524769|NCT00485433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25524770|NCT00485433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524771|NCT00485433|Sensory System Agents|sensory system agents|mesh-ancestor
25524772|NCT00485433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25524773|NCT00485433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25524774|NCT00485433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25524775|NCT00485433|Adrenergic Agents|adrenergic agents|mesh-ancestor
25524776|NCT00485433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25524777|NCT00485433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524778|NCT00485433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25524779|NCT00485433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25524780|NCT00485433|Autonomic Agents|autonomic agents|mesh-ancestor
25524781|NCT00485433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25524782|NCT00485433|Respiratory System Agents|respiratory system agents|mesh-ancestor
25524783|NCT00485433|Mydriatics|mydriatics|mesh-ancestor
25524784|NCT00485433|Sympathomimetics|sympathomimetics|mesh-ancestor
25524785|NCT00485433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25524786|NCT00485472|Lacosamide|lacosamide|mesh-list
25524787|NCT00485472|Anticonvulsants|anticonvulsants|mesh-ancestor
25524788|NCT00485472|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25524789|NCT00485472|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25524790|NCT00485472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25524791|NCT00485472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524792|NCT00485485|Docetaxel|docetaxel|mesh-list
24667303|NCT05459649|Prednisone|prednisone|mesh-list
25646802|NCT01462929|Anticonvulsants|anticonvulsants|mesh-ancestor
25646803|NCT01462942|Bromides|bromides|mesh-list
25646804|NCT01462942|Formoterol Fumarate|formoterol fumarate|mesh-list
25646805|NCT01462942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25646806|NCT01462942|Autonomic Agents|autonomic agents|mesh-ancestor
25524795|NCT00485485|Tubulin Modulators|tubulin modulators|mesh-ancestor
25524796|NCT00485485|Antimitotic Agents|antimitotic agents|mesh-ancestor
25524797|NCT00485485|Mitosis Modulators|mitosis modulators|mesh-ancestor
25524798|NCT00485485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524799|NCT00485485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25524800|NCT00485485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524801|NCT00485589|Methotrexate|methotrexate|mesh-list
25524802|NCT00485589|Ocrelizumab|ocrelizumab|mesh-list
25524803|NCT00485589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25524804|NCT00485589|Abortifacient Agents|abortifacient agents|mesh-ancestor
25524805|NCT00485589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25524806|NCT00485589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524807|NCT00485589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25524808|NCT00485589|Antimetabolites|antimetabolites|mesh-ancestor
25524809|NCT00485589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524810|NCT00485589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524811|NCT00485589|Dermatologic Agents|dermatologic agents|mesh-ancestor
25524812|NCT00485589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524813|NCT00485589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25524814|NCT00485589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25823458|NCT00004834|Imipramine|imipramine|mesh-list
25823459|NCT00004834|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25823460|NCT00004834|Antidepressive Agents|antidepressive agents|mesh-ancestor
25823461|NCT00004834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25823462|NCT00004834|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25823463|NCT00004834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25143556|NCT02941562|Leucovorin|leucovorin|mesh-list
25524815|NCT00485589|Immunologic Factors|immunologic factors|mesh-ancestor
25524816|NCT00485589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25524817|NCT00485589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25524818|NCT00485732|Vaccines|vaccines|mesh-list
25524819|NCT00485732|Immunologic Factors|immunologic factors|mesh-ancestor
25524820|NCT00485732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524821|NCT00485758|Niacin|niacin|mesh-list
25524822|NCT00485758|Niacinamide|niacinamide|mesh-list
25524823|NCT00485758|Nicotinic Acids|nicotinic acids|mesh-list
25524824|NCT00485758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25524825|NCT00485758|Antimetabolites|antimetabolites|mesh-ancestor
25524826|NCT00485758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524827|NCT00485758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25524828|NCT00485758|Vasodilator Agents|vasodilator agents|mesh-ancestor
25524829|NCT00485758|Vitamin B Complex|vitamin b complex|mesh-ancestor
25524830|NCT00485758|Vitamins|vitamins|mesh-ancestor
25524831|NCT00485758|Micronutrients|micronutrients|mesh-ancestor
25524832|NCT00485758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524833|NCT00485836|Ranibizumab|ranibizumab|mesh-list
25524834|NCT00485836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25524835|NCT00485836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25524836|NCT00485836|Growth Substances|growth substances|mesh-ancestor
25524837|NCT00485836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524838|NCT00485836|Growth Inhibitors|growth inhibitors|mesh-ancestor
25524839|NCT00485836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524840|NCT00485953|Risedronic Acid|risedronic acid|mesh-list
25524841|NCT00485953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25524842|NCT00485953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25524843|NCT00485953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524844|NCT00485953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25524845|NCT00485953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524846|NCT00485953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25524847|NCT00486018|Ranibizumab|ranibizumab|mesh-list
25524848|NCT00486018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25524849|NCT00486018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24667672|NCT05343572|Plerixafor|plerixafor|mesh-list
25646807|NCT01462942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24952508|NCT03893864|Vitamins|vitamins|mesh-ancestor
25524850|NCT00486018|Growth Substances|growth substances|mesh-ancestor
25524851|NCT00486018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524852|NCT00486018|Growth Inhibitors|growth inhibitors|mesh-ancestor
25646808|NCT01462942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524853|NCT00486018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524854|NCT00486031|Balsalazide|balsalazide|mesh-list
25524855|NCT00486031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25524856|NCT00486031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25524857|NCT00486031|Analgesics|analgesics|mesh-ancestor
25524858|NCT00486031|Sensory System Agents|sensory system agents|mesh-ancestor
25524859|NCT00486031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25524860|NCT00486031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524861|NCT00486031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25524862|NCT00486031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25524863|NCT00486031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25524864|NCT00486044|Simvastatin|simvastatin|mesh-list
25524865|NCT00486044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25524866|NCT00486044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25646809|NCT01462942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25646810|NCT01462942|Respiratory System Agents|respiratory system agents|mesh-ancestor
25646811|NCT01462942|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25646812|NCT01462942|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25646813|NCT01462942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25646814|NCT01462942|Adrenergic Agents|adrenergic agents|mesh-ancestor
25646815|NCT01462942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25646816|NCT01462942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524867|NCT00486044|Antimetabolites|antimetabolites|mesh-ancestor
25524868|NCT00486044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524869|NCT00486044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25524870|NCT00486044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25524871|NCT00486044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524872|NCT00486330|Ritonavir|ritonavir|mesh-list
25524873|NCT00486330|Tipranavir|tipranavir|mesh-list
25524874|NCT00486330|Buprenorphine|buprenorphine|mesh-list
25524875|NCT00486330|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25524876|NCT00486330|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25524877|NCT00486330|Protease Inhibitors|protease inhibitors|mesh-ancestor
25524878|NCT00486330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524879|NCT00486330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524880|NCT00486330|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25524881|NCT00486330|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25524882|NCT00486330|Antiviral Agents|antiviral agents|mesh-ancestor
25107683|NCT03138031|Ethanol|ethanol|mesh-list
25107684|NCT03138031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25107685|NCT03138031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25107686|NCT03138031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25524883|NCT00486330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25524884|NCT00486330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25524885|NCT00486330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25524886|NCT00486330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25524887|NCT00486330|Narcotics|narcotics|mesh-ancestor
25524888|NCT00486330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25524889|NCT00486330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524890|NCT00486330|Analgesics|analgesics|mesh-ancestor
25524891|NCT00486330|Sensory System Agents|sensory system agents|mesh-ancestor
25524892|NCT00486330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25524893|NCT00486330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25524894|NCT00486434|Calcitonin|calcitonin|mesh-list
25524895|NCT00486434|Salmon calcitonin|salmon calcitonin|mesh-list
25524896|NCT00486434|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
25524897|NCT00486434|Katacalcin|katacalcin|mesh-list
25524898|NCT00486434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25524899|NCT00486434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524900|NCT00486434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25524901|NCT00486434|Vasodilator Agents|vasodilator agents|mesh-ancestor
25524902|NCT00486603|Hydroxychloroquine|hydroxychloroquine|mesh-list
25524903|NCT00486603|Temozolomide|temozolomide|mesh-list
25524904|NCT00486603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25524905|NCT00486603|Alkylating Agents|alkylating agents|mesh-ancestor
25524906|NCT00486603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524907|NCT00486603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524908|NCT00486603|Antimalarials|antimalarials|mesh-ancestor
25524909|NCT00486603|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25524910|NCT00486603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25646817|NCT01462942|Anticonvulsants|anticonvulsants|mesh-ancestor
25646818|NCT01463033|Levetiracetam|levetiracetam|mesh-list
25646819|NCT01463033|Anticonvulsants|anticonvulsants|mesh-ancestor
25646820|NCT01463033|Nootropic Agents|nootropic agents|mesh-ancestor
25646821|NCT01463098|Zolpidem|zolpidem|mesh-list
25646822|NCT01463098|Lemborexant|lemborexant|mesh-list
25646823|NCT01463098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25646824|NCT01463098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25646825|NCT01463098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25646826|NCT01463098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524911|NCT00486603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25524912|NCT00486603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524913|NCT00486603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25524914|NCT00486642|Bicalutamide|bicalutamide|mesh-list
25524915|NCT00486642|Androgen Antagonists|androgen antagonists|mesh-ancestor
25524916|NCT00486642|Hormone Antagonists|hormone antagonists|mesh-ancestor
25524917|NCT00486642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25524918|NCT00486642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524919|NCT00486642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524920|NCT00486720|Vorinostat|vorinostat|mesh-list
25524921|NCT00486720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524922|NCT00486720|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25524923|NCT00486720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524924|NCT00486720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524925|NCT00486759|Bevacizumab|bevacizumab|mesh-list
25524926|NCT00486759|Rituximab|rituximab|mesh-list
25524927|NCT00486759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25524928|NCT00486759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25524929|NCT00486759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25524930|NCT00486759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25524931|NCT00486759|Growth Substances|growth substances|mesh-ancestor
25524932|NCT00486759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524933|NCT00486759|Growth Inhibitors|growth inhibitors|mesh-ancestor
25524934|NCT00486759|Immunologic Factors|immunologic factors|mesh-ancestor
25524935|NCT00486759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25524936|NCT00486811|Oxycodone|oxycodone|mesh-list
25524937|NCT00486811|Tapentadol|tapentadol|mesh-list
25524938|NCT00486811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25524939|NCT00486811|Narcotics|narcotics|mesh-ancestor
25524940|NCT00486811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25524941|NCT00486811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524942|NCT00486811|Analgesics|analgesics|mesh-ancestor
25524943|NCT00486811|Sensory System Agents|sensory system agents|mesh-ancestor
25524944|NCT00486811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25524945|NCT00486811|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25524946|NCT00486811|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25524947|NCT00486811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25524948|NCT00486811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524949|NCT00486811|Adrenergic Agents|adrenergic agents|mesh-ancestor
25524950|NCT00486811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25524951|NCT00486824|Indomethacin|indomethacin|mesh-list
25524952|NCT00486824|Nifedipine|nifedipine|mesh-list
25524953|NCT00486824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25524954|NCT00486824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25524955|NCT00486824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524956|NCT00486824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25524957|NCT00486824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524958|NCT00486824|Vasodilator Agents|vasodilator agents|mesh-ancestor
25524959|NCT00486824|Tocolytic Agents|tocolytic agents|mesh-ancestor
25524960|NCT00486824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25524961|NCT00486824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25524962|NCT00486824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25524963|NCT00486824|Analgesics|analgesics|mesh-ancestor
25524964|NCT00486824|Sensory System Agents|sensory system agents|mesh-ancestor
25524965|NCT00486824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25524966|NCT00486824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25524967|NCT00486824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25524968|NCT00486824|Gout Suppressants|gout suppressants|mesh-ancestor
25524969|NCT00486824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25524970|NCT00486824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25524971|NCT00486837|Protease Inhibitors|protease inhibitors|mesh-list
25524972|NCT00486837|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25524973|NCT00486837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823464|NCT00004834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25646827|NCT01463098|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25524974|NCT00486837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524975|NCT00486837|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25524976|NCT00486837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25524977|NCT00486863|Praziquantel|praziquantel|mesh-list
25524978|NCT00486863|Anthelmintics|anthelmintics|mesh-ancestor
25524979|NCT00486863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25524980|NCT00486863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25524982|NCT00486902|N-Methylaspartate|n-methylaspartate|mesh-list
25524983|NCT00486902|Analgesics|analgesics|mesh-ancestor
25524984|NCT00486902|Sensory System Agents|sensory system agents|mesh-ancestor
25524985|NCT00486902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25524986|NCT00486902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25524987|NCT00486902|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25524988|NCT00486902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25524989|NCT00486902|Anesthetics, General|anesthetics, general|mesh-ancestor
25524990|NCT00486902|Anesthetics|anesthetics|mesh-ancestor
25524991|NCT00486902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25524992|NCT00486902|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25524993|NCT00486902|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25524994|NCT00486902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25524995|NCT00486902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25524996|NCT00486902|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
25524997|NCT00486954|Paclitaxel|paclitaxel|mesh-list
25524998|NCT00486954|Lapatinib|lapatinib|mesh-list
25524999|NCT00486954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25525000|NCT00486954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525001|NCT00486954|Tubulin Modulators|tubulin modulators|mesh-ancestor
25525002|NCT00486954|Antimitotic Agents|antimitotic agents|mesh-ancestor
25525003|NCT00486954|Mitosis Modulators|mitosis modulators|mesh-ancestor
25525004|NCT00486954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525005|NCT00486954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25525006|NCT00486954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525007|NCT00487084|Lidocaine|lidocaine|mesh-list
25525008|NCT00487084|Morphine|morphine|mesh-list
25525009|NCT00487084|Anesthetics, Local|anesthetics, local|mesh-ancestor
25525010|NCT00487084|Anesthetics|anesthetics|mesh-ancestor
25525011|NCT00487084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25525012|NCT00487084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525013|NCT00487084|Sensory System Agents|sensory system agents|mesh-ancestor
25525014|NCT00487084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25525015|NCT00487084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25525016|NCT00487084|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25525017|NCT00487084|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25525018|NCT00487084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25525019|NCT00487084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525020|NCT00487084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25525021|NCT00487084|Narcotics|narcotics|mesh-ancestor
25525022|NCT00487084|Analgesics|analgesics|mesh-ancestor
25525023|NCT00487188|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25525024|NCT00487188|Enfuvirtide|enfuvirtide|mesh-list
25525025|NCT00487188|Antiviral Agents|antiviral agents|mesh-ancestor
25525026|NCT00487188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25525027|NCT00487188|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25525028|NCT00487188|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25525029|NCT00487188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525030|NCT00487188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25525031|NCT00487240|Insulin|insulin|mesh-list
25525032|NCT00487240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25525033|NCT00487240|Insulin Lispro|insulin lispro|mesh-list
24992874|NCT02650271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24992875|NCT02650271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525034|NCT00487240|Insulin Detemir|insulin detemir|mesh-list
25525035|NCT00487240|Protamines|protamines|mesh-list
25525036|NCT00487240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25525037|NCT00487240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525038|NCT00487240|Heparin Antagonists|heparin antagonists|mesh-ancestor
25525039|NCT00487240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525040|NCT00487240|Coagulants|coagulants|mesh-ancestor
25525041|NCT00487435|Tapentadol|tapentadol|mesh-list
25525042|NCT00487435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25525043|NCT00487435|Narcotics|narcotics|mesh-ancestor
25525044|NCT00487435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25525045|NCT00487435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525046|NCT00487435|Analgesics|analgesics|mesh-ancestor
25525047|NCT00487435|Sensory System Agents|sensory system agents|mesh-ancestor
25646828|NCT01463098|GABA Agonists|gaba agonists|mesh-ancestor
25525048|NCT00487435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25525049|NCT00487435|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25525050|NCT00487435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25525051|NCT00487435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25525052|NCT00487435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525053|NCT00487435|Adrenergic Agents|adrenergic agents|mesh-ancestor
25525054|NCT00487435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25525055|NCT00487539|Golimumab|golimumab|mesh-list
25525056|NCT00487539|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25525057|NCT00487539|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25525058|NCT00487539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25525059|NCT00487539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25525060|NCT00487539|Immunologic Factors|immunologic factors|mesh-ancestor
25525061|NCT00487539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525062|NCT00487669|Paclitaxel|paclitaxel|mesh-list
25525063|NCT00487669|Pemetrexed|pemetrexed|mesh-list
25525064|NCT00487669|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
25525065|NCT00487669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25525066|NCT00487669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525067|NCT00487669|Tubulin Modulators|tubulin modulators|mesh-ancestor
25525068|NCT00487669|Antimitotic Agents|antimitotic agents|mesh-ancestor
25525069|NCT00487669|Mitosis Modulators|mitosis modulators|mesh-ancestor
25525070|NCT00487669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525071|NCT00487669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525072|NCT00487669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25525073|NCT00487669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25525074|NCT00487721|Silymarin|silymarin|mesh-list
25525075|NCT00487721|Antioxidants|antioxidants|mesh-ancestor
25525076|NCT00487721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525077|NCT00487721|Protective Agents|protective agents|mesh-ancestor
25525078|NCT00487721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525079|NCT00487747|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25525080|NCT00487747|Antiviral Agents|antiviral agents|mesh-ancestor
25525081|NCT00487747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25525082|NCT00487825|Methotrexate|methotrexate|mesh-list
25525083|NCT00487825|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25525084|NCT00487825|Abortifacient Agents|abortifacient agents|mesh-ancestor
25525085|NCT00487825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25525086|NCT00487825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525087|NCT00487825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25525088|NCT00487825|Antimetabolites|antimetabolites|mesh-ancestor
25525089|NCT00487825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525090|NCT00487825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525091|NCT00487825|Dermatologic Agents|dermatologic agents|mesh-ancestor
25525092|NCT00487825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525093|NCT00487825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25525094|NCT00487825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25525095|NCT00487825|Immunologic Factors|immunologic factors|mesh-ancestor
25525096|NCT00487825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25525097|NCT00487825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25525098|NCT00487942|Modafinil|modafinil|mesh-list
25525099|NCT00487942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25525100|NCT00487942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525101|NCT00487942|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25525102|NCT00487942|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25525103|NCT00487942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25525104|NCT00487942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525105|NCT00488059|Enfuvirtide|enfuvirtide|mesh-list
25525106|NCT00488059|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
25525107|NCT00488059|Integrase Inhibitors|integrase inhibitors|mesh-list
25525108|NCT00488059|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25525109|NCT00488059|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25525110|NCT00488059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525111|NCT00488059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25525112|NCT00488059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25525113|NCT00488059|Antiviral Agents|antiviral agents|mesh-ancestor
25525114|NCT00488059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25525115|NCT00488059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525116|NCT00488319|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25525117|NCT00488319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25525118|NCT00488319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25525119|NCT00488319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25525120|NCT00488319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525121|NCT00488319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25525122|NCT00488319|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25525123|NCT00488319|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25525124|NCT00488319|Serotonin Agents|serotonin agents|mesh-ancestor
25525125|NCT00488319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25525126|NCT00488319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525127|NCT00488319|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25525128|NCT00488319|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25525129|NCT00488319|Dopamine Agents|dopamine agents|mesh-ancestor
25525130|NCT00488345|Tigecycline|tigecycline|mesh-list
25525131|NCT00488345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25525132|NCT00488345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25525133|NCT00488345|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25525134|NCT00488345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525135|NCT00488345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525137|NCT00488475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25525138|NCT00488475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25525139|NCT00488475|Analgesics|analgesics|mesh-ancestor
25525140|NCT00488475|Sensory System Agents|sensory system agents|mesh-ancestor
25525141|NCT00488475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25525142|NCT00488475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525143|NCT00488475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25525144|NCT00488475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25525145|NCT00488475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25525146|NCT00488475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25525147|NCT00488475|Immunologic Factors|immunologic factors|mesh-ancestor
25525148|NCT00488488|Tigecycline|tigecycline|mesh-list
25525149|NCT00488488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25525150|NCT00488488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25525151|NCT00488488|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25525152|NCT00488488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525153|NCT00488488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525154|NCT00488514|Naproxen|naproxen|mesh-list
25525155|NCT00488514|Sumatriptan|sumatriptan|mesh-list
25525156|NCT00488514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25525157|NCT00488514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25525158|NCT00488514|Analgesics|analgesics|mesh-ancestor
25525159|NCT00488514|Sensory System Agents|sensory system agents|mesh-ancestor
25525160|NCT00488514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25525161|NCT00488514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525162|NCT00488514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25525163|NCT00488514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25525164|NCT00488514|Gout Suppressants|gout suppressants|mesh-ancestor
25525165|NCT00488514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25525166|NCT00488514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525167|NCT00488514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525168|NCT00488514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25525169|NCT00488514|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25525170|NCT00488514|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25525171|NCT00488514|Serotonin Agents|serotonin agents|mesh-ancestor
25525172|NCT00488514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25525173|NCT00488592|Molgramostim|molgramostim|mesh-list
25525174|NCT00488592|Sargramostim|sargramostim|mesh-list
25525175|NCT00488592|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25525176|NCT00488592|Immunologic Factors|immunologic factors|mesh-ancestor
24993099|NCT00938912|Anticonvulsants|anticonvulsants|mesh-ancestor
25143820|NCT02940379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993100|NCT00938912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24993101|NCT00938912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24993104|NCT00925652|Cyclophosphamide|cyclophosphamide|mesh-list
25525177|NCT00488592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525178|NCT00488592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525179|NCT00488592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25525180|NCT00488618|Cariprazine|cariprazine|mesh-list
25525181|NCT00488618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25525182|NCT00488618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25525183|NCT00488618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25525184|NCT00488618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525185|NCT00488618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25525186|NCT00488631|Golimumab|golimumab|mesh-list
25525187|NCT00488631|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25525188|NCT00488631|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25525189|NCT00488631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25646830|NCT01463098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25525190|NCT00488631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25525191|NCT00488631|Immunologic Factors|immunologic factors|mesh-ancestor
25525192|NCT00488631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525193|NCT00488683|Vaccines|vaccines|mesh-list
25525194|NCT00488683|Immunologic Factors|immunologic factors|mesh-ancestor
25525195|NCT00488683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525196|NCT00488774|Golimumab|golimumab|mesh-list
25525197|NCT00488774|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25525198|NCT00488774|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25525199|NCT00488774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25525200|NCT00488774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25525201|NCT00488774|Immunologic Factors|immunologic factors|mesh-ancestor
25525202|NCT00488774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525203|NCT00488826|Vaccines|vaccines|mesh-list
25525204|NCT00488826|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25525205|NCT00488826|Immunologic Factors|immunologic factors|mesh-ancestor
25525206|NCT00488826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525207|NCT00488982|Docetaxel|docetaxel|mesh-list
25525208|NCT00488982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525209|NCT00488982|Tubulin Modulators|tubulin modulators|mesh-ancestor
25525210|NCT00488982|Antimitotic Agents|antimitotic agents|mesh-ancestor
25525211|NCT00488982|Mitosis Modulators|mitosis modulators|mesh-ancestor
25525212|NCT00488982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525213|NCT00489086|Tazarotene|tazarotene|mesh-list
25525214|NCT00489086|Dermatologic Agents|dermatologic agents|mesh-ancestor
25525215|NCT00489086|Keratolytic Agents|keratolytic agents|mesh-ancestor
25525216|NCT00489281|Mycophenolic Acid|mycophenolic acid|mesh-list
25525217|NCT00489281|Sirolimus|sirolimus|mesh-list
25525218|NCT00489281|Cyclophosphamide|cyclophosphamide|mesh-list
25525219|NCT00489281|Fludarabine|fludarabine|mesh-list
25525220|NCT00489281|Levetiracetam|levetiracetam|mesh-list
25525221|NCT00489281|Thymoglobulin|thymoglobulin|mesh-list
25525222|NCT00489281|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25525223|NCT00489281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25525224|NCT00489281|Immunologic Factors|immunologic factors|mesh-ancestor
25525225|NCT00489281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525226|NCT00489281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25525227|NCT00489281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25525228|NCT00489281|Alkylating Agents|alkylating agents|mesh-ancestor
25525229|NCT00489281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525230|NCT00489281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525231|NCT00489281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25525232|NCT00489281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25525233|NCT00489281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25525234|NCT00489281|Antitubercular Agents|antitubercular agents|mesh-ancestor
25525235|NCT00489281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25525236|NCT00489281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25525237|NCT00489281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525238|NCT00489281|Antifungal Agents|antifungal agents|mesh-ancestor
25525239|NCT00489281|Anticonvulsants|anticonvulsants|mesh-ancestor
25525240|NCT00489281|Nootropic Agents|nootropic agents|mesh-ancestor
25525241|NCT00489359|Carboplatin|carboplatin|mesh-list
25525242|NCT00489359|Pemetrexed|pemetrexed|mesh-list
25525243|NCT00489359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525244|NCT00489359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525245|NCT00489359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993129|NCT00925652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24993138|NCT00604617|Interferons|interferons|mesh-list
24993139|NCT00604617|Interferon-gamma|interferon-gamma|mesh-list
24993140|NCT00604617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993141|NCT00604617|Antiviral Agents|antiviral agents|mesh-ancestor
24993142|NCT00604617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24993143|NCT00579826|Letrozole|letrozole|mesh-list
24993144|NCT00579826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797711|NCT01957436|Hormones|hormones|mesh-ancestor
25525246|NCT00489359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25525247|NCT00489359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25525248|NCT00489411|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25525249|NCT00489411|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25525250|NCT00489411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25525251|NCT00489411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25525252|NCT00489411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525253|NCT00489411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25525254|NCT00489411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525257|NCT00489411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25525258|NCT00489411|Antidepressive Agents|antidepressive agents|mesh-ancestor
25525259|NCT00489411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25525260|NCT00489411|Dopamine Agents|dopamine agents|mesh-ancestor
25525261|NCT00489424|Acetaminophen|acetaminophen|mesh-list
25525262|NCT00489424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25525263|NCT00489424|Analgesics|analgesics|mesh-ancestor
25525264|NCT00489424|Sensory System Agents|sensory system agents|mesh-ancestor
25525265|NCT00489424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25525266|NCT00489424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525267|NCT00489424|Antipyretics|antipyretics|mesh-ancestor
25525268|NCT00489476|Loxapine|loxapine|mesh-list
25525269|NCT00489476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25525270|NCT00489476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25525271|NCT00489476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25525272|NCT00489476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525273|NCT00489476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25525274|NCT00489476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25525275|NCT00489476|Dopamine Agents|dopamine agents|mesh-ancestor
25525276|NCT00489476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25525277|NCT00489476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525278|NCT00489489|Interferons|interferons|mesh-list
25525279|NCT00489489|Interferon-beta|interferon-beta|mesh-list
25525280|NCT00489489|Teriflunomide|teriflunomide|mesh-list
25525281|NCT00489489|Interferon beta-1b|interferon beta-1b|mesh-list
25525282|NCT00489489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525283|NCT00489489|Antiviral Agents|antiviral agents|mesh-ancestor
25525284|NCT00489489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25525285|NCT00489489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25525286|NCT00489489|Immunologic Factors|immunologic factors|mesh-ancestor
25525287|NCT00489489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525288|NCT00489489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25525289|NCT00489489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25525290|NCT00489489|Analgesics|analgesics|mesh-ancestor
25525291|NCT00489489|Sensory System Agents|sensory system agents|mesh-ancestor
25525292|NCT00489489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25525293|NCT00489489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25525294|NCT00489489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25525295|NCT00489489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25525296|NCT00489541|Paclitaxel|paclitaxel|mesh-list
25525297|NCT00489541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25525298|NCT00489541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525299|NCT00489541|Tubulin Modulators|tubulin modulators|mesh-ancestor
25525300|NCT00489541|Antimitotic Agents|antimitotic agents|mesh-ancestor
25525301|NCT00489541|Mitosis Modulators|mitosis modulators|mesh-ancestor
25525302|NCT00489541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525303|NCT00489554|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25525304|NCT00489554|Immunologic Factors|immunologic factors|mesh-ancestor
25525305|NCT00489554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525306|NCT00489736|Amiodarone|amiodarone|mesh-list
25525307|NCT00489736|Dronedarone|dronedarone|mesh-list
25525308|NCT00489736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25525309|NCT00489736|Vasodilator Agents|vasodilator agents|mesh-ancestor
25525310|NCT00489736|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25525311|NCT00489736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25525312|NCT00489736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525313|NCT00489736|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25525314|NCT00489736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25525315|NCT00489736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25525316|NCT00489736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525317|NCT00489736|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25525318|NCT00489736|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25525354|NCT00489866|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25525355|NCT00489866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25525356|NCT00489918|Teriparatide|teriparatide|mesh-list
25525357|NCT00489918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25525358|NCT00489918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525359|NCT00489918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25525360|NCT00490009|Acetaminophen|acetaminophen|mesh-list
25525361|NCT00490009|Iodine|iodine|mesh-list
25525362|NCT00490009|Diphenhydramine|diphenhydramine|mesh-list
25525363|NCT00490009|Promethazine|promethazine|mesh-list
25525364|NCT00490009|Cadexomer iodine|cadexomer iodine|mesh-list
25525365|NCT00490009|Tositumomab I-131|tositumomab i-131|mesh-list
25525366|NCT00490009|Lugol's solution|lugol's solution|mesh-list
25525367|NCT00490009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25525368|NCT00490009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25525369|NCT00490009|Analgesics|analgesics|mesh-ancestor
25525370|NCT00490009|Sensory System Agents|sensory system agents|mesh-ancestor
25525371|NCT00490009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25525372|NCT00490009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525373|NCT00490009|Antipyretics|antipyretics|mesh-ancestor
25525374|NCT00490009|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25525375|NCT00490009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25525376|NCT00490009|Trace Elements|trace elements|mesh-ancestor
25525377|NCT00490009|Micronutrients|micronutrients|mesh-ancestor
25525378|NCT00490009|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25525379|NCT00490009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25525380|NCT00490009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25525381|NCT00490009|Anesthetics, Local|anesthetics, local|mesh-ancestor
25525382|NCT00490009|Anesthetics|anesthetics|mesh-ancestor
25525383|NCT00490009|Antiemetics|antiemetics|mesh-ancestor
25525384|NCT00490009|Autonomic Agents|autonomic agents|mesh-ancestor
25525385|NCT00490009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25525386|NCT00490009|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25525387|NCT00490009|Histamine Antagonists|histamine antagonists|mesh-ancestor
25525388|NCT00490009|Histamine Agents|histamine agents|mesh-ancestor
25525389|NCT00490009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25525390|NCT00490009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525391|NCT00490009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25525392|NCT00490009|Antipruritics|antipruritics|mesh-ancestor
25525393|NCT00490009|Dermatologic Agents|dermatologic agents|mesh-ancestor
25525394|NCT00490009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525395|NCT00490009|Hemostatics|hemostatics|mesh-ancestor
25525396|NCT00490009|Coagulants|coagulants|mesh-ancestor
25525397|NCT00490022|Dihydrotestosterone|dihydrotestosterone|mesh-list
25525398|NCT00490022|Androgens|androgens|mesh-ancestor
25525399|NCT00490022|Hormones|hormones|mesh-ancestor
25525400|NCT00490022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25525401|NCT00490022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525402|NCT00490061|Lapatinib|lapatinib|mesh-list
25525403|NCT00490061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525404|NCT00490061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25525405|NCT00490061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525406|NCT00490061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525407|NCT00490100|Mecasermin|mecasermin|mesh-list
25525408|NCT00490100|Growth Substances|growth substances|mesh-ancestor
25525409|NCT00490100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525410|NCT00490139|Trastuzumab|trastuzumab|mesh-list
25525411|NCT00490139|Lapatinib|lapatinib|mesh-list
25525412|NCT00490139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25525413|NCT00490139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525414|NCT00490139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25525415|NCT00490139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525416|NCT00490139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525417|NCT00490269|Dronabinol|dronabinol|mesh-list
25525418|NCT00490269|Hallucinogens|hallucinogens|mesh-ancestor
25525419|NCT00490269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525420|NCT00490269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25525421|NCT00490269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25525422|NCT00490269|Analgesics|analgesics|mesh-ancestor
25525423|NCT00490269|Sensory System Agents|sensory system agents|mesh-ancestor
25525424|NCT00490269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25525425|NCT00490269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25525426|NCT00490269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25525427|NCT00490269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25525428|NCT00490269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525429|NCT00490269|Hormones|hormones|mesh-ancestor
25525430|NCT00490269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25525431|NCT00490477|Polymyxins|polymyxins|mesh-list
25525432|NCT00490477|Polymyxin B|polymyxin b|mesh-list
25525433|NCT00490477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25525434|NCT00490477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25525435|NCT00490490|Iodine|iodine|mesh-list
25525436|NCT00490490|Lugol's solution|lugol's solution|mesh-list
25525437|NCT00490490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25525438|NCT00490490|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25525439|NCT00490490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25525440|NCT00490490|Trace Elements|trace elements|mesh-ancestor
25525441|NCT00490490|Micronutrients|micronutrients|mesh-ancestor
25525442|NCT00490490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525443|NCT00490490|Hemostatics|hemostatics|mesh-ancestor
25525444|NCT00490490|Coagulants|coagulants|mesh-ancestor
25525445|NCT00490529|Cyclophosphamide|cyclophosphamide|mesh-list
25525446|NCT00490529|Rituximab|rituximab|mesh-list
25525447|NCT00490529|Vaccines|vaccines|mesh-list
25525448|NCT00490529|Immunologic Factors|immunologic factors|mesh-ancestor
25525449|NCT00490529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525450|NCT00490529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25525451|NCT00490529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25525452|NCT00490529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25525453|NCT00490529|Alkylating Agents|alkylating agents|mesh-ancestor
25525454|NCT00490529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525455|NCT00490529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525456|NCT00490529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25525457|NCT00490529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25525458|NCT00490542|Ziprasidone|ziprasidone|mesh-list
25525459|NCT00490542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25525460|NCT00490542|Serotonin Agents|serotonin agents|mesh-ancestor
25525461|NCT00490542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25525462|NCT00490542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525463|NCT00490542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525464|NCT00490542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25525465|NCT00490542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25525466|NCT00490542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25525467|NCT00490542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25525468|NCT00490542|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25525469|NCT00490542|Dopamine Agents|dopamine agents|mesh-ancestor
25525470|NCT00490555|Methyltestosterone|methyltestosterone|mesh-list
25525471|NCT00490555|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25525472|NCT00490555|Medroxyprogesterone|medroxyprogesterone|mesh-list
25525473|NCT00490555|Testosterone|testosterone|mesh-list
25525474|NCT00490555|Testosterone undecanoate|testosterone undecanoate|mesh-list
25525475|NCT00490555|Testosterone enanthate|testosterone enanthate|mesh-list
25525476|NCT00490555|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25525477|NCT00490555|Dutasteride|dutasteride|mesh-list
25525478|NCT00490555|Androgens|androgens|mesh-ancestor
25525479|NCT00490555|Hormones|hormones|mesh-ancestor
25525480|NCT00490555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25525481|NCT00490555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525482|NCT00490555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25525483|NCT00490555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525484|NCT00490555|Anabolic Agents|anabolic agents|mesh-ancestor
25525485|NCT00490555|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25525486|NCT00490555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25525487|NCT00490555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525488|NCT00490555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525489|NCT00490555|Hormone Antagonists|hormone antagonists|mesh-ancestor
25525490|NCT00490555|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25525491|NCT00490555|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25525492|NCT00490555|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25525493|NCT00490555|Contraceptive Agents|contraceptive agents|mesh-ancestor
25525494|NCT00490555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25525495|NCT00490555|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25525496|NCT00490555|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25525497|NCT00490555|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25525498|NCT00490568|Rosiglitazone|rosiglitazone|mesh-list
25525499|NCT00490568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25525500|NCT00490568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823465|NCT00004834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107820|NCT03136705|Micronutrients|micronutrients|mesh-ancestor
25107821|NCT03136705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107822|NCT03136705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25107823|NCT03136705|Antimetabolites|antimetabolites|mesh-ancestor
25107824|NCT03136705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107825|NCT03136705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25525502|NCT00490646|Trastuzumab|trastuzumab|mesh-list
25525503|NCT00490646|Epothilones|epothilones|mesh-list
25525504|NCT00490646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525505|NCT00490646|Tubulin Modulators|tubulin modulators|mesh-ancestor
25525506|NCT00490646|Antimitotic Agents|antimitotic agents|mesh-ancestor
25525507|NCT00490646|Mitosis Modulators|mitosis modulators|mesh-ancestor
25525508|NCT00490646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525509|NCT00490646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25525510|NCT00490698|Zoledronic Acid|zoledronic acid|mesh-list
25525511|NCT00490698|Atorvastatin|atorvastatin|mesh-list
25525512|NCT00490698|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25525513|NCT00490698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25525514|NCT00490698|Antimetabolites|antimetabolites|mesh-ancestor
25525515|NCT00490698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525516|NCT00490698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25525517|NCT00490698|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25525518|NCT00490698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525519|NCT00490698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25525520|NCT00490698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525521|NCT00490724|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25525522|NCT00490724|Natriuretic Agents|natriuretic agents|mesh-ancestor
25525523|NCT00490724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525524|NCT00490802|Oxytocin|oxytocin|mesh-list
25525525|NCT00490802|Oxytocics|oxytocics|mesh-ancestor
25525526|NCT00490802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25525527|NCT00490802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525528|NCT00490815|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
25525529|NCT00490815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25525530|NCT00490815|Glucocorticoids|glucocorticoids|mesh-ancestor
25525531|NCT00490815|Hormones|hormones|mesh-ancestor
25525532|NCT00490815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25525533|NCT00490815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525534|NCT00490919|Buprenorphine|buprenorphine|mesh-list
25525535|NCT00490919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25525536|NCT00490919|Narcotics|narcotics|mesh-ancestor
25525537|NCT00490919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25525538|NCT00490919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525539|NCT00490919|Analgesics|analgesics|mesh-ancestor
25525540|NCT00490919|Sensory System Agents|sensory system agents|mesh-ancestor
25525541|NCT00490919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25525542|NCT00490919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25525543|NCT00490971|Olanzapine|olanzapine|mesh-list
25525544|NCT00490971|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25525545|NCT00490971|Antiemetics|antiemetics|mesh-ancestor
25525546|NCT00490971|Autonomic Agents|autonomic agents|mesh-ancestor
25525547|NCT00490971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25525548|NCT00490971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525549|NCT00490971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25525550|NCT00490971|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25525551|NCT00490971|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25525552|NCT00490971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25525553|NCT00490971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25525554|NCT00490971|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25525555|NCT00490971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25525556|NCT00490971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25525557|NCT00490971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525558|NCT00490971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25525559|NCT00490971|Serotonin Agents|serotonin agents|mesh-ancestor
25525560|NCT00490971|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25525561|NCT00490971|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25525562|NCT00490971|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25525563|NCT00490971|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25525564|NCT00490971|Dopamine Agents|dopamine agents|mesh-ancestor
25525565|NCT00491075|Gemcitabine|gemcitabine|mesh-list
25525566|NCT00491075|Pemetrexed|pemetrexed|mesh-list
25525567|NCT00491075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25823466|NCT00004834|Adrenergic Agents|adrenergic agents|mesh-ancestor
24450219|NCT00318084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24450220|NCT00318084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24450221|NCT00318084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24450224|NCT00318162|Naltrexone|naltrexone|mesh-list
24450240|NCT00318201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24450241|NCT00318201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24450252|NCT00318318|Estrogens|estrogens|mesh-ancestor
25525568|NCT00491075|Antimetabolites|antimetabolites|mesh-ancestor
25525569|NCT00491075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525570|NCT00491075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525571|NCT00491075|Antiviral Agents|antiviral agents|mesh-ancestor
25525572|NCT00491075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25525573|NCT00491075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525574|NCT00491075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25525575|NCT00491075|Immunologic Factors|immunologic factors|mesh-ancestor
25525576|NCT00491075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525577|NCT00491075|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25525578|NCT00491075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25646831|NCT01463098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646832|NCT01463098|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25646833|NCT01463111|Lamotrigine|lamotrigine|mesh-list
25646834|NCT01463111|Valproic Acid|valproic acid|mesh-list
25646835|NCT01463111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25646836|NCT01463111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646837|NCT01463111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646838|NCT01463111|Antimanic Agents|antimanic agents|mesh-ancestor
25646839|NCT01463111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25646840|NCT01463111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25646841|NCT01463111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525579|NCT00491179|Interferons|interferons|mesh-list
25525580|NCT00491179|Ribavirin|ribavirin|mesh-list
25525581|NCT00491179|Interferon-alpha|interferon-alpha|mesh-list
25525582|NCT00491179|Interferon alpha-2|interferon alpha-2|mesh-list
25525583|NCT00491179|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25525584|NCT00491179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525585|NCT00491179|Antiviral Agents|antiviral agents|mesh-ancestor
25525586|NCT00491179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25525587|NCT00491179|Antimetabolites|antimetabolites|mesh-ancestor
25525588|NCT00491179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525589|NCT00491179|Immunologic Factors|immunologic factors|mesh-ancestor
25525590|NCT00491179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525591|NCT00491244|Interferons|interferons|mesh-list
25525592|NCT00491244|Ribavirin|ribavirin|mesh-list
25525593|NCT00491244|Interferon-alpha|interferon-alpha|mesh-list
25525594|NCT00491244|Interferon alpha-2|interferon alpha-2|mesh-list
25525595|NCT00491244|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25525596|NCT00491244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525597|NCT00491244|Antiviral Agents|antiviral agents|mesh-ancestor
25525598|NCT00491244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25525599|NCT00491244|Antimetabolites|antimetabolites|mesh-ancestor
25525600|NCT00491244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525601|NCT00491244|Immunologic Factors|immunologic factors|mesh-ancestor
25525602|NCT00491244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525603|NCT00491322|Ergocalciferols|ergocalciferols|mesh-list
25525604|NCT00491322|Vitamin D|vitamin d|mesh-list
25525605|NCT00491322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25525606|NCT00491322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525607|NCT00491322|Vitamins|vitamins|mesh-ancestor
25525608|NCT00491322|Micronutrients|micronutrients|mesh-ancestor
25525609|NCT00491322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25525610|NCT00491374|Mometasone Furoate|mometasone furoate|mesh-list
25525611|NCT00491374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25525612|NCT00491374|Dermatologic Agents|dermatologic agents|mesh-ancestor
25525613|NCT00491374|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25525614|NCT00491530|Calcium, Dietary|calcium, dietary|mesh-list
25525615|NCT00491530|Atorvastatin|atorvastatin|mesh-list
25525616|NCT00491530|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25525617|NCT00491530|Simvastatin|simvastatin|mesh-list
25525618|NCT00491530|Fenofibric acid|fenofibric acid|mesh-list
25525619|NCT00491530|Calcium|calcium|mesh-list
25525620|NCT00491530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25525621|NCT00491530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525622|NCT00491530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25525623|NCT00491530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25525624|NCT00491530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25525625|NCT00491530|Antimetabolites|antimetabolites|mesh-ancestor
25525626|NCT00491530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525627|NCT00491530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25525628|NCT00491530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25525629|NCT00491530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525630|NCT00491556|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25525631|NCT00491556|Antiviral Agents|antiviral agents|mesh-ancestor
25525632|NCT00491556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25525633|NCT00491751|Ascorbic Acid|ascorbic acid|mesh-list
25525634|NCT00491751|Atorvastatin|atorvastatin|mesh-list
25525635|NCT00491751|Vitamins|vitamins|mesh-ancestor
25525636|NCT00491751|Micronutrients|micronutrients|mesh-ancestor
25525637|NCT00491751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525638|NCT00491751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25525639|NCT00491751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25525640|NCT00491751|Antimetabolites|antimetabolites|mesh-ancestor
25525641|NCT00491751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525642|NCT00491751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25525643|NCT00491751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24937108|NCT04032860|Entecavir|entecavir|mesh-list
25525644|NCT00491751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525645|NCT00491751|Antioxidants|antioxidants|mesh-ancestor
25525646|NCT00491751|Protective Agents|protective agents|mesh-ancestor
25525647|NCT00491764|Posaconazole|posaconazole|mesh-list
25525648|NCT00491764|Terbinafine|terbinafine|mesh-list
25525649|NCT00491764|Antifungal Agents|antifungal agents|mesh-ancestor
25525650|NCT00491764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25525651|NCT00491764|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25525652|NCT00491764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25525653|NCT00491764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25525654|NCT00491764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25525655|NCT00491764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25525656|NCT00491764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525657|NCT00491764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525658|NCT00491764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25525659|NCT00491764|Hormone Antagonists|hormone antagonists|mesh-ancestor
25525660|NCT00491764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25525661|NCT00491764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525662|NCT00491894|Glycopyrrolate|glycopyrrolate|mesh-list
25525663|NCT00491894|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25525664|NCT00491894|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25525665|NCT00491894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25525666|NCT00491894|Cholinergic Agents|cholinergic agents|mesh-ancestor
25525667|NCT00491894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25525668|NCT00491894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525669|NCT00491894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525670|NCT00492024|Moxifloxacin|moxifloxacin|mesh-list
25525671|NCT00492024|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25525672|NCT00492024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25525673|NCT00492024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25525674|NCT00492024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25525675|NCT00492024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25525676|NCT00492024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525677|NCT00492024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525678|NCT00492024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525679|NCT00492024|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25525680|NCT00492024|Contraceptive Agents|contraceptive agents|mesh-ancestor
25525681|NCT00492024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25525682|NCT00492024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525683|NCT00492024|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25525684|NCT00492024|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25525685|NCT00492024|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25525686|NCT00492063|Vaccines|vaccines|mesh-list
25525687|NCT00492063|Immunologic Factors|immunologic factors|mesh-ancestor
25525688|NCT00492063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525689|NCT00492089|Bevacizumab|bevacizumab|mesh-list
25525690|NCT00492089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25525691|NCT00492089|Antibodies|antibodies|mesh-list
25525692|NCT00492089|Immunoglobulins|immunoglobulins|mesh-list
25525693|NCT00492089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25525694|NCT00492089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525695|NCT00492089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25525696|NCT00492089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25525697|NCT00492089|Growth Substances|growth substances|mesh-ancestor
25525698|NCT00492089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525699|NCT00492089|Growth Inhibitors|growth inhibitors|mesh-ancestor
25525700|NCT00492089|Immunologic Factors|immunologic factors|mesh-ancestor
25525701|NCT00492206|Cetuximab|cetuximab|mesh-list
25525702|NCT00492206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25525703|NCT00492206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525704|NCT00492232|Zolpidem|zolpidem|mesh-list
25525705|NCT00492232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25525706|NCT00492232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25525707|NCT00492232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25525708|NCT00492232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525709|NCT00492232|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24785841|NCT01916863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24785842|NCT01916863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785843|NCT01916902|Ticagrelor|ticagrelor|mesh-list
24785844|NCT01916902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24785845|NCT01916902|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25107838|NCT03136510|Anticoagulants|anticoagulants|mesh-ancestor
25107839|NCT03136341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25107840|NCT03136341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25823467|NCT00004834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25107841|NCT03136341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25525712|NCT00492232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25525713|NCT00492232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525714|NCT00492284|Dexamethasone|dexamethasone|mesh-list
25525715|NCT00492284|Ranibizumab|ranibizumab|mesh-list
25525716|NCT00492284|Verteporfin|verteporfin|mesh-list
25525717|NCT00492284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25525718|NCT00492284|Antiemetics|antiemetics|mesh-ancestor
25525719|NCT00492284|Autonomic Agents|autonomic agents|mesh-ancestor
25525720|NCT00492284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25525721|NCT00492284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525722|NCT00492284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25525723|NCT00492284|Glucocorticoids|glucocorticoids|mesh-ancestor
25525724|NCT00492284|Hormones|hormones|mesh-ancestor
25525725|NCT00492284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25525726|NCT00492284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25525727|NCT00492284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525728|NCT00492284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25525729|NCT00492284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25525730|NCT00492284|Growth Substances|growth substances|mesh-ancestor
25525731|NCT00492284|Growth Inhibitors|growth inhibitors|mesh-ancestor
25525732|NCT00492284|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25525733|NCT00492284|Dermatologic Agents|dermatologic agents|mesh-ancestor
25525734|NCT00492297|Sorafenib|sorafenib|mesh-list
25525735|NCT00492297|Dacarbazine|dacarbazine|mesh-list
25525736|NCT00492297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525737|NCT00492297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25525738|NCT00492297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525739|NCT00492297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525740|NCT00492297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25525741|NCT00492297|Alkylating Agents|alkylating agents|mesh-ancestor
25525742|NCT00492336|Rasagiline|rasagiline|mesh-list
25525743|NCT00492336|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25525744|NCT00492336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525745|NCT00492336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525746|NCT00492336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25525747|NCT00492336|Protective Agents|protective agents|mesh-ancestor
25525748|NCT00492336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525749|NCT00492401|Decitabine|decitabine|mesh-list
25525750|NCT00492401|Azacitidine|azacitidine|mesh-list
25525751|NCT00492401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25525752|NCT00492401|Antimetabolites|antimetabolites|mesh-ancestor
25525753|NCT00492401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525754|NCT00492401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525755|NCT00492401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525756|NCT00492531|Sildenafil Citrate|sildenafil citrate|mesh-list
25525757|NCT00492531|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
25525758|NCT00492531|Vasodilator Agents|vasodilator agents|mesh-ancestor
25525759|NCT00492531|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25525760|NCT00492531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525761|NCT00492531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525762|NCT00492531|Urological Agents|urological agents|mesh-ancestor
25525763|NCT00492544|Vaccines|vaccines|mesh-list
25525764|NCT00492544|Immunologic Factors|immunologic factors|mesh-ancestor
25525765|NCT00492544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525766|NCT00492557|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25525767|NCT00492557|Immunologic Factors|immunologic factors|mesh-ancestor
25525768|NCT00492557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525769|NCT00492622|Omeprazole|omeprazole|mesh-list
25525770|NCT00492622|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25525771|NCT00492622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25525772|NCT00492622|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25525773|NCT00492622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598674|NCT00957203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25823468|NCT00004834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823469|NCT00004838|Succimer|succimer|mesh-list
25823470|NCT00004838|Antidotes|antidotes|mesh-ancestor
25823471|NCT00004838|Protective Agents|protective agents|mesh-ancestor
25823472|NCT00004838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823473|NCT00004838|Chelating Agents|chelating agents|mesh-ancestor
25823474|NCT00004838|Sequestering Agents|sequestering agents|mesh-ancestor
25163082|NCT02899364|Antidotes|antidotes|mesh-ancestor
24939551|NCT04008888|Dexamethasone|dexamethasone|mesh-list
24993650|NCT05415826|Hormones|hormones|mesh-ancestor
25525774|NCT00492622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525775|NCT00492726|Moxifloxacin|moxifloxacin|mesh-list
25525776|NCT00492726|Ertapenem|ertapenem|mesh-list
25525777|NCT00492726|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25525778|NCT00492726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25525779|NCT00492726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25525780|NCT00492726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25525781|NCT00492726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25525782|NCT00492726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525783|NCT00492726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525784|NCT00492726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525785|NCT00492726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25525786|NCT00492726|Contraceptive Agents|contraceptive agents|mesh-ancestor
25525787|NCT00492726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25525788|NCT00492726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525789|NCT00492726|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25525790|NCT00492726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25525791|NCT00492726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25525792|NCT00492752|Sorafenib|sorafenib|mesh-list
25525793|NCT00492752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525794|NCT00492752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25525795|NCT00492752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525796|NCT00492752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525797|NCT00492856|Methotrexate|methotrexate|mesh-list
25525798|NCT00492856|Mercaptopurine|mercaptopurine|mesh-list
25525799|NCT00492856|Tretinoin|tretinoin|mesh-list
25525800|NCT00492856|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25525801|NCT00492856|Abortifacient Agents|abortifacient agents|mesh-ancestor
25525802|NCT00492856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25525803|NCT00492856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525804|NCT00492856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25525805|NCT00492856|Antimetabolites|antimetabolites|mesh-ancestor
25525806|NCT00492856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525807|NCT00492856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525808|NCT00492856|Dermatologic Agents|dermatologic agents|mesh-ancestor
25525809|NCT00492856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525810|NCT00492856|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25525811|NCT00492856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25525812|NCT00492856|Immunologic Factors|immunologic factors|mesh-ancestor
25525813|NCT00492856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25525814|NCT00492856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25525815|NCT00492856|Keratolytic Agents|keratolytic agents|mesh-ancestor
25525816|NCT00492921|Cyclophosphamide|cyclophosphamide|mesh-list
25525817|NCT00492921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25525818|NCT00492921|Immunologic Factors|immunologic factors|mesh-ancestor
25525819|NCT00492921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525820|NCT00492921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25525821|NCT00492921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25525822|NCT00492921|Alkylating Agents|alkylating agents|mesh-ancestor
25525823|NCT00492921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525824|NCT00492921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525825|NCT00492921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25525826|NCT00492973|Cefuroxime|cefuroxime|mesh-list
25525827|NCT00492973|Methylprednisolone|methylprednisolone|mesh-list
25525828|NCT00492973|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25525829|NCT00492973|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25525830|NCT00492973|Prednisolone|prednisolone|mesh-list
25525831|NCT00492973|Prednisolone acetate|prednisolone acetate|mesh-list
25525832|NCT00492973|Clonidine|clonidine|mesh-list
25525833|NCT00492973|Epinephrine|epinephrine|mesh-list
25525834|NCT00492973|Morphine|morphine|mesh-list
25525835|NCT00492973|Bupivacaine|bupivacaine|mesh-list
25525836|NCT00492973|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25525837|NCT00492973|Prednisolone phosphate|prednisolone phosphate|mesh-list
25525838|NCT00492973|Anesthetics, Local|anesthetics, local|mesh-ancestor
25823475|NCT00004838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823476|NCT00004840|Hormones|hormones|mesh-list
25823477|NCT00004840|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
25823478|NCT00004840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25823479|NCT00004840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144532|NCT02935972|Anesthetics|anesthetics|mesh-ancestor
25163083|NCT02899364|Protective Agents|protective agents|mesh-ancestor
25163084|NCT02899364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993682|NCT05415436|Propofol|propofol|mesh-list
25525839|NCT00492973|Anesthetics|anesthetics|mesh-ancestor
25525840|NCT00492973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25525841|NCT00492973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525842|NCT00492973|Sensory System Agents|sensory system agents|mesh-ancestor
25525843|NCT00492973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25525844|NCT00492973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25525845|NCT00492973|Narcotics|narcotics|mesh-ancestor
25525846|NCT00492973|Analgesics|analgesics|mesh-ancestor
25525847|NCT00492973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25525848|NCT00492973|Antiemetics|antiemetics|mesh-ancestor
25525849|NCT00492973|Autonomic Agents|autonomic agents|mesh-ancestor
25525850|NCT00492973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25525851|NCT00492973|Glucocorticoids|glucocorticoids|mesh-ancestor
25525852|NCT00492973|Hormones|hormones|mesh-ancestor
25525853|NCT00492973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25525854|NCT00492973|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25525855|NCT00492973|Protective Agents|protective agents|mesh-ancestor
25525856|NCT00492973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25525857|NCT00492973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525858|NCT00492973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25525859|NCT00492973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25525860|NCT00492973|Adrenergic Agents|adrenergic agents|mesh-ancestor
25525861|NCT00492973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25525862|NCT00492973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525863|NCT00492973|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25525864|NCT00492973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25525865|NCT00492973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25525866|NCT00492973|Respiratory System Agents|respiratory system agents|mesh-ancestor
25525867|NCT00492973|Mydriatics|mydriatics|mesh-ancestor
25525868|NCT00492973|Sympathomimetics|sympathomimetics|mesh-ancestor
25525869|NCT00492973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25525870|NCT00492973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25525871|NCT00492973|Sympatholytics|sympatholytics|mesh-ancestor
25525872|NCT00492973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25525873|NCT00492973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25525874|NCT00492973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25525875|NCT00493012|Vitamin D|vitamin d|mesh-list
25525876|NCT00493012|Vitamins|vitamins|mesh-ancestor
25525877|NCT00493012|Micronutrients|micronutrients|mesh-ancestor
25525878|NCT00493012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525879|NCT00493012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25525880|NCT00493038|Amoxicillin|amoxicillin|mesh-list
25525881|NCT00493038|Moxifloxacin|moxifloxacin|mesh-list
25525882|NCT00493038|Clavulanic Acid|clavulanic acid|mesh-list
25525883|NCT00493038|Clavulanic Acids|clavulanic acids|mesh-list
25525884|NCT00493038|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25525885|NCT00493038|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25525886|NCT00493038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25525887|NCT00493038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25525888|NCT00493038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25525889|NCT00493038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25525890|NCT00493038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525891|NCT00493038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525892|NCT00493038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525893|NCT00493038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25525894|NCT00493038|Contraceptive Agents|contraceptive agents|mesh-ancestor
25525895|NCT00493038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25525896|NCT00493038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525897|NCT00493038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25525898|NCT00493038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25525899|NCT00493038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25525900|NCT00493038|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25525902|NCT00493064|Nicotinic Acids|nicotinic acids|mesh-list
25525903|NCT00493064|Niacinamide|niacinamide|mesh-list
25525904|NCT00493064|Prednisolone|prednisolone|mesh-list
25525905|NCT00493064|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25525906|NCT00493064|Methylprednisolone|methylprednisolone|mesh-list
25525907|NCT00493064|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24993749|NCT05410197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24993750|NCT05410197|Immunologic Factors|immunologic factors|mesh-ancestor
24993751|NCT05410197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993752|NCT05410197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24993753|NCT05409872|Vitamin D|vitamin d|mesh-list
24993754|NCT05409872|Vitamins|vitamins|mesh-list
24993755|NCT05409872|Inositol|inositol|mesh-list
25525908|NCT00493064|Prednisolone acetate|prednisolone acetate|mesh-list
25525909|NCT00493064|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25525910|NCT00493064|Prednisolone phosphate|prednisolone phosphate|mesh-list
25525911|NCT00493064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25525912|NCT00493064|Glucocorticoids|glucocorticoids|mesh-ancestor
25525914|NCT00493064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25525915|NCT00493064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525916|NCT00493064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25525917|NCT00493064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525918|NCT00493064|Antiemetics|antiemetics|mesh-ancestor
25525919|NCT00493064|Autonomic Agents|autonomic agents|mesh-ancestor
25525920|NCT00493064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25525921|NCT00493064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25525922|NCT00493064|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25525923|NCT00493064|Protective Agents|protective agents|mesh-ancestor
25525924|NCT00493064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25525925|NCT00493064|Antimetabolites|antimetabolites|mesh-ancestor
25525926|NCT00493064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525927|NCT00493064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25525928|NCT00493064|Vasodilator Agents|vasodilator agents|mesh-ancestor
25525929|NCT00493064|Vitamin B Complex|vitamin b complex|mesh-ancestor
25525930|NCT00493064|Vitamins|vitamins|mesh-ancestor
25525931|NCT00493064|Micronutrients|micronutrients|mesh-ancestor
25525932|NCT00493181|Oprelvekin|oprelvekin|mesh-list
25525933|NCT00493181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525934|NCT00493220|Ceftriaxone|ceftriaxone|mesh-list
25525935|NCT00493220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25525936|NCT00493220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25525937|NCT00493246|Acetaminophen|acetaminophen|mesh-list
25525938|NCT00493246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25525939|NCT00493246|Analgesics|analgesics|mesh-ancestor
25525940|NCT00493246|Sensory System Agents|sensory system agents|mesh-ancestor
25525941|NCT00493246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25525942|NCT00493246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525943|NCT00493246|Antipyretics|antipyretics|mesh-ancestor
25525944|NCT00493311|Acetaminophen|acetaminophen|mesh-list
25525945|NCT00493311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25525946|NCT00493311|Analgesics|analgesics|mesh-ancestor
25525947|NCT00493311|Sensory System Agents|sensory system agents|mesh-ancestor
25525948|NCT00493311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25525949|NCT00493311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525950|NCT00493311|Antipyretics|antipyretics|mesh-ancestor
25525951|NCT00493454|Rituximab|rituximab|mesh-list
25525952|NCT00493454|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25525953|NCT00493454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25525954|NCT00493454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525955|NCT00493454|Immunologic Factors|immunologic factors|mesh-ancestor
25525956|NCT00493454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525957|NCT00493454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25525958|NCT00493636|Gemcitabine|gemcitabine|mesh-list
25525959|NCT00493636|Capecitabine|capecitabine|mesh-list
25525960|NCT00493636|Sorafenib|sorafenib|mesh-list
25525961|NCT00493636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25525962|NCT00493636|Antimetabolites|antimetabolites|mesh-ancestor
25525963|NCT00493636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525964|NCT00493636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525965|NCT00493636|Antiviral Agents|antiviral agents|mesh-ancestor
25525966|NCT00493636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25525967|NCT00493636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25525968|NCT00493636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25525969|NCT00493636|Immunologic Factors|immunologic factors|mesh-ancestor
25525970|NCT00493636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525971|NCT00493636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25525972|NCT00493649|Cyclophosphamide|cyclophosphamide|mesh-list
25525973|NCT00493649|Docetaxel|docetaxel|mesh-list
25525974|NCT00493649|Trastuzumab|trastuzumab|mesh-list
25525975|NCT00493649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25107850|NCT03136237|Digoxin|digoxin|mesh-list
25107851|NCT03136237|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25107852|NCT03136237|Cyclosporins|cyclosporins|mesh-list
25107853|NCT03136237|Berotralstat|berotralstat|mesh-list
25107854|NCT03136237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107855|NCT03136237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107856|NCT03136237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25107857|NCT03136237|Immunologic Factors|immunologic factors|mesh-ancestor
25107859|NCT03136237|Antifungal Agents|antifungal agents|mesh-ancestor
25525976|NCT00493649|Immunologic Factors|immunologic factors|mesh-ancestor
25525977|NCT00493649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25525978|NCT00493649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25525979|NCT00493649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25525980|NCT00493649|Alkylating Agents|alkylating agents|mesh-ancestor
25525981|NCT00493649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525982|NCT00493649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525983|NCT00493649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25525984|NCT00493649|Tubulin Modulators|tubulin modulators|mesh-ancestor
25525985|NCT00493649|Antimitotic Agents|antimitotic agents|mesh-ancestor
25525986|NCT00493649|Mitosis Modulators|mitosis modulators|mesh-ancestor
25525987|NCT00493649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25525988|NCT00493805|Interferons|interferons|mesh-list
25525989|NCT00493805|Ribavirin|ribavirin|mesh-list
25525990|NCT00493805|Interferon-alpha|interferon-alpha|mesh-list
25525991|NCT00493805|Interferon alpha-2|interferon alpha-2|mesh-list
25525992|NCT00493805|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25525993|NCT00493805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25525994|NCT00493805|Antiviral Agents|antiviral agents|mesh-ancestor
25525995|NCT00493805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25525996|NCT00493805|Antimetabolites|antimetabolites|mesh-ancestor
25525997|NCT00493805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25525998|NCT00493805|Immunologic Factors|immunologic factors|mesh-ancestor
25525999|NCT00493805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526000|NCT00493974|Zileuton|zileuton|mesh-list
25526001|NCT00493974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25526002|NCT00493974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25526003|NCT00493974|Analgesics|analgesics|mesh-ancestor
25526004|NCT00493974|Sensory System Agents|sensory system agents|mesh-ancestor
25526005|NCT00493974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25526006|NCT00493974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526007|NCT00493974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25526008|NCT00493974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25526009|NCT00493974|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25526010|NCT00493974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526011|NCT00493974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526012|NCT00493974|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25526013|NCT00493974|Hormone Antagonists|hormone antagonists|mesh-ancestor
25526014|NCT00493974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25526015|NCT00494013|Insulin Lispro|insulin lispro|mesh-list
25526016|NCT00494013|Protamines|protamines|mesh-list
25526017|NCT00494013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25526018|NCT00494013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526019|NCT00494013|Heparin Antagonists|heparin antagonists|mesh-ancestor
25526020|NCT00494013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526021|NCT00494013|Coagulants|coagulants|mesh-ancestor
25526022|NCT00494026|Carboplatin|carboplatin|mesh-list
25526023|NCT00494026|Pemetrexed|pemetrexed|mesh-list
25526024|NCT00494026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526025|NCT00494026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526026|NCT00494026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526027|NCT00494026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25526028|NCT00494026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25526029|NCT00494091|Sirolimus|sirolimus|mesh-list
25526030|NCT00494091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25526031|NCT00494091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25526032|NCT00494091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25526033|NCT00494091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526034|NCT00494091|Antifungal Agents|antifungal agents|mesh-ancestor
25526035|NCT00494091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25526036|NCT00494091|Immunologic Factors|immunologic factors|mesh-ancestor
25526037|NCT00494091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526038|NCT00494221|Leucovorin|leucovorin|mesh-list
25526039|NCT00494221|Fluorouracil|fluorouracil|mesh-list
25526040|NCT00494221|Oxaliplatin|oxaliplatin|mesh-list
25526041|NCT00494221|Cediranib|cediranib|mesh-list
25526042|NCT00494221|Levoleucovorin|levoleucovorin|mesh-list
25526043|NCT00494221|Antimetabolites|antimetabolites|mesh-ancestor
25526044|NCT00494221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526045|NCT00494221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25526046|NCT00494221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526047|NCT00494221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25526048|NCT00494221|Immunologic Factors|immunologic factors|mesh-ancestor
25526049|NCT00494221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526050|NCT00494221|Antidotes|antidotes|mesh-ancestor
25526051|NCT00494221|Protective Agents|protective agents|mesh-ancestor
25823480|NCT00004842|Budesonide|budesonide|mesh-list
25526052|NCT00494221|Vitamin B Complex|vitamin b complex|mesh-ancestor
25526053|NCT00494221|Vitamins|vitamins|mesh-ancestor
25526054|NCT00494221|Micronutrients|micronutrients|mesh-ancestor
25823481|NCT00004842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25526055|NCT00494221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25526056|NCT00494221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526057|NCT00494299|Sorafenib|sorafenib|mesh-list
25526058|NCT00494299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526059|NCT00494299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25526060|NCT00494299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526061|NCT00494299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526062|NCT00494442|Olaparib|olaparib|mesh-list
25526063|NCT00494442|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25526064|NCT00494442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526065|NCT00494442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526066|NCT00494442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526067|NCT00494481|Docetaxel|docetaxel|mesh-list
25526068|NCT00494481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526069|NCT00494481|Tubulin Modulators|tubulin modulators|mesh-ancestor
25526070|NCT00494481|Antimitotic Agents|antimitotic agents|mesh-ancestor
25526071|NCT00494481|Mitosis Modulators|mitosis modulators|mesh-ancestor
25526072|NCT00494481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526073|NCT00494494|Nepafenac|nepafenac|mesh-list
25526074|NCT00494494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25526075|NCT00494494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25526076|NCT00494494|Analgesics|analgesics|mesh-ancestor
25526077|NCT00494494|Sensory System Agents|sensory system agents|mesh-ancestor
25526078|NCT00494494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25526079|NCT00494494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526080|NCT00494494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25526081|NCT00494494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25526082|NCT00494507|Dichlorphenamide|dichlorphenamide|mesh-list
25526083|NCT00494507|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25526084|NCT00494507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526085|NCT00494507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526086|NCT00494676|Methamphetamine|methamphetamine|mesh-list
25526087|NCT00494676|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25526088|NCT00494676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526089|NCT00494676|Sympathomimetics|sympathomimetics|mesh-ancestor
25526090|NCT00494676|Autonomic Agents|autonomic agents|mesh-ancestor
25526091|NCT00494676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25526092|NCT00494676|Dopamine Agents|dopamine agents|mesh-ancestor
25526093|NCT00494676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25526094|NCT00494676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526095|NCT00494676|Adrenergic Agents|adrenergic agents|mesh-ancestor
25526096|NCT00494676|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25526097|NCT00494676|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25526098|NCT00494676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25526099|NCT00494676|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25526100|NCT00494780|Prednisone|prednisone|mesh-list
25526101|NCT00494780|Prednisolone|prednisolone|mesh-list
25526102|NCT00494780|Cyclophosphamide|cyclophosphamide|mesh-list
25526103|NCT00494780|Doxorubicin|doxorubicin|mesh-list
25526104|NCT00494780|Vincristine|vincristine|mesh-list
25526105|NCT00494780|Ofatumumab|ofatumumab|mesh-list
25526106|NCT00494780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25526107|NCT00494780|Immunologic Factors|immunologic factors|mesh-ancestor
25526108|NCT00494780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526109|NCT00494780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25526110|NCT00494780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24994014|NCT05038618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24994015|NCT05038618|Protease Inhibitors|protease inhibitors|mesh-ancestor
24994016|NCT05038618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24994017|NCT05038618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994019|NCT05037487|Hallucinogens|hallucinogens|mesh-ancestor
24994020|NCT05037487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994021|NCT05037487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24842065|NCT02219672|Ritonavir|ritonavir|mesh-list
24994022|NCT05037487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24994023|NCT05037487|Analgesics|analgesics|mesh-ancestor
24994024|NCT05037487|Sensory System Agents|sensory system agents|mesh-ancestor
24994025|NCT05037487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24994026|NCT05037487|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24994027|NCT05037487|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24994028|NCT05037487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24994030|NCT05037487|Hormones|hormones|mesh-ancestor
25526116|NCT00494780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25526117|NCT00494780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25526119|NCT00494780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25526120|NCT00494780|Glucocorticoids|glucocorticoids|mesh-ancestor
25526121|NCT00494780|Hormones|hormones|mesh-ancestor
25526122|NCT00494780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25526123|NCT00494780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25526124|NCT00494780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25526125|NCT00494780|Tubulin Modulators|tubulin modulators|mesh-ancestor
25526126|NCT00494780|Antimitotic Agents|antimitotic agents|mesh-ancestor
25526127|NCT00494780|Mitosis Modulators|mitosis modulators|mesh-ancestor
25526128|NCT00494871|Warfarin|warfarin|mesh-list
25526129|NCT00494871|Rivaroxaban|rivaroxaban|mesh-list
25526130|NCT00494871|Anticoagulants|anticoagulants|mesh-ancestor
25526131|NCT00494871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25526132|NCT00494871|Antithrombins|antithrombins|mesh-ancestor
25526133|NCT00494871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25526134|NCT00494871|Protease Inhibitors|protease inhibitors|mesh-ancestor
25526135|NCT00494871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526136|NCT00494871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526137|NCT00495079|Vincristine|vincristine|mesh-list
25526138|NCT00495079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25526139|NCT00495079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526140|NCT00495079|Tubulin Modulators|tubulin modulators|mesh-ancestor
25526141|NCT00495079|Antimitotic Agents|antimitotic agents|mesh-ancestor
25526142|NCT00495079|Mitosis Modulators|mitosis modulators|mesh-ancestor
25526143|NCT00495079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526144|NCT00495170|Paclitaxel|paclitaxel|mesh-list
25526145|NCT00495170|Carboplatin|carboplatin|mesh-list
25526146|NCT00495170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25526147|NCT00495170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526148|NCT00495170|Tubulin Modulators|tubulin modulators|mesh-ancestor
25526149|NCT00495170|Antimitotic Agents|antimitotic agents|mesh-ancestor
25526150|NCT00495170|Mitosis Modulators|mitosis modulators|mesh-ancestor
25526151|NCT00495170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526152|NCT00495391|Ribavirin|ribavirin|mesh-list
25526153|NCT00495391|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25526154|NCT00495391|Nitazoxanide|nitazoxanide|mesh-list
25526155|NCT00495391|Antimetabolites|antimetabolites|mesh-ancestor
25526156|NCT00495391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526157|NCT00495391|Antiviral Agents|antiviral agents|mesh-ancestor
25526158|NCT00495391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25526159|NCT00495391|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25526160|NCT00495521|Aminosalicylic Acid|aminosalicylic acid|mesh-list
25526161|NCT00495521|Antitubercular Agents|antitubercular agents|mesh-ancestor
25526162|NCT00495521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25526163|NCT00495521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25526164|NCT00495586|Amoxicillin|amoxicillin|mesh-list
25526165|NCT00495586|Clavulanic Acids|clavulanic acids|mesh-list
25526166|NCT00495586|Clavulanic Acid|clavulanic acid|mesh-list
25526167|NCT00495586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25526168|NCT00495586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25526169|NCT00495586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526170|NCT00495586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526171|NCT00495586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25526172|NCT00495612|Omalizumab|omalizumab|mesh-list
25526173|NCT00495612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25526174|NCT00495612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25526175|NCT00495612|Respiratory System Agents|respiratory system agents|mesh-ancestor
24994090|NCT04930744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994091|NCT04930744|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24994092|NCT04930744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24994098|NCT04930744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25526176|NCT00495625|Sunitinib|sunitinib|mesh-list
25526177|NCT00495625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526178|NCT00495625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25526179|NCT00495625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25526180|NCT00495625|Growth Substances|growth substances|mesh-ancestor
25526181|NCT00495625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526182|NCT00495625|Growth Inhibitors|growth inhibitors|mesh-ancestor
25526183|NCT00495625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25526184|NCT00495625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526185|NCT00495625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526186|NCT00495677|PF 232798|pf 232798|mesh-list
25526187|NCT00495677|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25526188|NCT00495677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526189|NCT00495677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25526190|NCT00495677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25526191|NCT00495677|Antiviral Agents|antiviral agents|mesh-ancestor
25526192|NCT00495677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25526193|NCT00495755|Alemtuzumab|alemtuzumab|mesh-list
25526194|NCT00495755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25526195|NCT00495755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526196|NCT00495820|Methylphenidate|methylphenidate|mesh-list
25526197|NCT00495820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25526198|NCT00495820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526199|NCT00495820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25526200|NCT00495820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25526201|NCT00495820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25526202|NCT00495820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526203|NCT00495820|Dopamine Agents|dopamine agents|mesh-ancestor
25526204|NCT00495820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25526205|NCT00496015|Acetaminophen|acetaminophen|mesh-list
25526206|NCT00496015|Vaccines|vaccines|mesh-list
25526207|NCT00496015|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25526208|NCT00496015|Immunologic Factors|immunologic factors|mesh-ancestor
25526209|NCT00496015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526210|NCT00496015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25526211|NCT00496015|Analgesics|analgesics|mesh-ancestor
25526212|NCT00496015|Sensory System Agents|sensory system agents|mesh-ancestor
25526213|NCT00496015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25526214|NCT00496015|Antipyretics|antipyretics|mesh-ancestor
25526215|NCT00496054|Vaccines|vaccines|mesh-list
25526216|NCT00496054|Immunologic Factors|immunologic factors|mesh-ancestor
25526217|NCT00496054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526218|NCT00496197|Fluconazole|fluconazole|mesh-list
25526219|NCT00496197|Voriconazole|voriconazole|mesh-list
25526220|NCT00496197|Anidulafungin|anidulafungin|mesh-list
25526221|NCT00496197|Antifungal Agents|antifungal agents|mesh-ancestor
25526222|NCT00496197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25526223|NCT00496197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25526224|NCT00496197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25526225|NCT00496197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526226|NCT00496197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526227|NCT00496197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25526228|NCT00496197|Hormone Antagonists|hormone antagonists|mesh-ancestor
25526229|NCT00496197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25526230|NCT00496197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526231|NCT00496197|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25526232|NCT00496197|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25526233|NCT00496197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25526234|NCT00496340|Rituximab|rituximab|mesh-list
25526235|NCT00496340|Busulfan|busulfan|mesh-list
25526236|NCT00496340|Pentostatin|pentostatin|mesh-list
25526237|NCT00496340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24994153|NCT04829799|Sensory System Agents|sensory system agents|mesh-ancestor
24548115|NCT00707707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823482|NCT00004842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24994181|NCT04824417|Voriconazole|voriconazole|mesh-list
24994182|NCT04824417|Antifungal Agents|antifungal agents|mesh-ancestor
24994183|NCT04824417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24994184|NCT04824417|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24994185|NCT04824417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24994186|NCT04824417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24994187|NCT04824417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994188|NCT04824417|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25526239|NCT00496340|Immunologic Factors|immunologic factors|mesh-ancestor
25526240|NCT00496340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526241|NCT00496340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25526242|NCT00496340|Alkylating Agents|alkylating agents|mesh-ancestor
25526243|NCT00496340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526244|NCT00496340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25526245|NCT00496340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25526246|NCT00496340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25526247|NCT00496340|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25526248|NCT00496340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526249|NCT00496366|Capecitabine|capecitabine|mesh-list
25526250|NCT00496366|Lapatinib|lapatinib|mesh-list
25526251|NCT00496366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25526252|NCT00496366|Antimetabolites|antimetabolites|mesh-ancestor
25823483|NCT00004842|Autonomic Agents|autonomic agents|mesh-ancestor
25646842|NCT01463111|Anticonvulsants|anticonvulsants|mesh-ancestor
25526253|NCT00496366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526254|NCT00496366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526255|NCT00496366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25526256|NCT00496366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526257|NCT00496379|Epothilones|epothilones|mesh-list
25526258|NCT00496379|Sagopilone|sagopilone|mesh-list
25526259|NCT00496379|Tubulin Modulators|tubulin modulators|mesh-ancestor
25526260|NCT00496379|Antimitotic Agents|antimitotic agents|mesh-ancestor
25526261|NCT00496379|Mitosis Modulators|mitosis modulators|mesh-ancestor
25526262|NCT00496379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526263|NCT00496379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526264|NCT00496470|Budesonide|budesonide|mesh-list
25526265|NCT00496470|Bromides|bromides|mesh-list
25526266|NCT00496470|Formoterol Fumarate|formoterol fumarate|mesh-list
25526267|NCT00496470|Tiotropium Bromide|tiotropium bromide|mesh-list
25526268|NCT00496470|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25526269|NCT00496470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25526270|NCT00496470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25526271|NCT00496470|Autonomic Agents|autonomic agents|mesh-ancestor
25526272|NCT00496470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25526273|NCT00496470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526274|NCT00496470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25526275|NCT00496470|Respiratory System Agents|respiratory system agents|mesh-ancestor
25526276|NCT00496470|Glucocorticoids|glucocorticoids|mesh-ancestor
25526277|NCT00496470|Hormones|hormones|mesh-ancestor
25526278|NCT00496470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25526279|NCT00496470|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25526280|NCT00496470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25526281|NCT00496470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25526282|NCT00496470|Adrenergic Agents|adrenergic agents|mesh-ancestor
25526283|NCT00496470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25526284|NCT00496470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526285|NCT00496470|Parasympatholytics|parasympatholytics|mesh-ancestor
25526286|NCT00496470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25526287|NCT00496470|Cholinergic Agents|cholinergic agents|mesh-ancestor
25526288|NCT00496470|Anticonvulsants|anticonvulsants|mesh-ancestor
25526289|NCT00496483|Tacrolimus|tacrolimus|mesh-list
25526290|NCT00496483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25526291|NCT00496483|Immunologic Factors|immunologic factors|mesh-ancestor
25526292|NCT00496483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526293|NCT00496483|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25526294|NCT00496483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526295|NCT00496483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526296|NCT00496587|Gemcitabine|gemcitabine|mesh-list
25526297|NCT00496587|Bevacizumab|bevacizumab|mesh-list
25526298|NCT00496587|Capecitabine|capecitabine|mesh-list
25526299|NCT00496587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25526300|NCT00496587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526301|NCT00496587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25526302|NCT00496587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25526303|NCT00496587|Growth Substances|growth substances|mesh-ancestor
25526304|NCT00496587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526305|NCT00496587|Growth Inhibitors|growth inhibitors|mesh-ancestor
24994273|NCT04721873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994274|NCT04721873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24994275|NCT04721873|Appetite Depressants|appetite depressants|mesh-ancestor
24994276|NCT04721873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24994277|NCT04721873|Sympathomimetics|sympathomimetics|mesh-ancestor
24994278|NCT04721873|Autonomic Agents|autonomic agents|mesh-ancestor
25526306|NCT00496587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25526307|NCT00496587|Antimetabolites|antimetabolites|mesh-ancestor
25526308|NCT00496587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526309|NCT00496587|Antiviral Agents|antiviral agents|mesh-ancestor
25526310|NCT00496587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25526311|NCT00496587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526312|NCT00496587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25526313|NCT00496587|Immunologic Factors|immunologic factors|mesh-ancestor
25526314|NCT00496769|Aspirin|aspirin|mesh-list
25526315|NCT00496769|Apixaban|apixaban|mesh-list
25526316|NCT00496769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25526317|NCT00496769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25526318|NCT00496769|Analgesics|analgesics|mesh-ancestor
25526319|NCT00496769|Sensory System Agents|sensory system agents|mesh-ancestor
25526320|NCT00496769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25526321|NCT00496769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526322|NCT00496769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25526323|NCT00496769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25526324|NCT00496769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25526325|NCT00496769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25526326|NCT00496769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526327|NCT00496769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25526328|NCT00496769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25526329|NCT00496769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526330|NCT00496769|Antipyretics|antipyretics|mesh-ancestor
25526331|NCT00496769|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25526332|NCT00496769|Antithrombins|antithrombins|mesh-ancestor
25526333|NCT00496769|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25526334|NCT00496769|Protease Inhibitors|protease inhibitors|mesh-ancestor
25526335|NCT00496769|Anticoagulants|anticoagulants|mesh-ancestor
25526336|NCT00496808|Trastuzumab|trastuzumab|mesh-list
25526337|NCT00496808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25526338|NCT00496808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526339|NCT00496873|Cyclophosphamide|cyclophosphamide|mesh-list
25526340|NCT00496873|Rituximab|rituximab|mesh-list
25526341|NCT00496873|Pentostatin|pentostatin|mesh-list
25526342|NCT00496873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25526343|NCT00496873|Immunologic Factors|immunologic factors|mesh-ancestor
25526344|NCT00496873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526345|NCT00496873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25526346|NCT00496873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25526347|NCT00496873|Alkylating Agents|alkylating agents|mesh-ancestor
25526348|NCT00496873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526349|NCT00496873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526350|NCT00496873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25526351|NCT00496873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25526352|NCT00496873|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25526353|NCT00496873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526354|NCT00496964|Botulinum Toxins|botulinum toxins|mesh-list
25526355|NCT00496964|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25526356|NCT00496964|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25526357|NCT00496964|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25526358|NCT00496964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25526359|NCT00496964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526360|NCT00496964|Cholinergic Agents|cholinergic agents|mesh-ancestor
25526361|NCT00496964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25526362|NCT00496964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526363|NCT00496964|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25526364|NCT00496964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25526365|NCT00497055|Aripiprazole|aripiprazole|mesh-list
25526366|NCT00497055|Antidepressive Agents|antidepressive agents|mesh-ancestor
25526367|NCT00497055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25526368|NCT00497055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25526369|NCT00497055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25526370|NCT00497055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25526371|NCT00497055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526372|NCT00497055|Dopamine Agonists|dopamine agonists|mesh-ancestor
25526373|NCT00497055|Dopamine Agents|dopamine agents|mesh-ancestor
25526374|NCT00497055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25526375|NCT00497055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526376|NCT00497055|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24797860|NCT01958866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24797861|NCT01958866|Analgesics|analgesics|mesh-ancestor
24797862|NCT01958866|Sensory System Agents|sensory system agents|mesh-ancestor
25526377|NCT00497055|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25526379|NCT00497055|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25526380|NCT00497055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25526381|NCT00497055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25526382|NCT00497055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25526383|NCT00497081|Mirtazapine|mirtazapine|mesh-list
25526384|NCT00497081|Antidepressive Agents|antidepressive agents|mesh-ancestor
25526385|NCT00497081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25526386|NCT00497081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25526387|NCT00497081|Histamine Antagonists|histamine antagonists|mesh-ancestor
25526388|NCT00497081|Histamine Agents|histamine agents|mesh-ancestor
25526389|NCT00497081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25526390|NCT00497081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526391|NCT00497081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526392|NCT00497081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25526393|NCT00497081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25646843|NCT01463111|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25646844|NCT01463111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25646845|NCT01463111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25646846|NCT01463111|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25646847|NCT01463111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25526394|NCT00497081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25526395|NCT00497081|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25526396|NCT00497081|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25526397|NCT00497081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25526398|NCT00497081|Adrenergic Agents|adrenergic agents|mesh-ancestor
25526399|NCT00497081|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25526400|NCT00497081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25526401|NCT00497081|Serotonin Agents|serotonin agents|mesh-ancestor
25526402|NCT00497081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25646849|NCT01463111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25646850|NCT01463202|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25646851|NCT01463202|Medroxyprogesterone|medroxyprogesterone|mesh-list
25526403|NCT00497198|Bile Acids and Salts|bile acids and salts|mesh-list
25526404|NCT00497198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25526405|NCT00497770|Pemetrexed|pemetrexed|mesh-list
25526406|NCT00497770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526407|NCT00497770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526408|NCT00497770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526409|NCT00497770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25526410|NCT00497770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25526411|NCT00497796|Ganciclovir|ganciclovir|mesh-list
25526412|NCT00497796|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25526413|NCT00497796|Maribavir|maribavir|mesh-list
25526414|NCT00497796|Antiviral Agents|antiviral agents|mesh-ancestor
25526415|NCT00497796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25526416|NCT00497796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25526417|NCT00497796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526418|NCT00497796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526419|NCT00498173|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25526420|NCT00498173|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25526421|NCT00498173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25526422|NCT00498173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25526423|NCT00498173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526424|NCT00498173|Adrenergic Agents|adrenergic agents|mesh-ancestor
25526425|NCT00498173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25526426|NCT00498173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526427|NCT00498186|Rotigotine|rotigotine|mesh-list
25526428|NCT00498186|Dopamine Agonists|dopamine agonists|mesh-ancestor
25526429|NCT00498186|Dopamine Agents|dopamine agents|mesh-ancestor
25526430|NCT00498186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25526431|NCT00498186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526432|NCT00498186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526433|NCT00498355|Ranibizumab|ranibizumab|mesh-list
25526434|NCT00498355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25526435|NCT00498355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25526436|NCT00498355|Growth Substances|growth substances|mesh-ancestor
25526437|NCT00498355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526438|NCT00498355|Growth Inhibitors|growth inhibitors|mesh-ancestor
25526439|NCT00498355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526440|NCT00498368|Rituximab|rituximab|mesh-list
25526441|NCT00498368|Angiotensin II|angiotensin ii|mesh-list
25526442|NCT00498368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25526443|NCT00498368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526444|NCT00498368|Immunologic Factors|immunologic factors|mesh-ancestor
25526445|NCT00498368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526446|NCT00498368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25526447|NCT00498368|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25526448|NCT00498433|Amlodipine|amlodipine|mesh-list
25526449|NCT00498433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25526450|NCT00498433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25526451|NCT00498433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25526452|NCT00498433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526453|NCT00498433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25526454|NCT00498433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526455|NCT00498433|Vasodilator Agents|vasodilator agents|mesh-ancestor
25526456|NCT00498485|Sodium Oxybate|sodium oxybate|mesh-list
25526457|NCT00498485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25526458|NCT00498485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25526459|NCT00498485|Anesthetics, General|anesthetics, general|mesh-ancestor
25526461|NCT00498485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25526462|NCT00498485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526464|NCT00498550|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25526465|NCT00498550|Serotonin Agents|serotonin agents|mesh-ancestor
25526466|NCT00498550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25526467|NCT00498550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526468|NCT00498550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526469|NCT00498550|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25526470|NCT00498550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25526471|NCT00498550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25526472|NCT00498550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25526473|NCT00498550|GABA Antagonists|gaba antagonists|mesh-ancestor
25526474|NCT00498550|GABA Agents|gaba agents|mesh-ancestor
25526475|NCT00498602|Saponin QA-21V1|saponin qa-21v1|mesh-list
25526476|NCT00498602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25526477|NCT00498602|Immunologic Factors|immunologic factors|mesh-ancestor
25526478|NCT00498602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526479|NCT00498615|Fasudil|fasudil|mesh-list
25526480|NCT00498615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25526481|NCT00498615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25526482|NCT00498615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526483|NCT00498615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25526484|NCT00498615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526485|NCT00498615|Vasodilator Agents|vasodilator agents|mesh-ancestor
25526486|NCT00498615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25526487|NCT00498615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526488|NCT00498628|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25526489|NCT00498628|Antidepressive Agents|antidepressive agents|mesh-ancestor
25526490|NCT00498628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25526491|NCT00498628|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25526492|NCT00498628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25526493|NCT00498628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25526494|NCT00498628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526495|NCT00498797|Prednisolone|prednisolone|mesh-list
25526496|NCT00498797|Docetaxel|docetaxel|mesh-list
25526497|NCT00498797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526498|NCT00498797|Tubulin Modulators|tubulin modulators|mesh-ancestor
25526499|NCT00498797|Antimitotic Agents|antimitotic agents|mesh-ancestor
25526500|NCT00498797|Mitosis Modulators|mitosis modulators|mesh-ancestor
25526501|NCT00498797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526502|NCT00498797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25526503|NCT00498797|Glucocorticoids|glucocorticoids|mesh-ancestor
25526504|NCT00498797|Hormones|hormones|mesh-ancestor
25526505|NCT00498797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25526506|NCT00498797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526507|NCT00498797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25526508|NCT00498927|Temozolomide|temozolomide|mesh-list
25526509|NCT00498927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25526510|NCT00498927|Alkylating Agents|alkylating agents|mesh-ancestor
25526511|NCT00498927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526512|NCT00498927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526513|NCT00499031|Cetuximab|cetuximab|mesh-list
25526514|NCT00499031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25823484|NCT00004842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25823485|NCT00004842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823486|NCT00004842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25823487|NCT00004842|Respiratory System Agents|respiratory system agents|mesh-ancestor
25823488|NCT00004842|Glucocorticoids|glucocorticoids|mesh-ancestor
25823489|NCT00004842|Hormones|hormones|mesh-ancestor
25823490|NCT00004842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25526516|NCT00499083|Tamoxifen|tamoxifen|mesh-list
25526517|NCT00499083|Paclitaxel|paclitaxel|mesh-list
25526518|NCT00499083|Cyclophosphamide|cyclophosphamide|mesh-list
25526519|NCT00499083|Doxorubicin|doxorubicin|mesh-list
25526520|NCT00499083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25526521|NCT00499083|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25526522|NCT00499083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25526523|NCT00499083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526524|NCT00499083|Tubulin Modulators|tubulin modulators|mesh-ancestor
25526525|NCT00499083|Antimitotic Agents|antimitotic agents|mesh-ancestor
25646852|NCT01463202|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25646853|NCT01463202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25646854|NCT01463202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25526526|NCT00499083|Mitosis Modulators|mitosis modulators|mesh-ancestor
25526527|NCT00499083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526528|NCT00499083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25526529|NCT00499083|Immunologic Factors|immunologic factors|mesh-ancestor
25526530|NCT00499083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526531|NCT00499083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25526532|NCT00499083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25526533|NCT00499083|Alkylating Agents|alkylating agents|mesh-ancestor
25526534|NCT00499083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25526535|NCT00499083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25526536|NCT00499083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25526537|NCT00499083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25526538|NCT00499083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526539|NCT00499083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25526540|NCT00499083|Hormone Antagonists|hormone antagonists|mesh-ancestor
25526541|NCT00499083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25526542|NCT00499083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25526543|NCT00499083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25526544|NCT00499083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25526545|NCT00499083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25526546|NCT00499083|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25526547|NCT00499109|Gemcitabine|gemcitabine|mesh-list
25526548|NCT00499109|Carboplatin|carboplatin|mesh-list
25526549|NCT00499109|Docetaxel|docetaxel|mesh-list
25526550|NCT00499109|Vinorelbine|vinorelbine|mesh-list
25526551|NCT00499109|Antineoplastic Agents|antineoplastic agents|mesh-list
25526552|NCT00499109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25526553|NCT00499109|Antimetabolites|antimetabolites|mesh-ancestor
25526554|NCT00499109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526555|NCT00499109|Antiviral Agents|antiviral agents|mesh-ancestor
25526556|NCT00499109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25526557|NCT00499109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526558|NCT00499109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25526559|NCT00499109|Immunologic Factors|immunologic factors|mesh-ancestor
25526560|NCT00499109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526561|NCT00499109|Tubulin Modulators|tubulin modulators|mesh-ancestor
25526562|NCT00499109|Antimitotic Agents|antimitotic agents|mesh-ancestor
25526563|NCT00499109|Mitosis Modulators|mitosis modulators|mesh-ancestor
25526564|NCT00499109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25526565|NCT00499122|Cyclophosphamide|cyclophosphamide|mesh-list
25526566|NCT00499122|Docetaxel|docetaxel|mesh-list
25526567|NCT00499122|Doxorubicin|doxorubicin|mesh-list
25526568|NCT00499122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25526569|NCT00499122|Immunologic Factors|immunologic factors|mesh-ancestor
25526570|NCT00499122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526571|NCT00499122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25526572|NCT00499122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25526573|NCT00499122|Alkylating Agents|alkylating agents|mesh-ancestor
25526574|NCT00499122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526575|NCT00499122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526576|NCT00499122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25526577|NCT00499122|Tubulin Modulators|tubulin modulators|mesh-ancestor
25526578|NCT00499122|Antimitotic Agents|antimitotic agents|mesh-ancestor
25526579|NCT00499122|Mitosis Modulators|mitosis modulators|mesh-ancestor
24600573|NCT00959439|Naproxen|naproxen|mesh-list
25823491|NCT00004845|Naproxen|naproxen|mesh-list
25823492|NCT00004845|Rofecoxib|rofecoxib|mesh-list
25823493|NCT00004845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25823494|NCT00004845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25823495|NCT00004845|Analgesics|analgesics|mesh-ancestor
25823496|NCT00004845|Sensory System Agents|sensory system agents|mesh-ancestor
25526580|NCT00499122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25526581|NCT00499122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25526582|NCT00499122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25526583|NCT00499122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526584|NCT00499252|Paclitaxel|paclitaxel|mesh-list
25526585|NCT00499252|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25526586|NCT00499252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25526587|NCT00499252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526588|NCT00499252|Tubulin Modulators|tubulin modulators|mesh-ancestor
25646855|NCT01463202|Contraceptive Agents|contraceptive agents|mesh-ancestor
25823497|NCT00004845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25526589|NCT00499252|Antimitotic Agents|antimitotic agents|mesh-ancestor
25526590|NCT00499252|Mitosis Modulators|mitosis modulators|mesh-ancestor
25526591|NCT00499252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526592|NCT00499343|Rituximab|rituximab|mesh-list
25526593|NCT00499343|Etoposide|etoposide|mesh-list
25526594|NCT00499343|Ifosfamide|ifosfamide|mesh-list
25526595|NCT00499343|Sargramostim|sargramostim|mesh-list
25526596|NCT00499343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25526597|NCT00499343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526598|NCT00499343|Immunologic Factors|immunologic factors|mesh-ancestor
25526599|NCT00499343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526600|NCT00499343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25526601|NCT00499343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25526602|NCT00499343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25526603|NCT00499343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25526604|NCT00499343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526605|NCT00499343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526606|NCT00499343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25526607|NCT00499343|Alkylating Agents|alkylating agents|mesh-ancestor
25526608|NCT00499369|Leucovorin|leucovorin|mesh-list
25526609|NCT00499369|Bevacizumab|bevacizumab|mesh-list
25526610|NCT00499369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25526611|NCT00499369|Cetuximab|cetuximab|mesh-list
25526612|NCT00499369|Fluorouracil|fluorouracil|mesh-list
25526613|NCT00499369|Irinotecan|irinotecan|mesh-list
25526614|NCT00499369|Antibodies|antibodies|mesh-list
25526615|NCT00499369|Immunoglobulins|immunoglobulins|mesh-list
25526616|NCT00499369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25526617|NCT00499369|Levoleucovorin|levoleucovorin|mesh-list
25526618|NCT00499369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526619|NCT00499369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25526620|NCT00499369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25526621|NCT00499369|Growth Substances|growth substances|mesh-ancestor
25526622|NCT00499369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526623|NCT00499369|Growth Inhibitors|growth inhibitors|mesh-ancestor
25526624|NCT00499369|Immunologic Factors|immunologic factors|mesh-ancestor
25526625|NCT00499369|Antimetabolites|antimetabolites|mesh-ancestor
25526626|NCT00499369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526627|NCT00499369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25526628|NCT00499369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25526629|NCT00499369|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25526630|NCT00499369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25526631|NCT00499369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526632|NCT00499369|Antidotes|antidotes|mesh-ancestor
25526633|NCT00499369|Protective Agents|protective agents|mesh-ancestor
25526634|NCT00499369|Vitamin B Complex|vitamin b complex|mesh-ancestor
25526635|NCT00499369|Vitamins|vitamins|mesh-ancestor
25526636|NCT00499369|Micronutrients|micronutrients|mesh-ancestor
25526637|NCT00499408|Vitamin D|vitamin d|mesh-list
25526638|NCT00499408|Cholecalciferol|cholecalciferol|mesh-list
25526639|NCT00499408|Vitamins|vitamins|mesh-ancestor
25526640|NCT00499408|Micronutrients|micronutrients|mesh-ancestor
25526641|NCT00499408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526642|NCT00499408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25526643|NCT00499408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25526644|NCT00499460|Oxycodone|oxycodone|mesh-list
25526645|NCT00499460|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25526646|NCT00499460|Narcotics|narcotics|mesh-ancestor
25526647|NCT00499460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25526648|NCT00499460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526649|NCT00499460|Analgesics|analgesics|mesh-ancestor
25526650|NCT00499460|Sensory System Agents|sensory system agents|mesh-ancestor
25526651|NCT00499460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25526652|NCT00499473|Sunitinib|sunitinib|mesh-list
25526653|NCT00499473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526654|NCT00499473|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25526655|NCT00499473|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25526656|NCT00499473|Growth Substances|growth substances|mesh-ancestor
25526657|NCT00499473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823498|NCT00004845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823499|NCT00004845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25526658|NCT00499473|Growth Inhibitors|growth inhibitors|mesh-ancestor
25526659|NCT00499473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25823500|NCT00004845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25526660|NCT00499473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526661|NCT00499473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526662|NCT00499486|Sirolimus|sirolimus|mesh-list
25526663|NCT00499486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25526664|NCT00499486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25526665|NCT00499486|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25526666|NCT00499486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526667|NCT00499486|Antifungal Agents|antifungal agents|mesh-ancestor
25526668|NCT00499486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25526669|NCT00499486|Immunologic Factors|immunologic factors|mesh-ancestor
25526670|NCT00499486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526671|NCT00499603|Paclitaxel|paclitaxel|mesh-list
25526672|NCT00499603|Cyclophosphamide|cyclophosphamide|mesh-list
25526673|NCT00499603|Fluorouracil|fluorouracil|mesh-list
25526674|NCT00499603|Epirubicin|epirubicin|mesh-list
25526675|NCT00499603|Everolimus|everolimus|mesh-list
25526676|NCT00499603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25526677|NCT00499603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526678|NCT00499603|Tubulin Modulators|tubulin modulators|mesh-ancestor
25526679|NCT00499603|Antimitotic Agents|antimitotic agents|mesh-ancestor
25526680|NCT00499603|Mitosis Modulators|mitosis modulators|mesh-ancestor
25526681|NCT00499603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526682|NCT00499603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25526683|NCT00499603|Immunologic Factors|immunologic factors|mesh-ancestor
25526684|NCT00499603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526685|NCT00499603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25526686|NCT00499603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25526687|NCT00499603|Alkylating Agents|alkylating agents|mesh-ancestor
25526688|NCT00499603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25526689|NCT00499603|Antimetabolites|antimetabolites|mesh-ancestor
25526690|NCT00499603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25526691|NCT00499603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25526692|NCT00499603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25526693|NCT00499603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25526694|NCT00499603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526695|NCT00499616|Cyclophosphamide|cyclophosphamide|mesh-list
25526696|NCT00499616|Carboplatin|carboplatin|mesh-list
25526697|NCT00499616|Doxorubicin|doxorubicin|mesh-list
25526698|NCT00499616|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25526699|NCT00499616|Etoposide|etoposide|mesh-list
25526700|NCT00499616|Topotecan|topotecan|mesh-list
25526701|NCT00499616|Isotretinoin|isotretinoin|mesh-list
25526702|NCT00499616|Lenograstim|lenograstim|mesh-list
25526703|NCT00499616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25526704|NCT00499616|Immunologic Factors|immunologic factors|mesh-ancestor
25526705|NCT00499616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526706|NCT00499616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25526707|NCT00499616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25526708|NCT00499616|Alkylating Agents|alkylating agents|mesh-ancestor
25526709|NCT00499616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526710|NCT00499616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526711|NCT00499616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25526712|NCT00499616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25526713|NCT00499616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25526714|NCT00499616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25526715|NCT00499616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526716|NCT00499616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25526717|NCT00499616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25526718|NCT00499616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25526719|NCT00499616|Dermatologic Agents|dermatologic agents|mesh-ancestor
25526720|NCT00499655|Celecoxib|celecoxib|mesh-list
25526721|NCT00499655|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25526722|NCT00499655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526723|NCT00499655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25526724|NCT00499655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526725|NCT00499655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526726|NCT00499655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25526727|NCT00499655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25526728|NCT00499655|Analgesics|analgesics|mesh-ancestor
25526729|NCT00499655|Sensory System Agents|sensory system agents|mesh-ancestor
25823501|NCT00004845|Gout Suppressants|gout suppressants|mesh-ancestor
25823502|NCT00004845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25145517|NCT02929147|Morphine|morphine|mesh-list
25526730|NCT00499655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25526731|NCT00499655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526732|NCT00499655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25526733|NCT00499655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25526734|NCT00499655|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25526735|NCT00499655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25646856|NCT01463202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25526736|NCT00499681|Letrozole|letrozole|mesh-list
25526737|NCT00499681|Lapatinib|lapatinib|mesh-list
25526738|NCT00499681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526739|NCT00499681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25526740|NCT00499681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25526741|NCT00499681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526742|NCT00499681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526743|NCT00499681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25526744|NCT00499681|Hormone Antagonists|hormone antagonists|mesh-ancestor
25526745|NCT00499681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25526746|NCT00499681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526747|NCT00499681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25526748|NCT00499694|Bevacizumab|bevacizumab|mesh-list
25526749|NCT00499694|Satraplatin|satraplatin|mesh-list
25526750|NCT00499694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25526751|NCT00499694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526752|NCT00499694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25526753|NCT00499694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25526754|NCT00499694|Growth Substances|growth substances|mesh-ancestor
25526755|NCT00499694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526756|NCT00499694|Growth Inhibitors|growth inhibitors|mesh-ancestor
25526757|NCT00499746|Tramadol|tramadol|mesh-list
25526758|NCT00499746|Hydromorphone|hydromorphone|mesh-list
25526759|NCT00499746|Methylphenidate|methylphenidate|mesh-list
25526760|NCT00499746|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25526761|NCT00499746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526762|NCT00499746|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25526763|NCT00499746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25526764|NCT00499746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25526765|NCT00499746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526766|NCT00499746|Dopamine Agents|dopamine agents|mesh-ancestor
25526767|NCT00499746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25526768|NCT00499746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25526769|NCT00499746|Narcotics|narcotics|mesh-ancestor
25526770|NCT00499746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25526771|NCT00499746|Analgesics|analgesics|mesh-ancestor
25526772|NCT00499746|Sensory System Agents|sensory system agents|mesh-ancestor
25526773|NCT00499746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25526774|NCT00499863|Methylphenidate|methylphenidate|mesh-list
25526775|NCT00499863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25526776|NCT00499863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526777|NCT00499863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25526778|NCT00499863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25526779|NCT00499863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25526780|NCT00499863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526781|NCT00499863|Dopamine Agents|dopamine agents|mesh-ancestor
25526782|NCT00499863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25526783|NCT00499889|Vidarabine|vidarabine|mesh-list
25526784|NCT00499889|Methotrexate|methotrexate|mesh-list
25526785|NCT00499889|Fludarabine phosphate|fludarabine phosphate|mesh-list
25526786|NCT00499889|Fludarabine|fludarabine|mesh-list
25526787|NCT00499889|Busulfan|busulfan|mesh-list
25526788|NCT00499889|Imatinib Mesylate|imatinib mesylate|mesh-list
25526789|NCT00499889|Tacrolimus|tacrolimus|mesh-list
25526790|NCT00499889|Thymoglobulin|thymoglobulin|mesh-list
25526791|NCT00499889|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25526792|NCT00499889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25526793|NCT00499889|Abortifacient Agents|abortifacient agents|mesh-ancestor
25526794|NCT00499889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25526795|NCT00499889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526796|NCT00499889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25526797|NCT00499889|Antimetabolites|antimetabolites|mesh-ancestor
24591643|NCT00918021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24591644|NCT00918021|Serotonin Agents|serotonin agents|mesh-ancestor
24591654|NCT00918047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591655|NCT00918047|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24591656|NCT00918047|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24622105|NCT01065662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24622106|NCT01065662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25526798|NCT00499889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526799|NCT00499889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526800|NCT00499889|Dermatologic Agents|dermatologic agents|mesh-ancestor
25526801|NCT00499889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526802|NCT00499889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25526803|NCT00499889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25526804|NCT00499889|Immunologic Factors|immunologic factors|mesh-ancestor
25526805|NCT00499889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25526806|NCT00499889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25526807|NCT00499889|Antiviral Agents|antiviral agents|mesh-ancestor
25526808|NCT00499889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25526809|NCT00499889|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25526810|NCT00499889|Alkylating Agents|alkylating agents|mesh-ancestor
25526811|NCT00499889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25526812|NCT00499889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25526813|NCT00499889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25526814|NCT00500110|Docetaxel|docetaxel|mesh-list
25526815|NCT00500110|Imatinib Mesylate|imatinib mesylate|mesh-list
25526816|NCT00500110|Leuprolide|leuprolide|mesh-list
25526817|NCT00500110|Goserelin|goserelin|mesh-list
25526818|NCT00500110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526819|NCT00500110|Tubulin Modulators|tubulin modulators|mesh-ancestor
25526820|NCT00500110|Antimitotic Agents|antimitotic agents|mesh-ancestor
25526821|NCT00500110|Mitosis Modulators|mitosis modulators|mesh-ancestor
25526822|NCT00500110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526823|NCT00500110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25526824|NCT00500110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526825|NCT00500110|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25526826|NCT00500110|Fertility Agents|fertility agents|mesh-ancestor
25526827|NCT00500110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25526828|NCT00500110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526829|NCT00500110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25526830|NCT00500149|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25526831|NCT00500149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25526832|NCT00500149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526833|NCT00500149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25526834|NCT00500149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25526835|NCT00500149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25526836|NCT00500149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526837|NCT00500149|Dopamine Agents|dopamine agents|mesh-ancestor
25526838|NCT00500149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25526839|NCT00500240|Insulin|insulin|mesh-list
25526840|NCT00500240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25526841|NCT00500240|Insulin Glargine|insulin glargine|mesh-list
25526842|NCT00500240|Insulin Aspart|insulin aspart|mesh-list
25526843|NCT00500240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25526844|NCT00500240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526845|NCT00500266|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25526846|NCT00500266|Immunologic Factors|immunologic factors|mesh-ancestor
25526847|NCT00500266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526848|NCT00500292|Leucovorin|leucovorin|mesh-list
25526849|NCT00500292|Folic Acid|folic acid|mesh-list
25526850|NCT00500292|Fluorouracil|fluorouracil|mesh-list
25526851|NCT00500292|Oxaliplatin|oxaliplatin|mesh-list
25526852|NCT00500292|Levoleucovorin|levoleucovorin|mesh-list
25526853|NCT00500292|Antimetabolites|antimetabolites|mesh-ancestor
25526854|NCT00500292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526855|NCT00500292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25526856|NCT00500292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526857|NCT00500292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25526858|NCT00500292|Immunologic Factors|immunologic factors|mesh-ancestor
25526859|NCT00500292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994603|NCT03792867|Doxorubicin|doxorubicin|mesh-list
24994604|NCT03792867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24994609|NCT03792867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994622|NCT03668041|Gabapentin|gabapentin|mesh-list
24994623|NCT03668041|Trazodone|trazodone|mesh-list
24994624|NCT03668041|Eszopiclone|eszopiclone|mesh-list
24994625|NCT03668041|Analgesics|analgesics|mesh-ancestor
24994626|NCT03668041|Sensory System Agents|sensory system agents|mesh-ancestor
25107947|NCT03135795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25107948|NCT03135795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25107949|NCT03135795|Adrenergic Agents|adrenergic agents|mesh-ancestor
25526860|NCT00500292|Antidotes|antidotes|mesh-ancestor
25526861|NCT00500292|Protective Agents|protective agents|mesh-ancestor
25526862|NCT00500292|Vitamin B Complex|vitamin b complex|mesh-ancestor
25526863|NCT00500292|Vitamins|vitamins|mesh-ancestor
25526864|NCT00500292|Micronutrients|micronutrients|mesh-ancestor
25526865|NCT00500292|Hematinics|hematinics|mesh-ancestor
25526866|NCT00500318|Bromides|bromides|mesh-list
25526867|NCT00500318|Anticonvulsants|anticonvulsants|mesh-ancestor
25526868|NCT00500331|Pioglitazone|pioglitazone|mesh-list
25526869|NCT00500331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25646857|NCT01463202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526870|NCT00500331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526871|NCT00500357|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25526872|NCT00500357|Immunologic Factors|immunologic factors|mesh-ancestor
25526873|NCT00500357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526874|NCT00500370|Exenatide|exenatide|mesh-list
25526875|NCT00500370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25526876|NCT00500370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526877|NCT00500370|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25526878|NCT00500370|Incretins|incretins|mesh-ancestor
25526879|NCT00500370|Hormones|hormones|mesh-ancestor
25526880|NCT00500370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25526881|NCT00500539|Omalizumab|omalizumab|mesh-list
25526882|NCT00500539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25526883|NCT00500539|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25526884|NCT00500539|Respiratory System Agents|respiratory system agents|mesh-ancestor
25526885|NCT00500578|Ribavirin|ribavirin|mesh-list
25526886|NCT00500578|Antimetabolites|antimetabolites|mesh-ancestor
25526887|NCT00500578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526888|NCT00500578|Antiviral Agents|antiviral agents|mesh-ancestor
25526889|NCT00500578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25526890|NCT00500656|Icatibant|icatibant|mesh-list
25526891|NCT00500656|Tranexamic Acid|tranexamic acid|mesh-list
25526892|NCT00500656|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25526893|NCT00500656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25526894|NCT00500656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526895|NCT00500656|Hemostatics|hemostatics|mesh-ancestor
25526896|NCT00500656|Coagulants|coagulants|mesh-ancestor
25526897|NCT00500656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25526898|NCT00500656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25526899|NCT00500656|Analgesics|analgesics|mesh-ancestor
25526900|NCT00500656|Sensory System Agents|sensory system agents|mesh-ancestor
25526901|NCT00500656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25526902|NCT00500656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526903|NCT00500656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25526904|NCT00500656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25526905|NCT00500656|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
25526906|NCT00500656|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
25526907|NCT00500656|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25526908|NCT00500656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25526909|NCT00500656|Immunologic Factors|immunologic factors|mesh-ancestor
25526910|NCT00500760|Cisplatin|cisplatin|mesh-list
25526911|NCT00500760|Panitumumab|panitumumab|mesh-list
25526912|NCT00500760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526913|NCT00500760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25526914|NCT00501059|Aspirin|aspirin|mesh-list
25526915|NCT00501059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25526916|NCT00501059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25526917|NCT00501059|Analgesics|analgesics|mesh-ancestor
25526918|NCT00501059|Sensory System Agents|sensory system agents|mesh-ancestor
25526919|NCT00501059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25526920|NCT00501059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526921|NCT00501059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25526922|NCT00501059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25526923|NCT00501059|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25526924|NCT00501059|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25526925|NCT00501059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526926|NCT00501059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25526927|NCT00501059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25526928|NCT00501059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24994735|NCT03222856|Pembrolizumab|pembrolizumab|mesh-list
24994736|NCT03222856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24994737|NCT03222856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994738|NCT03217643|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24994739|NCT03217643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24994740|NCT03217643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994741|NCT03175978|Methotrexate|methotrexate|mesh-list
24994742|NCT03175978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526929|NCT00501059|Antipyretics|antipyretics|mesh-ancestor
25526930|NCT00501293|Methylphenidate|methylphenidate|mesh-list
25526931|NCT00501293|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25526932|NCT00501293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526933|NCT00501293|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25526934|NCT00501293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25526935|NCT00501293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25526936|NCT00501293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526937|NCT00501293|Dopamine Agents|dopamine agents|mesh-ancestor
25526938|NCT00501293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25526939|NCT00501540|Lithium Carbonate|lithium carbonate|mesh-list
25526940|NCT00501540|Antidepressive Agents|antidepressive agents|mesh-ancestor
25526941|NCT00501540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25526942|NCT00501540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25526943|NCT00501540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526944|NCT00501540|Antimanic Agents|antimanic agents|mesh-ancestor
25526945|NCT00501540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25526946|NCT00501540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25526947|NCT00501540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526949|NCT00501631|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25526950|NCT00501631|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25526951|NCT00501631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526952|NCT00501631|Sensory System Agents|sensory system agents|mesh-ancestor
25526953|NCT00501631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25526954|NCT00501644|Interferons|interferons|mesh-list
25526955|NCT00501644|Interferon-gamma|interferon-gamma|mesh-list
25526956|NCT00501644|Carboplatin|carboplatin|mesh-list
25526957|NCT00501644|Molgramostim|molgramostim|mesh-list
25526958|NCT00501644|Sargramostim|sargramostim|mesh-list
25526959|NCT00501644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526960|NCT00501644|Antiviral Agents|antiviral agents|mesh-ancestor
25526961|NCT00501644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25526962|NCT00501644|Immunologic Factors|immunologic factors|mesh-ancestor
25526963|NCT00501644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526964|NCT00501852|Glycopyrrolate|glycopyrrolate|mesh-list
25526965|NCT00501852|Tiotropium Bromide|tiotropium bromide|mesh-list
25526966|NCT00501852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25526967|NCT00501852|Autonomic Agents|autonomic agents|mesh-ancestor
25526968|NCT00501852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25526969|NCT00501852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526970|NCT00501852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25526971|NCT00501852|Respiratory System Agents|respiratory system agents|mesh-ancestor
25526972|NCT00501852|Parasympatholytics|parasympatholytics|mesh-ancestor
25526973|NCT00501852|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25526974|NCT00501852|Cholinergic Agents|cholinergic agents|mesh-ancestor
25526975|NCT00501852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25526976|NCT00501852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526977|NCT00501852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25526978|NCT00501852|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25526979|NCT00501891|Bevacizumab|bevacizumab|mesh-list
25526980|NCT00501891|Temozolomide|temozolomide|mesh-list
25526981|NCT00501891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25526982|NCT00501891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526983|NCT00501891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25526984|NCT00501891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25526985|NCT00501891|Growth Substances|growth substances|mesh-ancestor
25526986|NCT00501891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25526987|NCT00501891|Growth Inhibitors|growth inhibitors|mesh-ancestor
25526988|NCT00501891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25526989|NCT00501891|Alkylating Agents|alkylating agents|mesh-ancestor
25526990|NCT00501891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25526991|NCT00501943|Interferons|interferons|mesh-list
25526992|NCT00501943|Interferon-beta|interferon-beta|mesh-list
25526993|NCT00501943|Interferon beta-1a|interferon beta-1a|mesh-list
25526994|NCT00501943|Riluzole|riluzole|mesh-list
25526995|NCT00501943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25526996|NCT00501943|Antiviral Agents|antiviral agents|mesh-ancestor
25526997|NCT00501943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25526998|NCT00501943|Immunologic Factors|immunologic factors|mesh-ancestor
25526999|NCT00501943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527000|NCT00501943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25527001|NCT00501943|Anticonvulsants|anticonvulsants|mesh-ancestor
25527002|NCT00501943|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25527003|NCT00501943|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25527004|NCT00501943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24451284|NCT00323011|Bevacizumab|bevacizumab|mesh-list
25527024|NCT00502203|Paclitaxel|paclitaxel|mesh-list
25527025|NCT00502203|Carboplatin|carboplatin|mesh-list
24860399|NCT02309658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25527026|NCT00502203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25527027|NCT00502203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527028|NCT00502203|Tubulin Modulators|tubulin modulators|mesh-ancestor
25527029|NCT00502203|Antimitotic Agents|antimitotic agents|mesh-ancestor
25527031|NCT00502203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527032|NCT00502216|Naltrexone|naltrexone|mesh-list
25527033|NCT00502216|Varenicline|varenicline|mesh-list
25527034|NCT00502216|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25527035|NCT00502216|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25527036|NCT00502216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527037|NCT00502216|Sensory System Agents|sensory system agents|mesh-ancestor
25527038|NCT00502216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25527039|NCT00502216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25527040|NCT00502216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25527041|NCT00502216|Cholinergic Agents|cholinergic agents|mesh-ancestor
25527042|NCT00502216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25527043|NCT00502216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527044|NCT00502242|Ramipril|ramipril|mesh-list
25527045|NCT00502242|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25527046|NCT00502242|Protease Inhibitors|protease inhibitors|mesh-ancestor
25527047|NCT00502242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527048|NCT00502242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527049|NCT00502242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25823503|NCT00004845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823504|NCT00004845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823505|NCT00004845|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25823506|NCT00004852|Lamivudine|lamivudine|mesh-list
25823507|NCT00004852|Zidovudine|zidovudine|mesh-list
24994828|NCT02351544|Cholinergic Agents|cholinergic agents|mesh-ancestor
24994829|NCT02351544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25527050|NCT00502671|Capecitabine|capecitabine|mesh-list
25527051|NCT00502671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25527052|NCT00502671|Antimetabolites|antimetabolites|mesh-ancestor
25527053|NCT00502671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527054|NCT00502671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527055|NCT00502775|Fluticasone|fluticasone|mesh-list
25527056|NCT00502775|Xhance|xhance|mesh-list
25527057|NCT00502775|Fexofenadine|fexofenadine|mesh-list
25527058|NCT00502775|Terfenadine|terfenadine|mesh-list
25527059|NCT00502775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25527060|NCT00502775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25527061|NCT00502775|Autonomic Agents|autonomic agents|mesh-ancestor
25527062|NCT00502775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25527063|NCT00502775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527064|NCT00502775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25527065|NCT00502775|Respiratory System Agents|respiratory system agents|mesh-ancestor
25527066|NCT00502775|Dermatologic Agents|dermatologic agents|mesh-ancestor
25527067|NCT00502775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25527068|NCT00502775|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25527069|NCT00502775|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25527070|NCT00502775|Histamine Antagonists|histamine antagonists|mesh-ancestor
25527071|NCT00502775|Histamine Agents|histamine agents|mesh-ancestor
25527072|NCT00502775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25527073|NCT00502775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527074|NCT00502801|Doripenem|doripenem|mesh-list
25527075|NCT00502801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25527076|NCT00502801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25527077|NCT00502840|Rituximab|rituximab|mesh-list
25527078|NCT00502840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25527079|NCT00502840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527080|NCT00502840|Immunologic Factors|immunologic factors|mesh-ancestor
25527081|NCT00502840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527082|NCT00502840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25527083|NCT00502853|Rituximab|rituximab|mesh-list
25527084|NCT00502853|Methotrexate|methotrexate|mesh-list
25527085|NCT00502853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25527086|NCT00502853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527087|NCT00502853|Immunologic Factors|immunologic factors|mesh-ancestor
25527088|NCT00502853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527089|NCT00502853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25527090|NCT00502853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25527091|NCT00502853|Abortifacient Agents|abortifacient agents|mesh-ancestor
25527092|NCT00502853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25527093|NCT00502853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25527094|NCT00502853|Antimetabolites|antimetabolites|mesh-ancestor
25646858|NCT01463202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25823508|NCT00004852|Efavirenz|efavirenz|mesh-list
24938341|NCT04020133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25527095|NCT00502853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527096|NCT00502853|Dermatologic Agents|dermatologic agents|mesh-ancestor
25527097|NCT00502853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527098|NCT00502853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25527099|NCT00502853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25527100|NCT00502853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25527101|NCT00502905|Vidarabine|vidarabine|mesh-list
25527102|NCT00502905|Fludarabine|fludarabine|mesh-list
25527103|NCT00502905|Fludarabine phosphate|fludarabine phosphate|mesh-list
25527104|NCT00502905|Busulfan|busulfan|mesh-list
25527105|NCT00502905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527106|NCT00502905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25527107|NCT00502905|Antimetabolites|antimetabolites|mesh-ancestor
25527108|NCT00502905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527109|NCT00502905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25527110|NCT00502905|Immunologic Factors|immunologic factors|mesh-ancestor
25527111|NCT00502905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527112|NCT00502905|Antiviral Agents|antiviral agents|mesh-ancestor
25527113|NCT00502905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25527114|NCT00502905|Alkylating Agents|alkylating agents|mesh-ancestor
25527115|NCT00502905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25527116|NCT00502905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25527117|NCT00502996|Rituximab|rituximab|mesh-list
25527118|NCT00502996|Methotrexate|methotrexate|mesh-list
24994918|NCT00883480|Tubulin Modulators|tubulin modulators|mesh-ancestor
24994919|NCT00883480|Antimitotic Agents|antimitotic agents|mesh-ancestor
24994920|NCT00883480|Mitosis Modulators|mitosis modulators|mesh-ancestor
24994921|NCT00883480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24994922|NCT00446225|Carboplatin|carboplatin|mesh-list
24994923|NCT00446225|Docetaxel|docetaxel|mesh-list
24602181|NCT00967538|Etanercept|etanercept|mesh-list
25527119|NCT00502996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25527121|NCT00502996|Immunologic Factors|immunologic factors|mesh-ancestor
25527122|NCT00502996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527123|NCT00502996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25527124|NCT00502996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25527125|NCT00502996|Abortifacient Agents|abortifacient agents|mesh-ancestor
25527126|NCT00502996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25527127|NCT00502996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25527128|NCT00502996|Antimetabolites|antimetabolites|mesh-ancestor
25527129|NCT00502996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527130|NCT00502996|Dermatologic Agents|dermatologic agents|mesh-ancestor
25527131|NCT00502996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527132|NCT00502996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25527133|NCT00502996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25527134|NCT00502996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25527135|NCT00503113|Alendronate|alendronate|mesh-list
25527136|NCT00503113|Ibandronic Acid|ibandronic acid|mesh-list
25527137|NCT00503113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25527138|NCT00503113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527139|NCT00503139|Etanercept|etanercept|mesh-list
25527140|NCT00503139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25527141|NCT00503139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25527142|NCT00503139|Analgesics|analgesics|mesh-ancestor
25527143|NCT00503139|Sensory System Agents|sensory system agents|mesh-ancestor
25527144|NCT00503139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25527145|NCT00503139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527146|NCT00503139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25527147|NCT00503139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25527148|NCT00503139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25527149|NCT00503139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25527150|NCT00503139|Immunologic Factors|immunologic factors|mesh-ancestor
25527151|NCT00503399|Teriparatide|teriparatide|mesh-list
25527152|NCT00503399|Risedronic Acid|risedronic acid|mesh-list
25527153|NCT00503399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25527154|NCT00503399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655338|NCT01255891|Androgens|androgens|mesh-list
25527155|NCT00503399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25527156|NCT00503399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25527157|NCT00503399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25527158|NCT00503399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527159|NCT00503425|Rituximab|rituximab|mesh-list
25527160|NCT00503425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25527161|NCT00503425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527162|NCT00503425|Immunologic Factors|immunologic factors|mesh-ancestor
25646859|NCT01463202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25527163|NCT00503425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527164|NCT00503425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25527165|NCT00503685|Cetuximab|cetuximab|mesh-list
25527166|NCT00503685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25527167|NCT00503685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527168|NCT00503750|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25527169|NCT00503750|Vinorelbine|vinorelbine|mesh-list
25527170|NCT00503750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527171|NCT00503750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25527172|NCT00503750|Tubulin Modulators|tubulin modulators|mesh-ancestor
25527173|NCT00503750|Antimitotic Agents|antimitotic agents|mesh-ancestor
25527174|NCT00503750|Mitosis Modulators|mitosis modulators|mesh-ancestor
25527175|NCT00503750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527176|NCT00503776|Amifostine|amifostine|mesh-list
25527177|NCT00503776|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25527178|NCT00503776|Protective Agents|protective agents|mesh-ancestor
25527179|NCT00503776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527180|NCT00503906|Gemcitabine|gemcitabine|mesh-list
25527181|NCT00503906|Paclitaxel|paclitaxel|mesh-list
25527182|NCT00503906|Bevacizumab|bevacizumab|mesh-list
25527183|NCT00503906|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25527184|NCT00503906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25527185|NCT00503906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527186|NCT00503906|Tubulin Modulators|tubulin modulators|mesh-ancestor
25527187|NCT00503906|Antimitotic Agents|antimitotic agents|mesh-ancestor
25527188|NCT00503906|Mitosis Modulators|mitosis modulators|mesh-ancestor
25527189|NCT00503906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527190|NCT00503906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25527191|NCT00503906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25823509|NCT00004852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25527192|NCT00503906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25527194|NCT00503906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527195|NCT00503906|Growth Inhibitors|growth inhibitors|mesh-ancestor
25527196|NCT00503906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25527197|NCT00503906|Antimetabolites|antimetabolites|mesh-ancestor
25527198|NCT00503906|Antiviral Agents|antiviral agents|mesh-ancestor
25527199|NCT00503906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25527200|NCT00503906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527201|NCT00503906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25527202|NCT00503906|Immunologic Factors|immunologic factors|mesh-ancestor
25527203|NCT00503984|Prednisone|prednisone|mesh-list
25527204|NCT00503984|Docetaxel|docetaxel|mesh-list
25527205|NCT00503984|Azacitidine|azacitidine|mesh-list
25527206|NCT00503984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527207|NCT00503984|Tubulin Modulators|tubulin modulators|mesh-ancestor
25527208|NCT00503984|Antimitotic Agents|antimitotic agents|mesh-ancestor
25527209|NCT00503984|Mitosis Modulators|mitosis modulators|mesh-ancestor
25527210|NCT00503984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527211|NCT00503984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25527212|NCT00503984|Glucocorticoids|glucocorticoids|mesh-ancestor
25527213|NCT00503984|Hormones|hormones|mesh-ancestor
25527214|NCT00503984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25527215|NCT00503984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527216|NCT00503984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25527217|NCT00503984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25527218|NCT00503984|Antimetabolites|antimetabolites|mesh-ancestor
25527219|NCT00503984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527220|NCT00503997|Oxaliplatin|oxaliplatin|mesh-list
25527221|NCT00503997|Pemetrexed|pemetrexed|mesh-list
25527222|NCT00503997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527223|NCT00503997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527224|NCT00503997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527225|NCT00503997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25527226|NCT00503997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25527227|NCT00504023|Imiquimod|imiquimod|mesh-list
25527228|NCT00504023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25527229|NCT00504023|Immunologic Factors|immunologic factors|mesh-ancestor
25527230|NCT00504023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527231|NCT00504023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527232|NCT00504023|Interferon Inducers|interferon inducers|mesh-ancestor
25527233|NCT00504075|Immunoglobulins|immunoglobulins|mesh-list
25527234|NCT00504075|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25527235|NCT00504075|Antibodies|antibodies|mesh-list
25527236|NCT00504075|gamma-Globulins|gamma-globulins|mesh-list
25527237|NCT00504075|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25823510|NCT00004852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25527238|NCT00504075|Immunologic Factors|immunologic factors|mesh-ancestor
25527239|NCT00504075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527240|NCT00504153|Dasatinib|dasatinib|mesh-list
25527241|NCT00504153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527242|NCT00504153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25527243|NCT00504153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527244|NCT00504153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527245|NCT00504166|Alendronate|alendronate|mesh-list
25527246|NCT00504166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25527247|NCT00504166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527248|NCT00504257|Bevacizumab|bevacizumab|mesh-list
25527249|NCT00504257|Docetaxel|docetaxel|mesh-list
25527250|NCT00504257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25527251|NCT00504257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527252|NCT00504257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25527253|NCT00504257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25527254|NCT00504257|Growth Substances|growth substances|mesh-ancestor
25527255|NCT00504257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527256|NCT00504257|Growth Inhibitors|growth inhibitors|mesh-ancestor
25527257|NCT00504257|Tubulin Modulators|tubulin modulators|mesh-ancestor
25527258|NCT00504257|Antimitotic Agents|antimitotic agents|mesh-ancestor
25527259|NCT00504257|Mitosis Modulators|mitosis modulators|mesh-ancestor
25527260|NCT00504257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527261|NCT00504348|Tacrolimus|tacrolimus|mesh-list
25527262|NCT00504348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25823511|NCT00004852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163094|NCT02899182|Nitrous Oxide|nitrous oxide|mesh-list
24995065|NCT05418244|Autonomic Agents|autonomic agents|mesh-ancestor
24602924|NCT00971685|Hormones|hormones|mesh-ancestor
25527263|NCT00504348|Immunologic Factors|immunologic factors|mesh-ancestor
25527267|NCT00504348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527268|NCT00504504|Rituximab|rituximab|mesh-list
25527269|NCT00504504|Doxorubicin|doxorubicin|mesh-list
25527270|NCT00504504|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25527271|NCT00504504|Dacarbazine|dacarbazine|mesh-list
25527272|NCT00504504|Bleomycin|bleomycin|mesh-list
25527273|NCT00504504|Vinblastine|vinblastine|mesh-list
25527274|NCT00504504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25527275|NCT00504504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527276|NCT00504504|Immunologic Factors|immunologic factors|mesh-ancestor
25527277|NCT00504504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527278|NCT00504504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25527279|NCT00504504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25527280|NCT00504504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25527281|NCT00504504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25527282|NCT00504504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527283|NCT00504504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527284|NCT00504504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25527285|NCT00504504|Alkylating Agents|alkylating agents|mesh-ancestor
25527286|NCT00504504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25527287|NCT00504504|Tubulin Modulators|tubulin modulators|mesh-ancestor
25527288|NCT00504504|Antimitotic Agents|antimitotic agents|mesh-ancestor
25527289|NCT00504504|Mitosis Modulators|mitosis modulators|mesh-ancestor
25527290|NCT00504556|Warfarin|warfarin|mesh-list
25527291|NCT00504556|Edoxaban|edoxaban|mesh-list
25527292|NCT00504556|Anticoagulants|anticoagulants|mesh-ancestor
25527293|NCT00504556|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25527294|NCT00504556|Antithrombins|antithrombins|mesh-ancestor
25527295|NCT00504556|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25527296|NCT00504556|Protease Inhibitors|protease inhibitors|mesh-ancestor
25527297|NCT00504556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527298|NCT00504556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527299|NCT00504660|Celecoxib|celecoxib|mesh-list
25527300|NCT00504660|Capecitabine|capecitabine|mesh-list
25527301|NCT00504660|Thioguanine|thioguanine|mesh-list
25527302|NCT00504660|Temozolomide|temozolomide|mesh-list
25527303|NCT00504660|Lomustine|lomustine|mesh-list
25527304|NCT00504660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25527305|NCT00504660|Antimetabolites|antimetabolites|mesh-ancestor
25527306|NCT00504660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527307|NCT00504660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527308|NCT00504660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25527309|NCT00504660|Alkylating Agents|alkylating agents|mesh-ancestor
25527310|NCT00504660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25527311|NCT00504660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25527312|NCT00504660|Analgesics|analgesics|mesh-ancestor
25527313|NCT00504660|Sensory System Agents|sensory system agents|mesh-ancestor
25527314|NCT00504660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25527315|NCT00504660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527316|NCT00504660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25527317|NCT00504660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25527318|NCT00504660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25527319|NCT00504660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25527320|NCT00504660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527321|NCT00504725|Ketamine|ketamine|mesh-list
25527322|NCT00504725|Analgesics|analgesics|mesh-ancestor
25527323|NCT00504725|Sensory System Agents|sensory system agents|mesh-ancestor
25527324|NCT00504725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25527325|NCT00504725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527326|NCT00504725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25527327|NCT00504725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25527328|NCT00504725|Anesthetics, General|anesthetics, general|mesh-ancestor
25527329|NCT00504725|Anesthetics|anesthetics|mesh-ancestor
25527330|NCT00504725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25527331|NCT00504725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25527332|NCT00504725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25527333|NCT00504725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25527334|NCT00504725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527335|NCT00504751|Dexamethasone|dexamethasone|mesh-list
25527336|NCT00504751|Rituximab|rituximab|mesh-list
25527338|NCT00504751|Etoposide|etoposide|mesh-list
25527339|NCT00504751|Bortezomib|bortezomib|mesh-list
25527340|NCT00504751|Ifosfamide|ifosfamide|mesh-list
25527341|NCT00504751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25527342|NCT00504751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527343|NCT00504751|Immunologic Factors|immunologic factors|mesh-ancestor
25527344|NCT00504751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527345|NCT00504751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25527346|NCT00504751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25527347|NCT00504751|Antiemetics|antiemetics|mesh-ancestor
25527348|NCT00504751|Autonomic Agents|autonomic agents|mesh-ancestor
25527349|NCT00504751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25527350|NCT00504751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25527351|NCT00504751|Glucocorticoids|glucocorticoids|mesh-ancestor
25527352|NCT00504751|Hormones|hormones|mesh-ancestor
25527353|NCT00504751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25527354|NCT00504751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25527355|NCT00504751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25527356|NCT00504751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25527357|NCT00504751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25527358|NCT00504751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527359|NCT00504751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527360|NCT00504751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25527361|NCT00504751|Alkylating Agents|alkylating agents|mesh-ancestor
25527362|NCT00504777|Rituximab|rituximab|mesh-list
25527363|NCT00504777|Methotrexate|methotrexate|mesh-list
25527364|NCT00504777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25527365|NCT00504777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527366|NCT00504777|Immunologic Factors|immunologic factors|mesh-ancestor
25527367|NCT00504777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527368|NCT00504777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25527369|NCT00504777|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25527370|NCT00504777|Abortifacient Agents|abortifacient agents|mesh-ancestor
25527371|NCT00504777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25527372|NCT00504777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25527373|NCT00504777|Antimetabolites|antimetabolites|mesh-ancestor
25527374|NCT00504777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527375|NCT00504777|Dermatologic Agents|dermatologic agents|mesh-ancestor
25527376|NCT00504777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527377|NCT00504777|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25527378|NCT00504777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25527379|NCT00504777|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25527380|NCT00504829|Atorvastatin|atorvastatin|mesh-list
25527381|NCT00504829|Fenofibrate|fenofibrate|mesh-list
25527382|NCT00504829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25527383|NCT00504829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25527384|NCT00504829|Antimetabolites|antimetabolites|mesh-ancestor
25527385|NCT00504829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527386|NCT00504829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25527387|NCT00504829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25527388|NCT00504829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527389|NCT00504881|Brivaracetam|brivaracetam|mesh-list
25527390|NCT00504881|Anticonvulsants|anticonvulsants|mesh-ancestor
25527391|NCT00504894|Thiopental|thiopental|mesh-list
25527392|NCT00504894|Propofol|propofol|mesh-list
25527393|NCT00504894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25527394|NCT00504894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25527395|NCT00504894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527396|NCT00504894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25527397|NCT00504894|Anesthetics, General|anesthetics, general|mesh-ancestor
25527398|NCT00504894|Anesthetics|anesthetics|mesh-ancestor
25527399|NCT00504894|Anticonvulsants|anticonvulsants|mesh-ancestor
25527400|NCT00504894|GABA Modulators|gaba modulators|mesh-ancestor
25527401|NCT00504894|GABA Agents|gaba agents|mesh-ancestor
25527402|NCT00504894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25527403|NCT00504894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527404|NCT00505375|Abatacept|abatacept|mesh-list
24798019|NCT01959828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24798020|NCT01959828|Autonomic Agents|autonomic agents|mesh-ancestor
24798021|NCT01959828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24798022|NCT01959828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798023|NCT01959828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24798024|NCT01959828|Respiratory System Agents|respiratory system agents|mesh-ancestor
24798025|NCT01959828|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25527409|NCT00505375|Immunologic Factors|immunologic factors|mesh-ancestor
25527410|NCT00505375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527411|NCT00505375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25527412|NCT00505414|Morphine|morphine|mesh-list
25527413|NCT00505414|Tapentadol|tapentadol|mesh-list
25527414|NCT00505414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25527415|NCT00505414|Narcotics|narcotics|mesh-ancestor
25527416|NCT00505414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25527417|NCT00505414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527418|NCT00505414|Analgesics|analgesics|mesh-ancestor
25527419|NCT00505414|Sensory System Agents|sensory system agents|mesh-ancestor
25527420|NCT00505414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25527421|NCT00505414|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25527422|NCT00505414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25527423|NCT00505414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25527424|NCT00505414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527425|NCT00505414|Adrenergic Agents|adrenergic agents|mesh-ancestor
25527426|NCT00505414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25527427|NCT00505518|Psychotropic Drugs|psychotropic drugs|mesh-list
25527428|NCT00505635|Interferons|interferons|mesh-list
25527429|NCT00505635|Interferon-alpha|interferon-alpha|mesh-list
25527430|NCT00505635|Interferon alpha-2|interferon alpha-2|mesh-list
25527431|NCT00505635|Thalidomide|thalidomide|mesh-list
25527432|NCT00505635|Cisplatin|cisplatin|mesh-list
25527433|NCT00505635|Temozolomide|temozolomide|mesh-list
25527434|NCT00505635|Interleukin-2|interleukin-2|mesh-list
25527435|NCT00505635|Vinblastine|vinblastine|mesh-list
25527436|NCT00505635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527437|NCT00505635|Antiviral Agents|antiviral agents|mesh-ancestor
25527438|NCT00505635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25527439|NCT00505635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25527440|NCT00505635|Alkylating Agents|alkylating agents|mesh-ancestor
25527441|NCT00505635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527442|NCT00505635|Immunologic Factors|immunologic factors|mesh-ancestor
25527443|NCT00505635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527444|NCT00505635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25527445|NCT00505635|Analgesics|analgesics|mesh-ancestor
25527446|NCT00505635|Sensory System Agents|sensory system agents|mesh-ancestor
24861306|NCT02316899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25527447|NCT00505635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25527448|NCT00505635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25527449|NCT00505635|Leprostatic Agents|leprostatic agents|mesh-ancestor
25527450|NCT00505635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25527451|NCT00505635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25527452|NCT00505635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25527453|NCT00505635|Growth Substances|growth substances|mesh-ancestor
25527454|NCT00505635|Growth Inhibitors|growth inhibitors|mesh-ancestor
25527455|NCT00505635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25527456|NCT00505635|Tubulin Modulators|tubulin modulators|mesh-ancestor
25527457|NCT00505635|Antimitotic Agents|antimitotic agents|mesh-ancestor
25527458|NCT00505635|Mitosis Modulators|mitosis modulators|mesh-ancestor
25527459|NCT00505661|Letrozole|letrozole|mesh-list
25527460|NCT00505661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527461|NCT00505661|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25527462|NCT00505661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25527463|NCT00505661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527464|NCT00505661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527465|NCT00505661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25527466|NCT00505661|Hormone Antagonists|hormone antagonists|mesh-ancestor
25527467|NCT00505661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25527468|NCT00505661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527469|NCT00505687|Rotigotine|rotigotine|mesh-list
25527470|NCT00505687|Dopamine Agonists|dopamine agonists|mesh-ancestor
25527471|NCT00505687|Dopamine Agents|dopamine agents|mesh-ancestor
25527472|NCT00505687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25527473|NCT00505687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823512|NCT00004852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823513|NCT00004852|Antiviral Agents|antiviral agents|mesh-ancestor
25527479|NCT00505752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527480|NCT00505752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25527481|NCT00505778|Mesalamine|mesalamine|mesh-list
25527482|NCT00505778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25527483|NCT00505778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25527484|NCT00505778|Analgesics|analgesics|mesh-ancestor
25527485|NCT00505778|Sensory System Agents|sensory system agents|mesh-ancestor
25527486|NCT00505778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25527487|NCT00505778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527488|NCT00505778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25527489|NCT00505778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25527490|NCT00505895|Vidarabine|vidarabine|mesh-list
25527491|NCT00505895|Rituximab|rituximab|mesh-list
25527492|NCT00505895|Fludarabine|fludarabine|mesh-list
25527493|NCT00505895|Fludarabine phosphate|fludarabine phosphate|mesh-list
25527494|NCT00505895|Melphalan|melphalan|mesh-list
25527495|NCT00505895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25527496|NCT00505895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527497|NCT00505895|Immunologic Factors|immunologic factors|mesh-ancestor
25527498|NCT00505895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527499|NCT00505895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25527500|NCT00505895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25527501|NCT00505895|Antimetabolites|antimetabolites|mesh-ancestor
25527502|NCT00505895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527503|NCT00505895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25527504|NCT00505895|Antiviral Agents|antiviral agents|mesh-ancestor
25527505|NCT00505895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25527506|NCT00505895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25527507|NCT00505895|Alkylating Agents|alkylating agents|mesh-ancestor
25527508|NCT00505895|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25527509|NCT00505921|Cytarabine|cytarabine|mesh-list
25527510|NCT00505921|Cyclophosphamide|cyclophosphamide|mesh-list
25527511|NCT00505921|Melphalan|melphalan|mesh-list
25527512|NCT00505921|Carmustine|carmustine|mesh-list
25527513|NCT00505921|Fludarabine|fludarabine|mesh-list
25527514|NCT00505921|Fludarabine phosphate|fludarabine phosphate|mesh-list
25527515|NCT00505921|Etoposide|etoposide|mesh-list
25527516|NCT00505921|Etoposide phosphate|etoposide phosphate|mesh-list
25527517|NCT00505921|Molgramostim|molgramostim|mesh-list
25527518|NCT00505921|Alemtuzumab|alemtuzumab|mesh-list
25527519|NCT00505921|Sargramostim|sargramostim|mesh-list
25527520|NCT00505921|Lenograstim|lenograstim|mesh-list
25527521|NCT00505921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25527522|NCT00505921|Immunologic Factors|immunologic factors|mesh-ancestor
25527523|NCT00505921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527524|NCT00505921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25527525|NCT00505921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25527526|NCT00505921|Alkylating Agents|alkylating agents|mesh-ancestor
25527527|NCT00505921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527528|NCT00505921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527529|NCT00505921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25527530|NCT00505921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25527531|NCT00505921|Antimetabolites|antimetabolites|mesh-ancestor
25527532|NCT00505921|Antiviral Agents|antiviral agents|mesh-ancestor
25527533|NCT00505921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25527534|NCT00505921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24869583|NCT02804932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869584|NCT02804932|Sympathomimetics|sympathomimetics|mesh-ancestor
24869585|NCT02804932|Autonomic Agents|autonomic agents|mesh-ancestor
24869586|NCT02804932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25163096|NCT02899182|Anesthetics, General|anesthetics, general|mesh-ancestor
25163097|NCT02899182|Anesthetics|anesthetics|mesh-ancestor
25163098|NCT02899182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25163099|NCT02899182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646860|NCT01463202|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25646861|NCT01463202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25646862|NCT01463202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646863|NCT01463306|Pregabalin|pregabalin|mesh-list
25646864|NCT01463306|Analgesics|analgesics|mesh-ancestor
25823514|NCT00004852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25527546|NCT00506129|Melphalan|melphalan|mesh-list
25527547|NCT00506129|Thymoglobulin|thymoglobulin|mesh-list
25527548|NCT00506129|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25527549|NCT00506129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527550|NCT00506129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25527551|NCT00506129|Antimetabolites|antimetabolites|mesh-ancestor
25527552|NCT00506129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527553|NCT00506129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25527554|NCT00506129|Immunologic Factors|immunologic factors|mesh-ancestor
25527555|NCT00506129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527556|NCT00506129|Antiviral Agents|antiviral agents|mesh-ancestor
25527557|NCT00506129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25527558|NCT00506129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25527559|NCT00506129|Alkylating Agents|alkylating agents|mesh-ancestor
25527560|NCT00506129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25527561|NCT00506142|Vincristine|vincristine|mesh-list
25527562|NCT00506142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25527563|NCT00506142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527564|NCT00506142|Tubulin Modulators|tubulin modulators|mesh-ancestor
25527565|NCT00506142|Antimitotic Agents|antimitotic agents|mesh-ancestor
25527566|NCT00506142|Mitosis Modulators|mitosis modulators|mesh-ancestor
25527567|NCT00506142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527568|NCT00506155|Bevacizumab|bevacizumab|mesh-list
25527569|NCT00506155|Cisplatin|cisplatin|mesh-list
25527570|NCT00506155|Doxorubicin|doxorubicin|mesh-list
25527571|NCT00506155|Methotrexate|methotrexate|mesh-list
25527572|NCT00506155|Vinblastine|vinblastine|mesh-list
25527573|NCT00506155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25527574|NCT00506155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527575|NCT00506155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25527576|NCT00506155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25527577|NCT00506155|Growth Substances|growth substances|mesh-ancestor
25527578|NCT00506155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527579|NCT00506155|Growth Inhibitors|growth inhibitors|mesh-ancestor
25527580|NCT00506155|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25527581|NCT00506155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25527582|NCT00506155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25527583|NCT00506155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527584|NCT00506155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527585|NCT00506155|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25527586|NCT00506155|Abortifacient Agents|abortifacient agents|mesh-ancestor
25527587|NCT00506155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25527588|NCT00506155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25527589|NCT00506155|Antimetabolites|antimetabolites|mesh-ancestor
25527590|NCT00506155|Dermatologic Agents|dermatologic agents|mesh-ancestor
25527591|NCT00506155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25527592|NCT00506155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25527593|NCT00506155|Immunologic Factors|immunologic factors|mesh-ancestor
25527594|NCT00506155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24657877|NCT01269463|Methylphenidate|methylphenidate|mesh-list
25527595|NCT00506155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25527596|NCT00506155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24812542|NCT02053402|Vitamin D|vitamin d|mesh-list
24869710|NCT00563576|Contraceptive Agents|contraceptive agents|mesh-ancestor
25527597|NCT00506155|Tubulin Modulators|tubulin modulators|mesh-ancestor
25527598|NCT00506155|Antimitotic Agents|antimitotic agents|mesh-ancestor
25527599|NCT00506155|Mitosis Modulators|mitosis modulators|mesh-ancestor
25527600|NCT00506285|Methylphenidate|methylphenidate|mesh-list
25527601|NCT00506285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25527602|NCT00506285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527603|NCT00506285|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25527604|NCT00506285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25527605|NCT00506285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25527606|NCT00506285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527607|NCT00506285|Dopamine Agents|dopamine agents|mesh-ancestor
25527608|NCT00506285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25527609|NCT00506350|Vaccines|vaccines|mesh-list
25527610|NCT00506350|Immunologic Factors|immunologic factors|mesh-ancestor
25646865|NCT01463306|Sensory System Agents|sensory system agents|mesh-ancestor
25646866|NCT01463306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25646867|NCT01463306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646869|NCT01463306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25527611|NCT00506350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527612|NCT00506389|Mirtazapine|mirtazapine|mesh-list
25527613|NCT00506389|Antidepressive Agents|antidepressive agents|mesh-ancestor
25527614|NCT00506389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25527615|NCT00506389|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25527616|NCT00506389|Histamine Antagonists|histamine antagonists|mesh-ancestor
25527617|NCT00506389|Histamine Agents|histamine agents|mesh-ancestor
25527618|NCT00506389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25527619|NCT00506389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527620|NCT00506389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527621|NCT00506389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25527622|NCT00506389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25527623|NCT00506389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25527624|NCT00506389|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25527625|NCT00506389|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25527626|NCT00506389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25527627|NCT00506389|Adrenergic Agents|adrenergic agents|mesh-ancestor
25527628|NCT00506389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25527629|NCT00506389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25527630|NCT00506389|Serotonin Agents|serotonin agents|mesh-ancestor
25527631|NCT00506389|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25527632|NCT00506415|Rivastigmine|rivastigmine|mesh-list
25527633|NCT00506415|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25527634|NCT00506415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527635|NCT00506415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527636|NCT00506415|Cholinergic Agents|cholinergic agents|mesh-ancestor
25527637|NCT00506415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25527638|NCT00506415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527639|NCT00506415|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25527640|NCT00506415|Protective Agents|protective agents|mesh-ancestor
25527641|NCT00506519|Antithrombins|antithrombins|mesh-list
25527642|NCT00506519|Antithrombin III|antithrombin iii|mesh-list
25527643|NCT00506519|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25527644|NCT00506519|Protease Inhibitors|protease inhibitors|mesh-ancestor
25527645|NCT00506519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527646|NCT00506519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527647|NCT00506519|Anticoagulants|anticoagulants|mesh-ancestor
25527648|NCT00506597|Asparaginase|asparaginase|mesh-list
25527649|NCT00506597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527650|NCT00506662|Insulin|insulin|mesh-list
25527651|NCT00506662|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25527652|NCT00506662|Insulin Detemir|insulin detemir|mesh-list
25527653|NCT00506662|Isophane Insulin, Human|isophane insulin, human|mesh-list
25527654|NCT00506662|Insulin, Isophane|insulin, isophane|mesh-list
25527655|NCT00506662|Isophane insulin, beef|isophane insulin, beef|mesh-list
25527656|NCT00506662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25527657|NCT00506662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527658|NCT00506675|Atropine|atropine|mesh-list
25527659|NCT00506675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25527660|NCT00506675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25823515|NCT00004852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24995839|NCT04608344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995840|NCT04608344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24995841|NCT04608344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24995842|NCT04608344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549848|NCT00717730|Micronutrients|micronutrients|mesh-ancestor
25163102|NCT02899182|Sensory System Agents|sensory system agents|mesh-ancestor
25163103|NCT02899182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25527665|NCT00506675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25527666|NCT00506675|Respiratory System Agents|respiratory system agents|mesh-ancestor
25527667|NCT00506675|Mydriatics|mydriatics|mesh-ancestor
25527668|NCT00506675|Parasympatholytics|parasympatholytics|mesh-ancestor
25527669|NCT00506675|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25527670|NCT00506675|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25527671|NCT00506675|Cholinergic Agents|cholinergic agents|mesh-ancestor
25527672|NCT00506675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25527673|NCT00506675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527674|NCT00506779|Paclitaxel|paclitaxel|mesh-list
25527675|NCT00506779|Imatinib Mesylate|imatinib mesylate|mesh-list
25646870|NCT01463306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25527676|NCT00506779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25527677|NCT00506779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527678|NCT00506779|Tubulin Modulators|tubulin modulators|mesh-ancestor
25527679|NCT00506779|Antimitotic Agents|antimitotic agents|mesh-ancestor
25527680|NCT00506779|Mitosis Modulators|mitosis modulators|mesh-ancestor
25527681|NCT00506779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527682|NCT00506779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25527683|NCT00506779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527684|NCT00506831|Imatinib Mesylate|imatinib mesylate|mesh-list
25527685|NCT00506831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527686|NCT00506831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25527687|NCT00506831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527688|NCT00506831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527689|NCT00506857|Vidarabine|vidarabine|mesh-list
25527690|NCT00506857|Fludarabine|fludarabine|mesh-list
25527691|NCT00506857|Fludarabine phosphate|fludarabine phosphate|mesh-list
25527692|NCT00506857|Busulfan|busulfan|mesh-list
25527693|NCT00506857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527694|NCT00506857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25527695|NCT00506857|Antimetabolites|antimetabolites|mesh-ancestor
25527696|NCT00506857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527697|NCT00506857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25527698|NCT00506857|Immunologic Factors|immunologic factors|mesh-ancestor
25527699|NCT00506857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527700|NCT00506857|Antiviral Agents|antiviral agents|mesh-ancestor
25527701|NCT00506857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25527702|NCT00506857|Alkylating Agents|alkylating agents|mesh-ancestor
25527703|NCT00506857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25527704|NCT00506857|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25527705|NCT00506883|Colchicine|colchicine|mesh-list
25527706|NCT00506883|Gout Suppressants|gout suppressants|mesh-ancestor
25527707|NCT00506883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25527708|NCT00506883|Tubulin Modulators|tubulin modulators|mesh-ancestor
25527709|NCT00506883|Antimitotic Agents|antimitotic agents|mesh-ancestor
25527710|NCT00506883|Mitosis Modulators|mitosis modulators|mesh-ancestor
25527711|NCT00506883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527712|NCT00506883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527713|NCT00506922|Methotrexate|methotrexate|mesh-list
25527714|NCT00506922|Pentostatin|pentostatin|mesh-list
25527715|NCT00506922|Tacrolimus|tacrolimus|mesh-list
25527716|NCT00506922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25527717|NCT00506922|Abortifacient Agents|abortifacient agents|mesh-ancestor
25527718|NCT00506922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25527719|NCT00506922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527720|NCT00506922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25527721|NCT00506922|Antimetabolites|antimetabolites|mesh-ancestor
25527722|NCT00506922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527723|NCT00506922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527724|NCT00506922|Dermatologic Agents|dermatologic agents|mesh-ancestor
25527725|NCT00506922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527726|NCT00506922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25527727|NCT00506922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24630766|NCT01113489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823516|NCT00004852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25823517|NCT00004852|Antimetabolites|antimetabolites|mesh-ancestor
25823518|NCT00004852|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25527728|NCT00506922|Immunologic Factors|immunologic factors|mesh-ancestor
25527729|NCT00506922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25527730|NCT00506922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25527731|NCT00506922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25527732|NCT00506922|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25527733|NCT00506948|Mycophenolic Acid|mycophenolic acid|mesh-list
25527734|NCT00506948|Sirolimus|sirolimus|mesh-list
25527735|NCT00506948|Thymoglobulin|thymoglobulin|mesh-list
25527736|NCT00506948|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25527737|NCT00506948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25527738|NCT00506948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527739|NCT00506948|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25527740|NCT00506948|Antitubercular Agents|antitubercular agents|mesh-ancestor
25527741|NCT00506948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25527742|NCT00506948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25527743|NCT00506948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527744|NCT00506948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527745|NCT00506948|Antifungal Agents|antifungal agents|mesh-ancestor
25527746|NCT00506948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25527747|NCT00506948|Immunologic Factors|immunologic factors|mesh-ancestor
25527748|NCT00506948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527750|NCT00507026|Ketorolac|ketorolac|mesh-list
25527751|NCT00507026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25527752|NCT00507026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25527753|NCT00507026|Analgesics|analgesics|mesh-ancestor
25527754|NCT00507026|Sensory System Agents|sensory system agents|mesh-ancestor
25527755|NCT00507026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25527756|NCT00507026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527757|NCT00507026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25527758|NCT00507026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25527759|NCT00507026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25527760|NCT00507026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527761|NCT00507026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527762|NCT00507416|Thalidomide|thalidomide|mesh-list
25527763|NCT00507416|Dexamethasone|dexamethasone|mesh-list
25527764|NCT00507416|Prednisone|prednisone|mesh-list
25527765|NCT00507416|Bortezomib|bortezomib|mesh-list
25527766|NCT00507416|Melphalan|melphalan|mesh-list
25527767|NCT00507416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25527768|NCT00507416|Antiemetics|antiemetics|mesh-ancestor
25527769|NCT00507416|Autonomic Agents|autonomic agents|mesh-ancestor
25527770|NCT00507416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25527771|NCT00507416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527772|NCT00507416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25527773|NCT00507416|Glucocorticoids|glucocorticoids|mesh-ancestor
25527774|NCT00507416|Hormones|hormones|mesh-ancestor
25527775|NCT00507416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25527776|NCT00507416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25527777|NCT00507416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527778|NCT00507416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25527779|NCT00507416|Alkylating Agents|alkylating agents|mesh-ancestor
25527780|NCT00507416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527781|NCT00507416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25527782|NCT00507416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25527783|NCT00507416|Immunologic Factors|immunologic factors|mesh-ancestor
25527784|NCT00507416|Leprostatic Agents|leprostatic agents|mesh-ancestor
25527785|NCT00507416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25527786|NCT00507416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25527787|NCT00507416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25527788|NCT00507416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25527789|NCT00507416|Growth Substances|growth substances|mesh-ancestor
25527790|NCT00507416|Growth Inhibitors|growth inhibitors|mesh-ancestor
25527791|NCT00507429|Paclitaxel|paclitaxel|mesh-list
25527792|NCT00507429|Fosbretabulin|fosbretabulin|mesh-list
25527793|NCT00507429|Combretastatin|combretastatin|mesh-list
25527794|NCT00507429|Carboplatin|carboplatin|mesh-list
25527795|NCT00507429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25527796|NCT00507429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527797|NCT00507429|Tubulin Modulators|tubulin modulators|mesh-ancestor
24766718|NCT01796366|Insulin|insulin|mesh-list
24941719|NCT03988452|Darunavir|darunavir|mesh-list
24941720|NCT03988452|Tenofovir|tenofovir|mesh-list
24941721|NCT03988452|Lamivudine|lamivudine|mesh-list
24941722|NCT03988452|Zidovudine|zidovudine|mesh-list
24941723|NCT03988452|Dolutegravir|dolutegravir|mesh-list
24941724|NCT03988452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24423156|NCT00224822|Aripiprazole|aripiprazole|mesh-list
25527799|NCT00507429|Mitosis Modulators|mitosis modulators|mesh-ancestor
25527800|NCT00507429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527801|NCT00507442|Dexamethasone|dexamethasone|mesh-list
25527802|NCT00507442|Cyclophosphamide|cyclophosphamide|mesh-list
25527803|NCT00507442|Lenalidomide|lenalidomide|mesh-list
25527804|NCT00507442|Bortezomib|bortezomib|mesh-list
25527805|NCT00507442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25527806|NCT00507442|Immunologic Factors|immunologic factors|mesh-ancestor
25527807|NCT00507442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527808|NCT00507442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25527809|NCT00507442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25527810|NCT00507442|Alkylating Agents|alkylating agents|mesh-ancestor
25527811|NCT00507442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527812|NCT00507442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527813|NCT00507442|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25527814|NCT00507442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25527815|NCT00507442|Antiemetics|antiemetics|mesh-ancestor
25527816|NCT00507442|Autonomic Agents|autonomic agents|mesh-ancestor
25527817|NCT00507442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25527818|NCT00507442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25527819|NCT00507442|Glucocorticoids|glucocorticoids|mesh-ancestor
25527820|NCT00507442|Hormones|hormones|mesh-ancestor
25527821|NCT00507442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25527822|NCT00507442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25527823|NCT00507442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25527824|NCT00507442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25527825|NCT00507442|Growth Substances|growth substances|mesh-ancestor
25527826|NCT00507442|Growth Inhibitors|growth inhibitors|mesh-ancestor
25527827|NCT00507455|Tamsulosin|tamsulosin|mesh-list
25527828|NCT00507455|Solifenacin Succinate|solifenacin succinate|mesh-list
25527829|NCT00507455|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25527830|NCT00507455|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25527831|NCT00507455|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25527832|NCT00507455|Adrenergic Agents|adrenergic agents|mesh-ancestor
25527833|NCT00507455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25527834|NCT00507455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527835|NCT00507455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527836|NCT00507455|Urological Agents|urological agents|mesh-ancestor
25527837|NCT00507455|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25527838|NCT00507455|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25527839|NCT00507455|Cholinergic Agents|cholinergic agents|mesh-ancestor
25527840|NCT00507507|Tenofovir|tenofovir|mesh-list
25527841|NCT00507507|Antiviral Agents|antiviral agents|mesh-ancestor
25527842|NCT00507507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25527843|NCT00507507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25527844|NCT00507507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25527845|NCT00507507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527846|NCT00507507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527847|NCT00507507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25527848|NCT00507507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25527849|NCT00507689|Immunoglobulins|immunoglobulins|mesh-list
25527850|NCT00507689|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25527851|NCT00507689|Antibodies|antibodies|mesh-list
25527852|NCT00507689|Immunologic Factors|immunologic factors|mesh-ancestor
25527853|NCT00507689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527854|NCT00507728|Bupropion|bupropion|mesh-list
25527855|NCT00507728|Varenicline|varenicline|mesh-list
25527856|NCT00507728|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25527857|NCT00507728|Antidepressive Agents|antidepressive agents|mesh-ancestor
25527858|NCT00507728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25527859|NCT00507728|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25527860|NCT00507728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25527861|NCT00507728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25527862|NCT00507728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527863|NCT00507728|Dopamine Agents|dopamine agents|mesh-ancestor
25823519|NCT00004852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25823520|NCT00004852|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25823521|NCT00004852|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25823522|NCT00004852|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25823523|NCT00004852|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25823524|NCT00004853|Lenograstim|lenograstim|mesh-list
25823525|NCT00004853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25527896|NCT00508118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527897|NCT00508118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25527899|NCT00508118|Vasodilator Agents|vasodilator agents|mesh-ancestor
24996315|NCT03774472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996316|NCT03774472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996317|NCT03774472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25527900|NCT00508144|Pemetrexed|pemetrexed|mesh-list
25527901|NCT00508144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527902|NCT00508144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527903|NCT00508144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527904|NCT00508144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25527905|NCT00508144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25527906|NCT00508157|Olanzapine|olanzapine|mesh-list
25527907|NCT00508157|Risperidone|risperidone|mesh-list
25527908|NCT00508157|Aripiprazole|aripiprazole|mesh-list
25527909|NCT00508157|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25527910|NCT00508157|Antipsychotic Agents|antipsychotic agents|mesh-list
25527911|NCT00508157|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25527912|NCT00508157|Serotonin Agents|serotonin agents|mesh-ancestor
25527913|NCT00508157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25527914|NCT00508157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823526|NCT00004853|Immunologic Factors|immunologic factors|mesh-ancestor
25646871|NCT01463306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527915|NCT00508157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527916|NCT00508157|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25527917|NCT00508157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25527918|NCT00508157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25527919|NCT00508157|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25527920|NCT00508157|Dopamine Agents|dopamine agents|mesh-ancestor
25527921|NCT00508157|Antiemetics|antiemetics|mesh-ancestor
25527922|NCT00508157|Autonomic Agents|autonomic agents|mesh-ancestor
25527923|NCT00508157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25527924|NCT00508157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25527925|NCT00508157|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25527926|NCT00508157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25527927|NCT00508157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25527928|NCT00508157|Antidepressive Agents|antidepressive agents|mesh-ancestor
25527929|NCT00508157|Dopamine Agonists|dopamine agonists|mesh-ancestor
25527930|NCT00508157|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25527931|NCT00508157|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25527932|NCT00508157|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25527933|NCT00508157|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25527934|NCT00508274|Capecitabine|capecitabine|mesh-list
25527935|NCT00508274|Lapatinib|lapatinib|mesh-list
25527936|NCT00508274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25527937|NCT00508274|Antimetabolites|antimetabolites|mesh-ancestor
25527938|NCT00508274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527939|NCT00508274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527940|NCT00508274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25527941|NCT00508274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527942|NCT00508404|Panitumumab|panitumumab|mesh-list
25527943|NCT00508404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25527944|NCT00508404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527945|NCT00508469|Timolol|timolol|mesh-list
25527946|NCT00508469|Travoprost|travoprost|mesh-list
25527947|NCT00508469|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25527948|NCT00508469|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25527949|NCT00508469|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25527950|NCT00508469|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25527951|NCT00508469|Adrenergic Agents|adrenergic agents|mesh-ancestor
25527952|NCT00508469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25527953|NCT00508469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527954|NCT00508469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527955|NCT00508469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25527956|NCT00508469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25527957|NCT00508482|Lactulose|lactulose|mesh-list
25527958|NCT00508482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25527959|NCT00508742|Vaccines|vaccines|mesh-list
25527960|NCT00508742|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25527961|NCT00508742|Immunologic Factors|immunologic factors|mesh-ancestor
25527962|NCT00508742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527963|NCT00508924|Heparin|heparin|mesh-list
25527964|NCT00508924|Argatroban|argatroban|mesh-list
25527965|NCT00508924|Anticoagulants|anticoagulants|mesh-ancestor
25527966|NCT00508924|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25527967|NCT00508924|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24798165|NCT01961193|Trace Elements|trace elements|mesh-ancestor
24798166|NCT01961193|Micronutrients|micronutrients|mesh-ancestor
24934341|NCT04061772|Hormones|hormones|mesh-ancestor
24996388|NCT03568708|Hormones|hormones|mesh-ancestor
24934403|NCT04061512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24934404|NCT04061512|Antiemetics|antiemetics|mesh-ancestor
24934405|NCT04061512|Autonomic Agents|autonomic agents|mesh-ancestor
24934406|NCT04061512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24934408|NCT04061512|Glucocorticoids|glucocorticoids|mesh-ancestor
25527968|NCT00508924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527970|NCT00508924|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25527971|NCT00508924|Protease Inhibitors|protease inhibitors|mesh-ancestor
25527972|NCT00508924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527973|NCT00508924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25527974|NCT00509002|Gefitinib|gefitinib|mesh-list
25527975|NCT00509002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527976|NCT00509002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25527977|NCT00509002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527978|NCT00509002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527979|NCT00509028|Budesonide|budesonide|mesh-list
25527980|NCT00509028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25646872|NCT01463306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25646873|NCT01463306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25646874|NCT01463306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25646875|NCT01463306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25527981|NCT00509028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25527982|NCT00509028|Autonomic Agents|autonomic agents|mesh-ancestor
25527983|NCT00509028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25527984|NCT00509028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25527985|NCT00509028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25527986|NCT00509028|Respiratory System Agents|respiratory system agents|mesh-ancestor
25527987|NCT00509028|Glucocorticoids|glucocorticoids|mesh-ancestor
25527989|NCT00509028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25527990|NCT00509041|Dasatinib|dasatinib|mesh-list
25527991|NCT00509041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25527992|NCT00509041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25527993|NCT00509041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25527994|NCT00509041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25527995|NCT00509067|Olanzapine|olanzapine|mesh-list
25527996|NCT00509067|Risperidone|risperidone|mesh-list
25527997|NCT00509067|Aripiprazole|aripiprazole|mesh-list
25527998|NCT00509067|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25527999|NCT00509067|Ziprasidone|ziprasidone|mesh-list
25528000|NCT00509067|Choline|choline|mesh-list
25528001|NCT00509067|Galantamine|galantamine|mesh-list
25528002|NCT00509067|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
25528003|NCT00509067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25528004|NCT00509067|Serotonin Agents|serotonin agents|mesh-ancestor
25528005|NCT00509067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25528006|NCT00509067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528007|NCT00509067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528008|NCT00509067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25528009|NCT00509067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25528010|NCT00509067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25528011|NCT00509067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25528012|NCT00509067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25528013|NCT00509067|Dopamine Agents|dopamine agents|mesh-ancestor
25528014|NCT00509067|Antiemetics|antiemetics|mesh-ancestor
25528015|NCT00509067|Autonomic Agents|autonomic agents|mesh-ancestor
25528016|NCT00509067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25528017|NCT00509067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25528018|NCT00509067|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25528019|NCT00509067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25528020|NCT00509067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25528021|NCT00509067|Antidepressive Agents|antidepressive agents|mesh-ancestor
25528022|NCT00509067|Dopamine Agonists|dopamine agonists|mesh-ancestor
25528023|NCT00509067|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25528024|NCT00509067|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25528025|NCT00509067|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25528026|NCT00509067|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25528027|NCT00509067|Lipotropic Agents|lipotropic agents|mesh-ancestor
25528028|NCT00509067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25528029|NCT00509067|Antimetabolites|antimetabolites|mesh-ancestor
25528030|NCT00509067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25528031|NCT00509067|Nootropic Agents|nootropic agents|mesh-ancestor
25528032|NCT00509067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25528033|NCT00509067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528034|NCT00509067|Cholinergic Agents|cholinergic agents|mesh-ancestor
25528035|NCT00509067|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25528036|NCT00509093|Imatinib Mesylate|imatinib mesylate|mesh-list
25528037|NCT00509093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528038|NCT00509093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25528039|NCT00509093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528040|NCT00509093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528041|NCT00509106|Ceftriaxone|ceftriaxone|mesh-list
25528042|NCT00509106|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
25528043|NCT00509106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25528044|NCT00509106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25528045|NCT00509197|Fluticasone|fluticasone|mesh-list
25528046|NCT00509197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25528047|NCT00509197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25528048|NCT00509197|Autonomic Agents|autonomic agents|mesh-ancestor
25528049|NCT00509197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25528050|NCT00509197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528051|NCT00509197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25646877|NCT01463384|Minocycline|minocycline|mesh-list
25646878|NCT01463384|Tetracycline|tetracycline|mesh-list
25646879|NCT01463384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25528052|NCT00509197|Respiratory System Agents|respiratory system agents|mesh-ancestor
25528053|NCT00509197|Dermatologic Agents|dermatologic agents|mesh-ancestor
25528054|NCT00509197|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25528055|NCT00509236|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25528056|NCT00509236|Glipizide|glipizide|mesh-list
25528057|NCT00509236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25528058|NCT00509236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528059|NCT00509236|Incretins|incretins|mesh-ancestor
25528060|NCT00509236|Hormones|hormones|mesh-ancestor
25528061|NCT00509236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25528062|NCT00509236|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25528063|NCT00509236|Protease Inhibitors|protease inhibitors|mesh-ancestor
25528064|NCT00509236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528065|NCT00509236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528066|NCT00509249|Aflibercept|aflibercept|mesh-list
25528067|NCT00509249|Endothelial Growth Factors|endothelial growth factors|mesh-list
25528068|NCT00509249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25528069|NCT00509249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25528070|NCT00509249|Growth Substances|growth substances|mesh-ancestor
25528071|NCT00509249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528072|NCT00509249|Growth Inhibitors|growth inhibitors|mesh-ancestor
25528073|NCT00509249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528074|NCT00509262|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25528075|NCT00509262|Glipizide|glipizide|mesh-list
25528076|NCT00509262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25528077|NCT00509262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528078|NCT00509262|Incretins|incretins|mesh-ancestor
25528079|NCT00509262|Hormones|hormones|mesh-ancestor
25528080|NCT00509262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25528081|NCT00509262|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25528082|NCT00509262|Protease Inhibitors|protease inhibitors|mesh-ancestor
25528083|NCT00509262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528084|NCT00509262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528085|NCT00509288|Aldesleukin|aldesleukin|mesh-list
25528086|NCT00509288|Cyclophosphamide|cyclophosphamide|mesh-list
25528087|NCT00509288|Fludarabine|fludarabine|mesh-list
25528088|NCT00509288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25528089|NCT00509288|Immunologic Factors|immunologic factors|mesh-ancestor
25528090|NCT00509288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528091|NCT00509288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25528092|NCT00509288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25528093|NCT00509288|Alkylating Agents|alkylating agents|mesh-ancestor
25528094|NCT00509288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528095|NCT00509288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528096|NCT00509288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25528097|NCT00509288|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25528098|NCT00509288|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25528099|NCT00509288|Antiviral Agents|antiviral agents|mesh-ancestor
25528100|NCT00509288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25528101|NCT00509366|Gemcitabine|gemcitabine|mesh-list
25528102|NCT00509366|Cisplatin|cisplatin|mesh-list
25528103|NCT00509366|Docetaxel|docetaxel|mesh-list
25528104|NCT00509366|Pemetrexed|pemetrexed|mesh-list
25528105|NCT00509366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528106|NCT00509366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25528107|NCT00509366|Antimetabolites|antimetabolites|mesh-ancestor
25528108|NCT00509366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528109|NCT00509366|Antiviral Agents|antiviral agents|mesh-ancestor
25528110|NCT00509366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25163145|NCT02898961|Gentamicins|gentamicins|mesh-list
25163146|NCT02898961|Amikacin|amikacin|mesh-list
25163147|NCT02898961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25163148|NCT02898961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25163149|NCT02898961|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25163150|NCT02898961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163151|NCT02898961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163152|NCT02898792|Remifentanil|remifentanil|mesh-list
25528111|NCT00509366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528112|NCT00509366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25528113|NCT00509366|Immunologic Factors|immunologic factors|mesh-ancestor
25528114|NCT00509366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528115|NCT00509366|Tubulin Modulators|tubulin modulators|mesh-ancestor
25528117|NCT00509366|Mitosis Modulators|mitosis modulators|mesh-ancestor
25528118|NCT00509366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25528119|NCT00509366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25528121|NCT00509496|Cyclophosphamide|cyclophosphamide|mesh-list
25528122|NCT00509496|Fludarabine|fludarabine|mesh-list
25528123|NCT00509496|Fludarabine phosphate|fludarabine phosphate|mesh-list
25528124|NCT00509496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25528125|NCT00509496|Immunologic Factors|immunologic factors|mesh-ancestor
25528126|NCT00509496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528127|NCT00509496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25528128|NCT00509496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25528129|NCT00509496|Alkylating Agents|alkylating agents|mesh-ancestor
25528130|NCT00509496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528131|NCT00509496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528132|NCT00509496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25528133|NCT00509496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25528134|NCT00509496|Antimetabolites|antimetabolites|mesh-ancestor
25528135|NCT00509496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25528136|NCT00509496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25528137|NCT00509496|Antiviral Agents|antiviral agents|mesh-ancestor
25528138|NCT00509496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25528139|NCT00509665|Gemcitabine|gemcitabine|mesh-list
25528140|NCT00509665|Doxorubicin|doxorubicin|mesh-list
25528141|NCT00509665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25528142|NCT00509665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25528143|NCT00509665|Antimetabolites|antimetabolites|mesh-ancestor
25528144|NCT00509665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528145|NCT00509665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528146|NCT00509665|Antiviral Agents|antiviral agents|mesh-ancestor
25528147|NCT00509665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25528148|NCT00509665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528149|NCT00509665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25528150|NCT00509665|Immunologic Factors|immunologic factors|mesh-ancestor
25528151|NCT00509665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528152|NCT00509665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24862474|NCT02325583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25528153|NCT00509665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25528154|NCT00509665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25528155|NCT00509769|Trastuzumab|trastuzumab|mesh-list
25528156|NCT00509769|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25528157|NCT00509769|Maytansine|maytansine|mesh-list
25528158|NCT00509769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25528159|NCT00509769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528160|NCT00509769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25528161|NCT00509769|Tubulin Modulators|tubulin modulators|mesh-ancestor
25528162|NCT00509769|Antimitotic Agents|antimitotic agents|mesh-ancestor
25528163|NCT00509769|Mitosis Modulators|mitosis modulators|mesh-ancestor
25528164|NCT00509769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528165|NCT00509795|Ranibizumab|ranibizumab|mesh-list
25528166|NCT00509795|Aflibercept|aflibercept|mesh-list
25528167|NCT00509795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25528168|NCT00509795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25528169|NCT00509795|Growth Substances|growth substances|mesh-ancestor
25528170|NCT00509795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528171|NCT00509795|Growth Inhibitors|growth inhibitors|mesh-ancestor
25528172|NCT00509795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528173|NCT00509873|Gatifloxacin|gatifloxacin|mesh-list
25528174|NCT00509873|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25528175|NCT00509873|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25528176|NCT00509873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25528177|NCT00509873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25528178|NCT00509873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25528179|NCT00509873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25528180|NCT00509873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528181|NCT00509873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528182|NCT00509873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528183|NCT00509925|Insulin|insulin|mesh-list
25528184|NCT00509925|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25528185|NCT00509925|Insulin Aspart|insulin aspart|mesh-list
25528186|NCT00509925|Insulin Detemir|insulin detemir|mesh-list
25528187|NCT00509925|Isophane Insulin, Human|isophane insulin, human|mesh-list
25528188|NCT00509925|Insulin, Isophane|insulin, isophane|mesh-list
25528189|NCT00509925|Isophane insulin, beef|isophane insulin, beef|mesh-list
25528190|NCT00509925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25528191|NCT00509925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528192|NCT00510068|Everolimus|everolimus|mesh-list
25528193|NCT00510068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528194|NCT00510068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25528196|NCT00510068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528197|NCT00510146|Olanzapine|olanzapine|mesh-list
25528198|NCT00510146|Antiemetics|antiemetics|mesh-ancestor
25528199|NCT00510146|Autonomic Agents|autonomic agents|mesh-ancestor
25528200|NCT00510146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25528201|NCT00510146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528202|NCT00510146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25528203|NCT00510146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25528204|NCT00510146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25528205|NCT00510146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25528206|NCT00510146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25528207|NCT00510146|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25528208|NCT00510146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25528209|NCT00510146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25528210|NCT00510146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528211|NCT00510146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25528212|NCT00510146|Serotonin Agents|serotonin agents|mesh-ancestor
25528213|NCT00510224|Octreotide|octreotide|mesh-list
25528214|NCT00510224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25528215|NCT00510224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25528216|NCT00510224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528217|NCT00510276|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25528218|NCT00510276|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25528219|NCT00510276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25528220|NCT00510276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25528221|NCT00510276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528222|NCT00510276|Adrenergic Agents|adrenergic agents|mesh-ancestor
25528223|NCT00510276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25528224|NCT00510276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528225|NCT00510289|Sorafenib|sorafenib|mesh-list
25528226|NCT00510289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528227|NCT00510289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25528228|NCT00510289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528229|NCT00510289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528230|NCT00510484|Pancrelipase|pancrelipase|mesh-list
25528231|NCT00510484|Pancreatin|pancreatin|mesh-list
25528232|NCT00510484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25528233|NCT00510510|Glycopyrrolate|glycopyrrolate|mesh-list
25528234|NCT00510510|Bromides|bromides|mesh-list
25528235|NCT00510510|Anticonvulsants|anticonvulsants|mesh-ancestor
25528236|NCT00510510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25528237|NCT00510510|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25528238|NCT00510510|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25528239|NCT00510510|Cholinergic Agents|cholinergic agents|mesh-ancestor
25528240|NCT00510510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25528241|NCT00510510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528242|NCT00510510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528243|NCT00510653|Imatinib Mesylate|imatinib mesylate|mesh-list
25528244|NCT00510653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528245|NCT00510653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25528246|NCT00510653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528247|NCT00510653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528248|NCT00510783|Phenytoin|phenytoin|mesh-list
25528249|NCT00510783|Fosphenytoin|fosphenytoin|mesh-list
25528250|NCT00510783|Levetiracetam|levetiracetam|mesh-list
25528251|NCT00510783|Anticonvulsants|anticonvulsants|mesh-ancestor
25528252|NCT00510783|Nootropic Agents|nootropic agents|mesh-ancestor
25528253|NCT00510783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25528254|NCT00510783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25528255|NCT00510783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25528256|NCT00510783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528257|NCT00510783|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25528258|NCT00510783|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25528259|NCT00510809|Ethanol|ethanol|mesh-list
25528260|NCT00510809|Policosanol|policosanol|mesh-list
25528261|NCT00510809|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
25528262|NCT00510809|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25528263|NCT00510809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25528264|NCT00510809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25528265|NCT00510809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528266|NCT00510809|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25528268|NCT00510809|Antimetabolites|antimetabolites|mesh-ancestor
25528269|NCT00510809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528270|NCT00510809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528271|NCT00510809|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25528272|NCT00510809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25528273|NCT00510887|Dexamethasone|dexamethasone|mesh-list
25528274|NCT00510887|Rituximab|rituximab|mesh-list
25528275|NCT00510887|Fludarabine|fludarabine|mesh-list
25528276|NCT00510887|Bortezomib|bortezomib|mesh-list
25528277|NCT00510887|Mitoxantrone|mitoxantrone|mesh-list
25528278|NCT00510887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25528279|NCT00510887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528280|NCT00510887|Immunologic Factors|immunologic factors|mesh-ancestor
25528281|NCT00510887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528282|NCT00510887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25528283|NCT00510887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25528284|NCT00510887|Antiemetics|antiemetics|mesh-ancestor
25528285|NCT00510887|Autonomic Agents|autonomic agents|mesh-ancestor
25528286|NCT00510887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25528287|NCT00510887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25528288|NCT00510887|Glucocorticoids|glucocorticoids|mesh-ancestor
25528289|NCT00510887|Hormones|hormones|mesh-ancestor
25528290|NCT00510887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25528291|NCT00510887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25528292|NCT00510887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528293|NCT00510887|Analgesics|analgesics|mesh-ancestor
25528294|NCT00510887|Sensory System Agents|sensory system agents|mesh-ancestor
25528295|NCT00510887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25528296|NCT00510887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25528297|NCT00510887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528298|NCT00510952|Insulin|insulin|mesh-list
25528299|NCT00510952|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25528300|NCT00510952|Insulin Glargine|insulin glargine|mesh-list
25528301|NCT00510952|Insulin Lispro|insulin lispro|mesh-list
25528302|NCT00510952|Protamines|protamines|mesh-list
25528303|NCT00510952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25528304|NCT00510952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528305|NCT00510952|Heparin Antagonists|heparin antagonists|mesh-ancestor
25528306|NCT00510952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528307|NCT00510952|Coagulants|coagulants|mesh-ancestor
25528308|NCT00511004|Albendazole|albendazole|mesh-list
25528309|NCT00511004|Diethylcarbamazine|diethylcarbamazine|mesh-list
25528310|NCT00511004|Anthelmintics|anthelmintics|mesh-ancestor
25528311|NCT00511004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25528312|NCT00511004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25528313|NCT00511004|Anticestodal Agents|anticestodal agents|mesh-ancestor
25528314|NCT00511004|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25528315|NCT00511004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25528316|NCT00511004|Tubulin Modulators|tubulin modulators|mesh-ancestor
25528317|NCT00511004|Antimitotic Agents|antimitotic agents|mesh-ancestor
25528318|NCT00511004|Mitosis Modulators|mitosis modulators|mesh-ancestor
25528319|NCT00511004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528320|NCT00511004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528321|NCT00511004|Filaricides|filaricides|mesh-ancestor
25528322|NCT00511004|Antinematodal Agents|antinematodal agents|mesh-ancestor
25528323|NCT00511004|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25528324|NCT00511004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528325|NCT00511108|Pioglitazone|pioglitazone|mesh-list
25528326|NCT00511108|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25528327|NCT00511108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25528328|NCT00511108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528329|NCT00511108|Incretins|incretins|mesh-ancestor
25528330|NCT00511108|Hormones|hormones|mesh-ancestor
25528331|NCT00511108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25528332|NCT00511108|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25528333|NCT00511108|Protease Inhibitors|protease inhibitors|mesh-ancestor
24800747|NCT01978301|Immunologic Factors|immunologic factors|mesh-ancestor
24800748|NCT01978301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800750|NCT01978405|Thioctic Acid|thioctic acid|mesh-list
25528334|NCT00511108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528335|NCT00511108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528337|NCT00511147|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25528338|NCT00511147|gamma-Globulins|gamma-globulins|mesh-list
25528339|NCT00511147|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25528340|NCT00511147|Immunologic Factors|immunologic factors|mesh-ancestor
25528341|NCT00511147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528342|NCT00511173|Warfarin|warfarin|mesh-list
25528343|NCT00511173|Anticoagulants|anticoagulants|mesh-ancestor
25528344|NCT00511472|Insulin Glargine|insulin glargine|mesh-list
25528345|NCT00511472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25528346|NCT00511472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528347|NCT00511706|Dexamethasone|dexamethasone|mesh-list
25528348|NCT00511706|Ranibizumab|ranibizumab|mesh-list
25528349|NCT00511706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25528350|NCT00511706|Antiemetics|antiemetics|mesh-ancestor
25528351|NCT00511706|Autonomic Agents|autonomic agents|mesh-ancestor
25528352|NCT00511706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25528353|NCT00511706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528354|NCT00511706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25528355|NCT00511706|Glucocorticoids|glucocorticoids|mesh-ancestor
25528356|NCT00511706|Hormones|hormones|mesh-ancestor
25528357|NCT00511706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25528358|NCT00511706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25528359|NCT00511706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528360|NCT00511706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25528361|NCT00511706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25528362|NCT00511706|Growth Substances|growth substances|mesh-ancestor
25528363|NCT00511706|Growth Inhibitors|growth inhibitors|mesh-ancestor
25528364|NCT00511836|Naltrexone|naltrexone|mesh-list
25528365|NCT00511836|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25528366|NCT00511836|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25528367|NCT00511836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528368|NCT00511836|Sensory System Agents|sensory system agents|mesh-ancestor
25528369|NCT00511836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25528370|NCT00511875|Doxycycline|doxycycline|mesh-list
25528371|NCT00511875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25528372|NCT00511875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25528373|NCT00511875|Antimalarials|antimalarials|mesh-ancestor
25528374|NCT00511875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25528375|NCT00511875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25528376|NCT00511901|Epoetin Alfa|epoetin alfa|mesh-list
25528377|NCT00511901|Hematinics|hematinics|mesh-ancestor
25528378|NCT00511992|Paclitaxel|paclitaxel|mesh-list
25528379|NCT00511992|Bevacizumab|bevacizumab|mesh-list
25528380|NCT00511992|Cisplatin|cisplatin|mesh-list
25528381|NCT00511992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25528382|NCT00511992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528383|NCT00511992|Tubulin Modulators|tubulin modulators|mesh-ancestor
25528384|NCT00511992|Antimitotic Agents|antimitotic agents|mesh-ancestor
25528385|NCT00511992|Mitosis Modulators|mitosis modulators|mesh-ancestor
25528386|NCT00511992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528387|NCT00511992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25528388|NCT00511992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25528389|NCT00511992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25528390|NCT00511992|Growth Substances|growth substances|mesh-ancestor
25528391|NCT00511992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528392|NCT00511992|Growth Inhibitors|growth inhibitors|mesh-ancestor
25528393|NCT00512096|Paclitaxel|paclitaxel|mesh-list
25528394|NCT00512096|Cisplatin|cisplatin|mesh-list
25528395|NCT00512096|Ifosfamide|ifosfamide|mesh-list
25528396|NCT00512096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25528397|NCT00512096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528398|NCT00512096|Tubulin Modulators|tubulin modulators|mesh-ancestor
25528399|NCT00512096|Antimitotic Agents|antimitotic agents|mesh-ancestor
25528400|NCT00512096|Mitosis Modulators|mitosis modulators|mesh-ancestor
25528401|NCT00512096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528402|NCT00512096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25528403|NCT00512096|Alkylating Agents|alkylating agents|mesh-ancestor
25528404|NCT00512135|Botulinum Toxins|botulinum toxins|mesh-list
25528405|NCT00512135|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25528406|NCT00512135|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25528407|NCT00512135|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25528408|NCT00512135|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25528409|NCT00512135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25528410|NCT00512135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528411|NCT00512135|Cholinergic Agents|cholinergic agents|mesh-ancestor
25163157|NCT02898792|Analgesics|analgesics|mesh-ancestor
25528412|NCT00512135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25528413|NCT00512135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528414|NCT00512135|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25528415|NCT00512135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25528416|NCT00512252|Cytarabine|cytarabine|mesh-list
25646880|NCT01463384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25528418|NCT00512252|Etoposide|etoposide|mesh-list
25528419|NCT00512252|Mitoxantrone|mitoxantrone|mesh-list
25528420|NCT00512252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25528421|NCT00512252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528422|NCT00512252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25528423|NCT00512252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25528424|NCT00512252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528425|NCT00512252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528426|NCT00512252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25528427|NCT00512252|Antimetabolites|antimetabolites|mesh-ancestor
25528428|NCT00512252|Antiviral Agents|antiviral agents|mesh-ancestor
25528429|NCT00512252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25528430|NCT00512252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25528431|NCT00512252|Immunologic Factors|immunologic factors|mesh-ancestor
25528432|NCT00512252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528433|NCT00512252|Analgesics|analgesics|mesh-ancestor
25528434|NCT00512252|Sensory System Agents|sensory system agents|mesh-ancestor
25528435|NCT00512252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25528436|NCT00512252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25528437|NCT00512252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25528438|NCT00512278|Infliximab|infliximab|mesh-list
25528439|NCT00512278|Dermatologic Agents|dermatologic agents|mesh-ancestor
25528440|NCT00512278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25528441|NCT00512278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25528442|NCT00512707|Sildenafil Citrate|sildenafil citrate|mesh-list
25528443|NCT00512707|Testosterone|testosterone|mesh-list
25528444|NCT00512707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528445|NCT00512707|Androgens|androgens|mesh-ancestor
25528446|NCT00512707|Hormones|hormones|mesh-ancestor
25528447|NCT00512707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25528448|NCT00512707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528449|NCT00512707|Vasodilator Agents|vasodilator agents|mesh-ancestor
25528450|NCT00512707|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25528451|NCT00512707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25528452|NCT00512707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528453|NCT00512707|Urological Agents|urological agents|mesh-ancestor
25528454|NCT00512798|Bortezomib|bortezomib|mesh-list
25528455|NCT00512798|Temozolomide|temozolomide|mesh-list
25528456|NCT00512798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528457|NCT00512798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25528458|NCT00512798|Alkylating Agents|alkylating agents|mesh-ancestor
25528459|NCT00512798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528460|NCT00512876|Bevacizumab|bevacizumab|mesh-list
25528461|NCT00512876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25528462|NCT00512876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528463|NCT00512876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25528464|NCT00512876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25528465|NCT00512876|Growth Substances|growth substances|mesh-ancestor
25528466|NCT00512876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528467|NCT00512876|Growth Inhibitors|growth inhibitors|mesh-ancestor
25528468|NCT00512902|Imatinib Mesylate|imatinib mesylate|mesh-list
25528469|NCT00512902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528470|NCT00512902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25528471|NCT00512902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528472|NCT00512902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528473|NCT00513019|Lamotrigine|lamotrigine|mesh-list
25528474|NCT00513019|Anticonvulsants|anticonvulsants|mesh-list
25528475|NCT00513019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25528476|NCT00513019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25528477|NCT00513019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528478|NCT00513019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25528479|NCT00513019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528480|NCT00513019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25528481|NCT00513019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25528482|NCT00513019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25528483|NCT00513019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25528484|NCT00513019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25528485|NCT00513071|Saracatinib|saracatinib|mesh-list
25528486|NCT00513071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528487|NCT00513071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528488|NCT00513071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528489|NCT00513240|Epoetin Alfa|epoetin alfa|mesh-list
25528490|NCT00513240|Hematinics|hematinics|mesh-ancestor
25528491|NCT00513292|Paclitaxel|paclitaxel|mesh-list
25528492|NCT00513292|Cyclophosphamide|cyclophosphamide|mesh-list
25528493|NCT00513292|Trastuzumab|trastuzumab|mesh-list
25528494|NCT00513292|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25528495|NCT00513292|Epirubicin|epirubicin|mesh-list
25528496|NCT00513292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25528497|NCT00513292|Antibodies|antibodies|mesh-list
25528498|NCT00513292|Immunoglobulins|immunoglobulins|mesh-list
25528499|NCT00513292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25528500|NCT00513292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25528501|NCT00513292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528502|NCT00513292|Tubulin Modulators|tubulin modulators|mesh-ancestor
25528503|NCT00513292|Antimitotic Agents|antimitotic agents|mesh-ancestor
25528504|NCT00513292|Mitosis Modulators|mitosis modulators|mesh-ancestor
25528505|NCT00513292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528506|NCT00513292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25528507|NCT00513292|Immunologic Factors|immunologic factors|mesh-ancestor
25528508|NCT00513292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528509|NCT00513292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25528510|NCT00513292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25528511|NCT00513292|Alkylating Agents|alkylating agents|mesh-ancestor
25528512|NCT00513292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25528513|NCT00513292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25528514|NCT00513292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25528515|NCT00513292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25528516|NCT00513292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528517|NCT00513305|Cytarabine|cytarabine|mesh-list
25528518|NCT00513305|Arsenic Trioxide|arsenic trioxide|mesh-list
25528519|NCT00513305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25528520|NCT00513305|Antimetabolites|antimetabolites|mesh-ancestor
25528521|NCT00513305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528522|NCT00513305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528523|NCT00513305|Antiviral Agents|antiviral agents|mesh-ancestor
25528524|NCT00513305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25528525|NCT00513305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25528526|NCT00513305|Immunologic Factors|immunologic factors|mesh-ancestor
25528527|NCT00513305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528528|NCT00513357|Melatonin|melatonin|mesh-list
25528529|NCT00513357|Antioxidants|antioxidants|mesh-ancestor
25528530|NCT00513357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528531|NCT00513357|Protective Agents|protective agents|mesh-ancestor
25528532|NCT00513357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528533|NCT00513357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25528534|NCT00513370|Adalimumab|adalimumab|mesh-list
25528535|NCT00513370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25528536|NCT00513370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25528537|NCT00513435|Saracatinib|saracatinib|mesh-list
25528538|NCT00513435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528539|NCT00513435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528540|NCT00513435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528541|NCT00513474|Cyclosporine|cyclosporine|mesh-list
25528542|NCT00513474|Sirolimus|sirolimus|mesh-list
25528543|NCT00513474|Cyclophosphamide|cyclophosphamide|mesh-list
25528544|NCT00513474|Busulfan|busulfan|mesh-list
25528545|NCT00513474|Methotrexate|methotrexate|mesh-list
25528546|NCT00513474|Fludarabine|fludarabine|mesh-list
25528547|NCT00513474|Etoposide|etoposide|mesh-list
25528548|NCT00513474|Allopurinol|allopurinol|mesh-list
25528549|NCT00513474|Rasburicase|rasburicase|mesh-list
25528550|NCT00513474|Tacrolimus|tacrolimus|mesh-list
25528551|NCT00513474|Cyclosporins|cyclosporins|mesh-list
25528552|NCT00513474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25528553|NCT00513474|Immunologic Factors|immunologic factors|mesh-ancestor
25528554|NCT00513474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528555|NCT00513474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25823527|NCT00004853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823528|NCT00004854|Carvedilol|carvedilol|mesh-list
25823529|NCT00004854|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25823530|NCT00004854|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25823531|NCT00004854|Adrenergic Agents|adrenergic agents|mesh-ancestor
25823532|NCT00004854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25528556|NCT00513474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25528557|NCT00513474|Alkylating Agents|alkylating agents|mesh-ancestor
25528558|NCT00513474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528583|NCT00513500|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25528584|NCT00513500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25528585|NCT00513500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25528587|NCT00513500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25528588|NCT00513500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25528589|NCT00513526|Vaccines|vaccines|mesh-list
25528590|NCT00513526|Immunologic Factors|immunologic factors|mesh-ancestor
25528591|NCT00513526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528592|NCT00513604|Aldesleukin|aldesleukin|mesh-list
25528593|NCT00513604|Cyclophosphamide|cyclophosphamide|mesh-list
25528594|NCT00513604|Fludarabine|fludarabine|mesh-list
25528595|NCT00513604|Fludarabine phosphate|fludarabine phosphate|mesh-list
25528596|NCT00513604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25528597|NCT00513604|Immunologic Factors|immunologic factors|mesh-ancestor
25528598|NCT00513604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528599|NCT00513604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25528600|NCT00513604|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25528601|NCT00513604|Alkylating Agents|alkylating agents|mesh-ancestor
25528602|NCT00513604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528603|NCT00513604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528604|NCT00513604|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25528605|NCT00513604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25528606|NCT00513604|Antimetabolites|antimetabolites|mesh-ancestor
25528607|NCT00513604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25528608|NCT00513604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25528609|NCT00513604|Antiviral Agents|antiviral agents|mesh-ancestor
25528610|NCT00513604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25528611|NCT00513682|Pancrelipase|pancrelipase|mesh-list
25528612|NCT00513682|Pancreatin|pancreatin|mesh-list
25528613|NCT00513682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25528614|NCT00513695|Paclitaxel|paclitaxel|mesh-list
25528615|NCT00513695|Cyclophosphamide|cyclophosphamide|mesh-list
25528616|NCT00513695|Doxorubicin|doxorubicin|mesh-list
25528617|NCT00513695|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25528618|NCT00513695|Sunitinib|sunitinib|mesh-list
25528619|NCT00513695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25528620|NCT00513695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528621|NCT00513695|Tubulin Modulators|tubulin modulators|mesh-ancestor
25528622|NCT00513695|Antimitotic Agents|antimitotic agents|mesh-ancestor
25528623|NCT00513695|Mitosis Modulators|mitosis modulators|mesh-ancestor
25528624|NCT00513695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528625|NCT00513695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25528626|NCT00513695|Immunologic Factors|immunologic factors|mesh-ancestor
25528627|NCT00513695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528628|NCT00513695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25528629|NCT00513695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25528630|NCT00513695|Alkylating Agents|alkylating agents|mesh-ancestor
25528631|NCT00513695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25528632|NCT00513695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25528633|NCT00513695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25528634|NCT00513695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25528635|NCT00513695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528636|NCT00513695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25528637|NCT00513695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25528638|NCT00513695|Growth Substances|growth substances|mesh-ancestor
25528639|NCT00513695|Growth Inhibitors|growth inhibitors|mesh-ancestor
25528640|NCT00513695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25528641|NCT00513747|Rituximab|rituximab|mesh-list
25528642|NCT00513747|Fludarabine|fludarabine|mesh-list
25528643|NCT00513747|Fludarabine phosphate|fludarabine phosphate|mesh-list
25528644|NCT00513747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25528645|NCT00513747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528646|NCT00513747|Immunologic Factors|immunologic factors|mesh-ancestor
25528647|NCT00513747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528648|NCT00513747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25528649|NCT00513747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25528650|NCT00513747|Antimetabolites|antimetabolites|mesh-ancestor
25528651|NCT00513747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528652|NCT00513747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25528653|NCT00513799|Chlorhexidine|chlorhexidine|mesh-list
25528654|NCT00513799|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25528655|NCT00513799|Mupirocin|mupirocin|mesh-list
25528656|NCT00513799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25528657|NCT00513799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25528658|NCT00513799|Disinfectants|disinfectants|mesh-ancestor
25528659|NCT00513799|Dermatologic Agents|dermatologic agents|mesh-ancestor
25528660|NCT00513799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25528661|NCT00513799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25528662|NCT00513799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528663|NCT00513799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528664|NCT00514020|Leucovorin|leucovorin|mesh-list
25528665|NCT00514020|Fluorouracil|fluorouracil|mesh-list
25528666|NCT00514020|Oxaliplatin|oxaliplatin|mesh-list
25528667|NCT00514020|Calcium|calcium|mesh-list
25528668|NCT00514020|Levoleucovorin|levoleucovorin|mesh-list
25528669|NCT00514020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24806190|NCT02014428|Protective Agents|protective agents|mesh-ancestor
25528670|NCT00514020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528671|NCT00514020|Antimetabolites|antimetabolites|mesh-ancestor
25528672|NCT00514020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528673|NCT00514020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25528674|NCT00514020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528675|NCT00514020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25528676|NCT00514020|Immunologic Factors|immunologic factors|mesh-ancestor
25528677|NCT00514020|Antidotes|antidotes|mesh-ancestor
25528678|NCT00514020|Protective Agents|protective agents|mesh-ancestor
25528679|NCT00514020|Vitamin B Complex|vitamin b complex|mesh-ancestor
25528680|NCT00514020|Vitamins|vitamins|mesh-ancestor
25528681|NCT00514020|Micronutrients|micronutrients|mesh-ancestor
25528682|NCT00514137|Sunitinib|sunitinib|mesh-list
25528683|NCT00514137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528684|NCT00514137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25528685|NCT00514137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25528686|NCT00514137|Growth Substances|growth substances|mesh-ancestor
25528687|NCT00514137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528688|NCT00514137|Growth Inhibitors|growth inhibitors|mesh-ancestor
25528689|NCT00514137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25528690|NCT00514137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528691|NCT00514137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528692|NCT00514215|Molgramostim|molgramostim|mesh-list
25528693|NCT00514215|Sargramostim|sargramostim|mesh-list
25528694|NCT00514215|Immunologic Factors|immunologic factors|mesh-ancestor
25528695|NCT00514215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528696|NCT00514215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528697|NCT00514449|Valacyclovir|valacyclovir|mesh-list
25528698|NCT00514449|Antiviral Agents|antiviral agents|mesh-ancestor
25528699|NCT00514449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25528700|NCT00514514|Cyclosporine|cyclosporine|mesh-list
25528701|NCT00514514|Mycophenolic Acid|mycophenolic acid|mesh-list
25528702|NCT00514514|Everolimus|everolimus|mesh-list
25528703|NCT00514514|Cyclosporins|cyclosporins|mesh-list
25528704|NCT00514514|Basiliximab|basiliximab|mesh-list
25528705|NCT00514514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528706|NCT00514514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528707|NCT00514514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25528708|NCT00514514|Immunologic Factors|immunologic factors|mesh-ancestor
25528709|NCT00514514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528710|NCT00514514|Antifungal Agents|antifungal agents|mesh-ancestor
25528711|NCT00514514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25528712|NCT00514514|Dermatologic Agents|dermatologic agents|mesh-ancestor
25528713|NCT00514514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25528714|NCT00514514|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25528715|NCT00514514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528716|NCT00514514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25528717|NCT00514514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25528718|NCT00514514|Antitubercular Agents|antitubercular agents|mesh-ancestor
25528719|NCT00514514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25528720|NCT00514540|Cisplatin|cisplatin|mesh-list
25528721|NCT00514540|Carboplatin|carboplatin|mesh-list
25528722|NCT00514540|Docetaxel|docetaxel|mesh-list
25528723|NCT00514540|Etoposide|etoposide|mesh-list
25528724|NCT00514540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528725|NCT00514540|Tubulin Modulators|tubulin modulators|mesh-ancestor
25528726|NCT00514540|Antimitotic Agents|antimitotic agents|mesh-ancestor
25528727|NCT00514540|Mitosis Modulators|mitosis modulators|mesh-ancestor
25528728|NCT00514540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528729|NCT00514540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25528730|NCT00514540|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25528731|NCT00514540|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25528732|NCT00514540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528733|NCT00514683|Nintedanib|nintedanib|mesh-list
25528734|NCT00514683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528735|NCT00514683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25528736|NCT00514683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528737|NCT00514683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528738|NCT00514709|Vaccines|vaccines|mesh-list
25528739|NCT00514709|Immunologic Factors|immunologic factors|mesh-ancestor
24475408|NCT00410345|Luteolytic Agents|luteolytic agents|mesh-ancestor
25528740|NCT00514709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528741|NCT00514735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
25528742|NCT00514852|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25528743|NCT00514852|Lubricant Eye Drops|lubricant eye drops|mesh-list
25528745|NCT00514852|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25528746|NCT00514852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25528747|NCT00514852|Laxatives|laxatives|mesh-ancestor
25528748|NCT00514852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25528749|NCT00514852|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25528750|NCT00514852|Protective Agents|protective agents|mesh-ancestor
25528751|NCT00514852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528752|NCT00514904|Vaccines|vaccines|mesh-list
25528753|NCT00514904|Immunologic Factors|immunologic factors|mesh-ancestor
25528754|NCT00514904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528755|NCT00514917|Docetaxel|docetaxel|mesh-list
25528756|NCT00514917|Leuprolide|leuprolide|mesh-list
25528757|NCT00514917|Bicalutamide|bicalutamide|mesh-list
25528758|NCT00514917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528759|NCT00514917|Tubulin Modulators|tubulin modulators|mesh-ancestor
25528760|NCT00514917|Antimitotic Agents|antimitotic agents|mesh-ancestor
25528761|NCT00514917|Mitosis Modulators|mitosis modulators|mesh-ancestor
25528762|NCT00514917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528763|NCT00514917|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25528764|NCT00514917|Fertility Agents|fertility agents|mesh-ancestor
25528765|NCT00514917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25528766|NCT00514917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528767|NCT00514917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25528768|NCT00514917|Androgen Antagonists|androgen antagonists|mesh-ancestor
25528769|NCT00514917|Hormone Antagonists|hormone antagonists|mesh-ancestor
25528770|NCT00514917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25528771|NCT00514943|Cetuximab|cetuximab|mesh-list
25528772|NCT00514943|Afatinib|afatinib|mesh-list
25528773|NCT00514943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25528774|NCT00514943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528775|NCT00514943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25528776|NCT00514943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528777|NCT00514943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528778|NCT00515021|Eplerenone|eplerenone|mesh-list
25528779|NCT00515021|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25528780|NCT00515021|Hormone Antagonists|hormone antagonists|mesh-ancestor
25528781|NCT00515021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25528782|NCT00515021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528783|NCT00515021|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25528784|NCT00515021|Diuretics|diuretics|mesh-ancestor
25528785|NCT00515021|Natriuretic Agents|natriuretic agents|mesh-ancestor
25528786|NCT00515021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25528787|NCT00515034|Imipenem|imipenem|mesh-list
25528788|NCT00515034|Doripenem|doripenem|mesh-list
25528789|NCT00515034|Cilastatin|cilastatin|mesh-list
25528790|NCT00515034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25528791|NCT00515034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25528792|NCT00515034|Protease Inhibitors|protease inhibitors|mesh-ancestor
25528793|NCT00515034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528794|NCT00515034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528795|NCT00515073|Diphenhydramine|diphenhydramine|mesh-list
25528796|NCT00515073|Promethazine|promethazine|mesh-list
25528797|NCT00515073|Dexamethasone|dexamethasone|mesh-list
25528798|NCT00515073|Paclitaxel|paclitaxel|mesh-list
25528799|NCT00515073|Cimetidine|cimetidine|mesh-list
25528800|NCT00515073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25528801|NCT00515073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528802|NCT00515073|Tubulin Modulators|tubulin modulators|mesh-ancestor
25528803|NCT00515073|Antimitotic Agents|antimitotic agents|mesh-ancestor
25528804|NCT00515073|Mitosis Modulators|mitosis modulators|mesh-ancestor
25528805|NCT00515073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528806|NCT00515073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25528807|NCT00515073|Antiemetics|antiemetics|mesh-ancestor
25528808|NCT00515073|Autonomic Agents|autonomic agents|mesh-ancestor
25528809|NCT00515073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25528810|NCT00515073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528811|NCT00515073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25528812|NCT00515073|Glucocorticoids|glucocorticoids|mesh-ancestor
25528813|NCT00515073|Hormones|hormones|mesh-ancestor
25528814|NCT00515073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25528815|NCT00515073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25528816|NCT00515073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25528817|NCT00515073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25528818|NCT00515073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25528819|NCT00515073|Anesthetics, Local|anesthetics, local|mesh-ancestor
25528820|NCT00515073|Anesthetics|anesthetics|mesh-ancestor
25528821|NCT00515073|Sensory System Agents|sensory system agents|mesh-ancestor
25528822|NCT00515073|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25528823|NCT00515073|Histamine Antagonists|histamine antagonists|mesh-ancestor
25528824|NCT00515073|Histamine Agents|histamine agents|mesh-ancestor
25528825|NCT00515073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25528826|NCT00515073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25528827|NCT00515073|Antipruritics|antipruritics|mesh-ancestor
25528828|NCT00515073|Dermatologic Agents|dermatologic agents|mesh-ancestor
25528829|NCT00515073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25528830|NCT00515073|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25528831|NCT00515073|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25528832|NCT00515073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25528833|NCT00515073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528834|NCT00515086|Everolimus|everolimus|mesh-list
25528835|NCT00515086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528836|NCT00515086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25528837|NCT00515086|Immunologic Factors|immunologic factors|mesh-ancestor
25528838|NCT00515086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528839|NCT00515099|Thymoglobulin|thymoglobulin|mesh-list
25528840|NCT00515099|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25528841|NCT00515099|Immunologic Factors|immunologic factors|mesh-ancestor
25528842|NCT00515099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528843|NCT00515099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25528844|NCT00515177|Eszopiclone|eszopiclone|mesh-list
25528845|NCT00515177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25528846|NCT00515177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25528847|NCT00515177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528848|NCT00515216|Leucovorin|leucovorin|mesh-list
25528849|NCT00515216|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
25528850|NCT00515216|Tetrahydrofolates|tetrahydrofolates|mesh-list
25528851|NCT00515216|Fluorouracil|fluorouracil|mesh-list
25528852|NCT00515216|Oxaliplatin|oxaliplatin|mesh-list
25528853|NCT00515216|Levoleucovorin|levoleucovorin|mesh-list
25528854|NCT00515216|Antimetabolites|antimetabolites|mesh-ancestor
25528855|NCT00515216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528856|NCT00515216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25528857|NCT00515216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528858|NCT00515216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25528859|NCT00515216|Immunologic Factors|immunologic factors|mesh-ancestor
25528860|NCT00515216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528861|NCT00515216|Antidotes|antidotes|mesh-ancestor
25528862|NCT00515216|Protective Agents|protective agents|mesh-ancestor
25528863|NCT00515216|Vitamin B Complex|vitamin b complex|mesh-ancestor
25528864|NCT00515216|Vitamins|vitamins|mesh-ancestor
25528865|NCT00515216|Micronutrients|micronutrients|mesh-ancestor
25528866|NCT00515294|Caffeine|caffeine|mesh-list
25528867|NCT00515294|Methamphetamine|methamphetamine|mesh-list
25528868|NCT00515294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25528869|NCT00515294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528870|NCT00515294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25528871|NCT00515294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528872|NCT00515294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528873|NCT00515294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25528874|NCT00515294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25528875|NCT00515294|Purinergic Agents|purinergic agents|mesh-ancestor
25528876|NCT00515294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25528877|NCT00515294|Sympathomimetics|sympathomimetics|mesh-ancestor
25528878|NCT00515294|Autonomic Agents|autonomic agents|mesh-ancestor
25528879|NCT00515294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25528880|NCT00515294|Dopamine Agents|dopamine agents|mesh-ancestor
25528881|NCT00515294|Adrenergic Agents|adrenergic agents|mesh-ancestor
25528882|NCT00515294|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25528883|NCT00515294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25528884|NCT00515294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25528885|NCT00515294|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25528886|NCT00515411|Leucovorin|leucovorin|mesh-list
25528887|NCT00515411|Cisplatin|cisplatin|mesh-list
25528888|NCT00515411|Docetaxel|docetaxel|mesh-list
25528889|NCT00515411|Fluorouracil|fluorouracil|mesh-list
25528890|NCT00515411|Trastuzumab|trastuzumab|mesh-list
25528891|NCT00515411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528892|NCT00515411|Tubulin Modulators|tubulin modulators|mesh-ancestor
25528893|NCT00515411|Antimitotic Agents|antimitotic agents|mesh-ancestor
25528894|NCT00515411|Mitosis Modulators|mitosis modulators|mesh-ancestor
25528895|NCT00515411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528896|NCT00515411|Antimetabolites|antimetabolites|mesh-ancestor
25528897|NCT00515411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25528898|NCT00515411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25528899|NCT00515411|Immunologic Factors|immunologic factors|mesh-ancestor
25528900|NCT00515411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528901|NCT00515411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25528902|NCT00515411|Antidotes|antidotes|mesh-ancestor
25528903|NCT00515411|Protective Agents|protective agents|mesh-ancestor
25528904|NCT00515411|Vitamin B Complex|vitamin b complex|mesh-ancestor
25528905|NCT00515411|Vitamins|vitamins|mesh-ancestor
25528906|NCT00515411|Micronutrients|micronutrients|mesh-ancestor
25528907|NCT00515437|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
25528908|NCT00515437|Botulinum Toxins|botulinum toxins|mesh-list
25528909|NCT00515437|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25528910|NCT00515437|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25528911|NCT00515437|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25528912|NCT00515437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25528913|NCT00515437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528914|NCT00515437|Cholinergic Agents|cholinergic agents|mesh-ancestor
25528915|NCT00515437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25528916|NCT00515437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528917|NCT00515437|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25528918|NCT00515437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25528919|NCT00515437|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25528920|NCT00515463|Denosumab|denosumab|mesh-list
25528921|NCT00515463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25528922|NCT00515463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528923|NCT00515502|Tiotropium Bromide|tiotropium bromide|mesh-list
25528924|NCT00515502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25528925|NCT00515502|Autonomic Agents|autonomic agents|mesh-ancestor
25528926|NCT00515502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25528927|NCT00515502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528928|NCT00515502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25528929|NCT00515502|Respiratory System Agents|respiratory system agents|mesh-ancestor
25528930|NCT00515502|Parasympatholytics|parasympatholytics|mesh-ancestor
25528931|NCT00515502|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25528932|NCT00515502|Cholinergic Agents|cholinergic agents|mesh-ancestor
25528933|NCT00515502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25528934|NCT00515502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528935|NCT00515619|Lacosamide|lacosamide|mesh-list
25528936|NCT00515619|Anticonvulsants|anticonvulsants|mesh-ancestor
25528937|NCT00515619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25528938|NCT00515619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25528939|NCT00515619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25528940|NCT00515619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528941|NCT00515697|Ramucirumab|ramucirumab|mesh-list
25528942|NCT00515697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25528943|NCT00515723|Olanzapine|olanzapine|mesh-list
25528944|NCT00515723|Risperidone|risperidone|mesh-list
25528945|NCT00515723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25528946|NCT00515723|Ziprasidone|ziprasidone|mesh-list
25528947|NCT00515723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25528948|NCT00515723|Serotonin Agents|serotonin agents|mesh-ancestor
25528949|NCT00515723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25528950|NCT00515723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528951|NCT00515723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528952|NCT00515723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25528953|NCT00515723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25528954|NCT00515723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25528955|NCT00515723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25528956|NCT00515723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25528957|NCT00515723|Dopamine Agents|dopamine agents|mesh-ancestor
25528958|NCT00515723|Antiemetics|antiemetics|mesh-ancestor
25528959|NCT00515723|Autonomic Agents|autonomic agents|mesh-ancestor
25528960|NCT00515723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25528961|NCT00515723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25528962|NCT00515723|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25528963|NCT00515723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25528964|NCT00515723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25528965|NCT00515723|Antidepressive Agents|antidepressive agents|mesh-ancestor
25528967|NCT00515827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25528968|NCT00515827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25528969|NCT00515827|Antiviral Agents|antiviral agents|mesh-ancestor
25528970|NCT00515827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25528972|NCT00515827|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25528973|NCT00515827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25528974|NCT00515827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528975|NCT00515879|Cycloserine|cycloserine|mesh-list
25528976|NCT00515879|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25528977|NCT00515879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25528978|NCT00515879|Renal Agents|renal agents|mesh-ancestor
25528979|NCT00515879|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25528980|NCT00515879|Antitubercular Agents|antitubercular agents|mesh-ancestor
25528981|NCT00515879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25528982|NCT00515879|Antimetabolites|antimetabolites|mesh-ancestor
25528983|NCT00515879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25528984|NCT00516048|Exenatide|exenatide|mesh-list
25528985|NCT00516048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25528986|NCT00516048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528987|NCT00516048|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25528988|NCT00516048|Incretins|incretins|mesh-ancestor
25528989|NCT00516048|Hormones|hormones|mesh-ancestor
25528990|NCT00516048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25528991|NCT00516074|Exenatide|exenatide|mesh-list
25528992|NCT00516074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25528993|NCT00516074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25528994|NCT00516074|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25528995|NCT00516074|Incretins|incretins|mesh-ancestor
25528996|NCT00516074|Hormones|hormones|mesh-ancestor
25528997|NCT00516074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25528998|NCT00516139|Lamotrigine|lamotrigine|mesh-list
25528999|NCT00516139|Anticonvulsants|anticonvulsants|mesh-ancestor
25529000|NCT00516139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25529001|NCT00516139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25529002|NCT00516139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529003|NCT00516139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25529004|NCT00516139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529005|NCT00516139|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25529006|NCT00516139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25529007|NCT00516139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25529008|NCT00516139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25529009|NCT00516139|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25529010|NCT00516165|Everolimus|everolimus|mesh-list
25529011|NCT00516165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529012|NCT00516165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25529013|NCT00516165|Immunologic Factors|immunologic factors|mesh-ancestor
25529014|NCT00516165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529015|NCT00516217|Galiximab|galiximab|mesh-list
25529016|NCT00516217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25529017|NCT00516217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529018|NCT00516269|Methylphenidate|methylphenidate|mesh-list
25529019|NCT00516269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25529020|NCT00516269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529021|NCT00516269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25529022|NCT00516269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25529023|NCT00516269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25529024|NCT00516269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529025|NCT00516269|Dopamine Agents|dopamine agents|mesh-ancestor
25529026|NCT00516269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25529027|NCT00516295|Cyclophosphamide|cyclophosphamide|mesh-list
25529028|NCT00516295|Bevacizumab|bevacizumab|mesh-list
25529029|NCT00516295|Vincristine|vincristine|mesh-list
25529030|NCT00516295|Topotecan|topotecan|mesh-list
25529031|NCT00516295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25529032|NCT00516295|Antibodies|antibodies|mesh-list
25529033|NCT00516295|Immunoglobulins|immunoglobulins|mesh-list
25529034|NCT00516295|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25529035|NCT00516295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25529036|NCT00516295|Immunologic Factors|immunologic factors|mesh-ancestor
25529037|NCT00516295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529038|NCT00516295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25529039|NCT00516295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25529040|NCT00516295|Alkylating Agents|alkylating agents|mesh-ancestor
25529041|NCT00516295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529042|NCT00516295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529043|NCT00516295|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25529044|NCT00516295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25529045|NCT00516295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25529047|NCT00516295|Growth Inhibitors|growth inhibitors|mesh-ancestor
25529048|NCT00516295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25529049|NCT00516295|Tubulin Modulators|tubulin modulators|mesh-ancestor
25529050|NCT00516295|Antimitotic Agents|antimitotic agents|mesh-ancestor
25529051|NCT00516295|Mitosis Modulators|mitosis modulators|mesh-ancestor
25529052|NCT00516295|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25529053|NCT00516295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25529054|NCT00516295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529056|NCT00516386|Growth Substances|growth substances|mesh-ancestor
25529057|NCT00516386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529058|NCT00516503|Ketamine|ketamine|mesh-list
25529059|NCT00516503|Amitriptyline|amitriptyline|mesh-list
25529060|NCT00516503|Baclofen|baclofen|mesh-list
25529061|NCT00516503|Analgesics|analgesics|mesh-ancestor
25529062|NCT00516503|Sensory System Agents|sensory system agents|mesh-ancestor
25529063|NCT00516503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25529064|NCT00516503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529065|NCT00516503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25529066|NCT00516503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25529067|NCT00516503|Anesthetics, General|anesthetics, general|mesh-ancestor
25529068|NCT00516503|Anesthetics|anesthetics|mesh-ancestor
25529069|NCT00516503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25529070|NCT00516503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25529071|NCT00516503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25529072|NCT00516503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25529073|NCT00516503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529074|NCT00516503|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25529075|NCT00516503|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25529076|NCT00516503|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25529077|NCT00516503|GABA Agonists|gaba agonists|mesh-ancestor
25529078|NCT00516503|GABA Agents|gaba agents|mesh-ancestor
25529079|NCT00516503|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25529080|NCT00516503|Antidepressive Agents|antidepressive agents|mesh-ancestor
25529081|NCT00516503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25529082|NCT00516503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25529083|NCT00516503|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25529084|NCT00516503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25529085|NCT00516503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25529086|NCT00516503|Adrenergic Agents|adrenergic agents|mesh-ancestor
25529087|NCT00516893|Natalizumab|natalizumab|mesh-list
25529088|NCT00516893|Immunologic Factors|immunologic factors|mesh-ancestor
25529089|NCT00516893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529090|NCT00516906|Chlorhexidine|chlorhexidine|mesh-list
25529091|NCT00516906|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25529092|NCT00516906|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25529093|NCT00516906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25529094|NCT00516906|Disinfectants|disinfectants|mesh-ancestor
25529095|NCT00516906|Dermatologic Agents|dermatologic agents|mesh-ancestor
25529096|NCT00516919|Orlistat|orlistat|mesh-list
25529097|NCT00516919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529098|NCT00516919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529099|NCT00516919|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25529100|NCT00516919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25529101|NCT00517010|Ranibizumab|ranibizumab|mesh-list
25529102|NCT00517010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25529103|NCT00517010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25529104|NCT00517010|Growth Substances|growth substances|mesh-ancestor
25529105|NCT00517010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529106|NCT00517010|Growth Inhibitors|growth inhibitors|mesh-ancestor
25529107|NCT00517010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529108|NCT00517296|Adalimumab|adalimumab|mesh-list
25529109|NCT00517296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25529110|NCT00517296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25529111|NCT00517413|Epoetin Alfa|epoetin alfa|mesh-list
25529112|NCT00517413|Hematinics|hematinics|mesh-ancestor
25529113|NCT00517530|Obinutuzumab|obinutuzumab|mesh-list
25529114|NCT00517530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25529115|NCT00517530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529116|NCT00517556|Contraceptive Agents|contraceptive agents|mesh-list
25529117|NCT00517556|Contraceptives, Oral|contraceptives, oral|mesh-list
25529118|NCT00517556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25529119|NCT00517556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529120|NCT00517556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25529121|NCT00517595|Gemcitabine|gemcitabine|mesh-list
25529122|NCT00517595|Bevacizumab|bevacizumab|mesh-list
25529123|NCT00517595|Pemetrexed|pemetrexed|mesh-list
25529124|NCT00517595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25529125|NCT00517595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529126|NCT00517595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25529127|NCT00517595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25529128|NCT00517595|Growth Substances|growth substances|mesh-ancestor
25529129|NCT00517595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529130|NCT00517595|Growth Inhibitors|growth inhibitors|mesh-ancestor
25529131|NCT00517595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25529132|NCT00517595|Antimetabolites|antimetabolites|mesh-ancestor
25529133|NCT00517595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529134|NCT00517595|Antiviral Agents|antiviral agents|mesh-ancestor
25529135|NCT00517595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25529136|NCT00517595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529137|NCT00517595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25529138|NCT00517595|Immunologic Factors|immunologic factors|mesh-ancestor
25529139|NCT00517595|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25529140|NCT00517595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25529141|NCT00517829|Docetaxel|docetaxel|mesh-list
25529142|NCT00517829|Oxaliplatin|oxaliplatin|mesh-list
25529143|NCT00517829|Cetuximab|cetuximab|mesh-list
25529144|NCT00517829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529145|NCT00517829|Tubulin Modulators|tubulin modulators|mesh-ancestor
25529146|NCT00517829|Antimitotic Agents|antimitotic agents|mesh-ancestor
25529147|NCT00517829|Mitosis Modulators|mitosis modulators|mesh-ancestor
25529148|NCT00517829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529149|NCT00517829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25529150|NCT00517881|Epoetin Alfa|epoetin alfa|mesh-list
25529151|NCT00517881|Hematinics|hematinics|mesh-ancestor
25529152|NCT00517933|Sildenafil Citrate|sildenafil citrate|mesh-list
25529153|NCT00517933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529154|NCT00517933|Vasodilator Agents|vasodilator agents|mesh-ancestor
25529155|NCT00517933|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25529156|NCT00517933|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25529157|NCT00517933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529158|NCT00517933|Urological Agents|urological agents|mesh-ancestor
25529159|NCT00518011|Gemcitabine|gemcitabine|mesh-list
25529160|NCT00518011|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25529161|NCT00518011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25529162|NCT00518011|Antimetabolites|antimetabolites|mesh-ancestor
25529163|NCT00518011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529164|NCT00518011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529165|NCT00518011|Antiviral Agents|antiviral agents|mesh-ancestor
25529166|NCT00518011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25529167|NCT00518011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529168|NCT00518011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25529169|NCT00518011|Immunologic Factors|immunologic factors|mesh-ancestor
25529170|NCT00518011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529171|NCT00518011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25529172|NCT00518089|Gatifloxacin|gatifloxacin|mesh-list
25529173|NCT00518089|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25529174|NCT00518089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25529175|NCT00518089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25529176|NCT00518089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25529177|NCT00518089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25529178|NCT00518089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25529179|NCT00518089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529180|NCT00518089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529181|NCT00518089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529182|NCT00518115|Exenatide|exenatide|mesh-list
25529183|NCT00518115|rGLP-1 protein|rglp-1 protein|mesh-list
25529184|NCT00518115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25529185|NCT00518115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529186|NCT00518115|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25529187|NCT00518115|Incretins|incretins|mesh-ancestor
25529188|NCT00518115|Hormones|hormones|mesh-ancestor
25529189|NCT00518115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25529190|NCT00518154|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
25529191|NCT00518154|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25529192|NCT00518154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529193|NCT00518154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529194|NCT00518154|Cholinergic Agents|cholinergic agents|mesh-ancestor
25529195|NCT00518154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25529196|NCT00518154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646881|NCT01463384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25646882|NCT01463384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25646883|NCT01463384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646884|NCT01463982|Capecitabine|capecitabine|mesh-list
25646885|NCT01463982|Irinotecan|irinotecan|mesh-list
25646886|NCT01463982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25646887|NCT01463982|Antimetabolites|antimetabolites|mesh-ancestor
25529197|NCT00518180|Lactitol|lactitol|mesh-list
25529198|NCT00518180|Vaccines|vaccines|mesh-list
25529199|NCT00518180|Immunologic Factors|immunologic factors|mesh-ancestor
25529200|NCT00518180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529201|NCT00518180|Cathartics|cathartics|mesh-ancestor
25529202|NCT00518180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25529203|NCT00518206|Cyclophosphamide|cyclophosphamide|mesh-list
25529204|NCT00518206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25529205|NCT00518206|Immunologic Factors|immunologic factors|mesh-ancestor
25529206|NCT00518206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529207|NCT00518206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25529208|NCT00518206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25529209|NCT00518206|Alkylating Agents|alkylating agents|mesh-ancestor
25529210|NCT00518206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529211|NCT00518206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529212|NCT00518206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25529213|NCT00518284|Paclitaxel|paclitaxel|mesh-list
25529214|NCT00518284|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25529215|NCT00518284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25529216|NCT00518284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529217|NCT00518284|Tubulin Modulators|tubulin modulators|mesh-ancestor
25529218|NCT00518284|Antimitotic Agents|antimitotic agents|mesh-ancestor
25529219|NCT00518284|Mitosis Modulators|mitosis modulators|mesh-ancestor
25529220|NCT00518284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529221|NCT00518323|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25529222|NCT00518323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25529223|NCT00518323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25529224|NCT00518323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25529225|NCT00518323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529226|NCT00518323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25529227|NCT00518323|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25529228|NCT00518323|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25529229|NCT00518323|Serotonin Agents|serotonin agents|mesh-ancestor
25529230|NCT00518323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25529231|NCT00518323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529232|NCT00518323|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25529233|NCT00518323|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25529234|NCT00518323|Dopamine Agents|dopamine agents|mesh-ancestor
25529235|NCT00518531|Denosumab|denosumab|mesh-list
25529236|NCT00518531|Alendronate|alendronate|mesh-list
25529237|NCT00518531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25529238|NCT00518531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529239|NCT00518687|Vaccines|vaccines|mesh-list
25529240|NCT00518687|Immunologic Factors|immunologic factors|mesh-ancestor
25529241|NCT00518687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529242|NCT00518713|Clobazam|clobazam|mesh-list
25529243|NCT00518713|Anticonvulsants|anticonvulsants|mesh-ancestor
25529244|NCT00518713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25529245|NCT00518713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25529246|NCT00518713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25529247|NCT00518713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529248|NCT00518713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25529249|NCT00518713|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25529250|NCT00518713|GABA Agonists|gaba agonists|mesh-ancestor
25529251|NCT00518713|GABA Agents|gaba agents|mesh-ancestor
25529252|NCT00518713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25529253|NCT00518713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529254|NCT00518882|Liraglutide|liraglutide|mesh-list
25529255|NCT00518882|Exenatide|exenatide|mesh-list
25529256|NCT00518882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25529257|NCT00518882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529258|NCT00518882|Incretins|incretins|mesh-ancestor
25529259|NCT00518882|Hormones|hormones|mesh-ancestor
25529260|NCT00518882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25529261|NCT00518882|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25529262|NCT00518973|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25529263|NCT00518973|Antidepressive Agents|antidepressive agents|mesh-ancestor
25529264|NCT00518973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25529265|NCT00518973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25529267|NCT00518973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25529268|NCT00518973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529269|NCT00518986|Modafinil|modafinil|mesh-list
25529270|NCT00518986|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25529271|NCT00518986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529272|NCT00518986|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25529273|NCT00518986|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25529274|NCT00518986|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25529275|NCT00518986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529276|NCT00519077|Gefitinib|gefitinib|mesh-list
25529277|NCT00519077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529278|NCT00519077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25529279|NCT00519077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529280|NCT00519077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529281|NCT00519285|Prednisone|prednisone|mesh-list
25529282|NCT00519285|Prednisolone|prednisolone|mesh-list
25529283|NCT00519285|Docetaxel|docetaxel|mesh-list
25529284|NCT00519285|Aflibercept|aflibercept|mesh-list
25529285|NCT00519285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529286|NCT00519285|Tubulin Modulators|tubulin modulators|mesh-ancestor
25529287|NCT00519285|Antimitotic Agents|antimitotic agents|mesh-ancestor
25529288|NCT00519285|Mitosis Modulators|mitosis modulators|mesh-ancestor
25529289|NCT00519285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529290|NCT00519285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25529291|NCT00519285|Glucocorticoids|glucocorticoids|mesh-ancestor
25529292|NCT00519285|Hormones|hormones|mesh-ancestor
25529293|NCT00519285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25529294|NCT00519285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529295|NCT00519285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25529296|NCT00519285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25529297|NCT00519285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25529298|NCT00519285|Growth Substances|growth substances|mesh-ancestor
25529299|NCT00519285|Growth Inhibitors|growth inhibitors|mesh-ancestor
25529300|NCT00519428|Dexetimide|dexetimide|mesh-list
25529301|NCT00519428|Citalopram|citalopram|mesh-list
25529302|NCT00519428|Bupropion|bupropion|mesh-list
25529303|NCT00519428|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25529304|NCT00519428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25529305|NCT00519428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25529306|NCT00519428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529307|NCT00519428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25529308|NCT00519428|Serotonin Agents|serotonin agents|mesh-ancestor
25529309|NCT00519428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529310|NCT00519428|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25529311|NCT00519428|Antidepressive Agents|antidepressive agents|mesh-ancestor
25529312|NCT00519428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25529313|NCT00519428|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25529314|NCT00519428|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25529315|NCT00519428|Parasympatholytics|parasympatholytics|mesh-ancestor
25529316|NCT00519428|Autonomic Agents|autonomic agents|mesh-ancestor
25529317|NCT00519428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25529318|NCT00519428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25529319|NCT00519428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25529320|NCT00519428|Cholinergic Agents|cholinergic agents|mesh-ancestor
25529321|NCT00519428|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25529322|NCT00519428|Dopamine Agents|dopamine agents|mesh-ancestor
25529323|NCT00519428|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25529324|NCT00519428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25529325|NCT00519428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529326|NCT00519532|Rotigotine|rotigotine|mesh-list
25529327|NCT00519532|Dopamine Agonists|dopamine agonists|mesh-ancestor
25529328|NCT00519532|Dopamine Agents|dopamine agents|mesh-ancestor
25529329|NCT00519532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25529330|NCT00519532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529331|NCT00519532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529332|NCT00519584|Bupivacaine|bupivacaine|mesh-list
25529333|NCT00519584|Ropivacaine|ropivacaine|mesh-list
25529334|NCT00519584|Anesthetics, Local|anesthetics, local|mesh-ancestor
25529335|NCT00519584|Anesthetics|anesthetics|mesh-ancestor
25529336|NCT00519584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25529337|NCT00519584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529338|NCT00519584|Sensory System Agents|sensory system agents|mesh-ancestor
25529339|NCT00519584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25529340|NCT00519623|Insulin|insulin|mesh-list
25529373|NCT00520013|Tubulin Modulators|tubulin modulators|mesh-ancestor
25529374|NCT00520013|Antimitotic Agents|antimitotic agents|mesh-ancestor
25529375|NCT00520013|Mitosis Modulators|mitosis modulators|mesh-ancestor
25529376|NCT00520013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529377|NCT00520013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25529378|NCT00520013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25529379|NCT00520013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25529380|NCT00520013|Growth Substances|growth substances|mesh-ancestor
25529381|NCT00520013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529382|NCT00520013|Growth Inhibitors|growth inhibitors|mesh-ancestor
25529383|NCT00520013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25529384|NCT00520013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529385|NCT00520130|Cytarabine|cytarabine|mesh-list
25529386|NCT00520130|Cyclosporine|cyclosporine|mesh-list
25529387|NCT00520130|Rituximab|rituximab|mesh-list
25529388|NCT00520130|Alemtuzumab|alemtuzumab|mesh-list
25529389|NCT00520130|Fludarabine|fludarabine|mesh-list
25529390|NCT00520130|Cyclosporins|cyclosporins|mesh-list
25529391|NCT00520130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25529392|NCT00520130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529393|NCT00520130|Immunologic Factors|immunologic factors|mesh-ancestor
25529394|NCT00520130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529395|NCT00520130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25529396|NCT00520130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25529397|NCT00520130|Antimetabolites|antimetabolites|mesh-ancestor
25529398|NCT00520130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529399|NCT00520130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25529400|NCT00520130|Antiviral Agents|antiviral agents|mesh-ancestor
25529401|NCT00520130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25529402|NCT00520130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529403|NCT00520130|Antifungal Agents|antifungal agents|mesh-ancestor
25529404|NCT00520130|Dermatologic Agents|dermatologic agents|mesh-ancestor
25529405|NCT00520130|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25529406|NCT00520234|Caspofungin|caspofungin|mesh-list
25529407|NCT00520234|Antifungal Agents|antifungal agents|mesh-ancestor
25529408|NCT00520234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25529409|NCT00520234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529410|NCT00520234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529411|NCT00520286|Modafinil|modafinil|mesh-list
25529412|NCT00520286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25529413|NCT00520286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529414|NCT00520286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25529415|NCT00520286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25529416|NCT00520286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25529417|NCT00520286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529418|NCT00520403|Interferons|interferons|mesh-list
25529419|NCT00520403|Interferon-alpha|interferon-alpha|mesh-list
25529420|NCT00520403|Interferon alpha-2|interferon alpha-2|mesh-list
25529421|NCT00520403|Bevacizumab|bevacizumab|mesh-list
25529422|NCT00520403|Vinblastine|vinblastine|mesh-list
25529423|NCT00520403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25529424|NCT00520403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529425|NCT00520403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25529426|NCT00520403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25529427|NCT00520403|Growth Substances|growth substances|mesh-ancestor
25529428|NCT00520403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529429|NCT00520403|Growth Inhibitors|growth inhibitors|mesh-ancestor
25529430|NCT00520403|Antiviral Agents|antiviral agents|mesh-ancestor
25529431|NCT00520403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25529432|NCT00520403|Immunologic Factors|immunologic factors|mesh-ancestor
25529433|NCT00520403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25529434|NCT00520403|Tubulin Modulators|tubulin modulators|mesh-ancestor
25529435|NCT00520403|Antimitotic Agents|antimitotic agents|mesh-ancestor
25529436|NCT00520403|Mitosis Modulators|mitosis modulators|mesh-ancestor
25529437|NCT00520403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529438|NCT00520468|Cyclosporine|cyclosporine|mesh-list
25529439|NCT00520468|Prednisone|prednisone|mesh-list
25529440|NCT00520468|Epoetin Alfa|epoetin alfa|mesh-list
25529441|NCT00520468|Darbepoetin alfa|darbepoetin alfa|mesh-list
25529442|NCT00520468|Cyclosporins|cyclosporins|mesh-list
25529443|NCT00520468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25529444|NCT00520468|Glucocorticoids|glucocorticoids|mesh-ancestor
25529445|NCT00520468|Hormones|hormones|mesh-ancestor
25529446|NCT00520468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25646888|NCT01463982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646889|NCT01463982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646890|NCT01463982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25646891|NCT01463982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25646892|NCT01463982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529447|NCT00520468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529448|NCT00520468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25529449|NCT00520468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529450|NCT00520468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529451|NCT00520468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529452|NCT00520468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25529453|NCT00520468|Immunologic Factors|immunologic factors|mesh-ancestor
25529454|NCT00520468|Antifungal Agents|antifungal agents|mesh-ancestor
25529455|NCT00520468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25529456|NCT00520468|Dermatologic Agents|dermatologic agents|mesh-ancestor
25529457|NCT00520468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25529458|NCT00520468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25529459|NCT00520468|Hematinics|hematinics|mesh-ancestor
25529460|NCT00520481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25529461|NCT00520481|Immunologic Factors|immunologic factors|mesh-ancestor
25529462|NCT00520481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529463|NCT00520533|Sunitinib|sunitinib|mesh-list
25529464|NCT00520533|Antibodies|antibodies|mesh-list
25529465|NCT00520533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25529466|NCT00520533|Immunologic Factors|immunologic factors|mesh-ancestor
25529467|NCT00520533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529468|NCT00520533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529469|NCT00520533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25529470|NCT00520533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25529471|NCT00520533|Growth Substances|growth substances|mesh-ancestor
25529472|NCT00520533|Growth Inhibitors|growth inhibitors|mesh-ancestor
25529473|NCT00520533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25529474|NCT00520533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529475|NCT00520533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529476|NCT00520572|Etanercept|etanercept|mesh-list
25529477|NCT00520572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25529478|NCT00520572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25529479|NCT00520572|Analgesics|analgesics|mesh-ancestor
25529480|NCT00520572|Sensory System Agents|sensory system agents|mesh-ancestor
25529481|NCT00520572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25529482|NCT00520572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529483|NCT00520572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25529484|NCT00520572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25529485|NCT00520572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25529486|NCT00520572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25529487|NCT00520572|Immunologic Factors|immunologic factors|mesh-ancestor
25529488|NCT00520676|Carboplatin|carboplatin|mesh-list
25529489|NCT00520676|Docetaxel|docetaxel|mesh-list
25529490|NCT00520676|Pemetrexed|pemetrexed|mesh-list
25529491|NCT00520676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529492|NCT00520676|Tubulin Modulators|tubulin modulators|mesh-ancestor
25529493|NCT00520676|Antimitotic Agents|antimitotic agents|mesh-ancestor
25529494|NCT00520676|Mitosis Modulators|mitosis modulators|mesh-ancestor
25529495|NCT00520676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529496|NCT00520676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529497|NCT00520676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25529498|NCT00520676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25529499|NCT00520741|Lacosamide|lacosamide|mesh-list
25529500|NCT00520741|Anticonvulsants|anticonvulsants|mesh-ancestor
25529501|NCT00520741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25529502|NCT00520741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25529503|NCT00520741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25529504|NCT00520741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529505|NCT00520845|Celecoxib|celecoxib|mesh-list
25529506|NCT00520845|Docetaxel|docetaxel|mesh-list
25529507|NCT00520845|Pemetrexed|pemetrexed|mesh-list
25529508|NCT00520845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529509|NCT00520845|Tubulin Modulators|tubulin modulators|mesh-ancestor
25529510|NCT00520845|Antimitotic Agents|antimitotic agents|mesh-ancestor
25529511|NCT00520845|Mitosis Modulators|mitosis modulators|mesh-ancestor
25529512|NCT00520845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529513|NCT00520845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529514|NCT00520845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25529515|NCT00520845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25529516|NCT00520845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25529518|NCT00520845|Analgesics|analgesics|mesh-ancestor
25529519|NCT00520845|Sensory System Agents|sensory system agents|mesh-ancestor
25529520|NCT00520845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25529521|NCT00520845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529522|NCT00520845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25529523|NCT00520845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25529524|NCT00520845|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25529525|NCT00520845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25529526|NCT00520936|Pemetrexed|pemetrexed|mesh-list
25529527|NCT00520936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529528|NCT00520936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529529|NCT00520936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529530|NCT00520936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25529531|NCT00520936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25529532|NCT00520975|Paclitaxel|paclitaxel|mesh-list
25529533|NCT00520975|Bevacizumab|bevacizumab|mesh-list
25529534|NCT00520975|Carboplatin|carboplatin|mesh-list
25529535|NCT00520975|Trastuzumab|trastuzumab|mesh-list
25529536|NCT00520975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25529538|NCT00520975|Immunoglobulins|immunoglobulins|mesh-list
25529539|NCT00520975|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25529540|NCT00520975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25529541|NCT00520975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529542|NCT00520975|Tubulin Modulators|tubulin modulators|mesh-ancestor
25529543|NCT00520975|Antimitotic Agents|antimitotic agents|mesh-ancestor
25529544|NCT00520975|Mitosis Modulators|mitosis modulators|mesh-ancestor
25529545|NCT00520975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529546|NCT00520975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25529547|NCT00520975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25529548|NCT00520975|Growth Substances|growth substances|mesh-ancestor
25529549|NCT00520975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529550|NCT00520975|Growth Inhibitors|growth inhibitors|mesh-ancestor
25529551|NCT00520975|Immunologic Factors|immunologic factors|mesh-ancestor
25529552|NCT00521001|Everolimus|everolimus|mesh-list
25529553|NCT00521001|Temozolomide|temozolomide|mesh-list
25529554|NCT00521001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529555|NCT00521001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25529556|NCT00521001|Immunologic Factors|immunologic factors|mesh-ancestor
25529557|NCT00521001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529558|NCT00521001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25529559|NCT00521001|Alkylating Agents|alkylating agents|mesh-ancestor
25529560|NCT00521001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529561|NCT00521014|Cytarabine|cytarabine|mesh-list
25529562|NCT00521014|Rituximab|rituximab|mesh-list
25529563|NCT00521014|Etoposide|etoposide|mesh-list
25529564|NCT00521014|Melphalan|melphalan|mesh-list
25529565|NCT00521014|Carmustine|carmustine|mesh-list
25529566|NCT00521014|Sargramostim|sargramostim|mesh-list
25529567|NCT00521014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25529568|NCT00521014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529569|NCT00521014|Immunologic Factors|immunologic factors|mesh-ancestor
25529570|NCT00521014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529571|NCT00521014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25529572|NCT00521014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25529573|NCT00521014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25529574|NCT00521014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25529575|NCT00521014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529576|NCT00521014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529577|NCT00521014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25529578|NCT00521014|Antimetabolites|antimetabolites|mesh-ancestor
25529579|NCT00521014|Antiviral Agents|antiviral agents|mesh-ancestor
25529580|NCT00521014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25529581|NCT00521014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25529582|NCT00521014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25529583|NCT00521014|Alkylating Agents|alkylating agents|mesh-ancestor
25529584|NCT00521014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25529585|NCT00521144|Topotecan|topotecan|mesh-list
25529586|NCT00521144|Obatoclax|obatoclax|mesh-list
25529587|NCT00521144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25529588|NCT00521144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25529589|NCT00521144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529590|NCT00521144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529591|NCT00521144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529592|NCT00521339|Apremilast|apremilast|mesh-list
25529593|NCT00521339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25529594|NCT00521339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25529595|NCT00521339|Analgesics|analgesics|mesh-ancestor
25529596|NCT00521339|Sensory System Agents|sensory system agents|mesh-ancestor
25529597|NCT00521339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25529598|NCT00521339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529599|NCT00521339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25529600|NCT00521339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25529601|NCT00521339|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25529602|NCT00521339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25529603|NCT00521339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529604|NCT00521339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529605|NCT00521365|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25529606|NCT00521365|Antidepressive Agents|antidepressive agents|mesh-ancestor
25529607|NCT00521365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25529608|NCT00521365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25529609|NCT00521365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25529610|NCT00521365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25529611|NCT00521365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529612|NCT00521404|Gemcitabine|gemcitabine|mesh-list
25529613|NCT00521404|Antibodies|antibodies|mesh-list
25529614|NCT00521404|Immunologic Factors|immunologic factors|mesh-ancestor
25529615|NCT00521404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529616|NCT00521404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25529617|NCT00521404|Antimetabolites|antimetabolites|mesh-ancestor
25529618|NCT00521404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529619|NCT00521404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529620|NCT00521404|Antiviral Agents|antiviral agents|mesh-ancestor
25529621|NCT00521404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25529622|NCT00521404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529623|NCT00521404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25529624|NCT00521456|Ketorolac|ketorolac|mesh-list
25529625|NCT00521456|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25529626|NCT00521456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25529627|NCT00521456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25529628|NCT00521456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25529629|NCT00521456|Analgesics|analgesics|mesh-ancestor
25529630|NCT00521456|Sensory System Agents|sensory system agents|mesh-ancestor
25529631|NCT00521456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25529632|NCT00521456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529633|NCT00521456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25529634|NCT00521456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25529635|NCT00521456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25529636|NCT00521456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529637|NCT00521456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529638|NCT00521586|Vaccines|vaccines|mesh-list
25529639|NCT00521586|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25529640|NCT00521586|Immunologic Factors|immunologic factors|mesh-ancestor
25529641|NCT00521586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529642|NCT00521989|Prednisolone|prednisolone|mesh-list
25529643|NCT00521989|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25529644|NCT00521989|Methylprednisolone|methylprednisolone|mesh-list
25529645|NCT00521989|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25529646|NCT00521989|Prednisolone acetate|prednisolone acetate|mesh-list
25529647|NCT00521989|Dipyridamole|dipyridamole|mesh-list
25529648|NCT00521989|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25529649|NCT00521989|Prednisolone phosphate|prednisolone phosphate|mesh-list
25529650|NCT00521989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25529651|NCT00521989|Glucocorticoids|glucocorticoids|mesh-ancestor
25529652|NCT00521989|Hormones|hormones|mesh-ancestor
25529653|NCT00521989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25529654|NCT00521989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529655|NCT00521989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25529656|NCT00521989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529657|NCT00521989|Antiemetics|antiemetics|mesh-ancestor
25529658|NCT00521989|Autonomic Agents|autonomic agents|mesh-ancestor
25529659|NCT00521989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25529660|NCT00521989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25529661|NCT00521989|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25529662|NCT00521989|Protective Agents|protective agents|mesh-ancestor
24807507|NCT02022358|Vitamins|vitamins|mesh-ancestor
25529663|NCT00521989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25529664|NCT00521989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529665|NCT00521989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529666|NCT00521989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25529667|NCT00521989|Vasodilator Agents|vasodilator agents|mesh-ancestor
25529668|NCT00522041|Nitroglycerin|nitroglycerin|mesh-list
25529669|NCT00522041|Vasodilator Agents|vasodilator agents|mesh-ancestor
25529670|NCT00522275|Lacosamide|lacosamide|mesh-list
25529671|NCT00522275|Anticonvulsants|anticonvulsants|mesh-ancestor
25529672|NCT00522275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25529673|NCT00522275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25529674|NCT00522275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25529675|NCT00522275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529676|NCT00522379|Rotigotine|rotigotine|mesh-list
25529677|NCT00522379|Dopamine Agonists|dopamine agonists|mesh-ancestor
25529678|NCT00522379|Dopamine Agents|dopamine agents|mesh-ancestor
25529679|NCT00522379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25529680|NCT00522379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529681|NCT00522379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529682|NCT00522392|Dexamethasone|dexamethasone|mesh-list
25529683|NCT00522392|Lenalidomide|lenalidomide|mesh-list
25529684|NCT00522392|Bortezomib|bortezomib|mesh-list
25529685|NCT00522392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25529686|NCT00522392|Antiemetics|antiemetics|mesh-ancestor
25529687|NCT00522392|Autonomic Agents|autonomic agents|mesh-ancestor
25529688|NCT00522392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25529689|NCT00522392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529690|NCT00522392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25529691|NCT00522392|Glucocorticoids|glucocorticoids|mesh-ancestor
25529692|NCT00522392|Hormones|hormones|mesh-ancestor
25529693|NCT00522392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25529694|NCT00522392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25529695|NCT00522392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529696|NCT00522392|Immunologic Factors|immunologic factors|mesh-ancestor
25529697|NCT00522392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25529698|NCT00522392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25529699|NCT00522392|Growth Substances|growth substances|mesh-ancestor
25529700|NCT00522392|Growth Inhibitors|growth inhibitors|mesh-ancestor
25529701|NCT00522431|Testosterone|testosterone|mesh-list
25529702|NCT00522431|Androgens|androgens|mesh-ancestor
25529703|NCT00522431|Hormones|hormones|mesh-ancestor
25529704|NCT00522431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25529705|NCT00522431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529706|NCT00522548|Mycophenolic Acid|mycophenolic acid|mesh-list
25529707|NCT00522548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25529708|NCT00522548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529709|NCT00522548|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25529710|NCT00522548|Antitubercular Agents|antitubercular agents|mesh-ancestor
25529711|NCT00522548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25529712|NCT00522548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25529713|NCT00522548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529714|NCT00522548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529715|NCT00522795|Paclitaxel|paclitaxel|mesh-list
25529716|NCT00522795|Cisplatin|cisplatin|mesh-list
25529717|NCT00522795|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
25529718|NCT00522795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25529719|NCT00522795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529720|NCT00522795|Tubulin Modulators|tubulin modulators|mesh-ancestor
25529721|NCT00522795|Antimitotic Agents|antimitotic agents|mesh-ancestor
25529722|NCT00522795|Mitosis Modulators|mitosis modulators|mesh-ancestor
25529723|NCT00522795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529724|NCT00523237|Raltegravir Potassium|raltegravir potassium|mesh-list
25529725|NCT00523237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25529726|NCT00523237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25529727|NCT00523237|Antiviral Agents|antiviral agents|mesh-ancestor
25529728|NCT00523237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25529729|NCT00523237|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25529730|NCT00523237|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25529731|NCT00523237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529732|NCT00523237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529733|NCT00523419|Pemetrexed|pemetrexed|mesh-list
25529734|NCT00523419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529735|NCT00523419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529736|NCT00523419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529737|NCT00523419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25529738|NCT00523419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25529739|NCT00523549|Amlodipine|amlodipine|mesh-list
25529740|NCT00523549|Valsartan|valsartan|mesh-list
25529741|NCT00523549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25646894|NCT01464190|Chelating Agents|chelating agents|mesh-ancestor
25529742|NCT00523549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25529743|NCT00523549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25529744|NCT00523549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529745|NCT00523549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25529746|NCT00523549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529747|NCT00523549|Vasodilator Agents|vasodilator agents|mesh-ancestor
25529748|NCT00523549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25529749|NCT00523549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25529750|NCT00523640|Gemcitabine|gemcitabine|mesh-list
25529751|NCT00523640|Bevacizumab|bevacizumab|mesh-list
25529752|NCT00523640|Capecitabine|capecitabine|mesh-list
25529753|NCT00523640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25529754|NCT00523640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529755|NCT00523640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25529756|NCT00523640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25529757|NCT00523640|Growth Substances|growth substances|mesh-ancestor
25529758|NCT00523640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823533|NCT00004854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529759|NCT00523640|Growth Inhibitors|growth inhibitors|mesh-ancestor
25529760|NCT00523640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25529761|NCT00523640|Antimetabolites|antimetabolites|mesh-ancestor
25529762|NCT00523640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529763|NCT00523640|Antiviral Agents|antiviral agents|mesh-ancestor
25529764|NCT00523640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25529765|NCT00523640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529766|NCT00523640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25529767|NCT00523640|Immunologic Factors|immunologic factors|mesh-ancestor
25529768|NCT00523705|Citalopram|citalopram|mesh-list
25529769|NCT00523705|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25529770|NCT00523705|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25529771|NCT00523705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25529772|NCT00523705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529773|NCT00523705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25529774|NCT00523705|Serotonin Agents|serotonin agents|mesh-ancestor
25529775|NCT00523705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529776|NCT00523705|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25529777|NCT00523705|Antidepressive Agents|antidepressive agents|mesh-ancestor
25529778|NCT00523705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25529779|NCT00523718|Riluzole|riluzole|mesh-list
25529780|NCT00523718|Anticonvulsants|anticonvulsants|mesh-ancestor
25529781|NCT00523718|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25529782|NCT00523718|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25529783|NCT00523718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25529784|NCT00523718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529785|NCT00523718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529786|NCT00523718|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25529787|NCT00523718|Protective Agents|protective agents|mesh-ancestor
25529788|NCT00523744|Amlodipine|amlodipine|mesh-list
25529789|NCT00523744|Valsartan|valsartan|mesh-list
25529790|NCT00523744|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25529791|NCT00523744|Olmesartan|olmesartan|mesh-list
25529792|NCT00523744|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25529793|NCT00523744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25529794|NCT00523744|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25529795|NCT00523744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25529796|NCT00523744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529797|NCT00523744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25529798|NCT00523744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529799|NCT00523744|Vasodilator Agents|vasodilator agents|mesh-ancestor
25529800|NCT00523744|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25529801|NCT00523744|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25529802|NCT00523744|Diuretics|diuretics|mesh-ancestor
25529803|NCT00523744|Natriuretic Agents|natriuretic agents|mesh-ancestor
25529804|NCT00523744|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25529805|NCT00523848|Thalidomide|thalidomide|mesh-list
25529806|NCT00523848|Doxorubicin|doxorubicin|mesh-list
25529807|NCT00523848|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25529808|NCT00523848|Bortezomib|bortezomib|mesh-list
25529809|NCT00523848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25529810|NCT00523848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529811|NCT00523848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25529812|NCT00523848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25646895|NCT01464190|Sequestering Agents|sequestering agents|mesh-ancestor
25646896|NCT01464190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646897|NCT01464229|Iloperidone|iloperidone|mesh-list
25529813|NCT00523848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529814|NCT00523848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529815|NCT00523848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25529816|NCT00523848|Immunologic Factors|immunologic factors|mesh-ancestor
25529817|NCT00523848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529818|NCT00523848|Leprostatic Agents|leprostatic agents|mesh-ancestor
25529819|NCT00523848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25529820|NCT00523848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25529821|NCT00523848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25529822|NCT00523848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25529823|NCT00523848|Growth Substances|growth substances|mesh-ancestor
25529824|NCT00523848|Growth Inhibitors|growth inhibitors|mesh-ancestor
25529825|NCT00523978|Sotalol|sotalol|mesh-list
25529826|NCT00523978|Flecainide|flecainide|mesh-list
25529827|NCT00523978|Propafenone|propafenone|mesh-list
25529828|NCT00523978|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25529829|NCT00523978|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25529830|NCT00523978|Adrenergic Agents|adrenergic agents|mesh-ancestor
25529831|NCT00523978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25529832|NCT00523978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529833|NCT00523978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529834|NCT00523978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25529835|NCT00523978|Sympatholytics|sympatholytics|mesh-ancestor
25529836|NCT00523978|Autonomic Agents|autonomic agents|mesh-ancestor
25529837|NCT00523978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25529838|NCT00523978|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25529839|NCT00523978|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25529840|NCT00523978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25529841|NCT00523991|Tiotropium Bromide|tiotropium bromide|mesh-list
25529842|NCT00523991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25529843|NCT00523991|Autonomic Agents|autonomic agents|mesh-ancestor
25529844|NCT00523991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25529845|NCT00523991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529846|NCT00523991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25529847|NCT00523991|Respiratory System Agents|respiratory system agents|mesh-ancestor
25529848|NCT00523991|Parasympatholytics|parasympatholytics|mesh-ancestor
25529849|NCT00523991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25529850|NCT00523991|Cholinergic Agents|cholinergic agents|mesh-ancestor
25529851|NCT00523991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25529852|NCT00523991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529853|NCT00524017|Cetuximab|cetuximab|mesh-list
25529854|NCT00524017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25529855|NCT00524017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529856|NCT00524030|Pregabalin|pregabalin|mesh-list
25529857|NCT00524030|Analgesics|analgesics|mesh-ancestor
25529858|NCT00524030|Sensory System Agents|sensory system agents|mesh-ancestor
25529859|NCT00524030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25529860|NCT00524030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529861|NCT00524030|Anticonvulsants|anticonvulsants|mesh-ancestor
25529862|NCT00524030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25529863|NCT00524030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25529864|NCT00524030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529865|NCT00524030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25529866|NCT00524030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25529867|NCT00524030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25529868|NCT00524030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25529869|NCT00524030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25529870|NCT00524043|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25529871|NCT00524043|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25529872|NCT00524043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25529873|NCT00524043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25529874|NCT00524043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529875|NCT00524043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25529876|NCT00524043|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25529877|NCT00524043|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25529878|NCT00524043|Serotonin Agents|serotonin agents|mesh-ancestor
25529879|NCT00524043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25529880|NCT00524043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529881|NCT00524043|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25529882|NCT00524043|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25646898|NCT01464229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25646899|NCT01464229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25529883|NCT00524043|Dopamine Agents|dopamine agents|mesh-ancestor
25529884|NCT00524121|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25529885|NCT00524121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529886|NCT00524121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25529887|NCT00524121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529888|NCT00524121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529889|NCT00524173|Tenofovir|tenofovir|mesh-list
25529890|NCT00524173|Emtricitabine|emtricitabine|mesh-list
25529891|NCT00524173|Antiviral Agents|antiviral agents|mesh-ancestor
25529892|NCT00524173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25529893|NCT00524173|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25529894|NCT00524173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25529895|NCT00524173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529896|NCT00524173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529897|NCT00524173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25529898|NCT00524173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25529899|NCT00524225|Oprelvekin|oprelvekin|mesh-list
25529900|NCT00524225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529901|NCT00524264|Ketorolac|ketorolac|mesh-list
25529902|NCT00524264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25529903|NCT00524264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25529904|NCT00524264|Analgesics|analgesics|mesh-ancestor
25529905|NCT00524264|Sensory System Agents|sensory system agents|mesh-ancestor
25148766|NCT04630964|Niacin|niacin|mesh-list
25529906|NCT00524264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25529907|NCT00524264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529908|NCT00524264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25529909|NCT00524264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25529910|NCT00524264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25529911|NCT00524264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529912|NCT00524264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529913|NCT00524303|Paclitaxel|paclitaxel|mesh-list
25529914|NCT00524303|Trastuzumab|trastuzumab|mesh-list
25529915|NCT00524303|Lapatinib|lapatinib|mesh-list
25529916|NCT00524303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25529917|NCT00524303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529918|NCT00524303|Tubulin Modulators|tubulin modulators|mesh-ancestor
25529919|NCT00524303|Antimitotic Agents|antimitotic agents|mesh-ancestor
25529920|NCT00524303|Mitosis Modulators|mitosis modulators|mesh-ancestor
25529921|NCT00524303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529922|NCT00524303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25529923|NCT00524303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25529924|NCT00524303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529925|NCT00524316|Doxorubicin|doxorubicin|mesh-list
25529926|NCT00524316|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25529927|NCT00524316|Sunitinib|sunitinib|mesh-list
25529928|NCT00524316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25529929|NCT00524316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529930|NCT00524316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25529931|NCT00524316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25529932|NCT00524316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529933|NCT00524316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529934|NCT00524316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25529935|NCT00524316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25529936|NCT00524316|Growth Substances|growth substances|mesh-ancestor
25529937|NCT00524316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529938|NCT00524316|Growth Inhibitors|growth inhibitors|mesh-ancestor
25529939|NCT00524316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25529940|NCT00524342|Oprelvekin|oprelvekin|mesh-list
25529941|NCT00524342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529942|NCT00524368|Ritonavir|ritonavir|mesh-list
25529943|NCT00524368|Darunavir|darunavir|mesh-list
25529944|NCT00524368|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25529945|NCT00524368|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25529946|NCT00524368|Protease Inhibitors|protease inhibitors|mesh-ancestor
25529947|NCT00524368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25529948|NCT00524368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529949|NCT00524368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25529950|NCT00524368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25529951|NCT00524368|Antiviral Agents|antiviral agents|mesh-ancestor
25529952|NCT00524368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25529953|NCT00524368|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25529954|NCT00524368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25529955|NCT00524472|Insulin|insulin|mesh-list
25646900|NCT01464229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25646901|NCT01464229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646902|NCT01464229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25646903|NCT01464307|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25529956|NCT00524472|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25529957|NCT00524472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25529958|NCT00524472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529959|NCT00524576|Vaccines|vaccines|mesh-list
25529960|NCT00524576|Immunologic Factors|immunologic factors|mesh-ancestor
25529961|NCT00524576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529962|NCT00524589|Calcitriol|calcitriol|mesh-list
25529963|NCT00524589|Dexamethasone|dexamethasone|mesh-list
25529964|NCT00524589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25529965|NCT00524589|Antiemetics|antiemetics|mesh-ancestor
25529966|NCT00524589|Autonomic Agents|autonomic agents|mesh-ancestor
25529967|NCT00524589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25529968|NCT00524589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529969|NCT00524589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25529970|NCT00524589|Glucocorticoids|glucocorticoids|mesh-ancestor
25529971|NCT00524589|Hormones|hormones|mesh-ancestor
25529972|NCT00524589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25529973|NCT00524589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25529974|NCT00524589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529975|NCT00524589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25529976|NCT00524589|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25529977|NCT00524589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25529978|NCT00524589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25529979|NCT00524589|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25529980|NCT00524589|Vitamins|vitamins|mesh-ancestor
25529981|NCT00524589|Micronutrients|micronutrients|mesh-ancestor
25529982|NCT00524589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25529983|NCT00524680|Cholecalciferol|cholecalciferol|mesh-list
25529985|NCT00524680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25529986|NCT00524680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25529987|NCT00524680|Vitamins|vitamins|mesh-ancestor
25529988|NCT00524680|Micronutrients|micronutrients|mesh-ancestor
25529989|NCT00524680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25529990|NCT00525031|Interferons|interferons|mesh-list
25529991|NCT00525031|Interferon-alpha|interferon-alpha|mesh-list
25529992|NCT00525031|Interferon alpha-2|interferon alpha-2|mesh-list
25529993|NCT00525031|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25529994|NCT00525031|Temozolomide|temozolomide|mesh-list
25529995|NCT00525031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25529996|NCT00525031|Antiviral Agents|antiviral agents|mesh-ancestor
25529997|NCT00525031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25529998|NCT00525031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25529999|NCT00525031|Alkylating Agents|alkylating agents|mesh-ancestor
25530000|NCT00525031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530001|NCT00525031|Immunologic Factors|immunologic factors|mesh-ancestor
25530002|NCT00525031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530003|NCT00525044|Ambroxol|ambroxol|mesh-list
25530004|NCT00525044|Expectorants|expectorants|mesh-ancestor
25530005|NCT00525044|Respiratory System Agents|respiratory system agents|mesh-ancestor
25530006|NCT00525057|Dalteparin|dalteparin|mesh-list
25530007|NCT00525057|Tinzaparin|tinzaparin|mesh-list
25530008|NCT00525057|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25530009|NCT00525057|Anticoagulants|anticoagulants|mesh-ancestor
25530010|NCT00525057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25530011|NCT00525057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25530012|NCT00525057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530013|NCT00525135|Valproic Acid|valproic acid|mesh-list
25530014|NCT00525135|Anticonvulsants|anticonvulsants|mesh-ancestor
25530015|NCT00525135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530016|NCT00525135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530017|NCT00525135|GABA Agents|gaba agents|mesh-ancestor
25530018|NCT00525135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25530019|NCT00525135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530020|NCT00525135|Antimanic Agents|antimanic agents|mesh-ancestor
25530021|NCT00525135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25530022|NCT00525135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25530023|NCT00525135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25530024|NCT00525148|Afatinib|afatinib|mesh-list
25530025|NCT00525148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530026|NCT00525148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25530027|NCT00525148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823534|NCT00004854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823535|NCT00004854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25646904|NCT01464307|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25646905|NCT01464307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25530028|NCT00525148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530029|NCT00525161|Sorafenib|sorafenib|mesh-list
25530030|NCT00525161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530031|NCT00525161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25530032|NCT00525161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530033|NCT00525161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530034|NCT00525265|Tolvaptan|tolvaptan|mesh-list
25530035|NCT00525265|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25530036|NCT00525265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530037|NCT00525265|Natriuretic Agents|natriuretic agents|mesh-ancestor
25530038|NCT00525265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530039|NCT00525421|Curcumin|curcumin|mesh-list
25530040|NCT00525421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25530041|NCT00525421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25530042|NCT00525421|Analgesics|analgesics|mesh-ancestor
25530043|NCT00525421|Sensory System Agents|sensory system agents|mesh-ancestor
25530044|NCT00525421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25530045|NCT00525421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530046|NCT00525421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25530047|NCT00525421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25530048|NCT00525421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530049|NCT00525421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530050|NCT00525421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530051|NCT00525499|Androgens|androgens|mesh-list
25530052|NCT00525499|Hormones|hormones|mesh-ancestor
25530053|NCT00525499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25530054|NCT00525499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530055|NCT00525512|Tiotropium Bromide|tiotropium bromide|mesh-list
25530056|NCT00525512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25530057|NCT00525512|Autonomic Agents|autonomic agents|mesh-ancestor
25530058|NCT00525512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25530059|NCT00525512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530060|NCT00525512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25530061|NCT00525512|Respiratory System Agents|respiratory system agents|mesh-ancestor
25530062|NCT00525512|Parasympatholytics|parasympatholytics|mesh-ancestor
25530063|NCT00525512|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25530064|NCT00525512|Cholinergic Agents|cholinergic agents|mesh-ancestor
25530065|NCT00525512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25530066|NCT00525512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530067|NCT00525525|Bevacizumab|bevacizumab|mesh-list
25530068|NCT00525525|Temozolomide|temozolomide|mesh-list
25530069|NCT00525525|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25530070|NCT00525525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25530071|NCT00525525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530072|NCT00525525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25530073|NCT00525525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25530074|NCT00525525|Growth Substances|growth substances|mesh-ancestor
25530075|NCT00525525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530076|NCT00525525|Growth Inhibitors|growth inhibitors|mesh-ancestor
25530077|NCT00525525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25530078|NCT00525525|Alkylating Agents|alkylating agents|mesh-ancestor
25530079|NCT00525525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530080|NCT00525525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25530081|NCT00525525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530082|NCT00525590|Carmustine|carmustine|mesh-list
25530083|NCT00525590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25530084|NCT00525590|Alkylating Agents|alkylating agents|mesh-ancestor
25530085|NCT00525590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530086|NCT00525590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530087|NCT00525603|Vidarabine|vidarabine|mesh-list
25530088|NCT00525603|Cyclophosphamide|cyclophosphamide|mesh-list
25530089|NCT00525603|Rituximab|rituximab|mesh-list
25530090|NCT00525603|Fludarabine|fludarabine|mesh-list
25530091|NCT00525603|Fludarabine phosphate|fludarabine phosphate|mesh-list
25530092|NCT00525603|Alemtuzumab|alemtuzumab|mesh-list
25530093|NCT00525603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25530094|NCT00525603|Immunologic Factors|immunologic factors|mesh-ancestor
25530095|NCT00525603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530096|NCT00525603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25530097|NCT00525603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25646906|NCT01464307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646907|NCT01464307|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25646908|NCT01464307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25646909|NCT01464307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646910|NCT01464307|Cholinergic Agents|cholinergic agents|mesh-ancestor
25646911|NCT01464307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25646912|NCT01464359|Cyclophosphamide|cyclophosphamide|mesh-list
25530098|NCT00525603|Alkylating Agents|alkylating agents|mesh-ancestor
25530099|NCT00525603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530100|NCT00525603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530101|NCT00525603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25530102|NCT00525603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25530103|NCT00525603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25530104|NCT00525603|Antimetabolites|antimetabolites|mesh-ancestor
25530105|NCT00525603|Antiviral Agents|antiviral agents|mesh-ancestor
25530106|NCT00525603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25530107|NCT00525733|Ritonavir|ritonavir|mesh-list
25530108|NCT00525733|Darunavir|darunavir|mesh-list
25530109|NCT00525733|Raltegravir Potassium|raltegravir potassium|mesh-list
25530110|NCT00525733|Maraviroc|maraviroc|mesh-list
25530111|NCT00525733|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25530112|NCT00525733|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25530113|NCT00525733|Protease Inhibitors|protease inhibitors|mesh-ancestor
25530114|NCT00525733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530115|NCT00525733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530116|NCT00525733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25530117|NCT00525733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25530118|NCT00525733|Antiviral Agents|antiviral agents|mesh-ancestor
25530119|NCT00525733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25530120|NCT00525733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25530121|NCT00525733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25530122|NCT00525733|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25530123|NCT00525733|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25530124|NCT00525733|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25530125|NCT00525733|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25530126|NCT00525733|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25530127|NCT00525785|Leucovorin|leucovorin|mesh-list
25530128|NCT00525785|Folic Acid|folic acid|mesh-list
25530129|NCT00525785|Fluorouracil|fluorouracil|mesh-list
25530130|NCT00525785|Oxaliplatin|oxaliplatin|mesh-list
25530131|NCT00525785|Levoleucovorin|levoleucovorin|mesh-list
25530151|NCT00525798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25530152|NCT00525798|Vasodilator Agents|vasodilator agents|mesh-ancestor
25530153|NCT00525824|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25530154|NCT00525824|Simvastatin|simvastatin|mesh-list
25530155|NCT00525824|Ezetimibe|ezetimibe|mesh-list
25530156|NCT00525824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25530157|NCT00525824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25530158|NCT00525824|Antimetabolites|antimetabolites|mesh-ancestor
25530159|NCT00525824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530160|NCT00525824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25530161|NCT00525824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25530162|NCT00525824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530163|NCT00525837|Varenicline|varenicline|mesh-list
25530164|NCT00525837|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25530165|NCT00525837|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25530166|NCT00525837|Cholinergic Agents|cholinergic agents|mesh-ancestor
25530167|NCT00525837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25530168|NCT00525837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530169|NCT00525837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530170|NCT00525876|Vidarabine|vidarabine|mesh-list
25530171|NCT00525876|Cyclophosphamide|cyclophosphamide|mesh-list
25530172|NCT00525876|Rituximab|rituximab|mesh-list
25530173|NCT00525876|Fludarabine|fludarabine|mesh-list
25530174|NCT00525876|Fludarabine phosphate|fludarabine phosphate|mesh-list
25530175|NCT00525876|Alemtuzumab|alemtuzumab|mesh-list
25530176|NCT00525876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25530177|NCT00525876|Immunologic Factors|immunologic factors|mesh-ancestor
25530178|NCT00525876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530179|NCT00525876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25530180|NCT00525876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25530181|NCT00525876|Alkylating Agents|alkylating agents|mesh-ancestor
25530182|NCT00525876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530183|NCT00525876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530184|NCT00525876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25530185|NCT00525876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25530186|NCT00525876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25530187|NCT00525876|Antimetabolites|antimetabolites|mesh-ancestor
25530188|NCT00525876|Antiviral Agents|antiviral agents|mesh-ancestor
25530189|NCT00525876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25530190|NCT00525902|Adalimumab|adalimumab|mesh-list
25530191|NCT00525902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25530192|NCT00525902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25530193|NCT00525915|Fluorouracil|fluorouracil|mesh-list
25530194|NCT00525915|Oxaliplatin|oxaliplatin|mesh-list
25530195|NCT00525915|Antimetabolites|antimetabolites|mesh-ancestor
25530196|NCT00525915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530197|NCT00525915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25530198|NCT00525915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530199|NCT00525915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25530200|NCT00525915|Immunologic Factors|immunologic factors|mesh-ancestor
25530201|NCT00525915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530202|NCT00526058|Clotrimazole|clotrimazole|mesh-list
25530203|NCT00526058|Miconazole|miconazole|mesh-list
25530204|NCT00526058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25530205|NCT00526058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25530206|NCT00526058|Antifungal Agents|antifungal agents|mesh-ancestor
25530207|NCT00526058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25530208|NCT00526058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25530209|NCT00526058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530210|NCT00526058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530211|NCT00526058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25530212|NCT00526058|Hormone Antagonists|hormone antagonists|mesh-ancestor
25530213|NCT00526058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25530214|NCT00526058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530215|NCT00526058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25530216|NCT00526058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25530217|NCT00526097|Bisacodyl|bisacodyl|mesh-list
25530218|NCT00526097|Cathartics|cathartics|mesh-ancestor
25530219|NCT00526097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25530220|NCT00526097|Laxatives|laxatives|mesh-ancestor
25530221|NCT00526110|Docetaxel|docetaxel|mesh-list
25530222|NCT00526110|Fluorouracil|fluorouracil|mesh-list
25530223|NCT00526110|Oxaliplatin|oxaliplatin|mesh-list
25530224|NCT00526110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530225|NCT00526110|Tubulin Modulators|tubulin modulators|mesh-ancestor
25530226|NCT00526110|Antimitotic Agents|antimitotic agents|mesh-ancestor
25530227|NCT00526110|Mitosis Modulators|mitosis modulators|mesh-ancestor
25530228|NCT00526110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530229|NCT00526110|Antimetabolites|antimetabolites|mesh-ancestor
25530230|NCT00526110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25530231|NCT00526110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25530232|NCT00526110|Immunologic Factors|immunologic factors|mesh-ancestor
25530233|NCT00526110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530234|NCT00526292|Cyclophosphamide|cyclophosphamide|mesh-list
25530235|NCT00526292|Fludarabine|fludarabine|mesh-list
25530236|NCT00526292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25530237|NCT00526292|Immunologic Factors|immunologic factors|mesh-ancestor
25530238|NCT00526292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530239|NCT00526292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25530240|NCT00526292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25530241|NCT00526292|Alkylating Agents|alkylating agents|mesh-ancestor
25530242|NCT00526292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530243|NCT00526292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530244|NCT00526292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25530245|NCT00526474|Vorapaxar|vorapaxar|mesh-list
24482900|NCT00440921|Hemostatics|hemostatics|mesh-ancestor
25530246|NCT00526474|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25530247|NCT00526591|Everolimus|everolimus|mesh-list
25530248|NCT00526591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530249|NCT00526591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25530250|NCT00526591|Immunologic Factors|immunologic factors|mesh-ancestor
25530251|NCT00526591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530252|NCT00526630|Methylphenidate|methylphenidate|mesh-list
25530253|NCT00526630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25530254|NCT00526630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530255|NCT00526630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25530256|NCT00526630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25530257|NCT00526630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25530258|NCT00526630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530259|NCT00526630|Dopamine Agents|dopamine agents|mesh-ancestor
25646913|NCT01464359|Busulfan|busulfan|mesh-list
25530260|NCT00526630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25530261|NCT00526656|Sunitinib|sunitinib|mesh-list
25530262|NCT00526656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530263|NCT00526656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25530264|NCT00526656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25530265|NCT00526656|Growth Substances|growth substances|mesh-ancestor
25530266|NCT00526656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530267|NCT00526656|Growth Inhibitors|growth inhibitors|mesh-ancestor
25530268|NCT00526656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25530269|NCT00526656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530270|NCT00526656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530271|NCT00526669|Capecitabine|capecitabine|mesh-list
25530272|NCT00526669|Lapatinib|lapatinib|mesh-list
25530273|NCT00526669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25530274|NCT00526669|Antimetabolites|antimetabolites|mesh-ancestor
25530275|NCT00526669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530276|NCT00526669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530277|NCT00526669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25530278|NCT00526669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530279|NCT00526799|Sorafenib|sorafenib|mesh-list
25530280|NCT00526799|Topotecan|topotecan|mesh-list
25530281|NCT00526799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530282|NCT00526799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25530283|NCT00526799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530284|NCT00526799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530285|NCT00526799|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25530286|NCT00526799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25530287|NCT00526890|Selenium|selenium|mesh-list
25530288|NCT00526890|Paclitaxel|paclitaxel|mesh-list
25530289|NCT00526890|Carboplatin|carboplatin|mesh-list
25530290|NCT00526890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25530291|NCT00526890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530292|NCT00526890|Tubulin Modulators|tubulin modulators|mesh-ancestor
25530293|NCT00526890|Antimitotic Agents|antimitotic agents|mesh-ancestor
25530294|NCT00526890|Mitosis Modulators|mitosis modulators|mesh-ancestor
25530295|NCT00526890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530296|NCT00526890|Antioxidants|antioxidants|mesh-ancestor
25530297|NCT00526890|Protective Agents|protective agents|mesh-ancestor
25530298|NCT00526890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530299|NCT00526890|Trace Elements|trace elements|mesh-ancestor
25530300|NCT00526890|Micronutrients|micronutrients|mesh-ancestor
25530301|NCT00527072|Infliximab|infliximab|mesh-list
25530302|NCT00527072|Dermatologic Agents|dermatologic agents|mesh-ancestor
25530303|NCT00527072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25530304|NCT00527072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25530305|NCT00527111|Fluorouracil|fluorouracil|mesh-list
25530306|NCT00527111|Cetuximab|cetuximab|mesh-list
25530307|NCT00527111|Antimetabolites|antimetabolites|mesh-ancestor
25530308|NCT00527111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530309|NCT00527111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25530310|NCT00527111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530311|NCT00527111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25530312|NCT00527111|Immunologic Factors|immunologic factors|mesh-ancestor
25530313|NCT00527111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530314|NCT00527111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25530315|NCT00527124|Prednisone|prednisone|mesh-list
25530316|NCT00527124|Docetaxel|docetaxel|mesh-list
25530317|NCT00527124|Cediranib|cediranib|mesh-list
25530318|NCT00527124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530319|NCT00527124|Tubulin Modulators|tubulin modulators|mesh-ancestor
25530320|NCT00527124|Antimitotic Agents|antimitotic agents|mesh-ancestor
25530321|NCT00527124|Mitosis Modulators|mitosis modulators|mesh-ancestor
25530322|NCT00527124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530323|NCT00527124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25530324|NCT00527124|Glucocorticoids|glucocorticoids|mesh-ancestor
25530325|NCT00527124|Hormones|hormones|mesh-ancestor
25530326|NCT00527124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25530327|NCT00527124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530328|NCT00527124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25530329|NCT00527124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530330|NCT00527124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25530331|NCT00527332|Fentanyl|fentanyl|mesh-list
25530332|NCT00527332|Morphine|morphine|mesh-list
25530333|NCT00527332|Bupivacaine|bupivacaine|mesh-list
25646914|NCT01464359|Fludarabine|fludarabine|mesh-list
25530334|NCT00527332|Propofol|propofol|mesh-list
25530335|NCT00527332|Anesthetics, Local|anesthetics, local|mesh-ancestor
25530336|NCT00527332|Anesthetics|anesthetics|mesh-ancestor
25646915|NCT01464359|Interleukin-2|interleukin-2|mesh-list
25646916|NCT01464359|Allopurinol|allopurinol|mesh-list
25646917|NCT01464359|Levetiracetam|levetiracetam|mesh-list
25646918|NCT01464359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25646919|NCT01464359|Immunologic Factors|immunologic factors|mesh-ancestor
25646920|NCT01464359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646921|NCT01464359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25646922|NCT01464359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25646923|NCT01464359|Alkylating Agents|alkylating agents|mesh-ancestor
25530337|NCT00527332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25530338|NCT00527332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530339|NCT00527332|Sensory System Agents|sensory system agents|mesh-ancestor
25530340|NCT00527332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25530341|NCT00527332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25530342|NCT00527332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25530343|NCT00527332|Anesthetics, General|anesthetics, general|mesh-ancestor
25530344|NCT00527332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25530345|NCT00527332|Narcotics|narcotics|mesh-ancestor
25530346|NCT00527332|Analgesics|analgesics|mesh-ancestor
25530347|NCT00527332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25530349|NCT00527397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25530350|NCT00527397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530351|NCT00527423|Aflibercept|aflibercept|mesh-list
25530352|NCT00527423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25530353|NCT00527423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25530354|NCT00527423|Growth Substances|growth substances|mesh-ancestor
25530355|NCT00527423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530356|NCT00527423|Growth Inhibitors|growth inhibitors|mesh-ancestor
25530357|NCT00527423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530358|NCT00527475|Ranibizumab|ranibizumab|mesh-list
25530359|NCT00527475|Verteporfin|verteporfin|mesh-list
25530360|NCT00527475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25530361|NCT00527475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25530362|NCT00527475|Growth Substances|growth substances|mesh-ancestor
25530363|NCT00527475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530364|NCT00527475|Growth Inhibitors|growth inhibitors|mesh-ancestor
25530365|NCT00527475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530366|NCT00527475|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25530367|NCT00527475|Dermatologic Agents|dermatologic agents|mesh-ancestor
25530368|NCT00527514|Amlodipine|amlodipine|mesh-list
25530369|NCT00527514|Olmesartan|olmesartan|mesh-list
25530370|NCT00527514|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25530371|NCT00527514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25530372|NCT00527514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25530373|NCT00527514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25530374|NCT00527514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530375|NCT00527514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25530376|NCT00527514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530377|NCT00527514|Vasodilator Agents|vasodilator agents|mesh-ancestor
25530378|NCT00527514|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25530379|NCT00527514|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25530380|NCT00527592|Travoprost|travoprost|mesh-list
25530381|NCT00527592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25530382|NCT00527592|Latanoprost|latanoprost|mesh-list
24467687|NCT00378456|Hematinics|hematinics|mesh-ancestor
25530383|NCT00527592|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25530384|NCT00527592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25530385|NCT00527605|Dutasteride|dutasteride|mesh-list
25530386|NCT00527605|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25530387|NCT00527605|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25530388|NCT00527605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530389|NCT00527605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530390|NCT00527605|Hormone Antagonists|hormone antagonists|mesh-ancestor
25530391|NCT00527605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25530392|NCT00527605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530393|NCT00527618|Valacyclovir|valacyclovir|mesh-list
25530394|NCT00527618|Acyclovir|acyclovir|mesh-list
25530395|NCT00527618|Antiviral Agents|antiviral agents|mesh-ancestor
25530396|NCT00527618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25530397|NCT00527644|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25530398|NCT00527644|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
25530399|NCT00527644|beta-Endorphin|beta-endorphin|mesh-list
25530400|NCT00527644|Hormones|hormones|mesh-ancestor
25530401|NCT00527644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24764105|NCT01779401|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25530402|NCT00527644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530403|NCT00527644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25530404|NCT00527644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530405|NCT00527735|Paclitaxel|paclitaxel|mesh-list
25530406|NCT00527735|Carboplatin|carboplatin|mesh-list
25530407|NCT00527735|Ipilimumab|ipilimumab|mesh-list
25530408|NCT00527735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25530409|NCT00527735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530410|NCT00527735|Tubulin Modulators|tubulin modulators|mesh-ancestor
25530411|NCT00527735|Antimitotic Agents|antimitotic agents|mesh-ancestor
24459168|NCT00343798|Antifungal Agents|antifungal agents|mesh-ancestor
24459169|NCT00343798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24459170|NCT00343798|Dermatologic Agents|dermatologic agents|mesh-ancestor
24459171|NCT00343798|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24459172|NCT00343798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25823536|NCT00004854|Antioxidants|antioxidants|mesh-ancestor
25530413|NCT00527735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530414|NCT00527735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25530415|NCT00527735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25530416|NCT00527787|Naproxen|naproxen|mesh-list
25530417|NCT00527787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25530418|NCT00527787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25530419|NCT00527787|Analgesics|analgesics|mesh-ancestor
25530420|NCT00527787|Sensory System Agents|sensory system agents|mesh-ancestor
25530421|NCT00527787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25530422|NCT00527787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530423|NCT00527787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25530424|NCT00527787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25530425|NCT00527787|Gout Suppressants|gout suppressants|mesh-ancestor
25530426|NCT00527787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25530427|NCT00527787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530428|NCT00527787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530429|NCT00527826|Fluticasone|fluticasone|mesh-list
25530431|NCT00527826|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25530432|NCT00527826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25530433|NCT00527826|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25530434|NCT00527826|Autonomic Agents|autonomic agents|mesh-ancestor
25530435|NCT00527826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25530436|NCT00527826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530437|NCT00527826|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25530438|NCT00527826|Respiratory System Agents|respiratory system agents|mesh-ancestor
25530439|NCT00527826|Dermatologic Agents|dermatologic agents|mesh-ancestor
25530440|NCT00527826|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25530441|NCT00527826|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25530442|NCT00527826|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25530443|NCT00527826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25530444|NCT00527826|Adrenergic Agents|adrenergic agents|mesh-ancestor
25530445|NCT00527826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25530446|NCT00527826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530447|NCT00527878|Ranitidine|ranitidine|mesh-list
25530448|NCT00527878|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
25530449|NCT00527878|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25530450|NCT00527878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25530451|NCT00527878|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25530452|NCT00527878|Histamine Antagonists|histamine antagonists|mesh-ancestor
25530453|NCT00527878|Histamine Agents|histamine agents|mesh-ancestor
25530454|NCT00527878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25530455|NCT00527878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530456|NCT00527878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530457|NCT00527904|Naproxen|naproxen|mesh-list
25530458|NCT00527904|Esomeprazole|esomeprazole|mesh-list
25530459|NCT00527904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25530460|NCT00527904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25530461|NCT00527904|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25530462|NCT00527904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530463|NCT00527904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530464|NCT00527904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25530465|NCT00527904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25530466|NCT00527904|Analgesics|analgesics|mesh-ancestor
25530467|NCT00527904|Sensory System Agents|sensory system agents|mesh-ancestor
25530468|NCT00527904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25530469|NCT00527904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530470|NCT00527904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25530471|NCT00527904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25530472|NCT00527904|Gout Suppressants|gout suppressants|mesh-ancestor
25530473|NCT00527904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25530474|NCT00527943|Vorapaxar|vorapaxar|mesh-list
25530475|NCT00527943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25530476|NCT00528190|Itraconazole|itraconazole|mesh-list
25530477|NCT00528190|Antifungal Agents|antifungal agents|mesh-ancestor
25530478|NCT00528190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25530479|NCT00528190|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25530480|NCT00528190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25530481|NCT00528190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530482|NCT00528190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530483|NCT00528190|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25530484|NCT00528190|Hormone Antagonists|hormone antagonists|mesh-ancestor
25530485|NCT00528190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25530486|NCT00528190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530487|NCT00528190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25530488|NCT00528268|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25530489|NCT00528268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530490|NCT00528372|Metformin|metformin|mesh-list
25530491|NCT00528372|Dapagliflozin|dapagliflozin|mesh-list
25530492|NCT00528372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25530493|NCT00528372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530494|NCT00528372|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25530495|NCT00528372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530496|NCT00528398|Cytarabine|cytarabine|mesh-list
25530497|NCT00528398|Idarubicin|idarubicin|mesh-list
25530498|NCT00528398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25530499|NCT00528398|Antimetabolites|antimetabolites|mesh-ancestor
25530500|NCT00528398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530501|NCT00528398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530502|NCT00528398|Antiviral Agents|antiviral agents|mesh-ancestor
25530503|NCT00528398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25530504|NCT00528398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25530505|NCT00528398|Immunologic Factors|immunologic factors|mesh-ancestor
25530506|NCT00528398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530507|NCT00528398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25530508|NCT00528398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25530509|NCT00528398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25530510|NCT00528398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530511|NCT00528411|Aspirin|aspirin|mesh-list
25530512|NCT00528411|Clopidogrel|clopidogrel|mesh-list
25530513|NCT00528411|Ticagrelor|ticagrelor|mesh-list
25530514|NCT00528411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25530515|NCT00528411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25530516|NCT00528411|Analgesics|analgesics|mesh-ancestor
25530517|NCT00528411|Sensory System Agents|sensory system agents|mesh-ancestor
25530518|NCT00528411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25530519|NCT00528411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530520|NCT00528411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25530521|NCT00528411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25530522|NCT00528411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25530523|NCT00528411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25530524|NCT00528411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530525|NCT00528411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25530526|NCT00528411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25530527|NCT00528411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530528|NCT00528411|Antipyretics|antipyretics|mesh-ancestor
25530529|NCT00528411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25530530|NCT00528411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25530531|NCT00528411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25530532|NCT00528411|Purinergic Agents|purinergic agents|mesh-ancestor
25530533|NCT00528411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25530534|NCT00528450|Idarubicin|idarubicin|mesh-list
25530535|NCT00528450|Arsenic Trioxide|arsenic trioxide|mesh-list
25530536|NCT00528450|Tretinoin|tretinoin|mesh-list
25530537|NCT00528450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25530538|NCT00528450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530539|NCT00528450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25530540|NCT00528450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25530541|NCT00528450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530542|NCT00528450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530543|NCT00528450|Keratolytic Agents|keratolytic agents|mesh-ancestor
25530544|NCT00528450|Dermatologic Agents|dermatologic agents|mesh-ancestor
25530545|NCT00528528|Ribavirin|ribavirin|mesh-list
25530546|NCT00528528|Interferon-alpha|interferon-alpha|mesh-list
25530547|NCT00528528|Interferon alpha-2|interferon alpha-2|mesh-list
25530548|NCT00528528|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
25530549|NCT00528528|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25530550|NCT00528528|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25530551|NCT00528528|Antimetabolites|antimetabolites|mesh-ancestor
25530552|NCT00528528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530553|NCT00528528|Antiviral Agents|antiviral agents|mesh-ancestor
25530554|NCT00528528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25530555|NCT00528528|Immunologic Factors|immunologic factors|mesh-ancestor
25530556|NCT00528528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530557|NCT00528528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530558|NCT00528541|Botulinum Toxins|botulinum toxins|mesh-list
25530559|NCT00528541|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25530561|NCT00528541|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25530562|NCT00528541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25530563|NCT00528541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530564|NCT00528541|Cholinergic Agents|cholinergic agents|mesh-ancestor
25530565|NCT00528541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25530566|NCT00528541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530567|NCT00528541|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25530568|NCT00528541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25530569|NCT00528567|Bevacizumab|bevacizumab|mesh-list
25530570|NCT00528567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25530571|NCT00528567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530572|NCT00528567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25530573|NCT00528567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25530574|NCT00528567|Growth Substances|growth substances|mesh-ancestor
25530575|NCT00528567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530576|NCT00528567|Growth Inhibitors|growth inhibitors|mesh-ancestor
25530577|NCT00528580|Simvastatin|simvastatin|mesh-list
25530578|NCT00528580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25530579|NCT00528580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25530580|NCT00528580|Antimetabolites|antimetabolites|mesh-ancestor
25530581|NCT00528580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530582|NCT00528580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25530583|NCT00528580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25530584|NCT00528580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530585|NCT00528645|Saracatinib|saracatinib|mesh-list
25530586|NCT00528645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530587|NCT00528645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530588|NCT00528645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530589|NCT00528788|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
25530590|NCT00528788|Vitamins|vitamins|mesh-ancestor
25530591|NCT00528788|Micronutrients|micronutrients|mesh-ancestor
25530592|NCT00528788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530593|NCT00528788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25530594|NCT00528866|Docetaxel|docetaxel|mesh-list
25530595|NCT00528866|Bicalutamide|bicalutamide|mesh-list
25530596|NCT00528866|Flutamide|flutamide|mesh-list
25530597|NCT00528866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530598|NCT00528866|Tubulin Modulators|tubulin modulators|mesh-ancestor
25530599|NCT00528866|Antimitotic Agents|antimitotic agents|mesh-ancestor
25530600|NCT00528866|Mitosis Modulators|mitosis modulators|mesh-ancestor
25530601|NCT00528866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530602|NCT00528866|Androgen Antagonists|androgen antagonists|mesh-ancestor
25530603|NCT00528866|Hormone Antagonists|hormone antagonists|mesh-ancestor
25530604|NCT00528866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25530605|NCT00528866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530606|NCT00528866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25530607|NCT00528879|Metformin|metformin|mesh-list
25530608|NCT00528879|Dapagliflozin|dapagliflozin|mesh-list
25530609|NCT00528879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25530610|NCT00528879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530611|NCT00528879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25530612|NCT00528879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530613|NCT00528957|Tenofovir|tenofovir|mesh-list
25530614|NCT00528957|Zidovudine|zidovudine|mesh-list
25530615|NCT00528957|Stavudine|stavudine|mesh-list
25530616|NCT00528957|Antiviral Agents|antiviral agents|mesh-ancestor
25530617|NCT00528957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25530618|NCT00528957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25530619|NCT00528957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25823537|NCT00004854|Protective Agents|protective agents|mesh-ancestor
25530620|NCT00528957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530621|NCT00528957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530623|NCT00528957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25530624|NCT00528957|Antimetabolites|antimetabolites|mesh-ancestor
25530625|NCT00528970|Methylnaltrexone|methylnaltrexone|mesh-list
25530626|NCT00528970|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25530627|NCT00528970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530628|NCT00528970|Sensory System Agents|sensory system agents|mesh-ancestor
25530629|NCT00528970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25530630|NCT00528996|Bromides|bromides|mesh-list
25530631|NCT00528996|Tiotropium Bromide|tiotropium bromide|mesh-list
25823538|NCT00004854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25530632|NCT00528996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25530633|NCT00528996|Autonomic Agents|autonomic agents|mesh-ancestor
25530634|NCT00528996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25530635|NCT00528996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530636|NCT00528996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25530637|NCT00528996|Respiratory System Agents|respiratory system agents|mesh-ancestor
25530638|NCT00528996|Parasympatholytics|parasympatholytics|mesh-ancestor
25530639|NCT00528996|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25530640|NCT00528996|Cholinergic Agents|cholinergic agents|mesh-ancestor
25530641|NCT00528996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25530642|NCT00528996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530643|NCT00528996|Anticonvulsants|anticonvulsants|mesh-ancestor
25530644|NCT00529035|Interleukin-2|interleukin-2|mesh-list
25530645|NCT00529035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530646|NCT00529035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25530647|NCT00529035|Analgesics|analgesics|mesh-ancestor
25530648|NCT00529035|Sensory System Agents|sensory system agents|mesh-ancestor
25530649|NCT00529035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25530650|NCT00529035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530651|NCT00529087|Bromides|bromides|mesh-list
25530652|NCT00529087|Methylnaltrexone|methylnaltrexone|mesh-list
25530653|NCT00529087|Anticonvulsants|anticonvulsants|mesh-ancestor
25530654|NCT00529087|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25530655|NCT00529087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530656|NCT00529087|Sensory System Agents|sensory system agents|mesh-ancestor
25530657|NCT00529087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25530658|NCT00529100|Cisplatin|cisplatin|mesh-list
25530659|NCT00529100|Pemetrexed|pemetrexed|mesh-list
25530660|NCT00529100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530661|NCT00529100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530662|NCT00529100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530663|NCT00529100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25530664|NCT00529100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25530665|NCT00529126|Epinephrine|epinephrine|mesh-list
25530666|NCT00529126|Bupivacaine|bupivacaine|mesh-list
25530667|NCT00529126|Anesthetics, Local|anesthetics, local|mesh-ancestor
25530668|NCT00529126|Anesthetics|anesthetics|mesh-ancestor
25530669|NCT00529126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25530670|NCT00529126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530671|NCT00529126|Sensory System Agents|sensory system agents|mesh-ancestor
25530672|NCT00529126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25530673|NCT00529126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25530674|NCT00529126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25530675|NCT00529126|Adrenergic Agents|adrenergic agents|mesh-ancestor
25530676|NCT00529126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25530677|NCT00529126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530678|NCT00529126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25530679|NCT00529126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25530680|NCT00529126|Autonomic Agents|autonomic agents|mesh-ancestor
25530681|NCT00529126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25530682|NCT00529126|Respiratory System Agents|respiratory system agents|mesh-ancestor
25530683|NCT00529126|Mydriatics|mydriatics|mesh-ancestor
25530684|NCT00529126|Sympathomimetics|sympathomimetics|mesh-ancestor
25530685|NCT00529126|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25530686|NCT00529191|Atorvastatin|atorvastatin|mesh-list
25530687|NCT00529191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25530688|NCT00529191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25530689|NCT00529191|Antimetabolites|antimetabolites|mesh-ancestor
25530690|NCT00529191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530691|NCT00529191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25530692|NCT00529191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25530693|NCT00529191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530694|NCT00529204|Exenatide|exenatide|mesh-list
25530695|NCT00529204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24926670|NCT04139629|Immunologic Factors|immunologic factors|mesh-ancestor
24459284|NCT00344149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459285|NCT00344149|Immunologic Factors|immunologic factors|mesh-ancestor
24459286|NCT00344149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459287|NCT00344149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24459288|NCT00344201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24459290|NCT00344201|Coagulants|coagulants|mesh-ancestor
24459291|NCT00344227|Ranibizumab|ranibizumab|mesh-list
24459292|NCT00344227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25530696|NCT00529204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530697|NCT00529204|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25530698|NCT00529204|Incretins|incretins|mesh-ancestor
25530699|NCT00529204|Hormones|hormones|mesh-ancestor
25530700|NCT00529204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25530701|NCT00529243|Raltegravir Potassium|raltegravir potassium|mesh-list
25530702|NCT00529243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25530703|NCT00529243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25530704|NCT00529243|Antiviral Agents|antiviral agents|mesh-ancestor
25530705|NCT00529243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25530706|NCT00529243|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25530707|NCT00529243|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25530708|NCT00529243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530709|NCT00529243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530710|NCT00529373|Calcium, Dietary|calcium, dietary|mesh-list
25530711|NCT00529373|Vitamin D|vitamin d|mesh-list
25530712|NCT00529373|Cholecalciferol|cholecalciferol|mesh-list
25530713|NCT00529373|Calcium Carbonate|calcium carbonate|mesh-list
25530714|NCT00529373|Calcium|calcium|mesh-list
25530715|NCT00529373|Vitamins|vitamins|mesh-ancestor
25530716|NCT00529373|Micronutrients|micronutrients|mesh-ancestor
25530717|NCT00529373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530718|NCT00529373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25530719|NCT00529373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25530720|NCT00529373|Antacids|antacids|mesh-ancestor
25530721|NCT00529373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530722|NCT00529373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25530723|NCT00529399|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25530724|NCT00529399|Aluminum sulfate|aluminum sulfate|mesh-list
25530725|NCT00529399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25530726|NCT00529399|Immunologic Factors|immunologic factors|mesh-ancestor
25530727|NCT00529399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530728|NCT00529399|Antacids|antacids|mesh-ancestor
25530729|NCT00529399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530730|NCT00529399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25530731|NCT00529451|Ramipril|ramipril|mesh-list
25530732|NCT00529451|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25530733|NCT00529451|Protease Inhibitors|protease inhibitors|mesh-ancestor
25530734|NCT00529451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530735|NCT00529451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530736|NCT00529451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25530737|NCT00529529|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25530738|NCT00529529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25530739|NCT00529529|Autonomic Agents|autonomic agents|mesh-ancestor
25530740|NCT00529529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25530741|NCT00529529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530742|NCT00529529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25530743|NCT00529529|Respiratory System Agents|respiratory system agents|mesh-ancestor
25530744|NCT00529529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25530745|NCT00529529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25530746|NCT00529529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25530747|NCT00529529|Adrenergic Agents|adrenergic agents|mesh-ancestor
25530748|NCT00529529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25530749|NCT00529529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530750|NCT00529542|Atorvastatin|atorvastatin|mesh-list
25530751|NCT00529542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25530752|NCT00529542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25530753|NCT00529542|Antimetabolites|antimetabolites|mesh-ancestor
25530754|NCT00529542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530755|NCT00529542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25530756|NCT00529542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25530757|NCT00529542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530758|NCT00529555|Minocycline|minocycline|mesh-list
25530759|NCT00529555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25530760|NCT00529555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25646924|NCT01464359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646925|NCT01464359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530761|NCT00529633|Thalidomide|thalidomide|mesh-list
25530762|NCT00529633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25530763|NCT00529633|Immunologic Factors|immunologic factors|mesh-ancestor
25530764|NCT00529633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530765|NCT00529633|Leprostatic Agents|leprostatic agents|mesh-ancestor
25530766|NCT00529633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25530767|NCT00529633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25530768|NCT00529633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25823539|NCT00004854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25530769|NCT00529633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25530770|NCT00529633|Growth Substances|growth substances|mesh-ancestor
25530771|NCT00529633|Growth Inhibitors|growth inhibitors|mesh-ancestor
25530772|NCT00529633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530773|NCT00529789|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25530774|NCT00529789|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25530775|NCT00529789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25530776|NCT00529789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25530777|NCT00529789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530778|NCT00529789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25530779|NCT00529789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530780|NCT00529789|Analgesics|analgesics|mesh-ancestor
25530781|NCT00529789|Sensory System Agents|sensory system agents|mesh-ancestor
25530782|NCT00529789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25530783|NCT00529789|Antidepressive Agents|antidepressive agents|mesh-ancestor
25530784|NCT00529789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25530785|NCT00529789|Dopamine Agents|dopamine agents|mesh-ancestor
25530787|NCT00529802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530788|NCT00529802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25530789|NCT00529802|Immunologic Factors|immunologic factors|mesh-ancestor
25530790|NCT00529802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530791|NCT00530023|Insulin|insulin|mesh-list
25530792|NCT00530023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25530793|NCT00530023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530794|NCT00530075|Gusperimus|gusperimus|mesh-list
25530795|NCT00530075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25530796|NCT00530075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530797|NCT00530075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25530798|NCT00530075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530799|NCT00530075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25530800|NCT00530075|Immunologic Factors|immunologic factors|mesh-ancestor
25530801|NCT00530075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25530802|NCT00530075|Protective Agents|protective agents|mesh-ancestor
25530803|NCT00530088|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
25530804|NCT00530088|Trioxsalen|trioxsalen|mesh-list
25530805|NCT00530088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530806|NCT00530088|Dermatologic Agents|dermatologic agents|mesh-ancestor
25530807|NCT00530088|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25530808|NCT00530218|Ganciclovir|ganciclovir|mesh-list
25530809|NCT00530218|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25530810|NCT00530218|Antiviral Agents|antiviral agents|mesh-ancestor
25530811|NCT00530218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25530812|NCT00530218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25530813|NCT00530218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530814|NCT00530218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530815|NCT00530257|Methylphenidate|methylphenidate|mesh-list
25530816|NCT00530257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25530817|NCT00530257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530818|NCT00530257|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25530819|NCT00530257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25530820|NCT00530257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25530821|NCT00530257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530822|NCT00530257|Dopamine Agents|dopamine agents|mesh-ancestor
25530823|NCT00530257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25530824|NCT00530270|Dexamethasone|dexamethasone|mesh-list
25530825|NCT00530270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25530826|NCT00530270|Antiemetics|antiemetics|mesh-ancestor
25530827|NCT00530270|Autonomic Agents|autonomic agents|mesh-ancestor
25530828|NCT00530270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25530829|NCT00530270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530830|NCT00530270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25530831|NCT00530270|Glucocorticoids|glucocorticoids|mesh-ancestor
25530832|NCT00530270|Hormones|hormones|mesh-ancestor
25530833|NCT00530270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25530834|NCT00530270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25530836|NCT00530335|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25530837|NCT00530335|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25530838|NCT00530335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25530839|NCT00530335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25530840|NCT00530335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530841|NCT00530335|Adrenergic Agents|adrenergic agents|mesh-ancestor
25530842|NCT00530335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25530843|NCT00530335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530844|NCT00530348|Interferons|interferons|mesh-list
25530845|NCT00530348|Interferon-beta|interferon-beta|mesh-list
25530874|NCT00530764|Dronabinol|dronabinol|mesh-list
25530875|NCT00530764|Cannabidiol|cannabidiol|mesh-list
25530876|NCT00530764|Analgesics|analgesics|mesh-ancestor
25530877|NCT00530764|Sensory System Agents|sensory system agents|mesh-ancestor
25530878|NCT00530764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25530879|NCT00530764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530880|NCT00530764|Anticonvulsants|anticonvulsants|mesh-ancestor
25530881|NCT00530764|Hallucinogens|hallucinogens|mesh-ancestor
25530882|NCT00530764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25530883|NCT00530764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25530884|NCT00530764|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25530885|NCT00530764|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25530886|NCT00530764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25530887|NCT00530764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530888|NCT00530764|Hormones|hormones|mesh-ancestor
25530889|NCT00530764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25530890|NCT00530777|Valacyclovir|valacyclovir|mesh-list
25530891|NCT00530777|Antiviral Agents|antiviral agents|mesh-ancestor
25530892|NCT00530777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25530893|NCT00530790|Ropinirole|ropinirole|mesh-list
25530894|NCT00530790|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25530895|NCT00530790|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25530896|NCT00530790|Dopamine Agonists|dopamine agonists|mesh-ancestor
25530897|NCT00530790|Dopamine Agents|dopamine agents|mesh-ancestor
25530898|NCT00530790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25530899|NCT00530790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530900|NCT00530790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530901|NCT00530803|Lidocaine|lidocaine|mesh-list
25530902|NCT00530803|Tetracaine|tetracaine|mesh-list
25530903|NCT00530803|Prilocaine|prilocaine|mesh-list
25530904|NCT00530803|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25530905|NCT00530803|Anesthetics, Local|anesthetics, local|mesh-ancestor
25530906|NCT00530803|Anesthetics|anesthetics|mesh-ancestor
25530907|NCT00530803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25530908|NCT00530803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530909|NCT00530803|Sensory System Agents|sensory system agents|mesh-ancestor
25530910|NCT00530803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25530911|NCT00530803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25530912|NCT00530803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25530913|NCT00530803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25530914|NCT00530803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25530915|NCT00530803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530916|NCT00530803|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25530917|NCT00530842|Fluticasone|fluticasone|mesh-list
25530918|NCT00530842|Tiotropium Bromide|tiotropium bromide|mesh-list
25530919|NCT00530842|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25530920|NCT00530842|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25530921|NCT00530842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25530922|NCT00530842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25530923|NCT00530842|Autonomic Agents|autonomic agents|mesh-ancestor
25530924|NCT00530842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25530925|NCT00530842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530926|NCT00530842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25530927|NCT00530842|Respiratory System Agents|respiratory system agents|mesh-ancestor
25530928|NCT00530842|Dermatologic Agents|dermatologic agents|mesh-ancestor
25530929|NCT00530842|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25530930|NCT00530842|Parasympatholytics|parasympatholytics|mesh-ancestor
25530931|NCT00530842|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25530932|NCT00530842|Cholinergic Agents|cholinergic agents|mesh-ancestor
25530933|NCT00530842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25530934|NCT00530842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530935|NCT00530842|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25530937|NCT00530842|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25530938|NCT00530842|Adrenergic Agents|adrenergic agents|mesh-ancestor
25530939|NCT00530842|Glucocorticoids|glucocorticoids|mesh-ancestor
25530940|NCT00530842|Hormones|hormones|mesh-ancestor
25530941|NCT00530842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25530942|NCT00530842|Sympathomimetics|sympathomimetics|mesh-ancestor
25530943|NCT00530855|Lacosamide|lacosamide|mesh-list
25530944|NCT00530855|Anticonvulsants|anticonvulsants|mesh-ancestor
25530945|NCT00530855|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25530946|NCT00530855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25530947|NCT00530855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25530948|NCT00530855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530949|NCT00530920|Ritonavir|ritonavir|mesh-list
25530950|NCT00530920|Tipranavir|tipranavir|mesh-list
25530951|NCT00530920|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25530952|NCT00530920|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25530953|NCT00530920|Protease Inhibitors|protease inhibitors|mesh-ancestor
25530954|NCT00530920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530955|NCT00530920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530956|NCT00530920|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25530957|NCT00530920|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25530958|NCT00530920|Antiviral Agents|antiviral agents|mesh-ancestor
25530959|NCT00530920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25530960|NCT00530920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25530961|NCT00530920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25530962|NCT00530946|Amlodipine|amlodipine|mesh-list
25530963|NCT00530946|Atorvastatin|atorvastatin|mesh-list
25530964|NCT00530946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25530965|NCT00530946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25530966|NCT00530946|Antimetabolites|antimetabolites|mesh-ancestor
25530967|NCT00530946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530968|NCT00530946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25530969|NCT00530946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25530970|NCT00530946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25530971|NCT00530946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25530972|NCT00530946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25530973|NCT00530946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25530974|NCT00530946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25530975|NCT00530946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530976|NCT00530946|Vasodilator Agents|vasodilator agents|mesh-ancestor
25530977|NCT00531011|Paclitaxel|paclitaxel|mesh-list
25530978|NCT00531011|Everolimus|everolimus|mesh-list
25530979|NCT00531011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25530980|NCT00531011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25530981|NCT00531011|Tubulin Modulators|tubulin modulators|mesh-ancestor
25530982|NCT00531011|Antimitotic Agents|antimitotic agents|mesh-ancestor
25530983|NCT00531011|Mitosis Modulators|mitosis modulators|mesh-ancestor
25530984|NCT00531011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25530985|NCT00531011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25530986|NCT00531011|Immunologic Factors|immunologic factors|mesh-ancestor
25530987|NCT00531011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530988|NCT00531050|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25530989|NCT00531050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25530990|NCT00531050|Autonomic Agents|autonomic agents|mesh-ancestor
25530991|NCT00531050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25530992|NCT00531050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25530993|NCT00531050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25530994|NCT00531050|Respiratory System Agents|respiratory system agents|mesh-ancestor
25530995|NCT00531050|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25530996|NCT00531050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25530997|NCT00531050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25530998|NCT00531050|Adrenergic Agents|adrenergic agents|mesh-ancestor
25530999|NCT00531050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25531000|NCT00531050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531001|NCT00531206|Ritonavir|ritonavir|mesh-list
25531002|NCT00531206|Tipranavir|tipranavir|mesh-list
25531003|NCT00531206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25531004|NCT00531206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25531005|NCT00531206|Protease Inhibitors|protease inhibitors|mesh-ancestor
25646926|NCT01464359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25531007|NCT00531206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531008|NCT00531206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25531009|NCT00531206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25531010|NCT00531206|Antiviral Agents|antiviral agents|mesh-ancestor
25531011|NCT00531206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25531012|NCT00531206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25531013|NCT00531206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25531014|NCT00531284|Dexamethasone|dexamethasone|mesh-list
25531015|NCT00531284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25531016|NCT00531284|Antiemetics|antiemetics|mesh-ancestor
25531017|NCT00531284|Autonomic Agents|autonomic agents|mesh-ancestor
25531018|NCT00531284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25531019|NCT00531284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531020|NCT00531284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25531022|NCT00531284|Hormones|hormones|mesh-ancestor
25531023|NCT00531284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25531024|NCT00531284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25531025|NCT00531284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531026|NCT00531427|Buprenorphine|buprenorphine|mesh-list
25531027|NCT00531427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25531028|NCT00531427|Narcotics|narcotics|mesh-ancestor
25531029|NCT00531427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25531030|NCT00531427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531031|NCT00531427|Analgesics|analgesics|mesh-ancestor
25531032|NCT00531427|Sensory System Agents|sensory system agents|mesh-ancestor
25531033|NCT00531427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25531034|NCT00531427|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25531035|NCT00531453|Thalidomide|thalidomide|mesh-list
25531036|NCT00531453|Dexamethasone|dexamethasone|mesh-list
25531037|NCT00531453|Dexamethasone acetate|dexamethasone acetate|mesh-list
25531038|NCT00531453|Cyclophosphamide|cyclophosphamide|mesh-list
25531039|NCT00531453|Bortezomib|bortezomib|mesh-list
25531040|NCT00531453|BB 1101|bb 1101|mesh-list
25531041|NCT00531453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25531042|NCT00531453|Immunologic Factors|immunologic factors|mesh-ancestor
25531043|NCT00531453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531044|NCT00531453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25531045|NCT00531453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25531046|NCT00531453|Alkylating Agents|alkylating agents|mesh-ancestor
25531047|NCT00531453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531048|NCT00531453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531049|NCT00531453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25531050|NCT00531453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25531051|NCT00531453|Antiemetics|antiemetics|mesh-ancestor
25531052|NCT00531453|Autonomic Agents|autonomic agents|mesh-ancestor
25531053|NCT00531453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25531054|NCT00531453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25531055|NCT00531453|Glucocorticoids|glucocorticoids|mesh-ancestor
25531056|NCT00531453|Hormones|hormones|mesh-ancestor
25531057|NCT00531453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25531058|NCT00531453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25531059|NCT00531453|Protease Inhibitors|protease inhibitors|mesh-ancestor
25531060|NCT00531453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531061|NCT00531453|Leprostatic Agents|leprostatic agents|mesh-ancestor
25531062|NCT00531453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25531063|NCT00531453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25531064|NCT00531453|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25531065|NCT00531453|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25531066|NCT00531453|Growth Substances|growth substances|mesh-ancestor
25531067|NCT00531453|Growth Inhibitors|growth inhibitors|mesh-ancestor
25531068|NCT00531479|Voriconazole|voriconazole|mesh-list
25531069|NCT00531479|Anidulafungin|anidulafungin|mesh-list
25531070|NCT00531479|Antifungal Agents|antifungal agents|mesh-ancestor
25531071|NCT00531479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25531072|NCT00531479|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25531073|NCT00531479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25531074|NCT00531479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531075|NCT00531479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531076|NCT00531479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25531077|NCT00531479|Hormone Antagonists|hormone antagonists|mesh-ancestor
25531078|NCT00531479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25531079|NCT00531479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646927|NCT01464359|Antimetabolites|antimetabolites|mesh-ancestor
25531080|NCT00531479|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25531082|NCT00531518|Aripiprazole|aripiprazole|mesh-list
25531083|NCT00531518|Bupropion|bupropion|mesh-list
25531084|NCT00531518|Fluoxetine|fluoxetine|mesh-list
25531085|NCT00531518|Sertraline|sertraline|mesh-list
25531086|NCT00531518|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25531087|NCT00531518|Antidepressive Agents|antidepressive agents|mesh-ancestor
25531088|NCT00531518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25531089|NCT00531518|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25531090|NCT00531518|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25531091|NCT00531518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25531092|NCT00531518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531093|NCT00531518|Dopamine Agents|dopamine agents|mesh-ancestor
25531094|NCT00531518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25531095|NCT00531518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531096|NCT00531518|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25531097|NCT00531518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25531098|NCT00531518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531099|NCT00531518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25531100|NCT00531518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25531101|NCT00531518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25531102|NCT00531518|Dopamine Agonists|dopamine agonists|mesh-ancestor
25531103|NCT00531518|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25531104|NCT00531518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25531105|NCT00531518|Serotonin Agents|serotonin agents|mesh-ancestor
25531106|NCT00531518|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25531107|NCT00531518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25531108|NCT00531518|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25531109|NCT00531518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25531110|NCT00531518|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25531111|NCT00531518|Anticonvulsants|anticonvulsants|mesh-ancestor
25531112|NCT00531518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25531113|NCT00531518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25531114|NCT00531518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25531115|NCT00531843|PENTA|penta|mesh-list
25531116|NCT00531843|Fondaparinux|fondaparinux|mesh-list
25531117|NCT00531843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25531118|NCT00531843|Antithrombins|antithrombins|mesh-ancestor
25531119|NCT00531843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25531120|NCT00531843|Protease Inhibitors|protease inhibitors|mesh-ancestor
25531121|NCT00531843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531122|NCT00531843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531123|NCT00531843|Anticoagulants|anticoagulants|mesh-ancestor
25531124|NCT00531843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25531125|NCT00531843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25531126|NCT00531882|Pioglitazone|pioglitazone|mesh-list
25531127|NCT00531882|Ibuprofen|ibuprofen|mesh-list
25531128|NCT00531882|Simvastatin|simvastatin|mesh-list
25531129|NCT00531882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25531130|NCT00531882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25531131|NCT00531882|Analgesics|analgesics|mesh-ancestor
25531132|NCT00531882|Sensory System Agents|sensory system agents|mesh-ancestor
25531133|NCT00531882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25531134|NCT00531882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531135|NCT00531882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25531136|NCT00531882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25531137|NCT00531882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25531138|NCT00531882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531139|NCT00531882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531140|NCT00531882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25531141|NCT00531882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25531142|NCT00531882|Antimetabolites|antimetabolites|mesh-ancestor
25531143|NCT00531882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25531144|NCT00531882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25531145|NCT00531882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25531146|NCT00531934|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25531147|NCT00531934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531148|NCT00531934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25531149|NCT00531934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531150|NCT00531934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531151|NCT00531947|Selegiline|selegiline|mesh-list
25531152|NCT00531947|Antidepressive Agents|antidepressive agents|mesh-ancestor
25646928|NCT01464359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25646929|NCT01464359|Analgesics|analgesics|mesh-ancestor
25531153|NCT00531947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25531154|NCT00531947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25531155|NCT00531947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25531156|NCT00531947|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25531157|NCT00531947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531158|NCT00531947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531159|NCT00531947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25531160|NCT00531947|Protective Agents|protective agents|mesh-ancestor
25531161|NCT00531947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531162|NCT00531960|Bevacizumab|bevacizumab|mesh-list
25531163|NCT00531960|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25531164|NCT00531960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25531165|NCT00531960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531166|NCT00531960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25823540|NCT00004854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25531167|NCT00531960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25531168|NCT00531960|Growth Substances|growth substances|mesh-ancestor
25531169|NCT00531960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531170|NCT00531960|Growth Inhibitors|growth inhibitors|mesh-ancestor
25531171|NCT00531960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25531172|NCT00531960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531173|NCT00531960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531174|NCT00532129|Rituximab|rituximab|mesh-list
25531175|NCT00532129|Chlorambucil|chlorambucil|mesh-list
25531176|NCT00532129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25531177|NCT00532129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531178|NCT00532129|Immunologic Factors|immunologic factors|mesh-ancestor
25531179|NCT00532129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531180|NCT00532129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25531181|NCT00532129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25531182|NCT00532129|Alkylating Agents|alkylating agents|mesh-ancestor
25531183|NCT00532129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531184|NCT00532155|Dexamethasone|dexamethasone|mesh-list
25531185|NCT00532155|Docetaxel|docetaxel|mesh-list
25531186|NCT00532155|Aflibercept|aflibercept|mesh-list
25531187|NCT00532155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25531188|NCT00532155|Antiemetics|antiemetics|mesh-ancestor
25531189|NCT00532155|Autonomic Agents|autonomic agents|mesh-ancestor
25531190|NCT00532155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25531191|NCT00532155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531192|NCT00532155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25531193|NCT00532155|Glucocorticoids|glucocorticoids|mesh-ancestor
25531194|NCT00532155|Hormones|hormones|mesh-ancestor
25531195|NCT00532155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25531196|NCT00532155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25531197|NCT00532155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531198|NCT00532155|Tubulin Modulators|tubulin modulators|mesh-ancestor
25531199|NCT00532155|Antimitotic Agents|antimitotic agents|mesh-ancestor
25531200|NCT00532155|Mitosis Modulators|mitosis modulators|mesh-ancestor
25531201|NCT00532155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531202|NCT00532155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25531203|NCT00532155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25531204|NCT00532155|Growth Substances|growth substances|mesh-ancestor
25531205|NCT00532155|Growth Inhibitors|growth inhibitors|mesh-ancestor
25531206|NCT00532259|Pidilizumab|pidilizumab|mesh-list
25531207|NCT00532259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25531208|NCT00532259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531209|NCT00532298|Vaccines|vaccines|mesh-list
25531210|NCT00532298|Immunologic Factors|immunologic factors|mesh-ancestor
25531211|NCT00532298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531212|NCT00532441|Docetaxel|docetaxel|mesh-list
25531213|NCT00532441|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25531214|NCT00532441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531215|NCT00532441|Tubulin Modulators|tubulin modulators|mesh-ancestor
25531216|NCT00532441|Antimitotic Agents|antimitotic agents|mesh-ancestor
25531217|NCT00532441|Mitosis Modulators|mitosis modulators|mesh-ancestor
25531218|NCT00532441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531219|NCT00532441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25531220|NCT00532441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531221|NCT00532480|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25531222|NCT00532480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24543829|NCT00685607|Antifoaming Agents|antifoaming agents|mesh-ancestor
25646930|NCT01464359|Sensory System Agents|sensory system agents|mesh-ancestor
25646931|NCT01464359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25646932|NCT01464359|Anticonvulsants|anticonvulsants|mesh-ancestor
25646933|NCT01464359|Nootropic Agents|nootropic agents|mesh-ancestor
25646934|NCT01464359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531223|NCT00532480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25531224|NCT00532480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25531225|NCT00532480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531226|NCT00532480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25531227|NCT00532480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531229|NCT00532480|Sensory System Agents|sensory system agents|mesh-ancestor
25531230|NCT00532480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25531231|NCT00532480|Antidepressive Agents|antidepressive agents|mesh-ancestor
25531232|NCT00532480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25531233|NCT00532480|Dopamine Agents|dopamine agents|mesh-ancestor
25531234|NCT00532493|Prazosin|prazosin|mesh-list
25531235|NCT00532493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25531236|NCT00532493|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25531237|NCT00532493|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25531238|NCT00532493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25823541|NCT00004854|Vasodilator Agents|vasodilator agents|mesh-ancestor
25531240|NCT00532493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25531241|NCT00532493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531242|NCT00532493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531243|NCT00532779|Naltrexone|naltrexone|mesh-list
25531244|NCT00532779|Bupropion|bupropion|mesh-list
25531245|NCT00532779|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25531246|NCT00532779|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25531247|NCT00532779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531248|NCT00532779|Sensory System Agents|sensory system agents|mesh-ancestor
25531249|NCT00532779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25531250|NCT00532779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25531251|NCT00532779|Antidepressive Agents|antidepressive agents|mesh-ancestor
25531252|NCT00532779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25531253|NCT00532779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25531254|NCT00532779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25531255|NCT00532779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25531256|NCT00532779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531257|NCT00532779|Dopamine Agents|dopamine agents|mesh-ancestor
25531258|NCT00532779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25531259|NCT00532779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25531260|NCT00532779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25531261|NCT00532779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531262|NCT00532844|Vitamins|vitamins|mesh-list
25531263|NCT00532844|Ascorbic Acid|ascorbic acid|mesh-list
25531264|NCT00532844|Verapamil|verapamil|mesh-list
25531265|NCT00532844|Micronutrients|micronutrients|mesh-ancestor
25531266|NCT00532844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531267|NCT00532844|Antioxidants|antioxidants|mesh-ancestor
25531268|NCT00532844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531269|NCT00532844|Protective Agents|protective agents|mesh-ancestor
25531270|NCT00532844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25531271|NCT00532844|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25531272|NCT00532844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25531273|NCT00532844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25531274|NCT00532844|Vasodilator Agents|vasodilator agents|mesh-ancestor
25531275|NCT00532883|Hydroxyurea|hydroxyurea|mesh-list
25531276|NCT00532883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531277|NCT00532883|Antisickling Agents|antisickling agents|mesh-ancestor
25531278|NCT00532883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531279|NCT00532883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531280|NCT00532883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25531281|NCT00532935|Metformin|metformin|mesh-list
25531282|NCT00532935|Pioglitazone|pioglitazone|mesh-list
25531283|NCT00532935|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25531284|NCT00532935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25531285|NCT00532935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531286|NCT00532935|Incretins|incretins|mesh-ancestor
25531287|NCT00532935|Hormones|hormones|mesh-ancestor
25531288|NCT00532935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25531289|NCT00532935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25531290|NCT00532935|Protease Inhibitors|protease inhibitors|mesh-ancestor
25646935|NCT01464359|Gout Suppressants|gout suppressants|mesh-ancestor
25646936|NCT01464359|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25646937|NCT01464359|Antioxidants|antioxidants|mesh-ancestor
25646938|NCT01464359|Protective Agents|protective agents|mesh-ancestor
25646939|NCT01464424|Bimatoprost|bimatoprost|mesh-list
25646940|NCT01464424|Travoprost|travoprost|mesh-list
25646941|NCT01464424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25646942|NCT01464424|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25646943|NCT01464424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25646944|NCT01464697|Progesterone|progesterone|mesh-list
25646945|NCT01464697|Progestins|progestins|mesh-ancestor
25531291|NCT00532935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531292|NCT00532935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531293|NCT00532948|Capecitabine|capecitabine|mesh-list
25531294|NCT00532948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25531295|NCT00532948|Antimetabolites|antimetabolites|mesh-ancestor
25531296|NCT00532948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531297|NCT00532948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531298|NCT00533117|Fluoxetine|fluoxetine|mesh-list
25531299|NCT00533117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25531300|NCT00533117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25531301|NCT00533117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25531302|NCT00533117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531303|NCT00533117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25531304|NCT00533117|Serotonin Agents|serotonin agents|mesh-ancestor
25531305|NCT00533117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531306|NCT00533117|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25531307|NCT00533117|Antidepressive Agents|antidepressive agents|mesh-ancestor
25531308|NCT00533117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25823542|NCT00004854|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25531309|NCT00533117|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25531310|NCT00533117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25531311|NCT00533117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531312|NCT00533429|Bevacizumab|bevacizumab|mesh-list
25531313|NCT00533429|Carboplatin|carboplatin|mesh-list
25531315|NCT00533429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25531316|NCT00533429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531317|NCT00533429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25531318|NCT00533429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25531319|NCT00533429|Growth Substances|growth substances|mesh-ancestor
25531320|NCT00533429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531321|NCT00533429|Growth Inhibitors|growth inhibitors|mesh-ancestor
25531322|NCT00533429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531323|NCT00533429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531324|NCT00533429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25531325|NCT00533429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25531326|NCT00533442|Mycophenolic Acid|mycophenolic acid|mesh-list
25531327|NCT00533442|Sirolimus|sirolimus|mesh-list
25531328|NCT00533442|Tacrolimus|tacrolimus|mesh-list
25531329|NCT00533442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25531330|NCT00533442|Immunologic Factors|immunologic factors|mesh-ancestor
25531331|NCT00533442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531332|NCT00533442|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25531333|NCT00533442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531334|NCT00533442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531335|NCT00533442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25531336|NCT00533442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531337|NCT00533442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25531338|NCT00533442|Antitubercular Agents|antitubercular agents|mesh-ancestor
25531339|NCT00533442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25531340|NCT00533442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25531341|NCT00533442|Antifungal Agents|antifungal agents|mesh-ancestor
25531342|NCT00533507|Vaccines|vaccines|mesh-list
25531343|NCT00533507|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25531344|NCT00533507|Immunologic Factors|immunologic factors|mesh-ancestor
25531345|NCT00533507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531346|NCT00533546|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
25531347|NCT00533546|Protein C|protein c|mesh-list
25531348|NCT00533546|Anticoagulants|anticoagulants|mesh-ancestor
25531349|NCT00533546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25531350|NCT00533546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25531351|NCT00533546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531352|NCT00533546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25646946|NCT01464697|Hormones|hormones|mesh-ancestor
25823543|NCT00004854|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25646947|NCT01464697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25646948|NCT01464697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646949|NCT01464788|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25646950|NCT01464788|Argatroban|argatroban|mesh-list
25531353|NCT00533702|Dacarbazine|dacarbazine|mesh-list
25531354|NCT00533702|Ramucirumab|ramucirumab|mesh-list
25531355|NCT00533702|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25531356|NCT00533702|Imidazole|imidazole|mesh-list
25531357|NCT00533702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25531358|NCT00533702|Alkylating Agents|alkylating agents|mesh-ancestor
25531359|NCT00533702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531360|NCT00533702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531361|NCT00533702|Immunologic Factors|immunologic factors|mesh-ancestor
25531362|NCT00533702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531363|NCT00533702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531364|NCT00533845|Bupivacaine|bupivacaine|mesh-list
25531365|NCT00533845|Anesthetics, Local|anesthetics, local|mesh-ancestor
25531366|NCT00533845|Anesthetics|anesthetics|mesh-ancestor
25531367|NCT00533845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25531368|NCT00533845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531369|NCT00533845|Sensory System Agents|sensory system agents|mesh-ancestor
25531370|NCT00533845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25531371|NCT00533897|Abatacept|abatacept|mesh-list
25531372|NCT00533897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25531373|NCT00533897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531374|NCT00533897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531375|NCT00533897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25531376|NCT00533897|Immunologic Factors|immunologic factors|mesh-ancestor
25531377|NCT00533897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531378|NCT00533897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25531379|NCT00533910|Rifaximin|rifaximin|mesh-list
25531380|NCT00533910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25531381|NCT00533910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25531382|NCT00533910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25531383|NCT00534001|Bupropion|bupropion|mesh-list
25531384|NCT00534001|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25531385|NCT00534001|Antidepressive Agents|antidepressive agents|mesh-ancestor
25531386|NCT00534001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25531387|NCT00534001|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25531388|NCT00534001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25531389|NCT00534001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25531390|NCT00534001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531391|NCT00534001|Dopamine Agents|dopamine agents|mesh-ancestor
25531392|NCT00534001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25531393|NCT00534001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531394|NCT00534001|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25531395|NCT00534001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25531396|NCT00534001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531397|NCT00534313|Abatacept|abatacept|mesh-list
25531398|NCT00534313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25531399|NCT00534313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531400|NCT00534313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531401|NCT00534313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25531402|NCT00534313|Immunologic Factors|immunologic factors|mesh-ancestor
25531403|NCT00534313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531404|NCT00534313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25531405|NCT00534352|Ritonavir|ritonavir|mesh-list
25531406|NCT00534352|Darunavir|darunavir|mesh-list
25531407|NCT00534352|Etravirine|etravirine|mesh-list
25531408|NCT00534352|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25531409|NCT00534352|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25531410|NCT00534352|Protease Inhibitors|protease inhibitors|mesh-ancestor
25531411|NCT00534352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531412|NCT00534352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531413|NCT00534352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25531414|NCT00534352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25531415|NCT00534352|Antiviral Agents|antiviral agents|mesh-ancestor
25531416|NCT00534352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25531417|NCT00534352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25531418|NCT00534352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25531419|NCT00534352|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25531420|NCT00534352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25531421|NCT00534404|Nicotine|nicotine|mesh-list
25646951|NCT01464788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25646952|NCT01464788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25646953|NCT01464788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646954|NCT01464788|Antithrombins|antithrombins|mesh-ancestor
25646955|NCT01464788|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25646956|NCT01464788|Protease Inhibitors|protease inhibitors|mesh-ancestor
25531422|NCT00534404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25531423|NCT00534404|Autonomic Agents|autonomic agents|mesh-ancestor
25531424|NCT00534404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25531425|NCT00534404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531426|NCT00534404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25531427|NCT00534404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25531428|NCT00534404|Cholinergic Agents|cholinergic agents|mesh-ancestor
25531429|NCT00534404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25531430|NCT00534404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531431|NCT00534417|Capecitabine|capecitabine|mesh-list
25531432|NCT00534417|Fulvestrant|fulvestrant|mesh-list
25531433|NCT00534417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25531434|NCT00534417|Antimetabolites|antimetabolites|mesh-ancestor
25531435|NCT00534417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531436|NCT00534417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531437|NCT00534417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25531438|NCT00534417|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25531439|NCT00534417|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25531440|NCT00534417|Hormone Antagonists|hormone antagonists|mesh-ancestor
25531441|NCT00534417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25531442|NCT00534417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531443|NCT00534495|Rilonacept|rilonacept|mesh-list
25531444|NCT00534495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25531445|NCT00534599|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25531446|NCT00534599|Antidepressive Agents|antidepressive agents|mesh-ancestor
25531447|NCT00534599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25531448|NCT00534599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25531449|NCT00534599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25531450|NCT00534599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25531451|NCT00534599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531452|NCT00534794|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25531453|NCT00534794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25531454|NCT00534794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25531455|NCT00534794|Analgesics|analgesics|mesh-ancestor
25531456|NCT00534794|Sensory System Agents|sensory system agents|mesh-ancestor
25531457|NCT00534794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25531458|NCT00534794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531459|NCT00534794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25531460|NCT00534794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25531461|NCT00534794|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25531462|NCT00534794|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25531463|NCT00534794|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25531464|NCT00534794|Histamine Antagonists|histamine antagonists|mesh-ancestor
25531465|NCT00534794|Histamine Agents|histamine agents|mesh-ancestor
25531466|NCT00534794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25531467|NCT00534794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531468|NCT00534833|Vaccines|vaccines|mesh-list
25531469|NCT00534833|Immunologic Factors|immunologic factors|mesh-ancestor
25531470|NCT00534833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531471|NCT00535002|Yohimbine|yohimbine|mesh-list
25531472|NCT00535002|Mydriatics|mydriatics|mesh-ancestor
25531473|NCT00535002|Autonomic Agents|autonomic agents|mesh-ancestor
25531474|NCT00535002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25531475|NCT00535002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531476|NCT00535002|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25531477|NCT00535002|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25531478|NCT00535002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25531479|NCT00535002|Adrenergic Agents|adrenergic agents|mesh-ancestor
25531480|NCT00535002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25531481|NCT00535002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531482|NCT00535002|Urological Agents|urological agents|mesh-ancestor
25531483|NCT00535132|Risperidone|risperidone|mesh-list
25531484|NCT00535132|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25531485|NCT00535132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25531486|NCT00535132|Serotonin Agents|serotonin agents|mesh-ancestor
25531487|NCT00535132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25531488|NCT00535132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646957|NCT01464788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531489|NCT00535132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531490|NCT00535132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25531491|NCT00535132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25531492|NCT00535132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25531493|NCT00535132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25531494|NCT00535132|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25531495|NCT00535132|Dopamine Agents|dopamine agents|mesh-ancestor
25531496|NCT00535132|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25531497|NCT00535132|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25531498|NCT00535145|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25531499|NCT00535145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25531500|NCT00535145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25531501|NCT00535145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25531502|NCT00535145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531503|NCT00535145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25531504|NCT00535145|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25531505|NCT00535145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25531506|NCT00535145|Serotonin Agents|serotonin agents|mesh-ancestor
25531507|NCT00535145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25531508|NCT00535145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531509|NCT00535145|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25531510|NCT00535145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25531511|NCT00535145|Dopamine Agents|dopamine agents|mesh-ancestor
25531513|NCT00535288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531514|NCT00535288|Antidepressive Agents|antidepressive agents|mesh-ancestor
25531515|NCT00535288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25531516|NCT00535288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25531517|NCT00535288|Histamine Antagonists|histamine antagonists|mesh-ancestor
25531518|NCT00535288|Histamine Agents|histamine agents|mesh-ancestor
25531519|NCT00535288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25531520|NCT00535288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531521|NCT00535288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25531522|NCT00535288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25531523|NCT00535288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25531524|NCT00535288|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25531525|NCT00535288|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25531526|NCT00535288|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25531527|NCT00535288|Adrenergic Agents|adrenergic agents|mesh-ancestor
25531528|NCT00535288|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25531529|NCT00535288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25531530|NCT00535288|Serotonin Agents|serotonin agents|mesh-ancestor
25531531|NCT00535288|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25531532|NCT00535392|Levetiracetam|levetiracetam|mesh-list
25531533|NCT00535392|Anticonvulsants|anticonvulsants|mesh-ancestor
25531534|NCT00535392|Nootropic Agents|nootropic agents|mesh-ancestor
25531535|NCT00535587|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
25531536|NCT00535587|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25531537|NCT00535587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531538|NCT00535587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531539|NCT00535587|Cholinergic Agents|cholinergic agents|mesh-ancestor
25531540|NCT00535587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25531541|NCT00535587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531542|NCT00535613|Propofol|propofol|mesh-list
25531543|NCT00535613|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25531544|NCT00535613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25531545|NCT00535613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531546|NCT00535613|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25531547|NCT00535613|Anesthetics, General|anesthetics, general|mesh-ancestor
25531548|NCT00535613|Anesthetics|anesthetics|mesh-ancestor
25531549|NCT00535652|Ertapenem|ertapenem|mesh-list
25531550|NCT00535652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25531551|NCT00535652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25531552|NCT00535730|Vaccines|vaccines|mesh-list
25531553|NCT00535730|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25531554|NCT00535730|Immunologic Factors|immunologic factors|mesh-ancestor
25531555|NCT00535730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531556|NCT00535743|Bromides|bromides|mesh-list
25531557|NCT00535743|Rocuronium|rocuronium|mesh-list
25531558|NCT00535743|Anticonvulsants|anticonvulsants|mesh-ancestor
25531559|NCT00535743|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25531560|NCT00535743|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25531561|NCT00535743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25531562|NCT00535743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25646958|NCT01464788|Anticoagulants|anticoagulants|mesh-ancestor
25646959|NCT01464788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25646960|NCT01464827|Ritonavir|ritonavir|mesh-list
25646961|NCT01464827|Ribavirin|ribavirin|mesh-list
25646962|NCT01464827|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25646963|NCT01464827|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25646964|NCT01464827|Protease Inhibitors|protease inhibitors|mesh-ancestor
25531563|NCT00535743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531564|NCT00535782|Methotrexate|methotrexate|mesh-list
25531565|NCT00535782|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25531566|NCT00535782|Abortifacient Agents|abortifacient agents|mesh-ancestor
25531567|NCT00535782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25531568|NCT00535782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531569|NCT00535782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25531570|NCT00535782|Antimetabolites|antimetabolites|mesh-ancestor
25531571|NCT00535782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531572|NCT00535782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531573|NCT00535782|Dermatologic Agents|dermatologic agents|mesh-ancestor
25531574|NCT00535782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531575|NCT00535782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25531576|NCT00535782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25531577|NCT00535782|Immunologic Factors|immunologic factors|mesh-ancestor
25531578|NCT00535782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25531579|NCT00535782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25531580|NCT00535847|Interferons|interferons|mesh-list
25531581|NCT00535847|Ribavirin|ribavirin|mesh-list
25531582|NCT00535847|Interferon-alpha|interferon-alpha|mesh-list
25531583|NCT00535847|Interferon alpha-2|interferon alpha-2|mesh-list
25531584|NCT00535847|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25531585|NCT00535847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531586|NCT00535847|Antiviral Agents|antiviral agents|mesh-ancestor
25531587|NCT00535847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25531588|NCT00535847|Antimetabolites|antimetabolites|mesh-ancestor
25531589|NCT00535847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531590|NCT00535847|Immunologic Factors|immunologic factors|mesh-ancestor
25531591|NCT00535847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531592|NCT00535873|Lenalidomide|lenalidomide|mesh-list
25531593|NCT00535873|Immunologic Factors|immunologic factors|mesh-ancestor
25531594|NCT00535873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531595|NCT00535873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25531596|NCT00535873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25531597|NCT00535873|Growth Substances|growth substances|mesh-ancestor
25531598|NCT00535873|Growth Inhibitors|growth inhibitors|mesh-ancestor
25531599|NCT00535873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531600|NCT00535925|Aspirin|aspirin|mesh-list
25531601|NCT00535925|Atenolol|atenolol|mesh-list
25531602|NCT00535925|Amlodipine|amlodipine|mesh-list
25531603|NCT00535925|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25531604|NCT00535925|Clonidine|clonidine|mesh-list
25531605|NCT00535925|Ramipril|ramipril|mesh-list
25531606|NCT00535925|Irbesartan|irbesartan|mesh-list
25531607|NCT00535925|Doxazosin|doxazosin|mesh-list
25531608|NCT00535925|Furosemide|furosemide|mesh-list
25531609|NCT00535925|Epoetin Alfa|epoetin alfa|mesh-list
25531610|NCT00535925|Simvastatin|simvastatin|mesh-list
25531611|NCT00535925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531612|NCT00535925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25531613|NCT00535925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25531614|NCT00535925|Analgesics|analgesics|mesh-ancestor
25531615|NCT00535925|Sensory System Agents|sensory system agents|mesh-ancestor
25531616|NCT00535925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25531617|NCT00535925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25531618|NCT00535925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25531619|NCT00535925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25531620|NCT00535925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25531621|NCT00535925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531622|NCT00535925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25531623|NCT00535925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25531624|NCT00535925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531625|NCT00535925|Antipyretics|antipyretics|mesh-ancestor
25531626|NCT00535925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25531627|NCT00535925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25531628|NCT00535925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25531629|NCT00535925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25531630|NCT00535925|Vasodilator Agents|vasodilator agents|mesh-ancestor
25531631|NCT00535925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25531632|NCT00535925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25531633|NCT00535925|Antimetabolites|antimetabolites|mesh-ancestor
25531634|NCT00535925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25531635|NCT00535925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25531636|NCT00535925|Diuretics|diuretics|mesh-ancestor
25531637|NCT00535925|Natriuretic Agents|natriuretic agents|mesh-ancestor
25531638|NCT00535925|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25531639|NCT00535925|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25531640|NCT00535925|Sympatholytics|sympatholytics|mesh-ancestor
25531641|NCT00535925|Autonomic Agents|autonomic agents|mesh-ancestor
25531642|NCT00535925|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25531643|NCT00535925|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25531644|NCT00535925|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25531645|NCT00535925|Adrenergic Agents|adrenergic agents|mesh-ancestor
25531646|NCT00535925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25531647|NCT00535925|Hematinics|hematinics|mesh-ancestor
25531648|NCT00535925|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25531649|NCT00535925|Protease Inhibitors|protease inhibitors|mesh-ancestor
25531650|NCT00535925|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25531651|NCT00535925|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25531652|NCT00535925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25531653|NCT00535925|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25531654|NCT00535925|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25531655|NCT00535925|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25531656|NCT00535925|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25531657|NCT00535925|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25531658|NCT00535938|Botulinum Toxins|botulinum toxins|mesh-list
25531659|NCT00535938|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25531660|NCT00535938|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25531661|NCT00535938|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25531662|NCT00535938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25531663|NCT00535938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531664|NCT00535938|Cholinergic Agents|cholinergic agents|mesh-ancestor
25531665|NCT00535938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25531666|NCT00535938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531667|NCT00535938|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25531668|NCT00535938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25531669|NCT00536107|Docetaxel|docetaxel|mesh-list
25531670|NCT00536107|Gefitinib|gefitinib|mesh-list
25531671|NCT00536107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531672|NCT00536107|Tubulin Modulators|tubulin modulators|mesh-ancestor
25531673|NCT00536107|Antimitotic Agents|antimitotic agents|mesh-ancestor
25531674|NCT00536107|Mitosis Modulators|mitosis modulators|mesh-ancestor
25531675|NCT00536107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531676|NCT00536107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25531677|NCT00536107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531678|NCT00536120|Natalizumab|natalizumab|mesh-list
25531679|NCT00536120|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
25823544|NCT00004855|Ritonavir|ritonavir|mesh-list
25531680|NCT00536120|Immunologic Factors|immunologic factors|mesh-ancestor
25531681|NCT00536120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531682|NCT00536120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25531683|NCT00536172|Citalopram|citalopram|mesh-list
25531684|NCT00536172|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25531685|NCT00536172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25531686|NCT00536172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25531687|NCT00536172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531688|NCT00536172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25531689|NCT00536172|Serotonin Agents|serotonin agents|mesh-ancestor
25531690|NCT00536172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531691|NCT00536172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25531692|NCT00536172|Antidepressive Agents|antidepressive agents|mesh-ancestor
25531693|NCT00536172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25531694|NCT00536198|Sertraline|sertraline|mesh-list
25531695|NCT00536198|Antidepressive Agents|antidepressive agents|mesh-ancestor
25531696|NCT00536198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25531697|NCT00536198|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25531698|NCT00536198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25531699|NCT00536198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25531700|NCT00536198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531701|NCT00536198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25531702|NCT00536198|Serotonin Agents|serotonin agents|mesh-ancestor
25531703|NCT00536198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531704|NCT00536263|Interferons|interferons|mesh-list
25823545|NCT00004855|Lopinavir|lopinavir|mesh-list
25531705|NCT00536263|Interferon-alpha|interferon-alpha|mesh-list
25531706|NCT00536263|Interferon alpha-2|interferon alpha-2|mesh-list
25531707|NCT00536263|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25531708|NCT00536263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531709|NCT00536263|Antiviral Agents|antiviral agents|mesh-ancestor
25531710|NCT00536263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25531711|NCT00536263|Immunologic Factors|immunologic factors|mesh-ancestor
25531712|NCT00536263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531713|NCT00536341|Rituximab|rituximab|mesh-list
25531714|NCT00536341|Fludarabine|fludarabine|mesh-list
25531715|NCT00536341|Lenalidomide|lenalidomide|mesh-list
25531716|NCT00536341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25531717|NCT00536341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531718|NCT00536341|Immunologic Factors|immunologic factors|mesh-ancestor
25531719|NCT00536341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531720|NCT00536341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25531721|NCT00536341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25531722|NCT00536341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25531723|NCT00536341|Growth Substances|growth substances|mesh-ancestor
25531724|NCT00536341|Growth Inhibitors|growth inhibitors|mesh-ancestor
25531725|NCT00536471|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25531726|NCT00536471|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25531727|NCT00536471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25531728|NCT00536471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25531729|NCT00536471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531730|NCT00536471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25531731|NCT00536471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531732|NCT00536471|Analgesics|analgesics|mesh-ancestor
25531733|NCT00536471|Sensory System Agents|sensory system agents|mesh-ancestor
25531734|NCT00536471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25531735|NCT00536471|Antidepressive Agents|antidepressive agents|mesh-ancestor
25531736|NCT00536471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25531737|NCT00536471|Dopamine Agents|dopamine agents|mesh-ancestor
25531738|NCT00536484|Fesoterodine|fesoterodine|mesh-list
25531739|NCT00536484|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25531740|NCT00536484|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25531741|NCT00536484|Cholinergic Agents|cholinergic agents|mesh-ancestor
25531742|NCT00536484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25531743|NCT00536484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531744|NCT00536484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531745|NCT00536484|Urological Agents|urological agents|mesh-ancestor
25531746|NCT00536510|Niacin|niacin|mesh-list
25531747|NCT00536510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25531748|NCT00536510|Antimetabolites|antimetabolites|mesh-ancestor
25531749|NCT00536510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531750|NCT00536510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25531751|NCT00536510|Vasodilator Agents|vasodilator agents|mesh-ancestor
25531752|NCT00536510|Vitamin B Complex|vitamin b complex|mesh-ancestor
25823546|NCT00004855|Lamivudine|lamivudine|mesh-list
25531784|NCT00536731|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25531785|NCT00536731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25531786|NCT00536731|Respiratory System Agents|respiratory system agents|mesh-ancestor
25531787|NCT00536731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25531788|NCT00536731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25531789|NCT00536731|Autonomic Agents|autonomic agents|mesh-ancestor
25531790|NCT00536731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25531791|NCT00536731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531792|NCT00536731|Glucocorticoids|glucocorticoids|mesh-ancestor
25531793|NCT00536731|Hormones|hormones|mesh-ancestor
25531794|NCT00536731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25531795|NCT00536809|Capecitabine|capecitabine|mesh-list
25531796|NCT00536809|Oxaliplatin|oxaliplatin|mesh-list
25531797|NCT00536809|Lapatinib|lapatinib|mesh-list
25531798|NCT00536809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25531799|NCT00536809|Antimetabolites|antimetabolites|mesh-ancestor
25531800|NCT00536809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531801|NCT00536809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531802|NCT00536809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25531803|NCT00536809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531804|NCT00536874|Gemcitabine|gemcitabine|mesh-list
25531805|NCT00536874|Oxaliplatin|oxaliplatin|mesh-list
25531806|NCT00536874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25531807|NCT00536874|Antimetabolites|antimetabolites|mesh-ancestor
25531808|NCT00536874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531809|NCT00536874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646965|NCT01464827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531810|NCT00536874|Antiviral Agents|antiviral agents|mesh-ancestor
25531811|NCT00536874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25531812|NCT00536874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531813|NCT00536874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25531814|NCT00536874|Immunologic Factors|immunologic factors|mesh-ancestor
25531815|NCT00536874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531816|NCT00536913|Budesonide|budesonide|mesh-list
25531817|NCT00536913|Formoterol Fumarate|formoterol fumarate|mesh-list
25531818|NCT00536913|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25531819|NCT00536913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25531820|NCT00536913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25531821|NCT00536913|Autonomic Agents|autonomic agents|mesh-ancestor
25531822|NCT00536913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25531823|NCT00536913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531824|NCT00536913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25531825|NCT00536913|Respiratory System Agents|respiratory system agents|mesh-ancestor
25531826|NCT00536913|Glucocorticoids|glucocorticoids|mesh-ancestor
25531827|NCT00536913|Hormones|hormones|mesh-ancestor
25531828|NCT00536913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25531829|NCT00536913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25531830|NCT00536913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25531831|NCT00536913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25531832|NCT00536913|Adrenergic Agents|adrenergic agents|mesh-ancestor
25531833|NCT00536913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25531834|NCT00536913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531835|NCT00536939|Paclitaxel|paclitaxel|mesh-list
25531836|NCT00536939|Bevacizumab|bevacizumab|mesh-list
25531837|NCT00536939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25531838|NCT00536939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531839|NCT00536939|Tubulin Modulators|tubulin modulators|mesh-ancestor
25531840|NCT00536939|Antimitotic Agents|antimitotic agents|mesh-ancestor
25531841|NCT00536939|Mitosis Modulators|mitosis modulators|mesh-ancestor
25531842|NCT00536939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531843|NCT00536939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25531844|NCT00536939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25531845|NCT00536939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25531846|NCT00536939|Growth Substances|growth substances|mesh-ancestor
25531847|NCT00536939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531848|NCT00536939|Growth Inhibitors|growth inhibitors|mesh-ancestor
25531849|NCT00536991|Calcitriol|calcitriol|mesh-list
25531850|NCT00536991|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
25531851|NCT00536991|Ketoconazole|ketoconazole|mesh-list
25531852|NCT00536991|Hydrocortisone|hydrocortisone|mesh-list
25531853|NCT00536991|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25531854|NCT00536991|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25531855|NCT00536991|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25531856|NCT00536991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25531857|NCT00536991|Antifungal Agents|antifungal agents|mesh-ancestor
25531858|NCT00536991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25531859|NCT00536991|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25531860|NCT00536991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25531861|NCT00536991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531862|NCT00536991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531863|NCT00536991|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25531864|NCT00536991|Hormone Antagonists|hormone antagonists|mesh-ancestor
25531865|NCT00536991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25531866|NCT00536991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531867|NCT00536991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25531868|NCT00536991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25531869|NCT00536991|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25531870|NCT00536991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25531871|NCT00536991|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25531872|NCT00536991|Vitamins|vitamins|mesh-ancestor
25531873|NCT00536991|Micronutrients|micronutrients|mesh-ancestor
25531874|NCT00536991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25531875|NCT00537017|Levodopa|levodopa|mesh-list
25531876|NCT00537017|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25531877|NCT00537017|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25531878|NCT00537017|Dopamine Agents|dopamine agents|mesh-ancestor
25531879|NCT00537017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25531880|NCT00537017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823547|NCT00004855|Nevirapine|nevirapine|mesh-list
25531881|NCT00537017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531882|NCT00537030|Asparaginase|asparaginase|mesh-list
25531883|NCT00537030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531884|NCT00537056|Sunitinib|sunitinib|mesh-list
25531885|NCT00537056|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25531886|NCT00537056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531887|NCT00537056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25531888|NCT00537056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25531889|NCT00537056|Growth Substances|growth substances|mesh-ancestor
25531890|NCT00537056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531891|NCT00537056|Growth Inhibitors|growth inhibitors|mesh-ancestor
25531892|NCT00537056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25531893|NCT00537056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531894|NCT00537056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531895|NCT00537056|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25531896|NCT00537082|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25531897|NCT00537082|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25531898|NCT00537082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531899|NCT00537082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25531900|NCT00537082|Immunologic Factors|immunologic factors|mesh-ancestor
25531901|NCT00537082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531902|NCT00537238|Pregabalin|pregabalin|mesh-list
25531903|NCT00537238|Levetiracetam|levetiracetam|mesh-list
25531904|NCT00537238|Analgesics|analgesics|mesh-ancestor
25531905|NCT00537238|Sensory System Agents|sensory system agents|mesh-ancestor
25531906|NCT00537238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25531907|NCT00537238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531908|NCT00537238|Anticonvulsants|anticonvulsants|mesh-ancestor
25531909|NCT00537238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25531910|NCT00537238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25531911|NCT00537238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531912|NCT00537238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25531913|NCT00537238|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25531914|NCT00537238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25531915|NCT00537238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25531916|NCT00537238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25531917|NCT00537238|Nootropic Agents|nootropic agents|mesh-ancestor
25531918|NCT00537277|Insulin Aspart|insulin aspart|mesh-list
25531919|NCT00537277|Biphasic Insulins|biphasic insulins|mesh-list
25531920|NCT00537277|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
25531921|NCT00537277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25531922|NCT00537277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531923|NCT00537290|Rituximab|rituximab|mesh-list
25531924|NCT00537290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25531925|NCT00537290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531926|NCT00537290|Immunologic Factors|immunologic factors|mesh-ancestor
25531927|NCT00537290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394463|NCT00133354|Anastrozole|anastrozole|mesh-list
25531929|NCT00537303|Insulin|insulin|mesh-list
25531930|NCT00537303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25531931|NCT00537303|Insulin Aspart|insulin aspart|mesh-list
25531932|NCT00537303|Insulin, Long-Acting|insulin, long-acting|mesh-list
25531933|NCT00537303|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25531934|NCT00537303|Insulin Detemir|insulin detemir|mesh-list
25531935|NCT00537303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25531936|NCT00537303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531937|NCT00537316|Azathioprine|azathioprine|mesh-list
25531938|NCT00537316|Infliximab|infliximab|mesh-list
25531939|NCT00537316|Dermatologic Agents|dermatologic agents|mesh-ancestor
25531940|NCT00537316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25531941|NCT00537316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25531942|NCT00537316|Antimetabolites|antimetabolites|mesh-ancestor
25531943|NCT00537316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531944|NCT00537316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25531945|NCT00537316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25531946|NCT00537316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25531947|NCT00537316|Immunologic Factors|immunologic factors|mesh-ancestor
25531948|NCT00537316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531949|NCT00537329|Anidulafungin|anidulafungin|mesh-list
25531950|NCT00537329|Antifungal Agents|antifungal agents|mesh-ancestor
25531951|NCT00537329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25531952|NCT00537381|Prednisone|prednisone|mesh-list
25531953|NCT00537381|Docetaxel|docetaxel|mesh-list
25531954|NCT00537381|Intetumumab|intetumumab|mesh-list
25531955|NCT00537381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25646966|NCT01464827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25646967|NCT01464827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25823548|NCT00004855|Abacavir|abacavir|mesh-list
25531956|NCT00537381|Tubulin Modulators|tubulin modulators|mesh-ancestor
25531957|NCT00537381|Antimitotic Agents|antimitotic agents|mesh-ancestor
25531958|NCT00537381|Mitosis Modulators|mitosis modulators|mesh-ancestor
25531959|NCT00537381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531960|NCT00537381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25531961|NCT00537381|Glucocorticoids|glucocorticoids|mesh-ancestor
25531962|NCT00537381|Hormones|hormones|mesh-ancestor
25531963|NCT00537381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25531964|NCT00537381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25531965|NCT00537381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25531966|NCT00537381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25531967|NCT00537394|Raltegravir Potassium|raltegravir potassium|mesh-list
25531968|NCT00537394|Maraviroc|maraviroc|mesh-list
25531969|NCT00537394|Darunavir|darunavir|mesh-list
25531970|NCT00537394|Tipranavir|tipranavir|mesh-list
25531971|NCT00537394|Enfuvirtide|enfuvirtide|mesh-list
25531972|NCT00537394|Etravirine|etravirine|mesh-list
25531973|NCT00537394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25531974|NCT00537394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25531975|NCT00537394|Antiviral Agents|antiviral agents|mesh-ancestor
25531976|NCT00537394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25531977|NCT00537394|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25531978|NCT00537394|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25531979|NCT00537394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25531980|NCT00537394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531981|NCT00537394|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25531982|NCT00537394|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25531983|NCT00537394|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25531984|NCT00537394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25531985|NCT00537394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25531986|NCT00537394|Protease Inhibitors|protease inhibitors|mesh-ancestor
25531987|NCT00537394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25531988|NCT00537394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25531989|NCT00537407|Ribavirin|ribavirin|mesh-list
25531990|NCT00537407|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25531991|NCT00537407|Antimetabolites|antimetabolites|mesh-ancestor
25531992|NCT00537407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25531993|NCT00537407|Antiviral Agents|antiviral agents|mesh-ancestor
25531994|NCT00537407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25531995|NCT00537511|Cisplatin|cisplatin|mesh-list
25531996|NCT00537511|Etoposide|etoposide|mesh-list
25531997|NCT00537511|Etoposide phosphate|etoposide phosphate|mesh-list
25531998|NCT00537511|Pomalidomide|pomalidomide|mesh-list
25531999|NCT00537511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532000|NCT00537511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25532001|NCT00537511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25532002|NCT00537511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25532003|NCT00537511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532004|NCT00537511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532005|NCT00537511|Immunologic Factors|immunologic factors|mesh-ancestor
25532006|NCT00537511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532007|NCT00537511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25532008|NCT00537511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25532009|NCT00537511|Growth Substances|growth substances|mesh-ancestor
25532010|NCT00537511|Growth Inhibitors|growth inhibitors|mesh-ancestor
25532011|NCT00537680|Ubiquinone|ubiquinone|mesh-list
25532012|NCT00537680|Idebenone|idebenone|mesh-list
25532013|NCT00537680|Antioxidants|antioxidants|mesh-ancestor
25532014|NCT00537680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532015|NCT00537680|Protective Agents|protective agents|mesh-ancestor
25532016|NCT00537680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532017|NCT00537680|Micronutrients|micronutrients|mesh-ancestor
25532018|NCT00537745|Naltrexone|naltrexone|mesh-list
25532019|NCT00537745|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25532020|NCT00537745|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25532021|NCT00537745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532022|NCT00537745|Sensory System Agents|sensory system agents|mesh-ancestor
25532023|NCT00537745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25532024|NCT00537771|Tamoxifen|tamoxifen|mesh-list
25532025|NCT00537771|Anastrozole|anastrozole|mesh-list
25532026|NCT00537771|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25532027|NCT00537771|Hormone Antagonists|hormone antagonists|mesh-ancestor
24546418|NCT00698269|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25532028|NCT00537771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25532029|NCT00537771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532030|NCT00537771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25532031|NCT00537771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532032|NCT00537771|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25532033|NCT00537771|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25532034|NCT00537771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25532035|NCT00537771|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25532036|NCT00537771|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25532037|NCT00537771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532038|NCT00537771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532039|NCT00537810|Sibutramine|sibutramine|mesh-list
25532040|NCT00537810|Antidepressive Agents|antidepressive agents|mesh-ancestor
25532041|NCT00537810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25532042|NCT00537810|Appetite Depressants|appetite depressants|mesh-ancestor
25532043|NCT00537810|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25532045|NCT00537823|Bevacizumab|bevacizumab|mesh-list
25532046|NCT00537823|Cetuximab|cetuximab|mesh-list
25532047|NCT00537823|Fluorouracil|fluorouracil|mesh-list
25532048|NCT00537823|Oxaliplatin|oxaliplatin|mesh-list
25532049|NCT00537823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25532050|NCT00537823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532051|NCT00537823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25532052|NCT00537823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25532053|NCT00537823|Growth Substances|growth substances|mesh-ancestor
25532054|NCT00537823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532055|NCT00537823|Growth Inhibitors|growth inhibitors|mesh-ancestor
25532056|NCT00537823|Antimetabolites|antimetabolites|mesh-ancestor
25532057|NCT00537823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532058|NCT00537823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25532059|NCT00537823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25532060|NCT00537823|Immunologic Factors|immunologic factors|mesh-ancestor
25532061|NCT00537823|Antidotes|antidotes|mesh-ancestor
25532062|NCT00537823|Protective Agents|protective agents|mesh-ancestor
25532063|NCT00537823|Vitamin B Complex|vitamin b complex|mesh-ancestor
25532064|NCT00537823|Vitamins|vitamins|mesh-ancestor
25532065|NCT00537823|Micronutrients|micronutrients|mesh-ancestor
25532066|NCT00537940|Pregabalin|pregabalin|mesh-list
25532067|NCT00537940|Gabapentin|gabapentin|mesh-list
25532068|NCT00537940|Analgesics|analgesics|mesh-ancestor
25532069|NCT00537940|Sensory System Agents|sensory system agents|mesh-ancestor
25532070|NCT00537940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25532071|NCT00537940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532072|NCT00537940|Anticonvulsants|anticonvulsants|mesh-ancestor
25532073|NCT00537940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25532074|NCT00537940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25532075|NCT00537940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532076|NCT00537940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25532077|NCT00537940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25532078|NCT00537940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25532079|NCT00537940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25532080|NCT00537940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25532081|NCT00537940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25532082|NCT00537940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25532083|NCT00537940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25532084|NCT00537940|Antimanic Agents|antimanic agents|mesh-ancestor
25532085|NCT00537979|Ergocalciferols|ergocalciferols|mesh-list
25532086|NCT00537979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25532087|NCT00537979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532088|NCT00537979|Vitamins|vitamins|mesh-ancestor
25532089|NCT00537979|Micronutrients|micronutrients|mesh-ancestor
25532090|NCT00537979|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25532091|NCT00538291|Capecitabine|capecitabine|mesh-list
25532092|NCT00538291|Cetuximab|cetuximab|mesh-list
25532093|NCT00538291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25532094|NCT00538291|Antimetabolites|antimetabolites|mesh-ancestor
25532095|NCT00538291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532096|NCT00538291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532097|NCT00538291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25532098|NCT00538304|Bimatoprost|bimatoprost|mesh-list
25532099|NCT00538304|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25532100|NCT00538304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25532101|NCT00538304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25532102|NCT00538434|Reslizumab|reslizumab|mesh-list
25646968|NCT01464827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25646969|NCT01464827|Antiviral Agents|antiviral agents|mesh-ancestor
25646970|NCT01464827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25646971|NCT01464827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25646972|NCT01464827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25646973|NCT01464827|Antimetabolites|antimetabolites|mesh-ancestor
25646974|NCT01464840|Azithromycin|azithromycin|mesh-list
25646975|NCT01464840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25646976|NCT01464840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25646977|NCT01464879|Testosterone|testosterone|mesh-list
25532103|NCT00538434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25532104|NCT00538434|Respiratory System Agents|respiratory system agents|mesh-ancestor
25532105|NCT00538590|Mitomycins|mitomycins|mesh-list
25532106|NCT00538590|Mitomycin|mitomycin|mesh-list
25532107|NCT00538590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25532108|NCT00538590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532109|NCT00538590|Alkylating Agents|alkylating agents|mesh-ancestor
25532110|NCT00538590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532111|NCT00538590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25532112|NCT00538590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532113|NCT00538616|Dexmedetomidine|dexmedetomidine|mesh-list
25532114|NCT00538616|Propofol|propofol|mesh-list
25532115|NCT00538616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25532116|NCT00538616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25532117|NCT00538616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532118|NCT00538616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25532119|NCT00538616|Anesthetics, General|anesthetics, general|mesh-ancestor
25532120|NCT00538616|Anesthetics|anesthetics|mesh-ancestor
25532121|NCT00538616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25532122|NCT00538616|Analgesics|analgesics|mesh-ancestor
25532123|NCT00538616|Sensory System Agents|sensory system agents|mesh-ancestor
25532124|NCT00538616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25532125|NCT00538616|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25532126|NCT00538616|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25532127|NCT00538616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25532128|NCT00538616|Adrenergic Agents|adrenergic agents|mesh-ancestor
25532129|NCT00538616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25532130|NCT00538616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532131|NCT00538642|Ziprasidone|ziprasidone|mesh-list
25532132|NCT00538642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25532133|NCT00538642|Serotonin Agents|serotonin agents|mesh-ancestor
25532134|NCT00538642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25532135|NCT00538642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532136|NCT00538642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532137|NCT00538642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25532138|NCT00538642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25532139|NCT00538642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25532140|NCT00538642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25532141|NCT00538642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25532142|NCT00538642|Dopamine Agents|dopamine agents|mesh-ancestor
25532143|NCT00538681|Cisplatin|cisplatin|mesh-list
25532144|NCT00538681|Pemetrexed|pemetrexed|mesh-list
25532145|NCT00538681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532146|NCT00538681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532147|NCT00538681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532148|NCT00538681|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25532149|NCT00538681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25532150|NCT00538733|Clarithromycin|clarithromycin|mesh-list
25532151|NCT00538733|Thalidomide|thalidomide|mesh-list
25532152|NCT00538733|Dexamethasone|dexamethasone|mesh-list
25532153|NCT00538733|Lenalidomide|lenalidomide|mesh-list
25532154|NCT00538733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25532155|NCT00538733|Antiemetics|antiemetics|mesh-ancestor
25532156|NCT00538733|Autonomic Agents|autonomic agents|mesh-ancestor
25532157|NCT00538733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25532158|NCT00538733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532159|NCT00538733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25532160|NCT00538733|Glucocorticoids|glucocorticoids|mesh-ancestor
25532161|NCT00538733|Hormones|hormones|mesh-ancestor
25532162|NCT00538733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25532163|NCT00538733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25532164|NCT00538733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532165|NCT00538733|Immunologic Factors|immunologic factors|mesh-ancestor
25532166|NCT00538733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25823549|NCT00004855|Stavudine|stavudine|mesh-list
25646978|NCT01464879|Androgens|androgens|mesh-ancestor
25532167|NCT00538733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25532168|NCT00538733|Growth Substances|growth substances|mesh-ancestor
25532169|NCT00538733|Growth Inhibitors|growth inhibitors|mesh-ancestor
25532170|NCT00538733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25532171|NCT00538733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25532172|NCT00538733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25532173|NCT00538733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532174|NCT00538733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532175|NCT00538733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25532176|NCT00538733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25532177|NCT00538733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25532178|NCT00538733|Leprostatic Agents|leprostatic agents|mesh-ancestor
25532179|NCT00538785|Palivizumab|palivizumab|mesh-list
25532180|NCT00538785|Antiviral Agents|antiviral agents|mesh-ancestor
25532181|NCT00538785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25532182|NCT00538824|Thalidomide|thalidomide|mesh-list
25532183|NCT00538824|Dexamethasone|dexamethasone|mesh-list
25532184|NCT00538824|Lenalidomide|lenalidomide|mesh-list
25532185|NCT00538824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25532186|NCT00538824|Antiemetics|antiemetics|mesh-ancestor
25532187|NCT00538824|Autonomic Agents|autonomic agents|mesh-ancestor
25532188|NCT00538824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25532189|NCT00538824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532190|NCT00538824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25532191|NCT00538824|Glucocorticoids|glucocorticoids|mesh-ancestor
25532192|NCT00538824|Hormones|hormones|mesh-ancestor
25532193|NCT00538824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25532194|NCT00538824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25532195|NCT00538824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532196|NCT00538824|Immunologic Factors|immunologic factors|mesh-ancestor
25532197|NCT00538824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25532198|NCT00538824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25532199|NCT00538824|Growth Substances|growth substances|mesh-ancestor
25532200|NCT00538824|Growth Inhibitors|growth inhibitors|mesh-ancestor
25532201|NCT00538824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25532202|NCT00538824|Leprostatic Agents|leprostatic agents|mesh-ancestor
25532203|NCT00538824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25532204|NCT00538824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25532205|NCT00538850|Fentanyl|fentanyl|mesh-list
25532206|NCT00538850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25532207|NCT00538850|Narcotics|narcotics|mesh-ancestor
25532208|NCT00538850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25532209|NCT00538850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532210|NCT00538850|Analgesics|analgesics|mesh-ancestor
25532211|NCT00538850|Sensory System Agents|sensory system agents|mesh-ancestor
25532212|NCT00538850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25532213|NCT00538850|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25532214|NCT00538850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25532215|NCT00538850|Anesthetics, General|anesthetics, general|mesh-ancestor
25532216|NCT00538850|Anesthetics|anesthetics|mesh-ancestor
25532217|NCT00538863|Fentanyl|fentanyl|mesh-list
25532218|NCT00538863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25532219|NCT00538863|Narcotics|narcotics|mesh-ancestor
25532220|NCT00538863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25532221|NCT00538863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532222|NCT00538863|Analgesics|analgesics|mesh-ancestor
25532223|NCT00538863|Sensory System Agents|sensory system agents|mesh-ancestor
25532224|NCT00538863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25532225|NCT00538863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25532226|NCT00538863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25532227|NCT00538863|Anesthetics, General|anesthetics, general|mesh-ancestor
25532228|NCT00538863|Anesthetics|anesthetics|mesh-ancestor
25532229|NCT00538902|Adalimumab|adalimumab|mesh-list
25532230|NCT00538902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25532231|NCT00538902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25532232|NCT00538915|Immunoglobulins|immunoglobulins|mesh-list
25532233|NCT00538915|Antibodies|antibodies|mesh-list
25532234|NCT00538915|gamma-Globulins|gamma-globulins|mesh-list
25532235|NCT00538915|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25532236|NCT00538915|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25532237|NCT00538915|Immunologic Factors|immunologic factors|mesh-ancestor
25532238|NCT00538915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532239|NCT00539006|Fluticasone|fluticasone|mesh-list
25532241|NCT00539006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25532242|NCT00539006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25532243|NCT00539006|Autonomic Agents|autonomic agents|mesh-ancestor
25532244|NCT00539006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25646979|NCT01464879|Hormones|hormones|mesh-ancestor
25532245|NCT00539006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532246|NCT00539006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25532247|NCT00539006|Respiratory System Agents|respiratory system agents|mesh-ancestor
25532248|NCT00539006|Dermatologic Agents|dermatologic agents|mesh-ancestor
25532249|NCT00539006|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25532250|NCT00539032|Vaccines|vaccines|mesh-list
25532251|NCT00539032|Immunologic Factors|immunologic factors|mesh-ancestor
25532252|NCT00539032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532253|NCT00539188|Acetylcysteine|acetylcysteine|mesh-list
25532254|NCT00539188|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25532255|NCT00539188|Antiviral Agents|antiviral agents|mesh-ancestor
25532256|NCT00539188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25532257|NCT00539188|Expectorants|expectorants|mesh-ancestor
25532258|NCT00539188|Respiratory System Agents|respiratory system agents|mesh-ancestor
25532259|NCT00539188|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25532260|NCT00539188|Antioxidants|antioxidants|mesh-ancestor
25532261|NCT00539188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532262|NCT00539188|Protective Agents|protective agents|mesh-ancestor
25532263|NCT00539188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532264|NCT00539188|Antidotes|antidotes|mesh-ancestor
25532265|NCT00539240|Antidepressive Agents|antidepressive agents|mesh-list
25532266|NCT00539240|Nortriptyline|nortriptyline|mesh-list
25532267|NCT00539240|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
25532268|NCT00539240|Rabeprazole|rabeprazole|mesh-list
25532269|NCT00539240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25532270|NCT00539240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25532271|NCT00539240|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25532272|NCT00539240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532273|NCT00539240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532274|NCT00539240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25532275|NCT00539240|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25532276|NCT00539240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25532277|NCT00539240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25532278|NCT00539240|Adrenergic Agents|adrenergic agents|mesh-ancestor
25532279|NCT00539240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25532280|NCT00539240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532281|NCT00539305|Methyltestosterone|methyltestosterone|mesh-list
25532282|NCT00539305|Testosterone|testosterone|mesh-list
25532283|NCT00539305|Testosterone undecanoate|testosterone undecanoate|mesh-list
25532284|NCT00539305|Testosterone enanthate|testosterone enanthate|mesh-list
25532285|NCT00539305|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25532286|NCT00539305|Androgens|androgens|mesh-ancestor
25532287|NCT00539305|Hormones|hormones|mesh-ancestor
25532288|NCT00539305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25532289|NCT00539305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532290|NCT00539305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25532291|NCT00539305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532292|NCT00539305|Anabolic Agents|anabolic agents|mesh-ancestor
25532293|NCT00539500|Carboplatin|carboplatin|mesh-list
25532294|NCT00539500|Etoposide|etoposide|mesh-list
25532295|NCT00539500|Melphalan|melphalan|mesh-list
25532296|NCT00539500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532297|NCT00539500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25532298|NCT00539500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25532299|NCT00539500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25532300|NCT00539500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532301|NCT00539500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532302|NCT00539500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25532303|NCT00539500|Alkylating Agents|alkylating agents|mesh-ancestor
25532304|NCT00539500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25532305|NCT00539500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25532306|NCT00539500|Immunologic Factors|immunologic factors|mesh-ancestor
25532307|NCT00539500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532308|NCT00539513|Acetylcysteine|acetylcysteine|mesh-list
25202952|NCT02717871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25532309|NCT00539513|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25532310|NCT00539513|Antiviral Agents|antiviral agents|mesh-ancestor
25532311|NCT00539513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25532312|NCT00539513|Expectorants|expectorants|mesh-ancestor
25532313|NCT00539513|Respiratory System Agents|respiratory system agents|mesh-ancestor
25532314|NCT00539513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25532315|NCT00539513|Antioxidants|antioxidants|mesh-ancestor
25532316|NCT00539513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532317|NCT00539513|Protective Agents|protective agents|mesh-ancestor
25532318|NCT00539513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532319|NCT00539513|Antidotes|antidotes|mesh-ancestor
25646980|NCT01464879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25646981|NCT01464879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532321|NCT00539526|Travoprost|travoprost|mesh-list
25532322|NCT00539526|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25532323|NCT00539526|Latanoprost|latanoprost|mesh-list
25532324|NCT00539526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25532325|NCT00539526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25532326|NCT00539695|Aldesleukin|aldesleukin|mesh-list
25532327|NCT00539695|Interleukin-2|interleukin-2|mesh-list
25532328|NCT00539695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532329|NCT00539695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25532330|NCT00539695|Analgesics|analgesics|mesh-ancestor
25532331|NCT00539695|Sensory System Agents|sensory system agents|mesh-ancestor
25532332|NCT00539695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25532333|NCT00539695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532334|NCT00539695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25532335|NCT00539695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25532336|NCT00539695|Antiviral Agents|antiviral agents|mesh-ancestor
25532337|NCT00539695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25532338|NCT00539734|Ranibizumab|ranibizumab|mesh-list
25532339|NCT00539734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25532340|NCT00539734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25532341|NCT00539734|Growth Substances|growth substances|mesh-ancestor
25532342|NCT00539734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532343|NCT00539734|Growth Inhibitors|growth inhibitors|mesh-ancestor
25532344|NCT00539734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532345|NCT00539864|Hemagglutinins|hemagglutinins|mesh-list
25532346|NCT00539864|Agglutinins|agglutinins|mesh-ancestor
25532347|NCT00539864|Immunologic Factors|immunologic factors|mesh-ancestor
25532348|NCT00539864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532349|NCT00539942|PENTA|penta|mesh-list
25532350|NCT00539942|Fondaparinux|fondaparinux|mesh-list
25532351|NCT00539942|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25532352|NCT00539942|Antithrombins|antithrombins|mesh-ancestor
25532353|NCT00539942|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25532354|NCT00539942|Protease Inhibitors|protease inhibitors|mesh-ancestor
25532355|NCT00539942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532356|NCT00539942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532357|NCT00539942|Anticoagulants|anticoagulants|mesh-ancestor
25532358|NCT00539942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25532359|NCT00539942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25532360|NCT00539994|Retapamulin|retapamulin|mesh-list
25532361|NCT00539994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25532362|NCT00539994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25532363|NCT00540007|Lenalidomide|lenalidomide|mesh-list
25532364|NCT00540007|Immunologic Factors|immunologic factors|mesh-ancestor
25532365|NCT00540007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532366|NCT00540007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25532367|NCT00540007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25532368|NCT00540007|Growth Substances|growth substances|mesh-ancestor
25532369|NCT00540007|Growth Inhibitors|growth inhibitors|mesh-ancestor
25532370|NCT00540007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532371|NCT00540046|Copper|copper|mesh-list
25532372|NCT00540046|Trace Elements|trace elements|mesh-ancestor
25532373|NCT00540046|Micronutrients|micronutrients|mesh-ancestor
25532374|NCT00540046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532375|NCT00540124|Tadalafil|tadalafil|mesh-list
25532376|NCT00540124|Tamsulosin|tamsulosin|mesh-list
25532377|NCT00540124|Vasodilator Agents|vasodilator agents|mesh-ancestor
25532378|NCT00540124|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25532379|NCT00540124|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25532380|NCT00540124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532381|NCT00540124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532382|NCT00540124|Urological Agents|urological agents|mesh-ancestor
25532383|NCT00540124|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25532384|NCT00540124|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25532385|NCT00540124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25532386|NCT00540124|Adrenergic Agents|adrenergic agents|mesh-ancestor
25532387|NCT00540124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25532388|NCT00540124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532389|NCT00540293|Atorvastatin|atorvastatin|mesh-list
25532390|NCT00540293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25532391|NCT00540293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25532392|NCT00540293|Antimetabolites|antimetabolites|mesh-ancestor
25532393|NCT00540293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532394|NCT00540293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25532395|NCT00540293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25532396|NCT00540293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532397|NCT00540436|Ambrisentan|ambrisentan|mesh-list
25532398|NCT00540436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25532399|NCT00540449|Efavirenz|efavirenz|mesh-list
25532400|NCT00540449|Rilpivirine|rilpivirine|mesh-list
25532401|NCT00540449|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25532402|NCT00540449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25532403|NCT00540449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532404|NCT00540449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532405|NCT00540449|Antiviral Agents|antiviral agents|mesh-ancestor
25532406|NCT00540449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25532407|NCT00540449|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25532408|NCT00540449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25532409|NCT00540449|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25532410|NCT00540449|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25532411|NCT00540449|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25532412|NCT00540449|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25532413|NCT00540449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25532414|NCT00540449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25532415|NCT00540514|Paclitaxel|paclitaxel|mesh-list
25532416|NCT00540514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25532417|NCT00540514|Carboplatin|carboplatin|mesh-list
25532418|NCT00540514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25532419|NCT00540514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532420|NCT00540514|Tubulin Modulators|tubulin modulators|mesh-ancestor
25532421|NCT00540514|Antimitotic Agents|antimitotic agents|mesh-ancestor
25532422|NCT00540514|Mitosis Modulators|mitosis modulators|mesh-ancestor
25532423|NCT00540514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532424|NCT00540579|Gemcitabine|gemcitabine|mesh-list
25532425|NCT00540579|Pomalidomide|pomalidomide|mesh-list
25532426|NCT00540579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25532427|NCT00540579|Antimetabolites|antimetabolites|mesh-ancestor
25532428|NCT00540579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532429|NCT00540579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532430|NCT00540579|Antiviral Agents|antiviral agents|mesh-ancestor
25532431|NCT00540579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25532432|NCT00540579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532433|NCT00540579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25532434|NCT00540579|Immunologic Factors|immunologic factors|mesh-ancestor
25532435|NCT00540579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532436|NCT00540579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25532437|NCT00540579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25532438|NCT00540579|Growth Substances|growth substances|mesh-ancestor
25532439|NCT00540579|Growth Inhibitors|growth inhibitors|mesh-ancestor
25532440|NCT00540644|Prednisone|prednisone|mesh-list
25532441|NCT00540644|Cyclophosphamide|cyclophosphamide|mesh-list
25532442|NCT00540644|Lenalidomide|lenalidomide|mesh-list
25532443|NCT00540644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25532444|NCT00540644|Immunologic Factors|immunologic factors|mesh-ancestor
25532445|NCT00540644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532446|NCT00540644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25532447|NCT00540644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25532448|NCT00540644|Alkylating Agents|alkylating agents|mesh-ancestor
25532449|NCT00540644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532450|NCT00540644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532451|NCT00540644|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25532452|NCT00540644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25532453|NCT00540644|Glucocorticoids|glucocorticoids|mesh-ancestor
25532454|NCT00540644|Hormones|hormones|mesh-ancestor
25532455|NCT00540644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25532456|NCT00540644|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25532457|NCT00540644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25532458|NCT00540644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25532459|NCT00540644|Growth Substances|growth substances|mesh-ancestor
25532460|NCT00540644|Growth Inhibitors|growth inhibitors|mesh-ancestor
25532462|NCT00540722|Retinol acetate|retinol acetate|mesh-list
25532463|NCT00540722|Gossypol acetic acid|gossypol acetic acid|mesh-list
25532465|NCT00540722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25532466|NCT00540722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25532467|NCT00540722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25532468|NCT00540722|Immunologic Factors|immunologic factors|mesh-ancestor
25532469|NCT00540722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532470|NCT00540722|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25532471|NCT00540722|Protective Agents|protective agents|mesh-ancestor
25532472|NCT00540722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532473|NCT00540722|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25532474|NCT00540722|Contraceptive Agents|contraceptive agents|mesh-ancestor
25532475|NCT00540722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25532476|NCT00540722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25532477|NCT00540722|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25532478|NCT00540722|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
25532479|NCT00540722|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
25532480|NCT00540982|Vinorelbine|vinorelbine|mesh-list
25532482|NCT00540982|Anesthetics, Local|anesthetics, local|mesh-ancestor
25532483|NCT00540982|Anesthetics|anesthetics|mesh-ancestor
25532484|NCT00540982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25532485|NCT00540982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532486|NCT00540982|Sensory System Agents|sensory system agents|mesh-ancestor
25532487|NCT00540982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25532488|NCT00540982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25532489|NCT00540982|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25532490|NCT00540982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25532491|NCT00540982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25532492|NCT00540982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532493|NCT00540982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25532494|NCT00540982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532495|NCT00540982|Tubulin Modulators|tubulin modulators|mesh-ancestor
25532496|NCT00540982|Antimitotic Agents|antimitotic agents|mesh-ancestor
25532497|NCT00540982|Mitosis Modulators|mitosis modulators|mesh-ancestor
25532498|NCT00541034|Cyclophosphamide|cyclophosphamide|mesh-list
25532499|NCT00541034|Rituximab|rituximab|mesh-list
25532500|NCT00541034|Pentostatin|pentostatin|mesh-list
25532501|NCT00541034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25532502|NCT00541034|Immunologic Factors|immunologic factors|mesh-ancestor
25532503|NCT00541034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532504|NCT00541034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25532505|NCT00541034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25532506|NCT00541034|Alkylating Agents|alkylating agents|mesh-ancestor
25532507|NCT00541034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532508|NCT00541034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532509|NCT00541034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25532510|NCT00541034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25532511|NCT00541034|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25532512|NCT00541034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532513|NCT00541099|Bevacizumab|bevacizumab|mesh-list
25532514|NCT00541099|Docetaxel|docetaxel|mesh-list
25532515|NCT00541099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25532516|NCT00541099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532517|NCT00541099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25532518|NCT00541099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25532519|NCT00541099|Growth Substances|growth substances|mesh-ancestor
25532520|NCT00541099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532521|NCT00541099|Growth Inhibitors|growth inhibitors|mesh-ancestor
25532522|NCT00541099|Tubulin Modulators|tubulin modulators|mesh-ancestor
25532523|NCT00541099|Antimitotic Agents|antimitotic agents|mesh-ancestor
25532524|NCT00541099|Mitosis Modulators|mitosis modulators|mesh-ancestor
25532525|NCT00541099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823550|NCT00004855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25823551|NCT00004855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25823552|NCT00004855|Protease Inhibitors|protease inhibitors|mesh-ancestor
25823553|NCT00004855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823554|NCT00004855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823555|NCT00004855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25823556|NCT00004855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25823557|NCT00004855|Antiviral Agents|antiviral agents|mesh-ancestor
25532526|NCT00541229|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25532527|NCT00541229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25532528|NCT00541229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532529|NCT00541229|Incretins|incretins|mesh-ancestor
25532530|NCT00541229|Hormones|hormones|mesh-ancestor
25532531|NCT00541229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25532532|NCT00541229|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25532533|NCT00541229|Protease Inhibitors|protease inhibitors|mesh-ancestor
25532534|NCT00541229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532535|NCT00541229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532536|NCT00541242|Bimatoprost|bimatoprost|mesh-list
25532537|NCT00541242|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25532538|NCT00541242|Latanoprost|latanoprost|mesh-list
25532539|NCT00541242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25532540|NCT00541242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25532541|NCT00541307|Heparin|heparin|mesh-list
25532542|NCT00541307|Anticoagulants|anticoagulants|mesh-ancestor
25532543|NCT00541307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25532544|NCT00541307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25532545|NCT00541307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532546|NCT00541346|Methylphenidate|methylphenidate|mesh-list
25532547|NCT00541346|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25532548|NCT00541346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532549|NCT00541346|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25532550|NCT00541346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25532551|NCT00541346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25532552|NCT00541346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532553|NCT00541346|Dopamine Agents|dopamine agents|mesh-ancestor
25532554|NCT00541346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25532555|NCT00541385|Artesunate|artesunate|mesh-list
25532556|NCT00541385|Lumefantrine|lumefantrine|mesh-list
25532557|NCT00541385|Pyronaridine|pyronaridine|mesh-list
25532558|NCT00541385|Antimalarials|antimalarials|mesh-ancestor
25532559|NCT00541385|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25532560|NCT00541385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25532561|NCT00541385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25532562|NCT00541385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532563|NCT00541385|Antiviral Agents|antiviral agents|mesh-ancestor
25532564|NCT00541385|Schistosomicides|schistosomicides|mesh-ancestor
25532565|NCT00541385|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25532566|NCT00541385|Anthelmintics|anthelmintics|mesh-ancestor
25532567|NCT00541450|Metformin|metformin|mesh-list
25532568|NCT00541450|Pioglitazone|pioglitazone|mesh-list
25532569|NCT00541450|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25532570|NCT00541450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25532571|NCT00541450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532572|NCT00541450|Incretins|incretins|mesh-ancestor
25532573|NCT00541450|Hormones|hormones|mesh-ancestor
25532574|NCT00541450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25532575|NCT00541450|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25532576|NCT00541450|Protease Inhibitors|protease inhibitors|mesh-ancestor
25532577|NCT00541450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532578|NCT00541450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532579|NCT00541658|Risedronic Acid|risedronic acid|mesh-list
25532580|NCT00541658|Etidronic Acid|etidronic acid|mesh-list
25532581|NCT00541658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25532582|NCT00541658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25532583|NCT00541658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532584|NCT00541658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25532585|NCT00541658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532586|NCT00541658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25532587|NCT00541671|Promethazine|promethazine|mesh-list
25532588|NCT00541671|Antipruritics|antipruritics|mesh-ancestor
25532589|NCT00541671|Dermatologic Agents|dermatologic agents|mesh-ancestor
25532590|NCT00541671|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25532591|NCT00541671|Histamine Antagonists|histamine antagonists|mesh-ancestor
25532592|NCT00541671|Histamine Agents|histamine agents|mesh-ancestor
25532593|NCT00541671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25532594|NCT00541671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532595|NCT00541671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532596|NCT00541671|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25532597|NCT00541775|Metformin|metformin|mesh-list
25823558|NCT00004855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25823559|NCT00004855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25823560|NCT00004855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25532607|NCT00541775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532608|NCT00541775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532609|NCT00541866|Cytarabine|cytarabine|mesh-list
25532610|NCT00541866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25532611|NCT00541866|Antimetabolites|antimetabolites|mesh-ancestor
25532612|NCT00541866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532613|NCT00541866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532614|NCT00541866|Antiviral Agents|antiviral agents|mesh-ancestor
25532615|NCT00541866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25532616|NCT00541866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25532617|NCT00541866|Immunologic Factors|immunologic factors|mesh-ancestor
25532618|NCT00541866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532620|NCT00541970|Immunologic Factors|immunologic factors|mesh-ancestor
25532621|NCT00541970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532622|NCT00542178|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25532623|NCT00542178|Simvastatin|simvastatin|mesh-list
25532624|NCT00542178|Fenofibrate|fenofibrate|mesh-list
25532625|NCT00542178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25532626|NCT00542178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25532627|NCT00542178|Antimetabolites|antimetabolites|mesh-ancestor
25532628|NCT00542178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532629|NCT00542178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25532630|NCT00542178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25532631|NCT00542178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532632|NCT00542178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532633|NCT00542191|Paclitaxel|paclitaxel|mesh-list
25532634|NCT00542191|Cyclophosphamide|cyclophosphamide|mesh-list
25532635|NCT00542191|Carboplatin|carboplatin|mesh-list
25532636|NCT00542191|Doxorubicin|doxorubicin|mesh-list
25532637|NCT00542191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25532638|NCT00542191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532639|NCT00542191|Tubulin Modulators|tubulin modulators|mesh-ancestor
25532640|NCT00542191|Antimitotic Agents|antimitotic agents|mesh-ancestor
25532641|NCT00542191|Mitosis Modulators|mitosis modulators|mesh-ancestor
25532642|NCT00542191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532643|NCT00542191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25532644|NCT00542191|Immunologic Factors|immunologic factors|mesh-ancestor
25532645|NCT00542191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532646|NCT00542191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25532647|NCT00542191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25532648|NCT00542191|Alkylating Agents|alkylating agents|mesh-ancestor
25532649|NCT00542191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25532650|NCT00542191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25532651|NCT00542191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25532652|NCT00542191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25532653|NCT00542191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823561|NCT00004855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25823562|NCT00004855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25823563|NCT00004855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25823564|NCT00004855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25823565|NCT00004855|Antimetabolites|antimetabolites|mesh-ancestor
25823566|NCT00004856|Trastuzumab|trastuzumab|mesh-list
25823567|NCT00004856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25823568|NCT00004856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823569|NCT00004857|Fludarabine|fludarabine|mesh-list
25532654|NCT00542269|Amlodipine|amlodipine|mesh-list
25532655|NCT00542269|Ramipril|ramipril|mesh-list
25532656|NCT00542269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25532657|NCT00542269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25532658|NCT00542269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25532659|NCT00542269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532660|NCT00542269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25532661|NCT00542269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532662|NCT00542269|Vasodilator Agents|vasodilator agents|mesh-ancestor
25532663|NCT00542269|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25532664|NCT00542269|Protease Inhibitors|protease inhibitors|mesh-ancestor
25532665|NCT00542269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532666|NCT00542308|Zalutumumab|zalutumumab|mesh-list
25532667|NCT00542308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25532668|NCT00542308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532669|NCT00542425|Teriparatide|teriparatide|mesh-list
25532670|NCT00542425|Abaloparatide|abaloparatide|mesh-list
25532671|NCT00542425|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
25532672|NCT00542425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25532673|NCT00542425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532674|NCT00542425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25532675|NCT00542620|Insulin|insulin|mesh-list
25532676|NCT00542620|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25532677|NCT00542620|Insulin Aspart|insulin aspart|mesh-list
25532678|NCT00542620|Insulin, Long-Acting|insulin, long-acting|mesh-list
25532679|NCT00542620|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25532680|NCT00542620|Insulin Detemir|insulin detemir|mesh-list
25532681|NCT00542620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25532682|NCT00542620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532683|NCT00542750|Acetylcysteine|acetylcysteine|mesh-list
25532684|NCT00542750|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25532685|NCT00542750|Antiviral Agents|antiviral agents|mesh-ancestor
25532686|NCT00542750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25532687|NCT00542750|Expectorants|expectorants|mesh-ancestor
25532688|NCT00542750|Respiratory System Agents|respiratory system agents|mesh-ancestor
25532689|NCT00542750|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25532690|NCT00542750|Antioxidants|antioxidants|mesh-ancestor
25532691|NCT00542750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532692|NCT00542750|Protective Agents|protective agents|mesh-ancestor
25532693|NCT00542750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532694|NCT00542750|Antidotes|antidotes|mesh-ancestor
25532695|NCT00542789|Esomeprazole|esomeprazole|mesh-list
25532696|NCT00542789|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25532697|NCT00542789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25532698|NCT00542789|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25532699|NCT00542789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532700|NCT00542789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532701|NCT00542815|Sevelamer|sevelamer|mesh-list
25532702|NCT00542815|Chelating Agents|chelating agents|mesh-ancestor
25532703|NCT00542815|Sequestering Agents|sequestering agents|mesh-ancestor
25532704|NCT00542815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532705|NCT00542828|Immunoglobulins|immunoglobulins|mesh-list
25532706|NCT00542828|Thymoglobulin|thymoglobulin|mesh-list
25532707|NCT00542828|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25532708|NCT00542828|Immunologic Factors|immunologic factors|mesh-ancestor
25532709|NCT00542828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532710|NCT00542828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25532711|NCT00542880|Fluticasone|fluticasone|mesh-list
25532712|NCT00542880|Budesonide|budesonide|mesh-list
25532713|NCT00542880|Formoterol Fumarate|formoterol fumarate|mesh-list
25532714|NCT00542880|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25532715|NCT00542880|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25532716|NCT00542880|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25532717|NCT00542880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25532718|NCT00542880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25532719|NCT00542880|Autonomic Agents|autonomic agents|mesh-ancestor
25532720|NCT00542880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25532721|NCT00542880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532722|NCT00542880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25532723|NCT00542880|Respiratory System Agents|respiratory system agents|mesh-ancestor
25532724|NCT00542880|Dermatologic Agents|dermatologic agents|mesh-ancestor
25532725|NCT00542880|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25532726|NCT00542880|Glucocorticoids|glucocorticoids|mesh-ancestor
25532727|NCT00542880|Hormones|hormones|mesh-ancestor
25532728|NCT00542880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25532729|NCT00542880|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25532730|NCT00542880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25532731|NCT00542880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25532732|NCT00542880|Adrenergic Agents|adrenergic agents|mesh-ancestor
25532733|NCT00542880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25532734|NCT00542880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532735|NCT00542880|Sympathomimetics|sympathomimetics|mesh-ancestor
25532737|NCT00542971|Sorafenib|sorafenib|mesh-list
25532738|NCT00542971|Idarubicin|idarubicin|mesh-list
25532739|NCT00542971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25532740|NCT00542971|Antimetabolites|antimetabolites|mesh-ancestor
25532741|NCT00542971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532742|NCT00542971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532743|NCT00542971|Antiviral Agents|antiviral agents|mesh-ancestor
25532744|NCT00542971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25532745|NCT00542971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25532746|NCT00542971|Immunologic Factors|immunologic factors|mesh-ancestor
25532747|NCT00542971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532748|NCT00542971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25532749|NCT00542971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532750|NCT00542971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25532751|NCT00542971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25532752|NCT00542971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25532753|NCT00542997|Immunoglobulins|immunoglobulins|mesh-list
25532754|NCT00542997|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25532755|NCT00542997|Antibodies|antibodies|mesh-list
25532756|NCT00542997|Immunologic Factors|immunologic factors|mesh-ancestor
25532757|NCT00542997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532758|NCT00543062|Moxifloxacin|moxifloxacin|mesh-list
25532759|NCT00543062|Prochlorperazine|prochlorperazine|mesh-list
25532760|NCT00543062|Loxapine|loxapine|mesh-list
25532761|NCT00543062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25532762|NCT00543062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25532763|NCT00543062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25532764|NCT00543062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25532765|NCT00543062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532766|NCT00543062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532767|NCT00543062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532768|NCT00543062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532769|NCT00543062|Antiemetics|antiemetics|mesh-ancestor
25532770|NCT00543062|Autonomic Agents|autonomic agents|mesh-ancestor
25532771|NCT00543062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25532772|NCT00543062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25532773|NCT00543062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25532774|NCT00543062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25532775|NCT00543062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25532776|NCT00543062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25532777|NCT00543062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25532778|NCT00543062|Dopamine Agents|dopamine agents|mesh-ancestor
25532779|NCT00543062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25532780|NCT00543101|Darunavir|darunavir|mesh-list
25532781|NCT00543101|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25532782|NCT00543101|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25532783|NCT00543101|Protease Inhibitors|protease inhibitors|mesh-ancestor
25532784|NCT00543101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532785|NCT00543101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532786|NCT00543101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25532787|NCT00543101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25532788|NCT00543101|Antiviral Agents|antiviral agents|mesh-ancestor
25532789|NCT00543101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25532790|NCT00543127|Fulvestrant|fulvestrant|mesh-list
25532791|NCT00543127|Anastrozole|anastrozole|mesh-list
25532792|NCT00543127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25532793|NCT00543127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532794|NCT00543127|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25532795|NCT00543127|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25532796|NCT00543127|Hormone Antagonists|hormone antagonists|mesh-ancestor
25532797|NCT00543127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25532798|NCT00543127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532799|NCT00543127|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25532800|NCT00543127|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25532801|NCT00543127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532802|NCT00543127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532803|NCT00543296|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
25532804|NCT00543296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25532805|NCT00543296|Glucocorticoids|glucocorticoids|mesh-ancestor
25532806|NCT00543296|Hormones|hormones|mesh-ancestor
25532807|NCT00543296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25532808|NCT00543296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532809|NCT00543309|Milrinone|milrinone|mesh-list
25532810|NCT00543309|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25532811|NCT00543309|Natriuretic Agents|natriuretic agents|mesh-ancestor
25532812|NCT00543309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532813|NCT00543309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25532814|NCT00543309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25532815|NCT00543309|Vasodilator Agents|vasodilator agents|mesh-ancestor
25532816|NCT00543309|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25532817|NCT00543309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25532818|NCT00543309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532819|NCT00543309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532820|NCT00543309|Protective Agents|protective agents|mesh-ancestor
25532821|NCT00543387|Docetaxel|docetaxel|mesh-list
25532822|NCT00543387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532823|NCT00543387|Tubulin Modulators|tubulin modulators|mesh-ancestor
25532824|NCT00543387|Antimitotic Agents|antimitotic agents|mesh-ancestor
25532825|NCT00543387|Mitosis Modulators|mitosis modulators|mesh-ancestor
25532826|NCT00543387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532827|NCT00543400|Heparin|heparin|mesh-list
25532828|NCT00543400|Calcium heparin|calcium heparin|mesh-list
25532829|NCT00543400|Anticoagulants|anticoagulants|mesh-ancestor
25532830|NCT00543400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25532831|NCT00543400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25532832|NCT00543400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532833|NCT00543439|Factor VIII|factor viii|mesh-list
25646983|NCT01464931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25646984|NCT01464931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646985|NCT01465022|Estrogens|estrogens|mesh-list
25646986|NCT01465022|Progestins|progestins|mesh-list
25646987|NCT01465022|Hormones|hormones|mesh-ancestor
25646988|NCT01465022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25646989|NCT01465022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646990|NCT01465178|Cholecalciferol|cholecalciferol|mesh-list
25646991|NCT01465178|Vitamin D|vitamin d|mesh-list
25646992|NCT01465178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25532834|NCT00543439|Coagulants|coagulants|mesh-ancestor
25532835|NCT00543569|Mycophenolic Acid|mycophenolic acid|mesh-list
25532836|NCT00543569|Alefacept|alefacept|mesh-list
25532837|NCT00543569|Tacrolimus|tacrolimus|mesh-list
25532838|NCT00543569|Basiliximab|basiliximab|mesh-list
25532839|NCT00543569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25532840|NCT00543569|Immunologic Factors|immunologic factors|mesh-ancestor
25532841|NCT00543569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532842|NCT00543569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25532843|NCT00543569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532844|NCT00543569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532845|NCT00543569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25532846|NCT00543569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532847|NCT00543569|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25532848|NCT00543569|Antitubercular Agents|antitubercular agents|mesh-ancestor
25532849|NCT00543569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25532850|NCT00543569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25532851|NCT00543569|Dermatologic Agents|dermatologic agents|mesh-ancestor
25532852|NCT00543725|Efavirenz|efavirenz|mesh-list
25532853|NCT00543725|Rilpivirine|rilpivirine|mesh-list
25532854|NCT00543725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25532855|NCT00543725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25532856|NCT00543725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532857|NCT00543725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532858|NCT00543725|Antiviral Agents|antiviral agents|mesh-ancestor
25532859|NCT00543725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25532860|NCT00543725|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25532861|NCT00543725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25532862|NCT00543725|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25532863|NCT00543725|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25532864|NCT00543725|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25532865|NCT00543725|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25532866|NCT00543725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25532867|NCT00543725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25532868|NCT00543855|Donepezil|donepezil|mesh-list
25532869|NCT00543855|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25532870|NCT00543855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532871|NCT00543855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532872|NCT00543855|Cholinergic Agents|cholinergic agents|mesh-ancestor
25532873|NCT00543855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25532874|NCT00543855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532875|NCT00543855|Nootropic Agents|nootropic agents|mesh-ancestor
25532876|NCT00544076|Sildenafil Citrate|sildenafil citrate|mesh-list
25532877|NCT00544076|Alprostadil|alprostadil|mesh-list
25532878|NCT00544076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532879|NCT00544076|Vasodilator Agents|vasodilator agents|mesh-ancestor
25532880|NCT00544076|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25532881|NCT00544076|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25532882|NCT00544076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532883|NCT00544076|Urological Agents|urological agents|mesh-ancestor
25532884|NCT00544076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25532886|NCT00544167|Cyclophosphamide|cyclophosphamide|mesh-list
25532887|NCT00544167|Doxorubicin|doxorubicin|mesh-list
25532888|NCT00544167|Sorafenib|sorafenib|mesh-list
25532889|NCT00544167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25532890|NCT00544167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532891|NCT00544167|Tubulin Modulators|tubulin modulators|mesh-ancestor
25532892|NCT00544167|Antimitotic Agents|antimitotic agents|mesh-ancestor
25532893|NCT00544167|Mitosis Modulators|mitosis modulators|mesh-ancestor
25532894|NCT00544167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532895|NCT00544167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25532896|NCT00544167|Immunologic Factors|immunologic factors|mesh-ancestor
25532897|NCT00544167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532898|NCT00544167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25532899|NCT00544167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25532900|NCT00544167|Alkylating Agents|alkylating agents|mesh-ancestor
25532901|NCT00544167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25532902|NCT00544167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25532903|NCT00544167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25532904|NCT00544167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25532905|NCT00544167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532906|NCT00544167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25532907|NCT00544440|Prednisone|prednisone|mesh-list
25532908|NCT00544440|Abiraterone Acetate|abiraterone acetate|mesh-list
25532909|NCT00544440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25532910|NCT00544440|Glucocorticoids|glucocorticoids|mesh-ancestor
25532911|NCT00544440|Hormones|hormones|mesh-ancestor
25532912|NCT00544440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25532913|NCT00544440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532914|NCT00544440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25532915|NCT00544440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532916|NCT00544440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25532917|NCT00544440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532918|NCT00544440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532919|NCT00544440|Hormone Antagonists|hormone antagonists|mesh-ancestor
25532920|NCT00544440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25532921|NCT00544544|Riluzole|riluzole|mesh-list
25532922|NCT00544544|Anticonvulsants|anticonvulsants|mesh-ancestor
25532923|NCT00544544|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25532924|NCT00544544|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25532925|NCT00544544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25532926|NCT00544544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532927|NCT00544544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532928|NCT00544544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25532929|NCT00544544|Protective Agents|protective agents|mesh-ancestor
25532930|NCT00544557|Etanercept|etanercept|mesh-list
25532931|NCT00544557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25532932|NCT00544557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25532933|NCT00544557|Analgesics|analgesics|mesh-ancestor
25532934|NCT00544557|Sensory System Agents|sensory system agents|mesh-ancestor
25532935|NCT00544557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25532936|NCT00544557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532937|NCT00544557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25532938|NCT00544557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25532939|NCT00544557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25532940|NCT00544557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25532941|NCT00544557|Immunologic Factors|immunologic factors|mesh-ancestor
25532942|NCT00544648|Paclitaxel|paclitaxel|mesh-list
25532943|NCT00544648|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25532944|NCT00544648|Carboplatin|carboplatin|mesh-list
25532945|NCT00544648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25532946|NCT00544648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532947|NCT00544648|Tubulin Modulators|tubulin modulators|mesh-ancestor
25532948|NCT00544648|Antimitotic Agents|antimitotic agents|mesh-ancestor
25532949|NCT00544648|Mitosis Modulators|mitosis modulators|mesh-ancestor
25532950|NCT00544648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823570|NCT00004857|Fludarabine phosphate|fludarabine phosphate|mesh-list
25532951|NCT00544713|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25532952|NCT00544713|Lubricant Eye Drops|lubricant eye drops|mesh-list
25532953|NCT00544713|Glycerol|glycerol|mesh-list
25532954|NCT00544713|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25532955|NCT00544713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25532956|NCT00544713|Laxatives|laxatives|mesh-ancestor
25532957|NCT00544713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25532958|NCT00544713|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25532959|NCT00544713|Protective Agents|protective agents|mesh-ancestor
25532960|NCT00544713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532961|NCT00544778|Doxorubicin|doxorubicin|mesh-list
25532962|NCT00544778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25532963|NCT00544778|Dexrazoxane|dexrazoxane|mesh-list
25532964|NCT00544778|Irinotecan|irinotecan|mesh-list
25532965|NCT00544778|Ifosfamide|ifosfamide|mesh-list
25532966|NCT00544778|Razoxane|razoxane|mesh-list
25532967|NCT00544778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25532968|NCT00544778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532969|NCT00544778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25532970|NCT00544778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25532971|NCT00544778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408475|NCT03437746|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25646993|NCT01465178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25646994|NCT01465178|Vitamins|vitamins|mesh-ancestor
25646995|NCT01465178|Micronutrients|micronutrients|mesh-ancestor
25646996|NCT01465178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25646997|NCT01465191|Morphine|morphine|mesh-list
25646998|NCT01465191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25646999|NCT01465191|Narcotics|narcotics|mesh-ancestor
25647000|NCT01465191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25532972|NCT00544778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532973|NCT00544778|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25532974|NCT00544778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532975|NCT00544778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25532976|NCT00544778|Alkylating Agents|alkylating agents|mesh-ancestor
25532977|NCT00544778|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25532978|NCT00544778|Protective Agents|protective agents|mesh-ancestor
25532979|NCT00544778|Antimitotic Agents|antimitotic agents|mesh-ancestor
25532980|NCT00544778|Mitosis Modulators|mitosis modulators|mesh-ancestor
25647001|NCT01465191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532981|NCT00544817|Temozolomide|temozolomide|mesh-list
25532982|NCT00544817|Sorafenib|sorafenib|mesh-list
25532983|NCT00544817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25532984|NCT00544817|Alkylating Agents|alkylating agents|mesh-ancestor
25532985|NCT00544817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532986|NCT00544817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25532987|NCT00544817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25532988|NCT00544817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25532989|NCT00544869|Tolvaptan|tolvaptan|mesh-list
25532990|NCT00544869|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25532991|NCT00544869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25532992|NCT00544869|Natriuretic Agents|natriuretic agents|mesh-ancestor
25532993|NCT00544869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25532994|NCT00544882|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25532995|NCT00544882|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25532996|NCT00544882|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25532997|NCT00544882|Desogestrel|desogestrel|mesh-list
25532998|NCT00544882|Oviol|oviol|mesh-list
25532999|NCT00544882|Estradiol|estradiol|mesh-list
25533000|NCT00544882|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25533001|NCT00544882|Estrogens|estrogens|mesh-ancestor
25533002|NCT00544882|Hormones|hormones|mesh-ancestor
25533003|NCT00544882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25533004|NCT00544882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533005|NCT00544882|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25533006|NCT00544882|Contraceptive Agents|contraceptive agents|mesh-ancestor
25533007|NCT00544882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25533008|NCT00544882|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25533009|NCT00544882|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25533010|NCT00544882|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25533011|NCT00544882|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25533012|NCT00544882|Progestins|progestins|mesh-ancestor
25533013|NCT00544882|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25533014|NCT00544908|Dasatinib|dasatinib|mesh-list
25533015|NCT00544908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533016|NCT00544908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25533017|NCT00544908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533018|NCT00544908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533019|NCT00545051|Ibandronic Acid|ibandronic acid|mesh-list
25533020|NCT00545051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25533021|NCT00545051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533022|NCT00545064|Timolol|timolol|mesh-list
25533023|NCT00545064|Dorzolamide|dorzolamide|mesh-list
25533024|NCT00545064|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25533025|NCT00545064|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25823571|NCT00004857|Alemtuzumab|alemtuzumab|mesh-list
25533026|NCT00545064|Adrenergic Agents|adrenergic agents|mesh-ancestor
25533027|NCT00545064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25533028|NCT00545064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533029|NCT00545064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533030|NCT00545064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25533031|NCT00545064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25533032|NCT00545064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533033|NCT00545064|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25533034|NCT00545077|Bevacizumab|bevacizumab|mesh-list
25533035|NCT00545077|Letrozole|letrozole|mesh-list
25533036|NCT00545077|Fulvestrant|fulvestrant|mesh-list
25647002|NCT01465191|Analgesics|analgesics|mesh-ancestor
25647003|NCT01465191|Sensory System Agents|sensory system agents|mesh-ancestor
25647004|NCT01465191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25647005|NCT01465347|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
25823572|NCT00004857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533037|NCT00545077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25533038|NCT00545077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533039|NCT00545077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25533040|NCT00545077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25533041|NCT00545077|Growth Substances|growth substances|mesh-ancestor
25533042|NCT00545077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533043|NCT00545077|Growth Inhibitors|growth inhibitors|mesh-ancestor
25533044|NCT00545077|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25533045|NCT00545077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25533046|NCT00545077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533047|NCT00545077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533048|NCT00545077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25533049|NCT00545077|Hormone Antagonists|hormone antagonists|mesh-ancestor
25533050|NCT00545077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25533051|NCT00545077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25533052|NCT00545077|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25533053|NCT00545103|Mesalamine|mesalamine|mesh-list
25533054|NCT00545103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25533055|NCT00545103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25533056|NCT00545103|Analgesics|analgesics|mesh-ancestor
25533057|NCT00545103|Sensory System Agents|sensory system agents|mesh-ancestor
25533058|NCT00545103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25533059|NCT00545103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533060|NCT00545103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25533061|NCT00545103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25533062|NCT00545168|Permethrin|permethrin|mesh-list
25533063|NCT00545168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533064|NCT00545168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533065|NCT00545181|Metronidazole|metronidazole|mesh-list
25533066|NCT00545181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25533067|NCT00545181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25533068|NCT00545181|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25533069|NCT00545181|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25533070|NCT00545233|Pioglitazone|pioglitazone|mesh-list
25533071|NCT00545233|Ribavirin|ribavirin|mesh-list
25533072|NCT00545233|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25533073|NCT00545233|Antimetabolites|antimetabolites|mesh-ancestor
25533074|NCT00545233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533075|NCT00545233|Antiviral Agents|antiviral agents|mesh-ancestor
25533076|NCT00545233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25533077|NCT00545233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25533078|NCT00545233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533079|NCT00545272|Formoterol Fumarate|formoterol fumarate|mesh-list
25533080|NCT00545272|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25533081|NCT00545272|Autonomic Agents|autonomic agents|mesh-ancestor
25533082|NCT00545272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25533083|NCT00545272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533084|NCT00545272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25533085|NCT00545272|Respiratory System Agents|respiratory system agents|mesh-ancestor
25533086|NCT00545272|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25533087|NCT00545272|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25533088|NCT00545272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25533089|NCT00545272|Adrenergic Agents|adrenergic agents|mesh-ancestor
25533090|NCT00545272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25533091|NCT00545272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533092|NCT00545298|Nitric Oxide|nitric oxide|mesh-list
25533093|NCT00545298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25533094|NCT00545298|Autonomic Agents|autonomic agents|mesh-ancestor
25533095|NCT00545298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25533096|NCT00545298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533097|NCT00545298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25533098|NCT00545298|Respiratory System Agents|respiratory system agents|mesh-ancestor
25533099|NCT00545298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25533100|NCT00545298|Antioxidants|antioxidants|mesh-ancestor
25533101|NCT00545298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533102|NCT00545298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25533103|NCT00545298|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25533104|NCT00545298|Vasodilator Agents|vasodilator agents|mesh-ancestor
25533105|NCT00545298|Gasotransmitters|gasotransmitters|mesh-ancestor
25533106|NCT00545298|Protective Agents|protective agents|mesh-ancestor
25533107|NCT00545363|Ibandronic Acid|ibandronic acid|mesh-list
25533108|NCT00545363|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25533109|NCT00545363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533110|NCT00545402|Mycophenolic Acid|mycophenolic acid|mesh-list
25533111|NCT00545402|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25533112|NCT00545402|Tacrolimus|tacrolimus|mesh-list
25533113|NCT00545402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25533114|NCT00545402|Immunologic Factors|immunologic factors|mesh-ancestor
25533115|NCT00545402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533116|NCT00545402|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25533117|NCT00545402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533118|NCT00545402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533119|NCT00545402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25533120|NCT00545402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533121|NCT00545402|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25533122|NCT00545402|Antitubercular Agents|antitubercular agents|mesh-ancestor
25533123|NCT00545402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25533124|NCT00545402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25533125|NCT00545402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25533126|NCT00545402|Glucocorticoids|glucocorticoids|mesh-ancestor
25533127|NCT00545402|Hormones|hormones|mesh-ancestor
25533128|NCT00545402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25533129|NCT00545402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25533130|NCT00545402|Protective Agents|protective agents|mesh-ancestor
25533131|NCT00545402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25533132|NCT00545532|Oseltamivir|oseltamivir|mesh-list
25533133|NCT00545532|Antiviral Agents|antiviral agents|mesh-ancestor
25533134|NCT00545532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25533135|NCT00545532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533136|NCT00545532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533137|NCT00545571|Epoetin Alfa|epoetin alfa|mesh-list
25533138|NCT00545571|Hematinics|hematinics|mesh-ancestor
25533139|NCT00545584|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25533140|NCT00545584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25533141|NCT00545584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533142|NCT00545584|Incretins|incretins|mesh-ancestor
25533143|NCT00545584|Hormones|hormones|mesh-ancestor
25533144|NCT00545584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25533145|NCT00545584|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25533146|NCT00545584|Protease Inhibitors|protease inhibitors|mesh-ancestor
25533147|NCT00545584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533148|NCT00545584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533149|NCT00545662|Choline|choline|mesh-list
25533150|NCT00545662|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
25533151|NCT00545662|Lipotropic Agents|lipotropic agents|mesh-ancestor
25533152|NCT00545662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25533153|NCT00545662|Antimetabolites|antimetabolites|mesh-ancestor
25533154|NCT00545662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533155|NCT00545662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25533156|NCT00545662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25533157|NCT00545662|Nootropic Agents|nootropic agents|mesh-ancestor
25533158|NCT00545688|Docetaxel|docetaxel|mesh-list
25533159|NCT00545688|Trastuzumab|trastuzumab|mesh-list
25533160|NCT00545688|Pertuzumab|pertuzumab|mesh-list
25533161|NCT00545688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533162|NCT00545688|Tubulin Modulators|tubulin modulators|mesh-ancestor
25533163|NCT00545688|Antimitotic Agents|antimitotic agents|mesh-ancestor
25533164|NCT00545688|Mitosis Modulators|mitosis modulators|mesh-ancestor
25533165|NCT00545688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533166|NCT00545688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25533167|NCT00545714|Cyclophosphamide|cyclophosphamide|mesh-list
25533168|NCT00545714|Rituximab|rituximab|mesh-list
25533169|NCT00545714|Fludarabine|fludarabine|mesh-list
25533170|NCT00545714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25533171|NCT00545714|Immunologic Factors|immunologic factors|mesh-ancestor
25533172|NCT00545714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533173|NCT00545714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25533174|NCT00545714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25533175|NCT00545714|Alkylating Agents|alkylating agents|mesh-ancestor
25533176|NCT00545714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533177|NCT00545714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533178|NCT00545714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25533179|NCT00545714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25533180|NCT00545740|Mesalamine|mesalamine|mesh-list
25533181|NCT00545740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25533182|NCT00545740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25533183|NCT00545740|Analgesics|analgesics|mesh-ancestor
25533184|NCT00545740|Sensory System Agents|sensory system agents|mesh-ancestor
25533185|NCT00545740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25533186|NCT00545740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533187|NCT00545740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25533188|NCT00545740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25533189|NCT00545753|Permethrin|permethrin|mesh-list
25533190|NCT00545753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533191|NCT00545753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533192|NCT00545779|Ibandronic Acid|ibandronic acid|mesh-list
25533193|NCT00545779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25533194|NCT00545779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533195|NCT00545792|Bevacizumab|bevacizumab|mesh-list
25533196|NCT00545792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25533197|NCT00545792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533198|NCT00545792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25533199|NCT00545792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25533200|NCT00545792|Growth Substances|growth substances|mesh-ancestor
25533201|NCT00545792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533202|NCT00545792|Growth Inhibitors|growth inhibitors|mesh-ancestor
25533203|NCT00545948|Cisplatin|cisplatin|mesh-list
25533204|NCT00545948|Pemetrexed|pemetrexed|mesh-list
25533205|NCT00545948|Vinorelbine|vinorelbine|mesh-list
25533206|NCT00545948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533207|NCT00545948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533208|NCT00545948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533209|NCT00545948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25533210|NCT00545948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25533211|NCT00545948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25533212|NCT00545948|Tubulin Modulators|tubulin modulators|mesh-ancestor
25533213|NCT00545948|Antimitotic Agents|antimitotic agents|mesh-ancestor
25533214|NCT00545948|Mitosis Modulators|mitosis modulators|mesh-ancestor
25533215|NCT00545974|Memantine|memantine|mesh-list
25533216|NCT00545974|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25533217|NCT00545974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25533218|NCT00545974|Dopamine Agents|dopamine agents|mesh-ancestor
25533219|NCT00545974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25533220|NCT00545974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533221|NCT00545974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533222|NCT00545974|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25533223|NCT00545974|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25533224|NCT00546000|Fluticasone|fluticasone|mesh-list
25533225|NCT00546000|Xhance|xhance|mesh-list
25533226|NCT00546000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25533227|NCT00546000|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25533228|NCT00546000|Autonomic Agents|autonomic agents|mesh-ancestor
25533229|NCT00546000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25533230|NCT00546000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533231|NCT00546000|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25533232|NCT00546000|Respiratory System Agents|respiratory system agents|mesh-ancestor
25533233|NCT00546000|Dermatologic Agents|dermatologic agents|mesh-ancestor
25533234|NCT00546000|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25533235|NCT00546078|Vaccines|vaccines|mesh-list
25533236|NCT00546078|Immunologic Factors|immunologic factors|mesh-ancestor
25533237|NCT00546078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533238|NCT00546104|Dasatinib|dasatinib|mesh-list
25533239|NCT00546104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533240|NCT00546104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25533241|NCT00546104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533242|NCT00546104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533243|NCT00546117|Lansoprazole|lansoprazole|mesh-list
25533244|NCT00546117|Dexlansoprazole|dexlansoprazole|mesh-list
25533245|NCT00546117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25533246|NCT00546117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25533247|NCT00546117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25533248|NCT00546117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533249|NCT00546117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823573|NCT00004857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25533250|NCT00546156|Paclitaxel|paclitaxel|mesh-list
25533251|NCT00546156|Cyclophosphamide|cyclophosphamide|mesh-list
25533252|NCT00546156|Bevacizumab|bevacizumab|mesh-list
25533253|NCT00546156|Doxorubicin|doxorubicin|mesh-list
25533254|NCT00546156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25533255|NCT00546156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533256|NCT00546156|Tubulin Modulators|tubulin modulators|mesh-ancestor
25533257|NCT00546156|Antimitotic Agents|antimitotic agents|mesh-ancestor
25533258|NCT00546156|Mitosis Modulators|mitosis modulators|mesh-ancestor
25533259|NCT00546156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533260|NCT00546156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25533261|NCT00546156|Immunologic Factors|immunologic factors|mesh-ancestor
25533262|NCT00546156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533263|NCT00546156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25533264|NCT00546156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25533265|NCT00546156|Alkylating Agents|alkylating agents|mesh-ancestor
25533266|NCT00546156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25533267|NCT00546156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25533268|NCT00546156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25533269|NCT00546156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25533270|NCT00546156|Growth Substances|growth substances|mesh-ancestor
25533271|NCT00546156|Growth Inhibitors|growth inhibitors|mesh-ancestor
25533272|NCT00546156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25533273|NCT00546156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25533274|NCT00546156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25533275|NCT00546156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533277|NCT00546351|Anticonvulsants|anticonvulsants|mesh-ancestor
25533278|NCT00546351|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25533279|NCT00546351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25533280|NCT00546351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25533281|NCT00546351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533282|NCT00546364|Docetaxel|docetaxel|mesh-list
25533283|NCT00546364|Capecitabine|capecitabine|mesh-list
25533284|NCT00546364|Epothilones|epothilones|mesh-list
25533285|NCT00546364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533286|NCT00546364|Tubulin Modulators|tubulin modulators|mesh-ancestor
25533287|NCT00546364|Antimitotic Agents|antimitotic agents|mesh-ancestor
25533288|NCT00546364|Mitosis Modulators|mitosis modulators|mesh-ancestor
25533289|NCT00546364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533290|NCT00546364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25533291|NCT00546364|Antimetabolites|antimetabolites|mesh-ancestor
25533292|NCT00546377|Cyclophosphamide|cyclophosphamide|mesh-list
25533293|NCT00546377|Rituximab|rituximab|mesh-list
25533294|NCT00546377|Mitoxantrone|mitoxantrone|mesh-list
25533295|NCT00546377|Pentostatin|pentostatin|mesh-list
25533296|NCT00546377|Sargramostim|sargramostim|mesh-list
25533297|NCT00546377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25533298|NCT00546377|Immunologic Factors|immunologic factors|mesh-ancestor
25533299|NCT00546377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533300|NCT00546377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25533301|NCT00546377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25533302|NCT00546377|Alkylating Agents|alkylating agents|mesh-ancestor
25533303|NCT00546377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533304|NCT00546377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533305|NCT00546377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25533306|NCT00546377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25533307|NCT00546377|Analgesics|analgesics|mesh-ancestor
25533308|NCT00546377|Sensory System Agents|sensory system agents|mesh-ancestor
25533309|NCT00546377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25533310|NCT00546377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25533311|NCT00546377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25533312|NCT00546377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533313|NCT00546377|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25533314|NCT00546481|Epoetin Alfa|epoetin alfa|mesh-list
25533315|NCT00546481|Hematinics|hematinics|mesh-ancestor
25533316|NCT00546572|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25533317|NCT00546572|Immunologic Factors|immunologic factors|mesh-ancestor
25533318|NCT00546572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533319|NCT00546637|Fesoterodine|fesoterodine|mesh-list
25533320|NCT00546637|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25533321|NCT00546637|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25533322|NCT00546637|Cholinergic Agents|cholinergic agents|mesh-ancestor
25533323|NCT00546637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25533324|NCT00546637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533338|NCT00546871|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25533339|NCT00546871|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25533340|NCT00546871|Immunologic Factors|immunologic factors|mesh-ancestor
25533341|NCT00546871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533342|NCT00546897|Lenalidomide|lenalidomide|mesh-list
25533343|NCT00546897|Immunologic Factors|immunologic factors|mesh-ancestor
25533344|NCT00546897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533345|NCT00546897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25533346|NCT00546897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25533347|NCT00546897|Growth Substances|growth substances|mesh-ancestor
25533348|NCT00546897|Growth Inhibitors|growth inhibitors|mesh-ancestor
25533349|NCT00546897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533350|NCT00546910|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25533351|NCT00546910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25533352|NCT00546910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25533353|NCT00546910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25533354|NCT00546910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533355|NCT00546910|Adrenergic Agents|adrenergic agents|mesh-ancestor
25533356|NCT00546910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25533357|NCT00546910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533358|NCT00547105|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25533359|NCT00547105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533360|NCT00547105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25533361|NCT00547105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533362|NCT00547105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533363|NCT00547118|Rimonabant|rimonabant|mesh-list
25533364|NCT00547118|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25533365|NCT00547118|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
25533366|NCT00547118|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25533367|NCT00547118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25533368|NCT00547118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533369|NCT00547118|Hormones|hormones|mesh-ancestor
25533370|NCT00547118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25533371|NCT00547118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533372|NCT00547157|Cisplatin|cisplatin|mesh-list
25533373|NCT00547157|Panitumumab|panitumumab|mesh-list
25533374|NCT00547157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533375|NCT00547157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25533376|NCT00547248|Vaccines|vaccines|mesh-list
25533377|NCT00547248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25533378|NCT00547248|Immunologic Factors|immunologic factors|mesh-ancestor
25533379|NCT00547248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533380|NCT00547365|Immunoglobulins|immunoglobulins|mesh-list
25533381|NCT00547365|Antibodies|antibodies|mesh-list
25533382|NCT00547365|gamma-Globulins|gamma-globulins|mesh-list
25533383|NCT00547365|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25533384|NCT00547365|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25533385|NCT00547365|Immunologic Factors|immunologic factors|mesh-ancestor
25533386|NCT00547365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823574|NCT00004857|Antimetabolites|antimetabolites|mesh-ancestor
25533388|NCT00547521|Abatacept|abatacept|mesh-list
25533389|NCT00547521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25533390|NCT00547521|Abortifacient Agents|abortifacient agents|mesh-ancestor
25533391|NCT00547521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25533392|NCT00547521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533393|NCT00547521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25533394|NCT00547521|Antimetabolites|antimetabolites|mesh-ancestor
25533395|NCT00547521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533396|NCT00547521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533397|NCT00547521|Dermatologic Agents|dermatologic agents|mesh-ancestor
25533398|NCT00547521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533399|NCT00547521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25533400|NCT00547521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25533401|NCT00547521|Immunologic Factors|immunologic factors|mesh-ancestor
25533402|NCT00547521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25533403|NCT00547521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25533404|NCT00547521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25533405|NCT00547534|Rituximab|rituximab|mesh-list
25533406|NCT00547534|Bortezomib|bortezomib|mesh-list
25533407|NCT00547534|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25533408|NCT00547534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25533409|NCT00547534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533410|NCT00547534|Immunologic Factors|immunologic factors|mesh-ancestor
25533411|NCT00547534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533412|NCT00547534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25533413|NCT00547534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25533414|NCT00547534|Alkylating Agents|alkylating agents|mesh-ancestor
25408476|NCT03437746|Prednisolone|prednisolone|mesh-list
25533415|NCT00547534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533416|NCT00547586|Bromides|bromides|mesh-list
25533417|NCT00547586|Methylnaltrexone|methylnaltrexone|mesh-list
25533418|NCT00547586|Anticonvulsants|anticonvulsants|mesh-ancestor
25533419|NCT00547586|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25533420|NCT00547586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533421|NCT00547586|Sensory System Agents|sensory system agents|mesh-ancestor
25533422|NCT00547586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25533423|NCT00547703|Nortriptyline|nortriptyline|mesh-list
25533424|NCT00547703|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25533425|NCT00547703|Antidepressive Agents|antidepressive agents|mesh-ancestor
25533426|NCT00547703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25533427|NCT00547703|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25533428|NCT00547703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25533429|NCT00547703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25533430|NCT00547703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533431|NCT00547703|Adrenergic Agents|adrenergic agents|mesh-ancestor
25533432|NCT00547703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25533433|NCT00547703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533434|NCT00547911|Carbidopa|carbidopa|mesh-list
25533435|NCT00547911|Entacapone|entacapone|mesh-list
25533436|NCT00547911|Droxidopa|droxidopa|mesh-list
25533437|NCT00547911|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25533438|NCT00547911|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25533439|NCT00547911|Dopamine Agents|dopamine agents|mesh-ancestor
25533440|NCT00547911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25533441|NCT00547911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533442|NCT00547911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533443|NCT00547911|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25533444|NCT00547911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533445|NCT00547911|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25533446|NCT00548132|Chlorhexidine|chlorhexidine|mesh-list
25533447|NCT00548132|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25533448|NCT00548132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25533449|NCT00548132|Disinfectants|disinfectants|mesh-ancestor
25533450|NCT00548145|Ezetimibe|ezetimibe|mesh-list
25533451|NCT00548145|Pitavastatin|pitavastatin|mesh-list
25533452|NCT00548145|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25533453|NCT00548145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25533454|NCT00548145|Antimetabolites|antimetabolites|mesh-ancestor
25533455|NCT00548145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533456|NCT00548145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25823575|NCT00004857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823576|NCT00004857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25823577|NCT00004857|Immunologic Factors|immunologic factors|mesh-ancestor
25823578|NCT00004857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533457|NCT00548145|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25533458|NCT00548145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533460|NCT00548184|Lapatinib|lapatinib|mesh-list
25533461|NCT00548184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25533462|NCT00548184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533463|NCT00548184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25533464|NCT00548184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533465|NCT00548184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533466|NCT00548197|Bevacizumab|bevacizumab|mesh-list
25533467|NCT00548197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25533468|NCT00548197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533469|NCT00548197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25533470|NCT00548197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25533471|NCT00548197|Growth Substances|growth substances|mesh-ancestor
25533472|NCT00548197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533473|NCT00548197|Growth Inhibitors|growth inhibitors|mesh-ancestor
25533474|NCT00548249|Iron|iron|mesh-list
25533475|NCT00548249|Trace Elements|trace elements|mesh-ancestor
25533476|NCT00548249|Micronutrients|micronutrients|mesh-ancestor
25533477|NCT00548249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533478|NCT00548262|Voriconazole|voriconazole|mesh-list
25533479|NCT00548262|Anidulafungin|anidulafungin|mesh-list
25533480|NCT00548262|Antifungal Agents|antifungal agents|mesh-ancestor
25533481|NCT00548262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25533482|NCT00548262|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25533483|NCT00548262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25533484|NCT00548262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533485|NCT00548262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533486|NCT00548262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25647006|NCT01465347|Antioxidants|antioxidants|mesh-ancestor
25823579|NCT00004857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25647007|NCT01465347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647008|NCT01465347|Protective Agents|protective agents|mesh-ancestor
25647009|NCT01465347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647010|NCT01465347|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25647011|NCT01465347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647012|NCT01465386|Bortezomib|bortezomib|mesh-list
25533487|NCT00548262|Hormone Antagonists|hormone antagonists|mesh-ancestor
25533488|NCT00548262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25533489|NCT00548262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533490|NCT00548262|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25533491|NCT00548405|Interferons|interferons|mesh-list
25533492|NCT00548405|Interferon-beta|interferon-beta|mesh-list
25533493|NCT00548405|Interferon beta-1a|interferon beta-1a|mesh-list
25533494|NCT00548405|Alemtuzumab|alemtuzumab|mesh-list
25533495|NCT00548405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533496|NCT00548405|Antiviral Agents|antiviral agents|mesh-ancestor
25533497|NCT00548405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25533498|NCT00548405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25533499|NCT00548405|Immunologic Factors|immunologic factors|mesh-ancestor
25533500|NCT00548405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533501|NCT00548405|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25533502|NCT00548418|Bevacizumab|bevacizumab|mesh-list
25533503|NCT00548418|Cisplatin|cisplatin|mesh-list
25533504|NCT00548418|Topotecan|topotecan|mesh-list
25533505|NCT00548418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25533506|NCT00548418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533507|NCT00548418|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25533508|NCT00548418|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25533509|NCT00548418|Growth Substances|growth substances|mesh-ancestor
25533510|NCT00548418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533511|NCT00548418|Growth Inhibitors|growth inhibitors|mesh-ancestor
25533512|NCT00548418|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25533513|NCT00548418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25533514|NCT00548418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533515|NCT00548418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533516|NCT00548431|Mercaptopurine|mercaptopurine|mesh-list
25533517|NCT00548431|Antimetabolites|antimetabolites|mesh-ancestor
25533518|NCT00548431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533519|NCT00548431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25533520|NCT00548431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533521|NCT00548431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25533522|NCT00548431|Immunologic Factors|immunologic factors|mesh-ancestor
25533523|NCT00548431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533524|NCT00548431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25533525|NCT00548431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533526|NCT00548470|Varenicline|varenicline|mesh-list
25533527|NCT00548470|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25533528|NCT00548470|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25533529|NCT00548470|Cholinergic Agents|cholinergic agents|mesh-ancestor
24650215|NCT01224509|Luteolytic Agents|luteolytic agents|mesh-ancestor
25533530|NCT00548470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25533531|NCT00548470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533532|NCT00548470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533533|NCT00548548|Bevacizumab|bevacizumab|mesh-list
25533534|NCT00548548|Cisplatin|cisplatin|mesh-list
25533535|NCT00548548|Fluorouracil|fluorouracil|mesh-list
25533536|NCT00548548|Capecitabine|capecitabine|mesh-list
25533537|NCT00548548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25533538|NCT00548548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533539|NCT00548548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25533540|NCT00548548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25533541|NCT00548548|Growth Substances|growth substances|mesh-ancestor
25533542|NCT00548548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533543|NCT00548548|Growth Inhibitors|growth inhibitors|mesh-ancestor
25533544|NCT00548548|Antimetabolites|antimetabolites|mesh-ancestor
25533545|NCT00548548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533546|NCT00548548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25533547|NCT00548548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25533548|NCT00548548|Immunologic Factors|immunologic factors|mesh-ancestor
25823580|NCT00004858|Genistein|genistein|mesh-list
25533549|NCT00548717|Mycophenolic Acid|mycophenolic acid|mesh-list
25533550|NCT00548717|Sirolimus|sirolimus|mesh-list
25647013|NCT01465386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533551|NCT00548717|Bortezomib|bortezomib|mesh-list
25533552|NCT00548717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25533553|NCT00548717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533554|NCT00548717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25533555|NCT00548717|Antitubercular Agents|antitubercular agents|mesh-ancestor
25533556|NCT00548717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25533557|NCT00548717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25533558|NCT00548717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533559|NCT00548717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533560|NCT00548717|Antifungal Agents|antifungal agents|mesh-ancestor
25533561|NCT00548717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25533562|NCT00548717|Immunologic Factors|immunologic factors|mesh-ancestor
25533563|NCT00548717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533564|NCT00548808|Insulin|insulin|mesh-list
25533565|NCT00548808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25533566|NCT00548808|Insulin Glargine|insulin glargine|mesh-list
25533567|NCT00548808|Insulin Lispro|insulin lispro|mesh-list
25533568|NCT00548808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25533569|NCT00548808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533570|NCT00548847|Interferons|interferons|mesh-list
25533571|NCT00548847|Interferon-alpha|interferon-alpha|mesh-list
25533572|NCT00548847|Interferon alpha-2|interferon alpha-2|mesh-list
25533573|NCT00548847|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25533574|NCT00548847|Molgramostim|molgramostim|mesh-list
25533575|NCT00548847|Sargramostim|sargramostim|mesh-list
25533576|NCT00548847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533577|NCT00548847|Antiviral Agents|antiviral agents|mesh-ancestor
25533578|NCT00548847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25533579|NCT00548847|Immunologic Factors|immunologic factors|mesh-ancestor
25533580|NCT00548847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533581|NCT00549042|Hydromorphone|hydromorphone|mesh-list
25533582|NCT00549042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25533583|NCT00549042|Narcotics|narcotics|mesh-ancestor
25533584|NCT00549042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25533585|NCT00549042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533586|NCT00549042|Analgesics|analgesics|mesh-ancestor
25533587|NCT00549042|Sensory System Agents|sensory system agents|mesh-ancestor
25533588|NCT00549042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25533589|NCT00549198|Tenofovir|tenofovir|mesh-list
25533590|NCT00549198|Lamivudine|lamivudine|mesh-list
25533591|NCT00549198|Emtricitabine|emtricitabine|mesh-list
25533592|NCT00549198|Efavirenz|efavirenz|mesh-list
25533593|NCT00549198|Abacavir|abacavir|mesh-list
25533594|NCT00549198|Antiviral Agents|antiviral agents|mesh-ancestor
25533595|NCT00549198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25533596|NCT00549198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25533597|NCT00549198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25533598|NCT00549198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533599|NCT00549198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533600|NCT00549198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25533601|NCT00549198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25533602|NCT00549198|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25533603|NCT00549198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25533604|NCT00549198|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25533605|NCT00549198|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25533606|NCT00549198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25533607|NCT00549198|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25533608|NCT00549302|Tadalafil|tadalafil|mesh-list
25533609|NCT00549302|Vasodilator Agents|vasodilator agents|mesh-ancestor
25533610|NCT00549302|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25533611|NCT00549302|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25533612|NCT00549302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533613|NCT00549302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533614|NCT00549302|Urological Agents|urological agents|mesh-ancestor
25533615|NCT00549393|Chlorhexidine|chlorhexidine|mesh-list
25533616|NCT00549393|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25533617|NCT00549393|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25533618|NCT00549393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25533619|NCT00549393|Disinfectants|disinfectants|mesh-ancestor
25533620|NCT00549393|Dermatologic Agents|dermatologic agents|mesh-ancestor
25533621|NCT00549445|Azithromycin|azithromycin|mesh-list
25533622|NCT00549445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25647014|NCT01465412|Adenosine|adenosine|mesh-list
25533623|NCT00549445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25533624|NCT00549549|Celecoxib|celecoxib|mesh-list
25533625|NCT00549549|Indomethacin|indomethacin|mesh-list
25533626|NCT00549549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25533627|NCT00549549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25533628|NCT00549549|Analgesics|analgesics|mesh-ancestor
25533629|NCT00549549|Sensory System Agents|sensory system agents|mesh-ancestor
25533630|NCT00549549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25533631|NCT00549549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533632|NCT00549549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25533633|NCT00549549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25533634|NCT00549549|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25533635|NCT00549549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25533636|NCT00549549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533637|NCT00549549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533638|NCT00549549|Gout Suppressants|gout suppressants|mesh-ancestor
25533639|NCT00549549|Tocolytic Agents|tocolytic agents|mesh-ancestor
25533640|NCT00549549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25533641|NCT00549562|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25533642|NCT00549562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25533643|NCT00549562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25533644|NCT00549562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25533645|NCT00549562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533646|NCT00549562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25533647|NCT00549562|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25533648|NCT00549562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25533649|NCT00549562|Serotonin Agents|serotonin agents|mesh-ancestor
25533650|NCT00549562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25533651|NCT00549562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533652|NCT00549562|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25533653|NCT00549562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25533654|NCT00549562|Dopamine Agents|dopamine agents|mesh-ancestor
25533655|NCT00549601|Rivastigmine|rivastigmine|mesh-list
25533656|NCT00549601|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25533657|NCT00549601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533658|NCT00549601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533659|NCT00549601|Cholinergic Agents|cholinergic agents|mesh-ancestor
25533660|NCT00549601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25533661|NCT00549601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533662|NCT00549601|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25533663|NCT00549601|Protective Agents|protective agents|mesh-ancestor
25533664|NCT00549640|Methylphenidate|methylphenidate|mesh-list
25533665|NCT00549640|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25533666|NCT00549640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533667|NCT00549640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25533668|NCT00549640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25533669|NCT00549640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25533670|NCT00549640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533671|NCT00549640|Dopamine Agents|dopamine agents|mesh-ancestor
25533672|NCT00549640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25533673|NCT00549718|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25533674|NCT00549718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25533675|NCT00549718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25533676|NCT00549718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25533677|NCT00549718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533678|NCT00549718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25533679|NCT00549718|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25533680|NCT00549718|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25533681|NCT00549718|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25533682|NCT00549718|Adrenergic Agents|adrenergic agents|mesh-ancestor
25533683|NCT00549718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25533684|NCT00549718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533685|NCT00549718|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25533686|NCT00549718|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25533687|NCT00549718|Serotonin Agents|serotonin agents|mesh-ancestor
25533688|NCT00549718|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25533689|NCT00549718|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25533690|NCT00549718|Dopamine Agents|dopamine agents|mesh-ancestor
25533691|NCT00549770|Valsartan|valsartan|mesh-list
25533692|NCT00549770|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25533693|NCT00549770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25533694|NCT00549770|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25533695|NCT00549770|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25533696|NCT00549770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533697|NCT00549783|Botulinum Toxins|botulinum toxins|mesh-list
25647015|NCT01465412|Analgesics|analgesics|mesh-ancestor
25647016|NCT01465412|Sensory System Agents|sensory system agents|mesh-ancestor
25647017|NCT01465412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25647018|NCT01465412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533698|NCT00549783|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25533699|NCT00549783|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25533700|NCT00549783|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25533701|NCT00549783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25533702|NCT00549783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533703|NCT00549783|Cholinergic Agents|cholinergic agents|mesh-ancestor
25533704|NCT00549783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25533705|NCT00549783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533706|NCT00549783|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25533707|NCT00549783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25647019|NCT01465412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25647020|NCT01465412|Vasodilator Agents|vasodilator agents|mesh-ancestor
25647021|NCT01465412|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25647022|NCT01465412|Purinergic Agonists|purinergic agonists|mesh-ancestor
25647023|NCT01465412|Purinergic Agents|purinergic agents|mesh-ancestor
25647024|NCT01465412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25657202|NCT01584388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533708|NCT00549822|Letrozole|letrozole|mesh-list
25533709|NCT00549822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533710|NCT00549822|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25533711|NCT00549822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25533712|NCT00549822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533713|NCT00549822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533714|NCT00549822|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25533715|NCT00549822|Hormone Antagonists|hormone antagonists|mesh-ancestor
25533716|NCT00549822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25533717|NCT00549822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533718|NCT00549900|Vaccines|vaccines|mesh-list
25533719|NCT00549900|Immunologic Factors|immunologic factors|mesh-ancestor
25533720|NCT00549900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533721|NCT00549939|Alfuzosin|alfuzosin|mesh-list
25533722|NCT00549939|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25533723|NCT00549939|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25533724|NCT00549939|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25533725|NCT00549939|Adrenergic Agents|adrenergic agents|mesh-ancestor
25533726|NCT00549939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25533727|NCT00549939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533728|NCT00549939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533729|NCT00549939|Urological Agents|urological agents|mesh-ancestor
25533730|NCT00550147|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25533731|NCT00550147|Methylphenidate|methylphenidate|mesh-list
25533732|NCT00550147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25533733|NCT00550147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533734|NCT00550147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25533735|NCT00550147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25533736|NCT00550147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25533737|NCT00550147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533738|NCT00550147|Dopamine Agents|dopamine agents|mesh-ancestor
25533739|NCT00550147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25533740|NCT00550147|Antidepressive Agents|antidepressive agents|mesh-ancestor
25533741|NCT00550147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25533742|NCT00550147|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25533743|NCT00550147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25533744|NCT00550147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25533745|NCT00550173|Pemetrexed|pemetrexed|mesh-list
25533746|NCT00550173|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25533747|NCT00550173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533748|NCT00550173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533749|NCT00550173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533750|NCT00550173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25533751|NCT00550173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25533752|NCT00550173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25533753|NCT00550238|Pimavanserin|pimavanserin|mesh-list
25533754|NCT00550238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25533755|NCT00550238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25533756|NCT00550238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25533757|NCT00550238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25533758|NCT00550238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25533759|NCT00550238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533760|NCT00550238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25533761|NCT00550238|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25533762|NCT00550238|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25533763|NCT00550238|Serotonin Agents|serotonin agents|mesh-ancestor
25533764|NCT00550238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25533765|NCT00550238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533766|NCT00550277|Panobinostat|panobinostat|mesh-list
25533767|NCT00550277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533768|NCT00550277|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25533769|NCT00550277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533770|NCT00550277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533771|NCT00550290|Cefazolin|cefazolin|mesh-list
25533772|NCT00550290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25533773|NCT00550290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25533774|NCT00550394|Topiramate|topiramate|mesh-list
25533775|NCT00550394|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25533776|NCT00550394|Antidepressive Agents|antidepressive agents|mesh-ancestor
25533777|NCT00550394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25533778|NCT00550394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25533779|NCT00550394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25533780|NCT00550394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25533781|NCT00550394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533782|NCT00550394|Anticonvulsants|anticonvulsants|mesh-ancestor
25533783|NCT00550394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25533784|NCT00550407|Lamotrigine|lamotrigine|mesh-list
25533785|NCT00550407|Anticonvulsants|anticonvulsants|mesh-ancestor
25533786|NCT00550407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25533787|NCT00550407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25533788|NCT00550407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533789|NCT00550407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25533790|NCT00550407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533791|NCT00550407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25533792|NCT00550407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25533793|NCT00550407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25533794|NCT00550407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25533795|NCT00550407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25533796|NCT00550420|Rosiglitazone|rosiglitazone|mesh-list
25533797|NCT00550420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25533798|NCT00550420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533799|NCT00550446|Adalimumab|adalimumab|mesh-list
25533800|NCT00550446|Tofacitinib|tofacitinib|mesh-list
25533801|NCT00550446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25533802|NCT00550446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25533803|NCT00550446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25533804|NCT00550446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533805|NCT00550446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533806|NCT00550459|Tolvaptan|tolvaptan|mesh-list
25533807|NCT00550459|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25533808|NCT00550459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533809|NCT00550459|Natriuretic Agents|natriuretic agents|mesh-ancestor
25533810|NCT00550459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533811|NCT00550537|Paclitaxel|paclitaxel|mesh-list
25533812|NCT00550537|Bevacizumab|bevacizumab|mesh-list
25533813|NCT00550537|Carboplatin|carboplatin|mesh-list
25533814|NCT00550537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25533815|NCT00550537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25533816|NCT00550537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533817|NCT00550537|Tubulin Modulators|tubulin modulators|mesh-ancestor
25533818|NCT00550537|Antimitotic Agents|antimitotic agents|mesh-ancestor
25533819|NCT00550537|Mitosis Modulators|mitosis modulators|mesh-ancestor
25533820|NCT00550537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533821|NCT00550537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25533822|NCT00550537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25533823|NCT00550537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25823581|NCT00004858|Immunoconjugates|immunoconjugates|mesh-list
25533824|NCT00550537|Growth Substances|growth substances|mesh-ancestor
25533825|NCT00550537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533826|NCT00550537|Growth Inhibitors|growth inhibitors|mesh-ancestor
25533827|NCT00550537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25533828|NCT00550537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533829|NCT00550550|Fluticasone|fluticasone|mesh-list
25533830|NCT00550550|Mometasone Furoate|mometasone furoate|mesh-list
25533831|NCT00550550|Loratadine|loratadine|mesh-list
25533832|NCT00550550|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25533833|NCT00550550|Prednisone|prednisone|mesh-list
25533834|NCT00550550|Albuterol|albuterol|mesh-list
25533835|NCT00550550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25533836|NCT00550550|Glucocorticoids|glucocorticoids|mesh-ancestor
25533837|NCT00550550|Hormones|hormones|mesh-ancestor
25533838|NCT00550550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25533839|NCT00550550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533840|NCT00550550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25533841|NCT00550550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533842|NCT00550550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25533843|NCT00550550|Autonomic Agents|autonomic agents|mesh-ancestor
25533844|NCT00550550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25533845|NCT00550550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25533846|NCT00550550|Respiratory System Agents|respiratory system agents|mesh-ancestor
25533847|NCT00550550|Dermatologic Agents|dermatologic agents|mesh-ancestor
25533848|NCT00550550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25533849|NCT00550550|Tocolytic Agents|tocolytic agents|mesh-ancestor
25533850|NCT00550550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25533851|NCT00550550|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25533852|NCT00550550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25533853|NCT00550550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25533854|NCT00550550|Adrenergic Agents|adrenergic agents|mesh-ancestor
25533855|NCT00550550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25533856|NCT00550550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533857|NCT00550550|Antipruritics|antipruritics|mesh-ancestor
25533858|NCT00550550|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25533859|NCT00550550|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25533860|NCT00550550|Histamine Antagonists|histamine antagonists|mesh-ancestor
25533861|NCT00550550|Histamine Agents|histamine agents|mesh-ancestor
25533862|NCT00550550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25533863|NCT00550550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25533864|NCT00550550|Analgesics|analgesics|mesh-ancestor
25533865|NCT00550550|Sensory System Agents|sensory system agents|mesh-ancestor
25533866|NCT00550550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25533867|NCT00550589|Cidofovir|cidofovir|mesh-list
25533868|NCT00550589|Antiviral Agents|antiviral agents|mesh-ancestor
25533869|NCT00550589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25533870|NCT00550589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533871|NCT00550589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533872|NCT00550615|Dasatinib|dasatinib|mesh-list
25533873|NCT00550615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533874|NCT00550615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25533875|NCT00550615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533876|NCT00550615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533877|NCT00550680|Epoetin Alfa|epoetin alfa|mesh-list
25533878|NCT00550680|Hematinics|hematinics|mesh-ancestor
25533879|NCT00550732|Posaconazole|posaconazole|mesh-list
25533880|NCT00550732|Antifungal Agents|antifungal agents|mesh-ancestor
25533881|NCT00550732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25533882|NCT00550732|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25533883|NCT00550732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25533884|NCT00550732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25533885|NCT00550732|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25533886|NCT00550732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25533887|NCT00550732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533888|NCT00550732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533889|NCT00550732|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25533890|NCT00550732|Hormone Antagonists|hormone antagonists|mesh-ancestor
25533891|NCT00550732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25533892|NCT00550732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533893|NCT00550771|Paclitaxel|paclitaxel|mesh-list
25533894|NCT00550771|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25533895|NCT00550771|Cyclophosphamide|cyclophosphamide|mesh-list
25533896|NCT00550771|Doxorubicin|doxorubicin|mesh-list
25533897|NCT00550771|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25533898|NCT00550771|Trastuzumab|trastuzumab|mesh-list
25823582|NCT00004858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25533899|NCT00550771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25533901|NCT00550771|Tubulin Modulators|tubulin modulators|mesh-ancestor
25533902|NCT00550771|Antimitotic Agents|antimitotic agents|mesh-ancestor
25533903|NCT00550771|Mitosis Modulators|mitosis modulators|mesh-ancestor
25533904|NCT00550771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533905|NCT00550771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25533906|NCT00550771|Immunologic Factors|immunologic factors|mesh-ancestor
25533907|NCT00550771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647025|NCT01465412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647026|NCT01465464|Orantinib|orantinib|mesh-list
25647027|NCT01465464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25647028|NCT01465464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533908|NCT00550771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25533909|NCT00550771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25533910|NCT00550771|Alkylating Agents|alkylating agents|mesh-ancestor
25533911|NCT00550771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25533912|NCT00550771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25533913|NCT00550771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25533914|NCT00550771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25533915|NCT00550771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533916|NCT00550771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25533917|NCT00550836|Gemcitabine|gemcitabine|mesh-list
25533918|NCT00550836|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25533919|NCT00550836|Panitumumab|panitumumab|mesh-list
25533920|NCT00550836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25533921|NCT00550836|Antimetabolites|antimetabolites|mesh-ancestor
25533922|NCT00550836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533923|NCT00550836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533924|NCT00550836|Antiviral Agents|antiviral agents|mesh-ancestor
25533925|NCT00550836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25533926|NCT00550836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533927|NCT00550836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25533928|NCT00550836|Immunologic Factors|immunologic factors|mesh-ancestor
25533929|NCT00550836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533930|NCT00550836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25533931|NCT00550836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25533932|NCT00550862|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25533933|NCT00550862|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25533934|NCT00550862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25533935|NCT00550953|Amlodipine|amlodipine|mesh-list
25533936|NCT00550953|Telmisartan|telmisartan|mesh-list
25533937|NCT00550953|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
25533938|NCT00550953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25533939|NCT00550953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25533940|NCT00550953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25533941|NCT00550953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533942|NCT00550953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25533943|NCT00550953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533944|NCT00550953|Vasodilator Agents|vasodilator agents|mesh-ancestor
25533945|NCT00550953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25533946|NCT00550953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25533947|NCT00551031|Vaccines|vaccines|mesh-list
25533948|NCT00551031|Immunologic Factors|immunologic factors|mesh-ancestor
25533949|NCT00551031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533950|NCT00551135|Pregabalin|pregabalin|mesh-list
25533951|NCT00551135|Analgesics|analgesics|mesh-ancestor
25533952|NCT00551135|Sensory System Agents|sensory system agents|mesh-ancestor
25533953|NCT00551135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25533954|NCT00551135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533955|NCT00551135|Anticonvulsants|anticonvulsants|mesh-ancestor
25533956|NCT00551135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25533957|NCT00551135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25533958|NCT00551135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533959|NCT00551135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25533960|NCT00551135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25533961|NCT00551135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25533962|NCT00551135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25533963|NCT00551135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25533964|NCT00551161|Memantine|memantine|mesh-list
25533965|NCT00551161|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25533966|NCT00551161|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25533967|NCT00551161|Dopamine Agents|dopamine agents|mesh-ancestor
25533968|NCT00551161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25533969|NCT00551161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533970|NCT00551161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533971|NCT00551161|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25533972|NCT00551161|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25533973|NCT00551174|Ibandronic Acid|ibandronic acid|mesh-list
25533974|NCT00551174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25647029|NCT01465464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533975|NCT00551174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533976|NCT00551200|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25533977|NCT00551200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533978|NCT00551213|Capecitabine|capecitabine|mesh-list
25533980|NCT00551213|Cetuximab|cetuximab|mesh-list
25533981|NCT00551213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25533982|NCT00551213|Antimetabolites|antimetabolites|mesh-ancestor
25533983|NCT00551213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25533984|NCT00551213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533985|NCT00551213|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25533986|NCT00551213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25533987|NCT00551213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25533988|NCT00551213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25533989|NCT00551291|Mycophenolic Acid|mycophenolic acid|mesh-list
25533990|NCT00551291|Prednisone|prednisone|mesh-list
25533991|NCT00551291|Epoetin Alfa|epoetin alfa|mesh-list
25533992|NCT00551291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25533993|NCT00551291|Glucocorticoids|glucocorticoids|mesh-ancestor
25533994|NCT00551291|Hormones|hormones|mesh-ancestor
25533995|NCT00551291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25533996|NCT00551291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25533997|NCT00551291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25533998|NCT00551291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25533999|NCT00551291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25534000|NCT00551291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25534001|NCT00551291|Antitubercular Agents|antitubercular agents|mesh-ancestor
25534002|NCT00551291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25534003|NCT00551291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25534004|NCT00551291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534005|NCT00551291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534006|NCT00551291|Hematinics|hematinics|mesh-ancestor
25534007|NCT00551421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25534008|NCT00551421|Cetuximab|cetuximab|mesh-list
25534009|NCT00551421|Pertuzumab|pertuzumab|mesh-list
25534010|NCT00551421|Irinotecan|irinotecan|mesh-list
25534011|NCT00551421|Antibodies|antibodies|mesh-list
25534012|NCT00551421|Immunoglobulins|immunoglobulins|mesh-list
25534013|NCT00551421|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25534014|NCT00551421|Immunologic Factors|immunologic factors|mesh-ancestor
25534015|NCT00551421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534016|NCT00551421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534017|NCT00551421|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25534018|NCT00551421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25534019|NCT00551421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534020|NCT00551421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534021|NCT00551460|Methotrexate|methotrexate|mesh-list
25534022|NCT00551460|Mercaptopurine|mercaptopurine|mesh-list
25534023|NCT00551460|Arsenic Trioxide|arsenic trioxide|mesh-list
25534024|NCT00551460|Tretinoin|tretinoin|mesh-list
25534025|NCT00551460|Gemtuzumab|gemtuzumab|mesh-list
25534026|NCT00551460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25534027|NCT00551460|Abortifacient Agents|abortifacient agents|mesh-ancestor
25534028|NCT00551460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25534029|NCT00551460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534030|NCT00551460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25534031|NCT00551460|Antimetabolites|antimetabolites|mesh-ancestor
25534032|NCT00551460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534033|NCT00551460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534034|NCT00551460|Dermatologic Agents|dermatologic agents|mesh-ancestor
25534035|NCT00551460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534036|NCT00551460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25534037|NCT00551460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25534038|NCT00551460|Immunologic Factors|immunologic factors|mesh-ancestor
25534039|NCT00551460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25534040|NCT00551460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25534041|NCT00551460|Keratolytic Agents|keratolytic agents|mesh-ancestor
25534042|NCT00551460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25534043|NCT00551525|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
25534044|NCT00551525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25534045|NCT00551525|Analgesics|analgesics|mesh-ancestor
24650974|NCT01228630|Fexofenadine|fexofenadine|mesh-list
25534046|NCT00551525|Sensory System Agents|sensory system agents|mesh-ancestor
25534047|NCT00551525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25534048|NCT00551525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534050|NCT00551642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25534051|NCT00551642|Autonomic Agents|autonomic agents|mesh-ancestor
25534052|NCT00551642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25534053|NCT00551642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534054|NCT00551642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25534055|NCT00551642|Respiratory System Agents|respiratory system agents|mesh-ancestor
25534056|NCT00551642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25534057|NCT00551642|Antioxidants|antioxidants|mesh-ancestor
25534058|NCT00551642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534059|NCT00551642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25534060|NCT00551642|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25534061|NCT00551642|Vasodilator Agents|vasodilator agents|mesh-ancestor
25534062|NCT00551642|Gasotransmitters|gasotransmitters|mesh-ancestor
25534063|NCT00551642|Protective Agents|protective agents|mesh-ancestor
25534064|NCT00551707|Prednisolone|prednisolone|mesh-list
25534065|NCT00551707|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25534066|NCT00551707|Methylprednisolone|methylprednisolone|mesh-list
25534067|NCT00551707|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25534068|NCT00551707|Prednisolone acetate|prednisolone acetate|mesh-list
25534069|NCT00551707|Dipyridamole|dipyridamole|mesh-list
25534070|NCT00551707|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25534071|NCT00551707|Prednisolone phosphate|prednisolone phosphate|mesh-list
25534072|NCT00551707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25534073|NCT00551707|Glucocorticoids|glucocorticoids|mesh-ancestor
25534074|NCT00551707|Hormones|hormones|mesh-ancestor
25534075|NCT00551707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25534076|NCT00551707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534077|NCT00551707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25534078|NCT00551707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534079|NCT00551707|Antiemetics|antiemetics|mesh-ancestor
25534080|NCT00551707|Autonomic Agents|autonomic agents|mesh-ancestor
25534081|NCT00551707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25534082|NCT00551707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25534083|NCT00551707|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25534084|NCT00551707|Protective Agents|protective agents|mesh-ancestor
25534085|NCT00551707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25534086|NCT00551707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534087|NCT00551707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534088|NCT00551707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25534089|NCT00551707|Vasodilator Agents|vasodilator agents|mesh-ancestor
25534090|NCT00551759|Docetaxel|docetaxel|mesh-list
25534091|NCT00551759|Fluorouracil|fluorouracil|mesh-list
25534092|NCT00551759|Oxaliplatin|oxaliplatin|mesh-list
25534093|NCT00551759|Cetuximab|cetuximab|mesh-list
25534094|NCT00551759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534095|NCT00551759|Tubulin Modulators|tubulin modulators|mesh-ancestor
25534096|NCT00551759|Antimitotic Agents|antimitotic agents|mesh-ancestor
25534097|NCT00551759|Mitosis Modulators|mitosis modulators|mesh-ancestor
25534098|NCT00551759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534099|NCT00551759|Antimetabolites|antimetabolites|mesh-ancestor
25534100|NCT00551759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25534101|NCT00551759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25534102|NCT00551759|Immunologic Factors|immunologic factors|mesh-ancestor
25534103|NCT00551759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534104|NCT00551759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25534105|NCT00552058|Certolizumab Pegol|certolizumab pegol|mesh-list
25534106|NCT00552058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25534107|NCT00552058|Immunologic Factors|immunologic factors|mesh-ancestor
25534108|NCT00552058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534109|NCT00552058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25534110|NCT00552071|Octreotide|octreotide|mesh-list
25534111|NCT00552071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25534112|NCT00552071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25534113|NCT00552071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534114|NCT00552110|Mometasone Furoate|mometasone furoate|mesh-list
25534115|NCT00552110|Phenylephrine|phenylephrine|mesh-list
25534116|NCT00552110|Oxymetazoline|oxymetazoline|mesh-list
25534117|NCT00552110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25534118|NCT00552110|Dermatologic Agents|dermatologic agents|mesh-ancestor
25534119|NCT00552110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25534120|NCT00552110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25534121|NCT00552110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25534122|NCT00552110|Adrenergic Agents|adrenergic agents|mesh-ancestor
25534123|NCT00552110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25647031|NCT01465659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25647032|NCT01465659|Alkylating Agents|alkylating agents|mesh-ancestor
25647033|NCT01465659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647034|NCT01465659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647035|NCT01465763|Tofacitinib|tofacitinib|mesh-list
25647036|NCT01465763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25647037|NCT01465763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534124|NCT00552110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534125|NCT00552110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534126|NCT00552110|Sympathomimetics|sympathomimetics|mesh-ancestor
25534127|NCT00552110|Autonomic Agents|autonomic agents|mesh-ancestor
25534128|NCT00552110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25534129|NCT00552110|Nasal Decongestants|nasal decongestants|mesh-ancestor
25534130|NCT00552110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25534131|NCT00552110|Respiratory System Agents|respiratory system agents|mesh-ancestor
25534132|NCT00552110|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25534133|NCT00552110|Mydriatics|mydriatics|mesh-ancestor
25534134|NCT00552110|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25534135|NCT00552110|Protective Agents|protective agents|mesh-ancestor
25534136|NCT00552175|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25534137|NCT00552175|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25534138|NCT00552175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25534139|NCT00552175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25534140|NCT00552175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534141|NCT00552175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25534142|NCT00552175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534143|NCT00552175|Analgesics|analgesics|mesh-ancestor
25534144|NCT00552175|Sensory System Agents|sensory system agents|mesh-ancestor
25534145|NCT00552175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25534146|NCT00552175|Antidepressive Agents|antidepressive agents|mesh-ancestor
25534147|NCT00552175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25534148|NCT00552175|Dopamine Agents|dopamine agents|mesh-ancestor
25534149|NCT00552188|Atreleuton|atreleuton|mesh-list
25534150|NCT00552188|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25534151|NCT00552188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534152|NCT00552188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534153|NCT00552240|Ritonavir|ritonavir|mesh-list
25534154|NCT00552240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25534155|NCT00552240|Tenofovir|tenofovir|mesh-list
25534156|NCT00552240|Emtricitabine|emtricitabine|mesh-list
25534157|NCT00552240|Nevirapine|nevirapine|mesh-list
25534158|NCT00552240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25534159|NCT00552240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25534160|NCT00552240|Protease Inhibitors|protease inhibitors|mesh-ancestor
25534161|NCT00552240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534162|NCT00552240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534163|NCT00552240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25534164|NCT00552240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25534165|NCT00552240|Antiviral Agents|antiviral agents|mesh-ancestor
25534166|NCT00552240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25534167|NCT00552240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25534168|NCT00552240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25534169|NCT00552240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25534170|NCT00552240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25534171|NCT00552240|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25534172|NCT00552240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25534173|NCT00552279|Vaccines|vaccines|mesh-list
25534174|NCT00552279|Immunologic Factors|immunologic factors|mesh-ancestor
25534175|NCT00552279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534176|NCT00552305|Lacosamide|lacosamide|mesh-list
25534177|NCT00552305|Anticonvulsants|anticonvulsants|mesh-ancestor
25534178|NCT00552305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25534179|NCT00552305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25534180|NCT00552305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25534181|NCT00552305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534182|NCT00552344|Certolizumab Pegol|certolizumab pegol|mesh-list
25534183|NCT00552344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25534184|NCT00552344|Immunologic Factors|immunologic factors|mesh-ancestor
25534185|NCT00552344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534186|NCT00552344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25534187|NCT00552409|Cholecalciferol|cholecalciferol|mesh-list
25534188|NCT00552409|Vitamin D|vitamin d|mesh-list
25534189|NCT00552409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25534190|NCT00552409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534191|NCT00552409|Vitamins|vitamins|mesh-ancestor
25534192|NCT00552409|Micronutrients|micronutrients|mesh-ancestor
25534193|NCT00552409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25534194|NCT00552422|Domperidone|domperidone|mesh-list
25823584|NCT00004858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534205|NCT00552578|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25534206|NCT00552578|Naloxone|naloxone|mesh-list
25534207|NCT00552578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25534208|NCT00552578|Narcotics|narcotics|mesh-ancestor
25534209|NCT00552578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25534210|NCT00552578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534211|NCT00552578|Analgesics|analgesics|mesh-ancestor
25534212|NCT00552578|Sensory System Agents|sensory system agents|mesh-ancestor
25534213|NCT00552578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25534214|NCT00552578|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25534215|NCT00552617|Rocuronium|rocuronium|mesh-list
25534216|NCT00552617|Vecuronium Bromide|vecuronium bromide|mesh-list
25534217|NCT00552617|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25534218|NCT00552617|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25534219|NCT00552617|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25534220|NCT00552617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25534221|NCT00552617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534222|NCT00552617|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25534223|NCT00552617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25534224|NCT00552617|Cholinergic Agents|cholinergic agents|mesh-ancestor
25534225|NCT00552617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25534226|NCT00552617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534227|NCT00552669|Sirolimus|sirolimus|mesh-list
25534228|NCT00552669|Paclitaxel|paclitaxel|mesh-list
25534229|NCT00552669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25534230|NCT00552669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534231|NCT00552669|Tubulin Modulators|tubulin modulators|mesh-ancestor
25534232|NCT00552669|Antimitotic Agents|antimitotic agents|mesh-ancestor
25534233|NCT00552669|Mitosis Modulators|mitosis modulators|mesh-ancestor
25534234|NCT00552669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534235|NCT00552669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25534236|NCT00552669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25534237|NCT00552669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25534238|NCT00552669|Antifungal Agents|antifungal agents|mesh-ancestor
25534239|NCT00552669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25534240|NCT00552669|Immunologic Factors|immunologic factors|mesh-ancestor
25534241|NCT00552669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534242|NCT00552695|Lidocaine|lidocaine|mesh-list
25534243|NCT00552695|Tetracaine|tetracaine|mesh-list
25534244|NCT00552695|Anesthetics, Local|anesthetics, local|mesh-ancestor
25534245|NCT00552695|Anesthetics|anesthetics|mesh-ancestor
25534246|NCT00552695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25534247|NCT00552695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534248|NCT00552695|Sensory System Agents|sensory system agents|mesh-ancestor
25534249|NCT00552695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25534250|NCT00552695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25534251|NCT00552695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25534252|NCT00552695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25534253|NCT00552695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25534254|NCT00552695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534255|NCT00552786|Acetylcysteine|acetylcysteine|mesh-list
25534256|NCT00552786|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25534257|NCT00552786|Antiviral Agents|antiviral agents|mesh-ancestor
25534258|NCT00552786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25534259|NCT00552786|Expectorants|expectorants|mesh-ancestor
25534260|NCT00552786|Respiratory System Agents|respiratory system agents|mesh-ancestor
25534261|NCT00552786|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25534262|NCT00552786|Antioxidants|antioxidants|mesh-ancestor
25534263|NCT00552786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534264|NCT00552786|Protective Agents|protective agents|mesh-ancestor
25534265|NCT00552786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534266|NCT00552786|Antidotes|antidotes|mesh-ancestor
25534267|NCT00553059|Dexamethasone|dexamethasone|mesh-list
25534268|NCT00553059|Dronabinol|dronabinol|mesh-list
25534269|NCT00553059|Palonosetron|palonosetron|mesh-list
25534270|NCT00553059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25534271|NCT00553059|Antiemetics|antiemetics|mesh-ancestor
25534272|NCT00553059|Autonomic Agents|autonomic agents|mesh-ancestor
25534273|NCT00553059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25534274|NCT00553059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534275|NCT00553059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25534276|NCT00553059|Glucocorticoids|glucocorticoids|mesh-ancestor
25534277|NCT00553059|Hormones|hormones|mesh-ancestor
25534278|NCT00553059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25534279|NCT00553059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25534280|NCT00553059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534281|NCT00553059|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25534282|NCT00553059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25534283|NCT00553059|Serotonin Agents|serotonin agents|mesh-ancestor
25534284|NCT00553059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25534285|NCT00553059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534286|NCT00553059|Hallucinogens|hallucinogens|mesh-ancestor
25534287|NCT00553059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25534288|NCT00553059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25534289|NCT00553059|Analgesics|analgesics|mesh-ancestor
25534290|NCT00553059|Sensory System Agents|sensory system agents|mesh-ancestor
25534291|NCT00553059|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25534292|NCT00553059|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25534293|NCT00553098|Cyclosporine|cyclosporine|mesh-list
25534294|NCT00553098|Mycophenolic Acid|mycophenolic acid|mesh-list
25534295|NCT00553098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25534296|NCT00553098|Alemtuzumab|alemtuzumab|mesh-list
25534297|NCT00553098|Fludarabine|fludarabine|mesh-list
25534298|NCT00553098|Fludarabine phosphate|fludarabine phosphate|mesh-list
25534299|NCT00553098|Antibodies|antibodies|mesh-list
25534300|NCT00553098|Immunoglobulins|immunoglobulins|mesh-list
25534301|NCT00553098|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25534302|NCT00553098|Cyclosporins|cyclosporins|mesh-list
25534303|NCT00553098|Immunologic Factors|immunologic factors|mesh-ancestor
25534304|NCT00553098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534305|NCT00553098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534306|NCT00553098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25534307|NCT00553098|Antimetabolites|antimetabolites|mesh-ancestor
25534308|NCT00553098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534309|NCT00553098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25534310|NCT00553098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534311|NCT00553098|Antifungal Agents|antifungal agents|mesh-ancestor
25534312|NCT00553098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25534313|NCT00553098|Dermatologic Agents|dermatologic agents|mesh-ancestor
25534314|NCT00553098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25534315|NCT00553098|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25534316|NCT00553098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25534317|NCT00553098|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25534318|NCT00553098|Antitubercular Agents|antitubercular agents|mesh-ancestor
25534319|NCT00553098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25534320|NCT00553150|Everolimus|everolimus|mesh-list
25534321|NCT00553150|Temozolomide|temozolomide|mesh-list
25534322|NCT00553150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534323|NCT00553150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25534324|NCT00553150|Immunologic Factors|immunologic factors|mesh-ancestor
25534325|NCT00553150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534326|NCT00553150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25534327|NCT00553150|Alkylating Agents|alkylating agents|mesh-ancestor
25534328|NCT00553150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534329|NCT00553202|Cyclosporine|cyclosporine|mesh-list
25534330|NCT00553202|Methylprednisolone|methylprednisolone|mesh-list
25534331|NCT00553202|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25534332|NCT00553202|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25534333|NCT00553202|Prednisolone|prednisolone|mesh-list
25534334|NCT00553202|Prednisolone acetate|prednisolone acetate|mesh-list
25534335|NCT00553202|Cyclophosphamide|cyclophosphamide|mesh-list
25534336|NCT00553202|Busulfan|busulfan|mesh-list
25534337|NCT00553202|Methotrexate|methotrexate|mesh-list
25534338|NCT00553202|Tacrolimus|tacrolimus|mesh-list
25534339|NCT00553202|Cyclosporins|cyclosporins|mesh-list
25534340|NCT00553202|Thymoglobulin|thymoglobulin|mesh-list
25534341|NCT00553202|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25534342|NCT00553202|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25534343|NCT00553202|Prednisolone phosphate|prednisolone phosphate|mesh-list
25534344|NCT00553202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25534345|NCT00553202|Immunologic Factors|immunologic factors|mesh-ancestor
25534346|NCT00553202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534347|NCT00553202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25534348|NCT00553202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25534349|NCT00553202|Alkylating Agents|alkylating agents|mesh-ancestor
25534350|NCT00553202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534351|NCT00553202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534352|NCT00553202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25534353|NCT00553202|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25823585|NCT00004858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859238|NCT02302547|Enfuvirtide|enfuvirtide|mesh-list
25534354|NCT00553202|Abortifacient Agents|abortifacient agents|mesh-ancestor
25534355|NCT00553202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25534356|NCT00553202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25534357|NCT00553202|Antimetabolites|antimetabolites|mesh-ancestor
25534358|NCT00553202|Dermatologic Agents|dermatologic agents|mesh-ancestor
25534359|NCT00553202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534360|NCT00553202|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25534361|NCT00553202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25534362|NCT00553202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25534363|NCT00553202|Antifungal Agents|antifungal agents|mesh-ancestor
25534364|NCT00553202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25534365|NCT00553202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25534366|NCT00553202|Antiemetics|antiemetics|mesh-ancestor
25534367|NCT00553202|Autonomic Agents|autonomic agents|mesh-ancestor
25534368|NCT00553202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25534369|NCT00553202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25534370|NCT00553202|Glucocorticoids|glucocorticoids|mesh-ancestor
25534371|NCT00553202|Hormones|hormones|mesh-ancestor
25534372|NCT00553202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25534373|NCT00553202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25534374|NCT00553202|Protective Agents|protective agents|mesh-ancestor
25534375|NCT00553202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25534376|NCT00553267|Amlodipine|amlodipine|mesh-list
25534377|NCT00553267|Telmisartan|telmisartan|mesh-list
25534378|NCT00553267|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
25534379|NCT00553267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25534380|NCT00553267|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25534381|NCT00553267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25534382|NCT00553267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534383|NCT00553267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25534384|NCT00553267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534385|NCT00553267|Vasodilator Agents|vasodilator agents|mesh-ancestor
25534386|NCT00553267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25534387|NCT00553267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25534388|NCT00553280|Pregabalin|pregabalin|mesh-list
25534389|NCT00553280|Analgesics|analgesics|mesh-ancestor
25534390|NCT00553280|Sensory System Agents|sensory system agents|mesh-ancestor
25534391|NCT00553280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25534392|NCT00553280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534393|NCT00553280|Anticonvulsants|anticonvulsants|mesh-ancestor
25534394|NCT00553280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25534395|NCT00553280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25534396|NCT00553280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534397|NCT00553280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25534398|NCT00553280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25534399|NCT00553280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25534400|NCT00553280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25534401|NCT00553280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25534402|NCT00553319|Amphetamine|amphetamine|mesh-list
25534403|NCT00553319|Adderall|adderall|mesh-list
25534404|NCT00553319|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25534405|NCT00553319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534406|NCT00553319|Sympathomimetics|sympathomimetics|mesh-ancestor
25534407|NCT00553319|Autonomic Agents|autonomic agents|mesh-ancestor
25534408|NCT00553319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25534409|NCT00553319|Dopamine Agents|dopamine agents|mesh-ancestor
25534410|NCT00553319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25534411|NCT00553319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534412|NCT00553319|Adrenergic Agents|adrenergic agents|mesh-ancestor
25534413|NCT00553319|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25534414|NCT00553319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25534415|NCT00553319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25534416|NCT00553319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25534417|NCT00553358|Paclitaxel|paclitaxel|mesh-list
25534418|NCT00553358|Trastuzumab|trastuzumab|mesh-list
25534419|NCT00553358|Lapatinib|lapatinib|mesh-list
25534420|NCT00553358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25534421|NCT00553358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25657204|NCT01584440|Quinidine|quinidine|mesh-list
25534422|NCT00553358|Tubulin Modulators|tubulin modulators|mesh-ancestor
25534423|NCT00553358|Antimitotic Agents|antimitotic agents|mesh-ancestor
25534424|NCT00553358|Mitosis Modulators|mitosis modulators|mesh-ancestor
25534425|NCT00553358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534426|NCT00553358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25534427|NCT00553358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25534428|NCT00553358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534429|NCT00553410|Letrozole|letrozole|mesh-list
25534430|NCT00553410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534431|NCT00553410|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25534432|NCT00553410|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25534433|NCT00553410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534434|NCT00553410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534435|NCT00553410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25534436|NCT00553410|Hormone Antagonists|hormone antagonists|mesh-ancestor
25534437|NCT00553410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25534438|NCT00553410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534439|NCT00553462|Paclitaxel|paclitaxel|mesh-list
25534440|NCT00553462|Carboplatin|carboplatin|mesh-list
25534441|NCT00553462|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25534442|NCT00553462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25534443|NCT00553462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25534444|NCT00553462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534445|NCT00553462|Tubulin Modulators|tubulin modulators|mesh-ancestor
25534446|NCT00553462|Antimitotic Agents|antimitotic agents|mesh-ancestor
25534447|NCT00553462|Mitosis Modulators|mitosis modulators|mesh-ancestor
25534448|NCT00553462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534449|NCT00553462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25534450|NCT00553462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534451|NCT00553475|Pregabalin|pregabalin|mesh-list
25534452|NCT00553475|Analgesics|analgesics|mesh-ancestor
25534453|NCT00553475|Sensory System Agents|sensory system agents|mesh-ancestor
25534454|NCT00553475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25534455|NCT00553475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534456|NCT00553475|Anticonvulsants|anticonvulsants|mesh-ancestor
25534457|NCT00553475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25534458|NCT00553475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25534459|NCT00553475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534460|NCT00553475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25534461|NCT00553475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25534462|NCT00553475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25534463|NCT00553475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25534464|NCT00553475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25534465|NCT00553501|Rituximab|rituximab|mesh-list
25534466|NCT00553501|Epratuzumab|epratuzumab|mesh-list
25534467|NCT00553501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25534468|NCT00553501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534469|NCT00553501|Immunologic Factors|immunologic factors|mesh-ancestor
25534470|NCT00553501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534471|NCT00553501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25534472|NCT00553514|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25534473|NCT00553514|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25534474|NCT00553514|Hormones|hormones|mesh-ancestor
25534475|NCT00553514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25534476|NCT00553514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534477|NCT00553514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25534478|NCT00553605|Ketoprofen|ketoprofen|mesh-list
25534479|NCT00553605|Parecoxib|parecoxib|mesh-list
25534480|NCT00553605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25534481|NCT00553605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25534482|NCT00553605|Analgesics|analgesics|mesh-ancestor
25534483|NCT00553605|Sensory System Agents|sensory system agents|mesh-ancestor
25534484|NCT00553605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25534485|NCT00553605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534486|NCT00553605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25534487|NCT00553605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25534488|NCT00553605|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25534489|NCT00553605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534490|NCT00553605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534491|NCT00553605|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25534492|NCT00553644|Lenalidomide|lenalidomide|mesh-list
25534493|NCT00553644|Bortezomib|bortezomib|mesh-list
25534494|NCT00553644|Immunologic Factors|immunologic factors|mesh-ancestor
25408477|NCT03437746|Prednisolone acetate|prednisolone acetate|mesh-list
25534495|NCT00553644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534496|NCT00553644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25534497|NCT00553644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25534498|NCT00553644|Growth Substances|growth substances|mesh-ancestor
25534499|NCT00553644|Growth Inhibitors|growth inhibitors|mesh-ancestor
25534500|NCT00553644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534503|NCT00553696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534504|NCT00553696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25534505|NCT00553696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25534506|NCT00553696|Growth Substances|growth substances|mesh-ancestor
25534507|NCT00553696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534508|NCT00553696|Growth Inhibitors|growth inhibitors|mesh-ancestor
25534509|NCT00553696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25534510|NCT00553696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534511|NCT00553696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534512|NCT00553735|Cyclosporine|cyclosporine|mesh-list
25534513|NCT00553735|Lubricant Eye Drops|lubricant eye drops|mesh-list
25534514|NCT00553735|Cyclosporins|cyclosporins|mesh-list
25534515|NCT00553735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534516|NCT00553735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534517|NCT00553735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25534518|NCT00553735|Immunologic Factors|immunologic factors|mesh-ancestor
25534519|NCT00553735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534520|NCT00553735|Antifungal Agents|antifungal agents|mesh-ancestor
25534521|NCT00553735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25534522|NCT00553735|Dermatologic Agents|dermatologic agents|mesh-ancestor
25534523|NCT00553735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25534524|NCT00553735|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25534525|NCT00553735|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25534526|NCT00553735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25534527|NCT00553839|Ketamine|ketamine|mesh-list
25534528|NCT00553839|Analgesics|analgesics|mesh-ancestor
25534529|NCT00553839|Sensory System Agents|sensory system agents|mesh-ancestor
25534530|NCT00553839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25534531|NCT00553839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534532|NCT00553839|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25534533|NCT00553839|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25534534|NCT00553839|Anesthetics, General|anesthetics, general|mesh-ancestor
25534535|NCT00553839|Anesthetics|anesthetics|mesh-ancestor
25534536|NCT00553839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25534537|NCT00553839|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25534538|NCT00553839|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25534539|NCT00553839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25534540|NCT00553839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534541|NCT00553969|Carvedilol|carvedilol|mesh-list
25534542|NCT00553969|Lisinopril|lisinopril|mesh-list
25534543|NCT00553969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25534544|NCT00553969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25534545|NCT00553969|Adrenergic Agents|adrenergic agents|mesh-ancestor
25534546|NCT00553969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25534547|NCT00553969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534548|NCT00553969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534549|NCT00553969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25534550|NCT00553969|Antioxidants|antioxidants|mesh-ancestor
25534551|NCT00553969|Protective Agents|protective agents|mesh-ancestor
25534552|NCT00553969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25534553|NCT00553969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25534554|NCT00553969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25534555|NCT00553969|Vasodilator Agents|vasodilator agents|mesh-ancestor
25534556|NCT00553969|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25534557|NCT00553969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25534558|NCT00553969|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25534559|NCT00553969|Protease Inhibitors|protease inhibitors|mesh-ancestor
25534560|NCT00553969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534561|NCT00553969|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25534562|NCT00554099|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25534563|NCT00554099|Mesalamine|mesalamine|mesh-list
25534564|NCT00554099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25534565|NCT00554099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25534566|NCT00554099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25534567|NCT00554099|Analgesics|analgesics|mesh-ancestor
25534568|NCT00554099|Sensory System Agents|sensory system agents|mesh-ancestor
25534569|NCT00554099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25657205|NCT01584440|Dextromethorphan|dextromethorphan|mesh-list
25534570|NCT00554099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534571|NCT00554099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25534572|NCT00554099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25534573|NCT00554216|Topiramate|topiramate|mesh-list
25534574|NCT00554216|Phentermine|phentermine|mesh-list
25534575|NCT00554216|Anticonvulsants|anticonvulsants|mesh-ancestor
24500919|NCT00526214|Analgesics|analgesics|mesh-ancestor
25534576|NCT00554216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25534577|NCT00554216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534578|NCT00554216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25534579|NCT00554216|Appetite Depressants|appetite depressants|mesh-ancestor
25534580|NCT00554216|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25534581|NCT00554216|Sympathomimetics|sympathomimetics|mesh-ancestor
25534582|NCT00554216|Autonomic Agents|autonomic agents|mesh-ancestor
25534583|NCT00554216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25534584|NCT00554216|Adrenergic Agents|adrenergic agents|mesh-ancestor
25534585|NCT00554216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25534586|NCT00554216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534587|NCT00554463|Cisplatin|cisplatin|mesh-list
25534588|NCT00554463|Etoposide|etoposide|mesh-list
25534589|NCT00554463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534590|NCT00554463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25534591|NCT00554463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25534592|NCT00554463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25534593|NCT00554463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534594|NCT00554463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534595|NCT00554619|Ambrisentan|ambrisentan|mesh-list
25534596|NCT00554619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25534597|NCT00554853|Pioglitazone|pioglitazone|mesh-list
25534598|NCT00554853|Nitroglycerin|nitroglycerin|mesh-list
25534599|NCT00554853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25534600|NCT00554853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534601|NCT00554853|Vasodilator Agents|vasodilator agents|mesh-ancestor
25534602|NCT00554970|Budesonide|budesonide|mesh-list
25534603|NCT00554970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25534604|NCT00554970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25534605|NCT00554970|Autonomic Agents|autonomic agents|mesh-ancestor
25534606|NCT00554970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25534607|NCT00554970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534608|NCT00554970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25534609|NCT00554970|Respiratory System Agents|respiratory system agents|mesh-ancestor
25534610|NCT00554970|Glucocorticoids|glucocorticoids|mesh-ancestor
25534611|NCT00554970|Hormones|hormones|mesh-ancestor
25534612|NCT00554970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25534613|NCT00555048|Cyclophosphamide|cyclophosphamide|mesh-list
25534614|NCT00555048|Busulfan|busulfan|mesh-list
25534615|NCT00555048|Methotrexate|methotrexate|mesh-list
25534616|NCT00555048|Alemtuzumab|alemtuzumab|mesh-list
25534617|NCT00555048|Tacrolimus|tacrolimus|mesh-list
25534618|NCT00555048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25534619|NCT00555048|Immunologic Factors|immunologic factors|mesh-ancestor
25534620|NCT00555048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534621|NCT00555048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25534622|NCT00555048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25534623|NCT00555048|Alkylating Agents|alkylating agents|mesh-ancestor
25534624|NCT00555048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534625|NCT00555048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534626|NCT00555048|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25534627|NCT00555048|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25534628|NCT00555048|Abortifacient Agents|abortifacient agents|mesh-ancestor
25534629|NCT00555048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25534630|NCT00555048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25534631|NCT00555048|Antimetabolites|antimetabolites|mesh-ancestor
25534632|NCT00555048|Dermatologic Agents|dermatologic agents|mesh-ancestor
25534633|NCT00555048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534634|NCT00555048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25534635|NCT00555048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25534636|NCT00555048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25534637|NCT00555048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24651971|NCT01234857|Immunologic Factors|immunologic factors|mesh-ancestor
24651972|NCT01234896|Nicotine|nicotine|mesh-list
24651973|NCT01234896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24651974|NCT01234896|Autonomic Agents|autonomic agents|mesh-ancestor
25823586|NCT00004858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25823587|NCT00004858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823588|NCT00004858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823589|NCT00004858|Phytoestrogens|phytoestrogens|mesh-ancestor
25823590|NCT00004858|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25823591|NCT00004858|Estrogens|estrogens|mesh-ancestor
25823592|NCT00004858|Hormones|hormones|mesh-ancestor
25823593|NCT00004858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25534639|NCT00555061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25534640|NCT00555061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25534641|NCT00555152|Lapatinib|lapatinib|mesh-list
25534642|NCT00555152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534643|NCT00555152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25534644|NCT00555152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534645|NCT00555152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534646|NCT00555217|Losartan|losartan|mesh-list
25534647|NCT00555217|Lisinopril|lisinopril|mesh-list
25534648|NCT00555217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25534649|NCT00555217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25534650|NCT00555217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25534651|NCT00555217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25534652|NCT00555217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534653|NCT00555217|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25534654|NCT00555217|Protease Inhibitors|protease inhibitors|mesh-ancestor
25534655|NCT00555217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534656|NCT00555217|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25534657|NCT00555217|Protective Agents|protective agents|mesh-ancestor
25534658|NCT00555217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534659|NCT00555321|Mycophenolic Acid|mycophenolic acid|mesh-list
25534660|NCT00555321|Abatacept|abatacept|mesh-list
25534661|NCT00555321|Tacrolimus|tacrolimus|mesh-list
25534662|NCT00555321|Basiliximab|basiliximab|mesh-list
25534663|NCT00555321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25534664|NCT00555321|Immunologic Factors|immunologic factors|mesh-ancestor
25534665|NCT00555321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534666|NCT00555321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25534667|NCT00555321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534668|NCT00555321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534669|NCT00555321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25534670|NCT00555321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534671|NCT00555321|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25534672|NCT00555321|Antitubercular Agents|antitubercular agents|mesh-ancestor
25534673|NCT00555321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25534674|NCT00555321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25534675|NCT00555321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25534676|NCT00555321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25534677|NCT00555425|Buprenorphine|buprenorphine|mesh-list
25534678|NCT00555425|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25534679|NCT00555425|Naloxone|naloxone|mesh-list
25534680|NCT00555425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25534681|NCT00555425|Narcotics|narcotics|mesh-ancestor
25534682|NCT00555425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25534683|NCT00555425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534684|NCT00555425|Analgesics|analgesics|mesh-ancestor
25534685|NCT00555425|Sensory System Agents|sensory system agents|mesh-ancestor
25534686|NCT00555425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25534687|NCT00555425|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25534688|NCT00555438|PENTA|penta|mesh-list
25534689|NCT00555438|Fondaparinux|fondaparinux|mesh-list
25534690|NCT00555438|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25534691|NCT00555438|Antithrombins|antithrombins|mesh-ancestor
25534692|NCT00555438|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25534693|NCT00555438|Protease Inhibitors|protease inhibitors|mesh-ancestor
25534694|NCT00555438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534695|NCT00555438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534696|NCT00555438|Anticoagulants|anticoagulants|mesh-ancestor
25534697|NCT00555438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25534698|NCT00555438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25534699|NCT00555464|Prednisone|prednisone|mesh-list
25534700|NCT00555464|Prednisolone|prednisolone|mesh-list
25534701|NCT00555464|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25534702|NCT00555464|Methylprednisolone|methylprednisolone|mesh-list
25534703|NCT00555464|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25534704|NCT00555464|Prednisolone acetate|prednisolone acetate|mesh-list
25534705|NCT00555464|Vincristine|vincristine|mesh-list
25534706|NCT00555464|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25534707|NCT00555464|Prednisolone phosphate|prednisolone phosphate|mesh-list
25534708|NCT00555464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25534709|NCT00555464|Glucocorticoids|glucocorticoids|mesh-ancestor
25534710|NCT00555464|Hormones|hormones|mesh-ancestor
24859682|NCT02305173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534711|NCT00555464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25534712|NCT00555464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534713|NCT00555464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25534714|NCT00555464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534715|NCT00555464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25534716|NCT00555464|Tubulin Modulators|tubulin modulators|mesh-ancestor
25534717|NCT00555464|Antimitotic Agents|antimitotic agents|mesh-ancestor
25534718|NCT00555464|Mitosis Modulators|mitosis modulators|mesh-ancestor
25534719|NCT00555464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534720|NCT00555464|Antiemetics|antiemetics|mesh-ancestor
25534721|NCT00555464|Autonomic Agents|autonomic agents|mesh-ancestor
25534722|NCT00555464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25534723|NCT00555464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25534724|NCT00555464|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25534725|NCT00555464|Protective Agents|protective agents|mesh-ancestor
25534726|NCT00555477|Anastrozole|anastrozole|mesh-list
25534727|NCT00555477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25534728|NCT00555477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534729|NCT00555477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25534730|NCT00555477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25534731|NCT00555477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534732|NCT00555477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534733|NCT00555477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25534734|NCT00555477|Hormone Antagonists|hormone antagonists|mesh-ancestor
25534735|NCT00555477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25534736|NCT00555477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534737|NCT00555581|Imatinib Mesylate|imatinib mesylate|mesh-list
25534738|NCT00555581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534739|NCT00555581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25534740|NCT00555581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534741|NCT00555581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534742|NCT00555620|Cisplatin|cisplatin|mesh-list
25534743|NCT00555620|Capecitabine|capecitabine|mesh-list
25534744|NCT00555620|Oxaliplatin|oxaliplatin|mesh-list
25534745|NCT00555620|Sunitinib|sunitinib|mesh-list
25534746|NCT00555620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534747|NCT00555620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25534748|NCT00555620|Antimetabolites|antimetabolites|mesh-ancestor
25534749|NCT00555620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534750|NCT00555620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25534751|NCT00555620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25534752|NCT00555620|Growth Substances|growth substances|mesh-ancestor
25534753|NCT00555620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534754|NCT00555620|Growth Inhibitors|growth inhibitors|mesh-ancestor
25534755|NCT00555620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25534756|NCT00555620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534757|NCT00555672|Cisplatin|cisplatin|mesh-list
25534758|NCT00555672|Fluorouracil|fluorouracil|mesh-list
25534759|NCT00555672|Sunitinib|sunitinib|mesh-list
25534760|NCT00555672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534761|NCT00555672|Antimetabolites|antimetabolites|mesh-ancestor
25534762|NCT00555672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536006|NCT00650182|Fentanyl|fentanyl|mesh-list
25534763|NCT00555672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25534764|NCT00555672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25534765|NCT00555672|Immunologic Factors|immunologic factors|mesh-ancestor
25534766|NCT00555672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534767|NCT00555672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25534768|NCT00555672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25534769|NCT00555672|Growth Substances|growth substances|mesh-ancestor
25534770|NCT00555672|Growth Inhibitors|growth inhibitors|mesh-ancestor
25534771|NCT00555672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25534772|NCT00555672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534773|NCT00555750|Eszopiclone|eszopiclone|mesh-list
25534774|NCT00555750|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25534775|NCT00555750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25534776|NCT00555750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534777|NCT00555880|Midodrine|midodrine|mesh-list
25534778|NCT00555880|Sympathomimetics|sympathomimetics|mesh-ancestor
25534779|NCT00555880|Autonomic Agents|autonomic agents|mesh-ancestor
25534780|NCT00555880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25534781|NCT00555880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534782|NCT00555880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25534783|NCT00555880|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25408478|NCT03437746|Anesthetics|anesthetics|mesh-list
25657206|NCT01584440|Antitussive Agents|antitussive agents|mesh-ancestor
25823594|NCT00004858|Immunologic Factors|immunologic factors|mesh-ancestor
25823595|NCT00004860|Leucovorin|leucovorin|mesh-list
25823596|NCT00004860|Tegafur|tegafur|mesh-list
25823597|NCT00004860|Calcium|calcium|mesh-list
25534784|NCT00555880|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25534785|NCT00555880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25534786|NCT00555880|Adrenergic Agents|adrenergic agents|mesh-ancestor
25534787|NCT00555880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25534788|NCT00555880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534789|NCT00555893|Oseltamivir|oseltamivir|mesh-list
25534790|NCT00555893|Antiviral Agents|antiviral agents|mesh-ancestor
25534791|NCT00555893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25534792|NCT00555893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534793|NCT00555893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534794|NCT00555906|Dexamethasone|dexamethasone|mesh-list
25534795|NCT00555906|Bortezomib|bortezomib|mesh-list
25534796|NCT00555906|Palbociclib|palbociclib|mesh-list
25534797|NCT00555906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25534798|NCT00555906|Antiemetics|antiemetics|mesh-ancestor
25534799|NCT00555906|Autonomic Agents|autonomic agents|mesh-ancestor
25534800|NCT00555906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25534801|NCT00555906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534802|NCT00555906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25534803|NCT00555906|Glucocorticoids|glucocorticoids|mesh-ancestor
25534804|NCT00555906|Hormones|hormones|mesh-ancestor
25534805|NCT00555906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25534806|NCT00555906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25534807|NCT00555906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534808|NCT00555906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25534809|NCT00555906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534810|NCT00555906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534811|NCT00555971|Omalizumab|omalizumab|mesh-list
25534812|NCT00555971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25534813|NCT00555971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25534814|NCT00555971|Respiratory System Agents|respiratory system agents|mesh-ancestor
25534815|NCT00555997|Ziprasidone|ziprasidone|mesh-list
25534816|NCT00555997|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25534817|NCT00555997|Serotonin Agents|serotonin agents|mesh-ancestor
25534818|NCT00555997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25534819|NCT00555997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534820|NCT00555997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534821|NCT00555997|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25534822|NCT00555997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25534823|NCT00555997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25534824|NCT00555997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25534825|NCT00555997|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25534826|NCT00555997|Dopamine Agents|dopamine agents|mesh-ancestor
25534827|NCT00556049|Gemcitabine|gemcitabine|mesh-list
25534828|NCT00556049|Sunitinib|sunitinib|mesh-list
25534829|NCT00556049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25534830|NCT00556049|Antimetabolites|antimetabolites|mesh-ancestor
25534831|NCT00556049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534832|NCT00556049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534833|NCT00556049|Antiviral Agents|antiviral agents|mesh-ancestor
25534834|NCT00556049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25534835|NCT00556049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534836|NCT00556049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25534837|NCT00556049|Immunologic Factors|immunologic factors|mesh-ancestor
25534838|NCT00556049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534839|NCT00556049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25534840|NCT00556049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25534841|NCT00556049|Growth Substances|growth substances|mesh-ancestor
25534842|NCT00556049|Growth Inhibitors|growth inhibitors|mesh-ancestor
25534843|NCT00556049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25534844|NCT00556140|Aripiprazole|aripiprazole|mesh-list
25534845|NCT00556140|Antidepressive Agents|antidepressive agents|mesh-ancestor
25534846|NCT00556140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25534847|NCT00556140|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25534848|NCT00556140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25534849|NCT00556140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25534850|NCT00556140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534851|NCT00556140|Dopamine Agonists|dopamine agonists|mesh-ancestor
25534852|NCT00556140|Dopamine Agents|dopamine agents|mesh-ancestor
24859804|NCT02305862|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24859805|NCT02305862|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25823598|NCT00004860|Levoleucovorin|levoleucovorin|mesh-list
25823599|NCT00004860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24859806|NCT02305862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24859807|NCT02305862|Antimetabolites|antimetabolites|mesh-ancestor
24859808|NCT02305862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859809|NCT02305862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25534853|NCT00556140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25534854|NCT00556140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534855|NCT00556140|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25534856|NCT00556140|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25534857|NCT00556140|Serotonin Agents|serotonin agents|mesh-ancestor
25534858|NCT00556140|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25534859|NCT00556140|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25534860|NCT00556140|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25534861|NCT00556140|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25534862|NCT00556322|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25534863|NCT00556322|Docetaxel|docetaxel|mesh-list
25534864|NCT00556322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534865|NCT00556322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25534866|NCT00556322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534867|NCT00556322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534868|NCT00556322|Tubulin Modulators|tubulin modulators|mesh-ancestor
25534869|NCT00556322|Antimitotic Agents|antimitotic agents|mesh-ancestor
25534870|NCT00556322|Mitosis Modulators|mitosis modulators|mesh-ancestor
25534871|NCT00556439|Abatacept|abatacept|mesh-list
25534872|NCT00556439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25534873|NCT00556439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534874|NCT00556439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534875|NCT00556439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25534876|NCT00556439|Immunologic Factors|immunologic factors|mesh-ancestor
25534877|NCT00556439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534878|NCT00556439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25534879|NCT00556452|Busulfan|busulfan|mesh-list
25534880|NCT00556452|Clofarabine|clofarabine|mesh-list
25534881|NCT00556452|Alkylating Agents|alkylating agents|mesh-ancestor
25534882|NCT00556452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534883|NCT00556452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25534884|NCT00556452|Immunologic Factors|immunologic factors|mesh-ancestor
25534885|NCT00556452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534886|NCT00556452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25534887|NCT00556452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534888|NCT00556452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25534889|NCT00556452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25534890|NCT00556452|Antimetabolites|antimetabolites|mesh-ancestor
25534891|NCT00556478|Lidocaine|lidocaine|mesh-list
25534892|NCT00556478|Prilocaine|prilocaine|mesh-list
25534893|NCT00556478|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25534894|NCT00556478|Anesthetics, Local|anesthetics, local|mesh-ancestor
25534895|NCT00556478|Anesthetics|anesthetics|mesh-ancestor
25534896|NCT00556478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25534897|NCT00556478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534898|NCT00556478|Sensory System Agents|sensory system agents|mesh-ancestor
25534899|NCT00556478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25534900|NCT00556478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25534901|NCT00556478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25534902|NCT00556478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25534903|NCT00556478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25534904|NCT00556478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534905|NCT00556478|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25534906|NCT00556491|Minocycline|minocycline|mesh-list
25534907|NCT00556491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25534908|NCT00556491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25534909|NCT00556504|Ribavirin|ribavirin|mesh-list
25534910|NCT00556504|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25534911|NCT00556504|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25534912|NCT00556504|Antimetabolites|antimetabolites|mesh-ancestor
25534913|NCT00556504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534914|NCT00556504|Antiviral Agents|antiviral agents|mesh-ancestor
25534915|NCT00556504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25534916|NCT00556673|Fluticasone|fluticasone|mesh-list
25534917|NCT00556673|Mometasone Furoate|mometasone furoate|mesh-list
25534918|NCT00556673|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25823600|NCT00004860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823601|NCT00004860|Antidotes|antidotes|mesh-ancestor
25823602|NCT00004860|Protective Agents|protective agents|mesh-ancestor
25823603|NCT00004860|Vitamin B Complex|vitamin b complex|mesh-ancestor
25823604|NCT00004860|Vitamins|vitamins|mesh-ancestor
25823605|NCT00004860|Micronutrients|micronutrients|mesh-ancestor
24930995|NCT04094909|Cisplatin|cisplatin|mesh-list
24813322|NCT02057796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25534919|NCT00556673|Maleic acid|maleic acid|mesh-list
25534920|NCT00556673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25534921|NCT00556673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25534922|NCT00556673|Autonomic Agents|autonomic agents|mesh-ancestor
25534923|NCT00556673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25534924|NCT00556673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534925|NCT00556673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25534926|NCT00556673|Respiratory System Agents|respiratory system agents|mesh-ancestor
25534927|NCT00556673|Dermatologic Agents|dermatologic agents|mesh-ancestor
25534928|NCT00556673|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25534929|NCT00556673|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25534930|NCT00556673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25534931|NCT00556673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25534932|NCT00556673|Adrenergic Agents|adrenergic agents|mesh-ancestor
25534933|NCT00556673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25534934|NCT00556673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534935|NCT00556673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534936|NCT00556712|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25534937|NCT00556712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534938|NCT00556712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25534939|NCT00556712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534940|NCT00556712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534941|NCT00556933|Mycophenolic Acid|mycophenolic acid|mesh-list
25534942|NCT00556933|Sirolimus|sirolimus|mesh-list
25534943|NCT00556933|Tacrolimus|tacrolimus|mesh-list
25534944|NCT00556933|Thymoglobulin|thymoglobulin|mesh-list
25534945|NCT00556933|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25534946|NCT00556933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25534947|NCT00556933|Immunologic Factors|immunologic factors|mesh-ancestor
25534948|NCT00556933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534949|NCT00556933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25534950|NCT00556933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534951|NCT00556933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534952|NCT00556933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25534953|NCT00556933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25534954|NCT00556933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25534955|NCT00556933|Antitubercular Agents|antitubercular agents|mesh-ancestor
25534956|NCT00556933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25534957|NCT00556933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25534958|NCT00556933|Antifungal Agents|antifungal agents|mesh-ancestor
25534959|NCT00556998|Voriconazole|voriconazole|mesh-list
25534960|NCT00556998|Antifungal Agents|antifungal agents|mesh-ancestor
25534961|NCT00556998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25534962|NCT00556998|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25534963|NCT00556998|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25534964|NCT00556998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534965|NCT00556998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534966|NCT00556998|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25534967|NCT00556998|Hormone Antagonists|hormone antagonists|mesh-ancestor
25534968|NCT00556998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25534969|NCT00556998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534970|NCT00556998|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25534971|NCT00557245|Tenofovir|tenofovir|mesh-list
25534972|NCT00557245|Emtricitabine|emtricitabine|mesh-list
25534973|NCT00557245|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25534974|NCT00557245|Antiviral Agents|antiviral agents|mesh-ancestor
25534975|NCT00557245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25534976|NCT00557245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25534977|NCT00557245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25534978|NCT00557245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25534979|NCT00557245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534980|NCT00557245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25534981|NCT00557245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25534982|NCT00557284|Montelukast|montelukast|mesh-list
25534983|NCT00557284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25534984|NCT00557284|Respiratory System Agents|respiratory system agents|mesh-ancestor
25534985|NCT00557284|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25534986|NCT00557284|Hormone Antagonists|hormone antagonists|mesh-ancestor
25823606|NCT00004860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25534987|NCT00557284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25534988|NCT00557284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534989|NCT00557284|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25534990|NCT00557284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25534991|NCT00557284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25534992|NCT00557310|Teriparatide|teriparatide|mesh-list
25534993|NCT00557310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25534994|NCT00557310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25534995|NCT00557310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25534996|NCT00557349|Omeprazole|omeprazole|mesh-list
25534997|NCT00557349|Famotidine|famotidine|mesh-list
25534998|NCT00557349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25534999|NCT00557349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25535000|NCT00557349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25535001|NCT00557349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535002|NCT00557349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535003|NCT00557349|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25535004|NCT00557349|Histamine Antagonists|histamine antagonists|mesh-ancestor
25535005|NCT00557349|Histamine Agents|histamine agents|mesh-ancestor
25535006|NCT00557349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25535007|NCT00557349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535008|NCT00557362|Voriconazole|voriconazole|mesh-list
25535009|NCT00557362|Natamycin|natamycin|mesh-list
25535010|NCT00557362|Antifungal Agents|antifungal agents|mesh-ancestor
25535011|NCT00557362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25535012|NCT00557362|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25535013|NCT00557362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25535014|NCT00557362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535015|NCT00557362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535016|NCT00557362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25535017|NCT00557362|Hormone Antagonists|hormone antagonists|mesh-ancestor
25535018|NCT00557362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25535019|NCT00557362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535020|NCT00557362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25535021|NCT00557362|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25535022|NCT00557362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25535023|NCT00557440|Fluticasone|fluticasone|mesh-list
25535024|NCT00557440|Xhance|xhance|mesh-list
25535025|NCT00557440|Mometasone Furoate|mometasone furoate|mesh-list
25535026|NCT00557440|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25535027|NCT00557440|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25535028|NCT00557440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25535029|NCT00557440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25535030|NCT00557440|Autonomic Agents|autonomic agents|mesh-ancestor
25535031|NCT00557440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25535032|NCT00557440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535033|NCT00557440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25535034|NCT00557440|Respiratory System Agents|respiratory system agents|mesh-ancestor
25535035|NCT00557440|Dermatologic Agents|dermatologic agents|mesh-ancestor
25535036|NCT00557440|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25535037|NCT00557440|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25535038|NCT00557440|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25535039|NCT00557440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25535040|NCT00557440|Adrenergic Agents|adrenergic agents|mesh-ancestor
25535041|NCT00557440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25535042|NCT00557440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535043|NCT00557440|Glucocorticoids|glucocorticoids|mesh-ancestor
25535044|NCT00557440|Hormones|hormones|mesh-ancestor
25535045|NCT00557440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25535046|NCT00557440|Sympathomimetics|sympathomimetics|mesh-ancestor
25535047|NCT00557466|Formoterol Fumarate|formoterol fumarate|mesh-list
25535048|NCT00557466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25535049|NCT00557466|Autonomic Agents|autonomic agents|mesh-ancestor
25535050|NCT00557466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25535051|NCT00557466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535052|NCT00557466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25535053|NCT00557466|Respiratory System Agents|respiratory system agents|mesh-ancestor
25535054|NCT00557466|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25535055|NCT00557466|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25535056|NCT00557466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25535057|NCT00557466|Adrenergic Agents|adrenergic agents|mesh-ancestor
25535058|NCT00557466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25823607|NCT00004860|Antimetabolites|antimetabolites|mesh-ancestor
25647038|NCT01465763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535059|NCT00557466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535060|NCT00557492|Gemcitabine|gemcitabine|mesh-list
25535061|NCT00557492|Bevacizumab|bevacizumab|mesh-list
25535062|NCT00557492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25829661|NCT00006246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535097|NCT00558012|Zoledronic Acid|zoledronic acid|mesh-list
25535098|NCT00558012|Calcium|calcium|mesh-list
25535099|NCT00558012|Vitamins|vitamins|mesh-ancestor
25535100|NCT00558012|Micronutrients|micronutrients|mesh-ancestor
25535101|NCT00558012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535102|NCT00558012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25535103|NCT00558012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25535104|NCT00558025|Pramipexole|pramipexole|mesh-list
25535105|NCT00558025|Antioxidants|antioxidants|mesh-ancestor
25535106|NCT00558025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535107|NCT00558025|Protective Agents|protective agents|mesh-ancestor
25535108|NCT00558025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535109|NCT00558025|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25535110|NCT00558025|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25535111|NCT00558025|Dopamine Agonists|dopamine agonists|mesh-ancestor
25535112|NCT00558025|Dopamine Agents|dopamine agents|mesh-ancestor
25535113|NCT00558025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25535114|NCT00558064|Amlodipine|amlodipine|mesh-list
25535115|NCT00558064|Telmisartan|telmisartan|mesh-list
25535116|NCT00558064|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
25535117|NCT00558064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25535118|NCT00558064|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25535119|NCT00558064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25535120|NCT00558064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535121|NCT00558064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25535122|NCT00558064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535123|NCT00558064|Vasodilator Agents|vasodilator agents|mesh-ancestor
25535124|NCT00558064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25535125|NCT00558064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25535126|NCT00558103|Lapatinib|lapatinib|mesh-list
25535127|NCT00558103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535128|NCT00558103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25535129|NCT00558103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535130|NCT00558103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535131|NCT00558259|Dabigatran|dabigatran|mesh-list
25535132|NCT00558259|Antithrombins|antithrombins|mesh-ancestor
25535133|NCT00558259|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25535134|NCT00558259|Protease Inhibitors|protease inhibitors|mesh-ancestor
25535135|NCT00558259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535136|NCT00558259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535137|NCT00558259|Anticoagulants|anticoagulants|mesh-ancestor
25535138|NCT00558272|Zoledronic Acid|zoledronic acid|mesh-list
25535139|NCT00558272|Saracatinib|saracatinib|mesh-list
25535140|NCT00558272|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25535141|NCT00558272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535142|NCT00558272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535143|NCT00558272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535144|NCT00558272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535145|NCT00558285|Glycopyrrolate|glycopyrrolate|mesh-list
25535146|NCT00558285|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25535147|NCT00558285|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25535148|NCT00558285|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25535149|NCT00558285|Cholinergic Agents|cholinergic agents|mesh-ancestor
25535150|NCT00558285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25535151|NCT00558285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535152|NCT00558285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535153|NCT00558363|Dutasteride|dutasteride|mesh-list
25535154|NCT00558363|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25535155|NCT00558363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25535156|NCT00558363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535157|NCT00558363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535158|NCT00558363|Hormone Antagonists|hormone antagonists|mesh-ancestor
25535159|NCT00558363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25535160|NCT00558363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535161|NCT00558428|Amlodipine|amlodipine|mesh-list
25535162|NCT00558428|Telmisartan|telmisartan|mesh-list
25535163|NCT00558428|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
25535164|NCT00558428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25535165|NCT00558428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25823608|NCT00004860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823609|NCT00004860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24540409|NCT00667901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25535166|NCT00558428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25535167|NCT00558428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535168|NCT00558428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25535169|NCT00558428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535170|NCT00558428|Vasodilator Agents|vasodilator agents|mesh-ancestor
25535171|NCT00558428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25535172|NCT00558428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25535174|NCT00558467|Antioxidants|antioxidants|mesh-ancestor
25535175|NCT00558467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535176|NCT00558467|Protective Agents|protective agents|mesh-ancestor
25535177|NCT00558467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535178|NCT00558467|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25535179|NCT00558467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25535180|NCT00558467|Dopamine Agonists|dopamine agonists|mesh-ancestor
25535181|NCT00558467|Dopamine Agents|dopamine agents|mesh-ancestor
25535182|NCT00558467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25535183|NCT00558519|Cytarabine|cytarabine|mesh-list
25535184|NCT00558519|Dexamethasone|dexamethasone|mesh-list
25535185|NCT00558519|Cyclophosphamide|cyclophosphamide|mesh-list
25535186|NCT00558519|Doxorubicin|doxorubicin|mesh-list
25535187|NCT00558519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25535188|NCT00558519|Methotrexate|methotrexate|mesh-list
25535189|NCT00558519|Vincristine|vincristine|mesh-list
25535190|NCT00558519|Daunorubicin|daunorubicin|mesh-list
25535191|NCT00558519|Mercaptopurine|mercaptopurine|mesh-list
25535192|NCT00558519|Pegaspargase|pegaspargase|mesh-list
25535193|NCT00558519|Thioguanine|thioguanine|mesh-list
25535194|NCT00558519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25535195|NCT00558519|Immunologic Factors|immunologic factors|mesh-ancestor
25535196|NCT00558519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535197|NCT00558519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25535198|NCT00558519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25535199|NCT00558519|Alkylating Agents|alkylating agents|mesh-ancestor
25535200|NCT00558519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535201|NCT00558519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535202|NCT00558519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25535203|NCT00558519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25535204|NCT00558519|Antiemetics|antiemetics|mesh-ancestor
25535205|NCT00558519|Autonomic Agents|autonomic agents|mesh-ancestor
25535206|NCT00558519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25535207|NCT00558519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25535208|NCT00558519|Glucocorticoids|glucocorticoids|mesh-ancestor
25535209|NCT00558519|Hormones|hormones|mesh-ancestor
25535210|NCT00558519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25535211|NCT00558519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25535212|NCT00558519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25535213|NCT00558519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25535214|NCT00558519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25535215|NCT00558519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535216|NCT00558519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25535217|NCT00558519|Abortifacient Agents|abortifacient agents|mesh-ancestor
25535218|NCT00558519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25535219|NCT00558519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25535220|NCT00558519|Antimetabolites|antimetabolites|mesh-ancestor
25535221|NCT00558519|Dermatologic Agents|dermatologic agents|mesh-ancestor
25535222|NCT00558519|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25535223|NCT00558519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25535224|NCT00558519|Antiviral Agents|antiviral agents|mesh-ancestor
25535225|NCT00558519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25535226|NCT00558519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25535227|NCT00558519|Tubulin Modulators|tubulin modulators|mesh-ancestor
25535228|NCT00558519|Antimitotic Agents|antimitotic agents|mesh-ancestor
25535229|NCT00558519|Mitosis Modulators|mitosis modulators|mesh-ancestor
25535230|NCT00558571|Empagliflozin|empagliflozin|mesh-list
25535231|NCT00558571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25535232|NCT00558571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535233|NCT00558571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25535234|NCT00558571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535235|NCT00558636|Paclitaxel|paclitaxel|mesh-list
25535236|NCT00558636|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25535237|NCT00558636|Carboplatin|carboplatin|mesh-list
25535238|NCT00558636|Sorafenib|sorafenib|mesh-list
25535239|NCT00558636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25535240|NCT00558636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535242|NCT00558636|Antimitotic Agents|antimitotic agents|mesh-ancestor
25535243|NCT00558636|Mitosis Modulators|mitosis modulators|mesh-ancestor
25535244|NCT00558636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535245|NCT00558636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25535246|NCT00558636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535247|NCT00558753|Pregabalin|pregabalin|mesh-list
25535248|NCT00558753|Analgesics|analgesics|mesh-ancestor
25535249|NCT00558753|Sensory System Agents|sensory system agents|mesh-ancestor
25535250|NCT00558753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25535251|NCT00558753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535252|NCT00558753|Anticonvulsants|anticonvulsants|mesh-ancestor
25535253|NCT00558753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25535254|NCT00558753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25535255|NCT00558753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535256|NCT00558753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25535257|NCT00558753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25535258|NCT00558753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25535259|NCT00558753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25535260|NCT00558753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25535261|NCT00558831|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25535262|NCT00558831|Dermatologic Agents|dermatologic agents|mesh-ancestor
25535263|NCT00558896|Dexamethasone|dexamethasone|mesh-list
25535264|NCT00558896|Pomalidomide|pomalidomide|mesh-list
25535265|NCT00558896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25535266|NCT00558896|Antiemetics|antiemetics|mesh-ancestor
25535267|NCT00558896|Autonomic Agents|autonomic agents|mesh-ancestor
25535268|NCT00558896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25535269|NCT00558896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535270|NCT00558896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25535271|NCT00558896|Glucocorticoids|glucocorticoids|mesh-ancestor
25535272|NCT00558896|Hormones|hormones|mesh-ancestor
25535273|NCT00558896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25535274|NCT00558896|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25535275|NCT00558896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535276|NCT00558896|Immunologic Factors|immunologic factors|mesh-ancestor
25535277|NCT00558896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25535278|NCT00558896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25535279|NCT00558896|Growth Substances|growth substances|mesh-ancestor
25535280|NCT00558896|Growth Inhibitors|growth inhibitors|mesh-ancestor
25535281|NCT00559104|Cyclophosphamide|cyclophosphamide|mesh-list
25535282|NCT00559104|Carmustine|carmustine|mesh-list
25535283|NCT00559104|Etoposide|etoposide|mesh-list
25535284|NCT00559104|Lenograstim|lenograstim|mesh-list
25535285|NCT00559104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25535286|NCT00559104|Immunologic Factors|immunologic factors|mesh-ancestor
25535287|NCT00559104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535288|NCT00559104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25535289|NCT00559104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25535290|NCT00559104|Alkylating Agents|alkylating agents|mesh-ancestor
25535291|NCT00559104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535292|NCT00559104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535293|NCT00559104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25535294|NCT00559104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25535295|NCT00559104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25535296|NCT00559104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25535297|NCT00559104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535298|NCT00559104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25535299|NCT00559273|Darbepoetin alfa|darbepoetin alfa|mesh-list
25535300|NCT00559273|Hematinics|hematinics|mesh-ancestor
25535301|NCT00559364|Omeprazole|omeprazole|mesh-list
25535302|NCT00559364|Pancrelipase|pancrelipase|mesh-list
25535303|NCT00559364|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25535304|NCT00559364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25535305|NCT00559364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25535306|NCT00559364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535307|NCT00559364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535308|NCT00559377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25535309|NCT00559377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25535310|NCT00559377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535311|NCT00559468|Bromides|bromides|mesh-list
25535312|NCT00559468|Propofol|propofol|mesh-list
25647039|NCT01465802|Doxycycline|doxycycline|mesh-list
25535313|NCT00559468|Sevoflurane|sevoflurane|mesh-list
25535315|NCT00559468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24540431|NCT00667966|Urological Agents|urological agents|mesh-ancestor
25535316|NCT00559468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25535317|NCT00559468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535318|NCT00559468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25535320|NCT00559468|Anesthetics|anesthetics|mesh-ancestor
25535321|NCT00559468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25535322|NCT00559468|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25535323|NCT00559468|Anticonvulsants|anticonvulsants|mesh-ancestor
25535324|NCT00559468|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25535325|NCT00559468|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25535326|NCT00559468|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25535327|NCT00559468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25535328|NCT00559507|Saracatinib|saracatinib|mesh-list
25535329|NCT00559507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535330|NCT00559507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535331|NCT00559507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535332|NCT00559585|Abatacept|abatacept|mesh-list
25535333|NCT00559585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25535334|NCT00559585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535335|NCT00559585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535336|NCT00559585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25535337|NCT00559585|Immunologic Factors|immunologic factors|mesh-ancestor
25535338|NCT00559585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535339|NCT00559585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25535340|NCT00559637|Epoetin Alfa|epoetin alfa|mesh-list
25535341|NCT00559637|Hematinics|hematinics|mesh-ancestor
25535342|NCT00559754|Bevacizumab|bevacizumab|mesh-list
25535343|NCT00559754|Docetaxel|docetaxel|mesh-list
25535344|NCT00559754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25535345|NCT00559754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535346|NCT00559754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25535347|NCT00559754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25535348|NCT00559754|Growth Substances|growth substances|mesh-ancestor
25535349|NCT00559754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535350|NCT00559754|Growth Inhibitors|growth inhibitors|mesh-ancestor
25535351|NCT00559754|Tubulin Modulators|tubulin modulators|mesh-ancestor
25535352|NCT00559754|Antimitotic Agents|antimitotic agents|mesh-ancestor
25535353|NCT00559754|Mitosis Modulators|mitosis modulators|mesh-ancestor
25535354|NCT00559754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535355|NCT00559845|Paclitaxel|paclitaxel|mesh-list
25535356|NCT00559845|Cyclophosphamide|cyclophosphamide|mesh-list
25535357|NCT00559845|Bevacizumab|bevacizumab|mesh-list
25535358|NCT00559845|Fluorouracil|fluorouracil|mesh-list
25535359|NCT00559845|Epirubicin|epirubicin|mesh-list
25535360|NCT00559845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25535361|NCT00559845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535362|NCT00559845|Tubulin Modulators|tubulin modulators|mesh-ancestor
25535363|NCT00559845|Antimitotic Agents|antimitotic agents|mesh-ancestor
25535364|NCT00559845|Mitosis Modulators|mitosis modulators|mesh-ancestor
25535365|NCT00559845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535366|NCT00559845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25535367|NCT00559845|Immunologic Factors|immunologic factors|mesh-ancestor
25535368|NCT00559845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535369|NCT00559845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25535370|NCT00559845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25535371|NCT00559845|Alkylating Agents|alkylating agents|mesh-ancestor
25535372|NCT00559845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25535373|NCT00559845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25535374|NCT00559845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25535375|NCT00559845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25535376|NCT00559845|Growth Substances|growth substances|mesh-ancestor
25535377|NCT00559845|Growth Inhibitors|growth inhibitors|mesh-ancestor
25535378|NCT00559845|Antimetabolites|antimetabolites|mesh-ancestor
25535379|NCT00559845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25535380|NCT00559845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25535381|NCT00559845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25535382|NCT00559845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25535383|NCT00559845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535384|NCT00559962|Atorvastatin|atorvastatin|mesh-list
25535385|NCT00559962|Ezetimibe|ezetimibe|mesh-list
25535386|NCT00559962|Fenofibrate|fenofibrate|mesh-list
25535387|NCT00559962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25535388|NCT00559962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25535389|NCT00559962|Antimetabolites|antimetabolites|mesh-ancestor
25535390|NCT00559962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535391|NCT00559962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25535392|NCT00559962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25535393|NCT00559962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535395|NCT00560066|Immunologic Factors|immunologic factors|mesh-ancestor
25535396|NCT00560066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535397|NCT00560352|Dexamethasone|dexamethasone|mesh-list
25535398|NCT00560352|Bortezomib|bortezomib|mesh-list
25535399|NCT00560352|Dasatinib|dasatinib|mesh-list
25535400|NCT00560352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25535401|NCT00560352|Antiemetics|antiemetics|mesh-ancestor
25535402|NCT00560352|Autonomic Agents|autonomic agents|mesh-ancestor
25535403|NCT00560352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25535404|NCT00560352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535405|NCT00560352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25535406|NCT00560352|Glucocorticoids|glucocorticoids|mesh-ancestor
25535407|NCT00560352|Hormones|hormones|mesh-ancestor
25535408|NCT00560352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25535409|NCT00560352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25535410|NCT00560352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535411|NCT00560352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25535412|NCT00560352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535413|NCT00560352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535414|NCT00560391|Dexamethasone|dexamethasone|mesh-list
25535415|NCT00560391|Dexamethasone acetate|dexamethasone acetate|mesh-list
25535416|NCT00560391|Lenalidomide|lenalidomide|mesh-list
25535417|NCT00560391|Dasatinib|dasatinib|mesh-list
25535418|NCT00560391|BB 1101|bb 1101|mesh-list
25535419|NCT00560391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25535420|NCT00560391|Antiemetics|antiemetics|mesh-ancestor
25535421|NCT00560391|Autonomic Agents|autonomic agents|mesh-ancestor
25535422|NCT00560391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25535423|NCT00560391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535424|NCT00560391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25535425|NCT00560391|Glucocorticoids|glucocorticoids|mesh-ancestor
25535426|NCT00560391|Hormones|hormones|mesh-ancestor
25535427|NCT00560391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25535428|NCT00560391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25535429|NCT00560391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535430|NCT00560391|Protease Inhibitors|protease inhibitors|mesh-ancestor
25535431|NCT00560391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535432|NCT00560391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535433|NCT00560391|Immunologic Factors|immunologic factors|mesh-ancestor
25535434|NCT00560391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25535435|NCT00560391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25535436|NCT00560391|Growth Substances|growth substances|mesh-ancestor
25535437|NCT00560391|Growth Inhibitors|growth inhibitors|mesh-ancestor
25535438|NCT00560391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25535439|NCT00560404|Epoetin Alfa|epoetin alfa|mesh-list
25535440|NCT00560404|Hematinics|hematinics|mesh-ancestor
25535441|NCT00560417|Insulin|insulin|mesh-list
25535442|NCT00560417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25535443|NCT00560417|Insulin Glargine|insulin glargine|mesh-list
25535444|NCT00560417|Insulin Lispro|insulin lispro|mesh-list
25535445|NCT00560417|Protamines|protamines|mesh-list
25535446|NCT00560417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25535447|NCT00560417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535448|NCT00560417|Heparin Antagonists|heparin antagonists|mesh-ancestor
25535449|NCT00560417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535450|NCT00560417|Coagulants|coagulants|mesh-ancestor
25535451|NCT00560508|Pramipexole|pramipexole|mesh-list
25535452|NCT00560508|Antioxidants|antioxidants|mesh-ancestor
25535453|NCT00560508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535454|NCT00560508|Protective Agents|protective agents|mesh-ancestor
25535455|NCT00560508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535456|NCT00560508|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25535457|NCT00560508|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25535458|NCT00560508|Dopamine Agonists|dopamine agonists|mesh-ancestor
25535459|NCT00560508|Dopamine Agents|dopamine agents|mesh-ancestor
25535460|NCT00560508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25535461|NCT00560573|Gemcitabine|gemcitabine|mesh-list
25535462|NCT00560573|Cisplatin|cisplatin|mesh-list
25823610|NCT00004861|Gemcitabine|gemcitabine|mesh-list
25535463|NCT00560573|Pemetrexed|pemetrexed|mesh-list
25823611|NCT00004861|Tacedinaline|tacedinaline|mesh-list
25647040|NCT01465802|Alclometasone dipropionate|alclometasone dipropionate|mesh-list
25647041|NCT01465802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25535464|NCT00560573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535465|NCT00560573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25535467|NCT00560573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535468|NCT00560573|Antiviral Agents|antiviral agents|mesh-ancestor
25535469|NCT00560573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25535470|NCT00560573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535471|NCT00560573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25535472|NCT00560573|Immunologic Factors|immunologic factors|mesh-ancestor
25535473|NCT00560573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535474|NCT00560573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25535475|NCT00560573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25535476|NCT00560612|Paroxetine|paroxetine|mesh-list
25535477|NCT00560612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25535478|NCT00560612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25535479|NCT00560612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25535480|NCT00560612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535481|NCT00560612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25535482|NCT00560612|Serotonin Agents|serotonin agents|mesh-ancestor
25535483|NCT00560612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535484|NCT00560612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25535485|NCT00560612|Antidepressive Agents|antidepressive agents|mesh-ancestor
25535486|NCT00560612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25535487|NCT00560612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25535488|NCT00560612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25535489|NCT00560612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535490|NCT00560703|Doxycycline|doxycycline|mesh-list
25535491|NCT00560703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25535492|NCT00560703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25535493|NCT00560703|Antimalarials|antimalarials|mesh-ancestor
25535494|NCT00560703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25535495|NCT00560703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25535496|NCT00560794|Blinatumomab|blinatumomab|mesh-list
25535497|NCT00560794|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25535498|NCT00560794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535499|NCT00560794|Immunologic Factors|immunologic factors|mesh-ancestor
25535500|NCT00560794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535501|NCT00560833|Mirtazapine|mirtazapine|mesh-list
25535502|NCT00560833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535503|NCT00560833|Antidepressive Agents|antidepressive agents|mesh-ancestor
25535504|NCT00560833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25535505|NCT00560833|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25535506|NCT00560833|Histamine Antagonists|histamine antagonists|mesh-ancestor
25535507|NCT00560833|Histamine Agents|histamine agents|mesh-ancestor
25535508|NCT00560833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25535509|NCT00560833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535510|NCT00560833|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25535511|NCT00560833|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25535512|NCT00560833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25535513|NCT00560833|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25535514|NCT00560833|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25535515|NCT00560833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25535516|NCT00560833|Adrenergic Agents|adrenergic agents|mesh-ancestor
25535517|NCT00560833|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25535518|NCT00560833|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25535519|NCT00560833|Serotonin Agents|serotonin agents|mesh-ancestor
25535520|NCT00560833|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25535521|NCT00560950|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25535522|NCT00560950|Immunologic Factors|immunologic factors|mesh-ancestor
25535523|NCT00560950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535524|NCT00561002|Vaccines|vaccines|mesh-list
25535525|NCT00561002|Immunologic Factors|immunologic factors|mesh-ancestor
25535526|NCT00561002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535527|NCT00561015|Ribavirin|ribavirin|mesh-list
25535528|NCT00561015|Interferon alpha-2|interferon alpha-2|mesh-list
25535529|NCT00561015|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25535530|NCT00561015|Antimetabolites|antimetabolites|mesh-ancestor
25535531|NCT00561015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535532|NCT00561015|Antiviral Agents|antiviral agents|mesh-ancestor
25535533|NCT00561015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25535534|NCT00561015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535535|NCT00561080|Vaccines|vaccines|mesh-list
25535536|NCT00561080|Immunologic Factors|immunologic factors|mesh-ancestor
25535537|NCT00561080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535538|NCT00561353|Ribavirin|ribavirin|mesh-list
25535539|NCT00561353|Simeprevir|simeprevir|mesh-list
25535540|NCT00561353|Antimetabolites|antimetabolites|mesh-ancestor
25535541|NCT00561353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535542|NCT00561353|Antiviral Agents|antiviral agents|mesh-ancestor
25535543|NCT00561353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25535544|NCT00561353|Protease Inhibitors|protease inhibitors|mesh-ancestor
25535545|NCT00561353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535546|NCT00561392|Rivastigmine|rivastigmine|mesh-list
25535547|NCT00561392|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25535548|NCT00561392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535549|NCT00561392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535550|NCT00561392|Cholinergic Agents|cholinergic agents|mesh-ancestor
25535551|NCT00561392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25535552|NCT00561392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535553|NCT00561392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25535554|NCT00561392|Protective Agents|protective agents|mesh-ancestor
25535556|NCT00561418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535557|NCT00561418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25535558|NCT00561418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535559|NCT00561418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535560|NCT00561470|Leucovorin|leucovorin|mesh-list
25535561|NCT00561470|Fluorouracil|fluorouracil|mesh-list
25535562|NCT00561470|Irinotecan|irinotecan|mesh-list
25535563|NCT00561470|Aflibercept|aflibercept|mesh-list
25535564|NCT00561470|Levoleucovorin|levoleucovorin|mesh-list
25535565|NCT00561470|Antimetabolites|antimetabolites|mesh-ancestor
25535566|NCT00561470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535567|NCT00561470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25535568|NCT00561470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535569|NCT00561470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25535570|NCT00561470|Immunologic Factors|immunologic factors|mesh-ancestor
25535571|NCT00561470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535572|NCT00561470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25535573|NCT00561470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25535574|NCT00561470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535575|NCT00561470|Antidotes|antidotes|mesh-ancestor
25535576|NCT00561470|Protective Agents|protective agents|mesh-ancestor
25535577|NCT00561470|Vitamin B Complex|vitamin b complex|mesh-ancestor
25535578|NCT00561470|Vitamins|vitamins|mesh-ancestor
25535579|NCT00561470|Micronutrients|micronutrients|mesh-ancestor
25535580|NCT00561470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25535581|NCT00561470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25535582|NCT00561470|Growth Substances|growth substances|mesh-ancestor
25535583|NCT00561470|Growth Inhibitors|growth inhibitors|mesh-ancestor
25535584|NCT00561574|Mirtazapine|mirtazapine|mesh-list
25535585|NCT00561574|Antidepressive Agents|antidepressive agents|mesh-ancestor
25535586|NCT00561574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25535587|NCT00561574|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25535588|NCT00561574|Histamine Antagonists|histamine antagonists|mesh-ancestor
25535589|NCT00561574|Histamine Agents|histamine agents|mesh-ancestor
25535590|NCT00561574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25535591|NCT00561574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535592|NCT00561574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535593|NCT00561574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25535594|NCT00561574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25535595|NCT00561574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25535596|NCT00561574|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25535597|NCT00561574|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25535598|NCT00561574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25535599|NCT00561574|Adrenergic Agents|adrenergic agents|mesh-ancestor
25535600|NCT00561574|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25535601|NCT00561574|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25535602|NCT00561574|Serotonin Agents|serotonin agents|mesh-ancestor
25535603|NCT00561574|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25535604|NCT00561678|Dexmedetomidine|dexmedetomidine|mesh-list
25535605|NCT00561678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25535606|NCT00561678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25535607|NCT00561678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535608|NCT00561678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25535609|NCT00561678|Analgesics|analgesics|mesh-ancestor
25535610|NCT00561678|Sensory System Agents|sensory system agents|mesh-ancestor
25535611|NCT00561678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25647042|NCT01465802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25647043|NCT01465802|Antimalarials|antimalarials|mesh-ancestor
25535612|NCT00561678|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25823612|NCT00004861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25823613|NCT00004861|Antimetabolites|antimetabolites|mesh-ancestor
25823614|NCT00004861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823615|NCT00004861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535613|NCT00561678|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25535614|NCT00561678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25535615|NCT00561678|Adrenergic Agents|adrenergic agents|mesh-ancestor
25535616|NCT00561678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25535617|NCT00561678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535618|NCT00561730|Pantoprazole|pantoprazole|mesh-list
25535619|NCT00561730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25535620|NCT00561730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25535621|NCT00561730|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25535622|NCT00561730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535623|NCT00561730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535624|NCT00561821|Mirtazapine|mirtazapine|mesh-list
25535625|NCT00561821|Antidepressive Agents|antidepressive agents|mesh-ancestor
25535626|NCT00561821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25535627|NCT00561821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25535628|NCT00561821|Histamine Antagonists|histamine antagonists|mesh-ancestor
25535629|NCT00561821|Histamine Agents|histamine agents|mesh-ancestor
25535630|NCT00561821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25535631|NCT00561821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535632|NCT00561821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535633|NCT00561821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25535634|NCT00561821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25535635|NCT00561821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25535636|NCT00561821|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25535637|NCT00561821|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25535638|NCT00561821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25535639|NCT00561821|Adrenergic Agents|adrenergic agents|mesh-ancestor
25535640|NCT00561821|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25535641|NCT00561821|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25535642|NCT00561821|Serotonin Agents|serotonin agents|mesh-ancestor
25535643|NCT00561821|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25535644|NCT00561834|Ranibizumab|ranibizumab|mesh-list
25535645|NCT00561834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25535646|NCT00561834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25535647|NCT00561834|Growth Substances|growth substances|mesh-ancestor
25535648|NCT00561834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535649|NCT00561834|Growth Inhibitors|growth inhibitors|mesh-ancestor
25535650|NCT00561834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535651|NCT00561925|Nevirapine|nevirapine|mesh-list
25535652|NCT00561925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25535653|NCT00561925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25535654|NCT00561925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535655|NCT00561925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535656|NCT00561925|Antiviral Agents|antiviral agents|mesh-ancestor
25535657|NCT00561925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25535658|NCT00561925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25535659|NCT00561925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25535660|NCT00561925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25535661|NCT00561925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25535662|NCT00561951|Fesoterodine|fesoterodine|mesh-list
25535663|NCT00561951|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25535664|NCT00561951|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25535665|NCT00561951|Cholinergic Agents|cholinergic agents|mesh-ancestor
25535666|NCT00561951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25535667|NCT00561951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535668|NCT00561951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535669|NCT00561951|Urological Agents|urological agents|mesh-ancestor
25535670|NCT00562094|Pantoprazole|pantoprazole|mesh-list
25535671|NCT00562094|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25535672|NCT00562094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25535673|NCT00562094|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25535674|NCT00562094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535675|NCT00562094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535676|NCT00562120|Fexofenadine|fexofenadine|mesh-list
25535677|NCT00562120|Terfenadine|terfenadine|mesh-list
25535678|NCT00562120|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25535679|NCT00562120|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25535680|NCT00562120|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25535681|NCT00562120|Histamine Antagonists|histamine antagonists|mesh-ancestor
25535682|NCT00562120|Histamine Agents|histamine agents|mesh-ancestor
25535683|NCT00562120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25535684|NCT00562120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535685|NCT00562120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535688|NCT00562159|Mometasone Furoate|mometasone furoate|mesh-list
25535689|NCT00562159|Loratadine|loratadine|mesh-list
25535690|NCT00562159|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25535691|NCT00562159|Prednisone|prednisone|mesh-list
25535692|NCT00562159|Albuterol|albuterol|mesh-list
25535693|NCT00562159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25535694|NCT00562159|Glucocorticoids|glucocorticoids|mesh-ancestor
25535695|NCT00562159|Hormones|hormones|mesh-ancestor
25535696|NCT00562159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25535697|NCT00562159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535698|NCT00562159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25535699|NCT00562159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535700|NCT00562159|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25535701|NCT00562159|Autonomic Agents|autonomic agents|mesh-ancestor
25535702|NCT00562159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25535703|NCT00562159|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25535704|NCT00562159|Respiratory System Agents|respiratory system agents|mesh-ancestor
25535705|NCT00562159|Dermatologic Agents|dermatologic agents|mesh-ancestor
25535706|NCT00562159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25535707|NCT00562159|Tocolytic Agents|tocolytic agents|mesh-ancestor
25535708|NCT00562159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25535709|NCT00562159|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25535710|NCT00562159|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25535711|NCT00562159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25535712|NCT00562159|Adrenergic Agents|adrenergic agents|mesh-ancestor
25535713|NCT00562159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25535714|NCT00562159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535715|NCT00562159|Antipruritics|antipruritics|mesh-ancestor
25535716|NCT00562159|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25535717|NCT00562159|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25535718|NCT00562159|Histamine Antagonists|histamine antagonists|mesh-ancestor
25535719|NCT00562159|Histamine Agents|histamine agents|mesh-ancestor
25535720|NCT00562159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25535721|NCT00562159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25535722|NCT00562159|Analgesics|analgesics|mesh-ancestor
25535723|NCT00562159|Sensory System Agents|sensory system agents|mesh-ancestor
25535724|NCT00562159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25535725|NCT00562328|Rituximab|rituximab|mesh-list
25535726|NCT00562328|Alemtuzumab|alemtuzumab|mesh-list
25535727|NCT00562328|Sargramostim|sargramostim|mesh-list
25535728|NCT00562328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25535729|NCT00562328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535730|NCT00562328|Immunologic Factors|immunologic factors|mesh-ancestor
25535731|NCT00562328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535732|NCT00562328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25535733|NCT00562588|Dipyridamole|dipyridamole|mesh-list
25535734|NCT00562588|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
25535735|NCT00562588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25535736|NCT00562588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535737|NCT00562588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535738|NCT00562588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25535739|NCT00562588|Vasodilator Agents|vasodilator agents|mesh-ancestor
25535740|NCT00562627|Ketorolac|ketorolac|mesh-list
25535741|NCT00562627|Epinephrine|epinephrine|mesh-list
25535742|NCT00562627|Racepinephrine|racepinephrine|mesh-list
25535743|NCT00562627|Fentanyl|fentanyl|mesh-list
25535744|NCT00562627|Morphine|morphine|mesh-list
25535745|NCT00562627|Bupivacaine|bupivacaine|mesh-list
25535746|NCT00562627|Ropivacaine|ropivacaine|mesh-list
25535747|NCT00562627|Epinephryl borate|epinephryl borate|mesh-list
25535748|NCT00562627|Anesthetics, Local|anesthetics, local|mesh-ancestor
25535749|NCT00562627|Anesthetics|anesthetics|mesh-ancestor
25535750|NCT00562627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25535751|NCT00562627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535752|NCT00562627|Sensory System Agents|sensory system agents|mesh-ancestor
25535753|NCT00562627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25535754|NCT00562627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25535755|NCT00562627|Narcotics|narcotics|mesh-ancestor
25535756|NCT00562627|Analgesics|analgesics|mesh-ancestor
25535757|NCT00562627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25535758|NCT00562627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25535759|NCT00562627|Anesthetics, General|anesthetics, general|mesh-ancestor
25535760|NCT00562627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25535761|NCT00562627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25535762|NCT00562627|Adrenergic Agents|adrenergic agents|mesh-ancestor
25535763|NCT00562627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25535764|NCT00562627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535765|NCT00562627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25535766|NCT00562627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25535767|NCT00562627|Autonomic Agents|autonomic agents|mesh-ancestor
25535768|NCT00562627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25535769|NCT00562627|Respiratory System Agents|respiratory system agents|mesh-ancestor
25535771|NCT00562627|Sympathomimetics|sympathomimetics|mesh-ancestor
25535772|NCT00562627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25535773|NCT00562627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25535774|NCT00562627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25535775|NCT00562627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25535776|NCT00562627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25535777|NCT00562627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25535778|NCT00562627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535779|NCT00562718|Capecitabine|capecitabine|mesh-list
25535780|NCT00562718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25535781|NCT00562718|Antimetabolites|antimetabolites|mesh-ancestor
25535782|NCT00562718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535783|NCT00562718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535784|NCT00562861|Lamotrigine|lamotrigine|mesh-list
25535785|NCT00562861|Carbamazepine|carbamazepine|mesh-list
25535786|NCT00562861|Valproic Acid|valproic acid|mesh-list
25535787|NCT00562861|Citalopram|citalopram|mesh-list
25535788|NCT00562861|Anticonvulsants|anticonvulsants|mesh-ancestor
25535789|NCT00562861|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25535790|NCT00562861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25535791|NCT00562861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535792|NCT00562861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25535793|NCT00562861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535794|NCT00562861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25535795|NCT00562861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25535796|NCT00562861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25535797|NCT00562861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25535798|NCT00562861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25535799|NCT00562861|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25535800|NCT00562861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25535801|NCT00562861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25535802|NCT00562861|Serotonin Agents|serotonin agents|mesh-ancestor
25535803|NCT00562861|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25535804|NCT00562861|Antidepressive Agents|antidepressive agents|mesh-ancestor
25535805|NCT00562861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25535806|NCT00562861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535807|NCT00562861|GABA Agents|gaba agents|mesh-ancestor
25535808|NCT00562861|Antimanic Agents|antimanic agents|mesh-ancestor
25535809|NCT00562861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25535810|NCT00562861|Analgesics|analgesics|mesh-ancestor
25535811|NCT00562861|Sensory System Agents|sensory system agents|mesh-ancestor
25535812|NCT00562861|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25535813|NCT00562861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25535814|NCT00562965|Dexamethasone|dexamethasone|mesh-list
25535815|NCT00562965|Prednisone|prednisone|mesh-list
25535816|NCT00562965|Prednisolone|prednisolone|mesh-list
25535817|NCT00562965|Cyclophosphamide|cyclophosphamide|mesh-list
25535818|NCT00562965|Rituximab|rituximab|mesh-list
25535819|NCT00562965|Fludarabine|fludarabine|mesh-list
25535820|NCT00562965|Vincristine|vincristine|mesh-list
25535821|NCT00562965|Mitoxantrone|mitoxantrone|mesh-list
25535822|NCT00562965|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25535823|NCT00562965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25535824|NCT00562965|Immunologic Factors|immunologic factors|mesh-ancestor
25535825|NCT00562965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535826|NCT00562965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25535827|NCT00562965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25535828|NCT00562965|Alkylating Agents|alkylating agents|mesh-ancestor
25535829|NCT00562965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535830|NCT00562965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535831|NCT00562965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25535832|NCT00562965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25535833|NCT00562965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25535834|NCT00562965|Antiemetics|antiemetics|mesh-ancestor
25535835|NCT00562965|Autonomic Agents|autonomic agents|mesh-ancestor
25535836|NCT00562965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25535837|NCT00562965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25535838|NCT00562965|Glucocorticoids|glucocorticoids|mesh-ancestor
25535839|NCT00562965|Hormones|hormones|mesh-ancestor
25535840|NCT00562965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25535841|NCT00562965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25535842|NCT00562965|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25535844|NCT00562965|Antimitotic Agents|antimitotic agents|mesh-ancestor
25535845|NCT00562965|Mitosis Modulators|mitosis modulators|mesh-ancestor
25535846|NCT00562965|Analgesics|analgesics|mesh-ancestor
25535847|NCT00562965|Sensory System Agents|sensory system agents|mesh-ancestor
25535848|NCT00562965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25535849|NCT00562965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25535850|NCT00562965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535851|NCT00562965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25535852|NCT00562978|Cyclophosphamide|cyclophosphamide|mesh-list
25535853|NCT00562978|Etoposide|etoposide|mesh-list
25535854|NCT00562978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25535855|NCT00562978|Immunologic Factors|immunologic factors|mesh-ancestor
25535856|NCT00562978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535857|NCT00562978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25535858|NCT00562978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25535859|NCT00562978|Alkylating Agents|alkylating agents|mesh-ancestor
25535860|NCT00562978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535861|NCT00562978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535862|NCT00562978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25535863|NCT00562978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25535864|NCT00562978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25535865|NCT00562978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25535866|NCT00562978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535867|NCT00563290|Dasatinib|dasatinib|mesh-list
25535868|NCT00563290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535869|NCT00563290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25535870|NCT00563290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535871|NCT00563290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535872|NCT00563316|Irinotecan|irinotecan|mesh-list
25535873|NCT00563316|Panitumumab|panitumumab|mesh-list
25535874|NCT00563316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25535875|NCT00563316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25535876|NCT00563316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535877|NCT00563316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535878|NCT00563316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535879|NCT00563316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25535880|NCT00563368|Topiramate|topiramate|mesh-list
25535881|NCT00563368|Phentermine|phentermine|mesh-list
25535882|NCT00563368|Anticonvulsants|anticonvulsants|mesh-ancestor
25535883|NCT00563368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25535884|NCT00563368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535885|NCT00563368|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25535886|NCT00563368|Appetite Depressants|appetite depressants|mesh-ancestor
25535887|NCT00563368|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25535888|NCT00563368|Sympathomimetics|sympathomimetics|mesh-ancestor
25535889|NCT00563368|Autonomic Agents|autonomic agents|mesh-ancestor
25535890|NCT00563368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25535891|NCT00563368|Adrenergic Agents|adrenergic agents|mesh-ancestor
25535892|NCT00563368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25535893|NCT00563368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535894|NCT00563381|Bromides|bromides|mesh-list
25535895|NCT00563381|Tiotropium Bromide|tiotropium bromide|mesh-list
25535896|NCT00563381|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25535897|NCT00563381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25535898|NCT00563381|Autonomic Agents|autonomic agents|mesh-ancestor
25535899|NCT00563381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25535900|NCT00563381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535901|NCT00563381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25535902|NCT00563381|Respiratory System Agents|respiratory system agents|mesh-ancestor
25535903|NCT00563381|Parasympatholytics|parasympatholytics|mesh-ancestor
25535904|NCT00563381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25535905|NCT00563381|Cholinergic Agents|cholinergic agents|mesh-ancestor
25535906|NCT00563381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25535907|NCT00563381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535908|NCT00563381|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25535909|NCT00563381|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25535910|NCT00563381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25535911|NCT00563381|Adrenergic Agents|adrenergic agents|mesh-ancestor
25535912|NCT00563381|Anticonvulsants|anticonvulsants|mesh-ancestor
25535913|NCT00563706|Risperidone|risperidone|mesh-list
25535949|NCT00564018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25535950|NCT00564018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535951|NCT00564018|Heparin Antagonists|heparin antagonists|mesh-ancestor
25535952|NCT00564018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535953|NCT00564018|Coagulants|coagulants|mesh-ancestor
25535954|NCT05560620|Caffeine|caffeine|mesh-list
25535955|NCT05560620|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25535956|NCT05560620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535957|NCT05560620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25535958|NCT05560620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25535959|NCT05560620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535960|NCT05560620|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25535961|NCT05560620|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25535962|NCT05560620|Purinergic Agents|purinergic agents|mesh-ancestor
25535963|NCT05560620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25535964|NCT05560542|Dexamethasone|dexamethasone|mesh-list
25535965|NCT05560542|Atropine|atropine|mesh-list
25535966|NCT05560542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25535967|NCT05560542|Antiemetics|antiemetics|mesh-ancestor
25535968|NCT05560542|Autonomic Agents|autonomic agents|mesh-ancestor
25535969|NCT05560542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25535970|NCT05560542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535971|NCT05560542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25535972|NCT05560542|Glucocorticoids|glucocorticoids|mesh-ancestor
25535973|NCT05560542|Hormones|hormones|mesh-ancestor
25535974|NCT05560542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25535975|NCT05560542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25535976|NCT05560542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25535977|NCT05560542|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25535978|NCT05560542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25535979|NCT05560542|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25535980|NCT05560542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25535981|NCT05560542|Respiratory System Agents|respiratory system agents|mesh-ancestor
25535982|NCT05560542|Mydriatics|mydriatics|mesh-ancestor
25535983|NCT05560542|Parasympatholytics|parasympatholytics|mesh-ancestor
25535984|NCT05560542|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25535985|NCT05560542|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25535986|NCT05560542|Cholinergic Agents|cholinergic agents|mesh-ancestor
25535987|NCT05560542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25535988|NCT05560542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535989|NCT05560516|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25535990|NCT05560516|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25535991|NCT05560516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25535992|NCT05560516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25535993|NCT05560516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25535994|NCT05560516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25535995|NCT05560516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25535996|NCT05560516|Analgesics|analgesics|mesh-ancestor
25535997|NCT05560516|Sensory System Agents|sensory system agents|mesh-ancestor
25535998|NCT05560516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25535999|NCT05560516|Antidepressive Agents|antidepressive agents|mesh-ancestor
25536000|NCT05560516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25536001|NCT05560516|Dopamine Agents|dopamine agents|mesh-ancestor
25536002|NCT05560399|Dexamethasone|dexamethasone|mesh-list
25536003|NCT05560399|Elotuzumab|elotuzumab|mesh-list
25536004|NCT05560399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25536005|NCT05560399|Antiemetics|antiemetics|mesh-ancestor
25536006|NCT05560399|Autonomic Agents|autonomic agents|mesh-ancestor
25536007|NCT05560399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25536008|NCT05560399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536009|NCT05560399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25536010|NCT05560399|Glucocorticoids|glucocorticoids|mesh-ancestor
25536011|NCT05560399|Hormones|hormones|mesh-ancestor
25536012|NCT05560399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25536013|NCT05560399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25536014|NCT05560399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536015|NCT05560373|Huperzine A|huperzine a|mesh-list
25536016|NCT05560373|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25536017|NCT05560373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25536018|NCT05560373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536028|NCT05560360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536029|NCT05560360|Antiviral Agents|antiviral agents|mesh-ancestor
25536030|NCT05560360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25536031|NCT05560360|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25536032|NCT05560360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25536033|NCT05560360|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25536034|NCT05560360|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25536035|NCT05560360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25536036|NCT05560360|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25536037|NCT05560308|Trastuzumab|trastuzumab|mesh-list
25536038|NCT05560308|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25536039|NCT05560308|Maytansine|maytansine|mesh-list
25536040|NCT05560308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25536041|NCT05560308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536042|NCT05560308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536043|NCT05560308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25536044|NCT05560308|Tubulin Modulators|tubulin modulators|mesh-ancestor
25536045|NCT05560308|Antimitotic Agents|antimitotic agents|mesh-ancestor
25536046|NCT05560308|Mitosis Modulators|mitosis modulators|mesh-ancestor
25536055|NCT05560230|Clonidine|clonidine|mesh-list
25536056|NCT05560230|Analgesics|analgesics|mesh-ancestor
25536057|NCT05560230|Sensory System Agents|sensory system agents|mesh-ancestor
25536058|NCT05560230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25536059|NCT05560230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536060|NCT05560230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25536061|NCT05560230|Sympatholytics|sympatholytics|mesh-ancestor
25536062|NCT05560230|Autonomic Agents|autonomic agents|mesh-ancestor
25536063|NCT05560230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25536064|NCT05560230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25536065|NCT05560230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25536066|NCT05560230|Adrenergic Agents|adrenergic agents|mesh-ancestor
25536067|NCT05560230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25536068|NCT05560230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536069|NCT05560165|Listerine|listerine|mesh-list
25536070|NCT05560165|Anesthetics|anesthetics|mesh-list
25536071|NCT05560165|Anesthetics, Local|anesthetics, local|mesh-list
25536072|NCT05560165|Fluorides|fluorides|mesh-list
25536073|NCT05560165|Sodium Fluoride|sodium fluoride|mesh-list
25536074|NCT05560165|Cariostatic Agents|cariostatic agents|mesh-ancestor
25536075|NCT05560165|Protective Agents|protective agents|mesh-ancestor
25536076|NCT05560165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536077|NCT05560165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25536078|NCT05560165|Sensory System Agents|sensory system agents|mesh-ancestor
25536079|NCT05560165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25536080|NCT05560165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25536081|NCT05560165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25536082|NCT05560035|Lidocaine|lidocaine|mesh-list
25536083|NCT05560035|Anesthetics, Local|anesthetics, local|mesh-ancestor
25536084|NCT05560035|Anesthetics|anesthetics|mesh-ancestor
25536085|NCT05560035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25536086|NCT05560035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536087|NCT05560035|Sensory System Agents|sensory system agents|mesh-ancestor
25536088|NCT05560035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25536089|NCT05560035|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25536090|NCT05560035|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25536091|NCT05560035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25647044|NCT01465802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25647045|NCT01465802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25647046|NCT01465802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25823616|NCT00004861|Antiviral Agents|antiviral agents|mesh-ancestor
25536092|NCT05560035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25536093|NCT05560035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536094|NCT05560009|Levodopa|levodopa|mesh-list
25536095|NCT05560009|Fluorides|fluorides|mesh-list
25536096|NCT05560009|Cariostatic Agents|cariostatic agents|mesh-ancestor
25536097|NCT05560009|Protective Agents|protective agents|mesh-ancestor
25536098|NCT05560009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536099|NCT05560009|Dopamine Agents|dopamine agents|mesh-ancestor
25823617|NCT00004861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25536100|NCT05560009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25536101|NCT05560009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536102|NCT05560009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25536103|NCT05560009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25536104|NCT05559996|Hyaluronic Acid|hyaluronic acid|mesh-list
25536105|NCT05559996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25536106|NCT05559996|Immunologic Factors|immunologic factors|mesh-ancestor
25536107|NCT05559996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536108|NCT05559996|Viscosupplements|viscosupplements|mesh-ancestor
25536109|NCT05559996|Protective Agents|protective agents|mesh-ancestor
25536110|NCT05559983|Aluminum phosphate|aluminum phosphate|mesh-list
25536112|NCT05559983|Immunologic Factors|immunologic factors|mesh-ancestor
25536113|NCT05559983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536114|NCT05559983|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25536115|NCT05559983|Antacids|antacids|mesh-ancestor
25536116|NCT05559983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536117|NCT05559983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25536118|NCT05559931|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
25536119|NCT05559931|Hallucinogens|hallucinogens|mesh-ancestor
25536120|NCT05559931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536121|NCT05559931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25536122|NCT05559931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25536123|NCT05559931|Serotonin Agents|serotonin agents|mesh-ancestor
25536124|NCT05559931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25536125|NCT05559931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536126|NCT05559931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25536127|NCT05559619|Calcium, Dietary|calcium, dietary|mesh-list
25536128|NCT05559619|Vitamin D|vitamin d|mesh-list
25536129|NCT05559619|Cholecalciferol|cholecalciferol|mesh-list
25536130|NCT05559619|Calcium Carbonate|calcium carbonate|mesh-list
25536131|NCT05559619|Calcium|calcium|mesh-list
25536132|NCT05559619|Vitamins|vitamins|mesh-ancestor
25536133|NCT05559619|Micronutrients|micronutrients|mesh-ancestor
25536134|NCT05559619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536135|NCT05559619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25536136|NCT05559619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25536137|NCT05559619|Antacids|antacids|mesh-ancestor
25536138|NCT05559619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536139|NCT05559619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25536140|NCT05559476|Vaccines|vaccines|mesh-list
25536141|NCT05559476|Immunologic Factors|immunologic factors|mesh-ancestor
25536142|NCT05559476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536143|NCT05559450|Blinatumomab|blinatumomab|mesh-list
25536144|NCT05559450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536145|NCT05559437|Bupivacaine|bupivacaine|mesh-list
25536146|NCT05559437|Levobupivacaine|levobupivacaine|mesh-list
25536147|NCT05559437|Anesthetics, Local|anesthetics, local|mesh-ancestor
25536148|NCT05559437|Anesthetics|anesthetics|mesh-ancestor
25536149|NCT05559437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25536150|NCT05559437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536151|NCT05559437|Sensory System Agents|sensory system agents|mesh-ancestor
25536152|NCT05559437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25536153|NCT05559398|Glenzocimab|glenzocimab|mesh-list
25536154|NCT05559398|Anticoagulants|anticoagulants|mesh-ancestor
25536155|NCT05559268|Denosumab|denosumab|mesh-list
25536156|NCT05559268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25536157|NCT05559268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536158|NCT05559164|Atorvastatin|atorvastatin|mesh-list
25536159|NCT05559164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25647047|NCT01465802|Glucocorticoids|glucocorticoids|mesh-ancestor
25536160|NCT05559164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25536161|NCT05559164|Antimetabolites|antimetabolites|mesh-ancestor
25536162|NCT05559164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536163|NCT05559164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25536181|NCT05558982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25536182|NCT05558982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536184|NCT05558878|Expectorants|expectorants|mesh-ancestor
25536185|NCT05558878|Respiratory System Agents|respiratory system agents|mesh-ancestor
25536186|NCT05556265|BMS-986165|bms-986165|mesh-list
25536187|NCT05556265|Dermatologic Agents|dermatologic agents|mesh-ancestor
25536188|NCT05556265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25536189|NCT05556265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25536190|NCT05556265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536191|NCT05555901|Bevacizumab|bevacizumab|mesh-list
25536192|NCT05555901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25536193|NCT05555901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536194|NCT05555901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25536195|NCT05555901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25536196|NCT05555901|Growth Substances|growth substances|mesh-ancestor
25536197|NCT05555901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536198|NCT05555901|Growth Inhibitors|growth inhibitors|mesh-ancestor
25536199|NCT05555329|Thalidomide|thalidomide|mesh-list
25536200|NCT05555329|Pomalidomide|pomalidomide|mesh-list
25536201|NCT05555329|Immunologic Factors|immunologic factors|mesh-ancestor
25536202|NCT05555329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536203|NCT05555329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25536204|NCT05555329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25536205|NCT05555329|Growth Substances|growth substances|mesh-ancestor
25536206|NCT05555329|Growth Inhibitors|growth inhibitors|mesh-ancestor
25536207|NCT05555329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536208|NCT05555329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25536209|NCT05555329|Leprostatic Agents|leprostatic agents|mesh-ancestor
25536210|NCT05555329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25536211|NCT05555329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25536212|NCT05554380|Paclitaxel|paclitaxel|mesh-list
25536213|NCT05554380|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25536214|NCT05554380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25536215|NCT05554380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536216|NCT05554380|Tubulin Modulators|tubulin modulators|mesh-ancestor
25536217|NCT05554380|Antimitotic Agents|antimitotic agents|mesh-ancestor
25536218|NCT05554380|Mitosis Modulators|mitosis modulators|mesh-ancestor
25536219|NCT05554380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536227|NCT05543642|Vaccines|vaccines|mesh-list
25536228|NCT05543642|Immunologic Factors|immunologic factors|mesh-ancestor
25536229|NCT05543642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536253|NCT05533580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25536254|NCT05533580|Anesthetics, General|anesthetics, general|mesh-ancestor
25536255|NCT05533580|Anesthetics|anesthetics|mesh-ancestor
25536256|NCT05533580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25536257|NCT05533580|Narcotics|narcotics|mesh-ancestor
25536258|NCT05533580|Analgesics|analgesics|mesh-ancestor
25536259|NCT05533580|Sensory System Agents|sensory system agents|mesh-ancestor
25536260|NCT05533580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25536261|NCT05533580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25536262|NCT05533580|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25536263|NCT05533580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25536264|NCT05533580|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25536265|NCT05533580|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25536266|NCT05533580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25536267|NCT05533580|Cholinergic Agents|cholinergic agents|mesh-ancestor
25536268|NCT05533580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25536269|NCT05533580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536270|NCT05533567|Sufentanil|sufentanil|mesh-list
25536271|NCT05533567|Dsuvia|dsuvia|mesh-list
25536272|NCT05533567|Propofol|propofol|mesh-list
25536273|NCT05533567|Cisatracurium|cisatracurium|mesh-list
25536274|NCT05533567|Atracurium|atracurium|mesh-list
25536275|NCT05533567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25536276|NCT05533567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25536277|NCT05533567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536278|NCT05533567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25536279|NCT05533567|Anesthetics, General|anesthetics, general|mesh-ancestor
25536280|NCT05533567|Anesthetics|anesthetics|mesh-ancestor
25536281|NCT05533567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25536282|NCT05533567|Narcotics|narcotics|mesh-ancestor
25536283|NCT05533567|Analgesics|analgesics|mesh-ancestor
25536284|NCT05533567|Sensory System Agents|sensory system agents|mesh-ancestor
25536285|NCT05533567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25536286|NCT05533567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25536287|NCT05533567|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25536288|NCT05533567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25536289|NCT05533567|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25536290|NCT05533567|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25536291|NCT05533567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25536292|NCT05533567|Cholinergic Agents|cholinergic agents|mesh-ancestor
25536293|NCT05533567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25536294|NCT05533567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536295|NCT05527314|Fentanyl|fentanyl|mesh-list
25536296|NCT05527314|Remifentanil|remifentanil|mesh-list
25536297|NCT05527314|Sevoflurane|sevoflurane|mesh-list
25536298|NCT05527314|Cisatracurium|cisatracurium|mesh-list
25536299|NCT05527314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25536300|NCT05527314|Narcotics|narcotics|mesh-ancestor
25536301|NCT05527314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25536302|NCT05527314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536303|NCT05527314|Analgesics|analgesics|mesh-ancestor
25536304|NCT05527314|Sensory System Agents|sensory system agents|mesh-ancestor
25536305|NCT05527314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25536306|NCT05527314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25536307|NCT05527314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25536308|NCT05527314|Anesthetics, General|anesthetics, general|mesh-ancestor
25536309|NCT05527314|Anesthetics|anesthetics|mesh-ancestor
25536310|NCT05527314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25536311|NCT05527314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25536312|NCT05527314|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25536313|NCT05527314|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25657207|NCT01584440|Respiratory System Agents|respiratory system agents|mesh-ancestor
25536333|NCT05503797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25536334|NCT05503797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536335|NCT05493111|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25536336|NCT05493111|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25536338|NCT05483491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536339|NCT05483491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25536340|NCT05483491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25536341|NCT05483491|Antiviral Agents|antiviral agents|mesh-ancestor
25536342|NCT05483491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25536353|NCT05466539|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25536354|NCT05466539|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25536355|NCT05466539|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25536356|NCT05466539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25536357|NCT05466539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536358|NCT05466539|Cholinergic Agents|cholinergic agents|mesh-ancestor
25536359|NCT05466539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25536360|NCT05466539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536361|NCT05466539|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25536362|NCT05466539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25536363|NCT05464420|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25536364|NCT05464420|Immunologic Factors|immunologic factors|mesh-ancestor
25536365|NCT05464420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536366|NCT05452772|Niacin|niacin|mesh-list
25536367|NCT05452772|Psilocybin|psilocybin|mesh-list
25536368|NCT05452772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25536369|NCT05452772|Antimetabolites|antimetabolites|mesh-ancestor
25536370|NCT05452772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536371|NCT05452772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25536372|NCT05452772|Vasodilator Agents|vasodilator agents|mesh-ancestor
25536373|NCT05452772|Vitamin B Complex|vitamin b complex|mesh-ancestor
25536374|NCT05452772|Vitamins|vitamins|mesh-ancestor
25536375|NCT05452772|Micronutrients|micronutrients|mesh-ancestor
25536376|NCT05452772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536377|NCT05452772|Hallucinogens|hallucinogens|mesh-ancestor
25536378|NCT05452772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25536379|NCT05446467|Cisplatin|cisplatin|mesh-list
25536380|NCT05446467|Pembrolizumab|pembrolizumab|mesh-list
25536381|NCT05446467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536382|NCT05446467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25536429|NCT05420961|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25536430|NCT05420961|Immunologic Factors|immunologic factors|mesh-ancestor
25536431|NCT05420961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536435|NCT05418777|Trimethoprim|trimethoprim|mesh-list
25536436|NCT05418777|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25536437|NCT05418777|Sulfamethoxazole|sulfamethoxazole|mesh-list
25536438|NCT05418777|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25536439|NCT05418777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25536440|NCT05418777|Renal Agents|renal agents|mesh-ancestor
25536441|NCT05418777|Antimalarials|antimalarials|mesh-ancestor
25536442|NCT05418777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25536443|NCT05418777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25536444|NCT05418777|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25536445|NCT05418777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25536446|NCT05418777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536447|NCT05418777|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25536448|NCT05418777|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25536449|NCT05418777|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25536450|NCT05418777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25536451|NCT05418699|Insulin|insulin|mesh-list
25536452|NCT05418699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25536453|NCT05418699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536454|NCT05415397|Celecoxib|celecoxib|mesh-list
25536455|NCT05415397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25536456|NCT05415397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25536457|NCT05415397|Analgesics|analgesics|mesh-ancestor
25536458|NCT05415397|Sensory System Agents|sensory system agents|mesh-ancestor
25536459|NCT05415397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25536460|NCT05415397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536461|NCT05415397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25536462|NCT05415397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25536463|NCT05415397|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25536464|NCT05415397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25536465|NCT05415397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275444|NCT02372188|Caffeine|caffeine|mesh-list
24940616|NCT03999437|Butenafine|butenafine|mesh-list
25647050|NCT01465802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536475|NCT05409716|Coagulants|coagulants|mesh-ancestor
25536476|NCT05408910|Rifaximin|rifaximin|mesh-list
25536477|NCT05408910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25536478|NCT05408910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25536479|NCT05408910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25536480|NCT05395910|Paclitaxel|paclitaxel|mesh-list
25536481|NCT05395910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25536482|NCT05395910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536483|NCT05395910|Tubulin Modulators|tubulin modulators|mesh-ancestor
25536484|NCT05395910|Antimitotic Agents|antimitotic agents|mesh-ancestor
25536485|NCT05395910|Mitosis Modulators|mitosis modulators|mesh-ancestor
25536486|NCT05395910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536487|NCT05393037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25536488|NCT05393037|Immunologic Factors|immunologic factors|mesh-ancestor
25536489|NCT05393037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536524|NCT05389046|Dexetimide|dexetimide|mesh-list
25536525|NCT05389046|Aripiprazole|aripiprazole|mesh-list
25536526|NCT05389046|Citalopram|citalopram|mesh-list
25536527|NCT05389046|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25536528|NCT05389046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25536529|NCT05389046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25536530|NCT05389046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536531|NCT05389046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25536532|NCT05389046|Serotonin Agents|serotonin agents|mesh-ancestor
25536533|NCT05389046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647055|NCT01465958|Immunologic Factors|immunologic factors|mesh-ancestor
25536541|NCT05389046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25536542|NCT05389046|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25536543|NCT05389046|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25536544|NCT05389046|Cholinergic Agents|cholinergic agents|mesh-ancestor
25536545|NCT05389046|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25536546|NCT05389046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25536547|NCT05389046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25536548|NCT05389046|Dopamine Agonists|dopamine agonists|mesh-ancestor
25536549|NCT05389046|Dopamine Agents|dopamine agents|mesh-ancestor
25536550|NCT05389046|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25536551|NCT05389046|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25536552|NCT05389046|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25536553|NCT05389046|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25536554|NCT05389046|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25536555|NCT05389046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25536556|NCT05382299|Gemcitabine|gemcitabine|mesh-list
25536557|NCT05382299|Paclitaxel|paclitaxel|mesh-list
25536558|NCT05382299|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25536560|NCT05382299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25536561|NCT05382299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536562|NCT05382299|Tubulin Modulators|tubulin modulators|mesh-ancestor
25536563|NCT05382299|Antimitotic Agents|antimitotic agents|mesh-ancestor
25536564|NCT05382299|Mitosis Modulators|mitosis modulators|mesh-ancestor
25536565|NCT05382299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536566|NCT05382299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25536567|NCT05382299|Antimetabolites|antimetabolites|mesh-ancestor
25536568|NCT05382299|Antiviral Agents|antiviral agents|mesh-ancestor
25536569|NCT05382299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25536570|NCT05382299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25536571|NCT05382299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25536572|NCT05382299|Immunologic Factors|immunologic factors|mesh-ancestor
25536573|NCT05382299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536574|NCT05374512|Paclitaxel|paclitaxel|mesh-list
25536575|NCT05374512|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25536576|NCT05374512|Carboplatin|carboplatin|mesh-list
25536577|NCT05374512|Capecitabine|capecitabine|mesh-list
25536578|NCT05374512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25536579|NCT05374512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536580|NCT05374512|Tubulin Modulators|tubulin modulators|mesh-ancestor
25536581|NCT05374512|Antimitotic Agents|antimitotic agents|mesh-ancestor
25536582|NCT05374512|Mitosis Modulators|mitosis modulators|mesh-ancestor
25536583|NCT05374512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536584|NCT05374512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25536585|NCT05374512|Antimetabolites|antimetabolites|mesh-ancestor
25536586|NCT05372744|Antidepressive Agents|antidepressive agents|mesh-list
25536587|NCT05372744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25536588|NCT05372614|Trastuzumab|trastuzumab|mesh-list
25536589|NCT05372614|Camptothecin|camptothecin|mesh-list
25536590|NCT05372614|Maleic acid|maleic acid|mesh-list
25536591|NCT05372614|Immunoconjugates|immunoconjugates|mesh-list
25536592|NCT05372614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25536593|NCT05372614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536594|NCT05372614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25536595|NCT05372614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536596|NCT05372614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25536597|NCT05372614|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25536598|NCT05372614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25536599|NCT05372614|Immunologic Factors|immunologic factors|mesh-ancestor
24400837|NCT00151489|Pregabalin|pregabalin|mesh-list
25536600|NCT05372614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536611|NCT05366816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536612|NCT05366816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25536613|NCT05366816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25536614|NCT05366816|Growth Substances|growth substances|mesh-ancestor
25536615|NCT05366816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536616|NCT05366816|Growth Inhibitors|growth inhibitors|mesh-ancestor
25536617|NCT05366816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25536618|NCT05366816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25536619|NCT05366816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536620|NCT05358704|Leucovorin|leucovorin|mesh-list
25536621|NCT05358704|Fluorouracil|fluorouracil|mesh-list
25536622|NCT05358704|Capecitabine|capecitabine|mesh-list
25536623|NCT05358704|Oxaliplatin|oxaliplatin|mesh-list
25536624|NCT05358704|Irinotecan|irinotecan|mesh-list
25536625|NCT05358704|Antimetabolites|antimetabolites|mesh-ancestor
25536626|NCT05358704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536627|NCT05358704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25536628|NCT05358704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536629|NCT05358704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25536630|NCT05358704|Immunologic Factors|immunologic factors|mesh-ancestor
24860537|NCT02310490|Diuretics|diuretics|mesh-ancestor
24860538|NCT02310490|Natriuretic Agents|natriuretic agents|mesh-ancestor
24860540|NCT02310997|Cyclophosphamide|cyclophosphamide|mesh-list
25536631|NCT05358704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536632|NCT05358704|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25536633|NCT05358704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25536634|NCT05358704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25536635|NCT05358704|Antidotes|antidotes|mesh-ancestor
25536636|NCT05358704|Protective Agents|protective agents|mesh-ancestor
25536637|NCT05358704|Vitamin B Complex|vitamin b complex|mesh-ancestor
25536638|NCT05358704|Vitamins|vitamins|mesh-ancestor
25536639|NCT05358704|Micronutrients|micronutrients|mesh-ancestor
25536665|NCT05337137|Bevacizumab|bevacizumab|mesh-list
25536666|NCT05337137|Nivolumab|nivolumab|mesh-list
25536667|NCT05337137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25536668|NCT05337137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536669|NCT05337137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25536670|NCT05337137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25536671|NCT05337137|Growth Substances|growth substances|mesh-ancestor
25536672|NCT05337137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536673|NCT05337137|Growth Inhibitors|growth inhibitors|mesh-ancestor
25536674|NCT05337137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25536746|NCT05259527|Vitamin D|vitamin d|mesh-list
25647065|NCT01465997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25536747|NCT05259527|Ergocalciferols|ergocalciferols|mesh-list
25536748|NCT05259527|Cholecalciferol|cholecalciferol|mesh-list
25536749|NCT05259527|Vitamins|vitamins|mesh-list
25536750|NCT05259527|Micronutrients|micronutrients|mesh-ancestor
25536751|NCT05259527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536752|NCT05259527|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25536753|NCT05259527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25536754|NCT05256745|Paclitaxel|paclitaxel|mesh-list
25536755|NCT05256745|Docetaxel|docetaxel|mesh-list
25536756|NCT05256745|Cyclophosphamide|cyclophosphamide|mesh-list
25536757|NCT05256745|Carboplatin|carboplatin|mesh-list
25536758|NCT05256745|Doxorubicin|doxorubicin|mesh-list
25536759|NCT05256745|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25536760|NCT05256745|Trastuzumab|trastuzumab|mesh-list
25536761|NCT05256745|Pertuzumab|pertuzumab|mesh-list
25536762|NCT05256745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25536763|NCT05256745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536764|NCT05256745|Tubulin Modulators|tubulin modulators|mesh-ancestor
25536765|NCT05256745|Antimitotic Agents|antimitotic agents|mesh-ancestor
25536766|NCT05256745|Mitosis Modulators|mitosis modulators|mesh-ancestor
25536767|NCT05256745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536768|NCT05256745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25536769|NCT05256745|Immunologic Factors|immunologic factors|mesh-ancestor
25536770|NCT05256745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536771|NCT05256745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25536772|NCT05256745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25536773|NCT05256745|Alkylating Agents|alkylating agents|mesh-ancestor
25536774|NCT05256745|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25536775|NCT05256745|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25536776|NCT05256745|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25536777|NCT05256745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25536778|NCT05256745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25536779|NCT05256745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25536780|NCT05255107|Riboflavin|riboflavin|mesh-list
25823620|NCT00004861|Immunologic Factors|immunologic factors|mesh-ancestor
25536781|NCT05255107|Lubricant Eye Drops|lubricant eye drops|mesh-list
25536782|NCT05255107|Vitamin B Complex|vitamin b complex|mesh-ancestor
25536784|NCT05255107|Micronutrients|micronutrients|mesh-ancestor
25536785|NCT05255107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536786|NCT05255107|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25536787|NCT05255107|Dermatologic Agents|dermatologic agents|mesh-ancestor
25536788|NCT05255107|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25536789|NCT05255107|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25536790|NCT05255016|Riboflavin|riboflavin|mesh-list
25536791|NCT05255016|Lubricant Eye Drops|lubricant eye drops|mesh-list
25536792|NCT05255016|Vitamin B Complex|vitamin b complex|mesh-ancestor
25536793|NCT05255016|Vitamins|vitamins|mesh-ancestor
25536794|NCT05255016|Micronutrients|micronutrients|mesh-ancestor
25536795|NCT05255016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536796|NCT05255016|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25536797|NCT05255016|Dermatologic Agents|dermatologic agents|mesh-ancestor
25536798|NCT05255016|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25536799|NCT05255016|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25536800|NCT05254639|Donepezil|donepezil|mesh-list
25536801|NCT05254639|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25536802|NCT05254639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25536803|NCT05254639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536804|NCT05254639|Cholinergic Agents|cholinergic agents|mesh-ancestor
25536805|NCT05254639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25536806|NCT05254639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536807|NCT05254639|Nootropic Agents|nootropic agents|mesh-ancestor
25536808|NCT05232929|Risdiplam|risdiplam|mesh-list
25536809|NCT05232929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25536810|NCT05232929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25536811|NCT05232929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536812|NCT05232071|Empagliflozin|empagliflozin|mesh-list
25536813|NCT05232071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25536814|NCT05232071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536815|NCT05232071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25536816|NCT05232071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536817|NCT05227716|Magnesium Sulfate|magnesium sulfate|mesh-list
25536818|NCT05227716|Analgesics|analgesics|mesh-ancestor
25536819|NCT05227716|Sensory System Agents|sensory system agents|mesh-ancestor
25536820|NCT05227716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25536821|NCT05227716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536822|NCT05227716|Anesthetics|anesthetics|mesh-ancestor
25536823|NCT05227716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25536824|NCT05227716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25536825|NCT05227716|Anticonvulsants|anticonvulsants|mesh-ancestor
25823621|NCT00004861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536827|NCT05227716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25536828|NCT05227716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536829|NCT05227716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25536830|NCT05227716|Tocolytic Agents|tocolytic agents|mesh-ancestor
25536831|NCT05227716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25536832|NCT05226598|Paclitaxel|paclitaxel|mesh-list
25536833|NCT05226598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25536834|NCT05226598|Cisplatin|cisplatin|mesh-list
25536835|NCT05226598|Carboplatin|carboplatin|mesh-list
25536836|NCT05226598|Pembrolizumab|pembrolizumab|mesh-list
25536837|NCT05226598|Pemetrexed|pemetrexed|mesh-list
25536838|NCT05226598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25536839|NCT05226598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536840|NCT05226598|Tubulin Modulators|tubulin modulators|mesh-ancestor
25536841|NCT05226598|Antimitotic Agents|antimitotic agents|mesh-ancestor
25536842|NCT05226598|Mitosis Modulators|mitosis modulators|mesh-ancestor
25536843|NCT05226598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536844|NCT05226598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25536845|NCT05226598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25536846|NCT05226598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25536847|NCT05226598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25536848|NCT05224141|Cisplatin|cisplatin|mesh-list
25536849|NCT05224141|Carboplatin|carboplatin|mesh-list
25536850|NCT05224141|Pembrolizumab|pembrolizumab|mesh-list
25536851|NCT05224141|Etoposide|etoposide|mesh-list
25536852|NCT05224141|Atezolizumab|atezolizumab|mesh-list
25536853|NCT05224141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536854|NCT05224141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25536855|NCT05224141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25536856|NCT05224141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25536857|NCT05224141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25536858|NCT05224141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25536859|NCT05224141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536861|NCT05222529|Bromides|bromides|mesh-list
25536862|NCT05222529|Anticonvulsants|anticonvulsants|mesh-ancestor
25536863|NCT05222529|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25536864|NCT05222529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25536865|NCT05222529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25536866|NCT05222529|Cholinergic Agents|cholinergic agents|mesh-ancestor
25536867|NCT05222529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25536868|NCT05222529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536869|NCT05222529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536878|NCT05214222|Paclitaxel|paclitaxel|mesh-list
25536879|NCT05214222|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25536880|NCT05214222|Cisplatin|cisplatin|mesh-list
25536881|NCT05214222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25536882|NCT05214222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536883|NCT05214222|Tubulin Modulators|tubulin modulators|mesh-ancestor
25536884|NCT05214222|Antimitotic Agents|antimitotic agents|mesh-ancestor
25536885|NCT05214222|Mitosis Modulators|mitosis modulators|mesh-ancestor
25536886|NCT05214222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536887|NCT05209074|Ivosidenib|ivosidenib|mesh-list
25536888|NCT05209074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536889|NCT05209074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25536890|NCT05209074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536891|NCT05198934|Trifluridine|trifluridine|mesh-list
25536892|NCT05198934|Panitumumab|panitumumab|mesh-list
25536893|NCT05198934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25536894|NCT05198934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536907|NCT05193994|Antiviral Agents|antiviral agents|mesh-ancestor
25536908|NCT05193994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25536909|NCT05193994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25536910|NCT05193994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25536911|NCT05193994|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25536912|NCT05193994|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25536920|NCT05174650|Atezolizumab|atezolizumab|mesh-list
25536921|NCT05174650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536922|NCT05170204|Durvalumab|durvalumab|mesh-list
25536923|NCT05170204|Pralsetinib|pralsetinib|mesh-list
25536924|NCT05170204|Entrectinib|entrectinib|mesh-list
25536925|NCT05170204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25536926|NCT05170204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536927|NCT05170204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25536928|NCT05170204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25536929|NCT05170204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536930|NCT05169658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25536931|NCT05169658|Obinutuzumab|obinutuzumab|mesh-list
25536932|NCT05169658|Antibodies|antibodies|mesh-list
25536933|NCT05169658|Immunoglobulins|immunoglobulins|mesh-list
24860861|NCT02313272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536934|NCT05169658|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25536935|NCT05169658|Immunoconjugates|immunoconjugates|mesh-list
25536936|NCT05169658|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25536937|NCT05169658|Immunologic Factors|immunologic factors|mesh-ancestor
25536938|NCT05169658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536939|NCT05169658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536940|NCT05150587|Rifaximin|rifaximin|mesh-list
25536941|NCT05150587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25536942|NCT05150587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25536943|NCT05150587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25536950|NCT05113940|Midazolam|midazolam|mesh-list
25536951|NCT05113940|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25536952|NCT05113940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25536953|NCT05113940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25536954|NCT05113940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536955|NCT05113940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25536956|NCT05113940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25536957|NCT05113940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25536958|NCT05113940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25536959|NCT05113940|Anesthetics, General|anesthetics, general|mesh-ancestor
25536960|NCT05113940|Anesthetics|anesthetics|mesh-ancestor
25536961|NCT05113940|GABA Modulators|gaba modulators|mesh-ancestor
25536962|NCT05113940|GABA Agents|gaba agents|mesh-ancestor
25536963|NCT05113940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25536964|NCT05113940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536965|NCT05111626|Nivolumab|nivolumab|mesh-list
25536966|NCT05111626|Bemarituzumab|bemarituzumab|mesh-list
25536967|NCT05111626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25536968|NCT05111626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25536969|NCT05111626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25536982|NCT05094336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25536984|NCT05085665|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25536985|NCT05085665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25536986|NCT05071794|Propofol|propofol|mesh-list
25536987|NCT05071794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25536988|NCT05071794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25536989|NCT05071794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25536990|NCT05071794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25536991|NCT05071794|Anesthetics, General|anesthetics, general|mesh-ancestor
25536992|NCT05071794|Anesthetics|anesthetics|mesh-ancestor
25536997|NCT05067283|Pembrolizumab|pembrolizumab|mesh-list
25536998|NCT05067283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25536999|NCT05067283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537000|NCT05063552|Bevacizumab|bevacizumab|mesh-list
25537001|NCT05063552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25537002|NCT05063552|Cetuximab|cetuximab|mesh-list
25537003|NCT05063552|Cisplatin|cisplatin|mesh-list
25537004|NCT05063552|Carboplatin|carboplatin|mesh-list
25537005|NCT05063552|Docetaxel|docetaxel|mesh-list
25537006|NCT05063552|Atezolizumab|atezolizumab|mesh-list
25537007|NCT05063552|Endothelial Growth Factors|endothelial growth factors|mesh-list
25537008|NCT05063552|Antibodies|antibodies|mesh-list
25823622|NCT00004861|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25537009|NCT05063552|Immunoglobulins|immunoglobulins|mesh-list
25537010|NCT05063552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25537011|NCT05063552|Immunoglobulin G|immunoglobulin g|mesh-list
25537012|NCT05063552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537013|NCT05063552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25537014|NCT05063552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25537015|NCT05063552|Growth Substances|growth substances|mesh-ancestor
25537016|NCT05063552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537017|NCT05063552|Growth Inhibitors|growth inhibitors|mesh-ancestor
25537018|NCT05063552|Immunologic Factors|immunologic factors|mesh-ancestor
25537019|NCT05063552|Tubulin Modulators|tubulin modulators|mesh-ancestor
25537020|NCT05063552|Antimitotic Agents|antimitotic agents|mesh-ancestor
25537021|NCT05063552|Mitosis Modulators|mitosis modulators|mesh-ancestor
25537022|NCT05063552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823623|NCT00004862|Cytarabine|cytarabine|mesh-list
25537054|NCT05051735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25537055|NCT05051735|Analgesics|analgesics|mesh-ancestor
25537056|NCT05051735|Sensory System Agents|sensory system agents|mesh-ancestor
25537057|NCT05051735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25537058|NCT05051735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537059|NCT05051735|Antipyretics|antipyretics|mesh-ancestor
25537060|NCT05047172|Aspirin|aspirin|mesh-list
25537061|NCT05047172|Rivaroxaban|rivaroxaban|mesh-list
25537062|NCT05047172|Clopidogrel|clopidogrel|mesh-list
25537063|NCT05047172|Ticagrelor|ticagrelor|mesh-list
25537064|NCT05047172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25537065|NCT05047172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25537066|NCT05047172|Analgesics|analgesics|mesh-ancestor
25537067|NCT05047172|Sensory System Agents|sensory system agents|mesh-ancestor
25537068|NCT05047172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25537069|NCT05047172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537070|NCT05047172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25537071|NCT05047172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25537072|NCT05047172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25537073|NCT05047172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25537074|NCT05047172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537075|NCT05047172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25537076|NCT05047172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25537077|NCT05047172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25537078|NCT05047172|Antipyretics|antipyretics|mesh-ancestor
25537079|NCT05047172|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25537080|NCT05047172|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25537081|NCT05047172|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25537082|NCT05047172|Purinergic Agents|purinergic agents|mesh-ancestor
25537083|NCT05047172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25537084|NCT05047172|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25537085|NCT05047172|Antithrombins|antithrombins|mesh-ancestor
25537086|NCT05047172|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24861035|NCT02314351|Dopamine Agents|dopamine agents|mesh-ancestor
25537087|NCT05047172|Protease Inhibitors|protease inhibitors|mesh-ancestor
25537088|NCT05047172|Anticoagulants|anticoagulants|mesh-ancestor
25537089|NCT05041946|Methylphenidate|methylphenidate|mesh-list
25537090|NCT05041946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25537091|NCT05041946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537092|NCT05041946|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25537093|NCT05041946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25537094|NCT05041946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25537095|NCT05041946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537096|NCT05041946|Dopamine Agents|dopamine agents|mesh-ancestor
25537097|NCT05041946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25537098|NCT05037929|Astegolimab|astegolimab|mesh-list
25537099|NCT05037929|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25537100|NCT05037929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25537101|NCT05037929|Antiviral Agents|antiviral agents|mesh-ancestor
25537102|NCT05037929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25537104|NCT05028075|Trace Elements|trace elements|mesh-ancestor
25537105|NCT05028075|Micronutrients|micronutrients|mesh-ancestor
25537106|NCT05028075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647081|NCT01466127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537141|NCT05004896|Anesthetics|anesthetics|mesh-ancestor
25537142|NCT05004896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25537143|NCT05004896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25537144|NCT05004896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25537145|NCT05004896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25537146|NCT05004896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537147|NCT05004896|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25537148|NCT05004896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25537149|NCT05004896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25537150|NCT05004896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25537151|NCT05004896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25537152|NCT05004896|GABA Modulators|gaba modulators|mesh-ancestor
25537153|NCT05004896|GABA Agents|gaba agents|mesh-ancestor
25537154|NCT04999020|Ravulizumab|ravulizumab|mesh-list
25537155|NCT04999020|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25537156|NCT04999020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25537157|NCT04999020|Immunologic Factors|immunologic factors|mesh-ancestor
25537158|NCT04999020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537159|NCT04991480|Niraparib|niraparib|mesh-list
25537160|NCT04991480|Talazoparib|talazoparib|mesh-list
25537161|NCT04991480|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25537162|NCT04991480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823624|NCT00004862|Fludarabine|fludarabine|mesh-list
25537163|NCT04991480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537164|NCT04991480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537165|NCT04971785|Firsocostat|firsocostat|mesh-list
25537166|NCT04971785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25537167|NCT04971785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537168|NCT04971226|Imatinib Mesylate|imatinib mesylate|mesh-list
25537169|NCT04971226|Dasatinib|dasatinib|mesh-list
25537170|NCT04971226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537171|NCT04971226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25537172|NCT04971226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25537173|NCT04971226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537174|NCT04961359|Vaccines|vaccines|mesh-list
25537175|NCT04961359|Immunologic Factors|immunologic factors|mesh-ancestor
25537176|NCT04961359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537177|NCT04938830|Palivizumab|palivizumab|mesh-list
25537178|NCT04938830|Antiviral Agents|antiviral agents|mesh-ancestor
25537179|NCT04938830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25537180|NCT04934800|Cladribine|cladribine|mesh-list
25537181|NCT04934800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537182|NCT04934800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25537183|NCT04934800|Immunologic Factors|immunologic factors|mesh-ancestor
25537184|NCT04934800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537205|NCT04924660|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
25537206|NCT04924660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25537207|NCT04924660|Vasodilator Agents|vasodilator agents|mesh-ancestor
25537217|NCT04912115|Ketamine|ketamine|mesh-list
25537218|NCT04912115|Analgesics|analgesics|mesh-ancestor
25537219|NCT04912115|Sensory System Agents|sensory system agents|mesh-ancestor
25537220|NCT04912115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25537221|NCT04912115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537222|NCT04912115|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25537223|NCT04912115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25537224|NCT04912115|Anesthetics, General|anesthetics, general|mesh-ancestor
25537225|NCT04912115|Anesthetics|anesthetics|mesh-ancestor
25537226|NCT04912115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25537227|NCT04912115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25537228|NCT04912115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25537229|NCT04912115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25537230|NCT04912115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537231|NCT04912115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25537232|NCT04912115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25537233|NCT04912115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25537234|NCT04912115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25537235|NCT04912115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25537236|NCT04912115|GABA Modulators|gaba modulators|mesh-ancestor
25537237|NCT04912115|GABA Agents|gaba agents|mesh-ancestor
25537239|NCT04904965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25537240|NCT04904965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25537241|NCT04904965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537242|NCT04904965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25537243|NCT04904965|Anesthetics, General|anesthetics, general|mesh-ancestor
25537244|NCT04904965|Anesthetics|anesthetics|mesh-ancestor
25537245|NCT04904588|Mycophenolic Acid|mycophenolic acid|mesh-list
25537246|NCT04904588|Cyclophosphamide|cyclophosphamide|mesh-list
25537247|NCT04904588|Melphalan|melphalan|mesh-list
25537248|NCT04904588|Busulfan|busulfan|mesh-list
25537249|NCT04904588|Fludarabine|fludarabine|mesh-list
25537250|NCT04904588|Tacrolimus|tacrolimus|mesh-list
25537251|NCT04904588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25537252|NCT04904588|Immunologic Factors|immunologic factors|mesh-ancestor
25537253|NCT04904588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537254|NCT04904588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25537255|NCT04904588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25537256|NCT04904588|Alkylating Agents|alkylating agents|mesh-ancestor
25537257|NCT04904588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537258|NCT04904588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537259|NCT04904588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25537260|NCT04904588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25537261|NCT04904588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25537262|NCT04904588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25537263|NCT04904588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25537264|NCT04904588|Antitubercular Agents|antitubercular agents|mesh-ancestor
25537265|NCT04904588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25537266|NCT04904588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25537278|NCT04901377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25537279|NCT04901377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25537280|NCT04901377|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25537281|NCT04901377|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25537282|NCT04901377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25537283|NCT04901377|Hormone Antagonists|hormone antagonists|mesh-ancestor
25537284|NCT04901377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25537285|NCT04901377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537286|NCT04895722|Pembrolizumab|pembrolizumab|mesh-list
25537287|NCT04895722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25537288|NCT04895722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537289|NCT04895709|Nivolumab|nivolumab|mesh-list
25537290|NCT04895709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25537291|NCT04895709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537292|NCT04895709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25537293|NCT04895709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537308|NCT04849910|Gemtuzumab|gemtuzumab|mesh-list
25537309|NCT04849910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25537310|NCT04849910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537311|NCT04827576|Docetaxel|docetaxel|mesh-list
25537312|NCT04827576|Magrolimab|magrolimab|mesh-list
25537313|NCT04827576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537314|NCT04827576|Tubulin Modulators|tubulin modulators|mesh-ancestor
25537315|NCT04827576|Antimitotic Agents|antimitotic agents|mesh-ancestor
25537316|NCT04827576|Mitosis Modulators|mitosis modulators|mesh-ancestor
25537317|NCT04827576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537318|NCT04827576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25537319|NCT04827056|Ethanol|ethanol|mesh-list
25537320|NCT04827056|Dexmedetomidine|dexmedetomidine|mesh-list
25537321|NCT04827056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25537322|NCT04827056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25537323|NCT04827056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537324|NCT04827056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25537325|NCT04827056|Analgesics|analgesics|mesh-ancestor
25537326|NCT04827056|Sensory System Agents|sensory system agents|mesh-ancestor
25537327|NCT04827056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25537328|NCT04827056|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25537329|NCT04827056|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25537330|NCT04827056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25537331|NCT04827056|Adrenergic Agents|adrenergic agents|mesh-ancestor
25537332|NCT04827056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25537333|NCT04827056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537334|NCT04827056|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25537335|NCT04827056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25537336|NCT04825678|Erenumab|erenumab|mesh-list
25537337|NCT04825678|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25537338|NCT04825678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537339|NCT04825678|Analgesics|analgesics|mesh-ancestor
25537340|NCT04825678|Sensory System Agents|sensory system agents|mesh-ancestor
25537341|NCT04825678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25537342|NCT04825678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537343|NCT04809285|Insulin|insulin|mesh-list
25537344|NCT04809285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25537345|NCT04809285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537346|NCT04808843|Dienogest|dienogest|mesh-list
25537347|NCT04808843|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25537348|NCT04808843|Contraceptive Agents|contraceptive agents|mesh-ancestor
25537349|NCT04808843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25537350|NCT04808843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537351|NCT04808843|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25537352|NCT04808843|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25537353|NCT04808843|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25537354|NCT04808843|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25537355|NCT04808843|Hormone Antagonists|hormone antagonists|mesh-ancestor
25537356|NCT04808843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25537357|NCT04808843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25537358|NCT04808843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537359|NCT04804553|Apremilast|apremilast|mesh-list
25537360|NCT04804553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25537361|NCT04804553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25537362|NCT04804553|Analgesics|analgesics|mesh-ancestor
25537363|NCT04804553|Sensory System Agents|sensory system agents|mesh-ancestor
25537364|NCT04804553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25537365|NCT04804553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537366|NCT04804553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25537367|NCT04804553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25537368|NCT04804553|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25537369|NCT04804553|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25537370|NCT04804553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25537371|NCT04804553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537372|NCT04799288|Teriflunomide|teriflunomide|mesh-list
25537373|NCT04799288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25537374|NCT04799288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25537375|NCT04799288|Analgesics|analgesics|mesh-ancestor
25537376|NCT04799288|Sensory System Agents|sensory system agents|mesh-ancestor
25537377|NCT04799288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25537378|NCT04799288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537379|NCT04799288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25537380|NCT04799288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25537381|NCT04799288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25537382|NCT04799288|Immunologic Factors|immunologic factors|mesh-ancestor
25537383|NCT04777071|Edetic Acid|edetic acid|mesh-list
25537384|NCT04777071|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25537385|NCT04777071|Chelating Agents|chelating agents|mesh-ancestor
25823625|NCT00004862|Fludarabine phosphate|fludarabine phosphate|mesh-list
25537386|NCT04777071|Sequestering Agents|sequestering agents|mesh-ancestor
25537387|NCT04777071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537388|NCT04777071|Anticoagulants|anticoagulants|mesh-ancestor
25537389|NCT04777071|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25537390|NCT04777071|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25537391|NCT04762069|Lomustine|lomustine|mesh-list
25537392|NCT04762069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25537393|NCT04762069|Alkylating Agents|alkylating agents|mesh-ancestor
25537394|NCT04762069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537395|NCT04762069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537396|NCT04742751|Metformin|metformin|mesh-list
25537397|NCT04742751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25537398|NCT04742751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537399|NCT04741204|Metformin|metformin|mesh-list
25537400|NCT04741204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25537401|NCT04741204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537402|NCT04738643|Varenicline|varenicline|mesh-list
25537403|NCT04738643|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25537404|NCT04738643|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25537405|NCT04738643|Cholinergic Agents|cholinergic agents|mesh-ancestor
25537406|NCT04738643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25537407|NCT04738643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537408|NCT04738643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537409|NCT04729959|Atezolizumab|atezolizumab|mesh-list
25537410|NCT04729959|Immunoglobulins|immunoglobulins|mesh-list
25537423|NCT04699240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25537424|NCT04699240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25537425|NCT04699240|Antifungal Agents|antifungal agents|mesh-ancestor
25537426|NCT04699240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25537427|NCT04699240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25537428|NCT04699240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25537429|NCT04699240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537430|NCT04699240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25537431|NCT04699240|Hormone Antagonists|hormone antagonists|mesh-ancestor
25537432|NCT04699240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25537433|NCT04699240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537434|NCT04699240|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25537435|NCT04699240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25537448|NCT04630756|Acalabrutinib|acalabrutinib|mesh-list
25537449|NCT04630756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537450|NCT04624243|Risperidone|risperidone|mesh-list
25537451|NCT04624243|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25537452|NCT04624243|Serotonin Agents|serotonin agents|mesh-ancestor
25537453|NCT04624243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25537454|NCT04624243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537455|NCT04624243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537456|NCT04624243|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25537457|NCT04624243|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25537458|NCT04624243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25537459|NCT04624243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25537460|NCT04624243|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25537461|NCT04624243|Dopamine Agents|dopamine agents|mesh-ancestor
25537462|NCT04613596|Pembrolizumab|pembrolizumab|mesh-list
25537463|NCT04613596|Adagrasib|adagrasib|mesh-list
25537464|NCT04613596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25537465|NCT04613596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537466|NCT04594694|Bezafibrate|bezafibrate|mesh-list
25537467|NCT04594694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25537468|NCT04594694|Antimetabolites|antimetabolites|mesh-ancestor
25537469|NCT04594694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537470|NCT04594694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25537471|NCT04587427|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25537472|NCT04587427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537473|NCT04564755|Abrocitinib|abrocitinib|mesh-list
25537474|NCT04564755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25537475|NCT04564755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25537476|NCT04564755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537483|NCT04544449|Ocrelizumab|ocrelizumab|mesh-list
25537484|NCT04544449|Immunologic Factors|immunologic factors|mesh-ancestor
25537485|NCT04544449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537500|NCT04518228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537502|NCT04518228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25537503|NCT04518228|Antiviral Agents|antiviral agents|mesh-ancestor
25537504|NCT04518228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25537505|NCT04518228|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25537506|NCT04518228|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25537507|NCT04518228|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25537508|NCT04518228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25537509|NCT04518228|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25537510|NCT04518228|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25537511|NCT04494425|Paclitaxel|paclitaxel|mesh-list
25537512|NCT04494425|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25537513|NCT04494425|Capecitabine|capecitabine|mesh-list
25537514|NCT04494425|Trastuzumab|trastuzumab|mesh-list
25537515|NCT04494425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25537516|NCT04494425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537517|NCT04494425|Tubulin Modulators|tubulin modulators|mesh-ancestor
25537518|NCT04494425|Antimitotic Agents|antimitotic agents|mesh-ancestor
25537519|NCT04494425|Mitosis Modulators|mitosis modulators|mesh-ancestor
25537520|NCT04494425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537521|NCT04494425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25537522|NCT04494425|Antimetabolites|antimetabolites|mesh-ancestor
25537523|NCT04494425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25537524|NCT04479813|Moxonidine|moxonidine|mesh-list
25537525|NCT04479813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25537526|NCT04478500|Minocycline|minocycline|mesh-list
25537527|NCT04478500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25537528|NCT04478500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25537529|NCT04474899|Amlodipine|amlodipine|mesh-list
25537530|NCT04474899|Moxonidine|moxonidine|mesh-list
25537531|NCT04474899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25537532|NCT04474899|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25537533|NCT04474899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25537534|NCT04474899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537535|NCT04474899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24530682|NCT00631722|Autonomic Agents|autonomic agents|mesh-ancestor
25537536|NCT04474899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537537|NCT04474899|Vasodilator Agents|vasodilator agents|mesh-ancestor
25537538|NCT04429542|Pembrolizumab|pembrolizumab|mesh-list
25537539|NCT04429542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25537540|NCT04429542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537541|NCT04421963|Olaparib|olaparib|mesh-list
25537542|NCT04421963|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25537543|NCT04421963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25537544|NCT04421963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537545|NCT04421963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647086|NCT01466153|Immunologic Factors|immunologic factors|mesh-ancestor
25537573|NCT04345471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25537574|NCT04345471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537575|NCT04345471|Antidepressive Agents|antidepressive agents|mesh-ancestor
25537576|NCT04345471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25537591|NCT04321330|Atezolizumab|atezolizumab|mesh-list
25537592|NCT04321330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537595|NCT04252742|Erenumab|erenumab|mesh-list
25537596|NCT04252742|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25537597|NCT04252742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537598|NCT04252742|Analgesics|analgesics|mesh-ancestor
25537599|NCT04252742|Sensory System Agents|sensory system agents|mesh-ancestor
25537600|NCT04252742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25537601|NCT04252742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537602|NCT04239599|Leuprolide|leuprolide|mesh-list
25537603|NCT04239599|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25537604|NCT04239599|Fertility Agents|fertility agents|mesh-ancestor
25537605|NCT04239599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25537606|NCT04239599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537607|NCT04239599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25537608|NCT04239599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823626|NCT00004862|Oblimersen|oblimersen|mesh-list
24656961|NCT01264783|RNS60|rns60|mesh-list
25537609|NCT04211090|Carboplatin|carboplatin|mesh-list
25537610|NCT04211090|Pemetrexed|pemetrexed|mesh-list
25537611|NCT04211090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537612|NCT04211090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25537613|NCT04211090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537614|NCT04211090|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25537615|NCT04211090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25537616|NCT04176835|Oxytocin|oxytocin|mesh-list
25537617|NCT04176835|Oxytocics|oxytocics|mesh-ancestor
25537618|NCT04176835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25537619|NCT04176835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537620|NCT04175613|Apremilast|apremilast|mesh-list
25537621|NCT04175613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25537622|NCT04175613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25537623|NCT04175613|Analgesics|analgesics|mesh-ancestor
25537624|NCT04175613|Sensory System Agents|sensory system agents|mesh-ancestor
25537625|NCT04175613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25537626|NCT04175613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537627|NCT04175613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25537628|NCT04175613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25537629|NCT04175613|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25537630|NCT04175613|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25823627|NCT00004862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537646|NCT04166331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537647|NCT04166331|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25537648|NCT04166331|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25537649|NCT04166331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25537650|NCT04166331|Adrenergic Agents|adrenergic agents|mesh-ancestor
25537651|NCT04166331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25537652|NCT04166331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537653|NCT04166331|Protective Agents|protective agents|mesh-ancestor
25537654|NCT04148872|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25537655|NCT04148872|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25537656|NCT04148872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25537657|NCT04148872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537658|NCT04148872|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25537659|NCT04148872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25537660|NCT04148872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537661|NCT04148872|Cholinergic Agents|cholinergic agents|mesh-ancestor
25537662|NCT04148872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25537663|NCT04132388|Adalimumab|adalimumab|mesh-list
25537664|NCT04132388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25537665|NCT04132388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25537666|NCT04125563|Capsaicin|capsaicin|mesh-list
25537667|NCT04125563|Antipruritics|antipruritics|mesh-ancestor
25537668|NCT04125563|Dermatologic Agents|dermatologic agents|mesh-ancestor
25537669|NCT04125563|Sensory System Agents|sensory system agents|mesh-ancestor
25537670|NCT04125563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25537671|NCT04125563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537688|NCT04092283|Paclitaxel|paclitaxel|mesh-list
25537689|NCT04092283|Etoposide|etoposide|mesh-list
25537690|NCT04092283|Podophyllotoxin|podophyllotoxin|mesh-list
25537691|NCT04092283|Cisplatin|cisplatin|mesh-list
25537692|NCT04092283|Carboplatin|carboplatin|mesh-list
25537693|NCT04092283|Pemetrexed|pemetrexed|mesh-list
25537694|NCT04092283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25537695|NCT04092283|Etoposide phosphate|etoposide phosphate|mesh-list
25537696|NCT04092283|Durvalumab|durvalumab|mesh-list
25537697|NCT04092283|Immunoglobulins|immunoglobulins|mesh-list
25537698|NCT04092283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25537699|NCT04092283|Immunoglobulin G|immunoglobulin g|mesh-list
25537700|NCT04092283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25537701|NCT04092283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537702|NCT04092283|Tubulin Modulators|tubulin modulators|mesh-ancestor
25537703|NCT04092283|Antimitotic Agents|antimitotic agents|mesh-ancestor
25537704|NCT04092283|Mitosis Modulators|mitosis modulators|mesh-ancestor
25537705|NCT04092283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537706|NCT04092283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25537707|NCT04092283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25537714|NCT04092283|Keratolytic Agents|keratolytic agents|mesh-ancestor
25537715|NCT04092283|Dermatologic Agents|dermatologic agents|mesh-ancestor
25537721|NCT04081688|Atezolizumab|atezolizumab|mesh-list
25537722|NCT04081688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25537723|NCT04081688|Immunoglobulins|immunoglobulins|mesh-list
25537724|NCT04081688|Immunoglobulin G|immunoglobulin g|mesh-list
25537725|NCT04081688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537726|NCT04081688|Immunologic Factors|immunologic factors|mesh-ancestor
25537727|NCT04081688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537731|NCT04047472|Aflibercept|aflibercept|mesh-list
25537732|NCT04047472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25537733|NCT04047472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25537734|NCT04047472|Growth Substances|growth substances|mesh-ancestor
25537735|NCT04047472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537736|NCT04047472|Growth Inhibitors|growth inhibitors|mesh-ancestor
25537737|NCT04047472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537751|NCT04037397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
25537752|NCT03990623|Liver Extracts|liver extracts|mesh-list
25537753|NCT03990623|Hematinics|hematinics|mesh-ancestor
25537754|NCT03988634|Valsartan|valsartan|mesh-list
25537755|NCT03988634|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25537756|NCT03988634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24541624|NCT00674167|Tubulin Modulators|tubulin modulators|mesh-ancestor
25537757|NCT03988634|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25537758|NCT03988634|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25537759|NCT03988634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537760|NCT03988387|Tenofovir|tenofovir|mesh-list
25537761|NCT03988387|Emtricitabine|emtricitabine|mesh-list
25537762|NCT03988387|Antiviral Agents|antiviral agents|mesh-ancestor
25537763|NCT03988387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25537764|NCT03988387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25537765|NCT03988387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25537766|NCT03988387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25537767|NCT03988387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537768|NCT03988387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25537769|NCT03988387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25537770|NCT03925025|Magnesium Sulfate|magnesium sulfate|mesh-list
25537771|NCT03925025|Nimodipine|nimodipine|mesh-list
25537772|NCT03925025|Analgesics|analgesics|mesh-ancestor
25537773|NCT03925025|Sensory System Agents|sensory system agents|mesh-ancestor
25537774|NCT03925025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25537775|NCT03925025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537776|NCT03925025|Anesthetics|anesthetics|mesh-ancestor
25537777|NCT03925025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25537778|NCT03925025|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25537779|NCT03925025|Anticonvulsants|anticonvulsants|mesh-ancestor
25537786|NCT03925025|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25537787|NCT03925025|Vasodilator Agents|vasodilator agents|mesh-ancestor
25537799|NCT03912909|Empagliflozin|empagliflozin|mesh-list
25537800|NCT03912909|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25537801|NCT03912909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537802|NCT03912909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25537803|NCT03912909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537804|NCT03899155|Nivolumab|nivolumab|mesh-list
25537805|NCT03899155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25537806|NCT03899155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537807|NCT03899155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25537808|NCT03899155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537809|NCT03887780|Rivaroxaban|rivaroxaban|mesh-list
25537810|NCT03887780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25537811|NCT03887780|Antithrombins|antithrombins|mesh-ancestor
25537812|NCT03887780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25537813|NCT03887780|Protease Inhibitors|protease inhibitors|mesh-ancestor
25537814|NCT03887780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25537815|NCT03887780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537816|NCT03887780|Anticoagulants|anticoagulants|mesh-ancestor
25537817|NCT03842839|Albuterol|albuterol|mesh-list
25537818|NCT03842839|Tiotropium Bromide|tiotropium bromide|mesh-list
25537819|NCT03842839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25537820|NCT03842839|Autonomic Agents|autonomic agents|mesh-ancestor
25537821|NCT03842839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25537822|NCT03842839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537823|NCT03842839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25537824|NCT03842839|Respiratory System Agents|respiratory system agents|mesh-ancestor
25537825|NCT03842839|Parasympatholytics|parasympatholytics|mesh-ancestor
25537826|NCT03842839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25537827|NCT03842839|Cholinergic Agents|cholinergic agents|mesh-ancestor
25537828|NCT03842839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25537829|NCT03842839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537830|NCT03842839|Tocolytic Agents|tocolytic agents|mesh-ancestor
24861396|NCT02317419|Antiviral Agents|antiviral agents|mesh-ancestor
24861397|NCT02317419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25537832|NCT03842839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25537833|NCT03842839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25537834|NCT03842839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25537835|NCT03842839|Adrenergic Agents|adrenergic agents|mesh-ancestor
25537836|NCT03841110|Aldesleukin|aldesleukin|mesh-list
25537837|NCT03841110|Cyclophosphamide|cyclophosphamide|mesh-list
25537838|NCT03841110|Pembrolizumab|pembrolizumab|mesh-list
25537839|NCT03841110|Nivolumab|nivolumab|mesh-list
25537840|NCT03841110|Fludarabine|fludarabine|mesh-list
25537841|NCT03841110|Atezolizumab|atezolizumab|mesh-list
25537842|NCT03841110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25537843|NCT03841110|Immunologic Factors|immunologic factors|mesh-ancestor
25537844|NCT03841110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537845|NCT03841110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25537846|NCT03841110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25537847|NCT03841110|Alkylating Agents|alkylating agents|mesh-ancestor
25537848|NCT03841110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537863|NCT03836040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25537864|NCT03836040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537865|NCT03836040|Immunologic Factors|immunologic factors|mesh-ancestor
25537866|NCT03811015|Cisplatin|cisplatin|mesh-list
25537867|NCT03811015|Nivolumab|nivolumab|mesh-list
25537868|NCT03811015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537869|NCT03811015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25537870|NCT03811015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25537871|NCT03811015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537872|NCT03799627|Epoetin Alfa|epoetin alfa|mesh-list
25537873|NCT03799627|Glycine|glycine|mesh-list
25537874|NCT03799627|Hematinics|hematinics|mesh-ancestor
25537875|NCT03799627|Glycine Agents|glycine agents|mesh-ancestor
25537876|NCT03799627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25537877|NCT03799627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537878|NCT03799627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537885|NCT03785678|Tenecteplase|tenecteplase|mesh-list
25537886|NCT03785678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25537887|NCT03785678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25537888|NCT03785678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537889|NCT03785405|Valsartan|valsartan|mesh-list
25537890|NCT03785405|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25537891|NCT03785405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25537892|NCT03785405|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25537893|NCT03785405|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25537894|NCT03785405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537895|NCT03767348|Nivolumab|nivolumab|mesh-list
25537896|NCT03767348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25537897|NCT03767348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537898|NCT03767348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25537899|NCT03767348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537900|NCT03735121|Atezolizumab|atezolizumab|mesh-list
25537901|NCT03735121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537910|NCT03704363|Infliximab|infliximab|mesh-list
25537911|NCT03704363|Dermatologic Agents|dermatologic agents|mesh-ancestor
25537912|NCT03704363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25537913|NCT03704363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25537914|NCT03700476|Gemcitabine|gemcitabine|mesh-list
25537915|NCT03700476|Cisplatin|cisplatin|mesh-list
25537916|NCT03700476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537917|NCT03700476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25537918|NCT03700476|Antimetabolites|antimetabolites|mesh-ancestor
25537919|NCT03700476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537920|NCT03700476|Antiviral Agents|antiviral agents|mesh-ancestor
25537921|NCT03700476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25537925|NCT03700476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537926|NCT03667846|Topiramate|topiramate|mesh-list
25537927|NCT03667846|Anticonvulsants|anticonvulsants|mesh-ancestor
25537928|NCT03667846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25537929|NCT03667846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537930|NCT03659136|Everolimus|everolimus|mesh-list
25537931|NCT03659136|Exemestane|exemestane|mesh-list
25537932|NCT03659136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537933|NCT03659136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25537934|NCT03659136|Immunologic Factors|immunologic factors|mesh-ancestor
25537935|NCT03659136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537936|NCT03659136|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25537937|NCT03659136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25537938|NCT03659136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25537939|NCT03659136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537940|NCT03659136|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25537941|NCT03659136|Hormone Antagonists|hormone antagonists|mesh-ancestor
25537942|NCT03659136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24407418|NCT00174499|Nicotine|nicotine|mesh-list
25537943|NCT03649321|Gemcitabine|gemcitabine|mesh-list
25537944|NCT03649321|Paclitaxel|paclitaxel|mesh-list
25537945|NCT03649321|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25537946|NCT03649321|Cisplatin|cisplatin|mesh-list
25537947|NCT03649321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25537948|NCT03649321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537949|NCT03649321|Tubulin Modulators|tubulin modulators|mesh-ancestor
25537950|NCT03649321|Antimitotic Agents|antimitotic agents|mesh-ancestor
25537951|NCT03649321|Mitosis Modulators|mitosis modulators|mesh-ancestor
25537952|NCT03649321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537953|NCT03649321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25537954|NCT03649321|Antimetabolites|antimetabolites|mesh-ancestor
25537955|NCT03649321|Antiviral Agents|antiviral agents|mesh-ancestor
25537956|NCT03649321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25537957|NCT03649321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25537958|NCT03649321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25537959|NCT03649321|Immunologic Factors|immunologic factors|mesh-ancestor
25537960|NCT03649321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537961|NCT03631173|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25537962|NCT03631173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25537965|NCT03586453|Osimertinib|osimertinib|mesh-list
25537966|NCT03586453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537967|NCT03586453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25537968|NCT03586453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25537969|NCT03586453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537970|NCT03519412|Pembrolizumab|pembrolizumab|mesh-list
25537971|NCT03519412|Temozolomide|temozolomide|mesh-list
25537972|NCT03519412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25537973|NCT03519412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537974|NCT03519412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25537975|NCT03519412|Alkylating Agents|alkylating agents|mesh-ancestor
25537976|NCT03519412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537977|NCT03440879|Goserelin|goserelin|mesh-list
25537978|NCT03440879|Androgens|androgens|mesh-list
25537979|NCT03440879|Hormones|hormones|mesh-ancestor
25537980|NCT03440879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25537981|NCT03440879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25537982|NCT03440879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25537983|NCT03440879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537984|NCT03424005|Gemcitabine|gemcitabine|mesh-list
25537985|NCT03424005|Paclitaxel|paclitaxel|mesh-list
25537986|NCT03424005|Bevacizumab|bevacizumab|mesh-list
25537987|NCT03424005|Carboplatin|carboplatin|mesh-list
25537988|NCT03424005|Capecitabine|capecitabine|mesh-list
25537989|NCT03424005|Atezolizumab|atezolizumab|mesh-list
25537990|NCT03424005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25537991|NCT03424005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25537992|NCT03424005|Tubulin Modulators|tubulin modulators|mesh-ancestor
25537993|NCT03424005|Antimitotic Agents|antimitotic agents|mesh-ancestor
25537994|NCT03424005|Mitosis Modulators|mitosis modulators|mesh-ancestor
25537995|NCT03424005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25537996|NCT03424005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25537997|NCT03424005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25537998|NCT03424005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25537999|NCT03424005|Growth Substances|growth substances|mesh-ancestor
25538000|NCT03424005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538001|NCT03424005|Growth Inhibitors|growth inhibitors|mesh-ancestor
25538002|NCT03424005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25538003|NCT03424005|Antimetabolites|antimetabolites|mesh-ancestor
25538004|NCT03424005|Antiviral Agents|antiviral agents|mesh-ancestor
25538005|NCT03424005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25538006|NCT03424005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538007|NCT03424005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25538008|NCT03424005|Immunologic Factors|immunologic factors|mesh-ancestor
25538009|NCT03419481|Pembrolizumab|pembrolizumab|mesh-list
25538010|NCT03419481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25538011|NCT03419481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538012|NCT03416244|Nivolumab|nivolumab|mesh-list
25538013|NCT03416244|Ipilimumab|ipilimumab|mesh-list
25538014|NCT03416244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25538015|NCT03416244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538016|NCT03416244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24820120|NCT02098837|Dolutegravir|dolutegravir|mesh-list
25538017|NCT03416244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538018|NCT03393884|Paclitaxel|paclitaxel|mesh-list
25538019|NCT03393884|Carboplatin|carboplatin|mesh-list
25538020|NCT03393884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25538021|NCT03393884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538022|NCT03393884|Tubulin Modulators|tubulin modulators|mesh-ancestor
25538023|NCT03393884|Antimitotic Agents|antimitotic agents|mesh-ancestor
25538024|NCT03393884|Mitosis Modulators|mitosis modulators|mesh-ancestor
25538025|NCT03393884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538026|NCT03390933|Fluoxetine|fluoxetine|mesh-list
25538027|NCT03390933|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25538028|NCT03390933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25538029|NCT03390933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25538030|NCT03390933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538031|NCT03390933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25538032|NCT03390933|Serotonin Agents|serotonin agents|mesh-ancestor
25538033|NCT03390933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538034|NCT03390933|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25538035|NCT03390933|Antidepressive Agents|antidepressive agents|mesh-ancestor
25538036|NCT03390933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25538037|NCT03390933|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25538038|NCT03390933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25538039|NCT03390933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538040|NCT03389477|Cisplatin|cisplatin|mesh-list
25538041|NCT03389477|Cetuximab|cetuximab|mesh-list
25538042|NCT03389477|Palbociclib|palbociclib|mesh-list
25538043|NCT03389477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538044|NCT03389477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25538045|NCT03389477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25538046|NCT03389477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538047|NCT03389477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538048|NCT03385304|Iodine|iodine|mesh-list
25538049|NCT03385304|Chlorhexidine|chlorhexidine|mesh-list
25538050|NCT03385304|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25538051|NCT03385304|Povidone-Iodine|povidone-iodine|mesh-list
25538052|NCT03385304|Povidone|povidone|mesh-list
25538053|NCT03385304|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25538054|NCT03385304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25538055|NCT03385304|Disinfectants|disinfectants|mesh-ancestor
25538056|NCT03385304|Dermatologic Agents|dermatologic agents|mesh-ancestor
25538057|NCT03385304|Trace Elements|trace elements|mesh-ancestor
25538058|NCT03385304|Micronutrients|micronutrients|mesh-ancestor
25538059|NCT03385304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538060|NCT03385304|Plasma Substitutes|plasma substitutes|mesh-ancestor
25538061|NCT03385304|Blood Substitutes|blood substitutes|mesh-ancestor
25538062|NCT03329950|Pembrolizumab|pembrolizumab|mesh-list
25538063|NCT03329950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25538064|NCT03329950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538065|NCT03294460|Ethanol|ethanol|mesh-list
25538066|NCT03294460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25538067|NCT03294460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25538068|NCT03294460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25538069|NCT03294460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538070|NCT03287908|Dexamethasone|dexamethasone|mesh-list
25647093|NCT01466179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538071|NCT03287908|Pomalidomide|pomalidomide|mesh-list
25647094|NCT01466192|Ribavirin|ribavirin|mesh-list
25538072|NCT03287908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25538073|NCT03287908|Antiemetics|antiemetics|mesh-ancestor
25538074|NCT03287908|Autonomic Agents|autonomic agents|mesh-ancestor
25538075|NCT03287908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25538076|NCT03287908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538077|NCT03287908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25538078|NCT03287908|Glucocorticoids|glucocorticoids|mesh-ancestor
25538079|NCT03287908|Hormones|hormones|mesh-ancestor
25538080|NCT03287908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25538081|NCT03287908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25538082|NCT03287908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538083|NCT03287908|Immunologic Factors|immunologic factors|mesh-ancestor
25538084|NCT03287908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25538085|NCT03287908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25538086|NCT03287908|Growth Substances|growth substances|mesh-ancestor
25538087|NCT03287908|Growth Inhibitors|growth inhibitors|mesh-ancestor
25538088|NCT03280563|Tamoxifen|tamoxifen|mesh-list
25538089|NCT03280563|Bevacizumab|bevacizumab|mesh-list
25538090|NCT03280563|Atezolizumab|atezolizumab|mesh-list
25538091|NCT03280563|Fulvestrant|fulvestrant|mesh-list
25538092|NCT03280563|Exemestane|exemestane|mesh-list
25538093|NCT03280563|Entinostat|entinostat|mesh-list
25538094|NCT03280563|Antibodies|antibodies|mesh-list
25538095|NCT03280563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25538096|NCT03280563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538097|NCT03280563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25538098|NCT03280563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25538099|NCT03280563|Growth Substances|growth substances|mesh-ancestor
25538100|NCT03280563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538101|NCT03280563|Growth Inhibitors|growth inhibitors|mesh-ancestor
25538102|NCT03280563|Immunologic Factors|immunologic factors|mesh-ancestor
25538103|NCT03280563|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25538104|NCT03280563|Hormone Antagonists|hormone antagonists|mesh-ancestor
25538105|NCT03280563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25538106|NCT03280563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25538107|NCT03280563|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25538108|NCT03280563|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25538109|NCT03280563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25538110|NCT03280563|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25538111|NCT03280563|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25538112|NCT03280563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25538113|NCT03280563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538114|NCT03280563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538115|NCT03280563|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25538116|NCT03277313|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25538117|NCT03277313|Immunologic Factors|immunologic factors|mesh-ancestor
25538118|NCT03277313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538119|NCT03243890|Vitamin D|vitamin d|mesh-list
25538120|NCT03243890|Vitamin K 2|vitamin k 2|mesh-list
25538121|NCT03243890|Vitamin K|vitamin k|mesh-list
25538122|NCT03243890|Vitamin MK 7|vitamin mk 7|mesh-list
25538123|NCT03243890|Vitamins|vitamins|mesh-ancestor
25538124|NCT03243890|Micronutrients|micronutrients|mesh-ancestor
25538125|NCT03243890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538126|NCT03243890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25538127|NCT03243890|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24861967|NCT02321579|Vitamin B 6|vitamin b 6|mesh-list
25538128|NCT03243890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25538129|NCT03243890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538130|NCT03243890|Hemostatics|hemostatics|mesh-ancestor
25538131|NCT03243890|Coagulants|coagulants|mesh-ancestor
25538132|NCT03239340|Osimertinib|osimertinib|mesh-list
25538133|NCT03239340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538134|NCT03239340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25538135|NCT03239340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538136|NCT03239340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538137|NCT03236792|Dexamethasone|dexamethasone|mesh-list
25538138|NCT03236792|Cyclophosphamide|cyclophosphamide|mesh-list
25538139|NCT03236792|Ixazomib|ixazomib|mesh-list
25538140|NCT03236792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25538141|NCT03236792|Immunologic Factors|immunologic factors|mesh-ancestor
25538142|NCT03236792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538143|NCT03236792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25538144|NCT03236792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25538145|NCT03236792|Alkylating Agents|alkylating agents|mesh-ancestor
25647095|NCT01466192|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25538146|NCT03236792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538147|NCT03236792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538148|NCT03236792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25538149|NCT03236792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25538151|NCT03236792|Autonomic Agents|autonomic agents|mesh-ancestor
25538152|NCT03236792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25538153|NCT03236792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25538154|NCT03236792|Glucocorticoids|glucocorticoids|mesh-ancestor
25538155|NCT03236792|Hormones|hormones|mesh-ancestor
25538156|NCT03236792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25538157|NCT03236792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25538158|NCT03236792|Protease Inhibitors|protease inhibitors|mesh-ancestor
25538159|NCT03236792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538160|NCT03232138|Sulforaphane|sulforaphane|mesh-list
25538161|NCT03232138|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25538162|NCT03232138|Protective Agents|protective agents|mesh-ancestor
25538163|NCT03232138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538164|NCT03232138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538165|NCT03214562|Cytarabine|cytarabine|mesh-list
25538166|NCT03214562|Fludarabine|fludarabine|mesh-list
25538167|NCT03214562|Venetoclax|venetoclax|mesh-list
25538168|NCT03214562|Idarubicin|idarubicin|mesh-list
25538169|NCT03214562|Lenograstim|lenograstim|mesh-list
25538170|NCT03214562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538171|NCT03214562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25538172|NCT03214562|Antimetabolites|antimetabolites|mesh-ancestor
25538173|NCT03214562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538174|NCT03214562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25538175|NCT03214562|Immunologic Factors|immunologic factors|mesh-ancestor
25538176|NCT03214562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538177|NCT03214562|Antiviral Agents|antiviral agents|mesh-ancestor
25538178|NCT03214562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25538179|NCT03214562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25538180|NCT03214562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25538181|NCT03214562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25538182|NCT03214562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25538183|NCT03214562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538184|NCT03213652|Ensartinib|ensartinib|mesh-list
25538185|NCT03213652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538186|NCT03213652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25538187|NCT03213652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538188|NCT03213652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538189|NCT03174405|Avelumab|avelumab|mesh-list
25538190|NCT03174405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25538191|NCT03174405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538192|NCT03172416|Oxaliplatin|oxaliplatin|mesh-list
25538193|NCT03172416|Nivolumab|nivolumab|mesh-list
25538194|NCT03172416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538195|NCT03172416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25538196|NCT03172416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25538197|NCT03172416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538198|NCT03155620|Olaparib|olaparib|mesh-list
25538199|NCT03155620|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25538200|NCT03155620|Palbociclib|palbociclib|mesh-list
25538201|NCT03155620|Vemurafenib|vemurafenib|mesh-list
25538202|NCT03155620|Tipifarnib|tipifarnib|mesh-list
25538203|NCT03155620|Ensartinib|ensartinib|mesh-list
25538204|NCT03155620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538205|NCT03155620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538206|NCT03155620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538207|NCT03155620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25538209|NCT03143270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25538210|NCT03143270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538211|NCT03143270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25538212|NCT03143270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538213|NCT03121677|Poly I-C|poly i-c|mesh-list
25538214|NCT03121677|Rituximab|rituximab|mesh-list
25538215|NCT03121677|Nivolumab|nivolumab|mesh-list
25538216|NCT03121677|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25538217|NCT03121677|Poly ICLC|poly iclc|mesh-list
25538218|NCT03121677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25538219|NCT03121677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538220|NCT03121677|Immunologic Factors|immunologic factors|mesh-ancestor
25538221|NCT03121677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538222|NCT03121677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25538245|NCT03092518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25538246|NCT03092518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25538247|NCT03092518|Chelating Agents|chelating agents|mesh-ancestor
25538248|NCT03092518|Sequestering Agents|sequestering agents|mesh-ancestor
25538250|NCT03065387|Palbociclib|palbociclib|mesh-list
25538251|NCT03065387|Trametinib|trametinib|mesh-list
25538252|NCT03065387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538253|NCT03065387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25538254|NCT03065387|Immunologic Factors|immunologic factors|mesh-ancestor
25538255|NCT03065387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538256|NCT03065387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25538257|NCT03065387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538258|NCT03065387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538259|NCT03036098|Gemcitabine|gemcitabine|mesh-list
25538260|NCT03036098|Cisplatin|cisplatin|mesh-list
25538261|NCT03036098|Carboplatin|carboplatin|mesh-list
25538262|NCT03036098|Nivolumab|nivolumab|mesh-list
25538263|NCT03036098|Ipilimumab|ipilimumab|mesh-list
25538264|NCT03036098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538265|NCT03036098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25538266|NCT03036098|Antimetabolites|antimetabolites|mesh-ancestor
25538267|NCT03036098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538268|NCT03036098|Antiviral Agents|antiviral agents|mesh-ancestor
25538269|NCT03036098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25538270|NCT03036098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538271|NCT03036098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25538272|NCT03036098|Immunologic Factors|immunologic factors|mesh-ancestor
25538273|NCT03036098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538274|NCT03036098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25538275|NCT03036098|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25647100|NCT01466270|Donepezil|donepezil|mesh-list
25647101|NCT01466270|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25647102|NCT01466270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538303|NCT02928224|Leucovorin|leucovorin|mesh-list
25538304|NCT02928224|Folic Acid|folic acid|mesh-list
25538305|NCT02928224|Fluorouracil|fluorouracil|mesh-list
25538306|NCT02928224|Irinotecan|irinotecan|mesh-list
25538307|NCT02928224|Cetuximab|cetuximab|mesh-list
25538308|NCT02928224|Levoleucovorin|levoleucovorin|mesh-list
25538309|NCT02928224|Antimetabolites|antimetabolites|mesh-ancestor
25647103|NCT01466270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538310|NCT02928224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538311|NCT02928224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25538312|NCT02928224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538313|NCT02928224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25538314|NCT02928224|Immunologic Factors|immunologic factors|mesh-ancestor
25538315|NCT02928224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538316|NCT02928224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25538317|NCT02928224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25538318|NCT02928224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538319|NCT02928224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25538320|NCT02928224|Antidotes|antidotes|mesh-ancestor
25538321|NCT02928224|Protective Agents|protective agents|mesh-ancestor
25538322|NCT02928224|Vitamin B Complex|vitamin b complex|mesh-ancestor
25538323|NCT02928224|Vitamins|vitamins|mesh-ancestor
25538324|NCT02928224|Micronutrients|micronutrients|mesh-ancestor
25538325|NCT02928224|Hematinics|hematinics|mesh-ancestor
25538326|NCT02871687|Simvastatin|simvastatin|mesh-list
25538327|NCT02871687|Pravastatin|pravastatin|mesh-list
25538328|NCT02871687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25538329|NCT02871687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25538330|NCT02871687|Antimetabolites|antimetabolites|mesh-ancestor
25538331|NCT02871687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538332|NCT02871687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25538333|NCT02871687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25538334|NCT02871687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538335|NCT02812212|Diuretics|diuretics|mesh-list
25538336|NCT02812212|Natriuretic Agents|natriuretic agents|mesh-ancestor
25538337|NCT02812212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538338|NCT02799602|Docetaxel|docetaxel|mesh-list
25538339|NCT02799602|Androgens|androgens|mesh-list
25538340|NCT02799602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538341|NCT02799602|Tubulin Modulators|tubulin modulators|mesh-ancestor
25538342|NCT02799602|Antimitotic Agents|antimitotic agents|mesh-ancestor
25538343|NCT02799602|Mitosis Modulators|mitosis modulators|mesh-ancestor
25538344|NCT02799602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538345|NCT02799602|Hormones|hormones|mesh-ancestor
25538346|NCT02799602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25538347|NCT02799602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538348|NCT02759835|Osimertinib|osimertinib|mesh-list
25538349|NCT02759835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538350|NCT02759835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25538351|NCT02759835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538352|NCT02759835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538353|NCT02702401|Pembrolizumab|pembrolizumab|mesh-list
25538354|NCT02702401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25538355|NCT02702401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538356|NCT02700841|Melphalan|melphalan|mesh-list
25538357|NCT02700841|Mechlorethamine|mechlorethamine|mesh-list
25538358|NCT02700841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25538359|NCT02700841|Alkylating Agents|alkylating agents|mesh-ancestor
25538360|NCT02700841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538361|NCT02700841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538362|NCT02700841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25538363|NCT02700841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25538364|NCT02700841|Immunologic Factors|immunologic factors|mesh-ancestor
25538365|NCT02700841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538366|NCT02675452|Itraconazole|itraconazole|mesh-list
25538367|NCT02675452|Azacitidine|azacitidine|mesh-list
25647104|NCT01466270|Cholinergic Agents|cholinergic agents|mesh-ancestor
25538398|NCT02481830|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25538399|NCT02481830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25538400|NCT02481830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538438|NCT02425904|Clofarabine|clofarabine|mesh-list
25538439|NCT02425904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25538440|NCT02425904|Antimetabolites|antimetabolites|mesh-ancestor
25538441|NCT02425904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538442|NCT02425904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538444|NCT02367040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25538445|NCT02367040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538469|NCT02247349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538470|NCT02247349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25538471|NCT02247349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538472|NCT02230891|Carvedilol|carvedilol|mesh-list
25538473|NCT02230891|Spironolactone|spironolactone|mesh-list
25538474|NCT02230891|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25538475|NCT02230891|Hormone Antagonists|hormone antagonists|mesh-ancestor
25538476|NCT02230891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25538477|NCT02230891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538478|NCT02230891|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25538479|NCT02230891|Diuretics|diuretics|mesh-ancestor
25538480|NCT02230891|Natriuretic Agents|natriuretic agents|mesh-ancestor
25538481|NCT02230891|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25538482|NCT02230891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25538483|NCT02230891|Adrenergic Agents|adrenergic agents|mesh-ancestor
25538484|NCT02230891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25538485|NCT02230891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538486|NCT02230891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25538487|NCT02230891|Antioxidants|antioxidants|mesh-ancestor
25538488|NCT02230891|Protective Agents|protective agents|mesh-ancestor
25538489|NCT02230891|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25538490|NCT02230891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25538491|NCT02230891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25538492|NCT02230891|Vasodilator Agents|vasodilator agents|mesh-ancestor
25538493|NCT02230891|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25538494|NCT02230891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24693827|NCT01422590|Hormones|hormones|mesh-ancestor
25538523|NCT02123108|Mycophenolic Acid|mycophenolic acid|mesh-list
25538524|NCT02123108|Tacrolimus|tacrolimus|mesh-list
25538525|NCT02123108|Basiliximab|basiliximab|mesh-list
25538526|NCT02123108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25538527|NCT02123108|Immunologic Factors|immunologic factors|mesh-ancestor
25538528|NCT02123108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538529|NCT02123108|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25538530|NCT02123108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538531|NCT02123108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538532|NCT02123108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25538533|NCT02123108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538534|NCT02123108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25538535|NCT02123108|Antitubercular Agents|antitubercular agents|mesh-ancestor
25538536|NCT02123108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25538537|NCT02123108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25538538|NCT02085148|Irinotecan|irinotecan|mesh-list
25538539|NCT02085148|Vincristine|vincristine|mesh-list
25538540|NCT02085148|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25538541|NCT02085148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25538542|NCT02085148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538543|NCT02085148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538544|NCT02085148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538545|NCT02085148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25538546|NCT02085148|Tubulin Modulators|tubulin modulators|mesh-ancestor
25538547|NCT02085148|Antimitotic Agents|antimitotic agents|mesh-ancestor
25538548|NCT02085148|Mitosis Modulators|mitosis modulators|mesh-ancestor
25538549|NCT02032810|Ipilimumab|ipilimumab|mesh-list
25538550|NCT02032810|Panobinostat|panobinostat|mesh-list
25538551|NCT02032810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25538552|NCT02032810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538553|NCT02032810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25538554|NCT02032810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538555|NCT02032810|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25538556|NCT02032810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538557|NCT02030964|Eflornithine|eflornithine|mesh-list
25538558|NCT02030964|Celecoxib|celecoxib|mesh-list
25538559|NCT02030964|Cyclophosphamide|cyclophosphamide|mesh-list
25538560|NCT02030964|Topotecan|topotecan|mesh-list
25538561|NCT02030964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25538562|NCT02030964|Immunologic Factors|immunologic factors|mesh-ancestor
25538563|NCT02030964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538564|NCT02030964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25538565|NCT02030964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25538566|NCT02030964|Alkylating Agents|alkylating agents|mesh-ancestor
25538567|NCT02030964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538568|NCT02030964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538569|NCT02030964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25538570|NCT02030964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25538571|NCT02030964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25538572|NCT02030964|Analgesics|analgesics|mesh-ancestor
25538573|NCT02030964|Sensory System Agents|sensory system agents|mesh-ancestor
25538574|NCT02030964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25538575|NCT02030964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25538576|NCT02030964|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25538577|NCT02030964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25538578|NCT02030964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538579|NCT02030964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25538580|NCT02030964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25538581|NCT02030964|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25538582|NCT02030964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25538583|NCT02030964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25538584|NCT02030964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25538585|NCT02030964|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
25538586|NCT01996865|Rituximab|rituximab|mesh-list
25538587|NCT01996865|Lenalidomide|lenalidomide|mesh-list
25538588|NCT01996865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25538589|NCT01996865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647109|NCT01466348|Caffeine|caffeine|mesh-list
25538591|NCT01996865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538592|NCT01996865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25538593|NCT01996865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25538594|NCT01996865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25538595|NCT01996865|Growth Substances|growth substances|mesh-ancestor
25538596|NCT01996865|Growth Inhibitors|growth inhibitors|mesh-ancestor
25538598|NCT01962948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25538599|NCT01962948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538600|NCT01962948|Tubulin Modulators|tubulin modulators|mesh-ancestor
25538601|NCT01962948|Antimitotic Agents|antimitotic agents|mesh-ancestor
25538602|NCT01962948|Mitosis Modulators|mitosis modulators|mesh-ancestor
25538603|NCT01962948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538604|NCT01910402|Ritonavir|ritonavir|mesh-list
25538605|NCT01910402|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25538606|NCT01910402|Tenofovir|tenofovir|mesh-list
25538607|NCT01910402|Lamivudine|lamivudine|mesh-list
25538608|NCT01910402|Emtricitabine|emtricitabine|mesh-list
25538609|NCT01910402|Dolutegravir|dolutegravir|mesh-list
25538610|NCT01910402|Abacavir|abacavir|mesh-list
25538611|NCT01910402|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25538612|NCT01910402|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25538613|NCT01910402|Protease Inhibitors|protease inhibitors|mesh-ancestor
25538614|NCT01910402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538615|NCT01910402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538616|NCT01910402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25538617|NCT01910402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25538618|NCT01910402|Antiviral Agents|antiviral agents|mesh-ancestor
25538619|NCT01910402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25538620|NCT01910402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25538621|NCT01910402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25538622|NCT01910402|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25538623|NCT01910402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25538624|NCT01910402|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25538625|NCT01910402|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25538626|NCT01867320|Raltegravir Potassium|raltegravir potassium|mesh-list
25538627|NCT01867320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25538628|NCT01867320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25538629|NCT01867320|Antiviral Agents|antiviral agents|mesh-ancestor
25538630|NCT01867320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25538631|NCT01867320|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25538632|NCT01867320|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25538633|NCT01867320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538634|NCT01867320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538635|NCT01815580|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25538636|NCT01815580|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25538637|NCT01815580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25538638|NCT01815580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25538639|NCT01815580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538640|NCT01815580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538641|NCT01815580|Antiviral Agents|antiviral agents|mesh-ancestor
25538642|NCT01815580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25538643|NCT01815580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25538644|NCT01815580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25538645|NCT01659151|Aldesleukin|aldesleukin|mesh-list
25538646|NCT01659151|Cyclophosphamide|cyclophosphamide|mesh-list
25538647|NCT01659151|Fludarabine|fludarabine|mesh-list
25538648|NCT01659151|Interleukin-2|interleukin-2|mesh-list
25538649|NCT01659151|Vemurafenib|vemurafenib|mesh-list
25538650|NCT01659151|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25538651|NCT01659151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25538652|NCT01659151|Immunologic Factors|immunologic factors|mesh-ancestor
25538653|NCT01659151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538654|NCT01659151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25538655|NCT01659151|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25538656|NCT01659151|Alkylating Agents|alkylating agents|mesh-ancestor
25538657|NCT01659151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538658|NCT01659151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538659|NCT01659151|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25538660|NCT01659151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25538661|NCT01659151|Analgesics|analgesics|mesh-ancestor
25538662|NCT01659151|Sensory System Agents|sensory system agents|mesh-ancestor
25538663|NCT01659151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25538665|NCT01659151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25538666|NCT01659151|Antiviral Agents|antiviral agents|mesh-ancestor
25538667|NCT01659151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25538668|NCT01659151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25538669|NCT01137604|Bevacizumab|bevacizumab|mesh-list
25538670|NCT01137604|Lenvatinib|lenvatinib|mesh-list
25538671|NCT01137604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25538672|NCT01137604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538673|NCT01137604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25538674|NCT01137604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25538675|NCT01137604|Growth Substances|growth substances|mesh-ancestor
25538676|NCT01137604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538677|NCT01137604|Growth Inhibitors|growth inhibitors|mesh-ancestor
25538678|NCT01137604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25538679|NCT01137604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538680|NCT01137604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538681|NCT01033552|Cyclosporine|cyclosporine|mesh-list
25538682|NCT01033552|Mycophenolic Acid|mycophenolic acid|mesh-list
25538683|NCT01033552|Cyclophosphamide|cyclophosphamide|mesh-list
25538684|NCT01033552|Fludarabine|fludarabine|mesh-list
25538685|NCT01033552|Cyclosporins|cyclosporins|mesh-list
25538686|NCT01033552|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25538687|NCT01033552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25538688|NCT01033552|Immunologic Factors|immunologic factors|mesh-ancestor
25538689|NCT01033552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538690|NCT01033552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25538691|NCT01033552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25538692|NCT01033552|Alkylating Agents|alkylating agents|mesh-ancestor
25538693|NCT01033552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538694|NCT01033552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538695|NCT01033552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25538696|NCT01033552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538697|NCT01033552|Antifungal Agents|antifungal agents|mesh-ancestor
25538698|NCT01033552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25538699|NCT01033552|Dermatologic Agents|dermatologic agents|mesh-ancestor
25538700|NCT01033552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25538701|NCT01033552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25538702|NCT01033552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25538703|NCT01033552|Antitubercular Agents|antitubercular agents|mesh-ancestor
25538704|NCT01033552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25538705|NCT00997906|Gemcitabine|gemcitabine|mesh-list
25538706|NCT00997906|Paclitaxel|paclitaxel|mesh-list
25538707|NCT00997906|Cisplatin|cisplatin|mesh-list
25538708|NCT00997906|Carboplatin|carboplatin|mesh-list
25538709|NCT00997906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25538710|NCT00997906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25538711|NCT00997906|Tubulin Modulators|tubulin modulators|mesh-ancestor
25538712|NCT00997906|Antimitotic Agents|antimitotic agents|mesh-ancestor
25538713|NCT00997906|Mitosis Modulators|mitosis modulators|mesh-ancestor
25538714|NCT00997906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538715|NCT00997906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25538716|NCT00997906|Antimetabolites|antimetabolites|mesh-ancestor
25538717|NCT00997906|Antiviral Agents|antiviral agents|mesh-ancestor
25538718|NCT00997906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25538719|NCT00997906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538720|NCT00997906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25538721|NCT00997906|Immunologic Factors|immunologic factors|mesh-ancestor
25538722|NCT00997906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538723|NCT00754208|Methylphenidate|methylphenidate|mesh-list
25538724|NCT00754208|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25538725|NCT00754208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538726|NCT00754208|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25538727|NCT00754208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25538728|NCT00754208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25538729|NCT00754208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538730|NCT00754208|Dopamine Agents|dopamine agents|mesh-ancestor
25538731|NCT00754208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25538732|NCT00634166|Anti-Infective Agents|anti-infective agents|mesh-list
25538733|NCT00634166|Amphotericin B|amphotericin b|mesh-list
25538734|NCT00634166|Clotrimazole|clotrimazole|mesh-list
25538735|NCT00634166|Miconazole|miconazole|mesh-list
25538736|NCT00634166|Bacitracin|bacitracin|mesh-list
25538737|NCT00634166|Mafenide|mafenide|mesh-list
25538738|NCT00634166|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25538745|NCT00634166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25538746|NCT00634166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25538747|NCT00634166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25538748|NCT00634166|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25538749|NCT00634166|Hormone Antagonists|hormone antagonists|mesh-ancestor
25538750|NCT00634166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25538751|NCT00634166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25538752|NCT00634166|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25538753|NCT00634166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25538754|NCT00634166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25538755|NCT00398307|Cisplatin|cisplatin|mesh-list
25538756|NCT00398307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823628|NCT00004862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25823629|NCT00004862|Antimetabolites|antimetabolites|mesh-ancestor
25823630|NCT00004862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823631|NCT00004862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25823632|NCT00004862|Immunologic Factors|immunologic factors|mesh-ancestor
25823633|NCT00004862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823634|NCT00004862|Antiviral Agents|antiviral agents|mesh-ancestor
24862630|NCT04929834|Emollients|emollients|mesh-list
24863046|NCT03646162|Fertility Agents|fertility agents|mesh-ancestor
24863047|NCT03646162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24863048|NCT03646162|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24863049|NCT03646162|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24863050|NCT03635788|Rilpivirine|rilpivirine|mesh-list
24863051|NCT03635788|Cabotegravir|cabotegravir|mesh-list
24863052|NCT03635788|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24863054|NCT03635788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24475501|NCT00410631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24475502|NCT00410631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25823635|NCT00004862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25823636|NCT00004863|Paclitaxel|paclitaxel|mesh-list
25823637|NCT00004863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25823638|NCT00004863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823639|NCT00004863|Tubulin Modulators|tubulin modulators|mesh-ancestor
25823640|NCT00004863|Antimitotic Agents|antimitotic agents|mesh-ancestor
24476627|NCT00415922|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25823641|NCT00004863|Mitosis Modulators|mitosis modulators|mesh-ancestor
25823642|NCT00004863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478839|NCT00424801|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24478841|NCT00424801|Diuretics|diuretics|mesh-ancestor
25823643|NCT00004864|Docetaxel|docetaxel|mesh-list
25823644|NCT00004864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823645|NCT00004864|Tubulin Modulators|tubulin modulators|mesh-ancestor
25823646|NCT00004864|Antimitotic Agents|antimitotic agents|mesh-ancestor
25163557|NCT02895022|Anesthetics|anesthetics|mesh-ancestor
25163558|NCT02895022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25823647|NCT00004864|Mitosis Modulators|mitosis modulators|mesh-ancestor
25823648|NCT00004864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823649|NCT00004865|Paclitaxel|paclitaxel|mesh-list
25823650|NCT00004865|Cisplatin|cisplatin|mesh-list
25163567|NCT02894957|Varenicline|varenicline|mesh-list
25203054|NCT02716857|Oxycodone|oxycodone|mesh-list
25647112|NCT01466348|Sensory System Agents|sensory system agents|mesh-ancestor
25647113|NCT01466348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25647114|NCT01466348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647115|NCT01466348|Antipyretics|antipyretics|mesh-ancestor
25647116|NCT01466348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25647117|NCT01466348|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24447302|NCT00308048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480129|NCT00429897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24480135|NCT00429897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24480136|NCT00429897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25823651|NCT00004865|Fluorouracil|fluorouracil|mesh-list
24480554|NCT00431249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24482112|NCT00437970|Metformin|metformin|mesh-list
24808219|NCT02025855|Respiratory System Agents|respiratory system agents|mesh-ancestor
24808220|NCT02025868|Raltegravir Potassium|raltegravir potassium|mesh-list
24808221|NCT02025868|Darunavir|darunavir|mesh-list
24808222|NCT02025868|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24808223|NCT02025868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24483237|NCT00442455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483238|NCT00442455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483484|NCT00443794|Analgesics|analgesics|mesh-ancestor
25823652|NCT00004865|Cetuximab|cetuximab|mesh-list
25823653|NCT00004865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25823654|NCT00004865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823655|NCT00004865|Tubulin Modulators|tubulin modulators|mesh-ancestor
25823656|NCT00004865|Antimitotic Agents|antimitotic agents|mesh-ancestor
25823657|NCT00004865|Mitosis Modulators|mitosis modulators|mesh-ancestor
25823658|NCT00004865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823659|NCT00004865|Antimetabolites|antimetabolites|mesh-ancestor
25823660|NCT00004865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25823661|NCT00004865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25823662|NCT00004865|Immunologic Factors|immunologic factors|mesh-ancestor
25823663|NCT00004865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823664|NCT00004865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25163675|NCT02894645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25163757|NCT05427747|Meropenem|meropenem|mesh-list
25163758|NCT05427747|Cefotaxime|cefotaxime|mesh-list
25163759|NCT05427747|Cefoxitin|cefoxitin|mesh-list
25163760|NCT05427747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25163761|NCT05427747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25163762|NCT05427721|Thymol|thymol|mesh-list
25163763|NCT05427721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25163764|NCT05427721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24486411|NCT00457717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486412|NCT00457769|Donepezil|donepezil|mesh-list
24486413|NCT00457769|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24487006|NCT00460915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24487007|NCT00460915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487009|NCT00460928|Immunoglobulins|immunoglobulins|mesh-list
24487010|NCT00460928|Antibodies|antibodies|mesh-list
25823665|NCT00004866|Exatecan|exatecan|mesh-list
25823666|NCT00004866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25823667|NCT00004866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25823668|NCT00004866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823669|NCT00004866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487569|NCT00463879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487659|NCT00464347|Hormones|hormones|mesh-ancestor
25163868|NCT05427084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163873|NCT05426798|Decitabine|decitabine|mesh-list
24488580|NCT00469443|Leucovorin|leucovorin|mesh-list
24489513|NCT00473720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163904|NCT05426486|Antimitotic Agents|antimitotic agents|mesh-ancestor
25163905|NCT05426486|Mitosis Modulators|mitosis modulators|mesh-ancestor
25163906|NCT05426486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163907|NCT05426486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25163912|NCT05426044|Metformin|metformin|mesh-list
25163913|NCT05426044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25163914|NCT05426044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490904|NCT00480402|Hormones|hormones|mesh-ancestor
24494726|NCT00496652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495715|NCT00501657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495717|NCT00501657|Hormones|hormones|mesh-ancestor
24495718|NCT00501657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24495720|NCT00501657|Protease Inhibitors|protease inhibitors|mesh-ancestor
24827695|NCT02140840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24827696|NCT02140840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24827697|NCT02140840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827698|NCT02140918|Fludrocortisone|fludrocortisone|mesh-list
24827699|NCT02140918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25823670|NCT00004866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823671|NCT00004867|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25823672|NCT00004867|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25823673|NCT00004867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823674|NCT00004868|Semaxinib|semaxinib|mesh-list
24447461|NCT00308529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24447462|NCT00308529|Growth Substances|growth substances|mesh-ancestor
24447463|NCT00308529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447464|NCT00308529|Growth Inhibitors|growth inhibitors|mesh-ancestor
24447465|NCT00308529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24447466|NCT00308529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24447467|NCT00308529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24447469|NCT00308542|Dexamethasone|dexamethasone|mesh-list
24497787|NCT00511849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497788|NCT00511849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24497789|NCT00511849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24497790|NCT00511849|Growth Substances|growth substances|mesh-ancestor
25164067|NCT05424016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25164068|NCT05424016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25164069|NCT05424016|Vasodilator Agents|vasodilator agents|mesh-ancestor
25164077|NCT05423834|Tenofovir|tenofovir|mesh-list
25164078|NCT05423834|Entecavir|entecavir|mesh-list
25164079|NCT05423834|Antiviral Agents|antiviral agents|mesh-ancestor
25164080|NCT05423834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25164083|NCT05423834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498581|NCT00515320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498766|NCT00516191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203109|NCT02716129|Narcotics|narcotics|mesh-ancestor
25203110|NCT02716129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25203111|NCT02716129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203112|NCT02716129|Analgesics|analgesics|mesh-ancestor
25203113|NCT02716129|Sensory System Agents|sensory system agents|mesh-ancestor
25203114|NCT02716129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25203115|NCT02716259|Fluorides|fluorides|mesh-list
24499346|NCT00519051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823675|NCT00004868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25164129|NCT05423197|Panitumumab|panitumumab|mesh-list
25823676|NCT00004868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24499813|NCT00521222|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24499814|NCT00521222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24499815|NCT00521222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24499816|NCT00521222|Autonomic Agents|autonomic agents|mesh-ancestor
24499862|NCT00521430|Busulfan|busulfan|mesh-list
24500089|NCT00522639|Deoxyglucose|deoxyglucose|mesh-list
24500094|NCT00522665|Irinotecan|irinotecan|mesh-list
25164187|NCT05420805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810369|NCT02039791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24887892|NCT04511195|Diclofenac|diclofenac|mesh-list
24810370|NCT02039804|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24810371|NCT02039804|Hyaluronic Acid|hyaluronic acid|mesh-list
24810372|NCT02039804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24500335|NCT00523887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24500336|NCT00523887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24500456|NCT00524381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24500466|NCT00524433|Vasodilator Agents|vasodilator agents|mesh-ancestor
24500468|NCT00524498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24500469|NCT00524524|Beta-lapachone|beta-lapachone|mesh-list
25823677|NCT00004868|Growth Substances|growth substances|mesh-ancestor
25823678|NCT00004868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823679|NCT00004868|Growth Inhibitors|growth inhibitors|mesh-ancestor
24500959|NCT00526305|Antimitotic Agents|antimitotic agents|mesh-ancestor
24500960|NCT00526305|Mitosis Modulators|mitosis modulators|mesh-ancestor
25823680|NCT00004868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24500969|NCT00526305|Analgesics|analgesics|mesh-ancestor
24501120|NCT00526877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501801|NCT00531128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501802|NCT00531128|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24501803|NCT00531167|Lamivudine|lamivudine|mesh-list
24501804|NCT00531167|Adefovir|adefovir|mesh-list
24501805|NCT00531167|Entecavir|entecavir|mesh-list
24501808|NCT00531167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823681|NCT00004868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25823682|NCT00004868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823683|NCT00004868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671211|NCT01324245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502047|NCT05319912|Chelating Agents|chelating agents|mesh-ancestor
24502048|NCT05319912|Sequestering Agents|sequestering agents|mesh-ancestor
25823684|NCT00004870|Irinotecan|irinotecan|mesh-list
25823685|NCT00004870|Oblimersen|oblimersen|mesh-list
25823686|NCT00004870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25823687|NCT00004870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25823688|NCT00004870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823689|NCT00004870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502293|NCT05302388|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24502294|NCT05302388|Prednisolone acetate|prednisolone acetate|mesh-list
24502387|NCT05165212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24520868|NCT05288777|Capecitabine|capecitabine|mesh-list
25823690|NCT00004870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823691|NCT00004871|Azacitidine|azacitidine|mesh-list
25823692|NCT00004871|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25823693|NCT00004871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25164314|NCT05400031|Propolis|propolis|mesh-list
24502790|NCT04416984|Immunologic Factors|immunologic factors|mesh-ancestor
24502791|NCT04416984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502807|NCT04325685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24503043|NCT03532022|Hydrocortisone|hydrocortisone|mesh-list
24503044|NCT03532022|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24503045|NCT03532022|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24503046|NCT03532022|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24503047|NCT03532022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24503048|NCT03532022|Antiemetics|antiemetics|mesh-ancestor
24503049|NCT03532022|Autonomic Agents|autonomic agents|mesh-ancestor
24503063|NCT03481634|Growth Inhibitors|growth inhibitors|mesh-ancestor
24503064|NCT03481634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503178|NCT02978391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24503179|NCT02978391|Respiratory System Agents|respiratory system agents|mesh-ancestor
24503180|NCT02978391|Mydriatics|mydriatics|mesh-ancestor
24503181|NCT02978391|Sympathomimetics|sympathomimetics|mesh-ancestor
25823694|NCT00004871|Antimetabolites|antimetabolites|mesh-ancestor
25823695|NCT00004871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823696|NCT00004871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503381|NCT01655225|GABA Agents|gaba agents|mesh-ancestor
24503382|NCT01655225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24503383|NCT01655225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503384|NCT01655225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503385|NCT01655225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24481455|NCT00434824|Testosterone enanthate|testosterone enanthate|mesh-list
25823697|NCT00004871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503507|NCT00532116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25823698|NCT00004872|Endostatins|endostatins|mesh-list
25823699|NCT00004872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823700|NCT00004872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25823701|NCT00004872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24503671|NCT00532584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24503672|NCT00532584|Glucocorticoids|glucocorticoids|mesh-ancestor
24503673|NCT00532584|Hormones|hormones|mesh-ancestor
24503674|NCT00532584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24503675|NCT00532584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503676|NCT00532584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24503677|NCT00532584|Respiratory System Agents|respiratory system agents|mesh-ancestor
24504066|NCT00533936|Antimitotic Agents|antimitotic agents|mesh-ancestor
24810619|NCT02041117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24810620|NCT02041117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24810621|NCT02041117|Antimetabolites|antimetabolites|mesh-ancestor
24859019|NCT02301130|Durvalumab|durvalumab|mesh-list
24504106|NCT00534183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24504107|NCT00534183|Serotonin Agents|serotonin agents|mesh-ancestor
24504108|NCT00534183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25823702|NCT00004872|Growth Substances|growth substances|mesh-ancestor
25823703|NCT00004872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823704|NCT00004872|Growth Inhibitors|growth inhibitors|mesh-ancestor
25823705|NCT00004873|Cisplatin|cisplatin|mesh-list
25823706|NCT00004873|Docetaxel|docetaxel|mesh-list
25823707|NCT00004873|Fluorouracil|fluorouracil|mesh-list
24504548|NCT00536770|Micronutrients|micronutrients|mesh-ancestor
24504549|NCT00536770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24504550|NCT00536783|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24504551|NCT00536783|Antidepressive Agents|antidepressive agents|mesh-ancestor
24504552|NCT00536783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24810708|NCT02041819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24770541|NCT01821040|Prednisone|prednisone|mesh-list
24810709|NCT02041819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823708|NCT00004873|Epirubicin|epirubicin|mesh-list
25823709|NCT00004873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810710|NCT02042027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24810711|NCT02042027|Immunologic Factors|immunologic factors|mesh-ancestor
24504553|NCT00536783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24504554|NCT00536783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24504555|NCT00536783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24504725|NCT00537953|Meglumine Antimoniate|meglumine antimoniate|mesh-list
24504726|NCT00537953|Antifungal Agents|antifungal agents|mesh-ancestor
24504727|NCT00537953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24504728|NCT00537953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504729|NCT00537953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24504730|NCT00537953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25164514|NCT05349448|Triamcinolone|triamcinolone|mesh-list
25164515|NCT05349448|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25164516|NCT05349448|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25164517|NCT05349448|Dexmedetomidine|dexmedetomidine|mesh-list
25164518|NCT05349448|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25164519|NCT05349448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25164520|NCT05349448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25164530|NCT05349448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25823710|NCT00004873|Tubulin Modulators|tubulin modulators|mesh-ancestor
25823711|NCT00004873|Antimitotic Agents|antimitotic agents|mesh-ancestor
25823712|NCT00004873|Mitosis Modulators|mitosis modulators|mesh-ancestor
25823713|NCT00004873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823714|NCT00004873|Antimetabolites|antimetabolites|mesh-ancestor
24828735|NCT02147379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24828755|NCT02147535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25823715|NCT00004873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24828791|NCT02147678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24828793|NCT02147730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24810797|NCT02042599|Anesthetics, General|anesthetics, general|mesh-ancestor
24759498|NCT01752075|Lenalidomide|lenalidomide|mesh-list
24828802|NCT02147808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24828803|NCT02147808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24828804|NCT02147808|Anesthetics, General|anesthetics, general|mesh-ancestor
24828805|NCT02147808|Anesthetics|anesthetics|mesh-ancestor
25081150|NCT03332602|Vitamins|vitamins|mesh-list
24828806|NCT02147808|GABA Modulators|gaba modulators|mesh-ancestor
25823716|NCT00004873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25823717|NCT00004873|Immunologic Factors|immunologic factors|mesh-ancestor
25823718|NCT00004873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823719|NCT00004873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25823720|NCT00004873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25823721|NCT00004873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25823722|NCT00004873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823723|NCT00004874|Iodine|iodine|mesh-list
25823724|NCT00004874|Tositumomab I-131|tositumomab i-131|mesh-list
25823725|NCT00004874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25823726|NCT00004874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25823727|NCT00004874|Trace Elements|trace elements|mesh-ancestor
24461605|NCT00352807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25203163|NCT02715869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203164|NCT02715687|Amiodarone|amiodarone|mesh-list
24461717|NCT00353184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24461808|NCT00353808|Adrenergic Agents|adrenergic agents|mesh-ancestor
25164613|NCT05310786|Sensory System Agents|sensory system agents|mesh-ancestor
25164614|NCT05310786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25164646|NCT05289492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25164647|NCT05289492|Antiemetics|antiemetics|mesh-ancestor
25164648|NCT05289492|Autonomic Agents|autonomic agents|mesh-ancestor
25164649|NCT05289492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25164650|NCT05289492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164651|NCT05289492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25164652|NCT05289492|Glucocorticoids|glucocorticoids|mesh-ancestor
25164653|NCT05289492|Hormones|hormones|mesh-ancestor
25164654|NCT05289492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25164655|NCT05289492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25164656|NCT05289492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25203209|NCT02715531|Paclitaxel|paclitaxel|mesh-list
24431007|NCT00249977|Capecitabine|capecitabine|mesh-list
24461842|NCT00354081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461843|NCT00354081|Hematinics|hematinics|mesh-ancestor
24461844|NCT00354094|Reboxetine|reboxetine|mesh-list
25823728|NCT00004874|Micronutrients|micronutrients|mesh-ancestor
24462067|NCT00354809|Antiemetics|antiemetics|mesh-ancestor
24830291|NCT02158286|Acetaminophen|acetaminophen|mesh-list
25823729|NCT00004874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657208|NCT01584440|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24462149|NCT00355251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462150|NCT00355251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24462151|NCT00355251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24462152|NCT00355251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462176|NCT00355290|Coagulants|coagulants|mesh-ancestor
24462177|NCT00355303|Misoprostol|misoprostol|mesh-list
24462178|NCT00355303|Dinoprostone|dinoprostone|mesh-list
24462179|NCT00355303|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24462180|NCT00355303|Abortifacient Agents|abortifacient agents|mesh-ancestor
24462181|NCT00355303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24462185|NCT00355303|Oxytocics|oxytocics|mesh-ancestor
24462770|NCT00357604|Moxifloxacin|moxifloxacin|mesh-list
25164760|NCT05220046|Hallucinogens|hallucinogens|mesh-ancestor
25164761|NCT05220046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164762|NCT05220046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25823730|NCT00004874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823731|NCT00004875|Heparin|heparin|mesh-list
25823732|NCT00004875|Enoxaparin|enoxaparin|mesh-list
25823733|NCT00004875|Anticoagulants|anticoagulants|mesh-ancestor
25823734|NCT00004875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25823735|NCT00004875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25823736|NCT00004875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823737|NCT00004876|Thalidomide|thalidomide|mesh-list
24630747|NCT01113424|Nicotine|nicotine|mesh-list
24631276|NCT01116700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24631302|NCT01116817|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24631303|NCT01116817|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24631304|NCT01116817|Protease Inhibitors|protease inhibitors|mesh-ancestor
24631305|NCT01116817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631306|NCT01116817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164788|NCT05184192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164789|NCT05184192|Anticonvulsants|anticonvulsants|mesh-ancestor
25164790|NCT05184192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25164791|NCT05184192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25164792|NCT05184192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25164793|NCT05184192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25164794|NCT05184192|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25164795|NCT05184192|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25164796|NCT05184192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25164797|NCT05184192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164798|NCT05184192|Antimanic Agents|antimanic agents|mesh-ancestor
24785399|NCT01914042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25164829|NCT05170334|Belinostat|belinostat|mesh-list
25164830|NCT05170334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25164831|NCT05170334|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25164832|NCT05170334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25164833|NCT05170334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164838|NCT05166876|Brequinar|brequinar|mesh-list
25164839|NCT05166876|Dipyridamole|dipyridamole|mesh-list
25164840|NCT05166876|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25164841|NCT05166876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631423|NCT01117636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631424|NCT01117636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24631425|NCT01117636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24631426|NCT01117636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631427|NCT01117636|Antipyretics|antipyretics|mesh-ancestor
24631429|NCT01117662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24811208|NCT02045693|Methadone|methadone|mesh-list
24632570|NCT01124539|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
24632571|NCT01124539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24632572|NCT01124539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632573|NCT01124539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24632574|NCT01124539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24789062|NCT01935505|Nicotine|nicotine|mesh-list
24632883|NCT01126073|Niacin|niacin|mesh-list
25042897|NCT01356160|Antiviral Agents|antiviral agents|mesh-ancestor
24394883|NCT00134511|Atorvastatin|atorvastatin|mesh-list
25657209|NCT01584440|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25657210|NCT01584440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25657211|NCT01584440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657212|NCT01584440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657213|NCT01584440|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25657214|NCT01584440|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24395067|NCT00135005|Imatinib Mesylate|imatinib mesylate|mesh-list
24395592|NCT00136448|Analgesics|analgesics|mesh-ancestor
24606750|NCT05408845|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
24395792|NCT00136942|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24395952|NCT00137397|Urological Agents|urological agents|mesh-ancestor
24395953|NCT00137410|Celecoxib|celecoxib|mesh-list
24395954|NCT00137410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24395955|NCT00137410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24395956|NCT00137410|Analgesics|analgesics|mesh-ancestor
24395957|NCT00137410|Sensory System Agents|sensory system agents|mesh-ancestor
24395958|NCT00137410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24395959|NCT00137410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395966|NCT00137462|Atorvastatin|atorvastatin|mesh-list
24395974|NCT00137462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395975|NCT00137501|Nifedipine|nifedipine|mesh-list
24395976|NCT00137501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25164908|NCT05138068|Adrenergic Agents|adrenergic agents|mesh-ancestor
25164909|NCT05134974|Phentolamine|phentolamine|mesh-list
25164910|NCT05134974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25164911|NCT05134974|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25164912|NCT05134974|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25164913|NCT05134974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25164914|NCT05134974|Adrenergic Agents|adrenergic agents|mesh-ancestor
25164915|NCT05134974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24396610|NCT00139386|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25164941|NCT05125796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25823738|NCT00004876|Carboplatin|carboplatin|mesh-list
25823739|NCT00004876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823740|NCT00004876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25823741|NCT00004876|Immunologic Factors|immunologic factors|mesh-ancestor
25823742|NCT00004876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823743|NCT00004876|Leprostatic Agents|leprostatic agents|mesh-ancestor
25823744|NCT00004876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25823745|NCT00004876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25823746|NCT00004876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25823747|NCT00004876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25823748|NCT00004876|Growth Substances|growth substances|mesh-ancestor
25823749|NCT00004876|Growth Inhibitors|growth inhibitors|mesh-ancestor
25823750|NCT00004878|Cytarabine|cytarabine|mesh-list
24397730|NCT00142467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811336|NCT02046447|Cholinergic Agents|cholinergic agents|mesh-ancestor
24811337|NCT02046447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24811340|NCT02046460|Aspirin|aspirin|mesh-list
24397806|NCT00142727|Methadone|methadone|mesh-list
25165010|NCT05087381|Anticestodal Agents|anticestodal agents|mesh-ancestor
25165011|NCT05087381|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25165012|NCT05087381|Anthelmintics|anthelmintics|mesh-ancestor
25165013|NCT05087381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25165014|NCT05087381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25165015|NCT05087381|Antinematodal Agents|antinematodal agents|mesh-ancestor
25165016|NCT05087381|Antipruritics|antipruritics|mesh-ancestor
25165017|NCT05087381|Dermatologic Agents|dermatologic agents|mesh-ancestor
25165018|NCT05087381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25165019|NCT05087381|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25165020|NCT05087381|Histamine Antagonists|histamine antagonists|mesh-ancestor
25165021|NCT05087381|Histamine Agents|histamine agents|mesh-ancestor
25165022|NCT05087381|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25165023|NCT05087381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25165024|NCT05087381|Expectorants|expectorants|mesh-ancestor
24397877|NCT00142896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24398088|NCT00143429|Latanoprost|latanoprost|mesh-list
24398983|NCT00146341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399201|NCT00146900|Antidepressive Agents|antidepressive agents|mesh-ancestor
24399202|NCT00146900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24399203|NCT00146913|Interferons|interferons|mesh-list
24399204|NCT00146913|Imatinib Mesylate|imatinib mesylate|mesh-list
24399205|NCT00146913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399206|NCT00146913|Antiviral Agents|antiviral agents|mesh-ancestor
24399207|NCT00146913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24399208|NCT00146913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24399272|NCT00147355|Acetaminophen|acetaminophen|mesh-list
24399273|NCT00147355|Ibuprofen|ibuprofen|mesh-list
24399796|NCT00148681|Doxorubicin|doxorubicin|mesh-list
24399978|NCT00149162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24399979|NCT00149162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24399980|NCT00149162|Analgesics|analgesics|mesh-ancestor
24399981|NCT00149162|Sensory System Agents|sensory system agents|mesh-ancestor
24399982|NCT00149162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25823751|NCT00004878|Methotrexate|methotrexate|mesh-list
25657215|NCT01584440|Adrenergic Agents|adrenergic agents|mesh-ancestor
24399983|NCT00149162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399985|NCT00149188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399986|NCT00149201|Fluorouracil|fluorouracil|mesh-list
24400267|NCT00150228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24400268|NCT00150228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400270|NCT00150241|Varenicline|varenicline|mesh-list
24400887|NCT00151541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24400888|NCT00151541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24400889|NCT00151541|Antimalarials|antimalarials|mesh-ancestor
24400903|NCT00151567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400904|NCT00151567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400905|NCT00151567|Urological Agents|urological agents|mesh-ancestor
24400906|NCT00151580|Ribavirin|ribavirin|mesh-list
24400907|NCT00151580|Antimetabolites|antimetabolites|mesh-ancestor
24400908|NCT00151580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400982|NCT00151827|Olmesartan|olmesartan|mesh-list
24400983|NCT00151827|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24400984|NCT00151827|Furosemide|furosemide|mesh-list
24400985|NCT00151827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24401015|NCT00151970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401016|NCT00151970|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24401017|NCT00151970|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24401018|NCT00151970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24401027|NCT00151983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24401050|NCT00152035|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24401051|NCT00152035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823752|NCT00004878|Fludarabine phosphate|fludarabine phosphate|mesh-list
24401052|NCT00152035|Sympathomimetics|sympathomimetics|mesh-ancestor
24401053|NCT00152035|Autonomic Agents|autonomic agents|mesh-ancestor
24401054|NCT00152035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24401119|NCT00152191|Fluorouracil|fluorouracil|mesh-list
24401224|NCT00152542|Nitric Oxide|nitric oxide|mesh-list
25823753|NCT00004878|Fludarabine|fludarabine|mesh-list
25823754|NCT00004878|Idarubicin|idarubicin|mesh-list
25823755|NCT00004878|Tacrolimus|tacrolimus|mesh-list
25823756|NCT00004878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25823757|NCT00004878|Abortifacient Agents|abortifacient agents|mesh-ancestor
25823758|NCT00004878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25823759|NCT00004878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401305|NCT00152646|Purinergic Agents|purinergic agents|mesh-ancestor
24401306|NCT00152646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24401307|NCT00152646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401308|NCT00152646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401309|NCT00152698|Irbesartan|irbesartan|mesh-list
24401310|NCT00152698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24829381|NCT02151929|Immunologic Factors|immunologic factors|mesh-ancestor
25165159|NCT05024552|Cytarabine|cytarabine|mesh-list
25165160|NCT05024552|Daunorubicin|daunorubicin|mesh-list
25165161|NCT05024552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25165162|NCT05024552|Antimetabolites|antimetabolites|mesh-ancestor
25165165|NCT05024552|Antiviral Agents|antiviral agents|mesh-ancestor
25165228|NCT04958122|Penicillins|penicillins|mesh-list
25165229|NCT04958122|Cefixime|cefixime|mesh-list
25165230|NCT04958122|Penicillin G Benzathine|penicillin g benzathine|mesh-list
24401335|NCT00152724|Antipyretics|antipyretics|mesh-ancestor
24401336|NCT00152724|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24401337|NCT00152724|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24401338|NCT00152724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24401339|NCT00152724|Purinergic Agents|purinergic agents|mesh-ancestor
24401340|NCT00152724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25823760|NCT00004878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25823761|NCT00004878|Antimetabolites|antimetabolites|mesh-ancestor
24401476|NCT00152997|Antioxidants|antioxidants|mesh-ancestor
25823762|NCT00004878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823763|NCT00004878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24401768|NCT00153998|Cetuximab|cetuximab|mesh-list
24401769|NCT00153998|Levoleucovorin|levoleucovorin|mesh-list
24401770|NCT00153998|Antimetabolites|antimetabolites|mesh-ancestor
24401771|NCT00153998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401772|NCT00153998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24401773|NCT00153998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24401774|NCT00153998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24401809|NCT00154037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401812|NCT00154050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25657216|NCT01584440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25823771|NCT00004878|Antiviral Agents|antiviral agents|mesh-ancestor
25823772|NCT00004878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402278|NCT00156299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25823773|NCT00004878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25823774|NCT00004878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25823775|NCT00004878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25823776|NCT00004878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25823777|NCT00004879|Panitumumab|panitumumab|mesh-list
25043392|NCT01266525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043393|NCT01266525|Cholinergic Agents|cholinergic agents|mesh-ancestor
25043394|NCT01266525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25043395|NCT01266525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043396|NCT01266525|Nootropic Agents|nootropic agents|mesh-ancestor
24403320|NCT00159770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24403321|NCT00159770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25165370|NCT04871607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25165371|NCT04871607|Immunologic Factors|immunologic factors|mesh-ancestor
25165372|NCT04871607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165373|NCT04871607|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25165374|NCT04871607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25165375|NCT04871607|Alkylating Agents|alkylating agents|mesh-ancestor
25165376|NCT04871607|Keratolytic Agents|keratolytic agents|mesh-ancestor
24403900|NCT00162045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24404177|NCT00162695|Ifosfamide|ifosfamide|mesh-list
24404178|NCT00162695|Carboplatin|carboplatin|mesh-list
24404455|NCT00163488|Hormones|hormones|mesh-ancestor
25823778|NCT00004879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24404529|NCT00163761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823779|NCT00004879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24404617|NCT00164242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540362|NCT00667485|Immunologic Factors|immunologic factors|mesh-ancestor
24404619|NCT00164242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24404668|NCT00164359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24404670|NCT00164411|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24404672|NCT00164411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405055|NCT00165399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405274|NCT00166400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24405462|NCT00167154|Serotonin Agents|serotonin agents|mesh-ancestor
24811729|NCT02048098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24811731|NCT02048189|Insulin Detemir|insulin detemir|mesh-list
24811732|NCT02048189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24811733|NCT02048189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811734|NCT02048215|Ephedrine|ephedrine|mesh-list
24811735|NCT02048215|Caffeine|caffeine|mesh-list
24678168|NCT01360060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25165557|NCT04752696|Antidotes|antidotes|mesh-ancestor
24811775|NCT02048319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24811776|NCT02048345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25647120|NCT01466348|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25647121|NCT01466348|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25647122|NCT01466348|Purinergic Agents|purinergic agents|mesh-ancestor
24405918|NCT00168766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24405920|NCT00168766|Protective Agents|protective agents|mesh-ancestor
24405921|NCT00168766|Immunologic Factors|immunologic factors|mesh-ancestor
24405922|NCT00168766|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24405925|NCT00168779|Telmisartan|telmisartan|mesh-list
25823782|NCT00004880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823783|NCT00004883|Trastuzumab|trastuzumab|mesh-list
25823784|NCT00004883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25101197|NCT03176693|Doxazosin|doxazosin|mesh-list
25165633|NCT04731844|Curcumin|curcumin|mesh-list
25165634|NCT04731844|Piperine|piperine|mesh-list
25165635|NCT04731844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25165636|NCT04731844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25165637|NCT04731844|Analgesics|analgesics|mesh-ancestor
25165638|NCT04731844|Sensory System Agents|sensory system agents|mesh-ancestor
25165639|NCT04731844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25165640|NCT04731844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811832|NCT02048540|Bevacizumab|bevacizumab|mesh-list
24811833|NCT02048540|Docetaxel|docetaxel|mesh-list
24811834|NCT02048540|Oxaliplatin|oxaliplatin|mesh-list
24811864|NCT02048683|Sevoflurane|sevoflurane|mesh-list
24678802|NCT01364376|Antidotes|antidotes|mesh-ancestor
25823785|NCT00004883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405983|NCT00168909|Vitamins|vitamins|mesh-ancestor
25165661|NCT04713371|Alkylating Agents|alkylating agents|mesh-ancestor
25165662|NCT04713371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25165663|NCT04713371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25165664|NCT04713371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25165665|NCT04713371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25165666|NCT04713371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25165667|NCT04693507|Antarelix|antarelix|mesh-list
25165668|NCT04693507|Hormone Antagonists|hormone antagonists|mesh-ancestor
25165669|NCT04693507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25165670|NCT04693507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165687|NCT04683614|Norepinephrine|norepinephrine|mesh-list
25165688|NCT04683614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25165689|NCT04683614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25165690|NCT04683614|Adrenergic Agents|adrenergic agents|mesh-ancestor
25101698|NCT03172988|Antiemetics|antiemetics|mesh-ancestor
24406385|NCT00169988|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24406386|NCT00169988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24406667|NCT00170989|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24406877|NCT00171496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24406878|NCT00171509|Cyclosporine|cyclosporine|mesh-list
24406879|NCT00171509|Cyclosporins|cyclosporins|mesh-list
24406880|NCT00171509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24406885|NCT00171509|Antifungal Agents|antifungal agents|mesh-ancestor
24406886|NCT00171509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24406887|NCT00171509|Dermatologic Agents|dermatologic agents|mesh-ancestor
24406891|NCT00171522|Tegaserod|tegaserod|mesh-list
24407018|NCT00171717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407019|NCT00171717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407020|NCT00171717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25165737|NCT04656184|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25165738|NCT04656184|Immunoglobulins|immunoglobulins|mesh-list
25165739|NCT04656184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25165740|NCT04656184|Antibodies|antibodies|mesh-list
25647124|NCT01466361|Nicotine|nicotine|mesh-list
25647125|NCT01466361|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25647126|NCT01466361|Autonomic Agents|autonomic agents|mesh-ancestor
25647127|NCT01466361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25647128|NCT01466361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647129|NCT01466361|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25647130|NCT01466361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24407050|NCT00171756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407310|NCT00174239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407311|NCT00174239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165741|NCT04656184|gamma-Globulins|gamma-globulins|mesh-list
25165742|NCT04656184|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24448434|NCT00311818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24541424|NCT00672659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24541425|NCT00672763|Calcium, Dietary|calcium, dietary|mesh-list
25823786|NCT00004884|Gemcitabine|gemcitabine|mesh-list
25823787|NCT00004884|Cisplatin|cisplatin|mesh-list
25823788|NCT00004884|Docetaxel|docetaxel|mesh-list
24407441|NCT00174538|Analgesics|analgesics|mesh-ancestor
24407442|NCT00174538|Sensory System Agents|sensory system agents|mesh-ancestor
24407760|NCT00175383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820106|NCT02098824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823789|NCT00004884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823790|NCT00004884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25823791|NCT00004884|Antimetabolites|antimetabolites|mesh-ancestor
25823792|NCT00004884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823793|NCT00004884|Antiviral Agents|antiviral agents|mesh-ancestor
25823794|NCT00004884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25823795|NCT00004884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823796|NCT00004884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25823797|NCT00004884|Immunologic Factors|immunologic factors|mesh-ancestor
25823798|NCT00004884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823799|NCT00004884|Tubulin Modulators|tubulin modulators|mesh-ancestor
25823800|NCT00004884|Antimitotic Agents|antimitotic agents|mesh-ancestor
25823801|NCT00004884|Mitosis Modulators|mitosis modulators|mesh-ancestor
25823802|NCT00004885|Leucovorin|leucovorin|mesh-list
25823803|NCT00004885|Fluorouracil|fluorouracil|mesh-list
25823804|NCT00004885|Irinotecan|irinotecan|mesh-list
25823805|NCT00004885|Calcium|calcium|mesh-list
25823806|NCT00004885|Levoleucovorin|levoleucovorin|mesh-list
25823807|NCT00004885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25823808|NCT00004885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823809|NCT00004885|Antimetabolites|antimetabolites|mesh-ancestor
25823810|NCT00004885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447090|NCT00307502|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25104382|NCT03152981|Remifentanil|remifentanil|mesh-list
25823811|NCT00004885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25823812|NCT00004885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823813|NCT00004885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25823814|NCT00004885|Immunologic Factors|immunologic factors|mesh-ancestor
25823815|NCT00004885|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25823816|NCT00004885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25823817|NCT00004885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823818|NCT00004885|Antidotes|antidotes|mesh-ancestor
25823819|NCT00004885|Protective Agents|protective agents|mesh-ancestor
25823820|NCT00004885|Vitamin B Complex|vitamin b complex|mesh-ancestor
24827583|NCT02140268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25823821|NCT00004885|Vitamins|vitamins|mesh-ancestor
25823822|NCT00004885|Micronutrients|micronutrients|mesh-ancestor
25823823|NCT00004886|Docetaxel|docetaxel|mesh-list
25823824|NCT00004886|Dofequidar|dofequidar|mesh-list
25823825|NCT00004886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823826|NCT00004886|Tubulin Modulators|tubulin modulators|mesh-ancestor
25823827|NCT00004886|Antimitotic Agents|antimitotic agents|mesh-ancestor
25823828|NCT00004886|Mitosis Modulators|mitosis modulators|mesh-ancestor
25823829|NCT00004886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823830|NCT00004887|Paclitaxel|paclitaxel|mesh-list
25165818|NCT04615910|Exenatide|exenatide|mesh-list
25165819|NCT04615910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25165820|NCT04615910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268366|NCT02416141|Analgesics|analgesics|mesh-ancestor
25823831|NCT00004887|Vinblastine|vinblastine|mesh-list
25823832|NCT00004887|Cisplatin|cisplatin|mesh-list
25823833|NCT00004887|Carboplatin|carboplatin|mesh-list
25823834|NCT00004887|Ifosfamide|ifosfamide|mesh-list
25823835|NCT00004887|Mitomycins|mitomycins|mesh-list
25823836|NCT00004887|Mitomycin|mitomycin|mesh-list
25823837|NCT00004887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25647132|NCT01466361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25647133|NCT01466361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647135|NCT01466387|Immunologic Factors|immunologic factors|mesh-ancestor
25647136|NCT01466387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823838|NCT00004887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25165821|NCT04615910|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25165822|NCT04615910|Incretins|incretins|mesh-ancestor
25165823|NCT04615910|Hormones|hormones|mesh-ancestor
25165824|NCT04615910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25165825|NCT04610671|Nivolumab|nivolumab|mesh-list
25165826|NCT04610671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25165827|NCT04610671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719167|NCT01559584|Hormones|hormones|mesh-ancestor
24827622|NCT02140450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827623|NCT02140450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827625|NCT02140450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24827626|NCT02140450|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25041737|NCT01590719|Fluorouracil|fluorouracil|mesh-list
25823839|NCT00004887|Tubulin Modulators|tubulin modulators|mesh-ancestor
25823840|NCT00004887|Antimitotic Agents|antimitotic agents|mesh-ancestor
25823841|NCT00004887|Mitosis Modulators|mitosis modulators|mesh-ancestor
25823842|NCT00004887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823843|NCT00004887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25823844|NCT00004887|Alkylating Agents|alkylating agents|mesh-ancestor
25823845|NCT00004887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25823846|NCT00004887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25823847|NCT00004887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823848|NCT00004889|Rituximab|rituximab|mesh-list
25823849|NCT00004889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25823850|NCT00004889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823851|NCT00004889|Immunologic Factors|immunologic factors|mesh-ancestor
25823852|NCT00004889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823853|NCT00004889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25823854|NCT00004890|Aldesleukin|aldesleukin|mesh-list
25823855|NCT00004890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823856|NCT00004890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25823857|NCT00004890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25823858|NCT00004890|Antiviral Agents|antiviral agents|mesh-ancestor
25823859|NCT00004890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25823860|NCT00004891|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25823861|NCT00004891|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25823862|NCT00004891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823863|NCT00004892|Carmustine|carmustine|mesh-list
25823864|NCT00004892|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
25823865|NCT00004892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25823866|NCT00004892|Alkylating Agents|alkylating agents|mesh-ancestor
25823867|NCT00004892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827700|NCT02140983|Liraglutide|liraglutide|mesh-list
25041490|NCT02513303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25041491|NCT02513303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25041492|NCT02513303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25041493|NCT02513303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041494|NCT02513303|Antifungal Agents|antifungal agents|mesh-ancestor
25041495|NCT02513303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25041496|NCT02513303|Immunologic Factors|immunologic factors|mesh-ancestor
24828342|NCT02145091|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24828837|NCT02147951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24828838|NCT02147951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828840|NCT02147964|Methyltestosterone|methyltestosterone|mesh-list
24828841|NCT02147964|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24828842|NCT02147964|Testosterone|testosterone|mesh-list
24828843|NCT02147964|Testosterone undecanoate|testosterone undecanoate|mesh-list
24828844|NCT02147964|Testosterone enanthate|testosterone enanthate|mesh-list
24828845|NCT02147964|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24828846|NCT02147964|Dutasteride|dutasteride|mesh-list
24828847|NCT02147964|Acyline|acyline|mesh-list
24828848|NCT02147964|Androgens|androgens|mesh-ancestor
24828849|NCT02147964|Hormones|hormones|mesh-ancestor
24828951|NCT02148432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25041547|NCT02488408|Antimetabolites|antimetabolites|mesh-ancestor
25041548|NCT02488408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041549|NCT02488408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041550|NCT02488408|Antiviral Agents|antiviral agents|mesh-ancestor
25165909|NCT04534270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25165910|NCT04534270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25165911|NCT04534270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165912|NCT04522167|Aflibercept|aflibercept|mesh-list
25165913|NCT04522167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25165914|NCT04522167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25165915|NCT04522167|Growth Substances|growth substances|mesh-ancestor
25165916|NCT04522167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165917|NCT04522167|Growth Inhibitors|growth inhibitors|mesh-ancestor
25165918|NCT04522167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25203416|NCT02714543|Viscosupplements|viscosupplements|mesh-ancestor
25823868|NCT00004892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24724447|NCT01593137|Metformin|metformin|mesh-list
25823869|NCT00004892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823870|NCT00004893|Interleukin-12|interleukin-12|mesh-list
25823871|NCT00004893|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24977008|NCT04671966|Estrogens|estrogens|mesh-ancestor
25823872|NCT00004893|Immunologic Factors|immunologic factors|mesh-ancestor
25823873|NCT00004893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823874|NCT00004893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25823875|NCT00004893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25823876|NCT00004893|Growth Substances|growth substances|mesh-ancestor
25823877|NCT00004893|Growth Inhibitors|growth inhibitors|mesh-ancestor
25823878|NCT00004893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823879|NCT00004900|Cyclophosphamide|cyclophosphamide|mesh-list
25823880|NCT00004900|Thiotepa|thiotepa|mesh-list
25823881|NCT00004900|Cisplatin|cisplatin|mesh-list
25823882|NCT00004900|Carboplatin|carboplatin|mesh-list
25165961|NCT04517396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24829415|NCT02152306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829418|NCT02152332|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24829419|NCT02152332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25823883|NCT00004900|Etoposide|etoposide|mesh-list
25165984|NCT04493164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25165985|NCT04493164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25165986|NCT04493164|Antiviral Agents|antiviral agents|mesh-ancestor
25165987|NCT04493164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25165988|NCT04493164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25165989|NCT04493164|Immunologic Factors|immunologic factors|mesh-ancestor
25823884|NCT00004900|Anastrozole|anastrozole|mesh-list
25823885|NCT00004900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25823886|NCT00004900|Immunologic Factors|immunologic factors|mesh-ancestor
25823887|NCT00004900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043833|NCT01198626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823888|NCT00004900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25823889|NCT00004900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24725546|NCT01598259|Melatonin|melatonin|mesh-list
25823890|NCT00004900|Alkylating Agents|alkylating agents|mesh-ancestor
25823891|NCT00004900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534308|NCT00646620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823892|NCT00004900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823893|NCT00004900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25823894|NCT00004900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25823895|NCT00004900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25823896|NCT00004900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25823897|NCT00004900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823898|NCT00004900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25043975|NCT01175785|Antimetabolites|antimetabolites|mesh-ancestor
24829590|NCT02153177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829592|NCT02153177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24829593|NCT02153177|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24829594|NCT02153177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25823899|NCT00004900|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25823900|NCT00004900|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25823901|NCT00004900|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25823902|NCT00004900|Hormone Antagonists|hormone antagonists|mesh-ancestor
25823903|NCT00004900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25823904|NCT00004901|Fluorouracil|fluorouracil|mesh-list
25823905|NCT00004901|Hydroxyurea|hydroxyurea|mesh-list
25823906|NCT00004901|Eniluracil|eniluracil|mesh-list
25823907|NCT00004901|Antimetabolites|antimetabolites|mesh-ancestor
25647138|NCT01466491|Anesthetics, Local|anesthetics, local|mesh-ancestor
25823908|NCT00004901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823909|NCT00004901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25823910|NCT00004901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823911|NCT00004901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25823912|NCT00004901|Immunologic Factors|immunologic factors|mesh-ancestor
25823913|NCT00004901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823914|NCT00004901|Antisickling Agents|antisickling agents|mesh-ancestor
25823915|NCT00004901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823916|NCT00004901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25823917|NCT00004903|Interferons|interferons|mesh-list
25823918|NCT00004903|Cytarabine|cytarabine|mesh-list
25823919|NCT00004903|Interferon-alpha|interferon-alpha|mesh-list
25823920|NCT00004903|Cyclophosphamide|cyclophosphamide|mesh-list
25823921|NCT00004903|Melphalan|melphalan|mesh-list
25823922|NCT00004903|Cisplatin|cisplatin|mesh-list
24637733|NCT01152827|Everolimus|everolimus|mesh-list
25823923|NCT00004903|Etoposide|etoposide|mesh-list
25166093|NCT04395079|Durvalumab|durvalumab|mesh-list
25166094|NCT04395079|Ipilimumab|ipilimumab|mesh-list
25166095|NCT04395079|Tremelimumab|tremelimumab|mesh-list
25166096|NCT04395079|Immunoglobulins|immunoglobulins|mesh-list
25166097|NCT04395079|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25166098|NCT04395079|Immunoglobulin G|immunoglobulin g|mesh-list
25166099|NCT04395079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25823924|NCT00004903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24638032|NCT01154569|Azithromycin|azithromycin|mesh-list
25823925|NCT00004903|Immunologic Factors|immunologic factors|mesh-ancestor
25823926|NCT00004903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823927|NCT00004903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25823928|NCT00004903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25823929|NCT00004903|Alkylating Agents|alkylating agents|mesh-ancestor
25823930|NCT00004903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823931|NCT00004903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25203418|NCT02714543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166158|NCT04332068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823932|NCT00004903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25823933|NCT00004903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25823934|NCT00004903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25823935|NCT00004903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25823936|NCT00004903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823937|NCT00004903|Antiviral Agents|antiviral agents|mesh-ancestor
25823938|NCT00004903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25823939|NCT00004903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24458624|NCT00338546|Anesthetics, Local|anesthetics, local|mesh-ancestor
25823940|NCT00004903|Antimetabolites|antimetabolites|mesh-ancestor
25823941|NCT00004904|Methylprednisolone|methylprednisolone|mesh-list
25823942|NCT00004904|Cyclophosphamide|cyclophosphamide|mesh-list
25823943|NCT00004904|Etoposide|etoposide|mesh-list
25823944|NCT00004904|Cladribine|cladribine|mesh-list
25166203|NCT04299438|Propranolol|propranolol|mesh-list
25166204|NCT04299438|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25166205|NCT04299438|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25166206|NCT04299438|Adrenergic Agents|adrenergic agents|mesh-ancestor
25166207|NCT04299438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25166208|NCT04299438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823945|NCT00004904|Tacrolimus|tacrolimus|mesh-list
25823946|NCT00004904|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25823947|NCT00004904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25823948|NCT00004904|Immunologic Factors|immunologic factors|mesh-ancestor
25823949|NCT00004904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823950|NCT00004904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25823951|NCT00004904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25823952|NCT00004904|Alkylating Agents|alkylating agents|mesh-ancestor
25823953|NCT00004904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25823954|NCT00004904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166261|NCT04230187|Micronutrients|micronutrients|mesh-ancestor
25823955|NCT00004904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25823956|NCT00004904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25823957|NCT00004904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25071932|NCT03405142|Chelating Agents|chelating agents|mesh-ancestor
25823958|NCT00004904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25823959|NCT00004904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823960|NCT00004904|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25823961|NCT00004904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25166301|NCT04180488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166302|NCT04180488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166303|NCT04173364|Ropivacaine|ropivacaine|mesh-list
25166304|NCT04173364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25166310|NCT04173364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25166312|NCT04171453|Analgesics|analgesics|mesh-ancestor
25166313|NCT04171453|Sensory System Agents|sensory system agents|mesh-ancestor
25166314|NCT04171453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25166315|NCT04171453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166316|NCT04171453|Anticonvulsants|anticonvulsants|mesh-ancestor
25166317|NCT04171453|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25166318|NCT04171453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25166319|NCT04171453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166320|NCT04171453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25166321|NCT04171453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25823962|NCT00004904|Antiemetics|antiemetics|mesh-ancestor
25823963|NCT00004904|Autonomic Agents|autonomic agents|mesh-ancestor
25823964|NCT00004904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24535813|NCT00649779|Albuterol|albuterol|mesh-list
24548390|NCT00709332|Norgestimate|norgestimate|mesh-list
25823965|NCT00004904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24459210|NCT00343876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459283|NCT00344149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25823966|NCT00004904|Glucocorticoids|glucocorticoids|mesh-ancestor
25823967|NCT00004904|Hormones|hormones|mesh-ancestor
24459505|NCT00344851|Incretins|incretins|mesh-ancestor
25823968|NCT00004904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25823969|NCT00004904|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24455313|NCT01808599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24394585|NCT00133692|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24537599|NCT00655408|Iron|iron|mesh-list
25823970|NCT00004904|Protective Agents|protective agents|mesh-ancestor
25823971|NCT00004905|Interferons|interferons|mesh-list
25823972|NCT00004905|Cytarabine|cytarabine|mesh-list
25823973|NCT00004905|Interferon-alpha|interferon-alpha|mesh-list
25823974|NCT00004905|Cyclophosphamide|cyclophosphamide|mesh-list
25823975|NCT00004905|Etoposide|etoposide|mesh-list
25823976|NCT00004905|Idarubicin|idarubicin|mesh-list
25823977|NCT00004905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24724022|NCT01590732|Etoposide|etoposide|mesh-list
24859656|NCT02304887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859657|NCT02304887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24859658|NCT02305030|Opicapone|opicapone|mesh-list
24859659|NCT02305030|Warfarin|warfarin|mesh-list
24652322|NCT01237808|Cytarabine|cytarabine|mesh-list
24541977|NCT00676221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24802235|NCT01989000|Gemcitabine|gemcitabine|mesh-list
24660563|NCT01284439|Viscosupplements|viscosupplements|mesh-ancestor
24542478|NCT00678964|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24542479|NCT00678964|Vinorelbine|vinorelbine|mesh-list
24542482|NCT00678964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542675|NCT00679679|Metformin|metformin|mesh-list
24862945|NCT03950076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24862946|NCT03950076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862947|NCT03950076|Anticoagulants|anticoagulants|mesh-ancestor
24862948|NCT03914885|Fludarabine|fludarabine|mesh-list
24862954|NCT03885089|Infliximab|infliximab|mesh-list
24862955|NCT03885089|Dermatologic Agents|dermatologic agents|mesh-ancestor
24862956|NCT03885089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24542747|NCT00680173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542748|NCT00680212|Beta Carotene|beta carotene|mesh-list
24806117|NCT02013856|Proanthocyanidin|proanthocyanidin|mesh-list
24806118|NCT02013856|Procyanidin|procyanidin|mesh-list
24806119|NCT02013856|Antioxidants|antioxidants|mesh-ancestor
25823978|NCT00004905|Immunologic Factors|immunologic factors|mesh-ancestor
24583953|NCT00877734|GABA Agents|gaba agents|mesh-ancestor
24806137|NCT02013986|Midazolam|midazolam|mesh-list
24475256|NCT00409630|Dermatologic Agents|dermatologic agents|mesh-ancestor
24475257|NCT00409630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24806233|NCT02014558|Midazolam|midazolam|mesh-list
24806234|NCT02014558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24806236|NCT02014558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24806237|NCT02014558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806238|NCT02014558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24806239|NCT02014558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24806666|NCT02017392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476917|NCT00416832|Procarbazine|procarbazine|mesh-list
24477553|NCT00419042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24477554|NCT00419042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477555|NCT00419042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24477556|NCT00419042|Immunologic Factors|immunologic factors|mesh-ancestor
24477557|NCT00419042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477558|NCT00419042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25823979|NCT00004905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823980|NCT00004905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25823981|NCT00004905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25823982|NCT00004905|Alkylating Agents|alkylating agents|mesh-ancestor
24479766|NCT00428311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666443|NCT01319279|Narcotics|narcotics|mesh-ancestor
24479816|NCT00428480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24479817|NCT00428480|Dopamine Agents|dopamine agents|mesh-ancestor
25166394|NCT04117659|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
24481751|NCT00436761|Methylprednisolone|methylprednisolone|mesh-list
24481752|NCT00436761|Melphalan|melphalan|mesh-list
24808028|NCT02024919|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24808029|NCT02024919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24808030|NCT02024919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482220|NCT00438178|Obatoclax|obatoclax|mesh-list
24622889|NCT01069055|Lornoxicam|lornoxicam|mesh-list
24622890|NCT01069055|Piroxicam|piroxicam|mesh-list
24622891|NCT01069055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24622892|NCT01069055|Analgesics|analgesics|mesh-ancestor
24622893|NCT01069055|Sensory System Agents|sensory system agents|mesh-ancestor
24809101|NCT02031211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24809102|NCT02031211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24809103|NCT02031211|Immunologic Factors|immunologic factors|mesh-ancestor
24809104|NCT02031289|Folic Acid|folic acid|mesh-list
24809105|NCT02031289|Vitamin B 12|vitamin b 12|mesh-list
24809106|NCT02031289|Hydroxocobalamin|hydroxocobalamin|mesh-list
24809107|NCT02031289|Epoetin Alfa|epoetin alfa|mesh-list
24809108|NCT02031289|Vitamins|vitamins|mesh-ancestor
24809119|NCT02031367|Hormones|hormones|mesh-ancestor
24488828|NCT00470210|Ribavirin|ribavirin|mesh-list
24489169|NCT00471627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24489944|NCT00475969|Dopamine Agents|dopamine agents|mesh-ancestor
24492428|NCT00486317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495144|NCT00498784|Levonorgestrel|levonorgestrel|mesh-list
24495145|NCT00498784|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24495160|NCT00498901|Letrozole|letrozole|mesh-list
24495563|NCT00501111|Cholinergic Agents|cholinergic agents|mesh-ancestor
24495564|NCT00501111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24495565|NCT00501111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495701|NCT00501618|Clozapine|clozapine|mesh-list
24495721|NCT00501657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809868|NCT02036489|Immunologic Factors|immunologic factors|mesh-ancestor
24809869|NCT02036489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24809870|NCT02036528|Doxycycline|doxycycline|mesh-list
24809871|NCT02036528|Ciprofloxacin|ciprofloxacin|mesh-list
24496509|NCT00505167|Donepezil|donepezil|mesh-list
24496510|NCT00505167|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24496511|NCT00505167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25005101|NCT04856176|Molgramostim|molgramostim|mesh-list
24502752|NCT04447716|Rituximab|rituximab|mesh-list
24502753|NCT04447716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24502754|NCT04447716|Lenalidomide|lenalidomide|mesh-list
25657217|NCT01584440|Antimalarials|antimalarials|mesh-ancestor
24496677|NCT00506051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496679|NCT00506051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810113|NCT02037919|Contraceptive Agents|contraceptive agents|mesh-ancestor
25657218|NCT01584440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25657219|NCT01584440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25657220|NCT01584440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25657221|NCT01584440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657222|NCT01584440|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25657223|NCT01584440|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25657224|NCT01584440|Cholinergic Agents|cholinergic agents|mesh-ancestor
25657225|NCT01584440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25657226|NCT01584440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24810128|NCT02037997|Pemetrexed|pemetrexed|mesh-list
24810129|NCT02037997|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24810130|NCT02037997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496852|NCT00507065|Sympathomimetics|sympathomimetics|mesh-ancestor
25823984|NCT00004905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497218|NCT00508898|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24497380|NCT00509743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497581|NCT00510588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497582|NCT00510614|Tinidazole|tinidazole|mesh-list
24497583|NCT00510614|Alkylating Agents|alkylating agents|mesh-ancestor
24498028|NCT00513110|Caffeine|caffeine|mesh-list
24498052|NCT00513162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24498053|NCT00513162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25823985|NCT00004905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24810295|NCT02039453|Anesthetics, General|anesthetics, general|mesh-ancestor
25823986|NCT00004905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24500500|NCT00524693|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25823987|NCT00004905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24500503|NCT00524693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500504|NCT00524693|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24500505|NCT00524693|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24500506|NCT00524693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500507|NCT00524706|Leucovorin|leucovorin|mesh-list
24500840|NCT00525928|Cholinergic Agents|cholinergic agents|mesh-ancestor
24500841|NCT00525928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24500842|NCT00525928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500843|NCT00525928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500846|NCT00525967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24500848|NCT00525967|Sensory System Agents|sensory system agents|mesh-ancestor
24500849|NCT00525967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24500850|NCT00525967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500851|NCT00525967|Antipyretics|antipyretics|mesh-ancestor
24500904|NCT00526175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24500993|NCT00526318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823988|NCT00004905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24501232|NCT00527540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24501237|NCT00527657|Thalidomide|thalidomide|mesh-list
24501684|NCT00530413|GABA Modulators|gaba modulators|mesh-ancestor
24501685|NCT00530413|GABA Agents|gaba agents|mesh-ancestor
24501686|NCT00530413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24501687|NCT00530413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25823989|NCT00004905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501726|NCT00530595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503199|NCT02843230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503201|NCT02712814|Hormones|hormones|mesh-ancestor
24503202|NCT02712814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24503203|NCT02712814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503204|NCT02670252|Cyclophosphamide|cyclophosphamide|mesh-list
24503205|NCT02670252|Busulfan|busulfan|mesh-list
24503206|NCT02670252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24503207|NCT02670252|Immunologic Factors|immunologic factors|mesh-ancestor
25823990|NCT00004905|Antiviral Agents|antiviral agents|mesh-ancestor
24503232|NCT02503839|Etoricoxib|etoricoxib|mesh-list
24503234|NCT02503839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24504213|NCT00534586|Anesthetics|anesthetics|mesh-ancestor
24810780|NCT02042482|Vitamins|vitamins|mesh-ancestor
24759533|NCT01752270|Cyproterone|cyproterone|mesh-list
24462295|NCT00355641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24631167|NCT01116219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24734821|NCT01654120|Hormones|hormones|mesh-ancestor
24398941|NCT00146211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24400897|NCT00151567|Tamsulosin|tamsulosin|mesh-list
24400901|NCT00151567|Adrenergic Agents|adrenergic agents|mesh-ancestor
24405288|NCT00166413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25823991|NCT00004905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24570484|NCT00805012|Docetaxel|docetaxel|mesh-list
24406894|NCT00171522|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24407595|NCT00174772|Docetaxel|docetaxel|mesh-list
24408138|NCT00176670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24820138|NCT02098889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24820140|NCT02098889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24820142|NCT02098889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24820143|NCT02098889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408442|NCT00177710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24408443|NCT00177710|Antifungal Agents|antifungal agents|mesh-ancestor
24408689|NCT00179062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24820877|NCT02102438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451832|NCT00324922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24410754|NCT00187005|Antimetabolites|antimetabolites|mesh-ancestor
24410847|NCT00187070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24410988|NCT00187161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24410989|NCT00187161|Antimetabolites|antimetabolites|mesh-ancestor
24410990|NCT00187161|Dermatologic Agents|dermatologic agents|mesh-ancestor
24821389|NCT02104778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24821390|NCT02104778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24821391|NCT02104778|Respiratory System Agents|respiratory system agents|mesh-ancestor
24821392|NCT02104778|Mydriatics|mydriatics|mesh-ancestor
24821393|NCT02104778|Sympathomimetics|sympathomimetics|mesh-ancestor
24821396|NCT02104843|Asunaprevir|asunaprevir|mesh-list
24411340|NCT00188773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411341|NCT00188773|Antiviral Agents|antiviral agents|mesh-ancestor
24411342|NCT00188773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24821469|NCT02105623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821539|NCT02106364|Insulin|insulin|mesh-list
24411600|NCT00189553|Tubulin Modulators|tubulin modulators|mesh-ancestor
24821711|NCT02107378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24821712|NCT02107378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24821716|NCT02107391|Leuprolide|leuprolide|mesh-list
24412120|NCT00190853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24412121|NCT00190853|Antidepressive Agents|antidepressive agents|mesh-ancestor
24412122|NCT00190853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24412124|NCT00190866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25823992|NCT00004905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24821932|NCT02108808|Ticagrelor|ticagrelor|mesh-list
24822051|NCT02109614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24822052|NCT02109614|Vasodilator Agents|vasodilator agents|mesh-ancestor
24822053|NCT02109614|Vitamin B Complex|vitamin b complex|mesh-ancestor
24822055|NCT02109614|Micronutrients|micronutrients|mesh-ancestor
24822056|NCT02109614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822057|NCT02109627|Cytarabine|cytarabine|mesh-list
24822058|NCT02109627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24822059|NCT02109627|Antimetabolites|antimetabolites|mesh-ancestor
24685499|NCT05271448|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24895418|NCT04129788|Bisacodyl|bisacodyl|mesh-list
24414573|NCT00198094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25823993|NCT00004905|Antimetabolites|antimetabolites|mesh-ancestor
24414669|NCT00198380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24414670|NCT00198380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24414671|NCT00198380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414672|NCT00198380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414673|NCT00198393|Gemcitabine|gemcitabine|mesh-list
24414779|NCT00198614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24414782|NCT00198614|Protective Agents|protective agents|mesh-ancestor
24414813|NCT00198848|Folic Acid|folic acid|mesh-list
24414814|NCT00198848|Hematinics|hematinics|mesh-ancestor
24414815|NCT00198848|Vitamin B Complex|vitamin b complex|mesh-ancestor
24414816|NCT00198848|Vitamins|vitamins|mesh-ancestor
24414817|NCT00198848|Micronutrients|micronutrients|mesh-ancestor
24414842|NCT00198978|Autonomic Agents|autonomic agents|mesh-ancestor
24414843|NCT00198978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24414844|NCT00198978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24414846|NCT00198978|Hormones|hormones|mesh-ancestor
24822471|NCT02112097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24822472|NCT02112097|Analgesics|analgesics|mesh-ancestor
24822473|NCT02112097|Sensory System Agents|sensory system agents|mesh-ancestor
24415036|NCT00199056|Cytarabine|cytarabine|mesh-list
24822728|NCT02112981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416684|NCT00203736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416685|NCT00203736|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24416687|NCT00203762|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24416689|NCT00203762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24416690|NCT00203775|Risperidone|risperidone|mesh-list
24822798|NCT02113540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24418258|NCT00209118|Serotonin Agents|serotonin agents|mesh-ancestor
24823030|NCT02114645|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25823994|NCT00004905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24823201|NCT02115594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24421506|NCT00219388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24421508|NCT00219388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421518|NCT00219466|Zinc|zinc|mesh-list
24823293|NCT02116400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823294|NCT02116465|Levodopa|levodopa|mesh-list
24823295|NCT02116465|Carbidopa|carbidopa|mesh-list
25823995|NCT00004906|Pamidronate|pamidronate|mesh-list
24421895|NCT00220493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24823363|NCT02116842|Anesthetics, General|anesthetics, general|mesh-ancestor
25823996|NCT00004906|Cyclophosphamide|cyclophosphamide|mesh-list
24823728|NCT02118727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823731|NCT02118727|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24927933|NCT04127916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927935|NCT04128020|Azacitidine|azacitidine|mesh-list
24927936|NCT04128020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24403131|NCT00159458|Gemcitabine|gemcitabine|mesh-list
24423886|NCT00227318|Candesartan cilexetil|candesartan cilexetil|mesh-list
24423887|NCT00227318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25823997|NCT00004906|Thiotepa|thiotepa|mesh-list
25823998|NCT00004906|Carboplatin|carboplatin|mesh-list
24824194|NCT02122081|Tacrolimus|tacrolimus|mesh-list
24424713|NCT00230477|Antiviral Agents|antiviral agents|mesh-ancestor
25823999|NCT00004906|Docetaxel|docetaxel|mesh-list
25824000|NCT00004906|Doxorubicin|doxorubicin|mesh-list
25824001|NCT00004906|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25824002|NCT00004906|Etoposide|etoposide|mesh-list
24427063|NCT00237263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427064|NCT00237289|Topiramate|topiramate|mesh-list
24427065|NCT00237289|Anticonvulsants|anticonvulsants|mesh-ancestor
24427066|NCT00237289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24427067|NCT00237289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427068|NCT00237302|Topiramate|topiramate|mesh-list
24427157|NCT00237536|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24427531|NCT00238329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24427532|NCT00238329|Immunologic Factors|immunologic factors|mesh-ancestor
24427533|NCT00238329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824484|NCT02123589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24824485|NCT02123589|GABA Modulators|gaba modulators|mesh-ancestor
24824486|NCT02123589|GABA Agents|gaba agents|mesh-ancestor
24427534|NCT00238329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24427552|NCT00238368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24429088|NCT00242606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24429089|NCT00242606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24429091|NCT00242606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24429478|NCT00244153|Dexamethasone|dexamethasone|mesh-list
24432071|NCT00253539|Hormone Antagonists|hormone antagonists|mesh-ancestor
24432072|NCT00253539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25824003|NCT00004906|Anastrozole|anastrozole|mesh-list
25824004|NCT00004906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24432431|NCT00254774|Antimanic Agents|antimanic agents|mesh-ancestor
24432432|NCT00254787|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24432433|NCT00254787|Antidepressive Agents|antidepressive agents|mesh-ancestor
24432434|NCT00254787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24432435|NCT00254787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24432439|NCT00254800|Exenatide|exenatide|mesh-list
24432705|NCT00255749|Epoetin Alfa|epoetin alfa|mesh-list
24432706|NCT00255749|Hematinics|hematinics|mesh-ancestor
24432707|NCT00255762|Paclitaxel|paclitaxel|mesh-list
24432708|NCT00255762|Bevacizumab|bevacizumab|mesh-list
24433011|NCT00257270|Analgesics|analgesics|mesh-ancestor
24433199|NCT00257855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24434174|NCT00261599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24434175|NCT00261599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24434176|NCT00261599|Anesthetics, General|anesthetics, general|mesh-ancestor
24434177|NCT00261599|Anesthetics|anesthetics|mesh-ancestor
24434178|NCT00261599|GABA Modulators|gaba modulators|mesh-ancestor
24434179|NCT00261599|GABA Agents|gaba agents|mesh-ancestor
24434180|NCT00261599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24434181|NCT00261599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434182|NCT00261612|Dexamethasone|dexamethasone|mesh-list
25824005|NCT00004906|Immunologic Factors|immunologic factors|mesh-ancestor
24825265|NCT02127918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24825266|NCT02127918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825267|NCT02127918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24825268|NCT02127918|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24825269|NCT02127918|GABA Agonists|gaba agonists|mesh-ancestor
25824006|NCT00004906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647140|NCT01466491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25647141|NCT01466491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647142|NCT01466491|Sensory System Agents|sensory system agents|mesh-ancestor
25647143|NCT01466491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25647144|NCT01466491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25647145|NCT01466491|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25824007|NCT00004906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24825270|NCT02127918|GABA Agents|gaba agents|mesh-ancestor
24825271|NCT02127918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24825272|NCT02127918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824008|NCT00004906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24581834|NCT00866463|Sildenafil Citrate|sildenafil citrate|mesh-list
24825273|NCT02127996|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24825274|NCT02127996|Incretins|incretins|mesh-ancestor
24825275|NCT02127996|Hormones|hormones|mesh-ancestor
24825276|NCT02127996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24825277|NCT02127996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166493|NCT03993132|Hormones|hormones|mesh-ancestor
24825279|NCT02128022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24825281|NCT02128061|Rituximab|rituximab|mesh-list
24435410|NCT00266162|Bosentan|bosentan|mesh-list
24435624|NCT00267306|Immunologic Factors|immunologic factors|mesh-ancestor
24436164|NCT00269217|Nicotinic Acids|nicotinic acids|mesh-list
24436165|NCT00269217|Simvastatin|simvastatin|mesh-list
24436175|NCT00269217|Vitamins|vitamins|mesh-ancestor
24436338|NCT00269763|Narcotics|narcotics|mesh-ancestor
24438499|NCT00276068|Desipramine|desipramine|mesh-list
24438680|NCT00276601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24438681|NCT00276601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24763622|NCT01775475|Hormones|hormones|mesh-ancestor
24438682|NCT00276601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24438683|NCT00276601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24438684|NCT00276601|Keratolytic Agents|keratolytic agents|mesh-ancestor
24438685|NCT00276640|Carboplatin|carboplatin|mesh-list
24438686|NCT00276640|Etoposide|etoposide|mesh-list
24438687|NCT00276640|Vincristine|vincristine|mesh-list
24438724|NCT00276705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438725|NCT00276705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25166495|NCT03993132|Incretins|incretins|mesh-ancestor
24440180|NCT00281944|Leucovorin|leucovorin|mesh-list
24441437|NCT00287391|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24441438|NCT00287391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24441439|NCT00287391|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24441440|NCT00287391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441441|NCT00287391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441445|NCT00287443|Hormones|hormones|mesh-list
24441648|NCT00287963|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24825813|NCT02130700|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24825814|NCT02130700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442701|NCT00292214|Acetaminophen|acetaminophen|mesh-list
24442936|NCT00293332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25824009|NCT00004906|Alkylating Agents|alkylating agents|mesh-ancestor
25824010|NCT00004906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824011|NCT00004906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824012|NCT00004906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25824013|NCT00004906|Tubulin Modulators|tubulin modulators|mesh-ancestor
25824014|NCT00004906|Antimitotic Agents|antimitotic agents|mesh-ancestor
24825863|NCT02130817|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24825864|NCT02130817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25824015|NCT00004906|Mitosis Modulators|mitosis modulators|mesh-ancestor
24825878|NCT02130817|Immunologic Factors|immunologic factors|mesh-ancestor
25824016|NCT00004906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25824017|NCT00004906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25824018|NCT00004906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25824019|NCT00004906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824020|NCT00004906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24825926|NCT02130869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24825927|NCT02130869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24825929|NCT02130869|Sensory System Agents|sensory system agents|mesh-ancestor
24825930|NCT02130869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24825931|NCT02130869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24697592|NCT01435837|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24697593|NCT01435837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824021|NCT00004906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25824022|NCT00004906|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25647146|NCT01466491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25647147|NCT01466491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25647148|NCT01466491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647150|NCT01466595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25647151|NCT01466595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25824023|NCT00004906|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25647152|NCT01466595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25647153|NCT01466660|Gefitinib|gefitinib|mesh-list
25824024|NCT00004906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25824025|NCT00004906|Hormone Antagonists|hormone antagonists|mesh-ancestor
25824026|NCT00004906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25824027|NCT00004906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25824028|NCT00004913|Leucovorin|leucovorin|mesh-list
25824029|NCT00004913|Cisplatin|cisplatin|mesh-list
25824030|NCT00004913|Docetaxel|docetaxel|mesh-list
25824031|NCT00004913|Fluorouracil|fluorouracil|mesh-list
25010818|NCT02939573|Azathioprine|azathioprine|mesh-list
25010819|NCT02939573|Gout Suppressants|gout suppressants|mesh-ancestor
25010820|NCT02939573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25010821|NCT02939573|Tubulin Modulators|tubulin modulators|mesh-ancestor
25010822|NCT02939573|Antimitotic Agents|antimitotic agents|mesh-ancestor
25010823|NCT02939573|Mitosis Modulators|mitosis modulators|mesh-ancestor
25010826|NCT02939573|Antimetabolites|antimetabolites|mesh-ancestor
24443119|NCT00293696|Bicalutamide|bicalutamide|mesh-list
24443120|NCT00293696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24443124|NCT00293696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24443125|NCT00293696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443127|NCT00293735|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24443128|NCT00293735|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24443129|NCT00293735|Adrenergic Agents|adrenergic agents|mesh-ancestor
24443130|NCT00293735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24443131|NCT00293735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443132|NCT00293735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010984|NCT02444741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25010985|NCT02444741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824032|NCT00004913|Calcium|calcium|mesh-list
25824033|NCT00004913|Levoleucovorin|levoleucovorin|mesh-list
25824034|NCT00004913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586025|NCT00888862|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24586061|NCT00889044|Purinergic Agents|purinergic agents|mesh-ancestor
24586062|NCT00889044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24586063|NCT00889044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586064|NCT00889044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902053|NCT04378283|Anesthetics, Local|anesthetics, local|mesh-ancestor
24902054|NCT04378283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24902055|NCT04378283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478718|NCT00424164|Lapatinib|lapatinib|mesh-list
24786959|NCT01922804|Vitamins|vitamins|mesh-list
24902992|NCT04368273|Antibodies|antibodies|mesh-list
24902993|NCT04368273|Immunologic Factors|immunologic factors|mesh-ancestor
24902994|NCT04368273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902995|NCT04368078|Lenvatinib|lenvatinib|mesh-list
24902996|NCT04368078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24902997|NCT04368078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24902998|NCT04368078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902999|NCT04368078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903095|NCT04366596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914989|NCT05252117|Mepivacaine|mepivacaine|mesh-list
24903243|NCT04365231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824035|NCT00004913|Tubulin Modulators|tubulin modulators|mesh-ancestor
25824036|NCT00004913|Antimitotic Agents|antimitotic agents|mesh-ancestor
25109029|NCT03127371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25109030|NCT03127449|Aflutinib|aflutinib|mesh-list
25109031|NCT03127449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25109032|NCT03127449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881155|NCT02977494|Hormones|hormones|mesh-ancestor
25824037|NCT00004913|Mitosis Modulators|mitosis modulators|mesh-ancestor
25824038|NCT00004913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824039|NCT00004913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25824040|NCT00004913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824041|NCT00004913|Antimetabolites|antimetabolites|mesh-ancestor
25824042|NCT00004913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25824043|NCT00004913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25075982|NCT03376841|Cenicriviroc|cenicriviroc|mesh-list
25075983|NCT03376841|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25076057|NCT03376178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25076058|NCT03376178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076059|NCT03376139|Zonisamide|zonisamide|mesh-list
25076060|NCT03376139|Anticonvulsants|anticonvulsants|mesh-ancestor
25076061|NCT03376139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25076062|NCT03376139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25824044|NCT00004913|Immunologic Factors|immunologic factors|mesh-ancestor
25076191|NCT03375138|Immunologic Factors|immunologic factors|mesh-ancestor
25824045|NCT00004913|Antidotes|antidotes|mesh-ancestor
25824046|NCT00004913|Protective Agents|protective agents|mesh-ancestor
25824047|NCT00004913|Vitamin B Complex|vitamin b complex|mesh-ancestor
25824048|NCT00004913|Vitamins|vitamins|mesh-ancestor
25824049|NCT00004913|Micronutrients|micronutrients|mesh-ancestor
25824050|NCT00004917|Cisplatin|cisplatin|mesh-list
25824051|NCT00004917|Epoetin Alfa|epoetin alfa|mesh-list
25824052|NCT00004917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824053|NCT00004917|Hematinics|hematinics|mesh-ancestor
25824054|NCT00004918|Sargramostim|sargramostim|mesh-list
25824055|NCT00004918|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25824056|NCT00004918|Immunologic Factors|immunologic factors|mesh-ancestor
25824057|NCT00004918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824058|NCT00004918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25076688|NCT03371095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25076689|NCT03371095|Immunologic Factors|immunologic factors|mesh-ancestor
25076690|NCT03371095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076691|NCT03371095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25076817|NCT03370588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076818|NCT03370562|Dexmedetomidine|dexmedetomidine|mesh-list
25824059|NCT00004919|Cisplatin|cisplatin|mesh-list
25077012|NCT03368430|Melatonin|melatonin|mesh-list
24819844|NCT02097381|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25077796|NCT03362073|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25077797|NCT03362073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24883813|NCT04760626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25824060|NCT00004919|Irinotecan|irinotecan|mesh-list
25202096|NCT02723838|Immunologic Factors|immunologic factors|mesh-ancestor
25202102|NCT02723500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25202104|NCT02723669|Acetylcysteine|acetylcysteine|mesh-list
25078043|NCT03359694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25078044|NCT03359694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25078045|NCT03359694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25078046|NCT03359694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078048|NCT03359681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24883983|NCT03759587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24954657|NCT03874026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24954658|NCT03874156|Atorvastatin|atorvastatin|mesh-list
25824061|NCT00004919|Amifostine|amifostine|mesh-list
24954792|NCT03871972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24954793|NCT03871972|Immunologic Factors|immunologic factors|mesh-ancestor
25824062|NCT00004919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824063|NCT00004919|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25824064|NCT00004919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25824065|NCT00004919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541327|NCT00672347|Clonidine|clonidine|mesh-list
24393682|NCT00130676|Luteolytic Agents|luteolytic agents|mesh-ancestor
24781526|NCT01890005|Antipyretics|antipyretics|mesh-ancestor
25202138|NCT02723448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24956016|NCT03858465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956017|NCT03858465|Protective Agents|protective agents|mesh-ancestor
24956018|NCT03858465|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24956325|NCT03855332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956326|NCT03855332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24956327|NCT03855332|Respiratory System Agents|respiratory system agents|mesh-ancestor
24956328|NCT03855332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24956329|NCT03855332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24956330|NCT03855332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24956331|NCT03855332|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24956332|NCT03855332|Protective Agents|protective agents|mesh-ancestor
24956333|NCT03855332|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25202142|NCT02723448|Immunologic Factors|immunologic factors|mesh-ancestor
25202143|NCT02723448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956336|NCT03855267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24956337|NCT03855267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24956345|NCT03855371|Antimetabolites|antimetabolites|mesh-ancestor
24463061|NCT00358488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24463219|NCT00359385|Alendronate|alendronate|mesh-list
24463220|NCT00359385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24463221|NCT00359385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463222|NCT00359567|Palonosetron|palonosetron|mesh-list
24957665|NCT03842800|Anesthetics, General|anesthetics, general|mesh-ancestor
24957667|NCT03842800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24957668|NCT03842800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24957669|NCT03842800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24957670|NCT03842800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24957671|NCT03842800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813975|NCT02061631|Hormones|hormones|mesh-ancestor
24465328|NCT00369018|Dermatologic Agents|dermatologic agents|mesh-ancestor
24475225|NCT00409526|Iloprost|iloprost|mesh-list
24957781|NCT03841526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24957782|NCT03841526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957783|NCT03841526|Incretins|incretins|mesh-ancestor
24957784|NCT03841812|Propofol|propofol|mesh-list
24957785|NCT03841812|Sevoflurane|sevoflurane|mesh-list
24957786|NCT03841812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24957787|NCT03841812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24957788|NCT03841812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957789|NCT03841812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24957790|NCT03841812|Anesthetics, General|anesthetics, general|mesh-ancestor
24957791|NCT03841812|Anesthetics|anesthetics|mesh-ancestor
24957794|NCT03841591|Metformin|metformin|mesh-list
24957813|NCT03841474|Citalopram|citalopram|mesh-list
24957814|NCT03841474|Sertraline|sertraline|mesh-list
24957815|NCT03841474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24957816|NCT03841474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24957817|NCT03841474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24957818|NCT03841474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824074|NCT00004920|Antimetabolites|antimetabolites|mesh-ancestor
25078549|NCT03355482|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25078550|NCT03355482|Prednisolone phosphate|prednisolone phosphate|mesh-list
24959915|NCT03821493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786333|NCT01919203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24786335|NCT01919255|Sodium sulfate|sodium sulfate|mesh-list
24786336|NCT01919255|Magnesium Oxide|magnesium oxide|mesh-list
24960326|NCT03817931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24960328|NCT03818048|Sevoflurane|sevoflurane|mesh-list
24920083|NCT04205240|Tacrolimus|tacrolimus|mesh-list
24920084|NCT04205240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24960659|NCT03814733|Ketamine|ketamine|mesh-list
24960660|NCT03814733|Alprazolam|alprazolam|mesh-list
24960661|NCT03814733|Analgesics|analgesics|mesh-ancestor
24960662|NCT03814733|Sensory System Agents|sensory system agents|mesh-ancestor
24960663|NCT03814733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24960800|NCT03814148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24960801|NCT03814148|Diuretics|diuretics|mesh-ancestor
24960802|NCT03814148|Natriuretic Agents|natriuretic agents|mesh-ancestor
24960803|NCT03814148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960804|NCT03814148|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24960805|NCT03814148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24960806|NCT03814148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078684|NCT03354338|Amoxicillin|amoxicillin|mesh-list
24961360|NCT03809065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961361|NCT03809065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961362|NCT03809065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24961363|NCT03809065|Sympathomimetics|sympathomimetics|mesh-ancestor
24961364|NCT03809065|Autonomic Agents|autonomic agents|mesh-ancestor
24890595|NCT04481841|Vitamins|vitamins|mesh-list
24807477|NCT02022293|Atorvastatin|atorvastatin|mesh-list
24788213|NCT01930318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24962709|NCT03795792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962710|NCT03795792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24962711|NCT03795792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24962712|NCT03795792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962713|NCT03795792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24962715|NCT03795584|Hemostatics|hemostatics|mesh-list
24789385|NCT01936805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789386|NCT01936805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24808040|NCT02024945|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24963583|NCT03789890|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24963584|NCT03790085|Olanzapine|olanzapine|mesh-list
24963585|NCT03790085|Risperidone|risperidone|mesh-list
24963807|NCT03789006|Basiliximab|basiliximab|mesh-list
24963808|NCT03789006|Thymoglobulin|thymoglobulin|mesh-list
24963809|NCT03789006|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24963810|NCT03789006|Immunologic Factors|immunologic factors|mesh-ancestor
24789624|NCT01938235|Exenatide|exenatide|mesh-list
24963811|NCT03789006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963812|NCT03789006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24963813|NCT03789006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24964390|NCT03783494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964392|NCT03783494|Anesthetics, General|anesthetics, general|mesh-ancestor
24964393|NCT03783494|Anesthetics|anesthetics|mesh-ancestor
24964666|NCT03781505|Acetaminophen|acetaminophen|mesh-list
24964667|NCT03781505|Ropivacaine|ropivacaine|mesh-list
24964668|NCT03781505|Anesthetics, Local|anesthetics, local|mesh-ancestor
24964669|NCT03781505|Anesthetics|anesthetics|mesh-ancestor
24964670|NCT03781505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24964763|NCT03780686|Dopamine|dopamine|mesh-list
24790866|NCT01945736|Respiratory System Agents|respiratory system agents|mesh-ancestor
24627016|NCT01090037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24627017|NCT01090037|Vasodilator Agents|vasodilator agents|mesh-ancestor
24627018|NCT01090037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24627020|NCT01090128|Cyclophosphamide|cyclophosphamide|mesh-list
24627021|NCT01090128|Doxorubicin|doxorubicin|mesh-list
24627022|NCT01090128|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24627023|NCT01090128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24627025|NCT01090128|Tubulin Modulators|tubulin modulators|mesh-ancestor
24627026|NCT01090128|Antimitotic Agents|antimitotic agents|mesh-ancestor
24627027|NCT01090128|Mitosis Modulators|mitosis modulators|mesh-ancestor
24484452|NCT00448409|Sargramostim|sargramostim|mesh-list
24964999|NCT03779282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24965000|NCT03779282|Anesthetics, General|anesthetics, general|mesh-ancestor
24965001|NCT03779282|Anesthetics|anesthetics|mesh-ancestor
24965002|NCT03779282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24965003|NCT03779282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24627164|NCT01090830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627165|NCT01090830|Growth Inhibitors|growth inhibitors|mesh-ancestor
24627166|NCT01090830|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24965545|NCT03775798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24965546|NCT03775993|Hormones|hormones|mesh-list
24965547|NCT03775993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24965548|NCT03775993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965549|NCT03775876|Dexmedetomidine|dexmedetomidine|mesh-list
24965550|NCT03775876|Propofol|propofol|mesh-list
24965551|NCT03775876|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24965552|NCT03775876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24774112|NCT01843868|Emetics|emetics|mesh-list
24965586|NCT03775902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25268764|NCT02414490|Antibodies|antibodies|mesh-list
24965587|NCT03775902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965676|NCT03775109|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24965677|NCT03775109|Immunologic Factors|immunologic factors|mesh-ancestor
24965678|NCT03775109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965679|NCT03775382|Ascorbic Acid|ascorbic acid|mesh-list
24965680|NCT03775382|Vitamins|vitamins|mesh-ancestor
24965762|NCT03774771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24965764|NCT03774693|Anesthetics|anesthetics|mesh-ancestor
24965765|NCT03774693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24965766|NCT03774693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965767|NCT03774693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24965768|NCT03774693|Narcotics|narcotics|mesh-ancestor
25079057|NCT03350737|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25824077|NCT00004920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902507|NCT04373018|Eusol|eusol|mesh-list
25824078|NCT00004921|Paclitaxel|paclitaxel|mesh-list
24464534|NCT00365313|Esomeprazole|esomeprazole|mesh-list
24464535|NCT00365313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24966878|NCT03764462|AD 101|ad 101|mesh-list
25079208|NCT03349489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25079209|NCT03349489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079210|NCT03349424|Somatostatin|somatostatin|mesh-list
24967237|NCT03761264|Dermatologic Agents|dermatologic agents|mesh-ancestor
24627431|NCT01092741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795006|NCT03962998|Lactulose|lactulose|mesh-list
24466255|NCT00372762|Furosemide|furosemide|mesh-list
25647156|NCT01466660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25647157|NCT01466660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25647158|NCT01466660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647159|NCT01466673|Moxifloxacin|moxifloxacin|mesh-list
25647160|NCT01466673|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25647161|NCT01466673|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25647162|NCT01466673|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25647163|NCT01466673|Desogestrel|desogestrel|mesh-list
25647164|NCT01466673|Norgestimate|norgestimate|mesh-list
25647165|NCT01466673|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25647166|NCT01466673|Estradiol|estradiol|mesh-list
24467433|NCT00377624|Immunologic Factors|immunologic factors|mesh-ancestor
24467434|NCT00377624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467436|NCT00377624|Protective Agents|protective agents|mesh-ancestor
24803328|NCT01995890|Nepafenac|nepafenac|mesh-list
24628295|NCT01097941|Vaccines|vaccines|mesh-list
24468387|NCT00381264|Antiemetics|antiemetics|mesh-ancestor
24469538|NCT00386269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469539|NCT00386269|Analgesics|analgesics|mesh-ancestor
24469540|NCT00386269|Sensory System Agents|sensory system agents|mesh-ancestor
24469541|NCT00386269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24469542|NCT00386269|Antitussive Agents|antitussive agents|mesh-ancestor
24469543|NCT00386269|Respiratory System Agents|respiratory system agents|mesh-ancestor
24469544|NCT00386282|Misoprostol|misoprostol|mesh-list
24469545|NCT00386282|Mifepristone|mifepristone|mesh-list
24469546|NCT00386282|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24469547|NCT00386282|Abortifacient Agents|abortifacient agents|mesh-ancestor
24470690|NCT00391014|Antifungal Agents|antifungal agents|mesh-ancestor
24470691|NCT00391105|Remifentanil|remifentanil|mesh-list
24470692|NCT00391105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24495909|NCT00502541|Glucocorticoids|glucocorticoids|mesh-ancestor
24896698|NCT04433533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24471038|NCT00393003|Anesthetics|anesthetics|mesh-list
24471039|NCT00393003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24471040|NCT00393003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471041|NCT00393107|Cyclophosphamide|cyclophosphamide|mesh-list
24471042|NCT00393107|Rituximab|rituximab|mesh-list
24471043|NCT00393107|Fludarabine|fludarabine|mesh-list
24471044|NCT00393107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24471045|NCT00393107|Immunologic Factors|immunologic factors|mesh-ancestor
24471046|NCT00393107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471047|NCT00393107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24471067|NCT00393198|Oxytocics|oxytocics|mesh-ancestor
24628563|NCT01099748|Respiratory System Agents|respiratory system agents|mesh-ancestor
24628565|NCT01099839|Miglitol|miglitol|mesh-list
24608967|NCT00994617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608968|NCT00994617|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24497237|NCT00508976|Anesthetics|anesthetics|mesh-ancestor
24897012|NCT04430998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24814532|NCT02065076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814534|NCT02065128|Antipruritics|antipruritics|mesh-ancestor
25824080|NCT00004921|Carboplatin|carboplatin|mesh-list
24628811|NCT01101568|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24628812|NCT01101568|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24628814|NCT01101568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628815|NCT01101568|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24628816|NCT01101568|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24816295|NCT02075970|Epoetin Alfa|epoetin alfa|mesh-list
24816459|NCT02077231|Vitamins|vitamins|mesh-list
24816460|NCT02077231|Vitamin A|vitamin a|mesh-list
24473558|NCT00403286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24473559|NCT00403286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473560|NCT00403312|Nicotine|nicotine|mesh-list
25013256|NCT03173456|Analgesics|analgesics|mesh-ancestor
25013295|NCT03101566|Nivolumab|nivolumab|mesh-list
24500086|NCT00522587|Analgesics|analgesics|mesh-ancestor
24759749|NCT01754324|Respiratory System Agents|respiratory system agents|mesh-ancestor
24759750|NCT01754649|Misoprostol|misoprostol|mesh-list
24759751|NCT01754649|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24475170|NCT00409253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24551574|NCT05373004|Protease Inhibitors|protease inhibitors|mesh-ancestor
24551575|NCT05373004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25824081|NCT00004921|Melphalan|melphalan|mesh-list
25268529|NCT02415335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449042|NCT00313976|Interferons|interferons|mesh-list
24551579|NCT05372887|Cyclobenzaprine|cyclobenzaprine|mesh-list
25647167|NCT01466673|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25647168|NCT01466673|Estrogens|estrogens|mesh-ancestor
25647169|NCT01466673|Hormones|hormones|mesh-ancestor
25647170|NCT01466673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25647171|NCT01466673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647172|NCT01466673|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25647173|NCT01466673|Contraceptive Agents|contraceptive agents|mesh-ancestor
25647174|NCT01466673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25647175|NCT01466673|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25824082|NCT00004921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24760714|NCT01759706|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24760736|NCT01759732|Immunologic Factors|immunologic factors|mesh-ancestor
24760737|NCT01759732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760738|NCT01759732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24761038|NCT01760746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24761039|NCT01760746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761346|NCT01762319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761347|NCT01762319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24761467|NCT01762787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24761597|NCT01763463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24761696|NCT01763749|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24761697|NCT01763749|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24761699|NCT01763749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24478651|NCT00423826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25824083|NCT00004921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24765529|NCT01789216|Analgesics|analgesics|mesh-ancestor
24556347|NCT00747279|Insulin|insulin|mesh-list
24765871|NCT01791114|Propranolol|propranolol|mesh-list
24767519|NCT01801423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767593|NCT01802489|Natriuretic Agents|natriuretic agents|mesh-ancestor
24767594|NCT01802489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767824|NCT01803503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767825|NCT01803503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24767864|NCT01803828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767866|NCT01804127|Rituximab|rituximab|mesh-list
24767899|NCT01804244|Rilpivirine|rilpivirine|mesh-list
25080577|NCT03337373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25080591|NCT03337191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25080592|NCT03337191|Anesthetics, Local|anesthetics, local|mesh-ancestor
25080593|NCT03337191|Anesthetics|anesthetics|mesh-ancestor
25080594|NCT03337126|Metronidazole|metronidazole|mesh-list
25080595|NCT03337126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24770250|NCT01819220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24770251|NCT01819220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24770377|NCT01820026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770379|NCT01820091|Antidotes|antidotes|mesh-ancestor
24772414|NCT01833676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24772415|NCT01833676|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24772416|NCT01833676|Anesthetics, General|anesthetics, general|mesh-ancestor
24772417|NCT01833676|Anesthetics|anesthetics|mesh-ancestor
24772418|NCT01833676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24772419|NCT01833676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967140|NCT03762538|Propofol|propofol|mesh-list
25202394|NCT02721862|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25202395|NCT02721862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25202396|NCT02721888|Liraglutide|liraglutide|mesh-list
25202397|NCT02721888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25207730|NCT03462017|Acetylcholine|acetylcholine|mesh-list
24773824|NCT01842230|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25017674|NCT03705351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017675|NCT03705351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24773834|NCT01842256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773835|NCT01842256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24682759|NCT01388387|Tacrolimus|tacrolimus|mesh-list
24773836|NCT01842256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24773852|NCT01842269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24773853|NCT01842269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773855|NCT01842321|Abiraterone Acetate|abiraterone acetate|mesh-list
25012666|NCT04666454|Analgesics|analgesics|mesh-ancestor
24774127|NCT01843868|Tubulin Modulators|tubulin modulators|mesh-ancestor
24793442|NCT03485534|Tenofovir|tenofovir|mesh-list
24793802|NCT02205047|Fluorouracil|fluorouracil|mesh-list
25067478|NCT03443726|Anesthetics, Local|anesthetics, local|mesh-ancestor
25067479|NCT03443726|Anesthetics|anesthetics|mesh-ancestor
25647176|NCT01466673|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25647177|NCT01466673|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25647178|NCT01466673|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25647179|NCT01466673|Progestins|progestins|mesh-ancestor
25647180|NCT01466673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25067480|NCT03443726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25067481|NCT03443726|Sensory System Agents|sensory system agents|mesh-ancestor
25067482|NCT03443609|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25067483|NCT03443609|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25067536|NCT03443141|Micronutrients|micronutrients|mesh-ancestor
24920908|NCT04196309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25067655|NCT03441412|Purinergic Agents|purinergic agents|mesh-ancestor
24522584|NCT03633110|Pembrolizumab|pembrolizumab|mesh-list
24522585|NCT03633110|Nivolumab|nivolumab|mesh-list
24522586|NCT03633110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24522587|NCT03633110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522588|NCT03633110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24522589|NCT03633110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522590|NCT03628066|Letrozole|letrozole|mesh-list
24522591|NCT03628066|Palbociclib|palbociclib|mesh-list
24522592|NCT03628066|Goserelin|goserelin|mesh-list
25067768|NCT03439787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25067769|NCT03439787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067770|NCT03439787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25067771|NCT03439787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25067772|NCT03439787|Autonomic Agents|autonomic agents|mesh-ancestor
25067773|NCT03439787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25067774|NCT03439787|Respiratory System Agents|respiratory system agents|mesh-ancestor
25067775|NCT03439787|Mydriatics|mydriatics|mesh-ancestor
25067776|NCT03439787|Sympathomimetics|sympathomimetics|mesh-ancestor
25067777|NCT03439787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25067779|NCT03439709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921657|NCT04188106|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24921658|NCT04188106|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24921659|NCT04188106|Cholinergic Agents|cholinergic agents|mesh-ancestor
24921660|NCT04188106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24921661|NCT04188106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921860|NCT04186299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24921861|NCT04186299|Sympatholytics|sympatholytics|mesh-ancestor
24921862|NCT04186299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24921863|NCT04186299|Anesthetics, Local|anesthetics, local|mesh-ancestor
24921864|NCT04186299|Anesthetics|anesthetics|mesh-ancestor
24921887|NCT04185857|Natriuretic Agents|natriuretic agents|mesh-ancestor
24921888|NCT04185675|Anesthetics|anesthetics|mesh-list
24922092|NCT04183738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24922093|NCT04183738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24922094|NCT04183738|Protease Inhibitors|protease inhibitors|mesh-ancestor
24922095|NCT04183738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24922096|NCT04183738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922097|NCT04183738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24922098|NCT04183738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24922099|NCT04183738|Antiviral Agents|antiviral agents|mesh-ancestor
24922100|NCT04183738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24922132|NCT04183114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623955|NCT01074073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24623956|NCT01074073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24623958|NCT01074073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24922463|NCT04179604|Simendan|simendan|mesh-list
24953408|NCT03885180|Anticoagulants|anticoagulants|mesh-ancestor
24922676|NCT04178109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24922677|NCT04177719|Oxytocin|oxytocin|mesh-list
24922678|NCT04177719|Oxytocics|oxytocics|mesh-ancestor
24922679|NCT04177719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24922680|NCT04177719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922681|NCT04177602|Trifluridine|trifluridine|mesh-list
24922682|NCT04177602|Capecitabine|capecitabine|mesh-list
24922683|NCT04177602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24922684|NCT04177602|Antimetabolites|antimetabolites|mesh-ancestor
24922685|NCT04177602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922686|NCT04177602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922687|NCT04177602|Antiviral Agents|antiviral agents|mesh-ancestor
24922688|NCT04177602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24922707|NCT04177173|Methotrexate|methotrexate|mesh-list
24922721|NCT04177173|Immunologic Factors|immunologic factors|mesh-ancestor
24922722|NCT04177173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24922723|NCT04177173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24463096|NCT00358683|Immunologic Factors|immunologic factors|mesh-ancestor
25647181|NCT01466673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24922724|NCT04177173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24827530|NCT02140073|Omeprazole|omeprazole|mesh-list
24827531|NCT02140073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24827532|NCT02140073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24827533|NCT02140073|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25824084|NCT00004921|Tubulin Modulators|tubulin modulators|mesh-ancestor
25824085|NCT00004921|Antimitotic Agents|antimitotic agents|mesh-ancestor
25068186|NCT03435744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24922931|NCT04174872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24922932|NCT04174872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24922933|NCT04174872|Anesthetics, General|anesthetics, general|mesh-ancestor
24922935|NCT04174872|GABA Modulators|gaba modulators|mesh-ancestor
24922936|NCT04174872|GABA Agents|gaba agents|mesh-ancestor
24922938|NCT04174339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922939|NCT04174339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24601729|NCT00965796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24542024|NCT00676468|Montelukast|montelukast|mesh-list
24603438|NCT00973804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603439|NCT00973804|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24603447|NCT00973869|Curcumin|curcumin|mesh-list
24605499|NCT00985556|Oxaliplatin|oxaliplatin|mesh-list
24605500|NCT00985556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24605501|NCT00985556|Antimetabolites|antimetabolites|mesh-ancestor
24605502|NCT00985556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605503|NCT00985556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24606004|NCT00988520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24606005|NCT00988520|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24606280|NCT00989703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25824086|NCT00004921|Mitosis Modulators|mitosis modulators|mesh-ancestor
24606356|NCT00990067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24606357|NCT00990067|Dopamine Agents|dopamine agents|mesh-ancestor
24606358|NCT00990067|Hallucinogens|hallucinogens|mesh-ancestor
24606385|NCT00990223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24606386|NCT00990223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606387|NCT00990223|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24606388|NCT00990223|Diuretics|diuretics|mesh-ancestor
24606389|NCT00990223|Natriuretic Agents|natriuretic agents|mesh-ancestor
24606391|NCT00990275|Ethanol|ethanol|mesh-list
24606877|NCT05407597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24636992|NCT01148277|GABA Modulators|gaba modulators|mesh-ancestor
24606878|NCT05407597|Immunologic Factors|immunologic factors|mesh-ancestor
24606879|NCT05407467|Curcumin|curcumin|mesh-list
24606880|NCT05407467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24606881|NCT05407467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24607178|NCT05072093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24607179|NCT05072093|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24608834|NCT00993876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24673226|NCT01336322|Metformin|metformin|mesh-list
24673766|NCT01340235|Erythromycin Estolate|erythromycin estolate|mesh-list
24673767|NCT01340235|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24673768|NCT01340235|Erythromycin stearate|erythromycin stearate|mesh-list
24673769|NCT01340235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24673770|NCT01340235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24821103|NCT02103569|Norethindrone|norethindrone|mesh-list
24673834|NCT01340547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673835|NCT01340599|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24673836|NCT01340599|Antioxidants|antioxidants|mesh-ancestor
24673848|NCT01340677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676751|NCT01352338|Hormones|hormones|mesh-ancestor
24680344|NCT01374308|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24680345|NCT01374308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542621|NCT00679614|Acetaminophen|acetaminophen|mesh-list
24680358|NCT01374464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24464950|NCT00367393|Immunologic Factors|immunologic factors|mesh-ancestor
24464951|NCT00367393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24681104|NCT01378286|Schistosomicides|schistosomicides|mesh-ancestor
25068570|NCT03432780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068571|NCT03432780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25068572|NCT03432780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693336|NCT01419730|Vitamin D|vitamin d|mesh-list
24681868|NCT01382407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681869|NCT01382472|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24681870|NCT01382472|Simvastatin|simvastatin|mesh-list
24681871|NCT01382472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24681872|NCT01382472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24681873|NCT01382472|Antimetabolites|antimetabolites|mesh-ancestor
24681874|NCT01382472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681877|NCT01382472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681910|NCT01382745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681911|NCT01382888|Heparin|heparin|mesh-list
24683616|NCT01393145|Respiratory System Agents|respiratory system agents|mesh-ancestor
24683618|NCT01393145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24683619|NCT01393145|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24683620|NCT01393145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24683621|NCT01393145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24683622|NCT01393145|Adrenergic Agents|adrenergic agents|mesh-ancestor
24683785|NCT01394133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683787|NCT01394133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24683788|NCT01394133|Antiviral Agents|antiviral agents|mesh-ancestor
24683789|NCT01394133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24683790|NCT01394133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24683791|NCT01394133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24683821|NCT01394354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24683828|NCT01394406|Ketamine|ketamine|mesh-list
25068662|NCT03432468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25068663|NCT03432468|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25068664|NCT03432468|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24821902|NCT02108743|Albuterol|albuterol|mesh-list
24684252|NCT01396200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684254|NCT01396200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24684257|NCT01396200|Antifungal Agents|antifungal agents|mesh-ancestor
24684712|NCT04598815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24684713|NCT04598815|Immunologic Factors|immunologic factors|mesh-ancestor
24684714|NCT04598815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684759|NCT04453449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24684760|NCT04453449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24684761|NCT04453449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24684762|NCT04453449|Anesthetics, General|anesthetics, general|mesh-ancestor
24684763|NCT04453449|Anesthetics|anesthetics|mesh-ancestor
24685302|NCT05274113|Hormones|hormones|mesh-ancestor
24685410|NCT05272930|Dienogest|dienogest|mesh-list
24685411|NCT05272930|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24685412|NCT05272930|Contraceptive Agents|contraceptive agents|mesh-ancestor
24685413|NCT05272930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24685414|NCT05272930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829662|NCT00006246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24685447|NCT05272696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24685448|NCT05272696|Tubulin Modulators|tubulin modulators|mesh-ancestor
25068726|NCT03431961|Glucocorticoids|glucocorticoids|mesh-ancestor
25068730|NCT03431961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25068731|NCT03431961|Immunologic Factors|immunologic factors|mesh-ancestor
25068732|NCT03431961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24831258|NCT02164565|Tranexamic Acid|tranexamic acid|mesh-list
24685826|NCT05168735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24685827|NCT05168735|Anesthetics, General|anesthetics, general|mesh-ancestor
24685828|NCT05168735|Anesthetics|anesthetics|mesh-ancestor
24685829|NCT05168735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24686275|NCT04919564|Furosemide|furosemide|mesh-list
24686276|NCT04919564|Diuretics|diuretics|mesh-ancestor
24686277|NCT04919564|Natriuretic Agents|natriuretic agents|mesh-ancestor
24686278|NCT04919564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686279|NCT04919564|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24640825|NCT01170260|Ethanol|ethanol|mesh-list
24686375|NCT04879823|Dexamethasone|dexamethasone|mesh-list
24686376|NCT04879823|Ibuprofen|ibuprofen|mesh-list
24686377|NCT04879823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24686378|NCT04879823|Antiemetics|antiemetics|mesh-ancestor
24611680|NCT01010295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24611681|NCT01010295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24686512|NCT04760691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24686514|NCT04760691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686515|NCT04760691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24686516|NCT04760691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24686628|NCT04674514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24686630|NCT04674514|Autonomic Agents|autonomic agents|mesh-ancestor
24686631|NCT04674514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24686632|NCT04674514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686633|NCT04674514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25068753|NCT03431909|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25068754|NCT03431909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25068756|NCT03431909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24687153|NCT04301271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25647182|NCT01466673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25647183|NCT01466673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25647184|NCT01466673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25647185|NCT01466673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647186|NCT01466673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647187|NCT01466673|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25829663|NCT00006247|Semaxinib|semaxinib|mesh-list
24687154|NCT04301271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24687155|NCT04301271|Antimetabolites|antimetabolites|mesh-ancestor
24687156|NCT04301271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687157|NCT04301271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24687158|NCT04301271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24687159|NCT04301271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24687160|NCT04301011|Pembrolizumab|pembrolizumab|mesh-list
24687517|NCT03937219|Ipilimumab|ipilimumab|mesh-list
24687518|NCT03937219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24687519|NCT03937219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24687520|NCT03937219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24687521|NCT03937219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687522|NCT03932318|Azacitidine|azacitidine|mesh-list
24687523|NCT03932318|Venetoclax|venetoclax|mesh-list
25202468|NCT02721082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24635350|NCT01138605|Protease Inhibitors|protease inhibitors|mesh-ancestor
25068780|NCT03431831|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25068781|NCT03431831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25068782|NCT03431831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068807|NCT03431714|Antiviral Agents|antiviral agents|mesh-ancestor
24687826|NCT03661996|Mydriatics|mydriatics|mesh-ancestor
24687827|NCT03661996|Sympathomimetics|sympathomimetics|mesh-ancestor
24687828|NCT03661996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24687829|NCT03661996|Antipruritics|antipruritics|mesh-ancestor
24687830|NCT03661996|Dermatologic Agents|dermatologic agents|mesh-ancestor
24687831|NCT03659799|Insulin|insulin|mesh-list
25068875|NCT03431142|Clopidogrel|clopidogrel|mesh-list
25068876|NCT03431142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25068877|NCT03431142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25068878|NCT03431142|Analgesics|analgesics|mesh-ancestor
25068879|NCT03431142|Sensory System Agents|sensory system agents|mesh-ancestor
25068880|NCT03431142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24687987|NCT03555877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24687988|NCT03555877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687989|NCT03555877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25068899|NCT03431077|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25068900|NCT03431077|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25068901|NCT03431077|Protease Inhibitors|protease inhibitors|mesh-ancestor
25068902|NCT03431077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25068903|NCT03431077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068998|NCT03430180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953613|NCT03883269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25069075|NCT03429179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25069076|NCT03429179|Narcotics|narcotics|mesh-ancestor
24637414|NCT01150162|Rebamipide|rebamipide|mesh-list
24611858|NCT01011036|Cholinergic Agents|cholinergic agents|mesh-ancestor
24611859|NCT01011036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25069155|NCT03428568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25069353|NCT03427086|Vitamins|vitamins|mesh-ancestor
25069354|NCT03427086|Micronutrients|micronutrients|mesh-ancestor
25069356|NCT03427086|Vitamin B Complex|vitamin b complex|mesh-ancestor
25069606|NCT03425461|Antibodies|antibodies|mesh-list
24691266|NCT01405989|Darexaban|darexaban|mesh-list
24693663|NCT01421706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24693664|NCT01421706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24693665|NCT01421706|Antidepressive Agents|antidepressive agents|mesh-ancestor
24693666|NCT01421706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25069868|NCT03423472|Vitamins|vitamins|mesh-ancestor
25069911|NCT03422978|Analgesics|analgesics|mesh-ancestor
24693984|NCT01423240|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24693985|NCT01423240|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24693986|NCT01423240|Dopamine Agents|dopamine agents|mesh-ancestor
24693988|NCT01423292|Anesthetics, Local|anesthetics, local|mesh-ancestor
24694344|NCT01425125|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24694345|NCT01425125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694425|NCT01425476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24694427|NCT01425476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24854291|NCT02272868|Laxatives|laxatives|mesh-ancestor
24694563|NCT05386160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694622|NCT05385744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24694623|NCT05385744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24694624|NCT05385744|Immunologic Factors|immunologic factors|mesh-ancestor
24694649|NCT05385406|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24694699|NCT05379413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25070035|NCT03422419|Heparin|heparin|mesh-list
25070036|NCT03422419|Anticoagulants|anticoagulants|mesh-ancestor
25070037|NCT03422419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25070038|NCT03422419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25070039|NCT03422419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070040|NCT03422406|Iodine|iodine|mesh-list
25070041|NCT03422406|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25070042|NCT03422406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24694702|NCT05379374|Anesthetics, Local|anesthetics, local|mesh-ancestor
24694703|NCT05379374|Anesthetics|anesthetics|mesh-ancestor
24694706|NCT05379374|Sensory System Agents|sensory system agents|mesh-ancestor
25824087|NCT00004921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694800|NCT05279183|Vasodilator Agents|vasodilator agents|mesh-ancestor
24612434|NCT01013987|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24612435|NCT01013987|Protease Inhibitors|protease inhibitors|mesh-ancestor
24612436|NCT01013987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612437|NCT01013987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612438|NCT01013987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24612439|NCT01013987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24612440|NCT01013987|Antiviral Agents|antiviral agents|mesh-ancestor
24612441|NCT01013987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24612442|NCT01013987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24695209|NCT04246762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24695210|NCT04246762|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24695211|NCT04246762|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24695212|NCT04246762|Purinergic Agents|purinergic agents|mesh-ancestor
24695213|NCT04246762|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24695214|NCT04246762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24695440|NCT03563222|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25824088|NCT00004921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25824089|NCT00004921|Immunologic Factors|immunologic factors|mesh-ancestor
24695476|NCT03444753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25824090|NCT00004921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824091|NCT00004921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24695477|NCT03444753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695478|NCT03417154|Cyclophosphamide|cyclophosphamide|mesh-list
24695787|NCT01231906|Etoposide phosphate|etoposide phosphate|mesh-list
24695788|NCT01231906|Topotecan|topotecan|mesh-list
24695789|NCT01231906|Podophyllotoxin|podophyllotoxin|mesh-list
24695818|NCT00223145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24612533|NCT01014364|Hydrocortisone|hydrocortisone|mesh-list
24612534|NCT01014364|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24612535|NCT01014364|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24612536|NCT01014364|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24612537|NCT01014364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24612538|NCT01014416|Tolvaptan|tolvaptan|mesh-list
24696274|NCT01428427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25202527|NCT02720822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24696275|NCT01428427|Antimetabolites|antimetabolites|mesh-ancestor
25202528|NCT02720822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626418|NCT01087359|Antioxidants|antioxidants|mesh-ancestor
24696430|NCT01429415|Tocolytic Agents|tocolytic agents|mesh-ancestor
24696431|NCT01429415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24696557|NCT01429935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824092|NCT00004921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24612699|NCT01015183|Dermatologic Agents|dermatologic agents|mesh-ancestor
24612700|NCT01015196|Daunorubicin|daunorubicin|mesh-list
24612701|NCT01015196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24612707|NCT01015209|Acetylcysteine|acetylcysteine|mesh-list
24696679|NCT01431053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24612719|NCT01015209|Protective Agents|protective agents|mesh-ancestor
24534282|NCT00646607|Vitamins|vitamins|mesh-ancestor
24697665|NCT01436188|Sensory System Agents|sensory system agents|mesh-ancestor
24697666|NCT01436188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24697669|NCT01436188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24698480|NCT01441388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698557|NCT01441908|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25070465|NCT03419442|Antimitotic Agents|antimitotic agents|mesh-ancestor
25070466|NCT03419442|Mitosis Modulators|mitosis modulators|mesh-ancestor
25824093|NCT00004921|Alkylating Agents|alkylating agents|mesh-ancestor
25070467|NCT03419442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070468|NCT03419429|Simvastatin|simvastatin|mesh-list
25070469|NCT03419429|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25070470|NCT03419429|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25070471|NCT03419429|Antimetabolites|antimetabolites|mesh-ancestor
25070472|NCT03419429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070473|NCT03419429|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24698614|NCT01442311|Ribavirin|ribavirin|mesh-list
24698872|NCT01443208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698873|NCT01443208|Antidepressive Agents|antidepressive agents|mesh-ancestor
24699243|NCT01445639|Sensory System Agents|sensory system agents|mesh-ancestor
24699244|NCT01445639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24699245|NCT01445639|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24612961|NCT01016054|Doxorubicin|doxorubicin|mesh-list
24699382|NCT01446445|Antiviral Agents|antiviral agents|mesh-ancestor
24612991|NCT01016223|Beclomethasone|beclomethasone|mesh-list
25070765|NCT03416348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070766|NCT03416270|Ertugliflozin|ertugliflozin|mesh-list
25070767|NCT03416270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25070768|NCT03416270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070769|NCT03416270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25071212|NCT03412409|Cytarabine|cytarabine|mesh-list
25071526|NCT03408145|Protective Agents|protective agents|mesh-ancestor
25071578|NCT03407521|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25071579|NCT03407521|Diuretics|diuretics|mesh-ancestor
25071789|NCT03406299|Antidotes|antidotes|mesh-ancestor
25072134|NCT03403049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25072135|NCT03403049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701429|NCT01458977|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25072523|NCT03401177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25072524|NCT03401177|Gout Suppressants|gout suppressants|mesh-ancestor
25072525|NCT03401177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24701504|NCT01459380|Bevacizumab|bevacizumab|mesh-list
24701505|NCT01459380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24701506|NCT01459380|Carboplatin|carboplatin|mesh-list
24701507|NCT01459380|Doxorubicin|doxorubicin|mesh-list
25072608|NCT03400423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25072609|NCT03400423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072611|NCT03400423|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24954000|NCT03879889|Nicotine|nicotine|mesh-list
24954001|NCT03879889|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24954002|NCT03879889|Autonomic Agents|autonomic agents|mesh-ancestor
25073297|NCT03395977|Rasburicase|rasburicase|mesh-list
25073298|NCT03395977|Gout Suppressants|gout suppressants|mesh-ancestor
24636467|NCT01145612|Adrenergic Agents|adrenergic agents|mesh-ancestor
24638006|NCT01154439|Analgesics|analgesics|mesh-ancestor
24638541|NCT01156961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24639976|NCT01165268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25073995|NCT03391570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25073997|NCT03391570|Analgesics|analgesics|mesh-ancestor
25074109|NCT03390712|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24641691|NCT01174914|Lamivudine|lamivudine|mesh-list
24642247|NCT01178645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24642348|NCT01179009|Sympatholytics|sympatholytics|mesh-ancestor
24642349|NCT01179009|Autonomic Agents|autonomic agents|mesh-ancestor
25074234|NCT03389724|Captopril|captopril|mesh-list
25074401|NCT03388814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074402|NCT03388814|Sensory System Agents|sensory system agents|mesh-ancestor
24643156|NCT01184196|Povidone-Iodine|povidone-iodine|mesh-list
24643157|NCT01184196|Povidone|povidone|mesh-list
25647191|NCT01466790|Sofosbuvir|sofosbuvir|mesh-list
24643170|NCT01184287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24550430|NCT00720564|Temozolomide|temozolomide|mesh-list
25647192|NCT01466790|Simeprevir|simeprevir|mesh-list
25647193|NCT01466790|Antimetabolites|antimetabolites|mesh-ancestor
25657227|NCT01584440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25074716|NCT03386591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074718|NCT03386591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25074719|NCT03386565|Lidocaine|lidocaine|mesh-list
25074720|NCT03386565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25074721|NCT03386565|Anesthetics, Local|anesthetics, local|mesh-ancestor
25074722|NCT03386565|Anesthetics|anesthetics|mesh-ancestor
25074723|NCT03386565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25074871|NCT03385356|Micronutrients|micronutrients|mesh-ancestor
25074872|NCT03385356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074873|NCT03385356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25074888|NCT03385226|Pembrolizumab|pembrolizumab|mesh-list
25074889|NCT03385226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25074890|NCT03385226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25074891|NCT03385174|Carbon Monoxide|carbon monoxide|mesh-list
25074892|NCT03385174|Antimetabolites|antimetabolites|mesh-ancestor
25074893|NCT03385174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074894|NCT03385174|Gasotransmitters|gasotransmitters|mesh-ancestor
24837972|NCT02194374|Antimetabolites|antimetabolites|mesh-ancestor
24643186|NCT01184391|Antimanic Agents|antimanic agents|mesh-ancestor
25075325|NCT03381755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24940646|NCT03999203|Antioxidants|antioxidants|mesh-ancestor
25075457|NCT03380949|Remifentanil|remifentanil|mesh-list
25075495|NCT03380728|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25075496|NCT03380728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25075497|NCT03380728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075498|NCT03380689|Bevacizumab|bevacizumab|mesh-list
25075499|NCT03380689|Irinotecan|irinotecan|mesh-list
25075500|NCT03380689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25075738|NCT03378427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075739|NCT03378427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075740|NCT03378427|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25075741|NCT03378427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25075887|NCT03377465|Natriuretic Agents|natriuretic agents|mesh-ancestor
25075888|NCT03377465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075889|NCT03377465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075890|NCT03377465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075892|NCT03377400|Durvalumab|durvalumab|mesh-list
25075893|NCT03377400|Tremelimumab|tremelimumab|mesh-list
25075894|NCT03377400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998481|NCT02630199|Tubulin Modulators|tubulin modulators|mesh-ancestor
24998482|NCT02630199|Antimitotic Agents|antimitotic agents|mesh-ancestor
24998483|NCT02630199|Mitosis Modulators|mitosis modulators|mesh-ancestor
24998484|NCT02630199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998486|NCT02611960|Capecitabine|capecitabine|mesh-list
24998487|NCT02611960|Docetaxel|docetaxel|mesh-list
24998488|NCT02611960|Pembrolizumab|pembrolizumab|mesh-list
24998489|NCT02611960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24998490|NCT02611960|Antimetabolites|antimetabolites|mesh-ancestor
24998491|NCT02611960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998492|NCT02611960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998493|NCT02611960|Antiviral Agents|antiviral agents|mesh-ancestor
24998494|NCT02611960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24998495|NCT02611960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998496|NCT02611960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24998497|NCT02611960|Immunologic Factors|immunologic factors|mesh-ancestor
25202608|NCT02720575|Vitamin D|vitamin d|mesh-list
24998755|NCT00979212|Panitumumab|panitumumab|mesh-list
24998756|NCT00979212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24998757|NCT00979212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998758|NCT00979212|Tubulin Modulators|tubulin modulators|mesh-ancestor
24998759|NCT00979212|Antimitotic Agents|antimitotic agents|mesh-ancestor
24998760|NCT00979212|Mitosis Modulators|mitosis modulators|mesh-ancestor
24998761|NCT00979212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048673|NCT00677053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25048674|NCT00677053|Antithrombins|antithrombins|mesh-ancestor
25048675|NCT00677053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24706167|NCT01488955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24706168|NCT01488955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24706169|NCT01489059|Ipilimumab|ipilimumab|mesh-list
24706170|NCT01489059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25048676|NCT00677053|Protease Inhibitors|protease inhibitors|mesh-ancestor
24998969|NCT05421741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998971|NCT05421416|Antipruritics|antipruritics|mesh-ancestor
24998972|NCT05421416|Dermatologic Agents|dermatologic agents|mesh-ancestor
24998973|NCT05421416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24998975|NCT05421416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24798323|NCT01962454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798324|NCT01962454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24999108|NCT05201079|Fidaxomicin|fidaxomicin|mesh-list
24999109|NCT05201079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24999110|NCT05201079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24999119|NCT05171231|Hemostatics|hemostatics|mesh-list
24999120|NCT05171231|Coagulants|coagulants|mesh-ancestor
24999170|NCT05083312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24999171|NCT05083312|Respiratory System Agents|respiratory system agents|mesh-ancestor
24999172|NCT05083312|Dermatologic Agents|dermatologic agents|mesh-ancestor
24999173|NCT05083312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24999174|NCT05071014|Pembrolizumab|pembrolizumab|mesh-list
24999219|NCT04969250|Immunologic Factors|immunologic factors|mesh-ancestor
24999220|NCT04969250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999221|NCT04895748|Everolimus|everolimus|mesh-list
24999222|NCT04895748|Spartalizumab|spartalizumab|mesh-list
24999223|NCT04895748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999224|NCT04895748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24999225|NCT04895748|Immunologic Factors|immunologic factors|mesh-ancestor
24999226|NCT04895748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999227|NCT04895748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24798366|NCT01963299|Ropivacaine|ropivacaine|mesh-list
24798367|NCT01963299|Anesthetics, Local|anesthetics, local|mesh-ancestor
24798368|NCT01963299|Anesthetics|anesthetics|mesh-ancestor
24798369|NCT01963299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24798370|NCT01963299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798371|NCT01963299|Sensory System Agents|sensory system agents|mesh-ancestor
24798372|NCT01963299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24798373|NCT01963299|Analgesics|analgesics|mesh-ancestor
24798374|NCT01963299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24798375|NCT01963299|Sympatholytics|sympatholytics|mesh-ancestor
25048777|NCT00670033|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25048778|NCT00670033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25048779|NCT00668772|Tiotropium Bromide|tiotropium bromide|mesh-list
25048780|NCT00668772|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25048781|NCT00668772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25048782|NCT00668772|Autonomic Agents|autonomic agents|mesh-ancestor
25048783|NCT00668772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25048784|NCT00668772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048785|NCT00668772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24999439|NCT04415944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999446|NCT04332341|Niacinamide|niacinamide|mesh-list
24999448|NCT04332341|Nicotinic Acids|nicotinic acids|mesh-list
24999449|NCT04332341|Vitamin B Complex|vitamin b complex|mesh-ancestor
24999451|NCT04332341|Micronutrients|micronutrients|mesh-ancestor
24999452|NCT04332341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999453|NCT04332341|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24798378|NCT01963299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24798379|NCT01963299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24798380|NCT01963299|Adrenergic Agents|adrenergic agents|mesh-ancestor
24798381|NCT01963299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24999475|NCT04209855|Maytansine|maytansine|mesh-list
24999476|NCT04209855|Doxorubicin|doxorubicin|mesh-list
24999477|NCT04209855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24999478|NCT04209855|Topotecan|topotecan|mesh-list
24999479|NCT04209855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24999480|NCT04209855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999481|NCT04209855|Tubulin Modulators|tubulin modulators|mesh-ancestor
24999482|NCT04209855|Antimitotic Agents|antimitotic agents|mesh-ancestor
24999483|NCT04209855|Mitosis Modulators|mitosis modulators|mesh-ancestor
24999484|NCT04209855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999485|NCT04209855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24999587|NCT03912220|Vitamin B Complex|vitamin b complex|mesh-ancestor
24999589|NCT03912220|Micronutrients|micronutrients|mesh-ancestor
24999590|NCT03912220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999591|NCT03912220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24999592|NCT03912220|Antimetabolites|antimetabolites|mesh-ancestor
24999623|NCT03762850|Irbesartan|irbesartan|mesh-list
24999684|NCT03516214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999685|NCT03516214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24999686|NCT03516214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24999687|NCT03516214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999688|NCT03502577|Cyclophosphamide|cyclophosphamide|mesh-list
24999690|NCT03502577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24999691|NCT03502577|Immunologic Factors|immunologic factors|mesh-ancestor
24999692|NCT03502577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999693|NCT03502577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24999694|NCT03502577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24999695|NCT03502577|Alkylating Agents|alkylating agents|mesh-ancestor
24643858|NCT01187862|Caffeine|caffeine|mesh-list
24643859|NCT01187862|Chlorzoxazone|chlorzoxazone|mesh-list
24643860|NCT01187862|Omeprazole|omeprazole|mesh-list
24999767|NCT03386357|Pembrolizumab|pembrolizumab|mesh-list
24999768|NCT03386357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24999769|NCT03386357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999770|NCT03354728|Vaccines|vaccines|mesh-list
24999771|NCT03354728|Immunologic Factors|immunologic factors|mesh-ancestor
24999801|NCT03121014|Methotrexate|methotrexate|mesh-list
24707152|NCT01494363|Immunologic Factors|immunologic factors|mesh-ancestor
24707153|NCT01494363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707154|NCT01494363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24707155|NCT01494363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24707156|NCT01494363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707157|NCT01494363|Antidotes|antidotes|mesh-ancestor
24999802|NCT03121014|Fludarabine|fludarabine|mesh-list
24999803|NCT03121014|Busulfan|busulfan|mesh-list
24999804|NCT03121014|Tacrolimus|tacrolimus|mesh-list
24999805|NCT03121014|Thymoglobulin|thymoglobulin|mesh-list
24999904|NCT02884219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999923|NCT02727803|Immunoglobulins|immunoglobulins|mesh-list
24999924|NCT02727803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24999925|NCT02727803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24999926|NCT02727803|Immunologic Factors|immunologic factors|mesh-ancestor
24999927|NCT02727803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999928|NCT02727803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24999929|NCT02727803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24707326|NCT01495195|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24707327|NCT01495195|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24707328|NCT01495195|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24707329|NCT01495195|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24707330|NCT01495195|Protective Agents|protective agents|mesh-ancestor
24707331|NCT01495208|Aflibercept|aflibercept|mesh-list
24707332|NCT01495208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24999991|NCT02342275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999992|NCT02342275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999993|NCT02342275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24999994|NCT02342275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24999995|NCT02342275|Vasodilator Agents|vasodilator agents|mesh-ancestor
24999996|NCT02342275|Sympatholytics|sympatholytics|mesh-ancestor
24999997|NCT02342275|Autonomic Agents|autonomic agents|mesh-ancestor
24999998|NCT02342275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25000000|NCT02199236|Capecitabine|capecitabine|mesh-list
25000085|NCT01827553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25000086|NCT01827553|Antimetabolites|antimetabolites|mesh-ancestor
25000087|NCT01827553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000088|NCT01827553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25000089|NCT01827553|Antiviral Agents|antiviral agents|mesh-ancestor
25000090|NCT01827553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25038211|NCT05263505|Dermatologic Agents|dermatologic agents|mesh-ancestor
25038212|NCT05263505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038218|NCT05262985|Durvalumab|durvalumab|mesh-list
25000091|NCT01827553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25000092|NCT01827553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25000095|NCT01700673|Azacitidine|azacitidine|mesh-list
24938038|NCT04022811|Bromfenac|bromfenac|mesh-list
24938039|NCT04022811|Hyaluronic Acid|hyaluronic acid|mesh-list
24938040|NCT04022811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24938041|NCT04022811|Antiemetics|antiemetics|mesh-ancestor
24938047|NCT04022811|Hormones|hormones|mesh-ancestor
25000203|NCT04166487|Pembrolizumab|pembrolizumab|mesh-list
25000204|NCT04166487|Pemetrexed|pemetrexed|mesh-list
25000205|NCT04166487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25000206|NCT04166487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25000207|NCT04166487|Tubulin Modulators|tubulin modulators|mesh-ancestor
25000208|NCT04166487|Antimitotic Agents|antimitotic agents|mesh-ancestor
25000209|NCT04166487|Mitosis Modulators|mitosis modulators|mesh-ancestor
25000210|NCT04166487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048898|NCT00658372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048899|NCT00658372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25048901|NCT00658372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048902|NCT00658372|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25048903|NCT00658372|Antidepressive Agents|antidepressive agents|mesh-ancestor
25824094|NCT00004921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25824095|NCT00004922|Irinotecan|irinotecan|mesh-list
24644051|NCT01188759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24644052|NCT01188759|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24644053|NCT01188759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25824096|NCT00004922|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25000405|NCT05343013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25000413|NCT05404919|Tenofovir|tenofovir|mesh-list
25000414|NCT05404919|Entecavir|entecavir|mesh-list
25000415|NCT05404919|Immunoglobulins|immunoglobulins|mesh-list
25000416|NCT05404919|Antibodies|antibodies|mesh-list
25000421|NCT05404919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25000422|NCT05404919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24841725|NCT02217683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644054|NCT01188759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644055|NCT01188759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644056|NCT01188759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24644057|NCT01188759|Hormone Antagonists|hormone antagonists|mesh-ancestor
24644058|NCT01188759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25824097|NCT00004922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25000423|NCT05404919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25000426|NCT05404919|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25038632|NCT04806386|Cathartics|cathartics|mesh-ancestor
25038633|NCT04806386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25038634|NCT04779554|Mitomycins|mitomycins|mesh-list
24707766|NCT01497574|Insulin|insulin|mesh-list
25038635|NCT04779554|Mitomycin|mitomycin|mesh-list
24822100|NCT02109861|Bortezomib|bortezomib|mesh-list
25038636|NCT04779554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25038638|NCT04779554|Alkylating Agents|alkylating agents|mesh-ancestor
25000511|NCT04344678|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25000512|NCT04344678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25000513|NCT04344678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25000514|NCT04344678|Urological Agents|urological agents|mesh-ancestor
25000523|NCT04311463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25000524|NCT04311463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25000525|NCT04311463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25000526|NCT04311463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000527|NCT04311463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25000528|NCT04311463|Serotonin Agents|serotonin agents|mesh-ancestor
25000529|NCT04311463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000583|NCT04175509|Sensory System Agents|sensory system agents|mesh-ancestor
25824098|NCT00004922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824099|NCT00004922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202633|NCT02720367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25202634|NCT02720367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202635|NCT02720367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25202636|NCT02720367|Immunologic Factors|immunologic factors|mesh-ancestor
24644098|NCT01189006|Dextromethorphan|dextromethorphan|mesh-list
24644099|NCT01189006|Antitussive Agents|antitussive agents|mesh-ancestor
24644100|NCT01189006|Respiratory System Agents|respiratory system agents|mesh-ancestor
24644101|NCT01189006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24644150|NCT01189448|Spiramycin|spiramycin|mesh-list
24644151|NCT01189448|Antimalarials|antimalarials|mesh-ancestor
24644152|NCT01189448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25000699|NCT03781440|Anesthetics|anesthetics|mesh-ancestor
25000896|NCT05462938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000949|NCT05462548|Immunologic Factors|immunologic factors|mesh-ancestor
25000950|NCT05462548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000952|NCT05462535|Amlodipine|amlodipine|mesh-list
25000953|NCT05462535|Chlorthalidone|chlorthalidone|mesh-list
25000954|NCT05462535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25000955|NCT05462535|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25000956|NCT05462535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25000957|NCT05462535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000958|NCT05462535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25000959|NCT05462535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000960|NCT05462535|Vasodilator Agents|vasodilator agents|mesh-ancestor
25000961|NCT05462535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25000962|NCT05462535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25000963|NCT05462535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25000997|NCT05461833|Octylonium|octylonium|mesh-list
24696312|NCT01428531|PENTA|penta|mesh-list
25000998|NCT05461833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25000999|NCT05461833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25001000|NCT05461833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25001001|NCT05461833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25001002|NCT05461833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25001008|NCT05461833|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25001009|NCT05461833|Cholinergic Agents|cholinergic agents|mesh-ancestor
25001010|NCT05461833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24938895|NCT04015661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938897|NCT04015375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24938898|NCT04015375|Antimalarials|antimalarials|mesh-ancestor
25001088|NCT05461261|Methylprednisolone|methylprednisolone|mesh-list
25001090|NCT05461261|Prednisolone acetate|prednisolone acetate|mesh-list
25001111|NCT05461235|Pembrolizumab|pembrolizumab|mesh-list
25001112|NCT05461235|Nivolumab|nivolumab|mesh-list
24945726|NCT03948178|Simendan|simendan|mesh-list
25048981|NCT00650832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048982|NCT00650832|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25048983|NCT00650832|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25048984|NCT00650832|Antiviral Agents|antiviral agents|mesh-ancestor
25048985|NCT00650832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25001393|NCT05342584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25001394|NCT05342584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25001396|NCT05342584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25001397|NCT05342584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25001398|NCT05342584|Immunologic Factors|immunologic factors|mesh-ancestor
25001399|NCT05342584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25001400|NCT05342584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25001401|NCT05342584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25001402|NCT05342584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24939371|NCT04010942|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24939372|NCT04010942|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24709124|NCT01504139|Progestins|progestins|mesh-ancestor
24939374|NCT04010903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24939375|NCT04010903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764018|NCT01779206|Tubulin Modulators|tubulin modulators|mesh-ancestor
24798497|NCT01963910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798498|NCT01963962|Copper|copper|mesh-list
25049098|NCT00635505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25001759|NCT05117476|Pembrolizumab|pembrolizumab|mesh-list
25001760|NCT05117476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25001761|NCT05117476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25001779|NCT05084508|Vaccines|vaccines|mesh-list
25001780|NCT05084508|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24709458|NCT01505894|BI 409306|bi 409306|mesh-list
25001781|NCT05084508|Immunologic Factors|immunologic factors|mesh-ancestor
25001892|NCT05002933|Insulin Glargine|insulin glargine|mesh-list
25001893|NCT05002933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25001894|NCT05002933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202656|NCT02720341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202657|NCT02719756|Metformin|metformin|mesh-list
25202658|NCT02719756|Dapagliflozin|dapagliflozin|mesh-list
25202659|NCT02719756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25202660|NCT02719756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202661|NCT02719756|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25824100|NCT00004922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824101|NCT00004923|Docetaxel|docetaxel|mesh-list
25824102|NCT00004923|Irinotecan|irinotecan|mesh-list
25824103|NCT00004923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824104|NCT00004923|Tubulin Modulators|tubulin modulators|mesh-ancestor
25824105|NCT00004923|Antimitotic Agents|antimitotic agents|mesh-ancestor
25049194|NCT00630201|Analgesics|analgesics|mesh-ancestor
25049195|NCT00630201|Sensory System Agents|sensory system agents|mesh-ancestor
24709861|NCT01507389|Liraglutide|liraglutide|mesh-list
25202662|NCT02719756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202663|NCT02719795|Ropivacaine|ropivacaine|mesh-list
25202664|NCT02719795|Anesthetics, Local|anesthetics, local|mesh-ancestor
25202665|NCT02719795|Anesthetics|anesthetics|mesh-ancestor
25202666|NCT02719795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25202667|NCT02719795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202668|NCT02719795|Sensory System Agents|sensory system agents|mesh-ancestor
25202669|NCT02719795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202670|NCT02719834|Acetaminophen|acetaminophen|mesh-list
25824106|NCT00004923|Mitosis Modulators|mitosis modulators|mesh-ancestor
25001985|NCT04950764|Seladelpar|seladelpar|mesh-list
25001987|NCT04950764|Antimetabolites|antimetabolites|mesh-ancestor
24644830|NCT01193400|Antiviral Agents|antiviral agents|mesh-ancestor
24644831|NCT01193400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24644852|NCT01193465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644854|NCT01193478|Antiviral Agents|antiviral agents|mesh-ancestor
25824107|NCT00004923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049196|NCT00630201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25049198|NCT00629980|Azithromycin|azithromycin|mesh-list
25049199|NCT00629980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25049200|NCT00629980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25049201|NCT00629941|Azithromycin|azithromycin|mesh-list
25049202|NCT00629941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25049203|NCT00629941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25049204|NCT00629590|Azithromycin|azithromycin|mesh-list
25049205|NCT00629590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25049206|NCT00629590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25049207|NCT00629551|Paroxetine|paroxetine|mesh-list
25049208|NCT00629551|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25049209|NCT00629551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24644938|NCT01194037|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24644940|NCT01194037|Antiviral Agents|antiviral agents|mesh-ancestor
24644941|NCT01194037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25049219|NCT00629551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25049220|NCT00629551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049221|NCT00626704|Doxorubicin|doxorubicin|mesh-list
24645019|NCT01194791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24645020|NCT01194791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24645021|NCT01194791|Growth Substances|growth substances|mesh-ancestor
24645022|NCT01194791|Growth Inhibitors|growth inhibitors|mesh-ancestor
25824108|NCT00004923|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24645024|NCT01194843|Anesthetics, Local|anesthetics, local|mesh-ancestor
24645025|NCT01194843|Anesthetics|anesthetics|mesh-ancestor
24645026|NCT01194843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24645027|NCT01194843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645028|NCT01194843|Sensory System Agents|sensory system agents|mesh-ancestor
25202672|NCT02719834|Analgesics|analgesics|mesh-ancestor
24645071|NCT01195428|Simvastatin|simvastatin|mesh-list
24645072|NCT01195428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25002235|NCT04796922|Rituximab|rituximab|mesh-list
25002236|NCT04796922|Obinutuzumab|obinutuzumab|mesh-list
25002237|NCT04796922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25002255|NCT04780321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843678|NCT02228772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24645139|NCT01196169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24645140|NCT01196208|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24645141|NCT01196208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24645142|NCT01196208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24645240|NCT01196767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24645241|NCT01196767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645242|NCT01196767|Sensory System Agents|sensory system agents|mesh-ancestor
24645243|NCT01196767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24645244|NCT01197001|Losartan|losartan|mesh-list
24645245|NCT01197001|Amlodipine|amlodipine|mesh-list
24645246|NCT01197001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24668668|NCT04650542|Serotonin Agents|serotonin agents|mesh-ancestor
25049256|NCT00625664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25049257|NCT00625664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25049258|NCT00625664|Antimetabolites|antimetabolites|mesh-ancestor
25049259|NCT00625664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049260|NCT00625664|Antiviral Agents|antiviral agents|mesh-ancestor
24645339|NCT01197664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645340|NCT01197781|Verapamil|verapamil|mesh-list
24645344|NCT01197781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645345|NCT01197781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24645398|NCT01198210|Dexamethasone acetate|dexamethasone acetate|mesh-list
24645399|NCT01198210|Ketamine|ketamine|mesh-list
24645400|NCT01198210|BB 1101|bb 1101|mesh-list
24645401|NCT01198210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24940053|NCT04004117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940054|NCT04004117|Analgesics|analgesics|mesh-ancestor
24940055|NCT04004117|Sensory System Agents|sensory system agents|mesh-ancestor
24940056|NCT04004117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24843856|NCT02229786|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24979921|NCT04971954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645531|NCT01198496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24645533|NCT01198496|Diuretics|diuretics|mesh-ancestor
24645590|NCT01198821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24645591|NCT01198821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824109|NCT00004923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25824110|NCT00004923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824111|NCT00004924|Paclitaxel|paclitaxel|mesh-list
25824112|NCT00004924|Irinotecan|irinotecan|mesh-list
25824113|NCT00004924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25824114|NCT00004924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824115|NCT00004924|Tubulin Modulators|tubulin modulators|mesh-ancestor
24645698|NCT01199406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24449929|NCT00317408|Vitamins|vitamins|mesh-ancestor
24645699|NCT01199406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645700|NCT01199406|Sensory System Agents|sensory system agents|mesh-ancestor
24645701|NCT01199406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24645702|NCT01199432|Cyclophosphamide|cyclophosphamide|mesh-list
24645704|NCT01199432|Epirubicin|epirubicin|mesh-list
24645705|NCT01199432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24645706|NCT01199432|Immunologic Factors|immunologic factors|mesh-ancestor
25002793|NCT04313959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25002794|NCT04313959|Anesthetics, Local|anesthetics, local|mesh-ancestor
25002795|NCT04313959|Anesthetics|anesthetics|mesh-ancestor
25002796|NCT04313959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25002797|NCT04313959|Sensory System Agents|sensory system agents|mesh-ancestor
25002798|NCT04300296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25002799|NCT04300296|Immunologic Factors|immunologic factors|mesh-ancestor
25002800|NCT04300296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646206|NCT01202474|Insulin glulisine|insulin glulisine|mesh-list
24646207|NCT01202474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24646208|NCT01202474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646209|NCT01202487|Lidocaine|lidocaine|mesh-list
24646210|NCT01202487|Epinephrine|epinephrine|mesh-list
24646211|NCT01202487|Tetracaine|tetracaine|mesh-list
24646212|NCT01202487|Anesthetics, Local|anesthetics, local|mesh-ancestor
24646213|NCT01202487|Anesthetics|anesthetics|mesh-ancestor
24646231|NCT01202487|Respiratory System Agents|respiratory system agents|mesh-ancestor
24646232|NCT01202487|Mydriatics|mydriatics|mesh-ancestor
24646276|NCT01202890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24646277|NCT01202890|Growth Substances|growth substances|mesh-ancestor
24646278|NCT01202890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646279|NCT01202890|Growth Inhibitors|growth inhibitors|mesh-ancestor
24646280|NCT01202890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24646281|NCT01202890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24646282|NCT01202890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24646283|NCT01202890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646284|NCT01202890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646285|NCT01202890|Immunologic Factors|immunologic factors|mesh-ancestor
24646565|NCT01204307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646566|NCT01204307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646567|NCT01204307|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24646568|NCT01204307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24646577|NCT01204333|Heparin|heparin|mesh-list
24646612|NCT01204437|Methotrexate|methotrexate|mesh-list
24646613|NCT01204437|Epirubicin|epirubicin|mesh-list
24646614|NCT01204437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24646615|NCT01204437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24646616|NCT01204437|Tubulin Modulators|tubulin modulators|mesh-ancestor
24646617|NCT01204437|Antimitotic Agents|antimitotic agents|mesh-ancestor
25002933|NCT04191616|Antiemetics|antiemetics|mesh-ancestor
25002934|NCT04191616|Autonomic Agents|autonomic agents|mesh-ancestor
24826492|NCT02134626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24844338|NCT02232360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24844339|NCT02232360|Antimetabolites|antimetabolites|mesh-ancestor
24844340|NCT02232360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646618|NCT01204437|Mitosis Modulators|mitosis modulators|mesh-ancestor
24646659|NCT01204476|Octreotide|octreotide|mesh-list
25002999|NCT04124614|Brexpiprazole|brexpiprazole|mesh-list
24940590|NCT03999866|Keratolytic Agents|keratolytic agents|mesh-ancestor
24940591|NCT03999866|Dermatologic Agents|dermatologic agents|mesh-ancestor
24940592|NCT03999775|Calcium, Dietary|calcium, dietary|mesh-list
24940593|NCT03999775|Vitamin D|vitamin d|mesh-list
24940594|NCT03999775|Ergocalciferols|ergocalciferols|mesh-list
24940595|NCT03999775|Cholecalciferol|cholecalciferol|mesh-list
24940596|NCT03999775|Vitamins|vitamins|mesh-list
24940597|NCT03999775|Calcium|calcium|mesh-list
24940598|NCT03999775|Micronutrients|micronutrients|mesh-ancestor
25647194|NCT01466790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647195|NCT01466790|Antiviral Agents|antiviral agents|mesh-ancestor
25647196|NCT01466790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25647197|NCT01466790|Protease Inhibitors|protease inhibitors|mesh-ancestor
25647198|NCT01466790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646660|NCT01204476|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24646661|NCT01204476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24646662|NCT01204476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24646663|NCT01204476|Immunologic Factors|immunologic factors|mesh-ancestor
24646664|NCT01204476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798611|NCT01964287|Immunologic Factors|immunologic factors|mesh-ancestor
24798612|NCT01964287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646700|NCT01204840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646701|NCT01204996|Gemcitabine|gemcitabine|mesh-list
24646702|NCT01204996|Paclitaxel|paclitaxel|mesh-list
24646763|NCT01205074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24646764|NCT01205074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24646765|NCT01205074|Adrenergic Agents|adrenergic agents|mesh-ancestor
24646766|NCT01205074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24646868|NCT01205282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25003093|NCT04032665|Antithrombins|antithrombins|mesh-ancestor
24647093|NCT01206205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24647094|NCT01206205|Growth Substances|growth substances|mesh-ancestor
24647095|NCT01206205|Growth Inhibitors|growth inhibitors|mesh-ancestor
24647096|NCT01206205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25003437|NCT03703271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24647239|NCT01207128|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24798681|NCT01964573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798682|NCT01964573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798685|NCT01964586|Racepinephrine|racepinephrine|mesh-list
24798686|NCT01964586|Dexmedetomidine|dexmedetomidine|mesh-list
24798687|NCT01964586|Epinephryl borate|epinephryl borate|mesh-list
24798688|NCT01964586|Anesthetics, Local|anesthetics, local|mesh-ancestor
24798689|NCT01964586|Anesthetics|anesthetics|mesh-ancestor
24798690|NCT01964586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25824116|NCT00004924|Antimitotic Agents|antimitotic agents|mesh-ancestor
24647448|NCT01208818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24647449|NCT01208818|Protease Inhibitors|protease inhibitors|mesh-ancestor
24647450|NCT01208818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24647452|NCT01208935|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24647462|NCT01209026|Xhance|xhance|mesh-list
24647473|NCT01209026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24647474|NCT01209026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24647475|NCT01209026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24647476|NCT01209026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24647477|NCT01209026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24647478|NCT01209026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24647479|NCT01209026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647480|NCT01209026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647527|NCT01209351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24647528|NCT01209351|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24647529|NCT01209351|Protective Agents|protective agents|mesh-ancestor
24647530|NCT01209351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647566|NCT01209455|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
24647567|NCT01209455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24647568|NCT01209455|Analgesics|analgesics|mesh-ancestor
24647569|NCT01209455|Sensory System Agents|sensory system agents|mesh-ancestor
24647572|NCT01209455|Antipyretics|antipyretics|mesh-ancestor
24941238|NCT03993236|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24941239|NCT03993236|Ezetimibe|ezetimibe|mesh-list
24941251|NCT03992937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24941252|NCT03992937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941253|NCT03992937|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24941254|NCT03992937|Contraceptive Agents|contraceptive agents|mesh-ancestor
24941255|NCT03992937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24941256|NCT03992937|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24941257|NCT03992937|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25049418|NCT00609323|Sensory System Agents|sensory system agents|mesh-ancestor
25049425|NCT00607256|Reboxetine|reboxetine|mesh-list
25824117|NCT00004924|Mitosis Modulators|mitosis modulators|mesh-ancestor
25049523|NCT00595699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049524|NCT00595699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25049525|NCT00595699|Antidepressive Agents|antidepressive agents|mesh-ancestor
25049526|NCT00595699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24777748|NCT01866397|Cidofovir|cidofovir|mesh-list
25004140|NCT02591953|Methylprednisolone|methylprednisolone|mesh-list
25004141|NCT02591953|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25004142|NCT02591953|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25004143|NCT02591953|Prednisolone|prednisolone|mesh-list
25004144|NCT02591953|Prednisolone acetate|prednisolone acetate|mesh-list
25004145|NCT02591953|Lidocaine|lidocaine|mesh-list
25004146|NCT02591953|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25004147|NCT02591953|Prednisolone phosphate|prednisolone phosphate|mesh-list
25004148|NCT02591953|Anesthetics, Local|anesthetics, local|mesh-ancestor
25004149|NCT02591953|Anesthetics|anesthetics|mesh-ancestor
25004150|NCT02591953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25049532|NCT00594984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25049533|NCT00594984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049534|NCT00594984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049535|NCT00594984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25049536|NCT00594984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25049537|NCT00589875|Valacyclovir|valacyclovir|mesh-list
25049538|NCT00589875|Antiviral Agents|antiviral agents|mesh-ancestor
25049539|NCT00589875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24648511|NCT01215136|Everolimus|everolimus|mesh-list
25049541|NCT00589823|Morphine|morphine|mesh-list
25049542|NCT00589823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25049543|NCT00589823|Narcotics|narcotics|mesh-ancestor
25049544|NCT00589823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25049545|NCT00589823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004313|NCT02151981|Osimertinib|osimertinib|mesh-list
25004314|NCT02151981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25004330|NCT02059499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25028122|NCT03613597|Etoposide|etoposide|mesh-list
24845987|NCT02240433|Sorafenib|sorafenib|mesh-list
24648619|NCT01216020|Cetuximab|cetuximab|mesh-list
25824118|NCT00004924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824119|NCT00004924|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25824120|NCT00004924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24648620|NCT01216020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648621|NCT01216020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24648622|NCT01216046|Ivacaftor|ivacaftor|mesh-list
24648623|NCT01216046|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25004461|NCT01142284|Cilostazol|cilostazol|mesh-list
24648731|NCT01216605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24648732|NCT01216605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648733|NCT01216644|Leucovorin|leucovorin|mesh-list
24648734|NCT01216644|Docetaxel|docetaxel|mesh-list
25824121|NCT00004924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648747|NCT01216644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648748|NCT01216644|Antidotes|antidotes|mesh-ancestor
24648749|NCT01216644|Protective Agents|protective agents|mesh-ancestor
24648750|NCT01216644|Vitamin B Complex|vitamin b complex|mesh-ancestor
24648751|NCT01216644|Vitamins|vitamins|mesh-ancestor
24592661|NCT00923663|Immunologic Factors|immunologic factors|mesh-ancestor
24592662|NCT00923663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592663|NCT00923663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24592664|NCT00923663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24648936|NCT01217580|Ropivacaine|ropivacaine|mesh-list
25824122|NCT00004925|Doxorubicin|doxorubicin|mesh-list
25824123|NCT00004925|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24650183|NCT01224457|GABA Modulators|gaba modulators|mesh-ancestor
24651078|NCT01229241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24651079|NCT01229241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651080|NCT01229241|Sensory System Agents|sensory system agents|mesh-ancestor
24651081|NCT01229241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24651082|NCT01229280|Darifenacin|darifenacin|mesh-list
25824124|NCT00004925|Trastuzumab|trastuzumab|mesh-list
24651408|NCT01231490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24651409|NCT01231490|Gout Suppressants|gout suppressants|mesh-ancestor
24652051|NCT01235416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24652164|NCT01236716|Antimetabolites|antimetabolites|mesh-ancestor
24652826|NCT01240265|Vitamins|vitamins|mesh-list
24653010|NCT01241409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24653150|NCT01242215|Immunologic Factors|immunologic factors|mesh-ancestor
24846732|NCT02243566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24653948|NCT01246362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24654027|NCT01246921|Fluticasone|fluticasone|mesh-list
25647199|NCT01467076|Alprostadil|alprostadil|mesh-list
24654028|NCT01246921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24654042|NCT01247077|Trace Elements|trace elements|mesh-ancestor
24654078|NCT01247493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25169612|NCT01792050|Paclitaxel|paclitaxel|mesh-list
24654079|NCT01247493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24654080|NCT01247493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24654081|NCT01247493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24654082|NCT01247493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24846802|NCT02244086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24846804|NCT02244112|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24625768|NCT01083407|Chlorhexidine|chlorhexidine|mesh-list
24654648|NCT01250652|Dermatologic Agents|dermatologic agents|mesh-ancestor
24654650|NCT01250743|Ascorbic Acid|ascorbic acid|mesh-list
24654651|NCT01250743|Micronutrients|micronutrients|mesh-ancestor
25824125|NCT00004925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24799059|NCT01966822|Protease Inhibitors|protease inhibitors|mesh-list
24654896|NCT01251991|Psyllium|psyllium|mesh-list
24655147|NCT01254617|Cetuximab|cetuximab|mesh-list
24655148|NCT01254617|Lenalidomide|lenalidomide|mesh-list
24655149|NCT01254617|Antibodies|antibodies|mesh-list
24946558|NCT03937687|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24946751|NCT03935152|Dydrogesterone|dydrogesterone|mesh-list
24946752|NCT03935152|Progestins|progestins|mesh-ancestor
24946753|NCT03935152|Hormones|hormones|mesh-ancestor
25049678|NCT00578955|Hormones|hormones|mesh-ancestor
24946754|NCT03935152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24946755|NCT03935152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946756|NCT03935139|Glycerol|glycerol|mesh-list
24718325|NCT01553942|Pemetrexed|pemetrexed|mesh-list
24718326|NCT01553942|Afatinib|afatinib|mesh-list
24946757|NCT03935139|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24846986|NCT02244515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24774681|NCT01847326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24655543|NCT01257139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655544|NCT01257139|Tubulin Modulators|tubulin modulators|mesh-ancestor
24847013|NCT02244632|Immunologic Factors|immunologic factors|mesh-ancestor
24655705|NCT00077285|Ifosfamide|ifosfamide|mesh-list
24655813|NCT01258296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24655817|NCT01258309|Ketorolac|ketorolac|mesh-list
24656426|NCT01261689|Dsuvia|dsuvia|mesh-list
24656436|NCT01261689|Analgesics|analgesics|mesh-ancestor
24659556|NCT01278459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24659700|NCT01279291|Antiviral Agents|antiviral agents|mesh-ancestor
24659701|NCT01279291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24659702|NCT01279291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24659703|NCT01279291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24659704|NCT01279291|Immunologic Factors|immunologic factors|mesh-ancestor
24659705|NCT01279291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659709|NCT01279434|Vitamins|vitamins|mesh-list
24660263|NCT01282515|Clobetasol|clobetasol|mesh-list
24661636|NCT01290211|Ritonavir|ritonavir|mesh-list
24799918|NCT01971918|Immunologic Factors|immunologic factors|mesh-ancestor
24800012|NCT01972828|Plasma Substitutes|plasma substitutes|mesh-ancestor
24663191|NCT01299181|Atorvastatin|atorvastatin|mesh-list
24663192|NCT01299181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25049942|NCT00553657|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25049943|NCT00553657|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25049944|NCT00553657|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25049945|NCT00553657|Cholinergic Agents|cholinergic agents|mesh-ancestor
24951450|NCT03904732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24663961|NCT01304316|Anesthetics|anesthetics|mesh-ancestor
24800219|NCT01974024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24800220|NCT01974024|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24800221|NCT01974024|Protective Agents|protective agents|mesh-ancestor
24800223|NCT01974024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24664872|NCT01309074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24664873|NCT01309074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24664874|NCT01309074|Antidepressive Agents|antidepressive agents|mesh-ancestor
25050028|NCT00544960|Tubulin Modulators|tubulin modulators|mesh-ancestor
25050029|NCT00544960|Antimitotic Agents|antimitotic agents|mesh-ancestor
25050030|NCT00544960|Mitosis Modulators|mitosis modulators|mesh-ancestor
25647201|NCT01467076|Vasodilator Agents|vasodilator agents|mesh-ancestor
25647202|NCT01467076|Urological Agents|urological agents|mesh-ancestor
25050031|NCT00544960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050033|NCT00544466|Fludarabine phosphate|fludarabine phosphate|mesh-list
25050034|NCT00544466|Melphalan|melphalan|mesh-list
25647203|NCT01467479|Interferons|interferons|mesh-list
25647204|NCT01467479|Ribavirin|ribavirin|mesh-list
25647205|NCT01467479|Interferon-alpha|interferon-alpha|mesh-list
25647206|NCT01467479|Interferon alpha-2|interferon alpha-2|mesh-list
25647207|NCT01467479|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25647208|NCT01467479|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25647211|NCT01467479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25647212|NCT01467479|Antimetabolites|antimetabolites|mesh-ancestor
25647213|NCT01467479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050035|NCT00544466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824126|NCT00004925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665417|NCT01312298|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
24665418|NCT01312298|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25647214|NCT01467479|Immunologic Factors|immunologic factors|mesh-ancestor
24665419|NCT01312298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24665420|NCT01312311|Docetaxel|docetaxel|mesh-list
24665421|NCT01312311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665422|NCT01312311|Tubulin Modulators|tubulin modulators|mesh-ancestor
24665423|NCT01312311|Antimitotic Agents|antimitotic agents|mesh-ancestor
24935611|NCT04048655|Cholinergic Agents|cholinergic agents|mesh-ancestor
24935612|NCT04048655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24935613|NCT04048655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935614|NCT04048655|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24935616|NCT04048655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24935618|NCT04048707|Midodrine|midodrine|mesh-list
24935619|NCT04048707|Angiotensin II|angiotensin ii|mesh-list
24935620|NCT04048707|Giapreza|giapreza|mesh-list
24935621|NCT04048707|Angiotensinogen|angiotensinogen|mesh-list
24935622|NCT04048707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24935623|NCT04048707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24935624|NCT04048707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665635|NCT01313819|Amantadine|amantadine|mesh-list
25824127|NCT00004925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24666428|NCT01319240|Incretins|incretins|mesh-ancestor
24666429|NCT01319240|Hormones|hormones|mesh-ancestor
24829909|NCT02155374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24952258|NCT03895788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24849597|NCT02249234|Cholinergic Agents|cholinergic agents|mesh-ancestor
24666439|NCT01319266|Antitussive Agents|antitussive agents|mesh-ancestor
24666440|NCT01319266|Respiratory System Agents|respiratory system agents|mesh-ancestor
24666444|NCT01319279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24452307|NCT00327106|Tranexamic Acid|tranexamic acid|mesh-list
24666445|NCT01319279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666446|NCT01319279|Analgesics|analgesics|mesh-ancestor
24666447|NCT01319279|Sensory System Agents|sensory system agents|mesh-ancestor
24935893|NCT04047004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935894|NCT04047004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24935895|NCT04047004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24935896|NCT04047004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24935897|NCT04047004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666808|NCT01321034|Niacin|niacin|mesh-list
24935971|NCT04045678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24667302|NCT05459649|Cyclosporine|cyclosporine|mesh-list
24667304|NCT05459649|Cyclosporins|cyclosporins|mesh-list
24667305|NCT05459649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24667306|NCT05459649|Glucocorticoids|glucocorticoids|mesh-ancestor
24667307|NCT05459649|Hormones|hormones|mesh-ancestor
24667363|NCT05455697|Rituximab|rituximab|mesh-list
24667364|NCT05455697|Doxorubicin|doxorubicin|mesh-list
24667365|NCT05455697|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24667366|NCT05455697|Vincristine|vincristine|mesh-list
24667367|NCT05455697|Daunorubicin|daunorubicin|mesh-list
25824128|NCT00004925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24936043|NCT04044976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24668331|NCT04948697|Bevacizumab|bevacizumab|mesh-list
24668332|NCT04948697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24668333|NCT04948697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24668334|NCT04948697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24668335|NCT04948697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24668336|NCT04948697|Growth Substances|growth substances|mesh-ancestor
24936084|NCT04044417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24668359|NCT04936763|Viscosupplements|viscosupplements|mesh-ancestor
25824129|NCT00004925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24686528|NCT04745299|Riluzole|riluzole|mesh-list
25824130|NCT00004925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824131|NCT00004925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25824132|NCT00004926|Vitamin D|vitamin d|mesh-list
25647215|NCT01467479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647216|NCT01467492|Interferons|interferons|mesh-list
25647217|NCT01467492|Ribavirin|ribavirin|mesh-list
25647218|NCT01467492|Interferon-alpha|interferon-alpha|mesh-list
25647220|NCT01467492|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25647221|NCT01467492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647222|NCT01467492|Antiviral Agents|antiviral agents|mesh-ancestor
25647223|NCT01467492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25824133|NCT00004926|Cholecalciferol|cholecalciferol|mesh-list
25824134|NCT00004926|Ro 23-7553|ro 23-7553|mesh-list
25824135|NCT00004926|Vitamins|vitamins|mesh-ancestor
24936161|NCT04043520|Hormones|hormones|mesh-ancestor
25824136|NCT00004926|Micronutrients|micronutrients|mesh-ancestor
25824137|NCT00004926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850332|NCT02252770|Nitric Oxide|nitric oxide|mesh-list
24615978|NCT01033318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25202773|NCT02718976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25202774|NCT02718976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25202775|NCT02718976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25202776|NCT02718976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202777|NCT02718976|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25202778|NCT02718976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25202779|NCT02718976|Adrenergic Agents|adrenergic agents|mesh-ancestor
25202780|NCT02718976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25202781|NCT02718976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25824138|NCT00004926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24937889|NCT04024527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24937890|NCT04024527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24937891|NCT04024527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24937892|NCT04024527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24937893|NCT04024527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937904|NCT04024384|Daratumumab|daratumumab|mesh-list
24937905|NCT04024384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24937906|NCT04024241|Cytarabine|cytarabine|mesh-list
25824139|NCT00004926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24937962|NCT04023630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24937963|NCT04023630|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24937964|NCT04023630|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25824140|NCT00004926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824141|NCT00004928|Zoledronic Acid|zoledronic acid|mesh-list
24535201|NCT00648778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535203|NCT00648791|Finasteride|finasteride|mesh-list
24851731|NCT02258620|Isosorbide|isosorbide|mesh-list
24938362|NCT04019548|Cisplatin|cisplatin|mesh-list
24938568|NCT04017741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938569|NCT04017741|Sensory System Agents|sensory system agents|mesh-ancestor
24938570|NCT04017741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24938571|NCT04017741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25824142|NCT00004928|Calcitriol|calcitriol|mesh-list
24728183|NCT01614431|Acetylcysteine|acetylcysteine|mesh-list
24536414|NCT00651235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24536415|NCT00651235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25050405|NCT00508989|Vitamins|vitamins|mesh-ancestor
25824143|NCT00004928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25824144|NCT00004928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824145|NCT00004928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25824146|NCT00004928|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25824147|NCT00004928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24536929|NCT00652886|Oxandrolone|oxandrolone|mesh-list
24728816|NCT01618474|Capecitabine|capecitabine|mesh-list
24942190|NCT03983460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24536930|NCT00652886|Androgens|androgens|mesh-ancestor
24536931|NCT00652886|Hormones|hormones|mesh-ancestor
25824148|NCT00004928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517093|NCT00605930|Niacin|niacin|mesh-list
25824149|NCT00004928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25824150|NCT00004928|Vitamins|vitamins|mesh-ancestor
25824151|NCT00004928|Micronutrients|micronutrients|mesh-ancestor
25824152|NCT00004930|Doxorubicin|doxorubicin|mesh-list
25824153|NCT00004930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25824154|NCT00004930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25050486|NCT00491738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24955144|NCT03867994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824155|NCT00004930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824156|NCT00004930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25824157|NCT00004930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25824158|NCT00004930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25647224|NCT01467492|Antimetabolites|antimetabolites|mesh-ancestor
25647225|NCT01467492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647226|NCT01467492|Immunologic Factors|immunologic factors|mesh-ancestor
25647227|NCT01467492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539046|NCT00661973|Glucocorticoids|glucocorticoids|mesh-ancestor
24539047|NCT00661973|Hormones|hormones|mesh-ancestor
25647228|NCT01467505|Interferons|interferons|mesh-list
25647229|NCT01467505|Ribavirin|ribavirin|mesh-list
25647230|NCT01467505|Interferon-alpha|interferon-alpha|mesh-list
25647231|NCT01467505|Interferon alpha-2|interferon alpha-2|mesh-list
25647232|NCT01467505|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24539048|NCT00661973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25824159|NCT00004930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443713|NCT00295893|Doxorubicin|doxorubicin|mesh-list
25824160|NCT00004931|Leucovorin|leucovorin|mesh-list
25824161|NCT00004931|Fluorouracil|fluorouracil|mesh-list
25824162|NCT00004931|Oxaliplatin|oxaliplatin|mesh-list
25824163|NCT00004931|Calcium|calcium|mesh-list
24539398|NCT00663689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24539399|NCT00663689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539400|NCT00663689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539401|NCT00663728|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24539402|NCT00663728|Vasodilator Agents|vasodilator agents|mesh-ancestor
24539403|NCT00663728|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24539404|NCT00663728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25824164|NCT00004931|Levoleucovorin|levoleucovorin|mesh-list
24539969|NCT00666068|Hormones|hormones|mesh-list
24764106|NCT01779401|Protective Agents|protective agents|mesh-ancestor
24764107|NCT01779401|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24764108|NCT01779401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24764109|NCT01779466|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24540119|NCT00666692|Paclitaxel|paclitaxel|mesh-list
24540120|NCT00666692|Bevacizumab|bevacizumab|mesh-list
24444921|NCT00299676|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24444922|NCT00299676|Autonomic Agents|autonomic agents|mesh-ancestor
25824165|NCT00004931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25824166|NCT00004931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824167|NCT00004931|Antimetabolites|antimetabolites|mesh-ancestor
25824168|NCT00004931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824169|NCT00004931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24939537|NCT04008966|Progestins|progestins|mesh-ancestor
25824170|NCT00004931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824171|NCT00004931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24543508|NCT00683995|Anesthetics|anesthetics|mesh-ancestor
24543830|NCT00685607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544127|NCT00687388|Sensory System Agents|sensory system agents|mesh-ancestor
24544128|NCT00687388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24447070|NCT00307307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447071|NCT00307411|Hormones|hormones|mesh-list
24544157|NCT00687648|Exemestane|exemestane|mesh-list
25824172|NCT00004931|Immunologic Factors|immunologic factors|mesh-ancestor
25824173|NCT00004931|Antidotes|antidotes|mesh-ancestor
25824174|NCT00004931|Protective Agents|protective agents|mesh-ancestor
25824175|NCT00004931|Vitamin B Complex|vitamin b complex|mesh-ancestor
25824176|NCT00004931|Vitamins|vitamins|mesh-ancestor
25824177|NCT00004931|Micronutrients|micronutrients|mesh-ancestor
24544247|NCT00688077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24544248|NCT00688077|Vasodilator Agents|vasodilator agents|mesh-ancestor
25824178|NCT00004932|Imatinib Mesylate|imatinib mesylate|mesh-list
25824179|NCT00004932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824180|NCT00004932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25824181|NCT00004932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824182|NCT00004932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824183|NCT00004933|Hydroxyurea|hydroxyurea|mesh-list
25824184|NCT00004933|Homoharringtonine|homoharringtonine|mesh-list
25824185|NCT00004933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824186|NCT00004933|Antisickling Agents|antisickling agents|mesh-ancestor
25824187|NCT00004933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824188|NCT00004933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824189|NCT00004933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24545193|NCT00692328|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24545194|NCT00692328|Dopamine Agents|dopamine agents|mesh-ancestor
25824190|NCT00004933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24446655|NCT00305552|Immunologic Factors|immunologic factors|mesh-ancestor
24446656|NCT00305552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647233|NCT01467505|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25647234|NCT01467505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746612|NCT04765514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24546419|NCT00698269|Insulin Detemir|insulin detemir|mesh-list
24546854|NCT00700765|Insulin Detemir|insulin detemir|mesh-list
24546855|NCT00700765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24547212|NCT00702975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24547213|NCT00702975|Growth Substances|growth substances|mesh-ancestor
24547214|NCT00702975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547220|NCT00703066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547222|NCT00703079|Lanreotide|lanreotide|mesh-list
24547223|NCT00703079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24547264|NCT00703300|Decitabine|decitabine|mesh-list
25824191|NCT00004933|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24547784|NCT00705692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24547785|NCT00705692|Immunologic Factors|immunologic factors|mesh-ancestor
25824192|NCT00004934|Paclitaxel|paclitaxel|mesh-list
25824193|NCT00004934|Carboplatin|carboplatin|mesh-list
25824194|NCT00004934|Epirubicin|epirubicin|mesh-list
25824195|NCT00004934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25824196|NCT00004934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824197|NCT00004934|Tubulin Modulators|tubulin modulators|mesh-ancestor
24827429|NCT02138994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24827430|NCT02138994|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24827432|NCT02139098|Zolpidem|zolpidem|mesh-list
24716898|NCT01544517|Renal Agents|renal agents|mesh-ancestor
25824198|NCT00004934|Antimitotic Agents|antimitotic agents|mesh-ancestor
25824199|NCT00004934|Mitosis Modulators|mitosis modulators|mesh-ancestor
24680842|NCT01376271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824200|NCT00004934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824201|NCT00004934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25824202|NCT00004934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25824203|NCT00004934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25824204|NCT00004934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824205|NCT00004938|Fluconazole|fluconazole|mesh-list
25824206|NCT00004938|Antifungal Agents|antifungal agents|mesh-ancestor
25824207|NCT00004938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25824208|NCT00004938|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25824209|NCT00004938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25824210|NCT00004938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824211|NCT00004938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824212|NCT00004938|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25824213|NCT00004938|Hormone Antagonists|hormone antagonists|mesh-ancestor
25824214|NCT00004938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25824215|NCT00004938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824216|NCT00004938|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25824217|NCT00004938|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25824218|NCT00004941|Infliximab|infliximab|mesh-list
25824219|NCT00004941|Antibodies|antibodies|mesh-list
25824220|NCT00004941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25824221|NCT00004941|Immunologic Factors|immunologic factors|mesh-ancestor
25824222|NCT00004941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824223|NCT00004941|Dermatologic Agents|dermatologic agents|mesh-ancestor
25824224|NCT00004941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25824225|NCT00004941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25824226|NCT00004979|Paclitaxel|paclitaxel|mesh-list
25824227|NCT00004979|Topotecan|topotecan|mesh-list
25824228|NCT00004979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25824229|NCT00004979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824230|NCT00004979|Tubulin Modulators|tubulin modulators|mesh-ancestor
25267640|NCT02422121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25824231|NCT00004979|Antimitotic Agents|antimitotic agents|mesh-ancestor
25824232|NCT00004979|Mitosis Modulators|mitosis modulators|mesh-ancestor
25824233|NCT00004979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684814|NCT03982693|Anticoagulants|anticoagulants|mesh-ancestor
25824234|NCT00004979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25824235|NCT00004979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25824236|NCT00004979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824237|NCT00004981|Lamivudine|lamivudine|mesh-list
25824238|NCT00004981|Zidovudine|zidovudine|mesh-list
25824239|NCT00004981|Abacavir|abacavir|mesh-list
25824240|NCT00004981|Dideoxynucleosides|dideoxynucleosides|mesh-list
25824241|NCT00004981|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25824242|NCT00004981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25824243|NCT00004981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24827994|NCT02142595|GABA Agents|gaba agents|mesh-ancestor
24828182|NCT02143934|Primaquine|primaquine|mesh-list
24828422|NCT02145559|Sirolimus|sirolimus|mesh-list
25267860|NCT02419820|APD791|apd791|mesh-list
25824249|NCT00004981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25824250|NCT00004981|Antimetabolites|antimetabolites|mesh-ancestor
25268058|NCT02417896|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25268059|NCT02417896|Hormone Antagonists|hormone antagonists|mesh-ancestor
25824251|NCT00004984|Insulin|insulin|mesh-list
25824252|NCT00004984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25824253|NCT00004984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25824254|NCT00004984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824255|NCT00004985|Nelfinavir|nelfinavir|mesh-list
25824256|NCT00004985|Capravirine|capravirine|mesh-list
24829498|NCT02152787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739058|NCT01678963|Growth Inhibitors|growth inhibitors|mesh-ancestor
25824257|NCT00004985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25824258|NCT00004985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25824259|NCT00004985|Protease Inhibitors|protease inhibitors|mesh-ancestor
25824260|NCT00004985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824261|NCT00004985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824262|NCT00004985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25824263|NCT00004985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25824264|NCT00004985|Antiviral Agents|antiviral agents|mesh-ancestor
25824265|NCT00004985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25824266|NCT00004985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25824267|NCT00004985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25824268|NCT00004986|Nitazoxanide|nitazoxanide|mesh-list
25824269|NCT00004986|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25824270|NCT00004986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24829602|NCT02153281|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24739725|NCT01683682|Nintedanib|nintedanib|mesh-list
24705869|NCT01487278|Misoprostol|misoprostol|mesh-list
25268164|NCT02417207|Entecavir|entecavir|mesh-list
24448751|NCT00313001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24448752|NCT00313001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448754|NCT00313001|Incretins|incretins|mesh-ancestor
25268201|NCT02416752|Remifentanil|remifentanil|mesh-list
25268202|NCT02416752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25268203|NCT02416752|Narcotics|narcotics|mesh-ancestor
25268204|NCT02416752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25268205|NCT02416752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451959|NCT00325455|Anacetrapib|anacetrapib|mesh-list
24741012|NCT01691001|Adrenergic Agents|adrenergic agents|mesh-ancestor
25824271|NCT00004990|Dexamethasone|dexamethasone|mesh-list
25050713|NCT00472693|Bevacizumab|bevacizumab|mesh-list
24741177|NCT01692483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24741180|NCT01692678|Dacarbazine|dacarbazine|mesh-list
25268268|NCT02416427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268269|NCT02416427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25268270|NCT02416427|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25268271|NCT02416427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24741684|NCT05290337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824272|NCT00004990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25824273|NCT00004990|Antiemetics|antiemetics|mesh-ancestor
24830289|NCT02158221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25824274|NCT00004990|Autonomic Agents|autonomic agents|mesh-ancestor
25268364|NCT02416141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25169977|NCT01712451|Xhance|xhance|mesh-list
25647235|NCT01467505|Antiviral Agents|antiviral agents|mesh-ancestor
25268369|NCT02416167|Dotinurad|dotinurad|mesh-list
25268370|NCT02416167|Uricosuric Agents|uricosuric agents|mesh-ancestor
25268371|NCT02416167|Gout Suppressants|gout suppressants|mesh-ancestor
25824275|NCT00004990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25824276|NCT00004990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824277|NCT00004990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25824278|NCT00004990|Glucocorticoids|glucocorticoids|mesh-ancestor
25824279|NCT00004990|Hormones|hormones|mesh-ancestor
25824280|NCT00004990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25824281|NCT00004990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24830587|NCT02160132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268400|NCT02416063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25268415|NCT02416128|Hormones|hormones|mesh-ancestor
25824282|NCT00004990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824283|NCT00004992|Metformin|metformin|mesh-list
25824284|NCT00004992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25824285|NCT00004992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824286|NCT00004993|Hormones|hormones|mesh-list
25824287|NCT00004993|Parathyroid Hormone|parathyroid hormone|mesh-list
25268458|NCT02415803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25268459|NCT02415803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25268460|NCT02415803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25268461|NCT02415803|Purinergic Agents|purinergic agents|mesh-ancestor
24464615|NCT00365612|Efavirenz|efavirenz|mesh-list
24464616|NCT00365612|Antiviral Agents|antiviral agents|mesh-ancestor
25824288|NCT00004993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25824289|NCT00004993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824290|NCT00004993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25824291|NCT00004997|Leucovorin|leucovorin|mesh-list
24449038|NCT00313963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449039|NCT00313963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24449041|NCT00313963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25824292|NCT00004997|Antidotes|antidotes|mesh-ancestor
25824293|NCT00004997|Protective Agents|protective agents|mesh-ancestor
25824294|NCT00004997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824295|NCT00004997|Vitamin B Complex|vitamin b complex|mesh-ancestor
25824296|NCT00004997|Vitamins|vitamins|mesh-ancestor
24745026|NCT04022200|Tubulin Modulators|tubulin modulators|mesh-ancestor
24745027|NCT04022200|Antimitotic Agents|antimitotic agents|mesh-ancestor
24745028|NCT04022200|Mitosis Modulators|mitosis modulators|mesh-ancestor
25824297|NCT00004997|Micronutrients|micronutrients|mesh-ancestor
25824298|NCT00004998|Lamivudine|lamivudine|mesh-list
25824299|NCT00004998|Zidovudine|zidovudine|mesh-list
25824300|NCT00004998|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
24463095|NCT00358683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24463097|NCT00358683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824301|NCT00004998|Capravirine|capravirine|mesh-list
25824302|NCT00004998|Nelfinavir|nelfinavir|mesh-list
25824303|NCT00004998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25824304|NCT00004998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25824305|NCT00004998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824306|NCT00004998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824307|NCT00004998|Antiviral Agents|antiviral agents|mesh-ancestor
25824308|NCT00004998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25824309|NCT00004998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25824310|NCT00004998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24830910|NCT02162121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24695916|NCT01426334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24410218|NCT00184899|Heparin|heparin|mesh-list
25824311|NCT00004998|Antimetabolites|antimetabolites|mesh-ancestor
25268621|NCT02414880|Rocuronium|rocuronium|mesh-list
25268622|NCT02414880|Neostigmine|neostigmine|mesh-list
24777746|NCT01866267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24777747|NCT01866267|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24777749|NCT01866397|Antiviral Agents|antiviral agents|mesh-ancestor
24777780|NCT01866553|Immunologic Factors|immunologic factors|mesh-ancestor
24778044|NCT01868802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25169613|NCT01792050|Docetaxel|docetaxel|mesh-list
25169683|NCT01780844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169685|NCT01780844|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25169741|NCT01777555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169742|NCT01777555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169743|NCT01776606|Botulinum Toxins|botulinum toxins|mesh-list
25169744|NCT01776606|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25824312|NCT00004998|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24457996|NCT00336167|Bezafibrate|bezafibrate|mesh-list
25169810|NCT01756924|Fusidic Acid|fusidic acid|mesh-list
25169811|NCT01756924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25169812|NCT01756924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25169813|NCT01756924|Antitubercular Agents|antitubercular agents|mesh-ancestor
25169814|NCT01756924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24746611|NCT04765514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779138|NCT01874002|Immunologic Factors|immunologic factors|mesh-ancestor
24779139|NCT01874002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779211|NCT01874717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25170045|NCT01697072|Cisplatin|cisplatin|mesh-list
25105819|NCT04860635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105820|NCT04852367|Doxorubicin|doxorubicin|mesh-list
25105821|NCT04852367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25105822|NCT04852367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105823|NCT04852367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25105824|NCT04852367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25105825|NCT04852367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25105826|NCT04852367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105827|NCT04850495|Prednisone|prednisone|mesh-list
25040726|NCT02920008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25040727|NCT02918019|Astegolimab|astegolimab|mesh-list
25040728|NCT02918019|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25824313|NCT00004998|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24420057|NCT00215046|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24420058|NCT00215046|Abortifacient Agents|abortifacient agents|mesh-ancestor
24420059|NCT00215046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25824314|NCT00004998|Protease Inhibitors|protease inhibitors|mesh-ancestor
25824315|NCT00004999|Lamivudine|lamivudine|mesh-list
25041578|NCT01621243|Gemcitabine|gemcitabine|mesh-list
24420353|NCT00215722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420354|NCT00215748|Dexamethasone|dexamethasone|mesh-list
24420355|NCT00215748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24420356|NCT00215748|Antiemetics|antiemetics|mesh-ancestor
24420362|NCT00215748|Hormones|hormones|mesh-ancestor
24420781|NCT00216775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25041799|NCT01581203|Antiviral Agents|antiviral agents|mesh-ancestor
24978813|NCT02774265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24978814|NCT02774265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24421188|NCT00218101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24421190|NCT00218101|Analgesics|analgesics|mesh-ancestor
24421194|NCT00218114|Valproic Acid|valproic acid|mesh-list
25824316|NCT00004999|Zidovudine|zidovudine|mesh-list
25041955|NCT01535508|Vitamin D|vitamin d|mesh-list
24978864|NCT02652468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24978866|NCT02652468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978867|NCT02652468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978868|NCT02652468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24978869|NCT02652468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24978870|NCT02652468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24458721|NCT00339014|Dopamine Agents|dopamine agents|mesh-ancestor
24422127|NCT00221442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422128|NCT00221442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24422129|NCT00221442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422130|NCT00221468|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24422131|NCT00221468|Antidepressive Agents|antidepressive agents|mesh-ancestor
25824317|NCT00004999|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
24422191|NCT00221598|Dialysis Solutions|dialysis solutions|mesh-list
24978923|NCT02393248|Trastuzumab|trastuzumab|mesh-list
24978924|NCT02393248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042136|NCT01497834|Asunaprevir|asunaprevir|mesh-list
24422287|NCT00221962|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24422288|NCT00221962|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24422289|NCT00221962|Serotonin Agents|serotonin agents|mesh-ancestor
24422290|NCT00221962|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24422306|NCT00221975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24422307|NCT00221975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25647236|NCT01467505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24422308|NCT00221975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24422310|NCT00221975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24422441|NCT00222495|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24422442|NCT00222495|Dopamine Agents|dopamine agents|mesh-ancestor
25105900|NCT04771923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25105901|NCT04771923|Autonomic Agents|autonomic agents|mesh-ancestor
24422740|NCT00223691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24422741|NCT00223691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24422996|NCT00224393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24535476|NCT00649207|Veliparib|veliparib|mesh-list
24979009|NCT01807182|Interleukin-2|interleukin-2|mesh-list
24423047|NCT00224510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24423074|NCT00224549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24423075|NCT00224549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24423077|NCT00224588|Analgesics|analgesics|mesh-ancestor
24423078|NCT00224588|Sensory System Agents|sensory system agents|mesh-ancestor
24423094|NCT00224679|Aspirin|aspirin|mesh-list
24423103|NCT00224679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24423104|NCT00224679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25042545|NCT01421056|Flurbiprofen|flurbiprofen|mesh-list
24423187|NCT00225043|Adrenergic Agents|adrenergic agents|mesh-ancestor
24979043|NCT01688076|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25042618|NCT01408082|BB 1101|bb 1101|mesh-list
25824318|NCT00004999|Capravirine|capravirine|mesh-list
25824319|NCT00004999|Nelfinavir|nelfinavir|mesh-list
25824320|NCT00004999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25824321|NCT00004999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25824322|NCT00004999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824323|NCT00004999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824324|NCT00004999|Antiviral Agents|antiviral agents|mesh-ancestor
24423328|NCT00225511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24423329|NCT00225511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621220|NCT01061112|Fluconazole|fluconazole|mesh-list
24621221|NCT01061112|Ketoprofen|ketoprofen|mesh-list
24979246|NCT05064332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24979251|NCT05034029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979252|NCT04966325|Moxifloxacin|moxifloxacin|mesh-list
24979253|NCT04966325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24979254|NCT04966325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24979267|NCT04936984|Abaloparatide|abaloparatide|mesh-list
25824325|NCT00004999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24424725|NCT00230490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24424727|NCT00230503|Pradefovir|pradefovir|mesh-list
24424728|NCT00230503|Antiviral Agents|antiviral agents|mesh-ancestor
24424729|NCT00230503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24424730|NCT00230503|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24424731|NCT00230503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24979299|NCT04812951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25824326|NCT00004999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24426390|NCT00235937|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24416190|NCT00202280|Vitamin B Complex|vitamin b complex|mesh-ancestor
24426829|NCT00236717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24426831|NCT00236717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24426887|NCT00236795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25824327|NCT00004999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24426960|NCT00236912|Renal Agents|renal agents|mesh-ancestor
24427497|NCT00238277|Temozolomide|temozolomide|mesh-list
24427498|NCT00238277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24427499|NCT00238277|Alkylating Agents|alkylating agents|mesh-ancestor
24427500|NCT00238277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979378|NCT04596657|Vitamin D|vitamin d|mesh-list
24979379|NCT04596657|Vitamins|vitamins|mesh-ancestor
24427503|NCT00238290|Letrozole|letrozole|mesh-list
24979419|NCT04454424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979420|NCT04454424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24428017|NCT00239421|Cholinergic Agents|cholinergic agents|mesh-ancestor
24428043|NCT00239447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25040925|NCT02736149|Ubenimex|ubenimex|mesh-list
25824328|NCT00004999|Antimetabolites|antimetabolites|mesh-ancestor
24430018|NCT00245908|Azithromycin|azithromycin|mesh-list
24431439|NCT00251706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24431440|NCT00251732|Antidepressive Agents|antidepressive agents|mesh-list
24431441|NCT00251732|Nortriptyline|nortriptyline|mesh-list
24433049|NCT00257387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040962|NCT02733432|Hormone Antagonists|hormone antagonists|mesh-ancestor
24433886|NCT00260364|Antiviral Agents|antiviral agents|mesh-ancestor
24433887|NCT00260364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25044150|NCT01133990|Bevacizumab|bevacizumab|mesh-list
24436336|NCT00269763|Fentanyl|fentanyl|mesh-list
25170160|NCT01677754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24436863|NCT00271635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044372|NCT01110746|Insulin|insulin|mesh-list
25824329|NCT00004999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24437232|NCT00273026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24437233|NCT00273026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24437234|NCT00273026|Adrenergic Agents|adrenergic agents|mesh-ancestor
24437243|NCT00273039|Serotonin Agents|serotonin agents|mesh-ancestor
25824330|NCT00004999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25824331|NCT00004999|Protease Inhibitors|protease inhibitors|mesh-ancestor
24979935|NCT04933383|Respiratory System Agents|respiratory system agents|mesh-ancestor
24979936|NCT04933383|Glucocorticoids|glucocorticoids|mesh-ancestor
24979937|NCT04933383|Hormones|hormones|mesh-ancestor
24437529|NCT00273962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437530|NCT00273962|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24437531|NCT00273962|Cholinergic Agents|cholinergic agents|mesh-ancestor
24437532|NCT00273975|Lamivudine|lamivudine|mesh-list
24437533|NCT00273975|Zidovudine|zidovudine|mesh-list
24437534|NCT00273975|Nevirapine|nevirapine|mesh-list
24843472|NCT02227823|Bromides|bromides|mesh-list
24646136|NCT01202097|Hormones|hormones|mesh-ancestor
25824332|NCT00005000|Lamivudine|lamivudine|mesh-list
24439114|NCT00277602|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24439115|NCT00277602|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25041008|NCT02700529|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25824333|NCT00005000|Zidovudine|zidovudine|mesh-list
25824334|NCT00005000|Efavirenz|efavirenz|mesh-list
25824335|NCT00005000|Stavudine|stavudine|mesh-list
24440046|NCT00281567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24980099|NCT05441761|Dexamethasone|dexamethasone|mesh-list
24440812|NCT00284921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24440813|NCT00284921|Antitubercular Agents|antitubercular agents|mesh-ancestor
24440814|NCT00284921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24440815|NCT00284921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24440816|NCT00284921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045067|NCT01001715|Fasinumab|fasinumab|mesh-list
24441778|NCT00288353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24441779|NCT00288353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441780|NCT00288353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24441781|NCT00288353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24441782|NCT00288353|Serotonin Agents|serotonin agents|mesh-ancestor
24441783|NCT00288353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24647611|NCT01209715|Hormones|hormones|mesh-ancestor
25824336|NCT00005000|Didanosine|didanosine|mesh-list
25824337|NCT00005000|Nelfinavir|nelfinavir|mesh-list
25041058|NCT02664558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25824338|NCT00005000|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
25824339|NCT00005000|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25824340|NCT00005000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25824341|NCT00005000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824342|NCT00005000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041086|NCT02654990|Antiemetics|antiemetics|mesh-ancestor
25824343|NCT00005000|Antiviral Agents|antiviral agents|mesh-ancestor
25824344|NCT00005000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25824345|NCT00005000|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25824346|NCT00005000|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25824347|NCT00005000|Antimetabolites|antimetabolites|mesh-ancestor
25041087|NCT02654990|Autonomic Agents|autonomic agents|mesh-ancestor
25824348|NCT00005000|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25824349|NCT00005000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25824350|NCT00005000|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25824351|NCT00005000|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24783961|NCT01905059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24980501|NCT05224089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980503|NCT05224089|Anesthetics|anesthetics|mesh-ancestor
25041120|NCT02638805|Exenatide|exenatide|mesh-list
24980532|NCT05199324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24458896|NCT00343096|Lorazepam|lorazepam|mesh-list
25046233|NCT00862524|Gemcitabine|gemcitabine|mesh-list
24859119|NCT02301806|Hormones|hormones|mesh-ancestor
25647237|NCT01467505|Antimetabolites|antimetabolites|mesh-ancestor
25647238|NCT01467505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647239|NCT01467505|Immunologic Factors|immunologic factors|mesh-ancestor
25647240|NCT01467505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647241|NCT01467583|PENTA|penta|mesh-list
25647242|NCT01467583|Fondaparinux|fondaparinux|mesh-list
25647243|NCT01467583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25647244|NCT01467583|Antithrombins|antithrombins|mesh-ancestor
25170203|NCT01661634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25170204|NCT01661634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170205|NCT01661634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25170206|NCT01661634|Respiratory System Agents|respiratory system agents|mesh-ancestor
25170208|NCT01661634|Natriuretic Agents|natriuretic agents|mesh-ancestor
25170209|NCT01661166|Fesoterodine|fesoterodine|mesh-list
25170217|NCT01660633|Melphalan|melphalan|mesh-list
25824352|NCT00005000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25824353|NCT00005000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25041121|NCT02638805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24859248|NCT02302547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24980694|NCT05024214|Growth Inhibitors|growth inhibitors|mesh-ancestor
24980695|NCT05024214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25041122|NCT02638805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041123|NCT02638805|Incretins|incretins|mesh-ancestor
25041124|NCT02638805|Hormones|hormones|mesh-ancestor
25041125|NCT02638805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25041126|NCT02638805|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25824354|NCT00005000|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25824355|NCT00005000|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25824356|NCT00005000|Protease Inhibitors|protease inhibitors|mesh-ancestor
25824357|NCT00005000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25824358|NCT00005000|Immunologic Factors|immunologic factors|mesh-ancestor
25824359|NCT00005000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824360|NCT00005002|Lamivudine|lamivudine|mesh-list
25824361|NCT00005002|Zidovudine|zidovudine|mesh-list
25824362|NCT00005002|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
24980775|NCT04945616|Sensory System Agents|sensory system agents|mesh-ancestor
25824363|NCT00005002|Nelfinavir|nelfinavir|mesh-list
25824364|NCT00005002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25824365|NCT00005002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25824366|NCT00005002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824367|NCT00005002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824368|NCT00005002|Antiviral Agents|antiviral agents|mesh-ancestor
25824369|NCT00005002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25824370|NCT00005002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25046798|NCT00835614|Cefprozil|cefprozil|mesh-list
24783987|NCT01905150|Antimetabolites|antimetabolites|mesh-ancestor
25041136|NCT02626338|Cytarabine|cytarabine|mesh-list
25046946|NCT00834873|Carvedilol|carvedilol|mesh-list
24860154|NCT02307721|Naloxone|naloxone|mesh-list
24448495|NCT00312000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25824371|NCT00005002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25824372|NCT00005002|Antimetabolites|antimetabolites|mesh-ancestor
25824373|NCT00005002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25824374|NCT00005002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25824375|NCT00005002|Protease Inhibitors|protease inhibitors|mesh-ancestor
25824376|NCT00005005|Alendronate|alendronate|mesh-list
25824377|NCT00005005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25824378|NCT00005005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824379|NCT00005006|Alendronate|alendronate|mesh-list
25824380|NCT00005006|Teriparatide|teriparatide|mesh-list
25824381|NCT00005006|Hormones|hormones|mesh-list
25041137|NCT02626338|Fludarabine|fludarabine|mesh-list
24981216|NCT04278846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981218|NCT04278846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24981219|NCT04263922|Valsartan|valsartan|mesh-list
24981220|NCT04263922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24981221|NCT04263922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24981222|NCT04263922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25824382|NCT00005006|Parathyroid Hormone|parathyroid hormone|mesh-list
25824383|NCT00005006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25824384|NCT00005006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824385|NCT00005006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25824386|NCT00005006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25824387|NCT00005007|Etanercept|etanercept|mesh-list
24682550|NCT01386671|Metformin|metformin|mesh-list
25647245|NCT01467583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25647246|NCT01467583|Protease Inhibitors|protease inhibitors|mesh-ancestor
25647247|NCT01467583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25647248|NCT01467583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647249|NCT01467583|Anticoagulants|anticoagulants|mesh-ancestor
25647250|NCT01467583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25647251|NCT01467583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25647252|NCT01467661|Anagrelide|anagrelide|mesh-list
25106150|NCT04346108|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25106151|NCT04346108|Immunoglobulin G|immunoglobulin g|mesh-list
25106152|NCT04346108|Immunologic Factors|immunologic factors|mesh-ancestor
24477711|NCT00419731|Dopamine Agents|dopamine agents|mesh-ancestor
25047487|NCT00807612|Tubulin Modulators|tubulin modulators|mesh-ancestor
24981235|NCT04216017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24981236|NCT04216017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24981237|NCT04216017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24981238|NCT04216017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24981239|NCT04216017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981240|NCT04216017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25047573|NCT00791154|Etoposide|etoposide|mesh-list
25047643|NCT00774761|Xhance|xhance|mesh-list
25824395|NCT00005007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25824396|NCT00005007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25824397|NCT00005007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25824398|NCT00005007|Immunologic Factors|immunologic factors|mesh-ancestor
25829469|NCT00006214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25829470|NCT00006214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829471|NCT00006214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25829472|NCT00006214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829473|NCT00006215|Docetaxel|docetaxel|mesh-list
25829474|NCT00006215|Vinorelbine|vinorelbine|mesh-list
25829475|NCT00006215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829476|NCT00006215|Tubulin Modulators|tubulin modulators|mesh-ancestor
25829477|NCT00006215|Antimitotic Agents|antimitotic agents|mesh-ancestor
25829478|NCT00006215|Mitosis Modulators|mitosis modulators|mesh-ancestor
25829479|NCT00006215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829480|NCT00006215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24981774|NCT01832402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25829481|NCT00006216|Ganciclovir|ganciclovir|mesh-list
24784094|NCT01906073|Morphine|morphine|mesh-list
24784095|NCT01906073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24784096|NCT01906073|Narcotics|narcotics|mesh-ancestor
24784118|NCT01906242|Eusol|eusol|mesh-list
24982027|NCT04447846|Cannabidiol|cannabidiol|mesh-list
25829482|NCT00006216|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25048471|NCT00694928|Clindamycin|clindamycin|mesh-list
25829483|NCT00006216|Antiviral Agents|antiviral agents|mesh-ancestor
25829484|NCT00006216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25829485|NCT00006216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25829486|NCT00006216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829487|NCT00006216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795730|NCT00075946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24795731|NCT00075946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795732|NCT00075946|Immunologic Factors|immunologic factors|mesh-ancestor
24795733|NCT00075946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795734|NCT00075946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24795736|NCT00003641|Interferon-alpha|interferon-alpha|mesh-list
25829488|NCT00006219|Clarithromycin|clarithromycin|mesh-list
24982550|NCT02308527|Alkylating Agents|alkylating agents|mesh-ancestor
24444625|NCT00298662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24444626|NCT00298662|Antiviral Agents|antiviral agents|mesh-ancestor
24444627|NCT00298662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24444628|NCT00298662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24444629|NCT00298662|Immunologic Factors|immunologic factors|mesh-ancestor
25829489|NCT00006219|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25203668|NCT02712957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25203669|NCT02712957|Gout Suppressants|gout suppressants|mesh-ancestor
25203670|NCT02712957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25203671|NCT02712957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203672|NCT02712957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203673|NCT02712944|Testosterone|testosterone|mesh-list
25203674|NCT02712944|Androgens|androgens|mesh-ancestor
25203675|NCT02712944|Hormones|hormones|mesh-ancestor
25203678|NCT02712866|Vedolizumab|vedolizumab|mesh-list
25824399|NCT00005009|Vaccines|vaccines|mesh-list
25824400|NCT00005009|Immunologic Factors|immunologic factors|mesh-ancestor
24828967|NCT02148783|Methylphenidate|methylphenidate|mesh-list
24983021|NCT00092573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24983022|NCT00092560|Ezetimibe|ezetimibe|mesh-list
24983023|NCT00092560|Fenofibrate|fenofibrate|mesh-list
24983024|NCT00092560|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25041271|NCT02591199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25824401|NCT00005009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824402|NCT00005010|Irbesartan|irbesartan|mesh-list
25824403|NCT00005010|Pravastatin|pravastatin|mesh-list
25106594|NCT02245672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24983214|NCT01857934|Analgesics|analgesics|mesh-ancestor
25041272|NCT02589275|Cyclobenzaprine|cyclobenzaprine|mesh-list
24784461|NCT01908075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24784462|NCT01908075|Sympathomimetics|sympathomimetics|mesh-ancestor
24784463|NCT01908114|Vaccines|vaccines|mesh-list
24784464|NCT01908114|Immunologic Factors|immunologic factors|mesh-ancestor
24784476|NCT01908257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784477|NCT01908257|Gout Suppressants|gout suppressants|mesh-ancestor
24784478|NCT01908257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24784479|NCT01908257|Uricosuric Agents|uricosuric agents|mesh-ancestor
25041273|NCT02589275|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24478585|NCT00423696|Irinotecan|irinotecan|mesh-list
25824404|NCT00005010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25824405|NCT00005010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25824406|NCT00005010|Antimetabolites|antimetabolites|mesh-ancestor
25824407|NCT00005010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824408|NCT00005010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25824409|NCT00005010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25824410|NCT00005010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824411|NCT00005010|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24784508|NCT01908322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445669|NCT00301990|Growth Substances|growth substances|mesh-ancestor
24445670|NCT00301990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445671|NCT00301990|Growth Inhibitors|growth inhibitors|mesh-ancestor
24445672|NCT00301990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24445724|NCT00302354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24847485|NCT02247362|Vaccines|vaccines|mesh-list
25824412|NCT00005010|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24983791|NCT05153772|Octreotide|octreotide|mesh-list
25041274|NCT02589275|Antidepressive Agents|antidepressive agents|mesh-ancestor
25041275|NCT02589275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25041276|NCT02589275|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25041277|NCT02589275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041278|NCT02589275|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25041280|NCT02589275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25824413|NCT00005010|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25824414|NCT00005012|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25824415|NCT00005012|Antiviral Agents|antiviral agents|mesh-ancestor
24983904|NCT05099107|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24983905|NCT05099107|Adrenergic Agents|adrenergic agents|mesh-ancestor
24983906|NCT05099107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24622888|NCT01069055|Acetaminophen|acetaminophen|mesh-list
25824416|NCT00005012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446237|NCT00304200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24446238|NCT00304200|Growth Substances|growth substances|mesh-ancestor
25647253|NCT01467661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25647254|NCT01467661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25647255|NCT01467661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647256|NCT01467661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25647257|NCT01467882|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25647258|NCT01467882|Luteolytic Agents|luteolytic agents|mesh-ancestor
25647259|NCT01467882|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25647260|NCT01467882|Contraceptive Agents|contraceptive agents|mesh-ancestor
24983970|NCT05031494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24747538|NCT00644228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24747539|NCT00644228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24446242|NCT00304200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446244|NCT00304213|Androgens|androgens|mesh-ancestor
24999892|NCT02884219|Ibuprofen|ibuprofen|mesh-list
24446400|NCT00304629|Nootropic Agents|nootropic agents|mesh-ancestor
25824417|NCT00005013|Sertraline|sertraline|mesh-list
24446452|NCT00304772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824418|NCT00005013|Antidepressive Agents|antidepressive agents|mesh-ancestor
25824419|NCT00005013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25048833|NCT00662740|Parasympatholytics|parasympatholytics|mesh-ancestor
24486021|NCT00455845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24784663|NCT01909830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784664|NCT01909830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24784665|NCT01909830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24784666|NCT01909843|Gontivimab|gontivimab|mesh-list
25106794|NCT03144843|Apatinib|apatinib|mesh-list
24984298|NCT04674020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984300|NCT04674020|Sensory System Agents|sensory system agents|mesh-ancestor
24984301|NCT04674020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24984302|NCT04674020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984303|NCT04667637|Edaravone|edaravone|mesh-list
24984596|NCT04356209|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24984597|NCT04356209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984598|NCT04352101|Citalopram|citalopram|mesh-list
24984599|NCT04352101|Bupropion|bupropion|mesh-list
24984600|NCT04352101|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24984601|NCT04352101|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24540172|NCT00666796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25000401|NCT05343013|Trifluridine|trifluridine|mesh-list
25000402|NCT05343013|Antimetabolites|antimetabolites|mesh-ancestor
25000403|NCT05343013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000404|NCT05343013|Antiviral Agents|antiviral agents|mesh-ancestor
24984726|NCT04163874|Pramlintide|pramlintide|mesh-list
25208332|NCT02643420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25000613|NCT04140396|Lidocaine|lidocaine|mesh-list
25048938|NCT00657501|Testosterone|testosterone|mesh-list
24984887|NCT03928158|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24984888|NCT03928158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984889|NCT03926052|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
24984890|NCT03926052|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24984891|NCT03926052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984905|NCT03924193|Dopamine Agents|dopamine agents|mesh-ancestor
25162533|NCT02904031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784769|NCT01910259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24784770|NCT01910259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24784772|NCT01910259|Protective Agents|protective agents|mesh-ancestor
25106913|NCT03143530|Ropivacaine|ropivacaine|mesh-list
25106914|NCT03143530|Anesthetics, Local|anesthetics, local|mesh-ancestor
25106915|NCT03143530|Anesthetics|anesthetics|mesh-ancestor
24860175|NCT02307864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25001038|NCT05461755|Dermatologic Agents|dermatologic agents|mesh-ancestor
24985064|NCT03711838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985065|NCT03711838|Protective Agents|protective agents|mesh-ancestor
24985066|NCT03711838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985067|NCT03711838|Antidotes|antidotes|mesh-ancestor
24985068|NCT03706898|Sofosbuvir|sofosbuvir|mesh-list
24985069|NCT03706898|Dolutegravir|dolutegravir|mesh-list
24985070|NCT03706898|Elsulfavirine|elsulfavirine|mesh-list
24985071|NCT03706898|Antiviral Agents|antiviral agents|mesh-ancestor
24985072|NCT03706898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24985073|NCT03706898|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25041291|NCT02580708|Trametinib|trametinib|mesh-list
25001415|NCT05335356|Ustekinumab|ustekinumab|mesh-list
24492696|NCT00487448|Idarubicin|idarubicin|mesh-list
24985299|NCT03513770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25647261|NCT01467882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25647262|NCT01467882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985300|NCT03513770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939373|NCT04010903|Insulin|insulin|mesh-list
25049169|NCT00631111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25647263|NCT01467882|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25647264|NCT01467882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25647265|NCT01467882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647266|NCT01467947|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
25170397|NCT01371630|Prednisone|prednisone|mesh-list
25170398|NCT01371630|Cyclophosphamide|cyclophosphamide|mesh-list
24412065|NCT00190762|Pemetrexed|pemetrexed|mesh-list
24939571|NCT04008888|Immunologic Factors|immunologic factors|mesh-ancestor
24939572|NCT04008888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24939573|NCT04008888|Alkylating Agents|alkylating agents|mesh-ancestor
24939574|NCT04008888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25001989|NCT04950764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25002074|NCT04929080|Antibodies|antibodies|mesh-list
24506353|NCT00544804|Lapatinib|lapatinib|mesh-list
25002273|NCT04752384|Tramadol|tramadol|mesh-list
25049231|NCT00626106|Exemestane|exemestane|mesh-list
25824420|NCT00005013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24510308|NCT00564200|Dexamethasone|dexamethasone|mesh-list
24496921|NCT00507221|Mitosis Modulators|mitosis modulators|mesh-ancestor
25824421|NCT00005013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24513368|NCT00580931|Niacin|niacin|mesh-list
25003181|NCT03959085|Vitamins|vitamins|mesh-ancestor
25049322|NCT00616811|Vildagliptin|vildagliptin|mesh-list
24798656|NCT01964404|Analgesics|analgesics|mesh-ancestor
25162866|NCT02901366|Dotinurad|dotinurad|mesh-list
25049343|NCT00616330|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25049344|NCT00616330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049347|NCT00616148|Cenobamate|cenobamate|mesh-list
25004007|NCT02826512|Niraparib|niraparib|mesh-list
25004008|NCT02826512|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25004009|NCT02826512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004011|NCT02826512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941617|NCT03989557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24941618|NCT03989557|Analgesics|analgesics|mesh-ancestor
25004419|NCT01773395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25004420|NCT01773395|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25004421|NCT01773395|Alkylating Agents|alkylating agents|mesh-ancestor
24941797|NCT03988036|Pertuzumab|pertuzumab|mesh-list
25049546|NCT00589823|Analgesics|analgesics|mesh-ancestor
24798822|NCT01965353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24988471|NCT02673151|Anticoagulants|anticoagulants|mesh-ancestor
25824422|NCT00005013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24988477|NCT02653092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24988478|NCT02653092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25824423|NCT00005013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824424|NCT00005013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25824425|NCT00005013|Serotonin Agents|serotonin agents|mesh-ancestor
25049655|NCT00579020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622204|NCT01065987|Adrenergic Agents|adrenergic agents|mesh-ancestor
24796908|NCT01953107|Trace Elements|trace elements|mesh-ancestor
24796909|NCT01953107|Micronutrients|micronutrients|mesh-ancestor
24796910|NCT01953107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796911|NCT01953120|Abatacept|abatacept|mesh-list
24796912|NCT01953120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24796913|NCT01953120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796914|NCT01953120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796917|NCT01953120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946291|NCT03941535|Vitamin K|vitamin k|mesh-list
24517745|NCT00609752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24811227|NCT02045849|Itraconazole|itraconazole|mesh-list
24863067|NCT03601455|Immunoglobulin G|immunoglobulin g|mesh-list
25824426|NCT00005013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824427|NCT00005014|Risperidone|risperidone|mesh-list
24517813|NCT00610077|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24517814|NCT00610077|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24517815|NCT00610103|Apomorphine|apomorphine|mesh-list
24517816|NCT00610103|Emetics|emetics|mesh-ancestor
24517817|NCT00610103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947375|NCT03929744|GABA Agents|gaba agents|mesh-ancestor
24989007|NCT05123820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24989008|NCT05123820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989009|NCT05123820|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24773963|NCT01843153|Ropivacaine|ropivacaine|mesh-list
25647267|NCT01467947|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25647268|NCT01467947|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25647269|NCT01467947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24518195|NCT05330273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455413|NCT01370486|Antioxidants|antioxidants|mesh-ancestor
24989159|NCT04473807|Sotalol|sotalol|mesh-list
25049681|NCT00578955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647270|NCT01467947|Immunologic Factors|immunologic factors|mesh-ancestor
25647271|NCT01467947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647272|NCT01467999|Guanfacine|guanfacine|mesh-list
25647273|NCT01467999|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24593223|NCT00927524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24989363|NCT05347316|Colchicine|colchicine|mesh-list
24863450|NCT04956302|Panobinostat|panobinostat|mesh-list
24863451|NCT04956302|Ichthammol|ichthammol|mesh-list
24521808|NCT04500158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24521809|NCT04500158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24950876|NCT03910556|Propofol|propofol|mesh-list
24405543|NCT00167583|Antifungal Agents|antifungal agents|mesh-ancestor
24561967|NCT00763893|Losartan|losartan|mesh-list
24820034|NCT02098499|Anesthetics, Local|anesthetics, local|mesh-ancestor
24989875|NCT04624958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989876|NCT04620252|Calcium, Dietary|calcium, dietary|mesh-list
24989929|NCT04585893|Rituximab|rituximab|mesh-list
24989930|NCT04585893|Etoposide|etoposide|mesh-list
24989931|NCT04585893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24863975|NCT02786537|Antimetabolites|antimetabolites|mesh-ancestor
24797155|NCT01954043|Rabeprazole|rabeprazole|mesh-list
24820499|NCT02099877|Fentanyl|fentanyl|mesh-list
24990249|NCT03382730|Disinfectants|disinfectants|mesh-ancestor
24409182|NCT00181220|GABA Agents|gaba agents|mesh-ancestor
24797181|NCT01954186|Oxytocin|oxytocin|mesh-list
24577551|NCT00844688|Gemcitabine|gemcitabine|mesh-list
24577552|NCT00844688|Sorafenib|sorafenib|mesh-list
24577553|NCT00844688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24577554|NCT00844688|Antimetabolites|antimetabolites|mesh-ancestor
24577557|NCT00844688|Antiviral Agents|antiviral agents|mesh-ancestor
24936070|NCT04044430|Nivolumab|nivolumab|mesh-list
24990764|NCT00783536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24936158|NCT04043520|Estradiol|estradiol|mesh-list
24410153|NCT00184795|Hormones|hormones|mesh-ancestor
24990801|NCT00511134|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24533278|NCT00642863|Vitamin D|vitamin d|mesh-list
24533279|NCT00642863|Vitamins|vitamins|mesh-list
24577045|NCT00841841|Acetaminophen|acetaminophen|mesh-list
24864743|NCT02741388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25824428|NCT00005014|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24864775|NCT02229136|Hormones|hormones|mesh-ancestor
24936398|NCT04040491|Lenalidomide|lenalidomide|mesh-list
24797282|NCT01955070|Ketamine|ketamine|mesh-list
24797288|NCT01955070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24797289|NCT01955070|Anesthetics, General|anesthetics, general|mesh-ancestor
24797290|NCT01955070|Anesthetics|anesthetics|mesh-ancestor
24797291|NCT01955070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24797293|NCT01955070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24936571|NCT04038853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24821258|NCT02104128|Bupropion|bupropion|mesh-list
25050232|NCT00529503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821426|NCT02105103|Insulin|insulin|mesh-list
24779170|NCT01874314|Moxifloxacin|moxifloxacin|mesh-list
24937279|NCT04030663|Papaverine|papaverine|mesh-list
24591951|NCT00919776|Hormones|hormones|mesh-ancestor
25824429|NCT00005014|Serotonin Agents|serotonin agents|mesh-ancestor
25824430|NCT00005014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25824431|NCT00005014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824432|NCT00005014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991589|NCT05123170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25824433|NCT00005014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25824434|NCT00005014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25824435|NCT00005014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24991621|NCT05105750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24785496|NCT01914744|Antiviral Agents|antiviral agents|mesh-ancestor
24412545|NCT00191581|Insulin|insulin|mesh-list
24785536|NCT01914965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779906|NCT01879527|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25824436|NCT00005014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25824437|NCT00005014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25824438|NCT00005014|Dopamine Agents|dopamine agents|mesh-ancestor
24414208|NCT00196599|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24992380|NCT03829891|Insulin Glargine|insulin glargine|mesh-list
25824439|NCT00005015|Fluoxetine|fluoxetine|mesh-list
25824440|NCT00005015|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24993217|NCT05200260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993505|NCT04518345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688650|NCT02810457|Paclitaxel|paclitaxel|mesh-list
25824441|NCT00005015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24955941|NCT03859375|Disinfectants|disinfectants|mesh-list
24417981|NCT00208260|Antidotes|antidotes|mesh-ancestor
24994018|NCT05037487|Dronabinol|dronabinol|mesh-list
24994079|NCT04930744|Pyrazinamide|pyrazinamide|mesh-list
24994145|NCT04829799|Ketorolac|ketorolac|mesh-list
24994146|NCT04829799|Lidocaine|lidocaine|mesh-list
24994147|NCT04829799|Phenylephrine|phenylephrine|mesh-list
25824443|NCT00005015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050563|NCT00486512|Antacids|antacids|mesh-ancestor
24994262|NCT04725695|Sensory System Agents|sensory system agents|mesh-ancestor
25824444|NCT00005015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25824445|NCT00005015|Serotonin Agents|serotonin agents|mesh-ancestor
25824446|NCT00005015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824447|NCT00005015|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25824448|NCT00005015|Antidepressive Agents|antidepressive agents|mesh-ancestor
24994330|NCT04565015|Immunologic Factors|immunologic factors|mesh-ancestor
24994334|NCT04535362|Autonomic Agents|autonomic agents|mesh-ancestor
25824449|NCT00005015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25824450|NCT00005015|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25824451|NCT00005015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25824452|NCT00005015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24994384|NCT04450212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994385|NCT04450212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24994386|NCT04450212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24994387|NCT04450212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956341|NCT03855267|Anesthetics|anesthetics|mesh-ancestor
25824453|NCT00005017|Ritonavir|ritonavir|mesh-list
25824454|NCT00005017|Amprenavir|amprenavir|mesh-list
25824455|NCT00005017|Lamivudine|lamivudine|mesh-list
25824456|NCT00005017|Abacavir|abacavir|mesh-list
24823084|NCT02114775|Hormones|hormones|mesh-list
25824457|NCT00005017|Stavudine|stavudine|mesh-list
24940364|NCT04002024|Dermatologic Agents|dermatologic agents|mesh-ancestor
24940366|NCT04002024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24419483|NCT00212186|Trace Elements|trace elements|mesh-ancestor
24785901|NCT01917058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24785902|NCT01917058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824458|NCT00005017|Efavirenz|efavirenz|mesh-list
25824459|NCT00005017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25824460|NCT00005017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25824461|NCT00005017|Protease Inhibitors|protease inhibitors|mesh-ancestor
25824462|NCT00005017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824463|NCT00005017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994500|NCT04022980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24994501|NCT04022980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797920|NCT01959074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797921|NCT01959074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24797936|NCT01959152|Imidacloprid|imidacloprid|mesh-list
24956632|NCT03852628|Naltrexone|naltrexone|mesh-list
24994796|NCT02684006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24994797|NCT02675465|Miglustat|miglustat|mesh-list
24602575|NCT00969566|Metformin|metformin|mesh-list
24622127|NCT01065701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24995172|NCT05417659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24995173|NCT05417659|Vasodilator Agents|vasodilator agents|mesh-ancestor
24995174|NCT05417659|Vitamin B Complex|vitamin b complex|mesh-ancestor
24995176|NCT05417659|Micronutrients|micronutrients|mesh-ancestor
24995177|NCT05417659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108061|NCT03134651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108062|NCT03134651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25108063|NCT03134651|Anesthetics, General|anesthetics, general|mesh-ancestor
25108064|NCT03134651|Anesthetics|anesthetics|mesh-ancestor
25108065|NCT03134638|Carboplatin|carboplatin|mesh-list
24786083|NCT01917877|Glucocorticoids|glucocorticoids|mesh-ancestor
24786085|NCT01917877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25108066|NCT03134638|Fulvestrant|fulvestrant|mesh-list
24995229|NCT05417165|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24941145|NCT03994692|Ether|ether|mesh-list
24418168|NCT00208819|Risperidone|risperidone|mesh-list
24798011|NCT01959477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798012|NCT01959477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647274|NCT01467999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24798013|NCT01959477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24798014|NCT01959477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24979922|NCT04959006|Antioxidants|antioxidants|mesh-list
25647275|NCT01467999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25647276|NCT01467999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25647277|NCT01467999|Adrenergic Agents|adrenergic agents|mesh-ancestor
25647278|NCT01467999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25647279|NCT01467999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647280|NCT01467999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781106|NCT01888042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621100|NCT01060683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621101|NCT01060683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24786763|NCT01921673|Docetaxel|docetaxel|mesh-list
24783254|NCT01900847|Sensory System Agents|sensory system agents|mesh-ancestor
24783255|NCT01900847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24783256|NCT01900847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783257|NCT01900847|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24783258|NCT01900847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24783259|NCT01900847|Anesthetics, General|anesthetics, general|mesh-ancestor
24783312|NCT01901003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24787030|NCT01923194|Hormones|hormones|mesh-ancestor
24920853|NCT04196946|Anesthetics|anesthetics|mesh-ancestor
24575874|NCT00834925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24575875|NCT00834925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575876|NCT00834925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24575877|NCT00834925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784008|NCT01905215|Immunologic Factors|immunologic factors|mesh-ancestor
25170544|NCT00585507|Fulvestrant|fulvestrant|mesh-list
25170545|NCT00585507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25170546|NCT00585507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170547|NCT00585507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24798015|NCT01959477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25824464|NCT00005017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25824465|NCT00005017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25824466|NCT00005017|Antiviral Agents|antiviral agents|mesh-ancestor
25824467|NCT00005017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25824468|NCT00005017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24604665|NCT00980850|Vaccines|vaccines|mesh-list
24957466|NCT03844529|Lidocaine|lidocaine|mesh-list
25824469|NCT00005017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25824470|NCT00005017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25824471|NCT00005017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25824472|NCT00005017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25824473|NCT00005017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24933401|NCT04071106|Betamethasone|betamethasone|mesh-list
24941436|NCT03991130|Nivolumab|nivolumab|mesh-list
24995556|NCT05071703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24995557|NCT05071703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24995558|NCT05071703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24995559|NCT05071703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24995560|NCT05071703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995561|NCT05071703|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24995562|NCT05053503|Lofexidine|lofexidine|mesh-list
24869704|NCT00563576|Estradiol|estradiol|mesh-list
24941555|NCT03989817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24941556|NCT03989817|Vasodilator Agents|vasodilator agents|mesh-ancestor
24941557|NCT03989817|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24941558|NCT03989817|Protective Agents|protective agents|mesh-ancestor
24941559|NCT03989817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957666|NCT03842800|Anesthetics|anesthetics|mesh-ancestor
25647281|NCT01468012|Levodopa|levodopa|mesh-list
25647282|NCT01468012|Carbidopa|carbidopa|mesh-list
25647283|NCT01468012|Entacapone|entacapone|mesh-list
24418311|NCT00209222|Vincristine|vincristine|mesh-list
25647284|NCT01468012|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25647285|NCT01468012|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25647286|NCT01468012|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25647287|NCT01468012|Dopamine Agents|dopamine agents|mesh-ancestor
25647288|NCT01468012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25647289|NCT01468012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647290|NCT01468012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647291|NCT01468012|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25647292|NCT01468012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25647293|NCT01468012|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25647294|NCT01468012|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25647295|NCT01468012|Immunologic Factors|immunologic factors|mesh-ancestor
25647296|NCT01468012|Dopamine Agonists|dopamine agonists|mesh-ancestor
25647297|NCT01468181|Dulaglutide|dulaglutide|mesh-list
25647298|NCT01468181|Biguanides|biguanides|mesh-list
25647299|NCT01468181|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
25647300|NCT01468181|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
25647301|NCT01468181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25647302|NCT01468181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647303|NCT01468181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24747945|NCT03012815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24747946|NCT03012815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24747947|NCT03012815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24747948|NCT03012815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24747949|NCT03012815|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24747950|NCT03012815|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24747951|NCT03012815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24747952|NCT03012815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24747968|NCT03006432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24747969|NCT03006432|Tubulin Modulators|tubulin modulators|mesh-ancestor
25170628|NCT00479765|Paclitaxel|paclitaxel|mesh-list
25170629|NCT00479765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25170630|NCT00479765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170631|NCT00479765|Tubulin Modulators|tubulin modulators|mesh-ancestor
25170632|NCT00479765|Antimitotic Agents|antimitotic agents|mesh-ancestor
25170633|NCT00479765|Mitosis Modulators|mitosis modulators|mesh-ancestor
25170634|NCT00479765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170644|NCT00373711|Iodine|iodine|mesh-list
25170645|NCT00373711|Cadexomer iodine|cadexomer iodine|mesh-list
25170646|NCT00373711|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25170647|NCT00373711|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25170648|NCT00373711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25170649|NCT00373711|Trace Elements|trace elements|mesh-ancestor
25170650|NCT00373711|Micronutrients|micronutrients|mesh-ancestor
25170651|NCT00373711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170652|NCT00373711|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25170653|NCT00373711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170654|NCT00364637|Anesthetics|anesthetics|mesh-list
25170655|NCT00364637|Sevoflurane|sevoflurane|mesh-list
24941604|NCT03989310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24941605|NCT03989310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24941606|NCT03989310|Trace Elements|trace elements|mesh-ancestor
24941607|NCT03989310|Micronutrients|micronutrients|mesh-ancestor
25050820|NCT00465959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24995954|NCT04468776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24995955|NCT04468776|Serotonin Agents|serotonin agents|mesh-ancestor
24995956|NCT04468776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24995957|NCT04468776|Antidepressive Agents|antidepressive agents|mesh-ancestor
24995959|NCT04464174|Carboplatin|carboplatin|mesh-list
24995960|NCT04464174|Capecitabine|capecitabine|mesh-list
24995961|NCT04464174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24423213|NCT00225108|Tinzaparin|tinzaparin|mesh-list
25647304|NCT01468181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647305|NCT01468207|Adalimumab|adalimumab|mesh-list
25647306|NCT01468207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25647307|NCT01468207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25647308|NCT01468233|Adalimumab|adalimumab|mesh-list
25647309|NCT01468233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25647310|NCT01468233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25647311|NCT01468311|Daclizumab|daclizumab|mesh-list
25647312|NCT01468311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25647313|NCT01468311|Immunologic Factors|immunologic factors|mesh-ancestor
25647314|NCT01468311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647315|NCT01468337|Interferons|interferons|mesh-list
25647316|NCT01468337|Interferon-gamma|interferon-gamma|mesh-list
25647317|NCT01468337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647318|NCT01468337|Antiviral Agents|antiviral agents|mesh-ancestor
25647319|NCT01468337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25647320|NCT01468350|4-Aminopyridine|4-aminopyridine|mesh-list
25647321|NCT01468350|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25647322|NCT01468350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25647323|NCT01468350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647324|NCT01468532|Prednisone|prednisone|mesh-list
25647325|NCT01468532|Docetaxel|docetaxel|mesh-list
25647326|NCT01468532|Pasireotide|pasireotide|mesh-list
25647327|NCT01468532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647328|NCT01468532|Tubulin Modulators|tubulin modulators|mesh-ancestor
25647329|NCT01468532|Antimitotic Agents|antimitotic agents|mesh-ancestor
25647330|NCT01468532|Mitosis Modulators|mitosis modulators|mesh-ancestor
25647331|NCT01468532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647332|NCT01468532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25647333|NCT01468532|Glucocorticoids|glucocorticoids|mesh-ancestor
25647334|NCT01468532|Hormones|hormones|mesh-ancestor
24996184|NCT04162873|Benzenesulfonamide|benzenesulfonamide|mesh-list
25657150|NCT01583374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170661|NCT00288080|Dexamethasone|dexamethasone|mesh-list
25170662|NCT00288080|Prednisone|prednisone|mesh-list
25170663|NCT00288080|Docetaxel|docetaxel|mesh-list
25170664|NCT00288080|Androgen Antagonists|androgen antagonists|mesh-list
25170665|NCT00288080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25170666|NCT00288080|Antiemetics|antiemetics|mesh-ancestor
25170667|NCT00288080|Autonomic Agents|autonomic agents|mesh-ancestor
25170668|NCT00288080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25170669|NCT00288080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996185|NCT04162873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24996186|NCT04162873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24996187|NCT04162873|Analgesics|analgesics|mesh-ancestor
24996188|NCT04162873|Sensory System Agents|sensory system agents|mesh-ancestor
25824474|NCT00005017|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25824475|NCT00005017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25824476|NCT00005017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24996283|NCT03912064|Ipilimumab|ipilimumab|mesh-list
24996284|NCT03912064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24996337|NCT03739476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25041377|NCT02565732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041378|NCT02565732|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25041379|NCT02565732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25041380|NCT02564744|Rituximab|rituximab|mesh-list
24871173|NCT04587687|Antibodies|antibodies|mesh-list
24423793|NCT00226889|Bosentan|bosentan|mesh-list
25050984|NCT00455156|ST 1435|st 1435|mesh-list
24942290|NCT03982381|Metformin|metformin|mesh-list
24807605|NCT02022722|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24807606|NCT02022722|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24807607|NCT02022722|Bupivacaine|bupivacaine|mesh-list
24807608|NCT02022722|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25824477|NCT00005017|Antimetabolites|antimetabolites|mesh-ancestor
25824478|NCT00005017|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25824479|NCT00005017|Antitubercular Agents|antitubercular agents|mesh-ancestor
25824480|NCT00005017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25824481|NCT00005018|Efavirenz|efavirenz|mesh-list
24942428|NCT03981029|Folic Acid|folic acid|mesh-list
24425284|NCT00232648|Budesonide|budesonide|mesh-list
25824482|NCT00005018|Abacavir|abacavir|mesh-list
24450350|NCT00318825|Analgesics|analgesics|mesh-ancestor
25824483|NCT00005018|Didanosine|didanosine|mesh-list
25824484|NCT00005018|Hydroxyurea|hydroxyurea|mesh-list
25824485|NCT00005018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25824486|NCT00005018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25824487|NCT00005018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824488|NCT00005018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824489|NCT00005018|Antiviral Agents|antiviral agents|mesh-ancestor
24959076|NCT03827408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25824490|NCT00005018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24924978|NCT04154852|Micronutrients|micronutrients|mesh-ancestor
24943398|NCT03971201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824491|NCT00005018|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24959412|NCT03825133|Hyaluronic Acid|hyaluronic acid|mesh-list
24458696|NCT00338910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24943625|NCT03968224|Metformin|metformin|mesh-list
25824492|NCT00005018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25824493|NCT00005018|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25824494|NCT00005018|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25824495|NCT00005018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25824496|NCT00005018|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25824497|NCT00005018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25824498|NCT00005018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25824499|NCT00005018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824500|NCT00005018|Antisickling Agents|antisickling agents|mesh-ancestor
25824501|NCT00005018|Antimetabolites|antimetabolites|mesh-ancestor
24458970|NCT00343239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647335|NCT01468532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25647336|NCT01468532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647337|NCT01468532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25647338|NCT01468558|Ketoconazole|ketoconazole|mesh-list
25647339|NCT01468558|Antifungal Agents|antifungal agents|mesh-ancestor
25647340|NCT01468558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25647341|NCT01468558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24458971|NCT00343265|Progesterone|progesterone|mesh-list
24458972|NCT00343265|Progestins|progestins|mesh-ancestor
24458973|NCT00343265|Hormones|hormones|mesh-ancestor
24458974|NCT00343265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25170740|NCT02893618|Diazoxide|diazoxide|mesh-list
24429592|NCT00244452|Cetrorelix|cetrorelix|mesh-list
25824502|NCT00005021|Paclitaxel|paclitaxel|mesh-list
25824503|NCT00005021|Carboplatin|carboplatin|mesh-list
25824504|NCT00005021|Topotecan|topotecan|mesh-list
25824505|NCT00005021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24825081|NCT02127164|Eusol|eusol|mesh-list
25824506|NCT00005021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824507|NCT00005021|Tubulin Modulators|tubulin modulators|mesh-ancestor
25824508|NCT00005021|Antimitotic Agents|antimitotic agents|mesh-ancestor
25824509|NCT00005021|Mitosis Modulators|mitosis modulators|mesh-ancestor
25824510|NCT00005021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824511|NCT00005021|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24825141|NCT02127684|Ranibizumab|ranibizumab|mesh-list
24431777|NCT00252863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25824512|NCT00005021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24960477|NCT03816267|Albuterol|albuterol|mesh-list
25824513|NCT00005021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824514|NCT00005022|Cisplatin|cisplatin|mesh-list
25824515|NCT00005022|Etoposide|etoposide|mesh-list
25824516|NCT00005022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824517|NCT00005022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24432837|NCT00256347|Morphine|morphine|mesh-list
25824518|NCT00005022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24433158|NCT00257712|Tesamorelin|tesamorelin|mesh-list
24459513|NCT00344942|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24459514|NCT00344942|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24459515|NCT00344942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24459516|NCT00344942|Glucocorticoids|glucocorticoids|mesh-ancestor
24459517|NCT00344942|Hormones|hormones|mesh-ancestor
24927293|NCT04134078|Protective Agents|protective agents|mesh-ancestor
24459525|NCT00344955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24459526|NCT00344955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24459527|NCT00344955|Antimetabolites|antimetabolites|mesh-ancestor
25051302|NCT00422019|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24700177|NCT01451229|Higenamine|higenamine|mesh-list
25824519|NCT00005022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25824520|NCT00005022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824521|NCT00005022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824522|NCT00005023|Sargramostim|sargramostim|mesh-list
25824523|NCT00005023|Immunologic Factors|immunologic factors|mesh-ancestor
25824524|NCT00005023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824525|NCT00005024|Cyclophosphamide|cyclophosphamide|mesh-list
25824526|NCT00005024|Carboplatin|carboplatin|mesh-list
25824527|NCT00005024|Doxorubicin|doxorubicin|mesh-list
25824528|NCT00005024|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24394274|NCT00132821|Bupropion|bupropion|mesh-list
24961561|NCT03807011|Fentanyl|fentanyl|mesh-list
24394708|NCT00134030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24394709|NCT00134030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394710|NCT00134030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394711|NCT00134030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24394712|NCT00134030|Abortifacient Agents|abortifacient agents|mesh-ancestor
24526544|NCT00612079|Sertindole|sertindole|mesh-list
25824529|NCT00005024|Granisetron|granisetron|mesh-list
25824530|NCT00005024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24647078|NCT01206049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24647079|NCT01206049|Immunologic Factors|immunologic factors|mesh-ancestor
25824531|NCT00005024|Immunologic Factors|immunologic factors|mesh-ancestor
25824532|NCT00005024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824533|NCT00005024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25824534|NCT00005024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25824535|NCT00005024|Alkylating Agents|alkylating agents|mesh-ancestor
24435791|NCT00268216|Dermatologic Agents|dermatologic agents|mesh-ancestor
25824536|NCT00005024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824537|NCT00005024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824538|NCT00005024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25824539|NCT00005024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25041415|NCT02539537|Levoleucovorin|levoleucovorin|mesh-list
24436678|NCT00270777|Anesthetics|anesthetics|mesh-ancestor
25824540|NCT00005024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25824541|NCT00005024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25824542|NCT00005024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824543|NCT00005024|Antiemetics|antiemetics|mesh-ancestor
25824544|NCT00005024|Autonomic Agents|autonomic agents|mesh-ancestor
25647342|NCT01468558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25824545|NCT00005024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25647343|NCT01468558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657151|NCT01583374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25824546|NCT00005024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25824547|NCT00005024|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24538685|NCT00660335|Secretin|secretin|mesh-list
25824548|NCT00005024|Serotonin Agents|serotonin agents|mesh-ancestor
25824549|NCT00005024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24438519|NCT00276081|Gabapentin|gabapentin|mesh-list
25824550|NCT00005025|Ganciclovir|ganciclovir|mesh-list
25824551|NCT00005025|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25824552|NCT00005025|Antiviral Agents|antiviral agents|mesh-ancestor
24538740|NCT00660647|Adalimumab|adalimumab|mesh-list
25824553|NCT00005025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25824554|NCT00005025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25824555|NCT00005025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824556|NCT00005025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824557|NCT00005026|Paclitaxel|paclitaxel|mesh-list
25824558|NCT00005026|Carboplatin|carboplatin|mesh-list
25824559|NCT00005026|Topotecan|topotecan|mesh-list
25824560|NCT00005026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25824561|NCT00005026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824562|NCT00005026|Tubulin Modulators|tubulin modulators|mesh-ancestor
25824563|NCT00005026|Antimitotic Agents|antimitotic agents|mesh-ancestor
25824564|NCT00005026|Mitosis Modulators|mitosis modulators|mesh-ancestor
25824565|NCT00005026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824566|NCT00005026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25824567|NCT00005026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25824568|NCT00005026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824569|NCT00005028|Paclitaxel|paclitaxel|mesh-list
25824570|NCT00005028|Bryostatin 1|bryostatin 1|mesh-list
25824571|NCT00005028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24441567|NCT00287820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24441568|NCT00287820|Dopamine Agents|dopamine agents|mesh-ancestor
25824572|NCT00005028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824573|NCT00005028|Tubulin Modulators|tubulin modulators|mesh-ancestor
25824574|NCT00005028|Antimitotic Agents|antimitotic agents|mesh-ancestor
25824575|NCT00005028|Mitosis Modulators|mitosis modulators|mesh-ancestor
24441862|NCT00288561|Ranibizumab|ranibizumab|mesh-list
24538958|NCT00661349|Lopinavir|lopinavir|mesh-list
25824576|NCT00005028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824577|NCT00005028|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25824578|NCT00005028|Immunologic Factors|immunologic factors|mesh-ancestor
25824579|NCT00005028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824580|NCT00005029|Topotecan|topotecan|mesh-list
25824581|NCT00005029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25824582|NCT00005029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24442256|NCT00290628|Antiemetics|antiemetics|mesh-ancestor
25824583|NCT00005029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824584|NCT00005029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824585|NCT00005029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824586|NCT00005030|Lonafarnib|lonafarnib|mesh-list
25824587|NCT00005030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824588|NCT00005030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824589|NCT00005031|Irofulven|irofulven|mesh-list
25824590|NCT00005031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25824591|NCT00005031|Alkylating Agents|alkylating agents|mesh-ancestor
25824592|NCT00005031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824593|NCT00005031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824594|NCT00005032|Paclitaxel|paclitaxel|mesh-list
25824595|NCT00005032|Oblimersen|oblimersen|mesh-list
25824596|NCT00005032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24450689|NCT00320047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824597|NCT00005032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824598|NCT00005032|Tubulin Modulators|tubulin modulators|mesh-ancestor
25824599|NCT00005032|Antimitotic Agents|antimitotic agents|mesh-ancestor
25824600|NCT00005032|Mitosis Modulators|mitosis modulators|mesh-ancestor
24947852|NCT03925233|Fluorouracil|fluorouracil|mesh-list
25657152|NCT01583374|Immunologic Factors|immunologic factors|mesh-ancestor
25657153|NCT01583374|Leprostatic Agents|leprostatic agents|mesh-ancestor
25657154|NCT01583374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25657155|NCT01583374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25657156|NCT01583374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25657157|NCT01583374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25657158|NCT01583374|Growth Substances|growth substances|mesh-ancestor
25657159|NCT01583374|Growth Inhibitors|growth inhibitors|mesh-ancestor
25657160|NCT01583374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25657161|NCT01583530|Belimumab|belimumab|mesh-list
25657162|NCT01583530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25824601|NCT00005032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824602|NCT00005033|Trastuzumab|trastuzumab|mesh-list
25824603|NCT00005033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25824604|NCT00005033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824605|NCT00005035|Oxaliplatin|oxaliplatin|mesh-list
25824606|NCT00005035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824607|NCT00005036|Leucovorin|leucovorin|mesh-list
25824608|NCT00005036|Fluorouracil|fluorouracil|mesh-list
25824609|NCT00005036|Oxaliplatin|oxaliplatin|mesh-list
25824610|NCT00005036|Irinotecan|irinotecan|mesh-list
25824611|NCT00005036|Calcium|calcium|mesh-list
24410297|NCT00185055|Irbesartan|irbesartan|mesh-list
25824612|NCT00005036|Levoleucovorin|levoleucovorin|mesh-list
25824613|NCT00005036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25824614|NCT00005036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963662|NCT03789370|Propofol|propofol|mesh-list
24948129|NCT03922815|Narcotics|narcotics|mesh-ancestor
24963814|NCT03789006|Analgesics|analgesics|mesh-ancestor
25824615|NCT00005036|Antimetabolites|antimetabolites|mesh-ancestor
25824616|NCT00005036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824617|NCT00005036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25824618|NCT00005036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824619|NCT00005036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25824620|NCT00005036|Immunologic Factors|immunologic factors|mesh-ancestor
24963940|NCT03787641|Protamines|protamines|mesh-list
24859216|NCT02302508|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24859217|NCT02302508|Purinergic Agents|purinergic agents|mesh-ancestor
24859218|NCT02302508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24859219|NCT02302508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859220|NCT02302508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948477|NCT03919448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582663|NCT00871039|Anesthetics|anesthetics|mesh-ancestor
24859677|NCT02305173|Dexamethasone|dexamethasone|mesh-list
24948851|NCT05401721|Natriuretic Agents|natriuretic agents|mesh-ancestor
25824621|NCT00005036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25824622|NCT00005036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25824623|NCT00005036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824624|NCT00005036|Antidotes|antidotes|mesh-ancestor
25824625|NCT00005036|Protective Agents|protective agents|mesh-ancestor
25824626|NCT00005036|Vitamin B Complex|vitamin b complex|mesh-ancestor
25051748|NCT00382811|Carboplatin|carboplatin|mesh-list
24949180|NCT05173688|Propofol|propofol|mesh-list
24860039|NCT02307305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25824627|NCT00005036|Vitamins|vitamins|mesh-ancestor
25824628|NCT00005036|Micronutrients|micronutrients|mesh-ancestor
25824629|NCT00005037|Temozolomide|temozolomide|mesh-list
25824630|NCT00005037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25824631|NCT00005037|Alkylating Agents|alkylating agents|mesh-ancestor
25824632|NCT00005037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051806|NCT00374166|Paroxetine|paroxetine|mesh-list
24540583|NCT00668603|Estradiol|estradiol|mesh-list
25824633|NCT00005037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824634|NCT00005038|Aldesleukin|aldesleukin|mesh-list
25824635|NCT00005038|Histamine|histamine|mesh-list
25824636|NCT00005038|Histamine phosphate|histamine phosphate|mesh-list
24860229|NCT02308137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25824637|NCT00005038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824638|NCT00005038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24775310|NCT01851486|Analgesics|analgesics|mesh-ancestor
24860295|NCT02308982|Immunoglobulins|immunoglobulins|mesh-list
24529517|NCT00626535|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25824639|NCT00005038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25824640|NCT00005038|Antiviral Agents|antiviral agents|mesh-ancestor
25824641|NCT00005038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25824642|NCT00005038|Histamine Agonists|histamine agonists|mesh-ancestor
25824643|NCT00005038|Histamine Agents|histamine agents|mesh-ancestor
24965431|NCT03777280|Cobalt|cobalt|mesh-list
24813325|NCT02057796|Antitubercular Agents|antitubercular agents|mesh-ancestor
24950482|NCT03915561|Parecoxib|parecoxib|mesh-list
25657163|NCT01583530|Immunologic Factors|immunologic factors|mesh-ancestor
24826643|NCT02135393|Folic Acid|folic acid|mesh-list
25657164|NCT01583530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657165|NCT01583543|Olaparib|olaparib|mesh-list
25657166|NCT01583543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25657167|NCT01583543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657168|NCT01583543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657169|NCT01583543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25657170|NCT01583686|Aldesleukin|aldesleukin|mesh-list
25657171|NCT01583686|Cyclophosphamide|cyclophosphamide|mesh-list
25170882|NCT02893371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25170883|NCT02893371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823098|NCT02115087|Morphine|morphine|mesh-list
25170884|NCT02893371|Dopamine Agonists|dopamine agonists|mesh-ancestor
25170885|NCT02893371|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25170886|NCT02893371|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25170887|NCT02893371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25170888|NCT02893371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25170889|NCT02893371|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25170890|NCT02893371|Analgesics|analgesics|mesh-ancestor
25824644|NCT00005038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24860498|NCT02310295|Hormones|hormones|mesh-ancestor
24965763|NCT03774693|Fentanyl|fentanyl|mesh-list
25824645|NCT00005038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642107|NCT01177579|Copper|copper|mesh-list
25824646|NCT00005038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824647|NCT00005039|Vaccines|vaccines|mesh-list
25824648|NCT00005039|Immunologic Factors|immunologic factors|mesh-ancestor
25824649|NCT00005039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860544|NCT02310997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24860545|NCT02310997|Immunologic Factors|immunologic factors|mesh-ancestor
25824650|NCT00005040|Arsenic Trioxide|arsenic trioxide|mesh-list
25824651|NCT00005040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824652|NCT00005041|Tipifarnib|tipifarnib|mesh-list
25824653|NCT00005041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541111|NCT00670878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541123|NCT00671008|Biphasic Insulins|biphasic insulins|mesh-list
25824654|NCT00005042|Semaxinib|semaxinib|mesh-list
24860810|NCT02312908|Anticonvulsants|anticonvulsants|mesh-ancestor
25824655|NCT00005042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24541209|NCT00671476|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24860898|NCT02313584|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24860899|NCT02313584|Protease Inhibitors|protease inhibitors|mesh-ancestor
24860900|NCT02313584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824656|NCT00005042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25824657|NCT00005042|Growth Substances|growth substances|mesh-ancestor
24451405|NCT00323583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541274|NCT00671801|Immunologic Factors|immunologic factors|mesh-ancestor
24541275|NCT00671801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541276|NCT00671801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24860973|NCT02314208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24860974|NCT02314208|Antimetabolites|antimetabolites|mesh-ancestor
25054019|NCT00002207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24861019|NCT02314351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24861020|NCT02314351|Narcotics|narcotics|mesh-ancestor
24861021|NCT02314351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24861022|NCT02314351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861023|NCT02314351|Analgesics|analgesics|mesh-ancestor
24861024|NCT02314351|Sensory System Agents|sensory system agents|mesh-ancestor
24861025|NCT02314351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24861026|NCT02314351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24861029|NCT02314351|Anesthetics|anesthetics|mesh-ancestor
24966345|NCT03768908|Artesunate|artesunate|mesh-list
24656139|NCT01260103|Temozolomide|temozolomide|mesh-list
24861101|NCT02314806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24861102|NCT02314806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24861103|NCT02314806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24861104|NCT02314806|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25824658|NCT00005042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824659|NCT00005042|Growth Inhibitors|growth inhibitors|mesh-ancestor
25824660|NCT00005042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861141|NCT02315196|Antimitotic Agents|antimitotic agents|mesh-ancestor
24861142|NCT02315196|Mitosis Modulators|mitosis modulators|mesh-ancestor
24541489|NCT00673296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24541490|NCT00673296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541496|NCT00673426|Enoxaparin|enoxaparin|mesh-list
25647344|NCT01468558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647345|NCT01468558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25647346|NCT01468558|Hormone Antagonists|hormone antagonists|mesh-ancestor
25647347|NCT01468558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25647348|NCT01468558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647349|NCT01468558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25647350|NCT01468584|Ribavirin|ribavirin|mesh-list
25647351|NCT01468584|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25647352|NCT01468584|Antimetabolites|antimetabolites|mesh-ancestor
25657172|NCT01583686|Fludarabine|fludarabine|mesh-list
25824661|NCT00005042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24862189|NCT02323516|Aspirin|aspirin|mesh-list
24862190|NCT02323516|Loperamide|loperamide|mesh-list
25824671|NCT00005046|Paclitaxel|paclitaxel|mesh-list
25052316|NCT00305656|Cediranib|cediranib|mesh-list
24862331|NCT02324452|Capecitabine|capecitabine|mesh-list
25052470|NCT00267280|Atorvastatin|atorvastatin|mesh-list
24615162|NCT01028261|CKD732|ckd732|mesh-list
25824672|NCT00005046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25824673|NCT00005046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451674|NCT00324480|Vorinostat|vorinostat|mesh-list
24827540|NCT02140073|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25824674|NCT00005046|Tubulin Modulators|tubulin modulators|mesh-ancestor
25824675|NCT00005046|Antimitotic Agents|antimitotic agents|mesh-ancestor
25824676|NCT00005046|Mitosis Modulators|mitosis modulators|mesh-ancestor
25824677|NCT00005046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446979|NCT00306813|Immunologic Factors|immunologic factors|mesh-ancestor
24446980|NCT00306813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446983|NCT00306813|Growth Substances|growth substances|mesh-ancestor
24862544|NCT05142904|Trace Elements|trace elements|mesh-ancestor
24542374|NCT00678457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24542375|NCT00678457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862634|NCT04881955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24862635|NCT04881955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24998172|NCT03469284|Methylene Blue|methylene blue|mesh-list
25053063|NCT00110422|Irbesartan|irbesartan|mesh-list
24862756|NCT04532502|Anesthetics|anesthetics|mesh-list
24998173|NCT03469284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24862999|NCT03779243|Antioxidants|antioxidants|mesh-ancestor
24863000|NCT03779243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863001|NCT03779243|Protective Agents|protective agents|mesh-ancestor
24661347|NCT01288963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24542791|NCT00680394|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24863029|NCT03696784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24863030|NCT03696784|Alkylating Agents|alkylating agents|mesh-ancestor
25203708|NCT02712658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25203709|NCT02712658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25203710|NCT02712658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25203711|NCT02712658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25203712|NCT02712658|Adrenergic Agents|adrenergic agents|mesh-ancestor
25203713|NCT02712658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25203714|NCT02712658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203746|NCT02712528|Sufentanil|sufentanil|mesh-list
25203747|NCT02712528|Remifentanil|remifentanil|mesh-list
25203748|NCT02712528|Sevoflurane|sevoflurane|mesh-list
25203749|NCT02712528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25203750|NCT02712528|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25203751|NCT02712528|Anesthetics, General|anesthetics, general|mesh-ancestor
25203752|NCT02712528|Anesthetics|anesthetics|mesh-ancestor
25203753|NCT02712528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25203754|NCT02712528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203755|NCT02712528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25203756|NCT02712528|Narcotics|narcotics|mesh-ancestor
25203757|NCT02712528|Analgesics|analgesics|mesh-ancestor
25203758|NCT02712528|Sensory System Agents|sensory system agents|mesh-ancestor
25824678|NCT00005048|Paclitaxel|paclitaxel|mesh-list
24863031|NCT03696784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863032|NCT03696784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863033|NCT03696784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24863034|NCT03693846|Nivolumab|nivolumab|mesh-list
24863035|NCT03693846|Ipilimumab|ipilimumab|mesh-list
24863036|NCT03693846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24863037|NCT03693846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863038|NCT03693846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24661451|NCT01289561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053363|NCT00057980|Celecoxib|celecoxib|mesh-list
24474761|NCT00407264|Dermatologic Agents|dermatologic agents|mesh-ancestor
24474762|NCT00407264|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24474763|NCT00407277|Nicotine|nicotine|mesh-list
24806082|NCT02013492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24806083|NCT02013492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24806084|NCT02013492|Vasodilator Agents|vasodilator agents|mesh-ancestor
24806085|NCT02013570|Dexmedetomidine|dexmedetomidine|mesh-list
24806086|NCT02013570|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24806087|NCT02013570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25824679|NCT00005048|Estramustine|estramustine|mesh-list
24661766|NCT01290900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661767|NCT01290900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661768|NCT01290900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24670584|NCT02274155|Antibodies|antibodies|mesh-list
24806166|NCT02014103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24474976|NCT00408278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24474977|NCT00408278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474980|NCT00408330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824680|NCT00005048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25053596|NCT00004914|Epoetin Alfa|epoetin alfa|mesh-list
25824681|NCT00005048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824682|NCT00005048|Tubulin Modulators|tubulin modulators|mesh-ancestor
25824683|NCT00005048|Antimitotic Agents|antimitotic agents|mesh-ancestor
24589222|NCT00906139|Anesthetics, General|anesthetics, general|mesh-ancestor
25647353|NCT01468584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647354|NCT01468584|Antiviral Agents|antiviral agents|mesh-ancestor
25647355|NCT01468584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25647356|NCT01468818|Cyclophosphamide|cyclophosphamide|mesh-list
25647357|NCT01468818|Fludarabine|fludarabine|mesh-list
25647358|NCT01468818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25647359|NCT01468818|Immunologic Factors|immunologic factors|mesh-ancestor
25647360|NCT01468818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647361|NCT01468818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25647362|NCT01468818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25647363|NCT01468818|Alkylating Agents|alkylating agents|mesh-ancestor
25647364|NCT01468818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647365|NCT01468818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647366|NCT01468818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25647367|NCT01468844|Minocycline|minocycline|mesh-list
25647368|NCT01468844|Bevacizumab|bevacizumab|mesh-list
25647369|NCT01468844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25647370|NCT01468844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647371|NCT01468844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25647372|NCT01468844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25053779|NCT00004230|Captopril|captopril|mesh-list
24828102|NCT02143362|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24806696|NCT02017613|Tenalisib|tenalisib|mesh-list
24806721|NCT02017873|Carbamide Peroxide|carbamide peroxide|mesh-list
25824684|NCT00005048|Mitosis Modulators|mitosis modulators|mesh-ancestor
24447251|NCT00307671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25824685|NCT00005048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824686|NCT00005048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24827593|NCT02140281|Cefadroxil|cefadroxil|mesh-list
24827594|NCT02140281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24447253|NCT00307723|Gemcitabine|gemcitabine|mesh-list
24447254|NCT00307723|Bevacizumab|bevacizumab|mesh-list
24447256|NCT00307723|Oxaliplatin|oxaliplatin|mesh-list
24447257|NCT00307723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24447261|NCT00307723|Growth Substances|growth substances|mesh-ancestor
24447262|NCT00307723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824687|NCT00005048|Alkylating Agents|alkylating agents|mesh-ancestor
25824688|NCT00005048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25824689|NCT00005049|Cisplatin|cisplatin|mesh-list
25824690|NCT00005049|Carboplatin|carboplatin|mesh-list
25824691|NCT00005049|Floxuridine|floxuridine|mesh-list
25824692|NCT00005049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824693|NCT00005049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25824694|NCT00005049|Antimetabolites|antimetabolites|mesh-ancestor
24937525|NCT04027972|Glycopyrrolate|glycopyrrolate|mesh-list
24476683|NCT00416143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476684|NCT00416169|Galantamine|galantamine|mesh-list
24420401|NCT00215956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476685|NCT00416169|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24476686|NCT00416169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476687|NCT00416169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476688|NCT00416169|Cholinergic Agents|cholinergic agents|mesh-ancestor
25824695|NCT00005049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824696|NCT00005050|Fluorouracil|fluorouracil|mesh-list
25824697|NCT00005050|Oxaliplatin|oxaliplatin|mesh-list
24447268|NCT00307723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24477352|NCT00418353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24477353|NCT00418353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824698|NCT00005050|Eniluracil|eniluracil|mesh-list
24446788|NCT00305903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824699|NCT00005050|Antimetabolites|antimetabolites|mesh-ancestor
25824700|NCT00005050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824701|NCT00005050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24807213|NCT02020330|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24807214|NCT02020330|Antimalarials|antimalarials|mesh-ancestor
24807215|NCT02020330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24807216|NCT02020330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24478113|NCT00421512|Sunitinib|sunitinib|mesh-list
25824702|NCT00005050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478665|NCT00423969|Galantamine|galantamine|mesh-list
24478672|NCT00423969|Serotonin Agents|serotonin agents|mesh-ancestor
24478695|NCT00423982|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24478696|NCT00423982|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24478697|NCT00423982|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24478698|NCT00423982|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24478699|NCT00423982|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24478700|NCT00423982|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24938375|NCT04019652|Moxifloxacin|moxifloxacin|mesh-list
24479045|NCT00425360|Immunologic Factors|immunologic factors|mesh-ancestor
24479104|NCT00425516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24479105|NCT00425516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24479106|NCT00425516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24479107|NCT00425516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479108|NCT00425568|Testosterone|testosterone|mesh-list
24829417|NCT02152332|Moxifloxacin|moxifloxacin|mesh-list
24622739|NCT01068327|Antimetabolites|antimetabolites|mesh-ancestor
24622740|NCT01068327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622741|NCT01068327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622742|NCT01068327|Antiviral Agents|antiviral agents|mesh-ancestor
24622743|NCT01068327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24807721|NCT02023424|Glatiramer Acetate|glatiramer acetate|mesh-list
24480107|NCT00429832|Anesthetics|anesthetics|mesh-ancestor
24480108|NCT00429832|Sensory System Agents|sensory system agents|mesh-ancestor
24480110|NCT00429871|Capecitabine|capecitabine|mesh-list
24480120|NCT00429871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24807886|NCT02024217|Tegafur|tegafur|mesh-list
24807887|NCT02024217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807888|NCT02024217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24807889|NCT02024217|Antimetabolites|antimetabolites|mesh-ancestor
24482983|NCT00441246|Nasal Decongestants|nasal decongestants|mesh-ancestor
25824703|NCT00005050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24483508|NCT00443794|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24483509|NCT00443794|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24483510|NCT00443794|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24483511|NCT00443794|Adrenergic Agents|adrenergic agents|mesh-ancestor
25824704|NCT00005050|Immunologic Factors|immunologic factors|mesh-ancestor
25041736|NCT01590719|Folic Acid|folic acid|mesh-list
24484788|NCT00450086|Mesalamine|mesalamine|mesh-list
25041796|NCT01581203|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25824705|NCT00005050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824706|NCT00005050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485521|NCT00453414|Vasodilator Agents|vasodilator agents|mesh-ancestor
24808793|NCT02029118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24485782|NCT00455026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24830219|NCT02157818|Midazolam|midazolam|mesh-list
24486081|NCT00456235|Antifungal Agents|antifungal agents|mesh-ancestor
24486287|NCT00457054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24486288|NCT00457054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486289|NCT00457067|Ranibizumab|ranibizumab|mesh-list
24486324|NCT00457119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486328|NCT00457145|Growth Substances|growth substances|mesh-ancestor
25824707|NCT00005051|Paclitaxel|paclitaxel|mesh-list
25824708|NCT00005051|Cisplatin|cisplatin|mesh-list
25824709|NCT00005051|Carboplatin|carboplatin|mesh-list
24486333|NCT00457223|Hemostatics|hemostatics|mesh-ancestor
24486580|NCT00458510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24487089|NCT00461578|Antiviral Agents|antiviral agents|mesh-ancestor
24829864|NCT02155088|Gemcitabine|gemcitabine|mesh-list
24829865|NCT02155088|Paclitaxel|paclitaxel|mesh-list
25056997|NCT03507842|Cytarabine|cytarabine|mesh-list
24490910|NCT00480558|Vaccines|vaccines|mesh-list
25824710|NCT00005051|Topotecan|topotecan|mesh-list
25824711|NCT00005051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25824712|NCT00005051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491903|NCT00484484|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24492484|NCT00486460|Antiviral Agents|antiviral agents|mesh-ancestor
25057456|NCT03504982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495716|NCT00501657|Incretins|incretins|mesh-ancestor
25057730|NCT03502434|Petrolatum|petrolatum|mesh-list
24496011|NCT00502970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496589|NCT00505700|Cytarabine|cytarabine|mesh-list
24622995|NCT01069536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24497355|NCT00509613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24810173|NCT02038452|Prednisolone|prednisolone|mesh-list
25824713|NCT00005051|Tubulin Modulators|tubulin modulators|mesh-ancestor
24827971|NCT02142595|Midazolam|midazolam|mesh-list
24827972|NCT02142595|Dexmedetomidine|dexmedetomidine|mesh-list
24827977|NCT02142595|Analgesics|analgesics|mesh-ancestor
24498819|NCT00516425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25824714|NCT00005051|Antimitotic Agents|antimitotic agents|mesh-ancestor
25824715|NCT00005051|Mitosis Modulators|mitosis modulators|mesh-ancestor
25164139|NCT05423015|Levan|levan|mesh-list
24828008|NCT02142751|Fosfomycin|fosfomycin|mesh-list
25824716|NCT00005051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824717|NCT00005051|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25824718|NCT00005051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25824719|NCT00005051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828012|NCT02142777|Equol|equol|mesh-list
24500333|NCT00523887|Sensory System Agents|sensory system agents|mesh-ancestor
24500334|NCT00523887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24810367|NCT02039791|Mitosis Modulators|mitosis modulators|mesh-ancestor
24810368|NCT02039791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500444|NCT00524199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500445|NCT00524251|Esomeprazole|esomeprazole|mesh-list
24823202|NCT02115594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501966|NCT00531791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24501967|NCT00531791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501968|NCT00531791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24501970|NCT00531856|Carbon Monoxide|carbon monoxide|mesh-list
24501971|NCT00531856|Antimetabolites|antimetabolites|mesh-ancestor
24501972|NCT00531856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824720|NCT00005054|Temozolomide|temozolomide|mesh-list
25824721|NCT00005054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25824722|NCT00005054|Alkylating Agents|alkylating agents|mesh-ancestor
25824723|NCT00005054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824725|NCT00005056|Bryostatin 1|bryostatin 1|mesh-list
25824726|NCT00005056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25824727|NCT00005056|Immunologic Factors|immunologic factors|mesh-ancestor
25824728|NCT00005056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824729|NCT00005056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24832577|NCT02171689|Afatinib|afatinib|mesh-list
24810474|NCT02040415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24721922|NCT01577992|Levodopa|levodopa|mesh-list
25824730|NCT00005057|Ganciclovir|ganciclovir|mesh-list
24503686|NCT00532623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832710|NCT02172105|Olodaterol|olodaterol|mesh-list
25824731|NCT00005057|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25824732|NCT00005057|Antiviral Agents|antiviral agents|mesh-ancestor
25824733|NCT00005057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25824734|NCT00005057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25824735|NCT00005057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606037|NCT00988715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25060766|NCT03476772|Nalbuphine|nalbuphine|mesh-list
25824736|NCT00005057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824737|NCT00005059|Paclitaxel|paclitaxel|mesh-list
25824738|NCT00005059|Carboplatin|carboplatin|mesh-list
24504959|NCT00538720|Vitamin D|vitamin d|mesh-list
25824739|NCT00005059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25824740|NCT00005059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810798|NCT02042599|Anesthetics|anesthetics|mesh-ancestor
25041527|NCT02502669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759480|NCT01751854|Citalopram|citalopram|mesh-list
25824741|NCT00005059|Tubulin Modulators|tubulin modulators|mesh-ancestor
24457499|NCT00334594|Pemetrexed|pemetrexed|mesh-list
25061291|NCT03472508|Protease Inhibitors|protease inhibitors|mesh-ancestor
24460605|NCT00349024|Immunologic Factors|immunologic factors|mesh-ancestor
24460606|NCT00349024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460607|NCT00349024|Viscosupplements|viscosupplements|mesh-ancestor
24460608|NCT00349024|Protective Agents|protective agents|mesh-ancestor
24460609|NCT00349024|Plasma Substitutes|plasma substitutes|mesh-ancestor
24460610|NCT00349024|Blood Substitutes|blood substitutes|mesh-ancestor
24460611|NCT00349076|Oxaliplatin|oxaliplatin|mesh-list
24460701|NCT00349258|Leuprolide|leuprolide|mesh-list
24451549|NCT00324142|Tinidazole|tinidazole|mesh-list
25061548|NCT03470454|Hormones|hormones|mesh-ancestor
24828983|NCT02148861|Insulin|insulin|mesh-list
25061619|NCT03469583|Entecavir|entecavir|mesh-list
24810951|NCT02043821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24810952|NCT02043821|Antimetabolites|antimetabolites|mesh-ancestor
24810953|NCT02043821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462079|NCT00354874|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24462272|NCT00355602|Renal Agents|renal agents|mesh-ancestor
24462632|NCT00357123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25824742|NCT00005059|Antimitotic Agents|antimitotic agents|mesh-ancestor
25824743|NCT00005059|Mitosis Modulators|mitosis modulators|mesh-ancestor
25824744|NCT00005059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824745|NCT00005060|Cisplatin|cisplatin|mesh-list
25824746|NCT00005060|Docetaxel|docetaxel|mesh-list
25824747|NCT00005060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824748|NCT00005060|Tubulin Modulators|tubulin modulators|mesh-ancestor
25824749|NCT00005060|Antimitotic Agents|antimitotic agents|mesh-ancestor
24462669|NCT00357188|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24462778|NCT00357604|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24462779|NCT00357604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25824750|NCT00005060|Mitosis Modulators|mitosis modulators|mesh-ancestor
25824751|NCT00005060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824752|NCT00005061|Bevacizumab|bevacizumab|mesh-list
24629676|NCT01107145|Artesunate|artesunate|mesh-list
25062324|NCT04923659|Nimodipine|nimodipine|mesh-list
24629849|NCT01108133|Hormones|hormones|mesh-ancestor
24630083|NCT01109485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630084|NCT01109498|Cyclosporine|cyclosporine|mesh-list
24630111|NCT01109511|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24630112|NCT01109615|Gemcitabine|gemcitabine|mesh-list
24630279|NCT01110616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24811082|NCT02044809|Anticonvulsants|anticonvulsants|mesh-ancestor
24631871|NCT01120665|Hormones|hormones|mesh-ancestor
24632886|NCT01126073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395427|NCT00135954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24395428|NCT00135954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24395429|NCT00135967|Mycophenolic Acid|mycophenolic acid|mesh-list
24395430|NCT00135967|Prednisone|prednisone|mesh-list
24395431|NCT00135967|Methylprednisolone|methylprednisolone|mesh-list
24811313|NCT02046421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25171226|NCT02890082|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25171227|NCT02890082|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25171228|NCT02890082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25171229|NCT02890368|Interferons|interferons|mesh-list
25171230|NCT02890368|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25171231|NCT02890368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25171232|NCT02890368|Immunoglobulin G|immunoglobulin g|mesh-list
25171233|NCT02890368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171234|NCT02890368|Antiviral Agents|antiviral agents|mesh-ancestor
24811314|NCT02046421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24811315|NCT02046421|Immunologic Factors|immunologic factors|mesh-ancestor
24811316|NCT02046421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811317|NCT02046421|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24811318|NCT02046421|Abortifacient Agents|abortifacient agents|mesh-ancestor
24395717|NCT00136734|Dopamine Agents|dopamine agents|mesh-ancestor
24395805|NCT00136968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24395984|NCT00137514|Chloroquine|chloroquine|mesh-list
24395985|NCT00137514|Amodiaquine|amodiaquine|mesh-list
24396262|NCT00138229|Antimetabolites|antimetabolites|mesh-ancestor
24396263|NCT00138229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24396265|NCT00138229|Antiviral Agents|antiviral agents|mesh-ancestor
25063669|NCT03466645|Vancomycin|vancomycin|mesh-list
25824753|NCT00005061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25824754|NCT00005061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396955|NCT00140465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824755|NCT00005061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25824756|NCT00005061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25824757|NCT00005061|Growth Substances|growth substances|mesh-ancestor
24397452|NCT00141570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824758|NCT00005061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397650|NCT00142181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24397688|NCT00142337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24397690|NCT00142337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24397725|NCT00142467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24397727|NCT00142467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397728|NCT00142467|Antiviral Agents|antiviral agents|mesh-ancestor
25041560|NCT02471222|Amantadine|amantadine|mesh-list
24811362|NCT02046460|Antipyretics|antipyretics|mesh-ancestor
24398450|NCT00144417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24398452|NCT00144417|Leprostatic Agents|leprostatic agents|mesh-ancestor
25824759|NCT00005061|Growth Inhibitors|growth inhibitors|mesh-ancestor
24398808|NCT00145730|Sensory System Agents|sensory system agents|mesh-ancestor
24398809|NCT00145730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24398812|NCT00145730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25043060|NCT01332656|Paclitaxel|paclitaxel|mesh-list
25824760|NCT00005064|Bortezomib|bortezomib|mesh-list
24674450|NCT05220319|Hormones|hormones|mesh-ancestor
24400009|NCT00149253|Analgesics|analgesics|mesh-ancestor
24400153|NCT00149942|Antitubercular Agents|antitubercular agents|mesh-ancestor
25824761|NCT00005064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824762|NCT00005065|Paclitaxel|paclitaxel|mesh-list
25824763|NCT00005065|Carboplatin|carboplatin|mesh-list
25043136|NCT01318642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400663|NCT00151073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24401313|NCT00152698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401315|NCT00152724|Celecoxib|celecoxib|mesh-list
24401333|NCT00152724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25647373|NCT01468844|Growth Substances|growth substances|mesh-ancestor
25647374|NCT01468844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647375|NCT01468844|Growth Inhibitors|growth inhibitors|mesh-ancestor
25647376|NCT01468844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25647377|NCT01468844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25647378|NCT01468909|Paclitaxel|paclitaxel|mesh-list
25647379|NCT01468909|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24567043|NCT00789308|Analgesics|analgesics|mesh-ancestor
25647380|NCT01468909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25647381|NCT01468909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647382|NCT01468909|Tubulin Modulators|tubulin modulators|mesh-ancestor
25647383|NCT01468909|Antimitotic Agents|antimitotic agents|mesh-ancestor
25647384|NCT01468909|Mitosis Modulators|mitosis modulators|mesh-ancestor
25657173|NCT01583686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25824764|NCT00005065|Motexafin gadolinium|motexafin gadolinium|mesh-list
25824765|NCT00005065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25824766|NCT00005065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647386|NCT01468987|Insulin|insulin|mesh-list
25824767|NCT00005065|Tubulin Modulators|tubulin modulators|mesh-ancestor
25824768|NCT00005065|Antimitotic Agents|antimitotic agents|mesh-ancestor
25824769|NCT00005065|Mitosis Modulators|mitosis modulators|mesh-ancestor
24748987|NCT01898117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24944354|NCT03961334|Antipyretics|antipyretics|mesh-ancestor
25824770|NCT00005065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824771|NCT00005065|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25824772|NCT00005065|Dermatologic Agents|dermatologic agents|mesh-ancestor
25824773|NCT00005066|Carmustine|carmustine|mesh-list
25824774|NCT00005066|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
25824775|NCT00005066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25824776|NCT00005066|Alkylating Agents|alkylating agents|mesh-ancestor
25824777|NCT00005066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171283|NCT02889549|Clopidogrel|clopidogrel|mesh-list
25171284|NCT02889549|Ticagrelor|ticagrelor|mesh-list
25171285|NCT02889549|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25824778|NCT00005066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824779|NCT00005066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25171286|NCT02889549|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24838125|NCT02195375|Hormones|hormones|mesh-ancestor
24401567|NCT00153270|Anticonvulsants|anticonvulsants|mesh-ancestor
24401568|NCT00153270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24401569|NCT00153270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401570|NCT00153270|GABA Agents|gaba agents|mesh-ancestor
24401571|NCT00153270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24401572|NCT00153270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401573|NCT00153270|Antimanic Agents|antimanic agents|mesh-ancestor
24401716|NCT00153868|Darbepoetin alfa|darbepoetin alfa|mesh-list
24401717|NCT00153868|Hematinics|hematinics|mesh-ancestor
24401805|NCT00154037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401806|NCT00154037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24838562|NCT02198482|Mitoxantrone|mitoxantrone|mesh-list
24401874|NCT00154180|Progesterone|progesterone|mesh-list
24401875|NCT00154180|Hormones|hormones|mesh-ancestor
24401877|NCT00154180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829388|NCT02151968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24829394|NCT02152176|Morphine|morphine|mesh-list
24401947|NCT00154271|Valsartan|valsartan|mesh-list
24401948|NCT00154271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24401949|NCT00154271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24401950|NCT00154271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24402268|NCT00156299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24402405|NCT00157092|Protease Inhibitors|protease inhibitors|mesh-ancestor
24402406|NCT00157092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402407|NCT00157092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402408|NCT00157105|Factor VIII|factor viii|mesh-list
24402409|NCT00157105|Coagulants|coagulants|mesh-ancestor
24402410|NCT00157118|Protein C|protein c|mesh-list
24839364|NCT02203604|Ipilimumab|ipilimumab|mesh-list
24402512|NCT00157547|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24402523|NCT00157586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24402524|NCT00157586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402525|NCT00157586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24402526|NCT00157586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839501|NCT02204852|Iloprost|iloprost|mesh-list
25647387|NCT01468987|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25647388|NCT01468987|Insulin Glargine|insulin glargine|mesh-list
25647389|NCT01468987|Insulin Lispro|insulin lispro|mesh-list
25647390|NCT01468987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25647391|NCT01468987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647392|NCT01469000|Pemetrexed|pemetrexed|mesh-list
25647393|NCT01469000|Gefitinib|gefitinib|mesh-list
25647394|NCT01469000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647395|NCT01469000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25647396|NCT01469000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647397|NCT01469000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25647398|NCT01469000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25647399|NCT01469000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25824783|NCT00005068|Leucovorin|leucovorin|mesh-list
25824784|NCT00005068|Fluorouracil|fluorouracil|mesh-list
24403122|NCT00159445|Antimetabolites|antimetabolites|mesh-ancestor
24403152|NCT00159471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043424|NCT01262261|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25824785|NCT00005068|Oxaliplatin|oxaliplatin|mesh-list
24403289|NCT00159731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403291|NCT00159731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24403292|NCT00159731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24403293|NCT00159731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403294|NCT00159731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24403295|NCT00159731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24623188|NCT01070615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623189|NCT01070628|Levodopa|levodopa|mesh-list
24811487|NCT02046915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24403296|NCT00159731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24403297|NCT00159731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24403298|NCT00159731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24403550|NCT00160888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451583|NCT00324324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25824786|NCT00005068|Irinotecan|irinotecan|mesh-list
24451584|NCT00324324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24403585|NCT00161018|Fluphenazine|fluphenazine|mesh-list
24403586|NCT00161018|Fluphenazine depot|fluphenazine depot|mesh-list
24403609|NCT00161070|Dipyridamole|dipyridamole|mesh-list
25824787|NCT00005068|Calcium|calcium|mesh-list
24451623|NCT00324467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24451624|NCT00324467|Immunologic Factors|immunologic factors|mesh-ancestor
24451625|NCT00324467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811503|NCT02047006|Antithrombins|antithrombins|mesh-ancestor
24811504|NCT02047006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24811505|NCT02047006|Protease Inhibitors|protease inhibitors|mesh-ancestor
24403712|NCT00161304|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24403713|NCT00161304|Androgens|androgens|mesh-ancestor
24840214|NCT02208583|Glucocorticoids|glucocorticoids|mesh-ancestor
24403893|NCT00162006|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24403894|NCT00162006|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24403895|NCT00162006|Immunologic Factors|immunologic factors|mesh-ancestor
24403896|NCT00162006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066726|NCT02099175|Vitamins|vitamins|mesh-ancestor
25824788|NCT00005068|Levoleucovorin|levoleucovorin|mesh-list
24403983|NCT00162318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403984|NCT00162331|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
24403985|NCT00162331|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24403987|NCT00162344|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
24811543|NCT02047149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24811544|NCT02047149|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25824789|NCT00005068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25824790|NCT00005068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824791|NCT00005068|Antimetabolites|antimetabolites|mesh-ancestor
25824792|NCT00005068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824793|NCT00005068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25824794|NCT00005068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824795|NCT00005068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25824796|NCT00005068|Immunologic Factors|immunologic factors|mesh-ancestor
25824797|NCT00005068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25824798|NCT00005068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24811595|NCT02047292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25824799|NCT00005068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701781|NCT01460979|Sirolimus|sirolimus|mesh-list
24405506|NCT00167479|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24841664|NCT02217319|Sevoflurane|sevoflurane|mesh-list
24952479|NCT03893695|Nivolumab|nivolumab|mesh-list
25067435|NCT03443778|Dexamethasone|dexamethasone|mesh-list
25824800|NCT00005068|Antidotes|antidotes|mesh-ancestor
25824801|NCT00005068|Protective Agents|protective agents|mesh-ancestor
24405932|NCT00168779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405933|NCT00168779|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24406114|NCT00169130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25824804|NCT00005068|Micronutrients|micronutrients|mesh-ancestor
24406197|NCT00169208|Sensory System Agents|sensory system agents|mesh-ancestor
24406202|NCT00169221|Gefitinib|gefitinib|mesh-list
25824805|NCT00005069|Arsenic Trioxide|arsenic trioxide|mesh-list
24541068|NCT00670696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842943|NCT02224443|GABA Modulators|gaba modulators|mesh-ancestor
24406545|NCT00170755|Cholinergic Agents|cholinergic agents|mesh-ancestor
24564887|NCT00778115|Loperamide|loperamide|mesh-list
24829868|NCT02155088|Tubulin Modulators|tubulin modulators|mesh-ancestor
24565705|NCT00782041|Folic Acid|folic acid|mesh-list
24565706|NCT00782041|Fluorouracil|fluorouracil|mesh-list
25824806|NCT00005069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824807|NCT00005070|Irofulven|irofulven|mesh-list
25068221|NCT03435289|Antimetabolites|antimetabolites|mesh-ancestor
24448421|NCT00311740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824808|NCT00005070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25824809|NCT00005070|Alkylating Agents|alkylating agents|mesh-ancestor
24448431|NCT00311753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24448432|NCT00311753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448433|NCT00311818|Insulin Glargine|insulin glargine|mesh-list
24448436|NCT00311857|Cetuximab|cetuximab|mesh-list
24843807|NCT02229734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407956|NCT00175981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24407957|NCT00175981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407958|NCT00175981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24407959|NCT00175981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24829870|NCT02155088|Mitosis Modulators|mitosis modulators|mesh-ancestor
25824810|NCT00005070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824811|NCT00005070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824812|NCT00005072|Interleukin-2|interleukin-2|mesh-list
25824813|NCT00005072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824814|NCT00005072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25824815|NCT00005072|Analgesics|analgesics|mesh-ancestor
24447477|NCT00308542|Hormones|hormones|mesh-ancestor
25824816|NCT00005072|Sensory System Agents|sensory system agents|mesh-ancestor
25824817|NCT00005072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24448077|NCT00310141|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25824818|NCT00005072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448335|NCT00311389|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24448336|NCT00311389|Latanoprost|latanoprost|mesh-list
24448337|NCT00311389|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24448338|NCT00311389|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25824819|NCT00005073|Zoledronic Acid|zoledronic acid|mesh-list
25824820|NCT00005073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25824821|NCT00005073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824822|NCT00005074|Alvocidib|alvocidib|mesh-list
25824823|NCT00005074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824824|NCT00005074|Growth Inhibitors|growth inhibitors|mesh-ancestor
24829578|NCT02153177|Omeprazole|omeprazole|mesh-list
24829579|NCT02153177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24448655|NCT00312533|Hylan|hylan|mesh-list
25824825|NCT00005074|Growth Substances|growth substances|mesh-ancestor
24846411|NCT02242656|Opium|opium|mesh-list
25824826|NCT00005074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824827|NCT00005074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25824828|NCT00005074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824829|NCT00005074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824830|NCT00005076|Irinotecan|irinotecan|mesh-list
25824831|NCT00005076|Cetuximab|cetuximab|mesh-list
25824832|NCT00005076|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25824833|NCT00005076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25824834|NCT00005076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824835|NCT00005076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824836|NCT00005076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071690|NCT03406819|Nitroprusside|nitroprusside|mesh-list
25824837|NCT00005076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25824838|NCT00005077|Oxaliplatin|oxaliplatin|mesh-list
24939290|NCT04010955|Edoxaban|edoxaban|mesh-list
25824839|NCT00005077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25072082|NCT03403647|Vitamin D|vitamin d|mesh-list
25824840|NCT00005078|Paclitaxel|paclitaxel|mesh-list
25824841|NCT00005078|Carboplatin|carboplatin|mesh-list
25824844|NCT00005078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824845|NCT00005078|Tubulin Modulators|tubulin modulators|mesh-ancestor
25824846|NCT00005078|Antimitotic Agents|antimitotic agents|mesh-ancestor
25824847|NCT00005078|Mitosis Modulators|mitosis modulators|mesh-ancestor
25824848|NCT00005078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824849|NCT00005081|Carmustine|carmustine|mesh-list
25824850|NCT00005081|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
24829637|NCT02153541|Dermatologic Agents|dermatologic agents|mesh-ancestor
25824851|NCT00005081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25824852|NCT00005081|Alkylating Agents|alkylating agents|mesh-ancestor
25824853|NCT00005081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073648|NCT03393988|Anesthetics|anesthetics|mesh-ancestor
25044540|NCT01082549|Iniparib|iniparib|mesh-list
25824854|NCT00005081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824855|NCT00005081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824856|NCT00005086|Gemcitabine|gemcitabine|mesh-list
25074023|NCT03391245|Vitamin D|vitamin d|mesh-list
24394388|NCT00133224|Docetaxel|docetaxel|mesh-list
24394402|NCT00133237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24394403|NCT00133237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824857|NCT00005086|Cisplatin|cisplatin|mesh-list
24394415|NCT00133250|Heparin|heparin|mesh-list
25824858|NCT00005086|Docetaxel|docetaxel|mesh-list
25824859|NCT00005086|Methotrexate|methotrexate|mesh-list
25824860|NCT00005086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824861|NCT00005086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25824862|NCT00005086|Antimetabolites|antimetabolites|mesh-ancestor
25824863|NCT00005086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824864|NCT00005086|Antiviral Agents|antiviral agents|mesh-ancestor
25824865|NCT00005086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25824866|NCT00005086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824867|NCT00005086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25074396|NCT03388827|Oxytocics|oxytocics|mesh-ancestor
25044621|NCT01071239|Cyclophosphamide|cyclophosphamide|mesh-list
25824868|NCT00005086|Immunologic Factors|immunologic factors|mesh-ancestor
24636166|NCT01143545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636168|NCT01143584|Cabergoline|cabergoline|mesh-list
24636262|NCT01144260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636275|NCT01144390|Methadone|methadone|mesh-list
25824869|NCT00005086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824870|NCT00005086|Tubulin Modulators|tubulin modulators|mesh-ancestor
25824871|NCT00005086|Antimitotic Agents|antimitotic agents|mesh-ancestor
25824872|NCT00005086|Mitosis Modulators|mitosis modulators|mesh-ancestor
25824873|NCT00005086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25824874|NCT00005086|Abortifacient Agents|abortifacient agents|mesh-ancestor
25824875|NCT00005086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25824876|NCT00005086|Dermatologic Agents|dermatologic agents|mesh-ancestor
25824877|NCT00005086|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25824878|NCT00005086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25824879|NCT00005086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25824880|NCT00005087|Paclitaxel|paclitaxel|mesh-list
25824881|NCT00005087|Cisplatin|cisplatin|mesh-list
25824882|NCT00005087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25824883|NCT00005087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824884|NCT00005087|Tubulin Modulators|tubulin modulators|mesh-ancestor
25824885|NCT00005087|Antimitotic Agents|antimitotic agents|mesh-ancestor
25824886|NCT00005087|Mitosis Modulators|mitosis modulators|mesh-ancestor
25824887|NCT00005087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824888|NCT00005088|Cisplatin|cisplatin|mesh-list
25824889|NCT00005088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824890|NCT00005089|Prednisone|prednisone|mesh-list
25824891|NCT00005089|Cyclophosphamide|cyclophosphamide|mesh-list
25044711|NCT01056393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25044712|NCT01056393|Antiviral Agents|antiviral agents|mesh-ancestor
25044714|NCT01056393|Immunologic Factors|immunologic factors|mesh-ancestor
25824892|NCT00005089|Rituximab|rituximab|mesh-list
25824893|NCT00005089|Doxorubicin|doxorubicin|mesh-list
25824894|NCT00005089|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25824895|NCT00005089|Vincristine|vincristine|mesh-list
25824896|NCT00005089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25824897|NCT00005089|Immunologic Factors|immunologic factors|mesh-ancestor
25824898|NCT00005089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075152|NCT03383185|Contraceptives, Oral|contraceptives, oral|mesh-list
25075416|NCT03381118|Antimetabolites|antimetabolites|mesh-ancestor
24859851|NCT02305979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824911|NCT00005089|Glucocorticoids|glucocorticoids|mesh-ancestor
25824912|NCT00005089|Hormones|hormones|mesh-ancestor
24860834|NCT02313064|CXA-10|cxa-10|mesh-list
24860894|NCT02313337|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24860895|NCT02313337|Cholinergic Agents|cholinergic agents|mesh-ancestor
24860896|NCT02313584|Dabigatran|dabigatran|mesh-list
24860897|NCT02313584|Antithrombins|antithrombins|mesh-ancestor
24541197|NCT00671424|Furosemide|furosemide|mesh-list
25824913|NCT00005089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25824914|NCT00005089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24861049|NCT02314468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861050|NCT02314481|Trastuzumab|trastuzumab|mesh-list
24861051|NCT02314481|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24655980|NCT01259050|Copper|copper|mesh-list
24861187|NCT02315573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24541481|NCT00673218|Respiratory System Agents|respiratory system agents|mesh-ancestor
24813351|NCT02058173|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24813352|NCT02058173|Amebicides|amebicides|mesh-ancestor
24813353|NCT02058173|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25076178|NCT03375398|PAZ320|paz320|mesh-list
25076266|NCT03374501|PAZ320|paz320|mesh-list
24861549|NCT02318511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24848851|NCT03374332|Gemtuzumab|gemtuzumab|mesh-list
24541842|NCT00675688|Bazedoxifene|bazedoxifene|mesh-list
25044862|NCT01025648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25076447|NCT03373149|Hormones|hormones|mesh-list
25076532|NCT03372447|Thiamine|thiamine|mesh-list
24862283|NCT02324088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813491|NCT02058693|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24813492|NCT02058706|Leuprolide|leuprolide|mesh-list
24813493|NCT02058706|Goserelin|goserelin|mesh-list
24813494|NCT02058706|Bicalutamide|bicalutamide|mesh-list
24813495|NCT02058706|Androgens|androgens|mesh-list
24659933|NCT01280994|Xenon|xenon|mesh-list
25076708|NCT03371043|Analgesics|analgesics|mesh-list
24542385|NCT00678457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24542386|NCT00678457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24813570|NCT02059031|Cabotegravir|cabotegravir|mesh-list
24813571|NCT02059031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24862829|NCT04218123|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24862830|NCT04218123|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24474843|NCT00407680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24474844|NCT00407680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24474845|NCT00407680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24474846|NCT00407680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474847|NCT00407719|Bevacizumab|bevacizumab|mesh-list
24474848|NCT00407719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24474849|NCT00407719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474850|NCT00407719|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24474852|NCT00407719|Growth Substances|growth substances|mesh-ancestor
24474954|NCT00408239|Enoxaparin|enoxaparin|mesh-list
24474987|NCT00408382|Atorvastatin|atorvastatin|mesh-list
24823427|NCT02117219|Tremelimumab|tremelimumab|mesh-list
24474988|NCT00408382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24474989|NCT00408382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24474990|NCT00408382|Antimetabolites|antimetabolites|mesh-ancestor
24474991|NCT00408382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474992|NCT00408382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24807033|NCT02019355|Dermatologic Agents|dermatologic agents|mesh-ancestor
24807034|NCT02019355|Emollients|emollients|mesh-ancestor
24807035|NCT02019381|Vitamin D|vitamin d|mesh-list
24476128|NCT00413127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476130|NCT00413179|Clomiphene|clomiphene|mesh-list
24476131|NCT00413179|Enclomiphene|enclomiphene|mesh-list
24476132|NCT00413179|Zuclomiphene|zuclomiphene|mesh-list
24476133|NCT00413179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24476134|NCT00413179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476139|NCT00413179|Fertility Agents|fertility agents|mesh-ancestor
24807104|NCT02019810|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24476733|NCT00416377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476915|NCT00416832|Etoposide|etoposide|mesh-list
24622717|NCT01068132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477378|NCT00418431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24664575|NCT01307839|Lidocaine|lidocaine|mesh-list
24849855|NCT02250859|Minocycline|minocycline|mesh-list
25824915|NCT00005089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25824916|NCT00005089|Tubulin Modulators|tubulin modulators|mesh-ancestor
24477828|NCT00420498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24477829|NCT00420498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477831|NCT00420498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24478685|NCT00423982|Rifampin|rifampin|mesh-list
24478686|NCT00423982|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24478687|NCT00423982|Cloxacillin|cloxacillin|mesh-list
24478688|NCT00423982|Anti-Infective Agents|anti-infective agents|mesh-list
24478689|NCT00423982|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24807629|NCT02022852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807630|NCT02022852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807631|NCT02022917|Bevacizumab|bevacizumab|mesh-list
24807633|NCT02022917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480880|NCT00432549|Almotriptan|almotriptan|mesh-list
24480881|NCT00432549|Anticonvulsants|anticonvulsants|mesh-ancestor
24480882|NCT00432549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24481045|NCT00433173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24481046|NCT00433173|Hormone Antagonists|hormone antagonists|mesh-ancestor
24481047|NCT00433186|Mycophenolic Acid|mycophenolic acid|mesh-list
24808036|NCT02024945|Autonomic Agents|autonomic agents|mesh-ancestor
24808037|NCT02024945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24808038|NCT02024945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808039|NCT02024945|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25824917|NCT00005089|Antimitotic Agents|antimitotic agents|mesh-ancestor
25824918|NCT00005089|Mitosis Modulators|mitosis modulators|mesh-ancestor
25824919|NCT00005090|Cyclophosphamide|cyclophosphamide|mesh-list
24850057|NCT02251509|Autonomic Agents|autonomic agents|mesh-ancestor
24482686|NCT00440219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24482687|NCT00440219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482688|NCT00440219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24482689|NCT00440219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24482690|NCT00440245|Albuterol|albuterol|mesh-list
24482691|NCT00440245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24482692|NCT00440245|Autonomic Agents|autonomic agents|mesh-ancestor
25824920|NCT00005090|Dacarbazine|dacarbazine|mesh-list
24850285|NCT02252614|Codeine|codeine|mesh-list
24500080|NCT00522587|Anesthetics, General|anesthetics, general|mesh-ancestor
24483124|NCT00441961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24483280|NCT00442637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24483281|NCT00442637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850470|NCT02253108|Everolimus|everolimus|mesh-list
24808411|NCT02026973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808412|NCT02026973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808413|NCT02026973|Hormones|hormones|mesh-ancestor
25041710|NCT01593228|Mitosis Modulators|mitosis modulators|mesh-ancestor
24850884|NCT02254174|Autonomic Agents|autonomic agents|mesh-ancestor
24808497|NCT02027454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823512|NCT02117726|Midazolam|midazolam|mesh-list
24808498|NCT02027454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808499|NCT02027454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808500|NCT02027454|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25824921|NCT00005090|Carmustine|carmustine|mesh-list
25203873|NCT02711917|Anesthetics|anesthetics|mesh-ancestor
25203874|NCT02711917|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25203875|NCT02711917|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25203876|NCT02711917|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25203877|NCT02711917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25203878|NCT02711449|Methylprednisolone|methylprednisolone|mesh-list
25203879|NCT02711449|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24808501|NCT02027454|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24484435|NCT00448305|Paclitaxel|paclitaxel|mesh-list
24808533|NCT02027792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24808534|NCT02027792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24485459|NCT00453115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485460|NCT00453115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24955735|NCT03862079|Nystatin|nystatin|mesh-list
24485772|NCT00454961|Lumefantrine|lumefantrine|mesh-list
24486011|NCT00455832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486097|NCT00456313|Respiratory System Agents|respiratory system agents|mesh-ancestor
24486098|NCT00456313|Glucocorticoids|glucocorticoids|mesh-ancestor
24486099|NCT00456313|Hormones|hormones|mesh-ancestor
24486100|NCT00456313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25824922|NCT00005090|Doxorubicin|doxorubicin|mesh-list
25824923|NCT00005090|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24486594|NCT00458614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24486595|NCT00458614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24486596|NCT00458614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24604290|NCT00978328|Oxycodone|oxycodone|mesh-list
24604291|NCT00978328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24604292|NCT00978328|Narcotics|narcotics|mesh-ancestor
24487967|NCT00466089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24489902|NCT00475813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489904|NCT00475826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24489906|NCT00475826|Antimetabolites|antimetabolites|mesh-ancestor
25824924|NCT00005090|Etoposide|etoposide|mesh-list
25824925|NCT00005090|Bleomycin|bleomycin|mesh-list
24492557|NCT00486694|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25824926|NCT00005090|Vinblastine|vinblastine|mesh-list
25045228|NCT00982696|Analgesics|analgesics|mesh-ancestor
24957122|NCT03847272|Glucocorticoids|glucocorticoids|mesh-ancestor
24494075|NCT00493623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24575281|NCT00830492|Fertility Agents|fertility agents|mesh-ancestor
24445166|NCT00300716|Memantine|memantine|mesh-list
25824927|NCT00005090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24495181|NCT00498953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495186|NCT00498953|Antimetabolites|antimetabolites|mesh-ancestor
25824928|NCT00005090|Immunologic Factors|immunologic factors|mesh-ancestor
25824929|NCT00005090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809823|NCT02036372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809824|NCT02036372|Incretins|incretins|mesh-ancestor
24809825|NCT02036372|Hormones|hormones|mesh-ancestor
25824930|NCT00005090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24445794|NCT00302627|Calcium|calcium|mesh-list
24497219|NCT00508898|Vitamins|vitamins|mesh-ancestor
24958355|NCT03834129|Analgesics|analgesics|mesh-ancestor
24851936|NCT02259855|Ribavirin|ribavirin|mesh-list
24958521|NCT03832465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24497676|NCT00511277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24497677|NCT00511277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24498098|NCT00513188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24498099|NCT00513188|Antiviral Agents|antiviral agents|mesh-ancestor
24498100|NCT00513188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24810212|NCT02038699|TIC10 compound|tic10 compound|mesh-list
24810213|NCT02038699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498247|NCT00513656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24958818|NCT03829566|Prednisolone|prednisolone|mesh-list
24958967|NCT03828682|Antiemetics|antiemetics|mesh-ancestor
25647400|NCT01469013|Methotrexate|methotrexate|mesh-list
25647401|NCT01469013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25647402|NCT01469013|Abortifacient Agents|abortifacient agents|mesh-ancestor
25647403|NCT01469013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25647404|NCT01469013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647405|NCT01469013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25647406|NCT01469013|Antimetabolites|antimetabolites|mesh-ancestor
25657174|NCT01583686|Immunologic Factors|immunologic factors|mesh-ancestor
24500083|NCT00522587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500084|NCT00522587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24500085|NCT00522587|Narcotics|narcotics|mesh-ancestor
24810357|NCT02039765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24959543|NCT03824314|GABA Agents|gaba agents|mesh-ancestor
24503140|NCT03153150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24503145|NCT03126331|Ipilimumab|ipilimumab|mesh-list
24589523|NCT00907985|Antiemetics|antiemetics|mesh-ancestor
25824931|NCT00005090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25824932|NCT00005090|Alkylating Agents|alkylating agents|mesh-ancestor
25824933|NCT00005090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504076|NCT00533936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24504077|NCT00533936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25824934|NCT00005090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824935|NCT00005090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24504181|NCT00534508|Tacrolimus|tacrolimus|mesh-list
24504182|NCT00534508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25824936|NCT00005090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25824937|NCT00005090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24504804|NCT00538187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430320|NCT00247130|Omeprazole|omeprazole|mesh-list
24960452|NCT03816592|Analgesics|analgesics|mesh-ancestor
24505092|NCT00539786|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24462330|NCT00355719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24960601|NCT03815448|Immunologic Factors|immunologic factors|mesh-ancestor
24631163|NCT01116219|Bevacizumab|bevacizumab|mesh-list
24631164|NCT01116219|Pemetrexed|pemetrexed|mesh-list
24398943|NCT00146224|Epoetin Alfa|epoetin alfa|mesh-list
24400890|NCT00151541|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24404056|NCT00162435|Anticoagulants|anticoagulants|mesh-ancestor
24404057|NCT00162461|Phenytoin|phenytoin|mesh-list
24404058|NCT00162461|Anticonvulsants|anticonvulsants|mesh-ancestor
24404059|NCT00162461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24404060|NCT00162461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24540260|NCT00667108|Gabapentin|gabapentin|mesh-list
24405031|NCT00165347|Vatalanib|vatalanib|mesh-list
24405225|NCT00165867|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24811636|NCT02047474|Vitamins|vitamins|mesh-ancestor
24961542|NCT03807362|CC-11050|cc-11050|mesh-list
24405542|NCT00167583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405544|NCT00167583|Dermatologic Agents|dermatologic agents|mesh-ancestor
24405545|NCT00167583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24405546|NCT00167583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24406146|NCT00169156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25166442|NCT04082442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25078719|NCT03354117|Analgesics|analgesics|mesh-ancestor
24562904|NCT00768859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24562905|NCT00768859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562906|NCT00768859|Tubulin Modulators|tubulin modulators|mesh-ancestor
24406549|NCT00170755|Urological Agents|urological agents|mesh-ancestor
24406551|NCT00170768|Darifenacin|darifenacin|mesh-list
24406552|NCT00170768|Parasympatholytics|parasympatholytics|mesh-ancestor
24567281|NCT00790439|Dextrans|dextrans|mesh-list
24567550|NCT00791531|Abortifacient Agents|abortifacient agents|mesh-ancestor
24567682|NCT00792168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24671032|NCT01323257|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24596527|NCT00943982|Antiviral Agents|antiviral agents|mesh-ancestor
24406831|NCT00171392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24406832|NCT00171392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24406833|NCT00171392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407030|NCT00171743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407031|NCT00171743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407032|NCT00171743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24407033|NCT00171743|Immunologic Factors|immunologic factors|mesh-ancestor
24407034|NCT00171743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407035|NCT00171743|Antifungal Agents|antifungal agents|mesh-ancestor
24407721|NCT00175227|Mannitol|mannitol|mesh-list
24962401|NCT03799172|Echinocandins|echinocandins|mesh-list
24820204|NCT02099240|Cycloserine|cycloserine|mesh-list
25647407|NCT01469013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422713|NCT00223691|Octreotide|octreotide|mesh-list
25647408|NCT01469013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647409|NCT01469013|Dermatologic Agents|dermatologic agents|mesh-ancestor
24820205|NCT02099240|Piperacillin|piperacillin|mesh-list
24820206|NCT02099240|Metronidazole|metronidazole|mesh-list
25647410|NCT01469013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25647411|NCT01469013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25171671|NCT02885961|Antithrombins|antithrombins|mesh-ancestor
25171672|NCT02885961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25171673|NCT02885961|Protease Inhibitors|protease inhibitors|mesh-ancestor
25171674|NCT02885961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25171675|NCT02885961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171676|NCT02885961|Anticoagulants|anticoagulants|mesh-ancestor
25171677|NCT02885727|Durvalumab|durvalumab|mesh-list
25171678|NCT02885727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25171679|NCT02885727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171680|NCT02885909|Insulin|insulin|mesh-list
25171681|NCT02885909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25171682|NCT02885909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171683|NCT02885740|Adenosine|adenosine|mesh-list
25171684|NCT02885740|Analgesics|analgesics|mesh-ancestor
25171685|NCT02885740|Sensory System Agents|sensory system agents|mesh-ancestor
25171686|NCT02885740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24820207|NCT02099240|Imipenem|imipenem|mesh-list
24820208|NCT02099240|Penicillins|penicillins|mesh-list
25824938|NCT00005090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24597702|NCT00950898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24408601|NCT00178828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24408602|NCT00178828|Antidepressive Agents|antidepressive agents|mesh-ancestor
24408603|NCT00178828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24408604|NCT00178828|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24408605|NCT00178828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24408606|NCT00178828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24408646|NCT00178971|Serotonin Agents|serotonin agents|mesh-ancestor
24408647|NCT00178971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24408651|NCT00179023|Ephedrine|ephedrine|mesh-list
24820387|NCT02099253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24820388|NCT02099253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24820389|NCT02099253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24820418|NCT02099396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820419|NCT02099396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24820420|NCT02099396|Immunologic Factors|immunologic factors|mesh-ancestor
24820421|NCT02099396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824939|NCT00005090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824940|NCT00005090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25824941|NCT00005090|Tubulin Modulators|tubulin modulators|mesh-ancestor
25824942|NCT00005090|Antimitotic Agents|antimitotic agents|mesh-ancestor
25824943|NCT00005090|Mitosis Modulators|mitosis modulators|mesh-ancestor
24408853|NCT00179751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24408904|NCT00180037|Coenzyme Q10|coenzyme q10|mesh-list
24408905|NCT00180037|Micronutrients|micronutrients|mesh-ancestor
24408907|NCT00180037|Vitamins|vitamins|mesh-ancestor
24820494|NCT02099825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24409154|NCT00181025|Melphalan|melphalan|mesh-list
24820698|NCT02101047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24820699|NCT02101047|Adrenergic Agents|adrenergic agents|mesh-ancestor
25647412|NCT01469013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25647413|NCT01469013|Immunologic Factors|immunologic factors|mesh-ancestor
25647414|NCT01469013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25647415|NCT01469013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25647416|NCT01469052|Axitinib|axitinib|mesh-list
25647417|NCT01469052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647418|NCT01469052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25647419|NCT01469052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25647420|NCT01469052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647421|NCT01469065|Nicotinic Acids|nicotinic acids|mesh-list
25647422|NCT01469065|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
25647423|NCT01469065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25647424|NCT01469065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647425|NCT01469065|Vitamin B Complex|vitamin b complex|mesh-ancestor
25647426|NCT01469065|Vitamins|vitamins|mesh-ancestor
25647427|NCT01469065|Micronutrients|micronutrients|mesh-ancestor
25647428|NCT01469065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824944|NCT00005091|Exatecan|exatecan|mesh-list
24599455|NCT04562129|Analgesics|analgesics|mesh-ancestor
24409809|NCT00183235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24410086|NCT00184197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171725|NCT02885597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24410087|NCT00184496|Methadone|methadone|mesh-list
24410088|NCT00184496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24683243|NCT01390896|Protease Inhibitors|protease inhibitors|mesh-ancestor
24600498|NCT00959075|Thiamine|thiamine|mesh-list
24410849|NCT00187070|Glucocorticoids|glucocorticoids|mesh-ancestor
24963966|NCT03786887|Nalbuphine|nalbuphine|mesh-list
25045260|NCT00979251|Dopamine Agents|dopamine agents|mesh-ancestor
24411024|NCT00187447|Indomethacin|indomethacin|mesh-list
25078908|NCT03352700|Dyclonine|dyclonine|mesh-list
24821468|NCT02105623|Antimetabolites|antimetabolites|mesh-ancestor
24821504|NCT02106104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24602038|NCT00967057|Antimetabolites|antimetabolites|mesh-ancestor
24620133|NCT01055522|Analgesics|analgesics|mesh-ancestor
24821782|NCT02107807|Lactitol|lactitol|mesh-list
24412111|NCT00190853|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24412112|NCT00190853|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24603888|NCT00976066|Naltrexone|naltrexone|mesh-list
24821838|NCT02108353|Protective Agents|protective agents|mesh-ancestor
24821839|NCT02108353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412315|NCT00191204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412316|NCT00191204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821917|NCT02108756|Pantoprazole|pantoprazole|mesh-list
24965012|NCT03779360|Clobetasol|clobetasol|mesh-list
24413567|NCT00194402|Nicotinic Acids|nicotinic acids|mesh-list
24822131|NCT02109913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24998415|NCT02881957|Vitamin D|vitamin d|mesh-list
24413717|NCT00194974|Adrenergic Agents|adrenergic agents|mesh-ancestor
24413721|NCT00194974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24414090|NCT00195923|Gentamicins|gentamicins|mesh-list
24822257|NCT02110719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24822258|NCT02110719|Analgesics|analgesics|mesh-ancestor
24965382|NCT03777761|Moxifloxacin|moxifloxacin|mesh-list
24822354|NCT02111265|Sufentanil|sufentanil|mesh-list
24823066|NCT02114697|Antimetabolites|antimetabolites|mesh-ancestor
24923949|NCT04165629|Analgesics|analgesics|mesh-ancestor
24416998|NCT00204646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24966689|NCT03766269|Dronabinol|dronabinol|mesh-list
24924180|NCT04162028|Anesthetics, General|anesthetics, general|mesh-ancestor
25142910|NCT02946294|Bupivacaine|bupivacaine|mesh-list
24417122|NCT00205634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24417123|NCT00205634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24924249|NCT04161508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24417348|NCT00206219|Antimetabolites|antimetabolites|mesh-ancestor
24417540|NCT00206765|Risperidone|risperidone|mesh-list
25824945|NCT00005091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24417550|NCT00206765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24417569|NCT00206778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24417570|NCT00206778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24417571|NCT00206778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24417572|NCT00206778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24417573|NCT00206778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24417574|NCT00206778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24500281|NCT00523458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25824946|NCT00005091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24417662|NCT00207051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24417663|NCT00207051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417742|NCT00207532|Folic Acid|folic acid|mesh-list
24500539|NCT00524875|Bevacizumab|bevacizumab|mesh-list
24822972|NCT02114502|Pyridoxine|pyridoxine|mesh-list
24822973|NCT02114502|Gemcitabine|gemcitabine|mesh-list
24418274|NCT00209209|Rituximab|rituximab|mesh-list
24418275|NCT00209209|Doxorubicin|doxorubicin|mesh-list
24418276|NCT00209209|Fludarabine|fludarabine|mesh-list
24418277|NCT00209209|Vincristine|vincristine|mesh-list
24418278|NCT00209209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24418279|NCT00209209|Immunologic Factors|immunologic factors|mesh-ancestor
24418280|NCT00209209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418281|NCT00209209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24418310|NCT00209222|Etoposide|etoposide|mesh-list
24418415|NCT00209586|Fospropofol|fospropofol|mesh-list
24418416|NCT00209586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25647429|NCT01469221|Apaziquone|apaziquone|mesh-list
24418417|NCT00209586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24418418|NCT00209586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418419|NCT00209599|Fospropofol|fospropofol|mesh-list
24418420|NCT00209599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24418421|NCT00209599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24418424|NCT00209612|Irinotecan|irinotecan|mesh-list
24925208|NCT04152434|Erenumab|erenumab|mesh-list
24925366|NCT04150575|Paclitaxel|paclitaxel|mesh-list
24418861|NCT00210379|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24418862|NCT00210379|Abortifacient Agents|abortifacient agents|mesh-ancestor
25203922|NCT02711579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24418863|NCT00210379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24823045|NCT02114645|Fertility Agents|fertility agents|mesh-ancestor
24823046|NCT02114645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24823048|NCT02114658|Sorafenib|sorafenib|mesh-list
24925481|NCT04149678|Ozanimod|ozanimod|mesh-list
24823063|NCT02114697|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24823064|NCT02114697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24823065|NCT02114697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24925629|NCT04148885|Paclitaxel|paclitaxel|mesh-list
24823081|NCT02114736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24823082|NCT02114736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24823083|NCT02114775|Sildenafil Citrate|sildenafil citrate|mesh-list
24823085|NCT02114775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24823086|NCT02114775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823087|NCT02114775|Vasodilator Agents|vasodilator agents|mesh-ancestor
24823088|NCT02114775|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24823115|NCT02115152|Alkylating Agents|alkylating agents|mesh-ancestor
24823117|NCT02115152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926056|NCT04144920|Oxymetazoline|oxymetazoline|mesh-list
24419629|NCT00213122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24419630|NCT00213122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419631|NCT00213122|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24419632|NCT00213200|Morphine|morphine|mesh-list
24419633|NCT00213200|Tetracaine|tetracaine|mesh-list
24419634|NCT00213200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24419635|NCT00213200|Narcotics|narcotics|mesh-ancestor
24419636|NCT00213200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24419637|NCT00213200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419766|NCT00213694|Celecoxib|celecoxib|mesh-list
24808097|NCT02025166|Acetaminophen|acetaminophen|mesh-list
24420008|NCT00214942|Sensory System Agents|sensory system agents|mesh-ancestor
24420009|NCT00214942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24420010|NCT00214942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24420011|NCT00214942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24420012|NCT00214942|Anesthetics, General|anesthetics, general|mesh-ancestor
24420014|NCT00214955|Fentanyl|fentanyl|mesh-list
24420015|NCT00214955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24420016|NCT00214955|Narcotics|narcotics|mesh-ancestor
24524103|NCT05266417|Insulin|insulin|mesh-list
24420158|NCT00215280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24926316|NCT04142840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24420440|NCT00216034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420441|NCT00216034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24420442|NCT00216034|Immunologic Factors|immunologic factors|mesh-ancestor
24926503|NCT04141319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24926504|NCT04141163|Metformin|metformin|mesh-list
24926505|NCT04141163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24421013|NCT00217503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24421014|NCT00217503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24421015|NCT00217503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24421016|NCT00217503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24421017|NCT00217503|Growth Substances|growth substances|mesh-ancestor
24421018|NCT00217503|Growth Inhibitors|growth inhibitors|mesh-ancestor
24421126|NCT00217711|Antimetabolites|antimetabolites|mesh-ancestor
24421127|NCT00217711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041712|NCT01593228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25824947|NCT00005091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829490|NCT00006219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24690911|NCT01404442|Midazolam|midazolam|mesh-list
24965396|NCT03777488|Hemostatics|hemostatics|mesh-ancestor
25041713|NCT01593228|Antimetabolites|antimetabolites|mesh-ancestor
24421777|NCT00220168|Antimetabolites|antimetabolites|mesh-ancestor
24421900|NCT00220493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421902|NCT00220493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24421903|NCT00220506|Modafinil|modafinil|mesh-list
24421904|NCT00220506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24421905|NCT00220506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421906|NCT00220506|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24422000|NCT00220857|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24422001|NCT00220857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422002|NCT00220857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041714|NCT01593228|Antiviral Agents|antiviral agents|mesh-ancestor
24823379|NCT02116868|Adrenergic Agents|adrenergic agents|mesh-ancestor
24422184|NCT00221520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24422185|NCT00221520|Anesthetics, General|anesthetics, general|mesh-ancestor
25647430|NCT01469221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647431|NCT01469234|Loratadine|loratadine|mesh-list
24422187|NCT00221520|GABA Modulators|gaba modulators|mesh-ancestor
24422188|NCT00221520|GABA Agents|gaba agents|mesh-ancestor
24422189|NCT00221520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24422210|NCT00221624|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24823402|NCT02116959|Mitosis Modulators|mitosis modulators|mesh-ancestor
24823403|NCT02116959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24823404|NCT02116959|Alkylating Agents|alkylating agents|mesh-ancestor
24823405|NCT02116959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24422305|NCT00221975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24422349|NCT00222183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24422495|NCT00222573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24422496|NCT00222573|Adrenergic Agents|adrenergic agents|mesh-ancestor
24422497|NCT00222651|Tenecteplase|tenecteplase|mesh-list
24422498|NCT00222651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24998417|NCT02881957|Vitamins|vitamins|mesh-ancestor
24823621|NCT02118142|Betaine|betaine|mesh-list
24823622|NCT02118142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24823623|NCT02118142|Lipotropic Agents|lipotropic agents|mesh-ancestor
24422545|NCT00222833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24422546|NCT00222833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422547|NCT00222833|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24422548|NCT00222833|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24422549|NCT00222833|Serotonin Agents|serotonin agents|mesh-ancestor
24817488|NCT02084355|Fentanyl|fentanyl|mesh-list
24422898|NCT00223717|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25824948|NCT00005091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422899|NCT00223717|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24422900|NCT00223717|Protease Inhibitors|protease inhibitors|mesh-ancestor
24422901|NCT00223743|Zonisamide|zonisamide|mesh-list
24422902|NCT00223743|Anticonvulsants|anticonvulsants|mesh-ancestor
24422903|NCT00223743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24422904|NCT00223743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24422905|NCT00223743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423192|NCT00225043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24423193|NCT00225043|Autonomic Agents|autonomic agents|mesh-ancestor
24423194|NCT00225043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24423195|NCT00225043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24423196|NCT00225043|Respiratory System Agents|respiratory system agents|mesh-ancestor
24423197|NCT00225043|Mydriatics|mydriatics|mesh-ancestor
24423198|NCT00225043|Sympathomimetics|sympathomimetics|mesh-ancestor
24423199|NCT00225043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24423200|NCT00225043|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24423201|NCT00225043|Nasal Decongestants|nasal decongestants|mesh-ancestor
24423202|NCT00225043|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24823785|NCT02118909|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24823786|NCT02118909|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24823787|NCT02118909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823788|NCT02118909|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24525649|NCT02974049|Ivermectin|ivermectin|mesh-list
24423436|NCT00225914|Antidepressive Agents|antidepressive agents|mesh-ancestor
24823890|NCT02119884|Terlipressin|terlipressin|mesh-list
24823891|NCT02119884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24823953|NCT02120339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24823954|NCT02120404|Esmolol|esmolol|mesh-list
24424872|NCT00231101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24823963|NCT02120547|Liver Extracts|liver extracts|mesh-list
24823964|NCT02120547|Hematinics|hematinics|mesh-ancestor
24823965|NCT02120547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24823966|NCT02120547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823968|NCT02120547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24823969|NCT02120547|Antiviral Agents|antiviral agents|mesh-ancestor
24824006|NCT02120703|Anticonvulsants|anticonvulsants|mesh-ancestor
24824007|NCT02120703|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24612216|NCT01012570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24423625|NCT00226447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423626|NCT00226447|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24423627|NCT00226447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24423629|NCT00226473|Vindesine|vindesine|mesh-list
24423630|NCT00226473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24423631|NCT00226473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24824035|NCT02120911|Pertuzumab|pertuzumab|mesh-list
24965503|NCT03776448|Charcoal|charcoal|mesh-list
24424116|NCT00227981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824185|NCT02122055|Narcotics|narcotics|mesh-ancestor
24824186|NCT02122055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24824187|NCT02122055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24824188|NCT02122055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24824189|NCT02122055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24824190|NCT02122055|GABA Modulators|gaba modulators|mesh-ancestor
24824191|NCT02122055|GABA Agents|gaba agents|mesh-ancestor
24824192|NCT02122081|Cyclophosphamide|cyclophosphamide|mesh-list
24824193|NCT02122081|Methotrexate|methotrexate|mesh-list
24824213|NCT02122081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824214|NCT02122081|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24824215|NCT02122081|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24965575|NCT03775707|Lenvatinib|lenvatinib|mesh-list
24424401|NCT00229138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24424402|NCT00229138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424403|NCT00229216|Tinidazole|tinidazole|mesh-list
24424404|NCT00229216|Alkylating Agents|alkylating agents|mesh-ancestor
24546150|NCT00696982|Glyburide|glyburide|mesh-list
24424405|NCT00229216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824949|NCT00005091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424441|NCT00229424|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24424442|NCT00229424|Histamine Antagonists|histamine antagonists|mesh-ancestor
24424443|NCT00229424|Histamine Agents|histamine agents|mesh-ancestor
24424444|NCT00229424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24424447|NCT00229450|Estrogens|estrogens|mesh-list
24424702|NCT00230464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24424703|NCT00230464|Protease Inhibitors|protease inhibitors|mesh-ancestor
24424704|NCT00230464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824319|NCT02122731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24694178|NCT01424332|Aspirin|aspirin|mesh-list
24424865|NCT00231075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424866|NCT00231075|Tubulin Modulators|tubulin modulators|mesh-ancestor
24424867|NCT00231075|Antimitotic Agents|antimitotic agents|mesh-ancestor
24424868|NCT00231075|Mitosis Modulators|mitosis modulators|mesh-ancestor
24424869|NCT00231075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424870|NCT00231101|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24424871|NCT00231101|Antidepressive Agents|antidepressive agents|mesh-ancestor
24424875|NCT00231101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24424876|NCT00231101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424877|NCT00231140|Thalidomide|thalidomide|mesh-list
25166486|NCT03993132|Glucagon|glucagon|mesh-list
24565782|NCT00782405|Serotonin Agents|serotonin agents|mesh-ancestor
24425067|NCT00231855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24527155|NCT00615212|Midazolam|midazolam|mesh-list
25824950|NCT00005092|Cyclophosphamide|cyclophosphamide|mesh-list
24928515|NCT04121338|Bupivacaine|bupivacaine|mesh-list
24425966|NCT00234871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426634|NCT00236431|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24426635|NCT00236431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24426636|NCT00236431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426637|NCT00236431|Cholinergic Agents|cholinergic agents|mesh-ancestor
24426638|NCT00236431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24426639|NCT00236431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426640|NCT00236431|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24426803|NCT00236665|Topiramate|topiramate|mesh-list
24426808|NCT00236678|Hematinics|hematinics|mesh-ancestor
24760671|NCT01759589|Propofol|propofol|mesh-list
24427029|NCT00237211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427030|NCT00237211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24427264|NCT00237874|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24427265|NCT00237874|Serotonin Agents|serotonin agents|mesh-ancestor
24427266|NCT00237874|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24427267|NCT00237874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24427268|NCT00237874|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24427269|NCT00237874|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24427271|NCT00237887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24427272|NCT00237887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24427273|NCT00237900|Leucovorin|leucovorin|mesh-list
24427274|NCT00237900|Fluorouracil|fluorouracil|mesh-list
24427275|NCT00237900|Gefitinib|gefitinib|mesh-list
24427276|NCT00237900|Antimetabolites|antimetabolites|mesh-ancestor
24427277|NCT00237900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427278|NCT00237900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24427279|NCT00237900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24824468|NCT02123589|Fentanyl|fentanyl|mesh-list
24427555|NCT00238368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25647432|NCT01469234|Fexofenadine|fexofenadine|mesh-list
25647433|NCT01469234|Terfenadine|terfenadine|mesh-list
25647434|NCT01469234|Antipruritics|antipruritics|mesh-ancestor
25647435|NCT01469234|Dermatologic Agents|dermatologic agents|mesh-ancestor
25647436|NCT01469234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25647437|NCT01469234|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24427557|NCT00238368|Alkylating Agents|alkylating agents|mesh-ancestor
24824678|NCT02124655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24428208|NCT00239954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428209|NCT00239954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25045288|NCT00973284|Mannitol|mannitol|mesh-list
24428711|NCT00241020|Octreotide|octreotide|mesh-list
24505105|NCT00539877|Irinotecan|irinotecan|mesh-list
24929130|NCT04115410|Cisplatin|cisplatin|mesh-list
24429064|NCT00242463|Testosterone Congeners|testosterone congeners|mesh-list
24429065|NCT00242463|Androgens|androgens|mesh-ancestor
24429066|NCT00242463|Hormones|hormones|mesh-ancestor
25824951|NCT00005092|Thiotepa|thiotepa|mesh-list
24429471|NCT00244127|Hormones|hormones|mesh-ancestor
24430058|NCT00246103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24430060|NCT00246103|Alkylating Agents|alkylating agents|mesh-ancestor
24430229|NCT00246532|Sensory System Agents|sensory system agents|mesh-ancestor
24929630|NCT04111289|Tirofiban|tirofiban|mesh-list
24430539|NCT00248183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430540|NCT00248209|Bupropion|bupropion|mesh-list
24430541|NCT00248209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24825084|NCT02127190|CXA-10|cxa-10|mesh-list
24431005|NCT00249964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24431607|NCT00252369|Infliximab|infliximab|mesh-list
24825167|NCT02127697|Cholinergic Agents|cholinergic agents|mesh-ancestor
24825168|NCT02127736|Amitriptyline|amitriptyline|mesh-list
24432375|NCT00254631|Analgesics|analgesics|mesh-ancestor
24432376|NCT00254631|Sensory System Agents|sensory system agents|mesh-ancestor
24432616|NCT00255528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24930338|NCT04101929|Irinotecan|irinotecan|mesh-list
24433086|NCT00257530|Imiquimod|imiquimod|mesh-list
24825221|NCT02127840|Sympathomimetics|sympathomimetics|mesh-ancestor
24825430|NCT02128334|Leuprolide|leuprolide|mesh-list
24568763|NCT00797472|Bleomycin|bleomycin|mesh-list
24435630|NCT00267319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825522|NCT02128893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435920|NCT00268515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777629|NCT01865305|Insulin Aspart|insulin aspart|mesh-list
24931782|NCT04085393|Granisetron|granisetron|mesh-list
24436736|NCT00271271|Vinorelbine|vinorelbine|mesh-list
24436737|NCT00271271|Oxaliplatin|oxaliplatin|mesh-list
24437660|NCT00274092|Parasympatholytics|parasympatholytics|mesh-ancestor
24437661|NCT00274092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25824952|NCT00005092|Methoxsalen|methoxsalen|mesh-list
24438274|NCT00275249|Analgesics|analgesics|mesh-ancestor
25824953|NCT00005092|Furocoumarins|furocoumarins|mesh-list
24439479|NCT00278967|Laxatives|laxatives|mesh-ancestor
24439480|NCT00279019|Tiotropium Bromide|tiotropium bromide|mesh-list
24439918|NCT00280878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24439992|NCT00281255|Allopurinol|allopurinol|mesh-list
24825759|NCT02130167|Parasympatholytics|parasympatholytics|mesh-ancestor
24440985|NCT00285623|Thrombin|thrombin|mesh-list
25824954|NCT00005092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25824955|NCT00005092|Immunologic Factors|immunologic factors|mesh-ancestor
25824956|NCT00005092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824957|NCT00005092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25041715|NCT01593228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25824958|NCT00005092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25824959|NCT00005092|Alkylating Agents|alkylating agents|mesh-ancestor
25824960|NCT00005092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824961|NCT00005092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824962|NCT00005092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25824963|NCT00005092|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25824964|NCT00005092|Dermatologic Agents|dermatologic agents|mesh-ancestor
25824965|NCT00005093|Gemcitabine|gemcitabine|mesh-list
25824966|NCT00005093|Tacedinaline|tacedinaline|mesh-list
25824967|NCT00005093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25824968|NCT00005093|Antimetabolites|antimetabolites|mesh-ancestor
25824969|NCT00005093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934430|NCT04061265|Anesthetics|anesthetics|mesh-ancestor
25824970|NCT00005093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24668602|NCT04734080|Analgesics|analgesics|mesh-ancestor
24966252|NCT03770013|Clonidine|clonidine|mesh-list
24668791|NCT04596033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765773|NCT01790542|Iron|iron|mesh-list
25824971|NCT00005093|Antiviral Agents|antiviral agents|mesh-ancestor
24413236|NCT00193336|Gefitinib|gefitinib|mesh-list
25824972|NCT00005093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24669800|NCT03611010|Atorvastatin|atorvastatin|mesh-list
25824973|NCT00005093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824974|NCT00005093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25824976|NCT00005093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25824977|NCT00005093|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25824978|NCT00005094|Celecoxib|celecoxib|mesh-list
25824979|NCT00005094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25824980|NCT00005094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25824981|NCT00005094|Analgesics|analgesics|mesh-ancestor
25824982|NCT00005094|Sensory System Agents|sensory system agents|mesh-ancestor
25824983|NCT00005094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25824984|NCT00005094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766473|NCT01795027|Oxaliplatin|oxaliplatin|mesh-list
24443311|NCT00294463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443312|NCT00294463|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24443333|NCT00294502|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24443334|NCT00294502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443336|NCT00294567|Calcium Channel Blockers|calcium channel blockers|mesh-list
24443337|NCT00294567|Calcium|calcium|mesh-list
24443343|NCT00294567|Vasodilator Agents|vasodilator agents|mesh-ancestor
25824985|NCT00005094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25824986|NCT00005094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24459116|NCT00343707|Vestipitant|vestipitant|mesh-list
24443392|NCT00294749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443393|NCT00294749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24443394|NCT00294749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24443395|NCT00294749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24443397|NCT00294775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24443399|NCT00294775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25824987|NCT00005094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24670286|NCT03101748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24670287|NCT03101748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24670288|NCT03101748|Tubulin Modulators|tubulin modulators|mesh-ancestor
24966424|NCT03768258|Hormones|hormones|mesh-ancestor
25824988|NCT00005094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24443709|NCT00295893|Paclitaxel|paclitaxel|mesh-list
25824989|NCT00005094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25824990|NCT00005094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824991|NCT00005096|Docetaxel|docetaxel|mesh-list
25824992|NCT00005096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25824993|NCT00005096|Tubulin Modulators|tubulin modulators|mesh-ancestor
25824994|NCT00005096|Antimitotic Agents|antimitotic agents|mesh-ancestor
25824995|NCT00005096|Mitosis Modulators|mitosis modulators|mesh-ancestor
25824996|NCT00005096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25824997|NCT00005104|Metformin|metformin|mesh-list
25824998|NCT00005104|Clomiphene|clomiphene|mesh-list
25824999|NCT00005104|Enclomiphene|enclomiphene|mesh-list
25825000|NCT00005104|Zuclomiphene|zuclomiphene|mesh-list
25825001|NCT00005104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25825002|NCT00005104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825003|NCT00005104|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25825004|NCT00005104|Hormone Antagonists|hormone antagonists|mesh-ancestor
24443807|NCT00295997|Alkylating Agents|alkylating agents|mesh-ancestor
24826781|NCT02135965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826782|NCT02135965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826783|NCT02135965|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24826784|NCT02135965|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24443907|NCT00296127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24443908|NCT00296127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443909|NCT00296127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443911|NCT00296179|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24782229|NCT01895010|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25825005|NCT00005104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25825006|NCT00005104|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25825007|NCT00005104|Fertility Agents|fertility agents|mesh-ancestor
25825008|NCT00005104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25825009|NCT00005104|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24826989|NCT02137083|Tubulin Modulators|tubulin modulators|mesh-ancestor
24826990|NCT02137083|Antimitotic Agents|antimitotic agents|mesh-ancestor
24826991|NCT02137083|Mitosis Modulators|mitosis modulators|mesh-ancestor
25169606|NCT01795911|Ribavirin|ribavirin|mesh-list
24827185|NCT02137733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825010|NCT00005104|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25825011|NCT00005106|Lamivudine|lamivudine|mesh-list
25825012|NCT00005106|Zidovudine|zidovudine|mesh-list
25825013|NCT00005106|Abacavir|abacavir|mesh-list
25041718|NCT01593228|Immunologic Factors|immunologic factors|mesh-ancestor
25155991|NCT05189223|Narcotics|narcotics|mesh-ancestor
25155992|NCT05189223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25155993|NCT05189223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115058|NCT03118713|Metformin|metformin|mesh-list
24540082|NCT00666575|Gabapentin|gabapentin|mesh-list
25825014|NCT00005106|Stavudine|stavudine|mesh-list
25825015|NCT00005106|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25825016|NCT00005106|Nelfinavir|nelfinavir|mesh-list
25825017|NCT00005106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25825018|NCT00005106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25825019|NCT00005106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825020|NCT00005106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825021|NCT00005106|Antiviral Agents|antiviral agents|mesh-ancestor
25825022|NCT00005106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25825023|NCT00005106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24449068|NCT00314158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449070|NCT00314171|Dorzolamide|dorzolamide|mesh-list
24449071|NCT00314171|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25825024|NCT00005106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25825025|NCT00005106|Antimetabolites|antimetabolites|mesh-ancestor
25825026|NCT00005106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25825027|NCT00005106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25825028|NCT00005106|Protease Inhibitors|protease inhibitors|mesh-ancestor
25825029|NCT00005107|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
25825030|NCT00005107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825031|NCT00005107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825032|NCT00005108|Estradiol|estradiol|mesh-list
25825033|NCT00005108|Progesterone|progesterone|mesh-list
25825034|NCT00005108|Estrogens|estrogens|mesh-ancestor
25825035|NCT00005108|Hormones|hormones|mesh-ancestor
25825036|NCT00005108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25825037|NCT00005108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783251|NCT01900847|Ketamine|ketamine|mesh-list
24849601|NCT02249299|Sensory System Agents|sensory system agents|mesh-ancestor
24849602|NCT02249299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24849603|NCT02249299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849621|NCT02249416|Antiviral Agents|antiviral agents|mesh-ancestor
24849622|NCT02249416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24849623|NCT02249416|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24849624|NCT02249416|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24851163|NCT02255734|Antiviral Agents|antiviral agents|mesh-ancestor
25041719|NCT01593228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851869|NCT02259738|Kallikreins|kallikreins|mesh-list
24851870|NCT02259738|Coagulants|coagulants|mesh-ancestor
24851871|NCT02259738|Fertility Agents, Male|fertility agents, male|mesh-ancestor
24851872|NCT02259738|Fertility Agents|fertility agents|mesh-ancestor
25071081|NCT03413059|Morphine|morphine|mesh-list
24851919|NCT02259816|Vasodilator Agents|vasodilator agents|mesh-ancestor
25169690|NCT01780428|Acetaminophen|acetaminophen|mesh-list
24851921|NCT02259816|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24851923|NCT02259829|Telmisartan|telmisartan|mesh-list
25045495|NCT00945802|Hormones|hormones|mesh-ancestor
25071953|NCT03404908|Morphine|morphine|mesh-list
24597740|NCT00951444|Carboplatin|carboplatin|mesh-list
24597741|NCT00951444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597742|NCT00951444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24597744|NCT00951444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597751|NCT00951574|Nadroparin|nadroparin|mesh-list
24597752|NCT00951574|Calcium|calcium|mesh-list
24597753|NCT00951574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24597754|NCT00951574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597917|NCT00952796|Ampicillin|ampicillin|mesh-list
24603011|NCT00972075|Antioxidants|antioxidants|mesh-ancestor
24533588|NCT00644553|Clarithromycin|clarithromycin|mesh-list
24770218|NCT01819064|Atropine|atropine|mesh-list
24770437|NCT01820455|Chlorhexidine|chlorhexidine|mesh-list
24770514|NCT01820962|Heparin|heparin|mesh-list
24926730|NCT04138420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24927370|NCT04133428|Valsartan|valsartan|mesh-list
24532779|NCT00641082|Clevudine|clevudine|mesh-list
25647438|NCT01469234|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25647439|NCT01469234|Histamine Antagonists|histamine antagonists|mesh-ancestor
25647440|NCT01469234|Histamine Agents|histamine agents|mesh-ancestor
25647441|NCT01469234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25647442|NCT01469234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785980|NCT01917448|Morphine|morphine|mesh-list
24771446|NCT01827293|Promethazine|promethazine|mesh-list
25019504|NCT03690778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24476596|NCT00415844|Levodopa|levodopa|mesh-list
24487341|NCT00462787|Topotecan|topotecan|mesh-list
25149327|NCT02867813|Evolocumab|evolocumab|mesh-list
24489624|NCT00474591|PENTA|penta|mesh-list
25108669|NCT03131141|Lefamulin|lefamulin|mesh-list
25043700|NCT01225380|Ribavirin|ribavirin|mesh-list
24496311|NCT00504244|Azathioprine|azathioprine|mesh-list
25045049|NCT01002248|Bortezomib|bortezomib|mesh-list
25041720|NCT01593228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25041721|NCT01593228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25120197|NCT04419389|Rituximab|rituximab|mesh-list
24457716|NCT00335010|Nitroglycerin|nitroglycerin|mesh-list
25126745|NCT03059979|Hormones|hormones|mesh-ancestor
24775186|NCT01850680|Vitamins|vitamins|mesh-ancestor
25128108|NCT03051022|Anesthetics|anesthetics|mesh-ancestor
24775513|NCT01852630|Imipenem|imipenem|mesh-list
25130062|NCT03036501|Risdiplam|risdiplam|mesh-list
24959968|NCT03820193|Celecoxib|celecoxib|mesh-list
24523044|NCT02897050|Docetaxel|docetaxel|mesh-list
24627395|NCT01092533|Mycophenolic Acid|mycophenolic acid|mesh-list
25134433|NCT03006211|Nitrous Oxide|nitrous oxide|mesh-list
25134813|NCT03004625|Ribavirin|ribavirin|mesh-list
25135050|NCT03002831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136311|NCT02992392|Dextrans|dextrans|mesh-list
25136972|NCT02987907|Dexamethasone|dexamethasone|mesh-list
25137682|NCT02983344|Fentanyl|fentanyl|mesh-list
25143966|NCT02939482|Hormones|hormones|mesh-ancestor
25145157|NCT02932020|Hormones|hormones|mesh-ancestor
25157019|NCT04840342|Amlodipine|amlodipine|mesh-list
25146365|NCT02922283|Interleukin-2|interleukin-2|mesh-list
25147158|NCT02915731|Vitamin A|vitamin a|mesh-list
25147249|NCT02915042|Analgesics|analgesics|mesh-ancestor
25148018|NCT02909335|Prednisolone|prednisolone|mesh-list
25158085|NCT04511234|Sirolimus|sirolimus|mesh-list
25149572|NCT05466695|Tadalafil|tadalafil|mesh-list
24949642|NCT04006288|Purinergic Agents|purinergic agents|mesh-ancestor
24954201|NCT03878667|Calcium|calcium|mesh-list
25160155|NCT03249012|Vitamins|vitamins|mesh-ancestor
25049236|NCT00626106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25002543|NCT04539366|Alkylating Agents|alkylating agents|mesh-ancestor
24859778|NCT02305823|Ziprasidone|ziprasidone|mesh-list
25825038|NCT00005108|Progestins|progestins|mesh-ancestor
24498565|NCT00515281|Vasodilator Agents|vasodilator agents|mesh-ancestor
25160311|NCT03020589|Tacrolimus|tacrolimus|mesh-list
24833474|NCT02174068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833476|NCT02174094|Clobazam|clobazam|mesh-list
24833477|NCT02174094|Anticonvulsants|anticonvulsants|mesh-ancestor
24844016|NCT02230800|Tocovid|tocovid|mesh-list
25160733|NCT02607748|Listerine|listerine|mesh-list
24959997|NCT03820193|Narcotics|narcotics|mesh-ancestor
24899594|NCT04402359|Meropenem|meropenem|mesh-list
25825039|NCT00005110|Albuterol|albuterol|mesh-list
25166755|NCT03690921|Cisplatin|cisplatin|mesh-list
25825040|NCT00005110|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25825041|NCT00005110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25167709|NCT02462811|Anesthetics|anesthetics|mesh-ancestor
25203518|NCT02714075|Zinc|zinc|mesh-list
24639867|NCT01164709|Bortezomib|bortezomib|mesh-list
24458684|NCT00338910|Budesonide|budesonide|mesh-list
25168631|NCT02104050|Dapansutrile|dapansutrile|mesh-list
25825042|NCT00005110|Autonomic Agents|autonomic agents|mesh-ancestor
25825043|NCT00005110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25825044|NCT00005110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825045|NCT00005110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24459353|NCT00344422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570228|NCT00803907|Immunologic Factors|immunologic factors|mesh-list
24570229|NCT00803907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24570231|NCT00803907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170276|NCT01643226|Vitamin B Complex|vitamin b complex|mesh-ancestor
25825046|NCT00005110|Respiratory System Agents|respiratory system agents|mesh-ancestor
25170465|NCT00976911|Growth Inhibitors|growth inhibitors|mesh-ancestor
25825047|NCT00005110|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25170860|NCT02893371|Serotonin Agents|serotonin agents|mesh-ancestor
25171002|NCT02892357|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25171005|NCT02892318|Atezolizumab|atezolizumab|mesh-list
25171140|NCT02890173|Eplerenone|eplerenone|mesh-list
25825048|NCT00005110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25171322|NCT02888899|Cathartics|cathartics|mesh-ancestor
25171477|NCT02887807|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25171478|NCT02887677|Dapagliflozin|dapagliflozin|mesh-list
25825049|NCT00005110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25171695|NCT02885948|Naloxone|naloxone|mesh-list
25126288|NCT03063307|Fluorides|fluorides|mesh-list
25172326|NCT02880345|Pembrolizumab|pembrolizumab|mesh-list
25172400|NCT02879669|Pemetrexed|pemetrexed|mesh-list
25172537|NCT02878772|Aspirin|aspirin|mesh-list
25172876|NCT02876549|Primaquine|primaquine|mesh-list
24862221|NCT02323607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24862222|NCT02323607|Antiviral Agents|antiviral agents|mesh-ancestor
25173710|NCT02869984|Ramosetron|ramosetron|mesh-list
25173786|NCT02869321|Narcotics|narcotics|mesh-ancestor
25173850|NCT02869035|Analgesics|analgesics|mesh-ancestor
25174203|NCT02866903|Bevacizumab|bevacizumab|mesh-list
24974051|NCT05175547|Clevidipine|clevidipine|mesh-list
25174357|NCT02866136|Alkylating Agents|alkylating agents|mesh-ancestor
25174431|NCT02865681|Zuclomiphene|zuclomiphene|mesh-list
25174880|NCT02862691|Antipyretics|antipyretics|mesh-ancestor
25174990|NCT02861976|Analgesics|analgesics|mesh-ancestor
25825050|NCT00005110|Adrenergic Agents|adrenergic agents|mesh-ancestor
25175231|NCT02860221|Mydriatics|mydriatics|mesh-ancestor
25175386|NCT02858804|Hormones|hormones|mesh-ancestor
24479000|NCT00425204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24479001|NCT00425204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479003|NCT00425217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24479004|NCT00425217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479005|NCT00425217|Immunologic Factors|immunologic factors|mesh-ancestor
24479006|NCT00425217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807486|NCT02022358|Folic Acid|folic acid|mesh-list
25175503|NCT02857842|Hormones|hormones|mesh-ancestor
25825051|NCT00005110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24480095|NCT00429832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25175578|NCT02857244|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25175579|NCT02857244|Modafinil|modafinil|mesh-list
25175580|NCT02857244|Donepezil|donepezil|mesh-list
25175581|NCT02857244|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25175720|NCT02856867|Micronutrients|micronutrients|mesh-ancestor
25175963|NCT02855294|Diuretics|diuretics|mesh-ancestor
24808745|NCT02028923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24808746|NCT02028923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808747|NCT02028923|Analgesics|analgesics|mesh-ancestor
24808748|NCT02028923|Sensory System Agents|sensory system agents|mesh-ancestor
24808749|NCT02028923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24808750|NCT02028949|Idarubicin|idarubicin|mesh-list
24808751|NCT02028949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25084097|NCT03309592|Tadalafil|tadalafil|mesh-list
25176867|NCT05379257|Diuretics|diuretics|mesh-ancestor
24486894|NCT00460473|Adrenergic Agents|adrenergic agents|mesh-ancestor
24486897|NCT00460486|Formaldehyde|formaldehyde|mesh-list
25177215|NCT05220020|Lenvatinib|lenvatinib|mesh-list
25177781|NCT04846829|Citalopram|citalopram|mesh-list
24604634|NCT00980551|Tubulin Modulators|tubulin modulators|mesh-ancestor
24604635|NCT00980551|Antimitotic Agents|antimitotic agents|mesh-ancestor
24604636|NCT00980551|Mitosis Modulators|mitosis modulators|mesh-ancestor
25825052|NCT00005110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825053|NCT00005110|Tocolytic Agents|tocolytic agents|mesh-ancestor
25177863|NCT04811014|Narcotics|narcotics|mesh-ancestor
25178152|NCT04636255|Calcium|calcium|mesh-list
24495860|NCT00502229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25180555|NCT00877214|Rituximab|rituximab|mesh-list
25181130|NCT02847000|Decitabine|decitabine|mesh-list
25181630|NCT05241912|Dobutamine|dobutamine|mesh-list
25181773|NCT04793568|Interferons|interferons|mesh-list
25181851|NCT04635241|Heparin|heparin|mesh-list
24397189|NCT00141050|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
25182151|NCT03936790|Fentanyl|fentanyl|mesh-list
25182289|NCT03213457|Estradiol|estradiol|mesh-list
25182711|NCT00726856|Ezetimibe|ezetimibe|mesh-list
25138289|NCT02979392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405714|NCT00167999|Piperacillin|piperacillin|mesh-list
25183139|NCT00140959|Autonomic Agents|autonomic agents|mesh-ancestor
25183310|NCT02844270|Sirolimus|sirolimus|mesh-list
25183379|NCT02843204|Pembrolizumab|pembrolizumab|mesh-list
25183432|NCT02842567|Vitamin E|vitamin e|mesh-list
24820233|NCT02099240|Bacitracin|bacitracin|mesh-list
25183750|NCT02839941|Tacrolimus|tacrolimus|mesh-list
25183906|NCT02839486|Vancomycin|vancomycin|mesh-list
25184065|NCT02838615|Hormones|hormones|mesh-ancestor
24820854|NCT02102321|Albendazole|albendazole|mesh-list
25184857|NCT02832778|Tenofovir|tenofovir|mesh-list
25184919|NCT02832700|Caseins|caseins|mesh-list
25185734|NCT02825797|Antibodies|antibodies|mesh-list
25186729|NCT02818816|Laxatives|laxatives|mesh-ancestor
24415695|NCT00200525|Apomorphine|apomorphine|mesh-list
24822823|NCT02113631|Antimetabolites|antimetabolites|mesh-ancestor
25187653|NCT02811289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25187759|NCT02810704|Aspirin|aspirin|mesh-list
25187955|NCT02809456|Nicorandil|nicorandil|mesh-list
25188488|NCT02805049|Micafungin|micafungin|mesh-list
25188701|NCT02803073|Anabolic Agents|anabolic agents|mesh-ancestor
25188774|NCT02802605|Bemiparin|bemiparin|mesh-list
24419549|NCT00212589|Vitamins|vitamins|mesh-ancestor
24420229|NCT00215397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25189225|NCT02799589|Analgesics|analgesics|mesh-ancestor
25825054|NCT00005110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25825055|NCT00005112|Hormones|hormones|mesh-list
24788314|NCT01930773|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24421224|NCT00218153|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24421225|NCT00218153|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24421226|NCT00218153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421227|NCT00218153|Sensory System Agents|sensory system agents|mesh-ancestor
24421228|NCT00218153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24421229|NCT00218166|Triazolam|triazolam|mesh-list
24421230|NCT00218166|Tiagabine|tiagabine|mesh-list
25105646|NCT05254405|GABA Agents|gaba agents|mesh-ancestor
25189489|NCT02797548|Antipyretics|antipyretics|mesh-ancestor
24823339|NCT02116790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24823340|NCT02116790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421953|NCT00220714|Antipsychotic Agents|antipsychotic agents|mesh-list
24977566|NCT02818023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977569|NCT02808572|Mitogens|mitogens|mesh-list
24977572|NCT02785224|Vasopressins|vasopressins|mesh-list
25189745|NCT02795039|Fulvestrant|fulvestrant|mesh-list
25189749|NCT02795039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25189892|NCT02793843|Antipruritics|antipruritics|mesh-ancestor
24422425|NCT00222482|Antimanic Agents|antimanic agents|mesh-ancestor
24422426|NCT00222482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24823473|NCT02117453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823476|NCT02117453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422509|NCT00222677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24823747|NCT02118870|Aspirin|aspirin|mesh-list
24823748|NCT02118870|Clopidogrel|clopidogrel|mesh-list
24823749|NCT02118870|Ticagrelor|ticagrelor|mesh-list
24823750|NCT02118870|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24422831|NCT00223717|Prazosin|prazosin|mesh-list
25190148|NCT02792140|Naltrexone|naltrexone|mesh-list
25190173|NCT02791815|Selexipag|selexipag|mesh-list
24823798|NCT02119039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24823799|NCT02119091|Moxifloxacin|moxifloxacin|mesh-list
24823800|NCT02119091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24423376|NCT00225706|Analgesics|analgesics|mesh-ancestor
25190333|NCT02790203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423682|NCT00226551|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24423683|NCT00226551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24423684|NCT00226551|Adrenergic Agents|adrenergic agents|mesh-ancestor
24423685|NCT00226551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25190522|NCT02789566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25190599|NCT02788643|Sequestering Agents|sequestering agents|mesh-ancestor
24423975|NCT00227656|Interferon-alpha|interferon-alpha|mesh-list
24423978|NCT00227656|Capecitabine|capecitabine|mesh-list
24423979|NCT00227656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24423980|NCT00227656|Antimetabolites|antimetabolites|mesh-ancestor
24546193|NCT00697060|Docetaxel|docetaxel|mesh-list
24424644|NCT00230035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24424645|NCT00230035|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24424646|NCT00230035|Protective Agents|protective agents|mesh-ancestor
24824291|NCT02122679|Coagulants|coagulants|mesh-ancestor
24824292|NCT02122692|Itraconazole|itraconazole|mesh-list
24824293|NCT02122692|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
24424678|NCT00230399|Analgesics|analgesics|mesh-ancestor
25825056|NCT00005112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25191254|NCT02784054|Thiotepa|thiotepa|mesh-list
25191255|NCT02784054|Carboplatin|carboplatin|mesh-list
24426311|NCT00235729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24426312|NCT00235729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426313|NCT00235781|Thymoglobulin|thymoglobulin|mesh-list
24824367|NCT02123069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25191532|NCT02782273|Ketorolac|ketorolac|mesh-list
24427647|NCT00238667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24427648|NCT00238667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24427649|NCT00238667|Analgesics|analgesics|mesh-ancestor
25192060|NCT02778828|Linezolid|linezolid|mesh-list
25192136|NCT02778659|Zolpidem|zolpidem|mesh-list
25192266|NCT02777411|Vaccines|vaccines|mesh-list
25192594|NCT02775877|Letrozole|letrozole|mesh-list
25192675|NCT02775292|Analgesics|analgesics|mesh-ancestor
25192758|NCT02774460|Amlodipine|amlodipine|mesh-list
24430840|NCT00249431|Sertraline|sertraline|mesh-list
24430869|NCT00249509|Dopamine Agents|dopamine agents|mesh-ancestor
24431409|NCT00251602|Parasympatholytics|parasympatholytics|mesh-ancestor
25647443|NCT01469234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431410|NCT00251602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24431411|NCT00251602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24431412|NCT00251602|Cholinergic Agents|cholinergic agents|mesh-ancestor
24825127|NCT02127593|Contraceptive Agents|contraceptive agents|mesh-ancestor
24431413|NCT00251654|Anesthetics|anesthetics|mesh-list
25647444|NCT01469364|Aztreonam|aztreonam|mesh-list
25196286|NCT02753205|Analgesics|analgesics|mesh-ancestor
25196431|NCT02752724|Anesthetics|anesthetics|mesh-ancestor
25196658|NCT05429684|Everolimus|everolimus|mesh-list
25197091|NCT04731025|Gentamicins|gentamicins|mesh-list
25197110|NCT04696445|Morphine|morphine|mesh-list
25197262|NCT04264208|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25197562|NCT03449459|Amikacin|amikacin|mesh-list
25197811|NCT02281981|Curcumin|curcumin|mesh-list
25197895|NCT02139852|Capsaicin|capsaicin|mesh-list
25198036|NCT00783367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25198227|NCT02750202|Vaccines|vaccines|mesh-list
25198530|NCT02748395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25198614|NCT02747537|Irinotecan|irinotecan|mesh-list
25199040|NCT02743663|Albuterol|albuterol|mesh-list
24826922|NCT02136823|Protective Agents|protective agents|mesh-ancestor
24826923|NCT02136823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24826924|NCT02136823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24997780|NCT04401709|Immunologic Factors|immunologic factors|mesh-ancestor
24549450|NCT00715351|Insulin|insulin|mesh-list
24550324|NCT00720291|Metronidazole|metronidazole|mesh-list
25825057|NCT00005112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825058|NCT00005113|Cyclosporine|cyclosporine|mesh-list
24826974|NCT02136979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24826975|NCT02136979|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24826976|NCT02136992|Pirfenidone|pirfenidone|mesh-list
24826977|NCT02136992|Analgesics|analgesics|mesh-ancestor
24826978|NCT02136992|Sensory System Agents|sensory system agents|mesh-ancestor
24826987|NCT02137083|Fulvestrant|fulvestrant|mesh-list
24801823|NCT01985828|Androgens|androgens|mesh-list
25199205|NCT02742805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199206|NCT02742805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25199207|NCT02742805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25199208|NCT02742805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25199209|NCT02742805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25199210|NCT02742805|Respiratory System Agents|respiratory system agents|mesh-ancestor
25199211|NCT02742623|Rivaroxaban|rivaroxaban|mesh-list
25199212|NCT02742623|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25825059|NCT00005113|Sirolimus|sirolimus|mesh-list
25199264|NCT02742467|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25199265|NCT02742467|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25199266|NCT02742467|Protease Inhibitors|protease inhibitors|mesh-ancestor
25199267|NCT02742467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199268|NCT02742181|Alvimopan|alvimopan|mesh-list
25043186|NCT01309932|Interferons|interferons|mesh-list
24464511|NCT00365287|Cyclosporins|cyclosporins|mesh-list
25825060|NCT00005113|Tacrolimus|tacrolimus|mesh-list
25825061|NCT00005113|Cyclosporins|cyclosporins|mesh-list
25825062|NCT00005113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25825063|NCT00005113|Immunologic Factors|immunologic factors|mesh-ancestor
25825064|NCT00005113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464562|NCT00365339|Antiviral Agents|antiviral agents|mesh-ancestor
24464563|NCT00365339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571945|NCT00812344|Hormone Antagonists|hormone antagonists|mesh-ancestor
25825065|NCT00005113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25647445|NCT01469364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25825066|NCT00005113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825067|NCT00005113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043747|NCT01207115|Naproxen|naproxen|mesh-list
24466063|NCT00371735|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24466374|NCT00373282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804127|NCT02001259|Lidocaine|lidocaine|mesh-list
24804128|NCT02001259|Anesthetics, Local|anesthetics, local|mesh-ancestor
24804234|NCT02001740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804275|NCT02001896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24804277|NCT02001909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25044159|NCT01133990|Growth Substances|growth substances|mesh-ancestor
24616803|NCT01039194|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24444053|NCT00296634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444054|NCT00296634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24444055|NCT00296686|Tranylcypromine|tranylcypromine|mesh-list
24789791|NCT01939093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24789792|NCT01939093|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24789793|NCT01939093|Histamine Antagonists|histamine antagonists|mesh-ancestor
24789795|NCT01939171|Thymoglobulin|thymoglobulin|mesh-list
24736103|NCT01660295|Dihydroergotamine|dihydroergotamine|mesh-list
24736104|NCT01660295|Certoparin|certoparin|mesh-list
24400600|NCT00150982|Alefacept|alefacept|mesh-list
24736139|NCT01660386|Protease Inhibitors|protease inhibitors|mesh-ancestor
24736140|NCT01660386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24736141|NCT01660386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736142|NCT01660386|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24736143|NCT01660386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24444056|NCT00296686|Dextroamphetamine|dextroamphetamine|mesh-list
25115288|NCT03116971|Etoposide|etoposide|mesh-list
25115379|NCT03116672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25825068|NCT00005113|Antifungal Agents|antifungal agents|mesh-ancestor
25825069|NCT00005113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24460518|NCT00348530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24460519|NCT00348530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24460520|NCT00348530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460521|NCT00348530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24460523|NCT00348530|Vasodilator Agents|vasodilator agents|mesh-ancestor
24827038|NCT02137239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25116011|NCT03111511|Anesthetics|anesthetics|mesh-ancestor
25098732|NCT03195946|Midazolam|midazolam|mesh-list
25116084|NCT03111186|Ibuprofen|ibuprofen|mesh-list
24552125|NCT04176419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25116156|NCT03110848|Antiemetics|antiemetics|mesh-ancestor
24552793|NCT00727831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24776257|NCT01857453|Etoposide|etoposide|mesh-list
24552862|NCT00728000|Gemcitabine|gemcitabine|mesh-list
24552863|NCT00728000|Oxaliplatin|oxaliplatin|mesh-list
24827039|NCT02137239|Glucocorticoids|glucocorticoids|mesh-ancestor
24827040|NCT02137239|Hormones|hormones|mesh-ancestor
25116526|NCT03108287|Antacids|antacids|mesh-ancestor
24554616|NCT00737256|Antidepressive Agents|antidepressive agents|mesh-ancestor
24570034|NCT00802815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24554617|NCT00737256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24554618|NCT00737256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24554619|NCT00737256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24562686|NCT00767715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24562687|NCT00767715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24562688|NCT00767715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24562690|NCT00767715|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24562691|NCT00767715|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24562692|NCT00767715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24562693|NCT00767715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562694|NCT00767715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24562727|NCT00767871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24562728|NCT00767871|Serotonin Agents|serotonin agents|mesh-ancestor
24562729|NCT00767871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562731|NCT00767871|Antidepressive Agents|antidepressive agents|mesh-ancestor
24444059|NCT00296686|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24791567|NCT03920007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25117181|NCT05375188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24444060|NCT00296686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24444061|NCT00296686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25117631|NCT04930458|Listerine|listerine|mesh-list
24569245|NCT00799539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24572279|NCT00814047|Adrenergic Agents|adrenergic agents|mesh-ancestor
25118404|NCT04181008|Amiloride|amiloride|mesh-list
25825070|NCT00005113|Dermatologic Agents|dermatologic agents|mesh-ancestor
25118460|NCT04146038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24573385|NCT00819754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24561899|NCT00763633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573486|NCT00820326|Serotonin Agents|serotonin agents|mesh-ancestor
25118530|NCT04021550|Antioxidants|antioxidants|mesh-ancestor
24444116|NCT00296751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25825071|NCT00005113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25825072|NCT00005113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25109984|NCT03120923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25109985|NCT03120923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792704|NCT04777006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792705|NCT04777006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24792706|NCT04777006|Serotonin Agents|serotonin agents|mesh-ancestor
24792707|NCT04777006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792709|NCT04777006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24577708|NCT00845598|Respiratory System Agents|respiratory system agents|mesh-ancestor
24444039|NCT00296608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24444040|NCT00296608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577735|NCT00845754|Ketorolac|ketorolac|mesh-list
24577736|NCT00845754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24577737|NCT00845754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24577738|NCT00845754|Analgesics|analgesics|mesh-ancestor
24577769|NCT00845819|Disinfectants|disinfectants|mesh-ancestor
24577770|NCT00845819|Dermatologic Agents|dermatologic agents|mesh-ancestor
24577771|NCT00845819|Trace Elements|trace elements|mesh-ancestor
24578121|NCT00846950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24578122|NCT00846950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24578123|NCT00846950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24578124|NCT00846950|GABA Modulators|gaba modulators|mesh-ancestor
24578125|NCT00846950|GABA Agents|gaba agents|mesh-ancestor
24578127|NCT00846950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795798|NCT01946256|Amoxicillin|amoxicillin|mesh-list
25009888|NCT05095857|Anesthetics, General|anesthetics, general|mesh-ancestor
25009889|NCT05095857|Anesthetics|anesthetics|mesh-ancestor
24579652|NCT00856700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579653|NCT00856804|Ribavirin|ribavirin|mesh-list
25119857|NCT05110001|Natamycin|natamycin|mesh-list
25825073|NCT00005113|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24580876|NCT00863915|Protease Inhibitors|protease inhibitors|mesh-ancestor
24580877|NCT00863915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580878|NCT00863915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580879|NCT00863915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24580880|NCT00863941|Bupropion|bupropion|mesh-list
24580922|NCT00864045|Olanzapine|olanzapine|mesh-list
24581337|NCT00864942|Growth Substances|growth substances|mesh-ancestor
24581338|NCT00864942|Growth Inhibitors|growth inhibitors|mesh-ancestor
24581853|NCT00866528|Paclitaxel|paclitaxel|mesh-list
24457949|NCT00335907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25120421|NCT03892044|Nivolumab|nivolumab|mesh-list
24584078|NCT00878449|Navitoclax|navitoclax|mesh-list
24633194|NCT01127555|Immunologic Factors|immunologic factors|mesh-ancestor
25825074|NCT00005113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24444120|NCT00296751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24444121|NCT00296751|Narcotics|narcotics|mesh-ancestor
25825075|NCT00005117|Pravastatin|pravastatin|mesh-list
25825076|NCT00005117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25120558|NCT03337087|Folic Acid|folic acid|mesh-list
24585071|NCT00883064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585072|NCT00883064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24585076|NCT00883155|Bupropion|bupropion|mesh-list
25120613|NCT03240068|Protease Inhibitors|protease inhibitors|mesh-ancestor
25065432|NCT05322499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819733|NCT02097043|Tedizolid phosphate|tedizolid phosphate|mesh-list
24916377|NCT04241380|Heparin|heparin|mesh-list
24827052|NCT02137239|Antitubercular Agents|antitubercular agents|mesh-ancestor
24916737|NCT04237935|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24917404|NCT04230330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24917406|NCT04230083|Nandrolone|nandrolone|mesh-list
24919181|NCT04213833|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25121970|NCT03097900|Purinergic Agents|purinergic agents|mesh-ancestor
24495232|NCT00498992|Antioxidants|antioxidants|mesh-ancestor
25825077|NCT00005117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25825078|NCT00005117|Antimetabolites|antimetabolites|mesh-ancestor
24790772|NCT01945047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24790773|NCT01945047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825079|NCT00005117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825080|NCT00005117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24623924|NCT01073995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24623925|NCT01073995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24623926|NCT01073995|Glucocorticoids|glucocorticoids|mesh-ancestor
25067223|NCT03445611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25067224|NCT03445611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067225|NCT03445611|Sensory System Agents|sensory system agents|mesh-ancestor
25067227|NCT03445611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25122131|NCT03096522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25122132|NCT03096522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25122133|NCT03096522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25122137|NCT03096457|Paromomycin|paromomycin|mesh-list
25067315|NCT03444519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067316|NCT03444506|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25067317|NCT03444506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25825081|NCT00005117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25040290|NCT03198728|Androgens|androgens|mesh-ancestor
25122536|NCT03093103|Empagliflozin|empagliflozin|mesh-list
24609198|NCT00995332|Keratolytic Agents|keratolytic agents|mesh-ancestor
24671999|NCT01329016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24672595|NCT01332617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672613|NCT01332617|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24672616|NCT01332617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24672909|NCT01334333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672910|NCT01334333|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24672954|NCT01334567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24672955|NCT01334567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24447208|NCT00307671|Prednisone|prednisone|mesh-list
24674243|NCT01342679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674245|NCT01342692|Azacitidine|azacitidine|mesh-list
24674246|NCT01342692|Idarubicin|idarubicin|mesh-list
24674247|NCT01342692|Valproic Acid|valproic acid|mesh-list
24674248|NCT01342692|Immunologic Factors|immunologic factors|mesh-ancestor
24674249|NCT01342692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674250|NCT01342692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25123367|NCT03085784|Aflibercept|aflibercept|mesh-list
24610597|NCT01003613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24610598|NCT01003613|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24610599|NCT01003613|Histamine Antagonists|histamine antagonists|mesh-ancestor
24610600|NCT01003613|Histamine Agents|histamine agents|mesh-ancestor
24610601|NCT01003613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24610604|NCT01003613|Hemostatics|hemostatics|mesh-ancestor
24675342|NCT00536380|Histamine Agents|histamine agents|mesh-ancestor
24675343|NCT00536380|Antipruritics|antipruritics|mesh-ancestor
24677489|NCT01356615|Calcium heparin|calcium heparin|mesh-list
24800363|NCT01975259|Glucagon|glucagon|mesh-list
24610869|NCT01005537|Antiviral Agents|antiviral agents|mesh-ancestor
24678187|NCT01360086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678188|NCT01360086|Antimetabolites|antimetabolites|mesh-ancestor
24678189|NCT01360086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679671|NCT01369719|Deferasirox|deferasirox|mesh-list
25124330|NCT03077503|Fentanyl|fentanyl|mesh-list
24681606|NCT01381354|Antioxidants|antioxidants|mesh-ancestor
24681683|NCT01381523|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25124488|NCT03075657|Haloperidol|haloperidol|mesh-list
24681949|NCT01383148|Antimetabolites|antimetabolites|mesh-ancestor
25124559|NCT03074825|Chiauranib|chiauranib|mesh-list
24682217|NCT01384812|Dinoprostone|dinoprostone|mesh-list
25124635|NCT03074136|Eusol|eusol|mesh-list
24683318|NCT01391221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24683319|NCT01391221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683341|NCT01391390|Melatonin|melatonin|mesh-list
24683640|NCT01393288|Antipruritics|antipruritics|mesh-ancestor
25124930|NCT03072121|Metoprolol|metoprolol|mesh-list
25647446|NCT01469364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25647447|NCT01469377|Cariprazine|cariprazine|mesh-list
25125023|NCT03071822|Alkylating Agents|alkylating agents|mesh-ancestor
24812700|NCT02054182|Cholecalciferol|cholecalciferol|mesh-list
24686076|NCT05064137|Listerine|listerine|mesh-list
24690646|NCT01403285|Imiquimod|imiquimod|mesh-list
25647448|NCT01469377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25647449|NCT01469377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25647450|NCT01469377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25125638|NCT03067792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125790|NCT03066544|Anesthetics, Local|anesthetics, local|mesh-ancestor
25825082|NCT00005117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699486|NCT01447069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24699487|NCT01447069|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24699597|NCT01447992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24699598|NCT01448018|Ranibizumab|ranibizumab|mesh-list
25825083|NCT00005118|Ritonavir|ritonavir|mesh-list
24699712|NCT01448720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25825084|NCT00005118|Indinavir|indinavir|mesh-list
24637531|NCT01151254|Propofol|propofol|mesh-list
25825085|NCT00005118|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25825086|NCT00005118|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24645766|NCT01199614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655152|NCT01254617|Immunologic Factors|immunologic factors|mesh-ancestor
25126888|NCT03059238|Narcotics|narcotics|mesh-ancestor
25825087|NCT00005118|Protease Inhibitors|protease inhibitors|mesh-ancestor
24827085|NCT02137278|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24827086|NCT02137278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24827087|NCT02137278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24666732|NCT01320709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24666733|NCT01320709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25825088|NCT00005118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25127189|NCT03057041|Analgesics|analgesics|mesh-ancestor
25825089|NCT00005118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825090|NCT00005118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25825091|NCT00005118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24450405|NCT00318981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25127601|NCT03054467|Amlodipine|amlodipine|mesh-list
25825092|NCT00005118|Antiviral Agents|antiviral agents|mesh-ancestor
25825093|NCT00005118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25825094|NCT00005118|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25825095|NCT00005118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25829491|NCT00006219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25829492|NCT00006219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24827091|NCT02137356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827092|NCT02137356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549122|NCT00713622|Zonisamide|zonisamide|mesh-list
24549283|NCT00714246|Tubulin Modulators|tubulin modulators|mesh-ancestor
25128112|NCT03051022|Narcotics|narcotics|mesh-ancestor
25829493|NCT00006219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829494|NCT00006219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829495|NCT00006219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25829496|NCT00006219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25829497|NCT00006219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25829498|NCT00006219|Immunologic Factors|immunologic factors|mesh-ancestor
24827096|NCT02137395|Autonomic Agents|autonomic agents|mesh-ancestor
25128255|NCT03049085|Ascorbic Acid|ascorbic acid|mesh-list
24940257|NCT04002700|Haloperidol|haloperidol|mesh-list
24940258|NCT04002700|Haloperidol decanoate|haloperidol decanoate|mesh-list
24940260|NCT04002700|Antiemetics|antiemetics|mesh-ancestor
24550347|NCT00720408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827098|NCT02137395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128515|NCT03047265|Tubulin Modulators|tubulin modulators|mesh-ancestor
25829499|NCT00006219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802003|NCT01986764|Estradiol|estradiol|mesh-list
24827099|NCT02137395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25829500|NCT00006220|Arsenic Trioxide|arsenic trioxide|mesh-list
25829501|NCT00006220|Tretinoin|tretinoin|mesh-list
25128697|NCT03045471|Tubulin Modulators|tubulin modulators|mesh-ancestor
25829502|NCT00006220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829503|NCT00006220|Keratolytic Agents|keratolytic agents|mesh-ancestor
25829504|NCT00006220|Dermatologic Agents|dermatologic agents|mesh-ancestor
25829505|NCT00006223|Flt3 ligand protein|flt3 ligand protein|mesh-list
25829506|NCT00006223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25829507|NCT00006223|Immunologic Factors|immunologic factors|mesh-ancestor
25829508|NCT00006223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829509|NCT00006223|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24702231|NCT01464606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24702232|NCT01464606|Tubulin Modulators|tubulin modulators|mesh-ancestor
24702233|NCT01464606|Antimitotic Agents|antimitotic agents|mesh-ancestor
24702234|NCT01464606|Mitosis Modulators|mitosis modulators|mesh-ancestor
24702235|NCT01464606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24702236|NCT01464606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24702237|NCT01464606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24702238|NCT01464606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24702239|NCT01464671|Heparin|heparin|mesh-list
24702240|NCT01464671|Bivalirudin|bivalirudin|mesh-list
24702356|NCT01465256|Antipyretics|antipyretics|mesh-ancestor
24702546|NCT01466478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825096|NCT00005119|Calcium|calcium|mesh-list
25825097|NCT00005119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25825098|NCT00005119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825099|NCT00005120|Calanolide A|calanolide a|mesh-list
25825100|NCT00005120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24827102|NCT02137395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24613425|NCT01019070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613427|NCT01019083|Albendazole|albendazole|mesh-list
24613428|NCT01019083|Secnidazole|secnidazole|mesh-list
24613429|NCT01019083|Zinc Sulfate|zinc sulfate|mesh-list
24613430|NCT01019083|Trace Elements|trace elements|mesh-ancestor
24703629|NCT01472926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703631|NCT01472978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24703633|NCT01472978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25825101|NCT00005120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24704008|NCT01476124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24704009|NCT01476137|Trametinib|trametinib|mesh-list
24704010|NCT01476137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24704011|NCT01476137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25129192|NCT03042429|Topotecan|topotecan|mesh-list
24704208|NCT01477190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25825102|NCT00005120|Antiviral Agents|antiviral agents|mesh-ancestor
24705265|NCT01483508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705267|NCT01483508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705268|NCT01483508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24705269|NCT01483508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24705270|NCT01483508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24705271|NCT01483638|Axitinib|axitinib|mesh-list
24705272|NCT01483638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705273|NCT01483638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25825103|NCT00005120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25129500|NCT03040531|Vitamins|vitamins|mesh-ancestor
24613640|NCT01020162|Antidepressive Agents|antidepressive agents|mesh-ancestor
24705758|NCT01486602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705759|NCT01486602|Tubulin Modulators|tubulin modulators|mesh-ancestor
24705760|NCT01486602|Antimitotic Agents|antimitotic agents|mesh-ancestor
24613649|NCT01020214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24613650|NCT01020214|Diuretics|diuretics|mesh-ancestor
24613651|NCT01020214|Natriuretic Agents|natriuretic agents|mesh-ancestor
24940694|NCT03999125|Glucocorticoids|glucocorticoids|mesh-ancestor
24940695|NCT03999125|Hormones|hormones|mesh-ancestor
25129578|NCT03040193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24706069|NCT01488396|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24706070|NCT01488396|Cyclosporins|cyclosporins|mesh-list
24706071|NCT01488396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706131|NCT01488734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24706132|NCT01488734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24706133|NCT01488773|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24706135|NCT01488773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24706136|NCT01488773|Autonomic Agents|autonomic agents|mesh-ancestor
24706143|NCT01488773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24706220|NCT01489319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24706221|NCT01489319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24706223|NCT01489319|Sensory System Agents|sensory system agents|mesh-ancestor
24706224|NCT01489319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24706273|NCT01489566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706274|NCT01489566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24706275|NCT01489566|Alkylating Agents|alkylating agents|mesh-ancestor
24706476|NCT01490216|Dopamine Agents|dopamine agents|mesh-ancestor
24613711|NCT01020383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24613713|NCT01020396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24613714|NCT01020396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24613715|NCT01020396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24613716|NCT01020396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24613717|NCT01020539|Fludarabine|fludarabine|mesh-list
24613718|NCT01020539|Busulfan|busulfan|mesh-list
24613719|NCT01020539|Gemtuzumab|gemtuzumab|mesh-list
24706961|NCT01493154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24706962|NCT01493310|Paclitaxel|paclitaxel|mesh-list
24707023|NCT01493622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24707024|NCT01493635|Analgesics|analgesics|mesh-list
24707025|NCT01493635|Sensory System Agents|sensory system agents|mesh-ancestor
25829510|NCT00006223|Protective Agents|protective agents|mesh-ancestor
24707026|NCT01493635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24707027|NCT01493635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707028|NCT01493648|Vitamin D|vitamin d|mesh-list
24707029|NCT01493648|Cholecalciferol|cholecalciferol|mesh-list
24707030|NCT01493648|Vitamins|vitamins|mesh-ancestor
25129973|NCT03036826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613843|NCT01021267|Saw palmetto extract|saw palmetto extract|mesh-list
24613844|NCT01021267|Urological Agents|urological agents|mesh-ancestor
24613871|NCT01021475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707361|NCT01495338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24707362|NCT01495338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707363|NCT01495338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24707364|NCT01495338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24443126|NCT00293735|Labetalol|labetalol|mesh-list
24707580|NCT01496742|Bevacizumab|bevacizumab|mesh-list
24707978|NCT01499108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25825104|NCT00005520|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24708619|NCT01501786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708620|NCT01501786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24709377|NCT01505283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130475|NCT03033199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24711238|NCT01514175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24711239|NCT01514175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24711240|NCT01514175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25199736|NCT02739061|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25130695|NCT03031444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24940936|NCT03996564|Acetaminophen|acetaminophen|mesh-list
24940939|NCT03996564|Diazepam|diazepam|mesh-list
24940940|NCT03996564|Hydrocodone|hydrocodone|mesh-list
24940941|NCT03996564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24711862|NCT01517399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25130782|NCT03030911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24713306|NCT01525043|Gout Suppressants|gout suppressants|mesh-ancestor
24614743|NCT01026129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25050777|NCT00468117|Daclizumab|daclizumab|mesh-list
25050778|NCT00468117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24714537|NCT01531166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714540|NCT01531192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25131291|NCT03026842|Analgesics|analgesics|mesh-ancestor
25131464|NCT03025906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25131538|NCT03025295|Analgesics|analgesics|mesh-ancestor
24716620|NCT01542723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716621|NCT01542762|Nadroparin|nadroparin|mesh-list
24716622|NCT01542762|Anticoagulants|anticoagulants|mesh-ancestor
24716623|NCT01542762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24716624|NCT01542762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24716625|NCT01542762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716626|NCT01542801|Ciprofloxacin|ciprofloxacin|mesh-list
25131849|NCT03023059|Dopamine Agents|dopamine agents|mesh-ancestor
24717999|NCT01551459|Sunitinib|sunitinib|mesh-list
25132084|NCT03021590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25132265|NCT03019991|Ritonavir|ritonavir|mesh-list
24719211|NCT01560013|Naltrexone|naltrexone|mesh-list
24719242|NCT01560065|Micronutrients|micronutrients|mesh-ancestor
24719244|NCT01560091|Tamsulosin|tamsulosin|mesh-list
25132339|NCT03019562|Fentanyl|fentanyl|mesh-list
25825105|NCT00005520|Candesartan|candesartan|mesh-list
25132478|NCT03018652|Antibodies|antibodies|mesh-list
24719950|NCT01565200|Trastuzumab|trastuzumab|mesh-list
24719951|NCT01565200|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24720033|NCT01565798|Copper|copper|mesh-list
24720221|NCT01567111|Metomidate|metomidate|mesh-list
24615463|NCT01029769|Antidepressive Agents|antidepressive agents|mesh-ancestor
24615464|NCT01029821|Heparin|heparin|mesh-list
25050897|NCT00463242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24941818|NCT03987698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941819|NCT03987698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941820|NCT03987308|Insulin Aspart|insulin aspart|mesh-list
24941821|NCT03987308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24941822|NCT03987308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941823|NCT03987529|Propofol|propofol|mesh-list
24721797|NCT01577095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24721899|NCT01577914|Carvedilol|carvedilol|mesh-list
25133125|NCT03014713|Narcotics|narcotics|mesh-ancestor
24725576|NCT01598363|Digoxin|digoxin|mesh-list
24726040|NCT01601327|Hormones|hormones|mesh-ancestor
24726721|NCT01605344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24726722|NCT01605344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24973392|NCT03709849|Clomiphene|clomiphene|mesh-list
25133834|NCT03009877|Fentanyl|fentanyl|mesh-list
24730147|NCT01626469|Captopril|captopril|mesh-list
25825106|NCT00005520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24731823|NCT01636609|Tosedostat|tosedostat|mesh-list
25134501|NCT03005860|Anesthetics, General|anesthetics, general|mesh-ancestor
24732174|NCT01638247|Exemestane|exemestane|mesh-list
24732508|NCT01639898|BB 1101|bb 1101|mesh-list
24734736|NCT01653470|Antimitotic Agents|antimitotic agents|mesh-ancestor
24734737|NCT01653470|Mitosis Modulators|mitosis modulators|mesh-ancestor
24734739|NCT01653470|Antimetabolites|antimetabolites|mesh-ancestor
25051121|NCT00439738|Diuretics|diuretics|mesh-ancestor
25045796|NCT00911443|Antiviral Agents|antiviral agents|mesh-ancestor
24943408|NCT03971279|Hormones|hormones|mesh-ancestor
25135854|NCT02995330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738638|NCT01676506|Growth Inhibitors|growth inhibitors|mesh-ancestor
24738686|NCT01676649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618093|NCT01046786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618094|NCT01046786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24618095|NCT01046786|Glucocorticoids|glucocorticoids|mesh-ancestor
24618096|NCT01046786|Hormones|hormones|mesh-ancestor
24618097|NCT01046786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24496974|NCT00507637|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24740261|NCT01687426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24740262|NCT01687426|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24740264|NCT01687426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24740749|NCT01690091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24740750|NCT01690091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740752|NCT01690104|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24740753|NCT01690104|Antitubercular Agents|antitubercular agents|mesh-ancestor
24864116|NCT00910650|Aldesleukin|aldesleukin|mesh-list
24857222|NCT02289768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24740801|NCT01690325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24740802|NCT01690325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24741118|NCT01691976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741121|NCT01692132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24741122|NCT01692132|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24741123|NCT01692132|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25136149|NCT02993588|Melatonin|melatonin|mesh-list
24618310|NCT01047722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618311|NCT01047722|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24618312|NCT01047722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24618314|NCT01047722|Antipyretics|antipyretics|mesh-ancestor
24742844|NCT05150756|Narcotics|narcotics|mesh-ancestor
25136356|NCT02991339|Dexamethasone|dexamethasone|mesh-list
24743555|NCT04750967|Anesthetics|anesthetics|mesh-ancestor
24743556|NCT04750967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24743557|NCT04750967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743558|NCT04750967|Sensory System Agents|sensory system agents|mesh-ancestor
24743559|NCT04750967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24743594|NCT04733547|Diuretics|diuretics|mesh-ancestor
25136409|NCT02990975|Anesthetics|anesthetics|mesh-ancestor
25136552|NCT02990507|Methyltestosterone|methyltestosterone|mesh-list
24744686|NCT04200651|Protective Agents|protective agents|mesh-ancestor
24744731|NCT04169438|Emollients|emollients|mesh-ancestor
24744940|NCT04082676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744942|NCT04082676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24530288|NCT00629681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24746009|NCT03460314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24530532|NCT00630929|Ibuprofen|ibuprofen|mesh-list
24746809|NCT03473925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24748051|NCT02978716|Immunologic Factors|immunologic factors|mesh-ancestor
24704251|NCT01477294|Caffeine|caffeine|mesh-list
24748129|NCT02901067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24704402|NCT01478074|Cytarabine|cytarabine|mesh-list
24749200|NCT01488890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749201|NCT01436396|Vaccines|vaccines|mesh-list
24749202|NCT01436396|Immunologic Factors|immunologic factors|mesh-ancestor
24749203|NCT01436396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749233|NCT01414777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25136936|NCT02987920|Celecoxib|celecoxib|mesh-list
25136984|NCT02987751|Insulin|insulin|mesh-list
24749921|NCT01694797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24749922|NCT01694797|Sympatholytics|sympatholytics|mesh-ancestor
24749924|NCT01694797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24749925|NCT01694797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749926|NCT01694797|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24824673|NCT02124642|Vitamins|vitamins|mesh-ancestor
24749927|NCT01694797|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24749928|NCT01694797|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24749929|NCT01694797|Adrenergic Agents|adrenergic agents|mesh-ancestor
24749930|NCT01694797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25825107|NCT00005520|Diuretics|diuretics|mesh-ancestor
24618939|NCT01050322|Immunologic Factors|immunologic factors|mesh-ancestor
24618940|NCT01050322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618941|NCT01050322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24618942|NCT01050322|Tubulin Modulators|tubulin modulators|mesh-ancestor
24618943|NCT01050322|Antimitotic Agents|antimitotic agents|mesh-ancestor
24750290|NCT01697436|Ribavirin|ribavirin|mesh-list
25137272|NCT02985697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25137347|NCT02985229|Misoprostol|misoprostol|mesh-list
25137469|NCT02985242|Empagliflozin|empagliflozin|mesh-list
24944541|NCT03959436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944542|NCT03959306|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24857697|NCT02293590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24752599|NCT01711125|GABA Agents|gaba agents|mesh-ancestor
24752600|NCT01711125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24752601|NCT01711125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752602|NCT01711229|Acetaminophen|acetaminophen|mesh-list
25825108|NCT00005520|Natriuretic Agents|natriuretic agents|mesh-ancestor
24417328|NCT00206193|Oxytocics|oxytocics|mesh-ancestor
25825109|NCT00005520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825110|NCT00005520|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25825111|NCT00005520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25825112|NCT00005520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825113|NCT00005520|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24753243|NCT01714388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24753244|NCT01714388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753245|NCT01714388|Analgesics|analgesics|mesh-ancestor
24753246|NCT01714388|Sensory System Agents|sensory system agents|mesh-ancestor
24753247|NCT01714388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24753351|NCT01714843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25046167|NCT00870688|Valproic Acid|valproic acid|mesh-list
24753650|NCT01716637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24754340|NCT01720056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544535|NCT00689442|Antimetabolites|antimetabolites|mesh-ancestor
24944732|NCT03958045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24944733|NCT03958045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24944734|NCT03958045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25137991|NCT02981121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25138075|NCT02980965|Cyclophosphamide|cyclophosphamide|mesh-list
25138076|NCT02980965|Docetaxel|docetaxel|mesh-list
25138077|NCT02980965|Fluorouracil|fluorouracil|mesh-list
24754632|NCT01722110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24754633|NCT01722110|Gout Suppressants|gout suppressants|mesh-ancestor
24754634|NCT01722110|Tocolytic Agents|tocolytic agents|mesh-ancestor
24542518|NCT00679120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24542581|NCT00679458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24542582|NCT00679458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542583|NCT00679458|Analgesics|analgesics|mesh-ancestor
24542584|NCT00679458|Sensory System Agents|sensory system agents|mesh-ancestor
24542585|NCT00679458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24542587|NCT00679484|Candesartan|candesartan|mesh-list
24542588|NCT00679484|Candesartan cilexetil|candesartan cilexetil|mesh-list
25138357|NCT02978547|Metformin|metformin|mesh-list
25825114|NCT00005520|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24542766|NCT00680329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24542768|NCT00680329|Adrenergic Agents|adrenergic agents|mesh-ancestor
25829511|NCT00006224|Gemcitabine|gemcitabine|mesh-list
24619493|NCT01052623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24619494|NCT01052623|Sympatholytics|sympatholytics|mesh-ancestor
25046355|NCT00851045|Antidotes|antidotes|mesh-ancestor
25829512|NCT00006224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24755298|NCT01725620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24755299|NCT01725620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24755300|NCT01725620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24755329|NCT01725906|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24755330|NCT01725906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24755331|NCT01725906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24755332|NCT01725906|Antitubercular Agents|antitubercular agents|mesh-ancestor
24755333|NCT01726075|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25138627|NCT02976246|Vitamin K|vitamin k|mesh-list
24755465|NCT01726582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24755466|NCT01726582|Antidotes|antidotes|mesh-ancestor
24755467|NCT01726582|Protective Agents|protective agents|mesh-ancestor
24755513|NCT01726920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24755515|NCT01726920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25046426|NCT00846989|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25829513|NCT00006224|Antimetabolites|antimetabolites|mesh-ancestor
24789671|NCT01938443|Trametinib|trametinib|mesh-list
25138955|NCT02974244|Exenatide|exenatide|mesh-list
25825115|NCT00005569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
25139234|NCT02972476|Xhance|xhance|mesh-list
25139286|NCT02972346|Hormones|hormones|mesh-ancestor
25825116|NCT00005569|Protease Inhibitors|protease inhibitors|mesh-list
24737130|NCT01667094|Ticarcillin|ticarcillin|mesh-list
24395195|NCT00135434|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24846106|NCT02241174|Eusol|eusol|mesh-list
25825117|NCT00005569|Secretory Leukocyte Peptidase Inhibitor|secretory leukocyte peptidase inhibitor|mesh-list
25139457|NCT02971254|Desflurane|desflurane|mesh-list
24945757|NCT03947229|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24945758|NCT03947229|Purinergic Agents|purinergic agents|mesh-ancestor
24945772|NCT03947411|Antiviral Agents|antiviral agents|mesh-ancestor
24945954|NCT03944317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402157|NCT00155246|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24402158|NCT00155246|Protective Agents|protective agents|mesh-ancestor
24402159|NCT00155246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139875|NCT02968082|Antiemetics|antiemetics|mesh-ancestor
24946177|NCT03942601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946178|NCT03942354|Moxifloxacin|moxifloxacin|mesh-list
25139954|NCT02967614|Timolol|timolol|mesh-list
24946345|NCT03940391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24946346|NCT03940391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140026|NCT02967172|Autonomic Agents|autonomic agents|mesh-ancestor
24407828|NCT00175643|Imiquimod|imiquimod|mesh-list
24407829|NCT00175643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24407830|NCT00175643|Immunologic Factors|immunologic factors|mesh-ancestor
24771680|NCT01828736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771681|NCT01828736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24771682|NCT01828736|Antimetabolites|antimetabolites|mesh-ancestor
24408185|NCT00176787|Antimetabolites|antimetabolites|mesh-ancestor
25825118|NCT00005569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408206|NCT00176813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24408207|NCT00176813|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24408208|NCT00176813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24619029|NCT01050517|Albendazole|albendazole|mesh-list
25140285|NCT02965859|Adefovir|adefovir|mesh-list
24414067|NCT00195871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24414068|NCT00195871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24414069|NCT00195871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24414070|NCT00195871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25825119|NCT00005569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415464|NCT00199576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24415465|NCT00199576|Glucocorticoids|glucocorticoids|mesh-ancestor
25825120|NCT00005569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24415907|NCT00201422|Amoxicillin|amoxicillin|mesh-list
24415908|NCT00201422|Clarithromycin|clarithromycin|mesh-list
24947036|NCT03932825|Nitrous Oxide|nitrous oxide|mesh-list
24460116|NCT00347425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25140990|NCT02960412|Natriuretic Agents|natriuretic agents|mesh-ancestor
24429716|NCT00244920|Growth Substances|growth substances|mesh-ancestor
24431356|NCT00251472|Paclitaxel|paclitaxel|mesh-list
25141198|NCT02959060|Rifampin|rifampin|mesh-list
24425535|NCT00233610|Tamoxifen|tamoxifen|mesh-list
24433377|NCT00258245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24435281|NCT00265863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435282|NCT00265863|Alkylating Agents|alkylating agents|mesh-ancestor
24460317|NCT00348153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24439499|NCT00279084|Hematinics|hematinics|mesh-ancestor
24439856|NCT00280540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439857|NCT00280540|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24439858|NCT00280540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24439859|NCT00280553|Bupivacaine|bupivacaine|mesh-list
24439886|NCT00280774|Memantine|memantine|mesh-list
24439887|NCT00280774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24439888|NCT00280774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24439889|NCT00280774|Dopamine Agents|dopamine agents|mesh-ancestor
24441162|NCT00286273|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24441163|NCT00286273|Tinzaparin|tinzaparin|mesh-list
25825121|NCT00005569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25047144|NCT00833521|GABA Agonists|gaba agonists|mesh-ancestor
25825122|NCT00005569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25825123|NCT00005569|Antiviral Agents|antiviral agents|mesh-ancestor
25825124|NCT00005569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24428215|NCT00239967|Rimonabant|rimonabant|mesh-list
25825125|NCT00005569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25825126|NCT00005571|Eculizumab|eculizumab|mesh-list
25825127|NCT00005571|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25142472|NCT02949778|Ropivacaine|ropivacaine|mesh-list
25825129|NCT00005571|Immunologic Factors|immunologic factors|mesh-ancestor
25825130|NCT00005571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825131|NCT00005574|Gentamicins|gentamicins|mesh-list
25825132|NCT00005574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24551399|NCT00726258|Ketamine|ketamine|mesh-list
24551439|NCT00726700|Prednisone|prednisone|mesh-list
24551448|NCT00726700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25143582|NCT02941822|Ambroxol|ambroxol|mesh-list
25143799|NCT02940301|Nivolumab|nivolumab|mesh-list
25143878|NCT02940405|Ketorolac|ketorolac|mesh-list
24553584|NCT00732121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553588|NCT00732186|Ipilimumab|ipilimumab|mesh-list
25825133|NCT00005574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24553820|NCT00732953|Tubulin Modulators|tubulin modulators|mesh-ancestor
25144346|NCT02936830|Glycerol|glycerol|mesh-list
24948005|NCT03923803|Vasodilator Agents|vasodilator agents|mesh-ancestor
24948006|NCT03923556|Neostigmine|neostigmine|mesh-list
24948007|NCT03923556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24948008|NCT03923556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24948009|NCT03923556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144420|NCT02935933|Dexmedetomidine|dexmedetomidine|mesh-list
24555299|NCT00741078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555300|NCT00741078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24555301|NCT00741078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825134|NCT00005574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25825135|NCT00005574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825136|NCT00005574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825137|NCT00005575|Imipramine|imipramine|mesh-list
25825138|NCT00005575|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24555599|NCT00742248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555601|NCT00742287|Procyanidin|procyanidin|mesh-list
24555602|NCT00742287|Antioxidants|antioxidants|mesh-ancestor
25825139|NCT00005575|Antidepressive Agents|antidepressive agents|mesh-ancestor
24555975|NCT00744536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555976|NCT00744536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24555977|NCT00744536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24556090|NCT00744913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25144769|NCT02934464|Leucovorin|leucovorin|mesh-list
25047560|NCT00792727|Ketoprofen|ketoprofen|mesh-list
24556679|NCT00749021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24556680|NCT00749021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24556681|NCT00749021|Growth Substances|growth substances|mesh-ancestor
24556682|NCT00749021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556683|NCT00749021|Growth Inhibitors|growth inhibitors|mesh-ancestor
24560636|NCT02106988|Antiemetics|antiemetics|mesh-ancestor
24556947|NCT00750451|Enoxaparin sodium|enoxaparin sodium|mesh-list
24556948|NCT00750451|Anticoagulants|anticoagulants|mesh-ancestor
24556949|NCT00750451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24556950|NCT00750451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24556951|NCT00750451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556952|NCT00750529|Donepezil|donepezil|mesh-list
24556953|NCT00750529|Galantamine|galantamine|mesh-list
24556954|NCT00750529|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24557288|NCT00752141|Oxybutynin|oxybutynin|mesh-list
24557289|NCT00752141|Parasympatholytics|parasympatholytics|mesh-ancestor
24557290|NCT00752141|Autonomic Agents|autonomic agents|mesh-ancestor
24557291|NCT00752141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24948073|NCT03923075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24948081|NCT03923075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24948082|NCT03923075|Adrenergic Agents|adrenergic agents|mesh-ancestor
24948083|NCT03923075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24948084|NCT03923075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557293|NCT00752141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24557426|NCT00752479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24557427|NCT00752479|Glucocorticoids|glucocorticoids|mesh-ancestor
24557628|NCT00753103|Antiemetics|antiemetics|mesh-ancestor
24557629|NCT00753103|Autonomic Agents|autonomic agents|mesh-ancestor
24557630|NCT00753103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24557631|NCT00753103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25047633|NCT00776373|Antimetabolites|antimetabolites|mesh-ancestor
24557678|NCT00753402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24557679|NCT00753402|Adrenergic Agents|adrenergic agents|mesh-ancestor
24557680|NCT00753402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24557681|NCT00753402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557682|NCT00753402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558113|NCT00755508|Gabapentin|gabapentin|mesh-list
25145375|NCT02930109|Cytarabine|cytarabine|mesh-list
24558365|NCT00756860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561802|NCT00762918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25146112|NCT02924454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24562218|NCT00765011|Cetuximab|cetuximab|mesh-list
25200104|NCT02736032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24948435|NCT03919812|Micronutrients|micronutrients|mesh-ancestor
24563192|NCT00770536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24563193|NCT00770536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25825140|NCT00005575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25146322|NCT02922660|Anesthetics, General|anesthetics, general|mesh-ancestor
24563350|NCT00771251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24563351|NCT00771251|Immunologic Factors|immunologic factors|mesh-ancestor
25146378|NCT02922075|Disinfectants|disinfectants|mesh-ancestor
25825141|NCT00005575|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25825142|NCT00005575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24948554|NCT03918590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24948555|NCT03918694|Ascorbic Acid|ascorbic acid|mesh-list
24948556|NCT03918694|Vitamins|vitamins|mesh-ancestor
24948557|NCT03918694|Micronutrients|micronutrients|mesh-ancestor
24568920|NCT00798083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24568921|NCT00798083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25825143|NCT00005575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24569514|NCT00800826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24570452|NCT00804921|Anticonvulsants|anticonvulsants|mesh-ancestor
24569696|NCT00801515|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24569697|NCT00801515|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24569698|NCT00801515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569699|NCT00801515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24570156|NCT00803556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570644|NCT00805558|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24570645|NCT00805558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24570646|NCT00805558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24570775|NCT00806741|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24570776|NCT00806741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24570777|NCT00806741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24570778|NCT00806741|Adrenergic Agents|adrenergic agents|mesh-ancestor
25825144|NCT00005575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571828|NCT00811980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24572677|NCT00816244|Atorvastatin|atorvastatin|mesh-list
25147399|NCT02913430|Fulvestrant|fulvestrant|mesh-list
24948920|NCT05401071|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24948924|NCT05401058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25047966|NCT00750633|Moxifloxacin|moxifloxacin|mesh-list
25147705|NCT02911597|Naltrexone|naltrexone|mesh-list
25147924|NCT02909751|Antioxidants|antioxidants|mesh-ancestor
25148094|NCT05312372|Paclitaxel|paclitaxel|mesh-list
24950821|NCT03911570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148175|NCT05311722|Ketamine|ketamine|mesh-list
24951015|NCT03909646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428665|NCT00240864|Ibuprofen|ibuprofen|mesh-list
24951017|NCT03909646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579524|NCT00855777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966341|NCT03769064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24446954|NCT00306735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25149086|NCT04148495|Analgesics|analgesics|mesh-ancestor
25149398|NCT05467761|Psilocybin|psilocybin|mesh-list
25149472|NCT05467384|Amlodipine|amlodipine|mesh-list
24582554|NCT00870311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24582555|NCT00870311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582557|NCT00870337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632900|NCT01126086|Anticoagulants|anticoagulants|mesh-ancestor
25149659|NCT05466279|Propofol|propofol|mesh-list
25149833|NCT05442268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25149965|NCT05386030|Sensory System Agents|sensory system agents|mesh-ancestor
25149966|NCT05386030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25149967|NCT05386030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25149968|NCT05386030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25149969|NCT05386030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25149970|NCT05386030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25149971|NCT05386030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048389|NCT00709371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25048390|NCT00709371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048394|NCT00708292|Dexamethasone|dexamethasone|mesh-list
24584902|NCT00882076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825145|NCT00005575|Adrenergic Agents|adrenergic agents|mesh-ancestor
25825146|NCT00005575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25150195|NCT05314569|Anesthetics|anesthetics|mesh-ancestor
25825147|NCT00005575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633971|NCT01131767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25150664|NCT05132153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150665|NCT05132153|Protective Agents|protective agents|mesh-ancestor
25150666|NCT05132153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25150667|NCT05131997|Atorvastatin|atorvastatin|mesh-list
25150668|NCT05131997|Ezetimibe|ezetimibe|mesh-list
25150669|NCT05131997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25150670|NCT05131997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25150736|NCT05073237|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25150737|NCT05073237|Hormone Antagonists|hormone antagonists|mesh-ancestor
25150738|NCT05073237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24587893|NCT00898417|Mitosis Modulators|mitosis modulators|mesh-ancestor
24798241|NCT01961752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24798242|NCT01961752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588191|NCT00901524|Ribavirin|ribavirin|mesh-list
24588192|NCT00901524|Interferon-alpha|interferon-alpha|mesh-list
25825148|NCT00005576|Aldesleukin|aldesleukin|mesh-list
24951690|NCT03901716|Narcotics|narcotics|mesh-ancestor
25151273|NCT04788823|Prednisone|prednisone|mesh-list
24827154|NCT02137616|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24634347|NCT01132911|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24634348|NCT01132911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634349|NCT01132911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634350|NCT01132989|Lenalidomide|lenalidomide|mesh-list
24634351|NCT01132989|Immunologic Factors|immunologic factors|mesh-ancestor
25151411|NCT04672382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25151902|NCT04345341|Bupivacaine|bupivacaine|mesh-list
24590944|NCT00914394|Adrenergic Agents|adrenergic agents|mesh-ancestor
24590945|NCT00914394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24590946|NCT00914394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590947|NCT00914394|Protective Agents|protective agents|mesh-ancestor
24590949|NCT00914420|Trapidil|trapidil|mesh-list
25200675|NCT02732678|Adrenergic Agents|adrenergic agents|mesh-ancestor
25200676|NCT02732678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25200677|NCT02732678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200678|NCT02732678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200679|NCT02732678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25200680|NCT02732678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25200681|NCT02732678|Vasodilator Agents|vasodilator agents|mesh-ancestor
25200682|NCT02732405|Grazoprevir|grazoprevir|mesh-list
24997549|NCT04592744|Giapreza|giapreza|mesh-list
24594303|NCT00933426|Paclitaxel|paclitaxel|mesh-list
24594322|NCT00933439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24594323|NCT00933439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594324|NCT00933439|Analgesics|analgesics|mesh-ancestor
24594643|NCT00934752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153426|NCT03090737|Nivolumab|nivolumab|mesh-list
25153691|NCT02496585|Prednisone|prednisone|mesh-list
25153822|NCT02213068|Immunologic Factors|immunologic factors|mesh-ancestor
25153823|NCT02213068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153824|NCT02213068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25153825|NCT02213068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25153826|NCT02213068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153827|NCT02213068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25153828|NCT02213068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200947|NCT02730845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24827157|NCT02137616|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24827159|NCT02137629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24827160|NCT02137629|Antimetabolites|antimetabolites|mesh-ancestor
25647451|NCT01469377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647452|NCT01469377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25647453|NCT01469546|Axitinib|axitinib|mesh-list
24863347|NCT05146245|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24863348|NCT05146245|Dopamine Agents|dopamine agents|mesh-ancestor
24863350|NCT05146089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24863351|NCT05146089|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24543144|NCT00681993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825151|NCT00005576|Isotretinoin|isotretinoin|mesh-list
24952217|NCT03896113|Analgesics|analgesics|mesh-ancestor
24952218|NCT03896113|Sensory System Agents|sensory system agents|mesh-ancestor
24863497|NCT04802356|Bortezomib|bortezomib|mesh-list
24863498|NCT04802356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24863499|NCT04802356|Antiemetics|antiemetics|mesh-ancestor
24543270|NCT00682825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
25052136|NCT00325650|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25052152|NCT00323037|Carvedilol|carvedilol|mesh-list
25052501|NCT00263042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825152|NCT00005576|Antibodies|antibodies|mesh-list
25052604|NCT00250822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052628|NCT00232752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25052629|NCT00232752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25052630|NCT00232752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24806901|NCT02018783|Listerine|listerine|mesh-list
25052777|NCT00145431|Antimetabolites|antimetabolites|mesh-ancestor
24540981|NCT00670410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813774|NCT02060279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052871|NCT00135343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25052872|NCT00135343|Antiviral Agents|antiviral agents|mesh-ancestor
25052873|NCT00135343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25052874|NCT00135343|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24864314|NCT04948463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24864315|NCT04948463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24446673|NCT00305630|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24446674|NCT00305630|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24446675|NCT00305630|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24857756|NCT02293889|Vitamin D|vitamin d|mesh-list
24864561|NCT03368729|Niraparib|niraparib|mesh-list
24864562|NCT03368729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24544463|NCT00689156|Antimitotic Agents|antimitotic agents|mesh-ancestor
24864573|NCT03344341|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24864737|NCT02741388|Autonomic Agents|autonomic agents|mesh-ancestor
24864738|NCT02741388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24864739|NCT02741388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24864740|NCT02741388|Glucocorticoids|glucocorticoids|mesh-ancestor
24864741|NCT02741388|Hormones|hormones|mesh-ancestor
24952322|NCT03894904|Anticoagulants|anticoagulants|mesh-ancestor
24952323|NCT03894904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24952324|NCT03894904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24952325|NCT03894904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952326|NCT03894904|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24952327|NCT03894904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952328|NCT03894904|Vasodilator Agents|vasodilator agents|mesh-ancestor
25012992|NCT03913091|Bupivacaine|bupivacaine|mesh-list
24858168|NCT02295709|Protease Inhibitors|protease inhibitors|mesh-ancestor
25825153|NCT00005576|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25825154|NCT00005576|Sargramostim|sargramostim|mesh-list
25825155|NCT00005576|Immunologic Factors|immunologic factors|mesh-ancestor
24865124|NCT04388501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25066434|NCT03205605|Oxybutynin|oxybutynin|mesh-list
25053307|NCT00069745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25053308|NCT00069745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053309|NCT00069745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25053310|NCT00069745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053311|NCT00067782|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25053422|NCT00052520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053423|NCT00052520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25825156|NCT00005576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751285|NCT01703312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25172890|NCT02876432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25172891|NCT02876432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25172892|NCT02876432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25053424|NCT00052520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25053425|NCT00052520|Antiviral Agents|antiviral agents|mesh-ancestor
25071211|NCT03412474|Antipyretics|antipyretics|mesh-ancestor
25053450|NCT00035789|Entecavir|entecavir|mesh-list
25053451|NCT00035789|Antiviral Agents|antiviral agents|mesh-ancestor
25053452|NCT00035789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24916656|NCT04238208|Lidocaine|lidocaine|mesh-list
24865198|NCT04252287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865207|NCT04231318|Hormones|hormones|mesh-ancestor
24787301|NCT01924325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24865243|NCT04111419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24865244|NCT04111419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24865245|NCT04111419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24865246|NCT04111419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24865247|NCT04111419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24865248|NCT04111419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24865249|NCT04111419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579560|NCT00856089|Retapamulin|retapamulin|mesh-list
24865297|NCT03962894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24865298|NCT03962894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865355|NCT03417479|Antimanic Agents|antimanic agents|mesh-ancestor
24865356|NCT03400306|Paclitaxel|paclitaxel|mesh-list
24865357|NCT03400306|Carboplatin|carboplatin|mesh-list
24865358|NCT03400306|Veliparib|veliparib|mesh-list
24865359|NCT03400306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25053623|NCT00004907|Busulfan|busulfan|mesh-list
24918378|NCT04220281|Nitroglycerin|nitroglycerin|mesh-list
24839279|NCT02203253|Hormones|hormones|mesh-ancestor
25053684|NCT00004897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25053685|NCT00004897|Immunologic Factors|immunologic factors|mesh-ancestor
25053686|NCT00004897|Antiviral Agents|antiviral agents|mesh-ancestor
25053808|NCT00004181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053809|NCT00004181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25053810|NCT00004175|Cyclophosphamide|cyclophosphamide|mesh-list
25053868|NCT00004169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25053869|NCT00004169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053871|NCT00004166|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25053872|NCT00004166|Protective Agents|protective agents|mesh-ancestor
25053873|NCT00004166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053874|NCT00004165|Melphalan|melphalan|mesh-list
24921868|NCT04186026|Glucagon|glucagon|mesh-list
24446065|NCT00303758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446066|NCT00303758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24446068|NCT00303758|Protective Agents|protective agents|mesh-ancestor
24446069|NCT00303758|Vitamin B Complex|vitamin b complex|mesh-ancestor
24937147|NCT04032236|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24937148|NCT04032236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24937149|NCT04032236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865771|NCT04991350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24865772|NCT04991350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865773|NCT04991350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24865774|NCT04991350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24865775|NCT04991350|Growth Substances|growth substances|mesh-ancestor
24545702|NCT00694408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865846|NCT04761887|Anesthetics|anesthetics|mesh-ancestor
24865847|NCT04761887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25053946|NCT00002411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24865852|NCT04750759|Camostat|camostat|mesh-list
24865853|NCT04750759|Protease Inhibitors|protease inhibitors|mesh-ancestor
24545782|NCT00694863|Adrenocorticotropin zinc|adrenocorticotropin zinc|mesh-list
24545783|NCT00694863|Hormones|hormones|mesh-ancestor
25825157|NCT00005576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825158|NCT00005576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25825159|NCT00005576|Analgesics|analgesics|mesh-ancestor
25825160|NCT00005576|Sensory System Agents|sensory system agents|mesh-ancestor
25825161|NCT00005576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25053982|NCT00002240|Didanosine|didanosine|mesh-list
25003156|NCT03959085|Antiemetics|antiemetics|mesh-ancestor
25054000|NCT00002224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25647454|NCT01469546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647455|NCT01469546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25647456|NCT01469546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657175|NCT01583686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865861|NCT04750759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25825163|NCT00005576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25825164|NCT00005576|Antiviral Agents|antiviral agents|mesh-ancestor
25825165|NCT00005576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25825166|NCT00005576|Dermatologic Agents|dermatologic agents|mesh-ancestor
25054210|NCT03531281|Alkylating Agents|alkylating agents|mesh-ancestor
25054211|NCT03531281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054212|NCT03531281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25054213|NCT03531281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25054214|NCT03531281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25054215|NCT03531281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25054216|NCT03531281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24808493|NCT02027454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24545873|NCT00695604|Autonomic Agents|autonomic agents|mesh-ancestor
24446120|NCT00303810|Alkylating Agents|alkylating agents|mesh-ancestor
25054386|NCT03530033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808696|NCT02028689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825167|NCT00005577|Gemcitabine|gemcitabine|mesh-list
24446221|NCT00304135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24446222|NCT00304135|Antimetabolites|antimetabolites|mesh-ancestor
25054711|NCT03528421|Cyclophosphamide|cyclophosphamide|mesh-list
25054712|NCT03528421|Fludarabine|fludarabine|mesh-list
25054713|NCT03528421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25054714|NCT03528421|Immunologic Factors|immunologic factors|mesh-ancestor
25054715|NCT03528421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054716|NCT03528421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25054717|NCT03528421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25825168|NCT00005577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24866363|NCT05153200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866364|NCT05153200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866365|NCT05153070|Cyclosporine|cyclosporine|mesh-list
24866366|NCT05153070|Cyclosporins|cyclosporins|mesh-list
24866367|NCT05153070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866368|NCT05153070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054730|NCT03528070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25054749|NCT03527836|Lidocaine|lidocaine|mesh-list
25054750|NCT03527836|Bupivacaine|bupivacaine|mesh-list
25054751|NCT03527836|Anesthetics, Local|anesthetics, local|mesh-ancestor
24866385|NCT05152901|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24866386|NCT05152901|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24866387|NCT05152901|Adrenergic Agents|adrenergic agents|mesh-ancestor
24866388|NCT05152901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24866524|NCT04702256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825169|NCT00005577|Antimetabolites|antimetabolites|mesh-ancestor
24796649|NCT01951430|Miconazole|miconazole|mesh-list
25825170|NCT00005577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054887|NCT03526367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25054888|NCT03526367|Antimetabolites|antimetabolites|mesh-ancestor
25054889|NCT03526367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054890|NCT03526367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25054891|NCT03526367|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25054892|NCT03526367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25054893|NCT03526315|Fluorides|fluorides|mesh-list
25054894|NCT03526315|Cariostatic Agents|cariostatic agents|mesh-ancestor
25054895|NCT03526315|Protective Agents|protective agents|mesh-ancestor
25054896|NCT03526315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488105|NCT00466596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488106|NCT00466596|Antioxidants|antioxidants|mesh-ancestor
24488396|NCT00468351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488397|NCT00468351|Growth Inhibitors|growth inhibitors|mesh-ancestor
24488398|NCT00468351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24488399|NCT00468351|Glucocorticoids|glucocorticoids|mesh-ancestor
24488400|NCT00468351|Hormones|hormones|mesh-ancestor
24867554|NCT04070443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24867555|NCT04070443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25825171|NCT00005577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24867662|NCT03194165|Ritonavir|ritonavir|mesh-list
24867663|NCT03194165|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24867664|NCT03194165|Darunavir|darunavir|mesh-list
25825172|NCT00005577|Antiviral Agents|antiviral agents|mesh-ancestor
24867838|NCT05154747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547893|NCT00706277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24547894|NCT00706277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24547895|NCT00706277|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24547896|NCT00706277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24547898|NCT00706576|Enkephalins|enkephalins|mesh-list
24547899|NCT00706576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825173|NCT00005577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25825174|NCT00005577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825175|NCT00005577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25825176|NCT00005577|Immunologic Factors|immunologic factors|mesh-ancestor
25825177|NCT00005577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825178|NCT00005578|Prednisone|prednisone|mesh-list
25825179|NCT00005578|Cyclophosphamide|cyclophosphamide|mesh-list
25825180|NCT00005578|Doxorubicin|doxorubicin|mesh-list
24886076|NCT03436433|Lacosamide|lacosamide|mesh-list
24596545|NCT00944307|TEMPO|tempo|mesh-list
25018835|NCT03696329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24868358|NCT05156450|Prednisone|prednisone|mesh-list
24868359|NCT05156450|Abiraterone Acetate|abiraterone acetate|mesh-list
24868360|NCT05156450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24868361|NCT05156450|Glucocorticoids|glucocorticoids|mesh-ancestor
24868362|NCT05156450|Hormones|hormones|mesh-ancestor
24868363|NCT05156450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24868397|NCT05112549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24868398|NCT05112549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825181|NCT00005578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24868409|NCT04934020|Metronidazole|metronidazole|mesh-list
24868410|NCT04934020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24868411|NCT04934020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24868412|NCT04934020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24868413|NCT04934020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24868414|NCT04843423|Cariprazine|cariprazine|mesh-list
25825182|NCT00005578|Etoposide|etoposide|mesh-list
25825183|NCT00005578|Vincristine|vincristine|mesh-list
25825184|NCT00005578|Bleomycin|bleomycin|mesh-list
25825185|NCT00005578|Dexrazoxane|dexrazoxane|mesh-list
25825186|NCT00005578|Razoxane|razoxane|mesh-list
25825187|NCT00005578|Lenograstim|lenograstim|mesh-list
25825188|NCT00005578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24862173|NCT02323451|Chitosan|chitosan|mesh-list
25825189|NCT00005578|Immunologic Factors|immunologic factors|mesh-ancestor
25825190|NCT00005578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825191|NCT00005578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25825192|NCT00005578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25825193|NCT00005578|Alkylating Agents|alkylating agents|mesh-ancestor
25825194|NCT00005578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491516|NCT00482846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491517|NCT00482846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491520|NCT00482846|Immunologic Factors|immunologic factors|mesh-ancestor
24868599|NCT04194814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24868600|NCT04194814|Respiratory System Agents|respiratory system agents|mesh-ancestor
24868601|NCT04185220|Mogamulizumab|mogamulizumab|mesh-list
24868640|NCT03743402|Analgesics, Opioid|analgesics, opioid|mesh-list
24868641|NCT03743402|Narcotics|narcotics|mesh-ancestor
25055122|NCT03523832|Analgesics|analgesics|mesh-ancestor
25055123|NCT03523832|Sensory System Agents|sensory system agents|mesh-ancestor
25055124|NCT03523832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25055125|NCT03523832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055126|NCT03523832|Anticonvulsants|anticonvulsants|mesh-ancestor
25055127|NCT03523832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25055128|NCT03523832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25055129|NCT03523832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869119|NCT04761614|Micronutrients|micronutrients|mesh-ancestor
25825195|NCT00005578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825196|NCT00005578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25825197|NCT00005578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25825198|NCT00005578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25825199|NCT00005578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24549421|NCT00715091|Diclofenac|diclofenac|mesh-list
25825200|NCT00005578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825201|NCT00005578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25825202|NCT00005578|Glucocorticoids|glucocorticoids|mesh-ancestor
25825203|NCT00005578|Hormones|hormones|mesh-ancestor
25825204|NCT00005578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24862893|NCT04097730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24814672|NCT02065947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25825205|NCT00005578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25825206|NCT00005578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25825207|NCT00005578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25825208|NCT00005578|Tubulin Modulators|tubulin modulators|mesh-ancestor
25825209|NCT00005578|Antimitotic Agents|antimitotic agents|mesh-ancestor
25825210|NCT00005578|Mitosis Modulators|mitosis modulators|mesh-ancestor
25825211|NCT00005578|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25825212|NCT00005578|Protective Agents|protective agents|mesh-ancestor
25825213|NCT00005579|Dolastatin 10|dolastatin 10|mesh-list
25825214|NCT00005579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825215|NCT00005579|Tubulin Modulators|tubulin modulators|mesh-ancestor
24495082|NCT00498316|Immunologic Factors|immunologic factors|mesh-ancestor
25055408|NCT03521167|Sensory System Agents|sensory system agents|mesh-ancestor
25055409|NCT03521167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25055410|NCT03521167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25055411|NCT03521167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25055412|NCT03521167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25055413|NCT03521167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25055414|NCT03521167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825216|NCT00005579|Antimitotic Agents|antimitotic agents|mesh-ancestor
25825217|NCT00005579|Mitosis Modulators|mitosis modulators|mesh-ancestor
25825218|NCT00005579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825219|NCT00005580|Fludarabine|fludarabine|mesh-list
24869794|NCT05159531|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24869795|NCT05159531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24869796|NCT05159531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24869797|NCT05159531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825220|NCT00005580|Fludarabine phosphate|fludarabine phosphate|mesh-list
25825221|NCT00005580|Bryostatin 1|bryostatin 1|mesh-list
25825222|NCT00005580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825223|NCT00005580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24869816|NCT05150431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25825224|NCT00005580|Antimetabolites|antimetabolites|mesh-ancestor
25055462|NCT03520985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25055463|NCT03520985|Antiemetics|antiemetics|mesh-ancestor
25055464|NCT03520985|Autonomic Agents|autonomic agents|mesh-ancestor
25055465|NCT03520985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25055466|NCT03520985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055467|NCT03520985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24809682|NCT02035904|Analgesics|analgesics|mesh-ancestor
25825225|NCT00005580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825226|NCT00005580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25825227|NCT00005580|Immunologic Factors|immunologic factors|mesh-ancestor
25825228|NCT00005580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825229|NCT00005580|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24869836|NCT05146687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869837|NCT05146687|Growth Inhibitors|growth inhibitors|mesh-ancestor
25201318|NCT02728622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25201319|NCT02728622|Hormone Antagonists|hormone antagonists|mesh-ancestor
25201320|NCT02728622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25201321|NCT02728622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825230|NCT00005581|Paclitaxel|paclitaxel|mesh-list
25825231|NCT00005581|Cyclophosphamide|cyclophosphamide|mesh-list
25825232|NCT00005581|Fluorouracil|fluorouracil|mesh-list
25825233|NCT00005581|Epirubicin|epirubicin|mesh-list
25825234|NCT00005581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24869852|NCT05142098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24869853|NCT05142098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24869855|NCT05142098|Sensory System Agents|sensory system agents|mesh-ancestor
24869856|NCT05142098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24869857|NCT05142098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25825235|NCT00005581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584746|NCT00881556|Lorazepam|lorazepam|mesh-list
24869918|NCT05111431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24869919|NCT05111431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24497086|NCT00507975|Nicotine|nicotine|mesh-list
25055537|NCT03520257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25055538|NCT03520257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055540|NCT03520062|Liraglutide|liraglutide|mesh-list
24956858|NCT03850028|Atezolizumab|atezolizumab|mesh-list
24809768|NCT02036151|Protective Agents|protective agents|mesh-ancestor
24809770|NCT02036164|Paclitaxel|paclitaxel|mesh-list
25055609|NCT03519152|Diclofenac|diclofenac|mesh-list
25055610|NCT03519152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25055611|NCT03519152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25055612|NCT03519152|Analgesics|analgesics|mesh-ancestor
25055613|NCT03519152|Sensory System Agents|sensory system agents|mesh-ancestor
25055614|NCT03519152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25055615|NCT03519152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825236|NCT00005581|Tubulin Modulators|tubulin modulators|mesh-ancestor
25055616|NCT03519152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25055617|NCT03519152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24500138|NCT00522886|Cetuximab|cetuximab|mesh-list
24870096|NCT03945448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870097|NCT03945448|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24870098|NCT03945448|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24870102|NCT03945448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24958199|NCT03835715|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24958651|NCT03830489|Vitamins|vitamins|mesh-ancestor
24870126|NCT03761810|Tretinoin|tretinoin|mesh-list
24870127|NCT03761810|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24870128|NCT03761810|Dermatologic Agents|dermatologic agents|mesh-ancestor
24870129|NCT03761810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870130|NCT03761810|Keratolytic Agents|keratolytic agents|mesh-ancestor
24870145|NCT03703778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021785|NCT03668418|Epirubicin|epirubicin|mesh-list
24864198|NCT05147857|Oxytocics|oxytocics|mesh-ancestor
24870223|NCT03122431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870224|NCT03122431|Leprostatic Agents|leprostatic agents|mesh-ancestor
24870225|NCT03122431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24870226|NCT03122431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24870227|NCT03122431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24870228|NCT03122431|Growth Substances|growth substances|mesh-ancestor
24870229|NCT03122431|Growth Inhibitors|growth inhibitors|mesh-ancestor
24870230|NCT03122431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870280|NCT02621151|Immunologic Factors|immunologic factors|mesh-ancestor
24870281|NCT02621151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870284|NCT02421341|Analgesics, Opioid|analgesics, opioid|mesh-list
24870285|NCT02421341|Analgesics|analgesics|mesh-list
24870286|NCT02421341|Narcotics|narcotics|mesh-ancestor
24870287|NCT02421341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24959531|NCT03824314|Analgesics|analgesics|mesh-ancestor
25055898|NCT03517033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25055899|NCT03517033|Adrenergic Agents|adrenergic agents|mesh-ancestor
25055900|NCT03517033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25055901|NCT03517033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055902|NCT03517033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457700|NCT00334932|Doxorubicin|doxorubicin|mesh-list
24939283|NCT04011124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939284|NCT04011124|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24939285|NCT04011124|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24814779|NCT02066662|Protease Inhibitors|protease inhibitors|mesh-ancestor
24814780|NCT02066662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527839|NCT00618501|Leucovorin|leucovorin|mesh-list
25825237|NCT00005581|Antimitotic Agents|antimitotic agents|mesh-ancestor
25825238|NCT00005581|Mitosis Modulators|mitosis modulators|mesh-ancestor
25825239|NCT00005581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825240|NCT00005581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25825241|NCT00005581|Immunologic Factors|immunologic factors|mesh-ancestor
25825242|NCT00005581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055923|NCT03516903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25055924|NCT03516903|Abortifacient Agents|abortifacient agents|mesh-ancestor
25055925|NCT03516903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24870502|NCT05067270|Anticoagulants|anticoagulants|mesh-ancestor
24870503|NCT05067270|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24870548|NCT04998786|Antiemetics|antiemetics|mesh-ancestor
24870549|NCT04998786|Autonomic Agents|autonomic agents|mesh-ancestor
24870550|NCT04998786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961233|NCT03810261|Vitamins|vitamins|mesh-list
24610624|NCT01004068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825243|NCT00005581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25825244|NCT00005581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25825245|NCT00005581|Alkylating Agents|alkylating agents|mesh-ancestor
25825246|NCT00005581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24871415|NCT03050814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825247|NCT00005581|Antimetabolites|antimetabolites|mesh-ancestor
25825248|NCT00005581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24872102|NCT05398861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24872103|NCT05398861|Growth Substances|growth substances|mesh-ancestor
24872104|NCT05398861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872105|NCT05398861|Growth Inhibitors|growth inhibitors|mesh-ancestor
25825249|NCT00005581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24872181|NCT05398679|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24872182|NCT05398679|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25825250|NCT00005581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24872185|NCT05398679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24872193|NCT05398653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825251|NCT00005581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25825252|NCT00005581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825253|NCT00005583|Cisplatin|cisplatin|mesh-list
25825254|NCT00005583|Doxorubicin|doxorubicin|mesh-list
25825255|NCT00005583|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25825256|NCT00005583|Epirubicin|epirubicin|mesh-list
24872402|NCT05389527|Lenvatinib|lenvatinib|mesh-list
24872403|NCT05389527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24872404|NCT05389527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872405|NCT05389527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24872406|NCT05389527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24872407|NCT05389527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872460|NCT05385523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24872461|NCT05385523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24872462|NCT05385523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872463|NCT05376228|Vancomycin|vancomycin|mesh-list
24872464|NCT05376228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24872465|NCT05376228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24872466|NCT05374954|Vaccines|vaccines|mesh-list
24872467|NCT05374954|Immunologic Factors|immunologic factors|mesh-ancestor
24872469|NCT05370716|Pregabalin|pregabalin|mesh-list
24446767|NCT00305825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825257|NCT00005583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023689|NCT03652467|Hormones|hormones|mesh-ancestor
24872637|NCT05298670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24872638|NCT05298670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872639|NCT05298670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872640|NCT05298670|Antiviral Agents|antiviral agents|mesh-ancestor
24872641|NCT05298670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25825258|NCT00005583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25825259|NCT00005583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25825260|NCT00005583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24762981|NCT01770470|Chitosan|chitosan|mesh-list
25079970|NCT03343652|Nivolumab|nivolumab|mesh-list
25825261|NCT00005583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788343|NCT01930864|Metformin|metformin|mesh-list
25825262|NCT00005583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825263|NCT00005584|Prednisone|prednisone|mesh-list
25825264|NCT00005584|Epirubicin|epirubicin|mesh-list
25825265|NCT00005584|Bleomycin|bleomycin|mesh-list
25825266|NCT00005584|Vinblastine|vinblastine|mesh-list
25825267|NCT00005584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24765123|NCT01786070|Autonomic Agents|autonomic agents|mesh-ancestor
24874371|NCT04777994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056342|NCT03513393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056346|NCT03513328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24810563|NCT02040818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24810565|NCT02040818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24827403|NCT02138799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24827404|NCT02138799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24788466|NCT01931514|Montelukast|montelukast|mesh-list
24827405|NCT02138799|Leprostatic Agents|leprostatic agents|mesh-ancestor
24827406|NCT02138799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24827407|NCT02138799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825268|NCT00005584|Glucocorticoids|glucocorticoids|mesh-ancestor
25825269|NCT00005584|Hormones|hormones|mesh-ancestor
25825270|NCT00005584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25825271|NCT00005584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939943|NCT04005430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825272|NCT00005584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25825273|NCT00005584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825274|NCT00005584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25825275|NCT00005584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25825276|NCT00005584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25825277|NCT00005584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825278|NCT00005584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825279|NCT00005584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25825280|NCT00005584|Tubulin Modulators|tubulin modulators|mesh-ancestor
25825281|NCT00005584|Antimitotic Agents|antimitotic agents|mesh-ancestor
25825283|NCT00005585|Leucovorin|leucovorin|mesh-list
24875877|NCT03816332|Cortisone|cortisone|mesh-list
25825284|NCT00005585|Cytarabine|cytarabine|mesh-list
24876271|NCT03623750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24876272|NCT03623750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24767932|NCT01804387|Adefovir|adefovir|mesh-list
24788648|NCT01932541|Serotonin Agents|serotonin agents|mesh-ancestor
25825285|NCT00005585|Dexamethasone|dexamethasone|mesh-list
25825286|NCT00005585|Cyclophosphamide|cyclophosphamide|mesh-list
25825287|NCT00005585|Methotrexate|methotrexate|mesh-list
25825288|NCT00005585|Vincristine|vincristine|mesh-list
25825289|NCT00005585|Daunorubicin|daunorubicin|mesh-list
25825290|NCT00005585|Asparaginase|asparaginase|mesh-list
24878907|NCT00329043|Leuprolide|leuprolide|mesh-list
24878908|NCT00329043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24878909|NCT00329043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24878910|NCT00329043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24878911|NCT00329043|Growth Substances|growth substances|mesh-ancestor
25825291|NCT00005585|Mercaptopurine|mercaptopurine|mesh-list
25825292|NCT00005585|Pegaspargase|pegaspargase|mesh-list
25056797|NCT03509584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25056838|NCT03509168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25056839|NCT03509168|Abortifacient Agents|abortifacient agents|mesh-ancestor
24702014|NCT01463592|Iodine|iodine|mesh-list
24708412|NCT01501214|Atosiban|atosiban|mesh-list
25825293|NCT00005585|Thioguanine|thioguanine|mesh-list
25825294|NCT00005585|Levoleucovorin|levoleucovorin|mesh-list
25825295|NCT00005585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25825296|NCT00005585|Immunologic Factors|immunologic factors|mesh-ancestor
24879876|NCT04326478|Azithromycin|azithromycin|mesh-list
24879877|NCT04326478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25825297|NCT00005585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771643|NCT01828463|Nitisinone|nitisinone|mesh-list
24771892|NCT01830465|Rituximab|rituximab|mesh-list
24880166|NCT04016753|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24880167|NCT04016753|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
25825298|NCT00005585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24880249|NCT03960008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24880250|NCT03960008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24778464|NCT01871129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056941|NCT03508804|Sensory System Agents|sensory system agents|mesh-ancestor
24880653|NCT03526354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880654|NCT03526354|Dopamine Agonists|dopamine agonists|mesh-ancestor
24880655|NCT03526354|Dopamine Agents|dopamine agents|mesh-ancestor
24880656|NCT03525002|Bromocriptine|bromocriptine|mesh-list
25056992|NCT03508102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25056993|NCT03508102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880924|NCT03179904|Tubulin Modulators|tubulin modulators|mesh-ancestor
24880925|NCT03179904|Antimitotic Agents|antimitotic agents|mesh-ancestor
24880926|NCT03179904|Mitosis Modulators|mitosis modulators|mesh-ancestor
24880927|NCT03179904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880928|NCT03179904|Immunologic Factors|immunologic factors|mesh-ancestor
24595376|NCT00938262|Antitubercular Agents|antitubercular agents|mesh-ancestor
25825299|NCT00005585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24881126|NCT03003962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24881127|NCT03003962|Antimetabolites|antimetabolites|mesh-ancestor
24881128|NCT03003962|Antiviral Agents|antiviral agents|mesh-ancestor
24881129|NCT03003962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24881130|NCT03003962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881131|NCT03003962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24788800|NCT01933906|Immunologic Factors|immunologic factors|mesh-ancestor
25291532|NCT05102448|Methotrexate|methotrexate|mesh-list
25291533|NCT05102448|Tofacitinib|tofacitinib|mesh-list
25291534|NCT05102448|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25291535|NCT05102448|Abortifacient Agents|abortifacient agents|mesh-ancestor
25291536|NCT05102448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25291537|NCT05102448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291538|NCT05102448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25291539|NCT05102448|Antimetabolites|antimetabolites|mesh-ancestor
25291540|NCT05102448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291541|NCT05102448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291542|NCT05102448|Dermatologic Agents|dermatologic agents|mesh-ancestor
25291543|NCT05102448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291544|NCT05102448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25291545|NCT05102448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25825300|NCT00005585|Alkylating Agents|alkylating agents|mesh-ancestor
25825301|NCT00005585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173253|NCT02873650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25173254|NCT02873650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25173255|NCT02873650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751988|NCT01707407|Antidepressive Agents|antidepressive agents|mesh-ancestor
25204134|NCT02710552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204135|NCT02710552|Vasodilator Agents|vasodilator agents|mesh-ancestor
25204136|NCT02710552|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25204137|NCT02710552|Protease Inhibitors|protease inhibitors|mesh-ancestor
25204138|NCT02710552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25204139|NCT02710552|Diuretics|diuretics|mesh-ancestor
25204140|NCT02710552|Natriuretic Agents|natriuretic agents|mesh-ancestor
25204142|NCT02710448|Metformin|metformin|mesh-list
25291546|NCT05102448|Immunologic Factors|immunologic factors|mesh-ancestor
25291547|NCT05102448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25291548|NCT05102448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25291549|NCT05102448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25291550|NCT05102422|Propofol|propofol|mesh-list
25291551|NCT05102422|Sevoflurane|sevoflurane|mesh-list
25291552|NCT05102422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25291553|NCT05102422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25291554|NCT05102422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291555|NCT05102422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25291556|NCT05102422|Anesthetics, General|anesthetics, general|mesh-ancestor
25291557|NCT05102422|Anesthetics|anesthetics|mesh-ancestor
25291558|NCT05102422|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25291559|NCT05102422|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25291560|NCT05102396|Mandelic Acids|mandelic acids|mesh-list
25291562|NCT05102396|Parasympatholytics|parasympatholytics|mesh-ancestor
25291563|NCT05102396|Autonomic Agents|autonomic agents|mesh-ancestor
25291564|NCT05102396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25291565|NCT05102396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291566|NCT05102396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25291567|NCT05102396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25291568|NCT05102396|Cholinergic Agents|cholinergic agents|mesh-ancestor
25291569|NCT05102396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25291570|NCT05102396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291571|NCT05102396|Urological Agents|urological agents|mesh-ancestor
25291572|NCT05102396|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25291573|NCT05102396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25291574|NCT05102396|Renal Agents|renal agents|mesh-ancestor
25291575|NCT05102058|Dexmedetomidine|dexmedetomidine|mesh-list
25291576|NCT05102058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25291577|NCT05102058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25291578|NCT05102058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291579|NCT05102058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25291580|NCT05102058|Analgesics|analgesics|mesh-ancestor
25291581|NCT05102058|Sensory System Agents|sensory system agents|mesh-ancestor
25291582|NCT05102058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25291583|NCT05102058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25291584|NCT05102058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25291585|NCT05102058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25291586|NCT05102058|Adrenergic Agents|adrenergic agents|mesh-ancestor
25291587|NCT05102058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25291588|NCT05102058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291589|NCT05102045|Memantine|memantine|mesh-list
25647457|NCT01469546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647458|NCT01469585|Doxycycline|doxycycline|mesh-list
25647459|NCT01469585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25647460|NCT01469585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25647461|NCT01469585|Antimalarials|antimalarials|mesh-ancestor
25647462|NCT01469585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25647463|NCT01469585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25647464|NCT01469637|Sulfamethoxazole|sulfamethoxazole|mesh-list
25647465|NCT01469637|Mesalamine|mesalamine|mesh-list
25647466|NCT01469637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25647467|NCT01469637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25647468|NCT01469637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25647469|NCT01469637|Analgesics|analgesics|mesh-ancestor
25647470|NCT01469637|Sensory System Agents|sensory system agents|mesh-ancestor
25647471|NCT01469637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25647472|NCT01469637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291591|NCT05102045|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25291592|NCT05102045|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25291593|NCT05102045|Dopamine Agents|dopamine agents|mesh-ancestor
25291594|NCT05102045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25291595|NCT05102045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291596|NCT05102045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291597|NCT05102045|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25291598|NCT05102045|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25291599|NCT05102045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291600|NCT05102045|Cholinergic Agents|cholinergic agents|mesh-ancestor
25291601|NCT05101954|Mitogens|mitogens|mesh-list
24881226|NCT02921893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881227|NCT02921893|Protease Inhibitors|protease inhibitors|mesh-ancestor
24881228|NCT02921893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291602|NCT05101954|Mitosis Modulators|mitosis modulators|mesh-ancestor
25291603|NCT05101954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291604|NCT05101928|Prednisone|prednisone|mesh-list
25291605|NCT05101928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25291606|NCT05101928|Glucocorticoids|glucocorticoids|mesh-ancestor
25291607|NCT05101928|Hormones|hormones|mesh-ancestor
25291608|NCT05101928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25291609|NCT05101928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291610|NCT05101928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25291611|NCT05101928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291612|NCT05101811|Vitamin D|vitamin d|mesh-list
25291613|NCT05101811|Ergocalciferols|ergocalciferols|mesh-list
25291614|NCT05101811|Cholecalciferol|cholecalciferol|mesh-list
25291615|NCT05101811|Vitamins|vitamins|mesh-list
25291616|NCT05101811|Micronutrients|micronutrients|mesh-ancestor
25291617|NCT05101811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291618|NCT05101811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25291619|NCT05101811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25291620|NCT05101798|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25291621|NCT05101798|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25291622|NCT05101798|Dermatologic Agents|dermatologic agents|mesh-ancestor
25291623|NCT05101785|Lidocaine|lidocaine|mesh-list
25291624|NCT05101785|Epinephrine|epinephrine|mesh-list
25291625|NCT05101785|Racepinephrine|racepinephrine|mesh-list
25291626|NCT05101785|Carticaine|carticaine|mesh-list
25291627|NCT05101785|Epinephryl borate|epinephryl borate|mesh-list
25291628|NCT05101785|Anesthetics, Local|anesthetics, local|mesh-ancestor
25291629|NCT05101785|Anesthetics|anesthetics|mesh-ancestor
25291630|NCT05101785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25291638|NCT05101785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291639|NCT05101785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25291640|NCT05101785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25291641|NCT05101785|Adrenergic Agents|adrenergic agents|mesh-ancestor
25291642|NCT05101785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25291643|NCT05101785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25291644|NCT05101785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25291645|NCT05101785|Autonomic Agents|autonomic agents|mesh-ancestor
25291646|NCT05101785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25291647|NCT05101785|Respiratory System Agents|respiratory system agents|mesh-ancestor
25291649|NCT05101785|Sympathomimetics|sympathomimetics|mesh-ancestor
25291650|NCT05101785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25291651|NCT05101447|Mycophenolic Acid|mycophenolic acid|mesh-list
25291652|NCT05101447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25291653|NCT05101447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291654|NCT05101447|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25291655|NCT05101447|Antitubercular Agents|antitubercular agents|mesh-ancestor
25291656|NCT05101447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25291657|NCT05101447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25291658|NCT05101447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291659|NCT05101447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291660|NCT05101291|Bupivacaine|bupivacaine|mesh-list
25291662|NCT05101291|Anesthetics|anesthetics|mesh-ancestor
25291663|NCT05101291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25291664|NCT05101291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291665|NCT05101291|Sensory System Agents|sensory system agents|mesh-ancestor
25291666|NCT05101291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24869482|NCT03365635|Ribavirin|ribavirin|mesh-list
24881259|NCT02833753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881260|NCT02805257|Mitomycins|mitomycins|mesh-list
24881261|NCT02805257|Mitomycin|mitomycin|mesh-list
24881262|NCT02805257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24881263|NCT02805257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291677|NCT05092074|Velpatasvir|velpatasvir|mesh-list
25291678|NCT05092074|Antiviral Agents|antiviral agents|mesh-ancestor
25291679|NCT05092074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25291680|NCT05091372|Lenalidomide|lenalidomide|mesh-list
25291681|NCT05091372|Immunologic Factors|immunologic factors|mesh-ancestor
25291682|NCT05091372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291683|NCT05091372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25291684|NCT05091372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25291685|NCT05091372|Growth Substances|growth substances|mesh-ancestor
25291686|NCT05091372|Growth Inhibitors|growth inhibitors|mesh-ancestor
25291687|NCT05091372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291688|NCT05083949|Metformin|metformin|mesh-list
25291689|NCT05083949|Empagliflozin|empagliflozin|mesh-list
25291690|NCT05083949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25291691|NCT05083949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291692|NCT05083949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25291693|NCT05083949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291694|NCT05058417|Empagliflozin|empagliflozin|mesh-list
25291695|NCT05058417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25291696|NCT05058417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291697|NCT05058417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25291698|NCT05058417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291699|NCT05037617|Oxytocin|oxytocin|mesh-list
25291700|NCT05037617|Oxytocics|oxytocics|mesh-ancestor
25291712|NCT05036473|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25291713|NCT05036473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291714|NCT05036473|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25291715|NCT05036473|Immunologic Factors|immunologic factors|mesh-ancestor
25291716|NCT05036473|Dopamine Agonists|dopamine agonists|mesh-ancestor
25291717|NCT05020444|Cyclophosphamide|cyclophosphamide|mesh-list
25291718|NCT05020444|Fludarabine|fludarabine|mesh-list
25291719|NCT05020444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25291720|NCT05020444|Immunologic Factors|immunologic factors|mesh-ancestor
25291721|NCT05020444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291722|NCT05020444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25291723|NCT05020444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25291724|NCT05020444|Alkylating Agents|alkylating agents|mesh-ancestor
25291725|NCT05020444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291726|NCT05020444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291727|NCT05020444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25291728|NCT04940013|Misoprostol|misoprostol|mesh-list
25291729|NCT04940013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25291730|NCT04940013|Abortifacient Agents|abortifacient agents|mesh-ancestor
25291731|NCT04940013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25291732|NCT04940013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291733|NCT04940013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25291734|NCT04940013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25291735|NCT04940013|Oxytocics|oxytocics|mesh-ancestor
25057065|NCT03507556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25057066|NCT03507556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25057067|NCT03507556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25057068|NCT03507556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396834|NCT00140101|Paclitaxel|paclitaxel|mesh-list
25291748|NCT04904692|Dimercaprol|dimercaprol|mesh-list
25291749|NCT04904692|Chelating Agents|chelating agents|mesh-ancestor
25291750|NCT04904692|Sequestering Agents|sequestering agents|mesh-ancestor
25291751|NCT04904692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291752|NCT04894864|Analgesics, Opioid|analgesics, opioid|mesh-list
25291753|NCT04894864|Anesthetics|anesthetics|mesh-list
25291754|NCT04894864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25291755|NCT04894864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291756|NCT04894864|Narcotics|narcotics|mesh-ancestor
25291757|NCT04894864|Analgesics|analgesics|mesh-ancestor
25291758|NCT04894864|Sensory System Agents|sensory system agents|mesh-ancestor
25291759|NCT04894864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25291760|NCT04719065|Mitoxantrone|mitoxantrone|mesh-list
25291761|NCT04719065|Analgesics|analgesics|mesh-ancestor
25291762|NCT04719065|Sensory System Agents|sensory system agents|mesh-ancestor
25291763|NCT04719065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25291764|NCT04719065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291765|NCT04719065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291918|NCT04260477|Ethambutol|ethambutol|mesh-list
25291766|NCT04719065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25291767|NCT04719065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25291768|NCT04719065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291769|NCT04719065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291770|NCT04659811|Pembrolizumab|pembrolizumab|mesh-list
25291771|NCT04659811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25291772|NCT04659811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291773|NCT04610476|Sulfasalazine|sulfasalazine|mesh-list
25291774|NCT04610476|Prednisolone|prednisolone|mesh-list
25291775|NCT04610476|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25291776|NCT04610476|Methylprednisolone|methylprednisolone|mesh-list
25291777|NCT04610476|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25291778|NCT04610476|Prednisolone acetate|prednisolone acetate|mesh-list
25291779|NCT04610476|Adalimumab|adalimumab|mesh-list
25291780|NCT04610476|Etanercept|etanercept|mesh-list
25291781|NCT04610476|Apremilast|apremilast|mesh-list
25291782|NCT04610476|Golimumab|golimumab|mesh-list
25291783|NCT04610476|Methotrexate|methotrexate|mesh-list
25291784|NCT04610476|Abatacept|abatacept|mesh-list
25291785|NCT04610476|Infliximab|infliximab|mesh-list
25291786|NCT04610476|Certolizumab Pegol|certolizumab pegol|mesh-list
25291787|NCT04610476|Ustekinumab|ustekinumab|mesh-list
25291788|NCT04610476|Ixekizumab|ixekizumab|mesh-list
25291789|NCT04610476|Tofacitinib|tofacitinib|mesh-list
25291790|NCT04610476|Leflunomide|leflunomide|mesh-list
25291791|NCT04610476|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25291792|NCT04610476|Prednisolone phosphate|prednisolone phosphate|mesh-list
25291793|NCT04610476|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25291794|NCT04610476|Abortifacient Agents|abortifacient agents|mesh-ancestor
25291795|NCT04610476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25291796|NCT04610476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291797|NCT04610476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25291798|NCT04610476|Antimetabolites|antimetabolites|mesh-ancestor
25291799|NCT04610476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291800|NCT04610476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291801|NCT04610476|Dermatologic Agents|dermatologic agents|mesh-ancestor
25291802|NCT04610476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291803|NCT04610476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25291804|NCT04610476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25291805|NCT04610476|Immunologic Factors|immunologic factors|mesh-ancestor
25291806|NCT04610476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25291807|NCT04610476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25291808|NCT04610476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25291809|NCT04610476|Glucocorticoids|glucocorticoids|mesh-ancestor
25291810|NCT04610476|Hormones|hormones|mesh-ancestor
25291811|NCT04610476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25291812|NCT04610476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25291813|NCT04610476|Antiemetics|antiemetics|mesh-ancestor
25291814|NCT04610476|Autonomic Agents|autonomic agents|mesh-ancestor
25291815|NCT04610476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25291816|NCT04610476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25291817|NCT04610476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25291818|NCT04610476|Protective Agents|protective agents|mesh-ancestor
25291819|NCT04610476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25291820|NCT04610476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25291821|NCT04610476|Analgesics|analgesics|mesh-ancestor
25291822|NCT04610476|Sensory System Agents|sensory system agents|mesh-ancestor
25291823|NCT04610476|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25291824|NCT04610476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25291825|NCT04610476|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25291826|NCT04610476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25291827|NCT04610476|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25291828|NCT04610476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25291829|NCT04565574|Rifampin|rifampin|mesh-list
25291830|NCT04565574|Rabeprazole|rabeprazole|mesh-list
25291831|NCT04565574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25291832|NCT04565574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25291833|NCT04565574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25291834|NCT04565574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291835|NCT04565574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291836|NCT04565574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25291837|NCT04565574|Antitubercular Agents|antitubercular agents|mesh-ancestor
25291838|NCT04565574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25291839|NCT04565574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25291840|NCT04565574|Leprostatic Agents|leprostatic agents|mesh-ancestor
25291841|NCT04565574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25291842|NCT04565574|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25291854|NCT04560634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291855|NCT04560634|Sympathomimetics|sympathomimetics|mesh-ancestor
25173503|NCT02872090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25173504|NCT02872090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25825302|NCT00005585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24944517|NCT03959969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25825303|NCT00005585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25173520|NCT02872064|Verteporfin|verteporfin|mesh-list
25173521|NCT02872064|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25173522|NCT02872064|Dermatologic Agents|dermatologic agents|mesh-ancestor
25204144|NCT02710448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204146|NCT02710409|Immunologic Factors|immunologic factors|mesh-ancestor
25204147|NCT02710409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204148|NCT02710396|Paclitaxel|paclitaxel|mesh-list
25204149|NCT02710396|Carboplatin|carboplatin|mesh-list
25204150|NCT02710396|Pembrolizumab|pembrolizumab|mesh-list
25204151|NCT02710396|Pemetrexed|pemetrexed|mesh-list
25291856|NCT04560634|Autonomic Agents|autonomic agents|mesh-ancestor
25291857|NCT04560634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25291858|NCT04560634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25291860|NCT04483544|Olaparib|olaparib|mesh-list
25291861|NCT04483544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25291862|NCT04483544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291863|NCT04483544|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25291864|NCT04483544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291865|NCT04483544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291871|NCT04433845|Psilocybin|psilocybin|mesh-list
25291872|NCT04433845|Hallucinogens|hallucinogens|mesh-ancestor
25291873|NCT04433845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291874|NCT04433845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25291875|NCT04364776|Durvalumab|durvalumab|mesh-list
25291876|NCT04364776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25291877|NCT04364776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291885|NCT04351295|Chloroquine|chloroquine|mesh-list
25291886|NCT04351295|Favipiravir|favipiravir|mesh-list
25291887|NCT04351295|Amebicides|amebicides|mesh-ancestor
25291888|NCT04351295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25291889|NCT04351295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25291890|NCT04351295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25291891|NCT04351295|Antimalarials|antimalarials|mesh-ancestor
25291892|NCT04351295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25291893|NCT04351295|Antiviral Agents|antiviral agents|mesh-ancestor
25291894|NCT04337177|Temozolomide|temozolomide|mesh-list
25291895|NCT04337177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25291896|NCT04337177|Alkylating Agents|alkylating agents|mesh-ancestor
25291897|NCT04337177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291898|NCT04337177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291899|NCT04316143|Zamicastat|zamicastat|mesh-list
25291900|NCT04316143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291901|NCT04316143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291902|NCT04308330|Vorinostat|vorinostat|mesh-list
25291903|NCT04308330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291904|NCT04308330|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25291905|NCT04308330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291906|NCT04308330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291907|NCT04271293|Edoxaban|edoxaban|mesh-list
25291908|NCT04271293|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25291909|NCT04271293|Antithrombins|antithrombins|mesh-ancestor
24816018|NCT02073552|Vitamins|vitamins|mesh-ancestor
25291910|NCT04271293|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25647473|NCT01469637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25647474|NCT01469637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25647475|NCT01469767|Fluocinonide|fluocinonide|mesh-list
25647476|NCT01469767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25647477|NCT01469767|Glucocorticoids|glucocorticoids|mesh-ancestor
25647478|NCT01469767|Hormones|hormones|mesh-ancestor
25647479|NCT01469767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25647480|NCT01469767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647481|NCT01469767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25647482|NCT01469819|Lubiprostone|lubiprostone|mesh-list
25647483|NCT01469819|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25647484|NCT01469819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25647485|NCT01469819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647486|NCT01470001|Solifenacin Succinate|solifenacin succinate|mesh-list
25291911|NCT04271293|Protease Inhibitors|protease inhibitors|mesh-ancestor
25291912|NCT04271293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291913|NCT04271293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173549|NCT02871713|Sensory System Agents|sensory system agents|mesh-ancestor
25291914|NCT04271293|Anticoagulants|anticoagulants|mesh-ancestor
25291915|NCT04260477|Rifampin|rifampin|mesh-list
25291916|NCT04260477|Isoniazid|isoniazid|mesh-list
25291917|NCT04260477|Pyrazinamide|pyrazinamide|mesh-list
25291926|NCT04260477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291928|NCT04260477|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25291929|NCT04260477|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25291930|NCT04260477|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25291931|NCT04260477|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25291932|NCT04260477|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25291933|NCT04260477|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25291934|NCT04260477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25291935|NCT04260477|Antimetabolites|antimetabolites|mesh-ancestor
25291936|NCT04260477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25291937|NCT04150913|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25291938|NCT04150913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25291948|NCT04059562|Irinotecan|irinotecan|mesh-list
25291949|NCT04059562|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25291950|NCT04059562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25291951|NCT04059562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291952|NCT04059562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291953|NCT04059562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291954|NCT04046107|Cemiplimab|cemiplimab|mesh-list
25291955|NCT04046107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25291956|NCT04046107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291964|NCT03959241|Mycophenolic Acid|mycophenolic acid|mesh-list
25291965|NCT03959241|Cyclophosphamide|cyclophosphamide|mesh-list
25291966|NCT03959241|Methotrexate|methotrexate|mesh-list
25291967|NCT03959241|Tacrolimus|tacrolimus|mesh-list
25291968|NCT03959241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25291969|NCT03959241|Immunologic Factors|immunologic factors|mesh-ancestor
25291970|NCT03959241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291971|NCT03959241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25291972|NCT03959241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25291973|NCT03959241|Alkylating Agents|alkylating agents|mesh-ancestor
25291974|NCT03959241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291975|NCT03959241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291976|NCT03959241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25291977|NCT03959241|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25291978|NCT03959241|Abortifacient Agents|abortifacient agents|mesh-ancestor
25291979|NCT03959241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25291980|NCT03959241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25291981|NCT03959241|Antimetabolites|antimetabolites|mesh-ancestor
25291982|NCT03959241|Dermatologic Agents|dermatologic agents|mesh-ancestor
25291983|NCT03959241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291984|NCT03959241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25291985|NCT03959241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25291986|NCT03959241|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25291987|NCT03959241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25291988|NCT03959241|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25291989|NCT03959241|Antitubercular Agents|antitubercular agents|mesh-ancestor
25291990|NCT03959241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25291991|NCT03959241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25292020|NCT03838744|Trabectedin|trabectedin|mesh-list
25292021|NCT03838744|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25292022|NCT03838744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25292023|NCT03838744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292024|NCT03838744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292025|NCT03838744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25292026|NCT03838744|Alkylating Agents|alkylating agents|mesh-ancestor
25292027|NCT03736629|Azithromycin|azithromycin|mesh-list
25292028|NCT03736629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25292029|NCT03736629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25292054|NCT03522753|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25292055|NCT03522753|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
24778840|NCT01872754|Anesthetics|anesthetics|mesh-ancestor
25057122|NCT03507387|Nasal Decongestants|nasal decongestants|mesh-ancestor
25057123|NCT03507387|Respiratory System Agents|respiratory system agents|mesh-ancestor
25057124|NCT03507387|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25057125|NCT03507387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25292056|NCT03522753|beta-Endorphin|beta-endorphin|mesh-list
25408479|NCT03437746|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25647487|NCT01470001|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25292058|NCT03522753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25292059|NCT03522753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292062|NCT03435939|Losartan|losartan|mesh-list
25292063|NCT03435939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25292064|NCT03435939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25292065|NCT03435939|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25292066|NCT03435939|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25292067|NCT03435939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292068|NCT03430791|Nivolumab|nivolumab|mesh-list
25292069|NCT03430791|Ipilimumab|ipilimumab|mesh-list
25292070|NCT03430791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25292071|NCT03430791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292072|NCT03430791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25292073|NCT03430791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292074|NCT03383224|Nicotine|nicotine|mesh-list
25292075|NCT03383224|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25292076|NCT03383224|Autonomic Agents|autonomic agents|mesh-ancestor
25292077|NCT03383224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25292078|NCT03383224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292085|NCT03229512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292086|NCT03229512|Vasodilator Agents|vasodilator agents|mesh-ancestor
25292087|NCT03229512|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25292088|NCT03229512|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25292089|NCT03229512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25292090|NCT03229512|Urological Agents|urological agents|mesh-ancestor
25292091|NCT03109353|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25292092|NCT03109353|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25292093|NCT03109353|Dermatologic Agents|dermatologic agents|mesh-ancestor
25292094|NCT03033914|Doxorubicin|doxorubicin|mesh-list
25292095|NCT03033914|Bleomycin|bleomycin|mesh-list
25292096|NCT03033914|Nivolumab|nivolumab|mesh-list
25292097|NCT03033914|Dacarbazine|dacarbazine|mesh-list
25292098|NCT03033914|Vinblastine|vinblastine|mesh-list
25292099|NCT03033914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25292100|NCT03033914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292101|NCT03033914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25292102|NCT03033914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25292103|NCT03033914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25292104|NCT03033914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292105|NCT03033914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25292106|NCT03033914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25292107|NCT03033914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25292108|NCT03033914|Alkylating Agents|alkylating agents|mesh-ancestor
25292109|NCT03033914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25292110|NCT03033914|Tubulin Modulators|tubulin modulators|mesh-ancestor
25292111|NCT03033914|Antimitotic Agents|antimitotic agents|mesh-ancestor
25292112|NCT03033914|Mitosis Modulators|mitosis modulators|mesh-ancestor
25292113|NCT03030118|Hydroxychloroquine|hydroxychloroquine|mesh-list
25292114|NCT03030118|Antimalarials|antimalarials|mesh-ancestor
25292115|NCT03030118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25292116|NCT03030118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25292117|NCT03030118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25292118|NCT03030118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25292119|NCT03030118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292120|NCT03030118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25292121|NCT03023124|Doxorubicin|doxorubicin|mesh-list
25292122|NCT03023124|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25292123|NCT03023124|Dacarbazine|dacarbazine|mesh-list
25292124|NCT03023124|Trabectedin|trabectedin|mesh-list
25292125|NCT03023124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25292190|NCT02683018|Hallucinogens|hallucinogens|mesh-ancestor
25292191|NCT02683018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292192|NCT02683018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25292193|NCT02683018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25292194|NCT02683018|Analgesics|analgesics|mesh-ancestor
25292195|NCT02683018|Sensory System Agents|sensory system agents|mesh-ancestor
25292196|NCT02683018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25292197|NCT02683018|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25292198|NCT02683018|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25292199|NCT02683018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25292200|NCT02683018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292201|NCT02683018|Hormones|hormones|mesh-ancestor
25292202|NCT02683018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25292203|NCT02675842|Dronabinol|dronabinol|mesh-list
25292206|NCT02675842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25292207|NCT02675842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25292208|NCT02675842|Analgesics|analgesics|mesh-ancestor
25292209|NCT02675842|Sensory System Agents|sensory system agents|mesh-ancestor
25292210|NCT02675842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25292211|NCT02675842|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25292218|NCT02615119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25292219|NCT02615119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25292220|NCT02615119|Adrenergic Agents|adrenergic agents|mesh-ancestor
25292221|NCT02615119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25292222|NCT02615119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292223|NCT02615119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292224|NCT02615119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25292225|NCT02615119|Autonomic Agents|autonomic agents|mesh-ancestor
25292226|NCT02615119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25292227|NCT02615119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25292228|NCT02615119|Respiratory System Agents|respiratory system agents|mesh-ancestor
25292229|NCT02615119|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25292230|NCT02615119|Sympathomimetics|sympathomimetics|mesh-ancestor
25292231|NCT02615119|Protective Agents|protective agents|mesh-ancestor
25292232|NCT02605486|Palbociclib|palbociclib|mesh-list
25292233|NCT02605486|Bicalutamide|bicalutamide|mesh-list
25292234|NCT02605486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292235|NCT02605486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25292236|NCT02605486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25292237|NCT02605486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292238|NCT02605486|Androgen Antagonists|androgen antagonists|mesh-ancestor
25292239|NCT02605486|Hormone Antagonists|hormone antagonists|mesh-ancestor
25292240|NCT02605486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25292241|NCT02605486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292242|NCT02598349|Capecitabine|capecitabine|mesh-list
25292243|NCT02598349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25292244|NCT02598349|Antimetabolites|antimetabolites|mesh-ancestor
25292245|NCT02598349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292246|NCT02598349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292247|NCT02574728|Sirolimus|sirolimus|mesh-list
25292248|NCT02574728|Celecoxib|celecoxib|mesh-list
25292249|NCT02574728|Cyclophosphamide|cyclophosphamide|mesh-list
25292250|NCT02574728|Etoposide|etoposide|mesh-list
25292251|NCT02574728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25292252|NCT02574728|Immunologic Factors|immunologic factors|mesh-ancestor
25292253|NCT02574728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292254|NCT02574728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25292255|NCT02574728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25292256|NCT02574728|Alkylating Agents|alkylating agents|mesh-ancestor
25292321|NCT05103397|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25292270|NCT02574728|Analgesics|analgesics|mesh-ancestor
25292271|NCT02574728|Sensory System Agents|sensory system agents|mesh-ancestor
25292272|NCT02574728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25292273|NCT02574728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25292274|NCT02574728|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25292275|NCT02574728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25292276|NCT02555293|Rifaximin|rifaximin|mesh-list
25292277|NCT02555293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25292278|NCT02555293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25292279|NCT02555293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25292293|NCT05104255|Anesthetics|anesthetics|mesh-list
25292294|NCT05104255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25292295|NCT05104255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292296|NCT05104138|Eplerenone|eplerenone|mesh-list
25292297|NCT05104138|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25292298|NCT05104138|Hormone Antagonists|hormone antagonists|mesh-ancestor
25292299|NCT05104138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25292300|NCT05104138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292301|NCT05104138|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25292302|NCT05104138|Diuretics|diuretics|mesh-ancestor
25292303|NCT05104138|Natriuretic Agents|natriuretic agents|mesh-ancestor
25292312|NCT05103501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25292313|NCT05103501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647488|NCT01470001|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25292314|NCT05103501|Antimetabolites|antimetabolites|mesh-ancestor
25292315|NCT05103501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292316|NCT05103501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25292317|NCT05103501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25292318|NCT05103501|Immunologic Factors|immunologic factors|mesh-ancestor
25292319|NCT05103501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292320|NCT05103397|Prednisolone|prednisolone|mesh-list
25292322|NCT05103397|Methylprednisolone|methylprednisolone|mesh-list
25292323|NCT05103397|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25292324|NCT05103397|Prednisolone acetate|prednisolone acetate|mesh-list
25292325|NCT05103397|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25292326|NCT05103397|Prednisolone phosphate|prednisolone phosphate|mesh-list
25292327|NCT05103397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25292328|NCT05103397|Glucocorticoids|glucocorticoids|mesh-ancestor
25292330|NCT05103397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25292331|NCT05103397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292332|NCT05103397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25292333|NCT05103397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292334|NCT05103397|Antiemetics|antiemetics|mesh-ancestor
25292335|NCT05103397|Autonomic Agents|autonomic agents|mesh-ancestor
25292336|NCT05103397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25292337|NCT05103397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25292338|NCT05103397|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25292339|NCT05103397|Protective Agents|protective agents|mesh-ancestor
25292340|NCT05103254|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
25292342|NCT05103254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25292343|NCT05103254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25292344|NCT05103254|Antimetabolites|antimetabolites|mesh-ancestor
25292345|NCT05103254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292346|NCT05103254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25292347|NCT05103254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25292348|NCT05103254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25292349|NCT05103254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292350|NCT05103098|Misoprostol|misoprostol|mesh-list
25292351|NCT05103098|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25292352|NCT05103098|Abortifacient Agents|abortifacient agents|mesh-ancestor
25292353|NCT05103098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25292354|NCT05103098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292355|NCT05103098|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25292356|NCT05103098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25292357|NCT05103098|Oxytocics|oxytocics|mesh-ancestor
25292358|NCT05103020|Bevacizumab|bevacizumab|mesh-list
25292359|NCT05103020|Cetuximab|cetuximab|mesh-list
25292360|NCT05103020|Oxaliplatin|oxaliplatin|mesh-list
25292361|NCT05103020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25292362|NCT05103020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292363|NCT05103020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25292364|NCT05103020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25292365|NCT05103020|Growth Substances|growth substances|mesh-ancestor
25292366|NCT05103020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292367|NCT05103020|Growth Inhibitors|growth inhibitors|mesh-ancestor
25292368|NCT05103007|Chlorotrianisene|chlorotrianisene|mesh-list
25292369|NCT05103007|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25292370|NCT05103007|Estrogens|estrogens|mesh-ancestor
25292371|NCT05103007|Hormones|hormones|mesh-ancestor
24714246|NCT01529541|Anagliptin|anagliptin|mesh-list
24780893|NCT01887184|Analgesics|analgesics|mesh-ancestor
25292378|NCT05092555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25292379|NCT05092555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292380|NCT05092555|Hemostatics|hemostatics|mesh-ancestor
25292381|NCT05092555|Coagulants|coagulants|mesh-ancestor
25292382|NCT05087199|Fibrin fragment D|fibrin fragment d|mesh-list
25292383|NCT05087199|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25292384|NCT05087199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25292385|NCT05087199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292386|NCT05087199|Hemostatics|hemostatics|mesh-ancestor
25292387|NCT05087199|Coagulants|coagulants|mesh-ancestor
25292388|NCT05060666|Ivermectin|ivermectin|mesh-list
25292389|NCT05060666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25292390|NCT05060666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25292391|NCT05048134|Trametinib|trametinib|mesh-list
25292392|NCT05048134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292393|NCT05048134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25292394|NCT05048134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25292395|NCT05048134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292396|NCT05019846|Bicalutamide|bicalutamide|mesh-list
25292397|NCT05019846|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25292398|NCT05019846|Androgen Antagonists|androgen antagonists|mesh-ancestor
25292399|NCT05019846|Hormone Antagonists|hormone antagonists|mesh-ancestor
25292400|NCT05019846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25292401|NCT05019846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292402|NCT05019846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292403|NCT05019846|Luteolytic Agents|luteolytic agents|mesh-ancestor
25292404|NCT05019846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25292405|NCT05019846|Contraceptive Agents|contraceptive agents|mesh-ancestor
25292406|NCT05019846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25292407|NCT05019846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25292408|NCT05019846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25292409|NCT04985851|Durvalumab|durvalumab|mesh-list
25292410|NCT04985851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25292411|NCT04985851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25292412|NCT04985851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292413|NCT04985851|Immunologic Factors|immunologic factors|mesh-ancestor
25292414|NCT04985851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292415|NCT04976374|Dexmedetomidine|dexmedetomidine|mesh-list
25292416|NCT04976374|Gabapentin|gabapentin|mesh-list
25292417|NCT04976374|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25292418|NCT04976374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25292419|NCT04976374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292420|NCT04976374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25292421|NCT04976374|Analgesics|analgesics|mesh-ancestor
25292422|NCT04976374|Sensory System Agents|sensory system agents|mesh-ancestor
25292423|NCT04976374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25292424|NCT04976374|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25292425|NCT04976374|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25292426|NCT04976374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25292427|NCT04976374|Adrenergic Agents|adrenergic agents|mesh-ancestor
25292428|NCT04976374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25292429|NCT04976374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292430|NCT04976374|Anticonvulsants|anticonvulsants|mesh-ancestor
25292431|NCT04976374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25292432|NCT04976374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25292433|NCT04976374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25292434|NCT04976374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25292435|NCT04976374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25292436|NCT04976374|Antimanic Agents|antimanic agents|mesh-ancestor
25292437|NCT04949412|Vitamin D|vitamin d|mesh-list
25292445|NCT04904614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292446|NCT04904614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292447|NCT04904614|Antiviral Agents|antiviral agents|mesh-ancestor
25292448|NCT04904614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25292449|NCT04874935|Lansoprazole|lansoprazole|mesh-list
25292450|NCT04874935|Dexlansoprazole|dexlansoprazole|mesh-list
25292451|NCT04874935|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25292452|NCT04874935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25292453|NCT04874935|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25292454|NCT04874935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25292458|NCT04834063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292460|NCT04834063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292461|NCT04834063|Trace Elements|trace elements|mesh-ancestor
25292462|NCT04834063|Micronutrients|micronutrients|mesh-ancestor
25292464|NCT04794205|Caryophyllene|caryophyllene|mesh-list
25292465|NCT04794205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25292466|NCT04794205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25292467|NCT04794205|Analgesics|analgesics|mesh-ancestor
25292468|NCT04794205|Sensory System Agents|sensory system agents|mesh-ancestor
25292469|NCT04794205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25292470|NCT04794205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292471|NCT04794205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25292472|NCT04794205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25292473|NCT04725032|Propofol|propofol|mesh-list
25292474|NCT04725032|Sevoflurane|sevoflurane|mesh-list
25292475|NCT04725032|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25292476|NCT04725032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25292477|NCT04725032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292478|NCT04725032|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25292479|NCT04725032|Anesthetics, General|anesthetics, general|mesh-ancestor
25292480|NCT04725032|Anesthetics|anesthetics|mesh-ancestor
25292481|NCT04725032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25292482|NCT04725032|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25292483|NCT04716114|Cytarabine|cytarabine|mesh-list
25292485|NCT04716114|Azacitidine|azacitidine|mesh-list
25292486|NCT04716114|Homoharringtonine|homoharringtonine|mesh-list
25292487|NCT04716114|Aclarubicin|aclarubicin|mesh-list
25292488|NCT04716114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292489|NCT04716114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25292490|NCT04716114|Antimetabolites|antimetabolites|mesh-ancestor
25292491|NCT04716114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292492|NCT04716114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25292493|NCT04716114|Immunologic Factors|immunologic factors|mesh-ancestor
25292494|NCT04716114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292495|NCT04716114|Antiviral Agents|antiviral agents|mesh-ancestor
25292496|NCT04716114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25292497|NCT04716114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25292498|NCT04716114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25292499|NCT04716114|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24626388|NCT01087099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626389|NCT01087099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626390|NCT01087138|Calcium|calcium|mesh-list
24626391|NCT01087138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24626392|NCT01087138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292509|NCT04667780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292510|NCT04667780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292511|NCT04655222|Interferons|interferons|mesh-list
25292512|NCT04655222|Interferon-beta|interferon-beta|mesh-list
25292513|NCT04655222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292514|NCT04655222|Antiviral Agents|antiviral agents|mesh-ancestor
25292515|NCT04655222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25292516|NCT04655222|Immunologic Factors|immunologic factors|mesh-ancestor
25292517|NCT04655222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292525|NCT04552327|Analgesics|analgesics|mesh-ancestor
25292526|NCT04552327|Sensory System Agents|sensory system agents|mesh-ancestor
25292527|NCT04552327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25292528|NCT04552327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292529|NCT04552327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25292530|NCT04552327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25292531|NCT04552327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25292532|NCT04552327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25292533|NCT04552327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292534|NCT04519905|Paclitaxel|paclitaxel|mesh-list
25292535|NCT04519905|Carboplatin|carboplatin|mesh-list
25292536|NCT04519905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25292537|NCT04519905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292538|NCT04519905|Tubulin Modulators|tubulin modulators|mesh-ancestor
25292539|NCT04519905|Antimitotic Agents|antimitotic agents|mesh-ancestor
25292540|NCT04519905|Mitosis Modulators|mitosis modulators|mesh-ancestor
25292541|NCT04519905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292542|NCT04482686|Vitamin D|vitamin d|mesh-list
25292543|NCT04482686|Cholecalciferol|cholecalciferol|mesh-list
25292544|NCT04482686|Vitamins|vitamins|mesh-list
25292545|NCT04482686|Ascorbic Acid|ascorbic acid|mesh-list
25292546|NCT04482686|Zinc|zinc|mesh-list
25292547|NCT04482686|Doxycycline|doxycycline|mesh-list
25292548|NCT04482686|Ivermectin|ivermectin|mesh-list
25292549|NCT04482686|Zinc Sulfate|zinc sulfate|mesh-list
25292550|NCT04482686|Micronutrients|micronutrients|mesh-ancestor
25292551|NCT04482686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292552|NCT04482686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25292553|NCT04482686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25292554|NCT04482686|Trace Elements|trace elements|mesh-ancestor
25292555|NCT04482686|Antioxidants|antioxidants|mesh-ancestor
25292556|NCT04482686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292557|NCT04482686|Protective Agents|protective agents|mesh-ancestor
25292558|NCT04482686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25292559|NCT04482686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25292560|NCT04482686|Antimalarials|antimalarials|mesh-ancestor
25292561|NCT04482686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25292562|NCT04482686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25292563|NCT04482686|Astringents|astringents|mesh-ancestor
25825304|NCT00005585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25292564|NCT04482686|Dermatologic Agents|dermatologic agents|mesh-ancestor
25292565|NCT04450407|Insulin|insulin|mesh-list
25292566|NCT04450407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25292567|NCT04450407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292568|NCT04423341|Cannabidiol|cannabidiol|mesh-list
25292569|NCT04423341|Anticonvulsants|anticonvulsants|mesh-ancestor
25825305|NCT00005585|Antiemetics|antiemetics|mesh-ancestor
25292570|NCT04323462|Insulin|insulin|mesh-list
25292571|NCT04323462|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25292572|NCT04323462|Insulin Glargine|insulin glargine|mesh-list
25292573|NCT04323462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25292578|NCT04318392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292579|NCT04279535|Ascorbic Acid|ascorbic acid|mesh-list
25292580|NCT04279535|Antioxidants|antioxidants|mesh-ancestor
25292581|NCT04279535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292582|NCT04279535|Protective Agents|protective agents|mesh-ancestor
25292583|NCT04279535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292584|NCT04279535|Vitamins|vitamins|mesh-ancestor
25292585|NCT04279535|Micronutrients|micronutrients|mesh-ancestor
24881941|NCT00389870|Immunologic Factors|immunologic factors|mesh-ancestor
24881942|NCT00389870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952685|NCT03892434|Dexamethasone|dexamethasone|mesh-list
25292631|NCT03983993|Niraparib|niraparib|mesh-list
25292632|NCT03983993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25292633|NCT03983993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292634|NCT03983993|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25292635|NCT03983993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25292636|NCT03983993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292637|NCT03765359|Metformin|metformin|mesh-list
25292638|NCT03765359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25292639|NCT03765359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292640|NCT03711604|Tenalisib|tenalisib|mesh-list
25292641|NCT03711604|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
25292642|NCT03711604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25292643|NCT03711604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292644|NCT03645603|Dexmedetomidine|dexmedetomidine|mesh-list
25292645|NCT03645603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25292646|NCT03645603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25292647|NCT03645603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292648|NCT03645603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25292649|NCT03645603|Analgesics|analgesics|mesh-ancestor
25292667|NCT03615742|Hormones|hormones|mesh-ancestor
25292668|NCT03615742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25292688|NCT03414502|Hydroxychloroquine|hydroxychloroquine|mesh-list
25292689|NCT03414502|Minocycline|minocycline|mesh-list
25292690|NCT03414502|Sulfasalazine|sulfasalazine|mesh-list
25292691|NCT03414502|Adalimumab|adalimumab|mesh-list
25292692|NCT03414502|Etanercept|etanercept|mesh-list
25292693|NCT03414502|Golimumab|golimumab|mesh-list
25292694|NCT03414502|Rituximab|rituximab|mesh-list
25292695|NCT03414502|Methotrexate|methotrexate|mesh-list
25292696|NCT03414502|Abatacept|abatacept|mesh-list
24952687|NCT03892434|Bevacizumab|bevacizumab|mesh-list
24952688|NCT03892434|BB 1101|bb 1101|mesh-list
24952689|NCT03892434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24952690|NCT03892434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292697|NCT03414502|Azathioprine|azathioprine|mesh-list
25292698|NCT03414502|Infliximab|infliximab|mesh-list
25292699|NCT03414502|Certolizumab Pegol|certolizumab pegol|mesh-list
25292700|NCT03414502|Leflunomide|leflunomide|mesh-list
25292701|NCT03414502|Tofacitinib|tofacitinib|mesh-list
25292702|NCT03414502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25292703|NCT03414502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292704|NCT03414502|Immunologic Factors|immunologic factors|mesh-ancestor
25292705|NCT03414502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292706|NCT03414502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25292707|NCT03414502|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25292708|NCT03414502|Abortifacient Agents|abortifacient agents|mesh-ancestor
25292709|NCT03414502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25292710|NCT03414502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25292711|NCT03414502|Antimetabolites|antimetabolites|mesh-ancestor
25292712|NCT03414502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292713|NCT03414502|Dermatologic Agents|dermatologic agents|mesh-ancestor
25292714|NCT03414502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25292715|NCT03414502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25292716|NCT03414502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25292717|NCT03414502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25292718|NCT03414502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25292719|NCT03414502|Antimalarials|antimalarials|mesh-ancestor
25292742|NCT03182751|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25292866|NCT05105412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25292743|NCT03182751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292744|NCT03182751|Hemostatics|hemostatics|mesh-ancestor
25292745|NCT03182751|Coagulants|coagulants|mesh-ancestor
25292746|NCT03054519|Metformin|metformin|mesh-list
25292747|NCT03054519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25292748|NCT03054519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292754|NCT02850263|Aflibercept|aflibercept|mesh-list
25292755|NCT02850263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25292756|NCT02850263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25292757|NCT02850263|Growth Substances|growth substances|mesh-ancestor
25292758|NCT02850263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292759|NCT02850263|Growth Inhibitors|growth inhibitors|mesh-ancestor
25292760|NCT02850263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292761|NCT02450812|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25292762|NCT02450812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292763|NCT02427451|Venetoclax|venetoclax|mesh-list
25292764|NCT02427451|Obinutuzumab|obinutuzumab|mesh-list
25292765|NCT02427451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292766|NCT02427451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25292767|NCT02398526|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25292768|NCT02398526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825306|NCT00005585|Autonomic Agents|autonomic agents|mesh-ancestor
24882046|NCT02975492|Micronutrients|micronutrients|mesh-ancestor
24882047|NCT02975492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882048|NCT02975492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25292787|NCT05106517|Zoledronic Acid|zoledronic acid|mesh-list
25292788|NCT05106517|Denosumab|denosumab|mesh-list
25292789|NCT05106517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25292790|NCT05106517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292799|NCT05106400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25292800|NCT05106400|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25292801|NCT05106400|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25292802|NCT05106400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25292803|NCT05106400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292804|NCT05106400|Antipruritics|antipruritics|mesh-ancestor
25292805|NCT05106400|Dermatologic Agents|dermatologic agents|mesh-ancestor
25292806|NCT05106179|Propranolol|propranolol|mesh-list
25292807|NCT05106179|Atenolol|atenolol|mesh-list
25292808|NCT05106179|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25292809|NCT05106179|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25292810|NCT05106179|Adrenergic Agents|adrenergic agents|mesh-ancestor
25292811|NCT05106179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25292812|NCT05106179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292813|NCT05106179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292814|NCT05106179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25292815|NCT05106179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25292816|NCT05106179|Vasodilator Agents|vasodilator agents|mesh-ancestor
25292817|NCT05106179|Sympatholytics|sympatholytics|mesh-ancestor
25292818|NCT05106179|Autonomic Agents|autonomic agents|mesh-ancestor
25292819|NCT05106179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25292820|NCT05106179|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24882068|NCT02855229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24882069|NCT02855229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24882070|NCT02835157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24882072|NCT02827526|Analgesics|analgesics|mesh-ancestor
24882073|NCT02827526|Sensory System Agents|sensory system agents|mesh-ancestor
24882079|NCT02827526|Anesthetics|anesthetics|mesh-ancestor
25292828|NCT05106023|Temozolomide|temozolomide|mesh-list
25292829|NCT05106023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25292830|NCT05106023|Alkylating Agents|alkylating agents|mesh-ancestor
25292831|NCT05106023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292832|NCT05106023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292850|NCT05105698|Dapagliflozin|dapagliflozin|mesh-list
25292851|NCT05105698|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25292852|NCT05105698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25292853|NCT05105698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292854|NCT05105698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25292855|NCT05105698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292856|NCT05105698|Protease Inhibitors|protease inhibitors|mesh-ancestor
25292857|NCT05105698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25292858|NCT05105412|Gemcitabine|gemcitabine|mesh-list
25292862|NCT05105412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292864|NCT05105412|Antiviral Agents|antiviral agents|mesh-ancestor
25292865|NCT05105412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25292867|NCT05105412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25292868|NCT05105412|Immunologic Factors|immunologic factors|mesh-ancestor
25292869|NCT05105412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25408480|NCT03437746|Prednisolone phosphate|prednisolone phosphate|mesh-list
25173951|NCT02867956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173952|NCT02867956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25173953|NCT02867930|Dexmedetomidine|dexmedetomidine|mesh-list
25173954|NCT02867930|Ketamine|ketamine|mesh-list
25292870|NCT05105412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25292871|NCT05105412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25292872|NCT05105412|Growth Substances|growth substances|mesh-ancestor
25292873|NCT05105412|Growth Inhibitors|growth inhibitors|mesh-ancestor
25292875|NCT05105347|Adalimumab|adalimumab|mesh-list
25292876|NCT05105347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25292877|NCT05105347|Glucocorticoids|glucocorticoids|mesh-ancestor
25292878|NCT05105347|Hormones|hormones|mesh-ancestor
25292879|NCT05105347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25292880|NCT05105347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292881|NCT05105347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25292882|NCT05105347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292883|NCT05105347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25292884|NCT05105256|Prednisolone|prednisolone|mesh-list
25292885|NCT05105256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25292886|NCT05105256|Glucocorticoids|glucocorticoids|mesh-ancestor
25292887|NCT05105256|Hormones|hormones|mesh-ancestor
25292888|NCT05105256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25292889|NCT05105256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292890|NCT05105256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25292891|NCT05105256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292896|NCT05105022|Propofol|propofol|mesh-list
25292897|NCT05105022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25292898|NCT05105022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25292899|NCT05105022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292900|NCT05105022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25292901|NCT05105022|Anesthetics, General|anesthetics, general|mesh-ancestor
25292902|NCT05105022|Anesthetics|anesthetics|mesh-ancestor
25292903|NCT05105009|Furosemide|furosemide|mesh-list
25292904|NCT05105009|Diuretics|diuretics|mesh-ancestor
25292905|NCT05105009|Natriuretic Agents|natriuretic agents|mesh-ancestor
25292906|NCT05105009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292907|NCT05105009|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25292908|NCT05105009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25292909|NCT05105009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292910|NCT05104931|Piroxicam|piroxicam|mesh-list
25292911|NCT05104931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25292912|NCT05104931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25292913|NCT05104931|Analgesics|analgesics|mesh-ancestor
25292914|NCT05104931|Sensory System Agents|sensory system agents|mesh-ancestor
25292915|NCT05104931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25292916|NCT05104931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292917|NCT05104931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25292918|NCT05104931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25292919|NCT05104931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25292920|NCT05104931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25292921|NCT05104931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292922|NCT05104788|Carboplatin|carboplatin|mesh-list
25292923|NCT05104788|Pemetrexed|pemetrexed|mesh-list
25292924|NCT05104788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292925|NCT05104788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25292926|NCT05104788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292927|NCT05104788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25292928|NCT05104788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25292929|NCT05104762|Immunoglobulins|immunoglobulins|mesh-list
25292930|NCT05104762|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25292931|NCT05104762|Antibodies|antibodies|mesh-list
25292932|NCT05104762|gamma-Globulins|gamma-globulins|mesh-list
25292933|NCT05104762|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25292947|NCT05104281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25292948|NCT05104281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25292949|NCT05104281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292950|NCT05087732|Lidocaine|lidocaine|mesh-list
25292951|NCT05087732|Anesthetics, Local|anesthetics, local|mesh-ancestor
25292952|NCT05087732|Anesthetics|anesthetics|mesh-ancestor
25292953|NCT05087732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25647489|NCT01470001|Cholinergic Agents|cholinergic agents|mesh-ancestor
25647490|NCT01470001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25647491|NCT01470001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647492|NCT01470001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292954|NCT05087732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25292956|NCT05087732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25292957|NCT05087732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25292959|NCT05087732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25292960|NCT05087732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25292961|NCT05087732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292962|NCT05076786|Carboplatin|carboplatin|mesh-list
25292963|NCT05076786|Etoposide|etoposide|mesh-list
25292964|NCT05076786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292965|NCT05076786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25292966|NCT05076786|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25292967|NCT05076786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25292968|NCT05076786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25292969|NCT05076786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292970|NCT05068752|Sorafenib|sorafenib|mesh-list
25292971|NCT05068752|Vemurafenib|vemurafenib|mesh-list
24789061|NCT01935505|Bupropion|bupropion|mesh-list
24882196|NCT02735707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24882197|NCT02735707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24882198|NCT02735707|Antioxidants|antioxidants|mesh-ancestor
24882199|NCT02735707|Protective Agents|protective agents|mesh-ancestor
25292972|NCT05068752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25292973|NCT05068752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25292974|NCT05068752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25292975|NCT05068752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292976|NCT05045183|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25292977|NCT05045183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
25292978|NCT05045183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24621628|NCT01063205|Expectorants|expectorants|mesh-ancestor
24882234|NCT02345850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24882235|NCT02345850|Immunologic Factors|immunologic factors|mesh-ancestor
24882236|NCT02345850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988284|NCT03513250|Antiemetics|antiemetics|mesh-ancestor
25292993|NCT04777422|Defibrotide|defibrotide|mesh-list
25292994|NCT04777422|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25292995|NCT04777422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25292996|NCT04777422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25292997|NCT04777422|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25292998|NCT04681105|Acetaminophen|acetaminophen|mesh-list
25292999|NCT04681105|Diphenhydramine|diphenhydramine|mesh-list
25293000|NCT04681105|Promethazine|promethazine|mesh-list
25293001|NCT04681105|Dexamethasone|dexamethasone|mesh-list
25293002|NCT04681105|Dexamethasone acetate|dexamethasone acetate|mesh-list
25293003|NCT04681105|Ibuprofen|ibuprofen|mesh-list
25293004|NCT04681105|Ranitidine|ranitidine|mesh-list
25293005|NCT04681105|Antibodies|antibodies|mesh-list
25293006|NCT04681105|Immunoglobulins|immunoglobulins|mesh-list
25293007|NCT04681105|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25293008|NCT04681105|BB 1101|bb 1101|mesh-list
25293009|NCT04681105|Immunologic Factors|immunologic factors|mesh-ancestor
25293010|NCT04681105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293011|NCT04681105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25293012|NCT04681105|Antiemetics|antiemetics|mesh-ancestor
25293013|NCT04681105|Autonomic Agents|autonomic agents|mesh-ancestor
25293014|NCT04681105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25293015|NCT04681105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25293016|NCT04681105|Glucocorticoids|glucocorticoids|mesh-ancestor
25293017|NCT04681105|Hormones|hormones|mesh-ancestor
25293018|NCT04681105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25293019|NCT04681105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25293020|NCT04681105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293021|NCT04681105|Protease Inhibitors|protease inhibitors|mesh-ancestor
25293022|NCT04681105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293023|NCT04681105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293024|NCT04681105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25293025|NCT04681105|Analgesics|analgesics|mesh-ancestor
25293026|NCT04681105|Sensory System Agents|sensory system agents|mesh-ancestor
25293027|NCT04681105|Antipyretics|antipyretics|mesh-ancestor
25293028|NCT04681105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25293029|NCT04681105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25293030|NCT04681105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25293031|NCT04681105|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25293032|NCT04681105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25293033|NCT04681105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25293034|NCT04681105|Anesthetics, Local|anesthetics, local|mesh-ancestor
25293036|NCT04681105|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25293037|NCT04681105|Histamine Antagonists|histamine antagonists|mesh-ancestor
25293038|NCT04681105|Histamine Agents|histamine agents|mesh-ancestor
25293039|NCT04681105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25293040|NCT04681105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25293041|NCT04681105|Antipruritics|antipruritics|mesh-ancestor
25293042|NCT04681105|Dermatologic Agents|dermatologic agents|mesh-ancestor
25293043|NCT04681105|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25293044|NCT04681105|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25293045|NCT04642950|Sargramostim|sargramostim|mesh-list
25293046|NCT04642950|Immunologic Factors|immunologic factors|mesh-ancestor
25293047|NCT04642950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293048|NCT04593914|Protective Agents|protective agents|mesh-list
25293049|NCT04593914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293050|NCT04578015|Metronidazole|metronidazole|mesh-list
25293051|NCT04578015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25293052|NCT04578015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25293053|NCT04578015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25293054|NCT04578015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25293055|NCT04573504|Clindamycin|clindamycin|mesh-list
25293056|NCT04573504|Clindamycin palmitate|clindamycin palmitate|mesh-list
25293057|NCT04573504|Clindamycin phosphate|clindamycin phosphate|mesh-list
25293058|NCT04573504|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25293059|NCT04573504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25293060|NCT04573504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25293061|NCT04573504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24789918|NCT01939691|Hormones|hormones|mesh-ancestor
24882283|NCT01850108|Immunologic Factors|immunologic factors|mesh-ancestor
24882284|NCT01850108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882285|NCT01850108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24882286|NCT01850108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24882287|NCT01850108|Alkylating Agents|alkylating agents|mesh-ancestor
25293062|NCT04573504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293063|NCT04573504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293064|NCT04573504|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25293065|NCT04528667|Abivertinib|abivertinib|mesh-list
25293066|NCT04528667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293067|NCT04528667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293068|NCT04528667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25293069|NCT04495257|Nivolumab|nivolumab|mesh-list
25293070|NCT04495257|Ipilimumab|ipilimumab|mesh-list
25293074|NCT04495257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293075|NCT04440007|Abivertinib|abivertinib|mesh-list
25293076|NCT04440007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293077|NCT04440007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293078|NCT04440007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25293079|NCT04434001|Thrombin|thrombin|mesh-list
25293080|NCT04434001|Hemostatics|hemostatics|mesh-ancestor
25293081|NCT04434001|Coagulants|coagulants|mesh-ancestor
25293082|NCT04426591|Biotin|biotin|mesh-list
25293083|NCT04426591|Vitamin B Complex|vitamin b complex|mesh-ancestor
25293084|NCT04426591|Vitamins|vitamins|mesh-ancestor
25293085|NCT04426591|Micronutrients|micronutrients|mesh-ancestor
25293086|NCT04426591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293087|NCT04374240|Tretazicar|tretazicar|mesh-list
25293088|NCT04374240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293089|NCT04230746|Trimethoprim|trimethoprim|mesh-list
25293090|NCT04230746|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25293091|NCT04230746|Sulfamethoxazole|sulfamethoxazole|mesh-list
25293092|NCT04230746|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25293093|NCT04230746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25293094|NCT04230746|Renal Agents|renal agents|mesh-ancestor
25293095|NCT04230746|Antimalarials|antimalarials|mesh-ancestor
25293096|NCT04230746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25293097|NCT04230746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25293098|NCT04230746|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25293099|NCT04230746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293100|NCT04230746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293101|NCT04230746|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25293102|NCT04230746|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25293103|NCT04230746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25293104|NCT04230746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25293105|NCT04201834|Risperidone|risperidone|mesh-list
25293106|NCT04201834|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25293107|NCT04201834|Serotonin Agents|serotonin agents|mesh-ancestor
25293108|NCT04201834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25293109|NCT04201834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293110|NCT04201834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293112|NCT04201834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25293113|NCT04201834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25293114|NCT04201834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25293115|NCT04201834|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25293116|NCT04201834|Dopamine Agents|dopamine agents|mesh-ancestor
25293118|NCT04194775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293119|NCT04194775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25293120|NCT04194775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293121|NCT04194775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293126|NCT03991741|Interleukin-2|interleukin-2|mesh-list
25293127|NCT03991741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293128|NCT03991741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25293129|NCT03991741|Analgesics|analgesics|mesh-ancestor
24882375|NCT00950989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24882377|NCT00950989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882378|NCT00950989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882379|NCT00950989|Dermatologic Agents|dermatologic agents|mesh-ancestor
24882380|NCT00950989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24882381|NCT00950989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24882382|NCT00950989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24882383|NCT00950989|Immunologic Factors|immunologic factors|mesh-ancestor
24882384|NCT00950989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25293130|NCT03991741|Sensory System Agents|sensory system agents|mesh-ancestor
25293131|NCT03991741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25293132|NCT03991741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293133|NCT03903692|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25293134|NCT03903692|Laxatives|laxatives|mesh-ancestor
25293135|NCT03903692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25293136|NCT03769688|Metronidazole|metronidazole|mesh-list
25293137|NCT03769688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25825307|NCT00005585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25825308|NCT00005585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25825309|NCT00005585|Glucocorticoids|glucocorticoids|mesh-ancestor
25825310|NCT00005585|Hormones|hormones|mesh-ancestor
25825311|NCT00005585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25825312|NCT00005585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25825313|NCT00005585|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25825314|NCT00005585|Abortifacient Agents|abortifacient agents|mesh-ancestor
25825315|NCT00005585|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25825316|NCT00005585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25825317|NCT00005585|Antimetabolites|antimetabolites|mesh-ancestor
25825318|NCT00005585|Dermatologic Agents|dermatologic agents|mesh-ancestor
25293156|NCT03620643|Fulvestrant|fulvestrant|mesh-list
25293157|NCT03620643|Crizotinib|crizotinib|mesh-list
25293158|NCT03620643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25293159|NCT03620643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293160|NCT03620643|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25293161|NCT03620643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25293162|NCT03620643|Hormone Antagonists|hormone antagonists|mesh-ancestor
25293163|NCT03620643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25293164|NCT03620643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293165|NCT03620643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25293166|NCT03620643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293167|NCT03620643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293168|NCT03572413|Bromides|bromides|mesh-list
25293169|NCT03572413|Rocuronium|rocuronium|mesh-list
25293170|NCT03572413|Anticonvulsants|anticonvulsants|mesh-ancestor
25293171|NCT03572413|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25293172|NCT03572413|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25293173|NCT03572413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25293174|NCT03572413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25293175|NCT03572413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293176|NCT03500484|Liraglutide|liraglutide|mesh-list
25293177|NCT03500484|Glucagon|glucagon|mesh-list
25293178|NCT03500484|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25293179|NCT03500484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25293180|NCT03500484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293181|NCT03500484|Incretins|incretins|mesh-ancestor
25293182|NCT03500484|Hormones|hormones|mesh-ancestor
25293183|NCT03500484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25293184|NCT03500484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25293185|NCT03349281|Cytarabine|cytarabine|mesh-list
25293187|NCT03349281|Hydrocortisone|hydrocortisone|mesh-list
25293188|NCT03349281|Doxorubicin|doxorubicin|mesh-list
25293189|NCT03349281|Methotrexate|methotrexate|mesh-list
25293190|NCT03349281|Vincristine|vincristine|mesh-list
25293191|NCT03349281|Asparaginase|asparaginase|mesh-list
25293192|NCT03349281|Pegaspargase|pegaspargase|mesh-list
25293193|NCT03349281|Pevonedistat|pevonedistat|mesh-list
25293194|NCT03349281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25293195|NCT03349281|Antiemetics|antiemetics|mesh-ancestor
25293196|NCT03349281|Autonomic Agents|autonomic agents|mesh-ancestor
25293197|NCT03349281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25293198|NCT03349281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293199|NCT03349281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25293200|NCT03349281|Glucocorticoids|glucocorticoids|mesh-ancestor
25293201|NCT03349281|Hormones|hormones|mesh-ancestor
25293274|NCT03142568|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25293209|NCT03349281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293210|NCT03349281|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25293211|NCT03349281|Abortifacient Agents|abortifacient agents|mesh-ancestor
25293212|NCT03349281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25293213|NCT03349281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25293214|NCT03349281|Antimetabolites|antimetabolites|mesh-ancestor
25293215|NCT03349281|Dermatologic Agents|dermatologic agents|mesh-ancestor
25293216|NCT03349281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25293217|NCT03349281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25293218|NCT03349281|Immunologic Factors|immunologic factors|mesh-ancestor
25293219|NCT03349281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25293220|NCT03349281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25293221|NCT03349281|Antiviral Agents|antiviral agents|mesh-ancestor
24882451|NCT05170828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882452|NCT05170828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24882453|NCT05170828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25293222|NCT03349281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25293223|NCT03349281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25293224|NCT03349281|Tubulin Modulators|tubulin modulators|mesh-ancestor
25293225|NCT03349281|Antimitotic Agents|antimitotic agents|mesh-ancestor
25293226|NCT03349281|Mitosis Modulators|mitosis modulators|mesh-ancestor
25293227|NCT03292666|Warfarin|warfarin|mesh-list
25293228|NCT03292666|Rivaroxaban|rivaroxaban|mesh-list
25293229|NCT03292666|Dabigatran|dabigatran|mesh-list
25293230|NCT03292666|Apixaban|apixaban|mesh-list
25293231|NCT03292666|Edoxaban|edoxaban|mesh-list
25293232|NCT03292666|Anticoagulants|anticoagulants|mesh-list
25293233|NCT03292666|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25293234|NCT03292666|Antithrombins|antithrombins|mesh-ancestor
25293235|NCT03292666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25293236|NCT03292666|Protease Inhibitors|protease inhibitors|mesh-ancestor
25293237|NCT03292666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293238|NCT03292666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293239|NCT03286842|Olaparib|olaparib|mesh-list
25293240|NCT03286842|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25293241|NCT03286842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293242|NCT03286842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293243|NCT03286842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293252|NCT03219775|Nivolumab|nivolumab|mesh-list
25293253|NCT03219775|Ipilimumab|ipilimumab|mesh-list
25293254|NCT03219775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25293255|NCT03219775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293256|NCT03219775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25293257|NCT03219775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293258|NCT03164564|Tenofovir|tenofovir|mesh-list
25293259|NCT03164564|Emtricitabine|emtricitabine|mesh-list
25293260|NCT03164564|Cabotegravir|cabotegravir|mesh-list
25293261|NCT03164564|Antiviral Agents|antiviral agents|mesh-ancestor
25293262|NCT03164564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25293263|NCT03164564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25293264|NCT03164564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25293265|NCT03164564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293266|NCT03164564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293267|NCT03164564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25293268|NCT03164564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25293269|NCT03164564|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25293270|NCT03164564|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25293271|NCT03142568|Sildenafil Citrate|sildenafil citrate|mesh-list
25293272|NCT03142568|Vasodilator Agents|vasodilator agents|mesh-ancestor
25293273|NCT03142568|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25293281|NCT03100045|Antimalarials|antimalarials|mesh-ancestor
25293282|NCT03100045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25174236|NCT02866955|Estramustine|estramustine|mesh-list
25174237|NCT02866955|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25174238|NCT02866955|Hormone Antagonists|hormone antagonists|mesh-ancestor
25174239|NCT02866955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25174240|NCT02866955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174241|NCT02866955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25174242|NCT02866955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174249|NCT02866786|Metformin|metformin|mesh-list
25293283|NCT03100045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25293284|NCT03100045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25293285|NCT03100045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293286|NCT03100045|Antiviral Agents|antiviral agents|mesh-ancestor
25293287|NCT03100045|Schistosomicides|schistosomicides|mesh-ancestor
25293288|NCT03100045|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25293289|NCT03100045|Anthelmintics|anthelmintics|mesh-ancestor
25293290|NCT02660281|Cyclophosphamide|cyclophosphamide|mesh-list
24882565|NCT05169112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24882566|NCT05169112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882567|NCT05169112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24882568|NCT05169112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882569|NCT05169021|Folic Acid|folic acid|mesh-list
24882570|NCT05169021|Vitamin B Complex|vitamin b complex|mesh-list
24882571|NCT05169021|Amlodipine|amlodipine|mesh-list
25293291|NCT02660281|Melphalan|melphalan|mesh-list
25293292|NCT02660281|Busulfan|busulfan|mesh-list
25293293|NCT02660281|Thiotepa|thiotepa|mesh-list
25293294|NCT02660281|Fludarabine|fludarabine|mesh-list
25293295|NCT02660281|Mesna|mesna|mesh-list
25293296|NCT02660281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25293297|NCT02660281|Immunologic Factors|immunologic factors|mesh-ancestor
25293298|NCT02660281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293299|NCT02660281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25293300|NCT02660281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25293301|NCT02660281|Alkylating Agents|alkylating agents|mesh-ancestor
25293302|NCT02660281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293303|NCT02660281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293304|NCT02660281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25293305|NCT02660281|Protective Agents|protective agents|mesh-ancestor
25293306|NCT02571530|Trastuzumab|trastuzumab|mesh-list
25293307|NCT02571530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25293308|NCT02571530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293309|NCT02438995|Cetuximab|cetuximab|mesh-list
25293310|NCT02438995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25293311|NCT02438995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293312|NCT05108389|Hemostatics|hemostatics|mesh-list
25293313|NCT05108389|Coagulants|coagulants|mesh-ancestor
25293314|NCT05108350|Metformin|metformin|mesh-list
25293315|NCT05108350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25293316|NCT05108350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293317|NCT05108220|Cannabidiol|cannabidiol|mesh-list
25293318|NCT05108220|Anticonvulsants|anticonvulsants|mesh-ancestor
25293319|NCT05108051|Oseltamivir|oseltamivir|mesh-list
25293320|NCT05108051|Antiviral Agents|antiviral agents|mesh-ancestor
25293321|NCT05108051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25293322|NCT05108051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293323|NCT05108051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293329|NCT05107921|Bromfenac|bromfenac|mesh-list
25293330|NCT05107921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25293331|NCT05107921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25293332|NCT05107921|Analgesics|analgesics|mesh-ancestor
25293333|NCT05107921|Sensory System Agents|sensory system agents|mesh-ancestor
25293334|NCT05107921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25293335|NCT05107921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293336|NCT05107921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25293337|NCT05107921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25293338|NCT05107791|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25647493|NCT01470001|Urological Agents|urological agents|mesh-ancestor
25647494|NCT01470027|Acetylcysteine|acetylcysteine|mesh-list
25647495|NCT01470027|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25647496|NCT01470027|Antiviral Agents|antiviral agents|mesh-ancestor
25647497|NCT01470027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25647498|NCT01470027|Expectorants|expectorants|mesh-ancestor
25647499|NCT01470027|Respiratory System Agents|respiratory system agents|mesh-ancestor
25293339|NCT05107791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25293340|NCT05107375|Vaccines|vaccines|mesh-list
25293341|NCT05107375|Immunologic Factors|immunologic factors|mesh-ancestor
25293342|NCT05107375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647500|NCT01470027|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25647501|NCT01470027|Antioxidants|antioxidants|mesh-ancestor
24974154|NCT05156684|Trace Elements|trace elements|mesh-ancestor
25293343|NCT05107063|Pravastatin|pravastatin|mesh-list
25293344|NCT05107063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25293345|NCT05107063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25293346|NCT05107063|Antimetabolites|antimetabolites|mesh-ancestor
25293347|NCT05107063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293349|NCT05107063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25293350|NCT05107063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293351|NCT05106803|Amoxicillin|amoxicillin|mesh-list
25293352|NCT05106803|Vancomycin|vancomycin|mesh-list
25293353|NCT05106803|Ciprofloxacin|ciprofloxacin|mesh-list
25293354|NCT05106803|Clindamycin|clindamycin|mesh-list
25293355|NCT05106803|Gentamicins|gentamicins|mesh-list
25293356|NCT05106803|Tetracycline|tetracycline|mesh-list
25293357|NCT05106803|Penicillins|penicillins|mesh-list
25293358|NCT05106803|Erythromycin|erythromycin|mesh-list
25293359|NCT05106803|Ampicillin|ampicillin|mesh-list
25293360|NCT05106803|Clavulanic Acids|clavulanic acids|mesh-list
25293361|NCT05106803|Clavulanic Acid|clavulanic acid|mesh-list
24827408|NCT02138799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293365|NCT05106803|Oxacillin|oxacillin|mesh-list
25293366|NCT05106803|Chloramphenicol|chloramphenicol|mesh-list
25293367|NCT05106803|Trimethoprim|trimethoprim|mesh-list
25293368|NCT05106803|Sulfamethoxazole|sulfamethoxazole|mesh-list
25293369|NCT05106803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25293370|NCT05106803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25293371|NCT05106803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25293372|NCT05106803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25293373|NCT05106803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293374|NCT05106803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293375|NCT05106803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293376|NCT05106803|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25293377|NCT05106803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25293378|NCT05106803|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25293379|NCT05106803|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25293380|NCT05106803|Renal Agents|renal agents|mesh-ancestor
25293381|NCT05106803|Antimalarials|antimalarials|mesh-ancestor
25293382|NCT05106803|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25293383|NCT05106803|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25293384|NCT05106803|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25293385|NCT05106803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25293386|NCT05106803|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25293387|NCT05106803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25293388|NCT05106803|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25293389|NCT05106751|Hyaluronic Acid|hyaluronic acid|mesh-list
25293390|NCT05106751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25293391|NCT05106751|Immunologic Factors|immunologic factors|mesh-ancestor
25293392|NCT05106751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293393|NCT05106751|Viscosupplements|viscosupplements|mesh-ancestor
25293394|NCT05106751|Protective Agents|protective agents|mesh-ancestor
25293395|NCT05106712|Vitamin D|vitamin d|mesh-list
25293396|NCT05106712|Cholecalciferol|cholecalciferol|mesh-list
25293397|NCT05106712|Letrozole|letrozole|mesh-list
25293398|NCT05106712|Clomiphene|clomiphene|mesh-list
25293399|NCT05106712|Enclomiphene|enclomiphene|mesh-list
25293400|NCT05106712|Zuclomiphene|zuclomiphene|mesh-list
25293401|NCT05106712|Vitamins|vitamins|mesh-ancestor
25293402|NCT05106712|Micronutrients|micronutrients|mesh-ancestor
25293403|NCT05106712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293404|NCT05106712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25293405|NCT05106712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293406|NCT05106712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25293407|NCT05106712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293408|NCT05106712|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25293409|NCT05106712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25293410|NCT05106712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293411|NCT05106712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25293412|NCT05106712|Hormone Antagonists|hormone antagonists|mesh-ancestor
25293413|NCT05106712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25293414|NCT05106712|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25293415|NCT05106712|Fertility Agents|fertility agents|mesh-ancestor
25293416|NCT05106712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25293417|NCT05106712|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25293418|NCT05106712|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25293444|NCT05004077|Vasodilator Agents|vasodilator agents|mesh-ancestor
25647502|NCT01470027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293445|NCT05004077|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25293446|NCT05004077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25293447|NCT05004077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293448|NCT05004077|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25293449|NCT05004077|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25293450|NCT05004077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25293451|NCT05004077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293452|NCT05004077|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25293453|NCT05004077|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25293454|NCT05004077|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25293455|NCT04977024|Vaccines|vaccines|mesh-list
25293456|NCT04977024|Immunologic Factors|immunologic factors|mesh-ancestor
25293464|NCT04903093|Abrocitinib|abrocitinib|mesh-list
25293465|NCT04903093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25293466|NCT04903093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25293467|NCT04903093|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25293468|NCT04903093|Histamine Antagonists|histamine antagonists|mesh-ancestor
25293469|NCT04903093|Histamine Agents|histamine agents|mesh-ancestor
25293470|NCT04903093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25293471|NCT04903093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293472|NCT04903093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293473|NCT04903093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25293474|NCT04903093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293475|NCT04833413|Insulin|insulin|mesh-list
25293476|NCT04833413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25293477|NCT04833413|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25293478|NCT04833413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293479|NCT04771689|Buprenorphine|buprenorphine|mesh-list
25293480|NCT04771689|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25293481|NCT04771689|Naloxone|naloxone|mesh-list
25293482|NCT04771689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25293483|NCT04771689|Narcotics|narcotics|mesh-ancestor
25293484|NCT04771689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25293485|NCT04771689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293486|NCT04771689|Analgesics|analgesics|mesh-ancestor
25293487|NCT04771689|Sensory System Agents|sensory system agents|mesh-ancestor
25293488|NCT04771689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25293489|NCT04771689|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24905415|NCT04347980|Dexamethasone|dexamethasone|mesh-list
25293524|NCT04722978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25293525|NCT04722978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25293526|NCT04722978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25293527|NCT04722978|Contraceptive Agents|contraceptive agents|mesh-ancestor
25293528|NCT04722978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25293529|NCT04722978|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25293530|NCT04722978|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25293531|NCT04722978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25293533|NCT04695106|Dabigatran|dabigatran|mesh-list
25293534|NCT04695106|Clopidogrel|clopidogrel|mesh-list
25293535|NCT04695106|Ticagrelor|ticagrelor|mesh-list
25293536|NCT04695106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25293537|NCT04695106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25293538|NCT04695106|Analgesics|analgesics|mesh-ancestor
25293539|NCT04695106|Sensory System Agents|sensory system agents|mesh-ancestor
25293540|NCT04695106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25293541|NCT04695106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293542|NCT04695106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25293543|NCT04695106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25293544|NCT04695106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25293545|NCT04695106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25293546|NCT04695106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293547|NCT04695106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25293548|NCT04695106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25293549|NCT04695106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293550|NCT04695106|Antipyretics|antipyretics|mesh-ancestor
25293551|NCT04695106|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25293552|NCT04695106|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25293553|NCT04695106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25293554|NCT04695106|Purinergic Agents|purinergic agents|mesh-ancestor
25293555|NCT04695106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25293556|NCT04695106|Antithrombins|antithrombins|mesh-ancestor
25293557|NCT04695106|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25293558|NCT04695106|Protease Inhibitors|protease inhibitors|mesh-ancestor
25293559|NCT04695106|Anticoagulants|anticoagulants|mesh-ancestor
25293560|NCT04658147|Nivolumab|nivolumab|mesh-list
25647503|NCT01470027|Protective Agents|protective agents|mesh-ancestor
25174386|NCT02865785|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25174387|NCT02865785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25174388|NCT02866032|Ciclopirox|ciclopirox|mesh-list
25174389|NCT02866032|Antifungal Agents|antifungal agents|mesh-ancestor
25174390|NCT02866032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24753251|NCT01714401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25293561|NCT04658147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25293562|NCT04658147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871190|NCT04578600|Growth Substances|growth substances|mesh-ancestor
25293563|NCT04658147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25293564|NCT04658147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293566|NCT04614974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25293567|NCT04614974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25293568|NCT04614974|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25293569|NCT04614974|Histamine Antagonists|histamine antagonists|mesh-ancestor
25293570|NCT04614974|Histamine Agents|histamine agents|mesh-ancestor
25293571|NCT04614974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25293572|NCT04614974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293573|NCT04614974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293575|NCT04576767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25293576|NCT04576767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293577|NCT04557644|Dermatologic Agents|dermatologic agents|mesh-list
25293578|NCT04537286|Paclitaxel|paclitaxel|mesh-list
25293579|NCT04537286|Cisplatin|cisplatin|mesh-list
25293580|NCT04537286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25293581|NCT04537286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293582|NCT04537286|Tubulin Modulators|tubulin modulators|mesh-ancestor
25293583|NCT04537286|Antimitotic Agents|antimitotic agents|mesh-ancestor
25293584|NCT04537286|Mitosis Modulators|mitosis modulators|mesh-ancestor
25293585|NCT04537286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293586|NCT04486625|Aztreonam|aztreonam|mesh-list
25293587|NCT04486625|Avibactam|avibactam|mesh-list
25293588|NCT04486625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25293589|NCT04486625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25293590|NCT04486625|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25293591|NCT04486625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293592|NCT04486625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293593|NCT04316364|Paclitaxel|paclitaxel|mesh-list
25293594|NCT04316364|Carboplatin|carboplatin|mesh-list
25293595|NCT04316364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25293596|NCT04316364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293597|NCT04316364|Tubulin Modulators|tubulin modulators|mesh-ancestor
25293598|NCT04316364|Antimitotic Agents|antimitotic agents|mesh-ancestor
25293599|NCT04316364|Mitosis Modulators|mitosis modulators|mesh-ancestor
25293600|NCT04316364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293601|NCT04235686|Amphetamine|amphetamine|mesh-list
25293602|NCT04235686|Dextroamphetamine|dextroamphetamine|mesh-list
25293603|NCT04235686|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25293604|NCT04235686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293605|NCT04235686|Sympathomimetics|sympathomimetics|mesh-ancestor
25293606|NCT04235686|Autonomic Agents|autonomic agents|mesh-ancestor
25293607|NCT04235686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25293608|NCT04235686|Dopamine Agents|dopamine agents|mesh-ancestor
25293609|NCT04235686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25293610|NCT04235686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293611|NCT04235686|Adrenergic Agents|adrenergic agents|mesh-ancestor
25293612|NCT04235686|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25293613|NCT04235686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25293614|NCT04235686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25293615|NCT04235686|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25293616|NCT04210141|Antivenins|antivenins|mesh-list
25293617|NCT04210141|Immunologic Factors|immunologic factors|mesh-ancestor
25293618|NCT04210141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293619|NCT04199767|Insulin|insulin|mesh-list
25293620|NCT04199767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25293621|NCT04199767|Insulin, Isophane|insulin, isophane|mesh-list
25293622|NCT04199767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25293623|NCT04199767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647504|NCT01470027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647505|NCT01470027|Antidotes|antidotes|mesh-ancestor
25647506|NCT01470118|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25647507|NCT01470118|Dextrans|dextrans|mesh-list
25647508|NCT01470118|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25647509|NCT01470118|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25647510|NCT01470118|Lubricant Eye Drops|lubricant eye drops|mesh-list
25293624|NCT04018872|Itraconazole|itraconazole|mesh-list
25293625|NCT04018872|Antifungal Agents|antifungal agents|mesh-ancestor
25293626|NCT04018872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25293627|NCT04018872|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25293628|NCT04018872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25293629|NCT04018872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293630|NCT04018872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293631|NCT04018872|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25293632|NCT04018872|Hormone Antagonists|hormone antagonists|mesh-ancestor
25293633|NCT04018872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24882766|NCT05002244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293634|NCT04018872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293635|NCT04018872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25293636|NCT04001777|Osimertinib|osimertinib|mesh-list
25293637|NCT04001777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293638|NCT04001777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25293639|NCT04001777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293640|NCT04001777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293641|NCT03982576|Nicotine|nicotine|mesh-list
25293642|NCT03982576|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25293643|NCT03982576|Autonomic Agents|autonomic agents|mesh-ancestor
25293644|NCT03982576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25293645|NCT03982576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293646|NCT03982576|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25293647|NCT03982576|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25293648|NCT03982576|Cholinergic Agents|cholinergic agents|mesh-ancestor
25293649|NCT03982576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25293650|NCT03982576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882809|NCT04957368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24882811|NCT04957368|Sensory System Agents|sensory system agents|mesh-ancestor
25293651|NCT03969641|Vaccines|vaccines|mesh-list
25293652|NCT03969641|Immunologic Factors|immunologic factors|mesh-ancestor
25293653|NCT03969641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293654|NCT03965923|Tenofovir|tenofovir|mesh-list
25293655|NCT03965923|Emtricitabine|emtricitabine|mesh-list
25293656|NCT03965923|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25293657|NCT03965923|Dapivirine|dapivirine|mesh-list
25293658|NCT03965923|Antiviral Agents|antiviral agents|mesh-ancestor
25293659|NCT03965923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25293660|NCT03965923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25293661|NCT03965923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25293662|NCT03965923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293663|NCT03965923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293664|NCT03965923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25293665|NCT03965923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25293666|NCT03933813|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25293667|NCT03933813|Hematinics|hematinics|mesh-ancestor
25293668|NCT03875144|Cisplatin|cisplatin|mesh-list
25293669|NCT03875144|Doxorubicin|doxorubicin|mesh-list
25293670|NCT03875144|Pemetrexed|pemetrexed|mesh-list
25293671|NCT03875144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293672|NCT03875144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25293673|NCT03875144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25293674|NCT03875144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25293675|NCT03875144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293676|NCT03875144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293677|NCT03875144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25293678|NCT03875144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25293679|NCT03740204|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25293680|NCT03740204|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25293681|NCT03740204|Estradiol|estradiol|mesh-list
25293682|NCT03740204|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25293683|NCT03740204|Progesterone|progesterone|mesh-list
25293684|NCT03740204|Estrogens|estrogens|mesh-ancestor
25293685|NCT03740204|Hormones|hormones|mesh-ancestor
25293686|NCT03740204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25293687|NCT03740204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293688|NCT03740204|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25293689|NCT03740204|Contraceptive Agents|contraceptive agents|mesh-ancestor
25293690|NCT03740204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25293691|NCT03740204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25293692|NCT03740204|Progestins|progestins|mesh-ancestor
25293693|NCT03726671|Choline|choline|mesh-list
25293694|NCT03726671|Lipotropic Agents|lipotropic agents|mesh-ancestor
25293695|NCT03726671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25293696|NCT03726671|Antimetabolites|antimetabolites|mesh-ancestor
25293697|NCT03726671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293698|NCT03726671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25293699|NCT03726671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25293700|NCT03726671|Nootropic Agents|nootropic agents|mesh-ancestor
25293702|NCT03701711|Immunologic Factors|immunologic factors|mesh-ancestor
25293703|NCT03701711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293704|NCT03701711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25293705|NCT03701711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25293706|NCT03701711|Growth Substances|growth substances|mesh-ancestor
25293707|NCT03701711|Growth Inhibitors|growth inhibitors|mesh-ancestor
25293708|NCT03701711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293732|NCT03587844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293734|NCT03579914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25293735|NCT03579914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25293736|NCT03579914|Sympatholytics|sympatholytics|mesh-ancestor
25293737|NCT03579914|Autonomic Agents|autonomic agents|mesh-ancestor
25293738|NCT03579914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25293739|NCT03579914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293740|NCT03579914|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25293741|NCT03579914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25293742|NCT03579914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25293743|NCT03579914|Adrenergic Agents|adrenergic agents|mesh-ancestor
25293744|NCT03579914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25293745|NCT03579914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293746|NCT03560258|Vaccines|vaccines|mesh-list
25293747|NCT03560258|Immunologic Factors|immunologic factors|mesh-ancestor
25293748|NCT03560258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293749|NCT03535363|Osimertinib|osimertinib|mesh-list
25293750|NCT03535363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293751|NCT03535363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25293752|NCT03535363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293753|NCT03535363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293754|NCT03371979|Pembrolizumab|pembrolizumab|mesh-list
25293755|NCT03371979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25293756|NCT03371979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293757|NCT03293017|Diazepam|diazepam|mesh-list
25293758|NCT03293017|Baclofen|baclofen|mesh-list
25293759|NCT03293017|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25293760|NCT03293017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293761|NCT03293017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25293762|NCT03293017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25293763|NCT03293017|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25293764|NCT03293017|GABA Agonists|gaba agonists|mesh-ancestor
25293765|NCT03293017|GABA Agents|gaba agents|mesh-ancestor
25293766|NCT03293017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25293767|NCT03293017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293768|NCT03293017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25293769|NCT03293017|Anticonvulsants|anticonvulsants|mesh-ancestor
25293770|NCT03293017|Antiemetics|antiemetics|mesh-ancestor
25293771|NCT03293017|Autonomic Agents|autonomic agents|mesh-ancestor
25293772|NCT03293017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25293773|NCT03293017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25293774|NCT03293017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25293775|NCT03293017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25293776|NCT03293017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25293777|NCT03293017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25293778|NCT03293017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25293779|NCT03293017|Anesthetics, General|anesthetics, general|mesh-ancestor
25293780|NCT03293017|Anesthetics|anesthetics|mesh-ancestor
25293781|NCT03293017|GABA Modulators|gaba modulators|mesh-ancestor
25293782|NCT03198559|Vorinostat|vorinostat|mesh-list
25293783|NCT03198559|Disulfiram|disulfiram|mesh-list
25293784|NCT03198559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293785|NCT03198559|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25293786|NCT03198559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293787|NCT03198559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293788|NCT03198559|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25293789|NCT03198559|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25293790|NCT03179943|Atezolizumab|atezolizumab|mesh-list
25293791|NCT03179943|Guadecitabine|guadecitabine|mesh-list
25293792|NCT03179943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293793|NCT03136263|Oxytocin|oxytocin|mesh-list
25293794|NCT03136263|Oxytocics|oxytocics|mesh-ancestor
25174596|NCT02864472|Ranibizumab|ranibizumab|mesh-list
25174597|NCT02864472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25174598|NCT02864472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25174599|NCT02864472|Growth Substances|growth substances|mesh-ancestor
25174600|NCT02864472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293795|NCT03136263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25293796|NCT03136263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293797|NCT03129113|Metformin|metformin|mesh-list
25293798|NCT03129113|Maraviroc|maraviroc|mesh-list
25293799|NCT03129113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25293800|NCT03129113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293801|NCT03129113|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25293802|NCT03129113|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25293803|NCT03129113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293804|NCT03129113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25293805|NCT03129113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25293806|NCT03129113|Antiviral Agents|antiviral agents|mesh-ancestor
25293807|NCT03129113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25293808|NCT03129113|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25293809|NCT03102125|Regadenoson|regadenoson|mesh-list
25293810|NCT03102125|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25293811|NCT03102125|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25293812|NCT03102125|Purinergic Agonists|purinergic agonists|mesh-ancestor
25293813|NCT03102125|Purinergic Agents|purinergic agents|mesh-ancestor
25293814|NCT03102125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25293815|NCT03102125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293816|NCT03102125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293818|NCT02982668|Mosapride|mosapride|mesh-list
25293819|NCT02982668|Antiemetics|antiemetics|mesh-ancestor
25293820|NCT02982668|Autonomic Agents|autonomic agents|mesh-ancestor
25293821|NCT02982668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25293822|NCT02982668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293823|NCT02982668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25293824|NCT02982668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25293825|NCT02982668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25293826|NCT02982668|Dopamine Agents|dopamine agents|mesh-ancestor
25293827|NCT02982668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25293828|NCT02982668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293829|NCT02982668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25293830|NCT02982668|Serotonin Agents|serotonin agents|mesh-ancestor
25293831|NCT02917096|Vidarabine|vidarabine|mesh-list
25293832|NCT02917096|Sirolimus|sirolimus|mesh-list
25293833|NCT02917096|Fludarabine|fludarabine|mesh-list
25293834|NCT02917096|Fludarabine phosphate|fludarabine phosphate|mesh-list
25293835|NCT02917096|Melphalan|melphalan|mesh-list
25293836|NCT02917096|Mechlorethamine|mechlorethamine|mesh-list
25293837|NCT02917096|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25293838|NCT02917096|Tacrolimus|tacrolimus|mesh-list
25293839|NCT02917096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293840|NCT02917096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25293841|NCT02917096|Antimetabolites|antimetabolites|mesh-ancestor
25293842|NCT02917096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293843|NCT02917096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25293844|NCT02917096|Immunologic Factors|immunologic factors|mesh-ancestor
25293845|NCT02917096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293846|NCT02917096|Antiviral Agents|antiviral agents|mesh-ancestor
25293847|NCT02917096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25293848|NCT02917096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25293849|NCT02917096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293850|NCT02917096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25293851|NCT02917096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25293852|NCT02917096|Antifungal Agents|antifungal agents|mesh-ancestor
25293853|NCT02917096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25293854|NCT02917096|Alkylating Agents|alkylating agents|mesh-ancestor
25293855|NCT02917096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25293856|NCT02913274|Paclitaxel|paclitaxel|mesh-list
25293857|NCT02913274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25293858|NCT02913274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293859|NCT02913274|Tubulin Modulators|tubulin modulators|mesh-ancestor
25293860|NCT02913274|Antimitotic Agents|antimitotic agents|mesh-ancestor
25293861|NCT02913274|Mitosis Modulators|mitosis modulators|mesh-ancestor
25647511|NCT01470118|Alcaftadine|alcaftadine|mesh-list
25647512|NCT01470118|Anticoagulants|anticoagulants|mesh-ancestor
25647513|NCT01470118|Plasma Substitutes|plasma substitutes|mesh-ancestor
25647514|NCT01470118|Blood Substitutes|blood substitutes|mesh-ancestor
25647515|NCT01470118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25174659|NCT02864095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25174660|NCT02864095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25293862|NCT02913274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293868|NCT02749513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25293869|NCT02749513|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25293870|NCT02749513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25293871|NCT02749513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293872|NCT02749513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293873|NCT02749513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25293874|NCT02749513|Hormone Antagonists|hormone antagonists|mesh-ancestor
24882866|NCT04847206|Hallucinogens|hallucinogens|mesh-ancestor
25293875|NCT02749513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25293876|NCT02749513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293877|NCT02749513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25293878|NCT02684227|Paclitaxel|paclitaxel|mesh-list
25293879|NCT02684227|Carboplatin|carboplatin|mesh-list
25293880|NCT02684227|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25293881|NCT02684227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25293882|NCT02684227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293883|NCT02684227|Tubulin Modulators|tubulin modulators|mesh-ancestor
25293884|NCT02684227|Antimitotic Agents|antimitotic agents|mesh-ancestor
25293885|NCT02684227|Mitosis Modulators|mitosis modulators|mesh-ancestor
25293886|NCT02684227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293887|NCT02682641|Rituximab|rituximab|mesh-list
25293888|NCT02682641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25293889|NCT02682641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293890|NCT02682641|Immunologic Factors|immunologic factors|mesh-ancestor
25293891|NCT02682641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293892|NCT02682641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25293893|NCT05110339|Dexmedetomidine|dexmedetomidine|mesh-list
25293894|NCT05110339|Ropivacaine|ropivacaine|mesh-list
25293895|NCT05110339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25293896|NCT05110339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25293897|NCT05110339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293898|NCT05110339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25293899|NCT05110339|Analgesics|analgesics|mesh-ancestor
25293900|NCT05110339|Sensory System Agents|sensory system agents|mesh-ancestor
25293901|NCT05110339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25293902|NCT05110339|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25293903|NCT05110339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25293904|NCT05110339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25293905|NCT05110339|Adrenergic Agents|adrenergic agents|mesh-ancestor
25293906|NCT05110339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25293907|NCT05110339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293908|NCT05110339|Anesthetics, Local|anesthetics, local|mesh-ancestor
25293909|NCT05110339|Anesthetics|anesthetics|mesh-ancestor
25293910|NCT05110170|Goserelin|goserelin|mesh-list
25293911|NCT05110170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25293912|NCT05110170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293913|NCT05110144|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25293914|NCT05110144|Amitriptyline|amitriptyline|mesh-list
25293915|NCT05110144|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25293916|NCT05110144|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25293917|NCT05110144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25293918|NCT05110144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293919|NCT05110144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25293920|NCT05110144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293921|NCT05110144|Analgesics|analgesics|mesh-ancestor
25293922|NCT05110144|Sensory System Agents|sensory system agents|mesh-ancestor
25293923|NCT05110144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25293924|NCT05110144|Antidepressive Agents|antidepressive agents|mesh-ancestor
25293925|NCT05110144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25293926|NCT05110144|Dopamine Agents|dopamine agents|mesh-ancestor
25293927|NCT05110144|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25293928|NCT05110144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25293929|NCT05110144|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25293930|NCT05110144|Adrenergic Agents|adrenergic agents|mesh-ancestor
25293931|NCT05110118|Bevacizumab|bevacizumab|mesh-list
25293932|NCT05110118|Endothelial Growth Factors|endothelial growth factors|mesh-list
25293933|NCT05110118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25647516|NCT01470118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25647517|NCT01470118|Analgesics|analgesics|mesh-ancestor
25293934|NCT05110118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25293937|NCT05110118|Growth Substances|growth substances|mesh-ancestor
25293938|NCT05110118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882944|NCT04726969|Anticestodal Agents|anticestodal agents|mesh-ancestor
24882945|NCT04726969|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24882946|NCT04726969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24882947|NCT04726969|Tubulin Modulators|tubulin modulators|mesh-ancestor
24882948|NCT04726969|Antimitotic Agents|antimitotic agents|mesh-ancestor
24882949|NCT04726969|Mitosis Modulators|mitosis modulators|mesh-ancestor
24882950|NCT04726969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882953|NCT04691960|Metformin|metformin|mesh-list
25293939|NCT05110118|Growth Inhibitors|growth inhibitors|mesh-ancestor
25293940|NCT05109650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25293941|NCT05109650|Antibodies|antibodies|mesh-list
25293942|NCT05109650|Immunoglobulins|immunoglobulins|mesh-list
25293943|NCT05109650|Immunologic Factors|immunologic factors|mesh-ancestor
25293944|NCT05109650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293945|NCT05109585|Antibodies|antibodies|mesh-list
25293946|NCT05109585|Immunoglobulins|immunoglobulins|mesh-list
25293947|NCT05109585|Immunoglobulin G|immunoglobulin g|mesh-list
25293948|NCT05109585|Immunologic Factors|immunologic factors|mesh-ancestor
25293949|NCT05109585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825319|NCT00005585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24882999|NCT04673617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25293950|NCT05109390|Cyclosporine|cyclosporine|mesh-list
25293951|NCT05109390|Simethicone|simethicone|mesh-list
25293952|NCT05109390|Omeprazole|omeprazole|mesh-list
25293953|NCT05109390|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
25293954|NCT05109390|Calcium Carbonate|calcium carbonate|mesh-list
25293955|NCT05109390|Magnesium Hydroxide|magnesium hydroxide|mesh-list
25293956|NCT05109390|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
25293957|NCT05109390|Antacids|antacids|mesh-list
25293958|NCT05109390|Tacrolimus|tacrolimus|mesh-list
25293959|NCT05109390|Cyclosporins|cyclosporins|mesh-list
25293960|NCT05109390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293961|NCT05109390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25293962|NCT05109390|Immunologic Factors|immunologic factors|mesh-ancestor
25293963|NCT05109390|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25293964|NCT05109390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293965|NCT05109390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293966|NCT05109390|Antifungal Agents|antifungal agents|mesh-ancestor
25293967|NCT05109390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24437881|NCT00274612|Ramipril|ramipril|mesh-list
25293968|NCT05109390|Dermatologic Agents|dermatologic agents|mesh-ancestor
25293969|NCT05109390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25293970|NCT05109390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25293971|NCT05109390|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25293972|NCT05109390|Antifoaming Agents|antifoaming agents|mesh-ancestor
25293973|NCT05109390|Emollients|emollients|mesh-ancestor
25293974|NCT05109377|Tadalafil|tadalafil|mesh-list
25293975|NCT05109377|Vasodilator Agents|vasodilator agents|mesh-ancestor
25293976|NCT05109377|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25293977|NCT05109377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25293978|NCT05109377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293979|NCT05109377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293980|NCT05109377|Urological Agents|urological agents|mesh-ancestor
25293981|NCT05109312|Acetaminophen|acetaminophen|mesh-list
25293982|NCT05109312|Ibuprofen|ibuprofen|mesh-list
25293983|NCT05109312|Bupivacaine|bupivacaine|mesh-list
25293984|NCT05109312|Anesthetics, Local|anesthetics, local|mesh-ancestor
25293985|NCT05109312|Anesthetics|anesthetics|mesh-ancestor
25293986|NCT05109312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25293987|NCT05109312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25293988|NCT05109312|Sensory System Agents|sensory system agents|mesh-ancestor
25293989|NCT05109312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25293990|NCT05109312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25293991|NCT05109312|Analgesics|analgesics|mesh-ancestor
25293992|NCT05109312|Antipyretics|antipyretics|mesh-ancestor
25293993|NCT05109312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25293994|NCT05109312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25293995|NCT05109312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25293996|NCT05109312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25293997|NCT05109312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25293998|NCT05109312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25293999|NCT05109299|Fluorides|fluorides|mesh-list
25294000|NCT05109299|Cariostatic Agents|cariostatic agents|mesh-ancestor
25294001|NCT05109299|Protective Agents|protective agents|mesh-ancestor
25294002|NCT05109299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294004|NCT05108714|Anesthetics, Local|anesthetics, local|mesh-ancestor
25294005|NCT05108714|Anesthetics|anesthetics|mesh-ancestor
25294006|NCT05108714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25294007|NCT05108714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294008|NCT05108714|Sensory System Agents|sensory system agents|mesh-ancestor
25294009|NCT05108714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25294010|NCT05108714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25294011|NCT05108714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25294012|NCT05108714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25294013|NCT05108714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25294014|NCT05108714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294015|NCT05108597|Misoprostol|misoprostol|mesh-list
25294016|NCT05108597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25294017|NCT05108597|Abortifacient Agents|abortifacient agents|mesh-ancestor
25294018|NCT05108597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25294019|NCT05108597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294020|NCT05108597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25294021|NCT05108597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25294022|NCT05108597|Oxytocics|oxytocics|mesh-ancestor
25294023|NCT05108545|Amphotericin B|amphotericin b|mesh-list
25294024|NCT05108545|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25294025|NCT05108545|Amebicides|amebicides|mesh-ancestor
25294026|NCT05108545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25294027|NCT05108545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25294028|NCT05108545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25294029|NCT05108545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25294030|NCT05108545|Antifungal Agents|antifungal agents|mesh-ancestor
25294031|NCT05102695|Fibrin fragment D|fibrin fragment d|mesh-list
25294032|NCT05102695|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25294033|NCT05102695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25294034|NCT05102695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294035|NCT05102695|Hemostatics|hemostatics|mesh-ancestor
25294036|NCT05102695|Coagulants|coagulants|mesh-ancestor
25294037|NCT05098847|Lenvatinib|lenvatinib|mesh-list
25294038|NCT05098847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294039|NCT05098847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25294041|NCT05098847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294042|NCT05097118|Ketamine|ketamine|mesh-list
25294043|NCT05097118|Bupivacaine|bupivacaine|mesh-list
25294044|NCT05097118|Anesthetics, Local|anesthetics, local|mesh-ancestor
25294045|NCT05097118|Anesthetics|anesthetics|mesh-ancestor
25294046|NCT05097118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25294047|NCT05097118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294048|NCT05097118|Sensory System Agents|sensory system agents|mesh-ancestor
25294049|NCT05097118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25294050|NCT05097118|Analgesics|analgesics|mesh-ancestor
25294051|NCT05097118|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25294052|NCT05097118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25294053|NCT05097118|Anesthetics, General|anesthetics, general|mesh-ancestor
25294054|NCT05097118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25294055|NCT05097118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25294056|NCT05097118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25294057|NCT05097118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294058|NCT05093920|Doxorubicin|doxorubicin|mesh-list
25294059|NCT05093920|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25294060|NCT05093920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25294061|NCT05093920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294062|NCT05093920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25294063|NCT05093920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25294064|NCT05093920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25294065|NCT05093920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294066|NCT05007769|Atezolizumab|atezolizumab|mesh-list
25294067|NCT05007769|Ramucirumab|ramucirumab|mesh-list
25294068|NCT05007769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294069|NCT04995094|Pembrolizumab|pembrolizumab|mesh-list
25294070|NCT04995094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25294071|NCT04995094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294072|NCT04772300|Sirolimus|sirolimus|mesh-list
25294073|NCT04772300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25294074|NCT04772300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25294075|NCT04772300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25294105|NCT04676477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294106|NCT04676477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25294108|NCT04676477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294109|NCT04595864|Leucovorin|leucovorin|mesh-list
25294110|NCT04595864|Oxaliplatin|oxaliplatin|mesh-list
25294111|NCT04595864|Calcium|calcium|mesh-list
25294112|NCT04595864|Levoleucovorin|levoleucovorin|mesh-list
25294113|NCT04595864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25294114|NCT04595864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294115|NCT04595864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294116|NCT04595864|Antidotes|antidotes|mesh-ancestor
25294117|NCT04595864|Protective Agents|protective agents|mesh-ancestor
25294118|NCT04595864|Vitamin B Complex|vitamin b complex|mesh-ancestor
25294119|NCT04595864|Vitamins|vitamins|mesh-ancestor
25294120|NCT04595864|Micronutrients|micronutrients|mesh-ancestor
25294121|NCT04583462|Metformin|metformin|mesh-list
25294122|NCT04583462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25294123|NCT04583462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294124|NCT04555343|Tranexamic Acid|tranexamic acid|mesh-list
25294125|NCT04555343|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25294126|NCT04555343|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24438583|NCT00276289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25294127|NCT04555343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294128|NCT04555343|Hemostatics|hemostatics|mesh-ancestor
25294129|NCT04555343|Coagulants|coagulants|mesh-ancestor
25294149|NCT04464408|Favipiravir|favipiravir|mesh-list
25294150|NCT04464408|Antiviral Agents|antiviral agents|mesh-ancestor
25294151|NCT04464408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25294152|NCT04456322|Cisplatin|cisplatin|mesh-list
25294153|NCT04456322|Nimotuzumab|nimotuzumab|mesh-list
25294154|NCT04456322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294166|NCT04383119|Antimetabolites|antimetabolites|mesh-ancestor
25294167|NCT04383119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294168|NCT04383119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294169|NCT04383119|Antiviral Agents|antiviral agents|mesh-ancestor
25294170|NCT04383119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25294171|NCT04383119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825320|NCT00005585|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25825321|NCT00005585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25294172|NCT04383119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25294173|NCT04383119|Immunologic Factors|immunologic factors|mesh-ancestor
25294490|NCT02633293|Treprostinil|treprostinil|mesh-list
25294174|NCT04383119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294175|NCT04383119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25294176|NCT04383119|Alkylating Agents|alkylating agents|mesh-ancestor
25294178|NCT04339218|Pembrolizumab|pembrolizumab|mesh-list
25294179|NCT04339218|Pemetrexed|pemetrexed|mesh-list
25294180|NCT04339218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294181|NCT04339218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25294182|NCT04339218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25294183|NCT04339218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294184|NCT04339218|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25294185|NCT04339218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25294186|NCT04309877|Theophylline|theophylline|mesh-list
25294187|NCT04309877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25294188|NCT04309877|Autonomic Agents|autonomic agents|mesh-ancestor
25294189|NCT04309877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25294190|NCT04309877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294191|NCT04309877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25294192|NCT04309877|Respiratory System Agents|respiratory system agents|mesh-ancestor
25294193|NCT04309877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25294194|NCT04309877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25294195|NCT04309877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294196|NCT04309877|Vasodilator Agents|vasodilator agents|mesh-ancestor
25294197|NCT04309877|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25294198|NCT04309877|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25294199|NCT04309877|Purinergic Agents|purinergic agents|mesh-ancestor
25294200|NCT04309877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25294201|NCT04305548|Trabectedin|trabectedin|mesh-list
25294202|NCT04305548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25294203|NCT04305548|Alkylating Agents|alkylating agents|mesh-ancestor
25294204|NCT04305548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294205|NCT04305548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294254|NCT04121299|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25294256|NCT04121299|Vasodilator Agents|vasodilator agents|mesh-ancestor
25294257|NCT04121299|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25294258|NCT04121299|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25294259|NCT04121299|Adrenergic Agents|adrenergic agents|mesh-ancestor
25294260|NCT04121299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25294261|NCT04121299|Antioxidants|antioxidants|mesh-ancestor
25294262|NCT04121299|Protective Agents|protective agents|mesh-ancestor
25294263|NCT04121299|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25174870|NCT02862691|Oxycodone|oxycodone|mesh-list
25294264|NCT04121299|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25294265|NCT04097912|Aspirin|aspirin|mesh-list
25294266|NCT04097912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25294267|NCT04097912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25294268|NCT04097912|Analgesics|analgesics|mesh-ancestor
25294269|NCT04097912|Sensory System Agents|sensory system agents|mesh-ancestor
25294270|NCT04097912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25294271|NCT04097912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294272|NCT04097912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25294273|NCT04097912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25294274|NCT04097912|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25294275|NCT04097912|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25294276|NCT04097912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294277|NCT04097912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25294278|NCT04097912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25294279|NCT04097912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25294280|NCT04097912|Antipyretics|antipyretics|mesh-ancestor
25294281|NCT04058873|Levonorgestrel|levonorgestrel|mesh-list
25294282|NCT04058873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25294283|NCT04058873|Contraceptive Agents|contraceptive agents|mesh-ancestor
25294284|NCT04058873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25294285|NCT04058873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294286|NCT04058873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25294287|NCT04058873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25294288|NCT04058873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25294289|NCT04040738|Anesthetics|anesthetics|mesh-list
25294290|NCT04040738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25294291|NCT04040738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294324|NCT03783351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25294325|NCT03783351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25294326|NCT03783351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25294327|NCT03783351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25294328|NCT03783351|Purinergic Agents|purinergic agents|mesh-ancestor
25294329|NCT03783351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25294330|NCT03783351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294331|NCT03783351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294333|NCT03682224|Bupivacaine|bupivacaine|mesh-list
25294334|NCT03682224|Anesthetics, Local|anesthetics, local|mesh-ancestor
25294335|NCT03682224|Anesthetics|anesthetics|mesh-ancestor
25294336|NCT03682224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25294337|NCT03682224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294338|NCT03682224|Sensory System Agents|sensory system agents|mesh-ancestor
25294339|NCT03682224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25294340|NCT03682224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25294341|NCT03682224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25294342|NCT03682224|Adrenergic Agents|adrenergic agents|mesh-ancestor
25294343|NCT03682224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25294344|NCT03682224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294345|NCT03682224|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25294346|NCT03682224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25294347|NCT03682224|Autonomic Agents|autonomic agents|mesh-ancestor
25294348|NCT03682224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25294349|NCT03682224|Respiratory System Agents|respiratory system agents|mesh-ancestor
25294350|NCT03682224|Mydriatics|mydriatics|mesh-ancestor
25294351|NCT03682224|Sympathomimetics|sympathomimetics|mesh-ancestor
25294352|NCT03682224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25294353|NCT03621748|Anesthetics|anesthetics|mesh-list
25294354|NCT03621748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25294355|NCT03621748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294356|NCT03579693|Niacinamide|niacinamide|mesh-list
25294357|NCT03579693|Niacin|niacin|mesh-list
25294358|NCT03579693|Nicotinic Acids|nicotinic acids|mesh-list
25294359|NCT03579693|Coenzyme Q10|coenzyme q10|mesh-list
25294360|NCT03579693|Vitamin B Complex|vitamin b complex|mesh-ancestor
25294361|NCT03579693|Vitamins|vitamins|mesh-ancestor
25294362|NCT03579693|Micronutrients|micronutrients|mesh-ancestor
25294363|NCT03579693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294364|NCT03579693|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25294365|NCT03579693|Antimetabolites|antimetabolites|mesh-ancestor
25294366|NCT03579693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294367|NCT03579693|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25294368|NCT03579693|Vasodilator Agents|vasodilator agents|mesh-ancestor
25294369|NCT03540901|Acetazolamide|acetazolamide|mesh-list
25647518|NCT01470118|Sensory System Agents|sensory system agents|mesh-ancestor
25294371|NCT03540901|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25294372|NCT03540901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25294373|NCT03540901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294375|NCT03540901|Natriuretic Agents|natriuretic agents|mesh-ancestor
25294376|NCT03540901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294377|NCT03540875|Remifentanil|remifentanil|mesh-list
25294378|NCT03540875|Propofol|propofol|mesh-list
25294379|NCT03540875|Anesthetics|anesthetics|mesh-ancestor
25294380|NCT03540875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25294381|NCT03540875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294382|NCT03540875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25294383|NCT03540875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25294384|NCT03540875|Anesthetics, General|anesthetics, general|mesh-ancestor
25294385|NCT03540875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25294386|NCT03540875|Narcotics|narcotics|mesh-ancestor
25294387|NCT03540875|Analgesics|analgesics|mesh-ancestor
25294388|NCT03540875|Sensory System Agents|sensory system agents|mesh-ancestor
25294389|NCT03540875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25294390|NCT03536507|Acetazolamide|acetazolamide|mesh-list
25294391|NCT03536507|Anticonvulsants|anticonvulsants|mesh-ancestor
25294392|NCT03536507|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25294393|NCT03536507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25294394|NCT03536507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294395|NCT03536507|Diuretics|diuretics|mesh-ancestor
25294396|NCT03536507|Natriuretic Agents|natriuretic agents|mesh-ancestor
25294397|NCT03536507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294398|NCT03522246|Nivolumab|nivolumab|mesh-list
25294399|NCT03522246|Rucaparib|rucaparib|mesh-list
25294400|NCT03522246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25294401|NCT03522246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294402|NCT03522246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25294403|NCT03522246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294404|NCT03522246|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25294405|NCT03522246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25294406|NCT03517735|Remifentanil|remifentanil|mesh-list
25294407|NCT03517735|Propofol|propofol|mesh-list
25294408|NCT03517735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25294409|NCT03517735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25294410|NCT03517735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294411|NCT03517735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25294412|NCT03517735|Anesthetics, General|anesthetics, general|mesh-ancestor
25294413|NCT03517735|Anesthetics|anesthetics|mesh-ancestor
25294414|NCT03517735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25294415|NCT03517735|Narcotics|narcotics|mesh-ancestor
25294416|NCT03517735|Analgesics|analgesics|mesh-ancestor
25294417|NCT03517735|Sensory System Agents|sensory system agents|mesh-ancestor
25294418|NCT03517735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25294419|NCT03507491|Gemcitabine|gemcitabine|mesh-list
25294420|NCT03507491|Paclitaxel|paclitaxel|mesh-list
25294421|NCT03507491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25294422|NCT03507491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294423|NCT03507491|Tubulin Modulators|tubulin modulators|mesh-ancestor
25294424|NCT03507491|Antimitotic Agents|antimitotic agents|mesh-ancestor
25294425|NCT03507491|Mitosis Modulators|mitosis modulators|mesh-ancestor
25294426|NCT03507491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294427|NCT03507491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25294428|NCT03507491|Antimetabolites|antimetabolites|mesh-ancestor
25294429|NCT03507491|Antiviral Agents|antiviral agents|mesh-ancestor
25294430|NCT03507491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25294431|NCT03507491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25294432|NCT03507491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25294433|NCT03507491|Immunologic Factors|immunologic factors|mesh-ancestor
25294434|NCT03507491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294435|NCT03400501|Insulin|insulin|mesh-list
25294436|NCT03400501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25294437|NCT03400501|Insulin Glargine|insulin glargine|mesh-list
25294438|NCT03400501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25294439|NCT03400501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294440|NCT03347838|Nivolumab|nivolumab|mesh-list
25294441|NCT03347838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25294442|NCT03347838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294443|NCT03347838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25294444|NCT03347838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294445|NCT02991807|Everolimus|everolimus|mesh-list
25294446|NCT02991807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294463|NCT02784262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294465|NCT02784262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25294466|NCT02784262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439783|NCT00280358|Adrenergic Agents|adrenergic agents|mesh-ancestor
25294467|NCT02784262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25294468|NCT02784262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25294469|NCT02722668|Mycophenolic Acid|mycophenolic acid|mesh-list
25294470|NCT02722668|Sirolimus|sirolimus|mesh-list
25294471|NCT02722668|Cyclophosphamide|cyclophosphamide|mesh-list
25294472|NCT02722668|Fludarabine|fludarabine|mesh-list
25294473|NCT02722668|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25294474|NCT02722668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25294475|NCT02722668|Immunologic Factors|immunologic factors|mesh-ancestor
25294476|NCT02722668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294477|NCT02722668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25294478|NCT02722668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25294479|NCT02722668|Alkylating Agents|alkylating agents|mesh-ancestor
25294480|NCT02722668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294481|NCT02722668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294482|NCT02722668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25294483|NCT02722668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25294484|NCT02722668|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25294485|NCT02722668|Antitubercular Agents|antitubercular agents|mesh-ancestor
25294486|NCT02722668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25294487|NCT02722668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25294488|NCT02722668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25294489|NCT02722668|Antifungal Agents|antifungal agents|mesh-ancestor
25294491|NCT02633293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25294499|NCT02570672|Metformin|metformin|mesh-list
25294500|NCT02570672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25294501|NCT02570672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294512|NCT05112471|Erythritol|erythritol|mesh-list
25294513|NCT05112471|Vasodilator Agents|vasodilator agents|mesh-ancestor
25294514|NCT05111860|Bevacizumab|bevacizumab|mesh-list
25294515|NCT05111860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25294516|NCT05111860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294517|NCT05111860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25294518|NCT05111860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25294519|NCT05111860|Growth Substances|growth substances|mesh-ancestor
25294520|NCT05111860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294521|NCT05111860|Growth Inhibitors|growth inhibitors|mesh-ancestor
25294522|NCT05111769|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25294523|NCT05111769|Natriuretic Agents|natriuretic agents|mesh-ancestor
25294524|NCT05111769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294534|NCT05111444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25294536|NCT05110651|Hydroxychloroquine|hydroxychloroquine|mesh-list
25294537|NCT05110651|Antimalarials|antimalarials|mesh-ancestor
25294538|NCT05110651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25294539|NCT05110651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25294540|NCT05110651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25294541|NCT05110651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25294542|NCT05110651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294543|NCT05110651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25294544|NCT05110482|Oxytocin|oxytocin|mesh-list
25294545|NCT05110482|Carbetocin|carbetocin|mesh-list
25294546|NCT05110482|Oxytocics|oxytocics|mesh-ancestor
25294547|NCT05110482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25294548|NCT05110482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294549|NCT05110469|Magnesium Sulfate|magnesium sulfate|mesh-list
25294550|NCT05110469|Meperidine|meperidine|mesh-list
25294551|NCT05110469|Analgesics|analgesics|mesh-ancestor
25294552|NCT05110469|Sensory System Agents|sensory system agents|mesh-ancestor
25294553|NCT05110469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25294554|NCT05110469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294555|NCT05110469|Anesthetics|anesthetics|mesh-ancestor
25294556|NCT05110469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25294557|NCT05110469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25294558|NCT05110469|Anticonvulsants|anticonvulsants|mesh-ancestor
25294559|NCT05110469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25294560|NCT05110469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25294561|NCT05110469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294562|NCT05110469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25294563|NCT05110469|Tocolytic Agents|tocolytic agents|mesh-ancestor
25294564|NCT05110469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25294565|NCT05110469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25294566|NCT05110469|Narcotics|narcotics|mesh-ancestor
25294567|NCT05110469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25294577|NCT05110391|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24825708|NCT02129764|Hormones|hormones|mesh-ancestor
25294578|NCT05110391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25294579|NCT05110391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872111|NCT05398757|Midazolam|midazolam|mesh-list
25825322|NCT00005585|Antiviral Agents|antiviral agents|mesh-ancestor
25825323|NCT00005585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25825324|NCT00005585|Antidotes|antidotes|mesh-ancestor
25825325|NCT00005585|Protective Agents|protective agents|mesh-ancestor
25825326|NCT00005585|Vitamin B Complex|vitamin b complex|mesh-ancestor
25294580|NCT05103735|Dexmedetomidine|dexmedetomidine|mesh-list
25294581|NCT05103735|Remifentanil|remifentanil|mesh-list
25294582|NCT05103735|Propofol|propofol|mesh-list
25294583|NCT05103735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25294584|NCT05103735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25294585|NCT05103735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294586|NCT05103735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25294587|NCT05103735|Anesthetics, General|anesthetics, general|mesh-ancestor
25294588|NCT05103735|Anesthetics|anesthetics|mesh-ancestor
25294589|NCT05103735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25294590|NCT05103735|Analgesics|analgesics|mesh-ancestor
25294591|NCT05103735|Sensory System Agents|sensory system agents|mesh-ancestor
25294592|NCT05103735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25294593|NCT05103735|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25294594|NCT05103735|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25294595|NCT05103735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25294596|NCT05103735|Adrenergic Agents|adrenergic agents|mesh-ancestor
25294597|NCT05103735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25294598|NCT05103735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294599|NCT05103735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25294601|NCT05101356|Antineoplastic Agents|antineoplastic agents|mesh-list
25294602|NCT05101356|Vaccines|vaccines|mesh-list
25294603|NCT05101356|Sargramostim|sargramostim|mesh-list
25294604|NCT05101356|Immunologic Factors|immunologic factors|mesh-ancestor
25294605|NCT05101356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294606|NCT05101109|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25294607|NCT05101109|Immunologic Factors|immunologic factors|mesh-ancestor
25294608|NCT05101109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294609|NCT05099250|Magnesium Sulfate|magnesium sulfate|mesh-list
25294610|NCT05099250|Bupivacaine|bupivacaine|mesh-list
25294611|NCT05099250|Anesthetics, Local|anesthetics, local|mesh-ancestor
25294612|NCT05099250|Anesthetics|anesthetics|mesh-ancestor
25294613|NCT05099250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25294614|NCT05099250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294615|NCT05099250|Sensory System Agents|sensory system agents|mesh-ancestor
25294616|NCT05099250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25294617|NCT05099250|Analgesics|analgesics|mesh-ancestor
25294618|NCT05099250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25294619|NCT05099250|Anticonvulsants|anticonvulsants|mesh-ancestor
25294620|NCT05099250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25294621|NCT05099250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25294622|NCT05099250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294623|NCT05099250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25294624|NCT05099250|Tocolytic Agents|tocolytic agents|mesh-ancestor
25294625|NCT05099250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25294626|NCT05094323|Bupivacaine|bupivacaine|mesh-list
25294627|NCT05094323|Anesthetics, Local|anesthetics, local|mesh-ancestor
25294628|NCT05094323|Anesthetics|anesthetics|mesh-ancestor
25294629|NCT05094323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25294630|NCT05094323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294631|NCT05094323|Sensory System Agents|sensory system agents|mesh-ancestor
25294632|NCT05094323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25825327|NCT00005585|Vitamins|vitamins|mesh-ancestor
25294633|NCT05079802|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25294634|NCT05079802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25294635|NCT05079802|Chitosan|chitosan|mesh-list
25294636|NCT05079802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25294637|NCT05079802|Antitubercular Agents|antitubercular agents|mesh-ancestor
25294638|NCT05079802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25294639|NCT05079802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25294640|NCT05079802|Antimetabolites|antimetabolites|mesh-ancestor
25294641|NCT05079802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294642|NCT05079802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25294643|NCT05079802|Chelating Agents|chelating agents|mesh-ancestor
25294644|NCT05079802|Sequestering Agents|sequestering agents|mesh-ancestor
25294645|NCT05079802|Hemostatics|hemostatics|mesh-ancestor
25294646|NCT05079802|Coagulants|coagulants|mesh-ancestor
25294647|NCT04974879|Osimertinib|osimertinib|mesh-list
25294648|NCT04974879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294649|NCT04974879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25294650|NCT04974879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25294651|NCT04974879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294652|NCT04910230|Niacinamide|niacinamide|mesh-list
25294653|NCT04910230|Niacin|niacin|mesh-list
25294654|NCT04910230|Nicotinic Acids|nicotinic acids|mesh-list
25294655|NCT04910230|Vitamin B Complex|vitamin b complex|mesh-ancestor
25294656|NCT04910230|Vitamins|vitamins|mesh-ancestor
25294657|NCT04910230|Micronutrients|micronutrients|mesh-ancestor
25294658|NCT04910230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294659|NCT04910230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25294660|NCT04910230|Antimetabolites|antimetabolites|mesh-ancestor
25294661|NCT04910230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294662|NCT04910230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25294663|NCT04910230|Vasodilator Agents|vasodilator agents|mesh-ancestor
25294664|NCT04781478|Chlorhexidine|chlorhexidine|mesh-list
25294665|NCT04781478|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25294666|NCT04781478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25294667|NCT04781478|Disinfectants|disinfectants|mesh-ancestor
25294668|NCT04774237|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25294684|NCT04774237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25294685|NCT04774237|Analgesics|analgesics|mesh-ancestor
25294686|NCT04774237|Sensory System Agents|sensory system agents|mesh-ancestor
25294687|NCT04774237|Protective Agents|protective agents|mesh-ancestor
25294688|NCT04685772|Methylprednisolone|methylprednisolone|mesh-list
25294689|NCT04685772|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25294690|NCT04685772|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25294691|NCT04685772|Prednisolone|prednisolone|mesh-list
25294692|NCT04685772|Prednisolone acetate|prednisolone acetate|mesh-list
25294693|NCT04685772|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25294694|NCT04685772|Prednisolone phosphate|prednisolone phosphate|mesh-list
25294695|NCT04685772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25294696|NCT04685772|Antiemetics|antiemetics|mesh-ancestor
25294697|NCT04685772|Autonomic Agents|autonomic agents|mesh-ancestor
25294698|NCT04685772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25294699|NCT04685772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294700|NCT04685772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25294701|NCT04685772|Glucocorticoids|glucocorticoids|mesh-ancestor
25294702|NCT04685772|Hormones|hormones|mesh-ancestor
25294703|NCT04685772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25294704|NCT04685772|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25294705|NCT04685772|Protective Agents|protective agents|mesh-ancestor
25294706|NCT04685772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25294707|NCT04685772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294708|NCT04674345|Sorafenib|sorafenib|mesh-list
25294709|NCT04674345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294710|NCT04674345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25294711|NCT04674345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25294712|NCT04674345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294713|NCT04615936|Methylene Blue|methylene blue|mesh-list
25294714|NCT04615936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25294715|NCT04615936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720850|NCT01571024|Leucovorin|leucovorin|mesh-list
25825328|NCT00005585|Micronutrients|micronutrients|mesh-ancestor
25294728|NCT04461028|Dexamethasone|dexamethasone|mesh-list
25647519|NCT01470118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25294729|NCT04461028|Bupivacaine|bupivacaine|mesh-list
25294730|NCT04461028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25647520|NCT01470118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647521|NCT01470118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25294731|NCT04461028|Antiemetics|antiemetics|mesh-ancestor
25294732|NCT04461028|Autonomic Agents|autonomic agents|mesh-ancestor
25294733|NCT04461028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25294734|NCT04461028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294735|NCT04461028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25294736|NCT04461028|Glucocorticoids|glucocorticoids|mesh-ancestor
25294737|NCT04461028|Hormones|hormones|mesh-ancestor
25294738|NCT04461028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25294739|NCT04461028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25294740|NCT04461028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294741|NCT04461028|Anesthetics, Local|anesthetics, local|mesh-ancestor
25294742|NCT04461028|Anesthetics|anesthetics|mesh-ancestor
25294743|NCT04461028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25294744|NCT04461028|Sensory System Agents|sensory system agents|mesh-ancestor
25294745|NCT04428775|Cromolyn Sodium|cromolyn sodium|mesh-list
25294746|NCT04428775|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
25294747|NCT04428775|Immunologic Factors|immunologic factors|mesh-ancestor
25294748|NCT04428775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294749|NCT04428775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25294750|NCT04428775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25294751|NCT04428775|Respiratory System Agents|respiratory system agents|mesh-ancestor
25294752|NCT04367909|Carboplatin|carboplatin|mesh-list
25294753|NCT04367909|Docetaxel|docetaxel|mesh-list
25294754|NCT04367909|Nimotuzumab|nimotuzumab|mesh-list
25294755|NCT04367909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294756|NCT04367909|Tubulin Modulators|tubulin modulators|mesh-ancestor
25294757|NCT04367909|Antimitotic Agents|antimitotic agents|mesh-ancestor
25294758|NCT04367909|Mitosis Modulators|mitosis modulators|mesh-ancestor
25294759|NCT04367909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294760|NCT04367909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25294761|NCT04342039|Budesonide|budesonide|mesh-list
25294762|NCT04342039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25294763|NCT04342039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25294764|NCT04342039|Autonomic Agents|autonomic agents|mesh-ancestor
25294765|NCT04342039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25294766|NCT04342039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294767|NCT04342039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25294768|NCT04342039|Respiratory System Agents|respiratory system agents|mesh-ancestor
25294769|NCT04342039|Glucocorticoids|glucocorticoids|mesh-ancestor
25294770|NCT04342039|Hormones|hormones|mesh-ancestor
25294771|NCT04342039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25057429|NCT03505047|Copper|copper|mesh-list
25294772|NCT04335058|Iron|iron|mesh-list
25294773|NCT04335058|Lactoferrin|lactoferrin|mesh-list
25294774|NCT04335058|Trace Elements|trace elements|mesh-ancestor
25294775|NCT04335058|Micronutrients|micronutrients|mesh-ancestor
25294776|NCT04335058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294777|NCT04335058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25294778|NCT04315311|Pancrelipase|pancrelipase|mesh-list
25294779|NCT04315311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25294780|NCT04285255|Lidocaine|lidocaine|mesh-list
25294781|NCT04285255|Fentanyl|fentanyl|mesh-list
25294782|NCT04285255|Dexmedetomidine|dexmedetomidine|mesh-list
25294783|NCT04285255|Ketamine|ketamine|mesh-list
25294784|NCT04285255|Anesthetics, Local|anesthetics, local|mesh-ancestor
25294785|NCT04285255|Anesthetics|anesthetics|mesh-ancestor
25294786|NCT04285255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25294787|NCT04285255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294788|NCT04285255|Sensory System Agents|sensory system agents|mesh-ancestor
25294789|NCT04285255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25294790|NCT04285255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25294791|NCT04285255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25294792|NCT04285255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25294793|NCT04285255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25294794|NCT04285255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294795|NCT04285255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25294796|NCT04285255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25294797|NCT04285255|Analgesics|analgesics|mesh-ancestor
25294798|NCT04285255|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25294799|NCT04285255|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25294800|NCT04285255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25294801|NCT04285255|Adrenergic Agents|adrenergic agents|mesh-ancestor
25294802|NCT04285255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25294803|NCT04285255|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25294804|NCT04285255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25294805|NCT04285255|Anesthetics, General|anesthetics, general|mesh-ancestor
25647522|NCT01470118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25204370|NCT02709031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25294806|NCT04285255|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25294807|NCT04285255|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25294808|NCT04285255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25294809|NCT04285255|Narcotics|narcotics|mesh-ancestor
25294810|NCT04285255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25294811|NCT04279574|Lithium Carbonate|lithium carbonate|mesh-list
25294812|NCT04279574|Antidepressive Agents|antidepressive agents|mesh-ancestor
25294813|NCT04279574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25294814|NCT04279574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25294815|NCT04279574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294822|NCT04196075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25294824|NCT04196075|Analgesics|analgesics|mesh-ancestor
25294825|NCT04196075|Sensory System Agents|sensory system agents|mesh-ancestor
25294826|NCT04196075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25294827|NCT04196075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294828|NCT04196075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25294829|NCT04196075|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25294830|NCT04196075|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25294831|NCT04196075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25294832|NCT04196075|Antiviral Agents|antiviral agents|mesh-ancestor
25294833|NCT04196075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25294834|NCT04169828|Leucovorin|leucovorin|mesh-list
25294835|NCT04169828|Folic Acid|folic acid|mesh-list
25294836|NCT04169828|Methotrexate|methotrexate|mesh-list
25294837|NCT04169828|Ondansetron|ondansetron|mesh-list
25294838|NCT04169828|Levoleucovorin|levoleucovorin|mesh-list
25294839|NCT04169828|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25294840|NCT04169828|Abortifacient Agents|abortifacient agents|mesh-ancestor
25294841|NCT04169828|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25825329|NCT00005585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25825330|NCT00005585|Tubulin Modulators|tubulin modulators|mesh-ancestor
25294842|NCT04169828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294843|NCT04169828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25294844|NCT04169828|Antimetabolites|antimetabolites|mesh-ancestor
25294845|NCT04169828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294846|NCT04169828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294847|NCT04169828|Dermatologic Agents|dermatologic agents|mesh-ancestor
25294848|NCT04169828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25294849|NCT04169828|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25294850|NCT04169828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25294851|NCT04169828|Immunologic Factors|immunologic factors|mesh-ancestor
25294852|NCT04169828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25294853|NCT04169828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25294854|NCT04169828|Antidotes|antidotes|mesh-ancestor
25294855|NCT04169828|Protective Agents|protective agents|mesh-ancestor
25294856|NCT04169828|Vitamin B Complex|vitamin b complex|mesh-ancestor
25294857|NCT04169828|Vitamins|vitamins|mesh-ancestor
25294858|NCT04169828|Micronutrients|micronutrients|mesh-ancestor
25294859|NCT04169828|Antiemetics|antiemetics|mesh-ancestor
25294860|NCT04169828|Autonomic Agents|autonomic agents|mesh-ancestor
25294861|NCT04169828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25294862|NCT04169828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25294863|NCT04169828|Antipruritics|antipruritics|mesh-ancestor
25294864|NCT04169828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25294865|NCT04169828|Serotonin Agents|serotonin agents|mesh-ancestor
25294866|NCT04169828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25294867|NCT04169828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25294868|NCT04169828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25294869|NCT04169828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25294870|NCT04169828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25294871|NCT04169828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25294872|NCT04169828|Hematinics|hematinics|mesh-ancestor
25294880|NCT04053322|Durvalumab|durvalumab|mesh-list
25294881|NCT04053322|Olaparib|olaparib|mesh-list
25294882|NCT04053322|Fulvestrant|fulvestrant|mesh-list
25294883|NCT04053322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25294884|NCT04053322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294885|NCT04053322|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25294886|NCT04053322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25294960|NCT03272464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294887|NCT04053322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647523|NCT01470118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25647524|NCT01470118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25647525|NCT01470118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25647526|NCT01470118|Histamine Antagonists|histamine antagonists|mesh-ancestor
25647527|NCT01470118|Histamine Agents|histamine agents|mesh-ancestor
24974762|NCT05291650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24974763|NCT05291650|Immunologic Factors|immunologic factors|mesh-ancestor
24974764|NCT05291650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974765|NCT05291650|Viscosupplements|viscosupplements|mesh-ancestor
24974766|NCT05291650|Protective Agents|protective agents|mesh-ancestor
25175203|NCT02860117|Ketamine|ketamine|mesh-list
25175204|NCT02860117|Analgesics|analgesics|mesh-ancestor
25175205|NCT02860117|Sensory System Agents|sensory system agents|mesh-ancestor
25175206|NCT02860117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25175207|NCT02860117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294888|NCT04053322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25294889|NCT04053322|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25294890|NCT04053322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25294891|NCT04053322|Hormone Antagonists|hormone antagonists|mesh-ancestor
25294892|NCT04053322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25294893|NCT04053322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294894|NCT04030182|Vitamin D|vitamin d|mesh-list
25294895|NCT04030182|Vitamins|vitamins|mesh-ancestor
25294896|NCT04030182|Micronutrients|micronutrients|mesh-ancestor
25294897|NCT04030182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294898|NCT04030182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25294899|NCT04000555|Vancomycin|vancomycin|mesh-list
25294900|NCT04000555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25294901|NCT04000555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25294902|NCT03863483|Docetaxel|docetaxel|mesh-list
25294903|NCT03863483|Pemetrexed|pemetrexed|mesh-list
25294904|NCT03863483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294905|NCT03863483|Tubulin Modulators|tubulin modulators|mesh-ancestor
25294906|NCT03863483|Antimitotic Agents|antimitotic agents|mesh-ancestor
25294907|NCT03863483|Mitosis Modulators|mitosis modulators|mesh-ancestor
25294908|NCT03863483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294909|NCT03863483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25294910|NCT03863483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25294911|NCT03863483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25294912|NCT03830411|Docetaxel|docetaxel|mesh-list
25294913|NCT03830411|Pemetrexed|pemetrexed|mesh-list
25294914|NCT03830411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25033745|NCT03571308|Prednisolone|prednisolone|mesh-list
25294915|NCT03830411|Tubulin Modulators|tubulin modulators|mesh-ancestor
25294916|NCT03830411|Antimitotic Agents|antimitotic agents|mesh-ancestor
25294917|NCT03830411|Mitosis Modulators|mitosis modulators|mesh-ancestor
25294918|NCT03830411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294919|NCT03830411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25294920|NCT03830411|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25294921|NCT03830411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25294923|NCT03661632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25294924|NCT03661632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294925|NCT03661632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25294926|NCT03661632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294927|NCT03512262|Abaloparatide|abaloparatide|mesh-list
25294928|NCT03512262|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
25294929|NCT03512262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25294930|NCT03512262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294931|NCT03512262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25294933|NCT03456882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25294934|NCT03456882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25294935|NCT03456882|Analgesics|analgesics|mesh-ancestor
25294936|NCT03456882|Sensory System Agents|sensory system agents|mesh-ancestor
25294937|NCT03456882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25294938|NCT03456882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294939|NCT03456882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25294940|NCT03456882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25294941|NCT03456882|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25294942|NCT03300479|Urapidil|urapidil|mesh-list
25647528|NCT01470118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25647529|NCT01470118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647530|NCT01470144|Epoprostenol|epoprostenol|mesh-list
25647531|NCT01470144|Tezosentan|tezosentan|mesh-list
25647532|NCT01470144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25647533|NCT01470144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25647534|NCT01470144|Vasodilator Agents|vasodilator agents|mesh-ancestor
25647535|NCT01470170|Alfentanil|alfentanil|mesh-list
25647536|NCT01470170|Propofol|propofol|mesh-list
25647537|NCT01470170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25294943|NCT03300479|Clevidipine|clevidipine|mesh-list
25294944|NCT03300479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25294945|NCT03300479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25294946|NCT03300479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294947|NCT03300479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25294948|NCT03300479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294949|NCT03300479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25294950|NCT03300479|Vasodilator Agents|vasodilator agents|mesh-ancestor
25294951|NCT03300479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24442021|NCT00289445|Vitamins|vitamins|mesh-ancestor
25294952|NCT03300479|Serotonin Agents|serotonin agents|mesh-ancestor
25294953|NCT03300479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25294954|NCT03300479|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25294955|NCT03300479|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25294956|NCT03300479|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25294957|NCT03300479|Adrenergic Agents|adrenergic agents|mesh-ancestor
25294958|NCT03272464|Trametinib|trametinib|mesh-list
25294959|NCT03272464|Dabrafenib|dabrafenib|mesh-list
25294964|NCT03262701|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25294965|NCT03262701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25294966|NCT03262701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25294967|NCT03070184|Metoprolol|metoprolol|mesh-list
25294968|NCT03070184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25294969|NCT03070184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25294970|NCT03070184|Sympatholytics|sympatholytics|mesh-ancestor
25294971|NCT03070184|Autonomic Agents|autonomic agents|mesh-ancestor
25294972|NCT03070184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25294973|NCT03070184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294974|NCT03070184|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25294975|NCT03070184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25294976|NCT03070184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25294977|NCT03070184|Adrenergic Agents|adrenergic agents|mesh-ancestor
25294978|NCT03070184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25294979|NCT03070184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294980|NCT03012425|Hydrocortisone|hydrocortisone|mesh-list
25294981|NCT03012425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25294982|NCT02781090|Nicotine|nicotine|mesh-list
25294983|NCT02781090|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25294984|NCT02781090|Autonomic Agents|autonomic agents|mesh-ancestor
25294985|NCT02781090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25294986|NCT02781090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294987|NCT02781090|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25294988|NCT02781090|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25294989|NCT02781090|Cholinergic Agents|cholinergic agents|mesh-ancestor
25294990|NCT02781090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25294991|NCT02781090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25294992|NCT02390531|Bevacizumab|bevacizumab|mesh-list
25294993|NCT02390531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25294994|NCT02390531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25294995|NCT02390531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25294996|NCT02390531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25294997|NCT02390531|Growth Substances|growth substances|mesh-ancestor
25294998|NCT02390531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25294999|NCT02390531|Growth Inhibitors|growth inhibitors|mesh-ancestor
25295005|NCT05116228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25295006|NCT05116228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295007|NCT05116228|Immunologic Factors|immunologic factors|mesh-ancestor
25295008|NCT05116228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295009|NCT05116228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25295010|NCT05116150|Grape Seed Extract|grape seed extract|mesh-list
25295011|NCT05116150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25295012|NCT05116150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295013|NCT05116150|Antioxidants|antioxidants|mesh-ancestor
25295014|NCT05116150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295015|NCT05116150|Protective Agents|protective agents|mesh-ancestor
25295016|NCT05116150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295017|NCT05116098|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
25295018|NCT05116098|Antioxidants|antioxidants|mesh-ancestor
25295019|NCT05116098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295020|NCT05116098|Protective Agents|protective agents|mesh-ancestor
25295021|NCT05116098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295022|NCT05116098|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25295023|NCT05116098|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25295024|NCT05116098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295025|NCT05116098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25295026|NCT05116007|Carboplatin|carboplatin|mesh-list
25295028|NCT05116007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295029|NCT05116007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25295030|NCT05116007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25295031|NCT05116007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25295032|NCT05116007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25295033|NCT05116007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295034|NCT05115994|Antihypertensive Agents|antihypertensive agents|mesh-list
25295045|NCT05115903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25295046|NCT05115903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25295047|NCT05115903|Analgesics|analgesics|mesh-ancestor
25295048|NCT05115903|Sensory System Agents|sensory system agents|mesh-ancestor
25295049|NCT05115903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25295050|NCT05115903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295051|NCT05115903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25295052|NCT05115903|Immunologic Factors|immunologic factors|mesh-ancestor
25295053|NCT05115903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25295055|NCT05115578|Remifentanil|remifentanil|mesh-list
25295056|NCT05115578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25295057|NCT05115578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25295058|NCT05115578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25295059|NCT05115578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295060|NCT05115578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25295061|NCT05115578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25295062|NCT05115578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25295063|NCT05115578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25295064|NCT05115578|Anesthetics, General|anesthetics, general|mesh-ancestor
25295065|NCT05115578|Anesthetics|anesthetics|mesh-ancestor
25295066|NCT05115578|GABA Modulators|gaba modulators|mesh-ancestor
25295067|NCT05115578|GABA Agents|gaba agents|mesh-ancestor
25295068|NCT05115578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25295069|NCT05115578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295070|NCT05115578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25295071|NCT05115578|Narcotics|narcotics|mesh-ancestor
25295072|NCT05115578|Analgesics|analgesics|mesh-ancestor
25295073|NCT05115578|Sensory System Agents|sensory system agents|mesh-ancestor
25295074|NCT05115578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25295075|NCT05115149|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
25295076|NCT05115149|Antioxidants|antioxidants|mesh-ancestor
25295077|NCT05115149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295078|NCT05115149|Protective Agents|protective agents|mesh-ancestor
25295079|NCT05115149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295080|NCT05115149|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25295081|NCT05115149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295082|NCT05114499|Donepezil|donepezil|mesh-list
25295083|NCT05114499|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25295084|NCT05114499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25295085|NCT05114499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295087|NCT05114499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25295088|NCT05114499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295089|NCT05114499|Nootropic Agents|nootropic agents|mesh-ancestor
25295090|NCT05114239|Timolol|timolol|mesh-list
25295091|NCT05114239|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25295092|NCT05114239|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25295093|NCT05114239|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25295094|NCT05114239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25295095|NCT05114239|Adrenergic Agents|adrenergic agents|mesh-ancestor
25295096|NCT05114239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25295097|NCT05114239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295098|NCT05114239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087491|NCT03279120|Tenofovir|tenofovir|mesh-list
24952730|NCT03892330|Antimitotic Agents|antimitotic agents|mesh-ancestor
25295099|NCT05114239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25295100|NCT05114239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25295116|NCT05113511|Bevacizumab|bevacizumab|mesh-list
25295117|NCT05113511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25295118|NCT05113511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295119|NCT05113511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25295120|NCT05113511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25295121|NCT05113511|Growth Substances|growth substances|mesh-ancestor
25295122|NCT05113511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295123|NCT05113511|Growth Inhibitors|growth inhibitors|mesh-ancestor
25295124|NCT05112692|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25295125|NCT05112692|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25204394|NCT02708693|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25204395|NCT02708693|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25204396|NCT02708693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25204397|NCT02708693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204398|NCT02708693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24754282|NCT01719926|Analgesics|analgesics|mesh-ancestor
25295126|NCT05112692|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25295127|NCT05112692|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25295128|NCT05112692|Cetrorelix|cetrorelix|mesh-list
25295129|NCT05112692|Menotropins|menotropins|mesh-list
25295130|NCT05112692|Estradiol|estradiol|mesh-list
25295131|NCT05112692|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25295132|NCT05112692|Progesterone|progesterone|mesh-list
25295133|NCT05112692|Dydrogesterone|dydrogesterone|mesh-list
25295134|NCT05112692|Estrogens|estrogens|mesh-ancestor
25295135|NCT05112692|Hormones|hormones|mesh-ancestor
25295136|NCT05112692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25295137|NCT05112692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295138|NCT05112692|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25295139|NCT05112692|Contraceptive Agents|contraceptive agents|mesh-ancestor
25295140|NCT05112692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25295141|NCT05112692|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25295142|NCT05112692|Progestins|progestins|mesh-ancestor
25295143|NCT05112692|Luteolytic Agents|luteolytic agents|mesh-ancestor
25295144|NCT05112692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25295145|NCT05112692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295146|NCT05112692|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25295147|NCT05112692|Fertility Agents|fertility agents|mesh-ancestor
25295148|NCT05112692|Hormone Antagonists|hormone antagonists|mesh-ancestor
25057524|NCT03504527|Respiratory System Agents|respiratory system agents|mesh-ancestor
25057525|NCT03504527|Glucocorticoids|glucocorticoids|mesh-ancestor
25057526|NCT03504527|Hormones|hormones|mesh-ancestor
24811774|NCT02048319|Hormones|hormones|mesh-ancestor
25295149|NCT05105919|Aspirin|aspirin|mesh-list
25295150|NCT05105919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25295151|NCT05105919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25295152|NCT05105919|Analgesics|analgesics|mesh-ancestor
25295153|NCT05105919|Sensory System Agents|sensory system agents|mesh-ancestor
25295154|NCT05105919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25295155|NCT05105919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295156|NCT05105919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25295157|NCT05105919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25295158|NCT05105919|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25295159|NCT05105919|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25295160|NCT05105919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295161|NCT05105919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25295162|NCT05105919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25295163|NCT05105919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25295164|NCT05105919|Antipyretics|antipyretics|mesh-ancestor
25295165|NCT05105685|Hormones|hormones|mesh-list
25295166|NCT05105685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25295167|NCT05105685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295168|NCT05102669|Antibodies|antibodies|mesh-list
25295169|NCT05102669|Immunologic Factors|immunologic factors|mesh-ancestor
25295170|NCT05102669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295171|NCT05096962|Antibodies|antibodies|mesh-list
25295172|NCT05096962|Immunologic Factors|immunologic factors|mesh-ancestor
25295173|NCT05096962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295174|NCT05091242|Clonidine|clonidine|mesh-list
25295175|NCT05091242|Analgesics|analgesics|mesh-ancestor
25295176|NCT05091242|Sensory System Agents|sensory system agents|mesh-ancestor
25295177|NCT05091242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25295178|NCT05091242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295179|NCT05091242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25295180|NCT05091242|Sympatholytics|sympatholytics|mesh-ancestor
25295181|NCT05091242|Autonomic Agents|autonomic agents|mesh-ancestor
25295203|NCT05073822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295204|NCT05073822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25647538|NCT01470170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25647539|NCT01470170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647540|NCT01470170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25647541|NCT01470170|Anesthetics, General|anesthetics, general|mesh-ancestor
25647542|NCT01470170|Anesthetics|anesthetics|mesh-ancestor
25647543|NCT01470170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25295205|NCT05073822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647544|NCT01470170|Narcotics|narcotics|mesh-ancestor
25295206|NCT05073822|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25295207|NCT05073822|Antitubercular Agents|antitubercular agents|mesh-ancestor
25295208|NCT05073822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25295209|NCT05073822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25295210|NCT05068336|Anesthetics|anesthetics|mesh-list
25295211|NCT05068336|Sevoflurane|sevoflurane|mesh-list
25295212|NCT05068336|Desflurane|desflurane|mesh-list
25295213|NCT05068336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25295214|NCT05068336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295215|NCT05068336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25295216|NCT05068336|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25295217|NCT05068336|Anesthetics, General|anesthetics, general|mesh-ancestor
25295218|NCT05062785|Insulin|insulin|mesh-list
25295219|NCT05062785|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25295220|NCT05062785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25295221|NCT05062785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295225|NCT05040126|Linezolid|linezolid|mesh-list
25295226|NCT05040126|Bedaquiline|bedaquiline|mesh-list
25295227|NCT05040126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25295228|NCT05040126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25295229|NCT05040126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25295230|NCT05040126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25295231|NCT05040126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295232|NCT05040126|Antitubercular Agents|antitubercular agents|mesh-ancestor
25295327|NCT04862468|Glucocorticoids|glucocorticoids|mesh-ancestor
25295274|NCT05015335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25295275|NCT05015335|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25295276|NCT05015335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25295277|NCT05015335|Immunologic Factors|immunologic factors|mesh-ancestor
25295278|NCT05015335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25295279|NCT05015335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25295280|NCT05015335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25295281|NCT04954339|Bevacizumab|bevacizumab|mesh-list
25295282|NCT04954339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25295283|NCT04954339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295284|NCT04954339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25295285|NCT04954339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25295286|NCT04954339|Growth Substances|growth substances|mesh-ancestor
25295287|NCT04954339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295288|NCT04954339|Growth Inhibitors|growth inhibitors|mesh-ancestor
25295294|NCT04951804|Bupivacaine|bupivacaine|mesh-list
25295295|NCT04951804|Anesthetics, Local|anesthetics, local|mesh-ancestor
25295296|NCT04951804|Anesthetics|anesthetics|mesh-ancestor
25295297|NCT04951804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25295298|NCT04951804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295299|NCT04951804|Sensory System Agents|sensory system agents|mesh-ancestor
25295300|NCT04951804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24827409|NCT02138799|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25825331|NCT00005585|Antimitotic Agents|antimitotic agents|mesh-ancestor
25825332|NCT00005585|Mitosis Modulators|mitosis modulators|mesh-ancestor
25825333|NCT00005585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24588466|NCT00902811|Artesunate|artesunate|mesh-list
25295307|NCT04939753|Sevoflurane|sevoflurane|mesh-list
25295308|NCT04939753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25295309|NCT04939753|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25295310|NCT04939753|Anesthetics, General|anesthetics, general|mesh-ancestor
25295311|NCT04939753|Anesthetics|anesthetics|mesh-ancestor
25295312|NCT04939753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25295313|NCT04939753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295314|NCT04937413|Evolocumab|evolocumab|mesh-list
25295315|NCT04937413|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25295316|NCT04937413|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25295317|NCT04937413|Antimetabolites|antimetabolites|mesh-ancestor
25295318|NCT04937413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295319|NCT04937413|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25295320|NCT04862468|Dexamethasone|dexamethasone|mesh-list
25295321|NCT04862468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25295322|NCT04862468|Antiemetics|antiemetics|mesh-ancestor
25295323|NCT04862468|Autonomic Agents|autonomic agents|mesh-ancestor
25295324|NCT04862468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25295325|NCT04862468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295326|NCT04862468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25295342|NCT04818489|Tubulin Modulators|tubulin modulators|mesh-ancestor
25295343|NCT04818489|Antimitotic Agents|antimitotic agents|mesh-ancestor
25295344|NCT04818489|Mitosis Modulators|mitosis modulators|mesh-ancestor
25295345|NCT04818489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295346|NCT04818489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295355|NCT04765787|Orphenadrine|orphenadrine|mesh-list
25295356|NCT04765787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25295357|NCT04765787|Analgesics|analgesics|mesh-ancestor
25295358|NCT04765787|Sensory System Agents|sensory system agents|mesh-ancestor
25295359|NCT04765787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25295360|NCT04765787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295361|NCT04765787|Antipyretics|antipyretics|mesh-ancestor
25295362|NCT04765787|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25295363|NCT04765787|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25295364|NCT04765787|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25295365|NCT04765787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25295366|NCT04765787|Parasympatholytics|parasympatholytics|mesh-ancestor
25295367|NCT04765787|Autonomic Agents|autonomic agents|mesh-ancestor
25295368|NCT04765787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25295369|NCT04765787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25295370|NCT04765787|Cholinergic Agents|cholinergic agents|mesh-ancestor
25295371|NCT04765787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25295372|NCT04765787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295373|NCT04765787|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
25295374|NCT04765787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25295375|NCT04765787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25295376|NCT04756791|Anesthetics|anesthetics|mesh-list
25295377|NCT04756791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25295378|NCT04756791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295379|NCT04748250|Phytoestrogens|phytoestrogens|mesh-list
25295380|NCT04748250|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25295381|NCT04748250|Estrogens|estrogens|mesh-ancestor
24716701|NCT01543347|Temocillin|temocillin|mesh-list
25295383|NCT04748250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25295384|NCT04748250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295385|NCT04726878|Acetaminophen|acetaminophen|mesh-list
25295386|NCT04726878|Oxycodone|oxycodone|mesh-list
25295387|NCT04726878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25295388|NCT04726878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295389|NCT04726878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25295390|NCT04726878|Analgesics|analgesics|mesh-ancestor
25295391|NCT04726878|Sensory System Agents|sensory system agents|mesh-ancestor
25295392|NCT04726878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25295393|NCT04726878|Antipyretics|antipyretics|mesh-ancestor
25295394|NCT04726878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25295395|NCT04726878|Narcotics|narcotics|mesh-ancestor
25295412|NCT04633772|Vasodilator Agents|vasodilator agents|mesh-ancestor
25295413|NCT04592783|Antihypertensive Agents|antihypertensive agents|mesh-list
25295414|NCT04585295|Betaine|betaine|mesh-list
25295415|NCT04585295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25295416|NCT04585295|Lipotropic Agents|lipotropic agents|mesh-ancestor
25295417|NCT04585295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25295418|NCT04585295|Antimetabolites|antimetabolites|mesh-ancestor
25295419|NCT04585295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295420|NCT04585295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25295421|NCT04583488|Docetaxel|docetaxel|mesh-list
25295422|NCT04583488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295423|NCT04583488|Tubulin Modulators|tubulin modulators|mesh-ancestor
25295424|NCT04583488|Antimitotic Agents|antimitotic agents|mesh-ancestor
25295425|NCT04583488|Mitosis Modulators|mitosis modulators|mesh-ancestor
25295426|NCT04583488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295427|NCT04568616|Letrozole|letrozole|mesh-list
25295428|NCT04568616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295429|NCT04568616|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25295430|NCT04568616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25295431|NCT04568616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25295432|NCT04568616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295433|NCT04568616|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25295434|NCT04568616|Hormone Antagonists|hormone antagonists|mesh-ancestor
25295435|NCT04568616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25295436|NCT04568616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295437|NCT04560868|Nicotine|nicotine|mesh-list
24454256|NCT04266730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295438|NCT04560868|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25295439|NCT04560868|Autonomic Agents|autonomic agents|mesh-ancestor
25295440|NCT04560868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25295441|NCT04560868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295442|NCT04560868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25295443|NCT04560868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25295444|NCT04560868|Cholinergic Agents|cholinergic agents|mesh-ancestor
25295445|NCT04560868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25175539|NCT02857309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175540|NCT02857309|Hormone Antagonists|hormone antagonists|mesh-ancestor
25175542|NCT02857309|Diuretics|diuretics|mesh-ancestor
25295446|NCT04560868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295447|NCT04557215|Acetylcysteine|acetylcysteine|mesh-list
25295448|NCT04557215|Rifaximin|rifaximin|mesh-list
25295449|NCT04557215|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25295450|NCT04557215|Antiviral Agents|antiviral agents|mesh-ancestor
25295451|NCT04557215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25295452|NCT04557215|Expectorants|expectorants|mesh-ancestor
25295453|NCT04557215|Respiratory System Agents|respiratory system agents|mesh-ancestor
25295454|NCT04557215|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25295455|NCT04557215|Antioxidants|antioxidants|mesh-ancestor
25295456|NCT04557215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295457|NCT04557215|Protective Agents|protective agents|mesh-ancestor
25295458|NCT04557215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295459|NCT04557215|Antidotes|antidotes|mesh-ancestor
25295460|NCT04557215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25295461|NCT04557215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25295462|NCT04526197|Celecoxib|celecoxib|mesh-list
25295463|NCT04526197|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
25295464|NCT04526197|Choline|choline|mesh-list
25295465|NCT04526197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25295466|NCT04526197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25295467|NCT04526197|Analgesics|analgesics|mesh-ancestor
25295468|NCT04526197|Sensory System Agents|sensory system agents|mesh-ancestor
25295469|NCT04526197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25295470|NCT04526197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295471|NCT04526197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25295472|NCT04526197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25295473|NCT04526197|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25295474|NCT04526197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25295475|NCT04526197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25295476|NCT04526197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295477|NCT04526197|Lipotropic Agents|lipotropic agents|mesh-ancestor
25295478|NCT04526197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25295498|NCT04468230|Autonomic Agents|autonomic agents|mesh-ancestor
25295499|NCT04468230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25295500|NCT04468230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295501|NCT04468230|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25295502|NCT04468230|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25295503|NCT04468230|Cholinergic Agents|cholinergic agents|mesh-ancestor
25295504|NCT04468230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25295505|NCT04468230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295526|NCT04432857|Pembrolizumab|pembrolizumab|mesh-list
25295527|NCT04432857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25295528|NCT04432857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295529|NCT04424225|Niacin|niacin|mesh-list
25295530|NCT04424225|Psilocybin|psilocybin|mesh-list
25295531|NCT04424225|Vitamins|vitamins|mesh-ancestor
25295532|NCT04424225|Micronutrients|micronutrients|mesh-ancestor
25295533|NCT04424225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295534|NCT04424225|Vitamin B Complex|vitamin b complex|mesh-ancestor
25295535|NCT04424225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25295536|NCT04424225|Antimetabolites|antimetabolites|mesh-ancestor
25295537|NCT04424225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295538|NCT04424225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25295539|NCT04424225|Vasodilator Agents|vasodilator agents|mesh-ancestor
25295540|NCT04424225|Hallucinogens|hallucinogens|mesh-ancestor
25295541|NCT04424225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25295542|NCT04418895|Leucovorin|leucovorin|mesh-list
25295543|NCT04418895|Fluorouracil|fluorouracil|mesh-list
25295544|NCT04418895|Capecitabine|capecitabine|mesh-list
25295545|NCT04418895|Oxaliplatin|oxaliplatin|mesh-list
25295546|NCT04418895|Levoleucovorin|levoleucovorin|mesh-list
25295547|NCT04418895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295548|NCT04418895|Antimetabolites|antimetabolites|mesh-ancestor
25295549|NCT04418895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295550|NCT04418895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25295551|NCT04418895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295552|NCT04418895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25295553|NCT04418895|Immunologic Factors|immunologic factors|mesh-ancestor
25295554|NCT04418895|Antidotes|antidotes|mesh-ancestor
25295555|NCT04418895|Protective Agents|protective agents|mesh-ancestor
25295556|NCT04418895|Vitamin B Complex|vitamin b complex|mesh-ancestor
25647545|NCT01470170|Analgesics|analgesics|mesh-ancestor
25647546|NCT01470170|Sensory System Agents|sensory system agents|mesh-ancestor
25657176|NCT01583686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24857851|NCT02294279|Hormones|hormones|mesh-ancestor
25175646|NCT02856919|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25175647|NCT02856919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25175648|NCT02856919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25175649|NCT02856919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25175650|NCT02856919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25175651|NCT02856919|Adrenergic Agents|adrenergic agents|mesh-ancestor
25175652|NCT02856919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25175653|NCT02856919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175654|NCT02856919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175655|NCT02856854|Cocaine|cocaine|mesh-list
25175656|NCT02856854|Oxazepam|oxazepam|mesh-list
25175657|NCT02856854|Metyrapone|metyrapone|mesh-list
25175658|NCT02856854|Anesthetics, Local|anesthetics, local|mesh-ancestor
25175659|NCT02856854|Anesthetics|anesthetics|mesh-ancestor
25175660|NCT02856854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25175661|NCT02856854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175662|NCT02856854|Sensory System Agents|sensory system agents|mesh-ancestor
25175663|NCT02856854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25175664|NCT02856854|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25175665|NCT02856854|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25175666|NCT02856854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25175667|NCT02856854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25175668|NCT02856854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175669|NCT02856854|Dopamine Agents|dopamine agents|mesh-ancestor
25295557|NCT04418895|Vitamins|vitamins|mesh-ancestor
25295561|NCT04414631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25295562|NCT04414631|Immunologic Factors|immunologic factors|mesh-ancestor
25295563|NCT04414631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295564|NCT04396535|Docetaxel|docetaxel|mesh-list
25295565|NCT04396535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295566|NCT04396535|Tubulin Modulators|tubulin modulators|mesh-ancestor
25295567|NCT04396535|Antimitotic Agents|antimitotic agents|mesh-ancestor
25295568|NCT04396535|Mitosis Modulators|mitosis modulators|mesh-ancestor
25295569|NCT04396535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295570|NCT04378426|Midazolam|midazolam|mesh-list
25295571|NCT04378426|Nitrous Oxide|nitrous oxide|mesh-list
24872985|NCT05438394|Melphalan|melphalan|mesh-list
25295572|NCT04378426|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25295573|NCT04378426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25295574|NCT04378426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25295575|NCT04378426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295576|NCT04378426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25295577|NCT04378426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25295578|NCT04378426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25295579|NCT04378426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25295580|NCT04378426|Anesthetics, General|anesthetics, general|mesh-ancestor
25295581|NCT04378426|Anesthetics|anesthetics|mesh-ancestor
25295582|NCT04378426|GABA Modulators|gaba modulators|mesh-ancestor
25295583|NCT04378426|GABA Agents|gaba agents|mesh-ancestor
25647547|NCT01470170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25647548|NCT01470196|Dexamethasone|dexamethasone|mesh-list
25647549|NCT01470196|Rituximab|rituximab|mesh-list
25647550|NCT01470196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25647551|NCT01470196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647552|NCT01470196|Immunologic Factors|immunologic factors|mesh-ancestor
25647553|NCT01470196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647554|NCT01470196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25647555|NCT01470196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25647556|NCT01470196|Antiemetics|antiemetics|mesh-ancestor
25647557|NCT01470196|Autonomic Agents|autonomic agents|mesh-ancestor
25647558|NCT01470196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25647559|NCT01470196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25647560|NCT01470196|Glucocorticoids|glucocorticoids|mesh-ancestor
25647561|NCT01470196|Hormones|hormones|mesh-ancestor
25647562|NCT01470196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25647563|NCT01470196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25647564|NCT01470248|Arsenic Trioxide|arsenic trioxide|mesh-list
25647565|NCT01470248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647566|NCT01470417|Gemcitabine|gemcitabine|mesh-list
25647567|NCT01470417|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25647568|NCT01470417|Paclitaxel|paclitaxel|mesh-list
25647569|NCT01470417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25647570|NCT01470417|Antimetabolites|antimetabolites|mesh-ancestor
25647571|NCT01470417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647572|NCT01470417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295584|NCT04378426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25295585|NCT04378426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295586|NCT04378426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25295587|NCT04378426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25295588|NCT04378426|Analgesics|analgesics|mesh-ancestor
25295589|NCT04378426|Sensory System Agents|sensory system agents|mesh-ancestor
25295590|NCT04378426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25295591|NCT04376281|Norepinephrine|norepinephrine|mesh-list
25295592|NCT04376281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25295593|NCT04376281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25295594|NCT04376281|Adrenergic Agents|adrenergic agents|mesh-ancestor
25295595|NCT04376281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25295596|NCT04376281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295597|NCT04376281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295598|NCT04376281|Sympathomimetics|sympathomimetics|mesh-ancestor
25295599|NCT04376281|Autonomic Agents|autonomic agents|mesh-ancestor
25295600|NCT04376281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25295601|NCT04376281|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25295602|NCT04332445|Hyaluronic Acid|hyaluronic acid|mesh-list
25295603|NCT04332445|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25295604|NCT04332445|Immunologic Factors|immunologic factors|mesh-ancestor
25295605|NCT04332445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295606|NCT04332445|Viscosupplements|viscosupplements|mesh-ancestor
25295607|NCT04332445|Protective Agents|protective agents|mesh-ancestor
25295608|NCT04316910|Anesthetics|anesthetics|mesh-list
25295609|NCT04316910|Anesthetics, General|anesthetics, general|mesh-list
25295610|NCT04316910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25295611|NCT04316910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295615|NCT04314050|Dexmedetomidine|dexmedetomidine|mesh-list
25295616|NCT04314050|Tramadol|tramadol|mesh-list
25295617|NCT04314050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25295618|NCT04314050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25295619|NCT04314050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295620|NCT04314050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25295621|NCT04314050|Analgesics|analgesics|mesh-ancestor
25295622|NCT04314050|Sensory System Agents|sensory system agents|mesh-ancestor
25295623|NCT04314050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25295624|NCT04314050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25295625|NCT04314050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25295626|NCT04314050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25295627|NCT04314050|Adrenergic Agents|adrenergic agents|mesh-ancestor
25295628|NCT04314050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25295774|NCT03943901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25295629|NCT04314050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295630|NCT04314050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25295631|NCT04314050|Narcotics|narcotics|mesh-ancestor
25295632|NCT04299490|Analgesics|analgesics|mesh-list
25825334|NCT00005585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25295653|NCT04279392|Zoledronic Acid|zoledronic acid|mesh-list
25295654|NCT04279392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25295655|NCT04279392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295694|NCT04198961|Analgesics, Opioid|analgesics, opioid|mesh-list
25295695|NCT04198961|Narcotics|narcotics|mesh-ancestor
25295696|NCT04198961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25295697|NCT04198961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295698|NCT04198961|Analgesics|analgesics|mesh-ancestor
25295699|NCT04198961|Sensory System Agents|sensory system agents|mesh-ancestor
25295700|NCT04198961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25295701|NCT04198623|Montelukast|montelukast|mesh-list
25295702|NCT04198623|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25295703|NCT04198623|Respiratory System Agents|respiratory system agents|mesh-ancestor
25295704|NCT04198623|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25295705|NCT04198623|Hormone Antagonists|hormone antagonists|mesh-ancestor
25295706|NCT04198623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25295720|NCT04134845|Dantrolene|dantrolene|mesh-list
25295721|NCT04134845|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25295722|NCT04134845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295723|NCT04134845|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25295724|NCT04134845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25295725|NCT04071457|Lenalidomide|lenalidomide|mesh-list
25295726|NCT04071457|Daratumumab|daratumumab|mesh-list
25295727|NCT04071457|Immunologic Factors|immunologic factors|mesh-ancestor
25295728|NCT04071457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295729|NCT04071457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25295730|NCT04071457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25295742|NCT04038346|Analgesics|analgesics|mesh-ancestor
25295743|NCT04038346|Sensory System Agents|sensory system agents|mesh-ancestor
25295744|NCT04038346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25295745|NCT04038346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295746|NCT04038346|Antipyretics|antipyretics|mesh-ancestor
25295747|NCT04038346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25295748|NCT04038346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25295749|NCT04038346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25295750|NCT04038346|Gout Suppressants|gout suppressants|mesh-ancestor
25295751|NCT04038346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25295752|NCT04038346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25295753|NCT04038346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295754|NCT04017936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25295755|NCT04017936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25295756|NCT03943901|Prednisone|prednisone|mesh-list
25295757|NCT03943901|Cyclophosphamide|cyclophosphamide|mesh-list
25295758|NCT03943901|Rituximab|rituximab|mesh-list
25295759|NCT03943901|Doxorubicin|doxorubicin|mesh-list
25295760|NCT03943901|Vincristine|vincristine|mesh-list
25295761|NCT03943901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25295762|NCT03943901|Immunologic Factors|immunologic factors|mesh-ancestor
25295763|NCT03943901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295764|NCT03943901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25295765|NCT03943901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25295766|NCT03943901|Alkylating Agents|alkylating agents|mesh-ancestor
25295767|NCT03943901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295768|NCT03943901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295769|NCT03943901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25295770|NCT03943901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25295771|NCT03943901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25295772|NCT03943901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25295773|NCT03943901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25295776|NCT03943901|Glucocorticoids|glucocorticoids|mesh-ancestor
25295777|NCT03943901|Hormones|hormones|mesh-ancestor
25295778|NCT03943901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25295779|NCT03943901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25295780|NCT03943901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25295783|NCT03943901|Mitosis Modulators|mitosis modulators|mesh-ancestor
25295784|NCT03932136|Sulforaphane|sulforaphane|mesh-list
25295785|NCT03932136|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25295786|NCT03932136|Protective Agents|protective agents|mesh-ancestor
25295787|NCT03932136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295788|NCT03932136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295789|NCT03919266|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25295790|NCT03919266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24816288|NCT02075749|Hormones|hormones|mesh-ancestor
25295791|NCT03891849|Octreotide|octreotide|mesh-list
25295792|NCT03891849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25295793|NCT03891849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25295794|NCT03891849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295795|NCT03890133|Pregabalin|pregabalin|mesh-list
25295796|NCT03890133|Analgesics|analgesics|mesh-ancestor
25295797|NCT03890133|Sensory System Agents|sensory system agents|mesh-ancestor
25295798|NCT03890133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25295799|NCT03890133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295800|NCT03890133|Anticonvulsants|anticonvulsants|mesh-ancestor
25295801|NCT03890133|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25295802|NCT03890133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25295803|NCT03890133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295804|NCT03890133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25295805|NCT03890133|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25295806|NCT03890133|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25295807|NCT03890133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25295808|NCT03890133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25175760|NCT02856776|Vitamin D|vitamin d|mesh-list
25295809|NCT03875638|Levetiracetam|levetiracetam|mesh-list
25295810|NCT03875638|Anticonvulsants|anticonvulsants|mesh-ancestor
25295811|NCT03875638|Nootropic Agents|nootropic agents|mesh-ancestor
25295812|NCT03874234|GSK3186899|gsk3186899|mesh-list
25295813|NCT03874234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25295814|NCT03874234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25295815|NCT03874234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295816|NCT03871647|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25295817|NCT03871647|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25295818|NCT03871647|Adrenergic Agents|adrenergic agents|mesh-ancestor
25295819|NCT03871647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25295820|NCT03871647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295821|NCT03871647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295822|NCT03727139|Rasagiline|rasagiline|mesh-list
25295823|NCT03727139|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25295824|NCT03727139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25295825|NCT03727139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295826|NCT03727139|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25295827|NCT03727139|Protective Agents|protective agents|mesh-ancestor
25295828|NCT03727139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295829|NCT03723772|Insulin|insulin|mesh-list
25295830|NCT03723772|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25295831|NCT03723772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25295832|NCT03723772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295835|NCT03678025|Prednisone|prednisone|mesh-list
25295836|NCT03678025|Cortisone|cortisone|mesh-list
25295837|NCT03678025|Docetaxel|docetaxel|mesh-list
25295838|NCT03678025|Leuprolide|leuprolide|mesh-list
25295839|NCT03678025|Goserelin|goserelin|mesh-list
25295840|NCT03678025|Bicalutamide|bicalutamide|mesh-list
25295841|NCT03678025|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25295842|NCT03678025|Flutamide|flutamide|mesh-list
25295843|NCT03678025|Nilutamide|nilutamide|mesh-list
25295844|NCT03678025|Tryptophan|tryptophan|mesh-list
25295845|NCT03678025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295846|NCT03678025|Tubulin Modulators|tubulin modulators|mesh-ancestor
25295847|NCT03678025|Antimitotic Agents|antimitotic agents|mesh-ancestor
25295848|NCT03678025|Mitosis Modulators|mitosis modulators|mesh-ancestor
25295849|NCT03678025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295850|NCT03678025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25295851|NCT03678025|Glucocorticoids|glucocorticoids|mesh-ancestor
25295852|NCT03678025|Hormones|hormones|mesh-ancestor
25295853|NCT03678025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25295854|NCT03678025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295855|NCT03678025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25295856|NCT03678025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25295871|NCT03631784|Pembrolizumab|pembrolizumab|mesh-list
25295872|NCT03631784|Pemetrexed|pemetrexed|mesh-list
25295873|NCT03631784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25295874|NCT03631784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295875|NCT03631784|Tubulin Modulators|tubulin modulators|mesh-ancestor
25295876|NCT03631784|Antimitotic Agents|antimitotic agents|mesh-ancestor
25295877|NCT03631784|Mitosis Modulators|mitosis modulators|mesh-ancestor
25295878|NCT03631784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295879|NCT03631784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25295880|NCT03631784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25295881|NCT03631784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25295882|NCT03631784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25295883|NCT03625986|Nicotine|nicotine|mesh-list
25295884|NCT03625986|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25295885|NCT03625986|Autonomic Agents|autonomic agents|mesh-ancestor
25295886|NCT03625986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25295887|NCT03625986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295888|NCT03625986|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25295889|NCT03625986|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25295890|NCT03625986|Cholinergic Agents|cholinergic agents|mesh-ancestor
25295891|NCT03625986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25295892|NCT03625986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093748|NCT03232307|Hormones|hormones|mesh-ancestor
25058011|NCT03500133|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25058012|NCT03500133|Protective Agents|protective agents|mesh-ancestor
25295937|NCT03418961|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25295938|NCT03418961|Adrenergic Agents|adrenergic agents|mesh-ancestor
25295939|NCT03418961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25295940|NCT03418961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647573|NCT01470417|Antiviral Agents|antiviral agents|mesh-ancestor
25295941|NCT03418961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295942|NCT03418961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25295944|NCT03418961|Protective Agents|protective agents|mesh-ancestor
25295945|NCT03418961|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25295946|NCT03418961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25295947|NCT03418961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25295948|NCT03418961|Vasodilator Agents|vasodilator agents|mesh-ancestor
25295949|NCT03418961|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25295950|NCT03418961|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25295951|NCT03416855|Insulin|insulin|mesh-list
25295952|NCT03416855|Insulin Aspart|insulin aspart|mesh-list
25295953|NCT03416855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25295954|NCT03416855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295973|NCT03342417|Nivolumab|nivolumab|mesh-list
25295974|NCT03342417|Ipilimumab|ipilimumab|mesh-list
25295975|NCT03342417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25295976|NCT03342417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295977|NCT03342417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25295978|NCT03342417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295979|NCT03293784|Nivolumab|nivolumab|mesh-list
25295980|NCT03293784|Ipilimumab|ipilimumab|mesh-list
25295981|NCT03293784|Infliximab|infliximab|mesh-list
25295982|NCT03293784|Certolizumab Pegol|certolizumab pegol|mesh-list
25295983|NCT03293784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25295984|NCT03293784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25295985|NCT03293784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25295986|NCT03293784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25295987|NCT03293784|Dermatologic Agents|dermatologic agents|mesh-ancestor
25295988|NCT03293784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25295989|NCT03293784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25295990|NCT03293784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25295991|NCT03293784|Immunologic Factors|immunologic factors|mesh-ancestor
25295992|NCT03293784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25295993|NCT03234309|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25296003|NCT03098563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296005|NCT03096041|Sensory System Agents|sensory system agents|mesh-ancestor
25296006|NCT03096041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25296007|NCT03096041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296008|NCT03069300|Acetylcysteine|acetylcysteine|mesh-list
25296009|NCT03069300|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25296010|NCT03069300|Antiviral Agents|antiviral agents|mesh-ancestor
25296011|NCT03069300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25296012|NCT03069300|Expectorants|expectorants|mesh-ancestor
25296013|NCT03069300|Respiratory System Agents|respiratory system agents|mesh-ancestor
25296014|NCT03069300|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25296015|NCT03069300|Antioxidants|antioxidants|mesh-ancestor
25296016|NCT03069300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296017|NCT03069300|Protective Agents|protective agents|mesh-ancestor
25296018|NCT03069300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296019|NCT03069300|Antidotes|antidotes|mesh-ancestor
25296020|NCT03067272|Contraceptive Agents|contraceptive agents|mesh-list
25296021|NCT03067272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25296022|NCT03067272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296023|NCT03063450|Nivolumab|nivolumab|mesh-list
25296024|NCT03063450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25296025|NCT03063450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296026|NCT03063450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25296027|NCT03063450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296028|NCT02936388|Cisplatin|cisplatin|mesh-list
25296029|NCT02936388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296030|NCT02893241|Cafedrine|cafedrine|mesh-list
25296031|NCT02893241|Theodrenaline|theodrenaline|mesh-list
25296032|NCT02893241|Ephedrine|ephedrine|mesh-list
25296033|NCT02893241|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25296034|NCT02893241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296035|NCT02893241|Sympathomimetics|sympathomimetics|mesh-ancestor
25296036|NCT02893241|Autonomic Agents|autonomic agents|mesh-ancestor
25296037|NCT02893241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25296038|NCT02893241|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25296039|NCT02893241|Adrenergic Agents|adrenergic agents|mesh-ancestor
25296040|NCT02893241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25296041|NCT02893241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296042|NCT02893241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25296043|NCT02893241|Vasodilator Agents|vasodilator agents|mesh-ancestor
25296044|NCT02839265|Flt3 ligand protein|flt3 ligand protein|mesh-list
25296045|NCT02839265|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25296046|NCT02839265|Immunologic Factors|immunologic factors|mesh-ancestor
25296047|NCT02839265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296048|NCT02839265|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25296049|NCT02839265|Protective Agents|protective agents|mesh-ancestor
25296050|NCT02807779|Dexamethasone|dexamethasone|mesh-list
25296051|NCT02807779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25296052|NCT02807779|Antiemetics|antiemetics|mesh-ancestor
25296053|NCT02807779|Autonomic Agents|autonomic agents|mesh-ancestor
25296054|NCT02807779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25296055|NCT02807779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296056|NCT02807779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25296057|NCT02807779|Glucocorticoids|glucocorticoids|mesh-ancestor
25296058|NCT02807779|Hormones|hormones|mesh-ancestor
25296059|NCT02807779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25296060|NCT02807779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25296061|NCT02807779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296065|NCT02680561|Fluticasone|fluticasone|mesh-list
25296066|NCT02680561|Xhance|xhance|mesh-list
25296067|NCT02680561|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25296068|NCT02680561|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25296069|NCT02680561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25296070|NCT02680561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25296071|NCT02680561|Autonomic Agents|autonomic agents|mesh-ancestor
25296072|NCT02680561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25296073|NCT02680561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296074|NCT02680561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25296075|NCT02680561|Respiratory System Agents|respiratory system agents|mesh-ancestor
25296076|NCT02680561|Dermatologic Agents|dermatologic agents|mesh-ancestor
25296077|NCT02680561|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25296078|NCT02680561|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25296079|NCT02680561|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25296080|NCT02680561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25296081|NCT02680561|Adrenergic Agents|adrenergic agents|mesh-ancestor
25296082|NCT02680561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25296083|NCT02680561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296084|NCT02680561|Glucocorticoids|glucocorticoids|mesh-ancestor
25296086|NCT02680561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25296087|NCT02680561|Sympathomimetics|sympathomimetics|mesh-ancestor
25296088|NCT02664935|Docetaxel|docetaxel|mesh-list
25296089|NCT02664935|Durvalumab|durvalumab|mesh-list
25296090|NCT02664935|Palbociclib|palbociclib|mesh-list
25296091|NCT02664935|Osimertinib|osimertinib|mesh-list
25296092|NCT02664935|Crizotinib|crizotinib|mesh-list
25296093|NCT02664935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296094|NCT02664935|Tubulin Modulators|tubulin modulators|mesh-ancestor
25296095|NCT02664935|Antimitotic Agents|antimitotic agents|mesh-ancestor
25296096|NCT02664935|Mitosis Modulators|mitosis modulators|mesh-ancestor
25296097|NCT02664935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296098|NCT02664935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25296099|NCT02664935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25296100|NCT02664935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25296101|NCT02636036|Nivolumab|nivolumab|mesh-list
25296102|NCT02636036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25296103|NCT02636036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296104|NCT02636036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25296105|NCT02636036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296106|NCT02592031|Goserelin|goserelin|mesh-list
25296107|NCT02592031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25296108|NCT02592031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296109|NCT02568124|Tranexamic Acid|tranexamic acid|mesh-list
25296110|NCT02568124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25296111|NCT02568124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25296112|NCT02568124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296113|NCT02568124|Hemostatics|hemostatics|mesh-ancestor
25296114|NCT02568124|Coagulants|coagulants|mesh-ancestor
25296115|NCT02437604|Fluticasone|fluticasone|mesh-list
25296116|NCT02437604|Xhance|xhance|mesh-list
25296117|NCT02437604|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25296118|NCT02437604|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25094520|NCT03226145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25296119|NCT02437604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25296120|NCT02437604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25296121|NCT02437604|Autonomic Agents|autonomic agents|mesh-ancestor
25296122|NCT02437604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25175920|NCT02855788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175921|NCT02855788|Antidotes|antidotes|mesh-ancestor
25175922|NCT02855788|Protective Agents|protective agents|mesh-ancestor
25296123|NCT02437604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296124|NCT02437604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25296125|NCT02437604|Respiratory System Agents|respiratory system agents|mesh-ancestor
25296126|NCT02437604|Dermatologic Agents|dermatologic agents|mesh-ancestor
25296127|NCT02437604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25296128|NCT02437604|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25296129|NCT02437604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25296130|NCT02437604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25296131|NCT02437604|Adrenergic Agents|adrenergic agents|mesh-ancestor
25296132|NCT02437604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25296133|NCT02437604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296134|NCT02437604|Glucocorticoids|glucocorticoids|mesh-ancestor
25296135|NCT02437604|Hormones|hormones|mesh-ancestor
25296136|NCT02437604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25296137|NCT02437604|Sympathomimetics|sympathomimetics|mesh-ancestor
25296138|NCT02384577|Budesonide|budesonide|mesh-list
25296139|NCT02384577|Formoterol Fumarate|formoterol fumarate|mesh-list
25296140|NCT02384577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25296159|NCT02203474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25296160|NCT02203474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296161|NCT02203474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25296162|NCT02203474|Respiratory System Agents|respiratory system agents|mesh-ancestor
25296163|NCT02203474|Parasympatholytics|parasympatholytics|mesh-ancestor
25296164|NCT02203474|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25296165|NCT02203474|Cholinergic Agents|cholinergic agents|mesh-ancestor
25296166|NCT02203474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25296167|NCT02203474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296169|NCT02092571|Progestins|progestins|mesh-ancestor
25296170|NCT02092571|Hormones|hormones|mesh-ancestor
25296171|NCT02092571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25296172|NCT02092571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941776|NCT03988075|Hydrocodone|hydrocodone|mesh-list
25296192|NCT02030457|Beclomethasone|beclomethasone|mesh-list
25296193|NCT02030457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25296194|NCT02030457|Glucocorticoids|glucocorticoids|mesh-ancestor
25296195|NCT02030457|Hormones|hormones|mesh-ancestor
25296196|NCT02030457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25296197|NCT02030457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296198|NCT02030457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25296199|NCT02030457|Respiratory System Agents|respiratory system agents|mesh-ancestor
25296200|NCT01975298|Interferons|interferons|mesh-list
25296201|NCT01975298|Interferon beta-1a|interferon beta-1a|mesh-list
25296202|NCT01975298|Interferon-beta|interferon-beta|mesh-list
25296203|NCT01975298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296204|NCT01975298|Antiviral Agents|antiviral agents|mesh-ancestor
25296205|NCT01975298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25296206|NCT01975298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25296207|NCT01975298|Immunologic Factors|immunologic factors|mesh-ancestor
25296208|NCT01975298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296237|NCT01236456|Cyclophosphamide|cyclophosphamide|mesh-list
25296238|NCT01236456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25296239|NCT01236456|Immunologic Factors|immunologic factors|mesh-ancestor
25296240|NCT01236456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296241|NCT01236456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25296242|NCT01236456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25296243|NCT01236456|Alkylating Agents|alkylating agents|mesh-ancestor
25296244|NCT01236456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296245|NCT01236456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296246|NCT01236456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25296248|NCT01061515|Capecitabine|capecitabine|mesh-list
25296249|NCT01061515|Oxaliplatin|oxaliplatin|mesh-list
25296250|NCT01061515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25296251|NCT01061515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296252|NCT01061515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25296253|NCT01061515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25296254|NCT01061515|Growth Substances|growth substances|mesh-ancestor
25296255|NCT01061515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296256|NCT01061515|Growth Inhibitors|growth inhibitors|mesh-ancestor
25647574|NCT01470417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25647575|NCT01470417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25647576|NCT01470417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25204536|NCT02707484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25204538|NCT02707445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25204539|NCT02707445|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25204540|NCT02707445|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25204541|NCT02707445|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25204542|NCT02707445|Purinergic Agents|purinergic agents|mesh-ancestor
25204543|NCT02707445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24944824|NCT03957174|Adrenergic Agents|adrenergic agents|mesh-ancestor
25296257|NCT01061515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25296258|NCT01061515|Antimetabolites|antimetabolites|mesh-ancestor
25296259|NCT01061515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296260|NCT00790010|Bevacizumab|bevacizumab|mesh-list
25296261|NCT00790010|Ipilimumab|ipilimumab|mesh-list
25296262|NCT00790010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25296263|NCT00790010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296264|NCT00790010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25296265|NCT00790010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25296266|NCT00790010|Growth Substances|growth substances|mesh-ancestor
25296267|NCT00790010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296268|NCT00790010|Growth Inhibitors|growth inhibitors|mesh-ancestor
25296269|NCT00790010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25296270|NCT00790010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296271|NCT00659126|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25296272|NCT00659126|Hematinics|hematinics|mesh-ancestor
25296273|NCT00659126|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25296274|NCT00659126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25296275|NCT05118048|Chrysarobin|chrysarobin|mesh-list
25296276|NCT05118048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25296277|NCT05118048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25296278|NCT05118048|Analgesics|analgesics|mesh-ancestor
25296279|NCT05118048|Sensory System Agents|sensory system agents|mesh-ancestor
25296280|NCT05118048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25296281|NCT05118048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296282|NCT05118048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25296283|NCT05118048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25296284|NCT05117983|Antidepressive Agents|antidepressive agents|mesh-list
25296285|NCT05117983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25296286|NCT05117957|Sorafenib|sorafenib|mesh-list
25296287|NCT05117957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296292|NCT05117866|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25296299|NCT05117125|Anticoagulants|anticoagulants|mesh-ancestor
25296300|NCT05117125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25296301|NCT05117125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25296302|NCT05117125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296303|NCT05117021|Bupivacaine|bupivacaine|mesh-list
25296304|NCT05117021|Anesthetics, Local|anesthetics, local|mesh-ancestor
25296305|NCT05117021|Anesthetics|anesthetics|mesh-ancestor
25296306|NCT05117021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25296307|NCT05117021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296308|NCT05117021|Sensory System Agents|sensory system agents|mesh-ancestor
25296309|NCT05117021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25296310|NCT05116995|Rivaroxaban|rivaroxaban|mesh-list
25296311|NCT05116995|Ticagrelor|ticagrelor|mesh-list
25296312|NCT05116995|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25296313|NCT05116995|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25296314|NCT05116995|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25296316|NCT05116995|Purinergic Agents|purinergic agents|mesh-ancestor
25296317|NCT05116995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25296318|NCT05116995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296319|NCT05116995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296320|NCT05116995|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25296321|NCT05116995|Antithrombins|antithrombins|mesh-ancestor
25296322|NCT05116995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25647577|NCT01470417|Immunologic Factors|immunologic factors|mesh-ancestor
25647578|NCT01470417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647579|NCT01470417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25647580|NCT01470417|Tubulin Modulators|tubulin modulators|mesh-ancestor
25647581|NCT01470417|Antimitotic Agents|antimitotic agents|mesh-ancestor
25647582|NCT01470417|Mitosis Modulators|mitosis modulators|mesh-ancestor
25647583|NCT01470469|Guanfacine|guanfacine|mesh-list
25647584|NCT01470469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25647585|NCT01470469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25296323|NCT05116995|Protease Inhibitors|protease inhibitors|mesh-ancestor
25296324|NCT05116995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25296325|NCT05116995|Anticoagulants|anticoagulants|mesh-ancestor
25296326|NCT05116462|Gemcitabine|gemcitabine|mesh-list
25296327|NCT05116462|Paclitaxel|paclitaxel|mesh-list
25296328|NCT05116462|Docetaxel|docetaxel|mesh-list
25296329|NCT05116462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25296330|NCT05116462|Carboplatin|carboplatin|mesh-list
25296331|NCT05116462|Pemetrexed|pemetrexed|mesh-list
25296332|NCT05116462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25296333|NCT05116462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296334|NCT05116462|Tubulin Modulators|tubulin modulators|mesh-ancestor
25296335|NCT05116462|Antimitotic Agents|antimitotic agents|mesh-ancestor
25296336|NCT05116462|Mitosis Modulators|mitosis modulators|mesh-ancestor
25296337|NCT05116462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296338|NCT05116462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25296339|NCT05116462|Antimetabolites|antimetabolites|mesh-ancestor
25296340|NCT05116462|Antiviral Agents|antiviral agents|mesh-ancestor
25296341|NCT05116462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25296342|NCT05116462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25296343|NCT05116462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25296344|NCT05116462|Immunologic Factors|immunologic factors|mesh-ancestor
25296345|NCT05116462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296346|NCT05116462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25296347|NCT05116462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25296348|NCT05116371|Levonorgestrel|levonorgestrel|mesh-list
25296349|NCT05116371|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25296350|NCT05116371|Contraceptive Agents|contraceptive agents|mesh-list
25296351|NCT05116371|Contraceptives, Oral|contraceptives, oral|mesh-list
25296352|NCT05116371|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25296353|NCT05116371|Estradiol|estradiol|mesh-list
25296354|NCT05116371|Estrogens|estrogens|mesh-ancestor
25296355|NCT05116371|Hormones|hormones|mesh-ancestor
25296356|NCT05116371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25296357|NCT05116371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296358|NCT05116371|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25296359|NCT05116371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25296360|NCT05116371|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25296361|NCT05116371|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25296362|NCT05116371|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25296363|NCT05116345|Dexamethasone|dexamethasone|mesh-list
25296364|NCT05116345|Dexamethasone acetate|dexamethasone acetate|mesh-list
25296365|NCT05116345|BB 1101|bb 1101|mesh-list
25296366|NCT05116345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25296367|NCT05116345|Antiemetics|antiemetics|mesh-ancestor
25296368|NCT05116345|Autonomic Agents|autonomic agents|mesh-ancestor
25296369|NCT05116345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25296370|NCT05116345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296371|NCT05116345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25296372|NCT05116345|Glucocorticoids|glucocorticoids|mesh-ancestor
25296373|NCT05116345|Hormones|hormones|mesh-ancestor
25296374|NCT05116345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25296375|NCT05116345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25296376|NCT05116345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296377|NCT05116345|Protease Inhibitors|protease inhibitors|mesh-ancestor
25296378|NCT05116345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25296379|NCT05116345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296380|NCT05116306|Hyaluronic Acid|hyaluronic acid|mesh-list
25296381|NCT05116306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25296382|NCT05116306|Immunologic Factors|immunologic factors|mesh-ancestor
25296383|NCT05116306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296384|NCT05116306|Viscosupplements|viscosupplements|mesh-ancestor
25296385|NCT05116306|Protective Agents|protective agents|mesh-ancestor
25296386|NCT05116293|Acetaminophen|acetaminophen|mesh-list
25296387|NCT05116293|Digoxin|digoxin|mesh-list
25296388|NCT05116293|Midazolam|midazolam|mesh-list
25296389|NCT05116293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25296390|NCT05116293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25296391|NCT05116293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25296392|NCT05116293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296393|NCT05116293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25296394|NCT05116293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25296395|NCT05116293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25296396|NCT05116293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25296397|NCT05116293|Anesthetics, General|anesthetics, general|mesh-ancestor
25296398|NCT05116293|Anesthetics|anesthetics|mesh-ancestor
25296399|NCT05116293|GABA Modulators|gaba modulators|mesh-ancestor
25296400|NCT05116293|GABA Agents|gaba agents|mesh-ancestor
25176036|NCT02854787|Autonomic Agents|autonomic agents|mesh-ancestor
25176056|NCT02853864|Propofol|propofol|mesh-list
25296401|NCT05116293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25296402|NCT05116293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296403|NCT05116293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25296404|NCT05116293|Analgesics|analgesics|mesh-ancestor
25296405|NCT05116293|Sensory System Agents|sensory system agents|mesh-ancestor
25296406|NCT05116293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25296407|NCT05116293|Antipyretics|antipyretics|mesh-ancestor
25296408|NCT05116293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25296409|NCT05116293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25296410|NCT05116293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25296411|NCT05116293|Protective Agents|protective agents|mesh-ancestor
25296412|NCT05107453|Levobupivacaine|levobupivacaine|mesh-list
25296413|NCT05107453|Anesthetics, Local|anesthetics, local|mesh-ancestor
25296414|NCT05107453|Anesthetics|anesthetics|mesh-ancestor
25296415|NCT05107453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25296416|NCT05107453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296417|NCT05107453|Sensory System Agents|sensory system agents|mesh-ancestor
25296418|NCT05107453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25296419|NCT05076097|Rituximab|rituximab|mesh-list
25296420|NCT05076097|Lenalidomide|lenalidomide|mesh-list
25296421|NCT05076097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25296422|NCT05076097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296423|NCT05076097|Immunologic Factors|immunologic factors|mesh-ancestor
25296424|NCT05076097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296425|NCT05076097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25296426|NCT05076097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25296427|NCT05076097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25296428|NCT05076097|Growth Substances|growth substances|mesh-ancestor
25296429|NCT05076097|Growth Inhibitors|growth inhibitors|mesh-ancestor
25296430|NCT05016895|Azithromycin|azithromycin|mesh-list
25296431|NCT05016895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25296432|NCT05016895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25296433|NCT05002530|Vitamin D|vitamin d|mesh-list
25296434|NCT05002530|Ergocalciferols|ergocalciferols|mesh-list
25296435|NCT05002530|Cholecalciferol|cholecalciferol|mesh-list
25296436|NCT05002530|Vitamins|vitamins|mesh-list
25296437|NCT05002530|Tretinoin|tretinoin|mesh-list
25296438|NCT05002530|Isotretinoin|isotretinoin|mesh-list
25296439|NCT05002530|Micronutrients|micronutrients|mesh-ancestor
25296440|NCT05002530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296441|NCT05002530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25296442|NCT05002530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25296443|NCT05002530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296444|NCT05002530|Keratolytic Agents|keratolytic agents|mesh-ancestor
25296445|NCT05002530|Dermatologic Agents|dermatologic agents|mesh-ancestor
24506259|NCT00544505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296446|NCT04940286|Gemcitabine|gemcitabine|mesh-list
25296447|NCT04940286|Paclitaxel|paclitaxel|mesh-list
25296448|NCT04940286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25296449|NCT04940286|Durvalumab|durvalumab|mesh-list
25296450|NCT04940286|Immunoglobulins|immunoglobulins|mesh-list
25296451|NCT04940286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25296452|NCT04940286|Immunoglobulin G|immunoglobulin g|mesh-list
25296453|NCT04940286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25296454|NCT04940286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296455|NCT04940286|Tubulin Modulators|tubulin modulators|mesh-ancestor
25296456|NCT04940286|Antimitotic Agents|antimitotic agents|mesh-ancestor
25296457|NCT04940286|Mitosis Modulators|mitosis modulators|mesh-ancestor
25296458|NCT04940286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296459|NCT04940286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25296460|NCT04940286|Antimetabolites|antimetabolites|mesh-ancestor
25296461|NCT04940286|Antiviral Agents|antiviral agents|mesh-ancestor
25296462|NCT04940286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25296463|NCT04940286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25296464|NCT04940286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25296465|NCT04940286|Immunologic Factors|immunologic factors|mesh-ancestor
25296466|NCT04940286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296467|NCT04940286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25058255|NCT03498235|Propofol|propofol|mesh-list
25296468|NCT04753437|Amoxicillin|amoxicillin|mesh-list
25296469|NCT04753437|Clarithromycin|clarithromycin|mesh-list
25647586|NCT01470469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25647587|NCT01470469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25296470|NCT04753437|Potassium Citrate|potassium citrate|mesh-list
25296471|NCT04753437|Esomeprazole|esomeprazole|mesh-list
25296472|NCT04753437|Bismuth|bismuth|mesh-list
25296481|NCT04753437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25296482|NCT04753437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25296484|NCT04753437|Diuretics|diuretics|mesh-ancestor
25296485|NCT04753437|Natriuretic Agents|natriuretic agents|mesh-ancestor
25296486|NCT04753437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296487|NCT04753437|Expectorants|expectorants|mesh-ancestor
25296488|NCT04753437|Respiratory System Agents|respiratory system agents|mesh-ancestor
25296489|NCT04690504|Melatonin|melatonin|mesh-list
25296490|NCT04690504|Antioxidants|antioxidants|mesh-ancestor
25296491|NCT04690504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296492|NCT04690504|Protective Agents|protective agents|mesh-ancestor
25296493|NCT04690504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296494|NCT04690504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25296495|NCT04675333|Carboplatin|carboplatin|mesh-list
25296496|NCT04675333|Pembrolizumab|pembrolizumab|mesh-list
25296497|NCT04675333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296498|NCT04675333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25296499|NCT04675294|Pembrolizumab|pembrolizumab|mesh-list
25296500|NCT04675294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25296501|NCT04675294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296502|NCT04671953|Metformin|metformin|mesh-list
25296503|NCT04671953|BMS-986165|bms-986165|mesh-list
25296504|NCT04671953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25296505|NCT04671953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296506|NCT04671953|Dermatologic Agents|dermatologic agents|mesh-ancestor
25296507|NCT04671953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25296508|NCT04671953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25296509|NCT04671953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296510|NCT04585061|Lidocaine|lidocaine|mesh-list
25296511|NCT04585061|Anesthetics, Local|anesthetics, local|mesh-ancestor
25296512|NCT04585061|Anesthetics|anesthetics|mesh-ancestor
25296513|NCT04585061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25296514|NCT04585061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296515|NCT04585061|Sensory System Agents|sensory system agents|mesh-ancestor
25296517|NCT04585061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25296518|NCT04585061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25296519|NCT04585061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25296520|NCT04585061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25296521|NCT04585061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296522|NCT04564365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25296523|NCT04564365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25296524|NCT04564365|Adrenergic Agents|adrenergic agents|mesh-ancestor
25296525|NCT04564365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25296526|NCT04564365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296527|NCT04564365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296538|NCT04480424|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25296539|NCT04480424|Immunologic Factors|immunologic factors|mesh-ancestor
25296540|NCT04480424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296541|NCT04450498|Vaccines|vaccines|mesh-list
25296542|NCT04450498|Immunologic Factors|immunologic factors|mesh-ancestor
25296543|NCT04450498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296544|NCT04431700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25296546|NCT04425174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25647588|NCT01470469|Adrenergic Agents|adrenergic agents|mesh-ancestor
25296547|NCT04425174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296548|NCT04418479|Aspirin|aspirin|mesh-list
25296549|NCT04418479|Clopidogrel|clopidogrel|mesh-list
25296550|NCT04418479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25296551|NCT04418479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25296552|NCT04418479|Analgesics|analgesics|mesh-ancestor
25296553|NCT04418479|Sensory System Agents|sensory system agents|mesh-ancestor
25296554|NCT04418479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25296555|NCT04418479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296556|NCT04418479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25296557|NCT04418479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25296558|NCT04418479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25296559|NCT04418479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25296560|NCT04418479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296561|NCT04418479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25296562|NCT04418479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25296563|NCT04418479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25296564|NCT04418479|Antipyretics|antipyretics|mesh-ancestor
25296565|NCT04418479|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25296566|NCT04418479|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25296567|NCT04418479|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25296568|NCT04418479|Purinergic Agents|purinergic agents|mesh-ancestor
25296569|NCT04418479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25296570|NCT04375735|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25296571|NCT04375735|Respiratory System Agents|respiratory system agents|mesh-ancestor
25296572|NCT04370379|Aflibercept|aflibercept|mesh-list
25296573|NCT04370379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25296574|NCT04370379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25296575|NCT04370379|Growth Substances|growth substances|mesh-ancestor
25296576|NCT04370379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296577|NCT04370379|Growth Inhibitors|growth inhibitors|mesh-ancestor
25296578|NCT04370379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296579|NCT04305899|BMS-986165|bms-986165|mesh-list
25296580|NCT04305899|Dermatologic Agents|dermatologic agents|mesh-ancestor
25296581|NCT04305899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25296582|NCT04305899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25296583|NCT04305899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296584|NCT04153604|Doxycycline|doxycycline|mesh-list
25296585|NCT04153604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25296586|NCT04153604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25296587|NCT04153604|Antimalarials|antimalarials|mesh-ancestor
25296588|NCT04153604|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25296604|NCT04126278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25296605|NCT04126278|Glucocorticoids|glucocorticoids|mesh-ancestor
25296606|NCT04126278|Hormones|hormones|mesh-ancestor
25296607|NCT04126278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25296608|NCT04126278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25296609|NCT04126278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296610|NCT04016714|Vaccines|vaccines|mesh-list
25296611|NCT04016714|Immunologic Factors|immunologic factors|mesh-ancestor
25296612|NCT04016714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296613|NCT04014803|Aspirin|aspirin|mesh-list
25296614|NCT04014803|Clopidogrel|clopidogrel|mesh-list
25296615|NCT04014803|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25296616|NCT04014803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25296617|NCT04014803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25296618|NCT04014803|Analgesics|analgesics|mesh-ancestor
25296619|NCT04014803|Sensory System Agents|sensory system agents|mesh-ancestor
25296620|NCT04014803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25296621|NCT04014803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296622|NCT04014803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25296623|NCT04014803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25296624|NCT04014803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25296625|NCT04014803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25296626|NCT04014803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296627|NCT04014803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25296628|NCT04014803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25296629|NCT04014803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25296630|NCT04014803|Antipyretics|antipyretics|mesh-ancestor
25296631|NCT04014803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25296632|NCT04014803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25296633|NCT04014803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25296634|NCT04014803|Purinergic Agents|purinergic agents|mesh-ancestor
25296635|NCT04014803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25296636|NCT04006119|Cemiplimab|cemiplimab|mesh-list
25176172|NCT02852798|Docetaxel|docetaxel|mesh-list
25296637|NCT04006119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25296638|NCT04006119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296639|NCT03971500|Aspirin|aspirin|mesh-list
25296640|NCT03971500|Ticagrelor|ticagrelor|mesh-list
25296641|NCT03971500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25296642|NCT03971500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25296643|NCT03971500|Analgesics|analgesics|mesh-ancestor
25296644|NCT03971500|Sensory System Agents|sensory system agents|mesh-ancestor
25296645|NCT03971500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25296646|NCT03971500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296647|NCT03971500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25296648|NCT03971500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25296649|NCT03971500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25296650|NCT03971500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25296651|NCT03971500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296652|NCT03971500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25296653|NCT03971500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25296654|NCT03971500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25296655|NCT03971500|Antipyretics|antipyretics|mesh-ancestor
25296656|NCT03971500|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25296657|NCT03971500|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25296658|NCT03971500|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25296659|NCT03971500|Purinergic Agents|purinergic agents|mesh-ancestor
25296660|NCT03971500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25296661|NCT03954132|Cholinergic Agents|cholinergic agents|mesh-list
25296662|NCT03954132|Muscarinic Antagonists|muscarinic antagonists|mesh-list
25296663|NCT03954132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25296673|NCT03929029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296674|NCT03929029|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25296675|NCT03929029|Immunologic Factors|immunologic factors|mesh-ancestor
25296676|NCT03929029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296677|NCT03890887|Itraconazole|itraconazole|mesh-list
25296678|NCT03890887|Antifungal Agents|antifungal agents|mesh-ancestor
25296679|NCT03890887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25296680|NCT03890887|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25296681|NCT03890887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25296682|NCT03890887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25296683|NCT03890887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296684|NCT03890887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25296685|NCT03890887|Hormone Antagonists|hormone antagonists|mesh-ancestor
25296686|NCT03890887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25296687|NCT03890887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296688|NCT03890887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25296689|NCT03827213|Bupivacaine|bupivacaine|mesh-list
25296690|NCT03827213|Anesthetics, Local|anesthetics, local|mesh-ancestor
25296691|NCT03827213|Anesthetics|anesthetics|mesh-ancestor
25296692|NCT03827213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25296693|NCT03827213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296694|NCT03827213|Sensory System Agents|sensory system agents|mesh-ancestor
25296695|NCT03827213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25296696|NCT03797469|Niacinamide|niacinamide|mesh-list
25296697|NCT03797469|Niacin|niacin|mesh-list
25296698|NCT03797469|Nicotinic Acids|nicotinic acids|mesh-list
25296699|NCT03797469|Vitamins|vitamins|mesh-ancestor
25296700|NCT03797469|Micronutrients|micronutrients|mesh-ancestor
25296701|NCT03797469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296702|NCT03797469|Vitamin B Complex|vitamin b complex|mesh-ancestor
25296703|NCT03797469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25296704|NCT03797469|Antimetabolites|antimetabolites|mesh-ancestor
25296705|NCT03797469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296706|NCT03797469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25296707|NCT03797469|Vasodilator Agents|vasodilator agents|mesh-ancestor
25296708|NCT03795701|Liraglutide|liraglutide|mesh-list
25296709|NCT03795701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25296710|NCT03795701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296711|NCT03795701|Incretins|incretins|mesh-ancestor
25296712|NCT03795701|Hormones|hormones|mesh-ancestor
25296713|NCT03795701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25296723|NCT03717129|Tenofovir|tenofovir|mesh-list
25296724|NCT03717129|Emtricitabine|emtricitabine|mesh-list
25296803|NCT02774590|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25296725|NCT03717129|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25647589|NCT01470469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25296727|NCT03717129|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25296728|NCT03717129|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25296730|NCT03717129|Antiviral Agents|antiviral agents|mesh-ancestor
25296731|NCT03717129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25296732|NCT03717129|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25296733|NCT03717129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25296734|NCT03717129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25296735|NCT03717129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296738|NCT03717129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25296739|NCT03717129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25296741|NCT03636295|Warfarin|warfarin|mesh-list
25296742|NCT03636295|Anticoagulants|anticoagulants|mesh-ancestor
25296743|NCT03573700|Cyclophosphamide|cyclophosphamide|mesh-list
25296744|NCT03573700|Fludarabine|fludarabine|mesh-list
25296745|NCT03573700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25296746|NCT03573700|Immunologic Factors|immunologic factors|mesh-ancestor
25296747|NCT03573700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296748|NCT03573700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25296749|NCT03573700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25296750|NCT03573700|Alkylating Agents|alkylating agents|mesh-ancestor
25296751|NCT03573700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296752|NCT03573700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296753|NCT03573700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25296754|NCT03533257|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
25296755|NCT03533257|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25296756|NCT03533257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296757|NCT03533257|Antiviral Agents|antiviral agents|mesh-ancestor
25296758|NCT03533257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25296759|NCT03533257|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25296760|NCT03533257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25296761|NCT03525873|Methylphenidate|methylphenidate|mesh-list
25296762|NCT03525873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25296763|NCT03525873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296764|NCT03525873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25296765|NCT03525873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25296766|NCT03525873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25296767|NCT03525873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296768|NCT03525873|Dopamine Agents|dopamine agents|mesh-ancestor
25296769|NCT03525873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25296770|NCT03463408|Nivolumab|nivolumab|mesh-list
25296771|NCT03463408|Ipilimumab|ipilimumab|mesh-list
25296772|NCT03463408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25296773|NCT03463408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296774|NCT03463408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25296775|NCT03463408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296776|NCT03460158|Hyaluronic Acid|hyaluronic acid|mesh-list
25296777|NCT03460158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25296778|NCT03460158|Immunologic Factors|immunologic factors|mesh-ancestor
25296779|NCT03460158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296780|NCT03460158|Viscosupplements|viscosupplements|mesh-ancestor
25296781|NCT03460158|Protective Agents|protective agents|mesh-ancestor
25296782|NCT03169985|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25296783|NCT03169985|Ezetimibe|ezetimibe|mesh-list
25296784|NCT03169985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25296785|NCT03169985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25296786|NCT03169985|Antimetabolites|antimetabolites|mesh-ancestor
25296787|NCT03169985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296788|NCT03169985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25296789|NCT03169985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25296790|NCT03169985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25296791|NCT03140670|Rucaparib|rucaparib|mesh-list
25296792|NCT03140670|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25296793|NCT03140670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25296794|NCT03140670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296795|NCT03140670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296799|NCT02934282|HBOC 201|hboc 201|mesh-list
25296800|NCT02934282|Blood Substitutes|blood substitutes|mesh-ancestor
25296801|NCT02774590|Timolol|timolol|mesh-list
25296802|NCT02774590|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25296804|NCT02774590|Adrenergic Agents|adrenergic agents|mesh-ancestor
25296805|NCT02774590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25296806|NCT02774590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296807|NCT02774590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296808|NCT02774590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25296809|NCT02774590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25296810|NCT02195947|Hormones|hormones|mesh-list
25296827|NCT01698307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25296828|NCT01698307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25296829|NCT05118984|Azithromycin|azithromycin|mesh-list
25296830|NCT05118984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25296831|NCT05118984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25296832|NCT05118672|Acetaminophen|acetaminophen|mesh-list
25296833|NCT05118672|Fexofenadine|fexofenadine|mesh-list
25296834|NCT05118672|Phenylephrine|phenylephrine|mesh-list
25296835|NCT05118672|Oxymetazoline|oxymetazoline|mesh-list
25296836|NCT05118672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25296837|NCT05118672|Analgesics|analgesics|mesh-ancestor
25296838|NCT05118672|Sensory System Agents|sensory system agents|mesh-ancestor
25296839|NCT05118672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25296840|NCT05118672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296841|NCT05118672|Antipyretics|antipyretics|mesh-ancestor
25296842|NCT05118672|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25296843|NCT05118672|Mydriatics|mydriatics|mesh-ancestor
25296844|NCT05118672|Autonomic Agents|autonomic agents|mesh-ancestor
25296845|NCT05118672|Sympathomimetics|sympathomimetics|mesh-ancestor
25296846|NCT05118672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25296847|NCT05118672|Nasal Decongestants|nasal decongestants|mesh-ancestor
25296848|NCT05118672|Respiratory System Agents|respiratory system agents|mesh-ancestor
25296849|NCT05118672|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25296850|NCT05118672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25296851|NCT05118672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25296852|NCT05118672|Adrenergic Agents|adrenergic agents|mesh-ancestor
25296853|NCT05118672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25296854|NCT05118672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296855|NCT05118672|Protective Agents|protective agents|mesh-ancestor
25296856|NCT05118672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25296857|NCT05118672|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25296858|NCT05118672|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25296859|NCT05118672|Histamine Antagonists|histamine antagonists|mesh-ancestor
25296860|NCT05118672|Histamine Agents|histamine agents|mesh-ancestor
25296861|NCT05118542|Methimazole|methimazole|mesh-list
25296862|NCT05118542|Propylthiouracil|propylthiouracil|mesh-list
25296863|NCT05118542|Antithyroid Agents|antithyroid agents|mesh-ancestor
25296864|NCT05118542|Hormone Antagonists|hormone antagonists|mesh-ancestor
25296865|NCT05118542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25296866|NCT05118542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296867|NCT05118542|Antimetabolites|antimetabolites|mesh-ancestor
25296868|NCT05118542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297483|NCT04752527|Venetoclax|venetoclax|mesh-list
25296902|NCT05084534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25296903|NCT05084534|Adrenergic Agents|adrenergic agents|mesh-ancestor
25296904|NCT05084534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25296905|NCT05084534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296906|NCT05081219|Insulin|insulin|mesh-list
25296907|NCT05081219|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25296908|NCT05081219|Empagliflozin|empagliflozin|mesh-list
25296909|NCT05081219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25296910|NCT05081219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296911|NCT05081219|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25296912|NCT05081219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296913|NCT05038475|Antibodies|antibodies|mesh-list
25296914|NCT05038475|Immunologic Factors|immunologic factors|mesh-ancestor
25296915|NCT05038475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296916|NCT05025163|Fluorides|fluorides|mesh-list
25296917|NCT05025163|Fluorides, Topical|fluorides, topical|mesh-list
25296918|NCT05025163|Cariostatic Agents|cariostatic agents|mesh-ancestor
25296919|NCT05025163|Protective Agents|protective agents|mesh-ancestor
25296920|NCT05025163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296921|NCT05018013|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25296922|NCT05018013|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25296923|NCT05018013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25296924|NCT05018013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25296925|NCT05018013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25296926|NCT05018013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25296927|NCT05018013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296928|NCT05018013|Analgesics|analgesics|mesh-ancestor
25176352|NCT02851095|Canagliflozin|canagliflozin|mesh-list
24880900|NCT03213158|Ixazomib|ixazomib|mesh-list
25296929|NCT05018013|Sensory System Agents|sensory system agents|mesh-ancestor
25296930|NCT05018013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25296931|NCT05018013|Antidepressive Agents|antidepressive agents|mesh-ancestor
25296932|NCT05018013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25296933|NCT05018013|Dopamine Agents|dopamine agents|mesh-ancestor
25296944|NCT04818372|Dexamethasone|dexamethasone|mesh-list
25296945|NCT04818372|Lenalidomide|lenalidomide|mesh-list
25296946|NCT04818372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25296947|NCT04818372|Antiemetics|antiemetics|mesh-ancestor
25296948|NCT04818372|Autonomic Agents|autonomic agents|mesh-ancestor
25296949|NCT04818372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25296950|NCT04818372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296951|NCT04818372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25296952|NCT04818372|Glucocorticoids|glucocorticoids|mesh-ancestor
25296953|NCT04818372|Hormones|hormones|mesh-ancestor
25296954|NCT04818372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25296955|NCT04818372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25296956|NCT04818372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25296957|NCT04818372|Immunologic Factors|immunologic factors|mesh-ancestor
25296958|NCT04818372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25297560|NCT04412395|Lactoferrin|lactoferrin|mesh-list
25296991|NCT04645316|Propofol|propofol|mesh-list
25296992|NCT04645316|Sevoflurane|sevoflurane|mesh-list
25296993|NCT04645316|Desflurane|desflurane|mesh-list
25296994|NCT04645316|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25296995|NCT04645316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25296996|NCT04645316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25296997|NCT04645316|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25296998|NCT04645316|Anesthetics, General|anesthetics, general|mesh-ancestor
25296999|NCT04645316|Anesthetics|anesthetics|mesh-ancestor
25297000|NCT04645316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25297001|NCT04645316|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25297002|NCT04594382|Analgesics, Opioid|analgesics, opioid|mesh-list
25297003|NCT04594382|Narcotics|narcotics|mesh-ancestor
25297004|NCT04594382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25297005|NCT04594382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297006|NCT04594382|Analgesics|analgesics|mesh-ancestor
25297007|NCT04594382|Sensory System Agents|sensory system agents|mesh-ancestor
25297008|NCT04594382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25297009|NCT04530604|Defibrotide|defibrotide|mesh-list
25297010|NCT04530604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25297011|NCT04530604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25297012|NCT04530604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297013|NCT04530604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25297014|NCT04451863|Caryophyllene|caryophyllene|mesh-list
25297015|NCT04451863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297016|NCT04451863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25297017|NCT04451863|Analgesics|analgesics|mesh-ancestor
25297018|NCT04451863|Sensory System Agents|sensory system agents|mesh-ancestor
25297019|NCT04451863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25297020|NCT04451863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25297021|NCT04451863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25297022|NCT04451863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25297023|NCT04450394|Insulin|insulin|mesh-list
25297024|NCT04450394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25297025|NCT04450394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297026|NCT04303325|Esketamine|esketamine|mesh-list
25297027|NCT04303325|Antidepressive Agents|antidepressive agents|mesh-ancestor
25297028|NCT04303325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25297029|NCT04247750|Sirolimus|sirolimus|mesh-list
25297030|NCT04247750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25297031|NCT04247750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25297032|NCT04247750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25297033|NCT04247750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25297034|NCT04247750|Antifungal Agents|antifungal agents|mesh-ancestor
25297055|NCT03906617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25297056|NCT03906617|Antiemetics|antiemetics|mesh-ancestor
25297057|NCT03906617|Autonomic Agents|autonomic agents|mesh-ancestor
25297058|NCT03906617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25297059|NCT03906617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297060|NCT03906617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25297061|NCT03906617|Glucocorticoids|glucocorticoids|mesh-ancestor
25297062|NCT03906617|Hormones|hormones|mesh-ancestor
25297063|NCT03906617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25657177|NCT01583686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25297064|NCT03906617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25204603|NCT02707315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25204604|NCT02707315|Antimetabolites|antimetabolites|mesh-ancestor
25204605|NCT02707315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204606|NCT02707315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25204607|NCT02707315|Antiviral Agents|antiviral agents|mesh-ancestor
25204608|NCT02707315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25204609|NCT02707315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25297065|NCT03906617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25297066|NCT03906617|Anesthetics, Local|anesthetics, local|mesh-ancestor
25297067|NCT03906617|Anesthetics|anesthetics|mesh-ancestor
25297068|NCT03906617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25297069|NCT03906617|Sensory System Agents|sensory system agents|mesh-ancestor
25297070|NCT03906617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25297071|NCT03906617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25297072|NCT03906617|Adrenergic Agents|adrenergic agents|mesh-ancestor
25297073|NCT03906617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25297074|NCT03906617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297075|NCT03906617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25297076|NCT03906617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25297077|NCT03906617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25297078|NCT03906617|Respiratory System Agents|respiratory system agents|mesh-ancestor
25297079|NCT03906617|Mydriatics|mydriatics|mesh-ancestor
25297080|NCT03906617|Sympathomimetics|sympathomimetics|mesh-ancestor
25297081|NCT03906617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25297082|NCT03897673|Iron|iron|mesh-list
25297083|NCT03897673|Trace Elements|trace elements|mesh-ancestor
25297084|NCT03897673|Micronutrients|micronutrients|mesh-ancestor
25297085|NCT03897673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297086|NCT03874494|Aripiprazole|aripiprazole|mesh-list
25297087|NCT03874494|Brexpiprazole|brexpiprazole|mesh-list
25297088|NCT03874494|Antidepressive Agents|antidepressive agents|mesh-ancestor
25297089|NCT03874494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25297090|NCT03874494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25297091|NCT03874494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25297092|NCT03874494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25297093|NCT03874494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297094|NCT03874494|Dopamine Agonists|dopamine agonists|mesh-ancestor
25297095|NCT03874494|Dopamine Agents|dopamine agents|mesh-ancestor
25297096|NCT03874494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25297097|NCT03874494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297098|NCT03874494|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25297099|NCT03874494|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25297100|NCT03874494|Serotonin Agents|serotonin agents|mesh-ancestor
25297101|NCT03874494|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25297102|NCT03874494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25297103|NCT03874494|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25297104|NCT03874494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25297105|NCT03862859|Warfarin|warfarin|mesh-list
25297106|NCT03862859|Anticoagulants|anticoagulants|mesh-ancestor
25297107|NCT03807817|Ethanol|ethanol|mesh-list
25297108|NCT03807817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25297109|NCT03807817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25297110|NCT03807817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25297637|NCT03423264|Antimanic Agents|antimanic agents|mesh-ancestor
25297140|NCT03677115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297141|NCT03677115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25297143|NCT03677115|Sensory System Agents|sensory system agents|mesh-ancestor
25297144|NCT03677115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25297145|NCT03677115|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25297146|NCT03677115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25297147|NCT03677115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25297148|NCT03677115|Adrenergic Agents|adrenergic agents|mesh-ancestor
25297149|NCT03677115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25297150|NCT03677115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297151|NCT03673228|Nicotine|nicotine|mesh-list
25297152|NCT03673228|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25297153|NCT03673228|Autonomic Agents|autonomic agents|mesh-ancestor
25297154|NCT03673228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25647590|NCT01470469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647591|NCT01470469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647592|NCT01470599|Tofacitinib|tofacitinib|mesh-list
25647593|NCT01470599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25647594|NCT01470599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25647595|NCT01470599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176455|NCT05382481|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25176456|NCT05382481|Dalteparin|dalteparin|mesh-list
25176457|NCT05382481|Anticoagulants|anticoagulants|mesh-ancestor
25176458|NCT05382481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25176459|NCT05382481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25176460|NCT05382481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176487|NCT05382390|Cytarabine|cytarabine|mesh-list
25176488|NCT05382390|Decitabine|decitabine|mesh-list
25176489|NCT05382390|Aclarubicin|aclarubicin|mesh-list
25176490|NCT05382390|Lenograstim|lenograstim|mesh-list
25176491|NCT05382390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25297155|NCT03673228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297156|NCT03673228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25297157|NCT03673228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25297158|NCT03673228|Cholinergic Agents|cholinergic agents|mesh-ancestor
25297159|NCT03673228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25297160|NCT03673228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297195|NCT03003325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25297196|NCT03003325|Analgesics|analgesics|mesh-ancestor
25297197|NCT03003325|Sensory System Agents|sensory system agents|mesh-ancestor
25297198|NCT03003325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25297199|NCT03003325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297200|NCT03003325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25297201|NCT03003325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25297202|NCT03003325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25297203|NCT03003325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25297204|NCT03003325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297205|NCT03003325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25297206|NCT03003325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25297207|NCT03003325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25297208|NCT03003325|Antipyretics|antipyretics|mesh-ancestor
25297209|NCT02578394|Methylprednisolone|methylprednisolone|mesh-list
25297210|NCT02578394|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25297211|NCT02578394|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25297212|NCT02578394|Prednisolone|prednisolone|mesh-list
25297213|NCT02578394|Prednisolone acetate|prednisolone acetate|mesh-list
25297214|NCT02578394|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25297215|NCT02578394|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25297216|NCT02578394|Prednisolone phosphate|prednisolone phosphate|mesh-list
25297217|NCT02578394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25297218|NCT02578394|Antiemetics|antiemetics|mesh-ancestor
25297219|NCT02578394|Autonomic Agents|autonomic agents|mesh-ancestor
25297220|NCT02578394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25297221|NCT02578394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297222|NCT02578394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25297223|NCT02578394|Glucocorticoids|glucocorticoids|mesh-ancestor
25297224|NCT02578394|Hormones|hormones|mesh-ancestor
25205326|NCT04931368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297225|NCT02578394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25297226|NCT02578394|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25297227|NCT02578394|Protective Agents|protective agents|mesh-ancestor
25297228|NCT02578394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25297229|NCT02578394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25297230|NCT02578394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25297231|NCT02184767|Loxapine|loxapine|mesh-list
25297232|NCT02184767|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25297233|NCT02184767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25297234|NCT02184767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25297235|NCT02184767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297236|NCT02184767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25297237|NCT02184767|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25297238|NCT02184767|Dopamine Agents|dopamine agents|mesh-ancestor
25297239|NCT02184767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25297240|NCT02184767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297241|NCT02122718|Allopurinol|allopurinol|mesh-list
25297242|NCT02122718|Antimetabolites|antimetabolites|mesh-ancestor
25647596|NCT01470612|Tofacitinib|tofacitinib|mesh-list
25647597|NCT01470612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25647598|NCT01470612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25647599|NCT01470612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647600|NCT01470651|Modafinil|modafinil|mesh-list
25647601|NCT01470651|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25647602|NCT01470651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647603|NCT01470651|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25647604|NCT01470651|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25657178|NCT01583686|Alkylating Agents|alkylating agents|mesh-ancestor
25176559|NCT05382182|Hormones|hormones|mesh-ancestor
25176560|NCT05382182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25176561|NCT05382182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176562|NCT05382143|Atosiban|atosiban|mesh-list
25176563|NCT05382143|Hormone Antagonists|hormone antagonists|mesh-ancestor
25176564|NCT05382143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25176565|NCT05382143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176566|NCT05382143|Tocolytic Agents|tocolytic agents|mesh-ancestor
25176567|NCT05382143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24808614|NCT02028403|BMS-936559|bms-936559|mesh-list
24485604|NCT00453908|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25131686|NCT03024515|Narcotics|narcotics|mesh-ancestor
25084021|NCT03310593|Cannabidiol|cannabidiol|mesh-list
25084022|NCT03310593|Anticonvulsants|anticonvulsants|mesh-ancestor
25084023|NCT03310567|Pembrolizumab|pembrolizumab|mesh-list
25084024|NCT03310567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25297243|NCT02122718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297244|NCT02122718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25297245|NCT02122718|Gout Suppressants|gout suppressants|mesh-ancestor
25297246|NCT02122718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25297247|NCT02122718|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25297248|NCT02122718|Antioxidants|antioxidants|mesh-ancestor
25297249|NCT02122718|Protective Agents|protective agents|mesh-ancestor
25297250|NCT02122718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297251|NCT01882816|Doxorubicin|doxorubicin|mesh-list
25297252|NCT01882816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25297253|NCT01882816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25297254|NCT01882816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25297255|NCT01882816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25297256|NCT01882816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25297269|NCT01758614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25297270|NCT01758614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297271|NCT01758614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25297272|NCT01758614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25297273|NCT01758614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25297274|NCT01758614|Antipyretics|antipyretics|mesh-ancestor
25297275|NCT01758614|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25297276|NCT01758614|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25297277|NCT01758614|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25297278|NCT01758614|Purinergic Agents|purinergic agents|mesh-ancestor
24904346|NCT04356222|Durvalumab|durvalumab|mesh-list
25297279|NCT01758614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25297280|NCT01593241|Carboplatin|carboplatin|mesh-list
25297281|NCT01593241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25297295|NCT00307242|Adefovir|adefovir|mesh-list
25297296|NCT00307242|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25297297|NCT00307242|Antiviral Agents|antiviral agents|mesh-ancestor
25297298|NCT00307242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25297299|NCT00307242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25297300|NCT00307242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25297301|NCT00307242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25297378|NCT05119452|Immunologic Factors|immunologic factors|mesh-ancestor
25297302|NCT00307242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297303|NCT05120687|Cyclosporine|cyclosporine|mesh-list
25297304|NCT05120687|Mycophenolic Acid|mycophenolic acid|mesh-list
25297305|NCT05120687|Adalimumab|adalimumab|mesh-list
25297306|NCT05120687|Cyclophosphamide|cyclophosphamide|mesh-list
25297307|NCT05120687|Methotrexate|methotrexate|mesh-list
25297308|NCT05120687|Cyclosporins|cyclosporins|mesh-list
25647605|NCT01470651|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25647606|NCT01470651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647607|NCT01470859|Levodopa|levodopa|mesh-list
25647608|NCT01470859|Carbidopa|carbidopa|mesh-list
25647609|NCT01470859|Pramipexole|pramipexole|mesh-list
25647610|NCT01470859|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25647611|NCT01470859|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25647612|NCT01470859|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25647613|NCT01470859|Dopamine Agents|dopamine agents|mesh-ancestor
25647614|NCT01470859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25647615|NCT01470859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647616|NCT01470859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647617|NCT01470859|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25647618|NCT01470859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25647619|NCT01470859|Antioxidants|antioxidants|mesh-ancestor
25647620|NCT01470859|Protective Agents|protective agents|mesh-ancestor
25084271|NCT03308253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24755182|NCT01725087|Tapentadol|tapentadol|mesh-list
24755216|NCT01725113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25084272|NCT03308253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25084273|NCT03308214|Imipenem|imipenem|mesh-list
25084274|NCT03308214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25084275|NCT03308214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25084276|NCT03308201|Letrozole|letrozole|mesh-list
25084635|NCT03304457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25084637|NCT03304457|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25084638|NCT03304457|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25084639|NCT03304457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25084640|NCT03304457|Adrenergic Agents|adrenergic agents|mesh-ancestor
25084703|NCT03303924|Sulbactam|sulbactam|mesh-list
25084704|NCT03303924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25084705|NCT03303924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24790898|NCT05410483|Docetaxel|docetaxel|mesh-list
25084960|NCT03302221|Sensory System Agents|sensory system agents|mesh-ancestor
25297309|NCT05120687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25297310|NCT05120687|Immunologic Factors|immunologic factors|mesh-ancestor
25297311|NCT05120687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297312|NCT05120687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25297313|NCT05120687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25297314|NCT05120687|Alkylating Agents|alkylating agents|mesh-ancestor
25297315|NCT05120687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297316|NCT05120687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25297317|NCT05120687|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25297318|NCT05120687|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25297319|NCT05120687|Abortifacient Agents|abortifacient agents|mesh-ancestor
25297320|NCT05120687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25297321|NCT05120687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25297322|NCT05120687|Antimetabolites|antimetabolites|mesh-ancestor
25297323|NCT05120687|Dermatologic Agents|dermatologic agents|mesh-ancestor
25297324|NCT05120687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25297325|NCT05120687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25297326|NCT05120687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25297327|NCT05120687|Antifungal Agents|antifungal agents|mesh-ancestor
25297328|NCT05120687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25297329|NCT05120687|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25297330|NCT05120687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25297331|NCT05120687|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25297332|NCT05120687|Antitubercular Agents|antitubercular agents|mesh-ancestor
25297333|NCT05120687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25297334|NCT05120687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25297335|NCT05120622|Tremelimumab|tremelimumab|mesh-list
25297336|NCT05120622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099704|NCT03188276|Ledipasvir|ledipasvir|mesh-list
24706991|NCT01493388|Insulin|insulin|mesh-list
25297337|NCT05120206|Chlorhexidine|chlorhexidine|mesh-list
25297338|NCT05120206|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25297339|NCT05120206|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25297340|NCT05120206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25297341|NCT05120206|Disinfectants|disinfectants|mesh-ancestor
25297342|NCT05120206|Dermatologic Agents|dermatologic agents|mesh-ancestor
25297343|NCT05120076|Dexamethasone|dexamethasone|mesh-list
25297344|NCT05120076|Dexamethasone acetate|dexamethasone acetate|mesh-list
25297345|NCT05120076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25297346|NCT05120076|Antiemetics|antiemetics|mesh-ancestor
25647621|NCT01470859|Dopamine Agonists|dopamine agonists|mesh-ancestor
25647622|NCT01470859|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25647623|NCT01470859|Immunologic Factors|immunologic factors|mesh-ancestor
25647624|NCT01470989|Triamcinolone|triamcinolone|mesh-list
25647625|NCT01470989|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25647626|NCT01470989|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25647627|NCT01470989|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25647628|NCT01470989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25647629|NCT01470989|Glucocorticoids|glucocorticoids|mesh-ancestor
25647630|NCT01470989|Hormones|hormones|mesh-ancestor
25647631|NCT01470989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25647632|NCT01470989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647633|NCT01470989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25647634|NCT01470989|Immunologic Factors|immunologic factors|mesh-ancestor
25647635|NCT01470989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25647636|NCT01470989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647637|NCT01471015|Darbepoetin alfa|darbepoetin alfa|mesh-list
25297347|NCT05120076|Autonomic Agents|autonomic agents|mesh-ancestor
25647638|NCT01471015|Hematinics|hematinics|mesh-ancestor
25297348|NCT05120076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25297349|NCT05120076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297350|NCT05120076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25297351|NCT05120076|Glucocorticoids|glucocorticoids|mesh-ancestor
25297352|NCT05120076|Hormones|hormones|mesh-ancestor
25297353|NCT05120076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25297354|NCT05120076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25297355|NCT05120076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25297356|NCT05119712|Terbinafine|terbinafine|mesh-list
25297357|NCT05119712|Antifungal Agents|antifungal agents|mesh-ancestor
25297358|NCT05119712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25297359|NCT05119712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25297360|NCT05119712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297361|NCT05119452|Adalimumab|adalimumab|mesh-list
25297362|NCT05119452|Etanercept|etanercept|mesh-list
25297363|NCT05119452|Golimumab|golimumab|mesh-list
25297364|NCT05119452|Infliximab|infliximab|mesh-list
25297365|NCT05119452|Certolizumab Pegol|certolizumab pegol|mesh-list
25297366|NCT05119452|Antirheumatic Agents|antirheumatic agents|mesh-list
25297367|NCT05119452|Tofacitinib|tofacitinib|mesh-list
25297368|NCT05119452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25297369|NCT05119452|Dermatologic Agents|dermatologic agents|mesh-ancestor
25297370|NCT05119452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25297371|NCT05119452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25297372|NCT05119452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25297373|NCT05119452|Analgesics|analgesics|mesh-ancestor
25297374|NCT05119452|Sensory System Agents|sensory system agents|mesh-ancestor
24915701|NCT04248998|Paclitaxel|paclitaxel|mesh-list
25297375|NCT05119452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25297376|NCT05119452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297377|NCT05119452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25297379|NCT05119452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25297380|NCT05119452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25297381|NCT05119452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297382|NCT05119452|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25297383|NCT05119439|Misoprostol|misoprostol|mesh-list
25297384|NCT05119439|Mifepristone|mifepristone|mesh-list
25297385|NCT05119439|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25297386|NCT05119439|Abortifacient Agents|abortifacient agents|mesh-ancestor
25297387|NCT05119439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25297388|NCT05119439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297389|NCT05119439|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25297390|NCT05119439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25297391|NCT05119439|Oxytocics|oxytocics|mesh-ancestor
25297392|NCT05119439|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25297393|NCT05119439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25297394|NCT05119439|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25297395|NCT05119439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25297396|NCT05119439|Contraceptive Agents|contraceptive agents|mesh-ancestor
25297397|NCT05119439|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25297398|NCT05119439|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25297399|NCT05119439|Hormone Antagonists|hormone antagonists|mesh-ancestor
25297400|NCT05119439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25297401|NCT05119439|Luteolytic Agents|luteolytic agents|mesh-ancestor
25297402|NCT05119439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25297403|NCT05119439|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25297404|NCT05119257|Antibodies|antibodies|mesh-list
25297405|NCT05119257|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25297406|NCT05119257|Immunologic Factors|immunologic factors|mesh-ancestor
25297416|NCT05108155|Autonomic Agents|autonomic agents|mesh-ancestor
25297417|NCT05108155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25297418|NCT05108155|Nootropic Agents|nootropic agents|mesh-ancestor
25297428|NCT05061992|Lactulose|lactulose|mesh-list
25297429|NCT05061992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25297430|NCT05021861|Cyproterone Acetate|cyproterone acetate|mesh-list
25297431|NCT05021861|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25297432|NCT05021861|Estradiol|estradiol|mesh-list
25297433|NCT05021861|Cyproterone|cyproterone|mesh-list
25297434|NCT05021861|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
25297435|NCT05021861|Estrogens|estrogens|mesh-ancestor
25297436|NCT05021861|Hormones|hormones|mesh-ancestor
25297437|NCT05021861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25297438|NCT05021861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297439|NCT05021861|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25297440|NCT05021861|Contraceptive Agents|contraceptive agents|mesh-ancestor
25297441|NCT05021861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25297442|NCT05021861|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25297443|NCT05021861|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25297444|NCT05021861|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25297445|NCT05021861|Androgen Antagonists|androgen antagonists|mesh-ancestor
25297446|NCT05021861|Hormone Antagonists|hormone antagonists|mesh-ancestor
24905259|NCT04349410|Losartan|losartan|mesh-list
25297447|NCT05021861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25297448|NCT05021861|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25297449|NCT04995874|Micronutrients|micronutrients|mesh-list
25297450|NCT04995874|Trace Elements|trace elements|mesh-list
25297451|NCT04995874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297452|NCT04990921|Pembrolizumab|pembrolizumab|mesh-list
25297453|NCT04990921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25297454|NCT04990921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25297455|NCT04824144|Dexmedetomidine|dexmedetomidine|mesh-list
25297456|NCT04824144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25297457|NCT04824144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25297458|NCT04824144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297459|NCT04824144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25297460|NCT04824144|Analgesics|analgesics|mesh-ancestor
25297461|NCT04824144|Sensory System Agents|sensory system agents|mesh-ancestor
25297462|NCT04824144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25297463|NCT04824144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25297464|NCT04824144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25297465|NCT04824144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25297466|NCT04824144|Adrenergic Agents|adrenergic agents|mesh-ancestor
25297467|NCT04824144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25297468|NCT04824144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297469|NCT04814745|Morphine|morphine|mesh-list
25297470|NCT04814745|Tramadol|tramadol|mesh-list
25297471|NCT04814745|Ropivacaine|ropivacaine|mesh-list
25297472|NCT04814745|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25297473|NCT04814745|Narcotics|narcotics|mesh-ancestor
25297474|NCT04814745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25297475|NCT04814745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297476|NCT04814745|Analgesics|analgesics|mesh-ancestor
25297477|NCT04814745|Sensory System Agents|sensory system agents|mesh-ancestor
25297478|NCT04814745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25297479|NCT04814745|Anesthetics, Local|anesthetics, local|mesh-ancestor
25297480|NCT04814745|Anesthetics|anesthetics|mesh-ancestor
25297481|NCT04752527|Sorafenib|sorafenib|mesh-list
25297482|NCT04752527|Decitabine|decitabine|mesh-list
25297484|NCT04752527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25297485|NCT04752527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25297486|NCT04752527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25297487|NCT04752527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297488|NCT04752527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25297489|NCT04752527|Antimetabolites|antimetabolites|mesh-ancestor
25297490|NCT04716335|Harmine|harmine|mesh-list
25297491|NCT04716335|Hallucinogens|hallucinogens|mesh-ancestor
25297492|NCT04716335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297493|NCT04716335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25297494|NCT04716335|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25297495|NCT04716335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25297496|NCT04716335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297497|NCT04640571|Metformin|metformin|mesh-list
25297498|NCT04640571|Valacyclovir|valacyclovir|mesh-list
25297499|NCT04640571|Enalaprilat|enalaprilat|mesh-list
25297500|NCT04640571|Enalapril|enalapril|mesh-list
25297501|NCT04640571|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
25297502|NCT04640571|Pravastatin|pravastatin|mesh-list
25297503|NCT04640571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25297504|NCT04640571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297505|NCT04640571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25297506|NCT04640571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25297507|NCT04640571|Antimetabolites|antimetabolites|mesh-ancestor
25297508|NCT04640571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297509|NCT04640571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25297510|NCT04640571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25297511|NCT04640571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25297512|NCT04640571|Antiviral Agents|antiviral agents|mesh-ancestor
25297513|NCT04640571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25297514|NCT04640571|Cathartics|cathartics|mesh-ancestor
25297515|NCT04640571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25297516|NCT04640571|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25297517|NCT04640571|Protease Inhibitors|protease inhibitors|mesh-ancestor
25297518|NCT04640571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25297519|NCT04572100|Paclitaxel|paclitaxel|mesh-list
25176755|NCT05380453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25176756|NCT05380453|Immunologic Factors|immunologic factors|mesh-ancestor
25176757|NCT05380453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176758|NCT05380388|Vaccines|vaccines|mesh-list
25176759|NCT05380388|Immunologic Factors|immunologic factors|mesh-ancestor
25176761|NCT05380310|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25297520|NCT04572100|Carboplatin|carboplatin|mesh-list
25297521|NCT04572100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25297522|NCT04572100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25297523|NCT04572100|Tubulin Modulators|tubulin modulators|mesh-ancestor
25297524|NCT04572100|Antimitotic Agents|antimitotic agents|mesh-ancestor
25297525|NCT04572100|Mitosis Modulators|mitosis modulators|mesh-ancestor
25297526|NCT04572100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297527|NCT04551885|Aldesleukin|aldesleukin|mesh-list
25297528|NCT04551885|Cyclophosphamide|cyclophosphamide|mesh-list
25297529|NCT04551885|Fludarabine|fludarabine|mesh-list
25297530|NCT04551885|Avelumab|avelumab|mesh-list
25297531|NCT04551885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25297532|NCT04551885|Immunologic Factors|immunologic factors|mesh-ancestor
25297533|NCT04551885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297534|NCT04551885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25297535|NCT04551885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25297536|NCT04551885|Alkylating Agents|alkylating agents|mesh-ancestor
25297537|NCT04551885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297538|NCT04551885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25297539|NCT04551885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25297540|NCT04551885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25297541|NCT04551885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25297542|NCT04551885|Antiviral Agents|antiviral agents|mesh-ancestor
25297543|NCT04551885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25297544|NCT04551885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25297545|NCT04497870|Peppermint oil|peppermint oil|mesh-list
25297546|NCT04497870|Menthol|menthol|mesh-list
25297547|NCT04497870|Antipruritics|antipruritics|mesh-ancestor
25297548|NCT04497870|Dermatologic Agents|dermatologic agents|mesh-ancestor
25297549|NCT04497870|Antiemetics|antiemetics|mesh-ancestor
25297550|NCT04497870|Autonomic Agents|autonomic agents|mesh-ancestor
25297551|NCT04497870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25297552|NCT04497870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297553|NCT04497870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25297554|NCT04497870|Parasympatholytics|parasympatholytics|mesh-ancestor
25297555|NCT04431141|Empagliflozin|empagliflozin|mesh-list
25297556|NCT04431141|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25297557|NCT04431141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297558|NCT04431141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25297559|NCT04431141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297561|NCT04412395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25297562|NCT04310748|Anesthetics|anesthetics|mesh-list
25297563|NCT04310748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25297564|NCT04310748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297565|NCT04294498|Entecavir|entecavir|mesh-list
25297566|NCT04294498|Durvalumab|durvalumab|mesh-list
25297567|NCT04294498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25297568|NCT04294498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25297569|NCT04294498|Antiviral Agents|antiviral agents|mesh-ancestor
25297570|NCT04294498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25297571|NCT04206488|Digoxin|digoxin|mesh-list
25297572|NCT04206488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25297573|NCT04206488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25297574|NCT04206488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25297575|NCT04206488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297576|NCT04206488|Protective Agents|protective agents|mesh-ancestor
25297577|NCT04206488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297578|NCT04188418|Fentanyl|fentanyl|mesh-list
25297579|NCT04188418|Morphine|morphine|mesh-list
25297580|NCT04188418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25297581|NCT04188418|Narcotics|narcotics|mesh-ancestor
25297582|NCT04188418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25647639|NCT01471054|Dexamethasone|dexamethasone|mesh-list
25647640|NCT01471054|Bevacizumab|bevacizumab|mesh-list
25647641|NCT01471054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25647642|NCT01471054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647643|NCT01471054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25297583|NCT04188418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297584|NCT04188418|Analgesics|analgesics|mesh-ancestor
25297585|NCT04188418|Sensory System Agents|sensory system agents|mesh-ancestor
25647644|NCT01471054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25297586|NCT04188418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25297587|NCT04188418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25297588|NCT04188418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25297589|NCT04188418|Anesthetics, General|anesthetics, general|mesh-ancestor
25297590|NCT04188418|Anesthetics|anesthetics|mesh-ancestor
25297591|NCT04007705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25297592|NCT03912363|Insulin|insulin|mesh-list
25297593|NCT03912363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25297594|NCT03912363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297595|NCT03901131|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25297596|NCT03901131|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25297597|NCT03901131|Norethindrone|norethindrone|mesh-list
25297598|NCT03901131|Norethindrone Acetate|norethindrone acetate|mesh-list
25297599|NCT03901131|Norethindrone enanthate|norethindrone enanthate|mesh-list
25297600|NCT03901131|Estradiol|estradiol|mesh-list
25297601|NCT03901131|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25297602|NCT03901131|Estrogens|estrogens|mesh-ancestor
25297603|NCT03901131|Hormones|hormones|mesh-ancestor
25297604|NCT03901131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25297605|NCT03901131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297606|NCT03901131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25297607|NCT03901131|Contraceptive Agents|contraceptive agents|mesh-ancestor
25297608|NCT03901131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25297609|NCT03901131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25297610|NCT03901131|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25297611|NCT03901131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25297612|NCT03901131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25297613|NCT03814317|Treprostinil|treprostinil|mesh-list
25297614|NCT03814317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25297615|NCT03688633|Candesartan|candesartan|mesh-list
25297616|NCT03688633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25297617|NCT03688633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25297618|NCT03688633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25297619|NCT03688633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297620|NCT03441750|Metformin|metformin|mesh-list
25297621|NCT03441750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25297622|NCT03441750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297623|NCT03423264|Gabapentin|gabapentin|mesh-list
25297624|NCT03423264|Analgesics|analgesics|mesh-ancestor
25297625|NCT03423264|Sensory System Agents|sensory system agents|mesh-ancestor
25297626|NCT03423264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25297627|NCT03423264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297644|NCT03225547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25297645|NCT03225547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297646|NCT03225547|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25297647|NCT03225547|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25297648|NCT03225547|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25297649|NCT03225547|Contraceptive Agents|contraceptive agents|mesh-ancestor
25297650|NCT03225547|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25297651|NCT03225547|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25297652|NCT03225547|Hormone Antagonists|hormone antagonists|mesh-ancestor
25297653|NCT03225547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25297654|NCT03225547|Luteolytic Agents|luteolytic agents|mesh-ancestor
25076044|NCT03376191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25076045|NCT03376191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076046|NCT03376178|Lidocaine|lidocaine|mesh-list
25297655|NCT03225547|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25297656|NCT03225547|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25297674|NCT03107182|Diphenhydramine|diphenhydramine|mesh-list
25297675|NCT03107182|Promethazine|promethazine|mesh-list
25297676|NCT03107182|Dexamethasone|dexamethasone|mesh-list
25297677|NCT03107182|Paclitaxel|paclitaxel|mesh-list
25297678|NCT03107182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25297679|NCT03107182|Carboplatin|carboplatin|mesh-list
25297680|NCT03107182|Nivolumab|nivolumab|mesh-list
25297681|NCT03107182|Hydroxyurea|hydroxyurea|mesh-list
25297682|NCT03107182|Famotidine|famotidine|mesh-list
25297683|NCT03107182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25297684|NCT03107182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25297685|NCT03107182|Tubulin Modulators|tubulin modulators|mesh-ancestor
25297686|NCT03107182|Antimitotic Agents|antimitotic agents|mesh-ancestor
25297687|NCT03107182|Mitosis Modulators|mitosis modulators|mesh-ancestor
25297688|NCT03107182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297689|NCT03107182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25297690|NCT03107182|Antiemetics|antiemetics|mesh-ancestor
25297691|NCT03107182|Autonomic Agents|autonomic agents|mesh-ancestor
25297692|NCT03107182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25297693|NCT03107182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297694|NCT03107182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25204688|NCT02707250|Sensory System Agents|sensory system agents|mesh-ancestor
25204689|NCT02707250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204690|NCT02707250|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25204692|NCT02707250|Analgesics|analgesics|mesh-ancestor
25204693|NCT02707250|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25204694|NCT02707094|Immunologic Factors|immunologic factors|mesh-list
25204696|NCT02707016|Sevoflurane|sevoflurane|mesh-list
25059010|NCT03491709|Cetuximab|cetuximab|mesh-list
25297695|NCT03107182|Glucocorticoids|glucocorticoids|mesh-ancestor
25297696|NCT03107182|Hormones|hormones|mesh-ancestor
25297697|NCT03107182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25297698|NCT03107182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25297699|NCT03107182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25297700|NCT03107182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25297701|NCT03107182|Antisickling Agents|antisickling agents|mesh-ancestor
25297702|NCT03107182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25297810|NCT00876031|Idarubicin|idarubicin|mesh-list
25297703|NCT03107182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25297704|NCT03107182|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25297705|NCT03107182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25297706|NCT03107182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25297707|NCT03107182|Anesthetics, Local|anesthetics, local|mesh-ancestor
25297708|NCT03107182|Anesthetics|anesthetics|mesh-ancestor
25297709|NCT03107182|Sensory System Agents|sensory system agents|mesh-ancestor
25297710|NCT03107182|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25297711|NCT03107182|Histamine Antagonists|histamine antagonists|mesh-ancestor
25297712|NCT03107182|Histamine Agents|histamine agents|mesh-ancestor
25297723|NCT02969837|Antiemetics|antiemetics|mesh-ancestor
25297724|NCT02969837|Autonomic Agents|autonomic agents|mesh-ancestor
25297725|NCT02969837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25297726|NCT02969837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297727|NCT02969837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25297728|NCT02969837|Glucocorticoids|glucocorticoids|mesh-ancestor
25297729|NCT02969837|Hormones|hormones|mesh-ancestor
25297730|NCT02969837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25297731|NCT02969837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25297732|NCT02969837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25297733|NCT02969837|Immunologic Factors|immunologic factors|mesh-ancestor
25297734|NCT02969837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25297735|NCT02969837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25297736|NCT02969837|Growth Substances|growth substances|mesh-ancestor
25297737|NCT02969837|Growth Inhibitors|growth inhibitors|mesh-ancestor
25297738|NCT02802852|Lenograstim|lenograstim|mesh-list
25297739|NCT02802852|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25297740|NCT02802852|Immunologic Factors|immunologic factors|mesh-ancestor
25297741|NCT02802852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297742|NCT02789020|Rasagiline|rasagiline|mesh-list
25297743|NCT02789020|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25297744|NCT02789020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25297745|NCT02789020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297746|NCT02789020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25297747|NCT02789020|Protective Agents|protective agents|mesh-ancestor
25297748|NCT02789020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297758|NCT02333149|Melatonin|melatonin|mesh-list
25297759|NCT02333149|Antioxidants|antioxidants|mesh-ancestor
25297760|NCT02333149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297761|NCT02333149|Protective Agents|protective agents|mesh-ancestor
25297762|NCT02333149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297763|NCT02333149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25297770|NCT02144857|Cyclosporine|cyclosporine|mesh-list
25297771|NCT02144857|Etanercept|etanercept|mesh-list
25297772|NCT02144857|Apremilast|apremilast|mesh-list
25297773|NCT02144857|Ustekinumab|ustekinumab|mesh-list
25297774|NCT02144857|Cyclosporins|cyclosporins|mesh-list
25297775|NCT02144857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25297776|NCT02144857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297777|NCT02144857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25297778|NCT02144857|Immunologic Factors|immunologic factors|mesh-ancestor
25647645|NCT01471054|Growth Substances|growth substances|mesh-ancestor
25647646|NCT01471054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647647|NCT01471054|Growth Inhibitors|growth inhibitors|mesh-ancestor
25647648|NCT01471054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25647649|NCT01471054|Antiemetics|antiemetics|mesh-ancestor
25647650|NCT01471054|Autonomic Agents|autonomic agents|mesh-ancestor
25647651|NCT01471054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25176904|NCT05378919|Immunologic Factors|immunologic factors|mesh-ancestor
25176905|NCT05378919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176906|NCT05378919|Hematinics|hematinics|mesh-ancestor
25176907|NCT05378919|Vitamin B Complex|vitamin b complex|mesh-ancestor
25176908|NCT05378919|Vitamins|vitamins|mesh-ancestor
25176909|NCT05378919|Micronutrients|micronutrients|mesh-ancestor
25176910|NCT05378919|Antidotes|antidotes|mesh-ancestor
25176912|NCT05378867|Bevacizumab|bevacizumab|mesh-list
25297779|NCT02144857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297780|NCT02144857|Antifungal Agents|antifungal agents|mesh-ancestor
25297781|NCT02144857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25297782|NCT02144857|Dermatologic Agents|dermatologic agents|mesh-ancestor
25297783|NCT02144857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25297784|NCT02144857|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25297785|NCT02144857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25297786|NCT02144857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25297787|NCT02144857|Analgesics|analgesics|mesh-ancestor
25297788|NCT02144857|Sensory System Agents|sensory system agents|mesh-ancestor
25297789|NCT02144857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25297793|NCT02144857|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25297797|NCT01462578|Azacitidine|azacitidine|mesh-list
25297798|NCT01462578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25297799|NCT01462578|Antimetabolites|antimetabolites|mesh-ancestor
25297800|NCT01462578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297801|NCT01462578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25297802|NCT01462578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25297803|NCT01219075|Phytoestrogens|phytoestrogens|mesh-list
25297804|NCT01219075|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25297805|NCT01219075|Estrogens|estrogens|mesh-ancestor
25297806|NCT01219075|Hormones|hormones|mesh-ancestor
25297807|NCT01219075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25297808|NCT01219075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297809|NCT00876031|Etoposide|etoposide|mesh-list
25297811|NCT00876031|Trofosfamide|trofosfamide|mesh-list
25297812|NCT00876031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25297813|NCT00876031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25297814|NCT00876031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25297815|NCT00876031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25297816|NCT00876031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25297817|NCT00876031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297818|NCT00876031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25297819|NCT00876031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25297820|NCT00876031|Immunologic Factors|immunologic factors|mesh-ancestor
25297821|NCT00876031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297822|NCT00876031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25297823|NCT00876031|Alkylating Agents|alkylating agents|mesh-ancestor
25297824|NCT05122455|Edoxaban|edoxaban|mesh-list
25297825|NCT05122455|Clopidogrel|clopidogrel|mesh-list
25297826|NCT05122455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25297827|NCT05122455|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25297828|NCT05122455|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25297829|NCT05122455|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25297830|NCT05122455|Purinergic Agents|purinergic agents|mesh-ancestor
25297831|NCT05122455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25297832|NCT05122455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297833|NCT05122455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297834|NCT05122455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25297835|NCT05122455|Antithrombins|antithrombins|mesh-ancestor
25297836|NCT05122455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25297837|NCT05122455|Protease Inhibitors|protease inhibitors|mesh-ancestor
25297838|NCT05122455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25297839|NCT05122455|Anticoagulants|anticoagulants|mesh-ancestor
25297840|NCT05122377|Goserelin|goserelin|mesh-list
25297841|NCT05122377|Leuprolide|leuprolide|mesh-list
25297842|NCT05122377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25297843|NCT05122377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25297844|NCT05122377|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25297845|NCT05122377|Fertility Agents|fertility agents|mesh-ancestor
25647652|NCT01471054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25647653|NCT01471054|Glucocorticoids|glucocorticoids|mesh-ancestor
25647654|NCT01471054|Hormones|hormones|mesh-ancestor
25647655|NCT01471054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25647656|NCT01471054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25647657|NCT01471093|Rebamipide|rebamipide|mesh-list
25647658|NCT01471093|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25297846|NCT05122377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24809024|NCT02030717|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24809025|NCT02030717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24809026|NCT02030717|Adrenergic Agents|adrenergic agents|mesh-ancestor
24809027|NCT02030717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24809028|NCT02030717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809029|NCT02030912|Amoxicillin|amoxicillin|mesh-list
24809030|NCT02030912|Minocycline|minocycline|mesh-list
24809031|NCT02030912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25176950|NCT05378555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25297847|NCT05122377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297848|NCT05122351|Acetaminophen|acetaminophen|mesh-list
25297849|NCT05122351|Bupivacaine|bupivacaine|mesh-list
25297850|NCT05122351|Anesthetics, Local|anesthetics, local|mesh-ancestor
25297851|NCT05122351|Anesthetics|anesthetics|mesh-ancestor
25297852|NCT05122351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25297853|NCT05122351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297854|NCT05122351|Sensory System Agents|sensory system agents|mesh-ancestor
25297855|NCT05122351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25297856|NCT05122351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25297857|NCT05122351|Analgesics|analgesics|mesh-ancestor
25297858|NCT05122351|Antipyretics|antipyretics|mesh-ancestor
25297859|NCT05122338|Lidocaine|lidocaine|mesh-list
25297860|NCT05122338|Ropivacaine|ropivacaine|mesh-list
25297861|NCT05122338|Esketamine|esketamine|mesh-list
25297862|NCT05122338|Anesthetics, Local|anesthetics, local|mesh-ancestor
25297863|NCT05122338|Anesthetics|anesthetics|mesh-ancestor
25297864|NCT05122338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25297865|NCT05122338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297866|NCT05122338|Sensory System Agents|sensory system agents|mesh-ancestor
25297867|NCT05122338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25297868|NCT05122338|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25297869|NCT05122338|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25297870|NCT05122338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25297871|NCT05122338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25297872|NCT05122338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297873|NCT05122338|Antidepressive Agents|antidepressive agents|mesh-ancestor
25297874|NCT05122338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25297875|NCT05122117|Methylene Blue|methylene blue|mesh-list
25297876|NCT05122117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25297877|NCT05122117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297878|NCT05121883|Edaravone|edaravone|mesh-list
25297879|NCT05121883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25297880|NCT05121883|Antioxidants|antioxidants|mesh-ancestor
25297881|NCT05121883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297882|NCT05121883|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25297883|NCT05121883|Protective Agents|protective agents|mesh-ancestor
25297884|NCT05121883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297885|NCT05121779|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25297886|NCT05121779|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25297887|NCT05121779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297888|NCT05121324|Midazolam|midazolam|mesh-list
25297889|NCT05121324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25297890|NCT05121324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25297891|NCT05121324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25297892|NCT05121324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297893|NCT05121324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25297894|NCT05121324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25297895|NCT05121324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25297896|NCT05121324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25297897|NCT05121324|Anesthetics, General|anesthetics, general|mesh-ancestor
25297898|NCT05121324|Anesthetics|anesthetics|mesh-ancestor
25297899|NCT05121324|GABA Modulators|gaba modulators|mesh-ancestor
25297900|NCT05121324|GABA Agents|gaba agents|mesh-ancestor
25297901|NCT05121324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25297902|NCT05121324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647659|NCT01471093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25647660|NCT01471093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25647661|NCT01471093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25647662|NCT01471093|Antioxidants|antioxidants|mesh-ancestor
25647663|NCT01471093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647664|NCT01471093|Protective Agents|protective agents|mesh-ancestor
25647665|NCT01471093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647666|NCT01471093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25647667|NCT01471171|Bromides|bromides|mesh-list
25297903|NCT05121233|Diclofenac|diclofenac|mesh-list
25647668|NCT01471171|Anticonvulsants|anticonvulsants|mesh-ancestor
24755655|NCT01728051|Melphalan|melphalan|mesh-list
25297904|NCT05121233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25297905|NCT05121233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25297906|NCT05121233|Analgesics|analgesics|mesh-ancestor
25297907|NCT05121233|Sensory System Agents|sensory system agents|mesh-ancestor
25297908|NCT05121233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25647669|NCT01471197|Pemetrexed|pemetrexed|mesh-list
25647670|NCT01471197|Ipilimumab|ipilimumab|mesh-list
25647671|NCT01471197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647672|NCT01471197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25647673|NCT01471197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647674|NCT01471197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25647675|NCT01471197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25297909|NCT05121233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297910|NCT05121233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25297911|NCT05121233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25297912|NCT05121233|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25297913|NCT05121233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25297914|NCT05121233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297915|NCT05120934|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25297916|NCT05120934|Amitriptyline|amitriptyline|mesh-list
25297917|NCT05120934|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25297918|NCT05120934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25297919|NCT05120934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25297920|NCT05120934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25297921|NCT05120934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25297922|NCT05120934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297923|NCT05120934|Analgesics|analgesics|mesh-ancestor
25297924|NCT05120934|Sensory System Agents|sensory system agents|mesh-ancestor
25297925|NCT05120934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25297926|NCT05120934|Antidepressive Agents|antidepressive agents|mesh-ancestor
25297927|NCT05120934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25297928|NCT05120934|Dopamine Agents|dopamine agents|mesh-ancestor
25297929|NCT05120934|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25297930|NCT05120934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25297931|NCT05120934|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25297932|NCT05120934|Adrenergic Agents|adrenergic agents|mesh-ancestor
25297933|NCT05114720|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25297934|NCT05114720|Moxifloxacin|moxifloxacin|mesh-list
25297935|NCT05114720|Cyclophosphamide|cyclophosphamide|mesh-list
25297936|NCT05114720|Docetaxel|docetaxel|mesh-list
25297937|NCT05114720|Doxorubicin|doxorubicin|mesh-list
25297938|NCT05114720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25298013|NCT05229991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25297950|NCT05114720|Antimitotic Agents|antimitotic agents|mesh-ancestor
25297951|NCT05114720|Mitosis Modulators|mitosis modulators|mesh-ancestor
25297952|NCT05114720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25297953|NCT05114720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25297954|NCT05114720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25297955|NCT05114720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25297956|NCT05114720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25297957|NCT05114720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25297958|NCT05114720|Contraceptive Agents|contraceptive agents|mesh-ancestor
25297959|NCT05114720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25297960|NCT05114720|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25297961|NCT05114720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25297962|NCT05114720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25297963|NCT05113394|Immunologic Factors|immunologic factors|mesh-list
25297964|NCT05113394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297965|NCT05112211|Doxycycline|doxycycline|mesh-list
25297966|NCT05112211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25297967|NCT05112211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25297968|NCT05112211|Antimalarials|antimalarials|mesh-ancestor
25297969|NCT05112211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25297970|NCT05112211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25297972|NCT05111717|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25297973|NCT05111717|Anesthetics, General|anesthetics, general|mesh-ancestor
25297974|NCT05111717|Anesthetics|anesthetics|mesh-ancestor
25297975|NCT05111717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25297976|NCT05111717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297977|NCT05110040|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25297978|NCT05110040|Immunologic Factors|immunologic factors|mesh-ancestor
25297979|NCT05110040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297992|NCT05073484|Antibodies|antibodies|mesh-list
25297993|NCT05073484|Immunoglobulins|immunoglobulins|mesh-list
25297994|NCT05073484|Immunologic Factors|immunologic factors|mesh-ancestor
25297995|NCT05073484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297996|NCT05230303|Caffeine|caffeine|mesh-list
25297997|NCT05230303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25297998|NCT05230303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25297999|NCT05230303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25298000|NCT05230303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298001|NCT05230303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298002|NCT05230303|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25298003|NCT05230303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25298004|NCT05230303|Purinergic Agents|purinergic agents|mesh-ancestor
25298005|NCT05230303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25298006|NCT05229991|Ritonavir|ritonavir|mesh-list
25298007|NCT05229991|Lonafarnib|lonafarnib|mesh-list
25298008|NCT05229991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25298009|NCT05229991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25298010|NCT05229991|Protease Inhibitors|protease inhibitors|mesh-ancestor
25298011|NCT05229991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298012|NCT05229991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298026|NCT05229796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298027|NCT05229627|Methylphenidate|methylphenidate|mesh-list
25298028|NCT05229627|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25298029|NCT05229627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25298030|NCT05229627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298031|NCT05229627|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25298032|NCT05229627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25298033|NCT05229627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25298034|NCT05229627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298035|NCT05229627|Dopamine Agents|dopamine agents|mesh-ancestor
25298036|NCT05229627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25298037|NCT05229627|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25298038|NCT05229627|Adrenergic Agents|adrenergic agents|mesh-ancestor
25298039|NCT05229536|Vaccines|vaccines|mesh-list
25298040|NCT05229536|Immunologic Factors|immunologic factors|mesh-ancestor
25298041|NCT05229536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298042|NCT05229510|Ribavirin|ribavirin|mesh-list
25298043|NCT05229510|Antimetabolites|antimetabolites|mesh-ancestor
25298044|NCT05229510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298045|NCT05229510|Antiviral Agents|antiviral agents|mesh-ancestor
25298046|NCT05229510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25298047|NCT05229497|Carboplatin|carboplatin|mesh-list
25298048|NCT05229497|Fluorouracil|fluorouracil|mesh-list
25298049|NCT05229497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25298050|NCT05229497|Antimetabolites|antimetabolites|mesh-ancestor
25205327|NCT04931368|Dermatologic Agents|dermatologic agents|mesh-ancestor
25298051|NCT05229497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298052|NCT05229497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25298053|NCT05229497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25298054|NCT05229497|Immunologic Factors|immunologic factors|mesh-ancestor
25298055|NCT05229497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298056|NCT05229276|Bone wax|bone wax|mesh-list
25298057|NCT05229276|Hemostatics|hemostatics|mesh-ancestor
25298058|NCT05229276|Coagulants|coagulants|mesh-ancestor
25298059|NCT05229042|Ricolinostat|ricolinostat|mesh-list
25298060|NCT05229042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25298061|NCT05229042|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25298062|NCT05229042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298063|NCT05229042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298076|NCT05228925|Vitamin D|vitamin d|mesh-list
25298077|NCT05228925|Vitamins|vitamins|mesh-ancestor
25298078|NCT05228925|Micronutrients|micronutrients|mesh-ancestor
25298079|NCT05228925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298080|NCT05228925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25298081|NCT05228743|Paclitaxel|paclitaxel|mesh-list
25298082|NCT05228743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25298083|NCT05228743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25298084|NCT05228743|Tubulin Modulators|tubulin modulators|mesh-ancestor
25298085|NCT05228743|Antimitotic Agents|antimitotic agents|mesh-ancestor
25298086|NCT05228743|Mitosis Modulators|mitosis modulators|mesh-ancestor
25298087|NCT05228743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298088|NCT05228483|Mometasone Furoate|mometasone furoate|mesh-list
25298089|NCT05228483|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25298090|NCT05228483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25298091|NCT05228483|Dermatologic Agents|dermatologic agents|mesh-ancestor
25298092|NCT05228483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25298093|NCT05228483|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25298094|NCT05228431|Capecitabine|capecitabine|mesh-list
25298095|NCT05228431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25298096|NCT05228431|Antimetabolites|antimetabolites|mesh-ancestor
25298097|NCT05228431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298098|NCT05228431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25298099|NCT05228418|Naltrexone|naltrexone|mesh-list
25298100|NCT05228418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25298101|NCT05228418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25298102|NCT05228418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298103|NCT05228418|Sensory System Agents|sensory system agents|mesh-ancestor
25298104|NCT05228418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25298105|NCT05222256|Simendan|simendan|mesh-list
25298106|NCT05222256|Epinephrine|epinephrine|mesh-list
25298107|NCT05222256|Racepinephrine|racepinephrine|mesh-list
25298108|NCT05222256|Epinephryl borate|epinephryl borate|mesh-list
25298109|NCT05222256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25298110|NCT05222256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25298111|NCT05222256|Adrenergic Agents|adrenergic agents|mesh-ancestor
25298112|NCT05222256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25298113|NCT05222256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298114|NCT05222256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298115|NCT05222256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25298116|NCT05222256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25298117|NCT05222256|Autonomic Agents|autonomic agents|mesh-ancestor
25298118|NCT05222256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25298119|NCT05222256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25298120|NCT05222256|Respiratory System Agents|respiratory system agents|mesh-ancestor
25298121|NCT05222256|Mydriatics|mydriatics|mesh-ancestor
25298122|NCT05222256|Sympathomimetics|sympathomimetics|mesh-ancestor
25298123|NCT05222256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25298124|NCT05222256|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25298125|NCT05222256|Vasodilator Agents|vasodilator agents|mesh-ancestor
25298126|NCT05222256|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25298127|NCT05222256|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25298128|NCT05222256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298129|NCT05222256|Protective Agents|protective agents|mesh-ancestor
25298130|NCT05220410|Psilocybin|psilocybin|mesh-list
25298131|NCT05220410|Hallucinogens|hallucinogens|mesh-ancestor
25298132|NCT05220410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298133|NCT05220410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25298134|NCT05188053|Ketorolac|ketorolac|mesh-list
25298135|NCT05188053|Epinephrine|epinephrine|mesh-list
25298136|NCT05188053|Ropivacaine|ropivacaine|mesh-list
25298137|NCT05188053|Anesthetics, Local|anesthetics, local|mesh-ancestor
25298138|NCT05188053|Anesthetics|anesthetics|mesh-ancestor
25298139|NCT05188053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25205328|NCT04931368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298140|NCT05188053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298141|NCT05188053|Sensory System Agents|sensory system agents|mesh-ancestor
25298142|NCT05188053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25298143|NCT05188053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25298144|NCT05188053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25298145|NCT05188053|Adrenergic Agents|adrenergic agents|mesh-ancestor
25298146|NCT05188053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25298147|NCT05188053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298148|NCT05188053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25298149|NCT05188053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25298150|NCT05188053|Autonomic Agents|autonomic agents|mesh-ancestor
25298151|NCT05188053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25298152|NCT05188053|Respiratory System Agents|respiratory system agents|mesh-ancestor
25298153|NCT05188053|Mydriatics|mydriatics|mesh-ancestor
25298154|NCT05188053|Sympathomimetics|sympathomimetics|mesh-ancestor
25298155|NCT05188053|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25298156|NCT05188053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25298157|NCT05188053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25298158|NCT05188053|Analgesics|analgesics|mesh-ancestor
25298159|NCT05188053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25101942|NCT03171740|Analgesics|analgesics|mesh-ancestor
25298160|NCT05188053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25298161|NCT05188053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25298162|NCT05188053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298163|NCT05183412|Methamphetamine|methamphetamine|mesh-list
25298312|NCT04620941|Chrysarobin|chrysarobin|mesh-list
25298171|NCT05183412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298172|NCT05183412|Adrenergic Agents|adrenergic agents|mesh-ancestor
25298173|NCT05183412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25298174|NCT05183412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25298175|NCT05183412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25086214|NCT03290963|Anesthetics|anesthetics|mesh-ancestor
25086215|NCT03290963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25086216|NCT03290963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25086217|NCT03290963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24755923|NCT01730222|Gemcitabine|gemcitabine|mesh-list
25086218|NCT03290963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25298176|NCT05183412|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25298185|NCT05136326|Capecitabine|capecitabine|mesh-list
25298186|NCT05136326|Temozolomide|temozolomide|mesh-list
25298187|NCT05136326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25298188|NCT05136326|Antimetabolites|antimetabolites|mesh-ancestor
25298189|NCT05136326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298190|NCT05136326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25298191|NCT05136326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25298192|NCT05136326|Alkylating Agents|alkylating agents|mesh-ancestor
25298193|NCT05121974|Azithromycin|azithromycin|mesh-list
25298194|NCT05121974|Ceftriaxone|ceftriaxone|mesh-list
25298195|NCT05121974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25298196|NCT05121974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25298197|NCT05102149|Vildagliptin|vildagliptin|mesh-list
25298198|NCT05102149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25298199|NCT05102149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298200|NCT05102149|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25298201|NCT05102149|Protease Inhibitors|protease inhibitors|mesh-ancestor
25298202|NCT05102149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298203|NCT05102149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298204|NCT05060991|Antimetabolites|antimetabolites|mesh-list
25298205|NCT05060991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298212|NCT05036421|Empagliflozin|empagliflozin|mesh-list
25298213|NCT05036421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25298214|NCT05036421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298215|NCT05036421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25298216|NCT05036421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298217|NCT05035186|Amoxicillin|amoxicillin|mesh-list
25298218|NCT05035186|Clarithromycin|clarithromycin|mesh-list
25298219|NCT05035186|Levofloxacin|levofloxacin|mesh-list
25298220|NCT05035186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25298221|NCT05035186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25298222|NCT05035186|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25298223|NCT05035186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298224|NCT05035186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298225|NCT05035186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25298226|NCT05035186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25298227|NCT05035186|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25298228|NCT05035186|Renal Agents|renal agents|mesh-ancestor
25298229|NCT05035186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25298230|NCT05035186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25298231|NCT05035186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25298232|NCT05035186|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25298234|NCT04987099|Lipotropic Agents|lipotropic agents|mesh-ancestor
25825335|NCT00005585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25298235|NCT04987099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25298236|NCT04987099|Antimetabolites|antimetabolites|mesh-ancestor
25298282|NCT04772209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298292|NCT04680988|Gemcitabine|gemcitabine|mesh-list
25298293|NCT04680988|Paclitaxel|paclitaxel|mesh-list
25298294|NCT04680988|Pemetrexed|pemetrexed|mesh-list
25298295|NCT04680988|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25298296|NCT04680988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25298297|NCT04680988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25298298|NCT04680988|Tubulin Modulators|tubulin modulators|mesh-ancestor
25298299|NCT04680988|Antimitotic Agents|antimitotic agents|mesh-ancestor
25298300|NCT04680988|Mitosis Modulators|mitosis modulators|mesh-ancestor
25298301|NCT04680988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298302|NCT04680988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25298303|NCT04680988|Antimetabolites|antimetabolites|mesh-ancestor
25298304|NCT04680988|Antiviral Agents|antiviral agents|mesh-ancestor
25298305|NCT04680988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25647676|NCT01471197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25647677|NCT01471197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25647678|NCT01471353|Capecitabine|capecitabine|mesh-list
25647679|NCT01471353|Sorafenib|sorafenib|mesh-list
25647680|NCT01471353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25647681|NCT01471353|Antimetabolites|antimetabolites|mesh-ancestor
25825337|NCT00005586|Fluorouracil|fluorouracil|mesh-list
25177234|NCT05191862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25177235|NCT05191862|Autonomic Agents|autonomic agents|mesh-ancestor
25177236|NCT05191862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25177237|NCT05191862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177238|NCT05191862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25177239|NCT05191862|Respiratory System Agents|respiratory system agents|mesh-ancestor
25177240|NCT05191862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25177241|NCT05191862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25177242|NCT05191862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825338|NCT00005586|Levoleucovorin|levoleucovorin|mesh-list
25177243|NCT05191862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25177244|NCT05191862|Vasodilator Agents|vasodilator agents|mesh-ancestor
25298306|NCT04680988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298307|NCT04680988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25298308|NCT04680988|Immunologic Factors|immunologic factors|mesh-ancestor
25298309|NCT04680988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298310|NCT04680988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25298311|NCT04680988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25298313|NCT04620941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25298314|NCT04620941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25298315|NCT04620941|Analgesics|analgesics|mesh-ancestor
25298316|NCT04620941|Sensory System Agents|sensory system agents|mesh-ancestor
25298317|NCT04620941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25298318|NCT04620941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298319|NCT04620941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25298320|NCT04620941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25298321|NCT04582591|Cannabidiol|cannabidiol|mesh-list
25298322|NCT04582591|Anticonvulsants|anticonvulsants|mesh-ancestor
25298323|NCT04538534|Nicardipine|nicardipine|mesh-list
25298324|NCT04538534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25298325|NCT04538534|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25298326|NCT04538534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25298327|NCT04538534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298328|NCT04538534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25298329|NCT04538534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298330|NCT04538534|Vasodilator Agents|vasodilator agents|mesh-ancestor
25298331|NCT04497883|Maribavir|maribavir|mesh-list
25298332|NCT04497883|Antiviral Agents|antiviral agents|mesh-ancestor
25298333|NCT04497883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25298334|NCT04441762|Ketorolac|ketorolac|mesh-list
25298335|NCT04441762|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25298336|NCT04441762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25298337|NCT04441762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25298338|NCT04441762|Analgesics|analgesics|mesh-ancestor
25298339|NCT04441762|Sensory System Agents|sensory system agents|mesh-ancestor
25298340|NCT04441762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25298341|NCT04441762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298342|NCT04441762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25298343|NCT04441762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25298344|NCT04441762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25298345|NCT04441762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298346|NCT04441762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298347|NCT04412694|Dexamethasone|dexamethasone|mesh-list
25298348|NCT04412694|Dexamethasone acetate|dexamethasone acetate|mesh-list
25298349|NCT04412694|BB 1101|bb 1101|mesh-list
25298350|NCT04412694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25298351|NCT04412694|Antiemetics|antiemetics|mesh-ancestor
25298352|NCT04412694|Autonomic Agents|autonomic agents|mesh-ancestor
25298353|NCT04412694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25647682|NCT01471353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647683|NCT01471353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647684|NCT01471353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25647685|NCT01471353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25647686|NCT01471379|Milnacipran|milnacipran|mesh-list
25647687|NCT01471379|Levomilnacipran|levomilnacipran|mesh-list
25647688|NCT01471379|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25647689|NCT01471379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25647690|NCT01471379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25647691|NCT01471379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647692|NCT01471379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25647693|NCT01471379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177305|NCT05176158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25177306|NCT05176158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25177307|NCT05176158|Analgesics|analgesics|mesh-ancestor
25177308|NCT05176158|Sensory System Agents|sensory system agents|mesh-ancestor
25177309|NCT05176158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25177331|NCT05158374|Aspirin|aspirin|mesh-list
25298354|NCT04412694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298355|NCT04412694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25298356|NCT04412694|Glucocorticoids|glucocorticoids|mesh-ancestor
25298357|NCT04412694|Hormones|hormones|mesh-ancestor
25298358|NCT04412694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25298359|NCT04412694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25298360|NCT04412694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25298361|NCT04412694|Protease Inhibitors|protease inhibitors|mesh-ancestor
25298362|NCT04412694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298363|NCT04412694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298364|NCT04351438|Heparin|heparin|mesh-list
25298365|NCT04351438|Citric Acid|citric acid|mesh-list
25298366|NCT04351438|Sodium Citrate|sodium citrate|mesh-list
25298367|NCT04351438|Anticoagulants|anticoagulants|mesh-ancestor
25298368|NCT04351438|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25298369|NCT04351438|Chelating Agents|chelating agents|mesh-ancestor
25298370|NCT04351438|Sequestering Agents|sequestering agents|mesh-ancestor
25298371|NCT04351438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298372|NCT04351438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25298373|NCT04351438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25298374|NCT04278651|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25298375|NCT04278651|Hematinics|hematinics|mesh-ancestor
25298376|NCT04278651|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25298377|NCT04278651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25298378|NCT04270643|Vitamin D|vitamin d|mesh-list
25298379|NCT04270643|Cholecalciferol|cholecalciferol|mesh-list
25298380|NCT04270643|Vitamins|vitamins|mesh-ancestor
25298381|NCT04270643|Micronutrients|micronutrients|mesh-ancestor
25298382|NCT04270643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298383|NCT04270643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25298384|NCT04270643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25298385|NCT04203498|Nabiximols|nabiximols|mesh-list
25298386|NCT04203498|Analgesics|analgesics|mesh-ancestor
25298387|NCT04203498|Sensory System Agents|sensory system agents|mesh-ancestor
25298388|NCT04203498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202045|NCT02723981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298389|NCT04203498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298390|NCT04200248|Aflibercept|aflibercept|mesh-list
25298391|NCT04200248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25298392|NCT04200248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25298393|NCT04200248|Growth Substances|growth substances|mesh-ancestor
25298394|NCT04200248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298395|NCT04200248|Growth Inhibitors|growth inhibitors|mesh-ancestor
25298396|NCT04200248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25298397|NCT04169191|Sildenafil Citrate|sildenafil citrate|mesh-list
25298398|NCT04169191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298399|NCT04169191|Vasodilator Agents|vasodilator agents|mesh-ancestor
25298400|NCT04169191|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25298401|NCT04169191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25298402|NCT04169191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298403|NCT04169191|Urological Agents|urological agents|mesh-ancestor
25298404|NCT04138615|Morphine|morphine|mesh-list
25298405|NCT04138615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25298406|NCT04138615|Narcotics|narcotics|mesh-ancestor
25298407|NCT04138615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25298408|NCT04138615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298409|NCT04138615|Analgesics|analgesics|mesh-ancestor
25298410|NCT04138615|Sensory System Agents|sensory system agents|mesh-ancestor
25298411|NCT04138615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25298412|NCT04119830|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
25298413|NCT04119830|Pembrolizumab|pembrolizumab|mesh-list
25298414|NCT04119830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25298415|NCT04119830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25298416|NCT04119830|Antiviral Agents|antiviral agents|mesh-ancestor
25647694|NCT01471379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25647695|NCT01471379|Analgesics|analgesics|mesh-ancestor
25647696|NCT01471379|Sensory System Agents|sensory system agents|mesh-ancestor
25647697|NCT01471379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25647698|NCT01471379|Antidepressive Agents|antidepressive agents|mesh-ancestor
25298417|NCT04119830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25647699|NCT01471379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25298418|NCT04084314|Erenumab|erenumab|mesh-list
25298419|NCT04084314|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25298420|NCT04084314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298421|NCT04084314|Analgesics|analgesics|mesh-ancestor
25298422|NCT04084314|Sensory System Agents|sensory system agents|mesh-ancestor
25298423|NCT04084314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25298424|NCT04084314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298425|NCT04082728|Dipyrone|dipyrone|mesh-list
25298426|NCT04082728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25298427|NCT04082728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25298428|NCT04082728|Analgesics|analgesics|mesh-ancestor
25298429|NCT04082728|Sensory System Agents|sensory system agents|mesh-ancestor
25298430|NCT04082728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25298431|NCT04082728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298432|NCT04082728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25298433|NCT04082728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25298434|NCT04082728|Antipyretics|antipyretics|mesh-ancestor
25298435|NCT04049786|Metoprolol|metoprolol|mesh-list
25298436|NCT04049786|Carvedilol|carvedilol|mesh-list
25298437|NCT04049786|Midazolam|midazolam|mesh-list
25298438|NCT04049786|Simvastatin|simvastatin|mesh-list
25298439|NCT04049786|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25298440|NCT04049786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25298441|NCT04049786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25298442|NCT04049786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298443|NCT04049786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25298444|NCT04049786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25298445|NCT04049786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25298446|NCT04049786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25298447|NCT04049786|Anesthetics, General|anesthetics, general|mesh-ancestor
25298448|NCT04049786|Anesthetics|anesthetics|mesh-ancestor
25298449|NCT04049786|GABA Modulators|gaba modulators|mesh-ancestor
25298450|NCT04049786|GABA Agents|gaba agents|mesh-ancestor
25298451|NCT04049786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25298452|NCT04049786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298453|NCT04049786|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25298454|NCT04049786|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25298455|NCT04049786|Antimetabolites|antimetabolites|mesh-ancestor
24570748|NCT00806611|Ethanol|ethanol|mesh-list
25298456|NCT04049786|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25298457|NCT04049786|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25298458|NCT04049786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298459|NCT04049786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25298460|NCT04049786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25298461|NCT04049786|Sympatholytics|sympatholytics|mesh-ancestor
25298462|NCT04049786|Autonomic Agents|autonomic agents|mesh-ancestor
25298463|NCT04049786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25298482|NCT04023253|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25298483|NCT04023253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25298484|NCT04023253|Cholinergic Agents|cholinergic agents|mesh-ancestor
25298485|NCT04023253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25298486|NCT04023253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298487|NCT04023253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298488|NCT04023253|Urological Agents|urological agents|mesh-ancestor
25298489|NCT04023253|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25298490|NCT04023253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25298491|NCT04023253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25298492|NCT04023253|Adrenergic Agents|adrenergic agents|mesh-ancestor
25298510|NCT03952143|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25298511|NCT03952143|Insulin Glargine|insulin glargine|mesh-list
25298512|NCT03952143|Insulin Lispro|insulin lispro|mesh-list
25298513|NCT03952143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25298514|NCT03952143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298523|NCT03829514|Fenofibrate|fenofibrate|mesh-list
25298524|NCT03829514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25298525|NCT03829514|Antimetabolites|antimetabolites|mesh-ancestor
25298526|NCT03829514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298527|NCT03829514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25298531|NCT03801200|Apatinib|apatinib|mesh-list
25298532|NCT03801200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25298533|NCT03801200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25298534|NCT03801200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298535|NCT03801200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298536|NCT03801122|Tranexamic Acid|tranexamic acid|mesh-list
25298537|NCT03801122|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25298538|NCT03801122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25298759|NCT03317613|Capsaicin|capsaicin|mesh-list
25204754|NCT02706535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25204755|NCT02706535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204756|NCT02706535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25298548|NCT03788291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25298550|NCT03771157|Immunologic Factors|immunologic factors|mesh-ancestor
25298551|NCT03771157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298552|NCT03752918|Niacin|niacin|mesh-list
25298553|NCT03752918|Nicotinic Acids|nicotinic acids|mesh-list
25298554|NCT03752918|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25298555|NCT03752918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25298556|NCT03752918|Antimetabolites|antimetabolites|mesh-ancestor
25298557|NCT03752918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298558|NCT03752918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25298559|NCT03752918|Vasodilator Agents|vasodilator agents|mesh-ancestor
25298560|NCT03752918|Vitamin B Complex|vitamin b complex|mesh-ancestor
25298561|NCT03752918|Vitamins|vitamins|mesh-ancestor
25298562|NCT03752918|Micronutrients|micronutrients|mesh-ancestor
25298563|NCT03752918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298564|NCT03752918|Hallucinogens|hallucinogens|mesh-ancestor
25298565|NCT03752918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25298566|NCT03752918|Serotonin Agents|serotonin agents|mesh-ancestor
25298567|NCT03752918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25298568|NCT03752918|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25298569|NCT03752918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25298570|NCT03752918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25298571|NCT03752918|Adrenergic Agents|adrenergic agents|mesh-ancestor
25298582|NCT03713801|Metformin|metformin|mesh-list
25298583|NCT03713801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25298584|NCT03713801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298585|NCT03704688|Trametinib|trametinib|mesh-list
25298586|NCT03704688|Ponatinib|ponatinib|mesh-list
25298587|NCT03704688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25298588|NCT03704688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25298589|NCT03704688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298590|NCT03704688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298591|NCT03684213|Ascorbic Acid|ascorbic acid|mesh-list
25298592|NCT03684213|Norepinephrine|norepinephrine|mesh-list
25298593|NCT03684213|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
25298594|NCT03684213|Antioxidants|antioxidants|mesh-ancestor
25298595|NCT03684213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298596|NCT03684213|Protective Agents|protective agents|mesh-ancestor
25298597|NCT03684213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298598|NCT03684213|Vitamins|vitamins|mesh-ancestor
25298599|NCT03684213|Micronutrients|micronutrients|mesh-ancestor
25298600|NCT03684213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25298601|NCT03684213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25298602|NCT03684213|Adrenergic Agents|adrenergic agents|mesh-ancestor
25298603|NCT03684213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25298604|NCT03684213|Sympathomimetics|sympathomimetics|mesh-ancestor
25298605|NCT03684213|Autonomic Agents|autonomic agents|mesh-ancestor
25298606|NCT03684213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25298607|NCT03684213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25298608|NCT03684213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298609|NCT03679780|Nitroprusside|nitroprusside|mesh-list
25298611|NCT03679780|Nitroarginine|nitroarginine|mesh-list
25298612|NCT03679780|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
25298613|NCT03679780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25298614|NCT03679780|Vasodilator Agents|vasodilator agents|mesh-ancestor
25298615|NCT03679780|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25298760|NCT03317613|Antipruritics|antipruritics|mesh-ancestor
25298622|NCT03672773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25298624|NCT03672773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298625|NCT03672773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25298626|NCT03672773|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25298627|NCT03672773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298628|NCT03667690|Fluconazole|fluconazole|mesh-list
25298629|NCT03667690|Caspofungin|caspofungin|mesh-list
25298630|NCT03667690|Rezafungin|rezafungin|mesh-list
25298631|NCT03667690|Antifungal Agents|antifungal agents|mesh-ancestor
25298632|NCT03667690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25298633|NCT03667690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25647700|NCT01471574|Interferons|interferons|mesh-list
25647701|NCT01471574|Ribavirin|ribavirin|mesh-list
25647702|NCT01471574|Interferon-alpha|interferon-alpha|mesh-list
25647703|NCT01471574|Interferon alpha-2|interferon alpha-2|mesh-list
25647704|NCT01471574|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25177445|NCT05101629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177446|NCT05090085|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
25177447|NCT05090085|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25177448|NCT05090085|Protective Agents|protective agents|mesh-ancestor
25177449|NCT05090085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177450|NCT05090085|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25177451|NCT05090085|Antioxidants|antioxidants|mesh-ancestor
25177452|NCT05090085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177454|NCT05083052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25298634|NCT03667690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25298635|NCT03667690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298636|NCT03667690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298637|NCT03667690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25298638|NCT03667690|Hormone Antagonists|hormone antagonists|mesh-ancestor
25298639|NCT03667690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25298640|NCT03667690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298641|NCT03667690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25298642|NCT03667690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25298643|NCT03625349|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
25298644|NCT03625349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298645|NCT03625349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298646|NCT03624101|Ivacaftor|ivacaftor|mesh-list
25298647|NCT03624101|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25298648|NCT03624101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25298649|NCT03624101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298658|NCT03598270|Gemcitabine|gemcitabine|mesh-list
25298659|NCT03598270|Paclitaxel|paclitaxel|mesh-list
25298660|NCT03598270|Carboplatin|carboplatin|mesh-list
25298661|NCT03598270|Doxorubicin|doxorubicin|mesh-list
25298662|NCT03598270|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25298663|NCT03598270|Atezolizumab|atezolizumab|mesh-list
25298664|NCT03598270|Niraparib|niraparib|mesh-list
25298665|NCT03598270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25298666|NCT03598270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25298667|NCT03598270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25298668|NCT03598270|Tubulin Modulators|tubulin modulators|mesh-ancestor
25298669|NCT03598270|Antimitotic Agents|antimitotic agents|mesh-ancestor
25298670|NCT03598270|Mitosis Modulators|mitosis modulators|mesh-ancestor
25298671|NCT03598270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298672|NCT03598270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25298673|NCT03598270|Antimetabolites|antimetabolites|mesh-ancestor
25298674|NCT03598270|Antiviral Agents|antiviral agents|mesh-ancestor
25298675|NCT03598270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25298676|NCT03598270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298677|NCT03598270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25298678|NCT03598270|Immunologic Factors|immunologic factors|mesh-ancestor
25298679|NCT03598270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298680|NCT03598270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25298681|NCT03598270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25298682|NCT03598270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25298683|NCT03598270|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25298684|NCT03580525|Nicotine|nicotine|mesh-list
25298685|NCT03580525|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25298686|NCT03580525|Autonomic Agents|autonomic agents|mesh-ancestor
25298687|NCT03580525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25298761|NCT03317613|Dermatologic Agents|dermatologic agents|mesh-ancestor
25298688|NCT03580525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298689|NCT03580525|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25298690|NCT03580525|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25298691|NCT03580525|Cholinergic Agents|cholinergic agents|mesh-ancestor
25059639|NCT03486548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25059640|NCT03486548|Antiemetics|antiemetics|mesh-ancestor
25647705|NCT01471574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647706|NCT01471574|Antiviral Agents|antiviral agents|mesh-ancestor
25647707|NCT01471574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25647708|NCT01471574|Antimetabolites|antimetabolites|mesh-ancestor
25647709|NCT01471574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647710|NCT01471574|Immunologic Factors|immunologic factors|mesh-ancestor
25647711|NCT01471574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647712|NCT01471639|Ketorolac|ketorolac|mesh-list
25647713|NCT01471639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25647714|NCT01471639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25059641|NCT03486548|Autonomic Agents|autonomic agents|mesh-ancestor
25298692|NCT03580525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25298693|NCT03580525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298694|NCT03560297|Nitrazepam|nitrazepam|mesh-list
25298695|NCT03560297|Anticonvulsants|anticonvulsants|mesh-ancestor
25298696|NCT03560297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25298697|NCT03560297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25298698|NCT03560297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298699|NCT03560297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25298700|NCT03560297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25298701|NCT03560297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25298702|NCT03560297|GABA Modulators|gaba modulators|mesh-ancestor
25298703|NCT03560297|GABA Agents|gaba agents|mesh-ancestor
25298704|NCT03560297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25298705|NCT03560297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298706|NCT03554707|Bevacizumab|bevacizumab|mesh-list
25298707|NCT03554707|Irinotecan|irinotecan|mesh-list
25298708|NCT03554707|Temozolomide|temozolomide|mesh-list
25298709|NCT03554707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25298710|NCT03554707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25298711|NCT03554707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25298712|NCT03554707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25298713|NCT03554707|Growth Substances|growth substances|mesh-ancestor
25298714|NCT03554707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298715|NCT03554707|Growth Inhibitors|growth inhibitors|mesh-ancestor
25298716|NCT03554707|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25298717|NCT03554707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25298718|NCT03554707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298719|NCT03554707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298720|NCT03554707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25298721|NCT03554707|Alkylating Agents|alkylating agents|mesh-ancestor
25298722|NCT03505723|Tranexamic Acid|tranexamic acid|mesh-list
25298723|NCT03505723|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25298724|NCT03505723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25298725|NCT03505723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298726|NCT03505723|Hemostatics|hemostatics|mesh-ancestor
25298727|NCT03505723|Coagulants|coagulants|mesh-ancestor
24916610|NCT04238767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25298728|NCT03472092|Amitriptyline|amitriptyline|mesh-list
25298729|NCT03472092|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25298730|NCT03472092|Antidepressive Agents|antidepressive agents|mesh-ancestor
25298731|NCT03472092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25298732|NCT03472092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25298733|NCT03472092|Analgesics|analgesics|mesh-ancestor
25298734|NCT03472092|Sensory System Agents|sensory system agents|mesh-ancestor
25298735|NCT03472092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25298736|NCT03472092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298737|NCT03472092|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25298738|NCT03472092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25298739|NCT03472092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25298740|NCT03472092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298741|NCT03472092|Adrenergic Agents|adrenergic agents|mesh-ancestor
25298742|NCT03472092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24732243|NCT01638624|Propofol|propofol|mesh-list
25298743|NCT03410875|Obinutuzumab|obinutuzumab|mesh-list
25298744|NCT03410875|Vemurafenib|vemurafenib|mesh-list
25298745|NCT03410875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25298746|NCT03410875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25298747|NCT03410875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25298748|NCT03410875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298749|NCT03410875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298750|NCT03343301|Bemarituzumab|bemarituzumab|mesh-list
25298751|NCT03343301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25298752|NCT03343301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25298753|NCT03321019|Capsaicin|capsaicin|mesh-list
25298754|NCT03321019|Antipruritics|antipruritics|mesh-ancestor
25298755|NCT03321019|Dermatologic Agents|dermatologic agents|mesh-ancestor
25298756|NCT03321019|Sensory System Agents|sensory system agents|mesh-ancestor
25298757|NCT03321019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25298758|NCT03321019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298785|NCT03251729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25298786|NCT03251729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298788|NCT03206073|Tremelimumab|tremelimumab|mesh-list
25298789|NCT03206073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25298790|NCT03206073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25298791|NCT03186404|Atorvastatin|atorvastatin|mesh-list
25298792|NCT03186404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25298793|NCT03186404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25298794|NCT03186404|Antimetabolites|antimetabolites|mesh-ancestor
25298795|NCT03186404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298796|NCT03186404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25298797|NCT03186404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25298798|NCT03186404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298799|NCT03098836|Prednisone|prednisone|mesh-list
25298800|NCT03098836|Abiraterone Acetate|abiraterone acetate|mesh-list
25298801|NCT03098836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25298802|NCT03098836|Glucocorticoids|glucocorticoids|mesh-ancestor
25298803|NCT03098836|Hormones|hormones|mesh-ancestor
25298804|NCT03098836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25298805|NCT03098836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298806|NCT03098836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25298807|NCT03098836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25298808|NCT03098836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25298809|NCT03098836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298810|NCT03098836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298811|NCT03098836|Hormone Antagonists|hormone antagonists|mesh-ancestor
25298812|NCT03098836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25298813|NCT03076164|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25298814|NCT03076164|Trametinib|trametinib|mesh-list
25298815|NCT03076164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25298816|NCT03076164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25298817|NCT03076164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298818|NCT03076164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298819|NCT03073070|Biotin|biotin|mesh-list
25298820|NCT03073070|Vitamin B Complex|vitamin b complex|mesh-ancestor
25298821|NCT03073070|Vitamins|vitamins|mesh-ancestor
25298822|NCT03073070|Micronutrients|micronutrients|mesh-ancestor
25298823|NCT03073070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298824|NCT03063944|Azacitidine|azacitidine|mesh-list
25298825|NCT03063944|Decitabine|decitabine|mesh-list
25298826|NCT03063944|Venetoclax|venetoclax|mesh-list
25298827|NCT03063944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25298828|NCT03063944|Antimetabolites|antimetabolites|mesh-ancestor
25298829|NCT03063944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298830|NCT03063944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25298831|NCT03063944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298832|NCT03060577|Evolocumab|evolocumab|mesh-list
25298833|NCT03060577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25298834|NCT03060577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25298835|NCT03060577|Antimetabolites|antimetabolites|mesh-ancestor
25298836|NCT03060577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298837|NCT03060577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25298838|NCT03025087|Hydroxychloroquine|hydroxychloroquine|mesh-list
25298839|NCT03025087|Antimalarials|antimalarials|mesh-ancestor
25298840|NCT03025087|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25298841|NCT03025087|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25298842|NCT03025087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25298843|NCT03025087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298844|NCT03025087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298845|NCT03025087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25298846|NCT02939742|Betamethasone|betamethasone|mesh-list
25298847|NCT02939742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25298848|NCT02939742|Glucocorticoids|glucocorticoids|mesh-ancestor
25298849|NCT02939742|Hormones|hormones|mesh-ancestor
25298850|NCT02939742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25298851|NCT02939742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298852|NCT02939742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25298853|NCT02939742|Respiratory System Agents|respiratory system agents|mesh-ancestor
25298854|NCT02905214|Sirolimus|sirolimus|mesh-list
25298855|NCT02905214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25298856|NCT02905214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25298857|NCT02905214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25298858|NCT02905214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25298859|NCT02905214|Antifungal Agents|antifungal agents|mesh-ancestor
25298860|NCT02905214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25298861|NCT02905214|Immunologic Factors|immunologic factors|mesh-ancestor
25298862|NCT02905214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298863|NCT02812433|Sildenafil Citrate|sildenafil citrate|mesh-list
25298864|NCT02812433|Vasodilator Agents|vasodilator agents|mesh-ancestor
25298865|NCT02812433|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25647715|NCT01471639|Analgesics|analgesics|mesh-ancestor
25298866|NCT02812433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25298867|NCT02812433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298868|NCT02812433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298869|NCT02812433|Urological Agents|urological agents|mesh-ancestor
25298870|NCT02737046|Interferons|interferons|mesh-list
25298871|NCT02737046|Interferon-alpha|interferon-alpha|mesh-list
25298872|NCT02737046|Interferon alpha-2|interferon alpha-2|mesh-list
25298874|NCT02737046|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25298875|NCT02737046|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
25298877|NCT02737046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25298878|NCT02737046|Antiviral Agents|antiviral agents|mesh-ancestor
25298879|NCT02737046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25298880|NCT02737046|Immunologic Factors|immunologic factors|mesh-ancestor
25298881|NCT02737046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298882|NCT02737046|Antimetabolites|antimetabolites|mesh-ancestor
25298883|NCT02737046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298884|NCT02737046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25298885|NCT02737046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25298886|NCT02737046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298887|NCT02737046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25298888|NCT02737046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25298889|NCT02737046|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25298890|NCT02723864|Veliparib|veliparib|mesh-list
25298891|NCT02723864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25298892|NCT02723864|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25298893|NCT02723864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298894|NCT02723864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298895|NCT02673996|Phenylephrine|phenylephrine|mesh-list
25298896|NCT02673996|Isoproterenol|isoproterenol|mesh-list
25298897|NCT02673996|Oxymetazoline|oxymetazoline|mesh-list
25298898|NCT02673996|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25298899|NCT02673996|Mydriatics|mydriatics|mesh-ancestor
25298900|NCT02673996|Autonomic Agents|autonomic agents|mesh-ancestor
25298901|NCT02673996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25298902|NCT02673996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298903|NCT02673996|Sympathomimetics|sympathomimetics|mesh-ancestor
25298904|NCT02673996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25298905|NCT02673996|Nasal Decongestants|nasal decongestants|mesh-ancestor
25298906|NCT02673996|Respiratory System Agents|respiratory system agents|mesh-ancestor
25298907|NCT02673996|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25298908|NCT02673996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25298909|NCT02673996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25298910|NCT02673996|Adrenergic Agents|adrenergic agents|mesh-ancestor
25298911|NCT02673996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25298912|NCT02673996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298930|NCT02597062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25298931|NCT02597062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25298932|NCT02597062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25298933|NCT02597062|Alkylating Agents|alkylating agents|mesh-ancestor
25298934|NCT02597062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298935|NCT02597062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25298936|NCT02597062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25298937|NCT02597062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25298938|NCT02597062|Antiemetics|antiemetics|mesh-ancestor
25298939|NCT02597062|Autonomic Agents|autonomic agents|mesh-ancestor
25298940|NCT02597062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25298941|NCT02597062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25298942|NCT02597062|Glucocorticoids|glucocorticoids|mesh-ancestor
25298943|NCT02597062|Hormones|hormones|mesh-ancestor
25298944|NCT02597062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25298945|NCT02597062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25298957|NCT02130882|Benralizumab|benralizumab|mesh-list
25298958|NCT02130882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25298959|NCT02130882|Respiratory System Agents|respiratory system agents|mesh-ancestor
25298971|NCT01976169|Palbociclib|palbociclib|mesh-list
25298972|NCT01976169|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25298973|NCT01976169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25298974|NCT01976169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25298975|NCT01976169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25298976|NCT01976169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25298977|NCT01976169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25298978|NCT01976169|Tubulin Modulators|tubulin modulators|mesh-ancestor
25298979|NCT01976169|Antimitotic Agents|antimitotic agents|mesh-ancestor
25298984|NCT01827111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25298985|NCT01827111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25298986|NCT01827111|Tubulin Modulators|tubulin modulators|mesh-ancestor
25298987|NCT01827111|Antimitotic Agents|antimitotic agents|mesh-ancestor
25298988|NCT01827111|Mitosis Modulators|mitosis modulators|mesh-ancestor
24509757|NCT00562068|Prednisolone|prednisolone|mesh-list
25299043|NCT01057121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25299044|NCT01004263|Rizatriptan|rizatriptan|mesh-list
25299045|NCT01004263|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25299046|NCT01004263|Serotonin Agents|serotonin agents|mesh-ancestor
25299047|NCT01004263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25299048|NCT01004263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299049|NCT01004263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299050|NCT01001234|Rizatriptan|rizatriptan|mesh-list
25299051|NCT01001234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25299052|NCT01001234|Serotonin Agents|serotonin agents|mesh-ancestor
25299053|NCT01001234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25299054|NCT01001234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299055|NCT01001234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299056|NCT00961792|Diphenhydramine|diphenhydramine|mesh-list
25299057|NCT00961792|Promethazine|promethazine|mesh-list
25299058|NCT00961792|Ethanol|ethanol|mesh-list
25299059|NCT00961792|Caffeine|caffeine|mesh-list
25299060|NCT00961792|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25299061|NCT00961792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299062|NCT00961792|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25299063|NCT00961792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25299064|NCT00961792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299065|NCT00961792|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25299066|NCT00961792|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25299067|NCT00961792|Purinergic Agents|purinergic agents|mesh-ancestor
25299068|NCT00961792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25299069|NCT00961792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25299070|NCT00961792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25299071|NCT00961792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25299072|NCT00961792|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25299073|NCT00961792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25299074|NCT00961792|Anesthetics, Local|anesthetics, local|mesh-ancestor
25299076|NCT00961792|Sensory System Agents|sensory system agents|mesh-ancestor
25299077|NCT00961792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25299078|NCT00961792|Antiemetics|antiemetics|mesh-ancestor
25299079|NCT00961792|Autonomic Agents|autonomic agents|mesh-ancestor
25299080|NCT00961792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25299081|NCT00961792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25299082|NCT00961792|Histamine Antagonists|histamine antagonists|mesh-ancestor
25299083|NCT00961792|Histamine Agents|histamine agents|mesh-ancestor
25299084|NCT00961792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25299085|NCT00961792|Antipruritics|antipruritics|mesh-ancestor
25299086|NCT00961792|Dermatologic Agents|dermatologic agents|mesh-ancestor
25299087|NCT00950846|Cyclophosphamide|cyclophosphamide|mesh-list
25299088|NCT00950846|Busulfan|busulfan|mesh-list
25299089|NCT00950846|Fludarabine|fludarabine|mesh-list
25299090|NCT00950846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25299091|NCT00950846|Immunologic Factors|immunologic factors|mesh-ancestor
25647716|NCT01471639|Sensory System Agents|sensory system agents|mesh-ancestor
25647717|NCT01471639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25647718|NCT01471639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647719|NCT01471639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25647720|NCT01471639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25647721|NCT01471639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25647722|NCT01471639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825339|NCT00005586|Antimetabolites|antimetabolites|mesh-ancestor
25299092|NCT00950846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299093|NCT00950846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25177713|NCT04907019|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25177714|NCT04907019|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25177715|NCT04907019|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25177716|NCT04907019|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25177725|NCT04883255|Dronabinol|dronabinol|mesh-list
25177726|NCT04883255|Cannabidiol|cannabidiol|mesh-list
25177727|NCT04883255|Anticonvulsants|anticonvulsants|mesh-ancestor
25299094|NCT00950846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25299095|NCT00950846|Alkylating Agents|alkylating agents|mesh-ancestor
25299096|NCT00950846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299097|NCT00950846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25299098|NCT00950846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25299099|NCT00924170|Cyclophosphamide|cyclophosphamide|mesh-list
25299100|NCT00924170|Fludarabine|fludarabine|mesh-list
25299101|NCT00924170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25299102|NCT00924170|Immunologic Factors|immunologic factors|mesh-ancestor
25299103|NCT00924170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299104|NCT00924170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25299105|NCT00924170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25299106|NCT00924170|Alkylating Agents|alkylating agents|mesh-ancestor
25299107|NCT00924170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299108|NCT00924170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25299109|NCT00924170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25299110|NCT00894556|Sumatriptan|sumatriptan|mesh-list
25299111|NCT00894556|Rizatriptan|rizatriptan|mesh-list
25299112|NCT00894556|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25299113|NCT00894556|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25299114|NCT00894556|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25299115|NCT00894556|Serotonin Agents|serotonin agents|mesh-ancestor
25299116|NCT00894556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25299117|NCT00894556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299118|NCT00894556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299119|NCT00840177|Cytarabine|cytarabine|mesh-list
25299120|NCT00840177|Idarubicin|idarubicin|mesh-list
25299121|NCT00840177|Pravastatin|pravastatin|mesh-list
25299122|NCT00840177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25299123|NCT00840177|Antimetabolites|antimetabolites|mesh-ancestor
25299124|NCT00840177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299125|NCT00840177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25299126|NCT00840177|Antiviral Agents|antiviral agents|mesh-ancestor
25299127|NCT00840177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25299128|NCT00840177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25299129|NCT00840177|Immunologic Factors|immunologic factors|mesh-ancestor
25299130|NCT00840177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299131|NCT00840177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25299132|NCT00840177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25299133|NCT00840177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25299134|NCT00840177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25299135|NCT00840177|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25299136|NCT00840177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25299137|NCT00840177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25299138|NCT00840177|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25299139|NCT00820950|Betamethasone|betamethasone|mesh-list
25299140|NCT00820950|Betamethasone Valerate|betamethasone valerate|mesh-list
25299141|NCT00820950|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25299142|NCT00820950|Betamethasone benzoate|betamethasone benzoate|mesh-list
25299143|NCT00820950|Calcipotriene|calcipotriene|mesh-list
25299144|NCT00820950|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25299145|NCT00820950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25299146|NCT00820950|Glucocorticoids|glucocorticoids|mesh-ancestor
25299147|NCT00820950|Hormones|hormones|mesh-ancestor
25299148|NCT00820950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25299149|NCT00820950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299150|NCT00820950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25299151|NCT00820950|Respiratory System Agents|respiratory system agents|mesh-ancestor
25299152|NCT00820950|Dermatologic Agents|dermatologic agents|mesh-ancestor
25299153|NCT00806416|Vitamin D|vitamin d|mesh-list
25647723|NCT01471639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647724|NCT01471691|Ranibizumab|ranibizumab|mesh-list
25647725|NCT01471691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25647726|NCT01471691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25647727|NCT01471691|Growth Substances|growth substances|mesh-ancestor
25647728|NCT01471691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647729|NCT01471691|Growth Inhibitors|growth inhibitors|mesh-ancestor
25299154|NCT00806416|Cholecalciferol|cholecalciferol|mesh-list
25299155|NCT00806416|Alendronate|alendronate|mesh-list
25299156|NCT00806416|Vitamins|vitamins|mesh-ancestor
25299157|NCT00806416|Micronutrients|micronutrients|mesh-ancestor
25299158|NCT00806416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299159|NCT00806416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25299160|NCT00806416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25299161|NCT00748904|Rifaximin|rifaximin|mesh-list
25299162|NCT00748904|Lactulose|lactulose|mesh-list
25299163|NCT00748904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25299164|NCT00748904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25299165|NCT00748904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25299166|NCT00729651|Cholecalciferol|cholecalciferol|mesh-list
25299167|NCT00729651|Vitamin D|vitamin d|mesh-list
25299168|NCT00729651|Alendronate|alendronate|mesh-list
25299169|NCT00729651|Calcium|calcium|mesh-list
25299170|NCT00729651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25299171|NCT00729651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299172|NCT00729651|Vitamins|vitamins|mesh-ancestor
25299173|NCT00729651|Micronutrients|micronutrients|mesh-ancestor
25299174|NCT00729651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25299175|NCT00698815|Pemetrexed|pemetrexed|mesh-list
25299176|NCT00698815|Sunitinib|sunitinib|mesh-list
25299177|NCT00698815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25299178|NCT00698815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25299179|NCT00698815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299180|NCT00698815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25299181|NCT00698815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25299182|NCT00698815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25299183|NCT00698815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25299184|NCT00698815|Growth Substances|growth substances|mesh-ancestor
25299185|NCT00698815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299186|NCT00698815|Growth Inhibitors|growth inhibitors|mesh-ancestor
25299187|NCT00698815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25299188|NCT00698022|Risperidone|risperidone|mesh-list
25299189|NCT00698022|Mifepristone|mifepristone|mesh-list
25299190|NCT00698022|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25299191|NCT00698022|Serotonin Agents|serotonin agents|mesh-ancestor
25299192|NCT00698022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25299193|NCT00698022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299194|NCT00698022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299195|NCT00698022|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25299196|NCT00698022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25299197|NCT00698022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25299198|NCT00698022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25299199|NCT00698022|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25299200|NCT00698022|Dopamine Agents|dopamine agents|mesh-ancestor
25299201|NCT00698022|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25299202|NCT00698022|Abortifacient Agents|abortifacient agents|mesh-ancestor
25299203|NCT00698022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25299204|NCT00698022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25299205|NCT00698022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25299206|NCT00698022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25299207|NCT00698022|Contraceptive Agents|contraceptive agents|mesh-ancestor
25299208|NCT00698022|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25299209|NCT00698022|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25299210|NCT00698022|Hormone Antagonists|hormone antagonists|mesh-ancestor
25299211|NCT00698022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25299212|NCT00698022|Luteolytic Agents|luteolytic agents|mesh-ancestor
25299213|NCT00698022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25299214|NCT00698022|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25299215|NCT00692913|Cholecalciferol|cholecalciferol|mesh-list
25299216|NCT00692913|Vitamin D|vitamin d|mesh-list
25299217|NCT00692913|Alendronate|alendronate|mesh-list
25299218|NCT00692913|Calcium|calcium|mesh-list
25299219|NCT00692913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25299220|NCT00692913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299221|NCT00692913|Vitamins|vitamins|mesh-ancestor
25299222|NCT00692913|Micronutrients|micronutrients|mesh-ancestor
25299223|NCT00692913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25299224|NCT00617708|Gemcitabine|gemcitabine|mesh-list
25299225|NCT00617708|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25299226|NCT00617708|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25299227|NCT00617708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25299228|NCT00617708|Antimetabolites|antimetabolites|mesh-ancestor
25299229|NCT00617708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207915|NCT01743651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25207916|NCT01743651|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25207917|NCT01743651|GABA Agonists|gaba agonists|mesh-ancestor
25207918|NCT01743651|GABA Agents|gaba agents|mesh-ancestor
25207919|NCT01743651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25207920|NCT01743651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207921|NCT01047683|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
25207922|NCT01047683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25207923|NCT01047683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25207924|NCT01047501|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
25207925|NCT01047501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25207926|NCT01047501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25207927|NCT00981656|Fluorouracil|fluorouracil|mesh-list
25207929|NCT00981656|Mitomycin|mitomycin|mesh-list
25207930|NCT00981656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207941|NCT00848731|Nitric Oxide|nitric oxide|mesh-list
25299230|NCT00617708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25299231|NCT00617708|Antiviral Agents|antiviral agents|mesh-ancestor
25299232|NCT00617708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25299233|NCT00617708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25299234|NCT00617708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25299235|NCT00617708|Immunologic Factors|immunologic factors|mesh-ancestor
25299236|NCT00617708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299237|NCT00617708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25299238|NCT00516737|Rizatriptan|rizatriptan|mesh-list
25299239|NCT00516737|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25299240|NCT00516737|Serotonin Agents|serotonin agents|mesh-ancestor
25299241|NCT00516737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25299242|NCT00516737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299243|NCT00516737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299244|NCT00358527|Mometasone Furoate|mometasone furoate|mesh-list
25299245|NCT00358527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25299246|NCT00358527|Dermatologic Agents|dermatologic agents|mesh-ancestor
25299247|NCT00358527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25299248|NCT00326898|Sorafenib|sorafenib|mesh-list
25299249|NCT00326898|Sunitinib|sunitinib|mesh-list
25299250|NCT00326898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25299251|NCT00326898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25299252|NCT00326898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25299253|NCT00326898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299254|NCT00326898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25299407|NCT04972396|Levonorgestrel|levonorgestrel|mesh-list
25299255|NCT00326898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25299256|NCT00326898|Growth Substances|growth substances|mesh-ancestor
25299257|NCT00326898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299258|NCT00326898|Growth Inhibitors|growth inhibitors|mesh-ancestor
25299259|NCT00156065|Haloperidol|haloperidol|mesh-list
25299260|NCT00156065|Haloperidol decanoate|haloperidol decanoate|mesh-list
25299261|NCT00156065|Asenapine|asenapine|mesh-list
25299262|NCT00156065|Antiemetics|antiemetics|mesh-ancestor
25299263|NCT00156065|Autonomic Agents|autonomic agents|mesh-ancestor
25299264|NCT00156065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25299265|NCT00156065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299266|NCT00156065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25299267|NCT00156065|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25299268|NCT00156065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25647730|NCT01471691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647731|NCT01471782|Blinatumomab|blinatumomab|mesh-list
25647732|NCT01471782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647733|NCT01472185|Ranolazine|ranolazine|mesh-list
25647734|NCT01472185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25647735|NCT01472185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25647736|NCT01472185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647737|NCT01472380|Efavirenz|efavirenz|mesh-list
25647738|NCT01472380|Fenofibric acid|fenofibric acid|mesh-list
25647739|NCT01472380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25647740|NCT01472380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25647741|NCT01472380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25647742|NCT01472380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647743|NCT01472380|Antiviral Agents|antiviral agents|mesh-ancestor
25647744|NCT01472380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25647745|NCT01472380|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25299269|NCT00156065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25299270|NCT00156065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25177825|NCT04831047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177826|NCT04831047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177827|NCT04831047|Sympathomimetics|sympathomimetics|mesh-ancestor
25177828|NCT04831047|Autonomic Agents|autonomic agents|mesh-ancestor
25177829|NCT04831047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25177830|NCT04831047|Nasal Decongestants|nasal decongestants|mesh-ancestor
25177831|NCT04831047|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25299271|NCT00156065|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25299272|NCT00156065|Dopamine Agents|dopamine agents|mesh-ancestor
25299273|NCT00156065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25299274|NCT00156065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299275|NCT00156065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25299276|NCT00150176|Asenapine|asenapine|mesh-list
25299277|NCT00150176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25299278|NCT00150176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25299279|NCT00150176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25299280|NCT00150176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299281|NCT00150176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25299282|NCT00148629|Mebendazole|mebendazole|mesh-list
25299283|NCT00148629|Piperazine|piperazine|mesh-list
25299284|NCT00148629|Piperazine citrate|piperazine citrate|mesh-list
25299285|NCT00148629|DMP 777|dmp 777|mesh-list
25299286|NCT00148629|Antinematodal Agents|antinematodal agents|mesh-ancestor
25299287|NCT00148629|Anthelmintics|anthelmintics|mesh-ancestor
25299288|NCT00148629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25299289|NCT00148629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25299290|NCT00148629|Tubulin Modulators|tubulin modulators|mesh-ancestor
25299291|NCT00148629|Antimitotic Agents|antimitotic agents|mesh-ancestor
25299292|NCT00148629|Mitosis Modulators|mitosis modulators|mesh-ancestor
25299368|NCT05037994|Antiemetics|antiemetics|mesh-ancestor
25299293|NCT00148629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299294|NCT00148629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25299295|NCT00148629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25299296|NCT00145509|Asenapine|asenapine|mesh-list
25299297|NCT00145509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25077469|NCT03364348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24450781|NCT00320580|Norelgestromin|norelgestromin|mesh-list
25299298|NCT00145509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25299299|NCT00145509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25299300|NCT00145509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299301|NCT00145509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25299302|NCT00145496|Olanzapine|olanzapine|mesh-list
25299303|NCT00145496|Asenapine|asenapine|mesh-list
25299304|NCT00145496|Antiemetics|antiemetics|mesh-ancestor
25299305|NCT00145496|Autonomic Agents|autonomic agents|mesh-ancestor
25299306|NCT00145496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25299307|NCT00145496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299308|NCT00145496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25299309|NCT00145496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25299310|NCT00145496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25299311|NCT00145496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25299312|NCT00145496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25299313|NCT00145496|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25299314|NCT00145496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25825340|NCT00005586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299315|NCT00145496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25299316|NCT00145496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299317|NCT00145496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25299318|NCT00145496|Serotonin Agents|serotonin agents|mesh-ancestor
25299319|NCT00145470|Asenapine|asenapine|mesh-list
25299320|NCT00145470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25299321|NCT00145470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25299322|NCT00145470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25299323|NCT00145470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299324|NCT00145470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25299325|NCT00129402|Simvastatin|simvastatin|mesh-list
25299326|NCT00129402|Ezetimibe|ezetimibe|mesh-list
25299327|NCT00129402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25299328|NCT00129402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25299329|NCT00129402|Antimetabolites|antimetabolites|mesh-ancestor
25299408|NCT04972396|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25647746|NCT01472380|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25647747|NCT01472380|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25647748|NCT01472380|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25647749|NCT01472380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25647750|NCT01472380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25647751|NCT01472380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25647752|NCT01472380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24757217|NCT01738607|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25299330|NCT00129402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299331|NCT00129402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25299332|NCT00129402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25299333|NCT00129402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25299334|NCT00101439|Ezetimibe|ezetimibe|mesh-list
25299335|NCT00101439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25299336|NCT00101439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25299337|NCT00101439|Antimetabolites|antimetabolites|mesh-ancestor
25299338|NCT00101439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299339|NCT00101439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25299340|NCT00096200|Paclitaxel|paclitaxel|mesh-list
25299341|NCT00096200|Carboplatin|carboplatin|mesh-list
25299342|NCT00096200|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25299343|NCT00096200|Sorafenib|sorafenib|mesh-list
25299344|NCT00096200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25299345|NCT00096200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25299346|NCT00096200|Tubulin Modulators|tubulin modulators|mesh-ancestor
25299347|NCT00096200|Antimitotic Agents|antimitotic agents|mesh-ancestor
25299348|NCT00096200|Mitosis Modulators|mitosis modulators|mesh-ancestor
25299349|NCT00096200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299350|NCT00096200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25299351|NCT00096200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25299352|NCT05037994|Prednisolone|prednisolone|mesh-list
25299353|NCT05037994|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25299354|NCT05037994|Methylprednisolone|methylprednisolone|mesh-list
25299355|NCT05037994|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25299356|NCT05037994|Prednisolone acetate|prednisolone acetate|mesh-list
25299357|NCT05037994|Gabapentin|gabapentin|mesh-list
25299358|NCT05037994|Bupivacaine|bupivacaine|mesh-list
25299359|NCT05037994|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25299360|NCT05037994|Prednisolone phosphate|prednisolone phosphate|mesh-list
25299361|NCT05037994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25299362|NCT05037994|Glucocorticoids|glucocorticoids|mesh-ancestor
25299363|NCT05037994|Hormones|hormones|mesh-ancestor
25299364|NCT05037994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25299365|NCT05037994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299366|NCT05037994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25299367|NCT05037994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25299369|NCT05037994|Autonomic Agents|autonomic agents|mesh-ancestor
25299370|NCT05037994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25299371|NCT05037994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25299372|NCT05037994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25299373|NCT05037994|Protective Agents|protective agents|mesh-ancestor
25299374|NCT05037994|Analgesics|analgesics|mesh-ancestor
25299375|NCT05037994|Sensory System Agents|sensory system agents|mesh-ancestor
25299376|NCT05037994|Anticonvulsants|anticonvulsants|mesh-ancestor
25299377|NCT05037994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25299378|NCT05037994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25299379|NCT05037994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25299380|NCT05037994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25299381|NCT05037994|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25299382|NCT05037994|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25299383|NCT05037994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25299384|NCT05037994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299385|NCT05037994|Antimanic Agents|antimanic agents|mesh-ancestor
25299386|NCT05037994|Anesthetics, Local|anesthetics, local|mesh-ancestor
25299387|NCT05037994|Anesthetics|anesthetics|mesh-ancestor
25299388|NCT05036434|Pembrolizumab|pembrolizumab|mesh-list
25299389|NCT05036434|Lenvatinib|lenvatinib|mesh-list
25299390|NCT05036434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25299391|NCT05036434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25299392|NCT05036434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25299393|NCT05036434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25299394|NCT05036434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299395|NCT04984616|Atorvastatin|atorvastatin|mesh-list
25299396|NCT04984616|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25299397|NCT04984616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25299398|NCT04984616|Antimetabolites|antimetabolites|mesh-ancestor
25299399|NCT04984616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299400|NCT04984616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25299401|NCT04984616|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25299402|NCT04984616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25299403|NCT04972396|Metformin|metformin|mesh-list
25647753|NCT01472380|Antimetabolites|antimetabolites|mesh-ancestor
25177906|NCT04781192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25177907|NCT04781192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25177921|NCT04776993|Methimazole|methimazole|mesh-list
25177922|NCT04776993|Antithyroid Agents|antithyroid agents|mesh-ancestor
25177923|NCT04776993|Hormone Antagonists|hormone antagonists|mesh-ancestor
25177924|NCT04776993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25177925|NCT04776993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177926|NCT04772001|Carboplatin|carboplatin|mesh-list
25177927|NCT04772001|Cisplatin|cisplatin|mesh-list
25177928|NCT04772001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25177929|NCT04768504|Tofacitinib|tofacitinib|mesh-list
25177930|NCT04768504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25299404|NCT04972396|Digoxin|digoxin|mesh-list
25299405|NCT04972396|Warfarin|warfarin|mesh-list
25299406|NCT04972396|Atorvastatin|atorvastatin|mesh-list
25299409|NCT04972396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25299410|NCT04972396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299411|NCT04972396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25299412|NCT04972396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25299413|NCT04972396|Antimetabolites|antimetabolites|mesh-ancestor
25299414|NCT04972396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299415|NCT04972396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25299416|NCT04972396|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25299417|NCT04972396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25299418|NCT04972396|Anticoagulants|anticoagulants|mesh-ancestor
25299419|NCT04972396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25299420|NCT04972396|Contraceptive Agents|contraceptive agents|mesh-ancestor
25299421|NCT04972396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25299422|NCT04972396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25299423|NCT04972396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25299424|NCT04972396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25299425|NCT04972396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25299426|NCT04972396|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25299427|NCT04972396|Protective Agents|protective agents|mesh-ancestor
25299428|NCT04972396|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25299429|NCT04972396|Estrogens|estrogens|mesh-ancestor
25299430|NCT04972396|Hormones|hormones|mesh-ancestor
25299431|NCT04972396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25299432|NCT04904952|Acetylcysteine|acetylcysteine|mesh-list
25299433|NCT04904952|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25299434|NCT04904952|Antiviral Agents|antiviral agents|mesh-ancestor
25299435|NCT04904952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25299436|NCT04904952|Expectorants|expectorants|mesh-ancestor
25299437|NCT04904952|Respiratory System Agents|respiratory system agents|mesh-ancestor
25299438|NCT04904952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25299439|NCT04904952|Antioxidants|antioxidants|mesh-ancestor
25299440|NCT04904952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299441|NCT04904952|Protective Agents|protective agents|mesh-ancestor
25299442|NCT04904952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299443|NCT04904952|Antidotes|antidotes|mesh-ancestor
25299444|NCT04810910|Molgramostim|molgramostim|mesh-list
25299456|NCT04746989|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25299457|NCT04746989|Antioxidants|antioxidants|mesh-ancestor
25299458|NCT04746989|Protective Agents|protective agents|mesh-ancestor
25299459|NCT04746989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299460|NCT04746989|Uricosuric Agents|uricosuric agents|mesh-ancestor
25299461|NCT04746989|Renal Agents|renal agents|mesh-ancestor
25299462|NCT04729049|Morphine|morphine|mesh-list
25299463|NCT04729049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25299464|NCT04729049|Narcotics|narcotics|mesh-ancestor
25299465|NCT04729049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25299466|NCT04729049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299467|NCT04729049|Analgesics|analgesics|mesh-ancestor
25647754|NCT01472380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25647755|NCT01472432|Vildagliptin|vildagliptin|mesh-list
25647756|NCT01472432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25647757|NCT01472432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647758|NCT01472432|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25647759|NCT01472432|Protease Inhibitors|protease inhibitors|mesh-ancestor
25647760|NCT01472432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25647761|NCT01472432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647762|NCT01472445|Vitamin D|vitamin d|mesh-list
25647763|NCT01472445|Cholecalciferol|cholecalciferol|mesh-list
25647764|NCT01472445|Vitamins|vitamins|mesh-ancestor
25647765|NCT01472445|Micronutrients|micronutrients|mesh-ancestor
25299468|NCT04729049|Sensory System Agents|sensory system agents|mesh-ancestor
25647766|NCT01472445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204873|NCT05264142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25204874|NCT05264142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25204875|NCT05264142|Serotonin Agents|serotonin agents|mesh-ancestor
25204876|NCT05264142|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25204877|NCT05264142|Antidepressive Agents|antidepressive agents|mesh-ancestor
25204878|NCT05264142|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25204879|NCT05264142|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25299469|NCT04729049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25299478|NCT04688931|Mitomycins|mitomycins|mesh-list
25299479|NCT04688931|Mitomycin|mitomycin|mesh-list
25299480|NCT04688931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25299481|NCT04688931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25299482|NCT04688931|Alkylating Agents|alkylating agents|mesh-ancestor
25299483|NCT04688931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299484|NCT04688931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25299485|NCT04688931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25299489|NCT04663711|Anesthetics|anesthetics|mesh-list
25299490|NCT04663711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25299491|NCT04663711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299492|NCT04582448|Insulin|insulin|mesh-list
25299493|NCT04582448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25299494|NCT04582448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299495|NCT04562558|Leucovorin|leucovorin|mesh-list
25299496|NCT04562558|Dactinomycin|dactinomycin|mesh-list
25299497|NCT04562558|Methotrexate|methotrexate|mesh-list
25299498|NCT04562558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299499|NCT04562558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25299500|NCT04562558|Abortifacient Agents|abortifacient agents|mesh-ancestor
25299501|NCT04562558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25299502|NCT04562558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25299503|NCT04562558|Antimetabolites|antimetabolites|mesh-ancestor
25299504|NCT04562558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299505|NCT04562558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25299506|NCT04562558|Dermatologic Agents|dermatologic agents|mesh-ancestor
25299507|NCT04562558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25299508|NCT04562558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25299509|NCT04562558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25299510|NCT04562558|Immunologic Factors|immunologic factors|mesh-ancestor
25299511|NCT04562558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25299512|NCT04562558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25299513|NCT04562558|Antidotes|antidotes|mesh-ancestor
25299514|NCT04562558|Protective Agents|protective agents|mesh-ancestor
25299515|NCT04562558|Vitamin B Complex|vitamin b complex|mesh-ancestor
25299516|NCT04562558|Vitamins|vitamins|mesh-ancestor
25299517|NCT04562558|Micronutrients|micronutrients|mesh-ancestor
25299518|NCT04562558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25299519|NCT04562558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25299520|NCT04562558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25299521|NCT04562558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25299522|NCT04529876|Abatacept|abatacept|mesh-list
25299524|NCT04529876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25299525|NCT04529876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299526|NCT04529876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25299527|NCT04529876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25299528|NCT04529876|Immunologic Factors|immunologic factors|mesh-ancestor
25299529|NCT04529876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299530|NCT04529876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25299531|NCT04529876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25299532|NCT04529876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25299533|NCT04529863|Abatacept|abatacept|mesh-list
25299534|NCT04529863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25299535|NCT04529863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299536|NCT04529863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25299537|NCT04529863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25299538|NCT04529863|Immunologic Factors|immunologic factors|mesh-ancestor
25299539|NCT04529863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299540|NCT04529863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25647767|NCT01472445|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25647768|NCT01472445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25647769|NCT01472549|Ethanol|ethanol|mesh-list
25647770|NCT01472549|Chlorhexidine|chlorhexidine|mesh-list
25647771|NCT01472549|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25647772|NCT01472549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25647773|NCT01472549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25177993|NCT04747912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25177994|NCT04747912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25177995|NCT04747912|Antimetabolites|antimetabolites|mesh-ancestor
25177996|NCT04747912|Dermatologic Agents|dermatologic agents|mesh-ancestor
25177997|NCT04747912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25177998|NCT04747912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25177999|NCT04747912|Immunologic Factors|immunologic factors|mesh-ancestor
25178000|NCT04747912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25178009|NCT04746547|Dolutegravir|dolutegravir|mesh-list
25299541|NCT04527744|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25299542|NCT04527744|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25299543|NCT04527744|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25299544|NCT04527744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25299545|NCT04527744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299546|NCT04527744|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25299547|NCT04527744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25299548|NCT04527744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299549|NCT04527744|Cholinergic Agents|cholinergic agents|mesh-ancestor
25299550|NCT04527744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25299551|NCT04443244|Botulinum Toxins|botulinum toxins|mesh-list
25299552|NCT04443244|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25299553|NCT04443244|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25299554|NCT04443244|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25299555|NCT04443244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25299556|NCT04443244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299557|NCT04443244|Cholinergic Agents|cholinergic agents|mesh-ancestor
25299558|NCT04443244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25299559|NCT04443244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299560|NCT04443244|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25299561|NCT04443244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25299562|NCT04421092|Lidocaine|lidocaine|mesh-list
25299563|NCT04421092|Anesthetics, Local|anesthetics, local|mesh-ancestor
25299564|NCT04421092|Anesthetics|anesthetics|mesh-ancestor
25299565|NCT04421092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25299566|NCT04421092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299567|NCT04421092|Sensory System Agents|sensory system agents|mesh-ancestor
25299568|NCT04421092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25299569|NCT04421092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25299570|NCT04421092|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25299571|NCT04421092|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25299572|NCT04421092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25299573|NCT04421092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299574|NCT04408898|Pembrolizumab|pembrolizumab|mesh-list
25299575|NCT04408898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25299576|NCT04408898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25299577|NCT04402385|Aspirin|aspirin|mesh-list
25299578|NCT04402385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25299579|NCT04402385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25299580|NCT04402385|Analgesics|analgesics|mesh-ancestor
25299796|NCT03066739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25299581|NCT04402385|Sensory System Agents|sensory system agents|mesh-ancestor
25299582|NCT04402385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25299583|NCT04402385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299584|NCT04402385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25299585|NCT04402385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25299586|NCT04402385|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25299587|NCT04402385|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25299588|NCT04402385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299589|NCT04402385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25299590|NCT04402385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25299591|NCT04402385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25299592|NCT04402385|Antipyretics|antipyretics|mesh-ancestor
25299593|NCT04393103|Atropine|atropine|mesh-list
25299594|NCT04393103|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25647774|NCT01472549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647775|NCT01472549|Disinfectants|disinfectants|mesh-ancestor
25647776|NCT01472835|Fentanyl|fentanyl|mesh-list
25647777|NCT01472835|Midazolam|midazolam|mesh-list
25647778|NCT01472835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25647779|NCT01472835|Narcotics|narcotics|mesh-ancestor
25647780|NCT01472835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25647781|NCT01472835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647782|NCT01472835|Analgesics|analgesics|mesh-ancestor
25647783|NCT01472835|Sensory System Agents|sensory system agents|mesh-ancestor
25178075|NCT04686760|Nitroglycerin|nitroglycerin|mesh-list
25178076|NCT04686760|Vasodilator Agents|vasodilator agents|mesh-ancestor
25178077|NCT04685915|Acalabrutinib|acalabrutinib|mesh-list
25178078|NCT04685915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178079|NCT04682431|Pembrolizumab|pembrolizumab|mesh-list
25178080|NCT04682431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25178081|NCT04682431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178082|NCT04669782|Teriparatide|teriparatide|mesh-list
25178083|NCT04669782|Vitamin K|vitamin k|mesh-list
25178084|NCT04669782|Vitamins|vitamins|mesh-ancestor
25178085|NCT04669782|Micronutrients|micronutrients|mesh-ancestor
25299608|NCT04393103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25299609|NCT04393103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299610|NCT04393103|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25299611|NCT04393103|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25299612|NCT04393103|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25299613|NCT04347616|Aldesleukin|aldesleukin|mesh-list
25299614|NCT04347616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25299615|NCT04347616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25299616|NCT04347616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25299617|NCT04347616|Antiviral Agents|antiviral agents|mesh-ancestor
25299618|NCT04347616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25299632|NCT04235205|Cholestyramine Resin|cholestyramine resin|mesh-list
25299633|NCT04235205|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25299634|NCT04235205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25299635|NCT04235205|Antimetabolites|antimetabolites|mesh-ancestor
25299636|NCT04235205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299637|NCT04235205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25299638|NCT04209868|Bupivacaine|bupivacaine|mesh-list
25299639|NCT04209868|Levobupivacaine|levobupivacaine|mesh-list
25299640|NCT04209868|Anesthetics, Local|anesthetics, local|mesh-ancestor
25299641|NCT04209868|Anesthetics|anesthetics|mesh-ancestor
25299642|NCT04209868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25299643|NCT04209868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299644|NCT04209868|Sensory System Agents|sensory system agents|mesh-ancestor
25299645|NCT04209868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25299646|NCT04209504|Bupivacaine|bupivacaine|mesh-list
25299647|NCT04209504|Ropivacaine|ropivacaine|mesh-list
25299648|NCT04209504|Anesthetics, Local|anesthetics, local|mesh-ancestor
25299649|NCT04209504|Anesthetics|anesthetics|mesh-ancestor
25299650|NCT04209504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25299651|NCT04209504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299652|NCT04209504|Sensory System Agents|sensory system agents|mesh-ancestor
25299653|NCT04209504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25299666|NCT03874091|Epinephrine|epinephrine|mesh-list
25299667|NCT03874091|Racepinephrine|racepinephrine|mesh-list
25299669|NCT03874091|Bupivacaine|bupivacaine|mesh-list
25299670|NCT03874091|Epinephryl borate|epinephryl borate|mesh-list
25299674|NCT03874091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299675|NCT03874091|Sensory System Agents|sensory system agents|mesh-ancestor
25299676|NCT03874091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25299677|NCT03874091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25299678|NCT03874091|Narcotics|narcotics|mesh-ancestor
25299679|NCT03874091|Analgesics|analgesics|mesh-ancestor
25299680|NCT03874091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25299681|NCT03874091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25299682|NCT03874091|Adrenergic Agents|adrenergic agents|mesh-ancestor
25299683|NCT03874091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25299684|NCT03874091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299685|NCT03874091|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25299686|NCT03874091|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25299687|NCT03874091|Autonomic Agents|autonomic agents|mesh-ancestor
25299688|NCT03874091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25299689|NCT03874091|Respiratory System Agents|respiratory system agents|mesh-ancestor
25647784|NCT01472835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25647785|NCT01472835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25647786|NCT01472835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25647787|NCT01472835|Anesthetics, General|anesthetics, general|mesh-ancestor
25647788|NCT01472835|Anesthetics|anesthetics|mesh-ancestor
25647789|NCT01472835|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25647790|NCT01472835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25647791|NCT01472835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25647792|NCT01472835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25647793|NCT01472835|GABA Modulators|gaba modulators|mesh-ancestor
25299690|NCT03874091|Mydriatics|mydriatics|mesh-ancestor
25299691|NCT03874091|Sympathomimetics|sympathomimetics|mesh-ancestor
25299692|NCT03874091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25299693|NCT03773276|Norepinephrine|norepinephrine|mesh-list
24757488|NCT01740336|Antimitotic Agents|antimitotic agents|mesh-ancestor
25094554|NCT03225352|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25094555|NCT03225352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094556|NCT03225352|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25094557|NCT03225352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25094558|NCT03225352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25096461|NCT03211988|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25096462|NCT03211988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25096463|NCT03211988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096464|NCT03211728|Pregabalin|pregabalin|mesh-list
25096465|NCT03211728|Analgesics|analgesics|mesh-ancestor
25096466|NCT03211728|Sensory System Agents|sensory system agents|mesh-ancestor
25096467|NCT03211728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25096469|NCT03211728|Anticonvulsants|anticonvulsants|mesh-ancestor
25299694|NCT03773276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25299695|NCT03773276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25299696|NCT03773276|Adrenergic Agents|adrenergic agents|mesh-ancestor
25299697|NCT03773276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25299698|NCT03773276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299699|NCT03773276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299700|NCT03773276|Sympathomimetics|sympathomimetics|mesh-ancestor
25299701|NCT03773276|Autonomic Agents|autonomic agents|mesh-ancestor
25299702|NCT03773276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25299703|NCT03773276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25299704|NCT03738696|Bupivacaine|bupivacaine|mesh-list
25299705|NCT03738696|Ropivacaine|ropivacaine|mesh-list
25299706|NCT03738696|Anesthetics, Local|anesthetics, local|mesh-ancestor
25299707|NCT03738696|Anesthetics|anesthetics|mesh-ancestor
25299708|NCT03738696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25299709|NCT03738696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299710|NCT03738696|Sensory System Agents|sensory system agents|mesh-ancestor
25299711|NCT03738696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25299715|NCT03704610|Dermatologic Agents|dermatologic agents|mesh-ancestor
25299716|NCT03704610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25299717|NCT03704610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25299718|NCT03679650|Decitabine|decitabine|mesh-list
25299719|NCT03679650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25299720|NCT03679650|Antimetabolites|antimetabolites|mesh-ancestor
25299721|NCT03679650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299722|NCT03679650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25299723|NCT03679650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25299724|NCT03662815|Molgramostim|molgramostim|mesh-list
25299725|NCT03662815|Sargramostim|sargramostim|mesh-list
25299726|NCT03662815|Immunologic Factors|immunologic factors|mesh-ancestor
25299727|NCT03662815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299728|NCT03662815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25299729|NCT03645148|Molgramostim|molgramostim|mesh-list
25299730|NCT03645148|Sargramostim|sargramostim|mesh-list
25299731|NCT03645148|Immunologic Factors|immunologic factors|mesh-ancestor
25299732|NCT03645148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299733|NCT03645148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25299734|NCT03612921|Amantadine|amantadine|mesh-list
25299735|NCT03612921|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25299736|NCT03612921|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25299737|NCT03612921|Antiviral Agents|antiviral agents|mesh-ancestor
25299738|NCT03612921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25299739|NCT03612921|Dopamine Agents|dopamine agents|mesh-ancestor
25299740|NCT03612921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25299741|NCT03612921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647794|NCT01472835|GABA Agents|gaba agents|mesh-ancestor
25647795|NCT01472835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25647796|NCT01472835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647797|NCT01472874|Trientine|trientine|mesh-list
25647798|NCT01472874|Chelating Agents|chelating agents|mesh-ancestor
25647799|NCT01472874|Sequestering Agents|sequestering agents|mesh-ancestor
25647800|NCT01472874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647801|NCT01472965|Ethanol|ethanol|mesh-list
25647802|NCT01472965|Heparin|heparin|mesh-list
25647803|NCT01472965|Calcium heparin|calcium heparin|mesh-list
25647804|NCT01472965|Anticoagulants|anticoagulants|mesh-ancestor
25647805|NCT01472965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25647806|NCT01472965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25299742|NCT03612921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647807|NCT01472965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647808|NCT01472965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25178139|NCT04643093|Pitavastatin|pitavastatin|mesh-list
25178140|NCT04643093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25178141|NCT04643093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25178142|NCT04643093|Antimetabolites|antimetabolites|mesh-ancestor
25178143|NCT04643093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178144|NCT04643093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25178145|NCT04643093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25202094|NCT02723838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25178146|NCT04643093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25178147|NCT04642807|Calpastatin|calpastatin|mesh-list
25178148|NCT04642807|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25299743|NCT03612921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25299744|NCT03612921|Analgesics|analgesics|mesh-ancestor
25299745|NCT03612921|Sensory System Agents|sensory system agents|mesh-ancestor
25299746|NCT03612921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25299761|NCT03490903|Analgesics|analgesics|mesh-ancestor
25299762|NCT03490903|Sensory System Agents|sensory system agents|mesh-ancestor
25299763|NCT03490903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25299764|NCT03490903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25299765|NCT03490903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25299766|NCT03490903|Anesthetics, General|anesthetics, general|mesh-ancestor
25299767|NCT03490903|Anesthetics|anesthetics|mesh-ancestor
25299768|NCT03490903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25299769|NCT03490903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25299770|NCT03490903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25299771|NCT03490903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25299772|NCT03490903|GABA Modulators|gaba modulators|mesh-ancestor
25299773|NCT03490903|GABA Agents|gaba agents|mesh-ancestor
25299774|NCT03490903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25299775|NCT03490903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299776|NCT03200288|Hyaluronic Acid|hyaluronic acid|mesh-list
25299777|NCT03200288|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25299778|NCT03200288|Immunologic Factors|immunologic factors|mesh-ancestor
25299779|NCT03200288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299780|NCT03200288|Viscosupplements|viscosupplements|mesh-ancestor
25299781|NCT03200288|Protective Agents|protective agents|mesh-ancestor
24588226|NCT00901615|Lenalidomide|lenalidomide|mesh-list
25299786|NCT03132532|Paclitaxel|paclitaxel|mesh-list
25299787|NCT03132532|Carboplatin|carboplatin|mesh-list
25299788|NCT03132532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25299789|NCT03132532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25299790|NCT03132532|Tubulin Modulators|tubulin modulators|mesh-ancestor
25299791|NCT03132532|Antimitotic Agents|antimitotic agents|mesh-ancestor
25299792|NCT03132532|Mitosis Modulators|mitosis modulators|mesh-ancestor
25299793|NCT03132532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299794|NCT03066739|Remifentanil|remifentanil|mesh-list
25299795|NCT03066739|Naloxone|naloxone|mesh-list
25299797|NCT03066739|Narcotics|narcotics|mesh-ancestor
25299798|NCT03066739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25299799|NCT03066739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299800|NCT03066739|Analgesics|analgesics|mesh-ancestor
25299801|NCT03066739|Sensory System Agents|sensory system agents|mesh-ancestor
25299802|NCT03066739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25299803|NCT03066739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25299804|NCT03061474|Niacinamide|niacinamide|mesh-list
25299806|NCT03061474|Nicotinic Acids|nicotinic acids|mesh-list
25299807|NCT03061474|Vitamin B Complex|vitamin b complex|mesh-ancestor
25299808|NCT03061474|Vitamins|vitamins|mesh-ancestor
25299809|NCT03061474|Micronutrients|micronutrients|mesh-ancestor
25299810|NCT03061474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299811|NCT03061474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25299812|NCT03061474|Antimetabolites|antimetabolites|mesh-ancestor
25299813|NCT03061474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299814|NCT03061474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25299815|NCT03061474|Vasodilator Agents|vasodilator agents|mesh-ancestor
25299819|NCT02929485|Bromocriptine|bromocriptine|mesh-list
25647809|NCT01472965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25647810|NCT01472965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25647811|NCT01472965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647812|NCT01473368|Amoxicillin|amoxicillin|mesh-list
25647813|NCT01473368|Clavulanic Acid|clavulanic acid|mesh-list
25647814|NCT01473368|Clavulanic Acids|clavulanic acids|mesh-list
25647815|NCT01473368|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25647816|NCT01473368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25647817|NCT01473368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25647818|NCT01473368|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25299820|NCT02929485|Tolcapone|tolcapone|mesh-list
25178193|NCT04612920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25178194|NCT04612920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25178195|NCT04612920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25178196|NCT04612920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25178197|NCT04612920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25178198|NCT04612920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178199|NCT04612920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25178200|NCT04612920|Narcotics|narcotics|mesh-ancestor
25178201|NCT04612920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25178202|NCT04610658|Nivolumab|nivolumab|mesh-list
25178203|NCT04610658|Ipilimumab|ipilimumab|mesh-list
25178204|NCT04610658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25299821|NCT02929485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25299822|NCT02929485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25299823|NCT02929485|Hormone Antagonists|hormone antagonists|mesh-ancestor
25299824|NCT02929485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25299855|NCT02829502|Exenatide|exenatide|mesh-list
25299856|NCT02829502|Glucagon|glucagon|mesh-list
25299857|NCT02829502|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25299858|NCT02829502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25299859|NCT02829502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299860|NCT02829502|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25299861|NCT02829502|Incretins|incretins|mesh-ancestor
25299862|NCT02829502|Hormones|hormones|mesh-ancestor
25299863|NCT02829502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25299864|NCT02829502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25299865|NCT02795351|Sildenafil Citrate|sildenafil citrate|mesh-list
25299866|NCT02795351|Vasodilator Agents|vasodilator agents|mesh-ancestor
25299867|NCT02795351|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25299868|NCT02795351|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25299869|NCT02795351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25299870|NCT02795351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299871|NCT02795351|Urological Agents|urological agents|mesh-ancestor
25299872|NCT02733133|Testosterone|testosterone|mesh-list
25299873|NCT02733133|Androgens|androgens|mesh-ancestor
25299874|NCT02733133|Hormones|hormones|mesh-ancestor
25299875|NCT02733133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25299876|NCT02733133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299877|NCT02697383|Dexamethasone|dexamethasone|mesh-list
25299878|NCT02697383|Ixazomib|ixazomib|mesh-list
25299879|NCT02697383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25299880|NCT02697383|Antiemetics|antiemetics|mesh-ancestor
25299881|NCT02697383|Autonomic Agents|autonomic agents|mesh-ancestor
25299882|NCT02697383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25299883|NCT02697383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299884|NCT02697383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25299885|NCT02697383|Glucocorticoids|glucocorticoids|mesh-ancestor
25299886|NCT02697383|Hormones|hormones|mesh-ancestor
25299887|NCT02697383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25299888|NCT02697383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25299889|NCT02697383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25299890|NCT02697383|Protease Inhibitors|protease inhibitors|mesh-ancestor
25299891|NCT02697383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25299892|NCT02697383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299893|NCT02683265|Methylphenidate|methylphenidate|mesh-list
25299894|NCT02683265|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25299895|NCT02683265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299896|NCT02683265|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25299897|NCT02683265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25299903|NCT02604446|Tapentadol|tapentadol|mesh-list
25299904|NCT02604446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25299905|NCT02604446|Narcotics|narcotics|mesh-ancestor
25647819|NCT01473368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25647820|NCT01473368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647821|NCT01473381|Dexetimide|dexetimide|mesh-list
25647822|NCT01473381|Citalopram|citalopram|mesh-list
25647823|NCT01473381|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
25647824|NCT01473381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25647825|NCT01473381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25647826|NCT01473381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25647827|NCT01473381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647828|NCT01473381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25647829|NCT01473381|Serotonin Agents|serotonin agents|mesh-ancestor
25647830|NCT01473381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178268|NCT04520451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25178269|NCT04520451|Hormones|hormones|mesh-ancestor
25178270|NCT04520451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25178271|NCT04520451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178272|NCT04520451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25178273|NCT04520451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178274|NCT04515394|Cetuximab|cetuximab|mesh-list
25178275|NCT04515394|Tepotinib|tepotinib|mesh-list
25178276|NCT04515394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25178277|NCT04515394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25299906|NCT02604446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25299907|NCT02604446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299908|NCT02604446|Analgesics|analgesics|mesh-ancestor
25299909|NCT02604446|Sensory System Agents|sensory system agents|mesh-ancestor
25299910|NCT02604446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25299911|NCT02604446|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25299912|NCT02604446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25299913|NCT02604446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25299914|NCT02604446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299915|NCT02604446|Adrenergic Agents|adrenergic agents|mesh-ancestor
25299916|NCT02604446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25299917|NCT02588326|Mometasone Furoate|mometasone furoate|mesh-list
25299918|NCT02588326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25299919|NCT02588326|Dermatologic Agents|dermatologic agents|mesh-ancestor
25299920|NCT02588326|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25299926|NCT02117076|Gabapentin|gabapentin|mesh-list
25299927|NCT02117076|Analgesics|analgesics|mesh-ancestor
25299928|NCT02117076|Sensory System Agents|sensory system agents|mesh-ancestor
25299929|NCT02117076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25299930|NCT02117076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299931|NCT02117076|Anticonvulsants|anticonvulsants|mesh-ancestor
25299932|NCT02117076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25299933|NCT02117076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25299934|NCT02117076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25299935|NCT02117076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25299936|NCT02117076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25299937|NCT02117076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25299938|NCT02117076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25299939|NCT02117076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299940|NCT02117076|Antimanic Agents|antimanic agents|mesh-ancestor
25299941|NCT01710176|Gemcitabine|gemcitabine|mesh-list
25299942|NCT01710176|Docetaxel|docetaxel|mesh-list
25299943|NCT01710176|Etoposide|etoposide|mesh-list
25299944|NCT01710176|Epirubicin|epirubicin|mesh-list
25299945|NCT01710176|Ifosfamide|ifosfamide|mesh-list
25299946|NCT01710176|Isophosphamide mustard|isophosphamide mustard|mesh-list
25299947|NCT01710176|Dacarbazine|dacarbazine|mesh-list
25299948|NCT01710176|Trabectedin|trabectedin|mesh-list
25299949|NCT01710176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25299950|NCT01710176|Antimetabolites|antimetabolites|mesh-ancestor
25299951|NCT01710176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299952|NCT01710176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25299953|NCT01710176|Antiviral Agents|antiviral agents|mesh-ancestor
25299954|NCT01710176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25299955|NCT01710176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25299956|NCT01710176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25299957|NCT01710176|Immunologic Factors|immunologic factors|mesh-ancestor
25299958|NCT01710176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299959|NCT01710176|Tubulin Modulators|tubulin modulators|mesh-ancestor
25299960|NCT01710176|Antimitotic Agents|antimitotic agents|mesh-ancestor
25299961|NCT01710176|Mitosis Modulators|mitosis modulators|mesh-ancestor
25299962|NCT01710176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25299963|NCT01710176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25299964|NCT01710176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25299965|NCT01710176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25647831|NCT01473381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25647832|NCT01473381|Antidepressive Agents|antidepressive agents|mesh-ancestor
25647833|NCT01473381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25647834|NCT01473381|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25647835|NCT01473381|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25647836|NCT01473381|Parasympatholytics|parasympatholytics|mesh-ancestor
25647837|NCT01473381|Autonomic Agents|autonomic agents|mesh-ancestor
25647838|NCT01473381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24455085|NCT02876107|Carboplatin|carboplatin|mesh-list
25647839|NCT01473381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25647840|NCT01473381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25178309|NCT04480853|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25178310|NCT04480853|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25178311|NCT04480853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178312|NCT04480853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25178313|NCT04480853|Immunologic Factors|immunologic factors|mesh-ancestor
25178314|NCT04480853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178332|NCT04476550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24494764|NCT00497003|Sympatholytics|sympatholytics|mesh-ancestor
25178333|NCT04476550|Immunologic Factors|immunologic factors|mesh-ancestor
25178334|NCT04476550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178342|NCT04449536|Mesna|mesna|mesh-list
25299966|NCT01710176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25299967|NCT01710176|Alkylating Agents|alkylating agents|mesh-ancestor
25299968|NCT00816582|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25299969|NCT00816582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25299970|NCT00816582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299971|NCT00584246|Pregabalin|pregabalin|mesh-list
25299972|NCT00584246|Analgesics|analgesics|mesh-ancestor
25299973|NCT00584246|Sensory System Agents|sensory system agents|mesh-ancestor
25299977|NCT00584246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24975904|NCT02573233|Xhance|xhance|mesh-list
25299978|NCT00584246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25299979|NCT00584246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25299980|NCT00584246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25299981|NCT00584246|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25299982|NCT00584246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25299983|NCT00584246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25299984|NCT00584246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25299985|NCT00584025|Levetiracetam|levetiracetam|mesh-list
25299986|NCT00584025|Anticonvulsants|anticonvulsants|mesh-ancestor
25299987|NCT00584025|Nootropic Agents|nootropic agents|mesh-ancestor
25299988|NCT05124353|Cerebrolysin|cerebrolysin|mesh-list
25299989|NCT05124353|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25299990|NCT05124353|Protective Agents|protective agents|mesh-ancestor
25299991|NCT05124353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299992|NCT05124353|Nootropic Agents|nootropic agents|mesh-ancestor
25299993|NCT05124314|Misoprostol|misoprostol|mesh-list
25299994|NCT05124314|Mifepristone|mifepristone|mesh-list
25299995|NCT05124314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25299996|NCT05124314|Abortifacient Agents|abortifacient agents|mesh-ancestor
25299997|NCT05124314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25299998|NCT05124314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25299999|NCT05124314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25300000|NCT05124314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25300001|NCT05124314|Oxytocics|oxytocics|mesh-ancestor
25300002|NCT05124314|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25300003|NCT05124314|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25300004|NCT05124314|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25300005|NCT05124314|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25300006|NCT05124314|Contraceptive Agents|contraceptive agents|mesh-ancestor
25300007|NCT05124314|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25300008|NCT05124314|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25300009|NCT05124314|Hormone Antagonists|hormone antagonists|mesh-ancestor
25300010|NCT05124314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25300011|NCT05124314|Luteolytic Agents|luteolytic agents|mesh-ancestor
25300012|NCT05124314|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25300013|NCT05124314|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25300014|NCT05123976|Olanzapine|olanzapine|mesh-list
25300015|NCT05123976|Antiemetics|antiemetics|mesh-ancestor
25300016|NCT05123976|Autonomic Agents|autonomic agents|mesh-ancestor
25300017|NCT05123976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25647841|NCT01473381|Cholinergic Agents|cholinergic agents|mesh-ancestor
25647842|NCT01473381|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25647843|NCT01473381|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25647844|NCT01473394|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
25647845|NCT01473394|Antidepressive Agents|antidepressive agents|mesh-ancestor
25647846|NCT01473394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25647847|NCT01473394|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25647848|NCT01473394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25202106|NCT02723669|Antiviral Agents|antiviral agents|mesh-ancestor
25647849|NCT01473394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25647850|NCT01473394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647851|NCT01473394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25178375|NCT04407754|Vitamin B Complex|vitamin b complex|mesh-ancestor
25178376|NCT04407754|Vitamins|vitamins|mesh-ancestor
25178377|NCT04407754|Micronutrients|micronutrients|mesh-ancestor
25178378|NCT04407754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178387|NCT04404049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25178388|NCT04404049|Antiviral Agents|antiviral agents|mesh-ancestor
25178389|NCT04404049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25178390|NCT04400539|Nivolumab|nivolumab|mesh-list
25178391|NCT04400539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24757777|NCT01742429|Ofloxacin|ofloxacin|mesh-list
25300018|NCT05123976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300019|NCT05123976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25300020|NCT05123976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25300021|NCT05123976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25300022|NCT05123976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25300023|NCT05123976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25300024|NCT05123976|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25300025|NCT05123976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25300026|NCT05123976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25300027|NCT05123976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300028|NCT05123976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25300029|NCT05123976|Serotonin Agents|serotonin agents|mesh-ancestor
25300030|NCT05123781|Metformin|metformin|mesh-list
25300031|NCT05123781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25300032|NCT05123781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300033|NCT05123287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25300034|NCT05123287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300035|NCT05123287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300036|NCT05123053|Amifampridine|amifampridine|mesh-list
25300037|NCT05123053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25300038|NCT05123053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25300039|NCT05123053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300040|NCT05123053|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25300041|NCT05123053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25300042|NCT05123053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300077|NCT05122741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25300078|NCT05122741|Analgesics|analgesics|mesh-ancestor
25300079|NCT05122741|Sensory System Agents|sensory system agents|mesh-ancestor
25300080|NCT05122741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25300081|NCT05122741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300082|NCT05122741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25300083|NCT05122741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25300084|NCT05122741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25300085|NCT05122741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25300086|NCT05122741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300087|NCT05122741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25300088|NCT05122741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25300089|NCT05122741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25300090|NCT05122741|Antipyretics|antipyretics|mesh-ancestor
25300091|NCT05122741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25300092|NCT05122741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25300093|NCT05122741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25300094|NCT05122741|Purinergic Agents|purinergic agents|mesh-ancestor
25300095|NCT05122741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25825341|NCT00005586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25300096|NCT05115773|Anesthetics|anesthetics|mesh-list
25647852|NCT01473394|Serotonin Agents|serotonin agents|mesh-ancestor
25647853|NCT01473394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647854|NCT01473394|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25647855|NCT01473394|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25647856|NCT01473407|Epoetin Alfa|epoetin alfa|mesh-list
25647857|NCT01473407|Hematinics|hematinics|mesh-ancestor
25647858|NCT01473420|Epoetin Alfa|epoetin alfa|mesh-list
25647859|NCT01473420|Hematinics|hematinics|mesh-ancestor
25647860|NCT01473524|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
25647861|NCT01473524|Cathartics|cathartics|mesh-ancestor
25647862|NCT01473524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25647863|NCT01473563|Pemetrexed|pemetrexed|mesh-list
25647864|NCT01473563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647865|NCT01473563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25178437|NCT04329949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178438|NCT04329949|Tubulin Modulators|tubulin modulators|mesh-ancestor
25178439|NCT04329949|Antimitotic Agents|antimitotic agents|mesh-ancestor
25178440|NCT04329949|Mitosis Modulators|mitosis modulators|mesh-ancestor
25178441|NCT04329949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178442|NCT04329442|Tenofovir|tenofovir|mesh-list
25178443|NCT04329442|Emtricitabine|emtricitabine|mesh-list
25178444|NCT04329442|Antiviral Agents|antiviral agents|mesh-ancestor
25178445|NCT04329442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25178446|NCT04329442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25178447|NCT04329442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25178448|NCT04329442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25178449|NCT04329442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178450|NCT04329442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25178451|NCT04329442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25178452|NCT04328337|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25178453|NCT04328337|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25178454|NCT04328337|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25178455|NCT04328337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25300097|NCT05115773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25300098|NCT05115773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300116|NCT05069974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25300117|NCT05069974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25300118|NCT05069974|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25300119|NCT05069974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25300155|NCT05001802|Anesthetics, Local|anesthetics, local|mesh-ancestor
25300156|NCT05001802|Anesthetics|anesthetics|mesh-ancestor
25300157|NCT05001802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25300158|NCT05001802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300159|NCT05001802|Sensory System Agents|sensory system agents|mesh-ancestor
25300160|NCT05001802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25300161|NCT04975958|Atezolizumab|atezolizumab|mesh-list
25300162|NCT04975958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300163|NCT04965389|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25300164|NCT04921189|Ascorbic Acid|ascorbic acid|mesh-list
25300166|NCT04921189|Hydrocortisone|hydrocortisone|mesh-list
25300167|NCT04921189|Antioxidants|antioxidants|mesh-ancestor
25300168|NCT04921189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300169|NCT04921189|Protective Agents|protective agents|mesh-ancestor
25300170|NCT04921189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300171|NCT04921189|Vitamins|vitamins|mesh-ancestor
25300172|NCT04921189|Micronutrients|micronutrients|mesh-ancestor
25300173|NCT04921189|Vitamin B Complex|vitamin b complex|mesh-ancestor
25300174|NCT04921189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25300175|NCT04875871|Copper|copper|mesh-list
25300176|NCT04875871|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25300177|NCT04875871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25300178|NCT04875871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300179|NCT04875871|Trace Elements|trace elements|mesh-ancestor
25300180|NCT04875871|Micronutrients|micronutrients|mesh-ancestor
25300181|NCT04875871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300194|NCT04827030|Ropivacaine|ropivacaine|mesh-list
25300195|NCT04827030|Anesthetics, Local|anesthetics, local|mesh-ancestor
25300196|NCT04827030|Anesthetics|anesthetics|mesh-ancestor
25300197|NCT04827030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25647866|NCT01473563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647867|NCT01473563|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25647868|NCT01473563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25647869|NCT01473589|Vitamin D|vitamin d|mesh-list
25647870|NCT01473589|Teriparatide|teriparatide|mesh-list
25647871|NCT01473589|Calcium|calcium|mesh-list
25647872|NCT01473589|Vitamins|vitamins|mesh-ancestor
25647873|NCT01473589|Micronutrients|micronutrients|mesh-ancestor
25647874|NCT01473589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647875|NCT01473589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25647876|NCT01473589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25647877|NCT01473602|Vitamin D|vitamin d|mesh-list
25647878|NCT01473602|Teriparatide|teriparatide|mesh-list
25647879|NCT01473602|Calcium|calcium|mesh-list
25647880|NCT01473602|Vitamins|vitamins|mesh-ancestor
25647881|NCT01473602|Micronutrients|micronutrients|mesh-ancestor
25647882|NCT01473602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647883|NCT01473602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25647884|NCT01473602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25647885|NCT01473745|Daminozide|daminozide|mesh-list
25647886|NCT01473745|Plant Growth Regulators|plant growth regulators|mesh-ancestor
25178489|NCT04308863|Chitosan|chitosan|mesh-list
25205329|NCT04931368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25178490|NCT04308863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178491|NCT04308863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25178492|NCT04308863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25178493|NCT04308863|Antimetabolites|antimetabolites|mesh-ancestor
25178494|NCT04308863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25178495|NCT04308863|Chelating Agents|chelating agents|mesh-ancestor
25178496|NCT04308863|Sequestering Agents|sequestering agents|mesh-ancestor
25178497|NCT04308863|Hemostatics|hemostatics|mesh-ancestor
25178498|NCT04308863|Coagulants|coagulants|mesh-ancestor
25825342|NCT00005586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300198|NCT04827030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300199|NCT04827030|Sensory System Agents|sensory system agents|mesh-ancestor
25300200|NCT04827030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25300201|NCT04781725|Cisplatin|cisplatin|mesh-list
25300202|NCT04781725|Vinblastine|vinblastine|mesh-list
25300203|NCT04781725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300204|NCT04781725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25300205|NCT04781725|Tubulin Modulators|tubulin modulators|mesh-ancestor
25300206|NCT04781725|Antimitotic Agents|antimitotic agents|mesh-ancestor
25300207|NCT04781725|Mitosis Modulators|mitosis modulators|mesh-ancestor
25300208|NCT04781725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300209|NCT04737603|Buprenorphine|buprenorphine|mesh-list
25300210|NCT04737603|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25300211|NCT04737603|Naloxone|naloxone|mesh-list
25300212|NCT04737603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25300213|NCT04737603|Narcotics|narcotics|mesh-ancestor
25300214|NCT04737603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25300215|NCT04737603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300216|NCT04737603|Analgesics|analgesics|mesh-ancestor
25300217|NCT04737603|Sensory System Agents|sensory system agents|mesh-ancestor
25300218|NCT04737603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25300219|NCT04737603|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25300220|NCT04637620|Sertraline|sertraline|mesh-list
25300221|NCT04637620|Antidepressive Agents|antidepressive agents|mesh-ancestor
25300222|NCT04637620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25300223|NCT04637620|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25300224|NCT04637620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25300225|NCT04637620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25300226|NCT04637620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300227|NCT04637620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25300228|NCT04637620|Serotonin Agents|serotonin agents|mesh-ancestor
25300229|NCT04637620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300230|NCT04595994|Gemcitabine|gemcitabine|mesh-list
25300231|NCT04595994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25300232|NCT04595994|Antimetabolites|antimetabolites|mesh-ancestor
25300233|NCT04595994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300234|NCT04595994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300235|NCT04595994|Antiviral Agents|antiviral agents|mesh-ancestor
25300236|NCT04595994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25300237|NCT04595994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25300238|NCT04595994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25300239|NCT04595994|Immunologic Factors|immunologic factors|mesh-ancestor
25300240|NCT04595994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300241|NCT04563845|Moxifloxacin|moxifloxacin|mesh-list
25300242|NCT04563845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25300243|NCT04563845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25300244|NCT04563845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25300245|NCT04563845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25300246|NCT04563845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25300247|NCT04563845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300248|NCT04563845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300249|NCT04563559|Prednisolone|prednisolone|mesh-list
25300250|NCT04563559|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25300251|NCT04563559|Methylprednisolone|methylprednisolone|mesh-list
25647887|NCT01473745|Growth Substances|growth substances|mesh-ancestor
25647888|NCT01473745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647889|NCT01473836|Metronidazole|metronidazole|mesh-list
25647890|NCT01473836|Ceftriaxone|ceftriaxone|mesh-list
25647891|NCT01473836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25647892|NCT01473836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25647893|NCT01473836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25647894|NCT01473836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25647895|NCT01473940|Gemcitabine|gemcitabine|mesh-list
25647896|NCT01473940|Ipilimumab|ipilimumab|mesh-list
25647897|NCT01473940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25300252|NCT04563559|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25300253|NCT04563559|Prednisolone acetate|prednisolone acetate|mesh-list
25300254|NCT04563559|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25300255|NCT04563559|Prednisolone phosphate|prednisolone phosphate|mesh-list
25300256|NCT04563559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25300257|NCT04563559|Glucocorticoids|glucocorticoids|mesh-ancestor
25300258|NCT04563559|Hormones|hormones|mesh-ancestor
25300259|NCT04563559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25300260|NCT04563559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300261|NCT04563559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25300262|NCT04563559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300263|NCT04563559|Antiemetics|antiemetics|mesh-ancestor
25300264|NCT04563559|Autonomic Agents|autonomic agents|mesh-ancestor
25300265|NCT04563559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25300266|NCT04563559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25300267|NCT04563559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25300268|NCT04563559|Protective Agents|protective agents|mesh-ancestor
25300269|NCT04359017|Lidocaine|lidocaine|mesh-list
25300270|NCT04359017|Anesthetics, Local|anesthetics, local|mesh-ancestor
25300271|NCT04359017|Anesthetics|anesthetics|mesh-ancestor
25300272|NCT04359017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25300274|NCT04359017|Sensory System Agents|sensory system agents|mesh-ancestor
25300275|NCT04359017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25300276|NCT04359017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25300277|NCT04359017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25300278|NCT04359017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25300279|NCT04359017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25300280|NCT04359017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300282|NCT04353310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25300283|NCT04353310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25300284|NCT04353310|Analgesics|analgesics|mesh-ancestor
25300285|NCT04353310|Sensory System Agents|sensory system agents|mesh-ancestor
25300286|NCT04353310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25300287|NCT04353310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300288|NCT04353310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25300289|NCT04353310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25300290|NCT04353310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300291|NCT04353310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25300292|NCT04353310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300293|NCT04330625|Volagidemab|volagidemab|mesh-list
25300294|NCT04330625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25300295|NCT04330625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300296|NCT04234022|Pomalidomide|pomalidomide|mesh-list
25300297|NCT04234022|Immunologic Factors|immunologic factors|mesh-ancestor
25300298|NCT04234022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300299|NCT04234022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25300300|NCT04234022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25300301|NCT04234022|Growth Substances|growth substances|mesh-ancestor
25300302|NCT04234022|Growth Inhibitors|growth inhibitors|mesh-ancestor
25300303|NCT04234022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300304|NCT04165993|Docetaxel|docetaxel|mesh-list
25300305|NCT04165993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300306|NCT04165993|Tubulin Modulators|tubulin modulators|mesh-ancestor
25300307|NCT04165993|Antimitotic Agents|antimitotic agents|mesh-ancestor
25300308|NCT04165993|Mitosis Modulators|mitosis modulators|mesh-ancestor
25300309|NCT04165993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300310|NCT04158635|Gemcitabine|gemcitabine|mesh-list
25300311|NCT04158635|Paclitaxel|paclitaxel|mesh-list
25300312|NCT04158635|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24955233|NCT03866681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24918159|NCT04222920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24955234|NCT03866681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24955236|NCT03866681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24955237|NCT03866681|Immunologic Factors|immunologic factors|mesh-ancestor
25300313|NCT04158635|Bosentan|bosentan|mesh-list
25300314|NCT04158635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25300315|NCT04158635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300316|NCT04158635|Tubulin Modulators|tubulin modulators|mesh-ancestor
25300317|NCT04158635|Antimitotic Agents|antimitotic agents|mesh-ancestor
25300318|NCT04158635|Mitosis Modulators|mitosis modulators|mesh-ancestor
25300319|NCT04158635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300320|NCT04158635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25300321|NCT04158635|Antimetabolites|antimetabolites|mesh-ancestor
25300322|NCT04158635|Antiviral Agents|antiviral agents|mesh-ancestor
25300323|NCT04158635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25300324|NCT04158635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25300325|NCT04158635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25300326|NCT04158635|Immunologic Factors|immunologic factors|mesh-ancestor
25300327|NCT04158635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647898|NCT01473940|Antibodies|antibodies|mesh-list
25178577|NCT04257448|Durvalumab|durvalumab|mesh-list
25178578|NCT04257448|Romidepsin|romidepsin|mesh-list
25178579|NCT04257448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25178580|NCT04257448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178581|NCT04257448|Tubulin Modulators|tubulin modulators|mesh-ancestor
25178582|NCT04257448|Antimitotic Agents|antimitotic agents|mesh-ancestor
24619885|NCT01054118|Hormones|hormones|mesh-ancestor
25178583|NCT04257448|Mitosis Modulators|mitosis modulators|mesh-ancestor
25178584|NCT04257448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178585|NCT04257448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25178586|NCT04257448|Antimetabolites|antimetabolites|mesh-ancestor
25178587|NCT04257448|Antiviral Agents|antiviral agents|mesh-ancestor
25178588|NCT04257448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25178589|NCT04257448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25178590|NCT04257448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25178591|NCT04257448|Immunologic Factors|immunologic factors|mesh-ancestor
25178592|NCT04257448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178593|NCT04257448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25178594|NCT04257448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25178595|NCT04257448|Growth Substances|growth substances|mesh-ancestor
25178596|NCT04257448|Growth Inhibitors|growth inhibitors|mesh-ancestor
25300328|NCT04158635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25300329|NCT04158635|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25300330|NCT04070378|Daratumumab|daratumumab|mesh-list
25300331|NCT04070378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300332|NCT03991988|Montelukast|montelukast|mesh-list
25300333|NCT03991988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25300334|NCT03991988|Respiratory System Agents|respiratory system agents|mesh-ancestor
25300335|NCT03991988|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25300336|NCT03991988|Hormone Antagonists|hormone antagonists|mesh-ancestor
25300337|NCT03991988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25300338|NCT03991988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825343|NCT00005586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25060327|NCT03480360|Mycophenolic Acid|mycophenolic acid|mesh-list
24617908|NCT01046006|Antiemetics|antiemetics|mesh-ancestor
25300339|NCT03991988|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25300340|NCT03991988|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25300341|NCT03991988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300342|NCT03984045|Lidocaine|lidocaine|mesh-list
25300343|NCT03984045|Prochlorperazine|prochlorperazine|mesh-list
25300344|NCT03984045|Anesthetics, Local|anesthetics, local|mesh-ancestor
25300345|NCT03984045|Anesthetics|anesthetics|mesh-ancestor
25300346|NCT03984045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25300347|NCT03984045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300348|NCT03984045|Sensory System Agents|sensory system agents|mesh-ancestor
25300349|NCT03984045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25300350|NCT03984045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25300351|NCT03984045|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25300352|NCT03984045|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25300353|NCT03984045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25300354|NCT03984045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300355|NCT03984045|Antiemetics|antiemetics|mesh-ancestor
25300356|NCT03984045|Autonomic Agents|autonomic agents|mesh-ancestor
25647899|NCT01473940|Immunoglobulins|immunoglobulins|mesh-list
25647900|NCT01473940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25647901|NCT01473940|Immunologic Factors|immunologic factors|mesh-ancestor
25647902|NCT01473940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647903|NCT01473940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25647904|NCT01473940|Antimetabolites|antimetabolites|mesh-ancestor
25647905|NCT01473940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647906|NCT01473940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647907|NCT01473940|Antiviral Agents|antiviral agents|mesh-ancestor
25647908|NCT01473940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25647909|NCT01473940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25647910|NCT01473940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25647911|NCT01473940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25647912|NCT01473953|Liraglutide|liraglutide|mesh-list
25647913|NCT01473953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25647914|NCT01473953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647915|NCT01473953|Incretins|incretins|mesh-ancestor
25647916|NCT01473953|Hormones|hormones|mesh-ancestor
25647917|NCT01473953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25647918|NCT01474018|Bromocriptine|bromocriptine|mesh-list
25647919|NCT01474018|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25178654|NCT04210505|Plasma Substitutes|plasma substitutes|mesh-ancestor
25178655|NCT04210505|Blood Substitutes|blood substitutes|mesh-ancestor
25178656|NCT04210505|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25178657|NCT04210505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25204968|NCT05260255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25204969|NCT05260255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25300357|NCT03984045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25300358|NCT03984045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25300359|NCT03984045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25300360|NCT03984045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25300361|NCT03984045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25300362|NCT03984045|Dopamine Agents|dopamine agents|mesh-ancestor
25300363|NCT03984045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25300364|NCT03930602|Fluvoxamine|fluvoxamine|mesh-list
25300365|NCT03930602|BMS-986165|bms-986165|mesh-list
25300366|NCT03930602|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25300367|NCT03930602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25300368|NCT03930602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25300369|NCT03930602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300370|NCT03930602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25300371|NCT03930602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25300372|NCT03930602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25300373|NCT03930602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25300374|NCT03930602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300375|NCT03930602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25300376|NCT03930602|Serotonin Agents|serotonin agents|mesh-ancestor
25300377|NCT03930602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25300378|NCT03930602|Antidepressive Agents|antidepressive agents|mesh-ancestor
25300379|NCT03930602|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25300380|NCT03930602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25300381|NCT03930602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25300382|NCT03930602|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25300383|NCT03930602|Dermatologic Agents|dermatologic agents|mesh-ancestor
25300384|NCT03930602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25300385|NCT03927144|Erenumab|erenumab|mesh-list
25300386|NCT03927144|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25300387|NCT03927144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300388|NCT03927144|Analgesics|analgesics|mesh-ancestor
25300389|NCT03927144|Sensory System Agents|sensory system agents|mesh-ancestor
25300390|NCT03927144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25300391|NCT03927144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300392|NCT03889795|Metformin|metformin|mesh-list
25300393|NCT03889795|Digoxin|digoxin|mesh-list
25300394|NCT03889795|Simvastatin|simvastatin|mesh-list
25300395|NCT03889795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25300396|NCT03889795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300397|NCT03889795|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25300398|NCT03889795|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25300399|NCT03889795|Antimetabolites|antimetabolites|mesh-ancestor
25300400|NCT03889795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300401|NCT03889795|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25300402|NCT03889795|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25300403|NCT03889795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25300404|NCT03889795|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24393303|NCT00129506|Oxytocics|oxytocics|mesh-ancestor
25300405|NCT03889795|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25300406|NCT03889795|Protective Agents|protective agents|mesh-ancestor
25300407|NCT03872791|Paclitaxel|paclitaxel|mesh-list
25300408|NCT03872791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25300409|NCT03872791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511252|NCT00567983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25300410|NCT03872791|Tubulin Modulators|tubulin modulators|mesh-ancestor
25300411|NCT03872791|Antimitotic Agents|antimitotic agents|mesh-ancestor
25300412|NCT03872791|Mitosis Modulators|mitosis modulators|mesh-ancestor
25300413|NCT03872791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300414|NCT03843151|Itraconazole|itraconazole|mesh-list
25300426|NCT03822793|Tranexamic Acid|tranexamic acid|mesh-list
25300427|NCT03822793|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25647920|NCT01474018|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25647921|NCT01474018|Hormone Antagonists|hormone antagonists|mesh-ancestor
25647922|NCT01474018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25647923|NCT01474018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647924|NCT01474018|Dopamine Agonists|dopamine agonists|mesh-ancestor
25647925|NCT01474018|Dopamine Agents|dopamine agents|mesh-ancestor
25178675|NCT04166877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178676|NCT04166877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25178677|NCT04166877|Tocolytic Agents|tocolytic agents|mesh-ancestor
25300428|NCT03822793|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25300429|NCT03822793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300430|NCT03822793|Hemostatics|hemostatics|mesh-ancestor
25300431|NCT03822793|Coagulants|coagulants|mesh-ancestor
25300445|NCT03710421|Cyclophosphamide|cyclophosphamide|mesh-list
25300446|NCT03710421|Fludarabine|fludarabine|mesh-list
25300447|NCT03710421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25300448|NCT03710421|Immunologic Factors|immunologic factors|mesh-ancestor
25300449|NCT03710421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300450|NCT03710421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25300451|NCT03710421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25300452|NCT03710421|Alkylating Agents|alkylating agents|mesh-ancestor
25300453|NCT03710421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300454|NCT03710421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300455|NCT03710421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25300456|NCT03663166|Nivolumab|nivolumab|mesh-list
25300457|NCT03663166|Ipilimumab|ipilimumab|mesh-list
25300458|NCT03663166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25300459|NCT03663166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300460|NCT03663166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25300461|NCT03663166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300462|NCT03661047|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
25300463|NCT03661047|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25300464|NCT03661047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25300465|NCT03554317|Nivolumab|nivolumab|mesh-list
25300466|NCT03554317|Methyltestosterone|methyltestosterone|mesh-list
25300467|NCT03554317|Testosterone|testosterone|mesh-list
25300468|NCT03554317|Testosterone undecanoate|testosterone undecanoate|mesh-list
25300469|NCT03554317|Testosterone enanthate|testosterone enanthate|mesh-list
25300470|NCT03554317|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25300471|NCT03554317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25300472|NCT03554317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300473|NCT03554317|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25300474|NCT03554317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300475|NCT03554317|Androgens|androgens|mesh-ancestor
25300476|NCT03554317|Hormones|hormones|mesh-ancestor
25300477|NCT03554317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25300478|NCT03554317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300479|NCT03554317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25300480|NCT03554317|Anabolic Agents|anabolic agents|mesh-ancestor
25300481|NCT03430063|Ipilimumab|ipilimumab|mesh-list
25300482|NCT03430063|Cemiplimab|cemiplimab|mesh-list
25300483|NCT03430063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25300487|NCT03422731|Alovudine|alovudine|mesh-list
25300488|NCT03422731|Antiviral Agents|antiviral agents|mesh-ancestor
25300489|NCT03422731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25300490|NCT03306394|Trifluridine|trifluridine|mesh-list
25300491|NCT03306394|Antimetabolites|antimetabolites|mesh-ancestor
25300492|NCT03306394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300493|NCT03306394|Antiviral Agents|antiviral agents|mesh-ancestor
25300494|NCT03306394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25300495|NCT03290950|Dexamethasone|dexamethasone|mesh-list
25300496|NCT03290950|Dexamethasone acetate|dexamethasone acetate|mesh-list
25300497|NCT03290950|Lenalidomide|lenalidomide|mesh-list
25300498|NCT03290950|Daratumumab|daratumumab|mesh-list
25300499|NCT03290950|BB 1101|bb 1101|mesh-list
25647926|NCT01474018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25647927|NCT01474018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647928|NCT01474109|Macitentan|macitentan|mesh-list
25647929|NCT01474109|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25647930|NCT01474109|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25647931|NCT01474109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300500|NCT03290950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24758297|NCT01744964|Emetics|emetics|mesh-ancestor
24809708|NCT02035982|Rivastigmine|rivastigmine|mesh-list
24809710|NCT02035982|Galantamine|galantamine|mesh-list
24809711|NCT02035982|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
24809712|NCT02035982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809713|NCT02035982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809714|NCT02035982|Cholinergic Agents|cholinergic agents|mesh-ancestor
24809715|NCT02035982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24809716|NCT02035982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809717|NCT02035982|Nootropic Agents|nootropic agents|mesh-ancestor
24809718|NCT02035982|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24809719|NCT02035982|Autonomic Agents|autonomic agents|mesh-ancestor
25300501|NCT03290950|Antiemetics|antiemetics|mesh-ancestor
25300502|NCT03290950|Autonomic Agents|autonomic agents|mesh-ancestor
25300503|NCT03290950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25300504|NCT03290950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300505|NCT03290950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25300506|NCT03290950|Glucocorticoids|glucocorticoids|mesh-ancestor
25300507|NCT03290950|Hormones|hormones|mesh-ancestor
25300508|NCT03290950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25300509|NCT03290950|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25300510|NCT03290950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300511|NCT03290950|Protease Inhibitors|protease inhibitors|mesh-ancestor
25300512|NCT03290950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25300513|NCT03290950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300514|NCT03290950|Immunologic Factors|immunologic factors|mesh-ancestor
25300515|NCT03290950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25300516|NCT03290950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25300517|NCT03290950|Growth Substances|growth substances|mesh-ancestor
25300518|NCT03290950|Growth Inhibitors|growth inhibitors|mesh-ancestor
25300519|NCT03249844|Methylprednisolone|methylprednisolone|mesh-list
25300520|NCT03249844|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25300521|NCT03249844|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25300522|NCT03249844|Prednisolone|prednisolone|mesh-list
25300523|NCT03249844|Prednisolone acetate|prednisolone acetate|mesh-list
25300524|NCT03249844|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25300525|NCT03249844|Prednisolone phosphate|prednisolone phosphate|mesh-list
25300526|NCT03249844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25300527|NCT03249844|Antiemetics|antiemetics|mesh-ancestor
25300528|NCT03249844|Autonomic Agents|autonomic agents|mesh-ancestor
25300529|NCT03249844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25300530|NCT03249844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300531|NCT03249844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25300532|NCT03249844|Glucocorticoids|glucocorticoids|mesh-ancestor
25300533|NCT03249844|Hormones|hormones|mesh-ancestor
25300534|NCT03249844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25300535|NCT03249844|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25300536|NCT03249844|Protective Agents|protective agents|mesh-ancestor
25300537|NCT03249844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25300538|NCT03249844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300539|NCT03172754|Nivolumab|nivolumab|mesh-list
25300540|NCT03172754|Axitinib|axitinib|mesh-list
25300541|NCT03172754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24884948|NCT03110744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25300542|NCT03172754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300543|NCT03172754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25300544|NCT03172754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300545|NCT03172754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25300546|NCT03172754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825344|NCT00005586|Immunologic Factors|immunologic factors|mesh-ancestor
24511391|NCT00568503|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25300551|NCT02755272|Gemcitabine|gemcitabine|mesh-list
25300552|NCT02755272|Carboplatin|carboplatin|mesh-list
25300553|NCT02755272|Pembrolizumab|pembrolizumab|mesh-list
25300554|NCT02755272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647932|NCT01474109|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25647933|NCT01474122|Macitentan|macitentan|mesh-list
25647934|NCT01474122|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25647935|NCT01474122|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25647936|NCT01474122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647937|NCT01474122|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25647938|NCT01474200|Furosemide|furosemide|mesh-list
25647939|NCT01474200|Diuretics|diuretics|mesh-list
25647940|NCT01474200|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
25647941|NCT01474200|Natriuretic Agents|natriuretic agents|mesh-ancestor
25647942|NCT01474200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178785|NCT04083157|Vaccines|vaccines|mesh-list
25178786|NCT04083157|Immunologic Factors|immunologic factors|mesh-ancestor
25178787|NCT04083157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178788|NCT04083157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25178789|NCT04083157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178790|NCT04083157|Interferon Inducers|interferon inducers|mesh-ancestor
24758398|NCT01745614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24758399|NCT01745614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758400|NCT01745614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300555|NCT02755272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25300556|NCT02755272|Antimetabolites|antimetabolites|mesh-ancestor
25300557|NCT02755272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300558|NCT02755272|Antiviral Agents|antiviral agents|mesh-ancestor
25300559|NCT02755272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25300560|NCT02755272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25300561|NCT02755272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25300562|NCT02755272|Immunologic Factors|immunologic factors|mesh-ancestor
25300563|NCT02755272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300564|NCT02755272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25300565|NCT02359513|Fluoxetine|fluoxetine|mesh-list
25300566|NCT02359513|Antidepressive Agents|antidepressive agents|mesh-list
25300567|NCT02359513|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25300568|NCT02359513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25300569|NCT02359513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25300570|NCT02359513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300571|NCT02359513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25300572|NCT02359513|Serotonin Agents|serotonin agents|mesh-ancestor
25300573|NCT02359513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300574|NCT02359513|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25300575|NCT02359513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25300576|NCT02359513|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25300577|NCT02359513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25300578|NCT02359513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25300579|NCT02267343|Nivolumab|nivolumab|mesh-list
25300580|NCT02267343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25300581|NCT02267343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300582|NCT02267343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25300583|NCT02267343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300584|NCT02261285|Nivolumab|nivolumab|mesh-list
25300585|NCT02261285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24955768|NCT03861598|Vasodilator Agents|vasodilator agents|mesh-ancestor
24955770|NCT03861598|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25300586|NCT02261285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300587|NCT02261285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25300588|NCT02261285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300589|NCT02256800|Leucovorin|leucovorin|mesh-list
25300590|NCT02256800|Bevacizumab|bevacizumab|mesh-list
25300591|NCT02256800|Irinotecan|irinotecan|mesh-list
25300592|NCT02256800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25300593|NCT02256800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300594|NCT02256800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25300595|NCT02256800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25300596|NCT02256800|Growth Substances|growth substances|mesh-ancestor
25300597|NCT02256800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300598|NCT02256800|Growth Inhibitors|growth inhibitors|mesh-ancestor
25300599|NCT02256800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25300600|NCT02256800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25300601|NCT02256800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25300602|NCT02256800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300603|NCT02256800|Antidotes|antidotes|mesh-ancestor
25300604|NCT02256800|Protective Agents|protective agents|mesh-ancestor
25300605|NCT02256800|Vitamin B Complex|vitamin b complex|mesh-ancestor
25300606|NCT02256800|Vitamins|vitamins|mesh-ancestor
25300607|NCT02256800|Micronutrients|micronutrients|mesh-ancestor
25300608|NCT02203682|Doxycycline|doxycycline|mesh-list
25300609|NCT02203682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25647943|NCT01474200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25647944|NCT01474200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647945|NCT01474213|Dexmedetomidine|dexmedetomidine|mesh-list
25647946|NCT01474213|Remifentanil|remifentanil|mesh-list
25647947|NCT01474213|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25647948|NCT01474213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25647949|NCT01474213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647950|NCT01474213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25647951|NCT01474213|Analgesics|analgesics|mesh-ancestor
25178852|NCT04047641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178853|NCT04047641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178854|NCT04047641|Antiviral Agents|antiviral agents|mesh-ancestor
25178855|NCT04047641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25178856|NCT04047641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25178857|NCT04047641|Immunologic Factors|immunologic factors|mesh-ancestor
25178858|NCT04047641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178859|NCT04047641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25178860|NCT04047641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25178861|NCT04047641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25178862|NCT04047641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25178871|NCT04042753|Ipilimumab|ipilimumab|mesh-list
25300610|NCT02203682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25300611|NCT02203682|Antimalarials|antimalarials|mesh-ancestor
25300612|NCT02203682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25300613|NCT02203682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25300614|NCT01903486|Prednisone|prednisone|mesh-list
25300615|NCT01903486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25300616|NCT01903486|Glucocorticoids|glucocorticoids|mesh-ancestor
25300617|NCT01903486|Hormones|hormones|mesh-ancestor
24738802|NCT01677546|Insulin|insulin|mesh-list
25300618|NCT01903486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25300619|NCT01903486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300620|NCT01903486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25300621|NCT01903486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300622|NCT01811368|Cyclosporine|cyclosporine|mesh-list
25300623|NCT01811368|Mycophenolic Acid|mycophenolic acid|mesh-list
25300624|NCT01811368|Rituximab|rituximab|mesh-list
25300625|NCT01811368|Cyclosporins|cyclosporins|mesh-list
25300626|NCT01811368|Thymoglobulin|thymoglobulin|mesh-list
25300627|NCT01811368|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25300628|NCT01811368|Immunoglobulins|immunoglobulins|mesh-list
25300629|NCT01811368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25300630|NCT01811368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300631|NCT01811368|Immunologic Factors|immunologic factors|mesh-ancestor
25300632|NCT01811368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300633|NCT01811368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25300635|NCT01811368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300636|NCT01811368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25300637|NCT01811368|Antifungal Agents|antifungal agents|mesh-ancestor
25300638|NCT01811368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25300639|NCT01811368|Dermatologic Agents|dermatologic agents|mesh-ancestor
25300640|NCT01811368|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25300641|NCT01811368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25300642|NCT01811368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25300643|NCT01811368|Antitubercular Agents|antitubercular agents|mesh-ancestor
25300644|NCT01811368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25300645|NCT01611116|Sirolimus|sirolimus|mesh-list
25300646|NCT01611116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25300647|NCT01611116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25300648|NCT01611116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25300649|NCT01611116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300650|NCT01611116|Antifungal Agents|antifungal agents|mesh-ancestor
25300651|NCT01611116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25300652|NCT01611116|Immunologic Factors|immunologic factors|mesh-ancestor
25300653|NCT01611116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300654|NCT01288625|Amifostine|amifostine|mesh-list
25300655|NCT01288625|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25300656|NCT01288625|Protective Agents|protective agents|mesh-ancestor
25300657|NCT01288625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300658|NCT00599170|Rituximab|rituximab|mesh-list
25647952|NCT01474213|Sensory System Agents|sensory system agents|mesh-ancestor
25647953|NCT01474213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25647954|NCT01474213|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25647955|NCT01474213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25647956|NCT01474213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25647957|NCT01474213|Adrenergic Agents|adrenergic agents|mesh-ancestor
25647958|NCT01474213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25647959|NCT01474213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647960|NCT01474213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25647961|NCT01474213|Narcotics|narcotics|mesh-ancestor
25647962|NCT01474239|Bevacizumab|bevacizumab|mesh-list
25647963|NCT01474239|Fotemustine|fotemustine|mesh-list
25300659|NCT00599170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25300660|NCT00599170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647964|NCT01474239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24758559|NCT01746771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758560|NCT01746771|Tubulin Modulators|tubulin modulators|mesh-ancestor
24758561|NCT01746771|Antimitotic Agents|antimitotic agents|mesh-ancestor
24758562|NCT01746771|Mitosis Modulators|mitosis modulators|mesh-ancestor
24758563|NCT01746771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758564|NCT01746771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25300661|NCT00599170|Immunologic Factors|immunologic factors|mesh-ancestor
25300662|NCT00599170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300663|NCT00599170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25300664|NCT05128292|Selenium|selenium|mesh-list
25300665|NCT05128292|Antioxidants|antioxidants|mesh-ancestor
25300666|NCT05128292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300667|NCT05128292|Protective Agents|protective agents|mesh-ancestor
25300668|NCT05128292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300669|NCT05128292|Trace Elements|trace elements|mesh-ancestor
25300670|NCT05128292|Micronutrients|micronutrients|mesh-ancestor
25300671|NCT05128175|Levodopa|levodopa|mesh-list
25300672|NCT05128175|Carbidopa|carbidopa|mesh-list
25300673|NCT05128175|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25300674|NCT05128175|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25300675|NCT05128175|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25300676|NCT05128175|Dopamine Agents|dopamine agents|mesh-ancestor
25300677|NCT05128175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25300678|NCT05128175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300679|NCT05128175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300680|NCT05128175|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25300681|NCT05128175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078236|NCT03358004|Capecitabine|capecitabine|mesh-list
25078237|NCT03358004|Vinorelbine|vinorelbine|mesh-list
25300682|NCT05128175|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25300683|NCT05128175|Immunologic Factors|immunologic factors|mesh-ancestor
25300684|NCT05128175|Dopamine Agonists|dopamine agonists|mesh-ancestor
25300685|NCT05128162|Psilocybin|psilocybin|mesh-list
25300686|NCT05128162|Hallucinogens|hallucinogens|mesh-ancestor
25300687|NCT05128162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300688|NCT05128162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25300689|NCT05127980|Antibodies|antibodies|mesh-list
25300690|NCT05127980|Autoantibodies|autoantibodies|mesh-list
25300691|NCT05127980|Immunologic Factors|immunologic factors|mesh-ancestor
25300692|NCT05127980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300693|NCT05127746|Donepezil|donepezil|mesh-list
25060492|NCT03479736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25300694|NCT05127746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25300695|NCT05127746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25300696|NCT05127746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300697|NCT05127746|Cholinergic Agents|cholinergic agents|mesh-ancestor
25300698|NCT05127746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25300699|NCT05127746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300700|NCT05127746|Nootropic Agents|nootropic agents|mesh-ancestor
25300701|NCT05127707|Analgesics, Opioid|analgesics, opioid|mesh-list
25300702|NCT05127707|Narcotics|narcotics|mesh-ancestor
25300703|NCT05127707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25300704|NCT05127707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300705|NCT05127707|Analgesics|analgesics|mesh-ancestor
25300706|NCT05127707|Sensory System Agents|sensory system agents|mesh-ancestor
25300707|NCT05127707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25300719|NCT05127369|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25300720|NCT05127369|Antidepressive Agents|antidepressive agents|mesh-ancestor
25300721|NCT05127369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25300722|NCT05127369|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25300723|NCT05127369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25300724|NCT05127369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25300726|NCT05126901|Hematinics|hematinics|mesh-ancestor
25300727|NCT05126693|Botulinum Toxins|botulinum toxins|mesh-list
25300728|NCT05126693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25300729|NCT05126693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25300730|NCT05126693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300731|NCT05126693|Cholinergic Agents|cholinergic agents|mesh-ancestor
25300732|NCT05126693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25647965|NCT01474239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647966|NCT01474239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25647967|NCT01474239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25647968|NCT01474239|Growth Substances|growth substances|mesh-ancestor
25647969|NCT01474239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647970|NCT01474239|Growth Inhibitors|growth inhibitors|mesh-ancestor
25178975|NCT03923725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25178976|NCT03923725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178978|NCT03923725|Schistosomicides|schistosomicides|mesh-ancestor
25178979|NCT03923725|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25178980|NCT03923725|Anthelmintics|anthelmintics|mesh-ancestor
25178981|NCT03922048|Bupivacaine|bupivacaine|mesh-list
25178982|NCT03922048|Anesthetics, Local|anesthetics, local|mesh-ancestor
24496364|NCT00504413|Anesthetics, General|anesthetics, general|mesh-ancestor
25178983|NCT03922048|Anesthetics|anesthetics|mesh-ancestor
25178984|NCT03922048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25178985|NCT03922048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178986|NCT03922048|Sensory System Agents|sensory system agents|mesh-ancestor
25178987|NCT03922048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25300733|NCT05126693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300734|NCT05126602|Vitamin D|vitamin d|mesh-list
25300735|NCT05126602|Ergocalciferols|ergocalciferols|mesh-list
25300736|NCT05126602|Cholecalciferol|cholecalciferol|mesh-list
25300737|NCT05126602|Vitamins|vitamins|mesh-list
25300738|NCT05126602|Micronutrients|micronutrients|mesh-ancestor
25300739|NCT05126602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300740|NCT05126602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25300741|NCT05126602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24955987|NCT03859219|Rozanolixizumab|rozanolixizumab|mesh-list
24955988|NCT03859219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24918684|NCT04217356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918687|NCT04217148|Dexamethasone|dexamethasone|mesh-list
24511696|NCT00570245|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24511697|NCT00570245|Vasodilator Agents|vasodilator agents|mesh-ancestor
25300747|NCT05126147|Hydroxychloroquine|hydroxychloroquine|mesh-list
25300748|NCT05126147|Antimalarials|antimalarials|mesh-ancestor
25300749|NCT05126147|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25300750|NCT05126147|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25300751|NCT05126147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25300752|NCT05126147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25300753|NCT05126147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300754|NCT05126147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25300758|NCT05126004|Acetylcysteine|acetylcysteine|mesh-list
25300759|NCT05126004|Azacitidine|azacitidine|mesh-list
25300760|NCT05126004|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25300761|NCT05126004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25300762|NCT05126004|Antimetabolites|antimetabolites|mesh-ancestor
25300763|NCT05126004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300764|NCT05126004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300765|NCT05126004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25300766|NCT05126004|Antiviral Agents|antiviral agents|mesh-ancestor
25300767|NCT05126004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25300768|NCT05126004|Expectorants|expectorants|mesh-ancestor
25300769|NCT05126004|Respiratory System Agents|respiratory system agents|mesh-ancestor
25300770|NCT05126004|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25300771|NCT05126004|Antioxidants|antioxidants|mesh-ancestor
25300772|NCT05126004|Protective Agents|protective agents|mesh-ancestor
25300773|NCT05126004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300774|NCT05126004|Antidotes|antidotes|mesh-ancestor
25300775|NCT05125718|Anti-Infective Agents|anti-infective agents|mesh-list
25300776|NCT05125718|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25300777|NCT05125640|Progesterone|progesterone|mesh-list
25300778|NCT05125640|Progestins|progestins|mesh-ancestor
25300779|NCT05125640|Hormones|hormones|mesh-ancestor
25300780|NCT05125640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25300781|NCT05125640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300782|NCT05125627|Progesterone|progesterone|mesh-list
25300783|NCT05125627|Progestins|progestins|mesh-ancestor
25300784|NCT05125627|Hormones|hormones|mesh-ancestor
25300785|NCT05125627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25300786|NCT05125627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647971|NCT01474486|Ergocalciferols|ergocalciferols|mesh-list
25647972|NCT01474486|Thiamine|thiamine|mesh-list
25647973|NCT01474486|Micronutrients|micronutrients|mesh-list
25647974|NCT01474486|Trace Elements|trace elements|mesh-list
25647975|NCT01474486|Vitamins|vitamins|mesh-ancestor
25647976|NCT01474486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647977|NCT01474486|Vitamin B Complex|vitamin b complex|mesh-ancestor
25647978|NCT01474486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25647979|NCT01474486|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25647980|NCT01474512|Ixekizumab|ixekizumab|mesh-list
25647981|NCT01474512|Dermatologic Agents|dermatologic agents|mesh-ancestor
25647982|NCT01474538|Insulin|insulin|mesh-list
25647983|NCT01474538|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25647984|NCT01474538|Insulin Aspart|insulin aspart|mesh-list
25300787|NCT05125588|Meloxicam|meloxicam|mesh-list
25647985|NCT01474538|Insulin Lispro|insulin lispro|mesh-list
25179049|NCT03775525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179050|NCT03775525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179051|NCT03770338|Teriparatide|teriparatide|mesh-list
25179052|NCT03770338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24620001|NCT01055236|Hydroxyzine|hydroxyzine|mesh-list
25179053|NCT03770338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179054|NCT03770338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25300788|NCT05125588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25300789|NCT05125588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25300790|NCT05125588|Analgesics|analgesics|mesh-ancestor
25300791|NCT05125588|Sensory System Agents|sensory system agents|mesh-ancestor
25300792|NCT05125588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25300793|NCT05125588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300794|NCT05125588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25300795|NCT05125588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25300796|NCT05125588|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24626608|NCT01088009|Adefovir|adefovir|mesh-list
25300797|NCT05125588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25300798|NCT05125588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25300799|NCT05125588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300800|NCT05125575|Metformin|metformin|mesh-list
25300801|NCT05125575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25300802|NCT05125575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300803|NCT05125549|Clopidogrel|clopidogrel|mesh-list
25300804|NCT05125549|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25300805|NCT05125549|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25300956|NCT05086393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25300806|NCT05125549|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25300807|NCT05125549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25300808|NCT05125549|Purinergic Agents|purinergic agents|mesh-ancestor
25300809|NCT05125549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25300810|NCT05125549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300811|NCT05125549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300812|NCT05125380|Acetic Acid|acetic acid|mesh-list
25300813|NCT05125380|Retinol acetate|retinol acetate|mesh-list
25300814|NCT05125380|Lugol's solution|lugol's solution|mesh-list
25300815|NCT05125380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25300816|NCT05125380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25300817|NCT05125380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25300818|NCT05125380|Immunologic Factors|immunologic factors|mesh-ancestor
25300819|NCT05125380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300820|NCT05125380|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25300821|NCT05125380|Protective Agents|protective agents|mesh-ancestor
25300822|NCT05125380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300823|NCT05125380|Hemostatics|hemostatics|mesh-ancestor
25300824|NCT05125380|Coagulants|coagulants|mesh-ancestor
25300825|NCT05125328|Remifentanil|remifentanil|mesh-list
25300826|NCT05125328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25300827|NCT05125328|Narcotics|narcotics|mesh-ancestor
25300828|NCT05125328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25300829|NCT05125328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300830|NCT05125328|Analgesics|analgesics|mesh-ancestor
25300831|NCT05125328|Sensory System Agents|sensory system agents|mesh-ancestor
25300832|NCT05125328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25300833|NCT05125055|Paclitaxel|paclitaxel|mesh-list
25300834|NCT05125055|Docetaxel|docetaxel|mesh-list
25300835|NCT05125055|Fluorouracil|fluorouracil|mesh-list
25300836|NCT05125055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25300837|NCT05125055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300838|NCT05125055|Tubulin Modulators|tubulin modulators|mesh-ancestor
25300839|NCT05125055|Antimitotic Agents|antimitotic agents|mesh-ancestor
25300840|NCT05125055|Mitosis Modulators|mitosis modulators|mesh-ancestor
25300841|NCT05125055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300842|NCT05125055|Antimetabolites|antimetabolites|mesh-ancestor
25300843|NCT05125055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25300844|NCT05125055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25300845|NCT05125055|Immunologic Factors|immunologic factors|mesh-ancestor
25300846|NCT05125055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647986|NCT01474538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25647987|NCT01474538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25647988|NCT01474551|Vemurafenib|vemurafenib|mesh-list
25647989|NCT01474551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25647990|NCT01474551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25647991|NCT01474551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25647992|NCT01474551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179074|NCT03755791|Atezolizumab|atezolizumab|mesh-list
25179075|NCT03755791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179076|NCT03755791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25179077|NCT03755791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25179078|NCT03755791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758765|NCT01747668|Vitamin E|vitamin e|mesh-list
25179088|NCT03741517|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25179089|NCT03741517|Edotreotide|edotreotide|mesh-list
25300847|NCT05125042|Amiodarone|amiodarone|mesh-list
25300848|NCT05125042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25300849|NCT05125042|Vasodilator Agents|vasodilator agents|mesh-ancestor
25300850|NCT05125042|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25300851|NCT05125042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25300852|NCT05125042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300853|NCT05125042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24885437|NCT05172570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300854|NCT05125042|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25300855|NCT05125042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25300856|NCT05125042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25301305|NCT04373733|Favipiravir|favipiravir|mesh-list
25300857|NCT05125042|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25300858|NCT05125042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25300859|NCT05125042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25300860|NCT05124951|Carboplatin|carboplatin|mesh-list
25300861|NCT05124951|Etoposide|etoposide|mesh-list
25300862|NCT05124951|Etoposide phosphate|etoposide phosphate|mesh-list
25300863|NCT05124951|Ifosfamide|ifosfamide|mesh-list
25300864|NCT05124951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300865|NCT05124951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25300866|NCT05124951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25300867|NCT05124951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25300868|NCT05124951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25300869|NCT05124951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300870|NCT05124951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25300871|NCT05124951|Alkylating Agents|alkylating agents|mesh-ancestor
25300872|NCT05124938|Hormones|hormones|mesh-list
25300873|NCT05124938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25300874|NCT05124938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300875|NCT05124730|Metformin|metformin|mesh-list
25300876|NCT05124730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25300877|NCT05124730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300878|NCT05124717|Metformin|metformin|mesh-list
25300879|NCT05124717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25300880|NCT05124717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300881|NCT05124431|Everolimus|everolimus|mesh-list
25300882|NCT05124431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300883|NCT05124431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25300884|NCT05124431|Immunologic Factors|immunologic factors|mesh-ancestor
25300885|NCT05124431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300886|NCT05115591|Anesthetics|anesthetics|mesh-list
25300887|NCT05115591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25300888|NCT05115591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300889|NCT05115201|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25300890|NCT05115201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25300891|NCT05109949|Dapagliflozin|dapagliflozin|mesh-list
25300892|NCT05109949|Empagliflozin|empagliflozin|mesh-list
25300893|NCT05109949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25300894|NCT05109949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300895|NCT05109949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25300896|NCT05109949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300897|NCT05104918|Vortioxetine|vortioxetine|mesh-list
25300898|NCT05104918|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25300899|NCT05104918|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25300900|NCT05104918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25300901|NCT05104918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25300902|NCT05104918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25647993|NCT01474590|Doxycycline|doxycycline|mesh-list
25647994|NCT01474590|Isotretinoin|isotretinoin|mesh-list
25647995|NCT01474590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25647996|NCT01474590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25647997|NCT01474590|Antimalarials|antimalarials|mesh-ancestor
25647998|NCT01474590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25647999|NCT01474590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25648000|NCT01474590|Dermatologic Agents|dermatologic agents|mesh-ancestor
25648001|NCT01474746|Sertraline|sertraline|mesh-list
25179141|NCT03672500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25179142|NCT03672500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25179143|NCT03672500|Adrenergic Agents|adrenergic agents|mesh-ancestor
25179144|NCT03672500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25179145|NCT03672500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496771|NCT00506623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25179146|NCT03672500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25179151|NCT03672500|Mydriatics|mydriatics|mesh-ancestor
25300903|NCT05104918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25300904|NCT05104918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300905|NCT05104918|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25300906|NCT05104918|Antidepressive Agents|antidepressive agents|mesh-ancestor
25300907|NCT05104918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25300908|NCT05104918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25300909|NCT05104918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25300910|NCT05104918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25300911|NCT05104918|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25300912|NCT05104918|Serotonin Agents|serotonin agents|mesh-ancestor
25300913|NCT05104918|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25300914|NCT05104918|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25300915|NCT05104918|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25300916|NCT05104918|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25300918|NCT05089942|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25300919|NCT05089942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25300920|NCT05089942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300921|NCT05087914|Naproxen|naproxen|mesh-list
25300922|NCT05087914|Levodopa|levodopa|mesh-list
25300923|NCT05087914|Carbidopa|carbidopa|mesh-list
25300924|NCT05087914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25300925|NCT05087914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25300926|NCT05087914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25300927|NCT05087914|Analgesics|analgesics|mesh-ancestor
25300928|NCT05087914|Sensory System Agents|sensory system agents|mesh-ancestor
25300929|NCT05087914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25300934|NCT05087914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25300935|NCT05087914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25300936|NCT05087914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300937|NCT05087914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25300938|NCT05087914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25300939|NCT05087914|Dopamine Agents|dopamine agents|mesh-ancestor
25300940|NCT05087914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25300941|NCT05087914|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25300942|NCT05087914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25300943|NCT05087914|Immunologic Factors|immunologic factors|mesh-ancestor
25300944|NCT05087914|Dopamine Agonists|dopamine agonists|mesh-ancestor
25300945|NCT05086393|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25300946|NCT05086393|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25300947|NCT05086393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25300948|NCT05086393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25300949|NCT05086393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300950|NCT05086393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25300951|NCT05086393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300952|NCT05086393|Analgesics|analgesics|mesh-ancestor
25300953|NCT05086393|Sensory System Agents|sensory system agents|mesh-ancestor
25300954|NCT05086393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25300955|NCT05086393|Antidepressive Agents|antidepressive agents|mesh-ancestor
25300957|NCT05086393|Dopamine Agents|dopamine agents|mesh-ancestor
25300958|NCT05073172|Sulfadiazine|sulfadiazine|mesh-list
25300959|NCT05073172|Silver Sulfadiazine|silver sulfadiazine|mesh-list
25300960|NCT05073172|Petrolatum|petrolatum|mesh-list
25300961|NCT05073172|Mineral Oil|mineral oil|mesh-list
25300962|NCT05073172|Emollients|emollients|mesh-ancestor
25300963|NCT05073172|Dermatologic Agents|dermatologic agents|mesh-ancestor
25300964|NCT05073172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25300965|NCT05073172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25648002|NCT01474746|Antidepressive Agents|antidepressive agents|mesh-ancestor
25648003|NCT01474746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25648004|NCT01474746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25648005|NCT01474746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25648006|NCT01474746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25648007|NCT01474746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648008|NCT01474746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25179214|NCT03542266|Antimetabolites|antimetabolites|mesh-ancestor
25179215|NCT03542266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179216|NCT03542266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179217|NCT03542266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25179218|NCT03537131|Dapagliflozin|dapagliflozin|mesh-list
25179219|NCT03537131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25179220|NCT03537131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179221|NCT03537131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25179222|NCT03537131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179223|NCT03534284|Trazodone|trazodone|mesh-list
25179224|NCT03534284|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25179225|NCT03534284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25179226|NCT03534284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25179227|NCT03534284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179228|NCT03534284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25179229|NCT03534284|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25300966|NCT05073172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25300967|NCT05073172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25300968|NCT05073172|Coccidiostats|coccidiostats|mesh-ancestor
25300969|NCT05073172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25300974|NCT05053880|Pembrolizumab|pembrolizumab|mesh-list
25300975|NCT05053880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25300976|NCT05053880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300977|NCT05047718|Vaccines|vaccines|mesh-list
25300978|NCT05047718|Immunologic Factors|immunologic factors|mesh-ancestor
25300979|NCT05047718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825345|NCT00005586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300980|NCT04979910|Ixekizumab|ixekizumab|mesh-list
25300981|NCT04979910|Dermatologic Agents|dermatologic agents|mesh-ancestor
25300982|NCT04943627|Gemcitabine|gemcitabine|mesh-list
25300983|NCT04943627|Irinotecan|irinotecan|mesh-list
25300984|NCT04943627|Pemetrexed|pemetrexed|mesh-list
25300985|NCT04943627|Topotecan|topotecan|mesh-list
25300986|NCT04943627|Vinorelbine|vinorelbine|mesh-list
25300987|NCT04943627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25300988|NCT04943627|Antimetabolites|antimetabolites|mesh-ancestor
25300989|NCT04943627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25300990|NCT04943627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25300991|NCT04943627|Antiviral Agents|antiviral agents|mesh-ancestor
25300992|NCT04943627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25300993|NCT04943627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25300994|NCT04943627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25300995|NCT04943627|Immunologic Factors|immunologic factors|mesh-ancestor
25300996|NCT04943627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25300997|NCT04943627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25300998|NCT04943627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25300999|NCT04943627|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25301000|NCT04943627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25301001|NCT04943627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25301002|NCT04943627|Tubulin Modulators|tubulin modulators|mesh-ancestor
25301003|NCT04943627|Antimitotic Agents|antimitotic agents|mesh-ancestor
25301004|NCT04943627|Mitosis Modulators|mitosis modulators|mesh-ancestor
25301005|NCT04941508|Dexmedetomidine|dexmedetomidine|mesh-list
25301010|NCT04941508|Analgesics|analgesics|mesh-ancestor
25301011|NCT04941508|Sensory System Agents|sensory system agents|mesh-ancestor
25648009|NCT01474746|Serotonin Agents|serotonin agents|mesh-ancestor
25648010|NCT01474746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648011|NCT01474772|Pregabalin|pregabalin|mesh-list
25648012|NCT01474772|Analgesics|analgesics|mesh-ancestor
25648013|NCT01474772|Sensory System Agents|sensory system agents|mesh-ancestor
25648014|NCT01474772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25648015|NCT01474772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648016|NCT01474772|Anticonvulsants|anticonvulsants|mesh-ancestor
25648017|NCT01474772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25648018|NCT01474772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25648019|NCT01474772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648020|NCT01474772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25648021|NCT01474772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25648022|NCT01474772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25648023|NCT01474772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25648024|NCT01474772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25301012|NCT04941508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25301013|NCT04941508|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25301014|NCT04941508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25301015|NCT04941508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25179285|NCT03523975|Rituximab|rituximab|mesh-list
25179286|NCT03523975|Lenalidomide|lenalidomide|mesh-list
25179287|NCT03523975|Venetoclax|venetoclax|mesh-list
25179288|NCT03523975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25179289|NCT03523975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758932|NCT01748526|Canagliflozin|canagliflozin|mesh-list
24496965|NCT00507585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24956420|NCT03854383|Misoprostol|misoprostol|mesh-list
24497109|NCT00508040|Immunologic Factors|immunologic factors|mesh-ancestor
25179290|NCT03523975|Immunologic Factors|immunologic factors|mesh-ancestor
25301016|NCT04941508|Adrenergic Agents|adrenergic agents|mesh-ancestor
25301017|NCT04941508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25301018|NCT04941508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301019|NCT04933331|Silver Nitrate|silver nitrate|mesh-list
25301020|NCT04933331|Fluorides|fluorides|mesh-list
25301021|NCT04933331|Fluorides, Topical|fluorides, topical|mesh-list
25301022|NCT04933331|Cariostatic Agents|cariostatic agents|mesh-ancestor
25301023|NCT04933331|Protective Agents|protective agents|mesh-ancestor
25301024|NCT04933331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301025|NCT04933331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25301026|NCT04933331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25301027|NCT04932213|Tropicamide|tropicamide|mesh-list
25301028|NCT04932213|Mydriatics|mydriatics|mesh-ancestor
25301029|NCT04932213|Autonomic Agents|autonomic agents|mesh-ancestor
25301030|NCT04932213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25301031|NCT04932213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301032|NCT04932213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25301033|NCT04932213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25301034|NCT04932213|Cholinergic Agents|cholinergic agents|mesh-ancestor
25301035|NCT04932213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25301036|NCT04932213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301037|NCT04909853|Ritonavir|ritonavir|mesh-list
25301038|NCT04909853|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25301039|NCT04909853|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25301040|NCT04909853|Protease Inhibitors|protease inhibitors|mesh-ancestor
25301041|NCT04909853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25301121|NCT04773405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25301042|NCT04909853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301043|NCT04909853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25301044|NCT04909853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25301045|NCT04909853|Antiviral Agents|antiviral agents|mesh-ancestor
25301046|NCT04909853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25301047|NCT04909853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25301048|NCT04909853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25301050|NCT04901988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25301051|NCT04901988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301052|NCT04901988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25301053|NCT04901988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301056|NCT04874831|Avelumab|avelumab|mesh-list
25301057|NCT04874831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25301058|NCT04874831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301061|NCT04862260|Atorvastatin|atorvastatin|mesh-list
25301062|NCT04862260|Ezetimibe|ezetimibe|mesh-list
25301063|NCT04862260|Evolocumab|evolocumab|mesh-list
25301064|NCT04862260|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25301065|NCT04862260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25301066|NCT04862260|Antimetabolites|antimetabolites|mesh-ancestor
25301067|NCT04862260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301068|NCT04862260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25301069|NCT04862260|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25301070|NCT04862260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25301071|NCT04846218|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25301072|NCT04846218|Progesterone|progesterone|mesh-list
25301073|NCT04846218|Progestins|progestins|mesh-ancestor
25301074|NCT04846218|Hormones|hormones|mesh-ancestor
25301075|NCT04846218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25301076|NCT04846218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301077|NCT04846218|Luteolytic Agents|luteolytic agents|mesh-ancestor
25648025|NCT01474915|Promethazine|promethazine|mesh-list
25648026|NCT01474915|Diphenhydramine|diphenhydramine|mesh-list
25648027|NCT01474915|Dexamethasone|dexamethasone|mesh-list
25648028|NCT01474915|Ondansetron|ondansetron|mesh-list
25648029|NCT01474915|Aprepitant|aprepitant|mesh-list
25648030|NCT01474915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25648031|NCT01474915|Antiemetics|antiemetics|mesh-ancestor
25648032|NCT01474915|Autonomic Agents|autonomic agents|mesh-ancestor
25648033|NCT01474915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25648034|NCT01474915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179359|NCT03504501|Lamotrigine|lamotrigine|mesh-list
25179360|NCT03504501|Lovastatin|lovastatin|mesh-list
25179361|NCT03504501|L 647318|l 647318|mesh-list
25179362|NCT03504501|Dihydromevinolin|dihydromevinolin|mesh-list
24497168|NCT00508664|Cetuximab|cetuximab|mesh-list
25179363|NCT03504501|Anticonvulsants|anticonvulsants|mesh-ancestor
25179364|NCT03504501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24497333|NCT00509470|Diuretics|diuretics|mesh-ancestor
25179365|NCT03504501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24449124|NCT00314509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25179366|NCT03504501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179367|NCT03504501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25179368|NCT03504501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179369|NCT03504501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25179370|NCT03504501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25179376|NCT03504501|Antimetabolites|antimetabolites|mesh-ancestor
25301078|NCT04846218|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25301079|NCT04846218|Contraceptive Agents|contraceptive agents|mesh-ancestor
25301080|NCT04846218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25301081|NCT04846218|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25301082|NCT04846218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25301083|NCT04846218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301084|NCT04841499|Niacinamide|niacinamide|mesh-list
25301085|NCT04841499|Niacin|niacin|mesh-list
25301086|NCT04841499|Nicotinic Acids|nicotinic acids|mesh-list
25301087|NCT04841499|Vitamin B Complex|vitamin b complex|mesh-ancestor
25301088|NCT04841499|Vitamins|vitamins|mesh-ancestor
25301089|NCT04841499|Micronutrients|micronutrients|mesh-ancestor
25301090|NCT04841499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301091|NCT04841499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25301092|NCT04841499|Antimetabolites|antimetabolites|mesh-ancestor
25301093|NCT04841499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301094|NCT04841499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25301095|NCT04841499|Vasodilator Agents|vasodilator agents|mesh-ancestor
25301096|NCT04773405|Lidocaine|lidocaine|mesh-list
25301097|NCT04773405|Epinephrine|epinephrine|mesh-list
25301098|NCT04773405|Levobupivacaine|levobupivacaine|mesh-list
25301099|NCT04773405|Anesthetics, Local|anesthetics, local|mesh-ancestor
25301100|NCT04773405|Anesthetics|anesthetics|mesh-ancestor
25301101|NCT04773405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25301102|NCT04773405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301103|NCT04773405|Sensory System Agents|sensory system agents|mesh-ancestor
25301104|NCT04773405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25301105|NCT04773405|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25301106|NCT04773405|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25301107|NCT04773405|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25301108|NCT04773405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25301109|NCT04773405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301110|NCT04773405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25301111|NCT04773405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25301112|NCT04773405|Adrenergic Agents|adrenergic agents|mesh-ancestor
25301113|NCT04773405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25301114|NCT04773405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25301115|NCT04773405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25301116|NCT04773405|Autonomic Agents|autonomic agents|mesh-ancestor
25301117|NCT04773405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25301118|NCT04773405|Respiratory System Agents|respiratory system agents|mesh-ancestor
25301119|NCT04773405|Mydriatics|mydriatics|mesh-ancestor
25301120|NCT04773405|Sympathomimetics|sympathomimetics|mesh-ancestor
25301122|NCT04754061|Psilocybin|psilocybin|mesh-list
25648035|NCT01474915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25648036|NCT01474915|Glucocorticoids|glucocorticoids|mesh-ancestor
25648037|NCT01474915|Hormones|hormones|mesh-ancestor
25648038|NCT01474915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25648039|NCT01474915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25648040|NCT01474915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25648041|NCT01474915|Antipruritics|antipruritics|mesh-ancestor
25648042|NCT01474915|Dermatologic Agents|dermatologic agents|mesh-ancestor
25648043|NCT01474915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25648044|NCT01474915|Serotonin Agents|serotonin agents|mesh-ancestor
25648045|NCT01474915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25648046|NCT01474915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648047|NCT01474915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25648048|NCT01474915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25648049|NCT01474915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25301123|NCT04754061|Hallucinogens|hallucinogens|mesh-ancestor
25205103|NCT05201846|Insulin|insulin|mesh-list
25179384|NCT03488667|Pembrolizumab|pembrolizumab|mesh-list
25179385|NCT03488667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25179386|NCT03488667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179387|NCT03485274|Vortioxetine|vortioxetine|mesh-list
25179388|NCT03485274|Antidepressive Agents|antidepressive agents|mesh-ancestor
25301124|NCT04754061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301125|NCT04754061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25301126|NCT04722601|Azacitidine|azacitidine|mesh-list
25301127|NCT04722601|Venetoclax|venetoclax|mesh-list
25301128|NCT04722601|Obinutuzumab|obinutuzumab|mesh-list
25301129|NCT04722601|Cc-486|cc-486|mesh-list
25301130|NCT04722601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25301131|NCT04722601|Antimetabolites|antimetabolites|mesh-ancestor
25301132|NCT04722601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301133|NCT04722601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301134|NCT04722601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25301135|NCT04722601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25301136|NCT04700514|Dexmedetomidine|dexmedetomidine|mesh-list
25301137|NCT04700514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25301138|NCT04700514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25301139|NCT04700514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301140|NCT04700514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25301141|NCT04700514|Analgesics|analgesics|mesh-ancestor
25301142|NCT04700514|Sensory System Agents|sensory system agents|mesh-ancestor
25301143|NCT04700514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25301144|NCT04700514|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25301145|NCT04700514|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25301146|NCT04700514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25301147|NCT04700514|Adrenergic Agents|adrenergic agents|mesh-ancestor
25301148|NCT04700514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25301149|NCT04700514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301150|NCT04693468|Palbociclib|palbociclib|mesh-list
25301151|NCT04693468|Axitinib|axitinib|mesh-list
25301152|NCT04693468|Crizotinib|crizotinib|mesh-list
25301153|NCT04693468|Talazoparib|talazoparib|mesh-list
25301154|NCT04693468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301155|NCT04693468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25301156|NCT04693468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25301164|NCT04654312|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25301165|NCT04654312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25301166|NCT04654312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301168|NCT04635644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25301169|NCT04635644|Narcotics|narcotics|mesh-ancestor
25301170|NCT04635644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25301171|NCT04635644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301172|NCT04635644|Analgesics|analgesics|mesh-ancestor
25301173|NCT04635644|Sensory System Agents|sensory system agents|mesh-ancestor
25301174|NCT04635644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25301183|NCT04617067|Gemcitabine|gemcitabine|mesh-list
25301184|NCT04617067|Paclitaxel|paclitaxel|mesh-list
25301185|NCT04617067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25301186|NCT04617067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301187|NCT04617067|Tubulin Modulators|tubulin modulators|mesh-ancestor
25301188|NCT04617067|Antimitotic Agents|antimitotic agents|mesh-ancestor
25301189|NCT04617067|Mitosis Modulators|mitosis modulators|mesh-ancestor
25301190|NCT04617067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301191|NCT04617067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25301192|NCT04617067|Antimetabolites|antimetabolites|mesh-ancestor
25301193|NCT04617067|Antiviral Agents|antiviral agents|mesh-ancestor
25301194|NCT04617067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25301195|NCT04617067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25301196|NCT04617067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25301197|NCT04617067|Immunologic Factors|immunologic factors|mesh-ancestor
25301198|NCT04617067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301199|NCT04584567|Doxycycline|doxycycline|mesh-list
25648050|NCT01474915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25648051|NCT01474915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24452277|NCT00326833|Hydroxocobalamin|hydroxocobalamin|mesh-list
25648052|NCT01474915|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25648053|NCT01474915|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25648054|NCT01474915|Histamine Antagonists|histamine antagonists|mesh-ancestor
25301200|NCT04584567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25301201|NCT04584567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25301202|NCT04584567|Antimalarials|antimalarials|mesh-ancestor
25301203|NCT04584567|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25301204|NCT04584567|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25301205|NCT04578886|Guanfacine|guanfacine|mesh-list
25301206|NCT04578886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25301207|NCT04578886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25301208|NCT04578886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25301209|NCT04578886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25301210|NCT04578886|Adrenergic Agents|adrenergic agents|mesh-ancestor
25301211|NCT04578886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25301212|NCT04578886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301213|NCT04578886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301214|NCT04576325|Voriconazole|voriconazole|mesh-list
25301215|NCT04576325|Antifungal Agents|antifungal agents|mesh-ancestor
25301216|NCT04576325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25301217|NCT04576325|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25301218|NCT04576325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25301219|NCT04576325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25301220|NCT04576325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301221|NCT04576325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25301222|NCT04576325|Hormone Antagonists|hormone antagonists|mesh-ancestor
25301223|NCT04576325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25301224|NCT04576325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301225|NCT04576325|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25301226|NCT04572828|Naproxen|naproxen|mesh-list
25301227|NCT04572828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25301228|NCT04572828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25301229|NCT04572828|Analgesics|analgesics|mesh-ancestor
25301249|NCT04558112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301271|NCT04473716|Paclitaxel|paclitaxel|mesh-list
25301272|NCT04473716|Cisplatin|cisplatin|mesh-list
25301273|NCT04473716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25301274|NCT04473716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301275|NCT04473716|Tubulin Modulators|tubulin modulators|mesh-ancestor
25301276|NCT04473716|Antimitotic Agents|antimitotic agents|mesh-ancestor
25301277|NCT04473716|Mitosis Modulators|mitosis modulators|mesh-ancestor
25301278|NCT04473716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301279|NCT04435691|Azacitidine|azacitidine|mesh-list
25301280|NCT04435691|Venetoclax|venetoclax|mesh-list
25301281|NCT04435691|Magrolimab|magrolimab|mesh-list
25301282|NCT04435691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25301283|NCT04435691|Antimetabolites|antimetabolites|mesh-ancestor
25301284|NCT04435691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301285|NCT04435691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301286|NCT04435691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25301287|NCT04435691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25301288|NCT04422743|Tramiprosate|tramiprosate|mesh-list
25301289|NCT04422743|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
25301290|NCT04422743|Nootropic Agents|nootropic agents|mesh-ancestor
25301291|NCT04422743|Anticonvulsants|anticonvulsants|mesh-ancestor
25301292|NCT04422743|GABA Agonists|gaba agonists|mesh-ancestor
25301293|NCT04422743|GABA Agents|gaba agents|mesh-ancestor
25301294|NCT04422743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25301295|NCT04422743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301296|NCT04422743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301297|NCT04413526|Chlorotrianisene|chlorotrianisene|mesh-list
25301298|NCT04413526|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25301299|NCT04413526|Estrogens|estrogens|mesh-ancestor
25301300|NCT04413526|Hormones|hormones|mesh-ancestor
25301301|NCT04413526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25301302|NCT04413526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301303|NCT04413526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25301304|NCT04413526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301311|NCT04334070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25301312|NCT04334070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25301314|NCT04266912|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25301315|NCT04266912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25301316|NCT04266912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301317|NCT04266912|Immunologic Factors|immunologic factors|mesh-ancestor
25301318|NCT04266912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301319|NCT04264663|Furazolidone|furazolidone|mesh-list
25301320|NCT04264663|Tinidazole|tinidazole|mesh-list
25301321|NCT04264663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25301322|NCT04264663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25301323|NCT04264663|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25301324|NCT04264663|Renal Agents|renal agents|mesh-ancestor
25301325|NCT04264663|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25301326|NCT04264663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25301327|NCT04264663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25301328|NCT04264663|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25301329|NCT04264663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25301330|NCT04264663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301331|NCT04264663|Alkylating Agents|alkylating agents|mesh-ancestor
25301332|NCT04264663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25301333|NCT04256434|Nalbuphine|nalbuphine|mesh-list
25301334|NCT04256434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25301335|NCT04256434|Narcotics|narcotics|mesh-ancestor
25301336|NCT04256434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25301337|NCT04256434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301338|NCT04256434|Analgesics|analgesics|mesh-ancestor
25301339|NCT04256434|Sensory System Agents|sensory system agents|mesh-ancestor
25301340|NCT04256434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25301346|NCT04185012|Benralizumab|benralizumab|mesh-list
25301347|NCT04185012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25301348|NCT04185012|Respiratory System Agents|respiratory system agents|mesh-ancestor
25301349|NCT04139655|Colchicine|colchicine|mesh-list
25301350|NCT04139655|Gout Suppressants|gout suppressants|mesh-ancestor
25301351|NCT04139655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25301352|NCT04139655|Tubulin Modulators|tubulin modulators|mesh-ancestor
25301353|NCT04139655|Antimitotic Agents|antimitotic agents|mesh-ancestor
25301354|NCT04139655|Mitosis Modulators|mitosis modulators|mesh-ancestor
25301355|NCT04139655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301356|NCT04139655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301357|NCT04122287|Levofloxacin|levofloxacin|mesh-list
25301358|NCT04122287|Ofloxacin|ofloxacin|mesh-list
25301359|NCT04122287|Tinidazole|tinidazole|mesh-list
25301360|NCT04122287|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25301361|NCT04122287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25301362|NCT04122287|Renal Agents|renal agents|mesh-ancestor
25301363|NCT04122287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25301364|NCT04122287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25301365|NCT04122287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25301366|NCT04122287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25301367|NCT04122287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301368|NCT04122287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301369|NCT04122287|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25301370|NCT04122287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25301371|NCT04122287|Alkylating Agents|alkylating agents|mesh-ancestor
25301372|NCT04122287|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25301373|NCT04122287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25301374|NCT04122287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25301375|NCT04095858|Methotrexate|methotrexate|mesh-list
25301376|NCT04095858|Tacrolimus|tacrolimus|mesh-list
25301377|NCT04095858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25301378|NCT04095858|Abortifacient Agents|abortifacient agents|mesh-ancestor
25301379|NCT04095858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25301380|NCT04095858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301381|NCT04095858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25301382|NCT04095858|Antimetabolites|antimetabolites|mesh-ancestor
24452308|NCT00327106|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25078366|NCT03357055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25301413|NCT04028115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301439|NCT03946527|Lanreotide|lanreotide|mesh-list
25301440|NCT03946527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301441|NCT03933163|Resveratrol|resveratrol|mesh-list
25301442|NCT03933163|Antioxidants|antioxidants|mesh-ancestor
25301443|NCT03933163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301444|NCT03933163|Protective Agents|protective agents|mesh-ancestor
25301445|NCT03933163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301446|NCT03933163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25301447|NCT03933163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25301448|NCT03927443|Bimatoprost|bimatoprost|mesh-list
25301449|NCT03927443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25301450|NCT03913247|Metronidazole|metronidazole|mesh-list
25301451|NCT03913247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25301452|NCT03913247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25301453|NCT03913247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25301454|NCT03913247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25301455|NCT03828045|Apremilast|apremilast|mesh-list
25301456|NCT03828045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25301457|NCT03828045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25301458|NCT03828045|Analgesics|analgesics|mesh-ancestor
25301467|NCT03828045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301469|NCT03825874|Amikacin|amikacin|mesh-list
25301470|NCT03825874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25301471|NCT03805841|Bromides|bromides|mesh-list
25301473|NCT03801434|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
25301474|NCT03801434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25301475|NCT03801434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25301476|NCT03801434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301498|NCT03719430|Doxorubicin|doxorubicin|mesh-list
25301499|NCT03719430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25301500|NCT03719430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301501|NCT03719430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25301502|NCT03719430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25301503|NCT03719430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25301504|NCT03719430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301506|NCT03693807|Fluorouracil|fluorouracil|mesh-list
25301507|NCT03693807|Floxuridine|floxuridine|mesh-list
25301508|NCT03693807|Oxaliplatin|oxaliplatin|mesh-list
25301509|NCT03693807|Irinotecan|irinotecan|mesh-list
25301510|NCT03693807|Cetuximab|cetuximab|mesh-list
25301511|NCT03693807|Panitumumab|panitumumab|mesh-list
25301512|NCT03693807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25301513|NCT03693807|Antimetabolites|antimetabolites|mesh-ancestor
25301514|NCT03693807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301515|NCT03693807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301516|NCT03693807|Antiviral Agents|antiviral agents|mesh-ancestor
25301517|NCT03693807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25301518|NCT03693807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25301519|NCT03693807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25301520|NCT03693807|Immunologic Factors|immunologic factors|mesh-ancestor
25301521|NCT03693807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301522|NCT03693807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25301523|NCT03693807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25301524|NCT03693807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25301525|NCT03693014|Pembrolizumab|pembrolizumab|mesh-list
25301526|NCT03693014|Nivolumab|nivolumab|mesh-list
25301527|NCT03693014|Ipilimumab|ipilimumab|mesh-list
25301528|NCT03693014|Atezolizumab|atezolizumab|mesh-list
25301529|NCT03693014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25301530|NCT03693014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301531|NCT03693014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25301532|NCT03693014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301553|NCT03577431|Cyclophosphamide|cyclophosphamide|mesh-list
25301554|NCT03577431|Everolimus|everolimus|mesh-list
25301555|NCT03577431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25301556|NCT03577431|Immunologic Factors|immunologic factors|mesh-ancestor
25301557|NCT03577431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301558|NCT03577431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25301559|NCT03577431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24957130|NCT03847441|Cholecalciferol|cholecalciferol|mesh-list
25301560|NCT03577431|Alkylating Agents|alkylating agents|mesh-ancestor
24957131|NCT03847441|Calcipotriene|calcipotriene|mesh-list
25301561|NCT03577431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301562|NCT03577431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301563|NCT03577431|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25301564|NCT03568929|Idelalisib|idelalisib|mesh-list
25301565|NCT03568929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301566|NCT03568929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25301567|NCT03568929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301568|NCT03537690|Paclitaxel|paclitaxel|mesh-list
25301569|NCT03537690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25301570|NCT03537690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25301571|NCT03537690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301572|NCT03537690|Tubulin Modulators|tubulin modulators|mesh-ancestor
25301573|NCT03537690|Antimitotic Agents|antimitotic agents|mesh-ancestor
25301574|NCT03537690|Mitosis Modulators|mitosis modulators|mesh-ancestor
25301575|NCT03537690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301585|NCT03510390|Metformin|metformin|mesh-list
25301586|NCT03510390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25301587|NCT03510390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301588|NCT03442088|Apremilast|apremilast|mesh-list
25301589|NCT03442088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25301590|NCT03442088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25301591|NCT03442088|Analgesics|analgesics|mesh-ancestor
25301592|NCT03442088|Sensory System Agents|sensory system agents|mesh-ancestor
25301593|NCT03442088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25301594|NCT03442088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301595|NCT03442088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25301596|NCT03442088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25301597|NCT03442088|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25179619|NCT03299660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179620|NCT03299660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25179621|NCT03299660|Immunologic Factors|immunologic factors|mesh-ancestor
25179622|NCT03299660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301598|NCT03442088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25301599|NCT03442088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25301600|NCT03442088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301601|NCT03291990|Temozolomide|temozolomide|mesh-list
25301602|NCT03291990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25301603|NCT03291990|Alkylating Agents|alkylating agents|mesh-ancestor
25301604|NCT03291990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301605|NCT03291990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301606|NCT03277924|Doxorubicin|doxorubicin|mesh-list
25301607|NCT03277924|Methotrexate|methotrexate|mesh-list
25301608|NCT03277924|Nivolumab|nivolumab|mesh-list
25301609|NCT03277924|Sunitinib|sunitinib|mesh-list
25301633|NCT03277924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25301634|NCT03277924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25301635|NCT03277924|Growth Substances|growth substances|mesh-ancestor
25301636|NCT03277924|Growth Inhibitors|growth inhibitors|mesh-ancestor
25301637|NCT03277924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25301638|NCT03277924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25301639|NCT03277924|Alkylating Agents|alkylating agents|mesh-ancestor
25301640|NCT03258853|Pancrelipase|pancrelipase|mesh-list
25301641|NCT03258853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25301642|NCT03257267|Cemiplimab|cemiplimab|mesh-list
25301643|NCT03257267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25301644|NCT03257267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301670|NCT03206151|Leucovorin|leucovorin|mesh-list
25301671|NCT03206151|Folic Acid|folic acid|mesh-list
25301672|NCT03206151|Fluorouracil|fluorouracil|mesh-list
25301673|NCT03206151|Irinotecan|irinotecan|mesh-list
25301674|NCT03206151|Levoleucovorin|levoleucovorin|mesh-list
25301675|NCT03206151|Antimetabolites|antimetabolites|mesh-ancestor
25301676|NCT03206151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301677|NCT03206151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25301678|NCT03206151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301679|NCT03206151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25301680|NCT03206151|Immunologic Factors|immunologic factors|mesh-ancestor
25301681|NCT03206151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301682|NCT03206151|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25301683|NCT03206151|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25301684|NCT03206151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25301685|NCT03206151|Antidotes|antidotes|mesh-ancestor
25301686|NCT03206151|Protective Agents|protective agents|mesh-ancestor
25301687|NCT03206151|Vitamin B Complex|vitamin b complex|mesh-ancestor
25301688|NCT03206151|Vitamins|vitamins|mesh-ancestor
25301689|NCT03206151|Micronutrients|micronutrients|mesh-ancestor
25301690|NCT03206151|Hematinics|hematinics|mesh-ancestor
25301691|NCT03165136|Hydroxychloroquine|hydroxychloroquine|mesh-list
25301692|NCT03165136|Antimalarials|antimalarials|mesh-ancestor
25301693|NCT03165136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25301694|NCT03165136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25301695|NCT03165136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25301696|NCT03165136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25301697|NCT03165136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301698|NCT03165136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25301699|NCT03131726|Simvastatin|simvastatin|mesh-list
25301700|NCT03131726|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25301701|NCT03131726|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25301702|NCT03131726|Antimetabolites|antimetabolites|mesh-ancestor
25301703|NCT03131726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301704|NCT03131726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25301705|NCT03131726|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25301706|NCT03131726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25301707|NCT03085719|Pembrolizumab|pembrolizumab|mesh-list
25301708|NCT03085719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25301709|NCT03085719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301710|NCT03049618|Pembrolizumab|pembrolizumab|mesh-list
25301711|NCT03049618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25301712|NCT03049618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301713|NCT03023462|Droperidol|droperidol|mesh-list
25648055|NCT01474915|Histamine Agents|histamine agents|mesh-ancestor
25648056|NCT01474915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25648057|NCT01474915|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25648058|NCT01474915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25301714|NCT03023462|Oxycodone|oxycodone|mesh-list
25301715|NCT03023462|Ondansetron|ondansetron|mesh-list
25825346|NCT00005586|Antidotes|antidotes|mesh-ancestor
25097433|NCT03204032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25097922|NCT03200613|Antithrombins|antithrombins|mesh-ancestor
25097923|NCT03200613|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25097924|NCT03200613|Protease Inhibitors|protease inhibitors|mesh-ancestor
25097925|NCT03200613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25179636|NCT03245840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24945428|NCT03950804|Eculizumab|eculizumab|mesh-list
25179637|NCT03245840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179638|NCT03245840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25179639|NCT03245840|Respiratory System Agents|respiratory system agents|mesh-ancestor
25301716|NCT03023462|Ropivacaine|ropivacaine|mesh-list
25301717|NCT03023462|Anesthetics, Local|anesthetics, local|mesh-ancestor
25301718|NCT03023462|Anesthetics|anesthetics|mesh-ancestor
25301719|NCT03023462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25301720|NCT03023462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301721|NCT03023462|Sensory System Agents|sensory system agents|mesh-ancestor
25301722|NCT03023462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25301723|NCT03023462|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25301724|NCT03023462|Narcotics|narcotics|mesh-ancestor
25301725|NCT03023462|Analgesics|analgesics|mesh-ancestor
25301726|NCT03023462|Antiemetics|antiemetics|mesh-ancestor
25301727|NCT03023462|Autonomic Agents|autonomic agents|mesh-ancestor
25301728|NCT03023462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25301729|NCT03023462|Antipruritics|antipruritics|mesh-ancestor
25301730|NCT03023462|Dermatologic Agents|dermatologic agents|mesh-ancestor
25301731|NCT03023462|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25301732|NCT03023462|Serotonin Agents|serotonin agents|mesh-ancestor
25301733|NCT03023462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25301734|NCT03023462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301735|NCT03023462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25301736|NCT03023462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25301737|NCT03023462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25301738|NCT03023462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25301739|NCT03023462|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25301740|NCT03023462|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25301741|NCT03023462|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25301742|NCT03023462|Dopamine Agents|dopamine agents|mesh-ancestor
25301744|NCT03023449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25301745|NCT03023449|Autonomic Agents|autonomic agents|mesh-ancestor
25301746|NCT03023449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25301747|NCT03023449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301748|NCT03023449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25301749|NCT03023449|Respiratory System Agents|respiratory system agents|mesh-ancestor
25301750|NCT03023449|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25301751|NCT03023449|Antioxidants|antioxidants|mesh-ancestor
25301752|NCT03023449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301753|NCT03023449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25301754|NCT03023449|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25301755|NCT03023449|Vasodilator Agents|vasodilator agents|mesh-ancestor
25301756|NCT03023449|Gasotransmitters|gasotransmitters|mesh-ancestor
25301757|NCT03023449|Protective Agents|protective agents|mesh-ancestor
25301758|NCT02994069|Cisplatin|cisplatin|mesh-list
25301759|NCT02994069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301760|NCT02987686|Infliximab|infliximab|mesh-list
25301761|NCT02987686|Dermatologic Agents|dermatologic agents|mesh-ancestor
25301762|NCT02987686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25301763|NCT02987686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25301764|NCT02963064|Antibodies|antibodies|mesh-list
25301765|NCT02963064|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25301785|NCT02909686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25301786|NCT02909686|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25301787|NCT02909686|Immunologic Factors|immunologic factors|mesh-ancestor
25301788|NCT02865928|Bupivacaine|bupivacaine|mesh-list
25301789|NCT02865928|Anesthetics, Local|anesthetics, local|mesh-ancestor
25301790|NCT02865928|Anesthetics|anesthetics|mesh-ancestor
25648059|NCT01474915|Anesthetics, Local|anesthetics, local|mesh-ancestor
25648060|NCT01474915|Anesthetics|anesthetics|mesh-ancestor
25648061|NCT01474915|Sensory System Agents|sensory system agents|mesh-ancestor
25648062|NCT01474993|Sulforaphane|sulforaphane|mesh-list
25648063|NCT01474993|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25648064|NCT01474993|Protective Agents|protective agents|mesh-ancestor
25648065|NCT01474993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648066|NCT01474993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25648067|NCT01475071|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
25648068|NCT01475071|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25648069|NCT01475071|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25648070|NCT01475071|Dermatologic Agents|dermatologic agents|mesh-ancestor
25179702|NCT03203525|Protective Agents|protective agents|mesh-ancestor
25179703|NCT03203525|Vitamin B Complex|vitamin b complex|mesh-ancestor
25179704|NCT03203525|Vitamins|vitamins|mesh-ancestor
25179705|NCT03203525|Micronutrients|micronutrients|mesh-ancestor
25179706|NCT03203525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25179707|NCT03203525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25179708|NCT03203525|Antifungal Agents|antifungal agents|mesh-ancestor
25179709|NCT03198741|Aspirin|aspirin|mesh-list
25179710|NCT03198741|Clopidogrel|clopidogrel|mesh-list
25179711|NCT03198741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25179712|NCT03198741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25179713|NCT03198741|Analgesics|analgesics|mesh-ancestor
25179714|NCT03198741|Sensory System Agents|sensory system agents|mesh-ancestor
25179715|NCT03198741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25179716|NCT03198741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179717|NCT03198741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25179718|NCT03198741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25179719|NCT03198741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25179720|NCT03198741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25179721|NCT03198741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179722|NCT03198741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25179723|NCT03198741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25179724|NCT03198741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25179725|NCT03198741|Antipyretics|antipyretics|mesh-ancestor
25179726|NCT03198741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25179727|NCT03198741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25179728|NCT03198741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25179729|NCT03198741|Purinergic Agents|purinergic agents|mesh-ancestor
25179730|NCT03198741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25301791|NCT02865928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25301792|NCT02865928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301793|NCT02865928|Sensory System Agents|sensory system agents|mesh-ancestor
25301794|NCT02865928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25301795|NCT02860091|Ropivacaine|ropivacaine|mesh-list
25301796|NCT02860091|Anesthetics, Local|anesthetics, local|mesh-ancestor
25301797|NCT02860091|Anesthetics|anesthetics|mesh-ancestor
25301798|NCT02860091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25301799|NCT02860091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301800|NCT02860091|Sensory System Agents|sensory system agents|mesh-ancestor
25301801|NCT02860091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25301802|NCT02825641|Oxytocin|oxytocin|mesh-list
25301803|NCT02825641|Dinoprostone|dinoprostone|mesh-list
25301804|NCT02825641|Oxytocics|oxytocics|mesh-ancestor
25301805|NCT02825641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25301806|NCT02825641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301807|NCT02824952|Osimertinib|osimertinib|mesh-list
25648071|NCT01475253|Lidocaine|lidocaine|mesh-list
25648072|NCT01475253|Anesthetics, Local|anesthetics, local|mesh-ancestor
25648073|NCT01475253|Anesthetics|anesthetics|mesh-ancestor
25648074|NCT01475253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25648075|NCT01475253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648076|NCT01475253|Sensory System Agents|sensory system agents|mesh-ancestor
25648077|NCT01475253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25648078|NCT01475253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25648079|NCT01475253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25648080|NCT01475253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25648081|NCT01475253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25648082|NCT01475253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648083|NCT01475331|Ethanol|ethanol|mesh-list
25648084|NCT01475331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25648085|NCT01475331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25648086|NCT01475331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25648087|NCT01475331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648088|NCT01475461|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25648089|NCT01475461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25648090|NCT01475461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648091|NCT01475461|Incretins|incretins|mesh-ancestor
25648092|NCT01475461|Hormones|hormones|mesh-ancestor
25648093|NCT01475461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25648094|NCT01475461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25648095|NCT01475461|Protease Inhibitors|protease inhibitors|mesh-ancestor
25648096|NCT01475461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25648097|NCT01475461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205106|NCT05201846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205113|NCT05194189|Ascorbic Acid|ascorbic acid|mesh-list
25205114|NCT05194189|Vitamins|vitamins|mesh-ancestor
25179793|NCT03087773|Empagliflozin|empagliflozin|mesh-list
25179794|NCT03087773|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25179795|NCT03087773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179796|NCT03087773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25179797|NCT03087773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179798|NCT03082755|Gabapentin|gabapentin|mesh-list
25179799|NCT03082755|Analgesics|analgesics|mesh-ancestor
25179800|NCT03082755|Sensory System Agents|sensory system agents|mesh-ancestor
25179801|NCT03082755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25179802|NCT03082755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179803|NCT03082755|Anticonvulsants|anticonvulsants|mesh-ancestor
25179804|NCT03082755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25179805|NCT03082755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25179806|NCT03082755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25179807|NCT03082755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25179808|NCT03082755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25179809|NCT03082755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25179812|NCT03082755|Antimanic Agents|antimanic agents|mesh-ancestor
25301808|NCT02824952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301809|NCT02824952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25301810|NCT02824952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25301811|NCT02824952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301812|NCT02730325|Immunoglobulins|immunoglobulins|mesh-list
25301813|NCT02730325|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25301814|NCT02730325|Antibodies|antibodies|mesh-list
25301815|NCT02730325|Immunologic Factors|immunologic factors|mesh-ancestor
25301816|NCT02730325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815700|NCT02071615|Caffeine|caffeine|mesh-list
25301837|NCT02512692|Gemcitabine|gemcitabine|mesh-list
25301838|NCT02512692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301839|NCT02512692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25301840|NCT02512692|Antimetabolites|antimetabolites|mesh-ancestor
25301841|NCT02512692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301955|NCT01869114|Azacitidine|azacitidine|mesh-list
25301956|NCT01869114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25301957|NCT01869114|Antimetabolites|antimetabolites|mesh-ancestor
25301958|NCT01869114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301959|NCT01869114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301960|NCT01869114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24957928|NCT03839251|Aripiprazole|aripiprazole|mesh-list
25301961|NCT01869114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25301962|NCT01869114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24512628|NCT00575913|Urological Agents|urological agents|mesh-ancestor
24512629|NCT00575952|Paclitaxel|paclitaxel|mesh-list
24512630|NCT00575952|Doxorubicin|doxorubicin|mesh-list
24512631|NCT00575952|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24512632|NCT00575952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24512633|NCT00575952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301963|NCT01869114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25301964|NCT01869114|Antifungal Agents|antifungal agents|mesh-ancestor
25301965|NCT01869114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25301966|NCT01869114|Immunologic Factors|immunologic factors|mesh-ancestor
25648098|NCT01475513|Moxifloxacin|moxifloxacin|mesh-list
25648099|NCT01475513|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25648100|NCT01475513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25648101|NCT01475513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25648102|NCT01475513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25648103|NCT01475513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25648104|NCT01475513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25648105|NCT01475513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648106|NCT01475513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25648107|NCT01475513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25648108|NCT01475513|Contraceptive Agents|contraceptive agents|mesh-ancestor
25648109|NCT01475513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25648110|NCT01475513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648111|NCT01475513|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25648112|NCT01475513|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25648113|NCT01475513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25648114|NCT01475643|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25648115|NCT01475643|Prednisolone|prednisolone|mesh-list
25648116|NCT01475643|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25648117|NCT01475643|Methylprednisolone|methylprednisolone|mesh-list
25179845|NCT03043547|Protective Agents|protective agents|mesh-ancestor
25179846|NCT03043547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179847|NCT03043547|Vitamin B Complex|vitamin b complex|mesh-ancestor
25179848|NCT03043547|Vitamins|vitamins|mesh-ancestor
25179849|NCT03043547|Micronutrients|micronutrients|mesh-ancestor
24498806|NCT00516412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498807|NCT00516425|Cyclophosphamide|cyclophosphamide|mesh-list
24498808|NCT00516425|Doxorubicin|doxorubicin|mesh-list
24810283|NCT02039362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24810284|NCT02039453|Fentanyl|fentanyl|mesh-list
24810285|NCT02039453|Meperidine|meperidine|mesh-list
24810286|NCT02039453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24810287|NCT02039453|Narcotics|narcotics|mesh-ancestor
24945544|NCT03949842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24810288|NCT02039453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24603156|NCT00972712|Bortezomib|bortezomib|mesh-list
24498809|NCT00516425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24498810|NCT00516425|Epirubicin|epirubicin|mesh-list
24498811|NCT00516425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24498868|NCT00516685|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
24498869|NCT00516685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25825347|NCT00005586|Protective Agents|protective agents|mesh-ancestor
25825348|NCT00005586|Vitamin B Complex|vitamin b complex|mesh-ancestor
24498870|NCT00516685|Immunologic Factors|immunologic factors|mesh-ancestor
24498871|NCT00516685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498872|NCT00516711|Sevoflurane|sevoflurane|mesh-list
24498873|NCT00516711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24498874|NCT00516711|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25301967|NCT01869114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301968|NCT01594398|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25301969|NCT01594398|Exemestane|exemestane|mesh-list
25301970|NCT01594398|Entinostat|entinostat|mesh-list
25301971|NCT01594398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25301972|NCT01594398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25301973|NCT01594398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25301974|NCT01594398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25301975|NCT01594398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25301976|NCT01594398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25301977|NCT01594398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25301978|NCT01594398|Hormone Antagonists|hormone antagonists|mesh-ancestor
25301979|NCT01594398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25301980|NCT01594398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301981|NCT01594398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25301982|NCT01573429|Bisphenol A|bisphenol a|mesh-list
25301983|NCT01573429|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25301984|NCT01573429|Estrogens|estrogens|mesh-ancestor
25301985|NCT01573429|Hormones|hormones|mesh-ancestor
25301986|NCT01573429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25301987|NCT01573429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25301988|NCT01573429|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25301989|NCT01573429|Antioxidants|antioxidants|mesh-ancestor
25648118|NCT01475643|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25648119|NCT01475643|Prednisolone acetate|prednisolone acetate|mesh-list
25648120|NCT01475643|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25648121|NCT01475643|Prednisolone phosphate|prednisolone phosphate|mesh-list
25648122|NCT01475643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25648123|NCT01475643|Glucocorticoids|glucocorticoids|mesh-ancestor
25648124|NCT01475643|Hormones|hormones|mesh-ancestor
25648125|NCT01475643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25648126|NCT01475643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648127|NCT01475643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25648128|NCT01475643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25648129|NCT01475643|Antiemetics|antiemetics|mesh-ancestor
25648130|NCT01475643|Autonomic Agents|autonomic agents|mesh-ancestor
25648131|NCT01475643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25648132|NCT01475643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25648133|NCT01475643|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25648134|NCT01475643|Protective Agents|protective agents|mesh-ancestor
25648135|NCT01475643|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25648136|NCT01475721|Fluticasone|fluticasone|mesh-list
25648137|NCT01475721|Xhance|xhance|mesh-list
25648138|NCT01475721|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25648139|NCT01475721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25648140|NCT01475721|Autonomic Agents|autonomic agents|mesh-ancestor
25648141|NCT01475721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25648142|NCT01475721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179886|NCT02981472|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25179887|NCT02981472|Tinzaparin|tinzaparin|mesh-list
25179888|NCT02981472|Dalteparin|dalteparin|mesh-list
25179889|NCT02981472|Warfarin|warfarin|mesh-list
25179890|NCT02981472|Apixaban|apixaban|mesh-list
25179891|NCT02981472|Vitamins|vitamins|mesh-ancestor
25179892|NCT02981472|Micronutrients|micronutrients|mesh-ancestor
25179893|NCT02981472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179894|NCT02981472|Anticoagulants|anticoagulants|mesh-ancestor
25179895|NCT02981472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25179896|NCT02981472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25179897|NCT02981472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179898|NCT02981472|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25179899|NCT02981472|Antithrombins|antithrombins|mesh-ancestor
25301999|NCT01478542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25302001|NCT01478542|Antimitotic Agents|antimitotic agents|mesh-ancestor
25302002|NCT01478542|Mitosis Modulators|mitosis modulators|mesh-ancestor
25302003|NCT01478542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302014|NCT00807651|Insulin|insulin|mesh-list
25302015|NCT00807651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25302016|NCT00807651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25302017|NCT00807651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302018|NCT00700791|Vitamins|vitamins|mesh-list
25302019|NCT00700791|Vitamin E|vitamin e|mesh-list
25302020|NCT00700791|Tocopherols|tocopherols|mesh-list
25302021|NCT00700791|Tocotrienols|tocotrienols|mesh-list
25302022|NCT00700791|alpha-Tocopherol|alpha-tocopherol|mesh-list
25302023|NCT00700791|Micronutrients|micronutrients|mesh-ancestor
25302024|NCT00700791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302025|NCT00700791|Antioxidants|antioxidants|mesh-ancestor
25302026|NCT00700791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302027|NCT00700791|Protective Agents|protective agents|mesh-ancestor
25302028|NCT00280202|Dimercaprol|dimercaprol|mesh-list
25302029|NCT00280202|Chelating Agents|chelating agents|mesh-ancestor
25302030|NCT00280202|Sequestering Agents|sequestering agents|mesh-ancestor
25302031|NCT00280202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302032|NCT05129670|Calcium Carbonate|calcium carbonate|mesh-list
25302033|NCT05129670|Antacids|antacids|mesh-ancestor
25302034|NCT05129670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302035|NCT05129670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25302036|NCT05129410|Mycophenolic Acid|mycophenolic acid|mesh-list
25302037|NCT05129410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25302038|NCT05129410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302039|NCT05129410|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25302040|NCT05129410|Antitubercular Agents|antitubercular agents|mesh-ancestor
25302041|NCT05129410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25302042|NCT05129410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25302043|NCT05129410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25302044|NCT05129410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302045|NCT05129085|Dexamethasone|dexamethasone|mesh-list
25302046|NCT05129085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25302047|NCT05129085|Antiemetics|antiemetics|mesh-ancestor
25302048|NCT05129085|Autonomic Agents|autonomic agents|mesh-ancestor
25302049|NCT05129085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25302050|NCT05129085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302051|NCT05129085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25302053|NCT05129085|Hormones|hormones|mesh-ancestor
25302054|NCT05129085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25302055|NCT05129085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25302056|NCT05129085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302057|NCT05129033|Omalizumab|omalizumab|mesh-list
25302058|NCT05129033|Itraconazole|itraconazole|mesh-list
25302059|NCT05129033|Prednisone|prednisone|mesh-list
25302060|NCT05129033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25648143|NCT01475721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25648144|NCT01475721|Respiratory System Agents|respiratory system agents|mesh-ancestor
25648145|NCT01475721|Glucocorticoids|glucocorticoids|mesh-ancestor
25648146|NCT01475721|Hormones|hormones|mesh-ancestor
25648147|NCT01475721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25648148|NCT01475721|Sympathomimetics|sympathomimetics|mesh-ancestor
25648149|NCT01475721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25648150|NCT01475721|Dermatologic Agents|dermatologic agents|mesh-ancestor
25648151|NCT01475721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25648152|NCT01475734|rGLP-1 protein|rglp-1 protein|mesh-list
25648153|NCT01475734|Incretins|incretins|mesh-ancestor
25648154|NCT01475734|Hormones|hormones|mesh-ancestor
25657179|NCT01583686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302061|NCT05129033|Glucocorticoids|glucocorticoids|mesh-ancestor
25302062|NCT05129033|Hormones|hormones|mesh-ancestor
25302063|NCT05129033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25302064|NCT05129033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302065|NCT05129033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25302066|NCT05129033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302067|NCT05129033|Antifungal Agents|antifungal agents|mesh-ancestor
25302068|NCT05129033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25302069|NCT05129033|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25302070|NCT05129033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25302071|NCT05129033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25302072|NCT05129033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302073|NCT05129033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25302074|NCT05129033|Hormone Antagonists|hormone antagonists|mesh-ancestor
25302075|NCT05129033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25302076|NCT05129033|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25302077|NCT05129033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25302078|NCT05129033|Respiratory System Agents|respiratory system agents|mesh-ancestor
25302079|NCT05128916|Terbinafine|terbinafine|mesh-list
25302080|NCT05128916|Antifungal Agents|antifungal agents|mesh-ancestor
25302081|NCT05128916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25302082|NCT05128916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25302083|NCT05128916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302084|NCT05128721|Vaccines|vaccines|mesh-list
25302085|NCT05128721|Immunologic Factors|immunologic factors|mesh-ancestor
25302086|NCT05128721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302087|NCT05128630|Durvalumab|durvalumab|mesh-list
25302088|NCT05128630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25302089|NCT05128630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302090|NCT05126511|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25302091|NCT05126511|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
25302092|NCT05126511|beta-Endorphin|beta-endorphin|mesh-list
25302093|NCT05126511|Hormones|hormones|mesh-ancestor
25302094|NCT05126511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25302095|NCT05126511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302096|NCT05126511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25302097|NCT05126511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544422|NCT00688961|Aspirin|aspirin|mesh-list
25302098|NCT05097794|Indapamide|indapamide|mesh-list
25302099|NCT05097794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25302100|NCT05097794|Diuretics|diuretics|mesh-ancestor
25302101|NCT05097794|Natriuretic Agents|natriuretic agents|mesh-ancestor
25302102|NCT05097794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302103|NCT05097794|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25302104|NCT05097794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25302105|NCT05097794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302106|NCT05073562|Folic Acid|folic acid|mesh-list
25302107|NCT05073562|Mebendazole|mebendazole|mesh-list
25302108|NCT05073562|Piperazine|piperazine|mesh-list
25302109|NCT05073562|Piperazine citrate|piperazine citrate|mesh-list
25302110|NCT05073562|DMP 777|dmp 777|mesh-list
25302111|NCT05073562|Hematinics|hematinics|mesh-ancestor
25302112|NCT05073562|Vitamin B Complex|vitamin b complex|mesh-ancestor
25302113|NCT05073562|Vitamins|vitamins|mesh-ancestor
25302114|NCT05073562|Micronutrients|micronutrients|mesh-ancestor
25302115|NCT05073562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302116|NCT05073562|Antinematodal Agents|antinematodal agents|mesh-ancestor
25302117|NCT05073562|Anthelmintics|anthelmintics|mesh-ancestor
25302118|NCT05073562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25302119|NCT05073562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25302120|NCT05073562|Tubulin Modulators|tubulin modulators|mesh-ancestor
25302121|NCT05073562|Antimitotic Agents|antimitotic agents|mesh-ancestor
25302122|NCT05073562|Mitosis Modulators|mitosis modulators|mesh-ancestor
25302123|NCT05073562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302124|NCT05073562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302125|NCT05073562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25302127|NCT04969731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25302128|NCT04969731|Antimetabolites|antimetabolites|mesh-ancestor
25302129|NCT04969731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302130|NCT04969731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302131|NCT04969731|Antiviral Agents|antiviral agents|mesh-ancestor
25302132|NCT04969731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25302133|NCT04969731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25302134|NCT04969731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25302135|NCT04969731|Immunologic Factors|immunologic factors|mesh-ancestor
25302136|NCT04969731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302137|NCT04955938|Ivosidenib|ivosidenib|mesh-list
25302138|NCT04955938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302139|NCT04955938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25302215|NCT04227314|Sensory System Agents|sensory system agents|mesh-ancestor
25302153|NCT04773184|Sensory System Agents|sensory system agents|mesh-ancestor
25302154|NCT04773184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25302155|NCT04773184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302171|NCT04405674|Bevacizumab|bevacizumab|mesh-list
25302172|NCT04405674|Carboplatin|carboplatin|mesh-list
25302173|NCT04405674|Pemetrexed|pemetrexed|mesh-list
25302174|NCT04405674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25302175|NCT04405674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302176|NCT04405674|Tubulin Modulators|tubulin modulators|mesh-ancestor
25302177|NCT04405674|Antimitotic Agents|antimitotic agents|mesh-ancestor
25302178|NCT04405674|Mitosis Modulators|mitosis modulators|mesh-ancestor
25302179|NCT04405674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302180|NCT04405674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25302181|NCT04405674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25302182|NCT04405674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25302183|NCT04405674|Growth Substances|growth substances|mesh-ancestor
25302184|NCT04405674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302185|NCT04405674|Growth Inhibitors|growth inhibitors|mesh-ancestor
25302186|NCT04405674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25302187|NCT04405674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25302188|NCT04405674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25302189|NCT04366518|Scopolamine|scopolamine|mesh-list
25302190|NCT04366518|Rivastigmine|rivastigmine|mesh-list
25302191|NCT04366518|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25302192|NCT04366518|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25302193|NCT04366518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25302194|NCT04366518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302195|NCT04366518|Cholinergic Agents|cholinergic agents|mesh-ancestor
25302196|NCT04366518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25302197|NCT04366518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302198|NCT04366518|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25302199|NCT04366518|Protective Agents|protective agents|mesh-ancestor
25302200|NCT04366518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25302201|NCT04366518|Antiemetics|antiemetics|mesh-ancestor
25302202|NCT04366518|Autonomic Agents|autonomic agents|mesh-ancestor
25302203|NCT04366518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25302204|NCT04366518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25302205|NCT04366518|Mydriatics|mydriatics|mesh-ancestor
25302206|NCT04366518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25302207|NCT04366518|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25302208|NCT04366518|Parasympatholytics|parasympatholytics|mesh-ancestor
25302209|NCT04330664|Adagrasib|adagrasib|mesh-list
25302210|NCT04330664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302211|NCT04227314|Apremilast|apremilast|mesh-list
25302212|NCT04227314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25302213|NCT04227314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25302214|NCT04227314|Analgesics|analgesics|mesh-ancestor
25302218|NCT04227314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25302219|NCT04227314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25302220|NCT04227314|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25302221|NCT04227314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25302222|NCT04227314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25302223|NCT04227314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302224|NCT04223648|Nivolumab|nivolumab|mesh-list
25302225|NCT04223648|Ipilimumab|ipilimumab|mesh-list
25302226|NCT04223648|Durvalumab|durvalumab|mesh-list
25302227|NCT04223648|Tremelimumab|tremelimumab|mesh-list
25302228|NCT04223648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25302229|NCT04223648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302230|NCT04223648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25302231|NCT04223648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302234|NCT04218708|Nicotine|nicotine|mesh-list
25302235|NCT04218708|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25302236|NCT04218708|Autonomic Agents|autonomic agents|mesh-ancestor
25302237|NCT04218708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25302238|NCT04218708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302239|NCT04218708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25302240|NCT04218708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25302241|NCT04218708|Cholinergic Agents|cholinergic agents|mesh-ancestor
25302242|NCT04218708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25302243|NCT04218708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302244|NCT04113720|Dexmedetomidine|dexmedetomidine|mesh-list
24497568|NCT00510471|Antibodies|antibodies|mesh-list
25302245|NCT04113720|Levobupivacaine|levobupivacaine|mesh-list
25302246|NCT04113720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25302247|NCT04113720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25302248|NCT04113720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302249|NCT04113720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25302250|NCT04113720|Analgesics|analgesics|mesh-ancestor
25302251|NCT04113720|Sensory System Agents|sensory system agents|mesh-ancestor
25302252|NCT04113720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25302253|NCT04113720|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25302254|NCT04113720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25302255|NCT04113720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25302256|NCT04113720|Adrenergic Agents|adrenergic agents|mesh-ancestor
25302257|NCT04113720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25302258|NCT04113720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302259|NCT04113720|Anesthetics, Local|anesthetics, local|mesh-ancestor
25302260|NCT04113720|Anesthetics|anesthetics|mesh-ancestor
25302261|NCT04094675|Sirolimus|sirolimus|mesh-list
25302262|NCT04094675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25302263|NCT04094675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25302264|NCT04094675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25302265|NCT04094675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302266|NCT04094675|Antifungal Agents|antifungal agents|mesh-ancestor
25302267|NCT04094675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25302268|NCT04094675|Immunologic Factors|immunologic factors|mesh-ancestor
25302269|NCT04094675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302270|NCT04076748|Sufentanil|sufentanil|mesh-list
25302271|NCT04076748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25302272|NCT04076748|Narcotics|narcotics|mesh-ancestor
25302273|NCT04076748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25302274|NCT04076748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302275|NCT04076748|Analgesics|analgesics|mesh-ancestor
25302276|NCT04076748|Sensory System Agents|sensory system agents|mesh-ancestor
25302277|NCT04076748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25302278|NCT04076748|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25302279|NCT04076748|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25302280|NCT04076748|Anesthetics, General|anesthetics, general|mesh-ancestor
25302281|NCT04076748|Anesthetics|anesthetics|mesh-ancestor
25302282|NCT04075981|Botulinum Toxins|botulinum toxins|mesh-list
24421653|NCT00219856|Propofol|propofol|mesh-list
25302283|NCT04075981|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25302284|NCT04075981|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25302285|NCT04075981|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25302286|NCT04075981|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25302287|NCT04075981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25302288|NCT04075981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302289|NCT04075981|Cholinergic Agents|cholinergic agents|mesh-ancestor
25302290|NCT04075981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25302291|NCT04075981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302292|NCT04075981|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25302293|NCT04075981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25302294|NCT04047862|Paclitaxel|paclitaxel|mesh-list
25302295|NCT04047862|Etoposide|etoposide|mesh-list
25302296|NCT04047862|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25302297|NCT04047862|Carboplatin|carboplatin|mesh-list
25302298|NCT04047862|Fluorouracil|fluorouracil|mesh-list
25302299|NCT04047862|Capecitabine|capecitabine|mesh-list
25302300|NCT04047862|Oxaliplatin|oxaliplatin|mesh-list
25302301|NCT04047862|Pemetrexed|pemetrexed|mesh-list
25302302|NCT04047862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25302303|NCT04047862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302304|NCT04047862|Tubulin Modulators|tubulin modulators|mesh-ancestor
25302305|NCT04047862|Antimitotic Agents|antimitotic agents|mesh-ancestor
25302306|NCT04047862|Mitosis Modulators|mitosis modulators|mesh-ancestor
25302658|NCT05131893|Tamoxifen|tamoxifen|mesh-list
25302307|NCT04047862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302308|NCT04047862|Antimetabolites|antimetabolites|mesh-ancestor
25302309|NCT04047862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25302310|NCT04047862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25302311|NCT04047862|Immunologic Factors|immunologic factors|mesh-ancestor
25302312|NCT04047862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302313|NCT04047862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25302314|NCT04047862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25302315|NCT04047862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25302316|NCT04047862|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25302317|NCT04047862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25302318|NCT04038489|Aspirin|aspirin|mesh-list
25180113|NCT02586038|Glucocorticoids|glucocorticoids|mesh-ancestor
25180114|NCT02586038|Hormones|hormones|mesh-ancestor
25180115|NCT02586038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25180116|NCT02586038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25180117|NCT02586038|Leprostatic Agents|leprostatic agents|mesh-ancestor
25180118|NCT02586038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25180119|NCT02586038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25180120|NCT02586038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25180121|NCT02586038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25180122|NCT02586038|Growth Substances|growth substances|mesh-ancestor
25180123|NCT02586038|Growth Inhibitors|growth inhibitors|mesh-ancestor
25180124|NCT02586038|Protease Inhibitors|protease inhibitors|mesh-ancestor
25180125|NCT02586038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180126|NCT02555839|Thalidomide|thalidomide|mesh-list
25180127|NCT02555839|Dexamethasone|dexamethasone|mesh-list
25180128|NCT02555839|Dexamethasone acetate|dexamethasone acetate|mesh-list
25180129|NCT02555839|Bortezomib|bortezomib|mesh-list
25180130|NCT02555839|Pomalidomide|pomalidomide|mesh-list
25180131|NCT02555839|BB 1101|bb 1101|mesh-list
25180132|NCT02555839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25180133|NCT02555839|Antiemetics|antiemetics|mesh-ancestor
25180134|NCT02555839|Autonomic Agents|autonomic agents|mesh-ancestor
25180138|NCT02555839|Glucocorticoids|glucocorticoids|mesh-ancestor
25302319|NCT04038489|Tamoxifen|tamoxifen|mesh-list
25302320|NCT04038489|Paclitaxel|paclitaxel|mesh-list
25302321|NCT04038489|Cyclophosphamide|cyclophosphamide|mesh-list
25302322|NCT04038489|Doxorubicin|doxorubicin|mesh-list
25302323|NCT04038489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25302324|NCT04038489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302325|NCT04038489|Tubulin Modulators|tubulin modulators|mesh-ancestor
25302326|NCT04038489|Antimitotic Agents|antimitotic agents|mesh-ancestor
25302327|NCT04038489|Mitosis Modulators|mitosis modulators|mesh-ancestor
25302328|NCT04038489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302329|NCT04038489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25302330|NCT04038489|Immunologic Factors|immunologic factors|mesh-ancestor
25302331|NCT04038489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302332|NCT04038489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25302333|NCT04038489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25302334|NCT04038489|Alkylating Agents|alkylating agents|mesh-ancestor
25302335|NCT04038489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25302336|NCT04038489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25302337|NCT04038489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25302338|NCT04038489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25302339|NCT04038489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25302340|NCT04038489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25302341|NCT04038489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25302342|NCT04038489|Analgesics|analgesics|mesh-ancestor
25302343|NCT04038489|Sensory System Agents|sensory system agents|mesh-ancestor
25302344|NCT04038489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25302345|NCT04038489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25302346|NCT04038489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25302347|NCT04038489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25302348|NCT04038489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25302349|NCT04038489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25302350|NCT04038489|Antipyretics|antipyretics|mesh-ancestor
25648155|NCT01475734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25648156|NCT01475734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648157|NCT01475825|Mipomersen|mipomersen|mesh-list
25648158|NCT01475825|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25648159|NCT01475825|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25648160|NCT01475825|Antimetabolites|antimetabolites|mesh-ancestor
25648161|NCT01475825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648162|NCT01475825|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25648163|NCT01475838|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25648164|NCT01475838|Antiviral Agents|antiviral agents|mesh-ancestor
25648165|NCT01475838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25648166|NCT01475838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25648167|NCT01475838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25648168|NCT01475955|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25648169|NCT01475955|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25648170|NCT01475955|Dermatologic Agents|dermatologic agents|mesh-ancestor
25648171|NCT01476202|Nicotine|nicotine|mesh-list
25648172|NCT01476202|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25648173|NCT01476202|Autonomic Agents|autonomic agents|mesh-ancestor
25648174|NCT01476202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25180194|NCT02415556|Insulin|insulin|mesh-list
25180195|NCT02415556|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25180196|NCT02415556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25180197|NCT02415556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825349|NCT00005586|Vitamins|vitamins|mesh-ancestor
25825350|NCT00005586|Micronutrients|micronutrients|mesh-ancestor
25825351|NCT00005589|Cytarabine|cytarabine|mesh-list
25825352|NCT00005589|Cyclophosphamide|cyclophosphamide|mesh-list
25825353|NCT00005589|Melphalan|melphalan|mesh-list
24396191|NCT00138060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180198|NCT02395601|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
25180199|NCT02395601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180201|NCT02389374|Chloroquine|chloroquine|mesh-list
25302351|NCT04038489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25302352|NCT04038489|Hormone Antagonists|hormone antagonists|mesh-ancestor
25302353|NCT04038489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25302354|NCT04038489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25302355|NCT04038489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25302356|NCT04038489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25302357|NCT04038489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25302358|NCT03956368|Atorvastatin|atorvastatin|mesh-list
25302359|NCT03956368|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25302360|NCT03956368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25302361|NCT03956368|Antimetabolites|antimetabolites|mesh-ancestor
25302362|NCT03956368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302363|NCT03956368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25302364|NCT03956368|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25302371|NCT03933007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25302373|NCT03933007|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25302374|NCT03933007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25302375|NCT03933007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25302376|NCT03933007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25302377|NCT03933007|Anesthetics, General|anesthetics, general|mesh-ancestor
25302378|NCT03933007|Anesthetics|anesthetics|mesh-ancestor
25302379|NCT03933007|GABA Modulators|gaba modulators|mesh-ancestor
25302380|NCT03933007|GABA Agents|gaba agents|mesh-ancestor
25302381|NCT03933007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25302382|NCT03933007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302383|NCT03933007|Gout Suppressants|gout suppressants|mesh-ancestor
25302384|NCT03933007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25302385|NCT03933007|Tubulin Modulators|tubulin modulators|mesh-ancestor
25302386|NCT03933007|Antimitotic Agents|antimitotic agents|mesh-ancestor
25302387|NCT03933007|Mitosis Modulators|mitosis modulators|mesh-ancestor
25302388|NCT03933007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302389|NCT03933007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25302390|NCT03933007|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25302391|NCT03933007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25302392|NCT03933007|Histamine Antagonists|histamine antagonists|mesh-ancestor
25302393|NCT03933007|Histamine Agents|histamine agents|mesh-ancestor
25302394|NCT03875287|Decitabine|decitabine|mesh-list
25302395|NCT03875287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25302396|NCT03875287|Antimetabolites|antimetabolites|mesh-ancestor
25302397|NCT03875287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302398|NCT03875287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302399|NCT03875287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25302400|NCT03805581|Defibrotide|defibrotide|mesh-list
25302401|NCT03805581|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25302402|NCT03805581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25302403|NCT03805581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302404|NCT03805581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25302411|NCT03732950|Pembrolizumab|pembrolizumab|mesh-list
25648175|NCT01476202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648176|NCT01476202|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25648177|NCT01476202|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25648178|NCT01476202|Cholinergic Agents|cholinergic agents|mesh-ancestor
25648179|NCT01476202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25648180|NCT01476202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648181|NCT01476267|Dalcetrapib|dalcetrapib|mesh-list
25648182|NCT01476267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25648183|NCT01476267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25648184|NCT01476267|Antimetabolites|antimetabolites|mesh-ancestor
25648185|NCT01476267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648186|NCT01476267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25180259|NCT02304809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180260|NCT02304809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180261|NCT02231775|Trametinib|trametinib|mesh-list
25180262|NCT02231775|Dabrafenib|dabrafenib|mesh-list
25180263|NCT02231775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180264|NCT02231775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25180265|NCT02231775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180266|NCT02231775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180267|NCT02219581|Dexamethasone|dexamethasone|mesh-list
25180268|NCT02219581|Dexamethasone acetate|dexamethasone acetate|mesh-list
25180269|NCT02219581|BB 1101|bb 1101|mesh-list
25180270|NCT02219581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25302412|NCT03732950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25302413|NCT03732950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302414|NCT03665506|Trifluridine|trifluridine|mesh-list
25302415|NCT03665506|Antimetabolites|antimetabolites|mesh-ancestor
25302416|NCT03665506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302417|NCT03665506|Antiviral Agents|antiviral agents|mesh-ancestor
25302418|NCT03665506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25302419|NCT03389022|Ketamine|ketamine|mesh-list
25302420|NCT03389022|Analgesics|analgesics|mesh-ancestor
25302421|NCT03389022|Sensory System Agents|sensory system agents|mesh-ancestor
25302422|NCT03389022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25302423|NCT03389022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302424|NCT03389022|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25302425|NCT03389022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25302426|NCT03389022|Anesthetics, General|anesthetics, general|mesh-ancestor
25302427|NCT03389022|Anesthetics|anesthetics|mesh-ancestor
25302428|NCT03389022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25302429|NCT03389022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25302430|NCT03389022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25302431|NCT03389022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25302432|NCT03389022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302433|NCT03344159|Spironolactone|spironolactone|mesh-list
25302434|NCT03344159|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25302435|NCT03344159|Hormone Antagonists|hormone antagonists|mesh-ancestor
25302436|NCT03344159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25302437|NCT03344159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302438|NCT03344159|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25302439|NCT03344159|Diuretics|diuretics|mesh-ancestor
25302457|NCT03259698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25302458|NCT03259698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25302459|NCT03259698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302460|NCT03259698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25302461|NCT03259698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25302462|NCT03222531|Sofosbuvir|sofosbuvir|mesh-list
25302463|NCT03222531|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25302464|NCT03222531|Velpatasvir|velpatasvir|mesh-list
25302465|NCT03222531|Antiviral Agents|antiviral agents|mesh-ancestor
25302466|NCT03222531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25302467|NCT03124355|Bromides|bromides|mesh-list
25302468|NCT03124355|Galantamine|galantamine|mesh-list
25302469|NCT03124355|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
25302470|NCT03124355|Anticonvulsants|anticonvulsants|mesh-ancestor
25302471|NCT03124355|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25302472|NCT03124355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25302473|NCT03124355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302474|NCT03124355|Cholinergic Agents|cholinergic agents|mesh-ancestor
25302475|NCT03124355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25302476|NCT03124355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302477|NCT03124355|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25302478|NCT03124355|Autonomic Agents|autonomic agents|mesh-ancestor
25648187|NCT01476345|Insulin Glargine|insulin glargine|mesh-list
25648188|NCT01476345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25648189|NCT01476345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648190|NCT01476449|Ranibizumab|ranibizumab|mesh-list
25648191|NCT01476449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25648192|NCT01476449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25648193|NCT01476449|Growth Substances|growth substances|mesh-ancestor
25648194|NCT01476449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648195|NCT01476449|Growth Inhibitors|growth inhibitors|mesh-ancestor
25648196|NCT01476449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25648197|NCT01476475|Insulin|insulin|mesh-list
25648198|NCT01476475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25648199|NCT01476475|Metformin|metformin|mesh-list
25180332|NCT02007512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180333|NCT02007512|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25302479|NCT03124355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25302480|NCT03124355|Nootropic Agents|nootropic agents|mesh-ancestor
25302498|NCT02937571|Dexamethasone|dexamethasone|mesh-list
25302499|NCT02937571|Lenalidomide|lenalidomide|mesh-list
25302500|NCT02937571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25302501|NCT02937571|Antiemetics|antiemetics|mesh-ancestor
25302502|NCT02937571|Autonomic Agents|autonomic agents|mesh-ancestor
25302503|NCT02937571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25302504|NCT02937571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302505|NCT02937571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25302506|NCT02937571|Glucocorticoids|glucocorticoids|mesh-ancestor
25302507|NCT02937571|Hormones|hormones|mesh-ancestor
25302508|NCT02937571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25302509|NCT02937571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25302510|NCT02937571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302511|NCT02937571|Immunologic Factors|immunologic factors|mesh-ancestor
25302512|NCT02937571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25302513|NCT02937571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25302514|NCT02937571|Growth Substances|growth substances|mesh-ancestor
25302515|NCT02937571|Growth Inhibitors|growth inhibitors|mesh-ancestor
25302516|NCT02648581|Ustekinumab|ustekinumab|mesh-list
25302533|NCT02464878|Analgesics|analgesics|mesh-ancestor
25302534|NCT02464878|Sensory System Agents|sensory system agents|mesh-ancestor
25302535|NCT02464878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25302536|NCT02464878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302537|NCT02464878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25302538|NCT02464878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25302539|NCT02464878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25302540|NCT02464878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25302541|NCT02464878|Immunologic Factors|immunologic factors|mesh-ancestor
25302542|NCT02464878|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25302543|NCT02464878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25302544|NCT02464878|Protease Inhibitors|protease inhibitors|mesh-ancestor
25302545|NCT02464878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25302546|NCT02464878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302563|NCT02010606|Bevacizumab|bevacizumab|mesh-list
25302564|NCT02010606|Temozolomide|temozolomide|mesh-list
25302565|NCT02010606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25302566|NCT02010606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302567|NCT02010606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25302568|NCT02010606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25302569|NCT02010606|Growth Substances|growth substances|mesh-ancestor
25302570|NCT02010606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302571|NCT02010606|Growth Inhibitors|growth inhibitors|mesh-ancestor
25302572|NCT02010606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25302573|NCT02010606|Alkylating Agents|alkylating agents|mesh-ancestor
25302574|NCT02010606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302575|NCT01794520|Dexamethasone|dexamethasone|mesh-list
25302576|NCT01794520|Venetoclax|venetoclax|mesh-list
25302577|NCT01794520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25302578|NCT01794520|Antiemetics|antiemetics|mesh-ancestor
25302579|NCT01794520|Autonomic Agents|autonomic agents|mesh-ancestor
25302580|NCT01794520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25302581|NCT01794520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302582|NCT01794520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25302583|NCT01794520|Glucocorticoids|glucocorticoids|mesh-ancestor
25302584|NCT01794520|Hormones|hormones|mesh-ancestor
25302585|NCT01794520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25302586|NCT01794520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25302587|NCT01794520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302638|NCT00754949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25302639|NCT00466531|Cyclophosphamide|cyclophosphamide|mesh-list
25302640|NCT00466531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25302641|NCT00466531|Immunologic Factors|immunologic factors|mesh-ancestor
25302642|NCT00466531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302643|NCT00466531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25302644|NCT00466531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25302645|NCT00466531|Alkylating Agents|alkylating agents|mesh-ancestor
25302646|NCT00466531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648200|NCT01476475|Insulin Glargine|insulin glargine|mesh-list
25648201|NCT01476475|Lixisenatide|lixisenatide|mesh-list
25648202|NCT01476475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25180404|NCT01796197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25180405|NCT01796197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180406|NCT01796197|Tubulin Modulators|tubulin modulators|mesh-ancestor
25180407|NCT01796197|Antimitotic Agents|antimitotic agents|mesh-ancestor
25180408|NCT01796197|Mitosis Modulators|mitosis modulators|mesh-ancestor
25205126|NCT05181462|Antiviral Agents|antiviral agents|mesh-ancestor
25302647|NCT00466531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302648|NCT00466531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25302649|NCT05132023|Metformin|metformin|mesh-list
25302650|NCT05132023|Empagliflozin|empagliflozin|mesh-list
25302651|NCT05132023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25302652|NCT05132023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302653|NCT05132023|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25302654|NCT05132023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302655|NCT05131984|Ocrelizumab|ocrelizumab|mesh-list
25302656|NCT05131984|Immunologic Factors|immunologic factors|mesh-ancestor
25302657|NCT05131984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302659|NCT05131893|Docetaxel|docetaxel|mesh-list
25302660|NCT05131893|Cyclophosphamide|cyclophosphamide|mesh-list
25302661|NCT05131893|Capecitabine|capecitabine|mesh-list
25302662|NCT05131893|Trastuzumab|trastuzumab|mesh-list
25302663|NCT05131893|Letrozole|letrozole|mesh-list
25302664|NCT05131893|Epirubicin|epirubicin|mesh-list
25302665|NCT05131893|Pertuzumab|pertuzumab|mesh-list
25302666|NCT05131893|Goserelin|goserelin|mesh-list
25302667|NCT05131893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302668|NCT05131893|Tubulin Modulators|tubulin modulators|mesh-ancestor
25302678|NCT05131893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25302679|NCT05131893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25302680|NCT05131893|Antimetabolites|antimetabolites|mesh-ancestor
25302681|NCT05131893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25302682|NCT05131893|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25302683|NCT05131893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25302684|NCT05131893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25302685|NCT05131893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25302686|NCT05131893|Hormone Antagonists|hormone antagonists|mesh-ancestor
25205330|NCT04931368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25302687|NCT05131893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25302688|NCT05131893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25302689|NCT05131893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25302690|NCT05131893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25302691|NCT05131893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25302692|NCT05131893|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25302693|NCT05131893|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25302694|NCT05131893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25302695|NCT05131841|Vinorelbine|vinorelbine|mesh-list
25302696|NCT05131841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25302697|NCT05131841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302698|NCT05131841|Tubulin Modulators|tubulin modulators|mesh-ancestor
25302699|NCT05131841|Antimitotic Agents|antimitotic agents|mesh-ancestor
25302700|NCT05131841|Mitosis Modulators|mitosis modulators|mesh-ancestor
25302701|NCT05131841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302702|NCT05131555|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
25302703|NCT05131555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25302704|NCT05131555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302705|NCT05131555|Histamine Antagonists|histamine antagonists|mesh-ancestor
25302706|NCT05131555|Histamine Agents|histamine agents|mesh-ancestor
25302707|NCT05131555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25302708|NCT05131555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711483|NCT01515592|Hormones|hormones|mesh-ancestor
25302709|NCT05131295|Dapsone|dapsone|mesh-list
25302710|NCT05131295|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25302711|NCT05131295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25302712|NCT05131295|Antimalarials|antimalarials|mesh-ancestor
25302713|NCT05131295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25302714|NCT05131295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25302715|NCT05131295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25302716|NCT05131295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25302717|NCT05131295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302718|NCT05131295|Leprostatic Agents|leprostatic agents|mesh-ancestor
25302719|NCT05131295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25648203|NCT01476475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648204|NCT01476696|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25648205|NCT01476696|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25648206|NCT01477320|Pantoprazole|pantoprazole|mesh-list
25648207|NCT01477320|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25648208|NCT01477320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25180451|NCT01679119|Gemcitabine|gemcitabine|mesh-list
25302720|NCT05131295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25302721|NCT05131295|Immunologic Factors|immunologic factors|mesh-ancestor
25302722|NCT05131295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302723|NCT05131295|Antacids|antacids|mesh-ancestor
25302724|NCT05131295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25302725|NCT05131178|Bupivacaine|bupivacaine|mesh-list
25302726|NCT05131178|Anesthetics, Local|anesthetics, local|mesh-ancestor
25302727|NCT05131178|Anesthetics|anesthetics|mesh-ancestor
25302728|NCT05131178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25302729|NCT05131178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302730|NCT05131178|Sensory System Agents|sensory system agents|mesh-ancestor
25302731|NCT05131178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25302772|NCT05130619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302774|NCT05130515|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25302775|NCT05130515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25302776|NCT05130515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302777|NCT05130515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302778|NCT05130398|Vaccines|vaccines|mesh-list
25302779|NCT05130398|Immunologic Factors|immunologic factors|mesh-ancestor
25302780|NCT05130398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302781|NCT05065554|Rituximab|rituximab|mesh-list
25302782|NCT05065554|Acalabrutinib|acalabrutinib|mesh-list
25302783|NCT05065554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25302784|NCT05065554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302785|NCT05065554|Immunologic Factors|immunologic factors|mesh-ancestor
25302786|NCT05065554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302787|NCT05065554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25302788|NCT05045950|Memantine|memantine|mesh-list
25302789|NCT05045950|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25302790|NCT05045950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25302791|NCT05045950|Dopamine Agents|dopamine agents|mesh-ancestor
25302792|NCT05045950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25302793|NCT05045950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302794|NCT05045950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302795|NCT05045950|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25302796|NCT05045950|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25302797|NCT05045638|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25302798|NCT05045638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25302799|NCT05045638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25302800|NCT05045638|Antimetabolites|antimetabolites|mesh-ancestor
25302801|NCT05045638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302802|NCT05045638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25302803|NCT05045638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25302804|NCT05045638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25302805|NCT05039086|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
25302806|NCT05039086|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
25302807|NCT05039086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25302808|NCT05039086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25302809|NCT05039086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302830|NCT04991571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25302831|NCT04991571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302837|NCT04968899|Dexamethasone|dexamethasone|mesh-list
25302838|NCT04968899|Immunoglobulins|immunoglobulins|mesh-list
25302839|NCT04968899|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25302840|NCT04968899|Antibodies|antibodies|mesh-list
25302841|NCT04968899|gamma-Globulins|gamma-globulins|mesh-list
25302842|NCT04968899|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25302843|NCT04968899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25302844|NCT04968899|Antiemetics|antiemetics|mesh-ancestor
25302845|NCT04968899|Autonomic Agents|autonomic agents|mesh-ancestor
25302846|NCT04968899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25302847|NCT04968899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302848|NCT04968899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25302849|NCT04968899|Glucocorticoids|glucocorticoids|mesh-ancestor
25302850|NCT04968899|Hormones|hormones|mesh-ancestor
25302851|NCT04968899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25302852|NCT04968899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25302853|NCT04968899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302854|NCT04968899|Immunologic Factors|immunologic factors|mesh-ancestor
25302855|NCT04922593|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25302856|NCT04922593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25302857|NCT04922593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25648209|NCT01477320|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25648210|NCT01477320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180523|NCT01199380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25180524|NCT01199380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180525|NCT01199380|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25180526|NCT01199380|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25180527|NCT01199380|Cholinergic Agents|cholinergic agents|mesh-ancestor
25180528|NCT01199380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25180529|NCT01199380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180530|NCT01064635|Letrozole|letrozole|mesh-list
25180531|NCT01064635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180532|NCT01064635|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25180533|NCT01064635|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25180534|NCT01064635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180535|NCT01064635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302858|NCT04922593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25302859|NCT04922593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302860|NCT04922593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25302861|NCT04922593|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25302862|NCT04922593|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25302863|NCT04922593|Serotonin Agents|serotonin agents|mesh-ancestor
25302864|NCT04922593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25302865|NCT04922593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302866|NCT04922593|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25302867|NCT04922593|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25302868|NCT04922593|Dopamine Agents|dopamine agents|mesh-ancestor
25302878|NCT04777708|Pembrolizumab|pembrolizumab|mesh-list
25302879|NCT04777708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25302880|NCT04777708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302881|NCT04691505|Hydroxychloroquine|hydroxychloroquine|mesh-list
25302882|NCT04691505|Methotrexate|methotrexate|mesh-list
25302883|NCT04691505|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25302884|NCT04691505|Abortifacient Agents|abortifacient agents|mesh-ancestor
24890068|NCT04486092|GABA Agents|gaba agents|mesh-ancestor
25302885|NCT04691505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25302886|NCT04691505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302887|NCT04691505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25302888|NCT04691505|Antimetabolites|antimetabolites|mesh-ancestor
25302898|NCT04691505|Antimalarials|antimalarials|mesh-ancestor
25302899|NCT04691505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25302900|NCT04691505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25302901|NCT04691505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25302902|NCT04576871|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25302903|NCT04576871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25302904|NCT04576871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302905|NCT04543071|Gemcitabine|gemcitabine|mesh-list
25302906|NCT04543071|Paclitaxel|paclitaxel|mesh-list
25302907|NCT04543071|Cemiplimab|cemiplimab|mesh-list
25302908|NCT04543071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25302909|NCT04543071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25302910|NCT04543071|Tubulin Modulators|tubulin modulators|mesh-ancestor
25302911|NCT04543071|Antimitotic Agents|antimitotic agents|mesh-ancestor
25302912|NCT04543071|Mitosis Modulators|mitosis modulators|mesh-ancestor
25302913|NCT04543071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302914|NCT04543071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25302915|NCT04543071|Antimetabolites|antimetabolites|mesh-ancestor
25302916|NCT04543071|Antiviral Agents|antiviral agents|mesh-ancestor
25302917|NCT04543071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25302918|NCT04543071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25302919|NCT04543071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25302920|NCT04543071|Immunologic Factors|immunologic factors|mesh-ancestor
25302921|NCT04543071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302922|NCT04543071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25648211|NCT01477320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648212|NCT01477333|Treprostinil|treprostinil|mesh-list
25648213|NCT01477333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25648214|NCT01477463|Vitamin D|vitamin d|mesh-list
25648215|NCT01477463|Ergocalciferols|ergocalciferols|mesh-list
25648216|NCT01477463|Cholecalciferol|cholecalciferol|mesh-list
25648217|NCT01477463|Vitamins|vitamins|mesh-list
25648218|NCT01477463|Micronutrients|micronutrients|mesh-ancestor
25648219|NCT01477463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648220|NCT01477463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25648221|NCT01477463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25656846|NCT01579513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25656847|NCT01579513|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24501464|NCT00528723|Albuterol|albuterol|mesh-list
25180645|NCT00474032|Botulinum Toxins|botulinum toxins|mesh-list
25180646|NCT00474032|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25180647|NCT00474032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25180648|NCT00474032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180649|NCT00474032|Cholinergic Agents|cholinergic agents|mesh-ancestor
25180650|NCT00474032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25180651|NCT00474032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180652|NCT00433420|Paclitaxel|paclitaxel|mesh-list
25180653|NCT00433420|Cyclophosphamide|cyclophosphamide|mesh-list
25180654|NCT00433420|Fluorouracil|fluorouracil|mesh-list
25180655|NCT00433420|Epirubicin|epirubicin|mesh-list
25180656|NCT00433420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25180657|NCT00433420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180658|NCT00433420|Tubulin Modulators|tubulin modulators|mesh-ancestor
25180659|NCT00433420|Antimitotic Agents|antimitotic agents|mesh-ancestor
25180660|NCT00433420|Mitosis Modulators|mitosis modulators|mesh-ancestor
25180661|NCT00433420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180662|NCT00433420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25180663|NCT00433420|Immunologic Factors|immunologic factors|mesh-ancestor
25180664|NCT00433420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180665|NCT00433420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25180666|NCT00433420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25180667|NCT00433420|Alkylating Agents|alkylating agents|mesh-ancestor
25180668|NCT00433420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25180669|NCT00433420|Antimetabolites|antimetabolites|mesh-ancestor
25180670|NCT00433420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25180671|NCT00433420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25180672|NCT00433420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25180673|NCT00433420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25180674|NCT00433420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180675|NCT00221988|Levetiracetam|levetiracetam|mesh-list
25180676|NCT00221988|Anticonvulsants|anticonvulsants|mesh-ancestor
25180677|NCT00221988|Nootropic Agents|nootropic agents|mesh-ancestor
25302923|NCT04535141|Olanzapine|olanzapine|mesh-list
24546018|NCT00696514|Folic Acid|folic acid|mesh-list
25302924|NCT04535141|Antiemetics|antiemetics|mesh-ancestor
25302925|NCT04535141|Autonomic Agents|autonomic agents|mesh-ancestor
25302926|NCT04535141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25302927|NCT04535141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302928|NCT04535141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25648222|NCT01477762|Dexamethasone|dexamethasone|mesh-list
25648223|NCT01477762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25648224|NCT01477762|Antiemetics|antiemetics|mesh-ancestor
25648225|NCT01477762|Autonomic Agents|autonomic agents|mesh-ancestor
25648226|NCT01477762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25648227|NCT01477762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648228|NCT01477762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25648229|NCT01477762|Glucocorticoids|glucocorticoids|mesh-ancestor
25648230|NCT01477762|Hormones|hormones|mesh-ancestor
25648231|NCT01477762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25648232|NCT01477762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25648233|NCT01477762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25648234|NCT01477853|Metformin|metformin|mesh-list
25648235|NCT01477853|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25648236|NCT01477853|Glimepiride|glimepiride|mesh-list
25648237|NCT01477853|Atorvastatin|atorvastatin|mesh-list
25648238|NCT01477853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25648239|NCT01477853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648240|NCT01477853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25648241|NCT01477853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25648242|NCT01477853|Antimetabolites|antimetabolites|mesh-ancestor
25648243|NCT01477853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648244|NCT01477853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25648245|NCT01477853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25648246|NCT01477853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25648247|NCT01477853|Incretins|incretins|mesh-ancestor
25648248|NCT01477853|Hormones|hormones|mesh-ancestor
25648249|NCT01477853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25648250|NCT01477853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25648251|NCT01477853|Protease Inhibitors|protease inhibitors|mesh-ancestor
25648252|NCT01477853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25648253|NCT01477853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25648254|NCT01477853|Immunologic Factors|immunologic factors|mesh-ancestor
25648255|NCT01477892|Remifentanil|remifentanil|mesh-list
25180678|NCT00002981|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25302929|NCT04535141|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25302930|NCT04535141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25302931|NCT04535141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25302932|NCT04535141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25302933|NCT04535141|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25302934|NCT04535141|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25302935|NCT04535141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25302936|NCT04535141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302937|NCT04535141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25302938|NCT04535141|Serotonin Agents|serotonin agents|mesh-ancestor
25302948|NCT04530149|Acetaminophen|acetaminophen|mesh-list
25302949|NCT04530149|Bupivacaine|bupivacaine|mesh-list
25302950|NCT04530149|Anesthetics, Local|anesthetics, local|mesh-ancestor
25302951|NCT04530149|Anesthetics|anesthetics|mesh-ancestor
25302952|NCT04530149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25302953|NCT04530149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302954|NCT04530149|Sensory System Agents|sensory system agents|mesh-ancestor
25302955|NCT04530149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25302956|NCT04530149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25302957|NCT04530149|Analgesics|analgesics|mesh-ancestor
25302958|NCT04530149|Antipyretics|antipyretics|mesh-ancestor
25302959|NCT04529902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
25302960|NCT04529902|Abatacept|abatacept|mesh-list
25302961|NCT04529902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25302962|NCT04529902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302967|NCT04529902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25302968|NCT04529902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25302969|NCT04486118|Lisinopril|lisinopril|mesh-list
25302970|NCT04486118|Benazepril|benazepril|mesh-list
25302971|NCT04486118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25302972|NCT04486118|Protease Inhibitors|protease inhibitors|mesh-ancestor
25302973|NCT04486118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25302974|NCT04486118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302975|NCT04486118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25302976|NCT04486118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25302977|NCT04486118|Protective Agents|protective agents|mesh-ancestor
25302978|NCT04486118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302979|NCT04353128|Melatonin|melatonin|mesh-list
25302980|NCT04353128|Antioxidants|antioxidants|mesh-ancestor
25302981|NCT04353128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302982|NCT04353128|Protective Agents|protective agents|mesh-ancestor
25302983|NCT04353128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302984|NCT04353128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25302988|NCT04325880|Tamsulosin|tamsulosin|mesh-list
25302989|NCT04325880|Solifenacin Succinate|solifenacin succinate|mesh-list
25302990|NCT04325880|Mirabegron|mirabegron|mesh-list
25302991|NCT04325880|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25302992|NCT04325880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25302993|NCT04325880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25302994|NCT04325880|Adrenergic Agents|adrenergic agents|mesh-ancestor
25302995|NCT04325880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25302996|NCT04325880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25302997|NCT04325880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25302998|NCT04325880|Urological Agents|urological agents|mesh-ancestor
25302999|NCT04325880|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25303000|NCT04325880|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25303001|NCT04325880|Cholinergic Agents|cholinergic agents|mesh-ancestor
25303002|NCT04325880|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25303003|NCT04325880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25303004|NCT04325880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25303005|NCT04263350|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25303007|NCT04263350|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25303008|NCT04263350|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25303009|NCT04263350|Protease Inhibitors|protease inhibitors|mesh-ancestor
25303010|NCT04263350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25303011|NCT04263350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303012|NCT04263350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25303013|NCT04263350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25303014|NCT04263350|Antiviral Agents|antiviral agents|mesh-ancestor
25303015|NCT04263350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25303016|NCT04263350|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25303017|NCT04263350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25648256|NCT01477892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25205142|NCT05174598|Calcipotriene|calcipotriene|mesh-list
25205143|NCT05174598|Dermatologic Agents|dermatologic agents|mesh-ancestor
25205144|NCT05174598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25205145|NCT05174598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205146|NCT05174598|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25205147|NCT05174598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25205148|NCT05174598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205149|NCT05174598|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25205150|NCT05174598|Vitamins|vitamins|mesh-ancestor
25303018|NCT04202458|Tenecteplase|tenecteplase|mesh-list
25303019|NCT04202458|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25303020|NCT04202458|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25303021|NCT04202458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303022|NCT04184453|Deferiprone|deferiprone|mesh-list
25303023|NCT04184453|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25303024|NCT04184453|Chelating Agents|chelating agents|mesh-ancestor
25303025|NCT04184453|Sequestering Agents|sequestering agents|mesh-ancestor
25303026|NCT04184453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303027|NCT04101643|Evolocumab|evolocumab|mesh-list
25303028|NCT04101643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25303029|NCT04101643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25303030|NCT04101643|Antimetabolites|antimetabolites|mesh-ancestor
25303031|NCT04101643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303032|NCT04101643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24858752|NCT02299310|Perindopril|perindopril|mesh-list
25303033|NCT03873493|Venetoclax|venetoclax|mesh-list
25303034|NCT03873493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303048|NCT03520231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303049|NCT03520231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303050|NCT03520231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25303051|NCT03520231|Antimetabolites|antimetabolites|mesh-ancestor
25303052|NCT03520231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303053|NCT03520231|Antiviral Agents|antiviral agents|mesh-ancestor
25303054|NCT03520231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25303055|NCT03520231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25303056|NCT03520231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25303057|NCT03520231|Immunologic Factors|immunologic factors|mesh-ancestor
25303058|NCT03520231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25303059|NCT03520231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25303060|NCT03171805|Propranolol|propranolol|mesh-list
25303061|NCT03171805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25303062|NCT03171805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25303063|NCT03171805|Adrenergic Agents|adrenergic agents|mesh-ancestor
25303064|NCT03171805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25303065|NCT03171805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303066|NCT03171805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303067|NCT03171805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25303068|NCT03171805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25303069|NCT03171805|Vasodilator Agents|vasodilator agents|mesh-ancestor
25303070|NCT03107416|Bumetanide|bumetanide|mesh-list
25303071|NCT03107416|Diuretics|diuretics|mesh-ancestor
25303072|NCT03107416|Natriuretic Agents|natriuretic agents|mesh-ancestor
25303073|NCT03107416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303074|NCT03107416|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25303075|NCT03107416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25303076|NCT03107416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303077|NCT03094234|Propranolol|propranolol|mesh-list
25303078|NCT03094234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25303079|NCT03094234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25303080|NCT03094234|Adrenergic Agents|adrenergic agents|mesh-ancestor
25303081|NCT03094234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25303082|NCT03094234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648257|NCT01477892|Narcotics|narcotics|mesh-ancestor
25648258|NCT01477892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25648259|NCT01477892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648260|NCT01477892|Analgesics|analgesics|mesh-ancestor
25648261|NCT01477892|Sensory System Agents|sensory system agents|mesh-ancestor
25648262|NCT01477892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25648263|NCT01478048|Dexamethasone|dexamethasone|mesh-list
25648264|NCT01478048|Dexamethasone acetate|dexamethasone acetate|mesh-list
25648265|NCT01478048|Bortezomib|bortezomib|mesh-list
25648266|NCT01478048|Elotuzumab|elotuzumab|mesh-list
25648267|NCT01478048|BB 1101|bb 1101|mesh-list
25180791|NCT02849730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25180792|NCT02849730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25180793|NCT02849730|Anesthetics, General|anesthetics, general|mesh-ancestor
25180799|NCT02849548|Suvorexant|suvorexant|mesh-list
25180800|NCT02849548|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25180801|NCT02849548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25180802|NCT02849548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25303083|NCT03094234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303084|NCT03094234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25303085|NCT03094234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25303086|NCT03094234|Vasodilator Agents|vasodilator agents|mesh-ancestor
25303087|NCT03042468|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25303088|NCT03042468|177Lu-PSMA-617|177lu-psma-617|mesh-list
25303089|NCT03042468|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25303090|NCT03042468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303091|NCT03034564|Droxidopa|droxidopa|mesh-list
25303092|NCT03034564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25303093|NCT03034564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25303094|NCT03034538|Zonisamide|zonisamide|mesh-list
25303095|NCT03034538|Anticonvulsants|anticonvulsants|mesh-ancestor
25303096|NCT03034538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25303097|NCT03034538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25303098|NCT03034538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303099|NCT03034538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25303100|NCT03034538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303101|NCT02918162|Pembrolizumab|pembrolizumab|mesh-list
25303102|NCT02918162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25303103|NCT02918162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24889560|NCT04492501|Remdesivir|remdesivir|mesh-list
25303116|NCT02468180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25303117|NCT02207465|Paclitaxel|paclitaxel|mesh-list
25303118|NCT02207465|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25303119|NCT02207465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25303120|NCT02207465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303121|NCT02207465|Tubulin Modulators|tubulin modulators|mesh-ancestor
25303122|NCT02207465|Antimitotic Agents|antimitotic agents|mesh-ancestor
25303123|NCT02207465|Mitosis Modulators|mitosis modulators|mesh-ancestor
25303124|NCT02207465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303125|NCT02045901|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
25303126|NCT02045901|Antiemetics|antiemetics|mesh-ancestor
25303127|NCT02045901|Autonomic Agents|autonomic agents|mesh-ancestor
25303128|NCT02045901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25303129|NCT02045901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303130|NCT02045901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25303131|NCT02045901|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25303132|NCT02045901|Histamine Antagonists|histamine antagonists|mesh-ancestor
25303133|NCT02045901|Histamine Agents|histamine agents|mesh-ancestor
25303134|NCT02045901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25303135|NCT02045901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303136|NCT01836068|Enfuvirtide|enfuvirtide|mesh-list
25303137|NCT01836068|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25303138|NCT01836068|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25303139|NCT01836068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303140|NCT01836068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25303141|NCT01836068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25303142|NCT01836068|Antiviral Agents|antiviral agents|mesh-ancestor
25303143|NCT01836068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25303144|NCT01308190|Capecitabine|capecitabine|mesh-list
25303145|NCT01308190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25303146|NCT01308190|Antimetabolites|antimetabolites|mesh-ancestor
25303147|NCT01308190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303148|NCT01308190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303149|NCT01210768|Cyclophosphamide|cyclophosphamide|mesh-list
25303150|NCT01210768|Doxorubicin|doxorubicin|mesh-list
25303151|NCT01210768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25303152|NCT01210768|Epirubicin|epirubicin|mesh-list
25303153|NCT01210768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25303154|NCT01210768|Immunologic Factors|immunologic factors|mesh-ancestor
25648268|NCT01478048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25648269|NCT01478048|Antiemetics|antiemetics|mesh-ancestor
25648270|NCT01478048|Autonomic Agents|autonomic agents|mesh-ancestor
25648271|NCT01478048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25648272|NCT01478048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648273|NCT01478048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25648274|NCT01478048|Glucocorticoids|glucocorticoids|mesh-ancestor
25180883|NCT02848768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180884|NCT02848768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25180885|NCT02848768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25180886|NCT02848768|Growth Substances|growth substances|mesh-ancestor
25180887|NCT02848768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180888|NCT02848768|Growth Inhibitors|growth inhibitors|mesh-ancestor
25180889|NCT02848768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25180890|NCT02848768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25303155|NCT01210768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303156|NCT01210768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25303157|NCT01210768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25303158|NCT01210768|Alkylating Agents|alkylating agents|mesh-ancestor
25303159|NCT01210768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303160|NCT01210768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303161|NCT01210768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25303162|NCT01210768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25303163|NCT01210768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25303164|NCT01210768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25303165|NCT01210768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25303166|NCT00719225|Abatacept|abatacept|mesh-list
25303167|NCT00719225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25303168|NCT00719225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303169|NCT00719225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303170|NCT00719225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25303171|NCT00719225|Immunologic Factors|immunologic factors|mesh-ancestor
25303172|NCT00719225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303173|NCT00719225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25303174|NCT00094016|Beclomethasone|beclomethasone|mesh-list
25303175|NCT00094016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25303176|NCT00094016|Glucocorticoids|glucocorticoids|mesh-ancestor
25303177|NCT00094016|Hormones|hormones|mesh-ancestor
24480349|NCT00430742|Hormones|hormones|mesh-ancestor
25303178|NCT00094016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25303179|NCT00094016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303180|NCT00094016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25303181|NCT00094016|Respiratory System Agents|respiratory system agents|mesh-ancestor
25303182|NCT05134350|Omeprazole|omeprazole|mesh-list
25303183|NCT05134350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25303184|NCT05134350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25303185|NCT05134350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25303186|NCT05134350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25303187|NCT05134350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303188|NCT05134337|Itraconazole|itraconazole|mesh-list
25303189|NCT05134337|Rifampin|rifampin|mesh-list
25303190|NCT05134337|Antifungal Agents|antifungal agents|mesh-ancestor
25303191|NCT05134337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25303192|NCT05134337|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25303193|NCT05134337|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25303194|NCT05134337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25303195|NCT05134337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303196|NCT05134337|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25303197|NCT05134337|Hormone Antagonists|hormone antagonists|mesh-ancestor
25303198|NCT05134337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25303199|NCT05134337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303200|NCT05134337|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25303201|NCT05134337|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25303202|NCT05134337|Antitubercular Agents|antitubercular agents|mesh-ancestor
25303203|NCT05134337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25303204|NCT05134337|Leprostatic Agents|leprostatic agents|mesh-ancestor
25303205|NCT05134337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25303206|NCT05134337|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25303207|NCT05134337|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25303208|NCT05134337|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25648275|NCT01478048|Hormones|hormones|mesh-ancestor
25648276|NCT01478048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25648277|NCT01478048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25648278|NCT01478048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25648279|NCT01478048|Protease Inhibitors|protease inhibitors|mesh-ancestor
25648280|NCT01478048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25648281|NCT01478048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648282|NCT01478256|Erythromycin|erythromycin|mesh-list
25303209|NCT05134337|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25303210|NCT05134337|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25303211|NCT05134337|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25303213|NCT05134298|Tazobactam|tazobactam|mesh-list
25303214|NCT05134298|Piperacillin|piperacillin|mesh-list
25303215|NCT05134298|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25303216|NCT05134298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25303217|NCT05134298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25303218|NCT05134298|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25303219|NCT05134298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25303220|NCT05134298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303221|NCT05134220|Calcium|calcium|mesh-list
25303222|NCT05134220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25303223|NCT05134220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303224|NCT05134194|Gemcitabine|gemcitabine|mesh-list
25303225|NCT05134194|Capecitabine|capecitabine|mesh-list
25303226|NCT05134194|Vinorelbine|vinorelbine|mesh-list
25303227|NCT05134194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25303228|NCT05134194|Antimetabolites|antimetabolites|mesh-ancestor
25303229|NCT05134194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303230|NCT05134194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303231|NCT05134194|Antiviral Agents|antiviral agents|mesh-ancestor
25303232|NCT05134194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25303233|NCT05134194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25303234|NCT05134194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25303235|NCT05134194|Immunologic Factors|immunologic factors|mesh-ancestor
25303236|NCT05134194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303237|NCT05134194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25303238|NCT05134194|Tubulin Modulators|tubulin modulators|mesh-ancestor
25303239|NCT05134194|Antimitotic Agents|antimitotic agents|mesh-ancestor
25303240|NCT05134194|Mitosis Modulators|mitosis modulators|mesh-ancestor
25303242|NCT05133791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25303243|NCT05133791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303244|NCT05133635|Methylprednisolone|methylprednisolone|mesh-list
25303245|NCT05133635|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25303246|NCT05133635|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25303247|NCT05133635|Prednisolone|prednisolone|mesh-list
25303248|NCT05133635|Prednisolone acetate|prednisolone acetate|mesh-list
25303249|NCT05133635|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25303250|NCT05133635|Prednisolone phosphate|prednisolone phosphate|mesh-list
25303251|NCT05133635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25303252|NCT05133635|Antiemetics|antiemetics|mesh-ancestor
25303253|NCT05133635|Autonomic Agents|autonomic agents|mesh-ancestor
25303254|NCT05133635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25303255|NCT05133635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303256|NCT05133635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25303257|NCT05133635|Glucocorticoids|glucocorticoids|mesh-ancestor
25303258|NCT05133635|Hormones|hormones|mesh-ancestor
25303259|NCT05133635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25303260|NCT05133635|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25303261|NCT05133635|Protective Agents|protective agents|mesh-ancestor
25303262|NCT05133635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25303263|NCT05133635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303264|NCT05133258|Ciprofloxacin|ciprofloxacin|mesh-list
25303265|NCT05133258|Dexamethasone|dexamethasone|mesh-list
25303266|NCT05133258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25303267|NCT05133258|Antiemetics|antiemetics|mesh-ancestor
25303268|NCT05133258|Autonomic Agents|autonomic agents|mesh-ancestor
25303269|NCT05133258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25303270|NCT05133258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303271|NCT05133258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25303272|NCT05133258|Glucocorticoids|glucocorticoids|mesh-ancestor
25303273|NCT05133258|Hormones|hormones|mesh-ancestor
25303274|NCT05133258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25303275|NCT05133258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25303276|NCT05133258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303277|NCT05133258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25303278|NCT05133258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25303279|NCT05133258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25303280|NCT05133258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25303281|NCT05133258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25303282|NCT05133258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303283|NCT05133258|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25303284|NCT05133258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25303285|NCT05133050|Ramipril|ramipril|mesh-list
25303286|NCT05133050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25303287|NCT05133050|Protease Inhibitors|protease inhibitors|mesh-ancestor
25303288|NCT05133050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25303289|NCT05133050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303290|NCT05133050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25303291|NCT05132777|Osimertinib|osimertinib|mesh-list
25303292|NCT05132777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303293|NCT05132777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25303294|NCT05132777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25303295|NCT05132777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303296|NCT05132712|Losartan|losartan|mesh-list
25303297|NCT05132712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25303298|NCT05132712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25303299|NCT05132712|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25303300|NCT05132712|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25303301|NCT05132712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303302|NCT05132413|Bevacizumab|bevacizumab|mesh-list
25303303|NCT05132413|Cisplatin|cisplatin|mesh-list
25303304|NCT05132413|Carboplatin|carboplatin|mesh-list
25303305|NCT05132413|Pemetrexed|pemetrexed|mesh-list
25303306|NCT05132413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25303307|NCT05132413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303308|NCT05132413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25303309|NCT05132413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25303310|NCT05132413|Growth Substances|growth substances|mesh-ancestor
25303311|NCT05132413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303312|NCT05132413|Growth Inhibitors|growth inhibitors|mesh-ancestor
25303313|NCT05132413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825354|NCT00005589|Carmustine|carmustine|mesh-list
25303314|NCT05132413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303315|NCT05132413|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25303316|NCT05132413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25303317|NCT05132270|Thalidomide|thalidomide|mesh-list
25303318|NCT05132270|Hydroxyurea|hydroxyurea|mesh-list
25303319|NCT05132270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25303320|NCT05132270|Immunologic Factors|immunologic factors|mesh-ancestor
25303321|NCT05132270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303322|NCT05132270|Leprostatic Agents|leprostatic agents|mesh-ancestor
25303323|NCT05132270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25303324|NCT05132270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25303325|NCT05132270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25303326|NCT05132270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25303327|NCT05132270|Growth Substances|growth substances|mesh-ancestor
25303328|NCT05132270|Growth Inhibitors|growth inhibitors|mesh-ancestor
25303329|NCT05132270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303330|NCT05132270|Antisickling Agents|antisickling agents|mesh-ancestor
25303331|NCT05132270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25303332|NCT05132270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303338|NCT05129176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25303339|NCT05129176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25303340|NCT05129176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25303341|NCT05129176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25303342|NCT05129176|Renal Agents|renal agents|mesh-ancestor
25303343|NCT05129176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25303344|NCT05129176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25303345|NCT05129176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25303346|NCT05129176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303347|NCT05129176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303348|NCT05129176|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25303349|NCT05129176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25303350|NCT05122546|Nivolumab|nivolumab|mesh-list
25303351|NCT05122546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25303352|NCT05122546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303353|NCT05122546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25303354|NCT05122546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303355|NCT05121038|Leucovorin|leucovorin|mesh-list
25303356|NCT05121038|Fluorouracil|fluorouracil|mesh-list
25303357|NCT05121038|Oxaliplatin|oxaliplatin|mesh-list
25303358|NCT05121038|Irinotecan|irinotecan|mesh-list
25303359|NCT05121038|Panitumumab|panitumumab|mesh-list
25303360|NCT05121038|Folfirinox|folfirinox|mesh-list
25303361|NCT05121038|Antimetabolites|antimetabolites|mesh-ancestor
25648283|NCT01478256|Erythromycin Estolate|erythromycin estolate|mesh-list
25303362|NCT05121038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303363|NCT05121038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25303364|NCT05121038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303365|NCT05121038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25303366|NCT05121038|Immunologic Factors|immunologic factors|mesh-ancestor
25303367|NCT05121038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303368|NCT05121038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25303369|NCT05121038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25303370|NCT05121038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25303371|NCT05121038|Antidotes|antidotes|mesh-ancestor
25303372|NCT05121038|Protective Agents|protective agents|mesh-ancestor
25303373|NCT05121038|Vitamin B Complex|vitamin b complex|mesh-ancestor
25303374|NCT05121038|Vitamins|vitamins|mesh-ancestor
25303375|NCT05121038|Micronutrients|micronutrients|mesh-ancestor
25303376|NCT05121038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25303382|NCT05031442|Zinc Oxide|zinc oxide|mesh-list
25303383|NCT05031442|Dermatologic Agents|dermatologic agents|mesh-ancestor
25303384|NCT05031442|Sunscreening Agents|sunscreening agents|mesh-ancestor
25303385|NCT05031442|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25303386|NCT05031442|Protective Agents|protective agents|mesh-ancestor
25303387|NCT05031442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303388|NCT05030857|Midazolam|midazolam|mesh-list
25303389|NCT05030857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25303390|NCT05030857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25303391|NCT05030857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25303392|NCT05030857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303393|NCT05030857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25303396|NCT05030857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25303397|NCT05030857|Anesthetics, General|anesthetics, general|mesh-ancestor
25303399|NCT05030857|GABA Modulators|gaba modulators|mesh-ancestor
25303400|NCT05030857|GABA Agents|gaba agents|mesh-ancestor
25303401|NCT05030857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25303402|NCT05030857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303403|NCT05027360|Nitroprusside|nitroprusside|mesh-list
25303404|NCT05027360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25303405|NCT05027360|Vasodilator Agents|vasodilator agents|mesh-ancestor
25303406|NCT05027360|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25303407|NCT05027360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303408|NCT05026606|Nivolumab|nivolumab|mesh-list
25303409|NCT05026606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25303428|NCT04912518|Dexmedetomidine|dexmedetomidine|mesh-list
25303429|NCT04912518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25303430|NCT04912518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25303431|NCT04912518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303432|NCT04912518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25303433|NCT04912518|Analgesics|analgesics|mesh-ancestor
25303434|NCT04912518|Sensory System Agents|sensory system agents|mesh-ancestor
25303435|NCT04912518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25303436|NCT04912518|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25303437|NCT04912518|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25303438|NCT04912518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25303439|NCT04912518|Adrenergic Agents|adrenergic agents|mesh-ancestor
25303440|NCT04912518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25303441|NCT04912518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303442|NCT04898764|Mometasone Furoate|mometasone furoate|mesh-list
25303443|NCT04898764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25303444|NCT04898764|Dermatologic Agents|dermatologic agents|mesh-ancestor
25303445|NCT04898764|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25303446|NCT04818320|Favipiravir|favipiravir|mesh-list
25303447|NCT04818320|Antiviral Agents|antiviral agents|mesh-ancestor
25303448|NCT04818320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25303471|NCT04656964|Midazolam|midazolam|mesh-list
25303472|NCT04656964|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25303473|NCT04656964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25303474|NCT04656964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25303475|NCT04656964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303476|NCT04656964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25303477|NCT04656964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25303478|NCT04656964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25303479|NCT04656964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25303480|NCT04656964|Anesthetics, General|anesthetics, general|mesh-ancestor
25303481|NCT04656964|Anesthetics|anesthetics|mesh-ancestor
25303482|NCT04656964|GABA Modulators|gaba modulators|mesh-ancestor
25303483|NCT04656964|GABA Agents|gaba agents|mesh-ancestor
25303484|NCT04656964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25303485|NCT04656964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181090|NCT02847013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25181091|NCT02847013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181092|NCT02847013|Sensory System Agents|sensory system agents|mesh-ancestor
25181093|NCT02847013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25181094|NCT02847091|Ipragliflozin|ipragliflozin|mesh-list
25181095|NCT02847091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25181096|NCT02847091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303486|NCT04605796|Bevacizumab|bevacizumab|mesh-list
25303530|NCT04313608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25303531|NCT04311710|Nivolumab|nivolumab|mesh-list
25303532|NCT04311710|Ipilimumab|ipilimumab|mesh-list
25303533|NCT04311710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25303534|NCT04311710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303535|NCT04311710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25303536|NCT04311710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303537|NCT04307134|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25303538|NCT04307134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25303539|NCT04307134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303540|NCT04307134|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25303544|NCT04244877|Rifaximin|rifaximin|mesh-list
25303545|NCT04244877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25303546|NCT04244877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25303547|NCT04244877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25303548|NCT04215120|Epoetin Alfa|epoetin alfa|mesh-list
25303549|NCT04215120|Hematinics|hematinics|mesh-ancestor
25303550|NCT04069897|Botulinum Toxins|botulinum toxins|mesh-list
25303551|NCT04069897|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25303552|NCT04069897|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25303553|NCT04069897|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25303554|NCT04069897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25205331|NCT04931368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25303555|NCT04069897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303556|NCT04069897|Cholinergic Agents|cholinergic agents|mesh-ancestor
25303557|NCT04069897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25303558|NCT04069897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303559|NCT04069897|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25303560|NCT04069897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25303561|NCT04012957|Darbepoetin alfa|darbepoetin alfa|mesh-list
25303562|NCT04012957|Hematinics|hematinics|mesh-ancestor
25303563|NCT03883581|Quinidine|quinidine|mesh-list
25303564|NCT03883581|Quinidine gluconate|quinidine gluconate|mesh-list
25303565|NCT03883581|Dextromethorphan|dextromethorphan|mesh-list
25303566|NCT03883581|Antitussive Agents|antitussive agents|mesh-ancestor
25303567|NCT03883581|Respiratory System Agents|respiratory system agents|mesh-ancestor
25303568|NCT03883581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25303569|NCT03883581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25303570|NCT03883581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25303571|NCT03883581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303572|NCT03883581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303573|NCT03883581|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25303574|NCT03883581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25303575|NCT03883581|Adrenergic Agents|adrenergic agents|mesh-ancestor
25303576|NCT03883581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25303577|NCT03883581|Antimalarials|antimalarials|mesh-ancestor
25303578|NCT03883581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25303579|NCT03883581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25303580|NCT03883581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25303581|NCT03883581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25303582|NCT03883581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25303583|NCT03883581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25303584|NCT03883581|Cholinergic Agents|cholinergic agents|mesh-ancestor
25303585|NCT03883581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25303586|NCT03883581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25303587|NCT03883581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25303588|NCT03883581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25303589|NCT03883581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25303590|NCT03854578|Citalopram|citalopram|mesh-list
25303591|NCT03854578|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25648284|NCT01478256|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25648285|NCT01478256|Erythromycin stearate|erythromycin stearate|mesh-list
25648286|NCT01478256|Besifloxacin|besifloxacin|mesh-list
25648287|NCT01478256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25648288|NCT01478256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25648289|NCT01478256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25648290|NCT01478256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25205209|NCT05052723|Pembrolizumab|pembrolizumab|mesh-list
25205210|NCT05052723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25205211|NCT05052723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25205215|NCT05044117|Capecitabine|capecitabine|mesh-list
25205216|NCT05044117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25205217|NCT05044117|Antimetabolites|antimetabolites|mesh-ancestor
25205218|NCT05044117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205219|NCT05044117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303592|NCT03854578|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25303593|NCT03854578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25303594|NCT03854578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303595|NCT03854578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25303596|NCT03854578|Serotonin Agents|serotonin agents|mesh-ancestor
25303597|NCT03854578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303598|NCT03854578|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25303599|NCT03854578|Antidepressive Agents|antidepressive agents|mesh-ancestor
25303600|NCT03854578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25303601|NCT03844412|Lidocaine|lidocaine|mesh-list
25303602|NCT03844412|Nortriptyline|nortriptyline|mesh-list
25303603|NCT03844412|Estradiol|estradiol|mesh-list
25303604|NCT03844412|Anesthetics, Local|anesthetics, local|mesh-ancestor
25303605|NCT03844412|Anesthetics|anesthetics|mesh-ancestor
25303606|NCT03844412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25303607|NCT03844412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303608|NCT03844412|Sensory System Agents|sensory system agents|mesh-ancestor
25303609|NCT03844412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25303610|NCT03844412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24963540|NCT03790384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303611|NCT03844412|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25303612|NCT03844412|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25303613|NCT03844412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25303614|NCT03844412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303615|NCT03844412|Estrogens|estrogens|mesh-ancestor
25303616|NCT03844412|Hormones|hormones|mesh-ancestor
25303617|NCT03844412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25303618|NCT03844412|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25303619|NCT03844412|Antidepressive Agents|antidepressive agents|mesh-ancestor
25303620|NCT03844412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25303621|NCT03844412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25303622|NCT03844412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25303623|NCT03844412|Adrenergic Agents|adrenergic agents|mesh-ancestor
25303624|NCT03844412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25303625|NCT03660059|Antirheumatic Agents|antirheumatic agents|mesh-list
25303626|NCT03660059|Peficitinib|peficitinib|mesh-list
25303627|NCT03660059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25303628|NCT03660059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303629|NCT03660059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25303630|NCT03660059|Immunologic Factors|immunologic factors|mesh-ancestor
25303631|NCT03660059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303632|NCT03512119|Ivacaftor|ivacaftor|mesh-list
25303633|NCT03512119|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25303634|NCT03512119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25303635|NCT03512119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303636|NCT03502148|Cisplatin|cisplatin|mesh-list
25303655|NCT03278691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25303657|NCT03278691|Analgesics|analgesics|mesh-ancestor
25303658|NCT03278691|Sensory System Agents|sensory system agents|mesh-ancestor
25303659|NCT03278691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25303660|NCT03278691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303661|NCT03278691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25303662|NCT03278691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25303663|NCT03278691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25303664|NCT03278691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25303665|NCT03278691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303666|NCT03274375|Rituximab|rituximab|mesh-list
25648291|NCT01478256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25648292|NCT01478256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648293|NCT01478256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25648294|NCT01478256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25648295|NCT01478256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25648296|NCT01478321|Bevacizumab|bevacizumab|mesh-list
25648297|NCT01478321|Temozolomide|temozolomide|mesh-list
25648298|NCT01478321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25181188|NCT02846493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25181189|NCT02846493|Glucocorticoids|glucocorticoids|mesh-ancestor
25181191|NCT02846493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25181192|NCT02846493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25181193|NCT02846493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303667|NCT03274375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25303668|NCT03274375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303669|NCT03274375|Immunologic Factors|immunologic factors|mesh-ancestor
25303670|NCT03274375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303671|NCT03274375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25303676|NCT02959619|Ensartinib|ensartinib|mesh-list
25303677|NCT02959619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303678|NCT02959619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25303679|NCT02959619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25303680|NCT02959619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303681|NCT02795520|OTS167|ots167|mesh-list
25303682|NCT02795520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25303683|NCT02795520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25303684|NCT02795520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303685|NCT02642809|Pembrolizumab|pembrolizumab|mesh-list
25303686|NCT02642809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25303687|NCT02642809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303688|NCT02620579|Propranolol|propranolol|mesh-list
25303689|NCT02620579|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25303690|NCT02620579|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25303691|NCT02620579|Adrenergic Agents|adrenergic agents|mesh-ancestor
25303692|NCT02620579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25303693|NCT02620579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303694|NCT02620579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303695|NCT02620579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25303696|NCT02620579|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25303697|NCT02620579|Vasodilator Agents|vasodilator agents|mesh-ancestor
25303713|NCT02370589|Vaccines|vaccines|mesh-list
25303714|NCT02370589|Immunologic Factors|immunologic factors|mesh-ancestor
25303715|NCT02370589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303716|NCT02313194|Buspirone|buspirone|mesh-list
25303717|NCT02313194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25303718|NCT02313194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25303719|NCT02313194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25303720|NCT02313194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303721|NCT02313194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25303722|NCT02313194|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25303723|NCT02313194|Serotonin Agents|serotonin agents|mesh-ancestor
25303724|NCT02313194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25303725|NCT02313194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303726|NCT02100956|Oxytocin|oxytocin|mesh-list
25303727|NCT02100956|Oxytocics|oxytocics|mesh-ancestor
25303728|NCT02100956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25303729|NCT02100956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303730|NCT01752049|Timolol|timolol|mesh-list
25303731|NCT01752049|Maleic acid|maleic acid|mesh-list
25303732|NCT01752049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25303733|NCT01752049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25303734|NCT01752049|Adrenergic Agents|adrenergic agents|mesh-ancestor
25303735|NCT01752049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25303736|NCT01752049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303737|NCT01752049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303738|NCT01752049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25303739|NCT01752049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25303740|NCT01752049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25303741|NCT01316523|Rituximab|rituximab|mesh-list
25303742|NCT01316523|Lenalidomide|lenalidomide|mesh-list
25303743|NCT01316523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25303744|NCT01316523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303745|NCT01316523|Immunologic Factors|immunologic factors|mesh-ancestor
25303746|NCT01316523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648299|NCT01478321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25648300|NCT01478321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25648301|NCT01478321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25648302|NCT01478321|Growth Substances|growth substances|mesh-ancestor
25648303|NCT01478321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648304|NCT01478321|Growth Inhibitors|growth inhibitors|mesh-ancestor
25656848|NCT01579513|Protective Agents|protective agents|mesh-ancestor
25181264|NCT02846090|Analgesics|analgesics|mesh-ancestor
25303747|NCT01316523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25303748|NCT01316523|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25303749|NCT01316523|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25303750|NCT01316523|Growth Substances|growth substances|mesh-ancestor
25303751|NCT01316523|Growth Inhibitors|growth inhibitors|mesh-ancestor
25303752|NCT00085774|Albuterol|albuterol|mesh-list
25303753|NCT00085774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25303754|NCT00085774|Autonomic Agents|autonomic agents|mesh-ancestor
25303755|NCT00085774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25303756|NCT00085774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303757|NCT00085774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25303758|NCT00085774|Respiratory System Agents|respiratory system agents|mesh-ancestor
25303759|NCT00085774|Tocolytic Agents|tocolytic agents|mesh-ancestor
25303760|NCT00085774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25303761|NCT00085774|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25303762|NCT00085774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25303763|NCT00085774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25303764|NCT00085774|Adrenergic Agents|adrenergic agents|mesh-ancestor
25303765|NCT00085774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25303766|NCT00085774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303767|NCT00071552|Fluticasone|fluticasone|mesh-list
25303768|NCT00071552|Xhance|xhance|mesh-list
25303769|NCT00071552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25303770|NCT00071552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25303771|NCT00071552|Autonomic Agents|autonomic agents|mesh-ancestor
25303772|NCT00071552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25303773|NCT00071552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303774|NCT00071552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25303775|NCT00071552|Respiratory System Agents|respiratory system agents|mesh-ancestor
25303776|NCT00071552|Dermatologic Agents|dermatologic agents|mesh-ancestor
25303777|NCT00071552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25303778|NCT05125146|Trazodone|trazodone|mesh-list
25303779|NCT05125146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25303780|NCT05125146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25303781|NCT05125146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25303782|NCT05125146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303783|NCT05125146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25303784|NCT05125146|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25303785|NCT05125146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25303786|NCT05125146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25303787|NCT05125146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303788|NCT05125146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25303789|NCT05125146|Serotonin Agents|serotonin agents|mesh-ancestor
25303790|NCT05125146|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25303791|NCT05125146|Antidepressive Agents|antidepressive agents|mesh-ancestor
25303792|NCT05136534|Anesthetics|anesthetics|mesh-list
25303793|NCT05136534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25303794|NCT05136534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303795|NCT05136521|Trazodone|trazodone|mesh-list
25303796|NCT05136521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25303797|NCT05136521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25303798|NCT05136521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25303799|NCT05136521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303800|NCT05136521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25303801|NCT05136521|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25303802|NCT05136521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25303803|NCT05136521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25303804|NCT05136521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303805|NCT05136521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25303806|NCT05136521|Serotonin Agents|serotonin agents|mesh-ancestor
25303807|NCT05136521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25303808|NCT05136521|Antidepressive Agents|antidepressive agents|mesh-ancestor
25303809|NCT05136508|Propofol|propofol|mesh-list
25303810|NCT05136508|Sevoflurane|sevoflurane|mesh-list
25303811|NCT05136508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25303812|NCT05136508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25303813|NCT05136508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303814|NCT05136508|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25303815|NCT05136508|Anesthetics, General|anesthetics, general|mesh-ancestor
25303816|NCT05136508|Anesthetics|anesthetics|mesh-ancestor
25303817|NCT05136508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25303818|NCT05136508|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25648305|NCT01478321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25303819|NCT05135858|Methotrexate|methotrexate|mesh-list
25303820|NCT05135858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25303821|NCT05135858|Abortifacient Agents|abortifacient agents|mesh-ancestor
25303822|NCT05135858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25303823|NCT05135858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303824|NCT05135858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25303825|NCT05135858|Antimetabolites|antimetabolites|mesh-ancestor
25303826|NCT05135858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303827|NCT05135858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303828|NCT05135858|Dermatologic Agents|dermatologic agents|mesh-ancestor
25303829|NCT05135858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25303830|NCT05135858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25303831|NCT05135858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25303832|NCT05135858|Immunologic Factors|immunologic factors|mesh-ancestor
25303833|NCT05135858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25303834|NCT05135858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25303835|NCT05135442|Bortezomib|bortezomib|mesh-list
25303836|NCT05135442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303837|NCT05135286|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25303838|NCT05135286|Carbachol|carbachol|mesh-list
25303839|NCT05135286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25303840|NCT05135286|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25303841|NCT05135286|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25303842|NCT05135286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25303843|NCT05135286|Adrenergic Agents|adrenergic agents|mesh-ancestor
25303844|NCT05135286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25303845|NCT05135286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303846|NCT05135286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303847|NCT05135286|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25303848|NCT05135286|Miotics|miotics|mesh-ancestor
25303849|NCT05135286|Autonomic Agents|autonomic agents|mesh-ancestor
25303850|NCT05135286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25303851|NCT05135286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25303852|NCT05135286|Cholinergic Agents|cholinergic agents|mesh-ancestor
25303853|NCT05135286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25303854|NCT05135286|Analgesics|analgesics|mesh-ancestor
25303855|NCT05135286|Sensory System Agents|sensory system agents|mesh-ancestor
25303856|NCT05135286|Protective Agents|protective agents|mesh-ancestor
25303857|NCT05135013|Drospirenone|drospirenone|mesh-list
25303858|NCT05135013|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25303859|NCT05135013|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25303860|NCT05135013|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25303861|NCT05135013|Norethindrone|norethindrone|mesh-list
25303862|NCT05135013|Norethindrone Acetate|norethindrone acetate|mesh-list
25303863|NCT05135013|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
25303869|NCT05135013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25303870|NCT05135013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303871|NCT05135013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25303872|NCT05135013|Contraceptive Agents|contraceptive agents|mesh-ancestor
25303873|NCT05135013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25303874|NCT05135013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25303875|NCT05135013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25303876|NCT05135013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25303877|NCT05135013|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25303878|NCT05135013|Hormone Antagonists|hormone antagonists|mesh-ancestor
25303879|NCT05135013|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25303880|NCT05135013|Diuretics|diuretics|mesh-ancestor
25303881|NCT05135013|Natriuretic Agents|natriuretic agents|mesh-ancestor
25303882|NCT05135013|Progestins|progestins|mesh-ancestor
25303883|NCT05135013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25303889|NCT05134558|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25303890|NCT05134558|Anesthetics, General|anesthetics, general|mesh-ancestor
25303891|NCT05134558|Anesthetics|anesthetics|mesh-ancestor
25303892|NCT05134558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25303893|NCT05134558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303894|NCT05134519|Trastuzumab|trastuzumab|mesh-list
25303895|NCT05134519|Antibodies|antibodies|mesh-list
25303896|NCT05134519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25303897|NCT05134519|Immunologic Factors|immunologic factors|mesh-ancestor
25303898|NCT05134519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303899|NCT05134519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25303900|NCT05134519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303901|NCT05133193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25303902|NCT05133193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25303903|NCT05133193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25303904|NCT05133193|Antitubercular Agents|antitubercular agents|mesh-ancestor
25303906|NCT05122169|Chlorhexidine|chlorhexidine|mesh-list
25303907|NCT05122169|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25303908|NCT05122169|Povidone-Iodine|povidone-iodine|mesh-list
25303910|NCT05122169|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25303911|NCT05122169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25303912|NCT05122169|Disinfectants|disinfectants|mesh-ancestor
25303913|NCT05122169|Dermatologic Agents|dermatologic agents|mesh-ancestor
25303914|NCT05122169|Trace Elements|trace elements|mesh-ancestor
25303915|NCT05122169|Micronutrients|micronutrients|mesh-ancestor
25303916|NCT05122169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303917|NCT05122169|Plasma Substitutes|plasma substitutes|mesh-ancestor
25303918|NCT05122169|Blood Substitutes|blood substitutes|mesh-ancestor
25303919|NCT05121571|Sorafenib|sorafenib|mesh-list
25303920|NCT05121571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303921|NCT05121571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25303922|NCT05121571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25303923|NCT05121571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303924|NCT05120362|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
25303925|NCT05120362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25303926|NCT05120362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25303927|NCT05120362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303928|NCT05087862|Anesthetics|anesthetics|mesh-list
25303929|NCT05087862|Anesthetics, Local|anesthetics, local|mesh-list
25303930|NCT05087862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25303931|NCT05087862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303932|NCT05087862|Sensory System Agents|sensory system agents|mesh-ancestor
25303933|NCT05087862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25303934|NCT05060523|Tolvaptan|tolvaptan|mesh-list
25303935|NCT05060523|Midodrine|midodrine|mesh-list
25303936|NCT05060523|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25303937|NCT05060523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303938|NCT05060523|Natriuretic Agents|natriuretic agents|mesh-ancestor
25303939|NCT05060523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303940|NCT05060523|Sympathomimetics|sympathomimetics|mesh-ancestor
25303941|NCT05060523|Autonomic Agents|autonomic agents|mesh-ancestor
25303942|NCT05060523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25303943|NCT05060523|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25303944|NCT05060523|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25303945|NCT05060523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25303946|NCT05060523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25303947|NCT05060523|Adrenergic Agents|adrenergic agents|mesh-ancestor
25303948|NCT05060523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25303949|NCT05024773|Paclitaxel|paclitaxel|mesh-list
25303950|NCT05024773|Hyaluronic Acid|hyaluronic acid|mesh-list
25303951|NCT05024773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25303952|NCT05024773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303953|NCT05024773|Tubulin Modulators|tubulin modulators|mesh-ancestor
25303954|NCT05024773|Antimitotic Agents|antimitotic agents|mesh-ancestor
25303955|NCT05024773|Mitosis Modulators|mitosis modulators|mesh-ancestor
25303956|NCT05024773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303957|NCT05024773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25303958|NCT05024773|Immunologic Factors|immunologic factors|mesh-ancestor
25303959|NCT05024773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303960|NCT05024773|Viscosupplements|viscosupplements|mesh-ancestor
25303961|NCT05024773|Protective Agents|protective agents|mesh-ancestor
25303962|NCT05020652|Hydroxyurea|hydroxyurea|mesh-list
25303963|NCT05020652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25303964|NCT05020652|Antisickling Agents|antisickling agents|mesh-ancestor
25303965|NCT05020652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25303966|NCT05020652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303967|NCT05020652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25303968|NCT05014334|Amoxicillin|amoxicillin|mesh-list
25303969|NCT05014334|Clarithromycin|clarithromycin|mesh-list
25303970|NCT05014334|Rabeprazole|rabeprazole|mesh-list
25303971|NCT05014334|Bismuth|bismuth|mesh-list
25303972|NCT05014334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25303973|NCT05014334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25303974|NCT05014334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25303975|NCT05014334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25303976|NCT05014334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303977|NCT05014334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25303978|NCT05014334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25303979|NCT05014334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24459887|NCT00346749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459888|NCT00346801|Celecoxib|celecoxib|mesh-list
24402817|NCT00158522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402818|NCT00158522|Immunologic Factors|immunologic factors|mesh-ancestor
25205238|NCT05024006|Antiviral Agents|antiviral agents|mesh-ancestor
25205239|NCT05024006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25205240|NCT05024006|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25205241|NCT05024006|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25205242|NCT05024006|Protease Inhibitors|protease inhibitors|mesh-ancestor
25205243|NCT05024006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205245|NCT05024006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25303980|NCT05014334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25303981|NCT05014334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25303983|NCT05014087|Digoxin|digoxin|mesh-list
25303984|NCT05014087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25303985|NCT05014087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25303986|NCT05014087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25303987|NCT05014087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25303988|NCT05014087|Protective Agents|protective agents|mesh-ancestor
25303989|NCT05014087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303990|NCT05002192|Eucalyptol|eucalyptol|mesh-list
25303991|NCT05002192|Ambroxol|ambroxol|mesh-list
25303992|NCT05002192|Expectorants|expectorants|mesh-list
25303993|NCT05002192|Respiratory System Agents|respiratory system agents|mesh-ancestor
25303994|NCT05002192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25303995|NCT05002192|Antitussive Agents|antitussive agents|mesh-ancestor
25303996|NCT05002192|Insect Repellents|insect repellents|mesh-ancestor
25303997|NCT05002192|Protective Agents|protective agents|mesh-ancestor
25303998|NCT05002192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25303999|NCT04973020|Efavirenz|efavirenz|mesh-list
25304000|NCT04973020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25304001|NCT04973020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25304002|NCT04973020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25304003|NCT04973020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304004|NCT04973020|Antiviral Agents|antiviral agents|mesh-ancestor
25304005|NCT04973020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25304006|NCT04973020|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25304007|NCT04973020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25304008|NCT04973020|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25304009|NCT04973020|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25304010|NCT04973020|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25304011|NCT04973020|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25304012|NCT04955249|Dexmedetomidine|dexmedetomidine|mesh-list
25304013|NCT04955249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25304014|NCT04955249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25304026|NCT04908787|Paclitaxel|paclitaxel|mesh-list
25304027|NCT04908787|Doxorubicin|doxorubicin|mesh-list
25304028|NCT04908787|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25304029|NCT04908787|Topotecan|topotecan|mesh-list
25304030|NCT04908787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25304031|NCT04908787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25304032|NCT04908787|Tubulin Modulators|tubulin modulators|mesh-ancestor
25304033|NCT04908787|Antimitotic Agents|antimitotic agents|mesh-ancestor
25304034|NCT04908787|Mitosis Modulators|mitosis modulators|mesh-ancestor
25304035|NCT04908787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304036|NCT04908787|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25304037|NCT04908787|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25304038|NCT04908787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25304039|NCT04908787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25304040|NCT04908787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25304048|NCT04886453|Morphine|morphine|mesh-list
25304049|NCT04886453|Anesthetics|anesthetics|mesh-list
25304050|NCT04886453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25304051|NCT04886453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648306|NCT01478321|Alkylating Agents|alkylating agents|mesh-ancestor
25648307|NCT01478321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648308|NCT01478581|Dexamethasone|dexamethasone|mesh-list
25648309|NCT01478581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25648310|NCT01478581|Antiemetics|antiemetics|mesh-ancestor
25648311|NCT01478581|Autonomic Agents|autonomic agents|mesh-ancestor
25648312|NCT01478581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25648313|NCT01478581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648314|NCT01478581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25648315|NCT01478581|Glucocorticoids|glucocorticoids|mesh-ancestor
25648316|NCT01478581|Hormones|hormones|mesh-ancestor
25304052|NCT04886453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25304053|NCT04886453|Narcotics|narcotics|mesh-ancestor
25304054|NCT04886453|Analgesics|analgesics|mesh-ancestor
25304055|NCT04886453|Sensory System Agents|sensory system agents|mesh-ancestor
25304056|NCT04886453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25304057|NCT04849832|Fesoterodine|fesoterodine|mesh-list
25304058|NCT04849832|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25304059|NCT04849832|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25304060|NCT04849832|Cholinergic Agents|cholinergic agents|mesh-ancestor
25304061|NCT04849832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25304062|NCT04849832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304063|NCT04849832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304064|NCT04849832|Urological Agents|urological agents|mesh-ancestor
25304066|NCT04780932|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25304067|NCT04780932|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25304068|NCT04780932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304069|NCT04780932|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25304076|NCT04745988|Pembrolizumab|pembrolizumab|mesh-list
25304077|NCT04745988|Lenvatinib|lenvatinib|mesh-list
25304078|NCT04745988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25304079|NCT04745988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25304080|NCT04745988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25304081|NCT04745988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25304082|NCT04745988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304083|NCT04717154|Nivolumab|nivolumab|mesh-list
25304084|NCT04717154|Ipilimumab|ipilimumab|mesh-list
24716848|NCT01544283|Lidocaine|lidocaine|mesh-list
25304085|NCT04717154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25304086|NCT04717154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25304087|NCT04717154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25304088|NCT04717154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304095|NCT04702464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304097|NCT04702464|Hormone Antagonists|hormone antagonists|mesh-ancestor
25304098|NCT04702464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25304099|NCT04702464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304100|NCT04702464|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25304101|NCT04702464|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25304102|NCT04697654|Hydroxychloroquine|hydroxychloroquine|mesh-list
25304103|NCT04697654|Antimalarials|antimalarials|mesh-ancestor
25304104|NCT04697654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25304105|NCT04697654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25304106|NCT04697654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25304107|NCT04697654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25304108|NCT04697654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304109|NCT04697654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25304117|NCT04644705|Niclosamide|niclosamide|mesh-list
25304118|NCT04644705|Anticestodal Agents|anticestodal agents|mesh-ancestor
25304119|NCT04644705|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25304120|NCT04644705|Anthelmintics|anthelmintics|mesh-ancestor
25304121|NCT04644705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25304122|NCT04644705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25304123|NCT04644705|Antinematodal Agents|antinematodal agents|mesh-ancestor
25304124|NCT04637555|Valsartan|valsartan|mesh-list
25304125|NCT04637555|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25304126|NCT04637555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25304127|NCT04637555|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25304128|NCT04637555|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25304129|NCT04637555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304130|NCT04607122|Landiolol|landiolol|mesh-list
25304131|NCT04607122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25304132|NCT04607122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25304133|NCT04607122|Adrenergic Agents|adrenergic agents|mesh-ancestor
25304134|NCT04607122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25304135|NCT04607122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304136|NCT04607122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304137|NCT04607122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25304138|NCT04576663|Phenylephrine|phenylephrine|mesh-list
25304139|NCT04576663|Oxymetazoline|oxymetazoline|mesh-list
25304140|NCT04576663|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25304141|NCT04576663|Mydriatics|mydriatics|mesh-ancestor
25304142|NCT04576663|Autonomic Agents|autonomic agents|mesh-ancestor
25304143|NCT04576663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25825355|NCT00005589|Rituximab|rituximab|mesh-list
25181523|NCT02844530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181524|NCT02844530|Chelating Agents|chelating agents|mesh-ancestor
25304144|NCT04576663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304145|NCT04576663|Sympathomimetics|sympathomimetics|mesh-ancestor
25304146|NCT04576663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25304147|NCT04576663|Nasal Decongestants|nasal decongestants|mesh-ancestor
25304148|NCT04576663|Respiratory System Agents|respiratory system agents|mesh-ancestor
25304149|NCT04576663|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25304150|NCT04576663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25304151|NCT04576663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25304152|NCT04576663|Adrenergic Agents|adrenergic agents|mesh-ancestor
25304153|NCT04576663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25304154|NCT04576663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825356|NCT00005589|Etoposide|etoposide|mesh-list
24513462|NCT00581685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25304155|NCT04576663|Protective Agents|protective agents|mesh-ancestor
25304156|NCT04556357|Phenylephrine|phenylephrine|mesh-list
25304157|NCT04556357|Oxymetazoline|oxymetazoline|mesh-list
25304158|NCT04556357|Norepinephrine|norepinephrine|mesh-list
25304159|NCT04556357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25304160|NCT04556357|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25304173|NCT04556357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304175|NCT04553939|Gemcitabine|gemcitabine|mesh-list
25304176|NCT04553939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25304177|NCT04553939|Antimetabolites|antimetabolites|mesh-ancestor
25304178|NCT04553939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304179|NCT04553939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25304180|NCT04553939|Antiviral Agents|antiviral agents|mesh-ancestor
25304181|NCT04553939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25304182|NCT04553939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25304183|NCT04553939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25304184|NCT04553939|Immunologic Factors|immunologic factors|mesh-ancestor
25304185|NCT04553939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304198|NCT04501939|Venetoclax|venetoclax|mesh-list
25304199|NCT04501939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25304200|NCT04468425|Tofacitinib|tofacitinib|mesh-list
25304201|NCT04468425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304202|NCT04468425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25304203|NCT04468425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25304204|NCT04434326|Vorolanib|vorolanib|mesh-list
25304205|NCT04434326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25304206|NCT04434326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25304207|NCT04434326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304208|NCT04426968|Interferons|interferons|mesh-list
25304209|NCT04426968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25304210|NCT04426968|Antiviral Agents|antiviral agents|mesh-ancestor
25304211|NCT04426968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25304212|NCT04400695|Paclitaxel|paclitaxel|mesh-list
25304213|NCT04400695|Vinorelbine|vinorelbine|mesh-list
25304214|NCT04400695|Docetaxel|docetaxel|mesh-list
25304215|NCT04400695|Capecitabine|capecitabine|mesh-list
25304216|NCT04400695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25304217|NCT04400695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25304218|NCT04400695|Tubulin Modulators|tubulin modulators|mesh-ancestor
25304219|NCT04400695|Antimitotic Agents|antimitotic agents|mesh-ancestor
25304220|NCT04400695|Mitosis Modulators|mitosis modulators|mesh-ancestor
25304221|NCT04400695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304222|NCT04400695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25304223|NCT04400695|Antimetabolites|antimetabolites|mesh-ancestor
25304224|NCT04359329|Estradiol|estradiol|mesh-list
25304225|NCT04359329|Estrogens|estrogens|mesh-ancestor
25304226|NCT04359329|Hormones|hormones|mesh-ancestor
25304227|NCT04359329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25304228|NCT04359329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304229|NCT04328506|Vorolanib|vorolanib|mesh-list
25304230|NCT04328506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25304231|NCT04328506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25304232|NCT04328506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304260|NCT04264897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25304261|NCT04264897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304263|NCT04246060|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
25304264|NCT04246060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304265|NCT04235140|Ivacaftor|ivacaftor|mesh-list
25304266|NCT04235140|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25648317|NCT01478581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25181597|NCT05242718|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25181598|NCT05242718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25181599|NCT05242718|Hormones|hormones|mesh-ancestor
25181600|NCT05242718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25181601|NCT05242718|Expectorants|expectorants|mesh-ancestor
25181602|NCT05242718|Respiratory System Agents|respiratory system agents|mesh-ancestor
25181603|NCT05242718|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25181604|NCT05242718|Antioxidants|antioxidants|mesh-ancestor
25304267|NCT04235140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25304268|NCT04235140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304269|NCT04203875|Abatacept|abatacept|mesh-list
25304270|NCT04203875|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25304271|NCT04203875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304272|NCT04203875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25304273|NCT04203875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25304274|NCT04203875|Immunologic Factors|immunologic factors|mesh-ancestor
25304275|NCT04203875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304276|NCT04203875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25304277|NCT04114539|Ecopipam|ecopipam|mesh-list
25304278|NCT04114539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25304279|NCT04114539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25304280|NCT04114539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25304545|NCT02689167|Growth Inhibitors|growth inhibitors|mesh-ancestor
25304281|NCT04114539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304282|NCT04114539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25304283|NCT04114539|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25304284|NCT04114539|Dopamine Agents|dopamine agents|mesh-ancestor
25304285|NCT04114539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25304286|NCT04114539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304288|NCT04094298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25304289|NCT04094298|Glucocorticoids|glucocorticoids|mesh-ancestor
25304290|NCT04094298|Hormones|hormones|mesh-ancestor
25304291|NCT04094298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25304292|NCT04094298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304293|NCT04094298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25304294|NCT04094298|Immunologic Factors|immunologic factors|mesh-ancestor
25825357|NCT00005589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25304309|NCT03976934|Tamsulosin|tamsulosin|mesh-list
25304323|NCT03909217|Citalopram|citalopram|mesh-list
25304324|NCT03909217|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25304325|NCT03909217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25304326|NCT03909217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25304327|NCT03909217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304328|NCT03909217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25304329|NCT03909217|Serotonin Agents|serotonin agents|mesh-ancestor
25304330|NCT03909217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304331|NCT03909217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25304332|NCT03909217|Antidepressive Agents|antidepressive agents|mesh-ancestor
25304333|NCT03909217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25304334|NCT03909217|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25304335|NCT03909217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25304336|NCT03909217|Parasympatholytics|parasympatholytics|mesh-ancestor
25304337|NCT03909217|Autonomic Agents|autonomic agents|mesh-ancestor
25304338|NCT03909217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25304339|NCT03909217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25304340|NCT03909217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25304341|NCT03909217|Cholinergic Agents|cholinergic agents|mesh-ancestor
25304348|NCT03870529|Vitamins|vitamins|mesh-list
25304349|NCT03870529|Vitamin A|vitamin a|mesh-list
25304350|NCT03870529|Anti-Infective Agents|anti-infective agents|mesh-list
25304351|NCT03870529|Retinol palmitate|retinol palmitate|mesh-list
25304352|NCT03870529|Micronutrients|micronutrients|mesh-ancestor
25304353|NCT03870529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304354|NCT03870529|Antioxidants|antioxidants|mesh-ancestor
25304355|NCT03870529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648318|NCT01478581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25648319|NCT01478581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25648320|NCT01478594|Bevacizumab|bevacizumab|mesh-list
25648321|NCT01478594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25648322|NCT01478594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25648323|NCT01478594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25648324|NCT01478594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25648325|NCT01478594|Growth Substances|growth substances|mesh-ancestor
25181656|NCT05239182|Immunologic Factors|immunologic factors|mesh-ancestor
25181657|NCT05239182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181658|NCT05217654|Dapagliflozin|dapagliflozin|mesh-list
25304356|NCT03870529|Protective Agents|protective agents|mesh-ancestor
25304357|NCT03870529|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25304358|NCT03870529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25304359|NCT03770546|Betamethasone|betamethasone|mesh-list
25304360|NCT03770546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25304361|NCT03770546|Glucocorticoids|glucocorticoids|mesh-ancestor
25304362|NCT03770546|Hormones|hormones|mesh-ancestor
25304363|NCT03770546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25304364|NCT03770546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304365|NCT03770546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25304366|NCT03770546|Respiratory System Agents|respiratory system agents|mesh-ancestor
25304367|NCT03763643|Rituximab|rituximab|mesh-list
25304368|NCT03763643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25304369|NCT03763643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25304370|NCT03763643|Immunologic Factors|immunologic factors|mesh-ancestor
24892374|NCT04463953|Ixazomib|ixazomib|mesh-list
25304371|NCT03763643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304372|NCT03763643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25304373|NCT03712202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25304374|NCT03712202|Nivolumab|nivolumab|mesh-list
25304375|NCT03712202|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25304376|NCT03712202|Doxorubicin|doxorubicin|mesh-list
25304377|NCT03712202|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25304378|NCT03712202|Daunorubicin|daunorubicin|mesh-list
25304379|NCT03712202|Bleomycin|bleomycin|mesh-list
25304380|NCT03712202|Dacarbazine|dacarbazine|mesh-list
25304381|NCT03712202|Vinblastine|vinblastine|mesh-list
25304382|NCT03712202|Antibodies|antibodies|mesh-list
25304383|NCT03712202|Immunoglobulins|immunoglobulins|mesh-list
25304384|NCT03712202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25304385|NCT03712202|Immunoconjugates|immunoconjugates|mesh-list
25304388|NCT03712202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304389|NCT03712202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25304390|NCT03712202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25304790|NCT05306002|Antioxidants|antioxidants|mesh-list
25304391|NCT03712202|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25304392|NCT03712202|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25304393|NCT03712202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25304394|NCT03712202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304395|NCT03712202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25304396|NCT03712202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25304397|NCT03712202|Alkylating Agents|alkylating agents|mesh-ancestor
25304398|NCT03712202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25304399|NCT03712202|Tubulin Modulators|tubulin modulators|mesh-ancestor
25304400|NCT03712202|Antimitotic Agents|antimitotic agents|mesh-ancestor
25304401|NCT03712202|Mitosis Modulators|mitosis modulators|mesh-ancestor
25304404|NCT03659539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25304405|NCT03659539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25304406|NCT03659539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304407|NCT03659539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25304408|NCT03659539|Anesthetics, General|anesthetics, general|mesh-ancestor
25304409|NCT03659539|Anesthetics|anesthetics|mesh-ancestor
25304410|NCT03659539|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25304411|NCT03630224|Plasma-lyte 148|plasma-lyte 148|mesh-list
25304412|NCT03630224|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25304413|NCT03630224|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25304414|NCT03627858|Beclomethasone|beclomethasone|mesh-list
25304415|NCT03627858|Glycopyrrolate|glycopyrrolate|mesh-list
25304416|NCT03627858|Formoterol Fumarate|formoterol fumarate|mesh-list
25304417|NCT03627858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25304418|NCT03627858|Autonomic Agents|autonomic agents|mesh-ancestor
25304419|NCT03627858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25304420|NCT03627858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304421|NCT03627858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25304422|NCT03627858|Respiratory System Agents|respiratory system agents|mesh-ancestor
25304423|NCT03627858|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25304424|NCT03627858|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25304425|NCT03627858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25304426|NCT03627858|Adrenergic Agents|adrenergic agents|mesh-ancestor
25648326|NCT01478594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648327|NCT01478594|Growth Inhibitors|growth inhibitors|mesh-ancestor
25648328|NCT01478828|Lovastatin|lovastatin|mesh-list
25304427|NCT03627858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25304428|NCT03627858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181706|NCT05007509|Immunologic Factors|immunologic factors|mesh-ancestor
25181707|NCT05007509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181717|NCT04972175|Insulin Lispro|insulin lispro|mesh-list
25181718|NCT04972175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25181719|NCT04972175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181720|NCT04967573|Rivaroxaban|rivaroxaban|mesh-list
25181721|NCT04967573|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25181722|NCT04967573|Antithrombins|antithrombins|mesh-ancestor
25181723|NCT04967573|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25304429|NCT03627858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25304430|NCT03627858|Glucocorticoids|glucocorticoids|mesh-ancestor
25304431|NCT03627858|Hormones|hormones|mesh-ancestor
25304432|NCT03627858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25304433|NCT03627858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25304434|NCT03627858|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25304435|NCT03627858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25304436|NCT03627858|Cholinergic Agents|cholinergic agents|mesh-ancestor
25304437|NCT03620123|Docetaxel|docetaxel|mesh-list
25304438|NCT03620123|Nivolumab|nivolumab|mesh-list
25304439|NCT03620123|Ipilimumab|ipilimumab|mesh-list
25304440|NCT03620123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25304441|NCT03620123|Tubulin Modulators|tubulin modulators|mesh-ancestor
25304442|NCT03620123|Antimitotic Agents|antimitotic agents|mesh-ancestor
25304443|NCT03620123|Mitosis Modulators|mitosis modulators|mesh-ancestor
25304444|NCT03620123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304445|NCT03620123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25304446|NCT03620123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25304447|NCT03601637|Ivacaftor|ivacaftor|mesh-list
25304448|NCT03601637|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25304449|NCT03601637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25304450|NCT03601637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758084|NCT01743820|Piperaquine|piperaquine|mesh-list
25304453|NCT03370172|Factor VIII|factor viii|mesh-list
25304454|NCT03370172|Coagulants|coagulants|mesh-ancestor
25304455|NCT03292146|Denosumab|denosumab|mesh-list
25304456|NCT03292146|Alendronate|alendronate|mesh-list
25304457|NCT03292146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25304458|NCT03292146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304459|NCT03270501|Golimumab|golimumab|mesh-list
25304460|NCT03270501|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25304461|NCT03270501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25304462|NCT03270501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25304463|NCT03270501|Immunologic Factors|immunologic factors|mesh-ancestor
25304464|NCT03270501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304465|NCT03159000|Lidocaine|lidocaine|mesh-list
25304466|NCT03159000|Bupivacaine|bupivacaine|mesh-list
25304467|NCT03159000|Anesthetics, Local|anesthetics, local|mesh-ancestor
25304468|NCT03159000|Anesthetics|anesthetics|mesh-ancestor
25304469|NCT03159000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25304470|NCT03159000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304471|NCT03159000|Sensory System Agents|sensory system agents|mesh-ancestor
25304472|NCT03159000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25304473|NCT03159000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25304474|NCT03159000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25304475|NCT03159000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25304476|NCT03159000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25304477|NCT03159000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304478|NCT03126643|Nivolumab|nivolumab|mesh-list
25304479|NCT03126643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25304480|NCT03126643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25304481|NCT03126643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25304482|NCT03126643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304483|NCT03126617|Elotuzumab|elotuzumab|mesh-list
25304484|NCT03126617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25304485|NCT03054792|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
25304486|NCT03054792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25408481|NCT03437746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25648329|NCT01478828|L 647318|l 647318|mesh-list
25648330|NCT01478828|Dihydromevinolin|dihydromevinolin|mesh-list
25648331|NCT01478828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25648332|NCT01478828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25648333|NCT01478828|Antimetabolites|antimetabolites|mesh-ancestor
25648334|NCT01478828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648335|NCT01478828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25648336|NCT01478828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25205294|NCT04942067|BB 1101|bb 1101|mesh-list
25304487|NCT03054792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304488|NCT03016819|Dacarbazine|dacarbazine|mesh-list
25304489|NCT03016819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25304490|NCT03016819|Alkylating Agents|alkylating agents|mesh-ancestor
25304491|NCT03016819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304492|NCT03016819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25304493|NCT02951364|Sofosbuvir|sofosbuvir|mesh-list
25304494|NCT02951364|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25304495|NCT02951364|Ledipasvir|ledipasvir|mesh-list
25304496|NCT02951364|Antiviral Agents|antiviral agents|mesh-ancestor
25304497|NCT02951364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25304498|NCT02889237|Calcium, Dietary|calcium, dietary|mesh-list
25304499|NCT02889237|Vitamin D|vitamin d|mesh-list
25304500|NCT02889237|Ergocalciferols|ergocalciferols|mesh-list
25304501|NCT02889237|Cholecalciferol|cholecalciferol|mesh-list
25304502|NCT02889237|Vitamins|vitamins|mesh-list
25304503|NCT02889237|Calcium|calcium|mesh-list
25304504|NCT02889237|Micronutrients|micronutrients|mesh-ancestor
25304505|NCT02889237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304506|NCT02889237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25304507|NCT02889237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25304508|NCT02856438|Dexamethasone|dexamethasone|mesh-list
25304509|NCT02856438|Lenalidomide|lenalidomide|mesh-list
25304510|NCT02856438|Elotuzumab|elotuzumab|mesh-list
25304511|NCT02856438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25304512|NCT02856438|Antiemetics|antiemetics|mesh-ancestor
25304513|NCT02856438|Autonomic Agents|autonomic agents|mesh-ancestor
25304514|NCT02856438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25304515|NCT02856438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304516|NCT02856438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25304517|NCT02856438|Glucocorticoids|glucocorticoids|mesh-ancestor
25304518|NCT02856438|Hormones|hormones|mesh-ancestor
25304519|NCT02856438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25304520|NCT02856438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25304521|NCT02856438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25304522|NCT02856438|Immunologic Factors|immunologic factors|mesh-ancestor
25304523|NCT02856438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25304524|NCT02856438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25304525|NCT02856438|Growth Substances|growth substances|mesh-ancestor
25304526|NCT02856438|Growth Inhibitors|growth inhibitors|mesh-ancestor
25304527|NCT02808182|Niacin|niacin|mesh-list
25304528|NCT02808182|Nicotinic Acids|nicotinic acids|mesh-list
25304529|NCT02808182|Niacinamide|niacinamide|mesh-list
25304530|NCT02808182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25304531|NCT02808182|Antimetabolites|antimetabolites|mesh-ancestor
25304532|NCT02808182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304533|NCT02808182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25304534|NCT02808182|Vasodilator Agents|vasodilator agents|mesh-ancestor
25304535|NCT02808182|Vitamin B Complex|vitamin b complex|mesh-ancestor
25304536|NCT02808182|Vitamins|vitamins|mesh-ancestor
25304537|NCT02808182|Micronutrients|micronutrients|mesh-ancestor
25304538|NCT02808182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304539|NCT02689167|Sunitinib|sunitinib|mesh-list
25304540|NCT02689167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25304541|NCT02689167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25304542|NCT02689167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25304543|NCT02689167|Growth Substances|growth substances|mesh-ancestor
25304544|NCT02689167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304546|NCT02689167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25304547|NCT02689167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25304548|NCT02689167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304549|NCT02591420|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25304551|NCT02591420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25304552|NCT02582697|Cisplatin|cisplatin|mesh-list
25304553|NCT02582697|Etoposide|etoposide|mesh-list
25304554|NCT02582697|Etoposide phosphate|etoposide phosphate|mesh-list
25304555|NCT02582697|Bleomycin|bleomycin|mesh-list
25304556|NCT02582697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25304557|NCT02582697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25304558|NCT02582697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25304559|NCT02582697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25304560|NCT02582697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25304561|NCT02582697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304562|NCT02582697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25304563|NCT02535221|Epirubicin|epirubicin|mesh-list
25304564|NCT02535221|Goserelin|goserelin|mesh-list
25648337|NCT01478828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25181805|NCT04748783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25181806|NCT04748783|Disinfectants|disinfectants|mesh-ancestor
25181807|NCT04748783|Dermatologic Agents|dermatologic agents|mesh-ancestor
25181808|NCT04701788|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25181809|NCT04701788|Immunologic Factors|immunologic factors|mesh-ancestor
25181810|NCT04701788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181811|NCT04700618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25181812|NCT04700618|Immunologic Factors|immunologic factors|mesh-ancestor
25181813|NCT04700618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181814|NCT04674410|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25181815|NCT04674410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25181840|NCT04646655|Anticoagulants|anticoagulants|mesh-ancestor
25181841|NCT04646655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25181842|NCT04646655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25181843|NCT04646655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181844|NCT04646356|Tacrolimus|tacrolimus|mesh-list
25181845|NCT04646356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25181846|NCT04646356|Immunologic Factors|immunologic factors|mesh-ancestor
24792050|NCT05413096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24894907|NCT05375084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25181847|NCT04646356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181848|NCT04646356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25181852|NCT04635241|Calcium heparin|calcium heparin|mesh-list
25304565|NCT02535221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25304566|NCT02535221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25304567|NCT02535221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25304568|NCT02535221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25304569|NCT02535221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25304570|NCT02535221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304571|NCT02535221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25304572|NCT02529904|Vaccines|vaccines|mesh-list
25304573|NCT02529904|Immunologic Factors|immunologic factors|mesh-ancestor
25304574|NCT02529904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304575|NCT02525796|Eplerenone|eplerenone|mesh-list
25304576|NCT02525796|Amiloride|amiloride|mesh-list
25304577|NCT02525796|Cinacalcet|cinacalcet|mesh-list
25304578|NCT02525796|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25304579|NCT02525796|Hormone Antagonists|hormone antagonists|mesh-ancestor
25304580|NCT02525796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25304581|NCT02525796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304582|NCT02525796|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25304583|NCT02525796|Diuretics|diuretics|mesh-ancestor
25304584|NCT02525796|Natriuretic Agents|natriuretic agents|mesh-ancestor
25304585|NCT02525796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25304586|NCT02525796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25304587|NCT02525796|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25304588|NCT02525796|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
25304589|NCT02525796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25304590|NCT02525796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25304591|NCT02525796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304592|NCT02525796|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
25304593|NCT02217345|Hormones|hormones|mesh-list
25648338|NCT01478971|Epoetin Alfa|epoetin alfa|mesh-list
25648339|NCT01478971|Hematinics|hematinics|mesh-ancestor
25648340|NCT01479127|Silicon|silicon|mesh-list
25648341|NCT01479127|Levodopa|levodopa|mesh-list
25648342|NCT01479127|Carbidopa|carbidopa|mesh-list
25648343|NCT01479127|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25648344|NCT01479127|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25648345|NCT01479127|Dopamine Agents|dopamine agents|mesh-ancestor
25648346|NCT01479127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25648347|NCT01479127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648348|NCT01479127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648349|NCT01479127|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25648350|NCT01479127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25648351|NCT01479127|Trace Elements|trace elements|mesh-ancestor
25648352|NCT01479127|Micronutrients|micronutrients|mesh-ancestor
25648353|NCT01479270|Epinephrine|epinephrine|mesh-list
25648354|NCT01479270|Ropivacaine|ropivacaine|mesh-list
25648355|NCT01479270|Anesthetics, Local|anesthetics, local|mesh-ancestor
25648356|NCT01479270|Anesthetics|anesthetics|mesh-ancestor
25648357|NCT01479270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25648358|NCT01479270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648359|NCT01479270|Sensory System Agents|sensory system agents|mesh-ancestor
25648360|NCT01479270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25181882|NCT04570176|Epinephrine|epinephrine|mesh-list
25181883|NCT04570176|Racepinephrine|racepinephrine|mesh-list
25181884|NCT04570176|Epinephryl borate|epinephryl borate|mesh-list
25181885|NCT04570176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25181886|NCT04570176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25181887|NCT04570176|Adrenergic Agents|adrenergic agents|mesh-ancestor
25181888|NCT04570176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25181889|NCT04570176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181890|NCT04570176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181897|NCT04570176|Mydriatics|mydriatics|mesh-ancestor
25304594|NCT02217345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25304595|NCT02217345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304596|NCT01996605|Oxytocin|oxytocin|mesh-list
25304597|NCT01996605|Oxytocics|oxytocics|mesh-ancestor
25304598|NCT01996605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25304599|NCT01996605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304600|NCT01669915|Vitamin D|vitamin d|mesh-list
25304601|NCT01669915|Ergocalciferols|ergocalciferols|mesh-list
25304602|NCT01669915|Cholecalciferol|cholecalciferol|mesh-list
25304603|NCT01669915|Vitamins|vitamins|mesh-list
25304604|NCT01669915|Micronutrients|micronutrients|mesh-ancestor
25304605|NCT01669915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304606|NCT01669915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25304607|NCT01669915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25304608|NCT01503489|Norepinephrine|norepinephrine|mesh-list
25304609|NCT01503489|Antidepressive Agents|antidepressive agents|mesh-list
25304610|NCT01503489|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
25304611|NCT01503489|Serotonin|serotonin|mesh-list
25304612|NCT01503489|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25304614|NCT01503489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25304615|NCT01503489|Adrenergic Agents|adrenergic agents|mesh-ancestor
25304616|NCT01503489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25304617|NCT01503489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304618|NCT01503489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304620|NCT01503489|Autonomic Agents|autonomic agents|mesh-ancestor
25304621|NCT01503489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25304622|NCT01503489|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25304623|NCT01503489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25304624|NCT01503489|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25304625|NCT01503489|Serotonin Agents|serotonin agents|mesh-ancestor
25304626|NCT01503489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25304627|NCT01503489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25304628|NCT01019616|Paclitaxel|paclitaxel|mesh-list
25304629|NCT01019616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25304630|NCT01019616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25304631|NCT01019616|Tubulin Modulators|tubulin modulators|mesh-ancestor
25304632|NCT01019616|Antimitotic Agents|antimitotic agents|mesh-ancestor
25304633|NCT01019616|Mitosis Modulators|mitosis modulators|mesh-ancestor
25304634|NCT01019616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304635|NCT00000587|Epoetin Alfa|epoetin alfa|mesh-list
25304636|NCT00000587|Hematinics|hematinics|mesh-ancestor
25304637|NCT05138146|Doxorubicin|doxorubicin|mesh-list
25304638|NCT05138146|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25304639|NCT05138146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25304640|NCT05138146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25304641|NCT05138146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25304642|NCT05138146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25304643|NCT05138146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25304644|NCT05138146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304645|NCT05137964|Vitamin D|vitamin d|mesh-list
25304646|NCT05137964|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
25304647|NCT05137964|Vitamins|vitamins|mesh-ancestor
25304648|NCT05137964|Micronutrients|micronutrients|mesh-ancestor
25304649|NCT05137964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304650|NCT05137964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25304653|NCT05137522|Methylprednisolone|methylprednisolone|mesh-list
25648361|NCT01479270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25648362|NCT01479270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25648363|NCT01479270|Adrenergic Agents|adrenergic agents|mesh-ancestor
25648364|NCT01479270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25648365|NCT01479270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648366|NCT01479270|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25648367|NCT01479270|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25648368|NCT01479270|Autonomic Agents|autonomic agents|mesh-ancestor
25648369|NCT01479270|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25181955|NCT04452565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25181956|NCT04452565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25181957|NCT04452565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181958|NCT04452565|Protease Inhibitors|protease inhibitors|mesh-ancestor
25181959|NCT04452565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25181960|NCT04452565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181961|NCT04452565|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25181962|NCT04452565|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25181963|NCT04452565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25181965|NCT04452565|Antiviral Agents|antiviral agents|mesh-ancestor
25304654|NCT05137522|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25304655|NCT05137522|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25304656|NCT05137522|Prednisolone|prednisolone|mesh-list
25304657|NCT05137522|Prednisolone acetate|prednisolone acetate|mesh-list
25304658|NCT05137522|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25304659|NCT05137522|Prednisolone phosphate|prednisolone phosphate|mesh-list
25304660|NCT05137522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25304661|NCT05137522|Antiemetics|antiemetics|mesh-ancestor
25304662|NCT05137522|Autonomic Agents|autonomic agents|mesh-ancestor
25304663|NCT05137522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25304664|NCT05137522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304665|NCT05137522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25304666|NCT05137522|Glucocorticoids|glucocorticoids|mesh-ancestor
25304667|NCT05137522|Hormones|hormones|mesh-ancestor
25304668|NCT05137522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25304669|NCT05137522|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25304670|NCT05137522|Protective Agents|protective agents|mesh-ancestor
25304671|NCT05137522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25304672|NCT05137522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25304673|NCT05137288|Atropine|atropine|mesh-list
25304674|NCT05137288|Ondansetron|ondansetron|mesh-list
25304675|NCT05137288|Bupivacaine|bupivacaine|mesh-list
25304676|NCT05137288|Anesthetics, Local|anesthetics, local|mesh-ancestor
25304677|NCT05137288|Anesthetics|anesthetics|mesh-ancestor
25304678|NCT05137288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25304679|NCT05137288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304680|NCT05137288|Sensory System Agents|sensory system agents|mesh-ancestor
25304681|NCT05137288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25304682|NCT05137288|Antiemetics|antiemetics|mesh-ancestor
25304683|NCT05137288|Autonomic Agents|autonomic agents|mesh-ancestor
25304684|NCT05137288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25304685|NCT05137288|Antipruritics|antipruritics|mesh-ancestor
25304686|NCT05137288|Dermatologic Agents|dermatologic agents|mesh-ancestor
25304687|NCT05137288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25304688|NCT05137288|Serotonin Agents|serotonin agents|mesh-ancestor
25304689|NCT05137288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25304690|NCT05137288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304692|NCT05137288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25304693|NCT05137288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25304694|NCT05137288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25304695|NCT05137288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25304696|NCT05137288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25304697|NCT05137288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25304698|NCT05137288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25304699|NCT05137288|Respiratory System Agents|respiratory system agents|mesh-ancestor
25304700|NCT05137288|Mydriatics|mydriatics|mesh-ancestor
25304701|NCT05137288|Parasympatholytics|parasympatholytics|mesh-ancestor
25304702|NCT05137288|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25304703|NCT05137288|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25304704|NCT05137288|Cholinergic Agents|cholinergic agents|mesh-ancestor
25304705|NCT05137197|Antidepressive Agents|antidepressive agents|mesh-list
25304706|NCT05137197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25304707|NCT05137184|Fentanyl|fentanyl|mesh-list
25648370|NCT01479270|Respiratory System Agents|respiratory system agents|mesh-ancestor
25648371|NCT01479270|Mydriatics|mydriatics|mesh-ancestor
25648372|NCT01479270|Sympathomimetics|sympathomimetics|mesh-ancestor
25648373|NCT01479270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25648374|NCT01479348|Tetrahydrouridine|tetrahydrouridine|mesh-list
25648375|NCT01479348|Antimetabolites|antimetabolites|mesh-ancestor
25648376|NCT01479348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648377|NCT01479374|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25648378|NCT01479374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25304708|NCT05137184|Morphine|morphine|mesh-list
25304709|NCT05137184|Methoxyflurane|methoxyflurane|mesh-list
25304710|NCT05137184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25648379|NCT01479374|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25825358|NCT00005589|Immunologic Factors|immunologic factors|mesh-ancestor
25182012|NCT04355143|Gout Suppressants|gout suppressants|mesh-ancestor
25182013|NCT04355143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25182014|NCT04355143|Tubulin Modulators|tubulin modulators|mesh-ancestor
25182015|NCT04355143|Antimitotic Agents|antimitotic agents|mesh-ancestor
25182016|NCT04355143|Mitosis Modulators|mitosis modulators|mesh-ancestor
25182017|NCT04355143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182018|NCT04355143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25182020|NCT04345796|Carvedilol|carvedilol|mesh-list
25182021|NCT04345796|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25182022|NCT04345796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182023|NCT04345796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25182024|NCT04345796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182025|NCT04345796|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25182026|NCT04345796|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25182027|NCT04345796|Adrenergic Agents|adrenergic agents|mesh-ancestor
25182028|NCT04345796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25182029|NCT04345796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25182030|NCT04345796|Antioxidants|antioxidants|mesh-ancestor
25304711|NCT05137184|Narcotics|narcotics|mesh-ancestor
25304712|NCT05137184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25304713|NCT05137184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304714|NCT05137184|Analgesics|analgesics|mesh-ancestor
25304715|NCT05137184|Sensory System Agents|sensory system agents|mesh-ancestor
25304716|NCT05137184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25304717|NCT05137184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25304718|NCT05137184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25304719|NCT05137184|Anesthetics, General|anesthetics, general|mesh-ancestor
25304720|NCT05137184|Anesthetics|anesthetics|mesh-ancestor
25304721|NCT05137184|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25304722|NCT05137145|Linaclotide|linaclotide|mesh-list
25304723|NCT05137145|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25304724|NCT05137145|Enzyme Activators|enzyme activators|mesh-ancestor
25304725|NCT05137145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304726|NCT05137145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25304727|NCT05136976|Rituximab|rituximab|mesh-list
25304728|NCT05136976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25304729|NCT05136976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25304730|NCT05136976|Immunologic Factors|immunologic factors|mesh-ancestor
25304731|NCT05136976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304732|NCT05136976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25304733|NCT05136924|Varenicline|varenicline|mesh-list
25304734|NCT05136924|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25304735|NCT05136924|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25304736|NCT05136924|Cholinergic Agents|cholinergic agents|mesh-ancestor
25304737|NCT05136924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25304738|NCT05136924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304739|NCT05136924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304740|NCT05135715|Trastuzumab|trastuzumab|mesh-list
25304741|NCT05135715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25304742|NCT05135715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25304743|NCT05135182|Metronidazole|metronidazole|mesh-list
25304744|NCT05135182|Furazolidone|furazolidone|mesh-list
25304745|NCT05135182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25648380|NCT01479374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25648381|NCT01479374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25648382|NCT01479374|Analgesics|analgesics|mesh-ancestor
25648383|NCT01479374|Sensory System Agents|sensory system agents|mesh-ancestor
25648384|NCT01479374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25648385|NCT01479374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648386|NCT01479374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25648387|NCT01479374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25648388|NCT01479374|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25648389|NCT01479374|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25648390|NCT01479374|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25648391|NCT01479374|Histamine Antagonists|histamine antagonists|mesh-ancestor
25648392|NCT01479374|Histamine Agents|histamine agents|mesh-ancestor
25648393|NCT01479374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25648394|NCT01479374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648395|NCT01479439|Losartan|losartan|mesh-list
25648396|NCT01479439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25648397|NCT01479439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24801552|NCT01984086|Albuterol|albuterol|mesh-list
25304746|NCT05135182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25205353|NCT04882293|Atorvastatin|atorvastatin|mesh-list
25205354|NCT04882293|Fenofibrate|fenofibrate|mesh-list
25205355|NCT04882293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25205356|NCT04882293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25205357|NCT04882293|Antimetabolites|antimetabolites|mesh-ancestor
25205358|NCT04882293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205359|NCT04882293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25205361|NCT04882293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25304747|NCT05135182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25304748|NCT05135182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25304749|NCT05135182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25304750|NCT05135182|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25304751|NCT05135182|Renal Agents|renal agents|mesh-ancestor
25304752|NCT05135182|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25304753|NCT05135182|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25304754|NCT05135182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25304755|NCT05135182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304756|NCT05135143|Antioxidants|antioxidants|mesh-list
25304757|NCT05135143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487050|NCT00461344|Docetaxel|docetaxel|mesh-list
25304758|NCT05135143|Protective Agents|protective agents|mesh-ancestor
25304759|NCT05135143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304760|NCT05133453|Pirfenidone|pirfenidone|mesh-list
25304761|NCT05133453|Analgesics|analgesics|mesh-ancestor
25304762|NCT05133453|Sensory System Agents|sensory system agents|mesh-ancestor
25304763|NCT05133453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25304764|NCT05133453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304777|NCT05125978|Sensory System Agents|sensory system agents|mesh-ancestor
25304778|NCT05125978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25304779|NCT05125978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25304780|NCT05125978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25304781|NCT05125978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25304782|NCT05125978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25304783|NCT05125978|Antipyretics|antipyretics|mesh-ancestor
25304784|NCT05125185|Insulin|insulin|mesh-list
25304785|NCT05125185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25304786|NCT05125185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304787|NCT05306028|Metformin|metformin|mesh-list
25304788|NCT05306028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25304789|NCT05306028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304791|NCT05306002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304792|NCT05306002|Protective Agents|protective agents|mesh-ancestor
25304793|NCT05306002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304794|NCT05305924|Fulvestrant|fulvestrant|mesh-list
25304795|NCT05305924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25304796|NCT05305924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25304797|NCT05305924|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25304798|NCT05305924|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25304799|NCT05305924|Hormone Antagonists|hormone antagonists|mesh-ancestor
25304800|NCT05305924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25304801|NCT05305924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304802|NCT05305898|Metformin|metformin|mesh-list
25304803|NCT05305898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25304804|NCT05305898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304812|NCT05305768|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25304813|NCT05305768|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25304814|NCT05305768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25304815|NCT05305768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304816|NCT05305768|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25304817|NCT05305768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25304818|NCT05305768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304819|NCT05305768|Cholinergic Agents|cholinergic agents|mesh-ancestor
25304820|NCT05305768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25304821|NCT05305560|Ivermectin|ivermectin|mesh-list
25304822|NCT05305560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25304823|NCT05305560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25304829|NCT05305456|Vitamins|vitamins|mesh-list
25648398|NCT01479439|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25648399|NCT01479439|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25648400|NCT01479439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648401|NCT01479465|Leucovorin|leucovorin|mesh-list
25648402|NCT01479465|Fluorouracil|fluorouracil|mesh-list
25648403|NCT01479465|Irinotecan|irinotecan|mesh-list
25648404|NCT01479465|Antimetabolites|antimetabolites|mesh-ancestor
25656849|NCT01579513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25304830|NCT05305456|Ascorbic Acid|ascorbic acid|mesh-list
25304831|NCT05305456|Micronutrients|micronutrients|mesh-ancestor
25304832|NCT05305456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304833|NCT05305456|Antioxidants|antioxidants|mesh-ancestor
25304834|NCT05305456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304835|NCT05305456|Protective Agents|protective agents|mesh-ancestor
25304864|NCT05305287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304866|NCT05305183|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25304867|NCT05305183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304868|NCT05305131|Gemcitabine|gemcitabine|mesh-list
25304869|NCT05305131|Bevacizumab|bevacizumab|mesh-list
25304870|NCT05305131|Pembrolizumab|pembrolizumab|mesh-list
25304871|NCT05305131|Cisplatin|cisplatin|mesh-list
25304872|NCT05305131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25304873|NCT05305131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25304874|NCT05305131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25304875|NCT05305131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25304876|NCT05305131|Growth Substances|growth substances|mesh-ancestor
25304877|NCT05305131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304878|NCT05305131|Growth Inhibitors|growth inhibitors|mesh-ancestor
25304879|NCT05305131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25304880|NCT05305131|Antimetabolites|antimetabolites|mesh-ancestor
25304881|NCT05305131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304882|NCT05305131|Antiviral Agents|antiviral agents|mesh-ancestor
25304883|NCT05305131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25304884|NCT05305131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25304885|NCT05305131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25304886|NCT05305131|Immunologic Factors|immunologic factors|mesh-ancestor
25304908|NCT05304845|Aspirin|aspirin|mesh-list
25304909|NCT05304845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25304910|NCT05304845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25304911|NCT05304845|Analgesics|analgesics|mesh-ancestor
25304912|NCT05304845|Sensory System Agents|sensory system agents|mesh-ancestor
25304913|NCT05304845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25304914|NCT05304845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304915|NCT05304845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25304916|NCT05304845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25304917|NCT05304845|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25304945|NCT05304598|Analgesics|analgesics|mesh-ancestor
25304946|NCT05304598|Sensory System Agents|sensory system agents|mesh-ancestor
25304947|NCT05304598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25304948|NCT05304598|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25304949|NCT05304598|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25304950|NCT05304598|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25304951|NCT05304598|Adrenergic Agents|adrenergic agents|mesh-ancestor
25304952|NCT05304598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25304953|NCT05304598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304954|NCT05304559|Ketamine|ketamine|mesh-list
25304955|NCT05304559|Esketamine|esketamine|mesh-list
25304956|NCT05304559|Analgesics|analgesics|mesh-ancestor
25304957|NCT05304559|Sensory System Agents|sensory system agents|mesh-ancestor
25304958|NCT05304559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25304959|NCT05304559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304960|NCT05304559|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25304961|NCT05304559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25304962|NCT05304559|Anesthetics, General|anesthetics, general|mesh-ancestor
25304963|NCT05304559|Anesthetics|anesthetics|mesh-ancestor
25304964|NCT05304559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25304965|NCT05304559|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25304966|NCT05304559|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25304967|NCT05304559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25304968|NCT05304559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25304969|NCT05304559|Antidepressive Agents|antidepressive agents|mesh-ancestor
25304970|NCT05304559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25304971|NCT05304520|Natalizumab|natalizumab|mesh-list
25304972|NCT05304520|Immunologic Factors|immunologic factors|mesh-ancestor
25304973|NCT05304520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304974|NCT05304351|Vaccines|vaccines|mesh-list
25304975|NCT05304351|Immunologic Factors|immunologic factors|mesh-ancestor
25304976|NCT05304351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25304977|NCT05304338|Chlorhexidine|chlorhexidine|mesh-list
25304978|NCT05304338|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25304979|NCT05304338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25304980|NCT05304338|Disinfectants|disinfectants|mesh-ancestor
25305039|NCT05303818|Rivaroxaban|rivaroxaban|mesh-list
25305040|NCT05303818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25182187|NCT03896880|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25182188|NCT03896880|Clotrimazole|clotrimazole|mesh-list
25182189|NCT03896880|Miconazole|miconazole|mesh-list
25182190|NCT03896880|Antifungal Agents|antifungal agents|mesh-list
25182191|NCT03896880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25182192|NCT03896880|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25182193|NCT03896880|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25182194|NCT03896880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25182195|NCT03896880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25182196|NCT03896880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182197|NCT03896880|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25182198|NCT03896880|Hormone Antagonists|hormone antagonists|mesh-ancestor
25182199|NCT03896880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25305041|NCT05303818|Antithrombins|antithrombins|mesh-ancestor
25305042|NCT05303818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25305043|NCT05303818|Protease Inhibitors|protease inhibitors|mesh-ancestor
25305044|NCT05303818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25305045|NCT05303818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305046|NCT05303818|Anticoagulants|anticoagulants|mesh-ancestor
25305047|NCT05303688|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
25305048|NCT05303688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25305049|NCT05303688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25305050|NCT05303688|Analgesics|analgesics|mesh-ancestor
25305051|NCT05303688|Sensory System Agents|sensory system agents|mesh-ancestor
25305052|NCT05303688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25305053|NCT05303688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305054|NCT05303688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25305055|NCT05303688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25305056|NCT05303597|Lidocaine|lidocaine|mesh-list
25305057|NCT05303597|Anesthetics, Local|anesthetics, local|mesh-ancestor
25305058|NCT05303597|Anesthetics|anesthetics|mesh-ancestor
25305059|NCT05303597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25305060|NCT05303597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305061|NCT05303597|Sensory System Agents|sensory system agents|mesh-ancestor
25305062|NCT05303597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25305063|NCT05303597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25305064|NCT05303597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25305065|NCT05303597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25305215|NCT05301660|Cholinergic Agents|cholinergic agents|mesh-ancestor
25305072|NCT05303480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25305073|NCT05303285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25305074|NCT05303285|Immunologic Factors|immunologic factors|mesh-ancestor
25305075|NCT05303285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305076|NCT05303272|Mycophenolic Acid|mycophenolic acid|mesh-list
25305077|NCT05303272|Abatacept|abatacept|mesh-list
25305078|NCT05303272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25305079|NCT05303272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25305080|NCT05303272|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25305081|NCT05303272|Antitubercular Agents|antitubercular agents|mesh-ancestor
25305082|NCT05303272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25305083|NCT05303272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25305084|NCT05303272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25305085|NCT05303272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305086|NCT05303272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25305087|NCT05303272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25305088|NCT05303272|Immunologic Factors|immunologic factors|mesh-ancestor
25305089|NCT05303272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305090|NCT05303272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25305091|NCT05303259|Bevacizumab|bevacizumab|mesh-list
25305387|NCT05260073|Tirbanibulin|tirbanibulin|mesh-list
25648405|NCT01479465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648406|NCT01479465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25648407|NCT01479465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25648408|NCT01479465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25648409|NCT01479465|Immunologic Factors|immunologic factors|mesh-ancestor
25648410|NCT01479465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648411|NCT01479465|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25648412|NCT01479465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25648413|NCT01479465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25648414|NCT01479465|Antidotes|antidotes|mesh-ancestor
25648415|NCT01479465|Protective Agents|protective agents|mesh-ancestor
25648416|NCT01479465|Vitamin B Complex|vitamin b complex|mesh-ancestor
25648417|NCT01479465|Vitamins|vitamins|mesh-ancestor
25648418|NCT01479465|Micronutrients|micronutrients|mesh-ancestor
25182245|NCT03673124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182246|NCT03635489|Paclitaxel|paclitaxel|mesh-list
25182247|NCT03635489|Bevacizumab|bevacizumab|mesh-list
25182248|NCT03635489|Carboplatin|carboplatin|mesh-list
25182250|NCT03635489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25305092|NCT05303259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25305093|NCT05303259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25305094|NCT05303259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25305095|NCT05303259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25305096|NCT05303259|Growth Substances|growth substances|mesh-ancestor
25305097|NCT05303259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305098|NCT05303259|Growth Inhibitors|growth inhibitors|mesh-ancestor
25305100|NCT05303090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25305101|NCT05303090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25305102|NCT05303090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25305103|NCT05303090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305104|NCT05302999|Gabapentin|gabapentin|mesh-list
25305105|NCT05302999|Analgesics|analgesics|mesh-ancestor
25305106|NCT05302999|Sensory System Agents|sensory system agents|mesh-ancestor
25305107|NCT05302999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25305108|NCT05302999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305109|NCT05302999|Anticonvulsants|anticonvulsants|mesh-ancestor
25305110|NCT05302999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25305111|NCT05302999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25305112|NCT05302999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25305113|NCT05302999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25305114|NCT05302999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25305115|NCT05302999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25305116|NCT05302999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25305117|NCT05302999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305118|NCT05302999|Antimanic Agents|antimanic agents|mesh-ancestor
25305119|NCT05302921|Nivolumab|nivolumab|mesh-list
25305120|NCT05302921|Ipilimumab|ipilimumab|mesh-list
25305121|NCT05302921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25305122|NCT05302921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25305123|NCT05302921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25305124|NCT05302921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305132|NCT05302817|Xenon|xenon|mesh-list
25305133|NCT05302817|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25305134|NCT05302817|Anesthetics, General|anesthetics, general|mesh-ancestor
25305135|NCT05302817|Anesthetics|anesthetics|mesh-ancestor
25305136|NCT05302817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25305137|NCT05302817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305138|NCT05302726|Estrogens|estrogens|mesh-list
25305139|NCT05302726|Hormones|hormones|mesh-ancestor
25305140|NCT05302726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25305141|NCT05302726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305142|NCT05302713|Calcium, Dietary|calcium, dietary|mesh-list
25305143|NCT05302713|Calcium Carbonate|calcium carbonate|mesh-list
25305144|NCT05302713|Calcium|calcium|mesh-list
25305145|NCT05302713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25305146|NCT05302713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305147|NCT05302713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25305148|NCT05302713|Antacids|antacids|mesh-ancestor
25305149|NCT05302713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305150|NCT05302713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25305151|NCT05302531|Amoxicillin|amoxicillin|mesh-list
25305152|NCT05302531|Levofloxacin|levofloxacin|mesh-list
25305153|NCT05302531|Ofloxacin|ofloxacin|mesh-list
25305154|NCT05302531|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25305155|NCT05302531|Trimethoprim|trimethoprim|mesh-list
25305156|NCT05302531|Sulfamethoxazole|sulfamethoxazole|mesh-list
25305157|NCT05302531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25305158|NCT05302531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25305159|NCT05302531|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25305160|NCT05302531|Renal Agents|renal agents|mesh-ancestor
25305161|NCT05302531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25305162|NCT05302531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25305163|NCT05302531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25305164|NCT05302531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648419|NCT01479517|Tetracaine|tetracaine|mesh-list
25648420|NCT01479517|Anesthetics, Local|anesthetics, local|mesh-ancestor
25648421|NCT01479517|Anesthetics|anesthetics|mesh-ancestor
25648422|NCT01479517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25648423|NCT01479517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208016|NCT03172780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208017|NCT03172780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25208018|NCT03172780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25208019|NCT03172780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25208020|NCT03172780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208021|NCT03172780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208022|NCT03169972|Factor VIII|factor viii|mesh-list
25208023|NCT03169972|BAX 855|bax 855|mesh-list
25208024|NCT03169972|Coagulants|coagulants|mesh-ancestor
25208025|NCT03151304|Azacitidine|azacitidine|mesh-list
25208026|NCT03151304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25208027|NCT03151304|Antimetabolites|antimetabolites|mesh-ancestor
25208028|NCT03151304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208029|NCT03151304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208030|NCT03151304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208031|NCT03134196|Valacyclovir|valacyclovir|mesh-list
25208032|NCT03134196|Antiviral Agents|antiviral agents|mesh-ancestor
25208033|NCT03134196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25208334|NCT02643420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825359|NCT00005589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182313|NCT02721342|Ramipril|ramipril|mesh-list
25182314|NCT02721342|Irbesartan|irbesartan|mesh-list
25182341|NCT02375672|Pembrolizumab|pembrolizumab|mesh-list
25305165|NCT05302531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25305166|NCT05302531|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25305167|NCT05302531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25305168|NCT05302531|Antimalarials|antimalarials|mesh-ancestor
25305169|NCT05302531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25305170|NCT05302531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25305171|NCT05302531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25305172|NCT05302531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25305173|NCT05302531|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25305174|NCT05302466|Silicon|silicon|mesh-list
25305175|NCT05302466|Trace Elements|trace elements|mesh-ancestor
25305176|NCT05302466|Micronutrients|micronutrients|mesh-ancestor
25305177|NCT05302466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305178|NCT05302232|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25305179|NCT05302232|Methylprednisolone|methylprednisolone|mesh-list
25305180|NCT05302232|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25305181|NCT05302232|Prednisolone|prednisolone|mesh-list
25305182|NCT05302232|Prednisolone acetate|prednisolone acetate|mesh-list
25305183|NCT05302232|Lidocaine|lidocaine|mesh-list
25305184|NCT05302232|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25305185|NCT05302232|Prednisolone phosphate|prednisolone phosphate|mesh-list
25305186|NCT05302232|Anesthetics, Local|anesthetics, local|mesh-ancestor
25305187|NCT05302232|Anesthetics|anesthetics|mesh-ancestor
25305188|NCT05302232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25305189|NCT05302232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305190|NCT05302232|Sensory System Agents|sensory system agents|mesh-ancestor
25305191|NCT05302232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25305192|NCT05302232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25305193|NCT05302232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25305194|NCT05302232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25408482|NCT03437746|Antiemetics|antiemetics|mesh-ancestor
25648424|NCT01479517|Sensory System Agents|sensory system agents|mesh-ancestor
25648425|NCT01479517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25648426|NCT01479530|Rasagiline|rasagiline|mesh-list
25648427|NCT01479530|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25648428|NCT01479530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25648429|NCT01479530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648430|NCT01479530|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25648431|NCT01479530|Protective Agents|protective agents|mesh-ancestor
25648432|NCT01479530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648433|NCT01479621|Fluticasone|fluticasone|mesh-list
25648434|NCT01479621|Xhance|xhance|mesh-list
25648435|NCT01479621|Albuterol|albuterol|mesh-list
25648436|NCT01479621|Adrenergic Agonists|adrenergic agonists|mesh-list
25648437|NCT01479621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25648438|NCT01479621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25648439|NCT01479621|Autonomic Agents|autonomic agents|mesh-ancestor
25648440|NCT01479621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25648441|NCT01479621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648442|NCT01479621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25648443|NCT01479621|Respiratory System Agents|respiratory system agents|mesh-ancestor
25648444|NCT01479621|Dermatologic Agents|dermatologic agents|mesh-ancestor
25648445|NCT01479621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24410914|NCT00187083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24404792|NCT00164801|Vasodilator Agents|vasodilator agents|mesh-ancestor
25182375|NCT02153645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25182376|NCT02153645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25182377|NCT02153645|Antiviral Agents|antiviral agents|mesh-ancestor
25182378|NCT02153645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25182379|NCT02153645|Dopamine Agents|dopamine agents|mesh-ancestor
25182380|NCT02153645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25182381|NCT02153645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182382|NCT02153645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182383|NCT02153645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25182384|NCT02153645|Analgesics|analgesics|mesh-ancestor
25182385|NCT02153645|Sensory System Agents|sensory system agents|mesh-ancestor
25182386|NCT02153645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25182387|NCT02153632|Amantadine|amantadine|mesh-list
25182388|NCT02153632|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25182389|NCT02153632|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25182390|NCT02153632|Antiviral Agents|antiviral agents|mesh-ancestor
25182391|NCT02153632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25182392|NCT02153632|Dopamine Agents|dopamine agents|mesh-ancestor
25182393|NCT02153632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24410945|NCT00187122|Hormones|hormones|mesh-ancestor
25182394|NCT02153632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182395|NCT02153632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182396|NCT02153632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25182397|NCT02153632|Analgesics|analgesics|mesh-ancestor
25182398|NCT02153632|Sensory System Agents|sensory system agents|mesh-ancestor
25305195|NCT05302232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25305196|NCT05302232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305197|NCT05302232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25305198|NCT05302232|Antiemetics|antiemetics|mesh-ancestor
25305199|NCT05302232|Autonomic Agents|autonomic agents|mesh-ancestor
25305200|NCT05302232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25305201|NCT05302232|Glucocorticoids|glucocorticoids|mesh-ancestor
25305202|NCT05302232|Hormones|hormones|mesh-ancestor
25305203|NCT05302232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25305204|NCT05302232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25305205|NCT05302232|Protective Agents|protective agents|mesh-ancestor
25305206|NCT05302232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25305207|NCT05302232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25305208|NCT05301660|Nicotine|nicotine|mesh-list
25305209|NCT05301660|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25305210|NCT05301660|Autonomic Agents|autonomic agents|mesh-ancestor
25305211|NCT05301660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25305212|NCT05301660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305213|NCT05301660|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25305214|NCT05301660|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25648446|NCT01479621|Tocolytic Agents|tocolytic agents|mesh-ancestor
25648447|NCT01479621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25648448|NCT01479621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25648449|NCT01479621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25648450|NCT01479621|Adrenergic Agents|adrenergic agents|mesh-ancestor
25648451|NCT01479621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25648452|NCT01479621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648453|NCT01479764|Glycopyrrolate|glycopyrrolate|mesh-list
25648454|NCT01479764|Neostigmine|neostigmine|mesh-list
25648455|NCT01479764|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25648456|NCT01479764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25648457|NCT01479764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648458|NCT01479764|Cholinergic Agents|cholinergic agents|mesh-ancestor
25648459|NCT01479764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25648460|NCT01479764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648461|NCT01479764|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25648462|NCT01479764|Autonomic Agents|autonomic agents|mesh-ancestor
25648463|NCT01479764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25648464|NCT01479764|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25648465|NCT01479764|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25648466|NCT01479764|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25648467|NCT01479868|Interferons|interferons|mesh-list
25648468|NCT01479868|Ribavirin|ribavirin|mesh-list
25648469|NCT01479868|Interferon-alpha|interferon-alpha|mesh-list
25648470|NCT01479868|Interferon alpha-2|interferon alpha-2|mesh-list
25648471|NCT01479868|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25648472|NCT01479868|Simeprevir|simeprevir|mesh-list
25182424|NCT01818167|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25305216|NCT05301660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25305217|NCT05301660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305218|NCT05287984|Cyclophosphamide|cyclophosphamide|mesh-list
25305219|NCT05287984|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25305220|NCT05287984|Rituximab|rituximab|mesh-list
25305221|NCT05287984|Fludarabine|fludarabine|mesh-list
25305222|NCT05287984|Zanubrutinib|zanubrutinib|mesh-list
25305223|NCT05287984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25305224|NCT05287984|Immunologic Factors|immunologic factors|mesh-ancestor
25305225|NCT05287984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305226|NCT05287984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25305227|NCT05287984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25305228|NCT05287984|Alkylating Agents|alkylating agents|mesh-ancestor
25305229|NCT05287984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305230|NCT05287984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25305231|NCT05287984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25305232|NCT05287984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25305233|NCT05287984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25305234|NCT05287984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25305235|NCT05287308|Paclitaxel|paclitaxel|mesh-list
25305236|NCT05287308|Docetaxel|docetaxel|mesh-list
25305237|NCT05287308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25305238|NCT05287308|Cyclophosphamide|cyclophosphamide|mesh-list
25305239|NCT05287308|Doxorubicin|doxorubicin|mesh-list
25305240|NCT05287308|Epirubicin|epirubicin|mesh-list
25305241|NCT05287308|Pirarubicin|pirarubicin|mesh-list
25305242|NCT05287308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25305243|NCT05287308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25305244|NCT05287308|Tubulin Modulators|tubulin modulators|mesh-ancestor
25305245|NCT05287308|Antimitotic Agents|antimitotic agents|mesh-ancestor
25305246|NCT05287308|Mitosis Modulators|mitosis modulators|mesh-ancestor
25305247|NCT05287308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305248|NCT05287308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25305249|NCT05287308|Immunologic Factors|immunologic factors|mesh-ancestor
25305251|NCT05287308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25305252|NCT05287308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25305253|NCT05287308|Alkylating Agents|alkylating agents|mesh-ancestor
25305254|NCT05287308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25305255|NCT05287308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25305256|NCT05287308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25305257|NCT05287308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25305258|NCT05287308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25305259|NCT05285800|Bupivacaine|bupivacaine|mesh-list
25305260|NCT05285800|Anesthetics, Local|anesthetics, local|mesh-ancestor
25305261|NCT05285800|Anesthetics|anesthetics|mesh-ancestor
25305262|NCT05285800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25305263|NCT05285800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305264|NCT05285800|Sensory System Agents|sensory system agents|mesh-ancestor
25305265|NCT05285800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25305266|NCT05284656|Folic Acid|folic acid|mesh-list
25305267|NCT05284656|Vitamin B Complex|vitamin b complex|mesh-list
25305268|NCT05284656|Pentoxifylline|pentoxifylline|mesh-list
25305269|NCT05284656|Hematinics|hematinics|mesh-ancestor
25305270|NCT05284656|Vitamins|vitamins|mesh-ancestor
25305271|NCT05284656|Micronutrients|micronutrients|mesh-ancestor
25305272|NCT05284656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305273|NCT05284656|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25305274|NCT05284656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25305275|NCT05284656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305276|NCT05284656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25305277|NCT05284656|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25305278|NCT05284656|Protective Agents|protective agents|mesh-ancestor
25305279|NCT05284656|Vasodilator Agents|vasodilator agents|mesh-ancestor
25305280|NCT05284656|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25305281|NCT05284656|Antioxidants|antioxidants|mesh-ancestor
25305282|NCT05284474|Mitogens|mitogens|mesh-list
25305283|NCT05284474|Mitosis Modulators|mitosis modulators|mesh-ancestor
25305284|NCT05284474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305285|NCT05283356|Ticagrelor|ticagrelor|mesh-list
25305286|NCT05283356|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25305287|NCT05283356|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25305288|NCT05283356|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25305289|NCT05283356|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25305290|NCT05283356|Purinergic Agents|purinergic agents|mesh-ancestor
25305291|NCT05283356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25825360|NCT00005589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25305314|NCT05281549|Tenecteplase|tenecteplase|mesh-list
25305315|NCT05281549|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25305316|NCT05281549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25305317|NCT05281549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305318|NCT05277636|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25305319|NCT05277636|Hallucinogens|hallucinogens|mesh-ancestor
25305320|NCT05277636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305321|NCT05277636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24894397|NCT04441112|Analgesics|analgesics|mesh-ancestor
24894398|NCT04441112|Sensory System Agents|sensory system agents|mesh-ancestor
24894402|NCT04440917|Apatinib|apatinib|mesh-list
25305322|NCT05277636|Serotonin Agents|serotonin agents|mesh-ancestor
25305323|NCT05277636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25305324|NCT05277636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305325|NCT05277636|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25305326|NCT05277636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25305327|NCT05277636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25305328|NCT05277636|Adrenergic Agents|adrenergic agents|mesh-ancestor
25305375|NCT05265507|Serotonin Agents|serotonin agents|mesh-ancestor
25305376|NCT05265507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25305377|NCT05265507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305378|NCT05265507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25305379|NCT05265507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25305380|NCT05265507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25305381|NCT05265507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25305382|NCT05265507|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25305383|NCT05265507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25305384|NCT05265507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25305385|NCT05265507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25305386|NCT05265507|Cholinergic Agents|cholinergic agents|mesh-ancestor
25305388|NCT05260073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25305389|NCT05260073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305400|NCT05245006|Antibodies|antibodies|mesh-list
25305401|NCT05245006|Immunoglobulins|immunoglobulins|mesh-list
25305402|NCT05245006|Immunologic Factors|immunologic factors|mesh-ancestor
25305403|NCT05245006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305404|NCT05243186|Methylphenidate|methylphenidate|mesh-list
25305405|NCT05243186|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25305406|NCT05243186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305407|NCT05243186|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25305408|NCT05243186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25305409|NCT05243186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25305410|NCT05243186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305411|NCT05243186|Dopamine Agents|dopamine agents|mesh-ancestor
25305412|NCT05243186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25305425|NCT05237726|Heparin|heparin|mesh-list
25305426|NCT05237726|Enoxaparin|enoxaparin|mesh-list
25305427|NCT05237726|Calcium heparin|calcium heparin|mesh-list
25305428|NCT05237726|Enoxaparin sodium|enoxaparin sodium|mesh-list
25305429|NCT05237726|Anticoagulants|anticoagulants|mesh-ancestor
25305430|NCT05237726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25305431|NCT05237726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25305432|NCT05237726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305433|NCT05229055|Ketamine|ketamine|mesh-list
25305434|NCT05229055|Analgesics|analgesics|mesh-ancestor
25305435|NCT05229055|Sensory System Agents|sensory system agents|mesh-ancestor
25305436|NCT05229055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25305437|NCT05229055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305446|NCT05229055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305448|NCT05217758|Mifepristone|mifepristone|mesh-list
25305449|NCT05217758|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25305450|NCT05217758|Abortifacient Agents|abortifacient agents|mesh-ancestor
25305451|NCT05217758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25305452|NCT05217758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305453|NCT05217758|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25305454|NCT05217758|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25305455|NCT05217758|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25305456|NCT05217758|Contraceptive Agents|contraceptive agents|mesh-ancestor
25305457|NCT05217758|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25305458|NCT05217758|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25305459|NCT05217758|Hormone Antagonists|hormone antagonists|mesh-ancestor
25408483|NCT03437746|Autonomic Agents|autonomic agents|mesh-ancestor
25305460|NCT05217758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25305461|NCT05217758|Luteolytic Agents|luteolytic agents|mesh-ancestor
25305462|NCT05217758|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25305463|NCT05217758|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25305472|NCT05205499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25305473|NCT05205499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25305474|NCT05205499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25305475|NCT05205499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25305476|NCT05205499|Antifungal Agents|antifungal agents|mesh-ancestor
25305477|NCT05205499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25305478|NCT05205499|Immunologic Factors|immunologic factors|mesh-ancestor
25305479|NCT05205499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305483|NCT05192798|Paclitaxel|paclitaxel|mesh-list
25305484|NCT05192798|Bevacizumab|bevacizumab|mesh-list
25305485|NCT05192798|Apatinib|apatinib|mesh-list
25305486|NCT05192798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25305487|NCT05192798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25305488|NCT05192798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25305489|NCT05192798|Tubulin Modulators|tubulin modulators|mesh-ancestor
25305490|NCT05192798|Antimitotic Agents|antimitotic agents|mesh-ancestor
25305491|NCT05192798|Mitosis Modulators|mitosis modulators|mesh-ancestor
25305492|NCT05192798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305493|NCT05192798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25305494|NCT05192798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25305495|NCT05192798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25305496|NCT05192798|Growth Substances|growth substances|mesh-ancestor
25305497|NCT05192798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305498|NCT05192798|Growth Inhibitors|growth inhibitors|mesh-ancestor
25305499|NCT05192798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25305500|NCT05192798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25305501|NCT05191225|Rituximab|rituximab|mesh-list
25305502|NCT05191225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25305503|NCT05191225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25305504|NCT05191225|Immunologic Factors|immunologic factors|mesh-ancestor
25305505|NCT05191225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305506|NCT05191225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25305507|NCT05185167|Propofol|propofol|mesh-list
25305508|NCT05185167|Anesthetics|anesthetics|mesh-list
25305509|NCT05185167|Desflurane|desflurane|mesh-list
25305510|NCT05185167|Anesthetics, General|anesthetics, general|mesh-list
25305511|NCT05185167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25305512|NCT05185167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25305536|NCT05128617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305537|NCT05128617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25305538|NCT05128617|Immunologic Factors|immunologic factors|mesh-ancestor
25305539|NCT05128617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305540|NCT05128617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25305541|NCT05128617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25305542|NCT05128617|Alkylating Agents|alkylating agents|mesh-ancestor
25305543|NCT05128617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25305544|NCT05128617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25305545|NCT05128617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25305546|NCT05128617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25305547|NCT05128617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25305548|NCT05121168|Bupivacaine|bupivacaine|mesh-list
25305549|NCT05121168|Anesthetics, Local|anesthetics, local|mesh-ancestor
25305550|NCT05121168|Anesthetics|anesthetics|mesh-ancestor
25305551|NCT05121168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25305552|NCT05121168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305553|NCT05121168|Sensory System Agents|sensory system agents|mesh-ancestor
25305554|NCT05121168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25305555|NCT05118945|Insulin|insulin|mesh-list
25305556|NCT05118945|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25305557|NCT05118945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25305558|NCT05118945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305561|NCT05108649|Nicotine|nicotine|mesh-list
25305562|NCT05108649|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25305563|NCT05108649|Autonomic Agents|autonomic agents|mesh-ancestor
25305564|NCT05108649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25305565|NCT05108649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305566|NCT05108649|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25305567|NCT05108649|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25305568|NCT05108649|Cholinergic Agents|cholinergic agents|mesh-ancestor
25305569|NCT05108649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25305570|NCT05108649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305572|NCT05100862|Lenalidomide|lenalidomide|mesh-list
25305573|NCT05100862|Zanubrutinib|zanubrutinib|mesh-list
25305574|NCT05100862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25305575|NCT05100862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25305576|NCT05100862|Immunologic Factors|immunologic factors|mesh-ancestor
25305577|NCT05100862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305578|NCT05100862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25305579|NCT05100862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25305580|NCT05100862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25305581|NCT05100862|Growth Substances|growth substances|mesh-ancestor
25305582|NCT05100862|Growth Inhibitors|growth inhibitors|mesh-ancestor
25305583|NCT05100862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25305584|NCT05100862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25305585|NCT05100862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305586|NCT05099913|Flupenthixol|flupenthixol|mesh-list
25305589|NCT05099913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25305590|NCT05099913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305591|NCT05099913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25305592|NCT05099913|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25305593|NCT05099913|Dopamine Agents|dopamine agents|mesh-ancestor
25305594|NCT05099913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25305595|NCT05099913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305596|NCT05097274|Choline|choline|mesh-list
25305597|NCT05097274|Lipotropic Agents|lipotropic agents|mesh-ancestor
25305598|NCT05097274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25305599|NCT05097274|Antimetabolites|antimetabolites|mesh-ancestor
25305600|NCT05097274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305601|NCT05097274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25305602|NCT05097274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25305603|NCT05097274|Nootropic Agents|nootropic agents|mesh-ancestor
25305604|NCT05097079|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
25305608|NCT05097079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25305609|NCT05097079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305610|NCT05097079|Cholinergic Agents|cholinergic agents|mesh-ancestor
25305611|NCT05097079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25305612|NCT05097079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305613|NCT05097079|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25305614|NCT05097079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25305615|NCT05084430|Pembrolizumab|pembrolizumab|mesh-list
25305616|NCT05084430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25305617|NCT05084430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25305620|NCT05065957|Capecitabine|capecitabine|mesh-list
25305621|NCT05065957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25305622|NCT05065957|Antimetabolites|antimetabolites|mesh-ancestor
25305623|NCT05065957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305624|NCT05065957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25305625|NCT05044962|Rilpivirine|rilpivirine|mesh-list
25305626|NCT05044962|Cabotegravir|cabotegravir|mesh-list
25305627|NCT05044962|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25305628|NCT05044962|Levonorgestrel|levonorgestrel|mesh-list
25305629|NCT05044962|Medroxyprogesterone|medroxyprogesterone|mesh-list
25305630|NCT05044962|Etonogestrel|etonogestrel|mesh-list
25305631|NCT05044962|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25305632|NCT05044962|Contraceptive Agents|contraceptive agents|mesh-ancestor
25305633|NCT05044962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25305634|NCT05044962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305635|NCT05044962|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25305636|NCT05044962|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25305637|NCT05044962|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25305638|NCT05044962|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25305639|NCT05044962|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25305640|NCT05044962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25305641|NCT05044962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25305642|NCT05044962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25305643|NCT05044962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25305644|NCT05044962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25305645|NCT05044962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305646|NCT05044962|Antiviral Agents|antiviral agents|mesh-ancestor
25305647|NCT05044962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25305648|NCT05044962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25305649|NCT05044962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25305650|NCT05044962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25305651|NCT05044962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25305653|NCT05043714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25305654|NCT05043714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25305655|NCT05043714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25305656|NCT05043714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305657|NCT05028946|Muromonab-CD3|muromonab-cd3|mesh-list
25305658|NCT05028946|Immunologic Factors|immunologic factors|mesh-ancestor
25305659|NCT05028946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305660|NCT05028946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25305664|NCT05019222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305665|NCT05019222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25305666|NCT05019222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25305667|NCT05019222|Anesthetics, General|anesthetics, general|mesh-ancestor
25305669|NCT05010148|Anesthetics, Local|anesthetics, local|mesh-ancestor
25305670|NCT05010148|Anesthetics|anesthetics|mesh-ancestor
25305671|NCT05010148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25305672|NCT05010148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305673|NCT05010148|Sensory System Agents|sensory system agents|mesh-ancestor
25305674|NCT05010148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25305675|NCT05010148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25305676|NCT05010148|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25305677|NCT05010148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25305678|NCT05010148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25305679|NCT05010148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305718|NCT04965454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25305719|NCT04965454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25305720|NCT04965454|Nootropic Agents|nootropic agents|mesh-ancestor
25305725|NCT04951986|Ofloxacin|ofloxacin|mesh-list
25305726|NCT04951986|Rifampin|rifampin|mesh-list
25305727|NCT04951986|Isoniazid|isoniazid|mesh-list
25305728|NCT04951986|Pyrazinamide|pyrazinamide|mesh-list
25305729|NCT04951986|Ethambutol|ethambutol|mesh-list
25305730|NCT04951986|Prednisone|prednisone|mesh-list
25305731|NCT04951986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25305732|NCT04951986|Glucocorticoids|glucocorticoids|mesh-ancestor
25305733|NCT04951986|Hormones|hormones|mesh-ancestor
25305734|NCT04951986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25305735|NCT04951986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305748|NCT04951986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25305749|NCT04951986|Antitubercular Agents|antitubercular agents|mesh-ancestor
25305750|NCT04951986|Leprostatic Agents|leprostatic agents|mesh-ancestor
25305751|NCT04951986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25305752|NCT04951986|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25305753|NCT04951986|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25305754|NCT04951986|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25305755|NCT04951986|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25305756|NCT04951986|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25305757|NCT04951986|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25305758|NCT04951986|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25305759|NCT04951986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25305760|NCT04951986|Antimetabolites|antimetabolites|mesh-ancestor
25305761|NCT04951986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25305762|NCT04943679|Interferons|interferons|mesh-list
25305763|NCT04943679|Interferon-alpha|interferon-alpha|mesh-list
25305764|NCT04943679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25305765|NCT04943679|Antiviral Agents|antiviral agents|mesh-ancestor
25305766|NCT04943679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25305767|NCT04943679|Immunologic Factors|immunologic factors|mesh-ancestor
25305768|NCT04943679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305777|NCT04938557|Insulin|insulin|mesh-list
25305778|NCT04938557|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25305779|NCT04938557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25305780|NCT04938557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305787|NCT04927884|Cyclophosphamide|cyclophosphamide|mesh-list
25305788|NCT04927884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25305789|NCT04927884|Immunologic Factors|immunologic factors|mesh-ancestor
25305790|NCT04927884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305791|NCT04927884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25305792|NCT04927884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25305793|NCT04927884|Alkylating Agents|alkylating agents|mesh-ancestor
25305794|NCT04927884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305795|NCT04927884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25305796|NCT04927884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25305797|NCT04895280|Triamcinolone|triamcinolone|mesh-list
25305798|NCT04895280|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25305799|NCT04895280|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25305800|NCT04895280|Ketorolac|ketorolac|mesh-list
25305801|NCT04895280|Bupivacaine|bupivacaine|mesh-list
25305802|NCT04895280|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25305803|NCT04895280|Anesthetics, Local|anesthetics, local|mesh-ancestor
25305804|NCT04895280|Anesthetics|anesthetics|mesh-ancestor
25305805|NCT04895280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25305806|NCT04895280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305807|NCT04895280|Sensory System Agents|sensory system agents|mesh-ancestor
25305808|NCT04895280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25305809|NCT04895280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25305810|NCT04895280|Glucocorticoids|glucocorticoids|mesh-ancestor
25305816|NCT04895280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305817|NCT04895280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25305818|NCT04895280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25305819|NCT04895280|Analgesics|analgesics|mesh-ancestor
25305820|NCT04895280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25305821|NCT04895280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25305822|NCT04892459|Vaccines|vaccines|mesh-list
25305823|NCT04892459|Immunologic Factors|immunologic factors|mesh-ancestor
25305824|NCT04892459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305825|NCT04881539|Cannabidiol|cannabidiol|mesh-list
25305826|NCT04881539|Anticonvulsants|anticonvulsants|mesh-ancestor
25305827|NCT04880278|Nabilone|nabilone|mesh-list
25305828|NCT04880278|Antiemetics|antiemetics|mesh-ancestor
25305829|NCT04880278|Autonomic Agents|autonomic agents|mesh-ancestor
25305830|NCT04880278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25305831|NCT04880278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305832|NCT04880278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25305833|NCT04880278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25305834|NCT04880278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25305835|NCT04880278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25305836|NCT04880278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25305837|NCT04879849|Pembrolizumab|pembrolizumab|mesh-list
25305838|NCT04879849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25305839|NCT04879849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25305840|NCT04865653|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
25305841|NCT04865653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25305842|NCT04865653|Hallucinogens|hallucinogens|mesh-ancestor
25305843|NCT04865653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305844|NCT04865653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25305845|NCT04865653|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25305846|NCT04865653|Serotonin Agents|serotonin agents|mesh-ancestor
25305847|NCT04865653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25305848|NCT04865653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305849|NCT04865653|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25305853|NCT04820686|Tenofovir|tenofovir|mesh-list
25305854|NCT04820686|Entecavir|entecavir|mesh-list
25305855|NCT04820686|Antiviral Agents|antiviral agents|mesh-ancestor
25305856|NCT04820686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25305857|NCT04820686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25305858|NCT04820686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25305859|NCT04820686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25305860|NCT04820686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305861|NCT04820686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25305862|NCT04820686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25305865|NCT04813614|Lidocaine|lidocaine|mesh-list
25305866|NCT04813614|Anesthetics, Local|anesthetics, local|mesh-ancestor
25305867|NCT04813614|Anesthetics|anesthetics|mesh-ancestor
25305868|NCT04813614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25305869|NCT04813614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305870|NCT04813614|Sensory System Agents|sensory system agents|mesh-ancestor
25305871|NCT04813614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25305872|NCT04813614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25305986|NCT04698057|Ciprofloxacin|ciprofloxacin|mesh-list
25305873|NCT04813614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25305874|NCT04813614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25305875|NCT04813614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25305876|NCT04813614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305877|NCT04813562|Vaccines|vaccines|mesh-list
25305878|NCT04813562|Immunologic Factors|immunologic factors|mesh-ancestor
25305879|NCT04813562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305880|NCT04800393|Propofol|propofol|mesh-list
25305881|NCT04800393|Sevoflurane|sevoflurane|mesh-list
25305882|NCT04800393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25305883|NCT04800393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25305884|NCT04800393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305885|NCT04800393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25305923|NCT04750070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25305924|NCT04750070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305925|NCT04750070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305926|NCT04750070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25305927|NCT04750070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25305928|NCT04750070|Autonomic Agents|autonomic agents|mesh-ancestor
25305929|NCT04750070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25305930|NCT04750070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25305931|NCT04750070|Respiratory System Agents|respiratory system agents|mesh-ancestor
25305933|NCT04750070|Sympathomimetics|sympathomimetics|mesh-ancestor
25305934|NCT04750070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25305935|NCT04750070|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25305936|NCT04750070|Dopamine Agents|dopamine agents|mesh-ancestor
25305937|NCT04750070|Protective Agents|protective agents|mesh-ancestor
25305938|NCT04741334|Anticoagulants|anticoagulants|mesh-list
25305939|NCT04741334|Dicumarol|dicumarol|mesh-list
25305940|NCT04741334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25305941|NCT04741334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25305942|NCT04741334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305943|NCT04741334|Uncoupling Agents|uncoupling agents|mesh-ancestor
25305944|NCT04734028|Aspirin|aspirin|mesh-list
25305945|NCT04734028|Clopidogrel|clopidogrel|mesh-list
25305946|NCT04734028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25305947|NCT04734028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25305948|NCT04734028|Analgesics|analgesics|mesh-ancestor
25305949|NCT04734028|Sensory System Agents|sensory system agents|mesh-ancestor
25305950|NCT04734028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25305951|NCT04734028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305952|NCT04734028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25305953|NCT04734028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25305954|NCT04734028|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25305955|NCT04734028|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25305956|NCT04734028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305957|NCT04734028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25305958|NCT04734028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25305959|NCT04734028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25305960|NCT04734028|Antipyretics|antipyretics|mesh-ancestor
25305961|NCT04734028|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25305962|NCT04734028|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25305963|NCT04734028|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25305964|NCT04734028|Purinergic Agents|purinergic agents|mesh-ancestor
25305965|NCT04734028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25305966|NCT04732195|Pilocarpine|pilocarpine|mesh-list
25305967|NCT04732195|Miotics|miotics|mesh-ancestor
25305968|NCT04732195|Autonomic Agents|autonomic agents|mesh-ancestor
25305969|NCT04732195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25305970|NCT04732195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25305971|NCT04732195|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25305972|NCT04732195|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25305973|NCT04732195|Cholinergic Agents|cholinergic agents|mesh-ancestor
25305974|NCT04732195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25305975|NCT04732195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305976|NCT04719221|Evolocumab|evolocumab|mesh-list
25305977|NCT04719221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25305978|NCT04719221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25305979|NCT04719221|Antimetabolites|antimetabolites|mesh-ancestor
25305980|NCT04719221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305981|NCT04719221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25305982|NCT04710134|Reslizumab|reslizumab|mesh-list
25305983|NCT04710134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25305984|NCT04710134|Respiratory System Agents|respiratory system agents|mesh-ancestor
25305985|NCT04698057|Amoxicillin|amoxicillin|mesh-list
25305987|NCT04698057|Clavulanic Acid|clavulanic acid|mesh-list
25305988|NCT04698057|Clavulanic Acids|clavulanic acids|mesh-list
25305989|NCT04698057|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25305990|NCT04698057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25305991|NCT04698057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25305992|NCT04698057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25305993|NCT04698057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25305994|NCT04698057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25305995|NCT04698057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25305997|NCT04698057|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25305998|NCT04698057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25305999|NCT04698057|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25306000|NCT04696757|Capecitabine|capecitabine|mesh-list
25306001|NCT04696757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25306002|NCT04696757|Antimetabolites|antimetabolites|mesh-ancestor
25306003|NCT04696757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306004|NCT04696757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306005|NCT04686799|Doxycycline|doxycycline|mesh-list
25306006|NCT04686799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25306007|NCT04686799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25306008|NCT04686799|Antimalarials|antimalarials|mesh-ancestor
25306009|NCT04686799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25306010|NCT04686799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25306011|NCT04684589|Tadalafil|tadalafil|mesh-list
25306012|NCT04684589|Vasodilator Agents|vasodilator agents|mesh-ancestor
25306013|NCT04684589|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25306014|NCT04684589|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25306015|NCT04684589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25306016|NCT04684589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306017|NCT04684589|Urological Agents|urological agents|mesh-ancestor
25306018|NCT04682834|Probenecid|probenecid|mesh-list
25306019|NCT04682834|Uricosuric Agents|uricosuric agents|mesh-ancestor
25306020|NCT04682834|Gout Suppressants|gout suppressants|mesh-ancestor
25306021|NCT04682834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25306022|NCT04682834|Renal Agents|renal agents|mesh-ancestor
25306023|NCT04682743|Acetaminophen|acetaminophen|mesh-list
25306024|NCT04682743|Ondansetron|ondansetron|mesh-list
25306025|NCT04682743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25306026|NCT04682743|Analgesics|analgesics|mesh-ancestor
25306027|NCT04682743|Sensory System Agents|sensory system agents|mesh-ancestor
25306028|NCT04682743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25306029|NCT04682743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306030|NCT04682743|Antipyretics|antipyretics|mesh-ancestor
25306031|NCT04682743|Antiemetics|antiemetics|mesh-ancestor
25306032|NCT04682743|Autonomic Agents|autonomic agents|mesh-ancestor
25306033|NCT04682743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25306034|NCT04682743|Antipruritics|antipruritics|mesh-ancestor
25306035|NCT04682743|Dermatologic Agents|dermatologic agents|mesh-ancestor
25306036|NCT04682743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25306037|NCT04682743|Serotonin Agents|serotonin agents|mesh-ancestor
25306038|NCT04682743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25306039|NCT04682743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306060|NCT04647500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25306061|NCT04647500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306062|NCT04647500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25306063|NCT04647500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25306064|NCT04647500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25306065|NCT04647500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306066|NCT04647500|Dopamine Agents|dopamine agents|mesh-ancestor
25306067|NCT04647500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25306068|NCT04636333|Vaccines|vaccines|mesh-list
25306069|NCT04636333|Immunologic Factors|immunologic factors|mesh-ancestor
25306070|NCT04636333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306071|NCT04623216|Azacitidine|azacitidine|mesh-list
25306072|NCT04623216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25306073|NCT04623216|Antimetabolites|antimetabolites|mesh-ancestor
25306074|NCT04623216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306075|NCT04623216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306076|NCT04623216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25306099|NCT04609111|Aspirin|aspirin|mesh-list
25306100|NCT04609111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25306101|NCT04609111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25306102|NCT04609111|Analgesics|analgesics|mesh-ancestor
25306103|NCT04609111|Sensory System Agents|sensory system agents|mesh-ancestor
25306104|NCT04609111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25306105|NCT04609111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306106|NCT04609111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25306107|NCT04609111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25306108|NCT04609111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25306109|NCT04609111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25306110|NCT04609111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306111|NCT04609111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25306126|NCT04560595|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25306127|NCT04560595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306128|NCT04560595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25306129|NCT04560595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25306130|NCT04560595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306131|NCT04560595|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25306132|NCT04560595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25306133|NCT04560595|Purinergic Agents|purinergic agents|mesh-ancestor
25306134|NCT04560595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25306135|NCT04546074|Pembrolizumab|pembrolizumab|mesh-list
25306136|NCT04546074|Imatinib Mesylate|imatinib mesylate|mesh-list
25306137|NCT04546074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25306138|NCT04546074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306139|NCT04546074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25306140|NCT04546074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25306141|NCT04546074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306148|NCT04529278|Liraglutide|liraglutide|mesh-list
25306149|NCT04529278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25306150|NCT04529278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306151|NCT04529278|Incretins|incretins|mesh-ancestor
25306152|NCT04529278|Hormones|hormones|mesh-ancestor
25306153|NCT04529278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25306154|NCT04518410|Bamlanivimab|bamlanivimab|mesh-list
25306155|NCT04518410|Gabexate|gabexate|mesh-list
25306156|NCT04518410|Immunoglobulins|immunoglobulins|mesh-list
25306157|NCT04518410|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25306158|NCT04518410|Antibodies|antibodies|mesh-list
25306159|NCT04518410|Camostat|camostat|mesh-list
25306160|NCT04518410|Immunologic Factors|immunologic factors|mesh-ancestor
25306161|NCT04518410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306162|NCT04518410|Protease Inhibitors|protease inhibitors|mesh-ancestor
25306163|NCT04518410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25306164|NCT04518410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306165|NCT04518410|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25306166|NCT04518410|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25306167|NCT04518410|Anticoagulants|anticoagulants|mesh-ancestor
25306168|NCT04518410|Antiviral Agents|antiviral agents|mesh-ancestor
25306169|NCT04518410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25306170|NCT04516161|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25306171|NCT04516161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306174|NCT04499196|Glucocorticoids|glucocorticoids|mesh-list
25306175|NCT04499196|Hormones|hormones|mesh-ancestor
25306176|NCT04499196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25306177|NCT04499196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801896|NCT01986270|Sumatriptan|sumatriptan|mesh-list
25306204|NCT04460352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306205|NCT04460352|Tubulin Modulators|tubulin modulators|mesh-ancestor
25306206|NCT04460352|Antimitotic Agents|antimitotic agents|mesh-ancestor
25306207|NCT04460352|Mitosis Modulators|mitosis modulators|mesh-ancestor
25306208|NCT04460352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306209|NCT04460352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25306210|NCT04460352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306211|NCT04460352|Antimetabolites|antimetabolites|mesh-ancestor
25306212|NCT04460352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25306213|NCT04460352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25306214|NCT04460352|Immunologic Factors|immunologic factors|mesh-ancestor
25306215|NCT04460352|Antidotes|antidotes|mesh-ancestor
25306216|NCT04460352|Protective Agents|protective agents|mesh-ancestor
25306217|NCT04460352|Vitamin B Complex|vitamin b complex|mesh-ancestor
25306218|NCT04460352|Vitamins|vitamins|mesh-ancestor
25306219|NCT04460352|Micronutrients|micronutrients|mesh-ancestor
25306239|NCT04440735|Atezolizumab|atezolizumab|mesh-list
25306240|NCT04440735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306241|NCT04430452|Durvalumab|durvalumab|mesh-list
25306242|NCT04430452|Ipilimumab|ipilimumab|mesh-list
25306243|NCT04430452|Tremelimumab|tremelimumab|mesh-list
25306244|NCT04430452|Immunoglobulins|immunoglobulins|mesh-list
25306245|NCT04430452|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25306246|NCT04430452|Immunoglobulin G|immunoglobulin g|mesh-list
25306247|NCT04430452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25306248|NCT04430452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306249|NCT04430452|Immunologic Factors|immunologic factors|mesh-ancestor
25306250|NCT04430452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306251|NCT04430452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25306252|NCT04430452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825361|NCT00005589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25306270|NCT04398914|Antimitotic Agents|antimitotic agents|mesh-ancestor
25306271|NCT04398914|Mitosis Modulators|mitosis modulators|mesh-ancestor
25306272|NCT04398914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306273|NCT04398914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25306278|NCT04390399|Gemcitabine|gemcitabine|mesh-list
25306279|NCT04390399|Paclitaxel|paclitaxel|mesh-list
25306280|NCT04390399|Cyclophosphamide|cyclophosphamide|mesh-list
25306281|NCT04390399|Fluorouracil|fluorouracil|mesh-list
25306282|NCT04390399|Irinotecan|irinotecan|mesh-list
25306283|NCT04390399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25306284|NCT04390399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306285|NCT04390399|Tubulin Modulators|tubulin modulators|mesh-ancestor
25306286|NCT04390399|Antimitotic Agents|antimitotic agents|mesh-ancestor
25306287|NCT04390399|Mitosis Modulators|mitosis modulators|mesh-ancestor
25306288|NCT04390399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306289|NCT04390399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25306290|NCT04390399|Immunologic Factors|immunologic factors|mesh-ancestor
25306291|NCT04390399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306292|NCT04390399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25306293|NCT04390399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25306294|NCT04390399|Alkylating Agents|alkylating agents|mesh-ancestor
25306295|NCT04390399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25306296|NCT04390399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25306297|NCT04390399|Antimetabolites|antimetabolites|mesh-ancestor
25306298|NCT04390399|Antiviral Agents|antiviral agents|mesh-ancestor
25306299|NCT04390399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25306300|NCT04390399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25306301|NCT04390399|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25306302|NCT04390399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25306303|NCT04390399|Antidotes|antidotes|mesh-ancestor
25306304|NCT04390399|Protective Agents|protective agents|mesh-ancestor
25306305|NCT04390399|Vitamin B Complex|vitamin b complex|mesh-ancestor
25306306|NCT04390399|Vitamins|vitamins|mesh-ancestor
25306307|NCT04390399|Micronutrients|micronutrients|mesh-ancestor
25306308|NCT04374578|Dulaglutide|dulaglutide|mesh-list
25306309|NCT04374578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25306310|NCT04374578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306314|NCT04348032|Apatinib|apatinib|mesh-list
25306315|NCT04348032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306316|NCT04348032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25306317|NCT04348032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25306318|NCT04348032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306319|NCT04301310|Rifampin|rifampin|mesh-list
25306320|NCT04301310|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25306321|NCT04301310|Antitubercular Agents|antitubercular agents|mesh-ancestor
25306322|NCT04301310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25306323|NCT04301310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25306324|NCT04301310|Leprostatic Agents|leprostatic agents|mesh-ancestor
25306325|NCT04301310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25306326|NCT04301310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25306327|NCT04301310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306328|NCT04301310|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25306329|NCT04301310|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25306330|NCT04301310|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25306331|NCT04301310|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25306332|NCT04301310|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25306333|NCT04301310|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25306334|NCT04288687|Niraparib|niraparib|mesh-list
25306335|NCT04288687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25306336|NCT04288687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25306337|NCT04288687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306338|NCT04288687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306339|NCT04282629|Milrinone|milrinone|mesh-list
25306348|NCT04282629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306349|NCT04280939|Anesthetics|anesthetics|mesh-list
25306350|NCT04280939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25306351|NCT04280939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306359|NCT04273165|Etravirine|etravirine|mesh-list
25306360|NCT04273165|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25306361|NCT04273165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25306362|NCT04273165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205332|NCT04899791|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
25306363|NCT04273165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306364|NCT04273165|Antiviral Agents|antiviral agents|mesh-ancestor
25306365|NCT04273165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25306366|NCT04272801|Tamoxifen|tamoxifen|mesh-list
25306367|NCT04272801|Letrozole|letrozole|mesh-list
25306368|NCT04272801|Anastrozole|anastrozole|mesh-list
25306369|NCT04272801|Exemestane|exemestane|mesh-list
25306370|NCT04272801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306371|NCT04272801|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25306372|NCT04272801|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25306373|NCT04272801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25306374|NCT04272801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306375|NCT04272801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25306376|NCT04272801|Hormone Antagonists|hormone antagonists|mesh-ancestor
25306377|NCT04272801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25306378|NCT04272801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306379|NCT04272801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25306380|NCT04272801|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25306381|NCT04272801|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25306382|NCT04272801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25306383|NCT04259645|Bupivacaine|bupivacaine|mesh-list
25306384|NCT04259645|Anesthetics, Local|anesthetics, local|mesh-ancestor
25306385|NCT04259645|Anesthetics|anesthetics|mesh-ancestor
25306386|NCT04259645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25306387|NCT04259645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306388|NCT04259645|Sensory System Agents|sensory system agents|mesh-ancestor
25306389|NCT04259645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25306390|NCT04258150|Nivolumab|nivolumab|mesh-list
25306391|NCT04258150|Ipilimumab|ipilimumab|mesh-list
25306392|NCT04258150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25306393|NCT04258150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306394|NCT04258150|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25306395|NCT04258150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306398|NCT04250493|Insulin|insulin|mesh-list
25306399|NCT04250493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25306400|NCT04250493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306406|NCT04227756|Psilocybin|psilocybin|mesh-list
25306407|NCT04227756|Mescaline|mescaline|mesh-list
25306408|NCT04227756|Hallucinogens|hallucinogens|mesh-ancestor
25306409|NCT04227756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306410|NCT04227756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25306411|NCT04227756|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25306412|NCT04227756|Serotonin Agents|serotonin agents|mesh-ancestor
25306413|NCT04227756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25306432|NCT04208997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25306433|NCT04208997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25306434|NCT04208997|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25306435|NCT04208997|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25306436|NCT04208997|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25306437|NCT04208997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25306438|NCT04208997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25306439|NCT04208997|Adrenergic Agents|adrenergic agents|mesh-ancestor
25306440|NCT04208997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25306441|NCT04208997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306442|NCT04208997|Sympatholytics|sympatholytics|mesh-ancestor
25306443|NCT04208997|Autonomic Agents|autonomic agents|mesh-ancestor
25306444|NCT04208997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25306446|NCT04201873|Pembrolizumab|pembrolizumab|mesh-list
25306447|NCT04201873|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25306448|NCT04201873|Vaccines|vaccines|mesh-list
25306449|NCT04201873|Poly ICLC|poly iclc|mesh-list
25306450|NCT04201873|Immunologic Factors|immunologic factors|mesh-ancestor
25306451|NCT04201873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306452|NCT04201873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25306453|NCT04201873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306454|NCT04201873|Interferon Inducers|interferon inducers|mesh-ancestor
25306455|NCT04201873|Laxatives|laxatives|mesh-ancestor
25306456|NCT04201873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25306457|NCT04201873|Antiviral Agents|antiviral agents|mesh-ancestor
25306458|NCT04201873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25306464|NCT04163900|Gemcitabine|gemcitabine|mesh-list
25306465|NCT04163900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306466|NCT04163900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25306467|NCT04163900|Antimetabolites|antimetabolites|mesh-ancestor
25306468|NCT04163900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306469|NCT04163900|Antiviral Agents|antiviral agents|mesh-ancestor
25306470|NCT04163900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25306471|NCT04163900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25306473|NCT04163900|Immunologic Factors|immunologic factors|mesh-ancestor
25306474|NCT04163900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306478|NCT04153188|Phenylephrine|phenylephrine|mesh-list
25306479|NCT04153188|Oxymetazoline|oxymetazoline|mesh-list
25306480|NCT04153188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25306481|NCT04153188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25306482|NCT04153188|Adrenergic Agents|adrenergic agents|mesh-ancestor
25306483|NCT04153188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25306484|NCT04153188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306485|NCT04153188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306486|NCT04153188|Sympathomimetics|sympathomimetics|mesh-ancestor
25306487|NCT04153188|Autonomic Agents|autonomic agents|mesh-ancestor
25306488|NCT04153188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25306489|NCT04153188|Nasal Decongestants|nasal decongestants|mesh-ancestor
25306490|NCT04153188|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25306491|NCT04153188|Respiratory System Agents|respiratory system agents|mesh-ancestor
25306492|NCT04153188|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25306493|NCT04153188|Mydriatics|mydriatics|mesh-ancestor
25306494|NCT04153188|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25306495|NCT04153188|Protective Agents|protective agents|mesh-ancestor
25306496|NCT04147221|Imipenem|imipenem|mesh-list
25306497|NCT04147221|Relebactam|relebactam|mesh-list
25306498|NCT04147221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25306499|NCT04147221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25306500|NCT04147221|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25306501|NCT04147221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25306502|NCT04147221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306503|NCT04140968|Progesterone|progesterone|mesh-list
25306504|NCT04140968|Progestins|progestins|mesh-ancestor
25306505|NCT04140968|Hormones|hormones|mesh-ancestor
25306506|NCT04140968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25306507|NCT04140968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306508|NCT04110444|Sildenafil Citrate|sildenafil citrate|mesh-list
25306509|NCT04110444|Vasodilator Agents|vasodilator agents|mesh-ancestor
25306510|NCT04110444|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25306511|NCT04110444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25306512|NCT04110444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25306513|NCT04110444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306514|NCT04110444|Urological Agents|urological agents|mesh-ancestor
25306515|NCT04108039|Cetrorelix|cetrorelix|mesh-list
25306516|NCT04108039|Progesterone|progesterone|mesh-list
25306517|NCT04108039|Ganirelix|ganirelix|mesh-list
25306518|NCT04108039|Progestins|progestins|mesh-ancestor
25306519|NCT04108039|Hormones|hormones|mesh-ancestor
25306520|NCT04108039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25306521|NCT04108039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306522|NCT04108039|Hormone Antagonists|hormone antagonists|mesh-ancestor
25306523|NCT04108039|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25306524|NCT04108039|Fertility Agents|fertility agents|mesh-ancestor
25306525|NCT04108039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25306526|NCT04103216|Nitazoxanide|nitazoxanide|mesh-list
25306527|NCT04103216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25306528|NCT04103216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25306529|NCT04102371|Plasma-lyte 148|plasma-lyte 148|mesh-list
25306530|NCT04102371|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25306531|NCT04102371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25306532|NCT04090710|Nivolumab|nivolumab|mesh-list
25306533|NCT04090710|Ipilimumab|ipilimumab|mesh-list
25306534|NCT04090710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25306535|NCT04090710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306536|NCT04090710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25306537|NCT04090710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306538|NCT04089865|Tranexamic Acid|tranexamic acid|mesh-list
25306539|NCT04089865|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25306540|NCT04089865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25306541|NCT04089865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306542|NCT04089865|Hemostatics|hemostatics|mesh-ancestor
25306543|NCT04089865|Coagulants|coagulants|mesh-ancestor
25306544|NCT04086147|Tenecteplase|tenecteplase|mesh-list
25306545|NCT04086147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25306546|NCT04086147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25306547|NCT04086147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306548|NCT04084860|Ketamine|ketamine|mesh-list
25306549|NCT04084860|Analgesics|analgesics|mesh-ancestor
25306550|NCT04084860|Sensory System Agents|sensory system agents|mesh-ancestor
25306551|NCT04084860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25306552|NCT04084860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306553|NCT04084860|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25306554|NCT04084860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25306555|NCT04084860|Anesthetics, General|anesthetics, general|mesh-ancestor
25306556|NCT04084860|Anesthetics|anesthetics|mesh-ancestor
25306557|NCT04084860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25306558|NCT04084860|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25306559|NCT04084860|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25306560|NCT04084860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25306561|NCT04084860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306577|NCT05431764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25306578|NCT05431764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306579|NCT05431764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306606|NCT05431413|Fluoxetine|fluoxetine|mesh-list
25306607|NCT05431413|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25306608|NCT05431413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25306609|NCT05431413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25306610|NCT05431413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306611|NCT05431413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25306612|NCT05431413|Serotonin Agents|serotonin agents|mesh-ancestor
25306613|NCT05431413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306614|NCT05431413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25306615|NCT05431413|Antidepressive Agents|antidepressive agents|mesh-ancestor
25306616|NCT05431413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25306617|NCT05431413|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25306618|NCT05431413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25306619|NCT05431413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25306620|NCT05431413|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25306621|NCT05431413|Protective Agents|protective agents|mesh-ancestor
25306624|NCT05431322|Dexmedetomidine|dexmedetomidine|mesh-list
25306625|NCT05431322|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25306626|NCT05431322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25306627|NCT05431322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306628|NCT05431322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25306629|NCT05431322|Analgesics|analgesics|mesh-ancestor
25306630|NCT05431322|Sensory System Agents|sensory system agents|mesh-ancestor
25306631|NCT05431322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25306635|NCT05431322|Adrenergic Agents|adrenergic agents|mesh-ancestor
25306636|NCT05431322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25306637|NCT05431322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306638|NCT05431283|Tofacitinib|tofacitinib|mesh-list
25306639|NCT05431283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25306640|NCT05431283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25306641|NCT05431283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306642|NCT05431257|Venetoclax|venetoclax|mesh-list
25306643|NCT05431257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306644|NCT05431244|Gemcitabine|gemcitabine|mesh-list
25306645|NCT05431244|Antiviral Agents|antiviral agents|mesh-list
25306646|NCT05431244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24472696|NCT00400322|Antiviral Agents|antiviral agents|mesh-ancestor
24472698|NCT00400335|Methyltestosterone|methyltestosterone|mesh-list
25825362|NCT00005589|Alkylating Agents|alkylating agents|mesh-ancestor
25306647|NCT05431244|Antimetabolites|antimetabolites|mesh-ancestor
25306648|NCT05431244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306649|NCT05431244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306650|NCT05431244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25306651|NCT05431244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25306652|NCT05431244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25306653|NCT05431244|Immunologic Factors|immunologic factors|mesh-ancestor
24468829|NCT00383656|Hormones|hormones|mesh-list
25306654|NCT05431244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306655|NCT05431218|Cholecalciferol|cholecalciferol|mesh-list
25306656|NCT05431218|Vitamin D|vitamin d|mesh-list
25306657|NCT05431218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25306658|NCT05431218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306659|NCT05431218|Vitamins|vitamins|mesh-ancestor
25306660|NCT05431218|Micronutrients|micronutrients|mesh-ancestor
25306661|NCT05431218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25306662|NCT05431062|Bupivacaine|bupivacaine|mesh-list
25306663|NCT05431062|Anesthetics, Local|anesthetics, local|mesh-ancestor
25306664|NCT05431062|Anesthetics|anesthetics|mesh-ancestor
25306665|NCT05431062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25306666|NCT05431062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306667|NCT05431062|Sensory System Agents|sensory system agents|mesh-ancestor
25306668|NCT05431062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25306669|NCT05431049|Anesthetics|anesthetics|mesh-list
25306670|NCT05431049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25306671|NCT05431049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306672|NCT05431023|Lactoferrin|lactoferrin|mesh-list
25306673|NCT05431023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25306674|NCT05430841|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25306675|NCT05430841|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25306676|NCT05430841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306677|NCT05430828|Evolocumab|evolocumab|mesh-list
25306678|NCT05430828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25306679|NCT05430828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25306680|NCT05430828|Antimetabolites|antimetabolites|mesh-ancestor
25306681|NCT05430828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306682|NCT05430828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25306683|NCT05430802|Pemetrexed|pemetrexed|mesh-list
25306684|NCT05430802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306685|NCT05430802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25306686|NCT05430802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306687|NCT05430802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25306688|NCT05430802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25306689|NCT05430711|Dinoprostone|dinoprostone|mesh-list
25306690|NCT05430711|Oxytocics|oxytocics|mesh-ancestor
25306691|NCT05430711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25306692|NCT05430711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306696|NCT05430438|Dialysis Solutions|dialysis solutions|mesh-list
25306697|NCT05430438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25306698|NCT05430399|Docetaxel|docetaxel|mesh-list
25306699|NCT05430399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306700|NCT05430399|Tubulin Modulators|tubulin modulators|mesh-ancestor
25306701|NCT05430399|Antimitotic Agents|antimitotic agents|mesh-ancestor
25306702|NCT05430399|Mitosis Modulators|mitosis modulators|mesh-ancestor
25306703|NCT05430399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306731|NCT05430230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306732|NCT05430217|Buspirone|buspirone|mesh-list
25306733|NCT05430217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25306734|NCT05430217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25306735|NCT05430217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25306736|NCT05430217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306737|NCT05430217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25306738|NCT05430217|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25306739|NCT05430217|Serotonin Agents|serotonin agents|mesh-ancestor
25306740|NCT05430217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25306741|NCT05430217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306742|NCT05430152|Naltrexone|naltrexone|mesh-list
25306743|NCT05430152|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25306744|NCT05430152|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25306745|NCT05430152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306746|NCT05430152|Sensory System Agents|sensory system agents|mesh-ancestor
25306747|NCT05430152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25306748|NCT05430087|Vitamin D|vitamin d|mesh-list
25306749|NCT05430087|Cholecalciferol|cholecalciferol|mesh-list
25306750|NCT05430087|Curcumin|curcumin|mesh-list
25306751|NCT05430087|Piperine|piperine|mesh-list
25306752|NCT05430087|Vitamins|vitamins|mesh-ancestor
25306753|NCT05430087|Micronutrients|micronutrients|mesh-ancestor
25306754|NCT05430087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306755|NCT05430087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25306756|NCT05430087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25306757|NCT05430087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25306758|NCT05430087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25306759|NCT05430087|Analgesics|analgesics|mesh-ancestor
25306760|NCT05430087|Sensory System Agents|sensory system agents|mesh-ancestor
25306761|NCT05430087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25306762|NCT05430087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25306763|NCT05430087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25306764|NCT05430087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306765|NCT05430087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25306766|NCT05430087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306767|NCT05430087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25306773|NCT05430048|Bisoprolol|bisoprolol|mesh-list
25306774|NCT05430048|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25306775|NCT05430048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25306776|NCT05430048|Sympatholytics|sympatholytics|mesh-ancestor
25306777|NCT05430048|Autonomic Agents|autonomic agents|mesh-ancestor
25306778|NCT05430048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25306928|NCT05245734|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25306785|NCT05430048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306787|NCT05430048|Coagulants|coagulants|mesh-ancestor
25306788|NCT05430048|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25306789|NCT05430048|Natriuretic Agents|natriuretic agents|mesh-ancestor
25306793|NCT05426252|Sirolimus|sirolimus|mesh-list
25306794|NCT05426252|Abatacept|abatacept|mesh-list
25306795|NCT05426252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25306796|NCT05426252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25306797|NCT05426252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25306798|NCT05426252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306799|NCT05426252|Antifungal Agents|antifungal agents|mesh-ancestor
25306800|NCT05426252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25306801|NCT05426252|Immunologic Factors|immunologic factors|mesh-ancestor
25306802|NCT05426252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306803|NCT05426252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25306804|NCT05426252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306805|NCT05426252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25306809|NCT05422664|Lacosamide|lacosamide|mesh-list
25306810|NCT05422664|Anticonvulsants|anticonvulsants|mesh-ancestor
25306811|NCT05422664|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25306812|NCT05422664|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25306813|NCT05422664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25306814|NCT05422664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306815|NCT05411497|Cyclophosphamide|cyclophosphamide|mesh-list
25306816|NCT05411497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25306817|NCT05411497|Immunologic Factors|immunologic factors|mesh-ancestor
25306818|NCT05411497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306819|NCT05411497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25306820|NCT05411497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25306821|NCT05411497|Alkylating Agents|alkylating agents|mesh-ancestor
25306822|NCT05411497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306823|NCT05411497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306824|NCT05411497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25306825|NCT05410847|Paclitaxel|paclitaxel|mesh-list
25306826|NCT05410847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25306827|NCT05410847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306828|NCT05410847|Tubulin Modulators|tubulin modulators|mesh-ancestor
25306829|NCT05410847|Antimitotic Agents|antimitotic agents|mesh-ancestor
25306830|NCT05410847|Mitosis Modulators|mitosis modulators|mesh-ancestor
25306831|NCT05410847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306832|NCT05408923|Chlorhexidine|chlorhexidine|mesh-list
25306833|NCT05408923|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25306834|NCT05408923|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25306835|NCT05408923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25306836|NCT05408923|Disinfectants|disinfectants|mesh-ancestor
25306837|NCT05408923|Dermatologic Agents|dermatologic agents|mesh-ancestor
25306838|NCT05391074|Vitamins|vitamins|mesh-list
25306839|NCT05391074|Micronutrients|micronutrients|mesh-ancestor
25306840|NCT05391074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306841|NCT05373212|Insulin Lispro|insulin lispro|mesh-list
25306842|NCT05373212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25306843|NCT05373212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306844|NCT05373199|Insulin Lispro|insulin lispro|mesh-list
25306845|NCT05373199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25306846|NCT05373199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306847|NCT05373186|Insulin Lispro|insulin lispro|mesh-list
25306848|NCT05373186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25306849|NCT05373186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306852|NCT05357833|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25306853|NCT05357833|Hematinics|hematinics|mesh-ancestor
25306929|NCT05245734|Immunologic Factors|immunologic factors|mesh-ancestor
25306887|NCT05342844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25306888|NCT05342844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25306889|NCT05342844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25306890|NCT05342844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25306891|NCT05342844|Adrenergic Agents|adrenergic agents|mesh-ancestor
25306892|NCT05342844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25306893|NCT05342844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306894|NCT05339113|FAPI-46|fapi-46|mesh-list
25306895|NCT05339113|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25306896|NCT05339113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306897|NCT05332795|Metformin|metformin|mesh-list
25306898|NCT05332795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25306899|NCT05332795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306905|NCT05258851|Ceftazidime|ceftazidime|mesh-list
25306906|NCT05258851|Colistin|colistin|mesh-list
25306907|NCT05258851|Avibactam|avibactam|mesh-list
25306908|NCT05258851|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
25306909|NCT05258851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25306910|NCT05258851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25306911|NCT05258851|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25306912|NCT05258851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25306913|NCT05258851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306914|NCT05253573|Nicotine|nicotine|mesh-list
25306915|NCT05253573|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25306916|NCT05253573|Autonomic Agents|autonomic agents|mesh-ancestor
25306917|NCT05253573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25306918|NCT05253573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306919|NCT05253573|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25306920|NCT05253573|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25306921|NCT05253573|Cholinergic Agents|cholinergic agents|mesh-ancestor
25306922|NCT05253573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25306923|NCT05253573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306924|NCT05245734|Immunoglobulins|immunoglobulins|mesh-list
25306925|NCT05245734|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25306926|NCT05245734|Antibodies|antibodies|mesh-list
25306927|NCT05245734|gamma-Globulins|gamma-globulins|mesh-list
25306936|NCT05239884|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25306937|NCT05239884|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25306938|NCT05239884|Cholinergic Agents|cholinergic agents|mesh-ancestor
25306939|NCT05239884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25306940|NCT05239884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306941|NCT05233722|Sirolimus|sirolimus|mesh-list
25306942|NCT05233722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306943|NCT05233722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25306944|NCT05233722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25306945|NCT05233722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25306946|NCT05233722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306947|NCT05233722|Antifungal Agents|antifungal agents|mesh-ancestor
25306948|NCT05233722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25306949|NCT05233722|Immunologic Factors|immunologic factors|mesh-ancestor
25306950|NCT05211570|Azacitidine|azacitidine|mesh-list
25306951|NCT05211570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25306952|NCT05211570|Antimetabolites|antimetabolites|mesh-ancestor
25306953|NCT05211570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306954|NCT05211570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306955|NCT05211570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25306962|NCT05205447|Itraconazole|itraconazole|mesh-list
25306963|NCT05205447|Carbamazepine|carbamazepine|mesh-list
25306964|NCT05205447|Antifungal Agents|antifungal agents|mesh-ancestor
25306965|NCT05205447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25306966|NCT05205447|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25306967|NCT05205447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25306968|NCT05205447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25306969|NCT05205447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25306970|NCT05205447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25306971|NCT05205447|Hormone Antagonists|hormone antagonists|mesh-ancestor
25306972|NCT05205447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25306973|NCT05205447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306974|NCT05205447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25306975|NCT05205447|Anticonvulsants|anticonvulsants|mesh-ancestor
25306976|NCT05205447|Antimanic Agents|antimanic agents|mesh-ancestor
25306977|NCT05205447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25306978|NCT05205447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25306979|NCT05205447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25306980|NCT05205447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25306981|NCT05205447|Analgesics|analgesics|mesh-ancestor
25306982|NCT05205447|Sensory System Agents|sensory system agents|mesh-ancestor
25308030|NCT00400946|Doxorubicin|doxorubicin|mesh-list
25306983|NCT05205447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25306984|NCT05205447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25306985|NCT05205447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25306986|NCT05205447|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25306987|NCT05205447|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25306988|NCT05191797|Atezolizumab|atezolizumab|mesh-list
25306989|NCT05191797|Immunoglobulins|immunoglobulins|mesh-list
25183404|NCT02842931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25183405|NCT02842931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183406|NCT02842931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25183407|NCT02842931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25183408|NCT02842931|Glucocorticoids|glucocorticoids|mesh-ancestor
25306990|NCT05191797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25306991|NCT05191797|Immunoglobulin G|immunoglobulin g|mesh-list
25306992|NCT05191797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25306993|NCT05191797|Immunologic Factors|immunologic factors|mesh-ancestor
25306994|NCT05191797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25306996|NCT05188313|Carboplatin|carboplatin|mesh-list
25306997|NCT05188313|Trastuzumab|trastuzumab|mesh-list
25306998|NCT05188313|Pertuzumab|pertuzumab|mesh-list
25306999|NCT05188313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25307000|NCT05188313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307001|NCT05188313|Tubulin Modulators|tubulin modulators|mesh-ancestor
25307002|NCT05188313|Antimitotic Agents|antimitotic agents|mesh-ancestor
25307003|NCT05188313|Mitosis Modulators|mitosis modulators|mesh-ancestor
25307004|NCT05188313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307015|NCT05150704|Methylprednisolone|methylprednisolone|mesh-list
25307016|NCT05150704|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25307017|NCT05150704|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25307018|NCT05150704|Prednisolone|prednisolone|mesh-list
25307019|NCT05150704|Prednisolone acetate|prednisolone acetate|mesh-list
25307020|NCT05150704|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25307021|NCT05150704|Prednisolone phosphate|prednisolone phosphate|mesh-list
25307022|NCT05150704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25307023|NCT05150704|Antiemetics|antiemetics|mesh-ancestor
25307024|NCT05150704|Autonomic Agents|autonomic agents|mesh-ancestor
25307025|NCT05150704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25307026|NCT05150704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307027|NCT05150704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25307028|NCT05150704|Glucocorticoids|glucocorticoids|mesh-ancestor
25307029|NCT05150704|Hormones|hormones|mesh-ancestor
25307030|NCT05150704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25307031|NCT05150704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25307032|NCT05150704|Protective Agents|protective agents|mesh-ancestor
25307033|NCT05150704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25307034|NCT05150704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307035|NCT05115838|Islatravir|islatravir|mesh-list
25307036|NCT05115838|Antiviral Agents|antiviral agents|mesh-ancestor
25307037|NCT05115838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25307038|NCT05115838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25307039|NCT05115838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307040|NCT05115838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25307041|NCT05115838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25307042|NCT05115838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24469515|NCT00386191|Clopidogrel|clopidogrel|mesh-list
25307076|NCT04971343|Antibodies|antibodies|mesh-list
25307114|NCT04941573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25307115|NCT04941573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307128|NCT04916691|Ropivacaine|ropivacaine|mesh-list
25307129|NCT04916691|Anesthetics, Local|anesthetics, local|mesh-ancestor
25307130|NCT04916691|Anesthetics|anesthetics|mesh-ancestor
25307131|NCT04916691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25307132|NCT04916691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307133|NCT04916691|Sensory System Agents|sensory system agents|mesh-ancestor
25307134|NCT04916691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25307136|NCT04884139|Lamivudine|lamivudine|mesh-list
25307137|NCT04884139|Emtricitabine|emtricitabine|mesh-list
25307138|NCT04884139|Dolutegravir|dolutegravir|mesh-list
25307139|NCT04884139|Antiviral Agents|antiviral agents|mesh-ancestor
25307140|NCT04884139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25307141|NCT04884139|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25307142|NCT04884139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25307143|NCT04884139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25307144|NCT04884139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307145|NCT04884139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25307146|NCT04884139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25307147|NCT04884139|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25307148|NCT04884139|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25307149|NCT04880785|Lamivudine|lamivudine|mesh-list
25648473|NCT01479868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25648474|NCT01479868|Antiviral Agents|antiviral agents|mesh-ancestor
25648475|NCT01479868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25648476|NCT01479868|Antimetabolites|antimetabolites|mesh-ancestor
25648477|NCT01479868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307150|NCT04880785|Dolutegravir|dolutegravir|mesh-list
25307151|NCT04880785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25307152|NCT04880785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25307153|NCT04880785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25307156|NCT04880785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25307157|NCT04880785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25307158|NCT04880785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25307159|NCT04880785|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25307160|NCT04880785|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25307162|NCT04833907|Levetiracetam|levetiracetam|mesh-list
25307163|NCT04833907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25307164|NCT04833907|Glucocorticoids|glucocorticoids|mesh-ancestor
25307165|NCT04833907|Hormones|hormones|mesh-ancestor
25307166|NCT04833907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25307167|NCT04833907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307168|NCT04833907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25307169|NCT04833907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307170|NCT04833907|Anticonvulsants|anticonvulsants|mesh-ancestor
25307171|NCT04833907|Nootropic Agents|nootropic agents|mesh-ancestor
25307172|NCT04821869|Albuterol|albuterol|mesh-list
25307173|NCT04821869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25307174|NCT04821869|Autonomic Agents|autonomic agents|mesh-ancestor
25307175|NCT04821869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25307176|NCT04821869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307177|NCT04821869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25307178|NCT04821869|Respiratory System Agents|respiratory system agents|mesh-ancestor
25307179|NCT04821869|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25307180|NCT04821869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25307181|NCT04821869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25307182|NCT04821869|Adrenergic Agents|adrenergic agents|mesh-ancestor
25307183|NCT04821869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25307184|NCT04821869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307185|NCT04821869|Tocolytic Agents|tocolytic agents|mesh-ancestor
25307186|NCT04821869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25307187|NCT04816890|Insulin Lispro|insulin lispro|mesh-list
25307188|NCT04816890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25307189|NCT04816890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307190|NCT04793815|Pembrolizumab|pembrolizumab|mesh-list
25307191|NCT04793815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25307192|NCT04793815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307193|NCT04786340|Pirenzepine|pirenzepine|mesh-list
25307194|NCT04786340|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24446824|NCT00306137|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24446826|NCT00306137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25307195|NCT04786340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25307196|NCT04786340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25307197|NCT04786340|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25307198|NCT04786340|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25307199|NCT04786340|Cholinergic Agents|cholinergic agents|mesh-ancestor
25307200|NCT04786340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25307201|NCT04786340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307202|NCT04786340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307203|NCT04775225|Lidocaine|lidocaine|mesh-list
25307204|NCT04775225|Anesthetics, Local|anesthetics, local|mesh-ancestor
25307205|NCT04775225|Anesthetics|anesthetics|mesh-ancestor
25307206|NCT04775225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25307207|NCT04775225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307208|NCT04775225|Sensory System Agents|sensory system agents|mesh-ancestor
25307209|NCT04775225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25307210|NCT04775225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25307211|NCT04775225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25307212|NCT04775225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25307213|NCT04775225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25307214|NCT04775225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307215|NCT04740008|Nicotine|nicotine|mesh-list
25307216|NCT04740008|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25307217|NCT04740008|Autonomic Agents|autonomic agents|mesh-ancestor
25307218|NCT04740008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25307219|NCT04740008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307220|NCT04740008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25307221|NCT04740008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25307222|NCT04740008|Cholinergic Agents|cholinergic agents|mesh-ancestor
25307223|NCT04740008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25307224|NCT04740008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307257|NCT04629976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25307258|NCT04629976|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25307262|NCT04629976|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25307263|NCT04629976|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25307264|NCT04622917|Methylprednisolone|methylprednisolone|mesh-list
25307265|NCT04622917|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25307266|NCT04622917|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25307268|NCT04622917|Prednisolone acetate|prednisolone acetate|mesh-list
25307269|NCT04622917|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25307270|NCT04622917|Prednisolone phosphate|prednisolone phosphate|mesh-list
25307271|NCT04622917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25307272|NCT04622917|Antiemetics|antiemetics|mesh-ancestor
25307273|NCT04622917|Autonomic Agents|autonomic agents|mesh-ancestor
25307274|NCT04622917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25307275|NCT04622917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307276|NCT04622917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25307277|NCT04622917|Glucocorticoids|glucocorticoids|mesh-ancestor
25307278|NCT04622917|Hormones|hormones|mesh-ancestor
25307279|NCT04622917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25307280|NCT04622917|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25307281|NCT04622917|Protective Agents|protective agents|mesh-ancestor
25307282|NCT04622917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25307283|NCT04622917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307284|NCT04579523|Cyclophosphamide|cyclophosphamide|mesh-list
25307285|NCT04579523|Fludarabine|fludarabine|mesh-list
25307286|NCT04579523|Fludarabine phosphate|fludarabine phosphate|mesh-list
25307287|NCT04579523|Daratumumab|daratumumab|mesh-list
25307288|NCT04579523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25307289|NCT04579523|Antibodies|antibodies|mesh-list
25307290|NCT04579523|Immunoglobulins|immunoglobulins|mesh-list
25307291|NCT04579523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25307292|NCT04579523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25307293|NCT04579523|Immunologic Factors|immunologic factors|mesh-ancestor
25307294|NCT04579523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307295|NCT04579523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25307296|NCT04579523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25079386|NCT03348098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079387|NCT03348098|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24470001|NCT00388388|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25307297|NCT04579523|Alkylating Agents|alkylating agents|mesh-ancestor
24515554|NCT00598169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24515555|NCT00598169|Alkylating Agents|alkylating agents|mesh-ancestor
24515556|NCT00598195|Ketamine|ketamine|mesh-list
24515557|NCT00598195|Analgesics|analgesics|mesh-ancestor
24515558|NCT00598195|Sensory System Agents|sensory system agents|mesh-ancestor
24433786|NCT00259896|Hormones|hormones|mesh-ancestor
25307331|NCT04407247|Infliximab|infliximab|mesh-list
25307332|NCT04407247|Vedolizumab|vedolizumab|mesh-list
25307333|NCT04407247|Immunoglobulins|immunoglobulins|mesh-list
25307334|NCT04407247|Immunoglobulin G|immunoglobulin g|mesh-list
25307335|NCT04407247|Immunologic Factors|immunologic factors|mesh-ancestor
25307336|NCT04407247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307337|NCT04407247|Dermatologic Agents|dermatologic agents|mesh-ancestor
25307338|NCT04407247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25307339|NCT04407247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25307343|NCT04349267|Nivolumab|nivolumab|mesh-list
25307344|NCT04349267|Cetuximab|cetuximab|mesh-list
25307345|NCT04349267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25307346|NCT04349267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307347|NCT04349267|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25307348|NCT04349267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307349|NCT04335968|Melatonin|melatonin|mesh-list
25307350|NCT04335968|Antioxidants|antioxidants|mesh-ancestor
25307351|NCT04335968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307352|NCT04335968|Protective Agents|protective agents|mesh-ancestor
25307353|NCT04335968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307354|NCT04335968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25307366|NCT04283604|Methylphenidate|methylphenidate|mesh-list
25307367|NCT04283604|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25307368|NCT04283604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307369|NCT04283604|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25307370|NCT04283604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25307371|NCT04283604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25307599|NCT03742414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25307387|NCT04214834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25307388|NCT04214834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307389|NCT04214834|Analgesics|analgesics|mesh-ancestor
25307390|NCT04214834|Sensory System Agents|sensory system agents|mesh-ancestor
25307391|NCT04214834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24408554|NCT00178620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24408555|NCT00178620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307392|NCT04214834|Antitussive Agents|antitussive agents|mesh-ancestor
25307393|NCT04214834|Respiratory System Agents|respiratory system agents|mesh-ancestor
25307395|NCT04198506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25307396|NCT04198506|Immunologic Factors|immunologic factors|mesh-ancestor
25307397|NCT04198506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307398|NCT04198506|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25307399|NCT04198506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25307400|NCT04198506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307402|NCT04196413|Fludarabine|fludarabine|mesh-list
25307403|NCT04196413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25307404|NCT04196413|Immunologic Factors|immunologic factors|mesh-ancestor
25307405|NCT04196413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307406|NCT04196413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25307407|NCT04196413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25307408|NCT04196413|Alkylating Agents|alkylating agents|mesh-ancestor
25307409|NCT04196413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307410|NCT04196413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307411|NCT04196413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25307430|NCT04140292|Cholecalciferol|cholecalciferol|mesh-list
25307431|NCT04140292|Vitamins|vitamins|mesh-ancestor
25307432|NCT04140292|Micronutrients|micronutrients|mesh-ancestor
25307433|NCT04140292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307434|NCT04140292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25307435|NCT04140292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25307436|NCT04132791|Aspirin|aspirin|mesh-list
25307437|NCT04132791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25307438|NCT04132791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25307439|NCT04132791|Analgesics|analgesics|mesh-ancestor
25307440|NCT04132791|Sensory System Agents|sensory system agents|mesh-ancestor
25307441|NCT04132791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25307442|NCT04132791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307443|NCT04132791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25307444|NCT04132791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25307445|NCT04132791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25307446|NCT04132791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25307467|NCT04121507|Fludarabine|fludarabine|mesh-list
25307468|NCT04121507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25307469|NCT04121507|Immunologic Factors|immunologic factors|mesh-ancestor
25307470|NCT04121507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307471|NCT04121507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25307472|NCT04121507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25307473|NCT04121507|Alkylating Agents|alkylating agents|mesh-ancestor
25307474|NCT04121507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307475|NCT04121507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307476|NCT04121507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25307477|NCT04120246|Acetic Acid|acetic acid|mesh-list
25307478|NCT04120246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25307479|NCT04120246|Trastuzumab|trastuzumab|mesh-list
25307480|NCT04120246|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
25307481|NCT04120246|Antibodies|antibodies|mesh-list
25307482|NCT04120246|Immunoglobulins|immunoglobulins|mesh-list
25307483|NCT04120246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25307484|NCT04120246|Immunologic Factors|immunologic factors|mesh-ancestor
25307485|NCT04120246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307486|NCT04120246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307487|NCT04120246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25307488|NCT04120246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25307508|NCT04065009|Ropivacaine|ropivacaine|mesh-list
25307509|NCT04065009|Anesthetics, Local|anesthetics, local|mesh-ancestor
25307510|NCT04065009|Anesthetics|anesthetics|mesh-ancestor
25307511|NCT04065009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25307512|NCT04065009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307513|NCT04065009|Sensory System Agents|sensory system agents|mesh-ancestor
25307514|NCT04065009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25307515|NCT04030195|Cyclophosphamide|cyclophosphamide|mesh-list
25307516|NCT04030195|Fludarabine|fludarabine|mesh-list
25307517|NCT04030195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25307518|NCT04030195|Immunologic Factors|immunologic factors|mesh-ancestor
25307519|NCT04030195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648478|NCT01479868|Immunologic Factors|immunologic factors|mesh-ancestor
25648479|NCT01479868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307521|NCT04030195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25307522|NCT04030195|Alkylating Agents|alkylating agents|mesh-ancestor
25307537|NCT03915964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25307538|NCT03915964|Analgesics|analgesics|mesh-ancestor
25307539|NCT03915964|Sensory System Agents|sensory system agents|mesh-ancestor
25307540|NCT03915964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25307541|NCT03915964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307542|NCT03915964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25307543|NCT03915964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25307544|NCT03915964|Immunologic Factors|immunologic factors|mesh-ancestor
25307571|NCT03892395|Vitamin D|vitamin d|mesh-list
25307572|NCT03892395|Vitamins|vitamins|mesh-list
25307573|NCT03892395|Vitamin B Complex|vitamin b complex|mesh-list
25307574|NCT03892395|Micronutrients|micronutrients|mesh-ancestor
25307575|NCT03892395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307576|NCT03892395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25307581|NCT03784326|Fluorouracil|fluorouracil|mesh-list
25307582|NCT03784326|Oxaliplatin|oxaliplatin|mesh-list
25307583|NCT03784326|Atezolizumab|atezolizumab|mesh-list
25307584|NCT03784326|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25307585|NCT03784326|Antimetabolites|antimetabolites|mesh-ancestor
25307586|NCT03784326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307587|NCT03784326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25307588|NCT03784326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307589|NCT03784326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25307590|NCT03784326|Immunologic Factors|immunologic factors|mesh-ancestor
25307591|NCT03784326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307592|NCT03742414|Fluticasone|fluticasone|mesh-list
25307593|NCT03742414|Xhance|xhance|mesh-list
25307594|NCT03742414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25307595|NCT03742414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25307596|NCT03742414|Autonomic Agents|autonomic agents|mesh-ancestor
25307597|NCT03742414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25307598|NCT03742414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307658|NCT03601078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25307659|NCT03601078|Growth Substances|growth substances|mesh-ancestor
25307660|NCT03601078|Growth Inhibitors|growth inhibitors|mesh-ancestor
25307661|NCT03601078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307730|NCT03283150|Propofol|propofol|mesh-list
25307731|NCT03283150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25307732|NCT03283150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25307733|NCT03283150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307734|NCT03283150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25307735|NCT03283150|Anesthetics, General|anesthetics, general|mesh-ancestor
25307736|NCT03283150|Anesthetics|anesthetics|mesh-ancestor
25307737|NCT03283150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25307738|NCT03283150|Analgesics|analgesics|mesh-ancestor
25307739|NCT03283150|Sensory System Agents|sensory system agents|mesh-ancestor
25307740|NCT03283150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25307741|NCT03283150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25307742|NCT03283150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25307743|NCT03283150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25307744|NCT03283150|Adrenergic Agents|adrenergic agents|mesh-ancestor
25307745|NCT03283150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25307746|NCT03283150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307747|NCT03283150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25307748|NCT03283150|Narcotics|narcotics|mesh-ancestor
25307749|NCT03263936|Cytarabine|cytarabine|mesh-list
25307750|NCT03263936|Fludarabine|fludarabine|mesh-list
25307751|NCT03263936|Decitabine|decitabine|mesh-list
25307758|NCT03263936|Immunologic Factors|immunologic factors|mesh-ancestor
25307759|NCT03263936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307761|NCT03263936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25307762|NCT03263936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25307763|NCT03263936|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25307764|NCT03263572|Cytarabine|cytarabine|mesh-list
25307765|NCT03263572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25307766|NCT03263572|Methotrexate|methotrexate|mesh-list
25307767|NCT03263572|Blinatumomab|blinatumomab|mesh-list
25307768|NCT03263572|Ponatinib|ponatinib|mesh-list
25307769|NCT03263572|Antibodies|antibodies|mesh-list
25307770|NCT03263572|Immunoglobulins|immunoglobulins|mesh-list
25307771|NCT03263572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25307772|NCT03263572|Muromonab-CD3|muromonab-cd3|mesh-list
25307773|NCT03263572|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25307774|NCT03263572|Immunologic Factors|immunologic factors|mesh-ancestor
25307775|NCT03263572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307776|NCT03263572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25648480|NCT01479868|Protease Inhibitors|protease inhibitors|mesh-ancestor
25307777|NCT03263572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25307778|NCT03263572|Abortifacient Agents|abortifacient agents|mesh-ancestor
25307779|NCT03263572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25307780|NCT03263572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25307781|NCT03263572|Antimetabolites|antimetabolites|mesh-ancestor
25307782|NCT03263572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307783|NCT03263572|Dermatologic Agents|dermatologic agents|mesh-ancestor
25307784|NCT03263572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25307785|NCT03263572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25307786|NCT03263572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25307787|NCT03263572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25307788|NCT03263572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25307789|NCT03263572|Antiviral Agents|antiviral agents|mesh-ancestor
25307790|NCT03263572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25307791|NCT03263572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25307799|NCT03136445|Tranexamic Acid|tranexamic acid|mesh-list
25307800|NCT03136445|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25307801|NCT03136445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25307802|NCT03136445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307803|NCT03136445|Hemostatics|hemostatics|mesh-ancestor
25307804|NCT03136445|Coagulants|coagulants|mesh-ancestor
25307805|NCT03136029|Antioxidants|antioxidants|mesh-list
25307806|NCT03136029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307807|NCT03136029|Protective Agents|protective agents|mesh-ancestor
25307808|NCT03136029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307809|NCT03082534|Pembrolizumab|pembrolizumab|mesh-list
25307810|NCT03082534|Cetuximab|cetuximab|mesh-list
24471071|NCT00393263|Glucocorticoids|glucocorticoids|mesh-ancestor
25307811|NCT03082534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25307812|NCT03082534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307813|NCT02979522|Doxorubicin|doxorubicin|mesh-list
25307814|NCT02979522|Dacarbazine|dacarbazine|mesh-list
25307815|NCT02979522|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25307816|NCT02979522|Vinblastine|vinblastine|mesh-list
25307817|NCT02979522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25307818|NCT02979522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307819|NCT02979522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25307820|NCT02979522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25307821|NCT02979522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25307822|NCT02979522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307823|NCT02979522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25307824|NCT02979522|Alkylating Agents|alkylating agents|mesh-ancestor
25307825|NCT02979522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25307826|NCT02979522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25307827|NCT02979522|Tubulin Modulators|tubulin modulators|mesh-ancestor
25307836|NCT02888041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307837|NCT02867384|Obinutuzumab|obinutuzumab|mesh-list
25307838|NCT02867384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25307839|NCT02867384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307840|NCT02867267|Thymalfasin|thymalfasin|mesh-list
25307841|NCT02867267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25307842|NCT02867267|Immunologic Factors|immunologic factors|mesh-ancestor
25307843|NCT02867267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307851|NCT02854696|Insulin|insulin|mesh-list
25307852|NCT02854696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25307853|NCT02854696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307862|NCT02782468|Azacitidine|azacitidine|mesh-list
25307863|NCT02782468|Pevonedistat|pevonedistat|mesh-list
25307864|NCT02782468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25307865|NCT02782468|Antimetabolites|antimetabolites|mesh-ancestor
25307866|NCT02782468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307867|NCT02782468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307868|NCT02782468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25307869|NCT02714218|Nivolumab|nivolumab|mesh-list
25307870|NCT02714218|Ipilimumab|ipilimumab|mesh-list
25307871|NCT02714218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25307872|NCT02714218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307873|NCT02714218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25307874|NCT02714218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829664|NCT00006247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25307893|NCT02579811|Axitinib|axitinib|mesh-list
25307894|NCT02579811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307895|NCT02579811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25307896|NCT02579811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25307920|NCT02447718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307937|NCT02047097|Dermatologic Agents|dermatologic agents|mesh-ancestor
25183781|NCT02839694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25183783|NCT02839694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25183784|NCT02839785|Ibuprofen|ibuprofen|mesh-list
25183785|NCT02839785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25183786|NCT02839785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25183787|NCT02839785|Analgesics|analgesics|mesh-ancestor
25183788|NCT02839785|Sensory System Agents|sensory system agents|mesh-ancestor
25183789|NCT02839785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25307938|NCT02047097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25307939|NCT02047097|Immunologic Factors|immunologic factors|mesh-ancestor
25307940|NCT02047097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307941|NCT02028364|Everolimus|everolimus|mesh-list
25307942|NCT02028364|Exemestane|exemestane|mesh-list
25307943|NCT02028364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307944|NCT02028364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25307945|NCT02028364|Immunologic Factors|immunologic factors|mesh-ancestor
25307946|NCT02028364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307947|NCT02028364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25307948|NCT02028364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25307949|NCT02028364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25307950|NCT02028364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25307951|NCT02028364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25307952|NCT02028364|Hormone Antagonists|hormone antagonists|mesh-ancestor
25307953|NCT02028364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25307961|NCT01938001|Rituximab|rituximab|mesh-list
25307962|NCT01938001|Lenalidomide|lenalidomide|mesh-list
25307963|NCT01938001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25307964|NCT01938001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25307965|NCT01938001|Immunologic Factors|immunologic factors|mesh-ancestor
25307966|NCT01938001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25307967|NCT01938001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25307968|NCT01938001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25307969|NCT01938001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25307970|NCT01938001|Growth Substances|growth substances|mesh-ancestor
25307971|NCT01938001|Growth Inhibitors|growth inhibitors|mesh-ancestor
25307998|NCT01473628|Rituximab|rituximab|mesh-list
25307999|NCT01473628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25308000|NCT01473628|Antibodies|antibodies|mesh-list
25308001|NCT01473628|Immunoglobulins|immunoglobulins|mesh-list
25308002|NCT01473628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25308003|NCT01473628|Immunologic Factors|immunologic factors|mesh-ancestor
25308004|NCT01473628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308005|NCT01473628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25308006|NCT01473628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25308007|NCT01125371|Ethanol|ethanol|mesh-list
25308008|NCT01125371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25308009|NCT01125371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25308010|NCT01125371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25308011|NCT01125371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308012|NCT01003028|Remifentanil|remifentanil|mesh-list
25308013|NCT01003028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25308014|NCT01003028|Narcotics|narcotics|mesh-ancestor
25308015|NCT01003028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25308016|NCT01003028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308017|NCT01003028|Analgesics|analgesics|mesh-ancestor
25308018|NCT01003028|Sensory System Agents|sensory system agents|mesh-ancestor
25308019|NCT01003028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25308020|NCT00400946|Leucovorin|leucovorin|mesh-list
25308021|NCT00400946|Cytarabine|cytarabine|mesh-list
25308022|NCT00400946|Dexamethasone|dexamethasone|mesh-list
25308023|NCT00400946|Methylprednisolone|methylprednisolone|mesh-list
25308024|NCT00400946|Prednisolone|prednisolone|mesh-list
25308025|NCT00400946|Hydrocortisone|hydrocortisone|mesh-list
25308026|NCT00400946|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25308027|NCT00400946|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25308028|NCT00400946|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25648481|NCT01479868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25648482|NCT01480076|4-Aminopyridine|4-aminopyridine|mesh-list
25648483|NCT01480076|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25648484|NCT01480076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25648485|NCT01480076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648486|NCT01480089|Ropivacaine|ropivacaine|mesh-list
25648487|NCT01480089|Anesthetics, Local|anesthetics, local|mesh-ancestor
25648488|NCT01480089|Anesthetics|anesthetics|mesh-ancestor
25648489|NCT01480089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24460032|NCT00347139|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25183845|NCT02839538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25183846|NCT02839538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183847|NCT02839421|Moxifloxacin|moxifloxacin|mesh-list
25183848|NCT02839421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25183849|NCT02839421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25183850|NCT02839421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25183851|NCT02839421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25308029|NCT00400946|Cyclophosphamide|cyclophosphamide|mesh-list
25308031|NCT00400946|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25308032|NCT00400946|Methotrexate|methotrexate|mesh-list
25308033|NCT00400946|Etoposide|etoposide|mesh-list
25308034|NCT00400946|Vincristine|vincristine|mesh-list
25308035|NCT00400946|Asparaginase|asparaginase|mesh-list
25308036|NCT00400946|Mercaptopurine|mercaptopurine|mesh-list
25308037|NCT00400946|Pegaspargase|pegaspargase|mesh-list
25308038|NCT00400946|Dexrazoxane|dexrazoxane|mesh-list
25308039|NCT00400946|Razoxane|razoxane|mesh-list
25308040|NCT00400946|Levoleucovorin|levoleucovorin|mesh-list
25308041|NCT00400946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25308042|NCT00400946|Immunologic Factors|immunologic factors|mesh-ancestor
25308043|NCT00400946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308044|NCT00400946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25308045|NCT00400946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25308046|NCT00400946|Alkylating Agents|alkylating agents|mesh-ancestor
25308047|NCT00400946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308048|NCT00400946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25308049|NCT00400946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25308050|NCT00400946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25308051|NCT00400946|Antiemetics|antiemetics|mesh-ancestor
25308052|NCT00400946|Autonomic Agents|autonomic agents|mesh-ancestor
25308053|NCT00400946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25308054|NCT00400946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25308055|NCT00400946|Glucocorticoids|glucocorticoids|mesh-ancestor
25308056|NCT00400946|Hormones|hormones|mesh-ancestor
25308057|NCT00400946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25308058|NCT00400946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25308059|NCT00400946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25308060|NCT00400946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25308061|NCT00400946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25308062|NCT00400946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25308063|NCT00400946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25308064|NCT00400946|Abortifacient Agents|abortifacient agents|mesh-ancestor
25308065|NCT00400946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25308066|NCT00400946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25308067|NCT00400946|Antimetabolites|antimetabolites|mesh-ancestor
25308068|NCT00400946|Dermatologic Agents|dermatologic agents|mesh-ancestor
25308069|NCT00400946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25308070|NCT00400946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25308071|NCT00400946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25308072|NCT00400946|Antiviral Agents|antiviral agents|mesh-ancestor
25308073|NCT00400946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25308074|NCT00400946|Antidotes|antidotes|mesh-ancestor
25308075|NCT00400946|Protective Agents|protective agents|mesh-ancestor
25308076|NCT00400946|Vitamin B Complex|vitamin b complex|mesh-ancestor
25308077|NCT00400946|Vitamins|vitamins|mesh-ancestor
25308078|NCT00400946|Micronutrients|micronutrients|mesh-ancestor
25308079|NCT00400946|Tubulin Modulators|tubulin modulators|mesh-ancestor
25308080|NCT00400946|Antimitotic Agents|antimitotic agents|mesh-ancestor
25308081|NCT00400946|Mitosis Modulators|mitosis modulators|mesh-ancestor
25308082|NCT00400946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25308083|NCT00400946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24700379|NCT01452217|Secretin|secretin|mesh-list
25308084|NCT00136435|Leucovorin|leucovorin|mesh-list
25308085|NCT00136435|Cytarabine|cytarabine|mesh-list
25308086|NCT00136435|Dexamethasone|dexamethasone|mesh-list
25308087|NCT00136435|Prednisone|prednisone|mesh-list
25308088|NCT00136435|Hydrocortisone|hydrocortisone|mesh-list
25648490|NCT01480089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648491|NCT01480089|Sensory System Agents|sensory system agents|mesh-ancestor
25648492|NCT01480089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25648493|NCT01480219|Voriconazole|voriconazole|mesh-list
25648494|NCT01480219|Antifungal Agents|antifungal agents|mesh-ancestor
25648495|NCT01480219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25648496|NCT01480219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25648497|NCT01480219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25308089|NCT00136435|Doxorubicin|doxorubicin|mesh-list
25308090|NCT00136435|Methotrexate|methotrexate|mesh-list
25308091|NCT00136435|Vincristine|vincristine|mesh-list
25308092|NCT00136435|Asparaginase|asparaginase|mesh-list
25308093|NCT00136435|Mercaptopurine|mercaptopurine|mesh-list
25308094|NCT00136435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25308095|NCT00136435|Antiemetics|antiemetics|mesh-ancestor
25308096|NCT00136435|Autonomic Agents|autonomic agents|mesh-ancestor
25308097|NCT00136435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25308098|NCT00136435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308099|NCT00136435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25308100|NCT00136435|Glucocorticoids|glucocorticoids|mesh-ancestor
25308101|NCT00136435|Hormones|hormones|mesh-ancestor
25308102|NCT00136435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25308103|NCT00136435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25308104|NCT00136435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25308105|NCT00136435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25308106|NCT00136435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25308107|NCT00136435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25308108|NCT00136435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25308195|NCT03990766|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25308109|NCT00136435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308110|NCT00136435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25308111|NCT00136435|Abortifacient Agents|abortifacient agents|mesh-ancestor
25308112|NCT00136435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25308113|NCT00136435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25308114|NCT00136435|Antimetabolites|antimetabolites|mesh-ancestor
25308115|NCT00136435|Dermatologic Agents|dermatologic agents|mesh-ancestor
25308116|NCT00136435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25308117|NCT00136435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25308118|NCT00136435|Immunologic Factors|immunologic factors|mesh-ancestor
25308119|NCT00136435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25308120|NCT00136435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25308121|NCT00136435|Antiviral Agents|antiviral agents|mesh-ancestor
25308122|NCT00136435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25308123|NCT00136435|Antidotes|antidotes|mesh-ancestor
25308124|NCT00136435|Protective Agents|protective agents|mesh-ancestor
25308125|NCT00136435|Vitamin B Complex|vitamin b complex|mesh-ancestor
25308126|NCT00136435|Vitamins|vitamins|mesh-ancestor
25308127|NCT00136435|Micronutrients|micronutrients|mesh-ancestor
25308128|NCT00136435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25308129|NCT00136435|Tubulin Modulators|tubulin modulators|mesh-ancestor
25308130|NCT00136435|Antimitotic Agents|antimitotic agents|mesh-ancestor
25308137|NCT04064918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308138|NCT04064918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308139|NCT04064918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25308140|NCT04064918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25308141|NCT04061746|Plasma-lyte 148|plasma-lyte 148|mesh-list
25308142|NCT04061746|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25308143|NCT04061746|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25308144|NCT04039347|Cyclosporine|cyclosporine|mesh-list
25308145|NCT04039347|Cyclosporins|cyclosporins|mesh-list
25308146|NCT04039347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25308147|NCT04039347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308148|NCT04039347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25308149|NCT04039347|Immunologic Factors|immunologic factors|mesh-ancestor
25308150|NCT04039347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308151|NCT04039347|Antifungal Agents|antifungal agents|mesh-ancestor
25308152|NCT04039347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25308153|NCT04039347|Dermatologic Agents|dermatologic agents|mesh-ancestor
25308154|NCT04039347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25308155|NCT04039347|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25308162|NCT03998839|Pyrimethamine|pyrimethamine|mesh-list
25308163|NCT03998839|Sulfadoxine|sulfadoxine|mesh-list
25308164|NCT03998839|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25308165|NCT03998839|Antimalarials|antimalarials|mesh-ancestor
25829665|NCT00006247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25308166|NCT03998839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25308167|NCT03998839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25308168|NCT03998839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25308169|NCT03998839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25308170|NCT03998839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25308171|NCT03998839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308172|NCT03998839|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25308173|NCT03998839|Renal Agents|renal agents|mesh-ancestor
25308174|NCT03995641|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25308175|NCT03995641|Bupivacaine|bupivacaine|mesh-list
25308176|NCT03995641|Anesthetics, Local|anesthetics, local|mesh-ancestor
25308177|NCT03995641|Anesthetics|anesthetics|mesh-ancestor
25308178|NCT03995641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25308179|NCT03995641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308181|NCT03995641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25308182|NCT03995641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25308183|NCT03995641|Glucocorticoids|glucocorticoids|mesh-ancestor
25308184|NCT03995641|Hormones|hormones|mesh-ancestor
25308185|NCT03995641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25308186|NCT03995641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25308187|NCT03995641|Immunologic Factors|immunologic factors|mesh-ancestor
25308188|NCT03990766|Theophylline|theophylline|mesh-list
25308189|NCT03990766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25308190|NCT03990766|Autonomic Agents|autonomic agents|mesh-ancestor
25308191|NCT03990766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25308192|NCT03990766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308193|NCT03990766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24472122|NCT00398424|Cisplatin|cisplatin|mesh-list
25308194|NCT03990766|Respiratory System Agents|respiratory system agents|mesh-ancestor
25308196|NCT03990766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25308197|NCT03990766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308198|NCT03990766|Vasodilator Agents|vasodilator agents|mesh-ancestor
25308199|NCT03990766|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25308200|NCT03990766|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25308201|NCT03990766|Purinergic Agents|purinergic agents|mesh-ancestor
25308202|NCT03990766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25308203|NCT03981211|Sofosbuvir|sofosbuvir|mesh-list
25308204|NCT03981211|Antiviral Agents|antiviral agents|mesh-ancestor
25308205|NCT03981211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25308226|NCT03954327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25308227|NCT03954327|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25308228|NCT03954327|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25308235|NCT03942120|Ustekinumab|ustekinumab|mesh-list
25308236|NCT03942120|Dermatologic Agents|dermatologic agents|mesh-ancestor
25308237|NCT03938831|Fentanyl|fentanyl|mesh-list
25308238|NCT03938831|Dexmedetomidine|dexmedetomidine|mesh-list
25308239|NCT03938831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25308240|NCT03938831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25308241|NCT03938831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308242|NCT03938831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25308243|NCT03938831|Analgesics|analgesics|mesh-ancestor
25308244|NCT03938831|Sensory System Agents|sensory system agents|mesh-ancestor
25308245|NCT03938831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25308246|NCT03938831|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25308247|NCT03938831|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25308248|NCT03938831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25308249|NCT03938831|Adrenergic Agents|adrenergic agents|mesh-ancestor
25308250|NCT03938831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25308251|NCT03938831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308252|NCT03938831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25308253|NCT03938831|Narcotics|narcotics|mesh-ancestor
25308254|NCT03938831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25308255|NCT03938831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25308256|NCT03938831|Anesthetics, General|anesthetics, general|mesh-ancestor
25308257|NCT03938831|Anesthetics|anesthetics|mesh-ancestor
25308258|NCT03930680|Dexrazoxane|dexrazoxane|mesh-list
25308259|NCT03930680|Razoxane|razoxane|mesh-list
25308260|NCT03930680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25308261|NCT03930680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25308262|NCT03930680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25308263|NCT03930680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25308264|NCT03930680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25308265|NCT03930680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308266|NCT03930680|Protective Agents|protective agents|mesh-ancestor
25308267|NCT03930680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308268|NCT03930680|Antimitotic Agents|antimitotic agents|mesh-ancestor
25308269|NCT03930680|Mitosis Modulators|mitosis modulators|mesh-ancestor
25308270|NCT03891914|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25308271|NCT03891914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25308272|NCT03891914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308273|NCT03869944|Lamivudine|lamivudine|mesh-list
25308274|NCT03869944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25308275|NCT03869944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25308276|NCT03869944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25308277|NCT03869944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308278|NCT03869944|Antiviral Agents|antiviral agents|mesh-ancestor
25308279|NCT03869944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25308280|NCT03869944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25308281|NCT03869944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25308283|NCT03867357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25308284|NCT03867357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25308285|NCT03864094|Phenylephrine|phenylephrine|mesh-list
25308286|NCT03864094|Oxymetazoline|oxymetazoline|mesh-list
25308287|NCT03864094|Norepinephrine|norepinephrine|mesh-list
25308288|NCT03864094|Ephedrine|ephedrine|mesh-list
25308289|NCT03864094|Pseudoephedrine|pseudoephedrine|mesh-list
25308290|NCT03864094|Remifentanil|remifentanil|mesh-list
25308291|NCT03864094|Propofol|propofol|mesh-list
25308292|NCT03864094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25308293|NCT03864094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25308294|NCT03864094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308295|NCT03864094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25308296|NCT03864094|Anesthetics, General|anesthetics, general|mesh-ancestor
25308297|NCT03864094|Anesthetics|anesthetics|mesh-ancestor
25308298|NCT03864094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25308299|NCT03864094|Narcotics|narcotics|mesh-ancestor
25308300|NCT03864094|Analgesics|analgesics|mesh-ancestor
25308301|NCT03864094|Sensory System Agents|sensory system agents|mesh-ancestor
25308302|NCT03864094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25308303|NCT03864094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25308304|NCT03864094|Mydriatics|mydriatics|mesh-ancestor
25308305|NCT03864094|Autonomic Agents|autonomic agents|mesh-ancestor
25308306|NCT03864094|Sympathomimetics|sympathomimetics|mesh-ancestor
25308307|NCT03864094|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25308308|NCT03864094|Nasal Decongestants|nasal decongestants|mesh-ancestor
25308309|NCT03864094|Respiratory System Agents|respiratory system agents|mesh-ancestor
25308310|NCT03864094|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25308311|NCT03864094|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25308312|NCT03864094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25308313|NCT03864094|Adrenergic Agents|adrenergic agents|mesh-ancestor
25308314|NCT03864094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25308315|NCT03864094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308316|NCT03864094|Protective Agents|protective agents|mesh-ancestor
25308317|NCT03864094|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25308318|NCT03864094|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25308319|NCT03864094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25308320|NCT03862833|Zoledronic Acid|zoledronic acid|mesh-list
25308321|NCT03862833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25308322|NCT03862833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308323|NCT03855917|Sofosbuvir|sofosbuvir|mesh-list
25308324|NCT03855917|Antiviral Agents|antiviral agents|mesh-ancestor
25308325|NCT03855917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25308326|NCT03843970|Bupivacaine|bupivacaine|mesh-list
25308327|NCT03843970|Levobupivacaine|levobupivacaine|mesh-list
25308328|NCT03843970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25308329|NCT03843970|Anesthetics, Local|anesthetics, local|mesh-ancestor
25308330|NCT03843970|Anesthetics|anesthetics|mesh-ancestor
25308331|NCT03843970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25308332|NCT03843970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308333|NCT03843970|Sensory System Agents|sensory system agents|mesh-ancestor
25308334|NCT03843970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25308335|NCT03841201|Nivolumab|nivolumab|mesh-list
25308336|NCT03841201|Lenvatinib|lenvatinib|mesh-list
25308337|NCT03841201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25308338|NCT03841201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25308339|NCT03841201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25308340|NCT03841201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308341|NCT03841201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25308342|NCT03841201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25308343|NCT03841058|Abaloparatide|abaloparatide|mesh-list
25308344|NCT03841058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25308345|NCT03841058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308346|NCT03836352|Cyclophosphamide|cyclophosphamide|mesh-list
25308347|NCT03836352|Pembrolizumab|pembrolizumab|mesh-list
25308348|NCT03836352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25308349|NCT03836352|Immunologic Factors|immunologic factors|mesh-ancestor
25308350|NCT03836352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308351|NCT03836352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25308352|NCT03836352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25308353|NCT03836352|Alkylating Agents|alkylating agents|mesh-ancestor
25308354|NCT03836352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308355|NCT03836352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25308356|NCT03836352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25308357|NCT03836352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25308405|NCT03780829|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25308406|NCT03780829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25308407|NCT03780829|Renal Agents|renal agents|mesh-ancestor
25308408|NCT03780829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24628644|NCT01100216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628645|NCT01100216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24628646|NCT01100216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25308409|NCT03780829|Antitubercular Agents|antitubercular agents|mesh-ancestor
25308410|NCT03780829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25308411|NCT03780829|Antimetabolites|antimetabolites|mesh-ancestor
25308412|NCT03780829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308428|NCT03750786|Leucovorin|leucovorin|mesh-list
25308429|NCT03750786|Antidotes|antidotes|mesh-ancestor
25308430|NCT03750786|Protective Agents|protective agents|mesh-ancestor
25308431|NCT03750786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308432|NCT03750786|Vitamin B Complex|vitamin b complex|mesh-ancestor
25308433|NCT03750786|Vitamins|vitamins|mesh-ancestor
25308441|NCT03748966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308442|NCT03748966|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25308444|NCT03748966|Micronutrients|micronutrients|mesh-ancestor
25308445|NCT03748966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25308446|NCT03748433|Insulin|insulin|mesh-list
25308447|NCT03748433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25308448|NCT03748433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308457|NCT03698006|Ropivacaine|ropivacaine|mesh-list
25308458|NCT03698006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25308459|NCT03698006|Anesthetics, Local|anesthetics, local|mesh-ancestor
25308460|NCT03698006|Anesthetics|anesthetics|mesh-ancestor
25308461|NCT03698006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25308462|NCT03698006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308463|NCT03698006|Sensory System Agents|sensory system agents|mesh-ancestor
25308464|NCT03698006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25308472|NCT03657342|Cyclosporine|cyclosporine|mesh-list
25308473|NCT03657342|Cyclosporins|cyclosporins|mesh-list
25308474|NCT03657342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25308475|NCT03657342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308476|NCT03657342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25308477|NCT03657342|Immunologic Factors|immunologic factors|mesh-ancestor
25308478|NCT03657342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308479|NCT03657342|Antifungal Agents|antifungal agents|mesh-ancestor
25308480|NCT03657342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25308481|NCT03657342|Dermatologic Agents|dermatologic agents|mesh-ancestor
25308482|NCT03657342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25308483|NCT03657342|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25308484|NCT03656926|Cyclosporine|cyclosporine|mesh-list
25308485|NCT03656926|Cyclosporins|cyclosporins|mesh-list
25308486|NCT03656926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25308487|NCT03656926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308488|NCT03656926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25308489|NCT03656926|Immunologic Factors|immunologic factors|mesh-ancestor
25308490|NCT03656926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308491|NCT03656926|Antifungal Agents|antifungal agents|mesh-ancestor
25308492|NCT03656926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25308493|NCT03656926|Dermatologic Agents|dermatologic agents|mesh-ancestor
25308494|NCT03656926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25308495|NCT03656926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25308499|NCT03646617|Nivolumab|nivolumab|mesh-list
25308500|NCT03646617|Ipilimumab|ipilimumab|mesh-list
25308501|NCT03646617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25308502|NCT03646617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25308503|NCT03646617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25308504|NCT03646617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308505|NCT03643744|Celecoxib|celecoxib|mesh-list
25308506|NCT03643744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25308507|NCT03643744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25201674|NCT02726126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25825363|NCT00005589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308516|NCT03643744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25308517|NCT03643744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308518|NCT03606837|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25308519|NCT03606837|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25308520|NCT03606837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308521|NCT03600090|Paclitaxel|paclitaxel|mesh-list
25308522|NCT03600090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25308523|NCT03600090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25308524|NCT03600090|Tubulin Modulators|tubulin modulators|mesh-ancestor
25308526|NCT03600090|Mitosis Modulators|mitosis modulators|mesh-ancestor
25308527|NCT03600090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308528|NCT03595150|Diclofenac|diclofenac|mesh-list
25308529|NCT03595150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25308530|NCT03595150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25308531|NCT03595150|Analgesics|analgesics|mesh-ancestor
25308532|NCT03595150|Sensory System Agents|sensory system agents|mesh-ancestor
25308533|NCT03595150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25308534|NCT03595150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308535|NCT03595150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25308536|NCT03595150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25308537|NCT03595150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25308538|NCT03595150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25308539|NCT03595150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308540|NCT03594175|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25308541|NCT03594175|Reteplase|reteplase|mesh-list
25308542|NCT03594175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25308543|NCT03594175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25308544|NCT03594175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308550|NCT03581734|Vaccines|vaccines|mesh-list
25308551|NCT03581734|Immunologic Factors|immunologic factors|mesh-ancestor
25308552|NCT03581734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308553|NCT03576989|Mineral Oil|mineral oil|mesh-list
25308554|NCT03576989|Emollients|emollients|mesh-ancestor
25308555|NCT03576989|Dermatologic Agents|dermatologic agents|mesh-ancestor
25308556|NCT03568318|Upadacitinib|upadacitinib|mesh-list
25308557|NCT03568318|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25308558|NCT03568318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25308559|NCT03568318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25308560|NCT03568318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308561|NCT03568318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24689091|NCT02299999|Vinblastine|vinblastine|mesh-list
25308565|NCT03493646|Azacitidine|azacitidine|mesh-list
25308567|NCT03493646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25308568|NCT03493646|Antimetabolites|antimetabolites|mesh-ancestor
25308569|NCT03493646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308570|NCT03493646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25308571|NCT03493646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25308584|NCT03457896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25308586|NCT03451370|Bevacizumab|bevacizumab|mesh-list
25308587|NCT03451370|Capecitabine|capecitabine|mesh-list
25308588|NCT03451370|Oxaliplatin|oxaliplatin|mesh-list
25308589|NCT03451370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25308590|NCT03451370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25308591|NCT03451370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25308592|NCT03451370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25308593|NCT03451370|Growth Substances|growth substances|mesh-ancestor
25308594|NCT03451370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308595|NCT03451370|Growth Inhibitors|growth inhibitors|mesh-ancestor
25308596|NCT03451370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25308597|NCT03451370|Antimetabolites|antimetabolites|mesh-ancestor
25308598|NCT03451370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308599|NCT03444298|Vitamin E|vitamin e|mesh-list
25308600|NCT03444298|Tocopherols|tocopherols|mesh-list
25308601|NCT03444298|Tocotrienols|tocotrienols|mesh-list
25308602|NCT03444298|alpha-Tocopherol|alpha-tocopherol|mesh-list
25308603|NCT03444298|gamma-Tocopherol|gamma-tocopherol|mesh-list
25308604|NCT03444298|Vitamins|vitamins|mesh-ancestor
25308605|NCT03444298|Micronutrients|micronutrients|mesh-ancestor
25308606|NCT03444298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308607|NCT03444298|Antioxidants|antioxidants|mesh-ancestor
25308608|NCT03444298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308609|NCT03444298|Protective Agents|protective agents|mesh-ancestor
25308610|NCT03417986|Thiethylperazine|thiethylperazine|mesh-list
25308611|NCT03417986|Antiemetics|antiemetics|mesh-ancestor
25308612|NCT03417986|Autonomic Agents|autonomic agents|mesh-ancestor
25308613|NCT03417986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25308614|NCT03417986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308615|NCT03417986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25308616|NCT03417986|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25308617|NCT03417986|Dopamine Agents|dopamine agents|mesh-ancestor
25308618|NCT03417986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25308619|NCT03417986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308620|NCT03379207|Dimercaprol|dimercaprol|mesh-list
25308623|NCT03379207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308624|NCT03376659|Bevacizumab|bevacizumab|mesh-list
25308625|NCT03376659|Durvalumab|durvalumab|mesh-list
25308626|NCT03376659|Capecitabine|capecitabine|mesh-list
25308627|NCT03376659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25308628|NCT03376659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25308629|NCT03376659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25308630|NCT03376659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25308631|NCT03376659|Growth Substances|growth substances|mesh-ancestor
25308632|NCT03376659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062902|NCT03530995|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25308633|NCT03376659|Growth Inhibitors|growth inhibitors|mesh-ancestor
25308634|NCT03376659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25308635|NCT03376659|Antimetabolites|antimetabolites|mesh-ancestor
25308636|NCT03376659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308638|NCT03345173|Analgesics|analgesics|mesh-ancestor
25308639|NCT03345173|Sensory System Agents|sensory system agents|mesh-ancestor
25308640|NCT03345173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25308641|NCT03345173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308642|NCT03345173|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25308643|NCT03345173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25308644|NCT03345173|Anesthetics, General|anesthetics, general|mesh-ancestor
25308645|NCT03345173|Anesthetics|anesthetics|mesh-ancestor
25308646|NCT03345173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25308647|NCT03345173|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25308648|NCT03345173|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25308649|NCT03345173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25308650|NCT03345173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308651|NCT03336528|Insulin Glargine|insulin glargine|mesh-list
25308652|NCT03336528|Insulin Aspart|insulin aspart|mesh-list
25308653|NCT03336528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25308678|NCT03322215|Fulvestrant|fulvestrant|mesh-list
25308679|NCT03322215|Palbociclib|palbociclib|mesh-list
25308680|NCT03322215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25308681|NCT03322215|Antimetabolites|antimetabolites|mesh-ancestor
25308682|NCT03322215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308683|NCT03322215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25308684|NCT03322215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25308685|NCT03322215|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25308686|NCT03322215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25308687|NCT03322215|Hormone Antagonists|hormone antagonists|mesh-ancestor
25308688|NCT03322215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25308689|NCT03322215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308690|NCT03322215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25308691|NCT03322215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25308692|NCT03311334|Pembrolizumab|pembrolizumab|mesh-list
25308693|NCT03311334|Nivolumab|nivolumab|mesh-list
25308694|NCT03311334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25308695|NCT03311334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25308696|NCT03311334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25308697|NCT03311334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308700|NCT03298087|Leuprolide|leuprolide|mesh-list
25825364|NCT00005589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827419|NCT02138812|Antimitotic Agents|antimitotic agents|mesh-ancestor
24827420|NCT02138812|Mitosis Modulators|mitosis modulators|mesh-ancestor
24827421|NCT02138812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827422|NCT02138929|Everolimus|everolimus|mesh-list
24827423|NCT02138929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25308701|NCT03298087|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25308702|NCT03298087|Fertility Agents|fertility agents|mesh-ancestor
25308703|NCT03298087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25308704|NCT03298087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308705|NCT03298087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25308706|NCT03298087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25308707|NCT03294694|Fulvestrant|fulvestrant|mesh-list
25308708|NCT03294694|Spartalizumab|spartalizumab|mesh-list
25308709|NCT03294694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25308710|NCT03294694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25308711|NCT03294694|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25308712|NCT03294694|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25308713|NCT03294694|Hormone Antagonists|hormone antagonists|mesh-ancestor
25308714|NCT03294694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25308715|NCT03294694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308716|NCT03294694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25308717|NCT03294694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308718|NCT03292458|Sodium Oxybate|sodium oxybate|mesh-list
25308719|NCT03292458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25308720|NCT03292458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25308721|NCT03292458|Anesthetics, General|anesthetics, general|mesh-ancestor
25308722|NCT03292458|Anesthetics|anesthetics|mesh-ancestor
25308723|NCT03292458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25308724|NCT03292458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308725|NCT03290560|Kallikreins|kallikreins|mesh-list
25308726|NCT03290560|Coagulants|coagulants|mesh-ancestor
25308727|NCT03290560|Fertility Agents, Male|fertility agents, male|mesh-ancestor
25308728|NCT03290560|Fertility Agents|fertility agents|mesh-ancestor
25308729|NCT03290560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25308730|NCT03290560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308731|NCT03258281|Evolocumab|evolocumab|mesh-list
25308732|NCT03258281|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25308733|NCT03258281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25308734|NCT03258281|Antimetabolites|antimetabolites|mesh-ancestor
25308735|NCT03258281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308736|NCT03258281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25308737|NCT03235986|Poractant alfa|poractant alfa|mesh-list
25308738|NCT03235986|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
25308739|NCT03235986|Respiratory System Agents|respiratory system agents|mesh-ancestor
25308740|NCT03199547|Azithromycin|azithromycin|mesh-list
25308741|NCT03199547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25308742|NCT03199547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25308743|NCT03189641|Cilostazol|cilostazol|mesh-list
25308744|NCT03189641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25308745|NCT03189641|Autonomic Agents|autonomic agents|mesh-ancestor
25308746|NCT03189641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25308747|NCT03189641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308748|NCT03189641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25308749|NCT03189641|Respiratory System Agents|respiratory system agents|mesh-ancestor
25308750|NCT03189641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25308751|NCT03189641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25308752|NCT03189641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308753|NCT03189641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25308754|NCT03189641|Vasodilator Agents|vasodilator agents|mesh-ancestor
25308755|NCT03189641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25308756|NCT03189641|Protective Agents|protective agents|mesh-ancestor
25308757|NCT03189641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25308758|NCT03189641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25308759|NCT03189641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25308760|NCT03161223|Azacitidine|azacitidine|mesh-list
25308761|NCT03161223|Durvalumab|durvalumab|mesh-list
25308762|NCT03161223|Romidepsin|romidepsin|mesh-list
25308763|NCT03161223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25308764|NCT03161223|Antimetabolites|antimetabolites|mesh-ancestor
25308765|NCT03161223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308766|NCT03161223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25308767|NCT03161223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25308768|NCT03161223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25308769|NCT03161223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24827425|NCT02138929|Immunologic Factors|immunologic factors|mesh-ancestor
24827426|NCT02138929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308770|NCT03113942|Thalidomide|thalidomide|mesh-list
25308771|NCT03113942|Pomalidomide|pomalidomide|mesh-list
25308772|NCT03113942|Immunologic Factors|immunologic factors|mesh-ancestor
25308773|NCT03113942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308774|NCT03113942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25308775|NCT03113942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25308776|NCT03113942|Growth Substances|growth substances|mesh-ancestor
25308777|NCT03113942|Growth Inhibitors|growth inhibitors|mesh-ancestor
25308778|NCT03113942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25308779|NCT03113942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25308780|NCT03113942|Leprostatic Agents|leprostatic agents|mesh-ancestor
25308781|NCT03113942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25308782|NCT03113942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25308783|NCT03109093|Blinatumomab|blinatumomab|mesh-list
25308784|NCT03109093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25308785|NCT03104270|Dexamethasone|dexamethasone|mesh-list
25308786|NCT03104270|Pomalidomide|pomalidomide|mesh-list
25308788|NCT03104270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25308789|NCT03104270|Antiemetics|antiemetics|mesh-ancestor
25308790|NCT03104270|Autonomic Agents|autonomic agents|mesh-ancestor
25308791|NCT03104270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25308792|NCT03104270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308793|NCT03104270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25308794|NCT03104270|Glucocorticoids|glucocorticoids|mesh-ancestor
25308795|NCT03104270|Hormones|hormones|mesh-ancestor
25308796|NCT03104270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25308797|NCT03104270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25308798|NCT03104270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25308799|NCT03104270|Immunologic Factors|immunologic factors|mesh-ancestor
25308800|NCT03104270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25308801|NCT03104270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25308802|NCT03104270|Growth Substances|growth substances|mesh-ancestor
25308803|NCT03104270|Growth Inhibitors|growth inhibitors|mesh-ancestor
25308804|NCT03084536|Acetaminophen|acetaminophen|mesh-list
25308805|NCT03084536|Celecoxib|celecoxib|mesh-list
25308806|NCT03084536|Fentanyl|fentanyl|mesh-list
25308807|NCT03084536|Midazolam|midazolam|mesh-list
25308808|NCT03084536|Gabapentin|gabapentin|mesh-list
25308809|NCT03084536|Bupivacaine|bupivacaine|mesh-list
25308810|NCT03084536|Anesthetics, Local|anesthetics, local|mesh-ancestor
25308811|NCT03084536|Anesthetics|anesthetics|mesh-ancestor
25308812|NCT03084536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25308813|NCT03084536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308814|NCT03084536|Sensory System Agents|sensory system agents|mesh-ancestor
25308815|NCT03084536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25308816|NCT03084536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25308817|NCT03084536|Narcotics|narcotics|mesh-ancestor
25308818|NCT03084536|Analgesics|analgesics|mesh-ancestor
25308819|NCT03084536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25308820|NCT03084536|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25308821|NCT03084536|Anesthetics, General|anesthetics, general|mesh-ancestor
25308822|NCT03084536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25308823|NCT03084536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25308824|NCT03084536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25308825|NCT03084536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25308826|NCT03084536|GABA Modulators|gaba modulators|mesh-ancestor
25308827|NCT03084536|GABA Agents|gaba agents|mesh-ancestor
25308828|NCT03084536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25308829|NCT03084536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308830|NCT03084536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25308831|NCT03084536|Antipyretics|antipyretics|mesh-ancestor
25308832|NCT03084536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25308833|NCT03084536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25308834|NCT03084536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25308835|NCT03084536|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25308836|NCT03084536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25308837|NCT03084536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25308838|NCT03084536|Anticonvulsants|anticonvulsants|mesh-ancestor
25308839|NCT03084536|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25308840|NCT03084536|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25308841|NCT03084536|Antimanic Agents|antimanic agents|mesh-ancestor
25308842|NCT03083067|Budesonide|budesonide|mesh-list
25308843|NCT03083067|Bromides|bromides|mesh-list
25308844|NCT03083067|Formoterol Fumarate|formoterol fumarate|mesh-list
25308845|NCT03083067|Tiotropium Bromide|tiotropium bromide|mesh-list
25308846|NCT03083067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25308847|NCT03083067|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25308848|NCT03083067|Autonomic Agents|autonomic agents|mesh-ancestor
25308849|NCT03083067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25308850|NCT03083067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308851|NCT03083067|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25308852|NCT03083067|Respiratory System Agents|respiratory system agents|mesh-ancestor
25308853|NCT03083067|Glucocorticoids|glucocorticoids|mesh-ancestor
25308854|NCT03083067|Hormones|hormones|mesh-ancestor
25308855|NCT03083067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25308856|NCT03083067|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25308857|NCT03083067|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25308858|NCT03083067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25308859|NCT03083067|Adrenergic Agents|adrenergic agents|mesh-ancestor
25308860|NCT03083067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25308861|NCT03083067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308862|NCT03083067|Parasympatholytics|parasympatholytics|mesh-ancestor
25648498|NCT01480219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25308863|NCT03083067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25308864|NCT03083067|Cholinergic Agents|cholinergic agents|mesh-ancestor
25308866|NCT03043807|Docetaxel|docetaxel|mesh-list
25308867|NCT03043807|Leuprolide|leuprolide|mesh-list
25308868|NCT03043807|Abiraterone Acetate|abiraterone acetate|mesh-list
25308869|NCT03043807|Bicalutamide|bicalutamide|mesh-list
25308870|NCT03043807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25308871|NCT03043807|Tubulin Modulators|tubulin modulators|mesh-ancestor
25308872|NCT03043807|Antimitotic Agents|antimitotic agents|mesh-ancestor
25308873|NCT03043807|Mitosis Modulators|mitosis modulators|mesh-ancestor
25308948|NCT02809820|Carvedilol|carvedilol|mesh-list
25308879|NCT03043807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25308880|NCT03043807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25308881|NCT03043807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25308882|NCT03043807|Hormone Antagonists|hormone antagonists|mesh-ancestor
25308883|NCT03043807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25308884|NCT03043807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25308885|NCT03043807|Androgen Antagonists|androgen antagonists|mesh-ancestor
25308887|NCT03020875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25308888|NCT03020875|Analgesics|analgesics|mesh-ancestor
25308889|NCT03020875|Sensory System Agents|sensory system agents|mesh-ancestor
25308890|NCT03020875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25308891|NCT03020875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308892|NCT03020875|Antipyretics|antipyretics|mesh-ancestor
25308893|NCT02996305|Gaboxadol|gaboxadol|mesh-list
25308894|NCT02996305|Analgesics|analgesics|mesh-ancestor
25308895|NCT02996305|Sensory System Agents|sensory system agents|mesh-ancestor
25308896|NCT02996305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25308897|NCT02996305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308898|NCT02996305|Anticonvulsants|anticonvulsants|mesh-ancestor
25308899|NCT02996305|GABA Agonists|gaba agonists|mesh-ancestor
25308900|NCT02996305|GABA Agents|gaba agents|mesh-ancestor
25308901|NCT02996305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25308902|NCT02996305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308903|NCT02976753|Factor VIII|factor viii|mesh-list
25308904|NCT02976753|Coagulants|coagulants|mesh-ancestor
25308908|NCT02912988|Letrozole|letrozole|mesh-list
25308909|NCT02912988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25308910|NCT02912988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25308911|NCT02912988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25308912|NCT02912988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25308913|NCT02912988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308914|NCT02912988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25308915|NCT02912988|Hormone Antagonists|hormone antagonists|mesh-ancestor
25308916|NCT02912988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25308917|NCT02912988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308922|NCT02870348|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25308923|NCT02870348|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25308924|NCT02870348|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25308925|NCT02870348|Protease Inhibitors|protease inhibitors|mesh-ancestor
25308926|NCT02870348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25308927|NCT02870348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308928|NCT02854488|Ipilimumab|ipilimumab|mesh-list
25308929|NCT02854488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25308930|NCT02854488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25308931|NCT02854488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25308932|NCT02854488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308933|NCT02841280|Chlorthalidone|chlorthalidone|mesh-list
25308934|NCT02841280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25308935|NCT02841280|Diuretics|diuretics|mesh-ancestor
25308936|NCT02841280|Natriuretic Agents|natriuretic agents|mesh-ancestor
25308937|NCT02841280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308938|NCT02841280|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25308939|NCT02841280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25308940|NCT02841280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308941|NCT02838745|Pemetrexed|pemetrexed|mesh-list
25308942|NCT02838745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25308943|NCT02838745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25308944|NCT02838745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25308945|NCT02838745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25308946|NCT02838745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25308947|NCT02809820|Metoprolol|metoprolol|mesh-list
25308961|NCT02809820|Antioxidants|antioxidants|mesh-ancestor
25308962|NCT02809820|Protective Agents|protective agents|mesh-ancestor
25308963|NCT02809820|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25308964|NCT02809820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25308965|NCT02809820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25308966|NCT02809820|Vasodilator Agents|vasodilator agents|mesh-ancestor
25308967|NCT02809820|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25308968|NCT02809820|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25308970|NCT02804022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25308971|NCT02804022|Narcotics|narcotics|mesh-ancestor
25308972|NCT02804022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25308973|NCT02804022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308974|NCT02804022|Analgesics|analgesics|mesh-ancestor
25308975|NCT02804022|Sensory System Agents|sensory system agents|mesh-ancestor
25308976|NCT02804022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25308977|NCT02799095|Pembrolizumab|pembrolizumab|mesh-list
25308978|NCT02799095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25308979|NCT02799095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25308980|NCT02786498|Vitamin D|vitamin d|mesh-list
25308981|NCT02786498|Cholecalciferol|cholecalciferol|mesh-list
25308982|NCT02786498|Vitamins|vitamins|mesh-ancestor
25308983|NCT02786498|Micronutrients|micronutrients|mesh-ancestor
25308984|NCT02786498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25308985|NCT02786498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25308986|NCT02786498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25308999|NCT02729116|Ertapenem|ertapenem|mesh-list
25309000|NCT02729116|Sitafloxacin|sitafloxacin|mesh-list
25309001|NCT02729116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25309002|NCT02729116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25309003|NCT02729116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25309004|NCT02729116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25309005|NCT02729116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25309006|NCT02729116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309007|NCT02729116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309008|NCT02675426|Upadacitinib|upadacitinib|mesh-list
25309009|NCT02675426|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25309010|NCT02675426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25309011|NCT02675426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25309012|NCT02675426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309013|NCT02675426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25309014|NCT02646748|Pembrolizumab|pembrolizumab|mesh-list
25309015|NCT02646748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25309016|NCT02646748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309017|NCT02635672|Pembrolizumab|pembrolizumab|mesh-list
25309018|NCT02635672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25309019|NCT02635672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309020|NCT02632448|Gemcitabine|gemcitabine|mesh-list
25309021|NCT02632448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25309022|NCT02632448|Antimetabolites|antimetabolites|mesh-ancestor
25309029|NCT02632448|Immunologic Factors|immunologic factors|mesh-ancestor
25309030|NCT02632448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309031|NCT02597660|Hormones|hormones|mesh-list
25309032|NCT02597660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25309033|NCT02597660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309034|NCT02592707|Dexamethasone|dexamethasone|mesh-list
25309035|NCT02592707|Ondansetron|ondansetron|mesh-list
25309036|NCT02592707|Antiemetics|antiemetics|mesh-list
25309037|NCT02592707|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
25309038|NCT02592707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25309039|NCT02592707|Autonomic Agents|autonomic agents|mesh-ancestor
25309040|NCT02592707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25309041|NCT02592707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309042|NCT02592707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25309043|NCT02592707|Glucocorticoids|glucocorticoids|mesh-ancestor
25309044|NCT02592707|Hormones|hormones|mesh-ancestor
25309045|NCT02592707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25309046|NCT02592707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25309047|NCT02592707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309048|NCT02592707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309049|NCT02592707|Antipruritics|antipruritics|mesh-ancestor
25309050|NCT02592707|Dermatologic Agents|dermatologic agents|mesh-ancestor
25309051|NCT02592707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25309052|NCT02592707|Serotonin Agents|serotonin agents|mesh-ancestor
25309053|NCT02592707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25309054|NCT02592707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25184491|NCT02836002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25309055|NCT02592707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25309056|NCT02592707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25309057|NCT02592707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25309058|NCT02592707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25309059|NCT02592707|Chelating Agents|chelating agents|mesh-ancestor
25309060|NCT02592707|Sequestering Agents|sequestering agents|mesh-ancestor
25309066|NCT02537314|Benzocaine|benzocaine|mesh-list
25309067|NCT02537314|Anesthetics, Local|anesthetics, local|mesh-ancestor
25309068|NCT02537314|Anesthetics|anesthetics|mesh-ancestor
25309069|NCT02537314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25309070|NCT02537314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309071|NCT02537314|Sensory System Agents|sensory system agents|mesh-ancestor
25309072|NCT02537314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25309073|NCT02499003|Obinutuzumab|obinutuzumab|mesh-list
25309074|NCT02499003|Pixantrone|pixantrone|mesh-list
25309075|NCT02499003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25309076|NCT02499003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309077|NCT02499003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25309078|NCT02499003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25309079|NCT02499003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25309080|NCT02499003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309081|NCT02498444|Treprostinil|treprostinil|mesh-list
25309082|NCT02498444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25825365|NCT00005589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25309083|NCT02487108|Acetaminophen|acetaminophen|mesh-list
25309084|NCT02487108|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25309085|NCT02487108|Hydrocodone|hydrocodone|mesh-list
25309086|NCT02487108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25309087|NCT02487108|Analgesics|analgesics|mesh-ancestor
25309088|NCT02487108|Sensory System Agents|sensory system agents|mesh-ancestor
25309089|NCT02487108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25309090|NCT02487108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309091|NCT02487108|Antipyretics|antipyretics|mesh-ancestor
25309092|NCT02487108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25309093|NCT02487108|Narcotics|narcotics|mesh-ancestor
25309094|NCT02487108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25309095|NCT02487108|Antitussive Agents|antitussive agents|mesh-ancestor
25309104|NCT02455557|Alkylating Agents|alkylating agents|mesh-ancestor
25309105|NCT02455557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309106|NCT02455557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309107|NCT02455557|Immunologic Factors|immunologic factors|mesh-ancestor
25309108|NCT02455557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309109|NCT02455557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25309110|NCT02455141|Cyclophosphamide|cyclophosphamide|mesh-list
25309112|NCT02455141|Epirubicin|epirubicin|mesh-list
25309113|NCT02455141|Taxane|taxane|mesh-list
25309114|NCT02455141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25309115|NCT02455141|Immunologic Factors|immunologic factors|mesh-ancestor
25309116|NCT02455141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309117|NCT02455141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25309118|NCT02455141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25309119|NCT02455141|Alkylating Agents|alkylating agents|mesh-ancestor
25309120|NCT02455141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309121|NCT02455141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309122|NCT02455141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25309123|NCT02455141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25309124|NCT02455141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25309125|NCT02455141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25309126|NCT02455141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25309127|NCT02439385|Curcumin|curcumin|mesh-list
25309128|NCT02439385|Bevacizumab|bevacizumab|mesh-list
25309129|NCT02439385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25309130|NCT02439385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309131|NCT02439385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25309132|NCT02439385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25309133|NCT02439385|Growth Substances|growth substances|mesh-ancestor
25309134|NCT02439385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309135|NCT02439385|Growth Inhibitors|growth inhibitors|mesh-ancestor
25309136|NCT02439385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25309137|NCT02439385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25309138|NCT02439385|Analgesics|analgesics|mesh-ancestor
25309139|NCT02439385|Sensory System Agents|sensory system agents|mesh-ancestor
25648499|NCT01480219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184575|NCT02835170|Immunoglobulins|immunoglobulins|mesh-list
24425713|NCT00234091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24425795|NCT00234390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25184576|NCT02835170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25184577|NCT02835170|Antibodies|antibodies|mesh-list
25184578|NCT02835170|Immunologic Factors|immunologic factors|mesh-ancestor
25184579|NCT02835170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184580|NCT02835183|Insulin|insulin|mesh-list
25184581|NCT02835183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25309140|NCT02439385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25309141|NCT02439385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25309142|NCT02439385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25309143|NCT02439385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25309144|NCT02439385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309145|NCT02419664|Edotreotide|edotreotide|mesh-list
25309146|NCT02419664|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25309147|NCT02419664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825366|NCT00005589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25825367|NCT00005589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25825368|NCT00005589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25825369|NCT00005589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25309158|NCT02387996|Nivolumab|nivolumab|mesh-list
25309159|NCT02387996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25309160|NCT02387996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309161|NCT02387996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25309162|NCT02387996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309166|NCT02349386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25309226|NCT02163356|Mitosis Modulators|mitosis modulators|mesh-ancestor
25825370|NCT00005589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825371|NCT00005589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25309302|NCT01876953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309227|NCT02163356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309228|NCT02163356|Antifungal Agents|antifungal agents|mesh-ancestor
25309229|NCT02163356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25309230|NCT02163356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25309231|NCT02163356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25309232|NCT02163356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25309233|NCT02163356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25309234|NCT02163356|Hormone Antagonists|hormone antagonists|mesh-ancestor
25309235|NCT02163356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25309236|NCT02163356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309237|NCT02163356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25309238|NCT02163356|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25309239|NCT02163356|Protective Agents|protective agents|mesh-ancestor
25309241|NCT02102477|Hormones|hormones|mesh-ancestor
25309242|NCT02102477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25309243|NCT02102477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309244|NCT02053051|Insulin Aspart|insulin aspart|mesh-list
25309245|NCT02053051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25309246|NCT02053051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309247|NCT02021006|Amoxicillin|amoxicillin|mesh-list
25309248|NCT02021006|Clavulanic Acid|clavulanic acid|mesh-list
25309249|NCT02021006|Clavulanic Acids|clavulanic acids|mesh-list
25309250|NCT02021006|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25309251|NCT02021006|Nitrofurantoin|nitrofurantoin|mesh-list
25309252|NCT02021006|Cefixime|cefixime|mesh-list
25309253|NCT02021006|Trimethoprim|trimethoprim|mesh-list
25309254|NCT02021006|Sulfamethoxazole|sulfamethoxazole|mesh-list
25309255|NCT02021006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25309256|NCT02021006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25309257|NCT02021006|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25309258|NCT02021006|Renal Agents|renal agents|mesh-ancestor
25309259|NCT02021006|Antimalarials|antimalarials|mesh-ancestor
25309260|NCT02021006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25309261|NCT02021006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25648500|NCT01480219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25648501|NCT01480219|Hormone Antagonists|hormone antagonists|mesh-ancestor
25648502|NCT01480219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25648503|NCT01480219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648504|NCT01480219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25648505|NCT01480232|Nicotine|nicotine|mesh-list
25648506|NCT01480232|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25648507|NCT01480232|Autonomic Agents|autonomic agents|mesh-ancestor
25309262|NCT02021006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25309263|NCT02021006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25309264|NCT02021006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309265|NCT02021006|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25309266|NCT02021006|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25309267|NCT02021006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25309268|NCT02021006|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25309269|NCT02013336|Cyclophosphamide|cyclophosphamide|mesh-list
25309270|NCT02013336|Irinotecan|irinotecan|mesh-list
25309271|NCT02013336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25309272|NCT02013336|Immunologic Factors|immunologic factors|mesh-ancestor
25309273|NCT02013336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309274|NCT02013336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25309275|NCT02013336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25309276|NCT02013336|Alkylating Agents|alkylating agents|mesh-ancestor
25309277|NCT02013336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309278|NCT02013336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309279|NCT02013336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25309280|NCT02013336|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25309281|NCT02013336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25309282|NCT02013336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25309283|NCT01921140|Olaparib|olaparib|mesh-list
25309284|NCT01921140|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25309285|NCT01921140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25309286|NCT01921140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309287|NCT01921140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309288|NCT01904032|Vitamin D|vitamin d|mesh-list
25309289|NCT01904032|Ergocalciferols|ergocalciferols|mesh-list
25309290|NCT01904032|Cholecalciferol|cholecalciferol|mesh-list
25309291|NCT01904032|Vitamins|vitamins|mesh-list
25309292|NCT01904032|Micronutrients|micronutrients|mesh-ancestor
25309293|NCT01904032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309294|NCT01904032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25309295|NCT01904032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25309296|NCT01876953|Cytarabine|cytarabine|mesh-list
25309297|NCT01876953|Dasatinib|dasatinib|mesh-list
25309298|NCT01876953|Idarubicin|idarubicin|mesh-list
25309299|NCT01876953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25309300|NCT01876953|Antimetabolites|antimetabolites|mesh-ancestor
25309301|NCT01876953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309304|NCT01876953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25309305|NCT01876953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25309306|NCT01876953|Immunologic Factors|immunologic factors|mesh-ancestor
25309307|NCT01876953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309308|NCT01876953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25309309|NCT01876953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25309310|NCT01876953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25309311|NCT01876953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25309312|NCT01876953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25309313|NCT01850355|Buspirone|buspirone|mesh-list
25309314|NCT01850355|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25309315|NCT01850355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25309316|NCT01850355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25309317|NCT01850355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309318|NCT01850355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25309319|NCT01850355|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25309320|NCT01850355|Serotonin Agents|serotonin agents|mesh-ancestor
25309321|NCT01850355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25309322|NCT01850355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309323|NCT01799629|Glycerol|glycerol|mesh-list
25309324|NCT01799629|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25309325|NCT01799629|Protective Agents|protective agents|mesh-ancestor
25309326|NCT01799629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309327|NCT01764711|Cosyntropin|cosyntropin|mesh-list
25309328|NCT01764711|Hormones|hormones|mesh-ancestor
25309329|NCT01764711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25309330|NCT01764711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309331|NCT01553071|Fenretinide|fenretinide|mesh-list
25309332|NCT01553071|Safingol|safingol|mesh-list
25309333|NCT01553071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309334|NCT01553071|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25309335|NCT01553071|Protective Agents|protective agents|mesh-ancestor
25309336|NCT01553071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309337|NCT01553071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825372|NCT00005589|Antimetabolites|antimetabolites|mesh-ancestor
25184654|NCT02834052|Poly I-C|poly i-c|mesh-list
25309338|NCT01553071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309339|NCT01551472|Vitamin E|vitamin e|mesh-list
25309340|NCT01551472|Vitamins|vitamins|mesh-ancestor
25309341|NCT01551472|Micronutrients|micronutrients|mesh-ancestor
25309342|NCT01551472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309343|NCT01551472|Antioxidants|antioxidants|mesh-ancestor
25309344|NCT01551472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309345|NCT01551472|Protective Agents|protective agents|mesh-ancestor
25309346|NCT01506973|Gemcitabine|gemcitabine|mesh-list
25309347|NCT01506973|Hydroxychloroquine|hydroxychloroquine|mesh-list
25309348|NCT01506973|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25309349|NCT01506973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25309350|NCT01506973|Antimetabolites|antimetabolites|mesh-ancestor
25309351|NCT01506973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309352|NCT01506973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309353|NCT01506973|Antiviral Agents|antiviral agents|mesh-ancestor
25309354|NCT01506973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25309355|NCT01506973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25309356|NCT01506973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25309357|NCT01506973|Immunologic Factors|immunologic factors|mesh-ancestor
25309358|NCT01506973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309359|NCT01506973|Antimalarials|antimalarials|mesh-ancestor
25309360|NCT01506973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25309361|NCT01506973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25309362|NCT01506973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25309363|NCT01347970|Carvedilol|carvedilol|mesh-list
25309364|NCT01347970|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25309365|NCT01347970|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25309366|NCT01347970|Adrenergic Agents|adrenergic agents|mesh-ancestor
25309367|NCT01347970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25309368|NCT01347970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309369|NCT01347970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309370|NCT01347970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25309371|NCT01347970|Antioxidants|antioxidants|mesh-ancestor
25309372|NCT01347970|Protective Agents|protective agents|mesh-ancestor
25309373|NCT01347970|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25309374|NCT01347970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25309375|NCT01347970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25309376|NCT01347970|Vasodilator Agents|vasodilator agents|mesh-ancestor
25309742|NCT05244811|Estradiol|estradiol|mesh-list
25309377|NCT01347970|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25309378|NCT01347970|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25309379|NCT01187810|Cytarabine|cytarabine|mesh-list
25309380|NCT01187810|Methotrexate|methotrexate|mesh-list
25309381|NCT01187810|Fenretinide|fenretinide|mesh-list
25825373|NCT00005589|Antiviral Agents|antiviral agents|mesh-ancestor
25825374|NCT00005589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25309382|NCT01187810|Retinamide|retinamide|mesh-list
25309383|NCT01187810|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25309384|NCT01187810|Abortifacient Agents|abortifacient agents|mesh-ancestor
25309385|NCT01187810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25309386|NCT01187810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309387|NCT01187810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25309392|NCT01187810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25309393|NCT01187810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25309394|NCT01187810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25309395|NCT01187810|Immunologic Factors|immunologic factors|mesh-ancestor
25309396|NCT01187810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25309397|NCT01187810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25309398|NCT01187810|Antiviral Agents|antiviral agents|mesh-ancestor
25309399|NCT01187810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25309400|NCT01187810|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25309401|NCT01187810|Protective Agents|protective agents|mesh-ancestor
25309402|NCT00931255|Sirolimus|sirolimus|mesh-list
25309403|NCT00931255|Tacrolimus|tacrolimus|mesh-list
25309404|NCT00931255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25309405|NCT00931255|Immunologic Factors|immunologic factors|mesh-ancestor
25309406|NCT00931255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309407|NCT00931255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25309408|NCT00931255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25309409|NCT00931255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309410|NCT00931255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25309411|NCT00931255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25309412|NCT00931255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25309413|NCT00931255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825375|NCT00005590|Levofloxacin|levofloxacin|mesh-list
25184726|NCT02833701|Vitamins|vitamins|mesh-list
25309414|NCT00931255|Antifungal Agents|antifungal agents|mesh-ancestor
25309415|NCT00540995|Etoposide|etoposide|mesh-list
25309416|NCT00540995|Podophyllotoxin|podophyllotoxin|mesh-list
25309417|NCT00540995|Etoposide phosphate|etoposide phosphate|mesh-list
25309418|NCT00540995|Busulfan|busulfan|mesh-list
25309419|NCT00540995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25309420|NCT00540995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309421|NCT00540995|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25309422|NCT00540995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25309423|NCT00540995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25309424|NCT00540995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309425|NCT00540995|Alkylating Agents|alkylating agents|mesh-ancestor
25309426|NCT00540995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25309427|NCT00540995|Immunologic Factors|immunologic factors|mesh-ancestor
25309428|NCT00540995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309429|NCT00540995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25309430|NCT00540995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25309431|NCT00540995|Keratolytic Agents|keratolytic agents|mesh-ancestor
25309432|NCT00540995|Dermatologic Agents|dermatologic agents|mesh-ancestor
25309433|NCT00540995|Tubulin Modulators|tubulin modulators|mesh-ancestor
25309434|NCT00540995|Antimitotic Agents|antimitotic agents|mesh-ancestor
25309435|NCT00540995|Mitosis Modulators|mitosis modulators|mesh-ancestor
25309436|NCT00484471|Valproic Acid|valproic acid|mesh-list
25309437|NCT00484471|Aripiprazole|aripiprazole|mesh-list
25309438|NCT00484471|Antidepressive Agents|antidepressive agents|mesh-ancestor
25309439|NCT00484471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25309440|NCT00484471|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25309441|NCT00484471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25309442|NCT00484471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25309443|NCT00484471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309444|NCT00484471|Dopamine Agonists|dopamine agonists|mesh-ancestor
25825376|NCT00005590|Ofloxacin|ofloxacin|mesh-list
25309445|NCT00484471|Dopamine Agents|dopamine agents|mesh-ancestor
25825377|NCT00005590|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25309446|NCT00484471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24677741|NCT01358240|Econazole|econazole|mesh-list
25309447|NCT00484471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309448|NCT00484471|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25309449|NCT00484471|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25309450|NCT00484471|Serotonin Agents|serotonin agents|mesh-ancestor
25309451|NCT00484471|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25309452|NCT00484471|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25309453|NCT00484471|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25309454|NCT00484471|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25309455|NCT00484471|Anticonvulsants|anticonvulsants|mesh-ancestor
25309456|NCT00484471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25309457|NCT00484471|GABA Agents|gaba agents|mesh-ancestor
25309458|NCT00484471|Antimanic Agents|antimanic agents|mesh-ancestor
25309459|NCT00015002|Betamethasone|betamethasone|mesh-list
25309460|NCT00015002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25309461|NCT00015002|Glucocorticoids|glucocorticoids|mesh-ancestor
25309462|NCT00015002|Hormones|hormones|mesh-ancestor
25309463|NCT00015002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25309464|NCT00015002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309465|NCT00015002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25309466|NCT00015002|Respiratory System Agents|respiratory system agents|mesh-ancestor
25309467|NCT05108974|Choline|choline|mesh-list
25309468|NCT05108974|Lipotropic Agents|lipotropic agents|mesh-ancestor
25309469|NCT05108974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25309470|NCT05108974|Antimetabolites|antimetabolites|mesh-ancestor
25309471|NCT05108974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309472|NCT05108974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25309473|NCT05108974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25309474|NCT05108974|Nootropic Agents|nootropic agents|mesh-ancestor
25309475|NCT05105139|Triclosan|triclosan|mesh-list
25309476|NCT05105139|Coal Tar|coal tar|mesh-list
25309477|NCT05105139|Allantoin|allantoin|mesh-list
25309478|NCT05105139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25309479|NCT05105139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25309480|NCT05105139|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25309481|NCT05105139|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25309482|NCT05105139|Antimetabolites|antimetabolites|mesh-ancestor
25309483|NCT05105139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309484|NCT05105139|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25309485|NCT05105139|Keratolytic Agents|keratolytic agents|mesh-ancestor
25309486|NCT05105139|Dermatologic Agents|dermatologic agents|mesh-ancestor
25825378|NCT00005590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25309488|NCT05103215|Anesthetics, Local|anesthetics, local|mesh-ancestor
25309489|NCT05103215|Anesthetics|anesthetics|mesh-ancestor
25309490|NCT05103215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25309491|NCT05103215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309492|NCT05103215|Sensory System Agents|sensory system agents|mesh-ancestor
25309493|NCT05103215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25309494|NCT05103215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25309495|NCT05103215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25309496|NCT05103215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25309497|NCT05103215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25309498|NCT05103215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309499|NCT05042700|Melatonin|melatonin|mesh-list
25309500|NCT05042700|Antioxidants|antioxidants|mesh-ancestor
25309501|NCT05042700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309502|NCT05042700|Protective Agents|protective agents|mesh-ancestor
25309503|NCT05042700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309504|NCT05042700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25309505|NCT05033483|Ferrous fumarate|ferrous fumarate|mesh-list
25309506|NCT05033483|Trace Elements|trace elements|mesh-ancestor
25309507|NCT05033483|Micronutrients|micronutrients|mesh-ancestor
25309508|NCT05033483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309509|NCT05015608|Carboplatin|carboplatin|mesh-list
25309510|NCT05015608|Pemetrexed|pemetrexed|mesh-list
25309511|NCT05015608|Osimertinib|osimertinib|mesh-list
25309512|NCT05015608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309513|NCT05015608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25309514|NCT05015608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309515|NCT05015608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25309516|NCT05015608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25309517|NCT05015608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25309518|NCT05001815|Insulin|insulin|mesh-list
25309519|NCT05001815|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25309520|NCT05001815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25309521|NCT05001815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309522|NCT05001555|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
25309523|NCT05001555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309524|NCT05001555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25309525|NCT05001555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25309526|NCT05001555|Analgesics|analgesics|mesh-ancestor
25309527|NCT05001555|Sensory System Agents|sensory system agents|mesh-ancestor
25309528|NCT05001555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25309529|NCT05001555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25309530|NCT05001555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25309531|NCT04975555|Siltuximab|siltuximab|mesh-list
25309532|NCT04975555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309575|NCT04895098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25309576|NCT04895098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25309577|NCT04895098|Antimetabolites|antimetabolites|mesh-ancestor
25309578|NCT04895098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309579|NCT04895098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25309580|NCT04895098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25309581|NCT04848454|Vinorelbine|vinorelbine|mesh-list
25309582|NCT04848454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309583|NCT04848454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25309584|NCT04848454|Tubulin Modulators|tubulin modulators|mesh-ancestor
25309585|NCT04848454|Antimitotic Agents|antimitotic agents|mesh-ancestor
25309586|NCT04848454|Mitosis Modulators|mitosis modulators|mesh-ancestor
25309587|NCT04848454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309588|NCT04785326|Ustekinumab|ustekinumab|mesh-list
25309589|NCT04785326|Dermatologic Agents|dermatologic agents|mesh-ancestor
25309590|NCT04771637|Dexmedetomidine|dexmedetomidine|mesh-list
25309591|NCT04771637|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25309592|NCT04771637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25309593|NCT04771637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309594|NCT04771637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25309595|NCT04771637|Analgesics|analgesics|mesh-ancestor
25309596|NCT04771637|Sensory System Agents|sensory system agents|mesh-ancestor
25309597|NCT04771637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25309598|NCT04771637|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25309599|NCT04771637|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25309600|NCT04771637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25309601|NCT04771637|Adrenergic Agents|adrenergic agents|mesh-ancestor
25309602|NCT04771637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25309603|NCT04771637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309604|NCT04737343|Azathioprine|azathioprine|mesh-list
25309605|NCT04737343|Leflunomide|leflunomide|mesh-list
25309615|NCT04563338|Bevacizumab|bevacizumab|mesh-list
25309616|NCT04563338|Atezolizumab|atezolizumab|mesh-list
25309617|NCT04563338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25309618|NCT04563338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309619|NCT04563338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25309620|NCT04563338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25309621|NCT04563338|Growth Substances|growth substances|mesh-ancestor
25309622|NCT04563338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309623|NCT04563338|Growth Inhibitors|growth inhibitors|mesh-ancestor
25309624|NCT04498273|Aspirin|aspirin|mesh-list
25309625|NCT04498273|Apixaban|apixaban|mesh-list
25309626|NCT04498273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25309627|NCT04498273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25309628|NCT04498273|Analgesics|analgesics|mesh-ancestor
25309629|NCT04498273|Sensory System Agents|sensory system agents|mesh-ancestor
25309630|NCT04498273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25309631|NCT04498273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309632|NCT04498273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25309633|NCT04498273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25309634|NCT04498273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25309635|NCT04498273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25309636|NCT04498273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309637|NCT04498273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25309638|NCT04498273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25309639|NCT04498273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25309640|NCT04498273|Antipyretics|antipyretics|mesh-ancestor
25309641|NCT04498273|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25309642|NCT04498273|Antithrombins|antithrombins|mesh-ancestor
25825379|NCT00005590|Renal Agents|renal agents|mesh-ancestor
25309643|NCT04498273|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25309644|NCT04498273|Protease Inhibitors|protease inhibitors|mesh-ancestor
25309645|NCT04498273|Anticoagulants|anticoagulants|mesh-ancestor
25309655|NCT04268498|Acetaminophen|acetaminophen|mesh-list
25309656|NCT04268498|Diphenhydramine|diphenhydramine|mesh-list
25309657|NCT04268498|Promethazine|promethazine|mesh-list
25309658|NCT04268498|Dexamethasone|dexamethasone|mesh-list
25309659|NCT04268498|Lenalidomide|lenalidomide|mesh-list
25309660|NCT04268498|Bortezomib|bortezomib|mesh-list
25309661|NCT04268498|Daratumumab|daratumumab|mesh-list
25309662|NCT04268498|Montelukast|montelukast|mesh-list
25309663|NCT04268498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25309664|NCT04268498|Antiemetics|antiemetics|mesh-ancestor
25309665|NCT04268498|Autonomic Agents|autonomic agents|mesh-ancestor
25309666|NCT04268498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25309667|NCT04268498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309668|NCT04268498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25309669|NCT04268498|Glucocorticoids|glucocorticoids|mesh-ancestor
25309670|NCT04268498|Hormones|hormones|mesh-ancestor
25309671|NCT04268498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25309672|NCT04268498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25309673|NCT04268498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309674|NCT04268498|Immunologic Factors|immunologic factors|mesh-ancestor
25309675|NCT04268498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25309676|NCT04268498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25309677|NCT04268498|Growth Substances|growth substances|mesh-ancestor
25309678|NCT04268498|Growth Inhibitors|growth inhibitors|mesh-ancestor
25309679|NCT04268498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25309680|NCT04268498|Analgesics|analgesics|mesh-ancestor
25309681|NCT04268498|Sensory System Agents|sensory system agents|mesh-ancestor
25309682|NCT04268498|Antipyretics|antipyretics|mesh-ancestor
25309683|NCT04268498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25309684|NCT04268498|Respiratory System Agents|respiratory system agents|mesh-ancestor
25309685|NCT04268498|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25309686|NCT04268498|Hormone Antagonists|hormone antagonists|mesh-ancestor
25309687|NCT04268498|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25309688|NCT04268498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25309689|NCT04268498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309690|NCT04268498|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25309691|NCT04268498|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25309692|NCT04268498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25309693|NCT04268498|Anesthetics, Local|anesthetics, local|mesh-ancestor
25309694|NCT04268498|Anesthetics|anesthetics|mesh-ancestor
25309695|NCT04268498|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25184932|NCT02832635|Alkylating Agents|alkylating agents|mesh-ancestor
25184933|NCT02832635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184934|NCT02832635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184935|NCT02832336|Caffeine|caffeine|mesh-list
25184936|NCT02832336|Caffeine citrate|caffeine citrate|mesh-list
25184937|NCT02832336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184939|NCT02832336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309696|NCT04268498|Histamine Antagonists|histamine antagonists|mesh-ancestor
25309697|NCT04268498|Histamine Agents|histamine agents|mesh-ancestor
25309698|NCT04268498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25309699|NCT04268498|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25309700|NCT04268498|Antipruritics|antipruritics|mesh-ancestor
25309701|NCT04268498|Dermatologic Agents|dermatologic agents|mesh-ancestor
25309702|NCT04248465|Ravulizumab|ravulizumab|mesh-list
25309703|NCT04248465|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25309704|NCT04248465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25309705|NCT04248465|Immunologic Factors|immunologic factors|mesh-ancestor
25309706|NCT04248465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309707|NCT05245227|Misoprostol|misoprostol|mesh-list
25309708|NCT05245227|Oxytocin|oxytocin|mesh-list
25309709|NCT05245227|Oxytocics|oxytocics|mesh-ancestor
25309710|NCT05245227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25309711|NCT05245227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309712|NCT05245227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25309713|NCT05245227|Abortifacient Agents|abortifacient agents|mesh-ancestor
25309714|NCT05245227|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25309715|NCT05245227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24460870|NCT00349791|Hormones|hormones|mesh-ancestor
24817643|NCT02084732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25309716|NCT05244954|Chloroquine|chloroquine|mesh-list
25309717|NCT05244954|Piperaquine|piperaquine|mesh-list
25309718|NCT05244954|Artenimol|artenimol|mesh-list
25309719|NCT05244954|Amebicides|amebicides|mesh-ancestor
25309720|NCT05244954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25309721|NCT05244954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25309722|NCT05244954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25309723|NCT05244954|Antimalarials|antimalarials|mesh-ancestor
25309724|NCT05244954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25309725|NCT05244837|Paclitaxel|paclitaxel|mesh-list
25309726|NCT05244837|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25309727|NCT05244837|Carboplatin|carboplatin|mesh-list
25309728|NCT05244837|Pemetrexed|pemetrexed|mesh-list
25309729|NCT05244837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25309730|NCT05244837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309731|NCT05244837|Tubulin Modulators|tubulin modulators|mesh-ancestor
25309732|NCT05244837|Antimitotic Agents|antimitotic agents|mesh-ancestor
25309733|NCT05244837|Mitosis Modulators|mitosis modulators|mesh-ancestor
25309734|NCT05244837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309735|NCT05244837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25309736|NCT05244837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25309737|NCT05244837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25309738|NCT05244811|Contraceptive Agents|contraceptive agents|mesh-list
25309739|NCT05244811|Contraceptives, Oral|contraceptives, oral|mesh-list
25309740|NCT05244811|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25309741|NCT05244811|Progestins|progestins|mesh-list
25309743|NCT05244811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25309744|NCT05244811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309745|NCT05244811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25309746|NCT05244811|Hormones|hormones|mesh-ancestor
25309747|NCT05244811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25309748|NCT05244811|Estrogens|estrogens|mesh-ancestor
25309749|NCT05244798|Paclitaxel|paclitaxel|mesh-list
25309750|NCT05244798|Cisplatin|cisplatin|mesh-list
25309751|NCT05244798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25309752|NCT05244798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25648508|NCT01480232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25648509|NCT01480232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648510|NCT01480232|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25648511|NCT01480232|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25648512|NCT01480232|Cholinergic Agents|cholinergic agents|mesh-ancestor
25648513|NCT01480232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25309753|NCT05244798|Tubulin Modulators|tubulin modulators|mesh-ancestor
25309754|NCT05244798|Antimitotic Agents|antimitotic agents|mesh-ancestor
25309755|NCT05244798|Mitosis Modulators|mitosis modulators|mesh-ancestor
25309756|NCT05244798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309757|NCT05244694|Insulin|insulin|mesh-list
25648514|NCT01480232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309766|NCT05244577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25309767|NCT05244577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25309768|NCT05244577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25309769|NCT05244577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25309770|NCT05244577|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25309771|NCT05244577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25309772|NCT05244577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25309773|NCT05244577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309774|NCT05244577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25309775|NCT05244577|Serotonin Agents|serotonin agents|mesh-ancestor
25309776|NCT05244460|Diphenhydramine|diphenhydramine|mesh-list
25309777|NCT05244460|Promethazine|promethazine|mesh-list
25309778|NCT05244460|Droperidol|droperidol|mesh-list
25309779|NCT05244460|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24760460|NCT01758120|Glucocorticoids|glucocorticoids|mesh-ancestor
25309780|NCT05244460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25309781|NCT05244460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25309782|NCT05244460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309783|NCT05244460|Anesthetics, Local|anesthetics, local|mesh-ancestor
25309784|NCT05244460|Anesthetics|anesthetics|mesh-ancestor
25309785|NCT05244460|Sensory System Agents|sensory system agents|mesh-ancestor
25309786|NCT05244460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25309787|NCT05244460|Antiemetics|antiemetics|mesh-ancestor
25309788|NCT05244460|Autonomic Agents|autonomic agents|mesh-ancestor
25309789|NCT05244460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25309790|NCT05244460|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25309791|NCT05244460|Histamine Antagonists|histamine antagonists|mesh-ancestor
25309792|NCT05244460|Histamine Agents|histamine agents|mesh-ancestor
25309793|NCT05244460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25309794|NCT05244460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309795|NCT05244460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25309796|NCT05244460|Antipruritics|antipruritics|mesh-ancestor
25309797|NCT05244460|Dermatologic Agents|dermatologic agents|mesh-ancestor
25309798|NCT05244460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25309799|NCT05244460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25309800|NCT05244460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25309801|NCT05244460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25309802|NCT05244460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25309803|NCT05244460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25309804|NCT05244460|Dopamine Agents|dopamine agents|mesh-ancestor
25309805|NCT05244200|Insulin|insulin|mesh-list
25309806|NCT05244200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25309807|NCT05244200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309808|NCT05244057|Interferons|interferons|mesh-list
25309809|NCT05244057|Tenofovir|tenofovir|mesh-list
25309810|NCT05244057|Interferon-alpha|interferon-alpha|mesh-list
25309811|NCT05244057|Interferon alpha-2|interferon alpha-2|mesh-list
25309812|NCT05244057|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25309813|NCT05244057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309814|NCT05244057|Antiviral Agents|antiviral agents|mesh-ancestor
25309815|NCT05244057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25309816|NCT05244057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25309817|NCT05244057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25309818|NCT05244057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25309819|NCT05244057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309820|NCT05244057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25309821|NCT05244057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25309822|NCT05244057|Immunologic Factors|immunologic factors|mesh-ancestor
25309823|NCT05244057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309832|NCT05243706|Loratadine|loratadine|mesh-list
25309833|NCT05243706|Antipruritics|antipruritics|mesh-ancestor
25309834|NCT05243706|Dermatologic Agents|dermatologic agents|mesh-ancestor
25309845|NCT05243693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309846|NCT05243446|Losartan|losartan|mesh-list
25309847|NCT05243446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25309848|NCT05243446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25309849|NCT05243446|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25309850|NCT05243446|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25309851|NCT05243446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309852|NCT05243355|Endostatins|endostatins|mesh-list
25309853|NCT05243355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309854|NCT05243355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25309855|NCT05243355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25309856|NCT05243355|Growth Substances|growth substances|mesh-ancestor
25309857|NCT05243355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309858|NCT05243355|Growth Inhibitors|growth inhibitors|mesh-ancestor
25309859|NCT05243290|Niacinamide|niacinamide|mesh-list
25309860|NCT05243290|Niacin|niacin|mesh-list
25185063|NCT02831205|Chromium|chromium|mesh-list
25309861|NCT05243290|Nicotinic Acids|nicotinic acids|mesh-list
25309862|NCT05243290|Vitamin B Complex|vitamin b complex|mesh-ancestor
25309863|NCT05243290|Vitamins|vitamins|mesh-ancestor
25309864|NCT05243290|Micronutrients|micronutrients|mesh-ancestor
25309865|NCT05243290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309866|NCT05243290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25825380|NCT00005590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25309867|NCT05243290|Antimetabolites|antimetabolites|mesh-ancestor
25309868|NCT05243290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309869|NCT05243290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25309870|NCT05243290|Vasodilator Agents|vasodilator agents|mesh-ancestor
25309871|NCT05239533|Nivolumab|nivolumab|mesh-list
25309872|NCT05239533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25309873|NCT05239533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25309874|NCT05239533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25309875|NCT05239533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25309876|NCT05239533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309877|NCT05239533|Immunologic Factors|immunologic factors|mesh-ancestor
25309878|NCT05239533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309890|NCT05213650|Methamphetamine|methamphetamine|mesh-list
25309891|NCT05213650|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25309892|NCT05213650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309893|NCT05213650|Sympathomimetics|sympathomimetics|mesh-ancestor
25309894|NCT05213650|Autonomic Agents|autonomic agents|mesh-ancestor
25309895|NCT05213650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25309896|NCT05213650|Dopamine Agents|dopamine agents|mesh-ancestor
25309897|NCT05213650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25309898|NCT05213650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309899|NCT05213650|Adrenergic Agents|adrenergic agents|mesh-ancestor
25309900|NCT05213650|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25309901|NCT05213650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25309902|NCT05213650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25309903|NCT05213650|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25309931|NCT05196945|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25309932|NCT05196945|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25309933|NCT05196945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25309934|NCT05196945|Antacids|antacids|mesh-ancestor
25309935|NCT05196945|Diuretics|diuretics|mesh-ancestor
25309936|NCT05196945|Natriuretic Agents|natriuretic agents|mesh-ancestor
25309937|NCT05196945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309938|NCT05196945|Expectorants|expectorants|mesh-ancestor
25309939|NCT05196945|Respiratory System Agents|respiratory system agents|mesh-ancestor
25309940|NCT05167331|Nitrous Oxide|nitrous oxide|mesh-list
25309941|NCT05167331|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25309942|NCT05167331|Anesthetics, General|anesthetics, general|mesh-ancestor
25309943|NCT05167331|Anesthetics|anesthetics|mesh-ancestor
25309944|NCT05167331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25309945|NCT05167331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309946|NCT05167331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25309947|NCT05167331|Analgesics|analgesics|mesh-ancestor
25309948|NCT05167331|Sensory System Agents|sensory system agents|mesh-ancestor
25309949|NCT05167331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25309950|NCT05160597|Edetic Acid|edetic acid|mesh-list
25309951|NCT05160597|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25309952|NCT05160597|Chelating Agents|chelating agents|mesh-ancestor
25309953|NCT05160597|Sequestering Agents|sequestering agents|mesh-ancestor
25309954|NCT05160597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309955|NCT05160597|Anticoagulants|anticoagulants|mesh-ancestor
25309956|NCT05160597|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25309957|NCT05160597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25309958|NCT05155007|Cyclosporine|cyclosporine|mesh-list
25309963|NCT05155007|Immunologic Factors|immunologic factors|mesh-ancestor
25309964|NCT05155007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25309965|NCT05155007|Antifungal Agents|antifungal agents|mesh-ancestor
25309966|NCT05155007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25309967|NCT05155007|Dermatologic Agents|dermatologic agents|mesh-ancestor
25309968|NCT05155007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25309969|NCT05155007|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25309970|NCT05154903|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
25309971|NCT05154903|Nootropic Agents|nootropic agents|mesh-ancestor
25309972|NCT05129475|Ritonavir|ritonavir|mesh-list
25309973|NCT05129475|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25309974|NCT05129475|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25309975|NCT05129475|Protease Inhibitors|protease inhibitors|mesh-ancestor
25309976|NCT05129475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205596|NCT04511039|Trifluridine|trifluridine|mesh-list
25205597|NCT04511039|Talazoparib|talazoparib|mesh-list
25205598|NCT04511039|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25205599|NCT04511039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205600|NCT04511039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205601|NCT04511039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25205602|NCT04511039|Antimetabolites|antimetabolites|mesh-ancestor
25205603|NCT04511039|Antiviral Agents|antiviral agents|mesh-ancestor
25205604|NCT04511039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25205608|NCT04470674|Carboplatin|carboplatin|mesh-list
25205609|NCT04470674|Pemetrexed|pemetrexed|mesh-list
25309977|NCT05129475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25309978|NCT05129475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25309979|NCT05129475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25309980|NCT05129475|Antiviral Agents|antiviral agents|mesh-ancestor
25309981|NCT05129475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25309982|NCT05129475|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25309983|NCT05129475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24998388|NCT02960646|Rituximab|rituximab|mesh-list
25310033|NCT04860713|Aspirin|aspirin|mesh-list
25310034|NCT04860713|Ketamine|ketamine|mesh-list
25310035|NCT04860713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25310036|NCT04860713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25310037|NCT04860713|Analgesics|analgesics|mesh-ancestor
25310038|NCT04860713|Sensory System Agents|sensory system agents|mesh-ancestor
25310039|NCT04860713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25310040|NCT04860713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310041|NCT04860713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25310042|NCT04860713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25310043|NCT04860713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25310044|NCT04860713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25310045|NCT04860713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310046|NCT04860713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25310047|NCT04860713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25310048|NCT04860713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25310049|NCT04860713|Antipyretics|antipyretics|mesh-ancestor
25310050|NCT04860713|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25310051|NCT04860713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25310052|NCT04860713|Anesthetics, General|anesthetics, general|mesh-ancestor
25310053|NCT04860713|Anesthetics|anesthetics|mesh-ancestor
25310054|NCT04860713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25310055|NCT04860713|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25310056|NCT04860713|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25310057|NCT04860713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25310058|NCT04799015|Dexamethasone|dexamethasone|mesh-list
25310059|NCT04799015|Metoclopramide|metoclopramide|mesh-list
25310060|NCT04799015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25310061|NCT04799015|Antiemetics|antiemetics|mesh-ancestor
25310062|NCT04799015|Autonomic Agents|autonomic agents|mesh-ancestor
25310063|NCT04799015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25310064|NCT04799015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310065|NCT04799015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25310066|NCT04799015|Glucocorticoids|glucocorticoids|mesh-ancestor
25310068|NCT04799015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25310069|NCT04799015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25310070|NCT04799015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310071|NCT04799015|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25310072|NCT04799015|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25310073|NCT04799015|Dopamine Agents|dopamine agents|mesh-ancestor
25310074|NCT04799015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25310075|NCT04799015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310076|NCT04716387|Milbemycin oxime|milbemycin oxime|mesh-list
25310077|NCT04716387|Anthelmintics|anthelmintics|mesh-ancestor
25310078|NCT04716387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25648515|NCT01480258|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25648516|NCT01480258|Immunologic Factors|immunologic factors|mesh-ancestor
25648517|NCT01480258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648518|NCT01480297|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
25648519|NCT01480297|Sodium Salicylate|sodium salicylate|mesh-list
25648520|NCT01480297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25648521|NCT01480297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25648522|NCT01480297|Analgesics|analgesics|mesh-ancestor
25648523|NCT01480297|Sensory System Agents|sensory system agents|mesh-ancestor
25648524|NCT01480297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25310079|NCT04716387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25310080|NCT04701593|Triamcinolone|triamcinolone|mesh-list
25310081|NCT04701593|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25310082|NCT04701593|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25310083|NCT04701593|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25310084|NCT04701593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25310085|NCT04701593|Glucocorticoids|glucocorticoids|mesh-ancestor
25310086|NCT04701593|Hormones|hormones|mesh-ancestor
24475706|NCT00411190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25310087|NCT04701593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25310088|NCT04701593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310089|NCT04701593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25310090|NCT04701593|Immunologic Factors|immunologic factors|mesh-ancestor
25310091|NCT04701593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25310092|NCT04701593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310093|NCT04611529|Ibuprofen|ibuprofen|mesh-list
25310094|NCT04611529|Diclofenac|diclofenac|mesh-list
25310095|NCT04611529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25825381|NCT00005590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25310096|NCT04611529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25310097|NCT04611529|Analgesics|analgesics|mesh-ancestor
25310098|NCT04611529|Sensory System Agents|sensory system agents|mesh-ancestor
25310099|NCT04611529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25310100|NCT04611529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310101|NCT04611529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25310102|NCT04611529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25310103|NCT04611529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25310104|NCT04611529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25310105|NCT04611529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310106|NCT04570332|Pembrolizumab|pembrolizumab|mesh-list
25310107|NCT04570332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25310108|NCT04570332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310109|NCT04552847|Octreotide|octreotide|mesh-list
25310110|NCT04552847|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
25310111|NCT04552847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25310112|NCT04552847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25310113|NCT04552847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310114|NCT04552847|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25310115|NCT04552847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310116|NCT04537078|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25310117|NCT04537078|Contraceptive Agents|contraceptive agents|mesh-list
25310118|NCT04537078|Contraceptives, Oral|contraceptives, oral|mesh-list
25310119|NCT04537078|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25310120|NCT04537078|Cetrorelix|cetrorelix|mesh-list
25310121|NCT04537078|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25310122|NCT04537078|Progesterone|progesterone|mesh-list
25310123|NCT04537078|Dydrogesterone|dydrogesterone|mesh-list
25310124|NCT04537078|Estradiol|estradiol|mesh-list
25310125|NCT04537078|Progestins|progestins|mesh-ancestor
25310126|NCT04537078|Hormones|hormones|mesh-ancestor
25310127|NCT04537078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25310128|NCT04537078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310129|NCT04537078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25310130|NCT04537078|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25310131|NCT04537078|Luteolytic Agents|luteolytic agents|mesh-ancestor
25310134|NCT04537078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310135|NCT04537078|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25310136|NCT04537078|Fertility Agents|fertility agents|mesh-ancestor
25310137|NCT04537078|Hormone Antagonists|hormone antagonists|mesh-ancestor
25310138|NCT04537078|Estrogens|estrogens|mesh-ancestor
25310139|NCT04509401|Vitamins|vitamins|mesh-list
25310140|NCT04509401|Vitamin B 6|vitamin b 6|mesh-list
25310141|NCT04509401|Pyridoxal|pyridoxal|mesh-list
25310142|NCT04509401|Pyridoxine|pyridoxine|mesh-list
25310143|NCT04509401|Vitamin B Complex|vitamin b complex|mesh-list
25310144|NCT04509401|Micronutrients|micronutrients|mesh-ancestor
25310145|NCT04509401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310146|NCT04457596|Trastuzumab|trastuzumab|mesh-list
25310147|NCT04457596|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25310148|NCT04457596|Maytansine|maytansine|mesh-list
25310149|NCT04457596|Tucatinib|tucatinib|mesh-list
25310150|NCT04457596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25310151|NCT04457596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310152|NCT04457596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25310153|NCT04457596|Tubulin Modulators|tubulin modulators|mesh-ancestor
25310154|NCT04457596|Antimitotic Agents|antimitotic agents|mesh-ancestor
25310155|NCT04457596|Mitosis Modulators|mitosis modulators|mesh-ancestor
25310156|NCT04457596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310157|NCT04457596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25310158|NCT04457596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25310162|NCT04430426|Glycolic acid|glycolic acid|mesh-list
25310163|NCT04430426|Keratolytic Agents|keratolytic agents|mesh-ancestor
25310164|NCT04430426|Dermatologic Agents|dermatologic agents|mesh-ancestor
24897727|NCT04422275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24897729|NCT04422275|Autonomic Agents|autonomic agents|mesh-ancestor
25310165|NCT04425252|Brequinar|brequinar|mesh-list
25310166|NCT04425252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310167|NCT04425252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25310168|NCT04425252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310169|NCT04425252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25310170|NCT04425252|Immunologic Factors|immunologic factors|mesh-ancestor
25310171|NCT04425252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310172|NCT04424862|Cyclosporine|cyclosporine|mesh-list
25310173|NCT04424862|Mycophenolic Acid|mycophenolic acid|mesh-list
25310174|NCT04424862|Prednisone|prednisone|mesh-list
25310175|NCT04424862|Cyclosporins|cyclosporins|mesh-list
25310176|NCT04424862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25310177|NCT04424862|Glucocorticoids|glucocorticoids|mesh-ancestor
25310178|NCT04424862|Hormones|hormones|mesh-ancestor
25310179|NCT04424862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25310180|NCT04424862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310181|NCT04424862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25310182|NCT04424862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310183|NCT04424862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25310184|NCT04424862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310185|NCT04424862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25310186|NCT04424862|Immunologic Factors|immunologic factors|mesh-ancestor
25310187|NCT04424862|Antifungal Agents|antifungal agents|mesh-ancestor
25310188|NCT04424862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25310189|NCT04424862|Dermatologic Agents|dermatologic agents|mesh-ancestor
25310190|NCT04424862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25310191|NCT04424862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25310192|NCT04424862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25310193|NCT04424862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25310194|NCT04424862|Antitubercular Agents|antitubercular agents|mesh-ancestor
25310195|NCT04424862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25825382|NCT00005590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25310196|NCT04313166|Copper|copper|mesh-list
25310197|NCT04313166|Trace Elements|trace elements|mesh-ancestor
25310198|NCT04313166|Micronutrients|micronutrients|mesh-ancestor
25310199|NCT04313166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310200|NCT04302766|Remdesivir|remdesivir|mesh-list
25310201|NCT04302766|Antimetabolites|antimetabolites|mesh-ancestor
25310202|NCT04302766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310203|NCT04302766|Antiviral Agents|antiviral agents|mesh-ancestor
25310204|NCT04302766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25310205|NCT04298229|Dapagliflozin|dapagliflozin|mesh-list
25310206|NCT04298229|Diuretics|diuretics|mesh-list
25310509|NCT03408873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25310230|NCT04268849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310231|NCT04268849|Protective Agents|protective agents|mesh-ancestor
25310232|NCT04268849|Hematinics|hematinics|mesh-ancestor
25310233|NCT04268849|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25310234|NCT04268849|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25310235|NCT04183335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
25310236|NCT04183335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25310237|NCT04183335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310238|NCT04140903|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25310239|NCT04140903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25310240|NCT04140903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25310241|NCT04140903|Antitubercular Agents|antitubercular agents|mesh-ancestor
25310242|NCT04133532|Metoprolol|metoprolol|mesh-list
25310243|NCT04133532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25310244|NCT04133532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25310245|NCT04133532|Sympatholytics|sympatholytics|mesh-ancestor
25310246|NCT04133532|Autonomic Agents|autonomic agents|mesh-ancestor
25310247|NCT04133532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25310248|NCT04133532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310249|NCT04133532|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25310250|NCT04133532|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25310251|NCT04133532|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25310252|NCT04133532|Adrenergic Agents|adrenergic agents|mesh-ancestor
25310253|NCT04133532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24899048|NCT04407234|Acetaminophen|acetaminophen|mesh-list
25310254|NCT04133532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310256|NCT04126135|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25310257|NCT04126135|Autonomic Agents|autonomic agents|mesh-ancestor
25310258|NCT04126135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25310259|NCT04126135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310260|NCT04126135|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25310261|NCT04126135|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25310262|NCT04126135|Cholinergic Agents|cholinergic agents|mesh-ancestor
25310263|NCT04126135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25310264|NCT04126135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310265|NCT04115319|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25310266|NCT04115319|Antidepressive Agents|antidepressive agents|mesh-ancestor
25310267|NCT04115319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25310268|NCT04115319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25310269|NCT04115319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25310270|NCT04115319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25310271|NCT04115319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310272|NCT03997448|Pembrolizumab|pembrolizumab|mesh-list
25310273|NCT03997448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25310274|NCT03997448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310275|NCT03962855|Ifetroban|ifetroban|mesh-list
25310276|NCT03962855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25310277|NCT03940326|Levetiracetam|levetiracetam|mesh-list
25310278|NCT03940326|Valproic Acid|valproic acid|mesh-list
25310279|NCT03940326|Anticonvulsants|anticonvulsants|mesh-ancestor
25310280|NCT03940326|Nootropic Agents|nootropic agents|mesh-ancestor
25310281|NCT03940326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25310510|NCT03408873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25310282|NCT03940326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310283|NCT03940326|GABA Agents|gaba agents|mesh-ancestor
25310284|NCT03940326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25310285|NCT03940326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310286|NCT03940326|Antimanic Agents|antimanic agents|mesh-ancestor
25310287|NCT03940326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25310288|NCT03940326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25310289|NCT03940326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25310290|NCT03892018|Paclitaxel|paclitaxel|mesh-list
25310291|NCT03892018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25310292|NCT03892018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310293|NCT03892018|Tubulin Modulators|tubulin modulators|mesh-ancestor
25310294|NCT03892018|Antimitotic Agents|antimitotic agents|mesh-ancestor
25310295|NCT03892018|Mitosis Modulators|mitosis modulators|mesh-ancestor
25310296|NCT03892018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310297|NCT03885921|Atorvastatin|atorvastatin|mesh-list
25310298|NCT03885921|Simvastatin|simvastatin|mesh-list
25310299|NCT03885921|Ezetimibe|ezetimibe|mesh-list
25310300|NCT03885921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25310301|NCT03885921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25310302|NCT03885921|Antimetabolites|antimetabolites|mesh-ancestor
25310303|NCT03885921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310304|NCT03885921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25310305|NCT03885921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25310306|NCT03885921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25310307|NCT03884452|Atorvastatin|atorvastatin|mesh-list
25310308|NCT03884452|Simvastatin|simvastatin|mesh-list
25310309|NCT03884452|Ezetimibe|ezetimibe|mesh-list
25310310|NCT03884452|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25310311|NCT03884452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25310312|NCT03884452|Antimetabolites|antimetabolites|mesh-ancestor
25310313|NCT03884452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310314|NCT03884452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25310315|NCT03884452|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25310316|NCT03884452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25310317|NCT03882996|Atorvastatin|atorvastatin|mesh-list
25310318|NCT03882996|Ezetimibe|ezetimibe|mesh-list
25310319|NCT03882996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25310320|NCT03882996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25310321|NCT03882996|Antimetabolites|antimetabolites|mesh-ancestor
25310322|NCT03882996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310323|NCT03882996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25310324|NCT03882996|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25310325|NCT03882996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25310326|NCT03882905|Ezetimibe|ezetimibe|mesh-list
25310327|NCT03882905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25310328|NCT03882905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25310329|NCT03882905|Antimetabolites|antimetabolites|mesh-ancestor
25310330|NCT03882905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310331|NCT03882905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25310332|NCT03882892|Ezetimibe|ezetimibe|mesh-list
25310333|NCT03882892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25310334|NCT03882892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25310335|NCT03882892|Antimetabolites|antimetabolites|mesh-ancestor
25310336|NCT03882892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310337|NCT03882892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25310338|NCT03875313|Talazoparib|talazoparib|mesh-list
25310339|NCT03875313|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25310340|NCT03875313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25310341|NCT03875313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310342|NCT03875313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310343|NCT03867318|Atorvastatin|atorvastatin|mesh-list
25310344|NCT03867318|Ezetimibe|ezetimibe|mesh-list
25310345|NCT03867318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25310346|NCT03867318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25310347|NCT03867318|Antimetabolites|antimetabolites|mesh-ancestor
25310348|NCT03867318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310349|NCT03867318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25310350|NCT03867318|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25310351|NCT03867318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25310352|NCT03867188|Bupivacaine|bupivacaine|mesh-list
25310353|NCT03867188|Anesthetics, Local|anesthetics, local|mesh-ancestor
25310354|NCT03867188|Anesthetics|anesthetics|mesh-ancestor
25310355|NCT03867188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25310356|NCT03867188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310415|NCT03713944|Bevacizumab|bevacizumab|mesh-list
25310416|NCT03713944|Carboplatin|carboplatin|mesh-list
25310417|NCT03713944|Pemetrexed|pemetrexed|mesh-list
25310418|NCT03713944|Atezolizumab|atezolizumab|mesh-list
25310419|NCT03713944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25310420|NCT03713944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310421|NCT03713944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25310422|NCT03713944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25310423|NCT03713944|Growth Substances|growth substances|mesh-ancestor
25310424|NCT03713944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310425|NCT03713944|Growth Inhibitors|growth inhibitors|mesh-ancestor
25310426|NCT03713944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25310427|NCT03713944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310428|NCT03713944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25310429|NCT03713944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25310430|NCT03708224|Atezolizumab|atezolizumab|mesh-list
25310431|NCT03708224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310436|NCT03681561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25310437|NCT03681561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310438|NCT03681561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25310439|NCT03681561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310440|NCT03639246|Paclitaxel|paclitaxel|mesh-list
25310441|NCT03639246|Doxorubicin|doxorubicin|mesh-list
25310442|NCT03639246|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25310443|NCT03639246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25310444|NCT03639246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310445|NCT03639246|Tubulin Modulators|tubulin modulators|mesh-ancestor
25310446|NCT03639246|Antimitotic Agents|antimitotic agents|mesh-ancestor
25310447|NCT03639246|Mitosis Modulators|mitosis modulators|mesh-ancestor
25310448|NCT03639246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310449|NCT03639246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25310450|NCT03639246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25310451|NCT03639246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25310452|NCT03639246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25310453|NCT03498378|Cetuximab|cetuximab|mesh-list
25310454|NCT03498378|Avelumab|avelumab|mesh-list
25310455|NCT03498378|Palbociclib|palbociclib|mesh-list
25310456|NCT03498378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25310457|NCT03498378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310458|NCT03498378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25310459|NCT03498378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25310460|NCT03498378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310461|NCT03466801|Prednisone|prednisone|mesh-list
25310462|NCT03466801|Glucocorticoids|glucocorticoids|mesh-list
25310463|NCT03466801|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25310464|NCT03466801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25310465|NCT03466801|Hormones|hormones|mesh-ancestor
25310549|NCT03332667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310466|NCT03466801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25310467|NCT03466801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310468|NCT03466801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25310469|NCT03466801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310470|NCT03466801|Immunologic Factors|immunologic factors|mesh-ancestor
25310471|NCT03466450|Temozolomide|temozolomide|mesh-list
25310472|NCT03466450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25310473|NCT03466450|Alkylating Agents|alkylating agents|mesh-ancestor
25310474|NCT03466450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310475|NCT03466450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310476|NCT03449888|Calcium, Dietary|calcium, dietary|mesh-list
25310478|NCT03449888|Regadenoson|regadenoson|mesh-list
25310479|NCT03449888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25310480|NCT03449888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310481|NCT03449888|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25310482|NCT03449888|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25310483|NCT03449888|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25310484|NCT03449888|Purinergic Agonists|purinergic agonists|mesh-ancestor
25310485|NCT03449888|Purinergic Agents|purinergic agents|mesh-ancestor
25310486|NCT03449888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25310487|NCT03449888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310488|NCT03415854|Gemcitabine|gemcitabine|mesh-list
25310489|NCT03415854|Paclitaxel|paclitaxel|mesh-list
25310490|NCT03415854|Cisplatin|cisplatin|mesh-list
25310491|NCT03415854|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25310492|NCT03415854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25310493|NCT03415854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310494|NCT03415854|Tubulin Modulators|tubulin modulators|mesh-ancestor
25310495|NCT03415854|Antimitotic Agents|antimitotic agents|mesh-ancestor
25310496|NCT03415854|Mitosis Modulators|mitosis modulators|mesh-ancestor
25310497|NCT03415854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310498|NCT03415854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25310499|NCT03415854|Antimetabolites|antimetabolites|mesh-ancestor
25310500|NCT03415854|Antiviral Agents|antiviral agents|mesh-ancestor
25310501|NCT03415854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25310502|NCT03415854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25310503|NCT03415854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25310504|NCT03415854|Immunologic Factors|immunologic factors|mesh-ancestor
25310505|NCT03415854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310506|NCT03408873|Aripiprazole|aripiprazole|mesh-list
25310507|NCT03408873|Antidepressive Agents|antidepressive agents|mesh-ancestor
25310508|NCT03408873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25310517|NCT03408873|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25310518|NCT03408873|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25310519|NCT03408873|Serotonin Agents|serotonin agents|mesh-ancestor
25310520|NCT03408873|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25310521|NCT03408873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25310522|NCT03408873|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25310523|NCT03408873|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25310524|NCT03396471|Pembrolizumab|pembrolizumab|mesh-list
25310525|NCT03396471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25310526|NCT03396471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310527|NCT03375645|Analgesics, Opioid|analgesics, opioid|mesh-list
25310528|NCT03375645|Narcotics|narcotics|mesh-ancestor
25310529|NCT03375645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25310530|NCT03375645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310531|NCT03375645|Analgesics|analgesics|mesh-ancestor
25310532|NCT03375645|Sensory System Agents|sensory system agents|mesh-ancestor
25310533|NCT03375645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25310534|NCT03363763|Sirolimus|sirolimus|mesh-list
25310535|NCT03363763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25310536|NCT03363763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25310537|NCT03363763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25310538|NCT03363763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310539|NCT03363763|Antifungal Agents|antifungal agents|mesh-ancestor
25310540|NCT03363763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25310541|NCT03363763|Immunologic Factors|immunologic factors|mesh-ancestor
25310542|NCT03363763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310543|NCT03332667|Vorinostat|vorinostat|mesh-list
25310544|NCT03332667|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
25310545|NCT03332667|Dinutuximab|dinutuximab|mesh-list
25310546|NCT03332667|Sargramostim|sargramostim|mesh-list
25310547|NCT03332667|Immunologic Factors|immunologic factors|mesh-ancestor
25310548|NCT03332667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310550|NCT03332667|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25310551|NCT03332667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25310552|NCT03332667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310553|NCT03332667|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25310554|NCT03321045|Trastuzumab|trastuzumab|mesh-list
25310555|NCT03321045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25310556|NCT03321045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310558|NCT03308396|Guadecitabine|guadecitabine|mesh-list
25310559|NCT03308396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25310560|NCT03308396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310567|NCT03283761|Leucovorin|leucovorin|mesh-list
25310568|NCT03283761|Paclitaxel|paclitaxel|mesh-list
25310569|NCT03283761|Fluorouracil|fluorouracil|mesh-list
25310570|NCT03283761|Oxaliplatin|oxaliplatin|mesh-list
25310571|NCT03283761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25310572|NCT03283761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310573|NCT03283761|Tubulin Modulators|tubulin modulators|mesh-ancestor
25310574|NCT03283761|Antimitotic Agents|antimitotic agents|mesh-ancestor
25310575|NCT03283761|Mitosis Modulators|mitosis modulators|mesh-ancestor
25310576|NCT03283761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310577|NCT03283761|Antimetabolites|antimetabolites|mesh-ancestor
25310578|NCT03283761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25310579|NCT03283761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25310580|NCT03283761|Immunologic Factors|immunologic factors|mesh-ancestor
25310581|NCT03283761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310582|NCT03283761|Antidotes|antidotes|mesh-ancestor
25310583|NCT03283761|Protective Agents|protective agents|mesh-ancestor
25310584|NCT03283761|Vitamin B Complex|vitamin b complex|mesh-ancestor
25310585|NCT03283761|Vitamins|vitamins|mesh-ancestor
25310586|NCT03283761|Micronutrients|micronutrients|mesh-ancestor
25310602|NCT03221400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310603|NCT03221400|Antidotes|antidotes|mesh-ancestor
25310604|NCT03221400|Protective Agents|protective agents|mesh-ancestor
25310605|NCT03221400|Vitamin B Complex|vitamin b complex|mesh-ancestor
25310607|NCT03221400|Micronutrients|micronutrients|mesh-ancestor
25310608|NCT03221400|Hematinics|hematinics|mesh-ancestor
25310609|NCT03221400|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25310610|NCT03221400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25310615|NCT03138720|Gemcitabine|gemcitabine|mesh-list
25310616|NCT03138720|Paclitaxel|paclitaxel|mesh-list
25310617|NCT03138720|Cisplatin|cisplatin|mesh-list
25310618|NCT03138720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25310619|NCT03138720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25310620|NCT03138720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310621|NCT03138720|Tubulin Modulators|tubulin modulators|mesh-ancestor
25310622|NCT03138720|Antimitotic Agents|antimitotic agents|mesh-ancestor
25310623|NCT03138720|Mitosis Modulators|mitosis modulators|mesh-ancestor
25310624|NCT03138720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310625|NCT03138720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25310626|NCT03138720|Antimetabolites|antimetabolites|mesh-ancestor
25310627|NCT03138720|Antiviral Agents|antiviral agents|mesh-ancestor
25310628|NCT03138720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25310629|NCT03138720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25310630|NCT03138720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25310631|NCT03138720|Immunologic Factors|immunologic factors|mesh-ancestor
25310632|NCT03138720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310633|NCT03137888|Temozolomide|temozolomide|mesh-list
25310634|NCT03137888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25310635|NCT03137888|Alkylating Agents|alkylating agents|mesh-ancestor
25310636|NCT03137888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310637|NCT03137888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310638|NCT03136809|Copper|copper|mesh-list
25310639|NCT03136809|Trace Elements|trace elements|mesh-ancestor
25310640|NCT03136809|Micronutrients|micronutrients|mesh-ancestor
25310641|NCT03136809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310654|NCT03107988|Cyclophosphamide|cyclophosphamide|mesh-list
25310655|NCT03107988|Topotecan|topotecan|mesh-list
25310656|NCT03107988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25310657|NCT03107988|Immunologic Factors|immunologic factors|mesh-ancestor
25310658|NCT03107988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310659|NCT03107988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25310660|NCT03107988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25310661|NCT03107988|Alkylating Agents|alkylating agents|mesh-ancestor
25310662|NCT03107988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310663|NCT03107988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310664|NCT03107988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25310665|NCT03107988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25310666|NCT03107988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25310667|NCT03107988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25310668|NCT03096288|Evolocumab|evolocumab|mesh-list
25310669|NCT03096288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25310670|NCT03096288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25310671|NCT03096288|Antimetabolites|antimetabolites|mesh-ancestor
25310672|NCT03096288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310673|NCT03096288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25310674|NCT03081156|Glycopyrrolate|glycopyrrolate|mesh-list
25310675|NCT03081156|Formoterol Fumarate|formoterol fumarate|mesh-list
25310676|NCT03081156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25310677|NCT03081156|Autonomic Agents|autonomic agents|mesh-ancestor
25310678|NCT03081156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25310679|NCT03081156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310680|NCT03081156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25310681|NCT03081156|Respiratory System Agents|respiratory system agents|mesh-ancestor
25310682|NCT03081156|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25310683|NCT03081156|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25310684|NCT03081156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25310685|NCT03081156|Adrenergic Agents|adrenergic agents|mesh-ancestor
25310686|NCT03081156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25310687|NCT03081156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310688|NCT03081156|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25310689|NCT03081156|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25310690|NCT03081156|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25310691|NCT03081156|Cholinergic Agents|cholinergic agents|mesh-ancestor
25310692|NCT02919436|Tamsulosin|tamsulosin|mesh-list
25310693|NCT02919436|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25310694|NCT02919436|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25310695|NCT02919436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25310696|NCT02919436|Adrenergic Agents|adrenergic agents|mesh-ancestor
25310697|NCT02919436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25310698|NCT02919436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310699|NCT02919436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310700|NCT02919436|Urological Agents|urological agents|mesh-ancestor
25310701|NCT02879136|Methylphenidate|methylphenidate|mesh-list
25310702|NCT02879136|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25310703|NCT02879136|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25310704|NCT02879136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310705|NCT02879136|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25310706|NCT02879136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25310707|NCT02879136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25310708|NCT02879136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310709|NCT02879136|Dopamine Agents|dopamine agents|mesh-ancestor
25310710|NCT02879136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25310711|NCT02879136|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25310712|NCT02879136|Adrenergic Agents|adrenergic agents|mesh-ancestor
24474187|NCT00405210|Sorafenib|sorafenib|mesh-list
25310713|NCT02875314|Cyclophosphamide|cyclophosphamide|mesh-list
25310714|NCT02875314|Thiotepa|thiotepa|mesh-list
25310715|NCT02875314|Cisplatin|cisplatin|mesh-list
25310716|NCT02875314|Carboplatin|carboplatin|mesh-list
25310717|NCT02875314|Methotrexate|methotrexate|mesh-list
25310718|NCT02875314|Etoposide|etoposide|mesh-list
25310719|NCT02875314|Etoposide phosphate|etoposide phosphate|mesh-list
25310720|NCT02875314|Vincristine|vincristine|mesh-list
25310721|NCT02875314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25310722|NCT02875314|Immunologic Factors|immunologic factors|mesh-ancestor
25310723|NCT02875314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310724|NCT02875314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25310725|NCT02875314|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25310726|NCT02875314|Alkylating Agents|alkylating agents|mesh-ancestor
25310727|NCT02875314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310728|NCT02875314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310729|NCT02875314|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25310730|NCT02875314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25310731|NCT02875314|Abortifacient Agents|abortifacient agents|mesh-ancestor
25310732|NCT02875314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25310733|NCT02875314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25310734|NCT02875314|Antimetabolites|antimetabolites|mesh-ancestor
25310735|NCT02875314|Dermatologic Agents|dermatologic agents|mesh-ancestor
25310736|NCT02875314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25310737|NCT02875314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25310738|NCT02875314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25825383|NCT00005590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25310739|NCT02875314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25310740|NCT02875314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25310741|NCT02875314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25310742|NCT02875314|Tubulin Modulators|tubulin modulators|mesh-ancestor
25310743|NCT02875314|Antimitotic Agents|antimitotic agents|mesh-ancestor
25310744|NCT02875314|Mitosis Modulators|mitosis modulators|mesh-ancestor
25310745|NCT02875132|Pembrolizumab|pembrolizumab|mesh-list
25310746|NCT02875132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25310747|NCT02875132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310748|NCT02178436|Gemcitabine|gemcitabine|mesh-list
25310749|NCT02178436|Paclitaxel|paclitaxel|mesh-list
25310750|NCT02178436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25310751|NCT02178436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25310752|NCT02178436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310753|NCT02178436|Tubulin Modulators|tubulin modulators|mesh-ancestor
25310754|NCT02178436|Antimitotic Agents|antimitotic agents|mesh-ancestor
25310755|NCT02178436|Mitosis Modulators|mitosis modulators|mesh-ancestor
25310756|NCT02178436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310757|NCT02178436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25310758|NCT02178436|Antimetabolites|antimetabolites|mesh-ancestor
25310759|NCT02178436|Antiviral Agents|antiviral agents|mesh-ancestor
25310760|NCT02178436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25310761|NCT02178436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25310762|NCT02178436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25310763|NCT02178436|Immunologic Factors|immunologic factors|mesh-ancestor
25310764|NCT02178436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310765|NCT02135484|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25310766|NCT02135484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310767|NCT02086604|Lenalidomide|lenalidomide|mesh-list
25310768|NCT02086604|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25310769|NCT02086604|Immunologic Factors|immunologic factors|mesh-ancestor
25310770|NCT02086604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310771|NCT02086604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25310772|NCT02086604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25310773|NCT02086604|Growth Substances|growth substances|mesh-ancestor
25310774|NCT02086604|Growth Inhibitors|growth inhibitors|mesh-ancestor
25310775|NCT02086604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310776|NCT02086604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25310777|NCT01983774|Esomeprazole|esomeprazole|mesh-list
25310778|NCT01983774|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25310779|NCT01983774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25310780|NCT01983774|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25310781|NCT01983774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25310782|NCT01983774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310783|NCT01970865|Crizotinib|crizotinib|mesh-list
25825384|NCT00005590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063422|NCT01453101|Fludarabine phosphate|fludarabine phosphate|mesh-list
25063424|NCT01453101|Melphalan|melphalan|mesh-list
24898934|NCT04409483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25310784|NCT01970865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310785|NCT01970865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25310786|NCT01970865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25310787|NCT01970865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310788|NCT01554410|Gemcitabine|gemcitabine|mesh-list
25310789|NCT01554410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310790|NCT01554410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25310791|NCT01554410|Antimetabolites|antimetabolites|mesh-ancestor
25310792|NCT01554410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310793|NCT01554410|Antiviral Agents|antiviral agents|mesh-ancestor
25310794|NCT01554410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25310795|NCT01554410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25310796|NCT01554410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25310797|NCT01554410|Immunologic Factors|immunologic factors|mesh-ancestor
25310798|NCT01554410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310799|NCT01499888|Sirolimus|sirolimus|mesh-list
25310800|NCT01499888|Alemtuzumab|alemtuzumab|mesh-list
25310801|NCT01499888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25310802|NCT01499888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25310803|NCT01499888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25310804|NCT01499888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25310805|NCT01499888|Antifungal Agents|antifungal agents|mesh-ancestor
25310806|NCT01499888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25310807|NCT01499888|Immunologic Factors|immunologic factors|mesh-ancestor
25310808|NCT01499888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311017|NCT00651404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25310809|NCT01499888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25310810|NCT00867191|Desloratadine|desloratadine|mesh-list
25310811|NCT00867191|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25310812|NCT00867191|Cholinergic Agents|cholinergic agents|mesh-ancestor
25310813|NCT00867191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25310814|NCT00867191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310815|NCT00867191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310816|NCT00867191|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25310817|NCT00867191|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25310818|NCT00867191|Histamine Antagonists|histamine antagonists|mesh-ancestor
25310819|NCT00867191|Histamine Agents|histamine agents|mesh-ancestor
25310820|NCT00835094|Mometasone Furoate|mometasone furoate|mesh-list
25310821|NCT00835094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25310822|NCT00835094|Dermatologic Agents|dermatologic agents|mesh-ancestor
25310823|NCT00835094|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25310824|NCT00834119|Mometasone Furoate|mometasone furoate|mesh-list
25310825|NCT00834119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25310826|NCT00834119|Dermatologic Agents|dermatologic agents|mesh-ancestor
25310827|NCT00834119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25310828|NCT00805584|Desloratadine|desloratadine|mesh-list
25310829|NCT00805584|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25310830|NCT00805584|Cholinergic Agents|cholinergic agents|mesh-ancestor
25310831|NCT00805584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25310832|NCT00805584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310833|NCT00805584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310834|NCT00805584|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25310835|NCT00805584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25310836|NCT00805584|Histamine Antagonists|histamine antagonists|mesh-ancestor
25310837|NCT00805584|Histamine Agents|histamine agents|mesh-ancestor
25310838|NCT00795522|Desloratadine|desloratadine|mesh-list
25310839|NCT00795522|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25310840|NCT00795522|Cholinergic Agents|cholinergic agents|mesh-ancestor
25310841|NCT00795522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25310842|NCT00795522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310843|NCT00795522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310844|NCT00795522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25310845|NCT00795522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25310846|NCT00795522|Histamine Antagonists|histamine antagonists|mesh-ancestor
25310847|NCT00795522|Histamine Agents|histamine agents|mesh-ancestor
25310848|NCT00795158|Desloratadine|desloratadine|mesh-list
25310849|NCT00795158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25825385|NCT00005590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825386|NCT00005590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25825387|NCT00005590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25825388|NCT00005591|Gemcitabine|gemcitabine|mesh-list
25825389|NCT00005591|Cetuximab|cetuximab|mesh-list
25829666|NCT00006247|Growth Substances|growth substances|mesh-ancestor
24517291|NCT00607152|Allopurinol|allopurinol|mesh-list
24517292|NCT00607152|Rasburicase|rasburicase|mesh-list
25310850|NCT00795158|Cholinergic Agents|cholinergic agents|mesh-ancestor
25310851|NCT00795158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25310852|NCT00795158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310853|NCT00795158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310854|NCT00795158|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25310855|NCT00795158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25310856|NCT00795158|Histamine Antagonists|histamine antagonists|mesh-ancestor
24907888|NCT04326868|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
25310857|NCT00795158|Histamine Agents|histamine agents|mesh-ancestor
25310858|NCT00794846|Cetirizine|cetirizine|mesh-list
25310859|NCT00794846|Desloratadine|desloratadine|mesh-list
25310860|NCT00794846|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25310861|NCT00794846|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25310862|NCT00794846|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25310863|NCT00794846|Histamine Antagonists|histamine antagonists|mesh-ancestor
25310864|NCT00794846|Histamine Agents|histamine agents|mesh-ancestor
25310865|NCT00794846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25310866|NCT00794846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310867|NCT00794846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310868|NCT00794846|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25310869|NCT00794846|Cholinergic Agents|cholinergic agents|mesh-ancestor
25310870|NCT00794768|Fexofenadine|fexofenadine|mesh-list
25310871|NCT00794768|Desloratadine|desloratadine|mesh-list
25310872|NCT00794768|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25310873|NCT00794768|Cholinergic Agents|cholinergic agents|mesh-ancestor
25310874|NCT00794768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25310875|NCT00794768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310876|NCT00794768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310877|NCT00794768|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25310878|NCT00794768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25310879|NCT00794768|Histamine Antagonists|histamine antagonists|mesh-ancestor
25310880|NCT00794768|Histamine Agents|histamine agents|mesh-ancestor
25310881|NCT00794768|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25310882|NCT00794599|Cetirizine|cetirizine|mesh-list
25310883|NCT00794599|Desloratadine|desloratadine|mesh-list
25310884|NCT00794599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25310885|NCT00794599|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25310886|NCT00794599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25310887|NCT00794599|Histamine Antagonists|histamine antagonists|mesh-ancestor
25310888|NCT00794599|Histamine Agents|histamine agents|mesh-ancestor
25310889|NCT00794599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25310890|NCT00794599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310891|NCT00794599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310892|NCT00794599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25310893|NCT00794599|Cholinergic Agents|cholinergic agents|mesh-ancestor
25310894|NCT00794495|Cetirizine|cetirizine|mesh-list
25310895|NCT00794495|Desloratadine|desloratadine|mesh-list
25310896|NCT00794495|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25310897|NCT00794495|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25310898|NCT00794495|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25310899|NCT00794495|Histamine Antagonists|histamine antagonists|mesh-ancestor
25310900|NCT00794495|Histamine Agents|histamine agents|mesh-ancestor
25310901|NCT00794495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25310902|NCT00794495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310903|NCT00794495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310904|NCT00794495|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25310905|NCT00794495|Cholinergic Agents|cholinergic agents|mesh-ancestor
25310906|NCT00794248|Fexofenadine|fexofenadine|mesh-list
25310907|NCT00794248|Desloratadine|desloratadine|mesh-list
25310908|NCT00794248|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25310909|NCT00794248|Cholinergic Agents|cholinergic agents|mesh-ancestor
25310910|NCT00794248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25310911|NCT00794248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310912|NCT00794248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310913|NCT00794248|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25310914|NCT00794248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25310915|NCT00794248|Histamine Antagonists|histamine antagonists|mesh-ancestor
25310916|NCT00794248|Histamine Agents|histamine agents|mesh-ancestor
25310917|NCT00794248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25310918|NCT00783354|Loratadine|loratadine|mesh-list
25310919|NCT00783354|Desloratadine|desloratadine|mesh-list
25310920|NCT00783354|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25109191|NCT03126656|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25310921|NCT00783354|Cholinergic Agents|cholinergic agents|mesh-ancestor
25310922|NCT00783354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25310923|NCT00783354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310924|NCT00783354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310925|NCT00783354|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25310926|NCT00783354|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25310927|NCT00783354|Histamine Antagonists|histamine antagonists|mesh-ancestor
25310928|NCT00783354|Histamine Agents|histamine agents|mesh-ancestor
25310929|NCT00783354|Antipruritics|antipruritics|mesh-ancestor
25310930|NCT00783354|Dermatologic Agents|dermatologic agents|mesh-ancestor
25310931|NCT00783354|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25310932|NCT00783237|Mometasone Furoate|mometasone furoate|mesh-list
25310933|NCT00783237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25310934|NCT00783237|Dermatologic Agents|dermatologic agents|mesh-ancestor
25310935|NCT00783237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25310936|NCT00783133|Fexofenadine|fexofenadine|mesh-list
25310937|NCT00783133|Desloratadine|desloratadine|mesh-list
25310938|NCT00783133|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25310939|NCT00783133|Cholinergic Agents|cholinergic agents|mesh-ancestor
25310940|NCT00783133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25310941|NCT00783133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310942|NCT00783133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310943|NCT00783133|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25310944|NCT00783133|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25310945|NCT00783133|Histamine Antagonists|histamine antagonists|mesh-ancestor
25310946|NCT00783133|Histamine Agents|histamine agents|mesh-ancestor
25310947|NCT00783133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25310948|NCT00779636|Desloratadine|desloratadine|mesh-list
25185841|NCT02824965|Pembrolizumab|pembrolizumab|mesh-list
25310949|NCT00779636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25310951|NCT00779636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25310952|NCT00779636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310953|NCT00779636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310954|NCT00779636|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25310955|NCT00779636|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25310956|NCT00779636|Histamine Antagonists|histamine antagonists|mesh-ancestor
25310957|NCT00779636|Histamine Agents|histamine agents|mesh-ancestor
25310958|NCT00763529|Fluticasone|fluticasone|mesh-list
25310959|NCT00763529|Mometasone Furoate|mometasone furoate|mesh-list
25310960|NCT00763529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25310961|NCT00763529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25310962|NCT00763529|Autonomic Agents|autonomic agents|mesh-ancestor
25310963|NCT00763529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25310964|NCT00763529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310965|NCT00763529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25310966|NCT00763529|Respiratory System Agents|respiratory system agents|mesh-ancestor
25310967|NCT00763529|Dermatologic Agents|dermatologic agents|mesh-ancestor
25310968|NCT00763529|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25310969|NCT00757562|Desloratadine|desloratadine|mesh-list
25310970|NCT00757562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25310971|NCT00757562|Cholinergic Agents|cholinergic agents|mesh-ancestor
25310972|NCT00757562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25310973|NCT00757562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25310974|NCT00757562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25310975|NCT00757562|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25310976|NCT00757562|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25310977|NCT00757562|Histamine Antagonists|histamine antagonists|mesh-ancestor
25310978|NCT00757562|Histamine Agents|histamine agents|mesh-ancestor
25310979|NCT00751075|Mometasone Furoate|mometasone furoate|mesh-list
25310980|NCT00751075|Amoxicillin|amoxicillin|mesh-list
25310981|NCT00751075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25310982|NCT00751075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25310983|NCT00751075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25310984|NCT00751075|Dermatologic Agents|dermatologic agents|mesh-ancestor
25310985|NCT00751075|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25310986|NCT00750750|Mometasone Furoate|mometasone furoate|mesh-list
25310987|NCT00750750|Amoxicillin|amoxicillin|mesh-list
24887368|NCT04517188|Iodine|iodine|mesh-list
24825966|NCT02131298|Palbociclib|palbociclib|mesh-list
25825390|NCT00005591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24517699|NCT00609401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517700|NCT00609401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899115|NCT04407000|Favipiravir|favipiravir|mesh-list
25310988|NCT00750750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25310989|NCT00750750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25310990|NCT00750750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25310991|NCT00750750|Dermatologic Agents|dermatologic agents|mesh-ancestor
25310992|NCT00750750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25310993|NCT00731185|Mometasone Furoate|mometasone furoate|mesh-list
25310994|NCT00731185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25310995|NCT00731185|Dermatologic Agents|dermatologic agents|mesh-ancestor
25310996|NCT00731185|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25310997|NCT00653835|Simvastatin|simvastatin|mesh-list
25310998|NCT00653835|Ezetimibe|ezetimibe|mesh-list
25310999|NCT00653835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25311000|NCT00653835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25311001|NCT00653835|Antimetabolites|antimetabolites|mesh-ancestor
25311002|NCT00653835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311003|NCT00653835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25311004|NCT00653835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25311005|NCT00653835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311006|NCT00653796|Atorvastatin|atorvastatin|mesh-list
25311007|NCT00653796|Ezetimibe|ezetimibe|mesh-list
25311008|NCT00653796|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25311009|NCT00653796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25311010|NCT00653796|Antimetabolites|antimetabolites|mesh-ancestor
25311011|NCT00653796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311012|NCT00653796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25311013|NCT00653796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25311014|NCT00653796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311015|NCT00651404|Ezetimibe|ezetimibe|mesh-list
25311016|NCT00651404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25648525|NCT01480297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648526|NCT01480297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25185883|NCT02824536|Immunoglobulins|immunoglobulins|mesh-list
25185884|NCT02824536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25185885|NCT02824536|Immunologic Factors|immunologic factors|mesh-ancestor
25185886|NCT02824536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311018|NCT00651404|Antimetabolites|antimetabolites|mesh-ancestor
25311019|NCT00651404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311020|NCT00651404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25311021|NCT00651391|Simvastatin|simvastatin|mesh-list
25311022|NCT00651391|Ezetimibe|ezetimibe|mesh-list
25311023|NCT00651391|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25311024|NCT00651391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25311025|NCT00651391|Antimetabolites|antimetabolites|mesh-ancestor
25311026|NCT00651391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311027|NCT00651391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25311028|NCT00651391|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25311029|NCT00651391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311030|NCT00651144|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25311031|NCT00651144|Ezetimibe|ezetimibe|mesh-list
25311032|NCT00651144|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25311033|NCT00651144|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25311034|NCT00651144|Antimetabolites|antimetabolites|mesh-ancestor
25311035|NCT00651144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311036|NCT00651144|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25311037|NCT00651144|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25311038|NCT00651144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311039|NCT00651014|Ezetimibe|ezetimibe|mesh-list
25311040|NCT00651014|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25311041|NCT00651014|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25311042|NCT00651014|Antimetabolites|antimetabolites|mesh-ancestor
25311043|NCT00651014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311044|NCT00651014|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25311045|NCT00650689|Atorvastatin|atorvastatin|mesh-list
25311046|NCT00650689|Ezetimibe|ezetimibe|mesh-list
25311047|NCT00650689|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25311048|NCT00650689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25311049|NCT00650689|Antimetabolites|antimetabolites|mesh-ancestor
25311050|NCT00650689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311051|NCT00650689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25311052|NCT00650689|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25311053|NCT00650689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311054|NCT00650663|Simvastatin|simvastatin|mesh-list
25311055|NCT00650663|Ezetimibe|ezetimibe|mesh-list
25311056|NCT00650663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24480753|NCT00432055|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24899265|NCT04405271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24899266|NCT04405271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24899267|NCT04405271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899268|NCT04405271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899269|NCT04405271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25311057|NCT00650663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25311058|NCT00650663|Antimetabolites|antimetabolites|mesh-ancestor
25311059|NCT00650663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311060|NCT00650663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25311061|NCT00650663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25311062|NCT00650663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311063|NCT00589420|Docetaxel|docetaxel|mesh-list
25311064|NCT00589420|Sorafenib|sorafenib|mesh-list
25311065|NCT00589420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25311066|NCT00589420|Tubulin Modulators|tubulin modulators|mesh-ancestor
25311067|NCT00589420|Antimitotic Agents|antimitotic agents|mesh-ancestor
25311068|NCT00589420|Mitosis Modulators|mitosis modulators|mesh-ancestor
25311069|NCT00589420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311070|NCT00589420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25311071|NCT00589420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311072|NCT00552097|Simvastatin|simvastatin|mesh-list
25311073|NCT00552097|Ezetimibe|ezetimibe|mesh-list
25311074|NCT00552097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25311075|NCT00552097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25311076|NCT00552097|Antimetabolites|antimetabolites|mesh-ancestor
25311077|NCT00552097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311078|NCT00552097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25648527|NCT01480297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25648528|NCT01480297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25648529|NCT01480297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25648530|NCT01480297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185956|NCT02824094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185957|NCT02824315|Simeprevir|simeprevir|mesh-list
25185958|NCT02824315|Odalasvir|odalasvir|mesh-list
25185959|NCT02824315|Antiviral Agents|antiviral agents|mesh-ancestor
25185960|NCT02824315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25185961|NCT02824315|Protease Inhibitors|protease inhibitors|mesh-ancestor
25185962|NCT02824315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185964|NCT02824406|Acetazolamide|acetazolamide|mesh-list
25311079|NCT00552097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25311080|NCT00552097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311081|NCT00398294|Simvastatin|simvastatin|mesh-list
25311082|NCT00398294|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25311083|NCT00398294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25311084|NCT00398294|Antimetabolites|antimetabolites|mesh-ancestor
25311085|NCT00398294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311086|NCT00398294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25311087|NCT00398294|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25311088|NCT00398294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311089|NCT00396175|Finasteride|finasteride|mesh-list
25311090|NCT00396175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311091|NCT00396175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311092|NCT00396175|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25311093|NCT00396175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25311094|NCT00396175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311095|NCT00396175|Hormone Antagonists|hormone antagonists|mesh-ancestor
25311096|NCT00396175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25311097|NCT00396175|Urological Agents|urological agents|mesh-ancestor
25311098|NCT00389896|Oxymetazoline|oxymetazoline|mesh-list
25311099|NCT00389896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25311100|NCT00389896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25311101|NCT00389896|Adrenergic Agents|adrenergic agents|mesh-ancestor
25311102|NCT00389896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25311103|NCT00389896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311104|NCT00389896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311105|NCT00389896|Sympathomimetics|sympathomimetics|mesh-ancestor
25311106|NCT00389896|Autonomic Agents|autonomic agents|mesh-ancestor
25311107|NCT00389896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25311108|NCT00389896|Nasal Decongestants|nasal decongestants|mesh-ancestor
25311109|NCT00389896|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25311110|NCT00389896|Respiratory System Agents|respiratory system agents|mesh-ancestor
25311111|NCT00370890|Gemcitabine|gemcitabine|mesh-list
25311112|NCT00370890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25311113|NCT00370890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25311114|NCT00370890|Antimetabolites|antimetabolites|mesh-ancestor
25311115|NCT00370890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311116|NCT00370890|Antiviral Agents|antiviral agents|mesh-ancestor
25311117|NCT00370890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25311118|NCT00370890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311119|NCT00370890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25311120|NCT00370890|Immunologic Factors|immunologic factors|mesh-ancestor
25311121|NCT00370890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311122|NCT04231565|Tenofovir|tenofovir|mesh-list
25311123|NCT04231565|Antiviral Agents|antiviral agents|mesh-ancestor
25311124|NCT04231565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25311125|NCT04231565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25311126|NCT04231565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25311127|NCT04231565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24583394|NCT00874406|Leucovorin|leucovorin|mesh-list
25311128|NCT04231565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311129|NCT04231565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25311130|NCT04231565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25825391|NCT00005591|Antimetabolites|antimetabolites|mesh-ancestor
25311131|NCT04123444|Iloprost|iloprost|mesh-list
25311132|NCT04123444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25648531|NCT01480596|Belimumab|belimumab|mesh-list
25648532|NCT01480596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25648533|NCT01480596|Immunologic Factors|immunologic factors|mesh-ancestor
25648534|NCT01480596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648535|NCT01480674|Trastuzumab|trastuzumab|mesh-list
25648536|NCT01480674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25648537|NCT01480674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25648538|NCT01480843|Insulin Glargine|insulin glargine|mesh-list
25648539|NCT01480843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25186029|NCT02823743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25186030|NCT02823743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25186031|NCT02823743|Analgesics|analgesics|mesh-ancestor
25186032|NCT02823743|Sensory System Agents|sensory system agents|mesh-ancestor
25186033|NCT02823743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25186034|NCT02823743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186035|NCT02823743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25186036|NCT02823743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25186037|NCT02823743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25186038|NCT02823743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25186039|NCT02823743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186040|NCT02823743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25186041|NCT02823743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25186042|NCT02823743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311133|NCT04123444|Vasodilator Agents|vasodilator agents|mesh-ancestor
25311134|NCT04116502|Interferons|interferons|mesh-list
25311135|NCT04116502|Interferon-alpha|interferon-alpha|mesh-list
25311136|NCT04116502|Interferon alpha-2|interferon alpha-2|mesh-list
25311137|NCT04116502|Hydroxyurea|hydroxyurea|mesh-list
25311138|NCT04116502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25311139|NCT04116502|Antiviral Agents|antiviral agents|mesh-ancestor
25311140|NCT04116502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25311141|NCT04116502|Immunologic Factors|immunologic factors|mesh-ancestor
25311142|NCT04116502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311143|NCT04116502|Antisickling Agents|antisickling agents|mesh-ancestor
25311144|NCT04116502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311145|NCT04116502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311146|NCT04116502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25311147|NCT04116047|Durvalumab|durvalumab|mesh-list
25311148|NCT04116047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25311149|NCT04116047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25311150|NCT04095845|Tacrine|tacrine|mesh-list
25311151|NCT04095845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25311152|NCT04095845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311153|NCT04095845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311154|NCT04095845|Cholinergic Agents|cholinergic agents|mesh-ancestor
25311155|NCT04095845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25311156|NCT04095845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311157|NCT04095845|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25311158|NCT04095845|Autonomic Agents|autonomic agents|mesh-ancestor
24481611|NCT00435955|Rituximab|rituximab|mesh-list
25311159|NCT04095845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25311161|NCT04092179|Venetoclax|venetoclax|mesh-list
25311162|NCT04092179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25311163|NCT04046900|Metronidazole|metronidazole|mesh-list
25311164|NCT04046900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25311165|NCT04046900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25311166|NCT04046900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25311167|NCT04046900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25311168|NCT04038099|Lidocaine|lidocaine|mesh-list
25311169|NCT04038099|Anesthetics, Local|anesthetics, local|mesh-ancestor
25311170|NCT04038099|Anesthetics|anesthetics|mesh-ancestor
25311171|NCT04038099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25311172|NCT04038099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311173|NCT04038099|Sensory System Agents|sensory system agents|mesh-ancestor
25311174|NCT04038099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25311175|NCT04038099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25311176|NCT04038099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25311177|NCT04038099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25311178|NCT04038099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25648540|NCT01480843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648541|NCT01481116|Glimepiride|glimepiride|mesh-list
25648542|NCT01481116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25648543|NCT01481116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25648544|NCT01481116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648545|NCT01481116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25648546|NCT01481116|Immunologic Factors|immunologic factors|mesh-ancestor
25648547|NCT01481545|Leucovorin|leucovorin|mesh-list
25648548|NCT01481545|Bevacizumab|bevacizumab|mesh-list
25648549|NCT01481545|Fluorouracil|fluorouracil|mesh-list
25648550|NCT01481545|Oxaliplatin|oxaliplatin|mesh-list
25648551|NCT01481545|Raltitrexed|raltitrexed|mesh-list
25648552|NCT01481545|Levoleucovorin|levoleucovorin|mesh-list
25648553|NCT01481545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25648554|NCT01481545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25648555|NCT01481545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25648556|NCT01481545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25186099|NCT02824042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25186100|NCT02824042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25186101|NCT02824042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25186102|NCT02824042|Tubulin Modulators|tubulin modulators|mesh-ancestor
25311179|NCT04038099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311181|NCT03991832|Olaparib|olaparib|mesh-list
25311182|NCT03991832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25311183|NCT03991832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25311184|NCT03991832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25311185|NCT03991832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311186|NCT03991832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311187|NCT03977896|Carbon-11 methionine|carbon-11 methionine|mesh-list
25311188|NCT03977896|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25311189|NCT03977896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311190|NCT03965741|Rivaroxaban|rivaroxaban|mesh-list
25311191|NCT03965741|Apixaban|apixaban|mesh-list
25311192|NCT03965741|Dabigatran|dabigatran|mesh-list
25311193|NCT03965741|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25311194|NCT03965741|Antithrombins|antithrombins|mesh-ancestor
25311195|NCT03965741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25311196|NCT03965741|Protease Inhibitors|protease inhibitors|mesh-ancestor
25311197|NCT03965741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311198|NCT03965741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311199|NCT03965741|Anticoagulants|anticoagulants|mesh-ancestor
25311200|NCT03961438|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
25311201|NCT03961438|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25311202|NCT03961438|Immunologic Factors|immunologic factors|mesh-ancestor
25311203|NCT03961438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311204|NCT03945812|Lenograstim|lenograstim|mesh-list
25311205|NCT03945812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25311206|NCT03945812|Immunologic Factors|immunologic factors|mesh-ancestor
25311207|NCT03945812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311208|NCT03913845|Lidocaine|lidocaine|mesh-list
25311209|NCT03913845|Epinephrine|epinephrine|mesh-list
25311210|NCT03913845|Racepinephrine|racepinephrine|mesh-list
25311211|NCT03913845|Epinephryl borate|epinephryl borate|mesh-list
25311212|NCT03913845|Anesthetics, Local|anesthetics, local|mesh-ancestor
25311213|NCT03913845|Anesthetics|anesthetics|mesh-ancestor
25311214|NCT03913845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25311215|NCT03913845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311216|NCT03913845|Sensory System Agents|sensory system agents|mesh-ancestor
25311217|NCT03913845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25311218|NCT03913845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25311219|NCT03913845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25311220|NCT03913845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25311221|NCT03913845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25311222|NCT03913845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311223|NCT03913845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25311224|NCT03913845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25311225|NCT03913845|Adrenergic Agents|adrenergic agents|mesh-ancestor
25311226|NCT03913845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25311227|NCT03913845|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25311228|NCT03913845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25311229|NCT03913845|Autonomic Agents|autonomic agents|mesh-ancestor
25311230|NCT03913845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25311231|NCT03913845|Respiratory System Agents|respiratory system agents|mesh-ancestor
25311232|NCT03913845|Mydriatics|mydriatics|mesh-ancestor
25311233|NCT03913845|Sympathomimetics|sympathomimetics|mesh-ancestor
25311252|NCT03834363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311254|NCT03834363|Sensory System Agents|sensory system agents|mesh-ancestor
25311332|NCT03029403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25311255|NCT03834363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25311256|NCT03834363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25311257|NCT03834363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25311258|NCT03834363|Anesthetics, General|anesthetics, general|mesh-ancestor
25311259|NCT03834363|Anesthetics|anesthetics|mesh-ancestor
25311260|NCT03792958|Vorolanib|vorolanib|mesh-list
25311261|NCT03792958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25311262|NCT03792958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408484|NCT03437746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25648557|NCT01481545|Growth Substances|growth substances|mesh-ancestor
25648558|NCT01481545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648559|NCT01481545|Growth Inhibitors|growth inhibitors|mesh-ancestor
25648560|NCT01481545|Antimetabolites|antimetabolites|mesh-ancestor
25205699|NCT04325802|Naltrexone|naltrexone|mesh-list
25311263|NCT03792958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311264|NCT03782350|Tranexamic Acid|tranexamic acid|mesh-list
25311265|NCT03782350|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25311266|NCT03782350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25311267|NCT03782350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311268|NCT03782350|Hemostatics|hemostatics|mesh-ancestor
25311269|NCT03782350|Coagulants|coagulants|mesh-ancestor
25311270|NCT03734731|Analgesics, Opioid|analgesics, opioid|mesh-list
25311271|NCT03734731|Narcotics|narcotics|mesh-ancestor
25311272|NCT03734731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25311273|NCT03734731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311274|NCT03734731|Analgesics|analgesics|mesh-ancestor
25311275|NCT03734731|Sensory System Agents|sensory system agents|mesh-ancestor
25311276|NCT03734731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25311277|NCT03691714|Cetuximab|cetuximab|mesh-list
25311278|NCT03691714|Durvalumab|durvalumab|mesh-list
25311279|NCT03691714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25311280|NCT03691714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25311281|NCT03636256|Docetaxel|docetaxel|mesh-list
25311282|NCT03636256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25311283|NCT03636256|Tubulin Modulators|tubulin modulators|mesh-ancestor
25311284|NCT03636256|Antimitotic Agents|antimitotic agents|mesh-ancestor
25311285|NCT03636256|Mitosis Modulators|mitosis modulators|mesh-ancestor
25311286|NCT03636256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311287|NCT03578965|Cefazolin|cefazolin|mesh-list
25311288|NCT03578965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25311289|NCT03578965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25311290|NCT03559400|Gentamicins|gentamicins|mesh-list
25311291|NCT03559400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25311292|NCT03559400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25311293|NCT03559400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25311294|NCT03559400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311295|NCT03559400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311296|NCT03519984|Cytarabine|cytarabine|mesh-list
25311297|NCT03519984|Vincristine|vincristine|mesh-list
25311298|NCT03519984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25311299|NCT03519984|Antimetabolites|antimetabolites|mesh-ancestor
25311300|NCT03519984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311301|NCT03519984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25311302|NCT03519984|Antiviral Agents|antiviral agents|mesh-ancestor
25311303|NCT03519984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25311304|NCT03519984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25311305|NCT03519984|Immunologic Factors|immunologic factors|mesh-ancestor
25311306|NCT03519984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311307|NCT03519984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25311308|NCT03519984|Tubulin Modulators|tubulin modulators|mesh-ancestor
25311309|NCT03519984|Antimitotic Agents|antimitotic agents|mesh-ancestor
25311310|NCT03519984|Mitosis Modulators|mitosis modulators|mesh-ancestor
25311312|NCT03287778|Vitamin B 6|vitamin b 6|mesh-list
25311313|NCT03287778|Vitamins|vitamins|mesh-ancestor
25311314|NCT03287778|Micronutrients|micronutrients|mesh-ancestor
25311315|NCT03287778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311316|NCT03287778|Vitamin B Complex|vitamin b complex|mesh-ancestor
25311317|NCT03277170|Montelukast|montelukast|mesh-list
25311318|NCT03277170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25311319|NCT03277170|Respiratory System Agents|respiratory system agents|mesh-ancestor
25311320|NCT03277170|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25311321|NCT03277170|Hormone Antagonists|hormone antagonists|mesh-ancestor
25311322|NCT03277170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25311323|NCT03277170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311324|NCT03277170|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25311325|NCT03277170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25311326|NCT03277170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311327|NCT03029403|Cyclophosphamide|cyclophosphamide|mesh-list
25311328|NCT03029403|Pembrolizumab|pembrolizumab|mesh-list
25311329|NCT03029403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25311330|NCT03029403|Immunologic Factors|immunologic factors|mesh-ancestor
25311331|NCT03029403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311333|NCT03029403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25311334|NCT03029403|Alkylating Agents|alkylating agents|mesh-ancestor
25311335|NCT03029403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311336|NCT03029403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25311337|NCT03029403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25656850|NCT01579513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25311338|NCT03029403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25311339|NCT02762669|Oxytocin|oxytocin|mesh-list
25311340|NCT02762669|Oxytocics|oxytocics|mesh-ancestor
25311341|NCT02762669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25311342|NCT02762669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311343|NCT02716948|Nivolumab|nivolumab|mesh-list
25311344|NCT02716948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25311345|NCT02716948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007983|NCT02410343|Hormones|hormones|mesh-list
24899513|NCT04403191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899514|NCT04403191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24899515|NCT04403191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24899516|NCT04403191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24899517|NCT04403191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24899518|NCT04403191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24899519|NCT04403321|Cyclosporine|cyclosporine|mesh-list
24722388|NCT01579994|Crizotinib|crizotinib|mesh-list
25311346|NCT02716948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25311347|NCT02716948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638755|NCT01157936|Antioxidants|antioxidants|mesh-ancestor
25311348|NCT02431897|Estrogens|estrogens|mesh-list
25311349|NCT02431897|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25311350|NCT02431897|Hormones|hormones|mesh-ancestor
25311351|NCT02431897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25311352|NCT02431897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311353|NCT01641107|Ponatinib|ponatinib|mesh-list
25311354|NCT01641107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25311355|NCT01641107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25311356|NCT01641107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311357|NCT01641107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311358|NCT00843037|Sunitinib|sunitinib|mesh-list
25311359|NCT00843037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25311360|NCT00843037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25311361|NCT00843037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25311362|NCT00843037|Growth Substances|growth substances|mesh-ancestor
25311363|NCT00843037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311364|NCT00843037|Growth Inhibitors|growth inhibitors|mesh-ancestor
25311365|NCT00843037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25311366|NCT00843037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311367|NCT00843037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311368|NCT00054964|Albuterol|albuterol|mesh-list
25311369|NCT00054964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25311370|NCT00054964|Autonomic Agents|autonomic agents|mesh-ancestor
25311371|NCT00054964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25311372|NCT00054964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311373|NCT00054964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25311374|NCT00054964|Respiratory System Agents|respiratory system agents|mesh-ancestor
25311375|NCT00054964|Tocolytic Agents|tocolytic agents|mesh-ancestor
25311376|NCT00054964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25311377|NCT00054964|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25311378|NCT00054964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25311379|NCT00054964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25311380|NCT00054964|Adrenergic Agents|adrenergic agents|mesh-ancestor
25311381|NCT00054964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25311382|NCT00054964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311383|NCT05073692|Liraglutide|liraglutide|mesh-list
25311384|NCT05073692|Empagliflozin|empagliflozin|mesh-list
25311385|NCT05073692|Exenatide|exenatide|mesh-list
25311386|NCT05073692|Glimepiride|glimepiride|mesh-list
25311387|NCT05073692|Linagliptin|linagliptin|mesh-list
25311388|NCT05073692|Saxagliptin|saxagliptin|mesh-list
25311389|NCT05073692|Alogliptin|alogliptin|mesh-list
25311390|NCT05073692|Glipizide|glipizide|mesh-list
25311391|NCT05073692|Glucagon|glucagon|mesh-list
25311392|NCT05073692|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25311393|NCT05073692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25311394|NCT05073692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311395|NCT05073692|Incretins|incretins|mesh-ancestor
25311396|NCT05073692|Hormones|hormones|mesh-ancestor
25311397|NCT05073692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25311398|NCT05073692|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25311399|NCT05073692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311400|NCT05073692|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25311401|NCT05073692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25311402|NCT05073692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25311403|NCT05073692|Immunologic Factors|immunologic factors|mesh-ancestor
25311404|NCT05073692|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25311405|NCT05073692|Protease Inhibitors|protease inhibitors|mesh-ancestor
25311406|NCT05073692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311407|NCT05073692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25311409|NCT05073640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25311410|NCT05073640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311411|NCT05073640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311412|NCT05073640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25311413|NCT05073640|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25311414|NCT05073640|Protective Agents|protective agents|mesh-ancestor
25311415|NCT05073640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311416|NCT05073640|Vasodilator Agents|vasodilator agents|mesh-ancestor
25311417|NCT05073640|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25311418|NCT05073640|Antioxidants|antioxidants|mesh-ancestor
25311419|NCT05073744|Morphine|morphine|mesh-list
25311420|NCT05073744|Nalbuphine|nalbuphine|mesh-list
25311421|NCT05073744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24899847|NCT04399525|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25311422|NCT05073744|Narcotics|narcotics|mesh-ancestor
25311423|NCT05073744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25311424|NCT05073744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311425|NCT05073744|Analgesics|analgesics|mesh-ancestor
25311426|NCT05073744|Sensory System Agents|sensory system agents|mesh-ancestor
25311427|NCT05073744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25311428|NCT05073094|Esmolol|esmolol|mesh-list
25311429|NCT05073094|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25311430|NCT05073094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25311431|NCT05073094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25311432|NCT05073094|Adrenergic Agents|adrenergic agents|mesh-ancestor
25311433|NCT05073094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25311434|NCT05073094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311435|NCT05073094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311436|NCT05073029|Vitamin D|vitamin d|mesh-list
25311437|NCT05073029|Cholecalciferol|cholecalciferol|mesh-list
25311438|NCT05073029|Vitamins|vitamins|mesh-ancestor
25311439|NCT05073029|Micronutrients|micronutrients|mesh-ancestor
25311440|NCT05073029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311441|NCT05073029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25311442|NCT05073029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25311443|NCT05072938|Nizatidine|nizatidine|mesh-list
25311444|NCT05072938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25311445|NCT05072938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25311446|NCT05072938|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25311447|NCT05072938|Histamine Antagonists|histamine antagonists|mesh-ancestor
25311448|NCT05072938|Histamine Agents|histamine agents|mesh-ancestor
25311449|NCT05072938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25311520|NCT05072405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311467|NCT05072873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311468|NCT05072873|Hemostatics|hemostatics|mesh-ancestor
25311469|NCT05072873|Coagulants|coagulants|mesh-ancestor
25311488|NCT05072821|Botulinum Toxins|botulinum toxins|mesh-list
25311489|NCT05072821|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25311490|NCT05072821|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25311491|NCT05072821|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24518498|NCT04908605|Protective Agents|protective agents|mesh-ancestor
24518499|NCT04908605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518500|NCT04908605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24900036|NCT04397653|Evolocumab|evolocumab|mesh-list
25311492|NCT05072821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25311493|NCT05072821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311494|NCT05072821|Cholinergic Agents|cholinergic agents|mesh-ancestor
25311495|NCT05072821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25311496|NCT05072821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311497|NCT05072821|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25311498|NCT05072821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25311499|NCT05072691|Immunoglobulins|immunoglobulins|mesh-list
25311500|NCT05072691|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25311501|NCT05072691|Antibodies|antibodies|mesh-list
25311502|NCT05072691|Immunologic Factors|immunologic factors|mesh-ancestor
25311509|NCT03363893|Hormone Antagonists|hormone antagonists|mesh-ancestor
25311510|NCT03363893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25311511|NCT03363893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311512|NCT05072405|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25311514|NCT05072405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25311515|NCT05072405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25186328|NCT02821390|Nepafenac|nepafenac|mesh-list
25186329|NCT02821390|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25186334|NCT02821390|Analgesics|analgesics|mesh-ancestor
25311516|NCT05072405|Antimetabolites|antimetabolites|mesh-ancestor
25311517|NCT05072405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311518|NCT05072405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25311519|NCT05072405|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25311521|NCT05072249|Naloxone|naloxone|mesh-list
25311522|NCT05072249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25311523|NCT05072249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311524|NCT05072249|Sensory System Agents|sensory system agents|mesh-ancestor
25311525|NCT05072249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25311526|NCT05072106|Bosentan|bosentan|mesh-list
25311527|NCT05072106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25311528|NCT05072106|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25311529|NCT05072106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311537|NCT05071482|Imatinib Mesylate|imatinib mesylate|mesh-list
25311538|NCT05071482|HH-GV-678|hh-gv-678|mesh-list
25311539|NCT05071482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25311540|NCT05071482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25311541|NCT05071482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311542|NCT05071482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311543|NCT05071781|Hormones|hormones|mesh-list
25311544|NCT05071781|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25311545|NCT05071781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25311546|NCT05071781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311547|NCT05071339|Ganirelix|ganirelix|mesh-list
25311548|NCT05071339|Hormone Antagonists|hormone antagonists|mesh-ancestor
25311549|NCT05071339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25311550|NCT05071339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311551|NCT05071118|Pregabalin|pregabalin|mesh-list
25311552|NCT05071118|Analgesics|analgesics|mesh-ancestor
25311553|NCT05071118|Sensory System Agents|sensory system agents|mesh-ancestor
25311554|NCT05071118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25311555|NCT05071118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311556|NCT05071118|Anticonvulsants|anticonvulsants|mesh-ancestor
25311557|NCT05071118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25311558|NCT05071118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25311559|NCT05071118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311560|NCT05071118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25311561|NCT05071118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25311562|NCT05071118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25311563|NCT05071118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25311564|NCT05071118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25311565|NCT05070520|Lumefantrine|lumefantrine|mesh-list
25311566|NCT05070520|Artemether|artemether|mesh-list
25311567|NCT05070520|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25311568|NCT05070520|Antimalarials|antimalarials|mesh-ancestor
25311569|NCT05070520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25311570|NCT05070520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25311571|NCT05070520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25311572|NCT05070416|Lithium Carbonate|lithium carbonate|mesh-list
25311573|NCT05070416|Antidepressive Agents|antidepressive agents|mesh-ancestor
25311574|NCT05070416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25311575|NCT05070416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311576|NCT05070416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311577|NCT05070416|Antimanic Agents|antimanic agents|mesh-ancestor
25311578|NCT05070416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25311579|NCT05070416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25311580|NCT05070416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311581|NCT05070468|Dexamethasone|dexamethasone|mesh-list
25311582|NCT05070468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25311583|NCT05070468|Antiemetics|antiemetics|mesh-ancestor
25311584|NCT05070468|Autonomic Agents|autonomic agents|mesh-ancestor
25311585|NCT05070468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25311586|NCT05070468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311587|NCT05070468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25311588|NCT05070468|Glucocorticoids|glucocorticoids|mesh-ancestor
25311589|NCT05070468|Hormones|hormones|mesh-ancestor
25311590|NCT05070468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25311591|NCT05070468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25648561|NCT01481545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648562|NCT01481545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25205758|NCT04246541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205759|NCT04246541|Antipyretics|antipyretics|mesh-ancestor
25205760|NCT04246541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25205761|NCT04246541|Narcotics|narcotics|mesh-ancestor
25205762|NCT04246541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25205763|NCT04246541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25205764|NCT04246541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25205765|NCT04246541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25205766|NCT04246541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25205767|NCT04246541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205768|NCT04246541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205769|NCT04242238|Avelumab|avelumab|mesh-list
25205770|NCT04242238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25205771|NCT04242238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208097|NCT03094052|Narcotics|narcotics|mesh-ancestor
25208098|NCT03094052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25208099|NCT03094052|Analgesics|analgesics|mesh-ancestor
25208100|NCT03094052|Sensory System Agents|sensory system agents|mesh-ancestor
24437181|NCT00272870|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
24413254|NCT00193362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25311592|NCT05070468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25311593|NCT05070598|Paclitaxel|paclitaxel|mesh-list
25311594|NCT05070598|Tegafur|tegafur|mesh-list
25311668|NCT05069779|Anticonvulsants|anticonvulsants|mesh-ancestor
25311602|NCT05070598|Antimetabolites|antimetabolites|mesh-ancestor
25311606|NCT05070195|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25311607|NCT05070195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25311608|NCT05070195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25311609|NCT05070195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311610|NCT05070195|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25311611|NCT05070195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25311612|NCT05070195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25311613|NCT05070195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25311614|NCT05070195|Anesthetics, General|anesthetics, general|mesh-ancestor
25311615|NCT05070195|Anesthetics|anesthetics|mesh-ancestor
25311616|NCT05070195|GABA Modulators|gaba modulators|mesh-ancestor
25311617|NCT05070195|GABA Agents|gaba agents|mesh-ancestor
25080562|NCT03337503|Hallucinogens|hallucinogens|mesh-ancestor
25311618|NCT05070195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25311619|NCT05070195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311620|NCT05070221|Axitinib|axitinib|mesh-list
25311621|NCT05070221|Antibodies|antibodies|mesh-list
25311622|NCT05070221|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25311623|NCT05070221|Immunologic Factors|immunologic factors|mesh-ancestor
25311624|NCT05070221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311625|NCT05070221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25311626|NCT05070221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25311627|NCT05070221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311628|NCT05070221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311629|NCT05069870|Itraconazole|itraconazole|mesh-list
25311630|NCT05069870|Rifampin|rifampin|mesh-list
25311631|NCT05069870|Gemfibrozil|gemfibrozil|mesh-list
25648563|NCT01481545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25648564|NCT01481545|Immunologic Factors|immunologic factors|mesh-ancestor
25648565|NCT01481545|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25648566|NCT01481545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25648567|NCT01481545|Antidotes|antidotes|mesh-ancestor
25648568|NCT01481545|Protective Agents|protective agents|mesh-ancestor
25648569|NCT01481545|Vitamin B Complex|vitamin b complex|mesh-ancestor
25648570|NCT01481545|Vitamins|vitamins|mesh-ancestor
25648571|NCT01481545|Micronutrients|micronutrients|mesh-ancestor
25648572|NCT01481740|Phenylephrine|phenylephrine|mesh-list
25648573|NCT01481740|Oxymetazoline|oxymetazoline|mesh-list
25648574|NCT01481740|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25648575|NCT01481740|Mydriatics|mydriatics|mesh-ancestor
25648576|NCT01481740|Autonomic Agents|autonomic agents|mesh-ancestor
25648577|NCT01481740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25648578|NCT01481740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648579|NCT01481740|Sympathomimetics|sympathomimetics|mesh-ancestor
25648580|NCT01481740|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25648581|NCT01481740|Nasal Decongestants|nasal decongestants|mesh-ancestor
25648582|NCT01481740|Respiratory System Agents|respiratory system agents|mesh-ancestor
25648583|NCT01481740|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25311632|NCT05069870|Antifungal Agents|antifungal agents|mesh-ancestor
25648584|NCT01481740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25648585|NCT01481740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25311633|NCT05069870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25311634|NCT05069870|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25311635|NCT05069870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25311636|NCT05069870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311637|NCT05069870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311638|NCT05069870|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24900624|NCT04392713|Ivermectin|ivermectin|mesh-list
25311639|NCT05069870|Hormone Antagonists|hormone antagonists|mesh-ancestor
25311640|NCT05069870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25311641|NCT05069870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311642|NCT05069870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25311643|NCT05069870|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25311644|NCT05069870|Antitubercular Agents|antitubercular agents|mesh-ancestor
25311645|NCT05069870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25311646|NCT05069870|Leprostatic Agents|leprostatic agents|mesh-ancestor
25311647|NCT05069870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25311648|NCT05069870|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25311649|NCT05069870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25311650|NCT05069870|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25311651|NCT05069870|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25311652|NCT05069870|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25311653|NCT05069870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25311654|NCT05069870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25311655|NCT05069870|Antimetabolites|antimetabolites|mesh-ancestor
25311656|NCT05069870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25311657|NCT05069870|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25311666|NCT05069779|Diazepam|diazepam|mesh-list
25311667|NCT05069779|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25311669|NCT05069779|Antiemetics|antiemetics|mesh-ancestor
25311670|NCT05069779|Autonomic Agents|autonomic agents|mesh-ancestor
25311671|NCT05069779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25311672|NCT05069779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311673|NCT05069779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25311674|NCT05069779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25311675|NCT05069779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25311676|NCT05069779|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25311677|NCT05069779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25311678|NCT05069779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25311679|NCT05069779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25311680|NCT05069779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25311681|NCT05069779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25311682|NCT05069779|Anesthetics, General|anesthetics, general|mesh-ancestor
25311683|NCT05069779|Anesthetics|anesthetics|mesh-ancestor
25311684|NCT05069779|GABA Modulators|gaba modulators|mesh-ancestor
25311685|NCT05069779|GABA Agents|gaba agents|mesh-ancestor
25311686|NCT05069779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25311687|NCT05069779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311688|NCT05069454|Vaccines|vaccines|mesh-list
25311689|NCT05069454|Immunologic Factors|immunologic factors|mesh-ancestor
25311690|NCT05069454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311691|NCT05069688|Rifampin|rifampin|mesh-list
25311692|NCT05069688|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25311693|NCT05069688|Antitubercular Agents|antitubercular agents|mesh-ancestor
25311694|NCT05069688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25311695|NCT05069688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25311696|NCT05069688|Leprostatic Agents|leprostatic agents|mesh-ancestor
25311697|NCT05069688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25311698|NCT05069688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311699|NCT05069688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311700|NCT05069688|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25311701|NCT05069688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25311702|NCT05069688|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25311703|NCT05069688|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25311704|NCT05069688|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25311705|NCT05069688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25311706|NCT05068960|Bupivacaine|bupivacaine|mesh-list
25311707|NCT05068960|Anesthetics, Local|anesthetics, local|mesh-ancestor
25311708|NCT05068960|Anesthetics|anesthetics|mesh-ancestor
25311709|NCT05068960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25311710|NCT05068960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311711|NCT05068960|Sensory System Agents|sensory system agents|mesh-ancestor
25311712|NCT05068960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25311713|NCT05069246|Chlorhexidine|chlorhexidine|mesh-list
25311714|NCT05069246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25311715|NCT05069246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25311716|NCT05069246|Disinfectants|disinfectants|mesh-ancestor
25311717|NCT05068453|Antibodies|antibodies|mesh-list
25311718|NCT05068453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25311719|NCT05068453|Immunologic Factors|immunologic factors|mesh-ancestor
25311720|NCT05068453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311721|NCT05067699|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
25311722|NCT05067699|Calcifediol|calcifediol|mesh-list
25311723|NCT05067699|Vitamins|vitamins|mesh-ancestor
25311724|NCT05067699|Micronutrients|micronutrients|mesh-ancestor
25311725|NCT05067699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311726|NCT05067699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25311727|NCT05067530|Paclitaxel|paclitaxel|mesh-list
25311728|NCT05067530|Carboplatin|carboplatin|mesh-list
25311729|NCT05067530|Palbociclib|palbociclib|mesh-list
25311730|NCT05067530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25311731|NCT05067530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25311732|NCT05067530|Tubulin Modulators|tubulin modulators|mesh-ancestor
25311733|NCT05067530|Antimitotic Agents|antimitotic agents|mesh-ancestor
25311734|NCT05067530|Mitosis Modulators|mitosis modulators|mesh-ancestor
25311735|NCT05067530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311736|NCT05067530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25311737|NCT05067530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311738|NCT05067517|Nintedanib|nintedanib|mesh-list
25311739|NCT05067517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25311740|NCT05067517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25311741|NCT05067517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311742|NCT05067517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311744|NCT05067153|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25311762|NCT05066958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25311763|NCT05066802|Folfirinox|folfirinox|mesh-list
25311764|NCT05066802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25311765|NCT05066568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25311766|NCT05066568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25311767|NCT05066568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311768|NCT05066516|Dapagliflozin|dapagliflozin|mesh-list
25311769|NCT05066516|Linagliptin|linagliptin|mesh-list
25311770|NCT05066516|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25311771|NCT05066516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311772|NCT05066516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25311773|NCT05066516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311774|NCT05066516|Incretins|incretins|mesh-ancestor
25311775|NCT05066516|Hormones|hormones|mesh-ancestor
25311776|NCT05066516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25311777|NCT05066516|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25311778|NCT05066516|Protease Inhibitors|protease inhibitors|mesh-ancestor
25311779|NCT05066516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311780|NCT05066633|Metoprolol|metoprolol|mesh-list
25311781|NCT05066633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25311782|NCT05066633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25311783|NCT05066633|Sympatholytics|sympatholytics|mesh-ancestor
25311784|NCT05066633|Autonomic Agents|autonomic agents|mesh-ancestor
25311785|NCT05066633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25311786|NCT05066633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311787|NCT05066633|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25311788|NCT05066633|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25311789|NCT05066633|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25311790|NCT05066633|Adrenergic Agents|adrenergic agents|mesh-ancestor
25311791|NCT05066633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25311792|NCT05066633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311811|NCT05066360|Hormones|hormones|mesh-list
25311812|NCT05066360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25311813|NCT05066360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311814|NCT05065658|Posaconazole|posaconazole|mesh-list
25311815|NCT05065658|Antifungal Agents|antifungal agents|mesh-ancestor
25311816|NCT05065658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25311817|NCT05065658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25311818|NCT05065658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25311823|NCT05065658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311824|NCT05065658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25311825|NCT05065658|Hormone Antagonists|hormone antagonists|mesh-ancestor
25311826|NCT05065658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25186548|NCT02819856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186549|NCT02819856|Protective Agents|protective agents|mesh-ancestor
25186550|NCT02819856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25186551|NCT02819856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25186552|NCT02819856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25186553|NCT02819661|Morphine|morphine|mesh-list
25186554|NCT02819661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25186555|NCT02819661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186556|NCT02819661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25311827|NCT05065658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311828|NCT05065905|Interferons|interferons|mesh-list
25311829|NCT05065905|Interferon-gamma|interferon-gamma|mesh-list
25311830|NCT05065905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25311831|NCT05065905|Antiviral Agents|antiviral agents|mesh-ancestor
25311832|NCT05065905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25311833|NCT05066035|Neostigmine|neostigmine|mesh-list
24553200|NCT00729911|Amiodarone|amiodarone|mesh-list
25311834|NCT05066035|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25311835|NCT05066035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311836|NCT05066035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311837|NCT05066035|Cholinergic Agents|cholinergic agents|mesh-ancestor
25311838|NCT05066035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25311839|NCT05066035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311840|NCT05066035|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25311841|NCT05066035|Autonomic Agents|autonomic agents|mesh-ancestor
25311842|NCT05066035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25311844|NCT05065164|Denosumab|denosumab|mesh-list
25311845|NCT05065164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25311846|NCT05065164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311847|NCT05065177|Vaccines|vaccines|mesh-list
25311848|NCT05065177|Immunologic Factors|immunologic factors|mesh-ancestor
25311849|NCT05065177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311854|NCT05064020|Tenofovir|tenofovir|mesh-list
25311855|NCT05064020|Emtricitabine|emtricitabine|mesh-list
25311856|NCT05064020|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25311857|NCT05064020|Antiviral Agents|antiviral agents|mesh-ancestor
25311858|NCT05064020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25311859|NCT05064020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25311860|NCT05064020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25311861|NCT05064020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311862|NCT05064020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311863|NCT05064020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25311864|NCT05064020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25311865|NCT05063838|Anesthetics|anesthetics|mesh-list
25311866|NCT05063838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25311867|NCT05063838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311868|NCT05063578|Lidocaine|lidocaine|mesh-list
25311869|NCT05063578|Anesthetics, Local|anesthetics, local|mesh-ancestor
25311870|NCT05063578|Anesthetics|anesthetics|mesh-ancestor
25311871|NCT05063578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25311872|NCT05063578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311873|NCT05063578|Sensory System Agents|sensory system agents|mesh-ancestor
25311874|NCT05063578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25311875|NCT05063578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25311876|NCT05063578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25311877|NCT05063578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25311878|NCT05063578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25311879|NCT05063578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311880|NCT05063513|Mycophenolic Acid|mycophenolic acid|mesh-list
25311881|NCT05063513|Rituximab|rituximab|mesh-list
25311882|NCT05063513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25311883|NCT05063513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25311884|NCT05063513|Immunologic Factors|immunologic factors|mesh-ancestor
25311885|NCT05063513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311886|NCT05063513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25648586|NCT01481740|Adrenergic Agents|adrenergic agents|mesh-ancestor
25648587|NCT01481740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25648588|NCT01481740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648589|NCT01481740|Protective Agents|protective agents|mesh-ancestor
25648590|NCT01481779|Insulin Lispro|insulin lispro|mesh-list
25648591|NCT01481779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25648592|NCT01481779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648593|NCT01482091|Fentanyl|fentanyl|mesh-list
25648594|NCT01482091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25648595|NCT01482091|Narcotics|narcotics|mesh-ancestor
25205783|NCT04230681|Hydromorphone|hydromorphone|mesh-list
25205784|NCT04230681|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25205785|NCT04230681|Narcotics|narcotics|mesh-ancestor
25205786|NCT04230681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25205787|NCT04230681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205788|NCT04230681|Analgesics|analgesics|mesh-ancestor
25205789|NCT04230681|Sensory System Agents|sensory system agents|mesh-ancestor
25205790|NCT04230681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25205791|NCT04230681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25205792|NCT04230681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25205793|NCT04230681|Anesthetics, General|anesthetics, general|mesh-ancestor
25205794|NCT04230681|Anesthetics|anesthetics|mesh-ancestor
25205795|NCT04225767|Calcium|calcium|mesh-list
25205811|NCT04181996|Colchicine|colchicine|mesh-list
25311887|NCT05063513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25311888|NCT05063513|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25311889|NCT05063513|Antitubercular Agents|antitubercular agents|mesh-ancestor
25311890|NCT05063513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25311891|NCT05063513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25311901|NCT05063422|Antimalarials|antimalarials|mesh-ancestor
25311902|NCT05063422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25311903|NCT05063422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25311904|NCT05063422|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25311905|NCT05063422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311906|NCT05063422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311907|NCT05063422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25311908|NCT05063422|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25311909|NCT05063422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25311910|NCT05063422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25311911|NCT05063422|Laxatives|laxatives|mesh-ancestor
25311912|NCT05063422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25311913|NCT05063318|Itraconazole|itraconazole|mesh-list
25311914|NCT05063318|Antifungal Agents|antifungal agents|mesh-ancestor
25311915|NCT05063318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25311916|NCT05063318|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25311917|NCT05063318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25311918|NCT05063318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311919|NCT05063318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311920|NCT05063318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25311921|NCT05063318|Hormone Antagonists|hormone antagonists|mesh-ancestor
25311922|NCT05063318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25311923|NCT05063318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311924|NCT05063318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25311925|NCT05063071|Tenofovir|tenofovir|mesh-list
25311926|NCT05063071|Antiviral Agents|antiviral agents|mesh-ancestor
25311927|NCT05063071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25311928|NCT05063071|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25311929|NCT05063071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25311930|NCT05063071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311931|NCT05063071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311932|NCT05063071|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25311933|NCT05063071|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25311934|NCT05062681|Dexamethasone|dexamethasone|mesh-list
25311935|NCT05062681|Methylprednisolone|methylprednisolone|mesh-list
25311936|NCT05062681|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25311937|NCT05062681|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25311938|NCT05062681|Prednisolone|prednisolone|mesh-list
25311939|NCT05062681|Prednisolone acetate|prednisolone acetate|mesh-list
24901368|NCT04385602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25312446|NCT05052359|Agglutinins|agglutinins|mesh-ancestor
25311940|NCT05062681|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25648596|NCT01482091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25648597|NCT01482091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648598|NCT01482091|Analgesics|analgesics|mesh-ancestor
25648599|NCT01482091|Sensory System Agents|sensory system agents|mesh-ancestor
25648600|NCT01482091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25648601|NCT01482091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25648602|NCT01482091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25648603|NCT01482091|Anesthetics, General|anesthetics, general|mesh-ancestor
25648604|NCT01482091|Anesthetics|anesthetics|mesh-ancestor
25648605|NCT01482169|Adenosine|adenosine|mesh-list
25648606|NCT01482169|Regadenoson|regadenoson|mesh-list
25648607|NCT01482169|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25648608|NCT01482169|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25311941|NCT05062681|Prednisolone phosphate|prednisolone phosphate|mesh-list
25311942|NCT05062681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25311943|NCT05062681|Antiemetics|antiemetics|mesh-ancestor
25311944|NCT05062681|Autonomic Agents|autonomic agents|mesh-ancestor
25311945|NCT05062681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25311946|NCT05062681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311947|NCT05062681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25311948|NCT05062681|Glucocorticoids|glucocorticoids|mesh-ancestor
25311949|NCT05062681|Hormones|hormones|mesh-ancestor
25311950|NCT05062681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25311951|NCT05062681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25311952|NCT05062681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25311953|NCT05062681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25311954|NCT05062681|Protective Agents|protective agents|mesh-ancestor
25311964|NCT05062486|Curcumin|curcumin|mesh-list
25311965|NCT05062486|Resveratrol|resveratrol|mesh-list
25311966|NCT05062486|Quercetin|quercetin|mesh-list
25311967|NCT05062486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25311968|NCT05062486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25311969|NCT05062486|Analgesics|analgesics|mesh-ancestor
25311970|NCT05062486|Sensory System Agents|sensory system agents|mesh-ancestor
25311971|NCT05062486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25311972|NCT05062486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311973|NCT05062486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25311974|NCT05062486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25311975|NCT05062486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25311976|NCT05062486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25311977|NCT05062486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311978|NCT05062486|Antioxidants|antioxidants|mesh-ancestor
25311979|NCT05062486|Protective Agents|protective agents|mesh-ancestor
25311980|NCT05062486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25311981|NCT05062395|Deoxyglucose|deoxyglucose|mesh-list
25311982|NCT05062395|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25311983|NCT05062395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25311984|NCT05062395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25311985|NCT05062395|Antimetabolites|antimetabolites|mesh-ancestor
25311986|NCT05062395|Antiviral Agents|antiviral agents|mesh-ancestor
25311987|NCT05062395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25311988|NCT05062304|Fluticasone|fluticasone|mesh-list
25311989|NCT05062304|Xhance|xhance|mesh-list
25311990|NCT05062304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25311991|NCT05062304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25311992|NCT05062304|Autonomic Agents|autonomic agents|mesh-ancestor
25311993|NCT05062304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25311994|NCT05062304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25311995|NCT05062304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25311996|NCT05062304|Respiratory System Agents|respiratory system agents|mesh-ancestor
25311997|NCT05062304|Dermatologic Agents|dermatologic agents|mesh-ancestor
25311998|NCT05062304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25311999|NCT05061732|Amoxicillin|amoxicillin|mesh-list
25312000|NCT05061732|Metronidazole|metronidazole|mesh-list
25312001|NCT05061732|Clarithromycin|clarithromycin|mesh-list
25312002|NCT05061732|Doxycycline|doxycycline|mesh-list
25312003|NCT05061732|Levofloxacin|levofloxacin|mesh-list
25312004|NCT05061732|Tetracycline|tetracycline|mesh-list
25312005|NCT05061732|Potassium Citrate|potassium citrate|mesh-list
25312006|NCT05061732|Rabeprazole|rabeprazole|mesh-list
25312007|NCT05061732|Bismuth|bismuth|mesh-list
25312008|NCT05061732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312009|NCT05061732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25312010|NCT05061732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25312011|NCT05061732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25312012|NCT05061732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25312013|NCT05061732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25312014|NCT05061732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312015|NCT05061732|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24901558|NCT04383418|Analgesics|analgesics|mesh-ancestor
25312016|NCT05061732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25312017|NCT05061732|Antimalarials|antimalarials|mesh-ancestor
25312018|NCT05061732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25312019|NCT05061732|Renal Agents|renal agents|mesh-ancestor
25312020|NCT05061732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25312021|NCT05061732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25312022|NCT05061732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25312023|NCT05061732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25312024|NCT05061732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25312025|NCT05061732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25312026|NCT05061732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25312027|NCT05061732|Antacids|antacids|mesh-ancestor
25186703|NCT02818803|Propolis|propolis|mesh-list
25312028|NCT05061732|Diuretics|diuretics|mesh-ancestor
25312029|NCT05061732|Natriuretic Agents|natriuretic agents|mesh-ancestor
25312030|NCT05061732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312031|NCT05061732|Expectorants|expectorants|mesh-ancestor
25312032|NCT05061732|Respiratory System Agents|respiratory system agents|mesh-ancestor
25312033|NCT05061641|Progesterone|progesterone|mesh-list
25312034|NCT05061641|Progestins|progestins|mesh-ancestor
25312035|NCT05061641|Hormones|hormones|mesh-ancestor
25312036|NCT05061641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25312037|NCT05061641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312038|NCT05061147|Azacitidine|azacitidine|mesh-list
25312039|NCT05061147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25312040|NCT05061147|Antimetabolites|antimetabolites|mesh-ancestor
25312041|NCT05061147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312042|NCT05061147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25312047|NCT05060822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25312048|NCT05060822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312049|NCT05060822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25312050|NCT05060822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25312051|NCT05060822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25312053|NCT05060822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25312054|NCT05060809|Vitamin K|vitamin k|mesh-list
25312055|NCT05060809|Vitamin K 1|vitamin k 1|mesh-list
25312056|NCT05060809|Vitamins|vitamins|mesh-ancestor
25312057|NCT05060809|Micronutrients|micronutrients|mesh-ancestor
25312058|NCT05060809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312059|NCT05060809|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25312060|NCT05060809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25312061|NCT05060809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312062|NCT05060809|Hemostatics|hemostatics|mesh-ancestor
25312063|NCT05060809|Coagulants|coagulants|mesh-ancestor
25312064|NCT05060731|Iron|iron|mesh-list
25312065|NCT05060731|Trace Elements|trace elements|mesh-ancestor
25312066|NCT05060731|Micronutrients|micronutrients|mesh-ancestor
25312067|NCT05060731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312068|NCT05060588|Valsartan|valsartan|mesh-list
25312069|NCT05060588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25312070|NCT05060588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25312071|NCT05060588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25312072|NCT05060588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25312073|NCT05060588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312074|NCT05060419|Meropenem|meropenem|mesh-list
25312075|NCT05060419|Tazobactam|tazobactam|mesh-list
25312076|NCT05060419|Piperacillin|piperacillin|mesh-list
25312077|NCT05060419|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25312078|NCT05060419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25312079|NCT05060419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25312080|NCT05060419|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25312081|NCT05060419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312082|NCT05060419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901781|NCT04380818|Hydroxychloroquine|hydroxychloroquine|mesh-list
25312083|NCT05060198|Lumefantrine|lumefantrine|mesh-list
25312084|NCT05060198|Artemether|artemether|mesh-list
25312085|NCT05060198|Piperaquine|piperaquine|mesh-list
25312086|NCT05060198|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25312087|NCT05060198|Artenimol|artenimol|mesh-list
25312088|NCT05060198|Antimalarials|antimalarials|mesh-ancestor
25312089|NCT05060198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25312090|NCT05060198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25312091|NCT05060198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25312092|NCT05059782|Coal Tar|coal tar|mesh-list
25312093|NCT05059782|Keratolytic Agents|keratolytic agents|mesh-ancestor
25312094|NCT05059782|Dermatologic Agents|dermatologic agents|mesh-ancestor
25312095|NCT05059418|Clonazepam|clonazepam|mesh-list
25312096|NCT05059418|Capsaicin|capsaicin|mesh-list
25312097|NCT05059418|Antipruritics|antipruritics|mesh-ancestor
25312098|NCT05059418|Dermatologic Agents|dermatologic agents|mesh-ancestor
25312099|NCT05059418|Sensory System Agents|sensory system agents|mesh-ancestor
25312100|NCT05059418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25312101|NCT05059418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312102|NCT05059418|Anticonvulsants|anticonvulsants|mesh-ancestor
25312103|NCT05059418|GABA Modulators|gaba modulators|mesh-ancestor
25312104|NCT05059418|GABA Agents|gaba agents|mesh-ancestor
25312105|NCT05059418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25312106|NCT05059418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312111|NCT05059145|Chlorhexidine|chlorhexidine|mesh-list
25648609|NCT01482169|Purinergic Agonists|purinergic agonists|mesh-ancestor
25312112|NCT05059145|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25312113|NCT05059145|Fluconazole|fluconazole|mesh-list
25312114|NCT05059145|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25312115|NCT05059145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25312116|NCT05059145|Disinfectants|disinfectants|mesh-ancestor
25312117|NCT05059145|Dermatologic Agents|dermatologic agents|mesh-ancestor
25312118|NCT05059145|Antifungal Agents|antifungal agents|mesh-ancestor
25312119|NCT05059145|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25312145|NCT05058677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25312146|NCT05058677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25312147|NCT05058677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25312148|NCT05058677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312161|NCT05058755|Etoposide|etoposide|mesh-list
25312162|NCT05058755|Lenalidomide|lenalidomide|mesh-list
25312163|NCT05058755|Azacitidine|azacitidine|mesh-list
25312164|NCT05058755|Pegaspargase|pegaspargase|mesh-list
25312165|NCT05058755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25312166|NCT05058755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25312167|NCT05058755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25312168|NCT05058755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25312169|NCT05058755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312170|NCT05058755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312171|NCT05058755|Immunologic Factors|immunologic factors|mesh-ancestor
25312172|NCT05058755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312173|NCT05058755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25312174|NCT05058755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25312175|NCT05058755|Growth Substances|growth substances|mesh-ancestor
25312176|NCT05058755|Growth Inhibitors|growth inhibitors|mesh-ancestor
25312177|NCT05058755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25312178|NCT05058755|Antimetabolites|antimetabolites|mesh-ancestor
25312179|NCT05058209|Triamcinolone|triamcinolone|mesh-list
25312180|NCT05058209|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25312181|NCT05058209|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25312182|NCT05058209|Betamethasone|betamethasone|mesh-list
25312183|NCT05058209|Betamethasone Valerate|betamethasone valerate|mesh-list
25312184|NCT05058209|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25312185|NCT05058209|Betamethasone benzoate|betamethasone benzoate|mesh-list
25312186|NCT05058209|Betamethasone acetate|betamethasone acetate|mesh-list
25312187|NCT05058209|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25312188|NCT05058209|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25312189|NCT05058209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25312190|NCT05058209|Glucocorticoids|glucocorticoids|mesh-ancestor
25312191|NCT05058209|Hormones|hormones|mesh-ancestor
25312192|NCT05058209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25312222|NCT05057845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312223|NCT05057663|Fluorouracil|fluorouracil|mesh-list
25312224|NCT05057663|Bleomycin|bleomycin|mesh-list
25312225|NCT05057663|Antimetabolites|antimetabolites|mesh-ancestor
25312226|NCT05057663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312227|NCT05057663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25312228|NCT05057663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25312229|NCT05057663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25312230|NCT05057663|Immunologic Factors|immunologic factors|mesh-ancestor
25312231|NCT05057663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312232|NCT05057663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25312233|NCT05057286|Botulinum Toxins|botulinum toxins|mesh-list
25312234|NCT05057286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25312235|NCT05057286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25312236|NCT05057286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25312237|NCT05057286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312238|NCT05057286|Cholinergic Agents|cholinergic agents|mesh-ancestor
25312239|NCT05057286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25312240|NCT05057286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312241|NCT05057286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25312242|NCT05057286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25312243|NCT05057351|Glycerol|glycerol|mesh-list
25312244|NCT05057351|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25312245|NCT05057351|Protective Agents|protective agents|mesh-ancestor
25312246|NCT05057351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312247|NCT05056896|Aspirin|aspirin|mesh-list
25312248|NCT05056896|Salicylic Acid|salicylic acid|mesh-list
25312249|NCT05056896|Salicylates|salicylates|mesh-list
25312250|NCT05056896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25312251|NCT05056896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25312252|NCT05056896|Analgesics|analgesics|mesh-ancestor
25312259|NCT05056896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25312260|NCT05056896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312261|NCT05056896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25312262|NCT05056896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25312263|NCT05056896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312264|NCT05056896|Antipyretics|antipyretics|mesh-ancestor
25312265|NCT05056896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25312266|NCT05056896|Antifungal Agents|antifungal agents|mesh-ancestor
25312267|NCT05056896|Keratolytic Agents|keratolytic agents|mesh-ancestor
25312277|NCT05056337|Lenvatinib|lenvatinib|mesh-list
25312278|NCT05056337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25312279|NCT05056337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25312280|NCT05056337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312281|NCT05056337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312282|NCT05056025|Vitamins|vitamins|mesh-list
25312283|NCT05056025|Micronutrients|micronutrients|mesh-ancestor
25312284|NCT05056025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312285|NCT05055895|Cholinergic Antagonists|cholinergic antagonists|mesh-list
25312286|NCT05055895|Cholinergic Agents|cholinergic agents|mesh-ancestor
25312287|NCT05055895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25312288|NCT05055895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312289|NCT05055895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312290|NCT05055544|Fosfomycin|fosfomycin|mesh-list
25312291|NCT05055544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25312292|NCT05055544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25312300|NCT05054465|Venetoclax|venetoclax|mesh-list
25312301|NCT05054465|Navitoclax|navitoclax|mesh-list
25312302|NCT05054465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25312303|NCT05054478|Daratumumab|daratumumab|mesh-list
25312304|NCT05054478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25312305|NCT05054426|Methotrexate|methotrexate|mesh-list
25312306|NCT05054426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25312307|NCT05054426|Abortifacient Agents|abortifacient agents|mesh-ancestor
25312308|NCT05054426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25312309|NCT05054426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312310|NCT05054426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25312311|NCT05054426|Antimetabolites|antimetabolites|mesh-ancestor
25312312|NCT05054426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312313|NCT05054426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25312314|NCT05054426|Dermatologic Agents|dermatologic agents|mesh-ancestor
25312315|NCT05054426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312316|NCT05054426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25312317|NCT05054426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25312318|NCT05054426|Immunologic Factors|immunologic factors|mesh-ancestor
25312319|NCT05054426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25312320|NCT05054426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25312321|NCT05054322|Fluticasone|fluticasone|mesh-list
25312322|NCT05054322|Xhance|xhance|mesh-list
25312323|NCT05054322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25312324|NCT05054322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25312325|NCT05054322|Autonomic Agents|autonomic agents|mesh-ancestor
25312326|NCT05054322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25312327|NCT05054322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312328|NCT05054322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25312329|NCT05054322|Respiratory System Agents|respiratory system agents|mesh-ancestor
25312330|NCT05054322|Dermatologic Agents|dermatologic agents|mesh-ancestor
25312331|NCT05054322|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25312339|NCT05054114|Interferons|interferons|mesh-list
25312340|NCT05054114|Interferon-gamma|interferon-gamma|mesh-list
25312341|NCT05054114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25312342|NCT05054114|Antiviral Agents|antiviral agents|mesh-ancestor
25312343|NCT05054114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25312352|NCT05053594|Neostigmine|neostigmine|mesh-list
25312447|NCT05052359|Immunologic Factors|immunologic factors|mesh-ancestor
25312353|NCT05053594|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25312354|NCT05053594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312355|NCT05053594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312356|NCT05053594|Cholinergic Agents|cholinergic agents|mesh-ancestor
25312357|NCT05053594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25312358|NCT05053594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312359|NCT05053594|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25312360|NCT05053594|Autonomic Agents|autonomic agents|mesh-ancestor
25312361|NCT05053594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25312362|NCT05053893|Valsartan|valsartan|mesh-list
25312363|NCT05053893|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25312364|NCT05053893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25186904|NCT02817503|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25312365|NCT05053893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25312366|NCT05053893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25312367|NCT05053893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312368|NCT05053841|Metformin|metformin|mesh-list
25312369|NCT05053841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25312370|NCT05053841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312371|NCT05053009|Ibuprofen|ibuprofen|mesh-list
25312372|NCT05053009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25312373|NCT05053009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25312374|NCT05053009|Analgesics|analgesics|mesh-ancestor
25312375|NCT05053009|Sensory System Agents|sensory system agents|mesh-ancestor
25312376|NCT05053009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25312377|NCT05053009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312378|NCT05053009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25312379|NCT05053009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25312380|NCT05053009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25312381|NCT05053009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312382|NCT05053009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312383|NCT05053386|Epirubicin|epirubicin|mesh-list
25312384|NCT05053386|Idarubicin|idarubicin|mesh-list
25312385|NCT05053386|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25312386|NCT05053386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25312387|NCT05053386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25312388|NCT05053386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25312389|NCT05053386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312390|NCT05053386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312391|NCT05052879|Tadalafil|tadalafil|mesh-list
25312392|NCT05052879|Vasodilator Agents|vasodilator agents|mesh-ancestor
25312393|NCT05052879|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25312394|NCT05052879|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25312395|NCT05052879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312396|NCT05052879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312397|NCT05052879|Urological Agents|urological agents|mesh-ancestor
25312398|NCT05052515|Ascorbic Acid|ascorbic acid|mesh-list
25312399|NCT05052515|Choline|choline|mesh-list
25312400|NCT05052515|Vitamins|vitamins|mesh-ancestor
25312401|NCT05052515|Micronutrients|micronutrients|mesh-ancestor
25312402|NCT05052515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312403|NCT05052515|Antioxidants|antioxidants|mesh-ancestor
25312404|NCT05052515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312405|NCT05052515|Protective Agents|protective agents|mesh-ancestor
25312406|NCT05052515|Lipotropic Agents|lipotropic agents|mesh-ancestor
25312407|NCT05052515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25312408|NCT05052515|Antimetabolites|antimetabolites|mesh-ancestor
25312409|NCT05052515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25312410|NCT05052515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25312411|NCT05052515|Nootropic Agents|nootropic agents|mesh-ancestor
25312412|NCT05052619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25312413|NCT05052619|Cefmetazole|cefmetazole|mesh-list
25312414|NCT05052619|Sulperazone|sulperazone|mesh-list
25312415|NCT05052619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25312416|NCT05052619|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25312417|NCT05052619|Renal Agents|renal agents|mesh-ancestor
25312418|NCT05052437|Capecitabine|capecitabine|mesh-list
25312419|NCT05052437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25312420|NCT05052437|Antimetabolites|antimetabolites|mesh-ancestor
25312439|NCT05052008|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25312440|NCT05052008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312442|NCT05052008|Sensory System Agents|sensory system agents|mesh-ancestor
25312443|NCT05052008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25312444|NCT05052008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312445|NCT05052359|Lectins|lectins|mesh-list
25312448|NCT05052359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312449|NCT05052359|Coagulants|coagulants|mesh-ancestor
25312450|NCT05051956|Palbociclib|palbociclib|mesh-list
25312451|NCT05051956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25312452|NCT05051956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25312453|NCT05051956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312454|NCT05051956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825392|NCT00005591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312474|NCT05051137|Hydroxychloroquine|hydroxychloroquine|mesh-list
25312475|NCT05051137|Sulfasalazine|sulfasalazine|mesh-list
25312476|NCT05051137|Infliximab|infliximab|mesh-list
25648610|NCT01482169|Purinergic Agents|purinergic agents|mesh-ancestor
25312477|NCT05051137|Antimalarials|antimalarials|mesh-ancestor
25312478|NCT05051137|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25312479|NCT05051137|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25312480|NCT05051137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25312481|NCT05051137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312482|NCT05051137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312483|NCT05051137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25312484|NCT05051137|Dermatologic Agents|dermatologic agents|mesh-ancestor
25312485|NCT05051137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25312486|NCT05051137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25312487|NCT05051137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25312488|NCT05051137|Analgesics|analgesics|mesh-ancestor
25312489|NCT05051137|Sensory System Agents|sensory system agents|mesh-ancestor
25312490|NCT05051137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25312491|NCT05051137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312492|NCT05051137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25312493|NCT05051163|Gentamicins|gentamicins|mesh-list
25312494|NCT05051163|Ceftriaxone|ceftriaxone|mesh-list
25312495|NCT05051163|Ampicillin|ampicillin|mesh-list
25312497|NCT05051163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25312498|NCT05051163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25312499|NCT05051163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312500|NCT05051163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312501|NCT05050656|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25312502|NCT05050656|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25312503|NCT05050656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25312504|NCT05050656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25312505|NCT05050656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312506|NCT05050656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25312507|NCT05050656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312508|NCT05050656|Analgesics|analgesics|mesh-ancestor
25312509|NCT05050656|Sensory System Agents|sensory system agents|mesh-ancestor
25312510|NCT05050656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25312511|NCT05050656|Antidepressive Agents|antidepressive agents|mesh-ancestor
25312512|NCT05050656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25312513|NCT05050656|Dopamine Agents|dopamine agents|mesh-ancestor
25312514|NCT05050604|Choline|choline|mesh-list
25312515|NCT05050604|Lipotropic Agents|lipotropic agents|mesh-ancestor
25312516|NCT05050604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25312517|NCT05050604|Antimetabolites|antimetabolites|mesh-ancestor
25312518|NCT05050604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312519|NCT05050604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25312520|NCT05050604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25312521|NCT05050604|Nootropic Agents|nootropic agents|mesh-ancestor
25312522|NCT05050357|Norethindrone|norethindrone|mesh-list
25312523|NCT05050357|Norethindrone Acetate|norethindrone acetate|mesh-list
25312524|NCT05050357|Progestins|progestins|mesh-list
25312525|NCT05050357|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25312526|NCT05050357|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25312527|NCT05050357|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25312528|NCT05050357|Contraceptive Agents|contraceptive agents|mesh-ancestor
25312529|NCT05050357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25312530|NCT05050357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312531|NCT05050357|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25312532|NCT05050357|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25312533|NCT05050357|Hormones|hormones|mesh-ancestor
25312534|NCT05050357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25312535|NCT05050188|Lansoprazole|lansoprazole|mesh-list
25312536|NCT05050188|Dexlansoprazole|dexlansoprazole|mesh-list
25312537|NCT05050188|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25312538|NCT05050188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25312539|NCT05050188|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25312540|NCT05050188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312617|NCT05049681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25312541|NCT05050188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312542|NCT05050071|Calcium, Dietary|calcium, dietary|mesh-list
25312543|NCT05050071|Calcium|calcium|mesh-list
25312544|NCT05050071|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25312545|NCT05050071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312546|NCT05050071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25312547|NCT05050448|Diclofenac|diclofenac|mesh-list
25312548|NCT05050448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25312549|NCT05050448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25312550|NCT05050448|Analgesics|analgesics|mesh-ancestor
25312551|NCT05050448|Sensory System Agents|sensory system agents|mesh-ancestor
25312552|NCT05050448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25312553|NCT05050448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312554|NCT05050448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25312555|NCT05050448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25312556|NCT05050448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25312557|NCT05050448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312558|NCT05050448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312560|NCT05049603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25312561|NCT05049603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25312562|NCT05049603|Antimetabolites|antimetabolites|mesh-ancestor
25312563|NCT05049603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312564|NCT05049603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25312565|NCT05049603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25312566|NCT05049603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312567|NCT05049473|Cytarabine|cytarabine|mesh-list
25312568|NCT05049473|Dexamethasone|dexamethasone|mesh-list
25312569|NCT05049473|Prednisone|prednisone|mesh-list
25312570|NCT05049473|Hydrocortisone|hydrocortisone|mesh-list
25312571|NCT05049473|Cyclophosphamide|cyclophosphamide|mesh-list
25312572|NCT05049473|Rituximab|rituximab|mesh-list
25312573|NCT05049473|Doxorubicin|doxorubicin|mesh-list
25312574|NCT05049473|Methotrexate|methotrexate|mesh-list
25312575|NCT05049473|Etoposide|etoposide|mesh-list
25312576|NCT05049473|Vincristine|vincristine|mesh-list
25312577|NCT05049473|Vindesine|vindesine|mesh-list
25312578|NCT05049473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25312579|NCT05049473|Immunologic Factors|immunologic factors|mesh-ancestor
25312580|NCT05049473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312581|NCT05049473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25312582|NCT05049473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25312583|NCT05049473|Alkylating Agents|alkylating agents|mesh-ancestor
25312584|NCT05049473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312585|NCT05049473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25312586|NCT05049473|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25312587|NCT05049473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25312588|NCT05049473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25312589|NCT05049473|Antiemetics|antiemetics|mesh-ancestor
25312590|NCT05049473|Autonomic Agents|autonomic agents|mesh-ancestor
25312591|NCT05049473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25312592|NCT05049473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25312593|NCT05049473|Glucocorticoids|glucocorticoids|mesh-ancestor
25312594|NCT05049473|Hormones|hormones|mesh-ancestor
25312595|NCT05049473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25312596|NCT05049473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25312597|NCT05049473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25312598|NCT05049473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25312599|NCT05049473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25312600|NCT05049473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312601|NCT05049473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25312602|NCT05049473|Abortifacient Agents|abortifacient agents|mesh-ancestor
25312603|NCT05049473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25312604|NCT05049473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25312605|NCT05049473|Antimetabolites|antimetabolites|mesh-ancestor
25312606|NCT05049473|Dermatologic Agents|dermatologic agents|mesh-ancestor
25312607|NCT05049473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25312608|NCT05049473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25312609|NCT05049473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25312610|NCT05049473|Antiviral Agents|antiviral agents|mesh-ancestor
25312611|NCT05049473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25312612|NCT05049473|Tubulin Modulators|tubulin modulators|mesh-ancestor
25312613|NCT05049473|Antimitotic Agents|antimitotic agents|mesh-ancestor
25312614|NCT05049473|Mitosis Modulators|mitosis modulators|mesh-ancestor
25312615|NCT05049681|Apatinib|apatinib|mesh-list
25312616|NCT05049681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25312618|NCT05049681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312619|NCT05049681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312621|NCT05048914|Dipyrone|dipyrone|mesh-list
25312622|NCT05048914|Ibuprofen|ibuprofen|mesh-list
25312623|NCT05048914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25312624|NCT05048914|Analgesics|analgesics|mesh-ancestor
25312625|NCT05048914|Sensory System Agents|sensory system agents|mesh-ancestor
25312626|NCT05048914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25312627|NCT05048914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312628|NCT05048914|Antipyretics|antipyretics|mesh-ancestor
25312629|NCT05048914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25312630|NCT05048914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25312631|NCT05048914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25312632|NCT05048914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25312633|NCT05048914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312634|NCT05048914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312635|NCT05048940|Vaccines|vaccines|mesh-list
25312636|NCT05048940|Immunologic Factors|immunologic factors|mesh-ancestor
25312637|NCT05048940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312638|NCT05048901|Lanreotide|lanreotide|mesh-list
25312639|NCT05048901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24818942|NCT02092012|Analgesics|analgesics|mesh-ancestor
25312640|NCT05048615|Itraconazole|itraconazole|mesh-list
25312641|NCT05048615|Azacitidine|azacitidine|mesh-list
25312642|NCT05048615|Venetoclax|venetoclax|mesh-list
25312643|NCT05048615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25312644|NCT05048615|Antimetabolites|antimetabolites|mesh-ancestor
25312684|NCT05048017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25312685|NCT05048017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25312686|NCT05048017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25312687|NCT05048017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312688|NCT05047874|Methylprednisolone|methylprednisolone|mesh-list
25312689|NCT05047874|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25312690|NCT05047874|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25312691|NCT05047874|Prednisolone|prednisolone|mesh-list
25312692|NCT05047874|Prednisolone acetate|prednisolone acetate|mesh-list
25312693|NCT05047874|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25312694|NCT05047874|Prednisolone phosphate|prednisolone phosphate|mesh-list
25312695|NCT05047874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25312696|NCT05047874|Antiemetics|antiemetics|mesh-ancestor
25312697|NCT05047874|Autonomic Agents|autonomic agents|mesh-ancestor
25312698|NCT05047874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25312699|NCT05047874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312700|NCT05047874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25312701|NCT05047874|Glucocorticoids|glucocorticoids|mesh-ancestor
25312702|NCT05047874|Hormones|hormones|mesh-ancestor
25312703|NCT05047874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25312704|NCT05047874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25312705|NCT05047874|Protective Agents|protective agents|mesh-ancestor
25312706|NCT05047874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25312707|NCT05047874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25312708|NCT05047848|Fulvestrant|fulvestrant|mesh-list
25312709|NCT05047848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25312710|NCT05047848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25312711|NCT05047848|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25312712|NCT05047848|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25312713|NCT05047848|Hormone Antagonists|hormone antagonists|mesh-ancestor
25312714|NCT05047848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25312715|NCT05047848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312716|NCT05047991|Leucovorin|leucovorin|mesh-list
25312717|NCT05047991|Gemcitabine|gemcitabine|mesh-list
25312718|NCT05047991|Paclitaxel|paclitaxel|mesh-list
25312719|NCT05047991|Fluorouracil|fluorouracil|mesh-list
25312720|NCT05047991|Oxaliplatin|oxaliplatin|mesh-list
25312722|NCT05047991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25312723|NCT05047991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25312724|NCT05047991|Tubulin Modulators|tubulin modulators|mesh-ancestor
25312725|NCT05047991|Antimitotic Agents|antimitotic agents|mesh-ancestor
25312726|NCT05047991|Mitosis Modulators|mitosis modulators|mesh-ancestor
25312727|NCT05047991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312728|NCT05047991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25312729|NCT05047991|Antimetabolites|antimetabolites|mesh-ancestor
25312730|NCT05047991|Antiviral Agents|antiviral agents|mesh-ancestor
25312731|NCT05047991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25312732|NCT05047991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312733|NCT05047991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25312734|NCT05047991|Immunologic Factors|immunologic factors|mesh-ancestor
25312735|NCT05047991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312736|NCT05047991|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25312737|NCT05047991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25312739|NCT05047991|Protective Agents|protective agents|mesh-ancestor
25312740|NCT05047991|Vitamin B Complex|vitamin b complex|mesh-ancestor
25312741|NCT05047991|Vitamins|vitamins|mesh-ancestor
25312742|NCT05047991|Micronutrients|micronutrients|mesh-ancestor
25312743|NCT05047978|Caseins|caseins|mesh-list
25312744|NCT05047978|Chelating Agents|chelating agents|mesh-ancestor
25312745|NCT05047978|Sequestering Agents|sequestering agents|mesh-ancestor
25187159|NCT02816151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187160|NCT02816151|Cholinergic Agents|cholinergic agents|mesh-ancestor
25187161|NCT02816151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25205860|NCT04120870|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25205861|NCT04120870|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25205862|NCT04120870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25205863|NCT04120870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205864|NCT04120870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25205866|NCT04083950|Vaccines|vaccines|mesh-list
25205867|NCT04083950|Immunologic Factors|immunologic factors|mesh-ancestor
25205868|NCT04083950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205869|NCT04083950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25205870|NCT04083950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25205871|NCT04083950|Analgesics|analgesics|mesh-ancestor
25205872|NCT04083950|Sensory System Agents|sensory system agents|mesh-ancestor
25205873|NCT04083950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25205874|NCT04083950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25205875|NCT04083950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25312746|NCT05047978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312747|NCT05047328|Inolimomab|inolimomab|mesh-list
25312748|NCT05047328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25312749|NCT05047328|Immunologic Factors|immunologic factors|mesh-ancestor
25312750|NCT05047328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312751|NCT05047133|Tranexamic Acid|tranexamic acid|mesh-list
25312752|NCT05047133|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25312753|NCT05047133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25312754|NCT05047133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312755|NCT05047133|Hemostatics|hemostatics|mesh-ancestor
25312756|NCT05047133|Coagulants|coagulants|mesh-ancestor
25312757|NCT05047393|Vitamin D|vitamin d|mesh-list
25312758|NCT05047393|Vitamins|vitamins|mesh-ancestor
25312759|NCT05047393|Micronutrients|micronutrients|mesh-ancestor
25312760|NCT05047393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312761|NCT05047393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25312762|NCT05047211|Dextrans|dextrans|mesh-list
25312763|NCT05047211|Iron-Dextran Complex|iron-dextran complex|mesh-list
25312764|NCT05047211|Anticoagulants|anticoagulants|mesh-ancestor
25312765|NCT05047211|Plasma Substitutes|plasma substitutes|mesh-ancestor
25312766|NCT05047211|Blood Substitutes|blood substitutes|mesh-ancestor
25312767|NCT05047211|Hematinics|hematinics|mesh-ancestor
25312768|NCT05046860|Dalbavancin|dalbavancin|mesh-list
25312769|NCT05046860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25312770|NCT05046860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25312771|NCT05047055|Moxifloxacin|moxifloxacin|mesh-list
25312772|NCT05047055|Rifampin|rifampin|mesh-list
25312773|NCT05047055|Isoniazid|isoniazid|mesh-list
25312774|NCT05047055|Pyrazinamide|pyrazinamide|mesh-list
25312775|NCT05047055|Ethambutol|ethambutol|mesh-list
25312776|NCT05047055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25312777|NCT05047055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25312778|NCT05047055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25312779|NCT05047055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25312780|NCT05047055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312781|NCT05047055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312782|NCT05047055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25648611|NCT01482169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25648612|NCT01482169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648613|NCT01482169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648614|NCT01482169|Analgesics|analgesics|mesh-ancestor
25648615|NCT01482169|Sensory System Agents|sensory system agents|mesh-ancestor
25648616|NCT01482169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25648617|NCT01482169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25648618|NCT01482169|Vasodilator Agents|vasodilator agents|mesh-ancestor
25648619|NCT01482715|Rucaparib|rucaparib|mesh-list
25648620|NCT01482715|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25648621|NCT01482715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25648622|NCT01482715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648623|NCT01482715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25648624|NCT01482767|Interferons|interferons|mesh-list
25648625|NCT01482767|Ribavirin|ribavirin|mesh-list
25648626|NCT01482767|Interferon-alpha|interferon-alpha|mesh-list
25648627|NCT01482767|Interferon alpha-2|interferon alpha-2|mesh-list
25648628|NCT01482767|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25648629|NCT01482767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25648630|NCT01482767|Antiviral Agents|antiviral agents|mesh-ancestor
24415029|NCT00199043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312783|NCT05047055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25312784|NCT05047055|Antitubercular Agents|antitubercular agents|mesh-ancestor
25312785|NCT05047055|Leprostatic Agents|leprostatic agents|mesh-ancestor
25312786|NCT05047055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25312787|NCT05047055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24910569|NCT04296240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25312788|NCT05047055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25312789|NCT05047055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25312790|NCT05047055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25312791|NCT05047055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25312792|NCT05047055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25312793|NCT05047055|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25312794|NCT05047055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25312795|NCT05047055|Antimetabolites|antimetabolites|mesh-ancestor
25312796|NCT05047055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25312810|NCT05046457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312811|NCT05046041|Misoprostol|misoprostol|mesh-list
25312812|NCT05046041|Mifepristone|mifepristone|mesh-list
25312813|NCT05046041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25312814|NCT05046041|Abortifacient Agents|abortifacient agents|mesh-ancestor
25312815|NCT05046041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25312816|NCT05046041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312817|NCT05046041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25312818|NCT05046041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25312819|NCT05046041|Oxytocics|oxytocics|mesh-ancestor
25312820|NCT05046041|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25312821|NCT05046041|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25312822|NCT05046041|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25312823|NCT05046041|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25312824|NCT05046041|Contraceptive Agents|contraceptive agents|mesh-ancestor
25312825|NCT05046041|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25312826|NCT05046041|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25312827|NCT05046041|Hormone Antagonists|hormone antagonists|mesh-ancestor
25312828|NCT05046041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25312829|NCT05046041|Luteolytic Agents|luteolytic agents|mesh-ancestor
25312830|NCT05046041|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25312831|NCT05046041|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25312832|NCT05046015|Carbamide Peroxide|carbamide peroxide|mesh-list
25312833|NCT05046015|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25312834|NCT05046015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25008238|NCT00826462|Hormones|hormones|mesh-ancestor
25312835|NCT05045651|Cimetidine|cimetidine|mesh-list
25312836|NCT05045651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25312837|NCT05045651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25312838|NCT05045651|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25312839|NCT05045651|Histamine Antagonists|histamine antagonists|mesh-ancestor
25312840|NCT05045651|Histamine Agents|histamine agents|mesh-ancestor
25312841|NCT05045651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25312842|NCT05045651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312843|NCT05045651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312844|NCT05045651|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25312845|NCT05045651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25312846|NCT05045651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312847|NCT05045508|Varenicline|varenicline|mesh-list
25312848|NCT05045508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25312849|NCT05045508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25312850|NCT05045508|Cholinergic Agents|cholinergic agents|mesh-ancestor
25312851|NCT05045508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25312852|NCT05045508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312853|NCT05045508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312854|NCT05045248|Apraclonidine|apraclonidine|mesh-list
25312855|NCT05045248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25312856|NCT05045248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25312857|NCT05045248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25312858|NCT05045248|Adrenergic Agents|adrenergic agents|mesh-ancestor
25312859|NCT05045248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25312860|NCT05045248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312861|NCT05045248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312862|NCT05045274|Aspirin|aspirin|mesh-list
25312863|NCT05045274|Dapagliflozin|dapagliflozin|mesh-list
25312864|NCT05045274|Angiotensin II|angiotensin ii|mesh-list
25656851|NCT01579578|Paclitaxel|paclitaxel|mesh-list
25187237|NCT02815111|Analgesics|analgesics|mesh-ancestor
25312865|NCT05045274|Giapreza|giapreza|mesh-list
25312866|NCT05045274|Clopidogrel|clopidogrel|mesh-list
25312867|NCT05045274|Ticagrelor|ticagrelor|mesh-list
25312868|NCT05045274|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
25312869|NCT05045274|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25312870|NCT05045274|Angiotensinogen|angiotensinogen|mesh-list
25312871|NCT05045274|Diuretics|diuretics|mesh-list
25312872|NCT05045274|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25312873|NCT05045274|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25312874|NCT05045274|Mineralocorticoids|mineralocorticoids|mesh-list
25312875|NCT05045274|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
25312876|NCT05045274|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
25312877|NCT05045274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25312878|NCT05045274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25312879|NCT05045274|Analgesics|analgesics|mesh-ancestor
25312880|NCT05045274|Sensory System Agents|sensory system agents|mesh-ancestor
25312881|NCT05045274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25312882|NCT05045274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312883|NCT05045274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25312884|NCT05045274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25312885|NCT05045274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25312886|NCT05045274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25312887|NCT05045274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312888|NCT05045274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25312889|NCT05045274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25312890|NCT05045274|Antipyretics|antipyretics|mesh-ancestor
25312891|NCT05045274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25312892|NCT05045274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25312893|NCT05045274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25312894|NCT05045274|Purinergic Agents|purinergic agents|mesh-ancestor
25312895|NCT05045274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25312896|NCT05045274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25312897|NCT05045274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25312898|NCT05045274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25312899|NCT05045274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25312900|NCT05045274|Antimetabolites|antimetabolites|mesh-ancestor
25312901|NCT05045274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25312902|NCT05045274|Natriuretic Agents|natriuretic agents|mesh-ancestor
25312903|NCT05045274|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25312904|NCT05045274|Adrenergic Agents|adrenergic agents|mesh-ancestor
25312905|NCT05045274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25312906|NCT05045274|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25312907|NCT05045274|Protease Inhibitors|protease inhibitors|mesh-ancestor
25312908|NCT05045274|Hormones|hormones|mesh-ancestor
25312909|NCT05045274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25312910|NCT05045274|Hormone Antagonists|hormone antagonists|mesh-ancestor
25312911|NCT05045274|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25312912|NCT05045443|Curcumin|curcumin|mesh-list
25312913|NCT05045443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25312914|NCT05045443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25312915|NCT05045443|Analgesics|analgesics|mesh-ancestor
25312916|NCT05045443|Sensory System Agents|sensory system agents|mesh-ancestor
25312917|NCT05045443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25312918|NCT05045443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312919|NCT05045443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25312920|NCT05045443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25312921|NCT05045443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25312922|NCT05045443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312923|NCT05045443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312924|NCT05045053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25312925|NCT05045053|Lifitegrast|lifitegrast|mesh-list
25312926|NCT05045053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25312927|NCT05044728|Paclitaxel|paclitaxel|mesh-list
25312928|NCT05044728|Carboplatin|carboplatin|mesh-list
25312929|NCT05044728|Antibodies|antibodies|mesh-list
25312930|NCT05044728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25312931|NCT05044728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25312932|NCT05044728|Tubulin Modulators|tubulin modulators|mesh-ancestor
25312933|NCT05044728|Antimitotic Agents|antimitotic agents|mesh-ancestor
25312934|NCT05044728|Mitosis Modulators|mitosis modulators|mesh-ancestor
25312935|NCT05044728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312936|NCT05044728|Immunologic Factors|immunologic factors|mesh-ancestor
25312937|NCT05044728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648631|NCT01482767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25187309|NCT02814630|Respiratory System Agents|respiratory system agents|mesh-ancestor
25187310|NCT02814058|Zolpidem|zolpidem|mesh-list
25187311|NCT02814058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25187312|NCT02814058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25187313|NCT02814058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25187314|NCT02814058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187315|NCT02814058|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25187316|NCT02814058|GABA Agonists|gaba agonists|mesh-ancestor
25187317|NCT02814058|GABA Agents|gaba agents|mesh-ancestor
25187318|NCT02814058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25187319|NCT02814058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312938|NCT05044169|Broncho-Vaxom|broncho-vaxom|mesh-list
25312939|NCT05044169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25312940|NCT05044169|Immunologic Factors|immunologic factors|mesh-ancestor
25312941|NCT05044169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312942|NCT05044429|Lidocaine|lidocaine|mesh-list
25312943|NCT05044429|Anesthetics, Local|anesthetics, local|mesh-ancestor
25312944|NCT05044429|Anesthetics|anesthetics|mesh-ancestor
25313451|NCT05035498|Norepinephrine|norepinephrine|mesh-list
25312970|NCT05044364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312971|NCT05044364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24827473|NCT02139345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24827474|NCT02139579|Bevacizumab|bevacizumab|mesh-list
24827475|NCT02139579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24827476|NCT02139579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827477|NCT02139579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24827478|NCT02139579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24911634|NCT04285528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24911635|NCT04285528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24911636|NCT04285528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25312972|NCT05044364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25312973|NCT05043935|Anti-Infective Agents|anti-infective agents|mesh-list
25312974|NCT05043935|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25312975|NCT05044091|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25312976|NCT05044091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25312977|NCT05044091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312978|NCT05044091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25312990|NCT05043740|Evolocumab|evolocumab|mesh-list
25312991|NCT05043740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25312992|NCT05043740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25312993|NCT05043740|Antimetabolites|antimetabolites|mesh-ancestor
25312994|NCT05043740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25312995|NCT05043740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25312996|NCT05043896|Tadalafil|tadalafil|mesh-list
25312997|NCT05043896|Vasodilator Agents|vasodilator agents|mesh-ancestor
25312998|NCT05043896|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25312999|NCT05043896|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25313000|NCT05043896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25313001|NCT05043896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313002|NCT05043896|Urological Agents|urological agents|mesh-ancestor
25313003|NCT05043506|Palbociclib|palbociclib|mesh-list
25313004|NCT05043506|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25313005|NCT05043506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25313006|NCT05043506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25313007|NCT05043506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25313452|NCT05035498|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25313019|NCT05043688|Tubulin Modulators|tubulin modulators|mesh-ancestor
25313020|NCT05043688|Antimitotic Agents|antimitotic agents|mesh-ancestor
25313021|NCT05043688|Mitosis Modulators|mitosis modulators|mesh-ancestor
25313022|NCT05043688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313024|NCT05043350|Famotidine|famotidine|mesh-list
25313025|NCT05043350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25313026|NCT05043350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25648632|NCT01482767|Antimetabolites|antimetabolites|mesh-ancestor
25648633|NCT01482767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648634|NCT01482767|Immunologic Factors|immunologic factors|mesh-ancestor
25648635|NCT01482767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648636|NCT01482910|Aflibercept|aflibercept|mesh-list
25648637|NCT01482910|Verteporfin|verteporfin|mesh-list
25648638|NCT01482910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25648639|NCT01482910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25648640|NCT01482910|Growth Substances|growth substances|mesh-ancestor
25648641|NCT01482910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648642|NCT01482910|Growth Inhibitors|growth inhibitors|mesh-ancestor
25313027|NCT05043350|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25313028|NCT05043350|Histamine Antagonists|histamine antagonists|mesh-ancestor
25313029|NCT05043350|Histamine Agents|histamine agents|mesh-ancestor
25313030|NCT05043350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25313031|NCT05043350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313032|NCT05043350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313033|NCT05043350|Antipruritics|antipruritics|mesh-ancestor
25313034|NCT05043350|Dermatologic Agents|dermatologic agents|mesh-ancestor
25313035|NCT05043350|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25313036|NCT05043350|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25313037|NCT05043350|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25313038|NCT05043194|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25313039|NCT05043194|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25313040|NCT05043194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25313041|NCT05043233|Methimazole|methimazole|mesh-list
25313042|NCT05043233|Antithyroid Agents|antithyroid agents|mesh-ancestor
25313043|NCT05043233|Hormone Antagonists|hormone antagonists|mesh-ancestor
25313044|NCT05043233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25065203|NCT03452345|Cholinergic Agents|cholinergic agents|mesh-ancestor
25313045|NCT05043233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313046|NCT05043129|Vaccines|vaccines|mesh-list
25313047|NCT05043129|Immunologic Factors|immunologic factors|mesh-ancestor
25313048|NCT05043129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717140|NCT01545856|Levodopa|levodopa|mesh-list
25313049|NCT05043142|Antibodies|antibodies|mesh-list
25313050|NCT05043142|Immunologic Factors|immunologic factors|mesh-ancestor
25313051|NCT05043142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313064|NCT05042817|Sufentanil|sufentanil|mesh-list
25313065|NCT05042817|Morphine|morphine|mesh-list
25313066|NCT05042817|Prilocaine|prilocaine|mesh-list
25313067|NCT05042817|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25313068|NCT05042817|Narcotics|narcotics|mesh-ancestor
25313069|NCT05042817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25313070|NCT05042817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313071|NCT05042817|Analgesics|analgesics|mesh-ancestor
25313072|NCT05042817|Sensory System Agents|sensory system agents|mesh-ancestor
25313073|NCT05042817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25313074|NCT05042817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25313075|NCT05042817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25313076|NCT05042817|Anesthetics, General|anesthetics, general|mesh-ancestor
25313077|NCT05042817|Anesthetics|anesthetics|mesh-ancestor
25313078|NCT05042817|Anesthetics, Local|anesthetics, local|mesh-ancestor
25313079|NCT05042635|Ixekizumab|ixekizumab|mesh-list
25313080|NCT05042635|Dermatologic Agents|dermatologic agents|mesh-ancestor
25313087|NCT05042336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25313088|NCT05042336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313090|NCT05042271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25313091|NCT05042271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25313092|NCT05042245|Silymarin|silymarin|mesh-list
25313093|NCT05042245|N-Methylaspartate|n-methylaspartate|mesh-list
25313094|NCT05042245|Antioxidants|antioxidants|mesh-ancestor
25313095|NCT05042245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313096|NCT05042245|Protective Agents|protective agents|mesh-ancestor
25313097|NCT05042245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313098|NCT05042245|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
25313099|NCT05042245|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25313100|NCT05042245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25313101|NCT05041985|Diazepam|diazepam|mesh-list
25313102|NCT05041985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25313103|NCT05041985|Anticonvulsants|anticonvulsants|mesh-ancestor
25313104|NCT05041985|Antiemetics|antiemetics|mesh-ancestor
25313105|NCT05041985|Autonomic Agents|autonomic agents|mesh-ancestor
25313106|NCT05041985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25313107|NCT05041985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313108|NCT05041985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25313109|NCT05041985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25313110|NCT05041985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25313111|NCT05041985|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25313112|NCT05041985|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25313113|NCT05041985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25313114|NCT05041985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25313115|NCT05041985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25313116|NCT05041985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25313117|NCT05041985|Anesthetics, General|anesthetics, general|mesh-ancestor
25313118|NCT05041985|Anesthetics|anesthetics|mesh-ancestor
24791175|NCT05068063|Anesthetics|anesthetics|mesh-ancestor
24912192|NCT04278807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24527536|NCT00617045|Dopamine Agents|dopamine agents|mesh-ancestor
25104943|NCT03149939|Gout Suppressants|gout suppressants|mesh-ancestor
25104944|NCT03149939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25104945|NCT03149913|Paclitaxel|paclitaxel|mesh-list
25104946|NCT03149913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25104947|NCT03149913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25104948|NCT03149913|Tubulin Modulators|tubulin modulators|mesh-ancestor
24528057|NCT00619398|Tacrolimus|tacrolimus|mesh-list
25104969|NCT03149432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104970|NCT03149432|Anticonvulsants|anticonvulsants|mesh-ancestor
25104971|NCT03149432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24998369|NCT03009201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24998370|NCT03009201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25048601|NCT00682981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24912194|NCT04278677|Melatonin|melatonin|mesh-list
24912209|NCT04278833|Glucocorticoids|glucocorticoids|mesh-ancestor
24912210|NCT04278833|Hormones|hormones|mesh-ancestor
24912211|NCT04278833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25065247|NCT03451682|Procyanidin|procyanidin|mesh-list
25313119|NCT05041985|GABA Modulators|gaba modulators|mesh-ancestor
25313120|NCT05041985|GABA Agents|gaba agents|mesh-ancestor
25313121|NCT05041985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25313122|NCT05041985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313123|NCT05042024|N-Methylaspartate|n-methylaspartate|mesh-list
25313124|NCT05042024|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
25313125|NCT05042024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25313126|NCT05042024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25313127|NCT05042024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313128|NCT05042024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313129|NCT05041582|Citalopram|citalopram|mesh-list
25313130|NCT05041582|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25313131|NCT05041582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25313132|NCT05041582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25313133|NCT05041582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313134|NCT05041582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25313135|NCT05041582|Serotonin Agents|serotonin agents|mesh-ancestor
25313136|NCT05041582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313137|NCT05041582|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25313138|NCT05041582|Antidepressive Agents|antidepressive agents|mesh-ancestor
25313139|NCT05041582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25313140|NCT05041790|Choline|choline|mesh-list
25313141|NCT05041790|Lipotropic Agents|lipotropic agents|mesh-ancestor
25313142|NCT05041790|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25313143|NCT05041790|Antimetabolites|antimetabolites|mesh-ancestor
25313144|NCT05041790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313145|NCT05041790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25313146|NCT05041790|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25313147|NCT05041790|Nootropic Agents|nootropic agents|mesh-ancestor
25313453|NCT05035498|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25313164|NCT05041270|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25313165|NCT05041270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25313166|NCT05041270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25313167|NCT05041270|Adrenergic Agents|adrenergic agents|mesh-ancestor
25313168|NCT05041270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25313169|NCT05041270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313170|NCT05041270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25313171|NCT05041270|Narcotics|narcotics|mesh-ancestor
25313172|NCT05040906|Rituximab|rituximab|mesh-list
25313173|NCT05040906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25648643|NCT01482910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25648644|NCT01482910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25648645|NCT01482910|Dermatologic Agents|dermatologic agents|mesh-ancestor
25648646|NCT01482962|Gemcitabine|gemcitabine|mesh-list
25648647|NCT01482962|Romidepsin|romidepsin|mesh-list
25648648|NCT01482962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25648649|NCT01482962|Antimetabolites|antimetabolites|mesh-ancestor
25648650|NCT01482962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648651|NCT01482962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25648652|NCT01482962|Antiviral Agents|antiviral agents|mesh-ancestor
25648653|NCT01482962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25648654|NCT01482962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25648655|NCT01482962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25648656|NCT01482962|Immunologic Factors|immunologic factors|mesh-ancestor
25648657|NCT01482962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313174|NCT05040906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25313175|NCT05040906|Immunologic Factors|immunologic factors|mesh-ancestor
25313176|NCT05040906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313177|NCT05040906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25313178|NCT05040828|Montelukast|montelukast|mesh-list
25313179|NCT05040828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25313180|NCT05040828|Respiratory System Agents|respiratory system agents|mesh-ancestor
25313181|NCT05040828|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25313182|NCT05040828|Hormone Antagonists|hormone antagonists|mesh-ancestor
25313183|NCT05040828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25313184|NCT05040828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313185|NCT05040828|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25313186|NCT05040828|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25313187|NCT05040828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313189|NCT05040724|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25313190|NCT05040724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25313191|NCT05040594|Lidocaine|lidocaine|mesh-list
25313192|NCT05040594|Anesthetics, Local|anesthetics, local|mesh-ancestor
25313193|NCT05040594|Anesthetics|anesthetics|mesh-ancestor
25313194|NCT05040594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25313195|NCT05040594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313196|NCT05040594|Sensory System Agents|sensory system agents|mesh-ancestor
25313197|NCT05040594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25313198|NCT05040594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25313199|NCT05040594|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25313200|NCT05040594|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25313201|NCT05040594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25313202|NCT05040594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313203|NCT05040217|Mitogens|mitogens|mesh-list
25313204|NCT05040217|Mitosis Modulators|mitosis modulators|mesh-ancestor
25313205|NCT05040217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313209|NCT05039580|Dexamethasone|dexamethasone|mesh-list
25313210|NCT05039580|Antibodies|antibodies|mesh-list
25313211|NCT05039580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25313212|NCT05039580|Immunologic Factors|immunologic factors|mesh-ancestor
25313213|NCT05039580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313214|NCT05039580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25313215|NCT05039580|Antiemetics|antiemetics|mesh-ancestor
25313216|NCT05039580|Autonomic Agents|autonomic agents|mesh-ancestor
25313217|NCT05039580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25313218|NCT05039580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25313219|NCT05039580|Glucocorticoids|glucocorticoids|mesh-ancestor
25313220|NCT05039580|Hormones|hormones|mesh-ancestor
25313221|NCT05039580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25313222|NCT05039580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25313223|NCT05039580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25313224|NCT05039606|Nedaplatin|nedaplatin|mesh-list
25313225|NCT05039606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25313226|NCT05038969|Esomeprazole|esomeprazole|mesh-list
25313227|NCT05038969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25313228|NCT05038969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25313229|NCT05038969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25313230|NCT05038969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25313231|NCT05038969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313232|NCT05038605|Metronidazole|metronidazole|mesh-list
25313233|NCT05038605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25313234|NCT05038605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25313235|NCT05038605|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25313236|NCT05038605|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25313237|NCT05038657|Atezolizumab|atezolizumab|mesh-list
25313238|NCT05038657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25313239|NCT05038072|Triamcinolone|triamcinolone|mesh-list
25313240|NCT05038072|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25313241|NCT05038072|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25313242|NCT05038072|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25313243|NCT05038072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25313244|NCT05038072|Glucocorticoids|glucocorticoids|mesh-ancestor
25313245|NCT05038072|Hormones|hormones|mesh-ancestor
25313246|NCT05038072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25313247|NCT05038072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313248|NCT05038072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25313249|NCT05038072|Immunologic Factors|immunologic factors|mesh-ancestor
25313250|NCT05038072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25313251|NCT05038072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187514|NCT02812368|Sympatholytics|sympatholytics|mesh-ancestor
25187515|NCT02812368|Autonomic Agents|autonomic agents|mesh-ancestor
25187516|NCT02812368|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25187517|NCT02812368|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25187518|NCT02812368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25187519|NCT02812368|Adrenergic Agents|adrenergic agents|mesh-ancestor
25187520|NCT02812368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25187521|NCT02812368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187522|NCT02812394|Levodopa|levodopa|mesh-list
25313252|NCT05038007|Bupivacaine|bupivacaine|mesh-list
25313253|NCT05038007|Anesthetics, Local|anesthetics, local|mesh-ancestor
25313254|NCT05038007|Anesthetics|anesthetics|mesh-ancestor
25313255|NCT05038007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25313256|NCT05038007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313257|NCT05038007|Sensory System Agents|sensory system agents|mesh-ancestor
25313258|NCT05038007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25313259|NCT05038111|Dexmedetomidine|dexmedetomidine|mesh-list
25313260|NCT05038111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25313261|NCT05038111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25313262|NCT05038111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313263|NCT05038111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25313264|NCT05038111|Analgesics|analgesics|mesh-ancestor
25313265|NCT05038111|Sensory System Agents|sensory system agents|mesh-ancestor
25313266|NCT05038111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25313267|NCT05038111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25313268|NCT05038111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25313269|NCT05038111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25313270|NCT05038111|Adrenergic Agents|adrenergic agents|mesh-ancestor
25313271|NCT05038111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25313272|NCT05038111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313273|NCT05038202|Mometasone Furoate|mometasone furoate|mesh-list
25313274|NCT05038202|Bromides|bromides|mesh-list
25313275|NCT05038202|Anticonvulsants|anticonvulsants|mesh-ancestor
25313276|NCT05038202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25313277|NCT05038202|Dermatologic Agents|dermatologic agents|mesh-ancestor
25313278|NCT05038202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25313279|NCT05038449|Colchicine|colchicine|mesh-list
25313280|NCT05038449|Gout Suppressants|gout suppressants|mesh-ancestor
25313281|NCT05038449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25313282|NCT05038449|Tubulin Modulators|tubulin modulators|mesh-ancestor
25313283|NCT05038449|Antimitotic Agents|antimitotic agents|mesh-ancestor
25313284|NCT05038449|Mitosis Modulators|mitosis modulators|mesh-ancestor
25313285|NCT05038449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313286|NCT05038449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25313287|NCT05038059|Acetic Acid|acetic acid|mesh-list
25313288|NCT05038059|Retinol acetate|retinol acetate|mesh-list
25313289|NCT05038059|Ethylene|ethylene|mesh-list
25313290|NCT05038059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25313291|NCT05038059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25313292|NCT05038059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25313293|NCT05038059|Immunologic Factors|immunologic factors|mesh-ancestor
25313294|NCT05038059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313295|NCT05038059|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25313296|NCT05038059|Protective Agents|protective agents|mesh-ancestor
25313297|NCT05038059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25313298|NCT05038059|Plant Growth Regulators|plant growth regulators|mesh-ancestor
25313299|NCT05038059|Growth Substances|growth substances|mesh-ancestor
25313322|NCT05037253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25313323|NCT05037240|Quercetin|quercetin|mesh-list
25313324|NCT05037240|Antioxidants|antioxidants|mesh-ancestor
25313325|NCT05037240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313326|NCT05037240|Protective Agents|protective agents|mesh-ancestor
25313327|NCT05037240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313328|NCT05037006|Anesthetics|anesthetics|mesh-list
25313329|NCT05037006|Sevoflurane|sevoflurane|mesh-list
25313330|NCT05037006|Neostigmine|neostigmine|mesh-list
25648658|NCT01482962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25648659|NCT01483144|Eflornithine|eflornithine|mesh-list
25648660|NCT01483144|Sulindac|sulindac|mesh-list
25648661|NCT01483144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25648662|NCT01483144|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25648663|NCT01483144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25648664|NCT01483144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25648665|NCT01483144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25648666|NCT01483144|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
25313331|NCT05037006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25648667|NCT01483144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25313332|NCT05037006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313333|NCT05037006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25313334|NCT05037006|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25313335|NCT05037006|Anesthetics, General|anesthetics, general|mesh-ancestor
25313336|NCT05037006|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25313337|NCT05037006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25313338|NCT05037006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313339|NCT05037006|Cholinergic Agents|cholinergic agents|mesh-ancestor
25313340|NCT05037006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25313341|NCT05037006|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25313342|NCT05037006|Autonomic Agents|autonomic agents|mesh-ancestor
25313343|NCT05037006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25313344|NCT05036824|Tinzaparin|tinzaparin|mesh-list
25313345|NCT05036824|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25313346|NCT05036824|Dalteparin|dalteparin|mesh-list
25313347|NCT05036824|Anticoagulants|anticoagulants|mesh-ancestor
25313348|NCT05036824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25313349|NCT05036824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25313350|NCT05036824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313356|NCT05036005|Pertuzumab|pertuzumab|mesh-list
25313357|NCT05036005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25313358|NCT05036005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25313359|NCT05035953|Edaravone|edaravone|mesh-list
25313360|NCT05035953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25313361|NCT05035953|Antioxidants|antioxidants|mesh-ancestor
25313362|NCT05035953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313363|NCT05035953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25313364|NCT05035953|Protective Agents|protective agents|mesh-ancestor
25313482|NCT05035485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25313365|NCT05035953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313366|NCT05036174|Diphenhydramine|diphenhydramine|mesh-list
25313367|NCT05036174|Promethazine|promethazine|mesh-list
25313368|NCT05036174|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25313369|NCT05036174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25313370|NCT05036174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25313371|NCT05036174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313372|NCT05036174|Anesthetics, Local|anesthetics, local|mesh-ancestor
25313373|NCT05036174|Anesthetics|anesthetics|mesh-ancestor
25313410|NCT05035745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25313411|NCT05035849|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25313413|NCT05035849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25313414|NCT05035849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313415|NCT05035849|Incretins|incretins|mesh-ancestor
25313416|NCT05035849|Hormones|hormones|mesh-ancestor
25313417|NCT05035849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25313418|NCT05035849|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25313419|NCT05035849|Protease Inhibitors|protease inhibitors|mesh-ancestor
25313420|NCT05035849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25313421|NCT05035849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313422|NCT05035849|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25313423|NCT05035381|Leucovorin|leucovorin|mesh-list
25313424|NCT05035381|Bevacizumab|bevacizumab|mesh-list
25313425|NCT05035381|Pembrolizumab|pembrolizumab|mesh-list
25313426|NCT05035381|Fluorouracil|fluorouracil|mesh-list
25313427|NCT05035381|Irinotecan|irinotecan|mesh-list
25313428|NCT05035381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25313429|NCT05035381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25313430|NCT05035381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25313431|NCT05035381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25313432|NCT05035381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25313433|NCT05035381|Growth Substances|growth substances|mesh-ancestor
25313434|NCT05035381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313435|NCT05035381|Growth Inhibitors|growth inhibitors|mesh-ancestor
25313436|NCT05035381|Antimetabolites|antimetabolites|mesh-ancestor
25313437|NCT05035381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313438|NCT05035381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25313439|NCT05035381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25313440|NCT05035381|Immunologic Factors|immunologic factors|mesh-ancestor
25313441|NCT05035381|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25313442|NCT05035381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25313443|NCT05035381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25313444|NCT05035381|Antidotes|antidotes|mesh-ancestor
25313445|NCT05035381|Protective Agents|protective agents|mesh-ancestor
25313446|NCT05035381|Vitamin B Complex|vitamin b complex|mesh-ancestor
25313447|NCT05035381|Vitamins|vitamins|mesh-ancestor
25313448|NCT05035381|Micronutrients|micronutrients|mesh-ancestor
25313449|NCT05035498|Phenylephrine|phenylephrine|mesh-list
25313450|NCT05035498|Oxymetazoline|oxymetazoline|mesh-list
25313454|NCT05035498|Mydriatics|mydriatics|mesh-ancestor
25313455|NCT05035498|Autonomic Agents|autonomic agents|mesh-ancestor
25313456|NCT05035498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25313457|NCT05035498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313458|NCT05035498|Sympathomimetics|sympathomimetics|mesh-ancestor
25313459|NCT05035498|Nasal Decongestants|nasal decongestants|mesh-ancestor
25313460|NCT05035498|Respiratory System Agents|respiratory system agents|mesh-ancestor
25313461|NCT05035498|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25313462|NCT05035498|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25313463|NCT05035498|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25313464|NCT05035498|Adrenergic Agents|adrenergic agents|mesh-ancestor
25313465|NCT05035498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25313466|NCT05035498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313467|NCT05035498|Protective Agents|protective agents|mesh-ancestor
25313468|NCT05035485|Phenylephrine|phenylephrine|mesh-list
25313469|NCT05035485|Oxymetazoline|oxymetazoline|mesh-list
25313470|NCT05035485|Norepinephrine|norepinephrine|mesh-list
25313471|NCT05035485|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25313472|NCT05035485|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25313473|NCT05035485|Mydriatics|mydriatics|mesh-ancestor
25313474|NCT05035485|Autonomic Agents|autonomic agents|mesh-ancestor
25313475|NCT05035485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25313476|NCT05035485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313477|NCT05035485|Sympathomimetics|sympathomimetics|mesh-ancestor
25313478|NCT05035485|Nasal Decongestants|nasal decongestants|mesh-ancestor
25313479|NCT05035485|Respiratory System Agents|respiratory system agents|mesh-ancestor
24624122|NCT01074879|Caseins|caseins|mesh-list
25313480|NCT05035485|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25313481|NCT05035485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25313484|NCT05035485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25313485|NCT05035485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313486|NCT05035485|Protective Agents|protective agents|mesh-ancestor
25313487|NCT05035472|Phenylephrine|phenylephrine|mesh-list
25313488|NCT05035472|Oxymetazoline|oxymetazoline|mesh-list
25313489|NCT05035472|Norepinephrine|norepinephrine|mesh-list
25313490|NCT05035472|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25313491|NCT05035472|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25313492|NCT05035472|Mydriatics|mydriatics|mesh-ancestor
25313493|NCT05035472|Autonomic Agents|autonomic agents|mesh-ancestor
25313494|NCT05035472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25313495|NCT05035472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313496|NCT05035472|Sympathomimetics|sympathomimetics|mesh-ancestor
25313497|NCT05035472|Nasal Decongestants|nasal decongestants|mesh-ancestor
25313498|NCT05035472|Respiratory System Agents|respiratory system agents|mesh-ancestor
25313499|NCT05035472|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25313500|NCT05035472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25313501|NCT05035472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25313502|NCT05035472|Adrenergic Agents|adrenergic agents|mesh-ancestor
25313503|NCT05035472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25313504|NCT05035472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313505|NCT05035472|Protective Agents|protective agents|mesh-ancestor
25313506|NCT05034965|Hyaluronic Acid|hyaluronic acid|mesh-list
25313507|NCT05034965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25313508|NCT05034965|Immunologic Factors|immunologic factors|mesh-ancestor
25313509|NCT05034965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313510|NCT05034965|Viscosupplements|viscosupplements|mesh-ancestor
25313511|NCT05034965|Protective Agents|protective agents|mesh-ancestor
25313513|NCT05035069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25313514|NCT05035069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25313515|NCT05035069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313516|NCT05035069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25313517|NCT05035069|Anesthetics, General|anesthetics, general|mesh-ancestor
25313518|NCT05035069|Anesthetics|anesthetics|mesh-ancestor
25313519|NCT05035147|Gemcitabine|gemcitabine|mesh-list
25313520|NCT05035147|Paclitaxel|paclitaxel|mesh-list
25008379|NCT05209295|Cc-486|cc-486|mesh-list
24488999|NCT00470977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489000|NCT00470990|Acyline|acyline|mesh-list
24489001|NCT00470990|Hormone Antagonists|hormone antagonists|mesh-ancestor
24489002|NCT00470990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24914344|NCT04255576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920691|NCT04199143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24914406|NCT04255134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313521|NCT05035147|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25313522|NCT05035147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25313529|NCT05035147|Antimetabolites|antimetabolites|mesh-ancestor
25313530|NCT05035147|Antiviral Agents|antiviral agents|mesh-ancestor
25313531|NCT05035147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25313532|NCT05035147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25313533|NCT05035147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25313534|NCT05035147|Immunologic Factors|immunologic factors|mesh-ancestor
25313535|NCT05035147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313536|NCT05034783|Exenatide|exenatide|mesh-list
25313537|NCT05034783|Edetic Acid|edetic acid|mesh-list
25313538|NCT05034783|Chelating Agents|chelating agents|mesh-ancestor
25313539|NCT05034783|Sequestering Agents|sequestering agents|mesh-ancestor
25313540|NCT05034783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313541|NCT05034783|Anticoagulants|anticoagulants|mesh-ancestor
25313542|NCT05034783|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25313543|NCT05034783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25313544|NCT05034783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313545|NCT05034783|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25313546|NCT05034783|Incretins|incretins|mesh-ancestor
25313547|NCT05034783|Hormones|hormones|mesh-ancestor
25313548|NCT05034783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25313549|NCT05034887|Trastuzumab|trastuzumab|mesh-list
25313550|NCT05034887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25313551|NCT05034887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25313552|NCT05034406|Lidocaine|lidocaine|mesh-list
25313553|NCT05034406|Levobupivacaine|levobupivacaine|mesh-list
25313554|NCT05034406|Anesthetics, Local|anesthetics, local|mesh-ancestor
25313555|NCT05034406|Anesthetics|anesthetics|mesh-ancestor
25313556|NCT05034406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25313557|NCT05034406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313558|NCT05034406|Sensory System Agents|sensory system agents|mesh-ancestor
25313559|NCT05034406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25313560|NCT05034406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25313561|NCT05034406|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25313562|NCT05034406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25313563|NCT05034406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25313564|NCT05034406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313566|NCT05034055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25313574|NCT05034133|Cisplatin|cisplatin|mesh-list
25313575|NCT05034133|Etoposide|etoposide|mesh-list
25313576|NCT05034133|Durvalumab|durvalumab|mesh-list
25313577|NCT05034133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25313578|NCT05034133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25313579|NCT05034133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25313580|NCT05034133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25313581|NCT05034133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25313582|NCT05034133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313583|NCT05034133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25313584|NCT05033314|Rivaroxaban|rivaroxaban|mesh-list
25313585|NCT05033314|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25313586|NCT05033314|Antithrombins|antithrombins|mesh-ancestor
25313587|NCT05033314|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25313588|NCT05033314|Protease Inhibitors|protease inhibitors|mesh-ancestor
25313589|NCT05033314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25313590|NCT05033314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313591|NCT05033314|Anticoagulants|anticoagulants|mesh-ancestor
25313592|NCT05033574|Hormones|hormones|mesh-list
25313593|NCT05033574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25313594|NCT05033574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313595|NCT05033704|Plasma protein fraction|plasma protein fraction|mesh-list
25313877|NCT05028049|Dsuvia|dsuvia|mesh-list
25313597|NCT05033704|Blood Substitutes|blood substitutes|mesh-ancestor
25313598|NCT05033535|Olmesartan|olmesartan|mesh-list
25313599|NCT05033535|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25313600|NCT05033535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25313601|NCT05033535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25313602|NCT05033535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25313603|NCT05033535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313604|NCT05033106|Bevacizumab|bevacizumab|mesh-list
25313605|NCT05033106|Ranibizumab|ranibizumab|mesh-list
25313606|NCT05033106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25313607|NCT05033106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25313608|NCT05033106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25313609|NCT05033106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25313610|NCT05033106|Growth Substances|growth substances|mesh-ancestor
25313611|NCT05033106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313612|NCT05033106|Growth Inhibitors|growth inhibitors|mesh-ancestor
25205968|NCT04005599|Anticonvulsants|anticonvulsants|mesh-ancestor
25205969|NCT04005599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25205970|NCT04005599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25205971|NCT04005599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205972|NCT04005599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25205973|NCT04005599|Tocolytic Agents|tocolytic agents|mesh-ancestor
25205974|NCT04005599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25205975|NCT03991299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25205976|NCT03991299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25205977|NCT03991299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25205978|NCT03991299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205979|NCT03991299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25205980|NCT03991299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25205981|NCT03991299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825394|NCT00005591|Antiviral Agents|antiviral agents|mesh-ancestor
25313613|NCT05032781|Minocycline|minocycline|mesh-list
25825395|NCT00005591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25825396|NCT00005591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825397|NCT00005591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25825398|NCT00005591|Immunologic Factors|immunologic factors|mesh-ancestor
25313614|NCT05032781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25313615|NCT05032781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25313616|NCT05032261|Norepinephrine|norepinephrine|mesh-list
25313617|NCT05032261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25313618|NCT05032261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25313619|NCT05032261|Adrenergic Agents|adrenergic agents|mesh-ancestor
25313620|NCT05032261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25313621|NCT05032261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313622|NCT05032261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313623|NCT05032261|Sympathomimetics|sympathomimetics|mesh-ancestor
25313624|NCT05032261|Autonomic Agents|autonomic agents|mesh-ancestor
25313625|NCT05032261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25313626|NCT05032261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25313627|NCT05032287|Tamsulosin|tamsulosin|mesh-list
25313628|NCT05032287|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25313629|NCT05032287|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25313630|NCT05032287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25313631|NCT05032287|Adrenergic Agents|adrenergic agents|mesh-ancestor
25313633|NCT05032287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313634|NCT05032287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313635|NCT05032287|Urological Agents|urological agents|mesh-ancestor
25313636|NCT05032248|Tacrolimus|tacrolimus|mesh-list
25313637|NCT05032248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25313638|NCT05032248|Immunologic Factors|immunologic factors|mesh-ancestor
25313639|NCT05032248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313640|NCT05032248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25313641|NCT05032248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25313642|NCT05032248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313643|NCT05031923|Anti-Infective Agents|anti-infective agents|mesh-list
25313644|NCT05031923|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25313645|NCT05031936|Ropivacaine|ropivacaine|mesh-list
25313646|NCT05031936|Anesthetics, Local|anesthetics, local|mesh-ancestor
25313647|NCT05031936|Anesthetics|anesthetics|mesh-ancestor
25313648|NCT05031936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25313649|NCT05031936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648668|NCT01483144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648669|NCT01483144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25648670|NCT01483144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25648671|NCT01483144|Analgesics|analgesics|mesh-ancestor
25648672|NCT01483144|Sensory System Agents|sensory system agents|mesh-ancestor
25648673|NCT01483144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25648674|NCT01483144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648675|NCT01483144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25648676|NCT01483144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25648677|NCT01483144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25648678|NCT01483560|Metformin|metformin|mesh-list
25648679|NCT01483560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25648680|NCT01483560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648681|NCT01483599|Adalimumab|adalimumab|mesh-list
25648682|NCT01483599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25648683|NCT01483599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25313650|NCT05031936|Sensory System Agents|sensory system agents|mesh-ancestor
25313651|NCT05031936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25313652|NCT05032001|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25313653|NCT05032001|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25313655|NCT05032001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313656|NCT05032001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25313657|NCT05032001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313658|NCT05032001|Protease Inhibitors|protease inhibitors|mesh-ancestor
25313659|NCT05032001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25313660|NCT05032118|Ketamine|ketamine|mesh-list
25313661|NCT05032118|Propofol|propofol|mesh-list
25313662|NCT05032118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25313667|NCT05032118|Anesthetics|anesthetics|mesh-ancestor
25313668|NCT05032118|Analgesics|analgesics|mesh-ancestor
25313669|NCT05032118|Sensory System Agents|sensory system agents|mesh-ancestor
25313670|NCT05032118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25313671|NCT05032118|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25313672|NCT05032118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25313673|NCT05032118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25313674|NCT05032118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25313675|NCT05032118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313676|NCT05031689|Sunscreening Agents|sunscreening agents|mesh-list
25313677|NCT05031689|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25313678|NCT05031689|Protective Agents|protective agents|mesh-ancestor
25313679|NCT05031689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313680|NCT05031689|Dermatologic Agents|dermatologic agents|mesh-ancestor
25313681|NCT05031676|Analgesics, Opioid|analgesics, opioid|mesh-list
25313682|NCT05031676|Anesthetics|anesthetics|mesh-list
25313683|NCT05031676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25313684|NCT05031676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313685|NCT05031676|Narcotics|narcotics|mesh-ancestor
25313686|NCT05031676|Analgesics|analgesics|mesh-ancestor
25313687|NCT05031676|Sensory System Agents|sensory system agents|mesh-ancestor
25313688|NCT05031676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25313692|NCT05031234|Morphine|morphine|mesh-list
25313693|NCT05031234|Anesthetics|anesthetics|mesh-list
25313694|NCT05031234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25313695|NCT05031234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313696|NCT05031234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25313697|NCT05031234|Narcotics|narcotics|mesh-ancestor
25313698|NCT05031234|Analgesics|analgesics|mesh-ancestor
25313699|NCT05031234|Sensory System Agents|sensory system agents|mesh-ancestor
25313700|NCT05031234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25313701|NCT05031143|Triamcinolone|triamcinolone|mesh-list
25008421|NCT05208398|Warfarin|warfarin|mesh-list
25825399|NCT00005591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825400|NCT00005591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25825401|NCT00005592|Rituximab|rituximab|mesh-list
24836548|NCT02186249|Nivolumab|nivolumab|mesh-list
24836549|NCT02186249|Ipilimumab|ipilimumab|mesh-list
25313702|NCT05031143|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25313703|NCT05031143|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25313704|NCT05031143|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25313705|NCT05031143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25313706|NCT05031143|Glucocorticoids|glucocorticoids|mesh-ancestor
25313707|NCT05031143|Hormones|hormones|mesh-ancestor
25313708|NCT05031143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25313710|NCT05031143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25313711|NCT05031143|Immunologic Factors|immunologic factors|mesh-ancestor
25313712|NCT05031143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25313713|NCT05031143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313714|NCT05030623|Tadalafil|tadalafil|mesh-list
25313715|NCT05030623|Vasodilator Agents|vasodilator agents|mesh-ancestor
25313716|NCT05030623|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25313717|NCT05030623|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25313718|NCT05030623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25313719|NCT05030623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313720|NCT05030623|Urological Agents|urological agents|mesh-ancestor
25313721|NCT05030545|Eplerenone|eplerenone|mesh-list
25313722|NCT05030545|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
25313723|NCT05030545|Mineralocorticoids|mineralocorticoids|mesh-list
25313724|NCT05030545|Hormone Antagonists|hormone antagonists|mesh-ancestor
25313725|NCT05030545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25313726|NCT05030545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187844|NCT02809768|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25187845|NCT02809768|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25313727|NCT05030545|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25313728|NCT05030545|Diuretics|diuretics|mesh-ancestor
25313735|NCT05030493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25313736|NCT05030493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25313737|NCT05030493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25313738|NCT05030493|Growth Substances|growth substances|mesh-ancestor
25313739|NCT05030493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313740|NCT05030493|Growth Inhibitors|growth inhibitors|mesh-ancestor
25313741|NCT05030116|Domperidone|domperidone|mesh-list
25313742|NCT05030116|Antiemetics|antiemetics|mesh-ancestor
25313743|NCT05030116|Autonomic Agents|autonomic agents|mesh-ancestor
25313744|NCT05030116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25313745|NCT05030116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313746|NCT05030116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25313747|NCT05030116|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25313748|NCT05030116|Dopamine Agents|dopamine agents|mesh-ancestor
25313749|NCT05030116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25313750|NCT05030116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313751|NCT05030077|Gemcitabine|gemcitabine|mesh-list
25313752|NCT05030077|Carboplatin|carboplatin|mesh-list
25313753|NCT05030077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25313754|NCT05030077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25313755|NCT05030077|Antimetabolites|antimetabolites|mesh-ancestor
25313756|NCT05030077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313757|NCT05030077|Antiviral Agents|antiviral agents|mesh-ancestor
25313758|NCT05030077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25313759|NCT05030077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25313760|NCT05030077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25313761|NCT05030077|Immunologic Factors|immunologic factors|mesh-ancestor
25313762|NCT05030077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313763|NCT05029453|Apatinib|apatinib|mesh-list
25313764|NCT05029453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25313765|NCT05029453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25313766|NCT05029453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25313767|NCT05029453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313774|NCT05029115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25313775|NCT05029115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313776|NCT05029115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25313777|NCT05029115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313778|NCT05029076|Liraglutide|liraglutide|mesh-list
25313779|NCT05029076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25313780|NCT05029076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313781|NCT05029076|Incretins|incretins|mesh-ancestor
25313782|NCT05029076|Hormones|hormones|mesh-ancestor
25313783|NCT05029076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25313784|NCT05029297|Capsaicin|capsaicin|mesh-list
25313785|NCT05029297|Antipruritics|antipruritics|mesh-ancestor
25313786|NCT05029297|Dermatologic Agents|dermatologic agents|mesh-ancestor
25313787|NCT05029297|Sensory System Agents|sensory system agents|mesh-ancestor
25313788|NCT05029297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25313789|NCT05029297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313790|NCT05029037|Ascorbic Acid|ascorbic acid|mesh-list
25313791|NCT05029037|Vitamins|vitamins|mesh-ancestor
25313792|NCT05029037|Micronutrients|micronutrients|mesh-ancestor
25313793|NCT05029037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313794|NCT05029037|Antioxidants|antioxidants|mesh-ancestor
25313795|NCT05029037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313796|NCT05029037|Protective Agents|protective agents|mesh-ancestor
25313797|NCT05029063|Rivaroxaban|rivaroxaban|mesh-list
25313798|NCT05029063|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25313799|NCT05029063|Antithrombins|antithrombins|mesh-ancestor
25313800|NCT05029063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25313801|NCT05029063|Protease Inhibitors|protease inhibitors|mesh-ancestor
25313802|NCT05029063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25313803|NCT05029063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825402|NCT00005592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25825403|NCT00005592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25313823|NCT05028907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25648684|NCT01483625|Tiotropium Bromide|tiotropium bromide|mesh-list
25648685|NCT01483625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25313824|NCT05028907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25648686|NCT01483625|Autonomic Agents|autonomic agents|mesh-ancestor
25313825|NCT05028907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25313826|NCT05028907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25313827|NCT05028907|Immunologic Factors|immunologic factors|mesh-ancestor
25313828|NCT05028907|Viscosupplements|viscosupplements|mesh-ancestor
25313829|NCT05028907|Protective Agents|protective agents|mesh-ancestor
25313830|NCT05028907|Antioxidants|antioxidants|mesh-ancestor
25313831|NCT05028907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313832|NCT05028907|Vitamins|vitamins|mesh-ancestor
25313833|NCT05028907|Micronutrients|micronutrients|mesh-ancestor
25313834|NCT05028907|Protease Inhibitors|protease inhibitors|mesh-ancestor
25313835|NCT05028907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25313836|NCT05028907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25313837|NCT05028907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25313838|NCT05028907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25313839|NCT05028907|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25313840|NCT05028907|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25313841|NCT05028907|Sympathomimetics|sympathomimetics|mesh-ancestor
25313842|NCT05028907|Nasal Decongestants|nasal decongestants|mesh-ancestor
25313843|NCT05028907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25313844|NCT05028907|Respiratory System Agents|respiratory system agents|mesh-ancestor
25313845|NCT05028803|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25313846|NCT05028803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25313847|NCT05028335|Carbamide Peroxide|carbamide peroxide|mesh-list
25313848|NCT05028335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25313849|NCT05028335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25313850|NCT05028322|Imiquimod|imiquimod|mesh-list
25313851|NCT05028322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25313852|NCT05028322|Immunologic Factors|immunologic factors|mesh-ancestor
25313853|NCT05028322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313854|NCT05028322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25313855|NCT05028322|Interferon Inducers|interferon inducers|mesh-ancestor
25313875|NCT05028049|Sufentanil|sufentanil|mesh-list
25313876|NCT05028049|Remifentanil|remifentanil|mesh-list
25313881|NCT05028049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313882|NCT05028049|Analgesics|analgesics|mesh-ancestor
25313883|NCT05028049|Sensory System Agents|sensory system agents|mesh-ancestor
25313884|NCT05028049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25313885|NCT05028049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25313886|NCT05028049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25313887|NCT05028049|Anesthetics, General|anesthetics, general|mesh-ancestor
25313888|NCT05028049|Anesthetics|anesthetics|mesh-ancestor
24838883|NCT02200991|Protease Inhibitors|protease inhibitors|mesh-ancestor
24838884|NCT02200991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24838885|NCT02200991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859033|NCT02301286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24751748|NCT01705951|Nicotine|nicotine|mesh-list
24839236|NCT02202993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752077|NCT01708330|Anesthetics, Local|anesthetics, local|mesh-ancestor
24752110|NCT01708447|Lidocaine|lidocaine|mesh-list
25313892|NCT05028140|Pioglitazone|pioglitazone|mesh-list
25313893|NCT05028140|Empagliflozin|empagliflozin|mesh-list
25313894|NCT05028140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25313895|NCT05028140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313896|NCT05028140|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25313897|NCT05028140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313898|NCT05027594|Dexamethasone|dexamethasone|mesh-list
25313899|NCT05027594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25313900|NCT05027594|Antiemetics|antiemetics|mesh-ancestor
25313901|NCT05027594|Autonomic Agents|autonomic agents|mesh-ancestor
25313902|NCT05027594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24680875|NCT01376440|Eusol|eusol|mesh-list
25313903|NCT05027594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313904|NCT05027594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25313905|NCT05027594|Glucocorticoids|glucocorticoids|mesh-ancestor
25313907|NCT05027594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25313908|NCT05027594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25313909|NCT05027594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25313910|NCT05027581|Hyaluronic Acid|hyaluronic acid|mesh-list
25313911|NCT05027581|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25313912|NCT05027581|Immunologic Factors|immunologic factors|mesh-ancestor
25313913|NCT05027581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313914|NCT05027581|Viscosupplements|viscosupplements|mesh-ancestor
25313915|NCT05027581|Protective Agents|protective agents|mesh-ancestor
25313916|NCT05027295|Riboflavin|riboflavin|mesh-list
25313917|NCT05027295|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25313918|NCT05027295|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25313919|NCT05027295|Vitamin B Complex|vitamin b complex|mesh-ancestor
25313920|NCT05027295|Vitamins|vitamins|mesh-ancestor
25187994|NCT02808988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206026|NCT03931408|Gentamicins|gentamicins|mesh-list
25206027|NCT03931408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25206028|NCT03931408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25206029|NCT03931408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25206030|NCT03931408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25206031|NCT03931408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187996|NCT02808949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25187997|NCT02808949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25187998|NCT02808949|Antiviral Agents|antiviral agents|mesh-ancestor
25187999|NCT02808949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25188000|NCT02809066|Calcium, Dietary|calcium, dietary|mesh-list
25188001|NCT02809066|Calcium|calcium|mesh-list
25313921|NCT05027295|Micronutrients|micronutrients|mesh-ancestor
25313922|NCT05027295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313923|NCT05027295|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25313924|NCT05027295|Dermatologic Agents|dermatologic agents|mesh-ancestor
25313925|NCT05027126|Folic Acid|folic acid|mesh-list
25313926|NCT05027126|Vitamin B Complex|vitamin b complex|mesh-list
25313927|NCT05027126|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
25313928|NCT05027126|Vitamins|vitamins|mesh-ancestor
25313929|NCT05027126|Micronutrients|micronutrients|mesh-ancestor
25313930|NCT05027126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313931|NCT05027126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25313932|NCT05027126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25313933|NCT05027126|Analgesics|analgesics|mesh-ancestor
25313934|NCT05027126|Sensory System Agents|sensory system agents|mesh-ancestor
25313935|NCT05027126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25313936|NCT05027126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25313937|NCT05027126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25313938|NCT05027126|Hematinics|hematinics|mesh-ancestor
25313939|NCT05027386|Irinotecan|irinotecan|mesh-list
25313940|NCT05027386|Temozolomide|temozolomide|mesh-list
25313941|NCT05027386|Apatinib|apatinib|mesh-list
25313942|NCT05027386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25313943|NCT05027386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25313944|NCT05027386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25313945|NCT05027386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313946|NCT05027386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25313947|NCT05027386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25313948|NCT05027386|Alkylating Agents|alkylating agents|mesh-ancestor
25313949|NCT05027386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25313950|NCT05027191|Sevoflurane|sevoflurane|mesh-list
25313951|NCT05027191|Desflurane|desflurane|mesh-list
25313952|NCT05027191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25313953|NCT05027191|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25313954|NCT05027191|Anesthetics, General|anesthetics, general|mesh-ancestor
25313955|NCT05027191|Anesthetics|anesthetics|mesh-ancestor
25313956|NCT05027191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25313957|NCT05027191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825404|NCT00005592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825405|NCT00005592|Immunologic Factors|immunologic factors|mesh-ancestor
25825406|NCT00005592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825407|NCT00005592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24786318|NCT01919047|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24786319|NCT01919047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24786320|NCT01919047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25313958|NCT05027243|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25313959|NCT05027243|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25648687|NCT01483625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25648688|NCT01483625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648689|NCT01483625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25648690|NCT01483625|Respiratory System Agents|respiratory system agents|mesh-ancestor
25648691|NCT01483625|Parasympatholytics|parasympatholytics|mesh-ancestor
25648692|NCT01483625|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25648693|NCT01483625|Cholinergic Agents|cholinergic agents|mesh-ancestor
25648694|NCT01483625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25648695|NCT01483625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648696|NCT01483651|Insulin|insulin|mesh-list
25648697|NCT01483651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25648698|NCT01483651|Glucagon|glucagon|mesh-list
25648699|NCT01483651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25648700|NCT01483651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313960|NCT05027243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25313961|NCT05027243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188039|NCT02808676|Micronutrients|micronutrients|mesh-ancestor
25313962|NCT05027243|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25313963|NCT05027243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25313964|NCT05027243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313965|NCT05027243|Cholinergic Agents|cholinergic agents|mesh-ancestor
25313966|NCT05027243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25313967|NCT05026398|Fenfluramine|fenfluramine|mesh-list
25313968|NCT05026398|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25313969|NCT05026398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25313970|NCT05026398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25313971|NCT05026398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313972|NCT05026398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25313973|NCT05026398|Serotonin Agents|serotonin agents|mesh-ancestor
25313974|NCT05026398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313975|NCT05026229|Cytarabine|cytarabine|mesh-list
25313976|NCT05026229|Prednisone|prednisone|mesh-list
25313977|NCT05026229|Methotrexate|methotrexate|mesh-list
25313978|NCT05026229|Vincristine|vincristine|mesh-list
25313979|NCT05026229|Dasatinib|dasatinib|mesh-list
25313980|NCT05026229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25313981|NCT05026229|Glucocorticoids|glucocorticoids|mesh-ancestor
25313982|NCT05026229|Hormones|hormones|mesh-ancestor
25313983|NCT05026229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25313984|NCT05026229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25313985|NCT05026229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25313986|NCT05026229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25313987|NCT05026229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25313988|NCT05026229|Abortifacient Agents|abortifacient agents|mesh-ancestor
25313989|NCT05026229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25313990|NCT05026229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25313991|NCT05026229|Antimetabolites|antimetabolites|mesh-ancestor
25313992|NCT05026229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25313993|NCT05026229|Dermatologic Agents|dermatologic agents|mesh-ancestor
25313994|NCT05026229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25313995|NCT05026229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25313996|NCT05026229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25313997|NCT05026229|Immunologic Factors|immunologic factors|mesh-ancestor
25313998|NCT05026229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25313999|NCT05026229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25314000|NCT05026229|Antiviral Agents|antiviral agents|mesh-ancestor
25314001|NCT05026229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25314002|NCT05026229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25314003|NCT05026229|Tubulin Modulators|tubulin modulators|mesh-ancestor
25314004|NCT05026229|Antimitotic Agents|antimitotic agents|mesh-ancestor
25314005|NCT05026229|Mitosis Modulators|mitosis modulators|mesh-ancestor
25314006|NCT05026229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25314007|NCT05025644|Dobutamine|dobutamine|mesh-list
25314008|NCT05025644|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25314009|NCT05025644|Sympathomimetics|sympathomimetics|mesh-ancestor
25314010|NCT05025644|Autonomic Agents|autonomic agents|mesh-ancestor
25314011|NCT05025644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25314012|NCT05025644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314013|NCT05025644|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25314014|NCT05025644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25314015|NCT05025644|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25314016|NCT05025644|Adrenergic Agents|adrenergic agents|mesh-ancestor
25314017|NCT05025644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25314018|NCT05025644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314019|NCT05025644|Protective Agents|protective agents|mesh-ancestor
25314020|NCT05025228|Acetaminophen|acetaminophen|mesh-list
25314021|NCT05025228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25314022|NCT05025228|Analgesics|analgesics|mesh-ancestor
25314023|NCT05025228|Sensory System Agents|sensory system agents|mesh-ancestor
25314024|NCT05025228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25314025|NCT05025228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314026|NCT05025228|Antipyretics|antipyretics|mesh-ancestor
25314027|NCT05025072|Hydroxyurea|hydroxyurea|mesh-list
25314028|NCT05025072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314029|NCT05025072|Antisickling Agents|antisickling agents|mesh-ancestor
25314030|NCT05025072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25314031|NCT05025072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314032|NCT05025072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25314033|NCT05025033|Paclitaxel|paclitaxel|mesh-list
25648701|NCT01483651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25314034|NCT05025033|Irinotecan|irinotecan|mesh-list
25188113|NCT02807922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25188114|NCT02807922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25314035|NCT05025033|Apatinib|apatinib|mesh-list
25314036|NCT05025033|Antibodies|antibodies|mesh-list
25314037|NCT05025033|Immunoglobulins|immunoglobulins|mesh-list
25314038|NCT05025033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25314039|NCT05025033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314040|NCT05025033|Tubulin Modulators|tubulin modulators|mesh-ancestor
25314041|NCT05025033|Antimitotic Agents|antimitotic agents|mesh-ancestor
25314042|NCT05025033|Mitosis Modulators|mitosis modulators|mesh-ancestor
25314043|NCT05025033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314044|NCT05025033|Immunologic Factors|immunologic factors|mesh-ancestor
25314045|NCT05025033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314046|NCT05025033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25314047|NCT05025033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25314048|NCT05025033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25314049|NCT05025033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25314050|NCT05025098|Azacitidine|azacitidine|mesh-list
25314051|NCT05025098|Venetoclax|venetoclax|mesh-list
25314052|NCT05025098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25314053|NCT05025098|Antimetabolites|antimetabolites|mesh-ancestor
25314054|NCT05025098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314055|NCT05025098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314056|NCT05025098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25314057|NCT05024799|Fentanyl|fentanyl|mesh-list
25314058|NCT05024799|Butorphanol|butorphanol|mesh-list
25314059|NCT05024799|Propofol|propofol|mesh-list
25314060|NCT05024799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25314061|NCT05024799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24605612|NCT00986466|Vitamin D|vitamin d|mesh-list
25314062|NCT05024799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314063|NCT05024799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25314064|NCT05024799|Anesthetics, General|anesthetics, general|mesh-ancestor
25314065|NCT05024799|Anesthetics|anesthetics|mesh-ancestor
25314066|NCT05024799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25314067|NCT05024799|Narcotics|narcotics|mesh-ancestor
25314068|NCT05024799|Analgesics|analgesics|mesh-ancestor
25314069|NCT05024799|Sensory System Agents|sensory system agents|mesh-ancestor
25314070|NCT05024799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25314071|NCT05024799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25314072|NCT05024799|Antitussive Agents|antitussive agents|mesh-ancestor
25314073|NCT05024799|Respiratory System Agents|respiratory system agents|mesh-ancestor
25314074|NCT05024799|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25314075|NCT05024825|Acetaminophen|acetaminophen|mesh-list
25314076|NCT05024825|Ibuprofen|ibuprofen|mesh-list
25314077|NCT05024825|Gabapentin|gabapentin|mesh-list
25314078|NCT05024825|Hydrocodone|hydrocodone|mesh-list
25314079|NCT05024825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25314080|NCT05024825|Analgesics|analgesics|mesh-ancestor
25314081|NCT05024825|Sensory System Agents|sensory system agents|mesh-ancestor
25314082|NCT05024825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25314083|NCT05024825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314084|NCT05024825|Antipyretics|antipyretics|mesh-ancestor
25314085|NCT05024825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25314086|NCT05024825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25314087|NCT05024825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25314088|NCT05024825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25314089|NCT05024825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25314090|NCT05024825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314091|NCT05024825|Anticonvulsants|anticonvulsants|mesh-ancestor
25314092|NCT05024825|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25314093|NCT05024825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25314094|NCT05024825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25314095|NCT05024825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25314096|NCT05024825|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25314097|NCT05024825|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25314098|NCT05024825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25314099|NCT05024825|Antimanic Agents|antimanic agents|mesh-ancestor
25314100|NCT05024825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25648702|NCT01483651|Hormones|hormones|mesh-ancestor
25648703|NCT01483651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25314101|NCT05024825|Narcotics|narcotics|mesh-ancestor
24560092|NCT03583359|Lidocaine|lidocaine|mesh-list
25825408|NCT00005593|Carboplatin|carboplatin|mesh-list
25825409|NCT00005593|Fludarabine|fludarabine|mesh-list
25825410|NCT00005593|Fludarabine phosphate|fludarabine phosphate|mesh-list
25314102|NCT05024825|Antitussive Agents|antitussive agents|mesh-ancestor
25314103|NCT05024825|Respiratory System Agents|respiratory system agents|mesh-ancestor
25314104|NCT05024604|Progesterone|progesterone|mesh-list
25314105|NCT05024604|Progestins|progestins|mesh-ancestor
25314106|NCT05024604|Hormones|hormones|mesh-ancestor
25314107|NCT05024604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25314108|NCT05024604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314109|NCT05024435|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25314110|NCT05024435|Respiratory System Agents|respiratory system agents|mesh-ancestor
25314111|NCT05024448|Prednisone|prednisone|mesh-list
25314112|NCT05024448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25314113|NCT05024448|Glucocorticoids|glucocorticoids|mesh-ancestor
25314114|NCT05024448|Hormones|hormones|mesh-ancestor
25314115|NCT05024448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25314116|NCT05024448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314117|NCT05024448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25314118|NCT05024448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314119|NCT05024877|Stanozolol|stanozolol|mesh-list
25314120|NCT05024877|Androgens|androgens|mesh-ancestor
25314121|NCT05024877|Hormones|hormones|mesh-ancestor
25314122|NCT05024877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25314123|NCT05024877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314124|NCT05024877|Anabolic Agents|anabolic agents|mesh-ancestor
25314125|NCT05024526|Edaravone|edaravone|mesh-list
25314126|NCT05024526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25314127|NCT05024526|Antioxidants|antioxidants|mesh-ancestor
25314128|NCT05024526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314129|NCT05024526|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25314130|NCT05024526|Protective Agents|protective agents|mesh-ancestor
25314131|NCT05024526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825411|NCT00005593|Topotecan|topotecan|mesh-list
25825412|NCT00005593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825413|NCT00005593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25825414|NCT00005593|Antimetabolites|antimetabolites|mesh-ancestor
25825415|NCT00005593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825416|NCT00005593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25108369|NCT03132584|Cyclophosphamide|cyclophosphamide|mesh-list
25108370|NCT03132584|Alemtuzumab|alemtuzumab|mesh-list
25108381|NCT03132272|Autoantibodies|autoantibodies|mesh-list
25314132|NCT05024565|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25314133|NCT05024565|Lactams|lactams|mesh-list
25314134|NCT05024565|beta-Lactams|beta-lactams|mesh-list
25314135|NCT05024565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25314136|NCT05024422|Pyridoxine|pyridoxine|mesh-list
25314137|NCT05024422|Vitamin B 6|vitamin b 6|mesh-list
25314138|NCT05024422|Cabergoline|cabergoline|mesh-list
25314139|NCT05024422|Vitamins|vitamins|mesh-ancestor
25314140|NCT05024422|Micronutrients|micronutrients|mesh-ancestor
25314141|NCT05024422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314142|NCT05024422|Vitamin B Complex|vitamin b complex|mesh-ancestor
25314143|NCT05024422|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25314144|NCT05024422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25314145|NCT05024422|Dopamine Agonists|dopamine agonists|mesh-ancestor
25314146|NCT05024422|Dopamine Agents|dopamine agents|mesh-ancestor
25314147|NCT05024422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25314148|NCT05024422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314149|NCT05024357|Dasatinib|dasatinib|mesh-list
25314150|NCT05024357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314151|NCT05024357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25314152|NCT05024357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25314153|NCT05024357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314154|NCT05024344|Dexamethasone|dexamethasone|mesh-list
25314155|NCT05024344|Ropivacaine|ropivacaine|mesh-list
25314156|NCT05024344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25314157|NCT05024344|Antiemetics|antiemetics|mesh-ancestor
25314158|NCT05024344|Autonomic Agents|autonomic agents|mesh-ancestor
25314159|NCT05024344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25314160|NCT05024344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314161|NCT05024344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25314162|NCT05024344|Glucocorticoids|glucocorticoids|mesh-ancestor
25314164|NCT05024344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25314165|NCT05024344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25314166|NCT05024344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314167|NCT05024344|Anesthetics, Local|anesthetics, local|mesh-ancestor
25314168|NCT05024344|Anesthetics|anesthetics|mesh-ancestor
25314169|NCT05024344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25314170|NCT05024344|Sensory System Agents|sensory system agents|mesh-ancestor
25314171|NCT05024318|Pembrolizumab|pembrolizumab|mesh-list
25314172|NCT05024318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25314173|NCT05024318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188216|NCT02807103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25188217|NCT02807103|Immunologic Factors|immunologic factors|mesh-ancestor
25188218|NCT02807103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188219|NCT02807103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25188220|NCT02807103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25188221|NCT02807103|Alkylating Agents|alkylating agents|mesh-ancestor
25188222|NCT02807103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188223|NCT02807103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188224|NCT02807103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25188225|NCT02807103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25825417|NCT00005593|Immunologic Factors|immunologic factors|mesh-ancestor
25825418|NCT00005593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314174|NCT05023915|Dexamethasone|dexamethasone|mesh-list
25314175|NCT05023915|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
25314176|NCT05023915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25314177|NCT05023915|Antiemetics|antiemetics|mesh-ancestor
25314178|NCT05023915|Autonomic Agents|autonomic agents|mesh-ancestor
25314179|NCT05023915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25314180|NCT05023915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314181|NCT05023915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25314182|NCT05023915|Glucocorticoids|glucocorticoids|mesh-ancestor
25314183|NCT05023915|Hormones|hormones|mesh-ancestor
25825419|NCT00005593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25825420|NCT00005593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25314184|NCT05023915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25314185|NCT05023915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25314186|NCT05023915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314187|NCT05023941|Acetazolamide|acetazolamide|mesh-list
25314188|NCT05023941|Anticonvulsants|anticonvulsants|mesh-ancestor
25314189|NCT05023941|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25314190|NCT05023941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25314193|NCT05023941|Natriuretic Agents|natriuretic agents|mesh-ancestor
25314194|NCT05023941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825421|NCT00005593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825422|NCT00005596|Leucovorin|leucovorin|mesh-list
25825423|NCT00005596|Cytarabine|cytarabine|mesh-list
25825424|NCT00005596|Dexamethasone|dexamethasone|mesh-list
25825425|NCT00005596|Cyclophosphamide|cyclophosphamide|mesh-list
24842675|NCT02222636|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25314195|NCT05024266|Paclitaxel|paclitaxel|mesh-list
25314196|NCT05024266|Carboplatin|carboplatin|mesh-list
25314197|NCT05024266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25314198|NCT05024266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314199|NCT05024266|Tubulin Modulators|tubulin modulators|mesh-ancestor
25314200|NCT05024266|Antimitotic Agents|antimitotic agents|mesh-ancestor
25314201|NCT05024266|Mitosis Modulators|mitosis modulators|mesh-ancestor
25314202|NCT05024266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314203|NCT05024084|Anesthetics|anesthetics|mesh-list
25314204|NCT05024084|Sevoflurane|sevoflurane|mesh-list
25314205|NCT05024084|Desflurane|desflurane|mesh-list
25314206|NCT05024084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25314207|NCT05024084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314208|NCT05024084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25314209|NCT05024084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25314210|NCT05024084|Anesthetics, General|anesthetics, general|mesh-ancestor
25314211|NCT05024019|Nimotuzumab|nimotuzumab|mesh-list
25314212|NCT05024019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25314213|NCT05024019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314214|NCT05023824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
25314215|NCT05023824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25314216|NCT05023824|Adrenergic Agents|adrenergic agents|mesh-ancestor
25314217|NCT05023824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25648704|NCT01483690|Dexamethasone|dexamethasone|mesh-list
25648705|NCT01483690|Dexamethasone acetate|dexamethasone acetate|mesh-list
25648706|NCT01483690|Methotrexate|methotrexate|mesh-list
25648707|NCT01483690|Vincristine|vincristine|mesh-list
25648708|NCT01483690|Decitabine|decitabine|mesh-list
25648709|NCT01483690|Asparaginase|asparaginase|mesh-list
25648710|NCT01483690|Mitoxantrone|mitoxantrone|mesh-list
25648711|NCT01483690|Vorinostat|vorinostat|mesh-list
25648712|NCT01483690|Pegaspargase|pegaspargase|mesh-list
25648713|NCT01483690|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25648714|NCT01483690|BB 1101|bb 1101|mesh-list
25648715|NCT01483690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25648716|NCT01483690|Antiemetics|antiemetics|mesh-ancestor
25648717|NCT01483690|Autonomic Agents|autonomic agents|mesh-ancestor
25648718|NCT01483690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25648719|NCT01483690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314218|NCT05023824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314219|NCT05023824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314220|NCT05023863|Thioctic Acid|thioctic acid|mesh-list
25314221|NCT05023863|Antioxidants|antioxidants|mesh-ancestor
25314222|NCT05023863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314223|NCT05023863|Protective Agents|protective agents|mesh-ancestor
25314224|NCT05023863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314225|NCT05023863|Vitamin B Complex|vitamin b complex|mesh-ancestor
25314226|NCT05023863|Vitamins|vitamins|mesh-ancestor
25314227|NCT05023863|Micronutrients|micronutrients|mesh-ancestor
25314228|NCT05023382|Teduglutide|teduglutide|mesh-list
25314229|NCT05023382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25314230|NCT05023382|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25314231|NCT05023382|Protective Agents|protective agents|mesh-ancestor
25314232|NCT05023382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314233|NCT05023408|Bleomycin|bleomycin|mesh-list
25314234|NCT05023408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25314235|NCT05023408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314236|NCT05023304|Prednisolone|prednisolone|mesh-list
25314237|NCT05023304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25314238|NCT05023304|Glucocorticoids|glucocorticoids|mesh-ancestor
25314239|NCT05023304|Hormones|hormones|mesh-ancestor
25314240|NCT05023304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25314241|NCT05023304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314242|NCT05023304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25314243|NCT05023304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314244|NCT05023759|Cannabidiol|cannabidiol|mesh-list
25314245|NCT05023759|Anticonvulsants|anticonvulsants|mesh-ancestor
25314246|NCT05023577|Metronidazole|metronidazole|mesh-list
25314247|NCT05023577|Clarithromycin|clarithromycin|mesh-list
25314248|NCT05023577|Levofloxacin|levofloxacin|mesh-list
25314249|NCT05023577|Ofloxacin|ofloxacin|mesh-list
25314250|NCT05023577|Potassium Citrate|potassium citrate|mesh-list
25314251|NCT05023577|Rabeprazole|rabeprazole|mesh-list
25314252|NCT05023577|Bismuth|bismuth|mesh-list
25314253|NCT05023577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314254|NCT05023577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25314255|NCT05023577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25314256|NCT05023577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25314257|NCT05023577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25314258|NCT05023577|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25314260|NCT05023577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25314261|NCT05023577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25314262|NCT05023577|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25314263|NCT05023577|Renal Agents|renal agents|mesh-ancestor
25314264|NCT05023577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25314265|NCT05023577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25314266|NCT05023577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825426|NCT00005596|Methotrexate|methotrexate|mesh-list
25825427|NCT00005596|Vincristine|vincristine|mesh-list
25825428|NCT00005596|Daunorubicin|daunorubicin|mesh-list
25825429|NCT00005596|Mercaptopurine|mercaptopurine|mesh-list
25825430|NCT00005596|Pegaspargase|pegaspargase|mesh-list
25825431|NCT00005596|Thioguanine|thioguanine|mesh-list
25825432|NCT00005596|Levoleucovorin|levoleucovorin|mesh-list
25825433|NCT00005596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24621373|NCT01062048|Hormones|hormones|mesh-ancestor
25314267|NCT05023577|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25314268|NCT05023577|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25314269|NCT05023577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25314270|NCT05023577|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25314271|NCT05023577|Antacids|antacids|mesh-ancestor
25314272|NCT05023577|Diuretics|diuretics|mesh-ancestor
25314273|NCT05023577|Natriuretic Agents|natriuretic agents|mesh-ancestor
25314274|NCT05023577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314275|NCT05023577|Expectorants|expectorants|mesh-ancestor
25314276|NCT05023577|Respiratory System Agents|respiratory system agents|mesh-ancestor
25314277|NCT05023122|Vitamin D|vitamin d|mesh-list
25314278|NCT05023122|Cholecalciferol|cholecalciferol|mesh-list
25314279|NCT05023122|Calcium|calcium|mesh-list
25314280|NCT05023122|Vitamins|vitamins|mesh-ancestor
25314281|NCT05023122|Micronutrients|micronutrients|mesh-ancestor
25314282|NCT05023122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314283|NCT05023122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25314284|NCT05023122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25314285|NCT05022030|Cetuximab|cetuximab|mesh-list
25314286|NCT05022030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25825434|NCT00005596|Immunologic Factors|immunologic factors|mesh-ancestor
25314287|NCT05022030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314289|NCT05021887|Xhance|xhance|mesh-list
25314290|NCT05021887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25314291|NCT05021887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25314292|NCT05021887|Autonomic Agents|autonomic agents|mesh-ancestor
25314293|NCT05021887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25314299|NCT05022186|Cannabidiol|cannabidiol|mesh-list
25314300|NCT05022186|Tramiprosate|tramiprosate|mesh-list
25314301|NCT05022186|Anticonvulsants|anticonvulsants|mesh-ancestor
25314302|NCT05022186|GABA Agonists|gaba agonists|mesh-ancestor
25314303|NCT05022186|GABA Agents|gaba agents|mesh-ancestor
25314304|NCT05022186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25314305|NCT05022186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314306|NCT05022186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827484|NCT02139618|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25825435|NCT00005596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825436|NCT00005596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25825437|NCT00005596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25825438|NCT00005596|Alkylating Agents|alkylating agents|mesh-ancestor
25825439|NCT00005596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825440|NCT00005596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825441|NCT00005596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25314307|NCT05021770|Thiotepa|thiotepa|mesh-list
25314308|NCT05021770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25314309|NCT05021770|Alkylating Agents|alkylating agents|mesh-ancestor
25314310|NCT05021770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314311|NCT05021770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314312|NCT05021770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25314313|NCT05021770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25314314|NCT05021770|Immunologic Factors|immunologic factors|mesh-ancestor
25314315|NCT05021770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314316|NCT05021588|Anticoagulants|anticoagulants|mesh-list
25314317|NCT05021406|Carvedilol|carvedilol|mesh-list
25314318|NCT05021406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25314319|NCT05021406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25314320|NCT05021406|Adrenergic Agents|adrenergic agents|mesh-ancestor
25314321|NCT05021406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25314322|NCT05021406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314323|NCT05021406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314324|NCT05021406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25314325|NCT05021406|Antioxidants|antioxidants|mesh-ancestor
25314326|NCT05021406|Protective Agents|protective agents|mesh-ancestor
25314327|NCT05021406|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25314328|NCT05021406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25314329|NCT05021406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25314330|NCT05021406|Vasodilator Agents|vasodilator agents|mesh-ancestor
25314331|NCT05021406|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25314332|NCT05021406|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25314337|NCT05021731|Rifampin|rifampin|mesh-list
25314338|NCT05021731|Rifapentine|rifapentine|mesh-list
25314339|NCT05021731|Isoniazid|isoniazid|mesh-list
25314340|NCT05021731|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25314341|NCT05021731|Antitubercular Agents|antitubercular agents|mesh-ancestor
25314342|NCT05021731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25314343|NCT05021731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25314344|NCT05021731|Leprostatic Agents|leprostatic agents|mesh-ancestor
25314345|NCT05021731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25314346|NCT05021731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25314347|NCT05021731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314348|NCT05021731|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25314349|NCT05021731|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25314350|NCT05021731|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25314351|NCT05021731|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25314352|NCT05021731|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25314353|NCT05021731|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25314354|NCT05021731|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25314355|NCT05021731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25314356|NCT05021731|Antimetabolites|antimetabolites|mesh-ancestor
25314357|NCT05021731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25314383|NCT05020704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314384|NCT05020704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25314385|NCT05020704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188408|NCT02805946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25188409|NCT02805946|Hormone Antagonists|hormone antagonists|mesh-ancestor
25188410|NCT02805946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25188411|NCT02805946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188412|NCT02805738|Tenofovir|tenofovir|mesh-list
25188413|NCT02805738|Antiviral Agents|antiviral agents|mesh-ancestor
25188414|NCT02805738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25188415|NCT02805738|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25188416|NCT02805738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25188417|NCT02805738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25188418|NCT02805738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188419|NCT02805738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25188420|NCT02805738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25188421|NCT02805920|Bupivacaine|bupivacaine|mesh-list
25314386|NCT05020483|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
25314387|NCT05020483|Coagulants|coagulants|mesh-ancestor
25314388|NCT05020600|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25314389|NCT05020600|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25314390|NCT05020600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25314391|NCT05020600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25314392|NCT05020600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314393|NCT05020600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25314394|NCT05020600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314395|NCT05020600|Analgesics|analgesics|mesh-ancestor
25314396|NCT05020600|Sensory System Agents|sensory system agents|mesh-ancestor
25314397|NCT05020600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25314398|NCT05020600|Antidepressive Agents|antidepressive agents|mesh-ancestor
24672061|NCT01329614|Autonomic Agents|autonomic agents|mesh-ancestor
25314399|NCT05020600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25314400|NCT05020600|Dopamine Agents|dopamine agents|mesh-ancestor
25314402|NCT05020210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25314403|NCT05020210|Protease Inhibitors|protease inhibitors|mesh-ancestor
25314404|NCT05020210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25314405|NCT05020210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314406|NCT05019755|Varespladib methyl|varespladib methyl|mesh-list
25314407|NCT05019755|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
25314408|NCT05019755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25314409|NCT05019755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314410|NCT05019586|Amoxicillin|amoxicillin|mesh-list
25314411|NCT05019586|Clarithromycin|clarithromycin|mesh-list
25314412|NCT05019586|Levofloxacin|levofloxacin|mesh-list
25314413|NCT05019586|Ofloxacin|ofloxacin|mesh-list
25314414|NCT05019586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25314415|NCT05019586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25314416|NCT05019586|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25314417|NCT05019586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25314418|NCT05019586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314419|NCT05019586|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25314420|NCT05019586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25314421|NCT05019586|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25314422|NCT05019586|Renal Agents|renal agents|mesh-ancestor
25314423|NCT05019586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25314424|NCT05019586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25314425|NCT05019586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314426|NCT05019586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25314427|NCT05019690|Paclitaxel|paclitaxel|mesh-list
25314428|NCT05019690|Apatinib|apatinib|mesh-list
25314429|NCT05019690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25314430|NCT05019690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25648720|NCT01483690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25648721|NCT01483690|Glucocorticoids|glucocorticoids|mesh-ancestor
25648722|NCT01483690|Hormones|hormones|mesh-ancestor
25648723|NCT01483690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25648724|NCT01483690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25648725|NCT01483690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25648726|NCT01483690|Protease Inhibitors|protease inhibitors|mesh-ancestor
25648727|NCT01483690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25648728|NCT01483690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648729|NCT01483690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25648730|NCT01483690|Abortifacient Agents|abortifacient agents|mesh-ancestor
25648731|NCT01483690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25648732|NCT01483690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25648733|NCT01483690|Antimetabolites|antimetabolites|mesh-ancestor
25208138|NCT03039036|Misoprostol|misoprostol|mesh-list
25208139|NCT03039036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25208140|NCT03039036|Abortifacient Agents|abortifacient agents|mesh-ancestor
25208141|NCT03039036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25208142|NCT03039036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208143|NCT03039036|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25208144|NCT03039036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25208145|NCT03039036|Oxytocics|oxytocics|mesh-ancestor
25208146|NCT02997605|Prednisone|prednisone|mesh-list
25208147|NCT02997605|Hydrocortisone|hydrocortisone|mesh-list
25208148|NCT02997605|Glucocorticoids|glucocorticoids|mesh-list
25314431|NCT05019690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314432|NCT05019690|Tubulin Modulators|tubulin modulators|mesh-ancestor
25314435|NCT05019690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314436|NCT05019690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25314437|NCT05019690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25314438|NCT05019417|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25314440|NCT05019417|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25314441|NCT05019417|Protective Agents|protective agents|mesh-ancestor
25314442|NCT05019417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314443|NCT05019417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314444|NCT05018923|Metronidazole|metronidazole|mesh-list
25314445|NCT05018923|Doxycycline|doxycycline|mesh-list
25314446|NCT05018923|Tetracycline|tetracycline|mesh-list
25314447|NCT05018923|Potassium Citrate|potassium citrate|mesh-list
25314448|NCT05018923|Rabeprazole|rabeprazole|mesh-list
25314449|NCT05018923|Bismuth|bismuth|mesh-list
24725820|NCT01599923|Antivenins|antivenins|mesh-list
24844561|NCT02233218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24844562|NCT02233218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24844563|NCT02233218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25314450|NCT05018923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314451|NCT05018923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25314452|NCT05018923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25314453|NCT05018923|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25314454|NCT05018923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25314455|NCT05018923|Antimalarials|antimalarials|mesh-ancestor
25314456|NCT05018923|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25314457|NCT05018923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25314458|NCT05018923|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25314459|NCT05018923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25314460|NCT05018923|Antacids|antacids|mesh-ancestor
25314461|NCT05018923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25314462|NCT05018923|Diuretics|diuretics|mesh-ancestor
25314463|NCT05018923|Natriuretic Agents|natriuretic agents|mesh-ancestor
25314464|NCT05018923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314465|NCT05018923|Expectorants|expectorants|mesh-ancestor
25314466|NCT05018923|Respiratory System Agents|respiratory system agents|mesh-ancestor
25314467|NCT05019326|Andrographolide|andrographolide|mesh-list
25314468|NCT05019326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25314469|NCT05019326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25314470|NCT05019326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25314471|NCT05019326|Analgesics|analgesics|mesh-ancestor
25314472|NCT05019326|Sensory System Agents|sensory system agents|mesh-ancestor
25314473|NCT05019326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25314474|NCT05019326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314475|NCT05019326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25314476|NCT05019326|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25314477|NCT05019326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25314478|NCT05019326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25314479|NCT05019326|Antiviral Agents|antiviral agents|mesh-ancestor
25314480|NCT05019326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24844813|NCT02234544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24844814|NCT02234544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24844815|NCT02234544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24844816|NCT02234544|Antimetabolites|antimetabolites|mesh-ancestor
25648734|NCT01483690|Dermatologic Agents|dermatologic agents|mesh-ancestor
25648735|NCT01483690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25648736|NCT01483690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25648737|NCT01483690|Immunologic Factors|immunologic factors|mesh-ancestor
25648738|NCT01483690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25648739|NCT01483690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25648740|NCT01483690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25648741|NCT01483690|Tubulin Modulators|tubulin modulators|mesh-ancestor
25648742|NCT01483690|Antimitotic Agents|antimitotic agents|mesh-ancestor
25648743|NCT01483690|Mitosis Modulators|mitosis modulators|mesh-ancestor
24874110|NCT04920981|Atezolizumab|atezolizumab|mesh-list
25314481|NCT05018988|Vitamin D|vitamin d|mesh-list
25314482|NCT05018988|Ergocalciferols|ergocalciferols|mesh-list
25314483|NCT05018988|Cholecalciferol|cholecalciferol|mesh-list
25314484|NCT05018988|Vitamins|vitamins|mesh-list
25314485|NCT05018988|Micronutrients|micronutrients|mesh-ancestor
25314486|NCT05018988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314487|NCT05018988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25314488|NCT05018988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25314489|NCT05018962|Paclitaxel|paclitaxel|mesh-list
25314490|NCT05018962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25314491|NCT05018962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314492|NCT05018962|Tubulin Modulators|tubulin modulators|mesh-ancestor
25314493|NCT05018962|Antimitotic Agents|antimitotic agents|mesh-ancestor
25314494|NCT05018962|Mitosis Modulators|mitosis modulators|mesh-ancestor
25314495|NCT05018962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314496|NCT05018637|Teriparatide|teriparatide|mesh-list
25314497|NCT05018637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25314498|NCT05018637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314499|NCT05018637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25314501|NCT05018364|Hematinics|hematinics|mesh-ancestor
25314502|NCT05018182|Leucovorin|leucovorin|mesh-list
25314503|NCT05018182|Folic Acid|folic acid|mesh-list
25314504|NCT05018182|Fluorouracil|fluorouracil|mesh-list
25314505|NCT05018182|Capecitabine|capecitabine|mesh-list
25314506|NCT05018182|Oxaliplatin|oxaliplatin|mesh-list
25314507|NCT05018182|Irinotecan|irinotecan|mesh-list
25314508|NCT05018182|Levoleucovorin|levoleucovorin|mesh-list
25314509|NCT05018182|Antimetabolites|antimetabolites|mesh-ancestor
25314510|NCT05018182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314511|NCT05018182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25314512|NCT05018182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314513|NCT05018182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25314514|NCT05018182|Immunologic Factors|immunologic factors|mesh-ancestor
25314515|NCT05018182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314516|NCT05018182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25314517|NCT05018182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25314518|NCT05018182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25314519|NCT05018182|Antidotes|antidotes|mesh-ancestor
25314520|NCT05018182|Protective Agents|protective agents|mesh-ancestor
25314521|NCT05018182|Vitamin B Complex|vitamin b complex|mesh-ancestor
25314522|NCT05018182|Vitamins|vitamins|mesh-ancestor
25314523|NCT05018182|Micronutrients|micronutrients|mesh-ancestor
25314524|NCT05018182|Hematinics|hematinics|mesh-ancestor
25314525|NCT05017987|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25314526|NCT05017987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314527|NCT05017987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25314528|NCT05017987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25314529|NCT05017987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25314530|NCT05017766|Anti-Infective Agents|anti-infective agents|mesh-list
25314531|NCT05017766|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25314532|NCT05017454|Mometasone Furoate|mometasone furoate|mesh-list
25314533|NCT05017454|Valproic Acid|valproic acid|mesh-list
25314534|NCT05017454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25314535|NCT05017454|Dermatologic Agents|dermatologic agents|mesh-ancestor
25314536|NCT05017454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25314537|NCT05017454|Anticonvulsants|anticonvulsants|mesh-ancestor
25314538|NCT05017454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25314539|NCT05017454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314540|NCT05017454|GABA Agents|gaba agents|mesh-ancestor
25314541|NCT05017454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25314542|NCT05017454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314543|NCT05017454|Antimanic Agents|antimanic agents|mesh-ancestor
25314544|NCT05017454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25314545|NCT05017454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25314546|NCT05017454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25314547|NCT05017311|Citalopram|citalopram|mesh-list
25108441|NCT03132181|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25108442|NCT03132181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314548|NCT05017311|Brexpiprazole|brexpiprazole|mesh-list
25314549|NCT05017311|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25314550|NCT05017311|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25314551|NCT05017311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25314552|NCT05017311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314553|NCT05017311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25648744|NCT01483690|Analgesics|analgesics|mesh-ancestor
25188582|NCT02804360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188583|NCT02804360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25188584|NCT02804360|Glucocorticoids|glucocorticoids|mesh-ancestor
25188585|NCT02804360|Hormones|hormones|mesh-ancestor
25188586|NCT02804360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25188589|NCT02804373|Oxytocin|oxytocin|mesh-list
25314554|NCT05017311|Serotonin Agents|serotonin agents|mesh-ancestor
25314555|NCT05017311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314556|NCT05017311|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25314557|NCT05017311|Antidepressive Agents|antidepressive agents|mesh-ancestor
25314558|NCT05017311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25314559|NCT05017311|Dopamine Agonists|dopamine agonists|mesh-ancestor
25314560|NCT05017311|Dopamine Agents|dopamine agents|mesh-ancestor
25314561|NCT05017428|Niacinamide|niacinamide|mesh-list
25314562|NCT05017428|Niacin|niacin|mesh-list
25314563|NCT05017428|Nicotinic Acids|nicotinic acids|mesh-list
25314564|NCT05017428|Vitamin B Complex|vitamin b complex|mesh-ancestor
25314565|NCT05017428|Vitamins|vitamins|mesh-ancestor
25314566|NCT05017428|Micronutrients|micronutrients|mesh-ancestor
25314567|NCT05017428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314568|NCT05017428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25314569|NCT05017428|Antimetabolites|antimetabolites|mesh-ancestor
25314570|NCT05017428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314571|NCT05017428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25314572|NCT05017428|Vasodilator Agents|vasodilator agents|mesh-ancestor
25314592|NCT05017155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314593|NCT05017155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25314594|NCT05017155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314595|NCT05017155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25314596|NCT05017155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25314597|NCT05017155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25314598|NCT05017155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25314599|NCT05017155|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25314600|NCT05017155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25314601|NCT05017155|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25314602|NCT05017116|Entecavir|entecavir|mesh-list
25314603|NCT05017116|Antiviral Agents|antiviral agents|mesh-ancestor
25314604|NCT05017116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25314610|NCT05016713|Chlorhexidine|chlorhexidine|mesh-list
25314611|NCT05016713|Fluorides|fluorides|mesh-list
25314612|NCT05016713|Cariostatic Agents|cariostatic agents|mesh-ancestor
25314613|NCT05016713|Protective Agents|protective agents|mesh-ancestor
25314614|NCT05016713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314615|NCT05016713|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25314616|NCT05016713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25314617|NCT05016713|Disinfectants|disinfectants|mesh-ancestor
25314618|NCT05016128|Ketamine|ketamine|mesh-list
25314619|NCT05016128|Esketamine|esketamine|mesh-list
25314620|NCT05016128|Analgesics|analgesics|mesh-ancestor
25314621|NCT05016128|Sensory System Agents|sensory system agents|mesh-ancestor
25314622|NCT05016128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24815213|NCT02068859|Sensory System Agents|sensory system agents|mesh-ancestor
24815214|NCT02068859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24815215|NCT02068859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611013|NCT01006187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25314623|NCT05016128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314624|NCT05016128|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25314625|NCT05016128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25314626|NCT05016128|Anesthetics, General|anesthetics, general|mesh-ancestor
25314627|NCT05016128|Anesthetics|anesthetics|mesh-ancestor
25314628|NCT05016128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25314629|NCT05016128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25314630|NCT05016128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25314631|NCT05016128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25314632|NCT05016128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314633|NCT05016128|Antidepressive Agents|antidepressive agents|mesh-ancestor
25314634|NCT05016128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25314635|NCT05016206|Moxifloxacin|moxifloxacin|mesh-list
25314636|NCT05016206|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25648745|NCT01483690|Sensory System Agents|sensory system agents|mesh-ancestor
25648746|NCT01483690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25648747|NCT01483690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25648748|NCT01483690|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25648749|NCT01484041|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25648750|NCT01484041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25314637|NCT05016206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25314638|NCT05016206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25314639|NCT05016206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25314640|NCT05016206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25314641|NCT05016206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25314642|NCT05016206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314643|NCT05016206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314644|NCT05016206|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25314645|NCT05016206|Contraceptive Agents|contraceptive agents|mesh-ancestor
25314646|NCT05016206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25314647|NCT05016206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314648|NCT05016206|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25314649|NCT05016206|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25314650|NCT05016206|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25314651|NCT05016440|Lisinopril|lisinopril|mesh-list
25314652|NCT05016440|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25314653|NCT05016440|Protease Inhibitors|protease inhibitors|mesh-ancestor
25314654|NCT05016440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25314655|NCT05016440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314656|NCT05016440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25314657|NCT05016440|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25314658|NCT05016440|Protective Agents|protective agents|mesh-ancestor
25314659|NCT05016440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314660|NCT05016349|Tamoxifen|tamoxifen|mesh-list
25314661|NCT05016349|Tocopherols|tocopherols|mesh-list
25314662|NCT05016349|Tretinoin|tretinoin|mesh-list
25314663|NCT05016349|Alitretinoin|alitretinoin|mesh-list
25314664|NCT05016349|Cannabidiol|cannabidiol|mesh-list
25314665|NCT05016349|Isotretinoin|isotretinoin|mesh-list
25314666|NCT05016349|Mifepristone|mifepristone|mesh-list
25314667|NCT05016349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25314668|NCT05016349|Hormone Antagonists|hormone antagonists|mesh-ancestor
25314669|NCT05016349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25314670|NCT05016349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314671|NCT05016349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25314672|NCT05016349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314673|NCT05016349|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25314674|NCT05016349|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25314675|NCT05016349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25314676|NCT05016349|Anticonvulsants|anticonvulsants|mesh-ancestor
25314677|NCT05016349|Keratolytic Agents|keratolytic agents|mesh-ancestor
25314678|NCT05016349|Dermatologic Agents|dermatologic agents|mesh-ancestor
25314679|NCT05016349|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25314680|NCT05016349|Abortifacient Agents|abortifacient agents|mesh-ancestor
25314681|NCT05016349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25314682|NCT05016349|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25314683|NCT05016349|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25314684|NCT05016349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25314685|NCT05016349|Contraceptive Agents|contraceptive agents|mesh-ancestor
25314686|NCT05016349|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25314687|NCT05016349|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25314688|NCT05016349|Luteolytic Agents|luteolytic agents|mesh-ancestor
25314689|NCT05016349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25314690|NCT05016349|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25314691|NCT05016349|Antioxidants|antioxidants|mesh-ancestor
25314692|NCT05016349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314693|NCT05016349|Protective Agents|protective agents|mesh-ancestor
25314694|NCT05016349|Vitamins|vitamins|mesh-ancestor
25314695|NCT05016349|Micronutrients|micronutrients|mesh-ancestor
25314696|NCT05016180|Ropivacaine|ropivacaine|mesh-list
25314697|NCT05016180|Anesthetics, Local|anesthetics, local|mesh-ancestor
25314698|NCT05016180|Anesthetics|anesthetics|mesh-ancestor
25314699|NCT05016180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25314700|NCT05016180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314701|NCT05016180|Sensory System Agents|sensory system agents|mesh-ancestor
25314702|NCT05016180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25314703|NCT05016063|Fludarabine|fludarabine|mesh-list
25314704|NCT05016063|Cyclophosphamide|cyclophosphamide|mesh-list
25314705|NCT05016063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314706|NCT05016063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314707|NCT05016063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25314708|NCT05016063|Immunologic Factors|immunologic factors|mesh-ancestor
25314709|NCT05016063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314710|NCT05016063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25314711|NCT05016063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25314712|NCT05016063|Alkylating Agents|alkylating agents|mesh-ancestor
25314713|NCT05016063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25314714|NCT05015907|Ropivacaine|ropivacaine|mesh-list
25314715|NCT05015907|Anesthetics, Local|anesthetics, local|mesh-ancestor
25314716|NCT05015907|Anesthetics|anesthetics|mesh-ancestor
25314717|NCT05015907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25314718|NCT05015907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314719|NCT05015907|Sensory System Agents|sensory system agents|mesh-ancestor
25314720|NCT05015907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25314722|NCT05015595|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25314723|NCT05015595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25314724|NCT05015595|Dopamine Agents|dopamine agents|mesh-ancestor
25314725|NCT05015595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25314726|NCT05015595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314727|NCT05015595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314728|NCT05015595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25314729|NCT05015595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25314730|NCT05015621|Leucovorin|leucovorin|mesh-list
25314731|NCT05015621|Fluorouracil|fluorouracil|mesh-list
25314732|NCT05015621|Irinotecan|irinotecan|mesh-list
25314733|NCT05015621|Calcium|calcium|mesh-list
25314734|NCT05015621|Levoleucovorin|levoleucovorin|mesh-list
25314735|NCT05015621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25314736|NCT05015621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314737|NCT05015621|Antimetabolites|antimetabolites|mesh-ancestor
25314738|NCT05015621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314739|NCT05015621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25314740|NCT05015621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314741|NCT05015621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25314742|NCT05015621|Immunologic Factors|immunologic factors|mesh-ancestor
25314743|NCT05015621|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25314744|NCT05015621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25314745|NCT05015621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25314746|NCT05015621|Antidotes|antidotes|mesh-ancestor
25314747|NCT05015621|Protective Agents|protective agents|mesh-ancestor
25314748|NCT05015621|Vitamin B Complex|vitamin b complex|mesh-ancestor
25314749|NCT05015621|Vitamins|vitamins|mesh-ancestor
25314750|NCT05015621|Micronutrients|micronutrients|mesh-ancestor
25314751|NCT05015829|Dobutamine|dobutamine|mesh-list
25314752|NCT05015829|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25314753|NCT05015829|Sympathomimetics|sympathomimetics|mesh-ancestor
25314754|NCT05015829|Autonomic Agents|autonomic agents|mesh-ancestor
25314755|NCT05015829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25314756|NCT05015829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314757|NCT05015829|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25314758|NCT05015829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25314759|NCT05015829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25314760|NCT05015829|Adrenergic Agents|adrenergic agents|mesh-ancestor
25314761|NCT05015829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25314762|NCT05015829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314763|NCT05015829|Protective Agents|protective agents|mesh-ancestor
25314764|NCT05015361|Propofol|propofol|mesh-list
25314765|NCT05015361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25314766|NCT05015361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25314767|NCT05015361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314768|NCT05015361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25314769|NCT05015361|Anesthetics, General|anesthetics, general|mesh-ancestor
25314770|NCT05015361|Anesthetics|anesthetics|mesh-ancestor
25314771|NCT05015322|Methylprednisolone|methylprednisolone|mesh-list
25314772|NCT05015322|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25314773|NCT05015322|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25314774|NCT05015322|Prednisolone|prednisolone|mesh-list
25314775|NCT05015322|Prednisolone acetate|prednisolone acetate|mesh-list
25314776|NCT05015322|Bupivacaine|bupivacaine|mesh-list
25314777|NCT05015322|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25314778|NCT05015322|Prednisolone phosphate|prednisolone phosphate|mesh-list
25314779|NCT05015322|Anesthetics, Local|anesthetics, local|mesh-ancestor
25825442|NCT00005596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24459005|NCT00343369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24459006|NCT00343369|Antiemetics|antiemetics|mesh-ancestor
25825443|NCT00005596|Antiemetics|antiemetics|mesh-ancestor
25314780|NCT05015322|Anesthetics|anesthetics|mesh-ancestor
25314781|NCT05015322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25314782|NCT05015322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314783|NCT05015322|Sensory System Agents|sensory system agents|mesh-ancestor
25314784|NCT05015322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25314785|NCT05015322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25314786|NCT05015322|Antiemetics|antiemetics|mesh-ancestor
25314787|NCT05015322|Autonomic Agents|autonomic agents|mesh-ancestor
25314788|NCT05015322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25314789|NCT05015322|Glucocorticoids|glucocorticoids|mesh-ancestor
25314790|NCT05015322|Hormones|hormones|mesh-ancestor
25314800|NCT05014711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25314801|NCT05014711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314803|NCT05014711|Sensory System Agents|sensory system agents|mesh-ancestor
25314804|NCT05014711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25314805|NCT05014711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25314806|NCT05014711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25314807|NCT05014711|Anesthetics, General|anesthetics, general|mesh-ancestor
25314808|NCT05014711|Anesthetics|anesthetics|mesh-ancestor
25314809|NCT05014685|Amoxicillin|amoxicillin|mesh-list
25314810|NCT05014685|Metronidazole|metronidazole|mesh-list
25314811|NCT05014685|Potassium Citrate|potassium citrate|mesh-list
25314812|NCT05014685|Rabeprazole|rabeprazole|mesh-list
25314813|NCT05014685|Bismuth|bismuth|mesh-list
25314814|NCT05014685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314815|NCT05014685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25314816|NCT05014685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25314817|NCT05014685|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25314818|NCT05014685|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25314819|NCT05014685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25314820|NCT05014685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25314821|NCT05014685|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25314822|NCT05014685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25314823|NCT05014685|Antacids|antacids|mesh-ancestor
25314824|NCT05014685|Diuretics|diuretics|mesh-ancestor
25314825|NCT05014685|Natriuretic Agents|natriuretic agents|mesh-ancestor
25314826|NCT05014685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314827|NCT05014685|Expectorants|expectorants|mesh-ancestor
25314828|NCT05014685|Respiratory System Agents|respiratory system agents|mesh-ancestor
25314829|NCT05014906|Minocycline|minocycline|mesh-list
25314830|NCT05014906|Azelaic acid|azelaic acid|mesh-list
25314831|NCT05014906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25314832|NCT05014906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25314833|NCT05014906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314834|NCT05014906|Dermatologic Agents|dermatologic agents|mesh-ancestor
25314839|NCT05014828|Lenvatinib|lenvatinib|mesh-list
25314840|NCT05014828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314841|NCT05014828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25314842|NCT05014828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25314843|NCT05014828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314844|NCT05014464|Crizotinib|crizotinib|mesh-list
25314845|NCT05014464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314846|NCT05014464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25314847|NCT05014464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25314848|NCT05014464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314849|NCT05014490|Etoricoxib|etoricoxib|mesh-list
25314850|NCT05014490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25314851|NCT05014490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25314852|NCT05014490|Analgesics|analgesics|mesh-ancestor
25314853|NCT05014490|Sensory System Agents|sensory system agents|mesh-ancestor
25314854|NCT05014490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25314855|NCT05014490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314856|NCT05014490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25314857|NCT05014490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25314858|NCT05014490|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25314859|NCT05014490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25314860|NCT05014490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25314861|NCT05014490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314869|NCT05014581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25314870|NCT05014581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25314871|NCT05014581|Adrenergic Agents|adrenergic agents|mesh-ancestor
25314872|NCT05014581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25314873|NCT05014581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314874|NCT05014581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314875|NCT05014581|Sympathomimetics|sympathomimetics|mesh-ancestor
25314876|NCT05014581|Autonomic Agents|autonomic agents|mesh-ancestor
25314877|NCT05014581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25314878|NCT05014581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25314879|NCT05014607|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25314880|NCT05014607|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25314881|NCT05014607|Immunologic Factors|immunologic factors|mesh-ancestor
25206149|NCT03815019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25206150|NCT03815019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314882|NCT05014607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314883|NCT05014594|Dapagliflozin|dapagliflozin|mesh-list
25314884|NCT05014594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25314885|NCT05014594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314886|NCT05014594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25314887|NCT05014594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314888|NCT05014373|Favipiravir|favipiravir|mesh-list
25314889|NCT05014373|Antiviral Agents|antiviral agents|mesh-ancestor
25314890|NCT05014373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25314891|NCT05014100|Lenalidomide|lenalidomide|mesh-list
25314892|NCT05014100|Immunologic Factors|immunologic factors|mesh-ancestor
25314893|NCT05014100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314894|NCT05014100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25314895|NCT05014100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25314896|NCT05014100|Growth Substances|growth substances|mesh-ancestor
25314897|NCT05014100|Growth Inhibitors|growth inhibitors|mesh-ancestor
25314898|NCT05014100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314899|NCT05014048|Vitamin D|vitamin d|mesh-list
25314900|NCT05014048|Cholecalciferol|cholecalciferol|mesh-list
25314901|NCT05014048|Vitamins|vitamins|mesh-ancestor
25314902|NCT05014048|Micronutrients|micronutrients|mesh-ancestor
25314903|NCT05014048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314904|NCT05014048|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25314905|NCT05014048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25825444|NCT00005596|Autonomic Agents|autonomic agents|mesh-ancestor
25825445|NCT00005596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25825446|NCT00005596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24459734|NCT00346242|Zoledronic Acid|zoledronic acid|mesh-list
25825447|NCT00005596|Glucocorticoids|glucocorticoids|mesh-ancestor
25825448|NCT00005596|Hormones|hormones|mesh-ancestor
25825449|NCT00005596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25825450|NCT00005596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25314906|NCT05013697|Paclitaxel|paclitaxel|mesh-list
25314907|NCT05013697|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25314908|NCT05013697|Cisplatin|cisplatin|mesh-list
25314909|NCT05013697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25314910|NCT05013697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314911|NCT05013697|Tubulin Modulators|tubulin modulators|mesh-ancestor
25314912|NCT05013697|Antimitotic Agents|antimitotic agents|mesh-ancestor
25314913|NCT05013697|Mitosis Modulators|mitosis modulators|mesh-ancestor
25314914|NCT05013697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314915|NCT05013060|Butyric Acid|butyric acid|mesh-list
25314916|NCT05013060|Histamine Antagonists|histamine antagonists|mesh-ancestor
25314917|NCT05013060|Histamine Agents|histamine agents|mesh-ancestor
25314918|NCT05013060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25314919|NCT05013060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314920|NCT05013060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314921|NCT05013112|Metformin|metformin|mesh-list
25314922|NCT05013112|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25314923|NCT05013112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25314924|NCT05013112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314925|NCT05013112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314926|NCT05013164|Leucovorin|leucovorin|mesh-list
25314927|NCT05013164|Folic Acid|folic acid|mesh-list
25314928|NCT05013164|Levoleucovorin|levoleucovorin|mesh-list
25314929|NCT05013164|Antidotes|antidotes|mesh-ancestor
25314930|NCT05013164|Protective Agents|protective agents|mesh-ancestor
25314931|NCT05013164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314932|NCT05013164|Vitamin B Complex|vitamin b complex|mesh-ancestor
25314933|NCT05013164|Vitamins|vitamins|mesh-ancestor
25314934|NCT05013164|Micronutrients|micronutrients|mesh-ancestor
25314935|NCT05013164|Hematinics|hematinics|mesh-ancestor
25314936|NCT05013034|Basiliximab|basiliximab|mesh-list
25314937|NCT05013034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25314939|NCT05013034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314940|NCT05013151|Castor Oil|castor oil|mesh-list
25314941|NCT05013151|Cathartics|cathartics|mesh-ancestor
25314942|NCT05013151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25314943|NCT05013268|Paclitaxel|paclitaxel|mesh-list
25314944|NCT05013268|Docetaxel|docetaxel|mesh-list
25314945|NCT05013268|Carboplatin|carboplatin|mesh-list
25648751|NCT01484041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25648752|NCT01484041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314946|NCT05013268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25314947|NCT05013268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977118|NCT03541447|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24977119|NCT03541447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314948|NCT05013268|Tubulin Modulators|tubulin modulators|mesh-ancestor
25314949|NCT05013268|Antimitotic Agents|antimitotic agents|mesh-ancestor
25314950|NCT05013268|Mitosis Modulators|mitosis modulators|mesh-ancestor
25314951|NCT05013268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314952|NCT05013320|Glycopyrrolate|glycopyrrolate|mesh-list
25314953|NCT05013320|Dexmedetomidine|dexmedetomidine|mesh-list
25314954|NCT05013320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25314955|NCT05013320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25314956|NCT05013320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314957|NCT05013320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25314958|NCT05013320|Analgesics|analgesics|mesh-ancestor
25314959|NCT05013320|Sensory System Agents|sensory system agents|mesh-ancestor
25314960|NCT05013320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25314961|NCT05013320|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25314962|NCT05013320|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25314963|NCT05013320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25314964|NCT05013320|Adrenergic Agents|adrenergic agents|mesh-ancestor
25314965|NCT05013320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25314966|NCT05013320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314967|NCT05013320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25314968|NCT05013320|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25314969|NCT05013320|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25314970|NCT05013320|Cholinergic Agents|cholinergic agents|mesh-ancestor
25314971|NCT05012137|Ropivacaine|ropivacaine|mesh-list
25314972|NCT05012137|Anesthetics, Local|anesthetics, local|mesh-ancestor
25314973|NCT05012137|Anesthetics|anesthetics|mesh-ancestor
25314974|NCT05012137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25314975|NCT05012137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314976|NCT05012137|Sensory System Agents|sensory system agents|mesh-ancestor
25314977|NCT05012137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25314978|NCT05012033|Prednisolone|prednisolone|mesh-list
25314979|NCT05012033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25314980|NCT05012033|Glucocorticoids|glucocorticoids|mesh-ancestor
25314981|NCT05012033|Hormones|hormones|mesh-ancestor
25314982|NCT05012033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25314983|NCT05012033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25314984|NCT05012033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25314985|NCT05012033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314986|NCT05011916|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25314987|NCT05011916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25314989|NCT05011487|Osimertinib|osimertinib|mesh-list
25314990|NCT05011487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25314991|NCT05011487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25314992|NCT05011487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25314993|NCT05011487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25314994|NCT05011487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25314995|NCT05011487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25314996|NCT05011669|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25314997|NCT05011669|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25314998|NCT05011669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25314999|NCT05011669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25315000|NCT05011669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315001|NCT05011669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25315002|NCT05011669|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25315003|NCT05011669|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25315004|NCT05011669|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25315005|NCT05011669|Adrenergic Agents|adrenergic agents|mesh-ancestor
25315006|NCT05011669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25315007|NCT05011669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315008|NCT05011669|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25315009|NCT05011669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25315010|NCT05011669|Serotonin Agents|serotonin agents|mesh-ancestor
24859704|NCT02305355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24859705|NCT02305355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24859706|NCT02305355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859707|NCT02305394|Ketamine|ketamine|mesh-list
24859708|NCT02305394|Propofol|propofol|mesh-list
25648753|NCT01484041|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25648754|NCT01484041|Hormone Antagonists|hormone antagonists|mesh-ancestor
25648755|NCT01484041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24859709|NCT02305394|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25315020|NCT05010876|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25315021|NCT05010876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25315022|NCT05010876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25315023|NCT05010876|Analgesics|analgesics|mesh-ancestor
25315024|NCT05010876|Sensory System Agents|sensory system agents|mesh-ancestor
25315025|NCT05010876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25315026|NCT05010876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315027|NCT05010876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25315028|NCT05010876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25315029|NCT05010876|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
25315030|NCT05010876|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
25315031|NCT05010876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315032|NCT05010876|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25315033|NCT05010876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25315034|NCT05010876|Immunologic Factors|immunologic factors|mesh-ancestor
25315035|NCT05010707|Spironolactone|spironolactone|mesh-list
25315036|NCT05010707|Hormones|hormones|mesh-list
25315037|NCT05010707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25315038|NCT05010707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315039|NCT05010707|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25315040|NCT05010707|Hormone Antagonists|hormone antagonists|mesh-ancestor
25315041|NCT05010707|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25315042|NCT05010707|Diuretics|diuretics|mesh-ancestor
25315043|NCT05010707|Natriuretic Agents|natriuretic agents|mesh-ancestor
25315044|NCT05010668|Lenvatinib|lenvatinib|mesh-list
25315045|NCT05010668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315046|NCT05010668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25315047|NCT05010668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25315048|NCT05010668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315049|NCT05010681|Lenvatinib|lenvatinib|mesh-list
25315050|NCT05010681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315051|NCT05010681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25315052|NCT05010681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25315053|NCT05010681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315054|NCT05010538|Sarecycline|sarecycline|mesh-list
25315055|NCT05010538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25315056|NCT05010538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25315057|NCT05010538|Dermatologic Agents|dermatologic agents|mesh-ancestor
25315058|NCT05010499|Bupivacaine|bupivacaine|mesh-list
25315059|NCT05010499|Levobupivacaine|levobupivacaine|mesh-list
25315060|NCT05010499|Anesthetics, Local|anesthetics, local|mesh-ancestor
25315061|NCT05010499|Anesthetics|anesthetics|mesh-ancestor
25315062|NCT05010499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25315063|NCT05010499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315064|NCT05010499|Sensory System Agents|sensory system agents|mesh-ancestor
25315065|NCT05010499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25315066|NCT05010434|Bevacizumab|bevacizumab|mesh-list
25315067|NCT05010434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25315068|NCT05010434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315069|NCT05010434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25315070|NCT05010434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25315071|NCT05010434|Growth Substances|growth substances|mesh-ancestor
25315072|NCT05010434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315073|NCT05010434|Growth Inhibitors|growth inhibitors|mesh-ancestor
25315074|NCT05010356|Insulin|insulin|mesh-list
25315075|NCT05010356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25315076|NCT05010356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315094|NCT05009953|Antidotes|antidotes|mesh-ancestor
25315095|NCT05009953|Protective Agents|protective agents|mesh-ancestor
25315096|NCT05009953|Vitamin B Complex|vitamin b complex|mesh-ancestor
25315097|NCT05009953|Vitamins|vitamins|mesh-ancestor
25315098|NCT05009953|Micronutrients|micronutrients|mesh-ancestor
25315099|NCT05009342|Calpastatin|calpastatin|mesh-list
25315100|NCT05009342|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25315101|NCT05009342|Protease Inhibitors|protease inhibitors|mesh-ancestor
25315102|NCT05009342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25315103|NCT05009342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315104|NCT05009498|Vitamin D|vitamin d|mesh-list
25315105|NCT05009498|Cholecalciferol|cholecalciferol|mesh-list
25315106|NCT05009498|Vitamins|vitamins|mesh-ancestor
25315107|NCT05009498|Micronutrients|micronutrients|mesh-ancestor
25315108|NCT05009498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315109|NCT05009498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25188902|NCT02801357|Lofexidine|lofexidine|mesh-list
25315110|NCT05009498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25315111|NCT05009017|Bevacizumab|bevacizumab|mesh-list
25315112|NCT05009017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25315113|NCT05009017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315114|NCT05009017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25315115|NCT05009017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25315116|NCT05009017|Growth Substances|growth substances|mesh-ancestor
25315117|NCT05009017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315118|NCT05009017|Growth Inhibitors|growth inhibitors|mesh-ancestor
25315137|NCT05008939|Sevoflurane|sevoflurane|mesh-list
25315138|NCT05008939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25315139|NCT05008939|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25315140|NCT05008939|Anesthetics, General|anesthetics, general|mesh-ancestor
25315141|NCT05008939|Anesthetics|anesthetics|mesh-ancestor
25315142|NCT05008939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25315143|NCT05008939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315144|NCT05008861|Pembrolizumab|pembrolizumab|mesh-list
25315145|NCT05008861|Nivolumab|nivolumab|mesh-list
25315146|NCT05008861|Durvalumab|durvalumab|mesh-list
25315148|NCT05008861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25315149|NCT05008861|Immunologic Factors|immunologic factors|mesh-ancestor
25315150|NCT05008861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315151|NCT05008861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25315152|NCT05008861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315153|NCT05008861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25315154|NCT05008861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315155|NCT05008523|Analgesics, Opioid|analgesics, opioid|mesh-list
25315156|NCT05008523|Narcotics|narcotics|mesh-ancestor
25315157|NCT05008523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25315158|NCT05008523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315159|NCT05008523|Analgesics|analgesics|mesh-ancestor
25825451|NCT00005596|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25315160|NCT05008523|Sensory System Agents|sensory system agents|mesh-ancestor
25315161|NCT05008523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25315162|NCT05008679|Oseltamivir|oseltamivir|mesh-list
25315163|NCT05008679|Antiviral Agents|antiviral agents|mesh-ancestor
25315164|NCT05008679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25315165|NCT05008679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25315241|NCT05007587|Fluorouracil|fluorouracil|mesh-list
25315166|NCT05008679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315167|NCT05008666|Azacitidine|azacitidine|mesh-list
25315168|NCT05008666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25315169|NCT05008666|Antimetabolites|antimetabolites|mesh-ancestor
25315170|NCT05008666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315171|NCT05008666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315172|NCT05008666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25315173|NCT05008458|Arginine Vasopressin|arginine vasopressin|mesh-list
25315174|NCT05008458|Hemostatics|hemostatics|mesh-ancestor
25315175|NCT05008458|Coagulants|coagulants|mesh-ancestor
25315176|NCT05008458|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25315177|NCT05008458|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25315178|NCT05008458|Natriuretic Agents|natriuretic agents|mesh-ancestor
25315179|NCT05008458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315180|NCT05008731|Botulinum Toxins|botulinum toxins|mesh-list
25315181|NCT05008731|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25315182|NCT05008731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25315183|NCT05008731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315184|NCT05008731|Cholinergic Agents|cholinergic agents|mesh-ancestor
25315185|NCT05008731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25315186|NCT05008731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315187|NCT05008367|Dexamethasone|dexamethasone|mesh-list
25315188|NCT05008367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25315189|NCT05008367|Antiemetics|antiemetics|mesh-ancestor
25315190|NCT05008367|Autonomic Agents|autonomic agents|mesh-ancestor
25315191|NCT05008367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25315192|NCT05008367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315193|NCT05008367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25315194|NCT05008367|Glucocorticoids|glucocorticoids|mesh-ancestor
25315195|NCT05008367|Hormones|hormones|mesh-ancestor
25315196|NCT05008367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25315197|NCT05008367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25315198|NCT05008367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861804|NCT02320240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25648756|NCT01484041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188979|NCT02801188|Dexmedetomidine|dexmedetomidine|mesh-list
25315199|NCT05008029|Anesthetics|anesthetics|mesh-list
25315200|NCT05008029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25315201|NCT05008029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315202|NCT05008068|Simvastatin|simvastatin|mesh-list
25315203|NCT05008068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25315204|NCT05008068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25315205|NCT05008068|Antimetabolites|antimetabolites|mesh-ancestor
25315206|NCT05008068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315207|NCT05008068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25315208|NCT05008068|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25315209|NCT05008068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25315210|NCT05008263|Liver Extracts|liver extracts|mesh-list
25315211|NCT05008263|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
25315212|NCT05008263|Hematinics|hematinics|mesh-ancestor
25315213|NCT05008263|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25315214|NCT05008263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315215|NCT05008237|Docetaxel|docetaxel|mesh-list
25315216|NCT05008237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315217|NCT05008237|Tubulin Modulators|tubulin modulators|mesh-ancestor
25315218|NCT05008237|Antimitotic Agents|antimitotic agents|mesh-ancestor
25315220|NCT05008237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315222|NCT05008250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25315223|NCT05008250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25315224|NCT05008250|Sympatholytics|sympatholytics|mesh-ancestor
25315225|NCT05008250|Autonomic Agents|autonomic agents|mesh-ancestor
25315226|NCT05008250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25315227|NCT05008250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315228|NCT05008250|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25315229|NCT05008250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25315230|NCT05008250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25315231|NCT05008250|Adrenergic Agents|adrenergic agents|mesh-ancestor
25315232|NCT05008250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25315233|NCT05008250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315234|NCT05007678|Leflunomide|leflunomide|mesh-list
25315235|NCT05007678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25315236|NCT05007678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315237|NCT05007678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25315238|NCT05007678|Immunologic Factors|immunologic factors|mesh-ancestor
25315239|NCT05007678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315242|NCT05007587|Raltitrexed|raltitrexed|mesh-list
25315243|NCT05007587|Oxaliplatin|oxaliplatin|mesh-list
25315244|NCT05007587|Lenvatinib|lenvatinib|mesh-list
25315245|NCT05007587|Antimetabolites|antimetabolites|mesh-ancestor
25315246|NCT05007587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315247|NCT05007587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25315248|NCT05007587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315249|NCT05007587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25315250|NCT05007587|Immunologic Factors|immunologic factors|mesh-ancestor
25315251|NCT05007587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315252|NCT05007587|Antidotes|antidotes|mesh-ancestor
25315253|NCT05007587|Protective Agents|protective agents|mesh-ancestor
25315254|NCT05007587|Vitamin B Complex|vitamin b complex|mesh-ancestor
25315255|NCT05007587|Vitamins|vitamins|mesh-ancestor
25315256|NCT05007587|Micronutrients|micronutrients|mesh-ancestor
25315257|NCT05007587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25315258|NCT05007587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25315259|NCT05007587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25315260|NCT05007860|Vaccines|vaccines|mesh-list
25315261|NCT05007860|Immunologic Factors|immunologic factors|mesh-ancestor
25315262|NCT05007860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315265|NCT05007340|Dimercaprol|dimercaprol|mesh-list
25315266|NCT05007340|Chelating Agents|chelating agents|mesh-ancestor
25315267|NCT05007340|Sequestering Agents|sequestering agents|mesh-ancestor
25315268|NCT05007340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315269|NCT05006911|Bromfenac|bromfenac|mesh-list
24742254|NCT05295355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25108596|NCT03131882|Immunologic Factors|immunologic factors|mesh-ancestor
25315270|NCT05006911|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25315271|NCT05006911|Phenylephrine|phenylephrine|mesh-list
25315272|NCT05006911|Oxymetazoline|oxymetazoline|mesh-list
25315273|NCT05006911|Hyaluronic Acid|hyaluronic acid|mesh-list
25315274|NCT05006911|Pilocarpine|pilocarpine|mesh-list
25315275|NCT05006911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25315276|NCT05006911|Immunologic Factors|immunologic factors|mesh-ancestor
25648757|NCT01484197|Maleic acid|maleic acid|mesh-list
25648758|NCT01484197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823151|NCT02115204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24823152|NCT02115204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24823154|NCT02115243|Ipilimumab|ipilimumab|mesh-list
25315277|NCT05006911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315278|NCT05006911|Viscosupplements|viscosupplements|mesh-ancestor
25315279|NCT05006911|Protective Agents|protective agents|mesh-ancestor
25315280|NCT05006911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25315281|NCT05006911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25315282|NCT05006911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25315283|NCT05006911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25315284|NCT05006911|Adrenergic Agents|adrenergic agents|mesh-ancestor
25315285|NCT05006911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25315286|NCT05006911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315287|NCT05006911|Sympathomimetics|sympathomimetics|mesh-ancestor
25315288|NCT05006911|Autonomic Agents|autonomic agents|mesh-ancestor
25315289|NCT05006911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25315290|NCT05006911|Nasal Decongestants|nasal decongestants|mesh-ancestor
25315291|NCT05006911|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25315292|NCT05006911|Respiratory System Agents|respiratory system agents|mesh-ancestor
25315293|NCT05006911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25315294|NCT05006911|Mydriatics|mydriatics|mesh-ancestor
25315295|NCT05006911|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25315296|NCT05006911|Miotics|miotics|mesh-ancestor
25315297|NCT05006911|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25315298|NCT05006911|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25315299|NCT05006911|Cholinergic Agents|cholinergic agents|mesh-ancestor
24679632|NCT01369472|Antioxidants|antioxidants|mesh-ancestor
25315300|NCT05006911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25315301|NCT05006911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25315302|NCT05006911|Analgesics|analgesics|mesh-ancestor
25315303|NCT05006911|Sensory System Agents|sensory system agents|mesh-ancestor
25315304|NCT05006911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25315305|NCT05006911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25315306|NCT05006898|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25315307|NCT05006898|Oxymetazoline|oxymetazoline|mesh-list
25315308|NCT05006898|Pilocarpine|pilocarpine|mesh-list
25315309|NCT05006898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25315310|NCT05006898|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25315311|NCT05006898|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25315312|NCT05006898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25315313|NCT05006898|Adrenergic Agents|adrenergic agents|mesh-ancestor
25315314|NCT05006898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25315315|NCT05006898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315316|NCT05006898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315317|NCT05006898|Sympathomimetics|sympathomimetics|mesh-ancestor
25315318|NCT05006898|Autonomic Agents|autonomic agents|mesh-ancestor
25315319|NCT05006898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25315320|NCT05006898|Nasal Decongestants|nasal decongestants|mesh-ancestor
25315321|NCT05006898|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25315322|NCT05006898|Respiratory System Agents|respiratory system agents|mesh-ancestor
25315323|NCT05006898|Miotics|miotics|mesh-ancestor
25315324|NCT05006898|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25315325|NCT05006898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25315326|NCT05006898|Cholinergic Agents|cholinergic agents|mesh-ancestor
25315327|NCT05006846|Analgesics, Opioid|analgesics, opioid|mesh-list
25315328|NCT05006846|Narcotics|narcotics|mesh-ancestor
25315329|NCT05006846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25315330|NCT05006846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315331|NCT05006846|Analgesics|analgesics|mesh-ancestor
25315332|NCT05006846|Sensory System Agents|sensory system agents|mesh-ancestor
25315333|NCT05006846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25315334|NCT05007223|Doxycycline|doxycycline|mesh-list
25315335|NCT05007223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25315336|NCT05007223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25315337|NCT05007223|Antimalarials|antimalarials|mesh-ancestor
25315338|NCT05007223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25315339|NCT05007223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25315340|NCT05006469|Dexamethasone|dexamethasone|mesh-list
25315341|NCT05006469|Doxorubicin|doxorubicin|mesh-list
25315342|NCT05006469|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25315343|NCT05006469|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25315344|NCT05006469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25315345|NCT05006469|Antiemetics|antiemetics|mesh-ancestor
25315346|NCT05006469|Autonomic Agents|autonomic agents|mesh-ancestor
25315347|NCT05006469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25648759|NCT01484197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648760|NCT01484275|Siltuximab|siltuximab|mesh-list
25648761|NCT01484275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315348|NCT05006469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315349|NCT05006469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25315350|NCT05006469|Glucocorticoids|glucocorticoids|mesh-ancestor
25315351|NCT05006469|Hormones|hormones|mesh-ancestor
25315352|NCT05006469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25315353|NCT05006469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25315354|NCT05006469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315355|NCT05006469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25315356|NCT05006469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315357|NCT05006469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25315358|NCT05006469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25315359|NCT05006469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25315360|NCT05006469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25315361|NCT05006469|Alkylating Agents|alkylating agents|mesh-ancestor
25315362|NCT05006664|Prednisone|prednisone|mesh-list
25315363|NCT05006664|Cyclophosphamide|cyclophosphamide|mesh-list
25315364|NCT05006664|Doxorubicin|doxorubicin|mesh-list
25315365|NCT05006664|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25315366|NCT05006664|Etoposide|etoposide|mesh-list
25315367|NCT05006664|Etoposide phosphate|etoposide phosphate|mesh-list
25315368|NCT05006664|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25315369|NCT05006664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25315370|NCT05006664|Immunologic Factors|immunologic factors|mesh-ancestor
25315520|NCT05004753|Artemisinin|artemisinin|mesh-list
25315435|NCT05006001|Colchicine|colchicine|mesh-list
25315436|NCT05006001|Gout Suppressants|gout suppressants|mesh-ancestor
25315437|NCT05006001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25315438|NCT05006001|Tubulin Modulators|tubulin modulators|mesh-ancestor
25315439|NCT05006001|Antimitotic Agents|antimitotic agents|mesh-ancestor
25315440|NCT05006001|Mitosis Modulators|mitosis modulators|mesh-ancestor
25315441|NCT05006001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315442|NCT05006001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315443|NCT05006209|Calcium|calcium|mesh-list
25315444|NCT05006209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25315521|NCT05004753|Dexamethasone|dexamethasone|mesh-list
25315445|NCT05006209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315446|NCT05006235|Epinephrine|epinephrine|mesh-list
25315447|NCT05006235|Albuterol|albuterol|mesh-list
25315448|NCT05006235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25315449|NCT05006235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25315450|NCT05006235|Adrenergic Agents|adrenergic agents|mesh-ancestor
25315451|NCT05006235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25315452|NCT05006235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315453|NCT05006235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315454|NCT05006235|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25315455|NCT05006235|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25315456|NCT05006235|Autonomic Agents|autonomic agents|mesh-ancestor
25315457|NCT05006235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25315458|NCT05006235|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25315459|NCT05006235|Respiratory System Agents|respiratory system agents|mesh-ancestor
25315460|NCT05006235|Mydriatics|mydriatics|mesh-ancestor
25315461|NCT05006235|Sympathomimetics|sympathomimetics|mesh-ancestor
25315462|NCT05006235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25315463|NCT05006235|Tocolytic Agents|tocolytic agents|mesh-ancestor
25315464|NCT05006235|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25315465|NCT05006235|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25315466|NCT05005494|Magnesium Sulfate|magnesium sulfate|mesh-list
25315467|NCT05005494|Analgesics|analgesics|mesh-ancestor
25315468|NCT05005494|Sensory System Agents|sensory system agents|mesh-ancestor
25315469|NCT05005494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25315470|NCT05005494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315471|NCT05005494|Anesthetics|anesthetics|mesh-ancestor
25315472|NCT05005494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25315473|NCT05005494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25315474|NCT05005494|Anticonvulsants|anticonvulsants|mesh-ancestor
25315475|NCT05005494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25315476|NCT05005494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25315477|NCT05005494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315478|NCT05005494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25315479|NCT05005494|Tocolytic Agents|tocolytic agents|mesh-ancestor
25315480|NCT05005494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25315481|NCT05005715|Dexmedetomidine|dexmedetomidine|mesh-list
25315482|NCT05005715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25315483|NCT05005715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25315484|NCT05005715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315485|NCT05005715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25315486|NCT05005715|Analgesics|analgesics|mesh-ancestor
25315487|NCT05005715|Sensory System Agents|sensory system agents|mesh-ancestor
25315488|NCT05005715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25315489|NCT05005715|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25315490|NCT05005715|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25315491|NCT05005715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25315492|NCT05005715|Adrenergic Agents|adrenergic agents|mesh-ancestor
25315493|NCT05005715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25315494|NCT05005715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315495|NCT05005637|Antitubercular Agents|antitubercular agents|mesh-list
25315496|NCT05005637|Prednisone|prednisone|mesh-list
25315497|NCT05005637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25315498|NCT05005637|Glucocorticoids|glucocorticoids|mesh-ancestor
25315499|NCT05005637|Hormones|hormones|mesh-ancestor
25315500|NCT05005637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25315501|NCT05005637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315502|NCT05005637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25315503|NCT05005637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315504|NCT05005637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25315505|NCT05005637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25315506|NCT05005741|Dulaglutide|dulaglutide|mesh-list
25315507|NCT05005741|Glucagon|glucagon|mesh-list
25315508|NCT05005741|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25315509|NCT05005741|Incretins|incretins|mesh-ancestor
25315510|NCT05005741|Hormones|hormones|mesh-ancestor
25205333|NCT04899791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25315511|NCT05005741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25315512|NCT05005741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315513|NCT05005741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25315514|NCT05005741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25315515|NCT05004909|Tretinoin|tretinoin|mesh-list
25315516|NCT05004909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315517|NCT05004909|Keratolytic Agents|keratolytic agents|mesh-ancestor
25315518|NCT05004909|Dermatologic Agents|dermatologic agents|mesh-ancestor
25315519|NCT05004753|Artemisinins|artemisinins|mesh-list
25315522|NCT05004753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25315524|NCT05004753|Autonomic Agents|autonomic agents|mesh-ancestor
25315525|NCT05004753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25315526|NCT05004753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315527|NCT05004753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25315528|NCT05004753|Glucocorticoids|glucocorticoids|mesh-ancestor
25315529|NCT05004753|Hormones|hormones|mesh-ancestor
25315530|NCT05004753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25315531|NCT05004753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25315532|NCT05004753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315533|NCT05004753|Antimalarials|antimalarials|mesh-ancestor
25315534|NCT05004753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25315535|NCT05004753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25315536|NCT05004753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25315537|NCT05004519|Dexmedetomidine|dexmedetomidine|mesh-list
25315538|NCT05004519|Remifentanil|remifentanil|mesh-list
25315539|NCT05004519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25315540|NCT05004519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25315541|NCT05004519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315542|NCT05004519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25315543|NCT05004519|Analgesics|analgesics|mesh-ancestor
25315544|NCT05004519|Sensory System Agents|sensory system agents|mesh-ancestor
25315545|NCT05004519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25315546|NCT05004519|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25315547|NCT05004519|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25315548|NCT05004519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25315549|NCT05004519|Adrenergic Agents|adrenergic agents|mesh-ancestor
25315550|NCT05004519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25315551|NCT05004519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315552|NCT05004519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25315553|NCT05004519|Narcotics|narcotics|mesh-ancestor
25315554|NCT05004545|Propofol|propofol|mesh-list
25315555|NCT05004545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25315556|NCT05004545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25315557|NCT05004545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315558|NCT05004545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25315559|NCT05004545|Anesthetics, General|anesthetics, general|mesh-ancestor
25315560|NCT05004545|Anesthetics|anesthetics|mesh-ancestor
25315561|NCT05004064|Rituximab|rituximab|mesh-list
25315562|NCT05004064|Acalabrutinib|acalabrutinib|mesh-list
25315563|NCT05004064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25315564|NCT05004064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315565|NCT05004064|Immunologic Factors|immunologic factors|mesh-ancestor
25315566|NCT05004064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315567|NCT05004064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25315568|NCT05004207|Lactulose|lactulose|mesh-list
25315569|NCT05004207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25315570|NCT05004142|Letrozole|letrozole|mesh-list
25315571|NCT05004142|Fulvestrant|fulvestrant|mesh-list
25315572|NCT05004142|Goserelin|goserelin|mesh-list
25315573|NCT05004142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315574|NCT05004142|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25315575|NCT05004142|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25315576|NCT05004142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25315577|NCT05004142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315578|NCT05004142|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25315579|NCT05004142|Hormone Antagonists|hormone antagonists|mesh-ancestor
25315580|NCT05004142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25315581|NCT05004142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315582|NCT05004142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25315583|NCT05004142|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25315584|NCT05003765|Magnesium Sulfate|magnesium sulfate|mesh-list
25315585|NCT05003765|Buprenorphine|buprenorphine|mesh-list
25315586|NCT05003765|Bupivacaine|bupivacaine|mesh-list
25315587|NCT05003765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25315588|NCT05003765|Anesthetics, Local|anesthetics, local|mesh-ancestor
25315589|NCT05003765|Anesthetics|anesthetics|mesh-ancestor
25315590|NCT05003765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25315591|NCT05003765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315592|NCT05003765|Sensory System Agents|sensory system agents|mesh-ancestor
25315593|NCT05003765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25315594|NCT05003765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25315595|NCT05003765|Narcotics|narcotics|mesh-ancestor
25315596|NCT05003765|Analgesics|analgesics|mesh-ancestor
25315597|NCT05003765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25315598|NCT05003765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25315599|NCT05003765|Anticonvulsants|anticonvulsants|mesh-ancestor
25315600|NCT05003765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25315601|NCT05003765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25315602|NCT05003765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315603|NCT05003765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25315604|NCT05003765|Tocolytic Agents|tocolytic agents|mesh-ancestor
25315605|NCT05003765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25315607|NCT05003752|Androgens|androgens|mesh-list
25315608|NCT05003752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25315609|NCT05003752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315610|NCT05003752|Hormones|hormones|mesh-ancestor
25315611|NCT05003752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25315612|NCT05003752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315613|NCT05003648|Pramipexole|pramipexole|mesh-list
25315614|NCT05003648|Antioxidants|antioxidants|mesh-ancestor
25315615|NCT05003648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315616|NCT05003648|Protective Agents|protective agents|mesh-ancestor
25315617|NCT05003648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315618|NCT05003648|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25315619|NCT05003648|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25315620|NCT05003648|Dopamine Agonists|dopamine agonists|mesh-ancestor
25315621|NCT05003648|Dopamine Agents|dopamine agents|mesh-ancestor
25315622|NCT05003648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25315623|NCT05003596|Methylprednisolone|methylprednisolone|mesh-list
25315624|NCT05003596|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25315625|NCT05003596|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25315626|NCT05003596|Prednisolone|prednisolone|mesh-list
25315627|NCT05003596|Prednisolone acetate|prednisolone acetate|mesh-list
25315628|NCT05003596|Narcotics|narcotics|mesh-list
25315629|NCT05003596|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25315630|NCT05003596|Prednisolone phosphate|prednisolone phosphate|mesh-list
25315631|NCT05003596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25315632|NCT05003596|Antiemetics|antiemetics|mesh-ancestor
25315633|NCT05003596|Autonomic Agents|autonomic agents|mesh-ancestor
25315634|NCT05003596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25315635|NCT05003596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315636|NCT05003596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25315637|NCT05003596|Glucocorticoids|glucocorticoids|mesh-ancestor
25315638|NCT05003596|Hormones|hormones|mesh-ancestor
25315639|NCT05003596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25315640|NCT05003596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25189315|NCT02799264|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25189316|NCT02799264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25189317|NCT02799264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189318|NCT02799264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25189319|NCT02799264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25189320|NCT02799264|Antiviral Agents|antiviral agents|mesh-ancestor
25206205|NCT03787095|Cemiplimab|cemiplimab|mesh-list
25315641|NCT05003596|Protective Agents|protective agents|mesh-ancestor
25315642|NCT05003596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25315643|NCT05003596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315644|NCT05003596|Analgesics|analgesics|mesh-ancestor
25315645|NCT05003596|Sensory System Agents|sensory system agents|mesh-ancestor
25108661|NCT03131050|Antiemetics|antiemetics|mesh-ancestor
25315646|NCT05003596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25315647|NCT05003700|Lenvatinib|lenvatinib|mesh-list
25315648|NCT05003700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315649|NCT05003700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25315650|NCT05003700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25315651|NCT05003700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315652|NCT05002725|Lidocaine|lidocaine|mesh-list
25315653|NCT05002725|Anesthetics, Local|anesthetics, local|mesh-ancestor
25315654|NCT05002725|Anesthetics|anesthetics|mesh-ancestor
25315655|NCT05002725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25315656|NCT05002725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315657|NCT05002725|Sensory System Agents|sensory system agents|mesh-ancestor
25205334|NCT04899791|Antioxidants|antioxidants|mesh-ancestor
25315658|NCT05002725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25315659|NCT05002725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25315660|NCT05002725|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25315661|NCT05002725|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25315662|NCT05002725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25315663|NCT05002725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315667|NCT05002673|Anesthetics|anesthetics|mesh-list
25315668|NCT05002673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25315669|NCT05002673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315670|NCT05002517|Methylprednisolone|methylprednisolone|mesh-list
25315671|NCT05002517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25315672|NCT05002517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25315673|NCT05002517|Prednisolone|prednisolone|mesh-list
25315674|NCT05002517|Prednisolone acetate|prednisolone acetate|mesh-list
25315675|NCT05002517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25315676|NCT05002517|Prednisolone phosphate|prednisolone phosphate|mesh-list
25315677|NCT05002517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25315678|NCT05002517|Antiemetics|antiemetics|mesh-ancestor
25315679|NCT05002517|Autonomic Agents|autonomic agents|mesh-ancestor
25315680|NCT05002517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25315681|NCT05002517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315682|NCT05002517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25315683|NCT05002517|Glucocorticoids|glucocorticoids|mesh-ancestor
25315684|NCT05002517|Hormones|hormones|mesh-ancestor
25315685|NCT05002517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25315686|NCT05002517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25315687|NCT05002517|Protective Agents|protective agents|mesh-ancestor
25315688|NCT05002517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25315689|NCT05002517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315690|NCT05002309|Antidepressive Agents|antidepressive agents|mesh-list
25315691|NCT05002309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25315693|NCT05002270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25315694|NCT05002270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315695|NCT05002361|Dexamethasone|dexamethasone|mesh-list
25648762|NCT01484340|Nicotine|nicotine|mesh-list
25648763|NCT01484340|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25648764|NCT01484340|Autonomic Agents|autonomic agents|mesh-ancestor
25648765|NCT01484340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25648766|NCT01484340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648767|NCT01484340|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25648768|NCT01484340|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25648769|NCT01484340|Cholinergic Agents|cholinergic agents|mesh-ancestor
25648770|NCT01484340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25825452|NCT00005596|Abortifacient Agents|abortifacient agents|mesh-ancestor
25315696|NCT05002361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25315697|NCT05002361|Antiemetics|antiemetics|mesh-ancestor
25315698|NCT05002361|Autonomic Agents|autonomic agents|mesh-ancestor
25315699|NCT05002361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25315700|NCT05002361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315701|NCT05002361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25315702|NCT05002361|Glucocorticoids|glucocorticoids|mesh-ancestor
25315703|NCT05002361|Hormones|hormones|mesh-ancestor
25315704|NCT05002361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25315705|NCT05002361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25315706|NCT05002361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315707|NCT05002686|Paclitaxel|paclitaxel|mesh-list
25315708|NCT05002686|Capecitabine|capecitabine|mesh-list
25315709|NCT05002686|Oxaliplatin|oxaliplatin|mesh-list
25315710|NCT05002686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25315711|NCT05002686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315712|NCT05002686|Tubulin Modulators|tubulin modulators|mesh-ancestor
25315713|NCT05002686|Antimitotic Agents|antimitotic agents|mesh-ancestor
25315714|NCT05002686|Mitosis Modulators|mitosis modulators|mesh-ancestor
25315715|NCT05002686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315716|NCT05002686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25315717|NCT05002686|Antimetabolites|antimetabolites|mesh-ancestor
25315718|NCT05002036|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25315719|NCT05002036|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25315720|NCT05002413|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25315721|NCT05002413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25315722|NCT05002101|Zinc|zinc|mesh-list
25315723|NCT05002101|Zinc Sulfate|zinc sulfate|mesh-list
25315724|NCT05002101|Trace Elements|trace elements|mesh-ancestor
25315725|NCT05002101|Micronutrients|micronutrients|mesh-ancestor
25315726|NCT05002101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315727|NCT05002101|Astringents|astringents|mesh-ancestor
25315728|NCT05002101|Dermatologic Agents|dermatologic agents|mesh-ancestor
25315729|NCT05001919|Mitogens|mitogens|mesh-list
25315730|NCT05001919|Mitosis Modulators|mitosis modulators|mesh-ancestor
25315731|NCT05001919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315732|NCT05001763|Prucalopride|prucalopride|mesh-list
25315733|NCT05001763|Laxatives|laxatives|mesh-ancestor
25315734|NCT05001763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25315735|NCT05001763|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
25315736|NCT05001763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25315737|NCT05001763|Serotonin Agents|serotonin agents|mesh-ancestor
25315738|NCT05001763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25315739|NCT05001763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315740|NCT05001763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315741|NCT05001854|Fludrocortisone|fludrocortisone|mesh-list
25315742|NCT05001854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25315743|NCT05001672|Tenofovir|tenofovir|mesh-list
25315744|NCT05001672|Antiviral Agents|antiviral agents|mesh-ancestor
25315745|NCT05001672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25315746|NCT05001672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25315747|NCT05001672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25315748|NCT05001672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25315749|NCT05001672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315750|NCT05001672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25315751|NCT05001672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25315752|NCT05001412|Carboplatin|carboplatin|mesh-list
25315753|NCT05001412|Etoposide|etoposide|mesh-list
25315754|NCT05001412|Apatinib|apatinib|mesh-list
25315755|NCT05001412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315756|NCT05001412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25315757|NCT05001412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25315758|NCT05001412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25315759|NCT05001412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25315760|NCT05001412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315761|NCT05001412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25315762|NCT05001776|PENTA|penta|mesh-list
25315763|NCT05001776|Fondaparinux|fondaparinux|mesh-list
25315764|NCT05001776|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25315765|NCT05001776|Antithrombins|antithrombins|mesh-ancestor
25315766|NCT05001776|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25315767|NCT05001776|Protease Inhibitors|protease inhibitors|mesh-ancestor
25315768|NCT05001776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25315769|NCT05001776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315771|NCT05001776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25315772|NCT05001776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25315773|NCT05001529|Antibodies|antibodies|mesh-list
25315774|NCT05001529|Immunologic Factors|immunologic factors|mesh-ancestor
25315775|NCT05001529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315776|NCT05001243|Bromfenac|bromfenac|mesh-list
25315777|NCT05001243|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25315778|NCT05001243|Phenylephrine|phenylephrine|mesh-list
25315779|NCT05001243|Oxymetazoline|oxymetazoline|mesh-list
25315780|NCT05001243|Hyaluronic Acid|hyaluronic acid|mesh-list
25315781|NCT05001243|Pilocarpine|pilocarpine|mesh-list
25315782|NCT05001243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25315783|NCT05001243|Immunologic Factors|immunologic factors|mesh-ancestor
25315784|NCT05001243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315785|NCT05001243|Viscosupplements|viscosupplements|mesh-ancestor
25315786|NCT05001243|Protective Agents|protective agents|mesh-ancestor
25315787|NCT05001243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25315788|NCT05001243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25315789|NCT05001243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25315790|NCT05001243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25315791|NCT05001243|Adrenergic Agents|adrenergic agents|mesh-ancestor
25315792|NCT05001243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25315793|NCT05001243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315794|NCT05001243|Sympathomimetics|sympathomimetics|mesh-ancestor
25315795|NCT05001243|Autonomic Agents|autonomic agents|mesh-ancestor
25315796|NCT05001243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25315797|NCT05001243|Nasal Decongestants|nasal decongestants|mesh-ancestor
25315798|NCT05001243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25315799|NCT05001243|Respiratory System Agents|respiratory system agents|mesh-ancestor
25315800|NCT05001243|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25315801|NCT05001243|Mydriatics|mydriatics|mesh-ancestor
25315802|NCT05001243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25315803|NCT05001243|Miotics|miotics|mesh-ancestor
25315804|NCT05001243|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25315805|NCT05001243|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25315806|NCT05001243|Cholinergic Agents|cholinergic agents|mesh-ancestor
25315807|NCT05001243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25315808|NCT05001243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25315809|NCT05001243|Analgesics|analgesics|mesh-ancestor
25315810|NCT05001243|Sensory System Agents|sensory system agents|mesh-ancestor
25315811|NCT05001243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25315812|NCT05001243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25315813|NCT05001061|Misoprostol|misoprostol|mesh-list
25315814|NCT05001061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25315815|NCT05001061|Abortifacient Agents|abortifacient agents|mesh-ancestor
25315816|NCT05001061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25315817|NCT05001061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315818|NCT05001061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25315819|NCT05001061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25315820|NCT05001061|Oxytocics|oxytocics|mesh-ancestor
25315821|NCT05001204|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
25315822|NCT05001204|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25315823|NCT05001204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315824|NCT05001074|Tacrolimus|tacrolimus|mesh-list
25315825|NCT05001074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25315828|NCT05001074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25315829|NCT05001074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25315830|NCT05001074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315831|NCT05001048|Phenylephrine|phenylephrine|mesh-list
25315832|NCT05001048|Oxymetazoline|oxymetazoline|mesh-list
25315833|NCT05001048|Synephrine|synephrine|mesh-list
25315834|NCT05001048|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25315835|NCT05001048|Mydriatics|mydriatics|mesh-ancestor
25315836|NCT05001048|Autonomic Agents|autonomic agents|mesh-ancestor
25315837|NCT05001048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25315838|NCT05001048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315839|NCT05001048|Sympathomimetics|sympathomimetics|mesh-ancestor
25315840|NCT05001048|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25315841|NCT05001048|Nasal Decongestants|nasal decongestants|mesh-ancestor
25315842|NCT05001048|Respiratory System Agents|respiratory system agents|mesh-ancestor
25315843|NCT05001048|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25315844|NCT05001048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25315845|NCT05001048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25315846|NCT05001048|Adrenergic Agents|adrenergic agents|mesh-ancestor
25315847|NCT05001048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25315848|NCT05001048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315849|NCT05001048|Protective Agents|protective agents|mesh-ancestor
25315850|NCT05000892|Paclitaxel|paclitaxel|mesh-list
25315851|NCT05000892|Carboplatin|carboplatin|mesh-list
25315852|NCT05000892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25315853|NCT05000892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315854|NCT05000892|Tubulin Modulators|tubulin modulators|mesh-ancestor
25315855|NCT05000892|Antimitotic Agents|antimitotic agents|mesh-ancestor
25315856|NCT05000892|Mitosis Modulators|mitosis modulators|mesh-ancestor
25315857|NCT05000892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315858|NCT05000697|Oxaliplatin|oxaliplatin|mesh-list
25315859|NCT05000697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315860|NCT05000086|Diphosphonates|diphosphonates|mesh-list
25315861|NCT05000086|Methylene diphosphonate|methylene diphosphonate|mesh-list
25315862|NCT05000086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25315863|NCT05000086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315864|NCT05000281|Ibuprofen|ibuprofen|mesh-list
25315865|NCT05000281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25315866|NCT05000281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25315867|NCT05000281|Analgesics|analgesics|mesh-ancestor
25315868|NCT05000281|Sensory System Agents|sensory system agents|mesh-ancestor
25315869|NCT05000281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25315870|NCT05000281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315871|NCT05000281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25315872|NCT05000281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25315873|NCT05000281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25315874|NCT05000281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25315875|NCT05000281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315878|NCT04999800|Pembrolizumab|pembrolizumab|mesh-list
25315879|NCT04999800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25315880|NCT04999800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315881|NCT04999878|Gemcitabine|gemcitabine|mesh-list
25315882|NCT04999878|Dexamethasone|dexamethasone|mesh-list
25315883|NCT04999878|Etoposide|etoposide|mesh-list
25315884|NCT04999878|Cisplatin|cisplatin|mesh-list
25315885|NCT04999878|Pegaspargase|pegaspargase|mesh-list
25315886|NCT04999878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25315887|NCT04999878|Antiemetics|antiemetics|mesh-ancestor
25315888|NCT04999878|Autonomic Agents|autonomic agents|mesh-ancestor
25315889|NCT04999878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25315890|NCT04999878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315891|NCT04999878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25315892|NCT04999878|Glucocorticoids|glucocorticoids|mesh-ancestor
25315893|NCT04999878|Hormones|hormones|mesh-ancestor
25315894|NCT04999878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25315895|NCT04999878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25315896|NCT04999878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315897|NCT04999878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25315898|NCT04999878|Antimetabolites|antimetabolites|mesh-ancestor
25315899|NCT04999878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315900|NCT04999878|Antiviral Agents|antiviral agents|mesh-ancestor
25315901|NCT04999878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25315902|NCT04999878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25315903|NCT04999878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25315904|NCT04999878|Immunologic Factors|immunologic factors|mesh-ancestor
25315905|NCT04999878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25315906|NCT04999878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25315907|NCT04999878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25315908|NCT04999930|Tiotropium Bromide|tiotropium bromide|mesh-list
25315909|NCT04999930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25315910|NCT04999930|Autonomic Agents|autonomic agents|mesh-ancestor
25315911|NCT04999930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25315912|NCT04999930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315913|NCT04999930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25315914|NCT04999930|Respiratory System Agents|respiratory system agents|mesh-ancestor
25315915|NCT04999930|Parasympatholytics|parasympatholytics|mesh-ancestor
25315916|NCT04999930|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25315917|NCT04999930|Cholinergic Agents|cholinergic agents|mesh-ancestor
25315918|NCT04999930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25315919|NCT04999930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315920|NCT04999540|Fulvestrant|fulvestrant|mesh-list
25315921|NCT04999540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25315922|NCT04999540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25315923|NCT04999540|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25315924|NCT04999540|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25315925|NCT04999540|Hormone Antagonists|hormone antagonists|mesh-ancestor
25315926|NCT04999540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25315927|NCT04999540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315928|NCT04999293|Clopidogrel|clopidogrel|mesh-list
25315929|NCT04999293|Ticagrelor|ticagrelor|mesh-list
25315930|NCT04999293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25315931|NCT04999293|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25315932|NCT04999293|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25315933|NCT04999293|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25315934|NCT04999293|Purinergic Agents|purinergic agents|mesh-ancestor
25315935|NCT04999293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25315936|NCT04999293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315937|NCT04999293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315938|NCT04999449|Scopolamine|scopolamine|mesh-list
25315939|NCT04999449|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25315940|NCT04999449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25315941|NCT04999449|Antiemetics|antiemetics|mesh-ancestor
25315942|NCT04999449|Autonomic Agents|autonomic agents|mesh-ancestor
25315943|NCT04999449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25315944|NCT04999449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315945|NCT04999449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25315946|NCT04999449|Mydriatics|mydriatics|mesh-ancestor
25315947|NCT04999449|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25315948|NCT04999449|Cholinergic Agents|cholinergic agents|mesh-ancestor
25315949|NCT04999449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25315950|NCT04999449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315951|NCT04999449|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25315952|NCT04999449|Parasympatholytics|parasympatholytics|mesh-ancestor
25315953|NCT04999176|Enoxaparin|enoxaparin|mesh-list
25315954|NCT04999176|Rivaroxaban|rivaroxaban|mesh-list
25315955|NCT04999176|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25315956|NCT04999176|Antithrombins|antithrombins|mesh-ancestor
25315957|NCT04999176|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25315958|NCT04999176|Protease Inhibitors|protease inhibitors|mesh-ancestor
25315959|NCT04999176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25315960|NCT04999176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315961|NCT04999176|Anticoagulants|anticoagulants|mesh-ancestor
25315962|NCT04999176|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25315963|NCT04999176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25315964|NCT04998903|Dimercaprol|dimercaprol|mesh-list
25315965|NCT04998903|Chelating Agents|chelating agents|mesh-ancestor
25315966|NCT04998903|Sequestering Agents|sequestering agents|mesh-ancestor
25315967|NCT04998903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315968|NCT04999137|Vitamins|vitamins|mesh-list
25315969|NCT04999137|Ascorbic Acid|ascorbic acid|mesh-list
25315970|NCT04999137|Thiamine|thiamine|mesh-list
25315971|NCT04999137|Micronutrients|micronutrients|mesh-ancestor
25315972|NCT04999137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315973|NCT04999137|Antioxidants|antioxidants|mesh-ancestor
25315974|NCT04999137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315975|NCT04999137|Protective Agents|protective agents|mesh-ancestor
25315976|NCT04999137|Vitamin B Complex|vitamin b complex|mesh-ancestor
25315977|NCT04998838|Tenofovir|tenofovir|mesh-list
25315978|NCT04998838|Immunoglobulins|immunoglobulins|mesh-list
25315979|NCT04998838|Antibodies|antibodies|mesh-list
25315980|NCT04998838|gamma-Globulins|gamma-globulins|mesh-list
25315981|NCT04998838|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25315982|NCT04998838|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25315983|NCT04998838|Antiviral Agents|antiviral agents|mesh-ancestor
25315984|NCT04998838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25315985|NCT04998838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25315986|NCT04998838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25315987|NCT04998838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25315988|NCT04998838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25315989|NCT04998838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25315990|NCT04998838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25315991|NCT04998838|Immunologic Factors|immunologic factors|mesh-ancestor
25315992|NCT04998838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315993|NCT04998071|Bupivacaine|bupivacaine|mesh-list
25315994|NCT04998071|Anesthetics, Local|anesthetics, local|mesh-ancestor
25315995|NCT04998071|Anesthetics|anesthetics|mesh-ancestor
25315996|NCT04998071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25315997|NCT04998071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25315998|NCT04998071|Sensory System Agents|sensory system agents|mesh-ancestor
25315999|NCT04998071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25316000|NCT04998344|Vaccines|vaccines|mesh-list
25316001|NCT04998344|Immunologic Factors|immunologic factors|mesh-ancestor
25316002|NCT04998344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316003|NCT04998253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25316004|NCT04998253|Propofol|propofol|mesh-list
25189603|NCT02796469|Vasodilator Agents|vasodilator agents|mesh-ancestor
25189604|NCT02796469|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25316005|NCT04998253|Sevoflurane|sevoflurane|mesh-list
25316006|NCT04998253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25316007|NCT04998253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25316008|NCT04998253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316009|NCT04998253|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25316010|NCT04998253|Anesthetics, General|anesthetics, general|mesh-ancestor
25316011|NCT04998253|Anesthetics|anesthetics|mesh-ancestor
24564983|NCT00778401|Gabapentin|gabapentin|mesh-list
25316012|NCT04998253|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25316013|NCT04998253|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25316014|NCT04998500|Hormones|hormones|mesh-list
25316015|NCT04998500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25316016|NCT04998500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316017|NCT04998214|Thrombin|thrombin|mesh-list
25316018|NCT04998214|Hemostatics|hemostatics|mesh-ancestor
25316019|NCT04998214|Coagulants|coagulants|mesh-ancestor
25316020|NCT04997967|Ketamine|ketamine|mesh-list
25316021|NCT04997967|Propofol|propofol|mesh-list
25316022|NCT04997967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25316023|NCT04997967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25316024|NCT04997967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316025|NCT04997967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25316026|NCT04997967|Anesthetics, General|anesthetics, general|mesh-ancestor
25316027|NCT04997967|Anesthetics|anesthetics|mesh-ancestor
25316028|NCT04997967|Analgesics|analgesics|mesh-ancestor
25316029|NCT04997967|Sensory System Agents|sensory system agents|mesh-ancestor
25316030|NCT04997967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25316031|NCT04997967|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25316032|NCT04997967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25316033|NCT04997967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25316034|NCT04997967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25316035|NCT04997967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316036|NCT04997980|Amiodarone|amiodarone|mesh-list
25316037|NCT04997980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25316038|NCT04997980|Vasodilator Agents|vasodilator agents|mesh-ancestor
25316039|NCT04997980|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25316040|NCT04997980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25316041|NCT04997980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316042|NCT04997980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25316043|NCT04997980|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25316044|NCT04997980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25316045|NCT04997980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316046|NCT04997980|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25316047|NCT04997980|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25316048|NCT04997980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25316049|NCT04997837|Capecitabine|capecitabine|mesh-list
25316050|NCT04997837|Tegafur|tegafur|mesh-list
25316051|NCT04997837|Oxaliplatin|oxaliplatin|mesh-list
25316058|NCT04997707|Sevoflurane|sevoflurane|mesh-list
25316059|NCT04997707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25316060|NCT04997707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25316061|NCT04997707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316062|NCT04997707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25316063|NCT04997707|Anesthetics, General|anesthetics, general|mesh-ancestor
25316064|NCT04997707|Anesthetics|anesthetics|mesh-ancestor
25316065|NCT04997707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25316066|NCT04997707|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25316067|NCT04997798|Trastuzumab|trastuzumab|mesh-list
25316068|NCT04997798|Letrozole|letrozole|mesh-list
25316069|NCT04997798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25316070|NCT04997798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25316071|NCT04997798|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25316072|NCT04997798|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25316073|NCT04997798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316074|NCT04997798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316075|NCT04997798|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25316076|NCT04997798|Hormone Antagonists|hormone antagonists|mesh-ancestor
25316077|NCT04997798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25316078|NCT04997798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648771|NCT01484340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648772|NCT01484431|Tadalafil|tadalafil|mesh-list
25825453|NCT00005596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24877187|NCT02897648|beta-Lactams|beta-lactams|mesh-list
24815980|NCT02073149|Fe(III)-EDTA|fe(iii)-edta|mesh-list
25316079|NCT04997564|Tenofovir|tenofovir|mesh-list
25316080|NCT04997564|Sofosbuvir|sofosbuvir|mesh-list
25316081|NCT04997564|Velpatasvir|velpatasvir|mesh-list
25316082|NCT04997564|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25316083|NCT04997564|Antiviral Agents|antiviral agents|mesh-ancestor
25316084|NCT04997564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25316085|NCT04997564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25316086|NCT04997564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25316087|NCT04997564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316088|NCT04997564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316089|NCT04997564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25316090|NCT04997564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25316091|NCT04997525|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25316092|NCT04997525|Estradiol|estradiol|mesh-list
25316093|NCT04997525|Progesterone|progesterone|mesh-list
25316094|NCT04997525|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25316095|NCT04997525|Estrogens|estrogens|mesh-ancestor
25316096|NCT04997525|Hormones|hormones|mesh-ancestor
25316097|NCT04997525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25316098|NCT04997525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316099|NCT04997525|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25316100|NCT04997525|Progestins|progestins|mesh-ancestor
25316107|NCT04996979|Ropivacaine|ropivacaine|mesh-list
25316108|NCT04996979|Anesthetics, Local|anesthetics, local|mesh-ancestor
25316109|NCT04996979|Anesthetics|anesthetics|mesh-ancestor
25316110|NCT04996979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25316111|NCT04996979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316112|NCT04996979|Sensory System Agents|sensory system agents|mesh-ancestor
25316113|NCT04996979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25316114|NCT04997291|Dexrazoxane|dexrazoxane|mesh-list
25316115|NCT04997291|Razoxane|razoxane|mesh-list
25316116|NCT04997291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25316117|NCT04997291|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25316118|NCT04997291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25316119|NCT04997291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25316120|NCT04997291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316121|NCT04997291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316122|NCT04997291|Protective Agents|protective agents|mesh-ancestor
25316123|NCT04997291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316124|NCT04997291|Antimitotic Agents|antimitotic agents|mesh-ancestor
25316125|NCT04997291|Mitosis Modulators|mitosis modulators|mesh-ancestor
25316126|NCT04997304|Albuterol|albuterol|mesh-list
25316127|NCT04997304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25316128|NCT04997304|Autonomic Agents|autonomic agents|mesh-ancestor
25316129|NCT04997304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25316130|NCT04997304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316131|NCT04997304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25316132|NCT04997304|Respiratory System Agents|respiratory system agents|mesh-ancestor
25316133|NCT04997304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25316134|NCT04997304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25316135|NCT04997304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25316136|NCT04997304|Adrenergic Agents|adrenergic agents|mesh-ancestor
25316137|NCT04997304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25316138|NCT04997304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316139|NCT04997304|Tocolytic Agents|tocolytic agents|mesh-ancestor
25316140|NCT04997304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25316141|NCT04996550|Metoprolol|metoprolol|mesh-list
25316142|NCT04996550|Carvedilol|carvedilol|mesh-list
25316143|NCT04996550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25316144|NCT04996550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25316145|NCT04996550|Sympatholytics|sympatholytics|mesh-ancestor
25316146|NCT04996550|Autonomic Agents|autonomic agents|mesh-ancestor
25316147|NCT04996550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25316148|NCT04996550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316149|NCT04996550|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25316150|NCT04996550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25316151|NCT04996550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25316152|NCT04996550|Adrenergic Agents|adrenergic agents|mesh-ancestor
25316153|NCT04996550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25316154|NCT04996550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316155|NCT04996550|Antioxidants|antioxidants|mesh-ancestor
25316156|NCT04996550|Protective Agents|protective agents|mesh-ancestor
25316157|NCT04996550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25316166|NCT04996433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25316167|NCT04996290|Ropivacaine|ropivacaine|mesh-list
25316168|NCT04996290|Anesthetics, Local|anesthetics, local|mesh-ancestor
25316169|NCT04996290|Anesthetics|anesthetics|mesh-ancestor
25316170|NCT04996290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25316171|NCT04996290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316172|NCT04996290|Sensory System Agents|sensory system agents|mesh-ancestor
25316173|NCT04996290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25316174|NCT04996134|Domperidone|domperidone|mesh-list
25316175|NCT04996134|Antiemetics|antiemetics|mesh-ancestor
25316176|NCT04996134|Autonomic Agents|autonomic agents|mesh-ancestor
25316177|NCT04996134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25316178|NCT04996134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316179|NCT04996134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25316180|NCT04996134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25316181|NCT04996134|Dopamine Agents|dopamine agents|mesh-ancestor
25316182|NCT04996134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25316183|NCT04996134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316184|NCT04996251|Bupivacaine|bupivacaine|mesh-list
25316185|NCT04996251|Anesthetics, Local|anesthetics, local|mesh-ancestor
25316186|NCT04996251|Anesthetics|anesthetics|mesh-ancestor
25316187|NCT04996251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25316188|NCT04996251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316189|NCT04996251|Sensory System Agents|sensory system agents|mesh-ancestor
25316190|NCT04996251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25316191|NCT04996498|Oxytocin|oxytocin|mesh-list
25316192|NCT04996498|Oxytocics|oxytocics|mesh-ancestor
25316193|NCT04996498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25316194|NCT04996498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316195|NCT04996160|Dexamethasone|dexamethasone|mesh-list
25316196|NCT04996160|Dexamethasone acetate|dexamethasone acetate|mesh-list
25316197|NCT04996160|Doxorubicin|doxorubicin|mesh-list
25316198|NCT04996160|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25316199|NCT04996160|Bortezomib|bortezomib|mesh-list
25316213|NCT04996160|Protease Inhibitors|protease inhibitors|mesh-ancestor
25316214|NCT04996160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316215|NCT04996160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316216|NCT04996160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25316217|NCT04996160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25316218|NCT04996160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25316219|NCT04996160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25316220|NCT04995354|Mitogens|mitogens|mesh-list
25316221|NCT04995354|Mitosis Modulators|mitosis modulators|mesh-ancestor
25316222|NCT04995354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756973|NCT01736878|Sorafenib|sorafenib|mesh-list
24887376|NCT04517188|Plasma Substitutes|plasma substitutes|mesh-ancestor
24816715|NCT02078388|Doxorubicin|doxorubicin|mesh-list
25648773|NCT01484431|Vasodilator Agents|vasodilator agents|mesh-ancestor
25648774|NCT01484431|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25648775|NCT01484431|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25648776|NCT01484431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25206281|NCT03685747|Vancomycin|vancomycin|mesh-list
25206282|NCT03685747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25206283|NCT03685747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25189746|NCT02795039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25189747|NCT02795039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189748|NCT02795039|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25189750|NCT02795039|Hormone Antagonists|hormone antagonists|mesh-ancestor
25189751|NCT02795039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25189753|NCT02794922|Vitamin B Complex|vitamin b complex|mesh-list
24816716|NCT02078388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24816717|NCT02078388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816718|NCT02078388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24816719|NCT02078388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24816720|NCT02078388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816721|NCT02078388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815611|NCT02071316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24815612|NCT02071316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24815613|NCT02071316|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24815614|NCT02071316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815616|NCT02071342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25316247|NCT04995133|Colistin|colistin|mesh-list
25316248|NCT04995133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25316249|NCT04995133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25316261|NCT04994951|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25316262|NCT04994951|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25316263|NCT04994951|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25316264|NCT04994951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25316265|NCT04994951|Glucocorticoids|glucocorticoids|mesh-ancestor
25316266|NCT04994951|Hormones|hormones|mesh-ancestor
25316267|NCT04994951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25316268|NCT04994951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316269|NCT04994951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25316270|NCT04994951|Immunologic Factors|immunologic factors|mesh-ancestor
25316271|NCT04994951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316272|NCT04994951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316273|NCT04995016|Pembrolizumab|pembrolizumab|mesh-list
25316274|NCT04995016|Axitinib|axitinib|mesh-list
25316275|NCT04995016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25316276|NCT04995016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25316277|NCT04995016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25316278|NCT04995016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316279|NCT04995016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316280|NCT04994860|Sildenafil Citrate|sildenafil citrate|mesh-list
25316281|NCT04994860|Zamicastat|zamicastat|mesh-list
25316282|NCT04994860|Vasodilator Agents|vasodilator agents|mesh-ancestor
25316283|NCT04994860|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25316284|NCT04994860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25316285|NCT04994860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316286|NCT04994860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316287|NCT04994860|Urological Agents|urological agents|mesh-ancestor
25316288|NCT04994626|Rituximab|rituximab|mesh-list
25316289|NCT04994626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25316290|NCT04994626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25316291|NCT04994626|Immunologic Factors|immunologic factors|mesh-ancestor
25316292|NCT04994626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316293|NCT04994626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25316294|NCT04994743|Cortisone|cortisone|mesh-list
25316295|NCT04994743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25316296|NCT04994353|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25316297|NCT04994314|Fluorides|fluorides|mesh-list
25316298|NCT04994314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316299|NCT04994314|Cariostatic Agents|cariostatic agents|mesh-ancestor
25316300|NCT04994314|Protective Agents|protective agents|mesh-ancestor
25316301|NCT04994262|Menthol|menthol|mesh-list
25316302|NCT04994262|Antipruritics|antipruritics|mesh-ancestor
25648777|NCT01484431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648778|NCT01484431|Urological Agents|urological agents|mesh-ancestor
25648779|NCT01484496|Belimumab|belimumab|mesh-list
25648780|NCT01484496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25648781|NCT01484496|Immunologic Factors|immunologic factors|mesh-ancestor
25648782|NCT01484496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648783|NCT01484561|Tofacitinib|tofacitinib|mesh-list
25648784|NCT01484561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25648785|NCT01484561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25656852|NCT01579578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25316303|NCT04994262|Dermatologic Agents|dermatologic agents|mesh-ancestor
25316304|NCT04994574|Tiotropium Bromide|tiotropium bromide|mesh-list
25316305|NCT04994574|Olodaterol|olodaterol|mesh-list
25316306|NCT04994574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25316307|NCT04994574|Autonomic Agents|autonomic agents|mesh-ancestor
25316308|NCT04994574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25316309|NCT04994574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316310|NCT04994574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25316311|NCT04994574|Respiratory System Agents|respiratory system agents|mesh-ancestor
25316312|NCT04994574|Parasympatholytics|parasympatholytics|mesh-ancestor
25316313|NCT04994574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25316314|NCT04994574|Cholinergic Agents|cholinergic agents|mesh-ancestor
25316315|NCT04994574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25316316|NCT04994574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316317|NCT04994236|Leucovorin|leucovorin|mesh-list
25316318|NCT04994236|Fluorouracil|fluorouracil|mesh-list
25316319|NCT04994236|Oxaliplatin|oxaliplatin|mesh-list
25316320|NCT04994236|Antimetabolites|antimetabolites|mesh-ancestor
25316321|NCT04994236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316322|NCT04994236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25316323|NCT04994236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25316324|NCT04994236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25316325|NCT04994236|Immunologic Factors|immunologic factors|mesh-ancestor
25316326|NCT04994236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316327|NCT04994236|Antidotes|antidotes|mesh-ancestor
25316328|NCT04994236|Protective Agents|protective agents|mesh-ancestor
25316329|NCT04994236|Vitamin B Complex|vitamin b complex|mesh-ancestor
25316330|NCT04994236|Vitamins|vitamins|mesh-ancestor
25316331|NCT04994236|Micronutrients|micronutrients|mesh-ancestor
25316332|NCT04994119|Warfarin|warfarin|mesh-list
25316333|NCT04994119|Zamicastat|zamicastat|mesh-list
25316334|NCT04994119|Anticoagulants|anticoagulants|mesh-ancestor
25316335|NCT04994119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316563|NCT04990791|Aspirin|aspirin|mesh-list
25316357|NCT04993040|Mitosis Modulators|mitosis modulators|mesh-ancestor
25316358|NCT04993040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24877952|NCT02208375|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25316359|NCT04992507|Anesthetics|anesthetics|mesh-list
25316360|NCT04992507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25316361|NCT04992507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316362|NCT04992468|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25316363|NCT04992468|Hormones|hormones|mesh-ancestor
25316364|NCT04992468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25316365|NCT04992468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316366|NCT04992533|Oxymetazoline|oxymetazoline|mesh-list
25316367|NCT04992533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25316368|NCT04992533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25316369|NCT04992533|Adrenergic Agents|adrenergic agents|mesh-ancestor
25316370|NCT04992533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25316371|NCT04992533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316372|NCT04992533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316373|NCT04992533|Sympathomimetics|sympathomimetics|mesh-ancestor
25316374|NCT04992533|Autonomic Agents|autonomic agents|mesh-ancestor
25316375|NCT04992533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25316376|NCT04992533|Nasal Decongestants|nasal decongestants|mesh-ancestor
25316377|NCT04992533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25316378|NCT04992533|Respiratory System Agents|respiratory system agents|mesh-ancestor
25316379|NCT04992481|Fluorides|fluorides|mesh-list
25316380|NCT04992481|Fluorides, Topical|fluorides, topical|mesh-list
25316381|NCT04992481|Cariostatic Agents|cariostatic agents|mesh-ancestor
25316382|NCT04992481|Protective Agents|protective agents|mesh-ancestor
25316383|NCT04992481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316384|NCT04992182|Vaccines|vaccines|mesh-list
25316385|NCT04992182|Immunologic Factors|immunologic factors|mesh-ancestor
25316386|NCT04992182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316387|NCT04992052|Bone wax|bone wax|mesh-list
25316388|NCT04992052|Hemostatics|hemostatics|mesh-ancestor
25316389|NCT04992052|Coagulants|coagulants|mesh-ancestor
25316390|NCT04992143|Sorafenib|sorafenib|mesh-list
25316391|NCT04992143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25316392|NCT04992143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25316393|NCT04992143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316394|NCT04992143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316395|NCT04991961|Antihypertensive Agents|antihypertensive agents|mesh-list
25316438|NCT04991584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25316439|NCT04991584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25316440|NCT04991584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189924|NCT02793544|Mesna|mesna|mesh-list
25316441|NCT04991584|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25316442|NCT04991584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25316443|NCT04991584|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25316444|NCT04991584|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25316445|NCT04991584|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25316446|NCT04991584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25316447|NCT04991584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25316448|NCT04991584|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25316449|NCT04991896|Metoprolol|metoprolol|mesh-list
25316450|NCT04991896|Sotalol|sotalol|mesh-list
25316451|NCT04991896|Flecainide|flecainide|mesh-list
25316452|NCT04991896|Bisoprolol|bisoprolol|mesh-list
25316453|NCT04991896|Betaxolol|betaxolol|mesh-list
25316454|NCT04991896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25316455|NCT04991896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25316456|NCT04991896|Sympatholytics|sympatholytics|mesh-ancestor
25316457|NCT04991896|Autonomic Agents|autonomic agents|mesh-ancestor
25316458|NCT04991896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25316459|NCT04991896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316460|NCT04991896|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25316461|NCT04991896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25316462|NCT04991896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25316463|NCT04991896|Adrenergic Agents|adrenergic agents|mesh-ancestor
25316464|NCT04991896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25316465|NCT04991896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316466|NCT04991896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25316467|NCT04991896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25316468|NCT04991896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25316470|NCT04991181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316471|NCT04991181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316481|NCT04991207|Bosentan|bosentan|mesh-list
25316482|NCT04991207|Zamicastat|zamicastat|mesh-list
25316483|NCT04991207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25316484|NCT04991207|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25316564|NCT04990791|Rivaroxaban|rivaroxaban|mesh-list
25316495|NCT04991155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316496|NCT04991155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316497|NCT04991298|Fentanyl|fentanyl|mesh-list
25316498|NCT04991298|Midazolam|midazolam|mesh-list
25316499|NCT04991298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25316500|NCT04991298|Narcotics|narcotics|mesh-ancestor
25316501|NCT04991298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25316502|NCT04991298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316503|NCT04991298|Analgesics|analgesics|mesh-ancestor
25316504|NCT04991298|Sensory System Agents|sensory system agents|mesh-ancestor
25316505|NCT04991298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25316506|NCT04991298|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25316507|NCT04991298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25316508|NCT04991298|Anesthetics, General|anesthetics, general|mesh-ancestor
25316509|NCT04991298|Anesthetics|anesthetics|mesh-ancestor
25316510|NCT04991298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25316511|NCT04991298|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25316512|NCT04991298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25316513|NCT04991298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25316514|NCT04991298|GABA Modulators|gaba modulators|mesh-ancestor
25316515|NCT04991298|GABA Agents|gaba agents|mesh-ancestor
25316516|NCT04991298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25316517|NCT04991298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316518|NCT04991194|Zamicastat|zamicastat|mesh-list
25316519|NCT04991194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316520|NCT04991194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316521|NCT04991012|Triamcinolone|triamcinolone|mesh-list
25316522|NCT04991012|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25316523|NCT04991012|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25316524|NCT04991012|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25316525|NCT04991012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25316526|NCT04991012|Glucocorticoids|glucocorticoids|mesh-ancestor
25316527|NCT04991012|Hormones|hormones|mesh-ancestor
25316528|NCT04991012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25316529|NCT04991012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316530|NCT04991012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25316531|NCT04991012|Immunologic Factors|immunologic factors|mesh-ancestor
25316532|NCT04991012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316533|NCT04991012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656853|NCT01579578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25316534|NCT04990830|Heparin|heparin|mesh-list
25316535|NCT04990830|Enoxaparin|enoxaparin|mesh-list
25316536|NCT04990830|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25316537|NCT04990830|Tinzaparin|tinzaparin|mesh-list
25316538|NCT04990830|Dalteparin|dalteparin|mesh-list
25316539|NCT04990830|Enoxaparin sodium|enoxaparin sodium|mesh-list
25316540|NCT04990830|Anticoagulants|anticoagulants|mesh-ancestor
25316541|NCT04990830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25316542|NCT04990830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25316543|NCT04990830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316556|NCT04990713|Ropivacaine|ropivacaine|mesh-list
25316557|NCT04990713|Anesthetics, Local|anesthetics, local|mesh-list
25316558|NCT04990713|Anesthetics|anesthetics|mesh-list
25316559|NCT04990713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25316560|NCT04990713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316561|NCT04990713|Sensory System Agents|sensory system agents|mesh-ancestor
25316562|NCT04990713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25316569|NCT04990791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25316570|NCT04990791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316571|NCT04990791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25316572|NCT04990791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25316573|NCT04990791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25316574|NCT04990791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25316575|NCT04990791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316576|NCT04990791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25316577|NCT04990791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25316578|NCT04990791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316579|NCT04990791|Antipyretics|antipyretics|mesh-ancestor
25316580|NCT04990791|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25316581|NCT04990791|Antithrombins|antithrombins|mesh-ancestor
25316582|NCT04990791|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25316583|NCT04990791|Protease Inhibitors|protease inhibitors|mesh-ancestor
25316584|NCT04990791|Anticoagulants|anticoagulants|mesh-ancestor
25316585|NCT04990752|Urinastatin|urinastatin|mesh-list
25316586|NCT04990752|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25316587|NCT04990752|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25316588|NCT04990752|Protease Inhibitors|protease inhibitors|mesh-ancestor
25316589|NCT04990752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316590|NCT04990752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316591|NCT04989985|Oxaliplatin|oxaliplatin|mesh-list
25316592|NCT04989985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25316597|NCT04990167|Bromides|bromides|mesh-list
25316598|NCT04990167|Tiotropium Bromide|tiotropium bromide|mesh-list
25316599|NCT04990167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25316600|NCT04990167|Autonomic Agents|autonomic agents|mesh-ancestor
25316601|NCT04990167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25316602|NCT04990167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316603|NCT04990167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25316604|NCT04990167|Respiratory System Agents|respiratory system agents|mesh-ancestor
25316605|NCT04990167|Parasympatholytics|parasympatholytics|mesh-ancestor
25316606|NCT04990167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25316607|NCT04990167|Cholinergic Agents|cholinergic agents|mesh-ancestor
25316608|NCT04990167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25316609|NCT04990167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316610|NCT04990167|Anticonvulsants|anticonvulsants|mesh-ancestor
25316611|NCT04989413|Dronabinol|dronabinol|mesh-list
25316612|NCT04989413|Cannabidiol|cannabidiol|mesh-list
25316613|NCT04989413|Anticonvulsants|anticonvulsants|mesh-ancestor
25316614|NCT04989413|Hallucinogens|hallucinogens|mesh-ancestor
25316615|NCT04989413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316616|NCT04989413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25316617|NCT04989413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25316618|NCT04989413|Analgesics|analgesics|mesh-ancestor
25316619|NCT04989413|Sensory System Agents|sensory system agents|mesh-ancestor
25316620|NCT04989413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25316621|NCT04989413|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25316622|NCT04989413|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25316623|NCT04989413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25316624|NCT04989413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316625|NCT04989413|Hormones|hormones|mesh-ancestor
25316626|NCT04989413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25316627|NCT04989335|Fludarabine|fludarabine|mesh-list
25316628|NCT04989335|Clofarabine|clofarabine|mesh-list
25316629|NCT04989335|Bisantrene|bisantrene|mesh-list
25316630|NCT04989335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25316631|NCT04989335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25316632|NCT04989335|Antimetabolites|antimetabolites|mesh-ancestor
25316633|NCT04989335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316634|NCT04989335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25316635|NCT04989400|Misoprostol|misoprostol|mesh-list
25316636|NCT04989400|Ulipristal acetate|ulipristal acetate|mesh-list
25316637|NCT04989400|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25316638|NCT04989400|Abortifacient Agents|abortifacient agents|mesh-ancestor
25316639|NCT04989400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25316640|NCT04989400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316641|NCT04989400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25316642|NCT04989400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25316643|NCT04989400|Oxytocics|oxytocics|mesh-ancestor
25316644|NCT04989400|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25316645|NCT04989400|Contraceptive Agents|contraceptive agents|mesh-ancestor
25316646|NCT04989400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25316647|NCT04989127|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25316648|NCT04989127|Penicillins|penicillins|mesh-list
25316649|NCT04989127|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25316650|NCT04989127|Analgesics|analgesics|mesh-list
25316651|NCT04989127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25316652|NCT04989127|Antitubercular Agents|antitubercular agents|mesh-ancestor
25316653|NCT04989127|Sensory System Agents|sensory system agents|mesh-ancestor
25316654|NCT04989127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25316655|NCT04989127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316656|NCT04989166|Curcumin|curcumin|mesh-list
25316657|NCT04989166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25316658|NCT04989166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25316659|NCT04989166|Analgesics|analgesics|mesh-ancestor
25316660|NCT04989166|Sensory System Agents|sensory system agents|mesh-ancestor
25316661|NCT04989166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25316662|NCT04989166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316663|NCT04989166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25316664|NCT04989166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25316665|NCT04989166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25316666|NCT04989166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316667|NCT04989166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316668|NCT04989140|Dexamethasone|dexamethasone|mesh-list
25316669|NCT04989140|Pomalidomide|pomalidomide|mesh-list
25316670|NCT04989140|Ixazomib|ixazomib|mesh-list
25316671|NCT04989140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25316672|NCT04989140|Antiemetics|antiemetics|mesh-ancestor
25316673|NCT04989140|Autonomic Agents|autonomic agents|mesh-ancestor
25316674|NCT04989140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25316675|NCT04989140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316676|NCT04989140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25316677|NCT04989140|Glucocorticoids|glucocorticoids|mesh-ancestor
25316678|NCT04989140|Hormones|hormones|mesh-ancestor
25316679|NCT04989140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25316680|NCT04989140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25316681|NCT04989140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25316682|NCT04989140|Immunologic Factors|immunologic factors|mesh-ancestor
25316683|NCT04989140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25316684|NCT04989140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25316685|NCT04989140|Growth Substances|growth substances|mesh-ancestor
25316686|NCT04989140|Growth Inhibitors|growth inhibitors|mesh-ancestor
25316687|NCT04989140|Protease Inhibitors|protease inhibitors|mesh-ancestor
25316688|NCT04989140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316689|NCT04989140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316690|NCT04988945|Durvalumab|durvalumab|mesh-list
25316691|NCT04988945|Tremelimumab|tremelimumab|mesh-list
25316692|NCT04988945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25316693|NCT04988945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25316694|NCT04989270|Anesthetics|anesthetics|mesh-list
25316695|NCT04989270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25316696|NCT04989270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316697|NCT04989257|Clopidogrel|clopidogrel|mesh-list
25316698|NCT04989257|Ticagrelor|ticagrelor|mesh-list
25316699|NCT04989257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25316700|NCT04989257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25316701|NCT04989257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25316702|NCT04989257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25316703|NCT04989257|Purinergic Agents|purinergic agents|mesh-ancestor
25316704|NCT04989257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25316705|NCT04989257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316706|NCT04989257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316707|NCT04988932|Nitric Oxide|nitric oxide|mesh-list
25190049|NCT02792491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190050|NCT02792491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25190051|NCT02792491|Glucocorticoids|glucocorticoids|mesh-ancestor
25190052|NCT02792491|Hormones|hormones|mesh-ancestor
25190053|NCT02792491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25190054|NCT02792491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25190055|NCT02792491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25190056|NCT02792491|Tubulin Modulators|tubulin modulators|mesh-ancestor
25190057|NCT02792491|Antimitotic Agents|antimitotic agents|mesh-ancestor
25316708|NCT04988932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25316709|NCT04988932|Autonomic Agents|autonomic agents|mesh-ancestor
25316710|NCT04988932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25316711|NCT04988932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316712|NCT04988932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25316713|NCT04988932|Respiratory System Agents|respiratory system agents|mesh-ancestor
25316714|NCT04988932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25316715|NCT04988932|Antioxidants|antioxidants|mesh-ancestor
25316716|NCT04988932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316717|NCT04988932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25316718|NCT04988932|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25316719|NCT04988932|Vasodilator Agents|vasodilator agents|mesh-ancestor
25316720|NCT04988932|Gasotransmitters|gasotransmitters|mesh-ancestor
25316721|NCT04988932|Protective Agents|protective agents|mesh-ancestor
25316723|NCT04989348|Progestins|progestins|mesh-list
25316724|NCT04989348|Hormone Antagonists|hormone antagonists|mesh-list
25316725|NCT04989348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25316726|NCT04989348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316727|NCT04988776|Bupivacaine|bupivacaine|mesh-list
25316728|NCT04988776|Anesthetics, Local|anesthetics, local|mesh-ancestor
25316729|NCT04988776|Anesthetics|anesthetics|mesh-ancestor
25316730|NCT04988776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25316731|NCT04988776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316732|NCT04988776|Sensory System Agents|sensory system agents|mesh-ancestor
25316733|NCT04988776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25316734|NCT04988789|Paclitaxel|paclitaxel|mesh-list
25316735|NCT04988789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24893303|NCT04451746|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24893305|NCT04451655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24893306|NCT04451655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893307|NCT04451395|Micronutrients|micronutrients|mesh-list
25316736|NCT04988789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25316737|NCT04988789|Tubulin Modulators|tubulin modulators|mesh-ancestor
25316738|NCT04988789|Antimitotic Agents|antimitotic agents|mesh-ancestor
25316739|NCT04988789|Mitosis Modulators|mitosis modulators|mesh-ancestor
25316740|NCT04988789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316741|NCT04988607|Bevacizumab|bevacizumab|mesh-list
25316742|NCT04988607|Osimertinib|osimertinib|mesh-list
25316743|NCT04988607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25316744|NCT04988607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25316745|NCT04988607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25316746|NCT04988607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25316747|NCT04988607|Growth Substances|growth substances|mesh-ancestor
25316748|NCT04988607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316749|NCT04988607|Growth Inhibitors|growth inhibitors|mesh-ancestor
25316750|NCT04988607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25316751|NCT04988607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316752|NCT04988607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316753|NCT04988646|Acyclovir|acyclovir|mesh-list
25316754|NCT04988646|Antiviral Agents|antiviral agents|mesh-ancestor
25316755|NCT04988646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25316756|NCT04988191|Bevacizumab|bevacizumab|mesh-list
25316757|NCT04988191|Irinotecan|irinotecan|mesh-list
25316758|NCT04988191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25316759|NCT04988191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25316760|NCT04988191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25648786|NCT01484561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648787|NCT01484626|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25648788|NCT01484626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25648789|NCT01484626|Alkylating Agents|alkylating agents|mesh-ancestor
25648790|NCT01484626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648791|NCT01484626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25648792|NCT01484873|Exenatide|exenatide|mesh-list
25648793|NCT01484873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24823754|NCT02118870|Sensory System Agents|sensory system agents|mesh-ancestor
24823755|NCT02118870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24823756|NCT02118870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823757|NCT02118870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24823758|NCT02118870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24422833|NCT00223717|Captopril|captopril|mesh-list
24422834|NCT00223717|Nifedipine|nifedipine|mesh-list
24422835|NCT00223717|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24422836|NCT00223717|Sildenafil Citrate|sildenafil citrate|mesh-list
24422837|NCT00223717|Nitroglycerin|nitroglycerin|mesh-list
24422838|NCT00223717|Dipyridamole|dipyridamole|mesh-list
24422839|NCT00223717|Carbidopa|carbidopa|mesh-list
24422840|NCT00223717|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
24422841|NCT00223717|Tamsulosin|tamsulosin|mesh-list
24422843|NCT00223717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25316761|NCT04988191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25316762|NCT04988191|Growth Substances|growth substances|mesh-ancestor
25316763|NCT04988191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316764|NCT04988191|Growth Inhibitors|growth inhibitors|mesh-ancestor
25316765|NCT04988191|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25316766|NCT04988191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25316767|NCT04988191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316768|NCT04988191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316769|NCT04988048|Vaccines|vaccines|mesh-list
25316770|NCT04988048|Immunologic Factors|immunologic factors|mesh-ancestor
25316771|NCT04988048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316772|NCT04988282|Methylprednisolone|methylprednisolone|mesh-list
25316773|NCT04988282|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25316774|NCT04988282|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25316775|NCT04988282|Prednisolone|prednisolone|mesh-list
25316776|NCT04988282|Prednisolone acetate|prednisolone acetate|mesh-list
25316777|NCT04988282|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25316778|NCT04988282|Prednisolone phosphate|prednisolone phosphate|mesh-list
25316779|NCT04988282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25316780|NCT04988282|Antiemetics|antiemetics|mesh-ancestor
25316781|NCT04988282|Autonomic Agents|autonomic agents|mesh-ancestor
25316782|NCT04988282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25316783|NCT04988282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316784|NCT04988282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25316797|NCT04987632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316798|NCT04987632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25316799|NCT04987632|Hormone Antagonists|hormone antagonists|mesh-ancestor
25316800|NCT04987632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25316801|NCT04987632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316817|NCT04987450|Prednisone|prednisone|mesh-list
25316818|NCT04987450|Methylprednisolone|methylprednisolone|mesh-list
25316819|NCT04987450|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25316820|NCT04987450|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25316821|NCT04987450|Prednisolone|prednisolone|mesh-list
25316822|NCT04987450|Prednisolone acetate|prednisolone acetate|mesh-list
25316823|NCT04987450|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25316824|NCT04987450|Prednisolone phosphate|prednisolone phosphate|mesh-list
25316825|NCT04987450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25316826|NCT04987450|Glucocorticoids|glucocorticoids|mesh-ancestor
25316827|NCT04987450|Hormones|hormones|mesh-ancestor
25316828|NCT04987450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25316829|NCT04987450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316830|NCT04987450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25316831|NCT04987450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25648794|NCT01484873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648795|NCT01484873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25648796|NCT01484873|Incretins|incretins|mesh-ancestor
25648797|NCT01484873|Hormones|hormones|mesh-ancestor
25648798|NCT01484873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25656854|NCT01579578|Tubulin Modulators|tubulin modulators|mesh-ancestor
25656855|NCT01579578|Antimitotic Agents|antimitotic agents|mesh-ancestor
25656856|NCT01579578|Mitosis Modulators|mitosis modulators|mesh-ancestor
25656857|NCT01579578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657180|NCT01583686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25657181|NCT01583686|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25657182|NCT01583686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25657183|NCT01583686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25657184|NCT01583686|Antiviral Agents|antiviral agents|mesh-ancestor
25316832|NCT04987450|Antiemetics|antiemetics|mesh-ancestor
25190159|NCT02791919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25190160|NCT02791919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25190161|NCT02791919|Antimetabolites|antimetabolites|mesh-ancestor
25190162|NCT02791919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316833|NCT04987450|Autonomic Agents|autonomic agents|mesh-ancestor
25316834|NCT04987450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25316835|NCT04987450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25316836|NCT04987450|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25316837|NCT04987450|Protective Agents|protective agents|mesh-ancestor
25316838|NCT04987567|Antioxidants|antioxidants|mesh-list
25316839|NCT04987567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316840|NCT04987567|Protective Agents|protective agents|mesh-ancestor
25316841|NCT04987567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316842|NCT04987554|Immunoferon|immunoferon|mesh-list
25316843|NCT04987554|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25316844|NCT04987554|Immunologic Factors|immunologic factors|mesh-ancestor
25316845|NCT04987554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316846|NCT04987242|Rasburicase|rasburicase|mesh-list
25316847|NCT04987242|Gout Suppressants|gout suppressants|mesh-ancestor
25316848|NCT04987242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25316850|NCT04986982|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25316851|NCT04986982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316852|NCT04986982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316853|NCT04986982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25316854|NCT04986982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25316855|NCT04986995|Opicapone|opicapone|mesh-list
25316856|NCT04986995|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25316860|NCT04986995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25316861|NCT04986813|Tranexamic Acid|tranexamic acid|mesh-list
25316862|NCT04986813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25316863|NCT04986813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25316864|NCT04986813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613155|NCT01017393|Ketamine|ketamine|mesh-list
25316865|NCT04986813|Hemostatics|hemostatics|mesh-ancestor
25316866|NCT04986813|Coagulants|coagulants|mesh-ancestor
25316867|NCT04986644|Hyaluronic Acid|hyaluronic acid|mesh-list
25316868|NCT04986644|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25316869|NCT04986644|Immunologic Factors|immunologic factors|mesh-ancestor
25316870|NCT04986644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316871|NCT04986644|Viscosupplements|viscosupplements|mesh-ancestor
25316872|NCT04986644|Protective Agents|protective agents|mesh-ancestor
25316873|NCT04986735|Empagliflozin|empagliflozin|mesh-list
25316874|NCT04986735|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25316875|NCT04986735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316876|NCT04986735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25316877|NCT04986735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316878|NCT04986371|Niraparib|niraparib|mesh-list
25316879|NCT04986371|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25316880|NCT04986371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316881|NCT04986371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316882|NCT04986371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25316883|NCT04986254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25316884|NCT04986254|Meropenem|meropenem|mesh-list
25316885|NCT04986254|Ceftriaxone|ceftriaxone|mesh-list
25316886|NCT04986254|Tazobactam|tazobactam|mesh-list
25316887|NCT04986254|Piperacillin|piperacillin|mesh-list
25316888|NCT04986254|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25316889|NCT04986254|Penicillin G|penicillin g|mesh-list
25316890|NCT04986254|Penicillin G Benzathine|penicillin g benzathine|mesh-list
25316891|NCT04986254|Penicillin G Procaine|penicillin g procaine|mesh-list
25316892|NCT04986254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25316893|NCT04986254|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25316894|NCT04986254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316895|NCT04986254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316896|NCT04986319|Vitamin D|vitamin d|mesh-list
25316897|NCT04986319|Vitamins|vitamins|mesh-ancestor
25316898|NCT04986319|Micronutrients|micronutrients|mesh-ancestor
25316899|NCT04986319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316900|NCT04986319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25316905|NCT04986098|Paclitaxel|paclitaxel|mesh-list
25648799|NCT01484951|Timolol|timolol|mesh-list
25648800|NCT01484951|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25648801|NCT01484951|Brinzolamide|brinzolamide|mesh-list
25648802|NCT01484951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25648803|NCT01484951|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25190184|NCT02791815|Anesthetics|anesthetics|mesh-ancestor
25190185|NCT02791815|GABA Modulators|gaba modulators|mesh-ancestor
25190186|NCT02791815|GABA Agents|gaba agents|mesh-ancestor
25190218|NCT02791256|Ribavirin|ribavirin|mesh-list
25316906|NCT04986098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25316907|NCT04986098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25316908|NCT04986098|Tubulin Modulators|tubulin modulators|mesh-ancestor
25316909|NCT04986098|Antimitotic Agents|antimitotic agents|mesh-ancestor
25316910|NCT04986098|Mitosis Modulators|mitosis modulators|mesh-ancestor
25316911|NCT04986098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316912|NCT04985656|Decitabine|decitabine|mesh-list
25316913|NCT04985656|Pevonedistat|pevonedistat|mesh-list
25317071|NCT04983615|GABA Modulators|gaba modulators|mesh-ancestor
25316914|NCT04985656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25316916|NCT04985656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316917|NCT04985656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25316918|NCT04985656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316919|NCT04985435|Adalimumab|adalimumab|mesh-list
25316920|NCT04985435|Etanercept|etanercept|mesh-list
25316921|NCT04985435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25316922|NCT04985435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25316923|NCT04985435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25316924|NCT04985435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25316925|NCT04985435|Analgesics|analgesics|mesh-ancestor
25316926|NCT04985435|Sensory System Agents|sensory system agents|mesh-ancestor
25316927|NCT04985435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25316928|NCT04985435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316929|NCT04985435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25316930|NCT04985435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25316931|NCT04985435|Immunologic Factors|immunologic factors|mesh-ancestor
25316932|NCT04985344|Propranolol|propranolol|mesh-list
25316933|NCT04985344|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25316934|NCT04985344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25316935|NCT04985344|Adrenergic Agents|adrenergic agents|mesh-ancestor
25316936|NCT04985344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25316937|NCT04985344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316938|NCT04985344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316939|NCT04985344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24701281|NCT01458015|Adrenergic Agents|adrenergic agents|mesh-ancestor
25316940|NCT04985344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25316941|NCT04985344|Vasodilator Agents|vasodilator agents|mesh-ancestor
25316942|NCT04985526|Octenidine|octenidine|mesh-list
25316943|NCT04985526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25316944|NCT04985526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24894262|NCT04443166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894263|NCT04443166|Viscosupplements|viscosupplements|mesh-ancestor
25316945|NCT04985669|Prucalopride|prucalopride|mesh-list
25316946|NCT04985669|Laxatives|laxatives|mesh-ancestor
25316947|NCT04985669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25316948|NCT04985669|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
25316949|NCT04985669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25316950|NCT04985669|Serotonin Agents|serotonin agents|mesh-ancestor
25316951|NCT04985669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25316952|NCT04985669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316953|NCT04985669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316954|NCT04985201|Irinotecan|irinotecan|mesh-list
25316955|NCT04985201|Simvastatin|simvastatin|mesh-list
25316956|NCT04985201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25316957|NCT04985201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25316958|NCT04985201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316959|NCT04985201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316960|NCT04985201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25316961|NCT04985201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25316962|NCT04985201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25316963|NCT04985201|Antimetabolites|antimetabolites|mesh-ancestor
25316964|NCT04985201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25316965|NCT04985201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25316966|NCT04984980|Gemcitabine|gemcitabine|mesh-list
25316967|NCT04984980|Bevacizumab|bevacizumab|mesh-list
25316968|NCT04984980|Oxaliplatin|oxaliplatin|mesh-list
25316969|NCT04984980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25316970|NCT04984980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25648804|NCT01484951|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25648805|NCT01484951|Adrenergic Agents|adrenergic agents|mesh-ancestor
25648806|NCT01484951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25316971|NCT04984980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25190257|NCT02790684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25190258|NCT02790684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190259|NCT02790671|Firuglipel|firuglipel|mesh-list
25190260|NCT02790671|Itraconazole|itraconazole|mesh-list
25190261|NCT02790671|Antifungal Agents|antifungal agents|mesh-ancestor
25190262|NCT02790671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25190263|NCT02790671|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25190273|NCT02790580|Cyclophosphamide|cyclophosphamide|mesh-list
25316972|NCT04984980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25316973|NCT04984980|Growth Substances|growth substances|mesh-ancestor
25316974|NCT04984980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316975|NCT04984980|Growth Inhibitors|growth inhibitors|mesh-ancestor
25316976|NCT04984980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25316977|NCT04984980|Antimetabolites|antimetabolites|mesh-ancestor
25316978|NCT04984980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25316979|NCT04984980|Antiviral Agents|antiviral agents|mesh-ancestor
25316980|NCT04984980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25316981|NCT04984980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25316982|NCT04984980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25316983|NCT04984980|Immunologic Factors|immunologic factors|mesh-ancestor
25316984|NCT04985110|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25316990|NCT04985110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25316991|NCT04985110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25316992|NCT04984408|Vaccines|vaccines|mesh-list
25316993|NCT04984408|Immunologic Factors|immunologic factors|mesh-ancestor
25316994|NCT04984408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316995|NCT04984200|Mydriatics|mydriatics|mesh-list
25316996|NCT04984200|Autonomic Agents|autonomic agents|mesh-ancestor
25316997|NCT04984200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25316998|NCT04984200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25316999|NCT04984577|Edaravone|edaravone|mesh-list
25317000|NCT04984577|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25317001|NCT04984577|Antioxidants|antioxidants|mesh-ancestor
25317002|NCT04984577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317003|NCT04984577|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25317004|NCT04984577|Protective Agents|protective agents|mesh-ancestor
25317013|NCT04984070|Contraceptives, Oral|contraceptives, oral|mesh-list
25317014|NCT04984070|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
25317015|NCT04984070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25317016|NCT04984070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25317017|NCT04984070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317018|NCT04984070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25317019|NCT04984070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25317020|NCT04984070|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25317021|NCT04984070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25317022|NCT04984070|Estrogens|estrogens|mesh-ancestor
25317023|NCT04984070|Hormones|hormones|mesh-ancestor
25317024|NCT04984070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25317025|NCT04984070|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25317026|NCT04984070|Hormone Antagonists|hormone antagonists|mesh-ancestor
25317027|NCT04984070|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25317028|NCT04984070|Diuretics|diuretics|mesh-ancestor
25317029|NCT04984070|Natriuretic Agents|natriuretic agents|mesh-ancestor
25317030|NCT04983849|Metronidazole|metronidazole|mesh-list
25317031|NCT04983849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25317032|NCT04983849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25317033|NCT04983849|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25317034|NCT04983849|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25317041|NCT04983550|Doxorubicin|doxorubicin|mesh-list
25317042|NCT04983550|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25317043|NCT04983550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25317044|NCT04983550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25317045|NCT04983550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25317046|NCT04983550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25317047|NCT04983550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25317048|NCT04983550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648807|NCT01484951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648808|NCT01484951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648809|NCT01484951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25648810|NCT01484951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25648811|NCT01484951|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25648812|NCT01484951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25648813|NCT01484977|Lacosamide|lacosamide|mesh-list
24823803|NCT02119091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25317049|NCT04983524|Propolis|propolis|mesh-list
25317050|NCT04983524|Calcium|calcium|mesh-list
25317051|NCT04983524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25317052|NCT04983524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317053|NCT04983524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25317054|NCT04983615|Fentanyl|fentanyl|mesh-list
25317055|NCT04983615|Midazolam|midazolam|mesh-list
25317056|NCT04983615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25317057|NCT04983615|Narcotics|narcotics|mesh-ancestor
25317058|NCT04983615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25317059|NCT04983615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317060|NCT04983615|Analgesics|analgesics|mesh-ancestor
25317061|NCT04983615|Sensory System Agents|sensory system agents|mesh-ancestor
25317062|NCT04983615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25317063|NCT04983615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25317064|NCT04983615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25317065|NCT04983615|Anesthetics, General|anesthetics, general|mesh-ancestor
25317066|NCT04983615|Anesthetics|anesthetics|mesh-ancestor
25317067|NCT04983615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25317068|NCT04983615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25317069|NCT04983615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25317070|NCT04983615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25317072|NCT04983615|GABA Agents|gaba agents|mesh-ancestor
25317073|NCT04983615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25317074|NCT04983615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317100|NCT04982874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25317101|NCT04982874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317112|NCT04982809|Dexamethasone|dexamethasone|mesh-list
25317113|NCT04982809|Prednisolone|prednisolone|mesh-list
25317114|NCT04982809|Betamethasone|betamethasone|mesh-list
25317115|NCT04982809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25317116|NCT04982809|Antiemetics|antiemetics|mesh-ancestor
25317117|NCT04982809|Autonomic Agents|autonomic agents|mesh-ancestor
25317118|NCT04982809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25317119|NCT04982809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317120|NCT04982809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25317121|NCT04982809|Glucocorticoids|glucocorticoids|mesh-ancestor
25317122|NCT04982809|Hormones|hormones|mesh-ancestor
25317123|NCT04982809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25317124|NCT04982809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25317125|NCT04982809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25317126|NCT04982809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25317127|NCT04982809|Respiratory System Agents|respiratory system agents|mesh-ancestor
25317128|NCT04982900|Aflutinib|aflutinib|mesh-list
25317129|NCT04982900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25317130|NCT04982900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25317131|NCT04982900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317132|NCT04982913|Oseltamivir|oseltamivir|mesh-list
25317133|NCT04982913|Antiviral Agents|antiviral agents|mesh-ancestor
25317134|NCT04982913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25317135|NCT04982913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25317136|NCT04982913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317137|NCT04982939|Oxaliplatin|oxaliplatin|mesh-list
25317138|NCT04982939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25317139|NCT04982692|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25317140|NCT04982692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25317141|NCT04982692|Immunologic Factors|immunologic factors|mesh-ancestor
25317142|NCT04982692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317143|NCT04982549|Paclitaxel|paclitaxel|mesh-list
25317144|NCT04982549|Carboplatin|carboplatin|mesh-list
25317145|NCT04982549|Pemetrexed|pemetrexed|mesh-list
25317146|NCT04982549|Durvalumab|durvalumab|mesh-list
25317147|NCT04982549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25317148|NCT04982549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25317149|NCT04982549|Tubulin Modulators|tubulin modulators|mesh-ancestor
25317150|NCT04982549|Antimitotic Agents|antimitotic agents|mesh-ancestor
25317154|NCT04982549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25317155|NCT04982549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25317156|NCT04982549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25317157|NCT04982016|Methamphetamine|methamphetamine|mesh-list
25317158|NCT04982016|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25317159|NCT04982016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648814|NCT01484977|Anticonvulsants|anticonvulsants|mesh-ancestor
25317160|NCT04982016|Sympathomimetics|sympathomimetics|mesh-ancestor
25317161|NCT04982016|Autonomic Agents|autonomic agents|mesh-ancestor
25317162|NCT04982016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25190343|NCT02790177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190344|NCT02790177|Viscosupplements|viscosupplements|mesh-ancestor
25190345|NCT02790177|Protective Agents|protective agents|mesh-ancestor
25206376|NCT03606642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25206377|NCT03606642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206378|NCT03606642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25206379|NCT03606642|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25206380|NCT03606642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25206381|NCT03606642|Antipyretics|antipyretics|mesh-ancestor
25317163|NCT04982016|Dopamine Agents|dopamine agents|mesh-ancestor
25317164|NCT04982016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25317165|NCT04982016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317166|NCT04982016|Adrenergic Agents|adrenergic agents|mesh-ancestor
25317167|NCT04982016|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25317168|NCT04982016|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25317169|NCT04982016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25317170|NCT04982016|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25317171|NCT04981899|Carboplatin|carboplatin|mesh-list
25317172|NCT04981899|Nivolumab|nivolumab|mesh-list
25317173|NCT04981899|Etoposide|etoposide|mesh-list
25317174|NCT04981899|Ifosfamide|ifosfamide|mesh-list
25317175|NCT04981899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25317176|NCT04981899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25317177|NCT04981899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25317178|NCT04981899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317179|NCT04981899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25317180|NCT04981899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25317181|NCT04981899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25317182|NCT04981899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25317183|NCT04981899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25317184|NCT04981899|Alkylating Agents|alkylating agents|mesh-ancestor
25317185|NCT04981951|Dexmedetomidine|dexmedetomidine|mesh-list
25317186|NCT04981951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25317187|NCT04981951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25317188|NCT04981951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317189|NCT04981951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25317190|NCT04981951|Analgesics|analgesics|mesh-ancestor
25317191|NCT04981951|Sensory System Agents|sensory system agents|mesh-ancestor
25317192|NCT04981951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25317193|NCT04981951|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25317194|NCT04981951|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25317195|NCT04981951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25317196|NCT04981951|Adrenergic Agents|adrenergic agents|mesh-ancestor
25317197|NCT04981951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25317198|NCT04981951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317199|NCT04981886|Bimatoprost|bimatoprost|mesh-list
25317200|NCT04981886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25317202|NCT04982055|Anticoagulants|anticoagulants|mesh-ancestor
25317203|NCT04982055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25317204|NCT04982055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25317205|NCT04982055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317206|NCT04981743|Vitamin D|vitamin d|mesh-list
25317207|NCT04981743|Vitamins|vitamins|mesh-ancestor
25317208|NCT04981743|Micronutrients|micronutrients|mesh-ancestor
25317209|NCT04981743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317210|NCT04981743|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24439025|NCT00277199|Abatacept|abatacept|mesh-list
24815808|NCT02072083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317211|NCT04981457|Misoprostol|misoprostol|mesh-list
25317212|NCT04981457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25317213|NCT04981457|Abortifacient Agents|abortifacient agents|mesh-ancestor
25317214|NCT04981457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25317215|NCT04981457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317216|NCT04981457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25648815|NCT01484977|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25648816|NCT01484977|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25648817|NCT01484977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25648818|NCT01484977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648819|NCT01485055|Infliximab|infliximab|mesh-list
25648820|NCT01485055|Basiliximab|basiliximab|mesh-list
25648821|NCT01485055|Dermatologic Agents|dermatologic agents|mesh-ancestor
25648822|NCT01485055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25648823|NCT01485055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25190358|NCT02789969|Analgesics|analgesics|mesh-ancestor
25190359|NCT02789969|Sensory System Agents|sensory system agents|mesh-ancestor
25190360|NCT02789969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25190361|NCT02789969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25190362|NCT02789969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25190363|NCT02789969|Anesthetics, General|anesthetics, general|mesh-ancestor
25190364|NCT02789969|Anesthetics|anesthetics|mesh-ancestor
25190365|NCT02789982|Propranolol|propranolol|mesh-list
25190366|NCT02789982|Adrenergic Agents|adrenergic agents|mesh-list
25317217|NCT04981457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25317218|NCT04981457|Oxytocics|oxytocics|mesh-ancestor
25317227|NCT04981327|Antithrombins|antithrombins|mesh-ancestor
25317228|NCT04981327|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25317229|NCT04981327|Protease Inhibitors|protease inhibitors|mesh-ancestor
25317230|NCT04981327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25317231|NCT04981327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317232|NCT04981327|Anticoagulants|anticoagulants|mesh-ancestor
25317233|NCT04981379|Hydroxychloroquine|hydroxychloroquine|mesh-list
25317234|NCT04981379|Favipiravir|favipiravir|mesh-list
25317235|NCT04981379|Antimalarials|antimalarials|mesh-ancestor
25317236|NCT04981379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25317237|NCT04981379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25317238|NCT04981379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25317239|NCT04981379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25317240|NCT04981379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317241|NCT04981379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25317242|NCT04981379|Antiviral Agents|antiviral agents|mesh-ancestor
25317243|NCT04981704|Itraconazole|itraconazole|mesh-list
25317244|NCT04981704|Phenytoin|phenytoin|mesh-list
25317245|NCT04981704|Paroxetine|paroxetine|mesh-list
25317246|NCT04981704|Antifungal Agents|antifungal agents|mesh-ancestor
25317247|NCT04981704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25317248|NCT04981704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25317249|NCT04981704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25317250|NCT04981704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25317251|NCT04981704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317252|NCT04981704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25317253|NCT04981704|Hormone Antagonists|hormone antagonists|mesh-ancestor
25317254|NCT04981704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25317255|NCT04981704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317256|NCT04981704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25317257|NCT04981704|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25317258|NCT04981704|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25317259|NCT04981704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25317260|NCT04981704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25317261|NCT04981704|Serotonin Agents|serotonin agents|mesh-ancestor
25317262|NCT04981704|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25317263|NCT04981704|Antidepressive Agents|antidepressive agents|mesh-ancestor
25317264|NCT04981704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25317265|NCT04981704|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25317266|NCT04981704|Anticonvulsants|anticonvulsants|mesh-ancestor
25317267|NCT04981704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25317268|NCT04981704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25317269|NCT04981704|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25317270|NCT04981704|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25317271|NCT04982211|Propranolol|propranolol|mesh-list
25317272|NCT04982211|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25317273|NCT04982211|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25317274|NCT04982211|Adrenergic Agents|adrenergic agents|mesh-ancestor
25317275|NCT04982211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25317276|NCT04982211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317277|NCT04982211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317278|NCT04982211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25317279|NCT04982211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25317280|NCT04982211|Vasodilator Agents|vasodilator agents|mesh-ancestor
25317281|NCT04981093|Dexamethasone|dexamethasone|mesh-list
25648824|NCT01485055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25648825|NCT01485055|Immunologic Factors|immunologic factors|mesh-ancestor
25648826|NCT01485055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648827|NCT01485094|Pregabalin|pregabalin|mesh-list
25648828|NCT01485094|Analgesics|analgesics|mesh-ancestor
25648829|NCT01485094|Sensory System Agents|sensory system agents|mesh-ancestor
25648830|NCT01485094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25648831|NCT01485094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190434|NCT02789579|Cefuroxime axetil|cefuroxime axetil|mesh-list
25317282|NCT04981093|Dexamethasone acetate|dexamethasone acetate|mesh-list
25317283|NCT04981093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24879435|NCT04765709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25317284|NCT04981093|Antiemetics|antiemetics|mesh-ancestor
25317285|NCT04981093|Autonomic Agents|autonomic agents|mesh-ancestor
25317286|NCT04981093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25317287|NCT04981093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317288|NCT04981093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25317289|NCT04981093|Glucocorticoids|glucocorticoids|mesh-ancestor
25317290|NCT04981093|Hormones|hormones|mesh-ancestor
25317291|NCT04981093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25317292|NCT04981093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25317293|NCT04981093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25317294|NCT04980885|Azacitidine|azacitidine|mesh-list
25317295|NCT04980885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25317302|NCT04980404|Antimetabolites|antimetabolites|mesh-ancestor
25317303|NCT04980404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317304|NCT04980404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25317305|NCT04980404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25317306|NCT04980170|Amoxicillin|amoxicillin|mesh-list
25317307|NCT04980170|Clindamycin|clindamycin|mesh-list
25317308|NCT04980170|Clindamycin palmitate|clindamycin palmitate|mesh-list
25317309|NCT04980170|Clindamycin phosphate|clindamycin phosphate|mesh-list
25317310|NCT04980170|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25317311|NCT04980170|Clavulanic Acids|clavulanic acids|mesh-list
25317312|NCT04980170|Clavulanic Acid|clavulanic acid|mesh-list
25317313|NCT04980170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25317314|NCT04980170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25317315|NCT04980170|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25317316|NCT04980170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25317317|NCT04980170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317318|NCT04980170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25317319|NCT04980105|Methylprednisolone|methylprednisolone|mesh-list
25317320|NCT04980105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25317321|NCT04980105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25317322|NCT04980105|Prednisolone|prednisolone|mesh-list
25317323|NCT04980105|Prednisolone acetate|prednisolone acetate|mesh-list
25317324|NCT04980105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25317325|NCT04980105|Prednisolone phosphate|prednisolone phosphate|mesh-list
25317326|NCT04980105|Hyaluronic Acid|hyaluronic acid|mesh-list
25317327|NCT04980105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25317328|NCT04980105|Antiemetics|antiemetics|mesh-ancestor
25317329|NCT04980105|Autonomic Agents|autonomic agents|mesh-ancestor
25317330|NCT04980105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25317331|NCT04980105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317332|NCT04980105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25317333|NCT04980105|Glucocorticoids|glucocorticoids|mesh-ancestor
25317334|NCT04980105|Hormones|hormones|mesh-ancestor
25317335|NCT04980105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25317336|NCT04980105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25317337|NCT04980105|Protective Agents|protective agents|mesh-ancestor
25317338|NCT04980105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25317339|NCT04980105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25317340|NCT04980105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25317341|NCT04980105|Immunologic Factors|immunologic factors|mesh-ancestor
25317342|NCT04980105|Viscosupplements|viscosupplements|mesh-ancestor
24442908|NCT00293176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25317519|NCT04977960|Diuretics|diuretics|mesh-ancestor
25317344|NCT04980144|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25317345|NCT04980144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25317346|NCT04979663|Gemcitabine|gemcitabine|mesh-list
25317347|NCT04979663|Oxaliplatin|oxaliplatin|mesh-list
25317348|NCT04979663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25317349|NCT04979663|Antimetabolites|antimetabolites|mesh-ancestor
25317350|NCT04979663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317351|NCT04979663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25317352|NCT04979663|Antiviral Agents|antiviral agents|mesh-ancestor
25317353|NCT04979663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25317354|NCT04979663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25317355|NCT04979663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25317356|NCT04979663|Immunologic Factors|immunologic factors|mesh-ancestor
25648832|NCT01485094|Anticonvulsants|anticonvulsants|mesh-ancestor
25317357|NCT04979663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317358|NCT04979650|Methylprednisolone|methylprednisolone|mesh-list
25317359|NCT04979650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25317367|NCT04979650|Autonomic Agents|autonomic agents|mesh-ancestor
25317368|NCT04979650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25317369|NCT04979650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317370|NCT04979650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25317371|NCT04979650|Glucocorticoids|glucocorticoids|mesh-ancestor
25317372|NCT04979650|Hormones|hormones|mesh-ancestor
25317373|NCT04979650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25317374|NCT04979650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25317375|NCT04979650|Protective Agents|protective agents|mesh-ancestor
25317376|NCT04979650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25317377|NCT04979650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25317385|NCT04979585|Paclitaxel|paclitaxel|mesh-list
25317386|NCT04979585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25317387|NCT04979585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25317388|NCT04979585|Tubulin Modulators|tubulin modulators|mesh-ancestor
25317389|NCT04979585|Antimitotic Agents|antimitotic agents|mesh-ancestor
25317390|NCT04979585|Mitosis Modulators|mitosis modulators|mesh-ancestor
25317391|NCT04979585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317392|NCT04979884|Cyclosporine|cyclosporine|mesh-list
25317393|NCT04979884|Interleukin-2|interleukin-2|mesh-list
25317394|NCT04979884|Cyclosporins|cyclosporins|mesh-list
25317395|NCT04979884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25317396|NCT04979884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317397|NCT04979884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25317398|NCT04979884|Immunologic Factors|immunologic factors|mesh-ancestor
25317399|NCT04979884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317400|NCT04979884|Antifungal Agents|antifungal agents|mesh-ancestor
25317401|NCT04979884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25317402|NCT04979884|Dermatologic Agents|dermatologic agents|mesh-ancestor
25317403|NCT04979884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25317404|NCT04979884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25317405|NCT04979884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25317406|NCT04979884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25317407|NCT04979884|Analgesics|analgesics|mesh-ancestor
25317408|NCT04979884|Sensory System Agents|sensory system agents|mesh-ancestor
25317409|NCT04979884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25317410|NCT04979832|Metronidazole|metronidazole|mesh-list
25317411|NCT04979832|Fosfomycin|fosfomycin|mesh-list
25317412|NCT04979832|Molgramostim|molgramostim|mesh-list
25317413|NCT04979832|Sargramostim|sargramostim|mesh-list
25825454|NCT00005596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25825455|NCT00005596|Antimetabolites|antimetabolites|mesh-ancestor
24879621|NCT04622735|Antipyretics|antipyretics|mesh-ancestor
25317414|NCT04979832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25317415|NCT04979832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25317416|NCT04979832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25317417|NCT04979832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25317418|NCT04979832|Immunologic Factors|immunologic factors|mesh-ancestor
25317419|NCT04979832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317420|NCT04979832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25317421|NCT04979923|Lidocaine|lidocaine|mesh-list
25317422|NCT04979923|Anesthetics, Local|anesthetics, local|mesh-ancestor
25317423|NCT04979923|Anesthetics|anesthetics|mesh-ancestor
25317424|NCT04979923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25317425|NCT04979923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317426|NCT04979923|Sensory System Agents|sensory system agents|mesh-ancestor
25317427|NCT04979923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25317428|NCT04979923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25317429|NCT04979923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25317430|NCT04979923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25317431|NCT04979923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25317447|NCT04979273|Epinephrine|epinephrine|mesh-list
25317448|NCT04979273|Racepinephrine|racepinephrine|mesh-list
25317449|NCT04979273|Epinephryl borate|epinephryl borate|mesh-list
25317450|NCT04979273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25317451|NCT04979273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25317452|NCT04979273|Adrenergic Agents|adrenergic agents|mesh-ancestor
25317453|NCT04979273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25317454|NCT04979273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317455|NCT04979273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317456|NCT04979273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25317457|NCT04979273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25317458|NCT04979273|Autonomic Agents|autonomic agents|mesh-ancestor
25317459|NCT04979273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25317460|NCT04979273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25317461|NCT04979273|Respiratory System Agents|respiratory system agents|mesh-ancestor
25317462|NCT04979273|Mydriatics|mydriatics|mesh-ancestor
25317463|NCT04979273|Sympathomimetics|sympathomimetics|mesh-ancestor
25317464|NCT04979273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25317465|NCT04979221|Cyproheptadine|cyproheptadine|mesh-list
25317466|NCT04979221|Antipruritics|antipruritics|mesh-ancestor
25317467|NCT04979221|Dermatologic Agents|dermatologic agents|mesh-ancestor
25317468|NCT04979221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25317469|NCT04979221|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25317470|NCT04979221|Histamine Antagonists|histamine antagonists|mesh-ancestor
25317471|NCT04979221|Histamine Agents|histamine agents|mesh-ancestor
25317472|NCT04979221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25317473|NCT04979221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317474|NCT04979221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317475|NCT04979221|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25317476|NCT04979221|Serotonin Agents|serotonin agents|mesh-ancestor
25317477|NCT04979221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25317478|NCT04979091|Hormones|hormones|mesh-list
25317479|NCT04979091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25317480|NCT04979091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790533|NCT01943422|Immunologic Factors|immunologic factors|mesh-ancestor
24879675|NCT04560660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24879676|NCT04560660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24879677|NCT04560660|GABA Modulators|gaba modulators|mesh-ancestor
24879678|NCT04560660|GABA Agents|gaba agents|mesh-ancestor
24879679|NCT04551521|Trastuzumab|trastuzumab|mesh-list
25317485|NCT04978688|Relugolix|relugolix|mesh-list
25317486|NCT04978688|Androgen Antagonists|androgen antagonists|mesh-ancestor
25317487|NCT04978688|Hormone Antagonists|hormone antagonists|mesh-ancestor
25317488|NCT04978688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25317489|NCT04978688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317498|NCT04978597|Opicapone|opicapone|mesh-list
25317499|NCT04978597|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25317500|NCT04978597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25317574|NCT04977791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25317501|NCT04978597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317502|NCT04978597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25317503|NCT04978597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25317504|NCT04978545|Chlorhexidine|chlorhexidine|mesh-list
25317505|NCT04978545|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25317506|NCT04978545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25317507|NCT04978545|Disinfectants|disinfectants|mesh-ancestor
25317508|NCT04978181|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25317509|NCT04978181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25317510|NCT04978181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25317511|NCT04978181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317512|NCT04977960|Canrenone|canrenone|mesh-list
25317513|NCT04977960|Canrenoic Acid|canrenoic acid|mesh-list
25317514|NCT04977960|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25317515|NCT04977960|Hormone Antagonists|hormone antagonists|mesh-ancestor
25317516|NCT04977960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25317517|NCT04977960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317518|NCT04977960|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25317520|NCT04977960|Natriuretic Agents|natriuretic agents|mesh-ancestor
25317521|NCT04978155|Anesthetics|anesthetics|mesh-list
25317522|NCT04978155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25317523|NCT04978155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825456|NCT00005596|Dermatologic Agents|dermatologic agents|mesh-ancestor
25825457|NCT00005596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825458|NCT00005596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25317524|NCT04977778|Fluorides|fluorides|mesh-list
25317525|NCT04977778|Tin Fluorides|tin fluorides|mesh-list
25317526|NCT04977778|Cariostatic Agents|cariostatic agents|mesh-ancestor
25317527|NCT04977778|Protective Agents|protective agents|mesh-ancestor
25317528|NCT04977778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317529|NCT04977674|Naltrexone|naltrexone|mesh-list
25317530|NCT04977674|Ketamine|ketamine|mesh-list
25317531|NCT04977674|Analgesics|analgesics|mesh-ancestor
25317532|NCT04977674|Sensory System Agents|sensory system agents|mesh-ancestor
25317533|NCT04977674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25317534|NCT04977674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317535|NCT04977674|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25317536|NCT04977674|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25317537|NCT04977674|Anesthetics, General|anesthetics, general|mesh-ancestor
25317538|NCT04977674|Anesthetics|anesthetics|mesh-ancestor
25648833|NCT01485094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25206441|NCT03403634|Immunologic Factors|immunologic factors|mesh-ancestor
25206442|NCT03403634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206443|NCT03403634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25206444|NCT03403634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25206445|NCT03403634|Analgesics|analgesics|mesh-ancestor
25206446|NCT03403634|Sensory System Agents|sensory system agents|mesh-ancestor
25206447|NCT03403634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25206448|NCT03403634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25317539|NCT04977674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25317540|NCT04977674|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25317541|NCT04977674|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25317542|NCT04977674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25317543|NCT04977674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317544|NCT04977674|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25317545|NCT04977674|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25317546|NCT04977908|Insulin|insulin|mesh-list
25317547|NCT04977908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25317548|NCT04977908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317549|NCT04977843|Dimercaprol|dimercaprol|mesh-list
25317550|NCT04977843|Chelating Agents|chelating agents|mesh-ancestor
25317551|NCT04977843|Sequestering Agents|sequestering agents|mesh-ancestor
25317552|NCT04977843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317553|NCT04977661|Vitamin E|vitamin e|mesh-list
25317554|NCT04977661|Tocopherols|tocopherols|mesh-list
25317555|NCT04977661|alpha-Tocopherol|alpha-tocopherol|mesh-list
25317556|NCT04977661|Pentoxifylline|pentoxifylline|mesh-list
25317557|NCT04977661|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25317558|NCT04977661|Vitamins|vitamins|mesh-ancestor
25317559|NCT04977661|Micronutrients|micronutrients|mesh-ancestor
25317560|NCT04977661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317561|NCT04977661|Antioxidants|antioxidants|mesh-ancestor
25317562|NCT04977661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317563|NCT04977661|Protective Agents|protective agents|mesh-ancestor
25317564|NCT04977661|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25317565|NCT04977661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25317566|NCT04977661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25317567|NCT04977661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25317568|NCT04977661|Vasodilator Agents|vasodilator agents|mesh-ancestor
25317569|NCT04977661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25317570|NCT04977661|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25317571|NCT04977661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25317572|NCT04977791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25317573|NCT04977791|Antibodies|antibodies|mesh-list
25317600|NCT04977427|Prednisolone phosphate|prednisolone phosphate|mesh-list
25317601|NCT04977427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25317602|NCT04977427|Glucocorticoids|glucocorticoids|mesh-ancestor
25317603|NCT04977427|Hormones|hormones|mesh-ancestor
25317604|NCT04977427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25317605|NCT04977427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317606|NCT04977427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25317607|NCT04977427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25317608|NCT04977427|Antiemetics|antiemetics|mesh-ancestor
25317609|NCT04977427|Autonomic Agents|autonomic agents|mesh-ancestor
25317610|NCT04977427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25317611|NCT04977427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25317612|NCT04977427|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25317613|NCT04977427|Protective Agents|protective agents|mesh-ancestor
25317614|NCT04977336|Acetaminophen|acetaminophen|mesh-list
25317615|NCT04977336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25317616|NCT04977336|Analgesics|analgesics|mesh-ancestor
25317617|NCT04977336|Sensory System Agents|sensory system agents|mesh-ancestor
25317618|NCT04977336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25317619|NCT04977336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317620|NCT04977336|Antipyretics|antipyretics|mesh-ancestor
25317621|NCT04977544|Sertraline|sertraline|mesh-list
25317622|NCT04977544|Antidepressive Agents|antidepressive agents|mesh-ancestor
25317623|NCT04977544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25648834|NCT01485094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25648835|NCT01485094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648836|NCT01485094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25648837|NCT01485094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25648838|NCT01485094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25648839|NCT01485094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25648840|NCT01485094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25648841|NCT01485172|Ropinirole|ropinirole|mesh-list
25317624|NCT04977544|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25317625|NCT04977544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25317626|NCT04977544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25317627|NCT04977544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317628|NCT04977544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25317629|NCT04977544|Serotonin Agents|serotonin agents|mesh-ancestor
25317630|NCT04977544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317631|NCT04977401|Glycerol|glycerol|mesh-list
25317632|NCT04977401|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25317633|NCT04977401|Protective Agents|protective agents|mesh-ancestor
25317634|NCT04977401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317635|NCT04977557|Thiamine|thiamine|mesh-list
25317636|NCT04977557|Vitamin B Complex|vitamin b complex|mesh-ancestor
25317637|NCT04977557|Vitamins|vitamins|mesh-ancestor
25317638|NCT04977557|Micronutrients|micronutrients|mesh-ancestor
25317639|NCT04977557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317640|NCT04977388|Droxidopa|droxidopa|mesh-list
25317641|NCT04977388|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25317642|NCT04977388|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25317643|NCT04976816|Triamcinolone|triamcinolone|mesh-list
25317644|NCT04976816|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25317788|NCT04974580|Cholinergic Agents|cholinergic agents|mesh-ancestor
25317645|NCT04976816|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25317646|NCT04976816|Betamethasone|betamethasone|mesh-list
25317647|NCT04976816|Betamethasone Valerate|betamethasone valerate|mesh-list
25317648|NCT04976816|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25317649|NCT04976816|Betamethasone benzoate|betamethasone benzoate|mesh-list
25317650|NCT04976816|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25317651|NCT04976816|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25317652|NCT04976816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25317653|NCT04976816|Glucocorticoids|glucocorticoids|mesh-ancestor
25317654|NCT04976816|Hormones|hormones|mesh-ancestor
25317655|NCT04976816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25317656|NCT04976816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317657|NCT04976816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25317658|NCT04976816|Immunologic Factors|immunologic factors|mesh-ancestor
25317659|NCT04976816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25317660|NCT04976816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317661|NCT04976816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25317662|NCT04976816|Respiratory System Agents|respiratory system agents|mesh-ancestor
25317663|NCT04976673|Triamcinolone|triamcinolone|mesh-list
25317664|NCT04976673|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25317665|NCT04976673|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25317666|NCT04976673|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25317667|NCT04976673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25317668|NCT04976673|Glucocorticoids|glucocorticoids|mesh-ancestor
25317669|NCT04976673|Hormones|hormones|mesh-ancestor
25317670|NCT04976673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25317671|NCT04976673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317672|NCT04976673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25317673|NCT04976673|Immunologic Factors|immunologic factors|mesh-ancestor
25317674|NCT04976673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25317675|NCT04976673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317676|NCT04976829|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25317677|NCT04976829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25317678|NCT04976478|Nimotuzumab|nimotuzumab|mesh-list
25317679|NCT04976478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25317680|NCT04976478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25317681|NCT04976088|Diclofenac|diclofenac|mesh-list
25317682|NCT04976088|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
25317683|NCT04976088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25317684|NCT04976088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25317685|NCT04976088|Analgesics|analgesics|mesh-ancestor
25317686|NCT04976088|Sensory System Agents|sensory system agents|mesh-ancestor
25317687|NCT04976088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25317688|NCT04976088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317689|NCT04976088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25317690|NCT04976088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25317691|NCT04976088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25317692|NCT04976088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25317693|NCT04976088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317694|NCT04975945|Ceftriaxone|ceftriaxone|mesh-list
25317695|NCT04975945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25317696|NCT04975945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25317697|NCT04975932|Chlorotrianisene|chlorotrianisene|mesh-list
25317698|NCT04975932|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25317699|NCT04975932|Estrogens|estrogens|mesh-ancestor
25317700|NCT04975932|Hormones|hormones|mesh-ancestor
25317701|NCT04975932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25317702|NCT04975932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317703|NCT04975932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25317704|NCT04975932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25317705|NCT04975971|Dexamethasone|dexamethasone|mesh-list
25317706|NCT04975971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25317707|NCT04975971|Antiemetics|antiemetics|mesh-ancestor
25317708|NCT04975971|Autonomic Agents|autonomic agents|mesh-ancestor
25317709|NCT04975971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25317710|NCT04975971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317711|NCT04975971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25317712|NCT04975971|Glucocorticoids|glucocorticoids|mesh-ancestor
25317713|NCT04975971|Hormones|hormones|mesh-ancestor
25317714|NCT04975971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25317715|NCT04975971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25317716|NCT04975971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25317717|NCT04975724|Citalopram|citalopram|mesh-list
25317718|NCT04975724|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25317719|NCT04975724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25317720|NCT04975724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25317721|NCT04975724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317722|NCT04975724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25317723|NCT04975724|Serotonin Agents|serotonin agents|mesh-ancestor
25317724|NCT04975724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317725|NCT04975724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25317726|NCT04975724|Antidepressive Agents|antidepressive agents|mesh-ancestor
25317727|NCT04975724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25317728|NCT04975373|Hyaluronic Acid|hyaluronic acid|mesh-list
25317729|NCT04975373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25317730|NCT04975373|Immunologic Factors|immunologic factors|mesh-ancestor
25317731|NCT04975373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317732|NCT04975373|Viscosupplements|viscosupplements|mesh-ancestor
25317733|NCT04975373|Protective Agents|protective agents|mesh-ancestor
25317734|NCT04975360|Caffeine|caffeine|mesh-list
25317735|NCT04975360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25317736|NCT04975360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317737|NCT04975360|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25317738|NCT04975360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25317739|NCT04975360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900330|NCT04395105|Antiemetics|antiemetics|mesh-ancestor
24900331|NCT04395105|Autonomic Agents|autonomic agents|mesh-ancestor
24817987|NCT02086292|Anesthetics, Local|anesthetics, local|mesh-ancestor
25317740|NCT04975360|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25317741|NCT04975360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25317742|NCT04975360|Purinergic Agents|purinergic agents|mesh-ancestor
25317743|NCT04975360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25825459|NCT00005596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24900605|NCT04392479|Aflibercept|aflibercept|mesh-list
24900606|NCT04392479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24900607|NCT04392479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25317744|NCT04975022|Insulin|insulin|mesh-list
25317745|NCT04975022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25317746|NCT04975022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317747|NCT04975074|Iron|iron|mesh-list
25317748|NCT04975074|Ferrous succinate|ferrous succinate|mesh-list
25317749|NCT04975074|Trace Elements|trace elements|mesh-ancestor
25317750|NCT04975074|Micronutrients|micronutrients|mesh-ancestor
25317751|NCT04975074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317752|NCT04975074|Hematinics|hematinics|mesh-ancestor
25317753|NCT04974827|Carboplatin|carboplatin|mesh-list
25317754|NCT04974827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25317755|NCT04974723|Teriparatide|teriparatide|mesh-list
25317756|NCT04974723|Abaloparatide|abaloparatide|mesh-list
25317757|NCT04974723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25317758|NCT04974723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317759|NCT04974723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25317760|NCT04974853|Complement System Proteins|complement system proteins|mesh-list
25317761|NCT04974853|Immunologic Factors|immunologic factors|mesh-ancestor
25317846|NCT04973319|Trastuzumab|trastuzumab|mesh-list
25317762|NCT04974853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317763|NCT04974944|Paclitaxel|paclitaxel|mesh-list
25317764|NCT04974944|Bevacizumab|bevacizumab|mesh-list
25317765|NCT04974944|Carboplatin|carboplatin|mesh-list
25317766|NCT04974944|Apatinib|apatinib|mesh-list
25317767|NCT04974944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25317768|NCT04974944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25317769|NCT04974944|Tubulin Modulators|tubulin modulators|mesh-ancestor
25317770|NCT04974944|Antimitotic Agents|antimitotic agents|mesh-ancestor
25317771|NCT04974944|Mitosis Modulators|mitosis modulators|mesh-ancestor
25317772|NCT04974944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317773|NCT04974944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25317774|NCT04974944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25317775|NCT04974944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25317776|NCT04974944|Growth Substances|growth substances|mesh-ancestor
25317777|NCT04974944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317778|NCT04974944|Growth Inhibitors|growth inhibitors|mesh-ancestor
25317779|NCT04974944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25317780|NCT04974944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25317781|NCT04974580|Nicotine|nicotine|mesh-list
25317782|NCT04974580|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25317783|NCT04974580|Autonomic Agents|autonomic agents|mesh-ancestor
25317784|NCT04974580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25317785|NCT04974580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317786|NCT04974580|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25317787|NCT04974580|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25317799|NCT04974060|Remifentanil|remifentanil|mesh-list
25317800|NCT04974060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25317801|NCT04974060|Narcotics|narcotics|mesh-ancestor
25317802|NCT04974060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25317803|NCT04974060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317804|NCT04974060|Analgesics|analgesics|mesh-ancestor
25317805|NCT04974060|Sensory System Agents|sensory system agents|mesh-ancestor
25317806|NCT04974060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25317807|NCT04973969|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25317808|NCT04973969|Luteolytic Agents|luteolytic agents|mesh-ancestor
25317809|NCT04973969|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25317810|NCT04973969|Contraceptive Agents|contraceptive agents|mesh-ancestor
25317811|NCT04973969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25317812|NCT04973969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317813|NCT04973969|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25317814|NCT04973969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25317815|NCT04973969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25317816|NCT04973787|Antirheumatic Agents|antirheumatic agents|mesh-list
25317817|NCT04973904|Paclitaxel|paclitaxel|mesh-list
24460584|NCT00348985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24902041|NCT04378231|Clavulanic Acid|clavulanic acid|mesh-list
25317818|NCT04973904|Bevacizumab|bevacizumab|mesh-list
25317819|NCT04973904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25317820|NCT04973904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25317821|NCT04973904|Tubulin Modulators|tubulin modulators|mesh-ancestor
25317822|NCT04973904|Antimitotic Agents|antimitotic agents|mesh-ancestor
25317823|NCT04973904|Mitosis Modulators|mitosis modulators|mesh-ancestor
25317824|NCT04973904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317825|NCT04973904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25317826|NCT04973904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25317827|NCT04973904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25317828|NCT04973904|Growth Substances|growth substances|mesh-ancestor
25317829|NCT04973904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317830|NCT04973904|Growth Inhibitors|growth inhibitors|mesh-ancestor
25317831|NCT04973462|Oseltamivir|oseltamivir|mesh-list
25317832|NCT04973462|Antiviral Agents|antiviral agents|mesh-ancestor
25317833|NCT04973462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25317834|NCT04973462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25317835|NCT04973462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317836|NCT04973722|Denosumab|denosumab|mesh-list
25317837|NCT04973722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25317838|NCT04973722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317839|NCT04973579|Anesthetics|anesthetics|mesh-list
25317840|NCT04973579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25317841|NCT04973579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317842|NCT04973033|Tofacitinib|tofacitinib|mesh-list
25317843|NCT04973033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25317844|NCT04973033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25317845|NCT04973033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317848|NCT04973319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25317849|NCT04973319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25317850|NCT04972942|Daratumumab|daratumumab|mesh-list
25206494|NCT03322280|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25206495|NCT03322280|Estrogens|estrogens|mesh-ancestor
25206496|NCT03322280|Hormones|hormones|mesh-ancestor
25206497|NCT03322280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25206498|NCT03322280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206499|NCT03322280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25206500|NCT03322280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206514|NCT03277495|Nicotine|nicotine|mesh-list
25206515|NCT03277495|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25206516|NCT03277495|Autonomic Agents|autonomic agents|mesh-ancestor
25206517|NCT03277495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25206518|NCT03277495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206519|NCT03277495|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25317851|NCT04972942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25317852|NCT04973293|Bevacizumab|bevacizumab|mesh-list
25317853|NCT04973293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25317854|NCT04973293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25317855|NCT04973293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25317856|NCT04973293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25317857|NCT04973293|Growth Substances|growth substances|mesh-ancestor
25317858|NCT04973293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317859|NCT04973293|Growth Inhibitors|growth inhibitors|mesh-ancestor
25317921|NCT04972513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25317922|NCT04972513|Autonomic Agents|autonomic agents|mesh-ancestor
25317923|NCT04972513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25317924|NCT04972513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317925|NCT04972513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25317926|NCT04972513|Respiratory System Agents|respiratory system agents|mesh-ancestor
25317927|NCT04972513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25317928|NCT04972513|Antioxidants|antioxidants|mesh-ancestor
25317929|NCT04972513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317930|NCT04972513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25317931|NCT04972513|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25317932|NCT04972513|Vasodilator Agents|vasodilator agents|mesh-ancestor
25317933|NCT04972513|Gasotransmitters|gasotransmitters|mesh-ancestor
25317934|NCT04972513|Protective Agents|protective agents|mesh-ancestor
25317935|NCT04972032|Estrogens|estrogens|mesh-list
25317936|NCT04972032|Hyaluronic Acid|hyaluronic acid|mesh-list
25317937|NCT04972032|Hormones|hormones|mesh-ancestor
25317938|NCT04972032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25317939|NCT04972032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317940|NCT04972032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25317941|NCT04972032|Immunologic Factors|immunologic factors|mesh-ancestor
25317942|NCT04972032|Viscosupplements|viscosupplements|mesh-ancestor
25317943|NCT04972032|Protective Agents|protective agents|mesh-ancestor
25317944|NCT04972045|Curcumin|curcumin|mesh-list
24691260|NCT01405872|Immunologic Factors|immunologic factors|mesh-ancestor
25317945|NCT04972045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25317946|NCT04972045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25317947|NCT04972045|Analgesics|analgesics|mesh-ancestor
25317948|NCT04972045|Sensory System Agents|sensory system agents|mesh-ancestor
25317949|NCT04972045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25317950|NCT04972045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317951|NCT04972045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25317952|NCT04972045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25317953|NCT04972045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25317954|NCT04972045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25317955|NCT04972045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317956|NCT04971759|Fentanyl|fentanyl|mesh-list
25317957|NCT04971759|Dexmedetomidine|dexmedetomidine|mesh-list
25317958|NCT04971759|Levobupivacaine|levobupivacaine|mesh-list
25317959|NCT04971759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25648842|NCT01485172|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25648843|NCT01485172|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25648844|NCT01485172|Dopamine Agonists|dopamine agonists|mesh-ancestor
25648845|NCT01485172|Dopamine Agents|dopamine agents|mesh-ancestor
25648846|NCT01485172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25648847|NCT01485172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648848|NCT01485172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648849|NCT01485380|Dexmedetomidine|dexmedetomidine|mesh-list
25648850|NCT01485380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25648851|NCT01485380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25648852|NCT01485380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648853|NCT01485380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25648854|NCT01485380|Analgesics|analgesics|mesh-ancestor
25317960|NCT04971759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25317961|NCT04971759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317962|NCT04971759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25317963|NCT04971759|Analgesics|analgesics|mesh-ancestor
25317964|NCT04971759|Sensory System Agents|sensory system agents|mesh-ancestor
25317965|NCT04971759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25317966|NCT04971759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25317967|NCT04971759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25317968|NCT04971759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25317969|NCT04971759|Adrenergic Agents|adrenergic agents|mesh-ancestor
25317970|NCT04971759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25317971|NCT04971759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317972|NCT04971759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25317973|NCT04971759|Narcotics|narcotics|mesh-ancestor
25317974|NCT04971759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25317975|NCT04971759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25317976|NCT04971759|Anesthetics, General|anesthetics, general|mesh-ancestor
25317977|NCT04971759|Anesthetics|anesthetics|mesh-ancestor
25317978|NCT04971759|Anesthetics, Local|anesthetics, local|mesh-ancestor
25317979|NCT04971382|Curcumin|curcumin|mesh-list
25317980|NCT04971382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25317981|NCT04971382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25317982|NCT04971382|Analgesics|analgesics|mesh-ancestor
25317983|NCT04971382|Sensory System Agents|sensory system agents|mesh-ancestor
25317984|NCT04971382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25317985|NCT04971382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25317986|NCT04971382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25317987|NCT04971382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25317988|NCT04971382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25317989|NCT04971382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25317990|NCT04971382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317991|NCT04971577|Simvastatin|simvastatin|mesh-list
25317992|NCT04971577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25317993|NCT04971577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25317994|NCT04971577|Antimetabolites|antimetabolites|mesh-ancestor
25317995|NCT04971577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25317996|NCT04971577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25317997|NCT04971577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25317998|NCT04971577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25317999|NCT04971304|Lenograstim|lenograstim|mesh-list
25318000|NCT04971304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25318001|NCT04971304|Immunologic Factors|immunologic factors|mesh-ancestor
25318002|NCT04971304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318003|NCT04971291|Bupropion|bupropion|mesh-list
25318004|NCT04971291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25318005|NCT04971291|Antidepressive Agents|antidepressive agents|mesh-ancestor
25318006|NCT04971291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25318007|NCT04971291|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25318008|NCT04971291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25318083|NCT04970251|Growth Inhibitors|growth inhibitors|mesh-ancestor
25318009|NCT04971291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25318010|NCT04971291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318011|NCT04971291|Dopamine Agents|dopamine agents|mesh-ancestor
25318012|NCT04971291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25318013|NCT04971291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318014|NCT04971291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25318015|NCT04971291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25318016|NCT04971291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318017|NCT04971239|Methotrexate|methotrexate|mesh-list
25318018|NCT04971239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25318019|NCT04971239|Abortifacient Agents|abortifacient agents|mesh-ancestor
25318020|NCT04971239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25318021|NCT04971239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318022|NCT04971239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25318023|NCT04971239|Antimetabolites|antimetabolites|mesh-ancestor
25318024|NCT04971239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318025|NCT04971239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318026|NCT04971239|Dermatologic Agents|dermatologic agents|mesh-ancestor
25318027|NCT04971239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318028|NCT04971239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25318029|NCT04971239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25318030|NCT04971239|Immunologic Factors|immunologic factors|mesh-ancestor
25318031|NCT04971239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25318032|NCT04971239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25318033|NCT04970719|Remdesivir|remdesivir|mesh-list
25318034|NCT04970719|Dexamethasone|dexamethasone|mesh-list
25318035|NCT04970719|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
25318036|NCT04970719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25318037|NCT04970719|Antiemetics|antiemetics|mesh-ancestor
25318038|NCT04970719|Autonomic Agents|autonomic agents|mesh-ancestor
25318039|NCT04970719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25318040|NCT04970719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318041|NCT04970719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25318042|NCT04970719|Glucocorticoids|glucocorticoids|mesh-ancestor
25318043|NCT04970719|Hormones|hormones|mesh-ancestor
25318044|NCT04970719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25318045|NCT04970719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25318046|NCT04970719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318047|NCT04970719|Antimetabolites|antimetabolites|mesh-ancestor
25318048|NCT04970719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318049|NCT04970719|Antiviral Agents|antiviral agents|mesh-ancestor
25318050|NCT04970719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25318051|NCT04970719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25318052|NCT04970719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318053|NCT04970576|Warfarin|warfarin|mesh-list
25318054|NCT04970576|Rivaroxaban|rivaroxaban|mesh-list
25318055|NCT04970576|Anticoagulants|anticoagulants|mesh-ancestor
25318058|NCT04970576|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25318059|NCT04970576|Protease Inhibitors|protease inhibitors|mesh-ancestor
25318060|NCT04970576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318061|NCT04970576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318062|NCT04970667|Flupenthixol|flupenthixol|mesh-list
25318063|NCT04970667|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
25318064|NCT04970667|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25318065|NCT04970667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25318066|NCT04970667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25318067|NCT04970667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318068|NCT04970667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25318069|NCT04970667|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25318070|NCT04970667|Dopamine Agents|dopamine agents|mesh-ancestor
25318071|NCT04970667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25318072|NCT04970667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318073|NCT04970602|Methylene Blue|methylene blue|mesh-list
25318074|NCT04970602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318075|NCT04970602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318076|NCT04970446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25318077|NCT04970446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25318078|NCT04970251|Aflibercept|aflibercept|mesh-list
25318079|NCT04970251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25318080|NCT04970251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25318081|NCT04970251|Growth Substances|growth substances|mesh-ancestor
25318082|NCT04970251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318093|NCT04970303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25318094|NCT04970303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25318095|NCT04970303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318096|NCT04970303|Dopamine Agents|dopamine agents|mesh-ancestor
25318097|NCT04970303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24440340|NCT00282451|Insulin Aspart|insulin aspart|mesh-list
25318107|NCT04970121|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25318108|NCT04970121|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25318109|NCT04970121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25318110|NCT04970121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25318111|NCT04970121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318112|NCT04970121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25318113|NCT04970121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318114|NCT04970121|Analgesics|analgesics|mesh-ancestor
25318115|NCT04970121|Sensory System Agents|sensory system agents|mesh-ancestor
25318116|NCT04970121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25318117|NCT04970121|Antidepressive Agents|antidepressive agents|mesh-ancestor
25318118|NCT04970121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25318119|NCT04970121|Dopamine Agents|dopamine agents|mesh-ancestor
25318120|NCT04970329|Dextrans|dextrans|mesh-list
25318121|NCT04970329|Anticoagulants|anticoagulants|mesh-ancestor
25318122|NCT04970329|Plasma Substitutes|plasma substitutes|mesh-ancestor
25318123|NCT04970329|Blood Substitutes|blood substitutes|mesh-ancestor
25318124|NCT04970238|Simendan|simendan|mesh-list
25318125|NCT04970238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25318126|NCT04970238|Vasodilator Agents|vasodilator agents|mesh-ancestor
25318127|NCT04970238|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25318128|NCT04970238|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25318129|NCT04970238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318130|NCT04970238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318131|NCT04970238|Protective Agents|protective agents|mesh-ancestor
25318132|NCT04970238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318133|NCT04970342|Alprazolam|alprazolam|mesh-list
25318134|NCT04970342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318135|NCT04970342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25318136|NCT04970342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25318137|NCT04970342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318138|NCT04970342|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25318139|NCT04970342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25318140|NCT04970342|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25318141|NCT04970342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25318142|NCT04970342|GABA Modulators|gaba modulators|mesh-ancestor
25318143|NCT04970342|GABA Agents|gaba agents|mesh-ancestor
25318144|NCT04970043|Pemetrexed|pemetrexed|mesh-list
25318145|NCT04970043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318146|NCT04970043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318147|NCT04970043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318148|NCT04970043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25318149|NCT04970043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25318150|NCT04969263|Vaccines|vaccines|mesh-list
25318151|NCT04969263|Immunologic Factors|immunologic factors|mesh-ancestor
25318152|NCT04969263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318153|NCT04969497|Zolmitriptan|zolmitriptan|mesh-list
25318154|NCT04969497|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25318155|NCT04969497|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25318156|NCT04969497|Serotonin Agents|serotonin agents|mesh-ancestor
25318157|NCT04969497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25318158|NCT04969497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318159|NCT04969497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318160|NCT04969133|Levobupivacaine|levobupivacaine|mesh-list
25318161|NCT04969133|Anesthetics, Local|anesthetics, local|mesh-ancestor
25318162|NCT04969133|Anesthetics|anesthetics|mesh-ancestor
25318163|NCT04969133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25318164|NCT04969133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318165|NCT04969133|Sensory System Agents|sensory system agents|mesh-ancestor
25318166|NCT04969133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25318167|NCT04968587|Dialysis Solutions|dialysis solutions|mesh-list
25318168|NCT04968587|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25825460|NCT00005596|Antiviral Agents|antiviral agents|mesh-ancestor
25825461|NCT00005596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25825462|NCT00005596|Antidotes|antidotes|mesh-ancestor
25825463|NCT00005596|Protective Agents|protective agents|mesh-ancestor
25825464|NCT00005596|Vitamin B Complex|vitamin b complex|mesh-ancestor
25825465|NCT00005596|Vitamins|vitamins|mesh-ancestor
25825466|NCT00005596|Micronutrients|micronutrients|mesh-ancestor
25825467|NCT00005596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25318169|NCT04968613|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
25318170|NCT04968613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318171|NCT04968613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318172|NCT04968613|Dopamine Agents|dopamine agents|mesh-ancestor
25318173|NCT04968613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25318174|NCT04968613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318175|NCT04968392|Dexmedetomidine|dexmedetomidine|mesh-list
25318176|NCT04968392|Levobupivacaine|levobupivacaine|mesh-list
25318177|NCT04968392|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25318178|NCT04968392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25318179|NCT04968392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318180|NCT04968392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25318181|NCT04968392|Analgesics|analgesics|mesh-ancestor
25318182|NCT04968392|Sensory System Agents|sensory system agents|mesh-ancestor
25318183|NCT04968392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25318184|NCT04968392|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25318185|NCT04968392|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25318186|NCT04968392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25318187|NCT04968392|Adrenergic Agents|adrenergic agents|mesh-ancestor
25318188|NCT04968392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25408485|NCT03437746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25656858|NCT01579812|Metformin|metformin|mesh-list
25825468|NCT00005596|Tubulin Modulators|tubulin modulators|mesh-ancestor
25318189|NCT04968392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318190|NCT04968392|Anesthetics, Local|anesthetics, local|mesh-ancestor
25318191|NCT04968392|Anesthetics|anesthetics|mesh-ancestor
25318192|NCT04968509|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
25318193|NCT04968509|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25318194|NCT04968509|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25318195|NCT04968509|Antimetabolites|antimetabolites|mesh-ancestor
25318196|NCT04968509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318197|NCT04968509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318198|NCT04968509|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25318199|NCT04968132|Analgesics, Opioid|analgesics, opioid|mesh-list
25318200|NCT04968132|Narcotics|narcotics|mesh-ancestor
25318201|NCT04968132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25318202|NCT04968132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318203|NCT04968132|Analgesics|analgesics|mesh-ancestor
25318204|NCT04968132|Sensory System Agents|sensory system agents|mesh-ancestor
25318205|NCT04968132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25318206|NCT04968002|Apatinib|apatinib|mesh-list
25318207|NCT04968002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318208|NCT04968002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25318209|NCT04968002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318280|NCT04967417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318213|NCT04967859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25318214|NCT04967859|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25318215|NCT04967859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318216|NCT04967859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825469|NCT00005596|Antimitotic Agents|antimitotic agents|mesh-ancestor
25318217|NCT04967469|Calcitriol|calcitriol|mesh-list
25318218|NCT04967469|Alfacalcidol|alfacalcidol|mesh-list
25318219|NCT04967469|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
25318220|NCT04967469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25318221|NCT04967469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318222|NCT04967469|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25318223|NCT04967469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25318224|NCT04967469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318225|NCT04967469|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25318226|NCT04967469|Vitamins|vitamins|mesh-ancestor
25318227|NCT04967469|Micronutrients|micronutrients|mesh-ancestor
25318228|NCT04967469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25318229|NCT04967950|Methotrexate|methotrexate|mesh-list
25318230|NCT04967950|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25318231|NCT04967950|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25318232|NCT04967950|Abortifacient Agents|abortifacient agents|mesh-ancestor
25318233|NCT04967950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25318234|NCT04967950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318235|NCT04967950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25318236|NCT04967950|Antimetabolites|antimetabolites|mesh-ancestor
25318237|NCT04967950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318238|NCT04967950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318239|NCT04967950|Dermatologic Agents|dermatologic agents|mesh-ancestor
25318240|NCT04967950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318241|NCT04967950|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25318242|NCT04967950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25318243|NCT04967950|Immunologic Factors|immunologic factors|mesh-ancestor
25318244|NCT04967950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25318245|NCT04967950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25318246|NCT04967326|Carbamazepine|carbamazepine|mesh-list
25318247|NCT04967326|Phenytoin|phenytoin|mesh-list
25318248|NCT04967326|Valproic Acid|valproic acid|mesh-list
25318249|NCT04967326|Anticonvulsants|anticonvulsants|mesh-list
25318250|NCT04967326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318251|NCT04967326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318252|NCT04967326|GABA Agents|gaba agents|mesh-ancestor
25318253|NCT04967326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25318254|NCT04967326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318255|NCT04967326|Antimanic Agents|antimanic agents|mesh-ancestor
25318256|NCT04967326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25318257|NCT04967326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25318258|NCT04967326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25318259|NCT04967326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25318260|NCT04967326|Analgesics|analgesics|mesh-ancestor
25318261|NCT04967326|Sensory System Agents|sensory system agents|mesh-ancestor
25318262|NCT04967326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25318263|NCT04967326|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25656859|NCT01579812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25191126|NCT02784717|Anticoagulants|anticoagulants|mesh-ancestor
25318264|NCT04967326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25318265|NCT04967326|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25318266|NCT04967326|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25318267|NCT04967326|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25318268|NCT04967326|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25318269|NCT04967417|Paclitaxel|paclitaxel|mesh-list
25318270|NCT04967417|Carboplatin|carboplatin|mesh-list
25318271|NCT04967417|Pembrolizumab|pembrolizumab|mesh-list
25318272|NCT04967417|Pemetrexed|pemetrexed|mesh-list
25318273|NCT04967417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25318274|NCT04967417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318275|NCT04967417|Tubulin Modulators|tubulin modulators|mesh-ancestor
25318276|NCT04967417|Antimitotic Agents|antimitotic agents|mesh-ancestor
25318277|NCT04967417|Mitosis Modulators|mitosis modulators|mesh-ancestor
25318278|NCT04967417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318279|NCT04967417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25318281|NCT04967417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25318282|NCT04967417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25318283|NCT04967196|Nivolumab|nivolumab|mesh-list
25825470|NCT00005596|Mitosis Modulators|mitosis modulators|mesh-ancestor
24568826|NCT00797771|Insulin|insulin|mesh-list
25825471|NCT00005596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25825472|NCT00005596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25825473|NCT00005596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25318308|NCT04966845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25318309|NCT04966845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318310|NCT04966884|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
25318311|NCT04966884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25318312|NCT04966884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318313|NCT04966884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318314|NCT04966338|Ocrelizumab|ocrelizumab|mesh-list
25318315|NCT04966338|Immunologic Factors|immunologic factors|mesh-ancestor
25318316|NCT04966338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318317|NCT04966299|Erythritol|erythritol|mesh-list
25318318|NCT04966299|Vasodilator Agents|vasodilator agents|mesh-ancestor
25318319|NCT04966234|Posaconazole|posaconazole|mesh-list
25318320|NCT04966234|Antifungal Agents|antifungal agents|mesh-ancestor
25318321|NCT04966234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25318322|NCT04966234|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25318323|NCT04966234|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25318324|NCT04966234|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25318325|NCT04966234|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25318326|NCT04966234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25318327|NCT04966234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318328|NCT04966234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318329|NCT04966234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25318330|NCT04966234|Hormone Antagonists|hormone antagonists|mesh-ancestor
25318331|NCT04966234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25318332|NCT04966234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318333|NCT04966429|Maraviroc|maraviroc|mesh-list
25318334|NCT04966429|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25318335|NCT04966429|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25318336|NCT04966429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318337|NCT04966429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25318338|NCT04966429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25318339|NCT04966429|Antiviral Agents|antiviral agents|mesh-ancestor
25318340|NCT04966429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25318341|NCT04966429|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25318342|NCT04965831|Aflutinib|aflutinib|mesh-list
25318343|NCT04965831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25318344|NCT04965831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318345|NCT04965831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318347|NCT04965545|Trace Elements|trace elements|mesh-ancestor
25318348|NCT04965545|Micronutrients|micronutrients|mesh-ancestor
25318349|NCT04965545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318350|NCT04965532|Anesthetics|anesthetics|mesh-list
25825474|NCT00005597|Temozolomide|temozolomide|mesh-list
25825475|NCT00005597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24568970|NCT00798252|Antimetabolites|antimetabolites|mesh-ancestor
25825476|NCT00005597|Alkylating Agents|alkylating agents|mesh-ancestor
25825477|NCT00005597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318351|NCT04965532|Propofol|propofol|mesh-list
25825478|NCT00005597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318374|NCT04965662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25318375|NCT04965662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25318376|NCT04965662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318377|NCT04965662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318378|NCT04965662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25318379|NCT04965662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25318380|NCT04965662|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25318381|NCT04965662|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25318382|NCT04965662|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24904295|NCT04356872|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24904297|NCT04356872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25318399|NCT04965298|Lansoprazole|lansoprazole|mesh-list
25318400|NCT04965298|Dexlansoprazole|dexlansoprazole|mesh-list
25318401|NCT04965298|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25318402|NCT04965298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25318403|NCT04965298|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25318404|NCT04965298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318408|NCT04965324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318410|NCT04965051|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25318411|NCT04965051|Insulin Aspart|insulin aspart|mesh-list
25318412|NCT04965051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25318413|NCT04965051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318414|NCT04964869|Epinephrine|epinephrine|mesh-list
25318415|NCT04964869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25318416|NCT04964869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25318417|NCT04964869|Adrenergic Agents|adrenergic agents|mesh-ancestor
24692564|NCT01415141|Antimetabolites|antimetabolites|mesh-ancestor
25318418|NCT04964869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25318419|NCT04964869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318420|NCT04964869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318421|NCT04964869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25318422|NCT04964869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25318440|NCT04964479|Pembrolizumab|pembrolizumab|mesh-list
25318441|NCT04964479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25318442|NCT04964479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24551428|NCT00726570|Tinzaparin|tinzaparin|mesh-list
25825479|NCT00005598|Azacitidine|azacitidine|mesh-list
25825480|NCT00005598|Amifostine|amifostine|mesh-list
25318450|NCT04964180|Indomethacin|indomethacin|mesh-list
25318451|NCT04964180|Lidocaine|lidocaine|mesh-list
25318452|NCT04964180|Anesthetics, Local|anesthetics, local|mesh-ancestor
25318453|NCT04964180|Anesthetics|anesthetics|mesh-ancestor
25318454|NCT04964180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25318455|NCT04964180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318456|NCT04964180|Sensory System Agents|sensory system agents|mesh-ancestor
25318457|NCT04964180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25318458|NCT04964180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25318459|NCT04964180|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25318460|NCT04964180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25318461|NCT04964180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25318462|NCT04964180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318463|NCT04964180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25318464|NCT04964180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25318465|NCT04964180|Analgesics|analgesics|mesh-ancestor
25318466|NCT04964180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25318467|NCT04964180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25318468|NCT04964180|Gout Suppressants|gout suppressants|mesh-ancestor
25318469|NCT04964180|Tocolytic Agents|tocolytic agents|mesh-ancestor
25318470|NCT04964180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25318471|NCT04964180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25318472|NCT04964180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318482|NCT04964414|Budesonide|budesonide|mesh-list
25318483|NCT04964414|Glucocorticoids|glucocorticoids|mesh-list
25318484|NCT04964414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25318485|NCT04964414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25318486|NCT04964414|Autonomic Agents|autonomic agents|mesh-ancestor
25318487|NCT04964414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25318488|NCT04964414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318489|NCT04964414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25318490|NCT04964414|Respiratory System Agents|respiratory system agents|mesh-ancestor
25318491|NCT04964414|Hormones|hormones|mesh-ancestor
25318492|NCT04964414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25318493|NCT04964219|Ketamine|ketamine|mesh-list
25318494|NCT04964219|Esketamine|esketamine|mesh-list
25318495|NCT04964219|Analgesics|analgesics|mesh-ancestor
25318496|NCT04964219|Sensory System Agents|sensory system agents|mesh-ancestor
25318497|NCT04964219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25318498|NCT04964219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318499|NCT04964219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25318500|NCT04964219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25318501|NCT04964219|Anesthetics, General|anesthetics, general|mesh-ancestor
25318502|NCT04964219|Anesthetics|anesthetics|mesh-ancestor
25318503|NCT04964219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25318504|NCT04964219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25318505|NCT04964219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25318506|NCT04964219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25318507|NCT04964219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318508|NCT04964219|Antidepressive Agents|antidepressive agents|mesh-ancestor
25318509|NCT04964219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25318511|NCT04963998|Trace Elements|trace elements|mesh-ancestor
25318512|NCT04963998|Micronutrients|micronutrients|mesh-ancestor
25318513|NCT04963998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318514|NCT04963673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
25318515|NCT04963673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318516|NCT04963673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318517|NCT04963712|Thymalfasin|thymalfasin|mesh-list
25318518|NCT04963712|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24904695|NCT04354376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24904696|NCT04354376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25069790|NCT03424135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24904697|NCT04354376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24904698|NCT04353986|Sofosbuvir|sofosbuvir|mesh-list
24904699|NCT04353986|Ledipasvir|ledipasvir|mesh-list
24904700|NCT04353986|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25318519|NCT04963712|Immunologic Factors|immunologic factors|mesh-ancestor
25318520|NCT04963712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318521|NCT04963881|Antibodies|antibodies|mesh-list
25318522|NCT04963881|Immunologic Factors|immunologic factors|mesh-ancestor
25318523|NCT04963881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318524|NCT04963595|Vinorelbine|vinorelbine|mesh-list
25318525|NCT04963595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25318526|NCT04963595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318527|NCT04963595|Tubulin Modulators|tubulin modulators|mesh-ancestor
25318528|NCT04963595|Antimitotic Agents|antimitotic agents|mesh-ancestor
25318529|NCT04963595|Mitosis Modulators|mitosis modulators|mesh-ancestor
25318530|NCT04963595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318531|NCT04963257|Aripiprazole|aripiprazole|mesh-list
25318532|NCT04963257|Fluvoxamine|fluvoxamine|mesh-list
25318533|NCT04963257|Sertraline|sertraline|mesh-list
25318534|NCT04963257|Antidepressive Agents|antidepressive agents|mesh-ancestor
25318535|NCT04963257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25318536|NCT04963257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25318537|NCT04963257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25318538|NCT04963257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25318539|NCT04963257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318540|NCT04963257|Dopamine Agonists|dopamine agonists|mesh-ancestor
25318541|NCT04963257|Dopamine Agents|dopamine agents|mesh-ancestor
25318542|NCT04963257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25318543|NCT04963257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318544|NCT04963257|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25318545|NCT04963257|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25318546|NCT04963257|Serotonin Agents|serotonin agents|mesh-ancestor
25318547|NCT04963257|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25318548|NCT04963257|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25318549|NCT04963257|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25318550|NCT04963257|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25318551|NCT04963257|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25318552|NCT04963257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25318553|NCT04963257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25318554|NCT04963257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25318555|NCT04963257|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25318556|NCT04963257|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25318557|NCT04963257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25318558|NCT04963257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318634|NCT04961970|Antimetabolites|antimetabolites|mesh-ancestor
25318559|NCT04963257|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25318560|NCT04963088|Capecitabine|capecitabine|mesh-list
25318561|NCT04963088|Oxaliplatin|oxaliplatin|mesh-list
25318562|NCT04963088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25318563|NCT04963088|Antimetabolites|antimetabolites|mesh-ancestor
25318564|NCT04963088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318565|NCT04963088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318566|NCT04962672|Anesthetics|anesthetics|mesh-list
25318567|NCT04962672|Propofol|propofol|mesh-list
25318568|NCT04962672|Sevoflurane|sevoflurane|mesh-list
25318569|NCT04962672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25318570|NCT04962672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318571|NCT04962672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25318572|NCT04962672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25318573|NCT04962672|Anesthetics, General|anesthetics, general|mesh-ancestor
25318574|NCT04962672|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25318575|NCT04962672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24905174|NCT04350671|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25318576|NCT04962958|Leucovorin|leucovorin|mesh-list
24623654|NCT01073007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25318577|NCT04962958|Fluorouracil|fluorouracil|mesh-list
25318578|NCT04962958|Oxaliplatin|oxaliplatin|mesh-list
25318579|NCT04962958|Antimetabolites|antimetabolites|mesh-ancestor
25318580|NCT04962958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318581|NCT04962958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25318582|NCT04962958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318583|NCT04962958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25318584|NCT04962958|Immunologic Factors|immunologic factors|mesh-ancestor
25318585|NCT04962958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318586|NCT04962958|Antidotes|antidotes|mesh-ancestor
25318587|NCT04962958|Protective Agents|protective agents|mesh-ancestor
25318588|NCT04962958|Vitamin B Complex|vitamin b complex|mesh-ancestor
25318589|NCT04962958|Vitamins|vitamins|mesh-ancestor
25318590|NCT04962958|Micronutrients|micronutrients|mesh-ancestor
25318591|NCT04962425|Trastuzumab|trastuzumab|mesh-list
25318592|NCT04962425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25318593|NCT04962425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318594|NCT04962451|Ticagrelor|ticagrelor|mesh-list
25318595|NCT04962451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25318596|NCT04962451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25318597|NCT04962451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25318598|NCT04962451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25318599|NCT04962451|Purinergic Agents|purinergic agents|mesh-ancestor
25318600|NCT04962451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25318601|NCT04962451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318602|NCT04962451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318603|NCT04962386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25318604|NCT04962386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25318605|NCT04962386|Hormones|hormones|mesh-list
25318606|NCT04962386|Estradiol|estradiol|mesh-list
25318607|NCT04962386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25318608|NCT04962386|Progesterone|progesterone|mesh-list
25318609|NCT04962386|Estrogens|estrogens|mesh-list
25318610|NCT04962386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25318611|NCT04962386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318612|NCT04962386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25318613|NCT04962386|Contraceptive Agents|contraceptive agents|mesh-ancestor
25318614|NCT04962386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25318615|NCT04962386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25318616|NCT04962386|Progestins|progestins|mesh-ancestor
25318617|NCT04962308|Vaccines|vaccines|mesh-list
25318618|NCT04962308|Immunologic Factors|immunologic factors|mesh-ancestor
25318619|NCT04962308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318620|NCT04962152|Nalbuphine|nalbuphine|mesh-list
25318621|NCT04962152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25318622|NCT04962152|Narcotics|narcotics|mesh-ancestor
25318623|NCT04962152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25318624|NCT04962152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318625|NCT04962152|Analgesics|analgesics|mesh-ancestor
25318626|NCT04962152|Sensory System Agents|sensory system agents|mesh-ancestor
25318627|NCT04962152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25318628|NCT04961970|Leucovorin|leucovorin|mesh-list
25318629|NCT04961970|Gemcitabine|gemcitabine|mesh-list
25318630|NCT04961970|Fluorouracil|fluorouracil|mesh-list
25318631|NCT04961970|Oxaliplatin|oxaliplatin|mesh-list
25318632|NCT04961970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318633|NCT04961970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25318635|NCT04961970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318636|NCT04961970|Antiviral Agents|antiviral agents|mesh-ancestor
25318637|NCT04961970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25318638|NCT04961970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318639|NCT04961970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25318640|NCT04961970|Immunologic Factors|immunologic factors|mesh-ancestor
25318641|NCT04961970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318642|NCT04961970|Antidotes|antidotes|mesh-ancestor
24623655|NCT01073007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825481|NCT00005598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24818538|NCT02089308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24818539|NCT02089308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318643|NCT04961970|Protective Agents|protective agents|mesh-ancestor
25318649|NCT04961684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25318650|NCT04961918|Durvalumab|durvalumab|mesh-list
25318651|NCT04961918|Lenvatinib|lenvatinib|mesh-list
25318652|NCT04961918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25318653|NCT04961918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318654|NCT04961918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25318655|NCT04961918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318656|NCT04961918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318657|NCT04961931|Empagliflozin|empagliflozin|mesh-list
24692927|NCT01417390|Cisplatin|cisplatin|mesh-list
25318658|NCT04961931|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25318659|NCT04961931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318660|NCT04961931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25318661|NCT04961931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318662|NCT04961788|Antibodies|antibodies|mesh-list
25318663|NCT04961788|Immunologic Factors|immunologic factors|mesh-ancestor
25318664|NCT04961788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318665|NCT04961632|Tamoxifen|tamoxifen|mesh-list
25318666|NCT04961632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25318667|NCT04961632|Hormone Antagonists|hormone antagonists|mesh-ancestor
25318668|NCT04961632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25318669|NCT04961632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318670|NCT04961632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25318671|NCT04961632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318672|NCT04961632|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25318673|NCT04961632|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25318674|NCT04961632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25318678|NCT04961268|Acetaminophen|acetaminophen|mesh-list
25318679|NCT04961268|Ibuprofen|ibuprofen|mesh-list
25318680|NCT04961268|Tramadol|tramadol|mesh-list
25318681|NCT04961268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25318682|NCT04961268|Analgesics|analgesics|mesh-ancestor
25318683|NCT04961268|Sensory System Agents|sensory system agents|mesh-ancestor
25318684|NCT04961268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25318685|NCT04961268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318686|NCT04961268|Antipyretics|antipyretics|mesh-ancestor
25318687|NCT04961268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25318688|NCT04961268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25318689|NCT04961268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25318690|NCT04961268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25318691|NCT04961268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318692|NCT04961268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318693|NCT04961268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25318694|NCT04961268|Narcotics|narcotics|mesh-ancestor
25318695|NCT04961268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25318696|NCT04961554|Anesthetics|anesthetics|mesh-list
25318697|NCT04961554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25318698|NCT04961554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318699|NCT04961307|Trastuzumab|trastuzumab|mesh-list
25318700|NCT04961307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25318701|NCT04961307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318702|NCT04961138|Lenvatinib|lenvatinib|mesh-list
25318703|NCT04961138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318704|NCT04961138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25318705|NCT04961138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905364|NCT04348006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24905365|NCT04348006|Antiemetics|antiemetics|mesh-ancestor
24905366|NCT04348006|Autonomic Agents|autonomic agents|mesh-ancestor
24905367|NCT04348006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24905368|NCT04348006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24905369|NCT04348006|Glucocorticoids|glucocorticoids|mesh-ancestor
24905371|NCT04348006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24905372|NCT04348006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25825482|NCT00005598|Antimetabolites|antimetabolites|mesh-ancestor
25318708|NCT04960943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25318709|NCT04960943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318784|NCT04958473|Axitinib|axitinib|mesh-list
25318719|NCT04960293|Hemostatics|hemostatics|mesh-ancestor
25318720|NCT04960293|Coagulants|coagulants|mesh-ancestor
25318721|NCT04959721|Triamcinolone|triamcinolone|mesh-list
25318722|NCT04959721|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25318723|NCT04959721|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25318724|NCT04959721|Bupivacaine|bupivacaine|mesh-list
25318725|NCT04959721|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25318726|NCT04959721|Anesthetics, Local|anesthetics, local|mesh-ancestor
25318727|NCT04959721|Anesthetics|anesthetics|mesh-ancestor
25318728|NCT04959721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25318729|NCT04959721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318730|NCT04959721|Sensory System Agents|sensory system agents|mesh-ancestor
24693044|NCT01418118|Dobutamine|dobutamine|mesh-list
25318731|NCT04959721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25318732|NCT04959721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25318733|NCT04959721|Glucocorticoids|glucocorticoids|mesh-ancestor
25318734|NCT04959721|Hormones|hormones|mesh-ancestor
25318735|NCT04959721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25318736|NCT04959721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25318737|NCT04959721|Immunologic Factors|immunologic factors|mesh-ancestor
25318738|NCT04959721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318739|NCT04959721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318740|NCT04959786|Ribavirin|ribavirin|mesh-list
25318741|NCT04959786|Ivermectin|ivermectin|mesh-list
25318742|NCT04959786|Nitazoxanide|nitazoxanide|mesh-list
25318743|NCT04959786|Antimetabolites|antimetabolites|mesh-ancestor
25318744|NCT04959786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318745|NCT04959786|Antiviral Agents|antiviral agents|mesh-ancestor
25318746|NCT04959786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25318747|NCT04959786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25318748|NCT04959578|Epoetin Alfa|epoetin alfa|mesh-list
25318749|NCT04959578|Darbepoetin alfa|darbepoetin alfa|mesh-list
25318750|NCT04959578|Hematinics|hematinics|mesh-ancestor
25318751|NCT04959591|Acetaminophen|acetaminophen|mesh-list
25318752|NCT04959591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25318753|NCT04959591|Analgesics|analgesics|mesh-ancestor
25318754|NCT04959591|Sensory System Agents|sensory system agents|mesh-ancestor
25318755|NCT04959591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25318756|NCT04959591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318757|NCT04959591|Antipyretics|antipyretics|mesh-ancestor
25318773|NCT04959500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318775|NCT04959409|Anesthetics, Local|anesthetics, local|mesh-ancestor
25318776|NCT04959409|Anesthetics|anesthetics|mesh-ancestor
25318777|NCT04959409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25318778|NCT04959409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318779|NCT04959409|Sensory System Agents|sensory system agents|mesh-ancestor
25318780|NCT04959409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25318781|NCT04958187|Mitogens|mitogens|mesh-list
25318782|NCT04958187|Mitosis Modulators|mitosis modulators|mesh-ancestor
24552905|NCT00728195|Olanzapine|olanzapine|mesh-list
25825483|NCT00005598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825484|NCT00005598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825485|NCT00005598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318783|NCT04958187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318785|NCT04958473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318786|NCT04958473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25318788|NCT04958473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318789|NCT04957940|SMOFlipid|smoflipid|mesh-list
25318790|NCT04957940|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25318791|NCT04957940|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25318792|NCT04957940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25318793|NCT04957927|Fluticasone|fluticasone|mesh-list
25318794|NCT04957927|Xhance|xhance|mesh-list
25318795|NCT04957927|Montelukast|montelukast|mesh-list
25318796|NCT04957927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25318797|NCT04957927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25318798|NCT04957927|Autonomic Agents|autonomic agents|mesh-ancestor
25318799|NCT04957927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25318800|NCT04957927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318801|NCT04957927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25318802|NCT04957927|Respiratory System Agents|respiratory system agents|mesh-ancestor
25318803|NCT04957927|Dermatologic Agents|dermatologic agents|mesh-ancestor
25318804|NCT04957927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25318805|NCT04957927|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25318817|NCT04957420|Dopamine Agonists|dopamine agonists|mesh-ancestor
25318818|NCT04957420|Dopamine Agents|dopamine agents|mesh-ancestor
25318819|NCT04957420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25318820|NCT04957420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318821|NCT04957420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318822|NCT04957329|Latanoprost|latanoprost|mesh-list
25318823|NCT04957329|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25318824|NCT04957329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25318825|NCT04957212|Carboplatin|carboplatin|mesh-list
25318826|NCT04957212|Docetaxel|docetaxel|mesh-list
25318836|NCT04956939|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25318837|NCT04956939|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25318838|NCT04956939|Dopamine Agents|dopamine agents|mesh-ancestor
25318839|NCT04956939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25318840|NCT04956939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318841|NCT04956939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318853|NCT04956419|Antifungal Agents|antifungal agents|mesh-ancestor
25318854|NCT04956419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25318855|NCT04956419|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25318856|NCT04956419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25318857|NCT04956419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318858|NCT04956419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318859|NCT04956419|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25318860|NCT04956419|Hormone Antagonists|hormone antagonists|mesh-ancestor
25318861|NCT04956419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25318862|NCT04956419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550963|NCT00723424|Digoxin|digoxin|mesh-list
25318863|NCT04956419|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25318864|NCT04956419|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25318865|NCT04956094|Uric Acid|uric acid|mesh-list
25318866|NCT04956094|Antioxidants|antioxidants|mesh-ancestor
25318867|NCT04956094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318868|NCT04956094|Protective Agents|protective agents|mesh-ancestor
25318869|NCT04956094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318870|NCT04955678|Sorbitol|sorbitol|mesh-list
25318871|NCT04955678|Calcium|calcium|mesh-list
25318872|NCT04955678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25318873|NCT04955678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318874|NCT04955678|Cathartics|cathartics|mesh-ancestor
25318875|NCT04955678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25318883|NCT04955834|Insulin|insulin|mesh-list
25318884|NCT04955834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25318885|NCT04955834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825486|NCT00005598|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25318886|NCT04955262|Nivolumab|nivolumab|mesh-list
25318887|NCT04955262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25318888|NCT04955262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318889|NCT04955262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25318890|NCT04955262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318918|NCT04954638|Sodium Hypochlorite|sodium hypochlorite|mesh-list
25318919|NCT04954638|Chlorine dioxide|chlorine dioxide|mesh-list
25318920|NCT04954638|Eusol|eusol|mesh-list
25318921|NCT04954638|Disinfectants|disinfectants|mesh-ancestor
25318922|NCT04954638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25318923|NCT04954638|Dental Disinfectants|dental disinfectants|mesh-ancestor
25318924|NCT04953754|Melatonin|melatonin|mesh-list
25318925|NCT04953754|Antioxidants|antioxidants|mesh-ancestor
25318926|NCT04953754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825487|NCT00005598|Protective Agents|protective agents|mesh-ancestor
25191518|NCT02782338|Sensory System Agents|sensory system agents|mesh-ancestor
25191519|NCT02782338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191520|NCT02782338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191521|NCT02782338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25191522|NCT02782338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25191523|NCT02782338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25191524|NCT02782338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25191525|NCT02782338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191526|NCT02782260|Dipyridamole|dipyridamole|mesh-list
25191527|NCT02782260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25191528|NCT02782260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25191529|NCT02782260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318927|NCT04953754|Protective Agents|protective agents|mesh-ancestor
25318928|NCT04953754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318929|NCT04953754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25318938|NCT04953871|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
25318939|NCT04953871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25318940|NCT04953741|Fluticasone|fluticasone|mesh-list
25318941|NCT04953741|Xhance|xhance|mesh-list
25318942|NCT04953741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25318943|NCT04953741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25318944|NCT04953741|Autonomic Agents|autonomic agents|mesh-ancestor
25318945|NCT04953741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25318946|NCT04953741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318947|NCT04953741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25318948|NCT04953741|Respiratory System Agents|respiratory system agents|mesh-ancestor
25318949|NCT04953741|Dermatologic Agents|dermatologic agents|mesh-ancestor
25318950|NCT04953741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25318951|NCT04954014|Bevacizumab|bevacizumab|mesh-list
25318952|NCT04954014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25318953|NCT04954014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25318954|NCT04954014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25318955|NCT04954014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25318956|NCT04954014|Growth Substances|growth substances|mesh-ancestor
24569920|NCT00802321|Dutasteride|dutasteride|mesh-list
25318957|NCT04954014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25318958|NCT04954014|Growth Inhibitors|growth inhibitors|mesh-ancestor
25318959|NCT04954040|Azithromycin|azithromycin|mesh-list
25318960|NCT04954040|Hydroxychloroquine|hydroxychloroquine|mesh-list
25318961|NCT04954040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25318962|NCT04954040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25318963|NCT04954040|Antimalarials|antimalarials|mesh-ancestor
25318964|NCT04954040|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25318965|NCT04954040|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25318966|NCT04954040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25318967|NCT04954040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25318984|NCT04952792|Apixaban|apixaban|mesh-list
25318985|NCT04952792|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25318986|NCT04952792|Antithrombins|antithrombins|mesh-ancestor
25318987|NCT04952792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25318988|NCT04952792|Protease Inhibitors|protease inhibitors|mesh-ancestor
25318989|NCT04952792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25648855|NCT01485380|Sensory System Agents|sensory system agents|mesh-ancestor
25648856|NCT01485380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25648857|NCT01485380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25648858|NCT01485380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25648859|NCT01485380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25648860|NCT01485380|Adrenergic Agents|adrenergic agents|mesh-ancestor
25648861|NCT01485380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25648862|NCT01485380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648863|NCT01485393|Dexmedetomidine|dexmedetomidine|mesh-list
25648864|NCT01485393|Zolpidem|zolpidem|mesh-list
25648865|NCT01485393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25648866|NCT01485393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25648867|NCT01485393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648868|NCT01485393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25648869|NCT01485393|Analgesics|analgesics|mesh-ancestor
25318990|NCT04952792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319018|NCT04952194|Dopamine Agents|dopamine agents|mesh-ancestor
25319019|NCT04952194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25319020|NCT04952194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319021|NCT04952194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319022|NCT04952194|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25319023|NCT04952194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25319024|NCT04952194|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25319025|NCT04952207|Sofosbuvir|sofosbuvir|mesh-list
25319026|NCT04952207|Antiviral Agents|antiviral agents|mesh-list
25319027|NCT04952207|Grazoprevir|grazoprevir|mesh-list
25319028|NCT04952207|Ledipasvir|ledipasvir|mesh-list
25319029|NCT04952207|Velpatasvir|velpatasvir|mesh-list
25319030|NCT04952207|Asunaprevir|asunaprevir|mesh-list
25319031|NCT04952207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25319032|NCT04952207|Protease Inhibitors|protease inhibitors|mesh-ancestor
25319033|NCT04952207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25319034|NCT04952207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319035|NCT04952272|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
25319036|NCT04952272|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25319037|NCT04952272|Immunologic Factors|immunologic factors|mesh-ancestor
25319038|NCT04952272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319039|NCT04951856|Evolocumab|evolocumab|mesh-list
25319040|NCT04951856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25319041|NCT04951856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25319042|NCT04951856|Antimetabolites|antimetabolites|mesh-ancestor
25319043|NCT04951856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319044|NCT04951856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25319045|NCT04952129|Selenium|selenium|mesh-list
25319046|NCT04952129|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
25319047|NCT04952129|Antioxidants|antioxidants|mesh-ancestor
25319048|NCT04952129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319049|NCT04952129|Protective Agents|protective agents|mesh-ancestor
25319050|NCT04952129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319051|NCT04952129|Trace Elements|trace elements|mesh-ancestor
25319052|NCT04952129|Micronutrients|micronutrients|mesh-ancestor
25319053|NCT04952129|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25319054|NCT04952129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319055|NCT04952051|Folic Acid|folic acid|mesh-list
25319056|NCT04952051|Vitamin B Complex|vitamin b complex|mesh-list
25319057|NCT04952051|Amlodipine|amlodipine|mesh-list
25319058|NCT04952051|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25319059|NCT04952051|Enalapril|enalapril|mesh-list
25319060|NCT04952051|Enalaprilat|enalaprilat|mesh-list
25319061|NCT04952051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25319062|NCT04952051|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25319063|NCT04952051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25319064|NCT04952051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319065|NCT04952051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25319066|NCT04952051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319067|NCT04952051|Vasodilator Agents|vasodilator agents|mesh-ancestor
25319068|NCT04952051|Diuretics|diuretics|mesh-ancestor
25319069|NCT04952051|Natriuretic Agents|natriuretic agents|mesh-ancestor
25319070|NCT04952051|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25319071|NCT04952051|Hematinics|hematinics|mesh-ancestor
25319072|NCT04952051|Vitamins|vitamins|mesh-ancestor
25319073|NCT04952051|Micronutrients|micronutrients|mesh-ancestor
25319074|NCT04952051|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25319075|NCT04952051|Protease Inhibitors|protease inhibitors|mesh-ancestor
25319076|NCT04952051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25319077|NCT04951791|SMOFlipid|smoflipid|mesh-list
25319078|NCT04951791|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25319079|NCT04951791|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25319080|NCT04951791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25319081|NCT04951713|Clarithromycin|clarithromycin|mesh-list
25319082|NCT04951713|Rifampin|rifampin|mesh-list
25319083|NCT04951713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25319084|NCT04951713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25319085|NCT04951713|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25319086|NCT04951713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25319087|NCT04951713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319088|NCT04951713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25319089|NCT04951713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25319090|NCT04951713|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25319091|NCT04951713|Antitubercular Agents|antitubercular agents|mesh-ancestor
25319092|NCT04951713|Leprostatic Agents|leprostatic agents|mesh-ancestor
25319093|NCT04951713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25319094|NCT04951713|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25319095|NCT04951713|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25319096|NCT04951713|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25319097|NCT04951713|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25319098|NCT04951713|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25319099|NCT04951713|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25319100|NCT04951752|Ropivacaine|ropivacaine|mesh-list
25319101|NCT04951752|Anesthetics, Local|anesthetics, local|mesh-ancestor
25319102|NCT04951752|Anesthetics|anesthetics|mesh-ancestor
25319103|NCT04951752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25319104|NCT04951752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319105|NCT04951752|Sensory System Agents|sensory system agents|mesh-ancestor
25319106|NCT04951752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25319107|NCT04951505|Cefepime|cefepime|mesh-list
25319108|NCT04951505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25319109|NCT04951505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25825488|NCT00005598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319110|NCT04951726|Neostigmine|neostigmine|mesh-list
25319111|NCT04951726|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25319112|NCT04951726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25319113|NCT04951726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319114|NCT04951726|Cholinergic Agents|cholinergic agents|mesh-ancestor
25319115|NCT04951726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25319116|NCT04951726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319117|NCT04951726|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25319128|NCT04951167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319129|NCT04951167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319130|NCT04951167|Sympathomimetics|sympathomimetics|mesh-ancestor
25319131|NCT04951167|Autonomic Agents|autonomic agents|mesh-ancestor
25319132|NCT04951167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25319133|NCT04951167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25319135|NCT04950933|Anticonvulsants|anticonvulsants|mesh-ancestor
25319136|NCT04950933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25319137|NCT04950933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25319138|NCT04950933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25319139|NCT04950933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319140|NCT04950933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319141|NCT04950933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25319142|NCT04950933|Protective Agents|protective agents|mesh-ancestor
25319143|NCT04951128|Anesthetics|anesthetics|mesh-list
25319144|NCT04951128|Anesthetics, Local|anesthetics, local|mesh-list
25319145|NCT04951128|Tranexamic Acid|tranexamic acid|mesh-list
25319146|NCT04951128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25319147|NCT04951128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319148|NCT04951128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25319149|NCT04951128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25319150|NCT04951128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825489|NCT00005599|Paclitaxel|paclitaxel|mesh-list
25191718|NCT02781753|Interferon alpha-2|interferon alpha-2|mesh-list
25191719|NCT02781753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25191720|NCT02781753|Antiviral Agents|antiviral agents|mesh-ancestor
25191721|NCT02781753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25191722|NCT02781753|Immunologic Factors|immunologic factors|mesh-ancestor
25319151|NCT04951128|Hemostatics|hemostatics|mesh-ancestor
25319152|NCT04951128|Coagulants|coagulants|mesh-ancestor
25319153|NCT04951128|Sensory System Agents|sensory system agents|mesh-ancestor
25319154|NCT04951128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25319155|NCT04951232|Cinepazide|cinepazide|mesh-list
25319156|NCT04951232|Vasodilator Agents|vasodilator agents|mesh-ancestor
25319167|NCT04950569|Simendan|simendan|mesh-list
25319168|NCT04950569|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25319169|NCT04950569|Vasodilator Agents|vasodilator agents|mesh-ancestor
25319170|NCT04950569|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25319171|NCT04950569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25319172|NCT04950569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25319256|NCT04948788|Oxaliplatin|oxaliplatin|mesh-list
25319173|NCT04950569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319174|NCT04950569|Protective Agents|protective agents|mesh-ancestor
25319175|NCT04950569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319176|NCT04950647|Nitrofurazone|nitrofurazone|mesh-list
25319177|NCT04950647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25319178|NCT04950205|Sevoflurane|sevoflurane|mesh-list
25319179|NCT04950205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25319180|NCT04950205|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25319181|NCT04950205|Anesthetics, General|anesthetics, general|mesh-ancestor
25319182|NCT04950205|Anesthetics|anesthetics|mesh-ancestor
25319183|NCT04950205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24555560|NCT00742066|Felodipine|felodipine|mesh-list
25319184|NCT04950205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319185|NCT04950049|Dexamethasone|dexamethasone|mesh-list
25319186|NCT04950049|Dexamethasone acetate|dexamethasone acetate|mesh-list
25319187|NCT04950049|BB 1101|bb 1101|mesh-list
25319188|NCT04950049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25319189|NCT04950049|Antiemetics|antiemetics|mesh-ancestor
25319190|NCT04950049|Autonomic Agents|autonomic agents|mesh-ancestor
25319191|NCT04950049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25319192|NCT04950049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319267|NCT04948957|Nitroglycerin|nitroglycerin|mesh-list
25319197|NCT04950049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25319198|NCT04950049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319200|NCT04950049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25319201|NCT04950049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319202|NCT04950400|Apatinib|apatinib|mesh-list
25319203|NCT04950400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319204|NCT04950400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25319205|NCT04950400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25319206|NCT04950400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319207|NCT04950530|Emtricitabine|emtricitabine|mesh-list
25319208|NCT04950530|Antiviral Agents|antiviral agents|mesh-ancestor
25319209|NCT04950530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25319210|NCT04950530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25319211|NCT04950530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25319212|NCT04950530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25319213|NCT04950530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319214|NCT04950530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25319215|NCT04950530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25319221|NCT04949932|Turmeric extract|turmeric extract|mesh-list
25319222|NCT04949932|Antioxidants|antioxidants|mesh-ancestor
25319223|NCT04949932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319224|NCT04949932|Protective Agents|protective agents|mesh-ancestor
25319225|NCT04949932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319226|NCT04949464|Nicotine|nicotine|mesh-list
25319227|NCT04949464|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25319228|NCT04949464|Autonomic Agents|autonomic agents|mesh-ancestor
25319229|NCT04949464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25319230|NCT04949464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319231|NCT04949464|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25648870|NCT01485393|Sensory System Agents|sensory system agents|mesh-ancestor
25648871|NCT01485393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25648872|NCT01485393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25648873|NCT01485393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25648874|NCT01485393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25319232|NCT04949464|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25319233|NCT04949464|Cholinergic Agents|cholinergic agents|mesh-ancestor
25319234|NCT04949464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25319235|NCT04949464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319236|NCT04949282|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25319237|NCT04949282|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25319238|NCT04949282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319239|NCT04949347|Glycerol|glycerol|mesh-list
25319240|NCT04949347|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25319241|NCT04949347|Protective Agents|protective agents|mesh-ancestor
25319242|NCT04949347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319243|NCT04948814|Vancomycin|vancomycin|mesh-list
25319244|NCT04948814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25319245|NCT04948814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25319246|NCT04948749|Sirolimus|sirolimus|mesh-list
25319247|NCT04948749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25319248|NCT04948749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25319249|NCT04948749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25319250|NCT04948749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319251|NCT04948749|Antifungal Agents|antifungal agents|mesh-ancestor
25319252|NCT04948749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25319253|NCT04948749|Immunologic Factors|immunologic factors|mesh-ancestor
25319254|NCT04948749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076416|NCT03373305|Piperidine|piperidine|mesh-list
25319255|NCT04948788|Gemcitabine|gemcitabine|mesh-list
25319257|NCT04948788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25319258|NCT04948788|Antimetabolites|antimetabolites|mesh-ancestor
25319259|NCT04948788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319260|NCT04948788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319261|NCT04948788|Antiviral Agents|antiviral agents|mesh-ancestor
25319262|NCT04948788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25319263|NCT04948788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25319264|NCT04948788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25319265|NCT04948788|Immunologic Factors|immunologic factors|mesh-ancestor
25319266|NCT04948788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319278|NCT04948801|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25319279|NCT04948801|Velpatasvir|velpatasvir|mesh-list
25319280|NCT04948801|Antiviral Agents|antiviral agents|mesh-ancestor
25319281|NCT04948801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25319292|NCT04948567|Magnesium Sulfate|magnesium sulfate|mesh-list
25319293|NCT04948567|Analgesics|analgesics|mesh-ancestor
25319294|NCT04948567|Sensory System Agents|sensory system agents|mesh-ancestor
25319295|NCT04948567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25319296|NCT04948567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319297|NCT04948567|Anesthetics|anesthetics|mesh-ancestor
25319298|NCT04948567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25319299|NCT04948567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25319300|NCT04948567|Anticonvulsants|anticonvulsants|mesh-ancestor
25319301|NCT04948567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25319302|NCT04948567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25319303|NCT04948567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319304|NCT04948567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25319305|NCT04948567|Tocolytic Agents|tocolytic agents|mesh-ancestor
25319306|NCT04948567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25319307|NCT04948203|Sirolimus|sirolimus|mesh-list
25319308|NCT04948203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25319309|NCT04948203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25319310|NCT04948203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25319311|NCT04948203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319312|NCT04948203|Antifungal Agents|antifungal agents|mesh-ancestor
25319313|NCT04948203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25319314|NCT04948203|Immunologic Factors|immunologic factors|mesh-ancestor
25319315|NCT04948203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319316|NCT04948294|Pyrithione zinc|pyrithione zinc|mesh-list
25319317|NCT04948294|Keratolytic Agents|keratolytic agents|mesh-ancestor
25319318|NCT04948294|Dermatologic Agents|dermatologic agents|mesh-ancestor
25319319|NCT04948125|Apatinib|apatinib|mesh-list
25319320|NCT04948125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319321|NCT04948125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25319322|NCT04948125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25319323|NCT04948125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319324|NCT04948385|Propofol|propofol|mesh-list
25319325|NCT04948385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25319326|NCT04948385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25319327|NCT04948385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319328|NCT04948385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25191820|NCT02780479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25191821|NCT02780479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25191822|NCT02780479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25191823|NCT02780505|Ascorbic Acid|ascorbic acid|mesh-list
25191825|NCT02780505|Micronutrients|micronutrients|mesh-ancestor
25191826|NCT02780505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191827|NCT02780505|Antioxidants|antioxidants|mesh-ancestor
25191828|NCT02780505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191829|NCT02780505|Protective Agents|protective agents|mesh-ancestor
25191830|NCT02780102|Methylphenidate|methylphenidate|mesh-list
25191831|NCT02780102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25191832|NCT02780102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191833|NCT02780102|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25191834|NCT02780102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25191835|NCT02780102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25191836|NCT02780102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319329|NCT04948385|Anesthetics, General|anesthetics, general|mesh-ancestor
25319330|NCT04948385|Anesthetics|anesthetics|mesh-ancestor
25319331|NCT04948372|Terlipressin|terlipressin|mesh-list
25319332|NCT04948372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25319333|NCT04948372|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25319334|NCT04947748|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25319335|NCT04947748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25319336|NCT04948164|Naproxen|naproxen|mesh-list
25319337|NCT04948164|Sumatriptan|sumatriptan|mesh-list
25319338|NCT04948164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25319339|NCT04948164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25319340|NCT04948164|Analgesics|analgesics|mesh-ancestor
25319341|NCT04948164|Sensory System Agents|sensory system agents|mesh-ancestor
25319342|NCT04948164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25319343|NCT04948164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319344|NCT04948164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25319345|NCT04948164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25319346|NCT04948164|Gout Suppressants|gout suppressants|mesh-ancestor
25319347|NCT04948164|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25319348|NCT04948164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25319349|NCT04948164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319350|NCT04948164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25319351|NCT04948164|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25319352|NCT04948164|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25319353|NCT04948164|Serotonin Agents|serotonin agents|mesh-ancestor
25319354|NCT04948164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25319355|NCT04947956|Apatinib|apatinib|mesh-list
25319356|NCT04947956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319357|NCT04947956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25319358|NCT04947956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25319359|NCT04947956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319360|NCT04948151|Sildenafil Citrate|sildenafil citrate|mesh-list
25319361|NCT04948151|Vasodilator Agents|vasodilator agents|mesh-ancestor
25319362|NCT04948151|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25319363|NCT04948151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25319364|NCT04948151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25319365|NCT04948151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648875|NCT01485393|Adrenergic Agents|adrenergic agents|mesh-ancestor
25648876|NCT01485393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25648877|NCT01485393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648878|NCT01485393|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25648879|NCT01485393|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25648880|NCT01485393|GABA Agonists|gaba agonists|mesh-ancestor
25648881|NCT01485393|GABA Agents|gaba agents|mesh-ancestor
25648882|NCT01485588|Immunoconjugates|immunoconjugates|mesh-list
25648883|NCT01485588|Immunologic Factors|immunologic factors|mesh-ancestor
25648884|NCT01485588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648885|NCT01485640|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25648886|NCT01485640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25648887|NCT01485640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25648888|NCT01485640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25648889|NCT01485640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648890|NCT01485640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25648891|NCT01485640|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25648892|NCT01485640|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25191895|NCT02779959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25191896|NCT02779959|Dopamine Agents|dopamine agents|mesh-ancestor
25191897|NCT02779959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25191898|NCT02779959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191899|NCT02779634|Coenzyme Q10|coenzyme q10|mesh-list
25191900|NCT02779634|Micronutrients|micronutrients|mesh-ancestor
25191901|NCT02779634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191902|NCT02779634|Vitamins|vitamins|mesh-ancestor
25191903|NCT02779348|Warfarin|warfarin|mesh-list
25191904|NCT02779348|Anticoagulants|anticoagulants|mesh-ancestor
25191905|NCT02779608|Docetaxel|docetaxel|mesh-list
25191906|NCT02779608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25191907|NCT02779608|Tubulin Modulators|tubulin modulators|mesh-ancestor
25191908|NCT02779608|Antimitotic Agents|antimitotic agents|mesh-ancestor
25319366|NCT04948151|Urological Agents|urological agents|mesh-ancestor
25319367|NCT04947826|Antibodies|antibodies|mesh-list
25319368|NCT04947826|Immunoglobulins|immunoglobulins|mesh-list
25319369|NCT04947826|Immunologic Factors|immunologic factors|mesh-ancestor
25319370|NCT04947826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319371|NCT04947566|Ibuprofen|ibuprofen|mesh-list
25319372|NCT04947566|Naproxen|naproxen|mesh-list
25319373|NCT04947566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25319374|NCT04947566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25319375|NCT04947566|Analgesics|analgesics|mesh-ancestor
25319376|NCT04947566|Sensory System Agents|sensory system agents|mesh-ancestor
25319377|NCT04947566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25319378|NCT04947566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319379|NCT04947566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25319380|NCT04947566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25319381|NCT04947566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25319382|NCT04947566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25319383|NCT04947566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319384|NCT04947566|Gout Suppressants|gout suppressants|mesh-ancestor
25319385|NCT04947423|Scopolamine|scopolamine|mesh-list
25319386|NCT04947423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25319387|NCT04947423|Antiemetics|antiemetics|mesh-ancestor
25319388|NCT04947423|Autonomic Agents|autonomic agents|mesh-ancestor
25319389|NCT04947423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25319390|NCT04947423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319391|NCT04947423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25319392|NCT04947423|Mydriatics|mydriatics|mesh-ancestor
25319393|NCT04947423|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25319394|NCT04947423|Cholinergic Agents|cholinergic agents|mesh-ancestor
25319395|NCT04947423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25319396|NCT04947423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319397|NCT04947423|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25319398|NCT04947267|Epinephrine|epinephrine|mesh-list
25319399|NCT04947267|Mepivacaine|mepivacaine|mesh-list
25319400|NCT04947267|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25319401|NCT04947267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25319402|NCT04947267|Adrenergic Agents|adrenergic agents|mesh-ancestor
25825490|NCT00005599|Bryostatin 1|bryostatin 1|mesh-list
25319403|NCT04947267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25319404|NCT04947267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319405|NCT04947267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319406|NCT04947267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25319407|NCT04947267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25319408|NCT04947267|Autonomic Agents|autonomic agents|mesh-ancestor
25319409|NCT04947267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25648893|NCT01485640|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25648894|NCT01485640|Adrenergic Agents|adrenergic agents|mesh-ancestor
25648895|NCT01485640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25648896|NCT01485640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648897|NCT01485640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25648898|NCT01485640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25648899|NCT01485640|Serotonin Agents|serotonin agents|mesh-ancestor
25648900|NCT01485640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25648901|NCT01485640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25648902|NCT01485640|Dopamine Agents|dopamine agents|mesh-ancestor
25648903|NCT01485796|Immunoglobulins|immunoglobulins|mesh-list
25648904|NCT01485796|Antibodies|antibodies|mesh-list
25648905|NCT01485796|gamma-Globulins|gamma-globulins|mesh-list
25648906|NCT01485796|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25319410|NCT04947267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25319411|NCT04947267|Respiratory System Agents|respiratory system agents|mesh-ancestor
25319412|NCT04947267|Mydriatics|mydriatics|mesh-ancestor
25319413|NCT04947267|Sympathomimetics|sympathomimetics|mesh-ancestor
25319414|NCT04947267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25319415|NCT04947267|Anesthetics, Local|anesthetics, local|mesh-ancestor
25319441|NCT04947345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25319442|NCT04947345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25319443|NCT04947345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319444|NCT04947345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25319445|NCT04947345|Anesthetics, General|anesthetics, general|mesh-ancestor
25319446|NCT04947345|Anesthetics|anesthetics|mesh-ancestor
25319447|NCT04947189|Dexamethasone|dexamethasone|mesh-list
25319448|NCT04947189|Docetaxel|docetaxel|mesh-list
25319449|NCT04947189|Seviteronel|seviteronel|mesh-list
25319450|NCT04947189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25319451|NCT04947189|Antiemetics|antiemetics|mesh-ancestor
25319452|NCT04947189|Autonomic Agents|autonomic agents|mesh-ancestor
25319454|NCT04947189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319455|NCT04947189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25319456|NCT04947189|Glucocorticoids|glucocorticoids|mesh-ancestor
25319457|NCT04947189|Hormones|hormones|mesh-ancestor
25319458|NCT04947189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25319459|NCT04947189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25319460|NCT04947189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319461|NCT04947189|Tubulin Modulators|tubulin modulators|mesh-ancestor
25319462|NCT04947189|Antimitotic Agents|antimitotic agents|mesh-ancestor
25319463|NCT04947189|Mitosis Modulators|mitosis modulators|mesh-ancestor
24694264|NCT01424709|Mitosis Modulators|mitosis modulators|mesh-ancestor
25319464|NCT04947189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319465|NCT04947189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25319466|NCT04947189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25319502|NCT04947241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25319503|NCT04947241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25319504|NCT04947241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25319505|NCT04947241|Immunologic Factors|immunologic factors|mesh-ancestor
25319506|NCT04947241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319508|NCT04946825|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25319509|NCT04946825|Autonomic Agents|autonomic agents|mesh-ancestor
25319510|NCT04946825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25319511|NCT04946825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319512|NCT04946825|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25319513|NCT04946825|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25319514|NCT04946825|Cholinergic Agents|cholinergic agents|mesh-ancestor
25319515|NCT04946825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25319516|NCT04946825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319522|NCT04946734|Aspirin|aspirin|mesh-list
25319523|NCT04946734|Clopidogrel|clopidogrel|mesh-list
25319524|NCT04946734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25319525|NCT04946734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25319526|NCT04946734|Analgesics|analgesics|mesh-ancestor
25319527|NCT04946734|Sensory System Agents|sensory system agents|mesh-ancestor
25319528|NCT04946734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25319529|NCT04946734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319530|NCT04946734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25319531|NCT04946734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25319532|NCT04946734|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25319533|NCT04946734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25319534|NCT04946734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319535|NCT04946734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25319536|NCT04946734|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25319537|NCT04946734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25319538|NCT04946734|Antipyretics|antipyretics|mesh-ancestor
25319539|NCT04946734|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25319540|NCT04946734|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25319541|NCT04946734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25319542|NCT04946734|Purinergic Agents|purinergic agents|mesh-ancestor
25319543|NCT04946734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25319544|NCT04946461|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25319545|NCT04946461|Dextroamphetamine|dextroamphetamine|mesh-list
25319546|NCT04946461|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25319547|NCT04946461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319548|NCT04946461|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25319549|NCT04946461|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25319550|NCT04946461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25319551|NCT04946461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319552|NCT04946461|Dopamine Agents|dopamine agents|mesh-ancestor
25191983|NCT02779283|Antiviral Agents|antiviral agents|mesh-ancestor
25319553|NCT04946461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25319555|NCT04946669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25319556|NCT04946669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319557|NCT04946669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319558|NCT04946669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25319559|NCT04946669|Immunologic Factors|immunologic factors|mesh-ancestor
25319560|NCT04946669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319561|NCT04946669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25319562|NCT04946383|Dasatinib|dasatinib|mesh-list
25319563|NCT04946383|Quercetin|quercetin|mesh-list
25319564|NCT04946383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319585|NCT04945954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25319586|NCT04945954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25319587|NCT04945954|Alkylating Agents|alkylating agents|mesh-ancestor
25319588|NCT04945954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319589|NCT04945954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319590|NCT04945954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25319591|NCT04946162|Tadalafil|tadalafil|mesh-list
25319592|NCT04946162|Vasodilator Agents|vasodilator agents|mesh-ancestor
25319593|NCT04946162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24694378|NCT01425320|Adapalene|adapalene|mesh-list
25319594|NCT04946162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25319595|NCT04946162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25319596|NCT04946162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319597|NCT04946162|Urological Agents|urological agents|mesh-ancestor
25319598|NCT04946227|Paclitaxel|paclitaxel|mesh-list
25319599|NCT04946227|Pembrolizumab|pembrolizumab|mesh-list
25319600|NCT04946227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25319601|NCT04946227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319602|NCT04946227|Tubulin Modulators|tubulin modulators|mesh-ancestor
25319603|NCT04946227|Antimitotic Agents|antimitotic agents|mesh-ancestor
25319604|NCT04946227|Mitosis Modulators|mitosis modulators|mesh-ancestor
25319605|NCT04946227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319606|NCT04946227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25319607|NCT04946123|Selenium|selenium|mesh-list
25319608|NCT04946123|Antioxidants|antioxidants|mesh-ancestor
25319609|NCT04946123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319610|NCT04946123|Protective Agents|protective agents|mesh-ancestor
25319611|NCT04946123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319612|NCT04946123|Trace Elements|trace elements|mesh-ancestor
25319613|NCT04946123|Micronutrients|micronutrients|mesh-ancestor
25319614|NCT04945824|Dexamethasone|dexamethasone|mesh-list
25319615|NCT04945824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25319616|NCT04945824|Antiemetics|antiemetics|mesh-ancestor
25319617|NCT04945824|Autonomic Agents|autonomic agents|mesh-ancestor
25319618|NCT04945824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25319619|NCT04945824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319620|NCT04945824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25319621|NCT04945824|Glucocorticoids|glucocorticoids|mesh-ancestor
25319622|NCT04945824|Hormones|hormones|mesh-ancestor
25319623|NCT04945824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25319624|NCT04945824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25319625|NCT04945824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008391|NCT05208931|Mitogens|mitogens|mesh-list
25319626|NCT04945681|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25319627|NCT04945681|Immunologic Factors|immunologic factors|mesh-ancestor
25319628|NCT04945681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319629|NCT04945694|Fentanyl|fentanyl|mesh-list
25319630|NCT04945694|Propofol|propofol|mesh-list
25319631|NCT04945694|Sevoflurane|sevoflurane|mesh-list
25319632|NCT04945694|Atracurium|atracurium|mesh-list
25319633|NCT04945694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25319634|NCT04945694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25319635|NCT04945694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319636|NCT04945694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25319637|NCT04945694|Anesthetics, General|anesthetics, general|mesh-ancestor
25319638|NCT04945694|Anesthetics|anesthetics|mesh-ancestor
25319640|NCT04945694|Narcotics|narcotics|mesh-ancestor
25319641|NCT04945694|Analgesics|analgesics|mesh-ancestor
25319642|NCT04945694|Sensory System Agents|sensory system agents|mesh-ancestor
25319643|NCT04945694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25319644|NCT04945694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25319645|NCT04945694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25319646|NCT04945694|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25648907|NCT01485796|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25319647|NCT04945694|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25319648|NCT04945694|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25319649|NCT04945694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25319650|NCT04945694|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25319651|NCT04945694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25319652|NCT04945694|Cholinergic Agents|cholinergic agents|mesh-ancestor
25319653|NCT04945694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25319654|NCT04945694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319655|NCT04945577|Vitamin D|vitamin d|mesh-list
25319656|NCT04945577|Vitamins|vitamins|mesh-ancestor
25319657|NCT04945577|Micronutrients|micronutrients|mesh-ancestor
25319658|NCT04945577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319659|NCT04945577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25319660|NCT04945226|Finasteride|finasteride|mesh-list
24694479|NCT01425658|Autonomic Agents|autonomic agents|mesh-ancestor
25319661|NCT04945226|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25319662|NCT04945226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25319663|NCT04945226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25319664|NCT04945226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319665|NCT04945226|Hormone Antagonists|hormone antagonists|mesh-ancestor
25319666|NCT04945226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25319667|NCT04945226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319668|NCT04945226|Urological Agents|urological agents|mesh-ancestor
25319669|NCT04945434|Methamphetamine|methamphetamine|mesh-list
25319670|NCT04945434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25319671|NCT04945434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319672|NCT04945434|Sympathomimetics|sympathomimetics|mesh-ancestor
25319673|NCT04945434|Autonomic Agents|autonomic agents|mesh-ancestor
25319674|NCT04945434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25319675|NCT04945434|Dopamine Agents|dopamine agents|mesh-ancestor
25319676|NCT04945434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25319677|NCT04945434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319678|NCT04945434|Adrenergic Agents|adrenergic agents|mesh-ancestor
25319679|NCT04945434|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25319680|NCT04945434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25319681|NCT04945434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25319682|NCT04945434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25319683|NCT04945070|Insulin|insulin|mesh-list
25319684|NCT04945070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25319685|NCT04945070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319686|NCT04945096|Cytarabine|cytarabine|mesh-list
25319687|NCT04945096|Acetylcysteine|acetylcysteine|mesh-list
25319688|NCT04945096|Cyclosporine|cyclosporine|mesh-list
25319689|NCT04945096|Cyclophosphamide|cyclophosphamide|mesh-list
25319690|NCT04945096|Busulfan|busulfan|mesh-list
25319691|NCT04945096|Semustine|semustine|mesh-list
25319692|NCT04945096|Decitabine|decitabine|mesh-list
25319693|NCT04945096|Cyclosporins|cyclosporins|mesh-list
25319694|NCT04945096|Thymoglobulin|thymoglobulin|mesh-list
25319695|NCT04945096|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25319696|NCT04945096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25319697|NCT04945096|Immunologic Factors|immunologic factors|mesh-ancestor
25319698|NCT04945096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319699|NCT04945096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25319700|NCT04945096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25319701|NCT04945096|Alkylating Agents|alkylating agents|mesh-ancestor
25319702|NCT04945096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319703|NCT04945096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319704|NCT04945096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25319705|NCT04945096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25319706|NCT04945096|Antimetabolites|antimetabolites|mesh-ancestor
25319707|NCT04945096|Antiviral Agents|antiviral agents|mesh-ancestor
25319708|NCT04945096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25319709|NCT04945096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25319710|NCT04945096|Antifungal Agents|antifungal agents|mesh-ancestor
25319711|NCT04945096|Dermatologic Agents|dermatologic agents|mesh-ancestor
25319712|NCT04945096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25319713|NCT04945096|Expectorants|expectorants|mesh-ancestor
25319718|NCT04944836|Clomiphene|clomiphene|mesh-list
25319719|NCT04944836|Enclomiphene|enclomiphene|mesh-list
25319720|NCT04944836|Zuclomiphene|zuclomiphene|mesh-list
25319721|NCT04944836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25319722|NCT04944836|Hormone Antagonists|hormone antagonists|mesh-ancestor
25319723|NCT04944836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25319724|NCT04944836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319725|NCT04944836|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25319726|NCT04944836|Fertility Agents|fertility agents|mesh-ancestor
25192146|NCT02778594|Levodopa|levodopa|mesh-list
25319727|NCT04944836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25319728|NCT04944836|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25319729|NCT04944836|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25319730|NCT04944966|Lumefantrine|lumefantrine|mesh-list
25319731|NCT04944966|Artemether|artemether|mesh-list
25319732|NCT04944966|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25319733|NCT04944966|Antimalarials|antimalarials|mesh-ancestor
25319734|NCT04944966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25319735|NCT04944966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25319736|NCT04944966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25319737|NCT04944381|Vaccines|vaccines|mesh-list
25319738|NCT04944381|Immunologic Factors|immunologic factors|mesh-ancestor
25319739|NCT04944381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319740|NCT04944602|Omalizumab|omalizumab|mesh-list
25319741|NCT04944602|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25319742|NCT04944602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25319743|NCT04944602|Respiratory System Agents|respiratory system agents|mesh-ancestor
25319744|NCT04944524|Methotrexate|methotrexate|mesh-list
25319745|NCT04944524|Tofacitinib|tofacitinib|mesh-list
25319746|NCT04944524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25319747|NCT04944524|Abortifacient Agents|abortifacient agents|mesh-ancestor
25319748|NCT04944524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25319749|NCT04944524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319750|NCT04944524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25319751|NCT04944524|Antimetabolites|antimetabolites|mesh-ancestor
25319752|NCT04944524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319753|NCT04944524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319754|NCT04944524|Dermatologic Agents|dermatologic agents|mesh-ancestor
25319755|NCT04944524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25319756|NCT04944524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25319757|NCT04944524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25319758|NCT04944524|Immunologic Factors|immunologic factors|mesh-ancestor
25319759|NCT04944524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25319760|NCT04944524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25319761|NCT04944524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25319762|NCT04943952|Asparaginase|asparaginase|mesh-list
25319763|NCT04943952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319764|NCT04944069|Bevacizumab|bevacizumab|mesh-list
25319765|NCT04944069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25319766|NCT04944069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319767|NCT04944069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25319768|NCT04944069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25319769|NCT04944069|Growth Substances|growth substances|mesh-ancestor
25319770|NCT04944069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319771|NCT04944069|Growth Inhibitors|growth inhibitors|mesh-ancestor
25319772|NCT04944641|Anticonvulsants|anticonvulsants|mesh-list
25319773|NCT04944082|Ivermectin|ivermectin|mesh-list
25319774|NCT04944082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25319775|NCT04944082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25319779|NCT04944212|Vitamin D|vitamin d|mesh-list
25319780|NCT04944212|Vitamins|vitamins|mesh-ancestor
25319781|NCT04944212|Micronutrients|micronutrients|mesh-ancestor
25319782|NCT04944212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319783|NCT04944212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25319784|NCT04943692|Metformin|metformin|mesh-list
25319785|NCT04943692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25319786|NCT04943692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319787|NCT04944173|Durvalumab|durvalumab|mesh-list
25319788|NCT04944173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25319789|NCT04944173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319790|NCT04943588|Antibodies|antibodies|mesh-list
25319800|NCT04943653|Antimitotic Agents|antimitotic agents|mesh-ancestor
25319801|NCT04943653|Mitosis Modulators|mitosis modulators|mesh-ancestor
25319802|NCT04943653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319803|NCT04943653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25319804|NCT04943653|Antimetabolites|antimetabolites|mesh-ancestor
25319805|NCT04943536|Bicalutamide|bicalutamide|mesh-list
25319806|NCT04943536|Androgen Antagonists|androgen antagonists|mesh-ancestor
25319807|NCT04943536|Hormone Antagonists|hormone antagonists|mesh-ancestor
25319808|NCT04943536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25319809|NCT04943536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319810|NCT04943536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319814|NCT04943237|Sulfasalazine|sulfasalazine|mesh-list
25319815|NCT04943237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25319816|NCT04943237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25648908|NCT01485796|Immunologic Factors|immunologic factors|mesh-ancestor
25319817|NCT04943237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25319818|NCT04943237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25319819|NCT04943237|Analgesics|analgesics|mesh-ancestor
25319820|NCT04943237|Sensory System Agents|sensory system agents|mesh-ancestor
25319821|NCT04943237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25319822|NCT04943237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319823|NCT04943237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25319824|NCT04943237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25319825|NCT04943029|Paclitaxel|paclitaxel|mesh-list
25319826|NCT04943029|Carboplatin|carboplatin|mesh-list
25319827|NCT04943029|Pemetrexed|pemetrexed|mesh-list
25319828|NCT04943029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25319829|NCT04943029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319830|NCT04943029|Tubulin Modulators|tubulin modulators|mesh-ancestor
25319831|NCT04943029|Antimitotic Agents|antimitotic agents|mesh-ancestor
25319832|NCT04943029|Mitosis Modulators|mitosis modulators|mesh-ancestor
25319833|NCT04943029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319834|NCT04943029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25319835|NCT04943029|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25319836|NCT04943029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24882914|NCT04769206|Cholinergic Agents|cholinergic agents|mesh-ancestor
25319842|NCT04942899|Capecitabine|capecitabine|mesh-list
25319843|NCT04942899|Letrozole|letrozole|mesh-list
25319844|NCT04942899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25319845|NCT04942899|Antimetabolites|antimetabolites|mesh-ancestor
25319846|NCT04942899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319847|NCT04942899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319848|NCT04942899|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25319849|NCT04942899|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25319850|NCT04942899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25319851|NCT04942899|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25319852|NCT04942899|Hormone Antagonists|hormone antagonists|mesh-ancestor
25319853|NCT04942899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25319854|NCT04942899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319855|NCT04943146|Aspirin|aspirin|mesh-list
25319856|NCT04943146|Prednisone|prednisone|mesh-list
25319857|NCT04943146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25319858|NCT04943146|Glucocorticoids|glucocorticoids|mesh-ancestor
25319859|NCT04943146|Hormones|hormones|mesh-ancestor
25319860|NCT04943146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25319861|NCT04943146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319862|NCT04943146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25320144|NCT04939662|Bevacizumab|bevacizumab|mesh-list
25319874|NCT04943146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25319876|NCT04943146|Antipyretics|antipyretics|mesh-ancestor
25319882|NCT04942886|Entecavir|entecavir|mesh-list
25319883|NCT04942886|Antiviral Agents|antiviral agents|mesh-ancestor
25319884|NCT04942886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25319892|NCT04942860|Methotrexate|methotrexate|mesh-list
25319893|NCT04942860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25319894|NCT04942860|Abortifacient Agents|abortifacient agents|mesh-ancestor
25319895|NCT04942860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25319896|NCT04942860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319897|NCT04942860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25319898|NCT04942860|Antimetabolites|antimetabolites|mesh-ancestor
25319899|NCT04942860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319900|NCT04942860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319901|NCT04942860|Dermatologic Agents|dermatologic agents|mesh-ancestor
25319902|NCT04942860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25319903|NCT04942860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25319904|NCT04942860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25319905|NCT04942860|Immunologic Factors|immunologic factors|mesh-ancestor
25319906|NCT04942860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25319907|NCT04942860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25319908|NCT04942834|Amiodarone|amiodarone|mesh-list
24560333|NCT02912572|Avelumab|avelumab|mesh-list
25319909|NCT04942834|Sotalol|sotalol|mesh-list
25319910|NCT04942834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
25319911|NCT04942834|Dronedarone|dronedarone|mesh-list
25319912|NCT04942834|Propafenone|propafenone|mesh-list
25319913|NCT04942834|Vasodilator Agents|vasodilator agents|mesh-ancestor
25319914|NCT04942834|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25319915|NCT04942834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25319916|NCT04942834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319917|NCT04942834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25319918|NCT04942834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25192257|NCT02777710|Durvalumab|durvalumab|mesh-list
25192258|NCT02777710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25192259|NCT02777710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25192260|NCT02777723|Hyaluronic Acid|hyaluronic acid|mesh-list
25192261|NCT02777723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25192262|NCT02777723|Immunologic Factors|immunologic factors|mesh-ancestor
25192263|NCT02777723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192264|NCT02777723|Viscosupplements|viscosupplements|mesh-ancestor
25192265|NCT02777723|Protective Agents|protective agents|mesh-ancestor
25192267|NCT02777411|Immunologic Factors|immunologic factors|mesh-ancestor
25192268|NCT02777411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192269|NCT02777489|Perindopril|perindopril|mesh-list
25192270|NCT02777489|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25319919|NCT04942834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25319920|NCT04942834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25319921|NCT04942834|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25319922|NCT04942834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25319923|NCT04942834|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25319924|NCT04942834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25319925|NCT04942834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25319926|NCT04942834|Adrenergic Agents|adrenergic agents|mesh-ancestor
25319927|NCT04942834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25319928|NCT04942834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319929|NCT04942834|Sympatholytics|sympatholytics|mesh-ancestor
25319930|NCT04942834|Autonomic Agents|autonomic agents|mesh-ancestor
25319931|NCT04942834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25319932|NCT04942834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25319933|NCT04942652|Itraconazole|itraconazole|mesh-list
25319934|NCT04942652|Esomeprazole|esomeprazole|mesh-list
25319935|NCT04942652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25319937|NCT04942652|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25319938|NCT04942652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25319939|NCT04942652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319940|NCT04942652|Antifungal Agents|antifungal agents|mesh-ancestor
25319941|NCT04942652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25319942|NCT04942652|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25319943|NCT04942652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25319944|NCT04942652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25319945|NCT04942652|Hormone Antagonists|hormone antagonists|mesh-ancestor
25319946|NCT04942652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25319947|NCT04942652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319948|NCT04942652|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25319950|NCT04942769|Antioxidants|antioxidants|mesh-ancestor
25319951|NCT04942769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25319952|NCT04942769|Protective Agents|protective agents|mesh-ancestor
25319953|NCT04942769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319954|NCT04942769|Trace Elements|trace elements|mesh-ancestor
25319955|NCT04942769|Micronutrients|micronutrients|mesh-ancestor
25319956|NCT04942496|Chlorhexidine|chlorhexidine|mesh-list
25319957|NCT04942496|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25319958|NCT04942496|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25319959|NCT04942496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25319960|NCT04942496|Disinfectants|disinfectants|mesh-ancestor
25319961|NCT04942496|Dermatologic Agents|dermatologic agents|mesh-ancestor
25319962|NCT04942301|Endostar protein|endostar protein|mesh-list
25319963|NCT04942301|Endostatins|endostatins|mesh-list
25319964|NCT04942301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25319965|NCT04942301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25319966|NCT04942301|Growth Substances|growth substances|mesh-ancestor
25319967|NCT04942301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648909|NCT01485796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648910|NCT01485887|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25648911|NCT01485887|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25648912|NCT01485887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25648913|NCT01485887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25648914|NCT01485887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648915|NCT01485887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25648916|NCT01485887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648917|NCT01485887|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25648918|NCT01485887|Antidepressive Agents|antidepressive agents|mesh-ancestor
25648919|NCT01485887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25648920|NCT01485991|Simeprevir|simeprevir|mesh-list
25319972|NCT04942002|Methylprednisolone|methylprednisolone|mesh-list
25319973|NCT04942002|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25319974|NCT04942002|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25319976|NCT04942002|Prednisolone acetate|prednisolone acetate|mesh-list
25319977|NCT04942002|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25319978|NCT04942002|Prednisolone phosphate|prednisolone phosphate|mesh-list
25319979|NCT04942002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25319980|NCT04942002|Antiemetics|antiemetics|mesh-ancestor
25319981|NCT04942002|Autonomic Agents|autonomic agents|mesh-ancestor
24571618|NCT00811083|Succimer|succimer|mesh-list
25319982|NCT04942002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25319983|NCT04942002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25319984|NCT04942002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25319985|NCT04942002|Glucocorticoids|glucocorticoids|mesh-ancestor
25319986|NCT04942002|Hormones|hormones|mesh-ancestor
25319987|NCT04942002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25319988|NCT04942002|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25319989|NCT04942002|Protective Agents|protective agents|mesh-ancestor
25319990|NCT04942002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25319991|NCT04942002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319992|NCT04941872|FAPI-46|fapi-46|mesh-list
25319993|NCT04941872|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25319994|NCT04941872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825491|NCT00005599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25825492|NCT00005599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25319995|NCT04941898|Factor VIII|factor viii|mesh-list
25319996|NCT04941898|BAX 855|bax 855|mesh-list
25319997|NCT04941898|Coagulants|coagulants|mesh-ancestor
25319998|NCT04941833|Desogestrel|desogestrel|mesh-list
25319999|NCT04941833|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25320000|NCT04941833|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25320001|NCT04941833|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25320002|NCT04941833|Contraceptive Agents|contraceptive agents|mesh-ancestor
25320003|NCT04941833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25320004|NCT04941833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320005|NCT04941833|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25320006|NCT04941833|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25320007|NCT04941833|Progestins|progestins|mesh-ancestor
25320009|NCT04941833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25320010|NCT04941911|Octreotide|octreotide|mesh-list
25320011|NCT04941911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25320012|NCT04941911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25320013|NCT04941911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25320014|NCT04941885|Cyclophosphamide|cyclophosphamide|mesh-list
25320015|NCT04941885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25320016|NCT04941885|Immunologic Factors|immunologic factors|mesh-ancestor
25320017|NCT04941885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320018|NCT04941885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25320019|NCT04941885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25320020|NCT04941885|Alkylating Agents|alkylating agents|mesh-ancestor
25320021|NCT04941885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320022|NCT04941885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25320023|NCT04941885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25320024|NCT04941846|Nimodipine|nimodipine|mesh-list
25320025|NCT04941846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25320026|NCT04941846|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25320027|NCT04941846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25320028|NCT04941846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320029|NCT04941846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25320030|NCT04941846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320031|NCT04941846|Vasodilator Agents|vasodilator agents|mesh-ancestor
25320032|NCT04941625|Cystatins|cystatins|mesh-list
25320033|NCT04941625|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25320034|NCT04941625|Protease Inhibitors|protease inhibitors|mesh-ancestor
25320035|NCT04941625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25648921|NCT01485991|Antiviral Agents|antiviral agents|mesh-ancestor
25320036|NCT04941625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320037|NCT04941417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25320038|NCT04941417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320039|NCT04941417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25320040|NCT04941131|Chlorhexidine|chlorhexidine|mesh-list
25320041|NCT04941131|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25320042|NCT04941131|Povidone-Iodine|povidone-iodine|mesh-list
25320043|NCT04941131|Povidone|povidone|mesh-list
25320044|NCT04941131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25320045|NCT04941131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25320046|NCT04941131|Disinfectants|disinfectants|mesh-ancestor
25320047|NCT04941131|Dermatologic Agents|dermatologic agents|mesh-ancestor
25320048|NCT04941131|Plasma Substitutes|plasma substitutes|mesh-ancestor
25320049|NCT04941131|Blood Substitutes|blood substitutes|mesh-ancestor
25320050|NCT04941118|Anesthetics|anesthetics|mesh-list
25320051|NCT04941118|Anesthetics, Local|anesthetics, local|mesh-list
25320052|NCT04941118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25320053|NCT04941118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320054|NCT04941118|Sensory System Agents|sensory system agents|mesh-ancestor
25320055|NCT04941118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25320056|NCT04940689|Lidocaine|lidocaine|mesh-list
25320057|NCT04940689|Dexmedetomidine|dexmedetomidine|mesh-list
25320058|NCT04940689|Remifentanil|remifentanil|mesh-list
25320059|NCT04940689|Anesthetics, Local|anesthetics, local|mesh-ancestor
25320060|NCT04940689|Anesthetics|anesthetics|mesh-ancestor
25320061|NCT04940689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25320062|NCT04940689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320063|NCT04940689|Sensory System Agents|sensory system agents|mesh-ancestor
25825493|NCT00005599|Tubulin Modulators|tubulin modulators|mesh-ancestor
25825494|NCT00005599|Antimitotic Agents|antimitotic agents|mesh-ancestor
25825495|NCT00005599|Mitosis Modulators|mitosis modulators|mesh-ancestor
25825496|NCT00005599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825497|NCT00005599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25320064|NCT04940689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25320065|NCT04940689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25320066|NCT04940689|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25320067|NCT04940689|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25320068|NCT04940689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25320069|NCT04940689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320087|NCT04940546|Capecitabine|capecitabine|mesh-list
25320088|NCT04940546|Oxaliplatin|oxaliplatin|mesh-list
25320558|NCT04934852|Pseudoephedrine|pseudoephedrine|mesh-list
25320089|NCT04940546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25320090|NCT04940546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25320091|NCT04940546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25320092|NCT04940546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25320093|NCT04940546|Growth Substances|growth substances|mesh-ancestor
25320094|NCT04940546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320095|NCT04940546|Growth Inhibitors|growth inhibitors|mesh-ancestor
25320096|NCT04940546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25320097|NCT04940546|Antimetabolites|antimetabolites|mesh-ancestor
25320098|NCT04940546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320099|NCT04940273|Remifentanil|remifentanil|mesh-list
25320100|NCT04940273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25320101|NCT04940273|Narcotics|narcotics|mesh-ancestor
25320102|NCT04940273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25320103|NCT04940273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320104|NCT04940273|Analgesics|analgesics|mesh-ancestor
25320105|NCT04940273|Sensory System Agents|sensory system agents|mesh-ancestor
25320106|NCT04940273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25320107|NCT04940299|Nivolumab|nivolumab|mesh-list
25320108|NCT04940299|Ipilimumab|ipilimumab|mesh-list
25320109|NCT04940299|Immunoglobulins|immunoglobulins|mesh-list
25320110|NCT04940299|Immunoglobulin G|immunoglobulin g|mesh-list
25320111|NCT04940299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25320112|NCT04940299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25320113|NCT04940299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25320114|NCT04940299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320115|NCT04940299|Immunologic Factors|immunologic factors|mesh-ancestor
25320116|NCT04940299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320117|NCT04940143|Botulinum Toxins|botulinum toxins|mesh-list
25320118|NCT04940143|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25825498|NCT00005599|Immunologic Factors|immunologic factors|mesh-ancestor
25192465|NCT02776202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192466|NCT02776202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25192467|NCT02776202|Immunologic Factors|immunologic factors|mesh-ancestor
25192468|NCT02776202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192469|NCT02776202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25192470|NCT02776202|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25192471|NCT02776202|Antitubercular Agents|antitubercular agents|mesh-ancestor
25192472|NCT02776202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25192473|NCT02776202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25192474|NCT02776202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429401|NCT00243815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24429402|NCT00243815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320119|NCT04940143|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25320120|NCT04940143|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25320121|NCT04940143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25320122|NCT04940143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320123|NCT04940143|Cholinergic Agents|cholinergic agents|mesh-ancestor
25320124|NCT04940143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25320125|NCT04940143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320126|NCT04940143|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25320127|NCT04940143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25825499|NCT00005599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320145|NCT04939662|Olaparib|olaparib|mesh-list
25320146|NCT04939662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25320147|NCT04939662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25320148|NCT04939662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25320149|NCT04939662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25320150|NCT04939662|Growth Substances|growth substances|mesh-ancestor
25320151|NCT04939662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320152|NCT04939662|Growth Inhibitors|growth inhibitors|mesh-ancestor
25320153|NCT04939662|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25320154|NCT04939662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25320155|NCT04939662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320156|NCT04939857|Trimetazidine|trimetazidine|mesh-list
25320157|NCT04939857|Vasodilator Agents|vasodilator agents|mesh-ancestor
25320158|NCT04939779|Delpazolid|delpazolid|mesh-list
25320159|NCT04939779|Oxazolidinones|oxazolidinones|mesh-list
25320160|NCT04939779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25320161|NCT04939779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25320162|NCT04939779|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25320163|NCT04939779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25320164|NCT04939779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320165|NCT04939675|Lamotrigine|lamotrigine|mesh-list
25320166|NCT04939675|Zonisamide|zonisamide|mesh-list
25320167|NCT04939675|Levetiracetam|levetiracetam|mesh-list
25320168|NCT04939675|Anticonvulsants|anticonvulsants|mesh-ancestor
25320169|NCT04939675|Nootropic Agents|nootropic agents|mesh-ancestor
25320170|NCT04939675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25320171|NCT04939675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25320172|NCT04939675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320173|NCT04939675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25320174|NCT04939675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320175|NCT04939675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25320176|NCT04939675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25320177|NCT04939675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25320178|NCT04939675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25320179|NCT04939675|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25320180|NCT04939766|Insulin|insulin|mesh-list
25320181|NCT04939766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25320182|NCT04939766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648922|NCT01485991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25648923|NCT01485991|Protease Inhibitors|protease inhibitors|mesh-ancestor
25648924|NCT01485991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25648925|NCT01485991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648926|NCT01486043|Metformin|metformin|mesh-list
25648927|NCT01486043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25648928|NCT01486043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648929|NCT01486615|Melatonin|melatonin|mesh-list
25648930|NCT01486615|Alprazolam|alprazolam|mesh-list
25648931|NCT01486615|Azaperone|azaperone|mesh-list
25648932|NCT01486615|Antioxidants|antioxidants|mesh-ancestor
25648933|NCT01486615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648934|NCT01486615|Protective Agents|protective agents|mesh-ancestor
25825500|NCT00005601|Cytarabine|cytarabine|mesh-list
25320187|NCT04939649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25320188|NCT04939649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320189|NCT04939649|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25320190|NCT04939649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25320191|NCT04939649|Anesthetics, General|anesthetics, general|mesh-ancestor
25320192|NCT04939649|Anesthetics|anesthetics|mesh-ancestor
25320193|NCT04939649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25320194|NCT04939649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25320195|NCT04939649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25320196|NCT04939649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25320197|NCT04939649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320198|NCT04939649|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25320199|NCT04939649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25320200|NCT04939649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25320201|NCT04939649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25320202|NCT04939649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25320203|NCT04939649|GABA Modulators|gaba modulators|mesh-ancestor
25320204|NCT04939649|GABA Agents|gaba agents|mesh-ancestor
25320205|NCT04939480|Atezolizumab|atezolizumab|mesh-list
25320206|NCT04939480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585241|NCT00884546|Antiemetics|antiemetics|mesh-ancestor
25320207|NCT04939441|Tenofovir|tenofovir|mesh-list
25320208|NCT04939441|Antiviral Agents|antiviral agents|mesh-ancestor
25320209|NCT04939441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25320210|NCT04939441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25320211|NCT04939441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25320212|NCT04939441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25320213|NCT04939441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320214|NCT04939441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25320215|NCT04939441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25320216|NCT04938583|Paclitaxel|paclitaxel|mesh-list
25320217|NCT04938583|Bevacizumab|bevacizumab|mesh-list
25320218|NCT04938583|Carboplatin|carboplatin|mesh-list
25320219|NCT04938583|Oregovomab|oregovomab|mesh-list
25320220|NCT04938583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25320221|NCT04938583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25320222|NCT04938583|Tubulin Modulators|tubulin modulators|mesh-ancestor
25320223|NCT04938583|Antimitotic Agents|antimitotic agents|mesh-ancestor
25320224|NCT04938583|Mitosis Modulators|mitosis modulators|mesh-ancestor
25320225|NCT04938583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320226|NCT04938583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25320227|NCT04938583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25320228|NCT04938583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25320229|NCT04938583|Growth Substances|growth substances|mesh-ancestor
25320230|NCT04938583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320231|NCT04938583|Growth Inhibitors|growth inhibitors|mesh-ancestor
25320232|NCT04938713|Ketamine|ketamine|mesh-list
25320233|NCT04938713|Esketamine|esketamine|mesh-list
25320234|NCT04938713|Analgesics|analgesics|mesh-ancestor
25320235|NCT04938713|Sensory System Agents|sensory system agents|mesh-ancestor
25320236|NCT04938713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25320237|NCT04938713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320238|NCT04938713|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25320239|NCT04938713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25320240|NCT04938713|Anesthetics, General|anesthetics, general|mesh-ancestor
25320241|NCT04938713|Anesthetics|anesthetics|mesh-ancestor
25320242|NCT04938713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25320243|NCT04938713|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25320244|NCT04938713|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25320245|NCT04938713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25320246|NCT04938713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320247|NCT04938713|Antidepressive Agents|antidepressive agents|mesh-ancestor
25320248|NCT04938713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25320249|NCT04938453|Nintedanib|nintedanib|mesh-list
25320250|NCT04938453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25320251|NCT04938453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25320252|NCT04938453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321118|NCT04924647|Lenalidomide|lenalidomide|mesh-list
25320253|NCT04938453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192578|NCT02775734|Antidotes|antidotes|mesh-ancestor
25192579|NCT02776397|Vitamin E|vitamin e|mesh-list
25192580|NCT02776397|Tocopherols|tocopherols|mesh-list
25192581|NCT02776397|alpha-Tocopherol|alpha-tocopherol|mesh-list
25192582|NCT02776397|Vitamins|vitamins|mesh-ancestor
25320257|NCT04938297|Rituximab|rituximab|mesh-list
25320258|NCT04938297|Lenalidomide|lenalidomide|mesh-list
25320259|NCT04938297|Zanubrutinib|zanubrutinib|mesh-list
25320260|NCT04938297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25320261|NCT04938297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25320262|NCT04938297|Immunologic Factors|immunologic factors|mesh-ancestor
25320263|NCT04938297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320264|NCT04938297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25320265|NCT04938297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25320266|NCT04938297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25320267|NCT04938297|Growth Substances|growth substances|mesh-ancestor
25320268|NCT04938297|Growth Inhibitors|growth inhibitors|mesh-ancestor
25320269|NCT04938297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25320270|NCT04938297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25320271|NCT04938297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320272|NCT04938011|Progesterone|progesterone|mesh-list
25320273|NCT04938011|Progestins|progestins|mesh-ancestor
25320274|NCT04938011|Hormones|hormones|mesh-ancestor
25320275|NCT04938011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25825501|NCT00005601|Dexamethasone|dexamethasone|mesh-list
25825502|NCT00005601|Rituximab|rituximab|mesh-list
25825503|NCT00005601|Cisplatin|cisplatin|mesh-list
25825504|NCT00005601|Sargramostim|sargramostim|mesh-list
25320276|NCT04938011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320277|NCT04938037|Methylprednisolone|methylprednisolone|mesh-list
25320278|NCT04938037|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25320279|NCT04938037|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25320280|NCT04938037|Prednisolone|prednisolone|mesh-list
25320281|NCT04938037|Prednisolone acetate|prednisolone acetate|mesh-list
25320282|NCT04938037|Bupivacaine|bupivacaine|mesh-list
25320283|NCT04938037|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25320284|NCT04938037|Prednisolone phosphate|prednisolone phosphate|mesh-list
25320285|NCT04938037|Anesthetics, Local|anesthetics, local|mesh-ancestor
25320286|NCT04938037|Anesthetics|anesthetics|mesh-ancestor
25320287|NCT04938037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25320288|NCT04938037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320289|NCT04938037|Sensory System Agents|sensory system agents|mesh-ancestor
25320290|NCT04938037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25320291|NCT04938037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25320292|NCT04938037|Antiemetics|antiemetics|mesh-ancestor
25320293|NCT04938037|Autonomic Agents|autonomic agents|mesh-ancestor
25320294|NCT04938037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25320295|NCT04938037|Glucocorticoids|glucocorticoids|mesh-ancestor
25320296|NCT04938037|Hormones|hormones|mesh-ancestor
25320297|NCT04938037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25320298|NCT04938037|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25320299|NCT04938037|Protective Agents|protective agents|mesh-ancestor
25320300|NCT04938037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25320301|NCT04938037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25320302|NCT04937946|Fentanyl|fentanyl|mesh-list
25320303|NCT04937946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25320304|NCT04937946|Narcotics|narcotics|mesh-ancestor
25320305|NCT04937946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25320306|NCT04937946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320307|NCT04937946|Analgesics|analgesics|mesh-ancestor
25320308|NCT04937946|Sensory System Agents|sensory system agents|mesh-ancestor
25320309|NCT04937946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25320310|NCT04937946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25320311|NCT04937946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25320312|NCT04937946|Anesthetics, General|anesthetics, general|mesh-ancestor
25320313|NCT04937946|Anesthetics|anesthetics|mesh-ancestor
25648935|NCT01486615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648936|NCT01486615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25648937|NCT01486615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25648938|NCT01486615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25648939|NCT01486615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25825505|NCT00005601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25320314|NCT04938102|Botulinum Toxins|botulinum toxins|mesh-list
25320315|NCT04938102|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25320316|NCT04938102|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25320317|NCT04938102|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25320318|NCT04938102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25320319|NCT04938102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320320|NCT04938102|Cholinergic Agents|cholinergic agents|mesh-ancestor
25320321|NCT04938102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25320322|NCT04938102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320323|NCT04938102|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25320324|NCT04938102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25320326|NCT04937907|Benazepril|benazepril|mesh-list
25320327|NCT04937907|Antimalarials|antimalarials|mesh-ancestor
25320328|NCT04937907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25320329|NCT04937907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25320330|NCT04937907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25320331|NCT04937907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25320332|NCT04937907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320333|NCT04937907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25320334|NCT04937907|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25320335|NCT04937907|Protease Inhibitors|protease inhibitors|mesh-ancestor
25320336|NCT04937907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25320337|NCT04937673|Paclitaxel|paclitaxel|mesh-list
25320338|NCT04937673|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25320339|NCT04937673|Cisplatin|cisplatin|mesh-list
25320340|NCT04937673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25320341|NCT04937673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25320342|NCT04937673|Tubulin Modulators|tubulin modulators|mesh-ancestor
25320343|NCT04937673|Antimitotic Agents|antimitotic agents|mesh-ancestor
25320344|NCT04937673|Mitosis Modulators|mitosis modulators|mesh-ancestor
25320345|NCT04937673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320346|NCT04937894|Tigecycline|tigecycline|mesh-list
25320347|NCT04937894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25825506|NCT00005601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572023|NCT00812760|Levodopa|levodopa|mesh-list
25825507|NCT00005601|Immunologic Factors|immunologic factors|mesh-ancestor
25320348|NCT04937894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25320349|NCT04937894|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25320350|NCT04937894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25320351|NCT04937894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320352|NCT04937569|Ivermectin|ivermectin|mesh-list
25320353|NCT04937569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25320354|NCT04937569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25320355|NCT04937634|Melphalan|melphalan|mesh-list
25320356|NCT04937634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25320357|NCT04937634|Alkylating Agents|alkylating agents|mesh-ancestor
25320358|NCT04937634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320359|NCT04937634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25320360|NCT04937634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25320361|NCT04937634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25320362|NCT04937634|Immunologic Factors|immunologic factors|mesh-ancestor
25320363|NCT04937634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320364|NCT04937140|Antibodies|antibodies|mesh-list
25320365|NCT04937140|Immunologic Factors|immunologic factors|mesh-ancestor
25320366|NCT04937140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320367|NCT04937101|Chlorpheniramine|chlorpheniramine|mesh-list
25320368|NCT04937101|Codeine|codeine|mesh-list
25320369|NCT04937101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25320370|NCT04937101|Narcotics|narcotics|mesh-ancestor
25320371|NCT04937101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25320372|NCT04937101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320373|NCT04937101|Analgesics|analgesics|mesh-ancestor
25320374|NCT04937101|Sensory System Agents|sensory system agents|mesh-ancestor
25320375|NCT04937101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25320376|NCT04937101|Antitussive Agents|antitussive agents|mesh-ancestor
25320377|NCT04937101|Respiratory System Agents|respiratory system agents|mesh-ancestor
25320378|NCT04937101|Antipruritics|antipruritics|mesh-ancestor
25320379|NCT04937101|Dermatologic Agents|dermatologic agents|mesh-ancestor
25320380|NCT04937101|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25320381|NCT04937101|Histamine Antagonists|histamine antagonists|mesh-ancestor
25320382|NCT04937101|Histamine Agents|histamine agents|mesh-ancestor
25320383|NCT04937101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25320384|NCT04937101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320385|NCT04937101|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25320386|NCT04937023|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25320387|NCT04937023|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24696547|NCT01429935|Ibuprofen|ibuprofen|mesh-list
25320388|NCT04937023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25320389|NCT04936711|Bupivacaine|bupivacaine|mesh-list
25320390|NCT04936711|Anesthetics, Local|anesthetics, local|mesh-ancestor
25320391|NCT04936711|Anesthetics|anesthetics|mesh-ancestor
25320392|NCT04936711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25320393|NCT04936711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320394|NCT04936711|Sensory System Agents|sensory system agents|mesh-ancestor
25320395|NCT04936711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25320396|NCT04936841|Pembrolizumab|pembrolizumab|mesh-list
25320397|NCT04936841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25320398|NCT04936841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825508|NCT00005601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825509|NCT00005601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25825510|NCT00005601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25320399|NCT04936971|Mycophenolic Acid|mycophenolic acid|mesh-list
25320400|NCT04936971|Everolimus|everolimus|mesh-list
25320401|NCT04936971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25320402|NCT04936971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25320403|NCT04936971|Immunologic Factors|immunologic factors|mesh-ancestor
25320404|NCT04936971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320405|NCT04936971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25320406|NCT04936971|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25320407|NCT04936971|Antitubercular Agents|antitubercular agents|mesh-ancestor
25320408|NCT04936971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25320409|NCT04936971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25320410|NCT04936971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25320411|NCT04936971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320412|NCT04936282|Tacrolimus|tacrolimus|mesh-list
25320413|NCT04936282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25320414|NCT04936282|Immunologic Factors|immunologic factors|mesh-ancestor
25320415|NCT04936282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320416|NCT04936282|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25320417|NCT04936282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25320418|NCT04936282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320419|NCT04936295|Fulvestrant|fulvestrant|mesh-list
25320420|NCT04936295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25320421|NCT04936295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25320422|NCT04936295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25320423|NCT04936295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25320424|NCT04936295|Hormone Antagonists|hormone antagonists|mesh-ancestor
25320425|NCT04936295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25320426|NCT04936295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320427|NCT04936204|Hyaluronic Acid|hyaluronic acid|mesh-list
25320428|NCT04936204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25320429|NCT04936204|Immunologic Factors|immunologic factors|mesh-ancestor
25320430|NCT04936204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320431|NCT04936204|Viscosupplements|viscosupplements|mesh-ancestor
25320432|NCT04936204|Protective Agents|protective agents|mesh-ancestor
25320434|NCT04936126|Pramipexole|pramipexole|mesh-list
25320435|NCT04936126|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25320436|NCT04936126|Antidepressive Agents|antidepressive agents|mesh-ancestor
25320437|NCT04936126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25320438|NCT04936126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25320439|NCT04936126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25320440|NCT04936126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25320441|NCT04936126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320442|NCT04936126|Antioxidants|antioxidants|mesh-ancestor
25320443|NCT04936126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320444|NCT04936126|Protective Agents|protective agents|mesh-ancestor
25320445|NCT04936126|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25320446|NCT04936126|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25320447|NCT04936126|Dopamine Agonists|dopamine agonists|mesh-ancestor
25320448|NCT04936126|Dopamine Agents|dopamine agents|mesh-ancestor
25320449|NCT04936126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25320450|NCT04936126|Antiviral Agents|antiviral agents|mesh-ancestor
25320451|NCT04936126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25320452|NCT04936126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25320453|NCT04936126|Analgesics|analgesics|mesh-ancestor
25320454|NCT04936126|Sensory System Agents|sensory system agents|mesh-ancestor
25320455|NCT04936126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25320456|NCT04935814|Vasopressins|vasopressins|mesh-list
25320457|NCT04935814|Arginine Vasopressin|arginine vasopressin|mesh-list
25320458|NCT04935814|Hemostatics|hemostatics|mesh-ancestor
25320459|NCT04935814|Coagulants|coagulants|mesh-ancestor
25320460|NCT04935814|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25320461|NCT04935814|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25320462|NCT04935814|Natriuretic Agents|natriuretic agents|mesh-ancestor
25320463|NCT04935814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320464|NCT04935788|Caseins|caseins|mesh-list
25320465|NCT04935788|Chelating Agents|chelating agents|mesh-ancestor
25320466|NCT04935788|Sequestering Agents|sequestering agents|mesh-ancestor
25320467|NCT04935788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320468|NCT04935658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25320469|NCT04935658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25320470|NCT04935658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320471|NCT04935450|Dimercaprol|dimercaprol|mesh-list
25320472|NCT04935450|Chelating Agents|chelating agents|mesh-ancestor
25320473|NCT04935450|Sequestering Agents|sequestering agents|mesh-ancestor
25077817|NCT03361800|Entinostat|entinostat|mesh-list
25320474|NCT04935450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320475|NCT04935515|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25320476|NCT04935515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25320477|NCT04935515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25320478|NCT04935515|Anticoagulants|anticoagulants|mesh-list
25320479|NCT04935515|Coagulants|coagulants|mesh-list
25320480|NCT04935515|Histamine Antagonists|histamine antagonists|mesh-list
25320481|NCT04935515|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25320482|NCT04935515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25320483|NCT04935515|Antitubercular Agents|antitubercular agents|mesh-ancestor
25320484|NCT04935515|Histamine Agents|histamine agents|mesh-ancestor
25320485|NCT04935515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25320486|NCT04935515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320487|NCT04935515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320488|NCT04935541|Dexmedetomidine|dexmedetomidine|mesh-list
25320489|NCT04935541|Remifentanil|remifentanil|mesh-list
25320490|NCT04935541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25320491|NCT04935541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25320492|NCT04935541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320493|NCT04935541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25320494|NCT04935541|Analgesics|analgesics|mesh-ancestor
25320495|NCT04935541|Sensory System Agents|sensory system agents|mesh-ancestor
25320496|NCT04935541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25320497|NCT04935541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25320498|NCT04935541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25320499|NCT04935541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25320500|NCT04935541|Adrenergic Agents|adrenergic agents|mesh-ancestor
25320501|NCT04935541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25320502|NCT04935541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320503|NCT04935541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25320504|NCT04935541|Narcotics|narcotics|mesh-ancestor
25320505|NCT04935034|Vitamin D|vitamin d|mesh-list
25320506|NCT04935034|Vitamins|vitamins|mesh-ancestor
25320507|NCT04935034|Micronutrients|micronutrients|mesh-ancestor
25320508|NCT04935034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320515|NCT04934930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25320516|NCT04934930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25320518|NCT04935073|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25320519|NCT04935073|Hormones|hormones|mesh-ancestor
25320520|NCT04935073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25320521|NCT04935073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320522|NCT04935073|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25202533|NCT02720770|Hormones|hormones|mesh-list
25320523|NCT04935073|Fertility Agents|fertility agents|mesh-ancestor
25320524|NCT04935073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25320525|NCT04935073|Hormone Antagonists|hormone antagonists|mesh-ancestor
25320534|NCT04934579|Rituximab|rituximab|mesh-list
25320535|NCT04934579|Methotrexate|methotrexate|mesh-list
25320536|NCT04934579|Lenalidomide|lenalidomide|mesh-list
25320537|NCT04934579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25320538|NCT04934579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25320539|NCT04934579|Immunologic Factors|immunologic factors|mesh-ancestor
25320540|NCT04934579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320541|NCT04934579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25320542|NCT04934579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25320543|NCT04934579|Abortifacient Agents|abortifacient agents|mesh-ancestor
25320544|NCT04934579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25320545|NCT04934579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25320546|NCT04934579|Antimetabolites|antimetabolites|mesh-ancestor
25320547|NCT04934579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320548|NCT04934579|Dermatologic Agents|dermatologic agents|mesh-ancestor
25320549|NCT04934579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25320550|NCT04934579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25320551|NCT04934579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25192820|NCT02774291|Fludarabine|fludarabine|mesh-list
25320552|NCT04934579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25320553|NCT04934579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25320554|NCT04934579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25320555|NCT04934579|Growth Substances|growth substances|mesh-ancestor
25320556|NCT04934579|Growth Inhibitors|growth inhibitors|mesh-ancestor
25320557|NCT04934852|Ephedrine|ephedrine|mesh-list
25320559|NCT04934852|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25320561|NCT04934852|Sympathomimetics|sympathomimetics|mesh-ancestor
25320562|NCT04934852|Autonomic Agents|autonomic agents|mesh-ancestor
25320563|NCT04934852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25320564|NCT04934852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25320565|NCT04934852|Adrenergic Agents|adrenergic agents|mesh-ancestor
25320566|NCT04934852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25320567|NCT04934852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320568|NCT04934852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25320569|NCT04934852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25320570|NCT04934852|Respiratory System Agents|respiratory system agents|mesh-ancestor
25320571|NCT04934852|Nasal Decongestants|nasal decongestants|mesh-ancestor
25320572|NCT04934618|Irinotecan|irinotecan|mesh-list
25320573|NCT04934618|Apatinib|apatinib|mesh-list
25320574|NCT04934618|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25320575|NCT04934618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25320576|NCT04934618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25320577|NCT04934618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320578|NCT04934618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25320579|NCT04934618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25320580|NCT04934514|Gemcitabine|gemcitabine|mesh-list
25320581|NCT04934514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25320582|NCT04934514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25320583|NCT04934514|Antimetabolites|antimetabolites|mesh-ancestor
25077901|NCT03361098|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25077903|NCT03361098|Hormones|hormones|mesh-ancestor
25077905|NCT03360981|Incretins|incretins|mesh-list
25320618|NCT04933630|Norepinephrine|norepinephrine|mesh-list
25320619|NCT04933630|Serotonin|serotonin|mesh-list
25320620|NCT04933630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25320621|NCT04933630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25320622|NCT04933630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25320623|NCT04933630|Adrenergic Agents|adrenergic agents|mesh-ancestor
25320624|NCT04933630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25320625|NCT04933630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320626|NCT04933630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320627|NCT04933630|Sympathomimetics|sympathomimetics|mesh-ancestor
25320628|NCT04933630|Autonomic Agents|autonomic agents|mesh-ancestor
25320629|NCT04933630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25320630|NCT04933630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25320631|NCT04933630|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25320632|NCT04933630|Serotonin Agents|serotonin agents|mesh-ancestor
25320633|NCT04933630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25320634|NCT04933630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25320635|NCT04933864|Methylene Blue|methylene blue|mesh-list
25320636|NCT04933864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25320637|NCT04933864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320638|NCT04933019|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25320639|NCT04933019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25320640|NCT04933292|Mycophenolic Acid|mycophenolic acid|mesh-list
25320641|NCT04933292|Methylprednisolone|methylprednisolone|mesh-list
25320642|NCT04933292|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25320643|NCT04933292|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25320644|NCT04933292|Prednisolone|prednisolone|mesh-list
25320645|NCT04933292|Prednisolone acetate|prednisolone acetate|mesh-list
25320646|NCT04933292|Azathioprine|azathioprine|mesh-list
25320647|NCT04933292|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25320648|NCT04933292|Prednisolone phosphate|prednisolone phosphate|mesh-list
25320649|NCT04933292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25320650|NCT04933292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25320651|NCT04933292|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25320652|NCT04933292|Antitubercular Agents|antitubercular agents|mesh-ancestor
25320653|NCT04933292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25320654|NCT04933292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25320655|NCT04933292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25320656|NCT04933292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648940|NCT01486615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25320657|NCT04933292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25320659|NCT04933292|Autonomic Agents|autonomic agents|mesh-ancestor
25320660|NCT04933292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25320661|NCT04933292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320662|NCT04933292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25320664|NCT04933292|Hormones|hormones|mesh-ancestor
25320751|NCT04931433|Sensory System Agents|sensory system agents|mesh-ancestor
25320665|NCT04933292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25320666|NCT04933292|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25320667|NCT04933292|Protective Agents|protective agents|mesh-ancestor
25320668|NCT04933292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25320669|NCT04933292|Antimetabolites|antimetabolites|mesh-ancestor
25320670|NCT04933292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25320671|NCT04933292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25320672|NCT04933292|Immunologic Factors|immunologic factors|mesh-ancestor
25320673|NCT04933292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25320674|NCT04933084|Analgesics, Opioid|analgesics, opioid|mesh-list
25320675|NCT04933084|Narcotics|narcotics|mesh-ancestor
25320676|NCT04933084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25320677|NCT04933084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320678|NCT04933084|Analgesics|analgesics|mesh-ancestor
25320679|NCT04933084|Sensory System Agents|sensory system agents|mesh-ancestor
25320680|NCT04933084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25320681|NCT04933266|Levobupivacaine|levobupivacaine|mesh-list
25320682|NCT04933266|Anesthetics, Local|anesthetics, local|mesh-ancestor
25320683|NCT04933266|Anesthetics|anesthetics|mesh-ancestor
25320684|NCT04933266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25320685|NCT04933266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320686|NCT04933266|Sensory System Agents|sensory system agents|mesh-ancestor
25320687|NCT04933266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25320688|NCT04933279|Iodine|iodine|mesh-list
25320689|NCT04933279|Cadexomer iodine|cadexomer iodine|mesh-list
25320690|NCT04933279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25320691|NCT04933279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25202098|NCT02723500|Xenon|xenon|mesh-list
25320692|NCT04933279|Trace Elements|trace elements|mesh-ancestor
25320693|NCT04933279|Micronutrients|micronutrients|mesh-ancestor
25320694|NCT04933279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320695|NCT04932564|Leflunomide|leflunomide|mesh-list
25320696|NCT04932564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25320697|NCT04932564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320698|NCT04932564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25320699|NCT04932564|Immunologic Factors|immunologic factors|mesh-ancestor
25320700|NCT04932564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320701|NCT04932746|Dexmedetomidine|dexmedetomidine|mesh-list
25320702|NCT04932746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25320703|NCT04932746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25320704|NCT04932746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320705|NCT04932746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25320706|NCT04932746|Analgesics|analgesics|mesh-ancestor
25320707|NCT04932746|Sensory System Agents|sensory system agents|mesh-ancestor
25320708|NCT04932746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25320709|NCT04932746|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25320710|NCT04932746|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25320711|NCT04932746|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25320712|NCT04932746|Adrenergic Agents|adrenergic agents|mesh-ancestor
25320713|NCT04932746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25320714|NCT04932746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320715|NCT04932434|Psilocybin|psilocybin|mesh-list
25320716|NCT04932434|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
25320717|NCT04932434|Hallucinogens|hallucinogens|mesh-ancestor
25320718|NCT04932434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320719|NCT04932434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25320720|NCT04932434|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25320721|NCT04932434|Serotonin Agents|serotonin agents|mesh-ancestor
25320722|NCT04932434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25320723|NCT04932434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320724|NCT04932434|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25320725|NCT04932135|Hormones|hormones|mesh-list
25320726|NCT04932135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25320727|NCT04932135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320740|NCT04931693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25320741|NCT04931693|Analgesics|analgesics|mesh-ancestor
25320742|NCT04931693|Sensory System Agents|sensory system agents|mesh-ancestor
25320743|NCT04931693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25320744|NCT04931693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320745|NCT04931693|Antipyretics|antipyretics|mesh-ancestor
25320746|NCT04931433|Lidocaine|lidocaine|mesh-list
25320747|NCT04931433|Anesthetics, Local|anesthetics, local|mesh-ancestor
25320748|NCT04931433|Anesthetics|anesthetics|mesh-ancestor
25320749|NCT04931433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25320750|NCT04931433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320752|NCT04931433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25320753|NCT04931433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25320754|NCT04931433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25320755|NCT04931433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25320756|NCT04931433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25320757|NCT04931433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320758|NCT04931524|Mitogens|mitogens|mesh-list
25320759|NCT04931524|Mitosis Modulators|mitosis modulators|mesh-ancestor
25320760|NCT04931524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320761|NCT04931355|Cetrorelix|cetrorelix|mesh-list
25320762|NCT04931355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25320763|NCT04931355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320764|NCT04931355|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25320765|NCT04931355|Fertility Agents|fertility agents|mesh-ancestor
25320766|NCT04931355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25320767|NCT04931355|Hormone Antagonists|hormone antagonists|mesh-ancestor
25320768|NCT04930952|Ethanol|ethanol|mesh-list
25320769|NCT04930952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25320770|NCT04930952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25320771|NCT04930952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25320772|NCT04930952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320773|NCT04931225|Landiolol|landiolol|mesh-list
25320774|NCT04931225|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25320775|NCT04931225|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25320776|NCT04931225|Adrenergic Agents|adrenergic agents|mesh-ancestor
25320777|NCT04931225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25320778|NCT04931225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320779|NCT04931225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320780|NCT04931225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25320781|NCT04931108|Atenolol|atenolol|mesh-list
25320782|NCT04931108|Nitrendipine|nitrendipine|mesh-list
25320783|NCT04931108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25320784|NCT04931108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25320785|NCT04931108|Sympatholytics|sympatholytics|mesh-ancestor
25320786|NCT04931108|Autonomic Agents|autonomic agents|mesh-ancestor
25320787|NCT04931108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25320788|NCT04931108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320789|NCT04931108|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25320790|NCT04931108|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25320791|NCT04931108|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25320792|NCT04931108|Adrenergic Agents|adrenergic agents|mesh-ancestor
25320793|NCT04931108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25320794|NCT04931108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320795|NCT04931108|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25320796|NCT04931108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25320797|NCT04931108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25320798|NCT04931108|Vasodilator Agents|vasodilator agents|mesh-ancestor
25320799|NCT04931121|Viscosupplements|viscosupplements|mesh-list
25320800|NCT04931121|Protective Agents|protective agents|mesh-ancestor
25320801|NCT04931121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320802|NCT04930562|Belumosudil|belumosudil|mesh-list
25320803|NCT04930562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25320804|NCT04930562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25320805|NCT04930562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320806|NCT04930627|Empagliflozin|empagliflozin|mesh-list
25320807|NCT04930627|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25320808|NCT04930627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320809|NCT04930627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25320810|NCT04930627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320811|NCT04930471|Metformin|metformin|mesh-list
25320812|NCT04930471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25320813|NCT04930471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320814|NCT04930211|Dexamethasone|dexamethasone|mesh-list
25320815|NCT04930211|Lidocaine|lidocaine|mesh-list
25320816|NCT04930211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25320817|NCT04930211|Antiemetics|antiemetics|mesh-ancestor
25320819|NCT04930211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25320820|NCT04930211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320821|NCT04930211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25320822|NCT04930211|Glucocorticoids|glucocorticoids|mesh-ancestor
25320823|NCT04930211|Hormones|hormones|mesh-ancestor
25825511|NCT00005601|Antiemetics|antiemetics|mesh-ancestor
25825512|NCT00005601|Autonomic Agents|autonomic agents|mesh-ancestor
25825513|NCT00005601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25825514|NCT00005601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25825515|NCT00005601|Glucocorticoids|glucocorticoids|mesh-ancestor
25825516|NCT00005601|Hormones|hormones|mesh-ancestor
25825517|NCT00005601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25320824|NCT04930211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25320825|NCT04930211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25320826|NCT04930211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25320827|NCT04930211|Anesthetics, Local|anesthetics, local|mesh-ancestor
25320828|NCT04930211|Anesthetics|anesthetics|mesh-ancestor
25320829|NCT04930211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25320830|NCT04930211|Sensory System Agents|sensory system agents|mesh-ancestor
25320831|NCT04930211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25320832|NCT04930211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25320833|NCT04930211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25320834|NCT04930211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25320835|NCT04930211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320836|NCT04930185|Vaccines|vaccines|mesh-list
25320837|NCT04930185|Immunologic Factors|immunologic factors|mesh-ancestor
25320838|NCT04930185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320839|NCT04930133|Afatinib|afatinib|mesh-list
25320840|NCT04930133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25320841|NCT04930133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25320842|NCT04930133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25320843|NCT04930133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320844|NCT04929652|Irinotecan|irinotecan|mesh-list
25320845|NCT04929652|Molgramostim|molgramostim|mesh-list
25320846|NCT04929652|Sargramostim|sargramostim|mesh-list
25320847|NCT04929652|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25320848|NCT04929652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25320849|NCT04929652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25320850|NCT04929652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320851|NCT04929652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25320852|NCT04929652|Immunologic Factors|immunologic factors|mesh-ancestor
25320853|NCT04929652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320854|NCT04929626|Magnesium Sulfate|magnesium sulfate|mesh-list
25320855|NCT04929626|Albuterol|albuterol|mesh-list
25320856|NCT04929626|Analgesics|analgesics|mesh-ancestor
25320857|NCT04929626|Sensory System Agents|sensory system agents|mesh-ancestor
25320858|NCT04929626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25320859|NCT04929626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320860|NCT04929626|Anesthetics|anesthetics|mesh-ancestor
25320861|NCT04929626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25320862|NCT04929626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25320863|NCT04929626|Anticonvulsants|anticonvulsants|mesh-ancestor
25320864|NCT04929626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25320865|NCT04929626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25321505|NCT04918576|Tranexamic Acid|tranexamic acid|mesh-list
25320868|NCT04929626|Tocolytic Agents|tocolytic agents|mesh-ancestor
25320869|NCT04929626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25320870|NCT04929626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25320871|NCT04929626|Autonomic Agents|autonomic agents|mesh-ancestor
25320872|NCT04929626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25320873|NCT04929626|Respiratory System Agents|respiratory system agents|mesh-ancestor
25320874|NCT04929626|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25320875|NCT04929626|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25320876|NCT04929626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25320877|NCT04929626|Adrenergic Agents|adrenergic agents|mesh-ancestor
25320878|NCT04929626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25320882|NCT04929522|Anesthetics|anesthetics|mesh-list
25320883|NCT04929522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25320884|NCT04929522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320885|NCT04929509|Listerine|listerine|mesh-list
25320886|NCT04929509|Fluorides|fluorides|mesh-list
25320887|NCT04929509|Sodium Fluoride|sodium fluoride|mesh-list
25320888|NCT04929509|Fluorides, Topical|fluorides, topical|mesh-list
25320889|NCT04929509|Cariostatic Agents|cariostatic agents|mesh-ancestor
25825518|NCT00005601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25825519|NCT00005601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25320890|NCT04929509|Protective Agents|protective agents|mesh-ancestor
25321117|NCT04924647|Dexamethasone|dexamethasone|mesh-list
25320892|NCT04929509|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25320893|NCT04929509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25320894|NCT04928365|Antibodies|antibodies|mesh-list
25320895|NCT04928365|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25320896|NCT04928365|Immunologic Factors|immunologic factors|mesh-ancestor
25320897|NCT04928365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320898|NCT04928495|Ascorbic Acid|ascorbic acid|mesh-list
25320899|NCT04928495|Acetylcysteine|acetylcysteine|mesh-list
25320900|NCT04928495|Bromhexine|bromhexine|mesh-list
25320901|NCT04928495|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25320902|NCT04928495|Vitamins|vitamins|mesh-ancestor
25320903|NCT04928495|Micronutrients|micronutrients|mesh-ancestor
25320904|NCT04928495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320905|NCT04928495|Antioxidants|antioxidants|mesh-ancestor
25320906|NCT04928495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320907|NCT04928495|Protective Agents|protective agents|mesh-ancestor
25320908|NCT04928495|Antiviral Agents|antiviral agents|mesh-ancestor
25320909|NCT04928495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25320910|NCT04928495|Expectorants|expectorants|mesh-ancestor
25320911|NCT04928495|Respiratory System Agents|respiratory system agents|mesh-ancestor
25320912|NCT04928495|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25320913|NCT04928495|Antidotes|antidotes|mesh-ancestor
25320914|NCT04928313|Glatiramer Acetate|glatiramer acetate|mesh-list
25320915|NCT04928313|(T,G)-A-L|(t,g)-a-l|mesh-list
25320916|NCT04928313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25320917|NCT04928313|Immunologic Factors|immunologic factors|mesh-ancestor
25320918|NCT04928313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320919|NCT04928313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25320920|NCT04928313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25320921|NCT04928079|Antiparkinson Agents|antiparkinson agents|mesh-list
25320922|NCT04928079|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25320923|NCT04928066|Prednisone|prednisone|mesh-list
25320924|NCT04928066|Tofacitinib|tofacitinib|mesh-list
25320925|NCT04928066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25320926|NCT04928066|Glucocorticoids|glucocorticoids|mesh-ancestor
25320927|NCT04928066|Hormones|hormones|mesh-ancestor
25320928|NCT04928066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25320929|NCT04928066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320930|NCT04928066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25320931|NCT04928066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25320932|NCT04928066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25320933|NCT04928066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25320934|NCT04928066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320935|NCT04927936|Vaccines|vaccines|mesh-list
25320936|NCT04927936|Immunologic Factors|immunologic factors|mesh-ancestor
25320937|NCT04927936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320938|NCT04927949|Cangrelor|cangrelor|mesh-list
25320939|NCT04927949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25320946|NCT04927949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320948|NCT04928586|Analgesics|analgesics|mesh-ancestor
25320949|NCT04928586|Sensory System Agents|sensory system agents|mesh-ancestor
25320950|NCT04928586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25320951|NCT04928586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320952|NCT04928586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25320953|NCT04928586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25320954|NCT04928586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25320955|NCT04928586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25320956|NCT04928586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25320957|NCT04928651|Clonidine|clonidine|mesh-list
25320958|NCT04928651|Analgesics|analgesics|mesh-ancestor
25320959|NCT04928651|Sensory System Agents|sensory system agents|mesh-ancestor
25320960|NCT04928651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25320961|NCT04928651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320962|NCT04928651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25320963|NCT04928651|Sympatholytics|sympatholytics|mesh-ancestor
25320964|NCT04928651|Autonomic Agents|autonomic agents|mesh-ancestor
25320965|NCT04928651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25825520|NCT00005601|Antimetabolites|antimetabolites|mesh-ancestor
25320966|NCT04928651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25320967|NCT04928651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25320968|NCT04928651|Adrenergic Agents|adrenergic agents|mesh-ancestor
25320969|NCT04928651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25320970|NCT04928651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320979|NCT04927858|Empagliflozin|empagliflozin|mesh-list
25320980|NCT04927858|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25320981|NCT04927858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320982|NCT04927858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25320983|NCT04927858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320984|NCT04927481|Mitoxantrone|mitoxantrone|mesh-list
25320985|NCT04927481|Analgesics|analgesics|mesh-ancestor
25320986|NCT04927481|Sensory System Agents|sensory system agents|mesh-ancestor
25320987|NCT04927481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25320988|NCT04927481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25320989|NCT04927481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25320990|NCT04927481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25320991|NCT04927481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25320992|NCT04927481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25320993|NCT04927481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25320994|NCT04927299|Losartan|losartan|mesh-list
25320995|NCT04927299|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25320996|NCT04927299|Chlorthalidone|chlorthalidone|mesh-list
25320997|NCT04927299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25320998|NCT04927299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25320999|NCT04927299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25321000|NCT04927299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25321001|NCT04927299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321002|NCT04927299|Diuretics|diuretics|mesh-ancestor
25321003|NCT04927299|Natriuretic Agents|natriuretic agents|mesh-ancestor
25321004|NCT04927299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321005|NCT04927299|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25321006|NCT04927299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25825521|NCT00005601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825522|NCT00005601|Antiviral Agents|antiviral agents|mesh-ancestor
25825523|NCT00005601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25321036|NCT04926753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321038|NCT04926480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25321039|NCT04926480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321040|NCT04926467|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25321041|NCT04926467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24897232|NCT04427098|Enoxaparin|enoxaparin|mesh-list
25321042|NCT04927039|Iloprost|iloprost|mesh-list
25321043|NCT04927039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25321044|NCT04927039|Vasodilator Agents|vasodilator agents|mesh-ancestor
25321064|NCT04926532|Sorafenib|sorafenib|mesh-list
25321065|NCT04926532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321066|NCT04926532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25321067|NCT04926532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321068|NCT04926532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321069|NCT04925973|Tofacitinib|tofacitinib|mesh-list
25321070|NCT04925973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25321071|NCT04925973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321072|NCT04925973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321073|NCT04926155|Metformin|metformin|mesh-list
25321074|NCT04926155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25321075|NCT04926155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321076|NCT04925531|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25321077|NCT04925531|Ampicillin|ampicillin|mesh-list
25321078|NCT04925531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25321092|NCT04925141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321093|NCT04925141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321094|NCT04925063|Metformin|metformin|mesh-list
25321095|NCT04925063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25321096|NCT04925063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321102|NCT04925167|Heparin|heparin|mesh-list
25321103|NCT04925167|Calcium heparin|calcium heparin|mesh-list
25321104|NCT04925167|Argatroban|argatroban|mesh-list
25321105|NCT04925167|Anticoagulants|anticoagulants|mesh-ancestor
25321106|NCT04925167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25321107|NCT04925167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25321108|NCT04925167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321109|NCT04925167|Antithrombins|antithrombins|mesh-ancestor
25321110|NCT04925167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25321111|NCT04925167|Protease Inhibitors|protease inhibitors|mesh-ancestor
25321112|NCT04925167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321113|NCT04925167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25321114|NCT04924868|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25321115|NCT04924868|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25321116|NCT04924868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25321119|NCT04924647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25321121|NCT04924647|Autonomic Agents|autonomic agents|mesh-ancestor
25321122|NCT04924647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25321123|NCT04924647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321124|NCT04924647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25321125|NCT04924647|Glucocorticoids|glucocorticoids|mesh-ancestor
25321126|NCT04924647|Hormones|hormones|mesh-ancestor
25321127|NCT04924647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25321128|NCT04924647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25321129|NCT04924647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321130|NCT04924647|Immunologic Factors|immunologic factors|mesh-ancestor
25321131|NCT04924647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25321132|NCT04924647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25321133|NCT04924647|Growth Substances|growth substances|mesh-ancestor
25321134|NCT04924647|Growth Inhibitors|growth inhibitors|mesh-ancestor
25321135|NCT04924946|Antihypertensive Agents|antihypertensive agents|mesh-list
25321136|NCT04924192|Irinotecan|irinotecan|mesh-list
25321137|NCT04924192|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25321138|NCT04924192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25321139|NCT04924192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321140|NCT04924192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321141|NCT04924192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321142|NCT04923152|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
25321143|NCT04923152|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25321144|NCT04923152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25321145|NCT04923152|Antimetabolites|antimetabolites|mesh-ancestor
25321146|NCT04923152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321147|NCT04923152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321148|NCT04923152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25321153|NCT04922996|Calcium Dobesilate|calcium dobesilate|mesh-list
25321154|NCT04922996|Calcium|calcium|mesh-list
25321713|NCT04917250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321156|NCT04922996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321158|NCT04922996|Coagulants|coagulants|mesh-ancestor
25321159|NCT04923113|Amoxicillin|amoxicillin|mesh-list
25321160|NCT04923113|Minocycline|minocycline|mesh-list
25321161|NCT04923113|Rabeprazole|rabeprazole|mesh-list
25321162|NCT04923113|Bismuth|bismuth|mesh-list
25321163|NCT04923113|Antibodies|antibodies|mesh-list
25321164|NCT04923113|Immunologic Factors|immunologic factors|mesh-ancestor
25321165|NCT04923113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321166|NCT04923113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25321167|NCT04923113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25321168|NCT04923113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25321169|NCT04923113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25321170|NCT04923113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25321171|NCT04923113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321172|NCT04923113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321173|NCT04923113|Antacids|antacids|mesh-ancestor
25321174|NCT04923516|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25321175|NCT04923516|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25321176|NCT04923516|Dermatologic Agents|dermatologic agents|mesh-ancestor
25321177|NCT04922359|Lidocaine|lidocaine|mesh-list
25321178|NCT04922359|Anesthetics, Local|anesthetics, local|mesh-ancestor
25321179|NCT04922359|Anesthetics|anesthetics|mesh-ancestor
25321180|NCT04922359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25321181|NCT04922359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321182|NCT04922359|Sensory System Agents|sensory system agents|mesh-ancestor
25321183|NCT04922359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25321184|NCT04922359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25321185|NCT04922359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25321186|NCT04922359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25321187|NCT04922359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25321188|NCT04922359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321189|NCT04922567|Prednisone|prednisone|mesh-list
25321190|NCT04922567|Cyclophosphamide|cyclophosphamide|mesh-list
25321191|NCT04922567|Doxorubicin|doxorubicin|mesh-list
25321192|NCT04922567|Vincristine|vincristine|mesh-list
25321193|NCT04922567|Lenalidomide|lenalidomide|mesh-list
25321194|NCT04922567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25321195|NCT04922567|Immunologic Factors|immunologic factors|mesh-ancestor
25321196|NCT04922567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321197|NCT04922567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25321198|NCT04922567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25321199|NCT04922567|Alkylating Agents|alkylating agents|mesh-ancestor
25321200|NCT04922567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321202|NCT04922567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25321203|NCT04922567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25321204|NCT04922567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25321205|NCT04922567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25321206|NCT04922567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321207|NCT04922567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25321208|NCT04922567|Glucocorticoids|glucocorticoids|mesh-ancestor
25321209|NCT04922567|Hormones|hormones|mesh-ancestor
25321210|NCT04922567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25321211|NCT04922567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25321212|NCT04922567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25321213|NCT04922567|Tubulin Modulators|tubulin modulators|mesh-ancestor
25321214|NCT04922567|Antimitotic Agents|antimitotic agents|mesh-ancestor
25321215|NCT04922567|Mitosis Modulators|mitosis modulators|mesh-ancestor
25321216|NCT04922567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25321217|NCT04922567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25321218|NCT04922567|Growth Substances|growth substances|mesh-ancestor
25321219|NCT04922567|Growth Inhibitors|growth inhibitors|mesh-ancestor
25321220|NCT04922450|Paclitaxel|paclitaxel|mesh-list
25321221|NCT04922450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25321222|NCT04922450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25321223|NCT04922450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321224|NCT04922450|Tubulin Modulators|tubulin modulators|mesh-ancestor
25321225|NCT04922450|Antimitotic Agents|antimitotic agents|mesh-ancestor
25321226|NCT04922450|Mitosis Modulators|mitosis modulators|mesh-ancestor
25321227|NCT04922450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321240|NCT04922034|Amoxicillin|amoxicillin|mesh-list
25321241|NCT04922034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25321242|NCT04922034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25321243|NCT04922008|Capecitabine|capecitabine|mesh-list
25321244|NCT04922008|Trastuzumab|trastuzumab|mesh-list
25321245|NCT04922008|Vinorelbine|vinorelbine|mesh-list
25321246|NCT04922008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25321247|NCT04922008|Antimetabolites|antimetabolites|mesh-ancestor
25321248|NCT04922008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321249|NCT04922008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321250|NCT04922008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25321251|NCT04922008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25321252|NCT04922008|Tubulin Modulators|tubulin modulators|mesh-ancestor
25321253|NCT04922008|Antimitotic Agents|antimitotic agents|mesh-ancestor
25321254|NCT04922008|Mitosis Modulators|mitosis modulators|mesh-ancestor
25321255|NCT04922151|Ranibizumab|ranibizumab|mesh-list
25321256|NCT04922151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25321257|NCT04922151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25321258|NCT04922151|Growth Substances|growth substances|mesh-ancestor
25321259|NCT04922151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321260|NCT04922151|Growth Inhibitors|growth inhibitors|mesh-ancestor
25321261|NCT04922151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321262|NCT04921930|Artesunate|artesunate|mesh-list
25321263|NCT04921930|Antimalarials|antimalarials|mesh-ancestor
25321264|NCT04921930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25321265|NCT04921930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25321266|NCT04921930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25321267|NCT04921930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321268|NCT04921930|Antiviral Agents|antiviral agents|mesh-ancestor
25321269|NCT04921930|Schistosomicides|schistosomicides|mesh-ancestor
25321270|NCT04921930|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25321271|NCT04921930|Anthelmintics|anthelmintics|mesh-ancestor
25321272|NCT04921878|Mitoxantrone|mitoxantrone|mesh-list
25321273|NCT04921878|Analgesics|analgesics|mesh-ancestor
25321274|NCT04921878|Sensory System Agents|sensory system agents|mesh-ancestor
25321275|NCT04921878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25321276|NCT04921878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321277|NCT04921878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321278|NCT04921878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25321279|NCT04921878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25321280|NCT04921878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321281|NCT04921878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321282|NCT04921657|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25321283|NCT04921657|Simvastatin|simvastatin|mesh-list
25321284|NCT04921657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25321285|NCT04921657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25321286|NCT04921657|Antimetabolites|antimetabolites|mesh-ancestor
24455183|NCT02448771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25321287|NCT04921657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321289|NCT04921657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25321290|NCT04921657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24393198|NCT00129090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24393200|NCT00129142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25321291|NCT04921670|Infliximab|infliximab|mesh-list
25321292|NCT04921670|Dermatologic Agents|dermatologic agents|mesh-ancestor
25321293|NCT04921670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25321294|NCT04921670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25321295|NCT04921904|Ramucirumab|ramucirumab|mesh-list
25321296|NCT04921904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321297|NCT04921566|Torsemide|torsemide|mesh-list
25321298|NCT04921566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25321299|NCT04921566|Diuretics|diuretics|mesh-ancestor
25321300|NCT04921566|Natriuretic Agents|natriuretic agents|mesh-ancestor
25321301|NCT04921566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321302|NCT04921566|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25321303|NCT04921566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25321304|NCT04921566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321305|NCT04921306|Clenbuterol|clenbuterol|mesh-list
25321306|NCT04921306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25321307|NCT04921306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25321308|NCT04921306|Adrenergic Agents|adrenergic agents|mesh-ancestor
25321309|NCT04921306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25321310|NCT04921306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321311|NCT04921306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321312|NCT04921306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25321313|NCT04921306|Autonomic Agents|autonomic agents|mesh-ancestor
25321314|NCT04921306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25321315|NCT04921306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25321316|NCT04921306|Respiratory System Agents|respiratory system agents|mesh-ancestor
25321317|NCT04921306|Sympathomimetics|sympathomimetics|mesh-ancestor
25321318|NCT04921111|Aluminum phosphate|aluminum phosphate|mesh-list
25321319|NCT04921111|Vaccines|vaccines|mesh-list
25321320|NCT04921111|Immunologic Factors|immunologic factors|mesh-ancestor
25321321|NCT04921111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321322|NCT04921111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25321323|NCT04921111|Antacids|antacids|mesh-ancestor
25321324|NCT04921111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321325|NCT04921111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25321326|NCT04921124|Teriparatide|teriparatide|mesh-list
25321327|NCT04921124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25321328|NCT04921124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321329|NCT04921124|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25321330|NCT04921046|Lidocaine|lidocaine|mesh-list
25321331|NCT04921046|Midazolam|midazolam|mesh-list
25321332|NCT04921046|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25321333|NCT04921046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25321334|NCT04921046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25321335|NCT04921046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321336|NCT04921046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25321337|NCT04921046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25321338|NCT04921046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25321339|NCT04921046|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25321340|NCT04921046|Anesthetics, General|anesthetics, general|mesh-ancestor
25321341|NCT04921046|Anesthetics|anesthetics|mesh-ancestor
25321342|NCT04921046|GABA Modulators|gaba modulators|mesh-ancestor
25321343|NCT04921046|GABA Agents|gaba agents|mesh-ancestor
25321344|NCT04921046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25321345|NCT04921046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321346|NCT04921046|Anesthetics, Local|anesthetics, local|mesh-ancestor
25321347|NCT04921046|Sensory System Agents|sensory system agents|mesh-ancestor
25321348|NCT04921046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25321349|NCT04921046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25321350|NCT04921046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25321351|NCT04921046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25321352|NCT04921046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25321353|NCT04920968|Rituximab|rituximab|mesh-list
25321356|NCT04920968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321357|NCT04920968|Immunologic Factors|immunologic factors|mesh-ancestor
25825524|NCT00005601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25321381|NCT04920669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25321382|NCT04920669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321383|NCT04920604|Anesthetics|anesthetics|mesh-list
25321384|NCT04920604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25321385|NCT04920604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321401|NCT04920708|Fulvestrant|fulvestrant|mesh-list
25321402|NCT04920708|Palbociclib|palbociclib|mesh-list
25321403|NCT04920708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25321404|NCT04920708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321405|NCT04920708|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25321406|NCT04920708|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25321407|NCT04920708|Hormone Antagonists|hormone antagonists|mesh-ancestor
25321408|NCT04920708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25321409|NCT04920708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321410|NCT04920708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25321411|NCT04920708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321412|NCT04920708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321417|NCT04921033|Prednisolone|prednisolone|mesh-list
25321418|NCT04921033|Budesonide|budesonide|mesh-list
25321419|NCT04921033|Azathioprine|azathioprine|mesh-list
25321420|NCT04921033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25321421|NCT04921033|Glucocorticoids|glucocorticoids|mesh-ancestor
25321422|NCT04921033|Hormones|hormones|mesh-ancestor
25321423|NCT04921033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25321424|NCT04921033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825525|NCT00005602|Carboplatin|carboplatin|mesh-list
25825526|NCT00005602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321425|NCT04921033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25321426|NCT04921033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321427|NCT04921033|Autonomic Agents|autonomic agents|mesh-ancestor
25321428|NCT04921033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25321429|NCT04921033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25321430|NCT04921033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25321431|NCT04921033|Respiratory System Agents|respiratory system agents|mesh-ancestor
25321432|NCT04921033|Antimetabolites|antimetabolites|mesh-ancestor
25321433|NCT04921033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321434|NCT04921033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25321435|NCT04921033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25321436|NCT04921033|Immunologic Factors|immunologic factors|mesh-ancestor
25321437|NCT04921033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25321438|NCT04920448|Acetylcysteine|acetylcysteine|mesh-list
25321439|NCT04920448|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25321440|NCT04920448|Antiviral Agents|antiviral agents|mesh-ancestor
25321441|NCT04920448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25321442|NCT04920448|Expectorants|expectorants|mesh-ancestor
25321443|NCT04920448|Respiratory System Agents|respiratory system agents|mesh-ancestor
25321444|NCT04920448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25321445|NCT04920448|Antioxidants|antioxidants|mesh-ancestor
25321446|NCT04920448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321447|NCT04920448|Protective Agents|protective agents|mesh-ancestor
25321448|NCT04920448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321449|NCT04920448|Antidotes|antidotes|mesh-ancestor
25321450|NCT04920500|Cytarabine|cytarabine|mesh-list
25321451|NCT04920500|Daunorubicin|daunorubicin|mesh-list
25321452|NCT04920500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25321453|NCT04920500|Antimetabolites|antimetabolites|mesh-ancestor
25321454|NCT04920500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321455|NCT04920500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321456|NCT04920500|Antiviral Agents|antiviral agents|mesh-ancestor
25321457|NCT04920500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25321458|NCT04920500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25321459|NCT04920500|Immunologic Factors|immunologic factors|mesh-ancestor
25321460|NCT04920500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321461|NCT04920500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25321462|NCT04920500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25321463|NCT04920500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25321464|NCT04920500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321465|NCT04919460|Tolonium Chloride|tolonium chloride|mesh-list
25321466|NCT04919460|Hemostatics|hemostatics|mesh-ancestor
25321467|NCT04919460|Coagulants|coagulants|mesh-ancestor
25321468|NCT04919460|Heparin Antagonists|heparin antagonists|mesh-ancestor
25321469|NCT04919460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827494|NCT02139761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827495|NCT02139761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24393683|NCT00130676|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25321470|NCT04919252|Vedolizumab|vedolizumab|mesh-list
25321471|NCT04919252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25321472|NCT04919174|Dexmedetomidine|dexmedetomidine|mesh-list
25321473|NCT04919174|Remifentanil|remifentanil|mesh-list
25321474|NCT04919174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25321475|NCT04919174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25321476|NCT04919174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321477|NCT04919174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25321478|NCT04919174|Analgesics|analgesics|mesh-ancestor
25321479|NCT04919174|Sensory System Agents|sensory system agents|mesh-ancestor
25321480|NCT04919174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25321481|NCT04919174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25321482|NCT04919174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25321483|NCT04919174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25321484|NCT04919174|Adrenergic Agents|adrenergic agents|mesh-ancestor
25321485|NCT04919174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25321486|NCT04919174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321487|NCT04919174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25321488|NCT04919174|Narcotics|narcotics|mesh-ancestor
25321489|NCT04918914|Dapsone|dapsone|mesh-list
25321490|NCT04918914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25321491|NCT04918914|Antimalarials|antimalarials|mesh-ancestor
25321492|NCT04918914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25321493|NCT04918914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25321494|NCT04918914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25321495|NCT04918914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321496|NCT04918914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321497|NCT04918914|Leprostatic Agents|leprostatic agents|mesh-ancestor
25321498|NCT04918914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25321499|NCT04918589|Tranexamic Acid|tranexamic acid|mesh-list
25321500|NCT04918589|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25321501|NCT04918589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25321502|NCT04918589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321503|NCT04918589|Hemostatics|hemostatics|mesh-ancestor
25321504|NCT04918589|Coagulants|coagulants|mesh-ancestor
25321506|NCT04918576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25321507|NCT04918576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25321508|NCT04918576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321509|NCT04918576|Hemostatics|hemostatics|mesh-ancestor
25321510|NCT04918576|Coagulants|coagulants|mesh-ancestor
25321511|NCT04918758|Sucralfate|sucralfate|mesh-list
25321512|NCT04918758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25321513|NCT04918758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25321514|NCT04918524|Aspirin|aspirin|mesh-list
25321515|NCT04918524|Hydroxychloroquine|hydroxychloroquine|mesh-list
25321516|NCT04918524|Prednisone|prednisone|mesh-list
25321517|NCT04918524|Heparin|heparin|mesh-list
25321518|NCT04918524|Enoxaparin|enoxaparin|mesh-list
25321519|NCT04918524|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25321520|NCT04918524|Tinzaparin|tinzaparin|mesh-list
25321521|NCT04918524|Dalteparin|dalteparin|mesh-list
25321522|NCT04918524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25321523|NCT04918524|Glucocorticoids|glucocorticoids|mesh-ancestor
25321524|NCT04918524|Hormones|hormones|mesh-ancestor
25321525|NCT04918524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25321526|NCT04918524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321527|NCT04918524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25321528|NCT04918524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321529|NCT04918524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25321530|NCT04918524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25321532|NCT04918524|Sensory System Agents|sensory system agents|mesh-ancestor
25321533|NCT04918524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25321534|NCT04918524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25321535|NCT04918524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25321536|NCT04918524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25321537|NCT04918524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321538|NCT04918524|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25321539|NCT04918524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24781517|NCT01890005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781518|NCT01890005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24781519|NCT01890005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24781520|NCT01890005|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24781521|NCT01890005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25321540|NCT04918524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321542|NCT04918524|Anticoagulants|anticoagulants|mesh-ancestor
25321543|NCT04918524|Antimalarials|antimalarials|mesh-ancestor
25321544|NCT04918524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25321545|NCT04918524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25321546|NCT04918524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25321547|NCT04918719|Acetylcysteine|acetylcysteine|mesh-list
25321548|NCT04918719|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25321549|NCT04918719|Antiviral Agents|antiviral agents|mesh-ancestor
25321550|NCT04918719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25321551|NCT04918719|Expectorants|expectorants|mesh-ancestor
25321552|NCT04918719|Respiratory System Agents|respiratory system agents|mesh-ancestor
25321553|NCT04918719|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25321554|NCT04918719|Antioxidants|antioxidants|mesh-ancestor
25321555|NCT04918719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321556|NCT04918719|Protective Agents|protective agents|mesh-ancestor
25321557|NCT04918719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321558|NCT04918719|Antidotes|antidotes|mesh-ancestor
25321559|NCT04918563|Nitroglycerin|nitroglycerin|mesh-list
25321560|NCT04918563|Acetylcholine|acetylcholine|mesh-list
25321561|NCT04918563|Vasodilator Agents|vasodilator agents|mesh-ancestor
25321562|NCT04918563|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25321563|NCT04918563|Cholinergic Agents|cholinergic agents|mesh-ancestor
25321564|NCT04918563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25321565|NCT04918563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321566|NCT04918563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321567|NCT04918862|Granisetron|granisetron|mesh-list
25321568|NCT04918862|Antiemetics|antiemetics|mesh-ancestor
25321569|NCT04918862|Autonomic Agents|autonomic agents|mesh-ancestor
25321570|NCT04918862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25321571|NCT04918862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321572|NCT04918862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24833200|NCT02173106|Antifungal Agents|antifungal agents|mesh-ancestor
25321573|NCT04918862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25321574|NCT04918862|Serotonin Agents|serotonin agents|mesh-ancestor
25321575|NCT04918862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25321576|NCT04918862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321577|NCT04918953|Methylprednisolone|methylprednisolone|mesh-list
25321578|NCT04918953|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25321579|NCT04918953|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25321581|NCT04918953|Prednisolone acetate|prednisolone acetate|mesh-list
25321582|NCT04918953|Budesonide|budesonide|mesh-list
25321583|NCT04918953|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25321584|NCT04918953|Prednisolone phosphate|prednisolone phosphate|mesh-list
25321585|NCT04918953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25321586|NCT04918953|Antiemetics|antiemetics|mesh-ancestor
25321587|NCT04918953|Autonomic Agents|autonomic agents|mesh-ancestor
25321588|NCT04918953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25321589|NCT04918953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321590|NCT04918953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25321591|NCT04918953|Glucocorticoids|glucocorticoids|mesh-ancestor
25321592|NCT04918953|Hormones|hormones|mesh-ancestor
25321593|NCT04918953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25321594|NCT04918953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25321595|NCT04918953|Protective Agents|protective agents|mesh-ancestor
25321597|NCT04918953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321598|NCT04918953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25321599|NCT04918953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25321600|NCT04918953|Respiratory System Agents|respiratory system agents|mesh-ancestor
25321601|NCT04918433|Anesthetics|anesthetics|mesh-list
25321602|NCT04918433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25321603|NCT04918433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321604|NCT04918264|Capecitabine|capecitabine|mesh-list
25321605|NCT04918264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25321606|NCT04918264|Antimetabolites|antimetabolites|mesh-ancestor
25193518|NCT02770443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25193523|NCT02770105|Caffeine|caffeine|mesh-list
25321607|NCT04918264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321608|NCT04918264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827497|NCT02139761|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24827498|NCT02139761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25321609|NCT04917679|Diacetylrhein|diacetylrhein|mesh-list
25321610|NCT04917679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25321611|NCT04917718|Tacrolimus|tacrolimus|mesh-list
25321612|NCT04917718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25321613|NCT04917718|Immunologic Factors|immunologic factors|mesh-ancestor
25321614|NCT04917718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321615|NCT04917718|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25321616|NCT04917718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321617|NCT04917718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321618|NCT04917692|Empagliflozin|empagliflozin|mesh-list
25321619|NCT04917692|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25321620|NCT04917692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321621|NCT04917692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25321622|NCT04917692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321623|NCT04917627|Vancomycin|vancomycin|mesh-list
25321624|NCT04917627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25321625|NCT04917627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25321626|NCT04917900|Paclitaxel|paclitaxel|mesh-list
25321627|NCT04917900|Trastuzumab|trastuzumab|mesh-list
25321628|NCT04917900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25321629|NCT04917900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25321630|NCT04917900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321631|NCT04917900|Tubulin Modulators|tubulin modulators|mesh-ancestor
25321632|NCT04917900|Antimitotic Agents|antimitotic agents|mesh-ancestor
25321633|NCT04917900|Mitosis Modulators|mitosis modulators|mesh-ancestor
25321634|NCT04917900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321635|NCT04917900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25321636|NCT04917757|Dexamethasone|dexamethasone|mesh-list
25321637|NCT04917757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25321638|NCT04917757|Antiemetics|antiemetics|mesh-ancestor
25321639|NCT04917757|Autonomic Agents|autonomic agents|mesh-ancestor
25321640|NCT04917757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25321641|NCT04917757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321642|NCT04917757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25321643|NCT04917757|Glucocorticoids|glucocorticoids|mesh-ancestor
25321644|NCT04917757|Hormones|hormones|mesh-ancestor
25321645|NCT04917757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25321646|NCT04917757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25321647|NCT04917757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321648|NCT04917497|Simendan|simendan|mesh-list
25321649|NCT04917497|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25321650|NCT04917497|Vasodilator Agents|vasodilator agents|mesh-ancestor
25321651|NCT04917497|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25321652|NCT04917497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25321653|NCT04917497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321654|NCT04917497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321655|NCT04917497|Protective Agents|protective agents|mesh-ancestor
25321656|NCT04917497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321657|NCT04917458|Vitamin D|vitamin d|mesh-list
25321658|NCT04917458|Cholecalciferol|cholecalciferol|mesh-list
25321659|NCT04917458|Vitamins|vitamins|mesh-ancestor
25321660|NCT04917458|Micronutrients|micronutrients|mesh-ancestor
25321661|NCT04917458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648941|NCT01486615|GABA Modulators|gaba modulators|mesh-ancestor
25648942|NCT01486615|GABA Agents|gaba agents|mesh-ancestor
25648943|NCT01486615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25648944|NCT01486615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25648945|NCT01486615|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25648946|NCT01486615|Dopamine Agents|dopamine agents|mesh-ancestor
25648947|NCT01486758|Azithromycin|azithromycin|mesh-list
25648948|NCT01486758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25321669|NCT04917484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25321670|NCT04917484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321672|NCT04917406|Lidocaine|lidocaine|mesh-list
25321673|NCT04917406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25321674|NCT04917406|Antiemetics|antiemetics|mesh-ancestor
25321675|NCT04917406|Autonomic Agents|autonomic agents|mesh-ancestor
25321676|NCT04917406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25321677|NCT04917406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321678|NCT04917406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25321679|NCT04917406|Glucocorticoids|glucocorticoids|mesh-ancestor
25321680|NCT04917406|Hormones|hormones|mesh-ancestor
25321681|NCT04917406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25321682|NCT04917406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25321683|NCT04917406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321684|NCT04917406|Anesthetics, Local|anesthetics, local|mesh-ancestor
25321685|NCT04917406|Anesthetics|anesthetics|mesh-ancestor
25321686|NCT04917406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25321687|NCT04917406|Sensory System Agents|sensory system agents|mesh-ancestor
25321688|NCT04917406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25321689|NCT04917406|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25321690|NCT04917406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25321691|NCT04917406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25321692|NCT04917406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574426|NCT00825149|Hormones|hormones|mesh-ancestor
25321693|NCT04917250|Gemcitabine|gemcitabine|mesh-list
25321694|NCT04917250|Dexamethasone|dexamethasone|mesh-list
25321695|NCT04917250|Etoposide|etoposide|mesh-list
25321696|NCT04917250|Pegaspargase|pegaspargase|mesh-list
25321697|NCT04917250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25321698|NCT04917250|Antiemetics|antiemetics|mesh-ancestor
25321699|NCT04917250|Autonomic Agents|autonomic agents|mesh-ancestor
25321700|NCT04917250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25321701|NCT04917250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321702|NCT04917250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25321703|NCT04917250|Glucocorticoids|glucocorticoids|mesh-ancestor
25321704|NCT04917250|Hormones|hormones|mesh-ancestor
25321705|NCT04917250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25321706|NCT04917250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25321707|NCT04917250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321708|NCT04917250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25321709|NCT04917250|Antimetabolites|antimetabolites|mesh-ancestor
25321710|NCT04917250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321711|NCT04917250|Antiviral Agents|antiviral agents|mesh-ancestor
25321712|NCT04917250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25321714|NCT04917250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25321715|NCT04917250|Immunologic Factors|immunologic factors|mesh-ancestor
25321716|NCT04917250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25321717|NCT04917250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25321718|NCT04917250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25321719|NCT04916925|Vitamin D|vitamin d|mesh-list
25321720|NCT04916925|Vitamins|vitamins|mesh-ancestor
25321721|NCT04916925|Micronutrients|micronutrients|mesh-ancestor
25321722|NCT04916925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321723|NCT04916925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25321724|NCT04916951|Amoxicillin|amoxicillin|mesh-list
25321725|NCT04916951|Cephalexin|cephalexin|mesh-list
25321726|NCT04916951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25321727|NCT04916951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25321728|NCT04916899|Rifampin|rifampin|mesh-list
25321729|NCT04916899|Isoniazid|isoniazid|mesh-list
25321730|NCT04916899|Pyrazinamide|pyrazinamide|mesh-list
25321731|NCT04916899|Ethambutol|ethambutol|mesh-list
25321732|NCT04916899|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25321733|NCT04916899|Antitubercular Agents|antitubercular agents|mesh-ancestor
25321734|NCT04916899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25321735|NCT04916899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25321736|NCT04916899|Leprostatic Agents|leprostatic agents|mesh-ancestor
25321737|NCT04916899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25321738|NCT04916899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321739|NCT04916899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321740|NCT04916899|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25321741|NCT04916899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25321742|NCT04916899|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25321743|NCT04916899|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25321744|NCT04916899|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25321745|NCT04916899|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25321746|NCT04916899|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25321747|NCT04916899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25321748|NCT04916899|Antimetabolites|antimetabolites|mesh-ancestor
25321749|NCT04916899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25321751|NCT04916886|Immunologic Factors|immunologic factors|mesh-ancestor
25321752|NCT04916886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321753|NCT04916821|Propolis|propolis|mesh-list
25321754|NCT04916821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25321755|NCT04916522|Colchicine|colchicine|mesh-list
25321756|NCT04916522|Gout Suppressants|gout suppressants|mesh-ancestor
25321757|NCT04916522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25321758|NCT04916522|Tubulin Modulators|tubulin modulators|mesh-ancestor
24898007|NCT04419038|Mitomycins|mitomycins|mesh-list
24629437|NCT01105299|Anastrozole|anastrozole|mesh-list
24571289|NCT00809029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571291|NCT00809042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24571292|NCT00809042|Antisickling Agents|antisickling agents|mesh-ancestor
24571293|NCT00809042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571294|NCT00809042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571295|NCT00809042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24571296|NCT00809068|Tibolone|tibolone|mesh-list
24571297|NCT00809068|Fenofibrate|fenofibrate|mesh-list
25321759|NCT04916522|Antimitotic Agents|antimitotic agents|mesh-ancestor
25321760|NCT04916522|Mitosis Modulators|mitosis modulators|mesh-ancestor
25321761|NCT04916522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321762|NCT04916522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321763|NCT04916665|Teduglutide|teduglutide|mesh-list
25321764|NCT04916665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25321765|NCT04916665|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25321766|NCT04916665|Protective Agents|protective agents|mesh-ancestor
25321767|NCT04916665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321768|NCT04916509|Fulvestrant|fulvestrant|mesh-list
25321769|NCT04916509|Palbociclib|palbociclib|mesh-list
25321770|NCT04916509|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25321771|NCT04916509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25321772|NCT04916509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321773|NCT04916509|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25321774|NCT04916509|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25321775|NCT04916509|Hormone Antagonists|hormone antagonists|mesh-ancestor
25321776|NCT04916509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25321777|NCT04916509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321778|NCT04916509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25321779|NCT04916509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321808|NCT04916353|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25321809|NCT04916353|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25321810|NCT04916353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25321811|NCT04916353|Glucocorticoids|glucocorticoids|mesh-ancestor
25321812|NCT04916353|Hormones|hormones|mesh-ancestor
25321813|NCT04916353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25321814|NCT04916353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321815|NCT04916353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25321816|NCT04916353|Immunologic Factors|immunologic factors|mesh-ancestor
25321817|NCT04916353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321818|NCT04916353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321823|NCT04916093|Metformin|metformin|mesh-list
25321824|NCT04916093|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25321825|NCT04916093|Vildagliptin|vildagliptin|mesh-list
25321826|NCT04916093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25321827|NCT04916093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206806|NCT05342818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24452129|NCT00326105|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25321830|NCT04916093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25321831|NCT04916093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25321832|NCT04916093|Protease Inhibitors|protease inhibitors|mesh-ancestor
25321833|NCT04916093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321834|NCT04916093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321835|NCT04915846|Tamoxifen|tamoxifen|mesh-list
25321836|NCT04915846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25321837|NCT04915846|Hormone Antagonists|hormone antagonists|mesh-ancestor
25321838|NCT04915846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25321839|NCT04915846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321840|NCT04915846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25321841|NCT04915846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321842|NCT04915846|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25321843|NCT04915846|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25321844|NCT04915846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25321845|NCT04915885|Contraceptive Agents|contraceptive agents|mesh-list
25321846|NCT04915885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25321847|NCT04915885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321848|NCT04916080|Acetylcysteine|acetylcysteine|mesh-list
25321868|NCT04915807|Taxane|taxane|mesh-list
25321869|NCT04915807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25321870|NCT04915807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321871|NCT04915807|Tubulin Modulators|tubulin modulators|mesh-ancestor
25321872|NCT04915807|Antimitotic Agents|antimitotic agents|mesh-ancestor
25321873|NCT04915807|Mitosis Modulators|mitosis modulators|mesh-ancestor
25321874|NCT04915807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321875|NCT04915807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25321876|NCT04915807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25321877|NCT04915807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321896|NCT04915586|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25321897|NCT04915586|Plasminogen|plasminogen|mesh-list
25321898|NCT04915586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25321899|NCT04915586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25321900|NCT04915586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321901|NCT04915482|Rituximab|rituximab|mesh-list
25009217|NCT02879162|Durvalumab|durvalumab|mesh-list
25321902|NCT04915482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25321903|NCT04915482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321904|NCT04915482|Immunologic Factors|immunologic factors|mesh-ancestor
25321905|NCT04915482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321906|NCT04915482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25321907|NCT04915365|Acetazolamide|acetazolamide|mesh-list
25321908|NCT04915365|Anticonvulsants|anticonvulsants|mesh-ancestor
25321909|NCT04915365|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25321910|NCT04915365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321911|NCT04915365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321912|NCT04915365|Diuretics|diuretics|mesh-ancestor
25321913|NCT04915365|Natriuretic Agents|natriuretic agents|mesh-ancestor
25321914|NCT04915365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321915|NCT04915287|Maleic acid|maleic acid|mesh-list
25321916|NCT04915287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321917|NCT04915287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956116|NCT03857581|Serotonin Agents|serotonin agents|mesh-ancestor
25321918|NCT04915456|Prednisolone|prednisolone|mesh-list
25321919|NCT04915456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25321920|NCT04915456|Glucocorticoids|glucocorticoids|mesh-ancestor
25321921|NCT04915456|Hormones|hormones|mesh-ancestor
25321922|NCT04915456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25321923|NCT04915456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321924|NCT04915456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25321925|NCT04915456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321926|NCT04914962|Lithium Carbonate|lithium carbonate|mesh-list
25321927|NCT04914962|Antidepressive Agents|antidepressive agents|mesh-ancestor
25321928|NCT04914962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25321929|NCT04914962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321930|NCT04914962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321931|NCT04914962|Antimanic Agents|antimanic agents|mesh-ancestor
25321932|NCT04914962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25321933|NCT04914962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25321934|NCT04914962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825527|NCT00005603|Cytarabine|cytarabine|mesh-list
25321936|NCT04914910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25321937|NCT04914910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321938|NCT04914936|Rifampin|rifampin|mesh-list
25321939|NCT04914936|Acalabrutinib|acalabrutinib|mesh-list
25321940|NCT04914936|Omeprazole|omeprazole|mesh-list
25321941|NCT04914936|Calcium Carbonate|calcium carbonate|mesh-list
25321942|NCT04914936|Calcium|calcium|mesh-list
25321943|NCT04914936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25321944|NCT04914936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321945|NCT04914936|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25321946|NCT04914936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25321947|NCT04914936|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25321948|NCT04914936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321949|NCT04914936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321950|NCT04914936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25321951|NCT04914936|Antitubercular Agents|antitubercular agents|mesh-ancestor
25321952|NCT04914936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25321953|NCT04914936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25321954|NCT04914936|Leprostatic Agents|leprostatic agents|mesh-ancestor
25321955|NCT04914936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25321956|NCT04914936|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25321957|NCT04914936|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25321958|NCT04914936|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25321959|NCT04914936|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25321960|NCT04914936|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25321961|NCT04914936|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25321962|NCT04914936|Antacids|antacids|mesh-ancestor
25321963|NCT04914936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321964|NCT04914390|Paclitaxel|paclitaxel|mesh-list
25321965|NCT04914390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25321966|NCT04914390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321967|NCT04914390|Tubulin Modulators|tubulin modulators|mesh-ancestor
25321968|NCT04914390|Antimitotic Agents|antimitotic agents|mesh-ancestor
25321969|NCT04914390|Mitosis Modulators|mitosis modulators|mesh-ancestor
25321970|NCT04914390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321971|NCT04914598|Cisplatin|cisplatin|mesh-list
25321972|NCT04914598|Endostar protein|endostar protein|mesh-list
25321973|NCT04914598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321974|NCT04914598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25321975|NCT04914598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25321976|NCT04914598|Growth Substances|growth substances|mesh-ancestor
25321977|NCT04914598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321978|NCT04914598|Growth Inhibitors|growth inhibitors|mesh-ancestor
25321979|NCT04913987|Cimetidine|cimetidine|mesh-list
25321980|NCT04913987|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25321981|NCT04913987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25321982|NCT04913987|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25321983|NCT04913987|Histamine Antagonists|histamine antagonists|mesh-ancestor
25321984|NCT04913987|Histamine Agents|histamine agents|mesh-ancestor
25321985|NCT04913987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25321986|NCT04913987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321987|NCT04913987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25321988|NCT04913987|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25321989|NCT04913987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25321990|NCT04913987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25321991|NCT04913896|Oxaliplatin|oxaliplatin|mesh-list
25321992|NCT04913896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25321993|NCT04913896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25321994|NCT04913896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25321995|NCT04913831|Cerebrolysin|cerebrolysin|mesh-list
25321996|NCT04913831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25321997|NCT04913831|Protective Agents|protective agents|mesh-ancestor
25322003|NCT04913922|Nivolumab|nivolumab|mesh-list
25322004|NCT04913922|Azacitidine|azacitidine|mesh-list
25322005|NCT04913922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25322006|NCT04913922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322007|NCT04913922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25322008|NCT04913922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322009|NCT04913922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25322010|NCT04913922|Antimetabolites|antimetabolites|mesh-ancestor
25322011|NCT04913922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322012|NCT04913389|Acetazolamide|acetazolamide|mesh-list
25322013|NCT04913389|Anticonvulsants|anticonvulsants|mesh-ancestor
25322014|NCT04913389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25322015|NCT04913389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322016|NCT04913389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322018|NCT04913389|Natriuretic Agents|natriuretic agents|mesh-ancestor
25322019|NCT04913389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322020|NCT04913402|Sufentanil|sufentanil|mesh-list
25322021|NCT04913402|Dsuvia|dsuvia|mesh-list
25322022|NCT04913402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25322023|NCT04913402|Narcotics|narcotics|mesh-ancestor
25322024|NCT04913402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25322025|NCT04913402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322026|NCT04913402|Analgesics|analgesics|mesh-ancestor
25322027|NCT04913402|Sensory System Agents|sensory system agents|mesh-ancestor
25322028|NCT04913402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25322029|NCT04913402|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25322030|NCT04913402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25322031|NCT04913402|Anesthetics, General|anesthetics, general|mesh-ancestor
25322032|NCT04913402|Anesthetics|anesthetics|mesh-ancestor
25322033|NCT04913103|Rituximab|rituximab|mesh-list
25322034|NCT04913103|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25322035|NCT04913103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25322036|NCT04913103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322037|NCT04913103|Immunologic Factors|immunologic factors|mesh-ancestor
25322038|NCT04913103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322039|NCT04913103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25322040|NCT04913103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25322041|NCT04913103|Alkylating Agents|alkylating agents|mesh-ancestor
25322042|NCT04913103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322043|NCT04912934|Insulin|insulin|mesh-list
25322044|NCT04912934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25322045|NCT04912934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322046|NCT04913311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25322047|NCT04913311|Dimercaprol|dimercaprol|mesh-list
25322048|NCT04913311|Chelating Agents|chelating agents|mesh-ancestor
25322049|NCT04913311|Sequestering Agents|sequestering agents|mesh-ancestor
25322050|NCT04913311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322051|NCT04913311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322052|NCT04912700|Vaccines|vaccines|mesh-list
25322053|NCT04912700|Immunologic Factors|immunologic factors|mesh-ancestor
25322054|NCT04912700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898301|NCT04415320|Ensartinib|ensartinib|mesh-list
24956338|NCT03855267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956339|NCT03855267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24956340|NCT03855267|Anesthetics, General|anesthetics, general|mesh-ancestor
24956342|NCT03855371|Decitabine|decitabine|mesh-list
24956343|NCT03855371|Arsenic Trioxide|arsenic trioxide|mesh-list
24956344|NCT03855371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25322060|NCT04912726|Sildenafil Citrate|sildenafil citrate|mesh-list
25322061|NCT04912726|Vasodilator Agents|vasodilator agents|mesh-ancestor
25322062|NCT04912726|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25322063|NCT04912726|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25322064|NCT04912726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322065|NCT04912726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322066|NCT04912726|Urological Agents|urological agents|mesh-ancestor
25322114|NCT04912271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25322115|NCT04912271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25322116|NCT04912271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322117|NCT04912271|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25322118|NCT04912271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25322119|NCT04912271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322120|NCT04912271|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25322121|NCT04912271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25322122|NCT04912271|Serotonin Agents|serotonin agents|mesh-ancestor
25322123|NCT04912193|Antithrombins|antithrombins|mesh-list
25322124|NCT04912193|Antithrombin III|antithrombin iii|mesh-list
24956424|NCT03854383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956425|NCT03854383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24956426|NCT03854383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25322125|NCT04912193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25322126|NCT04912193|Protease Inhibitors|protease inhibitors|mesh-ancestor
25322127|NCT04912193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322128|NCT04912193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322129|NCT04912193|Anticoagulants|anticoagulants|mesh-ancestor
25322131|NCT04912258|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25322132|NCT04912258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25322135|NCT04912258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322136|NCT04912297|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25322137|NCT04912297|Immunologic Factors|immunologic factors|mesh-ancestor
25322138|NCT04912297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322139|NCT04912128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
25322140|NCT04912128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25322141|NCT04912128|Growth Substances|growth substances|mesh-ancestor
25322142|NCT04912128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322143|NCT04912128|Growth Inhibitors|growth inhibitors|mesh-ancestor
25322144|NCT04912128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322145|NCT04911959|Lenvatinib|lenvatinib|mesh-list
25322146|NCT04911959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322147|NCT04911959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25322148|NCT04911959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322149|NCT04911959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322150|NCT04912141|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25322151|NCT04912141|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25322152|NCT04912141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25322153|NCT04912141|Immunologic Factors|immunologic factors|mesh-ancestor
25322154|NCT04912141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322155|NCT04912011|Canrenoic Acid|canrenoic acid|mesh-list
25322156|NCT04912011|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25322157|NCT04912011|Hormone Antagonists|hormone antagonists|mesh-ancestor
25322158|NCT04912011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25322159|NCT04912011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322160|NCT04912011|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25322161|NCT04912011|Diuretics|diuretics|mesh-ancestor
25322162|NCT04912011|Natriuretic Agents|natriuretic agents|mesh-ancestor
25322163|NCT04911621|Temozolomide|temozolomide|mesh-list
25322164|NCT04911621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25322165|NCT04911621|Alkylating Agents|alkylating agents|mesh-ancestor
25322166|NCT04911621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322167|NCT04911621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322168|NCT04911816|Hydroxychloroquine|hydroxychloroquine|mesh-list
25322169|NCT04911816|Antimalarials|antimalarials|mesh-ancestor
25322170|NCT04911816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25322171|NCT04911816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25322172|NCT04911816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25322173|NCT04911816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322174|NCT04911816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322175|NCT04911816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25322176|NCT04911127|Cannabidiol|cannabidiol|mesh-list
25322177|NCT04911127|Anticonvulsants|anticonvulsants|mesh-ancestor
25322178|NCT04911413|Tranexamic Acid|tranexamic acid|mesh-list
25322179|NCT04911413|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25322180|NCT04911413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25322181|NCT04911413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322182|NCT04911413|Hemostatics|hemostatics|mesh-ancestor
25322183|NCT04911413|Coagulants|coagulants|mesh-ancestor
25322184|NCT04911244|Dimercaprol|dimercaprol|mesh-list
25322185|NCT04911244|Chelating Agents|chelating agents|mesh-ancestor
25322186|NCT04911244|Sequestering Agents|sequestering agents|mesh-ancestor
25322187|NCT04911244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322188|NCT04910477|Atropine|atropine|mesh-list
25322189|NCT04910477|Dexmedetomidine|dexmedetomidine|mesh-list
24575247|NCT00830401|Antimalarials|antimalarials|mesh-ancestor
25322190|NCT04910477|Neostigmine|neostigmine|mesh-list
25825528|NCT00005603|Dexamethasone|dexamethasone|mesh-list
25825529|NCT00005603|Prednisone|prednisone|mesh-list
25825530|NCT00005603|Cyclophosphamide|cyclophosphamide|mesh-list
24956890|NCT03849664|Niacinamide|niacinamide|mesh-list
25322191|NCT04910477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25322192|NCT04910477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25322193|NCT04910477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322194|NCT04910477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25322195|NCT04910477|Analgesics|analgesics|mesh-ancestor
25648949|NCT01486758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25648950|NCT01486810|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
24543080|NCT00681902|Anesthetics|anesthetics|mesh-ancestor
25322196|NCT04910477|Sensory System Agents|sensory system agents|mesh-ancestor
25322197|NCT04910477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25322198|NCT04910477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25322199|NCT04910477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25322200|NCT04910477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25322201|NCT04910477|Adrenergic Agents|adrenergic agents|mesh-ancestor
25322202|NCT04910477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25322203|NCT04910477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322204|NCT04910477|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25322205|NCT04910477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25322206|NCT04910477|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25322207|NCT04910477|Autonomic Agents|autonomic agents|mesh-ancestor
25322208|NCT04910477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25322209|NCT04910477|Respiratory System Agents|respiratory system agents|mesh-ancestor
25322211|NCT04910477|Parasympatholytics|parasympatholytics|mesh-ancestor
25322212|NCT04910477|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25322213|NCT04910477|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25322214|NCT04910477|Cholinergic Agents|cholinergic agents|mesh-ancestor
25322215|NCT04910477|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25322216|NCT04910477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322217|NCT04910477|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25322219|NCT04910347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25322220|NCT04910347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322221|NCT04910347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25322222|NCT04910347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322223|NCT04910698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25322224|NCT04910698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25322225|NCT04910594|Epoetin Alfa|epoetin alfa|mesh-list
25322226|NCT04910594|Hematinics|hematinics|mesh-ancestor
25322227|NCT04910126|Doxorubicin|doxorubicin|mesh-list
25322228|NCT04910126|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25322229|NCT04910126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25322230|NCT04910126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322231|NCT04910126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25322232|NCT04910126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25322233|NCT04910126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322234|NCT04910126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322235|NCT04910165|Ropivacaine|ropivacaine|mesh-list
25322236|NCT04910165|Anesthetics, Local|anesthetics, local|mesh-ancestor
25322237|NCT04910165|Anesthetics|anesthetics|mesh-ancestor
25322238|NCT04910165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25322239|NCT04910165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322240|NCT04910165|Sensory System Agents|sensory system agents|mesh-ancestor
25322241|NCT04910165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25322242|NCT04909931|Vitamin D|vitamin d|mesh-list
25322243|NCT04909931|Ergocalciferols|ergocalciferols|mesh-list
25322244|NCT04909931|Vitamins|vitamins|mesh-ancestor
25322245|NCT04909931|Micronutrients|micronutrients|mesh-ancestor
25322246|NCT04909931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322247|NCT04909931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25322248|NCT04909931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25322249|NCT04909918|Dexamethasone|dexamethasone|mesh-list
25322250|NCT04909918|Methylprednisolone|methylprednisolone|mesh-list
25322251|NCT04909918|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25322252|NCT04909918|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25322253|NCT04909918|Prednisolone|prednisolone|mesh-list
25322254|NCT04909918|Prednisolone acetate|prednisolone acetate|mesh-list
25322255|NCT04909918|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25322256|NCT04909918|Prednisolone phosphate|prednisolone phosphate|mesh-list
25322257|NCT04909918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25322258|NCT04909918|Antiemetics|antiemetics|mesh-ancestor
25322259|NCT04909918|Autonomic Agents|autonomic agents|mesh-ancestor
25322260|NCT04909918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25322261|NCT04909918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322262|NCT04909918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25322263|NCT04909918|Glucocorticoids|glucocorticoids|mesh-ancestor
25322264|NCT04909918|Hormones|hormones|mesh-ancestor
25322265|NCT04909918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25322266|NCT04909918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25322267|NCT04909918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322268|NCT04909918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25322269|NCT04909918|Protective Agents|protective agents|mesh-ancestor
25322270|NCT04909684|Pembrolizumab|pembrolizumab|mesh-list
25648951|NCT01486810|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25322271|NCT04909684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25322272|NCT04909684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322273|NCT04909619|Anesthetics|anesthetics|mesh-list
25322274|NCT04909619|Anesthetics, Local|anesthetics, local|mesh-list
25322275|NCT04909619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25322276|NCT04909619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322277|NCT04909619|Sensory System Agents|sensory system agents|mesh-ancestor
25322278|NCT04909619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25322279|NCT04909775|Gemcitabine|gemcitabine|mesh-list
25322280|NCT04909775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322289|NCT04909775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827500|NCT02139761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25322298|NCT04908982|Aspirin|aspirin|mesh-list
25322299|NCT04908982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25322300|NCT04908982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25322301|NCT04908982|Analgesics|analgesics|mesh-ancestor
25322302|NCT04908982|Sensory System Agents|sensory system agents|mesh-ancestor
25322303|NCT04908982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25322304|NCT04908982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322305|NCT04908982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25322306|NCT04908982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25322307|NCT04908982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25322308|NCT04908982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25322309|NCT04908982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322310|NCT04908982|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25322311|NCT04908982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25322312|NCT04908982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322313|NCT04908982|Antipyretics|antipyretics|mesh-ancestor
25322314|NCT04909255|Solifenacin Succinate|solifenacin succinate|mesh-list
25322315|NCT04909255|Mirabegron|mirabegron|mesh-list
25322316|NCT04909255|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25322317|NCT04909255|Oxybutynin|oxybutynin|mesh-list
25322318|NCT04909255|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25322319|NCT04909255|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25322320|NCT04909255|Cholinergic Agents|cholinergic agents|mesh-ancestor
25322321|NCT04909255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25322322|NCT04909255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322323|NCT04909255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322324|NCT04909255|Urological Agents|urological agents|mesh-ancestor
25322325|NCT04909255|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25322326|NCT04909255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25322327|NCT04909255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25322328|NCT04909255|Adrenergic Agents|adrenergic agents|mesh-ancestor
25322329|NCT04909255|Parasympatholytics|parasympatholytics|mesh-ancestor
25322330|NCT04909255|Autonomic Agents|autonomic agents|mesh-ancestor
25322331|NCT04909255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25322332|NCT04909151|Methamphetamine|methamphetamine|mesh-list
25322333|NCT04909151|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25322334|NCT04909151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322335|NCT04909151|Sympathomimetics|sympathomimetics|mesh-ancestor
25322336|NCT04909151|Autonomic Agents|autonomic agents|mesh-ancestor
25322337|NCT04909151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25322338|NCT04909151|Dopamine Agents|dopamine agents|mesh-ancestor
25322339|NCT04909151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25322340|NCT04909151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322341|NCT04909151|Adrenergic Agents|adrenergic agents|mesh-ancestor
25322342|NCT04909151|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25322343|NCT04909151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25322344|NCT04909151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25322345|NCT04909151|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25322350|NCT04908566|Folfirinox|folfirinox|mesh-list
25322351|NCT04908566|Antibodies|antibodies|mesh-list
25322352|NCT04908566|Immunoglobulins|immunoglobulins|mesh-list
25322353|NCT04908566|Immunologic Factors|immunologic factors|mesh-ancestor
25322354|NCT04908566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322361|NCT04908813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322362|NCT04908813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322363|NCT04908813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25322365|NCT04908345|Methadone|methadone|mesh-list
25322366|NCT04908345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25322367|NCT04908345|Narcotics|narcotics|mesh-ancestor
25322368|NCT04908345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25322369|NCT04908345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322370|NCT04908345|Analgesics|analgesics|mesh-ancestor
25825531|NCT00005603|Doxorubicin|doxorubicin|mesh-list
25322371|NCT04908345|Sensory System Agents|sensory system agents|mesh-ancestor
25322372|NCT04908345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25322373|NCT04908345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25322374|NCT04908345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25322375|NCT04908345|Anesthetics, General|anesthetics, general|mesh-ancestor
25322376|NCT04908345|Anesthetics|anesthetics|mesh-ancestor
25322377|NCT04908345|Antitussive Agents|antitussive agents|mesh-ancestor
25322378|NCT04908345|Respiratory System Agents|respiratory system agents|mesh-ancestor
25322380|NCT04907708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25322381|NCT04907708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322382|NCT04907812|Tranexamic Acid|tranexamic acid|mesh-list
25322383|NCT04907812|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25322384|NCT04907812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25322385|NCT04907812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322386|NCT04907812|Hemostatics|hemostatics|mesh-ancestor
25322387|NCT04907812|Coagulants|coagulants|mesh-ancestor
25322388|NCT04907864|Ibuprofen|ibuprofen|mesh-list
25322389|NCT04907864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25322390|NCT04907864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25322391|NCT04907864|Analgesics|analgesics|mesh-ancestor
25322392|NCT04907864|Sensory System Agents|sensory system agents|mesh-ancestor
25322393|NCT04907864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25322394|NCT04907864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322395|NCT04907864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25322396|NCT04907864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25322397|NCT04907864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25322398|NCT04907864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322399|NCT04907864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825532|NCT00005603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25825533|NCT00005603|Methotrexate|methotrexate|mesh-list
25078355|NCT03357055|Analgesics|analgesics|mesh-ancestor
25078356|NCT03357055|Sensory System Agents|sensory system agents|mesh-ancestor
25078357|NCT03357055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078358|NCT03357055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322406|NCT04907838|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
25322407|NCT04907838|BQ 788|bq 788|mesh-list
25322408|NCT04907838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25322409|NCT04907838|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25322410|NCT04907838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322411|NCT04907838|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25322412|NCT04907474|Phenylephrine|phenylephrine|mesh-list
25322413|NCT04907474|Oxymetazoline|oxymetazoline|mesh-list
25322414|NCT04907474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25322415|NCT04907474|Tropicamide|tropicamide|mesh-list
25322416|NCT04907474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25322417|NCT04907474|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25322418|NCT04907474|Mydriatics|mydriatics|mesh-ancestor
25322419|NCT04907474|Autonomic Agents|autonomic agents|mesh-ancestor
25322420|NCT04907474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25322421|NCT04907474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322422|NCT04907474|Sympathomimetics|sympathomimetics|mesh-ancestor
25322423|NCT04907474|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25322424|NCT04907474|Nasal Decongestants|nasal decongestants|mesh-ancestor
25322425|NCT04907474|Respiratory System Agents|respiratory system agents|mesh-ancestor
25322426|NCT04907474|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25322427|NCT04907474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25322428|NCT04907474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25322429|NCT04907474|Adrenergic Agents|adrenergic agents|mesh-ancestor
25322430|NCT04907474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25322431|NCT04907474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322432|NCT04907474|Protective Agents|protective agents|mesh-ancestor
25322433|NCT04907474|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25322434|NCT04907474|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25322435|NCT04907474|Cholinergic Agents|cholinergic agents|mesh-ancestor
25322436|NCT04907747|Amoxicillin|amoxicillin|mesh-list
25322437|NCT04907747|Furazolidone|furazolidone|mesh-list
25322438|NCT04907747|Esomeprazole|esomeprazole|mesh-list
25322439|NCT04907747|Bismuth|bismuth|mesh-list
25322440|NCT04907747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25322441|NCT04907747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25322442|NCT04907747|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25322443|NCT04907747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25322444|NCT04907747|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25322445|NCT04907747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322446|NCT04907747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948264|NCT03920813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322447|NCT04907747|Antacids|antacids|mesh-ancestor
25322866|NCT04902261|Immunologic Factors|immunologic factors|mesh-ancestor
25322448|NCT04907747|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25322449|NCT04907747|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25322450|NCT04907747|Renal Agents|renal agents|mesh-ancestor
25322451|NCT04907747|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25322452|NCT04907747|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25322453|NCT04907747|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25322454|NCT04907747|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25322455|NCT04907123|Diuretics|diuretics|mesh-list
25322456|NCT04907123|Natriuretic Agents|natriuretic agents|mesh-ancestor
25322457|NCT04907123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322458|NCT04907149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25322459|NCT04907110|Niacinamide|niacinamide|mesh-list
25322460|NCT04907110|Vitamin B Complex|vitamin b complex|mesh-ancestor
25322461|NCT04907110|Vitamins|vitamins|mesh-ancestor
25322462|NCT04907110|Micronutrients|micronutrients|mesh-ancestor
25322463|NCT04907110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322464|NCT04907344|Paclitaxel|paclitaxel|mesh-list
25322465|NCT04907344|Carboplatin|carboplatin|mesh-list
25322466|NCT04907344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25322467|NCT04907344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322468|NCT04907344|Tubulin Modulators|tubulin modulators|mesh-ancestor
25078389|NCT03356873|Cholecalciferol|cholecalciferol|mesh-list
25078390|NCT03356873|Vitamins|vitamins|mesh-list
25078391|NCT03356873|Micronutrients|micronutrients|mesh-ancestor
25078392|NCT03356873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957112|NCT03847155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24957114|NCT03847155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25322469|NCT04907344|Antimitotic Agents|antimitotic agents|mesh-ancestor
25322470|NCT04907344|Mitosis Modulators|mitosis modulators|mesh-ancestor
25322471|NCT04907344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322472|NCT04906889|Lidocaine|lidocaine|mesh-list
25322473|NCT04906889|Dexmedetomidine|dexmedetomidine|mesh-list
25322474|NCT04906889|Remifentanil|remifentanil|mesh-list
25322475|NCT04906889|Anesthetics, Local|anesthetics, local|mesh-ancestor
25322476|NCT04906889|Anesthetics|anesthetics|mesh-ancestor
25322477|NCT04906889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25322478|NCT04906889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322479|NCT04906889|Sensory System Agents|sensory system agents|mesh-ancestor
25322480|NCT04906889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25322481|NCT04906889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25322482|NCT04906889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25322483|NCT04906889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25322484|NCT04906889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25322485|NCT04906889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322486|NCT04906889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25322487|NCT04906889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25322488|NCT04906889|Analgesics|analgesics|mesh-ancestor
25322489|NCT04906889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25322490|NCT04906889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25322491|NCT04906889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25322492|NCT04906889|Adrenergic Agents|adrenergic agents|mesh-ancestor
25322493|NCT04906889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25322494|NCT04906889|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25322495|NCT04906889|Narcotics|narcotics|mesh-ancestor
25322496|NCT04906876|Gemcitabine|gemcitabine|mesh-list
25322497|NCT04906876|Docetaxel|docetaxel|mesh-list
25322498|NCT04906876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25322499|NCT04906876|Antimetabolites|antimetabolites|mesh-ancestor
25322500|NCT04906876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322501|NCT04906876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322502|NCT04906876|Antiviral Agents|antiviral agents|mesh-ancestor
25322503|NCT04906876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25322504|NCT04906876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322505|NCT04906876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25322506|NCT04906876|Immunologic Factors|immunologic factors|mesh-ancestor
25322507|NCT04906876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322508|NCT04906876|Tubulin Modulators|tubulin modulators|mesh-ancestor
25322509|NCT04906876|Antimitotic Agents|antimitotic agents|mesh-ancestor
25322510|NCT04906876|Mitosis Modulators|mitosis modulators|mesh-ancestor
25322511|NCT04906772|Dexmedetomidine|dexmedetomidine|mesh-list
25322512|NCT04906772|Ketamine|ketamine|mesh-list
25322513|NCT04906772|Propofol|propofol|mesh-list
25648952|NCT01486810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322514|NCT04906772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25322515|NCT04906772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25322516|NCT04906772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322517|NCT04906772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25322518|NCT04906772|Anesthetics, General|anesthetics, general|mesh-ancestor
25322519|NCT04906772|Anesthetics|anesthetics|mesh-ancestor
25322520|NCT04906772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25322521|NCT04906772|Analgesics|analgesics|mesh-ancestor
25322522|NCT04906772|Sensory System Agents|sensory system agents|mesh-ancestor
25322523|NCT04906772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25322524|NCT04906772|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25322525|NCT04906772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25322526|NCT04906772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25322527|NCT04906772|Adrenergic Agents|adrenergic agents|mesh-ancestor
25322528|NCT04906772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25322529|NCT04906772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322530|NCT04906772|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25322531|NCT04906772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25322532|NCT04906772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25322533|NCT04906655|Glycopyrrolate|glycopyrrolate|mesh-list
25322534|NCT04906655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25322535|NCT04906655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25322536|NCT04906655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25322537|NCT04906655|Cholinergic Agents|cholinergic agents|mesh-ancestor
25322538|NCT04906655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25322539|NCT04906655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322540|NCT04906655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322541|NCT04906915|Ketamine|ketamine|mesh-list
25322542|NCT04906915|Analgesics|analgesics|mesh-ancestor
25322543|NCT04906915|Sensory System Agents|sensory system agents|mesh-ancestor
25322544|NCT04906915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25322545|NCT04906915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322546|NCT04906915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25322547|NCT04906915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25322548|NCT04906915|Anesthetics, General|anesthetics, general|mesh-ancestor
25322549|NCT04906915|Anesthetics|anesthetics|mesh-ancestor
25322550|NCT04906915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25322551|NCT04906915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25322552|NCT04906915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25322553|NCT04906915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25322554|NCT04906915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322555|NCT04906720|Colchicine|colchicine|mesh-list
25322556|NCT04906720|Gout Suppressants|gout suppressants|mesh-ancestor
25322557|NCT04906720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25322558|NCT04906720|Tubulin Modulators|tubulin modulators|mesh-ancestor
25322559|NCT04906720|Antimitotic Agents|antimitotic agents|mesh-ancestor
25322560|NCT04906720|Mitosis Modulators|mitosis modulators|mesh-ancestor
25322561|NCT04906720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322562|NCT04906720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322563|NCT04906317|Midazolam|midazolam|mesh-list
25322564|NCT04906317|Dezocine|dezocine|mesh-list
25322565|NCT04906317|Propofol|propofol|mesh-list
25322566|NCT04906317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25322567|NCT04906317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25322568|NCT04906317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322569|NCT04906317|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25322570|NCT04906317|Anesthetics, General|anesthetics, general|mesh-ancestor
25322571|NCT04906317|Anesthetics|anesthetics|mesh-ancestor
25322572|NCT04906317|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25322573|NCT04906317|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25322574|NCT04906317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25322575|NCT04906317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25322576|NCT04906317|GABA Modulators|gaba modulators|mesh-ancestor
25322577|NCT04906317|GABA Agents|gaba agents|mesh-ancestor
25322578|NCT04906317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25322579|NCT04906317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322580|NCT04906317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25322581|NCT04906317|Narcotics|narcotics|mesh-ancestor
25322582|NCT04906317|Analgesics|analgesics|mesh-ancestor
25322583|NCT04906317|Sensory System Agents|sensory system agents|mesh-ancestor
25322584|NCT04906317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25322585|NCT04906031|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
25322586|NCT04906031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25322587|NCT04906031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25322588|NCT04906031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25322589|NCT04906031|Schistosomicides|schistosomicides|mesh-ancestor
25322590|NCT04906031|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25322591|NCT04906031|Anthelmintics|anthelmintics|mesh-ancestor
25322592|NCT04906304|Mycophenolic Acid|mycophenolic acid|mesh-list
25322593|NCT04906304|Cyclosporine|cyclosporine|mesh-list
25322594|NCT04906304|Everolimus|everolimus|mesh-list
25322595|NCT04906304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322596|NCT04906304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25322597|NCT04906304|Immunologic Factors|immunologic factors|mesh-ancestor
25322598|NCT04906304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322599|NCT04906304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25322600|NCT04906304|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25322601|NCT04906304|Antitubercular Agents|antitubercular agents|mesh-ancestor
25322602|NCT04906304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25322603|NCT04906304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25322604|NCT04906304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322605|NCT04906304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322606|NCT04906304|Antifungal Agents|antifungal agents|mesh-ancestor
25322607|NCT04906304|Dermatologic Agents|dermatologic agents|mesh-ancestor
25322608|NCT04906304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25322609|NCT04906304|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25322610|NCT04906083|Mitogens|mitogens|mesh-list
25322611|NCT04906083|Mitosis Modulators|mitosis modulators|mesh-ancestor
25322612|NCT04906083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322613|NCT04906161|Vitamin D|vitamin d|mesh-list
25322614|NCT04906161|Calcium|calcium|mesh-list
25322615|NCT04906161|Vitamins|vitamins|mesh-ancestor
25322616|NCT04906161|Micronutrients|micronutrients|mesh-ancestor
25322617|NCT04906161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322618|NCT04906161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25322619|NCT04906161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25322620|NCT04905953|Neostigmine|neostigmine|mesh-list
25322621|NCT04905953|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25322622|NCT04905953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322623|NCT04905953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322624|NCT04905953|Cholinergic Agents|cholinergic agents|mesh-ancestor
25322625|NCT04905953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25322626|NCT04905953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322627|NCT04905953|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25322628|NCT04905953|Autonomic Agents|autonomic agents|mesh-ancestor
25322629|NCT04905953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25322630|NCT04905667|Trastuzumab|trastuzumab|mesh-list
25322631|NCT04905667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25322632|NCT04905667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322633|NCT04905563|Acetaminophen|acetaminophen|mesh-list
25322634|NCT04905563|Ibuprofen|ibuprofen|mesh-list
25322635|NCT04905563|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25322636|NCT04905563|Hydrocodone|hydrocodone|mesh-list
25322637|NCT04905563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25322638|NCT04905563|Analgesics|analgesics|mesh-ancestor
25322639|NCT04905563|Sensory System Agents|sensory system agents|mesh-ancestor
25322640|NCT04905563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25322641|NCT04905563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322642|NCT04905563|Antipyretics|antipyretics|mesh-ancestor
25322643|NCT04905563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25322644|NCT04905563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25322645|NCT04905563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25322646|NCT04905563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25322647|NCT04905563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322721|NCT04903847|Lamivudine|lamivudine|mesh-list
25322671|NCT04905108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322673|NCT04905108|Dermatologic Agents|dermatologic agents|mesh-ancestor
25322674|NCT04905043|Acalabrutinib|acalabrutinib|mesh-list
25322675|NCT04905043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322676|NCT04905147|Mosapride|mosapride|mesh-list
25322677|NCT04905147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25322678|NCT04905147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25322679|NCT04905147|Serotonin Agents|serotonin agents|mesh-ancestor
25322680|NCT04905147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25322681|NCT04905147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322682|NCT04905147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322688|NCT04904185|Cyclophosphamide|cyclophosphamide|mesh-list
25322689|NCT04904185|Pembrolizumab|pembrolizumab|mesh-list
25322690|NCT04904185|Fludarabine|fludarabine|mesh-list
25322691|NCT04904185|Fludarabine phosphate|fludarabine phosphate|mesh-list
25322692|NCT04904185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25322693|NCT04904185|Immunologic Factors|immunologic factors|mesh-ancestor
25322694|NCT04904185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322695|NCT04904185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25322696|NCT04904185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25322697|NCT04904185|Alkylating Agents|alkylating agents|mesh-ancestor
25322698|NCT04904185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322699|NCT04904185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322700|NCT04904185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25322701|NCT04904185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25322702|NCT04904185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25322704|NCT04904406|Lamivudine|lamivudine|mesh-list
25322705|NCT04904406|Abacavir|abacavir|mesh-list
25322706|NCT04904406|Dolutegravir|dolutegravir|mesh-list
25322707|NCT04904406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25322708|NCT04904406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25322709|NCT04904406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322710|NCT04904406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322711|NCT04904406|Antiviral Agents|antiviral agents|mesh-ancestor
25322712|NCT04904406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25322713|NCT04904406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25322714|NCT04904406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25322715|NCT04904406|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25322716|NCT04904406|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25322720|NCT04903847|Tenofovir|tenofovir|mesh-list
25322722|NCT04903847|Dolutegravir|dolutegravir|mesh-list
25322723|NCT04903847|Antiviral Agents|antiviral agents|mesh-ancestor
25322724|NCT04903847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24957691|NCT03842631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957692|NCT03842631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957693|NCT03842631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24957694|NCT03842631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24957695|NCT03842631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322725|NCT04903847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25322726|NCT04903847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25322727|NCT04903847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322728|NCT04903847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322729|NCT04903847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25322730|NCT04903847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25322731|NCT04903847|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25322732|NCT04903847|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25322733|NCT04903808|Allyl sulfide|allyl sulfide|mesh-list
25322734|NCT04903808|Antioxidants|antioxidants|mesh-ancestor
25322735|NCT04903808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322736|NCT04903808|Protective Agents|protective agents|mesh-ancestor
25322737|NCT04903808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322738|NCT04903808|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25322739|NCT04903808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322740|NCT04903808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25322741|NCT04903808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322742|NCT04903743|Magnesium Sulfate|magnesium sulfate|mesh-list
25322743|NCT04903743|Bupivacaine|bupivacaine|mesh-list
25322744|NCT04903743|Anesthetics, Local|anesthetics, local|mesh-ancestor
25322745|NCT04903743|Anesthetics|anesthetics|mesh-ancestor
25322746|NCT04903743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25322747|NCT04903743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322748|NCT04903743|Sensory System Agents|sensory system agents|mesh-ancestor
25322749|NCT04903743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25322750|NCT04903743|Analgesics|analgesics|mesh-ancestor
25322751|NCT04903743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25322752|NCT04903743|Anticonvulsants|anticonvulsants|mesh-ancestor
25322753|NCT04903743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25322754|NCT04903743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25322755|NCT04903743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322756|NCT04903743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25322757|NCT04903743|Tocolytic Agents|tocolytic agents|mesh-ancestor
25322758|NCT04903743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25322759|NCT04903678|Melphalan|melphalan|mesh-list
25322760|NCT04903678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25322761|NCT04903678|Alkylating Agents|alkylating agents|mesh-ancestor
25322762|NCT04903678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322763|NCT04903678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322764|NCT04903678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25322765|NCT04903678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25322766|NCT04903678|Immunologic Factors|immunologic factors|mesh-ancestor
25322767|NCT04903678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322768|NCT04903366|Timolol|timolol|mesh-list
25322769|NCT04903366|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25322770|NCT04903366|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25206890|NCT05267873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25206891|NCT05267873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25206892|NCT05267873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25206893|NCT05267873|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25206894|NCT05267873|Serotonin Agents|serotonin agents|mesh-ancestor
25322771|NCT04903366|Adrenergic Agents|adrenergic agents|mesh-ancestor
25322772|NCT04903366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25322773|NCT04903366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322774|NCT04903366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322775|NCT04903366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25322776|NCT04903366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25322777|NCT04903275|Fluorides|fluorides|mesh-list
25322778|NCT04903275|Fluorides, Topical|fluorides, topical|mesh-list
25322779|NCT04903275|Cariostatic Agents|cariostatic agents|mesh-ancestor
25322780|NCT04903275|Protective Agents|protective agents|mesh-ancestor
25322781|NCT04903275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322782|NCT04903054|Mycophenolic Acid|mycophenolic acid|mesh-list
25322783|NCT04903054|Prednisone|prednisone|mesh-list
25322784|NCT04903054|Methylprednisolone|methylprednisolone|mesh-list
25322785|NCT04903054|Tacrolimus|tacrolimus|mesh-list
25322786|NCT04903054|Thymoglobulin|thymoglobulin|mesh-list
25322787|NCT04903054|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25322788|NCT04903054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25322789|NCT04903054|Glucocorticoids|glucocorticoids|mesh-ancestor
25322790|NCT04903054|Hormones|hormones|mesh-ancestor
25322791|NCT04903054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25322799|NCT04903054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322800|NCT04903054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25322801|NCT04903054|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25322802|NCT04903054|Antitubercular Agents|antitubercular agents|mesh-ancestor
25322803|NCT04903054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25322804|NCT04903054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25322806|NCT04903054|Autonomic Agents|autonomic agents|mesh-ancestor
25322807|NCT04903054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25322808|NCT04903054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25322809|NCT04903054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25322810|NCT04903054|Protective Agents|protective agents|mesh-ancestor
25322811|NCT04902911|Antibodies|antibodies|mesh-list
25322812|NCT04902911|Immunoglobulin M|immunoglobulin m|mesh-list
25322813|NCT04902911|Immunologic Factors|immunologic factors|mesh-ancestor
25322814|NCT04902911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322815|NCT04902885|Carboplatin|carboplatin|mesh-list
25322816|NCT04902885|Etoposide|etoposide|mesh-list
25322817|NCT04902885|Topotecan|topotecan|mesh-list
25322818|NCT04902885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322819|NCT04902885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25322820|NCT04902885|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25322821|NCT04902885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25322822|NCT04902885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322823|NCT04902885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322824|NCT04902885|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25322825|NCT04902950|Tranexamic Acid|tranexamic acid|mesh-list
25322826|NCT04902950|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25322827|NCT04902950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25322828|NCT04902950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322829|NCT04902950|Hemostatics|hemostatics|mesh-ancestor
25322830|NCT04902950|Coagulants|coagulants|mesh-ancestor
24958031|NCT03837886|Calcium|calcium|mesh-list
25322840|NCT04902638|Dexamethasone|dexamethasone|mesh-list
25322841|NCT04902638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25322842|NCT04902638|Antiemetics|antiemetics|mesh-ancestor
25322843|NCT04902638|Autonomic Agents|autonomic agents|mesh-ancestor
25322844|NCT04902638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25322845|NCT04902638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322846|NCT04902638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25322847|NCT04902638|Glucocorticoids|glucocorticoids|mesh-ancestor
25322848|NCT04902638|Hormones|hormones|mesh-ancestor
25322849|NCT04902638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25322850|NCT04902638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25322851|NCT04902638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322852|NCT04902261|Gemcitabine|gemcitabine|mesh-list
25648953|NCT01486810|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25648954|NCT01486810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25648955|NCT01486810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25648956|NCT01486810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322853|NCT04902261|Paclitaxel|paclitaxel|mesh-list
25322854|NCT04902261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25322855|NCT04902261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322856|NCT04902261|Tubulin Modulators|tubulin modulators|mesh-ancestor
25322857|NCT04902261|Antimitotic Agents|antimitotic agents|mesh-ancestor
25322858|NCT04902261|Mitosis Modulators|mitosis modulators|mesh-ancestor
25322859|NCT04902261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322860|NCT04902261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25322861|NCT04902261|Antimetabolites|antimetabolites|mesh-ancestor
25322862|NCT04902261|Antiviral Agents|antiviral agents|mesh-ancestor
25322863|NCT04902261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25322864|NCT04902261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322865|NCT04902261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25322867|NCT04902261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322871|NCT04902495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322872|NCT04902495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25322873|NCT04902495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25322875|NCT04902222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25322876|NCT04902222|Narcotics|narcotics|mesh-ancestor
25322877|NCT04902222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25322878|NCT04902222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322879|NCT04902222|Analgesics|analgesics|mesh-ancestor
25322880|NCT04902222|Sensory System Agents|sensory system agents|mesh-ancestor
25322881|NCT04902222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25322885|NCT04902027|Mitoxantrone|mitoxantrone|mesh-list
25322886|NCT04902027|Analgesics|analgesics|mesh-ancestor
25322887|NCT04902027|Sensory System Agents|sensory system agents|mesh-ancestor
25322888|NCT04902027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25322889|NCT04902027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322890|NCT04902027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322891|NCT04902027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25322892|NCT04902027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25322893|NCT04902027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322894|NCT04902027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322895|NCT04902105|Mefenamic Acid|mefenamic acid|mesh-list
25322896|NCT04902105|Valproic Acid|valproic acid|mesh-list
25322897|NCT04902105|Ecopipam|ecopipam|mesh-list
25322898|NCT04902105|Anticonvulsants|anticonvulsants|mesh-ancestor
25322899|NCT04902105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322900|NCT04902105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322901|NCT04902105|GABA Agents|gaba agents|mesh-ancestor
25322902|NCT04902105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25322903|NCT04902105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322904|NCT04902105|Antimanic Agents|antimanic agents|mesh-ancestor
25322905|NCT04902105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25322906|NCT04902105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25322907|NCT04902105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25322908|NCT04902105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25322909|NCT04902105|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25322910|NCT04902105|Dopamine Agents|dopamine agents|mesh-ancestor
25322911|NCT04902105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25322912|NCT04902105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25322913|NCT04902105|Analgesics|analgesics|mesh-ancestor
25322914|NCT04902105|Sensory System Agents|sensory system agents|mesh-ancestor
25322915|NCT04902105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25322916|NCT04902105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25322917|NCT04902105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25322918|NCT04902105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25322919|NCT04901923|Itraconazole|itraconazole|mesh-list
25322920|NCT04901923|Acalabrutinib|acalabrutinib|mesh-list
25322921|NCT04901923|Antifungal Agents|antifungal agents|mesh-ancestor
25322922|NCT04901923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25322923|NCT04901923|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25322924|NCT04901923|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25322925|NCT04901923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322926|NCT04901923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322927|NCT04901923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25322928|NCT04901923|Hormone Antagonists|hormone antagonists|mesh-ancestor
25322929|NCT04901923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25322930|NCT04901923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322931|NCT04901923|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25322932|NCT04901923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25322933|NCT04901884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25322934|NCT04901884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25648957|NCT01486810|Dopamine Agents|dopamine agents|mesh-ancestor
25194431|NCT02764619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25194432|NCT02764619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194433|NCT02764619|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25194434|NCT02764619|Diuretics|diuretics|mesh-ancestor
25194435|NCT02764619|Natriuretic Agents|natriuretic agents|mesh-ancestor
25194436|NCT02764515|Methotrexate|methotrexate|mesh-list
25194437|NCT02764515|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25194438|NCT02764515|Abortifacient Agents|abortifacient agents|mesh-ancestor
25194439|NCT02764515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25194477|NCT02764749|Phenol|phenol|mesh-list
25322935|NCT04901884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322936|NCT04901494|Serotonin|serotonin|mesh-list
25322937|NCT04901494|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25322938|NCT04901494|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25322939|NCT04901494|Serotonin Agents|serotonin agents|mesh-ancestor
25322940|NCT04901494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25322941|NCT04901494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322942|NCT04901494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322943|NCT04901494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25322944|NCT04901494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25322945|NCT04901663|Amoxicillin|amoxicillin|mesh-list
25322946|NCT04901663|Clarithromycin|clarithromycin|mesh-list
25322947|NCT04901663|Omeprazole|omeprazole|mesh-list
25322948|NCT04901663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25322949|NCT04901663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25322950|NCT04901663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25322951|NCT04901663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25322952|NCT04901663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25322953|NCT04901663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322954|NCT04901663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322955|NCT04901663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25322956|NCT04901663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25322957|NCT04901663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25322958|NCT04901312|Analgesics, Opioid|analgesics, opioid|mesh-list
25322959|NCT04901312|Narcotics|narcotics|mesh-ancestor
25322960|NCT04901312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25322961|NCT04901312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322962|NCT04901312|Analgesics|analgesics|mesh-ancestor
25322963|NCT04901312|Sensory System Agents|sensory system agents|mesh-ancestor
25322964|NCT04901312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25322965|NCT04901117|Amoxicillin|amoxicillin|mesh-list
25322966|NCT04901117|Metronidazole|metronidazole|mesh-list
25322967|NCT04901117|Clarithromycin|clarithromycin|mesh-list
25322968|NCT04901117|Tetracycline|tetracycline|mesh-list
25322969|NCT04901117|Potassium Citrate|potassium citrate|mesh-list
25322970|NCT04901117|Bismuth|bismuth|mesh-list
25322971|NCT04901117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322972|NCT04901117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25322973|NCT04901117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25322974|NCT04901117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25322975|NCT04901117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25322976|NCT04901117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25322977|NCT04901117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25322978|NCT04901117|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25322979|NCT04901117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25322980|NCT04901117|Antacids|antacids|mesh-ancestor
25322981|NCT04901117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25322982|NCT04901117|Diuretics|diuretics|mesh-ancestor
25322983|NCT04901117|Natriuretic Agents|natriuretic agents|mesh-ancestor
25322984|NCT04901117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322985|NCT04901117|Expectorants|expectorants|mesh-ancestor
25322986|NCT04901117|Respiratory System Agents|respiratory system agents|mesh-ancestor
25322987|NCT04901065|Lidocaine|lidocaine|mesh-list
25322988|NCT04901065|Anesthetics, Local|anesthetics, local|mesh-ancestor
25322989|NCT04901065|Anesthetics|anesthetics|mesh-ancestor
25648958|NCT01486810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25648959|NCT01486927|Factor VIII|factor viii|mesh-list
25648960|NCT01486927|Coagulants|coagulants|mesh-ancestor
25648961|NCT01486966|Insulin|insulin|mesh-list
25648962|NCT01486966|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25648963|NCT01486966|Metformin|metformin|mesh-list
25648964|NCT01486966|Insulin Aspart|insulin aspart|mesh-list
25648965|NCT01486966|Insulin Detemir|insulin detemir|mesh-list
25648966|NCT01486966|Isophane Insulin, Human|isophane insulin, human|mesh-list
25648967|NCT01486966|Insulin, Isophane|insulin, isophane|mesh-list
25648968|NCT01486966|Isophane insulin, beef|isophane insulin, beef|mesh-list
25648969|NCT01486966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24560396|NCT02726997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25206929|NCT05244538|Remifentanil|remifentanil|mesh-list
25206930|NCT05244538|Propofol|propofol|mesh-list
25206931|NCT05244538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25206932|NCT05244538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25206933|NCT05244538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206934|NCT05244538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25206935|NCT05244538|Anesthetics, General|anesthetics, general|mesh-ancestor
25322990|NCT04901065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25322991|NCT04901065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25322992|NCT04901065|Sensory System Agents|sensory system agents|mesh-ancestor
25322993|NCT04901065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25322994|NCT04901065|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25322995|NCT04901065|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25322996|NCT04901065|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25322997|NCT04901065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25322998|NCT04901065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25322999|NCT04900948|Methylprednisolone|methylprednisolone|mesh-list
25323000|NCT04900948|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25323001|NCT04900948|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25323002|NCT04900948|Prednisolone|prednisolone|mesh-list
25323003|NCT04900948|Prednisolone acetate|prednisolone acetate|mesh-list
25323004|NCT04900948|Pimecrolimus|pimecrolimus|mesh-list
25323005|NCT04900948|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
25323006|NCT04900948|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25323007|NCT04900948|Prednisolone phosphate|prednisolone phosphate|mesh-list
25323008|NCT04900948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25323009|NCT04900948|Antiemetics|antiemetics|mesh-ancestor
25323010|NCT04900948|Autonomic Agents|autonomic agents|mesh-ancestor
25323011|NCT04900948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25323012|NCT04900948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323013|NCT04900948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25323014|NCT04900948|Glucocorticoids|glucocorticoids|mesh-ancestor
25323015|NCT04900948|Hormones|hormones|mesh-ancestor
25323016|NCT04900948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25323170|NCT04899570|Tubulin Modulators|tubulin modulators|mesh-ancestor
25323017|NCT04900948|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25323018|NCT04900948|Protective Agents|protective agents|mesh-ancestor
25323019|NCT04900948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25323020|NCT04900948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323097|NCT04899921|Ipilimumab|ipilimumab|mesh-list
25323021|NCT04900948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25323022|NCT04900948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25323023|NCT04900948|Analgesics|analgesics|mesh-ancestor
25323024|NCT04900948|Sensory System Agents|sensory system agents|mesh-ancestor
25323025|NCT04900948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25323026|NCT04900948|Dermatologic Agents|dermatologic agents|mesh-ancestor
25323027|NCT04900948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25323028|NCT04900948|Immunologic Factors|immunologic factors|mesh-ancestor
25323029|NCT04900948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25323030|NCT04900948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25323031|NCT04900948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323032|NCT04901104|Thymalfasin|thymalfasin|mesh-list
25323033|NCT04901104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25323034|NCT04901104|Immunologic Factors|immunologic factors|mesh-ancestor
25323035|NCT04901104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323036|NCT04900792|Ascorbic Acid|ascorbic acid|mesh-list
25323037|NCT04900792|Temozolomide|temozolomide|mesh-list
25323038|NCT04900792|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25323039|NCT04900792|Vitamins|vitamins|mesh-ancestor
25323040|NCT04900792|Micronutrients|micronutrients|mesh-ancestor
25323041|NCT04900792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323042|NCT04900792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25323043|NCT04900792|Alkylating Agents|alkylating agents|mesh-ancestor
25323044|NCT04900792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323045|NCT04900792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323046|NCT04900792|Antioxidants|antioxidants|mesh-ancestor
25648970|NCT01486966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648971|NCT01487161|Triamcinolone|triamcinolone|mesh-list
25648972|NCT01487161|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25648973|NCT01487161|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25648974|NCT01487161|FX006|fx006|mesh-list
25648975|NCT01487161|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25648976|NCT01487161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25648977|NCT01487161|Glucocorticoids|glucocorticoids|mesh-ancestor
25648978|NCT01487161|Hormones|hormones|mesh-ancestor
25194544|NCT02763969|Interferons|interferons|mesh-list
25323047|NCT04900792|Protective Agents|protective agents|mesh-ancestor
25323048|NCT04900792|Hematinics|hematinics|mesh-ancestor
25323049|NCT04900792|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25323050|NCT04900792|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25323051|NCT04900532|Tocotrienols|tocotrienols|mesh-list
25323052|NCT04900532|Vitamin E|vitamin e|mesh-list
25323053|NCT04900532|Tocopherols|tocopherols|mesh-list
25323054|NCT04900532|Antioxidants|antioxidants|mesh-ancestor
25323055|NCT04900532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323056|NCT04900532|Protective Agents|protective agents|mesh-ancestor
25323057|NCT04900532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323058|NCT04900532|Vitamins|vitamins|mesh-ancestor
24958669|NCT03830398|Acetaminophen|acetaminophen|mesh-list
25323059|NCT04900532|Micronutrients|micronutrients|mesh-ancestor
25323060|NCT04900415|Vitamin A|vitamin a|mesh-list
25323061|NCT04900415|Vitamins|vitamins|mesh-ancestor
25323062|NCT04900415|Micronutrients|micronutrients|mesh-ancestor
25323063|NCT04900415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323064|NCT04900571|Nitrofurantoin|nitrofurantoin|mesh-list
25323065|NCT04900571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25323066|NCT04900571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25323067|NCT04900571|Renal Agents|renal agents|mesh-ancestor
25323068|NCT04900571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25825534|NCT00005603|Vincristine|vincristine|mesh-list
25323069|NCT04900766|Mitoxantrone|mitoxantrone|mesh-list
25323070|NCT04900766|Analgesics|analgesics|mesh-ancestor
25323071|NCT04900766|Sensory System Agents|sensory system agents|mesh-ancestor
25323072|NCT04900766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25323073|NCT04900766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323074|NCT04900766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323075|NCT04900766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25323076|NCT04900766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25323077|NCT04900766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25323078|NCT04900766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323079|NCT04900311|Paclitaxel|paclitaxel|mesh-list
25323080|NCT04900311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25323081|NCT04900311|Trastuzumab|trastuzumab|mesh-list
25323082|NCT04900311|Pertuzumab|pertuzumab|mesh-list
25323083|NCT04900311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25323084|NCT04900311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323085|NCT04900311|Tubulin Modulators|tubulin modulators|mesh-ancestor
25323086|NCT04900311|Antimitotic Agents|antimitotic agents|mesh-ancestor
25323087|NCT04900311|Mitosis Modulators|mitosis modulators|mesh-ancestor
25323088|NCT04900311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323089|NCT04900311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25323090|NCT04900350|Azacitidine|azacitidine|mesh-list
25323091|NCT04900350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25323092|NCT04900350|Antimetabolites|antimetabolites|mesh-ancestor
25323093|NCT04900350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323094|NCT04900350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323095|NCT04900350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25323096|NCT04899921|Nivolumab|nivolumab|mesh-list
25323098|NCT04899921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25323099|NCT04899921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323100|NCT04899921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25323101|NCT04899921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323102|NCT04900155|Atorvastatin|atorvastatin|mesh-list
25323103|NCT04900155|Ezetimibe|ezetimibe|mesh-list
25323104|NCT04900155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25323105|NCT04900155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25323106|NCT04900155|Antimetabolites|antimetabolites|mesh-ancestor
25323107|NCT04900155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323108|NCT04900155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25323109|NCT04900155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25323110|NCT04900155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25323111|NCT04900129|Acetylcysteine|acetylcysteine|mesh-list
25323112|NCT04900129|Diclofenac|diclofenac|mesh-list
25323113|NCT04900129|Salicylates|salicylates|mesh-list
25323114|NCT04900129|Methyl salicylate|methyl salicylate|mesh-list
25323115|NCT04900129|Menthol|menthol|mesh-list
25323116|NCT04900129|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25323117|NCT04900129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25323118|NCT04900129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25323119|NCT04900129|Analgesics|analgesics|mesh-ancestor
25323120|NCT04900129|Sensory System Agents|sensory system agents|mesh-ancestor
25323121|NCT04900129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25656860|NCT01579812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194612|NCT02763839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25194618|NCT02764008|Bupivacaine|bupivacaine|mesh-list
25323122|NCT04900129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323123|NCT04900129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25323124|NCT04900129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25323125|NCT04900129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25323126|NCT04900129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25323127|NCT04900129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323128|NCT04900129|Antipruritics|antipruritics|mesh-ancestor
25323129|NCT04900129|Dermatologic Agents|dermatologic agents|mesh-ancestor
25323130|NCT04900129|Antiviral Agents|antiviral agents|mesh-ancestor
25323131|NCT04900129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25323132|NCT04900129|Expectorants|expectorants|mesh-ancestor
25323133|NCT04900129|Respiratory System Agents|respiratory system agents|mesh-ancestor
25323134|NCT04900129|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25323135|NCT04900129|Antioxidants|antioxidants|mesh-ancestor
25323136|NCT04900129|Protective Agents|protective agents|mesh-ancestor
25323137|NCT04900129|Antidotes|antidotes|mesh-ancestor
25323138|NCT04899765|Vaccines|vaccines|mesh-list
25323139|NCT04899765|BCG Vaccine|bcg vaccine|mesh-list
25323140|NCT04899765|Immunologic Factors|immunologic factors|mesh-ancestor
25323141|NCT04899765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323142|NCT04899765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25323143|NCT04899570|Prednisone|prednisone|mesh-list
25323144|NCT04899570|Cyclophosphamide|cyclophosphamide|mesh-list
25323145|NCT04899570|Rituximab|rituximab|mesh-list
25323146|NCT04899570|Epirubicin|epirubicin|mesh-list
25323147|NCT04899570|Zanubrutinib|zanubrutinib|mesh-list
25323148|NCT04899570|Vindesine|vindesine|mesh-list
25323149|NCT04899570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25323150|NCT04899570|Immunologic Factors|immunologic factors|mesh-ancestor
25323151|NCT04899570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323152|NCT04899570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25323153|NCT04899570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25323154|NCT04899570|Alkylating Agents|alkylating agents|mesh-ancestor
25323155|NCT04899570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323156|NCT04899570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323157|NCT04899570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25323158|NCT04899570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25323159|NCT04899570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25323160|NCT04899570|Glucocorticoids|glucocorticoids|mesh-ancestor
25323161|NCT04899570|Hormones|hormones|mesh-ancestor
25323162|NCT04899570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25323163|NCT04899570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25323164|NCT04899570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25323165|NCT04899570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25323166|NCT04899570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25323167|NCT04899570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25323168|NCT04899570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25323169|NCT04899570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25323174|NCT04899453|Methotrexate|methotrexate|mesh-list
25323175|NCT04899453|Zanubrutinib|zanubrutinib|mesh-list
25323176|NCT04899453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25323177|NCT04899453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323178|NCT04899453|Immunologic Factors|immunologic factors|mesh-ancestor
25323179|NCT04899453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323180|NCT04899453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25323181|NCT04899453|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25323182|NCT04899453|Abortifacient Agents|abortifacient agents|mesh-ancestor
25323183|NCT04899453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25323184|NCT04899453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25323185|NCT04899453|Antimetabolites|antimetabolites|mesh-ancestor
25323186|NCT04899453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323187|NCT04899453|Dermatologic Agents|dermatologic agents|mesh-ancestor
25323188|NCT04899453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25323189|NCT04899453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25323190|NCT04899453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25323191|NCT04899453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25323192|NCT04899453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25323193|NCT04899817|Granisetron|granisetron|mesh-list
25323194|NCT04899817|Antiemetics|antiemetics|mesh-ancestor
25323195|NCT04899817|Autonomic Agents|autonomic agents|mesh-ancestor
25323196|NCT04899817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25323197|NCT04899817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648979|NCT01487161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25656861|NCT01580020|Dexamethasone|dexamethasone|mesh-list
25194684|NCT02763007|Pioglitazone|pioglitazone|mesh-list
25323198|NCT04899817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25323199|NCT04899817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25323200|NCT04899817|Serotonin Agents|serotonin agents|mesh-ancestor
25323201|NCT04899817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25323202|NCT04899817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323203|NCT04899674|Bupropion|bupropion|mesh-list
25323204|NCT04899674|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25323205|NCT04899674|Antidepressive Agents|antidepressive agents|mesh-ancestor
25323206|NCT04899674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25323207|NCT04899674|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25323208|NCT04899674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25323209|NCT04899674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25323210|NCT04899674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323211|NCT04899674|Dopamine Agents|dopamine agents|mesh-ancestor
25323212|NCT04899674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25323213|NCT04899674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323214|NCT04899674|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25323215|NCT04899674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25323216|NCT04899674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25323217|NCT04899479|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25323218|NCT04899479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323219|NCT04899479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25323220|NCT04899479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323221|NCT04899414|Dexamethasone|dexamethasone|mesh-list
25323222|NCT04899414|Azacitidine|azacitidine|mesh-list
25323223|NCT04899414|Pegaspargase|pegaspargase|mesh-list
25323224|NCT04899414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25323225|NCT04899414|Antiemetics|antiemetics|mesh-ancestor
25323226|NCT04899414|Autonomic Agents|autonomic agents|mesh-ancestor
25323227|NCT04899414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25323228|NCT04899414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323229|NCT04899414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25323230|NCT04899414|Glucocorticoids|glucocorticoids|mesh-ancestor
25323231|NCT04899414|Hormones|hormones|mesh-ancestor
25323232|NCT04899414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25323233|NCT04899414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25323234|NCT04899414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323235|NCT04899414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25323236|NCT04899414|Antimetabolites|antimetabolites|mesh-ancestor
25323237|NCT04899414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323238|NCT04899414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25323239|NCT04899518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25323240|NCT04899518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25323244|NCT04898946|Vaccines|vaccines|mesh-list
25323249|NCT04898738|Hand Sanitizers|hand sanitizers|mesh-list
25323250|NCT04898738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25323251|NCT04898738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25323252|NCT04898738|Disinfectants|disinfectants|mesh-ancestor
25323253|NCT04898751|Pembrolizumab|pembrolizumab|mesh-list
25323254|NCT04898751|Nivolumab|nivolumab|mesh-list
25323255|NCT04898751|Ipilimumab|ipilimumab|mesh-list
25323256|NCT04898751|Durvalumab|durvalumab|mesh-list
25323257|NCT04898751|Avelumab|avelumab|mesh-list
25323258|NCT04898751|Cemiplimab|cemiplimab|mesh-list
25323259|NCT04898751|Atezolizumab|atezolizumab|mesh-list
25323260|NCT04898751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25323261|NCT04898751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25323262|NCT04898751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323263|NCT04898751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323264|NCT04898907|Moxifloxacin|moxifloxacin|mesh-list
25323265|NCT04898907|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25323266|NCT04898907|Mitogens|mitogens|mesh-list
25323267|NCT04898907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25323268|NCT04898907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25323269|NCT04898907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25323270|NCT04898907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25323271|NCT04898907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25323272|NCT04898907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323273|NCT04898907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323274|NCT04898907|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25323275|NCT04898907|Contraceptive Agents|contraceptive agents|mesh-ancestor
25323276|NCT04898907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25648980|NCT01487161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323277|NCT04898907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323278|NCT04898907|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25323279|NCT04898907|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25323280|NCT04898907|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25323281|NCT04898907|Mitosis Modulators|mitosis modulators|mesh-ancestor
25323282|NCT04898699|Tenofovir|tenofovir|mesh-list
25323283|NCT04898699|Emtricitabine|emtricitabine|mesh-list
25323284|NCT04898699|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25323285|NCT04898699|Antiviral Agents|antiviral agents|mesh-ancestor
25323286|NCT04898699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25323287|NCT04898699|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25323288|NCT04898699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25323289|NCT04898699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25323290|NCT04898699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323291|NCT04898699|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25078568|NCT03355352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25323292|NCT04898699|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25323293|NCT04898725|Vitamin D|vitamin d|mesh-list
25323294|NCT04898725|Cholecalciferol|cholecalciferol|mesh-list
25323295|NCT04898725|Vitamins|vitamins|mesh-ancestor
25323296|NCT04898725|Micronutrients|micronutrients|mesh-ancestor
25323297|NCT04898725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323298|NCT04898725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25323299|NCT04898725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25323300|NCT04898712|Tranexamic Acid|tranexamic acid|mesh-list
25323301|NCT04898712|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25323302|NCT04898712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25323303|NCT04898712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323304|NCT04898712|Hemostatics|hemostatics|mesh-ancestor
25323305|NCT04898712|Coagulants|coagulants|mesh-ancestor
25323306|NCT04898387|Timolol|timolol|mesh-list
25323307|NCT04898387|Bimatoprost|bimatoprost|mesh-list
25323308|NCT04898387|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25323309|NCT04898387|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25323310|NCT04898387|Adrenergic Agents|adrenergic agents|mesh-ancestor
25323311|NCT04898387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25323312|NCT04898387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323313|NCT04898387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323314|NCT04898387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25323315|NCT04898387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25323336|NCT04898023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323337|NCT04898023|Protective Agents|protective agents|mesh-ancestor
25323338|NCT04898023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323340|NCT04898023|Micronutrients|micronutrients|mesh-ancestor
25323341|NCT04898504|Floxuridine|floxuridine|mesh-list
25323342|NCT04898504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25323343|NCT04898504|Antimetabolites|antimetabolites|mesh-ancestor
25323344|NCT04898504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323345|NCT04898504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825535|NCT00005603|Daunorubicin|daunorubicin|mesh-list
25825536|NCT00005603|Asparaginase|asparaginase|mesh-list
25323377|NCT04898231|Methylprednisolone|methylprednisolone|mesh-list
25323378|NCT04898231|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25323379|NCT04898231|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25323380|NCT04898231|Prednisolone|prednisolone|mesh-list
25323381|NCT04898231|Prednisolone acetate|prednisolone acetate|mesh-list
25323382|NCT04898231|Infliximab|infliximab|mesh-list
25323383|NCT04898231|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25323384|NCT04898231|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25323385|NCT04898231|Prednisolone phosphate|prednisolone phosphate|mesh-list
25323386|NCT04898231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25323387|NCT04898231|Antiemetics|antiemetics|mesh-ancestor
25323388|NCT04898231|Autonomic Agents|autonomic agents|mesh-ancestor
25323389|NCT04898231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25323390|NCT04898231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323391|NCT04898231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25323392|NCT04898231|Glucocorticoids|glucocorticoids|mesh-ancestor
25323394|NCT04898231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25323395|NCT04898231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25323396|NCT04898231|Protective Agents|protective agents|mesh-ancestor
25323397|NCT04898231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25323398|NCT04898231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323399|NCT04898231|Dermatologic Agents|dermatologic agents|mesh-ancestor
25323400|NCT04898231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25825537|NCT00005603|Mercaptopurine|mercaptopurine|mesh-list
25206984|NCT05136846|Papaverine|papaverine|mesh-list
25206985|NCT05136846|Immunoglobulins|immunoglobulins|mesh-list
25206986|NCT05136846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25206987|NCT05136846|Immunoglobulin G|immunoglobulin g|mesh-list
25206988|NCT05136846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25206989|NCT05136846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206990|NCT05136846|Tubulin Modulators|tubulin modulators|mesh-ancestor
25207001|NCT05078060|Vaccines|vaccines|mesh-list
25323401|NCT04898270|Antipsychotic Agents|antipsychotic agents|mesh-list
25323402|NCT04898270|Flupenthixol|flupenthixol|mesh-list
25323403|NCT04898270|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
25323404|NCT04898270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25323405|NCT04898270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25323406|NCT04898270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323407|NCT04898270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25323408|NCT04898270|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25323409|NCT04898270|Dopamine Agents|dopamine agents|mesh-ancestor
25323410|NCT04898270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25323411|NCT04898270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323412|NCT04897984|Anti-Infective Agents|anti-infective agents|mesh-list
25323413|NCT04897984|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25323414|NCT04897971|Antibodies|antibodies|mesh-list
25323415|NCT04897971|Immunologic Factors|immunologic factors|mesh-ancestor
25323416|NCT04897971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323417|NCT04897958|Leuprolide|leuprolide|mesh-list
25323418|NCT04897958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25323419|NCT04897958|Fertility Agents|fertility agents|mesh-ancestor
25323420|NCT04897958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25323421|NCT04897958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323422|NCT04897958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25323423|NCT04897958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323424|NCT04897854|Folfirinox|folfirinox|mesh-list
25323425|NCT04897854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323426|NCT04897737|Tenofovir|tenofovir|mesh-list
25323427|NCT04897737|Antiviral Agents|antiviral agents|mesh-ancestor
25323428|NCT04897737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25323429|NCT04897737|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25323430|NCT04897737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25323431|NCT04897737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25323432|NCT04897737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323433|NCT04897737|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25323434|NCT04897737|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25323435|NCT04897516|Benzonidazole|benzonidazole|mesh-list
25323436|NCT04897516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25323437|NCT04897516|Immunologic Factors|immunologic factors|mesh-ancestor
25323438|NCT04897516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323439|NCT04897516|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25323440|NCT04897516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25323441|NCT04897516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25323442|NCT04897516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25323443|NCT04897503|Riboflavin|riboflavin|mesh-list
25323444|NCT04897503|Vitamin B Complex|vitamin b complex|mesh-ancestor
25323445|NCT04897503|Vitamins|vitamins|mesh-ancestor
25323446|NCT04897503|Micronutrients|micronutrients|mesh-ancestor
25323447|NCT04897503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323448|NCT04897503|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25323449|NCT04897503|Dermatologic Agents|dermatologic agents|mesh-ancestor
25323450|NCT04897386|Pemetrexed|pemetrexed|mesh-list
25323451|NCT04897386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323452|NCT04897386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25323453|NCT04897386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323454|NCT04897386|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25323455|NCT04897386|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25323456|NCT04897477|Azacitidine|azacitidine|mesh-list
25323457|NCT04897477|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25323458|NCT04897477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25323459|NCT04897477|Antimetabolites|antimetabolites|mesh-ancestor
24835937|NCT02183610|Hormones|hormones|mesh-ancestor
25323460|NCT04897477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648981|NCT01487161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25648982|NCT01487161|Immunologic Factors|immunologic factors|mesh-ancestor
25648983|NCT01487161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25648984|NCT01487161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648985|NCT01487200|Triamcinolone|triamcinolone|mesh-list
25648986|NCT01487200|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25648987|NCT01487200|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25648988|NCT01487200|FX006|fx006|mesh-list
25323461|NCT04897477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323462|NCT04897477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25323463|NCT04897477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25323464|NCT04897477|Alkylating Agents|alkylating agents|mesh-ancestor
25323465|NCT04897269|Progesterone|progesterone|mesh-list
25323466|NCT04897269|Progestins|progestins|mesh-ancestor
25323467|NCT04897269|Hormones|hormones|mesh-ancestor
25323542|NCT04895423|Immunologic Factors|immunologic factors|mesh-ancestor
25825538|NCT00005603|Thioguanine|thioguanine|mesh-list
25323476|NCT04896359|Protective Agents|protective agents|mesh-ancestor
25323477|NCT04896177|Sirolimus|sirolimus|mesh-list
25323478|NCT04896177|Paclitaxel|paclitaxel|mesh-list
25323479|NCT04896177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25323480|NCT04896177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323481|NCT04896177|Tubulin Modulators|tubulin modulators|mesh-ancestor
25323482|NCT04896177|Antimitotic Agents|antimitotic agents|mesh-ancestor
25323483|NCT04896177|Mitosis Modulators|mitosis modulators|mesh-ancestor
25323484|NCT04896177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323485|NCT04896177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25323486|NCT04896177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25323487|NCT04896177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25323488|NCT04896177|Antifungal Agents|antifungal agents|mesh-ancestor
25323489|NCT04896177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25323490|NCT04896177|Immunologic Factors|immunologic factors|mesh-ancestor
25323491|NCT04896177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323492|NCT04896125|Bimatoprost|bimatoprost|mesh-list
25323493|NCT04896125|Latanoprost|latanoprost|mesh-list
25323494|NCT04896125|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25323495|NCT04896125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25323496|NCT04896125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25323497|NCT04896164|Curcumin|curcumin|mesh-list
25323498|NCT04896164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25323499|NCT04896164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25323500|NCT04896164|Analgesics|analgesics|mesh-ancestor
25323501|NCT04896164|Sensory System Agents|sensory system agents|mesh-ancestor
25323502|NCT04896164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25323503|NCT04896164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323504|NCT04896164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25323505|NCT04896164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25323506|NCT04896164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323507|NCT04896164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25323508|NCT04896164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323518|NCT04895657|Tazobactam|tazobactam|mesh-list
25323519|NCT04895657|Piperacillin|piperacillin|mesh-list
25323520|NCT04895657|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25323521|NCT04895657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25323522|NCT04895657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25323523|NCT04895657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25323524|NCT04895657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25323525|NCT04895657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323526|NCT04895423|Cyclosporine|cyclosporine|mesh-list
25323527|NCT04895423|Mycophenolic Acid|mycophenolic acid|mesh-list
25323528|NCT04895423|Methotrexate|methotrexate|mesh-list
25323529|NCT04895423|Cyclosporins|cyclosporins|mesh-list
25323530|NCT04895423|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25323531|NCT04895423|Abortifacient Agents|abortifacient agents|mesh-ancestor
25323532|NCT04895423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25323533|NCT04895423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323534|NCT04895423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25323535|NCT04895423|Antimetabolites|antimetabolites|mesh-ancestor
25323536|NCT04895423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323537|NCT04895423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323538|NCT04895423|Dermatologic Agents|dermatologic agents|mesh-ancestor
25323539|NCT04895423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25323540|NCT04895423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25323541|NCT04895423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25323560|NCT04895800|Purinergic Agents|purinergic agents|mesh-ancestor
25323561|NCT04895800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25323581|NCT04895059|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25323582|NCT04895059|Ezetimibe|ezetimibe|mesh-list
25323583|NCT04895059|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25323584|NCT04895059|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25323585|NCT04895059|Antimetabolites|antimetabolites|mesh-ancestor
25323586|NCT04895059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323587|NCT04895059|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25323588|NCT04895059|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25323589|NCT04895059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25323591|NCT04895007|Immunologic Factors|immunologic factors|mesh-ancestor
25323592|NCT04895007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323593|NCT04895137|Bevacizumab|bevacizumab|mesh-list
25323594|NCT04895137|Antibodies|antibodies|mesh-list
25323595|NCT04895137|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25323596|NCT04895137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25323597|NCT04895137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323598|NCT04895137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25323599|NCT04895137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25323600|NCT04895137|Growth Substances|growth substances|mesh-ancestor
25323601|NCT04895137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323602|NCT04895137|Growth Inhibitors|growth inhibitors|mesh-ancestor
25323603|NCT04895137|Immunologic Factors|immunologic factors|mesh-ancestor
25323627|NCT04894617|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25323628|NCT04894617|Antiviral Agents|antiviral agents|mesh-ancestor
25323629|NCT04894617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25323630|NCT04894617|Dopamine Agents|dopamine agents|mesh-ancestor
25323631|NCT04894617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25323632|NCT04894617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323633|NCT04894617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323634|NCT04894617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25323635|NCT04894617|Analgesics|analgesics|mesh-ancestor
25323636|NCT04894617|Sensory System Agents|sensory system agents|mesh-ancestor
25323637|NCT04894617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25323638|NCT04893993|Thiamine|thiamine|mesh-list
25323639|NCT04893993|Vitamin B Complex|vitamin b complex|mesh-ancestor
25323640|NCT04893993|Vitamins|vitamins|mesh-ancestor
25323641|NCT04893993|Micronutrients|micronutrients|mesh-ancestor
25323642|NCT04893993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323643|NCT04893980|Aldesleukin|aldesleukin|mesh-list
25323644|NCT04893980|Interleukin-2|interleukin-2|mesh-list
25323645|NCT04893980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323646|NCT04893980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25323647|NCT04893980|Analgesics|analgesics|mesh-ancestor
25323648|NCT04893980|Sensory System Agents|sensory system agents|mesh-ancestor
25323649|NCT04893980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25323650|NCT04893980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323651|NCT04893980|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25323652|NCT04893980|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25323653|NCT04893980|Antiviral Agents|antiviral agents|mesh-ancestor
25323654|NCT04893980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25323655|NCT04893655|Dobutamine|dobutamine|mesh-list
25323656|NCT04893655|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25323657|NCT04893655|Sympathomimetics|sympathomimetics|mesh-ancestor
25323658|NCT04893655|Autonomic Agents|autonomic agents|mesh-ancestor
25323659|NCT04893655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25323660|NCT04893655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323661|NCT04893655|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25323662|NCT04893655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25323663|NCT04893655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25323664|NCT04893655|Adrenergic Agents|adrenergic agents|mesh-ancestor
25323665|NCT04893655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25323666|NCT04893655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323667|NCT04893655|Protective Agents|protective agents|mesh-ancestor
25323668|NCT04893733|Folic Acid|folic acid|mesh-list
25323669|NCT04893733|Vitamin B Complex|vitamin b complex|mesh-list
25323670|NCT04893733|Vitamins|vitamins|mesh-ancestor
25323671|NCT04893733|Micronutrients|micronutrients|mesh-ancestor
25323672|NCT04893733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323673|NCT04893733|Hematinics|hematinics|mesh-ancestor
25323674|NCT04893629|Digoxin|digoxin|mesh-list
25323675|NCT04893629|Captopril|captopril|mesh-list
25323676|NCT04893629|Furosemide|furosemide|mesh-list
25323677|NCT04893629|Diuretics|diuretics|mesh-ancestor
25323678|NCT04893629|Natriuretic Agents|natriuretic agents|mesh-ancestor
25323679|NCT04893629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635181|NCT01137656|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25323680|NCT04893629|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25323681|NCT04893629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25323682|NCT04893629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323683|NCT04893629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25323684|NCT04893629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25323685|NCT04893629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25323686|NCT04893629|Protective Agents|protective agents|mesh-ancestor
25323687|NCT04893629|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25323688|NCT04893629|Protease Inhibitors|protease inhibitors|mesh-ancestor
25323689|NCT04893629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25323690|NCT04893525|Buprenorphine|buprenorphine|mesh-list
25323691|NCT04893525|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25323692|NCT04893525|Naloxone|naloxone|mesh-list
25323693|NCT04893525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25323694|NCT04893525|Narcotics|narcotics|mesh-ancestor
25323695|NCT04893525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25323696|NCT04893525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323697|NCT04893525|Analgesics|analgesics|mesh-ancestor
25323698|NCT04893525|Sensory System Agents|sensory system agents|mesh-ancestor
25323699|NCT04893525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25323700|NCT04893525|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24899938|NCT04398771|Valsartan|valsartan|mesh-list
25323701|NCT04893356|Dacarbazine|dacarbazine|mesh-list
25323702|NCT04893356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25323703|NCT04893356|Alkylating Agents|alkylating agents|mesh-ancestor
25323704|NCT04893356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323705|NCT04893356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323706|NCT04893174|Hyaluronic Acid|hyaluronic acid|mesh-list
25323707|NCT04893174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25323708|NCT04893174|Immunologic Factors|immunologic factors|mesh-ancestor
25323709|NCT04893174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323710|NCT04893174|Viscosupplements|viscosupplements|mesh-ancestor
25323711|NCT04893174|Protective Agents|protective agents|mesh-ancestor
25323712|NCT04892953|Gemcitabine|gemcitabine|mesh-list
25323713|NCT04892953|Paclitaxel|paclitaxel|mesh-list
25323714|NCT04892953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25323715|NCT04892953|Carboplatin|carboplatin|mesh-list
25323716|NCT04892953|Pemetrexed|pemetrexed|mesh-list
25323717|NCT04892953|Durvalumab|durvalumab|mesh-list
25323718|NCT04892953|Immunoglobulins|immunoglobulins|mesh-list
25323719|NCT04892953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25323720|NCT04892953|Immunoglobulin G|immunoglobulin g|mesh-list
25323721|NCT04892953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25323722|NCT04892953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323723|NCT04892953|Tubulin Modulators|tubulin modulators|mesh-ancestor
25323724|NCT04892953|Antimitotic Agents|antimitotic agents|mesh-ancestor
25323725|NCT04892953|Mitosis Modulators|mitosis modulators|mesh-ancestor
25323726|NCT04892953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323727|NCT04892953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25323728|NCT04892953|Antimetabolites|antimetabolites|mesh-ancestor
25323729|NCT04892953|Antiviral Agents|antiviral agents|mesh-ancestor
25323730|NCT04892953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25323731|NCT04892953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25323732|NCT04892953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25323733|NCT04892953|Immunologic Factors|immunologic factors|mesh-ancestor
25323734|NCT04892953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323735|NCT04892953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25323736|NCT04892953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25323737|NCT04892953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25323738|NCT04893252|Durvalumab|durvalumab|mesh-list
25323739|NCT04893252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25323740|NCT04893252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323741|NCT04892732|Budesonide|budesonide|mesh-list
25323742|NCT04892732|Formoterol Fumarate|formoterol fumarate|mesh-list
25323743|NCT04892732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25323744|NCT04892732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25323745|NCT04892732|Autonomic Agents|autonomic agents|mesh-ancestor
25323746|NCT04892732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25323747|NCT04892732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323748|NCT04892732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25323749|NCT04892732|Respiratory System Agents|respiratory system agents|mesh-ancestor
25323750|NCT04892732|Glucocorticoids|glucocorticoids|mesh-ancestor
25323751|NCT04892732|Hormones|hormones|mesh-ancestor
25323752|NCT04892732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25323753|NCT04892732|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25323754|NCT04892732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25323755|NCT04892732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25323756|NCT04892732|Adrenergic Agents|adrenergic agents|mesh-ancestor
25323757|NCT04892732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25323758|NCT04892732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323759|NCT04892758|Mometasone Furoate|mometasone furoate|mesh-list
25323760|NCT04892758|Formoterol Fumarate|formoterol fumarate|mesh-list
25323761|NCT04892758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25323762|NCT04892758|Autonomic Agents|autonomic agents|mesh-ancestor
25323855|NCT04891861|Anticoagulants|anticoagulants|mesh-ancestor
25323763|NCT04892758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25323764|NCT04892758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561779|NCT00762749|Antiemetics|antiemetics|mesh-ancestor
25323765|NCT04892758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25323766|NCT04892758|Respiratory System Agents|respiratory system agents|mesh-ancestor
25323767|NCT04892758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25323768|NCT04892758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25323769|NCT04892758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25323782|NCT04892511|Phenylephrine|phenylephrine|mesh-list
25323783|NCT04892511|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25323784|NCT04892511|Mydriatics|mydriatics|mesh-ancestor
25323785|NCT04892511|Autonomic Agents|autonomic agents|mesh-ancestor
25323786|NCT04892511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25323787|NCT04892511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323788|NCT04892511|Sympathomimetics|sympathomimetics|mesh-ancestor
25323789|NCT04892511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25323790|NCT04892511|Nasal Decongestants|nasal decongestants|mesh-ancestor
25323791|NCT04892511|Respiratory System Agents|respiratory system agents|mesh-ancestor
25323792|NCT04892511|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25323793|NCT04892511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25323794|NCT04892511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25323795|NCT04892511|Adrenergic Agents|adrenergic agents|mesh-ancestor
25323796|NCT04892511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25323797|NCT04892511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323798|NCT04892511|Protective Agents|protective agents|mesh-ancestor
25323799|NCT04892511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25323800|NCT04892511|Vasodilator Agents|vasodilator agents|mesh-ancestor
25323801|NCT04892511|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25323802|NCT04892511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25323803|NCT04892511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25323804|NCT04892511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25323805|NCT04892511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25323806|NCT04892511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25323807|NCT04892511|Serotonin Agents|serotonin agents|mesh-ancestor
25323813|NCT04892654|Dolutegravir|dolutegravir|mesh-list
24962153|NCT03801746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25323814|NCT04892654|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25323815|NCT04892654|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25323816|NCT04892654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25323817|NCT04892654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323818|NCT04892654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25323819|NCT04892654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25323820|NCT04892654|Antiviral Agents|antiviral agents|mesh-ancestor
25323821|NCT04892654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25323822|NCT04892563|Morphine|morphine|mesh-list
25323823|NCT04892563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25323824|NCT04892563|Narcotics|narcotics|mesh-ancestor
25323825|NCT04892563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25323826|NCT04892563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323827|NCT04892563|Analgesics|analgesics|mesh-ancestor
25323828|NCT04892563|Sensory System Agents|sensory system agents|mesh-ancestor
25323829|NCT04892563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25323830|NCT04892303|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
25323831|NCT04892303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323832|NCT04892212|Sirolimus|sirolimus|mesh-list
25323833|NCT04892212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25323834|NCT04892212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25323835|NCT04892212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25323836|NCT04892212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323837|NCT04892212|Antifungal Agents|antifungal agents|mesh-ancestor
25323838|NCT04892212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25323839|NCT04892212|Immunologic Factors|immunologic factors|mesh-ancestor
25323840|NCT04892212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323841|NCT04892069|Insulin|insulin|mesh-list
25323842|NCT04892069|Insulin Aspart|insulin aspart|mesh-list
25323843|NCT04892069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25324069|NCT04888663|Trastuzumab|trastuzumab|mesh-list
25323844|NCT04892069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323846|NCT04891861|Apixaban|apixaban|mesh-list
25323847|NCT04891861|Edoxaban|edoxaban|mesh-list
25323848|NCT04891861|Dabigatran|dabigatran|mesh-list
25323849|NCT04891861|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25323850|NCT04891861|Antithrombins|antithrombins|mesh-ancestor
25323851|NCT04891861|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25323852|NCT04891861|Protease Inhibitors|protease inhibitors|mesh-ancestor
25323853|NCT04891861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25323854|NCT04891861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323856|NCT04891744|Thalidomide|thalidomide|mesh-list
25648989|NCT01487200|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25323857|NCT04891744|Dexamethasone|dexamethasone|mesh-list
25323858|NCT04891744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25323859|NCT04891744|Antiemetics|antiemetics|mesh-ancestor
25323860|NCT04891744|Autonomic Agents|autonomic agents|mesh-ancestor
25323861|NCT04891744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25323862|NCT04891744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323863|NCT04891744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25323864|NCT04891744|Glucocorticoids|glucocorticoids|mesh-ancestor
25323865|NCT04891744|Hormones|hormones|mesh-ancestor
25323866|NCT04891744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25323867|NCT04891744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25323868|NCT04891744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323869|NCT04891744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25323870|NCT04891744|Immunologic Factors|immunologic factors|mesh-ancestor
25323871|NCT04891744|Leprostatic Agents|leprostatic agents|mesh-ancestor
25323872|NCT04891744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25323873|NCT04891744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25323874|NCT04891744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25323875|NCT04891744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25323876|NCT04891744|Growth Substances|growth substances|mesh-ancestor
25323877|NCT04891744|Growth Inhibitors|growth inhibitors|mesh-ancestor
25323878|NCT04891900|Capecitabine|capecitabine|mesh-list
25323879|NCT04891900|Oxaliplatin|oxaliplatin|mesh-list
25323880|NCT04891900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25323881|NCT04891900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25323882|NCT04891900|Antimetabolites|antimetabolites|mesh-ancestor
25323883|NCT04891900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323884|NCT04891900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323885|NCT04891588|Timolol|timolol|mesh-list
25323886|NCT04891588|Latanoprost|latanoprost|mesh-list
25323887|NCT04891588|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25323888|NCT04891588|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25323889|NCT04891588|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25323890|NCT04891588|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25323891|NCT04891588|Adrenergic Agents|adrenergic agents|mesh-ancestor
25323892|NCT04891588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25323893|NCT04891588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323894|NCT04891588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323895|NCT04891588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25323896|NCT04891588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25323897|NCT04891497|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25323898|NCT04891497|Dermatologic Agents|dermatologic agents|mesh-ancestor
25323899|NCT04891497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25323900|NCT04891497|Immunologic Factors|immunologic factors|mesh-ancestor
25323901|NCT04891497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323902|NCT04891679|Misoprostol|misoprostol|mesh-list
25323903|NCT04891679|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25323904|NCT04891679|Abortifacient Agents|abortifacient agents|mesh-ancestor
25323905|NCT04891679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25323906|NCT04891679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323907|NCT04891679|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25323908|NCT04891679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25323909|NCT04891679|Oxytocics|oxytocics|mesh-ancestor
25323910|NCT04891458|Dexmedetomidine|dexmedetomidine|mesh-list
25323911|NCT04891458|Anesthetics|anesthetics|mesh-list
25323912|NCT04891458|Propofol|propofol|mesh-list
25323913|NCT04891458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25323914|NCT04891458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323915|NCT04891458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25323916|NCT04891458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25323917|NCT04891458|Anesthetics, General|anesthetics, general|mesh-ancestor
25323918|NCT04891458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25323919|NCT04891458|Analgesics|analgesics|mesh-ancestor
25323920|NCT04891458|Sensory System Agents|sensory system agents|mesh-ancestor
25323921|NCT04891458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25323922|NCT04891458|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25323923|NCT04891458|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25323924|NCT04891458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25323925|NCT04891458|Adrenergic Agents|adrenergic agents|mesh-ancestor
25323926|NCT04891458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25323927|NCT04891458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323928|NCT04891172|Immunoglobulins|immunoglobulins|mesh-list
25323929|NCT04891172|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25323930|NCT04891172|Antibodies|antibodies|mesh-list
25323931|NCT04891172|gamma-Globulins|gamma-globulins|mesh-list
25323932|NCT04891172|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25323933|NCT04891172|Immunologic Factors|immunologic factors|mesh-ancestor
25323934|NCT04891172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323935|NCT04891211|Vitamin D|vitamin d|mesh-list
25323936|NCT04891211|Vitamins|vitamins|mesh-ancestor
25323937|NCT04891211|Micronutrients|micronutrients|mesh-ancestor
25323938|NCT04891211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323939|NCT04891211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25323940|NCT04890626|Tenofovir|tenofovir|mesh-list
25323941|NCT04890626|Emtricitabine|emtricitabine|mesh-list
25323942|NCT04890626|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25323943|NCT04890626|Dexamethasone|dexamethasone|mesh-list
25323944|NCT04890626|Dexamethasone acetate|dexamethasone acetate|mesh-list
25323945|NCT04890626|BB 1101|bb 1101|mesh-list
25323946|NCT04890626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25323947|NCT04890626|Antiemetics|antiemetics|mesh-ancestor
25323948|NCT04890626|Autonomic Agents|autonomic agents|mesh-ancestor
25323949|NCT04890626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25323950|NCT04890626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323951|NCT04890626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25323952|NCT04890626|Glucocorticoids|glucocorticoids|mesh-ancestor
25323953|NCT04890626|Hormones|hormones|mesh-ancestor
25323954|NCT04890626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25323955|NCT04890626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25323956|NCT04890626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323957|NCT04890626|Protease Inhibitors|protease inhibitors|mesh-ancestor
25323958|NCT04890626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25323959|NCT04890626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323960|NCT04890626|Antiviral Agents|antiviral agents|mesh-ancestor
25323961|NCT04890626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25323962|NCT04890626|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25323963|NCT04890626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24962450|NCT03798522|Analgesics|analgesics|mesh-ancestor
25323964|NCT04890626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25323965|NCT04890626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25323966|NCT04890522|Gemcitabine|gemcitabine|mesh-list
25323967|NCT04890522|Fluorouracil|fluorouracil|mesh-list
25323968|NCT04890522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25323969|NCT04890522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25323970|NCT04890522|Antimetabolites|antimetabolites|mesh-ancestor
25323971|NCT04890522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323972|NCT04890522|Antiviral Agents|antiviral agents|mesh-ancestor
25323973|NCT04890522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25323974|NCT04890522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25323975|NCT04890522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25323976|NCT04890522|Immunologic Factors|immunologic factors|mesh-ancestor
25323977|NCT04890522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323978|NCT04890561|Lemborexant|lemborexant|mesh-list
25323979|NCT04890561|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25323980|NCT04890561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25323981|NCT04890561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25323982|NCT04890561|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25323983|NCT04890561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25323984|NCT04890561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25323985|NCT04890561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602816|NCT00971074|Hylan|hylan|mesh-list
25323986|NCT04890353|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25323987|NCT04890353|Dermatologic Agents|dermatologic agents|mesh-ancestor
25323988|NCT04890353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25323989|NCT04890353|Immunologic Factors|immunologic factors|mesh-ancestor
25323990|NCT04890353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25323991|NCT04890379|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25323992|NCT04890379|Dermatologic Agents|dermatologic agents|mesh-ancestor
25323993|NCT04890379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25323994|NCT04890379|Immunologic Factors|immunologic factors|mesh-ancestor
25324009|NCT04890418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324010|NCT04890392|Oxaliplatin|oxaliplatin|mesh-list
25324011|NCT04890392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25324012|NCT04890392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25324013|NCT04890392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324014|NCT04890470|Vasopressins|vasopressins|mesh-list
25324015|NCT04890470|Arginine Vasopressin|arginine vasopressin|mesh-list
25324016|NCT04890470|Oxytocin|oxytocin|mesh-list
25324017|NCT04890470|Oxytocics|oxytocics|mesh-ancestor
25324018|NCT04890470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25324019|NCT04890470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324020|NCT04890470|Hemostatics|hemostatics|mesh-ancestor
25195289|NCT02759393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25195290|NCT02759393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207029|NCT05042531|Azacitidine|azacitidine|mesh-list
25207030|NCT05042531|Dasatinib|dasatinib|mesh-list
25207031|NCT05042531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25207032|NCT05042531|Antimetabolites|antimetabolites|mesh-ancestor
25207033|NCT05042531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207034|NCT05042531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207035|NCT05042531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25207036|NCT05042531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25207037|NCT05042440|Factor VIII|factor viii|mesh-list
25207038|NCT05042440|BAX 855|bax 855|mesh-list
25195291|NCT02759042|Leronlimab|leronlimab|mesh-list
25195292|NCT02759042|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25195293|NCT02759042|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25324021|NCT04890470|Coagulants|coagulants|mesh-ancestor
25324022|NCT04890470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25324023|NCT04890470|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25324024|NCT04890470|Natriuretic Agents|natriuretic agents|mesh-ancestor
25324025|NCT04889768|Antibodies|antibodies|mesh-list
25324026|NCT04889768|Immunologic Factors|immunologic factors|mesh-ancestor
25324027|NCT04889768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324028|NCT04889781|Dexamethasone|dexamethasone|mesh-list
25324029|NCT04889781|Dexamethasone acetate|dexamethasone acetate|mesh-list
25324030|NCT04889781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25324031|NCT04889781|Antiemetics|antiemetics|mesh-ancestor
25324032|NCT04889781|Autonomic Agents|autonomic agents|mesh-ancestor
25324033|NCT04889781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25324034|NCT04889781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324035|NCT04889781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25324036|NCT04889781|Glucocorticoids|glucocorticoids|mesh-ancestor
25324037|NCT04889781|Hormones|hormones|mesh-ancestor
25324038|NCT04889781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25324039|NCT04889781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25324040|NCT04889781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25324041|NCT04889651|Abiraterone Acetate|abiraterone acetate|mesh-list
25324042|NCT04889651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25324043|NCT04889651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25324044|NCT04889651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25324045|NCT04889651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324046|NCT04889651|Hormone Antagonists|hormone antagonists|mesh-ancestor
25324047|NCT04889651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25324048|NCT04889651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324049|NCT04889651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24579281|NCT00854204|Darunavir|darunavir|mesh-list
25324064|NCT04889196|Fluorides|fluorides|mesh-list
25324065|NCT04889196|Cariostatic Agents|cariostatic agents|mesh-ancestor
25324066|NCT04889196|Protective Agents|protective agents|mesh-ancestor
25324067|NCT04889196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324068|NCT04888663|Paclitaxel|paclitaxel|mesh-list
25324070|NCT04888663|Ramucirumab|ramucirumab|mesh-list
25324071|NCT04888663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25324072|NCT04888663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25324073|NCT04888663|Tubulin Modulators|tubulin modulators|mesh-ancestor
25324074|NCT04888663|Antimitotic Agents|antimitotic agents|mesh-ancestor
25324075|NCT04888663|Mitosis Modulators|mitosis modulators|mesh-ancestor
25324076|NCT04888663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324077|NCT04888663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25324079|NCT04888728|Paroxetine|paroxetine|mesh-list
25324080|NCT04888728|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25648990|NCT01487200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25648991|NCT01487200|Glucocorticoids|glucocorticoids|mesh-ancestor
25648992|NCT01487200|Hormones|hormones|mesh-ancestor
25648993|NCT01487200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25648994|NCT01487200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25648995|NCT01487200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25648996|NCT01487200|Immunologic Factors|immunologic factors|mesh-ancestor
25648997|NCT01487200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25648998|NCT01487200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25648999|NCT01487265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25649000|NCT01487265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649001|NCT01487265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25649002|NCT01487265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649003|NCT01487265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195343|NCT02758990|Caffeine|caffeine|mesh-list
25324081|NCT04888728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25324082|NCT04888728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25324083|NCT04888728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324084|NCT04888728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25324085|NCT04888728|Serotonin Agents|serotonin agents|mesh-ancestor
25324086|NCT04888728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324087|NCT04888728|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25324088|NCT04888728|Antidepressive Agents|antidepressive agents|mesh-ancestor
25324089|NCT04888728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25324090|NCT04888728|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25324091|NCT04888728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25324092|NCT04888728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25324093|NCT04888728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25324094|NCT04888728|Vasodilator Agents|vasodilator agents|mesh-ancestor
25324095|NCT04888728|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25324096|NCT04888728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25324097|NCT04888728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25324098|NCT04888728|Adrenergic Agents|adrenergic agents|mesh-ancestor
25324099|NCT04888741|Cyclosporine|cyclosporine|mesh-list
25324100|NCT04888741|Sirolimus|sirolimus|mesh-list
25324101|NCT04888741|Mycophenolic Acid|mycophenolic acid|mesh-list
25324102|NCT04888741|Cyclophosphamide|cyclophosphamide|mesh-list
25324103|NCT04888741|Cyclosporins|cyclosporins|mesh-list
25324104|NCT04888741|Thymoglobulin|thymoglobulin|mesh-list
25324105|NCT04888741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25324106|NCT04888741|Immunologic Factors|immunologic factors|mesh-ancestor
25324107|NCT04888741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324108|NCT04888741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25324109|NCT04888741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25324110|NCT04888741|Alkylating Agents|alkylating agents|mesh-ancestor
25324111|NCT04888741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324112|NCT04888741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25324113|NCT04888741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25324114|NCT04888741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25324115|NCT04888741|Antifungal Agents|antifungal agents|mesh-ancestor
25324116|NCT04888741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25324117|NCT04888741|Dermatologic Agents|dermatologic agents|mesh-ancestor
25324118|NCT04888741|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25324119|NCT04888741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25324120|NCT04888741|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25324121|NCT04888741|Antitubercular Agents|antitubercular agents|mesh-ancestor
25324122|NCT04888741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25324123|NCT04888715|Pirfenidone|pirfenidone|mesh-list
25324124|NCT04888715|Nintedanib|nintedanib|mesh-list
25324125|NCT04888715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25324126|NCT04888715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25324127|NCT04888715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25324128|NCT04888715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324129|NCT04888715|Analgesics|analgesics|mesh-ancestor
25324130|NCT04888715|Sensory System Agents|sensory system agents|mesh-ancestor
25324131|NCT04888715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25324132|NCT04888715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324133|NCT04888715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25324134|NCT04888715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25324135|NCT04888715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25324136|NCT04888715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24579613|NCT00856570|Warfarin|warfarin|mesh-list
25324137|NCT04888403|Paclitaxel|paclitaxel|mesh-list
25324138|NCT04888403|Nedaplatin|nedaplatin|mesh-list
25324139|NCT04888403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25324140|NCT04888403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25324141|NCT04888403|Tubulin Modulators|tubulin modulators|mesh-ancestor
25324142|NCT04888403|Antimitotic Agents|antimitotic agents|mesh-ancestor
25324143|NCT04888403|Mitosis Modulators|mitosis modulators|mesh-ancestor
25324151|NCT04887818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324152|NCT04887818|Sensory System Agents|sensory system agents|mesh-ancestor
25324153|NCT04887818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25324154|NCT04887818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25324155|NCT04887818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25324156|NCT04887818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25324157|NCT04887818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25324158|NCT04887818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324159|NCT04887818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25195415|NCT02758782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25324160|NCT04887818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25324161|NCT04887818|Vasodilator Agents|vasodilator agents|mesh-ancestor
25324162|NCT04887818|Tocolytic Agents|tocolytic agents|mesh-ancestor
25324163|NCT04887818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25324164|NCT04887818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25324165|NCT04887961|Trabectedin|trabectedin|mesh-list
25324166|NCT04887961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25324167|NCT04887961|Alkylating Agents|alkylating agents|mesh-ancestor
25324168|NCT04887961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324169|NCT04887961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25324170|NCT04887649|Morphine|morphine|mesh-list
25324171|NCT04887649|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25324172|NCT04887649|Narcotics|narcotics|mesh-ancestor
25324173|NCT04887649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25324174|NCT04887649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324175|NCT04887649|Analgesics|analgesics|mesh-ancestor
25324176|NCT04887649|Sensory System Agents|sensory system agents|mesh-ancestor
25324177|NCT04887649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25324185|NCT04887844|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
25324186|NCT04887844|Lidocaine|lidocaine|mesh-list
25324187|NCT04887844|Anesthetics, Local|anesthetics, local|mesh-ancestor
25324188|NCT04887844|Anesthetics|anesthetics|mesh-ancestor
25324189|NCT04887844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25324190|NCT04887844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324191|NCT04887844|Sensory System Agents|sensory system agents|mesh-ancestor
25324192|NCT04887844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25324193|NCT04887844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25324194|NCT04887844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25324195|NCT04887844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25324196|NCT04887844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25324197|NCT04887844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324198|NCT04887844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25324199|NCT04887844|Glucocorticoids|glucocorticoids|mesh-ancestor
25324201|NCT04887844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25324202|NCT04887467|Apomorphine|apomorphine|mesh-list
25324203|NCT04887467|Emetics|emetics|mesh-ancestor
25324204|NCT04887467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324205|NCT04887467|Autonomic Agents|autonomic agents|mesh-ancestor
25324206|NCT04887467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25324207|NCT04887467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25324208|NCT04887467|Dopamine Agonists|dopamine agonists|mesh-ancestor
25324209|NCT04887467|Dopamine Agents|dopamine agents|mesh-ancestor
25324210|NCT04887467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25324211|NCT04887467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324212|NCT04887493|Alprostadil|alprostadil|mesh-list
25324213|NCT04887493|Misoprostol|misoprostol|mesh-list
25324214|NCT04887493|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25324215|NCT04887493|Abortifacient Agents|abortifacient agents|mesh-ancestor
25324216|NCT04887493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25324236|NCT04886869|Caffeine|caffeine|mesh-list
25324237|NCT04886869|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25324238|NCT04886869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324239|NCT04886869|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25324240|NCT04886869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25324241|NCT04886869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324242|NCT04886869|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25324243|NCT04886869|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25324244|NCT04886869|Purinergic Agents|purinergic agents|mesh-ancestor
25324245|NCT04886869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25324246|NCT04886752|Vitamins|vitamins|mesh-list
25324247|NCT04886752|Ascorbic Acid|ascorbic acid|mesh-list
25324248|NCT04886752|Vitamin B Complex|vitamin b complex|mesh-list
25324249|NCT04886752|Micronutrients|micronutrients|mesh-ancestor
25324250|NCT04886752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324251|NCT04886752|Antioxidants|antioxidants|mesh-ancestor
25324252|NCT04886752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324253|NCT04886752|Protective Agents|protective agents|mesh-ancestor
25324266|NCT04886414|Hand Sanitizers|hand sanitizers|mesh-list
25324267|NCT04886414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25324268|NCT04886414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25324269|NCT04886414|Disinfectants|disinfectants|mesh-ancestor
25649004|NCT01487577|Mycophenolic Acid|mycophenolic acid|mesh-list
25324270|NCT04886297|Resveratrol|resveratrol|mesh-list
25324271|NCT04886297|Antioxidants|antioxidants|mesh-ancestor
25324272|NCT04886297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324273|NCT04886297|Protective Agents|protective agents|mesh-ancestor
25324274|NCT04886297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324275|NCT04886297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25324276|NCT04886297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25324277|NCT04886362|Ivermectin|ivermectin|mesh-list
25324278|NCT04886362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25324279|NCT04886362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25324280|NCT04886193|Leucovorin|leucovorin|mesh-list
25324281|NCT04886193|Docetaxel|docetaxel|mesh-list
25324282|NCT04886193|Oxaliplatin|oxaliplatin|mesh-list
25324283|NCT04886193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25324284|NCT04886193|Tubulin Modulators|tubulin modulators|mesh-ancestor
25324285|NCT04886193|Antimitotic Agents|antimitotic agents|mesh-ancestor
25324286|NCT04886193|Mitosis Modulators|mitosis modulators|mesh-ancestor
25324287|NCT04886193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324288|NCT04886193|Antidotes|antidotes|mesh-ancestor
25324289|NCT04886193|Protective Agents|protective agents|mesh-ancestor
25324290|NCT04886193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324291|NCT04886193|Vitamin B Complex|vitamin b complex|mesh-ancestor
25324295|NCT04886167|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25324296|NCT04886167|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25324297|NCT04886167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25324298|NCT04886167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324299|NCT04886167|Cholinergic Agents|cholinergic agents|mesh-ancestor
25324300|NCT04886167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25324301|NCT04886167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324302|NCT04886167|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25324303|NCT04886167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25324307|NCT04885764|Vaccines|vaccines|mesh-list
25324308|NCT04885764|Immunologic Factors|immunologic factors|mesh-ancestor
25324309|NCT04885764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324311|NCT04885777|Anesthetics, Local|anesthetics, local|mesh-ancestor
25324312|NCT04885777|Anesthetics|anesthetics|mesh-ancestor
25324313|NCT04885777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25324314|NCT04885777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324315|NCT04885777|Sensory System Agents|sensory system agents|mesh-ancestor
25324316|NCT04885777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25324317|NCT04885777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25324318|NCT04885777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25324319|NCT04885777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25324320|NCT04885777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25324321|NCT04885777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324322|NCT04885660|Lisinopril|lisinopril|mesh-list
25324323|NCT04885660|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25324324|NCT04885660|Protease Inhibitors|protease inhibitors|mesh-ancestor
25324325|NCT04885660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25324326|NCT04885660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324327|NCT04885660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25324328|NCT04885660|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25324329|NCT04885660|Protective Agents|protective agents|mesh-ancestor
25324330|NCT04885660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324331|NCT04885855|Sofosbuvir|sofosbuvir|mesh-list
25324332|NCT04885855|Antiviral Agents|antiviral agents|mesh-ancestor
25324333|NCT04885855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25324334|NCT04885751|Rebamipide|rebamipide|mesh-list
25324335|NCT04885751|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25324336|NCT04885751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25324337|NCT04885751|Antioxidants|antioxidants|mesh-ancestor
25324338|NCT04885751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324339|NCT04885751|Protective Agents|protective agents|mesh-ancestor
25324340|NCT04885751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324341|NCT04885751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25324342|NCT04885803|Vitamin D|vitamin d|mesh-list
25324343|NCT04885803|Ergocalciferols|ergocalciferols|mesh-list
25324344|NCT04885803|Cholecalciferol|cholecalciferol|mesh-list
25324345|NCT04885803|Vitamins|vitamins|mesh-list
25324346|NCT04885803|Micronutrients|micronutrients|mesh-ancestor
25324347|NCT04885803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324348|NCT04885803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25324349|NCT04885803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25324350|NCT04885270|Cisplatin|cisplatin|mesh-list
25324351|NCT04885270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25324352|NCT04885426|Metformin|metformin|mesh-list
25195567|NCT02757495|Dexmedetomidine|dexmedetomidine|mesh-list
25195568|NCT02757495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25195569|NCT02757495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25195570|NCT02757495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562473|NCT00766545|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24562475|NCT00766545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25324353|NCT04885426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25324354|NCT04885426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324356|NCT04885413|Antibodies|antibodies|mesh-list
25324357|NCT04885413|Immunologic Factors|immunologic factors|mesh-ancestor
25324358|NCT04885413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324359|NCT04885413|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25324360|NCT04885413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25324361|NCT04885413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324362|NCT04885413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25324363|NCT04885153|Fenofibrate|fenofibrate|mesh-list
25324364|NCT04885153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25324365|NCT04885153|Antimetabolites|antimetabolites|mesh-ancestor
25324366|NCT04885153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324367|NCT04885153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25324391|NCT04885075|Anesthetics, General|anesthetics, general|mesh-ancestor
25324393|NCT04885075|GABA Modulators|gaba modulators|mesh-ancestor
25324394|NCT04885075|GABA Agents|gaba agents|mesh-ancestor
25324395|NCT04885075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25324396|NCT04885075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324397|NCT04885075|Anticonvulsants|anticonvulsants|mesh-ancestor
25324398|NCT04885075|Antiemetics|antiemetics|mesh-ancestor
25324399|NCT04885075|Autonomic Agents|autonomic agents|mesh-ancestor
25324400|NCT04885075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25324401|NCT04885075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25324402|NCT04885075|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25324403|NCT04885075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25324404|NCT04884919|Chitosan|chitosan|mesh-list
25324405|NCT04884919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25324406|NCT04884919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25324407|NCT04884919|Antimetabolites|antimetabolites|mesh-ancestor
25010013|NCT04789304|GABA Agents|gaba agents|mesh-ancestor
25324408|NCT04884919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324409|NCT04884919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25324410|NCT04884919|Chelating Agents|chelating agents|mesh-ancestor
25324411|NCT04884919|Sequestering Agents|sequestering agents|mesh-ancestor
25324412|NCT04884919|Hemostatics|hemostatics|mesh-ancestor
25324413|NCT04884919|Coagulants|coagulants|mesh-ancestor
25324414|NCT04885049|Racecadotril|racecadotril|mesh-list
25324415|NCT04885049|Antidiarrheals|antidiarrheals|mesh-ancestor
25324416|NCT04885049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25324417|NCT04885049|Protease Inhibitors|protease inhibitors|mesh-ancestor
25324418|NCT04885049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25324419|NCT04885049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324449|NCT04884503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25324450|NCT04884503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324451|NCT04884503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324452|NCT04884516|Vitamin A|vitamin a|mesh-list
25324453|NCT04884516|Vitamins|vitamins|mesh-ancestor
25324454|NCT04884516|Micronutrients|micronutrients|mesh-ancestor
25324455|NCT04884516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324456|NCT04884490|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25324457|NCT04884490|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25324458|NCT04884490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25324459|NCT04884490|Renal Agents|renal agents|mesh-ancestor
25324460|NCT04884490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25324461|NCT04884490|Antimalarials|antimalarials|mesh-ancestor
25324462|NCT04884490|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25324463|NCT04884490|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25324464|NCT04884282|Docetaxel|docetaxel|mesh-list
25324465|NCT04884282|Nivolumab|nivolumab|mesh-list
25324466|NCT04884282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25324467|NCT04884282|Tubulin Modulators|tubulin modulators|mesh-ancestor
25324468|NCT04884282|Antimitotic Agents|antimitotic agents|mesh-ancestor
25649005|NCT01487577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25649006|NCT01487577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649007|NCT01487577|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25649008|NCT01487577|Antitubercular Agents|antitubercular agents|mesh-ancestor
25649009|NCT01487577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25649010|NCT01487577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25195620|NCT02757365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25195621|NCT02757365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25324469|NCT04884282|Mitosis Modulators|mitosis modulators|mesh-ancestor
25324470|NCT04884282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324471|NCT04884282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25324472|NCT04884282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25324473|NCT04883996|Pilocarpine|pilocarpine|mesh-list
25324474|NCT04883996|Miotics|miotics|mesh-ancestor
25324475|NCT04883996|Autonomic Agents|autonomic agents|mesh-ancestor
25324476|NCT04883996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25324477|NCT04883996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324478|NCT04883996|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25324479|NCT04883996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25324480|NCT04883996|Cholinergic Agents|cholinergic agents|mesh-ancestor
24580498|NCT00861952|Emollients|emollients|mesh-ancestor
25324481|NCT04883996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25324482|NCT04883996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324483|NCT04884464|Chlorhexidine|chlorhexidine|mesh-list
25324484|NCT04884464|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25324485|NCT04884464|Hyaluronic Acid|hyaluronic acid|mesh-list
25324486|NCT04884464|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25324487|NCT04884464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25324488|NCT04884464|Disinfectants|disinfectants|mesh-ancestor
25324489|NCT04884464|Dermatologic Agents|dermatologic agents|mesh-ancestor
25324490|NCT04884464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25324491|NCT04884464|Immunologic Factors|immunologic factors|mesh-ancestor
25324492|NCT04884464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324493|NCT04884464|Viscosupplements|viscosupplements|mesh-ancestor
25324494|NCT04884464|Protective Agents|protective agents|mesh-ancestor
25324495|NCT04883840|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25324496|NCT04883840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25324497|NCT04883840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25324498|NCT04883840|Antimetabolites|antimetabolites|mesh-ancestor
25324499|NCT04883840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324500|NCT04883840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25324501|NCT04883840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25324502|NCT04883840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25324503|NCT04883736|Tretinoin|tretinoin|mesh-list
25324504|NCT04883736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25324505|NCT04883736|Keratolytic Agents|keratolytic agents|mesh-ancestor
25324506|NCT04883736|Dermatologic Agents|dermatologic agents|mesh-ancestor
25324507|NCT04883164|Antibodies|antibodies|mesh-list
25324508|NCT04883164|Immunologic Factors|immunologic factors|mesh-ancestor
25324509|NCT04883164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324510|NCT04883203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25324511|NCT04883203|Plasma-lyte 148|plasma-lyte 148|mesh-list
25324512|NCT04883203|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25324514|NCT04883034|Sensory System Agents|sensory system agents|mesh-ancestor
25324515|NCT04883034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25324516|NCT04883034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324521|NCT04882826|Sildenafil Citrate|sildenafil citrate|mesh-list
25324522|NCT04882826|Vasodilator Agents|vasodilator agents|mesh-ancestor
25324523|NCT04882826|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25324524|NCT04882826|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25324525|NCT04882826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25324526|NCT04882826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324527|NCT04882826|Urological Agents|urological agents|mesh-ancestor
25324528|NCT04882813|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25324529|NCT04882813|Dapagliflozin|dapagliflozin|mesh-list
25324530|NCT04882813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25324531|NCT04882813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324532|NCT04882813|Incretins|incretins|mesh-ancestor
25324533|NCT04882813|Hormones|hormones|mesh-ancestor
25324534|NCT04882813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25324535|NCT04882813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25324536|NCT04882813|Protease Inhibitors|protease inhibitors|mesh-ancestor
25324537|NCT04882813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25324538|NCT04882813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324539|NCT04882813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25324540|NCT04883125|Pioglitazone|pioglitazone|mesh-list
25649011|NCT01487577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649012|NCT01487577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324541|NCT04883125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25324542|NCT04883125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324543|NCT04882540|Brivaracetam|brivaracetam|mesh-list
25324544|NCT04882540|Anticonvulsants|anticonvulsants|mesh-ancestor
25324545|NCT04882462|Nimotuzumab|nimotuzumab|mesh-list
25324546|NCT04882462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25324547|NCT04882462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25324548|NCT04882683|Prednisone|prednisone|mesh-list
25324549|NCT04882683|Adalimumab|adalimumab|mesh-list
25324550|NCT04882683|Azathioprine|azathioprine|mesh-list
25324551|NCT04882683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25324552|NCT04882683|Glucocorticoids|glucocorticoids|mesh-ancestor
25324553|NCT04882683|Hormones|hormones|mesh-ancestor
25324554|NCT04882683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25324555|NCT04882683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324556|NCT04882683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25324557|NCT04882683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25324558|NCT04882683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25324559|NCT04882683|Antimetabolites|antimetabolites|mesh-ancestor
25324560|NCT04882683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324561|NCT04882683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25324562|NCT04882683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25324563|NCT04882683|Immunologic Factors|immunologic factors|mesh-ancestor
25324564|NCT04882358|Dapagliflozin|dapagliflozin|mesh-list
25324565|NCT04882358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25324566|NCT04882358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324567|NCT04882358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25324568|NCT04882358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324569|NCT04882163|Gemcitabine|gemcitabine|mesh-list
25324570|NCT04882163|Dexamethasone|dexamethasone|mesh-list
25324571|NCT04882163|Rituximab|rituximab|mesh-list
25324572|NCT04882163|Lenalidomide|lenalidomide|mesh-list
25324573|NCT04882163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25324574|NCT04882163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25324575|NCT04882163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25324576|NCT04882163|Immunologic Factors|immunologic factors|mesh-ancestor
25324577|NCT04882163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324578|NCT04882163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25324579|NCT04882163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25324580|NCT04882163|Antiemetics|antiemetics|mesh-ancestor
24580839|NCT00863889|Lidocaine|lidocaine|mesh-list
24964399|NCT03783676|Analgesics|analgesics|mesh-ancestor
25324581|NCT04882163|Autonomic Agents|autonomic agents|mesh-ancestor
25324582|NCT04882163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25324583|NCT04882163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25324584|NCT04882163|Glucocorticoids|glucocorticoids|mesh-ancestor
25324585|NCT04882163|Hormones|hormones|mesh-ancestor
25324586|NCT04882163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25324587|NCT04882163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25324588|NCT04882163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25324589|NCT04882163|Antimetabolites|antimetabolites|mesh-ancestor
25324590|NCT04882163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324591|NCT04882163|Antiviral Agents|antiviral agents|mesh-ancestor
25324592|NCT04882163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25324593|NCT04882163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25324594|NCT04882163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25324599|NCT04882163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25324600|NCT04882163|Alkylating Agents|alkylating agents|mesh-ancestor
25324601|NCT04881942|Menthol|menthol|mesh-list
25324602|NCT04881942|Nicotine|nicotine|mesh-list
25324603|NCT04881942|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25324604|NCT04881942|Autonomic Agents|autonomic agents|mesh-ancestor
25324605|NCT04881942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25324606|NCT04881942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324607|NCT04881942|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25324608|NCT04881942|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25324609|NCT04881942|Cholinergic Agents|cholinergic agents|mesh-ancestor
25324610|NCT04881942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25324611|NCT04881942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324612|NCT04881942|Antipruritics|antipruritics|mesh-ancestor
25324613|NCT04881942|Dermatologic Agents|dermatologic agents|mesh-ancestor
25324614|NCT04882020|Hydrocortisone|hydrocortisone|mesh-list
25324615|NCT04882020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25324616|NCT04881747|Lasmiditan|lasmiditan|mesh-list
25324617|NCT04881747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25324618|NCT04881747|Serotonin Agents|serotonin agents|mesh-ancestor
25324619|NCT04881747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25649013|NCT01487863|Abiraterone Acetate|abiraterone acetate|mesh-list
25324620|NCT04881747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324621|NCT04881747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324627|NCT04881474|Ibuprofen|ibuprofen|mesh-list
25324628|NCT04881474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25324629|NCT04881474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25324630|NCT04881474|Analgesics|analgesics|mesh-ancestor
25324631|NCT04881474|Sensory System Agents|sensory system agents|mesh-ancestor
25324632|NCT04881474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25324633|NCT04881474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324634|NCT04881474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25324635|NCT04881474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25324636|NCT04881474|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25324637|NCT04881474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25324638|NCT04881474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324639|NCT04881851|Folic Acid|folic acid|mesh-list
25324640|NCT04881851|Thioctic Acid|thioctic acid|mesh-list
25324641|NCT04881851|Inositol|inositol|mesh-list
25324642|NCT04881851|Hematinics|hematinics|mesh-ancestor
25324643|NCT04881851|Vitamin B Complex|vitamin b complex|mesh-ancestor
25324644|NCT04881851|Vitamins|vitamins|mesh-ancestor
25324645|NCT04881851|Micronutrients|micronutrients|mesh-ancestor
25324646|NCT04881851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324647|NCT04881851|Antioxidants|antioxidants|mesh-ancestor
25324648|NCT04881851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324649|NCT04881851|Protective Agents|protective agents|mesh-ancestor
25324650|NCT04881006|Dapagliflozin|dapagliflozin|mesh-list
25324651|NCT04881006|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25324652|NCT04881006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324653|NCT04881006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25324654|NCT04881006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324655|NCT04881110|Liraglutide|liraglutide|mesh-list
25324656|NCT04881110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25324657|NCT04881110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324658|NCT04881110|Incretins|incretins|mesh-ancestor
25324659|NCT04881110|Hormones|hormones|mesh-ancestor
25324660|NCT04881110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25324661|NCT04880993|Dapagliflozin|dapagliflozin|mesh-list
25324662|NCT04880993|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25324663|NCT04880993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324664|NCT04880993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25324665|NCT04880993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324666|NCT04880746|Cladribine|cladribine|mesh-list
25324667|NCT04880746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25324668|NCT04880746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25324669|NCT04880746|Immunologic Factors|immunologic factors|mesh-ancestor
25324670|NCT04880746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324679|NCT04880499|Micronutrients|micronutrients|mesh-ancestor
25324680|NCT04880499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324681|NCT04880499|Hematinics|hematinics|mesh-ancestor
25324682|NCT04880499|Vitamin B Complex|vitamin b complex|mesh-ancestor
25324683|NCT04880499|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25324684|NCT04880499|Dermatologic Agents|dermatologic agents|mesh-ancestor
25324685|NCT04879992|Amoxicillin|amoxicillin|mesh-list
25324686|NCT04879992|Metronidazole|metronidazole|mesh-list
25324687|NCT04879992|Tetracycline|tetracycline|mesh-list
25324688|NCT04879992|Rifabutin|rifabutin|mesh-list
25324689|NCT04879992|Potassium Citrate|potassium citrate|mesh-list
25324690|NCT04879992|Esomeprazole|esomeprazole|mesh-list
25324691|NCT04879992|Bismuth|bismuth|mesh-list
25324692|NCT04879992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324693|NCT04879992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25324694|NCT04879992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25324695|NCT04879992|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25324696|NCT04879992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25324697|NCT04879992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25324698|NCT04879992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25324699|NCT04879992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25324700|NCT04879992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25324701|NCT04879992|Antacids|antacids|mesh-ancestor
25324702|NCT04879992|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25324703|NCT04879992|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25324704|NCT04879992|Antitubercular Agents|antitubercular agents|mesh-ancestor
25324705|NCT04879992|Diuretics|diuretics|mesh-ancestor
25324706|NCT04879992|Natriuretic Agents|natriuretic agents|mesh-ancestor
25324707|NCT04879992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324708|NCT04879992|Expectorants|expectorants|mesh-ancestor
25324709|NCT04879992|Respiratory System Agents|respiratory system agents|mesh-ancestor
25195821|NCT02756312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195822|NCT02756377|Chlorhexidine|chlorhexidine|mesh-list
25195823|NCT02756377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25195824|NCT02756377|Cetylpyridinium|cetylpyridinium|mesh-list
25195827|NCT02756377|Disinfectants|disinfectants|mesh-ancestor
25324710|NCT04879966|Infliximab|infliximab|mesh-list
25324711|NCT04879966|Dermatologic Agents|dermatologic agents|mesh-ancestor
25324712|NCT04879966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25324713|NCT04879966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25324714|NCT04879446|Mitogens|mitogens|mesh-list
25324715|NCT04879446|Mitosis Modulators|mitosis modulators|mesh-ancestor
25324716|NCT04879446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324717|NCT04879511|Metformin|metformin|mesh-list
25324718|NCT04879511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25324719|NCT04879511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324727|NCT04879420|Teriparatide|teriparatide|mesh-list
25324728|NCT04879420|Risedronic Acid|risedronic acid|mesh-list
25324729|NCT04879420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25324730|NCT04879420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324731|NCT04879420|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25324732|NCT04879420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25324733|NCT04879420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25324734|NCT04879420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324735|NCT04879615|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25324736|NCT04879615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25324737|NCT04879615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25324738|NCT04879615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324739|NCT04879407|Warfarin|warfarin|mesh-list
25324740|NCT04879407|Rivaroxaban|rivaroxaban|mesh-list
25324741|NCT04879407|Anticoagulants|anticoagulants|mesh-ancestor
25324742|NCT04879407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25324743|NCT04879407|Antithrombins|antithrombins|mesh-ancestor
25324744|NCT04879407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25324745|NCT04879407|Protease Inhibitors|protease inhibitors|mesh-ancestor
25324746|NCT04879407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25324747|NCT04879407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324748|NCT04879004|Ropivacaine|ropivacaine|mesh-list
25324749|NCT04879004|Anesthetics, Local|anesthetics, local|mesh-ancestor
25324750|NCT04879004|Anesthetics|anesthetics|mesh-ancestor
25324751|NCT04879004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25324752|NCT04879004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324753|NCT04879004|Sensory System Agents|sensory system agents|mesh-ancestor
25324754|NCT04879004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25324755|NCT04878926|Midazolam|midazolam|mesh-list
25324756|NCT04878926|Propofol|propofol|mesh-list
25324757|NCT04878926|Anesthetics|anesthetics|mesh-list
25324758|NCT04878926|Anesthetics, Local|anesthetics, local|mesh-list
25324759|NCT04878926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25324760|NCT04878926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25324761|NCT04878926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324762|NCT04878926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25324763|NCT04878926|Anesthetics, General|anesthetics, general|mesh-ancestor
25324764|NCT04878926|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25324765|NCT04878926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25324766|NCT04878926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25324767|NCT04878926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25324768|NCT04878926|GABA Modulators|gaba modulators|mesh-ancestor
25324769|NCT04878926|GABA Agents|gaba agents|mesh-ancestor
25324770|NCT04878926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25324771|NCT04878926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324772|NCT04878926|Sensory System Agents|sensory system agents|mesh-ancestor
25324773|NCT04878926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25324774|NCT04879030|Moxifloxacin|moxifloxacin|mesh-list
25324775|NCT04879030|Ciprofloxacin|ciprofloxacin|mesh-list
25324776|NCT04879030|Levofloxacin|levofloxacin|mesh-list
25324778|NCT04879030|Ceftriaxone|ceftriaxone|mesh-list
25324779|NCT04879030|Tazobactam|tazobactam|mesh-list
25324780|NCT04879030|Piperacillin|piperacillin|mesh-list
25324781|NCT04879030|Clavulanic Acid|clavulanic acid|mesh-list
25324782|NCT04879030|Imipenem|imipenem|mesh-list
25324783|NCT04879030|Ceftazidime|ceftazidime|mesh-list
25324784|NCT04879030|Ertapenem|ertapenem|mesh-list
25649014|NCT01487863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649015|NCT01487863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25649016|NCT01487863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649017|NCT01487863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324785|NCT04879030|Lactams|lactams|mesh-list
25324786|NCT04879030|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25207080|NCT04908423|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25207081|NCT04908423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25207082|NCT04908423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25207083|NCT04908423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207084|NCT04908423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25207085|NCT04908423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24562780|NCT00768183|Sensory System Agents|sensory system agents|mesh-ancestor
25207086|NCT04908423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207087|NCT04908423|Cholinergic Agents|cholinergic agents|mesh-ancestor
25207088|NCT04908423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25207089|NCT04907539|Denosumab|denosumab|mesh-list
25207090|NCT04907539|Nivolumab|nivolumab|mesh-list
25207091|NCT04907539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25207092|NCT04907539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207093|NCT04907539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25207094|NCT04907539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207095|NCT04907539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25207096|NCT04907539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207097|NCT04891068|Azacitidine|azacitidine|mesh-list
25207098|NCT04891068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25207099|NCT04891068|Antimetabolites|antimetabolites|mesh-ancestor
25207101|NCT04891068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25324787|NCT04879030|Cefotaxime|cefotaxime|mesh-list
25324788|NCT04879030|Cefixime|cefixime|mesh-list
25324789|NCT04879030|beta-Lactams|beta-lactams|mesh-list
25324790|NCT04879030|Fluoroquinolones|fluoroquinolones|mesh-list
25324791|NCT04879030|Ticarcillin|ticarcillin|mesh-list
25324792|NCT04879030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25324793|NCT04879030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25324794|NCT04879030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25324795|NCT04879030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25324796|NCT04879030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25324797|NCT04879030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324798|NCT04879030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25324799|NCT04879030|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25324800|NCT04879030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25324801|NCT04879030|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25324802|NCT04879030|Renal Agents|renal agents|mesh-ancestor
25324803|NCT04879030|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25324804|NCT04879030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25324805|NCT04878835|Ranibizumab|ranibizumab|mesh-list
25324806|NCT04878835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25324807|NCT04878835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25324808|NCT04878835|Growth Substances|growth substances|mesh-ancestor
25825539|NCT00005603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25324809|NCT04878835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324810|NCT04878835|Growth Inhibitors|growth inhibitors|mesh-ancestor
25324811|NCT04878835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25324812|NCT04878770|Cyclosporine|cyclosporine|mesh-list
25324813|NCT04878770|Cyclosporins|cyclosporins|mesh-list
25324814|NCT04878770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649018|NCT01487863|Hormone Antagonists|hormone antagonists|mesh-ancestor
25649019|NCT01487863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25649020|NCT01487863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649021|NCT01487863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25649022|NCT01488019|Formoterol Fumarate|formoterol fumarate|mesh-list
25649023|NCT01488019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25649024|NCT01488019|Autonomic Agents|autonomic agents|mesh-ancestor
25649025|NCT01488019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25649026|NCT01488019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649027|NCT01488019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25649028|NCT01488019|Respiratory System Agents|respiratory system agents|mesh-ancestor
25649029|NCT01488019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25649030|NCT01488019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25649031|NCT01488019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25649032|NCT01488019|Adrenergic Agents|adrenergic agents|mesh-ancestor
25649033|NCT01488019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25649034|NCT01488019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649035|NCT01488071|Vortioxetine|vortioxetine|mesh-list
25649036|NCT01488071|S 20098|s 20098|mesh-list
25649037|NCT01488071|Antidepressive Agents|antidepressive agents|mesh-ancestor
25649038|NCT01488071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25649039|NCT01488071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25324815|NCT04878770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324816|NCT04878770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25324817|NCT04878770|Immunologic Factors|immunologic factors|mesh-ancestor
25324818|NCT04878770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324819|NCT04878770|Antifungal Agents|antifungal agents|mesh-ancestor
25324820|NCT04878770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25324821|NCT04878770|Dermatologic Agents|dermatologic agents|mesh-ancestor
25324822|NCT04878770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25324823|NCT04878770|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25324824|NCT04878718|Vancomycin|vancomycin|mesh-list
25324825|NCT04878718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25324826|NCT04878718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25324838|NCT04878497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324845|NCT04878042|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25324846|NCT04878042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25324847|NCT04878042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25324876|NCT04878016|Carboplatin|carboplatin|mesh-list
25324877|NCT04878016|Etoposide|etoposide|mesh-list
25324878|NCT04878016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25324879|NCT04878016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25324880|NCT04878016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25324881|NCT04878016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25324882|NCT04878016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25324883|NCT04878016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324891|NCT05257993|Gemcitabine|gemcitabine|mesh-list
25324892|NCT05257993|Paclitaxel|paclitaxel|mesh-list
25324893|NCT05257993|Folfirinox|folfirinox|mesh-list
25324894|NCT05257993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25324895|NCT05257993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25324896|NCT05257993|Tubulin Modulators|tubulin modulators|mesh-ancestor
25324897|NCT05257993|Antimitotic Agents|antimitotic agents|mesh-ancestor
25324898|NCT05257993|Mitosis Modulators|mitosis modulators|mesh-ancestor
25324899|NCT05257993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324900|NCT05257993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25324901|NCT05257993|Antimetabolites|antimetabolites|mesh-ancestor
25324902|NCT05257993|Antiviral Agents|antiviral agents|mesh-ancestor
25324930|NCT05257395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25324931|NCT05257395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324932|NCT05257395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25324934|NCT05257291|Antioxidants|antioxidants|mesh-ancestor
25324935|NCT05257291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324936|NCT05257291|Protective Agents|protective agents|mesh-ancestor
25324937|NCT05257291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324938|NCT05257291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25324967|NCT05256953|Anesthetics|anesthetics|mesh-list
25324968|NCT05256953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25324969|NCT05256953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25324970|NCT05256758|Fenofibrate|fenofibrate|mesh-list
25324971|NCT05256758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25324972|NCT05256758|Antimetabolites|antimetabolites|mesh-ancestor
25324973|NCT05256758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324974|NCT05256758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25324975|NCT05256719|Abatacept|abatacept|mesh-list
25324976|NCT05256719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25324977|NCT05256719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325052|NCT05255848|Anticoagulants|anticoagulants|mesh-ancestor
25324992|NCT05256342|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25324993|NCT05256342|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25324994|NCT05256342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25324995|NCT05256342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25324996|NCT05256342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25324997|NCT05256342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25324998|NCT05256342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325000|NCT05256342|Sensory System Agents|sensory system agents|mesh-ancestor
25325001|NCT05256342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25325002|NCT05256342|Antidepressive Agents|antidepressive agents|mesh-ancestor
25325003|NCT05256342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25325004|NCT05256342|Dopamine Agents|dopamine agents|mesh-ancestor
25325005|NCT05256342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25325006|NCT05256342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25325007|NCT05256342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25325008|NCT05256342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25325009|NCT05256342|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25325010|NCT05256342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25325011|NCT05256342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25325027|NCT05256173|Antioxidants|antioxidants|mesh-ancestor
25325028|NCT05256173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325029|NCT05256173|Protective Agents|protective agents|mesh-ancestor
25325030|NCT05256173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325031|NCT05256173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25325032|NCT05256147|Ibuprofen|ibuprofen|mesh-list
25325033|NCT05256147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25325034|NCT05256147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25325035|NCT05256147|Analgesics|analgesics|mesh-ancestor
25325036|NCT05256147|Sensory System Agents|sensory system agents|mesh-ancestor
25325037|NCT05256147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25325038|NCT05256147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325039|NCT05256147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25325040|NCT05256147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25325041|NCT05256147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25325042|NCT05256147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25325043|NCT05256147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325044|NCT05255991|Treprostinil|treprostinil|mesh-list
25325045|NCT05255991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25325046|NCT05255913|Fluorides|fluorides|mesh-list
25325047|NCT05255913|Cariostatic Agents|cariostatic agents|mesh-ancestor
25325048|NCT05255913|Protective Agents|protective agents|mesh-ancestor
25325049|NCT05255913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325050|NCT05255848|Heparin|heparin|mesh-list
25325051|NCT05255848|Calcium heparin|calcium heparin|mesh-list
25325067|NCT05231941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25325068|NCT05231941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325069|NCT05231941|Sensory System Agents|sensory system agents|mesh-ancestor
25325070|NCT05231941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25325071|NCT05231941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25325072|NCT05231941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25325073|NCT05231941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25325074|NCT05231941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25325075|NCT05231941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325076|NCT05231590|Myeloma Proteins|myeloma proteins|mesh-list
25325077|NCT05231590|Paraproteins|paraproteins|mesh-list
25325078|NCT05231590|Immunologic Factors|immunologic factors|mesh-ancestor
25325079|NCT05231590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325080|NCT05216575|Almitrine|almitrine|mesh-list
25325081|NCT05216575|Respiratory System Agents|respiratory system agents|mesh-ancestor
25325082|NCT05214417|Ketamine|ketamine|mesh-list
25325083|NCT05214417|Analgesics|analgesics|mesh-ancestor
25325084|NCT05214417|Sensory System Agents|sensory system agents|mesh-ancestor
25325085|NCT05214417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25325086|NCT05214417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325087|NCT05214417|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25325088|NCT05214417|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25325089|NCT05214417|Anesthetics, General|anesthetics, general|mesh-ancestor
25325090|NCT05214417|Anesthetics|anesthetics|mesh-ancestor
25325091|NCT05214417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25325092|NCT05214417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25325093|NCT05214417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25325094|NCT05214417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25325095|NCT05214417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325096|NCT05205252|Dexamethasone|dexamethasone|mesh-list
25325097|NCT05205252|Dexamethasone acetate|dexamethasone acetate|mesh-list
25325098|NCT05205252|Lenalidomide|lenalidomide|mesh-list
25325099|NCT05205252|Daratumumab|daratumumab|mesh-list
25325100|NCT05205252|Pomalidomide|pomalidomide|mesh-list
25325101|NCT05205252|Acalabrutinib|acalabrutinib|mesh-list
25325102|NCT05205252|BB 1101|bb 1101|mesh-list
25325103|NCT05205252|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25325104|NCT05205252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25325105|NCT05205252|Antiemetics|antiemetics|mesh-ancestor
25325106|NCT05205252|Autonomic Agents|autonomic agents|mesh-ancestor
25325107|NCT05205252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25325108|NCT05205252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325109|NCT05205252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25325110|NCT05205252|Glucocorticoids|glucocorticoids|mesh-ancestor
25325111|NCT05205252|Hormones|hormones|mesh-ancestor
25325112|NCT05205252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25325113|NCT05205252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25325114|NCT05205252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325115|NCT05205252|Protease Inhibitors|protease inhibitors|mesh-ancestor
25325116|NCT05205252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25325117|NCT05205252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325118|NCT05205252|Immunologic Factors|immunologic factors|mesh-ancestor
25325119|NCT05205252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25325120|NCT05205252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25325121|NCT05205252|Growth Substances|growth substances|mesh-ancestor
25325122|NCT05205252|Growth Inhibitors|growth inhibitors|mesh-ancestor
25325124|NCT05197842|Cyclophosphamide|cyclophosphamide|mesh-list
25325125|NCT05197842|Glucocorticoids|glucocorticoids|mesh-list
25325126|NCT05197842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25325127|NCT05197842|Immunologic Factors|immunologic factors|mesh-ancestor
25325128|NCT05197842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325140|NCT05189730|Carboplatin|carboplatin|mesh-list
25325141|NCT05189730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25325142|NCT05189730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325143|NCT05189730|Tubulin Modulators|tubulin modulators|mesh-ancestor
25325144|NCT05189730|Antimitotic Agents|antimitotic agents|mesh-ancestor
25325145|NCT05189730|Mitosis Modulators|mitosis modulators|mesh-ancestor
25325146|NCT05189730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325150|NCT05154123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25325151|NCT05154123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25325152|NCT05154123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25325153|NCT05154123|Antimetabolites|antimetabolites|mesh-ancestor
25325154|NCT05154123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325155|NCT05154123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25325156|NCT05154123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25325157|NCT05154123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25325158|NCT05028608|Carbamazepine|carbamazepine|mesh-list
25325159|NCT05028608|Midazolam|midazolam|mesh-list
25325160|NCT05028608|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25325161|NCT05028608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25325162|NCT05028608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25325163|NCT05028608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325164|NCT05028608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25325165|NCT05028608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25325166|NCT05028608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25325167|NCT05028608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25325168|NCT05028608|Anesthetics, General|anesthetics, general|mesh-ancestor
25325169|NCT05028608|Anesthetics|anesthetics|mesh-ancestor
25325170|NCT05028608|GABA Modulators|gaba modulators|mesh-ancestor
25325171|NCT05028608|GABA Agents|gaba agents|mesh-ancestor
25325172|NCT05028608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25325173|NCT05028608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325174|NCT05028608|Anticonvulsants|anticonvulsants|mesh-ancestor
25325175|NCT05028608|Antimanic Agents|antimanic agents|mesh-ancestor
25325176|NCT05028608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25325177|NCT05028608|Analgesics|analgesics|mesh-ancestor
25325178|NCT05028608|Sensory System Agents|sensory system agents|mesh-ancestor
25325179|NCT05028608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25325180|NCT05028608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25325181|NCT05028608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25325182|NCT05028608|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25325183|NCT05028608|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25325194|NCT04984317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25325195|NCT04984317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25325196|NCT04984317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25325197|NCT04984317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25325198|NCT04984317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325199|NCT04984317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25325200|NCT04984317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25325201|NCT04984317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325212|NCT04873596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25325213|NCT04873596|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25325214|NCT04873596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25325215|NCT04873596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25325216|NCT04873596|Adrenergic Agents|adrenergic agents|mesh-ancestor
25325217|NCT04873596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25325218|NCT04873596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325219|NCT04873596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25196106|NCT02754362|Immunologic Factors|immunologic factors|mesh-ancestor
25325220|NCT04873596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25325221|NCT04873596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25325222|NCT04873596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25325223|NCT04873596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25325224|NCT04873596|Anesthetics, General|anesthetics, general|mesh-ancestor
25325225|NCT04873596|Anesthetics|anesthetics|mesh-ancestor
25325226|NCT04873596|GABA Modulators|gaba modulators|mesh-ancestor
25325227|NCT04873596|GABA Agents|gaba agents|mesh-ancestor
24464588|NCT00365339|Histamine Agents|histamine agents|mesh-ancestor
24464589|NCT00365560|Tiotropium Bromide|tiotropium bromide|mesh-list
24464590|NCT00365560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24464591|NCT00365560|Autonomic Agents|autonomic agents|mesh-ancestor
25325234|NCT04685876|Bupivacaine|bupivacaine|mesh-list
25325235|NCT04685876|Anesthetics, Local|anesthetics, local|mesh-ancestor
25325236|NCT04685876|Anesthetics|anesthetics|mesh-ancestor
25325237|NCT04685876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25325238|NCT04685876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325239|NCT04685876|Sensory System Agents|sensory system agents|mesh-ancestor
25325240|NCT04685876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25325241|NCT04676399|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25325242|NCT04676399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25325243|NCT04676399|Diuretics|diuretics|mesh-ancestor
25325244|NCT04676399|Natriuretic Agents|natriuretic agents|mesh-ancestor
25325245|NCT04676399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325246|NCT04676399|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25325247|NCT04676399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25325248|NCT04676399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325249|NCT04605991|Insulin Glargine|insulin glargine|mesh-list
25325250|NCT04605991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25325251|NCT04605991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325252|NCT04569045|Lidocaine|lidocaine|mesh-list
25325253|NCT04569045|Anesthetics, Local|anesthetics, local|mesh-ancestor
25325254|NCT04569045|Anesthetics|anesthetics|mesh-ancestor
25325255|NCT04569045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25325256|NCT04569045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325257|NCT04569045|Sensory System Agents|sensory system agents|mesh-ancestor
25325258|NCT04569045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25325259|NCT04569045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25325260|NCT04569045|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25325261|NCT04569045|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25325262|NCT04569045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25325263|NCT04569045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325264|NCT04550195|Famotidine|famotidine|mesh-list
25325265|NCT04550195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25325266|NCT04550195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25325267|NCT04550195|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25325268|NCT04550195|Histamine Antagonists|histamine antagonists|mesh-ancestor
25325269|NCT04550195|Histamine Agents|histamine agents|mesh-ancestor
25325270|NCT04550195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25325271|NCT04550195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325272|NCT04550195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325273|NCT04537962|Listerine|listerine|mesh-list
25325274|NCT04537962|Cetylpyridinium|cetylpyridinium|mesh-list
25325275|NCT04537962|Fluorides|fluorides|mesh-list
25325276|NCT04537962|Sodium Fluoride|sodium fluoride|mesh-list
25325277|NCT04537962|Fluorophosphate|fluorophosphate|mesh-list
25325278|NCT04537962|Tin Fluorides|tin fluorides|mesh-list
25325279|NCT04537962|Cariostatic Agents|cariostatic agents|mesh-ancestor
25325280|NCT04537962|Protective Agents|protective agents|mesh-ancestor
25325281|NCT04537962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325282|NCT04537962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25325283|NCT04537962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25325284|NCT04525391|Durvalumab|durvalumab|mesh-list
25325285|NCT04525391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25325286|NCT04525391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325287|NCT04481048|Acetylcysteine|acetylcysteine|mesh-list
25325288|NCT04481048|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25325289|NCT04481048|Antiviral Agents|antiviral agents|mesh-ancestor
25325290|NCT04481048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25649040|NCT01488071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25649041|NCT01488071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25325291|NCT04481048|Expectorants|expectorants|mesh-ancestor
25325292|NCT04481048|Respiratory System Agents|respiratory system agents|mesh-ancestor
25325293|NCT04481048|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25208256|NCT02737436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208258|NCT02727998|Ketamine|ketamine|mesh-list
25208259|NCT02727998|Analgesics|analgesics|mesh-ancestor
25325294|NCT04481048|Antioxidants|antioxidants|mesh-ancestor
25325295|NCT04481048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325296|NCT04481048|Protective Agents|protective agents|mesh-ancestor
25325297|NCT04481048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325298|NCT04481048|Antidotes|antidotes|mesh-ancestor
25325299|NCT04469530|Sirolimus|sirolimus|mesh-list
25325300|NCT04469530|Celecoxib|celecoxib|mesh-list
25325301|NCT04469530|Cyclophosphamide|cyclophosphamide|mesh-list
25325302|NCT04469530|Etoposide|etoposide|mesh-list
25325303|NCT04469530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25325304|NCT04469530|Immunologic Factors|immunologic factors|mesh-ancestor
25325305|NCT04469530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966449|NCT03768024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24966450|NCT03767920|Dexamethasone|dexamethasone|mesh-list
24771181|NCT01825044|Antifungal Agents|antifungal agents|mesh-ancestor
25325306|NCT04469530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25325307|NCT04469530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25325308|NCT04469530|Alkylating Agents|alkylating agents|mesh-ancestor
25325309|NCT04469530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325310|NCT04469530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325311|NCT04469530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25325312|NCT04469530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25325313|NCT04469530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25325314|NCT04469530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25325315|NCT04469530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25325316|NCT04469530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25325317|NCT04469530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25325318|NCT04469530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25325319|NCT04469530|Antifungal Agents|antifungal agents|mesh-ancestor
25325320|NCT04469530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25325321|NCT04469530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25325322|NCT04469530|Analgesics|analgesics|mesh-ancestor
25325323|NCT04469530|Sensory System Agents|sensory system agents|mesh-ancestor
25325324|NCT04469530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25325325|NCT04469530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25325326|NCT04469530|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25325327|NCT04469530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25325328|NCT04425291|Vaccines|vaccines|mesh-list
25325329|NCT04425291|Immunologic Factors|immunologic factors|mesh-ancestor
25325330|NCT04425291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325331|NCT04423055|Contraceptive Agents|contraceptive agents|mesh-list
25325332|NCT04423055|Etonogestrel|etonogestrel|mesh-list
25325333|NCT04423055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25325334|NCT04423055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325335|NCT04423055|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25325336|NCT04423055|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25325337|NCT04389073|Cyclophosphamide|cyclophosphamide|mesh-list
25325338|NCT04389073|Bevacizumab|bevacizumab|mesh-list
25325339|NCT04389073|Capecitabine|capecitabine|mesh-list
25325340|NCT04389073|Vinorelbine|vinorelbine|mesh-list
25325341|NCT04389073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25325342|NCT04389073|Immunologic Factors|immunologic factors|mesh-ancestor
25325411|NCT04309916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25325344|NCT04389073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25325345|NCT04389073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25325346|NCT04389073|Alkylating Agents|alkylating agents|mesh-ancestor
25325347|NCT04389073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325348|NCT04389073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325349|NCT04389073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25325350|NCT04389073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25325351|NCT04389073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25325352|NCT04389073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25325353|NCT04389073|Growth Substances|growth substances|mesh-ancestor
25325354|NCT04389073|Growth Inhibitors|growth inhibitors|mesh-ancestor
25325355|NCT04389073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25325356|NCT04389073|Antimetabolites|antimetabolites|mesh-ancestor
25325357|NCT04389073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25649042|NCT01488071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649043|NCT01488071|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25649044|NCT01488071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25325358|NCT04389073|Tubulin Modulators|tubulin modulators|mesh-ancestor
25325359|NCT04389073|Antimitotic Agents|antimitotic agents|mesh-ancestor
25325360|NCT04389073|Mitosis Modulators|mitosis modulators|mesh-ancestor
25325361|NCT04371445|Dexamethasone|dexamethasone|mesh-list
25325362|NCT04371445|Prednisolone|prednisolone|mesh-list
25325363|NCT04371445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25325364|NCT04371445|Methylprednisolone|methylprednisolone|mesh-list
25325365|NCT04371445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25325366|NCT04371445|Prednisolone acetate|prednisolone acetate|mesh-list
25325367|NCT04371445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25325368|NCT04371445|Prednisolone phosphate|prednisolone phosphate|mesh-list
25325369|NCT04371445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25325370|NCT04371445|Antiemetics|antiemetics|mesh-ancestor
25325371|NCT04371445|Autonomic Agents|autonomic agents|mesh-ancestor
25325372|NCT04371445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25825540|NCT00005603|Immunologic Factors|immunologic factors|mesh-ancestor
24486784|NCT00460083|Immunologic Factors|immunologic factors|mesh-ancestor
24464922|NCT00367302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24464924|NCT00367302|Antitussive Agents|antitussive agents|mesh-ancestor
24464925|NCT00367302|Respiratory System Agents|respiratory system agents|mesh-ancestor
24464926|NCT00367315|Lumiracoxib|lumiracoxib|mesh-list
24464927|NCT00367315|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25325373|NCT04371445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325374|NCT04371445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25325375|NCT04371445|Glucocorticoids|glucocorticoids|mesh-ancestor
25325376|NCT04371445|Hormones|hormones|mesh-ancestor
25325377|NCT04371445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25325378|NCT04371445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25325379|NCT04371445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325380|NCT04371445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25325381|NCT04371445|Protective Agents|protective agents|mesh-ancestor
25325382|NCT04357782|Ascorbic Acid|ascorbic acid|mesh-list
25325383|NCT04357782|Vitamins|vitamins|mesh-ancestor
25325384|NCT04357782|Micronutrients|micronutrients|mesh-ancestor
25325385|NCT04357782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325386|NCT04357782|Antioxidants|antioxidants|mesh-ancestor
25325387|NCT04357782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325388|NCT04357782|Protective Agents|protective agents|mesh-ancestor
25325389|NCT04337073|Propofol|propofol|mesh-list
25325390|NCT04337073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25325391|NCT04337073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25325392|NCT04337073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325393|NCT04337073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25325394|NCT04337073|Anesthetics, General|anesthetics, general|mesh-ancestor
25325395|NCT04337073|Anesthetics|anesthetics|mesh-ancestor
25325396|NCT04316806|Rifaximin|rifaximin|mesh-list
25325397|NCT04316806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25325398|NCT04316806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25325399|NCT04316806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25325400|NCT04311606|Aflibercept|aflibercept|mesh-list
25325401|NCT04311606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25325402|NCT04311606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25325403|NCT04311606|Growth Substances|growth substances|mesh-ancestor
25325404|NCT04311606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325405|NCT04311606|Growth Inhibitors|growth inhibitors|mesh-ancestor
25325406|NCT04311606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325407|NCT04309916|Esomeprazole|esomeprazole|mesh-list
25325408|NCT04309916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25325409|NCT04309916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25325410|NCT04309916|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25325428|NCT04284397|Antipyretics|antipyretics|mesh-ancestor
25325432|NCT04270474|Cholinergic Antagonists|cholinergic antagonists|mesh-list
25325433|NCT04270474|Cholinergic Agents|cholinergic agents|mesh-ancestor
25325434|NCT04270474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25325435|NCT04270474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325436|NCT04270474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325437|NCT04245215|Ustekinumab|ustekinumab|mesh-list
25325438|NCT04245215|Dermatologic Agents|dermatologic agents|mesh-ancestor
25325442|NCT04189107|Dexamethasone|dexamethasone|mesh-list
25325443|NCT04189107|Dexamethasone acetate|dexamethasone acetate|mesh-list
25325444|NCT04189107|BB 1101|bb 1101|mesh-list
25325445|NCT04189107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25325446|NCT04189107|Antiemetics|antiemetics|mesh-ancestor
25325447|NCT04189107|Autonomic Agents|autonomic agents|mesh-ancestor
25079167|NCT03349827|Apatinib|apatinib|mesh-list
25325448|NCT04189107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25325449|NCT04189107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325450|NCT04189107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25325451|NCT04189107|Glucocorticoids|glucocorticoids|mesh-ancestor
25325452|NCT04189107|Hormones|hormones|mesh-ancestor
25325453|NCT04189107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25325454|NCT04189107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25325455|NCT04189107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325456|NCT04189107|Protease Inhibitors|protease inhibitors|mesh-ancestor
25325457|NCT04189107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25325458|NCT04189107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325459|NCT04112095|Norgestrel|norgestrel|mesh-list
25325460|NCT04112095|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25325461|NCT04112095|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25325462|NCT04112095|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25325463|NCT04112095|Contraceptive Agents|contraceptive agents|mesh-ancestor
25325464|NCT04112095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25325465|NCT04112095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325466|NCT04112095|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25325467|NCT04112095|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25325468|NCT04050553|Tirzepatide|tirzepatide|mesh-list
25325469|NCT04050553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25325470|NCT04050553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325471|NCT04050553|Incretins|incretins|mesh-ancestor
25325472|NCT04050553|Hormones|hormones|mesh-ancestor
25325473|NCT04050553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25325496|NCT03946891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25325497|NCT03946891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325499|NCT03934684|Dexamethasone acetate|dexamethasone acetate|mesh-list
25325500|NCT03934684|Lenalidomide|lenalidomide|mesh-list
25325501|NCT03934684|BB 1101|bb 1101|mesh-list
25325502|NCT03934684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25325503|NCT03934684|Antiemetics|antiemetics|mesh-ancestor
25325504|NCT03934684|Autonomic Agents|autonomic agents|mesh-ancestor
25325505|NCT03934684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25325506|NCT03934684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325507|NCT03934684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25325508|NCT03934684|Glucocorticoids|glucocorticoids|mesh-ancestor
25325509|NCT03934684|Hormones|hormones|mesh-ancestor
25325510|NCT03934684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25325511|NCT03934684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25325512|NCT03934684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325513|NCT03934684|Protease Inhibitors|protease inhibitors|mesh-ancestor
25325514|NCT03934684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25325515|NCT03934684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325516|NCT03934684|Immunologic Factors|immunologic factors|mesh-ancestor
25325517|NCT03934684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25325518|NCT03934684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25325519|NCT03934684|Growth Substances|growth substances|mesh-ancestor
25325520|NCT03934684|Growth Inhibitors|growth inhibitors|mesh-ancestor
25325521|NCT03911453|Rucaparib|rucaparib|mesh-list
25325522|NCT03911453|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25325523|NCT03911453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25325524|NCT03911453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325525|NCT03911453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325526|NCT03871049|Dexamethasone|dexamethasone|mesh-list
25325527|NCT03871049|Bupivacaine|bupivacaine|mesh-list
25325528|NCT03871049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25325529|NCT03871049|Antiemetics|antiemetics|mesh-ancestor
25325530|NCT03871049|Autonomic Agents|autonomic agents|mesh-ancestor
25325531|NCT03871049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25325532|NCT03871049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325533|NCT03871049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25325534|NCT03871049|Glucocorticoids|glucocorticoids|mesh-ancestor
25325535|NCT03871049|Hormones|hormones|mesh-ancestor
25325536|NCT03871049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25325537|NCT03871049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25325538|NCT03871049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325539|NCT03871049|Anesthetics, Local|anesthetics, local|mesh-ancestor
25325540|NCT03871049|Anesthetics|anesthetics|mesh-ancestor
25325541|NCT03871049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25325542|NCT03871049|Sensory System Agents|sensory system agents|mesh-ancestor
24627178|NCT01090895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895535|NCT03900949|Daunorubicin|daunorubicin|mesh-list
25325543|NCT03849625|Aspirin|aspirin|mesh-list
25325544|NCT03849625|Acetaminophen|acetaminophen|mesh-list
25325545|NCT03849625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25325546|NCT03849625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25325547|NCT03849625|Analgesics|analgesics|mesh-ancestor
24563425|NCT00771498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25196333|NCT02752815|Epirubicin|epirubicin|mesh-list
25196334|NCT02752815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25196335|NCT02752815|Immunologic Factors|immunologic factors|mesh-ancestor
25196336|NCT02752815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196337|NCT02752815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25196338|NCT02752815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25196339|NCT02752815|Alkylating Agents|alkylating agents|mesh-ancestor
25196340|NCT02752815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196341|NCT02752815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325548|NCT03849625|Sensory System Agents|sensory system agents|mesh-ancestor
25325549|NCT03849625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25325550|NCT03849625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325551|NCT03849625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25325552|NCT03849625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25325553|NCT03849625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25325554|NCT03849625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25325555|NCT03849625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325556|NCT03849625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25325557|NCT03849625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25325627|NCT03742986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25325628|NCT03742986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25325629|NCT03742986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25325630|NCT03742986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25325631|NCT03742986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25325636|NCT03612973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25325658|NCT03583255|Glucocorticoids|glucocorticoids|mesh-ancestor
25325659|NCT03583255|Hormones|hormones|mesh-ancestor
25325660|NCT03583255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25325661|NCT03583255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25325662|NCT03583255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325663|NCT03583255|Protease Inhibitors|protease inhibitors|mesh-ancestor
25325664|NCT03583255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25325665|NCT03583255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325666|NCT03583255|Dermatologic Agents|dermatologic agents|mesh-ancestor
25325667|NCT03557918|Tremelimumab|tremelimumab|mesh-list
25325668|NCT03557918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325691|NCT03442114|Hydroxyurea|hydroxyurea|mesh-list
25325692|NCT03442114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825541|NCT00005603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627307|NCT01091818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325693|NCT03442114|Antisickling Agents|antisickling agents|mesh-ancestor
25325694|NCT03442114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25325695|NCT03442114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325696|NCT03442114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25325697|NCT03352934|Avelumab|avelumab|mesh-list
25325698|NCT03352934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25325699|NCT03352934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325700|NCT03341689|Psilocybin|psilocybin|mesh-list
25325701|NCT03341689|Hallucinogens|hallucinogens|mesh-ancestor
25325702|NCT03341689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325703|NCT03341689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25325704|NCT03340766|Pembrolizumab|pembrolizumab|mesh-list
25325705|NCT03340766|Blinatumomab|blinatumomab|mesh-list
25325706|NCT03340766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25325707|NCT03340766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325709|NCT03300817|Interferon Inducers|interferon inducers|mesh-ancestor
25325710|NCT03300817|Immunologic Factors|immunologic factors|mesh-ancestor
25325786|NCT02178358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25325722|NCT03257033|Antiviral Agents|antiviral agents|mesh-ancestor
25325723|NCT03257033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25325724|NCT03257033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25325725|NCT03257033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25325726|NCT03257033|Immunologic Factors|immunologic factors|mesh-ancestor
25649045|NCT01488071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25649046|NCT01488071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649047|NCT01488071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25649048|NCT01488071|Serotonin Agents|serotonin agents|mesh-ancestor
25649049|NCT01488071|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25649050|NCT01488071|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25649051|NCT01488071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25649052|NCT01488071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25649053|NCT01488071|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25325727|NCT03257033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325728|NCT03250169|Alemtuzumab|alemtuzumab|mesh-list
25325729|NCT03250169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25325730|NCT03250169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325731|NCT03154580|Acetylcysteine|acetylcysteine|mesh-list
25325732|NCT03154580|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25325733|NCT03154580|Antiviral Agents|antiviral agents|mesh-ancestor
25325734|NCT03154580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25325735|NCT03154580|Expectorants|expectorants|mesh-ancestor
25325736|NCT03154580|Respiratory System Agents|respiratory system agents|mesh-ancestor
25325737|NCT03154580|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25325738|NCT03154580|Antioxidants|antioxidants|mesh-ancestor
25325739|NCT03154580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325740|NCT03154580|Protective Agents|protective agents|mesh-ancestor
25325741|NCT03154580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325742|NCT03154580|Antidotes|antidotes|mesh-ancestor
25325743|NCT03123978|Niclosamide|niclosamide|mesh-list
25325744|NCT03123978|Anticestodal Agents|anticestodal agents|mesh-ancestor
25325745|NCT03123978|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25325746|NCT03123978|Anthelmintics|anthelmintics|mesh-ancestor
25325747|NCT03123978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25325748|NCT03123978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25325749|NCT03123978|Antinematodal Agents|antinematodal agents|mesh-ancestor
25325756|NCT02706847|Upadacitinib|upadacitinib|mesh-list
25325757|NCT02706847|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25325758|NCT02706847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25325759|NCT02706847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25325760|NCT02706847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325761|NCT02706847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25325762|NCT02564900|Camptothecin|camptothecin|mesh-list
25325763|NCT02564900|Immunoconjugates|immunoconjugates|mesh-list
25325764|NCT02564900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25325765|NCT02564900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325766|NCT02564900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25325767|NCT02564900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24627469|NCT01092975|Phenylephrine|phenylephrine|mesh-list
25325768|NCT02564900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25325769|NCT02564900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325770|NCT02564900|Immunologic Factors|immunologic factors|mesh-ancestor
25325771|NCT02564900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325778|NCT02273362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25325779|NCT02273362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325780|NCT02273362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25325781|NCT02273362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25325782|NCT02273362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325784|NCT02178358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325785|NCT02178358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25325807|NCT01838174|Autonomic Agents|autonomic agents|mesh-ancestor
25325808|NCT01838174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25325809|NCT01838174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325810|NCT01838174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25325811|NCT01838174|Glucocorticoids|glucocorticoids|mesh-ancestor
25325812|NCT01838174|Hormones|hormones|mesh-ancestor
25325813|NCT01838174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25325814|NCT01838174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25325815|NCT01838174|Protective Agents|protective agents|mesh-ancestor
25325816|NCT01838174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25325817|NCT01838174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325818|NCT01532310|Belimumab|belimumab|mesh-list
25325819|NCT01532310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25325820|NCT01532310|Immunologic Factors|immunologic factors|mesh-ancestor
25325821|NCT01532310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325822|NCT01495637|Sargramostim|sargramostim|mesh-list
25325823|NCT01495637|Immunologic Factors|immunologic factors|mesh-ancestor
25325824|NCT01495637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325825|NCT01243190|Ofatumumab|ofatumumab|mesh-list
25325826|NCT01243190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325827|NCT00806390|Metoprolol|metoprolol|mesh-list
25325828|NCT00806390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25325829|NCT00806390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25325830|NCT00806390|Sympatholytics|sympatholytics|mesh-ancestor
25325831|NCT00806390|Autonomic Agents|autonomic agents|mesh-ancestor
25325832|NCT00806390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25325833|NCT00806390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649054|NCT01488188|Vaccines|vaccines|mesh-list
25196479|NCT02752308|Narcotics|narcotics|mesh-ancestor
25196480|NCT02752308|Analgesics|analgesics|mesh-ancestor
25196481|NCT02752308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25196482|NCT02752308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25196483|NCT02752308|Anesthetics, General|anesthetics, general|mesh-ancestor
25196484|NCT02752308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24563524|NCT00772187|Fentanyl|fentanyl|mesh-list
25196485|NCT02752308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25196486|NCT02752308|Adrenergic Agents|adrenergic agents|mesh-ancestor
25196487|NCT02752308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25196488|NCT02752308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196489|NCT02752308|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25325834|NCT00806390|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25325835|NCT00806390|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25325836|NCT00806390|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25325837|NCT00806390|Adrenergic Agents|adrenergic agents|mesh-ancestor
25325838|NCT00806390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25325839|NCT00806390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325840|NCT00566618|Zoledronic Acid|zoledronic acid|mesh-list
25325841|NCT00566618|Dasatinib|dasatinib|mesh-list
24465949|NCT00371319|Mycophenolic Acid|mycophenolic acid|mesh-list
24465950|NCT00371319|Tacrolimus|tacrolimus|mesh-list
24465951|NCT00371319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25325842|NCT00566618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325843|NCT00566618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25325844|NCT00566618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25325845|NCT00566618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325846|NCT00566618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25325847|NCT00566618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325848|NCT00442559|Montelukast|montelukast|mesh-list
25325849|NCT00442559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25325850|NCT00442559|Respiratory System Agents|respiratory system agents|mesh-ancestor
25325851|NCT00442559|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25325852|NCT00442559|Hormone Antagonists|hormone antagonists|mesh-ancestor
25325853|NCT00442559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25325854|NCT00442559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325855|NCT00442559|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25325856|NCT00442559|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25325857|NCT00442559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325885|NCT04877509|Antioxidants|antioxidants|mesh-ancestor
25325886|NCT04877509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325887|NCT04877509|Protective Agents|protective agents|mesh-ancestor
25325888|NCT04877509|Trace Elements|trace elements|mesh-ancestor
25325889|NCT04877509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24581372|NCT00865007|Ritonavir|ritonavir|mesh-list
24796924|NCT01953172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796927|NCT01953367|Tobramycin|tobramycin|mesh-list
24895868|NCT02960763|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25325916|NCT04877210|Insulin|insulin|mesh-list
25325917|NCT04877210|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25325918|NCT04877210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25325919|NCT04877210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325920|NCT04877106|Metformin|metformin|mesh-list
25325921|NCT04877106|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25325922|NCT04877106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25325923|NCT04877106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325924|NCT04877106|Incretins|incretins|mesh-ancestor
25325925|NCT04877106|Hormones|hormones|mesh-ancestor
25325926|NCT04877106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25649055|NCT01488188|Immunologic Factors|immunologic factors|mesh-ancestor
25649056|NCT01488188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649057|NCT01488279|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25649058|NCT01488279|Dexamethasone|dexamethasone|mesh-list
25649059|NCT01488279|Dexamethasone acetate|dexamethasone acetate|mesh-list
25649060|NCT01488279|BB 1101|bb 1101|mesh-list
25649061|NCT01488279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25649062|NCT01488279|Antiemetics|antiemetics|mesh-ancestor
25649063|NCT01488279|Autonomic Agents|autonomic agents|mesh-ancestor
25649064|NCT01488279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25649065|NCT01488279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649066|NCT01488279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25649067|NCT01488279|Glucocorticoids|glucocorticoids|mesh-ancestor
25649068|NCT01488279|Hormones|hormones|mesh-ancestor
25325927|NCT04877106|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25325928|NCT04877106|Protease Inhibitors|protease inhibitors|mesh-ancestor
25325933|NCT04876716|Isavuconazole|isavuconazole|mesh-list
25325934|NCT04876716|Anidulafungin|anidulafungin|mesh-list
25325935|NCT04876716|Antifungal Agents|antifungal agents|mesh-ancestor
25325936|NCT04876716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25325937|NCT04876716|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25325938|NCT04876716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25325939|NCT04876716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25325940|NCT04876716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325941|NCT04876716|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25325942|NCT04876716|Hormone Antagonists|hormone antagonists|mesh-ancestor
25325943|NCT04876716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25325944|NCT04876716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325945|NCT04876716|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25325946|NCT04876716|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25325947|NCT04876716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25325948|NCT04876716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25325949|NCT04876638|Minocycline|minocycline|mesh-list
25325950|NCT04876638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25325951|NCT04876638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25325952|NCT04876859|Anesthetics|anesthetics|mesh-list
25325953|NCT04876859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25325954|NCT04876859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325955|NCT04876807|Acalabrutinib|acalabrutinib|mesh-list
25325956|NCT04876807|Omeprazole|omeprazole|mesh-list
25325957|NCT04876807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25325958|NCT04876807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25325959|NCT04876807|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25325960|NCT04876807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25325961|NCT04876807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325962|NCT04876807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325966|NCT04876313|Paclitaxel|paclitaxel|mesh-list
25325967|NCT04876313|Nivolumab|nivolumab|mesh-list
25325968|NCT04876313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25325969|NCT04876313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25325970|NCT04876313|Tubulin Modulators|tubulin modulators|mesh-ancestor
25325971|NCT04876313|Antimitotic Agents|antimitotic agents|mesh-ancestor
25325972|NCT04876313|Mitosis Modulators|mitosis modulators|mesh-ancestor
25325973|NCT04876313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325974|NCT04876313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25325975|NCT04876313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25325976|NCT04876755|TEMPO|tempo|mesh-list
25325977|NCT04876755|TEMPOL-H|tempol-h|mesh-list
25325978|NCT04876755|Antioxidants|antioxidants|mesh-ancestor
25325979|NCT04876755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325980|NCT04876755|Protective Agents|protective agents|mesh-ancestor
25325981|NCT04876755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325982|NCT04876755|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25325983|NCT04876573|Cyproheptadine|cyproheptadine|mesh-list
25325984|NCT04876573|Antipruritics|antipruritics|mesh-ancestor
25325985|NCT04876573|Dermatologic Agents|dermatologic agents|mesh-ancestor
25325986|NCT04876573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25325987|NCT04876573|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25325988|NCT04876573|Histamine Antagonists|histamine antagonists|mesh-ancestor
25325989|NCT04876573|Histamine Agents|histamine agents|mesh-ancestor
25325990|NCT04876573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25325991|NCT04876573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25325992|NCT04876573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25325993|NCT04876573|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25325994|NCT04876573|Serotonin Agents|serotonin agents|mesh-ancestor
25325995|NCT04876573|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25325996|NCT04876521|Olanzapine|olanzapine|mesh-list
25325997|NCT04876521|Amisulpride|amisulpride|mesh-list
25325998|NCT04876521|Fluoxetine|fluoxetine|mesh-list
25325999|NCT04876521|Antiemetics|antiemetics|mesh-ancestor
25326000|NCT04876521|Autonomic Agents|autonomic agents|mesh-ancestor
25326001|NCT04876521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25326002|NCT04876521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326003|NCT04876521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25326004|NCT04876521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25326045|NCT04876261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326046|NCT04876261|Protective Agents|protective agents|mesh-ancestor
25326047|NCT04876261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326048|NCT04876261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25326050|NCT04875819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25326051|NCT04875819|Immunologic Factors|immunologic factors|mesh-ancestor
25326052|NCT04875819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326056|NCT04875767|Coal Tar|coal tar|mesh-list
25326057|NCT04875767|Keratolytic Agents|keratolytic agents|mesh-ancestor
25326058|NCT04875767|Dermatologic Agents|dermatologic agents|mesh-ancestor
25326059|NCT04875702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25326060|NCT04875702|Allopurinol|allopurinol|mesh-list
25326061|NCT04875702|Antimetabolites|antimetabolites|mesh-ancestor
25326062|NCT04875702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326063|NCT04875702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25326064|NCT04875702|Gout Suppressants|gout suppressants|mesh-ancestor
25326065|NCT04875702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25326066|NCT04875702|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25326068|NCT04875702|Protective Agents|protective agents|mesh-ancestor
25326069|NCT04875702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326077|NCT04875858|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25326078|NCT04875858|Immunologic Factors|immunologic factors|mesh-ancestor
25326095|NCT04874844|Immunologic Factors|immunologic factors|mesh-ancestor
25326096|NCT04874844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326097|NCT04875039|Dexamethasone|dexamethasone|mesh-list
25326098|NCT04875039|Dexamethasone acetate|dexamethasone acetate|mesh-list
25326099|NCT04875039|Dexmedetomidine|dexmedetomidine|mesh-list
25326100|NCT04875039|BB 1101|bb 1101|mesh-list
25326101|NCT04875039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25326102|NCT04875039|Antiemetics|antiemetics|mesh-ancestor
25326103|NCT04875039|Autonomic Agents|autonomic agents|mesh-ancestor
25326104|NCT04875039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25326105|NCT04875039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326106|NCT04875039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25326107|NCT04875039|Glucocorticoids|glucocorticoids|mesh-ancestor
25326108|NCT04875039|Hormones|hormones|mesh-ancestor
25326109|NCT04875039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25326110|NCT04875039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25326111|NCT04875039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25326112|NCT04875039|Protease Inhibitors|protease inhibitors|mesh-ancestor
25326113|NCT04875039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25326114|NCT04875039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326115|NCT04875039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25326116|NCT04875039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25326117|NCT04875039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25326118|NCT04875039|Analgesics|analgesics|mesh-ancestor
25326119|NCT04875039|Sensory System Agents|sensory system agents|mesh-ancestor
25326120|NCT04875039|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25326121|NCT04875039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25326122|NCT04875039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25326123|NCT04875039|Adrenergic Agents|adrenergic agents|mesh-ancestor
25326124|NCT04875039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25326125|NCT04874688|Provitamins|provitamins|mesh-list
25326126|NCT04874688|Beta Carotene|beta carotene|mesh-list
25326127|NCT04874688|Vitamins|vitamins|mesh-ancestor
25326128|NCT04874688|Micronutrients|micronutrients|mesh-ancestor
25326129|NCT04874688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326130|NCT04874675|Acetaminophen|acetaminophen|mesh-list
25326131|NCT04874675|Ibuprofen|ibuprofen|mesh-list
25326132|NCT04874675|Diclofenac|diclofenac|mesh-list
25326133|NCT04874675|Codeine|codeine|mesh-list
25326134|NCT04874675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25326135|NCT04874675|Analgesics|analgesics|mesh-ancestor
25326136|NCT04874675|Sensory System Agents|sensory system agents|mesh-ancestor
25326137|NCT04874675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25326138|NCT04874675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326139|NCT04874675|Antipyretics|antipyretics|mesh-ancestor
25326140|NCT04874675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25326141|NCT04874675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25326142|NCT04874675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25326143|NCT04874675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25326144|NCT04874675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25326145|NCT04874675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649069|NCT01488279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25326146|NCT04874675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25326147|NCT04874675|Narcotics|narcotics|mesh-ancestor
25196628|NCT02751307|Serotonin Agents|serotonin agents|mesh-ancestor
25196629|NCT02751307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25196630|NCT02751307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196631|NCT02751307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25196632|NCT02751307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25196633|NCT02751307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25196634|NCT02751307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25326148|NCT04874675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25326149|NCT04874675|Antitussive Agents|antitussive agents|mesh-ancestor
25326150|NCT04874675|Respiratory System Agents|respiratory system agents|mesh-ancestor
25326151|NCT04874506|TEMPO|tempo|mesh-list
25326152|NCT04874506|TEMPOL-H|tempol-h|mesh-list
25326153|NCT04874506|Antioxidants|antioxidants|mesh-ancestor
25326162|NCT04874246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25326163|NCT04874246|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25326164|NCT04874246|Natriuretic Agents|natriuretic agents|mesh-ancestor
25326165|NCT04874246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326167|NCT04874428|Apixaban|apixaban|mesh-list
25326168|NCT04874428|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25326169|NCT04874428|Antithrombins|antithrombins|mesh-ancestor
25326170|NCT04874428|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25326171|NCT04874428|Protease Inhibitors|protease inhibitors|mesh-ancestor
25326172|NCT04874428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25326173|NCT04874428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326174|NCT04874428|Anticoagulants|anticoagulants|mesh-ancestor
25326175|NCT04873531|Neostigmine|neostigmine|mesh-list
25326176|NCT04873531|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25326177|NCT04873531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25326178|NCT04873531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326179|NCT04873531|Cholinergic Agents|cholinergic agents|mesh-ancestor
25326180|NCT04873531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25326181|NCT04873531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326182|NCT04873531|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25326183|NCT04873531|Autonomic Agents|autonomic agents|mesh-ancestor
25326184|NCT04873531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25326185|NCT04874597|Ocrelizumab|ocrelizumab|mesh-list
25326186|NCT04874597|Immunologic Factors|immunologic factors|mesh-ancestor
25326187|NCT04874597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326188|NCT04873440|Manganese|manganese|mesh-list
25326189|NCT04873440|Trace Elements|trace elements|mesh-ancestor
25326190|NCT04873440|Micronutrients|micronutrients|mesh-ancestor
25326191|NCT04873440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326200|NCT04873479|Ketamine|ketamine|mesh-list
25825542|NCT00005603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25825543|NCT00005603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25326201|NCT04873479|Esketamine|esketamine|mesh-list
25326202|NCT04873479|Analgesics|analgesics|mesh-ancestor
25326203|NCT04873479|Sensory System Agents|sensory system agents|mesh-ancestor
25326204|NCT04873479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25326205|NCT04873479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326206|NCT04873479|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25326207|NCT04873479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25326208|NCT04873479|Anesthetics, General|anesthetics, general|mesh-ancestor
25326209|NCT04873479|Anesthetics|anesthetics|mesh-ancestor
25326210|NCT04873479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25326211|NCT04873479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25326212|NCT04873479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25326213|NCT04873479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25326214|NCT04873479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326215|NCT04873479|Antidepressive Agents|antidepressive agents|mesh-ancestor
25326216|NCT04873479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25326217|NCT04873349|Oleuropein|oleuropein|mesh-list
25326218|NCT04873349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25326219|NCT04873349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25326220|NCT04873349|Vasodilator Agents|vasodilator agents|mesh-ancestor
25326221|NCT04873284|Dexamethasone|dexamethasone|mesh-list
25326222|NCT04873284|Aprepitant|aprepitant|mesh-list
25326223|NCT04873284|Fosaprepitant|fosaprepitant|mesh-list
25326224|NCT04873284|Granisetron|granisetron|mesh-list
25649070|NCT01488279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25649071|NCT01488279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649072|NCT01488279|Protease Inhibitors|protease inhibitors|mesh-ancestor
25649073|NCT01488279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649074|NCT01488279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649075|NCT01488279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25649076|NCT01488279|Incretins|incretins|mesh-ancestor
25326225|NCT04873284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25196697|NCT05429567|Anesthetics, Local|anesthetics, local|mesh-ancestor
25196698|NCT05429567|Anesthetics|anesthetics|mesh-ancestor
25196699|NCT05429567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25196700|NCT05429567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196701|NCT05429567|Sensory System Agents|sensory system agents|mesh-ancestor
25196702|NCT05429567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25196703|NCT05429567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25196704|NCT05429567|Narcotics|narcotics|mesh-ancestor
25196705|NCT05429567|Analgesics|analgesics|mesh-ancestor
25326226|NCT04873284|Antiemetics|antiemetics|mesh-ancestor
25326227|NCT04873284|Autonomic Agents|autonomic agents|mesh-ancestor
25326228|NCT04873284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25326244|NCT04873102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25326245|NCT04873102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326247|NCT04873011|Antimalarials|antimalarials|mesh-ancestor
25326248|NCT04873011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25326249|NCT04873011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25326250|NCT04873011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25326251|NCT04873011|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25326252|NCT04873011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326253|NCT04873011|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25326254|NCT04873011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25326255|NCT04873011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25326256|NCT04873011|Analgesics|analgesics|mesh-ancestor
25326257|NCT04873011|Sensory System Agents|sensory system agents|mesh-ancestor
25326258|NCT04872985|Paclitaxel|paclitaxel|mesh-list
25326259|NCT04872985|Docetaxel|docetaxel|mesh-list
25326260|NCT04872985|Cyclophosphamide|cyclophosphamide|mesh-list
25326261|NCT04872985|Doxorubicin|doxorubicin|mesh-list
25326262|NCT04872985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25326263|NCT04872985|Epirubicin|epirubicin|mesh-list
25326264|NCT04872985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25326265|NCT04872985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25326266|NCT04872985|Tubulin Modulators|tubulin modulators|mesh-ancestor
25326267|NCT04872985|Antimitotic Agents|antimitotic agents|mesh-ancestor
25326268|NCT04872985|Mitosis Modulators|mitosis modulators|mesh-ancestor
25326269|NCT04872985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326270|NCT04872985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25326271|NCT04872985|Immunologic Factors|immunologic factors|mesh-ancestor
25326272|NCT04872985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326273|NCT04872985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25825544|NCT00005603|Alkylating Agents|alkylating agents|mesh-ancestor
25326274|NCT04872985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25326275|NCT04872985|Alkylating Agents|alkylating agents|mesh-ancestor
25326276|NCT04872985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25326277|NCT04872985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25326278|NCT04872985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25326279|NCT04872985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25326280|NCT04872985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25326281|NCT04872907|Fluorides|fluorides|mesh-list
25326282|NCT04872907|Fluorides, Topical|fluorides, topical|mesh-list
25326283|NCT04872907|Cariostatic Agents|cariostatic agents|mesh-ancestor
25326284|NCT04872907|Protective Agents|protective agents|mesh-ancestor
25326285|NCT04872907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326302|NCT04872881|Fentanyl|fentanyl|mesh-list
25326303|NCT04872881|Propofol|propofol|mesh-list
25326304|NCT04872881|Rocuronium|rocuronium|mesh-list
25326305|NCT04872881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25326306|NCT04872881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25326307|NCT04872881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326308|NCT04872881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25326309|NCT04872881|Anesthetics, General|anesthetics, general|mesh-ancestor
25326310|NCT04872881|Anesthetics|anesthetics|mesh-ancestor
25326311|NCT04872881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25326312|NCT04872881|Narcotics|narcotics|mesh-ancestor
25326313|NCT04872881|Analgesics|analgesics|mesh-ancestor
25326314|NCT04872881|Sensory System Agents|sensory system agents|mesh-ancestor
25326315|NCT04872881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25649077|NCT01488279|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25649078|NCT01488318|Cetuximab|cetuximab|mesh-list
25649079|NCT01488318|Dasatinib|dasatinib|mesh-list
25649080|NCT01488318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25649081|NCT01488318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649082|NCT01488318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25649083|NCT01488318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649084|NCT01488318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326316|NCT04872881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25207213|NCT04593680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207215|NCT04593680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25207216|NCT04591808|Perindopril|perindopril|mesh-list
25207217|NCT04591808|Atorvastatin|atorvastatin|mesh-list
25207218|NCT04591808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25207219|NCT04591808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25207220|NCT04591808|Antimetabolites|antimetabolites|mesh-ancestor
25207222|NCT04591808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25326317|NCT04872881|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25326318|NCT04872881|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25326319|NCT04872881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25326320|NCT04872634|Cetuximab|cetuximab|mesh-list
25326321|NCT04872634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25326322|NCT04872634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25326323|NCT04872270|Caffeine|caffeine|mesh-list
25326324|NCT04872270|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25326325|NCT04872270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326326|NCT04872270|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25326327|NCT04872270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25326328|NCT04872270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326329|NCT04872270|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25326330|NCT04872270|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25326331|NCT04872270|Purinergic Agents|purinergic agents|mesh-ancestor
25326332|NCT04872270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25326333|NCT04872400|Vancomycin|vancomycin|mesh-list
25326334|NCT04872400|Tobramycin|tobramycin|mesh-list
25326335|NCT04872400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25326336|NCT04872400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24793620|NCT02910414|Ethanol|ethanol|mesh-list
25326337|NCT04872192|Anesthetics|anesthetics|mesh-list
25326338|NCT04872192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25326339|NCT04872192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326340|NCT04872231|Voriconazole|voriconazole|mesh-list
25326341|NCT04872231|Antifungal Agents|antifungal agents|mesh-ancestor
25326342|NCT04872231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25326343|NCT04872231|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25326344|NCT04872231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25326345|NCT04872231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25326346|NCT04872231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326347|NCT04872231|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25326348|NCT04872231|Hormone Antagonists|hormone antagonists|mesh-ancestor
25326349|NCT04872231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25326350|NCT04872231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326351|NCT04872231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25326352|NCT04872283|Aspirin|aspirin|mesh-list
25326353|NCT04872283|Acetaminophen|acetaminophen|mesh-list
25326354|NCT04872283|Ketorolac|ketorolac|mesh-list
25326355|NCT04872283|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25326356|NCT04872283|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25326357|NCT04872283|Oxycodone|oxycodone|mesh-list
25326358|NCT04872283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25326359|NCT04872283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25326360|NCT04872283|Analgesics|analgesics|mesh-ancestor
25326361|NCT04872283|Sensory System Agents|sensory system agents|mesh-ancestor
25326362|NCT04872283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25326363|NCT04872283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326364|NCT04872283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25326365|NCT04872283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25326366|NCT04872283|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25326367|NCT04872283|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25326368|NCT04872283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326369|NCT04872283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25326370|NCT04872283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25326371|NCT04872283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649085|NCT01488409|Acipimox|acipimox|mesh-list
25649086|NCT01488409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25649087|NCT01488409|Antimetabolites|antimetabolites|mesh-ancestor
25649088|NCT01488409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649089|NCT01488409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25649090|NCT01488487|Everolimus|everolimus|mesh-list
25649091|NCT01488487|Pasireotide|pasireotide|mesh-list
25649092|NCT01488487|Somatostatin|somatostatin|mesh-list
25649093|NCT01488487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25196817|NCT05422144|Anti-Infective Agents|anti-infective agents|mesh-list
25196818|NCT05422144|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25196819|NCT05412056|Metformin|metformin|mesh-list
25196820|NCT05412056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25196821|NCT05412056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196822|NCT05411978|Ubiquinone|ubiquinone|mesh-list
25196823|NCT05411978|Idebenone|idebenone|mesh-list
25196824|NCT05411978|Antioxidants|antioxidants|mesh-ancestor
25196825|NCT05411978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196826|NCT05411978|Protective Agents|protective agents|mesh-ancestor
25196828|NCT05411978|Micronutrients|micronutrients|mesh-ancestor
25326372|NCT04872283|Antipyretics|antipyretics|mesh-ancestor
25326373|NCT04872283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25326374|NCT04872283|Narcotics|narcotics|mesh-ancestor
25326375|NCT04872283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25326376|NCT04872244|Levonorgestrel|levonorgestrel|mesh-list
25326377|NCT04872244|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25326380|NCT04872244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326381|NCT04872244|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25326382|NCT04872244|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25326383|NCT04872244|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25326385|NCT04872322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25326386|NCT04872322|Anesthetics, Local|anesthetics, local|mesh-ancestor
25326387|NCT04872322|Anesthetics|anesthetics|mesh-ancestor
25326388|NCT04872322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25326389|NCT04872322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326390|NCT04872322|Sensory System Agents|sensory system agents|mesh-ancestor
25326391|NCT04872322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25326395|NCT04871828|Leukotriene Antagonists|leukotriene antagonists|mesh-list
25326396|NCT04871828|Hormone Antagonists|hormone antagonists|mesh-ancestor
25326397|NCT04871828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25326398|NCT04871828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326399|NCT04871828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25326400|NCT04871828|Respiratory System Agents|respiratory system agents|mesh-ancestor
25326401|NCT04871724|Fluconazole|fluconazole|mesh-list
25326402|NCT04871724|Antifungal Agents|antifungal agents|mesh-ancestor
25326403|NCT04871724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25326404|NCT04871724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25326405|NCT04871724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25326406|NCT04871724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25326407|NCT04871724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326408|NCT04871724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25326409|NCT04871724|Hormone Antagonists|hormone antagonists|mesh-ancestor
25326410|NCT04871724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25326411|NCT04871724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326412|NCT04871724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25326413|NCT04871724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25326414|NCT04871802|Taxifolin|taxifolin|mesh-list
25326415|NCT04871802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25326416|NCT04871802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25326417|NCT04871802|Analgesics|analgesics|mesh-ancestor
25326418|NCT04871802|Sensory System Agents|sensory system agents|mesh-ancestor
25326419|NCT04871802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25326420|NCT04871802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326421|NCT04871802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25326422|NCT04871802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25326423|NCT04871633|Azithromycin|azithromycin|mesh-list
25326424|NCT04871633|Remdesivir|remdesivir|mesh-list
25326425|NCT04871633|Dexamethasone|dexamethasone|mesh-list
25326426|NCT04871633|Prednisolone|prednisolone|mesh-list
25326427|NCT04871633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25326428|NCT04871633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25326429|NCT04871633|Antiemetics|antiemetics|mesh-ancestor
25326430|NCT04871633|Autonomic Agents|autonomic agents|mesh-ancestor
25649094|NCT01488487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25649095|NCT01488487|Immunologic Factors|immunologic factors|mesh-ancestor
25649096|NCT01488487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649097|NCT01488487|Hormones|hormones|mesh-ancestor
25649098|NCT01488487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25649099|NCT01488578|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25649100|NCT01488578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25649101|NCT01488578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25649102|NCT01488578|Cholinergic Agents|cholinergic agents|mesh-ancestor
25649103|NCT01488578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25326431|NCT04871633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25326432|NCT04871633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326433|NCT04871633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25326434|NCT04871633|Glucocorticoids|glucocorticoids|mesh-ancestor
25326436|NCT04871633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25326437|NCT04871633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25326438|NCT04871633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809634|NCT02035397|Cholinergic Agents|cholinergic agents|mesh-ancestor
25326439|NCT04871633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326440|NCT04871633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25326441|NCT04871633|Protective Agents|protective agents|mesh-ancestor
25326442|NCT04871633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25326443|NCT04871633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25326444|NCT04871633|Antimetabolites|antimetabolites|mesh-ancestor
25326445|NCT04871633|Antiviral Agents|antiviral agents|mesh-ancestor
25326446|NCT04871750|Caseins|caseins|mesh-list
25326447|NCT04871750|Chelating Agents|chelating agents|mesh-ancestor
25326448|NCT04871750|Sequestering Agents|sequestering agents|mesh-ancestor
25326449|NCT04871750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326450|NCT04871646|Nafamostat|nafamostat|mesh-list
25326524|NCT04871152|Cholinergic Agents|cholinergic agents|mesh-ancestor
25326454|NCT04871646|Sensory System Agents|sensory system agents|mesh-ancestor
25326455|NCT04871646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25326456|NCT04871646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326457|NCT04871646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25326459|NCT04871646|Anticoagulants|anticoagulants|mesh-ancestor
25326460|NCT04871646|Protease Inhibitors|protease inhibitors|mesh-ancestor
25326461|NCT04871646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25326462|NCT04871646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326463|NCT04871646|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25326464|NCT04871646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25326465|NCT04871646|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25326466|NCT04871646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25326467|NCT04871646|Immunologic Factors|immunologic factors|mesh-ancestor
25326468|NCT04871321|Gemcitabine|gemcitabine|mesh-list
25326469|NCT04871321|Paclitaxel|paclitaxel|mesh-list
25326470|NCT04871321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25326471|NCT04871321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25326472|NCT04871321|Tubulin Modulators|tubulin modulators|mesh-ancestor
25326473|NCT04871321|Antimitotic Agents|antimitotic agents|mesh-ancestor
25326474|NCT04871321|Mitosis Modulators|mitosis modulators|mesh-ancestor
25326475|NCT04871321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326476|NCT04871321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25326477|NCT04871321|Antimetabolites|antimetabolites|mesh-ancestor
25326478|NCT04871321|Antiviral Agents|antiviral agents|mesh-ancestor
25326479|NCT04871321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25326480|NCT04871321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25326481|NCT04871321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25326482|NCT04871321|Immunologic Factors|immunologic factors|mesh-ancestor
25326483|NCT04871321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326484|NCT04871308|Dexmedetomidine|dexmedetomidine|mesh-list
25326485|NCT04871308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25326486|NCT04871308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25326487|NCT04871308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326488|NCT04871308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25326489|NCT04871308|Analgesics|analgesics|mesh-ancestor
25326490|NCT04871308|Sensory System Agents|sensory system agents|mesh-ancestor
25326491|NCT04871308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25326492|NCT04871308|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25326493|NCT04871308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25326494|NCT04871308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25326495|NCT04871308|Adrenergic Agents|adrenergic agents|mesh-ancestor
25326496|NCT04871308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25326497|NCT04871308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326502|NCT04871269|Dronabinol|dronabinol|mesh-list
25326503|NCT04871269|Hallucinogens|hallucinogens|mesh-ancestor
25326504|NCT04871269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326505|NCT04871269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25326506|NCT04871269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25326507|NCT04871269|Analgesics|analgesics|mesh-ancestor
25326508|NCT04871269|Sensory System Agents|sensory system agents|mesh-ancestor
25326509|NCT04871269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25326510|NCT04871269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25649106|NCT01488578|Urological Agents|urological agents|mesh-ancestor
25649107|NCT01488877|Spironolactone|spironolactone|mesh-list
25649108|NCT01488877|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25649109|NCT01488877|Hormone Antagonists|hormone antagonists|mesh-ancestor
25649110|NCT01488877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25649111|NCT01488877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649112|NCT01488877|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25649113|NCT01488877|Diuretics|diuretics|mesh-ancestor
25196907|NCT05177484|Hematinics|hematinics|mesh-ancestor
25196918|NCT05168566|Maleic acid|maleic acid|mesh-list
25196919|NCT05168566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25196920|NCT05168566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196922|NCT05130086|Antiviral Agents|antiviral agents|mesh-ancestor
25196923|NCT05130086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25196924|NCT05130086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25196929|NCT05112991|Lenvatinib|lenvatinib|mesh-list
25326511|NCT04871269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25326512|NCT04871269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25326513|NCT04871269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326514|NCT04871269|Hormones|hormones|mesh-ancestor
25326515|NCT04871269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25326516|NCT04871152|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25326517|NCT04871152|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25326518|NCT04871152|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25326519|NCT04871152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25326520|NCT04871152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326521|NCT04871152|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25326522|NCT04871152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25326523|NCT04871152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326540|NCT04870671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25326541|NCT04870671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25326543|NCT04870671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326544|NCT04870671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25326545|NCT04870671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25829667|NCT00006247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326558|NCT04870489|Isotretinoin|isotretinoin|mesh-list
25326559|NCT04870489|Dermatologic Agents|dermatologic agents|mesh-ancestor
25326560|NCT04870541|Nefopam|nefopam|mesh-list
25326561|NCT04870541|Ondansetron|ondansetron|mesh-list
25326562|NCT04870541|Antiemetics|antiemetics|mesh-ancestor
25326563|NCT04870541|Autonomic Agents|autonomic agents|mesh-ancestor
25326564|NCT04870541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25326565|NCT04870541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326566|NCT04870541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25326567|NCT04870541|Antipruritics|antipruritics|mesh-ancestor
25326568|NCT04870541|Dermatologic Agents|dermatologic agents|mesh-ancestor
25326569|NCT04870541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25326570|NCT04870541|Serotonin Agents|serotonin agents|mesh-ancestor
25326571|NCT04870541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25326572|NCT04870541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326573|NCT04870541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25326574|NCT04870541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25326575|NCT04870541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25326576|NCT04870541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25326577|NCT04870541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25326578|NCT04870541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25326579|NCT04870541|Analgesics|analgesics|mesh-ancestor
25326580|NCT04870541|Sensory System Agents|sensory system agents|mesh-ancestor
25326581|NCT04870502|Clomiphene|clomiphene|mesh-list
25326582|NCT04870502|Enclomiphene|enclomiphene|mesh-list
25326583|NCT04870502|Zuclomiphene|zuclomiphene|mesh-list
25649114|NCT01488877|Natriuretic Agents|natriuretic agents|mesh-ancestor
25649115|NCT01489020|Vaccines|vaccines|mesh-list
25649116|NCT01489020|Immunologic Factors|immunologic factors|mesh-ancestor
25649117|NCT01489020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649118|NCT01489189|Ranibizumab|ranibizumab|mesh-list
25649119|NCT01489189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25649120|NCT01489189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25326586|NCT04870502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25326588|NCT04870502|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25326589|NCT04870502|Fertility Agents|fertility agents|mesh-ancestor
25326590|NCT04870502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25326591|NCT04870502|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25326592|NCT04870502|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25326608|NCT04870190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25326609|NCT04870190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25326610|NCT04870190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326612|NCT04870060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25326613|NCT04870060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25326614|NCT04870060|Analgesics|analgesics|mesh-ancestor
25326615|NCT04870060|Sensory System Agents|sensory system agents|mesh-ancestor
25326616|NCT04870060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25326617|NCT04870060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326618|NCT04870060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25326619|NCT04870060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25326620|NCT04870060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25326621|NCT04870060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25326622|NCT04870060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326623|NCT04870073|Mannitol|mannitol|mesh-list
25326624|NCT04870073|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25326625|NCT04870073|Diuretics|diuretics|mesh-ancestor
25326626|NCT04870073|Natriuretic Agents|natriuretic agents|mesh-ancestor
25326627|NCT04870073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326631|NCT04869475|Arsenic Trioxide|arsenic trioxide|mesh-list
25326632|NCT04869475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25326633|NCT04869501|Atezolizumab|atezolizumab|mesh-list
25326634|NCT04869501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25326635|NCT04869579|Selenium|selenium|mesh-list
25326636|NCT04869579|Selenious Acid|selenious acid|mesh-list
25326637|NCT04869579|Antioxidants|antioxidants|mesh-ancestor
25326726|NCT04868552|Sensory System Agents|sensory system agents|mesh-ancestor
25326638|NCT04869579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326640|NCT04869579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326641|NCT04869579|Trace Elements|trace elements|mesh-ancestor
25326642|NCT04869579|Micronutrients|micronutrients|mesh-ancestor
25326643|NCT04869709|Betamethasone|betamethasone|mesh-list
25326644|NCT04869709|Betamethasone Valerate|betamethasone valerate|mesh-list
25326645|NCT04869709|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25326646|NCT04869709|Betamethasone benzoate|betamethasone benzoate|mesh-list
25326647|NCT04869709|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25326648|NCT04869709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25326649|NCT04869709|Glucocorticoids|glucocorticoids|mesh-ancestor
25649121|NCT01489189|Growth Substances|growth substances|mesh-ancestor
25649122|NCT01489189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649123|NCT01489189|Growth Inhibitors|growth inhibitors|mesh-ancestor
25649124|NCT01489189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649125|NCT01489254|Glatiramer Acetate|glatiramer acetate|mesh-list
25649126|NCT01489254|(T,G)-A-L|(t,g)-a-l|mesh-list
25649127|NCT01489254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25649128|NCT01489254|Immunologic Factors|immunologic factors|mesh-ancestor
25649129|NCT01489254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649130|NCT01489254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25649131|NCT01489254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25649132|NCT01489670|Bimatoprost|bimatoprost|mesh-list
25649133|NCT01489670|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25649134|NCT01489670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25197053|NCT04808999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25197054|NCT04808999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197055|NCT04799626|Levofloxacin|levofloxacin|mesh-list
25197056|NCT04799626|Ofloxacin|ofloxacin|mesh-list
25197057|NCT04799626|Meropenem|meropenem|mesh-list
25197058|NCT04799626|Tazobactam|tazobactam|mesh-list
25197061|NCT04799626|Biapenem|biapenem|mesh-list
25326650|NCT04869709|Hormones|hormones|mesh-ancestor
25326651|NCT04869709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25326652|NCT04869709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326653|NCT04869709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25326654|NCT04869709|Respiratory System Agents|respiratory system agents|mesh-ancestor
25326661|NCT04869176|Caffeine|caffeine|mesh-list
25326662|NCT04869176|Caffeine citrate|caffeine citrate|mesh-list
25326663|NCT04869176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326664|NCT04869176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25326665|NCT04869176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326666|NCT04869176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25326667|NCT04869176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25326668|NCT04869176|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25326675|NCT04869046|Levobupivacaine|levobupivacaine|mesh-list
25326676|NCT04869046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25326677|NCT04869046|Sensory System Agents|sensory system agents|mesh-ancestor
25326678|NCT04869046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25825545|NCT00005603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326679|NCT04869046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326680|NCT04869046|Antipyretics|antipyretics|mesh-ancestor
25326681|NCT04869046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25326682|NCT04869046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25326683|NCT04869046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25326684|NCT04869046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25326685|NCT04869046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25326686|NCT04869046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326687|NCT04869046|Anesthetics, Local|anesthetics, local|mesh-ancestor
25326688|NCT04869046|Anesthetics|anesthetics|mesh-ancestor
25326689|NCT04869046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25326690|NCT04868903|Vitamin D|vitamin d|mesh-list
25326691|NCT04868903|Cholecalciferol|cholecalciferol|mesh-list
25326692|NCT04868903|Vitamins|vitamins|mesh-ancestor
25326693|NCT04868903|Micronutrients|micronutrients|mesh-ancestor
25326694|NCT04868903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326695|NCT04868903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25326696|NCT04868903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25326697|NCT04868786|Mycophenolic Acid|mycophenolic acid|mesh-list
25326698|NCT04868786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25326699|NCT04868786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25326700|NCT04868786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25326701|NCT04868786|Antitubercular Agents|antitubercular agents|mesh-ancestor
25326702|NCT04868786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25326703|NCT04868786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25326704|NCT04868786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25326705|NCT04868786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326711|NCT04868747|Lidocaine|lidocaine|mesh-list
25326712|NCT04868747|Anesthetics, Local|anesthetics, local|mesh-ancestor
25326713|NCT04868747|Anesthetics|anesthetics|mesh-ancestor
25326714|NCT04868747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25326715|NCT04868747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326716|NCT04868747|Sensory System Agents|sensory system agents|mesh-ancestor
25326717|NCT04868747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25326718|NCT04868747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25326719|NCT04868747|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25326720|NCT04868747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25326721|NCT04868747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25326722|NCT04868747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326723|NCT04868552|Naloxone|naloxone|mesh-list
25326724|NCT04868552|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25326725|NCT04868552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326728|NCT04868513|Chlorhexidine|chlorhexidine|mesh-list
25649135|NCT01489670|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25649136|NCT01489826|HU 211|hu 211|mesh-list
25649137|NCT01489826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25649138|NCT01489826|Antiemetics|antiemetics|mesh-ancestor
25649139|NCT01489826|Autonomic Agents|autonomic agents|mesh-ancestor
25649140|NCT01489826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25207306|NCT04333654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25207307|NCT04333654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25207308|NCT04333654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25207309|NCT04333654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207310|NCT04333654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25207325|NCT04229615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207326|NCT04229615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25207327|NCT04229615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25207328|NCT04229615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326729|NCT04868513|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25326730|NCT04868513|Fluorides|fluorides|mesh-list
25326731|NCT04868513|Cariostatic Agents|cariostatic agents|mesh-ancestor
25326732|NCT04868513|Protective Agents|protective agents|mesh-ancestor
25326733|NCT04868513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326734|NCT04868513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25326735|NCT04868513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25326736|NCT04868513|Disinfectants|disinfectants|mesh-ancestor
25326737|NCT04868513|Dermatologic Agents|dermatologic agents|mesh-ancestor
25326738|NCT04868773|Trifluridine|trifluridine|mesh-list
25326739|NCT04868773|Antimetabolites|antimetabolites|mesh-ancestor
25326740|NCT04868773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326741|NCT04868773|Antiviral Agents|antiviral agents|mesh-ancestor
25326747|NCT04868175|Adrenergic Agents|adrenergic agents|mesh-ancestor
25326748|NCT04868175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25326749|NCT04868175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326750|NCT04868175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326751|NCT04868175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25326752|NCT04868175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25326753|NCT04868227|Vitamin D|vitamin d|mesh-list
25326754|NCT04868227|Cholecalciferol|cholecalciferol|mesh-list
25326755|NCT04868227|Vitamins|vitamins|mesh-ancestor
25326756|NCT04868227|Micronutrients|micronutrients|mesh-ancestor
25326757|NCT04868227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326758|NCT04868227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25326759|NCT04868227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25326760|NCT04868461|Caseins|caseins|mesh-list
25326761|NCT04868461|Chelating Agents|chelating agents|mesh-ancestor
25326762|NCT04868461|Sequestering Agents|sequestering agents|mesh-ancestor
25326763|NCT04868461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326764|NCT04868019|Fenofibrate|fenofibrate|mesh-list
25326765|NCT04868019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25326766|NCT04868019|Antimetabolites|antimetabolites|mesh-ancestor
25326767|NCT04868019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326768|NCT04868019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25326769|NCT04867980|Moxifloxacin|moxifloxacin|mesh-list
25326770|NCT04867980|Acalabrutinib|acalabrutinib|mesh-list
25326771|NCT04867980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25326772|NCT04867980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25326773|NCT04867980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25326774|NCT04867980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25326775|NCT04867980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25326776|NCT04867980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326777|NCT04867980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25326778|NCT04868253|Oxazepam|oxazepam|mesh-list
25326779|NCT04868253|Metyrapone|metyrapone|mesh-list
25326780|NCT04868253|Antimetabolites|antimetabolites|mesh-ancestor
25326781|NCT04868253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326782|NCT04868253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25326783|NCT04868253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25326784|NCT04868253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25326785|NCT04868253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326786|NCT04868253|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25326787|NCT04868253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25326788|NCT04868253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25649141|NCT01489826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649142|NCT01489826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25649143|NCT01489826|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25649144|NCT01489826|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25649145|NCT01489826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25649146|NCT01489826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649147|NCT01489826|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25649148|NCT01489826|Protective Agents|protective agents|mesh-ancestor
25649149|NCT01489891|Lidocaine|lidocaine|mesh-list
25197151|NCT04529135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197152|NCT04529135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25197153|NCT04529135|Analgesics|analgesics|mesh-ancestor
25197154|NCT04529135|Sensory System Agents|sensory system agents|mesh-ancestor
25197155|NCT04529135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25197156|NCT04529135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25197157|NCT04529135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25197158|NCT04529135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25197159|NCT04529135|Adrenergic Agents|adrenergic agents|mesh-ancestor
25197160|NCT04529135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25197161|NCT04529135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197162|NCT04529135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25197163|NCT04529135|Narcotics|narcotics|mesh-ancestor
25326789|NCT04868253|GABA Modulators|gaba modulators|mesh-ancestor
25326790|NCT04868253|GABA Agents|gaba agents|mesh-ancestor
25326791|NCT04868253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25326792|NCT04867993|Amikacin|amikacin|mesh-list
25326793|NCT04867993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25326794|NCT04867993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25326795|NCT04868058|Ropivacaine|ropivacaine|mesh-list
25326796|NCT04868058|Anesthetics, Local|anesthetics, local|mesh-ancestor
25326797|NCT04868058|Anesthetics|anesthetics|mesh-ancestor
25326798|NCT04868058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25326799|NCT04868058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326800|NCT04868058|Sensory System Agents|sensory system agents|mesh-ancestor
25326801|NCT04868058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24585633|NCT00886457|Decitabine|decitabine|mesh-list
24809182|NCT02031692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24809395|NCT02033434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24809559|NCT02034604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24809633|NCT02035397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719174|NCT01559727|Prednisone|prednisone|mesh-list
25825546|NCT00005603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825547|NCT00005603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25326806|NCT04867720|Everolimus|everolimus|mesh-list
25326807|NCT04867720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25326957|NCT04865224|Analgesics|analgesics|mesh-ancestor
25326808|NCT04867720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25326809|NCT04867720|Immunologic Factors|immunologic factors|mesh-ancestor
25326810|NCT04867720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326811|NCT04867941|Acalabrutinib|acalabrutinib|mesh-list
25326812|NCT04867941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25326814|NCT04867343|Remifentanil|remifentanil|mesh-list
25326815|NCT04867343|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25326816|NCT04867343|Narcotics|narcotics|mesh-ancestor
25326817|NCT04867343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25326818|NCT04867343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326819|NCT04867343|Analgesics|analgesics|mesh-ancestor
25326820|NCT04867343|Sensory System Agents|sensory system agents|mesh-ancestor
25326821|NCT04867343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25326822|NCT04867343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25326823|NCT04867343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25326824|NCT04867343|Anesthetics, General|anesthetics, general|mesh-ancestor
25326825|NCT04867343|Anesthetics|anesthetics|mesh-ancestor
25326826|NCT04867226|Colchicine|colchicine|mesh-list
25326827|NCT04867226|Gout Suppressants|gout suppressants|mesh-ancestor
25326828|NCT04867226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25326829|NCT04867226|Tubulin Modulators|tubulin modulators|mesh-ancestor
25326830|NCT04867226|Antimitotic Agents|antimitotic agents|mesh-ancestor
25326831|NCT04867226|Mitosis Modulators|mitosis modulators|mesh-ancestor
25326832|NCT04867226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326833|NCT04867226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25326834|NCT04867252|Inositol|inositol|mesh-list
25649150|NCT01489891|Anesthetics, Local|anesthetics, local|mesh-ancestor
25649151|NCT01489891|Anesthetics|anesthetics|mesh-ancestor
25649152|NCT01489891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25649153|NCT01489891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649154|NCT01489891|Sensory System Agents|sensory system agents|mesh-ancestor
25649155|NCT01489891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25649156|NCT01489891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25649157|NCT01489891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25649158|NCT01489891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25649159|NCT01489891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25649160|NCT01489891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649161|NCT01489956|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25326835|NCT04867252|Metformin|metformin|mesh-list
25197227|NCT04384692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25197228|NCT04384692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25197229|NCT04384692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25197230|NCT04384692|Antitubercular Agents|antitubercular agents|mesh-ancestor
25197231|NCT04384692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25197232|NCT04384692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25197233|NCT04359979|Tamsulosin|tamsulosin|mesh-list
25326836|NCT04867252|Pioglitazone|pioglitazone|mesh-list
25326837|NCT04867252|Resveratrol|resveratrol|mesh-list
25326838|NCT04867252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25326839|NCT04867252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326840|NCT04867252|Antioxidants|antioxidants|mesh-ancestor
25326841|NCT04867252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326842|NCT04867252|Protective Agents|protective agents|mesh-ancestor
25326843|NCT04867252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25326844|NCT04867252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25326845|NCT04867252|Vitamin B Complex|vitamin b complex|mesh-ancestor
25326846|NCT04867252|Vitamins|vitamins|mesh-ancestor
25326847|NCT04867252|Micronutrients|micronutrients|mesh-ancestor
25326848|NCT04866498|Analgesics|analgesics|mesh-list
25326849|NCT04866498|Sensory System Agents|sensory system agents|mesh-ancestor
25326850|NCT04866498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25326851|NCT04866498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326852|NCT04866654|Nivolumab|nivolumab|mesh-list
25326853|NCT04866654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25326854|NCT04866654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25326855|NCT04866654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25326856|NCT04866654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326857|NCT04866355|Ibuprofen|ibuprofen|mesh-list
25326858|NCT04866355|Scopolamine|scopolamine|mesh-list
25326859|NCT04866355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25326860|NCT04866355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25326861|NCT04866355|Analgesics|analgesics|mesh-ancestor
25326862|NCT04866355|Sensory System Agents|sensory system agents|mesh-ancestor
25326863|NCT04866355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25326864|NCT04866355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326865|NCT04866355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25326866|NCT04866355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25326867|NCT04866355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25326868|NCT04866355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25326869|NCT04866355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326870|NCT04866355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25326871|NCT04866355|Antiemetics|antiemetics|mesh-ancestor
25326872|NCT04866355|Autonomic Agents|autonomic agents|mesh-ancestor
25326873|NCT04866355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25326874|NCT04866355|Mydriatics|mydriatics|mesh-ancestor
25326875|NCT04866355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25825548|NCT00005603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24469249|NCT00385021|Antidotes|antidotes|mesh-ancestor
24469250|NCT00385021|Protective Agents|protective agents|mesh-ancestor
24469251|NCT00385021|Vitamin B Complex|vitamin b complex|mesh-ancestor
24469313|NCT00385437|Mirtazapine|mirtazapine|mesh-list
25326876|NCT04866355|Cholinergic Agents|cholinergic agents|mesh-ancestor
25326877|NCT04866355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25326878|NCT04866355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25326879|NCT04866485|Pembrolizumab|pembrolizumab|mesh-list
25326880|NCT04866485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25326891|NCT04866056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25326892|NCT04866056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25326893|NCT04865900|Antibodies|antibodies|mesh-list
25326894|NCT04865900|Immunologic Factors|immunologic factors|mesh-ancestor
25326895|NCT04865900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326896|NCT04865848|Anesthetics|anesthetics|mesh-list
25326897|NCT04865848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25326898|NCT04865848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326899|NCT04865705|Paclitaxel|paclitaxel|mesh-list
25326900|NCT04865705|Cisplatin|cisplatin|mesh-list
25326901|NCT04865705|Carboplatin|carboplatin|mesh-list
25649162|NCT01489956|Freund's Adjuvant|freund's adjuvant|mesh-list
25649163|NCT01489956|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
25649164|NCT01489956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25649165|NCT01489956|Immunologic Factors|immunologic factors|mesh-ancestor
25649166|NCT01489956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649167|NCT01489969|Melatonin|melatonin|mesh-list
25649168|NCT01489969|Antioxidants|antioxidants|mesh-ancestor
25326902|NCT04865705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25326903|NCT04865705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825549|NCT00005603|Antiemetics|antiemetics|mesh-ancestor
25197301|NCT04163406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197312|NCT04138875|Rituximab|rituximab|mesh-list
25197313|NCT04138875|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25197314|NCT04138875|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25197315|NCT04138875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25197316|NCT04138875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197317|NCT04138875|Immunologic Factors|immunologic factors|mesh-ancestor
25197318|NCT04138875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197319|NCT04138875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25197320|NCT04138875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25197321|NCT04138875|Alkylating Agents|alkylating agents|mesh-ancestor
25197322|NCT04138875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197323|NCT04130152|Letrozole|letrozole|mesh-list
25197324|NCT04130152|Palbociclib|palbociclib|mesh-list
25197325|NCT04130152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197326|NCT04130152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25825550|NCT00005603|Autonomic Agents|autonomic agents|mesh-ancestor
25326904|NCT04865705|Tubulin Modulators|tubulin modulators|mesh-ancestor
25326905|NCT04865705|Antimitotic Agents|antimitotic agents|mesh-ancestor
25326906|NCT04865705|Mitosis Modulators|mitosis modulators|mesh-ancestor
25326907|NCT04865705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326908|NCT04865991|Propofol|propofol|mesh-list
25326909|NCT04865991|Sevoflurane|sevoflurane|mesh-list
25326910|NCT04865991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25326911|NCT04865991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25326912|NCT04865991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326913|NCT04865991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25326914|NCT04865991|Anesthetics, General|anesthetics, general|mesh-ancestor
25326915|NCT04865991|Anesthetics|anesthetics|mesh-ancestor
25326916|NCT04865991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25326917|NCT04865991|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25326918|NCT04865510|Heparin|heparin|mesh-list
25326919|NCT04865510|Anticoagulants|anticoagulants|mesh-ancestor
25326920|NCT04865510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326921|NCT04865510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25326922|NCT04865510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25326923|NCT04865211|Bupivacaine|bupivacaine|mesh-list
25326924|NCT04865211|Anesthetics, Local|anesthetics, local|mesh-ancestor
25326925|NCT04865211|Anesthetics|anesthetics|mesh-ancestor
25326926|NCT04865211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25326927|NCT04865211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326928|NCT04865211|Sensory System Agents|sensory system agents|mesh-ancestor
25326929|NCT04865211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25326930|NCT04865445|Midazolam|midazolam|mesh-list
25326931|NCT04865445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25326932|NCT04865445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25326933|NCT04865445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25326934|NCT04865445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326935|NCT04865445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25326936|NCT04865445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25326937|NCT04865445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25326938|NCT04865445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25326939|NCT04865445|Anesthetics, General|anesthetics, general|mesh-ancestor
25326940|NCT04865445|Anesthetics|anesthetics|mesh-ancestor
25326941|NCT04865445|GABA Modulators|gaba modulators|mesh-ancestor
25326942|NCT04865445|GABA Agents|gaba agents|mesh-ancestor
25326943|NCT04865445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25326944|NCT04865445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326945|NCT04865250|Paclitaxel|paclitaxel|mesh-list
25075465|NCT03380936|Tacrolimus|tacrolimus|mesh-list
25649169|NCT01489969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649170|NCT01489969|Protective Agents|protective agents|mesh-ancestor
25649171|NCT01489969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649172|NCT01489969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25649173|NCT01490060|Dexamethasone|dexamethasone|mesh-list
25649174|NCT01490060|Dexamethasone acetate|dexamethasone acetate|mesh-list
25649175|NCT01490060|Doxorubicin|doxorubicin|mesh-list
25649176|NCT01490060|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25649177|NCT01490060|Vincristine|vincristine|mesh-list
25649178|NCT01490060|Ifosfamide|ifosfamide|mesh-list
25649179|NCT01490060|Isophosphamide mustard|isophosphamide mustard|mesh-list
25649180|NCT01490060|Fosaprepitant|fosaprepitant|mesh-list
25649181|NCT01490060|Aprepitant|aprepitant|mesh-list
25649182|NCT01490060|BB 1101|bb 1101|mesh-list
25649183|NCT01490060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25649184|NCT01490060|Antiemetics|antiemetics|mesh-ancestor
25649185|NCT01490060|Autonomic Agents|autonomic agents|mesh-ancestor
25649186|NCT01490060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25197398|NCT03955887|Dimercaprol|dimercaprol|mesh-list
25197399|NCT03955887|Chelating Agents|chelating agents|mesh-ancestor
25197400|NCT03955887|Sequestering Agents|sequestering agents|mesh-ancestor
25197401|NCT03955887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197402|NCT03946358|Atezolizumab|atezolizumab|mesh-list
25197403|NCT03946358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207341|NCT04177693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24567619|NCT00791804|Fentanyl|fentanyl|mesh-list
25197411|NCT03913741|Tisotumab vedotin|tisotumab vedotin|mesh-list
25197412|NCT03913741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25197413|NCT03913741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197414|NCT03894969|Vaccines|vaccines|mesh-list
25197415|NCT03894969|Immunologic Factors|immunologic factors|mesh-ancestor
25197416|NCT03894969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326946|NCT04865250|Carboplatin|carboplatin|mesh-list
25326947|NCT04865250|Atezolizumab|atezolizumab|mesh-list
25326948|NCT04865250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25326949|NCT04865250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25326950|NCT04865250|Tubulin Modulators|tubulin modulators|mesh-ancestor
25326951|NCT04865250|Antimitotic Agents|antimitotic agents|mesh-ancestor
25326952|NCT04865250|Mitosis Modulators|mitosis modulators|mesh-ancestor
25326953|NCT04865250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326954|NCT04865224|Chrysarobin|chrysarobin|mesh-list
25326955|NCT04865224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25326956|NCT04865224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25326967|NCT04865562|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25326968|NCT04865562|Androgens|androgens|mesh-ancestor
25326969|NCT04865562|Hormones|hormones|mesh-ancestor
25326970|NCT04865562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25326971|NCT04865562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326972|NCT04865562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25326973|NCT04865562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25326974|NCT04865562|Anabolic Agents|anabolic agents|mesh-ancestor
25326975|NCT04865380|Tranexamic Acid|tranexamic acid|mesh-list
25326976|NCT04865380|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25326977|NCT04865380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25326978|NCT04865380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326979|NCT04865380|Hemostatics|hemostatics|mesh-ancestor
25326980|NCT04865380|Coagulants|coagulants|mesh-ancestor
25326981|NCT04865185|Ethanol|ethanol|mesh-list
25326982|NCT04865185|Lidocaine|lidocaine|mesh-list
25326983|NCT04865185|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25326984|NCT04865185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25326985|NCT04865185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25326986|NCT04865185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25326987|NCT04865185|Anesthetics, Local|anesthetics, local|mesh-ancestor
25326988|NCT04865185|Anesthetics|anesthetics|mesh-ancestor
25326989|NCT04865185|Sensory System Agents|sensory system agents|mesh-ancestor
25326990|NCT04865185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25326991|NCT04865185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25326992|NCT04865185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25326993|NCT04865185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25326994|NCT04865185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25326995|NCT04865185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25326998|NCT04864977|Insulin|insulin|mesh-list
25326999|NCT04864977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25327000|NCT04864977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327001|NCT04864782|Paclitaxel|paclitaxel|mesh-list
25327002|NCT04864782|Carboplatin|carboplatin|mesh-list
25327003|NCT04864782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25327004|NCT04864782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327005|NCT04864782|Tubulin Modulators|tubulin modulators|mesh-ancestor
25649187|NCT01490060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649188|NCT01490060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25649189|NCT01490060|Glucocorticoids|glucocorticoids|mesh-ancestor
25649190|NCT01490060|Hormones|hormones|mesh-ancestor
25649191|NCT01490060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25649192|NCT01490060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25649193|NCT01490060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649194|NCT01490060|Protease Inhibitors|protease inhibitors|mesh-ancestor
25649195|NCT01490060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649196|NCT01490060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649197|NCT01490060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25649198|NCT01490060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25825551|NCT00005603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25197477|NCT03824535|Deoxyglucose|deoxyglucose|mesh-list
25197478|NCT03824535|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25197479|NCT03824535|Fluorides|fluorides|mesh-list
25197480|NCT03824535|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25197481|NCT03824535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567961|NCT00793663|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25197482|NCT03824535|Cariostatic Agents|cariostatic agents|mesh-ancestor
25197483|NCT03824535|Protective Agents|protective agents|mesh-ancestor
25197484|NCT03824535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197485|NCT03824535|Antimetabolites|antimetabolites|mesh-ancestor
25197486|NCT03824535|Antiviral Agents|antiviral agents|mesh-ancestor
25197487|NCT03824535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25197488|NCT03800693|Leucovorin|leucovorin|mesh-list
25197489|NCT03800693|Fluorouracil|fluorouracil|mesh-list
25197490|NCT03800693|Oxaliplatin|oxaliplatin|mesh-list
25197491|NCT03800693|Antimetabolites|antimetabolites|mesh-ancestor
25197492|NCT03800693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197493|NCT03800693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25197494|NCT03800693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197495|NCT03800693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25197496|NCT03800693|Immunologic Factors|immunologic factors|mesh-ancestor
25197497|NCT03800693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197498|NCT03800693|Antidotes|antidotes|mesh-ancestor
25197499|NCT03800693|Protective Agents|protective agents|mesh-ancestor
25197500|NCT03800693|Vitamin B Complex|vitamin b complex|mesh-ancestor
25197501|NCT03800693|Vitamins|vitamins|mesh-ancestor
25197502|NCT03800693|Micronutrients|micronutrients|mesh-ancestor
25197503|NCT03691064|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25197510|NCT03553446|Sevoflurane|sevoflurane|mesh-list
25327006|NCT04864782|Antimitotic Agents|antimitotic agents|mesh-ancestor
25327007|NCT04864782|Mitosis Modulators|mitosis modulators|mesh-ancestor
25327008|NCT04864782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327009|NCT04864717|Doxycycline|doxycycline|mesh-list
25327010|NCT04864717|Isotretinoin|isotretinoin|mesh-list
25327011|NCT04864717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25327012|NCT04864717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25327013|NCT04864717|Antimalarials|antimalarials|mesh-ancestor
25327014|NCT04864717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25327015|NCT04864717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25327016|NCT04864717|Dermatologic Agents|dermatologic agents|mesh-ancestor
25327017|NCT04864379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25327018|NCT04864379|Molgramostim|molgramostim|mesh-list
25327019|NCT04864379|Sargramostim|sargramostim|mesh-list
25327020|NCT04864379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327021|NCT04864379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327022|NCT04864379|Immunologic Factors|immunologic factors|mesh-ancestor
25649199|NCT01490060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25649200|NCT01490060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25649201|NCT01490060|Tubulin Modulators|tubulin modulators|mesh-ancestor
25649202|NCT01490060|Antimitotic Agents|antimitotic agents|mesh-ancestor
25649203|NCT01490060|Mitosis Modulators|mitosis modulators|mesh-ancestor
25649204|NCT01490060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25649205|NCT01490060|Alkylating Agents|alkylating agents|mesh-ancestor
25649206|NCT01490060|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25649207|NCT01490060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25649208|NCT01490073|Nitroglycerin|nitroglycerin|mesh-list
25649209|NCT01490073|Vasodilator Agents|vasodilator agents|mesh-ancestor
25649210|NCT01490086|Aripiprazole|aripiprazole|mesh-list
25649211|NCT01490086|RP5063|rp5063|mesh-list
24626474|NCT01087567|Insulin|insulin|mesh-list
25649212|NCT01490086|Antidepressive Agents|antidepressive agents|mesh-ancestor
25649213|NCT01490086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25649214|NCT01490086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25649215|NCT01490086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25649216|NCT01490086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25649217|NCT01490086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649218|NCT01490086|Dopamine Agonists|dopamine agonists|mesh-ancestor
25649219|NCT01490086|Dopamine Agents|dopamine agents|mesh-ancestor
25649220|NCT01490086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25649221|NCT01490086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649222|NCT01490086|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25649223|NCT01490086|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25649224|NCT01490086|Serotonin Agents|serotonin agents|mesh-ancestor
25649225|NCT01490086|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25649226|NCT01490086|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25327023|NCT04864379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197525|NCT03523273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25197527|NCT03508570|Ipilimumab|ipilimumab|mesh-list
25197528|NCT03508570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25327031|NCT04864314|Superoxide Dismutase|superoxide dismutase|mesh-list
25327032|NCT04864314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25327033|NCT04864314|Antioxidants|antioxidants|mesh-ancestor
25327038|NCT04864366|Antiviral Agents|antiviral agents|mesh-ancestor
25327039|NCT04864366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25327040|NCT04864366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25327041|NCT04864366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25327042|NCT04864366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25327043|NCT04864366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327044|NCT04864366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25327045|NCT04864366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25327053|NCT04864067|Leucovorin|leucovorin|mesh-list
25327054|NCT04864067|Capecitabine|capecitabine|mesh-list
25327055|NCT04864067|Oxaliplatin|oxaliplatin|mesh-list
25327056|NCT04864067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25327057|NCT04864067|Antimetabolites|antimetabolites|mesh-ancestor
25327058|NCT04864067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327059|NCT04864067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327060|NCT04864067|Antidotes|antidotes|mesh-ancestor
25327061|NCT04864067|Protective Agents|protective agents|mesh-ancestor
25327062|NCT04864067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327063|NCT04864067|Vitamin B Complex|vitamin b complex|mesh-ancestor
25327064|NCT04864067|Vitamins|vitamins|mesh-ancestor
25327065|NCT04864067|Micronutrients|micronutrients|mesh-ancestor
25327066|NCT04864509|Melatonin|melatonin|mesh-list
25327067|NCT04864509|Antioxidants|antioxidants|mesh-ancestor
25327068|NCT04864509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327069|NCT04864509|Protective Agents|protective agents|mesh-ancestor
25327070|NCT04864509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327071|NCT04864509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25327072|NCT04864496|Acetylcysteine|acetylcysteine|mesh-list
25327073|NCT04864496|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25327074|NCT04864496|Antiviral Agents|antiviral agents|mesh-ancestor
25327075|NCT04864496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25327076|NCT04864496|Expectorants|expectorants|mesh-ancestor
25327077|NCT04864496|Respiratory System Agents|respiratory system agents|mesh-ancestor
25327078|NCT04864496|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25327079|NCT04864496|Antioxidants|antioxidants|mesh-ancestor
25327080|NCT04864496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327081|NCT04864496|Protective Agents|protective agents|mesh-ancestor
25327082|NCT04864496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327083|NCT04864496|Antidotes|antidotes|mesh-ancestor
25327084|NCT04863742|Prednisolone|prednisolone|mesh-list
25327085|NCT04863742|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25327086|NCT04863742|Methylprednisolone|methylprednisolone|mesh-list
25327087|NCT04863742|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25327088|NCT04863742|Prednisolone acetate|prednisolone acetate|mesh-list
25327089|NCT04863742|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25327090|NCT04863742|Prednisolone phosphate|prednisolone phosphate|mesh-list
25327091|NCT04863742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25327092|NCT04863742|Glucocorticoids|glucocorticoids|mesh-ancestor
25327093|NCT04863742|Hormones|hormones|mesh-ancestor
25327094|NCT04863742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25327095|NCT04863742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327096|NCT04863742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25327097|NCT04863742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327098|NCT04863742|Antiemetics|antiemetics|mesh-ancestor
25327099|NCT04863742|Autonomic Agents|autonomic agents|mesh-ancestor
25327100|NCT04863742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25327101|NCT04863742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25327102|NCT04863742|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25327103|NCT04863742|Protective Agents|protective agents|mesh-ancestor
25327104|NCT04863807|Anesthetics|anesthetics|mesh-list
25327105|NCT04863807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25327106|NCT04863807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327107|NCT04863430|Oxaliplatin|oxaliplatin|mesh-list
25327108|NCT04863430|Apatinib|apatinib|mesh-list
25327109|NCT04863430|Tegafur|tegafur|mesh-list
25649227|NCT01490086|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25649228|NCT01490086|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25649229|NCT01490125|Glycopyrrolate|glycopyrrolate|mesh-list
25649230|NCT01490125|Albuterol|albuterol|mesh-list
25327110|NCT04863430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197599|NCT03260894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327111|NCT04863430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25327112|NCT04863430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25010758|NCT03077243|Cisplatin|cisplatin|mesh-list
25825552|NCT00005603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25327113|NCT04863430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327114|NCT04863430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25327115|NCT04863430|Antimetabolites|antimetabolites|mesh-ancestor
25327116|NCT04863183|Triamcinolone|triamcinolone|mesh-list
25327117|NCT04863183|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25327118|NCT04863183|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25327119|NCT04863183|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25327120|NCT04863183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25327121|NCT04863183|Glucocorticoids|glucocorticoids|mesh-ancestor
25327122|NCT04863183|Hormones|hormones|mesh-ancestor
25327123|NCT04863183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25327124|NCT04863183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327125|NCT04863183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25327126|NCT04863183|Immunologic Factors|immunologic factors|mesh-ancestor
25327127|NCT04863183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25327128|NCT04863183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327129|NCT04863274|Atorvastatin|atorvastatin|mesh-list
25327130|NCT04863274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25327131|NCT04863274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25327132|NCT04863274|Antimetabolites|antimetabolites|mesh-ancestor
25327133|NCT04863274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327134|NCT04863274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25327135|NCT04863274|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25327136|NCT04863274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25079403|NCT03347968|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24470213|NCT00389233|Micronutrients|micronutrients|mesh-ancestor
24470214|NCT00389233|Laxatives|laxatives|mesh-ancestor
24470219|NCT00389272|Analgesics|analgesics|mesh-ancestor
25327137|NCT04863365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25327138|NCT04863365|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25327139|NCT04863079|Pembrolizumab|pembrolizumab|mesh-list
25327140|NCT04863079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25327141|NCT04863079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327142|NCT04863001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
25327143|NCT04863105|Abiraterone Acetate|abiraterone acetate|mesh-list
25327144|NCT04863105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327145|NCT04863105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25327146|NCT04863105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25327147|NCT04863105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327148|NCT04863105|Hormone Antagonists|hormone antagonists|mesh-ancestor
25327149|NCT04863105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25327150|NCT04863105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327151|NCT04863105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25327152|NCT04862455|Pembrolizumab|pembrolizumab|mesh-list
25327153|NCT04862455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25327154|NCT04862455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327155|NCT04862767|Aldesleukin|aldesleukin|mesh-list
25327156|NCT04862767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327157|NCT04862767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25327158|NCT04862767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25327159|NCT04862767|Antiviral Agents|antiviral agents|mesh-ancestor
25327160|NCT04862767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25327161|NCT04862845|Pregabalin|pregabalin|mesh-list
25327162|NCT04862845|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25327163|NCT04862845|Analgesics|analgesics|mesh-ancestor
25327164|NCT04862845|Sensory System Agents|sensory system agents|mesh-ancestor
25327165|NCT04862845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25327166|NCT04862845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327167|NCT04862845|Anticonvulsants|anticonvulsants|mesh-ancestor
25327168|NCT04862845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25327169|NCT04862845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25327170|NCT04862845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327171|NCT04862845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25327172|NCT04862845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25327173|NCT04862845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25327174|NCT04862845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25327175|NCT04862845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25649231|NCT01490125|Tiotropium Bromide|tiotropium bromide|mesh-list
25197672|NCT02964078|Sensory System Agents|sensory system agents|mesh-ancestor
25197673|NCT02964078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25197674|NCT02964078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197675|NCT02964078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25197676|NCT02964078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25197677|NCT02964078|Antiviral Agents|antiviral agents|mesh-ancestor
25197678|NCT02964078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25197689|NCT02789345|Osimertinib|osimertinib|mesh-list
25197690|NCT02789345|Ramucirumab|ramucirumab|mesh-list
25197697|NCT02779855|Paclitaxel|paclitaxel|mesh-list
25327176|NCT04862845|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25327177|NCT04862845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25327178|NCT04862845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25327179|NCT04862845|Antidepressive Agents|antidepressive agents|mesh-ancestor
25327180|NCT04862845|Dopamine Agents|dopamine agents|mesh-ancestor
25327181|NCT04862091|Abiraterone Acetate|abiraterone acetate|mesh-list
25327182|NCT04862091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327183|NCT04862091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25327184|NCT04862091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25327185|NCT04862091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327186|NCT04862091|Hormone Antagonists|hormone antagonists|mesh-ancestor
25327187|NCT04862091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25327188|NCT04862091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327189|NCT04862091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25327190|NCT04862377|Budesonide|budesonide|mesh-list
25327191|NCT04862377|Poractant alfa|poractant alfa|mesh-list
25327192|NCT04862377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25327193|NCT04862377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25327194|NCT04862377|Autonomic Agents|autonomic agents|mesh-ancestor
25327195|NCT04862377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25327196|NCT04862377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327197|NCT04862377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25327198|NCT04862377|Respiratory System Agents|respiratory system agents|mesh-ancestor
25327199|NCT04862377|Glucocorticoids|glucocorticoids|mesh-ancestor
25327200|NCT04862377|Hormones|hormones|mesh-ancestor
25327201|NCT04862377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25327202|NCT04862377|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
25327203|NCT04862234|Dulaglutide|dulaglutide|mesh-list
25327204|NCT04862234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25010916|NCT02728648|Sensory System Agents|sensory system agents|mesh-ancestor
25010917|NCT02728648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25110206|NCT05464953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24967648|NCT03757650|Omeprazole|omeprazole|mesh-list
25327205|NCT04862234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327206|NCT04861948|Bevacizumab|bevacizumab|mesh-list
25327207|NCT04861948|Carboplatin|carboplatin|mesh-list
25327208|NCT04861948|Pemetrexed|pemetrexed|mesh-list
25327209|NCT04861948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25327210|NCT04861948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327211|NCT04861948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25327212|NCT04861948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25327213|NCT04861948|Growth Substances|growth substances|mesh-ancestor
25327214|NCT04861948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327215|NCT04861948|Growth Inhibitors|growth inhibitors|mesh-ancestor
25327216|NCT04861948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25327217|NCT04861948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327218|NCT04861948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25327219|NCT04861948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25327220|NCT04862117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25327221|NCT04862117|Cholinergic Agents|cholinergic agents|mesh-list
25327222|NCT04862117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25327223|NCT04862117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327224|NCT04862117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327225|NCT04861922|Heparin|heparin|mesh-list
25327226|NCT04861922|Calcium heparin|calcium heparin|mesh-list
25649232|NCT01490125|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25649233|NCT01490125|Autonomic Agents|autonomic agents|mesh-ancestor
25649234|NCT01490125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25649235|NCT01490125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649236|NCT01490125|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25649237|NCT01490125|Respiratory System Agents|respiratory system agents|mesh-ancestor
25649238|NCT01490125|Parasympatholytics|parasympatholytics|mesh-ancestor
25649239|NCT01490125|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25649240|NCT01490125|Cholinergic Agents|cholinergic agents|mesh-ancestor
25327227|NCT04861922|Anticoagulants|anticoagulants|mesh-ancestor
25327228|NCT04861922|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25327229|NCT04861922|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25327230|NCT04861922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327231|NCT04861142|Denosumab|denosumab|mesh-list
25327232|NCT04861142|Alendronate|alendronate|mesh-list
25327233|NCT04861142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25327234|NCT04861142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327235|NCT04861051|Ketamine|ketamine|mesh-list
25327236|NCT04861051|Analgesics|analgesics|mesh-ancestor
25327237|NCT04861051|Sensory System Agents|sensory system agents|mesh-ancestor
25327238|NCT04861051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25327239|NCT04861051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327240|NCT04861051|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25327241|NCT04861051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25327242|NCT04861051|Anesthetics, General|anesthetics, general|mesh-ancestor
25327243|NCT04861051|Anesthetics|anesthetics|mesh-ancestor
25327244|NCT04861051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25327245|NCT04861051|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25327246|NCT04861051|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25327247|NCT04861051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25327250|NCT04861103|Anticoagulants|anticoagulants|mesh-ancestor
25327251|NCT04861103|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25327252|NCT04861103|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25327253|NCT04861103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327254|NCT04860674|Carboplatin|carboplatin|mesh-list
25327255|NCT04860674|Etoposide|etoposide|mesh-list
25327256|NCT04860674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25327257|NCT04860674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327258|NCT04860674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25327259|NCT04860674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25327260|NCT04860674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25327261|NCT04860674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25327262|NCT04860674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327263|NCT04860856|Ropivacaine|ropivacaine|mesh-list
25327264|NCT04860856|Anesthetics, Local|anesthetics, local|mesh-ancestor
25327265|NCT04860856|Anesthetics|anesthetics|mesh-ancestor
25327266|NCT04860856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25327267|NCT04860856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327268|NCT04860856|Sensory System Agents|sensory system agents|mesh-ancestor
25327269|NCT04860856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25327276|NCT04861207|Cladribine|cladribine|mesh-list
25327277|NCT04861207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327278|NCT04861207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25327279|NCT04861207|Immunologic Factors|immunologic factors|mesh-ancestor
25327280|NCT04861207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327281|NCT04860531|Betamethasone|betamethasone|mesh-list
25327282|NCT04860531|Lidocaine|lidocaine|mesh-list
25327283|NCT04860531|Anesthetics, Local|anesthetics, local|mesh-ancestor
25327284|NCT04860531|Anesthetics|anesthetics|mesh-ancestor
25327285|NCT04860531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25327286|NCT04860531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327287|NCT04860531|Sensory System Agents|sensory system agents|mesh-ancestor
25327288|NCT04860531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25327289|NCT04860531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25327290|NCT04860531|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25327291|NCT04860531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25327292|NCT04860531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25327293|NCT04860531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327294|NCT04860531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25327295|NCT04860531|Glucocorticoids|glucocorticoids|mesh-ancestor
25327296|NCT04860531|Hormones|hormones|mesh-ancestor
25327297|NCT04860531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25327298|NCT04860531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25327299|NCT04860531|Respiratory System Agents|respiratory system agents|mesh-ancestor
25327300|NCT04860284|Hydroxychloroquine|hydroxychloroquine|mesh-list
25327301|NCT04860284|Antimalarials|antimalarials|mesh-ancestor
25327302|NCT04860284|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25327303|NCT04860284|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25327304|NCT04860284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25327305|NCT04860284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25327306|NCT04860284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327307|NCT04860284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25327308|NCT04860167|Diclofenac|diclofenac|mesh-list
25327309|NCT04860167|Lidocaine|lidocaine|mesh-list
25207354|NCT04177693|Antioxidants|antioxidants|mesh-ancestor
25207355|NCT04177693|Protective Agents|protective agents|mesh-ancestor
25207356|NCT04177693|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25207357|NCT04177693|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25207358|NCT04177693|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25207359|NCT04142086|Vaccines|vaccines|mesh-list
25207360|NCT04142086|Immunologic Factors|immunologic factors|mesh-ancestor
25207361|NCT04142086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207362|NCT04137887|Vaccines|vaccines|mesh-list
25207363|NCT04137887|Immunologic Factors|immunologic factors|mesh-ancestor
25207364|NCT04137887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207365|NCT04103385|Risedronic Acid|risedronic acid|mesh-list
25207366|NCT04103385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25207367|NCT04103385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25207368|NCT04103385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327310|NCT04860167|Propofol|propofol|mesh-list
25327311|NCT04860167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25327312|NCT04860167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25327313|NCT04860167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327314|NCT04860167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25327315|NCT04860167|Anesthetics, General|anesthetics, general|mesh-ancestor
25327316|NCT04860167|Anesthetics|anesthetics|mesh-ancestor
25327317|NCT04860167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25327318|NCT04860167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25327319|NCT04860167|Analgesics|analgesics|mesh-ancestor
25327323|NCT04860167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25327324|NCT04860167|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25327325|NCT04860167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25327326|NCT04860167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327327|NCT04860167|Anesthetics, Local|anesthetics, local|mesh-ancestor
25327328|NCT04860167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25327329|NCT04860167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25327330|NCT04860167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25327331|NCT04860167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25327332|NCT04860076|Pembrolizumab|pembrolizumab|mesh-list
25327333|NCT04860076|Nivolumab|nivolumab|mesh-list
25327334|NCT04860076|Ipilimumab|ipilimumab|mesh-list
25327335|NCT04860076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25327336|NCT04860076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327337|NCT04860076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25327338|NCT04860076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327342|NCT04860011|Dapagliflozin|dapagliflozin|mesh-list
25327343|NCT04860011|Metolazone|metolazone|mesh-list
25327344|NCT04860011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25327345|NCT04860011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327346|NCT04860011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25327347|NCT04860011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327348|NCT04860011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25327349|NCT04860011|Diuretics|diuretics|mesh-ancestor
25327350|NCT04860011|Natriuretic Agents|natriuretic agents|mesh-ancestor
25327351|NCT04860011|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25327352|NCT04860011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25327353|NCT04859738|Lidocaine|lidocaine|mesh-list
25327354|NCT04859738|Anesthetics, Local|anesthetics, local|mesh-ancestor
25327355|NCT04859738|Anesthetics|anesthetics|mesh-ancestor
25327356|NCT04859738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25327357|NCT04859738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998778|NCT00145795|Ritonavir|ritonavir|mesh-list
25327358|NCT04859738|Sensory System Agents|sensory system agents|mesh-ancestor
25327359|NCT04859738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25649241|NCT01490125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25649242|NCT01490125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649243|NCT01490125|Tocolytic Agents|tocolytic agents|mesh-ancestor
25649244|NCT01490125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25649245|NCT01490125|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25649246|NCT01490125|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25649247|NCT01490125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25649248|NCT01490125|Adrenergic Agents|adrenergic agents|mesh-ancestor
25649249|NCT01490125|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25649250|NCT01490125|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25649251|NCT01490580|Atropine|atropine|mesh-list
25649252|NCT01490580|Sufentanil|sufentanil|mesh-list
25649253|NCT01490580|Propofol|propofol|mesh-list
25649254|NCT01490580|Atracurium|atracurium|mesh-list
25649255|NCT01490580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25649256|NCT01490580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25197856|NCT02251821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25197857|NCT02251821|Abortifacient Agents|abortifacient agents|mesh-ancestor
25197858|NCT02251821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25197859|NCT02251821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25197860|NCT02251821|Antimetabolites|antimetabolites|mesh-ancestor
25197861|NCT02251821|Dermatologic Agents|dermatologic agents|mesh-ancestor
25197862|NCT02251821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25197863|NCT02251821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25197864|NCT02251821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25197865|NCT02251821|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25197866|NCT02251821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25197867|NCT02251821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25197868|NCT02251821|Antitubercular Agents|antitubercular agents|mesh-ancestor
25197869|NCT02251821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25825553|NCT00005603|Glucocorticoids|glucocorticoids|mesh-ancestor
25197870|NCT02251821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25197896|NCT02139852|Antipruritics|antipruritics|mesh-ancestor
25197897|NCT02139852|Dermatologic Agents|dermatologic agents|mesh-ancestor
25197901|NCT02081326|BCG Vaccine|bcg vaccine|mesh-list
25327360|NCT04859738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25327361|NCT04859738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25327362|NCT04859738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25327363|NCT04859738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25327364|NCT04859738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327365|NCT04859777|Pembrolizumab|pembrolizumab|mesh-list
25327366|NCT04859777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25327367|NCT04859777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327368|NCT04860219|Lactoferrin|lactoferrin|mesh-list
25327369|NCT04860219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25327370|NCT04859621|Vitamin D|vitamin d|mesh-list
25327372|NCT04859621|Cholecalciferol|cholecalciferol|mesh-list
25327374|NCT04859621|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25327375|NCT04859621|Micronutrients|micronutrients|mesh-ancestor
25327376|NCT04859621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327377|NCT04859621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25327378|NCT04859621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25327379|NCT04859621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25327380|NCT04859556|Dipivefrin|dipivefrin|mesh-list
25327381|NCT04859556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25327382|NCT04859556|Adrenergic Agents|adrenergic agents|mesh-ancestor
25327383|NCT04859556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25327384|NCT04859556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327385|NCT04859556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327386|NCT04859569|Denosumab|denosumab|mesh-list
25327387|NCT04859569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25327388|NCT04859569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327389|NCT04859530|Lugol's solution|lugol's solution|mesh-list
25327390|NCT04859530|Hemostatics|hemostatics|mesh-ancestor
25327391|NCT04859530|Coagulants|coagulants|mesh-ancestor
25327392|NCT04859283|Dexmedetomidine|dexmedetomidine|mesh-list
25327393|NCT04859283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24811174|NCT02045368|Immunologic Factors|immunologic factors|mesh-ancestor
25327395|NCT04859283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327396|NCT04859283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25327397|NCT04859283|Analgesics|analgesics|mesh-ancestor
25327398|NCT04859283|Sensory System Agents|sensory system agents|mesh-ancestor
25649257|NCT01490580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649258|NCT01490580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25649259|NCT01490580|Anesthetics, General|anesthetics, general|mesh-ancestor
25649260|NCT01490580|Anesthetics|anesthetics|mesh-ancestor
25649261|NCT01490580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25649262|NCT01490580|Narcotics|narcotics|mesh-ancestor
25649263|NCT01490580|Analgesics|analgesics|mesh-ancestor
25649264|NCT01490580|Sensory System Agents|sensory system agents|mesh-ancestor
25649265|NCT01490580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25649266|NCT01490580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25649267|NCT01490580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25649268|NCT01490580|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25649269|NCT01490580|Autonomic Agents|autonomic agents|mesh-ancestor
25649270|NCT01490580|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25649271|NCT01490580|Respiratory System Agents|respiratory system agents|mesh-ancestor
25649272|NCT01490580|Mydriatics|mydriatics|mesh-ancestor
25649273|NCT01490580|Parasympatholytics|parasympatholytics|mesh-ancestor
25649274|NCT01490580|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25649275|NCT01490580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25649276|NCT01490580|Cholinergic Agents|cholinergic agents|mesh-ancestor
25327402|NCT04859283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25327403|NCT04859283|Adrenergic Agents|adrenergic agents|mesh-ancestor
25327404|NCT04859283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25327405|NCT04859283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327406|NCT04859452|Metformin|metformin|mesh-list
25327407|NCT04859452|Glyburide|glyburide|mesh-list
25327408|NCT04859452|Valsartan|valsartan|mesh-list
25327409|NCT04859452|Simvastatin|simvastatin|mesh-list
25327410|NCT04859452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25327411|NCT04859452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327412|NCT04859452|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25327413|NCT04859452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25327414|NCT04859452|Antimetabolites|antimetabolites|mesh-ancestor
25327415|NCT04859452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327416|NCT04859452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25327417|NCT04859452|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25327418|NCT04859452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25327419|NCT04859452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25327420|NCT04859452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25327421|NCT04859452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25327422|NCT04859361|Imiquimod|imiquimod|mesh-list
25327423|NCT04859361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25327424|NCT04859361|Immunologic Factors|immunologic factors|mesh-ancestor
25327425|NCT04859361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327426|NCT04859361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327427|NCT04859361|Interferon Inducers|interferon inducers|mesh-ancestor
25327428|NCT04859322|Glucagon|glucagon|mesh-list
25327429|NCT04859322|Somatostatin|somatostatin|mesh-list
25327430|NCT04859322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327431|NCT04859322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25327432|NCT04859322|Hormones|hormones|mesh-ancestor
25327433|NCT04859322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25327434|NCT04859244|Remdesivir|remdesivir|mesh-list
25327435|NCT04859244|GS-441524|gs-441524|mesh-list
25327436|NCT04859244|Antimetabolites|antimetabolites|mesh-ancestor
25327437|NCT04859244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327438|NCT04859244|Antiviral Agents|antiviral agents|mesh-ancestor
25327439|NCT04859244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25327440|NCT04858997|Palbociclib|palbociclib|mesh-list
25327441|NCT04858997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327442|NCT04858997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25327443|NCT04858997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25327444|NCT04858997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327445|NCT04858841|Levetiracetam|levetiracetam|mesh-list
25327446|NCT04858841|Anticonvulsants|anticonvulsants|mesh-ancestor
25327447|NCT04858841|Nootropic Agents|nootropic agents|mesh-ancestor
25327448|NCT04858529|Carboplatin|carboplatin|mesh-list
25327449|NCT04858529|Docetaxel|docetaxel|mesh-list
25327450|NCT04858529|Trastuzumab|trastuzumab|mesh-list
25327451|NCT04858529|Pertuzumab|pertuzumab|mesh-list
25327452|NCT04858529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327453|NCT04858529|Tubulin Modulators|tubulin modulators|mesh-ancestor
25327454|NCT04858529|Antimitotic Agents|antimitotic agents|mesh-ancestor
25327455|NCT04858529|Mitosis Modulators|mitosis modulators|mesh-ancestor
25327456|NCT04858529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327457|NCT04858529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25327458|NCT04858516|Trastuzumab|trastuzumab|mesh-list
25327459|NCT04858516|Palbociclib|palbociclib|mesh-list
25327460|NCT04858516|Exemestane|exemestane|mesh-list
25327461|NCT04858516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25327462|NCT04858516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327469|NCT04858516|Hormone Antagonists|hormone antagonists|mesh-ancestor
25327470|NCT04858516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25327471|NCT04858516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628564|NCT01099839|Ipragliflozin|ipragliflozin|mesh-list
25327472|NCT04858633|Hydroxychloroquine|hydroxychloroquine|mesh-list
25327473|NCT04858633|Antimalarials|antimalarials|mesh-ancestor
25327474|NCT04858633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25327475|NCT04858633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25327476|NCT04858633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25327477|NCT04858633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25327478|NCT04858633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327479|NCT04858633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25327480|NCT04858087|Lumefantrine|lumefantrine|mesh-list
25327481|NCT04858087|Artemether|artemether|mesh-list
25327482|NCT04858087|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25327483|NCT04858087|Antimalarials|antimalarials|mesh-ancestor
25327484|NCT04858087|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25327485|NCT04858087|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25327486|NCT04858087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25327487|NCT04858048|Anesthetics|anesthetics|mesh-list
25327488|NCT04858048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25327489|NCT04858048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327499|NCT04857801|Teduglutide|teduglutide|mesh-list
25327500|NCT04857801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25327501|NCT04857801|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25327502|NCT04857801|Protective Agents|protective agents|mesh-ancestor
25327503|NCT04857801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327504|NCT04857840|Firibastat|firibastat|mesh-list
25327505|NCT04857840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25327506|NCT04857320|Insulin|insulin|mesh-list
25327507|NCT04857320|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25327508|NCT04857320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25327509|NCT04857320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327510|NCT04857333|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25327511|NCT04857333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25327512|NCT04857450|Ketamine|ketamine|mesh-list
25327513|NCT04857450|Etomidate|etomidate|mesh-list
25327514|NCT04857450|Analgesics|analgesics|mesh-ancestor
25327515|NCT04857450|Sensory System Agents|sensory system agents|mesh-ancestor
25327516|NCT04857450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25327517|NCT04857450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327518|NCT04857450|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25327519|NCT04857450|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25327520|NCT04857450|Anesthetics, General|anesthetics, general|mesh-ancestor
25327521|NCT04857450|Anesthetics|anesthetics|mesh-ancestor
25327522|NCT04857450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25327523|NCT04857450|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25327524|NCT04857450|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25327525|NCT04857450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25327526|NCT04857450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327527|NCT04857450|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25327528|NCT04857177|Ranibizumab|ranibizumab|mesh-list
25327529|NCT04857177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25327530|NCT04857177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25327531|NCT04857177|Growth Substances|growth substances|mesh-ancestor
25327532|NCT04857177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327533|NCT04857177|Growth Inhibitors|growth inhibitors|mesh-ancestor
25327534|NCT04857177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327550|NCT04856852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327551|NCT04856852|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25327552|NCT04856852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25327553|NCT04856852|Trace Elements|trace elements|mesh-ancestor
25327554|NCT04856852|Micronutrients|micronutrients|mesh-ancestor
25327555|NCT04856852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327557|NCT04856878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25327558|NCT04856878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25327559|NCT04856787|Fluorouracil|fluorouracil|mesh-list
25327560|NCT04856787|Antimetabolites|antimetabolites|mesh-ancestor
25327561|NCT04856787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327562|NCT04856787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25327563|NCT04856787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327564|NCT04856787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25327565|NCT04856787|Immunologic Factors|immunologic factors|mesh-ancestor
25327566|NCT04856787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327567|NCT04856969|Dapagliflozin|dapagliflozin|mesh-list
25327568|NCT04856969|Olmesartan|olmesartan|mesh-list
25327569|NCT04856969|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25327570|NCT04856969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327571|NCT04856969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25327572|NCT04856969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327573|NCT04856969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25327574|NCT04856969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25327575|NCT04856969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25327576|NCT04856644|Moxifloxacin|moxifloxacin|mesh-list
25327583|NCT04856644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25327584|NCT04856644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327585|NCT04856644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327586|NCT04856644|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25327587|NCT04856644|Antitubercular Agents|antitubercular agents|mesh-ancestor
25327588|NCT04856644|Leprostatic Agents|leprostatic agents|mesh-ancestor
25327589|NCT04856644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25327590|NCT04856644|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25327591|NCT04856644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25327592|NCT04856644|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25327593|NCT04856644|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25327594|NCT04856644|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25327595|NCT04856644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25327596|NCT04856371|Letrozole|letrozole|mesh-list
25327597|NCT04856371|Fulvestrant|fulvestrant|mesh-list
25327598|NCT04856371|Palbociclib|palbociclib|mesh-list
25327599|NCT04856371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327600|NCT04856371|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25327601|NCT04856371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25327602|NCT04856371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25327603|NCT04856371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327604|NCT04856371|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25327605|NCT04856371|Hormone Antagonists|hormone antagonists|mesh-ancestor
25327606|NCT04856371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25327607|NCT04856371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327608|NCT04856371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25327609|NCT04856371|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25327610|NCT04856371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25011496|NCT04899986|Disinfectants|disinfectants|mesh-ancestor
25327612|NCT04856137|Rituximab|rituximab|mesh-list
25327613|NCT04856137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25327614|NCT04856137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327615|NCT04856137|Tubulin Modulators|tubulin modulators|mesh-ancestor
25327616|NCT04856137|Antimitotic Agents|antimitotic agents|mesh-ancestor
25327617|NCT04856137|Mitosis Modulators|mitosis modulators|mesh-ancestor
25327618|NCT04856137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327619|NCT04856137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25327620|NCT04856137|Immunologic Factors|immunologic factors|mesh-ancestor
25327621|NCT04856137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327622|NCT04856137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25327623|NCT04856098|Glycopyrrolate|glycopyrrolate|mesh-list
25327624|NCT04856098|Bromides|bromides|mesh-list
25327625|NCT04856098|Maleic acid|maleic acid|mesh-list
25327626|NCT04856098|Charcoal|charcoal|mesh-list
25327627|NCT04856098|Anticonvulsants|anticonvulsants|mesh-ancestor
25327628|NCT04856098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25327629|NCT04856098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327630|NCT04856098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25327631|NCT04856098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25327632|NCT04856098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25327633|NCT04856098|Cholinergic Agents|cholinergic agents|mesh-ancestor
25327634|NCT04856098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25327635|NCT04856098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327636|NCT04856098|Antidotes|antidotes|mesh-ancestor
25327637|NCT04856098|Protective Agents|protective agents|mesh-ancestor
25327638|NCT04856111|Pirfenidone|pirfenidone|mesh-list
25327639|NCT04856111|Nintedanib|nintedanib|mesh-list
25327640|NCT04856111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327641|NCT04856111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25327642|NCT04856111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25327643|NCT04856111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327644|NCT04856111|Analgesics|analgesics|mesh-ancestor
25327645|NCT04856111|Sensory System Agents|sensory system agents|mesh-ancestor
25327648|NCT04856111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25327649|NCT04856111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25327650|NCT04856111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25327651|NCT04856111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25327652|NCT04855968|Analgesics|analgesics|mesh-list
25327653|NCT04855968|Sensory System Agents|sensory system agents|mesh-ancestor
25327654|NCT04855968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25327655|NCT04855968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327656|NCT04856124|Ketamine|ketamine|mesh-list
25327657|NCT04856124|Esketamine|esketamine|mesh-list
25327658|NCT04856124|Analgesics|analgesics|mesh-ancestor
25327659|NCT04856124|Sensory System Agents|sensory system agents|mesh-ancestor
25327660|NCT04856124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25327661|NCT04856124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327662|NCT04856124|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25327663|NCT04856124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25327664|NCT04856124|Anesthetics, General|anesthetics, general|mesh-ancestor
25327665|NCT04856124|Anesthetics|anesthetics|mesh-ancestor
25327666|NCT04856124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25327667|NCT04856124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25327668|NCT04856124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25327669|NCT04856124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25327670|NCT04856124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327671|NCT04856124|Antidepressive Agents|antidepressive agents|mesh-ancestor
25327672|NCT04856124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25327673|NCT04855279|Listerine|listerine|mesh-list
25327674|NCT04855279|Fluorides|fluorides|mesh-list
25327675|NCT04855279|Sodium Fluoride|sodium fluoride|mesh-list
25327676|NCT04855279|Glycerol|glycerol|mesh-list
25327692|NCT04855110|Anticoagulants|anticoagulants|mesh-ancestor
25327693|NCT04854837|Remdesivir|remdesivir|mesh-list
25327694|NCT04854837|Antimetabolites|antimetabolites|mesh-ancestor
25327695|NCT04854837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327696|NCT04854837|Antiviral Agents|antiviral agents|mesh-ancestor
25327697|NCT04854837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25327704|NCT04854759|Amantadine|amantadine|mesh-list
25327705|NCT04854759|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25327706|NCT04854759|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25327707|NCT04854759|Antiviral Agents|antiviral agents|mesh-ancestor
25327708|NCT04854759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25327709|NCT04854759|Dopamine Agents|dopamine agents|mesh-ancestor
25327710|NCT04854759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25327711|NCT04854759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327712|NCT04854759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327713|NCT04854759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25327714|NCT04854759|Analgesics|analgesics|mesh-ancestor
25327716|NCT04854759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25327717|NCT04854668|Bevacizumab|bevacizumab|mesh-list
25327718|NCT04854668|Capecitabine|capecitabine|mesh-list
25327719|NCT04854668|Oxaliplatin|oxaliplatin|mesh-list
25327720|NCT04854668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25327721|NCT04854668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327722|NCT04854668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25327723|NCT04854668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25327724|NCT04854668|Growth Substances|growth substances|mesh-ancestor
25327725|NCT04854668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327726|NCT04854668|Growth Inhibitors|growth inhibitors|mesh-ancestor
25327727|NCT04854668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25327728|NCT04854668|Antimetabolites|antimetabolites|mesh-ancestor
25327729|NCT04854668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327730|NCT04854460|Ivermectin|ivermectin|mesh-list
25327731|NCT04854460|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25327732|NCT04854460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25327739|NCT04854577|Anesthetics|anesthetics|mesh-list
24472445|NCT00399165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472446|NCT00399165|Anabolic Agents|anabolic agents|mesh-ancestor
25327740|NCT04854577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25327741|NCT04854577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327742|NCT04854538|Budesonide|budesonide|mesh-list
25327743|NCT04854538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25327744|NCT04854538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25327745|NCT04854538|Autonomic Agents|autonomic agents|mesh-ancestor
25825554|NCT00005603|Hormones|hormones|mesh-ancestor
25327746|NCT04854538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25327747|NCT04854538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327748|NCT04854538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25327749|NCT04854538|Respiratory System Agents|respiratory system agents|mesh-ancestor
25327750|NCT04854538|Glucocorticoids|glucocorticoids|mesh-ancestor
25327751|NCT04854538|Hormones|hormones|mesh-ancestor
25327752|NCT04854538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25327753|NCT04854369|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25327754|NCT04854369|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25327755|NCT04854369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327756|NCT04854044|TIC10 compound|tic10 compound|mesh-list
25327757|NCT04854044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327758|NCT04854252|Fentanyl|fentanyl|mesh-list
25327759|NCT04854252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25327760|NCT04854252|Narcotics|narcotics|mesh-ancestor
25327761|NCT04854252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25327762|NCT04854252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327763|NCT04854252|Analgesics|analgesics|mesh-ancestor
25327764|NCT04854252|Sensory System Agents|sensory system agents|mesh-ancestor
25327765|NCT04854252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25327766|NCT04854252|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25327767|NCT04854252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25327768|NCT04854252|Anesthetics, General|anesthetics, general|mesh-ancestor
25327769|NCT04854252|Anesthetics|anesthetics|mesh-ancestor
25327770|NCT04853758|Valsartan|valsartan|mesh-list
25327771|NCT04853758|Enalapril|enalapril|mesh-list
25327772|NCT04853758|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25327773|NCT04853758|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25327774|NCT04853758|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25327775|NCT04853758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25327776|NCT04853758|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25327777|NCT04853758|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25327778|NCT04853758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327779|NCT04853758|Protease Inhibitors|protease inhibitors|mesh-ancestor
25327780|NCT04853797|Calcium|calcium|mesh-list
25327781|NCT04853797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25327782|NCT04853797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327783|NCT04853875|Amoxicillin|amoxicillin|mesh-list
25327784|NCT04853875|Metronidazole|metronidazole|mesh-list
25327785|NCT04853875|Clarithromycin|clarithromycin|mesh-list
25327786|NCT04853875|Tetracycline|tetracycline|mesh-list
25327787|NCT04853875|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
25327788|NCT04853875|Bismuth|bismuth|mesh-list
25327789|NCT04853875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25327790|NCT04853875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25327791|NCT04853875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25327796|NCT04853875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25327797|NCT04853875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25327798|NCT04853875|Antacids|antacids|mesh-ancestor
25327799|NCT04853875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25327800|NCT04853875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25327801|NCT04853615|Empagliflozin|empagliflozin|mesh-list
25327802|NCT04853615|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25327803|NCT04853615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327804|NCT04853615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25327805|NCT04853615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327806|NCT04853446|Dexamethasone|dexamethasone|mesh-list
25327807|NCT04853446|Dexamethasone acetate|dexamethasone acetate|mesh-list
25327808|NCT04853446|BB 1101|bb 1101|mesh-list
24813655|NCT02059759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24813657|NCT02059772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24813658|NCT02059772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24813974|NCT02061631|Glucocorticoids|glucocorticoids|mesh-ancestor
24472566|NCT00399672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327809|NCT04853446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25327810|NCT04853446|Antiemetics|antiemetics|mesh-ancestor
25327811|NCT04853446|Autonomic Agents|autonomic agents|mesh-ancestor
25327812|NCT04853446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25327813|NCT04853446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327814|NCT04853446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25327823|NCT04853719|Aspirin|aspirin|mesh-list
25327824|NCT04853719|Rivaroxaban|rivaroxaban|mesh-list
25327825|NCT04853719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25327826|NCT04853719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25327827|NCT04853719|Analgesics|analgesics|mesh-ancestor
25327828|NCT04853719|Sensory System Agents|sensory system agents|mesh-ancestor
25198277|NCT02749890|Insulin Glargine|insulin glargine|mesh-list
25198278|NCT02749890|Lixisenatide|lixisenatide|mesh-list
25198279|NCT02749890|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25198280|NCT02749890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198281|NCT02750163|Acetaminophen|acetaminophen|mesh-list
25198282|NCT02750163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25198283|NCT02750163|Analgesics|analgesics|mesh-ancestor
25198284|NCT02750163|Sensory System Agents|sensory system agents|mesh-ancestor
25198285|NCT02750163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25198286|NCT02750163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198287|NCT02750163|Antipyretics|antipyretics|mesh-ancestor
25198288|NCT02749747|Sulpiride|sulpiride|mesh-list
25327829|NCT04853719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25327830|NCT04853719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327831|NCT04853719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25327832|NCT04853719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25327833|NCT04853719|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25327834|NCT04853719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25327835|NCT04853719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327836|NCT04853719|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25327837|NCT04853719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25327838|NCT04853719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25327839|NCT04853719|Antipyretics|antipyretics|mesh-ancestor
25327840|NCT04853719|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25327841|NCT04853719|Antithrombins|antithrombins|mesh-ancestor
25327842|NCT04853719|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25327843|NCT04853719|Protease Inhibitors|protease inhibitors|mesh-ancestor
25327844|NCT04853719|Anticoagulants|anticoagulants|mesh-ancestor
25327851|NCT04853628|Ethanol|ethanol|mesh-list
25327852|NCT04853628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25327853|NCT04853628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25327854|NCT04853628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25327855|NCT04853628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327856|NCT04853524|Tenofovir|tenofovir|mesh-list
25327857|NCT04853524|Emtricitabine|emtricitabine|mesh-list
25327858|NCT04853524|JNJ-56136379|jnj-56136379|mesh-list
25327859|NCT04853524|Antiviral Agents|antiviral agents|mesh-ancestor
25327860|NCT04853524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25327861|NCT04853524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25327862|NCT04853524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25327863|NCT04853524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25327864|NCT04853524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327865|NCT04853524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25327866|NCT04853524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25327867|NCT04853901|Remdesivir|remdesivir|mesh-list
25327868|NCT04853901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25327869|NCT04853901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327870|NCT04853901|Antimetabolites|antimetabolites|mesh-ancestor
25327871|NCT04853901|Antiviral Agents|antiviral agents|mesh-ancestor
25327887|NCT04853030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327892|NCT04852510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25327893|NCT04852510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327895|NCT04852315|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25327896|NCT04852315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327897|NCT04852315|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25327898|NCT04852315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25327899|NCT04852315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327900|NCT04852315|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25327901|NCT04852315|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25327902|NCT04852315|Purinergic Agents|purinergic agents|mesh-ancestor
25327903|NCT04852315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25327907|NCT04851769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
25327908|NCT04851769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25649277|NCT01490580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25649278|NCT01490580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649279|NCT01490580|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25649280|NCT01490580|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25649281|NCT01490580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25649282|NCT01490580|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25649283|NCT01490697|Cycloserine|cycloserine|mesh-list
25649284|NCT01490697|Mifepristone|mifepristone|mesh-list
25649285|NCT01490697|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25649286|NCT01490697|Abortifacient Agents|abortifacient agents|mesh-ancestor
25649287|NCT01490697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25198353|NCT02749409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25327909|NCT04851769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25327910|NCT04851769|Antimetabolites|antimetabolites|mesh-ancestor
25327911|NCT04851769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327912|NCT04851769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25327913|NCT04851769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25327914|NCT04851821|Quercetin|quercetin|mesh-list
25327915|NCT04851821|Antioxidants|antioxidants|mesh-ancestor
25327916|NCT04851821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327917|NCT04851821|Protective Agents|protective agents|mesh-ancestor
25327918|NCT04851821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327919|NCT04851977|Vaccines|vaccines|mesh-list
25327920|NCT04851977|Immunologic Factors|immunologic factors|mesh-ancestor
25327921|NCT04851977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327922|NCT04851548|Hyaluronic Acid|hyaluronic acid|mesh-list
25327923|NCT04851548|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25327924|NCT04851548|Immunologic Factors|immunologic factors|mesh-ancestor
25327925|NCT04851548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327926|NCT04851548|Viscosupplements|viscosupplements|mesh-ancestor
25327927|NCT04851548|Protective Agents|protective agents|mesh-ancestor
25327928|NCT04851626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25327929|NCT04851626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25327930|NCT04851626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327931|NCT04852081|Tamoxifen|tamoxifen|mesh-list
25327932|NCT04852081|Letrozole|letrozole|mesh-list
25327933|NCT04852081|Fulvestrant|fulvestrant|mesh-list
25327934|NCT04852081|Palbociclib|palbociclib|mesh-list
25327935|NCT04852081|Anastrozole|anastrozole|mesh-list
25327936|NCT04852081|Exemestane|exemestane|mesh-list
25327937|NCT04852081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25327938|NCT04852081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25327939|NCT04852081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25327940|NCT04852081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25327941|NCT04852081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327942|NCT04852081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25327943|NCT04852081|Hormone Antagonists|hormone antagonists|mesh-ancestor
25327944|NCT04852081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25327945|NCT04852081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327946|NCT04852081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25327947|NCT04852081|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25327948|NCT04852081|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25327949|NCT04852081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25327950|NCT04852081|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25327951|NCT04852081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25327952|NCT04851457|Tirofiban|tirofiban|mesh-list
25327955|NCT04851457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327956|NCT04851457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25327957|NCT04851392|Dronabinol|dronabinol|mesh-list
25327958|NCT04851392|Cannabidiol|cannabidiol|mesh-list
25327959|NCT04851392|Anticonvulsants|anticonvulsants|mesh-ancestor
25327960|NCT04851392|Hallucinogens|hallucinogens|mesh-ancestor
25327961|NCT04851392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25327962|NCT04851392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25327963|NCT04851392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25327964|NCT04851392|Analgesics|analgesics|mesh-ancestor
25327965|NCT04851392|Sensory System Agents|sensory system agents|mesh-ancestor
25327966|NCT04851392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25327967|NCT04851392|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25327968|NCT04851392|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25327969|NCT04851392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25327970|NCT04851392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327971|NCT04851392|Hormones|hormones|mesh-ancestor
25327972|NCT04851392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25327973|NCT04851015|Trimethoprim|trimethoprim|mesh-list
25327974|NCT04851015|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25327975|NCT04851015|Sulfamethoxazole|sulfamethoxazole|mesh-list
25327976|NCT04851015|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25327977|NCT04851015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25327978|NCT04851015|Renal Agents|renal agents|mesh-ancestor
25327979|NCT04851015|Antimalarials|antimalarials|mesh-ancestor
25327980|NCT04851015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25327981|NCT04851015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25327982|NCT04851015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25327983|NCT04851015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829668|NCT00006247|Growth Inhibitors|growth inhibitors|mesh-ancestor
25327984|NCT04851015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327985|NCT04851015|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25327986|NCT04851015|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25327987|NCT04851015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25327988|NCT04851015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25327990|NCT04851158|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25327991|NCT04851158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25327992|NCT04851158|Antitubercular Agents|antitubercular agents|mesh-ancestor
25327993|NCT04851002|Mitogens|mitogens|mesh-list
25327994|NCT04851002|Mitosis Modulators|mitosis modulators|mesh-ancestor
25327995|NCT04851002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25327996|NCT04850911|Ketamine|ketamine|mesh-list
25327997|NCT04850911|Analgesics|analgesics|mesh-ancestor
25327998|NCT04850911|Sensory System Agents|sensory system agents|mesh-ancestor
25327999|NCT04850911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25328000|NCT04850911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328001|NCT04850911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25328002|NCT04850911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25328003|NCT04850911|Anesthetics, General|anesthetics, general|mesh-ancestor
25328004|NCT04850911|Anesthetics|anesthetics|mesh-ancestor
25328005|NCT04850911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25328006|NCT04850911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25328007|NCT04850911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25328008|NCT04850911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25328009|NCT04850911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328010|NCT04851132|Durvalumab|durvalumab|mesh-list
25328011|NCT04851132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25328012|NCT04851132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328013|NCT04850885|Dexamethasone|dexamethasone|mesh-list
25328014|NCT04850885|Lidocaine|lidocaine|mesh-list
25328015|NCT04850885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25328016|NCT04850885|Antiemetics|antiemetics|mesh-ancestor
25328017|NCT04850885|Autonomic Agents|autonomic agents|mesh-ancestor
25328018|NCT04850885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24584363|NCT00880178|Niacin|niacin|mesh-list
24472832|NCT00400738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24472833|NCT00400738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24472834|NCT00400738|Protease Inhibitors|protease inhibitors|mesh-ancestor
24472835|NCT00400738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774737|NCT01847599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25825555|NCT00005603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25328020|NCT04850885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25328021|NCT04850885|Glucocorticoids|glucocorticoids|mesh-ancestor
25328022|NCT04850885|Hormones|hormones|mesh-ancestor
25328023|NCT04850885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25328027|NCT04850885|Anesthetics|anesthetics|mesh-ancestor
25328028|NCT04850885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25328029|NCT04850885|Sensory System Agents|sensory system agents|mesh-ancestor
25328030|NCT04850885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25328031|NCT04850885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25328032|NCT04850885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25328033|NCT04850885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25328034|NCT04850885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328035|NCT04850950|Tenofovir|tenofovir|mesh-list
25328036|NCT04850950|Antiviral Agents|antiviral agents|mesh-ancestor
25328037|NCT04850950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25328038|NCT04850950|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25328039|NCT04850950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25328040|NCT04850950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25328041|NCT04850950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328042|NCT04850950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25328043|NCT04850950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25012359|NCT05217342|Diuretics|diuretics|mesh-list
24472937|NCT00401180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472938|NCT00401180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25328047|NCT04850755|Nivolumab|nivolumab|mesh-list
25328048|NCT04850755|Ipilimumab|ipilimumab|mesh-list
25328049|NCT04850755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25328050|NCT04850755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328051|NCT04850755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25328052|NCT04850755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207460|NCT03903016|Insulin Lispro|insulin lispro|mesh-list
25207461|NCT03903016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25207462|NCT03903016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826589|NCT02135263|Enalapril|enalapril|mesh-list
25198453|NCT02748564|Aldesleukin|aldesleukin|mesh-list
25198454|NCT02748564|Pembrolizumab|pembrolizumab|mesh-list
25198455|NCT02748564|Interleukin-2|interleukin-2|mesh-list
25198456|NCT02748564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25198457|NCT02748564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198458|NCT02748564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25198459|NCT02748564|Analgesics|analgesics|mesh-ancestor
25198460|NCT02748564|Sensory System Agents|sensory system agents|mesh-ancestor
25198461|NCT02748564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25198462|NCT02748564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198463|NCT02748564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25198464|NCT02748564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25198465|NCT02748564|Antiviral Agents|antiviral agents|mesh-ancestor
25198466|NCT02748564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25198467|NCT02748265|Epoprostenol|epoprostenol|mesh-list
25328053|NCT04850560|Decitabine|decitabine|mesh-list
25328054|NCT04850560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25328055|NCT04850560|Antimetabolites|antimetabolites|mesh-ancestor
25328056|NCT04850560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328057|NCT04850560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328058|NCT04850560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25328059|NCT04850404|Ropivacaine|ropivacaine|mesh-list
25328060|NCT04850404|Rocuronium|rocuronium|mesh-list
25328061|NCT04850404|Anesthetics, Local|anesthetics, local|mesh-ancestor
25328062|NCT04850404|Anesthetics|anesthetics|mesh-ancestor
25328063|NCT04850404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25328064|NCT04850404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328065|NCT04850404|Sensory System Agents|sensory system agents|mesh-ancestor
25328066|NCT04850404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25328067|NCT04850404|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25328068|NCT04850404|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25328069|NCT04850404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25328070|NCT04850417|Aspirin|aspirin|mesh-list
25328071|NCT04850417|Clopidogrel|clopidogrel|mesh-list
25328072|NCT04850417|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25328073|NCT04850417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25328074|NCT04850417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25328075|NCT04850417|Analgesics|analgesics|mesh-ancestor
25328076|NCT04850417|Sensory System Agents|sensory system agents|mesh-ancestor
25328077|NCT04850417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25328078|NCT04850417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328079|NCT04850417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25328080|NCT04850417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25328081|NCT04850417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25328082|NCT04850417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25328083|NCT04850417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328084|NCT04850417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25328085|NCT04850417|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25328086|NCT04850417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25328087|NCT04850417|Antipyretics|antipyretics|mesh-ancestor
25328088|NCT04850417|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25328089|NCT04850417|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25328090|NCT04850417|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25649288|NCT01490697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649289|NCT01490697|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25649290|NCT01490697|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25649291|NCT01490697|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25649292|NCT01490697|Contraceptive Agents|contraceptive agents|mesh-ancestor
25649293|NCT01490697|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25649294|NCT01490697|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25649295|NCT01490697|Hormone Antagonists|hormone antagonists|mesh-ancestor
25649296|NCT01490697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25649297|NCT01490697|Luteolytic Agents|luteolytic agents|mesh-ancestor
25649298|NCT01490697|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25649299|NCT01490697|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25649300|NCT01490697|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25649301|NCT01490697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25649302|NCT01490697|Renal Agents|renal agents|mesh-ancestor
25649303|NCT01490697|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25649304|NCT01490697|Antitubercular Agents|antitubercular agents|mesh-ancestor
25328092|NCT04850417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25328093|NCT04850417|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25328094|NCT04850417|Adrenergic Agents|adrenergic agents|mesh-ancestor
25328095|NCT04850235|Paclitaxel|paclitaxel|mesh-list
24841202|NCT02214771|Fidaxomicin|fidaxomicin|mesh-list
25328096|NCT04850235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25328097|NCT04850235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328098|NCT04850235|Tubulin Modulators|tubulin modulators|mesh-ancestor
25328099|NCT04850235|Antimitotic Agents|antimitotic agents|mesh-ancestor
25328100|NCT04850235|Mitosis Modulators|mitosis modulators|mesh-ancestor
25328101|NCT04850235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328102|NCT04850261|Nafarelin|nafarelin|mesh-list
25328103|NCT04850261|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25328104|NCT04850261|Fertility Agents|fertility agents|mesh-ancestor
25328105|NCT04850261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24628699|NCT01100892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628700|NCT01101009|Amlodipine|amlodipine|mesh-list
24628701|NCT01101009|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24628702|NCT01101009|Olmesartan|olmesartan|mesh-list
24628703|NCT01101009|Perindopril|perindopril|mesh-list
24628704|NCT01101009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24628705|NCT01101009|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24628706|NCT01101009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24628707|NCT01101009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628709|NCT01101009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328106|NCT04850261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328107|NCT04850040|Oxaliplatin|oxaliplatin|mesh-list
25328108|NCT04850040|Apatinib|apatinib|mesh-list
25328109|NCT04850040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328110|NCT04850040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25328111|NCT04850040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25328112|NCT04850040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328113|NCT04850001|Aspirin|aspirin|mesh-list
25328114|NCT04850001|Clopidogrel|clopidogrel|mesh-list
25328115|NCT04850001|Atorvastatin|atorvastatin|mesh-list
25328116|NCT04850001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25328117|NCT04850001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25328118|NCT04850001|Analgesics|analgesics|mesh-ancestor
25328119|NCT04850001|Sensory System Agents|sensory system agents|mesh-ancestor
25328120|NCT04850001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25328121|NCT04850001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328122|NCT04850001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25328123|NCT04850001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25328124|NCT04850001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25328125|NCT04850001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25328126|NCT04850001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328127|NCT04850001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25328128|NCT04850001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25328129|NCT04850001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25328130|NCT04850001|Antipyretics|antipyretics|mesh-ancestor
25328131|NCT04850001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25328132|NCT04850001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25328133|NCT04850001|Antimetabolites|antimetabolites|mesh-ancestor
25328134|NCT04850001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25328135|NCT04850001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25328136|NCT04850001|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25328137|NCT04850001|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25328138|NCT04850001|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25328139|NCT04850001|Purinergic Agents|purinergic agents|mesh-ancestor
25328140|NCT04850001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25328141|NCT04849845|Insulin|insulin|mesh-list
25328142|NCT04849845|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25328143|NCT04849845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25328144|NCT04849845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328145|NCT04849858|Bupivacaine|bupivacaine|mesh-list
25328146|NCT04849858|Anesthetics, Local|anesthetics, local|mesh-ancestor
25328147|NCT04849858|Anesthetics|anesthetics|mesh-ancestor
25328148|NCT04849858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25328149|NCT04849858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328150|NCT04849858|Sensory System Agents|sensory system agents|mesh-ancestor
25328151|NCT04849858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25328152|NCT04849533|Mycophenolic Acid|mycophenolic acid|mesh-list
25328153|NCT04849533|Prednisone|prednisone|mesh-list
25328154|NCT04849533|Everolimus|everolimus|mesh-list
25328155|NCT04849533|Abatacept|abatacept|mesh-list
25328156|NCT04849533|Thymoglobulin|thymoglobulin|mesh-list
25328157|NCT04849533|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25328159|NCT04849533|Glucocorticoids|glucocorticoids|mesh-ancestor
25328160|NCT04849533|Hormones|hormones|mesh-ancestor
25328161|NCT04849533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25328162|NCT04849533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328163|NCT04849533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25328164|NCT04849533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328165|NCT04849533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25328166|NCT04849533|Immunologic Factors|immunologic factors|mesh-ancestor
25328167|NCT04849533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25328168|NCT04849533|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25328169|NCT04849533|Antitubercular Agents|antitubercular agents|mesh-ancestor
25328170|NCT04849533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25328171|NCT04849533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25328172|NCT04849533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25328173|NCT04849533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444338|NCT00297505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24444339|NCT00297544|Sildenafil Citrate|sildenafil citrate|mesh-list
24444340|NCT00297544|Vasodilator Agents|vasodilator agents|mesh-ancestor
25825556|NCT00005603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24628740|NCT01101204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24628741|NCT01101204|Antimetabolites|antimetabolites|mesh-ancestor
24628742|NCT01101204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666138|NCT01317589|Analgesics|analgesics|mesh-ancestor
25328174|NCT04849533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25328175|NCT04849533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25328176|NCT04849390|Mometasone Furoate|mometasone furoate|mesh-list
25328177|NCT04849390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25328178|NCT04849390|Dermatologic Agents|dermatologic agents|mesh-ancestor
25328179|NCT04849390|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25328180|NCT04849013|Ketanserin|ketanserin|mesh-list
25328181|NCT04849013|Mescaline|mescaline|mesh-list
25328182|NCT04849013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25328183|NCT04849013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25328184|NCT04849013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25328185|NCT04849013|Serotonin Agents|serotonin agents|mesh-ancestor
25328186|NCT04849013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25328187|NCT04849013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328188|NCT04849013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328189|NCT04849013|Hallucinogens|hallucinogens|mesh-ancestor
25328190|NCT04849013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25328191|NCT04849013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25328192|NCT04849026|Clozapine|clozapine|mesh-list
25328193|NCT04849026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25328194|NCT04849026|Serotonin Agents|serotonin agents|mesh-ancestor
25328195|NCT04849026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25328196|NCT04849026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328197|NCT04849026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328198|NCT04849026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25328199|NCT04849026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25328200|NCT04849026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25328201|NCT04849026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25328202|NCT04849026|GABA Antagonists|gaba antagonists|mesh-ancestor
25328203|NCT04849026|GABA Agents|gaba agents|mesh-ancestor
25328204|NCT04849299|Cyclosporine|cyclosporine|mesh-list
25328205|NCT04849299|Cyclosporins|cyclosporins|mesh-list
25328206|NCT04849299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25328207|NCT04849299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328208|NCT04849299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25328209|NCT04849299|Immunologic Factors|immunologic factors|mesh-ancestor
25328210|NCT04849299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328211|NCT04849299|Antifungal Agents|antifungal agents|mesh-ancestor
25328212|NCT04849299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25328213|NCT04849299|Dermatologic Agents|dermatologic agents|mesh-ancestor
25328214|NCT04849299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25328215|NCT04849299|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25328216|NCT04848974|Cytarabine|cytarabine|mesh-list
25328217|NCT04848974|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
25328218|NCT04848974|Cladribine|cladribine|mesh-list
25328219|NCT04848974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25328220|NCT04848974|Antimetabolites|antimetabolites|mesh-ancestor
25328221|NCT04848974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328222|NCT04848974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328223|NCT04848974|Antiviral Agents|antiviral agents|mesh-ancestor
25328224|NCT04848974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24473136|NCT00402142|Vaccines|vaccines|mesh-list
24473138|NCT00402142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473140|NCT00402181|Siltuximab|siltuximab|mesh-list
25328241|NCT04848467|Vaccines|vaccines|mesh-list
25328242|NCT04848467|Immunologic Factors|immunologic factors|mesh-ancestor
25328243|NCT04848467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328244|NCT04848259|Dexamethasone|dexamethasone|mesh-list
25328245|NCT04848259|Dexamethasone acetate|dexamethasone acetate|mesh-list
25328246|NCT04848259|BB 1101|bb 1101|mesh-list
25328247|NCT04848259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25328248|NCT04848259|Antiemetics|antiemetics|mesh-ancestor
25328249|NCT04848259|Autonomic Agents|autonomic agents|mesh-ancestor
25328250|NCT04848259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25328251|NCT04848259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328252|NCT04848259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25328253|NCT04848259|Glucocorticoids|glucocorticoids|mesh-ancestor
25328254|NCT04848259|Hormones|hormones|mesh-ancestor
25328255|NCT04848259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25328256|NCT04848259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25328257|NCT04848259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328258|NCT04848259|Protease Inhibitors|protease inhibitors|mesh-ancestor
25328259|NCT04848259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25328260|NCT04848259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328261|NCT04848246|Bupropion|bupropion|mesh-list
25328262|NCT04848246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25328263|NCT04848246|Antidepressive Agents|antidepressive agents|mesh-ancestor
25328264|NCT04848246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25328265|NCT04848246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25328266|NCT04848246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25328267|NCT04848246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25328268|NCT04848246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328269|NCT04848246|Dopamine Agents|dopamine agents|mesh-ancestor
25328270|NCT04848246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25328271|NCT04848246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328272|NCT04848246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25328273|NCT04848246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25328274|NCT04848246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816475|NCT02077257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24473622|NCT00403533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25825557|NCT00005603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25825558|NCT00005603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24473656|NCT00403715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24473657|NCT00403728|Cyclosporine|cyclosporine|mesh-list
24473658|NCT00403728|Cyclosporins|cyclosporins|mesh-list
24473659|NCT00403728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473661|NCT00403728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25328275|NCT04848181|Cyproterone Acetate|cyproterone acetate|mesh-list
25328276|NCT04848181|Finasteride|finasteride|mesh-list
25328277|NCT04848181|Cyproterone|cyproterone|mesh-list
25328278|NCT04848181|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25328279|NCT04848181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25328280|NCT04848181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25328281|NCT04848181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328282|NCT04848181|Hormone Antagonists|hormone antagonists|mesh-ancestor
25328289|NCT04848181|Contraceptive Agents|contraceptive agents|mesh-ancestor
25328290|NCT04848181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25328296|NCT04847791|Lactoferrin|lactoferrin|mesh-list
25328297|NCT04847791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25328298|NCT04848064|Cyclophosphamide|cyclophosphamide|mesh-list
25328299|NCT04848064|Fludarabine|fludarabine|mesh-list
25328300|NCT04848064|Mogamulizumab|mogamulizumab|mesh-list
25328301|NCT04848064|Immunoglobulins|immunoglobulins|mesh-list
25328302|NCT04848064|Immunoglobulin G|immunoglobulin g|mesh-list
25328303|NCT04848064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25328304|NCT04848064|Immunologic Factors|immunologic factors|mesh-ancestor
25328305|NCT04848064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328306|NCT04848064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25328307|NCT04848064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25328308|NCT04848064|Alkylating Agents|alkylating agents|mesh-ancestor
25328309|NCT04848064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328310|NCT04848064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328311|NCT04848064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25328312|NCT04847921|Dalbavancin|dalbavancin|mesh-list
25328313|NCT04847921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25328314|NCT04847921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25328315|NCT04847895|Ranibizumab|ranibizumab|mesh-list
25328316|NCT04847895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25328317|NCT04847895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25328324|NCT04847947|Vitamins|vitamins|mesh-ancestor
25328325|NCT04847947|Micronutrients|micronutrients|mesh-ancestor
25328326|NCT04847947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328327|NCT04847947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25328328|NCT04847947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25328329|NCT04847752|Aspirin|aspirin|mesh-list
25328330|NCT04847752|Warfarin|warfarin|mesh-list
25328331|NCT04847752|Rivaroxaban|rivaroxaban|mesh-list
25328332|NCT04847752|Dabigatran|dabigatran|mesh-list
25328333|NCT04847752|Anticoagulants|anticoagulants|mesh-list
25328334|NCT04847752|Clopidogrel|clopidogrel|mesh-list
25328335|NCT04847752|Atorvastatin|atorvastatin|mesh-list
25328336|NCT04847752|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25328337|NCT04847752|Evolocumab|evolocumab|mesh-list
25328338|NCT04847752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
25328339|NCT04847752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25328340|NCT04847752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25328341|NCT04847752|Analgesics|analgesics|mesh-ancestor
25328342|NCT04847752|Sensory System Agents|sensory system agents|mesh-ancestor
25328343|NCT04847752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25328344|NCT04847752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328345|NCT04847752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25328346|NCT04847752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25328347|NCT04847752|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25328348|NCT04847752|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25328349|NCT04847752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328350|NCT04847752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25328351|NCT04847752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25328352|NCT04847752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25328353|NCT04847752|Antipyretics|antipyretics|mesh-ancestor
25328354|NCT04847752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25328355|NCT04847752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25328356|NCT04847752|Antimetabolites|antimetabolites|mesh-ancestor
25328357|NCT04847752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25328358|NCT04847752|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25328359|NCT04847752|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25328360|NCT04847752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25328361|NCT04847752|Purinergic Agents|purinergic agents|mesh-ancestor
25328362|NCT04847752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25328363|NCT04847752|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25328364|NCT04847752|Antithrombins|antithrombins|mesh-ancestor
25328365|NCT04847752|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25328366|NCT04847752|Protease Inhibitors|protease inhibitors|mesh-ancestor
25328367|NCT04847622|Remdesivir|remdesivir|mesh-list
25328368|NCT04847622|Antimetabolites|antimetabolites|mesh-ancestor
25328369|NCT04847622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328370|NCT04847622|Antiviral Agents|antiviral agents|mesh-ancestor
25328371|NCT04847622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25328372|NCT04847661|Mefloquine|mefloquine|mesh-list
25328373|NCT04847661|Antimalarials|antimalarials|mesh-ancestor
25328374|NCT04847661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25328375|NCT04847661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25328376|NCT04847661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25328377|NCT04847687|Methylprednisolone|methylprednisolone|mesh-list
25328378|NCT04847687|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25328379|NCT04847687|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25328380|NCT04847687|Prednisolone|prednisolone|mesh-list
25328381|NCT04847687|Prednisolone acetate|prednisolone acetate|mesh-list
25328382|NCT04847687|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25328383|NCT04847687|Prednisolone phosphate|prednisolone phosphate|mesh-list
25328384|NCT04847687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25328385|NCT04847687|Antiemetics|antiemetics|mesh-ancestor
25328386|NCT04847687|Autonomic Agents|autonomic agents|mesh-ancestor
25328387|NCT04847687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25328388|NCT04847687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328389|NCT04847687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25328391|NCT04847687|Hormones|hormones|mesh-ancestor
25328392|NCT04847687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25328393|NCT04847687|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25328394|NCT04847687|Protective Agents|protective agents|mesh-ancestor
25328395|NCT04847687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25328396|NCT04847687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328397|NCT04847375|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25328398|NCT04847375|Respiratory System Agents|respiratory system agents|mesh-ancestor
25328399|NCT04847024|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
25328400|NCT04847024|Parecoxib|parecoxib|mesh-list
25328401|NCT04847024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25328402|NCT04847024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25328403|NCT04847024|Analgesics|analgesics|mesh-ancestor
25328404|NCT04847024|Sensory System Agents|sensory system agents|mesh-ancestor
24938430|NCT04018703|Midazolam|midazolam|mesh-list
25328405|NCT04847024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25328406|NCT04847024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328407|NCT04847024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25328408|NCT04847024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25328409|NCT04847024|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25328410|NCT04847024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24550497|NCT00720811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24550498|NCT00720811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550500|NCT00720811|Antimalarials|antimalarials|mesh-ancestor
24550501|NCT00720811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24473898|NCT00404404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473899|NCT00404404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24473900|NCT00404404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25328411|NCT04847024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25328412|NCT04847024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328413|NCT04847245|Pregabalin|pregabalin|mesh-list
25328414|NCT04847245|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25328415|NCT04847245|Esketamine|esketamine|mesh-list
25328416|NCT04847245|Analgesics|analgesics|mesh-ancestor
25328417|NCT04847245|Sensory System Agents|sensory system agents|mesh-ancestor
25328418|NCT04847245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25328419|NCT04847245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328420|NCT04847245|Anticonvulsants|anticonvulsants|mesh-ancestor
25328421|NCT04847245|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25328422|NCT04847245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25328423|NCT04847245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328424|NCT04847245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25328425|NCT04847245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25328426|NCT04847245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25328427|NCT04847245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25328428|NCT04847245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25328429|NCT04847245|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25328430|NCT04847245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25328431|NCT04847245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25328432|NCT04847245|Antidepressive Agents|antidepressive agents|mesh-ancestor
25328433|NCT04847245|Dopamine Agents|dopamine agents|mesh-ancestor
25328434|NCT04846673|Thioctic Acid|thioctic acid|mesh-list
25328435|NCT04846673|Pregabalin|pregabalin|mesh-list
25328436|NCT04846673|Analgesics|analgesics|mesh-ancestor
25328437|NCT04846673|Sensory System Agents|sensory system agents|mesh-ancestor
25328438|NCT04846673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25328439|NCT04846673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328440|NCT04846673|Anticonvulsants|anticonvulsants|mesh-ancestor
25328441|NCT04846673|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25328442|NCT04846673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25328443|NCT04846673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328444|NCT04846673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25328445|NCT04846673|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25328446|NCT04846673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25328447|NCT04846673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25328448|NCT04846673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25328449|NCT04846673|Antioxidants|antioxidants|mesh-ancestor
25328450|NCT04846673|Protective Agents|protective agents|mesh-ancestor
25328451|NCT04846673|Vitamin B Complex|vitamin b complex|mesh-ancestor
25328452|NCT04846673|Vitamins|vitamins|mesh-ancestor
25328453|NCT04846673|Micronutrients|micronutrients|mesh-ancestor
25328454|NCT04846621|Calcium Channel Blockers|calcium channel blockers|mesh-list
25328455|NCT04846621|Calcium|calcium|mesh-list
25328456|NCT04846621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25328457|NCT04846621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328458|NCT04846621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25328459|NCT04846621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328460|NCT04846855|Anesthetics|anesthetics|mesh-list
25328461|NCT04846855|Anesthetics, Local|anesthetics, local|mesh-list
25328462|NCT04846855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25328463|NCT04846855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328464|NCT04846855|Sensory System Agents|sensory system agents|mesh-ancestor
25328465|NCT04846855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25328467|NCT04846634|Paclitaxel|paclitaxel|mesh-list
25328468|NCT04846634|Docetaxel|docetaxel|mesh-list
25328469|NCT04846634|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25328470|NCT04846634|Cisplatin|cisplatin|mesh-list
25328471|NCT04846634|Carboplatin|carboplatin|mesh-list
25328472|NCT04846634|Pemetrexed|pemetrexed|mesh-list
25328473|NCT04846634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25328474|NCT04846634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328475|NCT04846634|Tubulin Modulators|tubulin modulators|mesh-ancestor
25328476|NCT04846634|Antimitotic Agents|antimitotic agents|mesh-ancestor
25825559|NCT00005603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25825560|NCT00005603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550524|NCT00720915|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24550525|NCT00720915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24550530|NCT00721032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24550531|NCT00721032|Vasodilator Agents|vasodilator agents|mesh-ancestor
24550532|NCT00721032|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24550533|NCT00721032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25328477|NCT04846634|Mitosis Modulators|mitosis modulators|mesh-ancestor
25328478|NCT04846634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328479|NCT04846634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25328480|NCT04846634|Antimetabolites|antimetabolites|mesh-ancestor
25328481|NCT04846634|Antiviral Agents|antiviral agents|mesh-ancestor
25328482|NCT04846634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25328483|NCT04846634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25328484|NCT04846634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25328485|NCT04846634|Immunologic Factors|immunologic factors|mesh-ancestor
25328487|NCT04846634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25328488|NCT04846634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25328489|NCT04846452|Paclitaxel|paclitaxel|mesh-list
25328490|NCT04846452|Carboplatin|carboplatin|mesh-list
25328491|NCT04846452|Pemetrexed|pemetrexed|mesh-list
25328492|NCT04846452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25328493|NCT04846452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328494|NCT04846452|Tubulin Modulators|tubulin modulators|mesh-ancestor
25328495|NCT04846452|Antimitotic Agents|antimitotic agents|mesh-ancestor
25328496|NCT04846452|Mitosis Modulators|mitosis modulators|mesh-ancestor
25328497|NCT04846452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328498|NCT04846452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25328499|NCT04846452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25328500|NCT04846452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25328501|NCT04846894|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25328502|NCT04846894|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25328503|NCT04846894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328504|NCT04846335|Doxycycline|doxycycline|mesh-list
25328505|NCT04846335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25328506|NCT04846335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25328507|NCT04846335|Antimalarials|antimalarials|mesh-ancestor
25328508|NCT04846335|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25328509|NCT04846335|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25328510|NCT04845880|Myeloma Proteins|myeloma proteins|mesh-list
25328511|NCT04845880|Paraproteins|paraproteins|mesh-list
25328512|NCT04845880|Immunologic Factors|immunologic factors|mesh-ancestor
25328513|NCT04845880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328514|NCT04845737|Vitamin D|vitamin d|mesh-list
25328515|NCT04845737|Vitamins|vitamins|mesh-ancestor
25328516|NCT04845737|Micronutrients|micronutrients|mesh-ancestor
25328517|NCT04845737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328518|NCT04845737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25328519|NCT04845607|Amiodarone|amiodarone|mesh-list
25328520|NCT04845607|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25328521|NCT04845607|Vasodilator Agents|vasodilator agents|mesh-ancestor
25328522|NCT04845607|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25328523|NCT04845607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25328827|NCT04841096|Metformin|metformin|mesh-list
25328524|NCT04845607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328525|NCT04845607|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25328526|NCT04845607|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25328527|NCT04845607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25328528|NCT04845607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25328529|NCT04845607|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25328530|NCT04845607|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25328531|NCT04845607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25328532|NCT04845672|Chlorhexidine|chlorhexidine|mesh-list
25328533|NCT04845672|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25328534|NCT04845672|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25328535|NCT04845672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25328536|NCT04845672|Disinfectants|disinfectants|mesh-ancestor
25328537|NCT04845672|Dermatologic Agents|dermatologic agents|mesh-ancestor
25328538|NCT04845646|Itraconazole|itraconazole|mesh-list
25328539|NCT04845646|Phenytoin|phenytoin|mesh-list
25328540|NCT04845646|Antifungal Agents|antifungal agents|mesh-ancestor
25328541|NCT04845646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25328542|NCT04845646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25328543|NCT04845646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25328544|NCT04845646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25328545|NCT04845646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328546|NCT04845646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25328547|NCT04845646|Hormone Antagonists|hormone antagonists|mesh-ancestor
25328548|NCT04845646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25328549|NCT04845646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328550|NCT04845646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25328551|NCT04845646|Anticonvulsants|anticonvulsants|mesh-ancestor
25328552|NCT04845646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25328553|NCT04845646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25328554|NCT04845646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25328555|NCT04845646|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25328556|NCT04845646|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25328557|NCT04845399|Factor VIII|factor viii|mesh-list
25328558|NCT04845399|Coagulants|coagulants|mesh-ancestor
25328579|NCT04845061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25328580|NCT04845061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328581|NCT04845061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328582|NCT04844775|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
25328583|NCT04844775|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25328584|NCT04844775|Immunologic Factors|immunologic factors|mesh-ancestor
25328585|NCT04844775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328586|NCT04844385|Paclitaxel|paclitaxel|mesh-list
25328587|NCT04844385|Capecitabine|capecitabine|mesh-list
25328588|NCT04844385|Nedaplatin|nedaplatin|mesh-list
25328589|NCT04844385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25328590|NCT04844385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328591|NCT04844385|Tubulin Modulators|tubulin modulators|mesh-ancestor
25328592|NCT04844385|Antimitotic Agents|antimitotic agents|mesh-ancestor
25328593|NCT04844385|Mitosis Modulators|mitosis modulators|mesh-ancestor
25328594|NCT04844385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328595|NCT04844385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25328596|NCT04844385|Antimetabolites|antimetabolites|mesh-ancestor
25328604|NCT04844333|Anesthetics|anesthetics|mesh-list
25328605|NCT04844333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25328606|NCT04844333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328613|NCT04843982|Esketamine|esketamine|mesh-list
25328614|NCT04843982|Antidepressive Agents|antidepressive agents|mesh-ancestor
25328615|NCT04843982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25328616|NCT04843943|Bevacizumab|bevacizumab|mesh-list
25328617|NCT04843943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25328618|NCT04843943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328619|NCT04843943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25328620|NCT04843943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25328621|NCT04843943|Growth Substances|growth substances|mesh-ancestor
25328622|NCT04843943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328623|NCT04843943|Growth Inhibitors|growth inhibitors|mesh-ancestor
25328630|NCT04843839|Nepafenac|nepafenac|mesh-list
25328631|NCT04843839|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25328632|NCT04843839|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25328633|NCT04843839|Lubricant Eye Drops|lubricant eye drops|mesh-list
25328634|NCT04843839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25328635|NCT04843839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25328640|NCT04843839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328641|NCT04843839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25328642|NCT04843839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25328643|NCT04843839|Laxatives|laxatives|mesh-ancestor
25328644|NCT04843839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25328645|NCT04843553|Niacinamide|niacinamide|mesh-list
25328647|NCT04843553|Nicotinic Acids|nicotinic acids|mesh-list
25328648|NCT04843553|Vitamins|vitamins|mesh-ancestor
25328649|NCT04843553|Micronutrients|micronutrients|mesh-ancestor
25328650|NCT04843553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328651|NCT04843553|Vitamin B Complex|vitamin b complex|mesh-ancestor
25328652|NCT04843553|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25328653|NCT04843553|Antimetabolites|antimetabolites|mesh-ancestor
25328654|NCT04843553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328655|NCT04843553|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25328656|NCT04843553|Vasodilator Agents|vasodilator agents|mesh-ancestor
25328657|NCT04843449|Itraconazole|itraconazole|mesh-list
25328658|NCT04843449|Rifampin|rifampin|mesh-list
25328659|NCT04843449|Antifungal Agents|antifungal agents|mesh-ancestor
25328660|NCT04843449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25328661|NCT04843449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25328662|NCT04843449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25328663|NCT04843449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24585366|NCT00885287|Artemether|artemether|mesh-list
24759758|NCT01754701|Iron|iron|mesh-list
25328664|NCT04843449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328665|NCT04843449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25328666|NCT04843449|Hormone Antagonists|hormone antagonists|mesh-ancestor
25328667|NCT04843449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25328668|NCT04843449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328669|NCT04843449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25328670|NCT04843449|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25328671|NCT04843449|Antitubercular Agents|antitubercular agents|mesh-ancestor
25328672|NCT04843449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25328673|NCT04843449|Leprostatic Agents|leprostatic agents|mesh-ancestor
25328674|NCT04843449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25328675|NCT04843449|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25328676|NCT04843449|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25328677|NCT04843449|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25328678|NCT04843449|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25328679|NCT04843449|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25328680|NCT04843449|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24633430|NCT01129388|Omeprazole|omeprazole|mesh-list
25328681|NCT04843644|Propolis|propolis|mesh-list
25328682|NCT04843644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25328683|NCT04843280|Coal Tar|coal tar|mesh-list
25328684|NCT04843280|Keratolytic Agents|keratolytic agents|mesh-ancestor
25328685|NCT04843280|Dermatologic Agents|dermatologic agents|mesh-ancestor
25328686|NCT04843098|Paclitaxel|paclitaxel|mesh-list
25328687|NCT04843098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25328688|NCT04843098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328689|NCT04843098|Tubulin Modulators|tubulin modulators|mesh-ancestor
25328690|NCT04843098|Antimitotic Agents|antimitotic agents|mesh-ancestor
25328691|NCT04843098|Mitosis Modulators|mitosis modulators|mesh-ancestor
25328692|NCT04843098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328693|NCT04842825|Cetrorelix|cetrorelix|mesh-list
25328694|NCT04842825|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25328695|NCT04842825|Hormones|hormones|mesh-ancestor
25328696|NCT04842825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25328697|NCT04842825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328698|NCT04842825|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25328699|NCT04842825|Fertility Agents|fertility agents|mesh-ancestor
25328700|NCT04842825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25328701|NCT04842825|Hormone Antagonists|hormone antagonists|mesh-ancestor
25328702|NCT04843007|Pemetrexed|pemetrexed|mesh-list
25328703|NCT04843007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328704|NCT04843007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25328705|NCT04843007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759856|NCT01755286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24759857|NCT01755286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24759858|NCT01755286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24759859|NCT01755286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24759861|NCT01755286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759862|NCT01755286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759865|NCT01755299|Caffeine|caffeine|mesh-list
25328748|NCT04842487|Lenalidomide|lenalidomide|mesh-list
25328749|NCT04842487|Doxorubicin|doxorubicin|mesh-list
25328750|NCT04842487|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25328751|NCT04842487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25328752|NCT04842487|Immunologic Factors|immunologic factors|mesh-ancestor
25328753|NCT04842487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328754|NCT04842487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25328755|NCT04842487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25199004|NCT02744196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25199005|NCT02744196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25199006|NCT02744196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25199007|NCT02744183|Benzocaine|benzocaine|mesh-list
25199008|NCT02744183|Anesthetics, Local|anesthetics, local|mesh-ancestor
25199009|NCT02744183|Anesthetics|anesthetics|mesh-ancestor
25199014|NCT02744131|Metformin|metformin|mesh-list
25328756|NCT04842487|Alkylating Agents|alkylating agents|mesh-ancestor
25328757|NCT04842487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328758|NCT04842487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328759|NCT04842487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25328760|NCT04842487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25328761|NCT04842487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25328762|NCT04842487|Glucocorticoids|glucocorticoids|mesh-ancestor
25328763|NCT04842487|Hormones|hormones|mesh-ancestor
25328764|NCT04842487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25328765|NCT04842487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25328766|NCT04842487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25328767|NCT04842487|Tubulin Modulators|tubulin modulators|mesh-ancestor
25328768|NCT04842487|Antimitotic Agents|antimitotic agents|mesh-ancestor
25328769|NCT04842487|Mitosis Modulators|mitosis modulators|mesh-ancestor
25328770|NCT04842487|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25328771|NCT04842487|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25328772|NCT04842487|Growth Substances|growth substances|mesh-ancestor
25328786|NCT04842383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25328787|NCT04842383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328788|NCT04842383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25328789|NCT04842383|Parasympatholytics|parasympatholytics|mesh-ancestor
25328791|NCT04842526|Temozolomide|temozolomide|mesh-list
25328792|NCT04842526|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25328793|NCT04842526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25328794|NCT04842526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25328795|NCT04842526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328796|NCT04842526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328797|NCT04842526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25328798|NCT04842526|Alkylating Agents|alkylating agents|mesh-ancestor
25328799|NCT04842331|Nitric Oxide|nitric oxide|mesh-list
25328800|NCT04842331|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25328801|NCT04842331|Autonomic Agents|autonomic agents|mesh-ancestor
25328802|NCT04842331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25328803|NCT04842331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328804|NCT04842331|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25328805|NCT04842331|Respiratory System Agents|respiratory system agents|mesh-ancestor
25328806|NCT04842331|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25328807|NCT04842331|Antioxidants|antioxidants|mesh-ancestor
25328808|NCT04842331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328809|NCT04842331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25328810|NCT04842331|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25328811|NCT04842331|Vasodilator Agents|vasodilator agents|mesh-ancestor
25328812|NCT04842331|Gasotransmitters|gasotransmitters|mesh-ancestor
25328813|NCT04842331|Protective Agents|protective agents|mesh-ancestor
25328814|NCT04841980|Rifaximin|rifaximin|mesh-list
25328815|NCT04841980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25328816|NCT04841980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25328817|NCT04841980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24760007|NCT01755728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760008|NCT01755845|Paclitaxel|paclitaxel|mesh-list
24760009|NCT01755845|Cisplatin|cisplatin|mesh-list
24760010|NCT01755845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24760011|NCT01755845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328818|NCT04841720|Metformin|metformin|mesh-list
25328819|NCT04841720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25328820|NCT04841720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328824|NCT04841551|Deoxycholic Acid|deoxycholic acid|mesh-list
25328825|NCT04841551|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25328826|NCT04841551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25328829|NCT04841096|Vildagliptin|vildagliptin|mesh-list
25328830|NCT04841096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25649305|NCT01490697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25649306|NCT01490697|Antimetabolites|antimetabolites|mesh-ancestor
25649307|NCT01490697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649308|NCT01490723|Mycophenolic Acid|mycophenolic acid|mesh-list
25649309|NCT01490723|Rituximab|rituximab|mesh-list
25649310|NCT01490723|Methotrexate|methotrexate|mesh-list
25649311|NCT01490723|Fludarabine|fludarabine|mesh-list
25649312|NCT01490723|Fludarabine phosphate|fludarabine phosphate|mesh-list
25199081|NCT02743260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25199082|NCT02743260|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25199083|NCT02743260|Protective Agents|protective agents|mesh-ancestor
25199084|NCT02743260|Antiviral Agents|antiviral agents|mesh-ancestor
25199085|NCT02743260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25199086|NCT02743260|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25199087|NCT02743260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25199088|NCT02743260|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25199089|NCT02743260|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25199090|NCT02743260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25199091|NCT02743260|Antimetabolites|antimetabolites|mesh-ancestor
25199092|NCT02743260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25199093|NCT02743455|Vaccines|vaccines|mesh-list
25199094|NCT02743455|Immunologic Factors|immunologic factors|mesh-ancestor
25199095|NCT02743455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328831|NCT04841096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328832|NCT04841096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25328833|NCT04841096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25328834|NCT04841096|Immunologic Factors|immunologic factors|mesh-ancestor
25328835|NCT04841096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25328836|NCT04841096|Protease Inhibitors|protease inhibitors|mesh-ancestor
25328837|NCT04841096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25328838|NCT04841096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013823|NCT05221775|Lenvatinib|lenvatinib|mesh-list
24474723|NCT00407186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328839|NCT04841369|Vaccines|vaccines|mesh-list
25328840|NCT04841369|Immunologic Factors|immunologic factors|mesh-ancestor
25328985|NCT04839627|Progestins|progestins|mesh-ancestor
25328879|NCT04841018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25328881|NCT04841018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328882|NCT04841018|Protease Inhibitors|protease inhibitors|mesh-ancestor
25328883|NCT04841018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25328884|NCT04841018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328885|NCT04840992|Vaccines|vaccines|mesh-list
25328886|NCT04840992|Immunologic Factors|immunologic factors|mesh-ancestor
25328887|NCT04840992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328888|NCT04840550|Lansoprazole|lansoprazole|mesh-list
25328889|NCT04840550|Dexlansoprazole|dexlansoprazole|mesh-list
25328890|NCT04840550|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25328891|NCT04840550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25328892|NCT04840550|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25328893|NCT04840550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25328894|NCT04840550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328895|NCT04840394|Pembrolizumab|pembrolizumab|mesh-list
25328896|NCT04840394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25328897|NCT04840394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328898|NCT04840511|Lidocaine|lidocaine|mesh-list
25328899|NCT04840511|Anesthetics, Local|anesthetics, local|mesh-ancestor
25328900|NCT04840511|Anesthetics|anesthetics|mesh-ancestor
25328901|NCT04840511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25328902|NCT04840511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328903|NCT04840511|Sensory System Agents|sensory system agents|mesh-ancestor
25328904|NCT04840511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25328905|NCT04840511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25328906|NCT04840511|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24800382|NCT01975363|Curcumin|curcumin|mesh-list
25649313|NCT01490723|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25649314|NCT01490723|Tacrolimus|tacrolimus|mesh-list
25649315|NCT01490723|Thymoglobulin|thymoglobulin|mesh-list
25649316|NCT01490723|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25649317|NCT01490723|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25649318|NCT01490723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25649319|NCT01490723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649320|NCT01490723|Immunologic Factors|immunologic factors|mesh-ancestor
25649321|NCT01490723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649322|NCT01490723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25649323|NCT01490723|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25649324|NCT01490723|Abortifacient Agents|abortifacient agents|mesh-ancestor
25649325|NCT01490723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25649326|NCT01490723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25649327|NCT01490723|Antimetabolites|antimetabolites|mesh-ancestor
25649328|NCT01490723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207625|NCT03666000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25207626|NCT03664882|Fexofenadine|fexofenadine|mesh-list
25207627|NCT03664882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25207628|NCT03664882|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25207629|NCT03664882|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25207630|NCT03664882|Histamine Antagonists|histamine antagonists|mesh-ancestor
25207631|NCT03664882|Histamine Agents|histamine agents|mesh-ancestor
24760258|NCT01756989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25328907|NCT04840511|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25328908|NCT04840511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25328909|NCT04840511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328910|NCT04840745|Leuprolide|leuprolide|mesh-list
25328911|NCT04840745|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25328912|NCT04840745|Fertility Agents|fertility agents|mesh-ancestor
25328913|NCT04840745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25328914|NCT04840745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328915|NCT04840745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25328916|NCT04840745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328917|NCT04840238|Cholecalciferol|cholecalciferol|mesh-list
25328918|NCT04840238|Vitamin D|vitamin d|mesh-list
25328919|NCT04840238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25328920|NCT04840238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328921|NCT04840238|Vitamins|vitamins|mesh-ancestor
25328922|NCT04840238|Micronutrients|micronutrients|mesh-ancestor
25328923|NCT04840238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25328924|NCT04840290|Paclitaxel|paclitaxel|mesh-list
25328925|NCT04840290|Carboplatin|carboplatin|mesh-list
25328926|NCT04840290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25328927|NCT04840290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328928|NCT04840290|Tubulin Modulators|tubulin modulators|mesh-ancestor
25328929|NCT04840290|Antimitotic Agents|antimitotic agents|mesh-ancestor
25328930|NCT04840290|Mitosis Modulators|mitosis modulators|mesh-ancestor
25328931|NCT04840290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328932|NCT04839913|Antibodies|antibodies|mesh-list
25328933|NCT04839913|Immunologic Factors|immunologic factors|mesh-ancestor
25328934|NCT04839913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328935|NCT04839666|Propofol|propofol|mesh-list
25328936|NCT04839666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25328937|NCT04839666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25328939|NCT04839666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25328940|NCT04839666|Anesthetics, General|anesthetics, general|mesh-ancestor
25328941|NCT04839666|Anesthetics|anesthetics|mesh-ancestor
25328942|NCT04839731|Fluorouracil|fluorouracil|mesh-list
25328943|NCT04839731|Calcipotriene|calcipotriene|mesh-list
25328944|NCT04839731|Antimetabolites|antimetabolites|mesh-ancestor
25328945|NCT04839731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328946|NCT04839731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25328947|NCT04839731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25328948|NCT04839731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25328949|NCT04839731|Immunologic Factors|immunologic factors|mesh-ancestor
25328950|NCT04839731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328951|NCT04839731|Dermatologic Agents|dermatologic agents|mesh-ancestor
25328952|NCT04839653|Vancomycin|vancomycin|mesh-list
25328953|NCT04839653|Gentamicins|gentamicins|mesh-list
25328954|NCT04839653|Ceftriaxone|ceftriaxone|mesh-list
25328955|NCT04839653|Polymyxins|polymyxins|mesh-list
25328956|NCT04839653|Cefotaxime|cefotaxime|mesh-list
25328957|NCT04839653|Cefoxitin|cefoxitin|mesh-list
25328958|NCT04839653|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25328959|NCT04839653|Polymyxin B|polymyxin b|mesh-list
25328960|NCT04839653|Amphotericin B|amphotericin b|mesh-list
25328961|NCT04839653|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25328962|NCT04839653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25328963|NCT04839653|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25328964|NCT04839653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25328965|NCT04839653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25328966|NCT04839653|Amebicides|amebicides|mesh-ancestor
25649329|NCT01490723|Dermatologic Agents|dermatologic agents|mesh-ancestor
25649330|NCT01490723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649331|NCT01490723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25649332|NCT01490723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25649333|NCT01490723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25649334|NCT01490723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25649335|NCT01490723|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25328967|NCT04839653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25328968|NCT04839653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25328969|NCT04839653|Antifungal Agents|antifungal agents|mesh-ancestor
25328970|NCT04839536|Sevoflurane|sevoflurane|mesh-list
25825561|NCT00005603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25825562|NCT00005603|Abortifacient Agents|abortifacient agents|mesh-ancestor
25199107|NCT02743234|Vancomycin|vancomycin|mesh-list
25199108|NCT02743234|Fidaxomicin|fidaxomicin|mesh-list
25199109|NCT02743234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25199110|NCT02743234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25328971|NCT04839536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25328972|NCT04839536|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25328973|NCT04839536|Anesthetics, General|anesthetics, general|mesh-ancestor
25328974|NCT04839536|Anesthetics|anesthetics|mesh-ancestor
25328975|NCT04839536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25328976|NCT04839536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328977|NCT04839549|Fluorometholone|fluorometholone|mesh-list
25328978|NCT04839549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24760507|NCT01758263|Sympatholytics|sympatholytics|mesh-ancestor
24760508|NCT01758263|Autonomic Agents|autonomic agents|mesh-ancestor
24760509|NCT01758263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24898154|NCT04418089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25825563|NCT00005603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25825564|NCT00005603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25328979|NCT04839549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328980|NCT04839549|Glucocorticoids|glucocorticoids|mesh-ancestor
25328981|NCT04839549|Hormones|hormones|mesh-ancestor
25328982|NCT04839549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25328983|NCT04839549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25328984|NCT04839627|Progesterone|progesterone|mesh-list
25328989|NCT04839445|Anesthetics|anesthetics|mesh-list
25328990|NCT04839445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25328991|NCT04839445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328992|NCT04839224|Phenylephrine|phenylephrine|mesh-list
25328993|NCT04839224|Oxymetazoline|oxymetazoline|mesh-list
25328994|NCT04839224|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25328995|NCT04839224|Mydriatics|mydriatics|mesh-ancestor
25328996|NCT04839224|Autonomic Agents|autonomic agents|mesh-ancestor
25328997|NCT04839224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25328998|NCT04839224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25328999|NCT04839224|Sympathomimetics|sympathomimetics|mesh-ancestor
25329000|NCT04839224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25329001|NCT04839224|Nasal Decongestants|nasal decongestants|mesh-ancestor
25329002|NCT04839224|Respiratory System Agents|respiratory system agents|mesh-ancestor
25329003|NCT04839224|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25329004|NCT04839224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25329005|NCT04839224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25329006|NCT04839224|Adrenergic Agents|adrenergic agents|mesh-ancestor
25329007|NCT04839224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25329008|NCT04839224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329009|NCT04839224|Protective Agents|protective agents|mesh-ancestor
25329010|NCT04839471|Afatinib|afatinib|mesh-list
25329011|NCT04839471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329012|NCT04839471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25329013|NCT04839471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25329014|NCT04839471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329015|NCT04839198|Nicotine|nicotine|mesh-list
25329016|NCT04839198|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25329017|NCT04839198|Autonomic Agents|autonomic agents|mesh-ancestor
25329018|NCT04839198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25329019|NCT04839198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329020|NCT04839198|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25329021|NCT04839198|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25329022|NCT04839198|Cholinergic Agents|cholinergic agents|mesh-ancestor
25329023|NCT04839198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25329024|NCT04839198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329025|NCT04839237|Metformin|metformin|mesh-list
25329026|NCT04839237|Liraglutide|liraglutide|mesh-list
25329027|NCT04839237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25329028|NCT04839237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329029|NCT04839237|Incretins|incretins|mesh-ancestor
25329030|NCT04839237|Hormones|hormones|mesh-ancestor
25329031|NCT04839237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25010580|NCT03667716|Nivolumab|nivolumab|mesh-list
25014062|NCT05085873|Midazolam|midazolam|mesh-list
25014063|NCT05085873|Sodium Oxybate|sodium oxybate|mesh-list
25649336|NCT01490723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25649337|NCT01490723|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25649338|NCT01490723|Antitubercular Agents|antitubercular agents|mesh-ancestor
25649339|NCT01490723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25825565|NCT00005603|Antimetabolites|antimetabolites|mesh-ancestor
25825566|NCT00005603|Dermatologic Agents|dermatologic agents|mesh-ancestor
25825567|NCT00005603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25014064|NCT05085873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25014065|NCT05085873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25014066|NCT05085873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25014067|NCT05085873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014068|NCT05085873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25329035|NCT04838704|Mycophenolic Acid|mycophenolic acid|mesh-list
25329036|NCT04838704|Methotrexate|methotrexate|mesh-list
25329037|NCT04838704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25329038|NCT04838704|Abortifacient Agents|abortifacient agents|mesh-ancestor
25329039|NCT04838704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25329040|NCT04838704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329041|NCT04838704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25329042|NCT04838704|Antimetabolites|antimetabolites|mesh-ancestor
25329043|NCT04838704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329044|NCT04838704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329045|NCT04838704|Dermatologic Agents|dermatologic agents|mesh-ancestor
25329046|NCT04838704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25329047|NCT04838704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25329048|NCT04838704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25329049|NCT04838704|Immunologic Factors|immunologic factors|mesh-ancestor
25329050|NCT04838704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25329051|NCT04838704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25329072|NCT04838665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25329073|NCT04838665|Adrenergic Agents|adrenergic agents|mesh-ancestor
25329074|NCT04838665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25329075|NCT04838665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329076|NCT04838665|Protective Agents|protective agents|mesh-ancestor
25329077|NCT04838665|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25329078|NCT04838665|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25329079|NCT04838665|Cholinergic Agents|cholinergic agents|mesh-ancestor
25329080|NCT04838665|Parasympatholytics|parasympatholytics|mesh-ancestor
25329081|NCT04838860|Siltuximab|siltuximab|mesh-list
25329082|NCT04838860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329090|NCT04838145|Ribavirin|ribavirin|mesh-list
25329091|NCT04838145|Pleconaril|pleconaril|mesh-list
25329092|NCT04838145|Antimetabolites|antimetabolites|mesh-ancestor
25329093|NCT04838145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329094|NCT04838145|Antiviral Agents|antiviral agents|mesh-ancestor
25329095|NCT04838145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25329096|NCT04838132|Ropivacaine|ropivacaine|mesh-list
25329097|NCT04838132|Anesthetics, Local|anesthetics, local|mesh-ancestor
25329098|NCT04838132|Anesthetics|anesthetics|mesh-ancestor
25329099|NCT04838132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25329100|NCT04838132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329101|NCT04838132|Sensory System Agents|sensory system agents|mesh-ancestor
25329102|NCT04838132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25329103|NCT04837885|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25329104|NCT04837885|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25329105|NCT04837885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329120|NCT04838080|Vaccines|vaccines|mesh-list
25329121|NCT04838080|Immunologic Factors|immunologic factors|mesh-ancestor
25329123|NCT04837664|Nystatin|nystatin|mesh-list
25329124|NCT04837664|Curcumin|curcumin|mesh-list
25329125|NCT04837664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25329126|NCT04837664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25329127|NCT04837664|Analgesics|analgesics|mesh-ancestor
25329128|NCT04837664|Sensory System Agents|sensory system agents|mesh-ancestor
25329129|NCT04837664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25329148|NCT04837131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329168|NCT04837170|Ketamine|ketamine|mesh-list
25329169|NCT04837170|Esketamine|esketamine|mesh-list
25329170|NCT04837170|Analgesics|analgesics|mesh-ancestor
25329171|NCT04837170|Sensory System Agents|sensory system agents|mesh-ancestor
25329172|NCT04837170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25329173|NCT04837170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329174|NCT04837170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25329175|NCT04837170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25329176|NCT04837170|Anesthetics, General|anesthetics, general|mesh-ancestor
25329177|NCT04837170|Anesthetics|anesthetics|mesh-ancestor
25649340|NCT01490723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25649341|NCT01490723|Alkylating Agents|alkylating agents|mesh-ancestor
25329178|NCT04837170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25649342|NCT01490788|Amitriptyline|amitriptyline|mesh-list
25329179|NCT04837170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25329180|NCT04837170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25329181|NCT04837170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25329182|NCT04837170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329183|NCT04837170|Antidepressive Agents|antidepressive agents|mesh-ancestor
25329184|NCT04837170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25329185|NCT04837261|Propranolol|propranolol|mesh-list
25329186|NCT04837261|Amiodarone|amiodarone|mesh-list
25329187|NCT04837261|Flecainide|flecainide|mesh-list
25329188|NCT04837261|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25329189|NCT04837261|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25329190|NCT04837261|Adrenergic Agents|adrenergic agents|mesh-ancestor
25329191|NCT04837261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25329192|NCT04837261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329193|NCT04837261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329194|NCT04837261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25329195|NCT04837261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25329196|NCT04837261|Vasodilator Agents|vasodilator agents|mesh-ancestor
25329197|NCT04837261|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25329198|NCT04837261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25329199|NCT04837261|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25329200|NCT04837261|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25329201|NCT04837261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25329202|NCT04837261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25329203|NCT04837261|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25329204|NCT04837261|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25329228|NCT04836806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329230|NCT04836806|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25329231|NCT04836806|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25329232|NCT04836728|Paclitaxel|paclitaxel|mesh-list
25329233|NCT04836728|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25329234|NCT04836728|Carboplatin|carboplatin|mesh-list
25329235|NCT04836728|Pemetrexed|pemetrexed|mesh-list
25329236|NCT04836728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25329237|NCT04836728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25329238|NCT04836728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329239|NCT04836728|Tubulin Modulators|tubulin modulators|mesh-ancestor
25329240|NCT04836728|Antimitotic Agents|antimitotic agents|mesh-ancestor
25329241|NCT04836728|Mitosis Modulators|mitosis modulators|mesh-ancestor
25329242|NCT04836728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329243|NCT04836728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25329244|NCT04836728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25329245|NCT04836728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25329246|NCT04836533|Antidepressive Agents|antidepressive agents|mesh-list
25329247|NCT04836533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24775476|NCT01852539|Analgesics|analgesics|mesh-ancestor
25329257|NCT04836819|Lidocaine|lidocaine|mesh-list
25329258|NCT04836819|Dexmedetomidine|dexmedetomidine|mesh-list
25329259|NCT04836819|Ketamine|ketamine|mesh-list
25329260|NCT04836819|Anesthetics, Local|anesthetics, local|mesh-ancestor
25329261|NCT04836819|Anesthetics|anesthetics|mesh-ancestor
25329262|NCT04836819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25329263|NCT04836819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329264|NCT04836819|Sensory System Agents|sensory system agents|mesh-ancestor
25329265|NCT04836819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25329266|NCT04836819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25329267|NCT04836819|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25329268|NCT04836819|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25329269|NCT04836819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25329270|NCT04836819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329271|NCT04836819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25329272|NCT04836819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25329273|NCT04836819|Analgesics|analgesics|mesh-ancestor
25329274|NCT04836819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25329275|NCT04836819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25329276|NCT04836819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24761326|NCT01762306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25329296|NCT04836507|Cyclophosphamide|cyclophosphamide|mesh-list
25329297|NCT04836507|Fludarabine|fludarabine|mesh-list
25329298|NCT04836507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25329299|NCT04836507|Immunologic Factors|immunologic factors|mesh-ancestor
25329300|NCT04836507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329301|NCT04836507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25649343|NCT01490788|Cyclobenzaprine|cyclobenzaprine|mesh-list
25199134|NCT02743104|Anesthetics, Local|anesthetics, local|mesh-ancestor
25199135|NCT02743104|Anesthetics|anesthetics|mesh-ancestor
25199136|NCT02743104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25329302|NCT04836507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25329303|NCT04836507|Alkylating Agents|alkylating agents|mesh-ancestor
25329304|NCT04836507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329305|NCT04836507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329306|NCT04836507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25329307|NCT04836078|Chitosan|chitosan|mesh-list
25329308|NCT04836078|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25329309|NCT04836078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25329310|NCT04836078|Antimetabolites|antimetabolites|mesh-ancestor
25329311|NCT04836078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329312|NCT04836078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25329313|NCT04836078|Chelating Agents|chelating agents|mesh-ancestor
25329314|NCT04836078|Sequestering Agents|sequestering agents|mesh-ancestor
25329315|NCT04836078|Hemostatics|hemostatics|mesh-ancestor
25329316|NCT04836078|Coagulants|coagulants|mesh-ancestor
25329317|NCT04836156|Cyclophosphamide|cyclophosphamide|mesh-list
25329318|NCT04836156|Carboplatin|carboplatin|mesh-list
25329319|NCT04836156|Docetaxel|docetaxel|mesh-list
25329320|NCT04836156|Epirubicin|epirubicin|mesh-list
25329321|NCT04836156|Phenobarbital|phenobarbital|mesh-list
25329322|NCT04836156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25329323|NCT04836156|Immunologic Factors|immunologic factors|mesh-ancestor
25329324|NCT04836156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329325|NCT04836156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25329326|NCT04836156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25329327|NCT04836156|Alkylating Agents|alkylating agents|mesh-ancestor
25329328|NCT04836156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329329|NCT04836156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329330|NCT04836156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25329331|NCT04836156|Tubulin Modulators|tubulin modulators|mesh-ancestor
25329332|NCT04836156|Antimitotic Agents|antimitotic agents|mesh-ancestor
25329333|NCT04836156|Mitosis Modulators|mitosis modulators|mesh-ancestor
25329334|NCT04836156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25329335|NCT04836156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25329336|NCT04836156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25329337|NCT04836156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25329338|NCT04836156|Anticonvulsants|anticonvulsants|mesh-ancestor
25329339|NCT04836156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25329340|NCT04836156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25329341|NCT04836156|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25329342|NCT04836156|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25329343|NCT04836156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25329344|NCT04836156|GABA Modulators|gaba modulators|mesh-ancestor
25329345|NCT04836156|GABA Agents|gaba agents|mesh-ancestor
25329346|NCT04836156|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25329347|NCT04836156|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25329404|NCT04835259|Selenium|selenium|mesh-list
25329405|NCT04835259|Antioxidants|antioxidants|mesh-ancestor
25329406|NCT04835259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329407|NCT04835259|Protective Agents|protective agents|mesh-ancestor
25329408|NCT04835259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329409|NCT04835259|Trace Elements|trace elements|mesh-ancestor
25329410|NCT04835259|Micronutrients|micronutrients|mesh-ancestor
25329411|NCT04835233|Methyldopa|methyldopa|mesh-list
25329412|NCT04835233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25329413|NCT04835233|Sympatholytics|sympatholytics|mesh-ancestor
25329414|NCT04835233|Autonomic Agents|autonomic agents|mesh-ancestor
25329415|NCT04835233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25329416|NCT04835233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329417|NCT04835233|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25329418|NCT04835233|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25329419|NCT04835233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25329420|NCT04835233|Adrenergic Agents|adrenergic agents|mesh-ancestor
25329497|NCT04834440|Anesthetics, Local|anesthetics, local|mesh-ancestor
25329424|NCT04834986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329425|NCT04834986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25329426|NCT04834986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408486|NCT03437746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25649344|NCT01490788|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25649345|NCT01490788|Antidepressive Agents|antidepressive agents|mesh-ancestor
25649346|NCT01490788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25649347|NCT01490788|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25329427|NCT04834986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329430|NCT04835064|Folfirinox|folfirinox|mesh-list
25329431|NCT04835064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25329432|NCT04835064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329433|NCT04835064|Tubulin Modulators|tubulin modulators|mesh-ancestor
25329434|NCT04835064|Antimitotic Agents|antimitotic agents|mesh-ancestor
25329435|NCT04835064|Mitosis Modulators|mitosis modulators|mesh-ancestor
25329436|NCT04835064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329437|NCT04835064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25329438|NCT04835064|Antimetabolites|antimetabolites|mesh-ancestor
25329439|NCT04835064|Antiviral Agents|antiviral agents|mesh-ancestor
25329440|NCT04835064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25329441|NCT04835064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25329442|NCT04835064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25329443|NCT04835064|Immunologic Factors|immunologic factors|mesh-ancestor
25329444|NCT04835064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329445|NCT04835116|Acetaminophen|acetaminophen|mesh-list
25329446|NCT04835116|Tramadol|tramadol|mesh-list
25329447|NCT04835116|Analgesics|analgesics|mesh-list
25329448|NCT04835116|Orphenadrine|orphenadrine|mesh-list
25329449|NCT04835116|Dimenhydrinate|dimenhydrinate|mesh-list
25329450|NCT04835116|Bupivacaine|bupivacaine|mesh-list
25329451|NCT04835116|Anesthetics, Local|anesthetics, local|mesh-ancestor
25329452|NCT04835116|Anesthetics|anesthetics|mesh-ancestor
25329453|NCT04835116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25329454|NCT04835116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329455|NCT04835116|Sensory System Agents|sensory system agents|mesh-ancestor
25329456|NCT04835116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25329457|NCT04835116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25329458|NCT04835116|Antipyretics|antipyretics|mesh-ancestor
25329459|NCT04835116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25329460|NCT04835116|Narcotics|narcotics|mesh-ancestor
25329461|NCT04835116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25329462|NCT04835116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25329463|NCT04835116|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25329464|NCT04835116|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25329465|NCT04835116|Parasympatholytics|parasympatholytics|mesh-ancestor
25329466|NCT04835116|Autonomic Agents|autonomic agents|mesh-ancestor
25329467|NCT04835116|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25329468|NCT04835116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25329469|NCT04835116|Cholinergic Agents|cholinergic agents|mesh-ancestor
25329470|NCT04835116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25329471|NCT04835116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329472|NCT04835116|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
25329473|NCT04835116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25329474|NCT04835116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25329475|NCT04835116|Antiemetics|antiemetics|mesh-ancestor
25329476|NCT04835116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25329477|NCT04835116|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25329478|NCT04835116|Histamine Antagonists|histamine antagonists|mesh-ancestor
25329479|NCT04835116|Histamine Agents|histamine agents|mesh-ancestor
25329483|NCT04834791|Letrozole|letrozole|mesh-list
25329484|NCT04834791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329485|NCT04834791|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25329486|NCT04834791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25329487|NCT04834791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25329488|NCT04834791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329489|NCT04834791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25329490|NCT04834791|Hormone Antagonists|hormone antagonists|mesh-ancestor
25329491|NCT04834791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25329492|NCT04834791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329493|NCT04835025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25329494|NCT04835025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329495|NCT04835025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329496|NCT04834440|Ropivacaine|ropivacaine|mesh-list
25329503|NCT04834752|Esomeprazole|esomeprazole|mesh-list
25329504|NCT04834752|Omeprazole|omeprazole|mesh-list
25329505|NCT04834752|Rabeprazole|rabeprazole|mesh-list
24967793|NCT03756727|Vitamins|vitamins|mesh-ancestor
25329506|NCT04834752|Pantoprazole|pantoprazole|mesh-list
25329507|NCT04834752|Lansoprazole|lansoprazole|mesh-list
25329508|NCT04834752|Dexlansoprazole|dexlansoprazole|mesh-list
25329509|NCT04834752|Famotidine|famotidine|mesh-list
25329510|NCT04834752|Ranitidine|ranitidine|mesh-list
25329511|NCT04834752|Cimetidine|cimetidine|mesh-list
25329512|NCT04834752|Nizatidine|nizatidine|mesh-list
25329513|NCT04834752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25825568|NCT00005603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25329514|NCT04834752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25329515|NCT04834752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25329516|NCT04834752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25329517|NCT04834752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329518|NCT04834752|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25329519|NCT04834752|Histamine Antagonists|histamine antagonists|mesh-ancestor
25329520|NCT04834752|Histamine Agents|histamine agents|mesh-ancestor
25329521|NCT04834752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25329522|NCT04834752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329523|NCT04834752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25329524|NCT04834752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25329525|NCT04834674|Apatinib|apatinib|mesh-list
25329526|NCT04834674|Antibodies|antibodies|mesh-list
25329527|NCT04834674|Immunologic Factors|immunologic factors|mesh-ancestor
25329528|NCT04834674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329529|NCT04834674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329530|NCT04834674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25329531|NCT04834674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25329532|NCT04834674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761594|NCT01763463|Autonomic Agents|autonomic agents|mesh-ancestor
25329533|NCT04834427|Ketamine|ketamine|mesh-list
25329534|NCT04834427|Esketamine|esketamine|mesh-list
25329535|NCT04834427|Analgesics|analgesics|mesh-ancestor
25329536|NCT04834427|Sensory System Agents|sensory system agents|mesh-ancestor
25329537|NCT04834427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25329538|NCT04834427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329539|NCT04834427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25329540|NCT04834427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25329541|NCT04834427|Anesthetics, General|anesthetics, general|mesh-ancestor
25329542|NCT04834427|Anesthetics|anesthetics|mesh-ancestor
25329543|NCT04834427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25329544|NCT04834427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25329545|NCT04834427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25329546|NCT04834427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25329547|NCT04834427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329548|NCT04834427|Antidepressive Agents|antidepressive agents|mesh-ancestor
25329549|NCT04834427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25329552|NCT04834375|Dexamethasone|dexamethasone|mesh-list
25329553|NCT04834375|Dexamethasone acetate|dexamethasone acetate|mesh-list
25329554|NCT04834375|BB 1101|bb 1101|mesh-list
25329555|NCT04834375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25329556|NCT04834375|Antiemetics|antiemetics|mesh-ancestor
25329557|NCT04834375|Autonomic Agents|autonomic agents|mesh-ancestor
25329558|NCT04834375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25329559|NCT04834375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329560|NCT04834375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25329561|NCT04834375|Glucocorticoids|glucocorticoids|mesh-ancestor
25329562|NCT04834375|Hormones|hormones|mesh-ancestor
25329563|NCT04834375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25329564|NCT04834375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25329565|NCT04834375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329566|NCT04834375|Protease Inhibitors|protease inhibitors|mesh-ancestor
25329567|NCT04834375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25329568|NCT04834375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329592|NCT04833738|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25329593|NCT04833738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25329594|NCT04833738|Glucocorticoids|glucocorticoids|mesh-ancestor
25329595|NCT04833738|Hormones|hormones|mesh-ancestor
25329596|NCT04833738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25329597|NCT04833738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329598|NCT04833738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25329599|NCT04833738|Immunologic Factors|immunologic factors|mesh-ancestor
25329600|NCT04833738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25329601|NCT04833738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329602|NCT04833738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25329603|NCT04833738|Viscosupplements|viscosupplements|mesh-ancestor
25329604|NCT04833738|Protective Agents|protective agents|mesh-ancestor
25329605|NCT04833777|Lidocaine|lidocaine|mesh-list
25329606|NCT04833777|Bupivacaine|bupivacaine|mesh-list
25649348|NCT01490788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649349|NCT01490788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25649350|NCT01490788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25329607|NCT04833777|Anesthetics, Local|anesthetics, local|mesh-list
25011078|NCT01971970|Adalimumab|adalimumab|mesh-list
25329608|NCT04833777|Anesthetics|anesthetics|mesh-list
25329609|NCT04833777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25329610|NCT04833777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329611|NCT04833777|Sensory System Agents|sensory system agents|mesh-ancestor
25329612|NCT04833777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25329613|NCT04833777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25329614|NCT04833777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25329615|NCT04833777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25329616|NCT04833777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25329617|NCT04833777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329618|NCT04833205|Nimotuzumab|nimotuzumab|mesh-list
25329619|NCT04833205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25329620|NCT04833205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329621|NCT04833218|Propranolol|propranolol|mesh-list
25329622|NCT04833218|Clonidine|clonidine|mesh-list
25329623|NCT04833218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25329624|NCT04833218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25329625|NCT04833218|Adrenergic Agents|adrenergic agents|mesh-ancestor
25329626|NCT04833218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25329627|NCT04833218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329628|NCT04833218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329629|NCT04833218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25329630|NCT04833218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25329631|NCT04833218|Vasodilator Agents|vasodilator agents|mesh-ancestor
25329632|NCT04833218|Analgesics|analgesics|mesh-ancestor
25329633|NCT04833218|Sensory System Agents|sensory system agents|mesh-ancestor
25329634|NCT04833218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25329635|NCT04833218|Sympatholytics|sympatholytics|mesh-ancestor
25329636|NCT04833218|Autonomic Agents|autonomic agents|mesh-ancestor
25329637|NCT04833218|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25329638|NCT04833218|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25329639|NCT04833218|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25329666|NCT04833374|Prednisolone phosphate|prednisolone phosphate|mesh-list
25329667|NCT04833374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25329668|NCT04833374|Glucocorticoids|glucocorticoids|mesh-ancestor
25329669|NCT04833374|Hormones|hormones|mesh-ancestor
25329670|NCT04833374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25329671|NCT04833374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329672|NCT04833374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25329673|NCT04833374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329674|NCT04833374|Antiemetics|antiemetics|mesh-ancestor
25329675|NCT04833374|Autonomic Agents|autonomic agents|mesh-ancestor
25329676|NCT04833374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25329677|NCT04833374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25329678|NCT04833374|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25825569|NCT00005603|Antiviral Agents|antiviral agents|mesh-ancestor
25329679|NCT04833374|Protective Agents|protective agents|mesh-ancestor
25329680|NCT04833101|Vaccines|vaccines|mesh-list
25329681|NCT04833101|Immunologic Factors|immunologic factors|mesh-ancestor
25329682|NCT04833101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329683|NCT04833036|Irinotecan|irinotecan|mesh-list
25329684|NCT04833036|Cetuximab|cetuximab|mesh-list
25329685|NCT04833036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25329686|NCT04833036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25329687|NCT04833036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25329688|NCT04833036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329689|NCT04833036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329690|NCT04833036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25329691|NCT04833296|Ropivacaine|ropivacaine|mesh-list
25329692|NCT04833296|Anesthetics, Local|anesthetics, local|mesh-ancestor
25329693|NCT04833296|Anesthetics|anesthetics|mesh-ancestor
25329694|NCT04833296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25329695|NCT04833296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329696|NCT04833296|Sensory System Agents|sensory system agents|mesh-ancestor
25329697|NCT04833296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25329698|NCT04832906|Ulipristal acetate|ulipristal acetate|mesh-list
25329699|NCT04832906|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25329700|NCT04832906|Contraceptive Agents|contraceptive agents|mesh-ancestor
25329701|NCT04832906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25329702|NCT04832906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329703|NCT04832906|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25329704|NCT04832880|Remdesivir|remdesivir|mesh-list
25329705|NCT04832880|Dexamethasone|dexamethasone|mesh-list
25329706|NCT04832880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25329707|NCT04832880|Antiemetics|antiemetics|mesh-ancestor
25329708|NCT04832880|Autonomic Agents|autonomic agents|mesh-ancestor
25329709|NCT04832880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25329710|NCT04832880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329711|NCT04832880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25329712|NCT04832880|Glucocorticoids|glucocorticoids|mesh-ancestor
25329713|NCT04832880|Hormones|hormones|mesh-ancestor
25329714|NCT04832880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25329715|NCT04832880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25329716|NCT04832880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329717|NCT04832880|Antimetabolites|antimetabolites|mesh-ancestor
25329718|NCT04832880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329719|NCT04832880|Antiviral Agents|antiviral agents|mesh-ancestor
25329720|NCT04832880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25329721|NCT04832945|Ivermectin|ivermectin|mesh-list
25329782|NCT04832204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329784|NCT04831541|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25329785|NCT04831541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329786|NCT04831528|Bevacizumab|bevacizumab|mesh-list
25329787|NCT04831528|Trastuzumab|trastuzumab|mesh-list
25329788|NCT04831528|Cetuximab|cetuximab|mesh-list
25329789|NCT04831528|Pertuzumab|pertuzumab|mesh-list
25329790|NCT04831528|Lapatinib|lapatinib|mesh-list
25329791|NCT04831528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25329792|NCT04831528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329793|NCT04831528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25329794|NCT04831528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25329795|NCT04831528|Growth Substances|growth substances|mesh-ancestor
25329796|NCT04831528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329797|NCT04831528|Growth Inhibitors|growth inhibitors|mesh-ancestor
25329818|NCT04831255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25329819|NCT04831255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329820|NCT04831255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25329821|NCT04831255|Immunologic Factors|immunologic factors|mesh-ancestor
25329822|NCT04831255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25329823|NCT04831255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329824|NCT04831294|Cannabidiol|cannabidiol|mesh-list
25329825|NCT04831294|Anticonvulsants|anticonvulsants|mesh-ancestor
25329829|NCT04830969|Chlorhexidine|chlorhexidine|mesh-list
25329830|NCT04830969|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25329831|NCT04830969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25329832|NCT04830969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25329833|NCT04830969|Disinfectants|disinfectants|mesh-ancestor
25329834|NCT04830969|Dermatologic Agents|dermatologic agents|mesh-ancestor
25329835|NCT04830878|Methotrexate|methotrexate|mesh-list
25329836|NCT04830878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25329837|NCT04830878|Abortifacient Agents|abortifacient agents|mesh-ancestor
25329838|NCT04830878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25329839|NCT04830878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329840|NCT04830878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25329841|NCT04830878|Antimetabolites|antimetabolites|mesh-ancestor
25329842|NCT04830878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329843|NCT04830878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329844|NCT04830878|Dermatologic Agents|dermatologic agents|mesh-ancestor
25329845|NCT04830878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25329846|NCT04830878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25329847|NCT04830878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25329848|NCT04830878|Immunologic Factors|immunologic factors|mesh-ancestor
25329849|NCT04830878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25329850|NCT04830878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25329851|NCT04830943|Cerebrolysin|cerebrolysin|mesh-list
25329852|NCT04830943|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25329853|NCT04830943|Protective Agents|protective agents|mesh-ancestor
25329854|NCT04830943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329855|NCT04830943|Nootropic Agents|nootropic agents|mesh-ancestor
25329856|NCT04830579|Etoricoxib|etoricoxib|mesh-list
25329857|NCT04830579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25329858|NCT04830579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25329859|NCT04830579|Analgesics|analgesics|mesh-ancestor
25329860|NCT04830579|Sensory System Agents|sensory system agents|mesh-ancestor
25329861|NCT04830579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25329862|NCT04830579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329863|NCT04830579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25329864|NCT04830579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25329865|NCT04830579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25329866|NCT04830579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25329867|NCT04830579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25329868|NCT04830579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329908|NCT04829773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25329909|NCT04829773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329910|NCT04829773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25329911|NCT04829773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25329912|NCT04829773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25329913|NCT04829773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25329914|NCT04829773|Anesthetics, General|anesthetics, general|mesh-ancestor
25329915|NCT04829773|Anesthetics|anesthetics|mesh-ancestor
25329916|NCT04829773|GABA Modulators|gaba modulators|mesh-ancestor
25329917|NCT04829773|GABA Agents|gaba agents|mesh-ancestor
25329918|NCT04829773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25329919|NCT04829773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329924|NCT04829695|Lumefantrine|lumefantrine|mesh-list
25329925|NCT04829695|Artemether|artemether|mesh-list
25329926|NCT04829695|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25329927|NCT04829695|Amodiaquine|amodiaquine|mesh-list
25329928|NCT04829695|Antimalarials|antimalarials|mesh-ancestor
25329929|NCT04829695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25329930|NCT04829695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25329931|NCT04829695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25329932|NCT04829695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329933|NCT04829695|Antiviral Agents|antiviral agents|mesh-ancestor
25329934|NCT04829695|Schistosomicides|schistosomicides|mesh-ancestor
25329935|NCT04829695|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25329936|NCT04829695|Anthelmintics|anthelmintics|mesh-ancestor
25329937|NCT04829435|Rasburicase|rasburicase|mesh-list
25329938|NCT04829435|Gout Suppressants|gout suppressants|mesh-ancestor
25329939|NCT04829435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25329940|NCT04829487|Vitamin D|vitamin d|mesh-list
25329941|NCT04829487|Ergocalciferols|ergocalciferols|mesh-list
25329942|NCT04829487|Vitamins|vitamins|mesh-ancestor
25329943|NCT04829487|Micronutrients|micronutrients|mesh-ancestor
25329944|NCT04829487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329945|NCT04829487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25329946|NCT04829487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25329947|NCT04829565|Botulinum Toxins|botulinum toxins|mesh-list
25329948|NCT04829565|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25329949|NCT04829565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25329950|NCT04829565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329951|NCT04829565|Cholinergic Agents|cholinergic agents|mesh-ancestor
25329952|NCT04829565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25329953|NCT04829565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329954|NCT04829097|Temozolomide|temozolomide|mesh-list
25329955|NCT04829097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25329956|NCT04829097|Alkylating Agents|alkylating agents|mesh-ancestor
25329957|NCT04829097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329958|NCT04829097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329959|NCT04829019|Osimertinib|osimertinib|mesh-list
25329960|NCT04829019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329961|NCT04829019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25329962|NCT04829019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25329963|NCT04829019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329964|NCT04828824|Moxifloxacin|moxifloxacin|mesh-list
25329965|NCT04828824|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25329966|NCT04828824|Norgestimate|norgestimate|mesh-list
25329967|NCT04828824|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25329969|NCT04828824|Estrogens|estrogens|mesh-ancestor
25329970|NCT04828824|Hormones|hormones|mesh-ancestor
25329971|NCT04828824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25329972|NCT04828824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968205|NCT03753269|Fasudil|fasudil|mesh-list
24620282|NCT01056237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24620283|NCT01056237|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24620284|NCT01056237|Antitubercular Agents|antitubercular agents|mesh-ancestor
24620285|NCT01056237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25329973|NCT04828824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25329974|NCT04828824|Contraceptive Agents|contraceptive agents|mesh-ancestor
25329975|NCT04828824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25329976|NCT04828824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25329977|NCT04828824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25329978|NCT04828824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25329979|NCT04828824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25329980|NCT04828824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25329981|NCT04828824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25329982|NCT04828824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25329983|NCT04828824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25329984|NCT04828824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25329985|NCT04828824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25329986|NCT04828824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25329987|NCT04828824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25329988|NCT04828525|Dexamethasone|dexamethasone|mesh-list
25329989|NCT04828525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25329990|NCT04828525|Antiemetics|antiemetics|mesh-ancestor
25329991|NCT04828525|Autonomic Agents|autonomic agents|mesh-ancestor
25329992|NCT04828525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25329993|NCT04828525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25329994|NCT04828525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25329995|NCT04828525|Glucocorticoids|glucocorticoids|mesh-ancestor
25329996|NCT04828525|Hormones|hormones|mesh-ancestor
25329997|NCT04828525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25329998|NCT04828525|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25329999|NCT04828525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330000|NCT04828642|Vitamins|vitamins|mesh-list
25330001|NCT04828642|Ascorbic Acid|ascorbic acid|mesh-list
25330002|NCT04828642|Vitamin E|vitamin e|mesh-list
25330003|NCT04828642|Tocopherols|tocopherols|mesh-list
25330004|NCT04828642|Micronutrients|micronutrients|mesh-ancestor
25330005|NCT04828642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330006|NCT04828642|Antioxidants|antioxidants|mesh-ancestor
25330007|NCT04828642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330008|NCT04828642|Protective Agents|protective agents|mesh-ancestor
25330009|NCT04828564|Ribavirin|ribavirin|mesh-list
25330010|NCT04828564|Favipiravir|favipiravir|mesh-list
25330011|NCT04828564|Antimetabolites|antimetabolites|mesh-ancestor
25330012|NCT04828564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330013|NCT04828564|Antiviral Agents|antiviral agents|mesh-ancestor
25330014|NCT04828564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25330015|NCT04828135|Xenon|xenon|mesh-list
25330016|NCT04828135|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25330017|NCT04828135|Anesthetics, General|anesthetics, general|mesh-ancestor
25330018|NCT04828135|Anesthetics|anesthetics|mesh-ancestor
25330019|NCT04828135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25330020|NCT04828135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330021|NCT04828031|Vitamin D|vitamin d|mesh-list
25330022|NCT04828031|Vitamins|vitamins|mesh-ancestor
25330023|NCT04828031|Micronutrients|micronutrients|mesh-ancestor
25330024|NCT04828031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330025|NCT04828031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25330026|NCT04828057|Timolol|timolol|mesh-list
25330027|NCT04828057|Bimatoprost|bimatoprost|mesh-list
25330028|NCT04828057|Travoprost|travoprost|mesh-list
25330029|NCT04828057|Latanoprost|latanoprost|mesh-list
25330030|NCT04828057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25330031|NCT04828057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25330032|NCT04828057|Adrenergic Agents|adrenergic agents|mesh-ancestor
25330033|NCT04828057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25330034|NCT04828057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330035|NCT04828057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330036|NCT04828057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25330037|NCT04828057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25330038|NCT04828057|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25330039|NCT04828057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25330040|NCT04828226|Clonidine|clonidine|mesh-list
25330041|NCT04828226|Analgesics|analgesics|mesh-ancestor
25330042|NCT04828226|Sensory System Agents|sensory system agents|mesh-ancestor
25330043|NCT04828226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25330044|NCT04828226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330045|NCT04828226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25330046|NCT04828226|Sympatholytics|sympatholytics|mesh-ancestor
25330047|NCT04828226|Autonomic Agents|autonomic agents|mesh-ancestor
25330048|NCT04828226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25330049|NCT04828226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25825570|NCT00005603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25330050|NCT04828226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25330051|NCT04828226|Adrenergic Agents|adrenergic agents|mesh-ancestor
25330052|NCT04828226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25330053|NCT04828226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330057|NCT04827966|Fluorides|fluorides|mesh-list
25330058|NCT04827966|Sodium Fluoride|sodium fluoride|mesh-list
25330059|NCT04827966|Caseins|caseins|mesh-list
25330060|NCT04827966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25330061|NCT04827966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330062|NCT04827966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25330063|NCT04827966|Cariostatic Agents|cariostatic agents|mesh-ancestor
25330064|NCT04827966|Protective Agents|protective agents|mesh-ancestor
25330065|NCT04827966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25330066|NCT04827966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25330067|NCT04827966|Chelating Agents|chelating agents|mesh-ancestor
25330068|NCT04827966|Sequestering Agents|sequestering agents|mesh-ancestor
25330069|NCT04827966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330070|NCT04828395|Paclitaxel|paclitaxel|mesh-list
25330071|NCT04828395|Etoposide|etoposide|mesh-list
25330072|NCT04828395|Cisplatin|cisplatin|mesh-list
25330073|NCT04828395|Carboplatin|carboplatin|mesh-list
25330074|NCT04828395|Pemetrexed|pemetrexed|mesh-list
25330075|NCT04828395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25330076|NCT04828395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330077|NCT04828395|Tubulin Modulators|tubulin modulators|mesh-ancestor
25330078|NCT04828395|Antimitotic Agents|antimitotic agents|mesh-ancestor
25330079|NCT04828395|Mitosis Modulators|mitosis modulators|mesh-ancestor
25330080|NCT04828395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330081|NCT04828395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25330082|NCT04828395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25330083|NCT04828395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330084|NCT04828395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25330085|NCT04828395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25330086|NCT04827667|Dimercaprol|dimercaprol|mesh-list
25330087|NCT04827667|Chelating Agents|chelating agents|mesh-ancestor
25330088|NCT04827667|Sequestering Agents|sequestering agents|mesh-ancestor
25330089|NCT04827667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330090|NCT04827784|Anesthetics|anesthetics|mesh-list
25330091|NCT04827784|Anesthetics, Local|anesthetics, local|mesh-list
25330092|NCT04827784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25330093|NCT04827784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330094|NCT04827784|Sensory System Agents|sensory system agents|mesh-ancestor
25330139|NCT04826822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25330140|NCT04826822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25330141|NCT04826822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330142|NCT04826822|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25330143|NCT04826822|Hormone Antagonists|hormone antagonists|mesh-ancestor
25330144|NCT04826822|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25330145|NCT04826822|Diuretics|diuretics|mesh-ancestor
25330146|NCT04826822|Natriuretic Agents|natriuretic agents|mesh-ancestor
25330147|NCT04826900|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25330148|NCT04826900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25330149|NCT04826900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25330150|NCT04826900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330151|NCT04826900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25330152|NCT04826900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25330153|NCT04826900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330154|NCT04826900|Cholinergic Agents|cholinergic agents|mesh-ancestor
25330155|NCT04826900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25330156|NCT04826679|Paclitaxel|paclitaxel|mesh-list
25330157|NCT04826679|Cisplatin|cisplatin|mesh-list
25330158|NCT04826679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25330159|NCT04826679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330160|NCT04826679|Tubulin Modulators|tubulin modulators|mesh-ancestor
25330161|NCT04826679|Antimitotic Agents|antimitotic agents|mesh-ancestor
25330162|NCT04826679|Mitosis Modulators|mitosis modulators|mesh-ancestor
25330163|NCT04826679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330164|NCT04826198|Olaparib|olaparib|mesh-list
25330165|NCT04826198|Niraparib|niraparib|mesh-list
25330166|NCT04826198|Rucaparib|rucaparib|mesh-list
25408487|NCT03437746|Glucocorticoids|glucocorticoids|mesh-ancestor
25649351|NCT01490788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25649352|NCT01490788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25649353|NCT01490788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25330167|NCT04826198|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25330168|NCT04826198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330169|NCT04826198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330171|NCT04826562|Lamivudine|lamivudine|mesh-list
25330172|NCT04826562|Dolutegravir|dolutegravir|mesh-list
25330173|NCT04826562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25330174|NCT04826562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25330175|NCT04826562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330176|NCT04826562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330177|NCT04826562|Antiviral Agents|antiviral agents|mesh-ancestor
25330178|NCT04826562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25330179|NCT04826562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25825571|NCT00005603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24620374|NCT01056757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620375|NCT01056757|Antiviral Agents|antiviral agents|mesh-ancestor
24620376|NCT01056757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25330180|NCT04826562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25330181|NCT04826562|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25330182|NCT04826562|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25330183|NCT04826406|Apatinib|apatinib|mesh-list
25330184|NCT04826406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330185|NCT04826406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25330186|NCT04826406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330187|NCT04826406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330188|NCT04826432|Pasireotide|pasireotide|mesh-list
25330189|NCT04826432|Hormones|hormones|mesh-ancestor
25330190|NCT04826432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25330191|NCT04826432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330192|NCT04826497|Nicorandil|nicorandil|mesh-list
25330193|NCT04826497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25330194|NCT04826497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25330195|NCT04826497|Vasodilator Agents|vasodilator agents|mesh-ancestor
25330196|NCT04826497|Vitamin B Complex|vitamin b complex|mesh-ancestor
25330197|NCT04826497|Vitamins|vitamins|mesh-ancestor
25330198|NCT04826497|Micronutrients|micronutrients|mesh-ancestor
25330199|NCT04826497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330200|NCT04826510|Lithium Carbonate|lithium carbonate|mesh-list
25330201|NCT04826510|Perospirone|perospirone|mesh-list
25330202|NCT04826510|Antidepressive Agents|antidepressive agents|mesh-ancestor
25330203|NCT04826510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25330204|NCT04826510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330205|NCT04826510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330206|NCT04826510|Antimanic Agents|antimanic agents|mesh-ancestor
25330207|NCT04826510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25330208|NCT04826510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25330209|NCT04826510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330210|NCT04826510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25330211|NCT04825938|Paclitaxel|paclitaxel|mesh-list
25330212|NCT04825938|Carboplatin|carboplatin|mesh-list
25330213|NCT04825938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25330214|NCT04825938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330215|NCT04825938|Tubulin Modulators|tubulin modulators|mesh-ancestor
25330216|NCT04825938|Antimitotic Agents|antimitotic agents|mesh-ancestor
25330217|NCT04825938|Mitosis Modulators|mitosis modulators|mesh-ancestor
25330218|NCT04825938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330219|NCT04826016|Paclitaxel|paclitaxel|mesh-list
25330220|NCT04826016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25330221|NCT04826016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330222|NCT04826016|Tubulin Modulators|tubulin modulators|mesh-ancestor
25330223|NCT04826016|Antimitotic Agents|antimitotic agents|mesh-ancestor
25330224|NCT04826016|Mitosis Modulators|mitosis modulators|mesh-ancestor
25330225|NCT04826016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330226|NCT04825795|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25330227|NCT04825795|Protease Inhibitors|protease inhibitors|mesh-ancestor
25330228|NCT04825795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330229|NCT04825795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330230|NCT04825795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25330231|NCT04825795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330232|NCT04824924|Venetoclax|venetoclax|mesh-list
25330233|NCT04824924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330234|NCT04825093|Vitamin D|vitamin d|mesh-list
25330235|NCT04825093|Vitamins|vitamins|mesh-ancestor
25330236|NCT04825093|Micronutrients|micronutrients|mesh-ancestor
25330237|NCT04825093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330238|NCT04825093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25330246|NCT04824599|Ropivacaine|ropivacaine|mesh-list
25330247|NCT04824599|Anesthetics, Local|anesthetics, local|mesh-list
25330248|NCT04824599|Anesthetics|anesthetics|mesh-list
25330249|NCT04824599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25330250|NCT04824599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330251|NCT04824599|Sensory System Agents|sensory system agents|mesh-ancestor
25330252|NCT04824599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25330253|NCT04824898|Simvastatin|simvastatin|mesh-list
25330254|NCT04824898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25330255|NCT04824898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25330256|NCT04824898|Antimetabolites|antimetabolites|mesh-ancestor
25330257|NCT04824898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330258|NCT04824898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25330259|NCT04824898|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25330260|NCT04824898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330261|NCT04824937|Talazoparib|talazoparib|mesh-list
25330262|NCT04824937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25330263|NCT04824937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330264|NCT04824937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330265|NCT04824937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330266|NCT04824612|Triamcinolone|triamcinolone|mesh-list
25330267|NCT04824612|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25330268|NCT04824612|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25330269|NCT04824612|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25330270|NCT04824612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25330271|NCT04824612|Glucocorticoids|glucocorticoids|mesh-ancestor
25330273|NCT04824612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25330274|NCT04824612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330275|NCT04824612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25330276|NCT04824612|Immunologic Factors|immunologic factors|mesh-ancestor
25330277|NCT04824612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330278|NCT04824612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330279|NCT04824352|Apatinib|apatinib|mesh-list
25330280|NCT04824352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330281|NCT04824352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25330282|NCT04824352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330283|NCT04824352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330284|NCT04824404|Buprenorphine|buprenorphine|mesh-list
25330285|NCT04824404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25330286|NCT04824404|Narcotics|narcotics|mesh-ancestor
25330287|NCT04824404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25330288|NCT04824404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330289|NCT04824404|Analgesics|analgesics|mesh-ancestor
25330290|NCT04824404|Sensory System Agents|sensory system agents|mesh-ancestor
25330291|NCT04824404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25330292|NCT04824404|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25330293|NCT04824261|Clotrimazole|clotrimazole|mesh-list
25330294|NCT04824261|Miconazole|miconazole|mesh-list
25330295|NCT04824261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25330296|NCT04824261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25330297|NCT04824261|Antifungal Agents|antifungal agents|mesh-ancestor
25330298|NCT04824261|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25330299|NCT04824261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25330300|NCT04824261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330301|NCT04824261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330302|NCT04824261|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25330303|NCT04824261|Hormone Antagonists|hormone antagonists|mesh-ancestor
25330304|NCT04824261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25330305|NCT04824261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330306|NCT04824261|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25330307|NCT04824261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25330308|NCT04824391|Vaccines|vaccines|mesh-list
25330309|NCT04824391|Immunologic Factors|immunologic factors|mesh-ancestor
25330310|NCT04824391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330311|NCT04823962|Molgramostim|molgramostim|mesh-list
25330312|NCT04823962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330331|NCT04823390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25649354|NCT01490788|Analgesics|analgesics|mesh-ancestor
25649355|NCT01490788|Sensory System Agents|sensory system agents|mesh-ancestor
25330336|NCT04823390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25330337|NCT04823390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25330338|NCT04823390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25330339|NCT04823390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25330340|NCT04823390|GABA Modulators|gaba modulators|mesh-ancestor
25330341|NCT04823390|GABA Agents|gaba agents|mesh-ancestor
25330342|NCT04823390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25330343|NCT04823390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330344|NCT04823403|Nivolumab|nivolumab|mesh-list
25330345|NCT04823403|Ipilimumab|ipilimumab|mesh-list
25330346|NCT04823403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25330347|NCT04823403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330348|NCT04823403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25330349|NCT04823403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330350|NCT04823260|Niacinamide|niacinamide|mesh-list
25330351|NCT04823260|Niacin|niacin|mesh-list
25330352|NCT04823260|Nicotinic Acids|nicotinic acids|mesh-list
25330353|NCT04823260|Vitamin B Complex|vitamin b complex|mesh-ancestor
25330354|NCT04823260|Vitamins|vitamins|mesh-ancestor
25330355|NCT04823260|Micronutrients|micronutrients|mesh-ancestor
25330356|NCT04823260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330357|NCT04823260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25330358|NCT04823260|Antimetabolites|antimetabolites|mesh-ancestor
25330359|NCT04823260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330360|NCT04823260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25330361|NCT04823260|Vasodilator Agents|vasodilator agents|mesh-ancestor
25330362|NCT04822909|Thalidomide|thalidomide|mesh-list
25330363|NCT04822909|Apremilast|apremilast|mesh-list
25330364|NCT04822909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25330365|NCT04822909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25330366|NCT04822909|Analgesics|analgesics|mesh-ancestor
25330367|NCT04822909|Sensory System Agents|sensory system agents|mesh-ancestor
25330368|NCT04822909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25330369|NCT04822909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330370|NCT04822909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25330371|NCT04822909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25330372|NCT04822909|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25330373|NCT04822909|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25330374|NCT04822909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330375|NCT04822909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330376|NCT04822909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25330377|NCT04822909|Immunologic Factors|immunologic factors|mesh-ancestor
25330378|NCT04822909|Leprostatic Agents|leprostatic agents|mesh-ancestor
25330379|NCT04822909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25330380|NCT04822909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25330381|NCT04822909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25330382|NCT04822909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25330383|NCT04822909|Growth Substances|growth substances|mesh-ancestor
25330384|NCT04822909|Growth Inhibitors|growth inhibitors|mesh-ancestor
25330385|NCT04822909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330386|NCT04822649|Adenosine|adenosine|mesh-list
25330387|NCT04822649|Analgesics|analgesics|mesh-ancestor
25016425|NCT05224336|Niacin|niacin|mesh-list
25330388|NCT04822649|Sensory System Agents|sensory system agents|mesh-ancestor
25330389|NCT04822649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25330390|NCT04822649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330391|NCT04822649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25330392|NCT04822649|Vasodilator Agents|vasodilator agents|mesh-ancestor
25330393|NCT04822649|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25330394|NCT04822649|Purinergic Agonists|purinergic agonists|mesh-ancestor
25330395|NCT04822649|Purinergic Agents|purinergic agents|mesh-ancestor
25330396|NCT04822649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25330397|NCT04822649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767001|NCT01798251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330398|NCT04822415|Mepivacaine|mepivacaine|mesh-list
25330399|NCT04822415|Carticaine|carticaine|mesh-list
25330400|NCT04822415|Anesthetics, Local|anesthetics, local|mesh-ancestor
25330401|NCT04822415|Anesthetics|anesthetics|mesh-ancestor
25408488|NCT03437746|Hormones|hormones|mesh-ancestor
25649356|NCT01490788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25649357|NCT01490788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25085963|NCT03293927|Narcotics|narcotics|mesh-ancestor
25330402|NCT04822415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25330403|NCT04822415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330404|NCT04822415|Sensory System Agents|sensory system agents|mesh-ancestor
25330405|NCT04822415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25330406|NCT04822064|Dexmedetomidine|dexmedetomidine|mesh-list
25330407|NCT04822064|Ketamine|ketamine|mesh-list
25330408|NCT04822064|Chloral Hydrate|chloral hydrate|mesh-list
25330409|NCT04822064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25330410|NCT04822064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25330411|NCT04822064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330412|NCT04822064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25330413|NCT04822064|Analgesics|analgesics|mesh-ancestor
25330414|NCT04822064|Sensory System Agents|sensory system agents|mesh-ancestor
25330415|NCT04822064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25330416|NCT04822064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25330417|NCT04822064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25330418|NCT04822064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25330419|NCT04822064|Adrenergic Agents|adrenergic agents|mesh-ancestor
25330420|NCT04822064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25330421|NCT04822064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330422|NCT04822064|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25330423|NCT04822064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25330424|NCT04822064|Anesthetics, General|anesthetics, general|mesh-ancestor
25330425|NCT04822064|Anesthetics|anesthetics|mesh-ancestor
25330426|NCT04822064|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25330427|NCT04822064|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25330428|NCT04822012|Antibodies|antibodies|mesh-list
25330429|NCT04822012|Immunoglobulin G|immunoglobulin g|mesh-list
25330430|NCT04822012|Progesterone|progesterone|mesh-list
25330431|NCT04822012|Estrogens|estrogens|mesh-list
25330432|NCT04822012|Immunologic Factors|immunologic factors|mesh-ancestor
25330433|NCT04822012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330434|NCT04822012|Progestins|progestins|mesh-ancestor
25330435|NCT04822012|Hormones|hormones|mesh-ancestor
25330436|NCT04822012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25330437|NCT04822038|Vitamin D|vitamin d|mesh-list
25330438|NCT04822038|Cholecalciferol|cholecalciferol|mesh-list
25330439|NCT04822038|Vitamins|vitamins|mesh-ancestor
25330440|NCT04822038|Micronutrients|micronutrients|mesh-ancestor
25330441|NCT04822038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330442|NCT04822038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25330443|NCT04822038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25330444|NCT04821947|Bupivacaine|bupivacaine|mesh-list
25330445|NCT04821947|Anesthetics, Local|anesthetics, local|mesh-list
25330446|NCT04821947|Anesthetics|anesthetics|mesh-list
25330447|NCT04821947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25330448|NCT04821947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330449|NCT04821947|Sensory System Agents|sensory system agents|mesh-ancestor
25330450|NCT04821947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25330451|NCT04822090|Immunoglobulins|immunoglobulins|mesh-list
25330452|NCT04822090|Antibodies|antibodies|mesh-list
25330453|NCT04822090|gamma-Globulins|gamma-globulins|mesh-list
25330454|NCT04822090|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25330455|NCT04822090|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25330456|NCT04822090|Immunologic Factors|immunologic factors|mesh-ancestor
25330457|NCT04822090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330458|NCT04821843|Paclitaxel|paclitaxel|mesh-list
25330459|NCT04821843|Nimotuzumab|nimotuzumab|mesh-list
25330460|NCT04821843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25330461|NCT04821843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330462|NCT04821843|Tubulin Modulators|tubulin modulators|mesh-ancestor
25330463|NCT04821843|Antimitotic Agents|antimitotic agents|mesh-ancestor
25330464|NCT04821843|Mitosis Modulators|mitosis modulators|mesh-ancestor
25330537|NCT04821063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25330482|NCT04821765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330483|NCT04821765|Tubulin Modulators|tubulin modulators|mesh-ancestor
25330484|NCT04821765|Antimitotic Agents|antimitotic agents|mesh-ancestor
25330485|NCT04821765|Mitosis Modulators|mitosis modulators|mesh-ancestor
25330486|NCT04821765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330487|NCT04821765|Immunologic Factors|immunologic factors|mesh-ancestor
25330488|NCT04821765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330489|NCT04821323|Indomethacin|indomethacin|mesh-list
25330490|NCT04821323|Mannitol|mannitol|mesh-list
25330491|NCT04821323|Lactulose|lactulose|mesh-list
25330492|NCT04821323|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25330493|NCT04821323|Diuretics|diuretics|mesh-ancestor
25825573|NCT00005603|Antimitotic Agents|antimitotic agents|mesh-ancestor
24775303|NCT01851473|Analgesics|analgesics|mesh-ancestor
25199242|NCT02742233|Saxagliptin|saxagliptin|mesh-list
25199243|NCT02742233|Incretins|incretins|mesh-ancestor
25199244|NCT02742233|Hormones|hormones|mesh-ancestor
25199245|NCT02742233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25199246|NCT02742233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330494|NCT04821323|Natriuretic Agents|natriuretic agents|mesh-ancestor
25330495|NCT04821323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330496|NCT04821323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25330497|NCT04821323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25330498|NCT04821323|Analgesics|analgesics|mesh-ancestor
25330499|NCT04821323|Sensory System Agents|sensory system agents|mesh-ancestor
25330500|NCT04821323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25330501|NCT04821323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25330502|NCT04821323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25330503|NCT04821323|Gout Suppressants|gout suppressants|mesh-ancestor
25330504|NCT04821323|Tocolytic Agents|tocolytic agents|mesh-ancestor
25330505|NCT04821323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25330506|NCT04821323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25330507|NCT04821323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330508|NCT04821323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330509|NCT04821323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25330510|NCT04821804|Hyaluronic Acid|hyaluronic acid|mesh-list
25330511|NCT04821804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25330512|NCT04821804|Immunologic Factors|immunologic factors|mesh-ancestor
25330513|NCT04821804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330514|NCT04821804|Viscosupplements|viscosupplements|mesh-ancestor
25330515|NCT04821804|Protective Agents|protective agents|mesh-ancestor
25330516|NCT04821687|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
25330517|NCT04821687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330518|NCT04821687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330519|NCT04821687|Dopamine Agents|dopamine agents|mesh-ancestor
25330520|NCT04821687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25330521|NCT04821687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330522|NCT04821063|Moxifloxacin|moxifloxacin|mesh-list
25330523|NCT04821063|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25330524|NCT04821063|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
25330525|NCT04821063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25330526|NCT04821063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25330527|NCT04821063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25330528|NCT04821063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25330529|NCT04821063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330530|NCT04821063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330531|NCT04821063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330532|NCT04821063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25330533|NCT04821063|Contraceptive Agents|contraceptive agents|mesh-ancestor
25330534|NCT04821063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25330535|NCT04821063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330536|NCT04821063|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25330538|NCT04821063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25330539|NCT04821063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25330540|NCT04821206|Antirheumatic Agents|antirheumatic agents|mesh-list
25330541|NCT04821206|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
25330542|NCT04821206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25330543|NCT04821206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330544|NCT04821206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330545|NCT04821193|Chlorhexidine|chlorhexidine|mesh-list
25330546|NCT04821193|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25330547|NCT04821193|Disinfectants|disinfectants|mesh-list
25330548|NCT04821193|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25330549|NCT04821193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25330550|NCT04821193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25330551|NCT04821193|Dermatologic Agents|dermatologic agents|mesh-ancestor
25330552|NCT04820751|Cyproheptadine|cyproheptadine|mesh-list
25330553|NCT04820751|Antipruritics|antipruritics|mesh-ancestor
25330554|NCT04820751|Dermatologic Agents|dermatologic agents|mesh-ancestor
25330555|NCT04820751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25330556|NCT04820751|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25649358|NCT01490788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25649359|NCT01490788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649360|NCT01490788|Adrenergic Agents|adrenergic agents|mesh-ancestor
25649361|NCT01490788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25649362|NCT01490866|Leucovorin|leucovorin|mesh-list
25330558|NCT04820751|Histamine Agents|histamine agents|mesh-ancestor
25330559|NCT04820751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25330560|NCT04820751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330561|NCT04820751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330562|NCT04820751|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25330563|NCT04820751|Serotonin Agents|serotonin agents|mesh-ancestor
25330564|NCT04820751|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25330565|NCT04820933|Tenofovir|tenofovir|mesh-list
25330566|NCT04820933|Emtricitabine|emtricitabine|mesh-list
25330567|NCT04820933|Antiviral Agents|antiviral agents|mesh-ancestor
25330568|NCT04820933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25330569|NCT04820933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25330570|NCT04820933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25330571|NCT04820933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330572|NCT04820933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330573|NCT04820933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25330574|NCT04820933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25330575|NCT04820803|Cetylpyridinium|cetylpyridinium|mesh-list
25330576|NCT04820803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25330577|NCT04820803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25330578|NCT04820439|Pertuzumab|pertuzumab|mesh-list
25330579|NCT04820439|Antibodies|antibodies|mesh-list
25330580|NCT04820439|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25330581|NCT04820439|Mitogens|mitogens|mesh-list
25330582|NCT04820439|Immunologic Factors|immunologic factors|mesh-ancestor
25330583|NCT04820439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330584|NCT04820439|Mitosis Modulators|mitosis modulators|mesh-ancestor
25330585|NCT04820439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330586|NCT04820439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25330587|NCT04820439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25016728|NCT04661137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25330588|NCT04819971|Docetaxel|docetaxel|mesh-list
25330589|NCT04819971|Oxaliplatin|oxaliplatin|mesh-list
25330590|NCT04819971|Trastuzumab|trastuzumab|mesh-list
25330591|NCT04819971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330592|NCT04819971|Tubulin Modulators|tubulin modulators|mesh-ancestor
25330593|NCT04819971|Antimitotic Agents|antimitotic agents|mesh-ancestor
25330594|NCT04819971|Mitosis Modulators|mitosis modulators|mesh-ancestor
25330595|NCT04819971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330596|NCT04819971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25330597|NCT04819906|Moxifloxacin|moxifloxacin|mesh-list
25330598|NCT04819906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25330599|NCT04819906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25330600|NCT04819906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25330601|NCT04819906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25330602|NCT04819906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330603|NCT04819906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330604|NCT04819906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330605|NCT04820010|Insulin|insulin|mesh-list
25330606|NCT04820010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25330607|NCT04820010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330608|NCT04819776|Iloperidone|iloperidone|mesh-list
25330609|NCT04819776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25330610|NCT04819776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25330611|NCT04819776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25330612|NCT04819776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330613|NCT04819776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25330614|NCT04820101|Dexmedetomidine|dexmedetomidine|mesh-list
25330615|NCT04820101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25330616|NCT04820101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25330617|NCT04820101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330618|NCT04820101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25330619|NCT04820101|Analgesics|analgesics|mesh-ancestor
25330620|NCT04820101|Sensory System Agents|sensory system agents|mesh-ancestor
25330621|NCT04820101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25330622|NCT04820101|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25330623|NCT04820101|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25330624|NCT04820101|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25330625|NCT04820101|Adrenergic Agents|adrenergic agents|mesh-ancestor
25330626|NCT04820101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25330627|NCT04820101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330628|NCT04819867|Propolis|propolis|mesh-list
25330629|NCT04819867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25330631|NCT04819503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25330632|NCT04819503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330633|NCT04819438|Riluzole|riluzole|mesh-list
25330634|NCT04819438|Anticonvulsants|anticonvulsants|mesh-ancestor
25330635|NCT04819438|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25330636|NCT04819438|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25330637|NCT04819438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25330638|NCT04819438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330639|NCT04819438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330640|NCT04819438|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25330641|NCT04819438|Protective Agents|protective agents|mesh-ancestor
25330642|NCT04819828|Diclofenac|diclofenac|mesh-list
25330643|NCT04819828|Tamsulosin|tamsulosin|mesh-list
25330644|NCT04819828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25330645|NCT04819828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25330646|NCT04819828|Analgesics|analgesics|mesh-ancestor
25330647|NCT04819828|Sensory System Agents|sensory system agents|mesh-ancestor
25330648|NCT04819828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25330649|NCT04819828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330650|NCT04819828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25330651|NCT04819828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25330652|NCT04819828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25330653|NCT04819828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330654|NCT04819828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330732|NCT04817904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330655|NCT04819828|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25330656|NCT04819828|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25330657|NCT04819828|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25330658|NCT04819828|Adrenergic Agents|adrenergic agents|mesh-ancestor
25330659|NCT04819828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25016867|NCT03918915|Atropine|atropine|mesh-list
24768976|NCT01811836|Zinc|zinc|mesh-list
25330660|NCT04819828|Urological Agents|urological agents|mesh-ancestor
25330661|NCT04818931|Cefazolin|cefazolin|mesh-list
25330662|NCT04818931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25330663|NCT04818931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25330664|NCT04819204|Cetrorelix|cetrorelix|mesh-list
25330665|NCT04819204|Testosterone|testosterone|mesh-list
25330666|NCT04819204|Androgens|androgens|mesh-ancestor
25330667|NCT04819204|Hormones|hormones|mesh-ancestor
25330668|NCT04819204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25330669|NCT04819204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330670|NCT04819204|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25330671|NCT04819204|Fertility Agents|fertility agents|mesh-ancestor
25330672|NCT04819204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25330673|NCT04819204|Hormone Antagonists|hormone antagonists|mesh-ancestor
25330674|NCT04819217|Charcoal|charcoal|mesh-list
25330675|NCT04819217|Antidotes|antidotes|mesh-ancestor
25330676|NCT04819217|Protective Agents|protective agents|mesh-ancestor
25330677|NCT04819217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330678|NCT04819243|Atezolizumab|atezolizumab|mesh-list
25330679|NCT04819243|Talazoparib|talazoparib|mesh-list
25330680|NCT04819243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330681|NCT04819243|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25330682|NCT04819243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330683|NCT04819243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330684|NCT04818723|Montelukast|montelukast|mesh-list
25330685|NCT04818723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25330689|NCT04818723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25330690|NCT04818723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330691|NCT04818723|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25330692|NCT04818723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25330693|NCT04818723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330695|NCT04818736|Immunologic Factors|immunologic factors|mesh-ancestor
25330696|NCT04818736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330697|NCT04818749|Dexamethasone|dexamethasone|mesh-list
25330698|NCT04818749|Dexamethasone acetate|dexamethasone acetate|mesh-list
25330699|NCT04818749|Dexmedetomidine|dexmedetomidine|mesh-list
25330700|NCT04818749|BB 1101|bb 1101|mesh-list
25330701|NCT04818749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25330702|NCT04818749|Antiemetics|antiemetics|mesh-ancestor
25330703|NCT04818749|Autonomic Agents|autonomic agents|mesh-ancestor
25330704|NCT04818749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25330705|NCT04818749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330706|NCT04818749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25330707|NCT04818749|Glucocorticoids|glucocorticoids|mesh-ancestor
25330708|NCT04818749|Hormones|hormones|mesh-ancestor
25330709|NCT04818749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25330710|NCT04818749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25330711|NCT04818749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330712|NCT04818749|Protease Inhibitors|protease inhibitors|mesh-ancestor
25330713|NCT04818749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330714|NCT04818749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330715|NCT04818749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25330716|NCT04818749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25330717|NCT04818749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25330718|NCT04818749|Analgesics|analgesics|mesh-ancestor
25330719|NCT04818749|Sensory System Agents|sensory system agents|mesh-ancestor
25330720|NCT04818749|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25330721|NCT04818749|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25330722|NCT04818749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25330723|NCT04818749|Adrenergic Agents|adrenergic agents|mesh-ancestor
25330724|NCT04818749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25330725|NCT04817904|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25330726|NCT04817904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25330727|NCT04817904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25330728|NCT04817904|Antimetabolites|antimetabolites|mesh-ancestor
25330729|NCT04817904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330730|NCT04817904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25330731|NCT04817904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25016947|NCT03787654|Urological Agents|urological agents|mesh-ancestor
25330737|NCT04817865|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25330738|NCT04817865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25330739|NCT04817982|Dexamethasone|dexamethasone|mesh-list
25330740|NCT04817982|Dexamethasone acetate|dexamethasone acetate|mesh-list
25330741|NCT04817982|Lidocaine|lidocaine|mesh-list
25330742|NCT04817982|BB 1101|bb 1101|mesh-list
25330743|NCT04817982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25330744|NCT04817982|Antiemetics|antiemetics|mesh-ancestor
25330745|NCT04817982|Autonomic Agents|autonomic agents|mesh-ancestor
25330746|NCT04817982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25330747|NCT04817982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330748|NCT04817982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25330749|NCT04817982|Glucocorticoids|glucocorticoids|mesh-ancestor
25330750|NCT04817982|Hormones|hormones|mesh-ancestor
25330751|NCT04817982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25330752|NCT04817982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25330753|NCT04817982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330754|NCT04817982|Protease Inhibitors|protease inhibitors|mesh-ancestor
25330755|NCT04817982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330756|NCT04817982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330757|NCT04817982|Anesthetics, Local|anesthetics, local|mesh-ancestor
25330758|NCT04817982|Anesthetics|anesthetics|mesh-ancestor
25017116|NCT02489942|Empagliflozin|empagliflozin|mesh-list
25330759|NCT04817982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25330760|NCT04817982|Sensory System Agents|sensory system agents|mesh-ancestor
25330761|NCT04817982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25330762|NCT04817982|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25330763|NCT04817982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25330764|NCT04817982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25330765|NCT04818099|Vortioxetine|vortioxetine|mesh-list
25330766|NCT04818099|Antidepressive Agents|antidepressive agents|mesh-ancestor
25330767|NCT04818099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25330768|NCT04818099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25330769|NCT04818099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25330770|NCT04818099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25330771|NCT04818099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330772|NCT04818099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25330773|NCT04818099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25330774|NCT04818099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25330775|NCT04818099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330776|NCT04818099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25330777|NCT04818099|Serotonin Agents|serotonin agents|mesh-ancestor
25330778|NCT04818099|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25330779|NCT04818099|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25330780|NCT04818099|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25330781|NCT04818099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25330782|NCT04817969|Cimetidine|cimetidine|mesh-list
25330783|NCT04817969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25330784|NCT04817969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25330785|NCT04817969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25330786|NCT04817969|Histamine Antagonists|histamine antagonists|mesh-ancestor
25330787|NCT04817969|Histamine Agents|histamine agents|mesh-ancestor
25330788|NCT04817969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25330789|NCT04817969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330790|NCT04817969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330791|NCT04817969|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25330792|NCT04817969|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25330793|NCT04817969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330794|NCT04818151|Warfarin|warfarin|mesh-list
25330795|NCT04818151|Apixaban|apixaban|mesh-list
25330796|NCT04818151|Anticoagulants|anticoagulants|mesh-ancestor
25330797|NCT04818151|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25330798|NCT04818151|Antithrombins|antithrombins|mesh-ancestor
25330799|NCT04818151|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25330800|NCT04818151|Protease Inhibitors|protease inhibitors|mesh-ancestor
25330801|NCT04818151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330802|NCT04818151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330803|NCT04817800|Azelastine|azelastine|mesh-list
25330804|NCT04817800|Beclomethasone|beclomethasone|mesh-list
25330805|NCT04817800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25330806|NCT04817800|Glucocorticoids|glucocorticoids|mesh-ancestor
25330807|NCT04817800|Hormones|hormones|mesh-ancestor
25330808|NCT04817800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25330809|NCT04817800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330810|NCT04817800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25330811|NCT04817800|Respiratory System Agents|respiratory system agents|mesh-ancestor
25330812|NCT04817800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25330813|NCT04817800|Autonomic Agents|autonomic agents|mesh-ancestor
25330814|NCT04817800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25330815|NCT04817800|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25330816|NCT04817800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330817|NCT04817800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330818|NCT04817800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25330819|NCT04817800|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25330820|NCT04817800|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25330821|NCT04817800|Histamine Antagonists|histamine antagonists|mesh-ancestor
25330822|NCT04817800|Histamine Agents|histamine agents|mesh-ancestor
25330823|NCT04817800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25330824|NCT04817527|Edaravone|edaravone|mesh-list
25330825|NCT04817527|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25330826|NCT04817527|Antioxidants|antioxidants|mesh-ancestor
25330827|NCT04817527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330828|NCT04817527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25330829|NCT04817527|Protective Agents|protective agents|mesh-ancestor
25330830|NCT04817527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012223|NCT00357565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25330835|NCT04817202|Immunologic Factors|immunologic factors|mesh-ancestor
25330836|NCT04817202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330837|NCT04817202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330838|NCT04816968|Vancomycin|vancomycin|mesh-list
25330839|NCT04816968|Meropenem|meropenem|mesh-list
25330840|NCT04816968|Tazobactam|tazobactam|mesh-list
25330841|NCT04816968|Piperacillin|piperacillin|mesh-list
25330842|NCT04816968|Cefepime|cefepime|mesh-list
25330843|NCT04816968|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25330844|NCT04816968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25330845|NCT04816968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25330846|NCT04816968|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25330847|NCT04816968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330848|NCT04816968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330849|NCT04816838|Osimertinib|osimertinib|mesh-list
25330850|NCT04816838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330851|NCT04816838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25330852|NCT04816838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330853|NCT04816838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330859|NCT04816344|Anesthetics|anesthetics|mesh-list
25330860|NCT04816344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25330861|NCT04816344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330862|NCT04816461|Piperaquine|piperaquine|mesh-list
25330863|NCT04816461|Sulfadoxine|sulfadoxine|mesh-list
25330864|NCT04816461|Artenimol|artenimol|mesh-list
25330865|NCT04816461|Amodiaquine|amodiaquine|mesh-list
25330866|NCT04816461|Antimalarials|antimalarials|mesh-ancestor
25330867|NCT04816461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25330868|NCT04816461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25330869|NCT04816461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25330870|NCT04816461|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25330871|NCT04816461|Renal Agents|renal agents|mesh-ancestor
25330872|NCT04816253|Methylprednisolone|methylprednisolone|mesh-list
25330873|NCT04816253|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25330874|NCT04816253|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25330875|NCT04816253|Prednisolone|prednisolone|mesh-list
25330876|NCT04816253|Prednisolone acetate|prednisolone acetate|mesh-list
25330877|NCT04816253|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25330878|NCT04816253|Prednisolone phosphate|prednisolone phosphate|mesh-list
25330879|NCT04816253|Hyaluronic Acid|hyaluronic acid|mesh-list
25330880|NCT04816253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25330881|NCT04816253|Antiemetics|antiemetics|mesh-ancestor
25330882|NCT04816253|Autonomic Agents|autonomic agents|mesh-ancestor
25330883|NCT04816253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25330884|NCT04816253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330885|NCT04816253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25330886|NCT04816253|Glucocorticoids|glucocorticoids|mesh-ancestor
25330887|NCT04816253|Hormones|hormones|mesh-ancestor
25330888|NCT04816253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25330889|NCT04816253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25330890|NCT04816253|Protective Agents|protective agents|mesh-ancestor
25330891|NCT04816253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25330892|NCT04816253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330893|NCT04816253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25330894|NCT04816253|Immunologic Factors|immunologic factors|mesh-ancestor
25330895|NCT04816253|Viscosupplements|viscosupplements|mesh-ancestor
25330896|NCT04816097|Dexamethasone|dexamethasone|mesh-list
25330897|NCT04816097|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25330898|NCT04816097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25330899|NCT04816097|Antiemetics|antiemetics|mesh-ancestor
25330900|NCT04816097|Autonomic Agents|autonomic agents|mesh-ancestor
25330901|NCT04816097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25330902|NCT04816097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330903|NCT04816097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25330904|NCT04816097|Glucocorticoids|glucocorticoids|mesh-ancestor
25330905|NCT04816097|Hormones|hormones|mesh-ancestor
25012284|NCT05218915|Dulaglutide|dulaglutide|mesh-list
24967141|NCT03762538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25330912|NCT04816240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25330913|NCT04816240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330914|NCT04816240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25330915|NCT04816240|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25330916|NCT04816240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25330917|NCT04816240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25330918|NCT04816240|Adrenergic Agents|adrenergic agents|mesh-ancestor
25330919|NCT04816240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25330920|NCT04816240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330922|NCT04815265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25330923|NCT04815265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25330924|NCT04815265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330925|NCT04815265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25330926|NCT04815265|Analgesics|analgesics|mesh-ancestor
25330927|NCT04815265|Sensory System Agents|sensory system agents|mesh-ancestor
25330928|NCT04815265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25330929|NCT04815265|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25330930|NCT04815265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25330931|NCT04815265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25330932|NCT04815265|Adrenergic Agents|adrenergic agents|mesh-ancestor
25330933|NCT04815265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25330934|NCT04815265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330935|NCT04815408|Paclitaxel|paclitaxel|mesh-list
25330936|NCT04815408|Carboplatin|carboplatin|mesh-list
25330937|NCT04815408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25330938|NCT04815408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25330939|NCT04815408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330940|NCT04815408|Tubulin Modulators|tubulin modulators|mesh-ancestor
25330941|NCT04815408|Antimitotic Agents|antimitotic agents|mesh-ancestor
25330942|NCT04815408|Mitosis Modulators|mitosis modulators|mesh-ancestor
25330943|NCT04815408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330944|NCT04815395|Oxytocin|oxytocin|mesh-list
25330945|NCT04815395|Oxytocics|oxytocics|mesh-ancestor
25330946|NCT04815395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25330947|NCT04815395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081102|NCT03332953|Nicotine|nicotine|mesh-list
25330948|NCT04815187|Montelukast|montelukast|mesh-list
25330949|NCT04815187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25330950|NCT04815187|Respiratory System Agents|respiratory system agents|mesh-ancestor
25330951|NCT04815187|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25330952|NCT04815187|Hormone Antagonists|hormone antagonists|mesh-ancestor
25330953|NCT04815187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25330954|NCT04815187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330955|NCT04815187|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25330956|NCT04815187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25330957|NCT04815187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330958|NCT04815200|Copper|copper|mesh-list
25330959|NCT04815200|Nickel|nickel|mesh-list
25330960|NCT04815200|Trace Elements|trace elements|mesh-ancestor
25330961|NCT04815200|Micronutrients|micronutrients|mesh-ancestor
25330962|NCT04815200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330970|NCT04814719|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
25330971|NCT04814719|Anticoagulants|anticoagulants|mesh-ancestor
25330974|NCT04814303|Morphine|morphine|mesh-list
25330975|NCT04814303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25330976|NCT04814303|Narcotics|narcotics|mesh-ancestor
25330977|NCT04814303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25330978|NCT04814303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25330979|NCT04814303|Analgesics|analgesics|mesh-ancestor
25330980|NCT04814303|Sensory System Agents|sensory system agents|mesh-ancestor
25330981|NCT04814303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25330982|NCT04814511|Permethrin|permethrin|mesh-list
25330983|NCT04814511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330984|NCT04814511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330985|NCT04814485|Paclitaxel|paclitaxel|mesh-list
25330986|NCT04814485|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25330987|NCT04814485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25330988|NCT04814485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330989|NCT04814485|Tubulin Modulators|tubulin modulators|mesh-ancestor
25330990|NCT04814485|Antimitotic Agents|antimitotic agents|mesh-ancestor
25330991|NCT04814485|Mitosis Modulators|mitosis modulators|mesh-ancestor
25330992|NCT04814485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330993|NCT04814043|Lenvatinib|lenvatinib|mesh-list
25330994|NCT04814043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25330995|NCT04814043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25330996|NCT04814043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25330997|NCT04814043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25330998|NCT04814043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25330999|NCT04814030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25331000|NCT04814030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331001|NCT04814030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331002|NCT04814589|Ezetimibe|ezetimibe|mesh-list
25331003|NCT04814589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25331004|NCT04814589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25331005|NCT04814589|Antimetabolites|antimetabolites|mesh-ancestor
25331006|NCT04814589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331007|NCT04814589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25331008|NCT04813913|Bevacizumab|bevacizumab|mesh-list
25331009|NCT04813913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25331010|NCT04813913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331011|NCT04813913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25331012|NCT04813913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25331013|NCT04813913|Growth Substances|growth substances|mesh-ancestor
25331014|NCT04813913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331015|NCT04813913|Growth Inhibitors|growth inhibitors|mesh-ancestor
25331016|NCT04813952|Sevoflurane|sevoflurane|mesh-list
25331017|NCT04813952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25331018|NCT04813952|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25331019|NCT04813952|Anesthetics, General|anesthetics, general|mesh-ancestor
25331020|NCT04813952|Anesthetics|anesthetics|mesh-ancestor
25331021|NCT04813952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25331022|NCT04813952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331023|NCT04814056|Afatinib|afatinib|mesh-list
25331024|NCT04814056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331025|NCT04814056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25331026|NCT04814056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331027|NCT04814056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331028|NCT04814381|Magnesium Sulfate|magnesium sulfate|mesh-list
25331029|NCT04814381|Ketamine|ketamine|mesh-list
24790601|NCT01943877|Propolis|propolis|mesh-list
24790602|NCT01943877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25331030|NCT04814381|Analgesics|analgesics|mesh-ancestor
25331031|NCT04814381|Sensory System Agents|sensory system agents|mesh-ancestor
25331032|NCT04814381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25331033|NCT04814381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331034|NCT04814381|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25331035|NCT04814381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25331036|NCT04814381|Anesthetics, General|anesthetics, general|mesh-ancestor
25331037|NCT04814381|Anesthetics|anesthetics|mesh-ancestor
25331038|NCT04814381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25331039|NCT04814381|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25331040|NCT04814381|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25331041|NCT04814381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25331042|NCT04814381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331043|NCT04814381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25331044|NCT04814381|Anticonvulsants|anticonvulsants|mesh-ancestor
25331045|NCT04814381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25331046|NCT04814381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25331047|NCT04814381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25331048|NCT04814381|Tocolytic Agents|tocolytic agents|mesh-ancestor
25331049|NCT04814381|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25331050|NCT04813874|Nitrous Oxide|nitrous oxide|mesh-list
25331051|NCT04813874|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25331052|NCT04813874|Anesthetics, General|anesthetics, general|mesh-ancestor
25331053|NCT04813874|Anesthetics|anesthetics|mesh-ancestor
25331054|NCT04813874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25331055|NCT04813874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331056|NCT04813874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25331057|NCT04813874|Analgesics|analgesics|mesh-ancestor
25331058|NCT04813874|Sensory System Agents|sensory system agents|mesh-ancestor
25331059|NCT04813874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25331060|NCT04813848|Fluorides|fluorides|mesh-list
25331061|NCT04813848|Cariostatic Agents|cariostatic agents|mesh-ancestor
25331062|NCT04813848|Protective Agents|protective agents|mesh-ancestor
25331063|NCT04813848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331064|NCT04813523|Cisplatin|cisplatin|mesh-list
25331065|NCT04813523|Pembrolizumab|pembrolizumab|mesh-list
25331066|NCT04813523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331067|NCT04813523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25331068|NCT04813471|Folic Acid|folic acid|mesh-list
25331069|NCT04813471|Nicorandil|nicorandil|mesh-list
25331070|NCT04813471|Vitamin B Complex|vitamin b complex|mesh-list
25331071|NCT04813471|Atorvastatin|atorvastatin|mesh-list
25331072|NCT04813471|Vitamins|vitamins|mesh-ancestor
25331073|NCT04813471|Micronutrients|micronutrients|mesh-ancestor
25331074|NCT04813471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331075|NCT04813471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25331076|NCT04813471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25331077|NCT04813471|Antimetabolites|antimetabolites|mesh-ancestor
25331078|NCT04813471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331079|NCT04813471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25331080|NCT04813471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25331081|NCT04813471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331082|NCT04813471|Hematinics|hematinics|mesh-ancestor
25331083|NCT04813471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25331084|NCT04813471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25331085|NCT04813471|Vasodilator Agents|vasodilator agents|mesh-ancestor
25331086|NCT04813653|Cyclosporine|cyclosporine|mesh-list
25331087|NCT04813653|Dexamethasone|dexamethasone|mesh-list
25331088|NCT04813653|Cyclosporins|cyclosporins|mesh-list
25331089|NCT04813653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25331090|NCT04813653|Antiemetics|antiemetics|mesh-ancestor
25331091|NCT04813653|Autonomic Agents|autonomic agents|mesh-ancestor
25331092|NCT04813653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25331093|NCT04813653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331094|NCT04813653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25331095|NCT04813653|Glucocorticoids|glucocorticoids|mesh-ancestor
25331096|NCT04813653|Hormones|hormones|mesh-ancestor
25331097|NCT04813653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25331098|NCT04813653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25331099|NCT04813653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331100|NCT04813653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331101|NCT04813653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649363|NCT01490866|Bevacizumab|bevacizumab|mesh-list
25649364|NCT01490866|Fluorouracil|fluorouracil|mesh-list
25649365|NCT01490866|Oxaliplatin|oxaliplatin|mesh-list
24803801|NCT01998685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25331102|NCT04813653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25331103|NCT04813653|Immunologic Factors|immunologic factors|mesh-ancestor
25331104|NCT04813653|Antifungal Agents|antifungal agents|mesh-ancestor
25331105|NCT04813653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25331106|NCT04813653|Dermatologic Agents|dermatologic agents|mesh-ancestor
25331107|NCT04813653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25331108|NCT04813653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25825574|NCT00005603|Mitosis Modulators|mitosis modulators|mesh-ancestor
25331109|NCT04812457|Povidone-Iodine|povidone-iodine|mesh-list
25331110|NCT04812457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24650188|NCT01224470|Dexmedetomidine|dexmedetomidine|mesh-list
25331111|NCT04812457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25331112|NCT04812470|Melphalan|melphalan|mesh-list
25331113|NCT04812470|Interleukin-2|interleukin-2|mesh-list
25331114|NCT04812470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25331115|NCT04812470|Alkylating Agents|alkylating agents|mesh-ancestor
25331116|NCT04812470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331117|NCT04812470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331118|NCT04812470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25331119|NCT04812470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25331120|NCT04812470|Immunologic Factors|immunologic factors|mesh-ancestor
25331121|NCT04812470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331122|NCT04812470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25331123|NCT04812470|Analgesics|analgesics|mesh-ancestor
25331124|NCT04812470|Sensory System Agents|sensory system agents|mesh-ancestor
25331125|NCT04812470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25331126|NCT04812860|Tramadol|tramadol|mesh-list
25331127|NCT04812860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25331128|NCT04812860|Narcotics|narcotics|mesh-ancestor
25331129|NCT04812860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25331130|NCT04812860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331131|NCT04812860|Analgesics|analgesics|mesh-ancestor
25331132|NCT04812860|Sensory System Agents|sensory system agents|mesh-ancestor
25331133|NCT04812860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25331134|NCT04812379|Aripiprazole|aripiprazole|mesh-list
25331135|NCT04812379|Antidepressive Agents|antidepressive agents|mesh-ancestor
25331136|NCT04812379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25331137|NCT04812379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25331138|NCT04812379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25331139|NCT04812379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25331140|NCT04812379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331141|NCT04812379|Dopamine Agonists|dopamine agonists|mesh-ancestor
25331142|NCT04812379|Dopamine Agents|dopamine agents|mesh-ancestor
25331143|NCT04812379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25331144|NCT04812379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331145|NCT04812379|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25331146|NCT04812379|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25331147|NCT04812379|Serotonin Agents|serotonin agents|mesh-ancestor
25331148|NCT04812379|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25331149|NCT04812379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25331150|NCT04812379|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25331151|NCT04812379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25331152|NCT04812509|Denosumab|denosumab|mesh-list
25331153|NCT04812509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25331154|NCT04812509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331155|NCT04811573|Thalidomide|thalidomide|mesh-list
25331156|NCT04811573|Apremilast|apremilast|mesh-list
25331157|NCT04811573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25331158|NCT04811573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25331159|NCT04811573|Analgesics|analgesics|mesh-ancestor
25331160|NCT04811573|Sensory System Agents|sensory system agents|mesh-ancestor
25331161|NCT04811573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25331162|NCT04811573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331163|NCT04811573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25331164|NCT04811573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25331165|NCT04811573|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25331166|NCT04811573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25331167|NCT04811573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331168|NCT04811573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331169|NCT04811573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25331170|NCT04811573|Immunologic Factors|immunologic factors|mesh-ancestor
25331171|NCT04811573|Leprostatic Agents|leprostatic agents|mesh-ancestor
25331172|NCT04811573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25649366|NCT01490866|Axitinib|axitinib|mesh-list
25825575|NCT00005604|Aldesleukin|aldesleukin|mesh-list
25825576|NCT00005604|Interleukin-2|interleukin-2|mesh-list
24804413|NCT02002325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466447|NCT00373581|Anesthetics|anesthetics|mesh-ancestor
24598929|NCT05351606|Bupropion|bupropion|mesh-list
25331173|NCT04811573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25331174|NCT04811573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25331175|NCT04811573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25331176|NCT04811573|Growth Substances|growth substances|mesh-ancestor
25331177|NCT04811573|Growth Inhibitors|growth inhibitors|mesh-ancestor
25331178|NCT04811573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331179|NCT04811911|Methotrexate|methotrexate|mesh-list
25331180|NCT04811911|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25331181|NCT04811911|Abortifacient Agents|abortifacient agents|mesh-ancestor
25331182|NCT04811911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25331183|NCT04811911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331184|NCT04811911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25331185|NCT04811911|Antimetabolites|antimetabolites|mesh-ancestor
25331186|NCT04811911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331187|NCT04811911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331188|NCT04811911|Dermatologic Agents|dermatologic agents|mesh-ancestor
25331189|NCT04811911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331190|NCT04811911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25331191|NCT04811911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25331192|NCT04811911|Immunologic Factors|immunologic factors|mesh-ancestor
25331193|NCT04811911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25331194|NCT04811911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25331195|NCT04811339|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
25331196|NCT04811339|Antidiarrheals|antidiarrheals|mesh-ancestor
25331197|NCT04811339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25331198|NCT04811326|Latanoprost|latanoprost|mesh-list
25331199|NCT04811326|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25331200|NCT04811326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25331201|NCT04811274|Dimercaprol|dimercaprol|mesh-list
25331202|NCT04811274|Chelating Agents|chelating agents|mesh-ancestor
25331203|NCT04811274|Sequestering Agents|sequestering agents|mesh-ancestor
25331204|NCT04811274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331205|NCT04811209|Analgesics|analgesics|mesh-list
25331206|NCT04811209|Anesthetics|anesthetics|mesh-list
25331458|NCT04808895|Aspirin|aspirin|mesh-list
25331207|NCT04811209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25331208|NCT04811209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331209|NCT04811209|Sensory System Agents|sensory system agents|mesh-ancestor
25331210|NCT04811209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25331211|NCT04811313|Bupivacaine|bupivacaine|mesh-list
25331212|NCT04811313|Tranexamic Acid|tranexamic acid|mesh-list
25331213|NCT04811313|Anesthetics, Local|anesthetics, local|mesh-ancestor
25331214|NCT04811313|Anesthetics|anesthetics|mesh-ancestor
25331215|NCT04811313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25331216|NCT04811313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331217|NCT04811313|Sensory System Agents|sensory system agents|mesh-ancestor
25331218|NCT04811313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25331219|NCT04811313|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25331220|NCT04811313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25331221|NCT04811313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331222|NCT04811313|Hemostatics|hemostatics|mesh-ancestor
25331223|NCT04811313|Coagulants|coagulants|mesh-ancestor
25331224|NCT04811001|Osimertinib|osimertinib|mesh-list
25331225|NCT04811001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331226|NCT04811001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25331227|NCT04811001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331228|NCT04811001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331229|NCT04810819|Methylprednisolone|methylprednisolone|mesh-list
25331230|NCT04810819|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25331231|NCT04810819|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25331232|NCT04810819|Prednisolone|prednisolone|mesh-list
25331233|NCT04810819|Prednisolone acetate|prednisolone acetate|mesh-list
25331234|NCT04810819|Dyphylline|dyphylline|mesh-list
25331235|NCT04810819|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25331236|NCT04810819|Prednisolone phosphate|prednisolone phosphate|mesh-list
25331237|NCT04810819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25331238|NCT04810819|Antiemetics|antiemetics|mesh-ancestor
25331239|NCT04810819|Autonomic Agents|autonomic agents|mesh-ancestor
25331240|NCT04810819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25331241|NCT04810819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649367|NCT01490866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25649368|NCT01490866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649369|NCT01490866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25051926|NCT00363636|Galiximab|galiximab|mesh-list
25331242|NCT04810819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25331243|NCT04810819|Glucocorticoids|glucocorticoids|mesh-ancestor
25331244|NCT04810819|Hormones|hormones|mesh-ancestor
25331245|NCT04810819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25331246|NCT04810819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25331247|NCT04810819|Protective Agents|protective agents|mesh-ancestor
25331248|NCT04810819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25331249|NCT04810819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331250|NCT04810819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25331251|NCT04810819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25331252|NCT04810819|Respiratory System Agents|respiratory system agents|mesh-ancestor
25331253|NCT04810819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25331254|NCT04810819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331255|NCT04810819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331256|NCT04810819|Vasodilator Agents|vasodilator agents|mesh-ancestor
25331257|NCT04810754|Daratumumab|daratumumab|mesh-list
25331258|NCT04810754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331259|NCT04810507|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25331260|NCT04810507|Anagliptin|anagliptin|mesh-list
25331261|NCT04810507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25331262|NCT04810507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331263|NCT04810507|Incretins|incretins|mesh-ancestor
25331264|NCT04810507|Hormones|hormones|mesh-ancestor
25331265|NCT04810507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25331266|NCT04810507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25331267|NCT04810507|Protease Inhibitors|protease inhibitors|mesh-ancestor
25331268|NCT04810507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331269|NCT04810507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331270|NCT04810572|Silymarin|silymarin|mesh-list
25331271|NCT04810572|Antioxidants|antioxidants|mesh-ancestor
25331272|NCT04810572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331273|NCT04810572|Protective Agents|protective agents|mesh-ancestor
25331274|NCT04810572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331275|NCT04810585|Aflibercept|aflibercept|mesh-list
25331276|NCT04810585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25331277|NCT04810585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25331282|NCT04809818|Aspirin|aspirin|mesh-list
25331283|NCT04809818|Dabigatran|dabigatran|mesh-list
25331284|NCT04809818|Apixaban|apixaban|mesh-list
25331285|NCT04809818|Clopidogrel|clopidogrel|mesh-list
25331456|NCT04808648|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25331286|NCT04809818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25331287|NCT04809818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25331288|NCT04809818|Analgesics|analgesics|mesh-ancestor
25331289|NCT04809818|Sensory System Agents|sensory system agents|mesh-ancestor
25331290|NCT04809818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25331291|NCT04809818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331292|NCT04809818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25331293|NCT04809818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25331294|NCT04809818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25331295|NCT04809818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25331296|NCT04809818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331297|NCT04809818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25331298|NCT04809818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25331299|NCT04809818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331300|NCT04809818|Antipyretics|antipyretics|mesh-ancestor
25331301|NCT04809818|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25331302|NCT04809818|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25331303|NCT04809818|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25331304|NCT04809818|Purinergic Agents|purinergic agents|mesh-ancestor
25331305|NCT04809818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25331306|NCT04809818|Antithrombins|antithrombins|mesh-ancestor
25331307|NCT04809818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25331308|NCT04809818|Protease Inhibitors|protease inhibitors|mesh-ancestor
25331309|NCT04809818|Anticoagulants|anticoagulants|mesh-ancestor
25331310|NCT04809818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25331311|NCT04809935|Ethanol|ethanol|mesh-list
25331312|NCT04809935|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25331313|NCT04809935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25331314|NCT04809935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25649370|NCT01490866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25649371|NCT01490866|Growth Substances|growth substances|mesh-ancestor
25091310|NCT03249311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24670880|NCT01457781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331315|NCT04809935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331316|NCT04810156|Mycophenolic Acid|mycophenolic acid|mesh-list
25331317|NCT04810156|Methylprednisolone|methylprednisolone|mesh-list
25331318|NCT04810156|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25331319|NCT04810156|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25331320|NCT04810156|Prednisolone|prednisolone|mesh-list
25331321|NCT04810156|Prednisolone acetate|prednisolone acetate|mesh-list
25331322|NCT04810156|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25331323|NCT04810156|Tacrolimus|tacrolimus|mesh-list
25331324|NCT04810156|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25331325|NCT04810156|Prednisolone phosphate|prednisolone phosphate|mesh-list
25331326|NCT04810156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25331327|NCT04810156|Immunologic Factors|immunologic factors|mesh-ancestor
25331328|NCT04810156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331329|NCT04810156|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25331330|NCT04810156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331331|NCT04810156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331332|NCT04810156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25331333|NCT04810156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331334|NCT04810156|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25331335|NCT04810156|Antitubercular Agents|antitubercular agents|mesh-ancestor
25331336|NCT04810156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25331337|NCT04810156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25331338|NCT04810156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25331339|NCT04810156|Antiemetics|antiemetics|mesh-ancestor
25331340|NCT04810156|Autonomic Agents|autonomic agents|mesh-ancestor
25331341|NCT04810156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25331342|NCT04810156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25331343|NCT04810156|Glucocorticoids|glucocorticoids|mesh-ancestor
25331344|NCT04810156|Hormones|hormones|mesh-ancestor
25331345|NCT04810156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25331346|NCT04810156|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25331347|NCT04810156|Protective Agents|protective agents|mesh-ancestor
25331348|NCT04810156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25331349|NCT04810156|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25331363|NCT04809584|Dermatologic Agents|dermatologic agents|mesh-ancestor
25331365|NCT04809649|Antifungal Agents|antifungal agents|mesh-ancestor
25331366|NCT04809649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25331367|NCT04809649|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25331368|NCT04809649|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25331369|NCT04809649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331370|NCT04809649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331371|NCT04809649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25331372|NCT04809649|Hormone Antagonists|hormone antagonists|mesh-ancestor
25331457|NCT04808648|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25331373|NCT04809649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25331374|NCT04809649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331375|NCT04809649|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25331376|NCT04809532|Tramadol|tramadol|mesh-list
25331377|NCT04809532|Bupivacaine|bupivacaine|mesh-list
25331378|NCT04809532|Anesthetics, Local|anesthetics, local|mesh-ancestor
25331379|NCT04809532|Anesthetics|anesthetics|mesh-ancestor
25331380|NCT04809532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25331381|NCT04809532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331382|NCT04809532|Sensory System Agents|sensory system agents|mesh-ancestor
25331383|NCT04809532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25331384|NCT04809532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25331385|NCT04809532|Narcotics|narcotics|mesh-ancestor
25331386|NCT04809532|Analgesics|analgesics|mesh-ancestor
25331394|NCT04809142|Gemcitabine|gemcitabine|mesh-list
25331395|NCT04809142|Capecitabine|capecitabine|mesh-list
25331396|NCT04809142|Oxaliplatin|oxaliplatin|mesh-list
25331397|NCT04809142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25331398|NCT04809142|Antimetabolites|antimetabolites|mesh-ancestor
25331399|NCT04809142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331400|NCT04809142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331401|NCT04809142|Antiviral Agents|antiviral agents|mesh-ancestor
25331402|NCT04809142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25331403|NCT04809142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331404|NCT04809142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25649372|NCT01490866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649373|NCT01490866|Growth Inhibitors|growth inhibitors|mesh-ancestor
25331405|NCT04809142|Immunologic Factors|immunologic factors|mesh-ancestor
25331406|NCT04809142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331407|NCT04809181|Azacitidine|azacitidine|mesh-list
25331408|NCT04809181|Venetoclax|venetoclax|mesh-list
25331409|NCT04809181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25331410|NCT04809181|Antimetabolites|antimetabolites|mesh-ancestor
25331411|NCT04809181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331412|NCT04809181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331413|NCT04809181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331414|NCT04808739|Adalimumab|adalimumab|mesh-list
25331415|NCT04808739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25331416|NCT04808739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25331417|NCT04808856|Methylprednisolone|methylprednisolone|mesh-list
25331418|NCT04808856|Hormones|hormones|mesh-list
25331419|NCT04808856|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25331420|NCT04808856|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
25331421|NCT04808856|beta-Endorphin|beta-endorphin|mesh-list
25331422|NCT04808856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25331423|NCT04808856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331424|NCT04808856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25331425|NCT04808856|Antiemetics|antiemetics|mesh-ancestor
25331426|NCT04808856|Autonomic Agents|autonomic agents|mesh-ancestor
25331427|NCT04808856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25331428|NCT04808856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25331429|NCT04808856|Glucocorticoids|glucocorticoids|mesh-ancestor
25331432|NCT04808856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25331433|NCT04808856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331434|NCT04808648|Itraconazole|itraconazole|mesh-list
25331435|NCT04808648|Rifampin|rifampin|mesh-list
25331436|NCT04808648|Antifungal Agents|antifungal agents|mesh-ancestor
25331437|NCT04808648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25331438|NCT04808648|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25331439|NCT04808648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25331440|NCT04808648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331441|NCT04808648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331442|NCT04808648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25331443|NCT04808648|Hormone Antagonists|hormone antagonists|mesh-ancestor
25331444|NCT04808648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25331445|NCT04808648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331446|NCT04808648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25331447|NCT04808648|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25331448|NCT04808648|Antitubercular Agents|antitubercular agents|mesh-ancestor
25331449|NCT04808648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25331450|NCT04808648|Leprostatic Agents|leprostatic agents|mesh-ancestor
25331451|NCT04808648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25331452|NCT04808648|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25331453|NCT04808648|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25331454|NCT04808648|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25331455|NCT04808648|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25331459|NCT04808895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25331461|NCT04808895|Analgesics|analgesics|mesh-ancestor
25331462|NCT04808895|Sensory System Agents|sensory system agents|mesh-ancestor
25331463|NCT04808895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25331464|NCT04808895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331465|NCT04808895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25331466|NCT04808895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25331467|NCT04808895|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25331468|NCT04808895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25331469|NCT04808895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331470|NCT04808895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25331471|NCT04808895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25331472|NCT04808895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331473|NCT04808895|Antipyretics|antipyretics|mesh-ancestor
25331474|NCT04808791|Trifluridine|trifluridine|mesh-list
25331475|NCT04808791|Oxaliplatin|oxaliplatin|mesh-list
25331476|NCT04808791|Irinotecan|irinotecan|mesh-list
25331477|NCT04808791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331478|NCT04808791|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25331479|NCT04808791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25067534|NCT03443141|Vitamin E|vitamin e|mesh-list
25331480|NCT04808791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331481|NCT04808791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331482|NCT04808791|Antimetabolites|antimetabolites|mesh-ancestor
24713635|NCT01526850|Glucocorticoids|glucocorticoids|mesh-list
25331483|NCT04808791|Antiviral Agents|antiviral agents|mesh-ancestor
25331484|NCT04808791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25331485|NCT04808687|Paclitaxel|paclitaxel|mesh-list
25331486|NCT04808687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25331487|NCT04808687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331488|NCT04808687|Tubulin Modulators|tubulin modulators|mesh-ancestor
25331489|NCT04808687|Antimitotic Agents|antimitotic agents|mesh-ancestor
25331490|NCT04808687|Mitosis Modulators|mitosis modulators|mesh-ancestor
25331491|NCT04808687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331492|NCT04808622|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
25331493|NCT04808622|Antioxidants|antioxidants|mesh-ancestor
25331494|NCT04808622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331495|NCT04808622|Protective Agents|protective agents|mesh-ancestor
25331496|NCT04808622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331497|NCT04808622|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25331498|NCT04808622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331518|NCT04807829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25331519|NCT04807829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25331521|NCT04807569|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25331522|NCT04807569|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25331523|NCT04807569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25331524|NCT04807569|Adrenergic Agents|adrenergic agents|mesh-ancestor
25331525|NCT04807569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25331526|NCT04807569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331527|NCT04807569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331528|NCT04807569|Urological Agents|urological agents|mesh-ancestor
25331529|NCT04807634|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25331530|NCT04807634|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
25331531|NCT04807634|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25331532|NCT04807634|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25331533|NCT04807413|Nitric Oxide|nitric oxide|mesh-list
25331534|NCT04807413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25331535|NCT04807413|Autonomic Agents|autonomic agents|mesh-ancestor
25331536|NCT04807413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25331537|NCT04807413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331538|NCT04807413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25331539|NCT04807413|Respiratory System Agents|respiratory system agents|mesh-ancestor
25331540|NCT04807413|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25331541|NCT04807413|Antioxidants|antioxidants|mesh-ancestor
25331542|NCT04807413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331543|NCT04807413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25331544|NCT04807413|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25331545|NCT04807413|Vasodilator Agents|vasodilator agents|mesh-ancestor
25331546|NCT04807413|Gasotransmitters|gasotransmitters|mesh-ancestor
25331547|NCT04807413|Protective Agents|protective agents|mesh-ancestor
25331558|NCT04807543|Castor Oil|castor oil|mesh-list
25331559|NCT04807543|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
25331560|NCT04807543|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
25331561|NCT04807543|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25331562|NCT04807543|Hormone Antagonists|hormone antagonists|mesh-ancestor
25331563|NCT04807543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25331564|NCT04807543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331565|NCT04807543|Progestins|progestins|mesh-ancestor
25331566|NCT04807543|Hormones|hormones|mesh-ancestor
25331567|NCT04807543|Cathartics|cathartics|mesh-ancestor
25331568|NCT04807543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25331569|NCT04807140|Paclitaxel|paclitaxel|mesh-list
25331570|NCT04807140|Carboplatin|carboplatin|mesh-list
25331571|NCT04807140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25331572|NCT04807140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331573|NCT04807140|Tubulin Modulators|tubulin modulators|mesh-ancestor
25331574|NCT04807140|Antimitotic Agents|antimitotic agents|mesh-ancestor
25331575|NCT04807140|Mitosis Modulators|mitosis modulators|mesh-ancestor
25331576|NCT04807140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331578|NCT04807309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25331579|NCT04807309|Hormone Antagonists|hormone antagonists|mesh-ancestor
25331580|NCT04807309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25331581|NCT04807309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331582|NCT04807166|Paclitaxel|paclitaxel|mesh-list
25331583|NCT04807166|Carboplatin|carboplatin|mesh-list
25331584|NCT04807166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25331585|NCT04807166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649374|NCT01490866|Antimetabolites|antimetabolites|mesh-ancestor
24714535|NCT01531166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25331586|NCT04807166|Tubulin Modulators|tubulin modulators|mesh-ancestor
25331587|NCT04807166|Antimitotic Agents|antimitotic agents|mesh-ancestor
25331588|NCT04807166|Mitosis Modulators|mitosis modulators|mesh-ancestor
25331589|NCT04807166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331590|NCT04807335|Sufentanil|sufentanil|mesh-list
25331591|NCT04807335|Ketamine|ketamine|mesh-list
25331592|NCT04807335|Analgesics|analgesics|mesh-ancestor
25331593|NCT04807335|Sensory System Agents|sensory system agents|mesh-ancestor
25331594|NCT04807335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25331595|NCT04807335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331596|NCT04807335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25331597|NCT04807335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25331598|NCT04807335|Anesthetics, General|anesthetics, general|mesh-ancestor
25331599|NCT04807335|Anesthetics|anesthetics|mesh-ancestor
25331600|NCT04807335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25331601|NCT04807335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25331602|NCT04807335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25331603|NCT04807335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25331604|NCT04807335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331605|NCT04807335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25331606|NCT04807335|Narcotics|narcotics|mesh-ancestor
25331607|NCT04807335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25331608|NCT04807101|Midazolam|midazolam|mesh-list
25331609|NCT04807101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25331610|NCT04807101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25331611|NCT04807101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25331612|NCT04807101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331613|NCT04807101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25331614|NCT04807101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25331615|NCT04807101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25331616|NCT04807101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25331617|NCT04807101|Anesthetics, General|anesthetics, general|mesh-ancestor
25331618|NCT04807101|Anesthetics|anesthetics|mesh-ancestor
25331619|NCT04807101|GABA Modulators|gaba modulators|mesh-ancestor
25331620|NCT04807101|GABA Agents|gaba agents|mesh-ancestor
25331621|NCT04807101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25331622|NCT04807101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331623|NCT04807127|Pembrolizumab|pembrolizumab|mesh-list
25331624|NCT04807127|Durvalumab|durvalumab|mesh-list
25331625|NCT04807127|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25331626|NCT04807127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25331627|NCT04807127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331628|NCT04807127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331629|NCT04806945|Paclitaxel|paclitaxel|mesh-list
25331630|NCT04806945|Carboplatin|carboplatin|mesh-list
25331631|NCT04806945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25331632|NCT04806945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331633|NCT04806945|Tubulin Modulators|tubulin modulators|mesh-ancestor
25331634|NCT04806945|Antimitotic Agents|antimitotic agents|mesh-ancestor
25331635|NCT04806945|Mitosis Modulators|mitosis modulators|mesh-ancestor
25331636|NCT04806945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331637|NCT04807114|Pembrolizumab|pembrolizumab|mesh-list
25331638|NCT04807114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25331639|NCT04807114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25331640|NCT04807114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331641|NCT04807114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331642|NCT04806737|Teriflunomide|teriflunomide|mesh-list
25331643|NCT04806737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25331644|NCT04806737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25331645|NCT04806737|Analgesics|analgesics|mesh-ancestor
25018308|NCT03700229|Rituximab|rituximab|mesh-list
25331646|NCT04806737|Sensory System Agents|sensory system agents|mesh-ancestor
25331647|NCT04806737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25331648|NCT04806737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331654|NCT04806633|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25331655|NCT04806633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331656|NCT04806633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25331657|NCT04806633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331658|NCT04806906|Azacitidine|azacitidine|mesh-list
25331659|NCT04806906|Cc-486|cc-486|mesh-list
25331660|NCT04806906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25331661|NCT04806906|Antimetabolites|antimetabolites|mesh-ancestor
25408567|NCT03434379|Bevacizumab|bevacizumab|mesh-list
25656862|NCT01580020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25825577|NCT00005604|Interleukin-12|interleukin-12|mesh-list
24718809|NCT01557270|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24718861|NCT01557478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798894|NCT01965925|Modafinil|modafinil|mesh-list
25331662|NCT04806906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331663|NCT04806906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331664|NCT04806906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331665|NCT04806425|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25331666|NCT04806425|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25331667|NCT04806425|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25331668|NCT04806425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25331669|NCT04806438|Lidocaine|lidocaine|mesh-list
25331670|NCT04806438|Anesthetics, Local|anesthetics, local|mesh-ancestor
25331671|NCT04806438|Anesthetics|anesthetics|mesh-ancestor
25331672|NCT04806438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25331673|NCT04806438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331674|NCT04806438|Sensory System Agents|sensory system agents|mesh-ancestor
25331675|NCT04806438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25331676|NCT04806438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25331677|NCT04806438|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25331678|NCT04806438|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25331679|NCT04806438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25331680|NCT04806438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331681|NCT04806230|Mirtazapine|mirtazapine|mesh-list
25331682|NCT04806230|Citalopram|citalopram|mesh-list
25331683|NCT04806230|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25331684|NCT04806230|Sertraline|sertraline|mesh-list
25331685|NCT04806230|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25331686|NCT04806230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25331687|NCT04806230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25331688|NCT04806230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331689|NCT04806230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25331690|NCT04806230|Serotonin Agents|serotonin agents|mesh-ancestor
25331691|NCT04806230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331692|NCT04806230|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25331693|NCT04806230|Antidepressive Agents|antidepressive agents|mesh-ancestor
25331694|NCT04806230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25331695|NCT04806230|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25331696|NCT04806230|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25331697|NCT04806230|Histamine Antagonists|histamine antagonists|mesh-ancestor
25331698|NCT04806230|Histamine Agents|histamine agents|mesh-ancestor
25331699|NCT04806230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25331700|NCT04806230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25331701|NCT04806230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25331702|NCT04806230|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25331703|NCT04806230|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25331704|NCT04806230|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25331705|NCT04806230|Adrenergic Agents|adrenergic agents|mesh-ancestor
25331706|NCT04806230|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25331707|NCT04806230|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25331708|NCT04806230|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25331713|NCT04805775|Propofol|propofol|mesh-list
25331714|NCT04805775|Desflurane|desflurane|mesh-list
25331715|NCT04805775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25331716|NCT04805775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25331717|NCT04805775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331718|NCT04805775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25331719|NCT04805775|Anesthetics, General|anesthetics, general|mesh-ancestor
25331720|NCT04805775|Anesthetics|anesthetics|mesh-ancestor
25331721|NCT04805775|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25331722|NCT04805801|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25331723|NCT04805801|Immunologic Factors|immunologic factors|mesh-ancestor
25331724|NCT04805801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331725|NCT04805957|Sulforaphane|sulforaphane|mesh-list
25331726|NCT04805957|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25331727|NCT04805957|Protective Agents|protective agents|mesh-ancestor
25331728|NCT04805957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331729|NCT04805957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331730|NCT04805944|Dolutegravir|dolutegravir|mesh-list
24651775|NCT01233791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25331731|NCT04805944|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25331732|NCT04805944|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25649375|NCT01490866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649376|NCT01490866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25331733|NCT04805944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331734|NCT04805944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331735|NCT04805944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25331736|NCT04805944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25331737|NCT04805944|Antiviral Agents|antiviral agents|mesh-ancestor
25331738|NCT04805944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25331739|NCT04805827|Gabapentin|gabapentin|mesh-list
25331740|NCT04805827|Analgesics|analgesics|mesh-ancestor
25331741|NCT04805827|Sensory System Agents|sensory system agents|mesh-ancestor
25331742|NCT04805827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25331743|NCT04805827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331744|NCT04805827|Anticonvulsants|anticonvulsants|mesh-ancestor
25331745|NCT04805827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25331746|NCT04805827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25331747|NCT04805827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25331748|NCT04805827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25331749|NCT04805827|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25331750|NCT04805827|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25331751|NCT04805827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25331752|NCT04805827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331753|NCT04805827|Antimanic Agents|antimanic agents|mesh-ancestor
25331754|NCT04805710|Rivaroxaban|rivaroxaban|mesh-list
25331755|NCT04805710|Clopidogrel|clopidogrel|mesh-list
25331756|NCT04805710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25331757|NCT04805710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25331758|NCT04805710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25331759|NCT04805710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25331760|NCT04805710|Purinergic Agents|purinergic agents|mesh-ancestor
25331761|NCT04805710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25331762|NCT04805710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331763|NCT04805710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331764|NCT04805710|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25331765|NCT04805710|Antithrombins|antithrombins|mesh-ancestor
25331766|NCT04805710|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25331767|NCT04805710|Protease Inhibitors|protease inhibitors|mesh-ancestor
25331768|NCT04805710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331769|NCT04805710|Anticoagulants|anticoagulants|mesh-ancestor
25331770|NCT04805515|Nicotine|nicotine|mesh-list
25331771|NCT04805515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25331772|NCT04805515|Autonomic Agents|autonomic agents|mesh-ancestor
25331773|NCT04805515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25331774|NCT04805515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331775|NCT04805515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25331776|NCT04805515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25331777|NCT04805515|Cholinergic Agents|cholinergic agents|mesh-ancestor
25331778|NCT04805515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25331779|NCT04805515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331780|NCT04805229|Analgesics, Opioid|analgesics, opioid|mesh-list
25331781|NCT04805229|Narcotics|narcotics|mesh-ancestor
25018434|NCT03699293|Antipyretics|antipyretics|mesh-ancestor
25331782|NCT04805229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25331783|NCT04805229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331784|NCT04805229|Analgesics|analgesics|mesh-ancestor
25331785|NCT04805229|Sensory System Agents|sensory system agents|mesh-ancestor
25331786|NCT04805229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25331787|NCT04805281|Lithium Carbonate|lithium carbonate|mesh-list
25331788|NCT04805281|Antidepressive Agents|antidepressive agents|mesh-ancestor
25331789|NCT04805281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25331790|NCT04805281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331986|NCT04802785|Antacids|antacids|mesh-ancestor
25331791|NCT04805281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331792|NCT04805281|Antimanic Agents|antimanic agents|mesh-ancestor
25331793|NCT04805281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24651990|NCT01234935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331794|NCT04805281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25331816|NCT04805073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25331817|NCT04805034|Antiviral Agents|antiviral agents|mesh-list
25331818|NCT04805034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25331819|NCT04804696|Paclitaxel|paclitaxel|mesh-list
25331820|NCT04804696|Cisplatin|cisplatin|mesh-list
25331821|NCT04804696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25331822|NCT04804696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331823|NCT04804696|Tubulin Modulators|tubulin modulators|mesh-ancestor
25331824|NCT04804696|Antimitotic Agents|antimitotic agents|mesh-ancestor
25331825|NCT04804696|Mitosis Modulators|mitosis modulators|mesh-ancestor
25331826|NCT04804696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331827|NCT04804423|Listerine|listerine|mesh-list
24723849|NCT01589432|Anesthetics|anesthetics|mesh-ancestor
24723850|NCT01589432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24723851|NCT01589432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723982|NCT01590342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24723985|NCT01590342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331828|NCT04804423|Fluorides|fluorides|mesh-list
25331829|NCT04804423|Sodium Fluoride|sodium fluoride|mesh-list
25331830|NCT04804423|Fluorides, Topical|fluorides, topical|mesh-list
25331831|NCT04804423|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
25331832|NCT04804423|Cariostatic Agents|cariostatic agents|mesh-ancestor
25331833|NCT04804423|Protective Agents|protective agents|mesh-ancestor
25331834|NCT04804423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331835|NCT04804423|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25331836|NCT04804423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25331844|NCT04804267|Linaclotide|linaclotide|mesh-list
25331845|NCT04804267|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25331846|NCT04804267|Enzyme Activators|enzyme activators|mesh-ancestor
25331847|NCT04804267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331848|NCT04804267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25331849|NCT04803539|Capecitabine|capecitabine|mesh-list
25331850|NCT04803539|Apatinib|apatinib|mesh-list
25331851|NCT04803539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25331852|NCT04803539|Antimetabolites|antimetabolites|mesh-ancestor
25331853|NCT04803539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331854|NCT04803539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331855|NCT04803539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25331856|NCT04803539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331873|NCT04803500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25331874|NCT04803500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25331875|NCT04803500|Antimetabolites|antimetabolites|mesh-ancestor
25331876|NCT04803500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331877|NCT04803500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25331878|NCT04803500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25331879|NCT04803500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331880|NCT04803318|Everolimus|everolimus|mesh-list
25331881|NCT04803318|Lenvatinib|lenvatinib|mesh-list
25331882|NCT04803318|Trametinib|trametinib|mesh-list
25331883|NCT04803318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331884|NCT04803318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25331885|NCT04803318|Immunologic Factors|immunologic factors|mesh-ancestor
25331886|NCT04803318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331887|NCT04803318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25331888|NCT04803318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331889|NCT04803318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331890|NCT04803162|Omeprazole|omeprazole|mesh-list
25331891|NCT04803162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25331892|NCT04803162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25331893|NCT04803162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25331894|NCT04803162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331895|NCT04803162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331896|NCT04803175|Valsartan|valsartan|mesh-list
25331897|NCT04803175|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25331898|NCT04803175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25331899|NCT04803175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25331900|NCT04803175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25331901|NCT04803175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331902|NCT04803240|Hyaluronic Acid|hyaluronic acid|mesh-list
25331903|NCT04803240|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25331904|NCT04803240|Immunologic Factors|immunologic factors|mesh-ancestor
25331905|NCT04803240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331906|NCT04803240|Viscosupplements|viscosupplements|mesh-ancestor
25331907|NCT04803240|Protective Agents|protective agents|mesh-ancestor
25331908|NCT04803474|Hormones|hormones|mesh-list
25331987|NCT04802876|Spartalizumab|spartalizumab|mesh-list
25331909|NCT04803474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25331910|NCT04803474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331911|NCT04803370|Antibodies|antibodies|mesh-list
25331912|NCT04803370|Immunologic Factors|immunologic factors|mesh-ancestor
25331913|NCT04803370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649377|NCT01490866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25649378|NCT01490866|Immunologic Factors|immunologic factors|mesh-ancestor
25649379|NCT01490866|Antidotes|antidotes|mesh-ancestor
25649380|NCT01490866|Protective Agents|protective agents|mesh-ancestor
25649381|NCT01490866|Vitamin B Complex|vitamin b complex|mesh-ancestor
25649382|NCT01490866|Vitamins|vitamins|mesh-ancestor
25331915|NCT04802967|Ketoprofen lysine|ketoprofen lysine|mesh-list
25331916|NCT04802967|Gabapentin|gabapentin|mesh-list
25331917|NCT04802967|Analgesics|analgesics|mesh-ancestor
25331918|NCT04802967|Sensory System Agents|sensory system agents|mesh-ancestor
25331919|NCT04802967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25331920|NCT04802967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331921|NCT04802967|Anticonvulsants|anticonvulsants|mesh-ancestor
25331922|NCT04802967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25331923|NCT04802967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25331924|NCT04802967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25331925|NCT04802967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25331926|NCT04802967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25331927|NCT04802967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25331928|NCT04802967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25331929|NCT04802967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331930|NCT04802967|Antimanic Agents|antimanic agents|mesh-ancestor
25331931|NCT04802967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25331932|NCT04802967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25331933|NCT04802967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25331934|NCT04802967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25331935|NCT04802967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25331936|NCT04802967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331937|NCT04802928|Isoniazid|isoniazid|mesh-list
25331938|NCT04802928|Antitubercular Agents|antitubercular agents|mesh-ancestor
25331939|NCT04802928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25331940|NCT04802928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25331941|NCT04802928|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25331942|NCT04802928|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25331943|NCT04802928|Antimetabolites|antimetabolites|mesh-ancestor
25331944|NCT04802928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331945|NCT04802928|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25331946|NCT04802785|Aspirin|aspirin|mesh-list
25331947|NCT04802785|Domperidone|domperidone|mesh-list
25331948|NCT04802785|Melatonin|melatonin|mesh-list
25331949|NCT04802785|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
25331950|NCT04802785|Simethicone|simethicone|mesh-list
25331951|NCT04802785|Magnesium Hydroxide|magnesium hydroxide|mesh-list
25331952|NCT04802785|Citric Acid|citric acid|mesh-list
25331953|NCT04802785|Sodium Citrate|sodium citrate|mesh-list
25331954|NCT04802785|Anticoagulants|anticoagulants|mesh-ancestor
25331955|NCT04802785|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25331956|NCT04802785|Chelating Agents|chelating agents|mesh-ancestor
25331957|NCT04802785|Sequestering Agents|sequestering agents|mesh-ancestor
25331958|NCT04802785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331959|NCT04802785|Antioxidants|antioxidants|mesh-ancestor
25331960|NCT04802785|Protective Agents|protective agents|mesh-ancestor
25331961|NCT04802785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25331962|NCT04802785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25331963|NCT04802785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25331964|NCT04802785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25331965|NCT04802785|Analgesics|analgesics|mesh-ancestor
25331966|NCT04802785|Sensory System Agents|sensory system agents|mesh-ancestor
25331967|NCT04802785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25331968|NCT04802785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25331969|NCT04802785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25331970|NCT04802785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25331971|NCT04802785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25331972|NCT04802785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25331973|NCT04802785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25331974|NCT04802785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25331975|NCT04802785|Antipyretics|antipyretics|mesh-ancestor
25331976|NCT04802785|Antiemetics|antiemetics|mesh-ancestor
25331977|NCT04802785|Autonomic Agents|autonomic agents|mesh-ancestor
25331978|NCT04802785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25331979|NCT04802785|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25331980|NCT04802785|Dopamine Agents|dopamine agents|mesh-ancestor
25331981|NCT04802785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25331982|NCT04802785|Antifoaming Agents|antifoaming agents|mesh-ancestor
25331983|NCT04802785|Emollients|emollients|mesh-ancestor
25331984|NCT04802785|Dermatologic Agents|dermatologic agents|mesh-ancestor
25331985|NCT04802785|Nootropic Agents|nootropic agents|mesh-ancestor
25331988|NCT04802876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25331989|NCT04802876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25331990|NCT04802876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331991|NCT04802980|Gemcitabine|gemcitabine|mesh-list
25649383|NCT01490866|Micronutrients|micronutrients|mesh-ancestor
25331992|NCT04802980|Paclitaxel|paclitaxel|mesh-list
25331993|NCT04802980|Carboplatin|carboplatin|mesh-list
25331994|NCT04802980|Capecitabine|capecitabine|mesh-list
25331995|NCT04802980|Oxaliplatin|oxaliplatin|mesh-list
25331996|NCT04802980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25331997|NCT04802980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25331998|NCT04802980|Tubulin Modulators|tubulin modulators|mesh-ancestor
25331999|NCT04802980|Antimitotic Agents|antimitotic agents|mesh-ancestor
25332000|NCT04802980|Mitosis Modulators|mitosis modulators|mesh-ancestor
25332001|NCT04802980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332002|NCT04802980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25332003|NCT04802980|Antimetabolites|antimetabolites|mesh-ancestor
25332004|NCT04802980|Antiviral Agents|antiviral agents|mesh-ancestor
25332005|NCT04802980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25332006|NCT04802980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25332007|NCT04802980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25332008|NCT04802980|Immunologic Factors|immunologic factors|mesh-ancestor
25332009|NCT04802980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332010|NCT04802122|Propofol|propofol|mesh-list
25332011|NCT04802122|Sevoflurane|sevoflurane|mesh-list
25332012|NCT04802122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25332013|NCT04802122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25332014|NCT04802122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332015|NCT04802122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25332016|NCT04802122|Anesthetics, General|anesthetics, general|mesh-ancestor
25332017|NCT04802122|Anesthetics|anesthetics|mesh-ancestor
25332018|NCT04802122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25332019|NCT04802122|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25332020|NCT04802083|Eculizumab|eculizumab|mesh-list
25332021|NCT04802083|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25332022|NCT04802083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25332023|NCT04802083|Immunologic Factors|immunologic factors|mesh-ancestor
25332059|NCT04801966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25332060|NCT04801966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332061|NCT04801966|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25332062|NCT04801966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332063|NCT04801966|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25332065|NCT04801966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25332066|NCT04801511|Ascorbic Acid|ascorbic acid|mesh-list
25332067|NCT04801511|Vitamins|vitamins|mesh-ancestor
25332068|NCT04801511|Micronutrients|micronutrients|mesh-ancestor
25332069|NCT04801511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332070|NCT04801511|Antioxidants|antioxidants|mesh-ancestor
25332071|NCT04801511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332072|NCT04801511|Protective Agents|protective agents|mesh-ancestor
25332073|NCT04801303|Calcitriol|calcitriol|mesh-list
25332074|NCT04801303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25332075|NCT04801303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332076|NCT04801303|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25332077|NCT04801303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25332078|NCT04801303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332079|NCT04801303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25332080|NCT04801303|Vitamins|vitamins|mesh-ancestor
25332081|NCT04801303|Micronutrients|micronutrients|mesh-ancestor
25332082|NCT04801303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25332116|NCT04801342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25332117|NCT04801342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332118|NCT04801342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332119|NCT04801342|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25332120|NCT04801342|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25332122|NCT04801264|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
25332123|NCT04801264|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25332124|NCT04801264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332125|NCT04800978|Durvalumab|durvalumab|mesh-list
25332126|NCT04800978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25332127|NCT04800978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332128|NCT04801017|Artemisinins|artemisinins|mesh-list
25332129|NCT04801017|Artemisinin|artemisinin|mesh-list
25332130|NCT04801017|Trabedersen|trabedersen|mesh-list
25332131|NCT04801017|Antimalarials|antimalarials|mesh-ancestor
25332132|NCT04801017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25332133|NCT04801017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25332134|NCT04801017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25332135|NCT04801017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332136|NCT04801199|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25332137|NCT04801199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25332138|NCT04801199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332139|NCT04801199|Incretins|incretins|mesh-ancestor
25332140|NCT04801199|Hormones|hormones|mesh-ancestor
25332141|NCT04801199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25332142|NCT04801199|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25332143|NCT04801199|Protease Inhibitors|protease inhibitors|mesh-ancestor
25332144|NCT04801199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25332145|NCT04801199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332149|NCT04800367|Denosumab|denosumab|mesh-list
25332150|NCT04800367|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25332151|NCT04800367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332152|NCT04800081|Valsartan|valsartan|mesh-list
25332153|NCT04800081|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25332154|NCT04800081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25332155|NCT04800081|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25332156|NCT04800081|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25332157|NCT04800081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332158|NCT04799847|Catumaxomab|catumaxomab|mesh-list
25332159|NCT04799847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25332160|NCT04799873|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25332161|NCT04799873|Protein C Inhibitor|protein c inhibitor|mesh-list
25332162|NCT04799873|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25332163|NCT04799873|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25332164|NCT04799873|Protease Inhibitors|protease inhibitors|mesh-ancestor
25332165|NCT04799873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25332166|NCT04799873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332167|NCT04799925|Febuxostat|febuxostat|mesh-list
25332168|NCT04799925|Gout Suppressants|gout suppressants|mesh-ancestor
25332169|NCT04799925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25332170|NCT04799782|Mirtazapine|mirtazapine|mesh-list
25332171|NCT04799782|Antidepressive Agents|antidepressive agents|mesh-ancestor
25332172|NCT04799782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25332173|NCT04799782|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25332174|NCT04799782|Histamine Antagonists|histamine antagonists|mesh-ancestor
25332175|NCT04799782|Histamine Agents|histamine agents|mesh-ancestor
25332176|NCT04799782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25332177|NCT04799782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332178|NCT04799782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332179|NCT04799782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25332180|NCT04799782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25332181|NCT04799782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25332182|NCT04799782|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25332183|NCT04799782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25332184|NCT04799782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25332185|NCT04799782|Adrenergic Agents|adrenergic agents|mesh-ancestor
25332186|NCT04799782|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25332187|NCT04799782|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25332188|NCT04799782|Serotonin Agents|serotonin agents|mesh-ancestor
25332189|NCT04799782|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25332190|NCT04799743|Resveratrol|resveratrol|mesh-list
25332191|NCT04799743|Antioxidants|antioxidants|mesh-ancestor
25332192|NCT04799743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332193|NCT04799743|Protective Agents|protective agents|mesh-ancestor
25332194|NCT04799743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332195|NCT04799743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25332196|NCT04799743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25332198|NCT04799639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25332199|NCT04799639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332200|NCT04799639|Tubulin Modulators|tubulin modulators|mesh-ancestor
25332201|NCT04799639|Antimitotic Agents|antimitotic agents|mesh-ancestor
25332202|NCT04799639|Mitosis Modulators|mitosis modulators|mesh-ancestor
25332203|NCT04799639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332204|NCT04799314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25332205|NCT04799314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332206|NCT04799314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332207|NCT04799002|Melphalan|melphalan|mesh-list
25332208|NCT04799002|Topotecan|topotecan|mesh-list
25332292|NCT04797949|Analgesics|analgesics|mesh-ancestor
25332209|NCT04799002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25332210|NCT04799002|Alkylating Agents|alkylating agents|mesh-ancestor
25332211|NCT04799002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332212|NCT04799002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332213|NCT04799002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25332214|NCT04799002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25332215|NCT04799002|Immunologic Factors|immunologic factors|mesh-ancestor
25332216|NCT04799002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332217|NCT04799002|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25332218|NCT04799002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25332219|NCT04799002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25332220|NCT04799184|Epinephrine|epinephrine|mesh-list
25332221|NCT04799184|Racepinephrine|racepinephrine|mesh-list
25332222|NCT04799184|Bupivacaine|bupivacaine|mesh-list
25332223|NCT04799184|Levobupivacaine|levobupivacaine|mesh-list
25332224|NCT04799184|Epinephryl borate|epinephryl borate|mesh-list
25332225|NCT04799184|Anesthetics, Local|anesthetics, local|mesh-ancestor
25332226|NCT04799184|Anesthetics|anesthetics|mesh-ancestor
25332227|NCT04799184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25332228|NCT04799184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332229|NCT04799184|Sensory System Agents|sensory system agents|mesh-ancestor
25332230|NCT04799184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25332231|NCT04799184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25332232|NCT04799184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25332233|NCT04799184|Adrenergic Agents|adrenergic agents|mesh-ancestor
25332234|NCT04799184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25332235|NCT04799184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332236|NCT04799184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25332237|NCT04799184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25332238|NCT04799184|Autonomic Agents|autonomic agents|mesh-ancestor
25332239|NCT04799184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25332240|NCT04799184|Respiratory System Agents|respiratory system agents|mesh-ancestor
25332241|NCT04799184|Mydriatics|mydriatics|mesh-ancestor
25332242|NCT04799184|Sympathomimetics|sympathomimetics|mesh-ancestor
25332243|NCT04799184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25332244|NCT04798703|Paclitaxel|paclitaxel|mesh-list
25332245|NCT04798703|Hyaluronic Acid|hyaluronic acid|mesh-list
25332246|NCT04798703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25332247|NCT04798703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332248|NCT04798703|Tubulin Modulators|tubulin modulators|mesh-ancestor
25332249|NCT04798703|Antimitotic Agents|antimitotic agents|mesh-ancestor
25332250|NCT04798703|Mitosis Modulators|mitosis modulators|mesh-ancestor
25332254|NCT04798703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332255|NCT04798703|Viscosupplements|viscosupplements|mesh-ancestor
25332256|NCT04798703|Protective Agents|protective agents|mesh-ancestor
25332257|NCT04798729|Salicylic Acid|salicylic acid|mesh-list
25332258|NCT04798729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25332259|NCT04798729|Antifungal Agents|antifungal agents|mesh-ancestor
25332260|NCT04798729|Keratolytic Agents|keratolytic agents|mesh-ancestor
25332261|NCT04798729|Dermatologic Agents|dermatologic agents|mesh-ancestor
25332262|NCT04798612|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25332263|NCT04798612|Antiviral Agents|antiviral agents|mesh-ancestor
25332264|NCT04798612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25332265|NCT04798443|Hyaluronic Acid|hyaluronic acid|mesh-list
25332266|NCT04798443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25332267|NCT04798443|Immunologic Factors|immunologic factors|mesh-ancestor
25332268|NCT04798443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332269|NCT04798443|Viscosupplements|viscosupplements|mesh-ancestor
25332270|NCT04798443|Protective Agents|protective agents|mesh-ancestor
25332271|NCT04798313|Denosumab|denosumab|mesh-list
25332272|NCT04798313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25332273|NCT04798313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332274|NCT04798391|Dexamethasone|dexamethasone|mesh-list
25332275|NCT04798391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25332276|NCT04798391|Antiemetics|antiemetics|mesh-ancestor
25332277|NCT04798391|Autonomic Agents|autonomic agents|mesh-ancestor
25332278|NCT04798391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25332279|NCT04798391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332280|NCT04798391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25332281|NCT04798391|Glucocorticoids|glucocorticoids|mesh-ancestor
25332282|NCT04798391|Hormones|hormones|mesh-ancestor
25332283|NCT04798391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25332284|NCT04798391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25332285|NCT04798391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332289|NCT04797949|Aspirin|aspirin|mesh-list
25332290|NCT04797949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25332291|NCT04797949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25332293|NCT04797949|Sensory System Agents|sensory system agents|mesh-ancestor
25332294|NCT04797949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740900|NCT01690572|Mitosis Modulators|mitosis modulators|mesh-ancestor
24741039|NCT01691456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24741040|NCT01691456|Respiratory System Agents|respiratory system agents|mesh-ancestor
24741041|NCT01691456|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24741042|NCT01691456|Hormone Antagonists|hormone antagonists|mesh-ancestor
24742505|NCT05257447|Chlorzoxazone|chlorzoxazone|mesh-list
24742506|NCT05257447|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24742507|NCT05257447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742508|NCT05257447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25332295|NCT04797949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332296|NCT04797949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25332297|NCT04797949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25332298|NCT04797949|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25332299|NCT04797949|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25332300|NCT04797949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332301|NCT04797949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25332302|NCT04797949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25332303|NCT04797949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25332304|NCT04797949|Antipyretics|antipyretics|mesh-ancestor
25332305|NCT04797832|Ferric gluconate|ferric gluconate|mesh-list
25332306|NCT04797832|Hematinics|hematinics|mesh-ancestor
25332307|NCT04797546|Morphine|morphine|mesh-list
25332308|NCT04797546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25332309|NCT04797546|Narcotics|narcotics|mesh-ancestor
25332310|NCT04797546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25332311|NCT04797546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332312|NCT04797546|Analgesics|analgesics|mesh-ancestor
25332313|NCT04797546|Sensory System Agents|sensory system agents|mesh-ancestor
25332314|NCT04797546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25332315|NCT04797793|Adapalene|adapalene|mesh-list
25332316|NCT04797793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25332317|NCT04797793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25332318|NCT04797793|Analgesics|analgesics|mesh-ancestor
24600840|NCT00960830|Mirtazapine|mirtazapine|mesh-list
25332319|NCT04797793|Sensory System Agents|sensory system agents|mesh-ancestor
25332320|NCT04797793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25332321|NCT04797793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332322|NCT04797793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25332323|NCT04797793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25332324|NCT04797793|Dermatologic Agents|dermatologic agents|mesh-ancestor
25332325|NCT04797338|Nafarelin|nafarelin|mesh-list
25332326|NCT04797338|Progesterone|progesterone|mesh-list
25332334|NCT04797338|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25332335|NCT04797338|Hormone Antagonists|hormone antagonists|mesh-ancestor
25332336|NCT04797338|Estrogens|estrogens|mesh-ancestor
25332337|NCT04797338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25332338|NCT04797338|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25332339|NCT04797338|Fertility Agents|fertility agents|mesh-ancestor
25332347|NCT04797013|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25332348|NCT04797013|Plasminogen|plasminogen|mesh-list
25332349|NCT04797013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25332350|NCT04797013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25332351|NCT04797013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332352|NCT04796857|Lenalidomide|lenalidomide|mesh-list
25332354|NCT04796857|Immunologic Factors|immunologic factors|mesh-ancestor
25332355|NCT04796857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332356|NCT04796857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25332357|NCT04796857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25332358|NCT04796857|Growth Substances|growth substances|mesh-ancestor
25332359|NCT04796857|Growth Inhibitors|growth inhibitors|mesh-ancestor
25332360|NCT04796857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332361|NCT04796623|Fulvestrant|fulvestrant|mesh-list
25332362|NCT04796623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25332363|NCT04796623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332364|NCT04796623|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25332365|NCT04796623|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25649384|NCT01490866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25649385|NCT01490866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649386|NCT01490918|Metformin|metformin|mesh-list
25649387|NCT01490918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25649388|NCT01490918|Acarbose|acarbose|mesh-list
25649389|NCT01490918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25649390|NCT01490918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649391|NCT01490918|Incretins|incretins|mesh-ancestor
25649392|NCT01490918|Hormones|hormones|mesh-ancestor
25649393|NCT01490918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25006881|NCT04568902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006882|NCT04568902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006883|NCT04566692|Immunoglobulins|immunoglobulins|mesh-list
25006884|NCT04566692|gamma-Globulins|gamma-globulins|mesh-list
25006885|NCT04566692|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25006886|NCT04566692|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25006887|NCT04566692|Immunologic Factors|immunologic factors|mesh-ancestor
24745456|NCT03770299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332366|NCT04796623|Hormone Antagonists|hormone antagonists|mesh-ancestor
25332367|NCT04796623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25332368|NCT04796623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332369|NCT04796688|Cyclophosphamide|cyclophosphamide|mesh-list
25332370|NCT04796688|Fludarabine|fludarabine|mesh-list
25332371|NCT04796688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25332372|NCT04796688|Immunologic Factors|immunologic factors|mesh-ancestor
25332373|NCT04796688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332374|NCT04796688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25332375|NCT04796688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25332376|NCT04796688|Alkylating Agents|alkylating agents|mesh-ancestor
25332377|NCT04796688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332378|NCT04796688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332379|NCT04796688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25332380|NCT04796402|Bamlanivimab|bamlanivimab|mesh-list
25332381|NCT04796402|Antiviral Agents|antiviral agents|mesh-ancestor
25332382|NCT04796402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25332383|NCT04796714|Aspirin|aspirin|mesh-list
25332384|NCT04796714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25332385|NCT04796714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25332386|NCT04796714|Analgesics|analgesics|mesh-ancestor
25332387|NCT04796714|Sensory System Agents|sensory system agents|mesh-ancestor
25332388|NCT04796714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25019468|NCT03691090|Paclitaxel|paclitaxel|mesh-list
24636557|NCT01146028|Adrenergic Agents|adrenergic agents|mesh-ancestor
24636558|NCT01146028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24636559|NCT01146028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332389|NCT04796714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332390|NCT04796714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25332391|NCT04796714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25332392|NCT04796714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25332393|NCT04796714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25332394|NCT04796714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332395|NCT04796714|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25332396|NCT04796714|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25332408|NCT04796675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25332409|NCT04796675|Immunologic Factors|immunologic factors|mesh-ancestor
25332410|NCT04796675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332411|NCT04796675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25332412|NCT04796675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25332413|NCT04796675|Alkylating Agents|alkylating agents|mesh-ancestor
25332414|NCT04796675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332415|NCT04796675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332416|NCT04796675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25332417|NCT04796025|Bevacizumab|bevacizumab|mesh-list
25332418|NCT04796025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25332419|NCT04796025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332420|NCT04796025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25332421|NCT04796025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25332422|NCT04796025|Growth Substances|growth substances|mesh-ancestor
25332423|NCT04796025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332424|NCT04796025|Growth Inhibitors|growth inhibitors|mesh-ancestor
25332437|NCT04795479|Moxifloxacin|moxifloxacin|mesh-list
25332438|NCT04795479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25332439|NCT04795479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25332440|NCT04795479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25332441|NCT04795479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25649394|NCT01490918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25649395|NCT01490918|Protease Inhibitors|protease inhibitors|mesh-ancestor
25649396|NCT01490918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649397|NCT01490918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649398|NCT01490918|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25649399|NCT01490931|Ketorolac|ketorolac|mesh-list
25649400|NCT01490931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24618747|NCT01049633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748688|NCT02215980|Lenalidomide|lenalidomide|mesh-list
24748689|NCT02215980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24748690|NCT02215980|Antiemetics|antiemetics|mesh-ancestor
24748691|NCT02215980|Autonomic Agents|autonomic agents|mesh-ancestor
24748905|NCT01996267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748906|NCT01996267|Tubulin Modulators|tubulin modulators|mesh-ancestor
24748907|NCT01996267|Antimitotic Agents|antimitotic agents|mesh-ancestor
25332442|NCT04795479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25332443|NCT04795479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332444|NCT04795479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332445|NCT04794738|Morphine|morphine|mesh-list
25332446|NCT04794738|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25332447|NCT04794738|Narcotics|narcotics|mesh-ancestor
25332448|NCT04794738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25332449|NCT04794738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332450|NCT04794738|Analgesics|analgesics|mesh-ancestor
25332451|NCT04794738|Sensory System Agents|sensory system agents|mesh-ancestor
25332452|NCT04794738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25332466|NCT04794426|Fluorides|fluorides|mesh-list
25332467|NCT04794426|Cariostatic Agents|cariostatic agents|mesh-ancestor
25332468|NCT04794426|Protective Agents|protective agents|mesh-ancestor
25332469|NCT04794426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332470|NCT04794231|Chlorhexidine|chlorhexidine|mesh-list
25332471|NCT04794231|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25332472|NCT04794231|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25332479|NCT04794413|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25332480|NCT04794413|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25332481|NCT04794413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25332482|NCT04794413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332483|NCT04794413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25332484|NCT04794413|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25332485|NCT04794413|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25332487|NCT04794413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25332488|NCT04794413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332489|NCT04794504|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25332490|NCT04794504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25332491|NCT04794504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25332492|NCT04794504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332493|NCT04794504|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25332494|NCT04794504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25332495|NCT04794504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332496|NCT04794504|Cholinergic Agents|cholinergic agents|mesh-ancestor
25332497|NCT04794504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25332499|NCT04794049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25332500|NCT04794127|Pioglitazone|pioglitazone|mesh-list
25332501|NCT04794127|Trabectedin|trabectedin|mesh-list
25332502|NCT04794127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25332503|NCT04794127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332504|NCT04794127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25332505|NCT04794127|Alkylating Agents|alkylating agents|mesh-ancestor
25332506|NCT04794127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332507|NCT04794127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332508|NCT04794088|Imatinib Mesylate|imatinib mesylate|mesh-list
25332509|NCT04794088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332510|NCT04794088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25332511|NCT04794088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25332512|NCT04794088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332520|NCT04793711|Decanoic acid|decanoic acid|mesh-list
25332521|NCT04793711|Antifungal Agents|antifungal agents|mesh-ancestor
25332522|NCT04793711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25332523|NCT04793529|Cholecalciferol|cholecalciferol|mesh-list
25332524|NCT04793529|Vitamin D|vitamin d|mesh-list
25332525|NCT04793529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25332526|NCT04793529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332527|NCT04793529|Vitamins|vitamins|mesh-ancestor
25649401|NCT01490931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25649402|NCT01490931|Analgesics|analgesics|mesh-ancestor
25649403|NCT01490931|Sensory System Agents|sensory system agents|mesh-ancestor
25649404|NCT01490931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25649405|NCT01490931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649406|NCT01490931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25649407|NCT01490931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25649408|NCT01490931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25332528|NCT04793529|Micronutrients|micronutrients|mesh-ancestor
25332529|NCT04793529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25332530|NCT04793256|Listerine|listerine|mesh-list
25332531|NCT04793256|Fluorides|fluorides|mesh-list
25332532|NCT04793256|Sodium Fluoride|sodium fluoride|mesh-list
25332533|NCT04793256|Fluorides, Topical|fluorides, topical|mesh-list
25332534|NCT04793256|Cariostatic Agents|cariostatic agents|mesh-ancestor
25332535|NCT04793256|Protective Agents|protective agents|mesh-ancestor
25332536|NCT04793256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332537|NCT04793256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25332538|NCT04793256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25332539|NCT04793243|Vitamin D|vitamin d|mesh-list
25332540|NCT04793243|Cholecalciferol|cholecalciferol|mesh-list
25332541|NCT04793243|Vitamins|vitamins|mesh-ancestor
25332542|NCT04793243|Micronutrients|micronutrients|mesh-ancestor
25332543|NCT04793243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332544|NCT04793243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25332545|NCT04793243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25332546|NCT04793399|Atezolizumab|atezolizumab|mesh-list
25332547|NCT04793399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332548|NCT04793152|Vancomycin|vancomycin|mesh-list
25332549|NCT04793152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25332550|NCT04793152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25332551|NCT04793022|Anesthetics|anesthetics|mesh-list
25332552|NCT04793022|Propofol|propofol|mesh-list
25332553|NCT04793022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25332554|NCT04793022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332555|NCT04793022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25332556|NCT04793022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25332557|NCT04793022|Anesthetics, General|anesthetics, general|mesh-ancestor
25332558|NCT04792723|Aspirin|aspirin|mesh-list
25332559|NCT04792723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25332560|NCT04792723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25332561|NCT04792723|Analgesics|analgesics|mesh-ancestor
25332562|NCT04792723|Sensory System Agents|sensory system agents|mesh-ancestor
25332563|NCT04792723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25332564|NCT04792723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332565|NCT04792723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25332566|NCT04792723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25332567|NCT04792723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25332568|NCT04792723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25332569|NCT04792723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332570|NCT04792723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25332571|NCT04792723|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25332572|NCT04792723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25332573|NCT04792723|Antipyretics|antipyretics|mesh-ancestor
25332574|NCT04792645|Memantine|memantine|mesh-list
25332575|NCT04792645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25332576|NCT04792645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25332577|NCT04792645|Dopamine Agents|dopamine agents|mesh-ancestor
25332578|NCT04792645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25332579|NCT04792645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332580|NCT04792645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332581|NCT04792645|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25332582|NCT04792645|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25332583|NCT04792749|Metformin|metformin|mesh-list
25332584|NCT04792749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25332585|NCT04792749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332586|NCT04792710|Metronidazole|metronidazole|mesh-list
25332587|NCT04792710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25332588|NCT04792710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25332589|NCT04792710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25332590|NCT04792710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25332591|NCT04792840|Letrozole|letrozole|mesh-list
25332592|NCT04792840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332593|NCT04792840|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25332594|NCT04792840|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24605021|NCT00982891|Analgesics|analgesics|mesh-ancestor
25332595|NCT04792840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25332596|NCT04792840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332597|NCT04792840|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25332598|NCT04792840|Hormone Antagonists|hormone antagonists|mesh-ancestor
25332599|NCT04792840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25332600|NCT04792840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332601|NCT04792398|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25332602|NCT04792398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25408568|NCT03434379|Sorafenib|sorafenib|mesh-list
24400346|NCT00150384|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24400347|NCT00150384|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24400379|NCT00150436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24440552|NCT00283699|Albendazole|albendazole|mesh-list
24790143|NCT01941056|Immunologic Factors|immunologic factors|mesh-ancestor
24790144|NCT01941056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332603|NCT04792398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25332604|NCT04792398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332605|NCT04792398|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25332606|NCT04792398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25332607|NCT04792398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332608|NCT04792398|Cholinergic Agents|cholinergic agents|mesh-ancestor
25332609|NCT04792398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25332611|NCT04792333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25332612|NCT04792320|Charcoal|charcoal|mesh-list
25332613|NCT04792320|Antidotes|antidotes|mesh-ancestor
25332614|NCT04792320|Protective Agents|protective agents|mesh-ancestor
25332615|NCT04792320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332616|NCT04792138|Phenobarbital|phenobarbital|mesh-list
25332617|NCT04792138|Anticonvulsants|anticonvulsants|mesh-ancestor
25332618|NCT04792138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25332619|NCT04792138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25332620|NCT04792138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332621|NCT04792138|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25332622|NCT04792138|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25332845|NCT04789915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25332623|NCT04792138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25332624|NCT04792138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332625|NCT04792138|GABA Modulators|gaba modulators|mesh-ancestor
25332626|NCT04792138|GABA Agents|gaba agents|mesh-ancestor
25332627|NCT04792138|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25332628|NCT04792138|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25332629|NCT04792138|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25332630|NCT04792515|Apatinib|apatinib|mesh-list
25332631|NCT04792515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332632|NCT04792515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25332633|NCT04792515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25332634|NCT04792515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332635|NCT04792034|Cocaine|cocaine|mesh-list
25332636|NCT04792034|Anesthetics, Local|anesthetics, local|mesh-ancestor
25332637|NCT04792034|Anesthetics|anesthetics|mesh-ancestor
25332638|NCT04792034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25332639|NCT04792034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332640|NCT04792034|Sensory System Agents|sensory system agents|mesh-ancestor
25332641|NCT04792034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25332642|NCT04792034|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25332643|NCT04792034|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25332644|NCT04792034|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25332645|NCT04792034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25332646|NCT04792034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332647|NCT04792034|Dopamine Agents|dopamine agents|mesh-ancestor
25332648|NCT04792034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25332649|NCT04791774|Caseins|caseins|mesh-list
25332650|NCT04791774|Chelating Agents|chelating agents|mesh-ancestor
25332651|NCT04791774|Sequestering Agents|sequestering agents|mesh-ancestor
25332652|NCT04791774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605835|NCT00987636|Busulfan|busulfan|mesh-list
25332653|NCT04791345|Dexamethasone|dexamethasone|mesh-list
25332654|NCT04791345|Dexamethasone acetate|dexamethasone acetate|mesh-list
25332655|NCT04791345|Methylprednisolone|methylprednisolone|mesh-list
25332656|NCT04791345|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25332657|NCT04791345|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25332658|NCT04791345|Prednisolone|prednisolone|mesh-list
25332659|NCT04791345|Prednisolone acetate|prednisolone acetate|mesh-list
25332660|NCT04791345|Deflazacort|deflazacort|mesh-list
25332661|NCT04791345|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25332662|NCT04791345|Prednisolone phosphate|prednisolone phosphate|mesh-list
25332663|NCT04791345|BB 1101|bb 1101|mesh-list
25649409|NCT01490931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649410|NCT01490931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649411|NCT01491022|4-Aminopyridine|4-aminopyridine|mesh-list
25649412|NCT01491022|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25649413|NCT01491022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25332664|NCT04791345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25332665|NCT04791345|Antiemetics|antiemetics|mesh-ancestor
25332666|NCT04791345|Autonomic Agents|autonomic agents|mesh-ancestor
25332667|NCT04791345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25332668|NCT04791345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332669|NCT04791345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25332670|NCT04791345|Glucocorticoids|glucocorticoids|mesh-ancestor
25332671|NCT04791345|Hormones|hormones|mesh-ancestor
25332672|NCT04791345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25332673|NCT04791345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25332674|NCT04791345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332675|NCT04791345|Protease Inhibitors|protease inhibitors|mesh-ancestor
25332676|NCT04791345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25332677|NCT04791345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332678|NCT04791345|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25332679|NCT04791345|Protective Agents|protective agents|mesh-ancestor
25332680|NCT04791345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25332681|NCT04791345|Immunologic Factors|immunologic factors|mesh-ancestor
25332682|NCT04791332|Aticaprant|aticaprant|mesh-list
25332683|NCT04791332|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25332684|NCT04791332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332685|NCT04791332|Sensory System Agents|sensory system agents|mesh-ancestor
25332686|NCT04791332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25332687|NCT04791566|Dexamethasone|dexamethasone|mesh-list
25332688|NCT04791566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25332689|NCT04791566|Antiemetics|antiemetics|mesh-ancestor
25332690|NCT04791566|Autonomic Agents|autonomic agents|mesh-ancestor
25332691|NCT04791566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25332692|NCT04791566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332693|NCT04791566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25332694|NCT04791566|Glucocorticoids|glucocorticoids|mesh-ancestor
25332695|NCT04791566|Hormones|hormones|mesh-ancestor
25332696|NCT04791566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25825578|NCT00005604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332697|NCT04791566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25332698|NCT04791566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332700|NCT04791202|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25332701|NCT04791202|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25332702|NCT04791202|Prednisolone|prednisolone|mesh-list
25332703|NCT04791202|Prednisolone acetate|prednisolone acetate|mesh-list
25332704|NCT04791202|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25332705|NCT04791202|Prednisolone phosphate|prednisolone phosphate|mesh-list
25332706|NCT04791202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25332707|NCT04791202|Antiemetics|antiemetics|mesh-ancestor
25332708|NCT04791202|Autonomic Agents|autonomic agents|mesh-ancestor
25332709|NCT04791202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25332710|NCT04791202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332711|NCT04791202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25332712|NCT04791202|Glucocorticoids|glucocorticoids|mesh-ancestor
25332713|NCT04791202|Hormones|hormones|mesh-ancestor
25332714|NCT04791202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25332715|NCT04791202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25332716|NCT04791202|Protective Agents|protective agents|mesh-ancestor
25332717|NCT04791202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25332718|NCT04791202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332719|NCT04790838|Fluticasone|fluticasone|mesh-list
25332720|NCT04790838|Xhance|xhance|mesh-list
25332721|NCT04790838|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25332722|NCT04790838|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25332723|NCT04790838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25332724|NCT04790838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25332725|NCT04790838|Autonomic Agents|autonomic agents|mesh-ancestor
25332726|NCT04790838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25332727|NCT04790838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825579|NCT00005604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25332728|NCT04790838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25332729|NCT04790838|Respiratory System Agents|respiratory system agents|mesh-ancestor
25332730|NCT04790838|Dermatologic Agents|dermatologic agents|mesh-ancestor
25332731|NCT04790838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25332732|NCT04790838|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25332733|NCT04790838|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25332734|NCT04790838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25332735|NCT04790838|Adrenergic Agents|adrenergic agents|mesh-ancestor
25332736|NCT04790838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25332737|NCT04790838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332738|NCT04790838|Glucocorticoids|glucocorticoids|mesh-ancestor
25332740|NCT04790838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25332741|NCT04790838|Sympathomimetics|sympathomimetics|mesh-ancestor
25332742|NCT04791020|Lidocaine|lidocaine|mesh-list
25332743|NCT04791020|Anesthetics, Local|anesthetics, local|mesh-ancestor
25332744|NCT04791020|Anesthetics|anesthetics|mesh-ancestor
25332745|NCT04791020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25332746|NCT04791020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332747|NCT04791020|Sensory System Agents|sensory system agents|mesh-ancestor
25332748|NCT04791020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25332749|NCT04791020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25332750|NCT04791020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25332751|NCT04791020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25332752|NCT04791020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25332753|NCT04791020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332754|NCT04790812|Acetaminophen|acetaminophen|mesh-list
25332755|NCT04790812|Celecoxib|celecoxib|mesh-list
25332756|NCT04790812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25332757|NCT04790812|Analgesics|analgesics|mesh-ancestor
25332758|NCT04790812|Sensory System Agents|sensory system agents|mesh-ancestor
25332759|NCT04790812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25332760|NCT04790812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332761|NCT04790812|Antipyretics|antipyretics|mesh-ancestor
25332762|NCT04790812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25332763|NCT04790812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25332764|NCT04790812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25332765|NCT04790812|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25332766|NCT04790812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25332767|NCT04790812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25332768|NCT04790812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332769|NCT04791046|Antihypertensive Agents|antihypertensive agents|mesh-list
25332781|NCT04790708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25332782|NCT04790708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332783|NCT04790487|Chlorpheniramine|chlorpheniramine|mesh-list
25332784|NCT04790487|Antipruritics|antipruritics|mesh-ancestor
25332785|NCT04790487|Dermatologic Agents|dermatologic agents|mesh-ancestor
25332786|NCT04790487|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25332787|NCT04790487|Histamine Antagonists|histamine antagonists|mesh-ancestor
25332788|NCT04790487|Histamine Agents|histamine agents|mesh-ancestor
25332789|NCT04790487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25332790|NCT04790487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332791|NCT04790487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332792|NCT04790487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25332793|NCT04790448|Irinotecan|irinotecan|mesh-list
25332794|NCT04790448|Camptothecin|camptothecin|mesh-list
25332795|NCT04790448|Cetuximab|cetuximab|mesh-list
25332796|NCT04790448|Vemurafenib|vemurafenib|mesh-list
25332797|NCT04790448|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25332798|NCT04790448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25332799|NCT04790448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25332800|NCT04790448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332801|NCT04790448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332802|NCT04790448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25332803|NCT04790448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25332804|NCT04790448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25332805|NCT04790331|Verapamil|verapamil|mesh-list
25332806|NCT04790331|Diltiazem|diltiazem|mesh-list
25332807|NCT04790331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25332808|NCT04790331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25332809|NCT04790331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25332810|NCT04790331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332811|NCT04790331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25332812|NCT04790331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332813|NCT04790331|Vasodilator Agents|vasodilator agents|mesh-ancestor
25332814|NCT04790331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25332815|NCT04790136|Cannabidiol|cannabidiol|mesh-list
25332816|NCT04790136|Anticonvulsants|anticonvulsants|mesh-ancestor
25332828|NCT04789941|Irinotecan|irinotecan|mesh-list
25332829|NCT04789941|Cisplatin|cisplatin|mesh-list
25332830|NCT04789941|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25332831|NCT04789941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25332832|NCT04789941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25332833|NCT04789941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649414|NCT01491022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332834|NCT04789941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332835|NCT04789915|Memantine|memantine|mesh-list
25332836|NCT04789915|Amisulpride|amisulpride|mesh-list
25332837|NCT04789915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25332838|NCT04789915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25332839|NCT04789915|Dopamine Agents|dopamine agents|mesh-ancestor
25332840|NCT04789915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25332841|NCT04789915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332842|NCT04789915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332843|NCT04789915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25332844|NCT04789915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25332862|NCT04789005|Oxymetazoline|oxymetazoline|mesh-list
25332863|NCT04789005|Norepinephrine|norepinephrine|mesh-list
25332864|NCT04789005|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25332865|NCT04789005|Mydriatics|mydriatics|mesh-ancestor
25332866|NCT04789005|Autonomic Agents|autonomic agents|mesh-ancestor
25332867|NCT04789005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25332868|NCT04789005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332869|NCT04789005|Sympathomimetics|sympathomimetics|mesh-ancestor
25332870|NCT04789005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25332871|NCT04789005|Nasal Decongestants|nasal decongestants|mesh-ancestor
25332872|NCT04789005|Respiratory System Agents|respiratory system agents|mesh-ancestor
25332873|NCT04789005|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25332874|NCT04789005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25332875|NCT04789005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25332876|NCT04789005|Adrenergic Agents|adrenergic agents|mesh-ancestor
25332877|NCT04789005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25332878|NCT04789005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332879|NCT04789005|Protective Agents|protective agents|mesh-ancestor
25332880|NCT04788979|Melatonin|melatonin|mesh-list
25332881|NCT04788979|Antioxidants|antioxidants|mesh-ancestor
25332882|NCT04788979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332883|NCT04788979|Protective Agents|protective agents|mesh-ancestor
25332884|NCT04788979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332885|NCT04788979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25332886|NCT04788914|Charcoal|charcoal|mesh-list
25332887|NCT04788914|Antidotes|antidotes|mesh-ancestor
25332888|NCT04788914|Protective Agents|protective agents|mesh-ancestor
25332889|NCT04788914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332890|NCT04788654|Acetaminophen|acetaminophen|mesh-list
25332891|NCT04788654|Dexamethasone|dexamethasone|mesh-list
25332892|NCT04788654|Celecoxib|celecoxib|mesh-list
25332893|NCT04788654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25332894|NCT04788654|Antiemetics|antiemetics|mesh-ancestor
25332895|NCT04788654|Autonomic Agents|autonomic agents|mesh-ancestor
25332896|NCT04788654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25332897|NCT04788654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332898|NCT04788654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25332899|NCT04788654|Glucocorticoids|glucocorticoids|mesh-ancestor
25332900|NCT04788654|Hormones|hormones|mesh-ancestor
25332901|NCT04788654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25332902|NCT04788654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25332903|NCT04788654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332904|NCT04788654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25332905|NCT04788654|Analgesics|analgesics|mesh-ancestor
25332906|NCT04788654|Sensory System Agents|sensory system agents|mesh-ancestor
25332907|NCT04788654|Antipyretics|antipyretics|mesh-ancestor
25332908|NCT04788654|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25332909|NCT04788654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25332910|NCT04788654|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25332911|NCT04788654|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25332912|NCT04788654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25333045|NCT04786158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25332913|NCT04788654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332932|NCT04788355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25332933|NCT04788355|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25332934|NCT04788355|Antithrombins|antithrombins|mesh-ancestor
25332935|NCT04788355|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25020236|NCT03682172|Glucagon|glucagon|mesh-list
25332936|NCT04788355|Protease Inhibitors|protease inhibitors|mesh-ancestor
25332937|NCT04788355|Anticoagulants|anticoagulants|mesh-ancestor
25332938|NCT04788381|Bevacizumab|bevacizumab|mesh-list
25332939|NCT04788381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25408569|NCT03434379|Atezolizumab|atezolizumab|mesh-list
25332940|NCT04788381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25332941|NCT04788381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25332942|NCT04788381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25332943|NCT04788381|Growth Substances|growth substances|mesh-ancestor
25332944|NCT04788381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332945|NCT04788381|Growth Inhibitors|growth inhibitors|mesh-ancestor
25332946|NCT04788407|Nitazoxanide|nitazoxanide|mesh-list
25332947|NCT04788407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25332948|NCT04788407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25332949|NCT04788121|Tranexamic Acid|tranexamic acid|mesh-list
25332950|NCT04788121|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25332951|NCT04788121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25332952|NCT04788121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332953|NCT04788121|Hemostatics|hemostatics|mesh-ancestor
25332954|NCT04788121|Coagulants|coagulants|mesh-ancestor
25332955|NCT04788186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25332956|NCT04788186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25332957|NCT04788186|Adrenergic Agents|adrenergic agents|mesh-ancestor
25332958|NCT04788186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25332959|NCT04788186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332960|NCT04788186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332961|NCT04787848|Bromides|bromides|mesh-list
25332962|NCT04787848|Methylnaltrexone|methylnaltrexone|mesh-list
25332963|NCT04787848|Anticonvulsants|anticonvulsants|mesh-ancestor
25332964|NCT04787848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25332965|NCT04787848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332966|NCT04787848|Sensory System Agents|sensory system agents|mesh-ancestor
25332967|NCT04787848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25332968|NCT04787510|Heparin|heparin|mesh-list
25332969|NCT04787510|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25332970|NCT04787510|Tinzaparin|tinzaparin|mesh-list
25332971|NCT04787510|Dalteparin|dalteparin|mesh-list
25332972|NCT04787510|Anticoagulants|anticoagulants|mesh-ancestor
25332973|NCT04787510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25332974|NCT04787510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25332975|NCT04787510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25332986|NCT04787731|Lidocaine|lidocaine|mesh-list
25332987|NCT04787731|Bupivacaine|bupivacaine|mesh-list
25332988|NCT04787731|Anesthetics, Local|anesthetics, local|mesh-list
25332989|NCT04787731|Anesthetics|anesthetics|mesh-list
25332990|NCT04787731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25332991|NCT04787731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25332992|NCT04787731|Sensory System Agents|sensory system agents|mesh-ancestor
25332993|NCT04787731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25332994|NCT04787731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25332995|NCT04787731|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25333009|NCT04787276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25333010|NCT04787276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25333011|NCT04787276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25333012|NCT04786795|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25333013|NCT04786795|Pancreatin|pancreatin|mesh-list
25333014|NCT04786795|Pancrelipase|pancrelipase|mesh-list
25333015|NCT04786795|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25333016|NCT04786795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25333017|NCT04786613|Hyaluronic Acid|hyaluronic acid|mesh-list
25333018|NCT04786613|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25333019|NCT04786613|Immunologic Factors|immunologic factors|mesh-ancestor
25333020|NCT04786613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333021|NCT04786613|Viscosupplements|viscosupplements|mesh-ancestor
25333022|NCT04786613|Protective Agents|protective agents|mesh-ancestor
25333037|NCT04786158|Apomorphine|apomorphine|mesh-list
25333038|NCT04786158|Emetics|emetics|mesh-ancestor
25333039|NCT04786158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333040|NCT04786158|Autonomic Agents|autonomic agents|mesh-ancestor
25333041|NCT04786158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25333042|NCT04786158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25333043|NCT04786158|Dopamine Agonists|dopamine agonists|mesh-ancestor
25333044|NCT04786158|Dopamine Agents|dopamine agents|mesh-ancestor
25333046|NCT04786158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25333047|NCT04786327|Edetic Acid|edetic acid|mesh-list
25333048|NCT04786327|Mitogens|mitogens|mesh-list
25333049|NCT04786327|Pentetic Acid|pentetic acid|mesh-list
25333050|NCT04786327|Mitosis Modulators|mitosis modulators|mesh-ancestor
25649415|NCT01491035|Vortioxetine|vortioxetine|mesh-list
25333051|NCT04786327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25333052|NCT04786327|Anticoagulants|anticoagulants|mesh-ancestor
25825582|NCT00005604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25333053|NCT04786327|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25333054|NCT04786327|Chelating Agents|chelating agents|mesh-ancestor
25333055|NCT04786327|Sequestering Agents|sequestering agents|mesh-ancestor
25333056|NCT04786327|Antidotes|antidotes|mesh-ancestor
25333057|NCT04786327|Protective Agents|protective agents|mesh-ancestor
25333058|NCT04786327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333059|NCT04786327|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25333060|NCT04786470|Ropivacaine|ropivacaine|mesh-list
25333061|NCT04786470|Anesthetics, Local|anesthetics, local|mesh-ancestor
25333062|NCT04786470|Anesthetics|anesthetics|mesh-ancestor
25333063|NCT04786470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25333064|NCT04786470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333065|NCT04786470|Sensory System Agents|sensory system agents|mesh-ancestor
25333066|NCT04786470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25333067|NCT04785716|Niraparib|niraparib|mesh-list
25333068|NCT04785716|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25333069|NCT04785716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25333070|NCT04785716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25333071|NCT04785716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25333072|NCT04785755|Etilefrine|etilefrine|mesh-list
25333082|NCT04785755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25333083|NCT04785755|Hormone Antagonists|hormone antagonists|mesh-ancestor
25333084|NCT04785755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25333085|NCT04785755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25333086|NCT04785755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25333087|NCT04785755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25333088|NCT04785755|Adrenergic Agents|adrenergic agents|mesh-ancestor
25333089|NCT04785755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25333090|NCT04785755|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25333091|NCT04785755|Sympathomimetics|sympathomimetics|mesh-ancestor
25333092|NCT04785755|Autonomic Agents|autonomic agents|mesh-ancestor
25333093|NCT04785755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25333094|NCT04785755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25333095|NCT04785755|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25333096|NCT04785755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25333097|NCT04785755|Protective Agents|protective agents|mesh-ancestor
25333098|NCT04786002|Busulfan|busulfan|mesh-list
25333099|NCT04786002|Alkylating Agents|alkylating agents|mesh-ancestor
25333100|NCT04786002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25333101|NCT04786002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25333102|NCT04786002|Immunologic Factors|immunologic factors|mesh-ancestor
25333103|NCT04786002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333104|NCT04786002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25333105|NCT04786002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25333106|NCT04786002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25333107|NCT04785911|Antiemetics|antiemetics|mesh-list
25333108|NCT04785911|Histamine|histamine|mesh-list
25333109|NCT04785911|Histamine Agonists|histamine agonists|mesh-ancestor
25333110|NCT04785911|Histamine Agents|histamine agents|mesh-ancestor
25333111|NCT04785911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25333112|NCT04785911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25333113|NCT04785911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333114|NCT04785911|Autonomic Agents|autonomic agents|mesh-ancestor
25333115|NCT04785911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25333116|NCT04785911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25333117|NCT04785768|Morphine|morphine|mesh-list
25333118|NCT04785768|Hydromorphone|hydromorphone|mesh-list
25333119|NCT04785768|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25333120|NCT04785768|Narcotics|narcotics|mesh-ancestor
25333121|NCT04785768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25333122|NCT04785768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333123|NCT04785768|Analgesics|analgesics|mesh-ancestor
25333124|NCT04785768|Sensory System Agents|sensory system agents|mesh-ancestor
25333125|NCT04785768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25333126|NCT04785547|Blinatumomab|blinatumomab|mesh-list
25333127|NCT04785547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25333137|NCT04785183|Melatonin|melatonin|mesh-list
25333138|NCT04785183|Antioxidants|antioxidants|mesh-ancestor
24695604|NCT02767882|Glucocorticoids|glucocorticoids|mesh-ancestor
25333139|NCT04785183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25333140|NCT04785183|Protective Agents|protective agents|mesh-ancestor
25333141|NCT04785183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333142|NCT04785183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25333143|NCT04785118|Scopolamine|scopolamine|mesh-list
24443634|NCT00295555|Adrenergic Agents|adrenergic agents|mesh-ancestor
25825583|NCT00005604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825584|NCT00005604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25825585|NCT00005604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25825586|NCT00005604|Antiviral Agents|antiviral agents|mesh-ancestor
25825587|NCT00005604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25825588|NCT00005604|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25825589|NCT00005604|Immunologic Factors|immunologic factors|mesh-ancestor
24579180|NCT00853697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25333144|NCT04785118|Ondansetron|ondansetron|mesh-list
25333145|NCT04785118|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25333146|NCT04785118|Antiemetics|antiemetics|mesh-ancestor
25333147|NCT04785118|Autonomic Agents|autonomic agents|mesh-ancestor
25333156|NCT04785118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25333158|NCT04785118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25333159|NCT04785118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25333160|NCT04785118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25333161|NCT04785118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25333162|NCT04785118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25333163|NCT04785118|Mydriatics|mydriatics|mesh-ancestor
25333164|NCT04785118|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25333165|NCT04785118|Cholinergic Agents|cholinergic agents|mesh-ancestor
25333166|NCT04785118|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25333167|NCT04785118|Parasympatholytics|parasympatholytics|mesh-ancestor
25333168|NCT04785222|Dexmedetomidine|dexmedetomidine|mesh-list
25333169|NCT04785222|Bupivacaine|bupivacaine|mesh-list
25333170|NCT04785222|Anesthetics, Local|anesthetics, local|mesh-ancestor
25333171|NCT04785222|Anesthetics|anesthetics|mesh-ancestor
25333172|NCT04785222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25333173|NCT04785222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333174|NCT04785222|Sensory System Agents|sensory system agents|mesh-ancestor
25333175|NCT04785222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25333176|NCT04785222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25333177|NCT04785222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25333178|NCT04785222|Analgesics|analgesics|mesh-ancestor
25333179|NCT04785222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25333180|NCT04785222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25333181|NCT04785222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25333182|NCT04785222|Adrenergic Agents|adrenergic agents|mesh-ancestor
25333183|NCT04785222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25333184|NCT04785222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068426|NCT03433352|Methimazole|methimazole|mesh-list
25333185|NCT04784988|BAX 855|bax 855|mesh-list
25333186|NCT04784988|Coagulants|coagulants|mesh-ancestor
25333187|NCT04784728|Lidocaine|lidocaine|mesh-list
25333188|NCT04784728|Anesthetics, Local|anesthetics, local|mesh-ancestor
25333189|NCT04784728|Anesthetics|anesthetics|mesh-ancestor
25333190|NCT04784728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25333191|NCT04784728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333192|NCT04784728|Sensory System Agents|sensory system agents|mesh-ancestor
25333193|NCT04784728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25333194|NCT04784728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25333195|NCT04784728|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25333196|NCT04784728|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25333197|NCT04784728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25333198|NCT04784728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25333199|NCT04784910|Lansoprazole|lansoprazole|mesh-list
25333200|NCT04784910|Dexlansoprazole|dexlansoprazole|mesh-list
25333201|NCT04784910|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25333202|NCT04784910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25333203|NCT04784910|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25333204|NCT04784910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25333205|NCT04784910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25333206|NCT04784767|Saponin QA-21V1|saponin qa-21v1|mesh-list
25333207|NCT04784767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25333208|NCT04784767|Immunologic Factors|immunologic factors|mesh-ancestor
25333209|NCT04784767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649416|NCT01491035|Antidepressive Agents|antidepressive agents|mesh-ancestor
25649417|NCT01491035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25649418|NCT01491035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25649419|NCT01491035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25649420|NCT01491035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25649421|NCT01491035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649422|NCT01491035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25649423|NCT01491035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24551375|NCT00725829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24551376|NCT00725829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24551377|NCT00725946|Iodine|iodine|mesh-list
24551378|NCT00725946|Cadexomer iodine|cadexomer iodine|mesh-list
24551379|NCT00725946|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24551380|NCT00725946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24551381|NCT00725946|Trace Elements|trace elements|mesh-ancestor
24551382|NCT00725946|Micronutrients|micronutrients|mesh-ancestor
24551383|NCT00725946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333210|NCT04784481|Ivermectin|ivermectin|mesh-list
25333211|NCT04784481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25333212|NCT04784481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24675417|NCT00189280|Imiquimod|imiquimod|mesh-list
24679677|NCT01369719|Siderophores|siderophores|mesh-ancestor
24683860|NCT01394445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684339|NCT01396733|Thioctic Acid|thioctic acid|mesh-list
25023075|NCT03657758|Antimetabolites|antimetabolites|mesh-ancestor
24413700|NCT00194961|Hormones|hormones|mesh-list
25023558|NCT03653260|Lidocaine|lidocaine|mesh-list
25023655|NCT03652571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25069016|NCT03429972|Antimitotic Agents|antimitotic agents|mesh-ancestor
25069017|NCT03429972|Mitosis Modulators|mitosis modulators|mesh-ancestor
25019002|NCT03694587|Ibuprofen|ibuprofen|mesh-list
25016782|NCT04479566|Antacids|antacids|mesh-ancestor
25069359|NCT03426982|Heparin|heparin|mesh-list
25024684|NCT03643549|Temozolomide|temozolomide|mesh-list
25069536|NCT03425708|Febuxostat|febuxostat|mesh-list
25017091|NCT02616146|Levonorgestrel|levonorgestrel|mesh-list
24690755|NCT01403740|Immunologic Factors|immunologic factors|mesh-ancestor
24690756|NCT01403740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690817|NCT01404117|Antiviral Agents|antiviral agents|mesh-ancestor
25069605|NCT03425461|Ipilimumab|ipilimumab|mesh-list
24832315|NCT02171156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24832316|NCT02171156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24832317|NCT02171156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25017197|NCT02275546|NuvaRing|nuvaring|mesh-list
24612111|NCT01011998|GABA Agents|gaba agents|mesh-ancestor
24612112|NCT01011998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24612114|NCT01011998|Antimanic Agents|antimanic agents|mesh-ancestor
25025471|NCT03636932|Antiviral Agents|antiviral agents|mesh-ancestor
24692562|NCT01415141|Ribavirin|ribavirin|mesh-list
24693163|NCT01418586|Alfuzosin|alfuzosin|mesh-list
25026372|NCT03629262|Sufentanil|sufentanil|mesh-list
25026373|NCT03629262|Dexmedetomidine|dexmedetomidine|mesh-list
24974748|NCT05294172|Cisplatin|cisplatin|mesh-list
25069954|NCT03422796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825590|NCT00005604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24694212|NCT01424384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24612412|NCT01013805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612413|NCT01013805|Antidotes|antidotes|mesh-ancestor
24612414|NCT01013805|Protective Agents|protective agents|mesh-ancestor
24612415|NCT01013805|Vitamin B Complex|vitamin b complex|mesh-ancestor
24612416|NCT01013805|Vitamins|vitamins|mesh-ancestor
24612417|NCT01013805|Micronutrients|micronutrients|mesh-ancestor
24612418|NCT01013831|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24694455|NCT01425619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24694467|NCT01425658|Narcotics|narcotics|mesh-ancestor
24694493|NCT01425736|Docetaxel|docetaxel|mesh-list
24694565|NCT05386121|Meperidine|meperidine|mesh-list
24694566|NCT05386121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24694567|NCT05386121|Narcotics|narcotics|mesh-ancestor
24694620|NCT05385744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694621|NCT05385744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25027454|NCT03620253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25649424|NCT01491035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25649425|NCT01491035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649426|NCT01491035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25649427|NCT01491035|Serotonin Agents|serotonin agents|mesh-ancestor
25649428|NCT01491035|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25649429|NCT01491035|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25649430|NCT01491035|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25649431|NCT01491035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25649432|NCT01491113|Levetiracetam|levetiracetam|mesh-list
25027455|NCT03620253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070043|NCT03422406|Trace Elements|trace elements|mesh-ancestor
24694825|NCT05210439|Antitubercular Agents|antitubercular agents|mesh-ancestor
25018778|NCT03697044|Irinotecan|irinotecan|mesh-list
24694986|NCT04838808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694987|NCT04838808|Anticoagulants|anticoagulants|mesh-ancestor
25007999|NCT02343224|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25008000|NCT02343224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008001|NCT02343224|Antiviral Agents|antiviral agents|mesh-ancestor
25008002|NCT02343224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25008003|NCT02343224|Immunologic Factors|immunologic factors|mesh-ancestor
25008004|NCT02343224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109823|NCT03121521|Protective Agents|protective agents|mesh-ancestor
24694988|NCT04809103|Cisplatin|cisplatin|mesh-list
24695025|NCT04729517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695028|NCT04729517|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25825591|NCT00005604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25027944|NCT03615313|Antibodies|antibodies|mesh-list
25027945|NCT03615313|Immunologic Factors|immunologic factors|mesh-ancestor
25028059|NCT03614052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25825592|NCT00005604|Growth Substances|growth substances|mesh-ancestor
24695600|NCT02767882|Autonomic Agents|autonomic agents|mesh-ancestor
24697073|NCT01432587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24697074|NCT01432587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25825593|NCT00005604|Growth Inhibitors|growth inhibitors|mesh-ancestor
24697320|NCT01434147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24697321|NCT01434147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25029304|NCT03603418|Glucocorticoids|glucocorticoids|mesh-ancestor
24697531|NCT01435343|Antimetabolites|antimetabolites|mesh-ancestor
24697532|NCT01435343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697533|NCT01435343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24643469|NCT01185808|Ergocalciferols|ergocalciferols|mesh-list
24697534|NCT01435343|Immunologic Factors|immunologic factors|mesh-ancestor
24697535|NCT01435343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697536|NCT01435343|Antiviral Agents|antiviral agents|mesh-ancestor
24697537|NCT01435343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24697538|NCT01435343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25070317|NCT03420586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25070319|NCT03420586|Anesthetics|anesthetics|mesh-ancestor
24740790|NCT01690325|Bevacizumab|bevacizumab|mesh-list
25825594|NCT00005607|Leucovorin|leucovorin|mesh-list
24697631|NCT01435954|Silodosin|silodosin|mesh-list
24697632|NCT01435954|Terazosin|terazosin|mesh-list
24697633|NCT01435954|Alfuzosin|alfuzosin|mesh-list
24697634|NCT01435954|Dutasteride|dutasteride|mesh-list
24697635|NCT01435954|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24697636|NCT01435954|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24697637|NCT01435954|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25029398|NCT03602898|Antimetabolites|antimetabolites|mesh-ancestor
24697675|NCT01436422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825595|NCT00005607|Fluorouracil|fluorouracil|mesh-list
24697687|NCT01436513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697688|NCT01436539|Adefovir|adefovir|mesh-list
24697689|NCT01436539|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
24612796|NCT01015417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070343|NCT03420469|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24832938|NCT02172430|Cholinergic Agents|cholinergic agents|mesh-ancestor
24697695|NCT01436539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24697696|NCT01436539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697697|NCT01436539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25825596|NCT00005607|Irinotecan|irinotecan|mesh-list
24697698|NCT01436539|Antimetabolites|antimetabolites|mesh-ancestor
24697699|NCT01436539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24697700|NCT01436578|Posaconazole|posaconazole|mesh-list
24697701|NCT01436578|Antifungal Agents|antifungal agents|mesh-ancestor
25825597|NCT00005607|Calcium|calcium|mesh-list
25070352|NCT03420339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25070353|NCT03420339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070354|NCT03420313|Buprenorphine|buprenorphine|mesh-list
25070355|NCT03420313|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25070356|NCT03420313|Naloxone|naloxone|mesh-list
25825598|NCT00005607|Levoleucovorin|levoleucovorin|mesh-list
24697873|NCT01437709|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25649433|NCT01491113|Anticonvulsants|anticonvulsants|mesh-ancestor
25649434|NCT01491113|Nootropic Agents|nootropic agents|mesh-ancestor
25649435|NCT01491607|Vaccines|vaccines|mesh-list
25649436|NCT01491607|Immunologic Factors|immunologic factors|mesh-ancestor
25649437|NCT01491607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649438|NCT01491633|Dasatinib|dasatinib|mesh-list
25649439|NCT01491633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697874|NCT01437709|Ofatumumab|ofatumumab|mesh-list
25649440|NCT01491633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25825599|NCT00005607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24697875|NCT01437709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24697876|NCT01437709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24697877|NCT01437709|Alkylating Agents|alkylating agents|mesh-ancestor
24697878|NCT01437709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697879|NCT01437709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698051|NCT01438580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698052|NCT01438580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24698054|NCT01438580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24698055|NCT01438580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24698056|NCT01438580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698482|NCT01441388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24698483|NCT01441388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698484|NCT01441388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829779|NCT02154438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24829780|NCT02154438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829781|NCT02154438|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24829782|NCT02154438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25070502|NCT03418935|Niacin|niacin|mesh-list
25070530|NCT03418558|Trastuzumab|trastuzumab|mesh-list
25070531|NCT03418558|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25070532|NCT03418558|Maytansine|maytansine|mesh-list
25070533|NCT03418558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25070534|NCT03418558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25070535|NCT03418558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25070536|NCT03418558|Tubulin Modulators|tubulin modulators|mesh-ancestor
25070537|NCT03418558|Antimitotic Agents|antimitotic agents|mesh-ancestor
24698853|NCT01443169|Anticonvulsants|anticonvulsants|mesh-ancestor
24448782|NCT00313131|Metronidazole|metronidazole|mesh-list
25030168|NCT03597945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24448783|NCT00313131|Fluconazole|fluconazole|mesh-list
24699178|NCT01445262|Levocetirizine|levocetirizine|mesh-list
24612997|NCT01016223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24425951|NCT00234858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24699773|NCT01448837|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24699795|NCT01449110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699817|NCT01449188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25030613|NCT03594435|Ibudilast|ibudilast|mesh-list
25070943|NCT03414892|Globalagliatin|globalagliatin|mesh-list
24829806|NCT02154646|Gemcitabine|gemcitabine|mesh-list
25021066|NCT03674866|Insulin|insulin|mesh-list
25021145|NCT03674385|Vitamin E|vitamin e|mesh-list
25021274|NCT03673384|Xhance|xhance|mesh-list
25071748|NCT03406533|Anesthetics, General|anesthetics, general|mesh-ancestor
25071895|NCT03405194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25071896|NCT03405194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25071897|NCT03405194|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25071898|NCT03405168|Moxifloxacin|moxifloxacin|mesh-list
25031345|NCT03588494|Endostar protein|endostar protein|mesh-list
24700843|NCT01455350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24700844|NCT01455350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24700845|NCT01455350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25072327|NCT03402087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25072328|NCT03402048|Gemcitabine|gemcitabine|mesh-list
25072329|NCT03402048|Carboplatin|carboplatin|mesh-list
24953955|NCT03880357|Glucocorticoids|glucocorticoids|mesh-ancestor
25072331|NCT03402048|Pemetrexed|pemetrexed|mesh-list
25072332|NCT03402048|Vinorelbine|vinorelbine|mesh-list
25072333|NCT03402048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25072334|NCT03402048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25072335|NCT03402048|Antimetabolites|antimetabolites|mesh-ancestor
25072337|NCT03402048|Antiviral Agents|antiviral agents|mesh-ancestor
25072466|NCT03401476|Narcotics|narcotics|mesh-ancestor
24824897|NCT02125968|Oxymetazoline|oxymetazoline|mesh-list
24701425|NCT01458964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25021786|NCT03668418|Taxane|taxane|mesh-list
25072657|NCT03400111|Analgesics|analgesics|mesh-ancestor
25072658|NCT03400111|Sensory System Agents|sensory system agents|mesh-ancestor
25072659|NCT03400111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25072803|NCT03399435|Anesthetics|anesthetics|mesh-ancestor
25032093|NCT03583892|Gabapentin|gabapentin|mesh-list
25825600|NCT00005607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634657|NCT01134484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25073010|NCT03398031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073011|NCT03398031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25022018|NCT03666494|Narcotics|narcotics|mesh-ancestor
24634745|NCT01134861|Etoposide|etoposide|mesh-list
24634746|NCT01134861|Vinblastine|vinblastine|mesh-list
24635511|NCT01139749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635512|NCT01139749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635513|NCT01139840|Vitamin D|vitamin d|mesh-list
25073319|NCT03395873|Avelumab|avelumab|mesh-list
25032546|NCT03579927|Etoposide|etoposide|mesh-list
25825601|NCT00005607|Antimetabolites|antimetabolites|mesh-ancestor
24637560|NCT01151397|Ribavirin|ribavirin|mesh-list
25073632|NCT03393988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073634|NCT03393988|Analgesics|analgesics|mesh-ancestor
25033299|NCT03574649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25033303|NCT03574402|Gemcitabine|gemcitabine|mesh-list
25825602|NCT00005607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022863|NCT03658746|Ofloxacin|ofloxacin|mesh-list
25073803|NCT03393247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25073804|NCT03393247|Antimetabolites|antimetabolites|mesh-ancestor
24639499|NCT01161979|Zonisamide|zonisamide|mesh-list
24639793|NCT01164189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639804|NCT01164215|Immunologic Factors|immunologic factors|mesh-ancestor
24640073|NCT01165905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24640074|NCT01165905|Antimetabolites|antimetabolites|mesh-ancestor
24640075|NCT01165905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023172|NCT03656965|Acyclovir|acyclovir|mesh-list
25074081|NCT03390790|Anesthetics|anesthetics|mesh-ancestor
25074082|NCT03390790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24641307|NCT01172782|Narcotics|narcotics|mesh-ancestor
25034378|NCT03565133|Analgesics|analgesics|mesh-ancestor
25034379|NCT03565133|Sensory System Agents|sensory system agents|mesh-ancestor
25034382|NCT03564964|Serotonin Agents|serotonin agents|mesh-ancestor
25035342|NCT03556852|Oxytocics|oxytocics|mesh-ancestor
25074836|NCT03385525|Anticonvulsants|anticonvulsants|mesh-ancestor
25075160|NCT03383185|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25024166|NCT03648333|Niacin|niacin|mesh-list
25075816|NCT03377907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25075817|NCT03377842|Leucovorin|leucovorin|mesh-list
25075818|NCT03377842|Apatinib|apatinib|mesh-list
25075819|NCT03377842|Fluorouracil|fluorouracil|mesh-list
25075902|NCT03377348|Hormones|hormones|mesh-ancestor
24998807|NCT05422716|Baclofen|baclofen|mesh-list
25037045|NCT03541265|Anesthetics|anesthetics|mesh-ancestor
25037130|NCT03540212|Sofosbuvir|sofosbuvir|mesh-list
25825603|NCT00005607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25825604|NCT00005607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999450|NCT04332341|Vitamins|vitamins|mesh-ancestor
24798421|NCT01963559|Lidocaine|lidocaine|mesh-list
25037874|NCT03534895|Midazolam|midazolam|mesh-list
24643837|NCT01187615|Pemetrexed|pemetrexed|mesh-list
25038210|NCT05263505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24643998|NCT01188278|Dasatinib|dasatinib|mesh-list
24643999|NCT01188278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644097|NCT01188954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25039200|NCT04029610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25039481|NCT03824587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25039482|NCT03824587|Chelating Agents|chelating agents|mesh-ancestor
25039483|NCT03824587|Sequestering Agents|sequestering agents|mesh-ancestor
25039484|NCT03824587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039485|NCT03824587|Antacids|antacids|mesh-ancestor
25039486|NCT03824587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25039487|NCT03818828|Iodine|iodine|mesh-list
25039668|NCT03721965|Antiemetics|antiemetics|mesh-ancestor
25039757|NCT03676751|Azithromycin|azithromycin|mesh-list
25049177|NCT00630799|Leuprolide|leuprolide|mesh-list
24939878|NCT04005872|Calcium|calcium|mesh-list
25026754|NCT03625219|Prednisone|prednisone|mesh-list
24645063|NCT01195324|Warfarin|warfarin|mesh-list
24645070|NCT01195376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24829812|NCT02154646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24829829|NCT02154737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24646137|NCT01202097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24829830|NCT02154776|Letrozole|letrozole|mesh-list
24829832|NCT02154776|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24608995|NCT00994773|Tenofovir|tenofovir|mesh-list
25028207|NCT03612817|Timolol|timolol|mesh-list
24829836|NCT02154776|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25825605|NCT00005607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24649230|NCT01219036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649231|NCT01219036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24649232|NCT01219036|Respiratory System Agents|respiratory system agents|mesh-ancestor
24649233|NCT01219036|Glucocorticoids|glucocorticoids|mesh-ancestor
24649234|NCT01219036|Hormones|hormones|mesh-ancestor
24649531|NCT01220245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649532|NCT01220258|Azithromycin|azithromycin|mesh-list
24649533|NCT01220258|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24649534|NCT01220258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24649535|NCT01220258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24853919|NCT02270970|Belimumab|belimumab|mesh-list
24650222|NCT01224613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650291|NCT01224964|Montelukast|montelukast|mesh-list
24829837|NCT02154776|Hormone Antagonists|hormone antagonists|mesh-ancestor
24651096|NCT01229332|Carbidopa|carbidopa|mesh-list
24651220|NCT01230463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24651221|NCT01230463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25049633|NCT00579189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049634|NCT00579189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25049636|NCT00579020|Dexamethasone|dexamethasone|mesh-list
25029111|NCT03605056|Antiemetics|antiemetics|mesh-ancestor
24651914|NCT01234506|Micronutrients|micronutrients|mesh-ancestor
24651917|NCT01234506|Phytoestrogens|phytoestrogens|mesh-ancestor
25029126|NCT03604796|Acetaminophen|acetaminophen|mesh-list
24652038|NCT01235273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24652039|NCT01235273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652143|NCT01236651|Narcotics|narcotics|mesh-ancestor
24944314|NCT03961698|Growth Inhibitors|growth inhibitors|mesh-ancestor
24653508|NCT01244100|Antipyretics|antipyretics|mesh-ancestor
24654245|NCT01248338|Metoprolol|metoprolol|mesh-list
24654473|NCT01249690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24654563|NCT01250457|Timolol|timolol|mesh-list
24676875|NCT01352663|Insulin|insulin|mesh-list
24829844|NCT02154854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24654833|NCT01251796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24677501|NCT01356680|Prednisone|prednisone|mesh-list
24829848|NCT02154854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24987448|NCT01880567|Rituximab|rituximab|mesh-list
25030743|NCT03593044|Atropine|atropine|mesh-list
24678795|NCT01364376|Leucovorin|leucovorin|mesh-list
24656757|NCT01263860|Ribavirin|ribavirin|mesh-list
25031290|NCT03588871|Hydrogen Peroxide|hydrogen peroxide|mesh-list
24657773|NCT01269216|Leucovorin|leucovorin|mesh-list
24829849|NCT02154854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659948|NCT01281111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25031566|NCT03586947|Vitamin D|vitamin d|mesh-list
24799644|NCT01970059|Sympatholytics|sympatholytics|mesh-ancestor
25031901|NCT03585179|Hydroquinone|hydroquinone|mesh-list
25825606|NCT00005607|Immunologic Factors|immunologic factors|mesh-ancestor
24662891|NCT01297452|Carboplatin|carboplatin|mesh-list
25049958|NCT00553306|Alkylating Agents|alkylating agents|mesh-ancestor
25049959|NCT00553306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049960|NCT00553306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951845|NCT03900637|Letrozole|letrozole|mesh-list
24935465|NCT04050267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24935466|NCT04050176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
24935473|NCT04050059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24935474|NCT04050059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935475|NCT04050059|Sensory System Agents|sensory system agents|mesh-ancestor
24935476|NCT04050059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24935477|NCT04050059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24935478|NCT04050059|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25033252|NCT03574909|Aspirin|aspirin|mesh-list
24935634|NCT04048707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24666207|NCT01318044|Propofol|propofol|mesh-list
24829853|NCT02154932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24935866|NCT04047017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24829855|NCT02154932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24849714|NCT02249871|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24625519|NCT01082315|Cetuximab|cetuximab|mesh-list
24533502|NCT00644215|Mitomycins|mitomycins|mesh-list
24829856|NCT02154932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25008119|NCT01758328|Melphalan|melphalan|mesh-list
25008120|NCT01758328|Busulfan|busulfan|mesh-list
25008121|NCT01758328|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25008122|NCT01758328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008123|NCT01758328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008124|NCT01758328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25008125|NCT01758328|Immunologic Factors|immunologic factors|mesh-ancestor
25008126|NCT01758328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554633|NCT00737373|Leucovorin|leucovorin|mesh-list
24849947|NCT02251145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825607|NCT00005607|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25825608|NCT00005607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25825609|NCT00005607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825610|NCT00005607|Antidotes|antidotes|mesh-ancestor
24936310|NCT04042051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24936311|NCT04042051|Tubulin Modulators|tubulin modulators|mesh-ancestor
25825611|NCT00005607|Protective Agents|protective agents|mesh-ancestor
25034101|NCT03567629|Leucovorin|leucovorin|mesh-list
25825612|NCT00005607|Vitamin B Complex|vitamin b complex|mesh-ancestor
24850218|NCT02252341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25825613|NCT00005607|Vitamins|vitamins|mesh-ancestor
25825614|NCT00005607|Micronutrients|micronutrients|mesh-ancestor
25825615|NCT00005609|Rituximab|rituximab|mesh-list
25825616|NCT00005609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25825617|NCT00005609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825618|NCT00005609|Immunologic Factors|immunologic factors|mesh-ancestor
24686144|NCT05032508|Lidocaine|lidocaine|mesh-list
24850394|NCT02252913|Antimitotic Agents|antimitotic agents|mesh-ancestor
24850395|NCT02252913|Mitosis Modulators|mitosis modulators|mesh-ancestor
24850396|NCT02252913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850397|NCT02252926|Acetaminophen|acetaminophen|mesh-list
24850398|NCT02252926|Lidocaine|lidocaine|mesh-list
24850399|NCT02252926|Morphine|morphine|mesh-list
24850400|NCT02252926|Gabapentin|gabapentin|mesh-list
24953053|NCT03889366|Aprepitant|aprepitant|mesh-list
24850483|NCT02253199|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25825619|NCT00005609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936827|NCT04035785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24936829|NCT04035798|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24687083|NCT04391608|Tenofovir|tenofovir|mesh-list
24937071|NCT04033055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937072|NCT04033055|Sensory System Agents|sensory system agents|mesh-ancestor
24937073|NCT04033055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937074|NCT04033094|Morphine|morphine|mesh-list
24937104|NCT04032691|Adrenergic Agents|adrenergic agents|mesh-ancestor
24937105|NCT04032691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24937106|NCT04032691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937107|NCT04032860|Tenofovir|tenofovir|mesh-list
24850849|NCT02254148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850850|NCT02254148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24761906|NCT01765257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761907|NCT01765257|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24761908|NCT01765257|Protective Agents|protective agents|mesh-ancestor
24761909|NCT01765257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761912|NCT01765296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24761918|NCT01765296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24829857|NCT02154932|Oxytocics|oxytocics|mesh-ancestor
24937402|NCT04029467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24937403|NCT04029467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24937404|NCT04029467|Adrenergic Agents|adrenergic agents|mesh-ancestor
24937405|NCT04029467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24937406|NCT04029467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937407|NCT04029090|Edaravone|edaravone|mesh-list
24937408|NCT04029090|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24851044|NCT02255045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25825620|NCT00005609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25825621|NCT00005610|Sargramostim|sargramostim|mesh-list
25825622|NCT00005610|Immunologic Factors|immunologic factors|mesh-ancestor
25649441|NCT01491633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649442|NCT01491633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649443|NCT01491672|Everolimus|everolimus|mesh-list
25649444|NCT01491672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649445|NCT01491672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25649446|NCT01491672|Immunologic Factors|immunologic factors|mesh-ancestor
25649447|NCT01491672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649448|NCT01491737|Trastuzumab|trastuzumab|mesh-list
25649449|NCT01491737|Pertuzumab|pertuzumab|mesh-list
25825623|NCT00005610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554951|NCT00738829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24554952|NCT00738829|Antimetabolites|antimetabolites|mesh-ancestor
24554953|NCT00738829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554954|NCT00738829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24555038|NCT00739531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24555275|NCT00740922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24555326|NCT00741169|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25825624|NCT00005612|Paclitaxel|paclitaxel|mesh-list
24851057|NCT02255084|Antipruritics|antipruritics|mesh-ancestor
24851058|NCT02255084|Dermatologic Agents|dermatologic agents|mesh-ancestor
24851059|NCT02255162|Cytarabine|cytarabine|mesh-list
24851060|NCT02255162|Lenalidomide|lenalidomide|mesh-list
24534231|NCT00646529|Glucocorticoids|glucocorticoids|mesh-ancestor
24534232|NCT00646529|Hormones|hormones|mesh-ancestor
24534233|NCT00646529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25825625|NCT00005612|Etoposide|etoposide|mesh-list
25825626|NCT00005612|Cyclophosphamide|cyclophosphamide|mesh-list
25825627|NCT00005612|Carboplatin|carboplatin|mesh-list
25825628|NCT00005612|Topotecan|topotecan|mesh-list
25825629|NCT00005612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24937685|NCT04026074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937686|NCT04026074|Analgesics|analgesics|mesh-ancestor
24812210|NCT02050529|Hydralazine|hydralazine|mesh-list
24690368|NCT01401179|Clarithromycin|clarithromycin|mesh-list
25825630|NCT00005612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825631|NCT00005612|Tubulin Modulators|tubulin modulators|mesh-ancestor
25825632|NCT00005612|Antimitotic Agents|antimitotic agents|mesh-ancestor
25825633|NCT00005612|Mitosis Modulators|mitosis modulators|mesh-ancestor
25825634|NCT00005612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825635|NCT00005612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25825636|NCT00005612|Immunologic Factors|immunologic factors|mesh-ancestor
25825637|NCT00005612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825638|NCT00005612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25825639|NCT00005612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25825640|NCT00005612|Alkylating Agents|alkylating agents|mesh-ancestor
25825641|NCT00005612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25825642|NCT00005612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25825643|NCT00005612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24534367|NCT00646841|Doxazosin|doxazosin|mesh-list
24534368|NCT00646841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24534421|NCT00646945|Anesthetics, General|anesthetics, general|mesh-ancestor
24534432|NCT00647023|Metformin|metformin|mesh-list
24534439|NCT00647049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24534440|NCT00647049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24534441|NCT00647049|Immunologic Factors|immunologic factors|mesh-ancestor
25825644|NCT00005612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825645|NCT00005612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24450962|NCT00321178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24450963|NCT00321178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24450964|NCT00321178|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25825646|NCT00005613|Cyclophosphamide|cyclophosphamide|mesh-list
25825647|NCT00005613|Carmustine|carmustine|mesh-list
25825648|NCT00005613|Etoposide|etoposide|mesh-list
25825649|NCT00005613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25825650|NCT00005613|Immunologic Factors|immunologic factors|mesh-ancestor
25825651|NCT00005613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825652|NCT00005613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24831250|NCT02164552|Vitamin D|vitamin d|mesh-list
25825653|NCT00005613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25825654|NCT00005613|Alkylating Agents|alkylating agents|mesh-ancestor
25825655|NCT00005613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825656|NCT00005613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825657|NCT00005613|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25825658|NCT00005613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25825659|NCT00005613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25825660|NCT00005613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25825661|NCT00005613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649450|NCT01491737|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25649451|NCT01491737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25649452|NCT01491737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649453|NCT01491737|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25649454|NCT01491737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649455|NCT01491737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649456|NCT01491737|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25649457|NCT01491737|Hormone Antagonists|hormone antagonists|mesh-ancestor
24791191|NCT05049707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008333|NCT00281658|Lapatinib|lapatinib|mesh-list
25825662|NCT00005614|Gemcitabine|gemcitabine|mesh-list
25825663|NCT00005614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24534829|NCT00648076|GABA Agents|gaba agents|mesh-ancestor
25825664|NCT00005614|Antimetabolites|antimetabolites|mesh-ancestor
25825665|NCT00005614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825666|NCT00005614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825667|NCT00005614|Antiviral Agents|antiviral agents|mesh-ancestor
25825668|NCT00005614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25825669|NCT00005614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825670|NCT00005614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25825671|NCT00005614|Immunologic Factors|immunologic factors|mesh-ancestor
25825672|NCT00005614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825673|NCT00005615|Interferons|interferons|mesh-list
25825674|NCT00005615|Interferon-alpha|interferon-alpha|mesh-list
24451085|NCT00321802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24451086|NCT00321802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25035669|NCT03554109|Vitamins|vitamins|mesh-ancestor
24938143|NCT04021992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24938144|NCT04021992|Antimetabolites|antimetabolites|mesh-ancestor
24938145|NCT04021992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825675|NCT00005615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694054|NCT01423591|Infliximab|infliximab|mesh-list
25825676|NCT00005615|Antiviral Agents|antiviral agents|mesh-ancestor
25825677|NCT00005615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25825678|NCT00005615|Immunologic Factors|immunologic factors|mesh-ancestor
25825679|NCT00005615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535229|NCT00648817|Tenofovir|tenofovir|mesh-list
25825680|NCT00005616|Antibodies|antibodies|mesh-list
25825681|NCT00005616|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25825682|NCT00005616|Immunologic Factors|immunologic factors|mesh-ancestor
25825683|NCT00005616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825684|NCT00005618|Arsenic Trioxide|arsenic trioxide|mesh-list
25825685|NCT00005618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825686|NCT00005622|Cyclophosphamide|cyclophosphamide|mesh-list
25825687|NCT00005622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24535361|NCT00649038|Natriuretic Agents|natriuretic agents|mesh-ancestor
25050347|NCT00517153|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25050348|NCT00517153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25050349|NCT00517153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050350|NCT00517049|Rituximab|rituximab|mesh-list
25050351|NCT00517049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25825688|NCT00005622|Immunologic Factors|immunologic factors|mesh-ancestor
24938358|NCT04019496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535709|NCT00649597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535710|NCT00649610|Diclofenac|diclofenac|mesh-list
25825689|NCT00005622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825690|NCT00005622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25825691|NCT00005622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25825692|NCT00005622|Alkylating Agents|alkylating agents|mesh-ancestor
25825693|NCT00005622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825694|NCT00005622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825695|NCT00005622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25825696|NCT00005623|Cyproterone Acetate|cyproterone acetate|mesh-list
24535859|NCT00649844|Serotonin Agents|serotonin agents|mesh-ancestor
24535860|NCT00649844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535861|NCT00649844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825697|NCT00005623|Cyproterone|cyproterone|mesh-list
24535925|NCT00650013|Midodrine|midodrine|mesh-list
24829858|NCT02155023|Insulin|insulin|mesh-list
25825698|NCT00005623|Androgen Antagonists|androgen antagonists|mesh-ancestor
25825699|NCT00005623|Hormone Antagonists|hormone antagonists|mesh-ancestor
24536411|NCT00651235|Losartan|losartan|mesh-list
25036445|NCT03547375|Apatinib|apatinib|mesh-list
24829859|NCT02155023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24938737|NCT04016246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829860|NCT02155023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24938791|NCT04015908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825700|NCT00005623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25825701|NCT00005623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825702|NCT00005623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649458|NCT01491737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25825703|NCT00005623|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25825704|NCT00005623|Contraceptive Agents|contraceptive agents|mesh-ancestor
25408796|NCT03419364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24536989|NCT00653120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25036920|NCT03542214|Calcium|calcium|mesh-list
25825705|NCT00005623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25825706|NCT00005624|Tacedinaline|tacedinaline|mesh-list
25825707|NCT00005624|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25825708|NCT00005624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537004|NCT00653250|Celecoxib|celecoxib|mesh-list
24537066|NCT00653406|Risperidone|risperidone|mesh-list
25825709|NCT00005624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537094|NCT00653445|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25825710|NCT00005624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825711|NCT00005625|Trabectedin|trabectedin|mesh-list
25037127|NCT03540225|Hormones|hormones|mesh-ancestor
25825712|NCT00005625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25825713|NCT00005625|Alkylating Agents|alkylating agents|mesh-ancestor
25825714|NCT00005625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825715|NCT00005625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825716|NCT00005626|Irinotecan|irinotecan|mesh-list
25825717|NCT00005626|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25825718|NCT00005626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25825719|NCT00005626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825720|NCT00005626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537544|NCT00655122|Anticoagulants|anticoagulants|mesh-ancestor
24640689|NCT01169688|Oxymetazoline|oxymetazoline|mesh-list
24537710|NCT00655915|Anesthetics|anesthetics|mesh-ancestor
24537711|NCT00655915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25825721|NCT00005626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050482|NCT00491738|Sunitinib|sunitinib|mesh-list
24538295|NCT00658580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24939073|NCT04013386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24939084|NCT04013438|Saw palmetto extract|saw palmetto extract|mesh-list
25825722|NCT00005627|Carboplatin|carboplatin|mesh-list
25825723|NCT00005627|Docetaxel|docetaxel|mesh-list
25825724|NCT00005627|Estramustine|estramustine|mesh-list
25825725|NCT00005627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825726|NCT00005627|Tubulin Modulators|tubulin modulators|mesh-ancestor
25825727|NCT00005627|Antimitotic Agents|antimitotic agents|mesh-ancestor
25825728|NCT00005627|Mitosis Modulators|mitosis modulators|mesh-ancestor
25825729|NCT00005627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825730|NCT00005627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25825731|NCT00005627|Alkylating Agents|alkylating agents|mesh-ancestor
25825732|NCT00005627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25825733|NCT00005630|Sargramostim|sargramostim|mesh-list
25825734|NCT00005630|Immunologic Factors|immunologic factors|mesh-ancestor
24482360|NCT00438789|Eculizumab|eculizumab|mesh-list
24594601|NCT00934739|Thalidomide|thalidomide|mesh-list
25825735|NCT00005630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825736|NCT00005631|Rituximab|rituximab|mesh-list
25825737|NCT00005631|Carboplatin|carboplatin|mesh-list
24539668|NCT00664846|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24539670|NCT00664846|Purinergic Agents|purinergic agents|mesh-ancestor
24827541|NCT02140073|Dopamine Agents|dopamine agents|mesh-ancestor
24540288|NCT00667160|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24540289|NCT00667160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540290|NCT00667160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540291|NCT00667160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24939386|NCT04010578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24939387|NCT04010318|Anesthetics|anesthetics|mesh-list
24939388|NCT04010318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24544713|NCT00689845|Dermatologic Agents|dermatologic agents|mesh-ancestor
24827542|NCT02140073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25649459|NCT01491737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649460|NCT01491841|Rituximab|rituximab|mesh-list
24541124|NCT00671008|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
25649461|NCT01491841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25649462|NCT01491841|Pixantrone|pixantrone|mesh-list
25649463|NCT01491841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25649464|NCT01491841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649465|NCT01491841|Immunologic Factors|immunologic factors|mesh-ancestor
25649466|NCT01491841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825739|NCT00005631|Ifosfamide|ifosfamide|mesh-list
25825740|NCT00005631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24559114|NCT05291221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24559115|NCT05291221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24559116|NCT05291221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24559117|NCT05291221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24559118|NCT05291221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25825741|NCT00005631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825742|NCT00005631|Immunologic Factors|immunologic factors|mesh-ancestor
24671007|NCT01323218|Micronutrients|micronutrients|mesh-ancestor
25825743|NCT00005631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008483|NCT05207514|Antimitotic Agents|antimitotic agents|mesh-ancestor
24559456|NCT04767061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24559457|NCT04767061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24559458|NCT04767061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541126|NCT00671008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541128|NCT00671112|Bortezomib|bortezomib|mesh-list
24541129|NCT00671112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541130|NCT00671112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24939512|NCT04009044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24939515|NCT04009044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825744|NCT00005631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24939519|NCT04008784|Triamcinolone|triamcinolone|mesh-list
24939520|NCT04008784|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24939521|NCT04008784|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24597871|NCT00952432|Antimanic Agents|antimanic agents|mesh-ancestor
25825745|NCT00005631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25825746|NCT00005631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25825747|NCT00005631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25825748|NCT00005631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825749|NCT00005631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825750|NCT00005631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25825751|NCT00005631|Alkylating Agents|alkylating agents|mesh-ancestor
25825752|NCT00005634|Vorinostat|vorinostat|mesh-list
25825753|NCT00005634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939550|NCT04008966|Hormone Antagonists|hormone antagonists|mesh-ancestor
24939552|NCT04008888|Dexamethasone acetate|dexamethasone acetate|mesh-list
24939553|NCT04008888|Fludarabine|fludarabine|mesh-list
24764356|NCT01780883|Protective Agents|protective agents|mesh-ancestor
24542954|NCT00681174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24939639|NCT04008186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24939640|NCT04008186|Hormone Antagonists|hormone antagonists|mesh-ancestor
24939641|NCT04008186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24543346|NCT00683202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24543347|NCT00683202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24543348|NCT00683202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25825754|NCT00005634|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24544428|NCT00688961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544429|NCT00688961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24544430|NCT00688961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24544431|NCT00688961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24544432|NCT00688961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24544433|NCT00688961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544489|NCT00689169|Antiviral Agents|antiviral agents|mesh-ancestor
24939755|NCT04007341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24939756|NCT04007341|Adrenergic Agents|adrenergic agents|mesh-ancestor
24600553|NCT00959387|Paclitaxel|paclitaxel|mesh-list
24829862|NCT02155049|Bimatoprost|bimatoprost|mesh-list
25649467|NCT01491841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25649468|NCT01491841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25649469|NCT01491841|Alkylating Agents|alkylating agents|mesh-ancestor
25649470|NCT01491841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649471|NCT01491841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25649472|NCT01491841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25649473|NCT01491841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649474|NCT01491919|Lisinopril|lisinopril|mesh-list
25649475|NCT01491919|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25649476|NCT01491919|Protease Inhibitors|protease inhibitors|mesh-ancestor
25649477|NCT01491919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649478|NCT01491919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649479|NCT01491919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24561525|NCT00761241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24561527|NCT00761241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561562|NCT00761358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561564|NCT00761358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24561565|NCT00761358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561596|NCT00761644|Doxorubicin|doxorubicin|mesh-list
24546744|NCT00700024|Testosterone|testosterone|mesh-list
24546745|NCT00700024|Testosterone undecanoate|testosterone undecanoate|mesh-list
24546746|NCT00700024|Testosterone enanthate|testosterone enanthate|mesh-list
24547298|NCT00703352|Hormone Antagonists|hormone antagonists|mesh-ancestor
24836445|NCT02185859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25825755|NCT00005634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825756|NCT00005634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825757|NCT00005635|Paclitaxel|paclitaxel|mesh-list
25825758|NCT00005635|Trastuzumab|trastuzumab|mesh-list
25825759|NCT00005635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25040388|NCT03123783|Nivolumab|nivolumab|mesh-list
24447537|NCT00308841|Anesthetics|anesthetics|mesh-ancestor
24447538|NCT00308841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24447540|NCT00308841|Sensory System Agents|sensory system agents|mesh-ancestor
24547643|NCT00704951|Hormone Antagonists|hormone antagonists|mesh-ancestor
24547644|NCT00704951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24547646|NCT00704990|Vitamins|vitamins|mesh-list
25825760|NCT00005635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825761|NCT00005635|Tubulin Modulators|tubulin modulators|mesh-ancestor
25825762|NCT00005635|Antimitotic Agents|antimitotic agents|mesh-ancestor
25825763|NCT00005635|Mitosis Modulators|mitosis modulators|mesh-ancestor
25825764|NCT00005635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940037|NCT04004234|Mitosis Modulators|mitosis modulators|mesh-ancestor
24940038|NCT04004234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444087|NCT00296712|Bupropion|bupropion|mesh-list
24678559|NCT01363089|Ketorolac|ketorolac|mesh-list
24827041|NCT02137239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24827042|NCT02137239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827043|NCT02137239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24827044|NCT02137239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827045|NCT02137239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24827046|NCT02137239|Immunologic Factors|immunologic factors|mesh-ancestor
24827047|NCT02137239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24827048|NCT02137239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24827049|NCT02137239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444119|NCT00296751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267418|NCT02422823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267419|NCT02422823|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25267420|NCT02422823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25267421|NCT02422823|Autonomic Agents|autonomic agents|mesh-ancestor
25267422|NCT02422823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267423|NCT02422823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25267424|NCT02422823|Respiratory System Agents|respiratory system agents|mesh-ancestor
25267425|NCT02422823|Mydriatics|mydriatics|mesh-ancestor
25267426|NCT02422823|Sympathomimetics|sympathomimetics|mesh-ancestor
25267427|NCT02422823|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25267428|NCT02422823|Anesthetics, Local|anesthetics, local|mesh-ancestor
25267429|NCT02422823|Anesthetics|anesthetics|mesh-ancestor
25825765|NCT00005635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24610964|NCT01005927|Calcium|calcium|mesh-list
25825766|NCT00005636|Cisplatin|cisplatin|mesh-list
25825767|NCT00005636|Pemetrexed|pemetrexed|mesh-list
25825768|NCT00005636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825769|NCT00005636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825770|NCT00005636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825771|NCT00005636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25649480|NCT01491919|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25649481|NCT01491919|Protective Agents|protective agents|mesh-ancestor
25649482|NCT01491919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649483|NCT01491958|Methotrexate|methotrexate|mesh-list
25649484|NCT01491958|Atorvastatin|atorvastatin|mesh-list
25649485|NCT01491958|Tacrolimus|tacrolimus|mesh-list
25649486|NCT01491958|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25649487|NCT01491958|Abortifacient Agents|abortifacient agents|mesh-ancestor
25649488|NCT01491958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24456828|NCT00332345|Adrenergic Agents|adrenergic agents|mesh-ancestor
24456829|NCT00332345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24456830|NCT00332345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825781|NCT00005638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825782|NCT00005638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25825783|NCT00005638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24456835|NCT00332345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24516792|NCT00603434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24516794|NCT00603434|Dopamine Agents|dopamine agents|mesh-ancestor
25825784|NCT00005638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24827161|NCT02137629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827162|NCT02137629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827163|NCT02137629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825785|NCT00005638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714217|NCT01529320|Hormones|hormones|mesh-ancestor
25825786|NCT00005639|Azacitidine|azacitidine|mesh-list
25825787|NCT00005639|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25825788|NCT00005639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25825789|NCT00005639|Antimetabolites|antimetabolites|mesh-ancestor
24827181|NCT02137733|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25825790|NCT00005639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421092|NCT00217646|Sorafenib|sorafenib|mesh-list
25825791|NCT00005639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825792|NCT00005639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825793|NCT00005640|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
25825794|NCT00005640|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25825795|NCT00005640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829514|NCT00006224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449856|NCT00317330|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24449857|NCT00317330|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24449858|NCT00317330|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25829515|NCT00006224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829516|NCT00006224|Antiviral Agents|antiviral agents|mesh-ancestor
25829517|NCT00006224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25829518|NCT00006224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829519|NCT00006224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24940334|NCT04001959|Fluorides|fluorides|mesh-list
25050673|NCT00478595|Rimonabant|rimonabant|mesh-list
25825800|NCT00005641|Busulfan|busulfan|mesh-list
25825801|NCT00005641|Methotrexate|methotrexate|mesh-list
25825802|NCT00005641|Cyclosporins|cyclosporins|mesh-list
25825803|NCT00005641|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25825804|NCT00005641|Levoleucovorin|levoleucovorin|mesh-list
24853921|NCT02270970|Immunologic Factors|immunologic factors|mesh-ancestor
24829066|NCT02149758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24829067|NCT02149758|Analgesics|analgesics|mesh-ancestor
24829085|NCT02149888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25825805|NCT00005641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25825806|NCT00005641|Immunologic Factors|immunologic factors|mesh-ancestor
25825807|NCT00005641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825808|NCT00005641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25825809|NCT00005641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25825810|NCT00005641|Alkylating Agents|alkylating agents|mesh-ancestor
25825811|NCT00005641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825812|NCT00005641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825813|NCT00005641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25825814|NCT00005641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25825815|NCT00005641|Abortifacient Agents|abortifacient agents|mesh-ancestor
25825816|NCT00005641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25825817|NCT00005641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25825818|NCT00005641|Antimetabolites|antimetabolites|mesh-ancestor
25825819|NCT00005641|Dermatologic Agents|dermatologic agents|mesh-ancestor
25825820|NCT00005641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825821|NCT00005641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24556306|NCT00746837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25825822|NCT00005641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24421878|NCT00220454|Hydrocortisone|hydrocortisone|mesh-list
25825823|NCT00005641|Antidotes|antidotes|mesh-ancestor
24829613|NCT02153437|Sotalol|sotalol|mesh-list
25268117|NCT02417467|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24456851|NCT00332397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24456852|NCT00332397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25825824|NCT00005641|Protective Agents|protective agents|mesh-ancestor
25825825|NCT00005641|Vitamin B Complex|vitamin b complex|mesh-ancestor
25649489|NCT01491958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649490|NCT01491958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25649491|NCT01491958|Antimetabolites|antimetabolites|mesh-ancestor
25649492|NCT01491958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825826|NCT00005641|Vitamins|vitamins|mesh-ancestor
25825827|NCT00005641|Micronutrients|micronutrients|mesh-ancestor
25825835|NCT00005641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25268289|NCT02416388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25825837|NCT00005641|Hormones|hormones|mesh-ancestor
25825838|NCT00005641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24830167|NCT02157571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24830168|NCT02157571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24830169|NCT02157571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24830170|NCT02157571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616467|NCT01037491|Rabeprazole|rabeprazole|mesh-list
24940783|NCT03997864|Prazosin|prazosin|mesh-list
25825839|NCT00005641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24454929|NCT03161353|Carboplatin|carboplatin|mesh-list
25825840|NCT00005642|Semaxinib|semaxinib|mesh-list
25825841|NCT00005642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25825842|NCT00005642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25825843|NCT00005642|Growth Substances|growth substances|mesh-ancestor
24956862|NCT03849833|Vitamins|vitamins|mesh-ancestor
25825844|NCT00005642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825845|NCT00005642|Growth Inhibitors|growth inhibitors|mesh-ancestor
25825846|NCT00005642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825847|NCT00005642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25825848|NCT00005642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825849|NCT00005642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825850|NCT00005643|Doxorubicin|doxorubicin|mesh-list
25825851|NCT00005643|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25825852|NCT00005643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25825853|NCT00005643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825854|NCT00005643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25825855|NCT00005643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25825856|NCT00005643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825857|NCT00005643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825858|NCT00005644|Gemcitabine|gemcitabine|mesh-list
25825859|NCT00005644|Paclitaxel|paclitaxel|mesh-list
25825860|NCT00005644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25825861|NCT00005644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825862|NCT00005644|Tubulin Modulators|tubulin modulators|mesh-ancestor
25825863|NCT00005644|Antimitotic Agents|antimitotic agents|mesh-ancestor
25649494|NCT01491958|Dermatologic Agents|dermatologic agents|mesh-ancestor
24464474|NCT00365001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24464610|NCT00365586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25649495|NCT01491958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649496|NCT01491958|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25825866|NCT00005644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25825867|NCT00005644|Antimetabolites|antimetabolites|mesh-ancestor
25825868|NCT00005644|Antiviral Agents|antiviral agents|mesh-ancestor
25825869|NCT00005644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25825870|NCT00005644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825871|NCT00005644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25825872|NCT00005644|Immunologic Factors|immunologic factors|mesh-ancestor
25825873|NCT00005644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825874|NCT00005646|Paclitaxel|paclitaxel|mesh-list
24830759|NCT02161159|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24830760|NCT02161159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24729753|NCT01623713|Serotonin Agents|serotonin agents|mesh-ancestor
25825875|NCT00005646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25825876|NCT00005646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825877|NCT00005646|Tubulin Modulators|tubulin modulators|mesh-ancestor
25825878|NCT00005646|Antimitotic Agents|antimitotic agents|mesh-ancestor
25825879|NCT00005646|Mitosis Modulators|mitosis modulators|mesh-ancestor
25825880|NCT00005646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825881|NCT00005647|Paclitaxel|paclitaxel|mesh-list
25825882|NCT00005647|Semaxinib|semaxinib|mesh-list
25825883|NCT00005647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25825884|NCT00005647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24830762|NCT02161159|Cholinergic Agents|cholinergic agents|mesh-ancestor
24830763|NCT02161159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25825885|NCT00005647|Tubulin Modulators|tubulin modulators|mesh-ancestor
25825886|NCT00005647|Antimitotic Agents|antimitotic agents|mesh-ancestor
25825887|NCT00005647|Mitosis Modulators|mitosis modulators|mesh-ancestor
25825888|NCT00005647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825889|NCT00005647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25825890|NCT00005647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25825891|NCT00005647|Growth Substances|growth substances|mesh-ancestor
25825892|NCT00005647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825893|NCT00005647|Growth Inhibitors|growth inhibitors|mesh-ancestor
24456867|NCT00332436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24456868|NCT00332436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25825894|NCT00005647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25825895|NCT00005647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825896|NCT00005648|Gemcitabine|gemcitabine|mesh-list
24449036|NCT00313963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24449037|NCT00313963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24449040|NCT00313963|Tocolytic Agents|tocolytic agents|mesh-ancestor
25825897|NCT00005648|Tipifarnib|tipifarnib|mesh-list
25649497|NCT01491958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25649498|NCT01491958|Immunologic Factors|immunologic factors|mesh-ancestor
25649499|NCT01491958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25649500|NCT01491958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25649501|NCT01491958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25649502|NCT01491958|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25649503|NCT01491958|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25649504|NCT01491958|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25008739|NCT04577638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25008740|NCT04577638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008741|NCT04577638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25008742|NCT04577638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825898|NCT00005648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24830772|NCT02161237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825899|NCT00005648|Antimetabolites|antimetabolites|mesh-ancestor
25825900|NCT00005648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825901|NCT00005648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825902|NCT00005648|Antiviral Agents|antiviral agents|mesh-ancestor
25825903|NCT00005648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25825904|NCT00005648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825905|NCT00005648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25825906|NCT00005648|Immunologic Factors|immunologic factors|mesh-ancestor
25825907|NCT00005648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825908|NCT00005649|Paclitaxel|paclitaxel|mesh-list
25825909|NCT00005649|Capecitabine|capecitabine|mesh-list
25825910|NCT00005649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25825911|NCT00005649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825912|NCT00005649|Tubulin Modulators|tubulin modulators|mesh-ancestor
24465496|NCT00369863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24465497|NCT00369863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825913|NCT00005649|Antimitotic Agents|antimitotic agents|mesh-ancestor
25825914|NCT00005649|Mitosis Modulators|mitosis modulators|mesh-ancestor
25825915|NCT00005649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825916|NCT00005649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24730817|NCT01630642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25825917|NCT00005649|Antimetabolites|antimetabolites|mesh-ancestor
25825918|NCT00005652|Rituximab|rituximab|mesh-list
25825919|NCT00005652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25268593|NCT02415179|Glucocorticoids|glucocorticoids|mesh-ancestor
25825920|NCT00005652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825921|NCT00005652|Immunologic Factors|immunologic factors|mesh-ancestor
25825922|NCT00005652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825923|NCT00005652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25825924|NCT00005654|Metformin|metformin|mesh-list
24830883|NCT02161965|Phenindione|phenindione|mesh-list
24830884|NCT02161965|Anticoagulants|anticoagulants|mesh-ancestor
24830885|NCT02161965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24830886|NCT02161965|Antithrombins|antithrombins|mesh-ancestor
24830887|NCT02161965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25825925|NCT00005654|Clomiphene|clomiphene|mesh-list
25825926|NCT00005654|Enclomiphene|enclomiphene|mesh-list
25825927|NCT00005654|Zuclomiphene|zuclomiphene|mesh-list
25825928|NCT00005654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25825929|NCT00005654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825930|NCT00005654|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25825931|NCT00005654|Hormone Antagonists|hormone antagonists|mesh-ancestor
25825932|NCT00005654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25825933|NCT00005654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25825934|NCT00005654|Fertility Agents|fertility agents|mesh-ancestor
24940937|NCT03996564|Diclofenac|diclofenac|mesh-list
25825935|NCT00005654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25825936|NCT00005654|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25825937|NCT00005654|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25825938|NCT00005658|Glycine|glycine|mesh-list
24612569|NCT01014507|Goserelin|goserelin|mesh-list
25825939|NCT00005658|Glycine Agents|glycine agents|mesh-ancestor
25825940|NCT00005658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25825941|NCT00005658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825942|NCT00005658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825943|NCT00005663|Valacyclovir|valacyclovir|mesh-list
25825944|NCT00005663|Antiviral Agents|antiviral agents|mesh-ancestor
25825945|NCT00005663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25825946|NCT00005665|Interferons|interferons|mesh-list
25825947|NCT00005665|Interferon-alpha|interferon-alpha|mesh-list
25649505|NCT01491958|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25649506|NCT01492088|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25649507|NCT01492088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25649508|NCT01492088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649509|NCT01492101|Etirinotecan pegol|etirinotecan pegol|mesh-list
25649510|NCT01492101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649511|NCT01492101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25649512|NCT01492101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25825948|NCT00005665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25825949|NCT00005665|Antiviral Agents|antiviral agents|mesh-ancestor
25825950|NCT00005665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25825951|NCT00005665|Immunologic Factors|immunologic factors|mesh-ancestor
25825952|NCT00005665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268613|NCT02415023|Paclitaxel|paclitaxel|mesh-list
25268620|NCT02415023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825953|NCT00005668|Itraconazole|itraconazole|mesh-list
24830906|NCT02162121|Anesthetics, Local|anesthetics, local|mesh-list
25825954|NCT00005668|Antifungal Agents|antifungal agents|mesh-ancestor
24712140|NCT01518725|Vitamins|vitamins|mesh-ancestor
25825955|NCT00005668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25825956|NCT00005668|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25825957|NCT00005668|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25825958|NCT00005668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825959|NCT00005668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825960|NCT00005668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25825961|NCT00005668|Hormone Antagonists|hormone antagonists|mesh-ancestor
24718863|NCT01557634|Insulin|insulin|mesh-list
25825962|NCT00005668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24696081|NCT01427205|Cetuximab|cetuximab|mesh-list
25825963|NCT00005668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25825964|NCT00005668|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25825965|NCT00005673|Capravirine|capravirine|mesh-list
25825966|NCT00005673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25825967|NCT00005673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25825968|NCT00005673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449099|NCT00314314|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25825969|NCT00005673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825970|NCT00005673|Antiviral Agents|antiviral agents|mesh-ancestor
25825971|NCT00005673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25825972|NCT00005673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25825973|NCT00005673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25825974|NCT00005684|Heparin|heparin|mesh-list
25825975|NCT00005684|Warfarin|warfarin|mesh-list
25825976|NCT00005684|Anticoagulants|anticoagulants|mesh-ancestor
25825977|NCT00005684|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25825978|NCT00005684|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25825979|NCT00005684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829520|NCT00006224|Immunologic Factors|immunologic factors|mesh-ancestor
25829521|NCT00006224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829522|NCT00006226|Thalidomide|thalidomide|mesh-list
25829523|NCT00006226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25829524|NCT00006226|Immunologic Factors|immunologic factors|mesh-ancestor
25829525|NCT00006226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829526|NCT00006226|Leprostatic Agents|leprostatic agents|mesh-ancestor
25829527|NCT00006226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25829528|NCT00006226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24449919|NCT00317408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25829529|NCT00006226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25829530|NCT00006226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25829531|NCT00006226|Growth Substances|growth substances|mesh-ancestor
25829532|NCT00006226|Growth Inhibitors|growth inhibitors|mesh-ancestor
25829533|NCT00006226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829534|NCT00006228|Aldesleukin|aldesleukin|mesh-list
25829535|NCT00006228|Trastuzumab|trastuzumab|mesh-list
25829536|NCT00006228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25829537|NCT00006228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829538|NCT00006228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25829539|NCT00006228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25829540|NCT00006228|Antiviral Agents|antiviral agents|mesh-ancestor
25829541|NCT00006228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25829542|NCT00006229|Paclitaxel|paclitaxel|mesh-list
25829543|NCT00006229|Carboplatin|carboplatin|mesh-list
25829544|NCT00006229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25829545|NCT00006229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829546|NCT00006229|Tubulin Modulators|tubulin modulators|mesh-ancestor
25829547|NCT00006229|Antimitotic Agents|antimitotic agents|mesh-ancestor
25829548|NCT00006229|Mitosis Modulators|mitosis modulators|mesh-ancestor
25829549|NCT00006229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24454653|NCT03878524|Androgen Antagonists|androgen antagonists|mesh-ancestor
24454654|NCT03878524|Hormone Antagonists|hormone antagonists|mesh-ancestor
25829550|NCT00006230|Rubitecan|rubitecan|mesh-list
25829551|NCT00006230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829552|NCT00006230|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25829553|NCT00006230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25829554|NCT00006230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566033|NCT00784082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566034|NCT00784082|Antisickling Agents|antisickling agents|mesh-ancestor
24566035|NCT00784082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25825980|NCT00005762|Ritonavir|ritonavir|mesh-list
25825981|NCT00005762|Nelfinavir|nelfinavir|mesh-list
25825982|NCT00005762|Indinavir|indinavir|mesh-list
25825983|NCT00005762|Saquinavir|saquinavir|mesh-list
25825984|NCT00005762|Amprenavir|amprenavir|mesh-list
25825985|NCT00005762|Efavirenz|efavirenz|mesh-list
25825986|NCT00005762|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25825987|NCT00005762|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24831030|NCT02162537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24831031|NCT02162537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25825988|NCT00005762|Protease Inhibitors|protease inhibitors|mesh-ancestor
25825989|NCT00005762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24831075|NCT02162797|Zinc|zinc|mesh-list
24517667|NCT00609154|Hormones|hormones|mesh-ancestor
25825990|NCT00005762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25825991|NCT00005762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25825992|NCT00005762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25825993|NCT00005762|Antiviral Agents|antiviral agents|mesh-ancestor
25825994|NCT00005762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25825995|NCT00005762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25825996|NCT00005762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25825997|NCT00005762|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25825998|NCT00005762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25825999|NCT00005762|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25826000|NCT00005762|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25826001|NCT00005762|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25826002|NCT00005762|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25826003|NCT00005762|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25826004|NCT00005762|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25826005|NCT00005762|Antitubercular Agents|antitubercular agents|mesh-ancestor
25826006|NCT00005762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25826007|NCT00005764|Lamivudine|lamivudine|mesh-list
25826008|NCT00005764|Zidovudine|zidovudine|mesh-list
25826009|NCT00005764|Abacavir|abacavir|mesh-list
24465666|NCT00370500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24465667|NCT00370500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826010|NCT00005764|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25826011|NCT00005764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25826012|NCT00005764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25826013|NCT00005764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826014|NCT00005764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826015|NCT00005764|Antiviral Agents|antiviral agents|mesh-ancestor
25826016|NCT00005764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25826017|NCT00005764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25826018|NCT00005764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24831110|NCT02163174|Vasodilator Agents|vasodilator agents|mesh-ancestor
24831111|NCT02163174|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24831113|NCT02163213|Immunoglobulins|immunoglobulins|mesh-list
24831114|NCT02163213|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24831115|NCT02163213|Antibodies|antibodies|mesh-list
24831118|NCT02163291|Paclitaxel|paclitaxel|mesh-list
25826019|NCT00005764|Antimetabolites|antimetabolites|mesh-ancestor
25826020|NCT00005765|Nicotine|nicotine|mesh-list
25826021|NCT00005765|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25826022|NCT00005765|Autonomic Agents|autonomic agents|mesh-ancestor
25826023|NCT00005765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25826024|NCT00005765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826025|NCT00005765|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24766059|NCT01792102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826026|NCT00005765|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25826027|NCT00005765|Cholinergic Agents|cholinergic agents|mesh-ancestor
25826028|NCT00005765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25826029|NCT00005765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826030|NCT00005768|Estrogens|estrogens|mesh-list
25649513|NCT01492101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649514|NCT01492101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656863|NCT01580020|Antiemetics|antiemetics|mesh-ancestor
25656864|NCT01580020|Autonomic Agents|autonomic agents|mesh-ancestor
25826031|NCT00005768|Hormones|hormones|mesh-ancestor
25829669|NCT00006247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826035|NCT00005769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25826036|NCT00005769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826037|NCT00005773|Nitric Oxide|nitric oxide|mesh-list
25826038|NCT00005773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25826039|NCT00005773|Autonomic Agents|autonomic agents|mesh-ancestor
25826040|NCT00005773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25826041|NCT00005773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826042|NCT00005773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25826043|NCT00005773|Respiratory System Agents|respiratory system agents|mesh-ancestor
25826044|NCT00005773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25826045|NCT00005773|Antioxidants|antioxidants|mesh-ancestor
25826046|NCT00005773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826047|NCT00005773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25826048|NCT00005773|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25826049|NCT00005773|Vasodilator Agents|vasodilator agents|mesh-ancestor
25826050|NCT00005773|Gasotransmitters|gasotransmitters|mesh-ancestor
25826051|NCT00005773|Protective Agents|protective agents|mesh-ancestor
25826052|NCT00005774|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25826053|NCT00005774|Respiratory System Agents|respiratory system agents|mesh-ancestor
25826054|NCT00005775|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
25826055|NCT00005775|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25826056|NCT00005775|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25826057|NCT00005776|Nitric Oxide|nitric oxide|mesh-list
25826058|NCT00005776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25826059|NCT00005776|Autonomic Agents|autonomic agents|mesh-ancestor
25826060|NCT00005776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25826061|NCT00005776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826062|NCT00005776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25826063|NCT00005776|Respiratory System Agents|respiratory system agents|mesh-ancestor
25826064|NCT00005776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25826065|NCT00005776|Antioxidants|antioxidants|mesh-ancestor
25268866|NCT02414009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25268867|NCT02414009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25268868|NCT02414009|Antidotes|antidotes|mesh-ancestor
25268869|NCT02414009|Protective Agents|protective agents|mesh-ancestor
25050763|NCT00468403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25050764|NCT00468403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25050765|NCT00468403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25050766|NCT00468403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25826066|NCT00005776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826067|NCT00005776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25826068|NCT00005776|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24422560|NCT00222976|Naproxen|naproxen|mesh-list
25826069|NCT00005776|Vasodilator Agents|vasodilator agents|mesh-ancestor
25826070|NCT00005776|Gasotransmitters|gasotransmitters|mesh-ancestor
25826071|NCT00005776|Protective Agents|protective agents|mesh-ancestor
24465798|NCT00370747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24465799|NCT00370747|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24465800|NCT00370747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24465801|NCT00370747|Protease Inhibitors|protease inhibitors|mesh-ancestor
25826072|NCT00005777|Dexamethasone|dexamethasone|mesh-list
25826073|NCT00005777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25050768|NCT00468273|Antibodies|antibodies|mesh-list
25826074|NCT00005777|Antiemetics|antiemetics|mesh-ancestor
25826075|NCT00005777|Autonomic Agents|autonomic agents|mesh-ancestor
25826076|NCT00005777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25826077|NCT00005777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826078|NCT00005777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25826079|NCT00005777|Glucocorticoids|glucocorticoids|mesh-ancestor
25826080|NCT00005777|Hormones|hormones|mesh-ancestor
25826081|NCT00005777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25826082|NCT00005777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25826083|NCT00005777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465928|NCT00371124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24465929|NCT00371124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24465930|NCT00371124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24517786|NCT00609960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24517789|NCT00609999|Dasatinib|dasatinib|mesh-list
25826094|NCT00005782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25826095|NCT00005782|Immunologic Factors|immunologic factors|mesh-ancestor
25826096|NCT00005782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826097|NCT00005786|Arsenic Trioxide|arsenic trioxide|mesh-list
24466273|NCT00372801|Sensory System Agents|sensory system agents|mesh-ancestor
24466274|NCT00372801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24466275|NCT00372801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466279|NCT00372801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466281|NCT00372827|Travoprost|travoprost|mesh-list
24466293|NCT00372853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466294|NCT00372853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24466295|NCT00372853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24715690|NCT01538108|Paclitaxel|paclitaxel|mesh-list
24832087|NCT02170636|Pantoprazole|pantoprazole|mesh-list
24590146|NCT00910806|Antiviral Agents|antiviral agents|mesh-ancestor
24832088|NCT02170636|Dabigatran|dabigatran|mesh-list
24832089|NCT02170636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24832090|NCT02170636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24832091|NCT02170636|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24697882|NCT01437748|Bromides|bromides|mesh-list
24832104|NCT02170675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832115|NCT02170701|Dabigatran|dabigatran|mesh-list
25649515|NCT01492400|Dexamethasone|dexamethasone|mesh-list
25649516|NCT01492400|Ranibizumab|ranibizumab|mesh-list
25649517|NCT01492400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25649518|NCT01492400|Antiemetics|antiemetics|mesh-ancestor
25649519|NCT01492400|Autonomic Agents|autonomic agents|mesh-ancestor
25649520|NCT01492400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25649521|NCT01492400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649522|NCT01492400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25649523|NCT01492400|Glucocorticoids|glucocorticoids|mesh-ancestor
25649524|NCT01492400|Hormones|hormones|mesh-ancestor
25649525|NCT01492400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25649526|NCT01492400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25649527|NCT01492400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25269081|NCT02412150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826098|NCT00005786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466383|NCT00373451|Heparin|heparin|mesh-list
24466384|NCT00373451|Calcium heparin|calcium heparin|mesh-list
24466385|NCT00373451|Bivalirudin|bivalirudin|mesh-list
24466387|NCT00373451|Anticoagulants|anticoagulants|mesh-ancestor
24466388|NCT00373451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24466389|NCT00373451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25826100|NCT00005787|Flt3 ligand protein|flt3 ligand protein|mesh-list
25826101|NCT00005787|Sargramostim|sargramostim|mesh-list
25826102|NCT00005787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25826103|NCT00005787|Immunologic Factors|immunologic factors|mesh-ancestor
25826104|NCT00005787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826105|NCT00005787|Hematinics|hematinics|mesh-ancestor
25826106|NCT00005787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25826107|NCT00005787|Protective Agents|protective agents|mesh-ancestor
25826108|NCT00005791|Cisplatin|cisplatin|mesh-list
25826109|NCT00005791|Fluorouracil|fluorouracil|mesh-list
25826110|NCT00005791|Irinotecan|irinotecan|mesh-list
25826111|NCT00005791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826112|NCT00005791|Antimetabolites|antimetabolites|mesh-ancestor
25826113|NCT00005791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826114|NCT00005791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25826115|NCT00005791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25826116|NCT00005791|Immunologic Factors|immunologic factors|mesh-ancestor
25826117|NCT00005791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826118|NCT00005791|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25826119|NCT00005791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25826120|NCT00005791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826121|NCT00005792|Etoposide|etoposide|mesh-list
25826122|NCT00005792|Melphalan|melphalan|mesh-list
25826123|NCT00005792|Topotecan|topotecan|mesh-list
25826124|NCT00005792|Etoposide phosphate|etoposide phosphate|mesh-list
25826125|NCT00005792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25826126|NCT00005792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826127|NCT00005792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25826128|NCT00005792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25826129|NCT00005792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24941337|NCT03992326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24941338|NCT03992365|Bisacodyl|bisacodyl|mesh-list
24941339|NCT03992365|Sodium sulfate|sodium sulfate|mesh-list
24941340|NCT03992365|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24941341|NCT03992365|Cathartics|cathartics|mesh-ancestor
24941342|NCT03992365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24941343|NCT03992365|Laxatives|laxatives|mesh-ancestor
25269188|NCT02411695|Dopamine Agents|dopamine agents|mesh-ancestor
25269189|NCT02411604|Tacrolimus|tacrolimus|mesh-list
24941371|NCT03991442|Amlodipine|amlodipine|mesh-list
25826130|NCT00005792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826131|NCT00005792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25826132|NCT00005792|Alkylating Agents|alkylating agents|mesh-ancestor
25826133|NCT00005792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25826134|NCT00005792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25826135|NCT00005792|Immunologic Factors|immunologic factors|mesh-ancestor
25826136|NCT00005792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826137|NCT00005792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25826138|NCT00005793|Cytarabine|cytarabine|mesh-list
24456891|NCT00332553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24456892|NCT00332553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657488|NCT01267604|Antioxidants|antioxidants|mesh-ancestor
24456893|NCT00332553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24456894|NCT00332553|Contraceptive Agents|contraceptive agents|mesh-ancestor
24456895|NCT00332553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24467134|NCT00376337|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24467135|NCT00376337|Hormone Antagonists|hormone antagonists|mesh-ancestor
24456904|NCT00332553|Hormone Antagonists|hormone antagonists|mesh-ancestor
25045524|NCT00945646|Antiemetics|antiemetics|mesh-ancestor
25045525|NCT00945646|Autonomic Agents|autonomic agents|mesh-ancestor
25649528|NCT01492400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25649529|NCT01492400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25649530|NCT01492400|Growth Substances|growth substances|mesh-ancestor
25649531|NCT01492400|Growth Inhibitors|growth inhibitors|mesh-ancestor
25649532|NCT01492426|Ribavirin|ribavirin|mesh-list
25649533|NCT01492426|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25649534|NCT01492426|Antimetabolites|antimetabolites|mesh-ancestor
25649535|NCT01492426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045527|NCT00945646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045528|NCT00945646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25045529|NCT00945646|Glucocorticoids|glucocorticoids|mesh-ancestor
25045530|NCT00945646|Hormones|hormones|mesh-ancestor
24785837|NCT01916863|Canagliflozin|canagliflozin|mesh-list
24467858|NCT00378976|Valacyclovir|valacyclovir|mesh-list
25826139|NCT00005793|Etoposide|etoposide|mesh-list
24467958|NCT00379262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826140|NCT00005793|Daunorubicin|daunorubicin|mesh-list
25826141|NCT00005793|Topotecan|topotecan|mesh-list
24468260|NCT00380822|Miglitol|miglitol|mesh-list
24468265|NCT00380822|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25826142|NCT00005793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24456923|NCT00332631|Antidotes|antidotes|mesh-ancestor
24456925|NCT00332735|Carticaine|carticaine|mesh-list
24456926|NCT00332735|Anesthetics, Local|anesthetics, local|mesh-ancestor
24456943|NCT00332761|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24468928|NCT00383929|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25826143|NCT00005793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826144|NCT00005793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25826145|NCT00005793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25826146|NCT00005793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826147|NCT00005793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826148|NCT00005793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25826149|NCT00005793|Antimetabolites|antimetabolites|mesh-ancestor
25826150|NCT00005793|Antiviral Agents|antiviral agents|mesh-ancestor
25826151|NCT00005793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25826152|NCT00005793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24469407|NCT00385645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469476|NCT00385970|Micronutrients|micronutrients|mesh-ancestor
25826153|NCT00005793|Immunologic Factors|immunologic factors|mesh-ancestor
25826154|NCT00005793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469497|NCT00386074|Fe(III)-EDTA|fe(iii)-edta|mesh-list
24469501|NCT00386074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469502|NCT00386126|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24469503|NCT00386126|Hematinics|hematinics|mesh-ancestor
24469504|NCT00386178|Vitamin E|vitamin e|mesh-list
24469505|NCT00386178|Tocopherols|tocopherols|mesh-list
24469506|NCT00386178|Tocotrienols|tocotrienols|mesh-list
24469507|NCT00386178|alpha-Tocopherol|alpha-tocopherol|mesh-list
24469508|NCT00386178|gamma-Tocopherol|gamma-tocopherol|mesh-list
24833433|NCT02173912|Amlodipine|amlodipine|mesh-list
24469702|NCT00386802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24469703|NCT00386802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24469704|NCT00386815|Pemetrexed|pemetrexed|mesh-list
24469705|NCT00386815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469706|NCT00386815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24941814|NCT03987815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24833744|NCT02175407|Itraconazole|itraconazole|mesh-list
24469786|NCT00387374|Bevacizumab|bevacizumab|mesh-list
24469791|NCT00387374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24469815|NCT00387413|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24469816|NCT00387413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24469817|NCT00387413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25050893|NCT00463242|Serotonin Agents|serotonin agents|mesh-ancestor
24834255|NCT02177487|Telmisartan|telmisartan|mesh-list
24834256|NCT02177487|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
24834257|NCT02177487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24834258|NCT02177487|Diuretics|diuretics|mesh-ancestor
24834259|NCT02177487|Natriuretic Agents|natriuretic agents|mesh-ancestor
24834353|NCT02177955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25649536|NCT01492426|Antiviral Agents|antiviral agents|mesh-ancestor
25649537|NCT01492426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24834354|NCT02177955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25649538|NCT01492582|Vaccines|vaccines|mesh-list
25649539|NCT01492582|Immunologic Factors|immunologic factors|mesh-ancestor
25649540|NCT01492582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649541|NCT01492673|Cyclophosphamide|cyclophosphamide|mesh-list
25649542|NCT01492673|Bevacizumab|bevacizumab|mesh-list
25649543|NCT01492673|Topotecan|topotecan|mesh-list
25649544|NCT01492673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24834355|NCT02177955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24834356|NCT02177955|Anesthetics, General|anesthetics, general|mesh-ancestor
24834357|NCT02177955|Anesthetics|anesthetics|mesh-ancestor
24469818|NCT00387413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469819|NCT00387413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24469828|NCT00387413|Vitamins|vitamins|mesh-ancestor
24469830|NCT00387504|Fenretinide|fenretinide|mesh-list
24837461|NCT02191332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24470393|NCT00390026|Growth Inhibitors|growth inhibitors|mesh-ancestor
24470397|NCT00390039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24470442|NCT00390156|Growth Inhibitors|growth inhibitors|mesh-ancestor
24470547|NCT00390520|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24470548|NCT00390520|Protease Inhibitors|protease inhibitors|mesh-ancestor
24470567|NCT00390676|Docetaxel|docetaxel|mesh-list
24470613|NCT00390793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24470648|NCT00390871|Adrenergic Agents|adrenergic agents|mesh-ancestor
24470785|NCT00391911|Expectorants|expectorants|mesh-ancestor
24470800|NCT00392002|Esomeprazole|esomeprazole|mesh-list
24470873|NCT00392275|Renal Agents|renal agents|mesh-ancestor
24470876|NCT00392314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470877|NCT00392314|Antiviral Agents|antiviral agents|mesh-ancestor
24470962|NCT00392691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24470964|NCT00392691|Alkylating Agents|alkylating agents|mesh-ancestor
24470966|NCT00392691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24722552|NCT01581398|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24471057|NCT00393198|Contraceptive Agents|contraceptive agents|mesh-ancestor
24471058|NCT00393198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24471059|NCT00393198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471060|NCT00393198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24471139|NCT00393471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24471140|NCT00393471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24471141|NCT00393471|Analgesics|analgesics|mesh-ancestor
24471142|NCT00393471|Sensory System Agents|sensory system agents|mesh-ancestor
24771604|NCT01828385|Magnesium Sulfate|magnesium sulfate|mesh-list
24471143|NCT00393471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24941959|NCT03985865|Analgesics|analgesics|mesh-ancestor
24471412|NCT00395213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24471451|NCT00395382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24471452|NCT00395382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836451|NCT02185898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471853|NCT00397098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25826155|NCT00005793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25826156|NCT00005793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24836569|NCT02186366|Serotonin Agents|serotonin agents|mesh-ancestor
24836570|NCT02186366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24471884|NCT00397319|Hormones|hormones|mesh-list
24767109|NCT01798836|Estradiol|estradiol|mesh-list
25649545|NCT01492673|Immunologic Factors|immunologic factors|mesh-ancestor
25649546|NCT01492673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649547|NCT01492673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25649548|NCT01492673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25649549|NCT01492673|Alkylating Agents|alkylating agents|mesh-ancestor
25649550|NCT01492673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649551|NCT01492673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24836739|NCT02187211|Minocycline|minocycline|mesh-list
24475640|NCT00410982|Antiviral Agents|antiviral agents|mesh-ancestor
24475641|NCT00410982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24475643|NCT00410982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24475644|NCT00410982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24475645|NCT00410982|Alkylating Agents|alkylating agents|mesh-ancestor
24475646|NCT00410982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24475647|NCT00410995|Naproxen|naproxen|mesh-list
24475648|NCT00410995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24475649|NCT00410995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24475651|NCT00410995|Sensory System Agents|sensory system agents|mesh-ancestor
24475652|NCT00410995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24958036|NCT03837886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25826157|NCT00005796|Vincristine|vincristine|mesh-list
24837096|NCT02188888|Esmolol|esmolol|mesh-list
25050906|NCT00462202|Antimetabolites|antimetabolites|mesh-ancestor
25826158|NCT00005796|Lomustine|lomustine|mesh-list
25826159|NCT00005796|Procarbazine|procarbazine|mesh-list
24476597|NCT00415844|Carbidopa|carbidopa|mesh-list
24837465|NCT02191371|Propofol|propofol|mesh-list
24476598|NCT00415844|Entacapone|entacapone|mesh-list
24476599|NCT00415844|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24476600|NCT00415844|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24476601|NCT00415844|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24476602|NCT00415844|Dopamine Agents|dopamine agents|mesh-ancestor
24837702|NCT02192723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24476603|NCT00415844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24837969|NCT02194374|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24726236|NCT01602523|Budesonide|budesonide|mesh-list
25826160|NCT00005796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24519324|NCT02030990|Mitomycins|mitomycins|mesh-list
24838281|NCT02196740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24838282|NCT02196805|Probucol|probucol|mesh-list
25826161|NCT00005796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476654|NCT00415961|Mitosis Modulators|mitosis modulators|mesh-ancestor
24476689|NCT00416169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24476695|NCT00416208|Bortezomib|bortezomib|mesh-list
24476696|NCT00416208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476697|NCT00416221|Antidepressive Agents|antidepressive agents|mesh-list
24840444|NCT02210182|Pentamidine|pentamidine|mesh-list
24840445|NCT02210182|Antifungal Agents|antifungal agents|mesh-ancestor
24967069|NCT03763084|Anesthetics, General|anesthetics, general|mesh-ancestor
24967070|NCT03763084|Anesthetics|anesthetics|mesh-ancestor
24841073|NCT02213913|Etoposide|etoposide|mesh-list
24942135|NCT03983889|Fentanyl|fentanyl|mesh-list
24476868|NCT00416767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476869|NCT00416767|Antidotes|antidotes|mesh-ancestor
24476872|NCT00416767|Vitamins|vitamins|mesh-ancestor
24476873|NCT00416767|Micronutrients|micronutrients|mesh-ancestor
24476874|NCT00416819|Leucovorin|leucovorin|mesh-list
24476875|NCT00416819|Cytarabine|cytarabine|mesh-list
24841699|NCT02217631|Prednisolone phosphate|prednisolone phosphate|mesh-list
24841700|NCT02217631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24476876|NCT00416819|Rituximab|rituximab|mesh-list
24841907|NCT02218814|Anesthetics|anesthetics|mesh-ancestor
24476888|NCT00416819|Abortifacient Agents|abortifacient agents|mesh-ancestor
24842198|NCT02220036|Antacids|antacids|mesh-ancestor
25826162|NCT00005796|Tubulin Modulators|tubulin modulators|mesh-ancestor
24728157|NCT01614366|Amlodipine|amlodipine|mesh-list
24476931|NCT00416832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24476932|NCT00416832|Glucocorticoids|glucocorticoids|mesh-ancestor
24476934|NCT00416832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24843199|NCT02226289|Bevacizumab|bevacizumab|mesh-list
24476936|NCT00416832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24843620|NCT02228512|Etoposide|etoposide|mesh-list
24476954|NCT00416871|Interferons|interferons|mesh-list
24476955|NCT00416871|Interferon-alpha|interferon-alpha|mesh-list
24476957|NCT00416871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826163|NCT00005796|Antimitotic Agents|antimitotic agents|mesh-ancestor
24477071|NCT00417144|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24477074|NCT00417144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24477075|NCT00417144|Contraceptive Agents|contraceptive agents|mesh-ancestor
24477076|NCT00417144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25649552|NCT01492673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24845156|NCT02236715|Ipratropium|ipratropium|mesh-list
24477180|NCT00417716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24477211|NCT00417833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826164|NCT00005796|Mitosis Modulators|mitosis modulators|mesh-ancestor
24477324|NCT00418249|Antiviral Agents|antiviral agents|mesh-ancestor
24456952|NCT00332774|Analgesics|analgesics|mesh-ancestor
24477443|NCT00418600|Vitamins|vitamins|mesh-ancestor
24477444|NCT00418600|Micronutrients|micronutrients|mesh-ancestor
24477445|NCT00418600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456963|NCT00332787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24456964|NCT00332787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24456965|NCT00332787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456966|NCT00332787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24456970|NCT00332787|Antidepressive Agents|antidepressive agents|mesh-ancestor
24477490|NCT00418847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24477491|NCT00418847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24477492|NCT00418847|Antiviral Agents|antiviral agents|mesh-ancestor
24477493|NCT00418847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24477494|NCT00418847|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24477495|NCT00418847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24477496|NCT00418847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477497|NCT00418860|Aspirin|aspirin|mesh-list
24477615|NCT00419419|Vasodilator Agents|vasodilator agents|mesh-ancestor
24477616|NCT00419471|Citalopram|citalopram|mesh-list
24846466|NCT02242799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24846467|NCT02242812|Metoprolol|metoprolol|mesh-list
24846468|NCT02242812|Telmisartan|telmisartan|mesh-list
24452751|NCT05453045|Albendazole|albendazole|mesh-list
25826165|NCT00005796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270386|NCT02404844|Tamoxifen|tamoxifen|mesh-list
25826166|NCT00005796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25826167|NCT00005796|Alkylating Agents|alkylating agents|mesh-ancestor
25826168|NCT00005797|Cyclophosphamide|cyclophosphamide|mesh-list
24477650|NCT00419601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25826169|NCT00005797|Busulfan|busulfan|mesh-list
24477652|NCT00419601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24477653|NCT00419601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477654|NCT00419601|Analgesics|analgesics|mesh-ancestor
24477688|NCT00419692|Dopamine Agonists|dopamine agonists|mesh-ancestor
24477689|NCT00419692|Dopamine Agents|dopamine agents|mesh-ancestor
24477991|NCT00421109|Histamine Agents|histamine agents|mesh-ancestor
25826170|NCT00005797|Etoposide|etoposide|mesh-list
24478310|NCT00422240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24478311|NCT00422318|Benzbromarone|benzbromarone|mesh-list
24478339|NCT00422396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24478340|NCT00422396|Antimetabolites|antimetabolites|mesh-ancestor
24478341|NCT00422396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478342|NCT00422396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25826171|NCT00005797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25826172|NCT00005797|Immunologic Factors|immunologic factors|mesh-ancestor
24478378|NCT00422604|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24478379|NCT00422604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25649553|NCT01492673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25649554|NCT01492673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25649555|NCT01492673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25649556|NCT01492673|Growth Substances|growth substances|mesh-ancestor
25649557|NCT01492673|Growth Inhibitors|growth inhibitors|mesh-ancestor
25649558|NCT01492673|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24478381|NCT00422604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24456993|NCT00332891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456994|NCT00332891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456999|NCT00332904|Adrenergic Agents|adrenergic agents|mesh-ancestor
24457000|NCT00332904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24457001|NCT00332904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457002|NCT00332904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478435|NCT00422825|Imatinib Mesylate|imatinib mesylate|mesh-list
24478436|NCT00422825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478437|NCT00422825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24478448|NCT00422864|Immunologic Factors|immunologic factors|mesh-ancestor
24478449|NCT00422864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457025|NCT00332995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24457029|NCT00333008|Vincristine|vincristine|mesh-list
24478461|NCT00422994|Dopamine Agonists|dopamine agonists|mesh-ancestor
24478462|NCT00422994|Dopamine Agents|dopamine agents|mesh-ancestor
24478463|NCT00422994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24478464|NCT00422994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478465|NCT00422994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826173|NCT00005797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826174|NCT00005797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25826175|NCT00005797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25826176|NCT00005797|Alkylating Agents|alkylating agents|mesh-ancestor
24480354|NCT00430794|Hormone Antagonists|hormone antagonists|mesh-ancestor
24478597|NCT00423696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478598|NCT00423696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25826177|NCT00005797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457033|NCT00333008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24457034|NCT00333008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24478744|NCT00424203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24478745|NCT00424203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24478759|NCT00424242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24478760|NCT00424242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24457057|NCT00333021|Anticoagulants|anticoagulants|mesh-ancestor
24457058|NCT00333021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24457059|NCT00333021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24457060|NCT00333034|Etanercept|etanercept|mesh-list
24478869|NCT00424814|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
24478870|NCT00424814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24478871|NCT00424814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24457066|NCT00333034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457067|NCT00333034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24457069|NCT00333034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24457070|NCT00333034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24457071|NCT00333034|Immunologic Factors|immunologic factors|mesh-ancestor
24478971|NCT00425152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24478979|NCT00425152|Antinematodal Agents|antinematodal agents|mesh-ancestor
24478980|NCT00425152|Anthelmintics|anthelmintics|mesh-ancestor
24478981|NCT00425152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24479030|NCT00425243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479032|NCT00425347|Elotuzumab|elotuzumab|mesh-list
25826178|NCT00005797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826179|NCT00005797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25826180|NCT00005797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24424686|NCT00230451|Paclitaxel|paclitaxel|mesh-list
24479207|NCT00425997|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24479209|NCT00426010|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24479210|NCT00426010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479215|NCT00426010|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24479216|NCT00426010|Purinergic Agents|purinergic agents|mesh-ancestor
25826181|NCT00005797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25826182|NCT00005797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24479297|NCT00426296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24479333|NCT00426478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24479334|NCT00426478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24479347|NCT00426491|Abortifacient Agents|abortifacient agents|mesh-ancestor
24479380|NCT00426608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479591|NCT00427388|Hormones|hormones|mesh-ancestor
25649559|NCT01492673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24457111|NCT00333125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24479729|NCT00428142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24479730|NCT00428142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24479732|NCT00428142|Antimitotic Agents|antimitotic agents|mesh-ancestor
24479733|NCT00428142|Mitosis Modulators|mitosis modulators|mesh-ancestor
24479826|NCT00428519|Fosaprepitant|fosaprepitant|mesh-list
25826183|NCT00005797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826184|NCT00005798|Cyclophosphamide|cyclophosphamide|mesh-list
25826185|NCT00005798|Thiotepa|thiotepa|mesh-list
25826186|NCT00005798|Carboplatin|carboplatin|mesh-list
24457126|NCT00333151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479964|NCT00429234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479970|NCT00429234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479972|NCT00429247|Trastuzumab|trastuzumab|mesh-list
24847428|NCT02246920|Autonomic Agents|autonomic agents|mesh-ancestor
24847435|NCT02247128|Aspirin|aspirin|mesh-list
24479977|NCT00429377|Immunologic Factors|immunologic factors|mesh-ancestor
25826187|NCT00005798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24480081|NCT00429832|Promethazine|promethazine|mesh-list
24444206|NCT00296959|Topiramate|topiramate|mesh-list
24480299|NCT00430261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480300|NCT00430261|Growth Inhibitors|growth inhibitors|mesh-ancestor
25826188|NCT00005798|Immunologic Factors|immunologic factors|mesh-ancestor
24638321|NCT01155934|Risperidone|risperidone|mesh-list
24480401|NCT00430963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480402|NCT00430963|Cholinergic Agents|cholinergic agents|mesh-ancestor
24480403|NCT00430963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25826189|NCT00005798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480632|NCT00431522|Valproic Acid|valproic acid|mesh-list
24457173|NCT00333294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480905|NCT00432614|Citalopram|citalopram|mesh-list
24480906|NCT00432614|Amibegron|amibegron|mesh-list
25271241|NCT02400385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826190|NCT00005798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25826191|NCT00005798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25826192|NCT00005798|Alkylating Agents|alkylating agents|mesh-ancestor
25045549|NCT00944970|Adenosine|adenosine|mesh-list
24659966|NCT01281150|Antimitotic Agents|antimitotic agents|mesh-ancestor
25826193|NCT00005798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482012|NCT00437619|Calcipotriene|calcipotriene|mesh-list
25826194|NCT00005798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24426279|NCT00235521|Iloprost|iloprost|mesh-list
24482320|NCT00438737|Bevacizumab|bevacizumab|mesh-list
24482463|NCT00439062|Roxithromycin|roxithromycin|mesh-list
25826195|NCT00005798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25826196|NCT00005799|Cyclosporine|cyclosporine|mesh-list
25826197|NCT00005799|Mycophenolic Acid|mycophenolic acid|mesh-list
25826198|NCT00005799|Fludarabine|fludarabine|mesh-list
25826199|NCT00005799|Fludarabine phosphate|fludarabine phosphate|mesh-list
24482495|NCT00439283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24482496|NCT00439283|Abortifacient Agents|abortifacient agents|mesh-ancestor
24482497|NCT00439283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24482579|NCT00439829|Cetrorelix|cetrorelix|mesh-list
24482582|NCT00439829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24482584|NCT00439829|Hormone Antagonists|hormone antagonists|mesh-ancestor
24482849|NCT00440739|Autonomic Agents|autonomic agents|mesh-ancestor
24482850|NCT00440739|Urological Agents|urological agents|mesh-ancestor
24482851|NCT00440765|Bortezomib|bortezomib|mesh-list
24482852|NCT00440765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24482853|NCT00440778|Abciximab|abciximab|mesh-list
25826200|NCT00005799|Cyclosporins|cyclosporins|mesh-list
25826201|NCT00005799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826202|NCT00005799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25826203|NCT00005799|Antimetabolites|antimetabolites|mesh-ancestor
25826204|NCT00005799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457340|NCT00334048|Ropinirole|ropinirole|mesh-list
24483105|NCT00441870|Folic Acid|folic acid|mesh-list
24483257|NCT00442546|Anticonvulsants|anticonvulsants|mesh-ancestor
24483604|NCT00444236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483605|NCT00444249|Dipivefrin|dipivefrin|mesh-list
24483606|NCT00444249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24483607|NCT00444249|Adrenergic Agents|adrenergic agents|mesh-ancestor
24483611|NCT00444314|Sunitinib|sunitinib|mesh-list
24483747|NCT00444808|Katacalcin|katacalcin|mesh-list
24483812|NCT00445081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483813|NCT00445081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24483911|NCT00445874|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24483912|NCT00445874|Histamine Antagonists|histamine antagonists|mesh-ancestor
24483913|NCT00445874|Histamine Agents|histamine agents|mesh-ancestor
24426948|NCT00236886|Topiramate|topiramate|mesh-list
25009391|NCT01468831|Bevacizumab|bevacizumab|mesh-list
25009393|NCT01468831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486929|NCT00460642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486931|NCT00460642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24444193|NCT00296946|Bromides|bromides|mesh-list
24444194|NCT00296946|Ipratropium|ipratropium|mesh-list
24444195|NCT00296946|Anticonvulsants|anticonvulsants|mesh-ancestor
24444196|NCT00296946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24444197|NCT00296946|Autonomic Agents|autonomic agents|mesh-ancestor
25826205|NCT00005799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25826206|NCT00005799|Immunologic Factors|immunologic factors|mesh-ancestor
25826207|NCT00005799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492779|NCT00487812|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24850063|NCT02251509|Adrenergic Agents|adrenergic agents|mesh-ancestor
24850064|NCT02251509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24850065|NCT02251509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487342|NCT00462787|Vinorelbine|vinorelbine|mesh-list
24487379|NCT00462852|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24487380|NCT00462852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24487381|NCT00462852|Antimetabolites|antimetabolites|mesh-ancestor
25826208|NCT00005799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826209|NCT00005799|Antifungal Agents|antifungal agents|mesh-ancestor
24487420|NCT00463008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24487421|NCT00463008|Immunologic Factors|immunologic factors|mesh-ancestor
24850635|NCT02253836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24487498|NCT00463515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24487499|NCT00463515|Immunologic Factors|immunologic factors|mesh-ancestor
24487500|NCT00463515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487501|NCT00463541|Solifenacin Succinate|solifenacin succinate|mesh-list
24487502|NCT00463541|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24943916|NCT03965858|Esketamine|esketamine|mesh-list
25826210|NCT00005799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25826211|NCT00005799|Dermatologic Agents|dermatologic agents|mesh-ancestor
25826212|NCT00005799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25826213|NCT00005799|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25826214|NCT00005799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24444826|NCT00299247|Pyrimethamine|pyrimethamine|mesh-list
25826215|NCT00005799|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25826216|NCT00005799|Antitubercular Agents|antitubercular agents|mesh-ancestor
24850931|NCT02254239|Immunologic Factors|immunologic factors|mesh-ancestor
24850932|NCT02254239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826217|NCT00005799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25826218|NCT00005800|Docetaxel|docetaxel|mesh-list
24444827|NCT00299247|Sulfadoxine|sulfadoxine|mesh-list
25272455|NCT02392039|Histamine Antagonists|histamine antagonists|mesh-ancestor
25272456|NCT02392039|Histamine Agents|histamine agents|mesh-ancestor
25272460|NCT02392130|Clobetasol|clobetasol|mesh-list
24487551|NCT00463762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487552|NCT00463762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850942|NCT02254525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24850943|NCT02254525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24850944|NCT02254525|Analgesics|analgesics|mesh-ancestor
24850945|NCT02254525|Sensory System Agents|sensory system agents|mesh-ancestor
24850946|NCT02254525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24850947|NCT02254525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444830|NCT00299247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24494612|NCT00496028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850959|NCT02254629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24850960|NCT02254655|Antirheumatic Agents|antirheumatic agents|mesh-list
24850962|NCT02254655|Vasodilator Agents|vasodilator agents|mesh-ancestor
24850963|NCT02254668|Mycophenolic Acid|mycophenolic acid|mesh-list
24850964|NCT02254668|Everolimus|everolimus|mesh-list
24494272|NCT00494624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494273|NCT00494624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25272464|NCT02392130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25272465|NCT02392130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272466|NCT02392156|Factor VIII|factor viii|mesh-list
25272467|NCT02392156|Coagulants|coagulants|mesh-ancestor
25649560|NCT01492673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649561|NCT01492686|Edaravone|edaravone|mesh-list
25649562|NCT01492686|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25649563|NCT01492686|Antioxidants|antioxidants|mesh-ancestor
25649564|NCT01492686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649565|NCT01492686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25649566|NCT01492686|Protective Agents|protective agents|mesh-ancestor
25649567|NCT01492686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826220|NCT00005800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24586573|NCT00891306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25272468|NCT02392169|Methylphenidate|methylphenidate|mesh-list
25272469|NCT02392169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25272470|NCT02392169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275598|NCT02370862|Neostigmine|neostigmine|mesh-list
24487617|NCT00464191|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24487618|NCT00464191|Antidepressive Agents|antidepressive agents|mesh-ancestor
24487619|NCT00464191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24487620|NCT00464217|Idarubicin|idarubicin|mesh-list
24487621|NCT00464217|Molgramostim|molgramostim|mesh-list
24739495|NCT01681979|Xhance|xhance|mesh-list
24494274|NCT00494624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826221|NCT00005800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826222|NCT00005800|Tubulin Modulators|tubulin modulators|mesh-ancestor
25826223|NCT00005800|Antimitotic Agents|antimitotic agents|mesh-ancestor
25826224|NCT00005800|Mitosis Modulators|mitosis modulators|mesh-ancestor
24494380|NCT00494988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24660753|NCT01285596|Mirabegron|mirabegron|mesh-list
25826225|NCT00005800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826226|NCT00005800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25826227|NCT00005800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25826228|NCT00005800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24494447|NCT00495313|Metronidazole|metronidazole|mesh-list
24494448|NCT00495313|Doxycycline|doxycycline|mesh-list
24494449|NCT00495313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24494450|NCT00495313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24494451|NCT00495313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24494452|NCT00495313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24494453|NCT00495313|Antimalarials|antimalarials|mesh-ancestor
24494455|NCT00495326|Nevirapine|nevirapine|mesh-list
24494456|NCT00495326|Rifampin|rifampin|mesh-list
25826229|NCT00005800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272471|NCT02392169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25272472|NCT02392169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25272473|NCT02392169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25272474|NCT02392169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272475|NCT02392169|Dopamine Agents|dopamine agents|mesh-ancestor
25272476|NCT02392169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25272477|NCT02391844|Oxycodone|oxycodone|mesh-list
24487622|NCT00464217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24487624|NCT00464217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24739713|NCT01683656|Niacin|niacin|mesh-list
24851152|NCT02255591|Sympathomimetics|sympathomimetics|mesh-ancestor
24851153|NCT02255591|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24851154|NCT02255682|Simvastatin|simvastatin|mesh-list
24851155|NCT02255682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24851156|NCT02255682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24851157|NCT02255682|Antimetabolites|antimetabolites|mesh-ancestor
24851158|NCT02255682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851159|NCT02255682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24851160|NCT02255682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24851161|NCT02255682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851162|NCT02255734|Acyclovir|acyclovir|mesh-list
24494611|NCT00496028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487668|NCT00464373|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24943961|NCT03965286|Sofosbuvir|sofosbuvir|mesh-list
24851684|NCT02258009|Growth Inhibitors|growth inhibitors|mesh-ancestor
24487669|NCT00464373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24943962|NCT03965286|Ledipasvir|ledipasvir|mesh-list
24851756|NCT02258828|Dopamine Agents|dopamine agents|mesh-ancestor
24851767|NCT02258906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851769|NCT02259075|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24851770|NCT02259075|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24851771|NCT02259075|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24851772|NCT02259075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24851773|NCT02259075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851774|NCT02259075|Cholinergic Agents|cholinergic agents|mesh-ancestor
25649568|NCT01493089|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
25649569|NCT01493089|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24851775|NCT02259075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24851776|NCT02259075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649570|NCT01493089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649571|NCT01493089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574189|NCT00824109|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24574190|NCT00824135|Mycophenolic Acid|mycophenolic acid|mesh-list
24586707|NCT00891696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586709|NCT00891761|Dexamethasone acetate|dexamethasone acetate|mesh-list
25826230|NCT00005802|Cytarabine|cytarabine|mesh-list
24586710|NCT00891761|Ondansetron|ondansetron|mesh-list
24586711|NCT00891761|Casopitant|casopitant|mesh-list
24586712|NCT00891761|BB 1101|bb 1101|mesh-list
25826231|NCT00005802|Aldesleukin|aldesleukin|mesh-list
24627074|NCT01090596|Analgesics|analgesics|mesh-ancestor
24562520|NCT00766857|Exenatide|exenatide|mesh-list
24562521|NCT00766857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24562522|NCT00766857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562523|NCT00766857|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24851777|NCT02259075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24851783|NCT02259179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851784|NCT02259179|Sensory System Agents|sensory system agents|mesh-ancestor
24851785|NCT02259179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851786|NCT02259179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24851787|NCT02259179|Antidepressive Agents|antidepressive agents|mesh-ancestor
24851788|NCT02259179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24851789|NCT02259179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24851790|NCT02259179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24851791|NCT02259179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24487670|NCT00464373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487671|NCT00464373|Cholinergic Agents|cholinergic agents|mesh-ancestor
24487672|NCT00464373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24487674|NCT00464373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24487711|NCT00464594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852004|NCT02259985|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24852005|NCT02259985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24487747|NCT00464919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487748|NCT00464919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25826232|NCT00005802|Hydrocortisone|hydrocortisone|mesh-list
24487749|NCT00464919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487781|NCT00465036|Cathartics|cathartics|mesh-ancestor
24487782|NCT00465036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24487783|NCT00465075|Bazedoxifene|bazedoxifene|mesh-list
24487785|NCT00465075|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24427516|NCT00238316|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25826233|NCT00005802|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24488007|NCT00466180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24590837|NCT00913965|Atenolol|atenolol|mesh-list
24488640|NCT00469599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488642|NCT00469599|Micronutrients|micronutrients|mesh-ancestor
24488643|NCT00469651|Vaccines|vaccines|mesh-list
24591119|NCT00915200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24591120|NCT00915200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488644|NCT00469651|Immunologic Factors|immunologic factors|mesh-ancestor
24488645|NCT00469651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488647|NCT00469664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24488648|NCT00469664|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24592415|NCT00921700|Ibuprofen|ibuprofen|mesh-list
25826234|NCT00005802|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24488844|NCT00470249|Immunologic Factors|immunologic factors|mesh-ancestor
24488922|NCT00470561|Aspirin|aspirin|mesh-list
24488925|NCT00470561|Analgesics|analgesics|mesh-ancestor
25826235|NCT00005802|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25826236|NCT00005802|Methotrexate|methotrexate|mesh-list
24523361|NCT01721746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24594454|NCT00933998|Vitamin B 12|vitamin b 12|mesh-list
25649572|NCT01493180|Rebamipide|rebamipide|mesh-list
25649573|NCT01493180|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25649574|NCT01493180|Hyaluronic Acid|hyaluronic acid|mesh-list
25649575|NCT01493180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25649576|NCT01493180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25649577|NCT01493180|Immunologic Factors|immunologic factors|mesh-ancestor
25649578|NCT01493180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649579|NCT01493180|Viscosupplements|viscosupplements|mesh-ancestor
25649580|NCT01493180|Protective Agents|protective agents|mesh-ancestor
25649581|NCT01493180|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25649582|NCT01493180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25649583|NCT01493180|Antioxidants|antioxidants|mesh-ancestor
25649584|NCT01493180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826237|NCT00005802|Fludarabine phosphate|fludarabine phosphate|mesh-list
25826238|NCT00005802|Fludarabine|fludarabine|mesh-list
25826239|NCT00005802|Etoposide|etoposide|mesh-list
24489172|NCT00471640|Antiemetics|antiemetics|mesh-ancestor
24595249|NCT00937625|Vidarabine|vidarabine|mesh-list
24489212|NCT00471809|Hormones|hormones|mesh-ancestor
24489343|NCT00472472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489411|NCT00473005|Immunologic Factors|immunologic factors|mesh-ancestor
24745030|NCT04020848|Melatonin|melatonin|mesh-list
24596253|NCT00942565|Tramadol|tramadol|mesh-list
24812475|NCT02052388|Daptomycin|daptomycin|mesh-list
24489460|NCT00473460|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24489533|NCT00473980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24597117|NCT00947141|Foscarnet|foscarnet|mesh-list
24597818|NCT00952029|Leucovorin|leucovorin|mesh-list
25826240|NCT00005802|Mitoxantrone|mitoxantrone|mesh-list
24852969|NCT02264912|Ticagrelor|ticagrelor|mesh-list
25826241|NCT00005802|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24746252|NCT05438316|Ramipril|ramipril|mesh-list
25826242|NCT00005802|Abortifacient Agents|abortifacient agents|mesh-ancestor
25826243|NCT00005802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25826244|NCT00005802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489764|NCT00475293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24490001|NCT00476138|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24490002|NCT00476138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602247|NCT00967707|Nootropic Agents|nootropic agents|mesh-ancestor
25826245|NCT00005802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24602795|NCT00970996|Paclitaxel|paclitaxel|mesh-list
24603283|NCT00973154|Prednisone|prednisone|mesh-list
24603850|NCT00975897|Vitamins|vitamins|mesh-ancestor
24490574|NCT00478959|Growth Inhibitors|growth inhibitors|mesh-ancestor
24490581|NCT00478998|Tamsulosin|tamsulosin|mesh-list
24490659|NCT00479609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24490660|NCT00479609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490661|NCT00479661|Dexmedetomidine|dexmedetomidine|mesh-list
24490667|NCT00479661|Anesthetics, General|anesthetics, general|mesh-ancestor
24490668|NCT00479661|Anesthetics|anesthetics|mesh-ancestor
24490669|NCT00479661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24490670|NCT00479661|Analgesics|analgesics|mesh-ancestor
24490784|NCT00480116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826246|NCT00005802|Antimetabolites|antimetabolites|mesh-ancestor
24944338|NCT03961334|Edoxaban|edoxaban|mesh-list
24606122|NCT00988949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24799709|NCT01970553|Antiviral Agents|antiviral agents|mesh-ancestor
24606123|NCT00988949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606125|NCT00988949|Diuretics|diuretics|mesh-ancestor
24491143|NCT00481364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24774031|NCT01843439|Pyridoxine|pyridoxine|mesh-list
24457534|NCT00334672|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24491317|NCT00482079|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24491349|NCT00482209|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24491350|NCT00482209|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24606968|NCT05398731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853491|NCT02268565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
24491351|NCT00482222|Leucovorin|leucovorin|mesh-list
24491352|NCT00482222|Fluorouracil|fluorouracil|mesh-list
24491353|NCT00482222|Capecitabine|capecitabine|mesh-list
24491354|NCT00482222|Oxaliplatin|oxaliplatin|mesh-list
24491355|NCT00482222|Cetuximab|cetuximab|mesh-list
24491356|NCT00482222|Calcium|calcium|mesh-list
24491357|NCT00482222|Levoleucovorin|levoleucovorin|mesh-list
24491358|NCT00482222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24618812|NCT01049815|Calcium|calcium|mesh-list
24491428|NCT00482456|Sensory System Agents|sensory system agents|mesh-ancestor
24491429|NCT00482456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24491430|NCT00482495|Bevacizumab|bevacizumab|mesh-list
24491437|NCT00482495|Growth Inhibitors|growth inhibitors|mesh-ancestor
24491438|NCT00482508|Omalizumab|omalizumab|mesh-list
24491439|NCT00482508|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24491440|NCT00482508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24491441|NCT00482508|Respiratory System Agents|respiratory system agents|mesh-ancestor
24491915|NCT00484510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491916|NCT00484510|Antioxidants|antioxidants|mesh-ancestor
24428045|NCT00239460|Tiotropium Bromide|tiotropium bromide|mesh-list
24492279|NCT00485823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492280|NCT00485823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24492281|NCT00485823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24492282|NCT00485823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24492364|NCT00485979|Tubulin Modulators|tubulin modulators|mesh-ancestor
25117006|NCT03105466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826247|NCT00005802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826248|NCT00005802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24492397|NCT00486083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492398|NCT00486083|Dopamine Agents|dopamine agents|mesh-ancestor
24492399|NCT00486083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492400|NCT00486083|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24492401|NCT00486083|Adrenergic Agents|adrenergic agents|mesh-ancestor
24625955|NCT01084473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24492402|NCT00486122|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24492585|NCT00486876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24492587|NCT00486980|Antiviral Agents|antiviral agents|mesh-ancestor
24492588|NCT00486980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24492589|NCT00486980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492681|NCT00487253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24492683|NCT00487253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25826249|NCT00005802|Dermatologic Agents|dermatologic agents|mesh-ancestor
25826250|NCT00005802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857519|NCT02292173|Sorafenib|sorafenib|mesh-list
24492892|NCT00488566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24492893|NCT00488566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24457545|NCT00334672|Antiemetics|antiemetics|mesh-ancestor
24457551|NCT00334672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24457552|NCT00334672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24457553|NCT00334672|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24492976|NCT00488787|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24492977|NCT00488787|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24492978|NCT00488787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492982|NCT00488800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493119|NCT00489593|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24493120|NCT00489593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493122|NCT00489645|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
25208979|NCT02706054|Meloxicam|meloxicam|mesh-list
24494024|NCT00493402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494055|NCT00493532|Ibandronic Acid|ibandronic acid|mesh-list
24494058|NCT00493545|Poly ICLC|poly iclc|mesh-list
24494059|NCT00493545|Interferon Inducers|interferon inducers|mesh-ancestor
24494060|NCT00493545|Immunologic Factors|immunologic factors|mesh-ancestor
24494063|NCT00493610|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24494064|NCT00493610|Antiviral Agents|antiviral agents|mesh-ancestor
24494218|NCT00494377|Dopamine Agents|dopamine agents|mesh-ancestor
24494219|NCT00494429|Morphine|morphine|mesh-list
24494220|NCT00494429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24494221|NCT00494429|Narcotics|narcotics|mesh-ancestor
25826251|NCT00005802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24624238|NCT01075490|Clonidine|clonidine|mesh-list
24500010|NCT00522158|Atorvastatin|atorvastatin|mesh-list
24924622|NCT04158076|Ezetimibe|ezetimibe|mesh-list
24496151|NCT00503568|Vaccines|vaccines|mesh-list
24496472|NCT00504946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24497415|NCT00510003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24925637|NCT04148820|Aspirin|aspirin|mesh-list
24457602|NCT00334698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457603|NCT00334698|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25826252|NCT00005802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24498435|NCT00514618|Abortifacient Agents|abortifacient agents|mesh-ancestor
24498926|NCT00516841|Growth Substances|growth substances|mesh-ancestor
24525922|NCT02357810|Topotecan|topotecan|mesh-list
24499006|NCT00517270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25826253|NCT00005802|Immunologic Factors|immunologic factors|mesh-ancestor
24499580|NCT00520104|Ketamine|ketamine|mesh-list
24394364|NCT00133185|Losartan|losartan|mesh-list
24499692|NCT00520507|Serotonin Agents|serotonin agents|mesh-ancestor
24499732|NCT00520819|Antioxidants|antioxidants|mesh-list
24502149|NCT05319249|Talazoparib|talazoparib|mesh-list
24506081|NCT00544011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24506082|NCT00544011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525607|NCT03015974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24525608|NCT03015974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24525609|NCT03015974|Alkylating Agents|alkylating agents|mesh-ancestor
24506194|NCT00544232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24506196|NCT00544232|Antimetabolites|antimetabolites|mesh-ancestor
24510994|NCT00566891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24511133|NCT00567554|Everolimus|everolimus|mesh-list
24511146|NCT00567554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24526415|NCT00611650|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24511293|NCT00568152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24456484|NCT00331305|Sertraline|sertraline|mesh-list
24514210|NCT00589082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514314|NCT00589862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24514720|NCT00592566|Autonomic Agents|autonomic agents|mesh-ancestor
24514721|NCT00592566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24514722|NCT00592566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514723|NCT00592566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24514724|NCT00592566|Glucocorticoids|glucocorticoids|mesh-ancestor
24514737|NCT00592579|Mitosis Modulators|mitosis modulators|mesh-ancestor
24514787|NCT00592930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24514790|NCT00592930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826255|NCT00005802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25826256|NCT00005802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24945108|NCT03953677|Adrenergic Agents|adrenergic agents|mesh-ancestor
24527005|NCT00614328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514995|NCT00593710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24514996|NCT00593710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24515003|NCT00593853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516125|NCT00600639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24516127|NCT00600639|Hormones|hormones|mesh-ancestor
24528706|NCT00622349|Antimitotic Agents|antimitotic agents|mesh-ancestor
24517892|NCT00610506|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24517894|NCT00610506|Autonomic Agents|autonomic agents|mesh-ancestor
24517895|NCT00610506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24517976|NCT00610948|Leucovorin|leucovorin|mesh-list
24457769|NCT00335192|Tenofovir|tenofovir|mesh-list
24550192|NCT00719602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24518463|NCT04967508|Dermatologic Agents|dermatologic agents|mesh-ancestor
24518464|NCT04963036|Anesthetics|anesthetics|mesh-list
24518503|NCT04908605|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25826257|NCT00005802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24456776|NCT00332254|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24456777|NCT00332254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24518540|NCT04871412|Ergocalciferols|ergocalciferols|mesh-list
24518620|NCT04666740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24518752|NCT04372927|Durvalumab|durvalumab|mesh-list
24518822|NCT04151082|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24519273|NCT02543255|Abiraterone Acetate|abiraterone acetate|mesh-list
24519275|NCT02543255|Glucocorticoids|glucocorticoids|mesh-ancestor
24519574|NCT05332470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24519575|NCT05332470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24519576|NCT05332470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24519577|NCT05332353|BCG Vaccine|bcg vaccine|mesh-list
24519578|NCT05332353|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24519579|NCT05332353|Immunologic Factors|immunologic factors|mesh-ancestor
24521493|NCT04745975|Antiviral Agents|antiviral agents|mesh-ancestor
24521494|NCT04745975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24521843|NCT04472143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24521874|NCT04456439|Anesthetics, Local|anesthetics, local|mesh-ancestor
24522616|NCT03568097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24522617|NCT03568097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522694|NCT03412266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522695|NCT03412266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24522700|NCT03411031|Thalidomide|thalidomide|mesh-list
24522775|NCT03127592|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24522776|NCT03127592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522887|NCT03083678|Afatinib|afatinib|mesh-list
24523043|NCT02897050|Cyclophosphamide|cyclophosphamide|mesh-list
24523045|NCT02897050|Fluorouracil|fluorouracil|mesh-list
24523046|NCT02897050|Capecitabine|capecitabine|mesh-list
24523047|NCT02897050|Epirubicin|epirubicin|mesh-list
24523048|NCT02897050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24523272|NCT02268175|Prednisone|prednisone|mesh-list
24523278|NCT02268175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24481835|NCT00436930|Sargramostim|sargramostim|mesh-list
24481836|NCT00436930|Immunologic Factors|immunologic factors|mesh-ancestor
24481837|NCT00436930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481838|NCT00436943|Bupropion|bupropion|mesh-list
24481839|NCT00436943|Nicotine|nicotine|mesh-list
24481840|NCT00436943|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24481841|NCT00436943|Autonomic Agents|autonomic agents|mesh-ancestor
24523818|NCT05340153|Artenimol|artenimol|mesh-list
24576085|NCT00836628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24576086|NCT00836628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24576090|NCT00836667|Sertraline|sertraline|mesh-list
24523826|NCT05339802|Linezolid|linezolid|mesh-list
24524641|NCT04639986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524642|NCT04639986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24524643|NCT04639986|Antiviral Agents|antiviral agents|mesh-ancestor
24524644|NCT04639986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24524881|NCT04243122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24518748|NCT04372927|Cisplatin|cisplatin|mesh-list
24525129|NCT03927989|Nicotine|nicotine|mesh-list
24525791|NCT02744976|Metformin|metformin|mesh-list
24526118|NCT01227616|Hematinics|hematinics|mesh-ancestor
24526495|NCT00611845|Aprotinin|aprotinin|mesh-list
24526573|NCT00612261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24526575|NCT00612261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24526662|NCT00612612|Fludarabine|fludarabine|mesh-list
24526663|NCT00612612|Fludarabine phosphate|fludarabine phosphate|mesh-list
24526664|NCT00612612|Obatoclax|obatoclax|mesh-list
24526666|NCT00612612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526744|NCT00613054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526745|NCT00613054|Antisickling Agents|antisickling agents|mesh-ancestor
24526747|NCT00613067|Citalopram|citalopram|mesh-list
24526820|NCT00613457|Vindesine|vindesine|mesh-list
24526821|NCT00613457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24526822|NCT00613457|Immunologic Factors|immunologic factors|mesh-ancestor
25826258|NCT00005802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25826259|NCT00005802|Antiviral Agents|antiviral agents|mesh-ancestor
24400537|NCT00150826|Quinapril|quinapril|mesh-list
25826260|NCT00005802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25826261|NCT00005802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24527528|NCT00617045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527529|NCT00617045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24527603|NCT00617656|Docetaxel|docetaxel|mesh-list
24457853|NCT00335413|Natriuretic Agents|natriuretic agents|mesh-ancestor
24527976|NCT00619021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542006|NCT00676416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24408985|NCT00180128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24408986|NCT00180128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24408987|NCT00180128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24408988|NCT00180128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527978|NCT00619021|Antiviral Agents|antiviral agents|mesh-ancestor
24527979|NCT00619021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24527989|NCT00619034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24527991|NCT00619034|Sensory System Agents|sensory system agents|mesh-ancestor
24527992|NCT00619034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24527993|NCT00619034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527994|NCT00619034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24527995|NCT00619034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24528173|NCT00620204|Antimetabolites|antimetabolites|mesh-ancestor
24528193|NCT00620295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24528194|NCT00620295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528195|NCT00620295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24528196|NCT00620295|Immunologic Factors|immunologic factors|mesh-ancestor
24528197|NCT00620295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528199|NCT00620347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528200|NCT00620347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24528204|NCT00620347|Growth Inhibitors|growth inhibitors|mesh-ancestor
24528205|NCT00620347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24528206|NCT00620347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528207|NCT00620347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528208|NCT00620438|Efavirenz|efavirenz|mesh-list
24528209|NCT00620438|Nevirapine|nevirapine|mesh-list
24528210|NCT00620438|Rifampin|rifampin|mesh-list
24528244|NCT00620477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24528245|NCT00620490|Ropivacaine|ropivacaine|mesh-list
24528246|NCT00620490|Anesthetics, Local|anesthetics, local|mesh-ancestor
24528247|NCT00620490|Anesthetics|anesthetics|mesh-ancestor
24528272|NCT00620620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528273|NCT00620620|GABA Modulators|gaba modulators|mesh-ancestor
24528277|NCT00620646|Aspirin|aspirin|mesh-list
24528364|NCT00620919|Secretin|secretin|mesh-list
25649585|NCT01493180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649586|NCT01493427|Travoprost|travoprost|mesh-list
24528646|NCT00622037|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24528647|NCT00622037|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24528705|NCT00622349|Tubulin Modulators|tubulin modulators|mesh-ancestor
25649587|NCT01493427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25649588|NCT01493531|Allopurinol|allopurinol|mesh-list
24576632|NCT00839488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25104216|NCT03154567|Yohimbine|yohimbine|mesh-list
24634115|NCT01132157|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25009770|NCT05190627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009773|NCT05188417|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25009775|NCT05188417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24998420|NCT02881957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24407963|NCT00175981|Serotonin Agents|serotonin agents|mesh-ancestor
24457865|NCT00335439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528801|NCT00622843|Vaccines|vaccines|mesh-list
24528918|NCT00623376|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24528920|NCT00623376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24683348|NCT01391403|Artemisinin|artemisinin|mesh-list
25155878|NCT05243524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155879|NCT05243524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24411058|NCT00187551|Enfuvirtide|enfuvirtide|mesh-list
25156077|NCT05163483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25156195|NCT05098470|Metformin|metformin|mesh-list
25156268|NCT05080530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25156316|NCT05073627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25156317|NCT05073627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25156318|NCT05073627|Anticoagulants|anticoagulants|mesh-ancestor
25156319|NCT05073627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25156320|NCT05073627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25156321|NCT05071352|Nefopam|nefopam|mesh-list
24417311|NCT00206167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25156322|NCT05071352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25156323|NCT05071352|Analgesics|analgesics|mesh-ancestor
25156324|NCT05071352|Sensory System Agents|sensory system agents|mesh-ancestor
25156325|NCT05071352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24417562|NCT00206778|Valproic Acid|valproic acid|mesh-list
25156336|NCT05063734|Growth Inhibitors|growth inhibitors|mesh-ancestor
25156337|NCT05063734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25156451|NCT05026593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25156462|NCT05026567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25156463|NCT05026567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24421629|NCT00219778|Mifepristone|mifepristone|mesh-list
24422028|NCT00221000|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24708700|NCT01502046|Hormones|hormones|mesh-ancestor
24422151|NCT00221481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25156466|NCT05026567|Anesthetics|anesthetics|mesh-ancestor
25156467|NCT05026567|GABA Modulators|gaba modulators|mesh-ancestor
25156468|NCT05026567|GABA Agents|gaba agents|mesh-ancestor
25156469|NCT05026567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25156470|NCT05026567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25156471|NCT05021978|Pramoxine|pramoxine|mesh-list
25156472|NCT05021978|Anesthetics, Local|anesthetics, local|mesh-ancestor
24823712|NCT02118688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24823713|NCT02118688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25826262|NCT00005802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25826263|NCT00005802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24709885|NCT01507454|Estradiol|estradiol|mesh-list
24424181|NCT00228163|Teriflunomide|teriflunomide|mesh-list
24424182|NCT00228163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24424184|NCT00228163|Analgesics|analgesics|mesh-ancestor
24580655|NCT00862966|Heparin|heparin|mesh-list
25115498|NCT03115736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25115499|NCT03115736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24824275|NCT02122601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824276|NCT02122601|Viscosupplements|viscosupplements|mesh-ancestor
24824277|NCT02122601|Protective Agents|protective agents|mesh-ancestor
25826264|NCT00005802|Analgesics|analgesics|mesh-ancestor
25826265|NCT00005802|Sensory System Agents|sensory system agents|mesh-ancestor
25826266|NCT00005802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25826267|NCT00005804|Cyclophosphamide|cyclophosphamide|mesh-list
25826268|NCT00005804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25156576|NCT05007132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25156583|NCT05007132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25156591|NCT04977232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25649590|NCT01493531|Antimetabolites|antimetabolites|mesh-ancestor
25649591|NCT01493531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649592|NCT01493531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649593|NCT01493531|Gout Suppressants|gout suppressants|mesh-ancestor
25649594|NCT01493531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25649595|NCT01493531|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25156593|NCT04977232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576853|NCT00840684|Amsacrine|amsacrine|mesh-list
24576854|NCT00840684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24576855|NCT00840684|Antimetabolites|antimetabolites|mesh-ancestor
24576856|NCT00840684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576857|NCT00840684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24899355|NCT04404491|Capecitabine|capecitabine|mesh-list
24576655|NCT00839605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25156598|NCT04977232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25156599|NCT04974814|Atorvastatin|atorvastatin|mesh-list
25156600|NCT04974814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25156601|NCT04974814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25156602|NCT04974814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25156603|NCT04974814|Antimetabolites|antimetabolites|mesh-ancestor
25156604|NCT04974814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25156605|NCT04974814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25156617|NCT04971356|Ticagrelor|ticagrelor|mesh-list
25156618|NCT04971356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24429531|NCT00244296|Analgesics|analgesics|mesh-ancestor
24427561|NCT00238368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24824504|NCT02123628|Cefepime|cefepime|mesh-list
25156630|NCT04971356|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25156635|NCT04971356|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25156636|NCT04971356|Purinergic Agents|purinergic agents|mesh-ancestor
25156637|NCT04971356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25156820|NCT04910815|Rifaximin|rifaximin|mesh-list
25156821|NCT04910815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25156822|NCT04910815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25156823|NCT04910815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24776341|NCT01857817|Etodolac|etodolac|mesh-list
25156857|NCT04910178|Antioxidants|antioxidants|mesh-ancestor
25115799|NCT03112577|Xhance|xhance|mesh-list
25156885|NCT04902443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25115936|NCT03112031|Antifungal Agents|antifungal agents|mesh-ancestor
24622342|NCT01066689|Rituximab|rituximab|mesh-list
25115945|NCT03112031|Amebicides|amebicides|mesh-ancestor
25157112|NCT04805541|Autonomic Agents|autonomic agents|mesh-ancestor
25157125|NCT04800302|Analgesics|analgesics|mesh-ancestor
24779366|NCT01875757|Vitamins|vitamins|mesh-ancestor
24567598|NCT00791739|Pregabalin|pregabalin|mesh-list
24489499|NCT00473616|Irinotecan|irinotecan|mesh-list
24781920|NCT01892995|Ketamine|ketamine|mesh-list
24782280|NCT01895075|Budesonide|budesonide|mesh-list
24947825|NCT03925662|Bevacizumab|bevacizumab|mesh-list
24659042|NCT01275508|Adalimumab|adalimumab|mesh-list
25157411|NCT04721457|Povidone|povidone|mesh-list
25157412|NCT04721457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25157413|NCT04721457|Sodium Fluoride|sodium fluoride|mesh-list
25157414|NCT04721457|Plasma Substitutes|plasma substitutes|mesh-ancestor
24491305|NCT00481975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491306|NCT00482027|Vaccines|vaccines|mesh-list
25157415|NCT04721457|Blood Substitutes|blood substitutes|mesh-ancestor
25157435|NCT04710719|Triamcinolone|triamcinolone|mesh-list
25157458|NCT04704271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25157467|NCT04704271|Hormones|hormones|mesh-ancestor
24555204|NCT00740415|Hormones|hormones|mesh-ancestor
25157570|NCT04647916|Irinotecan|irinotecan|mesh-list
24492067|NCT00485108|Analgesics|analgesics|mesh-ancestor
25157597|NCT04638309|Azacitidine|azacitidine|mesh-list
25157600|NCT04638309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25157601|NCT04638309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25157602|NCT04638309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627892|NCT01095471|Immunologic Factors|immunologic factors|mesh-ancestor
24786358|NCT01919294|Anabolic Agents|anabolic agents|mesh-ancestor
25157731|NCT04615949|Cannabidiol|cannabidiol|mesh-list
25157737|NCT04599634|Venetoclax|venetoclax|mesh-list
25157863|NCT04561739|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25157898|NCT04556617|Olaparib|olaparib|mesh-list
25826269|NCT00005804|Immunologic Factors|immunologic factors|mesh-ancestor
25826270|NCT00005804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826271|NCT00005804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25826272|NCT00005804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25649596|NCT01493531|Antioxidants|antioxidants|mesh-ancestor
25649597|NCT01493531|Protective Agents|protective agents|mesh-ancestor
25649598|NCT01493531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649599|NCT01493531|Uricosuric Agents|uricosuric agents|mesh-ancestor
25649600|NCT01493531|Renal Agents|renal agents|mesh-ancestor
25649601|NCT01493557|Pantoprazole|pantoprazole|mesh-list
25649602|NCT01493557|Dabigatran|dabigatran|mesh-list
24829980|NCT02156336|Ranolazine|ranolazine|mesh-list
24494002|NCT00493363|Artesunate|artesunate|mesh-list
24448828|NCT00313157|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24830068|NCT02157181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25649603|NCT01493557|Antithrombins|antithrombins|mesh-ancestor
25649604|NCT01493557|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24793148|NCT03993327|Iodine|iodine|mesh-list
24563261|NCT00770744|Olanzapine|olanzapine|mesh-list
24804064|NCT02000804|Darapladib|darapladib|mesh-list
25826273|NCT00005804|Alkylating Agents|alkylating agents|mesh-ancestor
25826274|NCT00005804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826275|NCT00005804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24830314|NCT02158624|Growth Substances|growth substances|mesh-ancestor
24830318|NCT02158689|Letrozole|letrozole|mesh-list
25826276|NCT00005804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24830405|NCT02159131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24830427|NCT02159196|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24948583|NCT03918889|Anesthetics|anesthetics|mesh-ancestor
24968954|NCT03746652|Ixazomib|ixazomib|mesh-list
25826277|NCT00005806|Paclitaxel|paclitaxel|mesh-list
25826278|NCT00005806|Carboplatin|carboplatin|mesh-list
24830468|NCT02159313|Riociguat|riociguat|mesh-list
25082881|NCT03319238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082890|NCT03319238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25082922|NCT03319043|Hormones|hormones|mesh-ancestor
25826279|NCT00005806|Gefitinib|gefitinib|mesh-list
25826280|NCT00005806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24499416|NCT00519298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499843|NCT00521261|Antibodies|antibodies|mesh-list
25826281|NCT00005806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826282|NCT00005806|Tubulin Modulators|tubulin modulators|mesh-ancestor
25041872|NCT01567904|Semuloparin|semuloparin|mesh-list
25041873|NCT01567904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25041876|NCT01567059|Cytarabine|cytarabine|mesh-list
25041877|NCT01567059|Decitabine|decitabine|mesh-list
25826283|NCT00005806|Antimitotic Agents|antimitotic agents|mesh-ancestor
24830551|NCT02159911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24830552|NCT02159911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830553|NCT02159911|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24830554|NCT02159911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24830555|NCT02159911|Oxytocics|oxytocics|mesh-ancestor
25826284|NCT00005806|Mitosis Modulators|mitosis modulators|mesh-ancestor
25826285|NCT00005806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826286|NCT00005806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25826287|NCT00005806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826288|NCT00005807|Epothilones|epothilones|mesh-list
24830640|NCT02160301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24830641|NCT02160301|Antiemetics|antiemetics|mesh-ancestor
24830642|NCT02160301|Autonomic Agents|autonomic agents|mesh-ancestor
24830643|NCT02160301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25826289|NCT00005807|Tubulin Modulators|tubulin modulators|mesh-ancestor
24448992|NCT00313859|Antimetabolites|antimetabolites|mesh-ancestor
24948923|NCT05401058|Droperidol|droperidol|mesh-list
25826290|NCT00005807|Antimitotic Agents|antimitotic agents|mesh-ancestor
25826291|NCT00005807|Mitosis Modulators|mitosis modulators|mesh-ancestor
25826292|NCT00005807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826293|NCT00005807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826294|NCT00005808|Motexafin lutetium|motexafin lutetium|mesh-list
24949017|NCT05369351|Mirabegron|mirabegron|mesh-list
24830764|NCT02161159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830766|NCT02161159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25826295|NCT00005808|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25826296|NCT00005808|Dermatologic Agents|dermatologic agents|mesh-ancestor
25826297|NCT00005810|Carboplatin|carboplatin|mesh-list
24949157|NCT05189457|Docetaxel|docetaxel|mesh-list
24969580|NCT03742180|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24907340|NCT04331210|Analgesics|analgesics|mesh-ancestor
24940482|NCT04001348|Anticonvulsants|anticonvulsants|mesh-ancestor
25826298|NCT00005810|Docetaxel|docetaxel|mesh-list
25826299|NCT00005810|Estramustine|estramustine|mesh-list
25826300|NCT00005810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826301|NCT00005810|Tubulin Modulators|tubulin modulators|mesh-ancestor
24449048|NCT00313976|Immunologic Factors|immunologic factors|mesh-ancestor
25051750|NCT00382460|Pravastatin|pravastatin|mesh-list
24449049|NCT00313976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449050|NCT00313976|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25041972|NCT01527916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25041973|NCT01527916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041974|NCT01527916|Nootropic Agents|nootropic agents|mesh-ancestor
25826302|NCT00005810|Antimitotic Agents|antimitotic agents|mesh-ancestor
24949204|NCT05160363|Piperaquine|piperaquine|mesh-list
24949205|NCT05160363|Pyronaridine|pyronaridine|mesh-list
24949206|NCT05160363|Antimalarials|antimalarials|mesh-ancestor
24949207|NCT05160363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24949208|NCT05160363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25826303|NCT00005810|Mitosis Modulators|mitosis modulators|mesh-ancestor
25826304|NCT00005810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826307|NCT00005810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25215321|NCT02690792|Vitamin E|vitamin e|mesh-list
25826308|NCT00005811|Topotecan|topotecan|mesh-list
25826309|NCT00005811|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25215379|NCT02690103|Ribavirin|ribavirin|mesh-list
25826310|NCT00005811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25826311|NCT00005811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826312|NCT00005811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826313|NCT00005811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826314|NCT00005812|Temozolomide|temozolomide|mesh-list
25826315|NCT00005812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24830896|NCT02161991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25826316|NCT00005812|Alkylating Agents|alkylating agents|mesh-ancestor
25826317|NCT00005812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826318|NCT00005812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826319|NCT00005813|Antibodies|antibodies|mesh-list
25826320|NCT00005813|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25826321|NCT00005813|Immunologic Factors|immunologic factors|mesh-ancestor
24830899|NCT02161991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830900|NCT02162121|Ketorolac|ketorolac|mesh-list
24830901|NCT02162121|Buprenorphine|buprenorphine|mesh-list
24731294|NCT01633970|Vitamins|vitamins|mesh-ancestor
25826322|NCT00005813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826323|NCT00005814|Cisplatin|cisplatin|mesh-list
24449061|NCT00314158|Adrenergic Agents|adrenergic agents|mesh-ancestor
24449062|NCT00314158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25215495|NCT02689843|Diuretics|diuretics|mesh-ancestor
24449072|NCT00314171|Brinzolamide|brinzolamide|mesh-list
24449073|NCT00314171|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24830912|NCT02162121|Narcotics|narcotics|mesh-ancestor
24830913|NCT02162121|Analgesics|analgesics|mesh-ancestor
25272836|NCT02389400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25826324|NCT00005814|Cetuximab|cetuximab|mesh-list
25826325|NCT00005814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826326|NCT00005814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25826327|NCT00005815|Thalidomide|thalidomide|mesh-list
25826328|NCT00005815|Temozolomide|temozolomide|mesh-list
25826329|NCT00005815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25826330|NCT00005815|Alkylating Agents|alkylating agents|mesh-ancestor
25826331|NCT00005815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826332|NCT00005815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826333|NCT00005815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25826334|NCT00005815|Immunologic Factors|immunologic factors|mesh-ancestor
25826335|NCT00005815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826336|NCT00005815|Leprostatic Agents|leprostatic agents|mesh-ancestor
25826337|NCT00005815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24831053|NCT02162784|Budesonide|budesonide|mesh-list
25826338|NCT00005815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25826339|NCT00005815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25826340|NCT00005815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24830953|NCT02162134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830954|NCT02162134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24830955|NCT02162134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24830956|NCT02162134|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25826341|NCT00005815|Growth Substances|growth substances|mesh-ancestor
25826342|NCT00005815|Growth Inhibitors|growth inhibitors|mesh-ancestor
25826343|NCT00005818|Irinotecan|irinotecan|mesh-list
25826344|NCT00005818|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25826345|NCT00005818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25826346|NCT00005818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826347|NCT00005818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826348|NCT00005818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826349|NCT00005819|Paclitaxel|paclitaxel|mesh-list
25826350|NCT00005819|Cisplatin|cisplatin|mesh-list
25826351|NCT00005819|Fenretinide|fenretinide|mesh-list
24830998|NCT02162407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24830999|NCT02162407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831002|NCT02162485|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24831003|NCT02162485|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25826352|NCT00005819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25215792|NCT02687984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25215793|NCT02687984|Serotonin Agents|serotonin agents|mesh-ancestor
25408570|NCT03434379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24578467|NCT00849095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578469|NCT00849095|Tocolytic Agents|tocolytic agents|mesh-ancestor
25826353|NCT00005819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449111|NCT00314457|Bupivacaine|bupivacaine|mesh-list
24831015|NCT02162485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24831016|NCT02162485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24831017|NCT02162485|Adrenergic Agents|adrenergic agents|mesh-ancestor
25272845|NCT02389439|Schistosomicides|schistosomicides|mesh-ancestor
25826354|NCT00005819|Tubulin Modulators|tubulin modulators|mesh-ancestor
25272846|NCT02389439|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25272847|NCT02389439|Anthelmintics|anthelmintics|mesh-ancestor
25272848|NCT02389426|Bosentan|bosentan|mesh-list
25826355|NCT00005819|Antimitotic Agents|antimitotic agents|mesh-ancestor
25826356|NCT00005819|Mitosis Modulators|mitosis modulators|mesh-ancestor
25826357|NCT00005819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826358|NCT00005819|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25826359|NCT00005819|Protective Agents|protective agents|mesh-ancestor
24501473|NCT00528723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24501474|NCT00528723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24501475|NCT00528723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25826360|NCT00005819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826361|NCT00005822|Tamoxifen|tamoxifen|mesh-list
25826362|NCT00005822|Doxorubicin|doxorubicin|mesh-list
25826363|NCT00005822|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25826364|NCT00005822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25826365|NCT00005822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826366|NCT00005822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25826367|NCT00005822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25826368|NCT00005822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826369|NCT00005822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826370|NCT00005822|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25826371|NCT00005822|Hormone Antagonists|hormone antagonists|mesh-ancestor
25826372|NCT00005822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25826373|NCT00005822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831025|NCT02162485|Protective Agents|protective agents|mesh-ancestor
25826374|NCT00005822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25826375|NCT00005822|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25826376|NCT00005822|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25042003|NCT01517776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826377|NCT00005822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25826378|NCT00005823|Cytarabine|cytarabine|mesh-list
25826379|NCT00005823|Etoposide|etoposide|mesh-list
25826380|NCT00005823|Daunorubicin|daunorubicin|mesh-list
24831049|NCT02162693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831051|NCT02162693|Protective Agents|protective agents|mesh-ancestor
24831052|NCT02162745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25826381|NCT00005823|Mitoxantrone|mitoxantrone|mesh-list
25826382|NCT00005823|Idarubicin|idarubicin|mesh-list
25826383|NCT00005823|Hydroxyurea|hydroxyurea|mesh-list
25826384|NCT00005823|Tretinoin|tretinoin|mesh-list
25826385|NCT00005823|Thioguanine|thioguanine|mesh-list
25216142|NCT02686047|Hylan|hylan|mesh-list
24589268|NCT00906360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589269|NCT00906386|Varenicline|varenicline|mesh-list
24589270|NCT00906386|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24589271|NCT00906386|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24589272|NCT00906386|Cholinergic Agents|cholinergic agents|mesh-ancestor
24831126|NCT02163330|Anticonvulsants|anticonvulsants|mesh-ancestor
25826386|NCT00005823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25826387|NCT00005823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826388|NCT00005823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25826389|NCT00005823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25826390|NCT00005823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826391|NCT00005823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826392|NCT00005823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25649605|NCT01493557|Protease Inhibitors|protease inhibitors|mesh-ancestor
25649606|NCT01493557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649607|NCT01493557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649608|NCT01493557|Anticoagulants|anticoagulants|mesh-ancestor
25649609|NCT01493557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25826393|NCT00005823|Antimetabolites|antimetabolites|mesh-ancestor
25826394|NCT00005823|Antiviral Agents|antiviral agents|mesh-ancestor
25826395|NCT00005823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25826396|NCT00005823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25826397|NCT00005823|Immunologic Factors|immunologic factors|mesh-ancestor
25826398|NCT00005823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826399|NCT00005823|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25826400|NCT00005823|Analgesics|analgesics|mesh-ancestor
25826401|NCT00005823|Sensory System Agents|sensory system agents|mesh-ancestor
25826402|NCT00005823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25826403|NCT00005823|Antisickling Agents|antisickling agents|mesh-ancestor
25826404|NCT00005823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25826405|NCT00005823|Keratolytic Agents|keratolytic agents|mesh-ancestor
24831151|NCT02163707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24831152|NCT02163720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25042072|NCT01516073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25826406|NCT00005823|Dermatologic Agents|dermatologic agents|mesh-ancestor
25826407|NCT00005824|Cyclophosphamide|cyclophosphamide|mesh-list
25826408|NCT00005824|Busulfan|busulfan|mesh-list
25826409|NCT00005824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25826410|NCT00005824|Immunologic Factors|immunologic factors|mesh-ancestor
25826411|NCT00005824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826412|NCT00005824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25826413|NCT00005824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25826414|NCT00005824|Alkylating Agents|alkylating agents|mesh-ancestor
25826415|NCT00005824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826416|NCT00005824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826417|NCT00005824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25826418|NCT00005825|Cisplatin|cisplatin|mesh-list
25826419|NCT00005825|Vinorelbine|vinorelbine|mesh-list
25826420|NCT00005825|Mitomycins|mitomycins|mesh-list
25826421|NCT00005825|Mitomycin|mitomycin|mesh-list
25826422|NCT00005825|Tretinoin|tretinoin|mesh-list
25826423|NCT00005825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826424|NCT00005825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25826425|NCT00005825|Tubulin Modulators|tubulin modulators|mesh-ancestor
25826426|NCT00005825|Antimitotic Agents|antimitotic agents|mesh-ancestor
25826427|NCT00005825|Mitosis Modulators|mitosis modulators|mesh-ancestor
24501693|NCT00530478|Cholinergic Agents|cholinergic agents|mesh-ancestor
24501694|NCT00530478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24501695|NCT00530478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501696|NCT00530478|Nootropic Agents|nootropic agents|mesh-ancestor
24501697|NCT00530517|Sumatriptan|sumatriptan|mesh-list
25826428|NCT00005825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826429|NCT00005825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25826430|NCT00005825|Alkylating Agents|alkylating agents|mesh-ancestor
25826431|NCT00005825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25826432|NCT00005825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826433|NCT00005825|Keratolytic Agents|keratolytic agents|mesh-ancestor
25826434|NCT00005825|Dermatologic Agents|dermatologic agents|mesh-ancestor
25826435|NCT00005826|Rubitecan|rubitecan|mesh-list
24831218|NCT02164214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24831219|NCT02164214|Analgesics|analgesics|mesh-ancestor
24831220|NCT02164214|Sensory System Agents|sensory system agents|mesh-ancestor
24831221|NCT02164214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24831222|NCT02164214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831223|NCT02164214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24831224|NCT02164214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24831225|NCT02164214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24733477|NCT01646437|Antipyretics|antipyretics|mesh-ancestor
25826436|NCT00005826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826437|NCT00005826|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25042111|NCT01508026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042112|NCT01501513|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25042113|NCT01501513|Laxatives|laxatives|mesh-ancestor
25042115|NCT01499563|Risperidone|risperidone|mesh-list
25826438|NCT00005826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25826439|NCT00005826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826440|NCT00005826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826441|NCT00005827|Genistein|genistein|mesh-list
25826442|NCT00005827|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25826443|NCT00005827|Protective Agents|protective agents|mesh-ancestor
25649610|NCT01493557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25826444|NCT00005827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272884|NCT02389231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24831289|NCT02164604|Growth Substances|growth substances|mesh-ancestor
24579022|NCT00853008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24579023|NCT00853008|Abortifacient Agents|abortifacient agents|mesh-ancestor
24579024|NCT00853008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24579025|NCT00853008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24579026|NCT00853008|Antimetabolites|antimetabolites|mesh-ancestor
24579027|NCT00853008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579028|NCT00853008|Dermatologic Agents|dermatologic agents|mesh-ancestor
25826445|NCT00005827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826446|NCT00005827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25826447|NCT00005827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826448|NCT00005827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826449|NCT00005827|Phytoestrogens|phytoestrogens|mesh-ancestor
24831306|NCT02164773|Anesthetics|anesthetics|mesh-ancestor
24831307|NCT02164773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25826450|NCT00005827|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25826451|NCT00005827|Estrogens|estrogens|mesh-ancestor
25042152|NCT01495247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042153|NCT01495013|Glimepiride|glimepiride|mesh-list
25042154|NCT01495013|Atorvastatin|atorvastatin|mesh-list
25042155|NCT01495013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25042156|NCT01495013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25826452|NCT00005827|Hormones|hormones|mesh-ancestor
25826453|NCT00005827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25826454|NCT00005829|Gemcitabine|gemcitabine|mesh-list
25826455|NCT00005829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25826456|NCT00005829|Antimetabolites|antimetabolites|mesh-ancestor
25826457|NCT00005829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826458|NCT00005829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826459|NCT00005829|Antiviral Agents|antiviral agents|mesh-ancestor
25826460|NCT00005829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25058520|NCT03496246|Vitamin D|vitamin d|mesh-list
24831448|NCT02165449|Anesthetics, General|anesthetics, general|mesh-ancestor
24831449|NCT02165449|Anesthetics|anesthetics|mesh-ancestor
24831450|NCT02165449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25826461|NCT00005829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826462|NCT00005829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25826463|NCT00005829|Immunologic Factors|immunologic factors|mesh-ancestor
25826464|NCT00005829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969845|NCT03739606|Antibodies|antibodies|mesh-list
24831643|NCT02167633|Glucocorticoids|glucocorticoids|mesh-list
24831644|NCT02167633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25826465|NCT00005830|Cisplatin|cisplatin|mesh-list
25826466|NCT00005830|Doxorubicin|doxorubicin|mesh-list
25826467|NCT00005830|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25826468|NCT00005830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24831668|NCT02167698|Hormones|hormones|mesh-ancestor
25042215|NCT01484119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042216|NCT01483742|Ritonavir|ritonavir|mesh-list
25042217|NCT01483742|Ribavirin|ribavirin|mesh-list
25042233|NCT01482403|Ribavirin|ribavirin|mesh-list
25826469|NCT00005830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25826470|NCT00005830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25826471|NCT00005830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24831942|NCT02169856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24831943|NCT02169856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831944|NCT02169856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25826472|NCT00005830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951188|NCT03907371|Donepezil|donepezil|mesh-list
24831970|NCT02169882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24831972|NCT02169882|Hormones|hormones|mesh-ancestor
25826473|NCT00005830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826474|NCT00005831|Gemcitabine|gemcitabine|mesh-list
25826475|NCT00005831|Paclitaxel|paclitaxel|mesh-list
25826476|NCT00005831|Carboplatin|carboplatin|mesh-list
25826477|NCT00005831|Trastuzumab|trastuzumab|mesh-list
25826478|NCT00005831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25649611|NCT01493557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25649612|NCT01493687|Azelaic acid|azelaic acid|mesh-list
25649613|NCT01493687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649614|NCT01493687|Dermatologic Agents|dermatologic agents|mesh-ancestor
25649615|NCT01493947|Metronidazole|metronidazole|mesh-list
25649616|NCT01493947|Ivermectin|ivermectin|mesh-list
25649617|NCT01493947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25649618|NCT01493947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25649619|NCT01493947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25826479|NCT00005831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826480|NCT00005831|Tubulin Modulators|tubulin modulators|mesh-ancestor
25826481|NCT00005831|Antimitotic Agents|antimitotic agents|mesh-ancestor
24832117|NCT02170701|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25826483|NCT00005831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826484|NCT00005831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24805185|NCT02008006|Melphalan|melphalan|mesh-list
25083151|NCT03317730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25083152|NCT03317730|Narcotics|narcotics|mesh-ancestor
25083153|NCT03317730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25826485|NCT00005831|Antimetabolites|antimetabolites|mesh-ancestor
24832118|NCT02170701|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832119|NCT02170701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832120|NCT02170701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832121|NCT02170701|Anticoagulants|anticoagulants|mesh-ancestor
24832135|NCT02170766|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24832144|NCT02170792|Ranitidine|ranitidine|mesh-list
24832146|NCT02170792|Dabigatran|dabigatran|mesh-list
24832175|NCT02170831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826486|NCT00005831|Antiviral Agents|antiviral agents|mesh-ancestor
25826487|NCT00005831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24449231|NCT00314743|Ondansetron|ondansetron|mesh-list
24449232|NCT00314743|Aprepitant|aprepitant|mesh-list
25042247|NCT01481077|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24832269|NCT02171013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832271|NCT02171026|Amiodarone|amiodarone|mesh-list
24832272|NCT02171026|Dabigatran|dabigatran|mesh-list
24832273|NCT02171026|Antithrombins|antithrombins|mesh-ancestor
24832274|NCT02171026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25826488|NCT00005831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826489|NCT00005831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25826490|NCT00005831|Immunologic Factors|immunologic factors|mesh-ancestor
25826491|NCT00005831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826492|NCT00005831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25826493|NCT00005832|Tipifarnib|tipifarnib|mesh-list
25826494|NCT00005832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826495|NCT00005833|Tipifarnib|tipifarnib|mesh-list
25826496|NCT00005833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826497|NCT00005834|Thalidomide|thalidomide|mesh-list
24832291|NCT02171039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24971004|NCT03729310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826498|NCT00005834|Dexamethasone|dexamethasone|mesh-list
24503537|NCT00532168|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24971205|NCT03727464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24971206|NCT03727464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24503541|NCT00532194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24971539|NCT03725228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24971542|NCT03725228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24971543|NCT03725228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826499|NCT00005834|Cyclophosphamide|cyclophosphamide|mesh-list
25826500|NCT00005834|Cisplatin|cisplatin|mesh-list
25826501|NCT00005834|Etoposide|etoposide|mesh-list
24832306|NCT02171052|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832307|NCT02171052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832308|NCT02171052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832309|NCT02171052|Anticoagulants|anticoagulants|mesh-ancestor
24832310|NCT02171052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24832314|NCT02171156|Nintedanib|nintedanib|mesh-list
25826502|NCT00005834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25826503|NCT00005834|Immunologic Factors|immunologic factors|mesh-ancestor
25826504|NCT00005834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826505|NCT00005834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24951344|NCT03905317|Growth Substances|growth substances|mesh-ancestor
24971618|NCT03723824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24971619|NCT03723785|Insulin|insulin|mesh-list
24736057|NCT01659905|Montelukast|montelukast|mesh-list
24449260|NCT00314756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24832385|NCT02171442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832401|NCT02171468|Anticoagulants|anticoagulants|mesh-ancestor
24832402|NCT02171481|Dabigatran|dabigatran|mesh-list
24832403|NCT02171481|Antithrombins|antithrombins|mesh-ancestor
25826506|NCT00005834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25826507|NCT00005834|Alkylating Agents|alkylating agents|mesh-ancestor
24832417|NCT02171507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24794518|NCT05067387|Dronabinol|dronabinol|mesh-list
24794519|NCT05067387|Hallucinogens|hallucinogens|mesh-ancestor
24794520|NCT05067387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794521|NCT05067387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24794522|NCT05067387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25829670|NCT00006247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24579738|NCT00857376|Antioxidants|antioxidants|mesh-ancestor
24579740|NCT00857376|Protective Agents|protective agents|mesh-ancestor
25826508|NCT00005834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826509|NCT00005834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042267|NCT01480479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042268|NCT01480479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25042269|NCT01478178|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
25042270|NCT01478178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25042271|NCT01478178|Alkylating Agents|alkylating agents|mesh-ancestor
25042272|NCT01478178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042280|NCT01476904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25042281|NCT01476904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826510|NCT00005834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25826511|NCT00005834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25826512|NCT00005834|Antiemetics|antiemetics|mesh-ancestor
25826513|NCT00005834|Autonomic Agents|autonomic agents|mesh-ancestor
25826514|NCT00005834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24973278|NCT03710356|Hormone Antagonists|hormone antagonists|mesh-ancestor
25826515|NCT00005834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25826516|NCT00005834|Glucocorticoids|glucocorticoids|mesh-ancestor
25826517|NCT00005834|Hormones|hormones|mesh-ancestor
25826518|NCT00005834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25826519|NCT00005834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25826520|NCT00005834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24504798|NCT00538174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973429|NCT03709381|Hormones|hormones|mesh-ancestor
24973430|NCT03709381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24932026|NCT04083118|Sodium Fluoride|sodium fluoride|mesh-list
25826521|NCT00005834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25826522|NCT00005834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25826523|NCT00005834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826524|NCT00005834|Leprostatic Agents|leprostatic agents|mesh-ancestor
25826525|NCT00005834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24832420|NCT02171507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24832421|NCT02171507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25826526|NCT00005834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25826527|NCT00005834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25826528|NCT00005834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25826529|NCT00005834|Growth Substances|growth substances|mesh-ancestor
25826530|NCT00005834|Growth Inhibitors|growth inhibitors|mesh-ancestor
25826531|NCT00005835|Melphalan|melphalan|mesh-list
25826532|NCT00005835|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
25826533|NCT00005835|Immunologic Factors|immunologic factors|mesh-ancestor
25826534|NCT00005835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832437|NCT02171533|Antithrombins|antithrombins|mesh-ancestor
24832438|NCT02171533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832439|NCT02171533|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832440|NCT02171533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826535|NCT00005835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24832447|NCT02171533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826536|NCT00005835|Alkylating Agents|alkylating agents|mesh-ancestor
24663980|NCT01304342|Fentanyl|fentanyl|mesh-list
25826537|NCT00005835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449391|NCT00315432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449392|NCT00315484|Epoetin Alfa|epoetin alfa|mesh-list
24449393|NCT00315484|Darbepoetin alfa|darbepoetin alfa|mesh-list
24449394|NCT00315484|Hematinics|hematinics|mesh-ancestor
24449398|NCT00315510|Antimetabolites|antimetabolites|mesh-ancestor
25826538|NCT00005835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218477|NCT02670018|Metformin|metformin|mesh-list
24832606|NCT02171754|Ritonavir|ritonavir|mesh-list
24449447|NCT00315679|Pentoxifylline|pentoxifylline|mesh-list
24628686|NCT01100619|Rosiglitazone|rosiglitazone|mesh-list
25083987|NCT03311178|Dobutamine|dobutamine|mesh-list
25083988|NCT03311178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25083989|NCT03311178|Sympathomimetics|sympathomimetics|mesh-ancestor
25649620|NCT01493947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25649621|NCT01494038|Isoniazid|isoniazid|mesh-list
25649622|NCT01494038|Antitubercular Agents|antitubercular agents|mesh-ancestor
25649623|NCT01494038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25649624|NCT01494038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25649625|NCT01494038|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25649626|NCT01494038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25649627|NCT01494038|Antimetabolites|antimetabolites|mesh-ancestor
25649628|NCT01494038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580027|NCT00859703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24580028|NCT00859703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083991|NCT03311178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25083992|NCT03311178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826539|NCT00005835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25826540|NCT00005835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24832628|NCT02171780|Autonomic Agents|autonomic agents|mesh-ancestor
25826541|NCT00005835|Antimetabolites|antimetabolites|mesh-ancestor
25826542|NCT00005835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25826543|NCT00005835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952107|NCT03897660|Hemostatics|hemostatics|mesh-ancestor
25218938|NCT02666170|Vitamins|vitamins|mesh-ancestor
25826544|NCT00005835|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25826545|NCT00005835|Protective Agents|protective agents|mesh-ancestor
25826546|NCT00005836|Oxaliplatin|oxaliplatin|mesh-list
25826547|NCT00005836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826548|NCT00005837|Oxaliplatin|oxaliplatin|mesh-list
25826549|NCT00005837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24832713|NCT02172105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25826550|NCT00005838|Paclitaxel|paclitaxel|mesh-list
24832743|NCT02172157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826551|NCT00005838|Vinorelbine|vinorelbine|mesh-list
25826552|NCT00005838|Cisplatin|cisplatin|mesh-list
25826553|NCT00005838|Carboplatin|carboplatin|mesh-list
25826554|NCT00005838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25826555|NCT00005838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826556|NCT00005838|Tubulin Modulators|tubulin modulators|mesh-ancestor
25826557|NCT00005838|Antimitotic Agents|antimitotic agents|mesh-ancestor
25042510|NCT01425970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24832781|NCT02172235|Empagliflozin|empagliflozin|mesh-list
25826558|NCT00005838|Mitosis Modulators|mitosis modulators|mesh-ancestor
24832797|NCT02172261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25826559|NCT00005838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042557|NCT01418222|Leucovorin|leucovorin|mesh-list
25826560|NCT00005839|Capecitabine|capecitabine|mesh-list
25826561|NCT00005839|Oxaliplatin|oxaliplatin|mesh-list
25826562|NCT00005839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25826563|NCT00005839|Antimetabolites|antimetabolites|mesh-ancestor
25826564|NCT00005839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630504|NCT01111981|Hormones|hormones|mesh-ancestor
24630505|NCT01111981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25826565|NCT00005839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826566|NCT00005840|Paclitaxel|paclitaxel|mesh-list
24832845|NCT02172326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24451921|NCT00325286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451922|NCT00325286|Anticonvulsants|anticonvulsants|mesh-ancestor
24451923|NCT00325286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24451924|NCT00325286|Analgesics|analgesics|mesh-ancestor
24451925|NCT00325286|Sensory System Agents|sensory system agents|mesh-ancestor
24451926|NCT00325286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25826567|NCT00005840|Cisplatin|cisplatin|mesh-list
25042581|NCT01416064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25042582|NCT01416064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25087265|NCT03280316|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25042583|NCT01416064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25042584|NCT01416064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042585|NCT01416064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25042586|NCT01414920|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25042587|NCT01414920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25042588|NCT01414920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042596|NCT01410695|Methotrexate|methotrexate|mesh-list
25042597|NCT01410695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25649629|NCT01494038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25649630|NCT01494350|Gentamicins|gentamicins|mesh-list
25649631|NCT01494350|Paromomycin|paromomycin|mesh-list
25649632|NCT01494350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25649633|NCT01494350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25649634|NCT01494350|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24451953|NCT00325429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24451954|NCT00325429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451955|NCT00325429|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24763876|NCT01777919|Copper|copper|mesh-list
24832963|NCT02172456|Cholinergic Agents|cholinergic agents|mesh-ancestor
25829672|NCT00006247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829673|NCT00006248|Paclitaxel|paclitaxel|mesh-list
25053492|NCT00028067|Nelfinavir|nelfinavir|mesh-list
25088646|NCT03384212|Cladribine|cladribine|mesh-list
25088647|NCT03384212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24832996|NCT02172495|Tiotropium Bromide|tiotropium bromide|mesh-list
24832997|NCT02172495|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24832998|NCT02172495|Autonomic Agents|autonomic agents|mesh-ancestor
25829674|NCT00006248|Cisplatin|cisplatin|mesh-list
25042691|NCT01382654|Epinastine|epinastine|mesh-list
25042692|NCT01382654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25042693|NCT01382654|Autonomic Agents|autonomic agents|mesh-ancestor
25042694|NCT01382654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25042695|NCT01382654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833017|NCT02172508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24833018|NCT02172508|Cholinergic Agents|cholinergic agents|mesh-ancestor
24833019|NCT02172508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25090581|NCT03256487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24833021|NCT02172521|Bromides|bromides|mesh-list
24833022|NCT02172521|Tiotropium Bromide|tiotropium bromide|mesh-list
24833023|NCT02172521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24833024|NCT02172521|Autonomic Agents|autonomic agents|mesh-ancestor
24833025|NCT02172521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24833035|NCT02172534|Bromides|bromides|mesh-list
25829675|NCT00006248|Fluorouracil|fluorouracil|mesh-list
25042740|NCT01378676|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25649635|NCT01494350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649636|NCT01494350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829676|NCT00006248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25042741|NCT01378676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25042744|NCT01378676|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24833203|NCT02173106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24833204|NCT02173106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25649637|NCT01494350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25649638|NCT01494350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25649639|NCT01494467|Azelaic acid|azelaic acid|mesh-list
25649640|NCT01494467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649641|NCT01494467|Dermatologic Agents|dermatologic agents|mesh-ancestor
25829677|NCT00006248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829678|NCT00006248|Tubulin Modulators|tubulin modulators|mesh-ancestor
24833230|NCT02173288|Tolvaptan|tolvaptan|mesh-list
24833231|NCT02173288|Midodrine|midodrine|mesh-list
24742444|NCT05266248|Caffeine|caffeine|mesh-list
25042797|NCT01366131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25042798|NCT01366131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042799|NCT01366131|Tubulin Modulators|tubulin modulators|mesh-ancestor
25042800|NCT01366131|Antimitotic Agents|antimitotic agents|mesh-ancestor
25042801|NCT01366131|Mitosis Modulators|mitosis modulators|mesh-ancestor
24833322|NCT02173717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24833323|NCT02173717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742763|NCT05169268|Aripiprazole|aripiprazole|mesh-list
25826575|NCT00005841|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24664303|NCT01305850|Enalapril|enalapril|mesh-list
24833552|NCT02174328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24833553|NCT02174328|Analgesics|analgesics|mesh-ancestor
24833554|NCT02174328|Sensory System Agents|sensory system agents|mesh-ancestor
24833555|NCT02174328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24833557|NCT02174328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24833592|NCT02174588|GABA Agents|gaba agents|mesh-ancestor
24833593|NCT02174588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24833594|NCT02174588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833595|NCT02174666|Vitamin D|vitamin d|mesh-list
24833596|NCT02174666|Ergocalciferols|ergocalciferols|mesh-list
24833597|NCT02174666|Cholecalciferol|cholecalciferol|mesh-list
24833598|NCT02174666|Vitamins|vitamins|mesh-list
24833688|NCT02175342|Autonomic Agents|autonomic agents|mesh-ancestor
24833689|NCT02175342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24833690|NCT02175342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833691|NCT02175342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24833702|NCT02175355|Natriuretic Agents|natriuretic agents|mesh-ancestor
24833780|NCT02175589|Tubulin Modulators|tubulin modulators|mesh-ancestor
24833821|NCT02175901|Bismuth|bismuth|mesh-list
24833916|NCT02176200|Fenoterol|fenoterol|mesh-list
24833967|NCT02176304|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24833968|NCT02176304|Prednisolone phosphate|prednisolone phosphate|mesh-list
24833969|NCT02176304|Anesthetics, Local|anesthetics, local|mesh-ancestor
24833970|NCT02176304|Anesthetics|anesthetics|mesh-ancestor
25042836|NCT01360853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25042837|NCT01360853|Antimetabolites|antimetabolites|mesh-ancestor
25042838|NCT01360853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042839|NCT01360853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24834090|NCT02177253|Bromides|bromides|mesh-list
24834292|NCT02177539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24468565|NCT00382239|Exenatide|exenatide|mesh-list
24834451|NCT02178683|Tacrolimus|tacrolimus|mesh-list
25826576|NCT00005841|Immunologic Factors|immunologic factors|mesh-ancestor
25826577|NCT00005841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834927|NCT02181543|Adrenergic Agents|adrenergic agents|mesh-ancestor
25826578|NCT00005842|Trastuzumab|trastuzumab|mesh-list
24835417|NCT02182765|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24835473|NCT02182960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835683|NCT02183220|Sensory System Agents|sensory system agents|mesh-ancestor
24835685|NCT02183220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835687|NCT02183220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24835695|NCT02183246|Porfiromycin|porfiromycin|mesh-list
24835696|NCT02183246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25826579|NCT00005842|Tipifarnib|tipifarnib|mesh-list
25826580|NCT00005842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25042930|NCT01349868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25042957|NCT01345045|Sensory System Agents|sensory system agents|mesh-ancestor
24835760|NCT02183350|Protease Inhibitors|protease inhibitors|mesh-ancestor
24835761|NCT02183350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835763|NCT02183363|Linagliptin|linagliptin|mesh-list
24835792|NCT02183389|Protease Inhibitors|protease inhibitors|mesh-ancestor
24835810|NCT02183415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24835811|NCT02183415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835812|NCT02183415|Incretins|incretins|mesh-ancestor
24835813|NCT02183415|Hormones|hormones|mesh-ancestor
24835814|NCT02183415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24835818|NCT02183415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826581|NCT00005842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24835824|NCT02183428|Hormones|hormones|mesh-ancestor
24835881|NCT02183493|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24835931|NCT02183584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24835932|NCT02183610|Linagliptin|linagliptin|mesh-list
24835933|NCT02183610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24835981|NCT02183688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24835982|NCT02183688|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24836022|NCT02183805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24836062|NCT02184065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24836063|NCT02184065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24836064|NCT02184065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25090807|NCT03253887|Ethanol|ethanol|mesh-list
25042977|NCT01343966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25042978|NCT01343966|Immunologic Factors|immunologic factors|mesh-ancestor
25042979|NCT01343966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042980|NCT01339689|Ganaxolone|ganaxolone|mesh-list
25042981|NCT01339689|Neurosteroids|neurosteroids|mesh-ancestor
25649642|NCT01494506|Leucovorin|leucovorin|mesh-list
24836246|NCT02184819|Simendan|simendan|mesh-list
25826583|NCT00005843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24836279|NCT02184897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223058|NCT02641847|Docetaxel|docetaxel|mesh-list
24836295|NCT02185066|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24836298|NCT02185118|Isoflurane|isoflurane|mesh-list
24836299|NCT02185118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24836300|NCT02185118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24836301|NCT02185118|Anesthetics, General|anesthetics, general|mesh-ancestor
24836302|NCT02185118|Anesthetics|anesthetics|mesh-ancestor
24836347|NCT02185430|Dexmedetomidine|dexmedetomidine|mesh-list
24471867|NCT00397176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25091139|NCT03250494|Antiemetics|antiemetics|mesh-ancestor
24999561|NCT04013334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24836638|NCT02186769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24836639|NCT02186769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24472417|NCT00399126|Paclitaxel|paclitaxel|mesh-list
25043064|NCT01332656|Tubulin Modulators|tubulin modulators|mesh-ancestor
25043068|NCT01331850|Ritonavir|ritonavir|mesh-list
25826584|NCT00005844|Oxaliplatin|oxaliplatin|mesh-list
25829679|NCT00006248|Antimitotic Agents|antimitotic agents|mesh-ancestor
24837086|NCT02188654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837087|NCT02188771|Hyaluronic Acid|hyaluronic acid|mesh-list
24837088|NCT02188771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24837089|NCT02188771|Immunologic Factors|immunologic factors|mesh-ancestor
24412073|NCT00190801|Pemetrexed|pemetrexed|mesh-list
25064741|NCT03457233|Cetrorelix|cetrorelix|mesh-list
25091931|NCT03245996|Atenolol|atenolol|mesh-list
25649643|NCT01494506|Fluorouracil|fluorouracil|mesh-list
25649644|NCT01494506|Antimetabolites|antimetabolites|mesh-ancestor
25649645|NCT01494506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649646|NCT01494506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24837243|NCT02190526|Antidepressive Agents|antidepressive agents|mesh-ancestor
24837244|NCT02190526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25055938|NCT03516903|Hematinics|hematinics|mesh-ancestor
24837245|NCT02190526|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24837246|NCT02190526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25826585|NCT00005844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24837316|NCT02190994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24837324|NCT02191007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24837341|NCT02191020|Keratolytic Agents|keratolytic agents|mesh-ancestor
24837359|NCT02191124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24837360|NCT02191124|Serotonin Agents|serotonin agents|mesh-ancestor
24837376|NCT02191124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24837377|NCT02191124|Adrenergic Agents|adrenergic agents|mesh-ancestor
24837387|NCT02191176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837490|NCT02191527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837491|NCT02191527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24837492|NCT02191527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24837493|NCT02191566|Oxaliplatin|oxaliplatin|mesh-list
24837504|NCT02191670|Tenecteplase|tenecteplase|mesh-list
24837524|NCT02191826|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24837527|NCT02191826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837537|NCT02191891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24837538|NCT02191891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837562|NCT02191943|Protective Agents|protective agents|mesh-ancestor
25043141|NCT01314222|Analgesics|analgesics|mesh-ancestor
25043155|NCT01313572|Analgesics|analgesics|mesh-ancestor
25043166|NCT01312454|Travoprost|travoprost|mesh-list
24837572|NCT02192203|Diclofenac|diclofenac|mesh-list
24837574|NCT02192203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24837576|NCT02192203|Analgesics|analgesics|mesh-ancestor
24837620|NCT02192411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24837872|NCT02194166|Paclitaxel|paclitaxel|mesh-list
24837915|NCT02194218|Nevirapine|nevirapine|mesh-list
24837939|NCT02194283|Expectorants|expectorants|mesh-ancestor
25098476|NCT03197207|Analgesics|analgesics|mesh-ancestor
25099112|NCT03194009|Metformin|metformin|mesh-list
25099210|NCT03193073|Mitogens|mitogens|mesh-list
24838037|NCT02194855|Rocuronium|rocuronium|mesh-list
24838044|NCT02194881|Ivacaftor|ivacaftor|mesh-list
24838124|NCT02195375|Glucocorticoids|glucocorticoids|mesh-ancestor
24838130|NCT02195466|Fluconazole|fluconazole|mesh-list
24838154|NCT02195544|Hylan|hylan|mesh-list
24838155|NCT02195544|Viscosupplements|viscosupplements|mesh-ancestor
24838156|NCT02195544|Protective Agents|protective agents|mesh-ancestor
24838157|NCT02195544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838158|NCT02195557|Hylan|hylan|mesh-list
24838159|NCT02195557|Viscosupplements|viscosupplements|mesh-ancestor
24838162|NCT02195635|Octreotide|octreotide|mesh-list
24838309|NCT02197143|Esomeprazole|esomeprazole|mesh-list
24838319|NCT02197143|Histamine Agents|histamine agents|mesh-ancestor
25043248|NCT01295060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24597487|NCT00949572|Vaccines|vaccines|mesh-list
24838519|NCT02198378|Analgesics|analgesics|mesh-ancestor
24838617|NCT02198859|Lithium Carbonate|lithium carbonate|mesh-list
24838627|NCT02198924|Parecoxib|parecoxib|mesh-list
25043300|NCT01278134|Ritonavir|ritonavir|mesh-list
24838719|NCT02199678|Anesthetics|anesthetics|mesh-ancestor
24473547|NCT00403286|Autonomic Agents|autonomic agents|mesh-ancestor
24838963|NCT02201316|Mosapride|mosapride|mesh-list
24839078|NCT02202005|Nevirapine|nevirapine|mesh-list
24880490|NCT03625648|Pentoxifylline|pentoxifylline|mesh-list
24839106|NCT02202239|Remifentanil|remifentanil|mesh-list
25649647|NCT01494506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649648|NCT01494506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25649649|NCT01494506|Immunologic Factors|immunologic factors|mesh-ancestor
25649650|NCT01494506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839143|NCT02202473|Oxymatrine|oxymatrine|mesh-list
25043406|NCT01265901|Alkylating Agents|alkylating agents|mesh-ancestor
25043408|NCT01265901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24839202|NCT02202707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24839204|NCT02202707|Anticonvulsants|anticonvulsants|mesh-ancestor
24473674|NCT00403780|Anticonvulsants|anticonvulsants|mesh-ancestor
24839243|NCT02203097|Propofol|propofol|mesh-list
24582518|NCT00870220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582519|NCT00870220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24582520|NCT00870220|Contraceptive Agents|contraceptive agents|mesh-ancestor
24582521|NCT00870220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24582522|NCT00870220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24582523|NCT00870272|Misoprostol|misoprostol|mesh-list
24589233|NCT00906139|GABA Modulators|gaba modulators|mesh-ancestor
24582524|NCT00870272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24839255|NCT02203175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24977535|NCT02889809|Xhance|xhance|mesh-list
24839295|NCT02203253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24839296|NCT02203253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839297|NCT02203396|Cyclosporine|cyclosporine|mesh-list
24839298|NCT02203396|Levamisole|levamisole|mesh-list
24839299|NCT02203396|Cyclosporins|cyclosporins|mesh-list
24839306|NCT02203396|Antifungal Agents|antifungal agents|mesh-ancestor
24839307|NCT02203396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24839308|NCT02203396|Dermatologic Agents|dermatologic agents|mesh-ancestor
24839309|NCT02203396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24977665|NCT02496611|Hormones|hormones|mesh-ancestor
24839316|NCT02203422|Cyclosporins|cyclosporins|mesh-list
24839340|NCT02203461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24839341|NCT02203461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24415188|NCT00199095|Ifosfamide|ifosfamide|mesh-list
24811382|NCT02046538|Fluorouracil|fluorouracil|mesh-list
24839346|NCT02203461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25105712|NCT05149638|Hormones|hormones|mesh-ancestor
24839530|NCT02205112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24839353|NCT02203500|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24839354|NCT02203500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839355|NCT02203500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24839367|NCT02203604|Immunoglobulins|immunoglobulins|mesh-list
24839368|NCT02203604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24839401|NCT02203643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24839403|NCT02203643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24839417|NCT02203656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24839418|NCT02203656|Anabolic Agents|anabolic agents|mesh-ancestor
24839419|NCT02203760|Gemcitabine|gemcitabine|mesh-list
24839420|NCT02203760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24839421|NCT02203760|Antimetabolites|antimetabolites|mesh-ancestor
24839422|NCT02203760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977982|NCT01127256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24416937|NCT00204529|Immunologic Factors|immunologic factors|mesh-ancestor
24839423|NCT02203760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24839424|NCT02203760|Antiviral Agents|antiviral agents|mesh-ancestor
24839425|NCT02203760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24839437|NCT02204020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24839438|NCT02204202|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24839439|NCT02204202|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24417217|NCT00205946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24417218|NCT00205946|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24417219|NCT00205946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24417222|NCT00205946|Dopamine Agents|dopamine agents|mesh-ancestor
24839442|NCT02204397|Dermatologic Agents|dermatologic agents|mesh-ancestor
24839443|NCT02204475|Interferons|interferons|mesh-list
24839444|NCT02204475|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24839445|NCT02204475|Grazoprevir|grazoprevir|mesh-list
24839446|NCT02204475|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
24839447|NCT02204475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24839448|NCT02204475|Antiviral Agents|antiviral agents|mesh-ancestor
24839449|NCT02204475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24839454|NCT02204501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839507|NCT02204878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24839508|NCT02204878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24839509|NCT02204878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417414|NCT00206453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417415|NCT00206453|Tubulin Modulators|tubulin modulators|mesh-ancestor
25649651|NCT01494506|Antidotes|antidotes|mesh-ancestor
25649652|NCT01494506|Protective Agents|protective agents|mesh-ancestor
25649653|NCT01494506|Vitamin B Complex|vitamin b complex|mesh-ancestor
25649654|NCT01494506|Vitamins|vitamins|mesh-ancestor
25649655|NCT01494506|Micronutrients|micronutrients|mesh-ancestor
25649656|NCT01494532|Ropinirole|ropinirole|mesh-list
25649657|NCT01494532|Levodopa|levodopa|mesh-list
25649658|NCT01494532|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
24839510|NCT02204878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25649659|NCT01494532|Dopamine Agents|dopamine agents|mesh-ancestor
25826586|NCT00005845|Tipifarnib|tipifarnib|mesh-list
24583210|NCT00873756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583211|NCT00873756|Growth Inhibitors|growth inhibitors|mesh-ancestor
24583212|NCT00873769|Loxapine|loxapine|mesh-list
24583213|NCT00873769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24583214|NCT00873769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24839511|NCT02204878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24839512|NCT02204878|Analgesics|analgesics|mesh-ancestor
24839513|NCT02204878|Sensory System Agents|sensory system agents|mesh-ancestor
24839515|NCT02204878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795306|NCT03174184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24401216|NCT00152438|Hormones|hormones|mesh-ancestor
25826587|NCT00005845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417756|NCT00207584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24417757|NCT00207584|Antimalarials|antimalarials|mesh-ancestor
24417965|NCT00208234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24417966|NCT00208234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24417967|NCT00208234|Respiratory System Agents|respiratory system agents|mesh-ancestor
24417968|NCT00208234|Immunologic Factors|immunologic factors|mesh-ancestor
24839516|NCT02204878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24839517|NCT02204878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24839524|NCT02205112|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24839525|NCT02205112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24839526|NCT02205112|Renal Agents|renal agents|mesh-ancestor
24839527|NCT02205112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24839528|NCT02205112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24839529|NCT02205112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25057185|NCT03506828|Phenol|phenol|mesh-list
24418150|NCT00208741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24418151|NCT00208741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24839531|NCT02205112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839538|NCT02205151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24839546|NCT02205164|Autonomic Agents|autonomic agents|mesh-ancestor
24839547|NCT02205164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24839564|NCT02205242|Azithromycin|azithromycin|mesh-list
24598785|NCT00958100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24839571|NCT02205398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24839572|NCT02205398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24839573|NCT02205489|Cetirizine|cetirizine|mesh-list
24839574|NCT02205489|Acyclovir|acyclovir|mesh-list
24839575|NCT02205489|Ibuprofen|ibuprofen|mesh-list
24839576|NCT02205489|Methylprednisolone|methylprednisolone|mesh-list
25043414|NCT01265901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25043415|NCT01265901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043416|NCT01262261|Buprenorphine|buprenorphine|mesh-list
25043417|NCT01262261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25043418|NCT01262261|Narcotics|narcotics|mesh-ancestor
25043419|NCT01262261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25826588|NCT00005847|Interferons|interferons|mesh-list
25826589|NCT00005847|Interferon-alpha|interferon-alpha|mesh-list
25826590|NCT00005847|Paclitaxel|paclitaxel|mesh-list
25649660|NCT01494532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25649661|NCT01494532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649662|NCT01494532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649663|NCT01494532|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25649664|NCT01494532|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25649665|NCT01494532|Dopamine Agonists|dopamine agonists|mesh-ancestor
25649666|NCT01494584|Ezogabine|ezogabine|mesh-list
25649667|NCT01494584|Anticonvulsants|anticonvulsants|mesh-ancestor
25649668|NCT01494584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25649669|NCT01494584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826591|NCT00005847|Vinorelbine|vinorelbine|mesh-list
25043420|NCT01262261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839589|NCT02205489|Sensory System Agents|sensory system agents|mesh-ancestor
25057245|NCT03506763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24583415|NCT00874419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583416|NCT00874419|Antiviral Agents|antiviral agents|mesh-ancestor
24583417|NCT00874419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24583418|NCT00874419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24583453|NCT00874575|Vitamins|vitamins|mesh-list
24583454|NCT00874575|Micronutrients|micronutrients|mesh-ancestor
24583455|NCT00874575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857400|NCT02291536|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24857402|NCT02291536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857403|NCT02291536|Hormones|hormones|mesh-ancestor
24459909|NCT00346827|Autonomic Agents|autonomic agents|mesh-ancestor
24839596|NCT02205489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839597|NCT02205489|Antiemetics|antiemetics|mesh-ancestor
24839598|NCT02205489|Autonomic Agents|autonomic agents|mesh-ancestor
24533982|NCT00645580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24533983|NCT00645580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533984|NCT00645580|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24533985|NCT00645606|Rituximab|rituximab|mesh-list
24839600|NCT02205489|Glucocorticoids|glucocorticoids|mesh-ancestor
24839602|NCT02205489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24839603|NCT02205489|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24839604|NCT02205489|Protective Agents|protective agents|mesh-ancestor
24839616|NCT02205489|Histamine Agents|histamine agents|mesh-ancestor
24839617|NCT02205489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24839618|NCT02205489|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24839619|NCT02205502|Lidocaine|lidocaine|mesh-list
24839620|NCT02205502|Anesthetics, Local|anesthetics, local|mesh-ancestor
24839621|NCT02205502|Anesthetics|anesthetics|mesh-ancestor
24839622|NCT02205502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25826592|NCT00005847|Mitoxantrone|mitoxantrone|mesh-list
25826593|NCT00005847|Estramustine|estramustine|mesh-list
24839623|NCT02205502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839624|NCT02205502|Sensory System Agents|sensory system agents|mesh-ancestor
24839625|NCT02205502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25057260|NCT03506542|Mitomycin|mitomycin|mesh-list
24702230|NCT01464606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24839626|NCT02205502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24839627|NCT02205502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25826594|NCT00005847|Isotretinoin|isotretinoin|mesh-list
25826595|NCT00005847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24839638|NCT02205541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24839639|NCT02205541|Immunologic Factors|immunologic factors|mesh-ancestor
24534306|NCT00646620|Adrenergic Agents|adrenergic agents|mesh-ancestor
24534307|NCT00646620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25826596|NCT00005847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24839640|NCT02205541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839642|NCT02205554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24839643|NCT02205554|Narcotics|narcotics|mesh-ancestor
24839644|NCT02205554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24839645|NCT02205554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839646|NCT02205554|Analgesics|analgesics|mesh-ancestor
24813075|NCT02056379|Dexamethasone|dexamethasone|mesh-list
24813076|NCT02056379|Budesonide|budesonide|mesh-list
24839647|NCT02205554|Sensory System Agents|sensory system agents|mesh-ancestor
24839648|NCT02205554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24839649|NCT02205580|Sufentanil|sufentanil|mesh-list
24839651|NCT02205580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24839652|NCT02205580|Narcotics|narcotics|mesh-ancestor
25649670|NCT01494610|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25649671|NCT01494610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25649672|NCT01494610|Autonomic Agents|autonomic agents|mesh-ancestor
25649673|NCT01494610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25649674|NCT01494610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649675|NCT01494610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25649676|NCT01494610|Respiratory System Agents|respiratory system agents|mesh-ancestor
25649677|NCT01494610|Glucocorticoids|glucocorticoids|mesh-ancestor
25649678|NCT01494610|Hormones|hormones|mesh-ancestor
25649679|NCT01494610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24839653|NCT02205580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24584125|NCT00878657|Antiviral Agents|antiviral agents|mesh-ancestor
24839654|NCT02205580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839655|NCT02205580|Analgesics|analgesics|mesh-ancestor
24839659|NCT02205580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24839660|NCT02205580|Anesthetics, General|anesthetics, general|mesh-ancestor
24839661|NCT02205580|Anesthetics|anesthetics|mesh-ancestor
24839662|NCT02205619|Glycine|glycine|mesh-list
24839663|NCT02205619|Glycine Agents|glycine agents|mesh-ancestor
24839664|NCT02205619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25826597|NCT00005847|Tubulin Modulators|tubulin modulators|mesh-ancestor
24839679|NCT02205879|Sensory System Agents|sensory system agents|mesh-ancestor
24839680|NCT02205879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24839681|NCT02205879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839682|NCT02205879|Anticonvulsants|anticonvulsants|mesh-ancestor
24534435|NCT00647049|Cytarabine|cytarabine|mesh-list
24839686|NCT02205879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24839687|NCT02205879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24839688|NCT02205879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24839689|NCT02205879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24839690|NCT02205879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24839692|NCT02205892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24839693|NCT02205931|Topiramate|topiramate|mesh-list
24839694|NCT02205931|Lamotrigine|lamotrigine|mesh-list
24839696|NCT02205931|Carbamazepine|carbamazepine|mesh-list
24839697|NCT02205931|Phenytoin|phenytoin|mesh-list
24839698|NCT02205931|Rufinamide|rufinamide|mesh-list
24839699|NCT02205931|Levetiracetam|levetiracetam|mesh-list
24839700|NCT02205931|Valproic Acid|valproic acid|mesh-list
25826598|NCT00005847|Antimitotic Agents|antimitotic agents|mesh-ancestor
25826599|NCT00005847|Mitosis Modulators|mitosis modulators|mesh-ancestor
25826600|NCT00005847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826601|NCT00005847|Antiviral Agents|antiviral agents|mesh-ancestor
24839719|NCT02205931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24839720|NCT02205931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24839721|NCT02205931|GABA Agents|gaba agents|mesh-ancestor
24598927|NCT05351684|Antiviral Agents|antiviral agents|mesh-ancestor
24839722|NCT02205931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24839727|NCT02205931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24839749|NCT02206035|Methotrexate|methotrexate|mesh-list
24839750|NCT02206035|Tacrolimus|tacrolimus|mesh-list
25057359|NCT03505736|Adenosine|adenosine|mesh-list
25826602|NCT00005847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25826603|NCT00005847|Immunologic Factors|immunologic factors|mesh-ancestor
24534596|NCT00647660|Diuretics|diuretics|mesh-ancestor
24839751|NCT02206035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24839752|NCT02206035|Abortifacient Agents|abortifacient agents|mesh-ancestor
24839753|NCT02206035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24534626|NCT00647712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534627|NCT00647712|Antimanic Agents|antimanic agents|mesh-ancestor
24534628|NCT00647712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24534629|NCT00647712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24839754|NCT02206035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839755|NCT02206035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24839756|NCT02206035|Antimetabolites|antimetabolites|mesh-ancestor
24839757|NCT02206035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839758|NCT02206035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24839759|NCT02206035|Dermatologic Agents|dermatologic agents|mesh-ancestor
24839760|NCT02206035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826604|NCT00005847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839766|NCT02206035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24839770|NCT02206165|Amlodipine|amlodipine|mesh-list
24839783|NCT02206178|Acetylcysteine|acetylcysteine|mesh-list
24839784|NCT02206178|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24839785|NCT02206178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24839815|NCT02206204|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24883364|NCT03926624|Cytarabine|cytarabine|mesh-list
24857497|NCT02292069|Calcium|calcium|mesh-list
24857498|NCT02292069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24857499|NCT02292069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839816|NCT02206204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24839817|NCT02206204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24839818|NCT02206295|Selexipag|selexipag|mesh-list
24839819|NCT02206295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24839820|NCT02206308|Antibodies|antibodies|mesh-list
25649680|NCT01494610|Sympathomimetics|sympathomimetics|mesh-ancestor
25826605|NCT00005847|Analgesics|analgesics|mesh-ancestor
25826606|NCT00005847|Sensory System Agents|sensory system agents|mesh-ancestor
25826607|NCT00005847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24839821|NCT02206308|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25649681|NCT01494818|Hydrogen Peroxide|hydrogen peroxide|mesh-list
24839850|NCT02206425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24839851|NCT02206425|Glucocorticoids|glucocorticoids|mesh-ancestor
24839855|NCT02206425|Protease Inhibitors|protease inhibitors|mesh-ancestor
24839867|NCT02206477|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24839868|NCT02206477|Protective Agents|protective agents|mesh-ancestor
24839873|NCT02206490|Naltrexone|naltrexone|mesh-list
24839874|NCT02206490|Dextromethorphan|dextromethorphan|mesh-list
24839875|NCT02206490|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24839876|NCT02206490|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24839893|NCT02206503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24839894|NCT02206503|Alkylating Agents|alkylating agents|mesh-ancestor
24839895|NCT02206503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787996|NCT01928901|Thymol|thymol|mesh-list
24839969|NCT02206789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839970|NCT02206789|Antifungal Agents|antifungal agents|mesh-ancestor
24839971|NCT02206789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24839972|NCT02206789|Dermatologic Agents|dermatologic agents|mesh-ancestor
24839973|NCT02206789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24839974|NCT02206789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24839975|NCT02206789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24839978|NCT02206789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24839990|NCT02206815|Aspirin|aspirin|mesh-list
24839991|NCT02206815|Warfarin|warfarin|mesh-list
24840113|NCT02207660|Antimetabolites|antimetabolites|mesh-ancestor
24840114|NCT02207660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840115|NCT02207660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24840116|NCT02207660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24840117|NCT02207660|Immunologic Factors|immunologic factors|mesh-ancestor
24840118|NCT02207660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840119|NCT02207699|Moxifloxacin|moxifloxacin|mesh-list
24840126|NCT02207699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840130|NCT02207855|Chloroprocaine|chloroprocaine|mesh-list
24840135|NCT02207855|Sensory System Agents|sensory system agents|mesh-ancestor
24840136|NCT02207855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24840153|NCT02208128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24840155|NCT02208128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24840156|NCT02208128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840157|NCT02208128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840165|NCT02208245|Anesthetics, Local|anesthetics, local|mesh-ancestor
24840166|NCT02208245|Anesthetics|anesthetics|mesh-ancestor
24840167|NCT02208245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24840168|NCT02208245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199495|NCT02741024|Schistosomicides|schistosomicides|mesh-ancestor
25199496|NCT02741024|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25199497|NCT02741024|Anthelmintics|anthelmintics|mesh-ancestor
25199508|NCT02740647|Amoxicillin|amoxicillin|mesh-list
25199509|NCT02740647|Clavulanic Acid|clavulanic acid|mesh-list
25199510|NCT02740647|Clavulanic Acids|clavulanic acids|mesh-list
25199511|NCT02740647|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25199512|NCT02740647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25199513|NCT02740647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25010464|NCT04030559|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24840169|NCT02208245|Sensory System Agents|sensory system agents|mesh-ancestor
24840198|NCT02208505|Adrenergic Agents|adrenergic agents|mesh-ancestor
24840199|NCT02208505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535016|NCT00648414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25826608|NCT00005847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25826609|NCT00005847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24840200|NCT02208505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840201|NCT02208505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24840202|NCT02208505|Narcotics|narcotics|mesh-ancestor
24840209|NCT02208583|Tubulin Modulators|tubulin modulators|mesh-ancestor
25826610|NCT00005847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826611|NCT00005847|Dermatologic Agents|dermatologic agents|mesh-ancestor
25826612|NCT00005847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25826613|NCT00005847|Alkylating Agents|alkylating agents|mesh-ancestor
25826614|NCT00005847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25826615|NCT00005848|Tipifarnib|tipifarnib|mesh-list
24840210|NCT02208583|Antimitotic Agents|antimitotic agents|mesh-ancestor
24840211|NCT02208583|Mitosis Modulators|mitosis modulators|mesh-ancestor
24840212|NCT02208583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840215|NCT02208583|Hormones|hormones|mesh-ancestor
24840217|NCT02208583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840253|NCT02208778|Antidepressive Agents|antidepressive agents|mesh-ancestor
24840254|NCT02208778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24840255|NCT02208778|Dopamine Agents|dopamine agents|mesh-ancestor
24840256|NCT02208791|Sirolimus|sirolimus|mesh-list
24840257|NCT02208791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24840258|NCT02208791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24840259|NCT02208791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24840260|NCT02208791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24535150|NCT00648661|Dexetimide|dexetimide|mesh-list
24840302|NCT02209155|Verapamil|verapamil|mesh-list
24840303|NCT02209155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24840304|NCT02209155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24840305|NCT02209155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25826616|NCT00005848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24840338|NCT02209441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24840339|NCT02209441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24840340|NCT02209441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840377|NCT02209831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840378|NCT02209831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840380|NCT02209909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24840381|NCT02209909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24840382|NCT02209909|Analgesics|analgesics|mesh-ancestor
24840458|NCT02210260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24840580|NCT02211079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24840581|NCT02211079|Anesthetics, General|anesthetics, general|mesh-ancestor
24840582|NCT02211079|Anesthetics|anesthetics|mesh-ancestor
24840583|NCT02211079|GABA Modulators|gaba modulators|mesh-ancestor
24840584|NCT02211079|GABA Agents|gaba agents|mesh-ancestor
24840585|NCT02211079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24840586|NCT02211079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840668|NCT02211729|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24840669|NCT02211729|Amodiaquine|amodiaquine|mesh-list
24840670|NCT02211729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25649682|NCT01494818|Contact Lens Solutions|contact lens solutions|mesh-list
25649683|NCT01494818|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25649684|NCT01494818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25649685|NCT01494818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25649686|NCT01494818|Disinfectants|disinfectants|mesh-ancestor
25649687|NCT01494987|Glimepiride|glimepiride|mesh-list
25649688|NCT01494987|Ranolazine|ranolazine|mesh-list
25649689|NCT01494987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25649690|NCT01494987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25649691|NCT01494987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840671|NCT02211729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24840672|NCT02211729|Antimalarials|antimalarials|mesh-ancestor
24840811|NCT02212639|Protective Agents|protective agents|mesh-ancestor
24840812|NCT02212639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840814|NCT02212652|Ergocalciferols|ergocalciferols|mesh-list
24840815|NCT02212652|Cholecalciferol|cholecalciferol|mesh-list
24840817|NCT02212652|Micronutrients|micronutrients|mesh-ancestor
25826617|NCT00005849|Paclitaxel|paclitaxel|mesh-list
25826618|NCT00005849|Bryostatin 1|bryostatin 1|mesh-list
25826619|NCT00005849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25826620|NCT00005849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826621|NCT00005849|Tubulin Modulators|tubulin modulators|mesh-ancestor
24840818|NCT02212652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840819|NCT02212652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25826622|NCT00005849|Antimitotic Agents|antimitotic agents|mesh-ancestor
24840868|NCT02212990|Ibuprofen|ibuprofen|mesh-list
24840877|NCT02212990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24840935|NCT02213224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24840936|NCT02213224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600517|NCT00959218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24841023|NCT02213718|Narcotics|narcotics|mesh-ancestor
24841024|NCT02213718|Analgesics|analgesics|mesh-ancestor
24841132|NCT02214381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841133|NCT02214381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24841134|NCT02214381|Immunologic Factors|immunologic factors|mesh-ancestor
24841135|NCT02214381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841136|NCT02214381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24452514|NCT05458479|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24841169|NCT02214563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24841188|NCT02214680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24841189|NCT02214680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24841190|NCT02214680|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24841191|NCT02214680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24841192|NCT02214680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24841193|NCT02214706|Sirolimus|sirolimus|mesh-list
24841194|NCT02214706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24841195|NCT02214706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24452536|NCT05458180|Cyclophosphamide|cyclophosphamide|mesh-list
24841208|NCT02214810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24841209|NCT02214810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600775|NCT00960518|Adefovir|adefovir|mesh-list
24841210|NCT02214810|Sensory System Agents|sensory system agents|mesh-ancestor
24841211|NCT02214810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24841212|NCT02214966|Telmisartan|telmisartan|mesh-list
25043570|NCT01236638|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
24841252|NCT02215044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841289|NCT02215174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841331|NCT02215395|Hormones|hormones|mesh-ancestor
24841341|NCT02215434|Testosterone undecanoate|testosterone undecanoate|mesh-list
24841342|NCT02215434|Testosterone enanthate|testosterone enanthate|mesh-list
24841343|NCT02215434|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24841344|NCT02215434|Androgens|androgens|mesh-ancestor
24841345|NCT02215434|Hormones|hormones|mesh-ancestor
24841346|NCT02215434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24841370|NCT02215473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24841378|NCT02215499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24841429|NCT02215876|Doxorubicin|doxorubicin|mesh-list
24841430|NCT02215876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24841431|NCT02215876|Immunologic Factors|immunologic factors|mesh-ancestor
24841432|NCT02215876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841433|NCT02215876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24841488|NCT02216227|Disinfectants|disinfectants|mesh-ancestor
24536653|NCT00651976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536671|NCT00652002|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24536673|NCT00652002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24841492|NCT02216227|Micronutrients|micronutrients|mesh-ancestor
24452556|NCT05458180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24841552|NCT02216552|Protective Agents|protective agents|mesh-ancestor
24841560|NCT02216617|Docetaxel|docetaxel|mesh-list
24452561|NCT05458180|Analgesics|analgesics|mesh-ancestor
25043586|NCT01235039|Insulin|insulin|mesh-list
25058134|NCT03499171|Citalopram|citalopram|mesh-list
25826624|NCT00005849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841768|NCT02217852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043648|NCT01231347|Antiviral Agents|antiviral agents|mesh-ancestor
25043649|NCT01231347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25043654|NCT01230957|Vaccines|vaccines|mesh-list
24841846|NCT02218476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841981|NCT02219217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841982|NCT02219217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24841983|NCT02219217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24841984|NCT02219217|Antiviral Agents|antiviral agents|mesh-ancestor
24841985|NCT02219217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24841986|NCT02219217|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24842046|NCT02219659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24842050|NCT02219659|Anesthetics, General|anesthetics, general|mesh-ancestor
24842108|NCT02219698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842109|NCT02219698|Antipyretics|antipyretics|mesh-ancestor
24842110|NCT02219737|Rituximab|rituximab|mesh-list
24842111|NCT02219737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24842112|NCT02219737|Carboplatin|carboplatin|mesh-list
24842136|NCT02219737|Mitosis Modulators|mitosis modulators|mesh-ancestor
24842157|NCT02219867|Ketamine|ketamine|mesh-list
24842158|NCT02219867|Analgesics|analgesics|mesh-ancestor
24842159|NCT02219867|Sensory System Agents|sensory system agents|mesh-ancestor
24842160|NCT02219867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24842161|NCT02219867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842162|NCT02219867|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24842163|NCT02219867|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24463460|NCT00361075|Progestins|progestins|mesh-ancestor
24445070|NCT00300287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857825|NCT02294240|Hematinics|hematinics|mesh-ancestor
24842164|NCT02219867|Anesthetics, General|anesthetics, general|mesh-ancestor
24842165|NCT02219867|Anesthetics|anesthetics|mesh-ancestor
24842166|NCT02219867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24842184|NCT02220023|Autonomic Agents|autonomic agents|mesh-ancestor
24842185|NCT02220023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24842186|NCT02220023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842187|NCT02220023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24842188|NCT02220023|Respiratory System Agents|respiratory system agents|mesh-ancestor
24842189|NCT02220023|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25649692|NCT01494987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25649693|NCT01494987|Immunologic Factors|immunologic factors|mesh-ancestor
25065422|NCT05322499|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25826625|NCT00005849|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24842243|NCT02220335|Digoxin|digoxin|mesh-list
24842244|NCT02220335|Diuretics|diuretics|mesh-list
24842245|NCT02220335|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24842246|NCT02220335|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
24842247|NCT02220335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24842248|NCT02220335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24842249|NCT02220335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842388|NCT02220829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842432|NCT02221154|Hematinics|hematinics|mesh-ancestor
24842483|NCT02221453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24842566|NCT02221999|Paclitaxel|paclitaxel|mesh-list
24842591|NCT02222168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542640|NCT00679653|Metoprolol|metoprolol|mesh-list
24842990|NCT02224950|Chelating Agents|chelating agents|mesh-ancestor
24843005|NCT02225054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24843100|NCT02225652|Epirubicin|epirubicin|mesh-list
25826626|NCT00005849|Immunologic Factors|immunologic factors|mesh-ancestor
25826627|NCT00005849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843145|NCT02225795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843146|NCT02225795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843242|NCT02226367|Prazosin|prazosin|mesh-list
24843343|NCT02226978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24843401|NCT02227173|Analgesics|analgesics|mesh-ancestor
24843410|NCT02227212|Insulin Glargine|insulin glargine|mesh-list
25826628|NCT00005850|Gemcitabine|gemcitabine|mesh-list
25826629|NCT00005850|Cisplatin|cisplatin|mesh-list
25826630|NCT00005850|Fluoxetine|fluoxetine|mesh-list
24844054|NCT02231021|Incretins|incretins|mesh-ancestor
24844114|NCT02231320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24844115|NCT02231320|Autonomic Agents|autonomic agents|mesh-ancestor
24544494|NCT00689195|Analgesics|analgesics|mesh-ancestor
24844176|NCT02231606|Methamphetamine|methamphetamine|mesh-list
24844201|NCT02231762|Lanreotide|lanreotide|mesh-list
24844240|NCT02231931|Antimetabolites|antimetabolites|mesh-ancestor
24844256|NCT02232035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24844257|NCT02232035|Anticonvulsants|anticonvulsants|mesh-ancestor
24844258|NCT02232035|Antiemetics|antiemetics|mesh-ancestor
24844259|NCT02232035|Autonomic Agents|autonomic agents|mesh-ancestor
25649694|NCT01494987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25649695|NCT01494987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25649696|NCT01494987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649697|NCT01495000|Denosumab|denosumab|mesh-list
25649698|NCT01495000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25649699|NCT01495000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649700|NCT01495481|Adenosine|adenosine|mesh-list
25649701|NCT01495481|Dexmedetomidine|dexmedetomidine|mesh-list
25059535|NCT03487211|Citalopram|citalopram|mesh-list
24844267|NCT02232035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24844268|NCT02232035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24844269|NCT02232035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24844270|NCT02232035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24844271|NCT02232035|Anesthetics, General|anesthetics, general|mesh-ancestor
24844272|NCT02232035|Anesthetics|anesthetics|mesh-ancestor
24844398|NCT02232581|Dideoxynucleosides|dideoxynucleosides|mesh-list
24844507|NCT02233023|Sympathomimetics|sympathomimetics|mesh-ancestor
24844508|NCT02233023|Autonomic Agents|autonomic agents|mesh-ancestor
25043907|NCT01188187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24844845|NCT02234869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24844943|NCT02235337|Vitamins|vitamins|mesh-ancestor
24844944|NCT02235337|Micronutrients|micronutrients|mesh-ancestor
24844945|NCT02235337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844946|NCT02235337|Vitamin B Complex|vitamin b complex|mesh-ancestor
24844950|NCT02235389|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24844951|NCT02235389|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24844953|NCT02235402|Lacidipine|lacidipine|mesh-list
25826631|NCT00005850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043969|NCT01175785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25043970|NCT01175785|Alkylating Agents|alkylating agents|mesh-ancestor
25043971|NCT01175785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043972|NCT01175785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043973|NCT01175785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25043974|NCT01175785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25043976|NCT01175785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043978|NCT01175785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25043979|NCT01175785|Dermatologic Agents|dermatologic agents|mesh-ancestor
25069295|NCT03427437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24561559|NCT00761358|Z 338|z 338|mesh-list
24845083|NCT02236026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24845084|NCT02236026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845242|NCT02237131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845243|NCT02237131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24845245|NCT02237209|Immunologic Factors|immunologic factors|mesh-ancestor
24845246|NCT02237209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845247|NCT02237261|Prednisone|prednisone|mesh-list
24845248|NCT02237261|Bortezomib|bortezomib|mesh-list
24845304|NCT02237443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24845305|NCT02237443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24845589|NCT02238288|Mydriatics|mydriatics|mesh-ancestor
24845590|NCT02238288|Sympathomimetics|sympathomimetics|mesh-ancestor
24845591|NCT02238288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24845648|NCT02238366|Luteolytic Agents|luteolytic agents|mesh-ancestor
24858701|NCT02299115|Vigabatrin|vigabatrin|mesh-list
24845682|NCT02238444|Aspirin|aspirin|mesh-list
24845683|NCT02238444|Heparin|heparin|mesh-list
24845685|NCT02238444|Tinzaparin|tinzaparin|mesh-list
24845713|NCT02238470|Warfarin|warfarin|mesh-list
24845775|NCT02238808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24845782|NCT02238860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24845783|NCT02238860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845784|NCT02238860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25649702|NCT01495481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25649703|NCT01495481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25649704|NCT01495481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649705|NCT01495481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24845790|NCT02239107|Expectorants|expectorants|mesh-ancestor
24447553|NCT00308945|Travoprost|travoprost|mesh-list
25649706|NCT01495481|Analgesics|analgesics|mesh-ancestor
25649707|NCT01495481|Sensory System Agents|sensory system agents|mesh-ancestor
25649708|NCT01495481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24915777|NCT04248348|Anticoagulants|anticoagulants|mesh-ancestor
24915783|NCT04248309|Hormones|hormones|mesh-ancestor
24915790|NCT04248205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915791|NCT04248205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24915792|NCT04248205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24915793|NCT04248205|Anesthetics, General|anesthetics, general|mesh-ancestor
24845799|NCT02239276|Anticonvulsants|anticonvulsants|mesh-ancestor
24845800|NCT02239445|Dexmedetomidine|dexmedetomidine|mesh-list
24845801|NCT02239445|Chloral Hydrate|chloral hydrate|mesh-list
24845802|NCT02239445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24845803|NCT02239445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24845856|NCT02239731|Antimalarials|antimalarials|mesh-ancestor
24845857|NCT02239731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24845858|NCT02239731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24845859|NCT02239835|Ritonavir|ritonavir|mesh-list
24845924|NCT02240017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845936|NCT02240173|Autonomic Agents|autonomic agents|mesh-ancestor
24845937|NCT02240173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25044062|NCT01167166|ON 01910|on 01910|mesh-list
25044067|NCT01166412|Levonorgestrel|levonorgestrel|mesh-list
25826632|NCT00005850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25826633|NCT00005850|Antimetabolites|antimetabolites|mesh-ancestor
24666216|NCT01318044|GABA Agents|gaba agents|mesh-ancestor
25826634|NCT00005850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826635|NCT00005850|Antiviral Agents|antiviral agents|mesh-ancestor
24846007|NCT02240537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846008|NCT02240537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24846010|NCT02240602|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24476581|NCT00415831|Carbidopa|carbidopa|mesh-list
24887575|NCT04514770|Oxytocics|oxytocics|mesh-ancestor
25826636|NCT00005850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25826637|NCT00005850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826638|NCT00005850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24716153|NCT01540240|Zidovudine|zidovudine|mesh-list
24846035|NCT02240719|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24846036|NCT02240719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24846037|NCT02240719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24846107|NCT02241174|Disinfectants|disinfectants|mesh-ancestor
24846108|NCT02241174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24846109|NCT02241200|Darbepoetin alfa|darbepoetin alfa|mesh-list
24846110|NCT02241200|Hematinics|hematinics|mesh-ancestor
24846111|NCT02241278|Ketamine|ketamine|mesh-list
24846112|NCT02241278|Analgesics|analgesics|mesh-ancestor
25826639|NCT00005850|Immunologic Factors|immunologic factors|mesh-ancestor
25829680|NCT00006248|Mitosis Modulators|mitosis modulators|mesh-ancestor
24846164|NCT02241564|Sirolimus|sirolimus|mesh-list
24846202|NCT02241941|Daptomycin|daptomycin|mesh-list
24846226|NCT02242227|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24846227|NCT02242227|Respiratory System Agents|respiratory system agents|mesh-ancestor
24846234|NCT02242240|Formoterol Fumarate|formoterol fumarate|mesh-list
24846243|NCT02242240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24846244|NCT02242240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25649709|NCT01495481|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25649710|NCT01495481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25649711|NCT01495481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25649712|NCT01495481|Adrenergic Agents|adrenergic agents|mesh-ancestor
25649713|NCT01495481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25649714|NCT01495481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649715|NCT01495481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25649716|NCT01495481|Vasodilator Agents|vasodilator agents|mesh-ancestor
25649717|NCT01495481|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25649718|NCT01495481|Purinergic Agonists|purinergic agonists|mesh-ancestor
25649719|NCT01495481|Purinergic Agents|purinergic agents|mesh-ancestor
24549665|NCT00716612|Vitamins|vitamins|mesh-ancestor
24846306|NCT02242292|Parasympatholytics|parasympatholytics|mesh-ancestor
24846378|NCT02242474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24846379|NCT02242474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25044085|NCT01159249|Vildagliptin|vildagliptin|mesh-list
25044092|NCT01156753|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
25826640|NCT00005850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044127|NCT01138163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25044128|NCT01137968|Bevacizumab|bevacizumab|mesh-list
25044141|NCT01137526|Donepezil|donepezil|mesh-list
24461769|NCT00353678|Darexaban|darexaban|mesh-list
25044193|NCT01129674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25044194|NCT01129674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044195|NCT01129674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044196|NCT01129674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25044197|NCT01129674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25044202|NCT01129674|Antiemetics|antiemetics|mesh-ancestor
25826641|NCT00005850|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24846475|NCT02242812|Autonomic Agents|autonomic agents|mesh-ancestor
25826642|NCT00005850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24622398|NCT01066845|Tadalafil|tadalafil|mesh-list
25044222|NCT01129648|Antioxidants|antioxidants|mesh-ancestor
25826643|NCT00005850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24846621|NCT02243254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24846622|NCT02243254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25826646|NCT00005850|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25044330|NCT01113957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826647|NCT00005850|Antidepressive Agents|antidepressive agents|mesh-ancestor
25826648|NCT00005850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25826649|NCT00005850|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25826650|NCT00005850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25826652|NCT00005851|Mycophenolic Acid|mycophenolic acid|mesh-list
25826653|NCT00005851|Fludarabine|fludarabine|mesh-list
25826654|NCT00005851|Fludarabine phosphate|fludarabine phosphate|mesh-list
25826655|NCT00005851|Cyclosporins|cyclosporins|mesh-list
25826656|NCT00005851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826657|NCT00005851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25826658|NCT00005851|Antimetabolites|antimetabolites|mesh-ancestor
25062544|NCT04370301|Tacrolimus|tacrolimus|mesh-list
24630735|NCT01113281|Vaccines|vaccines|mesh-list
24479917|NCT00428883|Antidotes|antidotes|mesh-ancestor
24846835|NCT02244164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24463988|NCT00362921|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
24463989|NCT00362921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24859042|NCT02301286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25649720|NCT01495572|Aldesleukin|aldesleukin|mesh-list
25649721|NCT01495572|Cyclophosphamide|cyclophosphamide|mesh-list
25649722|NCT01495572|Fludarabine|fludarabine|mesh-list
25649723|NCT01495572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25649724|NCT01495572|Immunologic Factors|immunologic factors|mesh-ancestor
25649725|NCT01495572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649726|NCT01495572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25649727|NCT01495572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25826659|NCT00005851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826660|NCT00005851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25826661|NCT00005851|Immunologic Factors|immunologic factors|mesh-ancestor
25826662|NCT00005851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826663|NCT00005851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826664|NCT00005851|Antifungal Agents|antifungal agents|mesh-ancestor
25826665|NCT00005851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25826666|NCT00005851|Dermatologic Agents|dermatologic agents|mesh-ancestor
24846839|NCT02244164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846841|NCT02244190|Tipranavir|tipranavir|mesh-list
24846842|NCT02244190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24846843|NCT02244190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24846844|NCT02244190|Protease Inhibitors|protease inhibitors|mesh-ancestor
24846845|NCT02244190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24846846|NCT02244190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044356|NCT01111773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044363|NCT01111773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044364|NCT01110902|S 20098|s 20098|mesh-list
25044365|NCT01110902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25044366|NCT01110902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25044367|NCT01110902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044368|NCT01110889|S 20098|s 20098|mesh-list
24609377|NCT00996229|Resveratrol|resveratrol|mesh-list
24465506|NCT00369889|Growth Inhibitors|growth inhibitors|mesh-ancestor
24465507|NCT00369889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24465508|NCT00369889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24465509|NCT00369889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465511|NCT00369954|Carboplatin|carboplatin|mesh-list
24465514|NCT00369954|Antimetabolites|antimetabolites|mesh-ancestor
24846869|NCT02244229|Tamsulosin|tamsulosin|mesh-list
25826667|NCT00005851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24803409|NCT01996358|Rocuronium|rocuronium|mesh-list
25649728|NCT01495572|Alkylating Agents|alkylating agents|mesh-ancestor
25649729|NCT01495572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649730|NCT01495572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649731|NCT01495572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25649732|NCT01495572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25649733|NCT01495572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25649734|NCT01495572|Antiviral Agents|antiviral agents|mesh-ancestor
25649735|NCT01495572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25649736|NCT01495585|Lonafarnib|lonafarnib|mesh-list
24846958|NCT02244489|Capecitabine|capecitabine|mesh-list
24846959|NCT02244489|Oxaliplatin|oxaliplatin|mesh-list
24846960|NCT02244489|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
24846962|NCT02244489|Antimetabolites|antimetabolites|mesh-ancestor
24803944|NCT01999829|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25062933|NCT03442972|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24599015|NCT05351021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622688|NCT01067989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24622689|NCT01068054|Cyclosporine|cyclosporine|mesh-list
24804424|NCT02002390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25154452|NCT05471453|Tocotrienols|tocotrienols|mesh-list
25154467|NCT05471427|Tubulin Modulators|tubulin modulators|mesh-ancestor
25154474|NCT05471063|Fluconazole|fluconazole|mesh-list
24847001|NCT02244632|Irinotecan|irinotecan|mesh-list
24847002|NCT02244632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24847003|NCT02244632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24847004|NCT02244632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25826668|NCT00005851|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25826669|NCT00005851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25826670|NCT00005851|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24805013|NCT02006849|Hormones|hormones|mesh-ancestor
24467549|NCT00378066|Capecitabine|capecitabine|mesh-list
24847058|NCT02245022|Tenofovir|tenofovir|mesh-list
25063101|NCT03188172|Antiemetics|antiemetics|mesh-ancestor
25154485|NCT05471063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25154487|NCT05471063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25154488|NCT05471063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154497|NCT05471063|Protease Inhibitors|protease inhibitors|mesh-ancestor
25154498|NCT05471063|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25649737|NCT01495585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649738|NCT01495585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649739|NCT01495702|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25649740|NCT01495702|Antiviral Agents|antiviral agents|mesh-ancestor
25649741|NCT01495702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25649742|NCT01495702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25649743|NCT01495702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25649744|NCT01495793|Rotigotine|rotigotine|mesh-list
24847113|NCT02245191|Protective Agents|protective agents|mesh-ancestor
24847114|NCT02245191|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24847115|NCT02245256|Dexmedetomidine|dexmedetomidine|mesh-list
24847116|NCT02245256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24847128|NCT02245256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826672|NCT00005851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24473968|NCT00404586|Xhance|xhance|mesh-list
25063396|NCT01670500|Cyclophosphamide|cyclophosphamide|mesh-list
25649746|NCT01495793|Dopamine Agents|dopamine agents|mesh-ancestor
25649747|NCT01495793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25649748|NCT01495793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649749|NCT01495793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474095|NCT00404833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474096|NCT00404833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24474098|NCT00404833|Hormones|hormones|mesh-ancestor
24474099|NCT00404833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24805866|NCT02012335|Anesthetics|anesthetics|mesh-ancestor
24805875|NCT02012387|Immunologic Factors|immunologic factors|mesh-ancestor
24805876|NCT02012387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805877|NCT02012387|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24446361|NCT00304551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740217|NCT01687127|Folic Acid|folic acid|mesh-list
25826678|NCT00005852|Muromonab-CD3|muromonab-cd3|mesh-list
24847151|NCT02245321|Ferrous gluconate|ferrous gluconate|mesh-list
24847152|NCT02245321|Hematinics|hematinics|mesh-ancestor
24847153|NCT02245334|Povidone-Iodine|povidone-iodine|mesh-list
24847154|NCT02245334|Povidone|povidone|mesh-list
25826679|NCT00005852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25063441|NCT00753532|Vitamin E|vitamin e|mesh-list
24474237|NCT00405301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25826680|NCT00005852|Immunologic Factors|immunologic factors|mesh-ancestor
25826681|NCT00005852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446457|NCT00304772|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25826682|NCT00005852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25649751|NCT01495819|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25649752|NCT01495819|Autonomic Agents|autonomic agents|mesh-ancestor
25649753|NCT01495819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25000811|NCT03081858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25044454|NCT01094262|Analgesics|analgesics|mesh-list
25044455|NCT01094262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25826683|NCT00005852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24935974|NCT04045769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24935975|NCT04045769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24935976|NCT04045769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24830115|NCT02157337|Antimetabolites|antimetabolites|mesh-ancestor
25044458|NCT01094262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044459|NCT01094262|Sensory System Agents|sensory system agents|mesh-ancestor
25044460|NCT01094262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25044461|NCT01092104|Cenicriviroc|cenicriviroc|mesh-list
25063478|NCT03468478|Antifungal Agents|antifungal agents|mesh-ancestor
25826684|NCT00005852|Alkylating Agents|alkylating agents|mesh-ancestor
25826685|NCT00005852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826686|NCT00005852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044462|NCT01092104|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25044463|NCT01092104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044464|NCT01092104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25044465|NCT01092104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25826687|NCT00005852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25826688|NCT00005852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044466|NCT01092104|Antiviral Agents|antiviral agents|mesh-ancestor
25044467|NCT01092104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25154518|NCT05470881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25154519|NCT05470881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25154520|NCT05470881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25154521|NCT05470881|Autonomic Agents|autonomic agents|mesh-ancestor
25154522|NCT05470881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25154523|NCT05470881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154524|NCT05470881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25154525|NCT05470881|Respiratory System Agents|respiratory system agents|mesh-ancestor
25154526|NCT05470881|Mydriatics|mydriatics|mesh-ancestor
25154529|NCT05470881|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25154530|NCT05470881|Cholinergic Agents|cholinergic agents|mesh-ancestor
25154531|NCT05470881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25154532|NCT05470881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154549|NCT05470764|Amlodipine|amlodipine|mesh-list
25154553|NCT05470764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25154554|NCT05470764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25154555|NCT05470764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063521|NCT03468231|Oxaliplatin|oxaliplatin|mesh-list
25826689|NCT00005852|Antifungal Agents|antifungal agents|mesh-ancestor
25826690|NCT00005852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24806004|NCT02013232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24806005|NCT02013232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806006|NCT02013232|Dopamine Agonists|dopamine agonists|mesh-ancestor
24806007|NCT02013232|Dopamine Agents|dopamine agents|mesh-ancestor
24806008|NCT02013232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24806009|NCT02013232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806010|NCT02013232|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25154556|NCT05470764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25154557|NCT05470764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154558|NCT05470764|Vasodilator Agents|vasodilator agents|mesh-ancestor
25154559|NCT05470764|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24847155|NCT02245334|Plasma Substitutes|plasma substitutes|mesh-ancestor
25649754|NCT01495819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649755|NCT01495819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25649756|NCT01495819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25649757|NCT01495819|Cholinergic Agents|cholinergic agents|mesh-ancestor
25649758|NCT01495819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25649759|NCT01495819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847156|NCT02245334|Blood Substitutes|blood substitutes|mesh-ancestor
25649760|NCT01495858|Naproxen|naproxen|mesh-list
25649761|NCT01495858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25649762|NCT01495858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24847157|NCT02245334|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25826692|NCT00005852|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25826693|NCT00005852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25826694|NCT00005852|Antiemetics|antiemetics|mesh-ancestor
24826032|NCT02131948|Insulin Lispro|insulin lispro|mesh-list
25826695|NCT00005852|Autonomic Agents|autonomic agents|mesh-ancestor
25826696|NCT00005852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24936055|NCT04044651|Lenvatinib|lenvatinib|mesh-list
25826697|NCT00005852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25826698|NCT00005852|Glucocorticoids|glucocorticoids|mesh-ancestor
25826699|NCT00005852|Hormones|hormones|mesh-ancestor
25826700|NCT00005852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24847184|NCT02245438|Contraceptive Agents|contraceptive agents|mesh-ancestor
25826701|NCT00005852|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25826702|NCT00005852|Protective Agents|protective agents|mesh-ancestor
25826703|NCT00005853|Etanercept|etanercept|mesh-list
25233818|NCT02574819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24787058|NCT01923454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787059|NCT01923545|Lenograstim|lenograstim|mesh-list
24741256|NCT01693081|Emetics|emetics|mesh-ancestor
25154571|NCT05470647|Immunologic Factors|immunologic factors|mesh-ancestor
25063607|NCT03467256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24787096|NCT01923818|Analgesics|analgesics|mesh-ancestor
24787097|NCT01923818|Sensory System Agents|sensory system agents|mesh-ancestor
24626470|NCT01087554|Antifungal Agents|antifungal agents|mesh-ancestor
24787098|NCT01923818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24787099|NCT01923818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787100|NCT01923818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24818702|NCT02090348|Dermatologic Agents|dermatologic agents|mesh-ancestor
25826704|NCT00005853|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25649763|NCT01495858|Analgesics|analgesics|mesh-ancestor
25649764|NCT01495858|Sensory System Agents|sensory system agents|mesh-ancestor
25649765|NCT01495858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25649766|NCT01495858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649767|NCT01495858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25649768|NCT01495858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25649769|NCT01495858|Gout Suppressants|gout suppressants|mesh-ancestor
25826705|NCT00005853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25826709|NCT00005853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25826710|NCT00005853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826711|NCT00005853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25826712|NCT00005853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25826713|NCT00005853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24907816|NCT04327427|Antipyretics|antipyretics|mesh-ancestor
24847205|NCT02245451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24847207|NCT02245451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24847208|NCT02245451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826714|NCT00005853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25826715|NCT00005853|Immunologic Factors|immunologic factors|mesh-ancestor
24847328|NCT02246127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847329|NCT02246179|Lidocaine|lidocaine|mesh-list
24847330|NCT02246179|Epinephrine|epinephrine|mesh-list
24847331|NCT02246179|Prilocaine|prilocaine|mesh-list
24847332|NCT02246179|Carticaine|carticaine|mesh-list
24847333|NCT02246179|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25044552|NCT01082068|Letrozole|letrozole|mesh-list
24744326|NCT04356742|Metformin|metformin|mesh-list
25154622|NCT05470465|Antidepressive Agents|antidepressive agents|mesh-ancestor
24923850|NCT04166565|Bortezomib|bortezomib|mesh-list
24847341|NCT02246179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24847342|NCT02246179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24847343|NCT02246179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24847350|NCT02246179|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24847351|NCT02246179|Autonomic Agents|autonomic agents|mesh-ancestor
25649770|NCT01495858|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25649771|NCT01495858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649772|NCT01495858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649773|NCT01495923|Gabapentin|gabapentin|mesh-list
25649774|NCT01495923|Analgesics|analgesics|mesh-ancestor
25649775|NCT01495923|Sensory System Agents|sensory system agents|mesh-ancestor
25649776|NCT01495923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25649777|NCT01495923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649778|NCT01495923|Anticonvulsants|anticonvulsants|mesh-ancestor
25649779|NCT01495923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24847395|NCT02246816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24635178|NCT01137591|Protective Agents|protective agents|mesh-ancestor
25044605|NCT01072981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25044606|NCT01071902|Moxifloxacin|moxifloxacin|mesh-list
25044607|NCT01071902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25154672|NCT05470166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25154673|NCT05470166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25154674|NCT05470166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25154675|NCT05470166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25154676|NCT05470166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25154677|NCT05470166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826718|NCT00005854|Methotrexate|methotrexate|mesh-list
25154687|NCT05469984|Ampicillin|ampicillin|mesh-list
24935103|NCT04054531|Paclitaxel|paclitaxel|mesh-list
24847509|NCT02247414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24847510|NCT02247414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484218|NCT00447031|Hormones|hormones|mesh-ancestor
25064280|NCT03461575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24847550|NCT02247557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24847551|NCT02247557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24847600|NCT02248012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24847601|NCT02248012|Alkylating Agents|alkylating agents|mesh-ancestor
24847602|NCT02248012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847604|NCT02248051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25649780|NCT01495923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25649781|NCT01495923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25649782|NCT01495923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25649783|NCT01495923|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25826719|NCT00005854|Cyclosporins|cyclosporins|mesh-list
24521612|NCT04637529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24521614|NCT04637529|Analgesics|analgesics|mesh-ancestor
24521615|NCT04637529|Sensory System Agents|sensory system agents|mesh-ancestor
24521616|NCT04637529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25826721|NCT00005854|Immunologic Factors|immunologic factors|mesh-ancestor
24919961|NCT04206618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24919963|NCT04206631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24847605|NCT02248129|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24847609|NCT02248129|Natriuretic Agents|natriuretic agents|mesh-ancestor
24847610|NCT02248129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847611|NCT02248129|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24847612|NCT02248129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24847632|NCT02248155|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24847633|NCT02248155|Dopamine Agonists|dopamine agonists|mesh-ancestor
25826722|NCT00005854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635720|NCT01140971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635721|NCT01140971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24453442|NCT05008224|Immunologic Factors|immunologic factors|mesh-ancestor
25826723|NCT00005854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25826724|NCT00005854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24453484|NCT04998669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24453485|NCT04998669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24453486|NCT04996030|Arsenic Trioxide|arsenic trioxide|mesh-list
24453487|NCT04996030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25064458|NCT03460041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24477084|NCT00417157|Ganirelix|ganirelix|mesh-list
24453488|NCT04990232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24453489|NCT04990232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24453490|NCT04982796|Psilocybin|psilocybin|mesh-list
24453491|NCT04982796|Hallucinogens|hallucinogens|mesh-ancestor
24453492|NCT04982796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826725|NCT00005854|Alkylating Agents|alkylating agents|mesh-ancestor
25064492|NCT03459417|Analgesics|analgesics|mesh-ancestor
24847712|NCT02248428|Alkylating Agents|alkylating agents|mesh-ancestor
24484635|NCT00449501|Budesonide|budesonide|mesh-list
24635950|NCT01141998|Micronutrients|micronutrients|mesh-ancestor
24635951|NCT01141998|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24635952|NCT01142011|Belimumab|belimumab|mesh-list
24635953|NCT01142011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24635954|NCT01142011|Immunologic Factors|immunologic factors|mesh-ancestor
24635955|NCT01142011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489958|NCT00476073|Fluticasone|fluticasone|mesh-list
24635956|NCT01142245|Esomeprazole|esomeprazole|mesh-list
24635957|NCT01142245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24635958|NCT01142245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24635959|NCT01142245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24635960|NCT01142245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25005007|NCT05180214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25649784|NCT01495923|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25649785|NCT01495923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25649786|NCT01495923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649787|NCT01495923|Antimanic Agents|antimanic agents|mesh-ancestor
25649788|NCT01496131|Cyclophosphamide|cyclophosphamide|mesh-list
25649789|NCT01496131|Goserelin|goserelin|mesh-list
25649790|NCT01496131|Immunologic Factors|immunologic factors|mesh-ancestor
25649791|NCT01496131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649792|NCT01496131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25649793|NCT01496131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25649794|NCT01496131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25649795|NCT01496131|Alkylating Agents|alkylating agents|mesh-ancestor
25005008|NCT05180214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25005009|NCT05180214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25005010|NCT05180214|Analgesics|analgesics|mesh-ancestor
25005011|NCT05180214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25005012|NCT05180214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25005013|NCT05180214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24908321|NCT04321850|Zinc|zinc|mesh-list
25044627|NCT01071239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24493064|NCT00489372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493285|NCT00490308|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24493286|NCT00490308|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24493287|NCT00490308|Estradiol|estradiol|mesh-list
24493288|NCT00490308|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24493290|NCT00490308|Hormones|hormones|mesh-ancestor
24493291|NCT00490308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24493292|NCT00490308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493293|NCT00490308|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24493326|NCT00490412|Vitamins|vitamins|mesh-ancestor
24847808|NCT05353673|Incretins|incretins|mesh-ancestor
25826726|NCT00005854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826727|NCT00005854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24524985|NCT04140266|Dapivirine|dapivirine|mesh-list
24457627|NCT00334763|Growth Inhibitors|growth inhibitors|mesh-ancestor
24457629|NCT00334789|Tretinoin|tretinoin|mesh-list
24457630|NCT00334789|Belinostat|belinostat|mesh-list
24457631|NCT00334789|Isotretinoin|isotretinoin|mesh-list
24847838|NCT05353335|Antihypertensive Agents|antihypertensive agents|mesh-list
24847839|NCT05353283|Tenofovir|tenofovir|mesh-list
24847840|NCT05353283|Antiviral Agents|antiviral agents|mesh-ancestor
24847841|NCT05353283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24847842|NCT05353283|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24848572|NCT03954379|BB 1101|bb 1101|mesh-list
24847843|NCT05353283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24847844|NCT05353283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24847845|NCT05353283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847846|NCT05353283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24847847|NCT05353283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24636163|NCT01143545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25649796|NCT01496131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649797|NCT01496131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649798|NCT01496131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25649799|NCT01496131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25649800|NCT01496183|Olanzapine|olanzapine|mesh-list
25649801|NCT01496183|Antiemetics|antiemetics|mesh-ancestor
25649802|NCT01496183|Autonomic Agents|autonomic agents|mesh-ancestor
25649803|NCT01496183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24457706|NCT00334932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24847854|NCT05353192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636215|NCT01143974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24636217|NCT01143987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24636218|NCT01143987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636219|NCT01143987|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25064705|NCT03457597|GABA Agents|gaba agents|mesh-ancestor
24509476|NCT00560443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509477|NCT00560443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24509478|NCT00560443|Narcotics|narcotics|mesh-ancestor
25826728|NCT00005854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24509514|NCT00560599|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24636220|NCT01143987|Hormone Antagonists|hormone antagonists|mesh-ancestor
24636221|NCT01143987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24636223|NCT01144000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24512123|NCT00573001|Tenofovir|tenofovir|mesh-list
24636230|NCT01144065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636232|NCT01144091|Pentoxifylline|pentoxifylline|mesh-list
24636233|NCT01144091|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24636234|NCT01144091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826729|NCT00005854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25826730|NCT00005854|Abortifacient Agents|abortifacient agents|mesh-ancestor
25826731|NCT00005854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24453550|NCT04935177|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25826732|NCT00005854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25826733|NCT00005854|Antimetabolites|antimetabolites|mesh-ancestor
25154782|NCT05469204|Acetaminophen|acetaminophen|mesh-list
25154800|NCT05469204|Analgesics|analgesics|mesh-ancestor
24848273|NCT04710030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24637700|NCT01152723|Autonomic Agents|autonomic agents|mesh-ancestor
25154868|NCT05468879|Immunologic Factors|immunologic factors|mesh-ancestor
25154869|NCT05468840|Ketamine|ketamine|mesh-list
25154870|NCT05468840|Analgesics|analgesics|mesh-ancestor
25154871|NCT05468840|Sensory System Agents|sensory system agents|mesh-ancestor
25649804|NCT01496183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199550|NCT02740712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25199551|NCT02740712|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25199552|NCT02740712|Protective Agents|protective agents|mesh-ancestor
25199553|NCT02740712|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25199554|NCT02740712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25044829|NCT01033123|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25826734|NCT00005854|Dermatologic Agents|dermatologic agents|mesh-ancestor
25826735|NCT00005854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25154918|NCT05468645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154922|NCT05468606|Imiquimod|imiquimod|mesh-list
25154923|NCT05468606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25154924|NCT05468606|Immunologic Factors|immunologic factors|mesh-ancestor
25154925|NCT05468606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848366|NCT04553003|Antiemetics|antiemetics|mesh-ancestor
24848367|NCT04553003|Autonomic Agents|autonomic agents|mesh-ancestor
24848368|NCT04553003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24848381|NCT04509336|Baclofen|baclofen|mesh-list
25826736|NCT00005854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25826737|NCT00005854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25826738|NCT00005854|Antifungal Agents|antifungal agents|mesh-ancestor
24486662|NCT00459173|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24848445|NCT04199728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848446|NCT04199728|Incretins|incretins|mesh-ancestor
24848447|NCT04199728|Hormones|hormones|mesh-ancestor
24848448|NCT04199728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24848449|NCT04167813|Ondansetron|ondansetron|mesh-list
24848450|NCT04167813|Antiemetics|antiemetics|mesh-ancestor
25649805|NCT01496183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25649806|NCT01496183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25649807|NCT01496183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25649808|NCT01496183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25649809|NCT01496183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25649810|NCT01496183|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25649811|NCT01496183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25649812|NCT01496183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25649813|NCT01496183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649814|NCT01496183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25649815|NCT01496183|Serotonin Agents|serotonin agents|mesh-ancestor
25649816|NCT01496365|Pregabalin|pregabalin|mesh-list
25649817|NCT01496365|Analgesics|analgesics|mesh-ancestor
25826739|NCT00005854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24848519|NCT03993912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25826742|NCT00005855|Efaproxiral|efaproxiral|mesh-list
24528919|NCT00623376|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24866276|NCT01109004|Dexamethasone|dexamethasone|mesh-list
24528924|NCT00623402|Interferons|interferons|mesh-list
24453788|NCT04790513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529871|NCT00628160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529872|NCT00628160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529873|NCT00628160|Sympathomimetics|sympathomimetics|mesh-ancestor
24529874|NCT00628160|Autonomic Agents|autonomic agents|mesh-ancestor
24529875|NCT00628160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25649818|NCT01496365|Sensory System Agents|sensory system agents|mesh-ancestor
25649819|NCT01496365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25649820|NCT01496365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649821|NCT01496365|Anticonvulsants|anticonvulsants|mesh-ancestor
25649822|NCT01496365|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25649823|NCT01496365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25649824|NCT01496365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656865|NCT01580020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24532201|NCT00638560|Vitamins|vitamins|mesh-list
24532202|NCT00638560|Ascorbic Acid|ascorbic acid|mesh-list
24532203|NCT00638560|Vitamin E|vitamin e|mesh-list
25826743|NCT00005855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24531175|NCT00634400|Candesartan|candesartan|mesh-list
24532784|NCT00641082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24736432|NCT01662089|Zinc|zinc|mesh-list
24788543|NCT01932203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24788544|NCT01932203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24788545|NCT01932203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24788547|NCT01932203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788548|NCT01932203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25005547|NCT03793010|Immunologic Factors|immunologic factors|mesh-ancestor
25005548|NCT03781219|Vemurafenib|vemurafenib|mesh-list
25005549|NCT03781219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005550|NCT03781219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25005551|NCT03781219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457965|NCT00335933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24457966|NCT00335933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848541|NCT03970096|Fludarabine|fludarabine|mesh-list
24848542|NCT03970096|Tacrolimus|tacrolimus|mesh-list
24848543|NCT03970096|Cyclosporins|cyclosporins|mesh-list
24848544|NCT03970096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24848545|NCT03970096|Immunologic Factors|immunologic factors|mesh-ancestor
24848546|NCT03970096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848547|NCT03970096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24848548|NCT03970096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25649825|NCT01496365|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25649826|NCT01496365|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25649827|NCT01496365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25649828|NCT01496365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25649829|NCT01496365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25649830|NCT01496430|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25649831|NCT01496430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25826744|NCT00005855|Alkylating Agents|alkylating agents|mesh-ancestor
25649832|NCT01496430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24608112|NCT02315326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608113|NCT02315326|Dermatologic Agents|dermatologic agents|mesh-ancestor
25826745|NCT00005855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826746|NCT00005855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826747|NCT00005855|Antisickling Agents|antisickling agents|mesh-ancestor
25826748|NCT00005856|Oxaliplatin|oxaliplatin|mesh-list
25826749|NCT00005856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826750|NCT00005857|Docetaxel|docetaxel|mesh-list
25826751|NCT00005857|Trastuzumab|trastuzumab|mesh-list
25826752|NCT00005857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826753|NCT00005857|Tubulin Modulators|tubulin modulators|mesh-ancestor
24458018|NCT00336310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458019|NCT00336336|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24458020|NCT00336336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24449762|NCT00316927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24449764|NCT00316927|Autonomic Agents|autonomic agents|mesh-ancestor
24449765|NCT00316927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24449766|NCT00316927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449769|NCT00316927|Hormones|hormones|mesh-ancestor
25826754|NCT00005857|Antimitotic Agents|antimitotic agents|mesh-ancestor
25826755|NCT00005857|Mitosis Modulators|mitosis modulators|mesh-ancestor
25826756|NCT00005857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826757|NCT00005857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25076055|NCT03376178|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24487473|NCT00463268|Vitamins|vitamins|mesh-ancestor
24487474|NCT00463268|Micronutrients|micronutrients|mesh-ancestor
24458116|NCT00336648|Antiviral Agents|antiviral agents|mesh-ancestor
24458117|NCT00336648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24458118|NCT00336648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458119|NCT00336648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25829555|NCT00006230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829556|NCT00006232|Dexamethasone|dexamethasone|mesh-list
25829557|NCT00006232|Doxorubicin|doxorubicin|mesh-list
25109679|NCT03122353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25829558|NCT00006232|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25829559|NCT00006232|Vincristine|vincristine|mesh-list
24532679|NCT00640796|Analgesics|analgesics|mesh-ancestor
25829560|NCT00006232|Idarubicin|idarubicin|mesh-list
25829561|NCT00006232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25829562|NCT00006232|Antiemetics|antiemetics|mesh-ancestor
25829563|NCT00006232|Autonomic Agents|autonomic agents|mesh-ancestor
25829564|NCT00006232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25829565|NCT00006232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829566|NCT00006232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24848573|NCT03954379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24848574|NCT03954379|Antiemetics|antiemetics|mesh-ancestor
25065332|NCT03451266|Ascorbic Acid|ascorbic acid|mesh-list
25829567|NCT00006232|Glucocorticoids|glucocorticoids|mesh-ancestor
25829568|NCT00006232|Hormones|hormones|mesh-ancestor
25829569|NCT00006232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25829570|NCT00006232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25829571|NCT00006232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829572|NCT00006232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25829573|NCT00006232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25829574|NCT00006232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25829575|NCT00006232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458187|NCT00336947|Antimetabolites|antimetabolites|mesh-ancestor
24458188|NCT00336947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458189|NCT00336947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649833|NCT01496430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649834|NCT01496469|Febuxostat|febuxostat|mesh-list
25649835|NCT01496469|Gout Suppressants|gout suppressants|mesh-ancestor
25649836|NCT01496469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25649837|NCT01496612|Buspirone|buspirone|mesh-list
25649838|NCT01496612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25649839|NCT01496612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25829576|NCT00006232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826760|NCT00005858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702340|NCT01465152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702374|NCT01465503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24702375|NCT01465503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702376|NCT01465503|Antithrombins|antithrombins|mesh-ancestor
24702377|NCT01465503|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24702378|NCT01465503|Protease Inhibitors|protease inhibitors|mesh-ancestor
25005615|NCT03156816|Gout Suppressants|gout suppressants|mesh-ancestor
25005617|NCT03156816|Tubulin Modulators|tubulin modulators|mesh-ancestor
25005618|NCT03156816|Antimitotic Agents|antimitotic agents|mesh-ancestor
25005619|NCT03156816|Mitosis Modulators|mitosis modulators|mesh-ancestor
25005620|NCT03156816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005621|NCT03156816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005622|NCT03141983|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24702650|NCT01467115|Fluorouracil|fluorouracil|mesh-list
24702652|NCT01467115|Epoetin Alfa|epoetin alfa|mesh-list
24702653|NCT01467115|Levoleucovorin|levoleucovorin|mesh-list
24702654|NCT01467115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24702655|NCT01467115|Tubulin Modulators|tubulin modulators|mesh-ancestor
24754265|NCT01719835|Tubulin Modulators|tubulin modulators|mesh-ancestor
25826761|NCT00005859|Tipifarnib|tipifarnib|mesh-list
25826762|NCT00005859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24702656|NCT01467115|Antimitotic Agents|antimitotic agents|mesh-ancestor
24702657|NCT01467115|Mitosis Modulators|mitosis modulators|mesh-ancestor
24702718|NCT01467323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24702719|NCT01467323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702721|NCT01467362|V0034CR|v0034cr|mesh-list
24702722|NCT01467362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24702723|NCT01467362|Emollients|emollients|mesh-ancestor
24702724|NCT01467362|Dermatologic Agents|dermatologic agents|mesh-ancestor
25649840|NCT01496612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25649841|NCT01496612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649842|NCT01496612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25649843|NCT01496612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25649844|NCT01496612|Serotonin Agents|serotonin agents|mesh-ancestor
25649845|NCT01496612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25826763|NCT00005860|Leucovorin|leucovorin|mesh-list
24702755|NCT01467518|Antiviral Agents|antiviral agents|mesh-ancestor
24702756|NCT01467518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24702757|NCT01467531|Dolutegravir|dolutegravir|mesh-list
24702758|NCT01467531|Cabotegravir|cabotegravir|mesh-list
24848600|NCT03910387|Antiviral Agents|antiviral agents|mesh-ancestor
24848601|NCT03910387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24848602|NCT03910387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24848603|NCT03910387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24819531|NCT02095847|Proflavine|proflavine|mesh-list
24703437|NCT01471808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24703439|NCT01471808|Protease Inhibitors|protease inhibitors|mesh-ancestor
24703440|NCT01471808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703506|NCT01471990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826764|NCT00005860|Oxaliplatin|oxaliplatin|mesh-list
25826765|NCT00005860|Floxuridine|floxuridine|mesh-list
24703509|NCT01472016|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24703510|NCT01472016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25237398|NCT02550717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25237399|NCT02550717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25237400|NCT02550717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25237401|NCT02550717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24581046|NCT00864318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25237403|NCT02550717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25237404|NCT02550717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25237406|NCT02550717|Antipyretics|antipyretics|mesh-ancestor
24848604|NCT03910387|Immunologic Factors|immunologic factors|mesh-ancestor
24848605|NCT03910387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848613|NCT03843463|Dexetimide|dexetimide|mesh-list
24848614|NCT03843463|Citalopram|citalopram|mesh-list
24848615|NCT03843463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24848616|NCT03843463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25826766|NCT00005860|Calcium|calcium|mesh-list
25826767|NCT00005860|Levoleucovorin|levoleucovorin|mesh-list
24703852|NCT01475019|Antidepressive Agents|antidepressive agents|mesh-ancestor
24703853|NCT01475019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24703855|NCT01475032|Beclomethasone|beclomethasone|mesh-list
24848617|NCT03843463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24487609|NCT00464191|Citalopram|citalopram|mesh-list
24848643|NCT03838484|Nicotine|nicotine|mesh-list
25154931|NCT05468489|Carboplatin|carboplatin|mesh-list
25154932|NCT05468489|Etoposide|etoposide|mesh-list
25044852|NCT01027013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25044853|NCT01027013|Antioxidants|antioxidants|mesh-ancestor
25044854|NCT01027013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044855|NCT01027013|Protective Agents|protective agents|mesh-ancestor
25044856|NCT01027013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044857|NCT01027013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044858|NCT01025648|Epinephrine|epinephrine|mesh-list
25044859|NCT01025648|Racepinephrine|racepinephrine|mesh-list
25065391|NCT03451045|Dronabinol|dronabinol|mesh-list
25044860|NCT01025648|Epinephryl borate|epinephryl borate|mesh-list
25044861|NCT01025648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24848644|NCT03838484|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24848645|NCT03838484|Autonomic Agents|autonomic agents|mesh-ancestor
24848646|NCT03838484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24848647|NCT03838484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826768|NCT00005860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24704169|NCT01477021|Immunologic Factors|immunologic factors|mesh-ancestor
24704170|NCT01477021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704171|NCT01477021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24704173|NCT01477021|Alkylating Agents|alkylating agents|mesh-ancestor
24848677|NCT03686930|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24848678|NCT03670966|Vidarabine|vidarabine|mesh-list
24848679|NCT03670966|Mycophenolic Acid|mycophenolic acid|mesh-list
24848680|NCT03670966|Cyclophosphamide|cyclophosphamide|mesh-list
24848681|NCT03670966|Fludarabine|fludarabine|mesh-list
24704246|NCT01477268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24704247|NCT01477268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704248|NCT01477268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24848700|NCT03670966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24848701|NCT03670966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24848702|NCT03670966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24848703|NCT03670966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24848704|NCT03670966|Antitubercular Agents|antitubercular agents|mesh-ancestor
24848705|NCT03670966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24848706|NCT03670966|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24848707|NCT03637972|Nicotine|nicotine|mesh-list
24848708|NCT03637972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24581037|NCT00864305|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24581038|NCT00864305|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24581039|NCT00864305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581040|NCT00864305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581041|NCT00864305|Antimanic Agents|antimanic agents|mesh-ancestor
24581043|NCT00864318|Etoposide|etoposide|mesh-list
24581044|NCT00864318|Ifosfamide|ifosfamide|mesh-list
24581045|NCT00864318|Carboplatin|carboplatin|mesh-list
24848709|NCT03637972|Autonomic Agents|autonomic agents|mesh-ancestor
24848713|NCT03637972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25154933|NCT05468489|Etoposide phosphate|etoposide phosphate|mesh-list
24915413|NCT02631941|Budesonide|budesonide|mesh-list
24705329|NCT01484184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826769|NCT00005860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705461|NCT01485211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705462|NCT01485211|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24705463|NCT01485211|Dermatologic Agents|dermatologic agents|mesh-ancestor
24581047|NCT00864318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24581048|NCT00864318|Tubulin Modulators|tubulin modulators|mesh-ancestor
24581050|NCT00864318|Mitosis Modulators|mitosis modulators|mesh-ancestor
24581051|NCT00864318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581052|NCT00864318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25826770|NCT00005860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826771|NCT00005860|Antidotes|antidotes|mesh-ancestor
25826772|NCT00005860|Protective Agents|protective agents|mesh-ancestor
25826773|NCT00005860|Vitamin B Complex|vitamin b complex|mesh-ancestor
24487942|NCT00465907|Irinotecan|irinotecan|mesh-list
25826774|NCT00005860|Vitamins|vitamins|mesh-ancestor
24849564|NCT02249039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24848805|NCT03466151|Antifungal Agents|antifungal agents|mesh-ancestor
24848806|NCT03466151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24848807|NCT03466151|Immunologic Factors|immunologic factors|mesh-ancestor
25649846|NCT01496612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649847|NCT01496807|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25649848|NCT01496807|Ipilimumab|ipilimumab|mesh-list
25649849|NCT01496807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25649850|NCT01496807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24849175|NCT02506959|Immunologic Factors|immunologic factors|mesh-ancestor
24849176|NCT02506959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849177|NCT02506959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24849178|NCT02506959|Alkylating Agents|alkylating agents|mesh-ancestor
24453976|NCT04602377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24488592|NCT00469443|Antimetabolites|antimetabolites|mesh-ancestor
24849195|NCT02185417|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24849264|NCT01659606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24849265|NCT01659606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849266|NCT01659606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24849267|NCT01659606|Immunologic Factors|immunologic factors|mesh-ancestor
24709571|NCT01506167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24709572|NCT01506167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24709573|NCT01506167|Immunologic Factors|immunologic factors|mesh-ancestor
24709592|NCT01506336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709593|NCT01506388|Misoprostol|misoprostol|mesh-list
24709594|NCT01506388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24709595|NCT01506388|Abortifacient Agents|abortifacient agents|mesh-ancestor
25826777|NCT00005860|Antimetabolites|antimetabolites|mesh-ancestor
25826778|NCT00005860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826779|NCT00005861|Doxorubicin|doxorubicin|mesh-list
24849341|NCT00652574|Dasatinib|dasatinib|mesh-list
24849342|NCT00652574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24849343|NCT00652574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24849344|NCT00652574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849345|NCT00652574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849346|NCT00559936|Bevacizumab|bevacizumab|mesh-list
25826780|NCT00005861|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24849457|NCT02248753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24849458|NCT02248753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849459|NCT02248753|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24849460|NCT02248753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849461|NCT02248753|Protective Agents|protective agents|mesh-ancestor
24849462|NCT02248753|Vasodilator Agents|vasodilator agents|mesh-ancestor
24489493|NCT00473551|Antifungal Agents|antifungal agents|mesh-ancestor
24849467|NCT02248753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24849468|NCT02248753|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24849477|NCT02248792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24849478|NCT02248792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849479|NCT02248792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24849480|NCT02248792|Antimetabolites|antimetabolites|mesh-ancestor
24849481|NCT02248792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066447|NCT03205605|Renal Agents|renal agents|mesh-ancestor
24710618|NCT01511237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24710619|NCT01511237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24710620|NCT01511237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24849482|NCT02248792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24849483|NCT02248792|Dermatologic Agents|dermatologic agents|mesh-ancestor
24849484|NCT02248792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849485|NCT02248792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24849486|NCT02248792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24849487|NCT02248792|Immunologic Factors|immunologic factors|mesh-ancestor
24849488|NCT02248792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24849489|NCT02248792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24849490|NCT02248844|Botulinum Toxins|botulinum toxins|mesh-list
24849491|NCT02248844|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24849492|NCT02248844|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24849505|NCT02248870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24849509|NCT02248870|Hormones|hormones|mesh-ancestor
24849545|NCT02249026|Opiate Alkaloids|opiate alkaloids|mesh-list
24849546|NCT02249026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24849547|NCT02249026|Narcotics|narcotics|mesh-ancestor
24849548|NCT02249026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24849549|NCT02249026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849550|NCT02249026|Analgesics|analgesics|mesh-ancestor
24849551|NCT02249026|Sensory System Agents|sensory system agents|mesh-ancestor
24849552|NCT02249026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24849553|NCT02249026|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24849554|NCT02249039|Clonidine|clonidine|mesh-list
24849563|NCT02249039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24849584|NCT02249130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24849585|NCT02249130|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24849586|NCT02249130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24849587|NCT02249130|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24849588|NCT02249130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24711103|NCT01513564|Narcotics|narcotics|mesh-ancestor
25045030|NCT01005108|Antimanic Agents|antimanic agents|mesh-ancestor
25005876|NCT01816165|Acipimox|acipimox|mesh-list
25005877|NCT01816165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25005878|NCT01816165|Antimetabolites|antimetabolites|mesh-ancestor
25005879|NCT01816165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005880|NCT01816165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25005881|NCT01813929|Metformin|metformin|mesh-list
25005882|NCT01813929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25005883|NCT01813929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005884|NCT01693783|Ipilimumab|ipilimumab|mesh-list
25005885|NCT01693783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25005886|NCT01693783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005887|NCT01693783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25005890|NCT01502085|Vorinostat|vorinostat|mesh-list
25826781|NCT00005861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24849694|NCT02249702|Antiviral Agents|antiviral agents|mesh-ancestor
24849695|NCT02249702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24849696|NCT02249702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849697|NCT02249702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25826782|NCT00005861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24849699|NCT02249702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849700|NCT02249702|Tubulin Modulators|tubulin modulators|mesh-ancestor
24712872|NCT01523054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24712873|NCT01523054|Sympatholytics|sympatholytics|mesh-ancestor
25826783|NCT00005861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25826784|NCT00005861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25826785|NCT00005861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24713188|NCT01524575|Immunologic Factors|immunologic factors|mesh-ancestor
24713542|NCT01526499|Docetaxel|docetaxel|mesh-list
24849704|NCT02249702|Alkylating Agents|alkylating agents|mesh-ancestor
25826786|NCT00005861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826787|NCT00005862|Semaxinib|semaxinib|mesh-list
25045099|NCT01001091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045101|NCT01000922|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25045102|NCT01000922|Insulin Glargine|insulin glargine|mesh-list
25045103|NCT01000922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25045104|NCT01000922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045105|NCT00994292|Darexaban|darexaban|mesh-list
25045106|NCT00994292|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25045107|NCT00994292|Antithrombins|antithrombins|mesh-ancestor
24715540|NCT01537055|Renal Agents|renal agents|mesh-ancestor
25045112|NCT00994292|Anticoagulants|anticoagulants|mesh-ancestor
25045113|NCT00993382|Amiodarone|amiodarone|mesh-list
25045114|NCT00993382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25045115|NCT00993382|Vasodilator Agents|vasodilator agents|mesh-ancestor
25045116|NCT00993382|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25045117|NCT00993382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25045118|NCT00993382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045119|NCT00993382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25045120|NCT00993382|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25045122|NCT00993382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25077421|NCT03364842|Furosemide|furosemide|mesh-list
24849727|NCT02249910|Digoxin|digoxin|mesh-list
25006007|NCT05206721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25006026|NCT05206448|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25006027|NCT05206448|Fertility Agents|fertility agents|mesh-ancestor
25155181|NCT05444556|Repaglinide|repaglinide|mesh-list
25155182|NCT05444556|Quinidine|quinidine|mesh-list
25155183|NCT05444556|Digoxin|digoxin|mesh-list
25155184|NCT05444556|Dextromethorphan|dextromethorphan|mesh-list
25155185|NCT05444556|Omeprazole|omeprazole|mesh-list
25155186|NCT05444556|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25155187|NCT05444556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25155188|NCT05444556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25155200|NCT05444556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155201|NCT05444556|Antitussive Agents|antitussive agents|mesh-ancestor
25155202|NCT05444556|Respiratory System Agents|respiratory system agents|mesh-ancestor
25155203|NCT05444556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25155204|NCT05444556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25155205|NCT05444556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25155206|NCT05444556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24849728|NCT02249910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24849729|NCT02249910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715886|NCT01538875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715924|NCT01539031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24715925|NCT01539031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715926|NCT01539031|Nootropic Agents|nootropic agents|mesh-ancestor
24715959|NCT01539174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715960|NCT01539174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715961|NCT01539174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24716189|NCT01540500|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24716190|NCT01540500|Antidepressive Agents|antidepressive agents|mesh-ancestor
24716191|NCT01540500|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24615026|NCT01027494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24642296|NCT01178710|Simvastatin|simvastatin|mesh-list
25006045|NCT05206175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25006046|NCT05206175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25006047|NCT05206175|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25006048|NCT05205837|Letrozole|letrozole|mesh-list
25006049|NCT05205837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006050|NCT05205837|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25006051|NCT05205837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24454132|NCT04392531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24454133|NCT04392531|Dermatologic Agents|dermatologic agents|mesh-ancestor
24454134|NCT04392531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24454135|NCT04392531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25006083|NCT05205603|Mesalamine|mesalamine|mesh-list
24615070|NCT01027689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24615071|NCT01027689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24716423|NCT01541475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24450315|NCT00318760|Clonidine|clonidine|mesh-list
25826788|NCT00005862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24716485|NCT01541943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24503106|NCT03283566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24849747|NCT02250118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849748|NCT02250118|Growth Inhibitors|growth inhibitors|mesh-ancestor
24849750|NCT02250209|Oxaliplatin|oxaliplatin|mesh-list
24849751|NCT02250209|Trastuzumab|trastuzumab|mesh-list
24849752|NCT02250209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24849753|NCT02250209|Antimetabolites|antimetabolites|mesh-ancestor
24849754|NCT02250209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716544|NCT01542268|Pentoxifylline|pentoxifylline|mesh-list
24716545|NCT01542268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24716546|NCT01542268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716547|NCT01542268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716548|NCT01542268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24716549|NCT01542268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24716550|NCT01542268|Protective Agents|protective agents|mesh-ancestor
24716580|NCT01542463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826795|NCT00005862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826796|NCT00005862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826797|NCT00005863|Cytarabine|cytarabine|mesh-list
25077548|NCT03363841|Ibrexafungerp|ibrexafungerp|mesh-list
25826798|NCT00005863|Fludarabine|fludarabine|mesh-list
25826799|NCT00005863|Fludarabine phosphate|fludarabine phosphate|mesh-list
25826800|NCT00005863|Etoposide|etoposide|mesh-list
25826801|NCT00005863|Daunorubicin|daunorubicin|mesh-list
25826802|NCT00005863|Tretinoin|tretinoin|mesh-list
25067117|NCT03446937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615214|NCT01028443|Antifungal Agents|antifungal agents|mesh-ancestor
24615215|NCT01028443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24615216|NCT01028443|Dermatologic Agents|dermatologic agents|mesh-ancestor
24615217|NCT01028443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718381|NCT01554631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718382|NCT01554631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24758565|NCT01746823|Cyclosporine|cyclosporine|mesh-list
24758566|NCT01746823|Cyclosporins|cyclosporins|mesh-list
24758567|NCT01746823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758568|NCT01746823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758569|NCT01746823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24758570|NCT01746823|Immunologic Factors|immunologic factors|mesh-ancestor
24758571|NCT01746823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849786|NCT02250599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25826803|NCT00005863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006227|NCT05204056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25006229|NCT05204056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25006230|NCT05204056|Respiratory System Agents|respiratory system agents|mesh-ancestor
25155207|NCT05444556|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25045126|NCT00992732|Valganciclovir|valganciclovir|mesh-list
25067173|NCT03446547|Durvalumab|durvalumab|mesh-list
25067181|NCT03446495|Alkylating Agents|alkylating agents|mesh-ancestor
24720405|NCT01568281|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24849841|NCT02250820|GABA Modulators|gaba modulators|mesh-ancestor
24849842|NCT02250820|GABA Agents|gaba agents|mesh-ancestor
25826804|NCT00005863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24811988|NCT02049190|Onapristone|onapristone|mesh-list
24811989|NCT02049190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24811990|NCT02049190|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24811998|NCT02049203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812000|NCT02049229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24444167|NCT00296868|Vitamins|vitamins|mesh-ancestor
24444168|NCT00296868|Micronutrients|micronutrients|mesh-ancestor
24444169|NCT00296868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444170|NCT00296868|Antioxidants|antioxidants|mesh-ancestor
25826806|NCT00005863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826807|NCT00005863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25826808|NCT00005863|Immunologic Factors|immunologic factors|mesh-ancestor
25826809|NCT00005863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826810|NCT00005863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25826811|NCT00005863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25826812|NCT00005863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25826813|NCT00005863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849877|NCT02251041|Infliximab|infliximab|mesh-list
25239845|NCT02539316|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24829963|NCT02155777|Norinyl|norinyl|mesh-list
25826814|NCT00005863|Antiviral Agents|antiviral agents|mesh-ancestor
25077959|NCT03360279|Paclitaxel|paclitaxel|mesh-list
25826815|NCT00005863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25826816|NCT00005863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25826817|NCT00005863|Keratolytic Agents|keratolytic agents|mesh-ancestor
24849886|NCT02251041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849887|NCT02251041|Protective Agents|protective agents|mesh-ancestor
24859050|NCT02301494|Fluocinonide|fluocinonide|mesh-list
24444256|NCT00297206|Antiviral Agents|antiviral agents|mesh-ancestor
24444257|NCT00297206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24444258|NCT00297219|Calcium, Dietary|calcium, dietary|mesh-list
24444259|NCT00297219|Dialysis Solutions|dialysis solutions|mesh-list
25826818|NCT00005863|Dermatologic Agents|dermatologic agents|mesh-ancestor
25826819|NCT00005864|Sulfanilamides|sulfanilamides|mesh-list
24722957|NCT01583660|Antipyretics|antipyretics|mesh-ancestor
25826820|NCT00005864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25826821|NCT00005865|Vinorelbine|vinorelbine|mesh-list
25045152|NCT00991068|Anesthetics|anesthetics|mesh-ancestor
25826822|NCT00005865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24444324|NCT00297466|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24444325|NCT00297466|Cholinergic Agents|cholinergic agents|mesh-ancestor
24444326|NCT00297466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25826823|NCT00005865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24444387|NCT00297739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25826824|NCT00005865|Tubulin Modulators|tubulin modulators|mesh-ancestor
24444459|NCT00298025|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24444460|NCT00298025|Ganirelix|ganirelix|mesh-list
24444461|NCT00298025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24444462|NCT00298025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849980|NCT02251171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24849981|NCT02251171|Antiviral Agents|antiviral agents|mesh-ancestor
24849982|NCT02251171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25826825|NCT00005865|Antimitotic Agents|antimitotic agents|mesh-ancestor
25826826|NCT00005865|Mitosis Modulators|mitosis modulators|mesh-ancestor
25826827|NCT00005865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826828|NCT00005866|Cyclosporine|cyclosporine|mesh-list
25826829|NCT00005866|Cyclophosphamide|cyclophosphamide|mesh-list
25826830|NCT00005866|Busulfan|busulfan|mesh-list
25826831|NCT00005866|Methotrexate|methotrexate|mesh-list
25826832|NCT00005866|Cyclosporins|cyclosporins|mesh-list
24492299|NCT00485862|Sertraline|sertraline|mesh-list
24725184|NCT01596673|Sensory System Agents|sensory system agents|mesh-ancestor
24725185|NCT01596673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24512839|NCT00577109|Leucovorin|leucovorin|mesh-list
24725186|NCT01596673|Antitussive Agents|antitussive agents|mesh-ancestor
24725188|NCT01596686|Picosulfate sodium|picosulfate sodium|mesh-list
25826833|NCT00005866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24850002|NCT02251184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24644165|NCT01189526|Growth Inhibitors|growth inhibitors|mesh-ancestor
25826835|NCT00005866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850025|NCT02251223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25826836|NCT00005866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24492619|NCT00487032|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24492620|NCT00487032|Protective Agents|protective agents|mesh-ancestor
24444636|NCT00298675|Iniparib|iniparib|mesh-list
25826837|NCT00005866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25068056|NCT03436836|Sensory System Agents|sensory system agents|mesh-ancestor
24727154|NCT01608334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24727155|NCT01608334|Narcotics|narcotics|mesh-ancestor
24727156|NCT01608334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24727157|NCT01608334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727158|NCT01608334|Analgesics|analgesics|mesh-ancestor
25826838|NCT00005866|Alkylating Agents|alkylating agents|mesh-ancestor
24850053|NCT02251509|Carvedilol|carvedilol|mesh-list
24850054|NCT02251509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24850055|NCT02251509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25006554|NCT04892420|Hormones|hormones|mesh-ancestor
24850060|NCT02251509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24850061|NCT02251509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24850168|NCT02251964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24850169|NCT02251977|Leucovorin|leucovorin|mesh-list
24850170|NCT02251977|Fluorouracil|fluorouracil|mesh-list
25826839|NCT00005866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826840|NCT00005866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826841|NCT00005866|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25826842|NCT00005866|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25826843|NCT00005866|Abortifacient Agents|abortifacient agents|mesh-ancestor
25826844|NCT00005866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25826845|NCT00005866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25826846|NCT00005866|Antimetabolites|antimetabolites|mesh-ancestor
24850276|NCT02252523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24729865|NCT01624207|Antimetabolites|antimetabolites|mesh-ancestor
24730290|NCT01627262|Analgesics|analgesics|mesh-ancestor
25826847|NCT00005866|Dermatologic Agents|dermatologic agents|mesh-ancestor
24730942|NCT01631396|Neostigmine|neostigmine|mesh-list
24730943|NCT01631396|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24730944|NCT01631396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444736|NCT00299013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24444737|NCT00299013|Antiemetics|antiemetics|mesh-ancestor
24850525|NCT02253420|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24850526|NCT02253420|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24646971|NCT01205932|Enoxaparin|enoxaparin|mesh-list
25826848|NCT00005866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826849|NCT00005866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24732530|NCT01640002|Anticonvulsants|anticonvulsants|mesh-ancestor
24732766|NCT01641406|Bevacizumab|bevacizumab|mesh-list
24617279|NCT01042041|Doxorubicin|doxorubicin|mesh-list
24850662|NCT02253849|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24850663|NCT02253849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24850664|NCT02253862|Ritonavir|ritonavir|mesh-list
25068368|NCT03434106|Dextrans|dextrans|mesh-list
24850675|NCT02253862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24850676|NCT02253862|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24850677|NCT02253862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24850678|NCT02253862|Vasodilator Agents|vasodilator agents|mesh-ancestor
24850679|NCT02253862|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24850684|NCT02253875|Omeprazole|omeprazole|mesh-list
24493482|NCT00491114|Antimetabolites|antimetabolites|mesh-ancestor
25649851|NCT01496807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25649852|NCT01496807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649853|NCT01496807|Antiviral Agents|antiviral agents|mesh-ancestor
25649854|NCT01496807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25649855|NCT01496846|Lidocaine|lidocaine|mesh-list
25649856|NCT01496846|Carticaine|carticaine|mesh-list
25649857|NCT01496846|Anesthetics, Local|anesthetics, local|mesh-ancestor
25649858|NCT01496846|Anesthetics|anesthetics|mesh-ancestor
25649859|NCT01496846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25199599|NCT02739880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199600|NCT02739880|Viscosupplements|viscosupplements|mesh-ancestor
25199601|NCT02739880|Protective Agents|protective agents|mesh-ancestor
25826850|NCT00005866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25826851|NCT00005866|Antifungal Agents|antifungal agents|mesh-ancestor
24493523|NCT00491192|Diclofenac|diclofenac|mesh-list
24850758|NCT02253940|Antiviral Agents|antiviral agents|mesh-ancestor
24850759|NCT02253940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24735656|NCT01657513|Etanercept|etanercept|mesh-list
24850770|NCT02253953|Antiviral Agents|antiviral agents|mesh-ancestor
24850790|NCT02253966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25826852|NCT00005866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24739352|NCT01680718|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24739353|NCT01680718|Natriuretic Agents|natriuretic agents|mesh-ancestor
24739518|NCT01682161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25826853|NCT00005866|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25826854|NCT00005867|Prednisolone|prednisolone|mesh-list
24739968|NCT01685489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739969|NCT01685489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24740064|NCT01686217|Niacinamide|niacinamide|mesh-list
25240979|NCT04342585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25240980|NCT04342585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240981|NCT04240626|Acetaminophen|acetaminophen|mesh-list
24742827|NCT05150795|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24742828|NCT05150795|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24742829|NCT05150795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24532292|NCT00639015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24742856|NCT05146778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24742857|NCT05146778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24742858|NCT05146778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24742859|NCT05146778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24742861|NCT05146778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25241017|NCT04240626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25241018|NCT04240626|Cholinergic Agents|cholinergic agents|mesh-ancestor
25241024|NCT04240626|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24493984|NCT00493233|Antiemetics|antiemetics|mesh-ancestor
24743566|NCT04750967|Antidepressive Agents|antidepressive agents|mesh-ancestor
24743567|NCT04750967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24743568|NCT04750967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24743569|NCT04750967|Analgesics|analgesics|mesh-ancestor
24743570|NCT04750967|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24743572|NCT04750967|Adrenergic Agents|adrenergic agents|mesh-ancestor
24744010|NCT04540133|BB 1101|bb 1101|mesh-list
24744011|NCT04540133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24744012|NCT04540133|Antiemetics|antiemetics|mesh-ancestor
24850979|NCT02254759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24850980|NCT02254759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25078210|NCT03358212|Denosumab|denosumab|mesh-list
24850982|NCT02254759|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24494160|NCT00494104|Vitamins|vitamins|mesh-ancestor
24745839|NCT03573115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24494197|NCT00494312|Glyburide|glyburide|mesh-list
24683331|NCT01391377|Niacin|niacin|mesh-list
24789957|NCT01939743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24789958|NCT01939743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24789959|NCT01939743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25006925|NCT04502381|Amphotericin B|amphotericin b|mesh-list
25006926|NCT04502381|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25006927|NCT04502381|Deoxycholic Acid|deoxycholic acid|mesh-list
25006928|NCT04502381|Amebicides|amebicides|mesh-ancestor
25006929|NCT04502381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25006930|NCT04502381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25649860|NCT01496846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649861|NCT01496846|Sensory System Agents|sensory system agents|mesh-ancestor
25649862|NCT01496846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25649863|NCT01496846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25649864|NCT01496846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25649865|NCT01496846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25649866|NCT01496846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25649867|NCT01496846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649868|NCT01497197|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25649869|NCT01497197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25649870|NCT01497197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649871|NCT01497262|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25649872|NCT01497262|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25656866|NCT01580020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675255|NCT02250157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675267|NCT01547117|Carbon Monoxide|carbon monoxide|mesh-list
24675268|NCT01547117|Antimetabolites|antimetabolites|mesh-ancestor
24675269|NCT01547117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675270|NCT01547117|Gasotransmitters|gasotransmitters|mesh-ancestor
25826855|NCT00005867|Cyclophosphamide|cyclophosphamide|mesh-list
25826856|NCT00005867|Doxorubicin|doxorubicin|mesh-list
24748370|NCT02678572|Immunologic Factors|immunologic factors|mesh-ancestor
24748371|NCT02678572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748715|NCT02204241|Immunologic Factors|immunologic factors|mesh-ancestor
24748716|NCT02204241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748717|NCT02204241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24748752|NCT02168829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24748753|NCT02168829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24748754|NCT02168829|Analgesics|analgesics|mesh-ancestor
24748755|NCT02168829|Sensory System Agents|sensory system agents|mesh-ancestor
24748756|NCT02168829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24413140|NCT00193167|Topotecan|topotecan|mesh-list
24748791|NCT02162563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24748792|NCT02162563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24748793|NCT02162563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24748794|NCT02162563|Antidotes|antidotes|mesh-ancestor
24748795|NCT02162563|Protective Agents|protective agents|mesh-ancestor
24748796|NCT02162563|Vitamin B Complex|vitamin b complex|mesh-ancestor
24748797|NCT02162563|Vitamins|vitamins|mesh-ancestor
24748798|NCT02162563|Micronutrients|micronutrients|mesh-ancestor
24413175|NCT00193271|Docetaxel|docetaxel|mesh-list
25826857|NCT00005867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25068656|NCT03432572|Vitamins|vitamins|mesh-ancestor
24748898|NCT01996267|Paclitaxel|paclitaxel|mesh-list
24748899|NCT01996267|Cyclophosphamide|cyclophosphamide|mesh-list
24748900|NCT01996267|Carboplatin|carboplatin|mesh-list
24748901|NCT01996267|Fluorouracil|fluorouracil|mesh-list
24748902|NCT01996267|Trastuzumab|trastuzumab|mesh-list
24748903|NCT01996267|Pertuzumab|pertuzumab|mesh-list
24748904|NCT01996267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24749103|NCT01741103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749104|NCT01722331|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24749105|NCT01722331|Immunologic Factors|immunologic factors|mesh-ancestor
24749106|NCT01722331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749107|NCT01716117|Calcium Carbonate|calcium carbonate|mesh-list
24749108|NCT01716117|Antacids|antacids|mesh-ancestor
24749146|NCT01630590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24462981|NCT00358293|Tizanidine|tizanidine|mesh-list
25068679|NCT03432273|Nicotine|nicotine|mesh-list
24749953|NCT01695109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749954|NCT01695109|Incretins|incretins|mesh-ancestor
24749956|NCT01695109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24749957|NCT01695122|Valproic Acid|valproic acid|mesh-list
24749958|NCT01695122|Anticonvulsants|anticonvulsants|mesh-ancestor
24749959|NCT01695122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24749960|NCT01695122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749961|NCT01695122|GABA Agents|gaba agents|mesh-ancestor
24749962|NCT01695122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24494338|NCT00494897|Daunorubicin|daunorubicin|mesh-list
24750441|NCT01698593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24750443|NCT01698593|Adrenergic Agents|adrenergic agents|mesh-ancestor
24750444|NCT01698593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24750445|NCT01698593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750446|NCT01698593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24750447|NCT01698593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24750448|NCT01698593|Autonomic Agents|autonomic agents|mesh-ancestor
24750449|NCT01698593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24750450|NCT01698593|Respiratory System Agents|respiratory system agents|mesh-ancestor
24750451|NCT01698593|Mydriatics|mydriatics|mesh-ancestor
24750521|NCT01699204|Acetylcysteine|acetylcysteine|mesh-list
25068698|NCT03432195|Donepezil|donepezil|mesh-list
24619016|NCT01050478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24619017|NCT01050478|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24619018|NCT01050478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25649873|NCT01497262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649874|NCT01497262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25649875|NCT01497262|Immunologic Factors|immunologic factors|mesh-ancestor
25649876|NCT01497262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649877|NCT01497275|Rituximab|rituximab|mesh-list
24619019|NCT01050478|Serotonin Agents|serotonin agents|mesh-ancestor
25649878|NCT01497275|Bortezomib|bortezomib|mesh-list
25649879|NCT01497275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24750639|NCT01699802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619041|NCT01050517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751083|NCT01701921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751084|NCT01701921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24751120|NCT01702129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24751122|NCT01702181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25826858|NCT00005867|Etoposide|etoposide|mesh-list
25826859|NCT00005867|Vincristine|vincristine|mesh-list
25826860|NCT00005867|Mitoxantrone|mitoxantrone|mesh-list
24619069|NCT01050699|Fentanyl|fentanyl|mesh-list
25826861|NCT00005867|Bleomycin|bleomycin|mesh-list
24444839|NCT00299286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24789999|NCT01940081|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24790000|NCT01940081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24790001|NCT01940081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24790003|NCT01940081|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24619140|NCT01051011|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24619141|NCT01051011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24619142|NCT01051011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619143|NCT01051011|Incretins|incretins|mesh-ancestor
24619144|NCT01051011|Hormones|hormones|mesh-ancestor
24619145|NCT01051011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24619146|NCT01051102|Insulin|insulin|mesh-list
24619147|NCT01051102|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24752024|NCT01707823|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25826862|NCT00005867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25826863|NCT00005867|Immunologic Factors|immunologic factors|mesh-ancestor
25826864|NCT00005867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826865|NCT00005867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25826866|NCT00005867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25826867|NCT00005867|Alkylating Agents|alkylating agents|mesh-ancestor
25826868|NCT00005867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068755|NCT03431909|Antimetabolites|antimetabolites|mesh-ancestor
24753992|NCT01718626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754028|NCT01718808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25826869|NCT00005867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826870|NCT00005867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24851104|NCT02255370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851105|NCT02255370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24494457|NCT00495326|Isoniazid|isoniazid|mesh-list
25826871|NCT00005867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25826872|NCT00005867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25826873|NCT00005867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25826874|NCT00005867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756096|NCT01731158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756098|NCT01731158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25273983|NCT02381548|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25273984|NCT02381249|Octreotide|octreotide|mesh-list
25273985|NCT02381249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24494471|NCT00495326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25241379|NCT02864407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241380|NCT02846532|Aspirin|aspirin|mesh-list
25241381|NCT02846532|Rivaroxaban|rivaroxaban|mesh-list
25241382|NCT02846532|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25241383|NCT02846532|Antithrombins|antithrombins|mesh-ancestor
25241384|NCT02846532|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25241386|NCT02846532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25241387|NCT02846532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241388|NCT02846532|Anticoagulants|anticoagulants|mesh-ancestor
25241389|NCT02846532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25241390|NCT02846532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25241391|NCT02846532|Analgesics|analgesics|mesh-ancestor
25241392|NCT02846532|Sensory System Agents|sensory system agents|mesh-ancestor
25241393|NCT02846532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25241394|NCT02846532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241395|NCT02846532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25241396|NCT02846532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25241397|NCT02846532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25826875|NCT00005867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24851166|NCT02255747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24851167|NCT02255812|Quinine|quinine|mesh-list
24851168|NCT02255812|Citric Acid|citric acid|mesh-list
24851169|NCT02255812|Sodium Citrate|sodium citrate|mesh-list
24851170|NCT02255812|Antimalarials|antimalarials|mesh-ancestor
25068856|NCT03431285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757009|NCT01737177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24757010|NCT01737177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24757011|NCT01737177|Growth Substances|growth substances|mesh-ancestor
24757031|NCT01737294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757032|NCT01737307|Fluorides|fluorides|mesh-list
24757033|NCT01737307|Fluorides, Topical|fluorides, topical|mesh-list
24757034|NCT01737307|Cariostatic Agents|cariostatic agents|mesh-ancestor
24757035|NCT01737307|Protective Agents|protective agents|mesh-ancestor
24757036|NCT01737307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757037|NCT01737320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24790110|NCT01940952|Nootropic Agents|nootropic agents|mesh-ancestor
24790111|NCT01940952|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24790112|NCT01940952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25826876|NCT00005867|Tubulin Modulators|tubulin modulators|mesh-ancestor
25826877|NCT00005867|Antimitotic Agents|antimitotic agents|mesh-ancestor
25826878|NCT00005867|Mitosis Modulators|mitosis modulators|mesh-ancestor
25826879|NCT00005867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25826880|NCT00005867|Glucocorticoids|glucocorticoids|mesh-ancestor
24444841|NCT00299286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494616|NCT00496158|Adefovir|adefovir|mesh-list
24444842|NCT00299351|Romidepsin|romidepsin|mesh-list
25241476|NCT01751126|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25273992|NCT02381314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273993|NCT02381275|Tenofovir|tenofovir|mesh-list
25273994|NCT02381275|Antiviral Agents|antiviral agents|mesh-ancestor
25273995|NCT02381275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25273996|NCT02381275|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25273997|NCT02381275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25155266|NCT05431595|Haloperidol|haloperidol|mesh-list
25826881|NCT00005867|Hormones|hormones|mesh-ancestor
25241483|NCT01307306|Metformin|metformin|mesh-list
25241484|NCT01307306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25241485|NCT01307306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241486|NCT01299753|Propranolol|propranolol|mesh-list
25241487|NCT01299753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24937606|NCT04027179|Chlorhexidine|chlorhexidine|mesh-list
25241488|NCT01299753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25241489|NCT01299753|Adrenergic Agents|adrenergic agents|mesh-ancestor
25241490|NCT01299753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25241491|NCT01299753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241492|NCT01299753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241493|NCT01299753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25241494|NCT01299753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25241495|NCT01299753|Vasodilator Agents|vasodilator agents|mesh-ancestor
25241496|NCT01190228|Vaccines|vaccines|mesh-list
25241497|NCT01190228|Immunologic Factors|immunologic factors|mesh-ancestor
25241498|NCT01190228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241499|NCT01049035|Vaccines|vaccines|mesh-list
25241500|NCT01049035|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25241501|NCT01049035|Immunologic Factors|immunologic factors|mesh-ancestor
25241502|NCT01049035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241503|NCT00859781|Ketoconazole|ketoconazole|mesh-list
25241504|NCT00859781|Hydrocortisone|hydrocortisone|mesh-list
25241505|NCT00859781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25241517|NCT00727090|Conivaptan|conivaptan|mesh-list
25826882|NCT00005867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25826883|NCT00005867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24812229|NCT02050672|Inositol|inositol|mesh-list
25045175|NCT00990327|Vasodilator Agents|vasodilator agents|mesh-ancestor
25045176|NCT00990327|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25155274|NCT05431595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25155292|NCT05426395|Vitamin B 12|vitamin b 12|mesh-list
25155293|NCT05426395|Vitamin B Complex|vitamin b complex|mesh-list
25155294|NCT05426395|Micronutrients|micronutrients|mesh-ancestor
25155295|NCT05426395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155296|NCT05426395|Hematinics|hematinics|mesh-ancestor
25155297|NCT05426161|Botulinum Toxins|botulinum toxins|mesh-list
25155298|NCT05426161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25155299|NCT05426161|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25155300|NCT05426161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25155301|NCT05426161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25155302|NCT05426161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25155303|NCT05426161|Cholinergic Agents|cholinergic agents|mesh-ancestor
25155304|NCT05426161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25045179|NCT00990327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25826884|NCT00005867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24444855|NCT00299364|Hormones|hormones|mesh-ancestor
24437085|NCT00272636|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24437086|NCT00272636|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25826885|NCT00005867|Analgesics|analgesics|mesh-ancestor
25826886|NCT00005867|Sensory System Agents|sensory system agents|mesh-ancestor
25826887|NCT00005868|Cisplatin|cisplatin|mesh-list
25826888|NCT00005868|Docetaxel|docetaxel|mesh-list
25069826|NCT03423849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24437697|NCT00274170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24437698|NCT00274235|Pyrimethamine|pyrimethamine|mesh-list
24437699|NCT00274235|Sulfadoxine|sulfadoxine|mesh-list
24437700|NCT00274235|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25826889|NCT00005868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826890|NCT00005868|Tubulin Modulators|tubulin modulators|mesh-ancestor
25826891|NCT00005868|Antimitotic Agents|antimitotic agents|mesh-ancestor
24439395|NCT00278421|Rituximab|rituximab|mesh-list
25826892|NCT00005868|Mitosis Modulators|mitosis modulators|mesh-ancestor
25826893|NCT00005868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826894|NCT00005869|Gemcitabine|gemcitabine|mesh-list
25826895|NCT00005869|Rubitecan|rubitecan|mesh-list
25826896|NCT00005869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24955183|NCT03867214|Hemostatics|hemostatics|mesh-ancestor
24442002|NCT00289419|Adrenergic Agents|adrenergic agents|mesh-ancestor
24442003|NCT00289419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25826897|NCT00005869|Antimetabolites|antimetabolites|mesh-ancestor
25826898|NCT00005869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826899|NCT00005869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826900|NCT00005869|Antiviral Agents|antiviral agents|mesh-ancestor
25826901|NCT00005869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25826902|NCT00005869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826903|NCT00005869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24851578|NCT02257294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25007688|NCT02909452|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25007690|NCT02909452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007692|NCT02909036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25826904|NCT00005869|Immunologic Factors|immunologic factors|mesh-ancestor
25826905|NCT00005869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550722|NCT00721916|Vitamins|vitamins|mesh-ancestor
25826906|NCT00005869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25826907|NCT00005869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25826908|NCT00005870|Gemcitabine|gemcitabine|mesh-list
25826909|NCT00005870|Fluorouracil|fluorouracil|mesh-list
25826910|NCT00005870|Mitomycins|mitomycins|mesh-list
24851594|NCT02257398|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24851595|NCT02257398|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24851596|NCT02257463|Theophylline|theophylline|mesh-list
24851597|NCT02257463|Bronchodilator Agents|bronchodilator agents|mesh-list
24851598|NCT02257463|Autonomic Agents|autonomic agents|mesh-ancestor
24851599|NCT02257463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24461277|NCT00351715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24461278|NCT00351715|Antitussive Agents|antitussive agents|mesh-ancestor
24851600|NCT02257463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851603|NCT02257463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24851604|NCT02257463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851605|NCT02257463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24851606|NCT02257463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851607|NCT02257463|Vasodilator Agents|vasodilator agents|mesh-ancestor
24851608|NCT02257463|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24851609|NCT02257463|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24851610|NCT02257463|Purinergic Agents|purinergic agents|mesh-ancestor
24851611|NCT02257476|Dexamethasone|dexamethasone|mesh-list
25070135|NCT03421717|Chelating Agents|chelating agents|mesh-ancestor
25070136|NCT03421717|Sequestering Agents|sequestering agents|mesh-ancestor
25070137|NCT03421717|Hemostatics|hemostatics|mesh-ancestor
25070138|NCT03421717|Coagulants|coagulants|mesh-ancestor
25070139|NCT03421496|Cannabidiol|cannabidiol|mesh-list
24851612|NCT02257476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24851613|NCT02257476|Antiemetics|antiemetics|mesh-ancestor
24851614|NCT02257476|Autonomic Agents|autonomic agents|mesh-ancestor
24851615|NCT02257476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24553310|NCT00730288|Vaccines|vaccines|mesh-list
24851616|NCT02257476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851617|NCT02257476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24851618|NCT02257476|Glucocorticoids|glucocorticoids|mesh-ancestor
24851619|NCT02257476|Hormones|hormones|mesh-ancestor
24851620|NCT02257476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24851621|NCT02257476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25826911|NCT00005870|Mitomycin|mitomycin|mesh-list
24851627|NCT02257502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851628|NCT02257502|Growth Inhibitors|growth inhibitors|mesh-ancestor
24851630|NCT02257671|Contraceptive Agents|contraceptive agents|mesh-list
24851631|NCT02257671|Levonorgestrel|levonorgestrel|mesh-list
24851632|NCT02257671|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24851633|NCT02257671|Contraceptives, Oral|contraceptives, oral|mesh-list
24851634|NCT02257671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24652554|NCT01238965|Leucovorin|leucovorin|mesh-list
25070192|NCT03421119|Liraglutide|liraglutide|mesh-list
24554762|NCT00737971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24554763|NCT00737971|Glucocorticoids|glucocorticoids|mesh-ancestor
25826912|NCT00005870|Rubitecan|rubitecan|mesh-list
24444933|NCT00299819|Sifalimumab|sifalimumab|mesh-list
24444944|NCT00299858|Theophylline|theophylline|mesh-list
24444974|NCT00299910|Respiratory System Agents|respiratory system agents|mesh-ancestor
24444975|NCT00299910|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24444976|NCT00299910|Hormone Antagonists|hormone antagonists|mesh-ancestor
24444977|NCT00299910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24444978|NCT00299910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826913|NCT00005870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25826914|NCT00005870|Antimetabolites|antimetabolites|mesh-ancestor
25826915|NCT00005870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826916|NCT00005870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826917|NCT00005870|Antiviral Agents|antiviral agents|mesh-ancestor
25826918|NCT00005870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25826919|NCT00005870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826920|NCT00005870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24445117|NCT00300404|Hematinics|hematinics|mesh-ancestor
24563757|NCT00773201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24563758|NCT00773201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563759|NCT00773201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563760|NCT00773201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24511769|NCT00570856|Hematinics|hematinics|mesh-ancestor
24563767|NCT00773552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24563768|NCT00773552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24445118|NCT00300404|Antimalarials|antimalarials|mesh-ancestor
24445164|NCT00300664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25826921|NCT00005870|Immunologic Factors|immunologic factors|mesh-ancestor
25826922|NCT00005870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826923|NCT00005870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24564042|NCT00774904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24555055|NCT00739622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826924|NCT00005870|Alkylating Agents|alkylating agents|mesh-ancestor
25826925|NCT00005870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25274106|NCT02380625|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25274107|NCT02380625|Sunitinib|sunitinib|mesh-list
25274108|NCT02380625|Irbesartan|irbesartan|mesh-list
25070401|NCT03419910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564192|NCT00775580|Atenolol|atenolol|mesh-list
24445197|NCT00300794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24445198|NCT00300794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070412|NCT03419858|Naloxone|naloxone|mesh-list
24564247|NCT00775697|Respiratory System Agents|respiratory system agents|mesh-ancestor
24564250|NCT00775697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445199|NCT00300794|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24445200|NCT00300794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24445202|NCT00300794|Anesthetics|anesthetics|mesh-ancestor
24445203|NCT00300794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24445204|NCT00300794|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24445205|NCT00300794|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25155328|NCT05417113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078395|NCT03356834|Tenofovir|tenofovir|mesh-list
25826926|NCT00005870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25826927|NCT00005870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25826928|NCT00005871|Fluorouracil|fluorouracil|mesh-list
25826929|NCT00005871|Rubitecan|rubitecan|mesh-list
24445244|NCT00300924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24496526|NCT00505258|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
24851757|NCT02258828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25070457|NCT03419494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24851760|NCT02258828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24851761|NCT02258828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24851763|NCT02258906|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24851764|NCT02258906|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24851765|NCT02258906|Protease Inhibitors|protease inhibitors|mesh-ancestor
24851766|NCT02258906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653436|NCT01243827|Bisoprolol|bisoprolol|mesh-list
25826930|NCT00005871|Antimetabolites|antimetabolites|mesh-ancestor
25826931|NCT00005871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826932|NCT00005871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24564844|NCT00778024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24564845|NCT00778024|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24564846|NCT00778024|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25826933|NCT00005871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826934|NCT00005871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24445257|NCT00300950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24445262|NCT00301002|Alefacept|alefacept|mesh-list
24851778|NCT02259075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851779|NCT02259179|Naltrexone|naltrexone|mesh-list
24851780|NCT02259179|Bupropion|bupropion|mesh-list
24564865|NCT00778063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24564866|NCT00778063|Analgesics|analgesics|mesh-ancestor
24564874|NCT00778063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564876|NCT00778076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24564877|NCT00778076|Immunologic Factors|immunologic factors|mesh-ancestor
24564878|NCT00778076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564879|NCT00778076|Viscosupplements|viscosupplements|mesh-ancestor
24564880|NCT00778076|Protective Agents|protective agents|mesh-ancestor
24564881|NCT00778089|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
25826935|NCT00005871|Immunologic Factors|immunologic factors|mesh-ancestor
24564904|NCT00778128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564905|NCT00778141|Metformin|metformin|mesh-list
25826936|NCT00005871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445288|NCT00301106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24445289|NCT00301106|Growth Substances|growth substances|mesh-ancestor
24445290|NCT00301106|Growth Inhibitors|growth inhibitors|mesh-ancestor
24445291|NCT00301106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445292|NCT00301145|Varenicline|varenicline|mesh-list
25826937|NCT00005871|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25826938|NCT00005871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25826939|NCT00005871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826940|NCT00005872|Rubitecan|rubitecan|mesh-list
24851781|NCT02259179|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24851782|NCT02259179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24496659|NCT00505843|Levodopa|levodopa|mesh-list
24445325|NCT00301223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445326|NCT00301223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24445327|NCT00301223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24445328|NCT00301223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24565272|NCT00779493|Curcumin|curcumin|mesh-list
24957621|NCT03843229|Bufanolides|bufanolides|mesh-list
24957622|NCT03843229|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24957623|NCT03843229|Protective Agents|protective agents|mesh-ancestor
24957624|NCT03843229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445337|NCT00301236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445338|NCT00301236|Dopamine Agents|dopamine agents|mesh-ancestor
24445339|NCT00301236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24445340|NCT00301301|Gemcitabine|gemcitabine|mesh-list
24445342|NCT00301301|Cisplatin|cisplatin|mesh-list
24851797|NCT02259179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25243412|NCT05335317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24445347|NCT00301301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24445348|NCT00301301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24445350|NCT00301301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852072|NCT02260206|Mitosis Modulators|mitosis modulators|mesh-ancestor
24445357|NCT00301392|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24445358|NCT00301392|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24445360|NCT00301392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445363|NCT00301405|Thalidomide|thalidomide|mesh-list
24851809|NCT02259361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851814|NCT02259374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851815|NCT02259374|Sensory System Agents|sensory system agents|mesh-ancestor
24851816|NCT02259374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851817|NCT02259426|Piperaquine|piperaquine|mesh-list
24851818|NCT02259426|Primaquine|primaquine|mesh-list
24851819|NCT02259426|Artenimol|artenimol|mesh-list
24851820|NCT02259426|Antimalarials|antimalarials|mesh-ancestor
24851821|NCT02259426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24565828|NCT00783016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24565829|NCT00783016|Narcotics|narcotics|mesh-ancestor
24565830|NCT00783016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24445368|NCT00301405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24445369|NCT00301405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24445370|NCT00301405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24445371|NCT00301405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24445372|NCT00301405|Growth Substances|growth substances|mesh-ancestor
24445373|NCT00301405|Growth Inhibitors|growth inhibitors|mesh-ancestor
24445374|NCT00301405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445375|NCT00301457|Anastrozole|anastrozole|mesh-list
24445376|NCT00301457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24445377|NCT00301457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445378|NCT00301457|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24445379|NCT00301457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24445380|NCT00301457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851833|NCT02259543|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24851834|NCT02259543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851835|NCT02259543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851836|NCT02259543|Anticoagulants|anticoagulants|mesh-ancestor
24851837|NCT02259543|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24851838|NCT02259543|Chelating Agents|chelating agents|mesh-ancestor
24851839|NCT02259543|Sequestering Agents|sequestering agents|mesh-ancestor
24851840|NCT02259595|Acetylcysteine|acetylcysteine|mesh-list
24556597|NCT00748358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24556598|NCT00748358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566042|NCT00784186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24566043|NCT00784186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566044|NCT00784186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24566078|NCT00784316|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24566079|NCT00784316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24566081|NCT00784316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24566113|NCT00784446|Antimetabolites|antimetabolites|mesh-ancestor
24859056|NCT02301494|Interferon Inducers|interferon inducers|mesh-ancestor
24445381|NCT00301457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826941|NCT00005872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008808|NCT04365985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25008809|NCT04365985|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25008810|NCT04365985|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25008811|NCT04365985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25109916|NCT03121261|Anesthetics|anesthetics|mesh-ancestor
25109922|NCT03121222|Expectorants|expectorants|mesh-ancestor
25826942|NCT00005872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24556668|NCT00748787|Antidiarrheals|antidiarrheals|mesh-ancestor
24556669|NCT00748891|Cediranib|cediranib|mesh-list
25109923|NCT03121222|Respiratory System Agents|respiratory system agents|mesh-ancestor
25109924|NCT03121222|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25109925|NCT03121222|Antioxidants|antioxidants|mesh-ancestor
24445423|NCT00301574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445425|NCT00301574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24445426|NCT00301574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445427|NCT00301574|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24445434|NCT00301587|Norgestimate|norgestimate|mesh-list
24445436|NCT00301587|Estradiol|estradiol|mesh-list
24851876|NCT02259777|Telmisartan|telmisartan|mesh-list
24445666|NCT00301990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445667|NCT00301990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24445696|NCT00302289|Purinergic Agents|purinergic agents|mesh-ancestor
24445697|NCT00302289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25826943|NCT00005872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24445699|NCT00302341|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24445700|NCT00302341|Sulfamethoxazole|sulfamethoxazole|mesh-list
24445701|NCT00302341|Pafuramidine|pafuramidine|mesh-list
24445702|NCT00302341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25070980|NCT03414450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25070981|NCT03414450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25070982|NCT03414450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25070984|NCT03414333|Hormones|hormones|mesh-list
25155336|NCT05411861|Analgesics|analgesics|mesh-list
24851893|NCT02259790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851896|NCT02259790|Vasodilator Agents|vasodilator agents|mesh-ancestor
24851906|NCT02259803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24851907|NCT02259803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826944|NCT00005872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826945|NCT00005872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826946|NCT00005873|Rubitecan|rubitecan|mesh-list
25826947|NCT00005873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826948|NCT00005873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25826949|NCT00005873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25826950|NCT00005873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851910|NCT02259803|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24851911|NCT02259816|Amlodipine|amlodipine|mesh-list
24851912|NCT02259816|Telmisartan|telmisartan|mesh-list
24851913|NCT02259816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25244014|NCT05097976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25244015|NCT05097976|Antiemetics|antiemetics|mesh-ancestor
25244016|NCT05097976|Autonomic Agents|autonomic agents|mesh-ancestor
25244017|NCT05097976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25244018|NCT05097976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244019|NCT05097976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25244020|NCT05097976|Glucocorticoids|glucocorticoids|mesh-ancestor
25244021|NCT05097976|Hormones|hormones|mesh-ancestor
25244022|NCT05097976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25244023|NCT05097976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25244024|NCT05097976|Protective Agents|protective agents|mesh-ancestor
25244025|NCT05097976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25244026|NCT05097976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826951|NCT00005873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826952|NCT00005874|Rubitecan|rubitecan|mesh-list
25826953|NCT00005874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826954|NCT00005874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25826955|NCT00005874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25155349|NCT05411237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826956|NCT00005874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826957|NCT00005874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826958|NCT00005875|Rubitecan|rubitecan|mesh-list
24445853|NCT00302770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24445854|NCT00302770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445856|NCT00302822|Emtricitabine|emtricitabine|mesh-list
24812316|NCT02051387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812317|NCT02051387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24812318|NCT02051387|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24812319|NCT02051387|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24812320|NCT02051387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24812321|NCT02051387|Antidepressive Agents|antidepressive agents|mesh-ancestor
24812322|NCT02051387|Anticonvulsants|anticonvulsants|mesh-ancestor
24812323|NCT02051387|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24852044|NCT02260037|Histamine Agents|histamine agents|mesh-ancestor
24852065|NCT02260089|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24852066|NCT02260089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852068|NCT02260206|Gout Suppressants|gout suppressants|mesh-ancestor
24852069|NCT02260206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24852070|NCT02260206|Tubulin Modulators|tubulin modulators|mesh-ancestor
24852071|NCT02260206|Antimitotic Agents|antimitotic agents|mesh-ancestor
24852228|NCT02261129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25826959|NCT00005875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826960|NCT00005875|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25826961|NCT00005875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25155350|NCT05411237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24499168|NCT00518141|Keratolytic Agents|keratolytic agents|mesh-ancestor
25008870|NCT04094519|Protective Agents|protective agents|mesh-ancestor
24852278|NCT02261675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24852284|NCT02261675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25155351|NCT05411237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24499413|NCT00519298|Donepezil|donepezil|mesh-list
24852301|NCT02261844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852302|NCT02261844|Protective Agents|protective agents|mesh-ancestor
24852303|NCT02261844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852304|NCT02261844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25245269|NCT04166110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24852343|NCT02262156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852346|NCT02262169|Omeprazole|omeprazole|mesh-list
24567738|NCT00792350|Sorafenib|sorafenib|mesh-list
24852370|NCT02262416|Leuprolide|leuprolide|mesh-list
24589595|NCT00908180|Cytarabine|cytarabine|mesh-list
25649880|NCT01497275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649881|NCT01497275|Immunologic Factors|immunologic factors|mesh-ancestor
25649882|NCT01497275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649883|NCT01497275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25649884|NCT01497366|Sofosbuvir|sofosbuvir|mesh-list
25649885|NCT01497366|Antiviral Agents|antiviral agents|mesh-ancestor
25649886|NCT01497366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24852400|NCT02262520|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24852401|NCT02262520|Protective Agents|protective agents|mesh-ancestor
24852402|NCT02262520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852403|NCT02262533|Atenolol|atenolol|mesh-list
24852404|NCT02262533|Apixaban|apixaban|mesh-list
24852405|NCT02262533|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24589635|NCT00908271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589636|NCT00908297|Ubiquinone|ubiquinone|mesh-list
24589637|NCT00908297|Coenzyme Q10|coenzyme q10|mesh-list
24656673|NCT01263353|Hormones|hormones|mesh-ancestor
24634718|NCT01134718|Simeprevir|simeprevir|mesh-list
24589863|NCT00909454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589864|NCT00909454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24589865|NCT00909454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24589866|NCT00909506|Metformin|metformin|mesh-list
24589867|NCT00909506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24589868|NCT00909506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589918|NCT00909883|Botulinum Toxins|botulinum toxins|mesh-list
24590238|NCT00911287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24634899|NCT01135680|Protective Agents|protective agents|mesh-ancestor
24634900|NCT01135758|Ketamine|ketamine|mesh-list
24590463|NCT00912639|Mitosis Modulators|mitosis modulators|mesh-ancestor
24590540|NCT00913107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24590541|NCT00913107|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24590542|NCT00913107|Antimanic Agents|antimanic agents|mesh-ancestor
24590543|NCT00913107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24590544|NCT00913107|Analgesics|analgesics|mesh-ancestor
24590545|NCT00913107|Sensory System Agents|sensory system agents|mesh-ancestor
24590549|NCT00913120|Enoxaparin|enoxaparin|mesh-list
24590554|NCT00913224|Diclofenac|diclofenac|mesh-list
24591230|NCT00915616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24591231|NCT00915694|Nelfinavir|nelfinavir|mesh-list
24591232|NCT00915694|Temozolomide|temozolomide|mesh-list
24591241|NCT00915694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24591391|NCT00916123|Hormones|hormones|mesh-ancestor
25073342|NCT03395730|Oxytocin|oxytocin|mesh-list
24591525|NCT00917241|Methimazole|methimazole|mesh-list
24591599|NCT00917761|Entecavir|entecavir|mesh-list
24591629|NCT00918021|Olanzapine|olanzapine|mesh-list
24591630|NCT00918021|Antiemetics|antiemetics|mesh-ancestor
24657896|NCT01269515|Etoricoxib|etoricoxib|mesh-list
24591804|NCT00919022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24591805|NCT00919178|Vaccines|vaccines|mesh-list
24591811|NCT00919204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592058|NCT00920153|Carmustine|carmustine|mesh-list
24812366|NCT02051868|Paclitaxel|paclitaxel|mesh-list
24592163|NCT00920465|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24812368|NCT02051868|Fluorouracil|fluorouracil|mesh-list
24592520|NCT00922506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24592522|NCT00922506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826962|NCT00005875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592883|NCT00925977|Isophane insulin, beef|isophane insulin, beef|mesh-list
24592884|NCT00925977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24592886|NCT00926016|Pioglitazone|pioglitazone|mesh-list
24593290|NCT00927771|Azelaic acid|azelaic acid|mesh-list
25073760|NCT03393403|Analgesics|analgesics|mesh-ancestor
24852695|NCT02263872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24594221|NCT00933205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24594222|NCT00933205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24594306|NCT00933426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24594307|NCT00933426|Tubulin Modulators|tubulin modulators|mesh-ancestor
24594308|NCT00933426|Antimitotic Agents|antimitotic agents|mesh-ancestor
24594407|NCT00933790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24594408|NCT00933790|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24594409|NCT00933790|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24594413|NCT00933816|Sorafenib|sorafenib|mesh-list
24594577|NCT00934570|Metformin|metformin|mesh-list
24594578|NCT00934570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24594579|NCT00934570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594763|NCT00935467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631331|NCT01117116|Xhance|xhance|mesh-list
24575754|NCT00833963|Pertuzumab|pertuzumab|mesh-list
24594831|NCT00935571|Anesthetics|anesthetics|mesh-ancestor
24594899|NCT00936091|Vitamin A|vitamin a|mesh-list
24594985|NCT00936390|Androgen Antagonists|androgen antagonists|mesh-ancestor
24595228|NCT00937300|Analgesics|analgesics|mesh-ancestor
24595326|NCT00937924|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24595344|NCT00938184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24577518|NCT00844402|Antimetabolites|antimetabolites|mesh-ancestor
24595357|NCT00938197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595443|NCT00938600|Vitamin D|vitamin d|mesh-list
24595783|NCT00940550|Melatonin|melatonin|mesh-list
24812467|NCT02052336|Clarithromycin|clarithromycin|mesh-list
24596673|NCT00944814|Zinc|zinc|mesh-list
24852856|NCT02264236|Immunologic Factors|immunologic factors|mesh-ancestor
24596844|NCT00945997|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24597196|NCT00947596|Atropine|atropine|mesh-list
24852890|NCT02264626|Analgesics|analgesics|mesh-ancestor
24597755|NCT00951574|Anticoagulants|anticoagulants|mesh-ancestor
24597756|NCT00951574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24597757|NCT00951574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24597758|NCT00951574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597759|NCT00951600|Oxcarbazepine|oxcarbazepine|mesh-list
24597997|NCT00953303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24597998|NCT00953303|Antiemetics|antiemetics|mesh-ancestor
24598114|NCT00954005|Antimetabolites|antimetabolites|mesh-ancestor
24598334|NCT00955318|Dopamine Agonists|dopamine agonists|mesh-ancestor
24598837|NCT00958451|Vitamins|vitamins|mesh-ancestor
24599589|NCT04237012|Hormones|hormones|mesh-ancestor
24599885|NCT03387761|Nivolumab|nivolumab|mesh-list
24600061|NCT02711137|Gemcitabine|gemcitabine|mesh-list
25249842|NCT02523820|Xhance|xhance|mesh-list
24998981|NCT05421000|Anesthetics|anesthetics|mesh-list
24853163|NCT02266173|Pertuzumab|pertuzumab|mesh-list
24602095|NCT00967148|Dalteparin|dalteparin|mesh-list
25826963|NCT00005875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826964|NCT00005876|Rubitecan|rubitecan|mesh-list
25826965|NCT00005876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632752|NCT01125553|Insulin|insulin|mesh-list
24923065|NCT04173611|Bupivacaine|bupivacaine|mesh-list
24923110|NCT04172727|Sensory System Agents|sensory system agents|mesh-ancestor
25252561|NCT02506686|Meropenem|meropenem|mesh-list
24923976|NCT04164823|Analgesics|analgesics|mesh-list
24924121|NCT04162743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24924541|NCT04159142|Tubulin Modulators|tubulin modulators|mesh-ancestor
25826966|NCT00005876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24925412|NCT04150289|Panobinostat|panobinostat|mesh-list
24925540|NCT04148963|Loxapine|loxapine|mesh-list
24523925|NCT05338502|Histamine Agents|histamine agents|mesh-ancestor
24926070|NCT04144712|Caffeine citrate|caffeine citrate|mesh-list
24926290|NCT04143412|Diuretics|diuretics|mesh-ancestor
24926406|NCT04142151|Antipyretics|antipyretics|mesh-ancestor
24926415|NCT04141995|Irinotecan|irinotecan|mesh-list
24584722|NCT00881426|Cefprozil|cefprozil|mesh-list
24926704|NCT04138992|Cisplatin|cisplatin|mesh-list
24400920|NCT00151632|Tacrolimus|tacrolimus|mesh-list
24927045|NCT04136600|Immunologic Factors|immunologic factors|mesh-ancestor
24524972|NCT04171258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24927279|NCT04134078|Nitric Oxide|nitric oxide|mesh-list
24525258|NCT03724994|Paclitaxel|paclitaxel|mesh-list
24927373|NCT04133428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24751595|NCT01705002|Bevacizumab|bevacizumab|mesh-list
24526235|NCT00605215|Interferon beta-1a|interferon beta-1a|mesh-list
24927984|NCT04127500|Analgesics|analgesics|mesh-ancestor
24526540|NCT00611962|Tubulin Modulators|tubulin modulators|mesh-ancestor
24928139|NCT04124991|Durvalumab|durvalumab|mesh-list
24752564|NCT01711060|Oxytocin|oxytocin|mesh-list
24928332|NCT04123392|Cyclophosphamide|cyclophosphamide|mesh-list
24526847|NCT00613457|Antimetabolites|antimetabolites|mesh-ancestor
25256147|NCT02483715|Bismuth|bismuth|mesh-list
24928390|NCT04122716|Liraglutide|liraglutide|mesh-list
24527626|NCT00617747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24527631|NCT00617760|Vaccines|vaccines|mesh-list
24527653|NCT00617955|Aprotinin|aprotinin|mesh-list
24527666|NCT00617968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527667|NCT00618046|Oxcarbazepine|oxcarbazepine|mesh-list
24928714|NCT04119752|Curcumin|curcumin|mesh-list
24527723|NCT00618176|Nevirapine|nevirapine|mesh-list
24928773|NCT04119336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24928774|NCT04119336|Glucocorticoids|glucocorticoids|mesh-ancestor
24928775|NCT04119336|Hormones|hormones|mesh-ancestor
24928776|NCT04119336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24527759|NCT00618241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24928811|NCT04118556|Etanercept|etanercept|mesh-list
24527833|NCT00618423|Anesthetics|anesthetics|mesh-ancestor
24928881|NCT04117893|Dopamine Agents|dopamine agents|mesh-ancestor
24928892|NCT04117750|Cholecalciferol|cholecalciferol|mesh-list
24527876|NCT00618501|Micronutrients|micronutrients|mesh-ancestor
24928917|NCT04117178|Memantine|memantine|mesh-list
24928925|NCT04117178|Nootropic Agents|nootropic agents|mesh-ancestor
25020605|NCT03679013|Antipyretics|antipyretics|mesh-ancestor
24928941|NCT04117243|Oxytocin|oxytocin|mesh-list
24928957|NCT04117191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24505009|NCT00538967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24527943|NCT00618657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24654796|NCT01251471|Serotonin Agents|serotonin agents|mesh-ancestor
24928991|NCT04116528|Narcotics|narcotics|mesh-ancestor
24929027|NCT04115982|Vitamin D|vitamin d|mesh-list
24917831|NCT04225728|Iron|iron|mesh-list
24929038|NCT04115904|Ibuprofen|ibuprofen|mesh-list
24681259|NCT01379079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24929069|NCT04115800|Sirolimus|sirolimus|mesh-list
24505104|NCT00539799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528076|NCT00619541|Sorafenib|sorafenib|mesh-list
24624715|NCT01077752|Narcotics|narcotics|mesh-ancestor
24505184|NCT00540280|Gemcitabine|gemcitabine|mesh-list
24929160|NCT04115410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24929163|NCT04115462|Morphine|morphine|mesh-list
24528144|NCT00619996|Docetaxel|docetaxel|mesh-list
24528145|NCT00619996|Sorafenib|sorafenib|mesh-list
24983458|NCT05186363|Pyrimethamine|pyrimethamine|mesh-list
24528174|NCT00620204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929194|NCT04115163|Antiviral Agents|antiviral agents|mesh-ancestor
24528213|NCT00620438|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24528253|NCT00620581|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24929237|NCT04114461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24929238|NCT04114461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24929310|NCT04113915|Hormones|hormones|mesh-ancestor
24659190|NCT01276080|Donepezil|donepezil|mesh-list
25030513|NCT03595189|Cilastatin|cilastatin|mesh-list
24624771|NCT01078428|Petrolatum|petrolatum|mesh-list
24929570|NCT04110665|Oxycodone|oxycodone|mesh-list
24929598|NCT04110860|Voriconazole|voriconazole|mesh-list
24929658|NCT04110587|Analgesics|analgesics|mesh-list
24528528|NCT00621478|Diazepam|diazepam|mesh-list
24929795|NCT04108845|Immunologic Factors|immunologic factors|mesh-ancestor
24929834|NCT04107896|Silodosin|silodosin|mesh-list
24929938|NCT04107103|Nivolumab|nivolumab|mesh-list
25826967|NCT00005876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24930256|NCT04103125|Hyaluronic Acid|hyaluronic acid|mesh-list
24528826|NCT00623077|Mesna|mesna|mesh-list
24930309|NCT04102449|Apremilast|apremilast|mesh-list
24930336|NCT04102176|Protective Agents|protective agents|mesh-ancestor
25034824|NCT03562169|Hormones|hormones|mesh-ancestor
24930481|NCT04101708|Antacids|antacids|mesh-ancestor
24624903|NCT01079312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25258692|NCT02468531|Xenon|xenon|mesh-list
24930582|NCT04100226|Antacids|antacids|mesh-ancestor
24930632|NCT04099732|Antithrombins|antithrombins|mesh-ancestor
24930721|NCT04097847|Vitamin E|vitamin e|mesh-list
24624945|NCT01079455|Hyaluronic Acid|hyaluronic acid|mesh-list
24624946|NCT01079455|Anesthetics, Local|anesthetics, local|mesh-ancestor
24624947|NCT01079455|Anesthetics|anesthetics|mesh-ancestor
24624948|NCT01079455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24694799|NCT05279183|Erythritol|erythritol|mesh-list
24624949|NCT01079455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624950|NCT01079455|Sensory System Agents|sensory system agents|mesh-ancestor
24624951|NCT01079455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24528965|NCT00624000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528967|NCT00624026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24528968|NCT00624026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24930990|NCT04094805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24931067|NCT04093518|Estradiol|estradiol|mesh-list
24529253|NCT00625196|Xhance|xhance|mesh-list
24931258|NCT04091009|Buprenorphine|buprenorphine|mesh-list
24931294|NCT04090112|Lidocaine|lidocaine|mesh-list
24625041|NCT01080066|Cetuximab|cetuximab|mesh-list
24931468|NCT04088461|Metformin|metformin|mesh-list
24931479|NCT04088448|Metformin|metformin|mesh-list
24529417|NCT00625898|Antimetabolites|antimetabolites|mesh-ancestor
24529418|NCT00625898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24625132|NCT01080612|Pregabalin|pregabalin|mesh-list
24529491|NCT00626288|Mesalamine|mesalamine|mesh-list
24931921|NCT04083911|Antiviral Agents|antiviral agents|mesh-ancestor
24529564|NCT00626678|Antimetabolites|antimetabolites|mesh-ancestor
24932070|NCT04082962|Hormones|hormones|mesh-ancestor
24529594|NCT00626834|GABA Agents|gaba agents|mesh-ancestor
24932111|NCT04082858|Midazolam|midazolam|mesh-list
25155541|NCT05346601|Chiauranib|chiauranib|mesh-list
25260461|NCT02458625|Iron|iron|mesh-list
24932341|NCT04080713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25826968|NCT00005876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649887|NCT01497496|Methylprednisolone|methylprednisolone|mesh-list
24932407|NCT04079933|Cholinergic Agents|cholinergic agents|mesh-ancestor
24932473|NCT04079374|Analgesics|analgesics|mesh-ancestor
24932508|NCT04078711|Losartan|losartan|mesh-list
24932514|NCT04078659|Lidocaine|lidocaine|mesh-list
24529758|NCT00627731|Antiemetics|antiemetics|mesh-ancestor
24625168|NCT01080651|Hormone Antagonists|hormone antagonists|mesh-ancestor
24932688|NCT04077905|Hormones|hormones|mesh-ancestor
24932699|NCT04077736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934348|NCT04061772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24934349|NCT04062019|Aldesleukin|aldesleukin|mesh-list
25261921|NCT02450968|Hormones|hormones|mesh-ancestor
24934677|NCT04059978|Analgesics|analgesics|mesh-ancestor
24934714|NCT04059536|Aspirin|aspirin|mesh-list
24934715|NCT04059536|Heparin|heparin|mesh-list
24411537|NCT00189371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649888|NCT01497496|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24456367|NCT00330993|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24532497|NCT00640159|Selegiline|selegiline|mesh-list
25826969|NCT00005876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24669892|NCT03414034|Prednisone|prednisone|mesh-list
24669893|NCT03414034|Onvansertib|onvansertib|mesh-list
24532838|NCT00641264|Omeprazole|omeprazole|mesh-list
24670089|NCT03300947|GABA Modulators|gaba modulators|mesh-ancestor
24456554|NCT00331695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826970|NCT00005877|Rubitecan|rubitecan|mesh-list
25826971|NCT00005877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826972|NCT00005877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25826973|NCT00005877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25826974|NCT00005877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25826975|NCT00005877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24670346|NCT02936622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25826976|NCT00005878|Celecoxib|celecoxib|mesh-list
24670399|NCT02663622|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25826977|NCT00005878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24670837|NCT01759459|Lidocaine|lidocaine|mesh-list
24514594|NCT00591708|Calcium|calcium|mesh-list
25826978|NCT00005878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24402357|NCT00156884|Cisplatin|cisplatin|mesh-list
25826979|NCT00005878|Analgesics|analgesics|mesh-ancestor
25826980|NCT00005878|Sensory System Agents|sensory system agents|mesh-ancestor
25826981|NCT00005878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24455976|NCT00329472|Gemcitabine|gemcitabine|mesh-list
24394235|NCT00132639|Docetaxel|docetaxel|mesh-list
25826982|NCT00005878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826983|NCT00005878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25826984|NCT00005878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24635671|NCT01140620|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24635672|NCT01140620|Serotonin Agents|serotonin agents|mesh-ancestor
24635673|NCT01140620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25826985|NCT00005878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25826986|NCT00005878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24456012|NCT00329589|Bortezomib|bortezomib|mesh-list
25826987|NCT00005878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635779|NCT01141153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635780|NCT01141153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456016|NCT00329615|Isophane insulin, beef|isophane insulin, beef|mesh-list
24456017|NCT00329615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25826988|NCT00005878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25826989|NCT00005880|Budesonide|budesonide|mesh-list
24456038|NCT00329680|Sensory System Agents|sensory system agents|mesh-ancestor
24456040|NCT00329680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25826990|NCT00005880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24515173|NCT00595140|Hormones|hormones|mesh-ancestor
25826991|NCT00005880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25826992|NCT00005880|Autonomic Agents|autonomic agents|mesh-ancestor
24515189|NCT00595374|Isophane Insulin, Human|isophane insulin, human|mesh-list
25826993|NCT00005880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24515190|NCT00595374|Insulin, Isophane|insulin, isophane|mesh-list
25826994|NCT00005880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25826995|NCT00005880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25826996|NCT00005880|Respiratory System Agents|respiratory system agents|mesh-ancestor
25826997|NCT00005880|Glucocorticoids|glucocorticoids|mesh-ancestor
24456071|NCT00329810|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24456072|NCT00329810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24456073|NCT00329810|Serotonin Agents|serotonin agents|mesh-ancestor
24767749|NCT01802944|Insulin|insulin|mesh-list
25155625|NCT05323552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827000|NCT00005883|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
25827001|NCT00005883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827002|NCT00005883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456295|NCT00330824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25827003|NCT00005883|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24537496|NCT00654914|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24537651|NCT00655616|Adrenergic Agents|adrenergic agents|mesh-ancestor
25827004|NCT00005883|Protective Agents|protective agents|mesh-ancestor
25827005|NCT00005883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538071|NCT00657410|Hormones|hormones|mesh-ancestor
24538073|NCT00657410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25827006|NCT00005883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538223|NCT00657930|Insulin Detemir|insulin detemir|mesh-list
25827007|NCT00005884|Eflornithine|eflornithine|mesh-list
25827008|NCT00005884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827009|NCT00005884|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25827010|NCT00005884|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25827011|NCT00005884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25827012|NCT00005884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24856276|NCT02283476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827013|NCT00005884|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
25827014|NCT00005884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827015|NCT00005884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827016|NCT00005886|Tamoxifen|tamoxifen|mesh-list
24539985|NCT00666159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24539992|NCT00666159|Dermatologic Agents|dermatologic agents|mesh-ancestor
24537398|NCT00654524|Hormones|hormones|mesh-list
24540080|NCT00666484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24540147|NCT00666770|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24540148|NCT00666770|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24540149|NCT00666770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24540155|NCT00666783|Autonomic Agents|autonomic agents|mesh-ancestor
24540156|NCT00666783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24540157|NCT00666783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540159|NCT00666783|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24540160|NCT00666783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24540161|NCT00666783|Serotonin Agents|serotonin agents|mesh-ancestor
25827017|NCT00005886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25827018|NCT00005886|Hormone Antagonists|hormone antagonists|mesh-ancestor
25827019|NCT00005886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25827020|NCT00005886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827021|NCT00005886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25827022|NCT00005886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827023|NCT00005886|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25827024|NCT00005886|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25827025|NCT00005886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25827026|NCT00005887|Efaproxiral|efaproxiral|mesh-list
25827027|NCT00005887|Antisickling Agents|antisickling agents|mesh-ancestor
24646883|NCT01205360|Fentanyl|fentanyl|mesh-list
25827028|NCT00005889|Glucagon|glucagon|mesh-list
25827029|NCT00005889|Glycerol|glycerol|mesh-list
25827030|NCT00005889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827031|NCT00005889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24939010|NCT04013620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25827032|NCT00005889|Hormones|hormones|mesh-ancestor
25827033|NCT00005889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25827034|NCT00005889|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25827035|NCT00005889|Protective Agents|protective agents|mesh-ancestor
25827036|NCT00005890|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25827037|NCT00005890|Hormones|hormones|mesh-ancestor
25827038|NCT00005890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25827039|NCT00005890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546556|NCT00699049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24546558|NCT00699062|Montelukast|montelukast|mesh-list
24546559|NCT00699062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24546560|NCT00699062|Respiratory System Agents|respiratory system agents|mesh-ancestor
24546561|NCT00699062|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24546562|NCT00699062|Hormone Antagonists|hormone antagonists|mesh-ancestor
24515962|NCT00600145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25827040|NCT00005891|Cyclophosphamide|cyclophosphamide|mesh-list
25827041|NCT00005891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24647060|NCT01206049|Gemcitabine|gemcitabine|mesh-list
24647061|NCT01206049|Bevacizumab|bevacizumab|mesh-list
24647062|NCT01206049|Panitumumab|panitumumab|mesh-list
24647063|NCT01206049|Capecitabine|capecitabine|mesh-list
24647064|NCT01206049|Oxaliplatin|oxaliplatin|mesh-list
24647065|NCT01206049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25827042|NCT00005891|Immunologic Factors|immunologic factors|mesh-ancestor
25827043|NCT00005891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827044|NCT00005891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25827045|NCT00005891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25827046|NCT00005891|Alkylating Agents|alkylating agents|mesh-ancestor
25827047|NCT00005891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827048|NCT00005891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827049|NCT00005891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25827050|NCT00005892|Cyclophosphamide|cyclophosphamide|mesh-list
25827051|NCT00005892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827052|NCT00005892|Immunologic Factors|immunologic factors|mesh-ancestor
25827053|NCT00005892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827054|NCT00005892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25827055|NCT00005892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25827056|NCT00005892|Alkylating Agents|alkylating agents|mesh-ancestor
25827057|NCT00005892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827058|NCT00005892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827059|NCT00005892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24546564|NCT00699062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546565|NCT00699062|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24546566|NCT00699062|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24546602|NCT00699322|Glimepiride|glimepiride|mesh-list
24546603|NCT00699322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24546729|NCT00699946|Autonomic Agents|autonomic agents|mesh-ancestor
24647160|NCT01206569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045446|NCT00948961|Poly I-C|poly i-c|mesh-list
25045454|NCT00948961|Antiviral Agents|antiviral agents|mesh-ancestor
25045455|NCT00948961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25045456|NCT00948909|Donepezil|donepezil|mesh-list
25045457|NCT00948909|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25045458|NCT00948909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045459|NCT00948909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045460|NCT00948909|Cholinergic Agents|cholinergic agents|mesh-ancestor
25045461|NCT00948909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25045462|NCT00948909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045463|NCT00948909|Nootropic Agents|nootropic agents|mesh-ancestor
24856703|NCT02286453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459150|NCT00343798|Cyclosporine|cyclosporine|mesh-list
24647174|NCT01206803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24647175|NCT01206803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647210|NCT01206946|Hormones|hormones|mesh-ancestor
25827060|NCT00005893|Cyclophosphamide|cyclophosphamide|mesh-list
25155640|NCT05309616|Ixekizumab|ixekizumab|mesh-list
25155641|NCT05309616|Dermatologic Agents|dermatologic agents|mesh-ancestor
25155650|NCT05297864|Niraparib|niraparib|mesh-list
25155651|NCT05297864|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25155652|NCT05297864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25155653|NCT05297864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25155654|NCT05297864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25155676|NCT05292755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25155677|NCT05292755|Laxatives|laxatives|mesh-ancestor
25155678|NCT05292755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25155679|NCT05288907|Lidocaine|lidocaine|mesh-list
25155680|NCT05288907|Anesthetics, Local|anesthetics, local|mesh-ancestor
25155681|NCT05288907|Anesthetics|anesthetics|mesh-ancestor
24515972|NCT00600158|Hydromorphone|hydromorphone|mesh-list
25827061|NCT00005893|Busulfan|busulfan|mesh-list
25827062|NCT00005893|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25827063|NCT00005893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827064|NCT00005893|Immunologic Factors|immunologic factors|mesh-ancestor
25827065|NCT00005893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827066|NCT00005893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25827067|NCT00005893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24418578|NCT00209794|Renal Agents|renal agents|mesh-ancestor
24547054|NCT00702130|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24547057|NCT00702156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24547058|NCT00702156|Sympatholytics|sympatholytics|mesh-ancestor
24547059|NCT00702156|Autonomic Agents|autonomic agents|mesh-ancestor
25827078|NCT00005898|Cyclophosphamide|cyclophosphamide|mesh-list
24812412|NCT02052128|Onapristone|onapristone|mesh-list
25827079|NCT00005898|Fludarabine|fludarabine|mesh-list
24547881|NCT00706277|Sevoflurane|sevoflurane|mesh-list
24547882|NCT00706277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25827080|NCT00005898|Cyclosporins|cyclosporins|mesh-list
24647745|NCT01210456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24647746|NCT01210456|Expectorants|expectorants|mesh-ancestor
24647747|NCT01210456|Respiratory System Agents|respiratory system agents|mesh-ancestor
24647749|NCT01210456|Antioxidants|antioxidants|mesh-ancestor
24559719|NCT04459598|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24559720|NCT04459598|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25827081|NCT00005898|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25827082|NCT00005898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827083|NCT00005898|Immunologic Factors|immunologic factors|mesh-ancestor
25827084|NCT00005898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827085|NCT00005898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25827086|NCT00005898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25827087|NCT00005898|Alkylating Agents|alkylating agents|mesh-ancestor
25827088|NCT00005898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827089|NCT00005898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827090|NCT00005898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25827091|NCT00005898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827092|NCT00005898|Antifungal Agents|antifungal agents|mesh-ancestor
25827093|NCT00005898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25827094|NCT00005898|Dermatologic Agents|dermatologic agents|mesh-ancestor
25827095|NCT00005898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25827096|NCT00005898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25827097|NCT00005898|Antiemetics|antiemetics|mesh-ancestor
25827098|NCT00005898|Autonomic Agents|autonomic agents|mesh-ancestor
25827099|NCT00005898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24856881|NCT02287272|Cimetidine|cimetidine|mesh-list
25155687|NCT05288907|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24550266|NCT00719875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25827100|NCT00005898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25827101|NCT00005898|Glucocorticoids|glucocorticoids|mesh-ancestor
25827102|NCT00005898|Hormones|hormones|mesh-ancestor
25827103|NCT00005898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24678630|NCT01363284|Analgesics|analgesics|mesh-ancestor
25827104|NCT00005898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25827105|NCT00005898|Protective Agents|protective agents|mesh-ancestor
25827106|NCT00005912|Voriconazole|voriconazole|mesh-list
25827107|NCT00005912|Antifungal Agents|antifungal agents|mesh-ancestor
25827108|NCT00005912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25408571|NCT03434379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827109|NCT00005912|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25827118|NCT00005920|Caspofungin|caspofungin|mesh-list
25827119|NCT00005920|Antifungal Agents|antifungal agents|mesh-ancestor
25827120|NCT00005920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25827121|NCT00005920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827122|NCT00005920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827123|NCT00005921|Caspofungin|caspofungin|mesh-list
25827124|NCT00005921|Antifungal Agents|antifungal agents|mesh-ancestor
25827125|NCT00005921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25827126|NCT00005921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419062|NCT00210912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25827127|NCT00005921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827128|NCT00005922|Triamcinolone|triamcinolone|mesh-list
25827129|NCT00005922|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25827130|NCT00005922|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25827131|NCT00005922|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24648741|NCT01216644|Mitosis Modulators|mitosis modulators|mesh-ancestor
24648742|NCT01216644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648744|NCT01216644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24857049|NCT02288923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24857052|NCT02288962|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24857053|NCT02288962|Dopamine Agonists|dopamine agonists|mesh-ancestor
25827132|NCT00005922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25827133|NCT00005922|Glucocorticoids|glucocorticoids|mesh-ancestor
25827134|NCT00005922|Hormones|hormones|mesh-ancestor
25827135|NCT00005922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25827136|NCT00005922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827137|NCT00005922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827138|NCT00005922|Immunologic Factors|immunologic factors|mesh-ancestor
24857125|NCT02289391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24857126|NCT02289391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827139|NCT00005922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827140|NCT00005922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827141|NCT00005925|Muscimol|muscimol|mesh-list
25827142|NCT00005925|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24649028|NCT01218386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24649030|NCT01218386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24649031|NCT01218386|Estrogens|estrogens|mesh-ancestor
24649032|NCT01218386|Hormones|hormones|mesh-ancestor
24649033|NCT01218386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25827143|NCT00005925|GABA Agonists|gaba agonists|mesh-ancestor
25827144|NCT00005925|GABA Agents|gaba agents|mesh-ancestor
25827145|NCT00005925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25829577|NCT00006232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24649911|NCT01222611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24649912|NCT01222611|Antiviral Agents|antiviral agents|mesh-ancestor
24649913|NCT01222611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24649914|NCT01222650|Silodosin|silodosin|mesh-list
24650310|NCT01225094|Curcumin|curcumin|mesh-list
24812986|NCT02055703|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24812987|NCT02055703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651231|NCT01230541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651269|NCT01230983|Cytarabine|cytarabine|mesh-list
25827150|NCT00005926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25827151|NCT00005926|Antimetabolites|antimetabolites|mesh-ancestor
24654970|NCT01252524|Cathartics|cathartics|mesh-ancestor
25827152|NCT00005926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827153|NCT00005926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827154|NCT00005926|Antiviral Agents|antiviral agents|mesh-ancestor
25827155|NCT00005926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24449715|NCT00316745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24783517|NCT01902446|Disinfectants|disinfectants|mesh-ancestor
24768958|NCT01811615|Ethanol|ethanol|mesh-list
24768959|NCT01811615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25827156|NCT00005926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827157|NCT00005926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827158|NCT00005926|Immunologic Factors|immunologic factors|mesh-ancestor
25827159|NCT00005926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657044|NCT01265199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25827160|NCT00005926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24657178|NCT01266057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657179|NCT01266057|Antifungal Agents|antifungal agents|mesh-ancestor
25827161|NCT00005928|Ramipril|ramipril|mesh-list
25827162|NCT00005928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25827163|NCT00005928|Protease Inhibitors|protease inhibitors|mesh-ancestor
25827164|NCT00005928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827165|NCT00005928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827166|NCT00005928|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25827167|NCT00005931|Semaxinib|semaxinib|mesh-list
25827168|NCT00005931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25827169|NCT00005931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24658803|NCT01274104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24658805|NCT01274130|Metformin|metformin|mesh-list
25827170|NCT00005931|Growth Substances|growth substances|mesh-ancestor
25827171|NCT00005931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827172|NCT00005931|Growth Inhibitors|growth inhibitors|mesh-ancestor
25827173|NCT00005931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827174|NCT00005931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25827175|NCT00005931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827176|NCT00005931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827177|NCT00005934|Azacitidine|azacitidine|mesh-list
25827178|NCT00005934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25827179|NCT00005934|Antimetabolites|antimetabolites|mesh-ancestor
25827180|NCT00005934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827181|NCT00005934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827182|NCT00005934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649889|NCT01497496|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25827187|NCT00005935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827188|NCT00005935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827189|NCT00005935|Immunologic Factors|immunologic factors|mesh-ancestor
25827190|NCT00005935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827191|NCT00005935|Antifungal Agents|antifungal agents|mesh-ancestor
25827192|NCT00005935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25827193|NCT00005935|Dermatologic Agents|dermatologic agents|mesh-ancestor
25827194|NCT00005935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25827195|NCT00005935|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25827196|NCT00005935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25827197|NCT00005935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24456789|NCT00332293|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25827198|NCT00005935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25827199|NCT00005935|Antitubercular Agents|antitubercular agents|mesh-ancestor
25827200|NCT00005935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25827201|NCT00005938|Exatecan|exatecan|mesh-list
25827202|NCT00005938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24449748|NCT00316875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25827203|NCT00005938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25827204|NCT00005938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827205|NCT00005938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827206|NCT00005938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827207|NCT00005940|Iodine|iodine|mesh-list
25827208|NCT00005940|Cyclosporine|cyclosporine|mesh-list
25827209|NCT00005940|Cyclophosphamide|cyclophosphamide|mesh-list
24420026|NCT00214981|Modafinil|modafinil|mesh-list
25827210|NCT00005940|Busulfan|busulfan|mesh-list
24667039|NCT01321957|Irinotecan|irinotecan|mesh-list
25827211|NCT00005940|Methotrexate|methotrexate|mesh-list
25827212|NCT00005940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24456803|NCT00332306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456804|NCT00332306|Antiviral Agents|antiviral agents|mesh-ancestor
25827213|NCT00005940|Cyclosporins|cyclosporins|mesh-list
24516555|NCT00602407|Cilostazol|cilostazol|mesh-list
25827214|NCT00005940|Antibodies|antibodies|mesh-list
25827215|NCT00005940|Immunoglobulins|immunoglobulins|mesh-list
25827216|NCT00005940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25827217|NCT00005940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827218|NCT00005940|Immunologic Factors|immunologic factors|mesh-ancestor
25827219|NCT00005940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827220|NCT00005940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24459889|NCT00346801|Cisplatin|cisplatin|mesh-list
25827221|NCT00005940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25827222|NCT00005940|Alkylating Agents|alkylating agents|mesh-ancestor
25827223|NCT00005940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827224|NCT00005940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827225|NCT00005940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25827226|NCT00005940|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25827227|NCT00005940|Abortifacient Agents|abortifacient agents|mesh-ancestor
25827228|NCT00005940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24457514|NCT00334646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684121|NCT01395654|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24684122|NCT01395654|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25827229|NCT00005940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25827230|NCT00005940|Antimetabolites|antimetabolites|mesh-ancestor
25827231|NCT00005940|Dermatologic Agents|dermatologic agents|mesh-ancestor
25827232|NCT00005940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533715|NCT00644943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24533716|NCT00644943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24533717|NCT00644956|Sildenafil Citrate|sildenafil citrate|mesh-list
25827233|NCT00005940|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25827234|NCT00005940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25827235|NCT00005940|Antifungal Agents|antifungal agents|mesh-ancestor
25827236|NCT00005940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24533736|NCT00644982|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24533737|NCT00644982|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25827237|NCT00005940|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25827238|NCT00005940|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25827239|NCT00005940|Trace Elements|trace elements|mesh-ancestor
25827240|NCT00005940|Micronutrients|micronutrients|mesh-ancestor
25827241|NCT00005941|Cyclosporine|cyclosporine|mesh-list
25827242|NCT00005941|Mycophenolic Acid|mycophenolic acid|mesh-list
25827243|NCT00005941|Fludarabine|fludarabine|mesh-list
25827244|NCT00005941|Fludarabine phosphate|fludarabine phosphate|mesh-list
25827245|NCT00005941|Cyclosporins|cyclosporins|mesh-list
25827246|NCT00005941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827247|NCT00005941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25827248|NCT00005941|Antimetabolites|antimetabolites|mesh-ancestor
25827249|NCT00005941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827250|NCT00005941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827251|NCT00005941|Immunologic Factors|immunologic factors|mesh-ancestor
25827252|NCT00005941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602282|NCT00967967|Mometasone Furoate|mometasone furoate|mesh-list
25827253|NCT00005941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827254|NCT00005941|Antifungal Agents|antifungal agents|mesh-ancestor
25827255|NCT00005941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25827256|NCT00005941|Dermatologic Agents|dermatologic agents|mesh-ancestor
25827257|NCT00005941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25827258|NCT00005941|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25827259|NCT00005941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25827260|NCT00005941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25649890|NCT01497496|Prednisolone|prednisolone|mesh-list
25649891|NCT01497496|Prednisolone acetate|prednisolone acetate|mesh-list
25649892|NCT01497496|Lenalidomide|lenalidomide|mesh-list
25649893|NCT01497496|Ofatumumab|ofatumumab|mesh-list
25649894|NCT01497496|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25649895|NCT01497496|Prednisolone phosphate|prednisolone phosphate|mesh-list
25649896|NCT01497496|Immunologic Factors|immunologic factors|mesh-ancestor
25649897|NCT01497496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649898|NCT01497496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25649899|NCT01497496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25649900|NCT01497496|Growth Substances|growth substances|mesh-ancestor
25649901|NCT01497496|Growth Inhibitors|growth inhibitors|mesh-ancestor
25649902|NCT01497496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827261|NCT00005941|Antitubercular Agents|antitubercular agents|mesh-ancestor
25827265|NCT00005942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25827266|NCT00005942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449810|NCT00317070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449811|NCT00317070|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24449838|NCT00317200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449839|NCT00317200|Growth Inhibitors|growth inhibitors|mesh-ancestor
24449840|NCT00317252|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25050573|NCT00485563|Folic Acid|folic acid|mesh-list
25827267|NCT00005942|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25827268|NCT00005942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25827269|NCT00005942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827270|NCT00005943|Aldesleukin|aldesleukin|mesh-list
25827271|NCT00005943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827272|NCT00005943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25827273|NCT00005943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24420888|NCT00217178|Vitamins|vitamins|mesh-ancestor
24516772|NCT00603343|Parasympatholytics|parasympatholytics|mesh-ancestor
25827274|NCT00005943|Antiviral Agents|antiviral agents|mesh-ancestor
24625675|NCT01082848|Dopamine Agents|dopamine agents|mesh-ancestor
24548587|NCT00710359|Vitamins|vitamins|mesh-list
25011351|NCT05215743|Acetylcysteine|acetylcysteine|mesh-list
25827275|NCT00005943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25827276|NCT00005944|Leucovorin|leucovorin|mesh-list
25827277|NCT00005944|Fluorouracil|fluorouracil|mesh-list
25827278|NCT00005944|Mitomycins|mitomycins|mesh-list
25827279|NCT00005944|Mitomycin|mitomycin|mesh-list
25827280|NCT00005944|Calcium|calcium|mesh-list
25827281|NCT00005944|Levoleucovorin|levoleucovorin|mesh-list
25827282|NCT00005944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25827283|NCT00005944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827284|NCT00005944|Antimetabolites|antimetabolites|mesh-ancestor
25827285|NCT00005944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827286|NCT00005944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25011013|NCT02424851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25011014|NCT02424851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011015|NCT02424851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25011016|NCT02424851|Glucocorticoids|glucocorticoids|mesh-ancestor
25011017|NCT02424851|Hormones|hormones|mesh-ancestor
25011019|NCT02424851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25827287|NCT00005944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827288|NCT00005944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24443149|NCT00293787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25827289|NCT00005944|Immunologic Factors|immunologic factors|mesh-ancestor
25827290|NCT00005944|Antidotes|antidotes|mesh-ancestor
25827291|NCT00005944|Protective Agents|protective agents|mesh-ancestor
25011030|NCT02424851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25011031|NCT02424851|Growth Substances|growth substances|mesh-ancestor
25011032|NCT02424851|Growth Inhibitors|growth inhibitors|mesh-ancestor
25011033|NCT02423876|Hydromorphone|hydromorphone|mesh-list
25011034|NCT02423876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25827292|NCT00005944|Vitamin B Complex|vitamin b complex|mesh-ancestor
25827293|NCT00005944|Vitamins|vitamins|mesh-ancestor
25827294|NCT00005944|Micronutrients|micronutrients|mesh-ancestor
25827295|NCT00005944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25649903|NCT01497496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25649904|NCT01497496|Antiemetics|antiemetics|mesh-ancestor
25649905|NCT01497496|Autonomic Agents|autonomic agents|mesh-ancestor
25649906|NCT01497496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25649907|NCT01497496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25827296|NCT00005944|Alkylating Agents|alkylating agents|mesh-ancestor
25827297|NCT00005944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24685670|NCT05248724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25827298|NCT00005944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24685671|NCT05248724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685672|NCT05248724|Analgesics|analgesics|mesh-ancestor
24685673|NCT05248724|Sensory System Agents|sensory system agents|mesh-ancestor
24685674|NCT05248724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24685675|NCT05248724|Anesthetics, Local|anesthetics, local|mesh-ancestor
24685676|NCT05248724|Anesthetics|anesthetics|mesh-ancestor
25827299|NCT00005945|Cytarabine|cytarabine|mesh-list
24685700|NCT05245760|Carboplatin|carboplatin|mesh-list
24685701|NCT05245760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24685856|NCT05162118|Nivolumab|nivolumab|mesh-list
25827300|NCT00005945|Dexamethasone|dexamethasone|mesh-list
25827301|NCT00005945|Cyclophosphamide|cyclophosphamide|mesh-list
25827302|NCT00005945|Doxorubicin|doxorubicin|mesh-list
25827303|NCT00005945|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24825975|NCT02131298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24825976|NCT02131298|Hormone Antagonists|hormone antagonists|mesh-ancestor
24705948|NCT01487798|Insulin|insulin|mesh-list
25827304|NCT00005945|Methotrexate|methotrexate|mesh-list
25827305|NCT00005945|Vincristine|vincristine|mesh-list
25827306|NCT00005945|Daunorubicin|daunorubicin|mesh-list
25827307|NCT00005945|Asparaginase|asparaginase|mesh-list
25827308|NCT00005945|Mercaptopurine|mercaptopurine|mesh-list
25827309|NCT00005945|Pegaspargase|pegaspargase|mesh-list
25827310|NCT00005945|Thioguanine|thioguanine|mesh-list
25827311|NCT00005945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827312|NCT00005945|Immunologic Factors|immunologic factors|mesh-ancestor
25827313|NCT00005945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827314|NCT00005945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25827315|NCT00005945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25827316|NCT00005945|Alkylating Agents|alkylating agents|mesh-ancestor
25827317|NCT00005945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827318|NCT00005945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827319|NCT00005945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25827320|NCT00005945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25827321|NCT00005945|Antiemetics|antiemetics|mesh-ancestor
25827322|NCT00005945|Autonomic Agents|autonomic agents|mesh-ancestor
25827323|NCT00005945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25827324|NCT00005945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25827325|NCT00005945|Glucocorticoids|glucocorticoids|mesh-ancestor
25827326|NCT00005945|Hormones|hormones|mesh-ancestor
25011137|NCT01754779|Indapamide|indapamide|mesh-list
25827327|NCT00005945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25827328|NCT00005945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24825977|NCT02131298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24825978|NCT02131298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825979|NCT02131298|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24825980|NCT02131350|Ranibizumab|ranibizumab|mesh-list
25011143|NCT01754779|Chelating Agents|chelating agents|mesh-ancestor
24825981|NCT02131350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25827329|NCT00005945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25827330|NCT00005945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25827331|NCT00005945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25827332|NCT00005945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827333|NCT00005945|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25827334|NCT00005945|Abortifacient Agents|abortifacient agents|mesh-ancestor
25827335|NCT00005945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25827336|NCT00005945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24443150|NCT00293787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443151|NCT00293787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443152|NCT00293787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25827337|NCT00005945|Antimetabolites|antimetabolites|mesh-ancestor
25827338|NCT00005945|Dermatologic Agents|dermatologic agents|mesh-ancestor
25649908|NCT01497496|Glucocorticoids|glucocorticoids|mesh-ancestor
25649909|NCT01497496|Hormones|hormones|mesh-ancestor
25649910|NCT01497496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25649911|NCT01497496|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25649912|NCT01497496|Protective Agents|protective agents|mesh-ancestor
25649913|NCT01497496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25649914|NCT01497808|Ipilimumab|ipilimumab|mesh-list
25649915|NCT01497808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25649916|NCT01497808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649917|NCT01497808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25827339|NCT00005945|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25827340|NCT00005945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24686209|NCT04997759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24686210|NCT04997759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686211|NCT04997759|Cholinergic Agents|cholinergic agents|mesh-ancestor
24686212|NCT04997759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24686213|NCT04997759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686234|NCT04968522|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24686235|NCT04968522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686236|NCT04968522|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24686237|NCT04968522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24686238|NCT04968522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24686239|NCT04968522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827341|NCT00005945|Antiviral Agents|antiviral agents|mesh-ancestor
25827342|NCT00005945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25827343|NCT00005945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24825987|NCT02131480|Doxorubicin|doxorubicin|mesh-list
24825988|NCT02131480|Trabectedin|trabectedin|mesh-list
25827344|NCT00005945|Tubulin Modulators|tubulin modulators|mesh-ancestor
25011204|NCT01141712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25011205|NCT01141712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25011206|NCT01141712|Immunologic Factors|immunologic factors|mesh-ancestor
25011207|NCT01141712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011208|NCT01141712|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25011209|NCT01141712|Alkylating Agents|alkylating agents|mesh-ancestor
25827345|NCT00005945|Antimitotic Agents|antimitotic agents|mesh-ancestor
24938436|NCT04018703|Analgesics|analgesics|mesh-ancestor
25827346|NCT00005945|Mitosis Modulators|mitosis modulators|mesh-ancestor
25827347|NCT00005946|Cyclophosphamide|cyclophosphamide|mesh-list
25827348|NCT00005946|Etoposide|etoposide|mesh-list
25827349|NCT00005946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827350|NCT00005946|Immunologic Factors|immunologic factors|mesh-ancestor
25827351|NCT00005946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827352|NCT00005946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25827353|NCT00005946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24826002|NCT02131506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826003|NCT02131506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826004|NCT02131506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24826005|NCT02131506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24826006|NCT02131506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24826007|NCT02131545|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24826008|NCT02131545|Antidepressive Agents|antidepressive agents|mesh-ancestor
24826009|NCT02131545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24826010|NCT02131545|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24826011|NCT02131545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25827354|NCT00005946|Alkylating Agents|alkylating agents|mesh-ancestor
25827355|NCT00005946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827356|NCT00005946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826016|NCT02131688|Sensory System Agents|sensory system agents|mesh-ancestor
24826017|NCT02131688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24826018|NCT02131688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827357|NCT00005946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25827358|NCT00005946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25827359|NCT00005946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25827360|NCT00005946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25827361|NCT00005946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827362|NCT00005948|Interferons|interferons|mesh-list
25649918|NCT01497808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649919|NCT01497860|Vinorelbine|vinorelbine|mesh-list
25649920|NCT01497860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25649921|NCT01497860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649922|NCT01497860|Tubulin Modulators|tubulin modulators|mesh-ancestor
25649923|NCT01497860|Antimitotic Agents|antimitotic agents|mesh-ancestor
25649924|NCT01497860|Mitosis Modulators|mitosis modulators|mesh-ancestor
25649925|NCT01497860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649926|NCT01497899|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25649927|NCT01497899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25649928|NCT01497899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25649929|NCT01497899|Antiviral Agents|antiviral agents|mesh-ancestor
25649930|NCT01497899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25827363|NCT00005948|Interferon-alpha|interferon-alpha|mesh-list
24687227|NCT04223037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687229|NCT04212013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24687230|NCT04212013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24687231|NCT04212013|Immunologic Factors|immunologic factors|mesh-ancestor
24687232|NCT04212013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687257|NCT04164199|Temozolomide|temozolomide|mesh-list
25827364|NCT00005948|Aldesleukin|aldesleukin|mesh-list
25827365|NCT00005948|Busulfan|busulfan|mesh-list
25827366|NCT00005948|Sargramostim|sargramostim|mesh-list
25827367|NCT00005948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827368|NCT00005948|Antiviral Agents|antiviral agents|mesh-ancestor
25827369|NCT00005948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25827370|NCT00005948|Immunologic Factors|immunologic factors|mesh-ancestor
25827371|NCT00005948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827372|NCT00005948|Alkylating Agents|alkylating agents|mesh-ancestor
25827373|NCT00005948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827374|NCT00005948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827375|NCT00005948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25827376|NCT00005948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25827377|NCT00005948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24826038|NCT02132000|Hormone Antagonists|hormone antagonists|mesh-ancestor
24826039|NCT02132000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24826040|NCT02132000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826041|NCT02132000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24826042|NCT02132000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826043|NCT02132000|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24826044|NCT02132000|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25011440|NCT05130788|Nicotine|nicotine|mesh-list
24826045|NCT02132000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24826046|NCT02132026|Denosumab|denosumab|mesh-list
24826047|NCT02132026|Alendronate|alendronate|mesh-list
24826048|NCT02132026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24826049|NCT02132026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826050|NCT02132091|Vitamins|vitamins|mesh-list
25827378|NCT00005948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24826085|NCT02132286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24826087|NCT02132390|Toremifene|toremifene|mesh-list
24826088|NCT02132390|Goserelin|goserelin|mesh-list
24826089|NCT02132390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24826090|NCT02132390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826091|NCT02132390|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24826092|NCT02132390|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24826093|NCT02132390|Hormone Antagonists|hormone antagonists|mesh-ancestor
24826094|NCT02132390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24826095|NCT02132390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826096|NCT02132390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24826097|NCT02132403|Gemcitabine|gemcitabine|mesh-list
24826098|NCT02132403|Milk fat globule|milk fat globule|mesh-list
24826099|NCT02132403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24826100|NCT02132403|Antimetabolites|antimetabolites|mesh-ancestor
24826101|NCT02132403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826102|NCT02132403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826103|NCT02132403|Antiviral Agents|antiviral agents|mesh-ancestor
24826105|NCT02132403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826106|NCT02132403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24826107|NCT02132403|Immunologic Factors|immunologic factors|mesh-ancestor
24443209|NCT00293969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25827379|NCT00005949|Aldesleukin|aldesleukin|mesh-list
25827380|NCT00005949|Interleukin-2|interleukin-2|mesh-list
25827381|NCT00005949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649931|NCT01497938|Insulin|insulin|mesh-list
25649932|NCT01497938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25649933|NCT01497938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649934|NCT01498068|Interferons|interferons|mesh-list
25649935|NCT01498068|Ribavirin|ribavirin|mesh-list
25649936|NCT01498068|Interferon-alpha|interferon-alpha|mesh-list
25649937|NCT01498068|Interferon alpha-2|interferon alpha-2|mesh-list
25649938|NCT01498068|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25649939|NCT01498068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649940|NCT01498068|Antiviral Agents|antiviral agents|mesh-ancestor
25649941|NCT01498068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24688402|NCT03071601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24688403|NCT03071601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24611829|NCT01010958|Anticonvulsants|anticonvulsants|mesh-ancestor
24611830|NCT01010958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855187|NCT02277847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24688745|NCT02711826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24688746|NCT02711826|Analgesics|analgesics|mesh-ancestor
24688747|NCT02711826|Sensory System Agents|sensory system agents|mesh-ancestor
24688748|NCT02711826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24688749|NCT02711826|Antipyretics|antipyretics|mesh-ancestor
24688750|NCT02711826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688846|NCT02636322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24688847|NCT02636322|Glucocorticoids|glucocorticoids|mesh-ancestor
24688848|NCT02636322|Hormones|hormones|mesh-ancestor
24688849|NCT02636322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24688852|NCT02636322|Tubulin Modulators|tubulin modulators|mesh-ancestor
25827382|NCT00005949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25166514|NCT03974100|Denosumab|denosumab|mesh-list
24531616|NCT00636766|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
25827383|NCT00005949|Analgesics|analgesics|mesh-ancestor
25827384|NCT00005949|Sensory System Agents|sensory system agents|mesh-ancestor
25827385|NCT00005949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25827386|NCT00005949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827387|NCT00005949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25827388|NCT00005949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25827389|NCT00005949|Antiviral Agents|antiviral agents|mesh-ancestor
25827390|NCT00005949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25827391|NCT00005951|Irinotecan|irinotecan|mesh-list
25827392|NCT00005951|Temozolomide|temozolomide|mesh-list
25827393|NCT00005951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25827394|NCT00005951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25827395|NCT00005951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827396|NCT00005951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827397|NCT00005951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827398|NCT00005951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25827399|NCT00005951|Alkylating Agents|alkylating agents|mesh-ancestor
25827400|NCT00005952|Temozolomide|temozolomide|mesh-list
25827401|NCT00005952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25827402|NCT00005952|Alkylating Agents|alkylating agents|mesh-ancestor
25827403|NCT00005952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827404|NCT00005952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827405|NCT00005954|Temozolomide|temozolomide|mesh-list
25827406|NCT00005954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25827407|NCT00005954|Alkylating Agents|alkylating agents|mesh-ancestor
25827408|NCT00005954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827409|NCT00005954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827410|NCT00005955|Temozolomide|temozolomide|mesh-list
25827411|NCT00005955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25827412|NCT00005955|Alkylating Agents|alkylating agents|mesh-ancestor
25827413|NCT00005955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826115|NCT02132416|Anesthetics|anesthetics|mesh-list
24826116|NCT02132416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25827414|NCT00005955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827415|NCT00005958|Gemcitabine|gemcitabine|mesh-list
25827416|NCT00005958|Docetaxel|docetaxel|mesh-list
25827417|NCT00005958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25649942|NCT01498068|Antimetabolites|antimetabolites|mesh-ancestor
25649943|NCT01498068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649944|NCT01498068|Immunologic Factors|immunologic factors|mesh-ancestor
25649945|NCT01498068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649946|NCT01498120|Rotigotine|rotigotine|mesh-list
25649947|NCT01498120|Dopamine Agonists|dopamine agonists|mesh-ancestor
25649948|NCT01498120|Dopamine Agents|dopamine agents|mesh-ancestor
25649949|NCT01498120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25649950|NCT01498120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649951|NCT01498120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649952|NCT01498185|Dapagliflozin|dapagliflozin|mesh-list
25649953|NCT01498185|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25649954|NCT01498185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649955|NCT01498185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25827418|NCT00005958|Antimetabolites|antimetabolites|mesh-ancestor
25827419|NCT00005958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863929|NCT02922985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24863930|NCT02922985|Analgesics|analgesics|mesh-ancestor
24689450|NCT01515306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689451|NCT01515306|Tubulin Modulators|tubulin modulators|mesh-ancestor
25827420|NCT00005958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827421|NCT00005958|Antiviral Agents|antiviral agents|mesh-ancestor
25827422|NCT00005958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25011619|NCT04557449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25827423|NCT00005958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25166521|NCT03971071|Analgesics|analgesics|mesh-ancestor
25827424|NCT00005958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827425|NCT00005958|Immunologic Factors|immunologic factors|mesh-ancestor
25827426|NCT00005958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827427|NCT00005958|Tubulin Modulators|tubulin modulators|mesh-ancestor
25827428|NCT00005958|Antimitotic Agents|antimitotic agents|mesh-ancestor
25827429|NCT00005958|Mitosis Modulators|mitosis modulators|mesh-ancestor
25827430|NCT00005959|Prednisone|prednisone|mesh-list
25827431|NCT00005959|Cyclophosphamide|cyclophosphamide|mesh-list
25827432|NCT00005959|Rituximab|rituximab|mesh-list
25827433|NCT00005959|Doxorubicin|doxorubicin|mesh-list
25827434|NCT00005959|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25827435|NCT00005959|Vincristine|vincristine|mesh-list
25827436|NCT00005959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827437|NCT00005959|Immunologic Factors|immunologic factors|mesh-ancestor
25827438|NCT00005959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827439|NCT00005959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25827440|NCT00005959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25827441|NCT00005959|Alkylating Agents|alkylating agents|mesh-ancestor
25827442|NCT00005959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827443|NCT00005959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827444|NCT00005959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24826121|NCT02132416|Sensory System Agents|sensory system agents|mesh-ancestor
24707062|NCT01493856|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25827445|NCT00005959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25827446|NCT00005959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25827447|NCT00005959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25827448|NCT00005959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25827449|NCT00005959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827450|NCT00005959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25827451|NCT00005959|Glucocorticoids|glucocorticoids|mesh-ancestor
25827452|NCT00005959|Hormones|hormones|mesh-ancestor
25827453|NCT00005959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25827454|NCT00005959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25011693|NCT04369664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25827455|NCT00005959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25827456|NCT00005959|Tubulin Modulators|tubulin modulators|mesh-ancestor
25827457|NCT00005959|Antimitotic Agents|antimitotic agents|mesh-ancestor
25827458|NCT00005959|Mitosis Modulators|mitosis modulators|mesh-ancestor
25827459|NCT00005960|Cyclophosphamide|cyclophosphamide|mesh-list
25827460|NCT00005960|Docetaxel|docetaxel|mesh-list
25827461|NCT00005960|Doxorubicin|doxorubicin|mesh-list
25827462|NCT00005960|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25827463|NCT00005960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827464|NCT00005960|Immunologic Factors|immunologic factors|mesh-ancestor
25827465|NCT00005960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827466|NCT00005960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25827467|NCT00005960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25827468|NCT00005960|Alkylating Agents|alkylating agents|mesh-ancestor
25827469|NCT00005960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827470|NCT00005960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827471|NCT00005960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25827472|NCT00005960|Tubulin Modulators|tubulin modulators|mesh-ancestor
25827473|NCT00005960|Antimitotic Agents|antimitotic agents|mesh-ancestor
25166520|NCT03971071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827474|NCT00005960|Mitosis Modulators|mitosis modulators|mesh-ancestor
25827475|NCT00005960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25827476|NCT00005960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25827477|NCT00005960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25827478|NCT00005960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827479|NCT00005961|Carmustine|carmustine|mesh-list
25827480|NCT00005961|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
25649956|NCT01498185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649957|NCT01498289|Leucovorin|leucovorin|mesh-list
25649958|NCT01498289|Docetaxel|docetaxel|mesh-list
25649959|NCT01498289|Fluorouracil|fluorouracil|mesh-list
25827481|NCT00005961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25827482|NCT00005961|Alkylating Agents|alkylating agents|mesh-ancestor
25827483|NCT00005961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827484|NCT00005961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827485|NCT00005961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827486|NCT00005962|Cytarabine|cytarabine|mesh-list
25827487|NCT00005962|Cyclophosphamide|cyclophosphamide|mesh-list
24443262|NCT00294294|Immunologic Factors|immunologic factors|mesh-ancestor
24826127|NCT02132416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24707275|NCT01495039|Ionophores|ionophores|mesh-ancestor
25827488|NCT00005962|Daunorubicin|daunorubicin|mesh-list
25827489|NCT00005962|Topotecan|topotecan|mesh-list
25827490|NCT00005962|Gemtuzumab|gemtuzumab|mesh-list
25827491|NCT00005962|Sargramostim|sargramostim|mesh-list
25827492|NCT00005962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827493|NCT00005962|Immunologic Factors|immunologic factors|mesh-ancestor
25827494|NCT00005962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827495|NCT00005962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24443263|NCT00294294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443265|NCT00294359|Capecitabine|capecitabine|mesh-list
25827496|NCT00005962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25827497|NCT00005962|Alkylating Agents|alkylating agents|mesh-ancestor
25827498|NCT00005962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827499|NCT00005962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827500|NCT00005962|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25827501|NCT00005962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25827502|NCT00005962|Antimetabolites|antimetabolites|mesh-ancestor
25827503|NCT00005962|Antiviral Agents|antiviral agents|mesh-ancestor
25827504|NCT00005962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25827505|NCT00005962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25827506|NCT00005962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25827507|NCT00005962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25827508|NCT00005962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827509|NCT00005962|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25827510|NCT00005962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25827511|NCT00005963|Carboplatin|carboplatin|mesh-list
25827512|NCT00005963|Docetaxel|docetaxel|mesh-list
25827513|NCT00005963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827514|NCT00005963|Tubulin Modulators|tubulin modulators|mesh-ancestor
25827515|NCT00005963|Antimitotic Agents|antimitotic agents|mesh-ancestor
25827516|NCT00005963|Mitosis Modulators|mitosis modulators|mesh-ancestor
25827517|NCT00005963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827518|NCT00005964|Prednisone|prednisone|mesh-list
25827519|NCT00005964|Cyclophosphamide|cyclophosphamide|mesh-list
25827520|NCT00005964|Doxorubicin|doxorubicin|mesh-list
24826129|NCT02132416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827521|NCT00005964|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25827522|NCT00005964|Etoposide|etoposide|mesh-list
25827523|NCT00005964|Vincristine|vincristine|mesh-list
25827524|NCT00005964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827525|NCT00005964|Immunologic Factors|immunologic factors|mesh-ancestor
25827526|NCT00005964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827527|NCT00005964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25827528|NCT00005964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25827529|NCT00005964|Alkylating Agents|alkylating agents|mesh-ancestor
25827530|NCT00005964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827531|NCT00005964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827532|NCT00005964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25827533|NCT00005964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25827534|NCT00005964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25827535|NCT00005964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25827536|NCT00005964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827537|NCT00005964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25827538|NCT00005964|Glucocorticoids|glucocorticoids|mesh-ancestor
25827539|NCT00005964|Hormones|hormones|mesh-ancestor
25827540|NCT00005964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24968708|NCT03748940|Mirikizumab|mirikizumab|mesh-list
25011933|NCT03011814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011934|NCT03011814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25011940|NCT02947165|Spartalizumab|spartalizumab|mesh-list
25827541|NCT00005964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25827542|NCT00005964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25827543|NCT00005964|Tubulin Modulators|tubulin modulators|mesh-ancestor
25827544|NCT00005964|Antimitotic Agents|antimitotic agents|mesh-ancestor
25827545|NCT00005964|Mitosis Modulators|mitosis modulators|mesh-ancestor
25827546|NCT00005965|Cisplatin|cisplatin|mesh-list
25827547|NCT00005965|Bryostatin 1|bryostatin 1|mesh-list
25827548|NCT00005965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827549|NCT00005965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24690664|NCT01403363|Analgesics|analgesics|mesh-ancestor
24690824|NCT01404130|Isotretinoin|isotretinoin|mesh-list
24690825|NCT01404130|Dermatologic Agents|dermatologic agents|mesh-ancestor
24690827|NCT01404156|Paclitaxel|paclitaxel|mesh-list
24690828|NCT01404156|Docetaxel|docetaxel|mesh-list
24690829|NCT01404156|Carboplatin|carboplatin|mesh-list
24690830|NCT01404156|Fluorouracil|fluorouracil|mesh-list
24690831|NCT01404156|Oxaliplatin|oxaliplatin|mesh-list
25827550|NCT00005965|Immunologic Factors|immunologic factors|mesh-ancestor
25827551|NCT00005965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827552|NCT00005966|Interferons|interferons|mesh-list
25827553|NCT00005966|Interferon-alpha|interferon-alpha|mesh-list
25827554|NCT00005966|Thalidomide|thalidomide|mesh-list
25827555|NCT00005966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011976|NCT02721069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25011977|NCT02721069|Anesthetics, General|anesthetics, general|mesh-ancestor
25011978|NCT02721069|Anesthetics|anesthetics|mesh-ancestor
25827556|NCT00005966|Antiviral Agents|antiviral agents|mesh-ancestor
25827557|NCT00005966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24826133|NCT02132442|Vitamins|vitamins|mesh-ancestor
24826134|NCT02132442|Micronutrients|micronutrients|mesh-ancestor
24826135|NCT02132442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826136|NCT02132442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24826137|NCT02132442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24826138|NCT02132546|Chlorhexidine|chlorhexidine|mesh-list
24826139|NCT02132546|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24826140|NCT02132546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25827558|NCT00005966|Immunologic Factors|immunologic factors|mesh-ancestor
25827559|NCT00005966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827560|NCT00005966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827561|NCT00005966|Leprostatic Agents|leprostatic agents|mesh-ancestor
25827562|NCT00005966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25827563|NCT00005966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25827564|NCT00005966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25827565|NCT00005966|Growth Substances|growth substances|mesh-ancestor
25827566|NCT00005966|Growth Inhibitors|growth inhibitors|mesh-ancestor
25827567|NCT00005967|Tipifarnib|tipifarnib|mesh-list
25827568|NCT00005967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827569|NCT00005968|Irofulven|irofulven|mesh-list
25827570|NCT00005968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25827571|NCT00005968|Alkylating Agents|alkylating agents|mesh-ancestor
25827572|NCT00005968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827573|NCT00005968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827574|NCT00005969|Tretinoin|tretinoin|mesh-list
25827575|NCT00005969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25012042|NCT02335060|Acetylcysteine|acetylcysteine|mesh-list
25827576|NCT00005969|Keratolytic Agents|keratolytic agents|mesh-ancestor
24826152|NCT02132689|Anticoagulants|anticoagulants|mesh-ancestor
24826153|NCT02132897|Carbamazepine|carbamazepine|mesh-list
24826154|NCT02132897|Anticonvulsants|anticonvulsants|mesh-ancestor
24826155|NCT02132897|Antimanic Agents|antimanic agents|mesh-ancestor
24826156|NCT02132897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24826157|NCT02132897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24826158|NCT02132897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826159|NCT02132897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25827577|NCT00005969|Dermatologic Agents|dermatologic agents|mesh-ancestor
25827578|NCT00005970|Tamoxifen|tamoxifen|mesh-list
25827579|NCT00005970|Paclitaxel|paclitaxel|mesh-list
25827580|NCT00005970|Cyclophosphamide|cyclophosphamide|mesh-list
25827581|NCT00005970|Doxorubicin|doxorubicin|mesh-list
25827582|NCT00005970|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25827583|NCT00005970|Trastuzumab|trastuzumab|mesh-list
25827584|NCT00005970|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25827585|NCT00005970|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
24826168|NCT02132897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24826169|NCT02133014|Fluorouracil|fluorouracil|mesh-list
24826170|NCT02133014|Antimetabolites|antimetabolites|mesh-ancestor
24826171|NCT02133014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649960|NCT01498289|Oxaliplatin|oxaliplatin|mesh-list
25649961|NCT01498289|Irinotecan|irinotecan|mesh-list
25649962|NCT01498289|Calcium|calcium|mesh-list
25649963|NCT01498289|Levoleucovorin|levoleucovorin|mesh-list
25649964|NCT01498289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649965|NCT01498289|Tubulin Modulators|tubulin modulators|mesh-ancestor
25649966|NCT01498289|Antimitotic Agents|antimitotic agents|mesh-ancestor
25649967|NCT01498289|Mitosis Modulators|mitosis modulators|mesh-ancestor
24826172|NCT02133014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24826173|NCT02133014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826174|NCT02133014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24826175|NCT02133014|Immunologic Factors|immunologic factors|mesh-ancestor
24826176|NCT02133014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826177|NCT02133053|Beclomethasone|beclomethasone|mesh-list
24826178|NCT02133053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24826186|NCT02133105|Dobutamine|dobutamine|mesh-list
24826187|NCT02133105|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24826188|NCT02133105|Vasodilator Agents|vasodilator agents|mesh-ancestor
24826189|NCT02133105|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24826190|NCT02133105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24826191|NCT02133105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826192|NCT02133105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826193|NCT02133105|Protective Agents|protective agents|mesh-ancestor
24968793|NCT03747978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24826194|NCT02133105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826195|NCT02133105|Sympathomimetics|sympathomimetics|mesh-ancestor
24826196|NCT02133105|Autonomic Agents|autonomic agents|mesh-ancestor
24826197|NCT02133105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24826207|NCT02133287|Arsenic Trioxide|arsenic trioxide|mesh-list
24826208|NCT02133287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24826209|NCT02133287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24826210|NCT02133287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24826211|NCT02133287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826212|NCT02133287|Antifungal Agents|antifungal agents|mesh-ancestor
24826213|NCT02133287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24826214|NCT02133287|Immunologic Factors|immunologic factors|mesh-ancestor
24826215|NCT02133287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826216|NCT02133326|Acetaminophen|acetaminophen|mesh-list
24826217|NCT02133326|Ibuprofen|ibuprofen|mesh-list
24826218|NCT02133326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24826219|NCT02133326|Analgesics|analgesics|mesh-ancestor
24826220|NCT02133326|Sensory System Agents|sensory system agents|mesh-ancestor
24966366|NCT03768882|Antipyretics|antipyretics|mesh-ancestor
24452724|NCT05457465|Cannabidiol|cannabidiol|mesh-list
24456481|NCT00331240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24456482|NCT00331240|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24456483|NCT00331240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24826223|NCT02133326|Antipyretics|antipyretics|mesh-ancestor
24826224|NCT02133326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24826226|NCT02133326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24826227|NCT02133326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24826228|NCT02133326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826229|NCT02133326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827586|NCT00005970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25827587|NCT00005970|Antibodies|antibodies|mesh-list
25827588|NCT00005970|Immunoglobulins|immunoglobulins|mesh-list
25827589|NCT00005970|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25827590|NCT00005970|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25827591|NCT00005970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25827592|NCT00005970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827593|NCT00005970|Tubulin Modulators|tubulin modulators|mesh-ancestor
25827594|NCT00005970|Antimitotic Agents|antimitotic agents|mesh-ancestor
25827595|NCT00005970|Mitosis Modulators|mitosis modulators|mesh-ancestor
25827596|NCT00005970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827597|NCT00005970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827598|NCT00005970|Immunologic Factors|immunologic factors|mesh-ancestor
25827599|NCT00005970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826230|NCT02133378|Hemostatics|hemostatics|mesh-list
24826231|NCT02133378|Coagulants|coagulants|mesh-ancestor
24826233|NCT02133469|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24826234|NCT02133469|Immunologic Factors|immunologic factors|mesh-ancestor
24826235|NCT02133469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826236|NCT02133612|Paclitaxel|paclitaxel|mesh-list
24826237|NCT02133612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24826238|NCT02133612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24826239|NCT02133612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826240|NCT02133612|Tubulin Modulators|tubulin modulators|mesh-ancestor
24826241|NCT02133612|Antimitotic Agents|antimitotic agents|mesh-ancestor
24826242|NCT02133612|Mitosis Modulators|mitosis modulators|mesh-ancestor
25012188|NCT01491893|Vaccines|vaccines|mesh-list
24826243|NCT02133612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826244|NCT02133625|Pioglitazone|pioglitazone|mesh-list
24826245|NCT02133625|Carboplatin|carboplatin|mesh-list
24826246|NCT02133625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826247|NCT02133625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25656867|NCT01580020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25827600|NCT00005970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24826248|NCT02133625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826249|NCT02133638|Propofol|propofol|mesh-list
24826250|NCT02133638|Sevoflurane|sevoflurane|mesh-list
25827601|NCT00005970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24826276|NCT02133820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25827602|NCT00005970|Alkylating Agents|alkylating agents|mesh-ancestor
25827603|NCT00005970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25827604|NCT00005970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25827605|NCT00005970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25827606|NCT00005970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25827607|NCT00005970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827608|NCT00005970|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24826291|NCT02133924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24826292|NCT02133924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826293|NCT02133924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24826294|NCT02133924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826295|NCT02133924|Antiemetics|antiemetics|mesh-ancestor
24826296|NCT02133924|Autonomic Agents|autonomic agents|mesh-ancestor
24826297|NCT02133924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24826298|NCT02133924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24826299|NCT02133924|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24826300|NCT02133924|Protective Agents|protective agents|mesh-ancestor
24826301|NCT02133924|Immunologic Factors|immunologic factors|mesh-ancestor
24826302|NCT02133937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24826303|NCT02133937|Immunologic Factors|immunologic factors|mesh-ancestor
25827609|NCT00005970|Hormone Antagonists|hormone antagonists|mesh-ancestor
24826339|NCT02134093|Vecuronium Bromide|vecuronium bromide|mesh-list
24826340|NCT02134093|Rocuronium|rocuronium|mesh-list
24613890|NCT01021501|Vasodilator Agents|vasodilator agents|mesh-ancestor
25012313|NCT05218616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443307|NCT00294463|Progesterone|progesterone|mesh-list
25827610|NCT00005970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25827611|NCT00005970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25827612|NCT00005970|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25827613|NCT00005970|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25827614|NCT00005970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25827615|NCT00005970|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25827616|NCT00005971|Alvocidib|alvocidib|mesh-list
25827617|NCT00005971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827618|NCT00005971|Growth Inhibitors|growth inhibitors|mesh-ancestor
25827619|NCT00005971|Growth Substances|growth substances|mesh-ancestor
24826351|NCT02134093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25827620|NCT00005971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827621|NCT00005971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25827622|NCT00005971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827623|NCT00005971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827624|NCT00005972|Gemcitabine|gemcitabine|mesh-list
25827625|NCT00005972|Irinotecan|irinotecan|mesh-list
24826354|NCT02134093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24826356|NCT02134093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24826357|NCT02134093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24826358|NCT02134093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24826359|NCT02134093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24826360|NCT02134093|GABA Modulators|gaba modulators|mesh-ancestor
24826361|NCT02134093|GABA Agents|gaba agents|mesh-ancestor
25827626|NCT00005972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25827627|NCT00005972|Antimetabolites|antimetabolites|mesh-ancestor
25827628|NCT00005972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827629|NCT00005972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827630|NCT00005972|Antiviral Agents|antiviral agents|mesh-ancestor
25827631|NCT00005972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25827632|NCT00005972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827633|NCT00005972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827634|NCT00005972|Immunologic Factors|immunologic factors|mesh-ancestor
24583062|NCT00873275|Leucovorin|leucovorin|mesh-list
24826380|NCT02134249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25105880|NCT04824274|Anesthetics, General|anesthetics, general|mesh-ancestor
24826381|NCT02134249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826382|NCT02134249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826384|NCT02134262|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24826385|NCT02134262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827635|NCT00005972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827636|NCT00005972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25827637|NCT00005972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24692727|NCT01416038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692728|NCT01416038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692777|NCT01416246|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24855319|NCT02278926|Insulin|insulin|mesh-list
24855320|NCT02278926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24692778|NCT01416337|Trametinib|trametinib|mesh-list
25827638|NCT00005974|Alvocidib|alvocidib|mesh-list
25827639|NCT00005974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827640|NCT00005974|Growth Inhibitors|growth inhibitors|mesh-ancestor
25827641|NCT00005974|Growth Substances|growth substances|mesh-ancestor
25827642|NCT00005974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827643|NCT00005974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25827644|NCT00005974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827645|NCT00005974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827646|NCT00005975|Megestrol|megestrol|mesh-list
25827647|NCT00005975|Megestrol Acetate|megestrol acetate|mesh-list
25012389|NCT05217069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25012390|NCT05217069|Antidotes|antidotes|mesh-ancestor
25827648|NCT00005975|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25827649|NCT00005975|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25827650|NCT00005975|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25827651|NCT00005975|Contraceptive Agents|contraceptive agents|mesh-ancestor
25166546|NCT03911414|Expectorants|expectorants|mesh-ancestor
25827652|NCT00005975|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24826399|NCT02134288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826401|NCT02134288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826402|NCT02134288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24826403|NCT02134327|Midazolam|midazolam|mesh-list
24826404|NCT02134327|Dexmedetomidine|dexmedetomidine|mesh-list
24826405|NCT02134327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25827653|NCT00005975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827654|NCT00005975|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25827655|NCT00005975|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25827656|NCT00005975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25827657|NCT00005975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827658|NCT00005975|Appetite Stimulants|appetite stimulants|mesh-ancestor
25827659|NCT00005975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25827660|NCT00005976|Carboplatin|carboplatin|mesh-list
25827661|NCT00005976|NSC 366140|nsc 366140|mesh-list
25827662|NCT00005976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827663|NCT00005977|Leucovorin|leucovorin|mesh-list
25827664|NCT00005977|Cytarabine|cytarabine|mesh-list
25827665|NCT00005977|Dexamethasone|dexamethasone|mesh-list
25827666|NCT00005977|Cyclophosphamide|cyclophosphamide|mesh-list
25827667|NCT00005977|Ifosfamide|ifosfamide|mesh-list
25827668|NCT00005977|Doxorubicin|doxorubicin|mesh-list
25827669|NCT00005977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25827670|NCT00005977|Methotrexate|methotrexate|mesh-list
25827671|NCT00005977|Etoposide|etoposide|mesh-list
25827672|NCT00005977|Vincristine|vincristine|mesh-list
25827673|NCT00005977|Lenograstim|lenograstim|mesh-list
25827674|NCT00005977|Levoleucovorin|levoleucovorin|mesh-list
25827675|NCT00005977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827676|NCT00005977|Immunologic Factors|immunologic factors|mesh-ancestor
25827677|NCT00005977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827678|NCT00005977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25827679|NCT00005977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25827680|NCT00005977|Alkylating Agents|alkylating agents|mesh-ancestor
25827681|NCT00005977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827682|NCT00005977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827683|NCT00005977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25827684|NCT00005977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25827685|NCT00005977|Antiemetics|antiemetics|mesh-ancestor
25827686|NCT00005977|Autonomic Agents|autonomic agents|mesh-ancestor
25110424|NCT05463601|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25110425|NCT05463588|Methamphetamine|methamphetamine|mesh-list
25827687|NCT00005977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25827688|NCT00005977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25827689|NCT00005977|Glucocorticoids|glucocorticoids|mesh-ancestor
25649968|NCT01498289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649969|NCT01498289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25649970|NCT01498289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25649971|NCT01498289|Antimetabolites|antimetabolites|mesh-ancestor
25649972|NCT01498289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25827690|NCT00005977|Hormones|hormones|mesh-ancestor
25827691|NCT00005977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25829578|NCT00006232|Tubulin Modulators|tubulin modulators|mesh-ancestor
25827695|NCT00005977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25827696|NCT00005977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827697|NCT00005977|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25827698|NCT00005977|Abortifacient Agents|abortifacient agents|mesh-ancestor
25012613|NCT04724252|Antimanic Agents|antimanic agents|mesh-ancestor
25012614|NCT04719208|Chlorhexidine|chlorhexidine|mesh-list
25827699|NCT00005977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25827700|NCT00005977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25827701|NCT00005977|Antimetabolites|antimetabolites|mesh-ancestor
24826444|NCT02134366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826469|NCT02134405|Antioxidants|antioxidants|mesh-ancestor
24826470|NCT02134405|Protective Agents|protective agents|mesh-ancestor
24826471|NCT02134405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826472|NCT02134457|Ranibizumab|ranibizumab|mesh-list
24826473|NCT02134457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25827702|NCT00005977|Dermatologic Agents|dermatologic agents|mesh-ancestor
24536820|NCT00652639|GABA Modulators|gaba modulators|mesh-ancestor
24443379|NCT00294619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25827703|NCT00005977|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25827704|NCT00005977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25827705|NCT00005977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24826476|NCT02134457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827706|NCT00005977|Antiviral Agents|antiviral agents|mesh-ancestor
25827707|NCT00005977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25827708|NCT00005977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25827709|NCT00005977|Antidotes|antidotes|mesh-ancestor
25827710|NCT00005977|Protective Agents|protective agents|mesh-ancestor
25827711|NCT00005977|Vitamin B Complex|vitamin b complex|mesh-ancestor
25827712|NCT00005977|Vitamins|vitamins|mesh-ancestor
25827713|NCT00005977|Micronutrients|micronutrients|mesh-ancestor
25827714|NCT00005977|Tubulin Modulators|tubulin modulators|mesh-ancestor
25827715|NCT00005977|Antimitotic Agents|antimitotic agents|mesh-ancestor
25827716|NCT00005977|Mitosis Modulators|mitosis modulators|mesh-ancestor
25827717|NCT00005978|Carboplatin|carboplatin|mesh-list
25827718|NCT00005978|Etoposide|etoposide|mesh-list
25827719|NCT00005978|Melphalan|melphalan|mesh-list
25827720|NCT00005978|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
25827721|NCT00005978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827722|NCT00005978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25827723|NCT00005978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25827724|NCT00005978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25166548|NCT03911414|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25166549|NCT03911414|Antioxidants|antioxidants|mesh-ancestor
25166550|NCT03911414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166551|NCT03911414|Protective Agents|protective agents|mesh-ancestor
25166552|NCT03911414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827725|NCT00005978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827726|NCT00005978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012670|NCT04666454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25827727|NCT00005978|Immunologic Factors|immunologic factors|mesh-ancestor
25827728|NCT00005978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827729|NCT00005978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25827730|NCT00005978|Alkylating Agents|alkylating agents|mesh-ancestor
25827731|NCT00005978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25827732|NCT00005978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827733|NCT00005978|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25827734|NCT00005979|Leucovorin|leucovorin|mesh-list
25827735|NCT00005979|Fluorouracil|fluorouracil|mesh-list
25827736|NCT00005979|Irinotecan|irinotecan|mesh-list
25827737|NCT00005979|Calcium|calcium|mesh-list
25827738|NCT00005979|Levoleucovorin|levoleucovorin|mesh-list
25827739|NCT00005979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25827740|NCT00005979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827741|NCT00005979|Antimetabolites|antimetabolites|mesh-ancestor
25827742|NCT00005979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827743|NCT00005979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25827744|NCT00005979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827745|NCT00005979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827746|NCT00005979|Immunologic Factors|immunologic factors|mesh-ancestor
25827747|NCT00005979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25827750|NCT00005979|Antidotes|antidotes|mesh-ancestor
25827751|NCT00005979|Protective Agents|protective agents|mesh-ancestor
24443384|NCT00294736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443385|NCT00294736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443386|NCT00294749|Ciprofloxacin|ciprofloxacin|mesh-list
24443387|NCT00294749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24443388|NCT00294749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24443389|NCT00294749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24443390|NCT00294749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25166553|NCT03911414|Antidotes|antidotes|mesh-ancestor
25166554|NCT03911414|Vitamin B Complex|vitamin b complex|mesh-ancestor
25166555|NCT03911414|Vitamins|vitamins|mesh-ancestor
25166556|NCT03911414|Micronutrients|micronutrients|mesh-ancestor
25166557|NCT03911336|Acetaminophen|acetaminophen|mesh-list
25166558|NCT03911336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25166559|NCT03911336|Ketoprofen|ketoprofen|mesh-list
25166560|NCT03911336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25166561|NCT03911336|Analgesics|analgesics|mesh-ancestor
25166562|NCT03911336|Sensory System Agents|sensory system agents|mesh-ancestor
25166563|NCT03911336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25166564|NCT03911336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166566|NCT03911336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24443398|NCT00294775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24443400|NCT00294775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443401|NCT00294853|Calcium|calcium|mesh-list
24443402|NCT00294853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24443403|NCT00294853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443404|NCT00294892|Nevirapine|nevirapine|mesh-list
24443405|NCT00294892|Carbamazepine|carbamazepine|mesh-list
24443406|NCT00294892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24443407|NCT00294892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24826484|NCT02134483|Parathyroid Hormone|parathyroid hormone|mesh-list
24826485|NCT02134483|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24826486|NCT02134483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826487|NCT02134626|Simvastatin|simvastatin|mesh-list
24826488|NCT02134626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24826489|NCT02134626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24826490|NCT02134626|Antimetabolites|antimetabolites|mesh-ancestor
24826491|NCT02134626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012843|NCT04297150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25012845|NCT04297150|Anticoagulants|anticoagulants|mesh-ancestor
25827752|NCT00005979|Vitamin B Complex|vitamin b complex|mesh-ancestor
25827753|NCT00005979|Vitamins|vitamins|mesh-ancestor
25827754|NCT00005979|Micronutrients|micronutrients|mesh-ancestor
24826506|NCT02134717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25827755|NCT00005980|Doxorubicin|doxorubicin|mesh-list
25827756|NCT00005980|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25827757|NCT00005980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25827758|NCT00005980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827759|NCT00005980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25827760|NCT00005980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25827761|NCT00005980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827762|NCT00005980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827763|NCT00005981|Carmustine|carmustine|mesh-list
25012861|NCT04227327|Hormone Antagonists|hormone antagonists|mesh-ancestor
25827764|NCT00005981|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
25827765|NCT00005981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25827766|NCT00005981|Alkylating Agents|alkylating agents|mesh-ancestor
25827767|NCT00005981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827768|NCT00005981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827769|NCT00005981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829579|NCT00006232|Antimitotic Agents|antimitotic agents|mesh-ancestor
25829580|NCT00006232|Mitosis Modulators|mitosis modulators|mesh-ancestor
25829581|NCT00006233|Cyclosporine|cyclosporine|mesh-list
25829582|NCT00006233|Mycophenolic Acid|mycophenolic acid|mesh-list
25829583|NCT00006233|Fludarabine|fludarabine|mesh-list
25829584|NCT00006233|Fludarabine phosphate|fludarabine phosphate|mesh-list
25829585|NCT00006233|Cyclosporins|cyclosporins|mesh-list
25829586|NCT00006233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829587|NCT00006233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25829588|NCT00006233|Antimetabolites|antimetabolites|mesh-ancestor
25829589|NCT00006233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827770|NCT00005984|Interferons|interferons|mesh-list
25827771|NCT00005984|Interferon-alpha|interferon-alpha|mesh-list
25827772|NCT00005984|Cyclophosphamide|cyclophosphamide|mesh-list
25827773|NCT00005984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827774|NCT00005984|Immunologic Factors|immunologic factors|mesh-ancestor
25827775|NCT00005984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827776|NCT00005984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25827777|NCT00005984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25827778|NCT00005984|Alkylating Agents|alkylating agents|mesh-ancestor
25827779|NCT00005984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827780|NCT00005984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827781|NCT00005984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25827782|NCT00005984|Antiviral Agents|antiviral agents|mesh-ancestor
24443435|NCT00294931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827783|NCT00005984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25827784|NCT00005985|Cytarabine|cytarabine|mesh-list
25827785|NCT00005985|Dexamethasone|dexamethasone|mesh-list
25827786|NCT00005985|Cyclophosphamide|cyclophosphamide|mesh-list
25827787|NCT00005985|Carmustine|carmustine|mesh-list
25827788|NCT00005985|Etoposide|etoposide|mesh-list
25827789|NCT00005985|Mitoxantrone|mitoxantrone|mesh-list
25827790|NCT00005985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827791|NCT00005985|Immunologic Factors|immunologic factors|mesh-ancestor
25827792|NCT00005985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827793|NCT00005985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25827794|NCT00005985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25827795|NCT00005985|Alkylating Agents|alkylating agents|mesh-ancestor
25827796|NCT00005985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443457|NCT00294996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25827797|NCT00005985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827798|NCT00005985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25827799|NCT00005985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25827800|NCT00005985|Antiemetics|antiemetics|mesh-ancestor
25827801|NCT00005985|Autonomic Agents|autonomic agents|mesh-ancestor
25827802|NCT00005985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25827803|NCT00005985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25827804|NCT00005985|Glucocorticoids|glucocorticoids|mesh-ancestor
24443491|NCT00295178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24443492|NCT00295191|Dialysis Solutions|dialysis solutions|mesh-list
24443493|NCT00295191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24443495|NCT00295243|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24443496|NCT00295243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24443497|NCT00295243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826524|NCT02134938|Cathartics|cathartics|mesh-ancestor
24826525|NCT02134938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24826526|NCT02134964|Dapansutrile|dapansutrile|mesh-list
24826527|NCT02134964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24826528|NCT02134990|Docetaxel|docetaxel|mesh-list
24583222|NCT00873795|Aripiprazole|aripiprazole|mesh-list
24826529|NCT02134990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24709022|NCT01503788|Anesthetics|anesthetics|mesh-ancestor
25827805|NCT00005985|Hormones|hormones|mesh-ancestor
25827806|NCT00005985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25827807|NCT00005985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25827808|NCT00005985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25827809|NCT00005985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25827810|NCT00005985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25827811|NCT00005985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827812|NCT00005985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25827813|NCT00005985|Antimetabolites|antimetabolites|mesh-ancestor
25827814|NCT00005985|Antiviral Agents|antiviral agents|mesh-ancestor
25827815|NCT00005985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25827816|NCT00005985|Analgesics|analgesics|mesh-ancestor
25827817|NCT00005985|Sensory System Agents|sensory system agents|mesh-ancestor
25827818|NCT00005986|Interferons|interferons|mesh-list
25827819|NCT00005986|Interferon-alpha|interferon-alpha|mesh-list
25827820|NCT00005986|Cyclophosphamide|cyclophosphamide|mesh-list
25827821|NCT00005986|Busulfan|busulfan|mesh-list
25827822|NCT00005986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25012901|NCT04136366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012913|NCT04112641|Niacinamide|niacinamide|mesh-list
25827823|NCT00005986|Immunologic Factors|immunologic factors|mesh-ancestor
24443506|NCT00295308|Sensory System Agents|sensory system agents|mesh-ancestor
24443507|NCT00295308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25827824|NCT00005986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827825|NCT00005986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25827826|NCT00005986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25827827|NCT00005986|Alkylating Agents|alkylating agents|mesh-ancestor
24443508|NCT00295308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443541|NCT00295373|Antimetabolites|antimetabolites|mesh-ancestor
25827828|NCT00005986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827829|NCT00005986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827830|NCT00005986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25827831|NCT00005986|Antiviral Agents|antiviral agents|mesh-ancestor
25827832|NCT00005986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25827833|NCT00005987|Interferons|interferons|mesh-list
25827834|NCT00005987|Interferon-alpha|interferon-alpha|mesh-list
25827835|NCT00005987|Dexamethasone|dexamethasone|mesh-list
25827836|NCT00005987|Cyclophosphamide|cyclophosphamide|mesh-list
25827837|NCT00005987|Carmustine|carmustine|mesh-list
25166567|NCT03911336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25166568|NCT03911336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25166569|NCT03911336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827838|NCT00005987|Etoposide|etoposide|mesh-list
25827839|NCT00005987|Mitoxantrone|mitoxantrone|mesh-list
25827840|NCT00005987|Sargramostim|sargramostim|mesh-list
25827841|NCT00005987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827842|NCT00005987|Immunologic Factors|immunologic factors|mesh-ancestor
25827843|NCT00005987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827844|NCT00005987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25827845|NCT00005987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25827846|NCT00005987|Alkylating Agents|alkylating agents|mesh-ancestor
25827847|NCT00005987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827848|NCT00005987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826540|NCT02135029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24709223|NCT01504542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827849|NCT00005987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25827850|NCT00005987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25827851|NCT00005987|Antiemetics|antiemetics|mesh-ancestor
25827852|NCT00005987|Autonomic Agents|autonomic agents|mesh-ancestor
25827853|NCT00005987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24443547|NCT00295386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24654298|NCT01248611|Fentanyl|fentanyl|mesh-list
24443548|NCT00295386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24443549|NCT00295386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443557|NCT00295425|Cyclosporine|cyclosporine|mesh-list
24443571|NCT00295425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24443572|NCT00295425|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24443573|NCT00295425|Antitubercular Agents|antitubercular agents|mesh-ancestor
25827854|NCT00005987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25827855|NCT00005987|Glucocorticoids|glucocorticoids|mesh-ancestor
25827856|NCT00005987|Hormones|hormones|mesh-ancestor
25827857|NCT00005987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25827858|NCT00005987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25827859|NCT00005987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25827860|NCT00005987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25827861|NCT00005987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25827862|NCT00005987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827863|NCT00005987|Antiviral Agents|antiviral agents|mesh-ancestor
24826541|NCT02135029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24826544|NCT02135055|Morphine|morphine|mesh-list
24826545|NCT02135055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24826546|NCT02135055|Narcotics|narcotics|mesh-ancestor
24826547|NCT02135055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24826548|NCT02135055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827864|NCT00005987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25827865|NCT00005987|Analgesics|analgesics|mesh-ancestor
25827866|NCT00005987|Sensory System Agents|sensory system agents|mesh-ancestor
25013072|NCT03752307|Protective Agents|protective agents|mesh-ancestor
25827867|NCT00005988|Leucovorin|leucovorin|mesh-list
25827868|NCT00005988|Cyclosporine|cyclosporine|mesh-list
25827869|NCT00005988|Methylprednisolone|methylprednisolone|mesh-list
25827870|NCT00005988|Cyclophosphamide|cyclophosphamide|mesh-list
25827871|NCT00005988|Methotrexate|methotrexate|mesh-list
25827872|NCT00005988|Cyclosporins|cyclosporins|mesh-list
25827873|NCT00005988|Levoleucovorin|levoleucovorin|mesh-list
25827874|NCT00005988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827875|NCT00005988|Immunologic Factors|immunologic factors|mesh-ancestor
25408572|NCT03434379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25827876|NCT00005988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827877|NCT00005988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25827878|NCT00005988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25827879|NCT00005988|Alkylating Agents|alkylating agents|mesh-ancestor
25829590|NCT00006233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827880|NCT00005988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827881|NCT00005988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827882|NCT00005988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25827883|NCT00005988|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25827884|NCT00005988|Abortifacient Agents|abortifacient agents|mesh-ancestor
25827885|NCT00005988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25827886|NCT00005988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25827887|NCT00005988|Antimetabolites|antimetabolites|mesh-ancestor
25827888|NCT00005988|Dermatologic Agents|dermatologic agents|mesh-ancestor
25166570|NCT03911336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166571|NCT03885830|Imatinib Mesylate|imatinib mesylate|mesh-list
25827889|NCT00005988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827890|NCT00005988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25827891|NCT00005988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25827892|NCT00005988|Antidotes|antidotes|mesh-ancestor
25827893|NCT00005988|Protective Agents|protective agents|mesh-ancestor
25827894|NCT00005988|Vitamin B Complex|vitamin b complex|mesh-ancestor
25827895|NCT00005988|Vitamins|vitamins|mesh-ancestor
25827896|NCT00005988|Micronutrients|micronutrients|mesh-ancestor
25827897|NCT00005988|Antifungal Agents|antifungal agents|mesh-ancestor
25827898|NCT00005988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25827899|NCT00005988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25827900|NCT00005988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25827901|NCT00005988|Antiemetics|antiemetics|mesh-ancestor
25827902|NCT00005988|Autonomic Agents|autonomic agents|mesh-ancestor
25827903|NCT00005988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25827904|NCT00005988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25827905|NCT00005988|Glucocorticoids|glucocorticoids|mesh-ancestor
25827906|NCT00005988|Hormones|hormones|mesh-ancestor
25827907|NCT00005988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25827908|NCT00005988|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25827909|NCT00005989|Tipifarnib|tipifarnib|mesh-list
25827910|NCT00005989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827911|NCT00005990|Topotecan|topotecan|mesh-list
24826550|NCT02135055|Sensory System Agents|sensory system agents|mesh-ancestor
25827912|NCT00005990|Tipifarnib|tipifarnib|mesh-list
25013170|NCT03439293|Glucocorticoids|glucocorticoids|mesh-ancestor
25013171|NCT03439293|Hormones|hormones|mesh-ancestor
25827913|NCT00005990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25827914|NCT00005990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25827915|NCT00005990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827916|NCT00005990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827917|NCT00005990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827918|NCT00005991|Gemcitabine|gemcitabine|mesh-list
25827919|NCT00005991|Doxorubicin|doxorubicin|mesh-list
25827920|NCT00005991|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25827921|NCT00005991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25827922|NCT00005991|Antimetabolites|antimetabolites|mesh-ancestor
25827923|NCT00005991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827924|NCT00005991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827925|NCT00005991|Antiviral Agents|antiviral agents|mesh-ancestor
25827926|NCT00005991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25827927|NCT00005991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827928|NCT00005991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24443579|NCT00295464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24443580|NCT00295464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443581|NCT00295464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24443582|NCT00295464|Respiratory System Agents|respiratory system agents|mesh-ancestor
24443583|NCT00295542|Atenolol|atenolol|mesh-list
24443584|NCT00295542|Valsartan|valsartan|mesh-list
24443585|NCT00295542|Telmisartan|telmisartan|mesh-list
24443586|NCT00295542|Carvedilol|carvedilol|mesh-list
24443587|NCT00295542|Olmesartan|olmesartan|mesh-list
24443589|NCT00295542|Lisinopril|lisinopril|mesh-list
24443590|NCT00295542|Nebivolol|nebivolol|mesh-list
24443591|NCT00295542|Antihypertensive Agents|antihypertensive agents|mesh-list
24443592|NCT00295542|Doxazosin|doxazosin|mesh-list
24443593|NCT00295542|Indapamide|indapamide|mesh-list
24443594|NCT00295542|Quinapril|quinapril|mesh-list
24443595|NCT00295542|Torsemide|torsemide|mesh-list
24443596|NCT00295542|Spirapril|spirapril|mesh-list
24443597|NCT00295542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24443598|NCT00295542|Diuretics|diuretics|mesh-list
24443607|NCT00295542|Protective Agents|protective agents|mesh-ancestor
24443608|NCT00295542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24443609|NCT00295542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24443610|NCT00295542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24443611|NCT00295542|Vasodilator Agents|vasodilator agents|mesh-ancestor
24443612|NCT00295542|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24443613|NCT00295542|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24826558|NCT02135055|Anesthetics, General|anesthetics, general|mesh-ancestor
24826559|NCT02135055|Anesthetics|anesthetics|mesh-ancestor
24826560|NCT02135055|GABA Modulators|gaba modulators|mesh-ancestor
24826561|NCT02135055|GABA Agents|gaba agents|mesh-ancestor
24826562|NCT02135055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24826563|NCT02135055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583294|NCT00874003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24979344|NCT04707625|Aflibercept|aflibercept|mesh-list
24826565|NCT02135120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24826566|NCT02135120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826567|NCT02135120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24826568|NCT02135120|Narcotics|narcotics|mesh-ancestor
24826569|NCT02135120|Analgesics|analgesics|mesh-ancestor
24826570|NCT02135120|Sensory System Agents|sensory system agents|mesh-ancestor
24826571|NCT02135120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24709383|NCT01505283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24443618|NCT00295542|Natriuretic Agents|natriuretic agents|mesh-ancestor
25827930|NCT00005991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586258|NCT00889733|Cisplatin|cisplatin|mesh-list
25827931|NCT00005991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25827932|NCT00005991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25827933|NCT00005991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25827934|NCT00005993|Aldesleukin|aldesleukin|mesh-list
25827935|NCT00005993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827936|NCT00005993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25827937|NCT00005993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25827938|NCT00005993|Antiviral Agents|antiviral agents|mesh-ancestor
25827939|NCT00005993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25827940|NCT00005994|Ondansetron|ondansetron|mesh-list
25827941|NCT00005994|Antiemetics|antiemetics|mesh-ancestor
25827942|NCT00005994|Autonomic Agents|autonomic agents|mesh-ancestor
25827943|NCT00005994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25827944|NCT00005994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827945|NCT00005994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25827946|NCT00005994|Antipruritics|antipruritics|mesh-ancestor
25827947|NCT00005994|Dermatologic Agents|dermatologic agents|mesh-ancestor
25827948|NCT00005994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24826577|NCT02135224|Fentanyl|fentanyl|mesh-list
24826578|NCT02135224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24826579|NCT02135224|Narcotics|narcotics|mesh-ancestor
24826580|NCT02135224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24709438|NCT01505777|Mosapride|mosapride|mesh-list
25827949|NCT00005994|Serotonin Agents|serotonin agents|mesh-ancestor
25827950|NCT00005994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25827951|NCT00005994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586280|NCT00890110|Vaccines|vaccines|mesh-list
25827952|NCT00005994|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25827953|NCT00005994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25827954|NCT00005994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25827955|NCT00005994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25827956|NCT00005994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25827957|NCT00005996|Gemcitabine|gemcitabine|mesh-list
25827958|NCT00005996|Cisplatin|cisplatin|mesh-list
25827959|NCT00005996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827960|NCT00005996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25827961|NCT00005996|Antimetabolites|antimetabolites|mesh-ancestor
25827962|NCT00005996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827963|NCT00005996|Antiviral Agents|antiviral agents|mesh-ancestor
25827964|NCT00005996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25827965|NCT00005996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25110458|NCT05463367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25110459|NCT05463367|Narcotics|narcotics|mesh-ancestor
25110460|NCT05463367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25110462|NCT05463367|Analgesics|analgesics|mesh-ancestor
25827966|NCT00005996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827967|NCT00005996|Immunologic Factors|immunologic factors|mesh-ancestor
25827968|NCT00005996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827969|NCT00005998|Cytarabine|cytarabine|mesh-list
25827970|NCT00005998|Dexamethasone|dexamethasone|mesh-list
25827971|NCT00005998|Cyclophosphamide|cyclophosphamide|mesh-list
25827972|NCT00005998|Carmustine|carmustine|mesh-list
25827973|NCT00005998|Etoposide|etoposide|mesh-list
25827974|NCT00005998|Mitoxantrone|mitoxantrone|mesh-list
25827975|NCT00005998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25827976|NCT00005998|Immunologic Factors|immunologic factors|mesh-ancestor
25827977|NCT00005998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25827978|NCT00005998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24637781|NCT01153165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25052898|NCT00134238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25052900|NCT00134238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827979|NCT00005998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25827980|NCT00005998|Alkylating Agents|alkylating agents|mesh-ancestor
25827981|NCT00005998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25827982|NCT00005998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25827983|NCT00005998|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25827984|NCT00005998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25827985|NCT00005998|Antiemetics|antiemetics|mesh-ancestor
25827986|NCT00005998|Autonomic Agents|autonomic agents|mesh-ancestor
25827987|NCT00005998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25827988|NCT00005998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25827989|NCT00005998|Glucocorticoids|glucocorticoids|mesh-ancestor
25827990|NCT00005998|Hormones|hormones|mesh-ancestor
25827991|NCT00005998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25827992|NCT00005998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25827993|NCT00005998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25827994|NCT00005998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25827995|NCT00005998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25827996|NCT00005998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25013303|NCT03101566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25827997|NCT00005998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25827998|NCT00005998|Antimetabolites|antimetabolites|mesh-ancestor
25827999|NCT00005998|Antiviral Agents|antiviral agents|mesh-ancestor
25828000|NCT00005998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25828001|NCT00005998|Analgesics|analgesics|mesh-ancestor
25828002|NCT00005998|Sensory System Agents|sensory system agents|mesh-ancestor
25828003|NCT00005999|Arsenic Trioxide|arsenic trioxide|mesh-list
25828004|NCT00005999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828005|NCT00006000|Cisplatin|cisplatin|mesh-list
25828006|NCT00006000|Irinotecan|irinotecan|mesh-list
25828007|NCT00006000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828008|NCT00006000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25828009|NCT00006000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25828010|NCT00006000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828011|NCT00006000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828012|NCT00006001|Semaxinib|semaxinib|mesh-list
25828013|NCT00006001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25828014|NCT00006001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25828015|NCT00006001|Growth Substances|growth substances|mesh-ancestor
25828016|NCT00006001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828017|NCT00006001|Growth Inhibitors|growth inhibitors|mesh-ancestor
25828018|NCT00006001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828019|NCT00006001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25828020|NCT00006001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828021|NCT00006001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828022|NCT00006002|Dexamethasone|dexamethasone|mesh-list
25828023|NCT00006002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25828024|NCT00006002|Antiemetics|antiemetics|mesh-ancestor
25828025|NCT00006002|Autonomic Agents|autonomic agents|mesh-ancestor
25828026|NCT00006002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25828027|NCT00006002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828028|NCT00006002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25828029|NCT00006002|Glucocorticoids|glucocorticoids|mesh-ancestor
25828030|NCT00006002|Hormones|hormones|mesh-ancestor
25828031|NCT00006002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25828032|NCT00006002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25828033|NCT00006002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826581|NCT02135224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826582|NCT02135224|Analgesics|analgesics|mesh-ancestor
24826583|NCT02135224|Sensory System Agents|sensory system agents|mesh-ancestor
24826584|NCT02135224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24826585|NCT02135224|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24826586|NCT02135224|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24826587|NCT02135224|Anesthetics, General|anesthetics, general|mesh-ancestor
24826588|NCT02135224|Anesthetics|anesthetics|mesh-ancestor
24826590|NCT02135263|Methylphenidate|methylphenidate|mesh-list
24709558|NCT01506167|Capecitabine|capecitabine|mesh-list
25013363|NCT02992015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25013364|NCT02992015|Antimetabolites|antimetabolites|mesh-ancestor
25649973|NCT01498289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25649974|NCT01498289|Immunologic Factors|immunologic factors|mesh-ancestor
25649975|NCT01498289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25649976|NCT01498289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25013367|NCT02992015|Antiviral Agents|antiviral agents|mesh-ancestor
25828035|NCT00006003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25828036|NCT00006003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25828037|NCT00006003|Growth Substances|growth substances|mesh-ancestor
25828038|NCT00006003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828039|NCT00006003|Growth Inhibitors|growth inhibitors|mesh-ancestor
25828040|NCT00006003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828041|NCT00006003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25828042|NCT00006003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828043|NCT00006003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828044|NCT00006004|Gemcitabine|gemcitabine|mesh-list
25828045|NCT00006004|Paclitaxel|paclitaxel|mesh-list
25828046|NCT00006004|Cisplatin|cisplatin|mesh-list
25828047|NCT00006004|Carboplatin|carboplatin|mesh-list
25828048|NCT00006004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25828049|NCT00006004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828050|NCT00006004|Tubulin Modulators|tubulin modulators|mesh-ancestor
25828051|NCT00006004|Antimitotic Agents|antimitotic agents|mesh-ancestor
25828052|NCT00006004|Mitosis Modulators|mitosis modulators|mesh-ancestor
25828053|NCT00006004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828054|NCT00006004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25828055|NCT00006004|Antimetabolites|antimetabolites|mesh-ancestor
25828056|NCT00006004|Antiviral Agents|antiviral agents|mesh-ancestor
25828057|NCT00006004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25828058|NCT00006004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828059|NCT00006004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25013450|NCT02609737|Chelating Agents|chelating agents|mesh-ancestor
25828060|NCT00006004|Immunologic Factors|immunologic factors|mesh-ancestor
25828061|NCT00006004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828062|NCT00006005|Thalidomide|thalidomide|mesh-list
25828063|NCT00006005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25828064|NCT00006005|Immunologic Factors|immunologic factors|mesh-ancestor
25828065|NCT00006005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828066|NCT00006005|Leprostatic Agents|leprostatic agents|mesh-ancestor
25828067|NCT00006005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25828068|NCT00006005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25828069|NCT00006005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25828070|NCT00006005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25828071|NCT00006005|Growth Substances|growth substances|mesh-ancestor
25828072|NCT00006005|Growth Inhibitors|growth inhibitors|mesh-ancestor
25828073|NCT00006005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828074|NCT00006006|Interferons|interferons|mesh-list
25828075|NCT00006006|Interferon-alpha|interferon-alpha|mesh-list
25828076|NCT00006006|Thalidomide|thalidomide|mesh-list
25828077|NCT00006006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828078|NCT00006006|Antiviral Agents|antiviral agents|mesh-ancestor
25828079|NCT00006006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25828080|NCT00006006|Immunologic Factors|immunologic factors|mesh-ancestor
25828081|NCT00006006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013485|NCT02542956|Anesthetics, Local|anesthetics, local|mesh-ancestor
25013486|NCT02542956|Anesthetics|anesthetics|mesh-ancestor
25828082|NCT00006006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25828083|NCT00006006|Leprostatic Agents|leprostatic agents|mesh-ancestor
25828084|NCT00006006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25828085|NCT00006006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25828086|NCT00006006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25828087|NCT00006006|Growth Substances|growth substances|mesh-ancestor
25828088|NCT00006006|Growth Inhibitors|growth inhibitors|mesh-ancestor
25828089|NCT00006007|Gemcitabine|gemcitabine|mesh-list
25828090|NCT00006007|Pemetrexed|pemetrexed|mesh-list
25828091|NCT00006007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25828092|NCT00006007|Antimetabolites|antimetabolites|mesh-ancestor
25828093|NCT00006007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828094|NCT00006007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828095|NCT00006007|Antiviral Agents|antiviral agents|mesh-ancestor
25828096|NCT00006007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24443633|NCT00295555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25828097|NCT00006007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828098|NCT00006007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25828099|NCT00006007|Immunologic Factors|immunologic factors|mesh-ancestor
25828100|NCT00006007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828101|NCT00006007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25828102|NCT00006007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25828103|NCT00006008|Arsenic Trioxide|arsenic trioxide|mesh-list
25828104|NCT00006008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828105|NCT00006009|Visilizumab|visilizumab|mesh-list
25828106|NCT00006009|Immunologic Factors|immunologic factors|mesh-ancestor
25828107|NCT00006009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828108|NCT00006010|Gemcitabine|gemcitabine|mesh-list
25828109|NCT00006010|Docetaxel|docetaxel|mesh-list
25828110|NCT00006010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25828111|NCT00006010|Antimetabolites|antimetabolites|mesh-ancestor
25013517|NCT02440464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25013518|NCT02366728|Temozolomide|temozolomide|mesh-list
24826596|NCT02135263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828112|NCT00006010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828113|NCT00006010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828114|NCT00006010|Antiviral Agents|antiviral agents|mesh-ancestor
25166572|NCT03885830|Dasatinib|dasatinib|mesh-list
25166573|NCT03885830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166574|NCT03885830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25828115|NCT00006010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25828116|NCT00006010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828117|NCT00006010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25828118|NCT00006010|Immunologic Factors|immunologic factors|mesh-ancestor
24443649|NCT00295607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24443650|NCT00295607|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25828119|NCT00006010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828120|NCT00006010|Tubulin Modulators|tubulin modulators|mesh-ancestor
25828121|NCT00006010|Antimitotic Agents|antimitotic agents|mesh-ancestor
25828122|NCT00006010|Mitosis Modulators|mitosis modulators|mesh-ancestor
25828123|NCT00006012|Paclitaxel|paclitaxel|mesh-list
25828124|NCT00006012|Etoposide|etoposide|mesh-list
25828125|NCT00006012|Cisplatin|cisplatin|mesh-list
25828126|NCT00006012|Topotecan|topotecan|mesh-list
25828127|NCT00006012|Amifostine|amifostine|mesh-list
25828128|NCT00006012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25828129|NCT00006012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828130|NCT00006012|Tubulin Modulators|tubulin modulators|mesh-ancestor
25828131|NCT00006012|Antimitotic Agents|antimitotic agents|mesh-ancestor
25828132|NCT00006012|Mitosis Modulators|mitosis modulators|mesh-ancestor
25828133|NCT00006012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013566|NCT02236806|Ramipril|ramipril|mesh-list
25828134|NCT00006012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25828135|NCT00006012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25828136|NCT00006012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828137|NCT00006012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828138|NCT00006012|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25828139|NCT00006012|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25828140|NCT00006012|Protective Agents|protective agents|mesh-ancestor
25828141|NCT00006013|Semaxinib|semaxinib|mesh-list
25828142|NCT00006013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25828143|NCT00006013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25828144|NCT00006013|Growth Substances|growth substances|mesh-ancestor
25828145|NCT00006013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828146|NCT00006013|Growth Inhibitors|growth inhibitors|mesh-ancestor
24443652|NCT00295607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828147|NCT00006013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828148|NCT00006013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25828149|NCT00006013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24970334|NCT03734159|Ropivacaine|ropivacaine|mesh-list
25828150|NCT00006013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828151|NCT00006014|Semaxinib|semaxinib|mesh-list
25828152|NCT00006014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25828153|NCT00006014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25828154|NCT00006014|Growth Substances|growth substances|mesh-ancestor
25828155|NCT00006014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828156|NCT00006014|Growth Inhibitors|growth inhibitors|mesh-ancestor
25828157|NCT00006014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828158|NCT00006014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25828159|NCT00006014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826599|NCT02135263|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24826600|NCT02135263|Protease Inhibitors|protease inhibitors|mesh-ancestor
24826601|NCT02135263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828160|NCT00006014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828161|NCT00006015|Leucovorin|leucovorin|mesh-list
24917465|NCT04229459|Nivolumab|nivolumab|mesh-list
25828162|NCT00006015|Fluorouracil|fluorouracil|mesh-list
25828163|NCT00006015|Oxaliplatin|oxaliplatin|mesh-list
25828164|NCT00006015|Trastuzumab|trastuzumab|mesh-list
25828165|NCT00006015|Calcium|calcium|mesh-list
25828167|NCT00006015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25828168|NCT00006015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828169|NCT00006015|Antimetabolites|antimetabolites|mesh-ancestor
25828170|NCT00006015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828171|NCT00006015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25828172|NCT00006015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828173|NCT00006015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25828174|NCT00006015|Immunologic Factors|immunologic factors|mesh-ancestor
25828175|NCT00006015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25828176|NCT00006015|Antidotes|antidotes|mesh-ancestor
25828177|NCT00006015|Protective Agents|protective agents|mesh-ancestor
25828178|NCT00006015|Vitamin B Complex|vitamin b complex|mesh-ancestor
25828179|NCT00006015|Vitamins|vitamins|mesh-ancestor
25828180|NCT00006015|Micronutrients|micronutrients|mesh-ancestor
25828181|NCT00006016|Thalidomide|thalidomide|mesh-list
25828182|NCT00006016|Doxorubicin|doxorubicin|mesh-list
25828183|NCT00006016|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25828184|NCT00006016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25828185|NCT00006016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828186|NCT00006016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25828187|NCT00006016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25013645|NCT01399918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013646|NCT01399918|Growth Inhibitors|growth inhibitors|mesh-ancestor
25013647|NCT01399918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25013648|NCT01399918|Immunologic Factors|immunologic factors|mesh-ancestor
25013649|NCT01078454|Dexamethasone|dexamethasone|mesh-list
25013650|NCT01078454|Bortezomib|bortezomib|mesh-list
25013651|NCT01078454|Melphalan|melphalan|mesh-list
25013652|NCT01078454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24660107|NCT01281761|Antimetabolites|antimetabolites|mesh-ancestor
24660108|NCT01281761|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24660109|NCT01281761|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25828188|NCT00006016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828189|NCT00006016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828190|NCT00006016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25828191|NCT00006016|Immunologic Factors|immunologic factors|mesh-ancestor
25828192|NCT00006016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828193|NCT00006016|Leprostatic Agents|leprostatic agents|mesh-ancestor
25828194|NCT00006016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25828195|NCT00006016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25828196|NCT00006016|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25828197|NCT00006016|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25828198|NCT00006016|Growth Substances|growth substances|mesh-ancestor
25828199|NCT00006016|Growth Inhibitors|growth inhibitors|mesh-ancestor
25828200|NCT00006018|Paclitaxel|paclitaxel|mesh-list
25828201|NCT00006018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25828202|NCT00006018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828203|NCT00006018|Tubulin Modulators|tubulin modulators|mesh-ancestor
25828204|NCT00006018|Antimitotic Agents|antimitotic agents|mesh-ancestor
25828205|NCT00006018|Mitosis Modulators|mitosis modulators|mesh-ancestor
25828206|NCT00006018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828207|NCT00006019|Azacitidine|azacitidine|mesh-list
25828208|NCT00006019|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25828209|NCT00006019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25828210|NCT00006019|Antimetabolites|antimetabolites|mesh-ancestor
25828211|NCT00006019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828212|NCT00006019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828213|NCT00006019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828214|NCT00006021|Ascorbic Acid|ascorbic acid|mesh-list
25828215|NCT00006021|Arsenic Trioxide|arsenic trioxide|mesh-list
24443655|NCT00295672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828216|NCT00006021|Antioxidants|antioxidants|mesh-ancestor
25828217|NCT00006021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828218|NCT00006021|Protective Agents|protective agents|mesh-ancestor
25828219|NCT00006021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828220|NCT00006021|Vitamins|vitamins|mesh-ancestor
25828221|NCT00006021|Micronutrients|micronutrients|mesh-ancestor
25828222|NCT00006021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828223|NCT00006022|Aldesleukin|aldesleukin|mesh-list
25828224|NCT00006022|Bryostatin 1|bryostatin 1|mesh-list
25828225|NCT00006022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013702|NCT05223244|Glucocorticoids|glucocorticoids|mesh-ancestor
25828226|NCT00006022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25828227|NCT00006022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25828228|NCT00006022|Antiviral Agents|antiviral agents|mesh-ancestor
24642308|NCT01178788|Hormones|hormones|mesh-ancestor
25013704|NCT05223244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25828229|NCT00006022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25828230|NCT00006022|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25828231|NCT00006022|Immunologic Factors|immunologic factors|mesh-ancestor
25828232|NCT00006022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828233|NCT00006023|Capecitabine|capecitabine|mesh-list
25828234|NCT00006023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24443701|NCT00295841|Antimetabolites|antimetabolites|mesh-ancestor
24443702|NCT00295841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443703|NCT00295841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24443704|NCT00295841|Antiviral Agents|antiviral agents|mesh-ancestor
24443705|NCT00295841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24443706|NCT00295841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24443707|NCT00295841|Immunologic Factors|immunologic factors|mesh-ancestor
25166575|NCT03885830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443708|NCT00295841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443710|NCT00295893|Docetaxel|docetaxel|mesh-list
24443711|NCT00295893|Cyclophosphamide|cyclophosphamide|mesh-list
25828235|NCT00006023|Antimetabolites|antimetabolites|mesh-ancestor
25828236|NCT00006023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826628|NCT02135341|Botulinum Toxins|botulinum toxins|mesh-list
24826629|NCT02135341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24826630|NCT02135341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25828237|NCT00006023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828238|NCT00006024|Temozolomide|temozolomide|mesh-list
25828239|NCT00006024|Lomustine|lomustine|mesh-list
25828240|NCT00006024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25828241|NCT00006024|Alkylating Agents|alkylating agents|mesh-ancestor
25828242|NCT00006024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828243|NCT00006024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828244|NCT00006025|Irinotecan|irinotecan|mesh-list
25828245|NCT00006025|Temozolomide|temozolomide|mesh-list
25828246|NCT00006025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25828247|NCT00006025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25828248|NCT00006025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828249|NCT00006025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828250|NCT00006025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828251|NCT00006025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25110549|NCT05456269|Cytarabine|cytarabine|mesh-list
25828252|NCT00006025|Alkylating Agents|alkylating agents|mesh-ancestor
25828253|NCT00006026|Rubitecan|rubitecan|mesh-list
24826631|NCT02135341|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24826632|NCT02135341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24826633|NCT02135341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24826634|NCT02135341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710095|NCT01508429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24826635|NCT02135341|Cholinergic Agents|cholinergic agents|mesh-ancestor
24826636|NCT02135341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24826637|NCT02135341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826638|NCT02135341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24826639|NCT02135341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24826640|NCT02135354|Azithromycin|azithromycin|mesh-list
24826641|NCT02135354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24826642|NCT02135354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24826644|NCT02135393|Hematinics|hematinics|mesh-ancestor
24826645|NCT02135393|Vitamin B Complex|vitamin b complex|mesh-ancestor
24826646|NCT02135393|Vitamins|vitamins|mesh-ancestor
24826647|NCT02135393|Micronutrients|micronutrients|mesh-ancestor
24826648|NCT02135393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828254|NCT00006026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828255|NCT00006026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25828256|NCT00006026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25828257|NCT00006026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828258|NCT00006026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828259|NCT00006027|Paclitaxel|paclitaxel|mesh-list
25828260|NCT00006027|Cisplatin|cisplatin|mesh-list
25828261|NCT00006027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25828262|NCT00006027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828263|NCT00006027|Tubulin Modulators|tubulin modulators|mesh-ancestor
24767412|NCT01800643|Busulfan|busulfan|mesh-list
25828264|NCT00006027|Antimitotic Agents|antimitotic agents|mesh-ancestor
25828265|NCT00006027|Mitosis Modulators|mitosis modulators|mesh-ancestor
25828266|NCT00006027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828267|NCT00006028|Gemcitabine|gemcitabine|mesh-list
25828268|NCT00006028|Cisplatin|cisplatin|mesh-list
25828272|NCT00006028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828273|NCT00006028|Antiviral Agents|antiviral agents|mesh-ancestor
25828274|NCT00006028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25828275|NCT00006028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826686|NCT02135640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24826687|NCT02135640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828276|NCT00006028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25828277|NCT00006028|Immunologic Factors|immunologic factors|mesh-ancestor
25828278|NCT00006028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828279|NCT00006029|Gemcitabine|gemcitabine|mesh-list
25013779|NCT05222204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25013780|NCT05222204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828280|NCT00006029|Doxorubicin|doxorubicin|mesh-list
25828281|NCT00006029|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25828282|NCT00006029|Vinorelbine|vinorelbine|mesh-list
25828283|NCT00006029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25828284|NCT00006029|Antimetabolites|antimetabolites|mesh-ancestor
25828285|NCT00006029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828286|NCT00006029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828287|NCT00006029|Antiviral Agents|antiviral agents|mesh-ancestor
25828288|NCT00006029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25828289|NCT00006029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828290|NCT00006029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25828291|NCT00006029|Immunologic Factors|immunologic factors|mesh-ancestor
25828292|NCT00006029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828293|NCT00006029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25828294|NCT00006029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25828295|NCT00006029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25828296|NCT00006029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25828297|NCT00006029|Tubulin Modulators|tubulin modulators|mesh-ancestor
25828298|NCT00006029|Antimitotic Agents|antimitotic agents|mesh-ancestor
25828299|NCT00006029|Mitosis Modulators|mitosis modulators|mesh-ancestor
25828300|NCT00006030|Tamoxifen|tamoxifen|mesh-list
25828301|NCT00006030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24826690|NCT02135770|Anticoagulants|anticoagulants|mesh-ancestor
24826691|NCT02135770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24826692|NCT02135770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24826693|NCT02135770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826694|NCT02135822|Gemcitabine|gemcitabine|mesh-list
24826696|NCT02135822|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24826697|NCT02135822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24826698|NCT02135822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828302|NCT00006030|Hormone Antagonists|hormone antagonists|mesh-ancestor
25828303|NCT00006030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25828304|NCT00006030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828305|NCT00006030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25828306|NCT00006030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828307|NCT00006030|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25828308|NCT00006030|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25828309|NCT00006030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25828310|NCT00006032|Etoposide|etoposide|mesh-list
25203459|NCT02714179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25828311|NCT00006032|Topotecan|topotecan|mesh-list
25828312|NCT00006032|Ifosfamide|ifosfamide|mesh-list
25828313|NCT00006032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25828314|NCT00006032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828315|NCT00006032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25828316|NCT00006032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25828317|NCT00006032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828318|NCT00006032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828319|NCT00006032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25828320|NCT00006032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25828321|NCT00006032|Alkylating Agents|alkylating agents|mesh-ancestor
25828322|NCT00006033|Methotrexate|methotrexate|mesh-list
25828323|NCT00006033|Interleukin-2|interleukin-2|mesh-list
24586296|NCT00890175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25828324|NCT00006033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25828325|NCT00006033|Abortifacient Agents|abortifacient agents|mesh-ancestor
25828326|NCT00006033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25828327|NCT00006033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828328|NCT00006033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25828329|NCT00006033|Antimetabolites|antimetabolites|mesh-ancestor
25828330|NCT00006033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828331|NCT00006033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828332|NCT00006033|Dermatologic Agents|dermatologic agents|mesh-ancestor
24826701|NCT02135822|Mitosis Modulators|mitosis modulators|mesh-ancestor
25828333|NCT00006033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828334|NCT00006033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25828335|NCT00006033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25828336|NCT00006033|Immunologic Factors|immunologic factors|mesh-ancestor
25828337|NCT00006033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25828338|NCT00006033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25828339|NCT00006033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25828340|NCT00006033|Analgesics|analgesics|mesh-ancestor
25828341|NCT00006033|Sensory System Agents|sensory system agents|mesh-ancestor
25828342|NCT00006033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25828343|NCT00006034|Doxorubicin|doxorubicin|mesh-list
25828344|NCT00006034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25828345|NCT00006034|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
25828346|NCT00006034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25828347|NCT00006034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828348|NCT00006034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25828349|NCT00006034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25828350|NCT00006034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828351|NCT00006034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828352|NCT00006034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25828353|NCT00006034|Immunologic Factors|immunologic factors|mesh-ancestor
25828354|NCT00006034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828355|NCT00006035|Bleomycin|bleomycin|mesh-list
25828356|NCT00006035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25828357|NCT00006035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828358|NCT00006036|Cisplatin|cisplatin|mesh-list
25828359|NCT00006036|Lurtotecan|lurtotecan|mesh-list
25828360|NCT00006036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828361|NCT00006037|Fluorouracil|fluorouracil|mesh-list
25828362|NCT00006037|Irinotecan|irinotecan|mesh-list
25828363|NCT00006037|Antimetabolites|antimetabolites|mesh-ancestor
25828364|NCT00006037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828365|NCT00006037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25828366|NCT00006037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828367|NCT00006037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25828368|NCT00006037|Immunologic Factors|immunologic factors|mesh-ancestor
25828369|NCT00006037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828370|NCT00006037|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25828371|NCT00006037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25828372|NCT00006037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828373|NCT00006038|Leucovorin|leucovorin|mesh-list
25828374|NCT00006038|Cisplatin|cisplatin|mesh-list
25828375|NCT00006038|Docetaxel|docetaxel|mesh-list
25828376|NCT00006038|Fluorouracil|fluorouracil|mesh-list
25828377|NCT00006038|Floxuridine|floxuridine|mesh-list
25828378|NCT00006038|Calcium|calcium|mesh-list
25828379|NCT00006038|Levoleucovorin|levoleucovorin|mesh-list
24443773|NCT00295971|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25828380|NCT00006038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828381|NCT00006038|Tubulin Modulators|tubulin modulators|mesh-ancestor
25828382|NCT00006038|Antimitotic Agents|antimitotic agents|mesh-ancestor
25828383|NCT00006038|Mitosis Modulators|mitosis modulators|mesh-ancestor
25828384|NCT00006038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828385|NCT00006038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25828386|NCT00006038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828387|NCT00006038|Antimetabolites|antimetabolites|mesh-ancestor
25828388|NCT00006038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25828389|NCT00006038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25828390|NCT00006038|Immunologic Factors|immunologic factors|mesh-ancestor
25828391|NCT00006038|Antidotes|antidotes|mesh-ancestor
25828392|NCT00006038|Protective Agents|protective agents|mesh-ancestor
25828393|NCT00006038|Vitamin B Complex|vitamin b complex|mesh-ancestor
25828394|NCT00006038|Vitamins|vitamins|mesh-ancestor
25828395|NCT00006038|Micronutrients|micronutrients|mesh-ancestor
25828396|NCT00006039|Interferons|interferons|mesh-list
25828397|NCT00006039|Interferon-alpha|interferon-alpha|mesh-list
25013953|NCT05219656|Antifungal Agents|antifungal agents|mesh-ancestor
25828398|NCT00006039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24443783|NCT00295971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25828399|NCT00006039|Antiviral Agents|antiviral agents|mesh-ancestor
25203460|NCT02714179|Analgesics|analgesics|mesh-ancestor
25828400|NCT00006039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25203461|NCT02714179|Sensory System Agents|sensory system agents|mesh-ancestor
25828401|NCT00006039|Immunologic Factors|immunologic factors|mesh-ancestor
25828402|NCT00006039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443838|NCT00296010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24443839|NCT00296010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24443840|NCT00296010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24826758|NCT02135887|Antimetabolites|antimetabolites|mesh-ancestor
24826759|NCT02135887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014009|NCT05179499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25014010|NCT05179499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24443879|NCT00296049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24443880|NCT00296062|Bevacizumab|bevacizumab|mesh-list
25828403|NCT00006040|Etoposide|etoposide|mesh-list
24826775|NCT02135913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24826776|NCT02135965|Caffeine|caffeine|mesh-list
24826777|NCT02135965|Albuterol|albuterol|mesh-list
24826778|NCT02135965|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24826779|NCT02135965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826780|NCT02135965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24443912|NCT00296179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24443913|NCT00296179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24443914|NCT00296179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443915|NCT00296179|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24443916|NCT00296179|GABA Agonists|gaba agonists|mesh-ancestor
24443917|NCT00296179|GABA Agents|gaba agents|mesh-ancestor
24443918|NCT00296179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24443919|NCT00296179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443920|NCT00296205|Cyclophosphamide|cyclophosphamide|mesh-list
24443921|NCT00296205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24443922|NCT00296205|Immunologic Factors|immunologic factors|mesh-ancestor
24443923|NCT00296205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443934|NCT00296218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828404|NCT00006040|Antibodies|antibodies|mesh-list
25828405|NCT00006040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25828406|NCT00006040|Immunologic Factors|immunologic factors|mesh-ancestor
25828407|NCT00006040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828408|NCT00006040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25828409|NCT00006040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828410|NCT00006040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25828411|NCT00006040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25828412|NCT00006040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826792|NCT02135965|Tocolytic Agents|tocolytic agents|mesh-ancestor
24826793|NCT02135965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24826794|NCT02135965|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24826795|NCT02135965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24826796|NCT02135965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24711230|NCT01514175|Ibuprofen|ibuprofen|mesh-list
25828413|NCT00006040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014078|NCT05081375|Enoxaparin|enoxaparin|mesh-list
25828414|NCT00006041|Vaccines|vaccines|mesh-list
24826841|NCT02136511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826842|NCT02136511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24826843|NCT02136511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826844|NCT02136511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014129|NCT05011357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25828415|NCT00006041|Saponin QA-21V1|saponin qa-21v1|mesh-list
25828416|NCT00006041|Immunologic Factors|immunologic factors|mesh-ancestor
25828417|NCT00006041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828418|NCT00006041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25828419|NCT00006042|Mycophenolic Acid|mycophenolic acid|mesh-list
25828420|NCT00006042|Cyclophosphamide|cyclophosphamide|mesh-list
25828421|NCT00006042|Fludarabine|fludarabine|mesh-list
25828422|NCT00006042|Fludarabine phosphate|fludarabine phosphate|mesh-list
25828423|NCT00006042|Tacrolimus|tacrolimus|mesh-list
25828424|NCT00006042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25014192|NCT04915768|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24443975|NCT00296387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24826867|NCT02136641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24826868|NCT02136641|Anesthetics, General|anesthetics, general|mesh-ancestor
24826870|NCT02136641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24826871|NCT02136641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24826872|NCT02136641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25828425|NCT00006042|Immunologic Factors|immunologic factors|mesh-ancestor
24665034|NCT01309776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24665140|NCT01310361|Penicillin G|penicillin g|mesh-list
24665141|NCT01310361|Penicillin G Benzathine|penicillin g benzathine|mesh-list
24665142|NCT01310361|Penicillin G Procaine|penicillin g procaine|mesh-list
24665143|NCT01310361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24665322|NCT01311739|Hydroxocobalamin|hydroxocobalamin|mesh-list
24665323|NCT01311739|Vitamin B Complex|vitamin b complex|mesh-ancestor
24665324|NCT01311739|Vitamins|vitamins|mesh-ancestor
24665325|NCT01311739|Micronutrients|micronutrients|mesh-ancestor
25828426|NCT00006042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828427|NCT00006042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25828428|NCT00006042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25828429|NCT00006042|Alkylating Agents|alkylating agents|mesh-ancestor
25828430|NCT00006042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828431|NCT00006042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828432|NCT00006042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25014334|NCT04717765|Protective Agents|protective agents|mesh-ancestor
25014335|NCT04717765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014336|NCT04717765|Vitamins|vitamins|mesh-ancestor
25828433|NCT00006042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25828434|NCT00006042|Antimetabolites|antimetabolites|mesh-ancestor
25828435|NCT00006042|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24533597|NCT00644553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24533598|NCT00644553|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24444034|NCT00296608|Levoleucovorin|levoleucovorin|mesh-list
25828436|NCT00006042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826916|NCT02136823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826917|NCT02136823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826918|NCT02136823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24826919|NCT02136823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24826920|NCT02136823|Anticonvulsants|anticonvulsants|mesh-ancestor
24826921|NCT02136823|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25014338|NCT04704219|Pembrolizumab|pembrolizumab|mesh-list
25014339|NCT04704219|Lenvatinib|lenvatinib|mesh-list
25014340|NCT04704219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25014341|NCT04704219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25014342|NCT04704219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25014343|NCT04704219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25014344|NCT04704219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826995|NCT02137083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24826996|NCT02137083|Hormone Antagonists|hormone antagonists|mesh-ancestor
24826997|NCT02137083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24826998|NCT02137083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826999|NCT02137109|Natalizumab|natalizumab|mesh-list
24827000|NCT02137109|Immunologic Factors|immunologic factors|mesh-ancestor
24827003|NCT02137161|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
24827004|NCT02137161|Dexamethasone|dexamethasone|mesh-list
24827005|NCT02137161|Bromfenac|bromfenac|mesh-list
24827006|NCT02137161|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24827007|NCT02137161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24827008|NCT02137161|Antiemetics|antiemetics|mesh-ancestor
24827009|NCT02137161|Autonomic Agents|autonomic agents|mesh-ancestor
24827010|NCT02137161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25014383|NCT04625088|Respiratory System Agents|respiratory system agents|mesh-ancestor
25014384|NCT04625088|Mydriatics|mydriatics|mesh-ancestor
25014385|NCT04625088|Parasympatholytics|parasympatholytics|mesh-ancestor
25014386|NCT04625088|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25649977|NCT01498289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649978|NCT01498289|Antidotes|antidotes|mesh-ancestor
25649979|NCT01498289|Protective Agents|protective agents|mesh-ancestor
25649980|NCT01498289|Vitamin B Complex|vitamin b complex|mesh-ancestor
25649981|NCT01498289|Vitamins|vitamins|mesh-ancestor
25649982|NCT01498289|Micronutrients|micronutrients|mesh-ancestor
25649983|NCT01498419|Moxifloxacin|moxifloxacin|mesh-list
25649984|NCT01498419|Pyrazinamide|pyrazinamide|mesh-list
25649985|NCT01498419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25649986|NCT01498419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25649987|NCT01498419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25649988|NCT01498419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25649989|NCT01498419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643814|NCT01187537|Bupivacaine|bupivacaine|mesh-list
24952334|NCT03894839|Eusol|eusol|mesh-list
24857371|NCT02291367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24857372|NCT02291367|Dopamine Agents|dopamine agents|mesh-ancestor
25828437|NCT00006042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25828438|NCT00006042|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25014387|NCT04625088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25014388|NCT04625088|Cholinergic Agents|cholinergic agents|mesh-ancestor
25014389|NCT04625088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25014390|NCT04625088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014391|NCT04597671|Durvalumab|durvalumab|mesh-list
25649990|NCT01498419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25649991|NCT01498419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649992|NCT01498419|Antitubercular Agents|antitubercular agents|mesh-ancestor
25649993|NCT01498445|Decitabine|decitabine|mesh-list
25649994|NCT01498445|Dasatinib|dasatinib|mesh-list
25649995|NCT01498445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25649996|NCT01498445|Antimetabolites|antimetabolites|mesh-ancestor
25649997|NCT01498445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828439|NCT00006042|Antitubercular Agents|antitubercular agents|mesh-ancestor
25828440|NCT00006042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24827011|NCT02137161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827012|NCT02137161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25828441|NCT00006042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25828442|NCT00006043|Temozolomide|temozolomide|mesh-list
24827013|NCT02137161|Glucocorticoids|glucocorticoids|mesh-ancestor
24827014|NCT02137161|Hormones|hormones|mesh-ancestor
24827015|NCT02137161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24468233|NCT00380614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24827031|NCT02137239|Mycophenolic Acid|mycophenolic acid|mesh-list
24827033|NCT02137239|Methylprednisolone|methylprednisolone|mesh-list
24444049|NCT00296634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25828443|NCT00006043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24444050|NCT00296634|Immunologic Factors|immunologic factors|mesh-ancestor
25828444|NCT00006043|Alkylating Agents|alkylating agents|mesh-ancestor
25828445|NCT00006043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149922|NCT05399173|Coagulants|coagulants|mesh-ancestor
25149923|NCT05399173|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25149924|NCT05399173|Natriuretic Agents|natriuretic agents|mesh-ancestor
25149925|NCT05399173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149960|NCT05386030|Lidocaine|lidocaine|mesh-list
25149961|NCT05386030|Anesthetics, Local|anesthetics, local|mesh-ancestor
25149962|NCT05386030|Anesthetics|anesthetics|mesh-ancestor
25149963|NCT05386030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25149964|NCT05386030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828446|NCT00006043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828447|NCT00006044|Testosterone|testosterone|mesh-list
25828448|NCT00006044|Androgens|androgens|mesh-ancestor
25152254|NCT04167085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25014418|NCT04562779|Anesthetics|anesthetics|mesh-ancestor
25014419|NCT04562779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25152255|NCT04167085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25152262|NCT04166396|Resveratrol|resveratrol|mesh-list
25152263|NCT04166396|Antioxidants|antioxidants|mesh-ancestor
25152264|NCT04166396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25152265|NCT04166396|Protective Agents|protective agents|mesh-ancestor
25152266|NCT04166396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203464|NCT02714179|Antipyretics|antipyretics|mesh-ancestor
25828449|NCT00006044|Hormones|hormones|mesh-ancestor
25828450|NCT00006044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25828451|NCT00006044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828452|NCT00006045|Cytarabine|cytarabine|mesh-list
25014433|NCT04523363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828453|NCT00006045|Etoposide|etoposide|mesh-list
25828454|NCT00006045|Mitoxantrone|mitoxantrone|mesh-list
25828455|NCT00006045|Lintuzumab|lintuzumab|mesh-list
25828456|NCT00006045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25828457|NCT00006045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828458|NCT00006045|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25828459|NCT00006045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25828460|NCT00006045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25649998|NCT01498445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25649999|NCT01498445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650000|NCT01498445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25650001|NCT01498549|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25650002|NCT01498549|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24468156|NCT00380224|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24468157|NCT00380224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24468158|NCT00380224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24468159|NCT00380224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24468160|NCT00380224|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25014451|NCT04517435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25014452|NCT04517435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25014453|NCT04517435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25014454|NCT04517435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25014455|NCT04517435|Glucocorticoids|glucocorticoids|mesh-ancestor
25014457|NCT04517435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25014458|NCT04517435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25014459|NCT04517435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25014463|NCT04509050|Ivacaftor|ivacaftor|mesh-list
24468161|NCT00380224|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24468162|NCT00380224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24468235|NCT00380640|Trimethoprim|trimethoprim|mesh-list
24468236|NCT00380640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24456917|NCT00332631|Respiratory System Agents|respiratory system agents|mesh-ancestor
24456918|NCT00332631|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24576368|NCT00838214|Respiratory System Agents|respiratory system agents|mesh-ancestor
25014480|NCT04484922|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25014481|NCT04484922|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25014482|NCT04484922|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25014483|NCT04484922|Adrenergic Agents|adrenergic agents|mesh-ancestor
25014484|NCT04484922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25014485|NCT04484922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456919|NCT00332631|Antioxidants|antioxidants|mesh-ancestor
24941528|NCT03990571|Immunologic Factors|immunologic factors|mesh-ancestor
24480551|NCT00431249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24457157|NCT00333255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24457158|NCT00333255|Analgesics|analgesics|mesh-ancestor
24457159|NCT00333255|Sensory System Agents|sensory system agents|mesh-ancestor
24457160|NCT00333255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24457161|NCT00333255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942694|NCT03978884|Natriuretic Agents|natriuretic agents|mesh-ancestor
24480898|NCT00432588|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24480899|NCT00432588|Abortifacient Agents|abortifacient agents|mesh-ancestor
24480900|NCT00432588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24480901|NCT00432588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014487|NCT04446390|Sodium Fluoride|sodium fluoride|mesh-list
25014488|NCT04446390|Cariostatic Agents|cariostatic agents|mesh-ancestor
25014489|NCT04446390|Protective Agents|protective agents|mesh-ancestor
25014490|NCT04446390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014491|NCT04446390|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25014492|NCT04446390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25110646|NCT05414240|Ibudilast|ibudilast|mesh-list
24480902|NCT00432588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24480903|NCT00432588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24480904|NCT00432588|Oxytocics|oxytocics|mesh-ancestor
24481102|NCT00433277|Dermatologic Agents|dermatologic agents|mesh-ancestor
25828461|NCT00006045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828462|NCT00006045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25828463|NCT00006045|Antimetabolites|antimetabolites|mesh-ancestor
25828464|NCT00006045|Antiviral Agents|antiviral agents|mesh-ancestor
24481127|NCT00433433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481129|NCT00433459|Prednisolone|prednisolone|mesh-list
24481130|NCT00433459|Cyclophosphamide|cyclophosphamide|mesh-list
24481131|NCT00433459|Dacarbazine|dacarbazine|mesh-list
24481132|NCT00433459|Vincristine|vincristine|mesh-list
24481143|NCT00433459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25110653|NCT05414240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25110654|NCT05414240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25110655|NCT05414240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110656|NCT05414240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25110657|NCT05414240|Vasodilator Agents|vasodilator agents|mesh-ancestor
24971122|NCT03728465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24971123|NCT03728465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828465|NCT00006045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24481277|NCT00433953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24481278|NCT00433953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481279|NCT00433953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25828466|NCT00006045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25828468|NCT00006045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828469|NCT00006045|Analgesics|analgesics|mesh-ancestor
25828470|NCT00006045|Sensory System Agents|sensory system agents|mesh-ancestor
25828471|NCT00006045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24481343|NCT00434083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25828472|NCT00006045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24971125|NCT03728244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24971126|NCT03728244|Immunologic Factors|immunologic factors|mesh-ancestor
24971127|NCT03728244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971128|NCT03728244|Viscosupplements|viscosupplements|mesh-ancestor
24971129|NCT03728244|Protective Agents|protective agents|mesh-ancestor
24971130|NCT03728192|Camptothecin|camptothecin|mesh-list
24457219|NCT00333476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457220|NCT00333476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24457221|NCT00333476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25828473|NCT00006047|Etoposide|etoposide|mesh-list
25828474|NCT00006047|Rubitecan|rubitecan|mesh-list
25828475|NCT00006047|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
25828476|NCT00006047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25828477|NCT00006047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481667|NCT00436293|Docetaxel|docetaxel|mesh-list
24481668|NCT00436293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481669|NCT00436293|Tubulin Modulators|tubulin modulators|mesh-ancestor
25828478|NCT00006047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25828479|NCT00006047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25828480|NCT00006047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828481|NCT00006047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828482|NCT00006048|Gemcitabine|gemcitabine|mesh-list
25828483|NCT00006048|Cisplatin|cisplatin|mesh-list
24971150|NCT03728153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24586415|NCT00890565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24586416|NCT00890565|Serotonin Agents|serotonin agents|mesh-ancestor
24586417|NCT00890565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24586418|NCT00890565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586419|NCT00890604|Acetaminophen|acetaminophen|mesh-list
24586420|NCT00890604|Ibuprofen|ibuprofen|mesh-list
24586421|NCT00890604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24586422|NCT00890604|Analgesics|analgesics|mesh-ancestor
24482141|NCT00438048|Miotics|miotics|mesh-ancestor
24482142|NCT00438048|Autonomic Agents|autonomic agents|mesh-ancestor
24457255|NCT00333632|Analgesics|analgesics|mesh-ancestor
24457256|NCT00333632|Sensory System Agents|sensory system agents|mesh-ancestor
24457257|NCT00333632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24457258|NCT00333632|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24458644|NCT00338650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25828484|NCT00006048|Gefitinib|gefitinib|mesh-list
25828485|NCT00006048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828486|NCT00006048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25828487|NCT00006048|Antimetabolites|antimetabolites|mesh-ancestor
25828488|NCT00006048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828489|NCT00006048|Antiviral Agents|antiviral agents|mesh-ancestor
25828490|NCT00006048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24483591|NCT00444184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483592|NCT00444184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014517|NCT04400058|gamma-Globulins|gamma-globulins|mesh-list
25014519|NCT04400058|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25014520|NCT04400058|Immunologic Factors|immunologic factors|mesh-ancestor
25014521|NCT04400058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828491|NCT00006048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828492|NCT00006048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24483593|NCT00444184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24483594|NCT00444184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24483596|NCT00444223|Cariostatic Agents|cariostatic agents|mesh-ancestor
24483603|NCT00444236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828493|NCT00006048|Immunologic Factors|immunologic factors|mesh-ancestor
25828494|NCT00006048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828495|NCT00006048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25828496|NCT00006049|Paclitaxel|paclitaxel|mesh-list
25828497|NCT00006049|Carboplatin|carboplatin|mesh-list
25828498|NCT00006049|Gefitinib|gefitinib|mesh-list
24486001|NCT00455806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24486002|NCT00455806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24486003|NCT00455806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486004|NCT00455806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828499|NCT00006049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24486005|NCT00455806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486130|NCT00456430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25014559|NCT04322669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25014560|NCT04322669|Immunologic Factors|immunologic factors|mesh-ancestor
25014561|NCT04322669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014562|NCT04291521|Ketamine|ketamine|mesh-list
25014563|NCT04291521|Propofol|propofol|mesh-list
25014564|NCT04291521|Etomidate|etomidate|mesh-list
24486131|NCT00456430|Antidepressive Agents|antidepressive agents|mesh-ancestor
24486132|NCT00456430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24943816|NCT03966859|Atorvastatin|atorvastatin|mesh-list
24486562|NCT00458458|Leuprolide|leuprolide|mesh-list
24486563|NCT00458458|Norethindrone|norethindrone|mesh-list
24486564|NCT00458458|Norethindrone Acetate|norethindrone acetate|mesh-list
24486565|NCT00458458|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24486566|NCT00458458|Fertility Agents|fertility agents|mesh-ancestor
24486600|NCT00458718|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24486601|NCT00458718|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24486602|NCT00458718|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24486603|NCT00458718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25014598|NCT04230161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25014599|NCT04214691|Acetaminophen|acetaminophen|mesh-list
24486604|NCT00458718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486638|NCT00458991|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24486639|NCT00458991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486640|NCT00458991|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24486641|NCT00458991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486642|NCT00458991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486643|NCT00458991|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24943838|NCT03966378|Caseins|caseins|mesh-list
24493785|NCT00492466|Interferon-beta|interferon-beta|mesh-list
24493786|NCT00492466|Interferon beta-1a|interferon beta-1a|mesh-list
24493787|NCT00492466|Methylprednisolone|methylprednisolone|mesh-list
24493788|NCT00492466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493789|NCT00492466|Antiviral Agents|antiviral agents|mesh-ancestor
24493790|NCT00492466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493826|NCT00492518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24457566|NCT00334672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25014628|NCT04198116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25014629|NCT04198116|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25014630|NCT04198116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25014631|NCT04198116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25014632|NCT04198116|Adrenergic Agents|adrenergic agents|mesh-ancestor
25014633|NCT04183452|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
25014640|NCT04183452|Hormones|hormones|mesh-ancestor
24493945|NCT00493129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493946|NCT00493129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24493985|NCT00493233|Autonomic Agents|autonomic agents|mesh-ancestor
24493986|NCT00493233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25117008|NCT03105466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525444|NCT03333408|Clindamycin phosphate|clindamycin phosphate|mesh-list
24525445|NCT03333408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24525446|NCT03333408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25014644|NCT04157894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24505566|NCT00541463|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24506068|NCT00544011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24506069|NCT00544011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506070|NCT00544011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24457688|NCT00334880|Dopamine Agents|dopamine agents|mesh-ancestor
24457689|NCT00334880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24457691|NCT00334906|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25828500|NCT00006049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828501|NCT00006049|Tubulin Modulators|tubulin modulators|mesh-ancestor
25014654|NCT04095208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513616|NCT00584155|Ofloxacin|ofloxacin|mesh-list
24513617|NCT00584155|Levofloxacin|levofloxacin|mesh-list
24513664|NCT00584389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519744|NCT05242874|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24519745|NCT05242874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24519781|NCT05151471|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24519783|NCT05151471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519784|NCT05151471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24519828|NCT04907370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203465|NCT02714361|Vitamin D|vitamin d|mesh-list
24520060|NCT03980769|Antimetabolites|antimetabolites|mesh-ancestor
25828502|NCT00006049|Antimitotic Agents|antimitotic agents|mesh-ancestor
25828503|NCT00006049|Mitosis Modulators|mitosis modulators|mesh-ancestor
25828504|NCT00006049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520061|NCT03980769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520062|NCT03980769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24520063|NCT03980769|Immunologic Factors|immunologic factors|mesh-ancestor
25828505|NCT00006049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24520099|NCT03897335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24520135|NCT03879577|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24520136|NCT03879577|Hormone Antagonists|hormone antagonists|mesh-ancestor
24394218|NCT00132561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24520169|NCT03608657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24520170|NCT03608657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24576684|NCT00839761|Iron|iron|mesh-list
24520172|NCT03608657|Sensory System Agents|sensory system agents|mesh-ancestor
24520173|NCT03608657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24520246|NCT03486314|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24520247|NCT03486314|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24520248|NCT03486314|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24520249|NCT03486314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24520382|NCT02419287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520383|NCT02419287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24520384|NCT02419287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24520385|NCT02419287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520386|NCT02342444|Enoxaparin|enoxaparin|mesh-list
24520387|NCT02342444|Enoxaparin sodium|enoxaparin sodium|mesh-list
25014738|NCT03980314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397159|NCT00140933|Rofecoxib|rofecoxib|mesh-list
24520388|NCT02342444|Anticoagulants|anticoagulants|mesh-ancestor
24520428|NCT02020707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520966|NCT05217589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520968|NCT05210764|Anesthetics|anesthetics|mesh-list
24520969|NCT05210764|Propofol|propofol|mesh-list
24520970|NCT05210764|Sevoflurane|sevoflurane|mesh-list
24520971|NCT05210764|Esketamine|esketamine|mesh-list
24521005|NCT05210374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24521006|NCT05210374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521008|NCT05210374|Micronutrients|micronutrients|mesh-ancestor
24521009|NCT05210374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521010|NCT05210374|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24521011|NCT05210374|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
24521012|NCT05208333|Albendazole|albendazole|mesh-list
24521013|NCT05208333|Anthelmintics|anthelmintics|mesh-ancestor
24521161|NCT05037045|Incretins|incretins|mesh-ancestor
24430381|NCT00247507|Expectorants|expectorants|mesh-ancestor
24521236|NCT04951388|Protease Inhibitors|protease inhibitors|mesh-ancestor
24521237|NCT04951388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24521238|NCT04951388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014783|NCT03868956|Fibrin fragment D|fibrin fragment d|mesh-list
25014784|NCT03868956|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25014785|NCT03868956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24397296|NCT00141258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24521415|NCT04791059|Anesthetics, General|anesthetics, general|mesh-ancestor
24521416|NCT04791059|Anesthetics|anesthetics|mesh-ancestor
24527708|NCT00618163|Meloxicam|meloxicam|mesh-list
24521417|NCT04791059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24521452|NCT04763135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24521453|NCT04763135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24521454|NCT04763135|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25014792|NCT03841097|Tacrolimus|tacrolimus|mesh-list
25014793|NCT03841097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25014794|NCT03841097|Immunologic Factors|immunologic factors|mesh-ancestor
24790434|NCT01942447|Vancomycin|vancomycin|mesh-list
24521455|NCT04763135|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24521456|NCT04763135|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24521492|NCT04745975|Antimetabolites|antimetabolites|mesh-ancestor
24523817|NCT05340153|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24524880|NCT04243122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24526883|NCT00613561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24526999|NCT00614159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25014806|NCT03814356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25014807|NCT03814356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24527000|NCT00614159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25656868|NCT01580020|Glucocorticoids|glucocorticoids|mesh-ancestor
25828506|NCT00006049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527002|NCT00614328|Baclofen|baclofen|mesh-list
24527003|NCT00614328|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24527031|NCT00614653|Bevacizumab|bevacizumab|mesh-list
24527032|NCT00614653|Capecitabine|capecitabine|mesh-list
24527033|NCT00614653|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24527034|NCT00614653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24527035|NCT00614653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527036|NCT00614653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24527037|NCT00614653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24527038|NCT00614653|Growth Substances|growth substances|mesh-ancestor
24527039|NCT00614653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527040|NCT00614653|Growth Inhibitors|growth inhibitors|mesh-ancestor
24527041|NCT00614653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24527067|NCT00614757|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24457840|NCT00335348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24457841|NCT00335348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24457842|NCT00335348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527069|NCT00614757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527089|NCT00614835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527090|NCT00614835|Tubulin Modulators|tubulin modulators|mesh-ancestor
24431795|NCT00252889|Topotecan|topotecan|mesh-list
24527110|NCT00615134|Enfuvirtide|enfuvirtide|mesh-list
25014839|NCT03809624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24527111|NCT00615134|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24527112|NCT00615134|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24527113|NCT00615134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527114|NCT00615134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24527115|NCT00615134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24527209|NCT00615524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527210|NCT00615524|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24527211|NCT00615524|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24527212|NCT00615524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527213|NCT00615524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527214|NCT00615524|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24527215|NCT00615524|Hormone Antagonists|hormone antagonists|mesh-ancestor
24527216|NCT00615524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24527217|NCT00615524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527218|NCT00615602|Cyclophosphamide|cyclophosphamide|mesh-list
24527219|NCT00615602|Docetaxel|docetaxel|mesh-list
24527250|NCT00615667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24527251|NCT00615667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527252|NCT00615667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538409|NCT00659113|Tegafur|tegafur|mesh-list
24586432|NCT00890604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527253|NCT00615745|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24527254|NCT00615745|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24527375|NCT00616213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527377|NCT00616382|Pentoxifylline|pentoxifylline|mesh-list
24527378|NCT00616382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24527379|NCT00616382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24527380|NCT00616382|Analgesics|analgesics|mesh-ancestor
24527381|NCT00616382|Sensory System Agents|sensory system agents|mesh-ancestor
24527404|NCT00616460|Antithrombins|antithrombins|mesh-ancestor
24527405|NCT00616460|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24527406|NCT00616460|Protease Inhibitors|protease inhibitors|mesh-ancestor
24527407|NCT00616460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527442|NCT00616694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24527443|NCT00616694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527444|NCT00616694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24431999|NCT00253422|Exemestane|exemestane|mesh-list
24457848|NCT00335413|Hormone Antagonists|hormone antagonists|mesh-ancestor
24457849|NCT00335413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24399269|NCT00147303|Serotonin Agents|serotonin agents|mesh-ancestor
24527484|NCT00616850|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24527485|NCT00616850|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24527486|NCT00616850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24527487|NCT00616850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527527|NCT00617045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24527836|NCT00618423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25656869|NCT01580020|Hormones|hormones|mesh-ancestor
24527837|NCT00618423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24528397|NCT00620997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528398|NCT00620997|Sensory System Agents|sensory system agents|mesh-ancestor
24528399|NCT00620997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24528402|NCT00621036|Immunoglobulins|immunoglobulins|mesh-list
24528403|NCT00621036|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24528404|NCT00621036|Antibodies|antibodies|mesh-list
24528405|NCT00621036|Sargramostim|sargramostim|mesh-list
24528406|NCT00621036|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
24528515|NCT00621452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24457862|NCT00335439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24528516|NCT00621452|Alkylating Agents|alkylating agents|mesh-ancestor
24528517|NCT00621452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528518|NCT00621452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528519|NCT00621452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24528559|NCT00621647|Antidepressive Agents|antidepressive agents|mesh-ancestor
24528560|NCT00621647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24528590|NCT00621790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528591|NCT00621790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528592|NCT00621816|Nitroprusside|nitroprusside|mesh-list
24528593|NCT00621816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24528594|NCT00621816|Vasodilator Agents|vasodilator agents|mesh-ancestor
24528595|NCT00621816|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24528627|NCT00621998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24528629|NCT00621998|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24528630|NCT00621998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24528631|NCT00621998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24528632|NCT00622011|Risperidone|risperidone|mesh-list
24528633|NCT00622011|Zotepine|zotepine|mesh-list
24528634|NCT00622011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24528635|NCT00622011|Serotonin Agents|serotonin agents|mesh-ancestor
24528636|NCT00622011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24394223|NCT00132587|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
25166576|NCT03885830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015044|NCT03437421|Vitamins|vitamins|mesh-ancestor
24528971|NCT00624026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528972|NCT00624026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528973|NCT00624026|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24529119|NCT00624676|Dermatologic Agents|dermatologic agents|mesh-ancestor
24529120|NCT00624676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24529141|NCT00624741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529142|NCT00624741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015178|NCT03033225|Verteporfin|verteporfin|mesh-list
25155856|NCT05256537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25155857|NCT05256537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25155858|NCT05256537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25155859|NCT05256537|Antitubercular Agents|antitubercular agents|mesh-ancestor
25155860|NCT05256537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25115060|NCT03118713|Ipragliflozin|ipragliflozin|mesh-list
25115061|NCT03118713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24946587|NCT03937258|Probenecid|probenecid|mesh-list
24830530|NCT02159690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24830531|NCT02159690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830532|NCT02159690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830533|NCT02159690|Hormone Antagonists|hormone antagonists|mesh-ancestor
24830534|NCT02159690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24830535|NCT02159690|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24830536|NCT02159820|Paclitaxel|paclitaxel|mesh-list
24830537|NCT02159820|Carboplatin|carboplatin|mesh-list
24830538|NCT02159820|Decitabine|decitabine|mesh-list
24830539|NCT02159820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25828507|NCT00006050|Leucovorin|leucovorin|mesh-list
24830549|NCT02159911|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25828508|NCT00006050|Fluorouracil|fluorouracil|mesh-list
25828509|NCT00006050|Oxaliplatin|oxaliplatin|mesh-list
25828510|NCT00006050|Calcium|calcium|mesh-list
25828511|NCT00006050|Levoleucovorin|levoleucovorin|mesh-list
25828512|NCT00006050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25828513|NCT00006050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828514|NCT00006050|Antimetabolites|antimetabolites|mesh-ancestor
25828515|NCT00006050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828516|NCT00006050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25828517|NCT00006050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828519|NCT00006050|Immunologic Factors|immunologic factors|mesh-ancestor
25828520|NCT00006050|Antidotes|antidotes|mesh-ancestor
25828521|NCT00006050|Protective Agents|protective agents|mesh-ancestor
25828522|NCT00006050|Vitamin B Complex|vitamin b complex|mesh-ancestor
25828523|NCT00006050|Vitamins|vitamins|mesh-ancestor
25828524|NCT00006050|Micronutrients|micronutrients|mesh-ancestor
25828525|NCT00006051|Cisplatin|cisplatin|mesh-list
25828526|NCT00006051|Fluorouracil|fluorouracil|mesh-list
25828527|NCT00006051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828528|NCT00006051|Antimetabolites|antimetabolites|mesh-ancestor
25828529|NCT00006051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828530|NCT00006051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25828531|NCT00006051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25828532|NCT00006051|Immunologic Factors|immunologic factors|mesh-ancestor
25828533|NCT00006051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828534|NCT00006052|Imatinib Mesylate|imatinib mesylate|mesh-list
25828535|NCT00006052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828536|NCT00006052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25828537|NCT00006052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828538|NCT00006052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828539|NCT00006053|Imatinib Mesylate|imatinib mesylate|mesh-list
25828540|NCT00006053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828541|NCT00006053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25828542|NCT00006053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828543|NCT00006053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949209|NCT05160363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24949211|NCT05158998|Sevoflurane|sevoflurane|mesh-list
25828544|NCT00006054|Cyclosporine|cyclosporine|mesh-list
25828545|NCT00006054|Prednisone|prednisone|mesh-list
25828546|NCT00006054|Methylprednisolone|methylprednisolone|mesh-list
25828547|NCT00006054|Cyclophosphamide|cyclophosphamide|mesh-list
25828548|NCT00006054|Busulfan|busulfan|mesh-list
25828549|NCT00006054|Methotrexate|methotrexate|mesh-list
25828550|NCT00006054|Etoposide|etoposide|mesh-list
25828551|NCT00006054|Cyclosporins|cyclosporins|mesh-list
25828552|NCT00006054|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25828553|NCT00006054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25828554|NCT00006054|Immunologic Factors|immunologic factors|mesh-ancestor
25828555|NCT00006054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828556|NCT00006054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25828557|NCT00006054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25828558|NCT00006054|Alkylating Agents|alkylating agents|mesh-ancestor
25828559|NCT00006054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828560|NCT00006054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828561|NCT00006054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25828562|NCT00006054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24830893|NCT02161991|Autonomic Agents|autonomic agents|mesh-ancestor
24830894|NCT02161991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24731185|NCT01633099|Decitabine|decitabine|mesh-list
25828563|NCT00006054|Glucocorticoids|glucocorticoids|mesh-ancestor
25828564|NCT00006054|Hormones|hormones|mesh-ancestor
25828565|NCT00006054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25828566|NCT00006054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25828567|NCT00006054|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25828568|NCT00006054|Abortifacient Agents|abortifacient agents|mesh-ancestor
25828569|NCT00006054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25828570|NCT00006054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24949303|NCT05000047|Silicon|silicon|mesh-list
24449067|NCT00314158|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25015365|NCT02516696|Antiemetics|antiemetics|mesh-ancestor
25828571|NCT00006054|Antimetabolites|antimetabolites|mesh-ancestor
24831538|NCT02166632|Anesthetics, Local|anesthetics, local|mesh-ancestor
25828572|NCT00006054|Dermatologic Agents|dermatologic agents|mesh-ancestor
25828573|NCT00006054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828574|NCT00006054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25828575|NCT00006054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24830963|NCT02162251|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24830964|NCT02162251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731842|NCT01636622|Tubulin Modulators|tubulin modulators|mesh-ancestor
24830978|NCT02162303|Colchicine|colchicine|mesh-list
25828576|NCT00006054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25828577|NCT00006054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25650003|NCT01498549|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25828578|NCT00006054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25828579|NCT00006054|Antifungal Agents|antifungal agents|mesh-ancestor
25828581|NCT00006054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25828582|NCT00006054|Antiemetics|antiemetics|mesh-ancestor
25828583|NCT00006054|Autonomic Agents|autonomic agents|mesh-ancestor
25828584|NCT00006054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25828585|NCT00006054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24449117|NCT00314457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25828586|NCT00006054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25828587|NCT00006054|Protective Agents|protective agents|mesh-ancestor
25828588|NCT00006055|Cyclosporine|cyclosporine|mesh-list
25828589|NCT00006055|Prednisone|prednisone|mesh-list
25828590|NCT00006055|Methylprednisolone|methylprednisolone|mesh-list
25828591|NCT00006055|Cyclophosphamide|cyclophosphamide|mesh-list
25828592|NCT00006055|Cyclosporins|cyclosporins|mesh-list
25828593|NCT00006055|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25828594|NCT00006055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25828595|NCT00006055|Immunologic Factors|immunologic factors|mesh-ancestor
25828596|NCT00006055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828597|NCT00006055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25828598|NCT00006055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25828599|NCT00006055|Alkylating Agents|alkylating agents|mesh-ancestor
25828600|NCT00006055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828601|NCT00006055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828602|NCT00006055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25828603|NCT00006055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25828604|NCT00006055|Glucocorticoids|glucocorticoids|mesh-ancestor
25828605|NCT00006055|Hormones|hormones|mesh-ancestor
24449120|NCT00314509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24449121|NCT00314509|Autonomic Agents|autonomic agents|mesh-ancestor
24449122|NCT00314509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24463584|NCT00361517|Amphotericin B|amphotericin b|mesh-list
25828606|NCT00006055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25828607|NCT00006055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25828608|NCT00006055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828609|NCT00006055|Antifungal Agents|antifungal agents|mesh-ancestor
25828610|NCT00006055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25828611|NCT00006055|Dermatologic Agents|dermatologic agents|mesh-ancestor
25828612|NCT00006055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25828613|NCT00006055|Antiemetics|antiemetics|mesh-ancestor
25828614|NCT00006055|Autonomic Agents|autonomic agents|mesh-ancestor
25828615|NCT00006055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25828616|NCT00006055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25828617|NCT00006055|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25828618|NCT00006055|Protective Agents|protective agents|mesh-ancestor
25828619|NCT00006056|Cyclosporine|cyclosporine|mesh-list
25828620|NCT00006056|Cyclophosphamide|cyclophosphamide|mesh-list
25015488|NCT02245230|Phenylephrine|phenylephrine|mesh-list
25015519|NCT02155920|Everolimus|everolimus|mesh-list
24972118|NCT03720041|Ixazomib|ixazomib|mesh-list
25051910|NCT00364546|Adrenergic Agents|adrenergic agents|mesh-ancestor
25828621|NCT00006056|Busulfan|busulfan|mesh-list
25828622|NCT00006056|Methotrexate|methotrexate|mesh-list
25828623|NCT00006056|Etoposide|etoposide|mesh-list
25828624|NCT00006056|Cyclosporins|cyclosporins|mesh-list
25828625|NCT00006056|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25828626|NCT00006056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25828627|NCT00006056|Immunologic Factors|immunologic factors|mesh-ancestor
25828628|NCT00006056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828629|NCT00006056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25828630|NCT00006056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24972122|NCT03720041|Antiemetics|antiemetics|mesh-ancestor
25828631|NCT00006056|Alkylating Agents|alkylating agents|mesh-ancestor
25828632|NCT00006056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828633|NCT00006056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828634|NCT00006056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25828635|NCT00006056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25828636|NCT00006056|Abortifacient Agents|abortifacient agents|mesh-ancestor
25650004|NCT01498549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25650005|NCT01498549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650006|NCT01498549|Adrenergic Agents|adrenergic agents|mesh-ancestor
25828637|NCT00006056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25828638|NCT00006056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25828639|NCT00006056|Antimetabolites|antimetabolites|mesh-ancestor
25828640|NCT00006056|Dermatologic Agents|dermatologic agents|mesh-ancestor
25828641|NCT00006056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828642|NCT00006056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25828643|NCT00006056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25828644|NCT00006056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25828645|NCT00006056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25828646|NCT00006056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25828647|NCT00006056|Antifungal Agents|antifungal agents|mesh-ancestor
25828648|NCT00006056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25828649|NCT00006056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25828650|NCT00006062|Oxaliplatin|oxaliplatin|mesh-list
24831239|NCT02164448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831241|NCT02164448|Analgesics|analgesics|mesh-ancestor
24831242|NCT02164448|Sensory System Agents|sensory system agents|mesh-ancestor
24831243|NCT02164448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24831244|NCT02164448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24831245|NCT02164448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24831246|NCT02164448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24831247|NCT02164448|Adrenergic Agents|adrenergic agents|mesh-ancestor
25828651|NCT00006062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828652|NCT00006063|Pancrelipase|pancrelipase|mesh-list
25828653|NCT00006063|Pancreatin|pancreatin|mesh-list
24586583|NCT00891306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25828654|NCT00006063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25829591|NCT00006233|Immunologic Factors|immunologic factors|mesh-ancestor
25829592|NCT00006233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829593|NCT00006233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829594|NCT00006233|Antifungal Agents|antifungal agents|mesh-ancestor
25829595|NCT00006233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25829596|NCT00006233|Dermatologic Agents|dermatologic agents|mesh-ancestor
25829597|NCT00006233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25829598|NCT00006233|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25829599|NCT00006233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25829600|NCT00006233|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25829601|NCT00006233|Antitubercular Agents|antitubercular agents|mesh-ancestor
25829602|NCT00006233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25829603|NCT00006235|Carboplatin|carboplatin|mesh-list
25829604|NCT00006235|Doxorubicin|doxorubicin|mesh-list
25829605|NCT00006235|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25829606|NCT00006235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829607|NCT00006235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25829608|NCT00006235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25829609|NCT00006235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25829610|NCT00006235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829611|NCT00006235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829612|NCT00006239|Tretinoin|tretinoin|mesh-list
25829613|NCT00006239|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
24831287|NCT02164604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24831288|NCT02164604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25829614|NCT00006239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829615|NCT00006239|Keratolytic Agents|keratolytic agents|mesh-ancestor
25829616|NCT00006239|Dermatologic Agents|dermatologic agents|mesh-ancestor
25829617|NCT00006240|Dexamethasone|dexamethasone|mesh-list
25829618|NCT00006240|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25829619|NCT00006240|Sargramostim|sargramostim|mesh-list
25829620|NCT00006240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25829621|NCT00006240|Antiemetics|antiemetics|mesh-ancestor
25829622|NCT00006240|Autonomic Agents|autonomic agents|mesh-ancestor
25829623|NCT00006240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25829624|NCT00006240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829625|NCT00006240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25829626|NCT00006240|Glucocorticoids|glucocorticoids|mesh-ancestor
25829627|NCT00006240|Hormones|hormones|mesh-ancestor
25829628|NCT00006240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25829629|NCT00006240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25829630|NCT00006240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829631|NCT00006240|Immunologic Factors|immunologic factors|mesh-ancestor
25829632|NCT00006241|Lenograstim|lenograstim|mesh-list
24950585|NCT03914235|Lidocaine|lidocaine|mesh-list
25829633|NCT00006241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25829634|NCT00006241|Immunologic Factors|immunologic factors|mesh-ancestor
25829635|NCT00006241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650007|NCT01498549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25650008|NCT01498549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650009|NCT01498588|Cyclophosphamide|cyclophosphamide|mesh-list
25650010|NCT01498588|Doxorubicin|doxorubicin|mesh-list
25829636|NCT00006243|Sargramostim|sargramostim|mesh-list
25828656|NCT00006066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828657|NCT00006066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25828658|NCT00006066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25828659|NCT00006066|Antiviral Agents|antiviral agents|mesh-ancestor
25828660|NCT00006066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25828661|NCT00006070|Etanercept|etanercept|mesh-list
25828662|NCT00006070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25828663|NCT00006070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25828664|NCT00006070|Analgesics|analgesics|mesh-ancestor
25828665|NCT00006070|Sensory System Agents|sensory system agents|mesh-ancestor
25015655|NCT01144416|Hormones|hormones|mesh-ancestor
25828666|NCT00006070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25828667|NCT00006070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828668|NCT00006070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25828669|NCT00006070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25828670|NCT00006070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25828671|NCT00006070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25828672|NCT00006070|Immunologic Factors|immunologic factors|mesh-ancestor
25828673|NCT00006072|Rituximab|rituximab|mesh-list
25828674|NCT00006072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25042202|NCT01486849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24831477|NCT02165774|Neurotransmitter Agents|neurotransmitter agents|mesh-list
24831478|NCT02165774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831479|NCT02165774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831480|NCT02165813|Nitazoxanide|nitazoxanide|mesh-list
24831481|NCT02165813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25015669|NCT01077817|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25015674|NCT01065779|Alendronate|alendronate|mesh-list
24831482|NCT02165813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24831483|NCT02165917|Hyaluronic Acid|hyaluronic acid|mesh-list
24831484|NCT02165917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24831485|NCT02165917|Immunologic Factors|immunologic factors|mesh-ancestor
24831506|NCT02166229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831510|NCT02166229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24831511|NCT02166359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24831512|NCT02166359|Icodextrin|icodextrin|mesh-list
24831513|NCT02166359|Dialysis Solutions|dialysis solutions|mesh-ancestor
24831514|NCT02166450|Nystatin|nystatin|mesh-list
24831515|NCT02166450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24831516|NCT02166450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24831517|NCT02166450|Antifungal Agents|antifungal agents|mesh-ancestor
24831518|NCT02166450|Ionophores|ionophores|mesh-ancestor
24831519|NCT02166450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24831520|NCT02166450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831533|NCT02166593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831534|NCT02166593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24831535|NCT02166593|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24831536|NCT02166593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24831537|NCT02166632|Bupivacaine|bupivacaine|mesh-list
25828675|NCT00006072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828676|NCT00006072|Immunologic Factors|immunologic factors|mesh-ancestor
24831759|NCT02168634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831761|NCT02168751|Sevoflurane|sevoflurane|mesh-list
24831762|NCT02168751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24831763|NCT02168751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24831764|NCT02168751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831765|NCT02168751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24831766|NCT02168751|Anesthetics, General|anesthetics, general|mesh-ancestor
24831767|NCT02168751|Anesthetics|anesthetics|mesh-ancestor
24831768|NCT02168751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24831769|NCT02168751|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24831770|NCT02168881|Misoprostol|misoprostol|mesh-list
25828677|NCT00006072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828678|NCT00006072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25828679|NCT00006075|Chlorhexidine|chlorhexidine|mesh-list
25828680|NCT00006075|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25828681|NCT00006075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25828682|NCT00006075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25828683|NCT00006075|Disinfectants|disinfectants|mesh-ancestor
25828684|NCT00006075|Dermatologic Agents|dermatologic agents|mesh-ancestor
25828685|NCT00006077|Levodopa|levodopa|mesh-list
25042354|NCT01459679|Riboflavin|riboflavin|mesh-list
25650011|NCT01498588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25650012|NCT01498588|Immunologic Factors|immunologic factors|mesh-ancestor
25650013|NCT01498588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199687|NCT02739399|Mydriatics|mydriatics|mesh-ancestor
25042358|NCT01459679|Vitamins|vitamins|mesh-ancestor
25828686|NCT00006077|Domperidone|domperidone|mesh-list
25828687|NCT00006077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25828688|NCT00006077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25828689|NCT00006077|Dopamine Agents|dopamine agents|mesh-ancestor
25828690|NCT00006077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25828691|NCT00006077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828692|NCT00006077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828693|NCT00006077|Antiemetics|antiemetics|mesh-ancestor
25828694|NCT00006077|Autonomic Agents|autonomic agents|mesh-ancestor
25828695|NCT00006077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25828696|NCT00006077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25828697|NCT00006077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25828698|NCT00006078|Lycopene|lycopene|mesh-list
25828699|NCT00006078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25828700|NCT00006078|Antioxidants|antioxidants|mesh-ancestor
25828701|NCT00006078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828702|NCT00006078|Protective Agents|protective agents|mesh-ancestor
25828703|NCT00006078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828704|NCT00006078|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25828705|NCT00006078|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25828706|NCT00006078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828707|NCT00006079|Eflornithine|eflornithine|mesh-list
25828708|NCT00006079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828709|NCT00006079|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25828710|NCT00006079|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24590814|NCT00913887|Diclofenac|diclofenac|mesh-list
24832737|NCT02172144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24832738|NCT02172144|Respiratory System Agents|respiratory system agents|mesh-ancestor
25828711|NCT00006079|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25828712|NCT00006079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24796925|NCT01953172|Vitamins|vitamins|mesh-ancestor
25828713|NCT00006079|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
25828714|NCT00006079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828715|NCT00006079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828716|NCT00006080|Fenretinide|fenretinide|mesh-list
25828717|NCT00006080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828718|NCT00006080|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25828719|NCT00006080|Protective Agents|protective agents|mesh-ancestor
25828720|NCT00006080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828721|NCT00006081|Paclitaxel|paclitaxel|mesh-list
25828722|NCT00006081|Bryostatin 1|bryostatin 1|mesh-list
25015770|NCT00963469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25015771|NCT00960141|Loratadine|loratadine|mesh-list
25015772|NCT00960141|Montelukast|montelukast|mesh-list
25015773|NCT00960141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25828723|NCT00006081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25828724|NCT00006081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828725|NCT00006081|Tubulin Modulators|tubulin modulators|mesh-ancestor
25828726|NCT00006081|Antimitotic Agents|antimitotic agents|mesh-ancestor
25828727|NCT00006081|Mitosis Modulators|mitosis modulators|mesh-ancestor
25828728|NCT00006081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042505|NCT01425970|Interferons|interferons|mesh-list
25828729|NCT00006081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25828730|NCT00006081|Immunologic Factors|immunologic factors|mesh-ancestor
25828731|NCT00006081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015808|NCT00943397|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25015809|NCT00943397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828732|NCT00006082|Rubitecan|rubitecan|mesh-list
25828733|NCT00006082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828734|NCT00006082|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25828735|NCT00006082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25828736|NCT00006082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828737|NCT00006082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828738|NCT00006083|Dalteparin|dalteparin|mesh-list
25828739|NCT00006083|Anticoagulants|anticoagulants|mesh-ancestor
25828740|NCT00006083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25828741|NCT00006083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25828742|NCT00006083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828743|NCT00006084|Lintuzumab|lintuzumab|mesh-list
25828744|NCT00006084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25015821|NCT00911547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25650014|NCT01498588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25650015|NCT01498588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25650016|NCT01498588|Alkylating Agents|alkylating agents|mesh-ancestor
25657185|NCT01583686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25015857|NCT00817817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25015907|NCT00724789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015909|NCT00711607|Estradiol|estradiol|mesh-list
25015910|NCT00711607|Estrogens|estrogens|mesh-ancestor
24589279|NCT00906451|Antimetabolites|antimetabolites|mesh-ancestor
24589317|NCT00906828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24589318|NCT00906828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589319|NCT00906828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634467|NCT01133483|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24589320|NCT00906828|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24836634|NCT02186769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836635|NCT02186769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24836636|NCT02186769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24836637|NCT02186769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24837002|NCT02188394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043061|NCT01332656|Carboplatin|carboplatin|mesh-list
25043062|NCT01332656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25043063|NCT01332656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24837029|NCT02188472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25015972|NCT00702273|Progesterone|progesterone|mesh-list
24839968|NCT02206789|Immunologic Factors|immunologic factors|mesh-ancestor
25828747|NCT00006086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24840656|NCT02211690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24840657|NCT02211690|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24840658|NCT02211690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24840659|NCT02211690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840660|NCT02211690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840661|NCT02211690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24840662|NCT02211690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24840663|NCT02211690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24840664|NCT02211690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24840665|NCT02211729|Azithromycin|azithromycin|mesh-list
24840666|NCT02211729|Pyrimethamine|pyrimethamine|mesh-list
24840667|NCT02211729|Sulfadoxine|sulfadoxine|mesh-list
25829637|NCT00006243|Freund's Adjuvant|freund's adjuvant|mesh-list
25829638|NCT00006243|Immunologic Factors|immunologic factors|mesh-ancestor
25829639|NCT00006243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829640|NCT00006243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25829641|NCT00006245|Paclitaxel|paclitaxel|mesh-list
25829642|NCT00006245|Alvocidib|alvocidib|mesh-list
25829643|NCT00006245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25829644|NCT00006245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829645|NCT00006245|Tubulin Modulators|tubulin modulators|mesh-ancestor
25829646|NCT00006245|Antimitotic Agents|antimitotic agents|mesh-ancestor
25829647|NCT00006245|Mitosis Modulators|mitosis modulators|mesh-ancestor
25829648|NCT00006245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059383|NCT03488485|Sofosbuvir|sofosbuvir|mesh-list
24844702|NCT02233894|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24844773|NCT02234440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844975|NCT02235428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24945136|NCT03953326|Acetylcholine|acetylcholine|mesh-list
25016076|NCT00446056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25650017|NCT01498588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650018|NCT01498588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25650019|NCT01498588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25650020|NCT01498588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25828754|NCT00006088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847176|NCT02245438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24847177|NCT02245438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24953622|NCT03883022|Vancomycin|vancomycin|mesh-list
24847178|NCT02245438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24847179|NCT02245438|Estrogens|estrogens|mesh-ancestor
24847180|NCT02245438|Hormones|hormones|mesh-ancestor
24948085|NCT03923257|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25828755|NCT00006089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25828756|NCT00006089|Trastuzumab|trastuzumab|mesh-list
25016193|NCT00245570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25016194|NCT00245570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25016195|NCT00245570|Adrenergic Agents|adrenergic agents|mesh-ancestor
25016196|NCT00245570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25016197|NCT00245570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011570|NCT04703036|Glycine|glycine|mesh-list
25828757|NCT00006089|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
25063692|NCT03466567|Probenecid|probenecid|mesh-list
24847337|NCT02246179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847338|NCT02246179|Sensory System Agents|sensory system agents|mesh-ancestor
25154743|NCT05469529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25154744|NCT05469529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016226|NCT00140881|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25154745|NCT05469529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24949468|NCT04707391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949469|NCT04669457|Midazolam|midazolam|mesh-list
24614784|NCT01026363|Vitamin D|vitamin d|mesh-list
24949482|NCT04669457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24847992|NCT05289323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847993|NCT05289323|Cholinergic Agents|cholinergic agents|mesh-ancestor
25044713|NCT01056393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25044715|NCT01056393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016240|NCT00111709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25016241|NCT00111709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044716|NCT01055444|Lidocaine|lidocaine|mesh-list
25044717|NCT01055444|Tetracaine|tetracaine|mesh-list
24827235|NCT02137954|Lidocaine|lidocaine|mesh-list
25064955|NCT03455049|Analgesics|analgesics|mesh-ancestor
25650021|NCT01498588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25650022|NCT01498588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24848850|NCT03391466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24848916|NCT03283488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24586606|NCT00891397|Pregabalin|pregabalin|mesh-list
24848917|NCT03283488|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24848918|NCT03283488|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24848919|NCT03283488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24848920|NCT03283488|Contraceptive Agents|contraceptive agents|mesh-ancestor
24848921|NCT03283488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24848922|NCT03283488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24848923|NCT03283488|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24848924|NCT03283488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24848993|NCT03165994|Tubulin Modulators|tubulin modulators|mesh-ancestor
24848994|NCT03165994|Antimitotic Agents|antimitotic agents|mesh-ancestor
24848995|NCT03165994|Mitosis Modulators|mitosis modulators|mesh-ancestor
24848997|NCT03126435|Gemcitabine|gemcitabine|mesh-list
24848998|NCT03126435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24848999|NCT03126435|Antimetabolites|antimetabolites|mesh-ancestor
24849052|NCT02991456|Antipruritics|antipruritics|mesh-ancestor
24849053|NCT02991456|Dermatologic Agents|dermatologic agents|mesh-ancestor
24849054|NCT02991456|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24849055|NCT02991456|Serotonin Agents|serotonin agents|mesh-ancestor
25828760|NCT00006089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24849065|NCT02983578|Immunoglobulins|immunoglobulins|mesh-list
24849066|NCT02983578|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24849067|NCT02983578|Immunoglobulin G|immunoglobulin g|mesh-list
25828761|NCT00006089|Immunologic Factors|immunologic factors|mesh-ancestor
25155074|NCT05467852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25155076|NCT05467826|Ribavirin|ribavirin|mesh-list
25155077|NCT05467826|Sofosbuvir|sofosbuvir|mesh-list
25044928|NCT01018875|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25155078|NCT05467826|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25066361|NCT03507452|BAY 2287411|bay 2287411|mesh-list
25016370|NCT00043108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24849416|NCT02248584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066393|NCT03399539|Dexamethasone|dexamethasone|mesh-list
25066543|NCT02844907|Dexamethasone|dexamethasone|mesh-list
24849595|NCT02249234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24849596|NCT02249234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849599|NCT02249299|Nabiximols|nabiximols|mesh-list
24849600|NCT02249299|Analgesics|analgesics|mesh-ancestor
25828762|NCT00006089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828763|NCT00006089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828764|NCT00006090|Arsenic Trioxide|arsenic trioxide|mesh-list
25828765|NCT00006090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491401|NCT00482261|Antipyretics|antipyretics|mesh-ancestor
24811978|NCT02049073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24811979|NCT02049073|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24811980|NCT02049073|Protective Agents|protective agents|mesh-ancestor
24811981|NCT02049073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24811982|NCT02049073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24811983|NCT02049073|Anticonvulsants|anticonvulsants|mesh-ancestor
24811984|NCT02049073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24811985|NCT02049073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25650023|NCT01498588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650024|NCT01498679|Fluticasone|fluticasone|mesh-list
25828766|NCT00006091|Arsenic Trioxide|arsenic trioxide|mesh-list
25828767|NCT00006091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828768|NCT00006092|Arsenic Trioxide|arsenic trioxide|mesh-list
25828769|NCT00006092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828770|NCT00006094|Fluorouracil|fluorouracil|mesh-list
24940284|NCT04002349|Autonomic Agents|autonomic agents|mesh-ancestor
24940285|NCT04002349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25075947|NCT03377101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24801986|NCT01986660|Analgesics|analgesics|mesh-ancestor
25828771|NCT00006094|Oxaliplatin|oxaliplatin|mesh-list
25828772|NCT00006094|Antimetabolites|antimetabolites|mesh-ancestor
24550409|NCT00720512|Immunologic Factors|immunologic factors|mesh-ancestor
25045137|NCT00992563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25045138|NCT00992563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25045139|NCT00992563|Growth Substances|growth substances|mesh-ancestor
25045140|NCT00992563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045141|NCT00992563|Growth Inhibitors|growth inhibitors|mesh-ancestor
24851140|NCT02255591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24851141|NCT02255591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851142|NCT02255591|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24851143|NCT02255591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24851144|NCT02255591|Adrenergic Agents|adrenergic agents|mesh-ancestor
24851145|NCT02255591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24851146|NCT02255591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24494696|NCT00496405|Growth Inhibitors|growth inhibitors|mesh-ancestor
24851241|NCT02256150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24939361|NCT04010942|Metformin|metformin|mesh-list
24851242|NCT02256150|Immunologic Factors|immunologic factors|mesh-ancestor
24851243|NCT02256150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851244|NCT02256150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24851245|NCT02256150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24851246|NCT02256150|Alkylating Agents|alkylating agents|mesh-ancestor
24851247|NCT02256150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851248|NCT02256150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24851249|NCT02256150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24851250|NCT02256150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24851251|NCT02256150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25068974|NCT03430362|Scopolamine|scopolamine|mesh-list
25069570|NCT03425617|Olodaterol|olodaterol|mesh-list
24445586|NCT00301912|Fludarabine|fludarabine|mesh-list
24445587|NCT00301912|Busulfan|busulfan|mesh-list
24445588|NCT00301912|Tacrolimus|tacrolimus|mesh-list
24445647|NCT00301951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24445648|NCT00301951|Antimetabolites|antimetabolites|mesh-ancestor
24445649|NCT00301951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851864|NCT02259647|Sorafenib|sorafenib|mesh-list
24851865|NCT02259647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24851866|NCT02259647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24851867|NCT02259647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851868|NCT02259647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851873|NCT02259738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24851874|NCT02259738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851875|NCT02259777|Amlodipine|amlodipine|mesh-list
25070870|NCT03415594|Glucagon|glucagon|mesh-list
24445665|NCT00301990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24445764|NCT00302497|Immunologic Factors|immunologic factors|mesh-ancestor
25016494|NCT05183308|Clodronic Acid|clodronic acid|mesh-list
24445765|NCT00302497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851883|NCT02259777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445768|NCT00302523|Immunologic Factors|immunologic factors|mesh-ancestor
24445769|NCT00302523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445770|NCT00302523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24445771|NCT00302523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445787|NCT00302627|Calcium, Dietary|calcium, dietary|mesh-list
24445788|NCT00302627|Vitamin D|vitamin d|mesh-list
24445789|NCT00302627|Ergocalciferols|ergocalciferols|mesh-list
24445790|NCT00302627|Cholecalciferol|cholecalciferol|mesh-list
25650026|NCT01498679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25650027|NCT01498679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25650028|NCT01498679|Autonomic Agents|autonomic agents|mesh-ancestor
25650029|NCT01498679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650030|NCT01498679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650031|NCT01498679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25650032|NCT01498679|Respiratory System Agents|respiratory system agents|mesh-ancestor
25650033|NCT01498679|Dermatologic Agents|dermatologic agents|mesh-ancestor
25650034|NCT01498679|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25650035|NCT01498744|Clindamycin|clindamycin|mesh-list
25650036|NCT01498744|Clindamycin palmitate|clindamycin palmitate|mesh-list
25650037|NCT01498744|Clindamycin phosphate|clindamycin phosphate|mesh-list
25650038|NCT01498744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25650039|NCT01498744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24445814|NCT00302666|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24445815|NCT00302666|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25828773|NCT00006094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851885|NCT02259777|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24851886|NCT02259777|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24851888|NCT02259790|Telmisartan|telmisartan|mesh-list
25071021|NCT03413722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25828774|NCT00006094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25828775|NCT00006094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25016508|NCT05169866|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24851928|NCT02259829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851929|NCT02259829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24851930|NCT02259829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828776|NCT00006094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24812310|NCT02051387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24812311|NCT02051387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24812312|NCT02051387|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24812313|NCT02051387|Dopamine Agents|dopamine agents|mesh-ancestor
24812315|NCT02051387|Autonomic Agents|autonomic agents|mesh-ancestor
25071456|NCT03409432|Lenalidomide|lenalidomide|mesh-list
24812349|NCT02051738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25071515|NCT03408457|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24852000|NCT02259985|Autonomic Agents|autonomic agents|mesh-ancestor
24852001|NCT02259985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24852002|NCT02259985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852010|NCT02259998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24852011|NCT02259998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852012|NCT02259998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852013|NCT02259998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24852014|NCT02259998|Vasodilator Agents|vasodilator agents|mesh-ancestor
24852015|NCT02260011|Bromides|bromides|mesh-list
24852016|NCT02260011|Norflurane|norflurane|mesh-list
24852017|NCT02260011|Ipratropium|ipratropium|mesh-list
24852018|NCT02260011|Anticonvulsants|anticonvulsants|mesh-ancestor
24852019|NCT02260011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24498353|NCT00514111|Interferons|interferons|mesh-list
24852028|NCT02260011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852198|NCT02261077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852226|NCT02261116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828777|NCT00006094|Immunologic Factors|immunologic factors|mesh-ancestor
24852244|NCT02261298|Nivolumab|nivolumab|mesh-list
24852245|NCT02261298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24852246|NCT02261298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24852247|NCT02261298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24852248|NCT02261298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852249|NCT02261376|DS-1971a|ds-1971a|mesh-list
25072031|NCT03403985|Calcium|calcium|mesh-list
24589516|NCT00907985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24589517|NCT00907985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589518|NCT00907985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24589519|NCT00907985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24589520|NCT00907985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24589521|NCT00907985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24589522|NCT00907985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24589524|NCT00907985|Autonomic Agents|autonomic agents|mesh-ancestor
24589525|NCT00907985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25072420|NCT03401606|Narcotics|narcotics|mesh-ancestor
24589858|NCT00909454|Vitamin D|vitamin d|mesh-list
24589859|NCT00909454|Ergocalciferols|ergocalciferols|mesh-list
24589860|NCT00909454|Cholecalciferol|cholecalciferol|mesh-list
24589861|NCT00909454|Vitamins|vitamins|mesh-list
24589862|NCT00909454|Micronutrients|micronutrients|mesh-ancestor
24590168|NCT00910897|Protease Inhibitors|protease inhibitors|mesh-ancestor
24590169|NCT00910897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650040|NCT01498744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25650041|NCT01498744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25016637|NCT04905862|Analgesics|analgesics|mesh-list
24590361|NCT00912262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590363|NCT00912275|Lapatinib|lapatinib|mesh-list
24590364|NCT00912275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24590365|NCT00912275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24590366|NCT00912275|Tubulin Modulators|tubulin modulators|mesh-ancestor
24590367|NCT00912275|Antimitotic Agents|antimitotic agents|mesh-ancestor
24590368|NCT00912275|Mitosis Modulators|mitosis modulators|mesh-ancestor
24590411|NCT00912444|Tubulin Modulators|tubulin modulators|mesh-ancestor
24590412|NCT00912444|Antimitotic Agents|antimitotic agents|mesh-ancestor
24590413|NCT00912444|Mitosis Modulators|mitosis modulators|mesh-ancestor
24590414|NCT00912444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24590415|NCT00912444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24590416|NCT00912444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24590417|NCT00912444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590418|NCT00912457|Donepezil|donepezil|mesh-list
24590419|NCT00912457|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24590420|NCT00912457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634895|NCT01135680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634896|NCT01135680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24634897|NCT01135680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634898|NCT01135680|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24590747|NCT00913783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590748|NCT00913796|Potassium Citrate|potassium citrate|mesh-list
24590749|NCT00913796|Diuretics|diuretics|mesh-ancestor
24590750|NCT00913796|Natriuretic Agents|natriuretic agents|mesh-ancestor
25016690|NCT04804007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016691|NCT04787692|Analgesics, Opioid|analgesics, opioid|mesh-list
25016692|NCT04787692|Narcotics|narcotics|mesh-ancestor
25016693|NCT04787692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25016694|NCT04787692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016695|NCT04787692|Analgesics|analgesics|mesh-ancestor
24973314|NCT03710304|Hemostatics|hemostatics|mesh-ancestor
24590751|NCT00913796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590752|NCT00913796|Expectorants|expectorants|mesh-ancestor
24590753|NCT00913796|Respiratory System Agents|respiratory system agents|mesh-ancestor
24590754|NCT00913809|Desipramine|desipramine|mesh-list
25073025|NCT03397914|Colistin|colistin|mesh-list
24591459|NCT00916760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24591460|NCT00916760|Immunologic Factors|immunologic factors|mesh-ancestor
25073347|NCT03395665|Progesterone|progesterone|mesh-list
24812404|NCT02052024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24973316|NCT03710304|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24973317|NCT03710304|Abortifacient Agents|abortifacient agents|mesh-ancestor
24973318|NCT03710304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24812405|NCT02052024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812408|NCT02052024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812409|NCT02052024|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24812410|NCT02052024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24960856|NCT03813771|Analgesics|analgesics|mesh-ancestor
24812411|NCT02052024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24592466|NCT00921804|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24592469|NCT00921830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24592470|NCT00921830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24592472|NCT00921830|Sensory System Agents|sensory system agents|mesh-ancestor
24592473|NCT00921830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24592474|NCT00921830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592475|NCT00921830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24592476|NCT00921830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24595584|NCT00939614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24595585|NCT00939614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24595586|NCT00939614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24595587|NCT00939614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24595589|NCT00939718|Hydroxocobalamin|hydroxocobalamin|mesh-list
24595590|NCT00939718|Vitamins|vitamins|mesh-ancestor
24595591|NCT00939718|Micronutrients|micronutrients|mesh-ancestor
24595592|NCT00939718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595593|NCT00939718|Vitamin B Complex|vitamin b complex|mesh-ancestor
24595594|NCT00939718|Hematinics|hematinics|mesh-ancestor
24595595|NCT00939757|Mirabegron|mirabegron|mesh-list
24595596|NCT00939757|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24595773|NCT00940524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25650042|NCT01498744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450062|NCT00317746|Citalopram|citalopram|mesh-list
24595774|NCT00940524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24595775|NCT00940524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24595776|NCT00940524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24595777|NCT00940524|Antiviral Agents|antiviral agents|mesh-ancestor
24595778|NCT00940524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24595779|NCT00940524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24595780|NCT00940524|Analgesics|analgesics|mesh-ancestor
24595781|NCT00940524|Sensory System Agents|sensory system agents|mesh-ancestor
24595782|NCT00940524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24595844|NCT00940693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24595845|NCT00940693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24595847|NCT00940693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595955|NCT00941057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24595956|NCT00941057|Hormone Antagonists|hormone antagonists|mesh-ancestor
24595957|NCT00941057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24595958|NCT00941057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24595959|NCT00941057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24852833|NCT02264171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24852834|NCT02264171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24596115|NCT00941811|Imiquimod|imiquimod|mesh-list
24596116|NCT00941811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24596117|NCT00941811|Immunologic Factors|immunologic factors|mesh-ancestor
24596118|NCT00941811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596119|NCT00941811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596120|NCT00941811|Interferon Inducers|interferon inducers|mesh-ancestor
24596121|NCT00941824|Mycophenolic Acid|mycophenolic acid|mesh-list
24596122|NCT00941824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24596123|NCT00941824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596124|NCT00941824|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24596125|NCT00941824|Antitubercular Agents|antitubercular agents|mesh-ancestor
24596126|NCT00941824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24596127|NCT00941824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24596128|NCT00941824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596129|NCT00941824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954168|NCT03878771|Clobetasol|clobetasol|mesh-list
24812437|NCT02052167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25016739|NCT04633889|Sequestering Agents|sequestering agents|mesh-ancestor
24812438|NCT02052167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24812440|NCT02052180|Anesthetics, Local|anesthetics, local|mesh-ancestor
24812441|NCT02052180|Anesthetics|anesthetics|mesh-ancestor
24812443|NCT02052180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596251|NCT00942539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596484|NCT00943930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24596485|NCT00943930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24596486|NCT00943930|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24596487|NCT00943930|Hallucinogens|hallucinogens|mesh-ancestor
24596488|NCT00943930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24596489|NCT00943930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24596490|NCT00943930|Analgesics|analgesics|mesh-ancestor
24596491|NCT00943930|Sensory System Agents|sensory system agents|mesh-ancestor
24596492|NCT00943930|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24596517|NCT00943956|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24596519|NCT00943956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24596520|NCT00943956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24596576|NCT00944385|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25016776|NCT04479566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24596577|NCT00944385|Protease Inhibitors|protease inhibitors|mesh-ancestor
24596578|NCT00944385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596579|NCT00944385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596580|NCT00944398|Vitamins|vitamins|mesh-list
24596581|NCT00944398|Zinc|zinc|mesh-list
24596582|NCT00944398|Vitamin B Complex|vitamin b complex|mesh-list
24596583|NCT00944398|Zinc Sulfate|zinc sulfate|mesh-list
24596584|NCT00944398|Micronutrients|micronutrients|mesh-ancestor
24596585|NCT00944398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661445|NCT01289561|Ethanol|ethanol|mesh-list
24596727|NCT00944996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596728|NCT00944996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25650043|NCT01498822|Oxcarbazepine|oxcarbazepine|mesh-list
25650044|NCT01498822|Levetiracetam|levetiracetam|mesh-list
24701736|NCT01460602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24701737|NCT01460615|Hydrocortisone|hydrocortisone|mesh-list
24596729|NCT00944996|Serotonin Agents|serotonin agents|mesh-ancestor
24596730|NCT00944996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596731|NCT00944996|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24596732|NCT00944996|Antidepressive Agents|antidepressive agents|mesh-ancestor
24503734|NCT00532701|Ribavirin|ribavirin|mesh-list
24661618|NCT01290172|Somatostatin|somatostatin|mesh-list
24596903|NCT00946387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596904|NCT00946387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24597073|NCT00947063|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24597074|NCT00947063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24597075|NCT00947063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24597078|NCT00947063|Sensory System Agents|sensory system agents|mesh-ancestor
24597099|NCT00947128|Autonomic Agents|autonomic agents|mesh-ancestor
24597100|NCT00947128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24597101|NCT00947128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597102|NCT00947128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24597103|NCT00947128|Antipruritics|antipruritics|mesh-ancestor
24597104|NCT00947128|Dermatologic Agents|dermatologic agents|mesh-ancestor
24597105|NCT00947128|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24597264|NCT00947895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597265|NCT00948077|Isoniazid, pyrazinamide, rifampin drug combination|isoniazid, pyrazinamide, rifampin drug combination|mesh-list
24597266|NCT00948077|Antitubercular Agents|antitubercular agents|mesh-ancestor
24597490|NCT00949572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597491|NCT00949572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24597492|NCT00949598|Tamoxifen|tamoxifen|mesh-list
24597493|NCT00949598|Letrozole|letrozole|mesh-list
24597494|NCT00949598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597495|NCT00949598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597496|NCT00949598|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24597497|NCT00949598|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24597498|NCT00949598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597499|NCT00949598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24597500|NCT00949598|Hormone Antagonists|hormone antagonists|mesh-ancestor
24597501|NCT00949598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24597683|NCT00950794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24597684|NCT00950794|Respiratory System Agents|respiratory system agents|mesh-ancestor
24597685|NCT00950794|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24597686|NCT00950794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24597687|NCT00950794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24597738|NCT00951431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597739|NCT00951444|Gemcitabine|gemcitabine|mesh-list
25203466|NCT02714361|Cholecalciferol|cholecalciferol|mesh-list
24597919|NCT00952796|Sultamicillin|sultamicillin|mesh-list
24597920|NCT00952796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24597921|NCT00952796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25016904|NCT03840616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24597922|NCT00952796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24597923|NCT00952796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24597924|NCT00952796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597925|NCT00952796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597926|NCT00952796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597927|NCT00952796|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24597994|NCT00953303|Glucocorticoids|glucocorticoids|mesh-list
24597995|NCT00953303|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24598079|NCT00953589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598080|NCT00953589|Antiviral Agents|antiviral agents|mesh-ancestor
24598081|NCT00953589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24598082|NCT00953628|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24598095|NCT00953771|Hormone Antagonists|hormone antagonists|mesh-ancestor
24598096|NCT00953771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24598162|NCT00954252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24598176|NCT00954304|Antidiarrheals|antidiarrheals|mesh-list
24598177|NCT00954304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25016926|NCT03837977|Antimetabolites|antimetabolites|mesh-ancestor
25016927|NCT03837977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25016928|NCT03837977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25650045|NCT01498822|Anticonvulsants|anticonvulsants|mesh-ancestor
25650046|NCT01498822|Nootropic Agents|nootropic agents|mesh-ancestor
25650047|NCT01498822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25650048|NCT01498822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25199706|NCT02738983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016929|NCT03837977|Immunologic Factors|immunologic factors|mesh-ancestor
25016930|NCT03837977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016931|NCT03837977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24598178|NCT00954395|Fibrin Fibrinogen Degradation Products|fibrin fibrinogen degradation products|mesh-list
24504401|NCT00536003|Hormones|hormones|mesh-ancestor
24598195|NCT00954525|Antimetabolites|antimetabolites|mesh-ancestor
24852938|NCT02264834|Narcotics|narcotics|mesh-ancestor
24852939|NCT02264834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24598196|NCT00954525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598197|NCT00954525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598198|NCT00954525|Antiviral Agents|antiviral agents|mesh-ancestor
24598199|NCT00954525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24598200|NCT00954525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598201|NCT00954525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24598202|NCT00954525|Immunologic Factors|immunologic factors|mesh-ancestor
24598203|NCT00954525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24598205|NCT00954525|Protective Agents|protective agents|mesh-ancestor
24598206|NCT00954564|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25016945|NCT03787654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016946|NCT03787654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016948|NCT03772353|Letrozole|letrozole|mesh-list
25016949|NCT03772353|Fulvestrant|fulvestrant|mesh-list
25016961|NCT03697720|Naproxen|naproxen|mesh-list
24598207|NCT00954564|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24598208|NCT00954564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598209|NCT00954564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598210|NCT00954564|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24598211|NCT00954564|Hormone Antagonists|hormone antagonists|mesh-ancestor
24598212|NCT00954564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24598213|NCT00954564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598214|NCT00954603|Haloperidol|haloperidol|mesh-list
24598215|NCT00954603|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24598216|NCT00954603|Haloperidol decanoate|haloperidol decanoate|mesh-list
24598217|NCT00954603|Antidepressive Agents|antidepressive agents|mesh-ancestor
24598218|NCT00954603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24598222|NCT00954603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828778|NCT00006094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598330|NCT00955318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598331|NCT00955318|Autonomic Agents|autonomic agents|mesh-ancestor
25075328|NCT03381703|YH12852|yh12852|mesh-list
24598362|NCT00955695|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24598364|NCT00955695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598365|NCT00955695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24598432|NCT00956163|Methylene diphosphonate|methylene diphosphonate|mesh-list
24598433|NCT00956163|Listerine|listerine|mesh-list
24598434|NCT00956163|Fluorides|fluorides|mesh-list
24598435|NCT00956163|Sodium Fluoride|sodium fluoride|mesh-list
24598436|NCT00956163|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
24598639|NCT00957125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24598640|NCT00957125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24598641|NCT00957125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24598642|NCT00957125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598645|NCT00957177|Sensory System Agents|sensory system agents|mesh-ancestor
24598646|NCT00957177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24598647|NCT00957177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598648|NCT00957177|Anticonvulsants|anticonvulsants|mesh-ancestor
24598649|NCT00957177|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24598812|NCT00958269|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24598813|NCT00958269|Protease Inhibitors|protease inhibitors|mesh-ancestor
24598814|NCT00958269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852985|NCT02265068|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24598864|NCT05352165|Fluorouracil|fluorouracil|mesh-list
24598865|NCT05352165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24598866|NCT05352165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598867|NCT05352165|Antimetabolites|antimetabolites|mesh-ancestor
24598868|NCT05352165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598869|NCT05352165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24598870|NCT05352165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24598871|NCT05352165|Immunologic Factors|immunologic factors|mesh-ancestor
24598872|NCT05352165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598873|NCT05352126|Disinfectants|disinfectants|mesh-list
24598923|NCT05351684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650049|NCT01498822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24702551|NCT01466478|Vitamins|vitamins|mesh-ancestor
24598924|NCT05351684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598925|NCT05351684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24598926|NCT05351684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24598928|NCT05351684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24598931|NCT05351606|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24598932|NCT05351606|Autonomic Agents|autonomic agents|mesh-ancestor
24598933|NCT05351606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24598934|NCT05351606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598935|NCT05351606|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24598936|NCT05351606|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24599016|NCT05350592|Dobutamine|dobutamine|mesh-list
24599017|NCT05350592|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24599018|NCT05350592|Sympathomimetics|sympathomimetics|mesh-ancestor
24599019|NCT05350592|Autonomic Agents|autonomic agents|mesh-ancestor
24599020|NCT05350592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24599021|NCT05350592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599022|NCT05350592|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24599023|NCT05350592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24599024|NCT05350592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24599025|NCT05350592|Adrenergic Agents|adrenergic agents|mesh-ancestor
24540855|NCT00669812|Vincristine|vincristine|mesh-list
24599026|NCT05350592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24599027|NCT05350592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599028|NCT05350592|Protective Agents|protective agents|mesh-ancestor
24599029|NCT05350501|Nivolumab|nivolumab|mesh-list
24599030|NCT05350501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25828779|NCT00006095|Irinotecan|irinotecan|mesh-list
25075657|NCT03378934|Aspirin|aspirin|mesh-list
24599321|NCT04722718|Paclitaxel|paclitaxel|mesh-list
24599322|NCT04722718|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24599323|NCT04722718|Carboplatin|carboplatin|mesh-list
24599324|NCT04722718|Apatinib|apatinib|mesh-list
25075718|NCT03378427|Levofloxacin|levofloxacin|mesh-list
24599368|NCT04687800|Autonomic Agents|autonomic agents|mesh-ancestor
25017098|NCT02616146|Hormones|hormones|mesh-ancestor
24663819|NCT01303731|Fentanyl|fentanyl|mesh-list
24599724|NCT03951493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24599725|NCT03951493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599726|NCT03940729|Chlorhexidine|chlorhexidine|mesh-list
24599744|NCT03913559|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24599745|NCT03913559|Abortifacient Agents|abortifacient agents|mesh-ancestor
24599746|NCT03913559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24599747|NCT03913559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599748|NCT03913559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24599750|NCT03913559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599751|NCT03913559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599752|NCT03913559|Dermatologic Agents|dermatologic agents|mesh-ancestor
25048617|NCT00680472|Ketoprofen|ketoprofen|mesh-list
24599876|NCT03449758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24853064|NCT02265770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998526|NCT02566304|Vidarabine|vidarabine|mesh-list
24600058|NCT02748707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24600059|NCT02748707|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24600060|NCT02748707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24602473|NCT00968994|Dermatologic Agents|dermatologic agents|mesh-ancestor
24600105|NCT02573324|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24600106|NCT02573324|Alkylating Agents|alkylating agents|mesh-ancestor
24600107|NCT02573324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600108|NCT02573324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828780|NCT00006095|Vincristine|vincristine|mesh-list
24600110|NCT02573324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600111|NCT02545868|Vaccines|vaccines|mesh-list
24600112|NCT02545868|Immunologic Factors|immunologic factors|mesh-ancestor
24636350|NCT01144923|Gabapentin|gabapentin|mesh-list
24600113|NCT02545868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998579|NCT02467608|Isoniazid|isoniazid|mesh-list
24600167|NCT02139397|Eflornithine|eflornithine|mesh-list
24600168|NCT02139397|Bortezomib|bortezomib|mesh-list
24600169|NCT02139397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600170|NCT02139397|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24600171|NCT02139397|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24600172|NCT02139397|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24600173|NCT02139397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24600174|NCT02139397|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
24600175|NCT02139397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600176|NCT02139397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650050|NCT01498822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600368|NCT00567567|Doxorubicin|doxorubicin|mesh-list
24600369|NCT00567567|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24600370|NCT00567567|Etoposide|etoposide|mesh-list
24600371|NCT00567567|Vincristine|vincristine|mesh-list
24600372|NCT00567567|Etoposide phosphate|etoposide phosphate|mesh-list
24600373|NCT00567567|Topotecan|topotecan|mesh-list
25017204|NCT02275546|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25017207|NCT02275546|Estrogens|estrogens|mesh-ancestor
24853123|NCT02266030|Aspirin|aspirin|mesh-list
24853124|NCT02266030|Cilostazol|cilostazol|mesh-list
24600443|NCT00958633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600444|NCT00958633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24600445|NCT00958633|Serotonin Agents|serotonin agents|mesh-ancestor
24600446|NCT00958633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600447|NCT00958633|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24600448|NCT00958633|Antidepressive Agents|antidepressive agents|mesh-ancestor
24600536|NCT00959231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24600537|NCT00959231|Antimetabolites|antimetabolites|mesh-ancestor
24600538|NCT00959231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600539|NCT00959231|Antifungal Agents|antifungal agents|mesh-ancestor
24600540|NCT00959231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24600541|NCT00959231|Dermatologic Agents|dermatologic agents|mesh-ancestor
24600542|NCT00959231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24998733|NCT01376427|Antimetabolites|antimetabolites|mesh-ancestor
24636428|NCT01145430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24636429|NCT01145430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24636430|NCT01145430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24636431|NCT01145430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24600868|NCT00960960|Trastuzumab|trastuzumab|mesh-list
24600869|NCT00960960|Letrozole|letrozole|mesh-list
24600870|NCT00960960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24600871|NCT00960960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600872|NCT00960960|Tubulin Modulators|tubulin modulators|mesh-ancestor
24600873|NCT00960960|Antimitotic Agents|antimitotic agents|mesh-ancestor
24600874|NCT00960960|Mitosis Modulators|mitosis modulators|mesh-ancestor
24600875|NCT00960960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600876|NCT00960960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24600877|NCT00960960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24600878|NCT00960960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24600879|NCT00960960|Growth Substances|growth substances|mesh-ancestor
25017221|NCT02077166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25017222|NCT02077166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25017223|NCT02077166|Immunologic Factors|immunologic factors|mesh-ancestor
25017224|NCT02077166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017225|NCT02077166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25017226|NCT02077166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25017227|NCT02077166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24998902|NCT05422001|Ketamine|ketamine|mesh-list
24600943|NCT00961363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601000|NCT00961844|Alkylating Agents|alkylating agents|mesh-ancestor
24601001|NCT00961844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601002|NCT00961844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24601004|NCT00961857|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24601005|NCT00961857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24601006|NCT00961857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853151|NCT02266056|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24853152|NCT02266056|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24853153|NCT02266056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24853154|NCT02266056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853155|NCT02266160|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24853156|NCT02266160|Anesthetics, Local|anesthetics, local|mesh-ancestor
24601009|NCT00961857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24601010|NCT00961857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24601011|NCT00961857|Protease Inhibitors|protease inhibitors|mesh-ancestor
24601012|NCT00961857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601040|NCT00962299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24601041|NCT00962299|Respiratory System Agents|respiratory system agents|mesh-ancestor
24601042|NCT00962312|Capecitabine|capecitabine|mesh-list
24601044|NCT00962312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24601045|NCT00962312|Antimetabolites|antimetabolites|mesh-ancestor
24601046|NCT00962312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601047|NCT00962312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24601230|NCT00963573|Respiratory System Agents|respiratory system agents|mesh-ancestor
25045259|NCT00979251|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25045261|NCT00979251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25045262|NCT00979251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045266|NCT00979251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24601231|NCT00963573|Antipruritics|antipruritics|mesh-ancestor
24601232|NCT00963573|Dermatologic Agents|dermatologic agents|mesh-ancestor
24601233|NCT00963573|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24601234|NCT00963573|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24601388|NCT00964106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24601389|NCT00964106|Antimetabolites|antimetabolites|mesh-ancestor
24601390|NCT00964106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24601391|NCT00964106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24601422|NCT00964106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24601423|NCT00964106|Antitussive Agents|antitussive agents|mesh-ancestor
24601424|NCT00964106|Respiratory System Agents|respiratory system agents|mesh-ancestor
24834144|NCT02177344|Bromides|bromides|mesh-list
24601505|NCT00964535|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24601506|NCT00964535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24601572|NCT00964704|Growth Substances|growth substances|mesh-ancestor
24601573|NCT00964704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601574|NCT00964704|Growth Inhibitors|growth inhibitors|mesh-ancestor
24601834|NCT00966121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601866|NCT00966251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24601867|NCT00966290|Warfarin|warfarin|mesh-list
24601868|NCT00966290|Anticoagulants|anticoagulants|mesh-list
24853213|NCT02266537|Alfuzosin|alfuzosin|mesh-list
24853214|NCT02266537|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24853215|NCT02266537|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24853216|NCT02266537|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24853217|NCT02266537|Adrenergic Agents|adrenergic agents|mesh-ancestor
24853218|NCT02266537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665404|NCT01312077|Anesthetics|anesthetics|mesh-ancestor
24602120|NCT00967252|Antimetabolites|antimetabolites|mesh-ancestor
24602153|NCT00967421|Ethanol|ethanol|mesh-list
24602154|NCT00967421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24602155|NCT00967421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25048765|NCT00672412|Antiviral Agents|antiviral agents|mesh-ancestor
24602468|NCT00968955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602469|NCT00968955|Sensory System Agents|sensory system agents|mesh-ancestor
24602470|NCT00968955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24602471|NCT00968994|Petrolatum|petrolatum|mesh-list
24602472|NCT00968994|Emollients|emollients|mesh-ancestor
24602474|NCT00969033|Irinotecan|irinotecan|mesh-list
24602475|NCT00969033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24602476|NCT00969033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24602477|NCT00969033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24602478|NCT00969033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602479|NCT00969033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602480|NCT00969046|Epothilone B|epothilone b|mesh-list
24602481|NCT00969046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602482|NCT00969046|Tubulin Modulators|tubulin modulators|mesh-ancestor
24602483|NCT00969046|Antimitotic Agents|antimitotic agents|mesh-ancestor
24602484|NCT00969046|Mitosis Modulators|mitosis modulators|mesh-ancestor
24602485|NCT00969046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602486|NCT00969072|Dutasteride|dutasteride|mesh-list
24602487|NCT00969072|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25017357|NCT01498770|GABA Agents|gaba agents|mesh-ancestor
24602512|NCT00969137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24602513|NCT00969137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602514|NCT00969137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24602515|NCT00969137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24602516|NCT00969137|Cholinergic Agents|cholinergic agents|mesh-ancestor
24704060|NCT01476410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24704104|NCT01476592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704105|NCT01476592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24602517|NCT00969137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24602518|NCT00969137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602519|NCT00969163|Testosterone|testosterone|mesh-list
24602520|NCT00969163|Androgens|androgens|mesh-ancestor
24602521|NCT00969163|Hormones|hormones|mesh-ancestor
24602522|NCT00969163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24602523|NCT00969163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828781|NCT00006095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24602531|NCT00969293|Ecallantide|ecallantide|mesh-list
24853256|NCT02266927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24853257|NCT02266927|Autonomic Agents|autonomic agents|mesh-ancestor
24603886|NCT00976040|Antiviral Agents|antiviral agents|mesh-ancestor
24853258|NCT02266927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24602827|NCT00971126|Immunologic Factors|immunologic factors|mesh-ancestor
24602828|NCT00971126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602829|NCT00971126|Leprostatic Agents|leprostatic agents|mesh-ancestor
24602830|NCT00971126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24602831|NCT00971126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24602832|NCT00971126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24602833|NCT00971126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24603012|NCT00972075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603013|NCT00972075|Protective Agents|protective agents|mesh-ancestor
24603014|NCT00972075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603015|NCT00972075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24603016|NCT00972101|Mycophenolic Acid|mycophenolic acid|mesh-list
24603019|NCT00972101|Fludarabine phosphate|fludarabine phosphate|mesh-list
24603020|NCT00972101|Etoposide|etoposide|mesh-list
24603021|NCT00972101|Melphalan|melphalan|mesh-list
24603022|NCT00972101|Thiotepa|thiotepa|mesh-list
24603023|NCT00972101|Tacrolimus|tacrolimus|mesh-list
24603024|NCT00972101|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24603025|NCT00972101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24603081|NCT00972296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24603115|NCT00972426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24586834|NCT00892346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25017415|NCT01044056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25017416|NCT01044056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24603116|NCT00972426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798383|NCT01963325|Paclitaxel|paclitaxel|mesh-list
24853286|NCT02267057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24853288|NCT02267122|Mupirocin|mupirocin|mesh-list
24603238|NCT00972985|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24603239|NCT00972985|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24603240|NCT00972985|Anticonvulsants|anticonvulsants|mesh-ancestor
24603241|NCT00972985|Antiemetics|antiemetics|mesh-ancestor
24603242|NCT00972985|Autonomic Agents|autonomic agents|mesh-ancestor
24603243|NCT00972985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24603244|NCT00972985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24603452|NCT00973869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24603453|NCT00973869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603454|NCT00973869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24603455|NCT00973869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24603456|NCT00973869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603457|NCT00973869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25017428|NCT01005056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24604233|NCT00977964|Sequestering Agents|sequestering agents|mesh-ancestor
25017429|NCT01005056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017431|NCT01005056|Estrogens|estrogens|mesh-ancestor
24603458|NCT00973869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603459|NCT00973882|Carboplatin|carboplatin|mesh-list
24603614|NCT00974753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603615|NCT00974753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603616|NCT00974766|Glucocorticoids|glucocorticoids|mesh-list
24603617|NCT00974766|Hormones|hormones|mesh-ancestor
24462782|NCT00357604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24853329|NCT02267655|Autonomic Agents|autonomic agents|mesh-ancestor
25650051|NCT01498822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25650052|NCT01498822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25650053|NCT01498887|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25650054|NCT01498887|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24853330|NCT02267655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24603774|NCT00975533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24603775|NCT00975533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603776|NCT00975572|Vaccines|vaccines|mesh-list
24603777|NCT00975572|Immunologic Factors|immunologic factors|mesh-ancestor
24603778|NCT00975572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603779|NCT00975663|Tacrolimus|tacrolimus|mesh-list
24603780|NCT00975663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24603811|NCT00975767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603812|NCT00975767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24603813|NCT00975767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603870|NCT00975936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603871|NCT00975936|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24603872|NCT00975936|Hormone Antagonists|hormone antagonists|mesh-ancestor
24603873|NCT00975936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24603874|NCT00975936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603875|NCT00975936|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25828782|NCT00006095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24603885|NCT00976040|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24603887|NCT00976040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24603889|NCT00976066|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24603890|NCT00976066|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24603891|NCT00976066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017456|NCT00920361|Hormones|hormones|mesh-ancestor
24603893|NCT00976066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24603894|NCT00976092|Heparin|heparin|mesh-list
24603895|NCT00976092|Calcium heparin|calcium heparin|mesh-list
24603896|NCT00976092|Bivalirudin|bivalirudin|mesh-list
25203468|NCT02714361|Micronutrients|micronutrients|mesh-ancestor
24604056|NCT00977028|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24604057|NCT00977028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24604122|NCT00977288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24604123|NCT00977288|Antimetabolites|antimetabolites|mesh-ancestor
25017487|NCT00778999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017488|NCT00778999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24604142|NCT00977301|Antiemetics|antiemetics|mesh-ancestor
24853345|NCT02267681|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24853346|NCT02267681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24853347|NCT02267681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853348|NCT02267681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24853349|NCT02267681|Anesthetics, General|anesthetics, general|mesh-ancestor
24853350|NCT02267681|Anesthetics|anesthetics|mesh-ancestor
24604143|NCT00977301|Autonomic Agents|autonomic agents|mesh-ancestor
24604144|NCT00977301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24604145|NCT00977301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604146|NCT00977301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24604147|NCT00977301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24604148|NCT00977301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24604149|NCT00977301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24604150|NCT00977301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24604151|NCT00977301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24604152|NCT00977301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24604153|NCT00977301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24604154|NCT00977301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24629113|NCT01103206|Cinacalcet|cinacalcet|mesh-list
24604225|NCT00977873|Vitamin D|vitamin d|mesh-list
24604226|NCT00977873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24604227|NCT00977873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604228|NCT00977873|Vitamins|vitamins|mesh-ancestor
24604229|NCT00977873|Micronutrients|micronutrients|mesh-ancestor
24604230|NCT00977873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24604231|NCT00977964|Caseins|caseins|mesh-list
24604232|NCT00977964|Chelating Agents|chelating agents|mesh-ancestor
24604234|NCT00977964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604235|NCT00978081|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24604248|NCT00978146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24604250|NCT00978159|Famotidine|famotidine|mesh-list
24604251|NCT00978159|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24604252|NCT00978159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24604253|NCT00978159|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24798436|NCT01963663|Metformin|metformin|mesh-list
24604427|NCT00979472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604428|NCT00979472|Urological Agents|urological agents|mesh-ancestor
24604429|NCT00979537|Nisoldipine|nisoldipine|mesh-list
24604430|NCT00979537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24604431|NCT00979537|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24605185|NCT00983554|Hormone Antagonists|hormone antagonists|mesh-ancestor
24605186|NCT00983554|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24605187|NCT00983554|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24605188|NCT00983697|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24605189|NCT00983697|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24605190|NCT00983697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605267|NCT00984360|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24605268|NCT00984360|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24605269|NCT00984360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605270|NCT00984360|Sensory System Agents|sensory system agents|mesh-ancestor
24812526|NCT02052973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24812528|NCT02053142|Antiviral Agents|antiviral agents|mesh-ancestor
24608022|NCT02618577|Antithrombins|antithrombins|mesh-ancestor
25045268|NCT00978497|Antimetabolites|antimetabolites|mesh-ancestor
24608023|NCT02618577|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24608024|NCT02618577|Protease Inhibitors|protease inhibitors|mesh-ancestor
24608025|NCT02618577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605278|NCT00984386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24605299|NCT00984425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24605309|NCT00984438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605310|NCT00984438|Growth Inhibitors|growth inhibitors|mesh-ancestor
24605311|NCT00984438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24605312|NCT00984438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24605313|NCT00984438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543429|NCT00683735|Incretins|incretins|mesh-ancestor
24605314|NCT00984438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605316|NCT00984464|Carboplatin|carboplatin|mesh-list
24605317|NCT00984464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24999799|NCT03174353|Lanreotide|lanreotide|mesh-list
24605492|NCT00985387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605493|NCT00985387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605494|NCT00985387|Urological Agents|urological agents|mesh-ancestor
24812529|NCT02053142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24608050|NCT02509312|Ketorolac|ketorolac|mesh-list
24812530|NCT02053298|Timolol|timolol|mesh-list
24812531|NCT02053298|Dorzolamide|dorzolamide|mesh-list
24812532|NCT02053298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24671220|NCT01324258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24671221|NCT01324258|Antiviral Agents|antiviral agents|mesh-ancestor
24605689|NCT00986778|Lamivudine|lamivudine|mesh-list
24605690|NCT00986778|Adefovir|adefovir|mesh-list
24605691|NCT00986778|Entecavir|entecavir|mesh-list
24605715|NCT00986960|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24605716|NCT00986960|Hormones|hormones|mesh-ancestor
24605717|NCT00986960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24605718|NCT00986960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974180|NCT05148637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24974189|NCT05148637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24605719|NCT00987038|Midazolam|midazolam|mesh-list
24605720|NCT00987038|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24606701|NCT00991783|Digoxin|digoxin|mesh-list
24606702|NCT00991783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24606703|NCT00991783|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24606795|NCT05408208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24606796|NCT05408208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24606797|NCT05408208|Glucocorticoids|glucocorticoids|mesh-ancestor
24606865|NCT05407597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24606866|NCT05407597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24606868|NCT05407597|Sensory System Agents|sensory system agents|mesh-ancestor
24606869|NCT05407597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24606870|NCT05407597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606871|NCT05407597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24606872|NCT05407597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24606873|NCT05407597|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
24606874|NCT05407597|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
24606875|NCT05407597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828783|NCT00006095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828784|NCT00006095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828785|NCT00006095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828786|NCT00006095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25828787|NCT00006095|Tubulin Modulators|tubulin modulators|mesh-ancestor
25828788|NCT00006095|Antimitotic Agents|antimitotic agents|mesh-ancestor
24865423|NCT03087656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24865424|NCT03087656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828789|NCT00006095|Mitosis Modulators|mitosis modulators|mesh-ancestor
25828790|NCT00006096|Cisplatin|cisplatin|mesh-list
25828791|NCT00006096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630944|NCT01115127|Vitamins|vitamins|mesh-ancestor
25828792|NCT00006098|Bortezomib|bortezomib|mesh-list
25828793|NCT00006098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828794|NCT00006100|Aldesleukin|aldesleukin|mesh-list
25828795|NCT00006100|Fludarabine|fludarabine|mesh-list
25017681|NCT03705065|Anesthetics|anesthetics|mesh-ancestor
25017684|NCT03705065|Sensory System Agents|sensory system agents|mesh-ancestor
25828796|NCT00006100|Fludarabine phosphate|fludarabine phosphate|mesh-list
25828797|NCT00006100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828798|NCT00006100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25828799|NCT00006100|Antimetabolites|antimetabolites|mesh-ancestor
25828800|NCT00006100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828801|NCT00006100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25828802|NCT00006100|Immunologic Factors|immunologic factors|mesh-ancestor
25828803|NCT00006100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25111028|NCT05278065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25111029|NCT05278065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017702|NCT03704909|Mydriatics|mydriatics|mesh-ancestor
25017703|NCT03704909|Sympathomimetics|sympathomimetics|mesh-ancestor
25828804|NCT00006100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25828805|NCT00006100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25828806|NCT00006100|Antiviral Agents|antiviral agents|mesh-ancestor
25828807|NCT00006100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25828808|NCT00006103|Leucovorin|leucovorin|mesh-list
25828809|NCT00006103|Fluorouracil|fluorouracil|mesh-list
25828810|NCT00006103|Irinotecan|irinotecan|mesh-list
25828811|NCT00006103|Calcium|calcium|mesh-list
25828812|NCT00006103|Levoleucovorin|levoleucovorin|mesh-list
25828813|NCT00006103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25828814|NCT00006103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828815|NCT00006103|Antimetabolites|antimetabolites|mesh-ancestor
25828816|NCT00006103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828817|NCT00006103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25828818|NCT00006103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828819|NCT00006103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25828820|NCT00006103|Immunologic Factors|immunologic factors|mesh-ancestor
25828821|NCT00006103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25017706|NCT03704831|Anesthetics|anesthetics|mesh-list
25017707|NCT03704831|Anesthetics, Local|anesthetics, local|mesh-list
25017708|NCT03704831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25017709|NCT03704831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828822|NCT00006103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25828823|NCT00006103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828824|NCT00006103|Antidotes|antidotes|mesh-ancestor
25828825|NCT00006103|Protective Agents|protective agents|mesh-ancestor
25828826|NCT00006103|Vitamin B Complex|vitamin b complex|mesh-ancestor
25828827|NCT00006103|Vitamins|vitamins|mesh-ancestor
25828828|NCT00006103|Micronutrients|micronutrients|mesh-ancestor
25828829|NCT00006104|Docetaxel|docetaxel|mesh-list
25828830|NCT00006104|Trastuzumab|trastuzumab|mesh-list
25828831|NCT00006104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828832|NCT00006104|Tubulin Modulators|tubulin modulators|mesh-ancestor
25828833|NCT00006104|Antimitotic Agents|antimitotic agents|mesh-ancestor
25828834|NCT00006104|Mitosis Modulators|mitosis modulators|mesh-ancestor
25828835|NCT00006104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828836|NCT00006104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25828837|NCT00006105|Gemcitabine|gemcitabine|mesh-list
25048866|NCT00660881|Epratuzumab|epratuzumab|mesh-list
25048869|NCT00659191|Cabotegravir|cabotegravir|mesh-list
25828838|NCT00006105|Cisplatin|cisplatin|mesh-list
25828839|NCT00006105|Amifostine|amifostine|mesh-list
25828840|NCT00006105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25017770|NCT03704623|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25017771|NCT03704623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25017772|NCT03704623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580551|NCT00862264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25828841|NCT00006105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25650055|NCT01498887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828842|NCT00006105|Antimetabolites|antimetabolites|mesh-ancestor
25828843|NCT00006105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828844|NCT00006105|Antiviral Agents|antiviral agents|mesh-ancestor
25828845|NCT00006105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25828846|NCT00006105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828847|NCT00006105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24705709|NCT01486433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25828848|NCT00006105|Immunologic Factors|immunologic factors|mesh-ancestor
24533589|NCT00644553|Clavulanic Acid|clavulanic acid|mesh-list
24533590|NCT00644553|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25828849|NCT00006105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828850|NCT00006105|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25828851|NCT00006105|Protective Agents|protective agents|mesh-ancestor
25828852|NCT00006106|Cisplatin|cisplatin|mesh-list
25828853|NCT00006106|Fluorouracil|fluorouracil|mesh-list
25828854|NCT00006106|Dl1520|dl1520|mesh-list
25828855|NCT00006106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828856|NCT00006106|Antimetabolites|antimetabolites|mesh-ancestor
25828857|NCT00006106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828858|NCT00006106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25828859|NCT00006106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25017789|NCT03704246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25017790|NCT03704246|Immunologic Factors|immunologic factors|mesh-ancestor
25017791|NCT03704246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017792|NCT03704220|Warfarin|warfarin|mesh-list
25017793|NCT03704220|Anticoagulants|anticoagulants|mesh-ancestor
25017794|NCT03704181|Colchicine|colchicine|mesh-list
25828860|NCT00006106|Immunologic Factors|immunologic factors|mesh-ancestor
25828861|NCT00006106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828862|NCT00006107|Docetaxel|docetaxel|mesh-list
25828863|NCT00006107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828864|NCT00006107|Tubulin Modulators|tubulin modulators|mesh-ancestor
24533745|NCT00645060|Antibodies|antibodies|mesh-list
25828865|NCT00006107|Antimitotic Agents|antimitotic agents|mesh-ancestor
25828866|NCT00006107|Mitosis Modulators|mitosis modulators|mesh-ancestor
25828867|NCT00006107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828868|NCT00006108|Paclitaxel|paclitaxel|mesh-list
25828869|NCT00006108|Capecitabine|capecitabine|mesh-list
25828870|NCT00006108|Trastuzumab|trastuzumab|mesh-list
25828871|NCT00006108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25828872|NCT00006108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828873|NCT00006108|Tubulin Modulators|tubulin modulators|mesh-ancestor
25828874|NCT00006108|Antimitotic Agents|antimitotic agents|mesh-ancestor
25828875|NCT00006108|Mitosis Modulators|mitosis modulators|mesh-ancestor
25828876|NCT00006108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017802|NCT03704155|Botulinum Toxins|botulinum toxins|mesh-list
25017803|NCT03704155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25017804|NCT03704155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25017805|NCT03704155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25017806|NCT03704155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25017807|NCT03704155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017808|NCT03704155|Cholinergic Agents|cholinergic agents|mesh-ancestor
25017809|NCT03704155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25017810|NCT03704155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017811|NCT03704155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25017812|NCT03704155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25017813|NCT03704077|Paclitaxel|paclitaxel|mesh-list
25828877|NCT00006108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25828878|NCT00006108|Antimetabolites|antimetabolites|mesh-ancestor
25828879|NCT00006108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25828880|NCT00006111|Cisplatin|cisplatin|mesh-list
25828881|NCT00006111|Fluorouracil|fluorouracil|mesh-list
25828882|NCT00006111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828883|NCT00006111|Antimetabolites|antimetabolites|mesh-ancestor
25000579|NCT04179890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498706|NCT00516009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24498708|NCT00516009|Hormones|hormones|mesh-ancestor
24923109|NCT04172727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624163|NCT01074905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624164|NCT01074905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24624165|NCT01074905|Filaricides|filaricides|mesh-ancestor
24923229|NCT04171843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923230|NCT04171843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24923231|NCT04171843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24923232|NCT04171843|Alkylating Agents|alkylating agents|mesh-ancestor
24923233|NCT04171843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498845|NCT00516490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25017823|NCT03704077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24498846|NCT00516490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24498847|NCT00516490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25650056|NCT01498887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25829649|NCT00006245|Growth Inhibitors|growth inhibitors|mesh-ancestor
24706050|NCT01488266|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24923255|NCT04171739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24923256|NCT04171739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24923391|NCT04170530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923394|NCT04170790|Vasodilator Agents|vasodilator agents|mesh-ancestor
24923396|NCT04170790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24923397|NCT04170790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24974405|NCT04735913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974406|NCT04735913|Hormone Antagonists|hormone antagonists|mesh-ancestor
24974407|NCT04735913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24923398|NCT04170790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923399|NCT04170790|Urological Agents|urological agents|mesh-ancestor
24923400|NCT04170790|Incretins|incretins|mesh-ancestor
24923402|NCT04170790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24923513|NCT04169854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24923514|NCT04169854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923515|NCT04169841|Durvalumab|durvalumab|mesh-list
24923516|NCT04169841|Olaparib|olaparib|mesh-list
24923517|NCT04169841|Tremelimumab|tremelimumab|mesh-list
24923518|NCT04169841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24923519|NCT04169841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586836|NCT00892346|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24586837|NCT00892346|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24586838|NCT00892346|Growth Substances|growth substances|mesh-ancestor
24586842|NCT00892359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24586844|NCT00892385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24586845|NCT00892385|Alkylating Agents|alkylating agents|mesh-ancestor
24586846|NCT00892385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982054|NCT04391855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24923537|NCT04169763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24923644|NCT04168294|Anesthetics|anesthetics|mesh-ancestor
24923649|NCT04168138|Decitabine|decitabine|mesh-list
25000972|NCT05462496|Folfirinox|folfirinox|mesh-list
24923817|NCT04166812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24923818|NCT04166812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923819|NCT04166812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24923820|NCT04166812|Respiratory System Agents|respiratory system agents|mesh-ancestor
24586847|NCT00892385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586848|NCT00892398|Ranibizumab|ranibizumab|mesh-list
24586849|NCT00892398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24586850|NCT00892398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24586851|NCT00892398|Growth Substances|growth substances|mesh-ancestor
24586852|NCT00892398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586853|NCT00892398|Growth Inhibitors|growth inhibitors|mesh-ancestor
24586854|NCT00892398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586855|NCT00892424|Sorafenib|sorafenib|mesh-list
24586856|NCT00892424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784125|NCT01906307|Giapreza|giapreza|mesh-list
25828884|NCT00006111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923821|NCT04166812|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24499405|NCT00519259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24522947|NCT03012971|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24522948|NCT03012971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24522949|NCT03012971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24522950|NCT03012971|Adrenergic Agents|adrenergic agents|mesh-ancestor
24924492|NCT04159649|Letrozole|letrozole|mesh-list
24923823|NCT04166812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923824|NCT04166812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24923825|NCT04166812|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24923826|NCT04166812|Vasodilator Agents|vasodilator agents|mesh-ancestor
24923827|NCT04166812|Gasotransmitters|gasotransmitters|mesh-ancestor
24923828|NCT04166812|Protective Agents|protective agents|mesh-ancestor
24923830|NCT04166578|Anesthetics, Local|anesthetics, local|mesh-ancestor
24923831|NCT04166578|Anesthetics|anesthetics|mesh-ancestor
24624171|NCT01074970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24923939|NCT04165512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24923940|NCT04165512|Glucocorticoids|glucocorticoids|mesh-ancestor
24923941|NCT04165512|Hormones|hormones|mesh-ancestor
24923942|NCT04165512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24923943|NCT04165512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25650057|NCT01498887|Immunologic Factors|immunologic factors|mesh-ancestor
25657186|NCT01583985|Analgesics, Opioid|analgesics, opioid|mesh-list
24923944|NCT04165512|Immunologic Factors|immunologic factors|mesh-ancestor
24923945|NCT04165629|Aspirin|aspirin|mesh-list
24923946|NCT04165629|Clopidogrel|clopidogrel|mesh-list
24923947|NCT04165629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24923948|NCT04165629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24923950|NCT04165629|Sensory System Agents|sensory system agents|mesh-ancestor
24923951|NCT04165629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24923952|NCT04165629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923961|NCT04165629|Antipyretics|antipyretics|mesh-ancestor
24923970|NCT04165174|Immunologic Factors|immunologic factors|mesh-ancestor
24923971|NCT04165174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923972|NCT04165174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923973|NCT04165174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24923974|NCT04165174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048980|NCT00650832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924202|NCT04161690|Anesthetics, Local|anesthetics, local|mesh-ancestor
24924204|NCT04161690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24924205|NCT04161690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017869|NCT03703089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25017870|NCT03703089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25017871|NCT03703089|Tubulin Modulators|tubulin modulators|mesh-ancestor
24924209|NCT04161690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24924210|NCT04161690|Analgesics|analgesics|mesh-ancestor
24924211|NCT04161690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24924212|NCT04161690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24924213|NCT04161664|Paclitaxel|paclitaxel|mesh-list
24924214|NCT04161664|Carboplatin|carboplatin|mesh-list
24924215|NCT04161664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24924218|NCT04161664|Antimitotic Agents|antimitotic agents|mesh-ancestor
24924261|NCT04161482|Diuretics|diuretics|mesh-ancestor
24924262|NCT04161482|Natriuretic Agents|natriuretic agents|mesh-ancestor
24924263|NCT04161482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924264|NCT04161482|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24924265|NCT04161482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24924266|NCT04161482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924267|NCT04161339|Hydroxychloroquine|hydroxychloroquine|mesh-list
24924268|NCT04161339|Antimalarials|antimalarials|mesh-ancestor
24924269|NCT04161339|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24924270|NCT04161339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24924271|NCT04161339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24966860|NCT03764527|Artesunate|artesunate|mesh-list
24924345|NCT04161001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24396381|NCT00138944|Eplerenone|eplerenone|mesh-list
24924365|NCT04161027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24924366|NCT04161027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24924367|NCT04161027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24924368|NCT04160897|Tenofovir|tenofovir|mesh-list
24924369|NCT04160897|Entecavir|entecavir|mesh-list
24924370|NCT04160897|Antiviral Agents|antiviral agents|mesh-ancestor
24924371|NCT04160897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24924372|NCT04160897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25111051|NCT05262322|Rivaroxaban|rivaroxaban|mesh-list
24924373|NCT04160897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24924374|NCT04160897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25001388|NCT05342584|Cytarabine|cytarabine|mesh-list
24748363|NCT02678572|Melphalan|melphalan|mesh-list
24924487|NCT04159896|Nivolumab|nivolumab|mesh-list
24924488|NCT04159896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24924489|NCT04159896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924490|NCT04159896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24924491|NCT04159896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522987|NCT02978612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522988|NCT02978612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24523003|NCT02957032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24523004|NCT02957032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24523006|NCT02957032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523007|NCT02954991|Nivolumab|nivolumab|mesh-list
24924520|NCT04159181|Cathartics|cathartics|mesh-ancestor
24924522|NCT04159246|Antiviral Agents|antiviral agents|mesh-ancestor
24924523|NCT04159246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24924606|NCT04158830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24924608|NCT04158830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24924609|NCT04158830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24924610|NCT04158830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924611|NCT04158830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24924612|NCT04158830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24706618|NCT01490996|Antimetabolites|antimetabolites|mesh-ancestor
24523021|NCT02932956|Immunologic Factors|immunologic factors|mesh-ancestor
24523022|NCT02932956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523023|NCT02932956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24523024|NCT02932956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24523025|NCT02932956|Alkylating Agents|alkylating agents|mesh-ancestor
24924620|NCT04158076|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
24924621|NCT04158076|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24924623|NCT04158076|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24924686|NCT04157491|Antibodies|antibodies|mesh-list
24924694|NCT04157699|Tenofovir|tenofovir|mesh-list
24924695|NCT04157699|Antiviral Agents|antiviral agents|mesh-ancestor
24924696|NCT04157699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24924697|NCT04157699|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24924698|NCT04157699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24924699|NCT04157699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24523080|NCT02821507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523082|NCT02821507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24924706|NCT04157257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24924707|NCT04157257|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24924708|NCT04157257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24924709|NCT04157257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924710|NCT04157257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924764|NCT04156750|Metformin|metformin|mesh-list
24784965|NCT01911364|Autonomic Agents|autonomic agents|mesh-ancestor
24924765|NCT04156750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24924766|NCT04156750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017944|NCT03702803|Alprazolam|alprazolam|mesh-list
24924767|NCT04156555|Amoxicillin|amoxicillin|mesh-list
24924768|NCT04156555|Clavulanic Acid|clavulanic acid|mesh-list
24500558|NCT00524914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500560|NCT00524927|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24500561|NCT00524927|Anesthetics, General|anesthetics, general|mesh-ancestor
24500562|NCT00524927|Anesthetics|anesthetics|mesh-ancestor
25829650|NCT00006245|Growth Substances|growth substances|mesh-ancestor
24924878|NCT04155879|Antimitotic Agents|antimitotic agents|mesh-ancestor
25001658|NCT05227833|Pantoprazole|pantoprazole|mesh-list
24624288|NCT01075581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24624289|NCT01075581|Adrenergic Agents|adrenergic agents|mesh-ancestor
24624290|NCT01075581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24624291|NCT01075581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624292|NCT01075581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624293|NCT01075581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24624294|NCT01075581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24624295|NCT01075581|Autonomic Agents|autonomic agents|mesh-ancestor
24624307|NCT01075659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24624308|NCT01075659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24624309|NCT01075659|Cholinergic Agents|cholinergic agents|mesh-ancestor
24624310|NCT01075659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24624311|NCT01075659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925020|NCT04155008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25017983|NCT03702582|Anticoagulants|anticoagulants|mesh-ancestor
25017984|NCT03702582|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25017985|NCT03702582|Antithrombins|antithrombins|mesh-ancestor
25017986|NCT03702582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25017987|NCT03702582|Protease Inhibitors|protease inhibitors|mesh-ancestor
25017988|NCT03702582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925021|NCT04155008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925022|NCT04155008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24925023|NCT04155008|Glucocorticoids|glucocorticoids|mesh-ancestor
24925029|NCT04155008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24925030|NCT04155008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24925031|NCT04155008|Histamine Antagonists|histamine antagonists|mesh-ancestor
24925032|NCT04155008|Histamine Agents|histamine agents|mesh-ancestor
24925033|NCT04155008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24925034|NCT04155008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925035|NCT04155008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24925036|NCT04155008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24925037|NCT04155008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25049160|NCT00631111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925060|NCT04154735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24925061|NCT04154735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24925062|NCT04154735|Alkylating Agents|alkylating agents|mesh-ancestor
25650058|NCT01498887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925065|NCT04154735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24706870|NCT01492881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706871|NCT01492881|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24706872|NCT01492894|Cyclosporine|cyclosporine|mesh-list
24706873|NCT01492894|Sirolimus|sirolimus|mesh-list
24706874|NCT01492894|Tacrolimus|tacrolimus|mesh-list
24706875|NCT01492894|Cyclosporins|cyclosporins|mesh-list
24925066|NCT04154735|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24925067|NCT04154735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925068|NCT04154735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24925069|NCT04154735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24925070|NCT04154735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24925071|NCT04154735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24925074|NCT04154722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24925075|NCT04154722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24500771|NCT00525681|Cyclosporins|cyclosporins|mesh-list
24925128|NCT04153201|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24925129|NCT04153201|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24925130|NCT04153201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24925131|NCT04153201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925132|NCT04153201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925133|NCT04153201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24925134|NCT04153383|Milrinone|milrinone|mesh-list
24925135|NCT04153383|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24925136|NCT04153383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25018081|NCT03701919|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24500832|NCT00525889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24500833|NCT00525889|Antifungal Agents|antifungal agents|mesh-ancestor
24500834|NCT00525889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24500835|NCT00525889|Immunologic Factors|immunologic factors|mesh-ancestor
24500837|NCT00525928|Varenicline|varenicline|mesh-list
24523403|NCT01293682|Micronutrients|micronutrients|mesh-ancestor
24925296|NCT04151472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925298|NCT04151719|Bromides|bromides|mesh-list
24925299|NCT04151719|Methylnaltrexone|methylnaltrexone|mesh-list
24523694|NCT05340985|Cholecalciferol|cholecalciferol|mesh-list
25203469|NCT02714361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523696|NCT05340985|Vitamins|vitamins|mesh-list
24523697|NCT05340985|Dehydrocholesterols|dehydrocholesterols|mesh-list
24523698|NCT05340985|7-dehydrocholesterol|7-dehydrocholesterol|mesh-list
24925374|NCT04150536|Lidocaine|lidocaine|mesh-list
24925375|NCT04150536|Anesthetics, Local|anesthetics, local|mesh-ancestor
24925376|NCT04150536|Anesthetics|anesthetics|mesh-ancestor
24925377|NCT04150536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24925378|NCT04150536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925379|NCT04150536|Sensory System Agents|sensory system agents|mesh-ancestor
24925380|NCT04150536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24925381|NCT04150536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24925382|NCT04150536|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24925383|NCT04150536|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24925384|NCT04150536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24644903|NCT01193621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24644904|NCT01193621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24925405|NCT04150757|Anesthetics, General|anesthetics, general|mesh-ancestor
24925407|NCT04150757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24925408|NCT04150757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24925409|NCT04150757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25018124|NCT03701698|Glucocorticoids|glucocorticoids|mesh-ancestor
24925410|NCT04150757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24523963|NCT05338476|GABA Modulators|gaba modulators|mesh-ancestor
24523965|NCT05338476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24523966|NCT05338476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925615|NCT04149132|Gasotransmitters|gasotransmitters|mesh-ancestor
24925616|NCT04149132|Protective Agents|protective agents|mesh-ancestor
24925943|NCT04146259|Vitamins|vitamins|mesh-ancestor
24925944|NCT04146259|Micronutrients|micronutrients|mesh-ancestor
24925945|NCT04145856|Simethicone|simethicone|mesh-list
24925946|NCT04145856|Alverine|alverine|mesh-list
24925947|NCT04145856|Antifoaming Agents|antifoaming agents|mesh-ancestor
24925965|NCT04145583|Antifungal Agents|antifungal agents|mesh-ancestor
25650059|NCT01498952|Sorafenib|sorafenib|mesh-list
25650060|NCT01498952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25650061|NCT01498952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25650062|NCT01498952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650063|NCT01498952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657187|NCT01583985|Narcotics|narcotics|mesh-ancestor
24925966|NCT04145583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24925967|NCT04145583|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25650064|NCT01498978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25828885|NCT00006111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25828886|NCT00006111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24707391|NCT01495403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925968|NCT04145583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24925969|NCT04145583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24524062|NCT05307003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925991|NCT04145492|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24925992|NCT04145492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24925993|NCT04145492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926200|NCT04143906|Mitosis Modulators|mitosis modulators|mesh-ancestor
25018141|NCT03701581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018142|NCT03701529|Anesthetics|anesthetics|mesh-list
24926201|NCT04144192|Lidocaine|lidocaine|mesh-list
24926202|NCT04144192|Anesthetics, Local|anesthetics, local|mesh-ancestor
24926203|NCT04144192|Anesthetics|anesthetics|mesh-ancestor
24926204|NCT04144192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24926205|NCT04144192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926206|NCT04144192|Sensory System Agents|sensory system agents|mesh-ancestor
24926207|NCT04144192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24926208|NCT04144192|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24926209|NCT04144192|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24926210|NCT04144192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24545331|NCT00693056|beta-Lactams|beta-lactams|mesh-list
24926211|NCT04144192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24926212|NCT04144192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926213|NCT04143802|Dulaglutide|dulaglutide|mesh-list
24926214|NCT04143802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24926215|NCT04143802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926216|NCT04143685|Misoprostol|misoprostol|mesh-list
24926217|NCT04143685|Oxytocin|oxytocin|mesh-list
24926233|NCT04143854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926234|NCT04143854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24926235|NCT04143854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24926237|NCT04143581|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24926238|NCT04143581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926239|NCT04143581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25111133|NCT05134792|Immunoglobulins|immunoglobulins|mesh-list
25111134|NCT05134792|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25111135|NCT05134792|Antibodies|antibodies|mesh-list
24926240|NCT04143581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926241|NCT04143451|Imiquimod|imiquimod|mesh-list
24926256|NCT04143815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24926257|NCT04143815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24926258|NCT04143321|Empagliflozin|empagliflozin|mesh-list
24926259|NCT04143321|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24926260|NCT04143321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926261|NCT04143321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24926262|NCT04143321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926263|NCT04143165|Lidocaine|lidocaine|mesh-list
24926277|NCT04143256|Dermatologic Agents|dermatologic agents|mesh-ancestor
24926279|NCT04143412|Eplerenone|eplerenone|mesh-list
24926280|NCT04143412|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24926281|NCT04143412|Protease Inhibitors|protease inhibitors|mesh-ancestor
24926282|NCT04143412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24926283|NCT04143412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926284|NCT04143412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24926285|NCT04143412|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24926286|NCT04143412|Hormone Antagonists|hormone antagonists|mesh-ancestor
24502040|NCT05319912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24502042|NCT05319912|Lipotropic Agents|lipotropic agents|mesh-ancestor
24524094|NCT05279833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24524095|NCT05279833|Adrenergic Agents|adrenergic agents|mesh-ancestor
24524096|NCT05279833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24524100|NCT05279833|Sympatholytics|sympatholytics|mesh-ancestor
24524101|NCT05279833|Autonomic Agents|autonomic agents|mesh-ancestor
24524102|NCT05279833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24524104|NCT05266417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24524105|NCT05266417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524121|NCT05252923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25650066|NCT01498978|Antibodies|antibodies|mesh-list
25650067|NCT01498978|Immunoglobulins|immunoglobulins|mesh-list
25650068|NCT01498978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24524122|NCT05252923|Antimetabolites|antimetabolites|mesh-ancestor
24399850|NCT00148746|Analgesics|analgesics|mesh-ancestor
25049273|NCT00625651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926308|NCT04142840|Anesthetics, General|anesthetics, general|mesh-ancestor
24926309|NCT04142840|Anesthetics|anesthetics|mesh-ancestor
24926310|NCT04142840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24524146|NCT05232032|Nociceptin|nociceptin|mesh-list
24524147|NCT05232032|Vasodilator Agents|vasodilator agents|mesh-ancestor
24524148|NCT05227391|Letrozole|letrozole|mesh-list
24524149|NCT05227391|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24524150|NCT05227391|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24524151|NCT05227391|Estradiol|estradiol|mesh-list
24524152|NCT05227391|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24524153|NCT05227391|Estrogens|estrogens|mesh-ancestor
24524154|NCT05227391|Hormones|hormones|mesh-ancestor
24524155|NCT05227391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24524156|NCT05227391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524157|NCT05227391|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24524158|NCT05227391|Contraceptive Agents|contraceptive agents|mesh-ancestor
24524159|NCT05227391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24524160|NCT05227391|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24524161|NCT05227391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926314|NCT04142840|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24926399|NCT04142151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24926400|NCT04142151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24926401|NCT04142151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24940117|NCT04003376|Vitamin D|vitamin d|mesh-list
24586936|NCT00892827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25155434|NCT05371899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24926514|NCT04140578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24926515|NCT04140578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24926516|NCT04140487|Azacitidine|azacitidine|mesh-list
24926723|NCT04138901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24926724|NCT04138901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926725|NCT04138901|Sensory System Agents|sensory system agents|mesh-ancestor
24926726|NCT04138901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24926731|NCT04138420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926732|NCT04138420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24926733|NCT04138420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24926734|NCT04138420|Growth Substances|growth substances|mesh-ancestor
25018276|NCT03700515|Epoetin Alfa|epoetin alfa|mesh-list
25018277|NCT03700515|Hematinics|hematinics|mesh-ancestor
25018278|NCT03700489|Titanium dioxide|titanium dioxide|mesh-list
25018279|NCT03700489|Sunscreening Agents|sunscreening agents|mesh-ancestor
25018280|NCT03700489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25018281|NCT03700489|Protective Agents|protective agents|mesh-ancestor
25018282|NCT03700489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018283|NCT03700489|Dermatologic Agents|dermatologic agents|mesh-ancestor
25018284|NCT03700489|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25018285|NCT03700450|Cyclophosphamide|cyclophosphamide|mesh-list
25018286|NCT03700450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24926735|NCT04138420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926736|NCT04138420|Growth Inhibitors|growth inhibitors|mesh-ancestor
24926737|NCT04138381|Imatinib Mesylate|imatinib mesylate|mesh-list
24926738|NCT04138381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926739|NCT04138381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24926740|NCT04138381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24926741|NCT04138381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926742|NCT04138888|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24926743|NCT04138888|Olmesartan|olmesartan|mesh-list
24524669|NCT04532463|Amphotericin B|amphotericin b|mesh-list
24524670|NCT04532463|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24524671|NCT04532463|Flucytosine|flucytosine|mesh-list
24524672|NCT04532463|Antifungal Agents|antifungal agents|mesh-ancestor
24926941|NCT04137328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24926942|NCT04137276|Vitamins|vitamins|mesh-list
24926943|NCT04137276|Ascorbic Acid|ascorbic acid|mesh-list
24926944|NCT04137276|Thiamine|thiamine|mesh-list
24624463|NCT01076478|Respiratory System Agents|respiratory system agents|mesh-ancestor
24624464|NCT01076478|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24624465|NCT01076478|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25018291|NCT03700450|Alkylating Agents|alkylating agents|mesh-ancestor
24624466|NCT01076478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926945|NCT04137276|Vitamin B Complex|vitamin b complex|mesh-list
24926946|NCT04137276|Micronutrients|micronutrients|mesh-ancestor
24926947|NCT04137276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926951|NCT04137302|Hydrocortisone|hydrocortisone|mesh-list
24926952|NCT04137302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24613918|NCT01021592|Bortezomib|bortezomib|mesh-list
24926953|NCT04137380|Mirikizumab|mirikizumab|mesh-list
24926954|NCT04137380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24926955|NCT04137380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24926957|NCT04137380|Sensory System Agents|sensory system agents|mesh-ancestor
24926958|NCT04137380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24926959|NCT04137380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926960|NCT04137380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24926961|NCT04137380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24926962|NCT04137380|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24926963|NCT04137380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24524673|NCT04532463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24524674|NCT04532463|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24524675|NCT04532463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24524676|NCT04532463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24524677|NCT04532463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926974|NCT04137029|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24926975|NCT04137029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24926976|NCT04137029|Adrenergic Agents|adrenergic agents|mesh-ancestor
24926977|NCT04137029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24926978|NCT04137029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926979|NCT04137029|Parasympatholytics|parasympatholytics|mesh-ancestor
24926980|NCT04137029|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24926981|NCT04137029|Cholinergic Agents|cholinergic agents|mesh-ancestor
24524711|NCT04504734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24524719|NCT04504734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524720|NCT04504734|Protective Agents|protective agents|mesh-ancestor
24524721|NCT04500236|Anesthetics|anesthetics|mesh-list
24524722|NCT04500236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24524723|NCT04500236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524724|NCT04480918|Ketamine|ketamine|mesh-list
24524725|NCT04480918|Esketamine|esketamine|mesh-list
24524726|NCT04480918|Analgesics|analgesics|mesh-ancestor
24524727|NCT04480918|Sensory System Agents|sensory system agents|mesh-ancestor
24524728|NCT04480918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24524729|NCT04480918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080852|NCT03335124|Vitamins|vitamins|mesh-list
24524730|NCT04480918|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24524738|NCT04480918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524739|NCT04480918|Antidepressive Agents|antidepressive agents|mesh-ancestor
24524740|NCT04480918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24524741|NCT04479579|Apixaban|apixaban|mesh-list
24524742|NCT04479579|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24524743|NCT04479579|Antithrombins|antithrombins|mesh-ancestor
24524744|NCT04479579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24524745|NCT04479579|Protease Inhibitors|protease inhibitors|mesh-ancestor
24524746|NCT04479579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24524747|NCT04479579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524748|NCT04479579|Anticoagulants|anticoagulants|mesh-ancestor
24524749|NCT04477772|Antibodies|antibodies|mesh-list
24524750|NCT04477772|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24524751|NCT04477772|Immunologic Factors|immunologic factors|mesh-ancestor
24524752|NCT04477772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524753|NCT04446962|Lenalidomide|lenalidomide|mesh-list
24524754|NCT04446962|Immunologic Factors|immunologic factors|mesh-ancestor
24927023|NCT04136639|Proanthocyanidin|proanthocyanidin|mesh-list
24927024|NCT04136639|Grape Seed Extract|grape seed extract|mesh-list
24927026|NCT04136639|Sodium Fluoride|sodium fluoride|mesh-list
24927027|NCT04136639|Cariostatic Agents|cariostatic agents|mesh-ancestor
24927028|NCT04136639|Protective Agents|protective agents|mesh-ancestor
24927029|NCT04136639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927030|NCT04136639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24927031|NCT04136639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24927032|NCT04136639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927033|NCT04136639|Antioxidants|antioxidants|mesh-ancestor
24927034|NCT04136639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927035|NCT04136639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24401201|NCT00152412|Levocetirizine|levocetirizine|mesh-list
24927041|NCT04136470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927079|NCT04135885|Vitamins|vitamins|mesh-ancestor
24927080|NCT04135885|Micronutrients|micronutrients|mesh-ancestor
24927081|NCT04135885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927082|NCT04135833|Itraconazole|itraconazole|mesh-list
24502905|NCT04049799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24524788|NCT04358289|Anti-Infective Agents|anti-infective agents|mesh-list
25650069|NCT01498978|Immunologic Factors|immunologic factors|mesh-ancestor
24524789|NCT04358289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24524790|NCT04329039|Somatostatin|somatostatin|mesh-list
24524791|NCT04329039|Hormones|hormones|mesh-ancestor
24524792|NCT04329039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24524795|NCT04321668|Viscosupplements|viscosupplements|mesh-ancestor
24524796|NCT04321668|Protective Agents|protective agents|mesh-ancestor
24524797|NCT04321668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524798|NCT04318691|Dimercaprol|dimercaprol|mesh-list
24524799|NCT04318691|Chelating Agents|chelating agents|mesh-ancestor
24524800|NCT04318691|Sequestering Agents|sequestering agents|mesh-ancestor
24927083|NCT04135833|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
24927084|NCT04135833|Rifampin|rifampin|mesh-list
24927085|NCT04135833|Antifungal Agents|antifungal agents|mesh-ancestor
24927086|NCT04135833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24927087|NCT04135833|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24927088|NCT04135833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24927089|NCT04135833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927090|NCT04135833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927091|NCT04135833|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24927092|NCT04135833|Hormone Antagonists|hormone antagonists|mesh-ancestor
24927093|NCT04135833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24927094|NCT04135833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927095|NCT04135833|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24927096|NCT04135833|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24927097|NCT04135833|Antitubercular Agents|antitubercular agents|mesh-ancestor
24927098|NCT04135833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25203470|NCT02714361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25828887|NCT00006111|Immunologic Factors|immunologic factors|mesh-ancestor
24927099|NCT04135833|Leprostatic Agents|leprostatic agents|mesh-ancestor
24502933|NCT04020172|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24502934|NCT04020172|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24502935|NCT04020172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24502936|NCT04020172|Adrenergic Agents|adrenergic agents|mesh-ancestor
24502939|NCT04020172|Protective Agents|protective agents|mesh-ancestor
24524841|NCT04276259|Naltrexone|naltrexone|mesh-list
24524842|NCT04276259|Buprenorphine|buprenorphine|mesh-list
24524843|NCT04276259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24524844|NCT04276259|Narcotics|narcotics|mesh-ancestor
24524845|NCT04276259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24401267|NCT00152620|Prednisolone|prednisolone|mesh-list
24927170|NCT04135014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24927171|NCT04135014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927172|NCT04135014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24927174|NCT04135014|Sensory System Agents|sensory system agents|mesh-ancestor
24927175|NCT04135014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24927176|NCT04135014|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24927177|NCT04135014|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24927178|NCT04135014|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24624471|NCT01076478|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24624472|NCT01076478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24624473|NCT01076478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24624474|NCT01076491|Mannitol|mannitol|mesh-list
24624475|NCT01076491|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24624476|NCT01076491|Diuretics|diuretics|mesh-ancestor
24624477|NCT01076491|Natriuretic Agents|natriuretic agents|mesh-ancestor
24624478|NCT01076491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624479|NCT01076530|Temozolomide|temozolomide|mesh-list
24624480|NCT01076530|Vorinostat|vorinostat|mesh-list
24624481|NCT01076530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24624482|NCT01076530|Alkylating Agents|alkylating agents|mesh-ancestor
25003375|NCT03774810|Zolpidem|zolpidem|mesh-list
25828888|NCT00006111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828889|NCT00006112|Leucovorin|leucovorin|mesh-list
25828890|NCT00006112|Fluorouracil|fluorouracil|mesh-list
25828891|NCT00006112|Mitomycins|mitomycins|mesh-list
25828892|NCT00006112|Mitomycin|mitomycin|mesh-list
24525213|NCT03812588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525214|NCT03812588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24525215|NCT03812588|Serotonin Agents|serotonin agents|mesh-ancestor
24525216|NCT03812588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525217|NCT03812588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24401636|NCT00153543|Vaccines|vaccines|mesh-list
24525233|NCT03809988|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24525234|NCT03809988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24624515|NCT01076582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25828893|NCT00006112|Calcium|calcium|mesh-list
24709642|NCT01506544|Antisickling Agents|antisickling agents|mesh-ancestor
24624518|NCT01076582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24624519|NCT01076582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24624520|NCT01076582|Progestins|progestins|mesh-ancestor
24624521|NCT01076595|Interferons|interferons|mesh-list
24624522|NCT01076595|Interferon-beta|interferon-beta|mesh-list
24624523|NCT01076595|Interferon beta-1b|interferon beta-1b|mesh-list
24624524|NCT01076595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624525|NCT01076595|Antiviral Agents|antiviral agents|mesh-ancestor
24853321|NCT02267616|Etonogestrel|etonogestrel|mesh-list
24624526|NCT01076595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24927199|NCT04134650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24624527|NCT01076595|Immunologic Factors|immunologic factors|mesh-ancestor
24751430|NCT01704092|Analgesics|analgesics|mesh-ancestor
24927200|NCT04134650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927201|NCT04134650|Incretins|incretins|mesh-ancestor
24927356|NCT04134637|Sensory System Agents|sensory system agents|mesh-ancestor
24927358|NCT04133571|Lidocaine|lidocaine|mesh-list
24927366|NCT04133571|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24927367|NCT04133571|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24927368|NCT04133571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24927369|NCT04133571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927371|NCT04133428|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24927372|NCT04133428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24525302|NCT03673527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24525303|NCT03673527|Immunologic Factors|immunologic factors|mesh-ancestor
24525304|NCT03673527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525305|NCT03673527|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24525306|NCT03673527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525307|NCT03673527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018540|NCT03698630|Prednisolone|prednisolone|mesh-list
25828894|NCT00006112|Levoleucovorin|levoleucovorin|mesh-list
25018558|NCT03698630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25018559|NCT03698630|Protective Agents|protective agents|mesh-ancestor
24525308|NCT03664687|Zoledronic Acid|zoledronic acid|mesh-list
24525309|NCT03664687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24525310|NCT03664687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525311|NCT03663504|Metronidazole|metronidazole|mesh-list
24525312|NCT03663504|Neomycin|neomycin|mesh-list
24525313|NCT03663504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24525314|NCT03663504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24525315|NCT03663504|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24525316|NCT03663504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24525317|NCT03663504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25828895|NCT00006112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25828896|NCT00006112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828897|NCT00006112|Antimetabolites|antimetabolites|mesh-ancestor
25828898|NCT00006112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828899|NCT00006112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25828900|NCT00006112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828901|NCT00006112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25828902|NCT00006112|Immunologic Factors|immunologic factors|mesh-ancestor
25828903|NCT00006112|Antidotes|antidotes|mesh-ancestor
24525384|NCT03593655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24525385|NCT03593655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24525387|NCT03562871|Pembrolizumab|pembrolizumab|mesh-list
24525388|NCT03562871|Pemetrexed|pemetrexed|mesh-list
24525389|NCT03562871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525390|NCT03562871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24525391|NCT03562871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525392|NCT03562871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525393|NCT03562871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24525394|NCT03562871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25045287|NCT00975091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24525395|NCT03521102|Acetaminophen|acetaminophen|mesh-list
24525396|NCT03521102|Hydromorphone|hydromorphone|mesh-list
24525411|NCT03405090|Bronchodilator Agents|bronchodilator agents|mesh-list
24525412|NCT03405090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24525413|NCT03405090|Narcotics|narcotics|mesh-ancestor
24525414|NCT03405090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24525415|NCT03405090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525416|NCT03405090|Analgesics|analgesics|mesh-ancestor
24525417|NCT03405090|Sensory System Agents|sensory system agents|mesh-ancestor
24525418|NCT03405090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24525481|NCT03289741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25828904|NCT00006112|Protective Agents|protective agents|mesh-ancestor
24525493|NCT03259867|Nivolumab|nivolumab|mesh-list
24525494|NCT03259867|Tirapazamine|tirapazamine|mesh-list
24525495|NCT03259867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24927569|NCT04132011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24927570|NCT04132011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927571|NCT04132011|Analgesics|analgesics|mesh-ancestor
25018674|NCT03697824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018675|NCT03697824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24927572|NCT04132011|Sensory System Agents|sensory system agents|mesh-ancestor
24927573|NCT04132011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24927574|NCT04132102|Afatinib|afatinib|mesh-list
24927575|NCT04132102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927576|NCT04132102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24927577|NCT04132102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927578|NCT04132102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927579|NCT04131621|Nivolumab|nivolumab|mesh-list
24927580|NCT04131621|Ipilimumab|ipilimumab|mesh-list
24525683|NCT02927938|Immunologic Factors|immunologic factors|mesh-ancestor
24525684|NCT02927938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525685|NCT02883400|Spironolactone|spironolactone|mesh-list
24525686|NCT02883400|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24525687|NCT02883400|Hormone Antagonists|hormone antagonists|mesh-ancestor
24402345|NCT00156689|Levetiracetam|levetiracetam|mesh-list
24927589|NCT04131348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24927590|NCT04131348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927591|NCT04131348|Cholinergic Agents|cholinergic agents|mesh-ancestor
24927592|NCT04131348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25018684|NCT03697746|Acetaminophen|acetaminophen|mesh-list
25018685|NCT03697746|Ibuprofen|ibuprofen|mesh-list
25018686|NCT03697746|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
25018688|NCT03697746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25018689|NCT03697746|Analgesics|analgesics|mesh-ancestor
25018690|NCT03697746|Sensory System Agents|sensory system agents|mesh-ancestor
25018691|NCT03697746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018692|NCT03697746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927593|NCT04131348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927594|NCT04131348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24927595|NCT04131348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24927596|NCT04131582|Metformin|metformin|mesh-list
24503501|NCT00532116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24525706|NCT02856594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24965496|NCT03776409|Lactams|lactams|mesh-list
24525707|NCT02856594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525708|NCT02856594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24525709|NCT02856594|Analgesics|analgesics|mesh-ancestor
24525717|NCT02856594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525718|NCT02823574|Nivolumab|nivolumab|mesh-list
24525719|NCT02823574|Ipilimumab|ipilimumab|mesh-list
24927616|NCT04131283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24927617|NCT04131283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24927619|NCT04131283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018710|NCT03697668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018711|NCT03697668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018712|NCT03697668|Antimalarials|antimalarials|mesh-ancestor
25018726|NCT03697564|Nivolumab|nivolumab|mesh-list
24927620|NCT04131283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24927621|NCT04131283|Respiratory System Agents|respiratory system agents|mesh-ancestor
24927622|NCT04131283|Mydriatics|mydriatics|mesh-ancestor
24927623|NCT04131283|Sympathomimetics|sympathomimetics|mesh-ancestor
24402925|NCT00158821|Antimetabolites|antimetabolites|mesh-ancestor
24525988|NCT02161783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24525989|NCT02129348|Lithium Carbonate|lithium carbonate|mesh-list
24525990|NCT02129348|Antidepressive Agents|antidepressive agents|mesh-ancestor
24525991|NCT02129348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24525992|NCT02129348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525993|NCT02129348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525994|NCT02129348|Antimanic Agents|antimanic agents|mesh-ancestor
24525995|NCT02129348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24525996|NCT02129348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24927864|NCT04128878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24927865|NCT04128878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927866|NCT04128878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927867|NCT04128878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24927868|NCT04128878|Sympatholytics|sympatholytics|mesh-ancestor
24927869|NCT04128878|Autonomic Agents|autonomic agents|mesh-ancestor
24927870|NCT04128878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25828905|NCT00006112|Vitamin B Complex|vitamin b complex|mesh-ancestor
24526051|NCT01921166|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24526052|NCT01921166|Hormone Antagonists|hormone antagonists|mesh-ancestor
24526053|NCT01921166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24526054|NCT01921166|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24526078|NCT01845441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526079|NCT01845441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24526080|NCT01845441|Analgesics|analgesics|mesh-ancestor
24928021|NCT04127019|Mitosis Modulators|mitosis modulators|mesh-ancestor
24928022|NCT04127019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928023|NCT04127019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24928024|NCT04127019|Immunologic Factors|immunologic factors|mesh-ancestor
25018739|NCT03697265|Pregnanolone|pregnanolone|mesh-list
24928025|NCT04127019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928026|NCT04127019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24928027|NCT04127019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24928028|NCT04127019|Alkylating Agents|alkylating agents|mesh-ancestor
24928029|NCT04127019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24928030|NCT04127019|Antimetabolites|antimetabolites|mesh-ancestor
24928031|NCT04127019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24928032|NCT04127019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24928053|NCT04127227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928055|NCT04126811|Ifosfamide|ifosfamide|mesh-list
24928056|NCT04126811|Isophosphamide mustard|isophosphamide mustard|mesh-list
24928057|NCT04126811|Pirarubicin|pirarubicin|mesh-list
24928058|NCT04126811|Doxorubicin|doxorubicin|mesh-list
24928059|NCT04126811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24928060|NCT04126811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24928061|NCT04126811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24928062|NCT04126811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526646|NCT00612547|Artesunate|artesunate|mesh-list
24526647|NCT00612547|Amodiaquine|amodiaquine|mesh-list
24526648|NCT00612547|Antimalarials|antimalarials|mesh-ancestor
24526649|NCT00612547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24526650|NCT00612547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24526734|NCT00612989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25018777|NCT03697057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013299|NCT03101566|Antimetabolites|antimetabolites|mesh-ancestor
25018779|NCT03697044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25018780|NCT03697044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25018781|NCT03697044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24526735|NCT00612989|Alkylating Agents|alkylating agents|mesh-ancestor
24526738|NCT00612989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24928262|NCT04124094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24928263|NCT04124094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928264|NCT04124094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24941622|NCT03989557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24624650|NCT01077505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624651|NCT01077505|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24624653|NCT01077505|Hormones|hormones|mesh-ancestor
24624654|NCT01077505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24624655|NCT01077505|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24624656|NCT01077505|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25004282|NCT02187354|Blinatumomab|blinatumomab|mesh-list
24928295|NCT04123717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24928296|NCT04123717|Analgesics|analgesics|mesh-ancestor
24928297|NCT04123717|Sensory System Agents|sensory system agents|mesh-ancestor
24928298|NCT04123717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24928299|NCT04123717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928300|NCT04123717|Antipyretics|antipyretics|mesh-ancestor
24928301|NCT04123717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24928302|NCT04123717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24928303|NCT04123717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24928304|NCT04123717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24928305|NCT04123717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24928385|NCT04122599|Antioxidants|antioxidants|mesh-ancestor
24527027|NCT00614536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166593|NCT03850535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24527029|NCT00614588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24527030|NCT00614588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928411|NCT04122066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24928412|NCT04122105|Sildenafil Citrate|sildenafil citrate|mesh-list
24622142|NCT01065805|Alovudine|alovudine|mesh-list
24527096|NCT00614965|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24614292|NCT01023360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24527097|NCT00614965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24527098|NCT00614965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527163|NCT00615212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24527164|NCT00615212|Anesthetics, General|anesthetics, general|mesh-ancestor
24527166|NCT00615212|GABA Modulators|gaba modulators|mesh-ancestor
25018857|NCT03696121|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25018858|NCT03696121|Hemostatics|hemostatics|mesh-ancestor
24527167|NCT00615212|GABA Agents|gaba agents|mesh-ancestor
24527168|NCT00615212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24527169|NCT00615212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527170|NCT00615212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24527171|NCT00615212|Analgesics|analgesics|mesh-ancestor
24527172|NCT00615212|Sensory System Agents|sensory system agents|mesh-ancestor
24527173|NCT00615212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24527174|NCT00615212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24928516|NCT04121338|Anesthetics, Local|anesthetics, local|mesh-ancestor
24928517|NCT04121338|Anesthetics|anesthetics|mesh-ancestor
24928518|NCT04121338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24928519|NCT04121338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928520|NCT04121338|Sensory System Agents|sensory system agents|mesh-ancestor
24928531|NCT04121091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24928532|NCT04120883|Hydroxychloroquine|hydroxychloroquine|mesh-list
24928533|NCT04120883|Antimalarials|antimalarials|mesh-ancestor
24928534|NCT04120883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24928535|NCT04120883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24928536|NCT04120883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24928537|NCT04120883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24928538|NCT04120883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928539|NCT04120883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24928540|NCT04120779|Sulfamethazine|sulfamethazine|mesh-list
24928541|NCT04120779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24928542|NCT04120987|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24928543|NCT04120987|Lifitegrast|lifitegrast|mesh-list
24928544|NCT04120987|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24928545|NCT04120753|Amlodipine|amlodipine|mesh-list
24928546|NCT04120753|Olmesartan|olmesartan|mesh-list
24928547|NCT04120753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24928548|NCT04120753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24928549|NCT04120753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24928550|NCT04120753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928551|NCT04120753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24528435|NCT00621101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24929632|NCT04111289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24929633|NCT04111289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929634|NCT04111289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25828906|NCT00006112|Vitamins|vitamins|mesh-ancestor
24930020|NCT04106362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24930021|NCT04105985|Oxymetazoline|oxymetazoline|mesh-list
24529334|NCT00625495|Esomeprazole|esomeprazole|mesh-list
24529335|NCT00625495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24529336|NCT00625495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24625061|NCT01080417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24931333|NCT04090021|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24931334|NCT04090021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24931335|NCT04090021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931336|NCT04090021|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24931337|NCT04090021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24931338|NCT04090021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24931339|NCT04090021|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24931340|NCT04090021|Renal Agents|renal agents|mesh-ancestor
24931627|NCT04086940|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24931628|NCT04086940|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24931629|NCT04086940|Adrenergic Agents|adrenergic agents|mesh-ancestor
24931630|NCT04086940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24931631|NCT04086940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932939|NCT04075006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24932940|NCT04075006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018950|NCT03695445|Autonomic Agents|autonomic agents|mesh-ancestor
24936391|NCT04041128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933033|NCT04074551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25650070|NCT01498978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933034|NCT04074551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828907|NCT00006112|Micronutrients|micronutrients|mesh-ancestor
24711745|NCT01516762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24711747|NCT01516814|Calcium heparin|calcium heparin|mesh-list
24711748|NCT01516814|Warfarin|warfarin|mesh-list
24711749|NCT01516814|Rivaroxaban|rivaroxaban|mesh-list
24711750|NCT01516814|Anticoagulants|anticoagulants|mesh-ancestor
24711751|NCT01516814|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24711752|NCT01516814|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24936418|NCT04040465|Aspirin|aspirin|mesh-list
24625281|NCT01081535|Sensory System Agents|sensory system agents|mesh-ancestor
24530392|NCT00630084|Antiviral Agents|antiviral agents|mesh-ancestor
24975477|NCT03593811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24975478|NCT03593811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975479|NCT03593811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24975527|NCT03520686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24975528|NCT03478930|Omalizumab|omalizumab|mesh-list
24975529|NCT03478930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24975530|NCT03478930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24975531|NCT03478930|Respiratory System Agents|respiratory system agents|mesh-ancestor
24975533|NCT03477539|Daratumumab|daratumumab|mesh-list
24975534|NCT03477539|Immunologic Factors|immunologic factors|mesh-ancestor
24975535|NCT03477539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540382|NCT00667758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25828908|NCT00006112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25828909|NCT00006112|Alkylating Agents|alkylating agents|mesh-ancestor
25828910|NCT00006112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25828911|NCT00006112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828912|NCT00006113|Interferons|interferons|mesh-list
25828913|NCT00006113|Aldesleukin|aldesleukin|mesh-list
24933197|NCT04073927|Histamine Antagonists|histamine antagonists|mesh-ancestor
24936481|NCT04039880|Olorofim|olorofim|mesh-list
25155544|NCT05346601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933367|NCT04071574|Hormones|hormones|mesh-ancestor
24933415|NCT04071106|Protective Agents|protective agents|mesh-ancestor
24933417|NCT04070742|Minocycline|minocycline|mesh-list
24933418|NCT04070742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24933419|NCT04070742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24933420|NCT04070755|Minocycline|minocycline|mesh-list
24625295|NCT01081548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24933444|NCT04070495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25050219|NCT00529503|Rituximab|rituximab|mesh-list
24625296|NCT01081548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24975536|NCT03477539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24975537|NCT03477539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24975538|NCT03477539|Growth Substances|growth substances|mesh-ancestor
24975539|NCT03477539|Growth Inhibitors|growth inhibitors|mesh-ancestor
24582157|NCT00868426|Glucocorticoids|glucocorticoids|mesh-ancestor
24586985|NCT00893009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24586986|NCT00893009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586987|NCT00893009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24586988|NCT00893009|Respiratory System Agents|respiratory system agents|mesh-ancestor
24586989|NCT00893009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24586990|NCT00893009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24586991|NCT00893009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586992|NCT00893009|Vasodilator Agents|vasodilator agents|mesh-ancestor
24586994|NCT00893009|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24410447|NCT00185315|Iloprost|iloprost|mesh-list
24933540|NCT04069169|Anesthetics|anesthetics|mesh-ancestor
24952862|NCT03891433|Meropenem|meropenem|mesh-list
24933577|NCT04069286|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24933578|NCT04069286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24933579|NCT04069286|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24933580|NCT04069286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933581|NCT04069286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547973|NCT00707083|Dexamethasone|dexamethasone|mesh-list
24933583|NCT04069078|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24933584|NCT04069078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24933588|NCT04069078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650071|NCT01498978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25650072|NCT01498978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25650073|NCT01498978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650074|NCT01499134|Metoprolol|metoprolol|mesh-list
25650075|NCT01499134|Nebivolol|nebivolol|mesh-list
25650076|NCT01499134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25650077|NCT01499134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25650078|NCT01499134|Sympatholytics|sympatholytics|mesh-ancestor
25828914|NCT00006113|Interferon-gamma|interferon-gamma|mesh-list
24712158|NCT01518855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24712159|NCT01518933|Silybin|silybin|mesh-list
24712160|NCT01518933|Silymarin|silymarin|mesh-list
24933806|NCT04067102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24933807|NCT04067102|Immunologic Factors|immunologic factors|mesh-ancestor
24933808|NCT04067102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933809|NCT04067102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24530391|NCT00630084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530393|NCT00630084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24530394|NCT00630084|Antimetabolites|antimetabolites|mesh-ancestor
24530395|NCT00630084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530396|NCT00630084|Immunologic Factors|immunologic factors|mesh-ancestor
24530397|NCT00630084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586995|NCT00893009|Purinergic Agents|purinergic agents|mesh-ancestor
24586996|NCT00893009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24586997|NCT00893048|Prednisone|prednisone|mesh-list
24586998|NCT00893048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24586999|NCT00893048|Glucocorticoids|glucocorticoids|mesh-ancestor
24587000|NCT00893048|Hormones|hormones|mesh-ancestor
24530399|NCT00630097|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24530423|NCT00630175|GABA Agonists|gaba agonists|mesh-ancestor
24530424|NCT00630175|GABA Agents|gaba agents|mesh-ancestor
25828915|NCT00006113|Interleukin-4|interleukin-4|mesh-list
24933930|NCT04066088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24933945|NCT04065906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24933946|NCT04065906|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24933947|NCT04065906|Adrenergic Agents|adrenergic agents|mesh-ancestor
24933949|NCT04065919|Bupivacaine|bupivacaine|mesh-list
24530652|NCT00631527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24530654|NCT00631579|Gout Suppressants|gout suppressants|mesh-ancestor
24530655|NCT00631579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24530656|NCT00631592|Dolutegravir|dolutegravir|mesh-list
24530672|NCT00631618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24530673|NCT00631618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530674|NCT00631618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934490|NCT04060888|Ustekinumab|ustekinumab|mesh-list
24934491|NCT04060888|Dermatologic Agents|dermatologic agents|mesh-ancestor
24934492|NCT04061057|Lidocaine|lidocaine|mesh-list
24934493|NCT04061057|Anesthetics, Local|anesthetics, local|mesh-ancestor
24934494|NCT04061057|Anesthetics|anesthetics|mesh-ancestor
24934531|NCT04060771|Palonosetron|palonosetron|mesh-list
24934532|NCT04060771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24934533|NCT04060771|Antiemetics|antiemetics|mesh-ancestor
24934534|NCT04060771|Autonomic Agents|autonomic agents|mesh-ancestor
24934535|NCT04060771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24934536|NCT04060771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934537|NCT04060771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24934538|NCT04060771|Glucocorticoids|glucocorticoids|mesh-ancestor
24761279|NCT01762046|Glipizide|glipizide|mesh-list
24934636|NCT04060264|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24934674|NCT04059978|Narcotics|narcotics|mesh-ancestor
24934675|NCT04059978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24934676|NCT04059978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828916|NCT00006113|Sargramostim|sargramostim|mesh-list
24530868|NCT00632723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530869|NCT00632723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24530870|NCT00632723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530871|NCT00632723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530873|NCT00632762|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24530874|NCT00632762|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24530875|NCT00632762|Antiviral Agents|antiviral agents|mesh-ancestor
24530954|NCT00633386|Analgesics|analgesics|mesh-ancestor
24530955|NCT00633386|Sensory System Agents|sensory system agents|mesh-ancestor
25828917|NCT00006113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530973|NCT00633412|Histamine Antagonists|histamine antagonists|mesh-ancestor
24530975|NCT00633412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24530976|NCT00633412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530977|NCT00633425|Glimepiride|glimepiride|mesh-list
24935146|NCT04054284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531023|NCT00633581|Ascorbic Acid|ascorbic acid|mesh-list
24531024|NCT00633581|Vitamins|vitamins|mesh-ancestor
24531025|NCT00633581|Micronutrients|micronutrients|mesh-ancestor
24531026|NCT00633581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650079|NCT01499134|Autonomic Agents|autonomic agents|mesh-ancestor
25650080|NCT01499134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650081|NCT01499134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531027|NCT00633581|Antioxidants|antioxidants|mesh-ancestor
24531029|NCT00633581|Protective Agents|protective agents|mesh-ancestor
24531030|NCT00633659|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24531031|NCT00633659|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24531032|NCT00633659|Plasma Substitutes|plasma substitutes|mesh-ancestor
24531033|NCT00633659|Blood Substitutes|blood substitutes|mesh-ancestor
24531034|NCT00633672|Esomeprazole|esomeprazole|mesh-list
24531035|NCT00633672|Ranitidine|ranitidine|mesh-list
24531037|NCT00633672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24935205|NCT04054128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935207|NCT04053985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935208|NCT04053985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24935209|NCT04053985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935210|NCT04053985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24668562|NCT04837716|Carboplatin|carboplatin|mesh-list
24668563|NCT04837716|Pemetrexed|pemetrexed|mesh-list
24668564|NCT04837716|Ensartinib|ensartinib|mesh-list
24668565|NCT04837716|Endothelial Growth Factors|endothelial growth factors|mesh-list
24668566|NCT04837716|Antibodies|antibodies|mesh-list
24668567|NCT04837716|Immunoglobulins|immunoglobulins|mesh-list
24668590|NCT04764630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24668591|NCT04764630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24668592|NCT04764630|Sensory System Agents|sensory system agents|mesh-ancestor
24668593|NCT04764630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24668594|NCT04735549|Hormones|hormones|mesh-list
24668595|NCT04735549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24668596|NCT04735549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24668597|NCT04734080|Dronabinol|dronabinol|mesh-list
24456310|NCT00330824|Contraceptive Agents|contraceptive agents|mesh-ancestor
24531226|NCT00634595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24531228|NCT00634595|Tubulin Modulators|tubulin modulators|mesh-ancestor
24531229|NCT00634595|Antimitotic Agents|antimitotic agents|mesh-ancestor
24531230|NCT00634595|Mitosis Modulators|mitosis modulators|mesh-ancestor
24668664|NCT04650542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24668665|NCT04650542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24668666|NCT04650542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511853|NCT00571285|Vitamin D|vitamin d|mesh-list
24531249|NCT00634686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24531250|NCT00634686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24531251|NCT00634712|Candesartan|candesartan|mesh-list
24531252|NCT00634712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24531253|NCT00634712|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24531254|NCT00634712|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24531255|NCT00634712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531256|NCT00634725|Gemcitabine|gemcitabine|mesh-list
24531257|NCT00634725|Capecitabine|capecitabine|mesh-list
24531258|NCT00634725|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24531500|NCT00636064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24531615|NCT00636766|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24531619|NCT00636766|Hormones|hormones|mesh-ancestor
24531620|NCT00636766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25828918|NCT00006113|Antiviral Agents|antiviral agents|mesh-ancestor
24531692|NCT00636922|Everolimus|everolimus|mesh-list
24412946|NCT00192673|Asparaginase|asparaginase|mesh-list
25828919|NCT00006113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25828920|NCT00006113|Immunologic Factors|immunologic factors|mesh-ancestor
24531717|NCT00636935|Antitubercular Agents|antitubercular agents|mesh-ancestor
24531718|NCT00636935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24531719|NCT00636935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412987|NCT00192842|Gemcitabine|gemcitabine|mesh-list
24531841|NCT00637442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531892|NCT00637481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531893|NCT00637481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25019097|NCT03693599|Carbetocin|carbetocin|mesh-list
25019098|NCT03693599|Syntometrine|syntometrine|mesh-list
25019099|NCT03693599|Oxytocics|oxytocics|mesh-ancestor
25019100|NCT03693599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25019101|NCT03693599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019102|NCT03693573|Bevacizumab|bevacizumab|mesh-list
24531954|NCT00637637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24531955|NCT00637637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24512378|NCT00574639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045398|NCT00959036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045399|NCT00959036|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24413268|NCT00193388|Topotecan|topotecan|mesh-list
24456419|NCT00331084|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24456420|NCT00331084|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24456421|NCT00331084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24669509|NCT03884101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25828921|NCT00006113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828922|NCT00006113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25019151|NCT03693391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532390|NCT00639756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532391|NCT00639756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532392|NCT00639756|Gout Suppressants|gout suppressants|mesh-ancestor
24456464|NCT00331188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456465|NCT00331188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24456466|NCT00331214|Testosterone|testosterone|mesh-list
24669610|NCT03777982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24669611|NCT03777982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24669612|NCT03777982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24669613|NCT03777982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24669614|NCT03777982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24669615|NCT03777982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532774|NCT00641030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532775|NCT00641030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24532776|NCT00641030|Antimetabolites|antimetabolites|mesh-ancestor
24532778|NCT00641082|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
24532780|NCT00641082|Antiviral Agents|antiviral agents|mesh-ancestor
24532790|NCT00641095|Immunologic Factors|immunologic factors|mesh-ancestor
24532791|NCT00641095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532792|NCT00641095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24532793|NCT00641095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24532794|NCT00641095|Alkylating Agents|alkylating agents|mesh-ancestor
24532805|NCT00641160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532807|NCT00641173|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24532808|NCT00641173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24532835|NCT00641212|Glucocorticoids|glucocorticoids|mesh-ancestor
24532836|NCT00641212|Hormones|hormones|mesh-ancestor
24937420|NCT04029272|Hormones|hormones|mesh-ancestor
24532976|NCT00641914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24414222|NCT00196612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24456514|NCT00331500|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24456515|NCT00331500|Histamine Antagonists|histamine antagonists|mesh-ancestor
25019282|NCT03692286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25019283|NCT03692143|Alendronate|alendronate|mesh-list
25019284|NCT03692143|Teriparatide|teriparatide|mesh-list
25019285|NCT03692143|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25019286|NCT03692143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019288|NCT03692065|Apixaban|apixaban|mesh-list
25019289|NCT03692065|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24533249|NCT00642798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24937496|NCT04028323|Octreotide|octreotide|mesh-list
24414545|NCT00198055|Aripiprazole|aripiprazole|mesh-list
24456540|NCT00331604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24456541|NCT00331604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456542|NCT00331643|Epothilones|epothilones|mesh-list
24456543|NCT00331643|Epothilone B|epothilone b|mesh-list
24456544|NCT00331643|Tubulin Modulators|tubulin modulators|mesh-ancestor
24456545|NCT00331643|Antimitotic Agents|antimitotic agents|mesh-ancestor
24456546|NCT00331643|Mitosis Modulators|mitosis modulators|mesh-ancestor
25019290|NCT03692065|Antithrombins|antithrombins|mesh-ancestor
25019291|NCT03692065|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25019292|NCT03692065|Protease Inhibitors|protease inhibitors|mesh-ancestor
25019293|NCT03692065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24670117|NCT03251326|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24672661|NCT01332955|Ribavirin|ribavirin|mesh-list
24670234|NCT03181100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24670236|NCT03181100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24670237|NCT03181100|Growth Substances|growth substances|mesh-ancestor
24670238|NCT03181100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24670239|NCT03181100|Growth Inhibitors|growth inhibitors|mesh-ancestor
24670240|NCT03181100|Immunologic Factors|immunologic factors|mesh-ancestor
25650082|NCT01499134|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25650083|NCT01499134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25650084|NCT01499134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25650085|NCT01499134|Adrenergic Agents|adrenergic agents|mesh-ancestor
25650086|NCT01499134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25650087|NCT01499134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650088|NCT01499134|Vasodilator Agents|vasodilator agents|mesh-ancestor
24456601|NCT00331786|Autonomic Agents|autonomic agents|mesh-ancestor
25828923|NCT00006113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24533327|NCT00643136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25045431|NCT00953420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25019299|NCT03692026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045432|NCT00953420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25045433|NCT00953420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045434|NCT00953420|Tubulin Modulators|tubulin modulators|mesh-ancestor
25045435|NCT00953420|Antimitotic Agents|antimitotic agents|mesh-ancestor
25045436|NCT00953420|Mitosis Modulators|mitosis modulators|mesh-ancestor
24456640|NCT00331838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456641|NCT00331851|Metformin|metformin|mesh-list
24456642|NCT00331851|Insulin Glargine|insulin glargine|mesh-list
24456643|NCT00331851|Liraglutide|liraglutide|mesh-list
24456644|NCT00331851|Glimepiride|glimepiride|mesh-list
24455908|NCT00329368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24455909|NCT00329368|Antiviral Agents|antiviral agents|mesh-ancestor
24455910|NCT00329368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24455911|NCT00329368|Immunologic Factors|immunologic factors|mesh-ancestor
24455912|NCT00329368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455913|NCT00329368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24455914|NCT00329368|Analgesics|analgesics|mesh-ancestor
24455915|NCT00329368|Sensory System Agents|sensory system agents|mesh-ancestor
24455916|NCT00329368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24455917|NCT00329368|Hematinics|hematinics|mesh-ancestor
24455918|NCT00329368|Vitamins|vitamins|mesh-ancestor
24455919|NCT00329368|Micronutrients|micronutrients|mesh-ancestor
24455920|NCT00329368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24455921|NCT00329381|Omalizumab|omalizumab|mesh-list
24455922|NCT00329381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24455923|NCT00329381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24455924|NCT00329381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24404474|NCT00163553|Meperidine|meperidine|mesh-list
24938010|NCT04023292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24938012|NCT04023292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25828924|NCT00006113|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25828925|NCT00006113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25828926|NCT00006114|Vinorelbine|vinorelbine|mesh-list
25011582|NCT04703036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25011583|NCT04695652|Somatomedin B|somatomedin b|mesh-list
25011584|NCT04695652|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25011585|NCT04695652|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25011586|NCT04695652|Protease Inhibitors|protease inhibitors|mesh-ancestor
25011587|NCT04695652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011588|NCT04695652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011608|NCT04576078|Analgesics|analgesics|mesh-ancestor
25011609|NCT04576078|Sensory System Agents|sensory system agents|mesh-ancestor
25011610|NCT04576078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25011611|NCT04576078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011612|NCT04557449|Letrozole|letrozole|mesh-list
25011613|NCT04557449|Fulvestrant|fulvestrant|mesh-list
25011614|NCT04557449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011615|NCT04557449|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25011616|NCT04557449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25011617|NCT04557449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795388|NCT02807454|Dexamethasone|dexamethasone|mesh-list
25110344|NCT05463913|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25019388|NCT03691662|Adrenergic Agents|adrenergic agents|mesh-ancestor
25011766|NCT04083963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25011767|NCT04083963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011768|NCT04083963|Tubulin Modulators|tubulin modulators|mesh-ancestor
25011769|NCT04083963|Antimitotic Agents|antimitotic agents|mesh-ancestor
25011770|NCT04083963|Mitosis Modulators|mitosis modulators|mesh-ancestor
25011771|NCT04083963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011772|NCT04083963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25011773|NCT04083963|Immunologic Factors|immunologic factors|mesh-ancestor
25011774|NCT04083963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011775|NCT04083963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25011776|NCT04083963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24980404|NCT05303727|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24980405|NCT05303727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24714148|NCT01529229|Prednisolone|prednisolone|mesh-list
24980406|NCT05303727|Antifungal Agents|antifungal agents|mesh-ancestor
24980407|NCT05303727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24980408|NCT05303727|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24980409|NCT05303727|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24980410|NCT05303727|Antitubercular Agents|antitubercular agents|mesh-ancestor
25015314|NCT02601014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980457|NCT05263921|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24980458|NCT05263921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24458812|NCT00340080|Antiviral Agents|antiviral agents|mesh-ancestor
25015360|NCT02527200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015361|NCT02516696|Clarithromycin|clarithromycin|mesh-list
25015362|NCT02516696|Dexamethasone|dexamethasone|mesh-list
25015363|NCT02516696|Lenalidomide|lenalidomide|mesh-list
25015364|NCT02516696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25828927|NCT00006114|Mitoxantrone|mitoxantrone|mesh-list
25828928|NCT00006114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25828929|NCT00006114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828930|NCT00006114|Tubulin Modulators|tubulin modulators|mesh-ancestor
25828931|NCT00006114|Antimitotic Agents|antimitotic agents|mesh-ancestor
25828932|NCT00006114|Mitosis Modulators|mitosis modulators|mesh-ancestor
25016116|NCT00431093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016117|NCT00431093|Androgen Antagonists|androgen antagonists|mesh-ancestor
25016118|NCT00431093|Hormone Antagonists|hormone antagonists|mesh-ancestor
25016119|NCT00431093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25016120|NCT00431093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25016121|NCT00431093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25016122|NCT00431093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25016123|NCT00431093|Anabolic Agents|anabolic agents|mesh-ancestor
25016124|NCT00398931|Alendronate|alendronate|mesh-list
25016125|NCT00398931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016126|NCT00398931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24783973|NCT01905150|Leucovorin|leucovorin|mesh-list
25017059|NCT02668822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017060|NCT02668822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25017061|NCT02668822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25017062|NCT02668822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25017063|NCT02668822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25017064|NCT02668822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017089|NCT02616146|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25017090|NCT02616146|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25017092|NCT02616146|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25017093|NCT02616146|Etonogestrel|etonogestrel|mesh-list
25017094|NCT02616146|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25017095|NCT02616146|Estradiol|estradiol|mesh-list
25017096|NCT02616146|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25166594|NCT03850535|Antimetabolites|antimetabolites|mesh-ancestor
25017097|NCT02616146|Estrogens|estrogens|mesh-ancestor
25017201|NCT02275546|Contraceptive Agents|contraceptive agents|mesh-ancestor
25017202|NCT02275546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25017203|NCT02275546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576177|NCT00837317|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25017559|NCT00413764|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25017560|NCT00413764|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25017562|NCT00413764|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25017563|NCT00413764|Androgen Antagonists|androgen antagonists|mesh-ancestor
25017564|NCT00413764|Hormone Antagonists|hormone antagonists|mesh-ancestor
25019541|NCT03690622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25019542|NCT03690622|Analgesics|analgesics|mesh-ancestor
25017565|NCT00413764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25017566|NCT00413764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25017567|NCT00413764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25017568|NCT00413764|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25017676|NCT03705195|Gliclazide|gliclazide|mesh-list
25017677|NCT03705195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25017678|NCT03705195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017679|NCT03705065|Bupivacaine|bupivacaine|mesh-list
25017680|NCT03705065|Anesthetics, Local|anesthetics, local|mesh-ancestor
25018347|NCT03699904|Antiviral Agents|antiviral agents|mesh-ancestor
25018348|NCT03699904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25018349|NCT03699839|Vaccines|vaccines|mesh-list
25018350|NCT03699839|Immunologic Factors|immunologic factors|mesh-ancestor
25018351|NCT03699839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018352|NCT03699774|Firuglipel|firuglipel|mesh-list
25018353|NCT03699774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25018354|NCT03699774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25018355|NCT03699774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25018356|NCT03699774|Antimetabolites|antimetabolites|mesh-ancestor
25018357|NCT03699774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018358|NCT03699774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25018359|NCT03699774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24974836|NCT05241535|Moxifloxacin|moxifloxacin|mesh-list
25019566|NCT03690414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974840|NCT05241535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24974841|NCT05241535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24974842|NCT05241535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974843|NCT05241535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24974844|NCT05207709|Paclitaxel|paclitaxel|mesh-list
24974845|NCT05207709|Letrozole|letrozole|mesh-list
24974846|NCT05207709|Fulvestrant|fulvestrant|mesh-list
24974847|NCT05207709|Palbociclib|palbociclib|mesh-list
24974848|NCT05207709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24974849|NCT05207709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018375|NCT03699449|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25018412|NCT03699384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018413|NCT03699384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25018414|NCT03699332|Labetuzumab|labetuzumab|mesh-list
25018415|NCT03699332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25018416|NCT03699332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018417|NCT03699293|Aspirin|aspirin|mesh-list
25018418|NCT03699293|Celecoxib|celecoxib|mesh-list
25018419|NCT03699293|Naproxen|naproxen|mesh-list
25018420|NCT03699293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25018421|NCT03699293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25018422|NCT03699293|Analgesics|analgesics|mesh-ancestor
25018423|NCT03699293|Sensory System Agents|sensory system agents|mesh-ancestor
25018424|NCT03699293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018425|NCT03699293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018426|NCT03699293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25018427|NCT03699293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25018428|NCT03699293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25018429|NCT03699293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25018430|NCT03699293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018431|NCT03699293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25018483|NCT03698851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018485|NCT03698851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25018486|NCT03698851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018487|NCT03698851|Adrenergic Agents|adrenergic agents|mesh-ancestor
25018488|NCT03698851|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25018489|NCT03698851|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25018490|NCT03698851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25018491|NCT03698851|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25018516|NCT03698695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25018517|NCT03698695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25018518|NCT03698695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25018519|NCT03698682|Levofloxacin|levofloxacin|mesh-list
25018520|NCT03698682|Ofloxacin|ofloxacin|mesh-list
25018521|NCT03698682|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25018522|NCT03698682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25018523|NCT03698682|Renal Agents|renal agents|mesh-ancestor
25018524|NCT03698682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25018525|NCT03698682|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25018526|NCT03698682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25018527|NCT03698682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018528|NCT03698682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018529|NCT03698682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018530|NCT03698682|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25018531|NCT03698682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25018539|NCT03698630|Dexamethasone|dexamethasone|mesh-list
25018770|NCT03697161|Anticonvulsants|anticonvulsants|mesh-ancestor
25018771|NCT03697161|GABA Agonists|gaba agonists|mesh-ancestor
25018772|NCT03697161|GABA Agents|gaba agents|mesh-ancestor
25018773|NCT03697161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25018774|NCT03697161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019038|NCT03694119|Autonomic Agents|autonomic agents|mesh-ancestor
25019039|NCT03694119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25019046|NCT03694080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25019047|NCT03694080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714866|NCT01533220|Pheniramine|pheniramine|mesh-list
25019051|NCT03693976|Respiratory System Agents|respiratory system agents|mesh-ancestor
25019052|NCT03693885|Oxytocin|oxytocin|mesh-list
25019070|NCT03693833|Cannabidiol|cannabidiol|mesh-list
25019071|NCT03693833|Anticonvulsants|anticonvulsants|mesh-ancestor
24975544|NCT03476603|Irbesartan|irbesartan|mesh-list
25019072|NCT03693638|Fentanyl|fentanyl|mesh-list
25019073|NCT03693638|Bupivacaine|bupivacaine|mesh-list
25019074|NCT03693638|Anesthetics, Local|anesthetics, local|mesh-ancestor
25019075|NCT03693638|Anesthetics|anesthetics|mesh-ancestor
25019076|NCT03693638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25019077|NCT03693638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019078|NCT03693638|Sensory System Agents|sensory system agents|mesh-ancestor
25019079|NCT03693638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25019080|NCT03693638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25019081|NCT03693638|Narcotics|narcotics|mesh-ancestor
25019082|NCT03693638|Analgesics|analgesics|mesh-ancestor
25019083|NCT03693638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25019084|NCT03693638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25019085|NCT03693638|Anesthetics, General|anesthetics, general|mesh-ancestor
25111325|NCT04939909|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25111326|NCT04939909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25111327|NCT04939909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25111328|NCT04939909|Cholinergic Agents|cholinergic agents|mesh-ancestor
25111329|NCT04939909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25111330|NCT04939909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25111331|NCT04939909|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25111332|NCT04939909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25019714|NCT03688659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019715|NCT03688568|Imatinib Mesylate|imatinib mesylate|mesh-list
25019718|NCT03688568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25013582|NCT02236572|Everolimus|everolimus|mesh-list
24784362|NCT01907594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25019256|NCT03692416|Antimetabolites|antimetabolites|mesh-ancestor
25019257|NCT03692416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976324|NCT04154800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976325|NCT04154800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25111436|NCT04823065|Scopolamine|scopolamine|mesh-list
25111437|NCT04823065|Loperamide|loperamide|mesh-list
25111438|NCT04823065|Antidiarrheals|antidiarrheals|mesh-list
25111439|NCT04823065|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25111440|NCT04823065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25019258|NCT03692416|Dermatologic Agents|dermatologic agents|mesh-ancestor
25019259|NCT03692416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25019260|NCT03692416|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25019261|NCT03692416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25019270|NCT03692416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25019271|NCT03692416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25019273|NCT03692299|Metronidazole|metronidazole|mesh-list
25019274|NCT03692299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25019275|NCT03692299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25019276|NCT03692299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25019277|NCT03692299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25019278|NCT03692286|Calcium, Dietary|calcium, dietary|mesh-list
25019279|NCT03692286|Calcium|calcium|mesh-list
25019280|NCT03692286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25111447|NCT04823065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25111448|NCT04823065|Cholinergic Agents|cholinergic agents|mesh-ancestor
25111449|NCT04823065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24583163|NCT00873509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25019795|NCT03687905|Hydroxychloroquine|hydroxychloroquine|mesh-list
25019796|NCT03687905|Chloroquine|chloroquine|mesh-list
25019797|NCT03687905|Antimalarials|antimalarials|mesh-ancestor
25019798|NCT03687905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25019799|NCT03687905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25019800|NCT03687905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25019801|NCT03687905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25019802|NCT03687905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019803|NCT03687905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25019804|NCT03687905|Amebicides|amebicides|mesh-ancestor
25019805|NCT03687606|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25828933|NCT00006114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828934|NCT00006114|Analgesics|analgesics|mesh-ancestor
25828935|NCT00006114|Sensory System Agents|sensory system agents|mesh-ancestor
24541191|NCT00671372|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25650089|NCT01499134|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25650090|NCT01499134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25650091|NCT01499134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25019281|NCT03692286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019407|NCT03691636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25019408|NCT03691493|Tamoxifen|tamoxifen|mesh-list
25019409|NCT03691493|Letrozole|letrozole|mesh-list
25019410|NCT03691493|Fulvestrant|fulvestrant|mesh-list
25019411|NCT03691493|Palbociclib|palbociclib|mesh-list
25019412|NCT03691493|Anastrozole|anastrozole|mesh-list
25019413|NCT03691493|Exemestane|exemestane|mesh-list
25019414|NCT03691493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019415|NCT03691493|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25019416|NCT03691493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25019417|NCT03691493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25019418|NCT03691493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019419|NCT03691493|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25019420|NCT03691493|Hormone Antagonists|hormone antagonists|mesh-ancestor
25019421|NCT03691493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25019422|NCT03691493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019423|NCT03691493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25019424|NCT03691493|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25019425|NCT03691493|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25019426|NCT03691493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25019460|NCT03691337|Bupivacaine|bupivacaine|mesh-list
25019461|NCT03691337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25019462|NCT03691337|Anesthetics, Local|anesthetics, local|mesh-ancestor
25019463|NCT03691337|Anesthetics|anesthetics|mesh-ancestor
25019464|NCT03691337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25019465|NCT03691337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019466|NCT03691337|Sensory System Agents|sensory system agents|mesh-ancestor
25019467|NCT03691337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25019469|NCT03691090|Cisplatin|cisplatin|mesh-list
25019470|NCT03691090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25019485|NCT03691038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25019495|NCT03690947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25019496|NCT03690947|Growth Substances|growth substances|mesh-ancestor
25019497|NCT03690947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019498|NCT03690947|Growth Inhibitors|growth inhibitors|mesh-ancestor
25019499|NCT03690947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019501|NCT03690778|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25019502|NCT03690778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25019503|NCT03690778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019505|NCT03690778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25019506|NCT03690778|Antimetabolites|antimetabolites|mesh-ancestor
25019507|NCT03690778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019508|NCT03690778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25019509|NCT03690778|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25019510|NCT03690778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25019511|NCT03690739|Gemcitabine|gemcitabine|mesh-list
25019512|NCT03690739|Paclitaxel|paclitaxel|mesh-list
25019513|NCT03690739|Bevacizumab|bevacizumab|mesh-list
25019514|NCT03690739|Carboplatin|carboplatin|mesh-list
25019515|NCT03690739|Trabectedin|trabectedin|mesh-list
25019533|NCT03690739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25019535|NCT03690739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25019536|NCT03690739|Alkylating Agents|alkylating agents|mesh-ancestor
25019537|NCT03690622|Dexmedetomidine|dexmedetomidine|mesh-list
25019538|NCT03690622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25019539|NCT03690622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25019540|NCT03690622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019612|NCT03689894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019613|NCT03689894|Immunologic Factors|immunologic factors|mesh-ancestor
25019614|NCT03689894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019615|NCT03689894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25019616|NCT03689465|Cyclosporine|cyclosporine|mesh-list
25019631|NCT03689465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25019632|NCT03689465|Immunologic Factors|immunologic factors|mesh-ancestor
25019633|NCT03689465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25019634|NCT03689465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25019635|NCT03689465|Antifungal Agents|antifungal agents|mesh-ancestor
25019636|NCT03689465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25019637|NCT03689465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25019638|NCT03689465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25019639|NCT03689465|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25019640|NCT03689465|Antitubercular Agents|antitubercular agents|mesh-ancestor
25019641|NCT03689465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25019642|NCT03689114|Topiramate|topiramate|mesh-list
25019643|NCT03689114|Lamotrigine|lamotrigine|mesh-list
25019644|NCT03689114|Zonisamide|zonisamide|mesh-list
25019645|NCT03689114|Carbamazepine|carbamazepine|mesh-list
25019646|NCT03689114|Oxcarbazepine|oxcarbazepine|mesh-list
25019647|NCT03689114|Gabapentin|gabapentin|mesh-list
25019648|NCT03689114|Levetiracetam|levetiracetam|mesh-list
25019649|NCT03689114|Anticonvulsants|anticonvulsants|mesh-list
25019650|NCT03689114|Valproic Acid|valproic acid|mesh-list
25019651|NCT03689114|Analgesics|analgesics|mesh-ancestor
25106535|NCT02586831|Hormones|hormones|mesh-ancestor
25019706|NCT03688789|Hydrocortisone|hydrocortisone|mesh-list
25019707|NCT03688789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25019708|NCT03688659|Vancomycin|vancomycin|mesh-list
25019709|NCT03688659|Gentamicins|gentamicins|mesh-list
25019710|NCT03688659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25019711|NCT03688659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25019712|NCT03688659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25019713|NCT03688659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25019845|NCT03687255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019847|NCT03687229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25019848|NCT03687229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976370|NCT03945825|Vaccines|vaccines|mesh-list
25019849|NCT03687073|Silybin|silybin|mesh-list
25019850|NCT03687073|Indole-3-carbinol|indole-3-carbinol|mesh-list
25019851|NCT03687073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25019852|NCT03687073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019853|NCT03687073|Protective Agents|protective agents|mesh-ancestor
25019854|NCT03687073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019855|NCT03687073|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25019856|NCT03687034|Temozolomide|temozolomide|mesh-list
25019857|NCT03687034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25019858|NCT03687034|Alkylating Agents|alkylating agents|mesh-ancestor
25019859|NCT03687034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019860|NCT03687034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019861|NCT03687021|Progesterone|progesterone|mesh-list
25019862|NCT03687021|Progestins|progestins|mesh-ancestor
25019863|NCT03687021|Hormones|hormones|mesh-ancestor
25020137|NCT03683108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019926|NCT03686267|Antimanic Agents|antimanic agents|mesh-ancestor
25019927|NCT03686267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25019928|NCT03686267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25019929|NCT03686267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019930|NCT03686254|Bevacizumab|bevacizumab|mesh-list
25019931|NCT03686254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25019932|NCT03686254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019914|NCT03686657|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25019915|NCT03686657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25019916|NCT03686618|Secretin|secretin|mesh-list
25019917|NCT03686618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25019918|NCT03686618|Hormones|hormones|mesh-ancestor
25019919|NCT03686618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25019920|NCT03686618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25111451|NCT04823065|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25111452|NCT04823065|Parasympatholytics|parasympatholytics|mesh-ancestor
25111453|NCT04814875|Carboplatin|carboplatin|mesh-list
25019921|NCT03686267|Lithium Carbonate|lithium carbonate|mesh-list
25019922|NCT03686267|Antidepressive Agents|antidepressive agents|mesh-ancestor
25020022|NCT03684837|Micronutrients|micronutrients|mesh-ancestor
25020023|NCT03684837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020024|NCT03684837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25020025|NCT03684824|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25020079|NCT03684395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25111454|NCT04814875|Doxorubicin|doxorubicin|mesh-list
25020098|NCT03683563|Anticoagulants|anticoagulants|mesh-ancestor
25020099|NCT03683563|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25020100|NCT03683563|Chelating Agents|chelating agents|mesh-ancestor
25020101|NCT03683563|Sequestering Agents|sequestering agents|mesh-ancestor
25019970|NCT03685084|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25019971|NCT03685084|Piperacillin|piperacillin|mesh-list
25019972|NCT03685084|Cefepime|cefepime|mesh-list
25019973|NCT03685084|Lactams|lactams|mesh-list
25019974|NCT03685084|beta-Lactams|beta-lactams|mesh-list
25019975|NCT03685084|Enmetazobactam|enmetazobactam|mesh-list
25019976|NCT03685084|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25020102|NCT03683563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020103|NCT03683433|Azacitidine|azacitidine|mesh-list
25020104|NCT03683433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25020105|NCT03683433|Antimetabolites|antimetabolites|mesh-ancestor
24715727|NCT01538329|Analgesics|analgesics|mesh-ancestor
25020106|NCT03683433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020107|NCT03683433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25020108|NCT03683433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25020109|NCT03683329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25020129|NCT03683277|Growth Inhibitors|growth inhibitors|mesh-ancestor
25020130|NCT03683277|Protease Inhibitors|protease inhibitors|mesh-ancestor
25020131|NCT03683277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25020132|NCT03683277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020133|NCT03683108|Resveratrol|resveratrol|mesh-list
25020134|NCT03683108|Antioxidants|antioxidants|mesh-ancestor
25020135|NCT03683108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020136|NCT03683108|Protective Agents|protective agents|mesh-ancestor
25020146|NCT03683043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25021469|NCT03671174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25021470|NCT03671174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25021472|NCT03671174|Antipyretics|antipyretics|mesh-ancestor
25021473|NCT03671174|Anticoagulants|anticoagulants|mesh-ancestor
25021488|NCT03671070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25021489|NCT03671070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25021490|NCT03671070|Adrenergic Agents|adrenergic agents|mesh-ancestor
25021491|NCT03671070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25021492|NCT03671070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021493|NCT03671070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021535|NCT03670901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25021536|NCT03670901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25021552|NCT03670875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021553|NCT03670875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25021554|NCT03670875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25021555|NCT03670875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25021556|NCT03670875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25021557|NCT03670875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021559|NCT03670758|Anticoagulants|anticoagulants|mesh-ancestor
25021560|NCT03670706|Analgesics|analgesics|mesh-list
25021561|NCT03670706|Sensory System Agents|sensory system agents|mesh-ancestor
25021562|NCT03670706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25021563|NCT03670706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021564|NCT03670212|Hydrocortisone|hydrocortisone|mesh-list
25021565|NCT03670212|Yohimbine|yohimbine|mesh-list
25021566|NCT03670212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25021567|NCT03670212|Mydriatics|mydriatics|mesh-ancestor
25021568|NCT03670212|Autonomic Agents|autonomic agents|mesh-ancestor
25021569|NCT03670212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25021570|NCT03670212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021571|NCT03670212|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25021572|NCT03670212|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25021573|NCT03670212|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25021574|NCT03670212|Adrenergic Agents|adrenergic agents|mesh-ancestor
25021575|NCT03670212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25021576|NCT03670212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25111722|NCT04677049|Vasodilator Agents|vasodilator agents|mesh-ancestor
24978141|NCT05178745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24978144|NCT05178511|Ensartinib|ensartinib|mesh-list
25021639|NCT03669484|Fentanyl|fentanyl|mesh-list
25021640|NCT03669484|Bromides|bromides|mesh-list
25021641|NCT03669484|Propofol|propofol|mesh-list
25021642|NCT03669484|Rocuronium|rocuronium|mesh-list
25021643|NCT03669484|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25021710|NCT03669003|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
25021711|NCT03669003|Hemostatics|hemostatics|mesh-ancestor
25021712|NCT03669003|Coagulants|coagulants|mesh-ancestor
25021713|NCT03668964|Vitamin D|vitamin d|mesh-list
25021714|NCT03668964|Cholecalciferol|cholecalciferol|mesh-list
25021715|NCT03668964|Vitamins|vitamins|mesh-list
25021716|NCT03668964|Vitamin E|vitamin e|mesh-list
25021717|NCT03668964|Tocopherols|tocopherols|mesh-list
25021718|NCT03668964|alpha-Tocopherol|alpha-tocopherol|mesh-list
25021719|NCT03668964|Vitamin A|vitamin a|mesh-list
25650092|NCT01499147|Vidarabine|vidarabine|mesh-list
25650093|NCT01499147|Fludarabine|fludarabine|mesh-list
25021720|NCT03668964|Riboflavin|riboflavin|mesh-list
25021721|NCT03668964|Vitamin B Complex|vitamin b complex|mesh-list
25021722|NCT03668964|Micronutrients|micronutrients|mesh-ancestor
25021723|NCT03668964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021724|NCT03668964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25650094|NCT01499147|Fludarabine phosphate|fludarabine phosphate|mesh-list
25021956|NCT03666884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021957|NCT03666884|Antifungal Agents|antifungal agents|mesh-ancestor
25021958|NCT03666884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25021959|NCT03666884|Dermatologic Agents|dermatologic agents|mesh-ancestor
25021960|NCT03666884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25021961|NCT03666884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25021962|NCT03666715|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25021963|NCT03666715|Antipsychotic Agents|antipsychotic agents|mesh-list
25021964|NCT03666715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25021965|NCT03666715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25021966|NCT03666715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021967|NCT03666715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25021968|NCT03666715|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25021969|NCT03666715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25021970|NCT03666715|Serotonin Agents|serotonin agents|mesh-ancestor
25021971|NCT03666715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25021972|NCT03666715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021973|NCT03666715|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24978674|NCT03432741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24978675|NCT03432741|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25111771|NCT04631029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25111772|NCT04631029|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25111773|NCT04631029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585897|NCT00887770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25022207|NCT03665402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25022208|NCT03665402|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25022209|NCT03665402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25022210|NCT03665402|Antimetabolites|antimetabolites|mesh-ancestor
25022252|NCT03664622|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25022253|NCT03664622|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25022254|NCT03664622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25022255|NCT03664622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022256|NCT03664622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25022257|NCT03664622|Narcotics|narcotics|mesh-ancestor
25022258|NCT03664596|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25022259|NCT03664596|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25022260|NCT03664596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25022261|NCT03664440|Nevirapine|nevirapine|mesh-list
25022262|NCT03664440|Rilpivirine|rilpivirine|mesh-list
25022263|NCT03664440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25022264|NCT03664440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25022265|NCT03664440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022266|NCT03664440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022267|NCT03664440|Antiviral Agents|antiviral agents|mesh-ancestor
25022268|NCT03664440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25022269|NCT03664440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25022270|NCT03664440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25022271|NCT03664440|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25022272|NCT03664440|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25022273|NCT03664414|Pentoxifylline|pentoxifylline|mesh-list
25022274|NCT03664414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25022297|NCT03664375|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25022298|NCT03664375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24796108|NCT01947998|Warfarin|warfarin|mesh-list
25022640|NCT03661463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25022641|NCT03661463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25022642|NCT03661463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022644|NCT03661385|Nitric Oxide|nitric oxide|mesh-list
25022645|NCT03661385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25106868|NCT03144128|Vitamins|vitamins|mesh-ancestor
25025415|NCT03637400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25023403|NCT03655392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25023404|NCT03655392|Autonomic Agents|autonomic agents|mesh-ancestor
25023405|NCT03655392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023406|NCT03655392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023407|NCT03655392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25023408|NCT03655392|Respiratory System Agents|respiratory system agents|mesh-ancestor
25023973|NCT03649763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25024012|NCT03649334|Fentanyl|fentanyl|mesh-list
25024013|NCT03649334|Ketamine|ketamine|mesh-list
25024014|NCT03649334|Analgesics|analgesics|mesh-ancestor
25024015|NCT03649334|Sensory System Agents|sensory system agents|mesh-ancestor
25024016|NCT03649334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024017|NCT03649334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831885|NCT02169713|Urological Agents|urological agents|mesh-ancestor
24716559|NCT01542424|Insulin Aspart|insulin aspart|mesh-list
24716560|NCT01542424|Insulin Detemir|insulin detemir|mesh-list
24716619|NCT01542723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25024150|NCT03648437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25024151|NCT03648437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25024152|NCT03648437|Analgesics|analgesics|mesh-ancestor
25024153|NCT03648437|Sensory System Agents|sensory system agents|mesh-ancestor
25024154|NCT03648437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024155|NCT03648437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024156|NCT03648437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25024157|NCT03648437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25024158|NCT03648437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25024159|NCT03648437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24976673|NCT05275777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24976674|NCT05275777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25024160|NCT03648437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024161|NCT03648437|Antipyretics|antipyretics|mesh-ancestor
25024162|NCT03648437|Gout Suppressants|gout suppressants|mesh-ancestor
25024163|NCT03648437|Tocolytic Agents|tocolytic agents|mesh-ancestor
25080973|NCT03334136|Micronutrients|micronutrients|mesh-ancestor
25024319|NCT03647280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25024320|NCT03647280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24985605|NCT03078478|Insulin|insulin|mesh-list
25024452|NCT03645876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024453|NCT03645876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25024454|NCT03645850|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25024455|NCT03645850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25024456|NCT03645668|Meropenem|meropenem|mesh-list
25024457|NCT03645668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25024512|NCT03644966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25024513|NCT03644966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25024514|NCT03644823|Atezolizumab|atezolizumab|mesh-list
25024515|NCT03644823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25024516|NCT03644706|Potassium Citrate|potassium citrate|mesh-list
25024517|NCT03644706|Diuretics|diuretics|mesh-ancestor
25166595|NCT03850535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024518|NCT03644706|Natriuretic Agents|natriuretic agents|mesh-ancestor
25024519|NCT03644706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985734|NCT02809131|Levofloxacin|levofloxacin|mesh-list
25024562|NCT03644589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24587600|NCT00895778|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24589550|NCT00908089|Infliximab|infliximab|mesh-list
24587628|NCT00895960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24587629|NCT00895960|Alkylating Agents|alkylating agents|mesh-ancestor
24860964|NCT02314195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25025154|NCT03639519|Antioxidants|antioxidants|mesh-ancestor
25025155|NCT03639519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025156|NCT03639519|Protective Agents|protective agents|mesh-ancestor
25025157|NCT03639519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025158|NCT03639519|Vitamins|vitamins|mesh-ancestor
25025159|NCT03639519|Micronutrients|micronutrients|mesh-ancestor
25025160|NCT03639493|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
25025161|NCT03639493|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25025191|NCT03639467|Antimetabolites|antimetabolites|mesh-ancestor
24587669|NCT00896311|Vasodilator Agents|vasodilator agents|mesh-ancestor
24587671|NCT00896376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25025412|NCT03637400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25025413|NCT03637400|Antimalarials|antimalarials|mesh-ancestor
25025414|NCT03637400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25025416|NCT03637400|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25025418|NCT03637400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25025419|NCT03637400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25025420|NCT03637400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986277|NCT02004275|Autonomic Agents|autonomic agents|mesh-ancestor
25025673|NCT03634917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25025674|NCT03634917|Antacids|antacids|mesh-ancestor
25025675|NCT03634917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025676|NCT03634917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25025677|NCT03634917|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25020201|NCT03682276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25020202|NCT03682276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25020203|NCT03682276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25650095|NCT01499147|Melphalan|melphalan|mesh-list
25650096|NCT01499147|Busulfan|busulfan|mesh-list
25650097|NCT01499147|Thymoglobulin|thymoglobulin|mesh-list
25650098|NCT01499147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25020204|NCT03682276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020205|NCT03682211|Fentanyl|fentanyl|mesh-list
25020206|NCT03682211|Morphine|morphine|mesh-list
25020207|NCT03682211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25020208|NCT03682211|Narcotics|narcotics|mesh-ancestor
25020209|NCT03682211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25025678|NCT03634852|Moxifloxacin|moxifloxacin|mesh-list
25025679|NCT03634852|Dexamethasone|dexamethasone|mesh-list
25025680|NCT03634852|Triamcinolone|triamcinolone|mesh-list
25025681|NCT03634852|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25025682|NCT03634852|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25025683|NCT03634852|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25025684|NCT03634852|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25025685|NCT03634852|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25025686|NCT03634852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25025687|NCT03634852|Antiemetics|antiemetics|mesh-ancestor
25025688|NCT03634852|Autonomic Agents|autonomic agents|mesh-ancestor
25025790|NCT03634111|Anesthetics, Local|anesthetics, local|mesh-ancestor
25025791|NCT03634111|Anesthetics|anesthetics|mesh-ancestor
25025792|NCT03634059|Apatinib|apatinib|mesh-list
25025793|NCT03634059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25025794|NCT03634059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25025795|NCT03634059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25025796|NCT03634059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025797|NCT03634020|Sirolimus|sirolimus|mesh-list
25025798|NCT03634020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25025799|NCT03634020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25025800|NCT03634020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24784942|NCT01911247|Metformin|metformin|mesh-list
25026089|NCT03631966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026091|NCT03631953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25020222|NCT03682198|Autonomic Agents|autonomic agents|mesh-ancestor
25020223|NCT03682198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25020224|NCT03682198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020225|NCT03682198|Sympathomimetics|sympathomimetics|mesh-ancestor
25020226|NCT03682198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25020227|NCT03682198|Nasal Decongestants|nasal decongestants|mesh-ancestor
25020228|NCT03682198|Respiratory System Agents|respiratory system agents|mesh-ancestor
25020229|NCT03682198|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25020230|NCT03682198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25020231|NCT03682198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25020232|NCT03682198|Adrenergic Agents|adrenergic agents|mesh-ancestor
25020233|NCT03682198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25020234|NCT03682198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020235|NCT03682198|Protective Agents|protective agents|mesh-ancestor
25020237|NCT03682172|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25020239|NCT03682172|Hormones|hormones|mesh-ancestor
25026092|NCT03631953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25026093|NCT03631953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24861316|NCT02316964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25026128|NCT03631875|Analgesics|analgesics|mesh-ancestor
25026129|NCT03631875|Sensory System Agents|sensory system agents|mesh-ancestor
25026130|NCT03631875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25026131|NCT03631875|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25026132|NCT03631875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25026133|NCT03631875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25026134|NCT03631875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25020270|NCT03681613|Pyrantel Pamoate|pyrantel pamoate|mesh-list
25026135|NCT03631875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026136|NCT03631862|Apatinib|apatinib|mesh-list
25026137|NCT03631862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828936|NCT00006114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25828937|NCT00006114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828938|NCT00006114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25026144|NCT03631836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25026145|NCT03631836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25026146|NCT03631836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25026198|NCT03631121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25026216|NCT03630952|Aflibercept|aflibercept|mesh-list
25026217|NCT03630952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24796447|NCT01950000|Sensory System Agents|sensory system agents|mesh-ancestor
25112504|NCT04046328|Cholestyramine Resin|cholestyramine resin|mesh-list
25112505|NCT04046328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25112506|NCT04046328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25112507|NCT04046328|Antimetabolites|antimetabolites|mesh-ancestor
25112508|NCT04046328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717179|NCT01546103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24803843|NCT01998763|Vitamin D|vitamin d|mesh-list
24814194|NCT02063139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25112509|NCT04046328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25112510|NCT04029038|Cyclophosphamide|cyclophosphamide|mesh-list
24587771|NCT00896987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587772|NCT00896987|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24587773|NCT00896987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24587774|NCT00896987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24983429|NCT05187494|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24587775|NCT00896987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24587776|NCT00896987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25026263|NCT03630341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25026264|NCT03630341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25026331|NCT03629522|Antiemetics|antiemetics|mesh-ancestor
25026332|NCT03629522|Autonomic Agents|autonomic agents|mesh-ancestor
25026333|NCT03629522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25026334|NCT03629522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026335|NCT03629522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25026360|NCT03629418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25026361|NCT03629418|Adrenergic Agents|adrenergic agents|mesh-ancestor
25026362|NCT03629418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25112564|NCT04001647|Vitamins|vitamins|mesh-ancestor
25112565|NCT04001647|Micronutrients|micronutrients|mesh-ancestor
24795882|NCT01946555|Anesthetics|anesthetics|mesh-ancestor
25112566|NCT04001647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112567|NCT04001647|Antioxidants|antioxidants|mesh-ancestor
25112568|NCT04001647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112569|NCT04001647|Protective Agents|protective agents|mesh-ancestor
25112570|NCT04001647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25112571|NCT04001647|Vasodilator Agents|vasodilator agents|mesh-ancestor
25112572|NCT04001647|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25112573|NCT04001647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25026412|NCT03628625|Letrozole|letrozole|mesh-list
25026413|NCT03628625|Misoprostol|misoprostol|mesh-list
25026414|NCT03628625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25026415|NCT03628625|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25026416|NCT03628625|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25026417|NCT03628625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25026418|NCT03628625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026419|NCT03628625|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25026420|NCT03628625|Hormone Antagonists|hormone antagonists|mesh-ancestor
25020348|NCT03680716|Ropivacaine|ropivacaine|mesh-list
25026421|NCT03628625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25026422|NCT03628625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026423|NCT03628625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25026424|NCT03628625|Abortifacient Agents|abortifacient agents|mesh-ancestor
25026425|NCT03628625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25026426|NCT03628625|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25026427|NCT03628625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25026452|NCT03628430|Anesthetics|anesthetics|mesh-ancestor
25026453|NCT03628430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25026454|NCT03628430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026455|NCT03628430|Sensory System Agents|sensory system agents|mesh-ancestor
25020379|NCT03680573|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
25020380|NCT03680573|Antimetabolites|antimetabolites|mesh-ancestor
25020381|NCT03680573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020382|NCT03680573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24976905|NCT04817189|Dexamethasone|dexamethasone|mesh-list
25026456|NCT03628430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25026457|NCT03628430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24683085|NCT01389791|Anticonvulsants|anticonvulsants|mesh-ancestor
25026495|NCT03628131|Etoposide|etoposide|mesh-list
25026496|NCT03628131|Ifosfamide|ifosfamide|mesh-list
25026497|NCT03628131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25026498|NCT03628131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25026499|NCT03628131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25026500|NCT03628131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25026501|NCT03628131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25026502|NCT03628131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650099|NCT01499147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25650100|NCT01499147|Antimetabolites|antimetabolites|mesh-ancestor
25650101|NCT01499147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026503|NCT03628131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25026504|NCT03628131|Alkylating Agents|alkylating agents|mesh-ancestor
25026505|NCT03628079|Mebendazole|mebendazole|mesh-list
25026506|NCT03628079|Antinematodal Agents|antinematodal agents|mesh-ancestor
25026507|NCT03628079|Anthelmintics|anthelmintics|mesh-ancestor
25026508|NCT03628079|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24976913|NCT04817189|Autonomic Agents|autonomic agents|mesh-ancestor
24976914|NCT04817189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24976915|NCT04817189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026509|NCT03628079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25026510|NCT03628079|Tubulin Modulators|tubulin modulators|mesh-ancestor
25026511|NCT03628079|Antimitotic Agents|antimitotic agents|mesh-ancestor
25026512|NCT03628079|Mitosis Modulators|mitosis modulators|mesh-ancestor
25026513|NCT03628079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026514|NCT03628079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25026515|NCT03628053|Blinatumomab|blinatumomab|mesh-list
25026516|NCT03628053|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25026517|NCT03628053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25026518|NCT03628053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25026519|NCT03628053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25026520|NCT03628040|Ropivacaine|ropivacaine|mesh-list
25026521|NCT03628040|Anesthetics, Local|anesthetics, local|mesh-ancestor
25020391|NCT03680573|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25020392|NCT03680560|Trastuzumab|trastuzumab|mesh-list
25020393|NCT03680560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25026647|NCT03626298|Dermatologic Agents|dermatologic agents|mesh-ancestor
25026648|NCT03626259|Losartan|losartan|mesh-list
25026649|NCT03626259|Amlodipine|amlodipine|mesh-list
25026650|NCT03626259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25026651|NCT03626259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25026652|NCT03626259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25026653|NCT03626259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026654|NCT03626259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25026655|NCT03626259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026656|NCT03626259|Vasodilator Agents|vasodilator agents|mesh-ancestor
25026657|NCT03626259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25026658|NCT03626259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24983648|NCT05182957|Growth Substances|growth substances|mesh-ancestor
24983649|NCT05182957|Growth Inhibitors|growth inhibitors|mesh-ancestor
24983650|NCT05182957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24983651|NCT05182957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24983652|NCT05182957|Antimetabolites|antimetabolites|mesh-ancestor
24983653|NCT05182957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587878|NCT00898287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587880|NCT00898287|Antiviral Agents|antiviral agents|mesh-ancestor
24587881|NCT00898287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24587882|NCT00898287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587883|NCT00898287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25026753|NCT03625310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24587884|NCT00898287|Immunologic Factors|immunologic factors|mesh-ancestor
25112589|NCT03989609|Midazolam|midazolam|mesh-list
25112590|NCT03989609|Dexmedetomidine|dexmedetomidine|mesh-list
25112591|NCT03989609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25112592|NCT03989609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25112593|NCT03989609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112594|NCT03989609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25026780|NCT03625076|Sensory System Agents|sensory system agents|mesh-ancestor
25020442|NCT03680404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25020443|NCT03680404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25020444|NCT03680404|Antioxidants|antioxidants|mesh-ancestor
25020445|NCT03680404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25020446|NCT03680404|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25020447|NCT03680404|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25026791|NCT03625050|Esomeprazole|esomeprazole|mesh-list
25026792|NCT03625050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25026793|NCT03625050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25026794|NCT03625050|Analgesics|analgesics|mesh-ancestor
25026795|NCT03625050|Sensory System Agents|sensory system agents|mesh-ancestor
25026796|NCT03625050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25026797|NCT03625050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026798|NCT03625050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25026799|NCT03625050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25026800|NCT03625050|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25026801|NCT03625050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25026802|NCT03625050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25026803|NCT03625050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026805|NCT03625050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25026806|NCT03625050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25026807|NCT03625011|Gabapentin|gabapentin|mesh-list
25026808|NCT03625011|Analgesics|analgesics|mesh-ancestor
25026809|NCT03625011|Sensory System Agents|sensory system agents|mesh-ancestor
25026810|NCT03625011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25026811|NCT03625011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026812|NCT03625011|Anticonvulsants|anticonvulsants|mesh-ancestor
25020484|NCT03679546|Infliximab|infliximab|mesh-list
25026813|NCT03625011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25026814|NCT03625011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25026815|NCT03625011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25026816|NCT03625011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25026817|NCT03625011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25026818|NCT03625011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25026819|NCT03625011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25166596|NCT03850535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24786651|NCT01921218|Hormones|hormones|mesh-ancestor
25026820|NCT03625011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026821|NCT03625011|Antimanic Agents|antimanic agents|mesh-ancestor
25026848|NCT03624959|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25026849|NCT03624959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25026850|NCT03624959|Antitubercular Agents|antitubercular agents|mesh-ancestor
25026851|NCT03624959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25026852|NCT03624959|Leprostatic Agents|leprostatic agents|mesh-ancestor
25020538|NCT03679182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25020539|NCT03679182|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25020540|NCT03679182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25020555|NCT03679065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25020556|NCT03679065|Glucocorticoids|glucocorticoids|mesh-ancestor
25020557|NCT03679065|Hormones|hormones|mesh-ancestor
25020558|NCT03679065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25020559|NCT03679065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25020560|NCT03679065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25026853|NCT03624959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25026854|NCT03624959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25026855|NCT03624959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24987100|NCT04175834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25026971|NCT03623789|Antidepressive Agents|antidepressive agents|mesh-ancestor
25026972|NCT03623789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25026973|NCT03623789|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25026974|NCT03623789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25026975|NCT03623789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25020569|NCT03679052|Mirtazapine|mirtazapine|mesh-list
25020578|NCT03679052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25026976|NCT03623789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25026977|NCT03623789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25026978|NCT03623789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026979|NCT03623776|Carboplatin|carboplatin|mesh-list
25026981|NCT03623776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25026982|NCT03623776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25026983|NCT03623776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020579|NCT03679052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25020580|NCT03679052|Adrenergic Agents|adrenergic agents|mesh-ancestor
25020581|NCT03679052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25020582|NCT03679052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020583|NCT03679052|Antidepressive Agents|antidepressive agents|mesh-ancestor
25026984|NCT03623776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25026985|NCT03623776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25026986|NCT03623711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25026987|NCT03623711|Citalopram|citalopram|mesh-list
25026988|NCT03623711|Bupropion|bupropion|mesh-list
25026989|NCT03623711|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25026990|NCT03623711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25026991|NCT03623711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25026992|NCT03623711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026993|NCT03623711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25026994|NCT03623711|Serotonin Agents|serotonin agents|mesh-ancestor
25026995|NCT03623711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026996|NCT03623711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25020584|NCT03679052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25026997|NCT03623711|Antidepressive Agents|antidepressive agents|mesh-ancestor
25027008|NCT03623555|Hydrocortisone|hydrocortisone|mesh-list
25027009|NCT03623555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25027010|NCT03623529|Angiotensin II|angiotensin ii|mesh-list
25027011|NCT03623529|Giapreza|giapreza|mesh-list
25027012|NCT03623529|Angiotensinogen|angiotensinogen|mesh-list
25018295|NCT03700359|Etoposide|etoposide|mesh-list
25027013|NCT03623529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25027014|NCT03623529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24796588|NCT01951027|Lenograstim|lenograstim|mesh-list
25027068|NCT03623087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25027069|NCT03623087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24592176|NCT00920608|Abortifacient Agents|abortifacient agents|mesh-ancestor
24795920|NCT01946620|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24795921|NCT01946620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24795923|NCT01946620|Adrenergic Agents|adrenergic agents|mesh-ancestor
24795924|NCT01946620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24795925|NCT01946620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795926|NCT01946815|Atorvastatin|atorvastatin|mesh-list
25027140|NCT03622489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25027141|NCT03622489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027143|NCT03622450|Levofloxacin|levofloxacin|mesh-list
25027144|NCT03622450|Gentamicins|gentamicins|mesh-list
25027146|NCT03622450|Amikacin|amikacin|mesh-list
25027147|NCT03622450|Colistin|colistin|mesh-list
25027148|NCT03622450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25027149|NCT03622450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25027150|NCT03622450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25027151|NCT03622450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25027152|NCT03622450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25027153|NCT03622450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027154|NCT03622450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166597|NCT03850535|Antiviral Agents|antiviral agents|mesh-ancestor
25027155|NCT03622450|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25027156|NCT03622450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25027157|NCT03622450|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25027158|NCT03622450|Renal Agents|renal agents|mesh-ancestor
25027159|NCT03622450|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25027160|NCT03622060|Nicardipine|nicardipine|mesh-list
25027161|NCT03622060|Nitroglycerin|nitroglycerin|mesh-list
25027162|NCT03622060|Vasodilator Agents|vasodilator agents|mesh-ancestor
25027163|NCT03622060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24977138|NCT03439033|Chelating Agents|chelating agents|mesh-ancestor
25027182|NCT03622047|Adrenergic Agents|adrenergic agents|mesh-ancestor
25027183|NCT03622047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25027184|NCT03622047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027185|NCT03622047|Anesthetics, Local|anesthetics, local|mesh-ancestor
25027186|NCT03622047|Anesthetics|anesthetics|mesh-ancestor
25027187|NCT03622047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25027188|NCT03622047|Narcotics|narcotics|mesh-ancestor
25027189|NCT03622047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25027190|NCT03622047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25027191|NCT03622047|Anesthetics, General|anesthetics, general|mesh-ancestor
25027193|NCT03621995|Antioxidants|antioxidants|mesh-ancestor
24977156|NCT03362099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25027194|NCT03621995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027195|NCT03621995|Protective Agents|protective agents|mesh-ancestor
25027196|NCT03621995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027197|NCT03621904|Tamoxifen|tamoxifen|mesh-list
25027198|NCT03621904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-list
24977160|NCT03362099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977161|NCT03362099|Dopamine Agents|dopamine agents|mesh-ancestor
24977162|NCT03362099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24977163|NCT03362099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977164|NCT03362099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24977165|NCT03362099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24547868|NCT00706225|Estrogens|estrogens|mesh-list
25112656|NCT03970746|Pemetrexed|pemetrexed|mesh-list
25112657|NCT03970746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25112658|NCT03970746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25112659|NCT03970746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24806073|NCT02013453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25112707|NCT03928275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112708|NCT03928275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25112709|NCT03928275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25112710|NCT03928275|Antiviral Agents|antiviral agents|mesh-ancestor
25112711|NCT03928275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25112712|NCT03928275|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25027217|NCT03621683|Antioxidants|antioxidants|mesh-list
25027218|NCT03621683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027226|NCT03621618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25027227|NCT03621618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027228|NCT03621618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027229|NCT03621618|Sympathomimetics|sympathomimetics|mesh-ancestor
25027230|NCT03621618|Autonomic Agents|autonomic agents|mesh-ancestor
25027231|NCT03621618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027232|NCT03621618|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25027233|NCT03621618|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24987259|NCT03412799|Antimetabolites|antimetabolites|mesh-ancestor
25027264|NCT03621163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25027265|NCT03621163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25027266|NCT03621163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027267|NCT03621072|Fluconazole|fluconazole|mesh-list
25027268|NCT03621072|Antifungal Agents|antifungal agents|mesh-ancestor
25027269|NCT03621072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25027270|NCT03621072|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25027271|NCT03621072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25027273|NCT03621072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027274|NCT03621072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25027275|NCT03621072|Hormone Antagonists|hormone antagonists|mesh-ancestor
25027361|NCT03620591|Anesthetics|anesthetics|mesh-ancestor
25027362|NCT03620591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25027363|NCT03620591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027364|NCT03620591|Sensory System Agents|sensory system agents|mesh-ancestor
25027365|NCT03620591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027366|NCT03620591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25027367|NCT03620591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25027368|NCT03620591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25027369|NCT03620591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25027370|NCT03620591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027371|NCT03620526|Iloprost|iloprost|mesh-list
25027372|NCT03620526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25027373|NCT03620526|Vasodilator Agents|vasodilator agents|mesh-ancestor
25027374|NCT03620513|Lidocaine|lidocaine|mesh-list
25027375|NCT03620513|Phenylephrine|phenylephrine|mesh-list
25027376|NCT03620513|Oxymetazoline|oxymetazoline|mesh-list
25027411|NCT03620461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25027412|NCT03620461|Antiviral Agents|antiviral agents|mesh-ancestor
25027413|NCT03620461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25027414|NCT03620461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25027415|NCT03620461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25020655|NCT03678610|Ionomycin|ionomycin|mesh-list
25027416|NCT03620461|Immunologic Factors|immunologic factors|mesh-ancestor
25027417|NCT03620461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027447|NCT03620292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027448|NCT03620292|Growth Inhibitors|growth inhibitors|mesh-ancestor
25027449|NCT03620253|Modafinil|modafinil|mesh-list
25027450|NCT03620253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25027451|NCT03620253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027452|NCT03620253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25027518|NCT03619785|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25027519|NCT03619785|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25027520|NCT03619785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25027521|NCT03619785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027522|NCT03619785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25027523|NCT03619785|Narcotics|narcotics|mesh-ancestor
25027524|NCT03619785|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25027525|NCT03619785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25027526|NCT03619785|Antipyretics|antipyretics|mesh-ancestor
25027527|NCT03619785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25027528|NCT03619785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25027529|NCT03619785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25027530|NCT03619785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25027531|NCT03619785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25027532|NCT03619785|Anticonvulsants|anticonvulsants|mesh-ancestor
25027533|NCT03619785|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25027534|NCT03619785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25027535|NCT03619785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25027616|NCT03618355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25027617|NCT03618355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25027618|NCT03618355|Antifungal Agents|antifungal agents|mesh-ancestor
25027619|NCT03618355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25027620|NCT03618355|Immunologic Factors|immunologic factors|mesh-ancestor
25027621|NCT03618355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027623|NCT03618316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24987469|NCT01509339|Vancomycin|vancomycin|mesh-list
24564123|NCT00775164|Metformin|metformin|mesh-list
25112823|NCT03910452|Sirolimus|sirolimus|mesh-list
25112824|NCT03910452|Cyclophosphamide|cyclophosphamide|mesh-list
25112825|NCT03910452|Busulfan|busulfan|mesh-list
25112826|NCT03910452|Alemtuzumab|alemtuzumab|mesh-list
25112827|NCT03910452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25112828|NCT03910452|Immunologic Factors|immunologic factors|mesh-ancestor
25112829|NCT03910452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112830|NCT03910452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25112831|NCT03910452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25112840|NCT03910452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25027668|NCT03618108|Azithromycin|azithromycin|mesh-list
25027669|NCT03618108|Doxycycline|doxycycline|mesh-list
25027826|NCT03616405|Amoxicillin|amoxicillin|mesh-list
25027827|NCT03616405|Tetracycline|tetracycline|mesh-list
25027828|NCT03616405|Furazolidone|furazolidone|mesh-list
25027829|NCT03616405|Rabeprazole|rabeprazole|mesh-list
25027830|NCT03616405|Bismuth|bismuth|mesh-list
25027831|NCT03616405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25027832|NCT03616405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25027833|NCT03616405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25027834|NCT03616405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25027835|NCT03616405|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25027851|NCT03616301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25027852|NCT03616301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027853|NCT03616288|Thiamine|thiamine|mesh-list
25027854|NCT03616288|Vitamin B Complex|vitamin b complex|mesh-ancestor
25027855|NCT03616288|Vitamins|vitamins|mesh-ancestor
25027856|NCT03616288|Micronutrients|micronutrients|mesh-ancestor
25027857|NCT03616288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027858|NCT03616262|Lidocaine|lidocaine|mesh-list
25028894|NCT03607149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25028895|NCT03607149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028896|NCT03607149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25028897|NCT03607149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25028899|NCT03607110|Ketamine|ketamine|mesh-list
25029127|NCT03604796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25029128|NCT03604796|Analgesics|analgesics|mesh-ancestor
25029129|NCT03604796|Sensory System Agents|sensory system agents|mesh-ancestor
25029130|NCT03604796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25020804|NCT03676985|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25029131|NCT03604796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029132|NCT03604796|Antipyretics|antipyretics|mesh-ancestor
25029208|NCT03604224|Canagliflozin|canagliflozin|mesh-list
25029209|NCT03604224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25029210|NCT03604224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029211|NCT03604224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25166598|NCT03850535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25029212|NCT03604224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029213|NCT03604016|Tenofovir|tenofovir|mesh-list
25029214|NCT03604016|Antiviral Agents|antiviral agents|mesh-ancestor
25029215|NCT03604016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25029335|NCT03603119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25029336|NCT03603119|Antiemetics|antiemetics|mesh-ancestor
25029337|NCT03603119|Autonomic Agents|autonomic agents|mesh-ancestor
25029338|NCT03603119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25029339|NCT03603119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029340|NCT03603119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25029341|NCT03603119|Glucocorticoids|glucocorticoids|mesh-ancestor
25029342|NCT03603119|Hormones|hormones|mesh-ancestor
24988448|NCT02800824|Budesonide|budesonide|mesh-list
25029449|NCT03602638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020826|NCT03676764|Azithromycin|azithromycin|mesh-list
25020827|NCT03676764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25020829|NCT03676621|Misoprostol|misoprostol|mesh-list
25029450|NCT03602638|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25029452|NCT03602586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25029453|NCT03602586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029454|NCT03602547|Vorolanib|vorolanib|mesh-list
25029455|NCT03602547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25029456|NCT03602547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25029462|NCT03602508|Oxybutynin|oxybutynin|mesh-list
25029463|NCT03602508|Darifenacin|darifenacin|mesh-list
25029464|NCT03602508|Propiverine|propiverine|mesh-list
25029465|NCT03602508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25029466|NCT03602508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25029467|NCT03602508|Cholinergic Agents|cholinergic agents|mesh-ancestor
25029468|NCT03602508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25029469|NCT03602508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029470|NCT03602508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029471|NCT03602508|Urological Agents|urological agents|mesh-ancestor
25029472|NCT03602508|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25029473|NCT03602508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25029474|NCT03602508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25029475|NCT03602508|Adrenergic Agents|adrenergic agents|mesh-ancestor
25029541|NCT03602131|Antiviral Agents|antiviral agents|mesh-ancestor
25029542|NCT03602131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25029543|NCT03602131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25029544|NCT03602131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25029545|NCT03602131|Immunologic Factors|immunologic factors|mesh-ancestor
25029546|NCT03602131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020855|NCT03676504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25020856|NCT03676504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25020857|NCT03676504|Alkylating Agents|alkylating agents|mesh-ancestor
25020858|NCT03676504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029547|NCT03602131|Alkylating Agents|alkylating agents|mesh-ancestor
25029556|NCT03602118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25029557|NCT03602118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25029558|NCT03602118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029559|NCT03602118|GABA Modulators|gaba modulators|mesh-ancestor
25029560|NCT03602118|GABA Agents|gaba agents|mesh-ancestor
25029561|NCT03602118|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25029562|NCT03602118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25029563|NCT03602118|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25029565|NCT03602027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029632|NCT03601624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020886|NCT03676374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25020887|NCT03676374|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
25029633|NCT03601624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029634|NCT03601624|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25029635|NCT03601624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25029636|NCT03601624|Antiemetics|antiemetics|mesh-ancestor
25029637|NCT03601624|Autonomic Agents|autonomic agents|mesh-ancestor
25029638|NCT03601624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25029639|NCT03601624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25029640|NCT03601624|Glucocorticoids|glucocorticoids|mesh-ancestor
25029642|NCT03601624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25029643|NCT03601624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25029644|NCT03601624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25029645|NCT03601624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25029646|NCT03601624|Growth Substances|growth substances|mesh-ancestor
25029647|NCT03601624|Growth Inhibitors|growth inhibitors|mesh-ancestor
25029648|NCT03601611|Prednisolone|prednisolone|mesh-list
25029649|NCT03601611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25029650|NCT03601611|Glucocorticoids|glucocorticoids|mesh-ancestor
25029651|NCT03601611|Hormones|hormones|mesh-ancestor
25029715|NCT03600974|Serotonin Agents|serotonin agents|mesh-ancestor
25029716|NCT03600974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25113260|NCT03215524|Growth Substances|growth substances|mesh-ancestor
25113261|NCT03215524|Growth Inhibitors|growth inhibitors|mesh-ancestor
25113262|NCT03215524|Leprostatic Agents|leprostatic agents|mesh-ancestor
25031760|NCT03585998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797154|NCT01954043|Dabrafenib|dabrafenib|mesh-list
25032012|NCT03584529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25032013|NCT03584529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25032062|NCT03584178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032063|NCT03584178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25032064|NCT03584178|Respiratory System Agents|respiratory system agents|mesh-ancestor
25032065|NCT03584178|Glucocorticoids|glucocorticoids|mesh-ancestor
25032067|NCT03584178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25032068|NCT03584087|Terlipressin|terlipressin|mesh-list
25032069|NCT03584087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25032070|NCT03584087|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25032071|NCT03584074|Celecoxib|celecoxib|mesh-list
25032072|NCT03584074|Pregabalin|pregabalin|mesh-list
25032282|NCT03582332|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25032283|NCT03582319|Formaldehyde|formaldehyde|mesh-list
25032284|NCT03582319|Disinfectants|disinfectants|mesh-ancestor
25032285|NCT03582319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25032313|NCT03581916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032314|NCT03581903|Vaccines|vaccines|mesh-list
25032315|NCT03581903|Immunologic Factors|immunologic factors|mesh-ancestor
25032316|NCT03581903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032317|NCT03581877|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25032318|NCT03581877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25032319|NCT03581877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25032320|NCT03581877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032321|NCT03581773|Folic Acid|folic acid|mesh-list
25032322|NCT03581773|Hematinics|hematinics|mesh-ancestor
25032323|NCT03581773|Vitamin B Complex|vitamin b complex|mesh-ancestor
25032324|NCT03581773|Vitamins|vitamins|mesh-ancestor
25032325|NCT03581773|Micronutrients|micronutrients|mesh-ancestor
25032326|NCT03581773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032327|NCT03581630|Naltrexone|naltrexone|mesh-list
25032328|NCT03581630|Bupropion|bupropion|mesh-list
25020942|NCT03676114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25032329|NCT03581630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25032330|NCT03581630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25032331|NCT03581630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032332|NCT03581630|Sensory System Agents|sensory system agents|mesh-ancestor
25032333|NCT03581630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25032334|NCT03581630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25032335|NCT03581630|Antidepressive Agents|antidepressive agents|mesh-ancestor
25032336|NCT03581630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25032337|NCT03581630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24990432|NCT03009838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032363|NCT03580980|Morphine|morphine|mesh-list
25032364|NCT03580980|Levobupivacaine|levobupivacaine|mesh-list
25020974|NCT03675815|Ritonavir|ritonavir|mesh-list
25032365|NCT03580980|Analgesics|analgesics|mesh-ancestor
24989221|NCT04245423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032429|NCT03580876|Antimetabolites|antimetabolites|mesh-ancestor
25032430|NCT03580876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032431|NCT03580876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25032432|NCT03580876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032433|NCT03580876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25032434|NCT03580876|Immunologic Factors|immunologic factors|mesh-ancestor
25020981|NCT03675815|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24806069|NCT02013453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25020993|NCT03675815|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25032435|NCT03580876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032436|NCT03580876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25032437|NCT03580733|Caspofungin|caspofungin|mesh-list
25032446|NCT03580733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25032447|NCT03580733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25032448|NCT03580733|Hormone Antagonists|hormone antagonists|mesh-ancestor
25032449|NCT03580733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25032450|NCT03580733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032451|NCT03580733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25032452|NCT03580733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25032454|NCT03580694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25032455|NCT03580694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032456|NCT03580681|Vitamin E|vitamin e|mesh-list
25032457|NCT03580681|Vitamins|vitamins|mesh-ancestor
25032458|NCT03580681|Micronutrients|micronutrients|mesh-ancestor
25032459|NCT03580681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032460|NCT03580681|Antioxidants|antioxidants|mesh-ancestor
25032461|NCT03580681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032463|NCT03580590|Diltiazem|diltiazem|mesh-list
25032464|NCT03580590|Tranexamic Acid|tranexamic acid|mesh-list
25032465|NCT03580590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25032466|NCT03580590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25032467|NCT03580590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032468|NCT03580590|Hemostatics|hemostatics|mesh-ancestor
25032469|NCT03580590|Coagulants|coagulants|mesh-ancestor
25032470|NCT03580590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25032471|NCT03580590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25032472|NCT03580590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24990515|NCT02821026|Sirolimus|sirolimus|mesh-list
24989317|NCT05365464|Hormones|hormones|mesh-ancestor
24979923|NCT04959006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989318|NCT05365464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24989319|NCT05365464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989320|NCT05365438|Atorvastatin|atorvastatin|mesh-list
24989321|NCT05365438|Ezetimibe|ezetimibe|mesh-list
24989322|NCT05365438|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24989323|NCT05365438|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24989324|NCT05365438|Antimetabolites|antimetabolites|mesh-ancestor
24989325|NCT05365438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989326|NCT05365438|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24989327|NCT05365438|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24989328|NCT05365438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24989329|NCT05365425|Choline|choline|mesh-list
24989330|NCT05365425|Policosanol|policosanol|mesh-list
24989331|NCT05365425|Fenofibrate|fenofibrate|mesh-list
24989332|NCT05365425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24989333|NCT05365425|Antimetabolites|antimetabolites|mesh-ancestor
24989334|NCT05365425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989335|NCT05365425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25032574|NCT03579927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25032575|NCT03579927|Keratolytic Agents|keratolytic agents|mesh-ancestor
25032576|NCT03579927|Dermatologic Agents|dermatologic agents|mesh-ancestor
25032577|NCT03579927|Tubulin Modulators|tubulin modulators|mesh-ancestor
25032587|NCT03579888|Alkylating Agents|alkylating agents|mesh-ancestor
25032588|NCT03579888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032589|NCT03579888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032590|NCT03579888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25032591|NCT03579875|Methylprednisolone|methylprednisolone|mesh-list
25032592|NCT03579875|Cyclophosphamide|cyclophosphamide|mesh-list
25032593|NCT03579875|Busulfan|busulfan|mesh-list
25032594|NCT03579875|Rituximab|rituximab|mesh-list
25032595|NCT03579875|Fludarabine|fludarabine|mesh-list
25032596|NCT03579875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25032597|NCT03579875|Immunologic Factors|immunologic factors|mesh-ancestor
25032598|NCT03579875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032599|NCT03579875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25032600|NCT03579875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25021022|NCT03675555|Autonomic Agents|autonomic agents|mesh-ancestor
25021023|NCT03675555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25021024|NCT03675555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032601|NCT03579875|Alkylating Agents|alkylating agents|mesh-ancestor
25032602|NCT03579875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032677|NCT03579732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032678|NCT03579732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25032679|NCT03579732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25032680|NCT03579732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25032681|NCT03579732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25166599|NCT03850535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25032682|NCT03579732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032683|NCT03579732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25032684|NCT03579732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25032685|NCT03579732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25032687|NCT03579589|Neostigmine|neostigmine|mesh-list
25032688|NCT03579589|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25032689|NCT03579589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039949|NCT03553498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25113703|NCT02352948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113704|NCT02352948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25113706|NCT02352948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25032971|NCT03576677|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25033272|NCT03574857|Natriuretic Agents|natriuretic agents|mesh-ancestor
25034937|NCT03560973|Immunologic Factors|immunologic factors|mesh-ancestor
25034938|NCT03560973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034939|NCT03560908|Dasatinib|dasatinib|mesh-list
24992029|NCT04583592|Gabexate|gabexate|mesh-list
25035503|NCT03555188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035505|NCT03555188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25035506|NCT03555188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25021082|NCT03674671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25021083|NCT03674671|Anesthetics, General|anesthetics, general|mesh-ancestor
25021085|NCT03674671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25024010|NCT03649334|Ketorolac|ketorolac|mesh-list
25114252|NCT01038778|Aldesleukin|aldesleukin|mesh-list
25114253|NCT01038778|Deoxyglucose|deoxyglucose|mesh-list
25036131|NCT03549897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036133|NCT03549832|Ribavirin|ribavirin|mesh-list
25036135|NCT03549832|Simeprevir|simeprevir|mesh-list
25036136|NCT03549832|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25036137|NCT03549832|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25036138|NCT03549832|Protease Inhibitors|protease inhibitors|mesh-ancestor
25036139|NCT03549832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24785682|NCT01916174|Insulin|insulin|mesh-list
25036192|NCT03549663|Prednisone|prednisone|mesh-list
25036193|NCT03549663|Glucocorticoids|glucocorticoids|mesh-list
25036194|NCT03549663|Tacrolimus|tacrolimus|mesh-list
25036195|NCT03549663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25036196|NCT03549663|Hormones|hormones|mesh-ancestor
24603786|NCT00975728|Antioxidants|antioxidants|mesh-list
25036213|NCT03549611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25036214|NCT03549611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036215|NCT03549611|Antipyretics|antipyretics|mesh-ancestor
25036216|NCT03549611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25036217|NCT03549611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25036218|NCT03549611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25036219|NCT03549611|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25036220|NCT03549611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25036221|NCT03549611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036240|NCT03549312|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25036241|NCT03549312|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25036243|NCT03549312|Antiviral Agents|antiviral agents|mesh-ancestor
25036244|NCT03549312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25036245|NCT03549312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25036246|NCT03549312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25021137|NCT03674411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25021138|NCT03674411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25021139|NCT03674411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25021140|NCT03674411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25036247|NCT03549312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036248|NCT03549312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036249|NCT03549312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25036250|NCT03549312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25036251|NCT03549312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25036252|NCT03549312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25036287|NCT03549026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25036288|NCT03549026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25036289|NCT03549026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25036290|NCT03549026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036291|NCT03549026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25036292|NCT03549026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036293|NCT03549026|Analgesics|analgesics|mesh-ancestor
25036294|NCT03549026|Sensory System Agents|sensory system agents|mesh-ancestor
24992629|NCT03302286|Mannitol|mannitol|mesh-list
25036382|NCT03547895|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24992669|NCT03194321|Tacrolimus|tacrolimus|mesh-list
25036485|NCT03547024|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25036486|NCT03547024|JNJ-55308942|jnj-55308942|mesh-list
25036578|NCT03546283|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25036579|NCT03546283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036580|NCT03546283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036581|NCT03546283|Protective Agents|protective agents|mesh-ancestor
25036582|NCT03546283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036583|NCT03546088|Anesthetics|anesthetics|mesh-list
25036584|NCT03546088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25036585|NCT03546088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036586|NCT03546075|Resveratrol|resveratrol|mesh-list
25036587|NCT03546075|Antioxidants|antioxidants|mesh-ancestor
25036588|NCT03546075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036589|NCT03546075|Protective Agents|protective agents|mesh-ancestor
25036685|NCT03544723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25036686|NCT03544723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25036687|NCT03544723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039954|NCT03553498|Antipyretics|antipyretics|mesh-ancestor
25036750|NCT03543826|Rocuronium|rocuronium|mesh-list
25036751|NCT03543826|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25036752|NCT03543826|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25036753|NCT03543826|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25036754|NCT03543826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25036755|NCT03543826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036756|NCT03543774|Simvastatin|simvastatin|mesh-list
25036757|NCT03543774|Ezetimibe|ezetimibe|mesh-list
25036758|NCT03543774|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
25039955|NCT03553498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25036883|NCT03542422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25036884|NCT03542422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25036885|NCT03542422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036886|NCT03542422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036887|NCT03542357|Calcitonin|calcitonin|mesh-list
25036888|NCT03542357|Salmon calcitonin|salmon calcitonin|mesh-list
25036967|NCT03541928|Bicalutamide|bicalutamide|mesh-list
25036968|NCT03541928|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25036969|NCT03541928|Fertility Agents|fertility agents|mesh-ancestor
25036970|NCT03541928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25036971|NCT03541928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036972|NCT03541928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25036973|NCT03541928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25036974|NCT03541928|Androgen Antagonists|androgen antagonists|mesh-ancestor
25036975|NCT03541928|Hormone Antagonists|hormone antagonists|mesh-ancestor
25036976|NCT03541928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24480959|NCT00432887|Purinergic Agents|purinergic agents|mesh-ancestor
25036977|NCT03541928|Antiviral Agents|antiviral agents|mesh-ancestor
24604692|NCT00981201|Celecoxib|celecoxib|mesh-list
24992983|NCT01883804|Methyldopa|methyldopa|mesh-list
25037008|NCT03541759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25037009|NCT03541759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021265|NCT03673501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25037010|NCT03541759|Analgesics|analgesics|mesh-ancestor
25039956|NCT03553498|Narcotics|narcotics|mesh-ancestor
24994157|NCT04829799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24994158|NCT04829799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24994159|NCT04829799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994160|NCT04829799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24994161|NCT04829799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24994163|NCT04829799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24994164|NCT04829799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24994165|NCT04829799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24994166|NCT04829799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24994167|NCT04829799|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24994168|NCT04829799|Mydriatics|mydriatics|mesh-ancestor
24994169|NCT04829799|Autonomic Agents|autonomic agents|mesh-ancestor
24994170|NCT04829799|Sympathomimetics|sympathomimetics|mesh-ancestor
24994171|NCT04829799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24994172|NCT04829799|Nasal Decongestants|nasal decongestants|mesh-ancestor
24994173|NCT04829799|Respiratory System Agents|respiratory system agents|mesh-ancestor
24994174|NCT04829799|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24994175|NCT04829799|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24994176|NCT04829799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24994177|NCT04829799|Adrenergic Agents|adrenergic agents|mesh-ancestor
24994178|NCT04829799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24994179|NCT04829799|Protective Agents|protective agents|mesh-ancestor
24588954|NCT00904904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25166600|NCT03850535|Immunologic Factors|immunologic factors|mesh-ancestor
24588955|NCT00904904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24588956|NCT00904904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25037496|NCT03536910|Hemostatics|hemostatics|mesh-ancestor
25037601|NCT03536065|Analgesics, Opioid|analgesics, opioid|mesh-list
25037602|NCT03536065|Narcotics|narcotics|mesh-ancestor
25037603|NCT03536065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25037657|NCT03535870|Respiratory System Agents|respiratory system agents|mesh-ancestor
25037658|NCT03535870|Dermatologic Agents|dermatologic agents|mesh-ancestor
25037659|NCT03535870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25037719|NCT03535558|Renal Agents|renal agents|mesh-ancestor
25037720|NCT03535558|Antimalarials|antimalarials|mesh-ancestor
25037721|NCT03535558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25037722|NCT03535558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25037723|NCT03535558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25037724|NCT03535558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037725|NCT03535558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037726|NCT03535558|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25037727|NCT03535558|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25037728|NCT03535558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25037941|NCT03534479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721104|NCT01572181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24721105|NCT01572181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721106|NCT01572181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24721107|NCT01572181|Immunologic Factors|immunologic factors|mesh-ancestor
24721108|NCT01572181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577760|NCT00845819|Iodine|iodine|mesh-list
25037942|NCT03534388|Sodium Hypochlorite|sodium hypochlorite|mesh-list
25037943|NCT03534388|Eusol|eusol|mesh-list
25037944|NCT03534388|Disinfectants|disinfectants|mesh-ancestor
25037945|NCT03534388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25037946|NCT03534310|Liraglutide|liraglutide|mesh-list
25037971|NCT03534024|Sensory System Agents|sensory system agents|mesh-ancestor
25037972|NCT03534024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25037973|NCT03534024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037974|NCT03534024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25037975|NCT03534024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25037976|NCT03534024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25021370|NCT03672045|Carbetocin|carbetocin|mesh-list
25037977|NCT03534024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037978|NCT03534024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037979|NCT03533803|Indomethacin|indomethacin|mesh-list
25037980|NCT03533803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25038035|NCT03533335|Disinfectants|disinfectants|mesh-ancestor
25038036|NCT03533335|Dental Disinfectants|dental disinfectants|mesh-ancestor
25038037|NCT03533231|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25038038|NCT03533231|Metronidazole|metronidazole|mesh-list
25038039|NCT03533231|Ciprofloxacin|ciprofloxacin|mesh-list
25038166|NCT03532711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25038167|NCT03532711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038168|NCT03532711|Antidotes|antidotes|mesh-ancestor
25038169|NCT03532711|Protective Agents|protective agents|mesh-ancestor
25038170|NCT03532711|Vitamin B Complex|vitamin b complex|mesh-ancestor
25038171|NCT03532711|Vitamins|vitamins|mesh-ancestor
25038172|NCT03532711|Micronutrients|micronutrients|mesh-ancestor
25038199|NCT05263583|Bromides|bromides|mesh-list
25038200|NCT05263583|Anticonvulsants|anticonvulsants|mesh-ancestor
25038201|NCT05263505|Methotrexate|methotrexate|mesh-list
25038202|NCT05263505|Azathioprine|azathioprine|mesh-list
25038203|NCT05263505|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25021408|NCT03671733|Liraglutide|liraglutide|mesh-list
25038204|NCT05263505|Abortifacient Agents|abortifacient agents|mesh-ancestor
25038205|NCT05263505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25038206|NCT05263505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038207|NCT05263505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25038208|NCT05263505|Antimetabolites|antimetabolites|mesh-ancestor
25038209|NCT05263505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038213|NCT05263505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25038214|NCT05263505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25038215|NCT05263505|Immunologic Factors|immunologic factors|mesh-ancestor
25038216|NCT05263505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25038217|NCT05263505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25038219|NCT05262985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25038337|NCT05224401|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25038338|NCT05224401|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25038339|NCT05224401|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25038341|NCT05223101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25038342|NCT05223101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25038343|NCT05223101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24827754|NCT02141178|Anesthetics|anesthetics|mesh-ancestor
25038344|NCT05223101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045533|NCT00945646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038345|NCT05216211|Bupivacaine|bupivacaine|mesh-list
25038346|NCT05216211|Anesthetics, Local|anesthetics, local|mesh-ancestor
25038347|NCT05216211|Anesthetics|anesthetics|mesh-ancestor
25038348|NCT05216211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25038349|NCT05216211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038350|NCT05216211|Sensory System Agents|sensory system agents|mesh-ancestor
25038359|NCT05197439|Dexmedetomidine|dexmedetomidine|mesh-list
25038360|NCT05197439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25039958|NCT03546907|Cholinergic Agents|cholinergic agents|mesh-list
24979924|NCT04959006|Protective Agents|protective agents|mesh-ancestor
25650102|NCT01499147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25650103|NCT01499147|Immunologic Factors|immunologic factors|mesh-ancestor
25650104|NCT01499147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650105|NCT01499147|Antiviral Agents|antiviral agents|mesh-ancestor
25650106|NCT01499147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25650107|NCT01499147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25038639|NCT04779554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038699|NCT04634799|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25038700|NCT04634799|Protease Inhibitors|protease inhibitors|mesh-ancestor
25038701|NCT04634799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038703|NCT04624776|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25038704|NCT04624776|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25038705|NCT04624776|Prednisolone|prednisolone|mesh-list
25038706|NCT04624776|Prednisolone acetate|prednisolone acetate|mesh-list
25038761|NCT04542408|Dalteparin|dalteparin|mesh-list
25038762|NCT04542408|Edoxaban|edoxaban|mesh-list
25038763|NCT04542408|Anticoagulants|anticoagulants|mesh-list
25038764|NCT04542408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25038765|NCT04542408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25038766|NCT04542408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038767|NCT04542408|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25038768|NCT04542408|Antithrombins|antithrombins|mesh-ancestor
25039959|NCT03546907|Muscarinic Agonists|muscarinic agonists|mesh-list
25038808|NCT04516278|Growth Inhibitors|growth inhibitors|mesh-ancestor
25038809|NCT04507178|Nadroparin|nadroparin|mesh-list
25038810|NCT04507178|Anticoagulants|anticoagulants|mesh-ancestor
25038811|NCT04507178|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25038812|NCT04507178|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25038813|NCT04507178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038814|NCT04500899|Phenylephrine|phenylephrine|mesh-list
25038815|NCT04500899|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25038816|NCT04500899|Mydriatics|mydriatics|mesh-ancestor
25038817|NCT04500899|Autonomic Agents|autonomic agents|mesh-ancestor
25038818|NCT04500899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039305|NCT03915067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25039306|NCT03912233|Ivacaftor|ivacaftor|mesh-list
25039307|NCT03912233|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25039308|NCT03912233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25039309|NCT03912233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039423|NCT03840837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039425|NCT03840837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25039426|NCT03840837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039427|NCT03840837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25039428|NCT03840837|Protective Agents|protective agents|mesh-ancestor
25039430|NCT03836287|Bromides|bromides|mesh-list
25039431|NCT03836287|Anticonvulsants|anticonvulsants|mesh-ancestor
25039432|NCT03834753|Bevacizumab|bevacizumab|mesh-list
25039433|NCT03834753|Ranibizumab|ranibizumab|mesh-list
24587187|NCT00893724|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25039434|NCT03834753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25039435|NCT03834753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797933|NCT01959100|Azithromycin|azithromycin|mesh-list
25039514|NCT03798743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25039515|NCT03798743|Tubulin Modulators|tubulin modulators|mesh-ancestor
25039516|NCT03798743|Antimitotic Agents|antimitotic agents|mesh-ancestor
25039517|NCT03798743|Mitosis Modulators|mitosis modulators|mesh-ancestor
25039518|NCT03798743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039530|NCT03786770|Cholinergic Agents|cholinergic agents|mesh-ancestor
25039531|NCT03786770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25039541|NCT03780244|Mannitol|mannitol|mesh-list
25039542|NCT03780244|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25039543|NCT03780244|Diuretics|diuretics|mesh-ancestor
25039544|NCT03780244|Natriuretic Agents|natriuretic agents|mesh-ancestor
25039545|NCT03780244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039546|NCT03778554|Metoprolol|metoprolol|mesh-list
25039547|NCT03778554|Carvedilol|carvedilol|mesh-list
25039548|NCT03778554|Nebivolol|nebivolol|mesh-list
25039549|NCT03778554|Bisoprolol|bisoprolol|mesh-list
25039550|NCT03778554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25039551|NCT03778554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25039552|NCT03778554|Sympatholytics|sympatholytics|mesh-ancestor
25166601|NCT03850535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039553|NCT03778554|Autonomic Agents|autonomic agents|mesh-ancestor
25039554|NCT03778554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039596|NCT03766295|Immunologic Factors|immunologic factors|mesh-ancestor
25039597|NCT03766295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039598|NCT03761225|Prednisone|prednisone|mesh-list
25039599|NCT03761225|Docetaxel|docetaxel|mesh-list
25039600|NCT03761225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25039701|NCT03709121|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25039725|NCT03704584|Autonomic Agents|autonomic agents|mesh-ancestor
25039726|NCT03704584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25039727|NCT03704584|Glucocorticoids|glucocorticoids|mesh-ancestor
25039728|NCT03704584|Hormones|hormones|mesh-ancestor
25039729|NCT03704584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25039733|NCT03704584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25039734|NCT03699475|Cyclophosphamide|cyclophosphamide|mesh-list
25039735|NCT03699475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25039736|NCT03699475|Immunologic Factors|immunologic factors|mesh-ancestor
25039737|NCT03699475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039738|NCT03699475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25039739|NCT03699475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25039740|NCT03699475|Alkylating Agents|alkylating agents|mesh-ancestor
25039741|NCT03699475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039742|NCT03699475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25039743|NCT03699475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25039744|NCT03691974|Fasinumab|fasinumab|mesh-list
25039745|NCT03691974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25039746|NCT03691974|Analgesics|analgesics|mesh-ancestor
25039747|NCT03691974|Sensory System Agents|sensory system agents|mesh-ancestor
25039748|NCT03691974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039749|NCT03691974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039750|NCT03684278|Infliximab|infliximab|mesh-list
25039751|NCT03684278|Dermatologic Agents|dermatologic agents|mesh-ancestor
25039752|NCT03684278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25039767|NCT03662542|Golimumab|golimumab|mesh-list
25039816|NCT03647592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039817|NCT03647592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039818|NCT03647111|Crizotinib|crizotinib|mesh-list
25039819|NCT03647111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25039820|NCT03647111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25039821|NCT03647111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529166|NCT00624871|Ascorbic Acid|ascorbic acid|mesh-list
24529167|NCT00624871|Ibuprofen|ibuprofen|mesh-list
24529168|NCT00624871|Vitamins|vitamins|mesh-ancestor
24529238|NCT00625170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24529239|NCT00625170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24529240|NCT00625170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24529241|NCT00625170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24529242|NCT00625170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24529268|NCT00625209|Fludrocortisone|fludrocortisone|mesh-list
24529269|NCT00625209|Protein C|protein c|mesh-list
24529270|NCT00625209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24529271|NCT00625209|Anticoagulants|anticoagulants|mesh-ancestor
24994870|NCT01931709|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25158182|NCT04426825|Bevacizumab|bevacizumab|mesh-list
25158183|NCT04426825|Atezolizumab|atezolizumab|mesh-list
25158184|NCT04426825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25158185|NCT04426825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25158193|NCT04418557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108058|NCT03134651|Propofol|propofol|mesh-list
25039893|NCT03611751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25158576|NCT04227275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25158577|NCT04227275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25158578|NCT04224571|Rituximab|rituximab|mesh-list
25158579|NCT04224571|Bortezomib|bortezomib|mesh-list
25158580|NCT04224571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25158581|NCT04224571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25158582|NCT04224571|Immunologic Factors|immunologic factors|mesh-ancestor
25158583|NCT04224571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25158584|NCT04224571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24798041|NCT01960049|Anesthetics|anesthetics|mesh-ancestor
25159177|NCT03986424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159178|NCT03986424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25159179|NCT03986424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25159180|NCT03978208|Naproxen|naproxen|mesh-list
25159181|NCT03978208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24995843|NCT04564547|Islatravir|islatravir|mesh-list
25159416|NCT03828006|Red yeast rice|red yeast rice|mesh-list
24996052|NCT04352205|Protease Inhibitors|protease inhibitors|mesh-ancestor
25159483|NCT03789916|Sensory System Agents|sensory system agents|mesh-ancestor
25159484|NCT03789916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25159485|NCT03789916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25159486|NCT03789916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25159487|NCT03789916|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24996122|NCT04188119|Aspirin|aspirin|mesh-list
25021644|NCT03669484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25021647|NCT03669484|Anesthetics, General|anesthetics, general|mesh-ancestor
25159773|NCT03642132|Bevacizumab|bevacizumab|mesh-list
25159774|NCT03642132|Avelumab|avelumab|mesh-list
25159775|NCT03642132|Talazoparib|talazoparib|mesh-list
25159776|NCT03642132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25159777|NCT03642132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25159995|NCT03412747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25021703|NCT03669029|Golimumab|golimumab|mesh-list
24996643|NCT03033095|Etanercept|etanercept|mesh-list
25160078|NCT03326193|Bevacizumab|bevacizumab|mesh-list
25160079|NCT03326193|Niraparib|niraparib|mesh-list
25160080|NCT03326193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25160081|NCT03326193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25160082|NCT03326193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25160083|NCT03326193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25160084|NCT03326193|Growth Substances|growth substances|mesh-ancestor
25160085|NCT03326193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160086|NCT03326193|Growth Inhibitors|growth inhibitors|mesh-ancestor
25160087|NCT03326193|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25160088|NCT03326193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25160113|NCT03314935|Vitamin B Complex|vitamin b complex|mesh-ancestor
25160114|NCT03314935|Vitamins|vitamins|mesh-ancestor
25160115|NCT03314935|Micronutrients|micronutrients|mesh-ancestor
25160116|NCT03310125|Colchicine|colchicine|mesh-list
25160117|NCT03310125|Gout Suppressants|gout suppressants|mesh-ancestor
25160118|NCT03310125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25160119|NCT03310125|Tubulin Modulators|tubulin modulators|mesh-ancestor
25160120|NCT03310125|Antimitotic Agents|antimitotic agents|mesh-ancestor
25160121|NCT03310125|Mitosis Modulators|mitosis modulators|mesh-ancestor
25160122|NCT03310125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160123|NCT03310125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25160124|NCT03268382|Doxorubicin|doxorubicin|mesh-list
25160125|NCT03268382|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25160126|NCT03268382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25021817|NCT03668054|Bevacizumab|bevacizumab|mesh-list
25160231|NCT03151746|Sensory System Agents|sensory system agents|mesh-ancestor
25160232|NCT03151746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25160233|NCT03151746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160234|NCT03151746|Anticonvulsants|anticonvulsants|mesh-ancestor
25160235|NCT03151746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25160236|NCT03151746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25160237|NCT03151746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25160238|NCT03151746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25160239|NCT03151746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25160240|NCT03151746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25160241|NCT03151746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25160242|NCT03151746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160243|NCT03151746|Antimanic Agents|antimanic agents|mesh-ancestor
25160244|NCT03104491|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25160245|NCT03104491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25160246|NCT03104491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25160341|NCT03014622|Botulinum Toxins|botulinum toxins|mesh-list
25160342|NCT03014622|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25160343|NCT03014622|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25160344|NCT03014622|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25160375|NCT03007979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160376|NCT03007979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25160377|NCT03007979|Hormone Antagonists|hormone antagonists|mesh-ancestor
25160378|NCT03007979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25160379|NCT03007979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160380|NCT03007979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25160381|NCT03007979|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25160382|NCT03007979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25045569|NCT00944294|Binodenoson|binodenoson|mesh-list
24482499|NCT00439283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24482545|NCT00439504|Respiratory System Agents|respiratory system agents|mesh-ancestor
25828939|NCT00006114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25160554|NCT02881242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25160555|NCT02881242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160605|NCT02781519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25021853|NCT03667677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25021854|NCT03667677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25160606|NCT02781519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979925|NCT04959006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690228|NCT01400464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24690229|NCT01400464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690230|NCT01400464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24690258|NCT01400646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24690259|NCT01400646|Protease Inhibitors|protease inhibitors|mesh-ancestor
25160608|NCT02781519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25160609|NCT02778399|OBE2109|obe2109|mesh-list
25160610|NCT02778399|Hormone Antagonists|hormone antagonists|mesh-ancestor
25160611|NCT02778399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25160612|NCT02778399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160613|NCT02773238|Deoxyglucose|deoxyglucose|mesh-list
25160614|NCT02773238|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25160615|NCT02773238|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
25160616|NCT02773238|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
25160617|NCT02773238|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25160691|NCT02623439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160692|NCT02623439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25160775|NCT02511132|Immunologic Factors|immunologic factors|mesh-ancestor
25160776|NCT02511132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160777|NCT02511132|Tubulin Modulators|tubulin modulators|mesh-ancestor
25160778|NCT02511132|Antimitotic Agents|antimitotic agents|mesh-ancestor
25160779|NCT02511132|Mitosis Modulators|mitosis modulators|mesh-ancestor
25160780|NCT02511132|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25160781|NCT02511132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25160782|NCT02511132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25160783|NCT02511132|Alkylating Agents|alkylating agents|mesh-ancestor
25160784|NCT02510300|Sofosbuvir|sofosbuvir|mesh-list
25160785|NCT02510300|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25160786|NCT02510300|Ledipasvir|ledipasvir|mesh-list
25160787|NCT02510300|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25160788|NCT02510300|Velpatasvir|velpatasvir|mesh-list
25160789|NCT02510300|Antiviral Agents|antiviral agents|mesh-ancestor
25160790|NCT02510300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25166602|NCT03850535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25166603|NCT03850535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25166604|NCT03850535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25166605|NCT03850535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25166606|NCT03850301|Etifoxine|etifoxine|mesh-list
25160982|NCT02236013|Antimetabolites|antimetabolites|mesh-ancestor
25161016|NCT02202577|Plasma Substitutes|plasma substitutes|mesh-ancestor
25161017|NCT02202577|Blood Substitutes|blood substitutes|mesh-ancestor
24594682|NCT00935116|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25161062|NCT02178410|Micronutrients|micronutrients|mesh-ancestor
24800713|NCT01978015|Timolol|timolol|mesh-list
25161132|NCT01854684|Temoporfin|temoporfin|mesh-list
25161133|NCT01854684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161134|NCT01854684|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25161135|NCT01854684|Dermatologic Agents|dermatologic agents|mesh-ancestor
25161136|NCT01845805|Azacitidine|azacitidine|mesh-list
25161137|NCT01845805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25161138|NCT01845805|Antimetabolites|antimetabolites|mesh-ancestor
25161139|NCT01845805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161140|NCT01845805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161141|NCT01845805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25161142|NCT01834248|Poly I-C|poly i-c|mesh-list
25161143|NCT01834248|Decitabine|decitabine|mesh-list
25161144|NCT01834248|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25161145|NCT01834248|Poly ICLC|poly iclc|mesh-list
25120105|NCT04695704|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25120106|NCT04695704|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25120107|NCT04695704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120108|NCT04670796|Trastuzumab|trastuzumab|mesh-list
24803025|NCT01993979|Gemcitabine|gemcitabine|mesh-list
24529902|NCT00628238|Rituximab|rituximab|mesh-list
24529903|NCT00628238|Lenalidomide|lenalidomide|mesh-list
24529904|NCT00628238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25161174|NCT01808456|Immunologic Factors|immunologic factors|mesh-ancestor
25161175|NCT01808456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161176|NCT01764633|Evolocumab|evolocumab|mesh-list
25650108|NCT01499147|Alkylating Agents|alkylating agents|mesh-ancestor
25650109|NCT01499147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25650110|NCT01499199|Dolutegravir|dolutegravir|mesh-list
25650111|NCT01499199|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25650112|NCT01499199|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25650113|NCT01499199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828940|NCT00006114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022017|NCT03666494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25161177|NCT01764633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25161178|NCT01764633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25161179|NCT01764633|Antimetabolites|antimetabolites|mesh-ancestor
25161180|NCT01764633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161181|NCT01764633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25161182|NCT01744093|Doxycycline|doxycycline|mesh-list
25161183|NCT01744093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25161184|NCT01744093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25161185|NCT01744093|Antimalarials|antimalarials|mesh-ancestor
25161186|NCT01744093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25161187|NCT01744093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25161188|NCT01715714|Atorvastatin|atorvastatin|mesh-list
25161189|NCT01715714|Simvastatin|simvastatin|mesh-list
25161190|NCT01715714|Pravastatin|pravastatin|mesh-list
25161191|NCT01715714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25161192|NCT01715714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25161193|NCT01715714|Antimetabolites|antimetabolites|mesh-ancestor
25166607|NCT03850301|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25161194|NCT01715714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161195|NCT01715714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24803197|NCT01995019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161482|NCT00746590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161483|NCT00659711|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25161484|NCT00659711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25161485|NCT00659711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161486|NCT00659711|Incretins|incretins|mesh-ancestor
25161488|NCT00659711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25161489|NCT00659711|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25161490|NCT00659711|Protease Inhibitors|protease inhibitors|mesh-ancestor
25161491|NCT00659711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25161492|NCT00659711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161494|NCT00611572|Antidotes|antidotes|mesh-ancestor
25161495|NCT00611572|Protective Agents|protective agents|mesh-ancestor
25161496|NCT00611572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161497|NCT00611572|GABA Modulators|gaba modulators|mesh-ancestor
25161498|NCT00611572|GABA Agents|gaba agents|mesh-ancestor
25161499|NCT00611572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25161500|NCT00611572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166608|NCT03850301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25161617|NCT00042289|Raltegravir Potassium|raltegravir potassium|mesh-list
25161618|NCT00042289|Nevirapine|nevirapine|mesh-list
25161619|NCT00042289|Maraviroc|maraviroc|mesh-list
25161620|NCT00042289|Abacavir|abacavir|mesh-list
25161621|NCT00042289|Dolutegravir|dolutegravir|mesh-list
25161622|NCT00042289|Didanosine|didanosine|mesh-list
25161623|NCT00042289|Cobicistat|cobicistat|mesh-list
25161624|NCT00042289|Rilpivirine|rilpivirine|mesh-list
25161625|NCT00042289|Tipranavir|tipranavir|mesh-list
25161626|NCT00042289|Elvitegravir|elvitegravir|mesh-list
25161627|NCT00042289|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
25161629|NCT00042289|Efavirenz|efavirenz|mesh-list
25161630|NCT00042289|Rifampin|rifampin|mesh-list
25161631|NCT00042289|Isoniazid|isoniazid|mesh-list
25161632|NCT00042289|Linezolid|linezolid|mesh-list
25161633|NCT00042289|Cycloserine|cycloserine|mesh-list
25161634|NCT00042289|Amikacin|amikacin|mesh-list
25161635|NCT00042289|Pyrazinamide|pyrazinamide|mesh-list
25161636|NCT00042289|Ethambutol|ethambutol|mesh-list
24529911|NCT00628238|Growth Substances|growth substances|mesh-ancestor
24529912|NCT00628238|Growth Inhibitors|growth inhibitors|mesh-ancestor
24530331|NCT00629889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530332|NCT00629889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24530333|NCT00629889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24530696|NCT00631813|Laxatives|laxatives|mesh-ancestor
24530697|NCT00631813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24445580|NCT00301899|Trastuzumab|trastuzumab|mesh-list
24530698|NCT00631813|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24530699|NCT00631813|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24530700|NCT00631813|Serotonin Agents|serotonin agents|mesh-ancestor
24530730|NCT00632086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530732|NCT00632086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25122072|NCT03097003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25122073|NCT03097003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25122074|NCT03097003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122076|NCT03096990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24831399|NCT02165046|Sympathomimetics|sympathomimetics|mesh-ancestor
24530826|NCT00632606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24530827|NCT00632606|Antiemetics|antiemetics|mesh-ancestor
24530828|NCT00632606|Autonomic Agents|autonomic agents|mesh-ancestor
24530829|NCT00632606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24530830|NCT00632606|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24530831|NCT00632606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25828941|NCT00006115|Leucovorin|leucovorin|mesh-list
24531201|NCT00634439|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24531202|NCT00634439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25123336|NCT03086070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123338|NCT03085940|Antimalarials|antimalarials|mesh-ancestor
25123339|NCT03085940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25123340|NCT03085940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25123341|NCT03085940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25123342|NCT03085940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123343|NCT03085940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123344|NCT03085940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24531928|NCT00637611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24531929|NCT00637611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835277|NCT02182557|Epinastine|epinastine|mesh-list
25123516|NCT03084380|Cyclophosphamide|cyclophosphamide|mesh-list
25123517|NCT03084380|Fludarabine|fludarabine|mesh-list
25123518|NCT03084380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25123519|NCT03084380|Immunologic Factors|immunologic factors|mesh-ancestor
25123520|NCT03084380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124143|NCT03079219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124145|NCT03079219|Dermatologic Agents|dermatologic agents|mesh-ancestor
25124146|NCT03079219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25124147|NCT03079219|Serotonin Agents|serotonin agents|mesh-ancestor
25124148|NCT03079219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25124149|NCT03079219|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25124157|NCT03079219|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25124347|NCT03077503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25124348|NCT03077503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25828942|NCT00006115|Fluorouracil|fluorouracil|mesh-list
25828943|NCT00006115|Oxaliplatin|oxaliplatin|mesh-list
25125219|NCT03070379|Anesthetics, Local|anesthetics, local|mesh-ancestor
25125220|NCT03070379|Anesthetics|anesthetics|mesh-ancestor
25125221|NCT03070379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25125222|NCT03070379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125223|NCT03070379|Sensory System Agents|sensory system agents|mesh-ancestor
25125224|NCT03070379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125225|NCT03070379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25125226|NCT03070379|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25125227|NCT03070379|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25125228|NCT03070379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25125229|NCT03070379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125231|NCT03070405|Aminosalicylic Acid|aminosalicylic acid|mesh-list
25125232|NCT03070405|Antiviral Agents|antiviral agents|mesh-ancestor
25125257|NCT03070028|Phenol|phenol|mesh-list
25125963|NCT03065569|Sensory System Agents|sensory system agents|mesh-ancestor
25125964|NCT03065569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25828944|NCT00006115|Irinotecan|irinotecan|mesh-list
25828945|NCT00006115|Calcium|calcium|mesh-list
25828946|NCT00006115|Levoleucovorin|levoleucovorin|mesh-list
25828947|NCT00006115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25828948|NCT00006115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828949|NCT00006115|Antimetabolites|antimetabolites|mesh-ancestor
25828950|NCT00006115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828951|NCT00006115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25828952|NCT00006115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828953|NCT00006115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25828954|NCT00006115|Immunologic Factors|immunologic factors|mesh-ancestor
25828955|NCT00006115|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25828956|NCT00006115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25828957|NCT00006115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828958|NCT00006115|Antidotes|antidotes|mesh-ancestor
25828959|NCT00006115|Protective Agents|protective agents|mesh-ancestor
25828960|NCT00006115|Vitamin B Complex|vitamin b complex|mesh-ancestor
25828961|NCT00006115|Vitamins|vitamins|mesh-ancestor
25828962|NCT00006115|Micronutrients|micronutrients|mesh-ancestor
24457941|NCT00335699|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24457942|NCT00335699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24457943|NCT00335699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24457944|NCT00335699|Antimetabolites|antimetabolites|mesh-ancestor
25828963|NCT00006116|Gemcitabine|gemcitabine|mesh-list
25828964|NCT00006116|Cisplatin|cisplatin|mesh-list
25828965|NCT00006116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24401890|NCT00154193|Antifungal Agents|antifungal agents|mesh-ancestor
25022340|NCT03664050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25828966|NCT00006116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25127085|NCT03058224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25127086|NCT03058224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127087|NCT03058224|Antipyretics|antipyretics|mesh-ancestor
25127088|NCT03058237|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
25127089|NCT03058237|Baclofen|baclofen|mesh-list
25828968|NCT00006116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828969|NCT00006116|Antiviral Agents|antiviral agents|mesh-ancestor
25828970|NCT00006116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25828971|NCT00006116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25828972|NCT00006116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25127567|NCT03054610|Hormones|hormones|mesh-ancestor
25828973|NCT00006116|Immunologic Factors|immunologic factors|mesh-ancestor
25128077|NCT03050827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022391|NCT03662984|Ciprofibrate|ciprofibrate|mesh-list
25128078|NCT03050827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25128079|NCT03050827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25128080|NCT03050827|Cholinergic Agents|cholinergic agents|mesh-ancestor
25128081|NCT03050827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25128082|NCT03050827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128083|NCT03050827|Urological Agents|urological agents|mesh-ancestor
25128085|NCT03050957|Antipruritics|antipruritics|mesh-ancestor
25128086|NCT03050957|Dermatologic Agents|dermatologic agents|mesh-ancestor
25128087|NCT03051009|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25128088|NCT03051009|Hemostatics|hemostatics|mesh-ancestor
25128089|NCT03051009|Coagulants|coagulants|mesh-ancestor
25128090|NCT03051009|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25128091|NCT03051009|Natriuretic Agents|natriuretic agents|mesh-ancestor
25128093|NCT03051022|Dexamethasone|dexamethasone|mesh-list
25128260|NCT03049085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25128261|NCT03049085|Analgesics|analgesics|mesh-ancestor
25128950|NCT03044080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25128951|NCT03044080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449734|NCT00316849|Temozolomide|temozolomide|mesh-list
24449735|NCT00316849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24449736|NCT00316849|Alkylating Agents|alkylating agents|mesh-ancestor
24449737|NCT00316849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449738|NCT00316849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449739|NCT00316849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24449740|NCT00316849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25129704|NCT03038776|Hemagglutinins|hemagglutinins|mesh-list
25129705|NCT03038776|Agglutinins|agglutinins|mesh-ancestor
25129706|NCT03038776|Immunologic Factors|immunologic factors|mesh-ancestor
25129707|NCT03038776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129708|NCT03038607|Aspirin|aspirin|mesh-list
25129709|NCT03038607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25129710|NCT03038607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25129711|NCT03038607|Analgesics|analgesics|mesh-ancestor
25129712|NCT03038607|Sensory System Agents|sensory system agents|mesh-ancestor
25129713|NCT03038607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25129714|NCT03038607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129715|NCT03038607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25129716|NCT03038607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25129717|NCT03038607|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25129718|NCT03038607|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25129719|NCT03038607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129720|NCT03038607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25129721|NCT03038607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25828974|NCT00006116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828975|NCT00006117|Gemcitabine|gemcitabine|mesh-list
25828976|NCT00006117|Oxaliplatin|oxaliplatin|mesh-list
25828977|NCT00006117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25828978|NCT00006117|Antimetabolites|antimetabolites|mesh-ancestor
25828979|NCT00006117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25828980|NCT00006117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828981|NCT00006117|Antiviral Agents|antiviral agents|mesh-ancestor
25828982|NCT00006117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25828983|NCT00006117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131356|NCT03026478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25131357|NCT03026478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131358|NCT03026478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25131362|NCT03026205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25828984|NCT00006117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25828985|NCT00006117|Immunologic Factors|immunologic factors|mesh-ancestor
25828986|NCT00006117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25828987|NCT00006118|Gemcitabine|gemcitabine|mesh-list
25828988|NCT00006118|Paclitaxel|paclitaxel|mesh-list
25828989|NCT00006118|Cisplatin|cisplatin|mesh-list
25828990|NCT00006118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25828991|NCT00006118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25828992|NCT00006118|Tubulin Modulators|tubulin modulators|mesh-ancestor
25828993|NCT00006118|Antimitotic Agents|antimitotic agents|mesh-ancestor
25828994|NCT00006118|Mitosis Modulators|mitosis modulators|mesh-ancestor
25828995|NCT00006118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458048|NCT00336375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24532317|NCT00639327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24917038|NCT04234594|Panitumumab|panitumumab|mesh-list
24587190|NCT00893724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587191|NCT00893724|Antioxidants|antioxidants|mesh-ancestor
24587197|NCT00893724|Expectorants|expectorants|mesh-ancestor
25828996|NCT00006118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25828997|NCT00006118|Antimetabolites|antimetabolites|mesh-ancestor
25828998|NCT00006118|Antiviral Agents|antiviral agents|mesh-ancestor
24458137|NCT00336791|Doxorubicin|doxorubicin|mesh-list
24458138|NCT00336791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25828999|NCT00006118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25829000|NCT00006118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829001|NCT00006118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25829002|NCT00006118|Immunologic Factors|immunologic factors|mesh-ancestor
25829003|NCT00006118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829004|NCT00006119|Hydroxyurea|hydroxyurea|mesh-list
25829005|NCT00006119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829006|NCT00006119|Antisickling Agents|antisickling agents|mesh-ancestor
25829007|NCT00006119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829008|NCT00006119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829009|NCT00006119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25829010|NCT00006120|Paclitaxel|paclitaxel|mesh-list
25133764|NCT03010540|Analgesics|analgesics|mesh-ancestor
25133765|NCT03010540|Sensory System Agents|sensory system agents|mesh-ancestor
25133766|NCT03010540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25133767|NCT03010540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25134046|NCT03009006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134047|NCT03009006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25134048|NCT03009006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25134049|NCT03009006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25134050|NCT03009006|Disinfectants|disinfectants|mesh-ancestor
25829011|NCT00006120|Docetaxel|docetaxel|mesh-list
25829012|NCT00006120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25829013|NCT00006120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829014|NCT00006120|Tubulin Modulators|tubulin modulators|mesh-ancestor
25829015|NCT00006120|Antimitotic Agents|antimitotic agents|mesh-ancestor
25829016|NCT00006120|Mitosis Modulators|mitosis modulators|mesh-ancestor
25829017|NCT00006120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108495|NCT03131700|Growth Substances|growth substances|mesh-ancestor
25829018|NCT00006121|Oxaliplatin|oxaliplatin|mesh-list
25829019|NCT00006121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829020|NCT00006122|Cytarabine|cytarabine|mesh-list
25829021|NCT00006122|Etoposide|etoposide|mesh-list
25166611|NCT03850301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24484000|NCT00446069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25829022|NCT00006122|Mitoxantrone|mitoxantrone|mesh-list
25829023|NCT00006122|Idarubicin|idarubicin|mesh-list
25829024|NCT00006122|Gemtuzumab|gemtuzumab|mesh-list
25829025|NCT00006122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24532830|NCT00641212|Autonomic Agents|autonomic agents|mesh-ancestor
25829026|NCT00006122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829027|NCT00006122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25829028|NCT00006122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25829029|NCT00006122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829030|NCT00006122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829031|NCT00006122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25829032|NCT00006122|Antimetabolites|antimetabolites|mesh-ancestor
25829033|NCT00006122|Antiviral Agents|antiviral agents|mesh-ancestor
25829034|NCT00006122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25829035|NCT00006122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25829036|NCT00006122|Immunologic Factors|immunologic factors|mesh-ancestor
25022482|NCT03662412|Sirolimus|sirolimus|mesh-list
25829037|NCT00006122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829038|NCT00006122|Analgesics|analgesics|mesh-ancestor
25829039|NCT00006122|Sensory System Agents|sensory system agents|mesh-ancestor
25829040|NCT00006122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25829041|NCT00006122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25829042|NCT00006122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25829043|NCT00006123|Cyclophosphamide|cyclophosphamide|mesh-list
25829044|NCT00006123|Thiotepa|thiotepa|mesh-list
25829045|NCT00006123|Carmustine|carmustine|mesh-list
25829046|NCT00006123|Cisplatin|cisplatin|mesh-list
25829047|NCT00006123|Carboplatin|carboplatin|mesh-list
24845395|NCT02237820|Prednisone|prednisone|mesh-list
25135515|NCT02998424|Propofol|propofol|mesh-list
25135516|NCT02998424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25135517|NCT02998424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25135518|NCT02998424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135519|NCT02998424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25135520|NCT02998424|Anesthetics, General|anesthetics, general|mesh-ancestor
25135521|NCT02998424|Anesthetics|anesthetics|mesh-ancestor
24458172|NCT00336882|GABA Modulators|gaba modulators|mesh-ancestor
24458173|NCT00336882|GABA Agents|gaba agents|mesh-ancestor
24458174|NCT00336882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25022564|NCT03661775|Sensory System Agents|sensory system agents|mesh-ancestor
25022565|NCT03661775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25829048|NCT00006123|Trastuzumab|trastuzumab|mesh-list
25829049|NCT00006123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25829050|NCT00006123|Immunologic Factors|immunologic factors|mesh-ancestor
25135913|NCT02994953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25135914|NCT02994953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25135915|NCT02994953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829051|NCT00006123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829052|NCT00006123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24458175|NCT00336882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458176|NCT00336921|Alfuzosin|alfuzosin|mesh-list
24458177|NCT00336921|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25829053|NCT00006123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25829054|NCT00006123|Alkylating Agents|alkylating agents|mesh-ancestor
25829055|NCT00006123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137177|NCT02986451|Hormones|hormones|mesh-ancestor
25137195|NCT02986607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137196|NCT02986334|Naproxen|naproxen|mesh-list
25137197|NCT02986334|Omeprazole|omeprazole|mesh-list
25137198|NCT02986334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25137199|NCT02986334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25137200|NCT02986334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24979194|NCT05142735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24979195|NCT05142735|Expectorants|expectorants|mesh-ancestor
24979196|NCT05142735|Respiratory System Agents|respiratory system agents|mesh-ancestor
24979197|NCT05142735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24979198|NCT05142735|Antioxidants|antioxidants|mesh-ancestor
24979199|NCT05142735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979200|NCT05142735|Protective Agents|protective agents|mesh-ancestor
24979201|NCT05142735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979202|NCT05142735|Antidotes|antidotes|mesh-ancestor
24979203|NCT05140694|Empagliflozin|empagliflozin|mesh-list
24979204|NCT05140694|Dulaglutide|dulaglutide|mesh-list
25137201|NCT02986334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25137202|NCT02986334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137203|NCT02986334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25137204|NCT02986334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25137207|NCT02986334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25137208|NCT02986334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137209|NCT02986334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25137210|NCT02986334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25137211|NCT02986334|Gout Suppressants|gout suppressants|mesh-ancestor
25137212|NCT02986334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25137247|NCT02985736|Desoximetasone|desoximetasone|mesh-list
25137538|NCT02984865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25137539|NCT02984865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25137540|NCT02984865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25138024|NCT02981030|Luteolytic Agents|luteolytic agents|mesh-ancestor
25829056|NCT00006123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829057|NCT00006123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25829058|NCT00006123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24726920|NCT01606878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138025|NCT02981030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25138026|NCT02981030|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25046230|NCT00863369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25829059|NCT00006124|Celecoxib|celecoxib|mesh-list
25829060|NCT00006124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25829061|NCT00006124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25829062|NCT00006124|Analgesics|analgesics|mesh-ancestor
25829063|NCT00006124|Sensory System Agents|sensory system agents|mesh-ancestor
25829064|NCT00006124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25829065|NCT00006124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829066|NCT00006124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25829067|NCT00006124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25829068|NCT00006124|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25829069|NCT00006124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25829070|NCT00006124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829071|NCT00006124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533093|NCT00642226|Hormones|hormones|mesh-ancestor
24533094|NCT00642226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24533095|NCT00642226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533096|NCT00642252|Fluorides|fluorides|mesh-list
24533097|NCT00642252|Cariostatic Agents|cariostatic agents|mesh-ancestor
24533098|NCT00642252|Protective Agents|protective agents|mesh-ancestor
24533099|NCT00642252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829072|NCT00006125|Doxorubicin|doxorubicin|mesh-list
25829073|NCT00006125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25829074|NCT00006125|Topotecan|topotecan|mesh-list
25829075|NCT00006125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25829076|NCT00006125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829077|NCT00006125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25829078|NCT00006125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25829079|NCT00006125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829080|NCT00006125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138027|NCT02980809|Apatinib|apatinib|mesh-list
25138222|NCT02979665|Ranibizumab|ranibizumab|mesh-list
25138292|NCT02979392|Mitosis Modulators|mitosis modulators|mesh-ancestor
25138293|NCT02979392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138294|NCT02979223|Ascorbic Acid|ascorbic acid|mesh-list
25138295|NCT02979223|Picosulfate sodium|picosulfate sodium|mesh-list
25138296|NCT02979223|Magnesium citrate|magnesium citrate|mesh-list
25138297|NCT02979223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138298|NCT02979223|Antioxidants|antioxidants|mesh-ancestor
25138299|NCT02979223|Protective Agents|protective agents|mesh-ancestor
25138300|NCT02979223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138302|NCT02979223|Micronutrients|micronutrients|mesh-ancestor
25138303|NCT02979223|Cathartics|cathartics|mesh-ancestor
25138673|NCT02975986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138674|NCT02975999|Vasopressins|vasopressins|mesh-list
25138675|NCT02975999|Arginine Vasopressin|arginine vasopressin|mesh-list
25138676|NCT02975999|Hemostatics|hemostatics|mesh-ancestor
25138677|NCT02975999|Coagulants|coagulants|mesh-ancestor
25138678|NCT02975999|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25138679|NCT02975999|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25138680|NCT02975999|Natriuretic Agents|natriuretic agents|mesh-ancestor
25138681|NCT02975999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458225|NCT00337090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139519|NCT02970643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25139795|NCT02968693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25139796|NCT02968693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139799|NCT02968693|Vasodilator Agents|vasodilator agents|mesh-ancestor
25139800|NCT02968693|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25139801|NCT02968693|Protective Agents|protective agents|mesh-ancestor
25139803|NCT02968719|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25139804|NCT02968719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25139805|NCT02968719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139806|NCT02968719|Cholinergic Agents|cholinergic agents|mesh-ancestor
25139807|NCT02968719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25829081|NCT00006125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25140354|NCT02965248|Vitamins|vitamins|mesh-ancestor
25140574|NCT02963116|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25140575|NCT02963116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25650114|NCT01499199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829082|NCT00006126|Cyclophosphamide|cyclophosphamide|mesh-list
25829083|NCT00006126|Busulfan|busulfan|mesh-list
25829084|NCT00006126|Fludarabine|fludarabine|mesh-list
25140576|NCT02963116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25140577|NCT02963116|Antimetabolites|antimetabolites|mesh-ancestor
25140578|NCT02963116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140579|NCT02963116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25140580|NCT02963116|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25140921|NCT02961361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25140922|NCT02961361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141028|NCT02960113|Antiemetics|antiemetics|mesh-ancestor
25141104|NCT02959749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022721|NCT03660293|Captopril|captopril|mesh-list
25141105|NCT02959749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25141106|NCT02959749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25141107|NCT02959658|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25141108|NCT02959658|Dermatologic Agents|dermatologic agents|mesh-ancestor
25141109|NCT02959658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25141110|NCT02959658|Immunologic Factors|immunologic factors|mesh-ancestor
25141111|NCT02959658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141112|NCT02959554|Nivolumab|nivolumab|mesh-list
25141113|NCT02959554|Sunitinib|sunitinib|mesh-list
25142810|NCT02946970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25142811|NCT02946970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25142812|NCT02946970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25143033|NCT02945241|Cystatins|cystatins|mesh-list
25143034|NCT02945241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25143035|NCT02945241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25143036|NCT02945241|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25143037|NCT02945241|Protease Inhibitors|protease inhibitors|mesh-ancestor
25143038|NCT02945241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143039|NCT02945241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143040|NCT02945163|Tenofovir|tenofovir|mesh-list
25143041|NCT02945163|Lamivudine|lamivudine|mesh-list
25143042|NCT02945163|Efavirenz|efavirenz|mesh-list
25143043|NCT02945163|Antiviral Agents|antiviral agents|mesh-ancestor
25143044|NCT02945163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25143045|NCT02945163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25143063|NCT02945072|Sevoflurane|sevoflurane|mesh-list
25143154|NCT02944292|Propofol|propofol|mesh-list
25143335|NCT02943369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25143336|NCT02943369|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25143337|NCT02943369|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25143338|NCT02943369|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25143339|NCT02943369|Purinergic Agents|purinergic agents|mesh-ancestor
25143340|NCT02943369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25143341|NCT02943369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143501|NCT02942329|Apatinib|apatinib|mesh-list
25143565|NCT02941562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144038|NCT02939300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829085|NCT00006126|Fludarabine phosphate|fludarabine phosphate|mesh-list
25829086|NCT00006126|Etoposide|etoposide|mesh-list
24458240|NCT00337246|Alkylating Agents|alkylating agents|mesh-ancestor
25829087|NCT00006126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25829088|NCT00006126|Immunologic Factors|immunologic factors|mesh-ancestor
25108514|NCT03131973|Leucovorin|leucovorin|mesh-list
24458243|NCT00337246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24458244|NCT00337246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24458245|NCT00337246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24458247|NCT00337246|Analgesics|analgesics|mesh-ancestor
24533254|NCT00642798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24533256|NCT00642798|Protease Inhibitors|protease inhibitors|mesh-ancestor
24533257|NCT00642798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533258|NCT00642798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533259|NCT00642824|Bevacizumab|bevacizumab|mesh-list
25829089|NCT00006126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829090|NCT00006126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25829091|NCT00006126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25829092|NCT00006126|Alkylating Agents|alkylating agents|mesh-ancestor
25829093|NCT00006126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829094|NCT00006126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829095|NCT00006126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25829096|NCT00006126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25829097|NCT00006126|Antimetabolites|antimetabolites|mesh-ancestor
25829098|NCT00006126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25829099|NCT00006126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25829100|NCT00006126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25829101|NCT00006126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829102|NCT00006127|Amifostine|amifostine|mesh-list
25829103|NCT00006127|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25829104|NCT00006127|Protective Agents|protective agents|mesh-ancestor
25829105|NCT00006127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829106|NCT00006129|Testosterone|testosterone|mesh-list
25829107|NCT00006129|Androgens|androgens|mesh-ancestor
25145150|NCT02932020|Sensory System Agents|sensory system agents|mesh-ancestor
25145151|NCT02932020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25145152|NCT02932020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25145153|NCT02932020|Antiemetics|antiemetics|mesh-ancestor
25145154|NCT02932020|Autonomic Agents|autonomic agents|mesh-ancestor
25829108|NCT00006129|Hormones|hormones|mesh-ancestor
25829109|NCT00006129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25829110|NCT00006129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829111|NCT00006131|Valacyclovir|valacyclovir|mesh-list
25829112|NCT00006131|Antiviral Agents|antiviral agents|mesh-ancestor
25829113|NCT00006131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25022801|NCT03659162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25022810|NCT03659084|Deferasirox|deferasirox|mesh-list
25829114|NCT00006132|Acyclovir|acyclovir|mesh-list
25829115|NCT00006132|Antiviral Agents|antiviral agents|mesh-ancestor
24449972|NCT00317499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25829116|NCT00006132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25829117|NCT00006133|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25829118|NCT00006133|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25829119|NCT00006133|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25829120|NCT00006133|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25829121|NCT00006133|Medroxyprogesterone|medroxyprogesterone|mesh-list
24449973|NCT00317499|Immunologic Factors|immunologic factors|mesh-ancestor
24449975|NCT00317512|HBOC 201|hboc 201|mesh-list
25829122|NCT00006133|Norethindrone|norethindrone|mesh-list
24861958|NCT02321501|Everolimus|everolimus|mesh-list
25145778|NCT02927353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25145779|NCT02927444|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25145780|NCT02927444|Immunologic Factors|immunologic factors|mesh-ancestor
25829123|NCT00006133|Norethindrone Acetate|norethindrone acetate|mesh-list
25145918|NCT02925975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25146190|NCT02923687|Sensory System Agents|sensory system agents|mesh-ancestor
25022841|NCT03658850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022842|NCT03658785|Aldesleukin|aldesleukin|mesh-list
25022843|NCT03658785|Cyclophosphamide|cyclophosphamide|mesh-list
25146191|NCT02923687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25146192|NCT02923687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146193|NCT02923687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25146194|NCT02923687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25146195|NCT02923687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25146196|NCT02923687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146197|NCT02923687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146198|NCT02923557|Pirarubicin|pirarubicin|mesh-list
25146199|NCT02923557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813424|NCT02058446|Vasodilator Agents|vasodilator agents|mesh-ancestor
24813938|NCT02061267|Vitamin B Complex|vitamin b complex|mesh-ancestor
25147098|NCT02916602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25147099|NCT02916602|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25147100|NCT02916602|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25147102|NCT02916602|Natriuretic Agents|natriuretic agents|mesh-ancestor
25147103|NCT02916602|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24686607|NCT04682626|Cholecalciferol|cholecalciferol|mesh-list
25147726|NCT02911480|Oxytocin|oxytocin|mesh-list
25147727|NCT02911480|Oxytocics|oxytocics|mesh-ancestor
24546095|NCT00696722|Protease Inhibitors|protease inhibitors|mesh-ancestor
25148086|NCT05312398|Irinotecan|irinotecan|mesh-list
25148221|NCT05311085|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25148222|NCT05311085|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25829124|NCT00006133|Estradiol|estradiol|mesh-list
25829125|NCT00006133|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25829126|NCT00006133|Estrogens|estrogens|mesh-ancestor
25829127|NCT00006133|Hormones|hormones|mesh-ancestor
25829128|NCT00006133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25829129|NCT00006133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829130|NCT00006133|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25829131|NCT00006133|Contraceptive Agents|contraceptive agents|mesh-ancestor
25829132|NCT00006133|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25829133|NCT00006133|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25829134|NCT00006133|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25829135|NCT00006133|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24616712|NCT01038882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24616713|NCT01038882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24942262|NCT03982849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942263|NCT03982849|Protective Agents|protective agents|mesh-ancestor
24942264|NCT03982849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829136|NCT00006133|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25829137|NCT00006133|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25829138|NCT00006133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25829139|NCT00006133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829140|NCT00006135|Acyclovir|acyclovir|mesh-list
25829141|NCT00006135|Antiviral Agents|antiviral agents|mesh-ancestor
25022904|NCT03658733|Antacids|antacids|mesh-ancestor
25829142|NCT00006135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25829143|NCT00006136|Arginine butyrate|arginine butyrate|mesh-list
25829144|NCT00006136|Epoetin Alfa|epoetin alfa|mesh-list
25829145|NCT00006136|Hematinics|hematinics|mesh-ancestor
25829146|NCT00006136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829147|NCT00006137|Enalapril|enalapril|mesh-list
25829148|NCT00006137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25829149|NCT00006137|Protease Inhibitors|protease inhibitors|mesh-ancestor
25149114|NCT04019379|Calcium|calcium|mesh-list
25149235|NCT03694262|Bevacizumab|bevacizumab|mesh-list
25149310|NCT02955797|Vaccines|vaccines|mesh-list
25149311|NCT02955797|Immunologic Factors|immunologic factors|mesh-ancestor
25149312|NCT02955797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149313|NCT02884908|Pregabalin|pregabalin|mesh-list
25149314|NCT02884908|Analgesics|analgesics|mesh-ancestor
25149315|NCT02884908|Sensory System Agents|sensory system agents|mesh-ancestor
25149316|NCT02884908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25149317|NCT02884908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149318|NCT02884908|Anticonvulsants|anticonvulsants|mesh-ancestor
25149319|NCT02884908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25149320|NCT02884908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25149321|NCT02884908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149322|NCT02884908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25149323|NCT02884908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25149324|NCT02884908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25149325|NCT02884908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25149326|NCT02884908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25048283|NCT00717457|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25829150|NCT00006137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829151|NCT00006137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829152|NCT00006137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25829153|NCT00006144|Ritonavir|ritonavir|mesh-list
25829154|NCT00006144|Lopinavir|lopinavir|mesh-list
25829155|NCT00006144|Emtricitabine|emtricitabine|mesh-list
25829156|NCT00006144|Stavudine|stavudine|mesh-list
25149328|NCT02867813|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25149329|NCT02867813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25149330|NCT02867813|Antimetabolites|antimetabolites|mesh-ancestor
25149658|NCT05466279|Midazolam|midazolam|mesh-list
25149835|NCT05442268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25150539|NCT05177146|Ketamine|ketamine|mesh-list
25151209|NCT04828694|Naltrexone|naltrexone|mesh-list
25151365|NCT04734678|Infliximab|infliximab|mesh-list
25152754|NCT03809481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25152893|NCT03748810|Protease Inhibitors|protease inhibitors|mesh-ancestor
25153143|NCT03465787|Adrenergic Agents|adrenergic agents|mesh-ancestor
25153260|NCT03358693|Upadacitinib|upadacitinib|mesh-list
25040628|NCT02989597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25040657|NCT02978456|Immunologic Factors|immunologic factors|mesh-ancestor
25040658|NCT02978456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040659|NCT02975271|Serlopitant|serlopitant|mesh-list
25040660|NCT02975271|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25040661|NCT02975271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25040662|NCT02975271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040663|NCT02975271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039895|NCT03611751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548631|NCT00710788|Chelating Agents|chelating agents|mesh-ancestor
24589209|NCT00906126|Abortifacient Agents|abortifacient agents|mesh-ancestor
25650115|NCT01499199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25650116|NCT01499199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25650117|NCT01499199|Antiviral Agents|antiviral agents|mesh-ancestor
25650118|NCT01499199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25650119|NCT01499277|Vancomycin|vancomycin|mesh-list
25650120|NCT01499277|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
25650121|NCT01499277|Aztreonam|aztreonam|mesh-list
25041034|NCT02677298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25041213|NCT02606305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041214|NCT02606305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25041216|NCT02606305|Antimitotic Agents|antimitotic agents|mesh-ancestor
25041217|NCT02606305|Mitosis Modulators|mitosis modulators|mesh-ancestor
25041219|NCT02602353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25041220|NCT02602353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25041221|NCT02602353|Analgesics|analgesics|mesh-ancestor
25041222|NCT02602353|Sensory System Agents|sensory system agents|mesh-ancestor
24997803|NCT04326439|Cytarabine|cytarabine|mesh-list
25041223|NCT02602353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25041224|NCT02602353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041226|NCT02602353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25041227|NCT02598960|Nivolumab|nivolumab|mesh-list
25041459|NCT02521285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25041505|NCT02511886|GABA Agents|gaba agents|mesh-ancestor
25041506|NCT02511886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25041507|NCT02511886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041508|NCT02510599|Solithromycin|solithromycin|mesh-list
25041509|NCT02510599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25041510|NCT02510599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25041511|NCT02509845|Anti-Infective Agents|anti-infective agents|mesh-list
25041512|NCT02509845|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25041513|NCT02508038|Zoledronic Acid|zoledronic acid|mesh-list
25041514|NCT02508038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25041603|NCT01619332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041604|NCT01619332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041605|NCT01616524|Interferons|interferons|mesh-list
25041642|NCT01607294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041643|NCT01607294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25041644|NCT01607294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041778|NCT01582347|Naloxone|naloxone|mesh-list
25023079|NCT03657758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25023083|NCT03657602|Levonorgestrel|levonorgestrel|mesh-list
25023084|NCT03657602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25023085|NCT03657602|Contraceptive Agents|contraceptive agents|mesh-ancestor
25023086|NCT03657602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25023091|NCT03657550|Niacin|niacin|mesh-list
25041779|NCT01582347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25041780|NCT01582347|Narcotics|narcotics|mesh-ancestor
25041781|NCT01582347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25041782|NCT01582347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041819|NCT01581177|Adrenergic Agents|adrenergic agents|mesh-ancestor
25041820|NCT01581177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25041821|NCT01581177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041822|NCT01581138|Ribavirin|ribavirin|mesh-list
25041823|NCT01581138|Antimetabolites|antimetabolites|mesh-ancestor
25041824|NCT01581138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041825|NCT01581138|Antiviral Agents|antiviral agents|mesh-ancestor
25041826|NCT01581138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25041827|NCT01580696|Molgramostim|molgramostim|mesh-list
24979806|NCT05241054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24979807|NCT05241054|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24979808|NCT05241054|Vasodilator Agents|vasodilator agents|mesh-ancestor
24979811|NCT05241054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25041828|NCT01580696|Vaccines|vaccines|mesh-list
25041829|NCT01580696|Sargramostim|sargramostim|mesh-list
25041830|NCT01580696|Immunologic Factors|immunologic factors|mesh-ancestor
24814939|NCT02067416|Mitosis Modulators|mitosis modulators|mesh-ancestor
25041868|NCT01573351|Immunologic Factors|immunologic factors|mesh-ancestor
25041869|NCT01573351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039897|NCT03611751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25041917|NCT01555554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25041918|NCT01555554|Adrenergic Agents|adrenergic agents|mesh-ancestor
25041919|NCT01555554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25041920|NCT01555554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041921|NCT01555554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041922|NCT01555554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25041923|NCT01555554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25041924|NCT01555554|Vasodilator Agents|vasodilator agents|mesh-ancestor
25041925|NCT01554696|Methotrexate|methotrexate|mesh-list
25041926|NCT01554696|Peficitinib|peficitinib|mesh-list
24998672|NCT02232087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24998673|NCT02232087|Sympathomimetics|sympathomimetics|mesh-ancestor
25042034|NCT01516203|Pyrazinamide|pyrazinamide|mesh-list
25042036|NCT01516203|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25042087|NCT01510119|Everolimus|everolimus|mesh-list
25042088|NCT01510119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042089|NCT01510119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25042090|NCT01510119|Immunologic Factors|immunologic factors|mesh-ancestor
25042091|NCT01510119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042092|NCT01510119|Antimalarials|antimalarials|mesh-ancestor
25042093|NCT01510119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25042094|NCT01510119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25042095|NCT01510119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042096|NCT01510119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998404|NCT02960646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042124|NCT01499563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25042125|NCT01499563|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25042126|NCT01499563|Dopamine Agents|dopamine agents|mesh-ancestor
25042127|NCT01498328|Bevacizumab|bevacizumab|mesh-list
25042128|NCT01498328|Rindopepimut|rindopepimut|mesh-list
25042129|NCT01498328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25042130|NCT01498328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042131|NCT01498328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25042132|NCT01498328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25042133|NCT01498328|Growth Substances|growth substances|mesh-ancestor
25023212|NCT03656666|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24979894|NCT04984083|Coagulants|coagulants|mesh-ancestor
25042141|NCT01497704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042142|NCT01497704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24941811|NCT03987893|Laxatives|laxatives|mesh-ancestor
25042170|NCT01493505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25042172|NCT01493505|Tubulin Modulators|tubulin modulators|mesh-ancestor
25042173|NCT01493505|Antimitotic Agents|antimitotic agents|mesh-ancestor
25042174|NCT01493505|Mitosis Modulators|mitosis modulators|mesh-ancestor
25042175|NCT01493505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042176|NCT01493505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25042177|NCT01493505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25042178|NCT01493505|Growth Substances|growth substances|mesh-ancestor
25042179|NCT01493505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042180|NCT01493505|Growth Inhibitors|growth inhibitors|mesh-ancestor
25042181|NCT01489046|Tenofovir|tenofovir|mesh-list
25042182|NCT01489046|Lamivudine|lamivudine|mesh-list
25023240|NCT03656614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023241|NCT03656588|Iodine|iodine|mesh-list
25023242|NCT03656588|Chlorhexidine|chlorhexidine|mesh-list
25042183|NCT01489046|Efavirenz|efavirenz|mesh-list
25042184|NCT01489046|Antiviral Agents|antiviral agents|mesh-ancestor
25042185|NCT01489046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042186|NCT01489046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25042187|NCT01489046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25042188|NCT01489046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25042189|NCT01489046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042190|NCT01489046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25058386|NCT03497364|Bupivacaine|bupivacaine|mesh-list
25042235|NCT01482403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042237|NCT01482403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042238|NCT01482403|Antimetabolites|antimetabolites|mesh-ancestor
25042239|NCT01482403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042240|NCT01482390|Ribavirin|ribavirin|mesh-list
25042241|NCT01482390|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25042242|NCT01482390|Antimetabolites|antimetabolites|mesh-ancestor
25042311|NCT01470131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042312|NCT01470131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25042313|NCT01470131|Glucocorticoids|glucocorticoids|mesh-ancestor
25042315|NCT01470131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25042316|NCT01470131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25042317|NCT01470131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042318|NCT01466374|Antibodies|antibodies|mesh-list
25042319|NCT01466374|Immunoglobulins|immunoglobulins|mesh-list
25042320|NCT01466374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25042321|NCT01466374|Immunologic Factors|immunologic factors|mesh-ancestor
25042322|NCT01466374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042323|NCT01466088|Donepezil|donepezil|mesh-list
25042324|NCT01466088|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25042325|NCT01466088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25042326|NCT01466088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042327|NCT01466088|Cholinergic Agents|cholinergic agents|mesh-ancestor
25042329|NCT01466088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042330|NCT01466088|Nootropic Agents|nootropic agents|mesh-ancestor
25042331|NCT01464437|Metformin|metformin|mesh-list
25042332|NCT01464437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25042333|NCT01464437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042334|NCT01461317|Etrolizumab|etrolizumab|mesh-list
25042335|NCT01461317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25042336|NCT01461317|Immunologic Factors|immunologic factors|mesh-ancestor
25042337|NCT01461317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042338|NCT01460511|Epinephrine|epinephrine|mesh-list
24998937|NCT05421897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998938|NCT05421858|Fluconazole|fluconazole|mesh-list
24998939|NCT05421858|Caspofungin|caspofungin|mesh-list
25042383|NCT01455857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25042384|NCT01455857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042385|NCT01455857|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25042386|NCT01455857|Incretins|incretins|mesh-ancestor
25042387|NCT01455857|Hormones|hormones|mesh-ancestor
25039898|NCT03608397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25042513|NCT01425970|Antimetabolites|antimetabolites|mesh-ancestor
25042514|NCT01425970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042515|NCT01425970|Immunologic Factors|immunologic factors|mesh-ancestor
25042516|NCT01425970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042517|NCT01423149|Fosbretabulin|fosbretabulin|mesh-list
25042518|NCT01423149|Combretastatin|combretastatin|mesh-list
25042519|NCT01423149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25042520|NCT01423149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042521|NCT01423149|Tubulin Modulators|tubulin modulators|mesh-ancestor
25042522|NCT01423149|Antimitotic Agents|antimitotic agents|mesh-ancestor
25042523|NCT01423149|Mitosis Modulators|mitosis modulators|mesh-ancestor
25042524|NCT01423149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039899|NCT03608397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25042622|NCT01408082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25042623|NCT01408082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042624|NCT01408082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25042625|NCT01408082|Glucocorticoids|glucocorticoids|mesh-ancestor
25042627|NCT01408082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25042660|NCT01399684|Immunologic Factors|immunologic factors|mesh-ancestor
25042661|NCT01399684|Antidotes|antidotes|mesh-ancestor
25042662|NCT01399684|Protective Agents|protective agents|mesh-ancestor
25042663|NCT01399684|Vitamin B Complex|vitamin b complex|mesh-ancestor
25042664|NCT01399684|Vitamins|vitamins|mesh-ancestor
25042665|NCT01399684|Micronutrients|micronutrients|mesh-ancestor
25042666|NCT01399684|Hematinics|hematinics|mesh-ancestor
25042667|NCT01399580|Atrasentan|atrasentan|mesh-list
25042668|NCT01399580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042669|NCT01399580|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25042670|NCT01399580|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24589368|NCT00907036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24589371|NCT00907114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24589372|NCT00907114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24589373|NCT00907114|Analgesics|analgesics|mesh-ancestor
24589374|NCT00907114|Sensory System Agents|sensory system agents|mesh-ancestor
24589375|NCT00907114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24589376|NCT00907114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589377|NCT00907114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25042722|NCT01379209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042723|NCT01379209|Dermatologic Agents|dermatologic agents|mesh-ancestor
25042725|NCT01379209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25042726|NCT01379209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25042727|NCT01379209|Immunologic Factors|immunologic factors|mesh-ancestor
25042728|NCT01379209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25042729|NCT01379209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25042730|NCT01379209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25042731|NCT01379209|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25042732|NCT01379209|Antitubercular Agents|antitubercular agents|mesh-ancestor
25042757|NCT01373086|Hormone Antagonists|hormone antagonists|mesh-ancestor
25042758|NCT01373086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25042759|NCT01373086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042760|NCT01373086|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25042761|NCT01373086|Diuretics|diuretics|mesh-ancestor
25042762|NCT01373086|Natriuretic Agents|natriuretic agents|mesh-ancestor
25042763|NCT01373086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25042764|NCT01372475|Hyaluronic Acid|hyaluronic acid|mesh-list
25023344|NCT03655847|Dexmedetomidine|dexmedetomidine|mesh-list
25042765|NCT01372475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24937241|NCT04031703|Carboplatin|carboplatin|mesh-list
25042766|NCT01372475|Immunologic Factors|immunologic factors|mesh-ancestor
25042767|NCT01372475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042768|NCT01372475|Viscosupplements|viscosupplements|mesh-ancestor
25042817|NCT01365195|Ketamine|ketamine|mesh-list
25042818|NCT01365195|Analgesics|analgesics|mesh-ancestor
25042819|NCT01365195|Sensory System Agents|sensory system agents|mesh-ancestor
25042820|NCT01365195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25042821|NCT01365195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042822|NCT01365195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25042823|NCT01365195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25042824|NCT01365195|Anesthetics, General|anesthetics, general|mesh-ancestor
25042825|NCT01365195|Anesthetics|anesthetics|mesh-ancestor
25042826|NCT01365195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25042827|NCT01365195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25042828|NCT01365195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25042829|NCT01365195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24998405|NCT02960646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25042843|NCT01360853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25042844|NCT01360853|Immunologic Factors|immunologic factors|mesh-ancestor
25042845|NCT01360853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042846|NCT01360853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24997946|NCT04098302|Dutasteride|dutasteride|mesh-list
25042849|NCT01359566|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25042850|NCT01359566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042870|NCT01357642|Racepinephrine|racepinephrine|mesh-list
25042871|NCT01357642|Epinephryl borate|epinephryl borate|mesh-list
25042872|NCT01357642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25042873|NCT01357642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25042874|NCT01357642|Adrenergic Agents|adrenergic agents|mesh-ancestor
25042875|NCT01357642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25042876|NCT01357642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042877|NCT01357642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042878|NCT01357642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25042879|NCT01357642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24985207|NCT03578081|Hormones|hormones|mesh-ancestor
25042880|NCT01357642|Autonomic Agents|autonomic agents|mesh-ancestor
25042881|NCT01357642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25042882|NCT01357642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25042883|NCT01357642|Respiratory System Agents|respiratory system agents|mesh-ancestor
25042884|NCT01357642|Mydriatics|mydriatics|mesh-ancestor
25042885|NCT01357642|Sympathomimetics|sympathomimetics|mesh-ancestor
25042886|NCT01357642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25042887|NCT01356849|Atrasentan|atrasentan|mesh-list
25042888|NCT01356849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042889|NCT01356849|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25042890|NCT01356849|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25042891|NCT01356849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042892|NCT01356160|Ribavirin|ribavirin|mesh-list
25042893|NCT01356160|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25042894|NCT01356160|Ledipasvir|ledipasvir|mesh-list
24980147|NCT05441410|Antiviral Agents|antiviral agents|mesh-ancestor
24980148|NCT05441410|Schistosomicides|schistosomicides|mesh-ancestor
25042963|NCT01345045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999551|NCT04052334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24999552|NCT04052334|Alkylating Agents|alkylating agents|mesh-ancestor
24999553|NCT04052334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999555|NCT04052334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24999556|NCT04052334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24999557|NCT04052334|Analgesics|analgesics|mesh-ancestor
24999558|NCT04052334|Sensory System Agents|sensory system agents|mesh-ancestor
24587531|NCT00895544|Vaccines|vaccines|mesh-list
24587532|NCT00895544|Immunologic Factors|immunologic factors|mesh-ancestor
25023438|NCT03654612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24999559|NCT04052334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24828761|NCT02147548|Anticonvulsants|anticonvulsants|mesh-ancestor
24589400|NCT00907179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24589401|NCT00907270|Cholecalciferol|cholecalciferol|mesh-list
24589402|NCT00907270|Vitamin D|vitamin d|mesh-list
24589403|NCT00907270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24589404|NCT00907270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589405|NCT00907270|Vitamins|vitamins|mesh-ancestor
25043054|NCT01332812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25043055|NCT01332812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25043200|NCT01309932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043202|NCT01309932|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25043203|NCT01309932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25043204|NCT01309932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25043205|NCT01303783|Candesartan|candesartan|mesh-list
25043206|NCT01303783|Candesartan cilexetil|candesartan cilexetil|mesh-list
25043207|NCT01303783|Nifedipine|nifedipine|mesh-list
25043208|NCT01303783|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25043237|NCT01300208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043239|NCT01298687|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25043240|NCT01298687|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25043241|NCT01298687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25043242|NCT01297543|Lenograstim|lenograstim|mesh-list
25043243|NCT01297543|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25043244|NCT01297543|Immunologic Factors|immunologic factors|mesh-ancestor
25043245|NCT01297543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043246|NCT01295060|Octreotide|octreotide|mesh-list
25043271|NCT01281254|Trebananib|trebananib|mesh-list
25043272|NCT01281254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25023440|NCT03654365|Caffeine|caffeine|mesh-list
25043273|NCT01281254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25043274|NCT01281254|Growth Substances|growth substances|mesh-ancestor
25043275|NCT01281254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043345|NCT01272791|Bavituximab|bavituximab|mesh-list
25043346|NCT01272791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25043347|NCT01272791|Antimetabolites|antimetabolites|mesh-ancestor
25043348|NCT01272791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043349|NCT01272791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043350|NCT01272791|Antiviral Agents|antiviral agents|mesh-ancestor
25043373|NCT01270347|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25043374|NCT01270347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25043376|NCT01270347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25043377|NCT01270347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25043378|NCT01270347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25043379|NCT01270347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043380|NCT01270347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043381|NCT01270347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043382|NCT01270347|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25043383|NCT01270347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25043384|NCT01269658|Azithromycin|azithromycin|mesh-list
25043385|NCT01269658|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25043386|NCT01269658|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25043387|NCT01269658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25043388|NCT01269658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25043389|NCT01266525|Donepezil|donepezil|mesh-list
25043390|NCT01266525|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25043391|NCT01266525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998406|NCT02960646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25043429|NCT01261312|Azacitidine|azacitidine|mesh-list
25043430|NCT01261312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043431|NCT01261312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25043432|NCT01261312|Antimetabolites|antimetabolites|mesh-ancestor
24877122|NCT02935205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25043454|NCT01256762|Antimitotic Agents|antimitotic agents|mesh-ancestor
25043455|NCT01256762|Mitosis Modulators|mitosis modulators|mesh-ancestor
24937818|NCT04025203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937819|NCT04025203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24937820|NCT04025203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24731453|NCT01634789|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24731454|NCT01634789|Hormones|hormones|mesh-ancestor
24731455|NCT01634789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25043456|NCT01256762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043457|NCT01256762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25043458|NCT01256762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25023547|NCT03653520|Sensory System Agents|sensory system agents|mesh-ancestor
25023548|NCT03653520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25023549|NCT03653520|Anticonvulsants|anticonvulsants|mesh-ancestor
25023550|NCT03653520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25043537|NCT01242930|Motesanib diphosphate|motesanib diphosphate|mesh-list
25023551|NCT03653520|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25023552|NCT03653520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25023553|NCT03653520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25023554|NCT03653520|Anesthetics, General|anesthetics, general|mesh-ancestor
24470941|NCT00392561|Vitamin E|vitamin e|mesh-list
24470942|NCT00392561|Selenium|selenium|mesh-list
24470943|NCT00392561|Vitamins|vitamins|mesh-ancestor
24470944|NCT00392561|Micronutrients|micronutrients|mesh-ancestor
24470945|NCT00392561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470946|NCT00392561|Antioxidants|antioxidants|mesh-ancestor
24470947|NCT00392561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471184|NCT00393679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24471185|NCT00393679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24471186|NCT00393679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24471187|NCT00393679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24471188|NCT00393679|Antiviral Agents|antiviral agents|mesh-ancestor
24471273|NCT00394368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25043459|NCT01256762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25043460|NCT01256762|Growth Substances|growth substances|mesh-ancestor
25043461|NCT01256762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043462|NCT01256762|Growth Inhibitors|growth inhibitors|mesh-ancestor
25043463|NCT01256762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043464|NCT01256762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25043465|NCT01255709|Epinephrine|epinephrine|mesh-list
25043466|NCT01255709|Racepinephrine|racepinephrine|mesh-list
25043467|NCT01255709|Epinephryl borate|epinephryl borate|mesh-list
25043468|NCT01255709|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25043469|NCT01255709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25043470|NCT01255709|Adrenergic Agents|adrenergic agents|mesh-ancestor
25043471|NCT01255709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25043472|NCT01255709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043473|NCT01255709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043474|NCT01255709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25043475|NCT01255709|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25043476|NCT01255709|Autonomic Agents|autonomic agents|mesh-ancestor
25043477|NCT01255709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023555|NCT03653520|Anesthetics|anesthetics|mesh-ancestor
25023556|NCT03653520|GABA Modulators|gaba modulators|mesh-ancestor
25043478|NCT01255709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25043479|NCT01255709|Respiratory System Agents|respiratory system agents|mesh-ancestor
25043480|NCT01255709|Mydriatics|mydriatics|mesh-ancestor
25043481|NCT01255709|Sympathomimetics|sympathomimetics|mesh-ancestor
25043482|NCT01255709|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25043495|NCT01254136|Mitosis Modulators|mitosis modulators|mesh-ancestor
25043508|NCT01253603|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25043509|NCT01253603|Plant Growth Regulators|plant growth regulators|mesh-ancestor
25043510|NCT01253603|Growth Substances|growth substances|mesh-ancestor
25043511|NCT01252693|Goserelin|goserelin|mesh-list
25043512|NCT01252693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25043513|NCT01252693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043514|NCT01252628|Cetuximab|cetuximab|mesh-list
25043515|NCT01252628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25043516|NCT01252628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043518|NCT01248975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25043519|NCT01248975|Respiratory System Agents|respiratory system agents|mesh-ancestor
25043520|NCT01248975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25043521|NCT01248975|Hormone Antagonists|hormone antagonists|mesh-ancestor
24587544|NCT00895570|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25650122|NCT01499277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25650123|NCT01499277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25650124|NCT01499290|Metronidazole|metronidazole|mesh-list
25650125|NCT01499290|Meropenem|meropenem|mesh-list
25043522|NCT01248975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25650126|NCT01499290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25043523|NCT01248975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043524|NCT01248975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25043525|NCT01248975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25043526|NCT01248975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043527|NCT01243346|Crenolanib|crenolanib|mesh-list
25043528|NCT01243346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043529|NCT01243073|Imetelstat|imetelstat|mesh-list
25043530|NCT01243073|Motesanib diphosphate|motesanib diphosphate|mesh-list
25043531|NCT01243073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043532|NCT01243073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043533|NCT01243073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25023594|NCT03652896|Liver Extracts|liver extracts|mesh-list
25023595|NCT03652896|Hematinics|hematinics|mesh-ancestor
25023596|NCT03652870|Dexetimide|dexetimide|mesh-list
25023597|NCT03652870|Citalopram|citalopram|mesh-list
25043534|NCT01242930|Niacinamide|niacinamide|mesh-list
25043535|NCT01242930|Lenalidomide|lenalidomide|mesh-list
25043536|NCT01242930|Imetelstat|imetelstat|mesh-list
25043538|NCT01242930|Immunologic Factors|immunologic factors|mesh-ancestor
25043539|NCT01242930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043540|NCT01242930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25043541|NCT01242930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25043542|NCT01242930|Growth Substances|growth substances|mesh-ancestor
25043543|NCT01242930|Growth Inhibitors|growth inhibitors|mesh-ancestor
25043604|NCT01234779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043605|NCT01234779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25043608|NCT01234519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25043609|NCT01234519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043610|NCT01234519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25043611|NCT01234519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25043612|NCT01234519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043613|NCT01234519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023608|NCT03652870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25043614|NCT01234038|Paclitaxel|paclitaxel|mesh-list
25043615|NCT01234038|Carboplatin|carboplatin|mesh-list
25043616|NCT01234038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25043617|NCT01234038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043618|NCT01234038|Tubulin Modulators|tubulin modulators|mesh-ancestor
25043619|NCT01234038|Antimitotic Agents|antimitotic agents|mesh-ancestor
25043620|NCT01234038|Mitosis Modulators|mitosis modulators|mesh-ancestor
25043621|NCT01234038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043622|NCT01234025|Prednisone|prednisone|mesh-list
25043623|NCT01234025|Docetaxel|docetaxel|mesh-list
25043624|NCT01234025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043625|NCT01234025|Tubulin Modulators|tubulin modulators|mesh-ancestor
25043626|NCT01234025|Antimitotic Agents|antimitotic agents|mesh-ancestor
25043627|NCT01234025|Mitosis Modulators|mitosis modulators|mesh-ancestor
25043628|NCT01234025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043629|NCT01234025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25043684|NCT01225393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25043685|NCT01225393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023653|NCT03652571|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25043686|NCT01225393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25043687|NCT01225393|Antimetabolites|antimetabolites|mesh-ancestor
25043688|NCT01225393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043689|NCT01225393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043690|NCT01225393|Dermatologic Agents|dermatologic agents|mesh-ancestor
25043691|NCT01225393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043692|NCT01225393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25043693|NCT01225393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25043694|NCT01225393|Immunologic Factors|immunologic factors|mesh-ancestor
25043695|NCT01225393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25043696|NCT01225393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25043697|NCT01225393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25043698|NCT01225380|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25043699|NCT01225380|Interferon-alpha|interferon-alpha|mesh-list
25043701|NCT01225380|Antiviral Agents|antiviral agents|mesh-ancestor
25043702|NCT01225380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25043742|NCT01220271|Temozolomide|temozolomide|mesh-list
25043743|NCT01220271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25043744|NCT01220271|Alkylating Agents|alkylating agents|mesh-ancestor
25043745|NCT01220271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043746|NCT01220271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043748|NCT01207115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25043749|NCT01207115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25043750|NCT01207115|Analgesics|analgesics|mesh-ancestor
25043751|NCT01207115|Sensory System Agents|sensory system agents|mesh-ancestor
25043752|NCT01207115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24938027|NCT04022837|Pantoprazole|pantoprazole|mesh-list
25043753|NCT01207115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043754|NCT01207115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25043755|NCT01207115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25023725|NCT03652233|Afatinib|afatinib|mesh-list
25043756|NCT01207115|Gout Suppressants|gout suppressants|mesh-ancestor
25043757|NCT01207115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25043758|NCT01207115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043759|NCT01207115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043761|NCT01205061|Anesthetics, Local|anesthetics, local|mesh-ancestor
25043853|NCT01193361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043855|NCT01193140|Veliparib|veliparib|mesh-list
25043858|NCT01193140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043860|NCT01193140|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25043861|NCT01193140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043862|NCT01192880|Antipsychotic Agents|antipsychotic agents|mesh-list
25043879|NCT01192035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24877186|NCT02897648|Lactams|lactams|mesh-list
25023737|NCT03652116|Meperidine|meperidine|mesh-list
25043880|NCT01192035|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25043881|NCT01192035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25043882|NCT01192035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25043883|NCT01192035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25043884|NCT01192035|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25043885|NCT01192035|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25043886|NCT01192035|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25043887|NCT01192035|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25043888|NCT01192035|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25043889|NCT01189396|Albuterol|albuterol|mesh-list
25043890|NCT01189396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25043891|NCT01189396|Autonomic Agents|autonomic agents|mesh-ancestor
25043892|NCT01189396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25043893|NCT01189396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043894|NCT01189396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25043895|NCT01189396|Respiratory System Agents|respiratory system agents|mesh-ancestor
25043896|NCT01189396|Tocolytic Agents|tocolytic agents|mesh-ancestor
25043897|NCT01189396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25043898|NCT01189396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25043899|NCT01189396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25043900|NCT01189396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25043911|NCT01188187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043912|NCT01188187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25043913|NCT01188187|Glucocorticoids|glucocorticoids|mesh-ancestor
25043914|NCT01188187|Hormones|hormones|mesh-ancestor
25043915|NCT01188187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25043916|NCT01188187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25043917|NCT01188187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043918|NCT01188187|Tubulin Modulators|tubulin modulators|mesh-ancestor
25043919|NCT01188187|Antimitotic Agents|antimitotic agents|mesh-ancestor
25043920|NCT01188187|Mitosis Modulators|mitosis modulators|mesh-ancestor
25043921|NCT01188187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043922|NCT01186991|Paclitaxel|paclitaxel|mesh-list
25043923|NCT01186991|Bevacizumab|bevacizumab|mesh-list
24788902|NCT01934634|Paclitaxel|paclitaxel|mesh-list
25043924|NCT01186991|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25043925|NCT01186991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25043926|NCT01186991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043961|NCT01175785|Cyclophosphamide|cyclophosphamide|mesh-list
25043962|NCT01175785|Fludarabine|fludarabine|mesh-list
25043963|NCT01175785|Fludarabine phosphate|fludarabine phosphate|mesh-list
25044109|NCT01143064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044110|NCT01140217|Norethindrone|norethindrone|mesh-list
25044111|NCT01140217|Norethindrone Acetate|norethindrone acetate|mesh-list
25044112|NCT01140217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25044113|NCT01140217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25044114|NCT01140217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25044115|NCT01140217|Contraceptive Agents|contraceptive agents|mesh-ancestor
25044116|NCT01140217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25044117|NCT01140217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044118|NCT01140217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24732177|NCT01638247|Hormone Antagonists|hormone antagonists|mesh-ancestor
24732179|NCT01638247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044119|NCT01140217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25044132|NCT01137968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044133|NCT01137968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25044134|NCT01137968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25044135|NCT01137968|Growth Substances|growth substances|mesh-ancestor
25044136|NCT01137968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044137|NCT01137968|Growth Inhibitors|growth inhibitors|mesh-ancestor
25044138|NCT01137968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044139|NCT01137968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044168|NCT01133990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25044169|NCT01133990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25044170|NCT01133990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044171|NCT01133990|Antidotes|antidotes|mesh-ancestor
25044172|NCT01133990|Protective Agents|protective agents|mesh-ancestor
25044173|NCT01133990|Vitamin B Complex|vitamin b complex|mesh-ancestor
25044174|NCT01133990|Vitamins|vitamins|mesh-ancestor
25044175|NCT01133990|Micronutrients|micronutrients|mesh-ancestor
25044176|NCT01130142|Gemcitabine|gemcitabine|mesh-list
25044177|NCT01130142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25044178|NCT01130142|Antimetabolites|antimetabolites|mesh-ancestor
25044179|NCT01130142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044180|NCT01130142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044181|NCT01130142|Antiviral Agents|antiviral agents|mesh-ancestor
25044182|NCT01130142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25044183|NCT01130142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044225|NCT01128530|Linezolid|linezolid|mesh-list
25044226|NCT01128530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25044227|NCT01128530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25044228|NCT01128530|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25044229|NCT01128530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044230|NCT01128530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044231|NCT01128335|Tacrolimus|tacrolimus|mesh-list
24885419|NCT05172934|Tenecteplase|tenecteplase|mesh-list
25044379|NCT01107496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25044380|NCT01107496|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25044381|NCT01107496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25044382|NCT01107496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25044383|NCT01107496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044384|NCT01107496|Adrenergic Agents|adrenergic agents|mesh-ancestor
25044385|NCT01107496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25044386|NCT01107496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044387|NCT01106989|Lidocaine|lidocaine|mesh-list
25044388|NCT01106989|Tetracaine|tetracaine|mesh-list
25044389|NCT01106989|Anesthetics, Local|anesthetics, local|mesh-ancestor
25044390|NCT01106989|Anesthetics|anesthetics|mesh-ancestor
25044391|NCT01106989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25044392|NCT01106989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044393|NCT01106989|Sensory System Agents|sensory system agents|mesh-ancestor
24783276|NCT01900886|Ribavirin|ribavirin|mesh-list
25044394|NCT01106989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25044395|NCT01106989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25044396|NCT01106989|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25166619|NCT03834571|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25044397|NCT01106989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25044398|NCT01106989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25044399|NCT01106989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044400|NCT01106807|Adapalene|adapalene|mesh-list
25039900|NCT03608397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25044488|NCT01087151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044635|NCT01068704|Letrozole|letrozole|mesh-list
25044636|NCT01068704|Lapatinib|lapatinib|mesh-list
25044637|NCT01068704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044638|NCT01068704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24886709|NCT04523675|Acetylcysteine|acetylcysteine|mesh-list
25044672|NCT01064791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25044673|NCT01064791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044674|NCT01064791|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25044770|NCT01038804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044772|NCT01038739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25044773|NCT01038739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25044775|NCT01038739|Sensory System Agents|sensory system agents|mesh-ancestor
25650127|NCT01499290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25650128|NCT01499290|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24732536|NCT01640002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25044776|NCT01038739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25044777|NCT01038739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044778|NCT01038739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25044779|NCT01038739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25044780|NCT01037179|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25044781|NCT01037179|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25044782|NCT01037179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25044783|NCT01037179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25044784|NCT01037179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25044785|NCT01037179|Analgesics|analgesics|mesh-ancestor
25044915|NCT01020565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25044916|NCT01020097|Fluorides|fluorides|mesh-list
25044917|NCT01020097|Cariostatic Agents|cariostatic agents|mesh-ancestor
25044918|NCT01020097|Protective Agents|protective agents|mesh-ancestor
25044948|NCT01014078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25044949|NCT01012895|Interferons|interferons|mesh-list
25044950|NCT01012895|Ribavirin|ribavirin|mesh-list
25044951|NCT01012895|Interferon-alpha|interferon-alpha|mesh-list
25044952|NCT01012895|Interferon alpha-2|interferon alpha-2|mesh-list
25044953|NCT01012895|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25044954|NCT01012895|Asunaprevir|asunaprevir|mesh-list
25044955|NCT01012895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044956|NCT01012895|Antiviral Agents|antiviral agents|mesh-ancestor
25044957|NCT01012895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25044958|NCT01012895|Antimetabolites|antimetabolites|mesh-ancestor
25044959|NCT01012895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044960|NCT01012895|Immunologic Factors|immunologic factors|mesh-ancestor
25044961|NCT01012895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044962|NCT01012895|Protease Inhibitors|protease inhibitors|mesh-ancestor
25044963|NCT01012895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044964|NCT01009775|Docetaxel|docetaxel|mesh-list
25044965|NCT01009775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044966|NCT01009775|Tubulin Modulators|tubulin modulators|mesh-ancestor
25044967|NCT01009775|Antimitotic Agents|antimitotic agents|mesh-ancestor
25044968|NCT01009775|Mitosis Modulators|mitosis modulators|mesh-ancestor
25044997|NCT01007721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25044998|NCT01007721|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25044999|NCT01007721|Hormone Antagonists|hormone antagonists|mesh-ancestor
25045037|NCT01004081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25045038|NCT01004081|Hormone Antagonists|hormone antagonists|mesh-ancestor
25045039|NCT01004081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25045040|NCT01004081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045048|NCT01002248|Dexamethasone|dexamethasone|mesh-list
25045050|NCT01002248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25045051|NCT01002248|Antiemetics|antiemetics|mesh-ancestor
25045081|NCT01001338|Antioxidants|antioxidants|mesh-ancestor
25045082|NCT01001338|Protective Agents|protective agents|mesh-ancestor
25045083|NCT01001338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045084|NCT01001338|Uricosuric Agents|uricosuric agents|mesh-ancestor
25045086|NCT01001091|Dexamethasone|dexamethasone|mesh-list
25045087|NCT01001091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25045088|NCT01001091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25045089|NCT01001091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25045090|NCT01001091|Antiemetics|antiemetics|mesh-ancestor
25045193|NCT00987272|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25045194|NCT00987272|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25045195|NCT00987272|Histamine Antagonists|histamine antagonists|mesh-ancestor
25045196|NCT00987272|Histamine Agents|histamine agents|mesh-ancestor
25045197|NCT00987272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25045198|NCT00987272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045200|NCT00986882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24887717|NCT04513626|Antiviral Agents|antiviral agents|mesh-ancestor
25045313|NCT00968942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045314|NCT00968942|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24887817|NCT04511975|Azacitidine|azacitidine|mesh-list
25045340|NCT00966953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25045341|NCT00966953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25045342|NCT00966953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25045343|NCT00966953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045344|NCT00966953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25045345|NCT00966953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045346|NCT00966953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25045347|NCT00966953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25650129|NCT01499290|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25045408|NCT00957918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045409|NCT00957918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24733406|NCT01645787|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25045410|NCT00957918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25045411|NCT00957918|Cholinergic Agents|cholinergic agents|mesh-ancestor
25045412|NCT00957918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25045413|NCT00957918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045415|NCT00955981|Gout Suppressants|gout suppressants|mesh-ancestor
25045416|NCT00955981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25045417|NCT00955981|Uricosuric Agents|uricosuric agents|mesh-ancestor
25045419|NCT00953420|Dexamethasone|dexamethasone|mesh-list
25045420|NCT00953420|Carboplatin|carboplatin|mesh-list
25045421|NCT00953420|Docetaxel|docetaxel|mesh-list
25045422|NCT00953420|Lenograstim|lenograstim|mesh-list
25045423|NCT00953420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25045466|NCT00948753|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25039901|NCT03608397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25114849|NCT03120234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25114850|NCT03120234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25114851|NCT03120234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24888049|NCT04509323|Protective Agents|protective agents|mesh-ancestor
25114915|NCT03119623|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25114916|NCT03119623|Protease Inhibitors|protease inhibitors|mesh-ancestor
25114917|NCT03119623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25114918|NCT03119454|Betamethasone|betamethasone|mesh-list
25114919|NCT03119454|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
25114920|NCT03119454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25114921|NCT03119454|Glucocorticoids|glucocorticoids|mesh-ancestor
25114922|NCT03119454|Hormones|hormones|mesh-ancestor
25114923|NCT03119454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25114924|NCT03119454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25114925|NCT03119454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25114926|NCT03119454|Respiratory System Agents|respiratory system agents|mesh-ancestor
25114927|NCT03119636|Levodopa|levodopa|mesh-list
25114928|NCT03119636|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24980974|NCT04668859|Adrenergic Agents|adrenergic agents|mesh-ancestor
24980975|NCT04668859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24980976|NCT04668859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980979|NCT04648969|Hormones|hormones|mesh-list
25114929|NCT03119636|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24786670|NCT01921231|Prilocaine|prilocaine|mesh-list
25045606|NCT00938587|Glucocorticoids|glucocorticoids|mesh-ancestor
25045607|NCT00938587|Hormones|hormones|mesh-ancestor
25045608|NCT00938587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25045609|NCT00938587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25114954|NCT03119116|Anticoagulants|anticoagulants|mesh-ancestor
24498994|NCT00517179|Urological Agents|urological agents|mesh-ancestor
25114955|NCT03119077|Itraconazole|itraconazole|mesh-list
25114956|NCT03119077|Antifungal Agents|antifungal agents|mesh-ancestor
25114957|NCT03119077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25114958|NCT03119077|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25114959|NCT03119077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25114960|NCT03119077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25114961|NCT03119077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25114962|NCT03119077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25114963|NCT03119077|Hormone Antagonists|hormone antagonists|mesh-ancestor
25114964|NCT03119077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25114965|NCT03119077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25114966|NCT03119077|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25114967|NCT03119194|Opicapone|opicapone|mesh-list
25114968|NCT03119194|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25114969|NCT03119194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25115002|NCT03119038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25115003|NCT03119038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25115004|NCT03119038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25115005|NCT03119038|Sympatholytics|sympatholytics|mesh-ancestor
25115006|NCT03119038|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25115007|NCT03119324|Nimesulide|nimesulide|mesh-list
25115008|NCT03119324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25115070|NCT03118479|Androgens|androgens|mesh-ancestor
25115071|NCT03118479|Hormones|hormones|mesh-ancestor
25115072|NCT03118479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25650130|NCT01499355|Mycophenolic Acid|mycophenolic acid|mesh-list
25115073|NCT03118479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733764|NCT01648517|Docetaxel|docetaxel|mesh-list
24733765|NCT01648517|Vinorelbine|vinorelbine|mesh-list
24733766|NCT01648517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733767|NCT01648517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24617390|NCT01042782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24617391|NCT01042782|Immunologic Factors|immunologic factors|mesh-ancestor
25115074|NCT03118479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25115076|NCT03118479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25115077|NCT03118479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25115078|NCT03118479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25115079|NCT03118479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115080|NCT03118479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25115081|NCT03118479|Hormone Antagonists|hormone antagonists|mesh-ancestor
25115082|NCT03118362|Plasma-lyte 148|plasma-lyte 148|mesh-list
25115083|NCT03118362|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25115084|NCT03118362|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25115118|NCT03118076|Anesthetics, Local|anesthetics, local|mesh-ancestor
25115119|NCT03118076|Anesthetics|anesthetics|mesh-ancestor
25115121|NCT03118128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25115122|NCT03118128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115158|NCT03117894|Anesthetics, Local|anesthetics, local|mesh-ancestor
25115928|NCT03112031|Hormone Antagonists|hormone antagonists|mesh-ancestor
25115159|NCT03117894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25115160|NCT03117894|Antipyretics|antipyretics|mesh-ancestor
25115161|NCT03117894|Antiemetics|antiemetics|mesh-ancestor
25115162|NCT03117894|Autonomic Agents|autonomic agents|mesh-ancestor
25115163|NCT03117894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25115164|NCT03117894|Antipruritics|antipruritics|mesh-ancestor
25115165|NCT03117894|Dermatologic Agents|dermatologic agents|mesh-ancestor
25115195|NCT03117972|Growth Substances|growth substances|mesh-ancestor
25115196|NCT03117972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115197|NCT03117972|Growth Inhibitors|growth inhibitors|mesh-ancestor
25115198|NCT03117972|Antimetabolites|antimetabolites|mesh-ancestor
25115199|NCT03117972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115200|NCT03117972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25024278|NCT03647579|Analgesics|analgesics|mesh-ancestor
25115201|NCT03117972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25115202|NCT03117972|Immunologic Factors|immunologic factors|mesh-ancestor
25115203|NCT03117972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25115204|NCT03117972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25115205|NCT03117972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25115206|NCT03117972|Antidotes|antidotes|mesh-ancestor
25115207|NCT03117972|Protective Agents|protective agents|mesh-ancestor
25115208|NCT03117972|Vitamin B Complex|vitamin b complex|mesh-ancestor
25115209|NCT03117972|Vitamins|vitamins|mesh-ancestor
25115210|NCT03117972|Micronutrients|micronutrients|mesh-ancestor
25115211|NCT03117920|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
25115212|NCT03117920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25039902|NCT03608397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115330|NCT03116893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115331|NCT03116893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25115332|NCT03116893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25166620|NCT03834571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25115333|NCT03116893|Antitubercular Agents|antitubercular agents|mesh-ancestor
25115334|NCT03116893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25115335|NCT03116893|Leprostatic Agents|leprostatic agents|mesh-ancestor
25115336|NCT03116893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25115337|NCT03116893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25115338|NCT03116893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25115339|NCT03116893|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25115340|NCT03116893|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25115341|NCT03116893|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25115342|NCT03116893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24777089|NCT01862003|Leucovorin|leucovorin|mesh-list
25115343|NCT03116776|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25024321|NCT03647280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650131|NCT01499355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25650132|NCT01499355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25650133|NCT01499355|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25650134|NCT01499355|Antitubercular Agents|antitubercular agents|mesh-ancestor
25650135|NCT01499355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25650136|NCT01499355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25024322|NCT03647150|Amoxicillin|amoxicillin|mesh-list
25115344|NCT03116776|Hyaluronic Acid|hyaluronic acid|mesh-list
25115345|NCT03116776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25115346|NCT03116776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25115347|NCT03116776|Immunologic Factors|immunologic factors|mesh-ancestor
25115348|NCT03116776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115349|NCT03116776|Viscosupplements|viscosupplements|mesh-ancestor
25115350|NCT03116776|Protective Agents|protective agents|mesh-ancestor
25115351|NCT03116737|Benzocaine|benzocaine|mesh-list
25115382|NCT03116672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25115383|NCT03116672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115384|NCT03116490|Anesthetics|anesthetics|mesh-list
25115432|NCT03116269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25115433|NCT03116269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115434|NCT03116269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25024352|NCT03646825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024353|NCT03646825|Protective Agents|protective agents|mesh-ancestor
25024354|NCT03646825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024367|NCT03646526|Antidepressive Agents|antidepressive agents|mesh-ancestor
25024368|NCT03646526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25024369|NCT03646526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25024371|NCT03646526|Sensory System Agents|sensory system agents|mesh-ancestor
25024372|NCT03646526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024378|NCT03646526|Adrenergic Agents|adrenergic agents|mesh-ancestor
25115468|NCT03116308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115470|NCT03116308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25115471|NCT03116282|Ethanol|ethanol|mesh-list
25115472|NCT03116282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25115473|NCT03116282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25115512|NCT03115489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115513|NCT03115489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25115514|NCT03115489|Anesthetics, General|anesthetics, general|mesh-ancestor
25115515|NCT03115489|Anesthetics|anesthetics|mesh-ancestor
25115516|NCT03115489|Analgesics|analgesics|mesh-ancestor
25115517|NCT03115489|Sensory System Agents|sensory system agents|mesh-ancestor
25115518|NCT03115489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25115519|NCT03115489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25115520|NCT03115489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25115521|NCT03115489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25115522|NCT03115489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25115523|NCT03115489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115557|NCT03115255|Growth Substances|growth substances|mesh-ancestor
25115558|NCT03115255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115559|NCT03115255|Growth Inhibitors|growth inhibitors|mesh-ancestor
25115560|NCT03115255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25115562|NCT03115060|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25115563|NCT03115060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25115583|NCT03115073|Hormone Antagonists|hormone antagonists|mesh-ancestor
25115584|NCT03115073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25115585|NCT03115073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115586|NCT03115073|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25115587|NCT03115073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24501503|NCT00528983|Azacitidine|azacitidine|mesh-list
25115603|NCT03115099|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25115604|NCT03115099|Liraglutide|liraglutide|mesh-list
25115605|NCT03115099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25115606|NCT03115099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115607|NCT03115099|Incretins|incretins|mesh-ancestor
25115608|NCT03115099|Hormones|hormones|mesh-ancestor
25115612|NCT03115099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25115613|NCT03115099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115614|NCT03114813|Carvedilol|carvedilol|mesh-list
25115615|NCT03114813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25115647|NCT03114085|Antimetabolites|antimetabolites|mesh-ancestor
25115648|NCT03114085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115649|NCT03114085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25115650|NCT03114085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25115651|NCT03114085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25115652|NCT03114072|Methamphetamine|methamphetamine|mesh-list
25115653|NCT03114072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25115654|NCT03114072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115655|NCT03114072|Sympathomimetics|sympathomimetics|mesh-ancestor
25115656|NCT03114072|Autonomic Agents|autonomic agents|mesh-ancestor
25115657|NCT03114072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25115658|NCT03114072|Dopamine Agents|dopamine agents|mesh-ancestor
25115659|NCT03114072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25115695|NCT03113396|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25115696|NCT03113396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25115697|NCT03113396|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25115699|NCT03113396|GABA Agents|gaba agents|mesh-ancestor
25115700|NCT03113396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25115770|NCT03112889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115771|NCT03112889|Antimanic Agents|antimanic agents|mesh-ancestor
25115772|NCT03112889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25115773|NCT03112889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25115774|NCT03112889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25115775|NCT03112707|Aspirin|aspirin|mesh-list
25115776|NCT03112707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25115777|NCT03112707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25115778|NCT03112707|Analgesics|analgesics|mesh-ancestor
25115779|NCT03112707|Sensory System Agents|sensory system agents|mesh-ancestor
24891126|NCT04476069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25115815|NCT03112785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25115816|NCT03112785|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25115817|NCT03112785|Histamine Antagonists|histamine antagonists|mesh-ancestor
25115818|NCT03112785|Histamine Agents|histamine agents|mesh-ancestor
25115819|NCT03112785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25039903|NCT03608397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25115921|NCT03111966|Antiviral Agents|antiviral agents|mesh-ancestor
25115922|NCT03111966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25115923|NCT03112031|Tamoxifen|tamoxifen|mesh-list
25115924|NCT03112031|Fluconazole|fluconazole|mesh-list
25115925|NCT03112031|Amphotericin B|amphotericin b|mesh-list
25115926|NCT03112031|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25115927|NCT03112031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25115929|NCT03112031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25115985|NCT03111810|Protective Agents|protective agents|mesh-ancestor
25116016|NCT03111511|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25116017|NCT03111511|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25116018|NCT03111511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25116019|NCT03111511|Contraceptive Agents|contraceptive agents|mesh-ancestor
25166621|NCT03834571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25116020|NCT03111511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25116021|NCT03111511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25116022|NCT03111511|Estrogens|estrogens|mesh-ancestor
25116023|NCT03111511|Hormones|hormones|mesh-ancestor
25116024|NCT03111511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25116025|NCT03111511|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25116026|NCT03111511|Hormone Antagonists|hormone antagonists|mesh-ancestor
25116027|NCT03111511|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25116028|NCT03111511|Diuretics|diuretics|mesh-ancestor
25116029|NCT03111511|Natriuretic Agents|natriuretic agents|mesh-ancestor
25116030|NCT03111511|Antiviral Agents|antiviral agents|mesh-ancestor
25116031|NCT03111511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25116032|NCT03111511|Sequestering Agents|sequestering agents|mesh-ancestor
25116067|NCT03111433|Ubiquinone|ubiquinone|mesh-list
25116068|NCT03111433|Coenzyme Q10|coenzyme q10|mesh-list
25116069|NCT03111433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116070|NCT03111433|Micronutrients|micronutrients|mesh-ancestor
25116071|NCT03111433|Vitamins|vitamins|mesh-ancestor
25116072|NCT03111615|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25116073|NCT03111615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25116074|NCT03111615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25116075|NCT03111615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116076|NCT03111615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25116077|NCT03111615|Hormone Antagonists|hormone antagonists|mesh-ancestor
24892085|NCT04465773|Narcotics|narcotics|mesh-ancestor
25116112|NCT03111121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25116113|NCT03111121|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25116114|NCT03111121|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25116116|NCT03110952|Vaccines|vaccines|mesh-list
25116117|NCT03110952|Immunologic Factors|immunologic factors|mesh-ancestor
25116177|NCT03110640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25116178|NCT03110640|Immunologic Factors|immunologic factors|mesh-ancestor
25116179|NCT03110640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116180|NCT03110640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25116181|NCT03110640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25116182|NCT03110640|Alkylating Agents|alkylating agents|mesh-ancestor
25116183|NCT03110640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116238|NCT03109977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25116239|NCT03109977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25116240|NCT03110055|Grazoprevir|grazoprevir|mesh-list
24860798|NCT02312661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25116241|NCT03110055|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25116242|NCT03110055|Antiviral Agents|antiviral agents|mesh-ancestor
25116243|NCT03110055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25116244|NCT03109990|Dexmedetomidine|dexmedetomidine|mesh-list
25116245|NCT03109990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25116246|NCT03109990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25116247|NCT03109990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116248|NCT03109990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25116249|NCT03109990|Analgesics|analgesics|mesh-ancestor
25116250|NCT03109990|Sensory System Agents|sensory system agents|mesh-ancestor
25116251|NCT03109990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24892452|NCT04462614|Anticoagulants|anticoagulants|mesh-ancestor
25116282|NCT03109730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25116283|NCT03109730|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25116284|NCT03109730|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25116285|NCT03109730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25116286|NCT03109730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116288|NCT03109730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25116289|NCT03109756|Gaboxadol|gaboxadol|mesh-list
25116290|NCT03109756|Analgesics|analgesics|mesh-ancestor
25116291|NCT03109756|Sensory System Agents|sensory system agents|mesh-ancestor
25116292|NCT03109756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116293|NCT03109756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116294|NCT03109756|Anticonvulsants|anticonvulsants|mesh-ancestor
25116295|NCT03109756|GABA Agonists|gaba agonists|mesh-ancestor
25116296|NCT03109756|GABA Agents|gaba agents|mesh-ancestor
25116399|NCT03108833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25116400|NCT03108833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25116432|NCT03108690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116433|NCT03108807|Fibrin fragment D|fibrin fragment d|mesh-list
25116434|NCT03108807|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25116435|NCT03108807|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25116436|NCT03108807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116438|NCT03108807|Coagulants|coagulants|mesh-ancestor
25116439|NCT03108729|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25116440|NCT03108729|Anticonvulsants|anticonvulsants|mesh-ancestor
25116441|NCT03108729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25116442|NCT03108729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25116443|NCT03108729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25116444|NCT03108729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116670|NCT03107078|Protective Agents|protective agents|mesh-ancestor
25116672|NCT03106948|Penicillamine|penicillamine|mesh-list
25116673|NCT03106948|Antioxidants|antioxidants|mesh-ancestor
25116674|NCT03106948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116675|NCT03106948|Protective Agents|protective agents|mesh-ancestor
25024591|NCT03644446|Sympatholytics|sympatholytics|mesh-ancestor
25024592|NCT03644446|Autonomic Agents|autonomic agents|mesh-ancestor
25024593|NCT03644446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024631|NCT03643874|Albuterol|albuterol|mesh-list
25116676|NCT03106948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116677|NCT03106948|Vitamins|vitamins|mesh-ancestor
25116678|NCT03106948|Micronutrients|micronutrients|mesh-ancestor
25116679|NCT03106948|Antidotes|antidotes|mesh-ancestor
25116680|NCT03106948|Chelating Agents|chelating agents|mesh-ancestor
25116681|NCT03106948|Sequestering Agents|sequestering agents|mesh-ancestor
24893503|NCT04448821|Metformin|metformin|mesh-list
25116719|NCT03106818|Analgesics|analgesics|mesh-ancestor
25116909|NCT03105765|Anesthetics, General|anesthetics, general|mesh-ancestor
25116911|NCT03105765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25116975|NCT03105349|Ribavirin|ribavirin|mesh-list
25116976|NCT03105349|Sofosbuvir|sofosbuvir|mesh-list
25116977|NCT03105349|Grazoprevir|grazoprevir|mesh-list
25116978|NCT03105349|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25116979|NCT03105349|Antimetabolites|antimetabolites|mesh-ancestor
25116980|NCT03105349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116981|NCT03105349|Antiviral Agents|antiviral agents|mesh-ancestor
25116982|NCT03105349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25116983|NCT03105245|Thiopental|thiopental|mesh-list
25116984|NCT03105245|Anesthetics|anesthetics|mesh-list
25116985|NCT03105245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25116986|NCT03105245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116987|NCT03105245|Anticonvulsants|anticonvulsants|mesh-ancestor
25116988|NCT03105245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25116989|NCT03105245|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25116990|NCT03105245|Anesthetics, General|anesthetics, general|mesh-ancestor
25116991|NCT03105245|GABA Modulators|gaba modulators|mesh-ancestor
25116992|NCT03105245|GABA Agents|gaba agents|mesh-ancestor
25112262|NCT04258631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112263|NCT04258631|Sensory System Agents|sensory system agents|mesh-ancestor
25112264|NCT04258631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25112265|NCT04258631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25112266|NCT04258631|Narcotics|narcotics|mesh-ancestor
25112267|NCT04258631|Analgesics|analgesics|mesh-ancestor
25112268|NCT04239339|Citalopram|citalopram|mesh-list
25112269|NCT04239339|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25116993|NCT03105245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25117147|NCT05375630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117149|NCT05375630|Coagulants|coagulants|mesh-ancestor
25117150|NCT05375305|Morphine|morphine|mesh-list
25117151|NCT05375305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25117152|NCT05375305|Narcotics|narcotics|mesh-ancestor
25117153|NCT05375305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25117154|NCT05375305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117155|NCT05375305|Analgesics|analgesics|mesh-ancestor
25117156|NCT05375305|Sensory System Agents|sensory system agents|mesh-ancestor
25117157|NCT05375305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25117158|NCT05375240|Ceftriaxone|ceftriaxone|mesh-list
25166622|NCT03834571|Tubulin Modulators|tubulin modulators|mesh-ancestor
25117359|NCT05302804|Menthol|menthol|mesh-list
25117360|NCT05302804|Antipruritics|antipruritics|mesh-ancestor
25117361|NCT05302804|Dermatologic Agents|dermatologic agents|mesh-ancestor
25117435|NCT05261464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25117436|NCT05261464|Vasodilator Agents|vasodilator agents|mesh-ancestor
25117437|NCT05171062|Pembrolizumab|pembrolizumab|mesh-list
25117438|NCT05171062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25117439|NCT05171062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25117441|NCT05164367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25117442|NCT05164367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25117443|NCT05164367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25117444|NCT05164367|Autonomic Agents|autonomic agents|mesh-ancestor
25117445|NCT05164367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25117446|NCT05164367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117447|NCT05164367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25117448|NCT05164367|Respiratory System Agents|respiratory system agents|mesh-ancestor
25117449|NCT05164367|Mydriatics|mydriatics|mesh-ancestor
25117450|NCT05164367|Parasympatholytics|parasympatholytics|mesh-ancestor
25117451|NCT05164367|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25117479|NCT05133804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25117480|NCT05133804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25117481|NCT05133804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117482|NCT05133804|Dopamine Agents|dopamine agents|mesh-ancestor
25117483|NCT05133804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25117484|NCT05133804|Antidepressive Agents|antidepressive agents|mesh-ancestor
25117485|NCT05133804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25117486|NCT05133804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25117487|NCT05133804|Adrenergic Agents|adrenergic agents|mesh-ancestor
25117524|NCT05044611|Diuretics|diuretics|mesh-ancestor
25117525|NCT05044611|Natriuretic Agents|natriuretic agents|mesh-ancestor
25117526|NCT05044611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117527|NCT05044611|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
25117528|NCT05044611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25117529|NCT05044611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25117563|NCT05024734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25117564|NCT05020860|Paclitaxel|paclitaxel|mesh-list
25117565|NCT05020860|Cyclophosphamide|cyclophosphamide|mesh-list
25117566|NCT05020860|Carboplatin|carboplatin|mesh-list
25117567|NCT05020860|Doxorubicin|doxorubicin|mesh-list
25117568|NCT05020860|Trastuzumab|trastuzumab|mesh-list
25117569|NCT05020860|Pertuzumab|pertuzumab|mesh-list
25117570|NCT05020860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25117571|NCT05020860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25024736|NCT03643276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25024737|NCT03643276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024738|NCT03643276|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25024739|NCT03643276|Abortifacient Agents|abortifacient agents|mesh-ancestor
25024740|NCT03643276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25024741|NCT03643276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25024742|NCT03643276|Antimetabolites|antimetabolites|mesh-ancestor
25024743|NCT03643276|Dermatologic Agents|dermatologic agents|mesh-ancestor
25024744|NCT03643276|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25024745|NCT03643276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25024746|NCT03643276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25024747|NCT03643276|Antiviral Agents|antiviral agents|mesh-ancestor
25117617|NCT04966676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25117619|NCT04966676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25117708|NCT04859296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117710|NCT04859296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25045571|NCT00944294|Sensory System Agents|sensory system agents|mesh-ancestor
25045572|NCT00944294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24996497|NCT03387852|Fluticasone|fluticasone|mesh-list
25117758|NCT04832009|Ascorbic Acid|ascorbic acid|mesh-list
25117883|NCT04670471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117885|NCT04670471|Sensory System Agents|sensory system agents|mesh-ancestor
25117886|NCT04670471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25117887|NCT04669197|Gemcitabine|gemcitabine|mesh-list
25117888|NCT04669197|Hydroxychloroquine|hydroxychloroquine|mesh-list
25117890|NCT04669197|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25024768|NCT03642990|Vitamins|vitamins|mesh-ancestor
25117891|NCT04669197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25117892|NCT04669197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25117893|NCT04669197|Tubulin Modulators|tubulin modulators|mesh-ancestor
25117894|NCT04669197|Antimitotic Agents|antimitotic agents|mesh-ancestor
25117895|NCT04669197|Mitosis Modulators|mitosis modulators|mesh-ancestor
25117896|NCT04669197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117992|NCT04589663|Mometasone Furoate|mometasone furoate|mesh-list
25117993|NCT04589663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25117994|NCT04589663|Dermatologic Agents|dermatologic agents|mesh-ancestor
25117995|NCT04589663|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25117996|NCT04585841|Cannabidiol|cannabidiol|mesh-list
25118003|NCT04574479|Narcotics|narcotics|mesh-ancestor
25118004|NCT04574479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24985935|NCT02545283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985936|NCT02532231|Nivolumab|nivolumab|mesh-list
24985937|NCT02532231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24985938|NCT02532231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985939|NCT02532231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24985940|NCT02532231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024817|NCT03642600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25024818|NCT03642600|Hematinics|hematinics|mesh-ancestor
25024819|NCT03642600|Vitamin B Complex|vitamin b complex|mesh-ancestor
25118073|NCT04474366|Ropivacaine|ropivacaine|mesh-list
25118287|NCT04274426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25118288|NCT04274426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25118289|NCT04274426|Immunologic Factors|immunologic factors|mesh-ancestor
25118290|NCT04274426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118291|NCT04274426|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25118292|NCT04274426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25118293|NCT04274426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25118294|NCT04245865|Leucovorin|leucovorin|mesh-list
25118295|NCT04245865|Tocotrienols|tocotrienols|mesh-list
25118458|NCT04146038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118461|NCT04146038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25118462|NCT04115748|Adalimumab|adalimumab|mesh-list
25118463|NCT04115748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25118464|NCT04115748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25118465|NCT04113018|Dexamethasone|dexamethasone|mesh-list
25118466|NCT04113018|Lenalidomide|lenalidomide|mesh-list
25118467|NCT04113018|Daratumumab|daratumumab|mesh-list
25118468|NCT04113018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25118469|NCT04113018|Antiemetics|antiemetics|mesh-ancestor
25166623|NCT03834571|Antimitotic Agents|antimitotic agents|mesh-ancestor
25166624|NCT03834571|Mitosis Modulators|mitosis modulators|mesh-ancestor
25118470|NCT04113018|Autonomic Agents|autonomic agents|mesh-ancestor
25118471|NCT04113018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25118472|NCT04113018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118484|NCT04087408|Hormones|hormones|mesh-list
25118485|NCT04087408|Progesterone|progesterone|mesh-list
25118486|NCT04087408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25118487|NCT04087408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118488|NCT04087408|Progestins|progestins|mesh-ancestor
25118496|NCT04082520|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25118532|NCT04021550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118567|NCT03994731|Immunologic Factors|immunologic factors|mesh-ancestor
25118568|NCT03994731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25118569|NCT03994731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25118570|NCT03994731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25118571|NCT03994731|Analgesics|analgesics|mesh-ancestor
25118572|NCT03994731|Sensory System Agents|sensory system agents|mesh-ancestor
25118573|NCT03994731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25118574|NCT03994731|Antipyretics|antipyretics|mesh-ancestor
24476906|NCT00416819|Vitamins|vitamins|mesh-ancestor
25118647|NCT03965728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900392|NCT04394234|Anticoagulants|anticoagulants|mesh-list
25118682|NCT03954613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25118683|NCT03954613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118684|NCT03954613|Cholinergic Agents|cholinergic agents|mesh-ancestor
25118685|NCT03954613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25118686|NCT03954613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118688|NCT03954613|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25118689|NCT03954613|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25118690|NCT03954613|Dopamine Agents|dopamine agents|mesh-ancestor
25118691|NCT03954613|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25118692|NCT03954613|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25118755|NCT03870399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24587634|NCT00896077|Lisofylline|lisofylline|mesh-list
25119199|NCT02536794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119200|NCT02536794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25119201|NCT02536794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119203|NCT02506517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119204|NCT02506517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25119205|NCT02506517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25119206|NCT02506517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119207|NCT02489903|Gemcitabine|gemcitabine|mesh-list
25119208|NCT02489903|Paclitaxel|paclitaxel|mesh-list
25119209|NCT02489903|Etoposide|etoposide|mesh-list
25119210|NCT02489903|Vinorelbine|vinorelbine|mesh-list
25119243|NCT02428270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25119244|NCT02428270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024962|NCT03640468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25024963|NCT03640468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024964|NCT03640468|Sensory System Agents|sensory system agents|mesh-ancestor
25119245|NCT02428205|Propranolol|propranolol|mesh-list
25119246|NCT02428205|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25119247|NCT02428205|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25119248|NCT02428205|Adrenergic Agents|adrenergic agents|mesh-ancestor
25119249|NCT02428205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25119250|NCT02428205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119251|NCT02428205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119283|NCT02398656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119284|NCT02398656|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25119285|NCT02398656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25119286|NCT02375295|Ciprofloxacin|ciprofloxacin|mesh-list
25119287|NCT02375295|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25119292|NCT02375295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25119329|NCT02124187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25119330|NCT02124187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24902386|NCT04374279|Bicalutamide|bicalutamide|mesh-list
25119366|NCT02002819|Levetiracetam|levetiracetam|mesh-list
25119367|NCT02002819|Anticonvulsants|anticonvulsants|mesh-ancestor
25119368|NCT02002819|Nootropic Agents|nootropic agents|mesh-ancestor
25119473|NCT01715285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25045660|NCT00929968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25045661|NCT00929968|Autonomic Agents|autonomic agents|mesh-ancestor
25025015|NCT03640390|Anticonvulsants|anticonvulsants|mesh-ancestor
25025016|NCT03640390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25025019|NCT03640390|Tocolytic Agents|tocolytic agents|mesh-ancestor
25119559|NCT05403723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119560|NCT05403723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25119561|NCT05403723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25119562|NCT05403723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25119563|NCT05403723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25119564|NCT05403723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119565|NCT05403723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24725768|NCT01599572|Zinc|zinc|mesh-list
25119654|NCT05399290|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25119655|NCT05398913|Rimonabant|rimonabant|mesh-list
25119656|NCT05398913|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25119657|NCT05398913|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
25119658|NCT05398913|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25119659|NCT05398913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25829157|NCT00006144|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25829158|NCT00006144|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25829159|NCT00006144|Protease Inhibitors|protease inhibitors|mesh-ancestor
24736498|NCT01662622|Anesthetics, General|anesthetics, general|mesh-ancestor
24736499|NCT01662622|Anesthetics|anesthetics|mesh-ancestor
24942942|NCT03976102|Rituximab|rituximab|mesh-list
25199813|NCT02738502|Antiviral Agents|antiviral agents|mesh-ancestor
24736505|NCT01662687|Granisetron|granisetron|mesh-list
24736506|NCT01662687|Antiemetics|antiemetics|mesh-ancestor
24736507|NCT01662687|Autonomic Agents|autonomic agents|mesh-ancestor
24736533|NCT01662804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24736534|NCT01662804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24736536|NCT01662804|Sensory System Agents|sensory system agents|mesh-ancestor
24736537|NCT01662804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24736539|NCT01662869|Folic Acid|folic acid|mesh-list
24736540|NCT01662869|Oxaliplatin|oxaliplatin|mesh-list
25119660|NCT05398913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119661|NCT05398913|Hormones|hormones|mesh-ancestor
25119662|NCT05398913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25119696|NCT05328440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25119697|NCT05328440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25025059|NCT03640247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25025060|NCT03640247|Antitussive Agents|antitussive agents|mesh-ancestor
25025061|NCT03640247|Respiratory System Agents|respiratory system agents|mesh-ancestor
25025062|NCT03640221|Ertugliflozin|ertugliflozin|mesh-list
25025063|NCT03640221|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25025064|NCT03640221|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25025065|NCT03640221|Antihypertensive Agents|antihypertensive agents|mesh-list
25025066|NCT03640221|Diuretics|diuretics|mesh-ancestor
25119698|NCT05328440|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25119699|NCT05328440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25119700|NCT05328440|Hormone Antagonists|hormone antagonists|mesh-ancestor
25119701|NCT05328440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25119702|NCT05328440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119704|NCT05323175|Anesthetics, Local|anesthetics, local|mesh-ancestor
25119705|NCT05323175|Anesthetics|anesthetics|mesh-ancestor
25119734|NCT05279963|Antidepressive Agents|antidepressive agents|mesh-ancestor
25119735|NCT05279963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25119736|NCT05279963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25119737|NCT05279963|Analgesics|analgesics|mesh-ancestor
25119738|NCT05279963|Sensory System Agents|sensory system agents|mesh-ancestor
25119739|NCT05279963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25119740|NCT05279963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119741|NCT05279963|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25119742|NCT05279963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25119743|NCT05279963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25119744|NCT05279963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119814|NCT05137262|Cisplatin|cisplatin|mesh-list
25119815|NCT05137262|Doxorubicin|doxorubicin|mesh-list
25119872|NCT05080790|Dinutuximab|dinutuximab|mesh-list
25119873|NCT05080790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119874|NCT05080790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25109008|NCT03127800|Morphine|morphine|mesh-list
25119964|NCT05005689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119965|NCT05005689|Cariostatic Agents|cariostatic agents|mesh-ancestor
25119966|NCT05005689|Protective Agents|protective agents|mesh-ancestor
25120073|NCT04745351|Antimetabolites|antimetabolites|mesh-ancestor
25120074|NCT04745351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120075|NCT04745351|Antiviral Agents|antiviral agents|mesh-ancestor
25120076|NCT04745351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25650137|NCT01499355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650138|NCT01499355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650139|NCT01499368|Omeprazole|omeprazole|mesh-list
25650140|NCT01499368|Famotidine|famotidine|mesh-list
25650141|NCT01499368|Lafutidine|lafutidine|mesh-list
25650142|NCT01499368|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25650143|NCT01499368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25650144|NCT01499368|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25650145|NCT01499368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650146|NCT01499368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650147|NCT01499368|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25650148|NCT01499368|Histamine Antagonists|histamine antagonists|mesh-ancestor
25650149|NCT01499368|Histamine Agents|histamine agents|mesh-ancestor
25650150|NCT01499368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25650151|NCT01499368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617834|NCT01045889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25120146|NCT04582383|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25120148|NCT04582383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25120149|NCT04582383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120150|NCT04582383|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25120151|NCT04582383|Diuretics|diuretics|mesh-ancestor
25120152|NCT04582383|Natriuretic Agents|natriuretic agents|mesh-ancestor
25120153|NCT04577326|Cyclophosphamide|cyclophosphamide|mesh-list
25120154|NCT04577326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25120155|NCT04577326|Immunologic Factors|immunologic factors|mesh-ancestor
25120156|NCT04577326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120157|NCT04577326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25120188|NCT04475991|Antiviral Agents|antiviral agents|mesh-ancestor
25120189|NCT04475991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25120190|NCT04475991|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25120194|NCT04437225|Glycolic acid|glycolic acid|mesh-list
25120195|NCT04437225|Keratolytic Agents|keratolytic agents|mesh-ancestor
25120196|NCT04437225|Dermatologic Agents|dermatologic agents|mesh-ancestor
25120198|NCT04419389|Venetoclax|venetoclax|mesh-list
25120199|NCT04419389|Acalabrutinib|acalabrutinib|mesh-list
24818347|NCT02088398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25120289|NCT04276233|Adrenergic Agents|adrenergic agents|mesh-ancestor
25120290|NCT04276233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25039904|NCT03608397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25120388|NCT03957876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120389|NCT03957876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25120390|NCT03957876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25120391|NCT03957876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25120392|NCT03957876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25120393|NCT03955575|Liraglutide|liraglutide|mesh-list
25120394|NCT03955575|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
25120575|NCT03337087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25120576|NCT03337087|Antidotes|antidotes|mesh-ancestor
25120577|NCT03337087|Protective Agents|protective agents|mesh-ancestor
25120578|NCT03337087|Vitamin B Complex|vitamin b complex|mesh-ancestor
25120579|NCT03337087|Vitamins|vitamins|mesh-ancestor
25120580|NCT03337087|Micronutrients|micronutrients|mesh-ancestor
25120581|NCT03337087|Hematinics|hematinics|mesh-ancestor
25120582|NCT03337087|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25120583|NCT03332498|Pembrolizumab|pembrolizumab|mesh-list
25120584|NCT03332498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25120585|NCT03332498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120586|NCT03299088|Pembrolizumab|pembrolizumab|mesh-list
25120587|NCT03299088|Trametinib|trametinib|mesh-list
25120588|NCT03299088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24904026|NCT04359199|Durvalumab|durvalumab|mesh-list
25120837|NCT02514031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25121480|NCT03101735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121481|NCT03101423|Interleukin-2|interleukin-2|mesh-list
25121482|NCT03101423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121483|NCT03101423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25121484|NCT03101423|Analgesics|analgesics|mesh-ancestor
25121485|NCT03101423|Sensory System Agents|sensory system agents|mesh-ancestor
25121486|NCT03101423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25121487|NCT03101423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121488|NCT03101579|Folic Acid|folic acid|mesh-list
25121489|NCT03101579|Vitamin B 12|vitamin b 12|mesh-list
25121490|NCT03101579|Dexamethasone|dexamethasone|mesh-list
25121491|NCT03101579|Pemetrexed|pemetrexed|mesh-list
25121492|NCT03101579|Vitamins|vitamins|mesh-ancestor
25121493|NCT03101579|Micronutrients|micronutrients|mesh-ancestor
25121494|NCT03101579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121495|NCT03101579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25121496|NCT03101579|Antiemetics|antiemetics|mesh-ancestor
25121497|NCT03101579|Autonomic Agents|autonomic agents|mesh-ancestor
25121498|NCT03101579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24587672|NCT00896376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587673|NCT00896402|Iodine|iodine|mesh-list
24587674|NCT00896402|Chlorhexidine|chlorhexidine|mesh-list
24587675|NCT00896402|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24587676|NCT00896402|Povidone-Iodine|povidone-iodine|mesh-list
24587677|NCT00896402|Povidone|povidone|mesh-list
24587678|NCT00896402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25650152|NCT01499498|Sildenafil Citrate|sildenafil citrate|mesh-list
24587679|NCT00896402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24587697|NCT00896519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25121499|NCT03101579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25121500|NCT03101579|Glucocorticoids|glucocorticoids|mesh-ancestor
25121501|NCT03101579|Hormones|hormones|mesh-ancestor
25650153|NCT01499498|Vasodilator Agents|vasodilator agents|mesh-ancestor
24943324|NCT03972683|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24943325|NCT03972683|Cholinergic Agents|cholinergic agents|mesh-ancestor
25121502|NCT03101579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25121503|NCT03101579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25121504|NCT03101579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121505|NCT03101579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121506|NCT03101579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121507|NCT03101579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24591645|NCT00918034|Talaporfin|talaporfin|mesh-list
24587719|NCT00896519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24587720|NCT00896519|Tubulin Modulators|tubulin modulators|mesh-ancestor
24587721|NCT00896519|Antimitotic Agents|antimitotic agents|mesh-ancestor
24587722|NCT00896519|Mitosis Modulators|mitosis modulators|mesh-ancestor
25017271|NCT01965132|Analgesics|analgesics|mesh-ancestor
24587723|NCT00896558|Midazolam|midazolam|mesh-list
24587724|NCT00896558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24587725|NCT00896558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24587726|NCT00896558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24986220|NCT02122198|Estradiol|estradiol|mesh-list
25829160|NCT00006144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829161|NCT00006144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829162|NCT00006144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25121508|NCT03101579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25121510|NCT03101579|Vitamin B Complex|vitamin b complex|mesh-ancestor
25121511|NCT03101709|Cyclophosphamide|cyclophosphamide|mesh-list
25121512|NCT03101709|Fludarabine|fludarabine|mesh-list
25121513|NCT03101709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25121514|NCT03101709|Immunologic Factors|immunologic factors|mesh-ancestor
25121515|NCT03101709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121516|NCT03101709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24587727|NCT00896558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587752|NCT00896727|Antibodies|antibodies|mesh-list
24587753|NCT00896727|Immunologic Factors|immunologic factors|mesh-ancestor
24587754|NCT00896727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829163|NCT00006144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24474407|NCT00405925|Antimetabolites|antimetabolites|mesh-ancestor
24474408|NCT00405977|Magnesium Sulfate|magnesium sulfate|mesh-list
24474409|NCT00405977|Analgesics|analgesics|mesh-ancestor
24474410|NCT00405977|Sensory System Agents|sensory system agents|mesh-ancestor
24474411|NCT00405977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25829164|NCT00006144|Antiviral Agents|antiviral agents|mesh-ancestor
25829165|NCT00006144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25829166|NCT00006144|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24474487|NCT00406172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829167|NCT00006144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25829168|NCT00006144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25121517|NCT03101709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25121518|NCT03101709|Alkylating Agents|alkylating agents|mesh-ancestor
24881895|NCT00593567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25121555|NCT03101072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25121556|NCT03101072|Antitubercular Agents|antitubercular agents|mesh-ancestor
25121795|NCT03099122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25121797|NCT03099122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25121798|NCT03099122|Protective Agents|protective agents|mesh-ancestor
25121799|NCT03099408|Metronidazole|metronidazole|mesh-list
25121800|NCT03099408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25121801|NCT03099408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25121802|NCT03099408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25121803|NCT03099408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25121804|NCT03099213|Ramipril|ramipril|mesh-list
25121805|NCT03099213|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25121806|NCT03099213|Protease Inhibitors|protease inhibitors|mesh-ancestor
25121807|NCT03099213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650154|NCT01499498|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25650155|NCT01499498|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25122030|NCT03097068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25122116|NCT03096340|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
25650156|NCT01499498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650157|NCT01499498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650158|NCT01499498|Urological Agents|urological agents|mesh-ancestor
25650159|NCT01499576|Acetic Acid|acetic acid|mesh-list
25650160|NCT01499576|Retinol acetate|retinol acetate|mesh-list
25650161|NCT01499576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25650162|NCT01499576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25650163|NCT01499576|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24737215|NCT01667575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24737216|NCT01667575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25076363|NCT03373708|Docetaxel|docetaxel|mesh-list
25025295|NCT03638648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25025296|NCT03638648|Antimetabolites|antimetabolites|mesh-ancestor
25025297|NCT03638648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025298|NCT03638648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25025299|NCT03638440|Naloxegol|naloxegol|mesh-list
25025300|NCT03638440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25025301|NCT03638440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025302|NCT03638440|Sensory System Agents|sensory system agents|mesh-ancestor
25025303|NCT03638440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25025304|NCT03638401|Morphine|morphine|mesh-list
25025305|NCT03638401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25025306|NCT03638401|Narcotics|narcotics|mesh-ancestor
25025307|NCT03638401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25025308|NCT03638401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025309|NCT03638401|Analgesics|analgesics|mesh-ancestor
25025310|NCT03638401|Sensory System Agents|sensory system agents|mesh-ancestor
25025311|NCT03638401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25112327|NCT04174170|Antidepressive Agents|antidepressive agents|mesh-ancestor
25112328|NCT04174170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24986229|NCT02122198|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25122211|NCT03095469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122212|NCT03095469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25122213|NCT03095469|Analgesics|analgesics|mesh-ancestor
25076457|NCT03372837|Rituximab|rituximab|mesh-list
25122403|NCT03094403|Dermatologic Agents|dermatologic agents|mesh-ancestor
25122404|NCT03094468|Terbinafine|terbinafine|mesh-list
25122408|NCT03094468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122410|NCT03094507|Dolutegravir|dolutegravir|mesh-list
25128116|NCT03050710|Anesthetics|anesthetics|mesh-ancestor
25126207|NCT03063671|Anesthetics, General|anesthetics, general|mesh-ancestor
25126209|NCT03063671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25126210|NCT03063671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25045748|NCT00917826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25112329|NCT04174170|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25112330|NCT04174170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25112331|NCT04174170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25112332|NCT04174170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112333|NCT04174170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25112334|NCT04174170|Serotonin Agents|serotonin agents|mesh-ancestor
25112335|NCT04174170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112336|NCT04174170|Dopamine Agonists|dopamine agonists|mesh-ancestor
25112337|NCT04174170|Dopamine Agents|dopamine agents|mesh-ancestor
25112338|NCT04172558|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25112339|NCT04172558|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25112340|NCT04172558|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25126357|NCT03062904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126358|NCT03062904|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25126359|NCT03062904|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
25126360|NCT03062904|Respiratory System Agents|respiratory system agents|mesh-ancestor
25126361|NCT03062904|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25126362|NCT03062904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25126363|NCT03062904|Cholinergic Agents|cholinergic agents|mesh-ancestor
25126364|NCT03062904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25126365|NCT03062904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956216|NCT03856112|Venetoclax|venetoclax|mesh-list
25126530|NCT03061656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25126531|NCT03061656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25126532|NCT03061656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25126533|NCT03061656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25126534|NCT03061656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25126535|NCT03061656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126746|NCT03059979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25126747|NCT03059979|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25126748|NCT03059979|Protective Agents|protective agents|mesh-ancestor
25126749|NCT03059979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25126750|NCT03059979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25126751|NCT03060044|Fluticasone|fluticasone|mesh-list
25126753|NCT03060044|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25650164|NCT01499576|Immunologic Factors|immunologic factors|mesh-ancestor
25650165|NCT01499576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868324|NCT05156892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24737334|NCT01668446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24737335|NCT01668446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737336|NCT01668446|Vasodilator Agents|vasodilator agents|mesh-ancestor
24737337|NCT01668446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24956429|NCT03854383|Diuretics|diuretics|mesh-ancestor
24956476|NCT03854266|Heparin|heparin|mesh-list
24782292|NCT01895205|Hematinics|hematinics|mesh-ancestor
25127023|NCT03058419|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25127024|NCT03058419|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25127025|NCT03058419|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25127026|NCT03058419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25127027|NCT03058419|Purinergic Agents|purinergic agents|mesh-ancestor
25127028|NCT03058419|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25127178|NCT03057561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127179|NCT03057145|Olaparib|olaparib|mesh-list
25127180|NCT03057145|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25127181|NCT03057145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25129054|NCT03043326|Emtricitabine|emtricitabine|mesh-list
25127182|NCT03057145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127183|NCT03057145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25127185|NCT03057041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25127186|NCT03057041|Narcotics|narcotics|mesh-ancestor
25127187|NCT03057041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25127188|NCT03057041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127253|NCT03056495|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25127254|NCT03056495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25127255|NCT03056495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127256|NCT03056625|Vitamin A|vitamin a|mesh-list
25127257|NCT03056625|Vitamins|vitamins|mesh-ancestor
25127258|NCT03056625|Micronutrients|micronutrients|mesh-ancestor
25127259|NCT03056625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127260|NCT03056703|Aspirin|aspirin|mesh-list
25127261|NCT03056703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25127262|NCT03056703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25127291|NCT03056482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25127292|NCT03056482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25127293|NCT03056482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25127294|NCT03056482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25127295|NCT03056482|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25127297|NCT03056482|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25127298|NCT03056599|Gemcitabine|gemcitabine|mesh-list
25127299|NCT03056599|Interferons|interferons|mesh-list
25127300|NCT03056599|Interferon-alpha|interferon-alpha|mesh-list
25127301|NCT03056599|Interferon alpha-2|interferon alpha-2|mesh-list
25127302|NCT03056599|Aldesleukin|aldesleukin|mesh-list
25127303|NCT03056599|Interferon-gamma|interferon-gamma|mesh-list
25127304|NCT03056599|Docetaxel|docetaxel|mesh-list
25127305|NCT03056599|Doxorubicin|doxorubicin|mesh-list
25127306|NCT03056599|Pembrolizumab|pembrolizumab|mesh-list
25127307|NCT03056599|Nivolumab|nivolumab|mesh-list
25127308|NCT03056599|Bortezomib|bortezomib|mesh-list
25127309|NCT03056599|Ipilimumab|ipilimumab|mesh-list
25127310|NCT03056599|Atezolizumab|atezolizumab|mesh-list
25127311|NCT03056599|Durvalumab|durvalumab|mesh-list
25127312|NCT03056599|Avelumab|avelumab|mesh-list
25127592|NCT03054207|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25127594|NCT03054207|Purinergic Agents|purinergic agents|mesh-ancestor
25127595|NCT03054207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25025424|NCT03637361|Methadone|methadone|mesh-list
25127596|NCT03054207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127597|NCT03054207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127598|NCT03054285|Levetiracetam|levetiracetam|mesh-list
25127599|NCT03054285|Anticonvulsants|anticonvulsants|mesh-ancestor
25127600|NCT03054285|Nootropic Agents|nootropic agents|mesh-ancestor
25127602|NCT03054467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25127603|NCT03054467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25127604|NCT03054467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25650166|NCT01499576|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25650167|NCT01499576|Protective Agents|protective agents|mesh-ancestor
25650168|NCT01499576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25650169|NCT01499654|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
25650170|NCT01499654|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25650171|NCT01499654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650172|NCT01499667|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25127720|NCT03053947|Anesthetics, General|anesthetics, general|mesh-ancestor
25127722|NCT03053947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25127723|NCT03053947|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25127724|NCT03053947|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25127725|NCT03053947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25127726|NCT03053947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127728|NCT03053830|Analgesics|analgesics|mesh-ancestor
25127729|NCT03053830|Sensory System Agents|sensory system agents|mesh-ancestor
25127730|NCT03053830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25127731|NCT03053830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127732|NCT03053830|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25127733|NCT03053830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25127734|NCT03053830|Anesthetics, General|anesthetics, general|mesh-ancestor
25127735|NCT03053830|Anesthetics|anesthetics|mesh-ancestor
25127736|NCT03053830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25025462|NCT03636971|Viscosupplements|viscosupplements|mesh-ancestor
25127737|NCT03053830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25127738|NCT03053830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25127739|NCT03053830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25127740|NCT03053830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127741|NCT03053388|Nitric Oxide|nitric oxide|mesh-list
25127742|NCT03053388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25127743|NCT03053388|Autonomic Agents|autonomic agents|mesh-ancestor
25127744|NCT03053388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25127745|NCT03053388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127746|NCT03053388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25127813|NCT03052673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127814|NCT03052673|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25127815|NCT03052673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25127817|NCT03052673|Anesthetics|anesthetics|mesh-ancestor
25127818|NCT03052673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25127819|NCT03052673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25127820|NCT03052673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25127821|NCT03052673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25127822|NCT03052673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575286|NCT00830505|Xhance|xhance|mesh-list
25127979|NCT03051698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25127980|NCT03051698|Immunologic Factors|immunologic factors|mesh-ancestor
25127981|NCT03051698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127982|NCT03051503|Fentanyl|fentanyl|mesh-list
25127983|NCT03051503|Morphine|morphine|mesh-list
25127984|NCT03051503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25127985|NCT03051503|Narcotics|narcotics|mesh-ancestor
25127986|NCT03051503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25127987|NCT03051503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025494|NCT03636685|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25025495|NCT03636685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25127988|NCT03051503|Analgesics|analgesics|mesh-ancestor
25128029|NCT03051087|Hormone Antagonists|hormone antagonists|mesh-ancestor
25128527|NCT03046758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25128030|NCT03051087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25128031|NCT03051087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128032|NCT03051269|Calcium, Dietary|calcium, dietary|mesh-list
25128033|NCT03051269|Calcium|calcium|mesh-list
25128034|NCT03051269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25128035|NCT03051269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128036|NCT03051269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25128037|NCT03051243|Insulin|insulin|mesh-list
25128038|NCT03051243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25128039|NCT03051243|Linagliptin|linagliptin|mesh-list
25128040|NCT03051243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25128041|NCT03051243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128042|NCT03051243|Incretins|incretins|mesh-ancestor
25128043|NCT03051243|Hormones|hormones|mesh-ancestor
25128044|NCT03051243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25128045|NCT03051243|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25128046|NCT03051243|Protease Inhibitors|protease inhibitors|mesh-ancestor
25128047|NCT03051243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128048|NCT03051243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128049|NCT03050866|Antiemetics|antiemetics|mesh-list
25025523|NCT03636373|Etanercept|etanercept|mesh-list
25025524|NCT03636373|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25025525|NCT03636373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25025526|NCT03636373|Glucocorticoids|glucocorticoids|mesh-ancestor
25025527|NCT03636373|Hormones|hormones|mesh-ancestor
25025528|NCT03636373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25025529|NCT03636373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025530|NCT03636373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25025531|NCT03636373|Immunologic Factors|immunologic factors|mesh-ancestor
25025532|NCT03636373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25025533|NCT03636373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025534|NCT03636373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25025536|NCT03636373|Analgesics|analgesics|mesh-ancestor
25128050|NCT03050866|Histamine|histamine|mesh-list
25128051|NCT03050866|Histamine Antagonists|histamine antagonists|mesh-list
24957554|NCT03843879|Lidocaine|lidocaine|mesh-list
25128102|NCT03051022|Glucocorticoids|glucocorticoids|mesh-ancestor
25128104|NCT03051022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25128105|NCT03051022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25128106|NCT03051022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25128107|NCT03051022|Anesthetics, Local|anesthetics, local|mesh-ancestor
25128109|NCT03051022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25128110|NCT03051022|Sensory System Agents|sensory system agents|mesh-ancestor
25128111|NCT03051022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25128113|NCT03051022|Analgesics|analgesics|mesh-ancestor
24804593|NCT02003664|GABA Agents|gaba agents|mesh-ancestor
25128114|NCT03050710|Lidocaine|lidocaine|mesh-list
25128115|NCT03050710|Anesthetics, Local|anesthetics, local|mesh-ancestor
25128129|NCT03050437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128130|NCT03050437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24957594|NCT03843541|Protective Agents|protective agents|mesh-ancestor
25025545|NCT03636308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25128445|NCT03047278|Gabapentin|gabapentin|mesh-list
25128446|NCT03047278|Analgesics|analgesics|mesh-ancestor
25128447|NCT03047278|Sensory System Agents|sensory system agents|mesh-ancestor
25128448|NCT03047278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24957917|NCT03839537|Protective Agents|protective agents|mesh-ancestor
25128480|NCT03047057|Anesthetics, Local|anesthetics, local|mesh-ancestor
25128481|NCT03047057|Anesthetics|anesthetics|mesh-ancestor
25128482|NCT03047057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25128483|NCT03047057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128484|NCT03047057|Sensory System Agents|sensory system agents|mesh-ancestor
25128485|NCT03047057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25128486|NCT03047057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25128487|NCT03047057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25128488|NCT03047057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25128489|NCT03047057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24957943|NCT03839251|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25128520|NCT03046901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25128521|NCT03046901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25128522|NCT03046693|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
25128523|NCT03046693|Nootropic Agents|nootropic agents|mesh-ancestor
25128524|NCT03046758|Metronidazole|metronidazole|mesh-list
25128525|NCT03046758|Fosfomycin|fosfomycin|mesh-list
25128526|NCT03046758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25128528|NCT03046758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25025582|NCT03635905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25025583|NCT03635905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24739614|NCT01682902|Insulin|insulin|mesh-list
25025584|NCT03635905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25025585|NCT03635905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25128529|NCT03046758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25128530|NCT03046511|Cefazolin|cefazolin|mesh-list
25128531|NCT03046511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25128532|NCT03046511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25128533|NCT03046719|Bupivacaine|bupivacaine|mesh-list
25128534|NCT03046719|Anesthetics, Local|anesthetics, local|mesh-ancestor
25128535|NCT03046719|Anesthetics|anesthetics|mesh-ancestor
25128536|NCT03046719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24626718|NCT01088516|Zidovudine|zidovudine|mesh-list
25128591|NCT03046290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128593|NCT03046238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25128594|NCT03046238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25128595|NCT03046238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128596|NCT03046238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25128597|NCT03046238|Analgesics|analgesics|mesh-ancestor
25128598|NCT03046238|Sensory System Agents|sensory system agents|mesh-ancestor
24943733|NCT03967496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24737838|NCT01670812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737839|NCT01670812|Immunologic Factors|immunologic factors|mesh-ancestor
24737840|NCT01670812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737841|NCT01670812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24737842|NCT01670812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24737843|NCT01670812|Antiemetics|antiemetics|mesh-ancestor
24737860|NCT01670929|Hormones|hormones|mesh-ancestor
25128599|NCT03046238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25128667|NCT03045471|Rituximab|rituximab|mesh-list
25128668|NCT03045471|Etoposide|etoposide|mesh-list
25128669|NCT03045471|Vincristine|vincristine|mesh-list
25128670|NCT03045471|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25128671|NCT03045471|Prednisolone phosphate|prednisolone phosphate|mesh-list
25128672|NCT03045471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25128673|NCT03045471|Immunologic Factors|immunologic factors|mesh-ancestor
25128674|NCT03045471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128675|NCT03045471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25128676|NCT03045471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25128677|NCT03045471|Alkylating Agents|alkylating agents|mesh-ancestor
25128678|NCT03045471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128679|NCT03045471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25128741|NCT03045393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128743|NCT03045133|Methadone|methadone|mesh-list
25128744|NCT03045133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25128745|NCT03045133|Narcotics|narcotics|mesh-ancestor
25128746|NCT03045133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25128747|NCT03045133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128748|NCT03045133|Analgesics|analgesics|mesh-ancestor
25128749|NCT03045133|Sensory System Agents|sensory system agents|mesh-ancestor
25128750|NCT03045133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25128775|NCT03044964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25128776|NCT03044964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128778|NCT03044873|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25128779|NCT03044873|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25128780|NCT03044873|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25128781|NCT03044873|Antimetabolites|antimetabolites|mesh-ancestor
25128782|NCT03044873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128783|NCT03044873|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25128784|NCT03044873|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25128785|NCT03044873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128786|NCT03044873|Dermatologic Agents|dermatologic agents|mesh-ancestor
25128787|NCT03044873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25128788|NCT03044626|Nivolumab|nivolumab|mesh-list
25128789|NCT03044626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25128790|NCT03044626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25128791|NCT03044626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25128792|NCT03044626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128793|NCT03044743|Cyclophosphamide|cyclophosphamide|mesh-list
25128794|NCT03044743|Fludarabine|fludarabine|mesh-list
25128795|NCT03044743|Interleukin-2|interleukin-2|mesh-list
25025689|NCT03634852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25025690|NCT03634852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025691|NCT03634852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25025692|NCT03634852|Glucocorticoids|glucocorticoids|mesh-ancestor
25025693|NCT03634852|Hormones|hormones|mesh-ancestor
25025694|NCT03634852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25025695|NCT03634852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25025696|NCT03634852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25025697|NCT03634852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25025698|NCT03634852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25025699|NCT03634852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25025700|NCT03634852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25128796|NCT03044743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25128797|NCT03044743|Immunologic Factors|immunologic factors|mesh-ancestor
24958177|NCT03836157|Maytansine|maytansine|mesh-list
25650173|NCT01499667|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25650174|NCT01499667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650175|NCT01499667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25650176|NCT01499667|Immunologic Factors|immunologic factors|mesh-ancestor
25650177|NCT01499667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650178|NCT01499849|Dexamethasone|dexamethasone|mesh-list
25650179|NCT01499849|Granisetron|granisetron|mesh-list
25650180|NCT01499849|Rolapitant|rolapitant|mesh-list
24943857|NCT03966898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24943858|NCT03966898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128854|NCT03044561|Vasodilator Agents|vasodilator agents|mesh-ancestor
25128855|NCT03044561|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25128856|NCT03044561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25128857|NCT03044561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128858|NCT03044561|Urological Agents|urological agents|mesh-ancestor
25128859|NCT03044522|Analgesics, Opioid|analgesics, opioid|mesh-list
25128860|NCT03044522|Narcotics|narcotics|mesh-ancestor
25128861|NCT03044522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25128862|NCT03044522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128863|NCT03044522|Analgesics|analgesics|mesh-ancestor
25128864|NCT03044522|Sensory System Agents|sensory system agents|mesh-ancestor
25128865|NCT03044522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25128866|NCT03044938|Albuterol|albuterol|mesh-list
25128867|NCT03044938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25128868|NCT03044938|Autonomic Agents|autonomic agents|mesh-ancestor
25128869|NCT03044938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25025703|NCT03634852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25025704|NCT03634852|Contraceptive Agents|contraceptive agents|mesh-ancestor
25025705|NCT03634852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25025706|NCT03634852|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25025707|NCT03634852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25025708|NCT03634852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25025709|NCT03634852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25025710|NCT03634852|Immunologic Factors|immunologic factors|mesh-ancestor
25025711|NCT03634852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25025712|NCT03634735|Thiamine|thiamine|mesh-list
25025713|NCT03634735|Vitamins|vitamins|mesh-ancestor
25025714|NCT03634735|Micronutrients|micronutrients|mesh-ancestor
25025715|NCT03634735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025716|NCT03634735|Vitamin B Complex|vitamin b complex|mesh-ancestor
24590596|NCT00913315|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25025728|NCT03634605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25025729|NCT03634605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128870|NCT03044938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128871|NCT03044938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25128872|NCT03044938|Respiratory System Agents|respiratory system agents|mesh-ancestor
25128873|NCT03044938|Tocolytic Agents|tocolytic agents|mesh-ancestor
25128874|NCT03044938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25128875|NCT03044938|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25128877|NCT03044938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25128878|NCT03044938|Adrenergic Agents|adrenergic agents|mesh-ancestor
25128879|NCT03044938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25128880|NCT03044938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128913|NCT03044184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25128914|NCT03044184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25128915|NCT03044184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128916|NCT03044041|Tranexamic Acid|tranexamic acid|mesh-list
25128917|NCT03044041|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25128918|NCT03044041|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25128919|NCT03044041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128920|NCT03044041|Hemostatics|hemostatics|mesh-ancestor
25128921|NCT03044041|Coagulants|coagulants|mesh-ancestor
25128922|NCT03044093|Misoprostol|misoprostol|mesh-list
25128923|NCT03044093|Mifepristone|mifepristone|mesh-list
25128924|NCT03044093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25128925|NCT03044093|Abortifacient Agents|abortifacient agents|mesh-ancestor
25128958|NCT03043677|Vedolizumab|vedolizumab|mesh-list
25128959|NCT03043677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25128960|NCT03043677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25128961|NCT03043677|Dermatologic Agents|dermatologic agents|mesh-ancestor
25128962|NCT03043677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25128963|NCT03043677|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25128964|NCT03043677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25128965|NCT03043677|Immunologic Factors|immunologic factors|mesh-ancestor
25128966|NCT03043677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128967|NCT03043820|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25128968|NCT03043820|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25128969|NCT03043820|Hormone Antagonists|hormone antagonists|mesh-ancestor
25650181|NCT01499849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25650182|NCT01499849|Antiemetics|antiemetics|mesh-ancestor
25128970|NCT03043820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25650183|NCT01499849|Autonomic Agents|autonomic agents|mesh-ancestor
24738499|NCT01675895|Sensory System Agents|sensory system agents|mesh-ancestor
24738542|NCT01675986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24738543|NCT01675986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25128971|NCT03043820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128972|NCT03043820|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25128973|NCT03043820|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25078439|NCT03356444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25129003|NCT03043612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129004|NCT03043521|Dexlansoprazole|dexlansoprazole|mesh-list
25129005|NCT03043521|Lansoprazole|lansoprazole|mesh-list
25129006|NCT03043521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25129007|NCT03043521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25129008|NCT03043521|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25129009|NCT03043521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25129010|NCT03043521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129012|NCT03043430|Ketamine|ketamine|mesh-list
25129013|NCT03043430|Analgesics|analgesics|mesh-ancestor
25129014|NCT03043430|Sensory System Agents|sensory system agents|mesh-ancestor
25129015|NCT03043430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25129016|NCT03043430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129017|NCT03043430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25129052|NCT03043248|Protective Agents|protective agents|mesh-ancestor
25129053|NCT03043326|Tenofovir|tenofovir|mesh-list
25129055|NCT03043326|Antiviral Agents|antiviral agents|mesh-ancestor
25129056|NCT03043326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25129057|NCT03043326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25129058|NCT03043326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25129059|NCT03043326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25129060|NCT03043326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129088|NCT03043443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129089|NCT03043443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25129090|NCT03043495|Dexamethasone|dexamethasone|mesh-list
25129091|NCT03043495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25129092|NCT03043495|Antiemetics|antiemetics|mesh-ancestor
25025765|NCT03634332|Pembrolizumab|pembrolizumab|mesh-list
25129093|NCT03043495|Autonomic Agents|autonomic agents|mesh-ancestor
25129094|NCT03043495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25129095|NCT03043495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129096|NCT03043495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25129097|NCT03043495|Glucocorticoids|glucocorticoids|mesh-ancestor
25129098|NCT03043495|Hormones|hormones|mesh-ancestor
24457775|NCT00335192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24457776|NCT00335192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457777|NCT00335192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518430|NCT05059626|Estrogens|estrogens|mesh-list
25129099|NCT03043495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25129100|NCT03043495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25129101|NCT03043495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25129102|NCT03043157|Rocuronium|rocuronium|mesh-list
25129103|NCT03043157|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25129104|NCT03043157|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24958454|NCT03833063|Botulinum Toxins|botulinum toxins|mesh-list
25129138|NCT03043027|Bupivacaine|bupivacaine|mesh-list
25129139|NCT03043027|Anesthetics, Local|anesthetics, local|mesh-ancestor
25129140|NCT03043027|Anesthetics|anesthetics|mesh-ancestor
25129141|NCT03043027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25129142|NCT03043027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129143|NCT03043027|Sensory System Agents|sensory system agents|mesh-ancestor
25129144|NCT03043027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25129145|NCT03043066|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25129146|NCT03043066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25025801|NCT03634020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25129147|NCT03043066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25129214|NCT03042377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25129215|NCT03042377|Calcium|calcium|mesh-list
25129216|NCT03042377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25129217|NCT03042377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129218|NCT03042377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25129219|NCT03042377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25129220|NCT03042377|Antitubercular Agents|antitubercular agents|mesh-ancestor
25129221|NCT03042325|Alogliptin|alogliptin|mesh-list
25650184|NCT01499849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650185|NCT01499849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650186|NCT01499849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25129222|NCT03042325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25129223|NCT03042325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129224|NCT03042325|Incretins|incretins|mesh-ancestor
25129225|NCT03042325|Hormones|hormones|mesh-ancestor
25129256|NCT03041935|Ondansetron|ondansetron|mesh-list
25129257|NCT03041935|Propofol|propofol|mesh-list
25129258|NCT03041935|Ropivacaine|ropivacaine|mesh-list
25129259|NCT03041935|Sevoflurane|sevoflurane|mesh-list
25129260|NCT03041935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25025831|NCT03633630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129261|NCT03041935|Antiemetics|antiemetics|mesh-ancestor
25129262|NCT03041935|Autonomic Agents|autonomic agents|mesh-ancestor
25129263|NCT03041935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25129264|NCT03041935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129265|NCT03041935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25129266|NCT03041935|Glucocorticoids|glucocorticoids|mesh-ancestor
25129267|NCT03041935|Hormones|hormones|mesh-ancestor
25129268|NCT03041935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25129269|NCT03041935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24626761|NCT01088659|Antiviral Agents|antiviral agents|mesh-ancestor
25129324|NCT03041948|Glucocorticoids|glucocorticoids|mesh-ancestor
25129326|NCT03041948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24969301|NCT03743987|Pemetrexed|pemetrexed|mesh-list
25025847|NCT03633565|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25025848|NCT03633565|Prednisolone phosphate|prednisolone phosphate|mesh-list
25025849|NCT03633565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
25025850|NCT03633565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25025851|NCT03633565|Glucocorticoids|glucocorticoids|mesh-ancestor
25025852|NCT03633565|Hormones|hormones|mesh-ancestor
25025853|NCT03633565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25129327|NCT03041948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25129328|NCT03041948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25129329|NCT03041948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25129330|NCT03041948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25129332|NCT03041948|Anesthetics, General|anesthetics, general|mesh-ancestor
25129333|NCT03041948|Anesthetics|anesthetics|mesh-ancestor
25129334|NCT03041948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25129335|NCT03041948|Narcotics|narcotics|mesh-ancestor
25129336|NCT03041948|Analgesics|analgesics|mesh-ancestor
25129337|NCT03041948|Sensory System Agents|sensory system agents|mesh-ancestor
25129338|NCT03041948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25129339|NCT03041948|Antipyretics|antipyretics|mesh-ancestor
25129340|NCT03041948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25129341|NCT03041948|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25129342|NCT03041948|Antipruritics|antipruritics|mesh-ancestor
25025862|NCT03633565|Protective Agents|protective agents|mesh-ancestor
25129343|NCT03041948|Dermatologic Agents|dermatologic agents|mesh-ancestor
25129344|NCT03041948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25129345|NCT03041948|Serotonin Agents|serotonin agents|mesh-ancestor
25129346|NCT03041948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25129347|NCT03041948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166625|NCT03834571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166626|NCT03834493|Pembrolizumab|pembrolizumab|mesh-list
25166627|NCT03834493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25166628|NCT03834493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25129348|NCT03041948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25129349|NCT03041948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25129350|NCT03041948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25129351|NCT03041948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25129352|NCT03041948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25129353|NCT03041948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25129354|NCT03041948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25129355|NCT03041948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25129357|NCT03042182|Immunologic Factors|immunologic factors|mesh-ancestor
25078494|NCT03355716|Bupivacaine|bupivacaine|mesh-list
25129393|NCT03041506|Lidocaine|lidocaine|mesh-list
25129394|NCT03041506|Midazolam|midazolam|mesh-list
25129395|NCT03041506|Ketamine|ketamine|mesh-list
25129473|NCT03040752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25129474|NCT03040752|Adrenergic Agents|adrenergic agents|mesh-ancestor
25129475|NCT03040752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25129476|NCT03040817|Esomeprazole|esomeprazole|mesh-list
25129486|NCT03040817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129487|NCT03040765|Zoledronic Acid|zoledronic acid|mesh-list
25129488|NCT03040765|Denosumab|denosumab|mesh-list
25129489|NCT03040765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25129490|NCT03040765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129491|NCT03040635|Risdiplam|risdiplam|mesh-list
25829169|NCT00006144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25129492|NCT03040635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25129493|NCT03040635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25129494|NCT03040635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025952|NCT03632733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25129495|NCT03040531|Vitamin D|vitamin d|mesh-list
25129496|NCT03040531|Cholecalciferol|cholecalciferol|mesh-list
25129616|NCT03039608|Glucocorticoids|glucocorticoids|mesh-ancestor
25129617|NCT03039608|Hormones|hormones|mesh-ancestor
25129639|NCT03039426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25129640|NCT03039426|Analgesics|analgesics|mesh-ancestor
25129641|NCT03039426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25129642|NCT03039426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25129643|NCT03039426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25129644|NCT03039426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25129645|NCT03039426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129646|NCT03039478|Erythritol|erythritol|mesh-list
25129647|NCT03039478|Vasodilator Agents|vasodilator agents|mesh-ancestor
25129648|NCT03039205|Clopidogrel|clopidogrel|mesh-list
25129649|NCT03039205|Ticagrelor|ticagrelor|mesh-list
25129650|NCT03039205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25129651|NCT03039205|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25129652|NCT03039205|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25129653|NCT03039205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25129654|NCT03039205|Purinergic Agents|purinergic agents|mesh-ancestor
25829170|NCT00006144|Antimetabolites|antimetabolites|mesh-ancestor
25829171|NCT00006145|Valganciclovir|valganciclovir|mesh-list
25829172|NCT00006145|Antiviral Agents|antiviral agents|mesh-ancestor
25829173|NCT00006145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25829174|NCT00006152|Ritonavir|ritonavir|mesh-list
25829175|NCT00006152|Amprenavir|amprenavir|mesh-list
25829176|NCT00006152|Abacavir|abacavir|mesh-list
25829177|NCT00006152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25129664|NCT03038919|Testosterone undecanoate|testosterone undecanoate|mesh-list
25129665|NCT03038919|Testosterone enanthate|testosterone enanthate|mesh-list
25129666|NCT03038919|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25129667|NCT03038919|Androgens|androgens|mesh-ancestor
25129668|NCT03038919|Hormones|hormones|mesh-ancestor
25129669|NCT03038919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25129670|NCT03038919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129741|NCT03038451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25129742|NCT03038451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25129743|NCT03038451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25129766|NCT03038321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25129767|NCT03038321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25129768|NCT03038321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25129769|NCT03038321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25129770|NCT03038321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129771|NCT03038321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25129772|NCT03038321|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25129773|NCT03038321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25129774|NCT03038321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25129775|NCT03038321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25129776|NCT03038321|Analgesics|analgesics|mesh-ancestor
25129777|NCT03038321|Sensory System Agents|sensory system agents|mesh-ancestor
25129778|NCT03038321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24959017|NCT03827876|Calcipotriene|calcipotriene|mesh-list
24959018|NCT03827876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25129795|NCT03038217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25129796|NCT03038425|Ropivacaine|ropivacaine|mesh-list
25129797|NCT03038425|Anesthetics, Local|anesthetics, local|mesh-ancestor
25129798|NCT03038425|Anesthetics|anesthetics|mesh-ancestor
25026001|NCT03632460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25026002|NCT03632460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026003|NCT03632460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25026004|NCT03632460|Analgesics|analgesics|mesh-ancestor
25026005|NCT03632460|Sensory System Agents|sensory system agents|mesh-ancestor
25026006|NCT03632460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25026007|NCT03632460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25129799|NCT03038425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25129800|NCT03038425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129801|NCT03038425|Sensory System Agents|sensory system agents|mesh-ancestor
25129802|NCT03038425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25129803|NCT03038256|Capecitabine|capecitabine|mesh-list
25650187|NCT01499849|Glucocorticoids|glucocorticoids|mesh-ancestor
25650188|NCT01499849|Hormones|hormones|mesh-ancestor
24741286|NCT01693289|Letrozole|letrozole|mesh-list
24741287|NCT01693289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24741288|NCT01693289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741289|NCT01693289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24741290|NCT01693289|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25129804|NCT03038256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25129805|NCT03038256|Antimetabolites|antimetabolites|mesh-ancestor
25129811|NCT03038230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129812|NCT03038334|Magnesium Sulfate|magnesium sulfate|mesh-list
25129814|NCT03038334|Sensory System Agents|sensory system agents|mesh-ancestor
25129849|NCT03037944|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25129850|NCT03037944|Hormone Antagonists|hormone antagonists|mesh-ancestor
25129851|NCT03037944|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25129871|NCT03037775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129873|NCT03037736|Fluorouracil|fluorouracil|mesh-list
25129874|NCT03037736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25129875|NCT03037736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25129876|NCT03037736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25129877|NCT03037736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25129878|NCT03037736|Growth Substances|growth substances|mesh-ancestor
25129879|NCT03037736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129880|NCT03037736|Growth Inhibitors|growth inhibitors|mesh-ancestor
25129881|NCT03037736|Antimetabolites|antimetabolites|mesh-ancestor
25129882|NCT03037736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129883|NCT03037736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25129884|NCT03037736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25129885|NCT03037736|Immunologic Factors|immunologic factors|mesh-ancestor
25129886|NCT03037892|Fentanyl|fentanyl|mesh-list
25129887|NCT03037892|Midazolam|midazolam|mesh-list
25129888|NCT03037892|Remifentanil|remifentanil|mesh-list
25129889|NCT03037892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25129890|NCT03037892|Narcotics|narcotics|mesh-ancestor
25129891|NCT03037892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25129892|NCT03037892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129893|NCT03037892|Analgesics|analgesics|mesh-ancestor
25129894|NCT03037892|Sensory System Agents|sensory system agents|mesh-ancestor
25129895|NCT03037892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25129896|NCT03037892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25129897|NCT03037892|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25129898|NCT03037892|Anesthetics, General|anesthetics, general|mesh-ancestor
25129899|NCT03037892|Anesthetics|anesthetics|mesh-ancestor
25129900|NCT03037892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25129901|NCT03037892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25129902|NCT03037892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25129903|NCT03037892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25129904|NCT03037892|GABA Modulators|gaba modulators|mesh-ancestor
25129905|NCT03037892|GABA Agents|gaba agents|mesh-ancestor
25129906|NCT03037892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25129969|NCT03036826|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25129970|NCT03036826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25129971|NCT03036826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25130057|NCT03036605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130058|NCT03036605|Anesthetics, Local|anesthetics, local|mesh-ancestor
25130059|NCT03036605|Anesthetics|anesthetics|mesh-ancestor
25130060|NCT03036605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25130061|NCT03036605|Sensory System Agents|sensory system agents|mesh-ancestor
25130063|NCT03036501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25130064|NCT03036501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130065|NCT03036501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130066|NCT03036514|Sufentanil|sufentanil|mesh-list
25130067|NCT03036514|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25130068|NCT03036514|Narcotics|narcotics|mesh-ancestor
25130069|NCT03036514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25130070|NCT03036514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130071|NCT03036514|Analgesics|analgesics|mesh-ancestor
25130072|NCT03036514|Sensory System Agents|sensory system agents|mesh-ancestor
25130073|NCT03036514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130074|NCT03036514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25130075|NCT03036514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25650189|NCT01499849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25650190|NCT01499849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25650191|NCT01499849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25650192|NCT01499849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25130076|NCT03036514|Anesthetics, General|anesthetics, general|mesh-ancestor
25130077|NCT03036514|Anesthetics|anesthetics|mesh-ancestor
24943981|NCT03965247|Antidepressive Agents|antidepressive agents|mesh-ancestor
24943982|NCT03965247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24943983|NCT03965247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25130159|NCT03036085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25130160|NCT03036085|Adrenergic Agents|adrenergic agents|mesh-ancestor
25130161|NCT03036085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25130162|NCT03036085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130163|NCT03036085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25130164|NCT03036085|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25130165|NCT03036085|Autonomic Agents|autonomic agents|mesh-ancestor
25130166|NCT03036085|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25078547|NCT03355482|Prednisolone|prednisolone|mesh-list
25130195|NCT03035578|Analgesics|analgesics|mesh-ancestor
25130196|NCT03035578|Sensory System Agents|sensory system agents|mesh-ancestor
25130197|NCT03035578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130198|NCT03035617|Bupivacaine|bupivacaine|mesh-list
25130199|NCT03035617|Anesthetics, Local|anesthetics, local|mesh-ancestor
25130200|NCT03035617|Anesthetics|anesthetics|mesh-ancestor
25130201|NCT03035617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25130202|NCT03035617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130203|NCT03035617|Sensory System Agents|sensory system agents|mesh-ancestor
25130204|NCT03035617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130206|NCT03035357|Daratumumab|daratumumab|mesh-list
25130207|NCT03035357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25130208|NCT03035305|Pyrimethamine|pyrimethamine|mesh-list
25130209|NCT03035305|Sulfadoxine|sulfadoxine|mesh-list
25130210|NCT03035305|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25130211|NCT03035305|Amodiaquine|amodiaquine|mesh-list
25130212|NCT03035305|Antimalarials|antimalarials|mesh-ancestor
25130213|NCT03035305|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25130214|NCT03035305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25130215|NCT03035305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25130294|NCT03034733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130334|NCT03034382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130408|NCT03033654|Sunscreening Agents|sunscreening agents|mesh-list
25130409|NCT03033654|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25130410|NCT03033654|Protective Agents|protective agents|mesh-ancestor
25130453|NCT03033355|Cholinergic Agents|cholinergic agents|mesh-ancestor
25130454|NCT03033355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25130480|NCT03033368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25130481|NCT03033368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130482|NCT03033368|Antiviral Agents|antiviral agents|mesh-ancestor
25130483|NCT03033368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25130484|NCT03033368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25130485|NCT03033368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25130486|NCT03033147|Amoxicillin|amoxicillin|mesh-list
25130487|NCT03033147|Clavulanic Acid|clavulanic acid|mesh-list
25130488|NCT03033147|Clavulanic Acids|clavulanic acids|mesh-list
25130489|NCT03033147|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25130490|NCT03033147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25130491|NCT03033147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25130492|NCT03033147|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25130493|NCT03033147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25130494|NCT03033147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130495|NCT03033342|Omeprazole|omeprazole|mesh-list
25130496|NCT03033342|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25130497|NCT03033342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25130498|NCT03033342|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25130499|NCT03033342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25130500|NCT03033342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130501|NCT03032978|Calcium, Dietary|calcium, dietary|mesh-list
24959619|NCT03823625|Nivolumab|nivolumab|mesh-list
25130576|NCT03032458|Ketorolac|ketorolac|mesh-list
25130577|NCT03032458|Lidocaine|lidocaine|mesh-list
25130578|NCT03032458|Meperidine|meperidine|mesh-list
25130579|NCT03032458|Anesthetics, Local|anesthetics, local|mesh-ancestor
25130580|NCT03032458|Anesthetics|anesthetics|mesh-ancestor
24959658|NCT03823274|Aspirin|aspirin|mesh-list
25130603|NCT03032367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25130604|NCT03032419|Vaccines|vaccines|mesh-list
25130605|NCT03032419|Immunologic Factors|immunologic factors|mesh-ancestor
25130606|NCT03032419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650193|NCT01499849|Serotonin Agents|serotonin agents|mesh-ancestor
25650194|NCT01499849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25650195|NCT01499849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130607|NCT03032042|Azithromycin|azithromycin|mesh-list
25130608|NCT03032042|Albendazole|albendazole|mesh-list
25130609|NCT03032042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24742354|NCT05273996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24742355|NCT05273996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24742476|NCT05264584|Antioxidants|antioxidants|mesh-ancestor
24742477|NCT05264584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742478|NCT05264584|Protective Agents|protective agents|mesh-ancestor
24742479|NCT05264584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130610|NCT03032042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25130611|NCT03032042|Anthelmintics|anthelmintics|mesh-ancestor
25130612|NCT03032042|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25130613|NCT03032042|Anticestodal Agents|anticestodal agents|mesh-ancestor
25130614|NCT03032042|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25130615|NCT03032042|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25130616|NCT03032042|Tubulin Modulators|tubulin modulators|mesh-ancestor
25130617|NCT03032042|Antimitotic Agents|antimitotic agents|mesh-ancestor
25130618|NCT03032042|Mitosis Modulators|mitosis modulators|mesh-ancestor
25130619|NCT03032042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130620|NCT03032042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25130622|NCT03032315|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25130623|NCT03032315|Telmisartan|telmisartan|mesh-list
25130624|NCT03032315|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
25130625|NCT03032315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25130626|NCT03032315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25130627|NCT03032315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25130628|NCT03032315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130629|NCT03032315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25130630|NCT03032315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130666|NCT03031808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25130667|NCT03031808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25130668|NCT03031808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25130750|NCT03031353|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25130752|NCT03031353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24959818|NCT03822312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25130830|NCT03030976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25130832|NCT03030690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25130833|NCT03030690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130834|NCT03030690|Sympathomimetics|sympathomimetics|mesh-ancestor
25130835|NCT03030690|Autonomic Agents|autonomic agents|mesh-ancestor
25130836|NCT03030690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130837|NCT03030690|Dopamine Agents|dopamine agents|mesh-ancestor
25130921|NCT03030131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25130923|NCT03030287|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25130924|NCT03030287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25130925|NCT03030287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25130926|NCT03030287|Tubulin Modulators|tubulin modulators|mesh-ancestor
25130927|NCT03030287|Antimitotic Agents|antimitotic agents|mesh-ancestor
25130955|NCT03030105|Autonomic Agents|autonomic agents|mesh-ancestor
25130956|NCT03030105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130957|NCT03030105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25130958|NCT03030105|Mydriatics|mydriatics|mesh-ancestor
25130959|NCT03030105|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25130960|NCT03030105|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25130961|NCT03030105|Parasympatholytics|parasympatholytics|mesh-ancestor
25130962|NCT03030248|Vancomycin|vancomycin|mesh-list
25130963|NCT03030248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25130964|NCT03030248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25131004|NCT03029455|Ivacaftor|ivacaftor|mesh-list
25131006|NCT03029455|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25131007|NCT03029455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25131008|NCT03029455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131009|NCT03029494|Ascorbic Acid|ascorbic acid|mesh-list
25131010|NCT03029494|Vitamins|vitamins|mesh-ancestor
25131011|NCT03029494|Micronutrients|micronutrients|mesh-ancestor
25131228|NCT03027648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25131229|NCT03027648|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25131231|NCT03027284|Gemcitabine|gemcitabine|mesh-list
25131232|NCT03027284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25650196|NCT01499849|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25650197|NCT01499940|Vitamin D|vitamin d|mesh-list
25650198|NCT01499940|Cholecalciferol|cholecalciferol|mesh-list
25650199|NCT01499940|Vitamins|vitamins|mesh-ancestor
25650200|NCT01499940|Micronutrients|micronutrients|mesh-ancestor
25650201|NCT01499940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650202|NCT01499940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24618394|NCT01048138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24407670|NCT00174993|Pioglitazone|pioglitazone|mesh-list
24407671|NCT00174993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24618399|NCT01048177|Heparin|heparin|mesh-list
24618400|NCT01048177|Anesthetics, Local|anesthetics, local|mesh-ancestor
24743082|NCT05013502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743084|NCT05013229|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24743085|NCT05013229|Insulin Glargine|insulin glargine|mesh-list
24743086|NCT05013229|Insulin Aspart|insulin aspart|mesh-list
24743087|NCT05013229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24743221|NCT04950868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24743222|NCT04950868|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24743231|NCT04936854|Sirolimus|sirolimus|mesh-list
25131233|NCT03027284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25131234|NCT03027284|Antimetabolites|antimetabolites|mesh-ancestor
25131235|NCT03027284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131236|NCT03027284|Antiviral Agents|antiviral agents|mesh-ancestor
25131237|NCT03027284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25131238|NCT03027284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131239|NCT03027284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25131240|NCT03027284|Immunologic Factors|immunologic factors|mesh-ancestor
25131241|NCT03027284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131242|NCT03027167|Aspirin|aspirin|mesh-list
25131270|NCT03026933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25131271|NCT03026933|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25131273|NCT03026842|Cytarabine|cytarabine|mesh-list
25131274|NCT03026842|Decitabine|decitabine|mesh-list
25131275|NCT03026842|Daunorubicin|daunorubicin|mesh-list
25131276|NCT03026842|Mitoxantrone|mitoxantrone|mesh-list
25131277|NCT03026842|Aclacinomycins|aclacinomycins|mesh-list
25131278|NCT03026842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25131279|NCT03026842|Antimetabolites|antimetabolites|mesh-ancestor
25131280|NCT03026842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131281|NCT03026842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131282|NCT03026842|Antiviral Agents|antiviral agents|mesh-ancestor
25131283|NCT03026842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25131284|NCT03026842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25131285|NCT03026842|Immunologic Factors|immunologic factors|mesh-ancestor
25131286|NCT03026842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131287|NCT03026842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131288|NCT03026842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25131324|NCT03026946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25131325|NCT03026946|Immunologic Factors|immunologic factors|mesh-ancestor
25131326|NCT03026946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131327|NCT03026946|Antifungal Agents|antifungal agents|mesh-ancestor
25131328|NCT03026946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25131329|NCT03026946|Dermatologic Agents|dermatologic agents|mesh-ancestor
25131473|NCT03025906|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25131474|NCT03025477|Paclitaxel|paclitaxel|mesh-list
25131475|NCT03025477|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25131476|NCT03025477|Cisplatin|cisplatin|mesh-list
25131477|NCT03025477|Carboplatin|carboplatin|mesh-list
25131478|NCT03025477|Epirubicin|epirubicin|mesh-list
25131479|NCT03025477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25131480|NCT03025477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131481|NCT03025477|Tubulin Modulators|tubulin modulators|mesh-ancestor
25131482|NCT03025477|Antimitotic Agents|antimitotic agents|mesh-ancestor
25131483|NCT03025477|Mitosis Modulators|mitosis modulators|mesh-ancestor
25131486|NCT03025477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25131488|NCT03025477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131489|NCT03025594|Ketorolac|ketorolac|mesh-list
25026363|NCT03629418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026364|NCT03629418|Protective Agents|protective agents|mesh-ancestor
25650203|NCT01499940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25650204|NCT01500083|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25650205|NCT01500083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25650206|NCT01500083|Alkylating Agents|alkylating agents|mesh-ancestor
25650207|NCT01500083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650208|NCT01500083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25650209|NCT01500213|Dexamethasone|dexamethasone|mesh-list
25650210|NCT01500213|Granisetron|granisetron|mesh-list
25650211|NCT01500213|Rolapitant|rolapitant|mesh-list
25650212|NCT01500213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25650213|NCT01500213|Antiemetics|antiemetics|mesh-ancestor
25650214|NCT01500213|Autonomic Agents|autonomic agents|mesh-ancestor
25026365|NCT03629379|Ustekinumab|ustekinumab|mesh-list
25026366|NCT03629379|Vedolizumab|vedolizumab|mesh-list
24743749|NCT04640493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743750|NCT04640493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24743751|NCT04640493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743752|NCT04635098|Dexmedetomidine|dexmedetomidine|mesh-list
24743753|NCT04635098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25131490|NCT03025594|Epinephrine|epinephrine|mesh-list
25131491|NCT03025594|Levobupivacaine|levobupivacaine|mesh-list
25131492|NCT03025594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25131493|NCT03025594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25131494|NCT03025594|Adrenergic Agents|adrenergic agents|mesh-ancestor
25131495|NCT03025594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25078616|NCT03355053|Analgesics|analgesics|mesh-ancestor
25131533|NCT03025295|Dexmedetomidine|dexmedetomidine|mesh-list
25131565|NCT03024905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25131566|NCT03024905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131567|NCT03024905|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25131568|NCT03024905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25131569|NCT03024905|Oxytocics|oxytocics|mesh-ancestor
25131570|NCT03024957|Dexmedetomidine|dexmedetomidine|mesh-list
25131571|NCT03024957|Morphine|morphine|mesh-list
25131572|NCT03024957|Bupivacaine|bupivacaine|mesh-list
25131573|NCT03024957|Anesthetics, Local|anesthetics, local|mesh-ancestor
25131574|NCT03024957|Anesthetics|anesthetics|mesh-ancestor
25131575|NCT03024957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25131576|NCT03024957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131577|NCT03024957|Sensory System Agents|sensory system agents|mesh-ancestor
25131607|NCT03025113|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25131608|NCT03025113|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25131609|NCT03025113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25131610|NCT03025113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25131611|NCT03025113|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25131612|NCT03025113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25131613|NCT03025113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25131614|NCT03025113|Adrenergic Agents|adrenergic agents|mesh-ancestor
25131615|NCT03025113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25131617|NCT03024840|Sevoflurane|sevoflurane|mesh-list
25131618|NCT03024840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25131619|NCT03024840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25131620|NCT03024840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131784|NCT03023501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131785|NCT03023501|Antimanic Agents|antimanic agents|mesh-ancestor
25131786|NCT03023436|Fluorouracil|fluorouracil|mesh-list
25131787|NCT03023436|Capecitabine|capecitabine|mesh-list
25131788|NCT03023436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131789|NCT03023436|Antimetabolites|antimetabolites|mesh-ancestor
25131790|NCT03023436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131791|NCT03023436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25131792|NCT03023436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25131793|NCT03023436|Immunologic Factors|immunologic factors|mesh-ancestor
25131794|NCT03023436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131795|NCT03023306|Antiemetics|antiemetics|mesh-list
25131796|NCT03023306|Autonomic Agents|autonomic agents|mesh-ancestor
25131848|NCT03023059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25131850|NCT03023059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25131860|NCT03023020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25131861|NCT03023020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25131863|NCT03023020|Sensory System Agents|sensory system agents|mesh-ancestor
25131864|NCT03023020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25131865|NCT03023020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131866|NCT03023020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25131867|NCT03023020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25131868|NCT03023020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25131869|NCT03023020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25131870|NCT03023020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131871|NCT03023020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25131872|NCT03023020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131873|NCT03023020|Antipyretics|antipyretics|mesh-ancestor
25131874|NCT03023007|Anesthetics|anesthetics|mesh-list
25131875|NCT03023007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25650215|NCT01500213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650216|NCT01500213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650217|NCT01500213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25650218|NCT01500213|Glucocorticoids|glucocorticoids|mesh-ancestor
25650219|NCT01500213|Hormones|hormones|mesh-ancestor
25657188|NCT01583985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24744242|NCT04402658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744243|NCT04402658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24744244|NCT04402658|Respiratory System Agents|respiratory system agents|mesh-ancestor
24744245|NCT04402658|Tocolytic Agents|tocolytic agents|mesh-ancestor
24744246|NCT04402658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24744247|NCT04402658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24944042|NCT03964324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944043|NCT03964324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24944044|NCT03964324|Respiratory System Agents|respiratory system agents|mesh-ancestor
25131876|NCT03023007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131878|NCT03022838|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25131879|NCT03022838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131880|NCT03022838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25131881|NCT03022838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131882|NCT03022838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131883|NCT03022838|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25131884|NCT03022838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25131885|NCT03022838|Purinergic Agents|purinergic agents|mesh-ancestor
25131886|NCT03022838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25131887|NCT03022877|Simendan|simendan|mesh-list
25131888|NCT03022877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25131889|NCT03022877|Vasodilator Agents|vasodilator agents|mesh-ancestor
25131890|NCT03022877|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25131891|NCT03022877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25131892|NCT03022877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24960745|NCT03814343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131919|NCT03022318|Carbidopa|carbidopa|mesh-list
25131920|NCT03022318|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25131921|NCT03022318|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25131922|NCT03022318|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25131923|NCT03022318|Dopamine Agents|dopamine agents|mesh-ancestor
25131924|NCT03022318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25131925|NCT03022318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131926|NCT03022318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131927|NCT03022318|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25131928|NCT03022318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131929|NCT03022318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25131930|NCT03022318|Immunologic Factors|immunologic factors|mesh-ancestor
25131931|NCT03022318|Dopamine Agonists|dopamine agonists|mesh-ancestor
25131932|NCT03022409|Olaparib|olaparib|mesh-list
25131933|NCT03022409|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25131934|NCT03022409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131935|NCT03022409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131936|NCT03022409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131937|NCT03022240|Ondansetron|ondansetron|mesh-list
25131938|NCT03022240|Propofol|propofol|mesh-list
25131939|NCT03022240|Sevoflurane|sevoflurane|mesh-list
24960792|NCT03813979|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25131968|NCT03022201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25131969|NCT03022201|Dopamine Agents|dopamine agents|mesh-ancestor
25131970|NCT03022201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25131971|NCT03022201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131972|NCT03022253|Acetaminophen|acetaminophen|mesh-list
25131973|NCT03022253|Ibuprofen|ibuprofen|mesh-list
25131974|NCT03022253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25131975|NCT03022253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25131976|NCT03022253|Analgesics|analgesics|mesh-ancestor
25131977|NCT03022253|Sensory System Agents|sensory system agents|mesh-ancestor
25041722|NCT01593228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25131978|NCT03022253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25131979|NCT03022253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131980|NCT03022253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25131981|NCT03022253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25650220|NCT01500213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25650221|NCT01500213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25650222|NCT01500213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25650223|NCT01500213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25650224|NCT01500213|Serotonin Agents|serotonin agents|mesh-ancestor
25650225|NCT01500213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25650226|NCT01500213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650227|NCT01500213|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25650228|NCT01500226|Dexamethasone|dexamethasone|mesh-list
24744667|NCT04200651|Prednisolone|prednisolone|mesh-list
24744668|NCT04200651|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24744669|NCT04200651|Methylprednisolone|methylprednisolone|mesh-list
24744670|NCT04200651|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24744671|NCT04200651|Prednisolone acetate|prednisolone acetate|mesh-list
24744672|NCT04200651|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24744673|NCT04200651|Prednisolone phosphate|prednisolone phosphate|mesh-list
25131982|NCT03022253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25131983|NCT03022253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131984|NCT03022253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131985|NCT03022253|Antipyretics|antipyretics|mesh-ancestor
25131986|NCT03022500|Durvalumab|durvalumab|mesh-list
25132021|NCT03022123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25132022|NCT03022123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25132023|NCT03022123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25132024|NCT03022123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25132025|NCT03022123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25132026|NCT03022123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25132027|NCT03022123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25026522|NCT03628040|Anesthetics|anesthetics|mesh-ancestor
25026523|NCT03628040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25132443|NCT03018626|Tubulin Modulators|tubulin modulators|mesh-ancestor
25132444|NCT03018626|Antimitotic Agents|antimitotic agents|mesh-ancestor
25132445|NCT03018626|Mitosis Modulators|mitosis modulators|mesh-ancestor
25132446|NCT03018535|Methylprednisolone|methylprednisolone|mesh-list
25132448|NCT03018535|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25132449|NCT03018535|Prednisolone|prednisolone|mesh-list
25132450|NCT03018535|Prednisolone acetate|prednisolone acetate|mesh-list
25132451|NCT03018535|Cyclophosphamide|cyclophosphamide|mesh-list
25132452|NCT03018535|Rituximab|rituximab|mesh-list
25132453|NCT03018535|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25132454|NCT03018535|Prednisolone phosphate|prednisolone phosphate|mesh-list
25132455|NCT03018535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25132456|NCT03018535|Immunologic Factors|immunologic factors|mesh-ancestor
25132457|NCT03018535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132458|NCT03018535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25132459|NCT03018535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24961199|NCT03809949|Fentanyl|fentanyl|mesh-list
25132588|NCT03018015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132620|NCT03017703|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25132621|NCT03017703|Hormone Antagonists|hormone antagonists|mesh-ancestor
25132622|NCT03017703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25132623|NCT03017703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132624|NCT03017703|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25132625|NCT03017703|Diuretics|diuretics|mesh-ancestor
25132626|NCT03017703|Natriuretic Agents|natriuretic agents|mesh-ancestor
25132627|NCT03017703|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25132629|NCT03017768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25132630|NCT03017768|Antidepressive Agents|antidepressive agents|mesh-ancestor
25132631|NCT03017768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25132632|NCT03017807|Antibodies|antibodies|mesh-list
24961373|NCT03809143|Analgesics|analgesics|mesh-ancestor
25132682|NCT03017248|Analgesics|analgesics|mesh-ancestor
25132683|NCT03017248|Sensory System Agents|sensory system agents|mesh-ancestor
25132684|NCT03017248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25132685|NCT03017248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132686|NCT03017248|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25132687|NCT03017248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25132688|NCT03017248|Anesthetics, General|anesthetics, general|mesh-ancestor
25132689|NCT03017248|Anesthetics|anesthetics|mesh-ancestor
25132690|NCT03017248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25132691|NCT03017248|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25132692|NCT03017248|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25132693|NCT03017248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25132694|NCT03017248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132695|NCT03017248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25132696|NCT03017248|Narcotics|narcotics|mesh-ancestor
25132697|NCT03017391|Dexamethasone|dexamethasone|mesh-list
25132698|NCT03017391|Metoclopramide|metoclopramide|mesh-list
25650229|NCT01500226|Granisetron|granisetron|mesh-list
25650230|NCT01500226|Rolapitant|rolapitant|mesh-list
25650231|NCT01500226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25650232|NCT01500226|Antiemetics|antiemetics|mesh-ancestor
25650233|NCT01500226|Autonomic Agents|autonomic agents|mesh-ancestor
25650234|NCT01500226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650235|NCT01500226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829178|NCT00006152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25829179|NCT00006152|Protease Inhibitors|protease inhibitors|mesh-ancestor
24746920|NCT02679144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746921|NCT02679144|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24746922|NCT02679144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24747138|NCT01746173|Prednisone|prednisone|mesh-list
24944197|NCT03962725|Anesthetics, General|anesthetics, general|mesh-ancestor
24944198|NCT03962725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24944199|NCT03962725|Analgesics|analgesics|mesh-ancestor
24404727|NCT00164736|Ritonavir|ritonavir|mesh-list
24747149|NCT01746173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24411663|NCT00189657|Irinotecan|irinotecan|mesh-list
25132699|NCT03017391|Granisetron|granisetron|mesh-list
25132700|NCT03017391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25132754|NCT03017430|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25132755|NCT03017430|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25132756|NCT03017430|Dopamine Agents|dopamine agents|mesh-ancestor
25132757|NCT03017430|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25132758|NCT03017430|Immunologic Factors|immunologic factors|mesh-ancestor
25132759|NCT03017430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24524872|NCT04243122|Apixaban|apixaban|mesh-list
25132760|NCT03017430|GABA Agents|gaba agents|mesh-ancestor
25132761|NCT03017352|Exenatide|exenatide|mesh-list
25132762|NCT03017352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25132763|NCT03017352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132764|NCT03017352|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25132765|NCT03017352|Incretins|incretins|mesh-ancestor
25132766|NCT03017352|Hormones|hormones|mesh-ancestor
25132767|NCT03017352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25132768|NCT03017404|Cyclophosphamide|cyclophosphamide|mesh-list
25132769|NCT03017404|Docetaxel|docetaxel|mesh-list
25132770|NCT03017404|Doxorubicin|doxorubicin|mesh-list
25132771|NCT03017404|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25132772|NCT03017404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25132773|NCT03017404|Immunologic Factors|immunologic factors|mesh-ancestor
25132774|NCT03017404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132775|NCT03017404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25132776|NCT03017404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25132777|NCT03017404|Alkylating Agents|alkylating agents|mesh-ancestor
25132778|NCT03017404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132779|NCT03017404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25132780|NCT03017404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25132782|NCT03017404|Antimitotic Agents|antimitotic agents|mesh-ancestor
25132783|NCT03017404|Mitosis Modulators|mitosis modulators|mesh-ancestor
25132784|NCT03017404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25132785|NCT03017404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25268242|NCT02416869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25132786|NCT03017404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25132787|NCT03017404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25132789|NCT03016884|Immunologic Factors|immunologic factors|mesh-ancestor
25132790|NCT03016884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132791|NCT03016988|Cytarabine|cytarabine|mesh-list
25132821|NCT03016871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132823|NCT03016871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25132824|NCT03016871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25132825|NCT03016871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25132826|NCT03016871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25132827|NCT03016871|Alkylating Agents|alkylating agents|mesh-ancestor
25132828|NCT03016871|Keratolytic Agents|keratolytic agents|mesh-ancestor
25132829|NCT03016871|Dermatologic Agents|dermatologic agents|mesh-ancestor
25132830|NCT03016871|Tubulin Modulators|tubulin modulators|mesh-ancestor
25132831|NCT03016871|Antimitotic Agents|antimitotic agents|mesh-ancestor
25132832|NCT03016871|Mitosis Modulators|mitosis modulators|mesh-ancestor
25650236|NCT01500226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25650237|NCT01500226|Glucocorticoids|glucocorticoids|mesh-ancestor
25650238|NCT01500226|Hormones|hormones|mesh-ancestor
25650239|NCT01500226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25650240|NCT01500226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25650241|NCT01500226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25650242|NCT01500226|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25650243|NCT01500226|Serotonin Agents|serotonin agents|mesh-ancestor
25650244|NCT01500226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25650245|NCT01500226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132833|NCT03016806|Cyclophosphamide|cyclophosphamide|mesh-list
25132834|NCT03016806|Melphalan|melphalan|mesh-list
25132835|NCT03016806|Busulfan|busulfan|mesh-list
25132836|NCT03016806|Fludarabine|fludarabine|mesh-list
25132837|NCT03016806|Mesna|mesna|mesh-list
25132838|NCT03016806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24748257|NCT02754011|Capecitabine|capecitabine|mesh-list
24748259|NCT02754011|Antimetabolites|antimetabolites|mesh-ancestor
25132839|NCT03016806|Immunologic Factors|immunologic factors|mesh-ancestor
25132840|NCT03016806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132841|NCT03016806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25132842|NCT03016806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25132843|NCT03016806|Alkylating Agents|alkylating agents|mesh-ancestor
25132844|NCT03016806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132845|NCT03016806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25132846|NCT03016806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25132847|NCT03016806|Protective Agents|protective agents|mesh-ancestor
25132848|NCT03016715|Sirolimus|sirolimus|mesh-list
25132849|NCT03016715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25132850|NCT03016715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25132851|NCT03016715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25132852|NCT03016715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25132853|NCT03016715|Antifungal Agents|antifungal agents|mesh-ancestor
25132854|NCT03016715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25132855|NCT03016715|Immunologic Factors|immunologic factors|mesh-ancestor
25132856|NCT03016715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132857|NCT03016793|Puerarin|puerarin|mesh-list
25132858|NCT03016793|Vasodilator Agents|vasodilator agents|mesh-ancestor
25132859|NCT03016741|Prednisone|prednisone|mesh-list
25132917|NCT03016260|Immunologic Factors|immunologic factors|mesh-ancestor
25132980|NCT03015857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25132981|NCT03015857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132982|NCT03015857|Sensory System Agents|sensory system agents|mesh-ancestor
25132983|NCT03015857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25132984|NCT03015857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25133078|NCT03014947|Adalimumab|adalimumab|mesh-list
25133079|NCT03014947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25133080|NCT03014947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25133081|NCT03015168|Capecitabine|capecitabine|mesh-list
25133082|NCT03015168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25133083|NCT03015168|Antimetabolites|antimetabolites|mesh-ancestor
25133084|NCT03015168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133085|NCT03015168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25133086|NCT03015025|Acenocoumarol|acenocoumarol|mesh-list
25133087|NCT03015025|Anticoagulants|anticoagulants|mesh-ancestor
25133088|NCT03014843|Bromides|bromides|mesh-list
25133089|NCT03014843|Naloxone|naloxone|mesh-list
25133090|NCT03014843|Methylnaltrexone|methylnaltrexone|mesh-list
25133091|NCT03014843|Anticonvulsants|anticonvulsants|mesh-ancestor
25133092|NCT03014843|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25133093|NCT03014843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133094|NCT03014843|Sensory System Agents|sensory system agents|mesh-ancestor
25133095|NCT03014843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25133096|NCT03014882|Acetylcysteine|acetylcysteine|mesh-list
25133097|NCT03014882|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25133098|NCT03014882|Antiviral Agents|antiviral agents|mesh-ancestor
25133133|NCT03014687|Cephalosporins|cephalosporins|mesh-list
25133134|NCT03014687|Trimethoprim|trimethoprim|mesh-list
25133135|NCT03014687|Sulfamethoxazole|sulfamethoxazole|mesh-list
25133136|NCT03014687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25133137|NCT03014687|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25133138|NCT03014687|Renal Agents|renal agents|mesh-ancestor
25133139|NCT03014687|Antimalarials|antimalarials|mesh-ancestor
25133140|NCT03014687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24961808|NCT03805178|Abatacept|abatacept|mesh-list
25133248|NCT03013387|Octreotide|octreotide|mesh-list
25133249|NCT03013387|Edotreotide|edotreotide|mesh-list
25133250|NCT03013387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25133251|NCT03013387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25133252|NCT03013387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25133253|NCT03013387|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25133254|NCT03013387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133255|NCT03013556|Tenofovir|tenofovir|mesh-list
25133256|NCT03013556|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25133257|NCT03013556|Interferon-alpha|interferon-alpha|mesh-list
25133258|NCT03013556|Antiviral Agents|antiviral agents|mesh-ancestor
25133259|NCT03013556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25133260|NCT03013556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25133261|NCT03013556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25133262|NCT03013556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25133263|NCT03013556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133264|NCT03013556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25650246|NCT01500226|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25133265|NCT03013556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24748679|NCT02251548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24748741|NCT02185820|Hormones|hormones|mesh-ancestor
24748742|NCT02185820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24748743|NCT02185820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24748744|NCT02185820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748745|NCT02185820|Immunologic Factors|immunologic factors|mesh-ancestor
24748746|NCT02185820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24748760|NCT02168829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24748761|NCT02168829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24748762|NCT02168829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748763|NCT02168829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24748764|NCT02168829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24748767|NCT02168829|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24748768|NCT02168829|Antithrombins|antithrombins|mesh-ancestor
24748821|NCT02127086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133266|NCT03013556|Immunologic Factors|immunologic factors|mesh-ancestor
25133267|NCT03013556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133268|NCT03013205|Triamcinolone|triamcinolone|mesh-list
25133269|NCT03013205|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25133270|NCT03013205|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25133271|NCT03013205|Lidocaine|lidocaine|mesh-list
25133272|NCT03013205|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25133273|NCT03013205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25133274|NCT03013205|Glucocorticoids|glucocorticoids|mesh-ancestor
25133275|NCT03013205|Hormones|hormones|mesh-ancestor
25133276|NCT03013205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25133277|NCT03013205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133278|NCT03013205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24961908|NCT03804723|Prednisone|prednisone|mesh-list
25133302|NCT03013400|Antioxidants|antioxidants|mesh-ancestor
25133303|NCT03013400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133304|NCT03013400|Protective Agents|protective agents|mesh-ancestor
25133305|NCT03013400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25133306|NCT03013400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25133307|NCT03013400|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25133308|NCT03013634|Dexmedetomidine|dexmedetomidine|mesh-list
25133309|NCT03013634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25133310|NCT03013634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25133311|NCT03013634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133312|NCT03013634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25133313|NCT03013634|Analgesics|analgesics|mesh-ancestor
25133314|NCT03013634|Sensory System Agents|sensory system agents|mesh-ancestor
25133315|NCT03013634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25133316|NCT03013634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24526098|NCT01845441|GABA Modulators|gaba modulators|mesh-ancestor
25133317|NCT03013634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25133318|NCT03013634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25133319|NCT03013634|Adrenergic Agents|adrenergic agents|mesh-ancestor
25133320|NCT03013634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25133321|NCT03013634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133322|NCT03013322|Physostigmine|physostigmine|mesh-list
25133323|NCT03013322|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25133324|NCT03013322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24961974|NCT03803449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25133343|NCT03013036|Sevoflurane|sevoflurane|mesh-list
25133344|NCT03013036|Rocuronium|rocuronium|mesh-list
25133345|NCT03013036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25650247|NCT01500278|Adalimumab|adalimumab|mesh-list
25650248|NCT01500278|Methotrexate|methotrexate|mesh-list
25650249|NCT01500278|Certolizumab Pegol|certolizumab pegol|mesh-list
25650250|NCT01500278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25650251|NCT01500278|Abortifacient Agents|abortifacient agents|mesh-ancestor
25650252|NCT01500278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25650253|NCT01500278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650254|NCT01500278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25650255|NCT01500278|Antimetabolites|antimetabolites|mesh-ancestor
25650256|NCT01500278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650257|NCT01500278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25650258|NCT01500278|Dermatologic Agents|dermatologic agents|mesh-ancestor
25650259|NCT01500278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650260|NCT01500278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25650261|NCT01500278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25650262|NCT01500278|Immunologic Factors|immunologic factors|mesh-ancestor
25650263|NCT01500278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24413647|NCT00194753|Immunologic Factors|immunologic factors|mesh-ancestor
24413648|NCT00194753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413657|NCT00194766|Temozolomide|temozolomide|mesh-list
24749339|NCT01166113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24749340|NCT01166113|Immunologic Factors|immunologic factors|mesh-ancestor
24749341|NCT01166113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749342|NCT01166113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24749343|NCT01166113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24749344|NCT01166113|Alkylating Agents|alkylating agents|mesh-ancestor
24749349|NCT01166113|Glucocorticoids|glucocorticoids|mesh-ancestor
25133346|NCT03013036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25133347|NCT03013036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133348|NCT03013036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25133349|NCT03013036|Anesthetics, General|anesthetics, general|mesh-ancestor
25133350|NCT03013036|Anesthetics|anesthetics|mesh-ancestor
25133351|NCT03013036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25133352|NCT03013036|Narcotics|narcotics|mesh-ancestor
25133353|NCT03013036|Analgesics|analgesics|mesh-ancestor
25133354|NCT03013036|Sensory System Agents|sensory system agents|mesh-ancestor
25133355|NCT03013036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25133356|NCT03013036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25026858|NCT03624959|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25026859|NCT03624959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25026860|NCT03624959|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24983807|NCT05150782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25133366|NCT03013036|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25133367|NCT03013036|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25133368|NCT03013036|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25133371|NCT03013010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25133372|NCT03013010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25133373|NCT03013010|Antimetabolites|antimetabolites|mesh-ancestor
25133374|NCT03013010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133375|NCT03012945|Anesthetics|anesthetics|mesh-list
25133376|NCT03012945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25133377|NCT03012945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133465|NCT03012607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25133467|NCT03012607|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25133468|NCT03012659|Contraceptive Agents|contraceptive agents|mesh-list
25133469|NCT03012659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25133470|NCT03012659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133471|NCT03012230|Pembrolizumab|pembrolizumab|mesh-list
24767151|NCT01798979|Anesthetics|anesthetics|mesh-ancestor
25133550|NCT03011905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133551|NCT03011918|Vitamin D|vitamin d|mesh-list
25133552|NCT03011918|Vitamins|vitamins|mesh-ancestor
25133553|NCT03011918|Micronutrients|micronutrients|mesh-ancestor
25133554|NCT03011918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962183|NCT03801733|Analgesics|analgesics|mesh-ancestor
25133731|NCT03010670|Oxytocin|oxytocin|mesh-list
25133732|NCT03010670|Oxytocics|oxytocics|mesh-ancestor
25133783|NCT03010475|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25133784|NCT03010475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25133785|NCT03010436|Benralizumab|benralizumab|mesh-list
25133786|NCT03010436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25133787|NCT03010436|Respiratory System Agents|respiratory system agents|mesh-ancestor
25133788|NCT03010358|Obinutuzumab|obinutuzumab|mesh-list
25133789|NCT03010358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25133790|NCT03010358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25133792|NCT03010228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25133793|NCT03010228|Immunologic Factors|immunologic factors|mesh-ancestor
25133794|NCT03010228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133795|NCT03010267|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25133796|NCT03010267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25133797|NCT03010267|Hormone Antagonists|hormone antagonists|mesh-ancestor
25650264|NCT01500278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25650265|NCT01500278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25650266|NCT01500317|Oxycodone|oxycodone|mesh-list
25650267|NCT01500317|Tapentadol|tapentadol|mesh-list
25650268|NCT01500317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25650269|NCT01500317|Narcotics|narcotics|mesh-ancestor
25650270|NCT01500317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25650271|NCT01500317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650272|NCT01500317|Analgesics|analgesics|mesh-ancestor
25650273|NCT01500317|Sensory System Agents|sensory system agents|mesh-ancestor
25133798|NCT03010267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25133799|NCT03010267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133800|NCT03010267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25133801|NCT03010267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25133802|NCT03010267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25133803|NCT03010202|Dexamethasone|dexamethasone|mesh-list
25133805|NCT03010202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25133806|NCT03010202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25133807|NCT03010202|Immunologic Factors|immunologic factors|mesh-ancestor
25133826|NCT03010098|Anesthetics|anesthetics|mesh-ancestor
25133827|NCT03010098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25133828|NCT03010098|Narcotics|narcotics|mesh-ancestor
25133829|NCT03010098|Analgesics|analgesics|mesh-ancestor
25133830|NCT03010098|Sensory System Agents|sensory system agents|mesh-ancestor
25133831|NCT03010098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25133832|NCT03010072|Ferric Compounds|ferric compounds|mesh-list
25133833|NCT03010072|Hematinics|hematinics|mesh-ancestor
25133835|NCT03009877|Midazolam|midazolam|mesh-list
25133836|NCT03009877|Propofol|propofol|mesh-list
25133837|NCT03009877|Rocuronium|rocuronium|mesh-list
25133838|NCT03009877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25133839|NCT03009877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25133840|NCT03009877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133841|NCT03009877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25133842|NCT03009877|Anesthetics, General|anesthetics, general|mesh-ancestor
25133843|NCT03009877|Anesthetics|anesthetics|mesh-ancestor
25133844|NCT03009877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25133845|NCT03009877|Narcotics|narcotics|mesh-ancestor
25133846|NCT03009877|Analgesics|analgesics|mesh-ancestor
25133847|NCT03009877|Sensory System Agents|sensory system agents|mesh-ancestor
25133848|NCT03009877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25133849|NCT03009877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25133850|NCT03009877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25133851|NCT03009877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25133852|NCT03009877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25133853|NCT03009877|GABA Modulators|gaba modulators|mesh-ancestor
25133854|NCT03009877|GABA Agents|gaba agents|mesh-ancestor
25133855|NCT03009877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25133856|NCT03009877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133857|NCT03009877|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25133858|NCT03009877|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25133859|NCT03009877|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25133860|NCT03009916|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
25133861|NCT03009916|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25133862|NCT03009916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25133863|NCT03009916|Antimetabolites|antimetabolites|mesh-ancestor
25133864|NCT03009916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133865|NCT03009916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25133866|NCT03009643|Nitric Oxide|nitric oxide|mesh-list
25133895|NCT03009461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25133896|NCT03009461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25133897|NCT03009461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25133898|NCT03009461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133899|NCT03009500|Methylprednisolone|methylprednisolone|mesh-list
25133900|NCT03009500|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25133901|NCT03009500|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25112623|NCT03984955|Mannitol|mannitol|mesh-list
25134006|NCT03009058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134007|NCT03009058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25134008|NCT03009058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25134009|NCT03009058|Alkylating Agents|alkylating agents|mesh-ancestor
25134077|NCT03008512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134079|NCT03008551|Empagliflozin|empagliflozin|mesh-list
25134080|NCT03008551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25134108|NCT03008148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134110|NCT03007927|Dexamethasone|dexamethasone|mesh-list
25134111|NCT03007927|Bupivacaine|bupivacaine|mesh-list
25134112|NCT03007927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25134113|NCT03007927|Antiemetics|antiemetics|mesh-ancestor
25134114|NCT03007927|Autonomic Agents|autonomic agents|mesh-ancestor
25134115|NCT03007927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25134116|NCT03007927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134117|NCT03007927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25134118|NCT03007927|Glucocorticoids|glucocorticoids|mesh-ancestor
25134119|NCT03007927|Hormones|hormones|mesh-ancestor
25134120|NCT03007927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25134121|NCT03007927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25134122|NCT03007927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25134123|NCT03007927|Anesthetics, Local|anesthetics, local|mesh-ancestor
25134124|NCT03007927|Anesthetics|anesthetics|mesh-ancestor
25045765|NCT00914602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810940|NCT02043756|Mitoxantrone|mitoxantrone|mesh-list
24962614|NCT03797443|Antioxidants|antioxidants|mesh-ancestor
25134148|NCT03007992|Vinorelbine|vinorelbine|mesh-list
25134149|NCT03007992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25134150|NCT03007992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25134151|NCT03007992|Tubulin Modulators|tubulin modulators|mesh-ancestor
25134152|NCT03007992|Antimitotic Agents|antimitotic agents|mesh-ancestor
25134153|NCT03007992|Mitosis Modulators|mitosis modulators|mesh-ancestor
25134154|NCT03007992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134155|NCT03008057|Vitamin D|vitamin d|mesh-list
25134156|NCT03008057|Ergocalciferols|ergocalciferols|mesh-list
25134157|NCT03008057|Cholecalciferol|cholecalciferol|mesh-list
25134158|NCT03008057|Vitamins|vitamins|mesh-list
25134159|NCT03008057|Micronutrients|micronutrients|mesh-ancestor
25134160|NCT03008057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134161|NCT03008057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25134162|NCT03008057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25134163|NCT03008083|Clopidogrel|clopidogrel|mesh-list
25134164|NCT03008083|Ticagrelor|ticagrelor|mesh-list
25134165|NCT03008083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25134166|NCT03008083|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25134167|NCT03008083|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25134168|NCT03008083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25134169|NCT03008083|Purinergic Agents|purinergic agents|mesh-ancestor
25134170|NCT03008083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25134171|NCT03008083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134172|NCT03008083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134173|NCT03007810|Hemay005|hemay005|mesh-list
25134204|NCT03007381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134205|NCT03007381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25134206|NCT03007381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25134207|NCT03007381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25134208|NCT03007381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25134209|NCT03007381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134210|NCT03007303|Olanzapine|olanzapine|mesh-list
25134211|NCT03007303|Risperidone|risperidone|mesh-list
25134212|NCT03007303|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25134213|NCT03007303|Ziprasidone|ziprasidone|mesh-list
25134214|NCT03007303|Antipsychotic Agents|antipsychotic agents|mesh-list
25134215|NCT03007303|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25134316|NCT03007121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134317|NCT03007121|Sensory System Agents|sensory system agents|mesh-ancestor
25134318|NCT03007121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25134320|NCT03007121|Narcotics|narcotics|mesh-ancestor
25134388|NCT03006614|Antiviral Agents|antiviral agents|mesh-ancestor
25134389|NCT03006614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25134390|NCT03006614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25134391|NCT03006614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25134392|NCT03006614|Immunologic Factors|immunologic factors|mesh-ancestor
25134393|NCT03006614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134394|NCT03006614|Tubulin Modulators|tubulin modulators|mesh-ancestor
25134395|NCT03006614|Antimitotic Agents|antimitotic agents|mesh-ancestor
25134396|NCT03006614|Mitosis Modulators|mitosis modulators|mesh-ancestor
25134397|NCT03006614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25134398|NCT03006614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25134399|NCT03006614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25134400|NCT03006614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25134401|NCT03006614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25134434|NCT03006211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25134435|NCT03006211|Anesthetics, General|anesthetics, general|mesh-ancestor
25134436|NCT03006211|Anesthetics|anesthetics|mesh-ancestor
25134437|NCT03006211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25134438|NCT03006211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134439|NCT03006211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25134440|NCT03006211|Analgesics|analgesics|mesh-ancestor
25134441|NCT03006211|Sensory System Agents|sensory system agents|mesh-ancestor
25134442|NCT03006211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25134443|NCT03006211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25134444|NCT03006211|Autonomic Agents|autonomic agents|mesh-ancestor
24750772|NCT01700491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750773|NCT01700491|Sensory System Agents|sensory system agents|mesh-ancestor
24750785|NCT01700569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750786|NCT01700569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25829180|NCT00006152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750788|NCT01700569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750789|NCT01700569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24750790|NCT01700569|Antidotes|antidotes|mesh-ancestor
24750791|NCT01700569|Protective Agents|protective agents|mesh-ancestor
24750792|NCT01700569|Vitamin B Complex|vitamin b complex|mesh-ancestor
24750793|NCT01700569|Vitamins|vitamins|mesh-ancestor
24750794|NCT01700569|Micronutrients|micronutrients|mesh-ancestor
24750795|NCT01700569|Hematinics|hematinics|mesh-ancestor
24750796|NCT01700608|Plerixafor|plerixafor|mesh-list
24750797|NCT01700608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24750798|NCT01700608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24750799|NCT01700608|Antiviral Agents|antiviral agents|mesh-ancestor
24750800|NCT01700608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24540968|NCT00670345|Tranexamic Acid|tranexamic acid|mesh-list
24750801|NCT01700751|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24750802|NCT01700751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24750803|NCT01700751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24750804|NCT01700790|Ritonavir|ritonavir|mesh-list
24750823|NCT01700803|Trace Elements|trace elements|mesh-ancestor
24750824|NCT01700803|Micronutrients|micronutrients|mesh-ancestor
24750825|NCT01700803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750826|NCT01700803|Plasma Substitutes|plasma substitutes|mesh-ancestor
24750827|NCT01700803|Blood Substitutes|blood substitutes|mesh-ancestor
24750828|NCT01700881|Vitamin E|vitamin e|mesh-list
24750829|NCT01700881|Vitamins|vitamins|mesh-ancestor
24750830|NCT01700881|Micronutrients|micronutrients|mesh-ancestor
25051264|NCT00427440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25134445|NCT03006211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25134446|NCT03006211|Respiratory System Agents|respiratory system agents|mesh-ancestor
25134447|NCT03006211|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25134448|NCT03006211|Antioxidants|antioxidants|mesh-ancestor
25134449|NCT03006211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134480|NCT03006107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134481|NCT03006081|Aflibercept|aflibercept|mesh-list
25134485|NCT03006081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134486|NCT03006081|Growth Inhibitors|growth inhibitors|mesh-ancestor
25134487|NCT03006081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25134488|NCT03005860|Fentanyl|fentanyl|mesh-list
25134489|NCT03005860|Propofol|propofol|mesh-list
25134490|NCT03005860|Sevoflurane|sevoflurane|mesh-list
25134491|NCT03005860|Atracurium|atracurium|mesh-list
25134492|NCT03005860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25650274|NCT01500317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650275|NCT01500317|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25650276|NCT01500317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25650277|NCT01500317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25650278|NCT01500317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650279|NCT01500317|Adrenergic Agents|adrenergic agents|mesh-ancestor
25650280|NCT01500317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25650281|NCT01500382|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25650282|NCT01500382|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25650283|NCT01500382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25650284|NCT01500382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25650285|NCT01500382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25650286|NCT01500382|Cholinergic Agents|cholinergic agents|mesh-ancestor
25650287|NCT01500382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25650288|NCT01500382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650289|NCT01500382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650290|NCT01500382|Urological Agents|urological agents|mesh-ancestor
25650291|NCT01500434|Aspirin|aspirin|mesh-list
25650292|NCT01500434|Ticlopidine|ticlopidine|mesh-list
25650293|NCT01500434|Clopidogrel|clopidogrel|mesh-list
25650294|NCT01500434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25650295|NCT01500434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25650296|NCT01500434|Analgesics|analgesics|mesh-ancestor
25650297|NCT01500434|Sensory System Agents|sensory system agents|mesh-ancestor
25650298|NCT01500434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650299|NCT01500434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650300|NCT01500434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25650301|NCT01500434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25650302|NCT01500434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25134493|NCT03005860|Narcotics|narcotics|mesh-ancestor
25134531|NCT03005496|Dexamethasone acetate|dexamethasone acetate|mesh-list
25134604|NCT03005444|Protease Inhibitors|protease inhibitors|mesh-ancestor
25134605|NCT03005444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24963022|NCT03793075|Ketamine|ketamine|mesh-list
25134644|NCT03005717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134645|NCT03005678|Denosumab|denosumab|mesh-list
25134646|NCT03005678|Alendronate|alendronate|mesh-list
25134647|NCT03005678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25134648|NCT03005678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134649|NCT03005548|Morphine|morphine|mesh-list
25134650|NCT03005548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25134651|NCT03005548|Narcotics|narcotics|mesh-ancestor
25134652|NCT03005548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25134653|NCT03005548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134654|NCT03005548|Analgesics|analgesics|mesh-ancestor
25134655|NCT03005548|Sensory System Agents|sensory system agents|mesh-ancestor
25134656|NCT03005548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25134657|NCT03005483|Gabapentin|gabapentin|mesh-list
25134658|NCT03005483|Analgesics|analgesics|mesh-ancestor
25134659|NCT03005483|Sensory System Agents|sensory system agents|mesh-ancestor
25134660|NCT03005483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25134661|NCT03005483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134662|NCT03005483|Anticonvulsants|anticonvulsants|mesh-ancestor
25134663|NCT03005483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25134664|NCT03005483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25134665|NCT03005483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25134666|NCT03005483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25134667|NCT03005483|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25134702|NCT03005015|Doxorubicin|doxorubicin|mesh-list
25134703|NCT03005015|Lenvatinib|lenvatinib|mesh-list
24963089|NCT03792984|Metformin|metformin|mesh-list
25134770|NCT03005002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25134771|NCT03005002|Immunoglobulin G|immunoglobulin g|mesh-list
25134772|NCT03005002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25134773|NCT03005002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25134774|NCT03005002|Immunologic Factors|immunologic factors|mesh-ancestor
25134775|NCT03005002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134776|NCT03005002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25134777|NCT03005002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134807|NCT03005236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25134808|NCT03005236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134810|NCT03005145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25134811|NCT03005145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25134812|NCT03005145|Antitubercular Agents|antitubercular agents|mesh-ancestor
25134814|NCT03004625|Asunaprevir|asunaprevir|mesh-list
25134815|NCT03004625|Antimetabolites|antimetabolites|mesh-ancestor
25134816|NCT03004625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134818|NCT03004625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25134819|NCT03004625|Protease Inhibitors|protease inhibitors|mesh-ancestor
25134820|NCT03004625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25134821|NCT03004612|Metformin|metformin|mesh-list
25134822|NCT03004612|Linagliptin|linagliptin|mesh-list
25134823|NCT03004612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25134824|NCT03004612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134825|NCT03004612|Incretins|incretins|mesh-ancestor
25134826|NCT03004612|Hormones|hormones|mesh-ancestor
25134827|NCT03004612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25134828|NCT03004612|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25134829|NCT03004612|Protease Inhibitors|protease inhibitors|mesh-ancestor
25134830|NCT03004612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24963173|NCT03792295|Ibuprofen|ibuprofen|mesh-list
25134890|NCT03004339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25134902|NCT03004222|Anesthetics, Local|anesthetics, local|mesh-ancestor
25134903|NCT03004222|Anesthetics|anesthetics|mesh-ancestor
25134904|NCT03004222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25134905|NCT03004222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963249|NCT03791905|Paclitaxel|paclitaxel|mesh-list
25134925|NCT03004014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25134926|NCT03004014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134927|NCT03004014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25134928|NCT03004014|Anesthetics, General|anesthetics, general|mesh-ancestor
25134929|NCT03004014|Anesthetics|anesthetics|mesh-ancestor
25134941|NCT03003884|Propofol|propofol|mesh-list
25027276|NCT03621072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25027277|NCT03621072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027278|NCT03621072|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25027279|NCT03621072|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25027280|NCT03621046|Zolpidem|zolpidem|mesh-list
25027281|NCT03621046|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25027282|NCT03621046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24592459|NCT00921804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25134942|NCT03003884|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25134943|NCT03003884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25134944|NCT03003884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134945|NCT03003884|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25134946|NCT03003884|Anesthetics, General|anesthetics, general|mesh-ancestor
25134947|NCT03003884|Anesthetics|anesthetics|mesh-ancestor
25134948|NCT03003832|Analgesics, Opioid|analgesics, opioid|mesh-list
25134949|NCT03003832|Analgesics|analgesics|mesh-list
25134950|NCT03003832|Narcotics|narcotics|mesh-ancestor
25134951|NCT03003832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25134952|NCT03003832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134953|NCT03003832|Sensory System Agents|sensory system agents|mesh-ancestor
25134954|NCT03003832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25134956|NCT03003871|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25134957|NCT03003871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25134958|NCT03003871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25134959|NCT03003871|Disinfectants|disinfectants|mesh-ancestor
25134960|NCT03003871|Dermatologic Agents|dermatologic agents|mesh-ancestor
25134962|NCT03003728|Elotuzumab|elotuzumab|mesh-list
25134963|NCT03003728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25135051|NCT03002961|Buprenorphine|buprenorphine|mesh-list
25135052|NCT03002961|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25135053|NCT03002961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25135054|NCT03002961|Narcotics|narcotics|mesh-ancestor
25135055|NCT03002961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25135056|NCT03002961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135057|NCT03002961|Analgesics|analgesics|mesh-ancestor
25135058|NCT03002961|Sensory System Agents|sensory system agents|mesh-ancestor
24963342|NCT03791827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25135089|NCT03002493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25135090|NCT03002493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135091|NCT03002493|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25135092|NCT03002493|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25268305|NCT02416388|Antiviral Agents|antiviral agents|mesh-ancestor
25135096|NCT03002493|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25135097|NCT03002428|Teriparatide|teriparatide|mesh-list
25135098|NCT03002428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25135099|NCT03002428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135100|NCT03002428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24963400|NCT03791099|Metronidazole|metronidazole|mesh-list
25135193|NCT03001349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25135194|NCT03001349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25135195|NCT03001349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135196|NCT03001349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135197|NCT03001349|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25135198|NCT03001089|Fludrocortisone|fludrocortisone|mesh-list
25135199|NCT03001089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25135200|NCT03001193|Oxytocin|oxytocin|mesh-list
25135201|NCT03001193|Oxytocics|oxytocics|mesh-ancestor
25135202|NCT03001193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25135203|NCT03001193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135204|NCT03001102|Chlorhexidine|chlorhexidine|mesh-list
25135205|NCT03001102|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25135206|NCT03001102|Povidone-Iodine|povidone-iodine|mesh-list
25135207|NCT03001102|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
25135208|NCT03001102|Povidone|povidone|mesh-list
25135209|NCT03001102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25135210|NCT03001102|Disinfectants|disinfectants|mesh-ancestor
25135211|NCT03001102|Dermatologic Agents|dermatologic agents|mesh-ancestor
25135212|NCT03001102|Plasma Substitutes|plasma substitutes|mesh-ancestor
25135213|NCT03001102|Blood Substitutes|blood substitutes|mesh-ancestor
25135214|NCT03000946|Octreotide|octreotide|mesh-list
25135215|NCT03000946|Somatostatin|somatostatin|mesh-list
25135216|NCT03000946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25135217|NCT03000946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25135218|NCT03000946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135220|NCT03000946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25135221|NCT03000946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135222|NCT03001128|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25135223|NCT03001128|Antiviral Agents|antiviral agents|mesh-ancestor
25135224|NCT03001128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25135225|NCT03000660|Dexamethasone|dexamethasone|mesh-list
25135226|NCT03000660|Venetoclax|venetoclax|mesh-list
24963445|NCT03790540|Benzocaine|benzocaine|mesh-list
25135305|NCT03000218|Metformin|metformin|mesh-list
25135306|NCT03000218|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25135307|NCT03000218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25135308|NCT03000218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135309|NCT03000218|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25135310|NCT03000218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25135311|NCT03000205|Lidocaine|lidocaine|mesh-list
25135358|NCT02999776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25135359|NCT02999776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25135360|NCT02999776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25135361|NCT02999776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25135362|NCT02999776|Immunologic Factors|immunologic factors|mesh-ancestor
25135363|NCT02999815|Immunoglobulins|immunoglobulins|mesh-list
24528003|NCT00619203|Glycerol|glycerol|mesh-list
25135364|NCT02999815|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25135365|NCT02999815|Antibodies|antibodies|mesh-list
25135366|NCT02999815|Antitoxins|antitoxins|mesh-list
25135367|NCT02999815|Immunologic Factors|immunologic factors|mesh-ancestor
25135368|NCT02999815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135369|NCT02999841|Vildagliptin|vildagliptin|mesh-list
25135370|NCT02999841|Acarbose|acarbose|mesh-list
25135371|NCT02999841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25135372|NCT02999841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135373|NCT02999841|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25135374|NCT02999841|Protease Inhibitors|protease inhibitors|mesh-ancestor
25135375|NCT02999841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25135376|NCT02999841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135377|NCT02999841|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25135378|NCT02999906|Treprostinil|treprostinil|mesh-list
25135379|NCT02999906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25135380|NCT02999724|Gabapentin|gabapentin|mesh-list
25135382|NCT02999724|Sensory System Agents|sensory system agents|mesh-ancestor
25135383|NCT02999724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25135384|NCT02999724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135385|NCT02999724|Anticonvulsants|anticonvulsants|mesh-ancestor
25135406|NCT02999594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135407|NCT02999594|Analgesics|analgesics|mesh-ancestor
25135408|NCT02999594|Sensory System Agents|sensory system agents|mesh-ancestor
25135409|NCT02999594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25135410|NCT02999490|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25135411|NCT02999490|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25135412|NCT02999490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045766|NCT00914602|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25045767|NCT00914602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045768|NCT00914602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25045769|NCT00914602|Immunologic Factors|immunologic factors|mesh-ancestor
25045770|NCT00914602|Dopamine Agonists|dopamine agonists|mesh-ancestor
25045771|NCT00914290|Baclofen|baclofen|mesh-list
25045772|NCT00914290|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25045773|NCT00914290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045774|NCT00914290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25045775|NCT00914290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045776|NCT00914290|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25045777|NCT00914290|GABA Agonists|gaba agonists|mesh-ancestor
25045778|NCT00914290|GABA Agents|gaba agents|mesh-ancestor
25045779|NCT00914290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25045780|NCT00914290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045781|NCT00913393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25045782|NCT00913393|Immunologic Factors|immunologic factors|mesh-ancestor
25045783|NCT00913393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045784|NCT00911963|Ribavirin|ribavirin|mesh-list
25045785|NCT00911963|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25045786|NCT00911963|Antimetabolites|antimetabolites|mesh-ancestor
25045787|NCT00911963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045788|NCT00911963|Antiviral Agents|antiviral agents|mesh-ancestor
25045789|NCT00911963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25045790|NCT00911443|Interferons|interferons|mesh-list
25045791|NCT00911443|Interferon-alpha|interferon-alpha|mesh-list
25135459|NCT02998827|Azathioprine|azathioprine|mesh-list
25135460|NCT02998827|Infliximab|infliximab|mesh-list
25135461|NCT02998827|Dermatologic Agents|dermatologic agents|mesh-ancestor
25135462|NCT02998827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25135463|NCT02998827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25135464|NCT02998827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25135465|NCT02998827|Immunologic Factors|immunologic factors|mesh-ancestor
25135466|NCT02998827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135467|NCT02998827|Leprostatic Agents|leprostatic agents|mesh-ancestor
25135468|NCT02998827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25135469|NCT02998827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25135470|NCT02998827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25135471|NCT02998827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25135472|NCT02998827|Growth Substances|growth substances|mesh-ancestor
25135541|NCT02997995|Durvalumab|durvalumab|mesh-list
25135542|NCT02997995|Tremelimumab|tremelimumab|mesh-list
25135543|NCT02997995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24963797|NCT03788694|Anesthetics|anesthetics|mesh-ancestor
25027494|NCT03619824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25135626|NCT02997059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135627|NCT02997059|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25135628|NCT02997059|Hormone Antagonists|hormone antagonists|mesh-ancestor
25135644|NCT02996695|Chloroquine|chloroquine|mesh-list
25135645|NCT02996695|Antimalarials|antimalarials|mesh-ancestor
25135646|NCT02996695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25135647|NCT02996695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25135648|NCT02996695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25135649|NCT02996695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135650|NCT02996695|Antiviral Agents|antiviral agents|mesh-ancestor
25135651|NCT02996695|Schistosomicides|schistosomicides|mesh-ancestor
25135652|NCT02996695|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25135653|NCT02996695|Anthelmintics|anthelmintics|mesh-ancestor
25135654|NCT02996695|Amebicides|amebicides|mesh-ancestor
25135655|NCT02996695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25135656|NCT02996513|Vitamin A|vitamin a|mesh-list
25135657|NCT02996513|Vitamins|vitamins|mesh-ancestor
25135658|NCT02996513|Micronutrients|micronutrients|mesh-ancestor
25135720|NCT02995954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045857|NCT00905606|Anticonvulsants|anticonvulsants|mesh-ancestor
25045862|NCT00905567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25045863|NCT00905567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045864|NCT00905346|Topiramate|topiramate|mesh-list
25045865|NCT00905346|Anticonvulsants|anticonvulsants|mesh-ancestor
25045866|NCT00905346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25045867|NCT00905346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045868|NCT00905164|Topiramate|topiramate|mesh-list
25045904|NCT00901693|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25045905|NCT00900900|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25045906|NCT00900900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25045907|NCT00900900|Immunologic Factors|immunologic factors|mesh-ancestor
25135821|NCT02995642|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
25135822|NCT02995642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135823|NCT02995655|Azacitidine|azacitidine|mesh-list
25135824|NCT02995655|Heparin|heparin|mesh-list
25135825|NCT02995655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25135826|NCT02995655|Antimetabolites|antimetabolites|mesh-ancestor
25045929|NCT00892970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25045930|NCT00892970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25045931|NCT00892762|Travoprost|travoprost|mesh-list
25045932|NCT00892762|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25045933|NCT00892762|Latanoprost|latanoprost|mesh-list
25045934|NCT00892762|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25045935|NCT00892762|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25045936|NCT00892203|Sumatriptan|sumatriptan|mesh-list
25045937|NCT00892203|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25045938|NCT00892203|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25045939|NCT00892203|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25045940|NCT00892203|Serotonin Agents|serotonin agents|mesh-ancestor
25045941|NCT00892203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25045942|NCT00892203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045943|NCT00892203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045944|NCT00890968|Triamcinolone|triamcinolone|mesh-list
25045945|NCT00890968|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25135918|NCT02995083|Methylprednisolone|methylprednisolone|mesh-list
25135919|NCT02995083|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25135920|NCT02995083|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25135921|NCT02995083|Prednisolone|prednisolone|mesh-list
25135922|NCT02995083|Prednisolone acetate|prednisolone acetate|mesh-list
25135924|NCT02995083|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25135925|NCT02995083|Prednisolone phosphate|prednisolone phosphate|mesh-list
25135951|NCT02994745|Antimetabolites|antimetabolites|mesh-ancestor
25135952|NCT02994745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135953|NCT02994745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25135954|NCT02994745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25135955|NCT02994745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25135956|NCT02994888|Cetuximab|cetuximab|mesh-list
25135957|NCT02994888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25135958|NCT02994888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135959|NCT02994875|Acetylcysteine|acetylcysteine|mesh-list
25135960|NCT02994875|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24528710|NCT00622375|Mesalamine|mesalamine|mesh-list
25135961|NCT02994875|Antiviral Agents|antiviral agents|mesh-ancestor
25135962|NCT02994875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25135963|NCT02994875|Expectorants|expectorants|mesh-ancestor
25135964|NCT02994875|Respiratory System Agents|respiratory system agents|mesh-ancestor
25135965|NCT02994875|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25135966|NCT02994875|Antioxidants|antioxidants|mesh-ancestor
25135967|NCT02994875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135968|NCT02994875|Protective Agents|protective agents|mesh-ancestor
25135969|NCT02994875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135970|NCT02994875|Antidotes|antidotes|mesh-ancestor
25135971|NCT02994719|Amantadine|amantadine|mesh-list
25135972|NCT02994719|Levodopa|levodopa|mesh-list
25135973|NCT02994719|Carbidopa|carbidopa|mesh-list
25136004|NCT02995005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136005|NCT02995005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136006|NCT02995005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25136007|NCT02995005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25136008|NCT02994576|Atezolizumab|atezolizumab|mesh-list
25136009|NCT02994576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136015|NCT02994381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136017|NCT02994602|Testosterone|testosterone|mesh-list
25136018|NCT02994602|Androgens|androgens|mesh-ancestor
25045992|NCT00890149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25045993|NCT00889967|Ciprofloxacin|ciprofloxacin|mesh-list
25045994|NCT00889967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25045995|NCT00889967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25136071|NCT02994082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25136072|NCT02994082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25136073|NCT02994082|Cholinergic Agents|cholinergic agents|mesh-ancestor
25136074|NCT02994082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25136075|NCT02994082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136076|NCT02994082|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25136077|NCT02994082|Antidepressive Agents|antidepressive agents|mesh-ancestor
25136078|NCT02994082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25136079|NCT02994082|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25136080|NCT02994082|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25136081|NCT02994082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25136082|NCT02994082|Dopamine Agents|dopamine agents|mesh-ancestor
25136083|NCT02994082|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25136084|NCT02994082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25136085|NCT02994082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136087|NCT02995096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25136088|NCT02995096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25136089|NCT02995096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25136090|NCT02995096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136091|NCT02995096|Antifungal Agents|antifungal agents|mesh-ancestor
25136092|NCT02995096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25136093|NCT02995096|Immunologic Factors|immunologic factors|mesh-ancestor
25136094|NCT02995096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136095|NCT02993991|Durvalumab|durvalumab|mesh-list
25136096|NCT02993991|Mocetinostat|mocetinostat|mesh-list
25136097|NCT02993991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25136098|NCT02993991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136099|NCT02993991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25136100|NCT02993991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136182|NCT02993159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25136184|NCT02993029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25027719|NCT03617471|Analgesics|analgesics|mesh-ancestor
25027741|NCT03617432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136185|NCT02993029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25136186|NCT02993029|Analgesics|analgesics|mesh-ancestor
25136187|NCT02993029|Sensory System Agents|sensory system agents|mesh-ancestor
25136188|NCT02993029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25136300|NCT02992457|Simeprevir|simeprevir|mesh-list
25041723|NCT01593228|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25136301|NCT02992457|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25136302|NCT02992457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136303|NCT02992457|Antiviral Agents|antiviral agents|mesh-ancestor
25136304|NCT02992457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25136305|NCT02992457|Antimetabolites|antimetabolites|mesh-ancestor
25136306|NCT02992457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136307|NCT02992457|Immunologic Factors|immunologic factors|mesh-ancestor
25136308|NCT02992457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136309|NCT02992457|Protease Inhibitors|protease inhibitors|mesh-ancestor
25136310|NCT02992457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136312|NCT02992392|Anticoagulants|anticoagulants|mesh-ancestor
25136313|NCT02992392|Plasma Substitutes|plasma substitutes|mesh-ancestor
25136314|NCT02992392|Blood Substitutes|blood substitutes|mesh-ancestor
25136315|NCT02992340|Gemcitabine|gemcitabine|mesh-list
25136316|NCT02992340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136318|NCT02992340|Antimetabolites|antimetabolites|mesh-ancestor
25136319|NCT02992340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136320|NCT02992340|Antiviral Agents|antiviral agents|mesh-ancestor
25136321|NCT02992340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25136322|NCT02992340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136323|NCT02992340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25136324|NCT02992340|Immunologic Factors|immunologic factors|mesh-ancestor
25136325|NCT02992340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136327|NCT02992028|Micronutrients|micronutrients|mesh-ancestor
24964594|NCT03781869|Cisplatin|cisplatin|mesh-list
25136377|NCT02991209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25136385|NCT02991131|Linezolid|linezolid|mesh-list
25136386|NCT02991131|Tedizolid|tedizolid|mesh-list
25136387|NCT02991131|Tedizolid phosphate|tedizolid phosphate|mesh-list
25136388|NCT02991131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25136389|NCT02991131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25136390|NCT02991131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25136391|NCT02991131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136392|NCT02991131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136393|NCT02991157|Nimodipine|nimodipine|mesh-list
25136394|NCT02991157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25136395|NCT02991157|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25136396|NCT02991157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25136397|NCT02991157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136398|NCT02991157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25136426|NCT02991053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25136427|NCT02991053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25136428|NCT02991053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136429|NCT02990728|Metformin|metformin|mesh-list
25136430|NCT02990728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25136431|NCT02990728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136432|NCT02990962|Triamcinolone|triamcinolone|mesh-list
25136433|NCT02990962|Lidocaine|lidocaine|mesh-list
25136434|NCT02990962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25136435|NCT02990962|Glucocorticoids|glucocorticoids|mesh-ancestor
25136436|NCT02990962|Hormones|hormones|mesh-ancestor
25136437|NCT02990962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25136438|NCT02990962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136439|NCT02990962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136440|NCT02990962|Anesthetics, Local|anesthetics, local|mesh-ancestor
25136441|NCT02990962|Anesthetics|anesthetics|mesh-ancestor
25136442|NCT02990962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25136443|NCT02990962|Sensory System Agents|sensory system agents|mesh-ancestor
25136444|NCT02990962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25136475|NCT02990884|Sensory System Agents|sensory system agents|mesh-ancestor
25136476|NCT02990884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25136477|NCT02990884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136478|NCT02990884|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25136479|NCT02990884|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25136481|NCT02990884|Anesthetics|anesthetics|mesh-ancestor
25136482|NCT02990884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25136483|NCT02990884|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25136484|NCT02990884|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25136485|NCT02990884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24964710|NCT03781115|Autonomic Agents|autonomic agents|mesh-ancestor
25136519|NCT02990403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25136520|NCT02990403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136521|NCT02990403|Antipyretics|antipyretics|mesh-ancestor
25136522|NCT02990403|Anticoagulants|anticoagulants|mesh-ancestor
25136523|NCT02990403|Immunologic Factors|immunologic factors|mesh-ancestor
25136524|NCT02990403|Progestins|progestins|mesh-ancestor
25136525|NCT02990455|Nicotine|nicotine|mesh-list
25136526|NCT02990455|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25136527|NCT02990455|Autonomic Agents|autonomic agents|mesh-ancestor
25136560|NCT02990507|Hormones|hormones|mesh-ancestor
25136561|NCT02990507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25136562|NCT02990507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136563|NCT02990507|Androgens|androgens|mesh-ancestor
25136564|NCT02990468|Cisplatin|cisplatin|mesh-list
25136565|NCT02990468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136566|NCT02990546|Midodrine|midodrine|mesh-list
25136567|NCT02990546|Sympathomimetics|sympathomimetics|mesh-ancestor
25027859|NCT03616262|Anesthetics, Local|anesthetics, local|mesh-ancestor
25136572|NCT02990546|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25136573|NCT02990546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25136574|NCT02990546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25136575|NCT02990546|Adrenergic Agents|adrenergic agents|mesh-ancestor
25136576|NCT02990546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25136577|NCT02990546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136578|NCT02990286|Mycophenolic Acid|mycophenolic acid|mesh-list
25136580|NCT02990286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25136581|NCT02990286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136582|NCT02990286|Immunologic Factors|immunologic factors|mesh-ancestor
25136583|NCT02990286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984869|NCT03946111|Dopamine Agents|dopamine agents|mesh-ancestor
25027894|NCT03615950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25027895|NCT03615833|Vitamin D|vitamin d|mesh-list
25027896|NCT03615833|Cholecalciferol|cholecalciferol|mesh-list
25027897|NCT03615833|Vitamins|vitamins|mesh-ancestor
25027898|NCT03615833|Micronutrients|micronutrients|mesh-ancestor
25027899|NCT03615833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593403|NCT00928798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027903|NCT03615768|Clindamycin palmitate|clindamycin palmitate|mesh-list
25027904|NCT03615768|Clindamycin phosphate|clindamycin phosphate|mesh-list
25027906|NCT03615768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25027907|NCT03615768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24480497|NCT00431171|Antidepressive Agents|antidepressive agents|mesh-ancestor
24480498|NCT00431171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24480499|NCT00431171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829181|NCT00006152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480681|NCT00431678|Moxifloxacin|moxifloxacin|mesh-list
25136584|NCT02990286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25136585|NCT02990286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25136619|NCT02989870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25136620|NCT02989870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136621|NCT02989870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136622|NCT02989870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25136672|NCT02989623|Micronutrients|micronutrients|mesh-ancestor
25136673|NCT02989623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136674|NCT02989558|Aspirin|aspirin|mesh-list
25136675|NCT02989558|Clopidogrel|clopidogrel|mesh-list
25136676|NCT02989558|Ticagrelor|ticagrelor|mesh-list
25136677|NCT02989558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25136678|NCT02989558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25136679|NCT02989558|Analgesics|analgesics|mesh-ancestor
25136680|NCT02989558|Sensory System Agents|sensory system agents|mesh-ancestor
25136681|NCT02989558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25136682|NCT02989558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136683|NCT02989558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24964876|NCT03779789|Vortioxetine|vortioxetine|mesh-list
25136772|NCT02988869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25136773|NCT02988869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136774|NCT02988869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25136775|NCT02988869|Respiratory System Agents|respiratory system agents|mesh-ancestor
25136776|NCT02988869|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25136777|NCT02988869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25136778|NCT02988869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25136779|NCT02988869|Adrenergic Agents|adrenergic agents|mesh-ancestor
25136780|NCT02988869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25136781|NCT02988869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136783|NCT02988869|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25136784|NCT02988869|Cholinergic Agents|cholinergic agents|mesh-ancestor
25136786|NCT02988921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25136787|NCT02988921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136788|NCT02988921|Tubulin Modulators|tubulin modulators|mesh-ancestor
25136789|NCT02988921|Antimitotic Agents|antimitotic agents|mesh-ancestor
25136790|NCT02988921|Mitosis Modulators|mitosis modulators|mesh-ancestor
25055347|NCT03521960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136791|NCT02988921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136792|NCT02988908|Donepezil|donepezil|mesh-list
25155964|NCT05208307|Ichthammol|ichthammol|mesh-list
25136793|NCT02988908|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25136794|NCT02988908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136798|NCT02988908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136799|NCT02988908|Nootropic Agents|nootropic agents|mesh-ancestor
25136800|NCT02988700|Bupivacaine|bupivacaine|mesh-list
25136836|NCT02988440|Sorafenib|sorafenib|mesh-list
25136837|NCT02988440|Spartalizumab|spartalizumab|mesh-list
25136898|NCT02987985|Anesthetics, Local|anesthetics, local|mesh-ancestor
25136899|NCT02987985|Anesthetics|anesthetics|mesh-ancestor
25136900|NCT02987985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25027986|NCT03614494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25027987|NCT03614494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25027988|NCT03614494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25027989|NCT03614494|Analgesics|analgesics|mesh-ancestor
25027990|NCT03614494|Sensory System Agents|sensory system agents|mesh-ancestor
25136901|NCT02987985|Sensory System Agents|sensory system agents|mesh-ancestor
25136902|NCT02987985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25136903|NCT02987985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25136904|NCT02987985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25136905|NCT02987985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25136906|NCT02987985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136907|NCT02987985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25136908|NCT02987985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25136909|NCT02987985|Analgesics|analgesics|mesh-ancestor
25136910|NCT02987985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25268342|NCT02416258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25136911|NCT02987985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25136912|NCT02987985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25136913|NCT02987985|Adrenergic Agents|adrenergic agents|mesh-ancestor
25136914|NCT02987985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25136915|NCT02987985|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25136916|NCT02987985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25136917|NCT02987985|Anesthetics, General|anesthetics, general|mesh-ancestor
25136918|NCT02987985|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25136919|NCT02987985|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25136920|NCT02987985|Narcotics|narcotics|mesh-ancestor
25136932|NCT02987985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25028014|NCT03614429|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25028015|NCT03614429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25028016|NCT03614429|Disinfectants|disinfectants|mesh-ancestor
25028017|NCT03614403|Vitamin D|vitamin d|mesh-list
25028018|NCT03614403|Cholecalciferol|cholecalciferol|mesh-list
25028019|NCT03614403|Vitamins|vitamins|mesh-ancestor
25028020|NCT03614403|Micronutrients|micronutrients|mesh-ancestor
25028021|NCT03614403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028022|NCT03614403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25028023|NCT03614403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25028024|NCT03614273|Epinephrine|epinephrine|mesh-list
25028025|NCT03614273|Racepinephrine|racepinephrine|mesh-list
25028026|NCT03614273|Epinephryl borate|epinephryl borate|mesh-list
25028027|NCT03614273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25136933|NCT02987985|Serotonin Agents|serotonin agents|mesh-ancestor
25136934|NCT02987985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25136935|NCT02987920|Acetaminophen|acetaminophen|mesh-list
25136937|NCT02987920|Ketorolac|ketorolac|mesh-list
25136938|NCT02987920|Oxycodone|oxycodone|mesh-list
25136939|NCT02987920|Gabapentin|gabapentin|mesh-list
25136940|NCT02987920|Hydromorphone|hydromorphone|mesh-list
25136941|NCT02987920|Dextromethorphan|dextromethorphan|mesh-list
25136942|NCT02987920|Pantoprazole|pantoprazole|mesh-list
25136943|NCT02987920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25136944|NCT02987920|Analgesics|analgesics|mesh-ancestor
25136945|NCT02987920|Sensory System Agents|sensory system agents|mesh-ancestor
25136946|NCT02987920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25136947|NCT02987920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136948|NCT02987920|Antipyretics|antipyretics|mesh-ancestor
25136949|NCT02987920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25136950|NCT02987920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25136951|NCT02987920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25136952|NCT02987920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25650303|NCT01500434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25136953|NCT02987920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25136954|NCT02987920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136955|NCT02987920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944667|NCT03958344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24944668|NCT03958344|Protective Agents|protective agents|mesh-ancestor
25136956|NCT02987920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25136960|NCT02987920|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25136961|NCT02987920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25136962|NCT02987920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25136963|NCT02987920|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25136964|NCT02987920|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25136965|NCT02987920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25136967|NCT02987920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25136968|NCT02987920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25136969|NCT02987920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25136970|NCT02987920|Antitussive Agents|antitussive agents|mesh-ancestor
25136971|NCT02987920|Respiratory System Agents|respiratory system agents|mesh-ancestor
25136973|NCT02987907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25136974|NCT02987907|Antiemetics|antiemetics|mesh-ancestor
25136975|NCT02987907|Autonomic Agents|autonomic agents|mesh-ancestor
25136976|NCT02987907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25136977|NCT02987907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137015|NCT02987465|Hematinics|hematinics|mesh-ancestor
25137016|NCT02987465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25137017|NCT02987465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25137018|NCT02987465|Adrenergic Agents|adrenergic agents|mesh-ancestor
25137019|NCT02987465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25137020|NCT02987465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028065|NCT03613974|Lidocaine|lidocaine|mesh-list
25137021|NCT02987465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137022|NCT02987465|Sympathomimetics|sympathomimetics|mesh-ancestor
25137023|NCT02987465|Autonomic Agents|autonomic agents|mesh-ancestor
25137024|NCT02987465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25137025|NCT02987465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25137026|NCT02987465|Vasodilator Agents|vasodilator agents|mesh-ancestor
25137027|NCT02987465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25137028|NCT02987465|Cholinergic Agents|cholinergic agents|mesh-ancestor
25137030|NCT02987400|Obinutuzumab|obinutuzumab|mesh-list
25137031|NCT02987400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25137032|NCT02987400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25137062|NCT02987244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25137063|NCT02987244|Glucocorticoids|glucocorticoids|mesh-ancestor
25137064|NCT02987244|Hormones|hormones|mesh-ancestor
25137065|NCT02987244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25137066|NCT02987244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25137067|NCT02987244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25137068|NCT02987244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25137069|NCT02987244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25137070|NCT02987244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25137071|NCT02987244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25137072|NCT02987244|Tubulin Modulators|tubulin modulators|mesh-ancestor
25137073|NCT02987244|Antimitotic Agents|antimitotic agents|mesh-ancestor
25028111|NCT03613792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25028112|NCT03613792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25137074|NCT02987244|Mitosis Modulators|mitosis modulators|mesh-ancestor
25137075|NCT02987166|Pembrolizumab|pembrolizumab|mesh-list
25137076|NCT02987166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25137077|NCT02987166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25137078|NCT02987348|Insulin|insulin|mesh-list
25137079|NCT02987348|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25137080|NCT02987348|Exenatide|exenatide|mesh-list
25085369|NCT03298698|Prednisone|prednisone|mesh-list
25137081|NCT02987348|Insulin, Long-Acting|insulin, long-acting|mesh-list
25137117|NCT02986906|Glucocorticoids|glucocorticoids|mesh-ancestor
25137118|NCT02986906|Hormones|hormones|mesh-ancestor
25137119|NCT02986906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24965192|NCT03778281|Baclofen|baclofen|mesh-list
25137319|NCT02985671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25137320|NCT02985671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25137321|NCT02985671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25085632|NCT03296358|Dexamethasone|dexamethasone|mesh-list
25137322|NCT02985671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25137323|NCT02985671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25137324|NCT02985671|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25137325|NCT02985671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25137353|NCT02985229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25137358|NCT02985229|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25650304|NCT01500434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137359|NCT02985229|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25137360|NCT02985229|Contraceptive Agents|contraceptive agents|mesh-ancestor
25137361|NCT02985229|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25137362|NCT02985229|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25137363|NCT02985229|Hormone Antagonists|hormone antagonists|mesh-ancestor
25028149|NCT03613545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25137364|NCT02985229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25137365|NCT02985229|Luteolytic Agents|luteolytic agents|mesh-ancestor
25137366|NCT02985229|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25137367|NCT02985229|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25137368|NCT02985372|Cytarabine|cytarabine|mesh-list
25137369|NCT02985372|Decitabine|decitabine|mesh-list
25137370|NCT02985372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25137371|NCT02985372|Antimetabolites|antimetabolites|mesh-ancestor
25137372|NCT02985372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137529|NCT02984865|Sensory System Agents|sensory system agents|mesh-ancestor
25137530|NCT02984865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25137531|NCT02984865|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25137532|NCT02984865|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25137533|NCT02984865|Anesthetics, General|anesthetics, general|mesh-ancestor
25137577|NCT02984514|Deoxyglucose|deoxyglucose|mesh-list
25137578|NCT02984514|Antimetabolites|antimetabolites|mesh-ancestor
25137579|NCT02984514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137580|NCT02984514|Antiviral Agents|antiviral agents|mesh-ancestor
25137581|NCT02984514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25028188|NCT03613168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25028189|NCT03613168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028190|NCT03612947|Magnesium Sulfate|magnesium sulfate|mesh-list
25028191|NCT03612947|Bupivacaine|bupivacaine|mesh-list
25028192|NCT03612947|Anesthetics, Local|anesthetics, local|mesh-ancestor
25028193|NCT03612947|Anesthetics|anesthetics|mesh-ancestor
25028194|NCT03612947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25028195|NCT03612947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028196|NCT03612947|Sensory System Agents|sensory system agents|mesh-ancestor
24593715|NCT00930709|Botulinum Toxins|botulinum toxins|mesh-list
25028206|NCT03612947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25028210|NCT03612817|Adrenergic Agents|adrenergic agents|mesh-ancestor
25137582|NCT02984397|Ketotifen|ketotifen|mesh-list
25137583|NCT02984397|Antipruritics|antipruritics|mesh-ancestor
25137584|NCT02984397|Dermatologic Agents|dermatologic agents|mesh-ancestor
25137585|NCT02984397|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25137586|NCT02984397|Histamine Antagonists|histamine antagonists|mesh-ancestor
25137587|NCT02984397|Histamine Agents|histamine agents|mesh-ancestor
25137588|NCT02984397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25137589|NCT02984397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137590|NCT02984397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137591|NCT02984397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25046140|NCT00871481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25046141|NCT00871481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25046142|NCT00871481|Alkylating Agents|alkylating agents|mesh-ancestor
25046143|NCT00871481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137613|NCT02984072|Menthol|menthol|mesh-list
25137614|NCT02984072|Antipruritics|antipruritics|mesh-ancestor
25137615|NCT02984072|Dermatologic Agents|dermatologic agents|mesh-ancestor
25137616|NCT02983591|Misoprostol|misoprostol|mesh-list
25137617|NCT02983591|Oxytocin|oxytocin|mesh-list
25137618|NCT02983591|Oxytocics|oxytocics|mesh-ancestor
25137619|NCT02983591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25028224|NCT03612557|Penicillin G Benzathine|penicillin g benzathine|mesh-list
25028225|NCT03612557|Penicillin G Procaine|penicillin g procaine|mesh-list
25028226|NCT03612557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25028227|NCT03612557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25028228|NCT03612492|Lidocaine|lidocaine|mesh-list
25028229|NCT03612492|Anesthetics, Local|anesthetics, local|mesh-list
25028230|NCT03612492|Anesthetics|anesthetics|mesh-list
25028231|NCT03612492|Esmolol|esmolol|mesh-list
25028235|NCT03612492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24987759|NCT04990323|Vidarabine|vidarabine|mesh-list
25137620|NCT02983591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137621|NCT02983591|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25137622|NCT02983591|Abortifacient Agents|abortifacient agents|mesh-ancestor
25137623|NCT02983591|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25137624|NCT02983591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25137625|NCT02983890|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25137626|NCT02983890|Dicloxacillin|dicloxacillin|mesh-list
25137627|NCT02983890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25137628|NCT02983773|Dronabinol|dronabinol|mesh-list
24754435|NCT01720485|Histamine Agents|histamine agents|mesh-ancestor
24754463|NCT01720615|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24754464|NCT01720615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25137629|NCT02983773|Hallucinogens|hallucinogens|mesh-ancestor
25137630|NCT02983773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137631|NCT02983773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25137632|NCT02983773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25137633|NCT02983773|Analgesics|analgesics|mesh-ancestor
25137634|NCT02983773|Sensory System Agents|sensory system agents|mesh-ancestor
25137635|NCT02983773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25137636|NCT02983773|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25137637|NCT02983773|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25137638|NCT02983773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25028236|NCT03612492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25137639|NCT02983773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137640|NCT02983773|Hormones|hormones|mesh-ancestor
25137641|NCT02983773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25137642|NCT02983734|Cycloserine|cycloserine|mesh-list
25137643|NCT02983734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25137644|NCT02983734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25137645|NCT02983734|Renal Agents|renal agents|mesh-ancestor
25137646|NCT02983734|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24791720|NCT03416335|Pembrolizumab|pembrolizumab|mesh-list
24830559|NCT02160054|Tacrolimus|tacrolimus|mesh-list
25137674|NCT02983214|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25137675|NCT02983214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25137676|NCT02983214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25137677|NCT02983188|Antipsychotic Agents|antipsychotic agents|mesh-list
25137678|NCT02983188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25137679|NCT02983188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25137680|NCT02983188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137681|NCT02983188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25137683|NCT02983344|Ropivacaine|ropivacaine|mesh-list
25137684|NCT02983344|Anesthetics, Local|anesthetics, local|mesh-ancestor
25137685|NCT02983344|Anesthetics|anesthetics|mesh-ancestor
25137686|NCT02983344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25137687|NCT02983344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137688|NCT02983344|Sensory System Agents|sensory system agents|mesh-ancestor
25137689|NCT02983344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25137690|NCT02983344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25137691|NCT02983344|Narcotics|narcotics|mesh-ancestor
25137692|NCT02983344|Analgesics|analgesics|mesh-ancestor
25137693|NCT02983344|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25137792|NCT02982850|Sensory System Agents|sensory system agents|mesh-ancestor
25137793|NCT02982850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25028254|NCT03612440|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25028255|NCT03612440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25028256|NCT03612440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25137794|NCT02982850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137795|NCT02982850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25137796|NCT02982850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25137797|NCT02982850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25137798|NCT02982850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25137799|NCT02982850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137800|NCT02982850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25137801|NCT02982850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25137802|NCT02982850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25137803|NCT02982850|Antipyretics|antipyretics|mesh-ancestor
25137804|NCT02982850|Anticoagulants|anticoagulants|mesh-ancestor
25137805|NCT02982850|Antithrombins|antithrombins|mesh-ancestor
25137806|NCT02982850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25137807|NCT02982850|Protease Inhibitors|protease inhibitors|mesh-ancestor
25137809|NCT02982551|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25137810|NCT02982551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25137811|NCT02982551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137812|NCT02982486|Nivolumab|nivolumab|mesh-list
25137813|NCT02982486|Ipilimumab|ipilimumab|mesh-list
25137814|NCT02982486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25138207|NCT02980016|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25138209|NCT02980016|Antimetabolites|antimetabolites|mesh-ancestor
25138210|NCT02980016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046305|NCT00858702|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25650305|NCT01500434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25650306|NCT01500434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25650307|NCT01500434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046306|NCT00858702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25046307|NCT00858702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046308|NCT00858702|Natriuretic Agents|natriuretic agents|mesh-ancestor
25046309|NCT00858702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046310|NCT00857285|Losartan|losartan|mesh-list
25046311|NCT00857285|Olmesartan|olmesartan|mesh-list
25046312|NCT00857285|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25046313|NCT00857285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25046314|NCT00857285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25046315|NCT00857285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25046316|NCT00857285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25046317|NCT00857285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046318|NCT00855764|Paclitaxel|paclitaxel|mesh-list
25046319|NCT00855764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25046320|NCT00855764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25046321|NCT00855764|Tubulin Modulators|tubulin modulators|mesh-ancestor
25046322|NCT00855764|Antimitotic Agents|antimitotic agents|mesh-ancestor
25046323|NCT00855764|Mitosis Modulators|mitosis modulators|mesh-ancestor
25046324|NCT00855764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046325|NCT00855712|Cardioplegic Solutions|cardioplegic solutions|mesh-list
25046326|NCT00855712|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25046327|NCT00854945|ON 01910|on 01910|mesh-list
25046328|NCT00854945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25139237|NCT02972476|Formoterol Fumarate|formoterol fumarate|mesh-list
25139238|NCT02972476|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25139239|NCT02972476|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25139240|NCT02972476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25139241|NCT02972476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25139242|NCT02972476|Autonomic Agents|autonomic agents|mesh-ancestor
25139243|NCT02972476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25139368|NCT02971878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139369|NCT02971878|Protective Agents|protective agents|mesh-ancestor
25139370|NCT02971878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139371|NCT02971878|Vitamin B Complex|vitamin b complex|mesh-ancestor
25139372|NCT02971878|Vitamins|vitamins|mesh-ancestor
25139373|NCT02971878|Micronutrients|micronutrients|mesh-ancestor
25139374|NCT02971878|Nootropic Agents|nootropic agents|mesh-ancestor
25139375|NCT02971878|Antiviral Agents|antiviral agents|mesh-ancestor
25139376|NCT02971878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25139377|NCT02971878|Expectorants|expectorants|mesh-ancestor
25139378|NCT02971878|Respiratory System Agents|respiratory system agents|mesh-ancestor
25139379|NCT02971878|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25046621|NCT00839930|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25046622|NCT00839930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140804|NCT02961829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25140805|NCT02961829|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25140806|NCT02961829|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25047005|NCT00834613|Metformin|metformin|mesh-list
25047006|NCT00834613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25047007|NCT00834613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047008|NCT00834587|Metformin|metformin|mesh-list
25047009|NCT00834587|Glipizide|glipizide|mesh-list
25047010|NCT00834587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25047011|NCT00834587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047012|NCT00834574|Cefdinir|cefdinir|mesh-list
25047013|NCT00834574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25047014|NCT00834574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25047015|NCT00834561|Lamotrigine|lamotrigine|mesh-list
25047016|NCT00834561|Anticonvulsants|anticonvulsants|mesh-ancestor
25047017|NCT00834561|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25079585|NCT03346733|Psyllium|psyllium|mesh-list
25141463|NCT02957851|Sensory System Agents|sensory system agents|mesh-ancestor
25141464|NCT02957851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25141466|NCT02957643|Trace Elements|trace elements|mesh-ancestor
25141506|NCT02957630|Contraceptive Agents|contraceptive agents|mesh-ancestor
25141507|NCT02957630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25141508|NCT02957630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141509|NCT02957630|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25141510|NCT02957630|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24616914|NCT01039766|Oxytocin|oxytocin|mesh-list
25141542|NCT02957162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141544|NCT02957162|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25141545|NCT02957162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25141546|NCT02957279|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25141547|NCT02957279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24944793|NCT03957629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24944794|NCT03957629|Immunologic Factors|immunologic factors|mesh-ancestor
24944795|NCT03957629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944800|NCT03957291|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24944801|NCT03957291|Povidone-Iodine|povidone-iodine|mesh-list
25141549|NCT02957097|Analgesics|analgesics|mesh-ancestor
25141550|NCT02957097|Sensory System Agents|sensory system agents|mesh-ancestor
25141551|NCT02957097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25141552|NCT02957097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760189|NCT01756651|Fentanyl|fentanyl|mesh-list
25028388|NCT03610945|Antifungal Agents|antifungal agents|mesh-ancestor
25028389|NCT03610945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25141608|NCT02956408|Cholecalciferol|cholecalciferol|mesh-list
25141610|NCT02956408|Micronutrients|micronutrients|mesh-ancestor
25141611|NCT02956408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141612|NCT02956408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25141613|NCT02956408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25141614|NCT02956421|Vaccines|vaccines|mesh-list
25141647|NCT02955732|Dexmedetomidine|dexmedetomidine|mesh-list
25141648|NCT02955732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25141649|NCT02955732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25141650|NCT02955732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141651|NCT02955732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25141653|NCT02955732|Sensory System Agents|sensory system agents|mesh-ancestor
24551130|NCT00724035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25141684|NCT02955524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25141685|NCT02955524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25141686|NCT02955524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141687|NCT02955693|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25141688|NCT02955693|Dermatologic Agents|dermatologic agents|mesh-ancestor
25141689|NCT02955693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25141690|NCT02955693|Immunologic Factors|immunologic factors|mesh-ancestor
25141691|NCT02955693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141692|NCT02955706|Acetylcarnitine|acetylcarnitine|mesh-list
24551222|NCT00724620|Ribavirin|ribavirin|mesh-list
25141764|NCT02954939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25141799|NCT02954549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25079629|NCT03346538|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25047122|NCT00833937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047123|NCT00833937|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25047124|NCT00833937|GABA Agonists|gaba agonists|mesh-ancestor
25047225|NCT00830102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047226|NCT00830024|Alprazolam|alprazolam|mesh-list
25047227|NCT00830024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25047228|NCT00830024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25047229|NCT00830024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047230|NCT00830024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25047231|NCT00830024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25047232|NCT00830024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25047233|NCT00830024|GABA Modulators|gaba modulators|mesh-ancestor
25047234|NCT00830024|GABA Agents|gaba agents|mesh-ancestor
25047235|NCT00830024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25090958|NCT03252418|Protective Agents|protective agents|mesh-ancestor
25142252|NCT02951962|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25143627|NCT02941328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25142253|NCT02951962|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25142255|NCT02951897|Pemetrexed|pemetrexed|mesh-list
25142256|NCT02951897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142257|NCT02951897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25142258|NCT02951897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760858|NCT01760226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25142372|NCT02950441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142373|NCT02950441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25142448|NCT02949648|Nicotine|nicotine|mesh-list
25142449|NCT02949648|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25142450|NCT02949648|Autonomic Agents|autonomic agents|mesh-ancestor
25142451|NCT02949648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24979929|NCT04933383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25650308|NCT01500434|Antipyretics|antipyretics|mesh-ancestor
25650309|NCT01500434|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25650310|NCT01500434|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25650311|NCT01500434|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25650312|NCT01500434|Purinergic Agents|purinergic agents|mesh-ancestor
25650313|NCT01500434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25829183|NCT00006152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24723770|NCT01589068|Progesterone|progesterone|mesh-list
25199883|NCT02737813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25199884|NCT02737813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199885|NCT02737813|Sensory System Agents|sensory system agents|mesh-ancestor
25138135|NCT02980497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138136|NCT02980497|Cariostatic Agents|cariostatic agents|mesh-ancestor
25138137|NCT02980497|Protective Agents|protective agents|mesh-ancestor
25829184|NCT00006152|Antiviral Agents|antiviral agents|mesh-ancestor
25829185|NCT00006152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25829186|NCT00006152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25829187|NCT00006152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25829188|NCT00006152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25138162|NCT02980458|Deferiprone|deferiprone|mesh-list
25138163|NCT02980458|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25138177|NCT02980094|Vitamins|vitamins|mesh-list
25142551|NCT02949193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25142553|NCT02949193|Protease Inhibitors|protease inhibitors|mesh-ancestor
25142554|NCT02949193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25142555|NCT02949193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142556|NCT02948985|Cetuximab|cetuximab|mesh-list
25650314|NCT01500434|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25142557|NCT02948985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25142558|NCT02948985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142559|NCT02948998|Spironolactone|spironolactone|mesh-list
25142560|NCT02948998|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25142561|NCT02948998|Hormone Antagonists|hormone antagonists|mesh-ancestor
25142634|NCT02948075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142635|NCT02947932|Indomethacin|indomethacin|mesh-list
24985439|NCT03353675|Nivolumab|nivolumab|mesh-list
25142636|NCT02947932|Resveratrol|resveratrol|mesh-list
25142637|NCT02947932|Antioxidants|antioxidants|mesh-ancestor
25142638|NCT02947932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142639|NCT02947932|Protective Agents|protective agents|mesh-ancestor
25142640|NCT02947932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142641|NCT02947932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25142642|NCT02947932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25142643|NCT02947932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24761212|NCT01761656|Atorvastatin|atorvastatin|mesh-list
25142679|NCT02947620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25142680|NCT02947854|Photosensitizing Agents|photosensitizing agents|mesh-list
25142681|NCT02947854|Poly ICLC|poly iclc|mesh-list
25142712|NCT02947815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25142714|NCT02947737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25142715|NCT02947737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25142716|NCT02947737|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25142717|NCT02947737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047260|NCT00829790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25047261|NCT00829764|Doxycycline|doxycycline|mesh-list
25047262|NCT00829764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25047263|NCT00829764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25047264|NCT00829764|Antimalarials|antimalarials|mesh-ancestor
25047265|NCT00829764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25650315|NCT01500434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25650316|NCT01500694|Guanfacine|guanfacine|mesh-list
25650317|NCT01500694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25650318|NCT01500694|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25650319|NCT01500694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25650320|NCT01500694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25650321|NCT01500694|Adrenergic Agents|adrenergic agents|mesh-ancestor
25650322|NCT01500694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25650323|NCT01500694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650324|NCT01500694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650325|NCT01500720|Topotecan|topotecan|mesh-list
25650326|NCT01500720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25650327|NCT01500720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25650328|NCT01500720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650329|NCT01500720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650330|NCT01500720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25650331|NCT01501110|Acetylcysteine|acetylcysteine|mesh-list
25650332|NCT01501110|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25199900|NCT02737670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24542520|NCT00679146|Ketoprofen|ketoprofen|mesh-list
24594165|NCT00932880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028491|NCT03610230|Micronutrients|micronutrients|mesh-ancestor
25028492|NCT03610230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028493|NCT03610230|Hematinics|hematinics|mesh-ancestor
24594166|NCT00932880|Vasodilator Agents|vasodilator agents|mesh-ancestor
24594167|NCT00932971|Tenofovir|tenofovir|mesh-list
25028494|NCT03610178|Insulin|insulin|mesh-list
25047266|NCT00829764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25142860|NCT02946359|Growth Inhibitors|growth inhibitors|mesh-ancestor
25142861|NCT02946359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25142862|NCT02946359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25142863|NCT02946359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142865|NCT02946437|Propofol|propofol|mesh-list
25142866|NCT02946437|Sevoflurane|sevoflurane|mesh-list
25142867|NCT02946437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25142868|NCT02946437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25142869|NCT02946437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142870|NCT02946437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25142871|NCT02946437|Anesthetics, General|anesthetics, general|mesh-ancestor
25142872|NCT02946437|Anesthetics|anesthetics|mesh-ancestor
25142873|NCT02946437|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25142874|NCT02946437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25142875|NCT02946437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25142876|NCT02946437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25028507|NCT03610100|Antimetabolites|antimetabolites|mesh-ancestor
24484540|NCT00449137|Calcium|calcium|mesh-list
25142877|NCT02946437|GABA Modulators|gaba modulators|mesh-ancestor
25142878|NCT02946437|GABA Agents|gaba agents|mesh-ancestor
25142879|NCT02946437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25142881|NCT02946437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25142987|NCT02945644|Serotonin Agents|serotonin agents|mesh-ancestor
25142988|NCT02945644|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25142989|NCT02945644|Antidepressive Agents|antidepressive agents|mesh-ancestor
25142990|NCT02945527|Dexamethasone|dexamethasone|mesh-list
25142991|NCT02945527|Acetazolamide|acetazolamide|mesh-list
25142992|NCT02945527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25142993|NCT02945527|Antiemetics|antiemetics|mesh-ancestor
25142994|NCT02945527|Autonomic Agents|autonomic agents|mesh-ancestor
25142995|NCT02945527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25142996|NCT02945527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142997|NCT02945527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25142998|NCT02945527|Glucocorticoids|glucocorticoids|mesh-ancestor
25143000|NCT02945527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25143001|NCT02945527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25143002|NCT02945527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143003|NCT02945527|Anticonvulsants|anticonvulsants|mesh-ancestor
25143004|NCT02945527|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25143005|NCT02945527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143062|NCT02945215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25091865|NCT03246386|Posaconazole|posaconazole|mesh-list
25143064|NCT02945072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25143065|NCT02945072|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25143066|NCT02945072|Anesthetics, General|anesthetics, general|mesh-ancestor
25028540|NCT03609892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25028541|NCT03609892|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25028542|NCT03609892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25028547|NCT03609892|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25028548|NCT03609892|Renal Agents|renal agents|mesh-ancestor
25028549|NCT03609892|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25028550|NCT03609892|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25028551|NCT03609892|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25028552|NCT03609892|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25143067|NCT02945072|Anesthetics|anesthetics|mesh-ancestor
25143068|NCT02945072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25143069|NCT02945072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143070|NCT02944942|Anesthetics|anesthetics|mesh-list
25143071|NCT02944942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25143072|NCT02944942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143073|NCT02945020|Simeprevir|simeprevir|mesh-list
25143074|NCT02945020|Odalasvir|odalasvir|mesh-list
25143075|NCT02945020|Dabigatran|dabigatran|mesh-list
25143076|NCT02945020|Antithrombins|antithrombins|mesh-ancestor
25143077|NCT02945020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25650333|NCT01501110|Antiviral Agents|antiviral agents|mesh-ancestor
25143143|NCT02944734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650334|NCT01501110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24944856|NCT03956732|Chelating Agents|chelating agents|mesh-ancestor
25143145|NCT02944734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25143146|NCT02944734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25143147|NCT02944227|Ranibizumab|ranibizumab|mesh-list
25143148|NCT02944227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25028556|NCT03609827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028560|NCT03609827|Immunologic Factors|immunologic factors|mesh-ancestor
25143149|NCT02944227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25143150|NCT02944227|Growth Substances|growth substances|mesh-ancestor
25143151|NCT02944227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143152|NCT02944227|Growth Inhibitors|growth inhibitors|mesh-ancestor
25143153|NCT02944227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143155|NCT02944292|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25143156|NCT02944292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25143292|NCT02943798|Antimitotic Agents|antimitotic agents|mesh-ancestor
25143293|NCT02943798|Mitosis Modulators|mitosis modulators|mesh-ancestor
25143294|NCT02943798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143295|NCT02943798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25143296|NCT02943798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25143297|NCT02943798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143298|NCT02943902|Vaccines|vaccines|mesh-list
25143299|NCT02943902|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25143300|NCT02943902|Immunologic Factors|immunologic factors|mesh-ancestor
25143421|NCT02942693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25143422|NCT02942693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24786200|NCT01918514|Analgesics|analgesics|mesh-ancestor
25143460|NCT02942420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24761970|NCT01765608|Zonisamide|zonisamide|mesh-list
25143628|NCT02941328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143629|NCT02941328|Cholinergic Agents|cholinergic agents|mesh-ancestor
25143630|NCT02941328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25143631|NCT02941328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143632|NCT02941315|Captopril|captopril|mesh-list
25143633|NCT02941315|Spironolactone|spironolactone|mesh-list
25143634|NCT02941315|Furosemide|furosemide|mesh-list
25143635|NCT02941315|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25143636|NCT02941315|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25143637|NCT02941315|Hormone Antagonists|hormone antagonists|mesh-ancestor
25143638|NCT02941315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25143639|NCT02941315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143640|NCT02941315|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25143641|NCT02941315|Diuretics|diuretics|mesh-ancestor
24762059|NCT01765868|Betrixaban|betrixaban|mesh-list
25143680|NCT02940990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25143681|NCT02940990|Antimetabolites|antimetabolites|mesh-ancestor
25143780|NCT02940756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143781|NCT02940756|Antiviral Agents|antiviral agents|mesh-ancestor
25143782|NCT02940756|Schistosomicides|schistosomicides|mesh-ancestor
25143783|NCT02940756|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25047416|NCT00817986|GABA Agonists|gaba agonists|mesh-ancestor
25047417|NCT00817986|GABA Agents|gaba agents|mesh-ancestor
25047418|NCT00817986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25047419|NCT00817986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047420|NCT00817362|Trastuzumab|trastuzumab|mesh-list
25047421|NCT00817362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25028598|NCT03609489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028601|NCT03609424|Imatinib Mesylate|imatinib mesylate|mesh-list
25047422|NCT00817362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25047423|NCT00814372|Metformin|metformin|mesh-list
25047457|NCT00812240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047458|NCT00810732|Nifedipine|nifedipine|mesh-list
25047459|NCT00810732|Sitaxsentan|sitaxsentan|mesh-list
25047460|NCT00810732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25047461|NCT00810732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25047462|NCT00810732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047463|NCT00810732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25047464|NCT00810732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143810|NCT02940379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143811|NCT02940379|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25143812|NCT02940379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25143813|NCT02940379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25143814|NCT02940379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25143815|NCT02940379|Anesthetics, General|anesthetics, general|mesh-ancestor
25650335|NCT01501110|Expectorants|expectorants|mesh-ancestor
25829189|NCT00006152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24542796|NCT00680394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24542797|NCT00680394|Luteolytic Agents|luteolytic agents|mesh-ancestor
25143817|NCT02940379|GABA Modulators|gaba modulators|mesh-ancestor
25143818|NCT02940379|GABA Agents|gaba agents|mesh-ancestor
25143819|NCT02940379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25143922|NCT02940002|Calcipotriene|calcipotriene|mesh-list
25143923|NCT02940002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25143924|NCT02940002|Glucocorticoids|glucocorticoids|mesh-ancestor
25143925|NCT02940002|Hormones|hormones|mesh-ancestor
25143926|NCT02940002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25143927|NCT02940002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143928|NCT02940002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25143929|NCT02940002|Respiratory System Agents|respiratory system agents|mesh-ancestor
25143930|NCT02940002|Dermatologic Agents|dermatologic agents|mesh-ancestor
25143931|NCT02939833|Ropivacaine|ropivacaine|mesh-list
25028645|NCT03609190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25028648|NCT03609190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25143932|NCT02939833|Anesthetics, Local|anesthetics, local|mesh-ancestor
25143933|NCT02939833|Anesthetics|anesthetics|mesh-ancestor
25143934|NCT02939833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25143935|NCT02939833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143937|NCT02939833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25143963|NCT02939482|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25143964|NCT02939482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25143965|NCT02939482|Glucocorticoids|glucocorticoids|mesh-ancestor
25143967|NCT02939482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25143968|NCT02939482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143969|NCT02939482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25143970|NCT02939482|Immunologic Factors|immunologic factors|mesh-ancestor
25143971|NCT02939482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143972|NCT02939482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143978|NCT02939430|Autonomic Agents|autonomic agents|mesh-ancestor
25143979|NCT02939430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25143980|NCT02939430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143981|NCT02939430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25143982|NCT02939430|Respiratory System Agents|respiratory system agents|mesh-ancestor
25028697|NCT03608618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25028698|NCT03608618|Alkylating Agents|alkylating agents|mesh-ancestor
25028699|NCT03608618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028700|NCT03608618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028703|NCT03608514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25028704|NCT03608514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25028705|NCT03608501|Thalidomide|thalidomide|mesh-list
25028706|NCT03608501|Dexamethasone|dexamethasone|mesh-list
25028707|NCT03608501|Ixazomib|ixazomib|mesh-list
25028708|NCT03608501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25028709|NCT03608501|Antiemetics|antiemetics|mesh-ancestor
25028710|NCT03608501|Autonomic Agents|autonomic agents|mesh-ancestor
25028713|NCT03608501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25143983|NCT02939430|Mydriatics|mydriatics|mesh-ancestor
25143984|NCT02939430|Parasympatholytics|parasympatholytics|mesh-ancestor
25144019|NCT02939287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25144020|NCT02939287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144021|NCT02939287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25144022|NCT02939287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25144023|NCT02939287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25047478|NCT00808288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25047479|NCT00808288|Adrenergic Agents|adrenergic agents|mesh-ancestor
25047480|NCT00808288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25047481|NCT00808288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047482|NCT00807612|Paclitaxel|paclitaxel|mesh-list
25047483|NCT00807612|Carboplatin|carboplatin|mesh-list
25047484|NCT00807612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25047485|NCT00807612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25047486|NCT00807612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25047488|NCT00807612|Antimitotic Agents|antimitotic agents|mesh-ancestor
25047489|NCT00807612|Mitosis Modulators|mitosis modulators|mesh-ancestor
25047490|NCT00807612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047491|NCT00807612|Immunologic Factors|immunologic factors|mesh-ancestor
25650336|NCT01501110|Respiratory System Agents|respiratory system agents|mesh-ancestor
25650337|NCT01501110|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25650338|NCT01501110|Antioxidants|antioxidants|mesh-ancestor
25657189|NCT01583985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724928|NCT01595737|Simendan|simendan|mesh-list
25047492|NCT00807612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047493|NCT00806403|Reteplase|reteplase|mesh-list
25047494|NCT00806403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25047495|NCT00806403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25047496|NCT00806403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047497|NCT00805805|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
25047498|NCT00805805|Chelating Agents|chelating agents|mesh-ancestor
25047499|NCT00805805|Sequestering Agents|sequestering agents|mesh-ancestor
25047500|NCT00805805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028718|NCT03608501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028719|NCT03608501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028720|NCT03608501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25028721|NCT03608501|Immunologic Factors|immunologic factors|mesh-ancestor
25028722|NCT03608501|Leprostatic Agents|leprostatic agents|mesh-ancestor
25028723|NCT03608501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25028724|NCT03608501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25047501|NCT00805805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047502|NCT00805805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24762471|NCT01768351|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25144061|NCT02938988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144062|NCT02939235|Morphine|morphine|mesh-list
25144063|NCT02939235|Metoclopramide|metoclopramide|mesh-list
25144064|NCT02939235|Ticagrelor|ticagrelor|mesh-list
25144065|NCT02939235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25144066|NCT02939235|Narcotics|narcotics|mesh-ancestor
25144067|NCT02939235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25144068|NCT02939235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144069|NCT02939235|Analgesics|analgesics|mesh-ancestor
25144070|NCT02939235|Sensory System Agents|sensory system agents|mesh-ancestor
25144071|NCT02939235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25144072|NCT02939235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25144073|NCT02939235|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25144074|NCT02939235|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25144075|NCT02939235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25144076|NCT02939235|Purinergic Agents|purinergic agents|mesh-ancestor
25028762|NCT03608098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25028763|NCT03608098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25028764|NCT03608098|Adrenergic Agents|adrenergic agents|mesh-ancestor
25144106|NCT02939092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25144108|NCT02939092|Disinfectants|disinfectants|mesh-ancestor
25144109|NCT02938741|Thymoglobulin|thymoglobulin|mesh-list
25144110|NCT02938741|Immunologic Factors|immunologic factors|mesh-ancestor
25144111|NCT02938741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144112|NCT02938741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25144113|NCT02938546|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25144114|NCT02938546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25144115|NCT02938546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144117|NCT02938572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25144118|NCT02938572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144119|NCT02938468|Dexamethasone|dexamethasone|mesh-list
25144120|NCT02938468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25144121|NCT02938468|Antiemetics|antiemetics|mesh-ancestor
25144122|NCT02938468|Autonomic Agents|autonomic agents|mesh-ancestor
25028780|NCT03608046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144123|NCT02938468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25144185|NCT02938182|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25093063|NCT03237117|Hormones|hormones|mesh-list
25144187|NCT02938182|Purinergic Agents|purinergic agents|mesh-ancestor
25144188|NCT02938182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25144189|NCT02938182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144190|NCT02938182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144192|NCT02937662|Cyclophosphamide|cyclophosphamide|mesh-list
25144193|NCT02937662|Idarubicin|idarubicin|mesh-list
24620172|NCT01055756|Histamine Agents|histamine agents|mesh-ancestor
25144229|NCT02937896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25144230|NCT02937896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25144332|NCT02937012|Antimetabolites|antimetabolites|mesh-ancestor
24486448|NCT00458055|Niacin|niacin|mesh-list
25144333|NCT02937012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144334|NCT02937012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25144335|NCT02936895|Vitamin D|vitamin d|mesh-list
25144336|NCT02936895|Cholecalciferol|cholecalciferol|mesh-list
25144337|NCT02936895|Vitamins|vitamins|mesh-ancestor
25144338|NCT02936895|Micronutrients|micronutrients|mesh-ancestor
25657190|NCT01583985|Analgesics|analgesics|mesh-ancestor
24755210|NCT01725113|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24755211|NCT01725113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25144339|NCT02936895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486917|NCT00460616|Cabergoline|cabergoline|mesh-list
25144340|NCT02936895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25144341|NCT02936895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25144343|NCT02936830|Fluorides|fluorides|mesh-list
25144344|NCT02936830|Sodium Fluoride|sodium fluoride|mesh-list
25144345|NCT02936830|Fluorides, Topical|fluorides, topical|mesh-list
25144347|NCT02936830|Cariostatic Agents|cariostatic agents|mesh-ancestor
25144348|NCT02936830|Protective Agents|protective agents|mesh-ancestor
25144349|NCT02936830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144350|NCT02936830|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25144351|NCT02936830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24553535|NCT00731861|Vatalanib|vatalanib|mesh-list
25144379|NCT02936505|Dermatologic Agents|dermatologic agents|mesh-ancestor
25144380|NCT02936505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25144381|NCT02936505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25144382|NCT02936505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25144383|NCT02936505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25144551|NCT02935972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25144384|NCT02936505|Antitubercular Agents|antitubercular agents|mesh-ancestor
25144385|NCT02936505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25144386|NCT02936427|Dexamethasone|dexamethasone|mesh-list
25144387|NCT02936427|Dexamethasone acetate|dexamethasone acetate|mesh-list
25144388|NCT02936427|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25144389|NCT02936427|BB 1101|bb 1101|mesh-list
25144390|NCT02936427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25144391|NCT02936427|Antiemetics|antiemetics|mesh-ancestor
25144392|NCT02936427|Autonomic Agents|autonomic agents|mesh-ancestor
25144393|NCT02936427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25144394|NCT02936427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144395|NCT02936427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25144396|NCT02936427|Glucocorticoids|glucocorticoids|mesh-ancestor
25144397|NCT02936427|Hormones|hormones|mesh-ancestor
25144398|NCT02936427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25144399|NCT02936427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25144400|NCT02936427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25144437|NCT02935933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762817|NCT01769833|Interferons|interferons|mesh-list
25144472|NCT02935751|Apixaban|apixaban|mesh-list
25144473|NCT02935751|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25144474|NCT02935751|Antithrombins|antithrombins|mesh-ancestor
25144475|NCT02935751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25144476|NCT02935751|Protease Inhibitors|protease inhibitors|mesh-ancestor
25144477|NCT02935751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25144478|NCT02935751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144479|NCT02935751|Anticoagulants|anticoagulants|mesh-ancestor
25047545|NCT00796289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25047547|NCT00796289|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25047548|NCT00796289|Hormone Antagonists|hormone antagonists|mesh-ancestor
25144486|NCT02935998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25144487|NCT02935998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25144488|NCT02935998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25144489|NCT02935998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25144490|NCT02935998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25144491|NCT02935998|Dopamine Agents|dopamine agents|mesh-ancestor
25144492|NCT02935790|Nivolumab|nivolumab|mesh-list
25144493|NCT02935790|Ipilimumab|ipilimumab|mesh-list
25144494|NCT02935790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25144495|NCT02935790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25144496|NCT02935790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25144497|NCT02935790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144498|NCT02935829|Locust bean gum|locust bean gum|mesh-list
25144499|NCT02935829|Antidiarrheals|antidiarrheals|mesh-ancestor
25144500|NCT02935829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25144501|NCT02935959|Midazolam|midazolam|mesh-list
25144502|NCT02935959|Dexmedetomidine|dexmedetomidine|mesh-list
25144503|NCT02935959|Ketamine|ketamine|mesh-list
25144504|NCT02935959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25144505|NCT02935959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25650339|NCT01501110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144506|NCT02935959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144507|NCT02935959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25144508|NCT02935959|Analgesics|analgesics|mesh-ancestor
25829190|NCT00006152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25829191|NCT00006152|Antitubercular Agents|antitubercular agents|mesh-ancestor
25829192|NCT00006152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25829193|NCT00006154|Ritonavir|ritonavir|mesh-list
24857967|NCT02294552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25144509|NCT02935959|Sensory System Agents|sensory system agents|mesh-ancestor
25144510|NCT02935959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25144511|NCT02935959|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25144512|NCT02935959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25144513|NCT02935959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25144514|NCT02935959|Adrenergic Agents|adrenergic agents|mesh-ancestor
25144515|NCT02935959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25144516|NCT02935959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144517|NCT02935959|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25144518|NCT02935959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25144519|NCT02935959|Anesthetics, General|anesthetics, general|mesh-ancestor
25144520|NCT02935959|Anesthetics|anesthetics|mesh-ancestor
25144521|NCT02935959|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24998268|NCT03243058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25144522|NCT02935959|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25144523|NCT02935959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25144524|NCT02935959|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25144525|NCT02935959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25144526|NCT02935959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25144527|NCT02935959|GABA Modulators|gaba modulators|mesh-ancestor
25144528|NCT02935959|GABA Agents|gaba agents|mesh-ancestor
25144529|NCT02935972|Lidocaine|lidocaine|mesh-list
25144530|NCT02935972|Diazepam|diazepam|mesh-list
25144531|NCT02935972|Anesthetics, Local|anesthetics, local|mesh-ancestor
25144552|NCT02935972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25144553|NCT02935972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25028900|NCT03607110|Analgesics|analgesics|mesh-ancestor
25028901|NCT03607110|Sensory System Agents|sensory system agents|mesh-ancestor
25028902|NCT03607110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25028903|NCT03607110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028907|NCT03607110|Anesthetics|anesthetics|mesh-ancestor
25144554|NCT02935972|Anesthetics, General|anesthetics, general|mesh-ancestor
25144555|NCT02935972|GABA Modulators|gaba modulators|mesh-ancestor
25144556|NCT02935972|GABA Agents|gaba agents|mesh-ancestor
25144559|NCT02935855|Rivaroxaban|rivaroxaban|mesh-list
25144561|NCT02935855|Apixaban|apixaban|mesh-list
25093459|NCT03234673|Calcipotriene|calcipotriene|mesh-list
25144562|NCT02935855|Edoxaban|edoxaban|mesh-list
25144583|NCT02935582|Betamethasone|betamethasone|mesh-list
25144584|NCT02935582|Betamethasone Valerate|betamethasone valerate|mesh-list
25144585|NCT02935582|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25144586|NCT02935582|Betamethasone benzoate|betamethasone benzoate|mesh-list
25144587|NCT02935582|Calcipotriene|calcipotriene|mesh-list
25144588|NCT02935582|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25144589|NCT02935582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25144590|NCT02935582|Glucocorticoids|glucocorticoids|mesh-ancestor
25144591|NCT02935582|Hormones|hormones|mesh-ancestor
25144592|NCT02935582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25144593|NCT02935582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144594|NCT02935582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25144595|NCT02935582|Respiratory System Agents|respiratory system agents|mesh-ancestor
25144596|NCT02935582|Dermatologic Agents|dermatologic agents|mesh-ancestor
25144597|NCT02935530|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25144598|NCT02935530|Tinzaparin|tinzaparin|mesh-list
25144599|NCT02935530|Dalteparin|dalteparin|mesh-list
25144600|NCT02935530|Argatroban|argatroban|mesh-list
25144601|NCT02935530|Anticoagulants|anticoagulants|mesh-ancestor
25144602|NCT02935530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25144603|NCT02935530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25144604|NCT02935530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144605|NCT02935530|Antithrombins|antithrombins|mesh-ancestor
25144606|NCT02935530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25144607|NCT02935530|Protease Inhibitors|protease inhibitors|mesh-ancestor
25144643|NCT02935322|Chlorhexidine|chlorhexidine|mesh-list
25144644|NCT02935322|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25144645|NCT02935322|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25650340|NCT01501110|Protective Agents|protective agents|mesh-ancestor
25650341|NCT01501110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650342|NCT01501110|Antidotes|antidotes|mesh-ancestor
25650343|NCT01501162|Ethanol|ethanol|mesh-list
25650344|NCT01501162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25144646|NCT02935322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25144647|NCT02935322|Disinfectants|disinfectants|mesh-ancestor
25144648|NCT02935322|Dermatologic Agents|dermatologic agents|mesh-ancestor
25144675|NCT02935101|Prednisolone acetate|prednisolone acetate|mesh-list
25144676|NCT02935101|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25144712|NCT02934919|Sensory System Agents|sensory system agents|mesh-ancestor
25144713|NCT02934919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24763035|NCT01770964|Pregabalin|pregabalin|mesh-list
25144740|NCT02935010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25144741|NCT02935010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25144742|NCT02935010|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25144743|NCT02935010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25144744|NCT02935010|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25144745|NCT02935010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25144746|NCT02935010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25144747|NCT02935010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25144749|NCT02935010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25144750|NCT02935010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25144751|NCT02935010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25144752|NCT02935010|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25144753|NCT02935010|Antacids|antacids|mesh-ancestor
25144754|NCT02935010|Diuretics|diuretics|mesh-ancestor
25144755|NCT02935010|Natriuretic Agents|natriuretic agents|mesh-ancestor
25144756|NCT02935010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144757|NCT02935010|Expectorants|expectorants|mesh-ancestor
25144758|NCT02935010|Respiratory System Agents|respiratory system agents|mesh-ancestor
25144759|NCT02934763|Propranolol|propranolol|mesh-list
25144760|NCT02934763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25144761|NCT02934763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25144762|NCT02934763|Adrenergic Agents|adrenergic agents|mesh-ancestor
25144763|NCT02934763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25144764|NCT02934763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144765|NCT02934763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763065|NCT01771185|Gliclazide|gliclazide|mesh-list
25144801|NCT02934035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25144803|NCT02934035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144804|NCT02934035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25144805|NCT02934035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25144806|NCT02934035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25144807|NCT02934035|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25047565|NCT00792727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25047566|NCT00792727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047567|NCT00792727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25047568|NCT00792727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25047569|NCT00792727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25047570|NCT00792727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047571|NCT00792727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047572|NCT00791154|Carboplatin|carboplatin|mesh-list
25047574|NCT00791154|Rilotumumab|rilotumumab|mesh-list
25047575|NCT00791154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25047576|NCT00791154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25047577|NCT00791154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25047578|NCT00791154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25047579|NCT00791154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763185|NCT01771978|Diltiazem|diltiazem|mesh-list
25144852|NCT02934204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25144853|NCT02934204|Immunologic Factors|immunologic factors|mesh-ancestor
25144854|NCT02934204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25144855|NCT02934204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25144856|NCT02934204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25144857|NCT02934204|Alkylating Agents|alkylating agents|mesh-ancestor
25144859|NCT02934061|Analgesics|analgesics|mesh-ancestor
25144860|NCT02934061|Sensory System Agents|sensory system agents|mesh-ancestor
25144861|NCT02934061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24620201|NCT01055808|Insulin|insulin|mesh-list
25144932|NCT02933788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144934|NCT02933788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25144935|NCT02933788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25144936|NCT02933788|Antipyretics|antipyretics|mesh-ancestor
25144937|NCT02933788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25144938|NCT02933788|Autonomic Agents|autonomic agents|mesh-ancestor
25144939|NCT02933788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25144940|NCT02933788|Respiratory System Agents|respiratory system agents|mesh-ancestor
25144941|NCT02933788|Vasodilator Agents|vasodilator agents|mesh-ancestor
25144942|NCT02933788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25144943|NCT02933788|Protective Agents|protective agents|mesh-ancestor
25144944|NCT02933788|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24756363|NCT01732666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25047600|NCT00788541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25047601|NCT00788541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25047602|NCT00788541|Growth Substances|growth substances|mesh-ancestor
25029023|NCT03606174|Pembrolizumab|pembrolizumab|mesh-list
25047603|NCT00788541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047604|NCT00788541|Growth Inhibitors|growth inhibitors|mesh-ancestor
25047605|NCT00788541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25047606|NCT00788541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25047607|NCT00786201|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25047608|NCT00786201|Immunologic Factors|immunologic factors|mesh-ancestor
25047609|NCT00786201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047610|NCT00785226|Sorafenib|sorafenib|mesh-list
25047611|NCT00785226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25047612|NCT00785226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25047613|NCT00785226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25144972|NCT02933593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145049|NCT02933099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145051|NCT02933099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25145052|NCT02933099|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25145053|NCT02933099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25145054|NCT02933099|Serotonin Agents|serotonin agents|mesh-ancestor
25145055|NCT02932722|Anesthetics|anesthetics|mesh-list
25145056|NCT02932722|Propofol|propofol|mesh-list
25145057|NCT02932722|Sevoflurane|sevoflurane|mesh-list
25145058|NCT02932722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25145059|NCT02932722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145060|NCT02932722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25145061|NCT02932722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25145062|NCT02932722|Anesthetics, General|anesthetics, general|mesh-ancestor
25145063|NCT02932722|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25145064|NCT02932722|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25145065|NCT02932761|Goserelin|goserelin|mesh-list
25145066|NCT02932761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25145067|NCT02932761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145068|NCT02932774|Cetirizine|cetirizine|mesh-list
25145069|NCT02932774|Loratadine|loratadine|mesh-list
25145070|NCT02932774|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25145071|NCT02932774|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25145072|NCT02932774|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25145073|NCT02932774|Histamine Antagonists|histamine antagonists|mesh-ancestor
25145074|NCT02932774|Histamine Agents|histamine agents|mesh-ancestor
25145075|NCT02932774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25145076|NCT02932774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763311|NCT01772940|Protease Inhibitors|protease inhibitors|mesh-ancestor
25145107|NCT02932644|Vitamin D|vitamin d|mesh-list
25145108|NCT02932644|Ergocalciferols|ergocalciferols|mesh-list
25145109|NCT02932644|Cholecalciferol|cholecalciferol|mesh-list
25145110|NCT02932644|Vitamins|vitamins|mesh-list
25145111|NCT02932644|Micronutrients|micronutrients|mesh-ancestor
25145112|NCT02932644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145113|NCT02932644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25145114|NCT02932644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25145115|NCT02932436|Empagliflozin|empagliflozin|mesh-list
25145116|NCT02932436|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25145117|NCT02932436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145118|NCT02932436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25145119|NCT02932436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145155|NCT02932020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25145156|NCT02932020|Glucocorticoids|glucocorticoids|mesh-ancestor
25047628|NCT00776373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25047629|NCT00776373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25047630|NCT00776373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047631|NCT00776373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047632|NCT00776373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25047635|NCT00776373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25047636|NCT00776373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25047637|NCT00776373|Immunologic Factors|immunologic factors|mesh-ancestor
25047638|NCT00776373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145188|NCT02931903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25145189|NCT02931903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145191|NCT02931903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25650345|NCT01501162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24619744|NCT01053611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145192|NCT02931903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25145193|NCT02931903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145194|NCT02931786|Ketamine|ketamine|mesh-list
25145195|NCT02931786|Propofol|propofol|mesh-list
25145196|NCT02931786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25145197|NCT02931786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25145198|NCT02931786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145199|NCT02931786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25145200|NCT02931786|Anesthetics, General|anesthetics, general|mesh-ancestor
25145201|NCT02931786|Anesthetics|anesthetics|mesh-ancestor
25145202|NCT02931786|Analgesics|analgesics|mesh-ancestor
25145203|NCT02931786|Sensory System Agents|sensory system agents|mesh-ancestor
25145204|NCT02931786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25145205|NCT02931786|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25145236|NCT02931357|Hyaluronic Acid|hyaluronic acid|mesh-list
25145237|NCT02931357|Anesthetics, Local|anesthetics, local|mesh-ancestor
25145238|NCT02931357|Anesthetics|anesthetics|mesh-ancestor
25145239|NCT02931357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25145240|NCT02931357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145241|NCT02931357|Sensory System Agents|sensory system agents|mesh-ancestor
25145242|NCT02931357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25145243|NCT02931357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25145244|NCT02931357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25145245|NCT02931357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25113096|NCT03517969|Tubulin Modulators|tubulin modulators|mesh-ancestor
25145246|NCT02931357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25145247|NCT02931357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145248|NCT02931357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25145250|NCT02931357|Viscosupplements|viscosupplements|mesh-ancestor
25080047|NCT03342807|Insulin|insulin|mesh-list
25145284|NCT02931071|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25145285|NCT02931071|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25145286|NCT02931071|Antiviral Agents|antiviral agents|mesh-ancestor
25145287|NCT02931071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25145288|NCT02930733|Bupivacaine|bupivacaine|mesh-list
25145289|NCT02930733|Anesthetics, Local|anesthetics, local|mesh-ancestor
25145290|NCT02930733|Anesthetics|anesthetics|mesh-ancestor
25145291|NCT02930733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25145345|NCT02930707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145346|NCT02930707|Sensory System Agents|sensory system agents|mesh-ancestor
25145347|NCT02930707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25145348|NCT02930707|Analgesics|analgesics|mesh-ancestor
25145349|NCT02930707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25145382|NCT02930109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25145383|NCT02930109|Immunologic Factors|immunologic factors|mesh-ancestor
25145384|NCT02930109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145385|NCT02930031|Acetylcysteine|acetylcysteine|mesh-list
25145386|NCT02930031|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25145387|NCT02930031|Antiviral Agents|antiviral agents|mesh-ancestor
25145388|NCT02930031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25145389|NCT02930031|Expectorants|expectorants|mesh-ancestor
25145390|NCT02930031|Respiratory System Agents|respiratory system agents|mesh-ancestor
25145391|NCT02930031|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25145392|NCT02930031|Antioxidants|antioxidants|mesh-ancestor
24620294|NCT01056419|Hormone Antagonists|hormone antagonists|mesh-ancestor
25145426|NCT02929901|Purinergic Agents|purinergic agents|mesh-ancestor
25145427|NCT02929901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25145428|NCT02929914|Anti-Infective Agents|anti-infective agents|mesh-list
25145429|NCT02929914|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25145431|NCT02929706|Antimetabolites|antimetabolites|mesh-ancestor
24763578|NCT01774877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25145643|NCT02928575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25145813|NCT02926976|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25145814|NCT02926976|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25145815|NCT02926976|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25145816|NCT02926976|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25145989|NCT02924974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25145990|NCT02924974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25145991|NCT02924974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25145992|NCT02924974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25146137|NCT02923934|Ipilimumab|ipilimumab|mesh-list
25146138|NCT02923934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25146139|NCT02923934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25650346|NCT01501162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24757151|NCT01738100|Purinergic Agents|purinergic agents|mesh-ancestor
24757152|NCT01738100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24729949|NCT01624805|Cyclosporine|cyclosporine|mesh-list
25146140|NCT02923934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25146141|NCT02923934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146142|NCT02924090|Ketamine|ketamine|mesh-list
25146143|NCT02924090|Etomidate|etomidate|mesh-list
25146144|NCT02924090|Analgesics|analgesics|mesh-ancestor
25146145|NCT02924090|Sensory System Agents|sensory system agents|mesh-ancestor
25146146|NCT02924090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25146147|NCT02924090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146148|NCT02924090|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25146149|NCT02924090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25146150|NCT02924090|Anesthetics, General|anesthetics, general|mesh-ancestor
25146151|NCT02924090|Anesthetics|anesthetics|mesh-ancestor
25146152|NCT02924090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25146153|NCT02924090|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25146154|NCT02924090|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25146155|NCT02924090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25146156|NCT02924090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146157|NCT02924090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25268512|NCT02415335|Dexamethasone|dexamethasone|mesh-list
25146158|NCT02923999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25146159|NCT02923999|Antibodies|antibodies|mesh-list
25146160|NCT02923999|Immunoglobulins|immunoglobulins|mesh-list
25146161|NCT02923999|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25146162|NCT02923999|Immunologic Factors|immunologic factors|mesh-ancestor
25146163|NCT02923999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146164|NCT02923999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25146165|NCT02923856|Clarithromycin|clarithromycin|mesh-list
25146166|NCT02923856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25146167|NCT02923856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25146168|NCT02923856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25146169|NCT02923856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146170|NCT02923856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047777|NCT00764634|Immunologic Factors|immunologic factors|mesh-ancestor
25047778|NCT00764634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146225|NCT02923336|Adrenergic Agents|adrenergic agents|mesh-ancestor
25146226|NCT02923336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25146227|NCT02923336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146228|NCT02923336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146229|NCT02923336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25146230|NCT02923336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25146231|NCT02923336|Vasodilator Agents|vasodilator agents|mesh-ancestor
25146232|NCT02922894|Trazodone|trazodone|mesh-list
25146233|NCT02922894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25146234|NCT02922894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25146235|NCT02922894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25146236|NCT02922894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146237|NCT02922894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25146238|NCT02922894|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25146239|NCT02922894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25146240|NCT02922894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25146241|NCT02922894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146242|NCT02922894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25146243|NCT02922894|Serotonin Agents|serotonin agents|mesh-ancestor
25146244|NCT02922894|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25146245|NCT02922894|Antidepressive Agents|antidepressive agents|mesh-ancestor
25146266|NCT02922803|Calcium, Dietary|calcium, dietary|mesh-list
25146268|NCT02922803|Ergocalciferols|ergocalciferols|mesh-list
25146269|NCT02922803|Cholecalciferol|cholecalciferol|mesh-list
25146270|NCT02922803|Vitamins|vitamins|mesh-list
25146271|NCT02922803|Calcium|calcium|mesh-list
25146272|NCT02922803|Micronutrients|micronutrients|mesh-ancestor
25146273|NCT02922803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146274|NCT02922803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25146275|NCT02922803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25146276|NCT02922686|Floxacillin|floxacillin|mesh-list
25146277|NCT02922686|Penicillin V|penicillin v|mesh-list
25146278|NCT02922686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25146279|NCT02922686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25146280|NCT02922712|Nimesulide|nimesulide|mesh-list
24979930|NCT04933383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25650347|NCT01501162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650348|NCT01501929|Metoprolol|metoprolol|mesh-list
25650349|NCT01501929|Nebivolol|nebivolol|mesh-list
24757483|NCT01740271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757485|NCT01740336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24757486|NCT01740336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24757680|NCT01741623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25146281|NCT02922712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25146282|NCT02922712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25146283|NCT02922712|Analgesics|analgesics|mesh-ancestor
25146284|NCT02922712|Sensory System Agents|sensory system agents|mesh-ancestor
25146285|NCT02922712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25146286|NCT02922712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146287|NCT02922712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25146288|NCT02922712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25146289|NCT02922712|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25146290|NCT02922712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146291|NCT02922712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146292|NCT02922699|Omeprazole|omeprazole|mesh-list
25146293|NCT02922699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25146294|NCT02922699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25146295|NCT02922699|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25146296|NCT02922699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146297|NCT02922699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146298|NCT02922673|Aspirin|aspirin|mesh-list
25146299|NCT02922673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24764414|NCT01781442|Sirolimus|sirolimus|mesh-list
25146336|NCT02922465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146337|NCT02922465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146339|NCT02922426|Antiemetics|antiemetics|mesh-ancestor
25047807|NCT00760539|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25029305|NCT03603418|Hormones|hormones|mesh-ancestor
25047808|NCT00760539|Adrenergic Agents|adrenergic agents|mesh-ancestor
25047809|NCT00760539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25047810|NCT00760539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047811|NCT00760539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047812|NCT00760539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25047813|NCT00760539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25047814|NCT00760344|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25047815|NCT00760344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25146348|NCT02922426|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25146349|NCT02922426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25146350|NCT02922426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25146351|NCT02922426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146355|NCT02922491|Vitamins|vitamins|mesh-ancestor
25146356|NCT02922491|Micronutrients|micronutrients|mesh-ancestor
25146357|NCT02922491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146358|NCT02922491|Antioxidants|antioxidants|mesh-ancestor
25146359|NCT02922491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146360|NCT02922491|Protective Agents|protective agents|mesh-ancestor
25146361|NCT02922179|Insulin|insulin|mesh-list
25146362|NCT02922179|Insulin Detemir|insulin detemir|mesh-list
25146363|NCT02922179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25146364|NCT02922179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146366|NCT02922283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25146367|NCT02922283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25146368|NCT02922283|Analgesics|analgesics|mesh-ancestor
25146369|NCT02922283|Sensory System Agents|sensory system agents|mesh-ancestor
25146370|NCT02922283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25146371|NCT02922283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146372|NCT02922192|Antirheumatic Agents|antirheumatic agents|mesh-list
25146373|NCT02922075|Amoxicillin|amoxicillin|mesh-list
25146374|NCT02922075|Chlorhexidine|chlorhexidine|mesh-list
24786462|NCT01920113|Anesthetics|anesthetics|mesh-ancestor
25146375|NCT02922075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25146376|NCT02922075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25146377|NCT02922075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25146379|NCT02922166|SRX246|srx246|mesh-list
25146560|NCT02920905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25146562|NCT02920567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25146563|NCT02920567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25146564|NCT02920567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829194|NCT00006154|Indinavir|indinavir|mesh-list
25650350|NCT01501929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25650351|NCT01501929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25650352|NCT01501929|Sympatholytics|sympatholytics|mesh-ancestor
25650353|NCT01501929|Autonomic Agents|autonomic agents|mesh-ancestor
25829195|NCT00006154|Aldesleukin|aldesleukin|mesh-list
24758754|NCT01747616|Chelating Agents|chelating agents|mesh-ancestor
25829196|NCT00006154|Abacavir|abacavir|mesh-list
25146565|NCT02920515|Leuprolide|leuprolide|mesh-list
25146566|NCT02920515|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25146567|NCT02920515|Fertility Agents|fertility agents|mesh-ancestor
25146568|NCT02920515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25146569|NCT02920515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146570|NCT02920515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25146571|NCT02920515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25146572|NCT02920710|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24772674|NCT01834911|Adrenergic Agents|adrenergic agents|mesh-ancestor
24620369|NCT01056705|Vaccines|vaccines|mesh-list
25146712|NCT02919501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25146713|NCT02919501|Serotonin Agents|serotonin agents|mesh-ancestor
25146714|NCT02919501|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25146715|NCT02919501|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25146716|NCT02919501|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25146717|NCT02919501|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25146718|NCT02919579|Esketamine|esketamine|mesh-list
25146745|NCT02919371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25146746|NCT02919371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25146747|NCT02919371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25146748|NCT02919371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25146749|NCT02919371|Growth Substances|growth substances|mesh-ancestor
25047831|NCT00759135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047832|NCT00759135|Urological Agents|urological agents|mesh-ancestor
25047833|NCT00758966|Naltrexone|naltrexone|mesh-list
25047834|NCT00758966|Fluoxetine|fluoxetine|mesh-list
25047835|NCT00758966|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25047836|NCT00758966|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25047837|NCT00758966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047838|NCT00758966|Sensory System Agents|sensory system agents|mesh-ancestor
25047839|NCT00758966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25047840|NCT00758966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25047841|NCT00758966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25146750|NCT02919371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146751|NCT02919371|Growth Inhibitors|growth inhibitors|mesh-ancestor
25146752|NCT02919371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25146756|NCT02919202|Fluorides|fluorides|mesh-list
25146757|NCT02919202|Sodium Fluoride|sodium fluoride|mesh-list
25146758|NCT02919202|Fluorides, Topical|fluorides, topical|mesh-list
25146810|NCT02918812|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25146811|NCT02918812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25146812|NCT02918812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146813|NCT02918812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25146814|NCT02918812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25146815|NCT02918812|Analgesics|analgesics|mesh-ancestor
25146816|NCT02918812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25146817|NCT02918812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25146818|NCT02918812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25146819|NCT02918812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146820|NCT02918864|Oxytocin|oxytocin|mesh-list
25146821|NCT02918864|Oxytocics|oxytocics|mesh-ancestor
25146822|NCT02918864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24986306|NCT01978938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25147592|NCT02912494|Darbepoetin alfa|darbepoetin alfa|mesh-list
25146823|NCT02918864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146824|NCT02918825|Olanzapine|olanzapine|mesh-list
25146825|NCT02918825|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25146826|NCT02918825|Antiemetics|antiemetics|mesh-ancestor
25146827|NCT02918825|Autonomic Agents|autonomic agents|mesh-ancestor
24849628|NCT02249442|Ritonavir|ritonavir|mesh-list
25146828|NCT02918825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25146829|NCT02918825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146830|NCT02918825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25146831|NCT02918825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25146832|NCT02918825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25146833|NCT02918825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25146895|NCT02918747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25146896|NCT02918747|Tubulin Modulators|tubulin modulators|mesh-ancestor
25146897|NCT02918747|Antimitotic Agents|antimitotic agents|mesh-ancestor
25146898|NCT02918747|Mitosis Modulators|mitosis modulators|mesh-ancestor
25146921|NCT02918331|Hormones|hormones|mesh-ancestor
25146922|NCT02918331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24437462|NCT00273689|Adrenergic Agents|adrenergic agents|mesh-ancestor
25650354|NCT01501929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25146923|NCT02918331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25146924|NCT02918331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25146925|NCT02918331|Immunologic Factors|immunologic factors|mesh-ancestor
25146926|NCT02918331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25146927|NCT02918331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25146992|NCT02917525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146993|NCT02917525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25146994|NCT02917525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25146995|NCT02917525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146996|NCT02917525|Hemostatics|hemostatics|mesh-ancestor
25146997|NCT02917525|Coagulants|coagulants|mesh-ancestor
25146998|NCT02917200|Moxifloxacin|moxifloxacin|mesh-list
25146999|NCT02917200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25147000|NCT02917200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25147001|NCT02917200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25147002|NCT02917200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25147003|NCT02917200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25147004|NCT02917200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147005|NCT02917200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25147006|NCT02917005|Palbociclib|palbociclib|mesh-list
25147007|NCT02917005|Exemestane|exemestane|mesh-list
25147008|NCT02917005|Goserelin|goserelin|mesh-list
25147009|NCT02917005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25147010|NCT02917005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25147011|NCT02917005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047842|NCT00758966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25147111|NCT02916251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25147112|NCT02916251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147113|NCT02916251|Incretins|incretins|mesh-ancestor
25147114|NCT02916173|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25147115|NCT02916173|Hormones|hormones|mesh-list
25147116|NCT02916173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25147117|NCT02916173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147119|NCT02916238|Fluoxetine|fluoxetine|mesh-list
25147120|NCT02916238|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25147121|NCT02916238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25147122|NCT02916238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25147123|NCT02916238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147124|NCT02916238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25147125|NCT02916238|Serotonin Agents|serotonin agents|mesh-ancestor
25147126|NCT02916238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147127|NCT02916238|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25147128|NCT02916238|Antidepressive Agents|antidepressive agents|mesh-ancestor
25147129|NCT02916238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25147130|NCT02916238|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24765048|NCT01785836|Dapsone|dapsone|mesh-list
25147146|NCT02916121|Hematinics|hematinics|mesh-ancestor
25147147|NCT02916121|Vitamin B Complex|vitamin b complex|mesh-ancestor
25147148|NCT02916147|Propofol|propofol|mesh-list
25147149|NCT02916147|Sevoflurane|sevoflurane|mesh-list
25147150|NCT02916147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25147151|NCT02916147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25147152|NCT02916147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147153|NCT02916147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25147154|NCT02916147|Anesthetics, General|anesthetics, general|mesh-ancestor
25147155|NCT02916147|Anesthetics|anesthetics|mesh-ancestor
25147156|NCT02916147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25147157|NCT02916147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25147159|NCT02915731|Vitamins|vitamins|mesh-ancestor
25147160|NCT02915731|Micronutrients|micronutrients|mesh-ancestor
25147161|NCT02915731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147162|NCT02915666|Trametinib|trametinib|mesh-list
25147163|NCT02915666|Dabrafenib|dabrafenib|mesh-list
25147164|NCT02915666|Digoxin|digoxin|mesh-list
25147165|NCT02915666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25147166|NCT02915666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25147167|NCT02915666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25147168|NCT02915666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147169|NCT02915666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25147170|NCT02915666|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25047858|NCT00758563|Fluorides|fluorides|mesh-list
25047859|NCT00758563|Cariostatic Agents|cariostatic agents|mesh-ancestor
25047860|NCT00758563|Protective Agents|protective agents|mesh-ancestor
25047861|NCT00758563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829197|NCT00006154|Stavudine|stavudine|mesh-list
25047862|NCT00758563|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25047863|NCT00758563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25047864|NCT00758563|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25047865|NCT00758563|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25047866|NCT00758563|Antimetabolites|antimetabolites|mesh-ancestor
25047867|NCT00758563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047868|NCT00758563|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25047869|NCT00758290|Triclosan|triclosan|mesh-list
25047870|NCT00758290|Fluorides|fluorides|mesh-list
25047871|NCT00758290|Cariostatic Agents|cariostatic agents|mesh-ancestor
25047872|NCT00758290|Protective Agents|protective agents|mesh-ancestor
25047873|NCT00758290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047874|NCT00758290|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25047875|NCT00758290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25047876|NCT00758290|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25047877|NCT00758290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25147183|NCT02915796|Lenograstim|lenograstim|mesh-list
25147184|NCT02915796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25147185|NCT02915796|Immunologic Factors|immunologic factors|mesh-ancestor
25147186|NCT02915796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147187|NCT02915263|Immunoglobulins|immunoglobulins|mesh-list
25147188|NCT02915263|Immunologic Factors|immunologic factors|mesh-ancestor
25147189|NCT02915263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147190|NCT02915250|Insulin Lispro|insulin lispro|mesh-list
25147191|NCT02915250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25147192|NCT02915250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147193|NCT02915289|Chlorhexidine|chlorhexidine|mesh-list
25147194|NCT02915289|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25147195|NCT02915289|Povidone-Iodine|povidone-iodine|mesh-list
25147196|NCT02915289|Povidone|povidone|mesh-list
25147197|NCT02915289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25147198|NCT02915289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25147199|NCT02915289|Disinfectants|disinfectants|mesh-ancestor
25147200|NCT02915289|Dermatologic Agents|dermatologic agents|mesh-ancestor
25147227|NCT02915055|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25147230|NCT02915055|Analgesics|analgesics|mesh-ancestor
25147231|NCT02915055|Sensory System Agents|sensory system agents|mesh-ancestor
25147232|NCT02915055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25147233|NCT02915055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147234|NCT02915055|Antipyretics|antipyretics|mesh-ancestor
25147235|NCT02915055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25147236|NCT02915055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25147237|NCT02915055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25147238|NCT02915055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25147239|NCT02915055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25147240|NCT02915055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147241|NCT02915055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25147242|NCT02915055|Narcotics|narcotics|mesh-ancestor
25147243|NCT02915055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25147244|NCT02915042|Dexmedetomidine|dexmedetomidine|mesh-list
25147245|NCT02915042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25147246|NCT02915042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25147247|NCT02915042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147248|NCT02915042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25147256|NCT02915042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25147257|NCT02915042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147284|NCT02914678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25147285|NCT02914678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25147286|NCT02914678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25147287|NCT02914678|Anesthetics, General|anesthetics, general|mesh-ancestor
25147289|NCT02914639|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25147290|NCT02914639|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25147291|NCT02914613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25147292|NCT02914613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25147293|NCT02914626|Ranibizumab|ranibizumab|mesh-list
25147294|NCT02914626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25147295|NCT02914626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25147296|NCT02914626|Growth Substances|growth substances|mesh-ancestor
25147297|NCT02914626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147298|NCT02914626|Growth Inhibitors|growth inhibitors|mesh-ancestor
25147299|NCT02914626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25147303|NCT02914158|Tamoxifen|tamoxifen|mesh-list
25147304|NCT02914158|Goserelin|goserelin|mesh-list
25147305|NCT02914158|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25650355|NCT01501929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945449|NCT03950518|Anthelmintics|anthelmintics|mesh-ancestor
24945450|NCT03950518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24945451|NCT03950518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25829198|NCT00006154|Didanosine|didanosine|mesh-list
25829199|NCT00006154|Efavirenz|efavirenz|mesh-list
24945452|NCT03950518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25829200|NCT00006154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24945467|NCT03950544|Meropenem|meropenem|mesh-list
24945468|NCT03950544|Fosfomycin|fosfomycin|mesh-list
25147306|NCT02914158|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25147307|NCT02914158|Hormone Antagonists|hormone antagonists|mesh-ancestor
24765217|NCT01786655|Anesthetics, Local|anesthetics, local|mesh-ancestor
25147326|NCT02914015|Analgesics|analgesics|mesh-ancestor
25147327|NCT02914015|Sensory System Agents|sensory system agents|mesh-ancestor
25147328|NCT02914015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25147329|NCT02914054|Dexamethasone|dexamethasone|mesh-list
25147330|NCT02914054|Prednisone|prednisone|mesh-list
25147331|NCT02914054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25147332|NCT02914054|Antiemetics|antiemetics|mesh-ancestor
25147333|NCT02914054|Autonomic Agents|autonomic agents|mesh-ancestor
25147334|NCT02914054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25147335|NCT02914054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147336|NCT02914054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25147337|NCT02914054|Glucocorticoids|glucocorticoids|mesh-ancestor
25147338|NCT02914054|Hormones|hormones|mesh-ancestor
25147339|NCT02914054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25147340|NCT02914054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25147341|NCT02914054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25147342|NCT02914145|Piperaquine|piperaquine|mesh-list
25147343|NCT02914145|Artenimol|artenimol|mesh-list
25147344|NCT02914145|Antimalarials|antimalarials|mesh-ancestor
25147345|NCT02914145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25147346|NCT02914145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25147347|NCT02914145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25147348|NCT02913885|Fluorides|fluorides|mesh-list
25147349|NCT02913885|Fluorides, Topical|fluorides, topical|mesh-list
25147350|NCT02913885|Cariostatic Agents|cariostatic agents|mesh-ancestor
25147351|NCT02913885|Protective Agents|protective agents|mesh-ancestor
25147352|NCT02913885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147362|NCT02914028|Narcotics|narcotics|mesh-ancestor
24765265|NCT01787344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25147392|NCT02913573|Anesthetics, Local|anesthetics, local|mesh-ancestor
25147393|NCT02913573|Anesthetics|anesthetics|mesh-ancestor
25147394|NCT02913573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25147395|NCT02913573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147396|NCT02913573|Sensory System Agents|sensory system agents|mesh-ancestor
25147397|NCT02913573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25147398|NCT02913430|Tamoxifen|tamoxifen|mesh-list
25147400|NCT02913430|Palbociclib|palbociclib|mesh-list
25147401|NCT02913430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25147402|NCT02913430|Hormone Antagonists|hormone antagonists|mesh-ancestor
25147403|NCT02913430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25147404|NCT02913430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147405|NCT02913430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25147406|NCT02913430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24765305|NCT01787630|Viscosupplements|viscosupplements|mesh-ancestor
25147424|NCT02913469|Autonomic Agents|autonomic agents|mesh-ancestor
25147425|NCT02913469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25147426|NCT02913469|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25147427|NCT02913469|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25147428|NCT02913469|Dopamine Agents|dopamine agents|mesh-ancestor
25147429|NCT02913469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25147430|NCT02913469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147432|NCT02913508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25147433|NCT02913300|Lidocaine|lidocaine|mesh-list
25147434|NCT02913300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25147435|NCT02913300|Anesthetics, Local|anesthetics, local|mesh-ancestor
25147436|NCT02913300|Anesthetics|anesthetics|mesh-ancestor
25650356|NCT01501929|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25650357|NCT01501929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25650358|NCT01501929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25650359|NCT01501929|Adrenergic Agents|adrenergic agents|mesh-ancestor
25650360|NCT01501929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25650361|NCT01501929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650362|NCT01501929|Vasodilator Agents|vasodilator agents|mesh-ancestor
25147437|NCT02913300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25029604|NCT03601871|Hormones|hormones|mesh-ancestor
25147438|NCT02913300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147439|NCT02913300|Sensory System Agents|sensory system agents|mesh-ancestor
25147440|NCT02913300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25147441|NCT02913300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25147442|NCT02913300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25147443|NCT02913300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25147444|NCT02913300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25147445|NCT02913300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147447|NCT02913690|Vitamins|vitamins|mesh-ancestor
25047895|NCT00754988|Hormones|hormones|mesh-ancestor
25268597|NCT02415114|Resveratrol|resveratrol|mesh-list
25047896|NCT00754988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25047897|NCT00754988|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25047898|NCT00754988|Protease Inhibitors|protease inhibitors|mesh-ancestor
25047899|NCT00754988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047900|NCT00754988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047901|NCT00754221|Reboxetine|reboxetine|mesh-list
25047902|NCT00754221|Antidepressive Agents|antidepressive agents|mesh-ancestor
25047903|NCT00754221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25047904|NCT00754221|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25047905|NCT00754221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25047906|NCT00754221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25047907|NCT00754221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147471|NCT02913157|Hydroxychloroquine|hydroxychloroquine|mesh-list
25147472|NCT02913157|Antimalarials|antimalarials|mesh-ancestor
25147473|NCT02913157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25147474|NCT02913157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25147475|NCT02913157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25147476|NCT02913157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25147477|NCT02913157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147478|NCT02913157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25147479|NCT02913118|Amoxicillin|amoxicillin|mesh-list
25147480|NCT02913118|Azithromycin|azithromycin|mesh-list
25147481|NCT02913118|Doxycycline|doxycycline|mesh-list
25147482|NCT02913118|Minocycline|minocycline|mesh-list
25147483|NCT02913118|Cephalosporins|cephalosporins|mesh-list
25147484|NCT02913118|Fluoroquinolones|fluoroquinolones|mesh-list
24986537|NCT00193219|Leucovorin|leucovorin|mesh-list
25147485|NCT02913118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25147486|NCT02913118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25147487|NCT02913118|Antimalarials|antimalarials|mesh-ancestor
25147488|NCT02913118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25147489|NCT02913118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25147490|NCT02913118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25147491|NCT02913118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25147492|NCT02913118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147493|NCT02913066|Cisplatin|cisplatin|mesh-list
25147494|NCT02913066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25147495|NCT02912793|Betadex|betadex|mesh-list
25147546|NCT02912910|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25147548|NCT02912702|Dexamethasone|dexamethasone|mesh-list
25147549|NCT02912702|Methylprednisolone|methylprednisolone|mesh-list
25147550|NCT02912702|Doxorubicin|doxorubicin|mesh-list
25147551|NCT02912702|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25147552|NCT02912702|Etoposide|etoposide|mesh-list
25147553|NCT02912702|Etoposide phosphate|etoposide phosphate|mesh-list
25147554|NCT02912702|Pegaspargase|pegaspargase|mesh-list
25147555|NCT02912702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25147556|NCT02912702|Antiemetics|antiemetics|mesh-ancestor
25147557|NCT02912702|Autonomic Agents|autonomic agents|mesh-ancestor
25147558|NCT02912702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25147559|NCT02912702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147560|NCT02912702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25147561|NCT02912702|Glucocorticoids|glucocorticoids|mesh-ancestor
25147562|NCT02912702|Hormones|hormones|mesh-ancestor
24765475|NCT01788722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25147582|NCT02912676|Antimetabolites|antimetabolites|mesh-ancestor
25147583|NCT02912676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147584|NCT02912676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25147585|NCT02912676|Dermatologic Agents|dermatologic agents|mesh-ancestor
25147586|NCT02912676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25147587|NCT02912676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25147588|NCT02912676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25147589|NCT02912676|Immunologic Factors|immunologic factors|mesh-ancestor
25147590|NCT02912676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25147591|NCT02912676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25147593|NCT02912494|Hematinics|hematinics|mesh-ancestor
25147594|NCT02912156|Voriconazole|voriconazole|mesh-list
25147595|NCT02912156|Antifungal Agents|antifungal agents|mesh-ancestor
25147596|NCT02912156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25147597|NCT02912156|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25147598|NCT02912156|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25147599|NCT02912156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25147600|NCT02912156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147601|NCT02912156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25147602|NCT02912156|Hormone Antagonists|hormone antagonists|mesh-ancestor
25147603|NCT02912156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25147604|NCT02912156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147605|NCT02912156|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25147606|NCT02912169|Anesthetics|anesthetics|mesh-list
25147607|NCT02912169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25147608|NCT02912169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147609|NCT02912520|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25147610|NCT02912520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25147611|NCT02912182|Prednisolone|prednisolone|mesh-list
25147612|NCT02912182|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25147613|NCT02912182|Methylprednisolone|methylprednisolone|mesh-list
25147634|NCT02912247|Adalimumab|adalimumab|mesh-list
25147635|NCT02912247|Antibodies|antibodies|mesh-list
25147636|NCT02912247|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25029717|NCT03600974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25029718|NCT03600974|Antidepressive Agents|antidepressive agents|mesh-ancestor
25147642|NCT02912234|Apixaban|apixaban|mesh-list
25147643|NCT02912234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25147644|NCT02912234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25147645|NCT02912234|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25147646|NCT02912234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25147647|NCT02912234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147648|NCT02912234|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25047917|NCT00752570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25047918|NCT00752297|Botulinum Toxins|botulinum toxins|mesh-list
25047919|NCT00752297|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25047920|NCT00752297|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25047921|NCT00752297|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25047922|NCT00752297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25047923|NCT00752297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047924|NCT00752297|Cholinergic Agents|cholinergic agents|mesh-ancestor
25047925|NCT00752297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25047926|NCT00752297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047927|NCT00752297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25047928|NCT00752297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25047929|NCT00752258|Botulinum Toxins|botulinum toxins|mesh-list
25047930|NCT00752258|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25047931|NCT00752258|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25047932|NCT00752258|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25047933|NCT00752258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25047962|NCT00751231|Purinergic Agents|purinergic agents|mesh-ancestor
25047963|NCT00751231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25029749|NCT03600870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25047964|NCT00751231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047965|NCT00751231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047967|NCT00750633|Dexamethasone|dexamethasone|mesh-list
25047968|NCT00750633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25047969|NCT00750633|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25047970|NCT00750633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25047971|NCT00750633|Antiemetics|antiemetics|mesh-ancestor
25047972|NCT00750633|Autonomic Agents|autonomic agents|mesh-ancestor
25047973|NCT00750633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25047974|NCT00750633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047975|NCT00750633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25047976|NCT00750633|Glucocorticoids|glucocorticoids|mesh-ancestor
25047977|NCT00750633|Hormones|hormones|mesh-ancestor
24765630|NCT01789710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25147671|NCT02911870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147672|NCT02911870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25147674|NCT02911766|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25147675|NCT02911766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24787464|NCT01925352|Mitogens|mitogens|mesh-list
25051433|NCT00405743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25147676|NCT02911766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25029780|NCT03600727|Propofol|propofol|mesh-list
25147677|NCT02911766|Disinfectants|disinfectants|mesh-ancestor
25147678|NCT02911766|Dermatologic Agents|dermatologic agents|mesh-ancestor
25147713|NCT02911298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25147714|NCT02911298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25147715|NCT02911298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25147716|NCT02911350|Paclitaxel|paclitaxel|mesh-list
25147717|NCT02911350|Hormones|hormones|mesh-list
25147718|NCT02911350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25147719|NCT02911350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25147720|NCT02911350|Tubulin Modulators|tubulin modulators|mesh-ancestor
25147721|NCT02911350|Antimitotic Agents|antimitotic agents|mesh-ancestor
25147722|NCT02911350|Mitosis Modulators|mitosis modulators|mesh-ancestor
25097081|NCT03206944|Aspirin|aspirin|mesh-list
25147723|NCT02911350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147736|NCT02910778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25147738|NCT02910778|Antimetabolites|antimetabolites|mesh-ancestor
25147969|NCT02909465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25147739|NCT02910778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147740|NCT02910778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25147741|NCT02910778|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25147742|NCT02910778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25147743|NCT02910778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25147744|NCT02910778|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25147745|NCT02910778|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25147772|NCT02910518|Isophane Insulin, Human|isophane insulin, human|mesh-list
25147773|NCT02910518|Isophane insulin, beef|isophane insulin, beef|mesh-list
25147774|NCT02910518|Heparin|heparin|mesh-list
25147775|NCT02910518|Calcium heparin|calcium heparin|mesh-list
25147776|NCT02910518|Glucagon|glucagon|mesh-list
25147777|NCT02910518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25147778|NCT02910518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147779|NCT02910518|Anticoagulants|anticoagulants|mesh-ancestor
25147780|NCT02910518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25147781|NCT02910518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25147782|NCT02910518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147783|NCT02910518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25147784|NCT02910518|Hormones|hormones|mesh-ancestor
25147785|NCT02910518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25147786|NCT02910596|Bethanechol|bethanechol|mesh-list
25147787|NCT02910596|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25147788|NCT02910596|Autonomic Agents|autonomic agents|mesh-ancestor
25147789|NCT02910596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25147790|NCT02910596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147791|NCT02910596|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25147792|NCT02910596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25147793|NCT02910596|Cholinergic Agents|cholinergic agents|mesh-ancestor
25147794|NCT02910596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25147795|NCT02910596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147796|NCT02910570|Liraglutide|liraglutide|mesh-list
25147873|NCT02909933|Incretins|incretins|mesh-ancestor
25147874|NCT02909933|Hormones|hormones|mesh-ancestor
25147875|NCT02909933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25147876|NCT02910245|Prednisone|prednisone|mesh-list
25147877|NCT02910245|Mesalamine|mesalamine|mesh-list
25147878|NCT02910245|Mercaptopurine|mercaptopurine|mesh-list
25147879|NCT02910245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25147880|NCT02910245|Glucocorticoids|glucocorticoids|mesh-ancestor
25147881|NCT02910245|Hormones|hormones|mesh-ancestor
25147882|NCT02910245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25147883|NCT02910245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147884|NCT02910245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25147885|NCT02910245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25147914|NCT02909751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147915|NCT02909751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25147916|NCT02909751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25147917|NCT02909751|Alkylating Agents|alkylating agents|mesh-ancestor
25147918|NCT02909751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25147919|NCT02909751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25147920|NCT02909751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25147921|NCT02909751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25650363|NCT01501929|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24397699|NCT00142350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25147922|NCT02909751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25147923|NCT02909751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25147925|NCT02909751|Protective Agents|protective agents|mesh-ancestor
25147927|NCT02909751|Micronutrients|micronutrients|mesh-ancestor
25147928|NCT02909712|Pyrimethamine|pyrimethamine|mesh-list
25147929|NCT02909712|Piperaquine|piperaquine|mesh-list
25147930|NCT02909712|Sulfadoxine|sulfadoxine|mesh-list
25147931|NCT02909712|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25147932|NCT02909712|Artenimol|artenimol|mesh-list
25147933|NCT02909712|Antimalarials|antimalarials|mesh-ancestor
25147934|NCT02909712|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25147935|NCT02909712|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25147960|NCT02909465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25147961|NCT02909465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25147962|NCT02909465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25147963|NCT02909465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25147964|NCT02909465|GABA Modulators|gaba modulators|mesh-ancestor
25147965|NCT02909465|GABA Agents|gaba agents|mesh-ancestor
25147966|NCT02909465|Antiemetics|antiemetics|mesh-ancestor
25147967|NCT02909465|Autonomic Agents|autonomic agents|mesh-ancestor
25029916|NCT03599609|Simvastatin|simvastatin|mesh-list
25147968|NCT02909465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25147971|NCT02909465|Dopamine Agents|dopamine agents|mesh-ancestor
25147972|NCT02909465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25147973|NCT02909413|Sevoflurane|sevoflurane|mesh-list
25147974|NCT02909413|Desflurane|desflurane|mesh-list
25147975|NCT02909413|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25147976|NCT02909413|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25147977|NCT02909413|Anesthetics, General|anesthetics, general|mesh-ancestor
25147978|NCT02909413|Anesthetics|anesthetics|mesh-ancestor
25147979|NCT02909413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25147980|NCT02909413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147981|NCT02909400|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
25147982|NCT02909400|Antioxidants|antioxidants|mesh-ancestor
25147983|NCT02909400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147984|NCT02909400|Protective Agents|protective agents|mesh-ancestor
25147985|NCT02909400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148012|NCT02909478|Serotonin Agents|serotonin agents|mesh-ancestor
25148013|NCT02909335|Mycophenolic Acid|mycophenolic acid|mesh-list
25148014|NCT02909335|Prednisone|prednisone|mesh-list
25148015|NCT02909335|Methylprednisolone|methylprednisolone|mesh-list
25148016|NCT02909335|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25148017|NCT02909335|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25148019|NCT02909335|Prednisolone acetate|prednisolone acetate|mesh-list
25148020|NCT02909335|Everolimus|everolimus|mesh-list
25148021|NCT02909335|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25148022|NCT02909335|Prednisolone phosphate|prednisolone phosphate|mesh-list
25148023|NCT02909335|Tacrolimus|tacrolimus|mesh-list
25148024|NCT02909335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25148025|NCT02909335|Glucocorticoids|glucocorticoids|mesh-ancestor
25148026|NCT02909335|Hormones|hormones|mesh-ancestor
25148027|NCT02909335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25148028|NCT02909335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148029|NCT02909335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25148030|NCT02909335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148031|NCT02909335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25148032|NCT02909335|Immunologic Factors|immunologic factors|mesh-ancestor
25148033|NCT02909335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25148034|NCT02909335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25148035|NCT02909335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048015|NCT00749632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25048016|NCT00749632|Renal Agents|renal agents|mesh-ancestor
25048017|NCT00747318|Fluticasone|fluticasone|mesh-list
25113210|NCT03245151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048019|NCT00747318|Formoterol Fumarate|formoterol fumarate|mesh-list
25048020|NCT00747318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25048021|NCT00747318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25048022|NCT00747318|Autonomic Agents|autonomic agents|mesh-ancestor
25080322|NCT03340376|Doxorubicin|doxorubicin|mesh-list
25048051|NCT00744926|Incretins|incretins|mesh-ancestor
25048052|NCT00744926|Hormones|hormones|mesh-ancestor
25048053|NCT00744926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25048054|NCT00744926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048055|NCT00744367|Metformin|metformin|mesh-list
25048056|NCT00744367|Pioglitazone|pioglitazone|mesh-list
25048057|NCT00744367|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25048058|NCT00744367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25650364|NCT01501929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25048059|NCT00744367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048060|NCT00744367|Incretins|incretins|mesh-ancestor
25048061|NCT00744367|Hormones|hormones|mesh-ancestor
25048062|NCT00744367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25048063|NCT00744276|Danazol|danazol|mesh-list
25048064|NCT00744276|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25048065|NCT00744276|Hormone Antagonists|hormone antagonists|mesh-ancestor
25148097|NCT05312372|Tubulin Modulators|tubulin modulators|mesh-ancestor
25148098|NCT05312372|Antimitotic Agents|antimitotic agents|mesh-ancestor
25148099|NCT05312372|Mitosis Modulators|mitosis modulators|mesh-ancestor
25148100|NCT05312372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148101|NCT05312346|Hydroxocobalamin|hydroxocobalamin|mesh-list
25148102|NCT05312346|Vitamin B 12|vitamin b 12|mesh-list
25148103|NCT05312346|Hematinics|hematinics|mesh-ancestor
25148104|NCT05312346|Vitamin B Complex|vitamin b complex|mesh-ancestor
25148105|NCT05312346|Vitamins|vitamins|mesh-ancestor
25148106|NCT05312346|Micronutrients|micronutrients|mesh-ancestor
25148107|NCT05312346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148108|NCT05312294|Vaccines|vaccines|mesh-list
25148109|NCT05312294|Immunologic Factors|immunologic factors|mesh-ancestor
25148110|NCT05312294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148181|NCT05311722|Analgesics|analgesics|mesh-ancestor
25148182|NCT05311722|Sensory System Agents|sensory system agents|mesh-ancestor
25148183|NCT05311722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25148184|NCT05311722|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25148185|NCT05311722|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25148186|NCT05311722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25148187|NCT05311722|Adrenergic Agents|adrenergic agents|mesh-ancestor
25148188|NCT05311722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25148189|NCT05311722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148190|NCT05311722|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25148191|NCT05311722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25148192|NCT05311722|Anesthetics, General|anesthetics, general|mesh-ancestor
25148193|NCT05311722|Anesthetics|anesthetics|mesh-ancestor
25148194|NCT05311722|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24766161|NCT01793038|Clomiphene|clomiphene|mesh-list
25048082|NCT00743925|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
25048083|NCT00743795|Ribavirin|ribavirin|mesh-list
25048084|NCT00743795|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25048085|NCT00743795|Antimetabolites|antimetabolites|mesh-ancestor
25030006|NCT03599284|Clopidogrel|clopidogrel|mesh-list
25048086|NCT00743795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048087|NCT00743795|Antiviral Agents|antiviral agents|mesh-ancestor
25048088|NCT00743795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25048089|NCT00743002|Metformin|metformin|mesh-list
25048090|NCT00743002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25048092|NCT00741715|Atorvastatin|atorvastatin|mesh-list
25048093|NCT00741715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25048094|NCT00741715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25048095|NCT00741715|Antimetabolites|antimetabolites|mesh-ancestor
25048096|NCT00741715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048097|NCT00741715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25048098|NCT00741715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25148220|NCT05311085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048099|NCT00741715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25030043|NCT03598816|Durvalumab|durvalumab|mesh-list
25148253|NCT05296213|Calcium|calcium|mesh-list
25148254|NCT05296213|Fluorides|fluorides|mesh-list
25148255|NCT05296213|Caseins|caseins|mesh-list
25148280|NCT05268926|Dapagliflozin|dapagliflozin|mesh-list
25148281|NCT05268926|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25148282|NCT05268926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148283|NCT05268926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25148284|NCT05268926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148286|NCT05259631|Sevoflurane|sevoflurane|mesh-list
25148287|NCT05259631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25148288|NCT05259631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25148289|NCT05259631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148290|NCT05259631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25148291|NCT05259631|Anesthetics, General|anesthetics, general|mesh-ancestor
25148292|NCT05259631|Anesthetics|anesthetics|mesh-ancestor
25148293|NCT05259631|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25148294|NCT05259631|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25148295|NCT05247268|Letrozole|letrozole|mesh-list
25148296|NCT05247268|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25148297|NCT05247268|Megestrol|megestrol|mesh-list
25148298|NCT05247268|Megestrol Acetate|megestrol acetate|mesh-list
25148299|NCT05247268|Medroxyprogesterone|medroxyprogesterone|mesh-list
24399022|NCT00146497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24399024|NCT00146523|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24399025|NCT00146523|Abortifacient Agents|abortifacient agents|mesh-ancestor
24399061|NCT00146562|Immunologic Factors|immunologic factors|mesh-ancestor
25055845|NCT03517631|Busulfan|busulfan|mesh-list
25148300|NCT05247268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148301|NCT05247268|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25148302|NCT05247268|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25148336|NCT05189717|Everolimus|everolimus|mesh-list
25148337|NCT05189717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148338|NCT05189717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25148339|NCT05189717|Immunologic Factors|immunologic factors|mesh-ancestor
25148340|NCT05189717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148348|NCT05182463|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25148349|NCT05182463|Antiviral Agents|antiviral agents|mesh-ancestor
25148350|NCT05182463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25148354|NCT05148195|Leucovorin|leucovorin|mesh-list
25148355|NCT05148195|Docetaxel|docetaxel|mesh-list
25148388|NCT05124067|Dexamethasone|dexamethasone|mesh-list
25148389|NCT05124067|Dexamethasone acetate|dexamethasone acetate|mesh-list
24587999|NCT00900172|Paclitaxel|paclitaxel|mesh-list
25148390|NCT05124067|Dexmedetomidine|dexmedetomidine|mesh-list
25148391|NCT05124067|Ondansetron|ondansetron|mesh-list
25148393|NCT05124067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25148394|NCT05124067|Antiemetics|antiemetics|mesh-ancestor
25148395|NCT05124067|Autonomic Agents|autonomic agents|mesh-ancestor
25148396|NCT05124067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25148397|NCT05124067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148398|NCT05124067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25148399|NCT05124067|Glucocorticoids|glucocorticoids|mesh-ancestor
25148400|NCT05124067|Hormones|hormones|mesh-ancestor
25148401|NCT05124067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25048100|NCT00739349|Cyclosporine|cyclosporine|mesh-list
25048101|NCT00739349|Cyclosporins|cyclosporins|mesh-list
25048133|NCT00734461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25048135|NCT00734461|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25048136|NCT00734435|Zonisamide|zonisamide|mesh-list
25048137|NCT00734435|Olanzapine|olanzapine|mesh-list
25048138|NCT00734435|Antiemetics|antiemetics|mesh-ancestor
25048139|NCT00734435|Autonomic Agents|autonomic agents|mesh-ancestor
25048140|NCT00734435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25048141|NCT00734435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048142|NCT00734435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25048143|NCT00734435|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25048144|NCT00734435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25048145|NCT00734435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25148437|NCT05123040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25148438|NCT05123040|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25148439|NCT05123040|Protective Agents|protective agents|mesh-ancestor
25148441|NCT05117736|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25148442|NCT05117736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25148443|NCT05117736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25148444|NCT05117736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25148445|NCT05117736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148446|NCT05107960|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25148447|NCT05107960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25148448|NCT05107960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25148449|NCT05107960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148450|NCT05105061|Ketamine|ketamine|mesh-list
25148451|NCT05105061|Analgesics|analgesics|mesh-ancestor
25148452|NCT05105061|Sensory System Agents|sensory system agents|mesh-ancestor
25148453|NCT05105061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24766475|NCT01795131|Vitamin B 12|vitamin b 12|mesh-list
25148488|NCT05046535|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25148496|NCT05046535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148498|NCT05011214|Sevoflurane|sevoflurane|mesh-list
25148499|NCT05011214|Esketamine|esketamine|mesh-list
25650365|NCT01501929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25650366|NCT01502072|Ribavirin|ribavirin|mesh-list
25650367|NCT01502072|Antimetabolites|antimetabolites|mesh-ancestor
25650368|NCT01502072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650369|NCT01502072|Antiviral Agents|antiviral agents|mesh-ancestor
25650370|NCT01502072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25650371|NCT01502228|Sunitinib|sunitinib|mesh-list
25650372|NCT01502228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148500|NCT05011214|Analgesics|analgesics|mesh-ancestor
25148501|NCT05011214|Sensory System Agents|sensory system agents|mesh-ancestor
25148502|NCT05011214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25148503|NCT05011214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148504|NCT05011214|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25148532|NCT04965155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148533|NCT04965155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25148534|NCT04965155|Glucocorticoids|glucocorticoids|mesh-ancestor
25148535|NCT04965155|Hormones|hormones|mesh-ancestor
25148536|NCT04965155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25030147|NCT03598192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25030148|NCT03598192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25030149|NCT03598192|Anesthetics, General|anesthetics, general|mesh-ancestor
25030150|NCT03598075|Pramlintide|pramlintide|mesh-list
25030151|NCT03598075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25148537|NCT04965155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25148538|NCT04965155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148541|NCT04943757|Cyclophosphamide|cyclophosphamide|mesh-list
25148542|NCT04943757|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25148543|NCT04943757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25148544|NCT04943757|Immunologic Factors|immunologic factors|mesh-ancestor
25148545|NCT04943757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148546|NCT04943757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25148547|NCT04943757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25148548|NCT04943757|Alkylating Agents|alkylating agents|mesh-ancestor
24966386|NCT03768609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25148566|NCT04932083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25148568|NCT04932083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25148569|NCT04932083|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25148570|NCT04932083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25148571|NCT04932083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25148572|NCT04932083|GABA Modulators|gaba modulators|mesh-ancestor
25148574|NCT04932083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25148575|NCT04932083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148576|NCT04925960|Epalrestat|epalrestat|mesh-list
25148577|NCT04925960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25148578|NCT04925960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148583|NCT04907253|Quercetin|quercetin|mesh-list
25148584|NCT04907253|Antioxidants|antioxidants|mesh-ancestor
25148585|NCT04907253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148586|NCT04907253|Protective Agents|protective agents|mesh-ancestor
25148587|NCT04907253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148588|NCT04890873|Magnesium Hydroxide|magnesium hydroxide|mesh-list
25148589|NCT04890873|Antacids|antacids|mesh-ancestor
25148590|NCT04890873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148591|NCT04890873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25148608|NCT04863339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148610|NCT04863339|Coagulants|coagulants|mesh-ancestor
25148611|NCT04862143|Fulvestrant|fulvestrant|mesh-list
25148612|NCT04862143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25148613|NCT04862143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148614|NCT04862143|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25148615|NCT04862143|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25148655|NCT04844957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25098154|NCT03199521|Thrombin|thrombin|mesh-list
25148657|NCT04823845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25148658|NCT04823845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25148659|NCT04823845|Analgesics|analgesics|mesh-ancestor
25148660|NCT04823845|Sensory System Agents|sensory system agents|mesh-ancestor
25148661|NCT04823845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25048171|NCT00734292|Adrenergic Agents|adrenergic agents|mesh-ancestor
25048172|NCT00734292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25048173|NCT00734292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048174|NCT00734253|Pyridoxamine|pyridoxamine|mesh-list
25048175|NCT00734253|Vitamin B Complex|vitamin b complex|mesh-ancestor
25048176|NCT00734253|Vitamins|vitamins|mesh-ancestor
25048177|NCT00734253|Micronutrients|micronutrients|mesh-ancestor
25048178|NCT00734253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048201|NCT00726336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25048202|NCT00726336|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25048203|NCT00726336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25048204|NCT00726336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24437463|NCT00273689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24400668|NCT00151073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25048205|NCT00726336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048206|NCT00726336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25048207|NCT00726336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25048208|NCT00726336|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25048209|NCT00726336|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25048210|NCT00725881|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
25048211|NCT00725881|Antioxidants|antioxidants|mesh-ancestor
25048212|NCT00725881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048213|NCT00725881|Protective Agents|protective agents|mesh-ancestor
25048214|NCT00725881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048215|NCT00725881|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25048216|NCT00725881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048217|NCT00724841|Temozolomide|temozolomide|mesh-list
25048218|NCT00724841|Obatoclax|obatoclax|mesh-list
25048219|NCT00724841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25048220|NCT00724841|Alkylating Agents|alkylating agents|mesh-ancestor
25048221|NCT00724841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048222|NCT00724841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048223|NCT00724841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048224|NCT00724698|Desloratadine|desloratadine|mesh-list
25048225|NCT00724698|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25048226|NCT00724698|Cholinergic Agents|cholinergic agents|mesh-ancestor
25048227|NCT00724698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25048228|NCT00724698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766644|NCT01795976|Fludarabine|fludarabine|mesh-list
24588034|NCT00900445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24588035|NCT00900445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493308|NCT00490373|Pemetrexed|pemetrexed|mesh-list
25148723|NCT04660760|Trifluridine|trifluridine|mesh-list
25148724|NCT04660760|Paclitaxel|paclitaxel|mesh-list
25148725|NCT04660760|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25148726|NCT04660760|Ramucirumab|ramucirumab|mesh-list
25148727|NCT04660760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25148728|NCT04660760|Antibodies|antibodies|mesh-list
25148743|NCT04660045|Acalabrutinib|acalabrutinib|mesh-list
25030245|NCT03597555|Anesthetics, General|anesthetics, general|mesh-ancestor
25148744|NCT04660045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148745|NCT04656951|Daratumumab|daratumumab|mesh-list
25148746|NCT04656951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148747|NCT04640779|Salicylates|salicylates|mesh-list
25148748|NCT04640779|Choline|choline|mesh-list
25148772|NCT04630964|Vasodilator Agents|vasodilator agents|mesh-ancestor
25148773|NCT04630964|Vitamin B Complex|vitamin b complex|mesh-ancestor
25148774|NCT04630964|Vitamins|vitamins|mesh-ancestor
25148775|NCT04630964|Micronutrients|micronutrients|mesh-ancestor
25148776|NCT04630964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148777|NCT04630964|Hallucinogens|hallucinogens|mesh-ancestor
25148778|NCT04630964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25148791|NCT04607252|Metformin|metformin|mesh-list
25148792|NCT04607252|Megestrol|megestrol|mesh-list
25148793|NCT04607252|Megestrol Acetate|megestrol acetate|mesh-list
25148794|NCT04607252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25148795|NCT04607252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148796|NCT04607252|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25148797|NCT04607252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25148798|NCT04607252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25148799|NCT04607252|Contraceptive Agents|contraceptive agents|mesh-ancestor
24766799|NCT01796808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25148830|NCT04556084|Blinatumomab|blinatumomab|mesh-list
25148831|NCT04556084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148832|NCT04548583|Remestemcel-l|remestemcel-l|mesh-list
25148833|NCT04548583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25148834|NCT04548583|Antiviral Agents|antiviral agents|mesh-ancestor
25148835|NCT04548583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25148836|NCT04545866|Budesonide|budesonide|mesh-list
25148837|NCT04545866|Poractant alfa|poractant alfa|mesh-list
25148838|NCT04545866|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25148839|NCT04545866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25148840|NCT04545866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25148841|NCT04545866|Autonomic Agents|autonomic agents|mesh-ancestor
25148842|NCT04545866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25148843|NCT04545866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650373|NCT01502228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25148875|NCT04531059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25148876|NCT04531059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25148877|NCT04531059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25148878|NCT04531059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25148879|NCT04531059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24946157|NCT03942601|BB 1101|bb 1101|mesh-list
24946159|NCT03942601|Antiemetics|antiemetics|mesh-ancestor
25148880|NCT04531059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25148881|NCT04531059|Antacids|antacids|mesh-ancestor
25148882|NCT04531059|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25148883|NCT04531059|Diuretics|diuretics|mesh-ancestor
25148884|NCT04531059|Natriuretic Agents|natriuretic agents|mesh-ancestor
25148886|NCT04531059|Expectorants|expectorants|mesh-ancestor
25148887|NCT04531059|Respiratory System Agents|respiratory system agents|mesh-ancestor
25148888|NCT04515576|Dulaglutide|dulaglutide|mesh-list
25148889|NCT04515576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25148890|NCT04515576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148891|NCT04460560|Terlipressin|terlipressin|mesh-list
24766898|NCT01797718|Androgens|androgens|mesh-ancestor
25148922|NCT04366713|Antidiarrheals|antidiarrheals|mesh-list
25148923|NCT04366713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25148924|NCT04366713|Antimetabolites|antimetabolites|mesh-ancestor
25148925|NCT04366713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148926|NCT04366713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148927|NCT04366713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25148928|NCT04356326|Aspirin|aspirin|mesh-list
25148929|NCT04356326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25148930|NCT04356326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25148931|NCT04356326|Analgesics|analgesics|mesh-ancestor
25148932|NCT04356326|Sensory System Agents|sensory system agents|mesh-ancestor
25148933|NCT04356326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25148934|NCT04356326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148935|NCT04356326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24621055|NCT01060501|Vitamins|vitamins|mesh-ancestor
25148961|NCT04299880|Irinotecan|irinotecan|mesh-list
25148962|NCT04299880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25148963|NCT04299880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148964|NCT04299880|Tubulin Modulators|tubulin modulators|mesh-ancestor
25148965|NCT04299880|Antimitotic Agents|antimitotic agents|mesh-ancestor
25148966|NCT04299880|Mitosis Modulators|mitosis modulators|mesh-ancestor
25148967|NCT04299880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148968|NCT04299880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25148969|NCT04299880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25148970|NCT04299880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25148971|NCT04299880|Growth Substances|growth substances|mesh-ancestor
25148972|NCT04299880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148973|NCT04299880|Growth Inhibitors|growth inhibitors|mesh-ancestor
25148974|NCT04299880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25148975|NCT04299880|Antimetabolites|antimetabolites|mesh-ancestor
25148976|NCT04299880|Antiviral Agents|antiviral agents|mesh-ancestor
25148977|NCT04299880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25148978|NCT04299880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25148979|NCT04299880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25148980|NCT04299880|Immunologic Factors|immunologic factors|mesh-ancestor
25148981|NCT04299880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25148982|NCT04299880|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25148983|NCT04299880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25148984|NCT04299880|Antidotes|antidotes|mesh-ancestor
25148985|NCT04299880|Protective Agents|protective agents|mesh-ancestor
25148986|NCT04299880|Vitamin B Complex|vitamin b complex|mesh-ancestor
25148987|NCT04299880|Vitamins|vitamins|mesh-ancestor
25148988|NCT04299880|Micronutrients|micronutrients|mesh-ancestor
25149030|NCT04243616|Antimitotic Agents|antimitotic agents|mesh-ancestor
25149031|NCT04243616|Mitosis Modulators|mitosis modulators|mesh-ancestor
25149032|NCT04243616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149033|NCT04243616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25149034|NCT04243616|Immunologic Factors|immunologic factors|mesh-ancestor
25149035|NCT04243616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030423|NCT03595930|Autonomic Agents|autonomic agents|mesh-ancestor
25149036|NCT04243616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25149037|NCT04243616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25149038|NCT04243616|Alkylating Agents|alkylating agents|mesh-ancestor
25149039|NCT04243616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25149040|NCT04243616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25149041|NCT04243616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25149042|NCT04243616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25149043|NCT04243616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25149044|NCT04243616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25149045|NCT04239053|Bupivacaine|bupivacaine|mesh-list
25149046|NCT04239053|Anesthetics, Local|anesthetics, local|mesh-ancestor
25149047|NCT04239053|Anesthetics|anesthetics|mesh-ancestor
25650374|NCT01502228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24402557|NCT00157859|Chloroquine|chloroquine|mesh-list
25149048|NCT04239053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25149049|NCT04239053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149050|NCT04239053|Sensory System Agents|sensory system agents|mesh-ancestor
25149070|NCT04167670|Amoxicillin|amoxicillin|mesh-list
25149071|NCT04167670|Clarithromycin|clarithromycin|mesh-list
25149072|NCT04167670|Lansoprazole|lansoprazole|mesh-list
25149073|NCT04167670|Dexlansoprazole|dexlansoprazole|mesh-list
25149074|NCT04167670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25149075|NCT04167670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25149076|NCT04167670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25149077|NCT04167670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25149078|NCT04167670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149079|NCT04167670|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25149085|NCT04148495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25149087|NCT04148495|Sensory System Agents|sensory system agents|mesh-ancestor
25149088|NCT04148495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25149089|NCT04148495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149090|NCT04148495|Antipyretics|antipyretics|mesh-ancestor
25149091|NCT04119284|Terephthalic acid|terephthalic acid|mesh-list
25149092|NCT04119284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25149093|NCT04119284|Antioxidants|antioxidants|mesh-ancestor
25149094|NCT04119284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149095|NCT04119284|Protective Agents|protective agents|mesh-ancestor
25149096|NCT04119284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149097|NCT04105335|Pembrolizumab|pembrolizumab|mesh-list
25149113|NCT04019379|Calcium, Dietary|calcium, dietary|mesh-list
25149115|NCT04019379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25150117|NCT05322512|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25149116|NCT04019379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149117|NCT04019379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25149118|NCT04000009|Pimavanserin|pimavanserin|mesh-list
25149119|NCT04000009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25149120|NCT04000009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25149121|NCT04000009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25149122|NCT04000009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25030474|NCT03595397|Anesthetics, Local|anesthetics, local|mesh-ancestor
24767044|NCT01798472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25149145|NCT03910998|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25149146|NCT03910998|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25149147|NCT03910998|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25149148|NCT03910998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25149149|NCT03910998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149150|NCT03888079|Anesthetics|anesthetics|mesh-list
25149151|NCT03888079|Anesthetics, Local|anesthetics, local|mesh-list
25149152|NCT03888079|Anesthetics, General|anesthetics, general|mesh-list
25149153|NCT03888079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25149154|NCT03888079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149155|NCT03888079|Sensory System Agents|sensory system agents|mesh-ancestor
25149156|NCT03888079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25149157|NCT03883893|Acetaminophen|acetaminophen|mesh-list
25149158|NCT03883893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25149159|NCT03883893|Analgesics|analgesics|mesh-ancestor
25149160|NCT03883893|Sensory System Agents|sensory system agents|mesh-ancestor
25149161|NCT03883893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25149162|NCT03883893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149163|NCT03883893|Antipyretics|antipyretics|mesh-ancestor
25149169|NCT03847545|4-Aminopyridine|4-aminopyridine|mesh-list
25149170|NCT03847545|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25149171|NCT03847545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25149172|NCT03847545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149194|NCT03766581|Sensory System Agents|sensory system agents|mesh-ancestor
25149195|NCT03766581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25030494|NCT03595371|Dapansutrile|dapansutrile|mesh-list
25149196|NCT03766581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149197|NCT03766581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25149198|NCT03766581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25149199|NCT03766581|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25149200|NCT03766581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25149201|NCT03766581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149202|NCT03766581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25149203|NCT03766581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25650375|NCT01502228|Growth Substances|growth substances|mesh-ancestor
24403486|NCT00160511|Nootropic Agents|nootropic agents|mesh-ancestor
24403617|NCT00161070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25149204|NCT03766581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25149205|NCT03766581|Antipyretics|antipyretics|mesh-ancestor
25149206|NCT03766581|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25149207|NCT03766581|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25149208|NCT03766581|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25149209|NCT03766581|Purinergic Agents|purinergic agents|mesh-ancestor
25149219|NCT03732820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25149221|NCT03732820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25149222|NCT03729609|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25149223|NCT03729609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25149224|NCT03729609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048280|NCT00717457|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25048281|NCT00717457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25048282|NCT00717457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149236|NCT03694262|Atezolizumab|atezolizumab|mesh-list
25149237|NCT03694262|Rucaparib|rucaparib|mesh-list
25149238|NCT03694262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25149239|NCT03694262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25149240|NCT03694262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25166641|NCT03828799|Folfirinox|folfirinox|mesh-list
25117097|NCT05376852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25149241|NCT03694262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25149242|NCT03694262|Growth Substances|growth substances|mesh-ancestor
25149243|NCT03694262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149244|NCT03694262|Growth Inhibitors|growth inhibitors|mesh-ancestor
25149245|NCT03694262|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25149275|NCT03640754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149276|NCT03621982|Pembrolizumab|pembrolizumab|mesh-list
25149277|NCT03621982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25149278|NCT03621982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25149344|NCT02842866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149346|NCT02842853|Immunologic Factors|immunologic factors|mesh-ancestor
25149347|NCT02842853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149348|NCT02834559|Fluorouracil|fluorouracil|mesh-list
25149349|NCT02834559|Heparin|heparin|mesh-list
25149350|NCT02834559|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25149351|NCT02834559|Tinzaparin|tinzaparin|mesh-list
25149352|NCT02834559|Dalteparin|dalteparin|mesh-list
25149353|NCT02834559|Antimetabolites|antimetabolites|mesh-ancestor
25149354|NCT02834559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149355|NCT02834559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25149356|NCT02834559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25149390|NCT02752906|Vaccines|vaccines|mesh-list
25149391|NCT02752906|Immunologic Factors|immunologic factors|mesh-ancestor
25149392|NCT02752906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149393|NCT02716012|Sorafenib|sorafenib|mesh-list
25149394|NCT02716012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25149395|NCT02716012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25149396|NCT02716012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25149397|NCT02716012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149399|NCT05467761|Hallucinogens|hallucinogens|mesh-ancestor
25149400|NCT05467761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149401|NCT05467761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25149473|NCT05467384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25149474|NCT05467384|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25149475|NCT05467384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25149503|NCT05467189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25149504|NCT05467189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048284|NCT00717457|Incretins|incretins|mesh-ancestor
25048285|NCT00717457|Hormones|hormones|mesh-ancestor
25048286|NCT00717457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25048287|NCT00716534|Paclitaxel|paclitaxel|mesh-list
25048288|NCT00716534|Carboplatin|carboplatin|mesh-list
25048289|NCT00716534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25048290|NCT00716534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048291|NCT00716534|Tubulin Modulators|tubulin modulators|mesh-ancestor
25048292|NCT00716534|Antimitotic Agents|antimitotic agents|mesh-ancestor
25048293|NCT00716534|Mitosis Modulators|mitosis modulators|mesh-ancestor
25048294|NCT00716534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030591|NCT03594565|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25030592|NCT03594513|Dipyrone|dipyrone|mesh-list
25650376|NCT01502228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650377|NCT01502228|Growth Inhibitors|growth inhibitors|mesh-ancestor
24407056|NCT00171769|Certoparin|certoparin|mesh-list
24407057|NCT00171769|Anticoagulants|anticoagulants|mesh-ancestor
24407058|NCT00171782|Valsartan|valsartan|mesh-list
24407119|NCT00171912|Imatinib Mesylate|imatinib mesylate|mesh-list
25030593|NCT03594513|Chlorhexidine|chlorhexidine|mesh-list
25030594|NCT03594513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25030595|NCT03594513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25030596|NCT03594513|Disinfectants|disinfectants|mesh-ancestor
25030599|NCT03594513|Analgesics|analgesics|mesh-ancestor
25048295|NCT00714597|Enoxaparin|enoxaparin|mesh-list
25048296|NCT00714597|Semuloparin|semuloparin|mesh-list
25048297|NCT00714597|Enoxaparin sodium|enoxaparin sodium|mesh-list
25166642|NCT03828799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048298|NCT00714597|Anticoagulants|anticoagulants|mesh-ancestor
25048299|NCT00714597|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25048300|NCT00714597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25048301|NCT00714597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149560|NCT05466708|Adrenergic Agents|adrenergic agents|mesh-ancestor
25149561|NCT05466708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25149562|NCT05466708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149563|NCT05466708|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25149564|NCT05466708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25149565|NCT05466708|Anesthetics, General|anesthetics, general|mesh-ancestor
25149566|NCT05466708|Anesthetics|anesthetics|mesh-ancestor
25149567|NCT05466708|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25149568|NCT05466708|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25149569|NCT05466708|Antidepressive Agents|antidepressive agents|mesh-ancestor
25149570|NCT05466708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25149571|NCT05466695|Sildenafil Citrate|sildenafil citrate|mesh-list
25149573|NCT05466695|Vasodilator Agents|vasodilator agents|mesh-ancestor
25149574|NCT05466695|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25030607|NCT03594461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25030609|NCT03594461|Growth Substances|growth substances|mesh-ancestor
25149575|NCT05466695|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25149576|NCT05466695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25149577|NCT05466695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149578|NCT05466695|Urological Agents|urological agents|mesh-ancestor
25149579|NCT05466604|Dexamethasone|dexamethasone|mesh-list
25150118|NCT05322512|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25149589|NCT05466604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25149591|NCT05466578|Abrocitinib|abrocitinib|mesh-list
25149592|NCT05466578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25149593|NCT05466578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25149594|NCT05466578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149796|NCT05458375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25149797|NCT05458375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620404|NCT01056874|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25149829|NCT05442268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25149830|NCT05442268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25149831|NCT05442268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25149849|NCT05440383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25149850|NCT05440383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149851|NCT05440383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25149852|NCT05440383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25149876|NCT05426525|Empagliflozin|empagliflozin|mesh-list
25149877|NCT05426525|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25149878|NCT05426525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149879|NCT05426525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25149880|NCT05426525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048373|NCT00709865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25048374|NCT00709865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048375|NCT00709865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048376|NCT00709371|Zonisamide|zonisamide|mesh-list
25048377|NCT00709371|Bupropion|bupropion|mesh-list
25150011|NCT05357482|Hydroxyurea|hydroxyurea|mesh-list
25150012|NCT05357482|Immunologic Factors|immunologic factors|mesh-ancestor
25150013|NCT05357482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25150014|NCT05357482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25650378|NCT01502228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25650379|NCT01502228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650380|NCT01502228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650381|NCT01502293|Interleukin-12|interleukin-12|mesh-list
24408063|NCT00176449|Antidepressive Agents|antidepressive agents|mesh-ancestor
25150015|NCT05357482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25150016|NCT05357482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25150017|NCT05357482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25150018|NCT05357482|Antifungal Agents|antifungal agents|mesh-ancestor
25150019|NCT05357482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25150020|NCT05357482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25150021|NCT05357482|Antisickling Agents|antisickling agents|mesh-ancestor
25150022|NCT05357482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25166643|NCT03828019|Cyclosporine|cyclosporine|mesh-list
25150023|NCT05357482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150024|NCT05357482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25150025|NCT05357482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25150026|NCT05357482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24997277|NCT05213312|Nivolumab|nivolumab|mesh-list
24997278|NCT05213312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24997279|NCT05213312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24997280|NCT05213312|Tubulin Modulators|tubulin modulators|mesh-ancestor
24997281|NCT05213312|Antimitotic Agents|antimitotic agents|mesh-ancestor
24997316|NCT05192850|Metformin|metformin|mesh-list
25150079|NCT05341167|Phenylephrine|phenylephrine|mesh-list
25150080|NCT05341167|Oxymetazoline|oxymetazoline|mesh-list
25150081|NCT05341167|Norepinephrine|norepinephrine|mesh-list
25150082|NCT05341167|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25150083|NCT05341167|Mydriatics|mydriatics|mesh-ancestor
25150111|NCT05324761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25150112|NCT05324761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25150113|NCT05324761|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25150114|NCT05324761|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25150115|NCT05324761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25150116|NCT05324761|Antimanic Agents|antimanic agents|mesh-ancestor
25150119|NCT05322512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150120|NCT05321316|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25150121|NCT05321316|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25150122|NCT05321316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150206|NCT05314569|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24987635|NCT05190120|Anesthetics, Local|anesthetics, local|mesh-ancestor
25166644|NCT03828019|Adalimumab|adalimumab|mesh-list
25150255|NCT05308420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25150257|NCT05308030|Rivaroxaban|rivaroxaban|mesh-list
25150258|NCT05308030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25150259|NCT05308030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25150260|NCT05308030|Analgesics|analgesics|mesh-ancestor
25150261|NCT05308030|Sensory System Agents|sensory system agents|mesh-ancestor
25150262|NCT05308030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25150263|NCT05308030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25150264|NCT05308030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25150265|NCT05308030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25150266|NCT05308030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25150267|NCT05308030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25150268|NCT05308030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150269|NCT05308030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25150270|NCT05308030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25150271|NCT05308030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25150272|NCT05308030|Antipyretics|antipyretics|mesh-ancestor
25150273|NCT05308030|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25150274|NCT05308030|Antithrombins|antithrombins|mesh-ancestor
25150275|NCT05308030|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25150276|NCT05308030|Protease Inhibitors|protease inhibitors|mesh-ancestor
25150404|NCT05272202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25150405|NCT05272202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25150406|NCT05272202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25150407|NCT05272202|Anesthetics, General|anesthetics, general|mesh-ancestor
25150408|NCT05272202|Anesthetics|anesthetics|mesh-ancestor
25150419|NCT05258279|Carboplatin|carboplatin|mesh-list
25150420|NCT05258279|Pembrolizumab|pembrolizumab|mesh-list
25150421|NCT05258279|Pemetrexed|pemetrexed|mesh-list
25150422|NCT05258279|Lenvatinib|lenvatinib|mesh-list
25150439|NCT05242081|Sensory System Agents|sensory system agents|mesh-ancestor
25150440|NCT05242081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25150441|NCT05242081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25150442|NCT05242081|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25150443|NCT05242081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25150444|NCT05242081|Anesthetics, General|anesthetics, general|mesh-ancestor
25150445|NCT05242081|Anesthetics|anesthetics|mesh-ancestor
25650382|NCT01502293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25150446|NCT05242081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25150447|NCT05242081|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25150448|NCT05242081|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25150449|NCT05242081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25150450|NCT05242081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150485|NCT05231980|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25166645|NCT03828019|Methotrexate|methotrexate|mesh-list
25150487|NCT05231980|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25150488|NCT05209035|Trazodone|trazodone|mesh-list
25150489|NCT05209035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25150490|NCT05209035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25150491|NCT05209035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25150541|NCT05177146|Sensory System Agents|sensory system agents|mesh-ancestor
25150542|NCT05177146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25150543|NCT05177146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25150544|NCT05177146|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25150545|NCT05177146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25150546|NCT05177146|Anesthetics, General|anesthetics, general|mesh-ancestor
25150580|NCT05157867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030973|NCT03591536|Protective Agents|protective agents|mesh-ancestor
24591973|NCT00919815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591974|NCT00919880|Paclitaxel|paclitaxel|mesh-list
25048406|NCT00708292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25150614|NCT05152004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25150616|NCT05152004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25150617|NCT05152004|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25150624|NCT05144295|Lactulose|lactulose|mesh-list
25150625|NCT05144295|Bisacodyl|bisacodyl|mesh-list
25150626|NCT05144295|Picosulfate sodium|picosulfate sodium|mesh-list
25150627|NCT05144295|Lubiprostone|lubiprostone|mesh-list
25150628|NCT05144295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25150630|NCT05144295|Laxatives|laxatives|mesh-ancestor
25150631|NCT05144295|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25150632|NCT05144295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25150633|NCT05144295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150634|NCT05141344|Melatonin|melatonin|mesh-list
25150635|NCT05141344|Antioxidants|antioxidants|mesh-ancestor
25150647|NCT05136066|Peppermint oil|peppermint oil|mesh-list
25150648|NCT05136066|Antiemetics|antiemetics|mesh-ancestor
25150649|NCT05136066|Autonomic Agents|autonomic agents|mesh-ancestor
25150733|NCT05073237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25150734|NCT05073237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25150735|NCT05073237|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25150749|NCT05060068|Ketamine|ketamine|mesh-list
25150750|NCT05060068|Esketamine|esketamine|mesh-list
25150751|NCT05060068|Analgesics|analgesics|mesh-ancestor
25150752|NCT05060068|Sensory System Agents|sensory system agents|mesh-ancestor
25150753|NCT05060068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25150754|NCT05060068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25150755|NCT05060068|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25150756|NCT05060068|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25048425|NCT00707889|Antidotes|antidotes|mesh-ancestor
25048426|NCT00707889|Protective Agents|protective agents|mesh-ancestor
25166646|NCT03828019|Azathioprine|azathioprine|mesh-list
25048427|NCT00707889|Vitamin B Complex|vitamin b complex|mesh-ancestor
25048429|NCT00707889|Micronutrients|micronutrients|mesh-ancestor
25048430|NCT00707889|Hematinics|hematinics|mesh-ancestor
25048431|NCT00707304|Lactoferrin|lactoferrin|mesh-list
25048432|NCT00707304|Talactoferrin alfa|talactoferrin alfa|mesh-list
25048433|NCT00707304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25048434|NCT00707304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24798229|NCT01961752|Anesthetics, Local|anesthetics, local|mesh-ancestor
24798230|NCT01961752|Anesthetics|anesthetics|mesh-ancestor
24798231|NCT01961752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24798232|NCT01961752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080599|NCT03337035|Oxytocin|oxytocin|mesh-list
24768293|NCT01807286|Hormones|hormones|mesh-ancestor
25150904|NCT04992065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25150905|NCT04992065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25150938|NCT04953897|Decitabine|decitabine|mesh-list
25150939|NCT04953897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25150940|NCT04953897|Antimetabolites|antimetabolites|mesh-ancestor
25150941|NCT04953897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150942|NCT04953897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25150943|NCT04953897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24559397|NCT04908579|Ketamine|ketamine|mesh-list
25151018|NCT04922983|Botulinum Toxins|botulinum toxins|mesh-list
25113423|NCT02832544|Hemostatics|hemostatics|mesh-ancestor
25151026|NCT04922983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151044|NCT04910100|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25151045|NCT04910100|Adrenergic Agents|adrenergic agents|mesh-ancestor
25151046|NCT04910100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25151047|NCT04910100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25151048|NCT04910100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151049|NCT04910100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25151050|NCT04910100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25151051|NCT04910100|Vasodilator Agents|vasodilator agents|mesh-ancestor
25100647|NCT03180957|Adalimumab|adalimumab|mesh-list
25151052|NCT04910100|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25151053|NCT04910100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24768422|NCT01807962|Anesthetics|anesthetics|mesh-ancestor
25151135|NCT04885686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25151165|NCT04865029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25113441|NCT02832531|Antipyretics|antipyretics|mesh-ancestor
25113442|NCT02832531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25151166|NCT04865029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25151167|NCT04865029|Contraceptive Agents|contraceptive agents|mesh-ancestor
25151168|NCT04865029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25151169|NCT04865029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25151170|NCT04865029|Progestins|progestins|mesh-ancestor
25151171|NCT04858360|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25151172|NCT04858360|Anesthetics, Local|anesthetics, local|mesh-ancestor
25151173|NCT04858360|Anesthetics|anesthetics|mesh-ancestor
24896227|NCT01117441|Vindesine|vindesine|mesh-list
25151175|NCT04858360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151176|NCT04858360|Sensory System Agents|sensory system agents|mesh-ancestor
25151177|NCT04858360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25151178|NCT04858360|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24997351|NCT05133687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24997352|NCT05131828|Metformin|metformin|mesh-list
24997353|NCT05131828|Clemastine|clemastine|mesh-list
24997354|NCT05131828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24997355|NCT05131828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997378|NCT05101551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24997379|NCT05101551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24997387|NCT05027893|Moxifloxacin|moxifloxacin|mesh-list
24997389|NCT05027893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24997390|NCT05027893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24997391|NCT05027893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24997392|NCT05027893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24997393|NCT05027893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24997394|NCT05027893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997395|NCT05027893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24997396|NCT04989361|Hyaluronic Acid|hyaluronic acid|mesh-list
24997397|NCT04989361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24997398|NCT04989361|Immunologic Factors|immunologic factors|mesh-ancestor
24997399|NCT04989361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997400|NCT04989361|Viscosupplements|viscosupplements|mesh-ancestor
24997401|NCT04989361|Protective Agents|protective agents|mesh-ancestor
25151373|NCT04727775|Antiviral Agents|antiviral agents|mesh-ancestor
25151374|NCT04727775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25151378|NCT04706741|Prednisone|prednisone|mesh-list
25151379|NCT04706741|Prednisolone|prednisolone|mesh-list
25151380|NCT04706741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25151381|NCT04706741|Glucocorticoids|glucocorticoids|mesh-ancestor
25151382|NCT04706741|Hormones|hormones|mesh-ancestor
25151383|NCT04706741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25151384|NCT04706741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151385|NCT04706741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25151386|NCT04706741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24997447|NCT04815720|Pembrolizumab|pembrolizumab|mesh-list
24997448|NCT04815720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24997449|NCT04815720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24997453|NCT04809116|Pimavanserin|pimavanserin|mesh-list
24997454|NCT04809116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24997455|NCT04809116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24997456|NCT04809116|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24997457|NCT04809116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24997458|NCT04809116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24997459|NCT04809116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997460|NCT04809116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24997461|NCT04809116|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24997484|NCT04799236|Antifungal Agents|antifungal agents|mesh-ancestor
24997485|NCT04799236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25151484|NCT04622813|Acetaminophen|acetaminophen|mesh-list
25151485|NCT04622813|Ketoprofen|ketoprofen|mesh-list
25151486|NCT04622813|Nefopam|nefopam|mesh-list
25151487|NCT04622813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25151594|NCT04562441|Axitinib|axitinib|mesh-list
25151595|NCT04562441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25151626|NCT04551963|Antifungal Agents|antifungal agents|mesh-ancestor
25151627|NCT04551963|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25151628|NCT04551963|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25151629|NCT04551963|Hormone Antagonists|hormone antagonists|mesh-ancestor
25151630|NCT04551963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25151631|NCT04551963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151632|NCT04551963|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25151633|NCT04551963|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25151634|NCT04551963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25151635|NCT04551963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25151636|NCT04551963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25151637|NCT04551963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25151638|NCT04551963|Vasodilator Agents|vasodilator agents|mesh-ancestor
25151639|NCT04551963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25151640|NCT04551963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25031213|NCT03589222|Autonomic Agents|autonomic agents|mesh-ancestor
25166647|NCT03828019|Tacrolimus|tacrolimus|mesh-list
24935404|NCT04051099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24935405|NCT04051099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24935406|NCT04051099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24935407|NCT04051099|Adrenergic Agents|adrenergic agents|mesh-ancestor
25152038|NCT04273776|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24759892|NCT01755338|Protective Agents|protective agents|mesh-ancestor
24759893|NCT01755338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24759894|NCT01755338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759896|NCT01755377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24759897|NCT01755377|Immunologic Factors|immunologic factors|mesh-ancestor
24759898|NCT01755377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759899|NCT01755377|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24759900|NCT01755377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24759901|NCT01755377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24759902|NCT01755377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24759904|NCT01755403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24759905|NCT01755403|Immunologic Factors|immunologic factors|mesh-ancestor
25151781|NCT04462627|Immunologic Factors|immunologic factors|mesh-ancestor
25151782|NCT04462627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151791|NCT04449198|Resveratrol|resveratrol|mesh-list
25151792|NCT04449198|Antioxidants|antioxidants|mesh-ancestor
25151793|NCT04449198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25151794|NCT04449198|Protective Agents|protective agents|mesh-ancestor
25151795|NCT04449198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151796|NCT04449198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25151797|NCT04449198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25151815|NCT04428333|Pembrolizumab|pembrolizumab|mesh-list
25151851|NCT04397484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25151852|NCT04397484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25151853|NCT04397484|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25151854|NCT04397484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25151855|NCT04397484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25151864|NCT04397484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25151865|NCT04397484|Respiratory System Agents|respiratory system agents|mesh-ancestor
25151866|NCT04397484|Mydriatics|mydriatics|mesh-ancestor
25151867|NCT04397484|Sympathomimetics|sympathomimetics|mesh-ancestor
25151868|NCT04397484|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25151877|NCT04394416|Imatinib Mesylate|imatinib mesylate|mesh-list
25151878|NCT04394416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25151879|NCT04394416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25151880|NCT04394416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25151881|NCT04394416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25151948|NCT04312503|Autonomic Agents|autonomic agents|mesh-ancestor
25151949|NCT04312503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25151961|NCT04312503|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25151962|NCT04312503|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25151963|NCT04312503|Adrenergic Agents|adrenergic agents|mesh-ancestor
25151965|NCT04310995|Diltiazem|diltiazem|mesh-list
25151966|NCT04310995|Isosorbide|isosorbide|mesh-list
25151967|NCT04310995|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25151968|NCT04310995|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25151969|NCT04310995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25151970|NCT04310995|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25151971|NCT04310995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25113494|NCT02759588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25113495|NCT02759588|Growth Inhibitors|growth inhibitors|mesh-ancestor
25113496|NCT02740179|Eplerenone|eplerenone|mesh-list
25151972|NCT04310995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25151973|NCT04310995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25151974|NCT04310995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151975|NCT04310995|Vasodilator Agents|vasodilator agents|mesh-ancestor
25151976|NCT04310995|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25151977|NCT04310995|Diuretics|diuretics|mesh-ancestor
25151978|NCT04310995|Natriuretic Agents|natriuretic agents|mesh-ancestor
25151979|NCT04310995|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25151980|NCT04310995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25151981|NCT04310995|Vitamin B Complex|vitamin b complex|mesh-ancestor
25151982|NCT04310995|Vitamins|vitamins|mesh-ancestor
25151983|NCT04310995|Micronutrients|micronutrients|mesh-ancestor
25113526|NCT02723955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25113527|NCT02723955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25113528|NCT02723955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25113529|NCT02714881|Certolizumab Pegol|certolizumab pegol|mesh-list
24997532|NCT04630210|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25152039|NCT04273776|GABA Agonists|gaba agonists|mesh-ancestor
25152041|NCT04273776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25152093|NCT04261218|Tubulin Modulators|tubulin modulators|mesh-ancestor
25152094|NCT04261218|Antimitotic Agents|antimitotic agents|mesh-ancestor
25152095|NCT04261218|Mitosis Modulators|mitosis modulators|mesh-ancestor
25152096|NCT04261218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25152097|NCT04257487|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
25152098|NCT04257487|Anticoagulants|anticoagulants|mesh-ancestor
25152099|NCT04257487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25152100|NCT04257487|Antimetabolites|antimetabolites|mesh-ancestor
25152101|NCT04257487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25152102|NCT04257487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25152103|NCT04257487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25152104|NCT04257487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25152105|NCT04257487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25152106|NCT04257487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031302|NCT03588767|Anabolic Agents|anabolic agents|mesh-ancestor
25031305|NCT03588715|Interferons|interferons|mesh-list
25031322|NCT03588676|Melatonin|melatonin|mesh-list
25152347|NCT04108858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25152348|NCT04106830|Mycophenolic Acid|mycophenolic acid|mesh-list
25152349|NCT04106830|Azathioprine|azathioprine|mesh-list
25152350|NCT04106830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25152351|NCT04106830|Immunologic Factors|immunologic factors|mesh-ancestor
25152352|NCT04106830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25152353|NCT04106830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25152354|NCT04106830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25152355|NCT04106830|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25152356|NCT04106830|Antitubercular Agents|antitubercular agents|mesh-ancestor
25152357|NCT04106830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25152358|NCT04106830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25152359|NCT04106830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25152360|NCT04106830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25152361|NCT04106830|Antimetabolites|antimetabolites|mesh-ancestor
25152362|NCT04106830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25152363|NCT04106830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24997557|NCT04592744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25031372|NCT03588351|Chelating Agents|chelating agents|mesh-ancestor
24997558|NCT04592744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24997559|NCT04592744|Autonomic Agents|autonomic agents|mesh-ancestor
24997560|NCT04592744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24997561|NCT04592744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24997562|NCT04592744|Respiratory System Agents|respiratory system agents|mesh-ancestor
24997563|NCT04592744|Mydriatics|mydriatics|mesh-ancestor
25048436|NCT00704483|Sevelamer|sevelamer|mesh-list
25048437|NCT00704483|Chelating Agents|chelating agents|mesh-ancestor
25048438|NCT00704483|Sequestering Agents|sequestering agents|mesh-ancestor
25048439|NCT00704483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048440|NCT00704483|Hematinics|hematinics|mesh-ancestor
25048441|NCT00704158|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
25048442|NCT00704158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25048443|NCT00704158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048444|NCT00701883|Atorvastatin|atorvastatin|mesh-list
25048445|NCT00701883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25048446|NCT00701883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25048447|NCT00701883|Antimetabolites|antimetabolites|mesh-ancestor
25048448|NCT00701883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048449|NCT00701883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25048450|NCT00701883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25048451|NCT00701883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048452|NCT00698789|Metformin|metformin|mesh-list
25048453|NCT00698789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25048454|NCT00698789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854816|NCT02275702|Hormones|hormones|mesh-ancestor
25152391|NCT04101227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25152392|NCT04101227|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25152412|NCT04090879|Cholinergic Agents|cholinergic agents|mesh-ancestor
25152413|NCT04090879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25152414|NCT04090879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25152420|NCT04083365|Capecitabine|capecitabine|mesh-list
25152421|NCT04083365|Durvalumab|durvalumab|mesh-list
25152514|NCT03994874|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25152562|NCT03958877|Interferon-beta|interferon-beta|mesh-list
25152563|NCT03958877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25152564|NCT03958877|Antiviral Agents|antiviral agents|mesh-ancestor
25152565|NCT03958877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25152566|NCT03958877|Immunologic Factors|immunologic factors|mesh-ancestor
25152567|NCT03958877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031480|NCT03587324|Purinergic Agents|purinergic agents|mesh-ancestor
25031481|NCT03587324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25031483|NCT03587324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25152720|NCT03813875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25152721|NCT03813875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25152722|NCT03813875|Anesthetics, General|anesthetics, general|mesh-ancestor
25152723|NCT03813875|Anesthetics|anesthetics|mesh-ancestor
25152724|NCT03813875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25152725|NCT03813875|Narcotics|narcotics|mesh-ancestor
25031496|NCT03587285|Androgen Antagonists|androgen antagonists|mesh-ancestor
25031498|NCT03587220|Capsaicin|capsaicin|mesh-list
25152726|NCT03813875|Analgesics|analgesics|mesh-ancestor
25152770|NCT03809442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25152773|NCT03809442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25152774|NCT03809442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25152775|NCT03809442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25152776|NCT03809442|Analgesics|analgesics|mesh-ancestor
25152777|NCT03809442|Sensory System Agents|sensory system agents|mesh-ancestor
25152778|NCT03809442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25152779|NCT03809442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25152780|NCT03809442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25152781|NCT03809442|Adrenergic Agents|adrenergic agents|mesh-ancestor
25152782|NCT03809442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25152783|NCT03809442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624187|NCT01075113|Sorafenib|sorafenib|mesh-list
25152885|NCT03748810|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25152887|NCT03748810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25152888|NCT03748810|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25152889|NCT03748810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25152890|NCT03748810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25152891|NCT03748810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25152892|NCT03748810|Immunologic Factors|immunologic factors|mesh-ancestor
25152894|NCT03748810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25152895|NCT03737981|Venetoclax|venetoclax|mesh-list
25152896|NCT03737981|Obinutuzumab|obinutuzumab|mesh-list
25152897|NCT03737981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25152898|NCT03737981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24561510|NCT00761228|Emetics|emetics|mesh-ancestor
25152974|NCT03600701|Immunologic Factors|immunologic factors|mesh-ancestor
25152975|NCT03600701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166648|NCT03828019|Cyclosporins|cyclosporins|mesh-list
24769618|NCT01814865|Hormone Antagonists|hormone antagonists|mesh-ancestor
24997636|NCT04546828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997637|NCT04546828|Antiviral Agents|antiviral agents|mesh-ancestor
24997638|NCT04546828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24997639|NCT04546828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25031586|NCT03586934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997640|NCT04546828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24997641|NCT04546828|Immunologic Factors|immunologic factors|mesh-ancestor
24997642|NCT04546828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935564|NCT04048889|Ropivacaine|ropivacaine|mesh-list
24935565|NCT04048889|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24935566|NCT04048889|Anesthetics, Local|anesthetics, local|mesh-ancestor
24935567|NCT04048889|Anesthetics|anesthetics|mesh-ancestor
24935568|NCT04048889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25152992|NCT03583866|Candesartan|candesartan|mesh-list
25152993|NCT03583866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25152994|NCT03583866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25153002|NCT03583333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153003|NCT03583164|Olorofim|olorofim|mesh-list
25153004|NCT03583164|Antifungal Agents|antifungal agents|mesh-ancestor
25153005|NCT03583164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25153006|NCT03580902|Buprenorphine|buprenorphine|mesh-list
25153034|NCT03532139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153035|NCT03532139|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25153036|NCT03532139|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25153037|NCT03532139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25153038|NCT03532139|Anticoagulants|anticoagulants|mesh-ancestor
25153039|NCT03532139|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25153040|NCT03532139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25153041|NCT03527576|Dexamethasone|dexamethasone|mesh-list
25153042|NCT03527576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25153043|NCT03527576|Antiemetics|antiemetics|mesh-ancestor
25153044|NCT03527576|Autonomic Agents|autonomic agents|mesh-ancestor
25153045|NCT03527576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25153046|NCT03527576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153047|NCT03527576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25153048|NCT03527576|Glucocorticoids|glucocorticoids|mesh-ancestor
25153049|NCT03527576|Hormones|hormones|mesh-ancestor
25153050|NCT03527576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25153051|NCT03527576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25153052|NCT03527576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25153092|NCT03504488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25153093|NCT03504488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153094|NCT03504488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25153096|NCT03502668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25153097|NCT03502668|Antimetabolites|antimetabolites|mesh-ancestor
25031658|NCT03586674|Antimetabolites|antimetabolites|mesh-ancestor
25153132|NCT03465787|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25153133|NCT03465787|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25153134|NCT03465787|Antidepressive Agents|antidepressive agents|mesh-ancestor
25153135|NCT03465787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25153136|NCT03465787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25153137|NCT03465787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25153138|NCT03465787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25153139|NCT03465787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153140|NCT03465787|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25153141|NCT03465787|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25153142|NCT03465787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25103652|NCT03159845|Antiviral Agents|antiviral agents|mesh-ancestor
25153182|NCT03382938|Sensory System Agents|sensory system agents|mesh-ancestor
25153183|NCT03382938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25153184|NCT03382938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25153207|NCT03377543|Antipyretics|antipyretics|mesh-ancestor
25153208|NCT03374956|Liraglutide|liraglutide|mesh-list
25153209|NCT03374956|Topiramate|topiramate|mesh-list
25153210|NCT03374956|Phentermine|phentermine|mesh-list
25153211|NCT03374956|Naltrexone|naltrexone|mesh-list
25153212|NCT03374956|Bupropion|bupropion|mesh-list
25153213|NCT03374956|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25153214|NCT03374956|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25153215|NCT03374956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153216|NCT03374956|Sensory System Agents|sensory system agents|mesh-ancestor
25153217|NCT03374956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25153218|NCT03374956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25153219|NCT03374956|Incretins|incretins|mesh-ancestor
25153220|NCT03374956|Hormones|hormones|mesh-ancestor
25153221|NCT03374956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25153222|NCT03374956|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25153223|NCT03374956|Antidepressive Agents|antidepressive agents|mesh-ancestor
25153224|NCT03374956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25153225|NCT03374956|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25153226|NCT03374956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25153227|NCT03374956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24437464|NCT00273702|Acetylcysteine|acetylcysteine|mesh-list
24416612|NCT00203567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24416706|NCT00203788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416707|NCT00203788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416708|NCT00203788|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24416709|NCT00203788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24416710|NCT00203788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24416711|NCT00203788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25829201|NCT00006154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25153228|NCT03374956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153230|NCT03374956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25153231|NCT03374956|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25153232|NCT03374956|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25153233|NCT03374956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25153234|NCT03374956|Anticonvulsants|anticonvulsants|mesh-ancestor
25153235|NCT03374956|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25153236|NCT03374956|Appetite Depressants|appetite depressants|mesh-ancestor
25153279|NCT03279952|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
25153280|NCT03279952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153317|NCT03253289|Meclizine|meclizine|mesh-list
25153318|NCT03253289|Antiemetics|antiemetics|mesh-ancestor
25153319|NCT03253289|Autonomic Agents|autonomic agents|mesh-ancestor
25153320|NCT03253289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25166649|NCT03828019|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25153321|NCT03253289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153322|NCT03253289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25153323|NCT03253289|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25153324|NCT03253289|Histamine Antagonists|histamine antagonists|mesh-ancestor
25153325|NCT03253289|Histamine Agents|histamine agents|mesh-ancestor
25153326|NCT03253289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25153790|NCT02374021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25153327|NCT03253289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153328|NCT03253289|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25153329|NCT03250832|Bevacizumab|bevacizumab|mesh-list
24966845|NCT03764553|Vitamins|vitamins|mesh-ancestor
25031761|NCT03585998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25031762|NCT03585998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25153455|NCT03088293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25153456|NCT03088293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25153457|NCT03088293|Alkylating Agents|alkylating agents|mesh-ancestor
25153458|NCT03088293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153459|NCT03088293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25153460|NCT03088293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25153461|NCT03088293|Dermatologic Agents|dermatologic agents|mesh-ancestor
25153462|NCT03088293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24561190|NCT00758732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25153545|NCT02863419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153547|NCT02863419|Hormones|hormones|mesh-ancestor
25153548|NCT02863419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24770060|NCT01817803|Metolazone|metolazone|mesh-list
25153582|NCT02764762|Antimetabolites|antimetabolites|mesh-ancestor
25153583|NCT02764762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153584|NCT02764762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25153585|NCT02764762|Dermatologic Agents|dermatologic agents|mesh-ancestor
25153586|NCT02764762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25153587|NCT02764762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25153588|NCT02764762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25153589|NCT02764762|Immunologic Factors|immunologic factors|mesh-ancestor
25153590|NCT02764762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25153591|NCT02764762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25153592|NCT02764762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25153593|NCT02764762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24770122|NCT01818232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25153624|NCT02652052|Dasatinib|dasatinib|mesh-list
25153625|NCT02652052|Quercetin|quercetin|mesh-list
25153626|NCT02652052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25650383|NCT01502293|Immunologic Factors|immunologic factors|mesh-ancestor
25650384|NCT01502293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650385|NCT01502293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25650386|NCT01502293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25650387|NCT01502293|Growth Substances|growth substances|mesh-ancestor
25650388|NCT01502293|Growth Inhibitors|growth inhibitors|mesh-ancestor
25650389|NCT01502293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25650390|NCT01502306|Nicotine|nicotine|mesh-list
25829202|NCT00006154|Protease Inhibitors|protease inhibitors|mesh-ancestor
25153627|NCT02652052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25153628|NCT02652052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25153629|NCT02652052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153630|NCT02652052|Antioxidants|antioxidants|mesh-ancestor
25153631|NCT02652052|Protective Agents|protective agents|mesh-ancestor
25153632|NCT02652052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153633|NCT02607865|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25153634|NCT02607865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25153635|NCT02607865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153636|NCT02607865|Incretins|incretins|mesh-ancestor
25153637|NCT02607865|Hormones|hormones|mesh-ancestor
25153638|NCT02607865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25153639|NCT02607865|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25153640|NCT02607865|Protease Inhibitors|protease inhibitors|mesh-ancestor
25153641|NCT02607865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25153690|NCT02500147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997758|NCT04429685|Sensory System Agents|sensory system agents|mesh-ancestor
24997759|NCT04429685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24997760|NCT04429685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997761|NCT04429685|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25153771|NCT02374021|Antimetabolites|antimetabolites|mesh-ancestor
25153772|NCT02374021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153773|NCT02374021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25153774|NCT02374021|Dermatologic Agents|dermatologic agents|mesh-ancestor
25153775|NCT02374021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25153776|NCT02374021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25153777|NCT02374021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25153778|NCT02374021|Immunologic Factors|immunologic factors|mesh-ancestor
25153779|NCT02374021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25153780|NCT02374021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25153781|NCT02374021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25153782|NCT02374021|Antimalarials|antimalarials|mesh-ancestor
25153783|NCT02374021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25153784|NCT02374021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25153785|NCT02374021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25153786|NCT02374021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25153787|NCT02374021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25153788|NCT02374021|Analgesics|analgesics|mesh-ancestor
25153789|NCT02374021|Sensory System Agents|sensory system agents|mesh-ancestor
25153791|NCT02374021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25153876|NCT02116335|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25153877|NCT02116335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153880|NCT02115724|Thioctic Acid|thioctic acid|mesh-list
25153881|NCT02115724|Nitroglycerin|nitroglycerin|mesh-list
25153882|NCT02115724|Antioxidants|antioxidants|mesh-list
25153883|NCT02115724|Micronutrients|micronutrients|mesh-ancestor
25153884|NCT02115724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153885|NCT02115724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153886|NCT02115724|Protective Agents|protective agents|mesh-ancestor
25153887|NCT02115724|Vitamin B Complex|vitamin b complex|mesh-ancestor
25153888|NCT02115724|Vasodilator Agents|vasodilator agents|mesh-ancestor
24997810|NCT04326439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24997811|NCT04326439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24997812|NCT04326439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24997813|NCT04326439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24997814|NCT04326439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24997815|NCT04326439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997816|NCT04326439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24997817|NCT04326439|Antimetabolites|antimetabolites|mesh-ancestor
25153998|NCT01880957|Lamotrigine|lamotrigine|mesh-list
25153999|NCT01880957|Lithium Carbonate|lithium carbonate|mesh-list
25154000|NCT01880957|Antidepressive Agents|antidepressive agents|mesh-ancestor
25154001|NCT01880957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25154002|NCT01880957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25154050|NCT01803152|Interferon Inducers|interferon inducers|mesh-ancestor
25154051|NCT01715974|Molgramostim|molgramostim|mesh-list
25154052|NCT01715974|Sargramostim|sargramostim|mesh-list
25154053|NCT01715974|Immunologic Factors|immunologic factors|mesh-ancestor
25154054|NCT01715974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154055|NCT01715974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25154056|NCT01703949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25154057|NCT01703949|Nivolumab|nivolumab|mesh-list
25154058|NCT01703949|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25829203|NCT00006154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24997824|NCT04326439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24997825|NCT04326439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24997827|NCT04311632|Tacrolimus|tacrolimus|mesh-list
24997828|NCT04311632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24997829|NCT04311632|Immunologic Factors|immunologic factors|mesh-ancestor
24997830|NCT04311632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997831|NCT04311632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24997832|NCT04311632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24997833|NCT04311632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997834|NCT04311632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24997835|NCT04311632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24997836|NCT04311632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24997837|NCT04311632|Antitubercular Agents|antitubercular agents|mesh-ancestor
24997838|NCT04311632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24997839|NCT04311632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25154142|NCT01413100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25154143|NCT01413100|Immunologic Factors|immunologic factors|mesh-ancestor
25154144|NCT01413100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154145|NCT01413100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25154146|NCT01413100|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25154147|NCT01413100|Alkylating Agents|alkylating agents|mesh-ancestor
25154148|NCT01413100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770572|NCT01821235|Gabapentin|gabapentin|mesh-list
25154446|NCT00265798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25154447|NCT00265798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032203|NCT03583229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25032204|NCT03583229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032205|NCT03583229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24598661|NCT00957190|Adrenergic Agents|adrenergic agents|mesh-ancestor
24598722|NCT00957411|Cetuximab|cetuximab|mesh-list
25032207|NCT03583229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24856636|NCT02285829|Bromides|bromides|mesh-list
24997919|NCT04146298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997920|NCT04146298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24997921|NCT04146298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24997943|NCT04099641|Bavituximab|bavituximab|mesh-list
24997944|NCT04099641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24997945|NCT04099641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24997947|NCT04098302|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24997948|NCT04098302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24997949|NCT04098302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24997950|NCT04098302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997951|NCT04098302|Hormone Antagonists|hormone antagonists|mesh-ancestor
24997952|NCT04098302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24997953|NCT04098302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032252|NCT03582878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032253|NCT03582865|Tamoxifen|tamoxifen|mesh-list
25032254|NCT03582865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25032255|NCT03582865|Hormone Antagonists|hormone antagonists|mesh-ancestor
25032257|NCT03582865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997994|NCT04038255|Nicotine|nicotine|mesh-list
24997995|NCT04038255|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24998063|NCT03841565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650391|NCT01502306|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24422759|NCT00223691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24422854|NCT00223717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24422887|NCT00223717|Tocolytic Agents|tocolytic agents|mesh-ancestor
24998064|NCT03841565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825055|NCT02127060|Ascorbic Acid|ascorbic acid|mesh-list
24825149|NCT02127697|Albuterol|albuterol|mesh-list
24979678|NCT03032510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24980032|NCT04671875|Antibodies|antibodies|mesh-list
24998087|NCT03722849|Sensory System Agents|sensory system agents|mesh-ancestor
24998088|NCT03722849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24771003|NCT01824199|Omeprazole|omeprazole|mesh-list
24981390|NCT03564470|Dasatinib|dasatinib|mesh-list
24981391|NCT03564470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771037|NCT01824264|Hormones|hormones|mesh-ancestor
24795742|NCT00003641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795743|NCT01945840|Hormones|hormones|mesh-list
24795744|NCT01945840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24795745|NCT01945840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795746|NCT01945879|Heparin|heparin|mesh-list
24795747|NCT01945879|Enoxaparin|enoxaparin|mesh-list
24795748|NCT01945879|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24795749|NCT01945879|Tinzaparin|tinzaparin|mesh-list
24795750|NCT01945879|Dalteparin|dalteparin|mesh-list
24795751|NCT01945879|Anticoagulants|anticoagulants|mesh-ancestor
24795752|NCT01945879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24795753|NCT01945879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24795754|NCT01945879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795755|NCT01945892|Dexamethasone|dexamethasone|mesh-list
24795756|NCT01945892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24982310|NCT03135249|Alemtuzumab|alemtuzumab|mesh-list
24982311|NCT03135249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24982312|NCT03135249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24982313|NCT03132675|Pembrolizumab|pembrolizumab|mesh-list
24771078|NCT01824524|Hydromorphone|hydromorphone|mesh-list
24747524|NCT00644228|Antiemetics|antiemetics|mesh-ancestor
25048506|NCT00694135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829119|NCT02149953|Glycine|glycine|mesh-list
24829800|NCT02154594|Chlorhexidine|chlorhexidine|mesh-list
24589284|NCT00906516|Bevacizumab|bevacizumab|mesh-list
25048509|NCT00692484|Povidone-Iodine|povidone-iodine|mesh-list
25048510|NCT00692484|Povidone|povidone|mesh-list
25048511|NCT00692484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25048512|NCT00692484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25048513|NCT00692484|Disinfectants|disinfectants|mesh-ancestor
25048514|NCT00692484|Dermatologic Agents|dermatologic agents|mesh-ancestor
25048515|NCT00692484|Plasma Substitutes|plasma substitutes|mesh-ancestor
24984355|NCT04595266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984356|NCT04595266|Growth Inhibitors|growth inhibitors|mesh-ancestor
24984357|NCT04595266|Antimetabolites|antimetabolites|mesh-ancestor
24984358|NCT04595266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984359|NCT04595266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24984360|NCT04595266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24984361|NCT04595266|Immunologic Factors|immunologic factors|mesh-ancestor
25048516|NCT00692484|Blood Substitutes|blood substitutes|mesh-ancestor
24984555|NCT04412785|Cyclosporine|cyclosporine|mesh-list
24984630|NCT04296942|Trastuzumab|trastuzumab|mesh-list
25048518|NCT00692445|Dexetimide|dexetimide|mesh-list
25048519|NCT00692445|Citalopram|citalopram|mesh-list
25048520|NCT00692445|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25048521|NCT00692445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25048522|NCT00692445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25166650|NCT03828019|Abortifacient Agents|abortifacient agents|mesh-ancestor
25048523|NCT00692445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048524|NCT00692445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25048525|NCT00692445|Serotonin Agents|serotonin agents|mesh-ancestor
24784872|NCT01910766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24784873|NCT01910766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784875|NCT01910766|Fertility Agents|fertility agents|mesh-ancestor
25032341|NCT03581630|Dopamine Agents|dopamine agents|mesh-ancestor
24784876|NCT01910766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24966978|NCT03763760|Hormones|hormones|mesh-ancestor
24942762|NCT03978559|Antifungal Agents|antifungal agents|mesh-ancestor
24998124|NCT03654716|Cytarabine|cytarabine|mesh-list
24998125|NCT03654716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25650392|NCT01502306|Autonomic Agents|autonomic agents|mesh-ancestor
25650393|NCT01502306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24998126|NCT03654716|Antimetabolites|antimetabolites|mesh-ancestor
24998127|NCT03654716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650394|NCT01502306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423144|NCT00224809|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24423145|NCT00224809|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24423146|NCT00224809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24998128|NCT03654716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998129|NCT03654716|Antiviral Agents|antiviral agents|mesh-ancestor
24998130|NCT03654716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24998131|NCT03654716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24998132|NCT03654716|Immunologic Factors|immunologic factors|mesh-ancestor
24998133|NCT03654716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998134|NCT03645928|Pembrolizumab|pembrolizumab|mesh-list
24998135|NCT03645928|Nivolumab|nivolumab|mesh-list
24998136|NCT03645928|Ipilimumab|ipilimumab|mesh-list
24998137|NCT03645928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24998138|NCT03645928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998139|NCT03645928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24998140|NCT03645928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998141|NCT03612713|Oxycodone|oxycodone|mesh-list
24988536|NCT02432560|Sirolimus|sirolimus|mesh-list
24835795|NCT02183402|Linagliptin|linagliptin|mesh-list
24988805|NCT00033293|Prednisone|prednisone|mesh-list
24771174|NCT01825044|Cyclosporine|cyclosporine|mesh-list
24798279|NCT01962181|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24771262|NCT01825603|Immunologic Factors|immunologic factors|mesh-ancestor
24998209|NCT03430531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24998210|NCT03430531|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24998211|NCT03430531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24998212|NCT03430531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24998213|NCT03430531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998215|NCT03409198|Doxorubicin|doxorubicin|mesh-list
24998216|NCT03409198|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24995055|NCT05418348|Vasodilator Agents|vasodilator agents|mesh-ancestor
25048550|NCT00691964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24998267|NCT03243058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996102|NCT04249310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24997142|NCT05395494|Antitubercular Agents|antitubercular agents|mesh-ancestor
24998273|NCT03243058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24998274|NCT03243058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24936112|NCT04043897|Rifaximin|rifaximin|mesh-list
24998275|NCT03243058|Antiviral Agents|antiviral agents|mesh-ancestor
24998276|NCT03243058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24998277|NCT03181386|Warfarin|warfarin|mesh-list
24998278|NCT03181386|Rivaroxaban|rivaroxaban|mesh-list
24998279|NCT03181386|Dabigatran|dabigatran|mesh-list
24998280|NCT03181386|Apixaban|apixaban|mesh-list
24998281|NCT03181386|Anticoagulants|anticoagulants|mesh-ancestor
24998282|NCT03181386|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24998283|NCT03181386|Antithrombins|antithrombins|mesh-ancestor
24998284|NCT03181386|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24998285|NCT03181386|Protease Inhibitors|protease inhibitors|mesh-ancestor
24998286|NCT03181386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25032416|NCT03580889|Autonomic Agents|autonomic agents|mesh-ancestor
24998287|NCT03181386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998288|NCT03170180|Sunitinib|sunitinib|mesh-list
24998289|NCT03170180|Imatinib Mesylate|imatinib mesylate|mesh-list
24998290|NCT03170180|Gefitinib|gefitinib|mesh-list
24961919|NCT03804359|Immunologic Factors|immunologic factors|mesh-ancestor
24998291|NCT03170180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998292|NCT03170180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24998293|NCT03170180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24998294|NCT03170180|Growth Substances|growth substances|mesh-ancestor
24998295|NCT03170180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998296|NCT03170180|Growth Inhibitors|growth inhibitors|mesh-ancestor
24998297|NCT03170180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24998298|NCT03170180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998299|NCT03170180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998300|NCT03164993|Cyclophosphamide|cyclophosphamide|mesh-list
24998301|NCT03164993|Doxorubicin|doxorubicin|mesh-list
24998302|NCT03164993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24998303|NCT03164993|Atezolizumab|atezolizumab|mesh-list
24998304|NCT03164993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25650395|NCT01502306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25650396|NCT01502306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25650397|NCT01502306|Cholinergic Agents|cholinergic agents|mesh-ancestor
24998305|NCT03164993|Immunologic Factors|immunologic factors|mesh-ancestor
24847736|NCT02248454|Insulin Lispro|insulin lispro|mesh-list
24851344|NCT02256722|Propranolol|propranolol|mesh-list
24877294|NCT02856451|Nivolumab|nivolumab|mesh-list
24812224|NCT02050594|Ipilimumab|ipilimumab|mesh-list
24851580|NCT02257398|Moxifloxacin|moxifloxacin|mesh-list
25650398|NCT01502306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24578939|NCT00852436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24851686|NCT02258204|Ketamine|ketamine|mesh-list
24611766|NCT01010646|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
24815975|NCT02073084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24815976|NCT02073084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815977|NCT02073084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815978|NCT02073084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887513|NCT04515836|Olaparib|olaparib|mesh-list
25048547|NCT00691964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048548|NCT00691964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25048549|NCT00691964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24786815|NCT01921946|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25048555|NCT00691717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25048556|NCT00691717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25048557|NCT00691717|Growth Substances|growth substances|mesh-ancestor
25048558|NCT00691717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048559|NCT00691717|Growth Inhibitors|growth inhibitors|mesh-ancestor
25048560|NCT00691717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048561|NCT00691717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25048562|NCT00690456|Metformin|metformin|mesh-list
25048563|NCT00690456|Rimonabant|rimonabant|mesh-list
25048564|NCT00690456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25048565|NCT00690456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048566|NCT00690456|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24905944|NCT04343742|Chlorine dioxide|chlorine dioxide|mesh-list
24906436|NCT04340908|Dapagliflozin|dapagliflozin|mesh-list
24482290|NCT00438386|Dopamine Agonists|dopamine agonists|mesh-ancestor
24908622|NCT04318652|Antiemetics|antiemetics|mesh-ancestor
24998345|NCT03110484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24998346|NCT03110328|Pembrolizumab|pembrolizumab|mesh-list
24998347|NCT03110328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24998348|NCT03110328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998349|NCT03086538|Pemetrexed|pemetrexed|mesh-list
24998350|NCT03086538|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24998351|NCT03086538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998352|NCT03086538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998353|NCT03086538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998354|NCT03086538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24998355|NCT03086538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24998356|NCT03086538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24998357|NCT03069378|Pembrolizumab|pembrolizumab|mesh-list
24998358|NCT03069378|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
24998359|NCT03069378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24936263|NCT04042506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24936264|NCT04042506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24936265|NCT04042506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936267|NCT04042441|Insulin Aspart|insulin aspart|mesh-list
24936268|NCT04042441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24941596|NCT03989310|Mitosis Modulators|mitosis modulators|mesh-ancestor
24941597|NCT03989310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941598|NCT03989310|Immunologic Factors|immunologic factors|mesh-ancestor
24941599|NCT03989310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941600|NCT03989310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24941601|NCT03989310|Antimetabolites|antimetabolites|mesh-ancestor
24941602|NCT03989310|Antiviral Agents|antiviral agents|mesh-ancestor
24941603|NCT03989310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25050818|NCT00465959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24941608|NCT03989700|Thiamine|thiamine|mesh-list
24941609|NCT03989700|Vitamins|vitamins|mesh-ancestor
24941610|NCT03989700|Micronutrients|micronutrients|mesh-ancestor
24941611|NCT03989700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941646|NCT03989089|Pembrolizumab|pembrolizumab|mesh-list
24941647|NCT03989089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24854912|NCT02276300|Imiquimod|imiquimod|mesh-list
25051091|NCT00442039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25051092|NCT00442039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051094|NCT00441896|Neurosteroids|neurosteroids|mesh-ancestor
25051095|NCT00441896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25051096|NCT00441896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856002|NCT02282098|Mitosis Modulators|mitosis modulators|mesh-ancestor
24942945|NCT03976102|Immunologic Factors|immunologic factors|mesh-ancestor
24942946|NCT03976102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942947|NCT03976102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24943067|NCT03974789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051183|NCT00434811|Antifungal Agents|antifungal agents|mesh-ancestor
24943068|NCT03974789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24425678|NCT00234000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24943069|NCT03974789|Glucocorticoids|glucocorticoids|mesh-ancestor
24943070|NCT03974789|Hormones|hormones|mesh-ancestor
24943071|NCT03974789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24943072|NCT03974789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24943553|NCT03969758|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24943832|NCT03966547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24943833|NCT03966547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943834|NCT03966547|Sensory System Agents|sensory system agents|mesh-ancestor
24943835|NCT03966547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24943836|NCT03966378|Grape Seed Extract|grape seed extract|mesh-list
24943866|NCT03966326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943867|NCT03966326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24943868|NCT03966326|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24943869|NCT03966326|Anesthetics, General|anesthetics, general|mesh-ancestor
24943870|NCT03966326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25051234|NCT00430508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25051235|NCT00430508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051236|NCT00430508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25051237|NCT00430508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25051238|NCT00430092|Fluprednisolone|fluprednisolone|mesh-list
25051239|NCT00430092|Difluprednate|difluprednate|mesh-list
25051240|NCT00430092|Glucocorticoids|glucocorticoids|mesh-ancestor
25051241|NCT00430092|Hormones|hormones|mesh-ancestor
25051242|NCT00430092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24945251|NCT03952572|Tubulin Modulators|tubulin modulators|mesh-ancestor
24771731|NCT01829334|Listerine|listerine|mesh-list
25051378|NCT00411528|Antimitotic Agents|antimitotic agents|mesh-ancestor
25051379|NCT00411528|Mitosis Modulators|mitosis modulators|mesh-ancestor
25051380|NCT00411528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945320|NCT03951597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946036|NCT03943823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946037|NCT03943472|Cyclophosphamide|cyclophosphamide|mesh-list
24946038|NCT03943472|Fludarabine|fludarabine|mesh-list
24946039|NCT03943472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24946040|NCT03943472|Immunologic Factors|immunologic factors|mesh-ancestor
24946041|NCT03943472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946066|NCT03943407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24946067|NCT03943407|Immunologic Factors|immunologic factors|mesh-ancestor
24946068|NCT03943407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24946069|NCT03943407|Interferon Inducers|interferon inducers|mesh-ancestor
24946070|NCT03943407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24946071|NCT03943407|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24946072|NCT03943407|Protective Agents|protective agents|mesh-ancestor
24625999|NCT01084980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051440|NCT00403416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24961912|NCT03804723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24961913|NCT03804723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961914|NCT03804723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24961915|NCT03804723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24961917|NCT03804359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24961918|NCT03804359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24961920|NCT03804359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961922|NCT03804034|Molybdenum|molybdenum|mesh-list
24961923|NCT03804034|Trace Elements|trace elements|mesh-ancestor
24961924|NCT03804034|Micronutrients|micronutrients|mesh-ancestor
24946310|NCT03940742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24946311|NCT03940742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946312|NCT03940742|Incretins|incretins|mesh-ancestor
24946313|NCT03940742|Hormones|hormones|mesh-ancestor
24946314|NCT03940742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24946315|NCT03940664|Formaldehyde|formaldehyde|mesh-list
24946316|NCT03940664|Disinfectants|disinfectants|mesh-ancestor
24946317|NCT03940664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24946318|NCT03940807|Estradiol|estradiol|mesh-list
24946319|NCT03940807|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24946320|NCT03940807|Estrogens|estrogens|mesh-ancestor
24946321|NCT03940807|Hormones|hormones|mesh-ancestor
24946322|NCT03940807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24946323|NCT03940807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946324|NCT03940651|Anesthetics|anesthetics|mesh-list
25650399|NCT01502306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946325|NCT03940651|Anesthetics, General|anesthetics, general|mesh-list
24946326|NCT03940651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24946327|NCT03940651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946400|NCT03939884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24946401|NCT03939884|Analgesics|analgesics|mesh-ancestor
25032659|NCT03579758|Gemcitabine|gemcitabine|mesh-list
24946402|NCT03939884|Sensory System Agents|sensory system agents|mesh-ancestor
24946403|NCT03939884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24946437|NCT03939975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24946438|NCT03939975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800710|NCT01977989|Vancomycin|vancomycin|mesh-list
24626065|NCT01085487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24626066|NCT01085487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626067|NCT01085487|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24626068|NCT01085487|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24626070|NCT01085487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24626071|NCT01085487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771955|NCT01830530|Tocolytic Agents|tocolytic agents|mesh-ancestor
24964356|NCT03783728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964358|NCT03783728|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24964359|NCT03783728|Leprostatic Agents|leprostatic agents|mesh-ancestor
24964360|NCT03783754|Amlodipine|amlodipine|mesh-list
24964361|NCT03783754|Telmisartan|telmisartan|mesh-list
24964362|NCT03783754|Indapamide|indapamide|mesh-list
24964363|NCT03783754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24964364|NCT03783754|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24948846|NCT05401721|Arginine Vasopressin|arginine vasopressin|mesh-list
24948848|NCT05401721|Coagulants|coagulants|mesh-ancestor
24948849|NCT05401721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24948850|NCT05401721|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25051743|NCT00383422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24948916|NCT05401071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948918|NCT05401071|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24771996|NCT01830868|Zonisamide|zonisamide|mesh-list
24949640|NCT04006288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24949641|NCT04006288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24949643|NCT04006288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24949682|NCT03829332|Pembrolizumab|pembrolizumab|mesh-list
24949683|NCT03829332|Lenvatinib|lenvatinib|mesh-list
24949684|NCT03829332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24949685|NCT03829332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24949686|NCT03829332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24949687|NCT03829332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24949688|NCT03829332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772111|NCT01831661|Metformin|metformin|mesh-list
24950506|NCT03915132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052196|NCT00319969|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25052197|NCT00319969|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25052198|NCT00319969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25113674|NCT02392429|Antimetabolites|antimetabolites|mesh-ancestor
25052199|NCT00319969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052200|NCT00319969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052201|NCT00318656|Metformin|metformin|mesh-list
25052471|NCT00267280|Simvastatin|simvastatin|mesh-list
25052472|NCT00267280|Torcetrapib|torcetrapib|mesh-list
25052476|NCT00267280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806676|NCT02017405|Antibodies|antibodies|mesh-list
25052572|NCT00254891|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25052573|NCT00254891|Carboplatin|carboplatin|mesh-list
25052574|NCT00254891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25052575|NCT00254891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052576|NCT00254891|Tubulin Modulators|tubulin modulators|mesh-ancestor
25052577|NCT00254891|Antimitotic Agents|antimitotic agents|mesh-ancestor
25052578|NCT00254891|Mitosis Modulators|mitosis modulators|mesh-ancestor
24601665|NCT00965393|Bradykinin|bradykinin|mesh-list
25053322|NCT00065728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25062084|NCT05323149|Tranexamic Acid|tranexamic acid|mesh-list
25062085|NCT05323149|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25829651|NCT00006245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062136|NCT05272683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25062137|NCT05272683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062138|NCT05272683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25062140|NCT05255900|Antimetabolites|antimetabolites|mesh-ancestor
25062141|NCT05255900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419388|NCT00212017|Voglibose|voglibose|mesh-list
25062142|NCT05255900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824665|NCT02124525|Antioxidants|antioxidants|mesh-ancestor
24953228|NCT03887260|Fentanyl|fentanyl|mesh-list
24953229|NCT03887260|Morphine|morphine|mesh-list
24953230|NCT03887260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24953231|NCT03887260|Narcotics|narcotics|mesh-ancestor
24953232|NCT03887260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24953233|NCT03887260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063717|NCT03466528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25032765|NCT03578822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032766|NCT03578822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25032767|NCT03578822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25032768|NCT03578822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24989441|NCT05224050|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24989446|NCT05200143|Nivolumab|nivolumab|mesh-list
25063718|NCT03466528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25063719|NCT03466528|Anticonvulsants|anticonvulsants|mesh-ancestor
25829204|NCT00006154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443455|NCT00294996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829205|NCT00006154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25829206|NCT00006154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25829207|NCT00006154|Antiviral Agents|antiviral agents|mesh-ancestor
25829208|NCT00006154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25829209|NCT00006154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25032779|NCT03578640|Antiviral Agents|antiviral agents|mesh-ancestor
25048715|NCT00673478|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25067277|NCT03444831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25067278|NCT03444662|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
25067279|NCT03444662|Nootropic Agents|nootropic agents|mesh-ancestor
25067281|NCT03444649|Daunorubicin|daunorubicin|mesh-list
25067282|NCT03444649|Idarubicin|idarubicin|mesh-list
25067283|NCT03444649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25067380|NCT03443999|Immunologic Factors|immunologic factors|mesh-ancestor
25067381|NCT03443999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067383|NCT03443960|Cyclobenzaprine|cyclobenzaprine|mesh-list
25068846|NCT03431285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25068847|NCT03431285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068848|NCT03431285|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25068849|NCT03431285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25068850|NCT03431285|Anesthetics, General|anesthetics, general|mesh-ancestor
25068851|NCT03431285|Anesthetics|anesthetics|mesh-ancestor
25068852|NCT03431285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25068853|NCT03431285|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25068854|NCT03431285|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25068855|NCT03431285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24831368|NCT02165033|Budesonide|budesonide|mesh-list
25068930|NCT03430661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25068931|NCT03430661|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25068962|NCT03430505|Adrenergic Agents|adrenergic agents|mesh-ancestor
25068963|NCT03430505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25068964|NCT03430505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068965|NCT03430466|Fulvestrant|fulvestrant|mesh-list
25068966|NCT03430466|Tremelimumab|tremelimumab|mesh-list
25068967|NCT03430466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25068968|NCT03430466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25068969|NCT03430466|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25068970|NCT03430466|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25068971|NCT03430466|Hormone Antagonists|hormone antagonists|mesh-ancestor
25068999|NCT03430024|Estrogens|estrogens|mesh-list
25069000|NCT03430024|Hormones|hormones|mesh-ancestor
25070905|NCT03415191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25070906|NCT03415191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25070907|NCT03415191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25070908|NCT03415191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25070909|NCT03415191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070910|NCT03415087|Fentanyl|fentanyl|mesh-list
25070947|NCT03414879|Ketamine|ketamine|mesh-list
25070948|NCT03414879|Anesthetics, Local|anesthetics, local|mesh-ancestor
24833759|NCT02175420|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25071192|NCT03412500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25071195|NCT03412474|Bupivacaine|bupivacaine|mesh-list
25071196|NCT03412474|Anesthetics, Local|anesthetics, local|mesh-ancestor
25071197|NCT03412474|Anesthetics|anesthetics|mesh-ancestor
25071198|NCT03412474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25071199|NCT03412474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650400|NCT01502410|Sorafenib|sorafenib|mesh-list
25071200|NCT03412474|Sensory System Agents|sensory system agents|mesh-ancestor
25071201|NCT03412474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25071202|NCT03412474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25071203|NCT03412474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25071204|NCT03412474|Analgesics|analgesics|mesh-ancestor
25071205|NCT03412474|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25071206|NCT03412474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25071207|NCT03412474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25071208|NCT03412474|Adrenergic Agents|adrenergic agents|mesh-ancestor
25071209|NCT03412474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24564095|NCT00775086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072072|NCT03403790|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24620719|NCT01058577|Hormones|hormones|mesh-ancestor
25074325|NCT03389061|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25074326|NCT03389061|Antiviral Agents|antiviral agents|mesh-ancestor
24837296|NCT02190838|Metformin|metformin|mesh-list
25074363|NCT03388892|Tubulin Modulators|tubulin modulators|mesh-ancestor
25074364|NCT03388892|Antimitotic Agents|antimitotic agents|mesh-ancestor
25074365|NCT03388892|Mitosis Modulators|mitosis modulators|mesh-ancestor
25074366|NCT03388892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074367|NCT03388866|Immunologic Factors|immunologic factors|mesh-list
25074437|NCT03388463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074438|NCT03388372|Temozolomide|temozolomide|mesh-list
25074439|NCT03388372|Nimotuzumab|nimotuzumab|mesh-list
25074440|NCT03388372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25074441|NCT03388372|Alkylating Agents|alkylating agents|mesh-ancestor
25074442|NCT03388372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074443|NCT03388372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25074444|NCT03388372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24954194|NCT03878693|Antidotes|antidotes|mesh-ancestor
24954195|NCT03878693|Protective Agents|protective agents|mesh-ancestor
24954196|NCT03878693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954197|NCT03878693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24954198|NCT03878693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954199|NCT03878667|Calcium, Dietary|calcium, dietary|mesh-list
24954200|NCT03878667|Calcium Carbonate|calcium carbonate|mesh-list
24954202|NCT03878667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24772973|NCT01837108|Eplerenone|eplerenone|mesh-list
25074639|NCT03387098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25074640|NCT03387098|Tubulin Modulators|tubulin modulators|mesh-ancestor
25074641|NCT03387098|Antimitotic Agents|antimitotic agents|mesh-ancestor
25074642|NCT03387098|Mitosis Modulators|mitosis modulators|mesh-ancestor
24837670|NCT02192710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954238|NCT03877718|Serotonin Agents|serotonin agents|mesh-ancestor
24954239|NCT03877718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24954240|NCT03877718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954241|NCT03877718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954242|NCT03877718|Antipruritics|antipruritics|mesh-ancestor
25075087|NCT03383393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25075088|NCT03383393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075089|NCT03383393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24838215|NCT02196155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25075122|NCT03383315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25075124|NCT03383315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25075125|NCT03383315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075126|NCT03383315|Analgesics|analgesics|mesh-ancestor
25075127|NCT03383315|Sensory System Agents|sensory system agents|mesh-ancestor
25075128|NCT03383315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25075129|NCT03383315|Antiemetics|antiemetics|mesh-ancestor
25075315|NCT03381781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25075316|NCT03381781|Immunologic Factors|immunologic factors|mesh-ancestor
25075317|NCT03381781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075318|NCT03381781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075319|NCT03381755|Ticagrelor|ticagrelor|mesh-list
25075320|NCT03381755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25075321|NCT03381755|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25075322|NCT03381755|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25075323|NCT03381755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25075324|NCT03381755|Purinergic Agents|purinergic agents|mesh-ancestor
25075359|NCT03381664|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25081154|NCT03332602|Fesoterodine|fesoterodine|mesh-list
25075576|NCT03380039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25075577|NCT03380039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25075753|NCT03378427|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25075754|NCT03378427|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25075756|NCT03378427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25075789|NCT03378297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773153|NCT01837927|Glycopyrrolate|glycopyrrolate|mesh-list
24998614|NCT02447419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24998615|NCT02447419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998616|NCT02447419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998617|NCT02447406|Docetaxel|docetaxel|mesh-list
24998618|NCT02447406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998619|NCT02447406|Tubulin Modulators|tubulin modulators|mesh-ancestor
24998653|NCT02232087|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24998654|NCT02232087|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24998726|NCT01376427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24998727|NCT01376427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24998762|NCT00979212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24998763|NCT00777491|Gemcitabine|gemcitabine|mesh-list
24998764|NCT00777491|Cisplatin|cisplatin|mesh-list
24999025|NCT05322902|Propofol|propofol|mesh-list
25032870|NCT03577652|Purinergic Agents|purinergic agents|mesh-ancestor
25048712|NCT00674440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048713|NCT00674440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048714|NCT00673478|Tiotropium Bromide|tiotropium bromide|mesh-list
24798451|NCT01963741|Histamine Agonists|histamine agonists|mesh-ancestor
24798452|NCT01963741|Histamine Agents|histamine agents|mesh-ancestor
24999820|NCT03121014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25000093|NCT01827553|Immunologic Factors|immunologic factors|mesh-ancestor
25032908|NCT03577184|Metformin|metformin|mesh-list
25000094|NCT01827553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000096|NCT01700673|Sargramostim|sargramostim|mesh-list
25000112|NCT00979693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25000114|NCT00799058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25000115|NCT00799058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25000116|NCT00799058|Antiviral Agents|antiviral agents|mesh-ancestor
25000117|NCT00799058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25000118|NCT00775476|Acetylcysteine|acetylcysteine|mesh-list
25000119|NCT00775476|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25000120|NCT00775476|Antiviral Agents|antiviral agents|mesh-ancestor
25000121|NCT00775476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25000122|NCT00775476|Expectorants|expectorants|mesh-ancestor
25000123|NCT00775476|Respiratory System Agents|respiratory system agents|mesh-ancestor
25000124|NCT00775476|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25000125|NCT00775476|Antioxidants|antioxidants|mesh-ancestor
25000126|NCT00775476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000229|NCT04323436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25000230|NCT04323436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000231|NCT04323436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24938222|NCT04020666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938223|NCT04020653|Ferrous citrate|ferrous citrate|mesh-list
25000790|NCT03342027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25001104|NCT05461261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25001105|NCT05461261|Antiemetics|antiemetics|mesh-ancestor
25001106|NCT05461261|Autonomic Agents|autonomic agents|mesh-ancestor
25001107|NCT05461261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773661|NCT01841294|Lidocaine|lidocaine|mesh-list
25049056|NCT00641732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25049058|NCT00641732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049059|NCT00640484|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25049060|NCT00640484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25049061|NCT00640484|Autonomic Agents|autonomic agents|mesh-ancestor
25032931|NCT03576911|Ubiquinone|ubiquinone|mesh-list
25049062|NCT00640484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25049063|NCT00640484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049064|NCT00640484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24773760|NCT01841827|Cilostazol|cilostazol|mesh-list
25002240|NCT04796922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25002241|NCT04796922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25002243|NCT04792502|Immunologic Factors|immunologic factors|mesh-ancestor
25002244|NCT04792502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049232|NCT00626106|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25049233|NCT00626106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25049234|NCT00626106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25049235|NCT00626106|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24498566|NCT00515281|Gasotransmitters|gasotransmitters|mesh-ancestor
24498567|NCT00515281|Protective Agents|protective agents|mesh-ancestor
24498568|NCT00515320|Fluoxetine|fluoxetine|mesh-list
24498569|NCT00515320|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25049319|NCT00618098|Hemostatics|hemostatics|mesh-ancestor
25049320|NCT00618098|Coagulants|coagulants|mesh-ancestor
24599738|NCT03913559|Cytarabine|cytarabine|mesh-list
24940809|NCT03997500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24773885|NCT01842529|Botulinum Toxins|botulinum toxins|mesh-list
24998344|NCT03110484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24798650|NCT01964391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24798651|NCT01964404|Dronabinol|dronabinol|mesh-list
24798652|NCT01964404|Hallucinogens|hallucinogens|mesh-ancestor
24798653|NCT01964404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25003292|NCT03853694|Morphine|morphine|mesh-list
25003293|NCT03853694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25003294|NCT03853694|Narcotics|narcotics|mesh-ancestor
25003295|NCT03853694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25003296|NCT03853694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25003297|NCT03853694|Analgesics|analgesics|mesh-ancestor
25003298|NCT03853694|Sensory System Agents|sensory system agents|mesh-ancestor
25003299|NCT03853694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24774000|NCT01843296|Magnesium Sulfate|magnesium sulfate|mesh-list
24941259|NCT03992885|Pemetrexed|pemetrexed|mesh-list
25075924|NCT03377257|Serotonin Agents|serotonin agents|mesh-ancestor
25081250|NCT03332017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004320|NCT02087423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850402|NCT02252926|Anesthetics, Local|anesthetics, local|mesh-ancestor
24850404|NCT02252926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24850405|NCT02252926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829210|NCT00006154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24774394|NCT01845298|Rifampin|rifampin|mesh-list
25829211|NCT00006154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170856|NCT02893371|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25829212|NCT00006154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25829213|NCT00006154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24989787|NCT04776408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24989788|NCT04776408|Respiratory System Agents|respiratory system agents|mesh-ancestor
24978347|NCT04594408|Racepinephrine|racepinephrine|mesh-list
25166651|NCT03828019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24978348|NCT04594408|Tranexamic Acid|tranexamic acid|mesh-list
24978349|NCT04594408|Epinephryl borate|epinephryl borate|mesh-list
25829214|NCT00006154|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25105845|NCT04850495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105847|NCT04850495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25105848|NCT04850495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25105849|NCT04850495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24458335|NCT00337506|Dexamethasone|dexamethasone|mesh-list
25106091|NCT04509973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24784006|NCT01905150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25106092|NCT04509973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106093|NCT04469959|Levodopa|levodopa|mesh-list
25106094|NCT04469959|Carbidopa|carbidopa|mesh-list
24982365|NCT02913664|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24982366|NCT02913664|Angiotensinogen|angiotensinogen|mesh-list
24982367|NCT02913664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24982368|NCT02913664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982369|NCT02913664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24982370|NCT02913664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24982371|NCT02913664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982372|NCT02913664|Vasodilator Agents|vasodilator agents|mesh-ancestor
24982373|NCT02913664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24982374|NCT02913664|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24774488|NCT01845701|Schistosomicides|schistosomicides|mesh-ancestor
24982468|NCT02596503|Irinotecan|irinotecan|mesh-list
24982469|NCT02596503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24982470|NCT02596503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24982471|NCT02596503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24982472|NCT02596503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982473|NCT02596503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24982495|NCT02535091|Anticonvulsants|anticonvulsants|mesh-ancestor
24774518|NCT01846026|Vitamin D|vitamin d|mesh-list
24982778|NCT00400218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24982779|NCT00400218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24982780|NCT00400218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24982781|NCT00400218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24982782|NCT00400218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434316|NCT00262132|Antitubercular Agents|antitubercular agents|mesh-ancestor
24434317|NCT00262132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24434318|NCT00262132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24434319|NCT00262132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434320|NCT00262132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434321|NCT00262210|Prednisolone|prednisolone|mesh-list
24434322|NCT00262210|Cyclophosphamide|cyclophosphamide|mesh-list
24434345|NCT00262262|Anticonvulsants|anticonvulsants|mesh-ancestor
24434346|NCT00262262|Nootropic Agents|nootropic agents|mesh-ancestor
24434347|NCT00262275|Aspirin|aspirin|mesh-list
24434348|NCT00262275|Clopidogrel|clopidogrel|mesh-list
25033053|NCT03576508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795816|NCT01946295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795817|NCT01946295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795818|NCT01946373|Vidarabine|vidarabine|mesh-list
24795819|NCT01946373|Cyclophosphamide|cyclophosphamide|mesh-list
24982959|NCT00092690|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24982960|NCT00092690|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24929501|NCT04111432|Vaccines|vaccines|mesh-list
24982961|NCT00092690|Antimetabolites|antimetabolites|mesh-ancestor
24982962|NCT00092690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982963|NCT00092690|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24982964|NCT00092690|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24982965|NCT00092690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24982966|NCT00092664|Simvastatin|simvastatin|mesh-list
24982967|NCT00092664|Ezetimibe|ezetimibe|mesh-list
24774608|NCT01846832|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24983020|NCT00092573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106492|NCT02669173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784406|NCT01907867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24784407|NCT01907867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24784408|NCT01907867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24784409|NCT01907867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784410|NCT01907867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784411|NCT01907880|Zoledronic Acid|zoledronic acid|mesh-list
24784412|NCT01907880|Pamidronate|pamidronate|mesh-list
24784413|NCT01907880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24784414|NCT01907880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784415|NCT01907984|Diclofenac|diclofenac|mesh-list
24784416|NCT01907984|Midazolam|midazolam|mesh-list
24774653|NCT01847157|Prilocaine|prilocaine|mesh-list
24795881|NCT01946555|Anesthetics, General|anesthetics, general|mesh-ancestor
24983144|NCT02118610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983145|NCT02118610|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24983246|NCT01697527|Alkylating Agents|alkylating agents|mesh-ancestor
24983247|NCT01697527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983248|NCT01697527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24983249|NCT01697527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24983286|NCT01453946|Glucocorticoids|glucocorticoids|mesh-ancestor
24983287|NCT01453946|Hormones|hormones|mesh-ancestor
25829215|NCT00006154|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24983310|NCT00719966|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24983311|NCT00719966|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24983312|NCT00719966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24983313|NCT00719966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984172|NCT04750395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24984174|NCT04750395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24984175|NCT04750395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24984176|NCT04750395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24984177|NCT04750395|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24859177|NCT02302430|Oxytocin|oxytocin|mesh-list
24984216|NCT04734379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984217|NCT04734379|Vasodilator Agents|vasodilator agents|mesh-ancestor
24984218|NCT04734379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24984219|NCT04734379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650401|NCT01502410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25650402|NCT01502410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25650403|NCT01502410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650404|NCT01502410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650405|NCT01502423|Adalimumab|adalimumab|mesh-list
25650406|NCT01502423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25650407|NCT01502423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25650408|NCT01502644|Morphine|morphine|mesh-list
25650409|NCT01502644|Oxycodone|oxycodone|mesh-list
25650410|NCT01502644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25650411|NCT01502644|Narcotics|narcotics|mesh-ancestor
24434984|NCT00264628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24984220|NCT04731272|Dulaglutide|dulaglutide|mesh-list
24984266|NCT04702789|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24984267|NCT04702789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24984268|NCT04702789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24984269|NCT04702789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24984270|NCT04702789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24984271|NCT04702789|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24984272|NCT04702789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984273|NCT04702776|Hyaluronic Acid|hyaluronic acid|mesh-list
24984274|NCT04702776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24784687|NCT01909856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784688|NCT01910077|Tacrolimus|tacrolimus|mesh-list
25106777|NCT03145012|Histamine Antagonists|histamine antagonists|mesh-ancestor
25106778|NCT03145012|Histamine Agents|histamine agents|mesh-ancestor
25106779|NCT03145012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24774845|NCT01848197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796039|NCT01947699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796040|NCT01947777|Rifampin|rifampin|mesh-list
24796041|NCT01947777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24796042|NCT01947777|Antitubercular Agents|antitubercular agents|mesh-ancestor
24796043|NCT01947777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24796044|NCT01947777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24796105|NCT01947985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107031|NCT03143010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24861249|NCT02316327|Antimetabolites|antimetabolites|mesh-ancestor
24986704|NCT05188742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24986705|NCT05188742|Adrenergic Agents|adrenergic agents|mesh-ancestor
24775072|NCT01850095|Azelaic acid|azelaic acid|mesh-list
24986897|NCT04988074|Cemiplimab|cemiplimab|mesh-list
24861454|NCT02317861|Gout Suppressants|gout suppressants|mesh-ancestor
24986921|NCT04925193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24986922|NCT04925193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986923|NCT04925193|Immunologic Factors|immunologic factors|mesh-ancestor
24986924|NCT04925193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24986925|NCT04925193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24987021|NCT04560881|Immunologic Factors|immunologic factors|mesh-ancestor
24987022|NCT04560881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796543|NCT01950585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107059|NCT03142646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24833925|NCT02176200|Sympathomimetics|sympathomimetics|mesh-ancestor
24796544|NCT01950585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796547|NCT01950611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796548|NCT01950689|Nimorazole|nimorazole|mesh-list
24796549|NCT01950689|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
24796550|NCT01950689|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24796551|NCT01950689|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24987140|NCT03695172|Anesthetics|anesthetics|mesh-ancestor
24987141|NCT03695172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24987142|NCT03695172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987143|NCT03695172|Sensory System Agents|sensory system agents|mesh-ancestor
24987144|NCT03695172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24987145|NCT03554044|Tamoxifen|tamoxifen|mesh-list
24987276|NCT03391882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24987277|NCT03391882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24987278|NCT03391882|Dopamine Agonists|dopamine agonists|mesh-ancestor
24987279|NCT03391882|Dopamine Agents|dopamine agents|mesh-ancestor
24627348|NCT01092039|Lactoferrin|lactoferrin|mesh-list
24932291|NCT04081012|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24932293|NCT04081012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24932294|NCT04081012|Expectorants|expectorants|mesh-ancestor
24932295|NCT04081012|Respiratory System Agents|respiratory system agents|mesh-ancestor
24932384|NCT04080310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987430|NCT01970410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24987588|NCT05191394|Antibodies|antibodies|mesh-list
24987589|NCT05191394|Immunologic Factors|immunologic factors|mesh-ancestor
24987590|NCT05191394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987591|NCT05190952|Dexamethasone|dexamethasone|mesh-list
24987592|NCT05190952|Ketamine|ketamine|mesh-list
25650412|NCT01502644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25650413|NCT01502644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650414|NCT01502644|Analgesics|analgesics|mesh-ancestor
24435976|NCT00268567|Immunologic Factors|immunologic factors|mesh-ancestor
24988097|NCT04234464|Autonomic Agents|autonomic agents|mesh-ancestor
24988098|NCT04234464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24988099|NCT04234464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988100|NCT04234464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24988101|NCT04234464|Respiratory System Agents|respiratory system agents|mesh-ancestor
24577266|NCT00842686|Capecitabine|capecitabine|mesh-list
24785141|NCT01912378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24542548|NCT00679237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785156|NCT01912443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24785157|NCT01912443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24785158|NCT01912443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24785159|NCT01912443|Growth Substances|growth substances|mesh-ancestor
24785160|NCT01912443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785161|NCT01912443|Growth Inhibitors|growth inhibitors|mesh-ancestor
24785162|NCT01912534|Valsartan|valsartan|mesh-list
24785163|NCT01912534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24988513|NCT02567578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988514|NCT02523274|Resveratrol|resveratrol|mesh-list
24988515|NCT02523274|Antioxidants|antioxidants|mesh-ancestor
24988516|NCT02523274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988517|NCT02523274|Protective Agents|protective agents|mesh-ancestor
24988630|NCT02143063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24988631|NCT02143063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988632|NCT02143063|Sensory System Agents|sensory system agents|mesh-ancestor
24988633|NCT02143063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24988634|NCT02143063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24864386|NCT04715230|Haloperidol|haloperidol|mesh-list
24990455|NCT02983747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24990456|NCT02983747|Analgesics|analgesics|mesh-ancestor
24990457|NCT02983747|Sensory System Agents|sensory system agents|mesh-ancestor
24990458|NCT02983747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24990459|NCT02983747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990460|NCT02983747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24990461|NCT02983747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24775496|NCT01852604|Interferons|interferons|mesh-list
24990538|NCT02821026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24990539|NCT02821026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24990540|NCT02821026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24990542|NCT02787239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24990543|NCT02787239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990544|NCT02787239|Immunologic Factors|immunologic factors|mesh-ancestor
24990545|NCT02787239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990546|NCT02787239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24990550|NCT02754154|Warfarin|warfarin|mesh-list
24990551|NCT02754154|Rivaroxaban|rivaroxaban|mesh-list
24990552|NCT02754154|Dabigatran|dabigatran|mesh-list
24990553|NCT02754154|Apixaban|apixaban|mesh-list
24990554|NCT02754154|Anticoagulants|anticoagulants|mesh-ancestor
24990555|NCT02754154|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24797254|NCT01954784|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25033280|NCT03574701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033281|NCT03574649|Paclitaxel|paclitaxel|mesh-list
25033282|NCT03574649|Docetaxel|docetaxel|mesh-list
25033286|NCT03574649|Avelumab|avelumab|mesh-list
24797255|NCT01954784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24991236|NCT00468130|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24991237|NCT00468130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24991238|NCT00468130|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24991239|NCT00468130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24991240|NCT05197751|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24797415|NCT01955460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24797416|NCT01955460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24797417|NCT01955460|Antimetabolites|antimetabolites|mesh-ancestor
24797418|NCT01955460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24797419|NCT01955460|Analgesics|analgesics|mesh-ancestor
24545564|NCT00693849|Citalopram|citalopram|mesh-list
24992060|NCT04500509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24992654|NCT03253172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992655|NCT03253172|Expectorants|expectorants|mesh-ancestor
24992656|NCT03253172|Respiratory System Agents|respiratory system agents|mesh-ancestor
24992657|NCT03227471|Ivacaftor|ivacaftor|mesh-list
24992658|NCT03227471|Elexacaftor|elexacaftor|mesh-list
24992659|NCT03227471|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24992660|NCT03227471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24992661|NCT03227471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650415|NCT01502644|Sensory System Agents|sensory system agents|mesh-ancestor
25829216|NCT00006154|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25166652|NCT03828019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992923|NCT02505204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24992924|NCT02505204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24993079|NCT01358201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24993111|NCT00925652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24993737|NCT05410223|Renal Agents|renal agents|mesh-ancestor
24993738|NCT05410223|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
24993739|NCT05410223|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24993740|NCT05410197|Gemcitabine|gemcitabine|mesh-list
24993741|NCT05410197|Lenvatinib|lenvatinib|mesh-list
24547792|NCT00705770|Hydrocortisone|hydrocortisone|mesh-list
24993825|NCT05392361|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24993826|NCT05392361|GABA Agonists|gaba agonists|mesh-ancestor
24993827|NCT05392361|GABA Agents|gaba agents|mesh-ancestor
24993828|NCT05370547|Cyclophosphamide|cyclophosphamide|mesh-list
24993829|NCT05370547|Fludarabine|fludarabine|mesh-list
25033319|NCT03574402|Immunologic Factors|immunologic factors|mesh-ancestor
25033320|NCT03574402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033321|NCT03574402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25033322|NCT03574402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25033323|NCT03574402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24993830|NCT05370547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24993831|NCT05370547|Immunologic Factors|immunologic factors|mesh-ancestor
24993832|NCT05370547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993833|NCT05370547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24993834|NCT05370547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25004613|NCT02654132|Dexamethasone|dexamethasone|mesh-list
24993835|NCT05370547|Alkylating Agents|alkylating agents|mesh-ancestor
24993836|NCT05370547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993837|NCT05370547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993838|NCT05370547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24993839|NCT05348122|Dulaglutide|dulaglutide|mesh-list
24993840|NCT05348122|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
25107913|NCT03135977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24797949|NCT01959191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24797950|NCT01959191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24797951|NCT01959191|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24797952|NCT01959191|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24797953|NCT01959191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797954|NCT01959191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24996153|NCT04173325|Irinotecan|irinotecan|mesh-list
25033378|NCT03573986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24996154|NCT04173325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24996155|NCT04173325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934391|NCT04061512|Cyclophosphamide|cyclophosphamide|mesh-list
24996432|NCT03480776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996434|NCT03480776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24996435|NCT03480776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24996436|NCT03480776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24996437|NCT03480776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996438|NCT03480776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24996439|NCT03480776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24996440|NCT03480776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775933|NCT01855594|Lithium Carbonate|lithium carbonate|mesh-list
24996867|NCT01307423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996868|NCT01307423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996869|NCT01307423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24996870|NCT01307423|Immunologic Factors|immunologic factors|mesh-ancestor
24996871|NCT01307423|Leprostatic Agents|leprostatic agents|mesh-ancestor
25033394|NCT03573622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25033395|NCT03573622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25033396|NCT03573622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033397|NCT03573622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25033398|NCT03573622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24996872|NCT01307423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24996873|NCT01307423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24803018|NCT01993810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24844015|NCT02230735|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24844017|NCT02230800|Pentoxifylline|pentoxifylline|mesh-list
24873921|NCT04971837|Anticonvulsants|anticonvulsants|mesh-ancestor
24873922|NCT04971837|Cathartics|cathartics|mesh-ancestor
24873923|NCT04971837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24873935|NCT04960618|Gemcitabine|gemcitabine|mesh-list
25081490|NCT03329339|Antioxidants|antioxidants|mesh-ancestor
24845439|NCT02237937|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24845440|NCT02237937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24845442|NCT02237937|Sensory System Agents|sensory system agents|mesh-ancestor
24845443|NCT02237937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24845444|NCT02237937|Adrenergic Agents|adrenergic agents|mesh-ancestor
24776452|NCT01858090|Anesthetics|anesthetics|mesh-ancestor
24459010|NCT00343369|Glucocorticoids|glucocorticoids|mesh-ancestor
24459012|NCT00343369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24459013|NCT00343369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24459014|NCT00343369|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24459323|NCT00344383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24459324|NCT00344383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459325|NCT00344383|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24459327|NCT00344383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24459328|NCT00344383|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24459329|NCT00344383|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24459330|NCT00344383|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25829217|NCT00006154|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25829218|NCT00006154|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25033442|NCT03573102|Aspirin|aspirin|mesh-list
25033446|NCT03573102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25829219|NCT00006154|Antimetabolites|antimetabolites|mesh-ancestor
25829220|NCT00006155|Carboplatin|carboplatin|mesh-list
24776558|NCT01858571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108503|NCT03131791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108505|NCT03131791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25108506|NCT03131791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108507|NCT03131791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25108508|NCT03131791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108509|NCT03131843|Ethanol|ethanol|mesh-list
25829221|NCT00006155|Semaxinib|semaxinib|mesh-list
25829222|NCT00006155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829223|NCT00006155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25829224|NCT00006155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25829225|NCT00006155|Growth Substances|growth substances|mesh-ancestor
25829226|NCT00006155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829227|NCT00006155|Growth Inhibitors|growth inhibitors|mesh-ancestor
25829228|NCT00006155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25829229|NCT00006155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829230|NCT00006155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829231|NCT00006157|Desipramine|desipramine|mesh-list
25033470|NCT03573050|Cholinergic Agents|cholinergic agents|mesh-ancestor
25033482|NCT03572959|Hormones|hormones|mesh-ancestor
25033483|NCT03572959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25829232|NCT00006157|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25829233|NCT00006157|Antidepressive Agents|antidepressive agents|mesh-ancestor
25829234|NCT00006157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24815230|NCT02069080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25829235|NCT00006157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829236|NCT00006157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829237|NCT00006157|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25829238|NCT00006157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25829239|NCT00006157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25829240|NCT00006157|Adrenergic Agents|adrenergic agents|mesh-ancestor
25829241|NCT00006157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25108510|NCT03131843|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25829242|NCT00006157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829243|NCT00006158|Testosterone|testosterone|mesh-list
24786465|NCT01920113|Sensory System Agents|sensory system agents|mesh-ancestor
24786466|NCT01920113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24786467|NCT01920113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24786468|NCT01920113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24786469|NCT01920113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24786470|NCT01920113|Adrenergic Agents|adrenergic agents|mesh-ancestor
24786471|NCT01920113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24786472|NCT01920113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786473|NCT01920113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24786474|NCT01920113|Narcotics|narcotics|mesh-ancestor
24786475|NCT01920191|Poly ICLC|poly iclc|mesh-list
25108512|NCT03131843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25108513|NCT03131843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108549|NCT03131973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25650417|NCT01502761|Magnesium Sulfate|magnesium sulfate|mesh-list
25650418|NCT01502761|Analgesics|analgesics|mesh-ancestor
24439558|NCT00279344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25108550|NCT03131973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25108551|NCT03131973|Anesthetics, General|anesthetics, general|mesh-ancestor
25108552|NCT03131973|Anesthetics|anesthetics|mesh-ancestor
25108553|NCT03131973|GABA Modulators|gaba modulators|mesh-ancestor
25108554|NCT03131973|GABA Agents|gaba agents|mesh-ancestor
25108555|NCT03131973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25108556|NCT03131973|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24868453|NCT04645602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24868542|NCT04351061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868544|NCT04351061|Natriuretic Agents|natriuretic agents|mesh-ancestor
24776725|NCT01859585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24868667|NCT03600714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24868668|NCT03600714|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24868669|NCT03600714|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24868670|NCT03600714|Protease Inhibitors|protease inhibitors|mesh-ancestor
24868671|NCT03600714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24875839|NCT03819465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871471|NCT02426892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24871472|NCT02426892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871473|NCT02409368|Nivolumab|nivolumab|mesh-list
24871474|NCT02409368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24871475|NCT02409368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871476|NCT02409368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24871477|NCT02409368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871478|NCT02375555|Dexamethasone|dexamethasone|mesh-list
24871479|NCT02375555|Lenalidomide|lenalidomide|mesh-list
24871480|NCT02375555|Bortezomib|bortezomib|mesh-list
24871481|NCT02375555|Elotuzumab|elotuzumab|mesh-list
24871790|NCT04527289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24871793|NCT04525898|Narcotics|narcotics|mesh-ancestor
24873730|NCT05049213|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24873731|NCT05049213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24873732|NCT05041101|Halichondrin B|halichondrin b|mesh-list
24873733|NCT05041101|Tubulin Modulators|tubulin modulators|mesh-ancestor
24873734|NCT05041101|Antimitotic Agents|antimitotic agents|mesh-ancestor
24873735|NCT05041101|Mitosis Modulators|mitosis modulators|mesh-ancestor
24873736|NCT05041101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24873737|NCT05041101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24875781|NCT03839823|Letrozole|letrozole|mesh-list
24875782|NCT03839823|Anastrozole|anastrozole|mesh-list
24875783|NCT03839823|Goserelin|goserelin|mesh-list
24875784|NCT03839823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24875785|NCT03839823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24875786|NCT03839823|Tubulin Modulators|tubulin modulators|mesh-ancestor
24875787|NCT03839823|Antimitotic Agents|antimitotic agents|mesh-ancestor
24875788|NCT03839823|Mitosis Modulators|mitosis modulators|mesh-ancestor
24876598|NCT03344965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24876056|NCT03745352|Antimetabolites|antimetabolites|mesh-ancestor
24876102|NCT03728881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24876104|NCT03724084|Daunorubicin|daunorubicin|mesh-list
24876105|NCT03724084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24876106|NCT03724084|Antimetabolites|antimetabolites|mesh-ancestor
24876107|NCT03724084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24876108|NCT03724084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24876109|NCT03724084|Antiviral Agents|antiviral agents|mesh-ancestor
24776992|NCT01861015|Vasopressins|vasopressins|mesh-list
24477400|NCT00418496|Antiviral Agents|antiviral agents|mesh-ancestor
24777050|NCT01861535|Imiquimod|imiquimod|mesh-list
24878669|NCT01281176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24878671|NCT01281176|Tubulin Modulators|tubulin modulators|mesh-ancestor
24878672|NCT01281176|Antimitotic Agents|antimitotic agents|mesh-ancestor
24878673|NCT01281176|Mitosis Modulators|mitosis modulators|mesh-ancestor
24880778|NCT03344419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24880779|NCT03344419|Anesthetics, General|anesthetics, general|mesh-ancestor
24880780|NCT03344419|Anesthetics|anesthetics|mesh-ancestor
24881009|NCT03173053|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25108737|NCT03130452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24890510|NCT04482712|Sirolimus|sirolimus|mesh-list
24885978|NCT03835013|Glucagon|glucagon|mesh-list
24885979|NCT03835013|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24885980|NCT03835013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25650419|NCT01502761|Sensory System Agents|sensory system agents|mesh-ancestor
24464869|NCT00367185|Immunologic Factors|immunologic factors|mesh-ancestor
24886073|NCT03446612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24886074|NCT03446612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886075|NCT03446612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886077|NCT03436433|Levetiracetam|levetiracetam|mesh-list
24886078|NCT03436433|Anticonvulsants|anticonvulsants|mesh-ancestor
24886079|NCT03436433|Nootropic Agents|nootropic agents|mesh-ancestor
24886080|NCT03436433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24886081|NCT03436433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24886082|NCT03436433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24464949|NCT00367393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24886117|NCT03099863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25829244|NCT00006158|Androgens|androgens|mesh-ancestor
24886466|NCT04525664|Amoxicillin|amoxicillin|mesh-list
24886467|NCT04525664|Clarithromycin|clarithromycin|mesh-list
24886468|NCT04525664|Omeprazole|omeprazole|mesh-list
24886469|NCT04525664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24886470|NCT04525664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24877570|NCT02529852|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24877571|NCT02529852|Vincristine|vincristine|mesh-list
24877572|NCT02529852|Lenalidomide|lenalidomide|mesh-list
24877573|NCT02529852|Obinutuzumab|obinutuzumab|mesh-list
24877574|NCT02529852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24877575|NCT02529852|Immunologic Factors|immunologic factors|mesh-ancestor
24877576|NCT02529852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24877577|NCT02529852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24877578|NCT02529852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24877579|NCT02529852|Alkylating Agents|alkylating agents|mesh-ancestor
24877580|NCT02529852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887635|NCT04514029|Antimetabolites|antimetabolites|mesh-ancestor
24887636|NCT04514029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777210|NCT01862978|Heparin|heparin|mesh-list
24888031|NCT04509440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24888034|NCT04509440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24888035|NCT04509440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888036|NCT04509440|Sensory System Agents|sensory system agents|mesh-ancestor
24888037|NCT04509440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24888038|NCT04509102|Adderall|adderall|mesh-list
24888039|NCT04509102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24888040|NCT04509102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888041|NCT04509323|Huperzine A|huperzine a|mesh-list
24888042|NCT04509323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24888043|NCT04509323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24888044|NCT04509323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888045|NCT04509323|Cholinergic Agents|cholinergic agents|mesh-ancestor
24888046|NCT04509323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24816763|NCT02078648|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24816764|NCT02078648|Poly ICLC|poly iclc|mesh-list
24796377|NCT01949675|Vaccines|vaccines|mesh-list
24636402|NCT01145326|Lidocaine|lidocaine|mesh-list
24889568|NCT04491773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24889569|NCT04491773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889570|NCT04491773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889571|NCT04491773|Urological Agents|urological agents|mesh-ancestor
24889572|NCT04491786|Gabapentin|gabapentin|mesh-list
24889573|NCT04491786|Nefopam|nefopam|mesh-list
24889574|NCT04491786|Analgesics|analgesics|mesh-ancestor
24889575|NCT04491786|Sensory System Agents|sensory system agents|mesh-ancestor
24889576|NCT04491786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24957584|NCT03843541|Acetylcysteine|acetylcysteine|mesh-list
24890498|NCT04482985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24890499|NCT04482985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24890500|NCT04482985|Histamine Antagonists|histamine antagonists|mesh-ancestor
24890502|NCT04482985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24890503|NCT04482985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890504|NCT04482985|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24890505|NCT04482504|Vitamin D|vitamin d|mesh-list
24890506|NCT04482504|Vitamins|vitamins|mesh-ancestor
24890507|NCT04482504|Micronutrients|micronutrients|mesh-ancestor
24890508|NCT04482504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890509|NCT04482504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24890559|NCT04482257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24890560|NCT04482257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24890561|NCT04482257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24890778|NCT04480333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890779|NCT04480333|Protective Agents|protective agents|mesh-ancestor
24441251|NCT00286689|Hormones|hormones|mesh-list
24890780|NCT04480333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890782|NCT04480359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24890783|NCT04480359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24890960|NCT04477993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24890961|NCT04477993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24890962|NCT04477993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890963|NCT04477629|Mycophenolic Acid|mycophenolic acid|mesh-list
24816963|NCT02080078|Autonomic Agents|autonomic agents|mesh-ancestor
24816964|NCT02080078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24892367|NCT04463966|Tranexamic Acid|tranexamic acid|mesh-list
24892564|NCT04461925|Glucocorticoids|glucocorticoids|mesh-ancestor
24892565|NCT04461925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24892566|NCT04461925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24892567|NCT04461925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24878799|NCT00828854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24878800|NCT00828854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24878801|NCT00828854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24878802|NCT00828854|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24878803|NCT00782574|Olaparib|olaparib|mesh-list
24878804|NCT00782574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24878805|NCT00782574|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24878806|NCT00782574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24878807|NCT00782574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878808|NCT00753545|Olaparib|olaparib|mesh-list
24878809|NCT00753545|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24878810|NCT00753545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24878813|NCT00740805|Cyclophosphamide|cyclophosphamide|mesh-list
24878840|NCT00669734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24878841|NCT00669734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24878842|NCT00669734|Antioxidants|antioxidants|mesh-ancestor
24878844|NCT00669734|Protective Agents|protective agents|mesh-ancestor
25160971|NCT02335944|Nazartinib|nazartinib|mesh-list
24957585|NCT03843541|Ambroxol|ambroxol|mesh-list
24879252|NCT04923737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24879253|NCT04923737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24879283|NCT04910061|Niacinamide|niacinamide|mesh-list
24879284|NCT04910061|Niacin|niacin|mesh-list
24879285|NCT04910061|Nicotinic Acids|nicotinic acids|mesh-list
24879286|NCT04910061|Vitamin B Complex|vitamin b complex|mesh-ancestor
24879287|NCT04910061|Vitamins|vitamins|mesh-ancestor
24879288|NCT04910061|Micronutrients|micronutrients|mesh-ancestor
24815762|NCT02071888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879525|NCT04705818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24879526|NCT04705818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829245|NCT00006158|Hormones|hormones|mesh-ancestor
25829246|NCT00006158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25108992|NCT03128346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108993|NCT03128346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25108995|NCT03128346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25108996|NCT03128346|Antipyretics|antipyretics|mesh-ancestor
25108997|NCT03128346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25108998|NCT03128346|Narcotics|narcotics|mesh-ancestor
25108999|NCT03128346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24901727|NCT04382144|Sensory System Agents|sensory system agents|mesh-ancestor
24901728|NCT04382144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24901729|NCT04382014|Curcumin|curcumin|mesh-list
24880312|NCT03872180|Obinutuzumab|obinutuzumab|mesh-list
24880313|NCT03872180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24880314|NCT03872180|Alkylating Agents|alkylating agents|mesh-ancestor
24880315|NCT03872180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902381|NCT04374799|Heparin|heparin|mesh-list
24902382|NCT04374799|Anticoagulants|anticoagulants|mesh-ancestor
24902383|NCT04374799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24902384|NCT04374799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24880361|NCT03829371|Growth Substances|growth substances|mesh-ancestor
24902403|NCT04374071|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24880398|NCT03799835|Immunologic Factors|immunologic factors|mesh-ancestor
25113895|NCT02104310|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
24902490|NCT04372836|Coagulants|coagulants|mesh-ancestor
24902491|NCT04372836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24818295|NCT02087722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818296|NCT02087722|Protective Agents|protective agents|mesh-ancestor
24787005|NCT01923064|Ethiodized Oil|ethiodized oil|mesh-list
25650420|NCT01502761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24442093|NCT00290017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818309|NCT02087813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24880782|NCT03344419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24880783|NCT03344419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24880784|NCT03344419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24880876|NCT03224104|Alkylating Agents|alkylating agents|mesh-ancestor
24880878|NCT03224104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880905|NCT03203642|XL647|xl647|mesh-list
24815931|NCT02072785|Tubulin Modulators|tubulin modulators|mesh-ancestor
24815932|NCT02072785|Antimitotic Agents|antimitotic agents|mesh-ancestor
24815933|NCT02072785|Mitosis Modulators|mitosis modulators|mesh-ancestor
24957586|NCT03843541|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25166653|NCT03828019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25829247|NCT00006158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829248|NCT00006167|Oxandrolone|oxandrolone|mesh-list
24903565|NCT04362241|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24903566|NCT04362241|Prednisolone phosphate|prednisolone phosphate|mesh-list
24880975|NCT03173053|Chlorhexidine|chlorhexidine|mesh-list
24903785|NCT04361474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25113904|NCT02074436|Hemostatics|hemostatics|mesh-ancestor
25113905|NCT02074436|Coagulants|coagulants|mesh-ancestor
24903786|NCT04361474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24903787|NCT04361474|Respiratory System Agents|respiratory system agents|mesh-ancestor
24903789|NCT04361474|Hormones|hormones|mesh-ancestor
24903790|NCT04361474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24903791|NCT04361058|Nivolumab|nivolumab|mesh-list
24903792|NCT04361058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24904047|NCT04359095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24904048|NCT04359095|Gout Suppressants|gout suppressants|mesh-ancestor
24904049|NCT04359095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24904075|NCT04359316|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24904076|NCT04359316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627597|NCT01093937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076015|NCT03376555|Cholinergic Agents|cholinergic agents|mesh-ancestor
25076016|NCT03376555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24777927|NCT01867892|Antimetabolites|antimetabolites|mesh-ancestor
24882580|NCT05169021|Vitamins|vitamins|mesh-ancestor
25076970|NCT03369093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25076971|NCT03369067|Insulin|insulin|mesh-list
25076972|NCT03369067|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24882938|NCT04726969|Ivermectin|ivermectin|mesh-list
25077008|NCT03368547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623475|NCT01071681|Telmisartan|telmisartan|mesh-list
24956060|NCT03857854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24956061|NCT03857854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24956062|NCT03857854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24956464|NCT03854344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956465|NCT03854344|Sensory System Agents|sensory system agents|mesh-ancestor
24956466|NCT03854344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24956467|NCT03854344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24956468|NCT03854344|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24956469|NCT03854344|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24956502|NCT03853954|Methoxyflurane|methoxyflurane|mesh-list
24956503|NCT03853954|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24956504|NCT03853954|Anesthetics, General|anesthetics, general|mesh-ancestor
24956505|NCT03853954|Anesthetics|anesthetics|mesh-ancestor
24956725|NCT03851835|Autonomic Agents|autonomic agents|mesh-ancestor
24813034|NCT02056210|Plerixafor|plerixafor|mesh-list
24956726|NCT03851835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24957007|NCT03847818|Tubulin Modulators|tubulin modulators|mesh-ancestor
24957008|NCT03847818|Antimitotic Agents|antimitotic agents|mesh-ancestor
24957009|NCT03847818|Mitosis Modulators|mitosis modulators|mesh-ancestor
24957010|NCT03847818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957011|NCT03847818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24957529|NCT03844243|Mitosis Modulators|mitosis modulators|mesh-ancestor
24957530|NCT03844243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957531|NCT03843749|Trastuzumab|trastuzumab|mesh-list
24957532|NCT03843749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24957533|NCT03843749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24957534|NCT03844178|Tetracaine|tetracaine|mesh-list
25650421|NCT01502761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650422|NCT01502761|Anesthetics|anesthetics|mesh-ancestor
24957535|NCT03844178|Anesthetics, Local|anesthetics, local|mesh-ancestor
24437465|NCT00273702|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24957570|NCT03843736|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
24957572|NCT03843736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957573|NCT03843736|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24957574|NCT03843736|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24957575|NCT03843736|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24957576|NCT03843736|Estrogens|estrogens|mesh-ancestor
24957577|NCT03843736|Hormones|hormones|mesh-ancestor
24957578|NCT03843736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24957579|NCT03843736|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24957580|NCT03843736|Hormone Antagonists|hormone antagonists|mesh-ancestor
24957581|NCT03843736|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24957582|NCT03843736|Diuretics|diuretics|mesh-ancestor
24957583|NCT03843736|Natriuretic Agents|natriuretic agents|mesh-ancestor
24783463|NCT01902160|Immunoconjugates|immunoconjugates|mesh-list
24783464|NCT01902160|Immunologic Factors|immunologic factors|mesh-ancestor
24957792|NCT03841812|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24957793|NCT03841812|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24957795|NCT03841591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24957796|NCT03841591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957798|NCT03841383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24957799|NCT03841383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24957800|NCT03841383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957801|NCT03841383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24958333|NCT03833999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24784248|NCT01907061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24784324|NCT01907373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784325|NCT01907373|Uricosuric Agents|uricosuric agents|mesh-ancestor
24784326|NCT01907373|Gout Suppressants|gout suppressants|mesh-ancestor
24784327|NCT01907373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24958342|NCT03834012|Beclomethasone|beclomethasone|mesh-list
24958343|NCT03834012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24958344|NCT03834012|Glucocorticoids|glucocorticoids|mesh-ancestor
24958345|NCT03834012|Hormones|hormones|mesh-ancestor
24887437|NCT04516304|Equol|equol|mesh-list
24958377|NCT03833895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24958378|NCT03833895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24958379|NCT03833895|Adrenergic Agents|adrenergic agents|mesh-ancestor
24958380|NCT03833895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24958381|NCT03833895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958492|NCT03832816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24958493|NCT03832816|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24958494|NCT03832816|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24958495|NCT03832816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24958528|NCT03832465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24958529|NCT03832465|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24958530|NCT03832465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24958631|NCT03830827|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24958632|NCT03830827|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24958634|NCT03830957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24958635|NCT03830957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24958636|NCT03830957|Sympatholytics|sympatholytics|mesh-ancestor
24958637|NCT03830957|Autonomic Agents|autonomic agents|mesh-ancestor
24958638|NCT03830957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24958639|NCT03830957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958640|NCT03830957|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24958641|NCT03830957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24958642|NCT03830957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24958643|NCT03830957|Adrenergic Agents|adrenergic agents|mesh-ancestor
25650423|NCT01502761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25650424|NCT01502761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25650425|NCT01502761|Anticonvulsants|anticonvulsants|mesh-ancestor
25650426|NCT01502761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25650427|NCT01502761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25650428|NCT01502761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958792|NCT03829943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24958794|NCT03829774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24958879|NCT03829124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24958880|NCT03829124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958881|NCT03829124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25034033|NCT03568721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25034034|NCT03568721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25034035|NCT03568721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24958935|NCT03828929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958937|NCT03828929|Vitamin B Complex|vitamin b complex|mesh-ancestor
24958938|NCT03828838|177Lu-PSMA-617|177lu-psma-617|mesh-list
24958939|NCT03828838|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24958940|NCT03828838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958941|NCT03828643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24958942|NCT03828643|Immunologic Factors|immunologic factors|mesh-ancestor
24958943|NCT03828643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778331|NCT01870284|Adalimumab|adalimumab|mesh-list
25120097|NCT04712734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24990836|NCT03961789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24990837|NCT03961789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990838|NCT03961789|Analgesics|analgesics|mesh-ancestor
24990839|NCT03961789|Sensory System Agents|sensory system agents|mesh-ancestor
24959067|NCT03827408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24959068|NCT03827408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24959069|NCT03827408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24959070|NCT03827408|Adrenergic Agents|adrenergic agents|mesh-ancestor
24959071|NCT03827408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24959072|NCT03827408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959073|NCT03827408|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24959074|NCT03827408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24959075|NCT03827408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24959095|NCT03827122|Cholinergic Agents|cholinergic agents|mesh-ancestor
24959096|NCT03827122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24959098|NCT03827044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24959099|NCT03827044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24959101|NCT03827200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24959102|NCT03827278|Itraconazole|itraconazole|mesh-list
24959103|NCT03827278|Voriconazole|voriconazole|mesh-list
24959104|NCT03827278|Amphotericin B|amphotericin b|mesh-list
24959105|NCT03827278|Antifungal Agents|antifungal agents|mesh-ancestor
24785232|NCT01912755|Autonomic Agents|autonomic agents|mesh-ancestor
24785233|NCT01912755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24785234|NCT01912755|Respiratory System Agents|respiratory system agents|mesh-ancestor
24959326|NCT03825380|Bimatoprost|bimatoprost|mesh-list
24959327|NCT03825380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24959328|NCT03825250|Valproic Acid|valproic acid|mesh-list
24959329|NCT03825250|Anticonvulsants|anticonvulsants|mesh-ancestor
24959330|NCT03825250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24959331|NCT03825250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959332|NCT03825250|GABA Agents|gaba agents|mesh-ancestor
24570803|NCT00806767|Fludarabine|fludarabine|mesh-list
24959575|NCT03823911|Sofosbuvir|sofosbuvir|mesh-list
24959576|NCT03823911|Grazoprevir|grazoprevir|mesh-list
25034082|NCT03567928|Anesthetics|anesthetics|mesh-ancestor
25034083|NCT03567681|Oxcarbazepine|oxcarbazepine|mesh-list
25034084|NCT03567681|Anticonvulsants|anticonvulsants|mesh-ancestor
25034085|NCT03567681|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25034086|NCT03567681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25034087|NCT03567681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24959577|NCT03823911|Ledipasvir|ledipasvir|mesh-list
24959604|NCT03823976|Anesthetics|anesthetics|mesh-list
24959605|NCT03823976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24959606|NCT03823976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959607|NCT03823950|Lenograstim|lenograstim|mesh-list
24959608|NCT03823950|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24959609|NCT03823950|Immunologic Factors|immunologic factors|mesh-ancestor
24797355|NCT01955200|Cilostazol|cilostazol|mesh-list
25166655|NCT03828019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166656|NCT03828019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166657|NCT03828019|Dermatologic Agents|dermatologic agents|mesh-ancestor
24959724|NCT03822962|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24959725|NCT03822962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24959726|NCT03822962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959727|NCT03822962|Antipyretics|antipyretics|mesh-ancestor
24959728|NCT03822715|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25829250|NCT00006167|Hormones|hormones|mesh-ancestor
25829251|NCT00006167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25829252|NCT00006167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829253|NCT00006167|Anabolic Agents|anabolic agents|mesh-ancestor
25829254|NCT00006168|Methotrexate|methotrexate|mesh-list
25829255|NCT00006168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25829256|NCT00006168|Abortifacient Agents|abortifacient agents|mesh-ancestor
25829257|NCT00006168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25829258|NCT00006168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959729|NCT03822715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24959730|NCT03822715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24959731|NCT03822715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959732|NCT03822715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24959733|NCT03822715|Hormone Antagonists|hormone antagonists|mesh-ancestor
24959734|NCT03822715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24959736|NCT03822663|Caffeine|caffeine|mesh-list
25034119|NCT03567629|Antimetabolites|antimetabolites|mesh-ancestor
24959737|NCT03822663|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24959738|NCT03822663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959739|NCT03822663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24959740|NCT03822663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24959980|NCT03820193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24786084|NCT01917877|Hormones|hormones|mesh-ancestor
24959986|NCT03820193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959987|NCT03820193|Anticonvulsants|anticonvulsants|mesh-ancestor
24959988|NCT03820193|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24959989|NCT03820193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24959990|NCT03820193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24959991|NCT03820193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24959992|NCT03820193|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24959993|NCT03820193|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24959994|NCT03820193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24959995|NCT03820193|Antimanic Agents|antimanic agents|mesh-ancestor
25078601|NCT03355170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24959996|NCT03820193|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24959998|NCT03820193|Antitussive Agents|antitussive agents|mesh-ancestor
24959999|NCT03820193|Respiratory System Agents|respiratory system agents|mesh-ancestor
24960000|NCT03820193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24960001|NCT03820193|Antiemetics|antiemetics|mesh-ancestor
24960002|NCT03820193|Autonomic Agents|autonomic agents|mesh-ancestor
24960003|NCT03820193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24960278|NCT03818282|Mitosis Modulators|mitosis modulators|mesh-ancestor
24778562|NCT01871662|Silymarin|silymarin|mesh-list
24960427|NCT03817112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24960428|NCT03817112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960429|NCT03817112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24960430|NCT03817112|Anesthetics, General|anesthetics, general|mesh-ancestor
24601149|NCT00963027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24960432|NCT03817112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24960433|NCT03817112|Analgesics|analgesics|mesh-ancestor
24960434|NCT03817112|Sensory System Agents|sensory system agents|mesh-ancestor
24960435|NCT03817112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24960436|NCT03817112|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24960437|NCT03817112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24960553|NCT03815942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960555|NCT03815838|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24960557|NCT03815838|Dopamine Agents|dopamine agents|mesh-ancestor
24960558|NCT03815838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24889587|NCT04491786|Antimanic Agents|antimanic agents|mesh-ancestor
24960701|NCT03814447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24960702|NCT03814447|Alkylating Agents|alkylating agents|mesh-ancestor
25650429|NCT01502761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25650430|NCT01502761|Tocolytic Agents|tocolytic agents|mesh-ancestor
25650431|NCT01502761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25650432|NCT01502787|Metoprolol|metoprolol|mesh-list
25650433|NCT01502787|Nebivolol|nebivolol|mesh-list
25650434|NCT01502787|Angiotensin II|angiotensin ii|mesh-list
25650435|NCT01502787|Giapreza|giapreza|mesh-list
25650436|NCT01502787|Angiotensinogen|angiotensinogen|mesh-list
25650437|NCT01502787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25650438|NCT01502787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24437466|NCT00273702|Antiviral Agents|antiviral agents|mesh-ancestor
25650439|NCT01502787|Sympatholytics|sympatholytics|mesh-ancestor
25829259|NCT00006168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25829260|NCT00006168|Antimetabolites|antimetabolites|mesh-ancestor
25829261|NCT00006168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829262|NCT00006168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829263|NCT00006168|Dermatologic Agents|dermatologic agents|mesh-ancestor
24960703|NCT03814447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960704|NCT03814447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24960705|NCT03814447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24960707|NCT03814616|Pyronaridine|pyronaridine|mesh-list
24960708|NCT03814616|Antimalarials|antimalarials|mesh-ancestor
24960709|NCT03814616|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24960710|NCT03814616|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24960711|NCT03814616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24960712|NCT03814616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24960713|NCT03814616|Antiviral Agents|antiviral agents|mesh-ancestor
24960714|NCT03814616|Schistosomicides|schistosomicides|mesh-ancestor
25078653|NCT03354806|Analgesics|analgesics|mesh-list
25078654|NCT03354806|Sensory System Agents|sensory system agents|mesh-ancestor
25078655|NCT03354806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078656|NCT03354806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960826|NCT03813927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960827|NCT03813927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24960828|NCT03813940|Vaccines|vaccines|mesh-list
24960829|NCT03813940|Immunologic Factors|immunologic factors|mesh-ancestor
24960830|NCT03813940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960831|NCT03813771|Hydroxychloroquine|hydroxychloroquine|mesh-list
24960832|NCT03813771|Sulfasalazine|sulfasalazine|mesh-list
24960833|NCT03813771|Etanercept|etanercept|mesh-list
24960834|NCT03813771|Methotrexate|methotrexate|mesh-list
24960835|NCT03813771|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24961240|NCT03809897|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24961241|NCT03809897|Autonomic Agents|autonomic agents|mesh-ancestor
24961242|NCT03809897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961398|NCT03808844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24961399|NCT03808844|Anesthetics, General|anesthetics, general|mesh-ancestor
24961401|NCT03809078|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
24961402|NCT03809078|Bombesin|bombesin|mesh-list
24961403|NCT03809078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24961404|NCT03809078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961405|NCT03809078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24961406|NCT03809078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961572|NCT03807011|Anesthetics, General|anesthetics, general|mesh-ancestor
24961574|NCT03806673|Bupivacaine|bupivacaine|mesh-list
24961575|NCT03806673|Anesthetics, Local|anesthetics, local|mesh-ancestor
24961576|NCT03806673|Anesthetics|anesthetics|mesh-ancestor
25078708|NCT03354312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25078709|NCT03354312|Autonomic Agents|autonomic agents|mesh-ancestor
25078710|NCT03354312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25078711|NCT03354312|Respiratory System Agents|respiratory system agents|mesh-ancestor
25078713|NCT03354312|Sympathomimetics|sympathomimetics|mesh-ancestor
25078714|NCT03354312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25078715|NCT03354117|Meloxicam|meloxicam|mesh-list
25034250|NCT03566316|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25034251|NCT03566316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25034257|NCT03566316|Vasodilator Agents|vasodilator agents|mesh-ancestor
25078716|NCT03354117|Ulipristal acetate|ulipristal acetate|mesh-list
24778820|NCT01872546|Adalimumab|adalimumab|mesh-list
24961786|NCT03805282|Sensory System Agents|sensory system agents|mesh-ancestor
24961787|NCT03805282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961788|NCT03805282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24961789|NCT03805282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24961790|NCT03805282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24961791|NCT03805282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24961792|NCT03805282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961794|NCT03805360|Anesthetics, Local|anesthetics, local|mesh-list
24961795|NCT03805360|Anesthetics|anesthetics|mesh-list
24961796|NCT03805360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25034339|NCT03565406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24961797|NCT03805360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961798|NCT03805360|Sensory System Agents|sensory system agents|mesh-ancestor
24961799|NCT03805360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961800|NCT03805503|Chloroprocaine|chloroprocaine|mesh-list
25650440|NCT01502787|Autonomic Agents|autonomic agents|mesh-ancestor
25650441|NCT01502787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650442|NCT01502787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650443|NCT01502787|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24961801|NCT03805503|Procaine|procaine|mesh-list
24961802|NCT03805503|Anesthetics, Local|anesthetics, local|mesh-ancestor
24961803|NCT03805503|Anesthetics|anesthetics|mesh-ancestor
24864568|NCT03344341|Acarbose|acarbose|mesh-list
24512082|NCT00572663|Antiviral Agents|antiviral agents|mesh-ancestor
24512083|NCT00572663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24512084|NCT00572663|Expectorants|expectorants|mesh-ancestor
24512122|NCT00573001|Lopinavir|lopinavir|mesh-list
24890738|NCT04480775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24961837|NCT03805152|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24961838|NCT03805152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24787764|NCT01927406|Timolol|timolol|mesh-list
24961840|NCT03805152|Cholinergic Agents|cholinergic agents|mesh-ancestor
24961841|NCT03805152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24961842|NCT03805152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961843|NCT03805152|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24778849|NCT01872832|Verinurad|verinurad|mesh-list
25034365|NCT03565159|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25034366|NCT03565159|Immunologic Factors|immunologic factors|mesh-ancestor
25034367|NCT03565159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034368|NCT03565133|Quinine|quinine|mesh-list
25034369|NCT03565133|Antimalarials|antimalarials|mesh-ancestor
25034370|NCT03565133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25034371|NCT03565133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24962001|NCT03803371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962002|NCT03803371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962003|NCT03803371|Antipyretics|antipyretics|mesh-ancestor
24962004|NCT03803371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24962005|NCT03803371|Narcotics|narcotics|mesh-ancestor
24962006|NCT03803371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24962007|NCT03803254|Lenvatinib|lenvatinib|mesh-list
24962011|NCT03803254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962035|NCT03803267|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24962036|NCT03803267|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24962037|NCT03803267|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24962038|NCT03803267|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24962039|NCT03803267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24962040|NCT03803267|Cholinergic Agents|cholinergic agents|mesh-ancestor
24962387|NCT03799224|Antimetabolites|antimetabolites|mesh-ancestor
25078754|NCT03353857|Rifampin|rifampin|mesh-list
25078755|NCT03353857|Dienogest|dienogest|mesh-list
25078756|NCT03353857|Drospirenone|drospirenone|mesh-list
25078757|NCT03353857|Midazolam|midazolam|mesh-list
25078758|NCT03353857|Levonorgestrel|levonorgestrel|mesh-list
25078759|NCT03353857|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25078760|NCT03353857|Norethindrone|norethindrone|mesh-list
25078761|NCT03353857|Norethindrone Acetate|norethindrone acetate|mesh-list
25078762|NCT03353857|Desogestrel|desogestrel|mesh-list
25078763|NCT03353857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25078764|NCT03353857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24779010|NCT01873313|Ropivacaine|ropivacaine|mesh-list
24962705|NCT03795792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24962706|NCT03795792|Analgesics|analgesics|mesh-ancestor
24962707|NCT03795792|Sensory System Agents|sensory system agents|mesh-ancestor
24962708|NCT03795792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588462|NCT00902772|GABA Modulators|gaba modulators|mesh-ancestor
24962749|NCT03795649|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24962750|NCT03795649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962751|NCT03795649|Hemostatics|hemostatics|mesh-ancestor
24962752|NCT03795649|Coagulants|coagulants|mesh-ancestor
24962755|NCT03795597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24962756|NCT03795597|Alkylating Agents|alkylating agents|mesh-ancestor
24962757|NCT03795597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962758|NCT03795597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962759|NCT03795597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24891684|NCT04468438|Hormones|hormones|mesh-ancestor
25078791|NCT03353857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25078792|NCT03353857|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25078793|NCT03353857|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24962825|NCT03794505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24962826|NCT03794505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626885|NCT01089088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626886|NCT01089088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24626887|NCT01089088|Immunologic Factors|immunologic factors|mesh-ancestor
25081795|NCT03327168|Vasodilator Agents|vasodilator agents|mesh-ancestor
24963083|NCT03792971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963084|NCT03792971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963086|NCT03792971|Protective Agents|protective agents|mesh-ancestor
24963087|NCT03792984|Vitamin D|vitamin d|mesh-list
24963088|NCT03792984|Cholecalciferol|cholecalciferol|mesh-list
24892101|NCT04465695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963157|NCT03792139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24963158|NCT03792139|Hormone Antagonists|hormone antagonists|mesh-ancestor
24963159|NCT03792139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24963160|NCT03792139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963161|NCT03792139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24963162|NCT03792269|Capecitabine|capecitabine|mesh-list
24963163|NCT03792269|Oxaliplatin|oxaliplatin|mesh-list
24963164|NCT03792269|Irinotecan|irinotecan|mesh-list
24963165|NCT03792269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24963166|NCT03792269|Antimetabolites|antimetabolites|mesh-ancestor
25034466|NCT03564548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892172|NCT04465396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24963193|NCT03792152|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24963194|NCT03792152|Antithrombins|antithrombins|mesh-ancestor
24963195|NCT03792152|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24963196|NCT03792152|Protease Inhibitors|protease inhibitors|mesh-ancestor
24963197|NCT03792152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24963198|NCT03792152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570703|NCT00805857|Tipranavir|tipranavir|mesh-list
24963294|NCT03791801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24963320|NCT03791827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24963321|NCT03791827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24963322|NCT03791827|Alkylating Agents|alkylating agents|mesh-ancestor
24963323|NCT03791827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963324|NCT03791827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24963398|NCT03791294|Dermatologic Agents|dermatologic agents|mesh-ancestor
24963399|NCT03791294|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25039921|NCT03594058|Solabegron|solabegron|mesh-list
24620998|NCT01060293|Dopamine|dopamine|mesh-list
24964130|NCT03785015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964226|NCT03784443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24964227|NCT03784443|Growth Substances|growth substances|mesh-ancestor
24964709|NCT03781115|Antiemetics|antiemetics|mesh-ancestor
24964740|NCT03781011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964907|NCT03779633|Estradiol|estradiol|mesh-list
24964908|NCT03779633|Estrogens|estrogens|mesh-ancestor
24964909|NCT03779633|Hormones|hormones|mesh-ancestor
24964910|NCT03779633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24964911|NCT03779633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964912|NCT03779516|Lidocaine|lidocaine|mesh-list
24964913|NCT03779516|Anesthetics, Local|anesthetics, local|mesh-ancestor
24964914|NCT03779516|Anesthetics|anesthetics|mesh-ancestor
24627058|NCT01090466|Antiviral Agents|antiviral agents|mesh-ancestor
24627059|NCT01090466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24627060|NCT01090466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627061|NCT01090466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24627073|NCT01090596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24991278|NCT05196256|Levobupivacaine|levobupivacaine|mesh-list
24627075|NCT01090596|Sensory System Agents|sensory system agents|mesh-ancestor
24627076|NCT01090596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24627077|NCT01090596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627078|NCT01090596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24627079|NCT01090596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24627080|NCT01090596|Gout Suppressants|gout suppressants|mesh-ancestor
24627081|NCT01090596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24627082|NCT01090596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627083|NCT01090596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627084|NCT01090648|Etravirine|etravirine|mesh-list
24587733|NCT00896558|Anesthetics|anesthetics|mesh-ancestor
24998363|NCT03018834|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24998365|NCT03009201|Doxorubicin|doxorubicin|mesh-list
24998366|NCT03009201|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24998367|NCT03009201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24760145|NCT01756495|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24760146|NCT01756495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25034537|NCT03563950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034538|NCT03563950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25034544|NCT03563937|Rivaroxaban|rivaroxaban|mesh-list
24760147|NCT01756495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24760148|NCT01756495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24760183|NCT01756638|Glucocorticoids|glucocorticoids|mesh-ancestor
24760185|NCT01756638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25650444|NCT01502787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24760366|NCT01757756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760368|NCT01757756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24760369|NCT01757756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24760370|NCT01757756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24760371|NCT01757756|Anesthetics, General|anesthetics, general|mesh-ancestor
24760373|NCT01757756|GABA Modulators|gaba modulators|mesh-ancestor
24760374|NCT01757756|GABA Agents|gaba agents|mesh-ancestor
25079628|NCT03346538|Edaravone|edaravone|mesh-list
25079661|NCT03346252|Cholinergic Agents|cholinergic agents|mesh-ancestor
25079662|NCT03346252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25079663|NCT03346252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079664|NCT03346252|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25079665|NCT03346252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25079666|NCT03346226|Dexmedetomidine|dexmedetomidine|mesh-list
25079667|NCT03346226|Propofol|propofol|mesh-list
24760413|NCT01757899|Hormones|hormones|mesh-ancestor
24779887|NCT01879514|Prednisone|prednisone|mesh-list
24761363|NCT01762332|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24761364|NCT01762332|Adrenergic Agents|adrenergic agents|mesh-ancestor
24761365|NCT01762332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24761366|NCT01762332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761367|NCT01762436|Atenolol|atenolol|mesh-list
24761368|NCT01762436|Bisoprolol|bisoprolol|mesh-list
24761563|NCT01763424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25034601|NCT03563365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034602|NCT03563365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034637|NCT03563170|Capecitabine|capecitabine|mesh-list
25034638|NCT03563170|Cetuximab|cetuximab|mesh-list
25034679|NCT03563144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24761564|NCT01763424|Antimetabolites|antimetabolites|mesh-ancestor
24761565|NCT01763424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761566|NCT01763424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24761567|NCT01763424|Vasodilator Agents|vasodilator agents|mesh-ancestor
24761568|NCT01763424|Dermatologic Agents|dermatologic agents|mesh-ancestor
24761569|NCT01763424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24762100|NCT01766089|Adrenergic Agents|adrenergic agents|mesh-ancestor
24762101|NCT01766089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24762312|NCT01767545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24762314|NCT01767545|Autonomic Agents|autonomic agents|mesh-ancestor
25171822|NCT02884596|Serotonin|serotonin|mesh-list
24762431|NCT01768299|Misoprostol|misoprostol|mesh-list
24762465|NCT01768312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24627722|NCT01094535|Hormones|hormones|mesh-ancestor
24762555|NCT01768663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24762556|NCT01768663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24762693|NCT01769118|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24762694|NCT01769118|Purinergic Agents|purinergic agents|mesh-ancestor
24762752|NCT01769651|Respiratory System Agents|respiratory system agents|mesh-ancestor
24762754|NCT01769664|Clindamycin palmitate|clindamycin palmitate|mesh-list
24762755|NCT01769664|Clindamycin phosphate|clindamycin phosphate|mesh-list
24762756|NCT01769664|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24762850|NCT01769898|Purinergic Agents|purinergic agents|mesh-ancestor
24762852|NCT01769911|Etoposide|etoposide|mesh-list
24762853|NCT01769911|Etoposide phosphate|etoposide phosphate|mesh-list
24762902|NCT01770132|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
24762903|NCT01770132|Trioxsalen|trioxsalen|mesh-list
24762904|NCT01770132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24762905|NCT01770132|Antimetabolites|antimetabolites|mesh-ancestor
24762906|NCT01770132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762907|NCT01770132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24762908|NCT01770132|Antiviral Agents|antiviral agents|mesh-ancestor
24762909|NCT01770132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24762910|NCT01770132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762911|NCT01770132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24762912|NCT01770132|Immunologic Factors|immunologic factors|mesh-ancestor
24762913|NCT01770132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762914|NCT01770132|Dermatologic Agents|dermatologic agents|mesh-ancestor
25079958|NCT03343795|Hormones|hormones|mesh-ancestor
24762915|NCT01770132|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24762916|NCT01770171|Paclitaxel|paclitaxel|mesh-list
24762917|NCT01770171|Bevacizumab|bevacizumab|mesh-list
24762918|NCT01770171|Carboplatin|carboplatin|mesh-list
24763343|NCT01773005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24763345|NCT01773005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24763346|NCT01773005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24763347|NCT01773005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763348|NCT01773005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763349|NCT01773044|Lidocaine|lidocaine|mesh-list
25080078|NCT03342352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080079|NCT03342352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25080080|NCT03342352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25080081|NCT03342352|Immunologic Factors|immunologic factors|mesh-ancestor
25080082|NCT03342352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763577|NCT01774877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763614|NCT01775475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24763615|NCT01775475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24763616|NCT01775475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24763617|NCT01775475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24763618|NCT01775475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24763619|NCT01775475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763900|NCT01778101|Lansoprazole|lansoprazole|mesh-list
24763955|NCT01778413|Efavirenz|efavirenz|mesh-list
24763956|NCT01778413|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24763957|NCT01778413|Antiviral Agents|antiviral agents|mesh-ancestor
24763958|NCT01778413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24763959|NCT01778413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24764173|NCT01779843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24764174|NCT01779843|Antimetabolites|antimetabolites|mesh-ancestor
24764175|NCT01779843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764316|NCT01780558|Progestins|progestins|mesh-ancestor
24764317|NCT01780610|Letrozole|letrozole|mesh-list
24764318|NCT01780610|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24764319|NCT01780610|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24764320|NCT01780610|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24764321|NCT01780610|Hormones|hormones|mesh-list
24764322|NCT01780610|Estradiol|estradiol|mesh-list
24627212|NCT01091324|Antitussive Agents|antitussive agents|mesh-ancestor
24627213|NCT01091324|Respiratory System Agents|respiratory system agents|mesh-ancestor
24780411|NCT01884298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24764324|NCT01780610|Progesterone|progesterone|mesh-list
25080109|NCT03342079|Analgesics|analgesics|mesh-ancestor
25080110|NCT03342040|Bupivacaine|bupivacaine|mesh-list
25080111|NCT03342040|Ropivacaine|ropivacaine|mesh-list
25080112|NCT03342040|Anesthetics, Local|anesthetics, local|mesh-ancestor
24764388|NCT01780948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764390|NCT01781052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24764391|NCT01781052|Vasodilator Agents|vasodilator agents|mesh-ancestor
24764392|NCT01781273|Ethanol|ethanol|mesh-list
24764393|NCT01781273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24764394|NCT01781273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24764395|NCT01781273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24764396|NCT01781273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764397|NCT01781377|Metoclopramide|metoclopramide|mesh-list
24764398|NCT01781377|Propofol|propofol|mesh-list
24764399|NCT01781377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24764400|NCT01781377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24764401|NCT01781377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764402|NCT01781377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24764403|NCT01781377|Anesthetics, General|anesthetics, general|mesh-ancestor
24764462|NCT01781897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764547|NCT01782573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24764548|NCT01782573|Disinfectants|disinfectants|mesh-ancestor
24764549|NCT01782573|Dermatologic Agents|dermatologic agents|mesh-ancestor
24764550|NCT01782599|Nicotine|nicotine|mesh-list
24764551|NCT01782599|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24764552|NCT01782599|Autonomic Agents|autonomic agents|mesh-ancestor
24764553|NCT01782599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24764554|NCT01782599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780550|NCT01884896|Metoprolol|metoprolol|mesh-list
24764784|NCT01784250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24764785|NCT01784250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24764786|NCT01784250|Vasodilator Agents|vasodilator agents|mesh-ancestor
24764788|NCT01784250|Sensory System Agents|sensory system agents|mesh-ancestor
24764789|NCT01784250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24764790|NCT01784250|Sympatholytics|sympatholytics|mesh-ancestor
24764791|NCT01784250|Autonomic Agents|autonomic agents|mesh-ancestor
24764792|NCT01784250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24764793|NCT01784250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24764794|NCT01784250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24764795|NCT01784302|Raltegravir Potassium|raltegravir potassium|mesh-list
24966185|NCT03770663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24966186|NCT03770663|Immunologic Factors|immunologic factors|mesh-ancestor
24966187|NCT03770663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966188|NCT03770663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25829264|NCT00006168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829265|NCT00006168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25829266|NCT00006168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25829267|NCT00006168|Immunologic Factors|immunologic factors|mesh-ancestor
25829268|NCT00006168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25829269|NCT00006168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25829270|NCT00006174|Letrozole|letrozole|mesh-list
25829271|NCT00006174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829272|NCT00006174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25829273|NCT00006174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25829274|NCT00006174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829275|NCT00006174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626119|NCT01085617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24626120|NCT01085656|Combretastatin|combretastatin|mesh-list
24626121|NCT01085656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24902079|NCT04377867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24764871|NCT01784562|Enzyme Activators|enzyme activators|mesh-ancestor
24764872|NCT01784562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764874|NCT01784640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24764875|NCT01784640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764876|NCT01784640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764877|NCT01784640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24764878|NCT01784640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24765136|NCT01786200|Sensory System Agents|sensory system agents|mesh-ancestor
24765137|NCT01786200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24765138|NCT01786200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780703|NCT01886001|Chlorhexidine|chlorhexidine|mesh-list
24765286|NCT01787474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24765287|NCT01787474|Antimetabolites|antimetabolites|mesh-ancestor
24765288|NCT01787474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765289|NCT01787474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24765290|NCT01787474|Immunologic Factors|immunologic factors|mesh-ancestor
24765291|NCT01787474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765292|NCT01787474|Antiviral Agents|antiviral agents|mesh-ancestor
24765293|NCT01787474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24765294|NCT01787474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24765379|NCT01788254|Diuretics|diuretics|mesh-ancestor
24765380|NCT01788254|Natriuretic Agents|natriuretic agents|mesh-ancestor
24765381|NCT01788254|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24765382|NCT01788254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24765383|NCT01788254|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24765384|NCT01788254|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24765385|NCT01788254|Adrenergic Agents|adrenergic agents|mesh-ancestor
24765386|NCT01788254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24765433|NCT01788501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765434|NCT01788501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25034944|NCT03560856|Fulvestrant|fulvestrant|mesh-list
24458414|NCT00337792|Sensory System Agents|sensory system agents|mesh-ancestor
24458415|NCT00337792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24458416|NCT00337792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24458417|NCT00337792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24458418|NCT00337792|Anesthetics, General|anesthetics, general|mesh-ancestor
24458419|NCT00337792|Anesthetics|anesthetics|mesh-ancestor
24458420|NCT00337792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24458421|NCT00337792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24458422|NCT00337792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24458423|NCT00337792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25161646|NCT00042289|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24765435|NCT01788501|Dermatologic Agents|dermatologic agents|mesh-ancestor
24765436|NCT01788501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24765437|NCT01788501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24765438|NCT01788501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24765439|NCT01788501|Immunologic Factors|immunologic factors|mesh-ancestor
25650445|NCT01502787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25650446|NCT01502787|Adrenergic Agents|adrenergic agents|mesh-ancestor
25650447|NCT01502787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25650448|NCT01502787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650449|NCT01502787|Vasodilator Agents|vasodilator agents|mesh-ancestor
25650450|NCT01502787|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25650451|NCT01502787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25650452|NCT01502787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25650453|NCT01502787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25650454|NCT01502787|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25829276|NCT00006174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25829277|NCT00006174|Hormone Antagonists|hormone antagonists|mesh-ancestor
24801686|NCT01984931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25829652|NCT00006245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24437839|NCT00274560|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24437840|NCT00274560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24437842|NCT00274560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24437843|NCT00274560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765440|NCT01788501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24765441|NCT01788501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24765442|NCT01788501|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24765443|NCT01788501|Antifungal Agents|antifungal agents|mesh-ancestor
24765444|NCT01788501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24765445|NCT01788540|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24765446|NCT01788540|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24765447|NCT01788540|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24556236|NCT00746486|Budesonide|budesonide|mesh-list
24765448|NCT01788540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24765464|NCT01788722|Dienogest|dienogest|mesh-list
24765465|NCT01788722|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24765466|NCT01788722|Contraceptive Agents|contraceptive agents|mesh-ancestor
24765467|NCT01788722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24765468|NCT01788722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627226|NCT01091337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627227|NCT01091337|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24627228|NCT01091337|Respiratory System Agents|respiratory system agents|mesh-ancestor
24627229|NCT01091337|Tocolytic Agents|tocolytic agents|mesh-ancestor
24765890|NCT01791231|Canagliflozin|canagliflozin|mesh-list
24765891|NCT01791231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24765892|NCT01791231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765893|NCT01791231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24765894|NCT01791231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166664|NCT03828019|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25166665|NCT03828019|Antifungal Agents|antifungal agents|mesh-ancestor
25166666|NCT03828019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25166667|NCT03828019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25166668|NCT03791398|Nivolumab|nivolumab|mesh-list
25166669|NCT03791398|TIC10 compound|tic10 compound|mesh-list
25166670|NCT03791398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25166671|NCT03791398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166672|NCT03791398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25166673|NCT03791398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166682|NCT03758781|Nivolumab|nivolumab|mesh-list
25166683|NCT03758781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25166684|NCT03758781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166685|NCT03758781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25166686|NCT03758781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166687|NCT03758287|Gefitinib|gefitinib|mesh-list
25166688|NCT03758287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166689|NCT03758287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25166690|NCT03758287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25166691|NCT03758287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166692|NCT03757585|Inositol|inositol|mesh-list
25166693|NCT03757585|Acetylcysteine|acetylcysteine|mesh-list
25166694|NCT03757585|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25166695|NCT03757585|Antiviral Agents|antiviral agents|mesh-ancestor
25166696|NCT03757585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25166697|NCT03757585|Expectorants|expectorants|mesh-ancestor
25166698|NCT03757585|Respiratory System Agents|respiratory system agents|mesh-ancestor
25166699|NCT03757585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25166700|NCT03757585|Antioxidants|antioxidants|mesh-ancestor
25166701|NCT03757585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166702|NCT03757585|Protective Agents|protective agents|mesh-ancestor
25166703|NCT03757585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166704|NCT03757585|Antidotes|antidotes|mesh-ancestor
25166705|NCT03757585|Vitamin B Complex|vitamin b complex|mesh-ancestor
25166706|NCT03757585|Vitamins|vitamins|mesh-ancestor
25650455|NCT01502787|Protease Inhibitors|protease inhibitors|mesh-ancestor
25650456|NCT01502787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650457|NCT01502813|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
25650458|NCT01502813|Nootropic Agents|nootropic agents|mesh-ancestor
25650459|NCT01502956|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25650460|NCT01502956|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25650461|NCT01502956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25166707|NCT03757585|Micronutrients|micronutrients|mesh-ancestor
25829278|NCT00006174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24626136|NCT01085708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25829279|NCT00006174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829280|NCT00006180|Alendronate|alendronate|mesh-list
25829281|NCT00006180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24626137|NCT01085708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626138|NCT01085708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626140|NCT01085721|Phenylpropanolamine|phenylpropanolamine|mesh-list
25200008|NCT02737059|Codeine|codeine|mesh-list
25200009|NCT02737059|Naloxegol|naloxegol|mesh-list
25829282|NCT00006180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626141|NCT01085721|Pseudoephedrine|pseudoephedrine|mesh-list
24626143|NCT01085721|Guaifenesin|guaifenesin|mesh-list
24801690|NCT01985061|Alkylating Agents|alkylating agents|mesh-ancestor
24461087|NCT00350961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438207|NCT00275106|Antimetabolites|antimetabolites|mesh-ancestor
24438244|NCT00275184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438245|NCT00275184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25035072|NCT03560011|Immunoglobulins|immunoglobulins|mesh-list
25166777|NCT03685500|Protease Inhibitors|protease inhibitors|mesh-ancestor
25166778|NCT03685500|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25166779|NCT03685500|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25166780|NCT03678545|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25166781|NCT03678545|Immunologic Factors|immunologic factors|mesh-ancestor
25166782|NCT03678545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166783|NCT03678350|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
25166784|NCT03678350|Trioxsalen|trioxsalen|mesh-list
25166785|NCT03678350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166786|NCT03678350|Dermatologic Agents|dermatologic agents|mesh-ancestor
25166787|NCT03678350|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25166788|NCT03654053|Simvastatin|simvastatin|mesh-list
25166789|NCT03654053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25166790|NCT03654053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25166791|NCT03654053|Antimetabolites|antimetabolites|mesh-ancestor
25166792|NCT03654053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166793|NCT03654053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25166794|NCT03654053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25035303|NCT03557229|Vitamins|vitamins|mesh-list
25166829|NCT03635333|Nicotine|nicotine|mesh-list
25166830|NCT03635333|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25166831|NCT03635333|Autonomic Agents|autonomic agents|mesh-ancestor
25166832|NCT03635333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25166833|NCT03635333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166834|NCT03635333|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25166835|NCT03635333|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25166836|NCT03635333|Cholinergic Agents|cholinergic agents|mesh-ancestor
25166837|NCT03635333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25166838|NCT03635333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035314|NCT03557229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25035315|NCT03557229|Antiviral Agents|antiviral agents|mesh-ancestor
25035316|NCT03557229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25035317|NCT03557229|Expectorants|expectorants|mesh-ancestor
25035318|NCT03557229|Respiratory System Agents|respiratory system agents|mesh-ancestor
25035319|NCT03557229|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25650462|NCT01502956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650463|NCT01502956|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25650464|NCT01502956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25650465|NCT01502956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650466|NCT01502956|Cholinergic Agents|cholinergic agents|mesh-ancestor
25650467|NCT01502956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25650468|NCT01503229|Prednisone|prednisone|mesh-list
25650469|NCT01503229|Cortisone|cortisone|mesh-list
25650470|NCT01503229|Abiraterone Acetate|abiraterone acetate|mesh-list
25650471|NCT01503229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25650472|NCT01503229|Glucocorticoids|glucocorticoids|mesh-ancestor
25650473|NCT01503229|Hormones|hormones|mesh-ancestor
25650474|NCT01503229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25650475|NCT01503229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650476|NCT01503229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25650477|NCT01503229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25650478|NCT01503229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25650479|NCT01503229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25035320|NCT03557229|Antidotes|antidotes|mesh-ancestor
25035321|NCT03557112|Nimotuzumab|nimotuzumab|mesh-list
25829283|NCT00006185|Rosiglitazone|rosiglitazone|mesh-list
25829284|NCT00006185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25829285|NCT00006185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829286|NCT00006190|Lamivudine|lamivudine|mesh-list
25829287|NCT00006190|Efavirenz|efavirenz|mesh-list
25829288|NCT00006190|Stavudine|stavudine|mesh-list
25829289|NCT00006190|Nelfinavir|nelfinavir|mesh-list
25829290|NCT00006190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25829291|NCT00006190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25829292|NCT00006190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829293|NCT00006190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829294|NCT00006190|Antiviral Agents|antiviral agents|mesh-ancestor
25829295|NCT00006190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25829296|NCT00006190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25829297|NCT00006190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25829298|NCT00006190|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25829299|NCT00006190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25829300|NCT00006190|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25829301|NCT00006190|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25829302|NCT00006190|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25829303|NCT00006190|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25829304|NCT00006190|Antimetabolites|antimetabolites|mesh-ancestor
25035322|NCT03557112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25035323|NCT03557112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25035324|NCT03556917|Caffeine|caffeine|mesh-list
25035325|NCT03556917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25035326|NCT03556917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166864|NCT03615040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25166867|NCT03603808|Vaccines|vaccines|mesh-list
25166868|NCT03603808|Immunologic Factors|immunologic factors|mesh-ancestor
25166869|NCT03603808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035336|NCT03556852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25035337|NCT03556852|Abortifacient Agents|abortifacient agents|mesh-ancestor
25035338|NCT03556852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25203471|NCT02714361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25203472|NCT02714036|Ibudilast|ibudilast|mesh-list
25203473|NCT02714036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25203474|NCT02714036|Autonomic Agents|autonomic agents|mesh-ancestor
25203475|NCT02714036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25203476|NCT02714036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203477|NCT02714036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25203478|NCT02714036|Respiratory System Agents|respiratory system agents|mesh-ancestor
25203479|NCT02714036|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25035419|NCT03556098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25203480|NCT02714036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203481|NCT02714036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458425|NCT00337792|GABA Agents|gaba agents|mesh-ancestor
25829305|NCT00006190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25829306|NCT00006190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24458460|NCT00338052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24458461|NCT00338052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458462|NCT00338052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24458463|NCT00338052|Contraceptive Agents|contraceptive agents|mesh-ancestor
24458464|NCT00338052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24458465|NCT00338052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25829307|NCT00006190|Protease Inhibitors|protease inhibitors|mesh-ancestor
25829308|NCT00006195|Olanzapine|olanzapine|mesh-list
25829309|NCT00006195|Risperidone|risperidone|mesh-list
25829310|NCT00006195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25829311|NCT00006195|Serotonin Agents|serotonin agents|mesh-ancestor
24765959|NCT01791647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24765960|NCT01791647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650480|NCT01503229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650481|NCT01503229|Hormone Antagonists|hormone antagonists|mesh-ancestor
25650482|NCT01503229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25650483|NCT01503749|Lenograstim|lenograstim|mesh-list
25650484|NCT01503749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25650485|NCT01503749|Immunologic Factors|immunologic factors|mesh-ancestor
25650486|NCT01503749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650487|NCT01504204|Adapalene|adapalene|mesh-list
25650488|NCT01504204|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
25650489|NCT01504204|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24437467|NCT00273702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24765995|NCT01791881|Cholinergic Agents|cholinergic agents|mesh-ancestor
24765996|NCT01791881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24765997|NCT01791881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765998|NCT01791881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24765999|NCT01791881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24766033|NCT01792037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25166884|NCT03587038|Temozolomide|temozolomide|mesh-list
25166885|NCT03587038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25166886|NCT03587038|Alkylating Agents|alkylating agents|mesh-ancestor
25166887|NCT03587038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166888|NCT03587038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166889|NCT03582124|Panitumumab|panitumumab|mesh-list
25166890|NCT03582124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25166891|NCT03582124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166893|NCT03570983|Etoposide|etoposide|mesh-list
25166894|NCT03570983|Melphalan|melphalan|mesh-list
25166895|NCT03570983|Carmustine|carmustine|mesh-list
25166896|NCT03570983|Allopurinol|allopurinol|mesh-list
25166897|NCT03570983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25166898|NCT03570983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166899|NCT03570983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25166900|NCT03570983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25166901|NCT03570983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25035527|NCT03555071|Immunologic Factors|immunologic factors|mesh-ancestor
25035528|NCT03555071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166902|NCT03570983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166903|NCT03570983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25166904|NCT03570983|Antimetabolites|antimetabolites|mesh-ancestor
25166905|NCT03570983|Antiviral Agents|antiviral agents|mesh-ancestor
25166906|NCT03570983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25166907|NCT03570983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25166908|NCT03570983|Immunologic Factors|immunologic factors|mesh-ancestor
25166909|NCT03570983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166910|NCT03570983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25166911|NCT03570983|Alkylating Agents|alkylating agents|mesh-ancestor
25166912|NCT03570983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25166913|NCT03570983|Gout Suppressants|gout suppressants|mesh-ancestor
25166914|NCT03570983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25166915|NCT03570983|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25166916|NCT03570983|Antioxidants|antioxidants|mesh-ancestor
25166917|NCT03570983|Protective Agents|protective agents|mesh-ancestor
25166918|NCT03570827|Ascorbic Acid|ascorbic acid|mesh-list
25166919|NCT03570827|Methyltestosterone|methyltestosterone|mesh-list
25166920|NCT03570827|Androgens|androgens|mesh-list
25166921|NCT03570827|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25166922|NCT03570827|Hormones|hormones|mesh-ancestor
25166923|NCT03570827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25166924|NCT03570827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166925|NCT03570827|Antioxidants|antioxidants|mesh-ancestor
25166926|NCT03570827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166927|NCT03570827|Protective Agents|protective agents|mesh-ancestor
25166928|NCT03570827|Vitamins|vitamins|mesh-ancestor
25166929|NCT03570827|Micronutrients|micronutrients|mesh-ancestor
25166930|NCT03570827|Estrogens|estrogens|mesh-ancestor
25166931|NCT03570827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25166932|NCT03570827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166933|NCT03570827|Anabolic Agents|anabolic agents|mesh-ancestor
25166953|NCT03540758|Nicotinic Acids|nicotinic acids|mesh-list
24588734|NCT00904111|Lidocaine|lidocaine|mesh-list
25166954|NCT03540758|Niacinamide|niacinamide|mesh-list
25166955|NCT03540758|Diazoxide|diazoxide|mesh-list
25166956|NCT03540758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25166957|NCT03540758|Antimetabolites|antimetabolites|mesh-ancestor
25166958|NCT03540758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166959|NCT03540758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25166960|NCT03540758|Vasodilator Agents|vasodilator agents|mesh-ancestor
25166961|NCT03540758|Vitamin B Complex|vitamin b complex|mesh-ancestor
25166963|NCT03540758|Micronutrients|micronutrients|mesh-ancestor
25166964|NCT03540758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166965|NCT03540758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25166966|NCT03514017|Pembrolizumab|pembrolizumab|mesh-list
25166967|NCT03514017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25166968|NCT03514017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166994|NCT03478488|Antiviral Agents|antiviral agents|mesh-ancestor
25166995|NCT03478488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25166996|NCT03478488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25166997|NCT03478488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25166998|NCT03478488|Immunologic Factors|immunologic factors|mesh-ancestor
25166999|NCT03478488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167002|NCT03452865|Esomeprazole|esomeprazole|mesh-list
25167003|NCT03452865|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25167004|NCT03452865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25167005|NCT03452865|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25167006|NCT03452865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25167007|NCT03452865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167008|NCT03452839|Meropenem|meropenem|mesh-list
25167009|NCT03452839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25167010|NCT03452839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25167011|NCT03430882|Paclitaxel|paclitaxel|mesh-list
25167012|NCT03430882|Carboplatin|carboplatin|mesh-list
25167026|NCT03408119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25167027|NCT03404596|Nicotine|nicotine|mesh-list
25167028|NCT03404596|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25167029|NCT03404596|Autonomic Agents|autonomic agents|mesh-ancestor
25167030|NCT03404596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25167031|NCT03404596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167032|NCT03404596|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25167033|NCT03404596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25114175|NCT01204684|Poly ICLC|poly iclc|mesh-list
25167034|NCT03404596|Cholinergic Agents|cholinergic agents|mesh-ancestor
25167035|NCT03404596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25167036|NCT03404596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167037|NCT03396952|Aspirin|aspirin|mesh-list
25167038|NCT03396952|Pembrolizumab|pembrolizumab|mesh-list
25167039|NCT03396952|Ipilimumab|ipilimumab|mesh-list
25167040|NCT03396952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25167041|NCT03396952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167042|NCT03396952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25167043|NCT03396952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25167044|NCT03396952|Analgesics|analgesics|mesh-ancestor
25167045|NCT03396952|Sensory System Agents|sensory system agents|mesh-ancestor
25167046|NCT03396952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25167047|NCT03396952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167048|NCT03396952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25167049|NCT03396952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25167050|NCT03396952|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25167051|NCT03396952|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25167052|NCT03396952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167053|NCT03396952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25167054|NCT03396952|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25167055|NCT03396952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25167056|NCT03396952|Antipyretics|antipyretics|mesh-ancestor
25167057|NCT03396952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25114181|NCT01191697|Capecitabine|capecitabine|mesh-list
25114182|NCT01191697|Oxaliplatin|oxaliplatin|mesh-list
25650490|NCT01504204|Dermatologic Agents|dermatologic agents|mesh-ancestor
25829653|NCT00006245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24992436|NCT03770676|Trace Elements|trace elements|mesh-ancestor
24992440|NCT03764735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24437468|NCT00273702|Expectorants|expectorants|mesh-ancestor
25829312|NCT00006195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25035735|NCT03553433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035737|NCT03553329|Dabrafenib|dabrafenib|mesh-list
25167083|NCT03381183|Durvalumab|durvalumab|mesh-list
25167084|NCT03381183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25167085|NCT03381183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167086|NCT03378102|Interferon-gamma|interferon-gamma|mesh-list
25167087|NCT03378102|Antiviral Agents|antiviral agents|mesh-ancestor
25167088|NCT03378102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25167089|NCT03374254|Leucovorin|leucovorin|mesh-list
25167090|NCT03374254|Pembrolizumab|pembrolizumab|mesh-list
25167091|NCT03374254|Fluorouracil|fluorouracil|mesh-list
25167092|NCT03374254|Oxaliplatin|oxaliplatin|mesh-list
25167093|NCT03374254|Irinotecan|irinotecan|mesh-list
25167094|NCT03374254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167095|NCT03374254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25167096|NCT03374254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167097|NCT03374254|Antimetabolites|antimetabolites|mesh-ancestor
25167098|NCT03374254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167099|NCT03374254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25167100|NCT03374254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25167101|NCT03374254|Immunologic Factors|immunologic factors|mesh-ancestor
25167102|NCT03374254|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25167103|NCT03374254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25167104|NCT03374254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25167105|NCT03374254|Antidotes|antidotes|mesh-ancestor
25167106|NCT03374254|Protective Agents|protective agents|mesh-ancestor
25167107|NCT03374254|Vitamin B Complex|vitamin b complex|mesh-ancestor
25167108|NCT03374254|Vitamins|vitamins|mesh-ancestor
25167109|NCT03374254|Micronutrients|micronutrients|mesh-ancestor
25167110|NCT03312738|Everolimus|everolimus|mesh-list
25167111|NCT03312738|Exemestane|exemestane|mesh-list
25167112|NCT03312738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167113|NCT03312738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25167114|NCT03312738|Immunologic Factors|immunologic factors|mesh-ancestor
25167115|NCT03312738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167116|NCT03312738|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25167117|NCT03312738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25167118|NCT03312738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25167119|NCT03312738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167120|NCT03312738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25167121|NCT03312738|Hormone Antagonists|hormone antagonists|mesh-ancestor
25167122|NCT03312738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25167123|NCT03303339|Cytarabine|cytarabine|mesh-list
25167124|NCT03303339|Decitabine|decitabine|mesh-list
25167125|NCT03303339|Onvansertib|onvansertib|mesh-list
25167126|NCT03303339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25167127|NCT03303339|Antimetabolites|antimetabolites|mesh-ancestor
25167128|NCT03303339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167129|NCT03303339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167130|NCT03303339|Antiviral Agents|antiviral agents|mesh-ancestor
25167131|NCT03303339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25167132|NCT03303339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25167133|NCT03303339|Immunologic Factors|immunologic factors|mesh-ancestor
25167134|NCT03303339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167135|NCT03303339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25167136|NCT03303339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25167137|NCT03302234|Pembrolizumab|pembrolizumab|mesh-list
25167138|NCT03302234|Ipilimumab|ipilimumab|mesh-list
25035803|NCT03553173|Antidepressive Agents|antidepressive agents|mesh-ancestor
25035804|NCT03553173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25035805|NCT03553173|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25035806|NCT03553173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25035807|NCT03553173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25035808|NCT03553173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035885|NCT03552354|Argatroban|argatroban|mesh-list
25167139|NCT03302234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25167140|NCT03302234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167141|NCT03302234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25650491|NCT01504204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25650492|NCT01504204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25167190|NCT03252808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25167146|NCT03299946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25167147|NCT03299946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167148|NCT03291886|Exemestane|exemestane|mesh-list
25829313|NCT00006195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829314|NCT00006195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167149|NCT03291886|Entinostat|entinostat|mesh-list
25167150|NCT03291886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167151|NCT03291886|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25035894|NCT03552315|Trace Elements|trace elements|mesh-ancestor
24603388|NCT00973583|Vitamins|vitamins|mesh-ancestor
25035915|NCT03552146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25035916|NCT03552146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25035917|NCT03552146|Adrenergic Agents|adrenergic agents|mesh-ancestor
25035918|NCT03552146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25035919|NCT03552146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035920|NCT03552016|Riboflavin|riboflavin|mesh-list
25035921|NCT03552016|Vitamins|vitamins|mesh-ancestor
25035922|NCT03552016|Micronutrients|micronutrients|mesh-ancestor
25035923|NCT03552016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035924|NCT03552016|Vitamin B Complex|vitamin b complex|mesh-ancestor
25035925|NCT03552016|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25035926|NCT03552016|Dermatologic Agents|dermatologic agents|mesh-ancestor
24422117|NCT00221429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24422118|NCT00221429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24422119|NCT00221429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422120|NCT00221429|Anticonvulsants|anticonvulsants|mesh-ancestor
25167152|NCT03291886|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25167153|NCT03291886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25167154|NCT03291886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167155|NCT03291886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25167156|NCT03291886|Hormone Antagonists|hormone antagonists|mesh-ancestor
25167157|NCT03291886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25167158|NCT03291886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167159|NCT03291886|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25035927|NCT03551964|Ticagrelor|ticagrelor|mesh-list
25035928|NCT03551964|Cangrelor|cangrelor|mesh-list
25035929|NCT03551964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25035930|NCT03551964|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25035931|NCT03551964|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25035932|NCT03551964|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25035933|NCT03551964|Purinergic Agents|purinergic agents|mesh-ancestor
25035934|NCT03551964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25167164|NCT03272685|Nicotine|nicotine|mesh-list
25167165|NCT03272685|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25167166|NCT03272685|Autonomic Agents|autonomic agents|mesh-ancestor
25167167|NCT03272685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25167168|NCT03272685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167169|NCT03272685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25167170|NCT03272685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25167171|NCT03272685|Cholinergic Agents|cholinergic agents|mesh-ancestor
25167172|NCT03272685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25167173|NCT03272685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167174|NCT03258723|Metformin|metformin|mesh-list
25167175|NCT03258723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25167176|NCT03258723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167177|NCT03252808|Gemcitabine|gemcitabine|mesh-list
25167178|NCT03252808|Paclitaxel|paclitaxel|mesh-list
25167179|NCT03252808|Tegafur|tegafur|mesh-list
25167180|NCT03252808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25167181|NCT03252808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167182|NCT03252808|Tubulin Modulators|tubulin modulators|mesh-ancestor
25167183|NCT03252808|Antimitotic Agents|antimitotic agents|mesh-ancestor
25167184|NCT03252808|Mitosis Modulators|mitosis modulators|mesh-ancestor
25167185|NCT03252808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167186|NCT03252808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25167187|NCT03252808|Antimetabolites|antimetabolites|mesh-ancestor
25167188|NCT03252808|Antiviral Agents|antiviral agents|mesh-ancestor
25167189|NCT03252808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25167203|NCT03235505|Varenicline|varenicline|mesh-list
25167204|NCT03235505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25167205|NCT03235505|Autonomic Agents|autonomic agents|mesh-ancestor
25167206|NCT03235505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25167207|NCT03235505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650493|NCT01504204|Analgesics|analgesics|mesh-ancestor
25167208|NCT03235505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25167209|NCT03235505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25167210|NCT03235505|Cholinergic Agents|cholinergic agents|mesh-ancestor
25167211|NCT03235505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25650494|NCT01504204|Sensory System Agents|sensory system agents|mesh-ancestor
25167212|NCT03235505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035961|NCT03551652|Rocuronium|rocuronium|mesh-list
25035962|NCT03551652|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25035963|NCT03551652|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25035964|NCT03551652|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25035965|NCT03551652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25035966|NCT03551652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035967|NCT03551561|Chlorhexidine|chlorhexidine|mesh-list
25035968|NCT03551561|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25167213|NCT03232346|Buprenorphine|buprenorphine|mesh-list
25167214|NCT03232346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25167215|NCT03232346|Narcotics|narcotics|mesh-ancestor
25167216|NCT03232346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25167217|NCT03232346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167218|NCT03232346|Analgesics|analgesics|mesh-ancestor
25167219|NCT03232346|Sensory System Agents|sensory system agents|mesh-ancestor
25167220|NCT03232346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25167221|NCT03232346|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25167222|NCT03219268|Margetuximab|margetuximab|mesh-list
25167223|NCT03219268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167224|NCT03208244|Antiviral Agents|antiviral agents|mesh-list
25167225|NCT03208244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25167226|NCT03191461|Adenosine|adenosine|mesh-list
25167227|NCT03191461|Analgesics|analgesics|mesh-ancestor
25167228|NCT03191461|Sensory System Agents|sensory system agents|mesh-ancestor
25167229|NCT03191461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25167230|NCT03191461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167231|NCT03191461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25167232|NCT03191461|Vasodilator Agents|vasodilator agents|mesh-ancestor
25167233|NCT03191461|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25167234|NCT03191461|Purinergic Agonists|purinergic agonists|mesh-ancestor
25167235|NCT03191461|Purinergic Agents|purinergic agents|mesh-ancestor
25167236|NCT03191461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25167237|NCT03191461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167238|NCT03187379|Bupivacaine|bupivacaine|mesh-list
25167239|NCT03187379|Anesthetics, Local|anesthetics, local|mesh-ancestor
25167240|NCT03187379|Anesthetics|anesthetics|mesh-ancestor
25167241|NCT03187379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25167242|NCT03187379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167243|NCT03187379|Sensory System Agents|sensory system agents|mesh-ancestor
25167244|NCT03187379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25167270|NCT03182231|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25167271|NCT03182231|Incretins|incretins|mesh-ancestor
25167272|NCT03182231|Hormones|hormones|mesh-ancestor
25167273|NCT03182231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25167274|NCT03182192|Exenatide|exenatide|mesh-list
25167275|NCT03182192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25167276|NCT03182192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167277|NCT03182192|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25167278|NCT03182192|Incretins|incretins|mesh-ancestor
25167279|NCT03182192|Hormones|hormones|mesh-ancestor
25167280|NCT03182192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25167283|NCT03160846|Milrinone|milrinone|mesh-list
25167284|NCT03160846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25167285|NCT03160846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25167286|NCT03160846|Vasodilator Agents|vasodilator agents|mesh-ancestor
25167287|NCT03160846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25167288|NCT03160846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25167289|NCT03160846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829315|NCT00006195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25829316|NCT00006195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25829317|NCT00006195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24766034|NCT01792037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766186|NCT01793259|Abortifacient Agents|abortifacient agents|mesh-ancestor
24766361|NCT01794273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766363|NCT01794273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24766364|NCT01794273|Nasal Decongestants|nasal decongestants|mesh-ancestor
24766365|NCT01794273|Respiratory System Agents|respiratory system agents|mesh-ancestor
24766366|NCT01794273|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24766367|NCT01794273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24766368|NCT01794273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24766369|NCT01794273|Adrenergic Agents|adrenergic agents|mesh-ancestor
24781161|NCT01888302|Cisplatin|cisplatin|mesh-list
24966378|NCT03768713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966380|NCT03768713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25829318|NCT00006195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24966381|NCT03768713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966382|NCT03768609|Cyclosporine|cyclosporine|mesh-list
24966383|NCT03768609|Cyclosporins|cyclosporins|mesh-list
24966384|NCT03768609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966385|NCT03768609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080351|NCT03339804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080352|NCT03339804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25080353|NCT03339804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24966389|NCT03768609|Antifungal Agents|antifungal agents|mesh-ancestor
25080354|NCT03339804|Alkylating Agents|alkylating agents|mesh-ancestor
25080355|NCT03339804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766575|NCT01795430|Alkylating Agents|alkylating agents|mesh-ancestor
24766576|NCT01795430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24766577|NCT01795430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24766578|NCT01795430|Immunologic Factors|immunologic factors|mesh-ancestor
24766579|NCT01795430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766693|NCT01796132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766695|NCT01796132|Serotonin Agents|serotonin agents|mesh-ancestor
24766696|NCT01796132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781301|NCT01888835|Mirtazapine|mirtazapine|mesh-list
24766777|NCT01796730|Bambuterol|bambuterol|mesh-list
24766778|NCT01796730|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24766779|NCT01796730|Autonomic Agents|autonomic agents|mesh-ancestor
24766780|NCT01796730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24766788|NCT01796782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24766790|NCT01796808|Epinephrine|epinephrine|mesh-list
24766791|NCT01796808|Anesthetics, Local|anesthetics, local|mesh-list
24766792|NCT01796808|Anesthetics|anesthetics|mesh-list
24766793|NCT01796808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24766794|NCT01796808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766795|NCT01796808|Sensory System Agents|sensory system agents|mesh-ancestor
25114254|NCT01038778|Interleukin-2|interleukin-2|mesh-list
24766796|NCT01796808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24766962|NCT01797991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24557973|NCT00755027|Protective Agents|protective agents|mesh-ancestor
24557974|NCT00755027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767022|NCT01798277|Autonomic Agents|autonomic agents|mesh-ancestor
24767023|NCT01798277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24767025|NCT01798446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767026|NCT01798446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24767027|NCT01798446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767028|NCT01798446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767029|NCT01798459|Methylphenidate|methylphenidate|mesh-list
24767030|NCT01798459|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24767031|NCT01798459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767032|NCT01798459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24767033|NCT01798459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24767034|NCT01798459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24767035|NCT01798459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767036|NCT01798459|Dopamine Agents|dopamine agents|mesh-ancestor
24767037|NCT01798459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25167290|NCT03160846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167291|NCT03160846|Protective Agents|protective agents|mesh-ancestor
25167292|NCT03160846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167293|NCT03149770|Naloxone|naloxone|mesh-list
25167294|NCT03149770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25167295|NCT03149770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167296|NCT03149770|Sensory System Agents|sensory system agents|mesh-ancestor
25167297|NCT03149770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25167298|NCT03098589|Lenalidomide|lenalidomide|mesh-list
25167299|NCT03098589|Immunologic Factors|immunologic factors|mesh-ancestor
25167300|NCT03098589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167301|NCT03098589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25167302|NCT03098589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25167303|NCT03098589|Growth Substances|growth substances|mesh-ancestor
25167304|NCT03098589|Growth Inhibitors|growth inhibitors|mesh-ancestor
25167305|NCT03098589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167306|NCT03071406|Nivolumab|nivolumab|mesh-list
25167307|NCT03071406|Ipilimumab|ipilimumab|mesh-list
25167308|NCT03071406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25167309|NCT03071406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829319|NCT00006195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25650495|NCT01504204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25167310|NCT03071406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25167646|NCT02469155|Risperidone|risperidone|mesh-list
24992604|NCT03382834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25167311|NCT03071406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167312|NCT03050060|Nelfinavir|nelfinavir|mesh-list
25167313|NCT03050060|Pembrolizumab|pembrolizumab|mesh-list
25167314|NCT03050060|Nivolumab|nivolumab|mesh-list
25167315|NCT03050060|Atezolizumab|atezolizumab|mesh-list
25167316|NCT03050060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25167317|NCT03050060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25167318|NCT03050060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167319|NCT03050060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25167320|NCT03050060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167321|NCT03050060|Immunologic Factors|immunologic factors|mesh-ancestor
25167322|NCT03050060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167323|NCT03050060|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25167324|NCT03050060|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25167325|NCT03050060|Protease Inhibitors|protease inhibitors|mesh-ancestor
25167326|NCT03050060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25167327|NCT03050060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25167328|NCT03050060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25167329|NCT03050060|Antiviral Agents|antiviral agents|mesh-ancestor
25167330|NCT03050060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25167331|NCT03026517|Phenformin|phenformin|mesh-list
25167332|NCT03026517|Trametinib|trametinib|mesh-list
25167345|NCT02964884|L 647318|l 647318|mesh-list
25167346|NCT02964884|Dihydromevinolin|dihydromevinolin|mesh-list
25167347|NCT02964884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25167348|NCT02964884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25167349|NCT02964884|Antimetabolites|antimetabolites|mesh-ancestor
25167350|NCT02964884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167351|NCT02964884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25167352|NCT02964884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25167353|NCT02964884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203482|NCT02714036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25203483|NCT02714036|Vasodilator Agents|vasodilator agents|mesh-ancestor
25203484|NCT02713945|Simvastatin|simvastatin|mesh-list
25203485|NCT02713945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25203486|NCT02713945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25203487|NCT02713945|Antimetabolites|antimetabolites|mesh-ancestor
25203488|NCT02713945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203489|NCT02713945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25203490|NCT02713945|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25203491|NCT02713945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203492|NCT02713841|Insulin|insulin|mesh-list
25203493|NCT02713841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25203494|NCT02713841|Insulin Lispro|insulin lispro|mesh-list
25203495|NCT02713841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25167366|NCT02862275|Atezolizumab|atezolizumab|mesh-list
25167367|NCT02862275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167368|NCT02851056|Lenograstim|lenograstim|mesh-list
25167369|NCT02851056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25167370|NCT02851056|Immunologic Factors|immunologic factors|mesh-ancestor
25167371|NCT02851056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167372|NCT02837042|Pembrolizumab|pembrolizumab|mesh-list
25167373|NCT02837042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25167374|NCT02837042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167375|NCT02836925|Sofosbuvir|sofosbuvir|mesh-list
25167376|NCT02836925|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25167377|NCT02836925|Ledipasvir|ledipasvir|mesh-list
25167378|NCT02836925|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25167379|NCT02836925|Velpatasvir|velpatasvir|mesh-list
25167380|NCT02836925|Antiviral Agents|antiviral agents|mesh-ancestor
25167381|NCT02836925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25167382|NCT02830360|Amiodarone|amiodarone|mesh-list
25167383|NCT02830360|Sotalol|sotalol|mesh-list
25167384|NCT02830360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25167385|NCT02830360|Vasodilator Agents|vasodilator agents|mesh-ancestor
25167386|NCT02830360|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25167387|NCT02830360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25036330|NCT03548493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25167388|NCT02830360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167389|NCT02830360|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25167390|NCT02830360|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25167391|NCT02830360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25167392|NCT02830360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25167393|NCT02830360|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25167414|NCT02814916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25167415|NCT02814916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25829320|NCT00006195|Dopamine Agents|dopamine agents|mesh-ancestor
25829322|NCT00006195|Autonomic Agents|autonomic agents|mesh-ancestor
25829323|NCT00006195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25829324|NCT00006195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25829325|NCT00006195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25829326|NCT00006195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25829327|NCT00006195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25829328|NCT00006196|Vitamin D|vitamin d|mesh-list
25829329|NCT00006196|Vitamins|vitamins|mesh-ancestor
25829330|NCT00006196|Micronutrients|micronutrients|mesh-ancestor
25829331|NCT00006196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829332|NCT00006196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25829333|NCT00006198|Thalidomide|thalidomide|mesh-list
25829334|NCT00006198|Doxorubicin|doxorubicin|mesh-list
25829335|NCT00006198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24458578|NCT00338390|Dideoxynucleosides|dideoxynucleosides|mesh-list
25829336|NCT00006198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829337|NCT00006198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25829338|NCT00006198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25829339|NCT00006198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829340|NCT00006198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829341|NCT00006198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25829342|NCT00006198|Immunologic Factors|immunologic factors|mesh-ancestor
25829343|NCT00006198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829344|NCT00006198|Leprostatic Agents|leprostatic agents|mesh-ancestor
25829345|NCT00006198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25829346|NCT00006198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25829347|NCT00006198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25829348|NCT00006198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25167481|NCT02710643|Ofatumumab|ofatumumab|mesh-list
25167482|NCT02710643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167483|NCT02708836|Anesthetics|anesthetics|mesh-list
25167484|NCT02708836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25167485|NCT02708836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167486|NCT02698254|Bevacizumab|bevacizumab|mesh-list
25167487|NCT02698254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25167488|NCT02698254|Endothelial Growth Factors|endothelial growth factors|mesh-list
25167489|NCT02698254|Antibodies|antibodies|mesh-list
25167490|NCT02698254|Immunoglobulins|immunoglobulins|mesh-list
25167491|NCT02698254|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25167492|NCT02698254|Immunoglobulin G|immunoglobulin g|mesh-list
25167493|NCT02698254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167494|NCT02698254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25167495|NCT02698254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25036539|NCT03546634|Vaccines|vaccines|mesh-list
25167496|NCT02698254|Growth Substances|growth substances|mesh-ancestor
25167497|NCT02698254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167498|NCT02698254|Growth Inhibitors|growth inhibitors|mesh-ancestor
25167499|NCT02698254|Immunologic Factors|immunologic factors|mesh-ancestor
25167500|NCT02675959|Defibrotide|defibrotide|mesh-list
25167501|NCT02675959|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25167502|NCT02675959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25167503|NCT02675959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167504|NCT02675959|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25167588|NCT02572141|Antidotes|antidotes|mesh-ancestor
25167530|NCT02650986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167531|NCT02650986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25167532|NCT02650986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25167533|NCT02650986|Antimetabolites|antimetabolites|mesh-ancestor
25167534|NCT02650986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25167535|NCT02623751|Exemestane|exemestane|mesh-list
25167536|NCT02623751|Entinostat|entinostat|mesh-list
25167537|NCT02623751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167538|NCT02623751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25167539|NCT02623751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25167540|NCT02623751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25167541|NCT02623751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167542|NCT02623751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25167543|NCT02623751|Hormone Antagonists|hormone antagonists|mesh-ancestor
25167544|NCT02623751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25124599|NCT03074578|Hormones|hormones|mesh-ancestor
25167545|NCT02623751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167546|NCT02623751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25167557|NCT02598895|Carboplatin|carboplatin|mesh-list
25167558|NCT02598895|Docetaxel|docetaxel|mesh-list
25167559|NCT02598895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167560|NCT02598895|Tubulin Modulators|tubulin modulators|mesh-ancestor
25167561|NCT02598895|Antimitotic Agents|antimitotic agents|mesh-ancestor
25167562|NCT02598895|Mitosis Modulators|mitosis modulators|mesh-ancestor
25167563|NCT02598895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167576|NCT02572141|Leucovorin|leucovorin|mesh-list
25167577|NCT02572141|Fluorouracil|fluorouracil|mesh-list
25167578|NCT02572141|Capecitabine|capecitabine|mesh-list
25167579|NCT02572141|Oxaliplatin|oxaliplatin|mesh-list
25167580|NCT02572141|Levoleucovorin|levoleucovorin|mesh-list
25167581|NCT02572141|Antimetabolites|antimetabolites|mesh-ancestor
25167582|NCT02572141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167583|NCT02572141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25167584|NCT02572141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167585|NCT02572141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25167586|NCT02572141|Immunologic Factors|immunologic factors|mesh-ancestor
25167587|NCT02572141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167589|NCT02572141|Protective Agents|protective agents|mesh-ancestor
25167590|NCT02572141|Vitamin B Complex|vitamin b complex|mesh-ancestor
25167591|NCT02572141|Vitamins|vitamins|mesh-ancestor
25167592|NCT02572141|Micronutrients|micronutrients|mesh-ancestor
25167593|NCT02554383|Amoxicillin|amoxicillin|mesh-list
25167594|NCT02554383|Clavulanic Acid|clavulanic acid|mesh-list
25167595|NCT02554383|Clavulanic Acids|clavulanic acids|mesh-list
25167596|NCT02554383|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25167597|NCT02554383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25167598|NCT02554383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25167599|NCT02554383|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25167600|NCT02554383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25167601|NCT02554383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167602|NCT02554318|Rifampin|rifampin|mesh-list
25167603|NCT02554318|Isoniazid|isoniazid|mesh-list
25167604|NCT02554318|Pyrazinamide|pyrazinamide|mesh-list
25167605|NCT02554318|Ethambutol|ethambutol|mesh-list
25167606|NCT02554318|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25167607|NCT02554318|Antitubercular Agents|antitubercular agents|mesh-ancestor
25167608|NCT02554318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25167609|NCT02554318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25167610|NCT02554318|Leprostatic Agents|leprostatic agents|mesh-ancestor
25167611|NCT02554318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25167612|NCT02554318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25167613|NCT02554318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167614|NCT02554318|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25167615|NCT02554318|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25167616|NCT02554318|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25167617|NCT02554318|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25167618|NCT02554318|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25167619|NCT02554318|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25167620|NCT02554318|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25167621|NCT02554318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25167622|NCT02554318|Antimetabolites|antimetabolites|mesh-ancestor
25167623|NCT02554318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25167624|NCT02521363|Taxane|taxane|mesh-list
25167625|NCT02521363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167626|NCT02491983|Letrozole|letrozole|mesh-list
25167627|NCT02491983|Fulvestrant|fulvestrant|mesh-list
25167628|NCT02491983|Palbociclib|palbociclib|mesh-list
25167629|NCT02491983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167630|NCT02491983|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25167631|NCT02491983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25167632|NCT02491983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25167633|NCT02491983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167634|NCT02491983|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25167635|NCT02491983|Hormone Antagonists|hormone antagonists|mesh-ancestor
25167636|NCT02491983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25167637|NCT02491983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167638|NCT02491983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25167639|NCT02491983|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25167640|NCT02491983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25650496|NCT01504204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167641|NCT02470039|Insulin|insulin|mesh-list
25167642|NCT02470039|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25167643|NCT02470039|Insulin Glargine|insulin glargine|mesh-list
25036759|NCT03543774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25167644|NCT02470039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25167645|NCT02470039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167649|NCT02469155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25167650|NCT02469155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167651|NCT02469155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167652|NCT02469155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25167653|NCT02469155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25167654|NCT02469155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25167655|NCT02469155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25167656|NCT02469155|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25167657|NCT02469155|Dopamine Agents|dopamine agents|mesh-ancestor
25167658|NCT02466867|Naftifine|naftifine|mesh-list
25167659|NCT02466867|Antifungal Agents|antifungal agents|mesh-ancestor
25167660|NCT02466867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25167661|NCT02466243|Lenabasum|lenabasum|mesh-list
25167662|NCT02466243|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25167663|NCT02466243|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25167664|NCT02466243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25167665|NCT02466243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167666|NCT02466243|Hormones|hormones|mesh-ancestor
25167667|NCT02466243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25167668|NCT02466243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167669|NCT02465606|Triamcinolone|triamcinolone|mesh-list
25167670|NCT02465606|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25167671|NCT02465606|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25167672|NCT02465606|Hydrocortisone|hydrocortisone|mesh-list
25167673|NCT02465606|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25167674|NCT02465606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25167675|NCT02465606|Glucocorticoids|glucocorticoids|mesh-ancestor
25167676|NCT02465606|Hormones|hormones|mesh-ancestor
25167677|NCT02465606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25167678|NCT02465606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167679|NCT02465606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25167680|NCT02465606|Immunologic Factors|immunologic factors|mesh-ancestor
25167681|NCT02465606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25167682|NCT02465606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167683|NCT02462811|Acetaminophen|acetaminophen|mesh-list
25167684|NCT02462811|Promethazine|promethazine|mesh-list
25167685|NCT02462811|Diphenhydramine|diphenhydramine|mesh-list
25167686|NCT02462811|Hydrocodone|hydrocodone|mesh-list
25167687|NCT02462811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25167688|NCT02462811|Analgesics|analgesics|mesh-ancestor
25167689|NCT02462811|Sensory System Agents|sensory system agents|mesh-ancestor
25167690|NCT02462811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25167691|NCT02462811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167692|NCT02462811|Antipyretics|antipyretics|mesh-ancestor
25167693|NCT02462811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25829349|NCT00006198|Growth Substances|growth substances|mesh-ancestor
25829350|NCT00006198|Growth Inhibitors|growth inhibitors|mesh-ancestor
25829351|NCT00006199|Topotecan|topotecan|mesh-list
25829352|NCT00006199|Tipifarnib|tipifarnib|mesh-list
25829353|NCT00006199|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25829354|NCT00006199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25829355|NCT00006199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829356|NCT00006199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829357|NCT00006199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767038|NCT01798472|Cimetidine|cimetidine|mesh-list
24767089|NCT01798628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767090|NCT01798628|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25036889|NCT03542357|Sumatriptan|sumatriptan|mesh-list
24767091|NCT01798628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767092|NCT01798628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767093|NCT01798628|Hormone Antagonists|hormone antagonists|mesh-ancestor
24767094|NCT01798628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24767095|NCT01798628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767096|NCT01798628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24767097|NCT01798680|Vitamin D|vitamin d|mesh-list
25080401|NCT03339544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080403|NCT03339427|Vitamins|vitamins|mesh-ancestor
25080404|NCT03339427|Micronutrients|micronutrients|mesh-ancestor
25080405|NCT03339427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551329|NCT00725400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24551330|NCT00725400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24551332|NCT00725439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24551333|NCT00725439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24551387|NCT00725985|Immunologic Factors|immunologic factors|mesh-ancestor
24551388|NCT00725985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551390|NCT00726011|Anesthetics, Local|anesthetics, local|mesh-ancestor
24551391|NCT00726011|Anesthetics|anesthetics|mesh-ancestor
24551394|NCT00726011|Sensory System Agents|sensory system agents|mesh-ancestor
25080406|NCT03339427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25080407|NCT03339362|Methylprednisolone|methylprednisolone|mesh-list
25080408|NCT03339362|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25080409|NCT03339362|Bupivacaine|bupivacaine|mesh-list
25080410|NCT03339362|Anesthetics, Local|anesthetics, local|mesh-ancestor
24767339|NCT01800240|Pioglitazone|pioglitazone|mesh-list
24767340|NCT01800240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24767341|NCT01800240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767342|NCT01800292|Sildenafil Citrate|sildenafil citrate|mesh-list
24767343|NCT01800292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767344|NCT01800292|Vasodilator Agents|vasodilator agents|mesh-ancestor
24767345|NCT01800292|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24767346|NCT01800292|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24767347|NCT01800292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767348|NCT01800292|Urological Agents|urological agents|mesh-ancestor
24767350|NCT01800357|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
24767618|NCT01802593|Azathioprine|azathioprine|mesh-list
24620434|NCT01057069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24767710|NCT01802749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621104|NCT01060696|Scopolamine|scopolamine|mesh-list
24558781|NCT05434689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24558783|NCT05434689|Autonomic Agents|autonomic agents|mesh-ancestor
24767976|NCT01804777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080640|NCT03336840|Antiemetics|antiemetics|mesh-ancestor
25080641|NCT03336840|Autonomic Agents|autonomic agents|mesh-ancestor
24781944|NCT01893099|Sorafenib|sorafenib|mesh-list
24781954|NCT01893229|Olanzapine|olanzapine|mesh-list
25080677|NCT03336437|Estrogens|estrogens|mesh-ancestor
25080678|NCT03336437|Hormones|hormones|mesh-ancestor
25829358|NCT00006200|Thalidomide|thalidomide|mesh-list
24782011|NCT01893424|Analgesics|analgesics|mesh-ancestor
24769072|NCT01812369|Antiviral Agents|antiviral agents|mesh-ancestor
24620488|NCT01057264|Immunologic Factors|immunologic factors|mesh-ancestor
25829359|NCT00006200|Dacarbazine|dacarbazine|mesh-list
25167694|NCT02462811|Narcotics|narcotics|mesh-ancestor
25167695|NCT02462811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25167696|NCT02462811|Antitussive Agents|antitussive agents|mesh-ancestor
25167697|NCT02462811|Respiratory System Agents|respiratory system agents|mesh-ancestor
25167698|NCT02462811|Antipruritics|antipruritics|mesh-ancestor
25167699|NCT02462811|Dermatologic Agents|dermatologic agents|mesh-ancestor
25167700|NCT02462811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25167701|NCT02462811|Histamine Antagonists|histamine antagonists|mesh-ancestor
25167702|NCT02462811|Histamine Agents|histamine agents|mesh-ancestor
25167703|NCT02462811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25167704|NCT02462811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167705|NCT02462811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25167706|NCT02462811|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25167707|NCT02462811|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25167708|NCT02462811|Anesthetics, Local|anesthetics, local|mesh-ancestor
25167710|NCT02462811|Antiemetics|antiemetics|mesh-ancestor
25167711|NCT02462811|Autonomic Agents|autonomic agents|mesh-ancestor
25167712|NCT02462811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25167713|NCT02461927|Midazolam|midazolam|mesh-list
25167714|NCT02461927|Naltrexone|naltrexone|mesh-list
25167715|NCT02461927|Ketamine|ketamine|mesh-list
25650497|NCT01504204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25650498|NCT01504204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25650499|NCT01504412|Pregabalin|pregabalin|mesh-list
25650500|NCT01504412|Analgesics|analgesics|mesh-ancestor
25650501|NCT01504412|Sensory System Agents|sensory system agents|mesh-ancestor
25650502|NCT01504412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650503|NCT01504412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650504|NCT01504412|Anticonvulsants|anticonvulsants|mesh-ancestor
25650505|NCT01504412|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25167716|NCT02461927|Analgesics|analgesics|mesh-ancestor
25167717|NCT02461927|Sensory System Agents|sensory system agents|mesh-ancestor
25167718|NCT02461927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25167719|NCT02461927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650506|NCT01504412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24551675|NCT05203445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24551676|NCT05203445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24551677|NCT05203445|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24551678|NCT05203445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24551679|NCT05203445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551689|NCT05145296|Daratumumab|daratumumab|mesh-list
24551690|NCT05145296|Abatacept|abatacept|mesh-list
24551691|NCT05145296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24551692|NCT05145296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24551720|NCT05092828|Morphine|morphine|mesh-list
24551721|NCT05092828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25167720|NCT02461927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25167721|NCT02461927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25167722|NCT02461927|Anesthetics, General|anesthetics, general|mesh-ancestor
25167723|NCT02461927|Anesthetics|anesthetics|mesh-ancestor
25167724|NCT02461927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25167725|NCT02461927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25167726|NCT02461927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25167727|NCT02461927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25167728|NCT02461927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167729|NCT02461927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25167730|NCT02461927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25167731|NCT02461927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25167732|NCT02461927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25167733|NCT02461927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25167734|NCT02461927|GABA Modulators|gaba modulators|mesh-ancestor
25167735|NCT02461927|GABA Agents|gaba agents|mesh-ancestor
25167736|NCT02461927|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25167737|NCT02461927|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25167738|NCT02458014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25167739|NCT02458014|Blinatumomab|blinatumomab|mesh-list
25167740|NCT02458014|Antibodies|antibodies|mesh-list
25167741|NCT02458014|Immunoglobulins|immunoglobulins|mesh-list
25167742|NCT02458014|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25167743|NCT02458014|Muromonab-CD3|muromonab-cd3|mesh-list
25167744|NCT02458014|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25167745|NCT02458014|Immunologic Factors|immunologic factors|mesh-ancestor
25167746|NCT02458014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167747|NCT02458014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167748|NCT02458014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25167760|NCT02447276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25167761|NCT02447276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167762|NCT02446028|Insulin Lispro|insulin lispro|mesh-list
25167763|NCT02446028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25167764|NCT02446028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167765|NCT02438007|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
25167766|NCT02438007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25167767|NCT02438007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167768|NCT02437136|Pembrolizumab|pembrolizumab|mesh-list
25167769|NCT02437136|Entinostat|entinostat|mesh-list
25167770|NCT02437136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25167771|NCT02437136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167772|NCT02437136|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25167773|NCT02437136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25167774|NCT02437136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167775|NCT02436096|Cyclobenzaprine|cyclobenzaprine|mesh-list
25167776|NCT02436096|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25167777|NCT02436096|Antidepressive Agents|antidepressive agents|mesh-ancestor
25167778|NCT02436096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25167779|NCT02436096|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25167780|NCT02436096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167781|NCT02436096|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25167782|NCT02436096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650507|NCT01504412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650508|NCT01504412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25650509|NCT01504412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25650510|NCT01504412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25650511|NCT01504412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25650512|NCT01504412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25650513|NCT01504477|Bortezomib|bortezomib|mesh-list
25650514|NCT01504477|Panitumumab|panitumumab|mesh-list
25650515|NCT01504477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25650516|NCT01504477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25650517|NCT01504711|Fosaprepitant|fosaprepitant|mesh-list
24552248|NCT03743376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24552249|NCT03743376|Antiviral Agents|antiviral agents|mesh-ancestor
24552250|NCT03743376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25829360|NCT00006200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24552251|NCT03734653|Testosterone|testosterone|mesh-list
24552252|NCT03734653|Androgens|androgens|mesh-ancestor
24552253|NCT03734653|Hormones|hormones|mesh-ancestor
25167783|NCT02436096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25167784|NCT02436096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25167785|NCT02434744|Metformin|metformin|mesh-list
25167786|NCT02434744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25167787|NCT02434744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167788|NCT02421679|Cyclobenzaprine|cyclobenzaprine|mesh-list
25167789|NCT02421679|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25167790|NCT02421679|Antidepressive Agents|antidepressive agents|mesh-ancestor
25167791|NCT02421679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25167792|NCT02421679|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25167793|NCT02421679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167794|NCT02421679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25167795|NCT02421679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25167796|NCT02421679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25167797|NCT02421679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25167798|NCT02415621|Abiraterone Acetate|abiraterone acetate|mesh-list
25167799|NCT02415621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167800|NCT02415621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25167801|NCT02415621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25167802|NCT02415621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167803|NCT02415621|Hormone Antagonists|hormone antagonists|mesh-ancestor
25167804|NCT02415621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25167805|NCT02415621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167806|NCT02415621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25203496|NCT02713841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203497|NCT02713893|Econazole|econazole|mesh-list
25203498|NCT02713893|Benzydamine|benzydamine|mesh-list
25203499|NCT02713893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25203500|NCT02713893|Antifungal Agents|antifungal agents|mesh-ancestor
25203501|NCT02713893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25203502|NCT02713893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25203503|NCT02713893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25203504|NCT02713893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203505|NCT02713893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203506|NCT02713893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25203507|NCT02713893|Hormone Antagonists|hormone antagonists|mesh-ancestor
25203508|NCT02713893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25203509|NCT02713893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203510|NCT02714010|Gefitinib|gefitinib|mesh-list
25203511|NCT02714010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25203512|NCT02714010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25203513|NCT02714010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203514|NCT02714010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203515|NCT02713750|Contraceptive Agents|contraceptive agents|mesh-list
25203516|NCT02713750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25203517|NCT02713750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203520|NCT02714075|Zinc Sulfate|zinc sulfate|mesh-list
25203521|NCT02714075|Zinc Oxide|zinc oxide|mesh-list
25203522|NCT02714075|Citric Acid|citric acid|mesh-list
25203523|NCT02714075|Sodium Citrate|sodium citrate|mesh-list
25203524|NCT02714075|Anticoagulants|anticoagulants|mesh-ancestor
25203525|NCT02714075|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25203526|NCT02714075|Chelating Agents|chelating agents|mesh-ancestor
25203527|NCT02714075|Sequestering Agents|sequestering agents|mesh-ancestor
25203528|NCT02714075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203529|NCT02714075|Trace Elements|trace elements|mesh-ancestor
25203530|NCT02714075|Micronutrients|micronutrients|mesh-ancestor
25650518|NCT01504711|Aprepitant|aprepitant|mesh-list
25650519|NCT01504711|Antiemetics|antiemetics|mesh-ancestor
25650520|NCT01504711|Autonomic Agents|autonomic agents|mesh-ancestor
25650521|NCT01504711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25650522|NCT01504711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650523|NCT01504711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25650524|NCT01504711|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25650525|NCT01504711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25203531|NCT02714075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203532|NCT02714075|Astringents|astringents|mesh-ancestor
25203533|NCT02714075|Dermatologic Agents|dermatologic agents|mesh-ancestor
25203534|NCT02714075|Sunscreening Agents|sunscreening agents|mesh-ancestor
25203535|NCT02714075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25203536|NCT02714075|Protective Agents|protective agents|mesh-ancestor
25203537|NCT02713802|Propofol|propofol|mesh-list
25203538|NCT02713802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25203539|NCT02713802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25203540|NCT02713802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203541|NCT02713802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25829361|NCT00006200|Immunologic Factors|immunologic factors|mesh-ancestor
25167807|NCT02413827|Ipilimumab|ipilimumab|mesh-list
25167808|NCT02413827|Poly ICLC|poly iclc|mesh-list
25167809|NCT02413827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25037126|NCT03540225|Progestins|progestins|mesh-ancestor
25167810|NCT02413827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25167811|NCT02413827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167812|NCT02413827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25167813|NCT02413827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167814|NCT02413827|Interferon Inducers|interferon inducers|mesh-ancestor
25167815|NCT02413827|Immunologic Factors|immunologic factors|mesh-ancestor
25167816|NCT02413827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167817|NCT02406209|Prednisolone|prednisolone|mesh-list
25167818|NCT02406209|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25167819|NCT02406209|Methylprednisolone|methylprednisolone|mesh-list
25167820|NCT02406209|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25167821|NCT02406209|Prednisolone acetate|prednisolone acetate|mesh-list
25167822|NCT02406209|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25167823|NCT02406209|Prednisolone phosphate|prednisolone phosphate|mesh-list
25167824|NCT02406209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25167825|NCT02406209|Glucocorticoids|glucocorticoids|mesh-ancestor
25167826|NCT02406209|Hormones|hormones|mesh-ancestor
25167827|NCT02406209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25167828|NCT02406209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167829|NCT02406209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25167830|NCT02406209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167831|NCT02406209|Antiemetics|antiemetics|mesh-ancestor
25167832|NCT02406209|Autonomic Agents|autonomic agents|mesh-ancestor
25167833|NCT02406209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25167834|NCT02406209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25167835|NCT02406209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25167836|NCT02406209|Protective Agents|protective agents|mesh-ancestor
25167837|NCT02405585|Leucovorin|leucovorin|mesh-list
25167838|NCT02405585|Gemcitabine|gemcitabine|mesh-list
25167839|NCT02405585|Fluorouracil|fluorouracil|mesh-list
25167840|NCT02405585|Oxaliplatin|oxaliplatin|mesh-list
25167841|NCT02405585|Irinotecan|irinotecan|mesh-list
25167842|NCT02405585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25167843|NCT02405585|Antimetabolites|antimetabolites|mesh-ancestor
25167844|NCT02405585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167845|NCT02405585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167846|NCT02405585|Antiviral Agents|antiviral agents|mesh-ancestor
25167847|NCT02405585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25167848|NCT02405585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25167849|NCT02405585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25167850|NCT02405585|Immunologic Factors|immunologic factors|mesh-ancestor
25167851|NCT02405585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167852|NCT02405585|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25167853|NCT02405585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25167854|NCT02405585|Antidotes|antidotes|mesh-ancestor
25167862|NCT02405260|Incretins|incretins|mesh-ancestor
25167863|NCT02405260|Hormones|hormones|mesh-ancestor
25167864|NCT02405260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25167865|NCT02405260|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25167866|NCT02405260|Protease Inhibitors|protease inhibitors|mesh-ancestor
25167867|NCT02405260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25167868|NCT02405260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167869|NCT02402270|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25167870|NCT02402270|Laxatives|laxatives|mesh-ancestor
25167871|NCT02402270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25167872|NCT02401815|Sunitinib|sunitinib|mesh-list
25167873|NCT02401815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167874|NCT02401815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25167875|NCT02401815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25167876|NCT02401815|Growth Substances|growth substances|mesh-ancestor
25167877|NCT02401815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167878|NCT02401815|Growth Inhibitors|growth inhibitors|mesh-ancestor
25167879|NCT02401815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25829362|NCT00006200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167880|NCT02401815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203542|NCT02713802|Anesthetics, General|anesthetics, general|mesh-ancestor
25829363|NCT00006200|Leprostatic Agents|leprostatic agents|mesh-ancestor
24535054|NCT00648466|Sumatriptan|sumatriptan|mesh-list
25829364|NCT00006200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25829365|NCT00006200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25829366|NCT00006200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25829367|NCT00006200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25829368|NCT00006200|Growth Substances|growth substances|mesh-ancestor
25829369|NCT00006200|Growth Inhibitors|growth inhibitors|mesh-ancestor
25829370|NCT00006200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121904|NCT03098368|Rotigotine|rotigotine|mesh-list
24769647|NCT01815073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769871|NCT01816620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24769872|NCT01816620|Immunologic Factors|immunologic factors|mesh-ancestor
24769873|NCT01816620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24769874|NCT01816620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24769875|NCT01816620|Growth Substances|growth substances|mesh-ancestor
24769876|NCT01816620|Growth Inhibitors|growth inhibitors|mesh-ancestor
24769877|NCT01816646|Cidofovir|cidofovir|mesh-list
24769878|NCT01816646|Probenecid|probenecid|mesh-list
24769879|NCT01816646|Uricosuric Agents|uricosuric agents|mesh-ancestor
24769880|NCT01816646|Gout Suppressants|gout suppressants|mesh-ancestor
24769881|NCT01816646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24770629|NCT01821430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24770630|NCT01821430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24770631|NCT01821430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770675|NCT01821664|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24770676|NCT01821664|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24770677|NCT01821664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770678|NCT01821677|Danazol|danazol|mesh-list
24907968|NCT04325633|Naproxen|naproxen|mesh-list
25080845|NCT03335241|Fludarabine|fludarabine|mesh-list
24770690|NCT01821703|Natriuretic Agents|natriuretic agents|mesh-ancestor
24770691|NCT01821846|Liraglutide|liraglutide|mesh-list
24770692|NCT01821846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24770693|NCT01821846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770694|NCT01821846|Incretins|incretins|mesh-ancestor
24770758|NCT01822275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770759|NCT01822275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24770768|NCT01822405|Tocopherols|tocopherols|mesh-list
24770769|NCT01822405|Vitamin E|vitamin e|mesh-list
24966942|NCT03764202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24966943|NCT03764202|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25168014|NCT02339129|Ibuprofen|ibuprofen|mesh-list
24771107|NCT01824758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24771108|NCT01824758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24771109|NCT01824758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039924|NCT03594058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24771599|NCT01828359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771600|NCT01828359|Vasodilator Agents|vasodilator agents|mesh-ancestor
24771601|NCT01828359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24771602|NCT01828359|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24771603|NCT01828359|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24771605|NCT01828385|Analgesics|analgesics|mesh-ancestor
24771724|NCT01829178|Antimetabolites|antimetabolites|mesh-ancestor
24771725|NCT01829178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24771726|NCT01829178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24771727|NCT01829178|Immunologic Factors|immunologic factors|mesh-ancestor
25167881|NCT02401815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167882|NCT02401750|Naltrexone|naltrexone|mesh-list
25167883|NCT02401750|Oxycodone|oxycodone|mesh-list
25167884|NCT02401750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25167885|NCT02401750|Narcotics|narcotics|mesh-ancestor
25167886|NCT02401750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25167887|NCT02401750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167888|NCT02401750|Analgesics|analgesics|mesh-ancestor
25167889|NCT02401750|Sensory System Agents|sensory system agents|mesh-ancestor
25167890|NCT02401750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25167891|NCT02401750|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25167892|NCT02401750|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25167893|NCT02398500|Ranibizumab|ranibizumab|mesh-list
25167894|NCT02398500|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25167895|NCT02398500|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24553285|NCT00730223|Efavirenz|efavirenz|mesh-list
25167896|NCT02398500|Growth Substances|growth substances|mesh-ancestor
25167897|NCT02398500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167898|NCT02398500|Growth Inhibitors|growth inhibitors|mesh-ancestor
25167899|NCT02398500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167900|NCT02393937|Metronidazole|metronidazole|mesh-list
25167901|NCT02393937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25167902|NCT02393937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25167903|NCT02393937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25167904|NCT02393937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25167905|NCT02392026|Metronidazole|metronidazole|mesh-list
25167906|NCT02392026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25167907|NCT02392026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25167908|NCT02392026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25167909|NCT02392026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25167910|NCT02391571|Naltrexone|naltrexone|mesh-list
25037257|NCT03539172|Apatinib|apatinib|mesh-list
25037258|NCT03539172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167911|NCT02391571|Oxycodone|oxycodone|mesh-list
25167912|NCT02391571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25167913|NCT02391571|Narcotics|narcotics|mesh-ancestor
25167914|NCT02391571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25167915|NCT02391571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25167916|NCT02391571|Analgesics|analgesics|mesh-ancestor
25167917|NCT02391571|Sensory System Agents|sensory system agents|mesh-ancestor
25167918|NCT02391571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25167919|NCT02391571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25167920|NCT02391571|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25167921|NCT02390960|Sildenafil Citrate|sildenafil citrate|mesh-list
25167922|NCT02390960|Vasodilator Agents|vasodilator agents|mesh-ancestor
25167923|NCT02390960|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25167924|NCT02390960|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25167925|NCT02390960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25167926|NCT02390960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167927|NCT02390960|Urological Agents|urological agents|mesh-ancestor
25167928|NCT02389985|Paclitaxel|paclitaxel|mesh-list
25167929|NCT02389985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25167930|NCT02389985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25167931|NCT02389985|Tubulin Modulators|tubulin modulators|mesh-ancestor
25167932|NCT02389985|Antimitotic Agents|antimitotic agents|mesh-ancestor
25167933|NCT02389985|Mitosis Modulators|mitosis modulators|mesh-ancestor
25167934|NCT02389985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167935|NCT02382510|Tiotropium Bromide|tiotropium bromide|mesh-list
25167936|NCT02382510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25167937|NCT02382510|Autonomic Agents|autonomic agents|mesh-ancestor
25167938|NCT02382510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25167954|NCT02372578|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25167955|NCT02372578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25167956|NCT02372578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167957|NCT02372578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25167958|NCT02372578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25167959|NCT02372578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25167960|NCT02372578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25167961|NCT02372578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25167962|NCT02365649|Upadacitinib|upadacitinib|mesh-list
25167963|NCT02365649|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25167964|NCT02365649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25167965|NCT02365649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25167966|NCT02365649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25167967|NCT02365649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25168002|NCT02342249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168003|NCT02342249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168004|NCT02341989|Carboplatin|carboplatin|mesh-list
25168005|NCT02341989|Etoposide|etoposide|mesh-list
25168006|NCT02341989|Bleomycin|bleomycin|mesh-list
25168007|NCT02341989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168008|NCT02341989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25168009|NCT02341989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25168010|NCT02341989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25172883|NCT02876432|Diclofenac|diclofenac|mesh-list
25168011|NCT02341989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168012|NCT02341989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168013|NCT02341989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25168015|NCT02339129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25168016|NCT02339129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25168017|NCT02339129|Analgesics|analgesics|mesh-ancestor
25829654|NCT00006246|Busulfan|busulfan|mesh-list
24553493|NCT00731562|Varenicline|varenicline|mesh-list
25168018|NCT02339129|Sensory System Agents|sensory system agents|mesh-ancestor
25037421|NCT03537534|Anesthetics|anesthetics|mesh-ancestor
25037422|NCT03537534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25037423|NCT03537534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168019|NCT02339129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25168020|NCT02339129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168021|NCT02339129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25168022|NCT02339129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25168023|NCT02339129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25168024|NCT02339129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168025|NCT02339129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168026|NCT02339064|Apomorphine|apomorphine|mesh-list
25168028|NCT02339064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168029|NCT02339064|Autonomic Agents|autonomic agents|mesh-ancestor
25168030|NCT02339064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25168031|NCT02339064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25168032|NCT02339064|Dopamine Agonists|dopamine agonists|mesh-ancestor
25168033|NCT02339064|Dopamine Agents|dopamine agents|mesh-ancestor
25168034|NCT02339064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25168035|NCT02339064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829371|NCT00006200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25168036|NCT02336698|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25168037|NCT02336698|Immunologic Factors|immunologic factors|mesh-ancestor
25168038|NCT02336698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168039|NCT02336685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25829372|NCT00006200|Alkylating Agents|alkylating agents|mesh-ancestor
24458680|NCT00338793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458681|NCT00338793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24458682|NCT00338793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458685|NCT00338910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24458686|NCT00338910|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24458687|NCT00338910|Autonomic Agents|autonomic agents|mesh-ancestor
24458688|NCT00338910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24458689|NCT00338910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458690|NCT00338910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24407359|NCT00174330|Vasodilator Agents|vasodilator agents|mesh-ancestor
24458691|NCT00338910|Respiratory System Agents|respiratory system agents|mesh-ancestor
24458692|NCT00338910|Glucocorticoids|glucocorticoids|mesh-ancestor
24458693|NCT00338910|Hormones|hormones|mesh-ancestor
24458694|NCT00338910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25829373|NCT00006200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829374|NCT00006203|Naltrexone|naltrexone|mesh-list
24458697|NCT00338910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24458698|NCT00338910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24458699|NCT00338936|Valsartan|valsartan|mesh-list
24458700|NCT00338936|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24458701|NCT00338936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24458702|NCT00338936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24458703|NCT00338936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24458704|NCT00338936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458705|NCT00338936|Diuretics|diuretics|mesh-ancestor
24458706|NCT00338936|Natriuretic Agents|natriuretic agents|mesh-ancestor
25168040|NCT02336685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168041|NCT02336685|Immunologic Factors|immunologic factors|mesh-ancestor
25168042|NCT02335918|Nivolumab|nivolumab|mesh-list
25168043|NCT02335918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25168044|NCT02335918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168045|NCT02335918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25168046|NCT02335918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168047|NCT02333643|Digoxin|digoxin|mesh-list
25168048|NCT02333643|Furosemide|furosemide|mesh-list
25168049|NCT02333643|Diuretics|diuretics|mesh-ancestor
25168050|NCT02333643|Natriuretic Agents|natriuretic agents|mesh-ancestor
25168051|NCT02333643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751319|NCT01703455|Sorafenib|sorafenib|mesh-list
25168052|NCT02333643|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25168053|NCT02333643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25168054|NCT02333643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168055|NCT02333643|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25168056|NCT02333643|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25168057|NCT02333643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168058|NCT02333643|Protective Agents|protective agents|mesh-ancestor
25168059|NCT02332655|Cannabidiol|cannabidiol|mesh-list
25168060|NCT02332655|Anticonvulsants|anticonvulsants|mesh-ancestor
25168061|NCT02331134|Lenograstim|lenograstim|mesh-list
25168062|NCT02331134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25168063|NCT02331134|Immunologic Factors|immunologic factors|mesh-ancestor
25168064|NCT02331134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168065|NCT02329834|Furosemide|furosemide|mesh-list
25168066|NCT02329834|Diuretics|diuretics|mesh-ancestor
25168067|NCT02329834|Natriuretic Agents|natriuretic agents|mesh-ancestor
25168068|NCT02329834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168069|NCT02329834|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25168070|NCT02329834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25168071|NCT02329834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168072|NCT02326454|Talaporfin|talaporfin|mesh-list
25168073|NCT02326454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168074|NCT02326454|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25168075|NCT02326454|Dermatologic Agents|dermatologic agents|mesh-ancestor
25168076|NCT02324985|Ibuprofen|ibuprofen|mesh-list
24588958|NCT00904904|Analgesics|analgesics|mesh-ancestor
25168077|NCT02324985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25168078|NCT02324985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25168079|NCT02324985|Analgesics|analgesics|mesh-ancestor
25168080|NCT02324985|Sensory System Agents|sensory system agents|mesh-ancestor
25168081|NCT02324985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25168082|NCT02324985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168083|NCT02324985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25168084|NCT02324985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25168085|NCT02324985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25168086|NCT02324985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168087|NCT02324985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168088|NCT02324725|Naltrexone|naltrexone|mesh-list
25168089|NCT02324725|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25168090|NCT02324725|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25168091|NCT02324725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168092|NCT02324725|Sensory System Agents|sensory system agents|mesh-ancestor
25168093|NCT02324725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25168094|NCT02324309|Insulin Lispro|insulin lispro|mesh-list
25168095|NCT02324309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25168096|NCT02324309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168097|NCT02320708|Acetaminophen|acetaminophen|mesh-list
25168098|NCT02320708|Ibuprofen|ibuprofen|mesh-list
25168099|NCT02320708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25168100|NCT02320708|Analgesics|analgesics|mesh-ancestor
25168101|NCT02320708|Sensory System Agents|sensory system agents|mesh-ancestor
25168102|NCT02320708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25168103|NCT02320708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168104|NCT02320708|Antipyretics|antipyretics|mesh-ancestor
25168105|NCT02320708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25168106|NCT02320708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25168107|NCT02320708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25168108|NCT02320708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25168109|NCT02320708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168110|NCT02320708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168111|NCT02309671|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25168112|NCT02309671|Hormones|hormones|mesh-ancestor
25168113|NCT02309671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25168114|NCT02309671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168115|NCT02306291|Cytarabine|cytarabine|mesh-list
25168116|NCT02306291|Etoposide|etoposide|mesh-list
25168117|NCT02306291|Mitoxantrone|mitoxantrone|mesh-list
25168118|NCT02306291|Idarubicin|idarubicin|mesh-list
25168119|NCT02306291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25168120|NCT02306291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168121|NCT02306291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25168122|NCT02306291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25168123|NCT02306291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168124|NCT02306291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168125|NCT02306291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25168126|NCT02306291|Antimetabolites|antimetabolites|mesh-ancestor
25168127|NCT02306291|Antiviral Agents|antiviral agents|mesh-ancestor
25168128|NCT02306291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25168129|NCT02306291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25168130|NCT02306291|Immunologic Factors|immunologic factors|mesh-ancestor
25168131|NCT02306291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168132|NCT02306291|Analgesics|analgesics|mesh-ancestor
25168133|NCT02306291|Sensory System Agents|sensory system agents|mesh-ancestor
25829375|NCT00006203|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24553953|NCT00733525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24553954|NCT00733525|Antidepressive Agents|antidepressive agents|mesh-ancestor
24553955|NCT00733525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24553956|NCT00733525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24433078|NCT00257465|Vaccines|vaccines|mesh-list
24553957|NCT00733525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24553958|NCT00733525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553959|NCT00733538|Zoledronic Acid|zoledronic acid|mesh-list
25168134|NCT02306291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25168135|NCT02306291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25168136|NCT02302079|Ranibizumab|ranibizumab|mesh-list
25168137|NCT02302079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25168138|NCT02302079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25168139|NCT02302079|Growth Substances|growth substances|mesh-ancestor
25168140|NCT02302079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168141|NCT02302079|Growth Inhibitors|growth inhibitors|mesh-ancestor
25168142|NCT02302079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168143|NCT02301234|Celecoxib|celecoxib|mesh-list
25168144|NCT02301234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25168145|NCT02301234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25168146|NCT02301234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25168147|NCT02301234|Analgesics|analgesics|mesh-ancestor
25168148|NCT02301234|Sensory System Agents|sensory system agents|mesh-ancestor
25168149|NCT02301234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25168150|NCT02301234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168151|NCT02301234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25168152|NCT02301234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25168153|NCT02301234|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25168154|NCT02301234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25829376|NCT00006203|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25168155|NCT02301234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168156|NCT02301234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168157|NCT02301234|Immunologic Factors|immunologic factors|mesh-ancestor
25168158|NCT02300142|Vaccines|vaccines|mesh-list
25168159|NCT02300142|Immunologic Factors|immunologic factors|mesh-ancestor
25168160|NCT02300142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168161|NCT02296645|Ethanol|ethanol|mesh-list
25168162|NCT02296645|Chlorhexidine|chlorhexidine|mesh-list
25168163|NCT02296645|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25168164|NCT02296645|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25168165|NCT02296645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25168166|NCT02296645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25168167|NCT02296645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168168|NCT02296645|Disinfectants|disinfectants|mesh-ancestor
25168169|NCT02296645|Dermatologic Agents|dermatologic agents|mesh-ancestor
25168170|NCT02295865|Toreforant|toreforant|mesh-list
25168171|NCT02295865|Histamine Antagonists|histamine antagonists|mesh-ancestor
25168172|NCT02295865|Histamine Agents|histamine agents|mesh-ancestor
25168173|NCT02295865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25168174|NCT02295865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168175|NCT02295865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168176|NCT02289716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25168177|NCT02289716|Immunologic Factors|immunologic factors|mesh-ancestor
25168178|NCT02289716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168179|NCT02282215|Lenograstim|lenograstim|mesh-list
25168180|NCT02282215|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25168181|NCT02282215|Immunologic Factors|immunologic factors|mesh-ancestor
25168182|NCT02282215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168183|NCT02279823|Minoxidil|minoxidil|mesh-list
25168184|NCT02279823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25168185|NCT02279823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25168186|NCT02279823|Vasodilator Agents|vasodilator agents|mesh-ancestor
25168187|NCT02279602|Fosbretabulin|fosbretabulin|mesh-list
25168188|NCT02279602|Combretastatin|combretastatin|mesh-list
25168189|NCT02279602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25168190|NCT02279602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168191|NCT02279602|Tubulin Modulators|tubulin modulators|mesh-ancestor
25650526|NCT01504711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650527|NCT01504841|Etravirine|etravirine|mesh-list
25650528|NCT01504841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25650529|NCT01504841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25650530|NCT01504841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650531|NCT01504841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650532|NCT01504841|Antiviral Agents|antiviral agents|mesh-ancestor
25650533|NCT01504841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25008215|NCT00958737|Protective Agents|protective agents|mesh-ancestor
24554303|NCT00735501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24554304|NCT00735501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554305|NCT00735527|Lorazepam|lorazepam|mesh-list
24554306|NCT00735527|Anticonvulsants|anticonvulsants|mesh-ancestor
24554307|NCT00735527|Antiemetics|antiemetics|mesh-ancestor
24554320|NCT00735527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168192|NCT02279602|Antimitotic Agents|antimitotic agents|mesh-ancestor
25168193|NCT02279602|Mitosis Modulators|mitosis modulators|mesh-ancestor
25168194|NCT02279602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168196|NCT02278133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25168197|NCT02278133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25203543|NCT02713802|Anesthetics|anesthetics|mesh-ancestor
25203544|NCT02713763|Sunitinib|sunitinib|mesh-list
25203545|NCT02713763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25203546|NCT02713763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25203547|NCT02713763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25203548|NCT02713763|Growth Substances|growth substances|mesh-ancestor
25203549|NCT02713763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203550|NCT02713763|Growth Inhibitors|growth inhibitors|mesh-ancestor
25203552|NCT02713763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203553|NCT02713763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203554|NCT02713607|Doxycycline|doxycycline|mesh-list
25203555|NCT02713607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25203556|NCT02713607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25203557|NCT02713607|Antimalarials|antimalarials|mesh-ancestor
25203558|NCT02713607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25203559|NCT02713607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25203560|NCT02713282|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25203561|NCT02713282|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25037729|NCT03535558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25203562|NCT02713282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25203563|NCT02713282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25203564|NCT02713282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203565|NCT02713282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25203566|NCT02713282|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25203567|NCT02713282|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25203568|NCT02713282|Serotonin Agents|serotonin agents|mesh-ancestor
25203569|NCT02713282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25203570|NCT02713282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203571|NCT02713282|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25203572|NCT02713282|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25829377|NCT00006203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168198|NCT02272803|Dexamethasone|dexamethasone|mesh-list
25168199|NCT02272803|Lenalidomide|lenalidomide|mesh-list
25168200|NCT02272803|Elotuzumab|elotuzumab|mesh-list
25168201|NCT02272803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25168202|NCT02272803|Antiemetics|antiemetics|mesh-ancestor
25168203|NCT02272803|Autonomic Agents|autonomic agents|mesh-ancestor
25168204|NCT02272803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25168205|NCT02272803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168206|NCT02272803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25168207|NCT02272803|Glucocorticoids|glucocorticoids|mesh-ancestor
25168208|NCT02272803|Hormones|hormones|mesh-ancestor
25168209|NCT02272803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25168210|NCT02272803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25168211|NCT02272803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168212|NCT02272803|Immunologic Factors|immunologic factors|mesh-ancestor
25168213|NCT02272803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25168214|NCT02272803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25168215|NCT02272803|Growth Substances|growth substances|mesh-ancestor
25168216|NCT02272803|Growth Inhibitors|growth inhibitors|mesh-ancestor
25168217|NCT02271503|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25168218|NCT02271503|Carbidopa|carbidopa|mesh-list
25168219|NCT02271503|Levodopa|levodopa|mesh-list
25168220|NCT02271503|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25168221|NCT02271503|Immunologic Factors|immunologic factors|mesh-ancestor
25168222|NCT02271503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650534|NCT01504854|Resveratrol|resveratrol|mesh-list
25650535|NCT01504854|Antioxidants|antioxidants|mesh-ancestor
25650536|NCT01504854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25650537|NCT01504854|Protective Agents|protective agents|mesh-ancestor
25650538|NCT01504854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650539|NCT01504854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650540|NCT01504854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25168223|NCT02271503|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25168224|NCT02271503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25168225|NCT02271503|Dopamine Agonists|dopamine agonists|mesh-ancestor
25168226|NCT02271503|Dopamine Agents|dopamine agents|mesh-ancestor
25168227|NCT02271503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25168228|NCT02271503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168229|NCT02271503|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25168230|NCT02271503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168232|NCT02271334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25168233|NCT02271334|Autonomic Agents|autonomic agents|mesh-ancestor
25168234|NCT02271334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25168235|NCT02271334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168236|NCT02271334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25168237|NCT02271334|Respiratory System Agents|respiratory system agents|mesh-ancestor
25168238|NCT02271334|Tocolytic Agents|tocolytic agents|mesh-ancestor
25168239|NCT02271334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25168240|NCT02271334|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25168241|NCT02271334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25168242|NCT02271334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25168243|NCT02271334|Adrenergic Agents|adrenergic agents|mesh-ancestor
25168244|NCT02271334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25168245|NCT02271334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168246|NCT02257983|Ubiquinone|ubiquinone|mesh-list
25168247|NCT02257983|Micronutrients|micronutrients|mesh-ancestor
25168248|NCT02257983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168249|NCT02257619|Docetaxel|docetaxel|mesh-list
25168250|NCT02257619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168251|NCT02257619|Tubulin Modulators|tubulin modulators|mesh-ancestor
25168252|NCT02257619|Antimitotic Agents|antimitotic agents|mesh-ancestor
25168253|NCT02257619|Mitosis Modulators|mitosis modulators|mesh-ancestor
25168254|NCT02257619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168255|NCT02255409|Vaccines|vaccines|mesh-list
25168256|NCT02255409|Immunologic Factors|immunologic factors|mesh-ancestor
25168257|NCT02255409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168258|NCT02252835|Colchicine|colchicine|mesh-list
25168259|NCT02252835|Febuxostat|febuxostat|mesh-list
25168260|NCT02252835|Gout Suppressants|gout suppressants|mesh-ancestor
25168261|NCT02252835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25168262|NCT02252835|Tubulin Modulators|tubulin modulators|mesh-ancestor
25168263|NCT02252835|Antimitotic Agents|antimitotic agents|mesh-ancestor
25168264|NCT02252835|Mitosis Modulators|mitosis modulators|mesh-ancestor
25168265|NCT02252835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168266|NCT02252835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168267|NCT02244606|Fluconazole|fluconazole|mesh-list
25168268|NCT02244606|Micafungin|micafungin|mesh-list
25168269|NCT02244606|Ibrexafungerp|ibrexafungerp|mesh-list
25168270|NCT02244606|Antifungal Agents|antifungal agents|mesh-ancestor
25168271|NCT02244606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25168272|NCT02244606|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25168273|NCT02244606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25829378|NCT00006203|Sensory System Agents|sensory system agents|mesh-ancestor
25829379|NCT00006203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25829380|NCT00006204|Naltrexone|naltrexone|mesh-list
25829381|NCT00006204|Fluoxetine|fluoxetine|mesh-list
24458845|NCT00341250|Immunologic Factors|immunologic factors|mesh-ancestor
24458846|NCT00341250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458847|NCT00341250|Antacids|antacids|mesh-ancestor
24458848|NCT00341250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458849|NCT00341250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24458850|NCT00341432|Nicotine|nicotine|mesh-list
24458851|NCT00341432|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24771728|NCT01829178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771873|NCT01830335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24772022|NCT01831011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24772023|NCT01831011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772024|NCT01831011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24772025|NCT01831011|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24772026|NCT01831011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037889|NCT03534869|Analgesics|analgesics|mesh-list
25037893|NCT03534713|Paclitaxel|paclitaxel|mesh-list
24772027|NCT01831011|Antipyretics|antipyretics|mesh-ancestor
24772028|NCT01831011|Vasodilator Agents|vasodilator agents|mesh-ancestor
24772029|NCT01831011|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24772030|NCT01831011|Immunologic Factors|immunologic factors|mesh-ancestor
25650541|NCT01504867|Aspirin|aspirin|mesh-list
24772031|NCT01831050|Vaccines|vaccines|mesh-list
25650542|NCT01504867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25650543|NCT01504867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24555053|NCT00739622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25829382|NCT00006204|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25829383|NCT00006204|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25829384|NCT00006204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829385|NCT00006204|Sensory System Agents|sensory system agents|mesh-ancestor
24772032|NCT01831050|Immunologic Factors|immunologic factors|mesh-ancestor
24773062|NCT01837394|Dopamine Agents|dopamine agents|mesh-ancestor
24773063|NCT01837433|Prednisone|prednisone|mesh-list
24773064|NCT01837433|Glucocorticoids|glucocorticoids|mesh-list
24773065|NCT01837433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24773066|NCT01837433|Hormones|hormones|mesh-ancestor
24773067|NCT01837433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24773068|NCT01837433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773069|NCT01837433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24773070|NCT01837433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081140|NCT03332719|Immunologic Factors|immunologic factors|mesh-ancestor
25081141|NCT03332719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25168465|NCT02179151|Growth Substances|growth substances|mesh-ancestor
25168278|NCT02244606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25168280|NCT02244606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25168281|NCT02244606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25168293|NCT02236195|Mocetinostat|mocetinostat|mesh-list
25168294|NCT02236195|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25168295|NCT02236195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168296|NCT02236195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168297|NCT02236156|Metronidazole|metronidazole|mesh-list
25168298|NCT02236156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25168299|NCT02236156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25168300|NCT02236156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25168301|NCT02236156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25037981|NCT03533803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25168325|NCT02224235|Aspirin|aspirin|mesh-list
25168326|NCT02224235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25168327|NCT02224235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25168328|NCT02224235|Analgesics|analgesics|mesh-ancestor
25168329|NCT02224235|Sensory System Agents|sensory system agents|mesh-ancestor
25168330|NCT02224235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25168331|NCT02224235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168332|NCT02224235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25168333|NCT02224235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25168334|NCT02224235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25168335|NCT02224235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25168336|NCT02224235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168337|NCT02224235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25168338|NCT02224235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25168339|NCT02224235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168340|NCT02224235|Antipyretics|antipyretics|mesh-ancestor
25168341|NCT02221232|Ethanol|ethanol|mesh-list
25168342|NCT02221232|Chlorhexidine|chlorhexidine|mesh-list
25168343|NCT02221232|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25168344|NCT02221232|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25168345|NCT02221232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25168346|NCT02221232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25168347|NCT02221232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168348|NCT02221232|Disinfectants|disinfectants|mesh-ancestor
25168349|NCT02221232|Dermatologic Agents|dermatologic agents|mesh-ancestor
25168350|NCT02214550|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
25168351|NCT02214550|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25168352|NCT02214550|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25203573|NCT02713282|Dopamine Agents|dopamine agents|mesh-ancestor
24458852|NCT00341432|Autonomic Agents|autonomic agents|mesh-ancestor
25829386|NCT00006204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25038040|NCT03533231|Propolis|propolis|mesh-list
25038041|NCT03533231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25168353|NCT02214550|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25168354|NCT02214550|Contraceptive Agents|contraceptive agents|mesh-ancestor
25168355|NCT02214550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25650544|NCT01504867|Analgesics|analgesics|mesh-ancestor
25650545|NCT01504867|Sensory System Agents|sensory system agents|mesh-ancestor
25650546|NCT01504867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24947998|NCT03923803|Calcitonin|calcitonin|mesh-list
24555151|NCT00740259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24628830|NCT01101620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24555152|NCT00740259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168356|NCT02214550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168357|NCT02214550|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25168358|NCT02214550|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25168359|NCT02214550|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
25168360|NCT02214550|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25168361|NCT02212951|Insulin Lispro|insulin lispro|mesh-list
25168362|NCT02212951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25168363|NCT02212951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168364|NCT02210806|Albuterol|albuterol|mesh-list
25168365|NCT02210806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25168366|NCT02210806|Autonomic Agents|autonomic agents|mesh-ancestor
25168367|NCT02210806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25168368|NCT02210806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168369|NCT02210806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25168370|NCT02210806|Respiratory System Agents|respiratory system agents|mesh-ancestor
25168371|NCT02210806|Tocolytic Agents|tocolytic agents|mesh-ancestor
25168372|NCT02210806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25168373|NCT02210806|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25168374|NCT02210806|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25038068|NCT03533166|Disinfectants|disinfectants|mesh-ancestor
25038069|NCT03533127|Bevacizumab|bevacizumab|mesh-list
25038070|NCT03533127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25038071|NCT03533127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994759|NCT03100006|Nivolumab|nivolumab|mesh-list
24589076|NCT00905723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25038123|NCT03532841|Analgesics|analgesics|mesh-ancestor
25168375|NCT02210806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25168376|NCT02210806|Adrenergic Agents|adrenergic agents|mesh-ancestor
25168377|NCT02210806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25168378|NCT02210806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168379|NCT02207257|Edoxaban|edoxaban|mesh-list
25168380|NCT02207257|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25168381|NCT02207257|Antithrombins|antithrombins|mesh-ancestor
25168382|NCT02207257|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25168383|NCT02207257|Protease Inhibitors|protease inhibitors|mesh-ancestor
25168384|NCT02207257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168385|NCT02207257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168386|NCT02207257|Anticoagulants|anticoagulants|mesh-ancestor
25168387|NCT02206100|Enoxaparin|enoxaparin|mesh-list
25168388|NCT02206100|Anticoagulants|anticoagulants|mesh-ancestor
25168389|NCT02206100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25168403|NCT02205528|Hormones|hormones|mesh-ancestor
25168404|NCT02205528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25168405|NCT02204345|Paclitaxel|paclitaxel|mesh-list
25168406|NCT02204345|Carboplatin|carboplatin|mesh-list
25168407|NCT02204345|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25168408|NCT02204345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168409|NCT02204345|Tubulin Modulators|tubulin modulators|mesh-ancestor
25168410|NCT02204345|Antimitotic Agents|antimitotic agents|mesh-ancestor
25168411|NCT02204345|Mitosis Modulators|mitosis modulators|mesh-ancestor
25168412|NCT02204345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168414|NCT02200380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25168415|NCT02200380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25168416|NCT02200380|Antiviral Agents|antiviral agents|mesh-ancestor
25168417|NCT02200380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25038220|NCT05262985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038221|NCT05262608|Olaparib|olaparib|mesh-list
24606336|NCT00990028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25038231|NCT05262465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038476|NCT05092841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589108|NCT00905905|Simvastatin|simvastatin|mesh-list
25829387|NCT00006204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25829388|NCT00006204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25829389|NCT00006204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25650547|NCT01504867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650548|NCT01504867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25650549|NCT01504867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25650550|NCT01504867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25829390|NCT00006204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829391|NCT00006204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25200042|NCT02736591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25200043|NCT02736591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829393|NCT00006204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25829394|NCT00006204|Antidepressive Agents|antidepressive agents|mesh-ancestor
25829395|NCT00006204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25829396|NCT00006204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25829397|NCT00006204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25829398|NCT00006204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829399|NCT00006205|Topiramate|topiramate|mesh-list
25829400|NCT00006205|Ondansetron|ondansetron|mesh-list
25829401|NCT00006205|Antiemetics|antiemetics|mesh-ancestor
25829402|NCT00006205|Autonomic Agents|autonomic agents|mesh-ancestor
25829403|NCT00006205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25038869|NCT04445688|Adrenergic Agents|adrenergic agents|mesh-ancestor
25038870|NCT04445688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25038871|NCT04445688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038872|NCT04424641|Antibodies|antibodies|mesh-list
25038873|NCT04424641|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25038874|NCT04424641|Immunologic Factors|immunologic factors|mesh-ancestor
25038932|NCT04285671|Immunoglobulins|immunoglobulins|mesh-list
25168429|NCT02187302|Bevacizumab|bevacizumab|mesh-list
25168430|NCT02187302|Sunitinib|sunitinib|mesh-list
25168431|NCT02187302|Everolimus|everolimus|mesh-list
25168432|NCT02187302|Sorafenib|sorafenib|mesh-list
25168433|NCT02187302|Axitinib|axitinib|mesh-list
25168434|NCT02187302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25168437|NCT02187302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25168439|NCT02187302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168440|NCT02187302|Growth Inhibitors|growth inhibitors|mesh-ancestor
25168441|NCT02187302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25168442|NCT02187302|Immunologic Factors|immunologic factors|mesh-ancestor
25168443|NCT02187302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25168444|NCT02187302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168445|NCT02187302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168446|NCT02179749|Mifepristone|mifepristone|mesh-list
25168447|NCT02179749|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25039015|NCT04209296|Ketamine|ketamine|mesh-list
25039061|NCT04163185|Rizatriptan|rizatriptan|mesh-list
25168448|NCT02179749|Abortifacient Agents|abortifacient agents|mesh-ancestor
25039127|NCT04114136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039141|NCT04093765|Antimalarials|antimalarials|mesh-list
25039142|NCT04093765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25039189|NCT04029610|Anesthetics|anesthetics|mesh-ancestor
25168449|NCT02179749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25168450|NCT02179749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168451|NCT02179749|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25168452|NCT02179749|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25168453|NCT02179749|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25168454|NCT02179749|Contraceptive Agents|contraceptive agents|mesh-ancestor
25168455|NCT02179749|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25168456|NCT02179749|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25168457|NCT02179749|Hormone Antagonists|hormone antagonists|mesh-ancestor
25168458|NCT02179749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25168459|NCT02179749|Luteolytic Agents|luteolytic agents|mesh-ancestor
25168460|NCT02179749|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25168461|NCT02179749|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25168462|NCT02179151|CKD732|ckd732|mesh-list
25168463|NCT02179151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25168464|NCT02179151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25168466|NCT02179151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168467|NCT02179151|Growth Inhibitors|growth inhibitors|mesh-ancestor
25168468|NCT02179151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168469|NCT02178098|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
25168470|NCT02178098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25168471|NCT02178098|Antimetabolites|antimetabolites|mesh-ancestor
25168472|NCT02178098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168473|NCT02178098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25168474|NCT02178098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168475|NCT02178098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25168476|NCT02178098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168477|NCT02160678|Tazarotene|tazarotene|mesh-list
25650551|NCT01504867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25650552|NCT01504867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168478|NCT02160678|Dermatologic Agents|dermatologic agents|mesh-ancestor
25168479|NCT02160678|Keratolytic Agents|keratolytic agents|mesh-ancestor
25168480|NCT02160665|Tazarotene|tazarotene|mesh-list
25168481|NCT02160665|Dermatologic Agents|dermatologic agents|mesh-ancestor
25039311|NCT03911102|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25039339|NCT03888378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25039375|NCT03877289|Oxybutynin|oxybutynin|mesh-list
25039436|NCT03834753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25039437|NCT03834753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25039477|NCT03824587|Sevelamer|sevelamer|mesh-list
25039562|NCT03778554|Antioxidants|antioxidants|mesh-ancestor
25168482|NCT02160665|Keratolytic Agents|keratolytic agents|mesh-ancestor
25168483|NCT02158585|Lamotrigine|lamotrigine|mesh-list
25168484|NCT02158585|Anticonvulsants|anticonvulsants|mesh-ancestor
25168485|NCT02158585|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25168486|NCT02158585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25168487|NCT02158585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168488|NCT02158585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25168489|NCT02158585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168490|NCT02158585|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25168491|NCT02158585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25168492|NCT02158585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25168493|NCT02158585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25039822|NCT03647111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039824|NCT03646994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168500|NCT02153502|Dextromethorphan|dextromethorphan|mesh-list
25168501|NCT02153502|Antitussive Agents|antitussive agents|mesh-ancestor
25039870|NCT03617367|Cholinergic Agents|cholinergic agents|mesh-ancestor
25039871|NCT03617367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25039872|NCT03611881|Nicotine|nicotine|mesh-list
25039873|NCT03611881|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25039874|NCT03611881|Autonomic Agents|autonomic agents|mesh-ancestor
25039875|NCT03611881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24529153|NCT00624754|Hormones|hormones|mesh-ancestor
25168502|NCT02153502|Respiratory System Agents|respiratory system agents|mesh-ancestor
25168503|NCT02153502|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25168504|NCT02153502|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25168505|NCT02153502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25168506|NCT02153502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168507|NCT02153502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168508|NCT02153502|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25168509|NCT02153502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25168510|NCT02153502|Adrenergic Agents|adrenergic agents|mesh-ancestor
25168511|NCT02153502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25168512|NCT02153502|Antimalarials|antimalarials|mesh-ancestor
25168513|NCT02153502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25168514|NCT02153502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25168515|NCT02153502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25168516|NCT02153502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168517|NCT02153502|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25168518|NCT02153502|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25168519|NCT02153502|Cholinergic Agents|cholinergic agents|mesh-ancestor
25168520|NCT02153502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25117104|NCT05376722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25117105|NCT05376722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25117121|NCT05376202|Cetuximab|cetuximab|mesh-list
24529276|NCT00625248|Anticoagulants|anticoagulants|mesh-list
24529277|NCT00625248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25158152|NCT04453839|Protective Agents|protective agents|mesh-ancestor
24529320|NCT00625430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25168521|NCT02153502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25168522|NCT02153502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25168523|NCT02153502|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25158292|NCT04372940|Hemostatics|hemostatics|mesh-ancestor
25158328|NCT04351737|Antiemetics|antiemetics|mesh-ancestor
25158329|NCT04351737|Autonomic Agents|autonomic agents|mesh-ancestor
25158330|NCT04351737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25158388|NCT04326673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25158389|NCT04326673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25158390|NCT04326673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25158391|NCT04326673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25158392|NCT04326673|Anabolic Agents|anabolic agents|mesh-ancestor
25158537|NCT04254692|Anesthetics|anesthetics|mesh-ancestor
25158538|NCT04254692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25158539|NCT04254692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25158540|NCT04254692|Sensory System Agents|sensory system agents|mesh-ancestor
25158541|NCT04254692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24702216|NCT01464606|Doxorubicin|doxorubicin|mesh-list
25168524|NCT02153502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25168525|NCT02138630|Capsaicin|capsaicin|mesh-list
25168526|NCT02138630|Antipruritics|antipruritics|mesh-ancestor
25168527|NCT02138630|Dermatologic Agents|dermatologic agents|mesh-ancestor
25168528|NCT02138630|Sensory System Agents|sensory system agents|mesh-ancestor
25168529|NCT02138630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25168530|NCT02138630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168531|NCT02137343|Capecitabine|capecitabine|mesh-list
25168532|NCT02137343|Rilotumumab|rilotumumab|mesh-list
25168533|NCT02137343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168534|NCT02137343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25168535|NCT02137343|Antimetabolites|antimetabolites|mesh-ancestor
25168536|NCT02137343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168537|NCT02137343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25168538|NCT02135419|Fluorouracil|fluorouracil|mesh-list
25168539|NCT02135419|Imiquimod|imiquimod|mesh-list
25168540|NCT02135419|Antimetabolites|antimetabolites|mesh-ancestor
25168541|NCT02135419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168542|NCT02135419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25168543|NCT02135419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168544|NCT02135419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25168545|NCT02135419|Immunologic Factors|immunologic factors|mesh-ancestor
25168546|NCT02135419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168547|NCT02135419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25168548|NCT02135419|Interferon Inducers|interferon inducers|mesh-ancestor
25168549|NCT02130687|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25168550|NCT02130687|Aprepitant|aprepitant|mesh-list
25168551|NCT02130687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25168552|NCT02130687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168553|NCT02130687|Incretins|incretins|mesh-ancestor
25168554|NCT02130687|Hormones|hormones|mesh-ancestor
25168555|NCT02130687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25168556|NCT02130687|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25168557|NCT02130687|Protease Inhibitors|protease inhibitors|mesh-ancestor
25168558|NCT02130687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168559|NCT02130687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168560|NCT02130687|Antiemetics|antiemetics|mesh-ancestor
25168561|NCT02130687|Autonomic Agents|autonomic agents|mesh-ancestor
25158544|NCT04249596|Antidepressive Agents|antidepressive agents|mesh-ancestor
25168569|NCT02125266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25168570|NCT02125266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117691|NCT04860518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25117692|NCT04860518|Glucocorticoids|glucocorticoids|mesh-ancestor
25277933|NCT02354950|Cabotegravir|cabotegravir|mesh-list
25158852|NCT04157153|Sirolimus|sirolimus|mesh-list
25158867|NCT04157075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25158897|NCT04109066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25158898|NCT04109066|Tubulin Modulators|tubulin modulators|mesh-ancestor
25158899|NCT04109066|Antimitotic Agents|antimitotic agents|mesh-ancestor
25117786|NCT04823442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25117787|NCT04823442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25117790|NCT04782375|Antiviral Agents|antiviral agents|mesh-list
25117791|NCT04782375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25117792|NCT04762498|Methotrexate|methotrexate|mesh-list
25117798|NCT04762498|Antimetabolites|antimetabolites|mesh-ancestor
25168571|NCT02125266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25168572|NCT02125266|Antimetabolites|antimetabolites|mesh-ancestor
25168573|NCT02125266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168574|NCT02125266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168575|NCT02125266|Dermatologic Agents|dermatologic agents|mesh-ancestor
25168576|NCT02125266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168577|NCT02125266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25168578|NCT02125266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25168579|NCT02125266|Immunologic Factors|immunologic factors|mesh-ancestor
25168580|NCT02125266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25168581|NCT02125266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25168582|NCT02125253|Mometasone Furoate|mometasone furoate|mesh-list
25168583|NCT02125253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25168584|NCT02125253|Dermatologic Agents|dermatologic agents|mesh-ancestor
25168585|NCT02125253|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25168586|NCT02116998|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25168587|NCT02116998|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25650553|NCT01504867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25650554|NCT01504867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25650555|NCT01504867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25650557|NCT01504971|Rabeprazole|rabeprazole|mesh-list
25650558|NCT01504971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25051596|NCT00393991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051597|NCT00393952|Fluticasone|fluticasone|mesh-list
25051598|NCT00393952|Xhance|xhance|mesh-list
24555674|NCT00742768|Vitamins|vitamins|mesh-list
25168588|NCT02116998|Immunologic Factors|immunologic factors|mesh-ancestor
25168589|NCT02116998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168590|NCT02116998|Antacids|antacids|mesh-ancestor
25168591|NCT02116998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168592|NCT02116998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25278229|NCT02352597|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25278230|NCT02352597|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24995710|NCT04805268|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24995711|NCT04805268|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24995712|NCT04805268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704654|NCT01479504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168596|NCT02110368|Methyltestosterone|methyltestosterone|mesh-list
25168597|NCT02110368|Testosterone|testosterone|mesh-list
25168598|NCT02110368|Testosterone undecanoate|testosterone undecanoate|mesh-list
25168599|NCT02110368|Testosterone enanthate|testosterone enanthate|mesh-list
25168600|NCT02110368|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25168601|NCT02110368|Androgens|androgens|mesh-ancestor
25168602|NCT02110368|Hormones|hormones|mesh-ancestor
25168603|NCT02110368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25168604|NCT02110368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168605|NCT02110368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25168606|NCT02110368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168607|NCT02110368|Anabolic Agents|anabolic agents|mesh-ancestor
24529471|NCT00626158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529472|NCT00626158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24529473|NCT00626158|Antiviral Agents|antiviral agents|mesh-ancestor
25159202|NCT03950570|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25168608|NCT02106546|Paclitaxel|paclitaxel|mesh-list
25168609|NCT02106546|Carboplatin|carboplatin|mesh-list
25168610|NCT02106546|Veliparib|veliparib|mesh-list
25168611|NCT02106546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25168612|NCT02106546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168613|NCT02106546|Tubulin Modulators|tubulin modulators|mesh-ancestor
25168614|NCT02106546|Antimitotic Agents|antimitotic agents|mesh-ancestor
25168615|NCT02106546|Mitosis Modulators|mitosis modulators|mesh-ancestor
25168616|NCT02106546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168617|NCT02106546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25168618|NCT02106546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168619|NCT02104388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25168620|NCT02104388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24996219|NCT04066023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24862225|NCT02323607|Immunologic Factors|immunologic factors|mesh-ancestor
24996220|NCT04066023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705287|NCT01483729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24544435|NCT00688961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25168622|NCT02104245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25829404|NCT00006205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168623|NCT02104245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25168624|NCT02104245|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24458959|NCT00343239|Docetaxel|docetaxel|mesh-list
24458960|NCT00343239|Fluorouracil|fluorouracil|mesh-list
24458961|NCT00343239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458962|NCT00343239|Tubulin Modulators|tubulin modulators|mesh-ancestor
24458963|NCT00343239|Antimitotic Agents|antimitotic agents|mesh-ancestor
25829405|NCT00006205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25829406|NCT00006205|Antipruritics|antipruritics|mesh-ancestor
25829407|NCT00006205|Dermatologic Agents|dermatologic agents|mesh-ancestor
25829408|NCT00006205|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25829409|NCT00006205|Serotonin Agents|serotonin agents|mesh-ancestor
25829410|NCT00006205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25829411|NCT00006205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829412|NCT00006205|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25650559|NCT01504971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25650560|NCT01504971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25650561|NCT01504971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829413|NCT00006205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25829414|NCT00006205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25829415|NCT00006205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25829416|NCT00006205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25829417|NCT00006205|Anticonvulsants|anticonvulsants|mesh-ancestor
24535521|NCT00649285|Nitrofurantoin|nitrofurantoin|mesh-list
25168625|NCT02104245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25168626|NCT02104245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168627|NCT02104245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168628|NCT02104245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168629|NCT02104245|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25168630|NCT02104245|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25203574|NCT02713477|Insulin|insulin|mesh-list
25203575|NCT02713477|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24529780|NCT00627796|Lanreotide|lanreotide|mesh-list
24529781|NCT00627796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24529782|NCT00627809|Streptokinase|streptokinase|mesh-list
24529783|NCT00627809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24529826|NCT00627952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24529827|NCT00627952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24529828|NCT00627952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25203576|NCT02713477|Insulin Glargine|insulin glargine|mesh-list
25203577|NCT02713477|Lixisenatide|lixisenatide|mesh-list
25203578|NCT02713477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25203581|NCT02713139|Clotrimazole|clotrimazole|mesh-list
25829418|NCT00006205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25829419|NCT00006206|Naltrexone|naltrexone|mesh-list
25203583|NCT02713139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25203584|NCT02713139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25203585|NCT02713139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25203586|NCT02713139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25203587|NCT02713139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25203588|NCT02713139|Antifungal Agents|antifungal agents|mesh-ancestor
25203589|NCT02713139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25203590|NCT02713139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25203591|NCT02713139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203592|NCT02713139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203593|NCT02713139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25203594|NCT02713139|Hormone Antagonists|hormone antagonists|mesh-ancestor
25203595|NCT02713139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25203596|NCT02713139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203597|NCT02713139|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25203598|NCT02713139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25203599|NCT02713191|Fentanyl|fentanyl|mesh-list
25203600|NCT02713191|Midazolam|midazolam|mesh-list
25203601|NCT02713191|Dexmedetomidine|dexmedetomidine|mesh-list
25203602|NCT02713191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25203603|NCT02713191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25203604|NCT02713191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203605|NCT02713191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25203606|NCT02713191|Analgesics|analgesics|mesh-ancestor
25203607|NCT02713191|Sensory System Agents|sensory system agents|mesh-ancestor
25203608|NCT02713191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25203609|NCT02713191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25203610|NCT02713191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25203611|NCT02713191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25203612|NCT02713191|Adrenergic Agents|adrenergic agents|mesh-ancestor
25203613|NCT02713191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25203614|NCT02713191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203615|NCT02713191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25203616|NCT02713191|Narcotics|narcotics|mesh-ancestor
25203617|NCT02713191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25203618|NCT02713191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25203619|NCT02713191|Anesthetics, General|anesthetics, general|mesh-ancestor
25203620|NCT02713191|Anesthetics|anesthetics|mesh-ancestor
25168632|NCT02104050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25168633|NCT02103322|Imatinib Mesylate|imatinib mesylate|mesh-list
25168634|NCT02103322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168635|NCT02103322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25168636|NCT02103322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168637|NCT02103322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168638|NCT02102802|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25168639|NCT02102802|Hallucinogens|hallucinogens|mesh-ancestor
25160247|NCT03104491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25160248|NCT03097939|Nivolumab|nivolumab|mesh-list
24443138|NCT00293735|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25160249|NCT03097939|Ipilimumab|ipilimumab|mesh-list
25160254|NCT03096249|Oxytocin|oxytocin|mesh-list
25168640|NCT02102802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168641|NCT02102802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25168642|NCT02102802|Serotonin Agents|serotonin agents|mesh-ancestor
25168643|NCT02102802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25168644|NCT02102802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168645|NCT02102802|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25168646|NCT02102802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25168647|NCT02102802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25168648|NCT02102802|Adrenergic Agents|adrenergic agents|mesh-ancestor
25168649|NCT02101268|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
25168650|NCT02101268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25168651|NCT02101268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168652|NCT02101268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168653|NCT02092935|Vancomycin|vancomycin|mesh-list
25168654|NCT02092935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25168663|NCT02092922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168664|NCT02092922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168665|NCT02092454|Benzocaine|benzocaine|mesh-list
25168666|NCT02092454|Anesthetics, Local|anesthetics, local|mesh-ancestor
25168667|NCT02092454|Anesthetics|anesthetics|mesh-ancestor
25168668|NCT02092454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25168669|NCT02092454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168670|NCT02092454|Sensory System Agents|sensory system agents|mesh-ancestor
25168671|NCT02092454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25168672|NCT02092077|Hormones|hormones|mesh-list
25168673|NCT02092077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25160430|NCT02958865|PF-06700841|pf-06700841|mesh-list
25160483|NCT02917083|Alkylating Agents|alkylating agents|mesh-ancestor
25168674|NCT02092077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168675|NCT02083289|Latanoprost|latanoprost|mesh-list
25168676|NCT02083289|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25168677|NCT02083289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25168678|NCT02081300|Methyltestosterone|methyltestosterone|mesh-list
25168679|NCT02081300|Testosterone|testosterone|mesh-list
25168680|NCT02081300|Testosterone undecanoate|testosterone undecanoate|mesh-list
25168681|NCT02081300|Testosterone enanthate|testosterone enanthate|mesh-list
25168682|NCT02081300|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25168683|NCT02081300|Androgens|androgens|mesh-ancestor
25168684|NCT02081300|Hormones|hormones|mesh-ancestor
25160693|NCT02623439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25168685|NCT02081300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25168686|NCT02081300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168687|NCT02081300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25168688|NCT02081300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168689|NCT02081300|Anabolic Agents|anabolic agents|mesh-ancestor
25168690|NCT02081118|Exenatide|exenatide|mesh-list
25168691|NCT02081118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25168692|NCT02081118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168693|NCT02081118|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25168694|NCT02081118|Incretins|incretins|mesh-ancestor
25168695|NCT02081118|Hormones|hormones|mesh-ancestor
25168696|NCT02081118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25168697|NCT02077881|Gemcitabine|gemcitabine|mesh-list
25168698|NCT02077881|Paclitaxel|paclitaxel|mesh-list
25168699|NCT02077881|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25168700|NCT02077881|Tryptophan|tryptophan|mesh-list
25168701|NCT02077881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25168702|NCT02077881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829420|NCT00006206|Acamprosate|acamprosate|mesh-list
25168703|NCT02077881|Tubulin Modulators|tubulin modulators|mesh-ancestor
25168704|NCT02077881|Antimitotic Agents|antimitotic agents|mesh-ancestor
25168705|NCT02077881|Mitosis Modulators|mitosis modulators|mesh-ancestor
25168706|NCT02077881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168707|NCT02077881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25168708|NCT02077881|Antimetabolites|antimetabolites|mesh-ancestor
25168709|NCT02077881|Antiviral Agents|antiviral agents|mesh-ancestor
25168710|NCT02077881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25168712|NCT02077881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25168713|NCT02077881|Immunologic Factors|immunologic factors|mesh-ancestor
25168714|NCT02077881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25650562|NCT01504971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556540|NCT00748059|Antiemetics|antiemetics|mesh-ancestor
24556541|NCT00748059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24556542|NCT00748059|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25168715|NCT02077881|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25168716|NCT02077881|Antidepressive Agents|antidepressive agents|mesh-ancestor
25168717|NCT02077881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25161241|NCT01656343|Abatacept|abatacept|mesh-list
25161282|NCT01540253|Docetaxel|docetaxel|mesh-list
25161367|NCT01367002|Paclitaxel|paclitaxel|mesh-list
25168718|NCT02074007|Benzocaine|benzocaine|mesh-list
25168719|NCT02074007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168720|NCT02074007|Anesthetics, Local|anesthetics, local|mesh-ancestor
25168721|NCT02074007|Anesthetics|anesthetics|mesh-ancestor
25168722|NCT02074007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25168723|NCT02074007|Sensory System Agents|sensory system agents|mesh-ancestor
25168724|NCT02074007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25168725|NCT02073123|Pembrolizumab|pembrolizumab|mesh-list
25168726|NCT02073123|Nivolumab|nivolumab|mesh-list
25168727|NCT02073123|Ipilimumab|ipilimumab|mesh-list
25168728|NCT02073123|Tryptophan|tryptophan|mesh-list
25168729|NCT02073123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25168730|NCT02073123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168731|NCT02073123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25168732|NCT02073123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168733|NCT02073123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25168734|NCT02073123|Antidepressive Agents|antidepressive agents|mesh-ancestor
25168735|NCT02073123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25168736|NCT02072954|Asenapine|asenapine|mesh-list
25168737|NCT02072954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25168738|NCT02072954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25168739|NCT02072954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25168740|NCT02072954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168741|NCT02072954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25168742|NCT02072863|Prednisone|prednisone|mesh-list
25168743|NCT02072863|Melphalan|melphalan|mesh-list
25168744|NCT02072863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25168745|NCT02072863|Glucocorticoids|glucocorticoids|mesh-ancestor
25168746|NCT02072863|Hormones|hormones|mesh-ancestor
25168747|NCT02072863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25168748|NCT02072863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168749|NCT02072863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25168750|NCT02072863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168751|NCT02072863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25168752|NCT02072863|Alkylating Agents|alkylating agents|mesh-ancestor
25168753|NCT02072863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168754|NCT02072863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25168755|NCT02072863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25168756|NCT02072863|Immunologic Factors|immunologic factors|mesh-ancestor
25168757|NCT02072161|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
25168758|NCT02072161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25168759|NCT02072161|Antimetabolites|antimetabolites|mesh-ancestor
25168760|NCT02072161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161698|NCT00042289|Renal Agents|renal agents|mesh-ancestor
25120852|NCT02332928|Melatonin|melatonin|mesh-list
24529913|NCT00628290|Cannabidiol|cannabidiol|mesh-list
24529914|NCT00628290|Amisulpride|amisulpride|mesh-list
24529946|NCT00628550|Vasopressins|vasopressins|mesh-list
24529947|NCT00628550|Arginine Vasopressin|arginine vasopressin|mesh-list
24529948|NCT00628550|Epinephrine|epinephrine|mesh-list
24529982|NCT00628667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529983|NCT00628680|Heparin|heparin|mesh-list
25120945|NCT01295944|Bevacizumab|bevacizumab|mesh-list
25121243|NCT03104036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121244|NCT03104036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25121245|NCT03104036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24529984|NCT00628680|Anticoagulants|anticoagulants|mesh-ancestor
24529985|NCT00628680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24529986|NCT00628680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24529987|NCT00628680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529988|NCT00628706|Dronabinol|dronabinol|mesh-list
25650563|NCT01505114|Tenofovir|tenofovir|mesh-list
25650564|NCT01505114|Emtricitabine|emtricitabine|mesh-list
25650565|NCT01505114|Maraviroc|maraviroc|mesh-list
24530067|NCT00628914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24530215|NCT00629382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24530216|NCT00629382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24530217|NCT00629447|Tinzaparin|tinzaparin|mesh-list
25650566|NCT01505114|Antiviral Agents|antiviral agents|mesh-ancestor
24556910|NCT00750347|Analgesics|analgesics|mesh-ancestor
24530218|NCT00629447|Anticoagulants|anticoagulants|mesh-ancestor
24530219|NCT00629447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24530220|NCT00629447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25829421|NCT00006206|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25829422|NCT00006206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24530417|NCT00630175|Zolpidem|zolpidem|mesh-list
24530418|NCT00630175|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24530419|NCT00630175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24530420|NCT00630175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24706312|NCT01489683|Lidocaine|lidocaine|mesh-list
25168902|NCT02046694|Gout Suppressants|gout suppressants|mesh-ancestor
25168761|NCT02072161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25168762|NCT02072161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168763|NCT02072161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25168764|NCT02072161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168766|NCT02064426|Hematinics|hematinics|mesh-ancestor
25168767|NCT02063997|Colchicine|colchicine|mesh-list
25168768|NCT02063997|Allopurinol|allopurinol|mesh-list
25168769|NCT02063997|Gout Suppressants|gout suppressants|mesh-ancestor
25168770|NCT02063997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25168771|NCT02063997|Tubulin Modulators|tubulin modulators|mesh-ancestor
25168772|NCT02063997|Antimitotic Agents|antimitotic agents|mesh-ancestor
25168773|NCT02063997|Mitosis Modulators|mitosis modulators|mesh-ancestor
25168774|NCT02063997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168775|NCT02063997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168776|NCT02063997|Antimetabolites|antimetabolites|mesh-ancestor
25829423|NCT00006206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168777|NCT02063997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168778|NCT02063997|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25168779|NCT02063997|Antioxidants|antioxidants|mesh-ancestor
25168780|NCT02063997|Protective Agents|protective agents|mesh-ancestor
25168781|NCT02063997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122409|NCT03094507|Darunavir|darunavir|mesh-list
25122683|NCT03091595|Hormones|hormones|mesh-ancestor
25168782|NCT02063685|Prednisone|prednisone|mesh-list
25168783|NCT02063685|Cyclophosphamide|cyclophosphamide|mesh-list
25168784|NCT02063685|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25168785|NCT02063685|Rituximab|rituximab|mesh-list
25168786|NCT02063685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25168787|NCT02063685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25168788|NCT02063685|Immunologic Factors|immunologic factors|mesh-ancestor
25168789|NCT02063685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168790|NCT02063685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24533139|NCT00642434|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24706697|NCT01491204|Paclitaxel|paclitaxel|mesh-list
25168791|NCT02063685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25168792|NCT02063685|Alkylating Agents|alkylating agents|mesh-ancestor
25168793|NCT02063685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168794|NCT02063685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168795|NCT02063685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25168796|NCT02063685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25168797|NCT02063685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25168798|NCT02063685|Glucocorticoids|glucocorticoids|mesh-ancestor
25168799|NCT02063685|Hormones|hormones|mesh-ancestor
25168800|NCT02063685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25168801|NCT02063685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25168802|NCT02063295|CKD732|ckd732|mesh-list
25168803|NCT02063295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25168804|NCT02063295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25168805|NCT02063295|Growth Substances|growth substances|mesh-ancestor
25168806|NCT02063295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168807|NCT02063295|Growth Inhibitors|growth inhibitors|mesh-ancestor
25168808|NCT02063295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168809|NCT02061761|Nivolumab|nivolumab|mesh-list
25168810|NCT02061761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25168811|NCT02061761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168812|NCT02061761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25168813|NCT02061761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168814|NCT02058420|Tocotrienols|tocotrienols|mesh-list
25168815|NCT02058420|Vitamin E|vitamin e|mesh-list
25124985|NCT03072199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124986|NCT03072199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25829424|NCT00006206|Sensory System Agents|sensory system agents|mesh-ancestor
25168816|NCT02058420|Tocopherols|tocopherols|mesh-list
25125965|NCT03065660|Mifepristone|mifepristone|mesh-list
25125966|NCT03065660|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25650567|NCT01505114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25650568|NCT01505114|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25829425|NCT00006206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125967|NCT03065660|Abortifacient Agents|abortifacient agents|mesh-ancestor
25125968|NCT03065660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25125969|NCT03065660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125970|NCT03065660|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25125971|NCT03065660|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25125972|NCT03065660|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25125973|NCT03065660|Contraceptive Agents|contraceptive agents|mesh-ancestor
25126303|NCT03063359|Anesthetics, General|anesthetics, general|mesh-ancestor
25168818|NCT02058420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168819|NCT02058420|Protective Agents|protective agents|mesh-ancestor
25168822|NCT02058420|Micronutrients|micronutrients|mesh-ancestor
25168823|NCT02057380|Dexamethasone|dexamethasone|mesh-list
25168824|NCT02057380|Paclitaxel|paclitaxel|mesh-list
25168825|NCT02057380|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25168826|NCT02057380|Bortezomib|bortezomib|mesh-list
25168827|NCT02057380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25168828|NCT02057380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25168829|NCT02057380|Tubulin Modulators|tubulin modulators|mesh-ancestor
25168830|NCT02057380|Antimitotic Agents|antimitotic agents|mesh-ancestor
25168831|NCT02057380|Mitosis Modulators|mitosis modulators|mesh-ancestor
25168832|NCT02057380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25168833|NCT02057380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25168834|NCT02057380|Antiemetics|antiemetics|mesh-ancestor
25168835|NCT02057380|Autonomic Agents|autonomic agents|mesh-ancestor
25168836|NCT02057380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25168837|NCT02057380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25168838|NCT02057380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25168839|NCT02057380|Glucocorticoids|glucocorticoids|mesh-ancestor
25168840|NCT02057380|Hormones|hormones|mesh-ancestor
25168841|NCT02057380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25168842|NCT02057380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25168843|NCT02057380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25168844|NCT02057380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25168845|NCT02057315|Ketoprofen|ketoprofen|mesh-list
25168846|NCT02057315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25829426|NCT00006208|Emtricitabine|emtricitabine|mesh-list
25168847|NCT02057315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25168848|NCT02057315|Analgesics|analgesics|mesh-ancestor
25168849|NCT02057315|Sensory System Agents|sensory system agents|mesh-ancestor
25829427|NCT00006208|Efavirenz|efavirenz|mesh-list
25829428|NCT00006208|Stavudine|stavudine|mesh-list
24774645|NCT01847144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774646|NCT01847144|Incretins|incretins|mesh-ancestor
24774647|NCT01847144|Hormones|hormones|mesh-ancestor
24774648|NCT01847144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24774649|NCT01847144|Protease Inhibitors|protease inhibitors|mesh-ancestor
24774650|NCT01847144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774651|NCT01847144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783820|NCT01904214|Siponimod|siponimod|mesh-list
25829429|NCT00006208|Didanosine|didanosine|mesh-list
25829430|NCT00006208|Antiviral Agents|antiviral agents|mesh-ancestor
25829431|NCT00006208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25829432|NCT00006208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25829433|NCT00006208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25829434|NCT00006208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829435|NCT00006208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829436|NCT00006208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25829437|NCT00006208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25829438|NCT00006208|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25127092|NCT03058237|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24457958|NCT00335920|Hormones|hormones|mesh-ancestor
25127727|NCT03053830|Ketamine|ketamine|mesh-list
25128262|NCT03049085|Sensory System Agents|sensory system agents|mesh-ancestor
25829439|NCT00006208|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25128437|NCT03047733|Tacrolimus|tacrolimus|mesh-list
25128631|NCT03045770|Antidotes|antidotes|mesh-ancestor
24774801|NCT01848119|Sensory System Agents|sensory system agents|mesh-ancestor
24774802|NCT01848119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25081331|NCT03331211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24912247|NCT04278495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24774834|NCT01848132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24774835|NCT01848132|Glucocorticoids|glucocorticoids|mesh-ancestor
24774836|NCT01848132|Hormones|hormones|mesh-ancestor
24774837|NCT01848132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24774840|NCT01848132|Tubulin Modulators|tubulin modulators|mesh-ancestor
24774841|NCT01848132|Antimitotic Agents|antimitotic agents|mesh-ancestor
24774842|NCT01848132|Mitosis Modulators|mitosis modulators|mesh-ancestor
24774843|NCT01848197|Paclitaxel|paclitaxel|mesh-list
24774844|NCT01848197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24486888|NCT00460473|Analgesics|analgesics|mesh-ancestor
24774867|NCT01848340|Cabotegravir|cabotegravir|mesh-list
24774868|NCT01848340|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24774869|NCT01848340|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24774870|NCT01848340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774871|NCT01848340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774872|NCT01848340|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24774873|NCT01848340|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24774874|NCT01848340|Antiviral Agents|antiviral agents|mesh-ancestor
24774875|NCT01848340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24774876|NCT01848379|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24775355|NCT01851733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24775356|NCT01851733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24775393|NCT01851954|Clarithromycin|clarithromycin|mesh-list
24775412|NCT01851993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775413|NCT01851993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24775414|NCT01851993|Antipruritics|antipruritics|mesh-ancestor
24775415|NCT01851993|Dermatologic Agents|dermatologic agents|mesh-ancestor
24775416|NCT01851993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24775417|NCT01851993|Serotonin Agents|serotonin agents|mesh-ancestor
24775418|NCT01851993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24775419|NCT01851993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775420|NCT01851993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24775421|NCT01851993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25829440|NCT00006208|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25829441|NCT00006208|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25829442|NCT00006208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25829443|NCT00006208|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25829444|NCT00006208|Antimetabolites|antimetabolites|mesh-ancestor
24458011|NCT00336245|Contraceptive Agents|contraceptive agents|mesh-list
24458012|NCT00336245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24458014|NCT00336245|Trace Elements|trace elements|mesh-ancestor
24458021|NCT00336336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24458022|NCT00336336|Antimetabolites|antimetabolites|mesh-ancestor
25829655|NCT00006246|Alkylating Agents|alkylating agents|mesh-ancestor
25129722|NCT03038607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25129723|NCT03038607|Antipyretics|antipyretics|mesh-ancestor
25829656|NCT00006246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449763|NCT00316927|Antiemetics|antiemetics|mesh-ancestor
25130270|NCT03034850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130271|NCT03034850|Antimetabolites|antimetabolites|mesh-ancestor
25130272|NCT03034850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25130273|NCT03034850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25130282|NCT03035058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24775422|NCT01851993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24775423|NCT01851993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24775424|NCT01851993|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24775425|NCT01852253|Chlorhexidine|chlorhexidine|mesh-list
24775426|NCT01852253|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24775427|NCT01852253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24775428|NCT01852253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24775429|NCT01852253|Disinfectants|disinfectants|mesh-ancestor
24775430|NCT01852253|Dermatologic Agents|dermatologic agents|mesh-ancestor
24819204|NCT02094157|Dalteparin|dalteparin|mesh-list
24775461|NCT01852409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081424|NCT03329898|Hormones|hormones|mesh-ancestor
25081425|NCT03329898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25081426|NCT03329898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081427|NCT03329898|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25081428|NCT03329898|Contraceptive Agents|contraceptive agents|mesh-ancestor
24775578|NCT01853449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130972|NCT03029533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25130974|NCT03029676|Fentanyl|fentanyl|mesh-list
24873943|NCT04960618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282713|NCT03978767|Analgesics|analgesics|mesh-ancestor
25829657|NCT00006246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25829658|NCT00006246|Immunologic Factors|immunologic factors|mesh-ancestor
25131817|NCT03023358|Prednisone|prednisone|mesh-list
25131851|NCT03023059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557653|NCT00753207|Lapatinib|lapatinib|mesh-list
24557654|NCT00753207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24557655|NCT00753207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24557656|NCT00753207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24557657|NCT00753207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24437472|NCT00273702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437513|NCT00273949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24437514|NCT00273962|Albuterol|albuterol|mesh-list
24979933|NCT04933383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979934|NCT04933383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25162158|NCT02907593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437535|NCT00273975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24437536|NCT00273975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24437537|NCT00273975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829681|NCT00006248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829682|NCT00006248|Antimetabolites|antimetabolites|mesh-ancestor
25829683|NCT00006248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25829684|NCT00006248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25829685|NCT00006248|Immunologic Factors|immunologic factors|mesh-ancestor
24437578|NCT00274014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24437579|NCT00274014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437582|NCT00274027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24437583|NCT00274027|Autonomic Agents|autonomic agents|mesh-ancestor
24437584|NCT00274027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25829686|NCT00006248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829687|NCT00006249|Interferons|interferons|mesh-list
25829688|NCT00006249|Interferon-alpha|interferon-alpha|mesh-list
24437597|NCT00274040|Autonomic Agents|autonomic agents|mesh-ancestor
24437598|NCT00274040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24437599|NCT00274040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437600|NCT00274040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24437601|NCT00274040|Respiratory System Agents|respiratory system agents|mesh-ancestor
24437602|NCT00274040|Parasympatholytics|parasympatholytics|mesh-ancestor
25124651|NCT03073850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25124652|NCT03073850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124653|NCT03073850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24437603|NCT00274040|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24437604|NCT00274040|Cholinergic Agents|cholinergic agents|mesh-ancestor
24437605|NCT00274040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24979968|NCT04834024|Immunologic Factors|immunologic factors|mesh-ancestor
24979969|NCT04834024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979970|NCT04821141|Bazedoxifene|bazedoxifene|mesh-list
24979971|NCT04821141|Estrogens|estrogens|mesh-list
24979972|NCT04821141|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24979973|NCT04821141|Hormones|hormones|mesh-ancestor
25124662|NCT03073850|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25124663|NCT03073850|Antithrombins|antithrombins|mesh-ancestor
25124664|NCT03073850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25124665|NCT03073850|Protease Inhibitors|protease inhibitors|mesh-ancestor
25124666|NCT03073863|Atorvastatin|atorvastatin|mesh-list
25124667|NCT03073863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25124668|NCT03073863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24437681|NCT00274131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437688|NCT00274131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24437821|NCT00274534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437822|NCT00274534|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24437823|NCT00274534|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24437825|NCT00274534|Adrenergic Agents|adrenergic agents|mesh-ancestor
24437826|NCT00274547|Tiotropium Bromide|tiotropium bromide|mesh-list
24979977|NCT04821141|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24979978|NCT04821141|Hormone Antagonists|hormone antagonists|mesh-ancestor
24979979|NCT04821141|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24979981|NCT04788017|Antiviral Agents|antiviral agents|mesh-ancestor
25657228|NCT01584440|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25657229|NCT01584440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25657230|NCT01584518|Furosemide|furosemide|mesh-list
25657231|NCT01584518|Diuretics|diuretics|mesh-ancestor
25657232|NCT01584518|Natriuretic Agents|natriuretic agents|mesh-ancestor
25657233|NCT01584518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657234|NCT01584518|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25657235|NCT01584518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25657236|NCT01584518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802111|NCT01987310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24876039|NCT03766126|Immunologic Factors|immunologic factors|mesh-ancestor
25145210|NCT02931877|Propofol|propofol|mesh-list
24557849|NCT00754403|Metformin|metformin|mesh-list
24557850|NCT00754403|Pioglitazone|pioglitazone|mesh-list
24557851|NCT00754403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24557852|NCT00754403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557853|NCT00754429|Losartan|losartan|mesh-list
24557854|NCT00754429|Amlodipine|amlodipine|mesh-list
25829689|NCT00006249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829690|NCT00006249|Antiviral Agents|antiviral agents|mesh-ancestor
25829691|NCT00006249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25829692|NCT00006249|Immunologic Factors|immunologic factors|mesh-ancestor
24437853|NCT00274560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24437854|NCT00274560|Adrenergic Agents|adrenergic agents|mesh-ancestor
24437856|NCT00274573|Tiotropium Bromide|tiotropium bromide|mesh-list
24437857|NCT00274573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24437858|NCT00274573|Autonomic Agents|autonomic agents|mesh-ancestor
24437859|NCT00274573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124685|NCT03073408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25124686|NCT03073408|Anesthetics, General|anesthetics, general|mesh-ancestor
25124689|NCT03073317|Mitosis Modulators|mitosis modulators|mesh-ancestor
25124690|NCT03073317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124691|NCT03073343|Betaine|betaine|mesh-list
24437860|NCT00274573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829693|NCT00006249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437861|NCT00274573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24437862|NCT00274573|Respiratory System Agents|respiratory system agents|mesh-ancestor
24437863|NCT00274573|Parasympatholytics|parasympatholytics|mesh-ancestor
24437864|NCT00274573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24437865|NCT00274573|Cholinergic Agents|cholinergic agents|mesh-ancestor
24437866|NCT00274573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24437867|NCT00274573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437868|NCT00274573|Anticonvulsants|anticonvulsants|mesh-ancestor
24437869|NCT00274586|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
24437870|NCT00274586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24437872|NCT00274599|Ramipril|ramipril|mesh-list
24437873|NCT00274599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24437874|NCT00274599|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25204229|NCT02709824|Chlorhexidine|chlorhexidine|mesh-list
24437875|NCT00274599|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24437908|NCT00274677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437909|NCT00274677|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24437910|NCT00274677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25829694|NCT00006250|Dexamethasone|dexamethasone|mesh-list
24437923|NCT00274794|Rituximab|rituximab|mesh-list
24437924|NCT00274794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24437925|NCT00274794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25124718|NCT03073265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25124719|NCT03073265|Protease Inhibitors|protease inhibitors|mesh-ancestor
25124720|NCT03073265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124721|NCT03073265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124722|NCT03073265|Anticoagulants|anticoagulants|mesh-ancestor
25124723|NCT03073304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25124724|NCT03073057|Budesonide|budesonide|mesh-list
25124725|NCT03073057|Formoterol Fumarate|formoterol fumarate|mesh-list
25124726|NCT03073057|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25124727|NCT03073057|Charcoal|charcoal|mesh-list
25124728|NCT03073057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25124729|NCT03073057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25124730|NCT03073057|Autonomic Agents|autonomic agents|mesh-ancestor
25124731|NCT03073057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124732|NCT03073057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124734|NCT03073057|Respiratory System Agents|respiratory system agents|mesh-ancestor
24437932|NCT00274807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24437933|NCT00274807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24437934|NCT00274807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24437935|NCT00274807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24437936|NCT00274807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657237|NCT01584544|Capecitabine|capecitabine|mesh-list
25657238|NCT01584544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25657239|NCT01584544|Antimetabolites|antimetabolites|mesh-ancestor
25657240|NCT01584544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657241|NCT01584544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25657242|NCT01584648|Trametinib|trametinib|mesh-list
25657243|NCT01584648|Dabrafenib|dabrafenib|mesh-list
25657244|NCT01584648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829695|NCT00006250|Fludarabine|fludarabine|mesh-list
24558015|NCT00755118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829696|NCT00006250|Fludarabine phosphate|fludarabine phosphate|mesh-list
24437937|NCT00274807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437938|NCT00274807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24979982|NCT04788017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24979983|NCT04767776|Rivaroxaban|rivaroxaban|mesh-list
24979985|NCT04767776|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24437940|NCT00274807|Antiviral Agents|antiviral agents|mesh-ancestor
25124745|NCT03073057|Protective Agents|protective agents|mesh-ancestor
24437941|NCT00274807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24437942|NCT00274807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24437943|NCT00274807|Immunologic Factors|immunologic factors|mesh-ancestor
24437944|NCT00274807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162159|NCT02907593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24437945|NCT00274807|Analgesics|analgesics|mesh-ancestor
25044690|NCT01060579|Latanoprost|latanoprost|mesh-list
24437946|NCT00274807|Sensory System Agents|sensory system agents|mesh-ancestor
24437947|NCT00274807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24437948|NCT00274820|Ascorbic Acid|ascorbic acid|mesh-list
24437949|NCT00274820|Thalidomide|thalidomide|mesh-list
24437950|NCT00274820|Dexamethasone|dexamethasone|mesh-list
25124758|NCT03073369|Ergocalciferols|ergocalciferols|mesh-list
25124759|NCT03073369|Vitamin D|vitamin d|mesh-list
25124760|NCT03073369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25124761|NCT03073369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124762|NCT03073369|Vitamins|vitamins|mesh-ancestor
25124763|NCT03073369|Micronutrients|micronutrients|mesh-ancestor
25124764|NCT03073369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24437955|NCT00274820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24437956|NCT00274820|Antiemetics|antiemetics|mesh-ancestor
24437957|NCT00274820|Autonomic Agents|autonomic agents|mesh-ancestor
24437958|NCT00274820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124770|NCT03072849|Autonomic Agents|autonomic agents|mesh-ancestor
25124773|NCT03072849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24437959|NCT00274820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24437960|NCT00274820|Glucocorticoids|glucocorticoids|mesh-ancestor
24437961|NCT00274820|Hormones|hormones|mesh-ancestor
24437962|NCT00274820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24437963|NCT00274820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24438000|NCT00274872|Calcium|calcium|mesh-list
24438001|NCT00274872|Levoleucovorin|levoleucovorin|mesh-list
24438002|NCT00274872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24438003|NCT00274872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438004|NCT00274872|Antimetabolites|antimetabolites|mesh-ancestor
24438005|NCT00274872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124785|NCT03072485|Metformin|metformin|mesh-list
24438006|NCT00274872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24438007|NCT00274872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979986|NCT04767776|Antithrombins|antithrombins|mesh-ancestor
24979987|NCT04767776|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24979988|NCT04767776|Protease Inhibitors|protease inhibitors|mesh-ancestor
24979989|NCT04767776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24979990|NCT04767776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979991|NCT04767776|Anticoagulants|anticoagulants|mesh-ancestor
25124798|NCT03072485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25124799|NCT03072485|Analgesics|analgesics|mesh-ancestor
25124800|NCT03072485|Sensory System Agents|sensory system agents|mesh-ancestor
24979992|NCT04767776|Antidotes|antidotes|mesh-ancestor
24979994|NCT04767776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979995|NCT04756765|Talazoparib|talazoparib|mesh-list
24438038|NCT00274911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25657245|NCT01584648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25657246|NCT01584648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657247|NCT01584648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657248|NCT01584843|Botulinum Toxins|botulinum toxins|mesh-list
25657249|NCT01584843|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25657250|NCT01584843|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25657251|NCT01584843|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25657252|NCT01584843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25657253|NCT01584843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657254|NCT01584843|Cholinergic Agents|cholinergic agents|mesh-ancestor
25657255|NCT01584843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25657256|NCT01584843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558339|NCT00756340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24558356|NCT00756847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24558357|NCT00756847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438039|NCT00274911|Tubulin Modulators|tubulin modulators|mesh-ancestor
24438040|NCT00274911|Antimitotic Agents|antimitotic agents|mesh-ancestor
24438041|NCT00274911|Mitosis Modulators|mitosis modulators|mesh-ancestor
24438042|NCT00274911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438043|NCT00274911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25829697|NCT00006250|Mitoxantrone|mitoxantrone|mesh-list
24438065|NCT00274963|Alkylating Agents|alkylating agents|mesh-ancestor
24843639|NCT02228512|Hormones|hormones|mesh-ancestor
24438088|NCT00275015|Cytarabine|cytarabine|mesh-list
24438089|NCT00275015|Dexamethasone|dexamethasone|mesh-list
24438090|NCT00275015|Cyclophosphamide|cyclophosphamide|mesh-list
24438091|NCT00275015|Melphalan|melphalan|mesh-list
24438101|NCT00275015|Alkylating Agents|alkylating agents|mesh-ancestor
24438102|NCT00275015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438103|NCT00275015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438104|NCT00275015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24438116|NCT00275015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24438117|NCT00275015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24438118|NCT00275015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24438119|NCT00275015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438120|NCT00275015|Antiviral Agents|antiviral agents|mesh-ancestor
24438121|NCT00275015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24438123|NCT00275041|Cetuximab|cetuximab|mesh-list
24438124|NCT00275041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24438125|NCT00275041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25162160|NCT02907593|Respiratory System Agents|respiratory system agents|mesh-ancestor
25829698|NCT00006250|Chlorambucil|chlorambucil|mesh-list
24438195|NCT00275106|Glucocorticoids|glucocorticoids|mesh-ancestor
24438196|NCT00275106|Hormones|hormones|mesh-ancestor
24438215|NCT00275106|Vitamin B Complex|vitamin b complex|mesh-ancestor
24438216|NCT00275106|Vitamins|vitamins|mesh-ancestor
24438217|NCT00275106|Micronutrients|micronutrients|mesh-ancestor
25124820|NCT03072511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24438218|NCT00275106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24438219|NCT00275106|Tubulin Modulators|tubulin modulators|mesh-ancestor
24438220|NCT00275106|Antimitotic Agents|antimitotic agents|mesh-ancestor
24438221|NCT00275106|Mitosis Modulators|mitosis modulators|mesh-ancestor
24438222|NCT00275119|Gemcitabine|gemcitabine|mesh-list
24438223|NCT00275119|Fluorouracil|fluorouracil|mesh-list
24438224|NCT00275119|Oxaliplatin|oxaliplatin|mesh-list
24438225|NCT00275119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24438226|NCT00275119|Antimetabolites|antimetabolites|mesh-ancestor
25169541|NCT01825980|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25124837|NCT03072264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25124838|NCT03072264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124839|NCT03072394|Lidocaine|lidocaine|mesh-list
25124840|NCT03072394|Anesthetics, Local|anesthetics, local|mesh-list
25124841|NCT03072394|Anesthetics|anesthetics|mesh-list
24746949|NCT02500797|Nivolumab|nivolumab|mesh-list
24438227|NCT00275119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438228|NCT00275119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438229|NCT00275119|Antiviral Agents|antiviral agents|mesh-ancestor
24843714|NCT02228902|Hematinics|hematinics|mesh-ancestor
25829699|NCT00006250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25829700|NCT00006250|Antiemetics|antiemetics|mesh-ancestor
25829701|NCT00006250|Autonomic Agents|autonomic agents|mesh-ancestor
25829702|NCT00006250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24980019|NCT04724447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24980020|NCT04718922|Chlorhexidine|chlorhexidine|mesh-list
24438295|NCT00275418|Provitamins|provitamins|mesh-ancestor
24438296|NCT00275418|Vitamins|vitamins|mesh-ancestor
24438297|NCT00275418|Micronutrients|micronutrients|mesh-ancestor
24438298|NCT00275444|Tipranavir|tipranavir|mesh-list
24438299|NCT00275444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24438300|NCT00275444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24438301|NCT00275444|Antiviral Agents|antiviral agents|mesh-ancestor
24438302|NCT00275444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24438303|NCT00275457|Pramipexole|pramipexole|mesh-list
24438304|NCT00275457|Antioxidants|antioxidants|mesh-ancestor
24438313|NCT00275522|Sirolimus|sirolimus|mesh-list
25657257|NCT01584843|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25657258|NCT01584843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25657259|NCT01585025|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
25124846|NCT03072394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25124847|NCT03072394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25124848|NCT03072394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25413518|NCT03126916|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25875248|NCT04621149|Chlorine dioxide|chlorine dioxide|mesh-list
25829703|NCT00006250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564298|NCT00775814|Diuretics|diuretics|mesh-ancestor
24773597|NCT01840800|Ropivacaine|ropivacaine|mesh-list
24773598|NCT01840800|Anesthetics, Local|anesthetics, local|mesh-ancestor
24773599|NCT01840800|Anesthetics|anesthetics|mesh-ancestor
24802173|NCT01988311|Psilocybin|psilocybin|mesh-list
24558872|NCT05424796|Coagulants|coagulants|mesh-ancestor
24558873|NCT05422612|Fluoxetine|fluoxetine|mesh-list
24671005|NCT01323218|Vitamin D|vitamin d|mesh-list
25829704|NCT00006250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24558874|NCT05422612|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
24558875|NCT05422612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24558876|NCT05422612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24558880|NCT05422612|Serotonin Agents|serotonin agents|mesh-ancestor
25124849|NCT03072394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25162211|NCT02907307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438722|NCT00276705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24438723|NCT00276705|Immunologic Factors|immunologic factors|mesh-ancestor
24438728|NCT00276705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438729|NCT00276705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829705|NCT00006250|Glucocorticoids|glucocorticoids|mesh-ancestor
25829706|NCT00006250|Hormones|hormones|mesh-ancestor
25829707|NCT00006250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24843823|NCT02229760|Ritonavir|ritonavir|mesh-list
25829708|NCT00006250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25162161|NCT02907593|Glucocorticoids|glucocorticoids|mesh-ancestor
25829709|NCT00006250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439110|NCT00277589|Micronutrients|micronutrients|mesh-ancestor
24980062|NCT05442190|Hypericin|hypericin|mesh-list
24980063|NCT05442190|Antidepressive Agents|antidepressive agents|mesh-ancestor
24980064|NCT05442190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24980065|NCT05442190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980066|NCT05442190|Antiviral Agents|antiviral agents|mesh-ancestor
24980067|NCT05442190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24458526|NCT00338273|Dopamine Agents|dopamine agents|mesh-ancestor
25124890|NCT03072082|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25829710|NCT00006250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25829711|NCT00006250|Antimetabolites|antimetabolites|mesh-ancestor
25829712|NCT00006250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829713|NCT00006250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25829714|NCT00006250|Immunologic Factors|immunologic factors|mesh-ancestor
25829715|NCT00006250|Analgesics|analgesics|mesh-ancestor
25829716|NCT00006250|Sensory System Agents|sensory system agents|mesh-ancestor
25829717|NCT00006250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24439189|NCT00277862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439190|NCT00277862|Antiviral Agents|antiviral agents|mesh-ancestor
24439191|NCT00277862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24439192|NCT00277862|Immunologic Factors|immunologic factors|mesh-ancestor
24980079|NCT05442008|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
24439597|NCT00279487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169542|NCT01825980|Antiviral Agents|antiviral agents|mesh-ancestor
25124906|NCT03072290|Triamcinolone|triamcinolone|mesh-list
25124909|NCT03072290|Lidocaine|lidocaine|mesh-list
24439756|NCT00280267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24439757|NCT00280267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439759|NCT00280280|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24439760|NCT00280280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439761|NCT00280280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24439762|NCT00280280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25657260|NCT01585025|Cathartics|cathartics|mesh-ancestor
25657261|NCT01585025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25657262|NCT01585038|Efavirenz|efavirenz|mesh-list
25657263|NCT01585038|Rilpivirine|rilpivirine|mesh-list
25657264|NCT01585038|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25657265|NCT01585038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25657266|NCT01585038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657267|NCT01585038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657268|NCT01585038|Antiviral Agents|antiviral agents|mesh-ancestor
25657269|NCT01585038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25657270|NCT01585038|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24439866|NCT00280605|Alfuzosin|alfuzosin|mesh-list
24439956|NCT00280969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24439957|NCT00280969|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24439958|NCT00280969|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25413519|NCT03126916|Etoposide|etoposide|mesh-list
24948221|NCT03921775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24948222|NCT03921775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24948223|NCT03921775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948224|NCT03921775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24948238|NCT03921099|Ascorbic Acid|ascorbic acid|mesh-list
25829718|NCT00006250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25829719|NCT00006250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24559099|NCT05291364|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25829720|NCT00006250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24559163|NCT05230901|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24815394|NCT02070120|Mitomycin|mitomycin|mesh-list
24559232|NCT05170009|Oseltamivir|oseltamivir|mesh-list
24559233|NCT05170009|Baloxavir|baloxavir|mesh-list
24439959|NCT00280969|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24439960|NCT00280969|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25829721|NCT00006250|Alkylating Agents|alkylating agents|mesh-ancestor
25829722|NCT00006251|Cyclosporine|cyclosporine|mesh-list
25829723|NCT00006251|Mycophenolic Acid|mycophenolic acid|mesh-list
25829724|NCT00006251|Fludarabine|fludarabine|mesh-list
25829725|NCT00006251|Fludarabine phosphate|fludarabine phosphate|mesh-list
25124920|NCT03072290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25124921|NCT03072290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124922|NCT03072290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25829726|NCT00006251|Cyclosporins|cyclosporins|mesh-list
25124923|NCT03072290|Glucocorticoids|glucocorticoids|mesh-ancestor
25124924|NCT03072290|Hormones|hormones|mesh-ancestor
25124925|NCT03072290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25124926|NCT03072290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25124927|NCT03072290|Immunologic Factors|immunologic factors|mesh-ancestor
25124928|NCT03072290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124929|NCT03072121|Aspirin|aspirin|mesh-list
25124931|NCT03072121|Isosorbide|isosorbide|mesh-list
25124934|NCT03072121|Trimetazidine|trimetazidine|mesh-list
25125189|NCT03070678|Analgesics|analgesics|mesh-ancestor
25829727|NCT00006251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829728|NCT00006251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25829729|NCT00006251|Antimetabolites|antimetabolites|mesh-ancestor
25829730|NCT00006251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829731|NCT00006251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25829732|NCT00006251|Immunologic Factors|immunologic factors|mesh-ancestor
25829733|NCT00006251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041001|NCT02700529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25041002|NCT02700529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25041003|NCT02700529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25041004|NCT02700529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041005|NCT02700529|Protease Inhibitors|protease inhibitors|mesh-ancestor
25041006|NCT02700529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041007|NCT02700529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041009|NCT02700529|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25041010|NCT02700529|Antiviral Agents|antiviral agents|mesh-ancestor
25041011|NCT02689258|Bupivacaine|bupivacaine|mesh-list
25041012|NCT02689258|Anesthetics, Local|anesthetics, local|mesh-ancestor
25041013|NCT02689258|Anesthetics|anesthetics|mesh-ancestor
25041014|NCT02689258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25041015|NCT02689258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041016|NCT02689258|Sensory System Agents|sensory system agents|mesh-ancestor
25041017|NCT02689258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25041018|NCT02683239|Fasinumab|fasinumab|mesh-list
25162162|NCT02907593|Hormones|hormones|mesh-ancestor
25162163|NCT02907593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25162164|NCT02907593|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
25162165|NCT02907710|Endostar protein|endostar protein|mesh-list
25657271|NCT01585038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25657272|NCT01585038|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25657273|NCT01585038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25657274|NCT01585038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25657275|NCT01585038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25657276|NCT01585038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25657277|NCT01585038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25657278|NCT01585129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25657279|NCT01585129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25657280|NCT01585129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25657281|NCT01585129|Antitubercular Agents|antitubercular agents|mesh-ancestor
25657282|NCT01585168|Memantine|memantine|mesh-list
25657283|NCT01585168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25829734|NCT00006251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24559331|NCT05022927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24559332|NCT05022927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24559333|NCT05022927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24559334|NCT05022927|Growth Substances|growth substances|mesh-ancestor
24559335|NCT05022927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24559336|NCT05022927|Growth Inhibitors|growth inhibitors|mesh-ancestor
24559338|NCT05011760|Dextroamphetamine|dextroamphetamine|mesh-list
24559339|NCT05011760|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24559340|NCT05011760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24559341|NCT05011760|Sympathomimetics|sympathomimetics|mesh-ancestor
24559342|NCT05011760|Autonomic Agents|autonomic agents|mesh-ancestor
24559440|NCT04767061|Propranolol|propranolol|mesh-list
24559441|NCT04767061|Metoprolol|metoprolol|mesh-list
25162166|NCT02907710|Endostatins|endostatins|mesh-list
25162167|NCT02907710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25162168|NCT02907710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25162169|NCT02907710|Growth Substances|growth substances|mesh-ancestor
25162170|NCT02907710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162171|NCT02907710|Growth Inhibitors|growth inhibitors|mesh-ancestor
25162172|NCT02907710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162173|NCT02907554|Cyclosporine|cyclosporine|mesh-list
25162174|NCT02907554|Cyclosporins|cyclosporins|mesh-list
25162175|NCT02907554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25162176|NCT02907554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162177|NCT02907554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25162178|NCT02907554|Immunologic Factors|immunologic factors|mesh-ancestor
25162179|NCT02907554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162180|NCT02907554|Antifungal Agents|antifungal agents|mesh-ancestor
25162181|NCT02907554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25162182|NCT02907554|Dermatologic Agents|dermatologic agents|mesh-ancestor
25162183|NCT02907554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25162184|NCT02907554|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25162185|NCT02907632|Metoclopramide|metoclopramide|mesh-list
25162186|NCT02907632|Antiemetics|antiemetics|mesh-ancestor
25162187|NCT02907632|Autonomic Agents|autonomic agents|mesh-ancestor
25162188|NCT02907632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25162189|NCT02907632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162190|NCT02907632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25162191|NCT02907632|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25162192|NCT02907632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25162193|NCT02907632|Dopamine Agents|dopamine agents|mesh-ancestor
25162194|NCT02907632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25162195|NCT02907632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162198|NCT02907437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25162199|NCT02907307|Clotrimazole|clotrimazole|mesh-list
25162201|NCT02907307|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25162202|NCT02907307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25162203|NCT02907307|Antifungal Agents|antifungal agents|mesh-ancestor
25162204|NCT02907307|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25162205|NCT02907307|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25162206|NCT02907307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25162207|NCT02907307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162208|NCT02907307|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25162209|NCT02907307|Hormone Antagonists|hormone antagonists|mesh-ancestor
25162210|NCT02907307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25162212|NCT02907307|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25162213|NCT02907307|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25162214|NCT02907021|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25162215|NCT02907021|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25657284|NCT01585168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25657285|NCT01585168|Dopamine Agents|dopamine agents|mesh-ancestor
25657286|NCT01585168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25657287|NCT01585168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657288|NCT01585168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657289|NCT01585168|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25657290|NCT01585168|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25657291|NCT01585194|Nivolumab|nivolumab|mesh-list
25657292|NCT01585194|Ipilimumab|ipilimumab|mesh-list
25657293|NCT01585194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25657294|NCT01585194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25657295|NCT01585194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25657296|NCT01585194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24559579|NCT04643574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24559581|NCT04643574|Sensory System Agents|sensory system agents|mesh-ancestor
24559582|NCT04643574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24559584|NCT04640168|Dexamethasone|dexamethasone|mesh-list
24559585|NCT04640168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24559586|NCT04640168|Antiemetics|antiemetics|mesh-ancestor
24559587|NCT04640168|Autonomic Agents|autonomic agents|mesh-ancestor
24559588|NCT04640168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24559589|NCT04640168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829735|NCT00006251|Antifungal Agents|antifungal agents|mesh-ancestor
25829736|NCT00006251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25125029|NCT03071731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125030|NCT03071731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125031|NCT03071731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25125032|NCT03071731|Respiratory System Agents|respiratory system agents|mesh-ancestor
25125033|NCT03071731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25125035|NCT03071731|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24980100|NCT05441761|Mitoxantrone|mitoxantrone|mesh-list
24980101|NCT05441761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980102|NCT05441761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24440187|NCT00281944|Antimetabolites|antimetabolites|mesh-ancestor
24440188|NCT00281944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440189|NCT00281944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24440190|NCT00281944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440221|NCT00281983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125037|NCT03071536|Furosemide|furosemide|mesh-list
25125038|NCT03071536|Diuretics|diuretics|mesh-ancestor
25125039|NCT03071536|Natriuretic Agents|natriuretic agents|mesh-ancestor
25125040|NCT03071536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440222|NCT00281983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440223|NCT00281983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24440454|NCT00283179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24440455|NCT00283179|Dopamine Agents|dopamine agents|mesh-ancestor
24440507|NCT00283478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24440508|NCT00283478|Immunologic Factors|immunologic factors|mesh-ancestor
24440509|NCT00283478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980104|NCT05441761|Autonomic Agents|autonomic agents|mesh-ancestor
24783920|NCT01904747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783921|NCT01904786|Melatonin|melatonin|mesh-list
24440510|NCT00283517|Antipsychotic Agents|antipsychotic agents|mesh-list
24440511|NCT00283517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25125047|NCT03071549|Salicylic Acid|salicylic acid|mesh-list
25125048|NCT03071549|Salicylates|salicylates|mesh-list
25125049|NCT03071549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25125050|NCT03071549|Antifungal Agents|antifungal agents|mesh-ancestor
25125051|NCT03071549|Keratolytic Agents|keratolytic agents|mesh-ancestor
24440512|NCT00283517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24440513|NCT00283517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440514|NCT00283517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24440691|NCT00284271|Tubulin Modulators|tubulin modulators|mesh-ancestor
24440692|NCT00284271|Antimitotic Agents|antimitotic agents|mesh-ancestor
24440693|NCT00284271|Mitosis Modulators|mitosis modulators|mesh-ancestor
24440694|NCT00284271|Hematinics|hematinics|mesh-ancestor
24440695|NCT00284271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24440696|NCT00284323|Adenosine|adenosine|mesh-list
24440697|NCT00284323|Analgesics|analgesics|mesh-ancestor
24440698|NCT00284323|Sensory System Agents|sensory system agents|mesh-ancestor
24440699|NCT00284323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24440700|NCT00284323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440701|NCT00284323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24440702|NCT00284323|Vasodilator Agents|vasodilator agents|mesh-ancestor
24440703|NCT00284323|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24440705|NCT00284323|Purinergic Agents|purinergic agents|mesh-ancestor
25125059|NCT03071549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25125060|NCT03071549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25657297|NCT01585207|Vigabatrin|vigabatrin|mesh-list
25657298|NCT01585207|Anticonvulsants|anticonvulsants|mesh-ancestor
25657299|NCT01585207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657300|NCT01585207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657301|NCT01585207|GABA Agents|gaba agents|mesh-ancestor
25657302|NCT01585207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25657303|NCT01585207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657304|NCT01585246|Saw palmetto extract|saw palmetto extract|mesh-list
25657305|NCT01585246|Urological Agents|urological agents|mesh-ancestor
25657306|NCT01585272|Rivastigmine|rivastigmine|mesh-list
24559814|NCT04376268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24559815|NCT04376268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24559816|NCT04376268|Disinfectants|disinfectants|mesh-ancestor
24559817|NCT04376268|Dermatologic Agents|dermatologic agents|mesh-ancestor
24559844|NCT04249427|Erenumab|erenumab|mesh-list
24559845|NCT04249427|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
24559846|NCT04249427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24559847|NCT04249427|Analgesics|analgesics|mesh-ancestor
25125061|NCT03071549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24440706|NCT00284323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24440707|NCT00284323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440708|NCT00284336|Cyclophosphamide|cyclophosphamide|mesh-list
24440709|NCT00284336|Doxorubicin|doxorubicin|mesh-list
24440710|NCT00284336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24440711|NCT00284336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24440712|NCT00284336|Immunologic Factors|immunologic factors|mesh-ancestor
24440713|NCT00284336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440767|NCT00284687|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24440768|NCT00284687|Anthelmintics|anthelmintics|mesh-ancestor
24440769|NCT00284752|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24440771|NCT00284765|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
24440808|NCT00284791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24440809|NCT00284921|Mycophenolic Acid|mycophenolic acid|mesh-list
24440811|NCT00284921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162216|NCT02907021|Adrenergic Agents|adrenergic agents|mesh-ancestor
25829737|NCT00006251|Dermatologic Agents|dermatologic agents|mesh-ancestor
25829738|NCT00006251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25829739|NCT00006251|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25125078|NCT03071705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829740|NCT00006251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24441492|NCT00287651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24441493|NCT00287651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24441494|NCT00287651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441495|NCT00287664|Terlipressin|terlipressin|mesh-list
24441496|NCT00287664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24783922|NCT01904786|Antioxidants|antioxidants|mesh-ancestor
24441607|NCT00287924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441608|NCT00287924|Dermatologic Agents|dermatologic agents|mesh-ancestor
24441609|NCT00287924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441610|NCT00287924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24441611|NCT00287924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24441612|NCT00287924|Immunologic Factors|immunologic factors|mesh-ancestor
24441613|NCT00287924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24441614|NCT00287924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24441616|NCT00287937|Carboplatin|carboplatin|mesh-list
24441617|NCT00287937|Vorinostat|vorinostat|mesh-list
24441618|NCT00287937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24441619|NCT00287937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441620|NCT00287937|Tubulin Modulators|tubulin modulators|mesh-ancestor
24441621|NCT00287937|Antimitotic Agents|antimitotic agents|mesh-ancestor
24441622|NCT00287937|Mitosis Modulators|mitosis modulators|mesh-ancestor
24441623|NCT00287937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441711|NCT00288171|Allopurinol|allopurinol|mesh-list
25829741|NCT00006251|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24441712|NCT00288171|Antimetabolites|antimetabolites|mesh-ancestor
25125119|NCT03070938|Anti-Infective Agents|anti-infective agents|mesh-list
24441713|NCT00288171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441714|NCT00288171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441715|NCT00288171|Gout Suppressants|gout suppressants|mesh-ancestor
24441716|NCT00288171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24441732|NCT00288197|Antifungal Agents|antifungal agents|mesh-ancestor
24441733|NCT00288197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24441734|NCT00288197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25125123|NCT03071042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125124|NCT03071042|Tubulin Modulators|tubulin modulators|mesh-ancestor
25125125|NCT03071042|Antimitotic Agents|antimitotic agents|mesh-ancestor
25657307|NCT01585272|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25657308|NCT01585272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657309|NCT01585272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657310|NCT01585272|Cholinergic Agents|cholinergic agents|mesh-ancestor
25657311|NCT01585272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25657312|NCT01585272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657313|NCT01585272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25657314|NCT01585272|Protective Agents|protective agents|mesh-ancestor
24560249|NCT03086369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24560251|NCT03086369|Antiviral Agents|antiviral agents|mesh-ancestor
24560252|NCT03086369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24560253|NCT03086369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24948302|NCT03920644|Scopolamine|scopolamine|mesh-list
24948303|NCT03920644|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24948304|NCT03920644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24948305|NCT03920644|Antiemetics|antiemetics|mesh-ancestor
25125126|NCT03071042|Mitosis Modulators|mitosis modulators|mesh-ancestor
25125128|NCT03071042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24441735|NCT00288197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24441736|NCT00288197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441737|NCT00288197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441738|NCT00288197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24441739|NCT00288197|Hormone Antagonists|hormone antagonists|mesh-ancestor
24441758|NCT00288249|Tubulin Modulators|tubulin modulators|mesh-ancestor
24441759|NCT00288249|Antimitotic Agents|antimitotic agents|mesh-ancestor
24441760|NCT00288249|Mitosis Modulators|mitosis modulators|mesh-ancestor
24441761|NCT00288249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441763|NCT00288262|Antioxidants|antioxidants|mesh-ancestor
24441764|NCT00288262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794065|NCT05414058|Methylphenidate|methylphenidate|mesh-list
24783932|NCT01904981|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24783933|NCT01904981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783934|NCT01904981|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24783935|NCT01904981|Adrenergic Agents|adrenergic agents|mesh-ancestor
24783936|NCT01904981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24783937|NCT01904981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783938|NCT01904981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24783939|NCT01904981|Sympatholytics|sympatholytics|mesh-ancestor
24441774|NCT00288353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24441775|NCT00288353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441776|NCT00288353|Dopamine Agonists|dopamine agonists|mesh-ancestor
24441777|NCT00288353|Dopamine Agents|dopamine agents|mesh-ancestor
24441784|NCT00288353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25125141|NCT03070860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125142|NCT03070847|Tranexamic Acid|tranexamic acid|mesh-list
25125143|NCT03070847|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25125144|NCT03070847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24441806|NCT00288431|Doxorubicin|doxorubicin|mesh-list
24441807|NCT00288431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24441808|NCT00288431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441809|NCT00288431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24441810|NCT00288431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24441811|NCT00288431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441813|NCT00288431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25829742|NCT00006251|Antitubercular Agents|antitubercular agents|mesh-ancestor
25125158|NCT03070665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125159|NCT03070665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25125160|NCT03070665|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25125161|NCT03070574|Aminosalicylic Acid|aminosalicylic acid|mesh-list
25125162|NCT03070574|Mesalamine|mesalamine|mesh-list
24756270|NCT01731925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829743|NCT00006251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25829744|NCT00006252|Cyclophosphamide|cyclophosphamide|mesh-list
24441883|NCT00288717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24441885|NCT00288730|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24441890|NCT00288743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441891|NCT00288769|Vitamin B 12|vitamin b 12|mesh-list
24441965|NCT00289354|Vitamins|vitamins|mesh-ancestor
24441966|NCT00289354|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24441967|NCT00289354|Chelating Agents|chelating agents|mesh-ancestor
24441968|NCT00289354|Sequestering Agents|sequestering agents|mesh-ancestor
24441969|NCT00289354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441970|NCT00289406|Amlodipine|amlodipine|mesh-list
24441971|NCT00289406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25657315|NCT01585298|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25657316|NCT01585298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25657317|NCT01585298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657318|NCT01585298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25657319|NCT01585298|Immunologic Factors|immunologic factors|mesh-ancestor
25657320|NCT01585298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657321|NCT01585324|Ribavirin|ribavirin|mesh-list
24561185|NCT00758732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125163|NCT03070574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25125164|NCT03070574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25125165|NCT03070574|Analgesics|analgesics|mesh-ancestor
24441972|NCT00289406|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24441973|NCT00289406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24441974|NCT00289406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441975|NCT00289406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24441976|NCT00289406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441977|NCT00289406|Vasodilator Agents|vasodilator agents|mesh-ancestor
24441978|NCT00289419|Ketorolac|ketorolac|mesh-list
25106058|NCT04594746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458631|NCT00338624|Oxybutynin|oxybutynin|mesh-list
24442146|NCT00290108|Anesthetics|anesthetics|mesh-ancestor
24442147|NCT00290121|Olanzapine|olanzapine|mesh-list
24442148|NCT00290121|Antiemetics|antiemetics|mesh-ancestor
24442149|NCT00290121|Autonomic Agents|autonomic agents|mesh-ancestor
24442150|NCT00290121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24442151|NCT00290121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125176|NCT03070704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25125179|NCT03070704|Hormones|hormones|mesh-ancestor
24442152|NCT00290121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24442153|NCT00290121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24442154|NCT00290121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24442155|NCT00290121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24442156|NCT00290121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24442157|NCT00290121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25829745|NCT00006252|Fludarabine|fludarabine|mesh-list
25829746|NCT00006252|Fludarabine phosphate|fludarabine phosphate|mesh-list
25829747|NCT00006252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24442388|NCT00290836|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24442390|NCT00290836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442391|NCT00290836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442392|NCT00290849|Bivalirudin|bivalirudin|mesh-list
24442393|NCT00290849|Antithrombins|antithrombins|mesh-ancestor
24442394|NCT00290849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24442448|NCT00291109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442469|NCT00291122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442471|NCT00291148|Paroxetine|paroxetine|mesh-list
24442472|NCT00291148|Analgesics|analgesics|mesh-ancestor
25162217|NCT02907021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24442483|NCT00291148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24442484|NCT00291148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24442578|NCT00291720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442579|NCT00291720|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24442580|NCT00291720|Diuretics|diuretics|mesh-ancestor
24442581|NCT00291720|Natriuretic Agents|natriuretic agents|mesh-ancestor
24442582|NCT00291733|Levetiracetam|levetiracetam|mesh-list
24442583|NCT00291733|Anticonvulsants|anticonvulsants|mesh-ancestor
24442584|NCT00291733|Nootropic Agents|nootropic agents|mesh-ancestor
24442585|NCT00291746|Esomeprazole|esomeprazole|mesh-list
24442586|NCT00291746|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24442587|NCT00291746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24442617|NCT00291785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24442618|NCT00291785|Immunologic Factors|immunologic factors|mesh-ancestor
24442619|NCT00291785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442620|NCT00291785|Antidotes|antidotes|mesh-ancestor
24442621|NCT00291785|Protective Agents|protective agents|mesh-ancestor
24442622|NCT00291785|Vitamin B Complex|vitamin b complex|mesh-ancestor
24442623|NCT00291785|Vitamins|vitamins|mesh-ancestor
24442624|NCT00291785|Micronutrients|micronutrients|mesh-ancestor
24442737|NCT00292409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24442738|NCT00292409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442740|NCT00292409|Dopamine Agents|dopamine agents|mesh-ancestor
24442741|NCT00292409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24442742|NCT00292409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442778|NCT00292721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24442779|NCT00292721|Analgesics|analgesics|mesh-ancestor
24442780|NCT00292721|Sensory System Agents|sensory system agents|mesh-ancestor
24442781|NCT00292721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25106059|NCT04594746|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25106060|NCT04594746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25106061|NCT04594746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25106062|NCT04592237|Carboplatin|carboplatin|mesh-list
25106063|NCT04592237|Niraparib|niraparib|mesh-list
25657322|NCT01585324|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25106064|NCT04592237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24561392|NCT00759928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24561393|NCT00759928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561592|NCT00761540|Hormones|hormones|mesh-ancestor
25106065|NCT04592237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25125263|NCT03070054|Epinephrine|epinephrine|mesh-list
25106066|NCT04592237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25106067|NCT04592237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980114|NCT05441761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980115|NCT05441761|Antiviral Agents|antiviral agents|mesh-ancestor
24980116|NCT05441761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24442782|NCT00292721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442783|NCT00292721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24442784|NCT00292721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24442789|NCT00292734|Zolpidem|zolpidem|mesh-list
24442802|NCT00292747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25829748|NCT00006252|Immunologic Factors|immunologic factors|mesh-ancestor
25829749|NCT00006252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829750|NCT00006252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25829751|NCT00006252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25829752|NCT00006252|Alkylating Agents|alkylating agents|mesh-ancestor
25829753|NCT00006252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829754|NCT00006252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829755|NCT00006252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25829756|NCT00006252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25125304|NCT03069950|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24442937|NCT00293332|Growth Substances|growth substances|mesh-ancestor
25126235|NCT03063658|Antipyretics|antipyretics|mesh-ancestor
25829757|NCT00006252|Antimetabolites|antimetabolites|mesh-ancestor
25829758|NCT00006257|Paclitaxel|paclitaxel|mesh-list
25829759|NCT00006257|Semaxinib|semaxinib|mesh-list
25829760|NCT00006257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25829761|NCT00006257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829762|NCT00006257|Tubulin Modulators|tubulin modulators|mesh-ancestor
25829763|NCT00006257|Antimitotic Agents|antimitotic agents|mesh-ancestor
25829764|NCT00006257|Mitosis Modulators|mitosis modulators|mesh-ancestor
25125332|NCT03069820|Docetaxel|docetaxel|mesh-list
25125333|NCT03069820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125334|NCT03069820|Tubulin Modulators|tubulin modulators|mesh-ancestor
25125335|NCT03069820|Antimitotic Agents|antimitotic agents|mesh-ancestor
25125338|NCT03069768|Varenicline|varenicline|mesh-list
25829765|NCT00006257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829766|NCT00006257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25829767|NCT00006257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25829768|NCT00006257|Growth Substances|growth substances|mesh-ancestor
25829769|NCT00006257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829770|NCT00006257|Growth Inhibitors|growth inhibitors|mesh-ancestor
25829771|NCT00006257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25829772|NCT00006257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829773|NCT00006258|Cyclophosphamide|cyclophosphamide|mesh-list
25829774|NCT00006258|Cisplatin|cisplatin|mesh-list
25829775|NCT00006258|Methotrexate|methotrexate|mesh-list
25829776|NCT00006258|Etoposide|etoposide|mesh-list
25829777|NCT00006258|Vincristine|vincristine|mesh-list
25829778|NCT00006258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25125347|NCT03069911|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25125348|NCT03069911|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25829779|NCT00006258|Immunologic Factors|immunologic factors|mesh-ancestor
25829780|NCT00006258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125363|NCT03069339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25125364|NCT03069339|Antioxidants|antioxidants|mesh-ancestor
25125365|NCT03069339|Protective Agents|protective agents|mesh-ancestor
25125366|NCT03069339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25125367|NCT03069339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25125368|NCT03069339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25125369|NCT03069339|Vasodilator Agents|vasodilator agents|mesh-ancestor
25125372|NCT03069001|Ribavirin|ribavirin|mesh-list
25657323|NCT01585324|Antimetabolites|antimetabolites|mesh-ancestor
25657324|NCT01585324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657325|NCT01585324|Antiviral Agents|antiviral agents|mesh-ancestor
25657326|NCT01585324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25657327|NCT01585428|Aldesleukin|aldesleukin|mesh-list
25657328|NCT01585428|Cyclophosphamide|cyclophosphamide|mesh-list
25657329|NCT01585428|Fludarabine|fludarabine|mesh-list
25657330|NCT01585428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25657331|NCT01585428|Immunologic Factors|immunologic factors|mesh-ancestor
24561855|NCT00763204|Betamethasone|betamethasone|mesh-list
24561856|NCT00763204|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25829781|NCT00006258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25829782|NCT00006258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25202858|NCT02718261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25829783|NCT00006258|Alkylating Agents|alkylating agents|mesh-ancestor
25829784|NCT00006258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829785|NCT00006258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829786|NCT00006258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25829787|NCT00006258|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25125375|NCT03069001|Antimetabolites|antimetabolites|mesh-ancestor
25125376|NCT03069001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125377|NCT03069001|Antiviral Agents|antiviral agents|mesh-ancestor
25829788|NCT00006258|Abortifacient Agents|abortifacient agents|mesh-ancestor
25829789|NCT00006258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25829790|NCT00006258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25829791|NCT00006258|Antimetabolites|antimetabolites|mesh-ancestor
25829792|NCT00006258|Dermatologic Agents|dermatologic agents|mesh-ancestor
25829793|NCT00006258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829794|NCT00006258|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25829795|NCT00006258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25829796|NCT00006258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25829797|NCT00006258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25829798|NCT00006258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25829799|NCT00006258|Tubulin Modulators|tubulin modulators|mesh-ancestor
25829800|NCT00006258|Antimitotic Agents|antimitotic agents|mesh-ancestor
25829801|NCT00006258|Mitosis Modulators|mitosis modulators|mesh-ancestor
25829802|NCT00006260|Cisplatin|cisplatin|mesh-list
25829803|NCT00006260|Etoposide|etoposide|mesh-list
25829804|NCT00006260|Ifosfamide|ifosfamide|mesh-list
25829805|NCT00006260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829806|NCT00006260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25829807|NCT00006260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25829808|NCT00006260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25829809|NCT00006260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442968|NCT00293371|Docetaxel|docetaxel|mesh-list
25125408|NCT03069183|Ropivacaine|ropivacaine|mesh-list
25125424|NCT03069248|Antiviral Agents|antiviral agents|mesh-ancestor
24443010|NCT00293436|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25657332|NCT01585428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657333|NCT01585428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25657334|NCT01585428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25657335|NCT01585428|Alkylating Agents|alkylating agents|mesh-ancestor
25657336|NCT01585428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657337|NCT01585428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25657338|NCT01585428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25657339|NCT01585428|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25657340|NCT01585428|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25657341|NCT01585428|Antiviral Agents|antiviral agents|mesh-ancestor
25657342|NCT01585428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25657343|NCT01585441|Finasteride|finasteride|mesh-list
25657344|NCT01585441|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25657345|NCT01585441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25657346|NCT01585441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657347|NCT01585441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657348|NCT01585441|Hormone Antagonists|hormone antagonists|mesh-ancestor
25657349|NCT01585441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25657350|NCT01585441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657351|NCT01585441|Urological Agents|urological agents|mesh-ancestor
25657352|NCT01585558|Tamoxifen|tamoxifen|mesh-list
25657353|NCT01585558|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25657354|NCT01585558|Hormone Antagonists|hormone antagonists|mesh-ancestor
25657355|NCT01585558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25657356|NCT01585558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657357|NCT01585558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25657358|NCT01585558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25657359|NCT01585558|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25657360|NCT01585558|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25657361|NCT01585558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25657362|NCT01585584|Protease Inhibitors|protease inhibitors|mesh-list
25657363|NCT01585584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562331|NCT00766025|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24562332|NCT00766025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562333|NCT00766064|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24562548|NCT00766896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829810|NCT00006260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829811|NCT00006260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25125437|NCT03068832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125438|NCT03068832|Laxatives|laxatives|mesh-ancestor
25125439|NCT03068832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25125440|NCT03068832|Antiviral Agents|antiviral agents|mesh-ancestor
25125441|NCT03068832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25125442|NCT03068741|Ceftriaxone|ceftriaxone|mesh-list
25829812|NCT00006260|Alkylating Agents|alkylating agents|mesh-ancestor
25829813|NCT00006261|Cyclophosphamide|cyclophosphamide|mesh-list
25829814|NCT00006261|Docetaxel|docetaxel|mesh-list
25829815|NCT00006261|Doxorubicin|doxorubicin|mesh-list
25829816|NCT00006261|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25829817|NCT00006261|Fludarabine|fludarabine|mesh-list
25829818|NCT00006261|Fludarabine phosphate|fludarabine phosphate|mesh-list
25829819|NCT00006261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25829820|NCT00006261|Immunologic Factors|immunologic factors|mesh-ancestor
25829821|NCT00006261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829822|NCT00006261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25829823|NCT00006261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25125458|NCT03068650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25125459|NCT03068650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125479|NCT03068429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829824|NCT00006261|Alkylating Agents|alkylating agents|mesh-ancestor
25875249|NCT04621149|Famotidine|famotidine|mesh-list
25125488|NCT03068247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125489|NCT03068247|Analgesics|analgesics|mesh-ancestor
25162218|NCT02907021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162219|NCT02907021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041059|NCT02664558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041060|NCT02664558|Protease Inhibitors|protease inhibitors|mesh-ancestor
25041061|NCT02664558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041062|NCT02664558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041063|NCT02664558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25041064|NCT02664558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25041065|NCT02664558|Antiviral Agents|antiviral agents|mesh-ancestor
25041066|NCT02661282|Temozolomide|temozolomide|mesh-list
25041067|NCT02661282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25125505|NCT03068234|Sensory System Agents|sensory system agents|mesh-ancestor
25041068|NCT02661282|Alkylating Agents|alkylating agents|mesh-ancestor
25041069|NCT02661282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041070|NCT02661282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041071|NCT02659397|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
25041072|NCT02659397|Atorvastatin|atorvastatin|mesh-list
25041073|NCT02659397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25041074|NCT02659397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25041075|NCT02659397|Antimetabolites|antimetabolites|mesh-ancestor
25041076|NCT02659397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041077|NCT02659397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25041078|NCT02659397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25041079|NCT02659397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041080|NCT02659397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25041081|NCT02659397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041082|NCT02654990|Dexamethasone|dexamethasone|mesh-list
25041083|NCT02654990|Bortezomib|bortezomib|mesh-list
25041084|NCT02654990|Panobinostat|panobinostat|mesh-list
25041085|NCT02654990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25125521|NCT03068260|Analgesics|analgesics|mesh-ancestor
25657364|NCT01585584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657365|NCT01585831|Testosterone|testosterone|mesh-list
25657366|NCT01585831|Androgens|androgens|mesh-ancestor
25657367|NCT01585831|Hormones|hormones|mesh-ancestor
25657368|NCT01585831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25657369|NCT01585831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657370|NCT01585987|Ipilimumab|ipilimumab|mesh-list
25657371|NCT01585987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25657372|NCT01585987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25657373|NCT01585987|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25657374|NCT01585987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563137|NCT00770354|Letrozole|letrozole|mesh-list
25829825|NCT00006261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125539|NCT03067974|Sensory System Agents|sensory system agents|mesh-ancestor
25125540|NCT03067974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125541|NCT03067974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125542|NCT03067974|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25829826|NCT00006261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829827|NCT00006261|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25829828|NCT00006261|Tubulin Modulators|tubulin modulators|mesh-ancestor
25162221|NCT02906722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25162222|NCT02906722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25162223|NCT02906748|Parathyroid Hormone|parathyroid hormone|mesh-list
25162224|NCT02906748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25202859|NCT02718261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25202860|NCT02718261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202861|NCT02718261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202862|NCT02717884|Cytarabine|cytarabine|mesh-list
25202863|NCT02717884|Tretinoin|tretinoin|mesh-list
25202864|NCT02717884|Tranylcypromine|tranylcypromine|mesh-list
25202865|NCT02717884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25202866|NCT02717884|Antimetabolites|antimetabolites|mesh-ancestor
25202867|NCT02717884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202868|NCT02717884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25202869|NCT02717884|Antiviral Agents|antiviral agents|mesh-ancestor
25202870|NCT02717884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25202871|NCT02717884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25202872|NCT02717884|Immunologic Factors|immunologic factors|mesh-ancestor
25202873|NCT02717884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202874|NCT02717884|Keratolytic Agents|keratolytic agents|mesh-ancestor
25202875|NCT02717884|Dermatologic Agents|dermatologic agents|mesh-ancestor
25202876|NCT02717884|Antidepressive Agents|antidepressive agents|mesh-ancestor
25202877|NCT02717884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25125556|NCT03067883|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24623454|NCT01071525|Niacin|niacin|mesh-list
25202878|NCT02717884|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25202879|NCT02717884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202880|NCT02717884|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25829829|NCT00006261|Antimitotic Agents|antimitotic agents|mesh-ancestor
25829830|NCT00006261|Mitosis Modulators|mitosis modulators|mesh-ancestor
24980126|NCT05441631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24980127|NCT05441631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829831|NCT00006261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25829832|NCT00006261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25829833|NCT00006261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25829834|NCT00006261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125574|NCT03067896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125575|NCT03067896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25125577|NCT03067896|Analgesics|analgesics|mesh-ancestor
25829835|NCT00006261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25829836|NCT00006261|Antimetabolites|antimetabolites|mesh-ancestor
25829837|NCT00006263|Carboplatin|carboplatin|mesh-list
25829838|NCT00006263|Temozolomide|temozolomide|mesh-list
25829839|NCT00006263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829840|NCT00006263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25829841|NCT00006263|Alkylating Agents|alkylating agents|mesh-ancestor
25829842|NCT00006263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829843|NCT00006264|Zidovudine|zidovudine|mesh-list
25829844|NCT00006264|Aldesleukin|aldesleukin|mesh-list
25829845|NCT00006264|Ganciclovir|ganciclovir|mesh-list
25829846|NCT00006264|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25829847|NCT00006264|Antimetabolites|antimetabolites|mesh-ancestor
25829848|NCT00006264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829849|NCT00006264|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25829850|NCT00006264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25829851|NCT00006264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829852|NCT00006264|Antiviral Agents|antiviral agents|mesh-ancestor
25829853|NCT00006264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25657375|NCT01586091|Fexofenadine|fexofenadine|mesh-list
25657376|NCT01586091|Levocetirizine|levocetirizine|mesh-list
25657377|NCT01586091|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25657378|NCT01586091|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25657379|NCT01586091|Histamine Antagonists|histamine antagonists|mesh-ancestor
25657380|NCT01586091|Histamine Agents|histamine agents|mesh-ancestor
25657381|NCT01586091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25657382|NCT01586091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829854|NCT00006264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25829855|NCT00006264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25829856|NCT00006264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829857|NCT00006265|Cytarabine|cytarabine|mesh-list
25829858|NCT00006265|Gemtuzumab|gemtuzumab|mesh-list
25829859|NCT00006265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25125626|NCT03067753|Autonomic Agents|autonomic agents|mesh-ancestor
25829860|NCT00006265|Antimetabolites|antimetabolites|mesh-ancestor
25829861|NCT00006265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829862|NCT00006265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829863|NCT00006265|Antiviral Agents|antiviral agents|mesh-ancestor
25829864|NCT00006265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25829865|NCT00006265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25169543|NCT01825980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24980164|NCT05441215|Ritonavir|ritonavir|mesh-list
24980165|NCT05441215|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24980166|NCT05441215|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24980167|NCT05441215|Protease Inhibitors|protease inhibitors|mesh-ancestor
24980168|NCT05441215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24980169|NCT05441215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980170|NCT05441215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24980171|NCT05441215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25829866|NCT00006265|Immunologic Factors|immunologic factors|mesh-ancestor
25829867|NCT00006265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829868|NCT00006265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25829869|NCT00006267|Rubitecan|rubitecan|mesh-list
25829870|NCT00006267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125659|NCT03067597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829871|NCT00006267|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25829872|NCT00006267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25829873|NCT00006267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829874|NCT00006267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829875|NCT00006269|Irinotecan|irinotecan|mesh-list
25829876|NCT00006269|Octreotide|octreotide|mesh-list
25829877|NCT00006269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25829878|NCT00006269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25829879|NCT00006269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829880|NCT00006269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829881|NCT00006269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980172|NCT05441215|Antiviral Agents|antiviral agents|mesh-ancestor
24980173|NCT05441215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24980174|NCT05441215|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24980175|NCT05441215|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24980184|NCT05440864|Durvalumab|durvalumab|mesh-list
24980185|NCT05440864|Tremelimumab|tremelimumab|mesh-list
25829882|NCT00006269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25829883|NCT00006269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25829884|NCT00006270|Cosyntropin|cosyntropin|mesh-list
25829885|NCT00006270|Metyrapone|metyrapone|mesh-list
25829886|NCT00006270|Hormones|hormones|mesh-ancestor
25829887|NCT00006270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25162226|NCT02906995|Nicotine|nicotine|mesh-list
25829888|NCT00006270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829889|NCT00006270|Antimetabolites|antimetabolites|mesh-ancestor
25829890|NCT00006270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829891|NCT00006270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24980186|NCT05440864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24980194|NCT05440591|Metformin|metformin|mesh-list
24980195|NCT05440591|Dapagliflozin|dapagliflozin|mesh-list
24980196|NCT05440591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24980197|NCT05440591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980198|NCT05440591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25125713|NCT03067194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125714|NCT03067194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125715|NCT03067194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25125738|NCT03066791|Curcumin|curcumin|mesh-list
24980199|NCT05440591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980200|NCT05440578|Bevacizumab|bevacizumab|mesh-list
24980201|NCT05440578|Olaparib|olaparib|mesh-list
24980202|NCT05440578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24980203|NCT05440578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458671|NCT00338780|Antiviral Agents|antiviral agents|mesh-ancestor
24458672|NCT00338780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24458673|NCT00338780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25829892|NCT00006275|Calcitriol|calcitriol|mesh-list
24564059|NCT00774982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24564060|NCT00774982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564061|NCT00775034|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24564062|NCT00775034|Hemostatics|hemostatics|mesh-ancestor
24564063|NCT00775034|Coagulants|coagulants|mesh-ancestor
25829893|NCT00006275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25829894|NCT00006275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829895|NCT00006275|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24844593|NCT02233400|Acetaminophen|acetaminophen|mesh-list
24980220|NCT05431075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980221|NCT05431075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24980222|NCT05431075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24430973|NCT00249899|Simvastatin|simvastatin|mesh-list
24980223|NCT05431075|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24980224|NCT05431075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24980225|NCT05431075|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24980226|NCT05431075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24980227|NCT05431075|Antacids|antacids|mesh-ancestor
24980228|NCT05431075|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24980229|NCT05431075|Diuretics|diuretics|mesh-ancestor
24980230|NCT05431075|Natriuretic Agents|natriuretic agents|mesh-ancestor
24980231|NCT05431075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980232|NCT05431075|Expectorants|expectorants|mesh-ancestor
25829896|NCT00006275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25829897|NCT00006275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829898|NCT00006275|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25829899|NCT00006275|Vitamins|vitamins|mesh-ancestor
25125796|NCT03066544|Analgesics|analgesics|mesh-ancestor
24443160|NCT00293800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24443161|NCT00293800|Adrenergic Agents|adrenergic agents|mesh-ancestor
24443162|NCT00293800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25125816|NCT03066466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125817|NCT03066466|Dermatologic Agents|dermatologic agents|mesh-ancestor
25125818|NCT03066466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125819|NCT03066466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25125820|NCT03066466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25125821|NCT03066466|Immunologic Factors|immunologic factors|mesh-ancestor
25162227|NCT02906995|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24443182|NCT00293891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25829900|NCT00006275|Micronutrients|micronutrients|mesh-ancestor
25829901|NCT00006275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25829902|NCT00006276|Paclitaxel|paclitaxel|mesh-list
24438432|NCT00275938|Ribavirin|ribavirin|mesh-list
24980265|NCT05420467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24980266|NCT05420467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24980267|NCT05420467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24980268|NCT05420454|Paclitaxel|paclitaxel|mesh-list
24980269|NCT05420454|Docetaxel|docetaxel|mesh-list
24980270|NCT05420454|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24980271|NCT05420454|Cyclophosphamide|cyclophosphamide|mesh-list
24980272|NCT05420454|Carboplatin|carboplatin|mesh-list
24980273|NCT05420454|Trastuzumab|trastuzumab|mesh-list
24980274|NCT05420454|Epirubicin|epirubicin|mesh-list
24980275|NCT05420454|Pertuzumab|pertuzumab|mesh-list
24980276|NCT05420454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24980277|NCT05420454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980278|NCT05420454|Tubulin Modulators|tubulin modulators|mesh-ancestor
24980279|NCT05420454|Antimitotic Agents|antimitotic agents|mesh-ancestor
24980280|NCT05420454|Mitosis Modulators|mitosis modulators|mesh-ancestor
24795597|NCT01503632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795598|NCT01503632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24795599|NCT01503632|Immunologic Factors|immunologic factors|mesh-ancestor
24795600|NCT01503632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458695|NCT00338910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24795607|NCT01498458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125890|NCT03065842|Contraceptive Agents|contraceptive agents|mesh-list
25125891|NCT03065842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25125892|NCT03065842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125893|NCT03065868|Clarithromycin|clarithromycin|mesh-list
25657383|NCT01586091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657384|NCT01586091|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25657385|NCT01586156|Carvedilol|carvedilol|mesh-list
25657386|NCT01586156|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25657387|NCT01586156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25125894|NCT03065868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25657388|NCT01586156|Adrenergic Agents|adrenergic agents|mesh-ancestor
25657389|NCT01586156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25657390|NCT01586156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565258|NCT00779454|Capecitabine|capecitabine|mesh-list
25125895|NCT03065868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25125896|NCT03065868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25125897|NCT03065868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125898|NCT03065868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125901|NCT03066011|Voriconazole|voriconazole|mesh-list
25829903|NCT00006276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25829904|NCT00006276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162228|NCT02906995|Autonomic Agents|autonomic agents|mesh-ancestor
25829905|NCT00006276|Tubulin Modulators|tubulin modulators|mesh-ancestor
25829906|NCT00006276|Antimitotic Agents|antimitotic agents|mesh-ancestor
25829907|NCT00006276|Mitosis Modulators|mitosis modulators|mesh-ancestor
25829908|NCT00006276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829909|NCT00006279|Nevirapine|nevirapine|mesh-list
25829910|NCT00006279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25829911|NCT00006279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25829912|NCT00006279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125911|NCT03066011|Hormone Antagonists|hormone antagonists|mesh-ancestor
25125912|NCT03066011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25125913|NCT03066011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125915|NCT03066011|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25829913|NCT00006279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829914|NCT00006279|Antiviral Agents|antiviral agents|mesh-ancestor
25829915|NCT00006279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25829916|NCT00006279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25829917|NCT00006279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25829918|NCT00006279|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25829919|NCT00006279|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25829920|NCT00006280|Tobramycin|tobramycin|mesh-list
25829921|NCT00006280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25829922|NCT00006280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783959|NCT01905059|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24783960|NCT01905059|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25202881|NCT02717884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25125992|NCT03064906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25045746|NCT00917826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25829923|NCT00006286|Fluoxetine|fluoxetine|mesh-list
25829924|NCT00006286|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25829925|NCT00006286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25829926|NCT00006286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25829927|NCT00006286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829928|NCT00006286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24980326|NCT05375097|Analgesics|analgesics|mesh-ancestor
24980347|NCT05353829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24458759|NCT00339131|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25126022|NCT03064633|Adrenergic Agents|adrenergic agents|mesh-ancestor
25126023|NCT03064633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25126045|NCT03064191|Calcium|calcium|mesh-list
25041088|NCT02654990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25041089|NCT02654990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041090|NCT02654990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25041091|NCT02654990|Glucocorticoids|glucocorticoids|mesh-ancestor
25041092|NCT02654990|Hormones|hormones|mesh-ancestor
25041093|NCT02654990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25162229|NCT02906995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25162230|NCT02906995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162231|NCT02906995|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25162232|NCT02906995|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25162233|NCT02906995|Cholinergic Agents|cholinergic agents|mesh-ancestor
25162234|NCT02906995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25126055|NCT03064165|Anesthetics|anesthetics|mesh-ancestor
25126056|NCT03064165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25126057|NCT03064165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126058|NCT03064165|Sensory System Agents|sensory system agents|mesh-ancestor
25126059|NCT03064165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25126060|NCT03064165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25126061|NCT03064165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25126062|NCT03064165|Adrenergic Agents|adrenergic agents|mesh-ancestor
25126063|NCT03064165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25162235|NCT02906995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162236|NCT02906800|Digoxin|digoxin|mesh-list
25162237|NCT02906800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25162238|NCT02906800|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25162239|NCT02906800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25162240|NCT02906800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162241|NCT02906800|Protective Agents|protective agents|mesh-ancestor
25162242|NCT02906800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162243|NCT02906514|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
25162244|NCT02906514|Plasma Substitutes|plasma substitutes|mesh-ancestor
25162245|NCT02906514|Blood Substitutes|blood substitutes|mesh-ancestor
25162246|NCT02906553|Nitroglycerin|nitroglycerin|mesh-list
25162247|NCT02906553|Vasodilator Agents|vasodilator agents|mesh-ancestor
25162248|NCT02906254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25162249|NCT02906254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25162251|NCT02906150|Carboplatin|carboplatin|mesh-list
25162252|NCT02906150|Pemetrexed|pemetrexed|mesh-list
25162253|NCT02906150|Thymalfasin|thymalfasin|mesh-list
25162254|NCT02906150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162255|NCT02906150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25162256|NCT02906150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162257|NCT02906150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25162258|NCT02906150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25162259|NCT02906150|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25162260|NCT02906150|Immunologic Factors|immunologic factors|mesh-ancestor
25162261|NCT02906150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162262|NCT02906059|Irinotecan|irinotecan|mesh-list
25162263|NCT02906059|Adavosertib|adavosertib|mesh-list
25162264|NCT02906059|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25162265|NCT02906059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25162266|NCT02906059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25162267|NCT02906059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162268|NCT02906059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162269|NCT02906176|Voriconazole|voriconazole|mesh-list
25162270|NCT02906176|Antifungal Agents|antifungal agents|mesh-ancestor
25162271|NCT02906176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25162272|NCT02906176|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25162281|NCT02905994|Cytarabine|cytarabine|mesh-list
25162282|NCT02905994|Idarubicin|idarubicin|mesh-list
25162283|NCT02905994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25162284|NCT02905994|Antimetabolites|antimetabolites|mesh-ancestor
25162285|NCT02905994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162286|NCT02905994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162287|NCT02905994|Antiviral Agents|antiviral agents|mesh-ancestor
25162288|NCT02905994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25162289|NCT02905994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25162290|NCT02905994|Immunologic Factors|immunologic factors|mesh-ancestor
25162291|NCT02905994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162292|NCT02905994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25162293|NCT02905994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25162294|NCT02905994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25829929|NCT00006286|Serotonin Agents|serotonin agents|mesh-ancestor
24980542|NCT05182073|Cyclophosphamide|cyclophosphamide|mesh-list
25829930|NCT00006286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443203|NCT00293969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25829931|NCT00006286|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25829932|NCT00006286|Antidepressive Agents|antidepressive agents|mesh-ancestor
24980412|NCT05303727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24980413|NCT05303727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25829933|NCT00006286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25829934|NCT00006286|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25829935|NCT00006286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25829936|NCT00006286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829937|NCT00006291|Aldesleukin|aldesleukin|mesh-list
25829938|NCT00006291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25829939|NCT00006291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25829940|NCT00006291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24980494|NCT05224089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980495|NCT05224089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24980496|NCT05224089|Glucocorticoids|glucocorticoids|mesh-ancestor
24980497|NCT05224089|Hormones|hormones|mesh-ancestor
24980498|NCT05224089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25162295|NCT02905994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24980504|NCT05224089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24980505|NCT05224089|Sensory System Agents|sensory system agents|mesh-ancestor
24980506|NCT05224089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24980507|NCT05224089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24980508|NCT05224089|Adrenergic Agents|adrenergic agents|mesh-ancestor
25829941|NCT00006291|Antiviral Agents|antiviral agents|mesh-ancestor
25829942|NCT00006291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24566896|NCT00788424|Antiviral Agents|antiviral agents|mesh-ancestor
24566897|NCT00788424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24566908|NCT00788515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24566929|NCT00788580|Antifungal Agents|antifungal agents|mesh-ancestor
25200107|NCT02736071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25829943|NCT00006292|Infliximab|infliximab|mesh-list
25829944|NCT00006292|Dermatologic Agents|dermatologic agents|mesh-ancestor
24566958|NCT00788749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24566959|NCT00788749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24980509|NCT05224089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25126167|NCT03063580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24980510|NCT05224089|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24980511|NCT05224089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24980512|NCT05224089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24795608|NCT01427712|Pancrelipase|pancrelipase|mesh-list
25829945|NCT00006292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24622014|NCT01065220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24622015|NCT01065220|Androgen Antagonists|androgen antagonists|mesh-ancestor
24622016|NCT01065220|Hormone Antagonists|hormone antagonists|mesh-ancestor
24622017|NCT01065220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980513|NCT05224089|Respiratory System Agents|respiratory system agents|mesh-ancestor
24980514|NCT05224089|Mydriatics|mydriatics|mesh-ancestor
24980515|NCT05224089|Sympathomimetics|sympathomimetics|mesh-ancestor
24980516|NCT05224089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24980517|NCT05199324|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25829946|NCT00006292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25829947|NCT00006294|Amlodipine|amlodipine|mesh-list
25829948|NCT00006294|Lisinopril|lisinopril|mesh-list
24980520|NCT05199324|Ceftriaxone|ceftriaxone|mesh-list
24980521|NCT05199324|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24980522|NCT05199324|Fluoroquinolones|fluoroquinolones|mesh-list
24980523|NCT05199324|Trimethoprim|trimethoprim|mesh-list
24980524|NCT05199324|Sulfamethoxazole|sulfamethoxazole|mesh-list
24980525|NCT05199324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24980526|NCT05199324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24783963|NCT01905137|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24783964|NCT01905137|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24783965|NCT01905137|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24783966|NCT01905137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24783967|NCT01905137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783968|NCT01905137|Cholinergic Agents|cholinergic agents|mesh-ancestor
24783969|NCT01905137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24980527|NCT05199324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24980528|NCT05199324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24980529|NCT05199324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980530|NCT05199324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980531|NCT05199324|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25162296|NCT02905890|Norethindrone|norethindrone|mesh-list
25829949|NCT00006294|Chlorthalidone|chlorthalidone|mesh-list
25829950|NCT00006294|Doxazosin|doxazosin|mesh-list
24980533|NCT05199324|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24980534|NCT05199324|Renal Agents|renal agents|mesh-ancestor
24980535|NCT05199324|Antimalarials|antimalarials|mesh-ancestor
24980536|NCT05199324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24980537|NCT05199324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24980538|NCT05199324|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24980539|NCT05199324|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24980540|NCT05199324|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24980541|NCT05199324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25829951|NCT00006294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25106080|NCT04542135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106082|NCT04509973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25657391|NCT01586156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657392|NCT01586156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25657393|NCT01586156|Antioxidants|antioxidants|mesh-ancestor
25657394|NCT01586156|Protective Agents|protective agents|mesh-ancestor
25657395|NCT01586156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25657396|NCT01586156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25657397|NCT01586156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25657398|NCT01586156|Vasodilator Agents|vasodilator agents|mesh-ancestor
25657399|NCT01586156|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25829952|NCT00006294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25875250|NCT04621149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25106084|NCT04509973|Autonomic Agents|autonomic agents|mesh-ancestor
25829953|NCT00006294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25829954|NCT00006294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829955|NCT00006294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25829956|NCT00006294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829957|NCT00006294|Vasodilator Agents|vasodilator agents|mesh-ancestor
25829958|NCT00006294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25829959|NCT00006294|Protease Inhibitors|protease inhibitors|mesh-ancestor
24980669|NCT05030129|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24980670|NCT05030129|Antidepressive Agents|antidepressive agents|mesh-ancestor
24980671|NCT05030129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24980672|NCT05030129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24980673|NCT05030129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24980674|NCT05030129|Adrenergic Agents|adrenergic agents|mesh-ancestor
24980675|NCT05030129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25169544|NCT01825980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24980676|NCT05030129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980677|NCT05030129|Vasodilator Agents|vasodilator agents|mesh-ancestor
24980678|NCT05030129|Nootropic Agents|nootropic agents|mesh-ancestor
24980679|NCT05030129|Dopamine Agonists|dopamine agonists|mesh-ancestor
24980680|NCT05030129|Dopamine Agents|dopamine agents|mesh-ancestor
24980682|NCT05027100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25829960|NCT00006294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829961|NCT00006294|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25829962|NCT00006294|Protective Agents|protective agents|mesh-ancestor
25829963|NCT00006294|Diuretics|diuretics|mesh-ancestor
25829964|NCT00006294|Natriuretic Agents|natriuretic agents|mesh-ancestor
25829965|NCT00006294|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25829966|NCT00006294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25829967|NCT00006294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25829968|NCT00006294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25829969|NCT00006294|Adrenergic Agents|adrenergic agents|mesh-ancestor
25829970|NCT00006294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25829971|NCT00006299|Celecoxib|celecoxib|mesh-list
25829972|NCT00006299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25829973|NCT00006299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25829974|NCT00006299|Analgesics|analgesics|mesh-ancestor
25829975|NCT00006299|Sensory System Agents|sensory system agents|mesh-ancestor
25829976|NCT00006299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25829977|NCT00006299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829978|NCT00006299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25829979|NCT00006299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25829980|NCT00006299|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25829981|NCT00006299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24980688|NCT05024214|Lenvatinib|lenvatinib|mesh-list
24980689|NCT05024214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980690|NCT05024214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24980691|NCT05024214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24980692|NCT05024214|Growth Substances|growth substances|mesh-ancestor
24980693|NCT05024214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162299|NCT02905890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25829982|NCT00006299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25829983|NCT00006299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829984|NCT00006320|Anti-HIV Agents|anti-hiv agents|mesh-list
25829985|NCT00006320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25829986|NCT00006320|Antiviral Agents|antiviral agents|mesh-ancestor
25829987|NCT00006320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24980702|NCT05017025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25829988|NCT00006324|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25829989|NCT00006324|Levonorgestrel|levonorgestrel|mesh-list
25829990|NCT00006324|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25829991|NCT00006324|Medroxyprogesterone|medroxyprogesterone|mesh-list
25829992|NCT00006324|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
24845669|NCT02238418|Vitamin D|vitamin d|mesh-list
25829993|NCT00006324|Estradiol|estradiol|mesh-list
25829994|NCT00006324|Estrogens|estrogens|mesh-ancestor
25829995|NCT00006324|Hormones|hormones|mesh-ancestor
24980731|NCT04969705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980732|NCT04969705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24980734|NCT04969705|Sensory System Agents|sensory system agents|mesh-ancestor
24980735|NCT04969705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24980736|NCT04969705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24567928|NCT00793468|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24567929|NCT00793468|Cholinergic Agents|cholinergic agents|mesh-ancestor
24980737|NCT04969705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24980738|NCT04969705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24622018|NCT01065220|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24622019|NCT01065220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24622020|NCT01065220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622021|NCT01065220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622022|NCT01065220|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24622023|NCT01065220|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24622024|NCT01065220|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24622025|NCT01065220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24622026|NCT01065246|Catumaxomab|catumaxomab|mesh-list
24622027|NCT01065246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24622028|NCT01065259|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24622029|NCT01065259|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25829996|NCT00006324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25829997|NCT00006324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25829998|NCT00006324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25829999|NCT00006324|Contraceptive Agents|contraceptive agents|mesh-ancestor
25830000|NCT00006324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25830001|NCT00006324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25830002|NCT00006324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25830003|NCT00006324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24443485|NCT00295165|Sargramostim|sargramostim|mesh-list
24443486|NCT00295165|Immunologic Factors|immunologic factors|mesh-ancestor
24443487|NCT00295165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443488|NCT00295178|Vancomycin|vancomycin|mesh-list
24443489|NCT00295178|Daptomycin|daptomycin|mesh-list
24443490|NCT00295178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25830004|NCT00006324|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25830005|NCT00006324|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25830006|NCT00006324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25830007|NCT00006324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830008|NCT00006324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25830009|NCT00006325|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25830010|NCT00006325|Antiviral Agents|antiviral agents|mesh-ancestor
25830011|NCT00006325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25106088|NCT04509973|Glucocorticoids|glucocorticoids|mesh-ancestor
25126579|NCT03061006|Anticoagulants|anticoagulants|mesh-ancestor
25041133|NCT02634853|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25041134|NCT02634853|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25041135|NCT02626338|Vidarabine|vidarabine|mesh-list
24813250|NCT02057328|Telmisartan|telmisartan|mesh-list
24622046|NCT01065272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25830012|NCT00006326|Ritonavir|ritonavir|mesh-list
25830013|NCT00006326|Indinavir|indinavir|mesh-list
25830014|NCT00006326|Delavirdine|delavirdine|mesh-list
25830015|NCT00006326|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25830016|NCT00006326|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25830017|NCT00006326|Protease Inhibitors|protease inhibitors|mesh-ancestor
25830018|NCT00006326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830019|NCT00006326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830020|NCT00006326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25830021|NCT00006326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25830022|NCT00006326|Antiviral Agents|antiviral agents|mesh-ancestor
25830023|NCT00006326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25830024|NCT00006326|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25830025|NCT00006326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25830026|NCT00006326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25830027|NCT00006326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25830028|NCT00006330|Digoxin|digoxin|mesh-list
25830029|NCT00006330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24622047|NCT01065272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622049|NCT01065285|Immunologic Factors|immunologic factors|mesh-ancestor
24622050|NCT01065285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622051|NCT01065376|Cabergoline|cabergoline|mesh-list
24622052|NCT01065376|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24622053|NCT01065376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25126603|NCT03061032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25657400|NCT01586156|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25657401|NCT01586195|Vemurafenib|vemurafenib|mesh-list
24622054|NCT01065376|Dopamine Agonists|dopamine agonists|mesh-ancestor
25657402|NCT01586195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25657403|NCT01586195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24622056|NCT01065376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24622057|NCT01065376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622058|NCT01065376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980739|NCT04969705|Adrenergic Agents|adrenergic agents|mesh-ancestor
24980740|NCT04969705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24980741|NCT04969705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830030|NCT00006330|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25830031|NCT00006330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830032|NCT00006330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162304|NCT02905890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162305|NCT02905890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25162306|NCT02905890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25162307|NCT02906163|Gefitinib|gefitinib|mesh-list
25162308|NCT02906163|Afatinib|afatinib|mesh-list
25162309|NCT02906163|Thymalfasin|thymalfasin|mesh-list
25162310|NCT02906163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162311|NCT02906163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25162312|NCT02906163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25162313|NCT02906163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162314|NCT02906163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25162315|NCT02906163|Immunologic Factors|immunologic factors|mesh-ancestor
25162316|NCT02906163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162317|NCT02905864|Liraglutide|liraglutide|mesh-list
25126638|NCT03060785|Emtricitabine|emtricitabine|mesh-list
24980771|NCT04945616|Ticagrelor|ticagrelor|mesh-list
24980772|NCT04945616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24980773|NCT04945616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24980774|NCT04945616|Analgesics|analgesics|mesh-ancestor
25830033|NCT00006330|Protective Agents|protective agents|mesh-ancestor
25830034|NCT00006330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830035|NCT00006332|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
25830036|NCT00006332|Chelating Agents|chelating agents|mesh-ancestor
25830037|NCT00006332|Sequestering Agents|sequestering agents|mesh-ancestor
25830038|NCT00006332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830039|NCT00006332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830040|NCT00006332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25830041|NCT00006332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25162318|NCT02905864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24980776|NCT04945616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24980777|NCT04945616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980778|NCT04945616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24980779|NCT04945616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24980780|NCT04945616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24980781|NCT04945616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24980782|NCT04945616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980783|NCT04945616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24980784|NCT04945616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24980785|NCT04945616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24980786|NCT04945616|Antipyretics|antipyretics|mesh-ancestor
24845939|NCT02240173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25830042|NCT00006332|Growth Substances|growth substances|mesh-ancestor
25830043|NCT00006332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830044|NCT00006332|Growth Inhibitors|growth inhibitors|mesh-ancestor
25830045|NCT00006332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875251|NCT04621149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25875252|NCT04621149|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25875253|NCT04621149|Histamine Antagonists|histamine antagonists|mesh-ancestor
25875254|NCT04621149|Histamine Agents|histamine agents|mesh-ancestor
25875255|NCT04621149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25875256|NCT04621149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875257|NCT04621149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875258|NCT04621149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25875259|NCT04621149|Dental Disinfectants|dental disinfectants|mesh-ancestor
25875260|NCT04621149|Disinfectants|disinfectants|mesh-ancestor
25875261|NCT04612725|Benralizumab|benralizumab|mesh-list
25875262|NCT04612725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25875263|NCT04612725|Respiratory System Agents|respiratory system agents|mesh-ancestor
25875264|NCT04587830|Temozolomide|temozolomide|mesh-list
25875265|NCT04587830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25875266|NCT04587830|Alkylating Agents|alkylating agents|mesh-ancestor
25875267|NCT04587830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981022|NCT04551144|Contraceptive Agents|contraceptive agents|mesh-ancestor
25875268|NCT04587830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24568945|NCT00798148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569005|NCT00798460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24569006|NCT00798460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25830046|NCT00006337|Levodopa|levodopa|mesh-list
25830047|NCT00006337|Istradefylline|istradefylline|mesh-list
25830048|NCT00006337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25830049|NCT00006337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25830050|NCT00006337|Dopamine Agents|dopamine agents|mesh-ancestor
25830051|NCT00006337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24980789|NCT04945616|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24980790|NCT04945616|Purinergic Agents|purinergic agents|mesh-ancestor
24980791|NCT04945616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24980796|NCT04941105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25106089|NCT04509973|Hormones|hormones|mesh-ancestor
24980797|NCT04941105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24980798|NCT04941105|Antimetabolites|antimetabolites|mesh-ancestor
24980799|NCT04941105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980800|NCT04941105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24980801|NCT04904302|Nivolumab|nivolumab|mesh-list
24845992|NCT02240459|Fesoterodine|fesoterodine|mesh-list
25830052|NCT00006337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830053|NCT00006337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830054|NCT00006337|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
25830055|NCT00006337|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25830056|NCT00006337|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25830057|NCT00006337|Purinergic Agents|purinergic agents|mesh-ancestor
25830058|NCT00006339|Ritonavir|ritonavir|mesh-list
25830059|NCT00006339|Indinavir|indinavir|mesh-list
25830060|NCT00006339|Stavudine|stavudine|mesh-list
25830061|NCT00006339|Didanosine|didanosine|mesh-list
25830062|NCT00006339|Hydroxyurea|hydroxyurea|mesh-list
25830063|NCT00006339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25830064|NCT00006339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25830065|NCT00006339|Protease Inhibitors|protease inhibitors|mesh-ancestor
25830066|NCT00006339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830067|NCT00006339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830068|NCT00006339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25830069|NCT00006339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25830070|NCT00006339|Antiviral Agents|antiviral agents|mesh-ancestor
25830071|NCT00006339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25830072|NCT00006339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25830073|NCT00006339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25830074|NCT00006339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830075|NCT00006339|Antisickling Agents|antisickling agents|mesh-ancestor
25830076|NCT00006339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24980838|NCT04874610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24980839|NCT04874610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24980841|NCT04874610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24980842|NCT04874610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980844|NCT04823052|Gaboxadol|gaboxadol|mesh-list
24980845|NCT04823052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24980846|NCT04823052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24980847|NCT04823052|Analgesics|analgesics|mesh-ancestor
24980848|NCT04823052|Sensory System Agents|sensory system agents|mesh-ancestor
24980849|NCT04823052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24980850|NCT04823052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980851|NCT04823052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24980852|NCT04823052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24980853|NCT04823052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980854|NCT04823052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24980855|NCT04823052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458982|NCT00343369|Cytarabine|cytarabine|mesh-list
25830077|NCT00006339|Antimetabolites|antimetabolites|mesh-ancestor
25830078|NCT00006339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25830079|NCT00006340|Ganciclovir|ganciclovir|mesh-list
25830080|NCT00006340|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25830081|NCT00006340|Arginine butyrate|arginine butyrate|mesh-list
25830082|NCT00006340|Antiviral Agents|antiviral agents|mesh-ancestor
25830083|NCT00006340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25830084|NCT00006340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25657404|NCT01586195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657405|NCT01586195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657406|NCT01586312|Hyaluronic Acid|hyaluronic acid|mesh-list
25830085|NCT00006340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830086|NCT00006340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569782|NCT00801905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25830087|NCT00006340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830088|NCT00006343|Interferons|interferons|mesh-list
25830089|NCT00006343|Cytarabine|cytarabine|mesh-list
24783989|NCT01905150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783991|NCT01905150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783992|NCT01905150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783993|NCT01905150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24783994|NCT01905150|Immunologic Factors|immunologic factors|mesh-ancestor
24783995|NCT01905150|Tubulin Modulators|tubulin modulators|mesh-ancestor
24783996|NCT01905150|Antimitotic Agents|antimitotic agents|mesh-ancestor
24783997|NCT01905150|Mitosis Modulators|mitosis modulators|mesh-ancestor
24783998|NCT01905150|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24783999|NCT01905150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24784000|NCT01905150|Antidotes|antidotes|mesh-ancestor
24784001|NCT01905150|Protective Agents|protective agents|mesh-ancestor
24784002|NCT01905150|Vitamin B Complex|vitamin b complex|mesh-ancestor
24784003|NCT01905150|Antioxidants|antioxidants|mesh-ancestor
24784004|NCT01905150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24784005|NCT01905150|Alkylating Agents|alkylating agents|mesh-ancestor
25106090|NCT04509973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25106100|NCT04469959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106101|NCT04469959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106102|NCT04469959|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25106104|NCT04469959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25106105|NCT04469959|Immunologic Factors|immunologic factors|mesh-ancestor
25106106|NCT04469959|Dopamine Agonists|dopamine agonists|mesh-ancestor
25106107|NCT04443569|Lidocaine|lidocaine|mesh-list
25106108|NCT04443569|Anesthetics, Local|anesthetics, local|mesh-ancestor
25106109|NCT04443569|Anesthetics|anesthetics|mesh-ancestor
25106110|NCT04443569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25106111|NCT04443569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106112|NCT04443569|Sensory System Agents|sensory system agents|mesh-ancestor
25106124|NCT04356638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25106125|NCT04356638|Analgesics|analgesics|mesh-ancestor
25106126|NCT04356638|Sensory System Agents|sensory system agents|mesh-ancestor
25106127|NCT04356638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24980873|NCT04783857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25830090|NCT00006343|Interferon-alpha|interferon-alpha|mesh-list
25830091|NCT00006343|Imatinib Mesylate|imatinib mesylate|mesh-list
25830092|NCT00006343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830093|NCT00006343|Antiviral Agents|antiviral agents|mesh-ancestor
25830094|NCT00006343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25830095|NCT00006343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25830096|NCT00006343|Antimetabolites|antimetabolites|mesh-ancestor
25830097|NCT00006343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980875|NCT04783857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24980876|NCT04783857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24980877|NCT04783857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162319|NCT02905864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830098|NCT00006343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25830099|NCT00006343|Immunologic Factors|immunologic factors|mesh-ancestor
24448451|NCT00311870|Protective Agents|protective agents|mesh-ancestor
24448452|NCT00311870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448453|NCT00311870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24448454|NCT00311870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24448455|NCT00311870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25126935|NCT03058900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448471|NCT00311961|Prednisolone acetate|prednisolone acetate|mesh-list
24448472|NCT00311961|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24448473|NCT00311961|Prednisolone phosphate|prednisolone phosphate|mesh-list
24448474|NCT00311961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24448475|NCT00311961|Glucocorticoids|glucocorticoids|mesh-ancestor
24448480|NCT00311961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448489|NCT00311987|3,5-diiodothyropropionic acid|3,5-diiodothyropropionic acid|mesh-list
25657407|NCT01586312|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25657408|NCT01586312|Immunologic Factors|immunologic factors|mesh-ancestor
25657409|NCT01586312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657410|NCT01586312|Viscosupplements|viscosupplements|mesh-ancestor
25657411|NCT01586312|Protective Agents|protective agents|mesh-ancestor
25657412|NCT01586338|Hylan|hylan|mesh-list
25657413|NCT01586338|Viscosupplements|viscosupplements|mesh-ancestor
25657414|NCT01586338|Protective Agents|protective agents|mesh-ancestor
25657415|NCT01586338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657416|NCT01586806|Dexamethasone|dexamethasone|mesh-list
24448491|NCT00311987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24448492|NCT00311987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448493|NCT00312000|Capecitabine|capecitabine|mesh-list
24448494|NCT00312000|Irinotecan|irinotecan|mesh-list
25162320|NCT02905864|Incretins|incretins|mesh-ancestor
24846300|NCT02242292|Mydriatics|mydriatics|mesh-ancestor
25830100|NCT00006343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830101|NCT00006343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25830102|NCT00006343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448517|NCT00312104|Insulin|insulin|mesh-list
24448518|NCT00312104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24448519|NCT00312104|Insulin Glargine|insulin glargine|mesh-list
24448520|NCT00312104|Insulin Aspart|insulin aspart|mesh-list
25830103|NCT00006345|Dexamethasone|dexamethasone|mesh-list
25830104|NCT00006345|Denileukin diftitox|denileukin diftitox|mesh-list
25830105|NCT00006345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24980947|NCT04729608|Mitosis Modulators|mitosis modulators|mesh-ancestor
24980948|NCT04729608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980950|NCT04718155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24980951|NCT04718155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24980952|NCT04718155|Antimetabolites|antimetabolites|mesh-ancestor
24980953|NCT04718155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980954|NCT04718155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24980955|NCT04718155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24980956|NCT04718155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24980957|NCT04715763|Telmisartan|telmisartan|mesh-list
24846345|NCT02242396|Telmisartan|telmisartan|mesh-list
24448593|NCT00312273|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24448595|NCT00312273|Purinergic Agents|purinergic agents|mesh-ancestor
24448596|NCT00312273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24448641|NCT00312520|Prednisolone phosphate|prednisolone phosphate|mesh-list
24448642|NCT00312520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24448643|NCT00312520|Antiemetics|antiemetics|mesh-ancestor
24448644|NCT00312520|Autonomic Agents|autonomic agents|mesh-ancestor
24448645|NCT00312520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25830106|NCT00006345|Antiemetics|antiemetics|mesh-ancestor
25830107|NCT00006345|Autonomic Agents|autonomic agents|mesh-ancestor
25830108|NCT00006345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25830109|NCT00006345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830110|NCT00006345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25830111|NCT00006345|Glucocorticoids|glucocorticoids|mesh-ancestor
25162321|NCT02905864|Hormones|hormones|mesh-ancestor
25202882|NCT02717884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25202883|NCT02718079|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25202884|NCT02718079|Acetylcysteine|acetylcysteine|mesh-list
25202885|NCT02718079|Mannitol|mannitol|mesh-list
25202886|NCT02718079|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25830112|NCT00006345|Hormones|hormones|mesh-ancestor
25830113|NCT00006345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25830114|NCT00006345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25830115|NCT00006345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830116|NCT00006347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25830117|NCT00006347|Antibodies|antibodies|mesh-list
25830118|NCT00006347|Immunoglobulins|immunoglobulins|mesh-list
25830119|NCT00006347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25830120|NCT00006347|Immunologic Factors|immunologic factors|mesh-ancestor
25830121|NCT00006347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830122|NCT00006347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24981032|NCT04534881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24981033|NCT04534881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622059|NCT01065467|Panobinostat|panobinostat|mesh-list
25127029|NCT03058419|Antidepressive Agents|antidepressive agents|mesh-ancestor
25127030|NCT03058419|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25127031|NCT03058419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24622060|NCT01065467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795610|NCT01427712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24459073|NCT00343486|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25830123|NCT00006348|Ondansetron|ondansetron|mesh-list
25830124|NCT00006348|Antiemetics|antiemetics|mesh-ancestor
25830125|NCT00006348|Autonomic Agents|autonomic agents|mesh-ancestor
25830126|NCT00006348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25830127|NCT00006348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830128|NCT00006348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25830129|NCT00006348|Antipruritics|antipruritics|mesh-ancestor
25830130|NCT00006348|Dermatologic Agents|dermatologic agents|mesh-ancestor
24948652|NCT03918135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24948654|NCT03918135|Sensory System Agents|sensory system agents|mesh-ancestor
25830131|NCT00006348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25830132|NCT00006348|Serotonin Agents|serotonin agents|mesh-ancestor
25830133|NCT00006348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25830134|NCT00006348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830135|NCT00006348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25830136|NCT00006348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24795611|NCT01393509|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
24795612|NCT01393509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795613|NCT01369147|Clevidipine|clevidipine|mesh-list
24795615|NCT01369147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24795616|NCT01369147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24981043|NCT04521114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830137|NCT00006348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25830138|NCT00006348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25830139|NCT00006348|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25830140|NCT00006349|Vitamin E|vitamin e|mesh-list
24981047|NCT04521114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24981049|NCT04512261|Trastuzumab|trastuzumab|mesh-list
24981050|NCT04512261|Tucatinib|tucatinib|mesh-list
24981051|NCT04512261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25175358|NCT02858622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24795623|NCT01369147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795624|NCT01369147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24981052|NCT04512261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24981053|NCT04512261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24981054|NCT04512261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24981055|NCT04512261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981056|NCT04504942|Leronlimab|leronlimab|mesh-list
24981057|NCT04504942|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24981058|NCT04504942|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24981059|NCT04504942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981060|NCT04504942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25830141|NCT00006349|Donepezil|donepezil|mesh-list
25830142|NCT00006349|Vitamins|vitamins|mesh-ancestor
25830143|NCT00006349|Micronutrients|micronutrients|mesh-ancestor
25830144|NCT00006349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830145|NCT00006349|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25830146|NCT00006349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24981090|NCT04483115|Urological Agents|urological agents|mesh-ancestor
24981091|NCT04468958|Immunoglobulins|immunoglobulins|mesh-list
24981092|NCT04468958|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24981093|NCT04468958|Immunologic Factors|immunologic factors|mesh-ancestor
24981094|NCT04468958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981095|NCT04467281|Daratumumab|daratumumab|mesh-list
24981096|NCT04467281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24981097|NCT04448184|Tranexamic Acid|tranexamic acid|mesh-list
24981098|NCT04448184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24981099|NCT04448184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24981100|NCT04448184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981101|NCT04448184|Hemostatics|hemostatics|mesh-ancestor
24981102|NCT04448184|Coagulants|coagulants|mesh-ancestor
24981115|NCT04428671|Cemiplimab|cemiplimab|mesh-list
24981116|NCT04428671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24981117|NCT04428671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24981164|NCT04354025|Fludarabine|fludarabine|mesh-list
24981165|NCT04354025|Interleukin-2|interleukin-2|mesh-list
24981166|NCT04354025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24981167|NCT04354025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24981168|NCT04354025|Antimetabolites|antimetabolites|mesh-ancestor
24981169|NCT04354025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981170|NCT04354025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24981171|NCT04354025|Immunologic Factors|immunologic factors|mesh-ancestor
24981172|NCT04354025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981173|NCT04354025|Antiviral Agents|antiviral agents|mesh-ancestor
24981174|NCT04354025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24981175|NCT04354025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24981176|NCT04354025|Analgesics|analgesics|mesh-ancestor
24981177|NCT04354025|Sensory System Agents|sensory system agents|mesh-ancestor
24981178|NCT04354025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25657417|NCT01586806|Dexamethasone acetate|dexamethasone acetate|mesh-list
25657418|NCT01586806|Bupivacaine|bupivacaine|mesh-list
25657419|NCT01586806|BB 1101|bb 1101|mesh-list
25830147|NCT00006349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571759|NCT00811603|Cefazolin|cefazolin|mesh-list
24981179|NCT04348383|Defibrotide|defibrotide|mesh-list
24981180|NCT04348383|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24981181|NCT04348383|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24981182|NCT04348383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981183|NCT04348383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25830148|NCT00006349|Cholinergic Agents|cholinergic agents|mesh-ancestor
25830149|NCT00006349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25830150|NCT00006349|Nootropic Agents|nootropic agents|mesh-ancestor
25830151|NCT00006349|Antioxidants|antioxidants|mesh-ancestor
25830152|NCT00006349|Protective Agents|protective agents|mesh-ancestor
24981223|NCT04263922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784013|NCT01905371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830153|NCT00006350|Mycophenolic Acid|mycophenolic acid|mesh-list
25830154|NCT00006350|Tacrolimus|tacrolimus|mesh-list
25830155|NCT00006350|Daclizumab|daclizumab|mesh-list
25830156|NCT00006350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25830157|NCT00006350|Immunologic Factors|immunologic factors|mesh-ancestor
25830158|NCT00006350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830159|NCT00006350|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25830160|NCT00006350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830161|NCT00006350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830162|NCT00006350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25830163|NCT00006350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830164|NCT00006350|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25830165|NCT00006350|Antitubercular Agents|antitubercular agents|mesh-ancestor
25830166|NCT00006350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25830167|NCT00006350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25830168|NCT00006351|Gemcitabine|gemcitabine|mesh-list
25830169|NCT00006351|Lonafarnib|lonafarnib|mesh-list
25830170|NCT00006351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24448711|NCT00312754|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24448712|NCT00312754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25830171|NCT00006351|Antimetabolites|antimetabolites|mesh-ancestor
25830172|NCT00006351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830173|NCT00006351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830174|NCT00006351|Antiviral Agents|antiviral agents|mesh-ancestor
25830175|NCT00006351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25041143|NCT02626338|Crenolanib|crenolanib|mesh-list
25041144|NCT02626338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041145|NCT02626338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25041146|NCT02626338|Antimetabolites|antimetabolites|mesh-ancestor
25041147|NCT02626338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041148|NCT02626338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25041149|NCT02626338|Immunologic Factors|immunologic factors|mesh-ancestor
25041150|NCT02626338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041151|NCT02626338|Antiviral Agents|antiviral agents|mesh-ancestor
25041152|NCT02626338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25041153|NCT02626338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25041154|NCT02626338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25041155|NCT02626338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25041156|NCT02626338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041157|NCT02626338|Analgesics|analgesics|mesh-ancestor
25041158|NCT02626338|Sensory System Agents|sensory system agents|mesh-ancestor
25041159|NCT02626338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25041160|NCT02626338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25041161|NCT02620553|Insulin|insulin|mesh-list
25041162|NCT02620553|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25041163|NCT02620553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25041164|NCT02620553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041165|NCT02612922|Nitazoxanide|nitazoxanide|mesh-list
25041166|NCT02612922|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25041167|NCT02612922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25041168|NCT02609828|Tanezumab|tanezumab|mesh-list
25041169|NCT02609828|Analgesics|analgesics|mesh-ancestor
25041170|NCT02609828|Sensory System Agents|sensory system agents|mesh-ancestor
25041171|NCT02609828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25162322|NCT02905864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25162323|NCT02905695|Levobupivacaine|levobupivacaine|mesh-list
25041172|NCT02609828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162324|NCT02905695|Anesthetics, Local|anesthetics, local|mesh-ancestor
25162325|NCT02905695|Anesthetics|anesthetics|mesh-ancestor
25041173|NCT02609048|Seladelpar|seladelpar|mesh-list
25041174|NCT02609048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25413520|NCT03126916|Vincristine|vincristine|mesh-list
25830176|NCT00006351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830177|NCT00006351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25162326|NCT02905695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25162327|NCT02905695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162328|NCT02905695|Sensory System Agents|sensory system agents|mesh-ancestor
25162359|NCT02905734|Autonomic Agents|autonomic agents|mesh-ancestor
25162360|NCT02905734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25162361|NCT02905734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830178|NCT00006351|Immunologic Factors|immunologic factors|mesh-ancestor
25830179|NCT00006351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784023|NCT01905371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24784024|NCT01905371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24784025|NCT01905501|Anesthetics|anesthetics|mesh-list
24784026|NCT01905501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24784027|NCT01905501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830180|NCT00006352|Antibodies|antibodies|mesh-list
25830181|NCT00006352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25830182|NCT00006352|BCG Vaccine|bcg vaccine|mesh-list
25830183|NCT00006352|Immunologic Factors|immunologic factors|mesh-ancestor
25830184|NCT00006352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830185|NCT00006352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25830186|NCT00006353|Temozolomide|temozolomide|mesh-list
25830187|NCT00006353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25830188|NCT00006353|Alkylating Agents|alkylating agents|mesh-ancestor
25830189|NCT00006353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830190|NCT00006353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830191|NCT00006355|NSC 366140|nsc 366140|mesh-list
25830192|NCT00006355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25127350|NCT03056274|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25127351|NCT03056274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25127352|NCT03056118|Aspirin|aspirin|mesh-list
25830193|NCT00006356|Cisplatin|cisplatin|mesh-list
25830194|NCT00006356|Carboplatin|carboplatin|mesh-list
25830195|NCT00006356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830196|NCT00006357|Imatinib Mesylate|imatinib mesylate|mesh-list
25830197|NCT00006357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830198|NCT00006357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25830199|NCT00006357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830200|NCT00006357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830201|NCT00006358|Thalidomide|thalidomide|mesh-list
25830202|NCT00006358|Temozolomide|temozolomide|mesh-list
25830203|NCT00006358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25106141|NCT04356638|GABA Modulators|gaba modulators|mesh-ancestor
25106142|NCT04356638|GABA Agents|gaba agents|mesh-ancestor
25106143|NCT04352608|Vaccines|vaccines|mesh-list
25106144|NCT04352608|Immunologic Factors|immunologic factors|mesh-ancestor
25106145|NCT04352608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106146|NCT04346108|Immunoglobulins|immunoglobulins|mesh-list
25106147|NCT04346108|Antibodies|antibodies|mesh-list
25106148|NCT04346108|gamma-Globulins|gamma-globulins|mesh-list
25106149|NCT04346108|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25830204|NCT00006358|Alkylating Agents|alkylating agents|mesh-ancestor
25830205|NCT00006358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830206|NCT00006358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830207|NCT00006358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25830208|NCT00006358|Immunologic Factors|immunologic factors|mesh-ancestor
25127356|NCT03056118|Analgesics|analgesics|mesh-ancestor
25830209|NCT00006358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830210|NCT00006358|Leprostatic Agents|leprostatic agents|mesh-ancestor
25830211|NCT00006358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25830212|NCT00006358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25830213|NCT00006358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25830214|NCT00006358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25830215|NCT00006358|Growth Substances|growth substances|mesh-ancestor
25830216|NCT00006358|Growth Inhibitors|growth inhibitors|mesh-ancestor
25830217|NCT00006359|Androgen Antagonists|androgen antagonists|mesh-list
25127383|NCT03056053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25830218|NCT00006359|Hormone Antagonists|hormone antagonists|mesh-ancestor
25830219|NCT00006359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25830220|NCT00006359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830221|NCT00006361|Semaxinib|semaxinib|mesh-list
25830222|NCT00006361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25106168|NCT04237792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25106169|NCT04237792|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25106170|NCT04237792|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25830223|NCT00006361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25830224|NCT00006361|Growth Substances|growth substances|mesh-ancestor
25875269|NCT04576156|Imetelstat|imetelstat|mesh-list
25830225|NCT00006361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830226|NCT00006361|Growth Inhibitors|growth inhibitors|mesh-ancestor
25830227|NCT00006361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830228|NCT00006361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25830229|NCT00006361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830230|NCT00006361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830231|NCT00006362|Bortezomib|bortezomib|mesh-list
25830232|NCT00006362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830233|NCT00006363|Cytarabine|cytarabine|mesh-list
25106171|NCT04237792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25106172|NCT04237792|Adrenergic Agents|adrenergic agents|mesh-ancestor
25106173|NCT04237792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25106174|NCT04237792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106175|NCT04233749|Tranexamic Acid|tranexamic acid|mesh-list
25106176|NCT04233749|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25106177|NCT04233749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25106178|NCT04233749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106179|NCT04233749|Hemostatics|hemostatics|mesh-ancestor
24981232|NCT04216017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981233|NCT04216017|Sensory System Agents|sensory system agents|mesh-ancestor
24981234|NCT04216017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25162362|NCT02905734|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25830234|NCT00006363|Aldesleukin|aldesleukin|mesh-list
25830235|NCT00006363|Etoposide|etoposide|mesh-list
25830236|NCT00006363|Daunorubicin|daunorubicin|mesh-list
25830237|NCT00006363|Etoposide phosphate|etoposide phosphate|mesh-list
25830238|NCT00006363|Busulfan|busulfan|mesh-list
25830239|NCT00006363|Interleukin-2|interleukin-2|mesh-list
24981242|NCT04216017|Hormones|hormones|mesh-ancestor
24981245|NCT04216017|Immunologic Factors|immunologic factors|mesh-ancestor
24981246|NCT04189263|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25127424|NCT03055663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127425|NCT03055741|Donepezil|donepezil|mesh-list
24981247|NCT04189263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24981248|NCT04189263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24981249|NCT04189263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981250|NCT04189263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24981251|NCT04189263|Hormone Antagonists|hormone antagonists|mesh-ancestor
24981252|NCT04189263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24981253|NCT04189263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127454|NCT03055793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25127455|NCT03055793|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25830240|NCT00006363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25830241|NCT00006363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830242|NCT00006363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25830243|NCT00006363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25830244|NCT00006363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25162363|NCT02905734|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25127470|NCT03055507|Sensory System Agents|sensory system agents|mesh-ancestor
25127471|NCT03055507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25830245|NCT00006363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846452|NCT02242799|Antimalarials|antimalarials|mesh-ancestor
24981355|NCT03648892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830246|NCT00006363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25830247|NCT00006363|Antimetabolites|antimetabolites|mesh-ancestor
25830248|NCT00006363|Antiviral Agents|antiviral agents|mesh-ancestor
25830249|NCT00006363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25830250|NCT00006363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25830251|NCT00006363|Immunologic Factors|immunologic factors|mesh-ancestor
25830252|NCT00006363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127489|NCT03055312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127490|NCT03055312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25127491|NCT03055247|Ibuprofen|ibuprofen|mesh-list
25127493|NCT03055247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25162380|NCT02905461|Contraceptive Agents|contraceptive agents|mesh-list
25830253|NCT00006363|Alkylating Agents|alkylating agents|mesh-ancestor
25830254|NCT00006363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25830255|NCT00006363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25830256|NCT00006363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25830257|NCT00006363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25830258|NCT00006363|Analgesics|analgesics|mesh-ancestor
25830259|NCT00006363|Sensory System Agents|sensory system agents|mesh-ancestor
25830260|NCT00006363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25830261|NCT00006363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25830262|NCT00006363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25830263|NCT00006364|Homoharringtonine|homoharringtonine|mesh-list
25162364|NCT02905734|Cholinergic Agents|cholinergic agents|mesh-ancestor
25127505|NCT03055442|Vitamins|vitamins|mesh-ancestor
25127506|NCT03055442|Micronutrients|micronutrients|mesh-ancestor
25162365|NCT02905734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25830264|NCT00006364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25830265|NCT00006364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830266|NCT00006364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25830267|NCT00006364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830268|NCT00006364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127524|NCT03054948|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25127525|NCT03054948|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25830269|NCT00006366|Fluorouracil|fluorouracil|mesh-list
25830270|NCT00006366|Irinotecan|irinotecan|mesh-list
25106183|NCT04229095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24981405|NCT03502681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24981406|NCT03502681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25202887|NCT02718079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25041179|NCT02608697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25041180|NCT02608697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25041181|NCT02608697|Antimetabolites|antimetabolites|mesh-ancestor
25041182|NCT02608697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041183|NCT02608697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25106189|NCT04210180|Varenicline|varenicline|mesh-list
25041184|NCT02608697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25041185|NCT02608697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041186|NCT02607930|Lamivudine|lamivudine|mesh-list
25041187|NCT02607930|Triumeq|triumeq|mesh-list
25041188|NCT02607930|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25041189|NCT02607930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25041190|NCT02607930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041191|NCT02607930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041192|NCT02607930|Antiviral Agents|antiviral agents|mesh-ancestor
25041193|NCT02607930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25041194|NCT02607930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25041195|NCT02607930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25041196|NCT02606305|Bevacizumab|bevacizumab|mesh-list
25041197|NCT02606305|Pembrolizumab|pembrolizumab|mesh-list
25041198|NCT02606305|Carboplatin|carboplatin|mesh-list
25162366|NCT02905734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162367|NCT02905760|Furosemide|furosemide|mesh-list
25162368|NCT02905760|Diuretics|diuretics|mesh-list
25162369|NCT02905760|Natriuretic Agents|natriuretic agents|mesh-ancestor
25162370|NCT02905760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162371|NCT02905760|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25162372|NCT02905760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25162373|NCT02905760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162374|NCT02905513|Contraceptive Agents|contraceptive agents|mesh-list
25162375|NCT02905513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25162376|NCT02905513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162377|NCT02905526|Contraceptive Agents|contraceptive agents|mesh-list
25162378|NCT02905526|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25162379|NCT02905526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162387|NCT02905305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25162388|NCT02905305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162389|NCT02905305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25162390|NCT02905305|Glucocorticoids|glucocorticoids|mesh-ancestor
25162391|NCT02905305|Hormones|hormones|mesh-ancestor
25162392|NCT02905305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25162393|NCT02905305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25162394|NCT02905305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162395|NCT02905227|Zolmitriptan|zolmitriptan|mesh-list
25162396|NCT02905227|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25041199|NCT02606305|Doxorubicin|doxorubicin|mesh-list
25041200|NCT02606305|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25162397|NCT02905227|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25162398|NCT02905227|Serotonin Agents|serotonin agents|mesh-ancestor
25162399|NCT02905227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25162400|NCT02905227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162401|NCT02905227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162402|NCT02905058|Ketoprofen|ketoprofen|mesh-list
24574074|NCT00823381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24574075|NCT00823433|Penicillins|penicillins|mesh-list
24574076|NCT00823433|Penicillin V|penicillin v|mesh-list
24574077|NCT00823433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24574078|NCT00823433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24574080|NCT00823550|Entecavir|entecavir|mesh-list
24574081|NCT00823550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24574082|NCT00823550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24574083|NCT00823550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574084|NCT00823550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948714|NCT03917420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25162403|NCT02905058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25162404|NCT02905058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25162405|NCT02905058|Analgesics|analgesics|mesh-ancestor
25162406|NCT02905058|Sensory System Agents|sensory system agents|mesh-ancestor
25162407|NCT02905058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25162408|NCT02905058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162409|NCT02905058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25162410|NCT02905058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25162411|NCT02905058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25162412|NCT02905058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25162413|NCT02905058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162414|NCT02905045|Ketoprofen|ketoprofen|mesh-list
25202888|NCT02718079|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24447170|NCT00307645|Azathioprine|azathioprine|mesh-list
25830271|NCT00006366|Antimetabolites|antimetabolites|mesh-ancestor
25830272|NCT00006366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830273|NCT00006366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24981415|NCT03472365|Capecitabine|capecitabine|mesh-list
24981416|NCT03472365|Oxaliplatin|oxaliplatin|mesh-list
24981418|NCT03472365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24981419|NCT03472365|Antimetabolites|antimetabolites|mesh-ancestor
24981420|NCT03472365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981421|NCT03472365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24981422|NCT03472365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24981423|NCT03472365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24981424|NCT03434418|Osimertinib|osimertinib|mesh-list
24981425|NCT03434418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24981433|NCT03382977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981434|NCT03382977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24981437|NCT03367715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25830274|NCT00006366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830275|NCT00006366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25830276|NCT00006366|Immunologic Factors|immunologic factors|mesh-ancestor
25127638|NCT03054220|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25127641|NCT03054220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830277|NCT00006366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830278|NCT00006366|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24449342|NCT00315016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449343|NCT00315042|Penicillins|penicillins|mesh-list
25830279|NCT00006366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25830280|NCT00006366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830281|NCT00006367|Cytarabine|cytarabine|mesh-list
25830282|NCT00006367|Busulfan|busulfan|mesh-list
25830283|NCT00006367|Idarubicin|idarubicin|mesh-list
25830284|NCT00006367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25830285|NCT00006367|Antimetabolites|antimetabolites|mesh-ancestor
24795627|NCT01197066|Immunologic Factors|immunologic factors|mesh-ancestor
24795628|NCT01197066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795629|NCT01197066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24795630|NCT01124695|Tamoxifen|tamoxifen|mesh-list
24795631|NCT01124695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24795632|NCT01124695|Hormone Antagonists|hormone antagonists|mesh-ancestor
25413521|NCT03126916|Topotecan|topotecan|mesh-list
25657420|NCT01586806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25657421|NCT01586806|Antiemetics|antiemetics|mesh-ancestor
25657422|NCT01586806|Autonomic Agents|autonomic agents|mesh-ancestor
25657423|NCT01586806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25657424|NCT01586806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657425|NCT01586806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25657426|NCT01586806|Glucocorticoids|glucocorticoids|mesh-ancestor
25657427|NCT01586806|Hormones|hormones|mesh-ancestor
25657428|NCT01586806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25657429|NCT01586806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25657430|NCT01586806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24948906|NCT05401110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948908|NCT05401071|Rifampin|rifampin|mesh-list
24948909|NCT05401071|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24948910|NCT05401071|Antitubercular Agents|antitubercular agents|mesh-ancestor
24948911|NCT05401071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24948912|NCT05401071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24948913|NCT05401071|Leprostatic Agents|leprostatic agents|mesh-ancestor
24948914|NCT05401071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24948915|NCT05401071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24794066|NCT05414058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24981479|NCT03132454|Glucocorticoids|glucocorticoids|mesh-ancestor
24981480|NCT03132454|Hormones|hormones|mesh-ancestor
25204491|NCT02707913|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24981481|NCT03132454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24981482|NCT03132454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25830286|NCT00006367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830287|NCT00006367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830288|NCT00006367|Antiviral Agents|antiviral agents|mesh-ancestor
25830289|NCT00006367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25830290|NCT00006367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25830291|NCT00006367|Immunologic Factors|immunologic factors|mesh-ancestor
25830292|NCT00006367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830293|NCT00006367|Alkylating Agents|alkylating agents|mesh-ancestor
25830294|NCT00006367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25830295|NCT00006367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25830296|NCT00006367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25830297|NCT00006367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25830298|NCT00006367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25830299|NCT00006367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830300|NCT00006368|Edotreotide|edotreotide|mesh-list
25830301|NCT00006368|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25830302|NCT00006368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830303|NCT00006370|Edotreotide|edotreotide|mesh-list
25830304|NCT00006370|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25830305|NCT00006370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830306|NCT00006371|Ketoconazole|ketoconazole|mesh-list
24981483|NCT03132454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24981484|NCT03132454|Protease Inhibitors|protease inhibitors|mesh-ancestor
24981485|NCT03132454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24981486|NCT03132454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981487|NCT03132454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24981488|NCT03132454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24981489|NCT03132454|Antimetabolites|antimetabolites|mesh-ancestor
24981490|NCT03132454|Dermatologic Agents|dermatologic agents|mesh-ancestor
24981491|NCT03092817|Dexamethasone|dexamethasone|mesh-list
24981492|NCT03092817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24981494|NCT03092817|Autonomic Agents|autonomic agents|mesh-ancestor
24981495|NCT03092817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24981496|NCT03092817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981499|NCT03092817|Hormones|hormones|mesh-ancestor
25830307|NCT00006371|Hydrocortisone|hydrocortisone|mesh-list
25830308|NCT00006371|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24981509|NCT03040999|Pembrolizumab|pembrolizumab|mesh-list
24981510|NCT03040999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24981511|NCT03040999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24981512|NCT03028350|Ifetroban|ifetroban|mesh-list
25106184|NCT04229095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24981513|NCT03028350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24981514|NCT02993523|Azacitidine|azacitidine|mesh-list
25657431|NCT01586806|Protease Inhibitors|protease inhibitors|mesh-ancestor
25657432|NCT01586806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657433|NCT01586806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657434|NCT01586806|Anesthetics, Local|anesthetics, local|mesh-ancestor
25657435|NCT01586806|Anesthetics|anesthetics|mesh-ancestor
25657436|NCT01586806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25657437|NCT01586806|Sensory System Agents|sensory system agents|mesh-ancestor
25674263|NCT01769469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25674264|NCT01769469|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25674265|NCT01769469|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24981515|NCT02993523|Venetoclax|venetoclax|mesh-list
24981516|NCT02993523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24981517|NCT02993523|Antimetabolites|antimetabolites|mesh-ancestor
24981518|NCT02993523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200155|NCT02735928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24574642|NCT00826644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24574644|NCT00826644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574645|NCT00826644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24574750|NCT00827281|Antimetabolites|antimetabolites|mesh-ancestor
24574751|NCT00827281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574752|NCT00827307|Tamoxifen|tamoxifen|mesh-list
24981519|NCT02993523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24981520|NCT02993523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24981521|NCT02963766|Dulaglutide|dulaglutide|mesh-list
24981522|NCT02963766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24981523|NCT02963766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981524|NCT02956447|Hormones|hormones|mesh-list
24981525|NCT02956447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24981526|NCT02956447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830309|NCT00006371|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25830310|NCT00006371|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25830311|NCT00006371|Aminoglutethimide|aminoglutethimide|mesh-list
25169545|NCT01825980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25127747|NCT03053388|Respiratory System Agents|respiratory system agents|mesh-ancestor
25830312|NCT00006371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25830313|NCT00006371|Antifungal Agents|antifungal agents|mesh-ancestor
25830314|NCT00006371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25830315|NCT00006371|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24981527|NCT02918006|Vaccines|vaccines|mesh-list
24981528|NCT02918006|Immunologic Factors|immunologic factors|mesh-ancestor
24981529|NCT02918006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981530|NCT02820519|Loxapine|loxapine|mesh-list
24981531|NCT02820519|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24981532|NCT02820519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24981533|NCT02820519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24981534|NCT02820519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981535|NCT02820519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24981536|NCT02820519|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24981537|NCT02820519|Dopamine Agents|dopamine agents|mesh-ancestor
25830316|NCT00006371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25830317|NCT00006371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830318|NCT00006371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830319|NCT00006371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25830320|NCT00006371|Hormone Antagonists|hormone antagonists|mesh-ancestor
25830321|NCT00006371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25830322|NCT00006371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830323|NCT00006371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25830324|NCT00006371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25830325|NCT00006371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830326|NCT00006371|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25830327|NCT00006371|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25830328|NCT00006372|Gemcitabine|gemcitabine|mesh-list
25830329|NCT00006372|Doxorubicin|doxorubicin|mesh-list
25830330|NCT00006372|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25830331|NCT00006372|Vinorelbine|vinorelbine|mesh-list
25830332|NCT00006372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25830333|NCT00006372|Antimetabolites|antimetabolites|mesh-ancestor
25830334|NCT00006372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830335|NCT00006372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830336|NCT00006372|Antiviral Agents|antiviral agents|mesh-ancestor
24981548|NCT02725177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981549|NCT02694588|Infliximab|infliximab|mesh-list
24813463|NCT02058576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24981550|NCT02694588|Vedolizumab|vedolizumab|mesh-list
24981551|NCT02694588|Dermatologic Agents|dermatologic agents|mesh-ancestor
25657438|NCT01586819|Botulinum Toxins|botulinum toxins|mesh-list
25657439|NCT01586819|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25657440|NCT01586819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25657441|NCT01586819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657442|NCT01586819|Cholinergic Agents|cholinergic agents|mesh-ancestor
25657443|NCT01586819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25657444|NCT01586819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657445|NCT01586962|Acetaminophen|acetaminophen|mesh-list
25657446|NCT01586962|Pseudoephedrine|pseudoephedrine|mesh-list
24981657|NCT02220985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24981658|NCT02220985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25127899|NCT03052361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25127900|NCT03052361|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25127901|NCT03052140|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25127902|NCT03052140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25127904|NCT03051932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25127905|NCT03051932|Analgesics|analgesics|mesh-ancestor
25127906|NCT03051932|Sensory System Agents|sensory system agents|mesh-ancestor
25127907|NCT03051932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25127908|NCT03051932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127909|NCT03051932|Antipyretics|antipyretics|mesh-ancestor
24981659|NCT02220985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24981660|NCT02220985|Abortifacient Agents|abortifacient agents|mesh-ancestor
24981661|NCT02220985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24981662|NCT02220985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25106185|NCT04229095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576152|NCT00837187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24576153|NCT00837187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24576154|NCT00837187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576155|NCT00837187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24576156|NCT00837187|Analgesics|analgesics|mesh-ancestor
24576157|NCT00837187|Sensory System Agents|sensory system agents|mesh-ancestor
24576158|NCT00837187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24576159|NCT00837187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24478232|NCT00421967|Ketorolac|ketorolac|mesh-list
24451996|NCT00325689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576163|NCT00837187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576164|NCT00837187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576166|NCT00837239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25657447|NCT01586962|Ephedrine|ephedrine|mesh-list
25657448|NCT01586962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25657449|NCT01586962|Analgesics|analgesics|mesh-ancestor
25657450|NCT01586962|Sensory System Agents|sensory system agents|mesh-ancestor
25657451|NCT01586962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25657452|NCT01586962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657453|NCT01586962|Antipyretics|antipyretics|mesh-ancestor
25657454|NCT01586962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25657455|NCT01586962|Autonomic Agents|autonomic agents|mesh-ancestor
25106199|NCT04175886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106231|NCT04031729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24981664|NCT02220985|Dermatologic Agents|dermatologic agents|mesh-ancestor
24981665|NCT02220985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24981666|NCT02220985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24981667|NCT02220985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24981668|NCT02220985|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24981669|NCT02220985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24981670|NCT02220985|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24981671|NCT02220985|Antitubercular Agents|antitubercular agents|mesh-ancestor
25162416|NCT02905045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25162417|NCT02905045|Analgesics|analgesics|mesh-ancestor
24981672|NCT02220985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24981673|NCT02220985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24981721|NCT01952782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24981722|NCT01952782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981724|NCT01952782|Sensory System Agents|sensory system agents|mesh-ancestor
24981725|NCT01952782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24981747|NCT01858740|Methotrexate|methotrexate|mesh-list
24981748|NCT01858740|Fludarabine phosphate|fludarabine phosphate|mesh-list
24981749|NCT01858740|Fludarabine|fludarabine|mesh-list
25657458|NCT01586962|Nasal Decongestants|nasal decongestants|mesh-ancestor
25657459|NCT01586962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25657460|NCT01586962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25657461|NCT01586962|Sympathomimetics|sympathomimetics|mesh-ancestor
25657462|NCT01586962|Adrenergic Agents|adrenergic agents|mesh-ancestor
25657463|NCT01586962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25657464|NCT01586962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657465|NCT01586975|Aspirin|aspirin|mesh-list
25830348|NCT00006372|Mitosis Modulators|mitosis modulators|mesh-ancestor
25830349|NCT00006373|Etoposide|etoposide|mesh-list
25830350|NCT00006373|Topotecan|topotecan|mesh-list
25830351|NCT00006373|Ifosfamide|ifosfamide|mesh-list
25830352|NCT00006373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25830353|NCT00006373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24981756|NCT01858740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24981757|NCT01858740|Antimetabolites|antimetabolites|mesh-ancestor
24981758|NCT01858740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981759|NCT01858740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24981760|NCT01858740|Dermatologic Agents|dermatologic agents|mesh-ancestor
24981761|NCT01858740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24981762|NCT01858740|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24981763|NCT01858740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24981764|NCT01858740|Immunologic Factors|immunologic factors|mesh-ancestor
24981765|NCT01858740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24981766|NCT01858740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24981767|NCT01858740|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24981768|NCT01858740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24981769|NCT01858740|Alkylating Agents|alkylating agents|mesh-ancestor
24981770|NCT01858740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24981771|NCT01832402|Fentanyl|fentanyl|mesh-list
24981772|NCT01832402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24981773|NCT01832402|Narcotics|narcotics|mesh-ancestor
25041232|NCT02598557|Exemestane|exemestane|mesh-list
25041233|NCT02598557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041234|NCT02598557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25041235|NCT02598557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25041236|NCT02598557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041237|NCT02598557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041238|NCT02598557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25041239|NCT02598557|Hormone Antagonists|hormone antagonists|mesh-ancestor
25041240|NCT02598557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25041241|NCT02598557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041242|NCT02597634|Ibuprofen|ibuprofen|mesh-list
25041243|NCT02597634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25041244|NCT02597634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25041245|NCT02597634|Analgesics|analgesics|mesh-ancestor
25041246|NCT02597634|Sensory System Agents|sensory system agents|mesh-ancestor
25041247|NCT02597634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25041248|NCT02597634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041249|NCT02597634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25041250|NCT02597634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25041251|NCT02597634|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25041252|NCT02597634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041253|NCT02597634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041254|NCT02594254|Anti-Infective Agents|anti-infective agents|mesh-list
25041255|NCT02594254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25041256|NCT02591199|Lidocaine|lidocaine|mesh-list
25041257|NCT02591199|Heparin|heparin|mesh-list
25041258|NCT02591199|Anesthetics, Local|anesthetics, local|mesh-ancestor
25041259|NCT02591199|Anesthetics|anesthetics|mesh-ancestor
25041260|NCT02591199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25041261|NCT02591199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041262|NCT02591199|Sensory System Agents|sensory system agents|mesh-ancestor
25041263|NCT02591199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25041264|NCT02591199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25162418|NCT02905045|Sensory System Agents|sensory system agents|mesh-ancestor
25162419|NCT02905045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25162420|NCT02905045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162421|NCT02905045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25162422|NCT02905045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25162423|NCT02905045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25162424|NCT02905045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413522|NCT03126916|Etoposide phosphate|etoposide phosphate|mesh-list
25657466|NCT01586975|Clopidogrel|clopidogrel|mesh-list
25657467|NCT01586975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25657468|NCT01586975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25657469|NCT01586975|Analgesics|analgesics|mesh-ancestor
25657470|NCT01586975|Sensory System Agents|sensory system agents|mesh-ancestor
24950152|NCT02348203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24950153|NCT02348203|Analgesics|analgesics|mesh-ancestor
24950154|NCT02348203|Sensory System Agents|sensory system agents|mesh-ancestor
24950155|NCT02348203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24950156|NCT02348203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950157|NCT02348203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24950170|NCT02344680|Anti-HIV Agents|anti-hiv agents|mesh-list
24950171|NCT02344680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25162425|NCT02905045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202889|NCT02718079|Diuretics|diuretics|mesh-ancestor
25202890|NCT02718079|Natriuretic Agents|natriuretic agents|mesh-ancestor
25202891|NCT02718079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202892|NCT02718079|Antiviral Agents|antiviral agents|mesh-ancestor
25202893|NCT02718079|Expectorants|expectorants|mesh-ancestor
25202894|NCT02718079|Respiratory System Agents|respiratory system agents|mesh-ancestor
25202895|NCT02718079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25202896|NCT02718079|Antioxidants|antioxidants|mesh-ancestor
25202897|NCT02718079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202898|NCT02718079|Protective Agents|protective agents|mesh-ancestor
25202899|NCT02718079|Antidotes|antidotes|mesh-ancestor
25202900|NCT02718183|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25202901|NCT02718183|Carbamide Peroxide|carbamide peroxide|mesh-list
25202902|NCT02718183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25202903|NCT02718183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25207762|NCT03414723|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25207763|NCT03414723|Ramipril|ramipril|mesh-list
25207764|NCT03414723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25207765|NCT03414723|Protease Inhibitors|protease inhibitors|mesh-ancestor
25207766|NCT03414723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25207767|NCT03414723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207768|NCT03414723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25207769|NCT03414723|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25207770|NCT03414723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25207771|NCT03414723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207772|NCT03409276|Vaccines|vaccines|mesh-list
25207773|NCT03409276|Immunologic Factors|immunologic factors|mesh-ancestor
25207774|NCT03409276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207775|NCT03406000|Insulin Glargine|insulin glargine|mesh-list
25207776|NCT03406000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25207777|NCT03406000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981775|NCT01832402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657471|NCT01586975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25657472|NCT01586975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657473|NCT01586975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25657474|NCT01586975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25657475|NCT01586975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25657476|NCT01586975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25657477|NCT01586975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657478|NCT01586975|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25657479|NCT01586975|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25657480|NCT01586975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657481|NCT01586975|Antipyretics|antipyretics|mesh-ancestor
25657482|NCT01586975|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25657483|NCT01586975|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25657484|NCT01586975|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25657485|NCT01586975|Purinergic Agents|purinergic agents|mesh-ancestor
24981805|NCT01320280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24981806|NCT01320280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795642|NCT01097746|Carboplatin|carboplatin|mesh-list
24795643|NCT01097746|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24795644|NCT01097746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24795645|NCT01097746|Endothelial Growth Factors|endothelial growth factors|mesh-list
24795646|NCT01097746|Antibodies|antibodies|mesh-list
24795647|NCT01097746|Immunoglobulins|immunoglobulins|mesh-list
24795648|NCT01097746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24795649|NCT01097746|Immunoglobulin G|immunoglobulin g|mesh-list
24795650|NCT01097746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24795651|NCT01097746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795652|NCT01097746|Tubulin Modulators|tubulin modulators|mesh-ancestor
24795653|NCT01097746|Antimitotic Agents|antimitotic agents|mesh-ancestor
24795654|NCT01097746|Mitosis Modulators|mitosis modulators|mesh-ancestor
24795655|NCT01097746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795656|NCT01097746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24795657|NCT01097746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24795658|NCT01097746|Growth Substances|growth substances|mesh-ancestor
24795659|NCT01097746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128239|NCT03049267|Analgesics|analgesics|mesh-ancestor
24795660|NCT01097746|Growth Inhibitors|growth inhibitors|mesh-ancestor
24452119|NCT00326092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24784097|NCT01906073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24784098|NCT01906073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784099|NCT01906073|Analgesics|analgesics|mesh-ancestor
24784100|NCT01906073|Sensory System Agents|sensory system agents|mesh-ancestor
24784101|NCT01906073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24784102|NCT01906073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24784103|NCT01906073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24784104|NCT01906073|Anesthetics, General|anesthetics, general|mesh-ancestor
24784105|NCT01906073|Anesthetics|anesthetics|mesh-ancestor
24784106|NCT01906125|Palbociclib|palbociclib|mesh-list
25674266|NCT01769508|Fluorouracil|fluorouracil|mesh-list
24784107|NCT01906125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784108|NCT01906125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25830355|NCT00006373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25830356|NCT00006373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830357|NCT00006373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830358|NCT00006373|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25875270|NCT04576156|Motesanib diphosphate|motesanib diphosphate|mesh-list
25875271|NCT04576156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875272|NCT04576156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875273|NCT04576156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25875274|NCT04558918|Eculizumab|eculizumab|mesh-list
25875275|NCT04558918|Ravulizumab|ravulizumab|mesh-list
25875276|NCT04558918|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25875277|NCT04558918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25875278|NCT04558918|Immunologic Factors|immunologic factors|mesh-ancestor
24784114|NCT01906216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24784115|NCT01906216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784116|NCT01906242|Chlorhexidine|chlorhexidine|mesh-list
24784117|NCT01906242|Sodium Hypochlorite|sodium hypochlorite|mesh-list
24784119|NCT01906242|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24784120|NCT01906242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24784121|NCT01906242|Disinfectants|disinfectants|mesh-ancestor
24795662|NCT01079780|Irinotecan|irinotecan|mesh-list
24795663|NCT01079780|Cetuximab|cetuximab|mesh-list
24795664|NCT01079780|Ramucirumab|ramucirumab|mesh-list
24795665|NCT01079780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25162426|NCT02904772|Cyclosporine|cyclosporine|mesh-list
25830359|NCT00006373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25830360|NCT00006373|Alkylating Agents|alkylating agents|mesh-ancestor
24981928|NCT00852696|Urological Agents|urological agents|mesh-ancestor
24795666|NCT01079780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24795667|NCT01079780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795668|NCT01079780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795669|NCT01079780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795670|NCT01079780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24795672|NCT01042379|Paclitaxel|paclitaxel|mesh-list
24795673|NCT01042379|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24795674|NCT01042379|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25657486|NCT01586975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25657487|NCT01587001|Acetylcysteine|acetylcysteine|mesh-list
25657488|NCT01587001|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25657489|NCT01587001|Antiviral Agents|antiviral agents|mesh-ancestor
25657490|NCT01587001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25657491|NCT01587001|Expectorants|expectorants|mesh-ancestor
25657492|NCT01587001|Respiratory System Agents|respiratory system agents|mesh-ancestor
24795675|NCT01042379|Carboplatin|carboplatin|mesh-list
25657493|NCT01587001|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25830361|NCT00006374|Paclitaxel|paclitaxel|mesh-list
24576953|NCT00841126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795676|NCT01042379|Doxorubicin|doxorubicin|mesh-list
24795677|NCT01042379|Pembrolizumab|pembrolizumab|mesh-list
25106232|NCT04031729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24795679|NCT01042379|Irinotecan|irinotecan|mesh-list
24795680|NCT01042379|Durvalumab|durvalumab|mesh-list
24795681|NCT01042379|Letrozole|letrozole|mesh-list
24795682|NCT01042379|Olaparib|olaparib|mesh-list
24795683|NCT01042379|Pertuzumab|pertuzumab|mesh-list
24795684|NCT01042379|Veliparib|veliparib|mesh-list
24919839|NCT04208061|Dabigatran|dabigatran|mesh-list
24981807|NCT01320280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128397|NCT03047772|Atorvastatin|atorvastatin|mesh-list
24981896|NCT01081951|Olaparib|olaparib|mesh-list
25169547|NCT01818921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25162427|NCT02904772|Mycophenolic Acid|mycophenolic acid|mesh-list
25830362|NCT00006374|Etoposide|etoposide|mesh-list
25830363|NCT00006374|Cisplatin|cisplatin|mesh-list
25830364|NCT00006374|Topotecan|topotecan|mesh-list
25830365|NCT00006374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25830366|NCT00006374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830367|NCT00006374|Tubulin Modulators|tubulin modulators|mesh-ancestor
25830368|NCT00006374|Antimitotic Agents|antimitotic agents|mesh-ancestor
25830369|NCT00006374|Mitosis Modulators|mitosis modulators|mesh-ancestor
25830370|NCT00006374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657495|NCT01587001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657496|NCT01587001|Protective Agents|protective agents|mesh-ancestor
25657497|NCT01587001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657498|NCT01587001|Antidotes|antidotes|mesh-ancestor
25657499|NCT01587027|Aminophylline|aminophylline|mesh-list
25657500|NCT01587027|Methazolamide|methazolamide|mesh-list
25657501|NCT01587027|Theophylline|theophylline|mesh-list
25657502|NCT01587027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24981921|NCT00852696|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24981946|NCT00788671|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25128491|NCT03047109|Phenylephrine|phenylephrine|mesh-list
24981948|NCT00493961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24981961|NCT04563247|Antibodies|antibodies|mesh-list
24981962|NCT04563247|Immunologic Factors|immunologic factors|mesh-ancestor
24981963|NCT04563247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981971|NCT04508855|Heparin|heparin|mesh-list
24981972|NCT04508855|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24981973|NCT04508855|Tinzaparin|tinzaparin|mesh-list
24981974|NCT04508855|Dalteparin|dalteparin|mesh-list
25169548|NCT01818921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24981983|NCT04499950|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24981984|NCT04499950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981985|NCT04499950|Sensory System Agents|sensory system agents|mesh-ancestor
24981986|NCT04499950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24981987|NCT04499950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24981988|NCT04499950|Antidepressive Agents|antidepressive agents|mesh-ancestor
24981989|NCT04499950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24981990|NCT04499950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24981991|NCT04499950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24981992|NCT04499950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24981993|NCT04499950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981994|NCT04499950|Dopamine Agents|dopamine agents|mesh-ancestor
24981996|NCT04499950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25413523|NCT03126916|Dexrazoxane|dexrazoxane|mesh-list
25657503|NCT01587027|Autonomic Agents|autonomic agents|mesh-ancestor
25657504|NCT01587027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24982028|NCT04447846|Anticonvulsants|anticonvulsants|mesh-ancestor
24982029|NCT04398329|Bupivacaine|bupivacaine|mesh-list
24982030|NCT04398329|Anesthetics, Local|anesthetics, local|mesh-ancestor
24982031|NCT04398329|Anesthetics|anesthetics|mesh-ancestor
24982032|NCT04398329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24982033|NCT04398329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982034|NCT04398329|Sensory System Agents|sensory system agents|mesh-ancestor
24982035|NCT04398329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25128688|NCT03045471|Hormones|hormones|mesh-ancestor
24982036|NCT04391855|Dexmedetomidine|dexmedetomidine|mesh-list
24982037|NCT04391855|Tramadol|tramadol|mesh-list
24982038|NCT04391855|Ropivacaine|ropivacaine|mesh-list
24982039|NCT04391855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24982040|NCT04391855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24982041|NCT04391855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982042|NCT04391855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24982045|NCT04391855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24982046|NCT04391855|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25830375|NCT00006376|Tipifarnib|tipifarnib|mesh-list
25830376|NCT00006376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830377|NCT00006377|Paclitaxel|paclitaxel|mesh-list
25830378|NCT00006377|Carboplatin|carboplatin|mesh-list
24982056|NCT04371380|Rilpivirine|rilpivirine|mesh-list
24982057|NCT04371380|Cabotegravir|cabotegravir|mesh-list
24982058|NCT04371380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24982059|NCT04371380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24982060|NCT04371380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24982061|NCT04371380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162430|NCT02904772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24982062|NCT04371380|Antiviral Agents|antiviral agents|mesh-ancestor
24982063|NCT04371380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24982064|NCT04371380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25830379|NCT00006377|Doxorubicin|doxorubicin|mesh-list
25830380|NCT00006377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25830381|NCT00006377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25830382|NCT00006377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830383|NCT00006377|Tubulin Modulators|tubulin modulators|mesh-ancestor
25106297|NCT03117933|Antimitotic Agents|antimitotic agents|mesh-ancestor
24982071|NCT04266665|Dexmedetomidine|dexmedetomidine|mesh-list
24982072|NCT04266665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24982073|NCT04266665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25830386|NCT00006377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830387|NCT00006377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25830388|NCT00006377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25830389|NCT00006377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25830390|NCT00006377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830392|NCT00006378|Carboplatin|carboplatin|mesh-list
25162439|NCT02904772|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25162440|NCT02904772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25162441|NCT02904772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162442|NCT02904772|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24935585|NCT04049227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24935586|NCT04049227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935588|NCT04049045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24935589|NCT04049045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935590|NCT04049045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24935591|NCT04049045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997710|NCT04509193|Warfarin|warfarin|mesh-list
24997711|NCT04509193|Rivaroxaban|rivaroxaban|mesh-list
24997712|NCT04509193|Anticoagulants|anticoagulants|mesh-ancestor
24997713|NCT04509193|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24997714|NCT04509193|Antithrombins|antithrombins|mesh-ancestor
25128884|NCT03044366|Anesthetics|anesthetics|mesh-list
24997715|NCT04509193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24997716|NCT04509193|Protease Inhibitors|protease inhibitors|mesh-ancestor
24997717|NCT04509193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24997718|NCT04509193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830393|NCT00006378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25162443|NCT02904772|Antitubercular Agents|antitubercular agents|mesh-ancestor
25162444|NCT02904772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25162445|NCT02904772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25162446|NCT02904772|Glucocorticoids|glucocorticoids|mesh-ancestor
25162447|NCT02904772|Hormones|hormones|mesh-ancestor
25162448|NCT02904772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25162449|NCT02904772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25162450|NCT02904759|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25162451|NCT02904759|Hemostatics|hemostatics|mesh-ancestor
25162452|NCT02904759|Coagulants|coagulants|mesh-ancestor
25162453|NCT02904759|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25162454|NCT02904759|Natriuretic Agents|natriuretic agents|mesh-ancestor
25162455|NCT02904759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162456|NCT02904564|Fluorouracil|fluorouracil|mesh-list
25162457|NCT02904564|Antimetabolites|antimetabolites|mesh-ancestor
25162458|NCT02904564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162459|NCT02904564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25830394|NCT00006378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162460|NCT02904564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162461|NCT02904564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25162462|NCT02904564|Immunologic Factors|immunologic factors|mesh-ancestor
25162463|NCT02904564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162464|NCT02904538|Dexamethasone|dexamethasone|mesh-list
25162465|NCT02904538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25162466|NCT02904538|Antiemetics|antiemetics|mesh-ancestor
25162467|NCT02904538|Autonomic Agents|autonomic agents|mesh-ancestor
25162468|NCT02904538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25169549|NCT01818921|Growth Substances|growth substances|mesh-ancestor
25162469|NCT02904538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162470|NCT02904538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25162471|NCT02904538|Glucocorticoids|glucocorticoids|mesh-ancestor
25162472|NCT02904538|Hormones|hormones|mesh-ancestor
25162473|NCT02904538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24982081|NCT04266665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24982082|NCT04266665|Adrenergic Agents|adrenergic agents|mesh-ancestor
24982083|NCT04266665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24982084|NCT04266665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982086|NCT04259749|Antipruritics|antipruritics|mesh-ancestor
25830396|NCT00006378|Antimitotic Agents|antimitotic agents|mesh-ancestor
24982103|NCT04245748|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24982104|NCT04245748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24982105|NCT04245748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24982109|NCT04245748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982110|NCT04245748|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24982112|NCT04245748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24982113|NCT04245748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25162474|NCT02904538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24459644|NCT00345696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25129018|NCT03043430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24982175|NCT03837860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24982176|NCT03837860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24982177|NCT03837860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24982178|NCT03837860|Dopamine Agents|dopamine agents|mesh-ancestor
24982180|NCT03697629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24982181|NCT03677830|Acetaminophen|acetaminophen|mesh-list
24982182|NCT03677830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24982183|NCT03677830|Analgesics|analgesics|mesh-ancestor
24982184|NCT03677830|Sensory System Agents|sensory system agents|mesh-ancestor
24982185|NCT03677830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24982186|NCT03677830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982187|NCT03677830|Antipyretics|antipyretics|mesh-ancestor
24982188|NCT03583697|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
24982189|NCT03583697|Natriuretic Agents|natriuretic agents|mesh-ancestor
25202904|NCT02717923|Capecitabine|capecitabine|mesh-list
25202905|NCT02717923|Cetuximab|cetuximab|mesh-list
25202906|NCT02717923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25202907|NCT02717923|Antimetabolites|antimetabolites|mesh-ancestor
25830398|NCT00006378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830399|NCT00006379|Cyclophosphamide|cyclophosphamide|mesh-list
25657505|NCT01587027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657506|NCT01587027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25657507|NCT01587027|Respiratory System Agents|respiratory system agents|mesh-ancestor
24982254|NCT03379727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24982255|NCT03379727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982257|NCT03326492|Immunologic Factors|immunologic factors|mesh-ancestor
24982258|NCT03326492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982820|NCT00383552|Autonomic Agents|autonomic agents|mesh-ancestor
24982268|NCT03260023|Avelumab|avelumab|mesh-list
24982269|NCT03260023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24982270|NCT03260023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24982271|NCT03227458|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24982272|NCT03227458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24982273|NCT03227458|Immunologic Factors|immunologic factors|mesh-ancestor
24982274|NCT03227458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129188|NCT03042429|Ifosfamide|ifosfamide|mesh-list
24795729|NCT00075946|Rituximab|rituximab|mesh-list
25657508|NCT01587027|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25657509|NCT01587027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830409|NCT00006379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162475|NCT02904538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795737|NCT00003641|Interferon alpha-2|interferon alpha-2|mesh-list
24795738|NCT00003641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106324|NCT03070301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25106325|NCT03070301|Immunologic Factors|immunologic factors|mesh-ancestor
25106326|NCT03070301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106327|NCT03064113|Ipratropium|ipratropium|mesh-list
25106328|NCT03064113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25106329|NCT03064113|Autonomic Agents|autonomic agents|mesh-ancestor
25106330|NCT03064113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25106331|NCT03064113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106332|NCT03064113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25106333|NCT03064113|Respiratory System Agents|respiratory system agents|mesh-ancestor
25106334|NCT03064113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25106335|NCT03064113|Cholinergic Agents|cholinergic agents|mesh-ancestor
25106336|NCT03064113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25106337|NCT03064113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106338|NCT03049540|Tadalafil|tadalafil|mesh-list
25830410|NCT00006379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830411|NCT00006379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25830412|NCT00006379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25106350|NCT02940769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25106351|NCT02940769|Dopamine Agents|dopamine agents|mesh-ancestor
25106352|NCT02940769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25106353|NCT02940769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106354|NCT02940769|Adrenergic Agents|adrenergic agents|mesh-ancestor
25106355|NCT02940769|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25106356|NCT02940769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25106357|NCT02940769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25106358|NCT02940769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25106359|NCT02938013|Sofosbuvir|sofosbuvir|mesh-list
25106360|NCT02938013|Velpatasvir|velpatasvir|mesh-list
25106361|NCT02938013|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25106362|NCT02938013|Antiviral Agents|antiviral agents|mesh-ancestor
25106363|NCT02938013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24453456|NCT05008224|Glucocorticoids|glucocorticoids|mesh-ancestor
25129275|NCT03041935|Anesthetics|anesthetics|mesh-ancestor
24453480|NCT04998669|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
25657510|NCT01587027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657511|NCT01587027|Vasodilator Agents|vasodilator agents|mesh-ancestor
25657512|NCT01587027|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25657513|NCT01587027|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25657514|NCT01587027|Purinergic Agents|purinergic agents|mesh-ancestor
25657515|NCT01587027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25657516|NCT01587027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25657517|NCT01587027|Protective Agents|protective agents|mesh-ancestor
25657518|NCT01587027|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25657519|NCT01587027|Diuretics|diuretics|mesh-ancestor
24982399|NCT02703623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24982400|NCT02703623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24982401|NCT02703623|Glucocorticoids|glucocorticoids|mesh-ancestor
24982402|NCT02703623|Hormones|hormones|mesh-ancestor
24794069|NCT05414058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24982430|NCT02668770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24982431|NCT02668770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24982432|NCT02668770|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24982433|NCT02668770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982449|NCT02650648|Cyclophosphamide|cyclophosphamide|mesh-list
24982450|NCT02650648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24982451|NCT02650648|Immunologic Factors|immunologic factors|mesh-ancestor
24982452|NCT02650648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982474|NCT02596503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24982489|NCT02554253|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24982490|NCT02554253|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24982491|NCT02554253|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24982492|NCT02554253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24982493|NCT02554253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982494|NCT02535091|Cenobamate|cenobamate|mesh-list
24982528|NCT02441686|Growth Inhibitors|growth inhibitors|mesh-ancestor
24982530|NCT02382406|Carboplatin|carboplatin|mesh-list
24982531|NCT02382406|Pembrolizumab|pembrolizumab|mesh-list
24982532|NCT02382406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24982533|NCT02382406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24982534|NCT02382406|Tubulin Modulators|tubulin modulators|mesh-ancestor
24982535|NCT02382406|Antimitotic Agents|antimitotic agents|mesh-ancestor
24982536|NCT02382406|Mitosis Modulators|mitosis modulators|mesh-ancestor
24982537|NCT02382406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982538|NCT02382406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24982539|NCT02308527|Cyclophosphamide|cyclophosphamide|mesh-list
24982540|NCT02308527|Temozolomide|temozolomide|mesh-list
24982541|NCT02308527|Bevacizumab|bevacizumab|mesh-list
24982542|NCT02308527|Irinotecan|irinotecan|mesh-list
24982543|NCT02308527|Topotecan|topotecan|mesh-list
24982544|NCT02308527|Dinutuximab|dinutuximab|mesh-list
25162476|NCT02904499|Dabigatran|dabigatran|mesh-list
24982545|NCT02308527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24982546|NCT02308527|Immunologic Factors|immunologic factors|mesh-ancestor
24982547|NCT02308527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982548|NCT02308527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25129359|NCT03042091|Metronidazole|metronidazole|mesh-list
24475440|NCT00410462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982549|NCT02308527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24982551|NCT02308527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830418|NCT00006380|Immunologic Factors|immunologic factors|mesh-ancestor
25830419|NCT00006380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830420|NCT00006380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830421|NCT00006381|Celecoxib|celecoxib|mesh-list
25830422|NCT00006381|Trastuzumab|trastuzumab|mesh-list
25830423|NCT00006381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25129399|NCT03041506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129407|NCT03041506|Analgesics|analgesics|mesh-ancestor
25106392|NCT02812667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106394|NCT02797275|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25106396|NCT02797275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25106397|NCT02797275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106398|NCT02797275|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25106399|NCT02797275|Respiratory System Agents|respiratory system agents|mesh-ancestor
25106400|NCT02797275|Tocolytic Agents|tocolytic agents|mesh-ancestor
25106401|NCT02797275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25106409|NCT02790138|Vedolizumab|vedolizumab|mesh-list
25106410|NCT02790138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25106411|NCT02790138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25413524|NCT03126916|Razoxane|razoxane|mesh-list
25830424|NCT00006381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830428|NCT00006381|Sensory System Agents|sensory system agents|mesh-ancestor
25830429|NCT00006381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25830430|NCT00006381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830431|NCT00006381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25830432|NCT00006381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25207778|NCT03391193|Vaccines|vaccines|mesh-list
25830433|NCT00006381|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25830434|NCT00006381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25830435|NCT00006381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830436|NCT00006381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830437|NCT00006383|Vincristine|vincristine|mesh-list
24982583|NCT01524536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129448|NCT03040791|Nivolumab|nivolumab|mesh-list
24982584|NCT01524536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24982585|NCT01524536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24982586|NCT01485874|Doxorubicin|doxorubicin|mesh-list
24982587|NCT01485874|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24982589|NCT01485874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24982590|NCT01485874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24982591|NCT01485874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24982592|NCT01485874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24982593|NCT01485874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830438|NCT00006383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25830439|NCT00006383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830440|NCT00006383|Tubulin Modulators|tubulin modulators|mesh-ancestor
25830441|NCT00006383|Antimitotic Agents|antimitotic agents|mesh-ancestor
25830442|NCT00006383|Mitosis Modulators|mitosis modulators|mesh-ancestor
25830443|NCT00006383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830444|NCT00006384|Interferons|interferons|mesh-list
25830445|NCT00006384|Interferon-alpha|interferon-alpha|mesh-list
24982594|NCT01485874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982595|NCT01485874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24795781|NCT01945983|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24795782|NCT01946009|Cidofovir|cidofovir|mesh-list
24795783|NCT01946009|Antiviral Agents|antiviral agents|mesh-ancestor
24795784|NCT01946009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24795785|NCT01946009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795786|NCT01946009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795787|NCT01946035|Doxazosin|doxazosin|mesh-list
24795788|NCT01946035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24846985|NCT02244515|Adrenergic Agents|adrenergic agents|mesh-ancestor
25413525|NCT03126916|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
25162486|NCT02904369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24982684|NCT00739674|Calcium|calcium|mesh-list
24982685|NCT00739674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24982686|NCT00739674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982688|NCT00739674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24982715|NCT00480805|Losartan|losartan|mesh-list
24982716|NCT00480805|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24982717|NCT00480805|Ramipril|ramipril|mesh-list
24982718|NCT00480805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24982719|NCT00480805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24982720|NCT00480805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24982721|NCT00480805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24982722|NCT00480805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982723|NCT00480805|Diuretics|diuretics|mesh-ancestor
24982724|NCT00480805|Natriuretic Agents|natriuretic agents|mesh-ancestor
24982725|NCT00480805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982726|NCT00480805|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24982727|NCT00480805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25830453|NCT00006385|Sargramostim|sargramostim|mesh-list
25830454|NCT00006385|Freund's Adjuvant|freund's adjuvant|mesh-list
25830455|NCT00006385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830456|NCT00006385|Antiviral Agents|antiviral agents|mesh-ancestor
25830457|NCT00006385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25830458|NCT00006385|Immunologic Factors|immunologic factors|mesh-ancestor
25830459|NCT00006385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830460|NCT00006385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25830461|NCT00006386|Carmustine|carmustine|mesh-list
24982739|NCT00479713|Antimetabolites|antimetabolites|mesh-ancestor
24982747|NCT00457275|Antimetabolites|antimetabolites|mesh-ancestor
24982748|NCT00457275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982749|NCT00457275|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24982750|NCT00449111|Losartan|losartan|mesh-list
24982751|NCT00449111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24982752|NCT00449111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24982755|NCT00449111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830462|NCT00006386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24444213|NCT00296972|Antiviral Agents|antiviral agents|mesh-ancestor
24444377|NCT00297674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444378|NCT00297674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24444379|NCT00297674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24444419|NCT00297960|Olanzapine|olanzapine|mesh-list
24444420|NCT00297960|Ziprasidone|ziprasidone|mesh-list
24444421|NCT00297960|Antiemetics|antiemetics|mesh-ancestor
24444422|NCT00297960|Autonomic Agents|autonomic agents|mesh-ancestor
24481363|NCT00434135|Paclitaxel|paclitaxel|mesh-list
24982775|NCT00405964|Histamine Agents|histamine agents|mesh-ancestor
24982776|NCT00400218|Losartan|losartan|mesh-list
24982777|NCT00400218|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24784363|NCT01907594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784364|NCT01907594|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24784365|NCT01907594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24784366|NCT01907594|Renal Agents|renal agents|mesh-ancestor
24784367|NCT01907594|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24784368|NCT01907594|Antitubercular Agents|antitubercular agents|mesh-ancestor
24784369|NCT01907594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25106483|NCT02669173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25106484|NCT02669173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106485|NCT02669173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25106486|NCT02669173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25106487|NCT02669173|Growth Substances|growth substances|mesh-ancestor
25106488|NCT02669173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830463|NCT00006386|Alkylating Agents|alkylating agents|mesh-ancestor
25830464|NCT00006386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830465|NCT00006386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830467|NCT00006388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25106490|NCT02669173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25106491|NCT02669173|Antimetabolites|antimetabolites|mesh-ancestor
24982806|NCT00383721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24982807|NCT00383721|Respiratory System Agents|respiratory system agents|mesh-ancestor
24982808|NCT00383721|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24982809|NCT00383721|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24982810|NCT00383721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24982811|NCT00383721|Adrenergic Agents|adrenergic agents|mesh-ancestor
24982812|NCT00383721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24982813|NCT00383721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982814|NCT00383721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24982815|NCT00383721|Dermatologic Agents|dermatologic agents|mesh-ancestor
24982816|NCT00383721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24982817|NCT00383552|Mometasone Furoate|mometasone furoate|mesh-list
24982818|NCT00383552|Formoterol Fumarate|formoterol fumarate|mesh-list
24982819|NCT00383552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24982828|NCT00383552|Adrenergic Agents|adrenergic agents|mesh-ancestor
24982829|NCT00383552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25830468|NCT00006388|Hormone Antagonists|hormone antagonists|mesh-ancestor
25830469|NCT00006388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25830470|NCT00006388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830471|NCT00006388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25830472|NCT00006388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830473|NCT00006388|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25830474|NCT00006388|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25830475|NCT00006388|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24982843|NCT00383435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24982844|NCT00383435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24982845|NCT00383435|Adrenergic Agents|adrenergic agents|mesh-ancestor
24982846|NCT00383435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24982847|NCT00383435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982848|NCT00383435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24982865|NCT00381485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24982866|NCT00381485|Dermatologic Agents|dermatologic agents|mesh-ancestor
24982867|NCT00381485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24982869|NCT00379288|Xhance|xhance|mesh-list
24982872|NCT00379288|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25830476|NCT00006390|Cyclophosphamide|cyclophosphamide|mesh-list
25830477|NCT00006390|Alemtuzumab|alemtuzumab|mesh-list
25830478|NCT00006390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25830479|NCT00006390|Immunologic Factors|immunologic factors|mesh-ancestor
25830480|NCT00006390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830481|NCT00006390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25830482|NCT00006390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25830483|NCT00006390|Alkylating Agents|alkylating agents|mesh-ancestor
24444599|NCT00298571|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24444600|NCT00298571|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24444601|NCT00298571|Autonomic Agents|autonomic agents|mesh-ancestor
24444602|NCT00298571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24444603|NCT00298571|Respiratory System Agents|respiratory system agents|mesh-ancestor
24444604|NCT00298571|Mydriatics|mydriatics|mesh-ancestor
24444605|NCT00298571|Sympathomimetics|sympathomimetics|mesh-ancestor
24444606|NCT00298571|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24444607|NCT00298597|Epoetin Alfa|epoetin alfa|mesh-list
24444620|NCT00298636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444622|NCT00298662|Interferon-beta|interferon-beta|mesh-list
24444623|NCT00298662|Tacrolimus|tacrolimus|mesh-list
24444624|NCT00298662|Interferon beta-1b|interferon beta-1b|mesh-list
25207779|NCT03391193|Immunologic Factors|immunologic factors|mesh-ancestor
24982875|NCT00379288|Autonomic Agents|autonomic agents|mesh-ancestor
24982876|NCT00379288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24580564|NCT00862329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580565|NCT00862342|Bevacizumab|bevacizumab|mesh-list
24580567|NCT00862342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24580681|NCT00863161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982877|NCT00379288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982878|NCT00379288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24982879|NCT00379288|Respiratory System Agents|respiratory system agents|mesh-ancestor
25830484|NCT00006390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830485|NCT00006390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830486|NCT00006390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25830487|NCT00006390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25830488|NCT00006391|Oxaliplatin|oxaliplatin|mesh-list
25830489|NCT00006391|Topotecan|topotecan|mesh-list
25830490|NCT00006391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830491|NCT00006391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25830492|NCT00006391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25830493|NCT00006391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830494|NCT00006391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830495|NCT00006394|Hormones|hormones|mesh-list
24982890|NCT00379288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24982891|NCT00379288|Sympathomimetics|sympathomimetics|mesh-ancestor
25106542|NCT02574910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24982907|NCT00338260|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24982936|NCT00157963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982937|NCT00157963|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24982991|NCT00092625|Ezetimibe|ezetimibe|mesh-list
24982992|NCT00092625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24982993|NCT00092625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24982994|NCT00092625|Antimetabolites|antimetabolites|mesh-ancestor
25169551|NCT01818921|Growth Inhibitors|growth inhibitors|mesh-ancestor
24982995|NCT00092625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982996|NCT00092625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24982997|NCT00092612|Ezetimibe|ezetimibe|mesh-list
24982998|NCT00092612|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24982999|NCT00092612|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24983000|NCT00092612|Antimetabolites|antimetabolites|mesh-ancestor
24983001|NCT00092612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983002|NCT00092612|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24983003|NCT00092599|Ezetimibe|ezetimibe|mesh-list
24983004|NCT00092599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24983005|NCT00092599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24983006|NCT00092599|Antimetabolites|antimetabolites|mesh-ancestor
24983008|NCT00092599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24784418|NCT01907984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24784419|NCT01907984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24784420|NCT01907984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784421|NCT01907984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24784422|NCT01907984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24784423|NCT01907984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24784424|NCT01907984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25106526|NCT02586831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25106527|NCT02586831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657520|NCT01587027|Natriuretic Agents|natriuretic agents|mesh-ancestor
25657521|NCT01587079|Tiotropium Bromide|tiotropium bromide|mesh-list
25657522|NCT01587079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25657523|NCT01587079|Autonomic Agents|autonomic agents|mesh-ancestor
25657524|NCT01587079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25657525|NCT01587079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657526|NCT01587079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25657527|NCT01587079|Respiratory System Agents|respiratory system agents|mesh-ancestor
25657528|NCT01587079|Parasympatholytics|parasympatholytics|mesh-ancestor
25657529|NCT01587079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25657530|NCT01587079|Cholinergic Agents|cholinergic agents|mesh-ancestor
25657531|NCT01587079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25657532|NCT01587079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657533|NCT01587118|Asenapine|asenapine|mesh-list
25657534|NCT01587118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25657535|NCT01587118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25657536|NCT01587118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25657537|NCT01587118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657538|NCT01587118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24580902|NCT00864006|Anticonvulsants|anticonvulsants|mesh-ancestor
24580903|NCT00864006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580905|NCT00864006|GABA Agents|gaba agents|mesh-ancestor
24580924|NCT00864045|Antiemetics|antiemetics|mesh-ancestor
24580925|NCT00864045|Autonomic Agents|autonomic agents|mesh-ancestor
25106528|NCT02586831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25106529|NCT02586831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25830496|NCT00006394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25830497|NCT00006394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830498|NCT00006396|Zidovudine|zidovudine|mesh-list
25830499|NCT00006396|Nevirapine|nevirapine|mesh-list
25830500|NCT00006396|Antimetabolites|antimetabolites|mesh-ancestor
25830501|NCT00006396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830502|NCT00006396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25106538|NCT02586831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25106539|NCT02574910|Abiraterone Acetate|abiraterone acetate|mesh-list
25106540|NCT02574910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106541|NCT02574910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24983027|NCT00092560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983029|NCT00092209|Losartan|losartan|mesh-list
24983030|NCT00092209|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24983031|NCT00092209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24983032|NCT00092209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24983055|NCT00090298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983056|NCT00090298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24983057|NCT00090298|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24983058|NCT00090298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24983059|NCT00090181|Diclofenac|diclofenac|mesh-list
24983060|NCT00090181|Etoricoxib|etoricoxib|mesh-list
24983061|NCT00090181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24983062|NCT00090181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24983063|NCT00090181|Analgesics|analgesics|mesh-ancestor
24983098|NCT02765854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25129953|NCT03036995|Apremilast|apremilast|mesh-list
24983099|NCT02765854|Immunologic Factors|immunologic factors|mesh-ancestor
24983100|NCT02765854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24983101|NCT02765854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24983102|NCT02765854|Growth Substances|growth substances|mesh-ancestor
24983103|NCT02765854|Growth Inhibitors|growth inhibitors|mesh-ancestor
24983104|NCT02765854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983105|NCT02765854|Protease Inhibitors|protease inhibitors|mesh-ancestor
24983106|NCT02765854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24983128|NCT02207504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24983129|NCT02207504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24983130|NCT02207504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24983131|NCT02207504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983137|NCT02118610|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
24983138|NCT02118610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24795824|NCT01946373|Immunologic Factors|immunologic factors|mesh-ancestor
24795825|NCT01946373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795826|NCT01946373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24795827|NCT01946373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24795828|NCT01946373|Alkylating Agents|alkylating agents|mesh-ancestor
24795829|NCT01946373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795830|NCT01946373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795831|NCT01946373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24795833|NCT01946373|Antimetabolites|antimetabolites|mesh-ancestor
24795834|NCT01946373|Antiviral Agents|antiviral agents|mesh-ancestor
25129982|NCT03037073|Analgesics|analgesics|mesh-ancestor
24444760|NCT00299039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24444761|NCT00299039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24444762|NCT00299039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24444763|NCT00299039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657539|NCT01587274|Acetaminophen|acetaminophen|mesh-list
25657540|NCT01587274|Naproxen|naproxen|mesh-list
25657541|NCT01587274|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25657542|NCT01587274|Oxycodone|oxycodone|mesh-list
25657543|NCT01587274|Cyclobenzaprine|cyclobenzaprine|mesh-list
24444764|NCT00299039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444765|NCT00299039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25657544|NCT01587274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25657545|NCT01587274|Analgesics|analgesics|mesh-ancestor
25657546|NCT01587274|Sensory System Agents|sensory system agents|mesh-ancestor
25657547|NCT01587274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25657548|NCT01587274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581244|NCT00864799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581246|NCT00864799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24581247|NCT00864799|Oxytocics|oxytocics|mesh-ancestor
24983166|NCT02083250|Antimetabolites|antimetabolites|mesh-ancestor
24983194|NCT01857934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24983195|NCT01857934|Immunologic Factors|immunologic factors|mesh-ancestor
24983196|NCT01857934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621242|NCT01061112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25106545|NCT02574910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24621243|NCT01061112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24621244|NCT01061190|Propranolol|propranolol|mesh-list
24621245|NCT01061190|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24621246|NCT01061190|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25830503|NCT00006396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24621271|NCT01061372|Pregabalin|pregabalin|mesh-list
24621272|NCT01061372|Analgesics|analgesics|mesh-ancestor
24621273|NCT01061372|Sensory System Agents|sensory system agents|mesh-ancestor
24621274|NCT01061372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24621275|NCT01061372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621276|NCT01061372|Anticonvulsants|anticonvulsants|mesh-ancestor
24621277|NCT01061372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24621278|NCT01061372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24621279|NCT01061372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621280|NCT01061372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24621281|NCT01061372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24621282|NCT01061372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24784430|NCT01907984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784431|NCT01907984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25830504|NCT00006396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830505|NCT00006396|Antiviral Agents|antiviral agents|mesh-ancestor
25830506|NCT00006396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25830507|NCT00006396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25830508|NCT00006396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24784432|NCT01907984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24784433|NCT01907984|Analgesics|analgesics|mesh-ancestor
24784440|NCT01907997|Lidocaine|lidocaine|mesh-list
25106546|NCT02574910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106547|NCT02574910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25106548|NCT02518139|Tiotropium Bromide|tiotropium bromide|mesh-list
25106549|NCT02518139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25106550|NCT02518139|Autonomic Agents|autonomic agents|mesh-ancestor
25106551|NCT02518139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25106552|NCT02518139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106553|NCT02518139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25106554|NCT02518139|Respiratory System Agents|respiratory system agents|mesh-ancestor
25106555|NCT02518139|Parasympatholytics|parasympatholytics|mesh-ancestor
25106556|NCT02518139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25106557|NCT02518139|Cholinergic Agents|cholinergic agents|mesh-ancestor
25106558|NCT02518139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25106559|NCT02518139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106560|NCT02383251|Paclitaxel|paclitaxel|mesh-list
25106561|NCT02383251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25830509|NCT00006396|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24983215|NCT01857934|Sensory System Agents|sensory system agents|mesh-ancestor
24983216|NCT01857934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24983217|NCT01857934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25130087|NCT03036644|Nicotine|nicotine|mesh-list
24983218|NCT01857934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24983223|NCT01857934|Dermatologic Agents|dermatologic agents|mesh-ancestor
24983224|NCT01841177|Milrinone|milrinone|mesh-list
24983225|NCT01841177|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24983226|NCT01841177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24983227|NCT01841177|Vasodilator Agents|vasodilator agents|mesh-ancestor
24983228|NCT01841177|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24983229|NCT01841177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24983230|NCT01841177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24983231|NCT01841177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657549|NCT01587274|Antipyretics|antipyretics|mesh-ancestor
25657550|NCT01587274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25657551|NCT01587274|Narcotics|narcotics|mesh-ancestor
25657552|NCT01587274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25657553|NCT01587274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24983232|NCT01841177|Protective Agents|protective agents|mesh-ancestor
24983270|NCT01512888|Alkylating Agents|alkylating agents|mesh-ancestor
24983271|NCT01512888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983272|NCT01512888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24983273|NCT01512888|Immunologic Factors|immunologic factors|mesh-ancestor
24983274|NCT01512888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983275|NCT01512888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24983276|NCT01512888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24983277|NCT01512888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24983278|NCT01453946|Budesonide|budesonide|mesh-list
24983279|NCT01453946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24983280|NCT01453946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24983281|NCT01453946|Autonomic Agents|autonomic agents|mesh-ancestor
24983282|NCT01453946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24983283|NCT01453946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830510|NCT00006396|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24983319|NCT00637832|Prednisolone|prednisolone|mesh-list
24983340|NCT00637832|Tubulin Modulators|tubulin modulators|mesh-ancestor
24983341|NCT00637832|Antimitotic Agents|antimitotic agents|mesh-ancestor
24983342|NCT00637832|Mitosis Modulators|mitosis modulators|mesh-ancestor
24983343|NCT00637832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24983344|NCT00637832|Glucocorticoids|glucocorticoids|mesh-ancestor
24983345|NCT00637832|Hormones|hormones|mesh-ancestor
24983346|NCT00637832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24983347|NCT00637832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24983348|NCT00392327|Vitamin A|vitamin a|mesh-list
25130128|NCT03036202|Mydriatics|mydriatics|mesh-ancestor
24983349|NCT00392327|Cyclophosphamide|cyclophosphamide|mesh-list
24983350|NCT00392327|Cisplatin|cisplatin|mesh-list
24983351|NCT00392327|Carboplatin|carboplatin|mesh-list
24983352|NCT00392327|Vincristine|vincristine|mesh-list
24983353|NCT00392327|Tretinoin|tretinoin|mesh-list
24983354|NCT00392327|Isotretinoin|isotretinoin|mesh-list
24983355|NCT00392327|Lenograstim|lenograstim|mesh-list
24983356|NCT00392327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24983357|NCT00392327|Immunologic Factors|immunologic factors|mesh-ancestor
25162487|NCT02904369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24983358|NCT00392327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983359|NCT00392327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24983360|NCT00392327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24983361|NCT00392327|Alkylating Agents|alkylating agents|mesh-ancestor
24983362|NCT00392327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784482|NCT01908283|Immunologic Factors|immunologic factors|mesh-ancestor
24784483|NCT01908283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784484|NCT01908296|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24784485|NCT01908296|Fluvoxamine|fluvoxamine|mesh-list
24784486|NCT01908296|Antidepressive Agents|antidepressive agents|mesh-ancestor
24784487|NCT01908296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24784488|NCT01908296|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24784489|NCT01908296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24784490|NCT01908296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24784491|NCT01908296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784492|NCT01908296|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24784493|NCT01908296|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24784494|NCT01908296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24983363|NCT00392327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106601|NCT02245672|Adrenergic Agents|adrenergic agents|mesh-ancestor
25830511|NCT00006397|Ritonavir|ritonavir|mesh-list
25106602|NCT02245672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25106603|NCT02245672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830512|NCT00006397|Indinavir|indinavir|mesh-list
25830513|NCT00006397|Stavudine|stavudine|mesh-list
24794070|NCT05414058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25830514|NCT00006397|Didanosine|didanosine|mesh-list
25830515|NCT00006397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25830516|NCT00006397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25830517|NCT00006397|Protease Inhibitors|protease inhibitors|mesh-ancestor
25830518|NCT00006397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830519|NCT00006397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830520|NCT00006397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25830521|NCT00006397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25830522|NCT00006397|Antiviral Agents|antiviral agents|mesh-ancestor
25830523|NCT00006397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25830524|NCT00006397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25162488|NCT02904369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25830526|NCT00006397|Antimetabolites|antimetabolites|mesh-ancestor
24983399|NCT00085202|Cyclophosphamide|cyclophosphamide|mesh-list
24983401|NCT00085202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24983402|NCT00085202|Immunologic Factors|immunologic factors|mesh-ancestor
24983403|NCT00085202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983404|NCT00085202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25830527|NCT00006397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25830528|NCT00006397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25830529|NCT00006398|Timolol|timolol|mesh-list
25830530|NCT00006398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25830531|NCT00006398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25830532|NCT00006398|Adrenergic Agents|adrenergic agents|mesh-ancestor
25830533|NCT00006398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25830534|NCT00006398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830535|NCT00006398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983405|NCT00085202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24983406|NCT00085202|Alkylating Agents|alkylating agents|mesh-ancestor
24983407|NCT00085202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162489|NCT02904369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25162490|NCT02904369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983408|NCT00085202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169552|NCT01818921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830536|NCT00006398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25830537|NCT00006398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25830538|NCT00006399|Donepezil|donepezil|mesh-list
25830539|NCT00006399|Progesterone|progesterone|mesh-list
25830540|NCT00006399|Estrogens|estrogens|mesh-list
25830541|NCT00006399|Progestins|progestins|mesh-ancestor
25830542|NCT00006399|Hormones|hormones|mesh-ancestor
25830543|NCT00006399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25830544|NCT00006399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830545|NCT00006399|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25830546|NCT00006399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830547|NCT00006399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830548|NCT00006399|Cholinergic Agents|cholinergic agents|mesh-ancestor
25830549|NCT00006399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24983520|NCT05185284|Antimetabolites|antimetabolites|mesh-ancestor
24983521|NCT05185284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983522|NCT05185284|Antiviral Agents|antiviral agents|mesh-ancestor
24983523|NCT05185284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24983524|NCT05184803|Docetaxel|docetaxel|mesh-list
24983525|NCT05184803|Oxaliplatin|oxaliplatin|mesh-list
24983526|NCT05184803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830550|NCT00006399|Nootropic Agents|nootropic agents|mesh-ancestor
25830551|NCT00006401|Nitric Oxide|nitric oxide|mesh-list
25830552|NCT00006401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25830553|NCT00006401|Autonomic Agents|autonomic agents|mesh-ancestor
25830554|NCT00006401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25830555|NCT00006401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830556|NCT00006401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25162499|NCT02904304|Analgesics|analgesics|mesh-ancestor
25830557|NCT00006401|Respiratory System Agents|respiratory system agents|mesh-ancestor
25830558|NCT00006401|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25830559|NCT00006401|Antioxidants|antioxidants|mesh-ancestor
24983527|NCT05184803|Tubulin Modulators|tubulin modulators|mesh-ancestor
24983539|NCT05184517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830560|NCT00006401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830561|NCT00006401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25830562|NCT00006401|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25830563|NCT00006401|Vasodilator Agents|vasodilator agents|mesh-ancestor
24983567|NCT05184179|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24983568|NCT05184179|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25830564|NCT00006401|Gasotransmitters|gasotransmitters|mesh-ancestor
25830565|NCT00006401|Protective Agents|protective agents|mesh-ancestor
25830566|NCT00006412|Fenofibrate|fenofibrate|mesh-list
24444854|NCT00299364|Anabolic Agents|anabolic agents|mesh-ancestor
25830567|NCT00006412|Pravastatin|pravastatin|mesh-list
25830568|NCT00006412|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24983570|NCT05184101|Calcium heparin|calcium heparin|mesh-list
25830569|NCT00006412|Antimetabolites|antimetabolites|mesh-ancestor
24983571|NCT05184101|Anticoagulants|anticoagulants|mesh-ancestor
24983572|NCT05184101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24983573|NCT05184101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24983574|NCT05184101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983576|NCT05184049|Epalrestat|epalrestat|mesh-list
24983577|NCT05184049|Vitamin B Complex|vitamin b complex|mesh-ancestor
24983578|NCT05184049|Vitamins|vitamins|mesh-ancestor
24983579|NCT05184049|Micronutrients|micronutrients|mesh-ancestor
25830570|NCT00006412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830571|NCT00006412|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25830572|NCT00006412|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25830573|NCT00006412|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25830574|NCT00006412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830575|NCT00006427|Amitriptyline|amitriptyline|mesh-list
25830576|NCT00006427|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25830577|NCT00006427|Antidepressive Agents|antidepressive agents|mesh-ancestor
25830578|NCT00006427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25830579|NCT00006427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25830580|NCT00006427|Analgesics|analgesics|mesh-ancestor
25830581|NCT00006427|Sensory System Agents|sensory system agents|mesh-ancestor
25830582|NCT00006427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25830583|NCT00006427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830584|NCT00006427|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25830585|NCT00006427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25830586|NCT00006427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25830587|NCT00006427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830588|NCT00006427|Adrenergic Agents|adrenergic agents|mesh-ancestor
25830589|NCT00006427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25830590|NCT00006428|Amitriptyline|amitriptyline|mesh-list
25830591|NCT00006428|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25830592|NCT00006428|Antidepressive Agents|antidepressive agents|mesh-ancestor
25830593|NCT00006428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25830594|NCT00006428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25830595|NCT00006428|Analgesics|analgesics|mesh-ancestor
25830596|NCT00006428|Sensory System Agents|sensory system agents|mesh-ancestor
25830597|NCT00006428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25830598|NCT00006428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830599|NCT00006428|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25830600|NCT00006428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24847319|NCT02246049|Antidotes|antidotes|mesh-ancestor
25830601|NCT00006428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25830602|NCT00006428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445002|NCT00299936|Antiviral Agents|antiviral agents|mesh-ancestor
24445003|NCT00299936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24445004|NCT00299962|Interferons|interferons|mesh-list
24445005|NCT00299962|Interferon-beta|interferon-beta|mesh-list
24445006|NCT00299962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445007|NCT00299962|Antiviral Agents|antiviral agents|mesh-ancestor
24445008|NCT00299962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24445009|NCT00299962|Immunologic Factors|immunologic factors|mesh-ancestor
24445010|NCT00299962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445011|NCT00300014|Triamcinolone|triamcinolone|mesh-list
24445023|NCT00300040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24795896|NCT01946594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24795897|NCT01946594|Analgesics|analgesics|mesh-ancestor
24795898|NCT01946594|Sensory System Agents|sensory system agents|mesh-ancestor
24795899|NCT01946594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24795900|NCT01946594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795901|NCT01946594|Antipyretics|antipyretics|mesh-ancestor
24795903|NCT01946607|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24983628|NCT05183334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25657554|NCT01587274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24983655|NCT05182385|Venetoclax|venetoclax|mesh-list
24983656|NCT05182385|Blinatumomab|blinatumomab|mesh-list
24983657|NCT05182385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25657555|NCT01587274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25657556|NCT01587274|Gout Suppressants|gout suppressants|mesh-ancestor
25657557|NCT01587274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25657558|NCT01587274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657559|NCT01587274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657560|NCT01587274|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24951333|NCT03905759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24951334|NCT03905759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24582648|NCT00870961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24582649|NCT00870961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582650|NCT00870961|Vitamins|vitamins|mesh-ancestor
24582651|NCT00870961|Micronutrients|micronutrients|mesh-ancestor
24582652|NCT00870961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24582653|NCT00870987|Vaccines|vaccines|mesh-list
24983659|NCT05182138|Trace Elements|trace elements|mesh-ancestor
24983660|NCT05182138|Micronutrients|micronutrients|mesh-ancestor
24983661|NCT05182138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445024|NCT00300040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445025|NCT00300040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24445026|NCT00300040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24445027|NCT00300040|Blood Substitutes|blood substitutes|mesh-ancestor
24445028|NCT00300079|Brinzolamide|brinzolamide|mesh-list
24445029|NCT00300079|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24445030|NCT00300079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445031|NCT00300079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445032|NCT00300118|Budesonide|budesonide|mesh-list
24445033|NCT00300118|Mesalamine|mesalamine|mesh-list
24445034|NCT00300118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24983663|NCT05182112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24983664|NCT05182112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24983665|NCT05182112|Antimetabolites|antimetabolites|mesh-ancestor
24983666|NCT05182112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983667|NCT05182112|Antiviral Agents|antiviral agents|mesh-ancestor
24983668|NCT05182112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24983669|NCT05182112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24983670|NCT05182112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24983671|NCT05182112|Immunologic Factors|immunologic factors|mesh-ancestor
24983672|NCT05182112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983673|NCT05181969|Dextrans|dextrans|mesh-list
24983674|NCT05181969|Anticoagulants|anticoagulants|mesh-ancestor
24983675|NCT05181969|Plasma Substitutes|plasma substitutes|mesh-ancestor
24983676|NCT05181969|Blood Substitutes|blood substitutes|mesh-ancestor
24983677|NCT05180292|Carvedilol|carvedilol|mesh-list
24983678|NCT05180292|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24983679|NCT05180292|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24983680|NCT05180292|Adrenergic Agents|adrenergic agents|mesh-ancestor
24983681|NCT05180292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25830603|NCT00006428|Adrenergic Agents|adrenergic agents|mesh-ancestor
25830604|NCT00006428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24445137|NCT00300508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445139|NCT00300560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24445140|NCT00300560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24445141|NCT00300573|Dexelvucitabine|dexelvucitabine|mesh-list
24445142|NCT00300573|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24445143|NCT00300573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25830605|NCT00006441|Lamivudine|lamivudine|mesh-list
24445271|NCT00301054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24445272|NCT00301054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24445273|NCT00301054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25830606|NCT00006441|Zidovudine|zidovudine|mesh-list
24445388|NCT00301483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24445390|NCT00301483|Analgesics|analgesics|mesh-ancestor
24445391|NCT00301483|Sensory System Agents|sensory system agents|mesh-ancestor
24445392|NCT00301483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24445393|NCT00301483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445394|NCT00301483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24445395|NCT00301483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24445396|NCT00301483|Blood Substitutes|blood substitutes|mesh-ancestor
24445397|NCT00301509|Ribavirin|ribavirin|mesh-list
24445398|NCT00301509|Antimetabolites|antimetabolites|mesh-ancestor
24445399|NCT00301509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445478|NCT00301639|Methylphenidate|methylphenidate|mesh-list
25657561|NCT01587274|Antidepressive Agents|antidepressive agents|mesh-ancestor
25657562|NCT01587274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25657563|NCT01587274|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25657564|NCT01587274|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25657565|NCT01587274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25657566|NCT01587651|Ticagrelor|ticagrelor|mesh-list
25657567|NCT01587651|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25657568|NCT01587651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25657569|NCT01587651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24445480|NCT00301639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445481|NCT00301639|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24445482|NCT00301639|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24445483|NCT00301639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24784509|NCT01908335|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25106629|NCT01959633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106631|NCT01936688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24445484|NCT00301639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445486|NCT00301639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24445487|NCT00301652|Mycophenolic Acid|mycophenolic acid|mesh-list
24445488|NCT00301652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24445489|NCT00301652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445490|NCT00301652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24445491|NCT00301652|Antitubercular Agents|antitubercular agents|mesh-ancestor
24445492|NCT00301652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24983702|NCT05177939|gamma-Globulins|gamma-globulins|mesh-list
24445497|NCT00301665|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24445498|NCT00301665|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24445499|NCT00301665|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24445500|NCT00301665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24445501|NCT00301665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445502|NCT00301665|Cholinergic Agents|cholinergic agents|mesh-ancestor
24445503|NCT00301665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24445514|NCT00301730|Mitosis Modulators|mitosis modulators|mesh-ancestor
24445515|NCT00301730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106632|NCT01936688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25106633|NCT01936688|Analgesics|analgesics|mesh-ancestor
25106634|NCT01936688|Sensory System Agents|sensory system agents|mesh-ancestor
25106635|NCT01936688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25106636|NCT01936688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106637|NCT01936688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25106638|NCT01936688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25106639|NCT01936688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24483853|NCT00445497|Amoxicillin|amoxicillin|mesh-list
24445519|NCT00301730|Antiviral Agents|antiviral agents|mesh-ancestor
24445520|NCT00301730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24445523|NCT00301782|Vincristine|vincristine|mesh-list
24445524|NCT00301782|Bleomycin|bleomycin|mesh-list
24445525|NCT00301782|Etoposide phosphate|etoposide phosphate|mesh-list
24445562|NCT00301860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445563|NCT00301860|Dermatologic Agents|dermatologic agents|mesh-ancestor
24445564|NCT00301860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445565|NCT00301860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24445566|NCT00301860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24445567|NCT00301860|Immunologic Factors|immunologic factors|mesh-ancestor
24445568|NCT00301860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24445569|NCT00301860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24445570|NCT00301860|Antifungal Agents|antifungal agents|mesh-ancestor
24445571|NCT00301860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24445572|NCT00301860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24445573|NCT00301860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24445574|NCT00301860|Alkylating Agents|alkylating agents|mesh-ancestor
24445575|NCT00301860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24445578|NCT00301886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25106660|NCT00799396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25106661|NCT00799396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25106663|NCT00799396|Sensory System Agents|sensory system agents|mesh-ancestor
25106664|NCT00799396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25106665|NCT00799396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106666|NCT00799396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25106667|NCT00799396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25106668|NCT00799396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25106669|NCT00799396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25106670|NCT00799396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106671|NCT00799396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24445722|NCT00302354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445725|NCT00302367|Methylphenidate|methylphenidate|mesh-list
25106679|NCT00799396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25106680|NCT00069238|Prednisone|prednisone|mesh-list
25106681|NCT00069238|Cyclophosphamide|cyclophosphamide|mesh-list
24583140|NCT00873483|Femovan|femovan|mesh-list
25830607|NCT00006441|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25830608|NCT00006441|Aldesleukin|aldesleukin|mesh-list
25830609|NCT00006441|Nelfinavir|nelfinavir|mesh-list
25106687|NCT00069238|Immunologic Factors|immunologic factors|mesh-ancestor
25106688|NCT00069238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106689|NCT00069238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24983697|NCT05177939|Prednisolone acetate|prednisolone acetate|mesh-list
24983698|NCT05177939|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24983699|NCT05177939|Prednisolone phosphate|prednisolone phosphate|mesh-list
24983700|NCT05177939|Immunoglobulins|immunoglobulins|mesh-list
24983701|NCT05177939|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25130873|NCT03030703|Inositol|inositol|mesh-list
24847504|NCT02247414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24983771|NCT05163535|Elsulfavirine|elsulfavirine|mesh-list
24983772|NCT05163535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24983773|NCT05163535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24983774|NCT05163535|Antiviral Agents|antiviral agents|mesh-ancestor
24983775|NCT05163535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24983776|NCT05162573|177Lu-PSMA-617|177lu-psma-617|mesh-list
24983777|NCT05162573|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24983778|NCT05162573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983781|NCT05158608|Cyclophosphamide|cyclophosphamide|mesh-list
24983782|NCT05158608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24983783|NCT05158608|Immunologic Factors|immunologic factors|mesh-ancestor
24983784|NCT05158608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983785|NCT05158608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24983786|NCT05158608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24983787|NCT05158608|Alkylating Agents|alkylating agents|mesh-ancestor
24983788|NCT05158608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983792|NCT05153772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25830610|NCT00006441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24847511|NCT02247414|Antipyretics|antipyretics|mesh-ancestor
24983798|NCT05150782|Ascorbic Acid|ascorbic acid|mesh-list
24983799|NCT05150782|Curcumin|curcumin|mesh-list
24983800|NCT05150782|Antioxidants|antioxidants|mesh-ancestor
24983801|NCT05150782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983802|NCT05150782|Protective Agents|protective agents|mesh-ancestor
24983803|NCT05150782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921668|NCT04188249|Golimumab|golimumab|mesh-list
24983804|NCT05150782|Vitamins|vitamins|mesh-ancestor
24983805|NCT05150782|Micronutrients|micronutrients|mesh-ancestor
24983806|NCT05150782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24983811|NCT05150782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24983812|NCT05150782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24983813|NCT05150782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445879|NCT00302822|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24445881|NCT00302835|Sensory System Agents|sensory system agents|mesh-ancestor
24445882|NCT00302835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24445883|NCT00302835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445884|NCT00302913|Clopidogrel|clopidogrel|mesh-list
24983818|NCT05146674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24983819|NCT05146674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24983820|NCT05146674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983821|NCT05146674|Urological Agents|urological agents|mesh-ancestor
24983822|NCT05146635|Epirubicin|epirubicin|mesh-list
24983823|NCT05146635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24983824|NCT05146635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830611|NCT00006441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25830612|NCT00006441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830613|NCT00006441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830614|NCT00006441|Antiviral Agents|antiviral agents|mesh-ancestor
25162498|NCT02904304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25041281|NCT02589275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25176986|NCT05378191|Vaccines|vaccines|mesh-list
25041283|NCT02588677|Anticonvulsants|anticonvulsants|mesh-ancestor
25041284|NCT02588677|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25041285|NCT02588677|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25830615|NCT00006441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25830616|NCT00006441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24795904|NCT01946607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25830617|NCT00006441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25830618|NCT00006441|Antimetabolites|antimetabolites|mesh-ancestor
25830619|NCT00006441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162493|NCT02904304|Ibuprofen|ibuprofen|mesh-list
25830620|NCT00006441|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24795905|NCT01946607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24795906|NCT01946607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589282|NCT00906451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24589283|NCT00906451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589285|NCT00906516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24589286|NCT00906516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589287|NCT00906516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24589288|NCT00906516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24589289|NCT00906516|Growth Substances|growth substances|mesh-ancestor
25830621|NCT00006441|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25830622|NCT00006441|Protease Inhibitors|protease inhibitors|mesh-ancestor
25830623|NCT00006443|Lamivudine|lamivudine|mesh-list
25830624|NCT00006443|Stavudine|stavudine|mesh-list
25830625|NCT00006443|Nelfinavir|nelfinavir|mesh-list
24589290|NCT00906516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589291|NCT00906516|Growth Inhibitors|growth inhibitors|mesh-ancestor
24795908|NCT01946607|Serotonin Agents|serotonin agents|mesh-ancestor
24795909|NCT01946607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795910|NCT01946607|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24795911|NCT01946607|Antidepressive Agents|antidepressive agents|mesh-ancestor
24795912|NCT01946607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24795913|NCT01946620|Formoterol Fumarate|formoterol fumarate|mesh-list
24795914|NCT01946620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24795915|NCT01946620|Autonomic Agents|autonomic agents|mesh-ancestor
24795916|NCT01946620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25131151|NCT03028532|Clomiphene|clomiphene|mesh-list
25830626|NCT00006443|Indinavir|indinavir|mesh-list
25830627|NCT00006443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25830628|NCT00006443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24983866|NCT05119075|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24983867|NCT05119075|Sympathomimetics|sympathomimetics|mesh-ancestor
24983868|NCT05119075|Autonomic Agents|autonomic agents|mesh-ancestor
25830629|NCT00006443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830630|NCT00006443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830631|NCT00006443|Antiviral Agents|antiviral agents|mesh-ancestor
25830632|NCT00006443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24983869|NCT05119075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24983870|NCT05119075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983871|NCT05119075|Dopamine Agents|dopamine agents|mesh-ancestor
24983872|NCT05119075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24983873|NCT05119075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983874|NCT05119075|Protective Agents|protective agents|mesh-ancestor
24983875|NCT05111262|Budesonide|budesonide|mesh-list
24983876|NCT05111262|Formoterol Fumarate|formoterol fumarate|mesh-list
24983877|NCT05111262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24983878|NCT05111262|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24983879|NCT05111262|Autonomic Agents|autonomic agents|mesh-ancestor
24983880|NCT05111262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24983881|NCT05111262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983894|NCT05099107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24983895|NCT05099107|Autonomic Agents|autonomic agents|mesh-ancestor
24983896|NCT05099107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24983897|NCT05099107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784555|NCT01908556|Hormone Antagonists|hormone antagonists|mesh-ancestor
24446152|NCT00303836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446153|NCT00303836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24446154|NCT00303836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24446155|NCT00303836|Antimetabolites|antimetabolites|mesh-ancestor
24446156|NCT00303836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24446157|NCT00303836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25169553|NCT01818076|Botulinum Toxins|botulinum toxins|mesh-list
25162507|NCT02904304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999636|NCT03671811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24808331|NCT02026518|Vitamins|vitamins|mesh-ancestor
24808332|NCT02026518|Micronutrients|micronutrients|mesh-ancestor
24808333|NCT02026518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808334|NCT02026518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24808335|NCT02026518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24784573|NCT01908894|Insulin Lispro|insulin lispro|mesh-list
24784574|NCT01908894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24784575|NCT01908894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784576|NCT01909037|Curcumin|curcumin|mesh-list
25404143|NCT03682068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25830633|NCT00006443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25830634|NCT00006443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24633079|NCT01127100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633080|NCT01127100|Antimanic Agents|antimanic agents|mesh-ancestor
24633082|NCT01127178|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25830635|NCT00006443|Antimetabolites|antimetabolites|mesh-ancestor
24583935|NCT00877591|Leprostatic Agents|leprostatic agents|mesh-ancestor
24583936|NCT00877591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24784577|NCT01909037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24784578|NCT01909037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24784579|NCT01909037|Analgesics|analgesics|mesh-ancestor
24784580|NCT01909037|Sensory System Agents|sensory system agents|mesh-ancestor
24784581|NCT01909037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24784582|NCT01909037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784583|NCT01909037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24784584|NCT01909037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24784585|NCT01909037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784586|NCT01909037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131330|NCT03026946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24983933|NCT05064488|Protective Agents|protective agents|mesh-ancestor
24784587|NCT01909037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784588|NCT01909063|Vitamin D|vitamin d|mesh-list
24784589|NCT01909063|Ergocalciferols|ergocalciferols|mesh-list
25106690|NCT00069238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25106691|NCT00069238|Alkylating Agents|alkylating agents|mesh-ancestor
25106692|NCT00069238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784590|NCT01909063|Cholecalciferol|cholecalciferol|mesh-list
24784591|NCT01909063|Vitamins|vitamins|mesh-list
25106693|NCT00069238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106694|NCT00069238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25106695|NCT00069238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25106696|NCT00069238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25106697|NCT00069238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25106698|NCT00069238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25106717|NCT03145467|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25106718|NCT03145467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25106719|NCT03145467|Serotonin Agents|serotonin agents|mesh-ancestor
25106720|NCT03145467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25106721|NCT03145467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106722|NCT03145584|Bupivacaine|bupivacaine|mesh-list
25106723|NCT03145584|Anesthetics, Local|anesthetics, local|mesh-ancestor
25106724|NCT03145584|Anesthetics|anesthetics|mesh-ancestor
25106725|NCT03145584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24983898|NCT05099107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24983899|NCT05099107|Respiratory System Agents|respiratory system agents|mesh-ancestor
24983900|NCT05099107|Tocolytic Agents|tocolytic agents|mesh-ancestor
25162512|NCT02904304|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25162514|NCT02904304|Respiratory System Agents|respiratory system agents|mesh-ancestor
25162515|NCT02904304|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24983907|NCT05099107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983925|NCT05064488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24983926|NCT05064488|Antimetabolites|antimetabolites|mesh-ancestor
24983927|NCT05064488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983928|NCT05064488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24983929|NCT05064488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24983930|NCT05064488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24983931|NCT05064488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24983932|NCT05064488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24983935|NCT05064488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24983937|NCT05064488|Serotonin Agents|serotonin agents|mesh-ancestor
24983938|NCT05064488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24983939|NCT05061524|Omalizumab|omalizumab|mesh-list
24983940|NCT05061524|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24983941|NCT05061524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25657570|NCT01587651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25657571|NCT01587651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25657572|NCT01587651|Purinergic Agents|purinergic agents|mesh-ancestor
25657573|NCT01587651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25657574|NCT01587651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657575|NCT01587651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657576|NCT01587885|Omeprazole|omeprazole|mesh-list
25657577|NCT01587885|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24584044|NCT00878306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24584045|NCT00878306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24584046|NCT00878306|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24584047|NCT00878306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24584048|NCT00878306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24584051|NCT00878345|Pentobarbital|pentobarbital|mesh-list
25830636|NCT00006443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25830637|NCT00006443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25830638|NCT00006443|Protease Inhibitors|protease inhibitors|mesh-ancestor
25875279|NCT04558918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446250|NCT00304226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24446251|NCT00304226|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24446252|NCT00304226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24446268|NCT00304252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446269|NCT00304252|Immunologic Factors|immunologic factors|mesh-ancestor
24446270|NCT00304252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446271|NCT00304252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24446272|NCT00304291|Mitoxantrone|mitoxantrone|mesh-list
24446273|NCT00304291|Analgesics|analgesics|mesh-ancestor
24446274|NCT00304291|Sensory System Agents|sensory system agents|mesh-ancestor
24446275|NCT00304291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24446276|NCT00304291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446277|NCT00304291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446278|NCT00304291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25875280|NCT04548752|Pembrolizumab|pembrolizumab|mesh-list
25875281|NCT04548752|Olaparib|olaparib|mesh-list
25875282|NCT04548752|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25875283|NCT04548752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25875284|NCT04548752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24983984|NCT04952389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24795947|NCT01946984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24795948|NCT01946984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24795949|NCT01946984|Analgesics|analgesics|mesh-ancestor
24795950|NCT01946984|Sensory System Agents|sensory system agents|mesh-ancestor
24795951|NCT01946984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24795952|NCT01946984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162516|NCT02904304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24795959|NCT01947010|Immunologic Factors|immunologic factors|mesh-ancestor
24795960|NCT01947010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984004|NCT04905173|Vasodilator Agents|vasodilator agents|mesh-ancestor
24984005|NCT04889599|Docetaxel|docetaxel|mesh-list
24984006|NCT04889599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24984007|NCT04889599|Tubulin Modulators|tubulin modulators|mesh-ancestor
24984008|NCT04889599|Antimitotic Agents|antimitotic agents|mesh-ancestor
24984009|NCT04889599|Mitosis Modulators|mitosis modulators|mesh-ancestor
24984010|NCT04889599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984027|NCT04842422|Immunologic Factors|immunologic factors|mesh-ancestor
24984028|NCT04842422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984029|NCT04842422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24984030|NCT04842422|Interferon Inducers|interferon inducers|mesh-ancestor
24984032|NCT04840641|Floxacillin|floxacillin|mesh-list
24984033|NCT04840641|Losartan|losartan|mesh-list
24984034|NCT04840641|Metoprolol|metoprolol|mesh-list
24984035|NCT04840641|Midazolam|midazolam|mesh-list
25106726|NCT03145584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875285|NCT04548752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24784602|NCT01909089|Anesthetics, Local|anesthetics, local|mesh-ancestor
24784603|NCT01909089|Anesthetics|anesthetics|mesh-ancestor
24784620|NCT01909557|Acetylcarnitine|acetylcarnitine|mesh-list
24784621|NCT01909557|Vitamin B Complex|vitamin b complex|mesh-ancestor
24784622|NCT01909557|Vitamins|vitamins|mesh-ancestor
24784623|NCT01909557|Micronutrients|micronutrients|mesh-ancestor
24784624|NCT01909557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657578|NCT01587885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25657579|NCT01587885|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25657580|NCT01587885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657581|NCT01587885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657582|NCT01587989|Methotrexate|methotrexate|mesh-list
25657583|NCT01587989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25657584|NCT01587989|Abortifacient Agents|abortifacient agents|mesh-ancestor
25657585|NCT01587989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25200228|NCT02735343|Analgesics|analgesics|mesh-ancestor
25200229|NCT02735343|Sensory System Agents|sensory system agents|mesh-ancestor
25200230|NCT02735343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25200231|NCT02735343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200232|NCT02735343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25200233|NCT02735343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25200234|NCT02735343|Anesthetics, General|anesthetics, general|mesh-ancestor
25200235|NCT02735343|Anesthetics|anesthetics|mesh-ancestor
25200236|NCT02735343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25200237|NCT02735343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25200238|NCT02735343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25200239|NCT02735343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25200240|NCT02735343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200241|NCT02735343|Antiemetics|antiemetics|mesh-ancestor
24784625|NCT01909557|Nootropic Agents|nootropic agents|mesh-ancestor
25830639|NCT00006448|Methadone|methadone|mesh-list
25830640|NCT00006448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25830641|NCT00006448|Narcotics|narcotics|mesh-ancestor
25830642|NCT00006448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25830643|NCT00006448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830644|NCT00006448|Analgesics|analgesics|mesh-ancestor
25830645|NCT00006448|Sensory System Agents|sensory system agents|mesh-ancestor
25830646|NCT00006448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25830647|NCT00006448|Antitussive Agents|antitussive agents|mesh-ancestor
25830648|NCT00006448|Respiratory System Agents|respiratory system agents|mesh-ancestor
25830649|NCT00006449|Naltrexone|naltrexone|mesh-list
25830650|NCT00006449|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25830651|NCT00006449|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25830652|NCT00006449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830653|NCT00006449|Sensory System Agents|sensory system agents|mesh-ancestor
24784626|NCT01909622|Vitamin D|vitamin d|mesh-list
24784627|NCT01909622|Ergocalciferols|ergocalciferols|mesh-list
24784628|NCT01909622|Cholecalciferol|cholecalciferol|mesh-list
24784629|NCT01909622|Vitamins|vitamins|mesh-list
24784630|NCT01909622|Micronutrients|micronutrients|mesh-ancestor
24784631|NCT01909622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784632|NCT01909622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24784633|NCT01909622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24784634|NCT01909661|Caseins|caseins|mesh-list
24784635|NCT01909661|Chelating Agents|chelating agents|mesh-ancestor
24784636|NCT01909661|Sequestering Agents|sequestering agents|mesh-ancestor
24784637|NCT01909661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106727|NCT03145584|Sensory System Agents|sensory system agents|mesh-ancestor
25106728|NCT03145584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25106729|NCT03145194|Ticagrelor|ticagrelor|mesh-list
25106730|NCT03145194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25106731|NCT03145194|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25106732|NCT03145194|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25106733|NCT03145194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25106734|NCT03145194|Purinergic Agents|purinergic agents|mesh-ancestor
25106735|NCT03145194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25106736|NCT03145194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106737|NCT03145194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106738|NCT03145285|Abiraterone Acetate|abiraterone acetate|mesh-list
25106739|NCT03145285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106740|NCT03145285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25106741|NCT03145285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830654|NCT00006449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25657586|NCT01587989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657587|NCT01587989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25657588|NCT01587989|Antimetabolites|antimetabolites|mesh-ancestor
25657589|NCT01587989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657590|NCT01587989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25657591|NCT01587989|Dermatologic Agents|dermatologic agents|mesh-ancestor
25657592|NCT01587989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657593|NCT01587989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25657594|NCT01587989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25657595|NCT01587989|Immunologic Factors|immunologic factors|mesh-ancestor
25657596|NCT01587989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25657597|NCT01587989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25657598|NCT01588158|Acetaminophen|acetaminophen|mesh-list
25657599|NCT01588158|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25830655|NCT00006450|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25830656|NCT00006450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200279|NCT02735603|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25830657|NCT00006451|Cyclosporine|cyclosporine|mesh-list
25106744|NCT03145285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25106745|NCT03145285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106746|NCT03145285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25106747|NCT03145025|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
25830658|NCT00006451|Methylprednisolone|methylprednisolone|mesh-list
25830659|NCT00006451|Cyclophosphamide|cyclophosphamide|mesh-list
25830660|NCT00006451|Methotrexate|methotrexate|mesh-list
25131652|NCT03024580|Exemestane|exemestane|mesh-list
24446281|NCT00304291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446283|NCT00304317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24446285|NCT00304317|Analgesics|analgesics|mesh-ancestor
25162517|NCT02904304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25106759|NCT03144947|Mitosis Modulators|mitosis modulators|mesh-ancestor
25106760|NCT03144947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106761|NCT03144947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24984036|NCT04840641|Caffeine|caffeine|mesh-list
24984037|NCT04840641|Omeprazole|omeprazole|mesh-list
24984038|NCT04840641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24984039|NCT04840641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24984040|NCT04840641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24984041|NCT04840641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984042|NCT04840641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25131665|NCT03024580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24984046|NCT04840641|Anesthetics, General|anesthetics, general|mesh-ancestor
24984047|NCT04840641|Anesthetics|anesthetics|mesh-ancestor
24984048|NCT04840641|GABA Modulators|gaba modulators|mesh-ancestor
24984049|NCT04840641|GABA Agents|gaba agents|mesh-ancestor
24984050|NCT04840641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24984051|NCT04840641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984052|NCT04840641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24984053|NCT04840641|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24984054|NCT04840641|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24984055|NCT04840641|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24984068|NCT04840641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24984069|NCT04840641|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24984070|NCT04840641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24984071|NCT04840641|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24984072|NCT04840641|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24984073|NCT04840641|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24984074|NCT04840641|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24984075|NCT04840641|Sympatholytics|sympatholytics|mesh-ancestor
24984076|NCT04840641|Autonomic Agents|autonomic agents|mesh-ancestor
24984077|NCT04840641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24984078|NCT04840641|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24984079|NCT04840641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24984080|NCT04840641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24984081|NCT04840641|Adrenergic Agents|adrenergic agents|mesh-ancestor
24984082|NCT04840641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24984084|NCT04838223|Anesthetics, Local|anesthetics, local|mesh-ancestor
24984085|NCT04838223|Anesthetics|anesthetics|mesh-ancestor
24984086|NCT04838223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24984087|NCT04838223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657600|NCT01588158|Hydrocodone|hydrocodone|mesh-list
25657601|NCT01588158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25657602|NCT01588158|Analgesics|analgesics|mesh-ancestor
25657603|NCT01588158|Sensory System Agents|sensory system agents|mesh-ancestor
25657604|NCT01588158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25657605|NCT01588158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657606|NCT01588158|Antipyretics|antipyretics|mesh-ancestor
25657607|NCT01588158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25657608|NCT01588158|Narcotics|narcotics|mesh-ancestor
25657609|NCT01588158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25657610|NCT01588158|Antitussive Agents|antitussive agents|mesh-ancestor
25674267|NCT01769508|Oxaliplatin|oxaliplatin|mesh-list
25674268|NCT01769508|Lapatinib|lapatinib|mesh-list
25674269|NCT01769508|Antimetabolites|antimetabolites|mesh-ancestor
25674270|NCT01769508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674271|NCT01769508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25674272|NCT01769508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25674273|NCT01769508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25674274|NCT01769508|Immunologic Factors|immunologic factors|mesh-ancestor
24951404|NCT03904680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951405|NCT03904680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24951406|NCT03904680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24951407|NCT03904680|Abortifacient Agents|abortifacient agents|mesh-ancestor
24951408|NCT03904680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24951409|NCT03904680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25830661|NCT00006451|Cyclosporins|cyclosporins|mesh-list
24446421|NCT00304655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24446422|NCT00304655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24984104|NCT04802746|GABA Modulators|gaba modulators|mesh-ancestor
24984105|NCT04802746|GABA Agents|gaba agents|mesh-ancestor
24984106|NCT04802746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24984107|NCT04802746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984109|NCT04801043|Cilastatin|cilastatin|mesh-list
24984110|NCT04801043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24984111|NCT04801043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24984112|NCT04801043|Protease Inhibitors|protease inhibitors|mesh-ancestor
24984113|NCT04801043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984114|NCT04801043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984115|NCT04791176|Lenvatinib|lenvatinib|mesh-list
24984116|NCT04791176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24984140|NCT04782791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24984141|NCT04782791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784660|NCT01909830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984142|NCT04782791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24984143|NCT04782791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984144|NCT04776018|Daratumumab|daratumumab|mesh-list
24984145|NCT04776018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24984190|NCT04735965|Dexmedetomidine|dexmedetomidine|mesh-list
24984191|NCT04735965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24984192|NCT04735965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24859215|NCT02302508|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24859221|NCT02302547|Ritonavir|ritonavir|mesh-list
25131754|NCT03023527|Immunologic Factors|immunologic factors|mesh-ancestor
25830662|NCT00006451|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25830663|NCT00006451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25830664|NCT00006451|Immunologic Factors|immunologic factors|mesh-ancestor
25830665|NCT00006451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830666|NCT00006451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25830667|NCT00006451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25830668|NCT00006451|Alkylating Agents|alkylating agents|mesh-ancestor
25830669|NCT00006451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830670|NCT00006451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830671|NCT00006451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25830672|NCT00006451|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25830673|NCT00006451|Abortifacient Agents|abortifacient agents|mesh-ancestor
25830674|NCT00006451|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25830675|NCT00006451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25830676|NCT00006451|Antimetabolites|antimetabolites|mesh-ancestor
25830677|NCT00006451|Dermatologic Agents|dermatologic agents|mesh-ancestor
24984193|NCT04735965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984194|NCT04735965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24984195|NCT04735965|Analgesics|analgesics|mesh-ancestor
24984196|NCT04735965|Sensory System Agents|sensory system agents|mesh-ancestor
24984197|NCT04735965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24984198|NCT04735965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24984199|NCT04735965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24984200|NCT04735965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24984201|NCT04735965|Adrenergic Agents|adrenergic agents|mesh-ancestor
24984202|NCT04735965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24984203|NCT04735965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984204|NCT04735965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25131797|NCT03023306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24984205|NCT04735965|Narcotics|narcotics|mesh-ancestor
24984206|NCT04735965|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25657611|NCT01588158|Respiratory System Agents|respiratory system agents|mesh-ancestor
25657612|NCT01588158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25657613|NCT01588158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25657614|NCT01588158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25657615|NCT01588184|Bevacizumab|bevacizumab|mesh-list
25657616|NCT01588184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25830678|NCT00006451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830679|NCT00006451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24984208|NCT04734535|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
24984209|NCT04734535|Hemostatics|hemostatics|mesh-ancestor
24984210|NCT04734535|Coagulants|coagulants|mesh-ancestor
24984211|NCT04734379|Fasudil|fasudil|mesh-list
24984212|NCT04734379|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24984213|NCT04734379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25106772|NCT03145012|Ranitidine|ranitidine|mesh-list
24984214|NCT04734379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796001|NCT01947192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24796002|NCT01947192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24796003|NCT01947192|Disinfectants|disinfectants|mesh-ancestor
24796004|NCT01947205|Acetaminophen|acetaminophen|mesh-list
24796005|NCT01947205|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
24796006|NCT01947205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24796007|NCT01947205|Analgesics|analgesics|mesh-ancestor
24796008|NCT01947205|Sensory System Agents|sensory system agents|mesh-ancestor
24796009|NCT01947205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24796010|NCT01947205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796011|NCT01947205|Antipyretics|antipyretics|mesh-ancestor
24796012|NCT01947205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24796013|NCT01947205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24796014|NCT01947205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24796015|NCT01947309|Lenalidomide|lenalidomide|mesh-list
24796016|NCT01947309|Immunologic Factors|immunologic factors|mesh-ancestor
24796017|NCT01947309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796018|NCT01947309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24796019|NCT01947309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24796020|NCT01947309|Growth Substances|growth substances|mesh-ancestor
24796021|NCT01947309|Growth Inhibitors|growth inhibitors|mesh-ancestor
25106762|NCT03144596|Tamsulosin|tamsulosin|mesh-list
24784657|NCT01909830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784658|NCT01909830|Antiviral Agents|antiviral agents|mesh-ancestor
24784659|NCT01909830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24784662|NCT01909830|Immunologic Factors|immunologic factors|mesh-ancestor
24784667|NCT01909843|Antiviral Agents|antiviral agents|mesh-ancestor
24784668|NCT01909843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24784669|NCT01909856|Dexamethasone|dexamethasone|mesh-list
25830680|NCT00006451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25830681|NCT00006451|Antifungal Agents|antifungal agents|mesh-ancestor
25830682|NCT00006451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25830683|NCT00006451|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25830684|NCT00006451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25830685|NCT00006451|Antiemetics|antiemetics|mesh-ancestor
25830686|NCT00006451|Autonomic Agents|autonomic agents|mesh-ancestor
25830687|NCT00006451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25830688|NCT00006451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25830689|NCT00006451|Glucocorticoids|glucocorticoids|mesh-ancestor
25830690|NCT00006451|Hormones|hormones|mesh-ancestor
25830691|NCT00006451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25830692|NCT00006451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25830693|NCT00006451|Protective Agents|protective agents|mesh-ancestor
25830694|NCT00006452|Motexafin gadolinium|motexafin gadolinium|mesh-list
25830695|NCT00006452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830696|NCT00006452|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25830697|NCT00006452|Dermatologic Agents|dermatologic agents|mesh-ancestor
25830698|NCT00006453|Gemcitabine|gemcitabine|mesh-list
24784670|NCT01909856|Palonosetron|palonosetron|mesh-list
24784671|NCT01909856|Granisetron|granisetron|mesh-list
24784672|NCT01909856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784673|NCT01909856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24784674|NCT01909856|Antiemetics|antiemetics|mesh-ancestor
24784675|NCT01909856|Autonomic Agents|autonomic agents|mesh-ancestor
24784676|NCT01909856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24784677|NCT01909856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784678|NCT01909856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24784679|NCT01909856|Glucocorticoids|glucocorticoids|mesh-ancestor
24784681|NCT01909856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24784682|NCT01909856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24784683|NCT01909856|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24784684|NCT01909856|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24784685|NCT01909856|Serotonin Agents|serotonin agents|mesh-ancestor
24784686|NCT01909856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25106763|NCT03144596|Alfuzosin|alfuzosin|mesh-list
25106764|NCT03144596|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25404144|NCT03682068|Antimetabolites|antimetabolites|mesh-ancestor
25830699|NCT00006453|Carboplatin|carboplatin|mesh-list
25106765|NCT03144596|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25106766|NCT03144596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25106767|NCT03144596|Adrenergic Agents|adrenergic agents|mesh-ancestor
25106768|NCT03144596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25106769|NCT03144596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106770|NCT03144596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106771|NCT03144596|Urological Agents|urological agents|mesh-ancestor
25162518|NCT02904304|Adrenergic Agents|adrenergic agents|mesh-ancestor
25106774|NCT03145012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25106775|NCT03145012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25106776|NCT03145012|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25106788|NCT03144778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25106789|NCT03144778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106790|NCT03144778|Immunologic Factors|immunologic factors|mesh-ancestor
25106791|NCT03144778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106792|NCT03144778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25106793|NCT03144778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162519|NCT02904304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24984304|NCT04667637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24984305|NCT04667637|Antioxidants|antioxidants|mesh-ancestor
24984306|NCT04667637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984329|NCT04611763|Analgesics|analgesics|mesh-ancestor
24984330|NCT04611763|Sensory System Agents|sensory system agents|mesh-ancestor
24984331|NCT04611763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24859433|NCT02303639|Amiodarone|amiodarone|mesh-list
24984332|NCT04611763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162520|NCT02904304|Protective Agents|protective agents|mesh-ancestor
24984333|NCT04611763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24984334|NCT04611763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24984335|NCT04611763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24984336|NCT04611763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24984337|NCT04611763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24984338|NCT04611763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984339|NCT04611763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984340|NCT04608786|Capecitabine|capecitabine|mesh-list
24984341|NCT04608786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24984342|NCT04608786|Antimetabolites|antimetabolites|mesh-ancestor
24984343|NCT04608786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984344|NCT04608786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24984346|NCT04595266|Bevacizumab|bevacizumab|mesh-list
24984347|NCT04595266|Fluorouracil|fluorouracil|mesh-list
24984348|NCT04595266|Oxaliplatin|oxaliplatin|mesh-list
24984349|NCT04595266|Irinotecan|irinotecan|mesh-list
24984350|NCT04595266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24984351|NCT04595266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24984352|NCT04595266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24984353|NCT04595266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24984354|NCT04595266|Growth Substances|growth substances|mesh-ancestor
25830700|NCT00006453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24984368|NCT04595266|Vitamins|vitamins|mesh-ancestor
24984369|NCT04595266|Micronutrients|micronutrients|mesh-ancestor
24984370|NCT04594798|Prednisone|prednisone|mesh-list
24984371|NCT04594798|Cyclophosphamide|cyclophosphamide|mesh-list
24984372|NCT04594798|Rituximab|rituximab|mesh-list
24984373|NCT04594798|Doxorubicin|doxorubicin|mesh-list
24984374|NCT04594798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24984375|NCT04594798|Immunologic Factors|immunologic factors|mesh-ancestor
24984376|NCT04594798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984377|NCT04594798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24984378|NCT04594798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24984379|NCT04594798|Alkylating Agents|alkylating agents|mesh-ancestor
24984380|NCT04594798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984381|NCT04594798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24984382|NCT04594798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24984383|NCT04594798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24984384|NCT04594798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24984385|NCT04594798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24984386|NCT04594798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24984387|NCT04594798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984388|NCT04594798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24984389|NCT04594798|Glucocorticoids|glucocorticoids|mesh-ancestor
24984390|NCT04594798|Hormones|hormones|mesh-ancestor
25657617|NCT01588184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830702|NCT00006453|Antimetabolites|antimetabolites|mesh-ancestor
25830703|NCT00006453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830704|NCT00006453|Antiviral Agents|antiviral agents|mesh-ancestor
25830705|NCT00006453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25830706|NCT00006453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830707|NCT00006453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25830708|NCT00006453|Immunologic Factors|immunologic factors|mesh-ancestor
25830709|NCT00006453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585960|NCT00888602|Psyllium|psyllium|mesh-list
24585961|NCT00888602|Calcium polycarbophil|calcium polycarbophil|mesh-list
24585962|NCT00888602|Cathartics|cathartics|mesh-ancestor
24585963|NCT00888602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24585964|NCT00888602|Antidiarrheals|antidiarrheals|mesh-ancestor
24585965|NCT00888732|Insulin|insulin|mesh-list
24585966|NCT00888732|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24585967|NCT00888732|Insulin Aspart|insulin aspart|mesh-list
25830710|NCT00006454|Paclitaxel|paclitaxel|mesh-list
25830711|NCT00006454|Carboplatin|carboplatin|mesh-list
25830712|NCT00006454|Topotecan|topotecan|mesh-list
24633989|NCT01131780|Ibuprofen|ibuprofen|mesh-list
25830713|NCT00006454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24984391|NCT04594798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24984392|NCT04594798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24984393|NCT04592536|Alprazolam|alprazolam|mesh-list
24984394|NCT04592536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24984395|NCT04592536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24984396|NCT04592536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984464|NCT04508790|Growth Substances|growth substances|mesh-ancestor
24984465|NCT04508790|Growth Inhibitors|growth inhibitors|mesh-ancestor
24984466|NCT04508790|Dermatologic Agents|dermatologic agents|mesh-ancestor
24984467|NCT04508790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24984468|NCT04506372|Enzyme Inhibitors|enzyme inhibitors|mesh-list
24984469|NCT04506372|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24984470|NCT04506372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984471|NCT04506372|Protease Inhibitors|protease inhibitors|mesh-ancestor
24984472|NCT04505098|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
24984473|NCT04505098|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25131987|NCT03022500|Tremelimumab|tremelimumab|mesh-list
24984476|NCT04503668|Ondansetron|ondansetron|mesh-list
24984478|NCT04503668|Fosaprepitant|fosaprepitant|mesh-list
24984479|NCT04503668|Prochlorperazine|prochlorperazine|mesh-list
24984480|NCT04503668|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-list
24984481|NCT04503668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24984482|NCT04503668|Antiemetics|antiemetics|mesh-ancestor
24784706|NCT01910090|Sensory System Agents|sensory system agents|mesh-ancestor
24784707|NCT01910090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24813263|NCT02057367|Bupivacaine|bupivacaine|mesh-list
24784708|NCT01910090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24784709|NCT01910090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24784710|NCT01910090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24784711|NCT01910090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24784712|NCT01910090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24784713|NCT01910090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24784715|NCT01910142|Calcium|calcium|mesh-list
24784716|NCT01910142|Vitamins|vitamins|mesh-ancestor
24784717|NCT01910142|Micronutrients|micronutrients|mesh-ancestor
24830714|NCT02160574|Chlorhexidine|chlorhexidine|mesh-list
24984504|NCT04503668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24984505|NCT04503668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24984506|NCT04503668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25657618|NCT01588184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25657619|NCT01588184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25657620|NCT01588184|Growth Substances|growth substances|mesh-ancestor
25657621|NCT01588184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657622|NCT01588184|Growth Inhibitors|growth inhibitors|mesh-ancestor
25657623|NCT01588405|Treprostinil|treprostinil|mesh-list
25657624|NCT01588405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25657625|NCT01588418|Exenatide|exenatide|mesh-list
25657626|NCT01588418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25657627|NCT01588418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657628|NCT01588418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25657629|NCT01588418|Incretins|incretins|mesh-ancestor
25657630|NCT01588418|Hormones|hormones|mesh-ancestor
24984507|NCT04503668|Dopamine Agents|dopamine agents|mesh-ancestor
24984508|NCT04502550|Propofol|propofol|mesh-list
24984509|NCT04502550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24586436|NCT00890630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586437|NCT00890643|Prazosin|prazosin|mesh-list
24586438|NCT00890643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24586439|NCT00890643|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24586440|NCT00890643|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24586441|NCT00890643|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24586442|NCT00890643|Adrenergic Agents|adrenergic agents|mesh-ancestor
24586443|NCT00890643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25132029|NCT03022123|Hormones|hormones|mesh-ancestor
25132036|NCT03022006|Grazoprevir|grazoprevir|mesh-list
24796052|NCT01947777|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24796053|NCT01947777|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25162521|NCT02904304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24796054|NCT01947777|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24796055|NCT01947790|Metformin|metformin|mesh-list
24796056|NCT01947790|Pioglitazone|pioglitazone|mesh-list
25048900|NCT00658372|Serotonin Agents|serotonin agents|mesh-ancestor
24486657|NCT00459004|Hormones|hormones|mesh-ancestor
24796057|NCT01947790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25106807|NCT03144713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25106808|NCT03144713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25106809|NCT03144713|Adrenergic Agents|adrenergic agents|mesh-ancestor
25106810|NCT03144713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25106811|NCT03144713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106812|NCT03144713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25106813|NCT03144856|Apatinib|apatinib|mesh-list
25106814|NCT03144856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106815|NCT03144856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24796077|NCT01947920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796078|NCT01947920|Analgesics|analgesics|mesh-ancestor
24796079|NCT01947920|Sensory System Agents|sensory system agents|mesh-ancestor
24796080|NCT01947920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24796081|NCT01947933|Mirikizumab|mirikizumab|mesh-list
24796082|NCT01947933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24796083|NCT01947933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24796084|NCT01947933|Analgesics|analgesics|mesh-ancestor
24796090|NCT01947933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24796091|NCT01947933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24796092|NCT01947959|Rivaroxaban|rivaroxaban|mesh-list
24796093|NCT01947959|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24796094|NCT01947959|Antithrombins|antithrombins|mesh-ancestor
24796095|NCT01947959|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24796096|NCT01947959|Protease Inhibitors|protease inhibitors|mesh-ancestor
24796097|NCT01947959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796098|NCT01947959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796099|NCT01947959|Anticoagulants|anticoagulants|mesh-ancestor
24796100|NCT01947985|Rivaroxaban|rivaroxaban|mesh-list
24796101|NCT01947985|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24796102|NCT01947985|Antithrombins|antithrombins|mesh-ancestor
24796103|NCT01947985|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24796104|NCT01947985|Protease Inhibitors|protease inhibitors|mesh-ancestor
24796107|NCT01947985|Anticoagulants|anticoagulants|mesh-ancestor
24796109|NCT01947998|Rivaroxaban|rivaroxaban|mesh-list
24984522|NCT04481672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24984523|NCT04481672|Anticonvulsants|anticonvulsants|mesh-ancestor
24984524|NCT04481672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24984525|NCT04481672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24984526|NCT04481672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984527|NCT04481672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24984528|NCT04481672|Tocolytic Agents|tocolytic agents|mesh-ancestor
24984529|NCT04481672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24984530|NCT04470778|Famotidine|famotidine|mesh-list
24984531|NCT04470778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24984532|NCT04470778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24984590|NCT04356209|Pravastatin|pravastatin|mesh-list
24984591|NCT04356209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24984592|NCT04356209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24984593|NCT04356209|Antimetabolites|antimetabolites|mesh-ancestor
25657631|NCT01588418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25657632|NCT01588457|Lamotrigine|lamotrigine|mesh-list
25657633|NCT01588457|Valproic Acid|valproic acid|mesh-list
25657634|NCT01588457|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25657635|NCT01588457|Lithium Carbonate|lithium carbonate|mesh-list
25657636|NCT01588457|Antidepressive Agents|antidepressive agents|mesh-ancestor
25657637|NCT01588457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25657638|NCT01588457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25408573|NCT03434379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25162522|NCT02904304|Cholinergic Agents|cholinergic agents|mesh-ancestor
24984595|NCT04356209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25162523|NCT02904304|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24859754|NCT02305654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25132134|NCT03021057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830714|NCT00006454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830715|NCT00006454|Tubulin Modulators|tubulin modulators|mesh-ancestor
25830716|NCT00006454|Antimitotic Agents|antimitotic agents|mesh-ancestor
25830717|NCT00006454|Mitosis Modulators|mitosis modulators|mesh-ancestor
24796125|NCT01948024|Asenapine|asenapine|mesh-list
24796126|NCT01948024|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24796127|NCT01948024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24796128|NCT01948024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24796129|NCT01948024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796130|NCT01948024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24796131|NCT01948115|Nitrous Oxide|nitrous oxide|mesh-list
24796132|NCT01948115|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25132204|NCT03020329|Cisplatin|cisplatin|mesh-list
24796133|NCT01948115|Anesthetics, General|anesthetics, general|mesh-ancestor
24796134|NCT01948115|Anesthetics|anesthetics|mesh-ancestor
24859821|NCT02305901|Dopamine Agents|dopamine agents|mesh-ancestor
25830718|NCT00006454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830719|NCT00006454|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25830720|NCT00006454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25830721|NCT00006454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984689|NCT04177706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24984690|NCT04177706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984691|NCT04177706|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24984692|NCT04177706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24984693|NCT04177706|Anesthetics, General|anesthetics, general|mesh-ancestor
24984694|NCT04177706|Anesthetics|anesthetics|mesh-ancestor
24984695|NCT04177706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24984696|NCT04177706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24984697|NCT04177706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24984698|NCT04177706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24984699|NCT04177706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831000|NCT02162485|Fluticasone|fluticasone|mesh-list
24681467|NCT01380548|Iron|iron|mesh-list
25830722|NCT00006457|Oltipraz|oltipraz|mesh-list
25830723|NCT00006457|Antiviral Agents|antiviral agents|mesh-ancestor
25162524|NCT02904304|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25162525|NCT02904304|Histamine Antagonists|histamine antagonists|mesh-ancestor
25162526|NCT02904304|Histamine Agents|histamine agents|mesh-ancestor
25162527|NCT02904031|Leucovorin|leucovorin|mesh-list
25162528|NCT02904031|Fluorouracil|fluorouracil|mesh-list
25162529|NCT02904031|Oxaliplatin|oxaliplatin|mesh-list
25162530|NCT02904031|Panitumumab|panitumumab|mesh-list
25162531|NCT02904031|Levoleucovorin|levoleucovorin|mesh-list
25162532|NCT02904031|Antimetabolites|antimetabolites|mesh-ancestor
25207780|NCT03391193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984727|NCT04163874|Pancrelipase|pancrelipase|mesh-list
24984728|NCT04163874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24984729|NCT04163874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24984730|NCT04163874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984731|NCT04129996|Paclitaxel|paclitaxel|mesh-list
24859824|NCT02305901|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24859825|NCT02305901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25830724|NCT00006457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25830725|NCT00006457|Schistosomicides|schistosomicides|mesh-ancestor
25830726|NCT00006457|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25830727|NCT00006457|Anthelmintics|anthelmintics|mesh-ancestor
25830728|NCT00006457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25830729|NCT00006457|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25830730|NCT00006457|Protective Agents|protective agents|mesh-ancestor
25830731|NCT00006457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830732|NCT00006457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830733|NCT00006457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24859840|NCT02305940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24859841|NCT02305979|Loratadine|loratadine|mesh-list
24859842|NCT02305979|Antipruritics|antipruritics|mesh-ancestor
24859843|NCT02305979|Dermatologic Agents|dermatologic agents|mesh-ancestor
24859844|NCT02305979|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24859845|NCT02305979|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24859846|NCT02305979|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25408574|NCT03434379|Growth Substances|growth substances|mesh-ancestor
24881725|NCT01434602|Everolimus|everolimus|mesh-list
25830734|NCT00006457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25830735|NCT00006457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830736|NCT00006457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830737|NCT00006458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25830738|NCT00006458|Antibodies|antibodies|mesh-list
25830739|NCT00006458|Immunoglobulins|immunoglobulins|mesh-list
24984753|NCT04074967|Nivolumab|nivolumab|mesh-list
24984754|NCT04074967|Ipilimumab|ipilimumab|mesh-list
24984755|NCT04074967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24984756|NCT04074967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859854|NCT02305992|Anesthetics|anesthetics|mesh-list
25830740|NCT00006458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25830741|NCT00006458|Immunologic Factors|immunologic factors|mesh-ancestor
25830742|NCT00006458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830743|NCT00006458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830744|NCT00006459|Gemcitabine|gemcitabine|mesh-list
25830745|NCT00006459|Paclitaxel|paclitaxel|mesh-list
25830746|NCT00006459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25830747|NCT00006459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830748|NCT00006459|Tubulin Modulators|tubulin modulators|mesh-ancestor
25830749|NCT00006459|Antimitotic Agents|antimitotic agents|mesh-ancestor
25830750|NCT00006459|Mitosis Modulators|mitosis modulators|mesh-ancestor
24446708|NCT00305734|Antiviral Agents|antiviral agents|mesh-ancestor
25830751|NCT00006459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830752|NCT00006459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25830753|NCT00006459|Antimetabolites|antimetabolites|mesh-ancestor
25830754|NCT00006459|Antiviral Agents|antiviral agents|mesh-ancestor
24984757|NCT04074967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24984758|NCT04074967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984759|NCT04074759|Pembrolizumab|pembrolizumab|mesh-list
24984760|NCT04074759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24984761|NCT04074759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24984762|NCT04074174|Acetaminophen|acetaminophen|mesh-list
24984763|NCT04074174|Contraceptive Agents|contraceptive agents|mesh-list
24984764|NCT04074174|Contraceptives, Oral|contraceptives, oral|mesh-list
24984765|NCT04074174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24984766|NCT04074174|Analgesics|analgesics|mesh-ancestor
24984767|NCT04074174|Sensory System Agents|sensory system agents|mesh-ancestor
24984768|NCT04074174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24984769|NCT04074174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984770|NCT04074174|Antipyretics|antipyretics|mesh-ancestor
24859861|NCT02306031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24859862|NCT02306031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24859863|NCT02306031|Analgesics|analgesics|mesh-ancestor
24859864|NCT02306031|Sensory System Agents|sensory system agents|mesh-ancestor
25830755|NCT00006459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25830756|NCT00006459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830757|NCT00006459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25830758|NCT00006459|Immunologic Factors|immunologic factors|mesh-ancestor
25830759|NCT00006459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830760|NCT00006461|Cyclophosphamide|cyclophosphamide|mesh-list
25830761|NCT00006461|Cisplatin|cisplatin|mesh-list
25830762|NCT00006461|Etoposide|etoposide|mesh-list
25830763|NCT00006461|Vincristine|vincristine|mesh-list
25830764|NCT00006461|Etoposide phosphate|etoposide phosphate|mesh-list
25830765|NCT00006461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25830766|NCT00006461|Immunologic Factors|immunologic factors|mesh-ancestor
25830767|NCT00006461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830768|NCT00006461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25830769|NCT00006461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25830770|NCT00006461|Alkylating Agents|alkylating agents|mesh-ancestor
25830771|NCT00006461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984771|NCT04074174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24984772|NCT04074174|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24984773|NCT04068831|Avelumab|avelumab|mesh-list
24984774|NCT04068831|Talazoparib|talazoparib|mesh-list
24984775|NCT04068831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24984776|NCT04068831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24984777|NCT04068831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24784718|NCT01910142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784719|NCT01910142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24784720|NCT01910142|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24784721|NCT01910142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24784722|NCT01910142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784723|NCT01910142|Hemostatics|hemostatics|mesh-ancestor
24587133|NCT00893581|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24587134|NCT00893581|Antidepressive Agents|antidepressive agents|mesh-ancestor
24587135|NCT00893581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24587140|NCT00893594|Naproxen|naproxen|mesh-list
24784724|NCT01910142|Coagulants|coagulants|mesh-ancestor
24784725|NCT01910155|Ciprofloxacin|ciprofloxacin|mesh-list
24784726|NCT01910155|Dexamethasone|dexamethasone|mesh-list
24784727|NCT01910155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24784728|NCT01910155|Antiemetics|antiemetics|mesh-ancestor
24784729|NCT01910155|Autonomic Agents|autonomic agents|mesh-ancestor
24784730|NCT01910155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24784731|NCT01910155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859874|NCT02306070|Metformin|metformin|mesh-list
24859875|NCT02306070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24859876|NCT02306070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859877|NCT02306187|Eldecalcitol|eldecalcitol|mesh-list
24859880|NCT02306239|Terlipressin|terlipressin|mesh-list
25830772|NCT00006461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830773|NCT00006461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25830774|NCT00006461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25830775|NCT00006461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25830776|NCT00006461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25830777|NCT00006461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830778|NCT00006461|Tubulin Modulators|tubulin modulators|mesh-ancestor
25830779|NCT00006461|Antimitotic Agents|antimitotic agents|mesh-ancestor
25830780|NCT00006461|Mitosis Modulators|mitosis modulators|mesh-ancestor
25830781|NCT00006462|Gemcitabine|gemcitabine|mesh-list
25830782|NCT00006462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25830783|NCT00006462|Antimetabolites|antimetabolites|mesh-ancestor
24784732|NCT01910155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24784733|NCT01910155|Glucocorticoids|glucocorticoids|mesh-ancestor
24784735|NCT01910155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24784736|NCT01910155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24784737|NCT01910155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25132414|NCT03018626|Prednisone|prednisone|mesh-list
24784738|NCT01910155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24784739|NCT01910155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25106822|NCT03144882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25106823|NCT03144882|Analgesics|analgesics|mesh-ancestor
25106824|NCT03144882|Sensory System Agents|sensory system agents|mesh-ancestor
25106825|NCT03144882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25106833|NCT03144466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25830784|NCT00006462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830785|NCT00006462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830786|NCT00006462|Antiviral Agents|antiviral agents|mesh-ancestor
25830787|NCT00006462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25830788|NCT00006462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830789|NCT00006462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25830790|NCT00006462|Immunologic Factors|immunologic factors|mesh-ancestor
25830791|NCT00006462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830792|NCT00006463|Trabectedin|trabectedin|mesh-list
25830793|NCT00006463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25830794|NCT00006463|Alkylating Agents|alkylating agents|mesh-ancestor
25830795|NCT00006463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830796|NCT00006463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830797|NCT00006464|Cisplatin|cisplatin|mesh-list
25830798|NCT00006464|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
25830799|NCT00006464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830800|NCT00006464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25106842|NCT03144453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106843|NCT03144453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25106844|NCT03144453|Respiratory System Agents|respiratory system agents|mesh-ancestor
25106845|NCT03144453|Mydriatics|mydriatics|mesh-ancestor
25106846|NCT03144453|Parasympatholytics|parasympatholytics|mesh-ancestor
25106847|NCT03144453|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25106848|NCT03144453|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25106849|NCT03144453|Cholinergic Agents|cholinergic agents|mesh-ancestor
25106850|NCT03144453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25413526|NCT03126916|Dinutuximab|dinutuximab|mesh-list
25657639|NCT01588457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25657640|NCT01588457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25657641|NCT01588457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657642|NCT01588457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657643|NCT01588457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657644|NCT01588457|Antimanic Agents|antimanic agents|mesh-ancestor
25657645|NCT01588457|Anticonvulsants|anticonvulsants|mesh-ancestor
24626296|NCT01086527|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24626297|NCT01086527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626299|NCT01086553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24587329|NCT00894374|Artesunate|artesunate|mesh-list
25106851|NCT03144453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106852|NCT03144453|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25106853|NCT03144453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25106854|NCT03144453|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25106855|NCT03144401|Misoprostol|misoprostol|mesh-list
25106856|NCT03144401|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25106857|NCT03144401|Abortifacient Agents|abortifacient agents|mesh-ancestor
25830801|NCT00006464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830802|NCT00006464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830803|NCT00006465|Capecitabine|capecitabine|mesh-list
25830804|NCT00006465|Oxaliplatin|oxaliplatin|mesh-list
25830805|NCT00006465|Irinotecan|irinotecan|mesh-list
25830806|NCT00006465|Camptothecin|camptothecin|mesh-list
25830807|NCT00006465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25830808|NCT00006465|Antimetabolites|antimetabolites|mesh-ancestor
25830809|NCT00006465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830810|NCT00006465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830811|NCT00006465|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25830812|NCT00006465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25830813|NCT00006465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830814|NCT00006465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25830815|NCT00006467|Gemcitabine|gemcitabine|mesh-list
25830816|NCT00006467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25830817|NCT00006467|Antimetabolites|antimetabolites|mesh-ancestor
25830818|NCT00006467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830819|NCT00006467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24984803|NCT04019262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24984804|NCT04019262|Alkylating Agents|alkylating agents|mesh-ancestor
24984805|NCT04019262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984806|NCT04019262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25132537|NCT03018301|Ketamine|ketamine|mesh-list
25830820|NCT00006467|Antiviral Agents|antiviral agents|mesh-ancestor
25830821|NCT00006467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25830822|NCT00006467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830823|NCT00006467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25830824|NCT00006467|Immunologic Factors|immunologic factors|mesh-ancestor
25830825|NCT00006467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830826|NCT00006468|Leucovorin|leucovorin|mesh-list
25830827|NCT00006468|Fluorouracil|fluorouracil|mesh-list
25830828|NCT00006468|Oxaliplatin|oxaliplatin|mesh-list
25830829|NCT00006468|Calcium|calcium|mesh-list
25830830|NCT00006468|Levoleucovorin|levoleucovorin|mesh-list
25830831|NCT00006468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24984807|NCT04008628|Nitrous Oxide|nitrous oxide|mesh-list
24984808|NCT04008628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24984809|NCT04008628|Anesthetics, General|anesthetics, general|mesh-ancestor
24984810|NCT04008628|Anesthetics|anesthetics|mesh-ancestor
24984811|NCT04008628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24984812|NCT04008628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984813|NCT04008628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24984814|NCT04008628|Analgesics|analgesics|mesh-ancestor
24984815|NCT04008628|Sensory System Agents|sensory system agents|mesh-ancestor
24984816|NCT04008628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24984817|NCT04001894|Clopidogrel|clopidogrel|mesh-list
24984818|NCT04001894|Ticagrelor|ticagrelor|mesh-list
24984819|NCT04001894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24984820|NCT04001894|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24984821|NCT04001894|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24984822|NCT04001894|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25657646|NCT01588457|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25657647|NCT01588457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25657648|NCT01588457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25657649|NCT01588457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25657650|NCT01588457|GABA Agents|gaba agents|mesh-ancestor
25657651|NCT01588457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25657652|NCT01588470|Pioglitazone|pioglitazone|mesh-list
25657653|NCT01588470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25657654|NCT01588470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657655|NCT01588496|Evolocumab|evolocumab|mesh-list
24984829|NCT03988920|Sequestering Agents|sequestering agents|mesh-ancestor
24984830|NCT03988920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984832|NCT03982485|Apatinib|apatinib|mesh-list
24984833|NCT03982485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24984834|NCT03982485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24984835|NCT03982485|Tubulin Modulators|tubulin modulators|mesh-ancestor
24984870|NCT03946111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24984871|NCT03946111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24984872|NCT03946111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24984873|NCT03946111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984874|NCT03937596|Cycloserine|cycloserine|mesh-list
24984875|NCT03937596|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24984876|NCT03937596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24984877|NCT03937596|Renal Agents|renal agents|mesh-ancestor
24984878|NCT03937596|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24984879|NCT03937596|Antitubercular Agents|antitubercular agents|mesh-ancestor
24984880|NCT03937596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24984881|NCT03937596|Antimetabolites|antimetabolites|mesh-ancestor
24984882|NCT03937596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984883|NCT03928158|Valsartan|valsartan|mesh-list
24984884|NCT03928158|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24831173|NCT02163980|Dexmedetomidine|dexmedetomidine|mesh-list
25830832|NCT00006468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984885|NCT03928158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24984886|NCT03928158|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24984892|NCT03926052|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24984893|NCT03926052|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24984894|NCT03926052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24984895|NCT03926052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984897|NCT03926052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24984898|NCT03924193|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
24984899|NCT03924193|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24984900|NCT03924193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984901|NCT03924193|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24984902|NCT03924193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24984903|NCT03924193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24984904|NCT03924193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984906|NCT03924193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24984907|NCT03922880|Nivolumab|nivolumab|mesh-list
24984908|NCT03922880|Ipilimumab|ipilimumab|mesh-list
24796139|NCT01948115|Sensory System Agents|sensory system agents|mesh-ancestor
24796140|NCT01948115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24796141|NCT01948128|Vitamin D|vitamin d|mesh-list
24796142|NCT01948128|Ergocalciferols|ergocalciferols|mesh-list
24796143|NCT01948128|Cholecalciferol|cholecalciferol|mesh-list
24796144|NCT01948128|Vitamins|vitamins|mesh-list
24796145|NCT01948128|Micronutrients|micronutrients|mesh-ancestor
24576927|NCT00840957|Infliximab|infliximab|mesh-list
24796147|NCT01948128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24796148|NCT01948128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24796149|NCT01948232|Perindopril|perindopril|mesh-list
24796150|NCT01948232|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24796151|NCT01948232|Protease Inhibitors|protease inhibitors|mesh-ancestor
24796152|NCT01948232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796153|NCT01948232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984930|NCT03902314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860041|NCT02307305|Antipyretics|antipyretics|mesh-ancestor
25830833|NCT00006468|Antimetabolites|antimetabolites|mesh-ancestor
25830834|NCT00006468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830835|NCT00006468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25830836|NCT00006468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830837|NCT00006468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25830838|NCT00006468|Immunologic Factors|immunologic factors|mesh-ancestor
25830839|NCT00006468|Antidotes|antidotes|mesh-ancestor
25000847|NCT02906332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25000848|NCT02906332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25000849|NCT02906332|Immunologic Factors|immunologic factors|mesh-ancestor
25000850|NCT02906332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25000851|NCT02906332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25000852|NCT02906332|Growth Substances|growth substances|mesh-ancestor
25000854|NCT05463224|Lazertinib|lazertinib|mesh-list
25000855|NCT05463224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25000856|NCT05463224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25000880|NCT05462938|Propofol|propofol|mesh-list
24984976|NCT03829007|Immunologic Factors|immunologic factors|mesh-ancestor
24984977|NCT03829007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830840|NCT00006468|Protective Agents|protective agents|mesh-ancestor
25830841|NCT00006468|Vitamin B Complex|vitamin b complex|mesh-ancestor
25830842|NCT00006468|Vitamins|vitamins|mesh-ancestor
25830843|NCT00006468|Micronutrients|micronutrients|mesh-ancestor
24984994|NCT03800641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24984995|NCT03800641|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24984996|NCT03800641|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24984997|NCT03800641|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24984998|NCT03800641|Adrenergic Agents|adrenergic agents|mesh-ancestor
24984999|NCT03800641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24985000|NCT03800641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162535|NCT02904031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162536|NCT02904031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25162537|NCT02904031|Immunologic Factors|immunologic factors|mesh-ancestor
25162538|NCT02904031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162539|NCT02904031|Antidotes|antidotes|mesh-ancestor
25162540|NCT02904031|Protective Agents|protective agents|mesh-ancestor
25162541|NCT02904031|Vitamin B Complex|vitamin b complex|mesh-ancestor
25162543|NCT02904031|Micronutrients|micronutrients|mesh-ancestor
25162544|NCT02904031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25162545|NCT02903888|Levonorgestrel|levonorgestrel|mesh-list
25162546|NCT02903888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25162547|NCT02903888|Contraceptive Agents|contraceptive agents|mesh-ancestor
25162548|NCT02903888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25162549|NCT02903888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162550|NCT02903888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25162551|NCT02903888|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24784775|NCT01910259|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24784776|NCT01910259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24784777|NCT01910259|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24784778|NCT01910259|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24784779|NCT01910285|Sufentanil|sufentanil|mesh-list
24784781|NCT01910285|Remifentanil|remifentanil|mesh-list
24784782|NCT01910285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24784783|NCT01910285|Narcotics|narcotics|mesh-ancestor
24784784|NCT01910285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24784785|NCT01910285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576917|NCT00840931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24848422|NCT04422795|Ethyl Chloride|ethyl chloride|mesh-list
25830844|NCT00006469|Paclitaxel|paclitaxel|mesh-list
25830845|NCT00006469|Carboplatin|carboplatin|mesh-list
25830846|NCT00006469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24576928|NCT00840957|Dermatologic Agents|dermatologic agents|mesh-ancestor
24576929|NCT00840957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24576930|NCT00840957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24576931|NCT00841061|Ferrous fumarate|ferrous fumarate|mesh-list
25106901|NCT03143972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25106902|NCT03143972|Analgesics|analgesics|mesh-ancestor
25106903|NCT03143972|Sensory System Agents|sensory system agents|mesh-ancestor
25106904|NCT03143972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25106905|NCT03143972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25106906|NCT03143972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25106907|NCT03143972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25106908|NCT03143972|Adrenergic Agents|adrenergic agents|mesh-ancestor
25106909|NCT03143972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25162552|NCT02903888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25162553|NCT02904109|Mannitol|mannitol|mesh-list
25162554|NCT02904109|Triflusal|triflusal|mesh-list
25830847|NCT00006469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106916|NCT03143530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24985014|NCT03753087|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24985015|NCT03753087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985016|NCT03753087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24985017|NCT03753087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985018|NCT03735420|Xanthohumol|xanthohumol|mesh-list
24985019|NCT03735420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985020|NCT03735420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25830848|NCT00006469|Tubulin Modulators|tubulin modulators|mesh-ancestor
25830849|NCT00006469|Antimitotic Agents|antimitotic agents|mesh-ancestor
25830850|NCT00006469|Mitosis Modulators|mitosis modulators|mesh-ancestor
25830851|NCT00006469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830852|NCT00006470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25830853|NCT00006470|Vaccines|vaccines|mesh-list
25830854|NCT00006470|Antibodies|antibodies|mesh-list
25830855|NCT00006470|Immunoglobulins|immunoglobulins|mesh-list
25830856|NCT00006470|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25830857|NCT00006470|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
25830858|NCT00006470|Immunologic Factors|immunologic factors|mesh-ancestor
25830859|NCT00006470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830860|NCT00006470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830861|NCT00006471|Fenretinide|fenretinide|mesh-list
25830862|NCT00006471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830863|NCT00006471|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25830864|NCT00006471|Protective Agents|protective agents|mesh-ancestor
25830865|NCT00006471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830866|NCT00006472|Paclitaxel|paclitaxel|mesh-list
24985023|NCT03735420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985024|NCT03735420|Growth Inhibitors|growth inhibitors|mesh-ancestor
24985025|NCT03734237|Vaccines|vaccines|mesh-list
24985026|NCT03734237|Immunologic Factors|immunologic factors|mesh-ancestor
24486994|NCT00460876|Topotecan|topotecan|mesh-list
24985046|NCT03721328|Tobramycin|tobramycin|mesh-list
24985047|NCT03721328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25830867|NCT00006472|Carboplatin|carboplatin|mesh-list
25830868|NCT00006472|Fluorouracil|fluorouracil|mesh-list
25830869|NCT00006472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25830870|NCT00006472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830871|NCT00006472|Tubulin Modulators|tubulin modulators|mesh-ancestor
25830872|NCT00006472|Antimitotic Agents|antimitotic agents|mesh-ancestor
25830873|NCT00006472|Mitosis Modulators|mitosis modulators|mesh-ancestor
25830874|NCT00006472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830875|NCT00006472|Antimetabolites|antimetabolites|mesh-ancestor
25830876|NCT00006472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25830877|NCT00006472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25830878|NCT00006472|Immunologic Factors|immunologic factors|mesh-ancestor
25162555|NCT02904109|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25001039|NCT05461690|Niraparib|niraparib|mesh-list
25001040|NCT05461690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25001041|NCT05461690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25001042|NCT05461690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25001043|NCT05461690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830879|NCT00006472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830880|NCT00006473|Oxaliplatin|oxaliplatin|mesh-list
25830881|NCT00006473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830882|NCT00006474|Temozolomide|temozolomide|mesh-list
25830883|NCT00006474|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
24985048|NCT03721328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24985054|NCT03715153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24985055|NCT03715153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985056|NCT03711838|Acetylcysteine|acetylcysteine|mesh-list
24985057|NCT03711838|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24985058|NCT03711838|Antiviral Agents|antiviral agents|mesh-ancestor
24985059|NCT03711838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24985060|NCT03711838|Expectorants|expectorants|mesh-ancestor
25830884|NCT00006474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25830885|NCT00006474|Alkylating Agents|alkylating agents|mesh-ancestor
25830886|NCT00006474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830887|NCT00006474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830888|NCT00006474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830889|NCT00006475|Imatinib Mesylate|imatinib mesylate|mesh-list
25830890|NCT00006475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830891|NCT00006475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25830892|NCT00006475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830893|NCT00006475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830894|NCT00006476|Suramin|suramin|mesh-list
25830895|NCT00006476|Antinematodal Agents|antinematodal agents|mesh-ancestor
25830896|NCT00006476|Anthelmintics|anthelmintics|mesh-ancestor
25830897|NCT00006476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25830898|NCT00006476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25830899|NCT00006476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830900|NCT00006476|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25830901|NCT00006476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25830902|NCT00006479|Leucovorin|leucovorin|mesh-list
25830903|NCT00006479|Fluorouracil|fluorouracil|mesh-list
25830904|NCT00006479|Oxaliplatin|oxaliplatin|mesh-list
25830905|NCT00006479|Calcium|calcium|mesh-list
25200396|NCT02734173|Antiviral Agents|antiviral agents|mesh-ancestor
25177984|NCT04747912|Hormones|hormones|mesh-ancestor
25200397|NCT02734173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25200398|NCT02734173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25830906|NCT00006479|Levoleucovorin|levoleucovorin|mesh-list
25830907|NCT00006479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25830908|NCT00006479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830909|NCT00006479|Antimetabolites|antimetabolites|mesh-ancestor
25830910|NCT00006479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830911|NCT00006479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25830912|NCT00006479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830913|NCT00006479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24985061|NCT03711838|Respiratory System Agents|respiratory system agents|mesh-ancestor
25162556|NCT02904109|Diuretics|diuretics|mesh-ancestor
25162557|NCT02904109|Natriuretic Agents|natriuretic agents|mesh-ancestor
25162558|NCT02904109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162559|NCT02904109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25162560|NCT02903901|Melatonin|melatonin|mesh-list
25162561|NCT02903901|Antioxidants|antioxidants|mesh-ancestor
25162562|NCT02903901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162563|NCT02903901|Protective Agents|protective agents|mesh-ancestor
25162564|NCT02903901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162565|NCT02903901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24985063|NCT03711838|Antioxidants|antioxidants|mesh-ancestor
24985074|NCT03706898|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25830914|NCT00006479|Immunologic Factors|immunologic factors|mesh-ancestor
25830915|NCT00006479|Antidotes|antidotes|mesh-ancestor
25830916|NCT00006479|Protective Agents|protective agents|mesh-ancestor
25830917|NCT00006479|Vitamin B Complex|vitamin b complex|mesh-ancestor
25830918|NCT00006479|Vitamins|vitamins|mesh-ancestor
24985113|NCT03647852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24985114|NCT03647852|Glucocorticoids|glucocorticoids|mesh-ancestor
24985115|NCT03647852|Hormones|hormones|mesh-ancestor
24985116|NCT03647852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24985117|NCT03647852|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24985118|NCT03647852|Protective Agents|protective agents|mesh-ancestor
24796154|NCT01948232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24796155|NCT01948245|Taurolidine|taurolidine|mesh-list
24796156|NCT01948245|Heparin|heparin|mesh-list
24796157|NCT01948245|Calcium heparin|calcium heparin|mesh-list
24796158|NCT01948245|Anticoagulants|anticoagulants|mesh-ancestor
24848520|NCT03993912|Antiemetics|antiemetics|mesh-ancestor
25830919|NCT00006479|Micronutrients|micronutrients|mesh-ancestor
25830920|NCT00006480|Aldesleukin|aldesleukin|mesh-list
25830921|NCT00006480|Ganciclovir|ganciclovir|mesh-list
25830922|NCT00006480|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25001150|NCT05443971|Durvalumab|durvalumab|mesh-list
25001151|NCT05443971|Immunoglobulins|immunoglobulins|mesh-list
25830923|NCT00006480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830924|NCT00006480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24985142|NCT03629327|Aspirin|aspirin|mesh-list
24985143|NCT03629327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24985144|NCT03629327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24985145|NCT03629327|Analgesics|analgesics|mesh-ancestor
24985146|NCT03629327|Sensory System Agents|sensory system agents|mesh-ancestor
24985147|NCT03629327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24985148|NCT03629327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985167|NCT03604159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24576942|NCT00841113|Bicalutamide|bicalutamide|mesh-list
24784786|NCT01910285|Analgesics|analgesics|mesh-ancestor
24784787|NCT01910285|Sensory System Agents|sensory system agents|mesh-ancestor
24784788|NCT01910285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24576943|NCT00841113|Abarelix|abarelix|mesh-list
25413527|NCT03126916|Isotretinoin|isotretinoin|mesh-list
25657656|NCT01588496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25657657|NCT01588496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25657658|NCT01588496|Antimetabolites|antimetabolites|mesh-ancestor
25657659|NCT01588496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657660|NCT01588496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25657661|NCT01588561|Nicotine|nicotine|mesh-list
25657662|NCT01588561|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25657663|NCT01588561|Autonomic Agents|autonomic agents|mesh-ancestor
25657664|NCT01588561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25657665|NCT01588561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657666|NCT01588561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25657667|NCT01588561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25657668|NCT01588561|Cholinergic Agents|cholinergic agents|mesh-ancestor
24576946|NCT00841113|Androgen Antagonists|androgen antagonists|mesh-ancestor
24784789|NCT01910285|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24784790|NCT01910285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25132985|NCT03015857|Narcotics|narcotics|mesh-ancestor
24784791|NCT01910285|Anesthetics, General|anesthetics, general|mesh-ancestor
24784792|NCT01910285|Anesthetics|anesthetics|mesh-ancestor
24784793|NCT01910363|Botulinum Toxins|botulinum toxins|mesh-list
24784794|NCT01910363|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24784795|NCT01910363|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24784796|NCT01910363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24784797|NCT01910363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24784798|NCT01910363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162566|NCT02903498|Tegafur|tegafur|mesh-list
25162567|NCT02903498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25162568|NCT02903498|Antimetabolites|antimetabolites|mesh-ancestor
25162593|NCT02903719|Anesthetics|anesthetics|mesh-ancestor
24784800|NCT01910363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25162578|NCT02903524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24784801|NCT01910363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784802|NCT01910363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25106919|NCT03143530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25106921|NCT03143738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25106922|NCT03143738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106923|NCT03143452|Lidocaine|lidocaine|mesh-list
25106924|NCT03143452|Tetracaine|tetracaine|mesh-list
25106925|NCT03143452|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25106926|NCT03143452|Anesthetics, Local|anesthetics, local|mesh-ancestor
25106927|NCT03143452|Anesthetics|anesthetics|mesh-ancestor
25106928|NCT03143452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25106929|NCT03143452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106930|NCT03143452|Sensory System Agents|sensory system agents|mesh-ancestor
25106931|NCT03143452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25106932|NCT03143452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25106933|NCT03143452|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24487463|NCT00463203|Growth Substances|growth substances|mesh-ancestor
24985189|NCT03578172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24985200|NCT03578081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24985201|NCT03578081|Antiemetics|antiemetics|mesh-ancestor
24985202|NCT03578081|Autonomic Agents|autonomic agents|mesh-ancestor
24985203|NCT03578081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24985204|NCT03578081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133099|NCT03014882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25162579|NCT02903524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25162581|NCT02903524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162582|NCT02903524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162583|NCT02903524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25162584|NCT02903524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25162585|NCT02903524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25162586|NCT02903524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25162587|NCT02903524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25162588|NCT02903485|Anesthetics|anesthetics|mesh-list
25041286|NCT02588677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25041287|NCT02588677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041288|NCT02588677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041289|NCT02588677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25041290|NCT02588677|Protective Agents|protective agents|mesh-ancestor
25041292|NCT02580708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24997880|NCT04233047|Fostemsavir|fostemsavir|mesh-list
25049029|NCT00643383|Analgesics|analgesics|mesh-ancestor
24985206|NCT03578081|Glucocorticoids|glucocorticoids|mesh-ancestor
24985208|NCT03578081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24985209|NCT03578081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24985210|NCT03578081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985211|NCT03578081|Antipruritics|antipruritics|mesh-ancestor
24985212|NCT03578081|Dermatologic Agents|dermatologic agents|mesh-ancestor
24985223|NCT03578081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24985224|NCT03578081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24985225|NCT03578081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25830925|NCT00006480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24985226|NCT03578081|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24985229|NCT03562832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985230|NCT03562832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985242|NCT03539601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24985243|NCT03539601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24985244|NCT03539601|Analgesics|analgesics|mesh-ancestor
24985245|NCT03539601|Sensory System Agents|sensory system agents|mesh-ancestor
24985246|NCT03539601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24985247|NCT03539601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985248|NCT03539601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24985249|NCT03539601|Dermatologic Agents|dermatologic agents|mesh-ancestor
24985250|NCT03539601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24985251|NCT03539601|Immunologic Factors|immunologic factors|mesh-ancestor
24985252|NCT03539601|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24985253|NCT03539601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24985254|NCT03539601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985255|NCT03535688|Cycloserine|cycloserine|mesh-list
24985256|NCT03535688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24985257|NCT03535688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24985258|NCT03535688|Renal Agents|renal agents|mesh-ancestor
25162589|NCT02903485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25162590|NCT02903485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162591|NCT02903719|Ropivacaine|ropivacaine|mesh-list
25162592|NCT02903719|Anesthetics, Local|anesthetics, local|mesh-ancestor
25162594|NCT02903719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25162595|NCT02903719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162596|NCT02903719|Sensory System Agents|sensory system agents|mesh-ancestor
25208333|NCT02643420|Alkylating Agents|alkylating agents|mesh-ancestor
24939107|NCT04013243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24939108|NCT04013243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939109|NCT04013243|Anesthetics|anesthetics|mesh-ancestor
25830926|NCT00006480|Antiviral Agents|antiviral agents|mesh-ancestor
24492537|NCT00486668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24492539|NCT00486694|Chloroquine|chloroquine|mesh-list
24492540|NCT00486694|Pyrimethamine|pyrimethamine|mesh-list
24492541|NCT00486694|Sulfadoxine|sulfadoxine|mesh-list
24492542|NCT00486694|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25162597|NCT02903719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25162598|NCT02903537|Vitamin D|vitamin d|mesh-list
25162599|NCT02903537|Cholecalciferol|cholecalciferol|mesh-list
25162600|NCT02903537|Interferons|interferons|mesh-list
25162601|NCT02903537|Interferon-beta|interferon-beta|mesh-list
25162602|NCT02903537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162603|NCT02903537|Antiviral Agents|antiviral agents|mesh-ancestor
25162604|NCT02903537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25162605|NCT02903537|Immunologic Factors|immunologic factors|mesh-ancestor
25162606|NCT02903537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162607|NCT02903537|Vitamins|vitamins|mesh-ancestor
25162608|NCT02903537|Micronutrients|micronutrients|mesh-ancestor
24492543|NCT00486694|Antimalarials|antimalarials|mesh-ancestor
24492544|NCT00486694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24492545|NCT00486694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24492546|NCT00486694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24492547|NCT00486694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24492549|NCT00486694|Schistosomicides|schistosomicides|mesh-ancestor
24492550|NCT00486694|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24492551|NCT00486694|Anthelmintics|anthelmintics|mesh-ancestor
24492552|NCT00486694|Amebicides|amebicides|mesh-ancestor
24492553|NCT00486694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24492554|NCT00486694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24492555|NCT00486694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492558|NCT00486694|Renal Agents|renal agents|mesh-ancestor
24985259|NCT03535688|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24985260|NCT03535688|Antitubercular Agents|antitubercular agents|mesh-ancestor
24985261|NCT03535688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24985262|NCT03535688|Antimetabolites|antimetabolites|mesh-ancestor
24985276|NCT03522844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985277|NCT03522844|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24985278|NCT03522844|Antidepressive Agents|antidepressive agents|mesh-ancestor
24985279|NCT03522844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24985280|NCT03514719|Avelumab|avelumab|mesh-list
24985281|NCT03514719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24985282|NCT03514719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24985420|NCT03367871|Bevacizumab|bevacizumab|mesh-list
25202908|NCT02717923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202909|NCT02717923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25202910|NCT02717923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24985301|NCT03513770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985309|NCT03479671|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24985310|NCT03479671|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24985311|NCT03479671|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24985312|NCT03479671|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25830927|NCT00006480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25830928|NCT00006480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25162615|NCT02903004|Gemcitabine|gemcitabine|mesh-list
25162616|NCT02903004|Paclitaxel|paclitaxel|mesh-list
25041293|NCT02580708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25041294|NCT02580708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041295|NCT02580708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041296|NCT02580370|Botulinum Toxins|botulinum toxins|mesh-list
25041297|NCT02580370|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25041298|NCT02580370|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25041299|NCT02580370|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25041300|NCT02580370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25041323|NCT02580305|Serotonin Agents|serotonin agents|mesh-ancestor
25162617|NCT02903004|Carboplatin|carboplatin|mesh-list
25162618|NCT02903004|Doxorubicin|doxorubicin|mesh-list
25162619|NCT02903004|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25162620|NCT02903004|Topotecan|topotecan|mesh-list
25162621|NCT02903004|Trabectedin|trabectedin|mesh-list
25162622|NCT02903004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25162623|NCT02903004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162624|NCT02903004|Tubulin Modulators|tubulin modulators|mesh-ancestor
25162625|NCT02903004|Antimitotic Agents|antimitotic agents|mesh-ancestor
25162626|NCT02903004|Mitosis Modulators|mitosis modulators|mesh-ancestor
25162627|NCT02903004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162628|NCT02903004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25162629|NCT02903004|Antimetabolites|antimetabolites|mesh-ancestor
25162630|NCT02903004|Antiviral Agents|antiviral agents|mesh-ancestor
25162631|NCT02903004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25162632|NCT02903004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25162633|NCT02903004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25162634|NCT02903004|Immunologic Factors|immunologic factors|mesh-ancestor
25162635|NCT02903004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162636|NCT02903004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25162637|NCT02903004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25162638|NCT02903004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25162639|NCT02903004|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25162640|NCT02903004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25162641|NCT02903004|Alkylating Agents|alkylating agents|mesh-ancestor
25162642|NCT02902861|Methotrexate|methotrexate|mesh-list
25162643|NCT02902861|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25162644|NCT02902861|Abortifacient Agents|abortifacient agents|mesh-ancestor
25162645|NCT02902861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25162646|NCT02902861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162647|NCT02902861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25162648|NCT02902861|Antimetabolites|antimetabolites|mesh-ancestor
25162649|NCT02902861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162650|NCT02902861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162651|NCT02902861|Dermatologic Agents|dermatologic agents|mesh-ancestor
25162652|NCT02902861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25162653|NCT02902861|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24784823|NCT01910428|Asparaginase|asparaginase|mesh-list
24784824|NCT01910428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784825|NCT01910480|Ketoconazole|ketoconazole|mesh-list
24784826|NCT01910480|Antifungal Agents|antifungal agents|mesh-ancestor
24784827|NCT01910480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24784828|NCT01910480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25830929|NCT00006480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830930|NCT00006480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830931|NCT00006482|Gemcitabine|gemcitabine|mesh-list
24784842|NCT01910532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25106951|NCT03143465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25106953|NCT03143491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25106954|NCT03143491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106955|NCT03143491|Tubulin Modulators|tubulin modulators|mesh-ancestor
25830932|NCT00006482|Cisplatin|cisplatin|mesh-list
25830933|NCT00006482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830935|NCT00006482|Antimetabolites|antimetabolites|mesh-ancestor
25830936|NCT00006482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830937|NCT00006482|Antiviral Agents|antiviral agents|mesh-ancestor
25830938|NCT00006482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25830939|NCT00006482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830940|NCT00006482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25830941|NCT00006482|Immunologic Factors|immunologic factors|mesh-ancestor
25830942|NCT00006482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830943|NCT00006483|Sargramostim|sargramostim|mesh-list
25830944|NCT00006483|Immunologic Factors|immunologic factors|mesh-ancestor
25830945|NCT00006483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830946|NCT00006484|Paclitaxel|paclitaxel|mesh-list
25830947|NCT00006484|Carboplatin|carboplatin|mesh-list
25830948|NCT00006484|Tirapazamine|tirapazamine|mesh-list
25162654|NCT02902861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25830949|NCT00006484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25830950|NCT00006484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830951|NCT00006484|Tubulin Modulators|tubulin modulators|mesh-ancestor
25106957|NCT03143491|Mitosis Modulators|mitosis modulators|mesh-ancestor
25106958|NCT03143491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985318|NCT03476642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985319|NCT03476642|Sensory System Agents|sensory system agents|mesh-ancestor
24985320|NCT03476642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24985321|NCT03476642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24985322|NCT03476642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24985323|NCT03476642|Adrenergic Agents|adrenergic agents|mesh-ancestor
24985324|NCT03476642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24540873|NCT00669812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24860503|NCT02310295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860505|NCT02310347|Hallucinogens|hallucinogens|mesh-ancestor
24860506|NCT02310347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860507|NCT02310347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24860508|NCT02310347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25830952|NCT00006484|Antimitotic Agents|antimitotic agents|mesh-ancestor
25830953|NCT00006484|Mitosis Modulators|mitosis modulators|mesh-ancestor
25830954|NCT00006484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830955|NCT00006485|Irinotecan|irinotecan|mesh-list
25830956|NCT00006485|Alvocidib|alvocidib|mesh-list
25830957|NCT00006485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25830958|NCT00006485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25830959|NCT00006485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24985338|NCT03465280|Artemisinins|artemisinins|mesh-list
24985339|NCT03465280|Artemisinin|artemisinin|mesh-list
24985340|NCT03465280|Celecoxib|celecoxib|mesh-list
24985341|NCT03465280|Methotrexate|methotrexate|mesh-list
24985342|NCT03465280|Indole-3-carbinol|indole-3-carbinol|mesh-list
24985343|NCT03465280|Isotretinoin|isotretinoin|mesh-list
24985344|NCT03465280|Cimetidine|cimetidine|mesh-list
24985345|NCT03465280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830960|NCT00006485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830961|NCT00006485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830962|NCT00006485|Growth Inhibitors|growth inhibitors|mesh-ancestor
25830963|NCT00006485|Growth Substances|growth substances|mesh-ancestor
25830964|NCT00006485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830965|NCT00006485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25830966|NCT00006486|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
25830967|NCT00006486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25830968|NCT00006486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25830969|NCT00006486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25830970|NCT00006486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830971|NCT00006486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25830972|NCT00006486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830973|NCT00006487|Cisplatin|cisplatin|mesh-list
25830974|NCT00006487|Etoposide|etoposide|mesh-list
25830975|NCT00006487|Tirapazamine|tirapazamine|mesh-list
24796178|NCT01948336|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24796179|NCT01948336|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24796180|NCT01948336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24796181|NCT01948336|Adrenergic Agents|adrenergic agents|mesh-ancestor
24796182|NCT01948336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24796183|NCT01948336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830976|NCT00006487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796196|NCT01948401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24796197|NCT01948401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796198|NCT01948401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24796199|NCT01948401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796200|NCT01948505|Acetaminophen|acetaminophen|mesh-list
24796201|NCT01948505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24796202|NCT01948505|Analgesics|analgesics|mesh-ancestor
24796203|NCT01948505|Sensory System Agents|sensory system agents|mesh-ancestor
24796204|NCT01948505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24796205|NCT01948505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796207|NCT01948583|Hyaluronic Acid|hyaluronic acid|mesh-list
24796208|NCT01948583|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24796209|NCT01948583|Immunologic Factors|immunologic factors|mesh-ancestor
24796210|NCT01948583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796211|NCT01948583|Viscosupplements|viscosupplements|mesh-ancestor
25830977|NCT00006487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25830978|NCT00006487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25830979|NCT00006487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25830980|NCT00006487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25830981|NCT00006487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796216|NCT01948648|Antimetabolites|antimetabolites|mesh-ancestor
24796217|NCT01948648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796218|NCT01948648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24796220|NCT01948765|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24796221|NCT01948765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24796222|NCT01948765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796223|NCT01948765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24796224|NCT01948765|Anesthetics, General|anesthetics, general|mesh-ancestor
24796225|NCT01948765|Anesthetics|anesthetics|mesh-ancestor
24796226|NCT01948804|Letrozole|letrozole|mesh-list
24796227|NCT01948804|Clomiphene|clomiphene|mesh-list
24985348|NCT03465280|Abortifacient Agents|abortifacient agents|mesh-ancestor
24985349|NCT03465280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24985350|NCT03465280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24985351|NCT03465280|Antimetabolites|antimetabolites|mesh-ancestor
25169554|NCT01818076|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25133616|NCT03011476|Donepezil|donepezil|mesh-list
24985352|NCT03465280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830982|NCT00006493|Rosiglitazone|rosiglitazone|mesh-list
24985421|NCT03367871|Carboplatin|carboplatin|mesh-list
25830983|NCT00006493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25830984|NCT00006493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830985|NCT00006508|Insulin|insulin|mesh-list
25830986|NCT00006508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25830987|NCT00006508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25830988|NCT00006519|Capravirine|capravirine|mesh-list
25830989|NCT00006519|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25830990|NCT00006519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25830991|NCT00006519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24985353|NCT03465280|Dermatologic Agents|dermatologic agents|mesh-ancestor
24985354|NCT03465280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25162655|NCT02902861|Immunologic Factors|immunologic factors|mesh-ancestor
25162656|NCT02902861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25133666|NCT03011567|Ibuprofen|ibuprofen|mesh-list
25162657|NCT02902861|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25162658|NCT02903017|Tranexamic Acid|tranexamic acid|mesh-list
25162659|NCT02903017|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25001691|NCT05159778|Pembrolizumab|pembrolizumab|mesh-list
24494118|NCT00493870|Docetaxel|docetaxel|mesh-list
24985355|NCT03465280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24985356|NCT03465280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24985357|NCT03465280|Immunologic Factors|immunologic factors|mesh-ancestor
24985358|NCT03465280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24985359|NCT03465280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24985360|NCT03465280|Antiviral Agents|antiviral agents|mesh-ancestor
24985361|NCT03465280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25830992|NCT00006519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25830993|NCT00006519|Antiviral Agents|antiviral agents|mesh-ancestor
25830994|NCT00006519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25830995|NCT00006519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25830996|NCT00006519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24985373|NCT03465280|Histamine Antagonists|histamine antagonists|mesh-ancestor
24985374|NCT03465280|Histamine Agents|histamine agents|mesh-ancestor
24985375|NCT03465280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25830997|NCT00006578|Ritonavir|ritonavir|mesh-list
25830998|NCT00006578|Amprenavir|amprenavir|mesh-list
25830999|NCT00006578|Lamivudine|lamivudine|mesh-list
25200465|NCT02733705|Fentanyl|fentanyl|mesh-list
25200466|NCT02733705|Propofol|propofol|mesh-list
25200467|NCT02733705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25200468|NCT02733705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25200469|NCT02733705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200470|NCT02733705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25200471|NCT02733705|Anesthetics, General|anesthetics, general|mesh-ancestor
25200472|NCT02733705|Anesthetics|anesthetics|mesh-ancestor
25200473|NCT02733705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25151275|NCT04788823|Glucocorticoids|glucocorticoids|mesh-ancestor
24985376|NCT03465280|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24985377|NCT03465280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24985378|NCT03465280|Antimalarials|antimalarials|mesh-ancestor
24985394|NCT03421041|Autonomic Agents|autonomic agents|mesh-ancestor
24985395|NCT03421041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24985396|NCT03421041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985397|NCT03421041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24985398|NCT03421041|Glucocorticoids|glucocorticoids|mesh-ancestor
24985399|NCT03421041|Hormones|hormones|mesh-ancestor
24985400|NCT03421041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24985401|NCT03421041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24985402|NCT03421041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985403|NCT03377790|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24985404|NCT03377790|Cantharidin|cantharidin|mesh-list
24985405|NCT03377790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24985406|NCT03377790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162660|NCT02903017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25162661|NCT02903017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162662|NCT02903017|Hemostatics|hemostatics|mesh-ancestor
25162663|NCT02903017|Coagulants|coagulants|mesh-ancestor
25162664|NCT02902731|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25162665|NCT02902731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25162666|NCT02903069|Temozolomide|temozolomide|mesh-list
25162667|NCT02903069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25162668|NCT02903069|Alkylating Agents|alkylating agents|mesh-ancestor
25162669|NCT02903069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162670|NCT02903069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162671|NCT02902744|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
25162672|NCT02902744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25001748|NCT05132660|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25001749|NCT05132660|Dopamine Agents|dopamine agents|mesh-ancestor
25001750|NCT05132660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25001751|NCT05132660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25001752|NCT05132660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25001753|NCT05132660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25001754|NCT05132660|Immunologic Factors|immunologic factors|mesh-ancestor
25001755|NCT05132660|Dopamine Agonists|dopamine agonists|mesh-ancestor
24494280|NCT00494663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24985419|NCT03367871|Paclitaxel|paclitaxel|mesh-list
24985427|NCT03367871|Mitosis Modulators|mitosis modulators|mesh-ancestor
24985428|NCT03367871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985429|NCT03367871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24985430|NCT03367871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24985431|NCT03367871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24985432|NCT03367871|Growth Substances|growth substances|mesh-ancestor
24985433|NCT03367871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985434|NCT03367871|Growth Inhibitors|growth inhibitors|mesh-ancestor
24985435|NCT03365609|Bismuth|bismuth|mesh-list
24985436|NCT03365609|Antacids|antacids|mesh-ancestor
24923135|NCT04172740|Calcium|calcium|mesh-list
24985458|NCT03341078|Vasodilator Agents|vasodilator agents|mesh-ancestor
24794071|NCT05414058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985485|NCT03300518|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24923252|NCT04171739|Olorofim|olorofim|mesh-list
24985488|NCT03294109|Anesthetics, Local|anesthetics, local|mesh-ancestor
25657669|NCT01588561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25657670|NCT01588561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657671|NCT01588951|Cytarabine|cytarabine|mesh-list
25657672|NCT01588951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25657673|NCT01588951|Antimetabolites|antimetabolites|mesh-ancestor
25657674|NCT01588951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657675|NCT01588951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25657676|NCT01588951|Antiviral Agents|antiviral agents|mesh-ancestor
25657677|NCT01588951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25200480|NCT02733510|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25200481|NCT02733510|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25200482|NCT02733510|Prednisolone|prednisolone|mesh-list
25178554|NCT04273880|Vitamins|vitamins|mesh-ancestor
25200483|NCT02733510|Prednisolone acetate|prednisolone acetate|mesh-list
25200484|NCT02733510|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24805718|NCT02011841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200485|NCT02733510|Prednisolone phosphate|prednisolone phosphate|mesh-list
24634358|NCT01133080|Minocycline|minocycline|mesh-list
24634359|NCT01133080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25052066|NCT00338104|Insulin|insulin|mesh-list
24985489|NCT03294109|Anesthetics|anesthetics|mesh-ancestor
24836755|NCT02187315|Cisplatin|cisplatin|mesh-list
24985490|NCT03294109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24985491|NCT03294109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831000|NCT00006578|Abacavir|abacavir|mesh-list
25831001|NCT00006578|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25831002|NCT00006578|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25831003|NCT00006578|Protease Inhibitors|protease inhibitors|mesh-ancestor
25831004|NCT00006578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831005|NCT00006578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831006|NCT00006578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25831007|NCT00006578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25831008|NCT00006578|Antiviral Agents|antiviral agents|mesh-ancestor
25831009|NCT00006578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25831010|NCT00006578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25831011|NCT00006578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25831012|NCT00006578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25831013|NCT00006578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25162673|NCT02902744|Glucocorticoids|glucocorticoids|mesh-ancestor
25162674|NCT02902744|Hormones|hormones|mesh-ancestor
25162675|NCT02902744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25162676|NCT02902744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162677|NCT02902666|Acetaminophen|acetaminophen|mesh-list
25162678|NCT02902666|Codeine|codeine|mesh-list
25162679|NCT02902666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25162680|NCT02902666|Analgesics|analgesics|mesh-ancestor
25162681|NCT02902666|Sensory System Agents|sensory system agents|mesh-ancestor
25831014|NCT00006578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25831015|NCT00006578|Antitubercular Agents|antitubercular agents|mesh-ancestor
25831016|NCT00006578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25162682|NCT02902666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25162683|NCT02902666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049118|NCT00634829|Albuterol|albuterol|mesh-list
25831017|NCT00006591|Ritonavir|ritonavir|mesh-list
24985502|NCT03269409|Coal Tar|coal tar|mesh-list
24985503|NCT03269409|Keratolytic Agents|keratolytic agents|mesh-ancestor
24985504|NCT03269409|Dermatologic Agents|dermatologic agents|mesh-ancestor
25106960|NCT03143244|Midazolam|midazolam|mesh-list
25106961|NCT03143244|Dexmedetomidine|dexmedetomidine|mesh-list
24784849|NCT01910545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784850|NCT01910610|Bevacizumab|bevacizumab|mesh-list
24784851|NCT01910610|Cetuximab|cetuximab|mesh-list
24784852|NCT01910610|Panitumumab|panitumumab|mesh-list
24784853|NCT01910610|Irinotecan|irinotecan|mesh-list
24784854|NCT01910610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24784855|NCT01910610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784856|NCT01910610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24784857|NCT01910610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24784858|NCT01910610|Growth Substances|growth substances|mesh-ancestor
24784859|NCT01910610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784860|NCT01910610|Growth Inhibitors|growth inhibitors|mesh-ancestor
24784861|NCT01910610|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24985505|NCT03268005|Insulin|insulin|mesh-list
24985506|NCT03268005|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24985521|NCT03228186|Tubulin Modulators|tubulin modulators|mesh-ancestor
24985522|NCT03228186|Antimitotic Agents|antimitotic agents|mesh-ancestor
24985523|NCT03228186|Mitosis Modulators|mitosis modulators|mesh-ancestor
25657678|NCT01588951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25657679|NCT01588951|Immunologic Factors|immunologic factors|mesh-ancestor
25657680|NCT01588951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657681|NCT01588990|Leucovorin|leucovorin|mesh-list
25657682|NCT01588990|Bevacizumab|bevacizumab|mesh-list
25657683|NCT01588990|Capecitabine|capecitabine|mesh-list
25657684|NCT01588990|Oxaliplatin|oxaliplatin|mesh-list
25657685|NCT01588990|Irinotecan|irinotecan|mesh-list
25657686|NCT01588990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24985524|NCT03228186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657687|NCT01588990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589071|NCT00905684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24589128|NCT00905931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052067|NCT00338104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25052068|NCT00338104|Insulin Glargine|insulin glargine|mesh-list
25052069|NCT00338104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25052070|NCT00338104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052071|NCT00337532|Paclitaxel|paclitaxel|mesh-list
25052072|NCT00337532|Cisplatin|cisplatin|mesh-list
25052073|NCT00337532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24985525|NCT03228186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24985526|NCT03226756|Nivolumab|nivolumab|mesh-list
24985527|NCT03226756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24985528|NCT03226756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985529|NCT03226756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24985530|NCT03226756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985531|NCT03220854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24985532|NCT03220854|Antibodies|antibodies|mesh-list
24985533|NCT03220854|Immunoglobulins|immunoglobulins|mesh-list
24985534|NCT03220854|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24985535|NCT03220854|Immunologic Factors|immunologic factors|mesh-ancestor
24985536|NCT03220854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985537|NCT03220854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985538|NCT03187769|Olanzapine|olanzapine|mesh-list
24985539|NCT03187769|Antiemetics|antiemetics|mesh-ancestor
24985540|NCT03187769|Autonomic Agents|autonomic agents|mesh-ancestor
24985541|NCT03187769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24985542|NCT03187769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985543|NCT03187769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24985553|NCT03187769|Serotonin Agents|serotonin agents|mesh-ancestor
24985554|NCT03168438|Cyclophosphamide|cyclophosphamide|mesh-list
24985555|NCT03168438|Pembrolizumab|pembrolizumab|mesh-list
24985556|NCT03168438|Fludarabine|fludarabine|mesh-list
24985557|NCT03168438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24985570|NCT03132038|Nivolumab|nivolumab|mesh-list
25831018|NCT00006591|Amprenavir|amprenavir|mesh-list
25831019|NCT00006591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25831020|NCT00006591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25831021|NCT00006591|Protease Inhibitors|protease inhibitors|mesh-ancestor
25831022|NCT00006591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831023|NCT00006591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985571|NCT03132038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24985572|NCT03132038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985573|NCT03132038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24985574|NCT03132038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985575|NCT03128021|Milnacipran|milnacipran|mesh-list
24985576|NCT03128021|Citalopram|citalopram|mesh-list
24985577|NCT03128021|Levomilnacipran|levomilnacipran|mesh-list
24985578|NCT03128021|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24985579|NCT03128021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24985580|NCT03128021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24985581|NCT03128021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985582|NCT03128021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24985583|NCT03128021|Serotonin Agents|serotonin agents|mesh-ancestor
24985584|NCT03128021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985585|NCT03128021|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25162684|NCT02902666|Antipyretics|antipyretics|mesh-ancestor
24985586|NCT03128021|Antidepressive Agents|antidepressive agents|mesh-ancestor
24939575|NCT04008511|Capecitabine|capecitabine|mesh-list
24939576|NCT04008511|Oxaliplatin|oxaliplatin|mesh-list
24939577|NCT04008511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24939578|NCT04008511|Antimetabolites|antimetabolites|mesh-ancestor
24939579|NCT04008511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939580|NCT04008511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985587|NCT03128021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24985588|NCT03128021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24985589|NCT03128021|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25657688|NCT01588990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25657689|NCT01588990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25657690|NCT01588990|Growth Substances|growth substances|mesh-ancestor
25657691|NCT01588990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657692|NCT01588990|Growth Inhibitors|growth inhibitors|mesh-ancestor
25657693|NCT01588990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25657694|NCT01588990|Antimetabolites|antimetabolites|mesh-ancestor
25657695|NCT01588990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589135|NCT00905983|Docetaxel|docetaxel|mesh-list
24589136|NCT00905983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24589137|NCT00905983|Antimetabolites|antimetabolites|mesh-ancestor
24589138|NCT00905983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589139|NCT00905983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25057170|NCT03506919|Allopurinol|allopurinol|mesh-list
24589140|NCT00905983|Antiviral Agents|antiviral agents|mesh-ancestor
24589141|NCT00905983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24634445|NCT01133470|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24634447|NCT01133470|Histamine Antagonists|histamine antagonists|mesh-ancestor
25831025|NCT00006591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24589226|NCT00906139|Analgesics|analgesics|mesh-ancestor
24589227|NCT00906139|Sensory System Agents|sensory system agents|mesh-ancestor
24589228|NCT00906139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24589229|NCT00906139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24589230|NCT00906139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24589231|NCT00906139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24985590|NCT03128021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24985591|NCT03128021|Analgesics|analgesics|mesh-ancestor
24985592|NCT03128021|Sensory System Agents|sensory system agents|mesh-ancestor
24985593|NCT03110380|Dolutegravir|dolutegravir|mesh-list
24985594|NCT03110380|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
24985595|NCT03110380|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25831026|NCT00006591|Antiviral Agents|antiviral agents|mesh-ancestor
25831027|NCT00006591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25831028|NCT00006591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25831029|NCT00006591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25831030|NCT00006591|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25831031|NCT00006591|Antitubercular Agents|antitubercular agents|mesh-ancestor
25831032|NCT00006591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25831033|NCT00006617|Lamivudine|lamivudine|mesh-list
24985644|NCT03009487|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24985646|NCT03009487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24985647|NCT03009487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24985655|NCT02961881|Blinatumomab|blinatumomab|mesh-list
24985656|NCT02961881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985657|NCT02954523|Dasatinib|dasatinib|mesh-list
24985658|NCT02954523|Osimertinib|osimertinib|mesh-list
24985659|NCT02954523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985660|NCT02954523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24985661|NCT02954523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24985662|NCT02954523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831034|NCT00006617|Zidovudine|zidovudine|mesh-list
25831035|NCT00006617|Abacavir|abacavir|mesh-list
25162685|NCT02902666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25831036|NCT00006617|Amprenavir|amprenavir|mesh-list
25831037|NCT00006617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25831038|NCT00006617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25162686|NCT02902666|Narcotics|narcotics|mesh-ancestor
25162687|NCT02902666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25162688|NCT02902666|Antitussive Agents|antitussive agents|mesh-ancestor
25162689|NCT02902666|Respiratory System Agents|respiratory system agents|mesh-ancestor
25162690|NCT02902653|Misoprostol|misoprostol|mesh-list
25162691|NCT02902653|Dinoprostone|dinoprostone|mesh-list
25162692|NCT02902653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25162693|NCT02902653|Abortifacient Agents|abortifacient agents|mesh-ancestor
25657696|NCT01588990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25657697|NCT01588990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25657698|NCT01588990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657699|NCT01588990|Antidotes|antidotes|mesh-ancestor
25657700|NCT01588990|Protective Agents|protective agents|mesh-ancestor
25657701|NCT01588990|Vitamin B Complex|vitamin b complex|mesh-ancestor
25657702|NCT01588990|Vitamins|vitamins|mesh-ancestor
25657703|NCT01588990|Micronutrients|micronutrients|mesh-ancestor
25657704|NCT01589094|Gemcitabine|gemcitabine|mesh-list
25657705|NCT01589094|Cisplatin|cisplatin|mesh-list
25657706|NCT01589094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25657707|NCT01589094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25657708|NCT01589094|Antimetabolites|antimetabolites|mesh-ancestor
25657709|NCT01589094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657710|NCT01589094|Antiviral Agents|antiviral agents|mesh-ancestor
25657711|NCT01589094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25657712|NCT01589094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657713|NCT01589094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25831039|NCT00006617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25162695|NCT02902653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831040|NCT00006617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831041|NCT00006617|Antiviral Agents|antiviral agents|mesh-ancestor
25831042|NCT00006617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25831043|NCT00006617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25831044|NCT00006617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25831045|NCT00006617|Antimetabolites|antimetabolites|mesh-ancestor
24985663|NCT02927249|Aspirin|aspirin|mesh-list
24796228|NCT01948804|Cetrorelix|cetrorelix|mesh-list
24796229|NCT01948804|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24796230|NCT01948804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796231|NCT01948804|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24796232|NCT01948804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24796233|NCT01948804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796247|NCT01948817|Chelating Agents|chelating agents|mesh-ancestor
24796248|NCT01948817|Sequestering Agents|sequestering agents|mesh-ancestor
24796249|NCT01948817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796250|NCT01948895|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24796251|NCT01948895|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25831046|NCT00006617|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25831047|NCT00006617|Antitubercular Agents|antitubercular agents|mesh-ancestor
25831048|NCT00006617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25831049|NCT00006617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25831050|NCT00006617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25831051|NCT00006617|Protease Inhibitors|protease inhibitors|mesh-ancestor
25831052|NCT00006630|Immunoglobulins|immunoglobulins|mesh-list
24505129|NCT00540085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25133967|NCT03009292|Lenvatinib|lenvatinib|mesh-list
24505130|NCT00540085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505131|NCT00540098|Paroxetine|paroxetine|mesh-list
24505132|NCT00540098|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25831053|NCT00006630|Antibodies|antibodies|mesh-list
25831054|NCT00006630|gamma-Globulins|gamma-globulins|mesh-list
25831055|NCT00006630|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25831056|NCT00006630|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25831057|NCT00006630|Immunologic Factors|immunologic factors|mesh-ancestor
24796255|NCT01948895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24796256|NCT01948895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796257|NCT01948895|Antidepressive Agents|antidepressive agents|mesh-ancestor
24796258|NCT01948895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24796259|NCT01948921|Meperidine|meperidine|mesh-list
24796260|NCT01948921|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24796261|NCT01948921|Narcotics|narcotics|mesh-ancestor
24796262|NCT01948921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24796263|NCT01948921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796266|NCT01948921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24796267|NCT01948921|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24985664|NCT02927249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24985691|NCT02901483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985693|NCT02874651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985694|NCT02874651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24985695|NCT02874651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24985696|NCT02874651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985697|NCT02873195|Bevacizumab|bevacizumab|mesh-list
24985698|NCT02873195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24985699|NCT02873195|Capecitabine|capecitabine|mesh-list
24985700|NCT02873195|Atezolizumab|atezolizumab|mesh-list
24985701|NCT02873195|Endothelial Growth Factors|endothelial growth factors|mesh-list
24985702|NCT02873195|Antibodies|antibodies|mesh-list
24985703|NCT02873195|Immunoglobulins|immunoglobulins|mesh-list
24985704|NCT02873195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24985705|NCT02873195|Immunoglobulin G|immunoglobulin g|mesh-list
24985706|NCT02873195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985707|NCT02873195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25162696|NCT02902653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25049174|NCT00631111|Antipyretics|antipyretics|mesh-ancestor
24985708|NCT02873195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24985709|NCT02873195|Growth Substances|growth substances|mesh-ancestor
24985710|NCT02873195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985711|NCT02873195|Growth Inhibitors|growth inhibitors|mesh-ancestor
24985712|NCT02873195|Immunologic Factors|immunologic factors|mesh-ancestor
24985713|NCT02873195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24985714|NCT02873195|Antimetabolites|antimetabolites|mesh-ancestor
24985715|NCT02873195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589673|NCT00908362|Hormones|hormones|mesh-ancestor
24985760|NCT02785952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985761|NCT02784171|Pembrolizumab|pembrolizumab|mesh-list
24985762|NCT02784171|Pemetrexed|pemetrexed|mesh-list
24985763|NCT02784171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985764|NCT02784171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24985765|NCT02784171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24985766|NCT02784171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985767|NCT02784171|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24985768|NCT02784171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24860794|NCT02312661|Tubulin Modulators|tubulin modulators|mesh-ancestor
24541113|NCT00670878|Antiviral Agents|antiviral agents|mesh-ancestor
24505505|NCT00541216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505507|NCT00541281|Docetaxel|docetaxel|mesh-list
24505508|NCT00541281|Estramustine|estramustine|mesh-list
24505511|NCT00541281|Antimitotic Agents|antimitotic agents|mesh-ancestor
24505512|NCT00541281|Mitosis Modulators|mitosis modulators|mesh-ancestor
24505513|NCT00541281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505514|NCT00541281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24505545|NCT00541372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505546|NCT00541411|Dactinomycin|dactinomycin|mesh-list
24505547|NCT00541411|Vincristine|vincristine|mesh-list
24505548|NCT00541411|Ifosfamide|ifosfamide|mesh-list
24505549|NCT00541411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24505550|NCT00541411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505551|NCT00541411|Tubulin Modulators|tubulin modulators|mesh-ancestor
24985802|NCT02730429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985803|NCT02730429|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24985804|NCT02730429|Hormone Antagonists|hormone antagonists|mesh-ancestor
24505676|NCT00541905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505678|NCT00541905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24505680|NCT00541918|Sevoflurane|sevoflurane|mesh-list
24505681|NCT00541918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24505682|NCT00541918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24505683|NCT00541918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505684|NCT00541918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24505691|NCT00542022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25162697|NCT02902653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25162698|NCT02902653|Oxytocics|oxytocics|mesh-ancestor
25162699|NCT02902640|Trimethoprim|trimethoprim|mesh-list
25001988|NCT04950764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495028|NCT00498108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495029|NCT00498134|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
24495030|NCT00498134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24495031|NCT00498134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495032|NCT00498134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505695|NCT00542022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505741|NCT00542165|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24505743|NCT00542165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24505744|NCT00542165|Adrenergic Agents|adrenergic agents|mesh-ancestor
25831058|NCT00006630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831059|NCT00006656|Ethanol|ethanol|mesh-list
25831060|NCT00006656|Carmustine|carmustine|mesh-list
25831061|NCT00006656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25831062|NCT00006656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24985830|NCT02693821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24985831|NCT02693821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24985832|NCT02693821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860859|NCT02313272|Pembrolizumab|pembrolizumab|mesh-list
25831063|NCT00006656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24505753|NCT00542243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505754|NCT00542243|Hormone Antagonists|hormone antagonists|mesh-ancestor
24505755|NCT00542243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25831064|NCT00006656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831065|NCT00006656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25831066|NCT00006656|Alkylating Agents|alkylating agents|mesh-ancestor
25831067|NCT00006656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831068|NCT00006656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831069|NCT00006669|Prednisone|prednisone|mesh-list
25831070|NCT00006669|Cyclophosphamide|cyclophosphamide|mesh-list
25657714|NCT01589094|Immunologic Factors|immunologic factors|mesh-ancestor
25831071|NCT00006669|Rituximab|rituximab|mesh-list
24589941|NCT00909961|Zoledronic Acid|zoledronic acid|mesh-list
24589942|NCT00909961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24589943|NCT00909961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589944|NCT00909974|Micronutrients|micronutrients|mesh-list
24589945|NCT00909974|Trace Elements|trace elements|mesh-list
24589946|NCT00909974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589947|NCT00909987|Bevacizumab|bevacizumab|mesh-list
24589971|NCT00910065|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
25831072|NCT00006669|Doxorubicin|doxorubicin|mesh-list
25831073|NCT00006669|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24505770|NCT00542347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505771|NCT00542347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505772|NCT00542399|Insulin Detemir|insulin detemir|mesh-list
24505773|NCT00542399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24505774|NCT00542399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505776|NCT00542412|Anticonvulsants|anticonvulsants|mesh-ancestor
24505777|NCT00542412|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24505953|NCT00543504|Cetuximab|cetuximab|mesh-list
24505954|NCT00543504|Sunitinib|sunitinib|mesh-list
24505955|NCT00543504|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24505956|NCT00543504|Sorafenib|sorafenib|mesh-list
24505957|NCT00543504|Lapatinib|lapatinib|mesh-list
25134174|NCT03007810|Dermatologic Agents|dermatologic agents|mesh-ancestor
24505958|NCT00543504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24505959|NCT00543504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505960|NCT00543504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24985873|NCT02626715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985874|NCT02626715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24985875|NCT02626715|Immunologic Factors|immunologic factors|mesh-ancestor
24985876|NCT02626715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985877|NCT02626715|Antiviral Agents|antiviral agents|mesh-ancestor
24985878|NCT02626715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24985879|NCT02626715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24985880|NCT02626715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25162700|NCT02902640|Sulfamethoxazole|sulfamethoxazole|mesh-list
25162701|NCT02902640|Phenylpropanolamine|phenylpropanolamine|mesh-list
25162702|NCT02902640|Guaifenesin|guaifenesin|mesh-list
25162703|NCT02902640|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
25162704|NCT02902640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25162705|NCT02902640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25162706|NCT02902640|Renal Agents|renal agents|mesh-ancestor
25162707|NCT02902640|Antimalarials|antimalarials|mesh-ancestor
25002073|NCT04929080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25002075|NCT04929080|Immunoglobulins|immunoglobulins|mesh-list
25002076|NCT04929080|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25002077|NCT04929080|Immunoglobulin G|immunoglobulin g|mesh-list
24939728|NCT04007328|Prednisolone|prednisolone|mesh-list
25657715|NCT01589094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657716|NCT01589263|Tamsulosin|tamsulosin|mesh-list
25657717|NCT01589263|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25657718|NCT01589263|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25657719|NCT01589263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25657720|NCT01589263|Adrenergic Agents|adrenergic agents|mesh-ancestor
25657721|NCT01589263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25657722|NCT01589263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657723|NCT01589263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657724|NCT01589263|Urological Agents|urological agents|mesh-ancestor
25657725|NCT01589445|Metformin|metformin|mesh-list
25657726|NCT01589445|Pioglitazone|pioglitazone|mesh-list
25657727|NCT01589445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25657728|NCT01589445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831074|NCT00006669|Etoposide|etoposide|mesh-list
25002078|NCT04929080|Immunologic Factors|immunologic factors|mesh-ancestor
24985881|NCT02626715|Alkylating Agents|alkylating agents|mesh-ancestor
24985882|NCT02626715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24985883|NCT02589860|Melphalan|melphalan|mesh-list
24985884|NCT02589860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24860903|NCT02313727|Pamidronate|pamidronate|mesh-list
24505961|NCT00543504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24506039|NCT00543842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506040|NCT00543842|Growth Inhibitors|growth inhibitors|mesh-ancestor
24506041|NCT00543842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24506042|NCT00543842|Antimetabolites|antimetabolites|mesh-ancestor
24506043|NCT00543842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506044|NCT00543842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24506045|NCT00543842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506046|NCT00543933|Nitric Oxide|nitric oxide|mesh-list
24506054|NCT00543933|Antioxidants|antioxidants|mesh-ancestor
24985885|NCT02589860|Alkylating Agents|alkylating agents|mesh-ancestor
24985886|NCT02589860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985887|NCT02589860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985888|NCT02589860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24985889|NCT02589860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24985890|NCT02589860|Immunologic Factors|immunologic factors|mesh-ancestor
24985891|NCT02589860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985892|NCT02583789|Treprostinil|treprostinil|mesh-list
24985893|NCT02583789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24985895|NCT02556606|Ketamine|ketamine|mesh-list
24985896|NCT02556606|Analgesics|analgesics|mesh-ancestor
24985897|NCT02556606|Sensory System Agents|sensory system agents|mesh-ancestor
24985898|NCT02556606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24985899|NCT02556606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985900|NCT02556606|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24985902|NCT02556606|Anesthetics, General|anesthetics, general|mesh-ancestor
24506086|NCT00544037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506235|NCT00544362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506236|NCT00544362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24506237|NCT00544362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24506238|NCT00544362|Immunologic Factors|immunologic factors|mesh-ancestor
24506239|NCT00544362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506240|NCT00544362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24506241|NCT00544388|Levocetirizine|levocetirizine|mesh-list
24506243|NCT00544388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24506283|NCT00544570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506284|NCT00544570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25831075|NCT00006669|Vincristine|vincristine|mesh-list
25831076|NCT00006669|Sargramostim|sargramostim|mesh-list
25831077|NCT00006669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24506351|NCT00544791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162708|NCT02902640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25162709|NCT02902640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25162710|NCT02902640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25162711|NCT02902640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25162712|NCT02902640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162713|NCT02902640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25162714|NCT02902640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25162715|NCT02902640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25162716|NCT02902640|Expectorants|expectorants|mesh-ancestor
25162717|NCT02902640|Respiratory System Agents|respiratory system agents|mesh-ancestor
25162718|NCT02902640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25162719|NCT02902640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24506352|NCT00544791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25831078|NCT00006669|Immunologic Factors|immunologic factors|mesh-ancestor
25831079|NCT00006669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831080|NCT00006669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25831081|NCT00006669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24506483|NCT00545493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24506484|NCT00545493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506485|NCT00545493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506529|NCT00545675|GABA Agents|gaba agents|mesh-ancestor
24985903|NCT02556606|Anesthetics|anesthetics|mesh-ancestor
24985904|NCT02556606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24985905|NCT02556606|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24985906|NCT02556606|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24985907|NCT02556606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25831082|NCT00006669|Alkylating Agents|alkylating agents|mesh-ancestor
24985908|NCT02556606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985909|NCT02556606|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24985910|NCT02556606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24985911|NCT02556606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24985912|NCT02556606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24985913|NCT02556606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24985914|NCT02556606|GABA Modulators|gaba modulators|mesh-ancestor
24985915|NCT02556606|GABA Agents|gaba agents|mesh-ancestor
24985916|NCT02546999|Botulinum Toxins|botulinum toxins|mesh-list
24985917|NCT02546999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24985918|NCT02546999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24985919|NCT02546999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24985920|NCT02546999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985921|NCT02546999|Cholinergic Agents|cholinergic agents|mesh-ancestor
24985922|NCT02546999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24985923|NCT02546999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985924|NCT02546999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24985925|NCT02546999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24985929|NCT02545283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985930|NCT02545283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985932|NCT02545283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24985933|NCT02545283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24985934|NCT02545283|Immunologic Factors|immunologic factors|mesh-ancestor
24507228|NCT00549289|Cyclosporins|cyclosporins|mesh-list
24507234|NCT00549289|Antifungal Agents|antifungal agents|mesh-ancestor
24985962|NCT02465593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24985963|NCT02465593|Immunologic Factors|immunologic factors|mesh-ancestor
24985964|NCT02465593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985965|NCT02465268|Molgramostim|molgramostim|mesh-list
24985966|NCT02465268|Sargramostim|sargramostim|mesh-list
24985967|NCT02465268|Immunologic Factors|immunologic factors|mesh-ancestor
24985968|NCT02465268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985969|NCT02465268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985970|NCT02424019|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
24985971|NCT02424019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24985972|NCT02424019|Glucocorticoids|glucocorticoids|mesh-ancestor
24985973|NCT02424019|Hormones|hormones|mesh-ancestor
25106975|NCT03143244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25106976|NCT03143244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25106995|NCT03143036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25106996|NCT03143036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162720|NCT02902640|Adrenergic Agents|adrenergic agents|mesh-ancestor
24798573|NCT01964183|Urological Agents|urological agents|mesh-ancestor
24798574|NCT01964183|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24798575|NCT01964183|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24798576|NCT01964183|Cholinergic Agents|cholinergic agents|mesh-ancestor
24798577|NCT01964248|Lidocaine|lidocaine|mesh-list
24798578|NCT01964248|Prilocaine|prilocaine|mesh-list
24798579|NCT01964248|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24798580|NCT01964248|Anesthetics, Local|anesthetics, local|mesh-ancestor
24798581|NCT01964248|Anesthetics|anesthetics|mesh-ancestor
24798582|NCT01964248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24798583|NCT01964248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798592|NCT01964287|Leucovorin|leucovorin|mesh-list
24986038|NCT02393183|Selenium|selenium|mesh-list
24986039|NCT02393183|Antioxidants|antioxidants|mesh-list
24986040|NCT02393183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986041|NCT02393183|Protective Agents|protective agents|mesh-ancestor
24986042|NCT02393183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986043|NCT02393183|Trace Elements|trace elements|mesh-ancestor
24986044|NCT02393183|Micronutrients|micronutrients|mesh-ancestor
24986045|NCT02379520|Cyclophosphamide|cyclophosphamide|mesh-list
24986046|NCT02379520|Nivolumab|nivolumab|mesh-list
24986047|NCT02379520|Fludarabine|fludarabine|mesh-list
24986048|NCT02379520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24986049|NCT02379520|Immunologic Factors|immunologic factors|mesh-ancestor
24986050|NCT02379520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986051|NCT02379520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24986052|NCT02379520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24507258|NCT00549419|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24507259|NCT00549419|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24507260|NCT00549419|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24986053|NCT02379520|Alkylating Agents|alkylating agents|mesh-ancestor
24986054|NCT02379520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986055|NCT02379520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24777468|NCT01864187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24777469|NCT01864187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24777470|NCT01864187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24986056|NCT02379520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24986057|NCT02379520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24986058|NCT02379520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24796279|NCT01949038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796280|NCT01949038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24796281|NCT01949038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24796282|NCT01949038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24796283|NCT01949038|GABA Modulators|gaba modulators|mesh-ancestor
24796285|NCT01949038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24796286|NCT01949038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796287|NCT01949064|Salicylic Acid|salicylic acid|mesh-list
24796288|NCT01949064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24796289|NCT01949064|Antifungal Agents|antifungal agents|mesh-ancestor
25162721|NCT02902640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25162722|NCT02902640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162723|NCT02902640|Appetite Depressants|appetite depressants|mesh-ancestor
25162724|NCT02902640|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25162725|NCT02902640|Sympathomimetics|sympathomimetics|mesh-ancestor
25162726|NCT02902640|Autonomic Agents|autonomic agents|mesh-ancestor
25162727|NCT02902640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25162728|NCT02902640|Nasal Decongestants|nasal decongestants|mesh-ancestor
25162729|NCT02902640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25162730|NCT02902354|Nifedipine|nifedipine|mesh-list
25162731|NCT02902354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24796290|NCT01949064|Keratolytic Agents|keratolytic agents|mesh-ancestor
24796291|NCT01949064|Dermatologic Agents|dermatologic agents|mesh-ancestor
24796292|NCT01949129|Cyclophosphamide|cyclophosphamide|mesh-list
24796293|NCT01949129|Busulfan|busulfan|mesh-list
24796294|NCT01949129|Thiotepa|thiotepa|mesh-list
24796295|NCT01949129|Treosulfan|treosulfan|mesh-list
24796296|NCT01949129|Fludarabine|fludarabine|mesh-list
24796297|NCT01949129|Etoposide|etoposide|mesh-list
24796298|NCT01949129|Thymoglobulin|thymoglobulin|mesh-list
25831083|NCT00006669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831084|NCT00006669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831085|NCT00006669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24796309|NCT01949129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24796310|NCT01949129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24796311|NCT01949129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24796312|NCT01949129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24796313|NCT01949129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796314|NCT01949168|Ribavirin|ribavirin|mesh-list
24796315|NCT01949168|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24796316|NCT01949168|Antimetabolites|antimetabolites|mesh-ancestor
24796317|NCT01949168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923867|NCT04166565|Hormones|hormones|mesh-ancestor
24986071|NCT02333162|Mycophenolic Acid|mycophenolic acid|mesh-list
24986072|NCT02333162|Fludarabine|fludarabine|mesh-list
24507388|NCT00550199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507389|NCT00550199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507390|NCT00550199|Antiviral Agents|antiviral agents|mesh-ancestor
24507391|NCT00550199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24507392|NCT00550199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507393|NCT00550199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24507394|NCT00550199|Immunologic Factors|immunologic factors|mesh-ancestor
24507395|NCT00550199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507396|NCT00550199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24986079|NCT02333162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986081|NCT02333162|Immunologic Factors|immunologic factors|mesh-ancestor
24986082|NCT02333162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986083|NCT02333162|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24986084|NCT02333162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24986085|NCT02333162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24986086|NCT02333162|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24986087|NCT02333162|Antitubercular Agents|antitubercular agents|mesh-ancestor
25657729|NCT01589497|Moxifloxacin|moxifloxacin|mesh-list
25657730|NCT01589497|Rifampin|rifampin|mesh-list
25657731|NCT01589497|Isoniazid|isoniazid|mesh-list
24986088|NCT02333162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24986089|NCT02333162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25657732|NCT01589497|Pyrazinamide|pyrazinamide|mesh-list
25657733|NCT01589497|Ethambutol|ethambutol|mesh-list
25657734|NCT01589497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24986090|NCT02333162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24986091|NCT02333162|Alkylating Agents|alkylating agents|mesh-ancestor
24986092|NCT02333162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24986093|NCT02318342|Warfarin|warfarin|mesh-list
24986094|NCT02318342|Anticoagulants|anticoagulants|mesh-ancestor
24986114|NCT02303821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24986115|NCT02303821|Alkylating Agents|alkylating agents|mesh-ancestor
24986116|NCT02303821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986117|NCT02303821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986118|NCT02303821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24986119|NCT02303821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24986120|NCT02303821|Antiemetics|antiemetics|mesh-ancestor
24986146|NCT02303821|Analgesics|analgesics|mesh-ancestor
24986147|NCT02303821|Sensory System Agents|sensory system agents|mesh-ancestor
25169556|NCT01818076|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24861067|NCT02314533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861068|NCT02314533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24682678|NCT01387880|Everolimus|everolimus|mesh-list
24541376|NCT00672464|Antimetabolites|antimetabolites|mesh-ancestor
24541377|NCT00672464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541378|NCT00672464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24541379|NCT00672464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24541380|NCT00672464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24986156|NCT02287311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986157|NCT02287311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986158|NCT02287311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24986170|NCT02263729|Losartan|losartan|mesh-list
24986171|NCT02263729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24986172|NCT02263729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24986173|NCT02263729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24986174|NCT02263729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24986175|NCT02263729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986176|NCT02261415|Tranexamic Acid|tranexamic acid|mesh-list
24986177|NCT02261415|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24986178|NCT02261415|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24986179|NCT02261415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986180|NCT02261415|Hemostatics|hemostatics|mesh-ancestor
24986181|NCT02261415|Coagulants|coagulants|mesh-ancestor
24986182|NCT02225600|Oxytocin|oxytocin|mesh-list
24986183|NCT02225600|Oxytocics|oxytocics|mesh-ancestor
24986184|NCT02225600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24986185|NCT02225600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986186|NCT02223520|Chlorhexidine|chlorhexidine|mesh-list
24986187|NCT02223520|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24986188|NCT02223520|Mupirocin|mupirocin|mesh-list
24986189|NCT02223520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24986190|NCT02223520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24986191|NCT02223520|Disinfectants|disinfectants|mesh-ancestor
24986192|NCT02223520|Dermatologic Agents|dermatologic agents|mesh-ancestor
24986193|NCT02223520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24541382|NCT00672464|Autonomic Agents|autonomic agents|mesh-ancestor
24986196|NCT02223520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986197|NCT02220309|Pramipexole|pramipexole|mesh-list
24986198|NCT02220309|Antioxidants|antioxidants|mesh-ancestor
24986199|NCT02220309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986200|NCT02220309|Protective Agents|protective agents|mesh-ancestor
24986201|NCT02220309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489489|NCT00473551|Antiviral Agents|antiviral agents|mesh-ancestor
24507854|NCT00552734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508067|NCT00554138|Antimetabolites|antimetabolites|mesh-ancestor
24986214|NCT02126553|Growth Substances|growth substances|mesh-ancestor
24986215|NCT02126553|Growth Inhibitors|growth inhibitors|mesh-ancestor
24986216|NCT02126553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986218|NCT02122198|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24986219|NCT02122198|Medroxyprogesterone|medroxyprogesterone|mesh-list
24986222|NCT02122198|Hormones|hormones|mesh-ancestor
24986223|NCT02122198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24508068|NCT00554138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508069|NCT00554138|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24508070|NCT00554138|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24508071|NCT00554138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508072|NCT00554164|Prednisone|prednisone|mesh-list
24508073|NCT00554164|Cyclophosphamide|cyclophosphamide|mesh-list
24508074|NCT00554164|Doxorubicin|doxorubicin|mesh-list
24591330|NCT00915915|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24591331|NCT00915915|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24582903|NCT00872469|Hemostatics|hemostatics|mesh-ancestor
24591339|NCT00915915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24591345|NCT00916045|Mycophenolic Acid|mycophenolic acid|mesh-list
24591347|NCT00916045|Melphalan|melphalan|mesh-list
24591361|NCT00916045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591362|NCT00916045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591363|NCT00916045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24591365|NCT00916045|Antimetabolites|antimetabolites|mesh-ancestor
24508075|NCT00554164|Vincristine|vincristine|mesh-list
24508076|NCT00554164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25831086|NCT00006669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24508110|NCT00554177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24508111|NCT00554177|Luteolytic Agents|luteolytic agents|mesh-ancestor
24508112|NCT00554177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24508113|NCT00554177|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24508114|NCT00554203|Sulfasalazine|sulfasalazine|mesh-list
24508115|NCT00554203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24508116|NCT00554203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24508117|NCT00554203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24508118|NCT00554203|Analgesics|analgesics|mesh-ancestor
24508119|NCT00554203|Sensory System Agents|sensory system agents|mesh-ancestor
24508120|NCT00554203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24508121|NCT00554203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508122|NCT00554203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24508125|NCT00554242|Ascorbic Acid|ascorbic acid|mesh-list
25831087|NCT00006669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25162732|NCT02902354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25831088|NCT00006669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24508375|NCT00555256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508376|NCT00555256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508377|NCT00555256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24508378|NCT00555256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24508379|NCT00555256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24508380|NCT00555256|Antifungal Agents|antifungal agents|mesh-ancestor
24508383|NCT00555334|Lamivudine|lamivudine|mesh-list
24508402|NCT00555373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24508403|NCT00555373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24508404|NCT00555373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508405|NCT00555373|Antifungal Agents|antifungal agents|mesh-ancestor
24508407|NCT00555373|Immunologic Factors|immunologic factors|mesh-ancestor
25831089|NCT00006669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25831090|NCT00006669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831091|NCT00006669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25831092|NCT00006669|Glucocorticoids|glucocorticoids|mesh-ancestor
25831093|NCT00006669|Hormones|hormones|mesh-ancestor
25831094|NCT00006669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24609972|NCT00999271|Hormones|hormones|mesh-list
24509035|NCT00558142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509037|NCT00558142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509038|NCT00558142|Antidotes|antidotes|mesh-ancestor
24509039|NCT00558181|Methylprednisolone|methylprednisolone|mesh-list
24509040|NCT00558181|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24509041|NCT00558181|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24509042|NCT00558181|Prednisolone|prednisolone|mesh-list
24509043|NCT00558181|Prednisolone acetate|prednisolone acetate|mesh-list
24509044|NCT00558181|Rituximab|rituximab|mesh-list
25831095|NCT00006669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25831096|NCT00006669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25831097|NCT00006669|Tubulin Modulators|tubulin modulators|mesh-ancestor
24509133|NCT00558662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25831098|NCT00006669|Antimitotic Agents|antimitotic agents|mesh-ancestor
25657735|NCT01589497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25657736|NCT01589497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25657737|NCT01589497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25657738|NCT01589497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657739|NCT01589497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657740|NCT01589497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25657741|NCT01589497|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25657742|NCT01589497|Antitubercular Agents|antitubercular agents|mesh-ancestor
25657743|NCT01589497|Leprostatic Agents|leprostatic agents|mesh-ancestor
25657744|NCT01589497|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25831099|NCT00006669|Mitosis Modulators|mitosis modulators|mesh-ancestor
25831100|NCT00006682|Docetaxel|docetaxel|mesh-list
25831101|NCT00006682|Vinorelbine|vinorelbine|mesh-list
25831102|NCT00006682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831103|NCT00006682|Tubulin Modulators|tubulin modulators|mesh-ancestor
25831104|NCT00006682|Antimitotic Agents|antimitotic agents|mesh-ancestor
25831105|NCT00006682|Mitosis Modulators|mitosis modulators|mesh-ancestor
24967548|NCT03758729|Nivolumab|nivolumab|mesh-list
25831106|NCT00006682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831107|NCT00006682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24986232|NCT02122198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986233|NCT02122198|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24986234|NCT02122198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24986235|NCT02122198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24986236|NCT02122198|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24986237|NCT02079948|Folic Acid|folic acid|mesh-list
24986238|NCT02079948|Vitamin B Complex|vitamin b complex|mesh-list
24986239|NCT02079948|Methotrexate|methotrexate|mesh-list
24986240|NCT02079948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24509691|NCT00561704|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24509692|NCT00561704|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24509740|NCT00561964|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24509741|NCT00561964|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24986284|NCT02004275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24986285|NCT02004275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986286|NCT02004275|Immunologic Factors|immunologic factors|mesh-ancestor
24986287|NCT02004275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24986288|NCT02004275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24986289|NCT02004275|Growth Substances|growth substances|mesh-ancestor
24923980|NCT04164615|Capecitabine|capecitabine|mesh-list
24986290|NCT02004275|Growth Inhibitors|growth inhibitors|mesh-ancestor
25202911|NCT02717871|Moxifloxacin|moxifloxacin|mesh-list
24495990|NCT00502879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24986291|NCT02004275|Protease Inhibitors|protease inhibitors|mesh-ancestor
24986292|NCT02004275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24986293|NCT02004275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986294|NCT01978938|Levofloxacin|levofloxacin|mesh-list
24796318|NCT01949168|Antiviral Agents|antiviral agents|mesh-ancestor
24796319|NCT01949168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24796320|NCT01949233|Doxycycline|doxycycline|mesh-list
24796321|NCT01949233|Irbesartan|irbesartan|mesh-list
24796322|NCT01949233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24796323|NCT01949233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24796324|NCT01949233|Antimalarials|antimalarials|mesh-ancestor
24796325|NCT01949233|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24796326|NCT01949233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24796327|NCT01949233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24796328|NCT01949233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24796329|NCT01949233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24796330|NCT01949233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796331|NCT01949363|Cefixime|cefixime|mesh-list
24796341|NCT01949454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24541448|NCT00672776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796342|NCT01949454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796343|NCT01949454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24796344|NCT01949519|Lycopene|lycopene|mesh-list
24796345|NCT01949519|Docetaxel|docetaxel|mesh-list
24796346|NCT01949519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796347|NCT01949519|Tubulin Modulators|tubulin modulators|mesh-ancestor
24796348|NCT01949519|Antimitotic Agents|antimitotic agents|mesh-ancestor
24796349|NCT01949519|Mitosis Modulators|mitosis modulators|mesh-ancestor
24796350|NCT01949519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796351|NCT01949519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24796362|NCT01949571|Histamine Agents|histamine agents|mesh-ancestor
24796363|NCT01949571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24796364|NCT01949571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796365|NCT01949571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796366|NCT01949571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24796367|NCT01949571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24796368|NCT01949571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24796369|NCT01949571|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24796370|NCT01949571|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24796371|NCT01949571|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24796372|NCT01949571|Adrenergic Agents|adrenergic agents|mesh-ancestor
24796380|NCT01949766|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
24796381|NCT01949766|Glycerol|glycerol|mesh-list
24496224|NCT00503828|Sensory System Agents|sensory system agents|mesh-ancestor
24496225|NCT00503828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24496226|NCT00503828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831108|NCT00006695|Iodine|iodine|mesh-list
24496252|NCT00504062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24496253|NCT00504062|Respiratory System Agents|respiratory system agents|mesh-ancestor
24496254|NCT00504062|Dermatologic Agents|dermatologic agents|mesh-ancestor
24496255|NCT00504062|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24496256|NCT00504062|Glucocorticoids|glucocorticoids|mesh-ancestor
24496257|NCT00504062|Hormones|hormones|mesh-ancestor
24496282|NCT00504127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496286|NCT00504140|Interferon-alpha|interferon-alpha|mesh-list
24509974|NCT00563017|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24509975|NCT00563017|Serotonin Agents|serotonin agents|mesh-ancestor
24509976|NCT00563017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24509977|NCT00563017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509978|NCT00563017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509979|NCT00563017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24509980|NCT00563017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24509981|NCT00563017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24509982|NCT00563017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24509983|NCT00563017|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24510037|NCT00563160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24510038|NCT00563160|Antimetabolites|antimetabolites|mesh-ancestor
24510054|NCT00563238|Metoprolol|metoprolol|mesh-list
24510121|NCT00563485|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24510122|NCT00563485|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24796404|NCT01949818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24796405|NCT01949818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24796406|NCT01949818|Alkylating Agents|alkylating agents|mesh-ancestor
24510259|NCT00564031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24510260|NCT00564031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510261|NCT00564031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24510304|NCT00564187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24510305|NCT00564187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24510306|NCT00564187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25162734|NCT02902354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25162735|NCT02902354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162736|NCT02902354|Vasodilator Agents|vasodilator agents|mesh-ancestor
25657745|NCT01589497|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25657746|NCT01589497|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25657747|NCT01589497|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25657748|NCT01589497|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25657749|NCT01589497|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25831109|NCT00006695|Cytarabine|cytarabine|mesh-list
25200698|NCT02732197|Thiopental|thiopental|mesh-list
25162737|NCT02902354|Tocolytic Agents|tocolytic agents|mesh-ancestor
25162738|NCT02902354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25162739|NCT02902315|Vitamins|vitamins|mesh-list
25162740|NCT02902315|Ascorbic Acid|ascorbic acid|mesh-list
25162741|NCT02902315|Tocopherols|tocopherols|mesh-list
25162742|NCT02902315|alpha-Tocopherol|alpha-tocopherol|mesh-list
25162743|NCT02902315|Micronutrients|micronutrients|mesh-ancestor
25162744|NCT02902315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162745|NCT02902315|Antioxidants|antioxidants|mesh-ancestor
25202912|NCT02717871|Ciprofloxacin|ciprofloxacin|mesh-list
24510307|NCT00564187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831110|NCT00006695|Etoposide|etoposide|mesh-list
25831111|NCT00006695|Melphalan|melphalan|mesh-list
25831112|NCT00006695|Carmustine|carmustine|mesh-list
25831113|NCT00006695|Tositumomab I-131|tositumomab i-131|mesh-list
24510309|NCT00564200|Fludarabine|fludarabine|mesh-list
24510310|NCT00564200|Bortezomib|bortezomib|mesh-list
24510311|NCT00564200|Melphalan|melphalan|mesh-list
24510313|NCT00564200|Antiemetics|antiemetics|mesh-ancestor
24510329|NCT00564213|Mitomycins|mitomycins|mesh-list
24510330|NCT00564213|Mitomycin|mitomycin|mesh-list
24510331|NCT00564213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24510332|NCT00564213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510333|NCT00564213|Alkylating Agents|alkylating agents|mesh-ancestor
24510334|NCT00564213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510335|NCT00564213|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24796407|NCT01949818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986379|NCT01712789|Dexamethasone|dexamethasone|mesh-list
24796408|NCT01949818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986380|NCT01712789|Pomalidomide|pomalidomide|mesh-list
24986404|NCT01665794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986405|NCT01665794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24986406|NCT01665794|Glucocorticoids|glucocorticoids|mesh-ancestor
24986408|NCT01665794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24986409|NCT01665794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24986410|NCT01665794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986411|NCT01665794|Immunologic Factors|immunologic factors|mesh-ancestor
24986412|NCT01665794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24986413|NCT01665794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24510336|NCT00564213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510337|NCT00564252|Finasteride|finasteride|mesh-list
24986414|NCT01665794|Growth Substances|growth substances|mesh-ancestor
24986415|NCT01665794|Growth Inhibitors|growth inhibitors|mesh-ancestor
24986425|NCT01560572|Mycophenolic Acid|mycophenolic acid|mesh-list
24986426|NCT01560572|Prednisolone|prednisolone|mesh-list
24986427|NCT01560572|Tacrolimus|tacrolimus|mesh-list
24986428|NCT01560572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24986429|NCT01560572|Immunologic Factors|immunologic factors|mesh-ancestor
24986430|NCT01560572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986431|NCT01560572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24986432|NCT01560572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510945|NCT00566683|Antiemetics|antiemetics|mesh-ancestor
24986433|NCT01560572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986434|NCT01560572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24986435|NCT01560572|Glucocorticoids|glucocorticoids|mesh-ancestor
24986436|NCT01560572|Hormones|hormones|mesh-ancestor
24986437|NCT01560572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24986438|NCT01560572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24986439|NCT01560572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986440|NCT01560572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24986441|NCT01560572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24986446|NCT01543633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24986447|NCT01543633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24986448|NCT01543633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986449|NCT01543633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24986450|NCT01543633|Anesthetics, General|anesthetics, general|mesh-ancestor
24986451|NCT01543633|Anesthetics|anesthetics|mesh-ancestor
24986452|NCT01542736|Carboplatin|carboplatin|mesh-list
24986453|NCT01542736|Vincristine|vincristine|mesh-list
24986454|NCT01542736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986455|NCT01542736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24986456|NCT01542736|Tubulin Modulators|tubulin modulators|mesh-ancestor
24986457|NCT01542736|Antimitotic Agents|antimitotic agents|mesh-ancestor
24986458|NCT01542736|Mitosis Modulators|mitosis modulators|mesh-ancestor
24861209|NCT02315950|Botulinum Toxins|botulinum toxins|mesh-list
24626499|NCT01087593|Estradiol|estradiol|mesh-list
25831114|NCT00006695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25831115|NCT00006695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951873|NCT03899675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24986459|NCT01542736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809966|NCT02037009|Anesthetics|anesthetics|mesh-list
24986460|NCT01481974|Treprostinil|treprostinil|mesh-list
24986461|NCT01481974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24986462|NCT01465100|Liver Extracts|liver extracts|mesh-list
24986463|NCT01465100|Hematinics|hematinics|mesh-ancestor
24986464|NCT01442649|Leucovorin|leucovorin|mesh-list
24986465|NCT01442649|Folic Acid|folic acid|mesh-list
24986466|NCT01442649|Bevacizumab|bevacizumab|mesh-list
24986467|NCT01442649|Cetuximab|cetuximab|mesh-list
24986468|NCT01442649|Oxaliplatin|oxaliplatin|mesh-list
24986469|NCT01442649|Irinotecan|irinotecan|mesh-list
24986470|NCT01442649|Fluorouracil|fluorouracil|mesh-list
24986471|NCT01442649|Levoleucovorin|levoleucovorin|mesh-list
24986472|NCT01442649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24986473|NCT01442649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986474|NCT01442649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24986483|NCT01442649|Antidotes|antidotes|mesh-ancestor
24986492|NCT01442649|Immunologic Factors|immunologic factors|mesh-ancestor
24986493|NCT01147666|Epoetin Alfa|epoetin alfa|mesh-list
24510482|NCT00564655|Sensory System Agents|sensory system agents|mesh-ancestor
24510561|NCT00564993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24510562|NCT00564993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510563|NCT00564993|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24510564|NCT00564993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24510565|NCT00564993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24510566|NCT00564993|Adrenergic Agents|adrenergic agents|mesh-ancestor
24510567|NCT00564993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24510646|NCT00565227|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24510647|NCT00565227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510649|NCT00565240|NuvaRing|nuvaring|mesh-list
24510819|NCT00565708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24510857|NCT00565981|Alemtuzumab|alemtuzumab|mesh-list
24510858|NCT00565981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986509|NCT00670358|Lenalidomide|lenalidomide|mesh-list
25097247|NCT03205228|Omeprazole|omeprazole|mesh-list
24986510|NCT00670358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24986511|NCT00670358|Immunologic Factors|immunologic factors|mesh-ancestor
24986512|NCT00670358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986513|NCT00670358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24986514|NCT00670358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24986515|NCT00670358|Alkylating Agents|alkylating agents|mesh-ancestor
24986516|NCT00670358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986517|NCT00670358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986518|NCT00670358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24986519|NCT00670358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24986520|NCT00670358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24784883|NCT01910844|Immunologic Factors|immunologic factors|mesh-ancestor
24784884|NCT01910844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784885|NCT01910844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24784886|NCT01910844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24784914|NCT01910987|Dexamethasone|dexamethasone|mesh-list
24510885|NCT00566267|Antimetabolites|antimetabolites|mesh-ancestor
24510886|NCT00566267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510951|NCT00566683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24511015|NCT00566904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24511016|NCT00566904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24511017|NCT00566904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24511020|NCT00567034|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24511021|NCT00567034|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24511080|NCT00567372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24511081|NCT00567372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511082|NCT00567372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24511083|NCT00567372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24511084|NCT00567372|Growth Substances|growth substances|mesh-ancestor
24511085|NCT00567372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511086|NCT00567372|Growth Inhibitors|growth inhibitors|mesh-ancestor
24511087|NCT00567411|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24511088|NCT00567411|Apraclonidine|apraclonidine|mesh-list
25202913|NCT02717871|Levofloxacin|levofloxacin|mesh-list
25002637|NCT04447781|Citric Acid|citric acid|mesh-list
25657750|NCT01589497|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25002638|NCT04447781|Sodium Citrate|sodium citrate|mesh-list
25657751|NCT01589497|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25657752|NCT01589497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25657753|NCT01589497|Antimetabolites|antimetabolites|mesh-ancestor
25002639|NCT04447781|Anticoagulants|anticoagulants|mesh-ancestor
25002640|NCT04447781|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25002641|NCT04447781|Chelating Agents|chelating agents|mesh-ancestor
25002642|NCT04447781|Sequestering Agents|sequestering agents|mesh-ancestor
24511089|NCT00567411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24511090|NCT00567411|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24784937|NCT01911195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784938|NCT01911234|Freund's Adjuvant|freund's adjuvant|mesh-list
24784939|NCT01911234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24784940|NCT01911234|Immunologic Factors|immunologic factors|mesh-ancestor
24784941|NCT01911234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511101|NCT00567450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24511102|NCT00567450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511103|NCT00567450|Sensory System Agents|sensory system agents|mesh-ancestor
24511151|NCT00567554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24511152|NCT00567554|Growth Substances|growth substances|mesh-ancestor
24511153|NCT00567554|Growth Inhibitors|growth inhibitors|mesh-ancestor
24511154|NCT00567554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24511155|NCT00567554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24784948|NCT01911299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25106997|NCT03143036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25106998|NCT03143036|Glucocorticoids|glucocorticoids|mesh-ancestor
25106999|NCT03143036|Hormones|hormones|mesh-ancestor
25107000|NCT03143036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25107001|NCT03143036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25107002|NCT03143036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25107003|NCT03143036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25107004|NCT03143036|Immunologic Factors|immunologic factors|mesh-ancestor
25107005|NCT03143036|Leprostatic Agents|leprostatic agents|mesh-ancestor
25107006|NCT03143036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25107007|NCT03143036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25107008|NCT03143036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25107009|NCT03143036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25107010|NCT03143036|Growth Substances|growth substances|mesh-ancestor
25107011|NCT03143036|Growth Inhibitors|growth inhibitors|mesh-ancestor
25107012|NCT03143023|Fluorides|fluorides|mesh-list
25107013|NCT03143023|Cariostatic Agents|cariostatic agents|mesh-ancestor
25107014|NCT03143023|Protective Agents|protective agents|mesh-ancestor
25107015|NCT03143023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107016|NCT03142789|Cerivastatin|cerivastatin|mesh-list
25107017|NCT03142789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25107018|NCT03142789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25107019|NCT03142789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25107020|NCT03142789|Antimetabolites|antimetabolites|mesh-ancestor
25107021|NCT03142789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511367|NCT00568412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162746|NCT02902315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162747|NCT02902315|Protective Agents|protective agents|mesh-ancestor
25162748|NCT02902302|Ibuprofen|ibuprofen|mesh-list
25162749|NCT02902302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25162750|NCT02902302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25162751|NCT02902302|Analgesics|analgesics|mesh-ancestor
25162752|NCT02902302|Sensory System Agents|sensory system agents|mesh-ancestor
25162753|NCT02902302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25162754|NCT02902302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049274|NCT00625651|Growth Inhibitors|growth inhibitors|mesh-ancestor
25049275|NCT00625326|Calcipotriene|calcipotriene|mesh-list
25049276|NCT00625326|Dermatologic Agents|dermatologic agents|mesh-ancestor
25049277|NCT00624858|Naltrexone|naltrexone|mesh-list
24496769|NCT00506623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25162755|NCT02902302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24511368|NCT00568412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24511376|NCT00568477|Rituximab|rituximab|mesh-list
24511381|NCT00568477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24511382|NCT00568503|Bromides|bromides|mesh-list
24511383|NCT00568503|Tiotropium Bromide|tiotropium bromide|mesh-list
24986546|NCT00193219|Growth Substances|growth substances|mesh-ancestor
24986547|NCT00193219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986548|NCT00193219|Growth Inhibitors|growth inhibitors|mesh-ancestor
24986549|NCT00193219|Antimetabolites|antimetabolites|mesh-ancestor
24986550|NCT00193219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986551|NCT00193219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24986552|NCT00193219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24986553|NCT00193219|Immunologic Factors|immunologic factors|mesh-ancestor
24986554|NCT00193219|Antidotes|antidotes|mesh-ancestor
24511473|NCT00568880|Hydroxychloroquine|hydroxychloroquine|mesh-list
24511475|NCT00568880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511476|NCT00568880|Antimalarials|antimalarials|mesh-ancestor
24511477|NCT00568880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24511490|NCT00568971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162756|NCT02902302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25162757|NCT02902302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25162758|NCT02902302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25162759|NCT02902302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162760|NCT02902523|Tenofovir|tenofovir|mesh-list
25162761|NCT02902523|Antiviral Agents|antiviral agents|mesh-ancestor
25162762|NCT02902523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25162763|NCT02902523|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25162764|NCT02902523|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25162765|NCT02902523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25162766|NCT02902523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511492|NCT00568984|Repaglinide|repaglinide|mesh-list
24511493|NCT00568984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24511494|NCT00568984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511496|NCT00569088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24511497|NCT00569088|Diuretics|diuretics|mesh-ancestor
24511539|NCT00569452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511540|NCT00569465|Acetylcysteine|acetylcysteine|mesh-list
24511541|NCT00569465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24511542|NCT00569465|Antiviral Agents|antiviral agents|mesh-ancestor
24511543|NCT00569465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24986563|NCT00116142|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24986564|NCT00116142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831116|NCT00006695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24511719|NCT00570440|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25162770|NCT02902432|Endostatins|endostatins|mesh-list
25002767|NCT04316390|Vitamins|vitamins|mesh-list
25002768|NCT04316390|Ascorbic Acid|ascorbic acid|mesh-list
25002769|NCT04316390|Micronutrients|micronutrients|mesh-ancestor
25179904|NCT02981472|Hemostatics|hemostatics|mesh-ancestor
25002770|NCT04316390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25002771|NCT04316390|Antioxidants|antioxidants|mesh-ancestor
25002772|NCT04316390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25002773|NCT04316390|Protective Agents|protective agents|mesh-ancestor
25135179|NCT03001635|Oxytocin|oxytocin|mesh-list
25002781|NCT04313959|Dexamethasone|dexamethasone|mesh-list
25002782|NCT04313959|Ropivacaine|ropivacaine|mesh-list
25002784|NCT04313959|Antiemetics|antiemetics|mesh-ancestor
24511720|NCT00570440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24511721|NCT00570440|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24511722|NCT00570440|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24511723|NCT00570440|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24511726|NCT00570479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24511727|NCT00570479|Growth Substances|growth substances|mesh-ancestor
24511728|NCT00570479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511729|NCT00570479|Growth Inhibitors|growth inhibitors|mesh-ancestor
24512022|NCT00572208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24512055|NCT00572364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512056|NCT00572364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512059|NCT00572390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24512060|NCT00572390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512061|NCT00572559|Vancomycin|vancomycin|mesh-list
24512062|NCT00572559|Linezolid|linezolid|mesh-list
24512063|NCT00572559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24512064|NCT00572559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24512065|NCT00572559|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24512066|NCT00572559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512067|NCT00572559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512068|NCT00572637|Delanzomib|delanzomib|mesh-list
24512069|NCT00572637|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
24986588|NCT00070018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986589|NCT00070018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24986590|NCT00070018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24986591|NCT00070018|Alkylating Agents|alkylating agents|mesh-ancestor
24986592|NCT00070018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162788|NCT02902380|Sensory System Agents|sensory system agents|mesh-ancestor
25162789|NCT02902380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25162790|NCT02902380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25162791|NCT02902380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25002846|NCT04257500|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24592629|NCT00923390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24592630|NCT00923390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24592631|NCT00923390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25002847|NCT04257500|Etonogestrel|etonogestrel|mesh-list
25002848|NCT04257500|NuvaRing|nuvaring|mesh-list
24605385|NCT00984789|Estrogens|estrogens|mesh-ancestor
24986594|NCT00070018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24512106|NCT00572741|Protective Agents|protective agents|mesh-ancestor
24512107|NCT00572806|Insulin Aspart|insulin aspart|mesh-list
24512108|NCT00572806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25135256|NCT03000777|Melatonin|melatonin|mesh-list
24512109|NCT00572806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512110|NCT00572819|Misoprostol|misoprostol|mesh-list
24512111|NCT00572819|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24512112|NCT00572819|Abortifacient Agents|abortifacient agents|mesh-ancestor
24512113|NCT00572819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24512114|NCT00572819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512115|NCT00572819|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24512116|NCT00572819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24512117|NCT00572819|Oxytocics|oxytocics|mesh-ancestor
24512118|NCT00572884|Permethrin|permethrin|mesh-list
24512119|NCT00572884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831117|NCT00006695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24512170|NCT00573404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512173|NCT00573417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512174|NCT00573417|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24512175|NCT00573417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24512176|NCT00573417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24512177|NCT00573417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512178|NCT00573495|BIRC5 protein, human|birc5 protein, human|mesh-list
24512179|NCT00573495|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
24512180|NCT00573495|Protease Inhibitors|protease inhibitors|mesh-ancestor
24512181|NCT00573495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25179992|NCT02776917|Paclitaxel|paclitaxel|mesh-list
24512182|NCT00573495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512183|NCT00573547|Fluoxetine|fluoxetine|mesh-list
24986606|NCT00070018|Tubulin Modulators|tubulin modulators|mesh-ancestor
24986607|NCT00070018|Antimitotic Agents|antimitotic agents|mesh-ancestor
24986608|NCT00070018|Mitosis Modulators|mitosis modulators|mesh-ancestor
25135312|NCT03000205|Anesthetics, Local|anesthetics, local|mesh-ancestor
25135313|NCT03000205|Anesthetics|anesthetics|mesh-ancestor
25135314|NCT03000205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25135323|NCT03000036|Doxorubicin|doxorubicin|mesh-list
25831118|NCT00006695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831119|NCT00006695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831120|NCT00006695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25831121|NCT00006695|Antimetabolites|antimetabolites|mesh-ancestor
25831122|NCT00006695|Antiviral Agents|antiviral agents|mesh-ancestor
25831123|NCT00006695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25162792|NCT02902380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25162793|NCT02902380|Adrenergic Agents|adrenergic agents|mesh-ancestor
25162794|NCT02902380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25162795|NCT02902380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162797|NCT02902289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25162798|NCT02902289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25162799|NCT02902289|Analgesics|analgesics|mesh-ancestor
25162800|NCT02902289|Sensory System Agents|sensory system agents|mesh-ancestor
25162801|NCT02902289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25162802|NCT02902289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162803|NCT02902289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24496922|NCT00507221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512221|NCT00573638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24512222|NCT00573638|Latanoprost|latanoprost|mesh-list
24512223|NCT00573638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25657754|NCT01589497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25657755|NCT01589510|Bimatoprost|bimatoprost|mesh-list
25657756|NCT01589510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25657757|NCT01589510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25657758|NCT01589510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25657759|NCT01589653|Insulin|insulin|mesh-list
25657760|NCT01589653|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25657761|NCT01589653|Insulin Aspart|insulin aspart|mesh-list
25657762|NCT01589653|Insulin, Long-Acting|insulin, long-acting|mesh-list
25657763|NCT01589653|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25657764|NCT01589653|Biphasic Insulins|biphasic insulins|mesh-list
25674275|NCT01769508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951917|NCT03899337|Doxorubicin|doxorubicin|mesh-list
24951918|NCT03899337|Vincristine|vincristine|mesh-list
24951919|NCT03899337|Acalabrutinib|acalabrutinib|mesh-list
24951920|NCT03899337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24951921|NCT03899337|Immunologic Factors|immunologic factors|mesh-ancestor
24951922|NCT03899337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951923|NCT03899337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24592904|NCT00926107|Antifungal Agents|antifungal agents|mesh-ancestor
25831124|NCT00006695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25831125|NCT00006695|Immunologic Factors|immunologic factors|mesh-ancestor
25135342|NCT02999958|Vitamins|vitamins|mesh-ancestor
25831126|NCT00006695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831127|NCT00006695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25831128|NCT00006695|Alkylating Agents|alkylating agents|mesh-ancestor
25831129|NCT00006695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25831130|NCT00006695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24512391|NCT00574652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24512392|NCT00574730|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24512393|NCT00574730|Rituximab|rituximab|mesh-list
24512394|NCT00574730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24512395|NCT00574730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512396|NCT00574730|Immunologic Factors|immunologic factors|mesh-ancestor
24512397|NCT00574730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512398|NCT00574730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24512466|NCT00575354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24512467|NCT00575354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512468|NCT00575393|Gold Sodium Thiomalate|gold sodium thiomalate|mesh-list
24512469|NCT00575393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24512470|NCT00575406|Prednisolone|prednisolone|mesh-list
24512471|NCT00575406|Cyclophosphamide|cyclophosphamide|mesh-list
25831131|NCT00006695|Trace Elements|trace elements|mesh-ancestor
25831132|NCT00006695|Micronutrients|micronutrients|mesh-ancestor
25831133|NCT00006708|Rituximab|rituximab|mesh-list
24986635|NCT05189184|Paclitaxel|paclitaxel|mesh-list
24986636|NCT05189184|Apatinib|apatinib|mesh-list
24986637|NCT05189184|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24986638|NCT05189184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24512595|NCT00575835|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24512596|NCT00575835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25831134|NCT00006708|Carboplatin|carboplatin|mesh-list
25831135|NCT00006708|Etoposide|etoposide|mesh-list
25831136|NCT00006708|Ifosfamide|ifosfamide|mesh-list
25831137|NCT00006708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25831138|NCT00006708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831139|NCT00006708|Immunologic Factors|immunologic factors|mesh-ancestor
25831140|NCT00006708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831141|NCT00006708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25831142|NCT00006708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25831143|NCT00006708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25162804|NCT02902289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25162805|NCT02902289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25162806|NCT02902289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041333|NCT02578771|Methylene Blue|methylene blue|mesh-list
25041334|NCT02578771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041335|NCT02578771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049296|NCT00624351|Epratuzumab|epratuzumab|mesh-list
25831144|NCT00006708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25831145|NCT00006708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831146|NCT00006708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831147|NCT00006708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25831148|NCT00006708|Alkylating Agents|alkylating agents|mesh-ancestor
25831149|NCT00006734|Cyclophosphamide|cyclophosphamide|mesh-list
25831150|NCT00006734|Ifosfamide|ifosfamide|mesh-list
25831151|NCT00006734|Doxorubicin|doxorubicin|mesh-list
25657765|NCT01589653|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
25657766|NCT01589653|Insulin, Isophane|insulin, isophane|mesh-list
25657767|NCT01589653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25657768|NCT01589653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657769|NCT01589822|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25657770|NCT01589822|Hemostatics|hemostatics|mesh-ancestor
25657771|NCT01589822|Coagulants|coagulants|mesh-ancestor
25657772|NCT01589978|Aspirin|aspirin|mesh-list
25831152|NCT00006734|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25831153|NCT00006734|Etoposide|etoposide|mesh-list
25831154|NCT00006734|Vincristine|vincristine|mesh-list
25831155|NCT00006734|Lenograstim|lenograstim|mesh-list
25152678|NCT03878589|Oxytocin|oxytocin|mesh-list
24593023|NCT00926731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593025|NCT00926731|Antiviral Agents|antiviral agents|mesh-ancestor
24593026|NCT00926731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24593027|NCT00926731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25200748|NCT02732249|Clarithromycin|clarithromycin|mesh-list
25200749|NCT02732249|Potassium Citrate|potassium citrate|mesh-list
25200750|NCT02732249|Esomeprazole|esomeprazole|mesh-list
25200751|NCT02732249|Bismuth|bismuth|mesh-list
25200752|NCT02732249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200753|NCT02732249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25200764|NCT02732249|Antacids|antacids|mesh-ancestor
24512703|NCT00576225|Antimitotic Agents|antimitotic agents|mesh-ancestor
24512704|NCT00576225|Mitosis Modulators|mitosis modulators|mesh-ancestor
24512705|NCT00576225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512707|NCT00576238|Betamethasone Valerate|betamethasone valerate|mesh-list
24512708|NCT00576238|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24512709|NCT00576238|Betamethasone benzoate|betamethasone benzoate|mesh-list
24512710|NCT00576238|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24512711|NCT00576238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24512752|NCT00576433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24512753|NCT00576433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24849762|NCT02250482|Factor VIII|factor viii|mesh-list
24986658|NCT05189067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512755|NCT00576459|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
24512756|NCT00576459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25045792|NCT00911443|Interferon alpha-2|interferon alpha-2|mesh-list
25831156|NCT00006734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25831157|NCT00006734|Immunologic Factors|immunologic factors|mesh-ancestor
25831158|NCT00006734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831159|NCT00006734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25831160|NCT00006734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25831161|NCT00006734|Alkylating Agents|alkylating agents|mesh-ancestor
25831162|NCT00006734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831163|NCT00006734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512882|NCT00577200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24512883|NCT00577200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512884|NCT00577200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25831164|NCT00006734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24512885|NCT00577200|Anesthetics, General|anesthetics, general|mesh-ancestor
24512886|NCT00577200|Anesthetics|anesthetics|mesh-ancestor
24512887|NCT00577200|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25162807|NCT02902289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162808|NCT02902042|Pembrolizumab|pembrolizumab|mesh-list
25162809|NCT02902042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25162810|NCT02902042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162811|NCT02902133|Acetazolamide|acetazolamide|mesh-list
25162812|NCT02902133|Anticonvulsants|anticonvulsants|mesh-ancestor
25162813|NCT02902133|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25162814|NCT02902133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25162815|NCT02902133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162816|NCT02902133|Diuretics|diuretics|mesh-ancestor
25162817|NCT02902133|Natriuretic Agents|natriuretic agents|mesh-ancestor
25162818|NCT02902133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162819|NCT02902055|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
25162820|NCT02902055|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25162821|NCT02902055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25003000|NCT04124614|Antidepressive Agents|antidepressive agents|mesh-ancestor
25003001|NCT04124614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25003002|NCT04124614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25003003|NCT04124614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24940516|NCT04000789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657773|NCT01589978|Salicylic Acid|salicylic acid|mesh-list
25657774|NCT01589978|Salicylates|salicylates|mesh-list
25657775|NCT01589978|Ticlopidine|ticlopidine|mesh-list
25657776|NCT01589978|Clopidogrel|clopidogrel|mesh-list
25657777|NCT01589978|Ticagrelor|ticagrelor|mesh-list
25657778|NCT01589978|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25657779|NCT01589978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25657780|NCT01589978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25657781|NCT01589978|Analgesics|analgesics|mesh-ancestor
25657782|NCT01589978|Sensory System Agents|sensory system agents|mesh-ancestor
25657783|NCT01589978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25657784|NCT01589978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25003004|NCT04124614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25003005|NCT04124614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940588|NCT03999580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24940589|NCT03999866|Pyrithione zinc|pyrithione zinc|mesh-list
24497212|NCT00508898|Calcitriol|calcitriol|mesh-list
24512888|NCT00577200|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24512891|NCT00577200|GABA Modulators|gaba modulators|mesh-ancestor
24512949|NCT00577694|Antimetabolites|antimetabolites|mesh-ancestor
25831165|NCT00006734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25831166|NCT00006734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25831167|NCT00006734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25831168|NCT00006734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831169|NCT00006734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24513133|NCT00579046|Hematinics|hematinics|mesh-ancestor
24513134|NCT00579085|Ketamine|ketamine|mesh-list
24513140|NCT00579085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24513141|NCT00579085|Anesthetics, General|anesthetics, general|mesh-ancestor
25831170|NCT00006734|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25831171|NCT00006734|Tubulin Modulators|tubulin modulators|mesh-ancestor
25831172|NCT00006734|Antimitotic Agents|antimitotic agents|mesh-ancestor
25831173|NCT00006734|Mitosis Modulators|mitosis modulators|mesh-ancestor
25831174|NCT00006747|Cytarabine|cytarabine|mesh-list
25831175|NCT00006747|Methotrexate|methotrexate|mesh-list
25831176|NCT00006747|Etoposide|etoposide|mesh-list
25831177|NCT00006747|Melphalan|melphalan|mesh-list
25831178|NCT00006747|Carmustine|carmustine|mesh-list
25831179|NCT00006747|Tacrolimus|tacrolimus|mesh-list
25831180|NCT00006747|Sargramostim|sargramostim|mesh-list
25831181|NCT00006747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25831182|NCT00006747|Abortifacient Agents|abortifacient agents|mesh-ancestor
25831183|NCT00006747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24513362|NCT00580905|Purinergic Agents|purinergic agents|mesh-ancestor
24513363|NCT00580905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24513364|NCT00580905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162828|NCT02901977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162829|NCT02901977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25162830|NCT02901977|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25162831|NCT02901977|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25169557|NCT01818076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24796425|NCT01949857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796427|NCT01949909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24796448|NCT01950000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24796449|NCT01950000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24796450|NCT01950000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24796451|NCT01950000|Anesthetics, General|anesthetics, general|mesh-ancestor
24796452|NCT01950000|Anesthetics|anesthetics|mesh-ancestor
24796453|NCT01950182|Tamoxifen|tamoxifen|mesh-list
24796454|NCT01950182|Gemcitabine|gemcitabine|mesh-list
24796455|NCT01950182|Capecitabine|capecitabine|mesh-list
24796456|NCT01950182|Trastuzumab|trastuzumab|mesh-list
24796457|NCT01950182|Vinorelbine|vinorelbine|mesh-list
24796458|NCT01950182|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24924467|NCT04159870|Rifaximin|rifaximin|mesh-list
24986710|NCT05188495|Trastuzumab|trastuzumab|mesh-list
24986711|NCT05188495|Pertuzumab|pertuzumab|mesh-list
24986712|NCT05188495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24986713|NCT05188495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986758|NCT05169424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986759|NCT05169424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24986760|NCT05169424|Respiratory System Agents|respiratory system agents|mesh-ancestor
24986761|NCT05169424|Dermatologic Agents|dermatologic agents|mesh-ancestor
24986843|NCT05076409|BI 425809|bi 425809|mesh-list
24986844|NCT05076409|Antifungal Agents|antifungal agents|mesh-ancestor
24986845|NCT05076409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24986846|NCT05076409|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24986847|NCT05076409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24541676|NCT00674596|Ramipril|ramipril|mesh-list
25831184|NCT00006747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831185|NCT00006747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25831186|NCT00006747|Antimetabolites|antimetabolites|mesh-ancestor
25831187|NCT00006747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831188|NCT00006747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831189|NCT00006747|Dermatologic Agents|dermatologic agents|mesh-ancestor
25831190|NCT00006747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831191|NCT00006747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25831192|NCT00006747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25831193|NCT00006747|Immunologic Factors|immunologic factors|mesh-ancestor
25831194|NCT00006747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24593321|NCT00927875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24593326|NCT00927966|Everolimus|everolimus|mesh-list
25831195|NCT00006747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25162832|NCT02901977|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25162833|NCT02901977|Adrenergic Agents|adrenergic agents|mesh-ancestor
25162834|NCT02901977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25162835|NCT02901977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162836|NCT02902198|Quinine|quinine|mesh-list
25162837|NCT02902198|Antimalarials|antimalarials|mesh-ancestor
25162838|NCT02902198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25162839|NCT02902198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25162840|NCT02902198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25162841|NCT02902198|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25162842|NCT02902198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162843|NCT02902198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25831196|NCT00006747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25831197|NCT00006747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25135566|NCT02997800|Sympathomimetics|sympathomimetics|mesh-ancestor
24513409|NCT00581139|GABA Agents|gaba agents|mesh-ancestor
24513410|NCT00581139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24513439|NCT00581607|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24513440|NCT00581607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513441|NCT00581685|Celecoxib|celecoxib|mesh-list
24513442|NCT00581685|Pregabalin|pregabalin|mesh-list
24513444|NCT00581685|Sensory System Agents|sensory system agents|mesh-ancestor
24513445|NCT00581685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24513446|NCT00581685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513447|NCT00581685|Anticonvulsants|anticonvulsants|mesh-ancestor
24541689|NCT00674687|Analgesics|analgesics|mesh-ancestor
24784950|NCT01911299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784951|NCT01911299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24784952|NCT01911299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24784953|NCT01911299|Nootropic Agents|nootropic agents|mesh-ancestor
24784954|NCT01911299|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24784955|NCT01911299|Protective Agents|protective agents|mesh-ancestor
24784956|NCT01911299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784957|NCT01911325|Docetaxel|docetaxel|mesh-list
24784958|NCT01911325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784959|NCT01911325|Tubulin Modulators|tubulin modulators|mesh-ancestor
24784960|NCT01911325|Antimitotic Agents|antimitotic agents|mesh-ancestor
24784961|NCT01911325|Mitosis Modulators|mitosis modulators|mesh-ancestor
24541690|NCT00674687|Sensory System Agents|sensory system agents|mesh-ancestor
24541691|NCT00674687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24541692|NCT00674687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784962|NCT01911325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784963|NCT01911364|Tiotropium Bromide|tiotropium bromide|mesh-list
24784964|NCT01911364|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24784966|NCT01911364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24784967|NCT01911364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784968|NCT01911364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24784969|NCT01911364|Respiratory System Agents|respiratory system agents|mesh-ancestor
24513600|NCT00583986|Tocolytic Agents|tocolytic agents|mesh-ancestor
24513618|NCT00584155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24513619|NCT00584155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24513620|NCT00584155|Renal Agents|renal agents|mesh-ancestor
24513624|NCT00584155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24513644|NCT00584298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513645|NCT00584376|Pregabalin|pregabalin|mesh-list
24513646|NCT00584376|Analgesics|analgesics|mesh-ancestor
24513647|NCT00584376|Sensory System Agents|sensory system agents|mesh-ancestor
24513648|NCT00584376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24513649|NCT00584376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513650|NCT00584376|Anticonvulsants|anticonvulsants|mesh-ancestor
24513651|NCT00584376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24986879|NCT05017545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24986898|NCT04988074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24986899|NCT04988074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986900|NCT04984369|Cetuximab|cetuximab|mesh-list
24986901|NCT04984369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24986902|NCT04984369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25657785|NCT01589978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25657786|NCT01589978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25657787|NCT01589978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24593517|NCT00929877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593520|NCT00929955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24986903|NCT04971473|Hormones|hormones|mesh-list
24986904|NCT04971473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24986905|NCT04971473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986906|NCT04964284|Hormones|hormones|mesh-list
24986907|NCT04964284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24986908|NCT04964284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986909|NCT04925193|Dexamethasone|dexamethasone|mesh-list
24986910|NCT04925193|Daratumumab|daratumumab|mesh-list
24986911|NCT04925193|Pomalidomide|pomalidomide|mesh-list
24986912|NCT04925193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24986913|NCT04925193|Antiemetics|antiemetics|mesh-ancestor
24986914|NCT04925193|Autonomic Agents|autonomic agents|mesh-ancestor
24986915|NCT04925193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24986916|NCT04925193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986917|NCT04925193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25003178|NCT03959085|Antidotes|antidotes|mesh-ancestor
25003179|NCT03959085|Protective Agents|protective agents|mesh-ancestor
25003180|NCT03959085|Vitamin B Complex|vitamin b complex|mesh-ancestor
25003182|NCT03959085|Micronutrients|micronutrients|mesh-ancestor
25003184|NCT03959085|Tubulin Modulators|tubulin modulators|mesh-ancestor
24986918|NCT04925193|Glucocorticoids|glucocorticoids|mesh-ancestor
24986919|NCT04925193|Hormones|hormones|mesh-ancestor
25135660|NCT02996487|Vancomycin|vancomycin|mesh-list
24986920|NCT04925193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24796490|NCT01950403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796492|NCT01950416|Clopidogrel|clopidogrel|mesh-list
24796493|NCT01950416|Ticagrelor|ticagrelor|mesh-list
25831198|NCT00006747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25831199|NCT00006747|Antiviral Agents|antiviral agents|mesh-ancestor
25831200|NCT00006747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25831201|NCT00006747|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25831202|NCT00006747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25831203|NCT00006747|Alkylating Agents|alkylating agents|mesh-ancestor
25831204|NCT00006747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25831205|NCT00006760|Vinorelbine|vinorelbine|mesh-list
25831206|NCT00006760|Ifosfamide|ifosfamide|mesh-list
25831207|NCT00006760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24513701|NCT00584571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24861553|NCT02318511|Protective Agents|protective agents|mesh-ancestor
24796494|NCT01950416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24796495|NCT01950416|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24513743|NCT00584688|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24513744|NCT00584688|Antidepressive Agents|antidepressive agents|mesh-ancestor
24513745|NCT00584688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24513746|NCT00584688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24513747|NCT00584688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24796519|NCT01950507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796520|NCT01950507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24796521|NCT01950507|Respiratory System Agents|respiratory system agents|mesh-ancestor
24986952|NCT04786067|Abatacept|abatacept|mesh-list
24986953|NCT04786067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24986954|NCT04786067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986955|NCT04786067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986956|NCT04786067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24986957|NCT04786067|Immunologic Factors|immunologic factors|mesh-ancestor
24986958|NCT04786067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986959|NCT04786067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24986960|NCT04775680|Antibodies|antibodies|mesh-list
24986961|NCT04775680|Immunologic Factors|immunologic factors|mesh-ancestor
24986962|NCT04775680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986963|NCT04757363|Oxaliplatin|oxaliplatin|mesh-list
24986964|NCT04757363|Nivolumab|nivolumab|mesh-list
24986965|NCT04757363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135691|NCT02996227|Anesthetics, Local|anesthetics, local|mesh-ancestor
24986966|NCT04757363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24986967|NCT04757363|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24986968|NCT04757363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986972|NCT04681417|Carboplatin|carboplatin|mesh-list
24986973|NCT04681417|Etoposide|etoposide|mesh-list
25657788|NCT01589978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25657789|NCT01589978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657790|NCT01589978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24951952|NCT03899584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593638|NCT00930332|Antitussive Agents|antitussive agents|mesh-ancestor
24593639|NCT00930332|Respiratory System Agents|respiratory system agents|mesh-ancestor
24593640|NCT00930345|Sunitinib|sunitinib|mesh-list
24593672|NCT00930488|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24986974|NCT04681417|Etoposide phosphate|etoposide phosphate|mesh-list
24986975|NCT04681417|Vincristine|vincristine|mesh-list
24986976|NCT04681417|Melphalan|melphalan|mesh-list
24986977|NCT04681417|Topotecan|topotecan|mesh-list
24986978|NCT04681417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986982|NCT04681417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24986985|NCT04681417|Antimitotic Agents|antimitotic agents|mesh-ancestor
24986986|NCT04681417|Mitosis Modulators|mitosis modulators|mesh-ancestor
24986987|NCT04681417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24986988|NCT04681417|Alkylating Agents|alkylating agents|mesh-ancestor
24986989|NCT04681417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24986991|NCT04681417|Immunologic Factors|immunologic factors|mesh-ancestor
24986992|NCT04681417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986993|NCT04681417|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25162844|NCT02902198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25162845|NCT02902198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25162846|NCT02902198|Analgesics|analgesics|mesh-ancestor
25162847|NCT02902198|Sensory System Agents|sensory system agents|mesh-ancestor
25162848|NCT02901587|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24986994|NCT04657640|Iron|iron|mesh-list
24986995|NCT04657640|Trace Elements|trace elements|mesh-list
25049321|NCT00616811|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25049323|NCT00616811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25049324|NCT00616811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049325|NCT00616811|Incretins|incretins|mesh-ancestor
25049326|NCT00616811|Hormones|hormones|mesh-ancestor
25049327|NCT00616811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25049329|NCT00616811|Protease Inhibitors|protease inhibitors|mesh-ancestor
24986996|NCT04657640|Folic Acid|folic acid|mesh-list
24986997|NCT04657640|Micronutrients|micronutrients|mesh-list
24986998|NCT04657640|Vitamin B Complex|vitamin b complex|mesh-list
24986999|NCT04657640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987000|NCT04657640|Hematinics|hematinics|mesh-ancestor
24987001|NCT04657640|Vitamins|vitamins|mesh-ancestor
24987002|NCT04595513|Sirolimus|sirolimus|mesh-list
25045869|NCT00905164|Anticonvulsants|anticonvulsants|mesh-ancestor
24987003|NCT04595513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24987004|NCT04595513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24987005|NCT04595513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24987006|NCT04595513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987007|NCT04595513|Antifungal Agents|antifungal agents|mesh-ancestor
24987008|NCT04595513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24987009|NCT04595513|Immunologic Factors|immunologic factors|mesh-ancestor
24987010|NCT04595513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987011|NCT04589832|Entrectinib|entrectinib|mesh-list
24987012|NCT04589832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24987079|NCT04393350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987080|NCT04283669|Crizotinib|crizotinib|mesh-list
24987081|NCT04283669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987082|NCT04283669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24987083|NCT04283669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24987084|NCT04283669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831208|NCT00006760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831209|NCT00006760|Tubulin Modulators|tubulin modulators|mesh-ancestor
25831210|NCT00006760|Antimitotic Agents|antimitotic agents|mesh-ancestor
25831211|NCT00006760|Mitosis Modulators|mitosis modulators|mesh-ancestor
24987101|NCT04175834|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24987102|NCT04175834|Histamine Agents|histamine agents|mesh-ancestor
24987103|NCT04175834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24796523|NCT01950507|Hormones|hormones|mesh-ancestor
24987104|NCT04175834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657791|NCT01589978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25657792|NCT01589978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657793|NCT01589978|Antipyretics|antipyretics|mesh-ancestor
25657794|NCT01589978|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25657795|NCT01589978|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25657796|NCT01589978|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24987105|NCT04175834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796524|NCT01950507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24796525|NCT01950507|Antifungal Agents|antifungal agents|mesh-ancestor
24593930|NCT00931645|Alkylating Agents|alkylating agents|mesh-ancestor
25162849|NCT02901587|Antidepressive Agents|antidepressive agents|mesh-ancestor
25162850|NCT02901587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24796554|NCT01950793|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24796555|NCT01950793|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24796577|NCT01950923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796579|NCT01950923|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24796580|NCT01950923|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24861705|NCT02319564|Hormones|hormones|mesh-ancestor
25831212|NCT00006760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831213|NCT00006760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25831214|NCT00006760|Alkylating Agents|alkylating agents|mesh-ancestor
25831215|NCT00006773|Bortezomib|bortezomib|mesh-list
25831216|NCT00006773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513764|NCT00584779|Antimanic Agents|antimanic agents|mesh-ancestor
25831217|NCT00006786|Leucovorin|leucovorin|mesh-list
25831218|NCT00006786|Bevacizumab|bevacizumab|mesh-list
25831219|NCT00006786|Fluorouracil|fluorouracil|mesh-list
25831220|NCT00006786|Irinotecan|irinotecan|mesh-list
25162856|NCT02901561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24798654|NCT01964404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24798655|NCT01964404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24798657|NCT01964404|Sensory System Agents|sensory system agents|mesh-ancestor
24798658|NCT01964404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24798659|NCT01964404|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24798660|NCT01964404|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24798661|NCT01964404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24798662|NCT01964404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798663|NCT01964404|Hormones|hormones|mesh-ancestor
24798664|NCT01964404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24798665|NCT01964534|Gemcitabine|gemcitabine|mesh-list
24810194|NCT02038621|Capecitabine|capecitabine|mesh-list
24810195|NCT02038621|Oxaliplatin|oxaliplatin|mesh-list
24810196|NCT02038621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24810197|NCT02038621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796581|NCT01950923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796582|NCT01950923|Urological Agents|urological agents|mesh-ancestor
25162857|NCT02901561|Abortifacient Agents|abortifacient agents|mesh-ancestor
25162858|NCT02901561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25162859|NCT02901561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162860|NCT02901561|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24796583|NCT01950949|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24796584|NCT01950949|Plasma Substitutes|plasma substitutes|mesh-ancestor
24796585|NCT01950949|Blood Substitutes|blood substitutes|mesh-ancestor
24796586|NCT01951001|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24796587|NCT01951001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24796589|NCT01951027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24796590|NCT01951027|Immunologic Factors|immunologic factors|mesh-ancestor
24796591|NCT01951027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796592|NCT01951053|Citalopram|citalopram|mesh-list
24924910|NCT04155697|Disinfectants|disinfectants|mesh-ancestor
24513852|NCT00585559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513853|NCT00585559|Protective Agents|protective agents|mesh-ancestor
24513854|NCT00585559|Antidotes|antidotes|mesh-ancestor
24513855|NCT00585741|Alovudine|alovudine|mesh-list
24513856|NCT00585741|Antiviral Agents|antiviral agents|mesh-ancestor
24513858|NCT00585754|Guanfacine|guanfacine|mesh-list
25162861|NCT02901561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25202914|NCT02717871|Ofloxacin|ofloxacin|mesh-list
25202915|NCT02717871|Gentamicins|gentamicins|mesh-list
25202916|NCT02717871|Cefazolin|cefazolin|mesh-list
25202917|NCT02717871|Tobramycin|tobramycin|mesh-list
25202918|NCT02717871|Gatifloxacin|gatifloxacin|mesh-list
25657797|NCT01589978|Purinergic Agents|purinergic agents|mesh-ancestor
25202919|NCT02717871|Fluoroquinolones|fluoroquinolones|mesh-list
25202920|NCT02717871|Besifloxacin|besifloxacin|mesh-list
25202921|NCT02717871|Prednisolone|prednisolone|mesh-list
25202922|NCT02717871|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25657798|NCT01589978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25657799|NCT01589978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25657800|NCT01589978|Antifungal Agents|antifungal agents|mesh-ancestor
25657801|NCT01589978|Keratolytic Agents|keratolytic agents|mesh-ancestor
25657802|NCT01589978|Dermatologic Agents|dermatologic agents|mesh-ancestor
25657803|NCT01589978|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25657804|NCT01589978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25657805|NCT01590082|Doxycycline|doxycycline|mesh-list
25657806|NCT01590082|Temozolomide|temozolomide|mesh-list
25657807|NCT01590082|Ipilimumab|ipilimumab|mesh-list
25202923|NCT02717871|Methylprednisolone|methylprednisolone|mesh-list
25831221|NCT00006786|Calcium|calcium|mesh-list
25831222|NCT00006786|Levoleucovorin|levoleucovorin|mesh-list
25831223|NCT00006786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24785005|NCT01911494|Anticonvulsants|anticonvulsants|mesh-ancestor
25162865|NCT02901418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162867|NCT02901366|Uricosuric Agents|uricosuric agents|mesh-ancestor
25135809|NCT02995746|Hormones|hormones|mesh-ancestor
24810204|NCT02038634|Betamethasone|betamethasone|mesh-list
24498049|NCT00513162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24498050|NCT00513162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498051|NCT00513162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24498064|NCT00513188|Cytarabine|cytarabine|mesh-list
25107064|NCT03142828|Chlorhexidine|chlorhexidine|mesh-list
25107065|NCT03142828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25107066|NCT03142828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25107067|NCT03142828|Disinfectants|disinfectants|mesh-ancestor
25107068|NCT03142763|Choline|choline|mesh-list
25107069|NCT03142763|Lipotropic Agents|lipotropic agents|mesh-ancestor
24785006|NCT01911494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24785007|NCT01911494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25107070|NCT03142763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25107071|NCT03142763|Antimetabolites|antimetabolites|mesh-ancestor
25107072|NCT03142763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107073|NCT03142763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25107074|NCT03142763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25107075|NCT03142763|Nootropic Agents|nootropic agents|mesh-ancestor
25107076|NCT03142620|Vitamin D|vitamin d|mesh-list
25107077|NCT03142620|Cholecalciferol|cholecalciferol|mesh-list
25045946|NCT00890968|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25107078|NCT03142620|Amoxicillin|amoxicillin|mesh-list
25107079|NCT03142620|Clarithromycin|clarithromycin|mesh-list
25107080|NCT03142620|Clavulanic Acid|clavulanic acid|mesh-list
25107081|NCT03142620|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25107082|NCT03142620|Esomeprazole|esomeprazole|mesh-list
25107083|NCT03142620|Vitamins|vitamins|mesh-ancestor
25107084|NCT03142620|Micronutrients|micronutrients|mesh-ancestor
25107085|NCT03142620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107086|NCT03142620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25107087|NCT03142620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25107088|NCT03142620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24987173|NCT03554044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24987174|NCT03554044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24987176|NCT03554044|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24987199|NCT03470675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24987200|NCT03470675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24987201|NCT03470675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24987202|NCT03470675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24987203|NCT03470675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987204|NCT03470675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24987205|NCT03470675|Narcotics|narcotics|mesh-ancestor
24987206|NCT03467360|Etoposide|etoposide|mesh-list
24987207|NCT03467360|Acetazolamide|acetazolamide|mesh-list
24987208|NCT03467360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24987209|NCT03467360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987210|NCT03467360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24987211|NCT03467360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25162868|NCT02901366|Gout Suppressants|gout suppressants|mesh-ancestor
25162869|NCT02901366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25162870|NCT02901366|Renal Agents|renal agents|mesh-ancestor
25162871|NCT02901379|Atorvastatin|atorvastatin|mesh-list
25162872|NCT02901379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25162873|NCT02901379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25162874|NCT02901379|Antimetabolites|antimetabolites|mesh-ancestor
24987212|NCT03467360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849878|NCT02251041|Epoprostenol|epoprostenol|mesh-list
24987299|NCT03066622|Autonomic Agents|autonomic agents|mesh-ancestor
24987300|NCT03066622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24987301|NCT03066622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987302|NCT03066622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24987303|NCT03066622|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24987304|NCT03066622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24987305|NCT03066622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24987306|NCT03066622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24987307|NCT03066622|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24987308|NCT03066622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24987309|NCT03066622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24594839|NCT00935610|Caseins|caseins|mesh-list
24987310|NCT03066622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987311|NCT03066622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24987312|NCT03066622|Serotonin Agents|serotonin agents|mesh-ancestor
24987319|NCT02799212|Somatostatin|somatostatin|mesh-list
24987321|NCT02799212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24987322|NCT02799212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987323|NCT02553941|Azacitidine|azacitidine|mesh-list
24987324|NCT02553941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24987325|NCT02553941|Antimetabolites|antimetabolites|mesh-ancestor
24987326|NCT02553941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831224|NCT00006786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514153|NCT00588302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25831225|NCT00006786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25831226|NCT00006786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25831227|NCT00006786|Growth Substances|growth substances|mesh-ancestor
25135866|NCT02995057|Nickel|nickel|mesh-list
25831228|NCT00006786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831229|NCT00006786|Growth Inhibitors|growth inhibitors|mesh-ancestor
24514190|NCT00588835|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24514192|NCT00588913|Aldesleukin|aldesleukin|mesh-list
24514193|NCT00588913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514194|NCT00588913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24514195|NCT00588913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24514196|NCT00588913|Antiviral Agents|antiviral agents|mesh-ancestor
24514197|NCT00588913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24514198|NCT00588913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24514199|NCT00588913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514200|NCT00588926|Remifentanil|remifentanil|mesh-list
24514234|NCT00589238|Carboplatin|carboplatin|mesh-list
24514235|NCT00589238|Doxorubicin|doxorubicin|mesh-list
25831230|NCT00006786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25831231|NCT00006786|Antimetabolites|antimetabolites|mesh-ancestor
25162876|NCT02901379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25162877|NCT02901379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25831232|NCT00006786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831233|NCT00006786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25831234|NCT00006786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25831235|NCT00006786|Immunologic Factors|immunologic factors|mesh-ancestor
25831236|NCT00006786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25831237|NCT00006786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25831238|NCT00006786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25162878|NCT02901379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831239|NCT00006786|Antidotes|antidotes|mesh-ancestor
25831240|NCT00006786|Protective Agents|protective agents|mesh-ancestor
25831241|NCT00006786|Vitamin B Complex|vitamin b complex|mesh-ancestor
24796594|NCT01951053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24796595|NCT01951053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24796596|NCT01951053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796598|NCT01951053|Serotonin Agents|serotonin agents|mesh-ancestor
24796599|NCT01951053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796600|NCT01951053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24796601|NCT01951053|Antidepressive Agents|antidepressive agents|mesh-ancestor
25831242|NCT00006786|Vitamins|vitamins|mesh-ancestor
25831243|NCT00006786|Micronutrients|micronutrients|mesh-ancestor
25831244|NCT00006799|Megestrol|megestrol|mesh-list
25135942|NCT02995083|Hormones|hormones|mesh-ancestor
25831245|NCT00006799|Megestrol Acetate|megestrol acetate|mesh-list
25831246|NCT00006799|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25831247|NCT00006799|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24514270|NCT00589316|Immunoglobulins|immunoglobulins|mesh-list
24514271|NCT00589316|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24514272|NCT00589316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24514273|NCT00589316|Immunologic Factors|immunologic factors|mesh-ancestor
24514274|NCT00589316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657808|NCT01590082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25657809|NCT01590082|Alkylating Agents|alkylating agents|mesh-ancestor
25657810|NCT01590082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657811|NCT01590082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25657812|NCT01590082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25657813|NCT01590082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25657814|NCT01590082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25657815|NCT01590082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25657816|NCT01590082|Antimalarials|antimalarials|mesh-ancestor
25831248|NCT00006799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25831249|NCT00006799|Contraceptive Agents|contraceptive agents|mesh-ancestor
24514349|NCT00589953|Epoetin Alfa|epoetin alfa|mesh-list
24514350|NCT00589953|Hematinics|hematinics|mesh-ancestor
24514351|NCT00589992|Ibutilide|ibutilide|mesh-list
24590118|NCT00910780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24590119|NCT00910780|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24590120|NCT00910780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24590121|NCT00910780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24590122|NCT00910780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590123|NCT00910780|Dopamine Agonists|dopamine agonists|mesh-ancestor
24590124|NCT00910780|Dopamine Agents|dopamine agents|mesh-ancestor
24590125|NCT00910780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24590126|NCT00910780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590127|NCT00910780|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24590128|NCT00910780|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24590129|NCT00910780|Serotonin Agents|serotonin agents|mesh-ancestor
24590130|NCT00910780|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24590131|NCT00910780|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24590132|NCT00910780|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24590133|NCT00910780|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24590134|NCT00910780|Antiemetics|antiemetics|mesh-ancestor
24590135|NCT00910780|Autonomic Agents|autonomic agents|mesh-ancestor
24796609|NCT01951079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796611|NCT01951144|PF-06372865|pf-06372865|mesh-list
24796612|NCT01951144|Anticonvulsants|anticonvulsants|mesh-ancestor
24796613|NCT01951144|Antiemetics|antiemetics|mesh-ancestor
24796614|NCT01951144|Autonomic Agents|autonomic agents|mesh-ancestor
24796615|NCT01951144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24796616|NCT01951144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796617|NCT01951144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24987367|NCT02358681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987369|NCT02339168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24987370|NCT02339168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987371|NCT02269267|Tin Fluorides|tin fluorides|mesh-list
24987372|NCT02269267|Cariostatic Agents|cariostatic agents|mesh-ancestor
24987373|NCT02269267|Protective Agents|protective agents|mesh-ancestor
24987374|NCT02269267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987375|NCT02101788|Tamoxifen|tamoxifen|mesh-list
24987376|NCT02101788|Paclitaxel|paclitaxel|mesh-list
24987377|NCT02101788|Doxorubicin|doxorubicin|mesh-list
25162879|NCT02901353|Sirolimus|sirolimus|mesh-list
24798683|NCT01964586|Lidocaine|lidocaine|mesh-list
24987378|NCT02101788|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24987379|NCT02101788|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24987380|NCT02101788|Letrozole|letrozole|mesh-list
24987381|NCT02101788|Topotecan|topotecan|mesh-list
24987382|NCT02101788|Trametinib|trametinib|mesh-list
24987383|NCT02101788|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
24987384|NCT02101788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24987385|NCT02101788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987386|NCT02101788|Tubulin Modulators|tubulin modulators|mesh-ancestor
24987387|NCT02101788|Antimitotic Agents|antimitotic agents|mesh-ancestor
24987388|NCT02101788|Mitosis Modulators|mitosis modulators|mesh-ancestor
24987403|NCT02101788|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24987404|NCT02101788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24541902|NCT00675714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24987422|NCT01970410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24987423|NCT01970410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24987424|NCT01970410|Analgesics|analgesics|mesh-ancestor
24987425|NCT01970410|Sensory System Agents|sensory system agents|mesh-ancestor
24987467|NCT01622335|Sensory System Agents|sensory system agents|mesh-ancestor
24987468|NCT01622335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24987470|NCT01509339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24987471|NCT01509339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24987472|NCT01362374|Leucovorin|leucovorin|mesh-list
24796618|NCT01951144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24796619|NCT01951144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24796620|NCT01951144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24796621|NCT01951144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24796622|NCT01951144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24796623|NCT01951144|GABA Modulators|gaba modulators|mesh-ancestor
24796624|NCT01951144|GABA Agents|gaba agents|mesh-ancestor
24796625|NCT01951144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25107103|NCT03142607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25107104|NCT03142607|Disinfectants|disinfectants|mesh-ancestor
24834392|NCT02178293|Ketoprofen|ketoprofen|mesh-list
24796626|NCT01951144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796627|NCT01951209|Rifaximin|rifaximin|mesh-list
24796628|NCT01951209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24796629|NCT01951209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24796630|NCT01951209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24796631|NCT01951404|Allopurinol|allopurinol|mesh-list
24796632|NCT01951404|Antimetabolites|antimetabolites|mesh-ancestor
24796633|NCT01951404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796634|NCT01951404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796635|NCT01951404|Gout Suppressants|gout suppressants|mesh-ancestor
24796636|NCT01951404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24796637|NCT01951404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24796638|NCT01951404|Antioxidants|antioxidants|mesh-ancestor
24796639|NCT01951404|Protective Agents|protective agents|mesh-ancestor
24796640|NCT01951404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796641|NCT01951430|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24796642|NCT01951430|Cephalosporins|cephalosporins|mesh-list
24796644|NCT01951430|Itraconazole|itraconazole|mesh-list
24796652|NCT01951430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24541927|NCT00675896|Antidepressive Agents|antidepressive agents|mesh-ancestor
24541928|NCT00675896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24541929|NCT00675896|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24987500|NCT01164228|Antiviral Agents|antiviral agents|mesh-ancestor
24987501|NCT01164228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24987502|NCT01164228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24987503|NCT01164228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24987504|NCT01164228|Immunologic Factors|immunologic factors|mesh-ancestor
24987505|NCT01164228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987506|NCT01164228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24987507|NCT01164228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24987508|NCT01164228|Growth Substances|growth substances|mesh-ancestor
24987509|NCT01164228|Growth Inhibitors|growth inhibitors|mesh-ancestor
24987510|NCT01164228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24987511|NCT01012167|Galantamine|galantamine|mesh-list
24987512|NCT01012167|Oxytocin|oxytocin|mesh-list
24987513|NCT01012167|Oxytocics|oxytocics|mesh-ancestor
24987514|NCT01012167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24987515|NCT01012167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202926|NCT02717871|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24987516|NCT01012167|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24987517|NCT01012167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24987518|NCT01012167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987519|NCT01012167|Cholinergic Agents|cholinergic agents|mesh-ancestor
24987520|NCT01012167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24987521|NCT01012167|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24514442|NCT00590629|Niacin|niacin|mesh-list
24514443|NCT00590629|Nicotinic Acids|nicotinic acids|mesh-list
24514444|NCT00590629|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24514470|NCT00590785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514478|NCT00590785|Hormone Antagonists|hormone antagonists|mesh-ancestor
24514479|NCT00590785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24849941|NCT02251145|Ritonavir|ritonavir|mesh-list
24987541|NCT00924326|Antimetabolites|antimetabolites|mesh-ancestor
24987542|NCT00924326|Antiviral Agents|antiviral agents|mesh-ancestor
25831250|NCT00006799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24514526|NCT00591201|Dermatologic Agents|dermatologic agents|mesh-ancestor
24514527|NCT00591201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24514528|NCT00591201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24514529|NCT00591357|Loperamide|loperamide|mesh-list
24514530|NCT00591357|Antidiarrheals|antidiarrheals|mesh-list
25831251|NCT00006799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831252|NCT00006799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24514540|NCT00591487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24514541|NCT00591487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514542|NCT00591487|Sensory System Agents|sensory system agents|mesh-ancestor
24514543|NCT00591487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24514549|NCT00591526|Cytarabine|cytarabine|mesh-list
24514618|NCT00591994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24514665|NCT00592150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514666|NCT00592215|Misoprostol|misoprostol|mesh-list
24514667|NCT00592215|Mifepristone|mifepristone|mesh-list
24514668|NCT00592215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24514669|NCT00592215|Abortifacient Agents|abortifacient agents|mesh-ancestor
24514670|NCT00592215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24492097|NCT00485238|Acetazolamide|acetazolamide|mesh-list
24514795|NCT00592969|Biphasic Insulins|biphasic insulins|mesh-list
24987615|NCT05190952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24987616|NCT05190952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987618|NCT05190562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987619|NCT05190562|Astringents|astringents|mesh-ancestor
24987620|NCT05190562|Dermatologic Agents|dermatologic agents|mesh-ancestor
24987621|NCT05190341|Ibuprofen|ibuprofen|mesh-list
24987622|NCT05190341|Ketorolac|ketorolac|mesh-list
24541973|NCT00676156|Vitamins|vitamins|mesh-ancestor
24987623|NCT05190341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24987624|NCT05190341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24987625|NCT05190341|Analgesics|analgesics|mesh-ancestor
24987626|NCT05190341|Sensory System Agents|sensory system agents|mesh-ancestor
24987627|NCT05190341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24987636|NCT05190120|Anesthetics|anesthetics|mesh-ancestor
24987637|NCT05190120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24987638|NCT05190120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987639|NCT05190120|Sensory System Agents|sensory system agents|mesh-ancestor
24987640|NCT05190120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25049352|NCT00615251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25049353|NCT00615251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049354|NCT00614601|Vaccines|vaccines|mesh-list
25049355|NCT00614601|Immunologic Factors|immunologic factors|mesh-ancestor
25049357|NCT00613002|Testosterone|testosterone|mesh-list
24499050|NCT00517504|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25831253|NCT00006799|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25831254|NCT00006799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25831255|NCT00006799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831256|NCT00006799|Appetite Stimulants|appetite stimulants|mesh-ancestor
24514930|NCT00593463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24515026|NCT00593996|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24515027|NCT00593996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24515028|NCT00594087|Eszopiclone|eszopiclone|mesh-list
24515029|NCT00594087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24515056|NCT00594269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24515057|NCT00594269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515058|NCT00594269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515059|NCT00594269|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24515060|NCT00594269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24515061|NCT00594269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24515062|NCT00594269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25136167|NCT02993094|Ixazomib|ixazomib|mesh-list
24785019|NCT01911494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24785020|NCT01911507|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25162880|NCT02901353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25162881|NCT02901353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25162882|NCT02901353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25162883|NCT02901353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162884|NCT02901353|Antifungal Agents|antifungal agents|mesh-ancestor
24785021|NCT01911507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24515081|NCT00594347|Immunologic Factors|immunologic factors|mesh-ancestor
24515082|NCT00594347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515083|NCT00594373|Tenofovir|tenofovir|mesh-list
24515084|NCT00594373|Antiviral Agents|antiviral agents|mesh-ancestor
24515166|NCT00595140|Autonomic Agents|autonomic agents|mesh-ancestor
25107113|NCT03142516|Panitumumab|panitumumab|mesh-list
25107114|NCT03142516|Levoleucovorin|levoleucovorin|mesh-list
25107115|NCT03142516|Antimetabolites|antimetabolites|mesh-ancestor
25107116|NCT03142516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107117|NCT03142516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25107118|NCT03142516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25107119|NCT03142516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25107120|NCT03142516|Immunologic Factors|immunologic factors|mesh-ancestor
25107121|NCT03142516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107122|NCT03142516|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25107123|NCT03142516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25107124|NCT03142516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107125|NCT03142516|Antidotes|antidotes|mesh-ancestor
25107126|NCT03142516|Protective Agents|protective agents|mesh-ancestor
25107127|NCT03142516|Vitamin B Complex|vitamin b complex|mesh-ancestor
25107128|NCT03142516|Vitamins|vitamins|mesh-ancestor
25107129|NCT03142516|Micronutrients|micronutrients|mesh-ancestor
25107130|NCT03142516|Hematinics|hematinics|mesh-ancestor
24862121|NCT02323282|Ropivacaine|ropivacaine|mesh-list
25831257|NCT00006799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25831258|NCT00006812|Capecitabine|capecitabine|mesh-list
25831259|NCT00006812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25831260|NCT00006812|Antimetabolites|antimetabolites|mesh-ancestor
24596759|NCT00945308|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24596761|NCT00945347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596762|NCT00945347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596763|NCT00945347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24596764|NCT00945347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24596765|NCT00945347|Antiviral Agents|antiviral agents|mesh-ancestor
24596814|NCT00945789|Epoetin Alfa|epoetin alfa|mesh-list
25831261|NCT00006812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831262|NCT00006812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831263|NCT00006825|Doxorubicin|doxorubicin|mesh-list
25831264|NCT00006825|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25831265|NCT00006825|Trastuzumab|trastuzumab|mesh-list
25831266|NCT00006825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25831267|NCT00006825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831268|NCT00006825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25831269|NCT00006825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25831270|NCT00006825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831271|NCT00006825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831272|NCT00006825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25831273|NCT00006864|Aldesleukin|aldesleukin|mesh-list
25107131|NCT03142516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25107132|NCT03142165|Diphenhydramine|diphenhydramine|mesh-list
25107133|NCT03142165|Promethazine|promethazine|mesh-list
25107135|NCT03142165|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25107136|NCT03142165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25107137|NCT03142165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25107138|NCT03142165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107139|NCT03142165|Anesthetics, Local|anesthetics, local|mesh-ancestor
25107140|NCT03142165|Anesthetics|anesthetics|mesh-ancestor
25107141|NCT03142165|Sensory System Agents|sensory system agents|mesh-ancestor
25107142|NCT03142165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25107143|NCT03142165|Antiemetics|antiemetics|mesh-ancestor
25831274|NCT00006864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831275|NCT00006864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24515145|NCT00594867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24515146|NCT00594867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24515147|NCT00594867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515155|NCT00595049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515158|NCT00595140|Cabergoline|cabergoline|mesh-list
24515159|NCT00595140|Somatostatin|somatostatin|mesh-list
24515160|NCT00595140|Dopamine Agonists|dopamine agonists|mesh-list
24515161|NCT00595140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24515162|NCT00595140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24515163|NCT00595140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24515164|NCT00595140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24515165|NCT00595140|Sympathomimetics|sympathomimetics|mesh-ancestor
24515171|NCT00595140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107144|NCT03142165|Autonomic Agents|autonomic agents|mesh-ancestor
25107145|NCT03142165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25107146|NCT03142165|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24862133|NCT02323373|Tranexamic Acid|tranexamic acid|mesh-list
25107147|NCT03142165|Histamine Antagonists|histamine antagonists|mesh-ancestor
25107148|NCT03142165|Histamine Agents|histamine agents|mesh-ancestor
25107149|NCT03142165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25107150|NCT03142165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107151|NCT03142165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25107152|NCT03142165|Antipruritics|antipruritics|mesh-ancestor
25107153|NCT03142165|Dermatologic Agents|dermatologic agents|mesh-ancestor
25107154|NCT03142165|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25107155|NCT03142165|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25107158|NCT03142256|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25107159|NCT03142256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25107160|NCT03142256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25107161|NCT03142256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107162|NCT03142256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657817|NCT01590082|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25657818|NCT01590082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25657819|NCT01590433|Exenatide|exenatide|mesh-list
25657820|NCT01590433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25657821|NCT01590433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657822|NCT01590433|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25657823|NCT01590433|Incretins|incretins|mesh-ancestor
25657824|NCT01590433|Hormones|hormones|mesh-ancestor
24597577|NCT00950066|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24597578|NCT00950066|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24597580|NCT00950105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24597581|NCT00950105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24597583|NCT00950105|Sensory System Agents|sensory system agents|mesh-ancestor
24597584|NCT00950105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24597585|NCT00950105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597586|NCT00950105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25831276|NCT00006864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25831277|NCT00006864|Antiviral Agents|antiviral agents|mesh-ancestor
25831278|NCT00006864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25831279|NCT00006877|Temozolomide|temozolomide|mesh-list
25136283|NCT02992652|Allopurinol|allopurinol|mesh-list
25831280|NCT00006877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25831281|NCT00006877|Alkylating Agents|alkylating agents|mesh-ancestor
25831282|NCT00006877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831283|NCT00006877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831284|NCT00006890|Thalidomide|thalidomide|mesh-list
25831285|NCT00006890|Prednisone|prednisone|mesh-list
24515195|NCT00595543|Ketorolac|ketorolac|mesh-list
24515196|NCT00595543|Bromfenac|bromfenac|mesh-list
24515197|NCT00595543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24515198|NCT00595543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24515199|NCT00595543|Analgesics|analgesics|mesh-ancestor
25831286|NCT00006890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25831287|NCT00006890|Glucocorticoids|glucocorticoids|mesh-ancestor
24774712|NCT01847417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24785025|NCT01911598|Paclitaxel|paclitaxel|mesh-list
25107170|NCT03142542|Udenafil|udenafil|mesh-list
25107171|NCT03142542|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25107172|NCT03142542|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25107173|NCT03142542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107174|NCT03142542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107175|NCT03141827|Insulin|insulin|mesh-list
25107176|NCT03141827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24785091|NCT01911949|Sympathomimetics|sympathomimetics|mesh-ancestor
24515231|NCT00596050|Ketamine|ketamine|mesh-list
24515232|NCT00596050|Etomidate|etomidate|mesh-list
24515233|NCT00596050|Anesthetics, Local|anesthetics, local|mesh-ancestor
24515235|NCT00596050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24515236|NCT00596050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515237|NCT00596050|Sensory System Agents|sensory system agents|mesh-ancestor
24515238|NCT00596050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24515239|NCT00596050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24515261|NCT00596063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24515262|NCT00596063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515263|NCT00596115|Pramipexole|pramipexole|mesh-list
24987673|NCT05189769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24987674|NCT05189769|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24987675|NCT05189769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24987676|NCT05189704|Analgesics, Opioid|analgesics, opioid|mesh-list
24987677|NCT05189704|Narcotics|narcotics|mesh-ancestor
24987678|NCT05189704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24987679|NCT05189704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987680|NCT05189704|Analgesics|analgesics|mesh-ancestor
24987681|NCT05189704|Sensory System Agents|sensory system agents|mesh-ancestor
24987682|NCT05189704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24987683|NCT05186883|Parathyroid Hormone|parathyroid hormone|mesh-list
24862157|NCT02323412|Amoxicillin|amoxicillin|mesh-list
25831288|NCT00006890|Hormones|hormones|mesh-ancestor
25831289|NCT00006890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25831290|NCT00006890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657825|NCT01590433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25657826|NCT01590550|Dialysis Solutions|dialysis solutions|mesh-list
25657827|NCT01590550|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25657828|NCT01590758|Pexiganan|pexiganan|mesh-list
25657829|NCT01590758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25657830|NCT01590758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25657831|NCT01590771|Metformin|metformin|mesh-list
25657832|NCT01590771|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25657833|NCT01590771|Glimepiride|glimepiride|mesh-list
25831291|NCT00006890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25831292|NCT00006890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25657834|NCT01590771|Gliclazide|gliclazide|mesh-list
25831293|NCT00006890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24597965|NCT00953108|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24584937|NCT00882375|Nicotine|nicotine|mesh-list
24598460|NCT00956189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25831294|NCT00006890|Immunologic Factors|immunologic factors|mesh-ancestor
25831295|NCT00006890|Leprostatic Agents|leprostatic agents|mesh-ancestor
25831296|NCT00006890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25831297|NCT00006890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25831298|NCT00006890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25831299|NCT00006890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25831300|NCT00006890|Growth Substances|growth substances|mesh-ancestor
25831301|NCT00006890|Growth Inhibitors|growth inhibitors|mesh-ancestor
25831302|NCT00006929|Suramin|suramin|mesh-list
25831303|NCT00006929|Paclitaxel|paclitaxel|mesh-list
25831304|NCT00006929|Carboplatin|carboplatin|mesh-list
25046029|NCT00886600|Diuretics|diuretics|mesh-ancestor
25831305|NCT00006929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25831306|NCT00006929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831307|NCT00006929|Tubulin Modulators|tubulin modulators|mesh-ancestor
25831308|NCT00006929|Antimitotic Agents|antimitotic agents|mesh-ancestor
25831309|NCT00006929|Mitosis Modulators|mitosis modulators|mesh-ancestor
25831310|NCT00006929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831311|NCT00006929|Antinematodal Agents|antinematodal agents|mesh-ancestor
24987684|NCT05186883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25831312|NCT00006929|Anthelmintics|anthelmintics|mesh-ancestor
24515411|NCT00596986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24515412|NCT00596986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24515413|NCT00596986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515414|NCT00596986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24515415|NCT00596986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515416|NCT00596986|Analgesics|analgesics|mesh-ancestor
24515417|NCT00596986|Sensory System Agents|sensory system agents|mesh-ancestor
24515418|NCT00596986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24515419|NCT00596986|Antidepressive Agents|antidepressive agents|mesh-ancestor
24515420|NCT00596986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24515421|NCT00596986|Dopamine Agents|dopamine agents|mesh-ancestor
24515423|NCT00597064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24515424|NCT00597064|Glucocorticoids|glucocorticoids|mesh-ancestor
25831313|NCT00006929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25831314|NCT00006929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25831315|NCT00006929|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24515441|NCT00597233|Isophane Insulin, Human|isophane insulin, human|mesh-list
24515442|NCT00597233|Insulin, Isophane|insulin, isophane|mesh-list
24515476|NCT00597597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107177|NCT03141827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515482|NCT00597662|Dialysis Solutions|dialysis solutions|mesh-ancestor
24515483|NCT00597662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24515484|NCT00597688|Chlorhexidine|chlorhexidine|mesh-list
24515485|NCT00597688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24515486|NCT00597688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24515487|NCT00597688|Disinfectants|disinfectants|mesh-ancestor
25831316|NCT00006929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24515513|NCT00598091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24515514|NCT00598091|Immunologic Factors|immunologic factors|mesh-ancestor
24515515|NCT00598091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515516|NCT00598091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25831317|NCT00006942|Cisplatin|cisplatin|mesh-list
25831318|NCT00006942|Bryostatin 1|bryostatin 1|mesh-list
25831319|NCT00006942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831320|NCT00006942|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25831321|NCT00006942|Immunologic Factors|immunologic factors|mesh-ancestor
25831322|NCT00006942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831323|NCT00006968|Cyclosporine|cyclosporine|mesh-list
24515524|NCT00598156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515525|NCT00598156|Growth Inhibitors|growth inhibitors|mesh-ancestor
24515559|NCT00598195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24515560|NCT00598195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515561|NCT00598195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24515562|NCT00598195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25657835|NCT01590771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25657836|NCT01590771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657837|NCT01590771|Incretins|incretins|mesh-ancestor
25657838|NCT01590771|Hormones|hormones|mesh-ancestor
25657839|NCT01590771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25657840|NCT01590771|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25657841|NCT01590771|Protease Inhibitors|protease inhibitors|mesh-ancestor
25657842|NCT01590771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598905|NCT05351736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24598906|NCT05351736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598907|NCT05351736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24636227|NCT01144065|Androgens|androgens|mesh-ancestor
24636228|NCT01144065|Hormones|hormones|mesh-ancestor
24598950|NCT05351502|Nitric Oxide|nitric oxide|mesh-list
25831324|NCT00006968|Pentostatin|pentostatin|mesh-list
25831325|NCT00006968|Cyclosporins|cyclosporins|mesh-list
25831326|NCT00006968|Immunologic Factors|immunologic factors|mesh-ancestor
25831327|NCT00006968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831328|NCT00006968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831329|NCT00006968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831330|NCT00006968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25831331|NCT00006968|Antifungal Agents|antifungal agents|mesh-ancestor
25831332|NCT00006968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25831333|NCT00006968|Dermatologic Agents|dermatologic agents|mesh-ancestor
24515565|NCT00598195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24515566|NCT00598195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24515567|NCT00598195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24515568|NCT00598195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24515569|NCT00598195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136445|NCT02990962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24515571|NCT00598234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24515572|NCT00598234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24515642|NCT00598572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515643|NCT00598611|Loratadine|loratadine|mesh-list
24515644|NCT00598611|Desloratadine|desloratadine|mesh-list
24515645|NCT00598611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24515646|NCT00598611|Cholinergic Agents|cholinergic agents|mesh-ancestor
25831334|NCT00006968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25831335|NCT00006968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25831336|NCT00006968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831337|NCT00006968|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25831338|NCT00006981|Immunotoxins|immunotoxins|mesh-list
25831339|NCT00006981|Immunologic Factors|immunologic factors|mesh-ancestor
25831340|NCT00006981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875286|NCT04548752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875287|NCT04543617|Atezolizumab|atezolizumab|mesh-list
25875288|NCT04543617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25875289|NCT04543617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875290|NCT04543617|Immunologic Factors|immunologic factors|mesh-ancestor
25875291|NCT04543617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515736|NCT00598923|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24515739|NCT00598962|Rifabutin|rifabutin|mesh-list
24515740|NCT00598962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24515741|NCT00598962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24515742|NCT00598962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25875292|NCT04539236|Lenalidomide|lenalidomide|mesh-list
24515754|NCT00599079|Azithromycin|azithromycin|mesh-list
24515755|NCT00599079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25875293|NCT04539236|Luspatercept|luspatercept|mesh-list
25875294|NCT04539236|Immunologic Factors|immunologic factors|mesh-ancestor
25875295|NCT04539236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875296|NCT04539236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25875297|NCT04539236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25875298|NCT04539236|Growth Substances|growth substances|mesh-ancestor
25875299|NCT04539236|Growth Inhibitors|growth inhibitors|mesh-ancestor
25875300|NCT04539236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875301|NCT04539236|Hematinics|hematinics|mesh-ancestor
25875302|NCT04524000|Fulvestrant|fulvestrant|mesh-list
25875303|NCT04524000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24796682|NCT01951482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24796683|NCT01951508|Methylphenidate|methylphenidate|mesh-list
24796685|NCT01951508|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24796686|NCT01951508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657843|NCT01590771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657844|NCT01590771|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25657845|NCT01590771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25657846|NCT01590771|Immunologic Factors|immunologic factors|mesh-ancestor
25657847|NCT01590797|Metformin|metformin|mesh-list
25657848|NCT01590797|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25657849|NCT01590797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25657850|NCT01590797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657851|NCT01590797|Incretins|incretins|mesh-ancestor
25657852|NCT01590797|Hormones|hormones|mesh-ancestor
24863100|NCT03219528|Rifaximin|rifaximin|mesh-list
24796687|NCT01951508|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24862241|NCT02323906|Sorafenib|sorafenib|mesh-list
24862242|NCT02323906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24862244|NCT02323906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515932|NCT00600054|Antibodies|antibodies|mesh-list
25162887|NCT02901353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515933|NCT00600054|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24515934|NCT00600054|Immunologic Factors|immunologic factors|mesh-ancestor
24515935|NCT00600054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25003922|NCT02923128|Sensory System Agents|sensory system agents|mesh-ancestor
25003923|NCT02923128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25003924|NCT02923128|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25003925|NCT02923128|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25003926|NCT02923128|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25003927|NCT02923128|Adrenergic Agents|adrenergic agents|mesh-ancestor
25003928|NCT02923128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25003929|NCT02923128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25003930|NCT02923128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25003931|NCT02923128|Narcotics|narcotics|mesh-ancestor
25136535|NCT02990364|Lidocaine|lidocaine|mesh-list
25003932|NCT02923128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25003933|NCT02923128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25003934|NCT02923128|Anesthetics, General|anesthetics, general|mesh-ancestor
25003935|NCT02923128|Anesthetics|anesthetics|mesh-ancestor
25003936|NCT02921022|Gemcitabine|gemcitabine|mesh-list
25003938|NCT02921022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25003939|NCT02921022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25003940|NCT02921022|Tubulin Modulators|tubulin modulators|mesh-ancestor
25003941|NCT02921022|Antimitotic Agents|antimitotic agents|mesh-ancestor
25003942|NCT02921022|Mitosis Modulators|mitosis modulators|mesh-ancestor
25003944|NCT02921022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24500844|NCT00525967|Acetaminophen|acetaminophen|mesh-list
24515955|NCT00600145|Histamine Antagonists|histamine antagonists|mesh-ancestor
24515956|NCT00600145|Histamine Agents|histamine agents|mesh-ancestor
24515957|NCT00600145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24774713|NCT01847417|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24515989|NCT00600210|Carboplatin|carboplatin|mesh-list
25831341|NCT00007033|Magnesium Sulfate|magnesium sulfate|mesh-list
24516031|NCT00600301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516032|NCT00600301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796688|NCT01951508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24796689|NCT01951508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24796695|NCT01951508|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24796697|NCT01951560|Anticonvulsants|anticonvulsants|mesh-ancestor
24796698|NCT01951560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796699|NCT01951560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796700|NCT01951560|GABA Agents|gaba agents|mesh-ancestor
24796701|NCT01951560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24796702|NCT01951560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796703|NCT01951560|Antimanic Agents|antimanic agents|mesh-ancestor
24796704|NCT01951560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24796705|NCT01951560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25162888|NCT02901106|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25162889|NCT02901106|Dermatologic Agents|dermatologic agents|mesh-ancestor
25162890|NCT02901106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25162891|NCT02901106|Immunologic Factors|immunologic factors|mesh-ancestor
25162892|NCT02901106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162893|NCT02901288|Levofloxacin|levofloxacin|mesh-list
25162894|NCT02901288|Ofloxacin|ofloxacin|mesh-list
25162895|NCT02901288|Rifampin|rifampin|mesh-list
25657854|NCT01590797|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25657855|NCT01590797|Protease Inhibitors|protease inhibitors|mesh-ancestor
25657856|NCT01590797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657857|NCT01590797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657858|NCT01590875|Adenosine|adenosine|mesh-list
25657859|NCT01590875|Analgesics|analgesics|mesh-ancestor
25831342|NCT00007033|Analgesics|analgesics|mesh-ancestor
25162896|NCT02901288|Isoniazid|isoniazid|mesh-list
25831343|NCT00007033|Sensory System Agents|sensory system agents|mesh-ancestor
25831344|NCT00007033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25831345|NCT00007033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200886|NCT02731430|Analgesics|analgesics|mesh-ancestor
25657860|NCT01590875|Sensory System Agents|sensory system agents|mesh-ancestor
25657861|NCT01590875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25657862|NCT01590875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162897|NCT02901288|Pyrazinamide|pyrazinamide|mesh-list
25162899|NCT02901288|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25162900|NCT02901288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25162901|NCT02901288|Renal Agents|renal agents|mesh-ancestor
25162902|NCT02901288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25162903|NCT02901288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25162904|NCT02901288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25162905|NCT02901288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25162906|NCT02901288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162907|NCT02901288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162908|NCT02901288|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25162909|NCT02901288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25162910|NCT02901288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25162911|NCT02901288|Antitubercular Agents|antitubercular agents|mesh-ancestor
25004010|NCT02826512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941378|NCT03991442|Vasodilator Agents|vasodilator agents|mesh-ancestor
24941444|NCT03990961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24941445|NCT03990961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796706|NCT01951560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24516041|NCT00600405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24516042|NCT00600405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24796728|NCT01951729|Mydriatics|mydriatics|mesh-ancestor
24796729|NCT01951729|Parasympatholytics|parasympatholytics|mesh-ancestor
24796730|NCT01951729|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24796731|NCT01951729|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24796732|NCT01951729|Cholinergic Agents|cholinergic agents|mesh-ancestor
24796733|NCT01951729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24796734|NCT01951729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831346|NCT00007033|Anesthetics|anesthetics|mesh-ancestor
25831347|NCT00007033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25831348|NCT00007033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25831349|NCT00007033|Anticonvulsants|anticonvulsants|mesh-ancestor
25831350|NCT00007033|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25831351|NCT00007033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25831352|NCT00007033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831353|NCT00007033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25831354|NCT00007033|Tocolytic Agents|tocolytic agents|mesh-ancestor
24516114|NCT00600639|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24516116|NCT00600639|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24516117|NCT00600639|Methylprednisolone|methylprednisolone|mesh-list
24516118|NCT00600639|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24516119|NCT00600639|Prednisolone acetate|prednisolone acetate|mesh-list
24516120|NCT00600639|Albuterol|albuterol|mesh-list
24516121|NCT00600639|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24516122|NCT00600639|Prednisolone phosphate|prednisolone phosphate|mesh-list
24516126|NCT00600639|Glucocorticoids|glucocorticoids|mesh-ancestor
24796736|NCT01951846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796737|NCT01951846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24796738|NCT01951846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796739|NCT01951846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796740|NCT01951872|Caffeine|caffeine|mesh-list
24850215|NCT02252341|Acetylcysteine|acetylcysteine|mesh-list
24987778|NCT04990323|Antiviral Agents|antiviral agents|mesh-ancestor
25162912|NCT02901288|Leprostatic Agents|leprostatic agents|mesh-ancestor
25657863|NCT01590875|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25657864|NCT01590875|Vasodilator Agents|vasodilator agents|mesh-ancestor
25657865|NCT01590875|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25657866|NCT01590875|Purinergic Agonists|purinergic agonists|mesh-ancestor
25162913|NCT02901288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25413528|NCT03126916|Sargramostim|sargramostim|mesh-list
25657867|NCT01590875|Purinergic Agents|purinergic agents|mesh-ancestor
25657868|NCT01590875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25657869|NCT01590875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657870|NCT01590979|Ranolazine|ranolazine|mesh-list
25657871|NCT01590979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24626358|NCT01086956|Ropivacaine|ropivacaine|mesh-list
24626359|NCT01086956|Anesthetics, Local|anesthetics, local|mesh-ancestor
24626360|NCT01086956|Anesthetics|anesthetics|mesh-ancestor
24626361|NCT01086956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24626362|NCT01086956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626363|NCT01086956|Sensory System Agents|sensory system agents|mesh-ancestor
24626364|NCT01086956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25831355|NCT00007033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25162914|NCT02901288|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25162915|NCT02901288|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25162916|NCT02901288|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25162917|NCT02901288|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25162918|NCT02901288|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25049482|NCT00602602|Immunologic Factors|immunologic factors|mesh-ancestor
25049484|NCT00602329|Bevacizumab|bevacizumab|mesh-list
25049485|NCT00602329|Fluorouracil|fluorouracil|mesh-list
25049486|NCT00602329|Oxaliplatin|oxaliplatin|mesh-list
25049487|NCT00602329|Calcium|calcium|mesh-list
25049488|NCT00602329|Levoleucovorin|levoleucovorin|mesh-list
25049489|NCT00602329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24987811|NCT04939090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24987812|NCT04939090|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24987813|NCT04939090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24987814|NCT04939090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24987815|NCT04939090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987816|NCT04939090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24987817|NCT04939090|Serotonin Agents|serotonin agents|mesh-ancestor
24987818|NCT04939090|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24987819|NCT04939090|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24987833|NCT04865497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987834|NCT04823247|Interleukin-23|interleukin-23|mesh-list
24987835|NCT04823247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24987836|NCT04823247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24987837|NCT04823247|Growth Substances|growth substances|mesh-ancestor
24987838|NCT04823247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987839|NCT04823247|Growth Inhibitors|growth inhibitors|mesh-ancestor
24987840|NCT04823247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987841|NCT04817787|Metformin|metformin|mesh-list
24987842|NCT04817787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24987843|NCT04817787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987844|NCT04816162|Dexmedetomidine|dexmedetomidine|mesh-list
24987845|NCT04816162|Ketamine|ketamine|mesh-list
25831356|NCT00007059|Mycophenolic Acid|mycophenolic acid|mesh-list
25831357|NCT00007059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25831358|NCT00007059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831359|NCT00007059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25831360|NCT00007059|Antitubercular Agents|antitubercular agents|mesh-ancestor
25831361|NCT00007059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25831362|NCT00007059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25162919|NCT02901288|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25162920|NCT02901288|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25162921|NCT02901288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25162922|NCT02901288|Antimetabolites|antimetabolites|mesh-ancestor
25162923|NCT02901288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25831363|NCT00007059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831364|NCT00007059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831365|NCT00007189|Celecoxib|celecoxib|mesh-list
25831366|NCT00007189|Naproxen|naproxen|mesh-list
25831367|NCT00007189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25831368|NCT00007189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25831369|NCT00007189|Analgesics|analgesics|mesh-ancestor
24862323|NCT02324413|Autonomic Agents|autonomic agents|mesh-ancestor
24987846|NCT04816162|Propofol|propofol|mesh-list
24987847|NCT04816162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25657872|NCT01590979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25657873|NCT01590979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657874|NCT01591317|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25657875|NCT01591317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25657876|NCT01591382|Ketamine|ketamine|mesh-list
25657877|NCT01591382|Hydromorphone|hydromorphone|mesh-list
25657878|NCT01591382|Analgesics|analgesics|mesh-ancestor
25657879|NCT01591382|Sensory System Agents|sensory system agents|mesh-ancestor
25657880|NCT01591382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25657881|NCT01591382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200931|NCT02730949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200933|NCT02731040|Zoledronic Acid|zoledronic acid|mesh-list
25200934|NCT02731040|Diphosphonates|diphosphonates|mesh-list
25200935|NCT02731040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25200936|NCT02731040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200937|NCT02730975|Abiraterone Acetate|abiraterone acetate|mesh-list
25200938|NCT02730975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987848|NCT04816162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24987849|NCT04816162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987850|NCT04816162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24987851|NCT04816162|Anesthetics, General|anesthetics, general|mesh-ancestor
24987852|NCT04816162|Anesthetics|anesthetics|mesh-ancestor
24987853|NCT04816162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24987854|NCT04816162|Analgesics|analgesics|mesh-ancestor
24987855|NCT04816162|Sensory System Agents|sensory system agents|mesh-ancestor
24987856|NCT04816162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24987857|NCT04816162|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24987858|NCT04816162|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24987859|NCT04816162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24987860|NCT04816162|Adrenergic Agents|adrenergic agents|mesh-ancestor
24987861|NCT04816162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24987862|NCT04816162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004034|NCT02807636|Gemcitabine|gemcitabine|mesh-list
25004035|NCT02807636|Carboplatin|carboplatin|mesh-list
25004036|NCT02807636|Atezolizumab|atezolizumab|mesh-list
25004037|NCT02807636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25004038|NCT02807636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25004039|NCT02807636|Antimetabolites|antimetabolites|mesh-ancestor
25004040|NCT02807636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004047|NCT02764541|Tamoxifen|tamoxifen|mesh-list
24501195|NCT00527215|Hematinics|hematinics|mesh-ancestor
24987863|NCT04816162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24987864|NCT04816162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24987865|NCT04816162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24987866|NCT04809831|Chlorhexidine|chlorhexidine|mesh-list
24987867|NCT04809831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24987868|NCT04809831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24987869|NCT04809831|Disinfectants|disinfectants|mesh-ancestor
24987870|NCT04787965|Opicapone|opicapone|mesh-list
24987871|NCT04787965|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24987872|NCT04787965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24987873|NCT04787965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987874|NCT04787965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24862326|NCT02324413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24516268|NCT00601289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516269|NCT00601289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516271|NCT00601302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24516272|NCT00601302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24774714|NCT01847417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24785106|NCT01912053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24785107|NCT01912053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25831370|NCT00007189|Sensory System Agents|sensory system agents|mesh-ancestor
25831371|NCT00007189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25831372|NCT00007189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831373|NCT00007189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24987911|NCT04676802|Narcotics|narcotics|mesh-ancestor
25831374|NCT00007189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25831375|NCT00007189|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25831376|NCT00007189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25831377|NCT00007189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107188|NCT03141658|Analgesics|analgesics|mesh-ancestor
25107189|NCT03141658|Sensory System Agents|sensory system agents|mesh-ancestor
25657882|NCT01591382|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25657883|NCT01591382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25657884|NCT01591382|Anesthetics, General|anesthetics, general|mesh-ancestor
25657885|NCT01591382|Anesthetics|anesthetics|mesh-ancestor
25657886|NCT01591382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25657887|NCT01591382|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25657888|NCT01591382|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25657889|NCT01591382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25408575|NCT03434379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516321|NCT00601536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516326|NCT00601562|Zidovudine|zidovudine|mesh-list
25831378|NCT00007189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831379|NCT00007189|Gout Suppressants|gout suppressants|mesh-ancestor
25831380|NCT00007202|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25831381|NCT00007202|Stavudine|stavudine|mesh-list
25831382|NCT00007202|Didanosine|didanosine|mesh-list
25831383|NCT00007202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25831384|NCT00007202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25831385|NCT00007202|Protease Inhibitors|protease inhibitors|mesh-ancestor
25831386|NCT00007202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831387|NCT00007202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831388|NCT00007202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25831389|NCT00007202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25831390|NCT00007202|Antiviral Agents|antiviral agents|mesh-ancestor
25831391|NCT00007202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25831392|NCT00007202|Antimetabolites|antimetabolites|mesh-ancestor
25162932|NCT02901145|Cyclophosphamide|cyclophosphamide|mesh-list
25162933|NCT02901145|Nivolumab|nivolumab|mesh-list
25049529|NCT00594984|Irinotecan|irinotecan|mesh-list
25049530|NCT00594984|Cetuximab|cetuximab|mesh-list
24625745|NCT01083329|Niacin|niacin|mesh-list
25831393|NCT00007202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25107197|NCT03141658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25107198|NCT03141658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25107199|NCT03141658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25136801|NCT02988700|Anesthetics, Local|anesthetics, local|mesh-ancestor
25107200|NCT03141658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107201|NCT03141645|Ondansetron|ondansetron|mesh-list
25107202|NCT03141645|Antiemetics|antiemetics|mesh-ancestor
25107203|NCT03141645|Autonomic Agents|autonomic agents|mesh-ancestor
25107204|NCT03141645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25107205|NCT03141645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107206|NCT03141645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25831394|NCT00007202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25831395|NCT00007306|Hormones|hormones|mesh-list
25831396|NCT00007306|Parathyroid Hormone|parathyroid hormone|mesh-list
25831397|NCT00007306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25831398|NCT00007306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831399|NCT00007306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25831400|NCT00007358|Dexamethasone|dexamethasone|mesh-list
25831401|NCT00007358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25831402|NCT00007358|Antiemetics|antiemetics|mesh-ancestor
25831403|NCT00007358|Autonomic Agents|autonomic agents|mesh-ancestor
25831404|NCT00007358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25831405|NCT00007358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831406|NCT00007358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25831407|NCT00007358|Glucocorticoids|glucocorticoids|mesh-ancestor
25831408|NCT00007358|Hormones|hormones|mesh-ancestor
25831409|NCT00007358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25831410|NCT00007358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25831411|NCT00007358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831412|NCT00007423|polysaccharide-K|polysaccharide-k|mesh-list
25831413|NCT00007423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25831414|NCT00007423|Immunologic Factors|immunologic factors|mesh-ancestor
25831415|NCT00007423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831416|NCT00007423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25831417|NCT00007423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831418|NCT00007423|Antiviral Agents|antiviral agents|mesh-ancestor
25831419|NCT00007423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25136838|NCT02988440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136839|NCT02988440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25136840|NCT02988440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136843|NCT02988089|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25831420|NCT00007423|Interferon Inducers|interferon inducers|mesh-ancestor
25107213|NCT03141645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25107214|NCT03141645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25107215|NCT03141645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25107216|NCT03141645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25107217|NCT03141645|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25107218|NCT03141918|Curcumin|curcumin|mesh-list
25107219|NCT03141918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25107220|NCT03141918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25107221|NCT03141918|Analgesics|analgesics|mesh-ancestor
25107222|NCT03141918|Sensory System Agents|sensory system agents|mesh-ancestor
25831421|NCT00007423|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25831422|NCT00007423|Protective Agents|protective agents|mesh-ancestor
25831423|NCT00007436|Tenofovir|tenofovir|mesh-list
25200950|NCT02730845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25200951|NCT02730845|Analgesics|analgesics|mesh-ancestor
25200952|NCT02730845|Sensory System Agents|sensory system agents|mesh-ancestor
25200953|NCT02730845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25200954|NCT02730845|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25200955|NCT02730845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25200956|NCT02730845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25200957|NCT02730845|Adrenergic Agents|adrenergic agents|mesh-ancestor
25831424|NCT00007436|Antiviral Agents|antiviral agents|mesh-ancestor
25831425|NCT00007436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25831426|NCT00007436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25831427|NCT00007436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25831428|NCT00007436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831429|NCT00007436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831430|NCT00007436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25831431|NCT00007436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25831432|NCT00007527|Buprenorphine|buprenorphine|mesh-list
25831433|NCT00007527|Naloxone|naloxone|mesh-list
25162934|NCT02901145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25831434|NCT00007527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25162939|NCT02901145|Alkylating Agents|alkylating agents|mesh-ancestor
25831435|NCT00007527|Narcotics|narcotics|mesh-ancestor
25831436|NCT00007527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25831437|NCT00007527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162935|NCT02901145|Immunologic Factors|immunologic factors|mesh-ancestor
25162936|NCT02901145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162937|NCT02901145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25162938|NCT02901145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24516524|NCT00602303|Natriuretic Agents|natriuretic agents|mesh-ancestor
25004173|NCT02569489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25004174|NCT02569489|Tubulin Modulators|tubulin modulators|mesh-ancestor
25004175|NCT02569489|Antimitotic Agents|antimitotic agents|mesh-ancestor
25004176|NCT02569489|Mitosis Modulators|mitosis modulators|mesh-ancestor
25004177|NCT02569489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004178|NCT02569489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24516525|NCT00602303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831438|NCT00007527|Analgesics|analgesics|mesh-ancestor
25831439|NCT00007527|Sensory System Agents|sensory system agents|mesh-ancestor
25831440|NCT00007527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25831441|NCT00007527|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25831442|NCT00007592|Chlorthalidone|chlorthalidone|mesh-list
25831443|NCT00007592|Furosemide|furosemide|mesh-list
24560171|NCT03417687|Xenon|xenon|mesh-list
25831444|NCT00007592|Diuretics|diuretics|mesh-ancestor
25831445|NCT00007592|Natriuretic Agents|natriuretic agents|mesh-ancestor
25831446|NCT00007592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831447|NCT00007592|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25831448|NCT00007592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25831449|NCT00007592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831450|NCT00007592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25831451|NCT00007592|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24987887|NCT04770272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987888|NCT04770272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25831452|NCT00007605|Amiodarone|amiodarone|mesh-list
24987910|NCT04676802|Analgesics, Opioid|analgesics, opioid|mesh-list
25831453|NCT00007605|Sotalol|sotalol|mesh-list
25831454|NCT00007605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24516606|NCT00602550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24516607|NCT00602550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24516608|NCT00602550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516644|NCT00602693|Fludarabine|fludarabine|mesh-list
25657890|NCT01591382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657891|NCT01591382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25657892|NCT01591382|Narcotics|narcotics|mesh-ancestor
25657893|NCT01591460|Ribavirin|ribavirin|mesh-list
25657894|NCT01591460|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25657895|NCT01591460|Interferon-alpha|interferon-alpha|mesh-list
25657896|NCT01591460|Antimetabolites|antimetabolites|mesh-ancestor
25657897|NCT01591460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657898|NCT01591460|Antiviral Agents|antiviral agents|mesh-ancestor
25657899|NCT01591460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25831455|NCT00007605|Vasodilator Agents|vasodilator agents|mesh-ancestor
25831456|NCT00007605|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24863296|NCT00988247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24863297|NCT00988247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863298|NCT00988247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24863299|NCT00988247|Respiratory System Agents|respiratory system agents|mesh-ancestor
24863331|NCT00363038|Coagulants|coagulants|mesh-ancestor
24863332|NCT00363038|Emollients|emollients|mesh-ancestor
24863333|NCT00363038|Dermatologic Agents|dermatologic agents|mesh-ancestor
24863334|NCT05146271|Anesthetics|anesthetics|mesh-list
24863335|NCT05146271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25154111|NCT01468896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25154112|NCT01468896|Growth Substances|growth substances|mesh-ancestor
25154113|NCT01468896|Growth Inhibitors|growth inhibitors|mesh-ancestor
25154114|NCT01462890|Paclitaxel|paclitaxel|mesh-list
25154115|NCT01462890|Bevacizumab|bevacizumab|mesh-list
25154116|NCT01462890|Carboplatin|carboplatin|mesh-list
25154118|NCT01462890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863336|NCT05146271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516645|NCT00602693|Fludarabine phosphate|fludarabine phosphate|mesh-list
24516646|NCT00602693|Allopurinol|allopurinol|mesh-list
24516647|NCT00602693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24516648|NCT00602693|Immunologic Factors|immunologic factors|mesh-ancestor
25831457|NCT00007605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25831458|NCT00007605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831459|NCT00007605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25831460|NCT00007605|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25831461|NCT00007605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25831462|NCT00007605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831463|NCT00007605|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25831464|NCT00007605|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25831465|NCT00007605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25831466|NCT00007605|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25831467|NCT00007605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25831468|NCT00007605|Adrenergic Agents|adrenergic agents|mesh-ancestor
25831469|NCT00007605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25831470|NCT00007605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831471|NCT00007605|Sympatholytics|sympatholytics|mesh-ancestor
25831472|NCT00007605|Autonomic Agents|autonomic agents|mesh-ancestor
25831473|NCT00007605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25831474|NCT00007631|Tretinoin|tretinoin|mesh-list
24493517|NCT00491166|Analgesics|analgesics|mesh-ancestor
24987892|NCT04770272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24987894|NCT04770272|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24987895|NCT04770272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24987896|NCT04770272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24987897|NCT04770272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24987898|NCT04770272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24987899|NCT04716075|Acalabrutinib|acalabrutinib|mesh-list
24987900|NCT04716075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987901|NCT04713358|Nalmefene|nalmefene|mesh-list
25831475|NCT00007631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831476|NCT00007631|Keratolytic Agents|keratolytic agents|mesh-ancestor
25831477|NCT00007631|Dermatologic Agents|dermatologic agents|mesh-ancestor
25831478|NCT00007670|Lamotrigine|lamotrigine|mesh-list
25831479|NCT00007670|Carbamazepine|carbamazepine|mesh-list
25831480|NCT00007670|Gabapentin|gabapentin|mesh-list
25831481|NCT00007670|Analgesics|analgesics|mesh-ancestor
25831482|NCT00007670|Sensory System Agents|sensory system agents|mesh-ancestor
25831483|NCT00007670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25657900|NCT01591460|Immunologic Factors|immunologic factors|mesh-ancestor
25657901|NCT01591460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657902|NCT01591616|Lidocaine|lidocaine|mesh-list
25657903|NCT01591616|Prilocaine|prilocaine|mesh-list
25657904|NCT01591616|Anesthetics, Local|anesthetics, local|mesh-ancestor
25657905|NCT01591616|Anesthetics|anesthetics|mesh-ancestor
25657906|NCT01591616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25657907|NCT01591616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657908|NCT01591616|Sensory System Agents|sensory system agents|mesh-ancestor
25657909|NCT01591616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25657910|NCT01591616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25657911|NCT01591616|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25657912|NCT01591616|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25657913|NCT01591616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25657914|NCT01591616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657915|NCT01591733|Capecitabine|capecitabine|mesh-list
25657916|NCT01591733|Oxaliplatin|oxaliplatin|mesh-list
24863344|NCT05146245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25200959|NCT02730845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543143|NCT00681993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24543145|NCT00682006|Chlorhexidine|chlorhexidine|mesh-list
24543146|NCT00682006|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24543149|NCT00682006|Disinfectants|disinfectants|mesh-ancestor
25200977|NCT02730689|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25200978|NCT02730689|Ezetimibe|ezetimibe|mesh-list
25831484|NCT00007670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831485|NCT00007670|Anticonvulsants|anticonvulsants|mesh-ancestor
25831486|NCT00007670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25831487|NCT00007670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25831488|NCT00007670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24516743|NCT00603083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24516744|NCT00603083|Analgesics|analgesics|mesh-ancestor
24516746|NCT00603083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24850711|NCT02253901|Ritonavir|ritonavir|mesh-list
24987908|NCT04696952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24987909|NCT04696952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987912|NCT04676802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24862403|NCT02325011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24862404|NCT02325011|Anticonvulsants|anticonvulsants|mesh-ancestor
24862405|NCT02325011|Hallucinogens|hallucinogens|mesh-ancestor
24862406|NCT02325011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25831489|NCT00007670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25831490|NCT00007670|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25831491|NCT00007670|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24516791|NCT00603434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25831492|NCT00007670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25831493|NCT00007670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136979|NCT02987907|Glucocorticoids|glucocorticoids|mesh-ancestor
25831494|NCT00007670|Antimanic Agents|antimanic agents|mesh-ancestor
25831495|NCT00007670|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24516923|NCT00604682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24987913|NCT04676802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987914|NCT04676802|Analgesics|analgesics|mesh-ancestor
24987915|NCT04676802|Sensory System Agents|sensory system agents|mesh-ancestor
24987916|NCT04676802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24987917|NCT04668950|Fluvoxamine|fluvoxamine|mesh-list
24987918|NCT04668950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24987919|NCT04668950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24987920|NCT04668950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24987921|NCT04668950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205302|NCT04942067|Hormones|hormones|mesh-ancestor
24987938|NCT04631471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24987939|NCT04631471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517030|NCT00605605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517032|NCT00605683|Pramipexole|pramipexole|mesh-list
24517033|NCT00605683|Ropinirole|ropinirole|mesh-list
24517034|NCT00605683|Bromocriptine|bromocriptine|mesh-list
24517035|NCT00605683|Lisuride|lisuride|mesh-list
24517036|NCT00605683|Apomorphine|apomorphine|mesh-list
24517037|NCT00605683|Pergolide|pergolide|mesh-list
24517038|NCT00605683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24517039|NCT00605683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24517040|NCT00605683|Dopamine Agonists|dopamine agonists|mesh-ancestor
25162947|NCT02901301|Trastuzumab|trastuzumab|mesh-list
25162948|NCT02901301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162949|NCT02901301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24517041|NCT00605683|Dopamine Agents|dopamine agents|mesh-ancestor
25657917|NCT01591733|Irinotecan|irinotecan|mesh-list
25657918|NCT01591733|Folfirinox|folfirinox|mesh-list
25657919|NCT01591733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25657920|NCT01591733|Antimetabolites|antimetabolites|mesh-ancestor
25657921|NCT01591733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657922|NCT01591733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25657923|NCT01591733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25657924|NCT01591733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25657925|NCT01591733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657926|NCT01591746|Botulinum Toxins|botulinum toxins|mesh-list
25657927|NCT01591746|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24517042|NCT00605683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24517043|NCT00605683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952215|NCT03896113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24952216|NCT03896113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25110185|NCT05464979|Narcotics|narcotics|mesh-ancestor
25200995|NCT02730624|Tazobactam|tazobactam|mesh-list
24517044|NCT00605683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517045|NCT00605683|Antioxidants|antioxidants|mesh-ancestor
24862430|NCT02325180|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24987957|NCT04558502|Minocycline|minocycline|mesh-list
24987958|NCT04558502|Esomeprazole|esomeprazole|mesh-list
24987959|NCT04558502|Bismuth|bismuth|mesh-list
24987960|NCT04558502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24987961|NCT04558502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24987962|NCT04558502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24987963|NCT04558502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24987964|NCT04558502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24987965|NCT04558502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24987966|NCT04558502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987967|NCT04558502|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24987968|NCT04558502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24987969|NCT04558502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24987970|NCT04558502|Antacids|antacids|mesh-ancestor
24987971|NCT04550455|Cladribine|cladribine|mesh-list
24987972|NCT04550455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987973|NCT04550455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24987974|NCT04550455|Immunologic Factors|immunologic factors|mesh-ancestor
24987975|NCT04550455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987976|NCT04505735|Corticosterone|corticosterone|mesh-list
25831496|NCT00007670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25831497|NCT00007670|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25831498|NCT00007670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25831499|NCT00007670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25831500|NCT00007670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25831501|NCT00007670|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25831502|NCT00007670|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25831503|NCT00007683|Aspirin|aspirin|mesh-list
24542237|NCT00677755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24542238|NCT00677755|Abortifacient Agents|abortifacient agents|mesh-ancestor
24987980|NCT04479267|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24987981|NCT04479267|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24987983|NCT04479267|Prednisolone acetate|prednisolone acetate|mesh-list
24987984|NCT04479267|Hydrocortisone|hydrocortisone|mesh-list
24987985|NCT04479267|Cortisone|cortisone|mesh-list
24987986|NCT04479267|Cyclophosphamide|cyclophosphamide|mesh-list
24987987|NCT04479267|Rituximab|rituximab|mesh-list
24987988|NCT04479267|Doxorubicin|doxorubicin|mesh-list
24987989|NCT04479267|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24987990|NCT04479267|Antibodies|antibodies|mesh-list
24987991|NCT04479267|Immunoglobulins|immunoglobulins|mesh-list
24987992|NCT04479267|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24987993|NCT04479267|Immunoconjugates|immunoconjugates|mesh-list
24987994|NCT04479267|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24987995|NCT04479267|Prednisolone phosphate|prednisolone phosphate|mesh-list
24988013|NCT04479267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24988014|NCT04479267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25831504|NCT00007683|Warfarin|warfarin|mesh-list
25831505|NCT00007683|Clopidogrel|clopidogrel|mesh-list
25831506|NCT00007683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25831507|NCT00007683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24988024|NCT04471597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24988025|NCT04471597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988026|NCT04471597|Sensory System Agents|sensory system agents|mesh-ancestor
24517144|NCT00606203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24517179|NCT00606411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657928|NCT01591746|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25657929|NCT01591746|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25657930|NCT01591746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24517180|NCT00606437|Fludarabine|fludarabine|mesh-list
24517181|NCT00606437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517182|NCT00606450|Thalidomide|thalidomide|mesh-list
24517183|NCT00606450|Apremilast|apremilast|mesh-list
24517184|NCT00606450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25657931|NCT01591746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657932|NCT01591746|Cholinergic Agents|cholinergic agents|mesh-ancestor
25657933|NCT01591746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25657934|NCT01591746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657935|NCT01591746|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25004357|NCT01941875|Progesterone|progesterone|mesh-list
24517186|NCT00606450|Analgesics|analgesics|mesh-ancestor
24517187|NCT00606450|Sensory System Agents|sensory system agents|mesh-ancestor
25137120|NCT02986906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988051|NCT04297592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24517278|NCT00607074|Secnidazole|secnidazole|mesh-list
24517279|NCT00607074|Metronidazole|metronidazole|mesh-list
25831508|NCT00007683|Analgesics|analgesics|mesh-ancestor
25831509|NCT00007683|Sensory System Agents|sensory system agents|mesh-ancestor
25831510|NCT00007683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25831511|NCT00007683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988063|NCT04251715|BB 1101|bb 1101|mesh-list
24988064|NCT04251715|Deoxyuridine|deoxyuridine|mesh-list
24988065|NCT04251715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24988066|NCT04251715|Antiemetics|antiemetics|mesh-ancestor
24988067|NCT04251715|Autonomic Agents|autonomic agents|mesh-ancestor
24988068|NCT04251715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24988069|NCT04251715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137142|NCT02986503|Doxorubicin|doxorubicin|mesh-list
25137143|NCT02986503|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25137144|NCT02986503|Methotrexate|methotrexate|mesh-list
25137145|NCT02986503|Ifosfamide|ifosfamide|mesh-list
25137146|NCT02986503|Isophosphamide mustard|isophosphamide mustard|mesh-list
25137147|NCT02986503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25137148|NCT02986503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25137149|NCT02986503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25137150|NCT02986503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25137152|NCT02986503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137154|NCT02986503|Abortifacient Agents|abortifacient agents|mesh-ancestor
24988070|NCT04251715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24862489|NCT02325882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24862490|NCT02325882|Analgesics|analgesics|mesh-ancestor
24517305|NCT00607217|Vaccines|vaccines|mesh-list
24517306|NCT00607217|Immunologic Factors|immunologic factors|mesh-ancestor
24517326|NCT00607503|Autonomic Agents|autonomic agents|mesh-ancestor
24517327|NCT00607503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25831512|NCT00007683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24517338|NCT00607503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24517339|NCT00607503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517340|NCT00607542|Baclofen|baclofen|mesh-list
24517341|NCT00607542|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24517342|NCT00607542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517343|NCT00607542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24517344|NCT00607542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24517375|NCT00607581|Glucocorticoids|glucocorticoids|mesh-ancestor
24517376|NCT00607581|Hormones|hormones|mesh-ancestor
25831513|NCT00007683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25162950|NCT02901301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25162951|NCT02901301|Antimetabolites|antimetabolites|mesh-ancestor
25162952|NCT02901301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162953|NCT02901236|Bevacizumab|bevacizumab|mesh-list
25162954|NCT02901236|Mitomycins|mitomycins|mesh-list
25162955|NCT02901236|Mitomycin|mitomycin|mesh-list
25162956|NCT02901236|Antimetabolites|antimetabolites|mesh-list
25137162|NCT02986503|Immunologic Factors|immunologic factors|mesh-ancestor
25137163|NCT02986503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25137166|NCT02986503|Alkylating Agents|alkylating agents|mesh-ancestor
25162957|NCT02901236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25831514|NCT00007683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25831515|NCT00007683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25162958|NCT02901236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162959|NCT02901236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25004422|NCT01773395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25004423|NCT01773395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25004424|NCT01724346|Chlorambucil|chlorambucil|mesh-list
24988302|NCT03406156|Alkylating Agents|alkylating agents|mesh-ancestor
25004429|NCT01704859|Vitamin D|vitamin d|mesh-list
25004430|NCT01704859|Ergocalciferols|ergocalciferols|mesh-list
25004431|NCT01704859|Cholecalciferol|cholecalciferol|mesh-list
25004432|NCT01704859|Vitamins|vitamins|mesh-list
25004433|NCT01704859|Micronutrients|micronutrients|mesh-ancestor
25831516|NCT00007683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831517|NCT00007683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25831518|NCT00007683|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25831519|NCT00007683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831520|NCT00007683|Antipyretics|antipyretics|mesh-ancestor
25831521|NCT00007683|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25831522|NCT00007683|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25831523|NCT00007683|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25831524|NCT00007683|Purinergic Agents|purinergic agents|mesh-ancestor
25831525|NCT00007683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25831526|NCT00007683|Anticoagulants|anticoagulants|mesh-ancestor
25046096|NCT00875459|Insulin|insulin|mesh-list
25831527|NCT00007735|Doxycycline|doxycycline|mesh-list
25831528|NCT00007735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24517437|NCT00607958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24517438|NCT00607958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24517439|NCT00607958|Antiviral Agents|antiviral agents|mesh-ancestor
24517440|NCT00607958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24517441|NCT00607958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24796770|NCT01951885|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24796771|NCT01951885|Antitubercular Agents|antitubercular agents|mesh-ancestor
24796772|NCT01951885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24796773|NCT01951885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24796774|NCT01951898|Montelukast|montelukast|mesh-list
24796775|NCT01951898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24796776|NCT01951898|Respiratory System Agents|respiratory system agents|mesh-ancestor
25831529|NCT00007735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25831530|NCT00007735|Antimalarials|antimalarials|mesh-ancestor
25831531|NCT00007735|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25046125|NCT00872014|Growth Inhibitors|growth inhibitors|mesh-ancestor
25831532|NCT00007735|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25831533|NCT00007774|Haloperidol|haloperidol|mesh-list
25831534|NCT00007774|Olanzapine|olanzapine|mesh-list
25831535|NCT00007774|Haloperidol decanoate|haloperidol decanoate|mesh-list
25162960|NCT02901236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25162961|NCT02901236|Growth Substances|growth substances|mesh-ancestor
25162962|NCT02901236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25162963|NCT02901236|Growth Inhibitors|growth inhibitors|mesh-ancestor
25162964|NCT02901236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25162965|NCT02901236|Alkylating Agents|alkylating agents|mesh-ancestor
25162966|NCT02901236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162967|NCT02901236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25162968|NCT02901236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25162969|NCT02900820|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25162970|NCT02900820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25162971|NCT02900820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25162972|NCT02900820|Antitubercular Agents|antitubercular agents|mesh-ancestor
25162974|NCT02900729|Amlodipine|amlodipine|mesh-list
25137233|NCT02986594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25162975|NCT02900729|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25004496|NCT01074151|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25004497|NCT01074151|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25004498|NCT01074151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25831536|NCT00007774|Antiemetics|antiemetics|mesh-ancestor
25831537|NCT00007774|Autonomic Agents|autonomic agents|mesh-ancestor
25831538|NCT00007774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25831539|NCT00007774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517450|NCT00607984|Thiotepa|thiotepa|mesh-list
24517451|NCT00607984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24517452|NCT00607984|Alkylating Agents|alkylating agents|mesh-ancestor
25137248|NCT02985736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25137249|NCT02985736|Glucocorticoids|glucocorticoids|mesh-ancestor
25137250|NCT02985736|Hormones|hormones|mesh-ancestor
25137251|NCT02985736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25137252|NCT02985736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137253|NCT02985697|Midazolam|midazolam|mesh-list
24517453|NCT00607984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517454|NCT00607984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517455|NCT00607984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24517456|NCT00607984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24517457|NCT00607984|Immunologic Factors|immunologic factors|mesh-ancestor
24517458|NCT00607984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517459|NCT00608075|Lithium Carbonate|lithium carbonate|mesh-list
24517460|NCT00608075|Antidepressive Agents|antidepressive agents|mesh-ancestor
24517461|NCT00608075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24517462|NCT00608075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517463|NCT00608075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796785|NCT01951911|Analgesics|analgesics|mesh-ancestor
24796786|NCT01951911|Sensory System Agents|sensory system agents|mesh-ancestor
25408576|NCT03434379|Growth Inhibitors|growth inhibitors|mesh-ancestor
25831540|NCT00007774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25831541|NCT00007774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24796787|NCT01951911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24796788|NCT01951911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590276|NCT00911651|Ipratropium|ipratropium|mesh-list
24796789|NCT01951911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24796790|NCT01951911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24796792|NCT01951911|Anesthetics|anesthetics|mesh-ancestor
24796805|NCT01952314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24862513|NCT05144100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24862517|NCT05143281|Dexamethasone|dexamethasone|mesh-list
24517472|NCT00608101|Autonomic Agents|autonomic agents|mesh-ancestor
24517473|NCT00608101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24517474|NCT00608101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517475|NCT00608101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24517476|NCT00608101|Glucocorticoids|glucocorticoids|mesh-ancestor
24517477|NCT00608101|Hormones|hormones|mesh-ancestor
25831542|NCT00007774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25831543|NCT00007774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24862526|NCT05143281|Glucocorticoids|glucocorticoids|mesh-ancestor
24862527|NCT05143281|Hormones|hormones|mesh-ancestor
24862529|NCT05143281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24796806|NCT01952314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24796807|NCT01952314|Adrenergic Agents|adrenergic agents|mesh-ancestor
24796808|NCT01952314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24796809|NCT01952314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796810|NCT01952314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831544|NCT00007774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24988090|NCT04249739|Pembrolizumab|pembrolizumab|mesh-list
24988091|NCT04249739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24988092|NCT04249739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988093|NCT04234464|Budesonide|budesonide|mesh-list
25162976|NCT02900729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25162977|NCT02900729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25162978|NCT02900729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25162979|NCT02900729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988094|NCT04234464|Albuterol|albuterol|mesh-list
24988095|NCT04234464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24988096|NCT04234464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24988102|NCT04234464|Glucocorticoids|glucocorticoids|mesh-ancestor
25004502|NCT01074151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004503|NCT01074151|Analgesics|analgesics|mesh-ancestor
25004504|NCT01074151|Sensory System Agents|sensory system agents|mesh-ancestor
25004505|NCT01074151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25004506|NCT01074151|Antidepressive Agents|antidepressive agents|mesh-ancestor
25004507|NCT01074151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25004508|NCT01074151|Dopamine Agents|dopamine agents|mesh-ancestor
24965369|NCT03777644|Analgesics|analgesics|mesh-ancestor
24988103|NCT04234464|Hormones|hormones|mesh-ancestor
24988104|NCT04234464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24988105|NCT04234464|Tocolytic Agents|tocolytic agents|mesh-ancestor
24988106|NCT04234464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24988107|NCT04234464|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24988108|NCT04234464|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25162984|NCT02900729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25162986|NCT02900729|Diuretics|diuretics|mesh-ancestor
25162987|NCT02900729|Natriuretic Agents|natriuretic agents|mesh-ancestor
25162988|NCT02900729|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25162989|NCT02900742|Gemcitabine|gemcitabine|mesh-list
25162990|NCT02900742|Docetaxel|docetaxel|mesh-list
25162991|NCT02900742|Pemetrexed|pemetrexed|mesh-list
25162992|NCT02900742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25162993|NCT02900742|Antimetabolites|antimetabolites|mesh-ancestor
25162994|NCT02900742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25162995|NCT02900742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25162996|NCT02900742|Antiviral Agents|antiviral agents|mesh-ancestor
25162997|NCT02900742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25162998|NCT02900742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25162999|NCT02900742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25163000|NCT02900742|Immunologic Factors|immunologic factors|mesh-ancestor
25163001|NCT02900742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988133|NCT04204122|Moxifloxacin|moxifloxacin|mesh-list
24988134|NCT04204122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24988135|NCT04204122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24988136|NCT04204122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24988137|NCT04204122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24988138|NCT04204122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052429|NCT00286806|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
24988139|NCT04204122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137373|NCT02985372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988140|NCT04204122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988141|NCT04198805|Vitamins|vitamins|mesh-list
24835247|NCT02182531|Ephedrine|ephedrine|mesh-list
24988142|NCT04198805|Vitamin E|vitamin e|mesh-list
24988143|NCT04198805|Tocopherols|tocopherols|mesh-list
24988144|NCT04198805|Tocotrienols|tocotrienols|mesh-list
24988145|NCT04198805|alpha-Tocopherol|alpha-tocopherol|mesh-list
24988168|NCT04118387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988169|NCT04118387|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24988170|NCT04118387|GABA Agonists|gaba agonists|mesh-ancestor
24988171|NCT04118387|GABA Agents|gaba agents|mesh-ancestor
24988172|NCT04118387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24988183|NCT04118387|Serotonin Agents|serotonin agents|mesh-ancestor
24988184|NCT04089514|Adalimumab|adalimumab|mesh-list
24988185|NCT04089514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24988186|NCT04089514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24517503|NCT00608231|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24517504|NCT00608231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24517505|NCT00608231|Adrenergic Agents|adrenergic agents|mesh-ancestor
24988188|NCT03941509|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24988190|NCT03845114|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24988191|NCT03845114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24988192|NCT03845114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988193|NCT03789318|Acetaminophen|acetaminophen|mesh-list
24988194|NCT03789318|Fentanyl|fentanyl|mesh-list
24988195|NCT03789318|Oxycodone|oxycodone|mesh-list
24988196|NCT03789318|Hydromorphone|hydromorphone|mesh-list
24988197|NCT03789318|Bupivacaine|bupivacaine|mesh-list
24988198|NCT03789318|Anesthetics, Local|anesthetics, local|mesh-ancestor
24988199|NCT03789318|Anesthetics|anesthetics|mesh-ancestor
24988200|NCT03789318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24988201|NCT03789318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137399|NCT02985333|Tubulin Modulators|tubulin modulators|mesh-ancestor
25137400|NCT02985333|Antimitotic Agents|antimitotic agents|mesh-ancestor
25137401|NCT02985333|Mitosis Modulators|mitosis modulators|mesh-ancestor
25137402|NCT02985333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137411|NCT02985333|Antiemetics|antiemetics|mesh-ancestor
24988202|NCT03789318|Sensory System Agents|sensory system agents|mesh-ancestor
24988203|NCT03789318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24988204|NCT03789318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24988205|NCT03789318|Narcotics|narcotics|mesh-ancestor
24988206|NCT03789318|Analgesics|analgesics|mesh-ancestor
24988207|NCT03789318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24988208|NCT03789318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24988209|NCT03789318|Anesthetics, General|anesthetics, general|mesh-ancestor
24988210|NCT03789318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24988211|NCT03789318|Antipyretics|antipyretics|mesh-ancestor
24517506|NCT00608231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25182216|NCT03845582|Vitamin A|vitamin a|mesh-list
24517507|NCT00608231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517508|NCT00608335|Micafungin|micafungin|mesh-list
24517509|NCT00608335|Antifungal Agents|antifungal agents|mesh-ancestor
24517511|NCT00608361|Dasatinib|dasatinib|mesh-list
24517521|NCT00608374|Antimetabolites|antimetabolites|mesh-ancestor
24517522|NCT00608374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163002|NCT02900742|Tubulin Modulators|tubulin modulators|mesh-ancestor
24517523|NCT00608374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24517524|NCT00608374|Immunologic Factors|immunologic factors|mesh-ancestor
25169559|NCT01818076|Cholinergic Agents|cholinergic agents|mesh-ancestor
24517527|NCT00608374|Alkylating Agents|alkylating agents|mesh-ancestor
24517531|NCT00608595|Analgesics|analgesics|mesh-ancestor
24517533|NCT00608595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24517534|NCT00608595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517535|NCT00608595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25831545|NCT00007774|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25831546|NCT00007774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25831547|NCT00007774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24988231|NCT03724942|Dopamine Agents|dopamine agents|mesh-ancestor
24988233|NCT03646461|Cetuximab|cetuximab|mesh-list
24988234|NCT03646461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24988235|NCT03646461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988236|NCT03646461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25657936|NCT01591746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24988237|NCT03646461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988238|NCT03631004|Olanzapine|olanzapine|mesh-list
24988239|NCT03631004|Antiemetics|antiemetics|mesh-ancestor
24988240|NCT03631004|Autonomic Agents|autonomic agents|mesh-ancestor
25657937|NCT01591785|Retapamulin|retapamulin|mesh-list
25657938|NCT01591785|Petrolatum|petrolatum|mesh-list
25657939|NCT01591785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24813708|NCT02060006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
25052510|NCT00262990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052511|NCT00262990|Tubulin Modulators|tubulin modulators|mesh-ancestor
25052512|NCT00262990|Antimitotic Agents|antimitotic agents|mesh-ancestor
25052513|NCT00262990|Mitosis Modulators|mitosis modulators|mesh-ancestor
25831548|NCT00007774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988241|NCT03631004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24988242|NCT03631004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988243|NCT03631004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24988244|NCT03631004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24988245|NCT03631004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24988246|NCT03631004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24988247|NCT03631004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24988248|NCT03631004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25831549|NCT00007774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25137470|NCT02985242|Glimepiride|glimepiride|mesh-list
25831550|NCT00007774|Serotonin Agents|serotonin agents|mesh-ancestor
25831551|NCT00007774|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25831552|NCT00007774|Dopamine Agents|dopamine agents|mesh-ancestor
25831553|NCT00007774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25831554|NCT00007787|Cyclosporine|cyclosporine|mesh-list
25831555|NCT00007787|Tacrolimus|tacrolimus|mesh-list
25831556|NCT00007787|Cyclosporins|cyclosporins|mesh-list
25831557|NCT00007787|Thymoglobulin|thymoglobulin|mesh-list
25831558|NCT00007787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25831559|NCT00007787|Immunologic Factors|immunologic factors|mesh-ancestor
24517567|NCT00608699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24517568|NCT00608699|Antimetabolites|antimetabolites|mesh-ancestor
24517569|NCT00608699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796814|NCT01952314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24796815|NCT01952314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24796817|NCT01952561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24796818|NCT01952561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24796819|NCT01952561|Antiviral Agents|antiviral agents|mesh-ancestor
24796820|NCT01952561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24796822|NCT01952626|Palonosetron|palonosetron|mesh-list
24494454|NCT00495326|Efavirenz|efavirenz|mesh-list
24796834|NCT01952626|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24796835|NCT01952626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24796836|NCT01952626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24796837|NCT01952626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24796838|NCT01952626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24796839|NCT01952626|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24796841|NCT01952652|Codeine|codeine|mesh-list
24517570|NCT00608699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24517571|NCT00608699|Vasodilator Agents|vasodilator agents|mesh-ancestor
24517572|NCT00608699|Vitamin B Complex|vitamin b complex|mesh-ancestor
24517574|NCT00608699|Micronutrients|micronutrients|mesh-ancestor
24517575|NCT00608699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517576|NCT00608712|Esomeprazole|esomeprazole|mesh-list
24942778|NCT03978286|Serotonin Agents|serotonin agents|mesh-ancestor
24504430|NCT00536237|Niacin|niacin|mesh-list
24517592|NCT00608790|Albuterol|albuterol|mesh-list
24517593|NCT00608790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24517594|NCT00608790|Autonomic Agents|autonomic agents|mesh-ancestor
24796842|NCT01952652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24988295|NCT03513250|Parasympatholytics|parasympatholytics|mesh-ancestor
24988298|NCT03406156|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24988299|NCT03406156|Venetoclax|venetoclax|mesh-list
24988300|NCT03406156|Obinutuzumab|obinutuzumab|mesh-list
24988301|NCT03406156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24988303|NCT03406156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988304|NCT03406156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988305|NCT03406156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24988306|NCT03368963|Trifluridine|trifluridine|mesh-list
24988307|NCT03368963|Irinotecan|irinotecan|mesh-list
24988308|NCT03368963|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25657940|NCT01591785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25657941|NCT01591785|Emollients|emollients|mesh-ancestor
25657942|NCT01591785|Dermatologic Agents|dermatologic agents|mesh-ancestor
25657943|NCT01591837|Vaccines|vaccines|mesh-list
25657944|NCT01591837|Immunologic Factors|immunologic factors|mesh-ancestor
25657945|NCT01591837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657946|NCT01591863|Fidaxomicin|fidaxomicin|mesh-list
25831560|NCT00007787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657947|NCT01591863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25657948|NCT01591863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25657950|NCT01592006|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25657951|NCT01592006|Antimetabolites|antimetabolites|mesh-ancestor
25657952|NCT01592006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052540|NCT00260078|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25052541|NCT00260078|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25052542|NCT00260078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25052543|NCT00260078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24988309|NCT03368963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24988310|NCT03368963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988354|NCT03127215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988355|NCT03127215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988356|NCT03127215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988357|NCT03127215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24988358|NCT03127215|Alkylating Agents|alkylating agents|mesh-ancestor
25107230|NCT03141632|Dulaglutide|dulaglutide|mesh-list
24988367|NCT02935595|Ketamine|ketamine|mesh-list
24988373|NCT02935595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24988374|NCT02935595|Anesthetics, General|anesthetics, general|mesh-ancestor
24988375|NCT02935595|Anesthetics|anesthetics|mesh-ancestor
24988376|NCT02935595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24988377|NCT02935595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24988378|NCT02935595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24988379|NCT02935595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24988380|NCT02935595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988381|NCT02887248|Gemcitabine|gemcitabine|mesh-list
24988382|NCT02887248|Paclitaxel|paclitaxel|mesh-list
24988383|NCT02887248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25163003|NCT02900742|Antimitotic Agents|antimitotic agents|mesh-ancestor
25163004|NCT02900742|Mitosis Modulators|mitosis modulators|mesh-ancestor
25831561|NCT00007787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24988384|NCT02887248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988385|NCT02887248|Tubulin Modulators|tubulin modulators|mesh-ancestor
24988386|NCT02887248|Antimitotic Agents|antimitotic agents|mesh-ancestor
24988387|NCT02887248|Mitosis Modulators|mitosis modulators|mesh-ancestor
24988388|NCT02887248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494512|NCT00495365|Hematinics|hematinics|mesh-ancestor
25831562|NCT00007787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24862701|NCT04715191|Fludarabine phosphate|fludarabine phosphate|mesh-list
24988404|NCT02849990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24988405|NCT02849990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988406|NCT02849990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24988407|NCT02849990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988408|NCT02849990|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24988409|NCT02849990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988410|NCT02849990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988411|NCT02849990|Hormone Antagonists|hormone antagonists|mesh-ancestor
24988412|NCT02849990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24988413|NCT02849990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24988414|NCT02849990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24988415|NCT02849990|Analgesics|analgesics|mesh-ancestor
24988416|NCT02849990|Sensory System Agents|sensory system agents|mesh-ancestor
24988692|NCT02017964|Abortifacient Agents|abortifacient agents|mesh-ancestor
24988417|NCT02849990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24988418|NCT02849990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24988419|NCT02849990|Gout Suppressants|gout suppressants|mesh-ancestor
24988421|NCT02849990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24988422|NCT02849990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24988423|NCT02819752|Pembrolizumab|pembrolizumab|mesh-list
24988424|NCT02819752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24988425|NCT02819752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988426|NCT02817347|Tazobactam|tazobactam|mesh-list
24988427|NCT02817347|Piperacillin|piperacillin|mesh-list
24862715|NCT04703361|Antimetabolites|antimetabolites|mesh-ancestor
24862716|NCT04703361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862717|NCT04703361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25657953|NCT01592006|Antiviral Agents|antiviral agents|mesh-ancestor
25657954|NCT01592006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25657955|NCT01592045|Aldesleukin|aldesleukin|mesh-list
25657956|NCT01592045|Molgramostim|molgramostim|mesh-list
25657957|NCT01592045|Dinutuximab|dinutuximab|mesh-list
24863659|NCT04002037|Antiemetics|antiemetics|mesh-ancestor
24863660|NCT04002037|Autonomic Agents|autonomic agents|mesh-ancestor
24863661|NCT04002037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24862718|NCT04703361|Vasodilator Agents|vasodilator agents|mesh-ancestor
24862719|NCT04703361|Vitamin B Complex|vitamin b complex|mesh-ancestor
24835531|NCT02183051|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24988432|NCT02817347|Antiemetics|antiemetics|mesh-ancestor
24988433|NCT02817347|Autonomic Agents|autonomic agents|mesh-ancestor
24988434|NCT02817347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24988435|NCT02817347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988436|NCT02817347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24988437|NCT02817347|Glucocorticoids|glucocorticoids|mesh-ancestor
24988440|NCT02817347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24988441|NCT02817347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988442|NCT02817347|Protease Inhibitors|protease inhibitors|mesh-ancestor
24988443|NCT02817347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988444|NCT02817347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988445|NCT02817347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24988446|NCT02817347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24988447|NCT02817347|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24988449|NCT02800824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24988450|NCT02800824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24988451|NCT02800824|Autonomic Agents|autonomic agents|mesh-ancestor
24988452|NCT02800824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24988453|NCT02800824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988454|NCT02800824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24988455|NCT02800824|Respiratory System Agents|respiratory system agents|mesh-ancestor
24988456|NCT02800824|Glucocorticoids|glucocorticoids|mesh-ancestor
24988457|NCT02800824|Hormones|hormones|mesh-ancestor
24988458|NCT02800824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24988467|NCT02673151|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
24988468|NCT02673151|Chelating Agents|chelating agents|mesh-ancestor
24988469|NCT02673151|Sequestering Agents|sequestering agents|mesh-ancestor
24988470|NCT02673151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163005|NCT02900742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24988472|NCT02673151|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25137651|NCT02983630|Penicillins|penicillins|mesh-list
24796854|NCT01952652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24796855|NCT01952652|Narcotics|narcotics|mesh-ancestor
24796856|NCT01952652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24796857|NCT01952652|Antitussive Agents|antitussive agents|mesh-ancestor
24796858|NCT01952652|Respiratory System Agents|respiratory system agents|mesh-ancestor
24796859|NCT01952756|Cilostazol|cilostazol|mesh-list
24796860|NCT01952756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24796861|NCT01952756|Autonomic Agents|autonomic agents|mesh-ancestor
24590356|NCT00912262|Capsaicin|capsaicin|mesh-list
24796862|NCT01952756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24796863|NCT01952756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796864|NCT01952756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24796865|NCT01952756|Respiratory System Agents|respiratory system agents|mesh-ancestor
24796866|NCT01952756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24796867|NCT01952756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25107231|NCT03141632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24862730|NCT04674241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24517605|NCT00608790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24862765|NCT04496908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862766|NCT04496908|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24862767|NCT04496908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24862768|NCT04496908|Oxytocics|oxytocics|mesh-ancestor
24796868|NCT01952756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796869|NCT01952756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24796870|NCT01952756|Vasodilator Agents|vasodilator agents|mesh-ancestor
24796872|NCT01952756|Protective Agents|protective agents|mesh-ancestor
24796873|NCT01952756|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24796874|NCT01952756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24796875|NCT01952756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657958|NCT01592045|Isotretinoin|isotretinoin|mesh-list
25657959|NCT01592045|Sargramostim|sargramostim|mesh-list
25657960|NCT01592045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25657961|NCT01592045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25657962|NCT01592045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24796876|NCT01952769|Pidilizumab|pidilizumab|mesh-list
25137694|NCT02983344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24796877|NCT01952769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24796878|NCT01952769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796879|NCT01952886|Ondansetron|ondansetron|mesh-list
24796880|NCT01952886|Granisetron|granisetron|mesh-list
24796881|NCT01952886|Antiemetics|antiemetics|mesh-ancestor
24796882|NCT01952886|Autonomic Agents|autonomic agents|mesh-ancestor
24796883|NCT01952886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24796884|NCT01952886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796885|NCT01952886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24796886|NCT01952886|Antipruritics|antipruritics|mesh-ancestor
24796887|NCT01952886|Dermatologic Agents|dermatologic agents|mesh-ancestor
24796888|NCT01952886|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24796889|NCT01952886|Serotonin Agents|serotonin agents|mesh-ancestor
24542533|NCT00679146|Gout Suppressants|gout suppressants|mesh-ancestor
24494646|NCT00496275|Gemcitabine|gemcitabine|mesh-list
25831563|NCT00007787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831564|NCT00007787|Antifungal Agents|antifungal agents|mesh-ancestor
25831565|NCT00007787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24796890|NCT01952886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24796891|NCT01952886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796892|NCT01952886|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24796893|NCT01952886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24796894|NCT01952886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24796895|NCT01952886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24796896|NCT01952886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24796897|NCT01952951|Fluorouracil|fluorouracil|mesh-list
24796898|NCT01952951|Capecitabine|capecitabine|mesh-list
24590423|NCT00912457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24590424|NCT00912457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590425|NCT00912457|Nootropic Agents|nootropic agents|mesh-ancestor
24590426|NCT00912483|Heparin|heparin|mesh-list
24590427|NCT00912483|Calcium heparin|calcium heparin|mesh-list
24590428|NCT00912483|Anticoagulants|anticoagulants|mesh-ancestor
24590429|NCT00912483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24590430|NCT00912483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24590431|NCT00912483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590432|NCT00912535|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24590433|NCT00912535|Antidepressive Agents|antidepressive agents|mesh-ancestor
24988476|NCT02653092|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24988479|NCT02653092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988480|NCT02653092|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24988481|NCT02653092|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24988482|NCT02653092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24988483|NCT02593175|Paclitaxel|paclitaxel|mesh-list
25137755|NCT02982798|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25137756|NCT02982798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25137757|NCT02982798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137758|NCT02982798|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25046145|NCT00871481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24988484|NCT02593175|Carboplatin|carboplatin|mesh-list
24988485|NCT02593175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24988486|NCT02593175|Panitumumab|panitumumab|mesh-list
24988487|NCT02593175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24988488|NCT02593175|Antibodies|antibodies|mesh-list
24988489|NCT02593175|Immunoglobulins|immunoglobulins|mesh-list
24862773|NCT04384107|Vaccines|vaccines|mesh-list
25831566|NCT00007787|Dermatologic Agents|dermatologic agents|mesh-ancestor
25831567|NCT00007787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25831568|NCT00007813|Cyclophosphamide|cyclophosphamide|mesh-list
25831569|NCT00007813|Carboplatin|carboplatin|mesh-list
25831570|NCT00007813|Etoposide|etoposide|mesh-list
24813513|NCT02058823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813514|NCT02058823|Vasodilator Agents|vasodilator agents|mesh-ancestor
24988497|NCT02593175|Immunologic Factors|immunologic factors|mesh-ancestor
25046160|NCT00871182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25046161|NCT00871182|Respiratory System Agents|respiratory system agents|mesh-ancestor
25046162|NCT00871182|Parasympatholytics|parasympatholytics|mesh-ancestor
25046170|NCT00870688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988498|NCT02593175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988507|NCT02567578|YH12852|yh12852|mesh-list
24988508|NCT02567578|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24988509|NCT02567578|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24988510|NCT02567578|Serotonin Agents|serotonin agents|mesh-ancestor
24785142|NCT01912378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542552|NCT00679237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785143|NCT01912391|Selegiline|selegiline|mesh-list
24785144|NCT01912391|Antidepressive Agents|antidepressive agents|mesh-ancestor
25831571|NCT00007813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24785145|NCT01912391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24785146|NCT01912391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24785147|NCT01912391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24785148|NCT01912391|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24813524|NCT02058875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24813525|NCT02058875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813526|NCT02058875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24813527|NCT02058875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813528|NCT02058875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813529|NCT02058875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046176|NCT00870688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25046177|NCT00870688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25046178|NCT00870454|Pregabalin|pregabalin|mesh-list
25046179|NCT00870454|Analgesics|analgesics|mesh-ancestor
25046181|NCT00870454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25046182|NCT00870454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046183|NCT00870454|Anticonvulsants|anticonvulsants|mesh-ancestor
25046184|NCT00870454|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24813530|NCT02058875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24813531|NCT02058875|Immunologic Factors|immunologic factors|mesh-ancestor
24785149|NCT01912391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24785150|NCT01912391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785151|NCT01912391|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24785153|NCT01912391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785154|NCT01912443|Bevacizumab|bevacizumab|mesh-list
24785155|NCT01912443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24988531|NCT02452554|Tubulin Modulators|tubulin modulators|mesh-ancestor
24988532|NCT02452554|Antimitotic Agents|antimitotic agents|mesh-ancestor
24517617|NCT00608816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25831572|NCT00007813|Immunologic Factors|immunologic factors|mesh-ancestor
25831573|NCT00007813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831574|NCT00007813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25831575|NCT00007813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24517620|NCT00608816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24517621|NCT00608816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517622|NCT00608816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517623|NCT00608816|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25831576|NCT00007813|Alkylating Agents|alkylating agents|mesh-ancestor
25831577|NCT00007813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831578|NCT00007813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831579|NCT00007813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25831580|NCT00007813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24988588|NCT02323659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24988589|NCT02323659|Immunologic Factors|immunologic factors|mesh-ancestor
24988590|NCT02323659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24988795|NCT00352534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988594|NCT02318277|Durvalumab|durvalumab|mesh-list
25831581|NCT00007813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25831582|NCT00007813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25831583|NCT00007813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831584|NCT00007826|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25831585|NCT00007826|Vaccines|vaccines|mesh-list
25831586|NCT00007826|Antibodies|antibodies|mesh-list
25831587|NCT00007826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24988618|NCT02283853|Immunologic Factors|immunologic factors|mesh-ancestor
24988619|NCT02283853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988620|NCT02283853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24988621|NCT02176668|Esomeprazole|esomeprazole|mesh-list
24988622|NCT02176668|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24988623|NCT02176668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24988624|NCT02176668|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24988625|NCT02176668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542603|NCT00679523|Tavaborole|tavaborole|mesh-list
25831588|NCT00007826|BCG Vaccine|bcg vaccine|mesh-list
25831589|NCT00007826|Aluminum sulfate|aluminum sulfate|mesh-list
25831590|NCT00007826|Immunologic Factors|immunologic factors|mesh-ancestor
25831591|NCT00007826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831592|NCT00007826|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24862797|NCT04364997|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24862798|NCT04364997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24862799|NCT04364997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24862800|NCT04364997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988665|NCT02073097|Hormones|hormones|mesh-ancestor
25831593|NCT00007826|Antacids|antacids|mesh-ancestor
24988666|NCT02073097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24988667|NCT02073097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24988668|NCT02073097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24988669|NCT02073097|Tubulin Modulators|tubulin modulators|mesh-ancestor
24988670|NCT02073097|Antimitotic Agents|antimitotic agents|mesh-ancestor
24988671|NCT02073097|Mitosis Modulators|mitosis modulators|mesh-ancestor
24988672|NCT02073097|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24988673|NCT02073097|Antiviral Agents|antiviral agents|mesh-ancestor
24988674|NCT02073097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24988675|NCT02017964|Cyclophosphamide|cyclophosphamide|mesh-list
24988677|NCT02017964|Methotrexate|methotrexate|mesh-list
24988678|NCT02017964|Etoposide|etoposide|mesh-list
25137815|NCT02982486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25137816|NCT02982486|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25137817|NCT02982486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137818|NCT02982577|Pilocarpine|pilocarpine|mesh-list
25137819|NCT02982577|Miotics|miotics|mesh-ancestor
24988679|NCT02017964|Vincristine|vincristine|mesh-list
24988680|NCT02017964|Etoposide phosphate|etoposide phosphate|mesh-list
24988681|NCT02017964|Podophyllotoxin|podophyllotoxin|mesh-list
24988682|NCT02017964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24835868|NCT02183480|Incretins|incretins|mesh-ancestor
24988683|NCT02017964|Immunologic Factors|immunologic factors|mesh-ancestor
24988684|NCT02017964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988685|NCT02017964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24988686|NCT02017964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24988687|NCT02017964|Alkylating Agents|alkylating agents|mesh-ancestor
24988688|NCT02017964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988689|NCT02017964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988690|NCT02017964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24988691|NCT02017964|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25831594|NCT00007826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831595|NCT00007826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25831596|NCT00007852|Cytarabine|cytarabine|mesh-list
25137838|NCT02982512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25831597|NCT00007852|Rituximab|rituximab|mesh-list
25831598|NCT00007852|Etoposide|etoposide|mesh-list
25831599|NCT00007852|Melphalan|melphalan|mesh-list
25831600|NCT00007852|Carmustine|carmustine|mesh-list
24517659|NCT00609115|Antifungal Agents|antifungal agents|mesh-ancestor
24517660|NCT00609115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24517661|NCT00609141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24517662|NCT00609141|Immunologic Factors|immunologic factors|mesh-ancestor
24988693|NCT02017964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24988694|NCT02017964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24988695|NCT02017964|Antimetabolites|antimetabolites|mesh-ancestor
24988696|NCT02017964|Dermatologic Agents|dermatologic agents|mesh-ancestor
24988697|NCT02017964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988698|NCT02017964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24988699|NCT02017964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24988700|NCT02017964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24926446|NCT04142411|Viscosupplements|viscosupplements|mesh-ancestor
24988701|NCT02017964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24988702|NCT02017964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24988703|NCT02017964|Tubulin Modulators|tubulin modulators|mesh-ancestor
24988704|NCT02017964|Antimitotic Agents|antimitotic agents|mesh-ancestor
24988705|NCT02017964|Mitosis Modulators|mitosis modulators|mesh-ancestor
24988706|NCT02017964|Keratolytic Agents|keratolytic agents|mesh-ancestor
24988707|NCT01956110|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24988708|NCT01956110|Hormones|hormones|mesh-ancestor
24988709|NCT01956110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24988710|NCT01956110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988711|NCT01335581|Tretinoin|tretinoin|mesh-list
24988712|NCT01335581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988713|NCT01335581|Keratolytic Agents|keratolytic agents|mesh-ancestor
24988738|NCT00882895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24988739|NCT00882895|Antiemetics|antiemetics|mesh-ancestor
24988740|NCT00882895|Autonomic Agents|autonomic agents|mesh-ancestor
24988741|NCT00882895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24590434|NCT00912535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24590435|NCT00912535|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24590436|NCT00912535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24590437|NCT00912535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24590438|NCT00912535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831601|NCT00007852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25657963|NCT01592045|Antiviral Agents|antiviral agents|mesh-ancestor
25657964|NCT01592045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25657965|NCT01592045|Dermatologic Agents|dermatologic agents|mesh-ancestor
24590439|NCT00912548|Tamoxifen|tamoxifen|mesh-list
24590440|NCT00912548|Goserelin|goserelin|mesh-list
24590441|NCT00912548|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24796899|NCT01952951|Oxaliplatin|oxaliplatin|mesh-list
24796900|NCT01952951|Antimetabolites|antimetabolites|mesh-ancestor
24517663|NCT00609141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517665|NCT00609154|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24517666|NCT00609154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24517668|NCT00609154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24517669|NCT00609154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831602|NCT00007852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831603|NCT00007852|Immunologic Factors|immunologic factors|mesh-ancestor
25831604|NCT00007852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831605|NCT00007852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25831606|NCT00007852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25831607|NCT00007852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25831608|NCT00007852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25831609|NCT00007852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831610|NCT00007852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796901|NCT01952951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796902|NCT01952951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24796903|NCT01952951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25107233|NCT03141593|Vitamin D|vitamin d|mesh-list
25107234|NCT03141593|Ergocalciferols|ergocalciferols|mesh-list
24835939|NCT02183610|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24796904|NCT01952951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24796905|NCT01952951|Immunologic Factors|immunologic factors|mesh-ancestor
24796906|NCT01952951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796907|NCT01953107|Ferrous fumarate|ferrous fumarate|mesh-list
24796938|NCT01953406|Immunologic Factors|immunologic factors|mesh-ancestor
24796939|NCT01953406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796940|NCT01953406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24796941|NCT01953406|Alkylating Agents|alkylating agents|mesh-ancestor
24796942|NCT01953406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24796943|NCT01953406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796945|NCT01953419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796946|NCT01953419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988742|NCT00882895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24988743|NCT00882895|Glucocorticoids|glucocorticoids|mesh-ancestor
24988744|NCT00882895|Hormones|hormones|mesh-ancestor
25137922|NCT02981615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24517673|NCT00609180|Protective Agents|protective agents|mesh-ancestor
24517674|NCT00609180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517675|NCT00609193|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24517676|NCT00609193|Antidepressive Agents|antidepressive agents|mesh-ancestor
24517677|NCT00609193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24517678|NCT00609193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24517679|NCT00609193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24988745|NCT00882895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24988746|NCT00882895|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24988747|NCT00882895|Protective Agents|protective agents|mesh-ancestor
24988748|NCT00882895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24988750|NCT00867178|Cyclophosphamide|cyclophosphamide|mesh-list
24988752|NCT00867178|Cisplatin|cisplatin|mesh-list
24988753|NCT00867178|Carboplatin|carboplatin|mesh-list
24988754|NCT00867178|Etoposide|etoposide|mesh-list
24988755|NCT00867178|Vincristine|vincristine|mesh-list
25137933|NCT02981329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25137945|NCT02981212|Prednisolone|prednisolone|mesh-list
24517688|NCT00609375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24517689|NCT00609388|Tacrolimus|tacrolimus|mesh-list
24517690|NCT00609388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24517691|NCT00609388|Immunologic Factors|immunologic factors|mesh-ancestor
24517692|NCT00609388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517693|NCT00609388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24517694|NCT00609388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517695|NCT00609388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657966|NCT01592045|Immunologic Factors|immunologic factors|mesh-ancestor
25657967|NCT01592045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657968|NCT01592240|Bococizumab|bococizumab|mesh-list
25657969|NCT01592240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25657970|NCT01592240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25657971|NCT01592240|Antimetabolites|antimetabolites|mesh-ancestor
24863965|NCT02786537|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24863966|NCT02786537|Protease Inhibitors|protease inhibitors|mesh-ancestor
24517696|NCT00609401|Sorafenib|sorafenib|mesh-list
24517697|NCT00609401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517698|NCT00609401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25831611|NCT00007852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25831612|NCT00007852|Antimetabolites|antimetabolites|mesh-ancestor
25831613|NCT00007852|Antiviral Agents|antiviral agents|mesh-ancestor
25831614|NCT00007852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24988764|NCT00867178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24988765|NCT00867178|Alkylating Agents|alkylating agents|mesh-ancestor
24988766|NCT00867178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163006|NCT02900742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24945498|NCT03950271|Capecitabine|capecitabine|mesh-list
24988767|NCT00867178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988768|NCT00867178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24988770|NCT00867178|Micronutrients|micronutrients|mesh-ancestor
25831615|NCT00007852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24988771|NCT00867178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24988772|NCT00867178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24988773|NCT00867178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24988783|NCT00787176|Oxytocics|oxytocics|mesh-ancestor
24988784|NCT00787176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24988785|NCT00787176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988786|NCT00352534|Dactinomycin|dactinomycin|mesh-list
24988787|NCT00352534|Cactinomycin|cactinomycin|mesh-list
24988788|NCT00352534|Doxorubicin|doxorubicin|mesh-list
24988789|NCT00352534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24988790|NCT00352534|Vincristine|vincristine|mesh-list
24988791|NCT00352534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24988792|NCT00352534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988793|NCT00352534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24988794|NCT00352534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25107235|NCT03141593|Cholecalciferol|cholecalciferol|mesh-list
24517702|NCT00609531|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24517703|NCT00609531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24517704|NCT00609531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25137954|NCT02981212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137955|NCT02981212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24517705|NCT00609531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517706|NCT00609531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24517722|NCT00609557|Sensory System Agents|sensory system agents|mesh-ancestor
24517723|NCT00609557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25107236|NCT03141593|Vitamins|vitamins|mesh-list
24988808|NCT00033293|Antibodies|antibodies|mesh-list
24988809|NCT00033293|gamma-Globulins|gamma-globulins|mesh-list
25137970|NCT02981264|Sensory System Agents|sensory system agents|mesh-ancestor
24988810|NCT00033293|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24988811|NCT00033293|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24988812|NCT00033293|Hormones|hormones|mesh-list
24988813|NCT00033293|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24988814|NCT00033293|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
24988815|NCT00033293|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
24988816|NCT00033293|beta-Endorphin|beta-endorphin|mesh-list
24988817|NCT00033293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24988818|NCT00033293|Immunologic Factors|immunologic factors|mesh-ancestor
24988819|NCT00033293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988820|NCT00033293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24988831|NCT05193370|Vasopressins|vasopressins|mesh-list
24988832|NCT05193370|Arginine Vasopressin|arginine vasopressin|mesh-list
24988833|NCT05193370|Angiotensin II|angiotensin ii|mesh-list
24988834|NCT05193370|Giapreza|giapreza|mesh-list
24988835|NCT05193370|Angiotensinogen|angiotensinogen|mesh-list
24988836|NCT05193370|Hemostatics|hemostatics|mesh-ancestor
24988837|NCT05193370|Coagulants|coagulants|mesh-ancestor
24988842|NCT05193370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24988843|NCT05193370|Protease Inhibitors|protease inhibitors|mesh-ancestor
25657972|NCT01592240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25657973|NCT01592240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24988844|NCT05193370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25657974|NCT01592292|Adalimumab|adalimumab|mesh-list
25657975|NCT01592292|Etanercept|etanercept|mesh-list
25657976|NCT01592292|Rituximab|rituximab|mesh-list
25657977|NCT01592292|Infliximab|infliximab|mesh-list
25657978|NCT01592292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25657979|NCT01592292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25657980|NCT01592292|Immunologic Factors|immunologic factors|mesh-ancestor
24988845|NCT05193370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862957|NCT03885089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24862958|NCT03842436|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24862959|NCT03842436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24862960|NCT03842436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24862961|NCT03842436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24862962|NCT03842436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862963|NCT03842436|Antiviral Agents|antiviral agents|mesh-ancestor
24862964|NCT03842436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24862965|NCT03842436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24862966|NCT03842436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24517729|NCT00609570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138030|NCT02980809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25138031|NCT02980809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589310|NCT00906828|Levodopa|levodopa|mesh-list
24517730|NCT00609596|Dutasteride|dutasteride|mesh-list
24517731|NCT00609596|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24517732|NCT00609596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24517733|NCT00609596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517734|NCT00609596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517735|NCT00609596|Hormone Antagonists|hormone antagonists|mesh-ancestor
24517736|NCT00609596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24517737|NCT00609596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988861|NCT05193292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24988863|NCT05193227|Lidocaine|lidocaine|mesh-list
24988864|NCT05193227|Bupivacaine|bupivacaine|mesh-list
24988865|NCT05193227|Anesthetics, Local|anesthetics, local|mesh-ancestor
24988866|NCT05193227|Anesthetics|anesthetics|mesh-ancestor
24988867|NCT05193227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24988868|NCT05193227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988877|NCT05193214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24988878|NCT05193214|Immunologic Factors|immunologic factors|mesh-ancestor
24988879|NCT05193214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988880|NCT05193188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24988881|NCT05193188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862974|NCT03823534|Narcotics|narcotics|mesh-ancestor
24862975|NCT03823534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24862976|NCT03823534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862977|NCT03823534|Analgesics|analgesics|mesh-ancestor
24862978|NCT03823534|Sensory System Agents|sensory system agents|mesh-ancestor
24862979|NCT03823534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24862980|NCT03823534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24862981|NCT03823534|Antipyretics|antipyretics|mesh-ancestor
24862982|NCT03823534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24517739|NCT00609752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24517740|NCT00609752|Glucocorticoids|glucocorticoids|mesh-ancestor
24517741|NCT00609752|Hormones|hormones|mesh-ancestor
24517742|NCT00609752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24517743|NCT00609752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988882|NCT05193188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988883|NCT05192902|Anesthetics|anesthetics|mesh-list
24988884|NCT05192902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24988885|NCT05192902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988887|NCT05192681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988888|NCT05192681|Tubulin Modulators|tubulin modulators|mesh-ancestor
24988889|NCT05192681|Antimitotic Agents|antimitotic agents|mesh-ancestor
24988890|NCT05192681|Mitosis Modulators|mitosis modulators|mesh-ancestor
24988891|NCT05192681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517744|NCT00609752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24517746|NCT00609817|Dexamethasone|dexamethasone|mesh-list
24517747|NCT00609817|Bortezomib|bortezomib|mesh-list
24517748|NCT00609817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24517749|NCT00609817|Antiemetics|antiemetics|mesh-ancestor
24517750|NCT00609817|Autonomic Agents|autonomic agents|mesh-ancestor
25831616|NCT00007852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25831617|NCT00007852|Alkylating Agents|alkylating agents|mesh-ancestor
25831618|NCT00007852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25831619|NCT00007865|Rituximab|rituximab|mesh-list
25831620|NCT00007865|Carboplatin|carboplatin|mesh-list
25831621|NCT00007865|Etoposide|etoposide|mesh-list
25831622|NCT00007865|Ifosfamide|ifosfamide|mesh-list
24517751|NCT00609817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24864096|NCT01274611|Cholinergic Agents|cholinergic agents|mesh-ancestor
24864097|NCT01274611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24864098|NCT01274611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864101|NCT00960297|Paclitaxel|paclitaxel|mesh-list
24517752|NCT00609817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517753|NCT00609817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24517754|NCT00609817|Glucocorticoids|glucocorticoids|mesh-ancestor
25169558|NCT01818076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517756|NCT00609817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24517757|NCT00609817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24517758|NCT00609817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517759|NCT00609843|Ethiodized Oil|ethiodized oil|mesh-list
24517760|NCT00609843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517761|NCT00609856|Insulin Glargine|insulin glargine|mesh-list
24517762|NCT00609856|Pioglitazone|pioglitazone|mesh-list
24517763|NCT00609856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24517764|NCT00609856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831623|NCT00007865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25831624|NCT00007865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831625|NCT00007865|Immunologic Factors|immunologic factors|mesh-ancestor
24988892|NCT05192304|Maleic acid|maleic acid|mesh-list
24988893|NCT05192304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24518395|NCT05132595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988894|NCT05192304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988895|NCT05192213|Ascorbic Acid|ascorbic acid|mesh-list
24988896|NCT05192213|Thiamine|thiamine|mesh-list
24988900|NCT05192213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988901|NCT05192213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24988902|NCT05192213|Antioxidants|antioxidants|mesh-ancestor
24988903|NCT05192213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988904|NCT05192213|Protective Agents|protective agents|mesh-ancestor
24988905|NCT05192213|Vitamin B Complex|vitamin b complex|mesh-ancestor
24988906|NCT05191914|Fulvestrant|fulvestrant|mesh-list
24988907|NCT05191914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24988908|NCT05191914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988909|NCT05191914|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24988910|NCT05191914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24988911|NCT05191914|Hormone Antagonists|hormone antagonists|mesh-ancestor
24774715|NCT01847417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988921|NCT05191888|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24988922|NCT05191888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24988923|NCT05191888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988924|NCT05191888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988925|NCT05191888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24988926|NCT05191888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24988927|NCT05191888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24988931|NCT05189483|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24988932|NCT05189483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24988933|NCT05189483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988934|NCT05189483|Tubulin Modulators|tubulin modulators|mesh-ancestor
24988935|NCT05189483|Antimitotic Agents|antimitotic agents|mesh-ancestor
24988936|NCT05189483|Mitosis Modulators|mitosis modulators|mesh-ancestor
24988937|NCT05189483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988938|NCT05173857|Paclitaxel|paclitaxel|mesh-list
24988939|NCT05173857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24988940|NCT05173857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988941|NCT05173857|Tubulin Modulators|tubulin modulators|mesh-ancestor
24988942|NCT05173857|Antimitotic Agents|antimitotic agents|mesh-ancestor
24988943|NCT05173857|Mitosis Modulators|mitosis modulators|mesh-ancestor
24988944|NCT05173857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630843|NCT01114087|Imatinib Mesylate|imatinib mesylate|mesh-list
24988948|NCT05168527|Gemcitabine|gemcitabine|mesh-list
24988949|NCT05168527|Paclitaxel|paclitaxel|mesh-list
24988950|NCT05168527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24863040|NCT03646162|Zuclomiphene|zuclomiphene|mesh-list
25831626|NCT00007865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831627|NCT00007865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25657981|NCT01592292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657982|NCT01592292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25657983|NCT01592292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25657984|NCT01592292|Dermatologic Agents|dermatologic agents|mesh-ancestor
25657985|NCT01592292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25657986|NCT01592292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25052865|NCT00135343|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25052866|NCT00135343|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25201009|NCT02730481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201010|NCT02730572|Methylphenidate|methylphenidate|mesh-list
25201011|NCT02730572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25201012|NCT02730572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544102|NCT00687245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24864168|NCT00602667|Tubulin Modulators|tubulin modulators|mesh-ancestor
24864169|NCT00602667|Antimitotic Agents|antimitotic agents|mesh-ancestor
24864170|NCT00602667|Mitosis Modulators|mitosis modulators|mesh-ancestor
24864173|NCT00472186|Lansoprazole|lansoprazole|mesh-list
25831628|NCT00007865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25831629|NCT00007865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25831630|NCT00007865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25831631|NCT00007865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831632|NCT00007865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138178|NCT02980094|Vitamin E|vitamin e|mesh-list
25831633|NCT00007865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25831634|NCT00007865|Alkylating Agents|alkylating agents|mesh-ancestor
25831635|NCT00007878|Leucovorin|leucovorin|mesh-list
25831636|NCT00007878|Fluorouracil|fluorouracil|mesh-list
25831637|NCT00007878|Bortezomib|bortezomib|mesh-list
25831638|NCT00007878|Calcium|calcium|mesh-list
25831639|NCT00007878|Levoleucovorin|levoleucovorin|mesh-list
25831640|NCT00007878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25831641|NCT00007878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831642|NCT00007878|Antimetabolites|antimetabolites|mesh-ancestor
25831643|NCT00007878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831644|NCT00007878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25831645|NCT00007878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517793|NCT00609999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831646|NCT00007878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25831647|NCT00007878|Immunologic Factors|immunologic factors|mesh-ancestor
25831648|NCT00007878|Antidotes|antidotes|mesh-ancestor
25831649|NCT00007878|Protective Agents|protective agents|mesh-ancestor
25831650|NCT00007878|Vitamin B Complex|vitamin b complex|mesh-ancestor
25831651|NCT00007878|Vitamins|vitamins|mesh-ancestor
25831652|NCT00007878|Micronutrients|micronutrients|mesh-ancestor
25831653|NCT00007891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25831654|NCT00007891|Antibodies|antibodies|mesh-list
25831655|NCT00007891|Immunoglobulins|immunoglobulins|mesh-list
25831656|NCT00007891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25831657|NCT00007891|Immunologic Factors|immunologic factors|mesh-ancestor
25831658|NCT00007891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831659|NCT00007891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831660|NCT00007904|Tamoxifen|tamoxifen|mesh-list
25831661|NCT00007904|Paclitaxel|paclitaxel|mesh-list
25831662|NCT00007904|Cyclophosphamide|cyclophosphamide|mesh-list
25831663|NCT00007904|Doxorubicin|doxorubicin|mesh-list
25831664|NCT00007904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25831665|NCT00007904|Lenograstim|lenograstim|mesh-list
24988970|NCT05166811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24988971|NCT05166811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24988972|NCT05166811|Anticonvulsants|anticonvulsants|mesh-ancestor
24988973|NCT05166811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25138232|NCT02979704|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25138233|NCT02979704|Antimetabolites|antimetabolites|mesh-ancestor
24988974|NCT05166811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24988975|NCT05166811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988976|NCT05166811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24988977|NCT05166811|Tocolytic Agents|tocolytic agents|mesh-ancestor
25657987|NCT01592292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25657988|NCT01592292|Analgesics|analgesics|mesh-ancestor
25657989|NCT01592292|Sensory System Agents|sensory system agents|mesh-ancestor
25657990|NCT01592292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25657991|NCT01592292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25657992|NCT01592409|Dronabinol|dronabinol|mesh-list
25657993|NCT01592409|Hallucinogens|hallucinogens|mesh-ancestor
25657994|NCT01592409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25657995|NCT01592409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25657996|NCT01592409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25657997|NCT01592409|Analgesics|analgesics|mesh-ancestor
25657998|NCT01592409|Sensory System Agents|sensory system agents|mesh-ancestor
25657999|NCT01592409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25831666|NCT00007904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25831667|NCT00007904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544182|NCT00687648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24544183|NCT00687648|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24544184|NCT00687648|Hormone Antagonists|hormone antagonists|mesh-ancestor
24544187|NCT00687661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544188|NCT00687700|Propranolol|propranolol|mesh-list
24544189|NCT00687700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24686202|NCT05001724|Antimitotic Agents|antimitotic agents|mesh-ancestor
25831668|NCT00007904|Tubulin Modulators|tubulin modulators|mesh-ancestor
24864269|NCT05089565|Antibodies|antibodies|mesh-list
24988978|NCT05166811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24988979|NCT05149365|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24988980|NCT05149365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24988981|NCT05149365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988982|NCT05149365|Incretins|incretins|mesh-ancestor
24988983|NCT05149365|Hormones|hormones|mesh-ancestor
25163008|NCT02900352|Anticonvulsants|anticonvulsants|mesh-ancestor
24517818|NCT00610103|Autonomic Agents|autonomic agents|mesh-ancestor
24517819|NCT00610103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24517820|NCT00610103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24517821|NCT00610103|Dopamine Agonists|dopamine agonists|mesh-ancestor
24517822|NCT00610103|Dopamine Agents|dopamine agents|mesh-ancestor
24517823|NCT00610103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25831669|NCT00007904|Antimitotic Agents|antimitotic agents|mesh-ancestor
25831670|NCT00007904|Mitosis Modulators|mitosis modulators|mesh-ancestor
25138259|NCT02979548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25831671|NCT00007904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831672|NCT00007904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25831673|NCT00007904|Immunologic Factors|immunologic factors|mesh-ancestor
25831674|NCT00007904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831675|NCT00007904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25831676|NCT00007904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25831677|NCT00007904|Alkylating Agents|alkylating agents|mesh-ancestor
25831678|NCT00007904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25831679|NCT00007904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24517854|NCT00610350|Vasodilator Agents|vasodilator agents|mesh-ancestor
24517855|NCT00610350|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24774716|NCT01847456|Insulin|insulin|mesh-list
25831680|NCT00007904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24517863|NCT00610454|Nootropic Agents|nootropic agents|mesh-ancestor
24517864|NCT00610493|Sirolimus|sirolimus|mesh-list
24517914|NCT00610571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24517921|NCT00610584|Histamine Agents|histamine agents|mesh-ancestor
24517922|NCT00610584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24989010|NCT05123820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24989011|NCT05123820|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24989012|NCT05123820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24989013|NCT05103631|Cyclophosphamide|cyclophosphamide|mesh-list
24989014|NCT05103631|Fludarabine|fludarabine|mesh-list
24989015|NCT05103631|Fludarabine phosphate|fludarabine phosphate|mesh-list
24989016|NCT05103631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25138314|NCT02978976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138315|NCT02978976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25138316|NCT02978976|Respiratory System Agents|respiratory system agents|mesh-ancestor
25138318|NCT02979132|Trace Elements|trace elements|mesh-ancestor
25138319|NCT02979132|Micronutrients|micronutrients|mesh-ancestor
25138320|NCT02979132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989017|NCT05103631|Immunologic Factors|immunologic factors|mesh-ancestor
24989018|NCT05103631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989019|NCT05103631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24989020|NCT05103631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24517937|NCT00610610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24517938|NCT00610610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517939|NCT00610623|Azithromycin|azithromycin|mesh-list
24517940|NCT00610623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24517941|NCT00610623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24517942|NCT00610792|Doxorubicin|doxorubicin|mesh-list
24517993|NCT00610948|Vitamin B Complex|vitamin b complex|mesh-ancestor
24517995|NCT00610948|Micronutrients|micronutrients|mesh-ancestor
25658000|NCT01592409|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25658001|NCT01592409|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25658002|NCT01592409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25658003|NCT01592409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658004|NCT01592409|Hormones|hormones|mesh-ancestor
25658005|NCT01592409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25658006|NCT01592695|Ethanol|ethanol|mesh-list
25658007|NCT01592695|Bupropion|bupropion|mesh-list
25658008|NCT01592695|Nicotine|nicotine|mesh-list
25052910|NCT00130312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052911|NCT00130312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25052912|NCT00130312|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25052913|NCT00130312|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25052914|NCT00130312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25201015|NCT02730572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25201016|NCT02730572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052915|NCT00130312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052917|NCT00127634|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25052918|NCT00127634|Insulin Glargine|insulin glargine|mesh-list
24517996|NCT00610948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24517998|NCT00611000|Hematinics|hematinics|mesh-ancestor
25138340|NCT02978495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25138341|NCT02978495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138342|NCT02978495|Tubulin Modulators|tubulin modulators|mesh-ancestor
24517999|NCT00611000|Vitamin B Complex|vitamin b complex|mesh-ancestor
24518000|NCT00611000|Vitamins|vitamins|mesh-ancestor
24518001|NCT00611000|Micronutrients|micronutrients|mesh-ancestor
24518002|NCT00611000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518003|NCT00611039|Ritonavir|ritonavir|mesh-list
24518004|NCT00611039|Darunavir|darunavir|mesh-list
24518005|NCT00611039|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24518006|NCT00611039|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25831681|NCT00007904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25831682|NCT00007904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831683|NCT00007904|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25831684|NCT00007904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24518011|NCT00611039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24863109|NCT03111732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24518013|NCT00611039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24518014|NCT00611039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24518015|NCT00611039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24394217|NCT00132561|Anthelmintics|anthelmintics|mesh-ancestor
25831685|NCT00007904|Hormone Antagonists|hormone antagonists|mesh-ancestor
25831686|NCT00007904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25831687|NCT00007904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24518071|NCT05331651|Tropisetron|tropisetron|mesh-list
24518072|NCT05331651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24518073|NCT05331651|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24518074|NCT05331651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24518075|NCT05331651|Cholinergic Agents|cholinergic agents|mesh-ancestor
24518076|NCT05331651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24518077|NCT05331651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518078|NCT05331651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518079|NCT05331651|Antiemetics|antiemetics|mesh-ancestor
24518080|NCT05331651|Autonomic Agents|autonomic agents|mesh-ancestor
24518081|NCT05331651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24518082|NCT05331651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24518083|NCT05331651|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25183099|NCT00140985|Amlodipine|amlodipine|mesh-list
24518084|NCT05331651|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24518085|NCT05331651|Serotonin Agents|serotonin agents|mesh-ancestor
25831688|NCT00007904|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25831689|NCT00007904|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25831690|NCT00007904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25831691|NCT00007917|Gemcitabine|gemcitabine|mesh-list
25138409|NCT02977832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518109|NCT05331469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24518110|NCT05331469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518142|NCT05331131|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24518143|NCT05331131|Anesthetics, General|anesthetics, general|mesh-ancestor
24518144|NCT05331131|Anesthetics|anesthetics|mesh-ancestor
25658009|NCT01592695|Varenicline|varenicline|mesh-list
25658010|NCT01592695|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25658011|NCT01592695|Autonomic Agents|autonomic agents|mesh-ancestor
25658012|NCT01592695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25658013|NCT01592695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658014|NCT01592695|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25658015|NCT01592695|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25658016|NCT01592695|Cholinergic Agents|cholinergic agents|mesh-ancestor
25658017|NCT01592695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25658018|NCT01592695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658019|NCT01592695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24518145|NCT05331131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24518146|NCT05331131|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24518147|NCT05331131|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24518148|NCT05331131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24518149|NCT05331131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518169|NCT05330390|Nootropic Agents|nootropic agents|mesh-ancestor
24518171|NCT05330377|Mitoxantrone|mitoxantrone|mesh-list
24518172|NCT05330377|Cladribine|cladribine|mesh-list
24518173|NCT05330377|Lenograstim|lenograstim|mesh-list
24518174|NCT05330377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24518175|NCT05330377|Antimetabolites|antimetabolites|mesh-ancestor
24989160|NCT04473807|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24518176|NCT05330377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774717|NCT01847456|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24518192|NCT05330273|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24518193|NCT05330273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24518194|NCT05330273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24518203|NCT05330273|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24518204|NCT05330273|Antimalarials|antimalarials|mesh-ancestor
24518205|NCT05330273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24518281|NCT05329454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24518283|NCT05329454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831692|NCT00007917|Alvocidib|alvocidib|mesh-list
24989102|NCT04666389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107238|NCT03141593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107239|NCT03141593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25107240|NCT03141593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25107241|NCT03141398|Pancrelipase|pancrelipase|mesh-list
25107242|NCT03141398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25107243|NCT03141268|Lactulose|lactulose|mesh-list
25107244|NCT03141268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25107245|NCT03141476|Cefuroxime|cefuroxime|mesh-list
25107246|NCT03141476|Cefuroxime axetil|cefuroxime axetil|mesh-list
25107247|NCT03141476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25107248|NCT03141476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25107249|NCT03141554|Chlorhexidine|chlorhexidine|mesh-list
25107250|NCT03141554|Povidone-Iodine|povidone-iodine|mesh-list
25107251|NCT03141554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25107252|NCT03141554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25107253|NCT03141554|Disinfectants|disinfectants|mesh-ancestor
25107254|NCT03141125|Ethanol|ethanol|mesh-list
25107255|NCT03141125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25831693|NCT00007917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25831694|NCT00007917|Antimetabolites|antimetabolites|mesh-ancestor
25831695|NCT00007917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831696|NCT00007917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831697|NCT00007917|Antiviral Agents|antiviral agents|mesh-ancestor
24518393|NCT05132595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24989104|NCT04635631|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24989105|NCT04635631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24989106|NCT04635631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989107|NCT04635631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24989108|NCT04614168|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24989109|NCT04614168|Glycerol|glycerol|mesh-list
24989110|NCT04614168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989111|NCT04614168|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24989112|NCT04614168|Protective Agents|protective agents|mesh-ancestor
24989113|NCT04559139|Gemcitabine|gemcitabine|mesh-list
24989114|NCT04559139|Cisplatin|cisplatin|mesh-list
24989115|NCT04559139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24989116|NCT04559139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24989117|NCT04559139|Antimetabolites|antimetabolites|mesh-ancestor
24774718|NCT01847456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24989139|NCT04527549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518394|NCT05132595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24989140|NCT04527549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24989141|NCT04527549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24989142|NCT04527549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24989143|NCT04527549|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24989144|NCT04527549|Protective Agents|protective agents|mesh-ancestor
25046329|NCT00854945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25046330|NCT00854945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24989145|NCT04527549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989146|NCT04527549|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24544607|NCT00689624|Protective Agents|protective agents|mesh-ancestor
24544608|NCT00689624|Vitamin B Complex|vitamin b complex|mesh-ancestor
24544609|NCT00689624|Vitamins|vitamins|mesh-ancestor
24544610|NCT00689624|Micronutrients|micronutrients|mesh-ancestor
24544611|NCT00689624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24952287|NCT03895970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952288|NCT03895970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952297|NCT03895229|Empagliflozin|empagliflozin|mesh-list
24952298|NCT03895229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24989147|NCT04527549|Antioxidants|antioxidants|mesh-ancestor
24989148|NCT04477837|Rivaroxaban|rivaroxaban|mesh-list
24989149|NCT04477837|Apixaban|apixaban|mesh-list
24989150|NCT04477837|Edoxaban|edoxaban|mesh-list
24989151|NCT04477837|Dabigatran|dabigatran|mesh-list
24989152|NCT04477837|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24989153|NCT04477837|Antithrombins|antithrombins|mesh-ancestor
24989154|NCT04477837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24989155|NCT04477837|Protease Inhibitors|protease inhibitors|mesh-ancestor
24989156|NCT04477837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24989157|NCT04477837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989158|NCT04477837|Anticoagulants|anticoagulants|mesh-ancestor
24518398|NCT05132595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24518400|NCT05082909|Uricosuric Agents|uricosuric agents|mesh-ancestor
24518401|NCT05082909|Gout Suppressants|gout suppressants|mesh-ancestor
24518402|NCT05082909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24518403|NCT05082909|Renal Agents|renal agents|mesh-ancestor
24518404|NCT05069935|Cyclophosphamide|cyclophosphamide|mesh-list
24518459|NCT04981041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24518460|NCT04981041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518532|NCT04901676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25831698|NCT00007917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25138469|NCT02977169|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25138470|NCT02977169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25138471|NCT02977169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25138472|NCT02977169|Tubulin Modulators|tubulin modulators|mesh-ancestor
25138473|NCT02977169|Antimitotic Agents|antimitotic agents|mesh-ancestor
25138483|NCT02977286|Naloxegol|naloxegol|mesh-list
25831699|NCT00007917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24518639|NCT04623944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24518640|NCT04623944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24518696|NCT04524130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24518697|NCT04524130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24518698|NCT04524130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518699|NCT04524130|Analgesics|analgesics|mesh-ancestor
24518784|NCT04246437|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24518785|NCT04246437|Dopamine Agents|dopamine agents|mesh-ancestor
24989162|NCT04473807|Adrenergic Agents|adrenergic agents|mesh-ancestor
24989163|NCT04473807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24989164|NCT04473807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989165|NCT04473807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989166|NCT04473807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24989167|NCT04473807|Sympatholytics|sympatholytics|mesh-ancestor
24989168|NCT04473807|Autonomic Agents|autonomic agents|mesh-ancestor
24989169|NCT04473807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24989170|NCT04452344|Analgesics|analgesics|mesh-list
24989171|NCT04452344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989172|NCT04452344|Sensory System Agents|sensory system agents|mesh-ancestor
24989173|NCT04452344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24518786|NCT04246437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24518787|NCT04246437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518788|NCT04246437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138499|NCT02977065|Antimetabolites|antimetabolites|mesh-ancestor
25138500|NCT02977065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518789|NCT04246437|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24518790|NCT04246437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25413603|NCT03121586|Pimavanserin|pimavanserin|mesh-list
25658020|NCT01592695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25658021|NCT01592695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25658022|NCT01592695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25658023|NCT01592695|Antidepressive Agents|antidepressive agents|mesh-ancestor
25658024|NCT01592695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25658025|NCT01592695|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25658026|NCT01592695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25658027|NCT01592695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25658028|NCT01592695|Dopamine Agents|dopamine agents|mesh-ancestor
25658029|NCT01592695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24864822|NCT00943618|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24864823|NCT00943618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24864824|NCT00943618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24864832|NCT00943618|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24864833|NCT00943618|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24864834|NCT00943618|Cholinergic Agents|cholinergic agents|mesh-ancestor
24813962|NCT02061475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813964|NCT02061631|Dexamethasone acetate|dexamethasone acetate|mesh-list
24813965|NCT02061631|Docetaxel|docetaxel|mesh-list
24952333|NCT03894839|Glutaral|glutaral|mesh-list
25052938|NCT00120393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25052939|NCT00120393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24813966|NCT02061631|BB 1101|bb 1101|mesh-list
24813967|NCT02061631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24518791|NCT04246437|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24518792|NCT04234113|Pembrolizumab|pembrolizumab|mesh-list
24518793|NCT04234113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24518794|NCT04234113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24518795|NCT04186442|Botulinum Toxins|botulinum toxins|mesh-list
24518796|NCT04186442|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24518797|NCT04186442|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24518798|NCT04186442|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24518887|NCT04094961|Immunologic Factors|immunologic factors|mesh-ancestor
24518888|NCT04094961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24518890|NCT04094961|Growth Substances|growth substances|mesh-ancestor
24518891|NCT04094961|Growth Inhibitors|growth inhibitors|mesh-ancestor
24518935|NCT03889756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24519203|NCT03007329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519204|NCT03007329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24519205|NCT03007329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519206|NCT03007329|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24519371|NCT01791920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519372|NCT01791920|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24519373|NCT01791920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24989193|NCT04347239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519383|NCT01724866|Docetaxel|docetaxel|mesh-list
24519434|NCT01518556|Idarubicin|idarubicin|mesh-list
24519474|NCT01134250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24519475|NCT01134250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519477|NCT01134250|Antimitotic Agents|antimitotic agents|mesh-ancestor
24519478|NCT01134250|Mitosis Modulators|mitosis modulators|mesh-ancestor
24519479|NCT01134250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519480|NCT00588185|Deoxyglucose|deoxyglucose|mesh-list
24519481|NCT00588185|Testosterone|testosterone|mesh-list
24519482|NCT00588185|Dihydrotestosterone|dihydrotestosterone|mesh-list
24519483|NCT00588185|Androgens|androgens|mesh-ancestor
24519484|NCT00588185|Hormones|hormones|mesh-ancestor
24519485|NCT00588185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24519486|NCT00588185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519487|NCT00588185|Antimetabolites|antimetabolites|mesh-ancestor
24519488|NCT00588185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519489|NCT00588185|Antiviral Agents|antiviral agents|mesh-ancestor
24519490|NCT00588185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24519491|NCT05333289|Vaccines|vaccines|mesh-list
24519492|NCT05333289|Immunologic Factors|immunologic factors|mesh-ancestor
24519493|NCT05333289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658030|NCT01592695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25658031|NCT01592695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658032|NCT01592708|Erythromycin|erythromycin|mesh-list
25658033|NCT01592708|Ibuprofen|ibuprofen|mesh-list
25658034|NCT01592708|Ketorolac|ketorolac|mesh-list
25658035|NCT01592708|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25658036|NCT01592708|Fentanyl|fentanyl|mesh-list
25658037|NCT01592708|Scopolamine|scopolamine|mesh-list
25658038|NCT01592708|Droperidol|droperidol|mesh-list
25658039|NCT01592708|Remifentanil|remifentanil|mesh-list
25658040|NCT01592708|Hydrocodone|hydrocodone|mesh-list
25658041|NCT01592708|Ondansetron|ondansetron|mesh-list
25658042|NCT01592708|Antiemetics|antiemetics|mesh-list
25658043|NCT01592708|Propofol|propofol|mesh-list
25658044|NCT01592708|Anesthetics|anesthetics|mesh-ancestor
25658045|NCT01592708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25658046|NCT01592708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519494|NCT05333250|Modafinil|modafinil|mesh-list
24519495|NCT05333250|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24519496|NCT05333250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989204|NCT04285086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989205|NCT04285086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24989207|NCT04249167|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24989208|NCT04249167|Atezolizumab|atezolizumab|mesh-list
25138596|NCT02976259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138597|NCT02976259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25138598|NCT02976259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25138599|NCT02976259|Antiviral Agents|antiviral agents|mesh-ancestor
25138600|NCT02976259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25138601|NCT02976597|Morphine|morphine|mesh-list
24989209|NCT04249167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24989210|NCT04249167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24989211|NCT04249167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24989212|NCT04249167|Tubulin Modulators|tubulin modulators|mesh-ancestor
24989213|NCT04249167|Antimitotic Agents|antimitotic agents|mesh-ancestor
24989214|NCT04249167|Mitosis Modulators|mitosis modulators|mesh-ancestor
24989215|NCT04249167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926948|NCT04137276|Antioxidants|antioxidants|mesh-ancestor
24989223|NCT04245423|Sensory System Agents|sensory system agents|mesh-ancestor
24989224|NCT04245423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24519730|NCT05242874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24519732|NCT05242874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519733|NCT05242874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519734|NCT05242874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24519735|NCT05242874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24519736|NCT05242874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24519737|NCT05242874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24519746|NCT05232344|Estradiol|estradiol|mesh-list
24519758|NCT05195034|Analgesics|analgesics|mesh-ancestor
24519759|NCT05195034|Sensory System Agents|sensory system agents|mesh-ancestor
24519760|NCT05195034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24519761|NCT05195034|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24519762|NCT05195034|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24519763|NCT05195034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24796949|NCT01953419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24796950|NCT01953445|Paclitaxel|paclitaxel|mesh-list
24796951|NCT01953445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24796974|NCT01953536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590479|NCT00912756|Cilostazol|cilostazol|mesh-list
24863290|NCT01024608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24519764|NCT05195034|Adrenergic Agents|adrenergic agents|mesh-ancestor
25138647|NCT02975921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24796988|NCT01953679|Ulipristal acetate|ulipristal acetate|mesh-list
24796989|NCT01953679|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24796990|NCT01953679|Contraceptive Agents|contraceptive agents|mesh-ancestor
24796991|NCT01953679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24989234|NCT04230265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24989235|NCT04230265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24989237|NCT04218656|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24989238|NCT04218656|Antithrombins|antithrombins|mesh-ancestor
24989239|NCT04218656|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24989240|NCT04218656|Protease Inhibitors|protease inhibitors|mesh-ancestor
24989241|NCT04218656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24989242|NCT04218656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989243|NCT04218656|Anticoagulants|anticoagulants|mesh-ancestor
24989244|NCT04198363|Amoxicillin|amoxicillin|mesh-list
24989245|NCT04198363|Clarithromycin|clarithromycin|mesh-list
24989246|NCT04198363|Potassium Citrate|potassium citrate|mesh-list
24989247|NCT04198363|Esomeprazole|esomeprazole|mesh-list
24989258|NCT04198363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24989259|NCT04198363|Antacids|antacids|mesh-ancestor
24989260|NCT04198363|Diuretics|diuretics|mesh-ancestor
24989261|NCT04198363|Natriuretic Agents|natriuretic agents|mesh-ancestor
24989262|NCT04198363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989263|NCT04198363|Expectorants|expectorants|mesh-ancestor
24989264|NCT04198363|Respiratory System Agents|respiratory system agents|mesh-ancestor
24520389|NCT02342444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24520390|NCT02342444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24520391|NCT02342444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520392|NCT02339922|Rituximab|rituximab|mesh-list
24520393|NCT02339922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24520394|NCT02339922|Ixazomib|ixazomib|mesh-list
25053045|NCT00115050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24520395|NCT02339922|Antibodies|antibodies|mesh-list
24520398|NCT02339922|Glycine|glycine|mesh-list
24520421|NCT02020707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24520422|NCT02020707|Endothelial Growth Factors|endothelial growth factors|mesh-list
24520423|NCT02020707|Antibodies|antibodies|mesh-list
24520424|NCT02020707|Immunoglobulins|immunoglobulins|mesh-list
24520425|NCT02020707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24520426|NCT02020707|Immunoglobulin G|immunoglobulin g|mesh-list
24520427|NCT02020707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24520430|NCT02020707|Antimitotic Agents|antimitotic agents|mesh-ancestor
24520497|NCT00630565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520499|NCT00630565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24520500|NCT00630565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24520501|NCT00630565|Antiemetics|antiemetics|mesh-ancestor
24520502|NCT00630565|Autonomic Agents|autonomic agents|mesh-ancestor
24520503|NCT00630565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24520504|NCT00630565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24520505|NCT00630565|Glucocorticoids|glucocorticoids|mesh-ancestor
24520506|NCT00630565|Hormones|hormones|mesh-ancestor
24520509|NCT00630565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25831700|NCT00007917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24520886|NCT05246007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24520887|NCT05246007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520888|NCT05246007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24989299|NCT05366101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24989300|NCT05366101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24989337|NCT05365425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24520890|NCT05246007|Sensory System Agents|sensory system agents|mesh-ancestor
24520891|NCT05246007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24520892|NCT05246007|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24520898|NCT05243940|Lidocaine|lidocaine|mesh-list
24520933|NCT05237141|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24520934|NCT05228288|Pyrithione zinc|pyrithione zinc|mesh-list
24520935|NCT05228288|Keratolytic Agents|keratolytic agents|mesh-ancestor
24520936|NCT05228288|Dermatologic Agents|dermatologic agents|mesh-ancestor
24520937|NCT05225610|Dexmedetomidine|dexmedetomidine|mesh-list
24989347|NCT05365178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24989349|NCT05365165|Sevoflurane|sevoflurane|mesh-list
24989350|NCT05365165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24989351|NCT05365165|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24989352|NCT05365165|Anesthetics, General|anesthetics, general|mesh-ancestor
24989353|NCT05365165|Anesthetics|anesthetics|mesh-ancestor
24813677|NCT02059876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24813678|NCT02059876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138725|NCT02975440|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25138726|NCT02975583|Vorapaxar|vorapaxar|mesh-list
25138727|NCT02975583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25138728|NCT02975570|Levofloxacin|levofloxacin|mesh-list
25138729|NCT02975570|Ofloxacin|ofloxacin|mesh-list
25138730|NCT02975570|Linezolid|linezolid|mesh-list
25183429|NCT02842814|Hormones|hormones|mesh-ancestor
24863342|NCT05146245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520938|NCT05225610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24520939|NCT05225610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24520940|NCT05225610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520941|NCT05225610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24520942|NCT05225610|Analgesics|analgesics|mesh-ancestor
24521002|NCT05210374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24521003|NCT05210374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24521004|NCT05210374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24521007|NCT05210374|Trace Elements|trace elements|mesh-ancestor
24521014|NCT05208333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24521015|NCT05208333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24521016|NCT05208333|Anticestodal Agents|anticestodal agents|mesh-ancestor
24521017|NCT05208333|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24521018|NCT05208333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24521019|NCT05208333|Tubulin Modulators|tubulin modulators|mesh-ancestor
24521020|NCT05208333|Antimitotic Agents|antimitotic agents|mesh-ancestor
24521021|NCT05208333|Mitosis Modulators|mitosis modulators|mesh-ancestor
24521022|NCT05208333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521023|NCT05208333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24989359|NCT05365074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24989360|NCT05365074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989362|NCT05365074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25658047|NCT01592708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25658048|NCT01592708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25658049|NCT01592708|Anesthetics, General|anesthetics, general|mesh-ancestor
25658050|NCT01592708|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25658051|NCT01592708|Narcotics|narcotics|mesh-ancestor
25658052|NCT01592708|Analgesics|analgesics|mesh-ancestor
25658053|NCT01592708|Sensory System Agents|sensory system agents|mesh-ancestor
25053118|NCT00102466|Gliclazide|gliclazide|mesh-list
24863352|NCT05146089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863355|NCT05145634|Anticoagulants|anticoagulants|mesh-list
24863356|NCT05145543|Dexamethasone|dexamethasone|mesh-list
24863357|NCT05145543|Fentanyl|fentanyl|mesh-list
24863358|NCT05145543|Levobupivacaine|levobupivacaine|mesh-list
24863359|NCT05145543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24863360|NCT05145543|Antiemetics|antiemetics|mesh-ancestor
24863361|NCT05145543|Autonomic Agents|autonomic agents|mesh-ancestor
24863362|NCT05145543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24863363|NCT05145543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863364|NCT05145543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24521137|NCT05104554|Vitamins|vitamins|mesh-ancestor
24521183|NCT05018520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24521184|NCT05018520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24521185|NCT05018520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24521401|NCT04791059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24521402|NCT04791059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521403|NCT04791059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24521441|NCT04763135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521442|NCT04763135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24521443|NCT04763135|Serotonin Agents|serotonin agents|mesh-ancestor
24521444|NCT04763135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989373|NCT05324423|Gout Suppressants|gout suppressants|mesh-ancestor
24989374|NCT05324423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24989375|NCT05324423|Tubulin Modulators|tubulin modulators|mesh-ancestor
24989376|NCT05324423|Antimitotic Agents|antimitotic agents|mesh-ancestor
24989377|NCT05324423|Mitosis Modulators|mitosis modulators|mesh-ancestor
24989378|NCT05324423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989379|NCT05324423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24989380|NCT05322707|Budesonide|budesonide|mesh-list
24989381|NCT05322707|Formoterol Fumarate|formoterol fumarate|mesh-list
24989382|NCT05322707|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24989383|NCT05322707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24989384|NCT05322707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24785179|NCT01912638|Hyaluronic Acid|hyaluronic acid|mesh-list
24785180|NCT01912638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24785181|NCT01912638|Immunologic Factors|immunologic factors|mesh-ancestor
24785182|NCT01912638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785183|NCT01912638|Viscosupplements|viscosupplements|mesh-ancestor
25138831|NCT02975323|Antioxidants|antioxidants|mesh-ancestor
24785184|NCT01912638|Protective Agents|protective agents|mesh-ancestor
24785186|NCT01912677|Methyldopa|methyldopa|mesh-list
24785187|NCT01912677|Nifedipine|nifedipine|mesh-list
24785188|NCT01912677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24785189|NCT01912677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24785190|NCT01912677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785191|NCT01912677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25138832|NCT02975323|Protective Agents|protective agents|mesh-ancestor
24785192|NCT01912677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785193|NCT01912677|Vasodilator Agents|vasodilator agents|mesh-ancestor
24785194|NCT01912677|Tocolytic Agents|tocolytic agents|mesh-ancestor
25107256|NCT03141125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24521701|NCT04595565|Antimetabolites|antimetabolites|mesh-ancestor
24521447|NCT04763135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24521515|NCT04745728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25107257|NCT03141125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25107258|NCT03141125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107260|NCT03140982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25107261|NCT03140982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25107262|NCT03140982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107263|NCT03140982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24799454|NCT01969032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25107264|NCT03140982|Anesthetics, General|anesthetics, general|mesh-ancestor
25107265|NCT03140982|Anesthetics|anesthetics|mesh-ancestor
25107267|NCT03140956|Carbidopa|carbidopa|mesh-list
25107268|NCT03140956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25107269|NCT03140956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25831701|NCT00007917|Immunologic Factors|immunologic factors|mesh-ancestor
25053142|NCT00097357|Enoxaparin|enoxaparin|mesh-list
25053143|NCT00097357|Warfarin|warfarin|mesh-list
25053144|NCT00097357|Enoxaparin sodium|enoxaparin sodium|mesh-list
25053145|NCT00097357|Apixaban|apixaban|mesh-list
25053146|NCT00097357|Anticoagulants|anticoagulants|mesh-ancestor
25053147|NCT00097357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25053148|NCT00097357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25107270|NCT03140956|Dopamine Agents|dopamine agents|mesh-ancestor
25138838|NCT02975323|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25138839|NCT02975141|Gemcitabine|gemcitabine|mesh-list
25138840|NCT02975141|Paclitaxel|paclitaxel|mesh-list
25107271|NCT03140956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25107272|NCT03140956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107273|NCT03140956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107274|NCT03140956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25107275|NCT03140956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107276|NCT03140943|Thalidomide|thalidomide|mesh-list
25107277|NCT03140943|Dexamethasone|dexamethasone|mesh-list
25107278|NCT03140943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25107279|NCT03140943|Antiemetics|antiemetics|mesh-ancestor
25107280|NCT03140943|Autonomic Agents|autonomic agents|mesh-ancestor
25107281|NCT03140943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25107282|NCT03140943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107283|NCT03140943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25107284|NCT03140943|Glucocorticoids|glucocorticoids|mesh-ancestor
25831702|NCT00007917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543185|NCT00682279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863397|NCT05145270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24863398|NCT05145270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24521634|NCT04627142|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25138859|NCT02974985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24521635|NCT04627142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24521636|NCT04627142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24521637|NCT04627142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521638|NCT04627142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24521639|NCT04622904|Lidocaine|lidocaine|mesh-list
24521640|NCT04622904|Ketamine|ketamine|mesh-list
24521641|NCT04622904|Anesthetics, Local|anesthetics, local|mesh-ancestor
24521642|NCT04622904|Anesthetics|anesthetics|mesh-ancestor
25107285|NCT03140943|Hormones|hormones|mesh-ancestor
25107286|NCT03140943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25107287|NCT03140943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25107288|NCT03140943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25107289|NCT03140943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25107290|NCT03140943|Immunologic Factors|immunologic factors|mesh-ancestor
25107291|NCT03140943|Leprostatic Agents|leprostatic agents|mesh-ancestor
25107292|NCT03140943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25138881|NCT02974920|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25138882|NCT02974920|Antithrombins|antithrombins|mesh-ancestor
25138883|NCT02974920|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25138886|NCT02974933|Pemetrexed|pemetrexed|mesh-list
25107306|NCT03140553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25107307|NCT03140553|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25107308|NCT03140553|Alkylating Agents|alkylating agents|mesh-ancestor
24989431|NCT05261321|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24521643|NCT04622904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24521644|NCT04622904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521645|NCT04622904|Sensory System Agents|sensory system agents|mesh-ancestor
24521646|NCT04622904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24521699|NCT04595565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24521700|NCT04595565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24521803|NCT04500158|Anesthetics, Local|anesthetics, local|mesh-ancestor
24521806|NCT04500158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521807|NCT04500158|Sensory System Agents|sensory system agents|mesh-ancestor
24989387|NCT05322707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989388|NCT05322707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24989389|NCT05322707|Respiratory System Agents|respiratory system agents|mesh-ancestor
24989391|NCT05322707|Hormones|hormones|mesh-ancestor
24989392|NCT05322707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25658054|NCT01592708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25658055|NCT01592708|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25658056|NCT01592708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25658057|NCT01592708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25658058|NCT01592708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25658059|NCT01592708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24521810|NCT04500158|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24521811|NCT04500158|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24521812|NCT04500158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24521813|NCT04500158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521814|NCT04493203|Nivolumab|nivolumab|mesh-list
24521815|NCT04493203|Axitinib|axitinib|mesh-list
24521966|NCT04388683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24521967|NCT04388683|Autonomic Agents|autonomic agents|mesh-ancestor
25831703|NCT00007917|Growth Inhibitors|growth inhibitors|mesh-ancestor
25831704|NCT00007917|Growth Substances|growth substances|mesh-ancestor
24989393|NCT05322707|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24989394|NCT05322707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24989395|NCT05322707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24989396|NCT05322707|Adrenergic Agents|adrenergic agents|mesh-ancestor
24989397|NCT05322707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24989398|NCT05322707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989399|NCT05310643|Nivolumab|nivolumab|mesh-list
24989400|NCT05310643|Ipilimumab|ipilimumab|mesh-list
24989401|NCT05310643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24989402|NCT05310643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138927|NCT02974387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25138928|NCT02974387|Glucocorticoids|glucocorticoids|mesh-ancestor
25138929|NCT02974387|Hormones|hormones|mesh-ancestor
25138930|NCT02974387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24989403|NCT05310643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24989404|NCT05310643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989405|NCT05305248|Dexmedetomidine|dexmedetomidine|mesh-list
24989406|NCT05305248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24989407|NCT05305248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24989408|NCT05305248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989409|NCT05305248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24989410|NCT05305248|Analgesics|analgesics|mesh-ancestor
24989411|NCT05305248|Sensory System Agents|sensory system agents|mesh-ancestor
24989412|NCT05305248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24863471|NCT04907032|Mirabegron|mirabegron|mesh-list
24522248|NCT04081831|Aspirin|aspirin|mesh-list
24522249|NCT04081831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24522250|NCT04081831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24522251|NCT04081831|Analgesics|analgesics|mesh-ancestor
24522252|NCT04081831|Sensory System Agents|sensory system agents|mesh-ancestor
24989418|NCT05305248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989422|NCT05261321|Dronabinol|dronabinol|mesh-list
24989423|NCT05261321|Hallucinogens|hallucinogens|mesh-ancestor
24989424|NCT05261321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989425|NCT05261321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24989426|NCT05261321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24851657|NCT02257697|Sensory System Agents|sensory system agents|mesh-ancestor
24522449|NCT03805594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522600|NCT03628066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24522601|NCT03628066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989432|NCT05261321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24989433|NCT05261321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522674|NCT03421756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24522675|NCT03421756|Immunologic Factors|immunologic factors|mesh-ancestor
24522676|NCT03421756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405248|NCT00166153|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24522677|NCT03421756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24522678|NCT03414229|Pembrolizumab|pembrolizumab|mesh-list
24522679|NCT03414229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24522680|NCT03414229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522681|NCT03412266|Cytarabine|cytarabine|mesh-list
24522682|NCT03412266|Cyclophosphamide|cyclophosphamide|mesh-list
24522751|NCT03254654|Vinorelbine|vinorelbine|mesh-list
24522752|NCT03254654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522753|NCT03254654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24522754|NCT03254654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24522755|NCT03254654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797026|NCT01953744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24797027|NCT01953744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24797028|NCT01953757|Vitamins|vitamins|mesh-list
24797029|NCT01953757|Hydroxocobalamin|hydroxocobalamin|mesh-list
24797030|NCT01953757|Vitamin B 12|vitamin b 12|mesh-list
24797031|NCT01953757|Vitamin B Complex|vitamin b complex|mesh-list
24797032|NCT01953757|Micronutrients|micronutrients|mesh-ancestor
24797033|NCT01953757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522756|NCT03254654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25831705|NCT00007917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24522783|NCT03127592|Analgesics|analgesics|mesh-ancestor
24522992|NCT02960230|Nivolumab|nivolumab|mesh-list
24522993|NCT02960230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24522994|NCT02960230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522995|NCT02960230|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24522996|NCT02960230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522997|NCT02957032|Cytarabine|cytarabine|mesh-list
24522998|NCT02957032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24522999|NCT02957032|Antimetabolites|antimetabolites|mesh-ancestor
24523000|NCT02957032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139040|NCT02973958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25139041|NCT02973958|Analgesics|analgesics|mesh-ancestor
25139042|NCT02973958|Antipyretics|antipyretics|mesh-ancestor
25139043|NCT02973958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25139044|NCT02973958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25139045|NCT02973958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24993715|NCT05410223|Amoxicillin|amoxicillin|mesh-list
24523001|NCT02957032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24523002|NCT02957032|Antiviral Agents|antiviral agents|mesh-ancestor
24523005|NCT02957032|Immunologic Factors|immunologic factors|mesh-ancestor
24523035|NCT02909361|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24523036|NCT02909361|Hormone Antagonists|hormone antagonists|mesh-ancestor
24523037|NCT02909361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24523038|NCT02909361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523039|NCT02901717|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24523040|NCT02901717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24523041|NCT02901717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24523051|NCT02897050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24523052|NCT02897050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24523053|NCT02897050|Alkylating Agents|alkylating agents|mesh-ancestor
24523163|NCT02414269|Cyclophosphamide|cyclophosphamide|mesh-list
24523164|NCT02414269|Pembrolizumab|pembrolizumab|mesh-list
24523165|NCT02414269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24523166|NCT02414269|Immunologic Factors|immunologic factors|mesh-ancestor
24523167|NCT02414269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523168|NCT02414269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24797034|NCT01953757|Hematinics|hematinics|mesh-ancestor
24797035|NCT01953770|Cytarabine|cytarabine|mesh-list
24797036|NCT01953770|Prednisone|prednisone|mesh-list
24797037|NCT01953770|Methotrexate|methotrexate|mesh-list
24797038|NCT01953770|Daunorubicin|daunorubicin|mesh-list
24797039|NCT01953770|Asparaginase|asparaginase|mesh-list
24797040|NCT01953770|Pegaspargase|pegaspargase|mesh-list
24797041|NCT01953770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24989451|NCT05200143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989453|NCT05179421|Oxytocics|oxytocics|mesh-ancestor
25183662|NCT02840526|Fentanyl|fentanyl|mesh-list
24989454|NCT05179421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24989455|NCT05179421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989456|NCT05160090|Bupropion|bupropion|mesh-list
24989458|NCT05160090|Antidepressive Agents|antidepressive agents|mesh-ancestor
24989459|NCT05160090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24523169|NCT02414269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24523228|NCT02349906|Treosulfan|treosulfan|mesh-list
24523229|NCT02349906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25163012|NCT02900352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24523230|NCT02349906|Alkylating Agents|alkylating agents|mesh-ancestor
25202930|NCT02717871|Mydriatics|mydriatics|mesh-list
24523233|NCT02341911|Gemcitabine|gemcitabine|mesh-list
24523234|NCT02341911|Carboplatin|carboplatin|mesh-list
24523235|NCT02341911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24523378|NCT01661400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24523379|NCT01661400|Leprostatic Agents|leprostatic agents|mesh-ancestor
24523380|NCT01661400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24523381|NCT01661400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24523382|NCT01661400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24523383|NCT01661400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24523384|NCT01661400|Growth Substances|growth substances|mesh-ancestor
25139091|NCT02973646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25139092|NCT02973659|Oxybutynin|oxybutynin|mesh-list
25139093|NCT02973659|Parasympatholytics|parasympatholytics|mesh-ancestor
25139094|NCT02973659|Autonomic Agents|autonomic agents|mesh-ancestor
25139095|NCT02973659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25139096|NCT02973659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139097|NCT02973659|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25139098|NCT02973659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25139099|NCT02973659|Cholinergic Agents|cholinergic agents|mesh-ancestor
25139100|NCT02973659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25139101|NCT02973659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139103|NCT02973620|Simendan|simendan|mesh-list
24523385|NCT01661400|Growth Inhibitors|growth inhibitors|mesh-ancestor
24523386|NCT01503606|Clarithromycin|clarithromycin|mesh-list
24523387|NCT01503606|Cefazolin|cefazolin|mesh-list
24989460|NCT05160090|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24989461|NCT05160090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24989462|NCT05160090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24989463|NCT05160090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989464|NCT05160090|Dopamine Agents|dopamine agents|mesh-ancestor
24989465|NCT05160090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24989466|NCT05160090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989467|NCT05160090|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24989468|NCT05160090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24989469|NCT05160090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24989470|NCT05154994|Durvalumab|durvalumab|mesh-list
24989471|NCT05154994|Ipilimumab|ipilimumab|mesh-list
24989472|NCT05154994|Tremelimumab|tremelimumab|mesh-list
24989473|NCT05154994|Belinostat|belinostat|mesh-list
24989474|NCT05154994|Immunoglobulins|immunoglobulins|mesh-list
24989475|NCT05154994|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24989476|NCT05154994|Immunoglobulin G|immunoglobulin g|mesh-list
24989477|NCT05154994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24989478|NCT05154994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24989479|NCT05154994|Immunologic Factors|immunologic factors|mesh-ancestor
24989480|NCT05154994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444884|NCT00299572|Alendronate|alendronate|mesh-list
24523390|NCT01503606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25831706|NCT00007943|Gemcitabine|gemcitabine|mesh-list
25139112|NCT02973451|Bupivacaine|bupivacaine|mesh-list
24523391|NCT01503606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831707|NCT00007943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24523424|NCT00887536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24523425|NCT00887536|Growth Substances|growth substances|mesh-ancestor
24523429|NCT00887536|Mitosis Modulators|mitosis modulators|mesh-ancestor
24989487|NCT05148546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25107315|NCT03140553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24989495|NCT05143762|Autonomic Agents|autonomic agents|mesh-ancestor
24989496|NCT05143762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24989497|NCT05143762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989498|NCT05143762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24989499|NCT05143762|Glucocorticoids|glucocorticoids|mesh-ancestor
25139137|NCT02973581|Anesthetics, Local|anesthetics, local|mesh-ancestor
25139138|NCT02973581|Anesthetics|anesthetics|mesh-ancestor
25139139|NCT02973581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25139141|NCT02973581|Sensory System Agents|sensory system agents|mesh-ancestor
24989501|NCT05143762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24989502|NCT05143762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24523430|NCT00887536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24523431|NCT00887536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24523432|NCT00887536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24523435|NCT00867321|Sorafenib|sorafenib|mesh-list
24523436|NCT00867321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24523437|NCT00867321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24523438|NCT00867321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24523439|NCT00867321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24523440|NCT00867321|Growth Substances|growth substances|mesh-ancestor
24523441|NCT00867321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523442|NCT00867321|Growth Inhibitors|growth inhibitors|mesh-ancestor
24523443|NCT00867321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24523446|NCT00467142|Leucovorin|leucovorin|mesh-list
24523452|NCT00467142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24523453|NCT00467142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25139155|NCT02973113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25139156|NCT02973113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25139157|NCT02973113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25139159|NCT02973204|Everolimus|everolimus|mesh-list
24523454|NCT00467142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24523455|NCT00467142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24523456|NCT00467142|Growth Substances|growth substances|mesh-ancestor
25831708|NCT00007943|Antimetabolites|antimetabolites|mesh-ancestor
24865160|NCT04308837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25831709|NCT00007943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989520|NCT05132699|Cannabidiol|cannabidiol|mesh-list
24989521|NCT05132699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24863551|NCT04537910|Antiviral Agents|antiviral agents|mesh-ancestor
24863552|NCT04537910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24863553|NCT04512534|Antibodies|antibodies|mesh-list
24863554|NCT04512534|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
24863555|NCT04512534|Immunologic Factors|immunologic factors|mesh-ancestor
24863557|NCT04512534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24523551|NCT05341999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24523552|NCT05341999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523553|NCT05341856|Isosorbide|isosorbide|mesh-list
24523554|NCT05341856|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24523555|NCT05341856|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
24523556|NCT05341856|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25831710|NCT00007943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831711|NCT00007943|Antiviral Agents|antiviral agents|mesh-ancestor
25831712|NCT00007943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25831713|NCT00007943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25139175|NCT02973035|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25139176|NCT02973035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25139177|NCT02973035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989527|NCT05114486|Miotics|miotics|mesh-ancestor
24989528|NCT05114486|Autonomic Agents|autonomic agents|mesh-ancestor
24989529|NCT05114486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24989539|NCT05103228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24989540|NCT05103228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989541|NCT05103228|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24989542|NCT05103228|Fertility Agents|fertility agents|mesh-ancestor
24989543|NCT05103228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24989544|NCT05087212|Plerixafor|plerixafor|mesh-list
24989545|NCT05087212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24523897|NCT05338723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24523898|NCT05338723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24523899|NCT05338671|Anesthetics|anesthetics|mesh-list
24523900|NCT05338671|Anesthetics, Local|anesthetics, local|mesh-list
24523901|NCT05338671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24523902|NCT05338671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523986|NCT05338320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24523987|NCT05338320|Narcotics|narcotics|mesh-ancestor
24523988|NCT05338320|Analgesics|analgesics|mesh-ancestor
24523989|NCT05338320|Sensory System Agents|sensory system agents|mesh-ancestor
24989546|NCT05087212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24989547|NCT05087212|Antiviral Agents|antiviral agents|mesh-ancestor
24989548|NCT05087212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24989549|NCT05082480|Hyaluronic Acid|hyaluronic acid|mesh-list
24989550|NCT05082480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24989553|NCT05082480|Viscosupplements|viscosupplements|mesh-ancestor
24989554|NCT05082480|Protective Agents|protective agents|mesh-ancestor
24989555|NCT05067166|Ansuvimab|ansuvimab|mesh-list
24989556|NCT05067166|Antiviral Agents|antiviral agents|mesh-ancestor
24989557|NCT05067166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24989561|NCT05008887|Fluorouracil|fluorouracil|mesh-list
24989581|NCT05007522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24989582|NCT05007522|Analgesics|analgesics|mesh-ancestor
24989583|NCT05007522|Sensory System Agents|sensory system agents|mesh-ancestor
24989584|NCT05007522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24989585|NCT05007522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989586|NCT05007522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24989587|NCT05007522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24989588|NCT05007522|Gout Suppressants|gout suppressants|mesh-ancestor
24989590|NCT05007522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24989591|NCT05007522|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24989592|NCT05007522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24989593|NCT05007522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989594|NCT05007522|Antipruritics|antipruritics|mesh-ancestor
25139244|NCT02972476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139245|NCT02972476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24989595|NCT05007522|Dermatologic Agents|dermatologic agents|mesh-ancestor
24989596|NCT05007522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24989597|NCT05007522|Histamine Antagonists|histamine antagonists|mesh-ancestor
24524119|NCT05252923|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
24524120|NCT05252923|Anticoagulants|anticoagulants|mesh-ancestor
24524180|NCT05206110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831714|NCT00007943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25053364|NCT00057980|Epirubicin|epirubicin|mesh-list
24989607|NCT04988425|Prednisolone|prednisolone|mesh-list
24989608|NCT04988425|Prednisolone acetate|prednisolone acetate|mesh-list
24989609|NCT04988425|Antibodies|antibodies|mesh-list
24989610|NCT04988425|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24989611|NCT04988425|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24989612|NCT04988425|Prednisolone phosphate|prednisolone phosphate|mesh-list
24989613|NCT04988425|Immunologic Factors|immunologic factors|mesh-ancestor
24989614|NCT04988425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989615|NCT04988425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24989616|NCT04988425|Antiemetics|antiemetics|mesh-ancestor
24989617|NCT04988425|Autonomic Agents|autonomic agents|mesh-ancestor
24989618|NCT04988425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24989619|NCT04988425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24989620|NCT04988425|Glucocorticoids|glucocorticoids|mesh-ancestor
24989621|NCT04988425|Hormones|hormones|mesh-ancestor
25139316|NCT02972216|Docetaxel|docetaxel|mesh-list
25041362|NCT02570490|Linezolid|linezolid|mesh-list
25041363|NCT02570490|Fusidic Acid|fusidic acid|mesh-list
25041364|NCT02570490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25041365|NCT02570490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25049825|NCT00562497|Antiemetics|antiemetics|mesh-ancestor
24989622|NCT04988425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24989623|NCT04988425|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24989624|NCT04988425|Protective Agents|protective agents|mesh-ancestor
24989625|NCT04988425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24989626|NCT04988425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24524284|NCT05052229|Protective Agents|protective agents|mesh-ancestor
24524285|NCT05050500|Dapagliflozin|dapagliflozin|mesh-list
25831715|NCT00007943|Immunologic Factors|immunologic factors|mesh-ancestor
25139322|NCT02972255|Meropenem|meropenem|mesh-list
25107317|NCT03140553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24785264|NCT01913002|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24785265|NCT01913002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24785266|NCT01913015|Abiraterone Acetate|abiraterone acetate|mesh-list
25163013|NCT02900352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163023|NCT02900417|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25163024|NCT02900417|Protease Inhibitors|protease inhibitors|mesh-ancestor
25163025|NCT02900417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163026|NCT02900417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163028|NCT02900157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25163029|NCT02900157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163030|NCT02900430|Antifungal Agents|antifungal agents|mesh-list
25163031|NCT02900430|Clotrimazole|clotrimazole|mesh-list
25163032|NCT02900430|Miconazole|miconazole|mesh-list
25163033|NCT02900430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25163034|NCT02900430|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24524435|NCT04922424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25831716|NCT00007943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524465|NCT04914741|Glucocorticoids|glucocorticoids|mesh-ancestor
24524466|NCT04914741|Hormones|hormones|mesh-ancestor
24524467|NCT04914741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24524468|NCT04914741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24524469|NCT04898621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24524613|NCT04658654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524624|NCT04646837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24524625|NCT04646837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24989654|NCT04944771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989655|NCT04930887|Bupivacaine|bupivacaine|mesh-list
24609385|NCT00996385|Bortezomib|bortezomib|mesh-list
24609386|NCT00996385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609387|NCT00996411|Salvinorin A|salvinorin a|mesh-list
24609388|NCT00996411|Hallucinogens|hallucinogens|mesh-ancestor
24609390|NCT00996411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24524632|NCT04643470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25139338|NCT02971982|Alkylating Agents|alkylating agents|mesh-ancestor
24524633|NCT04643470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24524634|NCT04643470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24524635|NCT04643470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524636|NCT04639986|Gemcitabine|gemcitabine|mesh-list
24524637|NCT04639986|Capecitabine|capecitabine|mesh-list
24524654|NCT04572451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24524655|NCT04572451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24524656|NCT04572451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25139384|NCT02971644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139385|NCT02971475|Analgesics|analgesics|mesh-list
25831717|NCT00007956|Antibodies|antibodies|mesh-list
25139387|NCT02971475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24989659|NCT04930887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989660|NCT04930887|Sensory System Agents|sensory system agents|mesh-ancestor
24989661|NCT04930887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24525002|NCT04115644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24525003|NCT04115644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525004|NCT04115644|Sensory System Agents|sensory system agents|mesh-ancestor
25139401|NCT02971423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139402|NCT02971423|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25139405|NCT02971410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24525040|NCT04036929|Bazedoxifene|bazedoxifene|mesh-list
24525041|NCT04036929|Estrogens|estrogens|mesh-list
24525042|NCT04036929|Hormones|hormones|mesh-ancestor
24525043|NCT04036929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24525044|NCT04036929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525045|NCT04036929|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24525046|NCT04036929|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24525047|NCT04036929|Hormone Antagonists|hormone antagonists|mesh-ancestor
24525048|NCT04036929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24525090|NCT03974152|Nicotine|nicotine|mesh-list
24525091|NCT03974152|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25831718|NCT00007956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24525176|NCT03854929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25139423|NCT02971540|Analgesics|analgesics|mesh-ancestor
25139424|NCT02971540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25139428|NCT02971540|Antipyretics|antipyretics|mesh-ancestor
25831719|NCT00007956|Immunologic Factors|immunologic factors|mesh-ancestor
25831720|NCT00007956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525178|NCT03854929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525179|NCT03854929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25139444|NCT02971306|Acetylcysteine|acetylcysteine|mesh-list
24525180|NCT03854929|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24989712|NCT04865289|Tubulin Modulators|tubulin modulators|mesh-ancestor
24989689|NCT04878510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24989691|NCT04878510|Adrenergic Agents|adrenergic agents|mesh-ancestor
25107318|NCT03140553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25107319|NCT03140553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107320|NCT03140826|Meropenem|meropenem|mesh-list
25107321|NCT03140826|Tazobactam|tazobactam|mesh-list
24525182|NCT03851614|Durvalumab|durvalumab|mesh-list
24525183|NCT03851614|Olaparib|olaparib|mesh-list
24525184|NCT03851614|Cediranib|cediranib|mesh-list
25139458|NCT02971254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25139459|NCT02971254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24445022|NCT00300040|Sensory System Agents|sensory system agents|mesh-ancestor
24813845|NCT02060656|Immunologic Factors|immunologic factors|mesh-ancestor
24813846|NCT02060656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813847|NCT02060656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24813848|NCT02060656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24813849|NCT02060656|Antimetabolites|antimetabolites|mesh-ancestor
24813851|NCT02060656|Antiviral Agents|antiviral agents|mesh-ancestor
24525185|NCT03851614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24525186|NCT03851614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525187|NCT03851614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24525188|NCT03851614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525189|NCT03851614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525190|NCT03851614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25831721|NCT00007969|Verteporfin|verteporfin|mesh-list
24525248|NCT03760718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24525250|NCT03737253|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24525251|NCT03737253|Hormones|hormones|mesh-ancestor
24525426|NCT03364868|Insulin|insulin|mesh-list
24525427|NCT03364868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24525428|NCT03364868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525429|NCT03364686|Biotin|biotin|mesh-list
24525431|NCT03364686|Vitamins|vitamins|mesh-ancestor
24525447|NCT03333408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24525569|NCT03112434|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24525570|NCT03112434|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24525571|NCT03112434|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24814079|NCT02062255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24814080|NCT02062255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814081|NCT02062255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24814082|NCT02062255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25053467|NCT00035529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053468|NCT00035529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25053469|NCT00035529|Immunologic Factors|immunologic factors|mesh-ancestor
25053470|NCT00035529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053471|NCT00035529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25053472|NCT00031512|Pleconaril|pleconaril|mesh-list
25053473|NCT00031512|Antiviral Agents|antiviral agents|mesh-ancestor
24525572|NCT03112434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24525573|NCT03112434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525574|NCT03112434|Cholinergic Agents|cholinergic agents|mesh-ancestor
25139460|NCT02971254|Anesthetics, General|anesthetics, general|mesh-ancestor
25139461|NCT02971254|Anesthetics|anesthetics|mesh-ancestor
25139462|NCT02971254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25139463|NCT02971254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139464|NCT02971345|Iodine|iodine|mesh-list
25139465|NCT02971345|Cadexomer iodine|cadexomer iodine|mesh-list
25139466|NCT02971345|Epirubicin|epirubicin|mesh-list
25139467|NCT02971345|Ethiodized Oil|ethiodized oil|mesh-list
25139468|NCT02971345|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25139469|NCT02971345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24525575|NCT03112434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25107322|NCT03140826|Piperacillin|piperacillin|mesh-list
25107323|NCT03140826|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25107324|NCT03140826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25107325|NCT03140826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25107326|NCT03140826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24989692|NCT04878510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25139488|NCT02970773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139489|NCT02970773|Anticoagulants|anticoagulants|mesh-ancestor
25139490|NCT02970721|Antipsychotic Agents|antipsychotic agents|mesh-list
25139491|NCT02970721|Antidepressive Agents|antidepressive agents|mesh-list
25139492|NCT02970721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25139493|NCT02970721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25139494|NCT02970721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25139495|NCT02970721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139497|NCT02970916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25139498|NCT02970916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24864391|NCT04715230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864392|NCT04715230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24989696|NCT04876781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24989697|NCT04876781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989698|NCT04872218|Abatacept|abatacept|mesh-list
24989699|NCT04872218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24989700|NCT04872218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989701|NCT04872218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24989702|NCT04872218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24989703|NCT04872218|Immunologic Factors|immunologic factors|mesh-ancestor
25139499|NCT02970916|Growth Substances|growth substances|mesh-ancestor
25139500|NCT02970916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139501|NCT02970916|Growth Inhibitors|growth inhibitors|mesh-ancestor
25139502|NCT02970916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25139503|NCT02970630|Everolimus|everolimus|mesh-list
25139504|NCT02970630|Tacrolimus|tacrolimus|mesh-list
24864710|NCT02755844|Metformin|metformin|mesh-list
24864711|NCT02755844|Cyclophosphamide|cyclophosphamide|mesh-list
24864712|NCT02755844|Olaparib|olaparib|mesh-list
25658061|NCT01592708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658062|NCT01592708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658063|NCT01592708|Autonomic Agents|autonomic agents|mesh-ancestor
25658064|NCT01592708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25658065|NCT01592708|Antipruritics|antipruritics|mesh-ancestor
25658066|NCT01592708|Dermatologic Agents|dermatologic agents|mesh-ancestor
25658067|NCT01592708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25658068|NCT01592708|Serotonin Agents|serotonin agents|mesh-ancestor
25658069|NCT01592708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25658070|NCT01592708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25658071|NCT01592708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25658072|NCT01592708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24989704|NCT04872218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989705|NCT04872218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24865211|NCT04231318|Immunologic Factors|immunologic factors|mesh-ancestor
24865212|NCT04231318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24865213|NCT04231318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865218|NCT04177654|Mebendazole|mebendazole|mesh-list
24865219|NCT04177654|Benzimidazole|benzimidazole|mesh-list
24989706|NCT04865289|Paclitaxel|paclitaxel|mesh-list
24525659|NCT02974049|Antimitotic Agents|antimitotic agents|mesh-ancestor
24525660|NCT02974049|Mitosis Modulators|mitosis modulators|mesh-ancestor
24525661|NCT02974049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525662|NCT02974049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525664|NCT02974049|Antinematodal Agents|antinematodal agents|mesh-ancestor
24525665|NCT02974049|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24525666|NCT02974049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525667|NCT02937766|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
24525668|NCT02937766|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
24525669|NCT02937766|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24525720|NCT02823574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24525722|NCT02823574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25831722|NCT00007969|Detox adjuvant|detox adjuvant|mesh-list
24525844|NCT02632409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24525846|NCT02632409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24525847|NCT02632409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525848|NCT02619253|Pembrolizumab|pembrolizumab|mesh-list
24525849|NCT02619253|Vorinostat|vorinostat|mesh-list
24525861|NCT02586207|Pembrolizumab|pembrolizumab|mesh-list
24525926|NCT02357810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525927|NCT02357810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525928|NCT02343549|Bevacizumab|bevacizumab|mesh-list
25139505|NCT02970630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25139506|NCT02970630|Immunologic Factors|immunologic factors|mesh-ancestor
25139507|NCT02970630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139508|NCT02970630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25046511|NCT00841659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046512|NCT00841659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25046518|NCT00841542|Amlodipine|amlodipine|mesh-list
24525929|NCT02343549|Temozolomide|temozolomide|mesh-list
24525930|NCT02343549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24989707|NCT04865289|Carboplatin|carboplatin|mesh-list
24927449|NCT04132583|Sensory System Agents|sensory system agents|mesh-ancestor
24989708|NCT04865289|Pembrolizumab|pembrolizumab|mesh-list
24989709|NCT04865289|Lenvatinib|lenvatinib|mesh-list
24989710|NCT04865289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24989711|NCT04865289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525931|NCT02343549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525932|NCT02343549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24525933|NCT02343549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24525936|NCT02343549|Growth Inhibitors|growth inhibitors|mesh-ancestor
25831723|NCT00007969|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24526325|NCT00611143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24526327|NCT00611169|Tirofiban|tirofiban|mesh-list
24851848|NCT02259595|Antioxidants|antioxidants|mesh-ancestor
24526388|NCT00611494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526389|NCT00611494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24526390|NCT00611494|Antitubercular Agents|antitubercular agents|mesh-ancestor
24526391|NCT00611494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24526395|NCT00611507|Fluorouracil|fluorouracil|mesh-list
24526442|NCT00611689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526444|NCT00611728|Sunitinib|sunitinib|mesh-list
24526445|NCT00611728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25139574|NCT02970409|Anticoagulants|anticoagulants|mesh-ancestor
25139575|NCT02970409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25139576|NCT02970409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25139577|NCT02970409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139578|NCT02970383|Narcotics|narcotics|mesh-list
25139579|NCT02970383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25139580|NCT02970383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139581|NCT02970383|Analgesics|analgesics|mesh-ancestor
25139582|NCT02970383|Sensory System Agents|sensory system agents|mesh-ancestor
25413604|NCT03121586|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25658073|NCT01592708|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25658074|NCT01592708|Antitussive Agents|antitussive agents|mesh-ancestor
25658075|NCT01592708|Respiratory System Agents|respiratory system agents|mesh-ancestor
25658076|NCT01592708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25658077|NCT01592708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25139583|NCT02970383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25139584|NCT02970175|Terlipressin|terlipressin|mesh-list
25139585|NCT02970175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25139586|NCT02970175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24526764|NCT00613093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24526766|NCT00613132|Imatinib Mesylate|imatinib mesylate|mesh-list
24526767|NCT00613132|Hydroxyurea|hydroxyurea|mesh-list
24526768|NCT00613132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526769|NCT00613132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24526770|NCT00613132|Immunologic Factors|immunologic factors|mesh-ancestor
24526771|NCT00613132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526885|NCT00613600|Cathartics|cathartics|mesh-ancestor
24989757|NCT04820205|Dexmedetomidine|dexmedetomidine|mesh-list
24989758|NCT04820205|Ketamine|ketamine|mesh-list
24989770|NCT04820205|Adrenergic Agents|adrenergic agents|mesh-ancestor
24989771|NCT04820205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24797051|NCT01953770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24797052|NCT01953770|Antimetabolites|antimetabolites|mesh-ancestor
24797053|NCT01953770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797054|NCT01953770|Dermatologic Agents|dermatologic agents|mesh-ancestor
24797055|NCT01953770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24797056|NCT01953770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24797057|NCT01953770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24797058|NCT01953770|Immunologic Factors|immunologic factors|mesh-ancestor
24797059|NCT01953770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25139589|NCT02970097|Ropivacaine|ropivacaine|mesh-list
25139590|NCT02970097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25139591|NCT02970097|Narcotics|narcotics|mesh-ancestor
25139592|NCT02970097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25139594|NCT02970097|Analgesics|analgesics|mesh-ancestor
24797060|NCT01953770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24797061|NCT01953770|Antiviral Agents|antiviral agents|mesh-ancestor
24797062|NCT01953770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24797063|NCT01953770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24526886|NCT00613600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24526887|NCT00613613|Fenofibrate|fenofibrate|mesh-list
24526888|NCT00613613|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24526889|NCT00613613|Antimetabolites|antimetabolites|mesh-ancestor
24526890|NCT00613613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526891|NCT00613613|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24526892|NCT00613665|Vaccines|vaccines|mesh-list
24526893|NCT00613665|Immunologic Factors|immunologic factors|mesh-ancestor
24526894|NCT00613665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526895|NCT00613717|Vitamin D|vitamin d|mesh-list
24526896|NCT00613717|Vitamins|vitamins|mesh-list
24526983|NCT00614029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526984|NCT00614029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526987|NCT00614159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24797064|NCT01953770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24797065|NCT01953770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24797067|NCT01953796|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24797068|NCT01953796|Hormone Antagonists|hormone antagonists|mesh-ancestor
24797069|NCT01953796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24797070|NCT01953796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797071|NCT01953796|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24797072|NCT01953796|Fertility Agents|fertility agents|mesh-ancestor
24797073|NCT01953796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24820587|NCT02100423|Vitamin D|vitamin d|mesh-list
24797074|NCT01953796|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24797075|NCT01953796|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24797076|NCT01953835|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24797077|NCT01953835|Simvastatin|simvastatin|mesh-list
24797078|NCT01953835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24797079|NCT01953835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25139647|NCT02969733|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25139648|NCT02969733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25139649|NCT02969733|Anesthetics, General|anesthetics, general|mesh-ancestor
24609398|NCT00996424|Antioxidants|antioxidants|mesh-ancestor
24527184|NCT00615303|Dermatologic Agents|dermatologic agents|mesh-ancestor
24527186|NCT00615368|Hematinics|hematinics|mesh-ancestor
24527188|NCT00615381|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24527189|NCT00615381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24527190|NCT00615381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527191|NCT00615446|Gemcitabine|gemcitabine|mesh-list
24989813|NCT04703257|Dipyrone|dipyrone|mesh-list
24989814|NCT04703257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24989815|NCT04703257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25831724|NCT00007969|Dermatologic Agents|dermatologic agents|mesh-ancestor
24865344|NCT03417479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24865345|NCT03417479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865346|NCT03417479|Anticonvulsants|anticonvulsants|mesh-ancestor
24865347|NCT03417479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25058044|NCT03499743|Sensory System Agents|sensory system agents|mesh-ancestor
24865348|NCT03417479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24865349|NCT03417479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24989816|NCT04703257|Analgesics|analgesics|mesh-ancestor
24989817|NCT04703257|Sensory System Agents|sensory system agents|mesh-ancestor
24989818|NCT04703257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24989819|NCT04703257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139680|NCT02969629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25139681|NCT02969629|Dopamine Agonists|dopamine agonists|mesh-ancestor
25139682|NCT02969629|Dopamine Agents|dopamine agents|mesh-ancestor
25139683|NCT02969629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25139684|NCT02969629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139685|NCT02969681|Ascorbic Acid|ascorbic acid|mesh-list
25139686|NCT02969681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139687|NCT02969681|Vitamins|vitamins|mesh-ancestor
25139688|NCT02969681|Micronutrients|micronutrients|mesh-ancestor
24865301|NCT03916627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865302|NCT03893318|Lidocaine|lidocaine|mesh-list
24865303|NCT03893318|Anesthetics, Local|anesthetics, local|mesh-ancestor
24865304|NCT03893318|Anesthetics|anesthetics|mesh-ancestor
24865305|NCT03893318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24865306|NCT03893318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865307|NCT03893318|Sensory System Agents|sensory system agents|mesh-ancestor
24865308|NCT03893318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24545208|NCT00692510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24545216|NCT00692510|Anesthetics|anesthetics|mesh-ancestor
24865376|NCT03317795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24865377|NCT03317795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989820|NCT04703257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24989821|NCT04703257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24989822|NCT04703257|Antipyretics|antipyretics|mesh-ancestor
24989823|NCT04677959|Fluticasone|fluticasone|mesh-list
24989824|NCT04677959|Xhance|xhance|mesh-list
24989825|NCT04677959|Albuterol|albuterol|mesh-list
24989826|NCT04677959|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24989827|NCT04677959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24989828|NCT04677959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24989829|NCT04677959|Autonomic Agents|autonomic agents|mesh-ancestor
24989880|NCT04620252|Calcium|calcium|mesh-list
24989830|NCT04677959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25139689|NCT02969681|Antioxidants|antioxidants|mesh-ancestor
25139690|NCT02969681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139691|NCT02969681|Protective Agents|protective agents|mesh-ancestor
24989831|NCT04677959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107327|NCT03140826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24989832|NCT04677959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24989833|NCT04677959|Respiratory System Agents|respiratory system agents|mesh-ancestor
24989836|NCT04677959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24813729|NCT02060019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24527307|NCT00615810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24527308|NCT00615810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24527309|NCT00615823|Atorvastatin|atorvastatin|mesh-list
24527310|NCT00615823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24989837|NCT04677959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24989838|NCT04677959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24989839|NCT04677959|Adrenergic Agents|adrenergic agents|mesh-ancestor
24989840|NCT04677959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24989841|NCT04677959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139696|NCT02969447|Oxytocics|oxytocics|mesh-ancestor
25139697|NCT02969447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25658078|NCT01592708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25658079|NCT01592708|Mydriatics|mydriatics|mesh-ancestor
25658080|NCT01592708|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25658081|NCT01592708|Cholinergic Agents|cholinergic agents|mesh-ancestor
25658082|NCT01592708|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25658083|NCT01592708|Glucocorticoids|glucocorticoids|mesh-ancestor
25658084|NCT01592708|Hormones|hormones|mesh-ancestor
25658085|NCT01592708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25139698|NCT02969447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139699|NCT02969473|Cisplatin|cisplatin|mesh-list
25139700|NCT02969473|Docetaxel|docetaxel|mesh-list
25139701|NCT02969473|Fluorouracil|fluorouracil|mesh-list
25658086|NCT01592708|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25201053|NCT02730364|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24865400|NCT03115294|Theophylline|theophylline|mesh-list
25014468|NCT04503993|Antibodies|antibodies|mesh-list
25831725|NCT00007969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25658087|NCT01592708|Protective Agents|protective agents|mesh-ancestor
25139702|NCT02969473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25139703|NCT02969473|Tubulin Modulators|tubulin modulators|mesh-ancestor
24989843|NCT04677959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24989844|NCT04624984|Gemcitabine|gemcitabine|mesh-list
24989845|NCT04624984|Doxorubicin|doxorubicin|mesh-list
24989861|NCT04624984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24989862|NCT04624984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24989863|NCT04624984|Tubulin Modulators|tubulin modulators|mesh-ancestor
24863804|NCT03284047|Botulinum Toxins|botulinum toxins|mesh-list
24527311|NCT00615823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24527312|NCT00615823|Antimetabolites|antimetabolites|mesh-ancestor
25046556|NCT00840632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25046557|NCT00840476|Meloxicam|meloxicam|mesh-list
25046558|NCT00840476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24527313|NCT00615823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527314|NCT00615823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24527315|NCT00615823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24527316|NCT00615823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527318|NCT00615875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24527319|NCT00615875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24527320|NCT00615875|Analgesics|analgesics|mesh-ancestor
24527321|NCT00615875|Sensory System Agents|sensory system agents|mesh-ancestor
24527322|NCT00615875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24527323|NCT00615875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046561|NCT00840476|Sensory System Agents|sensory system agents|mesh-ancestor
25046562|NCT00840476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25046563|NCT00840476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046564|NCT00840476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25046565|NCT00840476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25046570|NCT00840411|Clarithromycin|clarithromycin|mesh-list
24527324|NCT00615875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24527384|NCT00616382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24527385|NCT00616382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24527386|NCT00616382|Gout Suppressants|gout suppressants|mesh-ancestor
24989865|NCT04624984|Mitosis Modulators|mitosis modulators|mesh-ancestor
24989866|NCT04624958|Rituximab|rituximab|mesh-list
24989867|NCT04624958|Zanubrutinib|zanubrutinib|mesh-list
24989868|NCT04624958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24989869|NCT04624958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24989870|NCT04624958|Immunologic Factors|immunologic factors|mesh-ancestor
24989871|NCT04624958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046578|NCT00840281|Cefprozil|cefprozil|mesh-list
24989872|NCT04624958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24989873|NCT04624958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24989874|NCT04624958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24989877|NCT04620252|Calcium Carbonate|calcium carbonate|mesh-list
24989878|NCT04620252|Citric Acid|citric acid|mesh-list
24989879|NCT04620252|Sodium Citrate|sodium citrate|mesh-list
24989881|NCT04620252|Fluorides|fluorides|mesh-list
24989882|NCT04620252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24989883|NCT04620252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989884|NCT04620252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24989885|NCT04620252|Anticoagulants|anticoagulants|mesh-ancestor
24989886|NCT04620252|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24989887|NCT04620252|Chelating Agents|chelating agents|mesh-ancestor
24527392|NCT00616382|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24989892|NCT04620252|Antacids|antacids|mesh-ancestor
24989893|NCT04620252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24989894|NCT04613024|Topiramate|topiramate|mesh-list
24989895|NCT04613024|Gabapentin|gabapentin|mesh-list
24989896|NCT04613024|Analgesics|analgesics|mesh-ancestor
24989897|NCT04613024|Sensory System Agents|sensory system agents|mesh-ancestor
24989898|NCT04613024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24989899|NCT04613024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989900|NCT04613024|Anticonvulsants|anticonvulsants|mesh-ancestor
24989901|NCT04613024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24989902|NCT04613024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25658088|NCT01592708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25658089|NCT01592708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24989903|NCT04613024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24989904|NCT04613024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25658090|NCT01592708|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24445978|NCT00303407|Nadroparin|nadroparin|mesh-list
24989905|NCT04613024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24989906|NCT04613024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24989907|NCT04613024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24785272|NCT01913015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24785273|NCT01913015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785274|NCT01913015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24527669|NCT00618046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24527769|NCT00618241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24527770|NCT00618241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24527771|NCT00618241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527772|NCT00618241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24527773|NCT00618241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24527774|NCT00618241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24527775|NCT00618241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24527776|NCT00618241|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24527858|NCT00618501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527859|NCT00618501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24785290|NCT01913106|Valacyclovir|valacyclovir|mesh-list
24785291|NCT01913106|Antiviral Agents|antiviral agents|mesh-ancestor
24785292|NCT01913106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24785293|NCT01913119|Romidepsin|romidepsin|mesh-list
24785294|NCT01913119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24785296|NCT01913379|Itraconazole|itraconazole|mesh-list
24785297|NCT01913379|Gemfibrozil|gemfibrozil|mesh-list
24785298|NCT01913379|Antifungal Agents|antifungal agents|mesh-ancestor
24785299|NCT01913379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25107328|NCT03140826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107329|NCT03140787|Lidocaine|lidocaine|mesh-list
25107330|NCT03140787|Anesthetics, Local|anesthetics, local|mesh-ancestor
25107331|NCT03140787|Anesthetics|anesthetics|mesh-ancestor
25107332|NCT03140787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24863863|NCT03190174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24863864|NCT03190174|Immunologic Factors|immunologic factors|mesh-ancestor
24863865|NCT03190174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529225|NCT00625092|Immunologic Factors|immunologic factors|mesh-ancestor
24527867|NCT00618501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24527868|NCT00618501|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24527869|NCT00618501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24527870|NCT00618501|Antiviral Agents|antiviral agents|mesh-ancestor
24527946|NCT00618657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527947|NCT00618657|Growth Inhibitors|growth inhibitors|mesh-ancestor
24527948|NCT00618657|Immunologic Factors|immunologic factors|mesh-ancestor
24529556|NCT00626678|Azathioprine|azathioprine|mesh-list
25139745|NCT02969239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139747|NCT02969239|Nasal Decongestants|nasal decongestants|mesh-ancestor
25139748|NCT02969239|Respiratory System Agents|respiratory system agents|mesh-ancestor
25139749|NCT02969239|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25139750|NCT02969239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25139751|NCT02969239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25139752|NCT02969239|Adrenergic Agents|adrenergic agents|mesh-ancestor
25139753|NCT02969239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25139754|NCT02969239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139755|NCT02969239|Protective Agents|protective agents|mesh-ancestor
25139756|NCT02968901|Tadalafil|tadalafil|mesh-list
25139757|NCT02968901|Macitentan|macitentan|mesh-list
24527953|NCT00618696|Immunologic Factors|immunologic factors|mesh-ancestor
25831726|NCT00007969|Immunologic Factors|immunologic factors|mesh-ancestor
24528853|NCT00623155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24863888|NCT03084549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107333|NCT03140787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528956|NCT00623857|Zinc|zinc|mesh-list
24528970|NCT00624026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24528975|NCT00624039|Pilocarpine|pilocarpine|mesh-list
24528976|NCT00624039|Miotics|miotics|mesh-ancestor
24528977|NCT00624039|Autonomic Agents|autonomic agents|mesh-ancestor
24528978|NCT00624039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24528979|NCT00624039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528980|NCT00624039|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25831727|NCT00007969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529111|NCT00624663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24529112|NCT00624663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529113|NCT00624663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24529114|NCT00624663|Protective Agents|protective agents|mesh-ancestor
24529115|NCT00624676|Salicylic Acid|salicylic acid|mesh-list
25139760|NCT02968901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25139761|NCT02968901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25139762|NCT02968901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139763|NCT02968901|Urological Agents|urological agents|mesh-ancestor
25139764|NCT02968901|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25139765|NCT02968901|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25139766|NCT02968901|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25139767|NCT02968927|Vitamin D|vitamin d|mesh-list
25139768|NCT02968927|Cholecalciferol|cholecalciferol|mesh-list
25139769|NCT02968927|Rifabutin|rifabutin|mesh-list
25139770|NCT02968927|Everolimus|everolimus|mesh-list
25139771|NCT02968927|Auranofin|auranofin|mesh-list
25139772|NCT02968927|CC-11050|cc-11050|mesh-list
25139773|NCT02968927|Vitamins|vitamins|mesh-ancestor
25139774|NCT02968927|Micronutrients|micronutrients|mesh-ancestor
24811000|NCT02044146|Clopidogrel|clopidogrel|mesh-list
24529128|NCT00624676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529129|NCT00624676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24529130|NCT00624676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24529131|NCT00624676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24529132|NCT00624676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529134|NCT00624702|Maleic acid|maleic acid|mesh-list
24529171|NCT00624871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24529219|NCT00625092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529220|NCT00625092|Antimetabolites|antimetabolites|mesh-ancestor
24529221|NCT00625092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529222|NCT00625092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24529223|NCT00625092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24529224|NCT00625092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24529230|NCT00625092|Micronutrients|micronutrients|mesh-ancestor
24529231|NCT00625170|Haloperidol|haloperidol|mesh-list
24529232|NCT00625170|Olanzapine|olanzapine|mesh-list
24529233|NCT00625170|Haloperidol decanoate|haloperidol decanoate|mesh-list
24529551|NCT00626665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24529553|NCT00626665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529554|NCT00626665|Urological Agents|urological agents|mesh-ancestor
24529555|NCT00626678|Prednisone|prednisone|mesh-list
24529557|NCT00626678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24529558|NCT00626678|Glucocorticoids|glucocorticoids|mesh-ancestor
24529627|NCT00627003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529628|NCT00627081|Remifentanil|remifentanil|mesh-list
25831728|NCT00007982|Cyclophosphamide|cyclophosphamide|mesh-list
25831729|NCT00007982|Thiotepa|thiotepa|mesh-list
25831730|NCT00007982|Carmustine|carmustine|mesh-list
24863898|NCT03026348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25107343|NCT03140384|Abortifacient Agents|abortifacient agents|mesh-ancestor
25107344|NCT03140384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24529840|NCT00627965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24529841|NCT00627965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529842|NCT00627965|Urological Agents|urological agents|mesh-ancestor
24529844|NCT00627991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24529845|NCT00627991|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24529846|NCT00627991|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24529847|NCT00627991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529942|NCT00628342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529944|NCT00628459|Trace Elements|trace elements|mesh-list
24529945|NCT00628459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831731|NCT00007982|Cisplatin|cisplatin|mesh-list
25831732|NCT00007982|Etoposide|etoposide|mesh-list
25046630|NCT00838799|Pregabalin|pregabalin|mesh-list
25831733|NCT00007982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24530044|NCT00628810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24530045|NCT00628810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24530046|NCT00628810|Immunologic Factors|immunologic factors|mesh-ancestor
24530142|NCT00629226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24530143|NCT00629252|Risperidone|risperidone|mesh-list
24530144|NCT00629252|Sertindole|sertindole|mesh-list
24530145|NCT00629252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24530146|NCT00629252|Serotonin Agents|serotonin agents|mesh-ancestor
24530147|NCT00629252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24530148|NCT00629252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530150|NCT00629252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24530224|NCT00629473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24530225|NCT00629473|Antiemetics|antiemetics|mesh-ancestor
24530226|NCT00629473|Autonomic Agents|autonomic agents|mesh-ancestor
25831734|NCT00007982|Immunologic Factors|immunologic factors|mesh-ancestor
24530227|NCT00629473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24530228|NCT00629473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107363|NCT03140449|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25107364|NCT03140449|Vitamins|vitamins|mesh-ancestor
25107365|NCT03140449|Micronutrients|micronutrients|mesh-ancestor
25107366|NCT03140449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25107367|NCT03140709|Oxytocin|oxytocin|mesh-list
25107368|NCT03140709|Oxytocics|oxytocics|mesh-ancestor
24530232|NCT00629473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24530233|NCT00629473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24530234|NCT00629473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530235|NCT00629473|Protease Inhibitors|protease inhibitors|mesh-ancestor
24530236|NCT00629473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530401|NCT00630097|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24530402|NCT00630097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24530403|NCT00630097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24530404|NCT00630097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530406|NCT00630110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530407|NCT00630110|Tubulin Modulators|tubulin modulators|mesh-ancestor
24530510|NCT00630708|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24530511|NCT00630708|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24530512|NCT00630708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530513|NCT00630708|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24530514|NCT00630708|Protease Inhibitors|protease inhibitors|mesh-ancestor
24530515|NCT00630708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530516|NCT00630851|Donepezil|donepezil|mesh-list
24530517|NCT00630851|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24530518|NCT00630851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530519|NCT00630851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530520|NCT00630851|Cholinergic Agents|cholinergic agents|mesh-ancestor
24530601|NCT00631124|Natriuretic Agents|natriuretic agents|mesh-ancestor
24530602|NCT00631150|Levetiracetam|levetiracetam|mesh-list
24530603|NCT00631150|Anticonvulsants|anticonvulsants|mesh-ancestor
24530604|NCT00631150|Nootropic Agents|nootropic agents|mesh-ancestor
24530605|NCT00631202|Epoetin Alfa|epoetin alfa|mesh-list
24530606|NCT00631202|Hematinics|hematinics|mesh-ancestor
24530607|NCT00631228|Everolimus|everolimus|mesh-list
24408345|NCT00177424|Sertraline|sertraline|mesh-list
24530608|NCT00631228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530609|NCT00631228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24530610|NCT00631228|Immunologic Factors|immunologic factors|mesh-ancestor
24530611|NCT00631228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530612|NCT00631501|Doxycycline|doxycycline|mesh-list
24530613|NCT00631501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24530625|NCT00631514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530627|NCT00631514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25107369|NCT03140709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25107370|NCT03140709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797083|NCT01953835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24797085|NCT01953848|Tamsulosin|tamsulosin|mesh-list
24797086|NCT01953848|Solifenacin Succinate|solifenacin succinate|mesh-list
25139869|NCT02968160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25139870|NCT02968160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25139871|NCT02968160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25139872|NCT02968082|Scopolamine|scopolamine|mesh-list
24797087|NCT01953848|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24797088|NCT01953848|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24797089|NCT01953848|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24797090|NCT01953848|Adrenergic Agents|adrenergic agents|mesh-ancestor
24797091|NCT01953848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24797092|NCT01953848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530628|NCT00631514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24530629|NCT00631514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24530630|NCT00631514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24530687|NCT00631722|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24530688|NCT00631722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24530689|NCT00631722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24530690|NCT00631722|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24530691|NCT00631722|Dopamine Agents|dopamine agents|mesh-ancestor
24530750|NCT00632255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408577|NCT03434379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25658091|NCT01592708|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24865568|NCT00109668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24530751|NCT00632255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530752|NCT00632268|Leucovorin|leucovorin|mesh-list
25139892|NCT02967939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25139893|NCT02967939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139894|NCT02967939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25139895|NCT02967939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25139896|NCT02967874|Hyaluronic Acid|hyaluronic acid|mesh-list
25139897|NCT02967874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25139898|NCT02967874|Immunologic Factors|immunologic factors|mesh-ancestor
24530753|NCT00632268|Everolimus|everolimus|mesh-list
25831735|NCT00007982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831736|NCT00007982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25831737|NCT00007982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25831738|NCT00007982|Alkylating Agents|alkylating agents|mesh-ancestor
25831739|NCT00007982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530782|NCT00632476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530783|NCT00632476|Protective Agents|protective agents|mesh-ancestor
24797093|NCT01953848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797094|NCT01953848|Urological Agents|urological agents|mesh-ancestor
24797095|NCT01953848|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24797096|NCT01953848|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24797097|NCT01953848|Cholinergic Agents|cholinergic agents|mesh-ancestor
24797099|NCT01953887|Solifenacin Succinate|solifenacin succinate|mesh-list
24797100|NCT01953887|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24797108|NCT01953887|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25169560|NCT01818076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25139910|NCT02967757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24989925|NCT04588688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24530784|NCT00632554|Prednisolone|prednisolone|mesh-list
24530785|NCT00632554|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24530786|NCT00632554|Methylprednisolone|methylprednisolone|mesh-list
24530787|NCT00632554|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25139935|NCT02967302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25139936|NCT02967653|Atorvastatin|atorvastatin|mesh-list
25139937|NCT02967653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24530788|NCT00632554|Prednisolone acetate|prednisolone acetate|mesh-list
24530789|NCT00632554|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24530790|NCT00632554|Prednisolone phosphate|prednisolone phosphate|mesh-list
24989935|NCT04585893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24989936|NCT04585893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24863976|NCT02710084|Oxytocin|oxytocin|mesh-list
24863977|NCT02710084|Oxytocics|oxytocics|mesh-ancestor
24863978|NCT02710084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24863979|NCT02710084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863980|NCT02645474|Ropivacaine|ropivacaine|mesh-list
24863981|NCT02645474|Anesthetics, Local|anesthetics, local|mesh-ancestor
24863982|NCT02645474|Anesthetics|anesthetics|mesh-ancestor
24863983|NCT02645474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24863984|NCT02645474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543860|NCT00685672|Mydriatics|mydriatics|mesh-ancestor
24530791|NCT00632554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24530792|NCT00632554|Glucocorticoids|glucocorticoids|mesh-ancestor
24530793|NCT00632554|Hormones|hormones|mesh-ancestor
24530794|NCT00632554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24530795|NCT00632554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530796|NCT00632554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24530797|NCT00632554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530818|NCT00632606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24530819|NCT00632606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24530820|NCT00632606|Anticonvulsants|anticonvulsants|mesh-ancestor
24530821|NCT00632606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24989945|NCT04573647|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24989946|NCT04573647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24989947|NCT04544267|Vaccines|vaccines|mesh-list
24989948|NCT04544267|Immunologic Factors|immunologic factors|mesh-ancestor
24989949|NCT04544267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989950|NCT04502602|Niraparib|niraparib|mesh-list
25107374|NCT03140488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989951|NCT04502602|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25658092|NCT01592708|Dopamine Agents|dopamine agents|mesh-ancestor
25658093|NCT01592747|Memantine|memantine|mesh-list
25658094|NCT01592747|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25053865|NCT00004169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25053866|NCT00004169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24989952|NCT04502602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24989953|NCT04502602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989954|NCT04502602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24989956|NCT04490018|Immunologic Factors|immunologic factors|mesh-ancestor
24989957|NCT04490018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989958|NCT04454515|Dexmedetomidine|dexmedetomidine|mesh-list
24989959|NCT04454515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24989960|NCT04454515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24543868|NCT00685776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24863985|NCT02645474|Sensory System Agents|sensory system agents|mesh-ancestor
24863986|NCT02645474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24863987|NCT02494258|Azacitidine|azacitidine|mesh-list
24863988|NCT02494258|Cc-486|cc-486|mesh-list
24863990|NCT02494258|Antimetabolites|antimetabolites|mesh-ancestor
25831740|NCT00007982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831741|NCT00007982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25831742|NCT00007982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25139988|NCT02967276|Autonomic Agents|autonomic agents|mesh-ancestor
25139989|NCT02967276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25139990|NCT02967276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139991|NCT02967276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25139992|NCT02967276|Glucocorticoids|glucocorticoids|mesh-ancestor
25139993|NCT02967276|Hormones|hormones|mesh-ancestor
25139994|NCT02967276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25139999|NCT02967432|Petrolatum|petrolatum|mesh-list
24530968|NCT00633412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24530969|NCT00633412|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25831743|NCT00007982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25831744|NCT00007982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24531051|NCT00633685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531053|NCT00633685|Serotonin Agents|serotonin agents|mesh-ancestor
24531054|NCT00633685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531155|NCT00634348|Antidepressive Agents|antidepressive agents|mesh-ancestor
24989961|NCT04454515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989962|NCT04454515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24989963|NCT04454515|Analgesics|analgesics|mesh-ancestor
24989964|NCT04454515|Sensory System Agents|sensory system agents|mesh-ancestor
24989965|NCT04454515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24989966|NCT04454515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24989967|NCT04454515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24989968|NCT04454515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24989969|NCT04454515|Adrenergic Agents|adrenergic agents|mesh-ancestor
24989970|NCT04454515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24989971|NCT04454515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989972|NCT04442022|Gemcitabine|gemcitabine|mesh-list
24989973|NCT04442022|Dexamethasone|dexamethasone|mesh-list
24989974|NCT04442022|Rituximab|rituximab|mesh-list
24989975|NCT04442022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24989976|NCT04442022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24531156|NCT00634348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25140018|NCT02967172|Anesthetics|anesthetics|mesh-ancestor
24531157|NCT00634348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24531158|NCT00634348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24531159|NCT00634348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24531160|NCT00634348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531161|NCT00634348|Dopamine Agonists|dopamine agonists|mesh-ancestor
24531162|NCT00634348|Dopamine Agents|dopamine agents|mesh-ancestor
24531163|NCT00634348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24531164|NCT00634348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531165|NCT00634348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24531205|NCT00634439|Adrenergic Agents|adrenergic agents|mesh-ancestor
24531206|NCT00634439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25140036|NCT02967211|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24531207|NCT00634439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531208|NCT00634491|Acetazolamide|acetazolamide|mesh-list
24531209|NCT00634491|Anticonvulsants|anticonvulsants|mesh-ancestor
24531210|NCT00634491|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24531211|NCT00634491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658095|NCT01592747|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25658096|NCT01592747|Dopamine Agents|dopamine agents|mesh-ancestor
25658097|NCT01592747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25048865|NCT00662506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25000228|NCT04323436|Spartalizumab|spartalizumab|mesh-list
24989980|NCT04442022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24989981|NCT04442022|Antiemetics|antiemetics|mesh-ancestor
24989982|NCT04442022|Autonomic Agents|autonomic agents|mesh-ancestor
24989983|NCT04442022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24989984|NCT04442022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24989985|NCT04442022|Glucocorticoids|glucocorticoids|mesh-ancestor
24989986|NCT04442022|Hormones|hormones|mesh-ancestor
24989987|NCT04442022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24989988|NCT04442022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24989989|NCT04442022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24989990|NCT04442022|Antimetabolites|antimetabolites|mesh-ancestor
24989991|NCT04442022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989992|NCT04442022|Antiviral Agents|antiviral agents|mesh-ancestor
24989993|NCT04442022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24989994|NCT04442022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24989995|NCT04442022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24813773|NCT02060279|Protective Agents|protective agents|mesh-ancestor
24531216|NCT00634556|Levodopa|levodopa|mesh-list
24531282|NCT00634881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24531283|NCT00634881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531284|NCT00634894|Letrozole|letrozole|mesh-list
24531285|NCT00634894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531286|NCT00634894|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24531287|NCT00634894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24531288|NCT00634894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24531289|NCT00634894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531290|NCT00634894|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24531291|NCT00634894|Hormone Antagonists|hormone antagonists|mesh-ancestor
24531292|NCT00634894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24531293|NCT00634894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531294|NCT00634959|Maraviroc|maraviroc|mesh-list
24531295|NCT00634959|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24531339|NCT00635258|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24531340|NCT00635258|Contraceptive Agents|contraceptive agents|mesh-ancestor
24531341|NCT00635258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24531343|NCT00635258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24531344|NCT00635258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531347|NCT00635284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24531479|NCT00636038|Carotenoids|carotenoids|mesh-list
24531480|NCT00636038|Antioxidants|antioxidants|mesh-ancestor
24531481|NCT00636038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531482|NCT00636038|Protective Agents|protective agents|mesh-ancestor
24531483|NCT00636038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531484|NCT00636038|Provitamins|provitamins|mesh-ancestor
24989997|NCT04429880|Oxytocics|oxytocics|mesh-ancestor
24989998|NCT04429880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24989999|NCT04429880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990000|NCT04342715|Paromomycin|paromomycin|mesh-list
24990001|NCT04342715|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
24990002|NCT04342715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24990003|NCT04342715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24990004|NCT04342715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24990005|NCT04342715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24990006|NCT04342715|Schistosomicides|schistosomicides|mesh-ancestor
24990007|NCT04342715|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24813789|NCT02060396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24813790|NCT02060396|Analgesics|analgesics|mesh-ancestor
24813791|NCT02060396|Sensory System Agents|sensory system agents|mesh-ancestor
25046698|NCT00837265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046699|NCT00836901|Amoxicillin|amoxicillin|mesh-list
25046700|NCT00836901|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25046701|NCT00836901|Clavulanic Acids|clavulanic acids|mesh-list
25046702|NCT00836901|Clavulanic Acid|clavulanic acid|mesh-list
25046703|NCT00836901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25046704|NCT00836901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25046705|NCT00836901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25046706|NCT00836901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24868060|NCT03994172|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24868061|NCT03994172|Chelating Agents|chelating agents|mesh-ancestor
24868062|NCT03994172|Sequestering Agents|sequestering agents|mesh-ancestor
24868063|NCT03994172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658098|NCT01592747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658099|NCT01592747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831745|NCT00007982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831746|NCT00007995|Interferons|interferons|mesh-list
24865708|NCT05150899|Histamine Antagonists|histamine antagonists|mesh-ancestor
24865709|NCT05150899|Histamine Agents|histamine agents|mesh-ancestor
24865710|NCT05148754|Elsulfavirine|elsulfavirine|mesh-list
24865711|NCT05148754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24865712|NCT05148754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24865713|NCT05148754|Antiviral Agents|antiviral agents|mesh-ancestor
24865714|NCT05148754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24884214|NCT02678143|Sirolimus|sirolimus|mesh-list
24865726|NCT05108740|Everolimus|everolimus|mesh-list
24865727|NCT05108740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865735|NCT05076513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24868064|NCT03994172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24868065|NCT03994172|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24868066|NCT03994172|Hormone Antagonists|hormone antagonists|mesh-ancestor
24813792|NCT02060396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24813793|NCT02060396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813794|NCT02060396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24813795|NCT02060396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24813796|NCT02060396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24813797|NCT02060396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24531485|NCT00636038|Vitamins|vitamins|mesh-ancestor
25658100|NCT01592747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25658101|NCT01592747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25658102|NCT01592773|Memantine|memantine|mesh-list
25658103|NCT01592773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25658104|NCT01592773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24531486|NCT00636038|Micronutrients|micronutrients|mesh-ancestor
24531487|NCT00636064|Parecoxib|parecoxib|mesh-list
24531488|NCT00636064|Valdecoxib|valdecoxib|mesh-list
24531489|NCT00636064|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24531490|NCT00636064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24531491|NCT00636064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24531492|NCT00636064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531493|NCT00636064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24531495|NCT00636064|Analgesics|analgesics|mesh-ancestor
24531538|NCT00636298|Growth Inhibitors|growth inhibitors|mesh-ancestor
24531539|NCT00636311|Gemcitabine|gemcitabine|mesh-list
24531540|NCT00636311|Bortezomib|bortezomib|mesh-list
24531541|NCT00636311|Vinorelbine|vinorelbine|mesh-list
24531542|NCT00636311|Ifosfamide|ifosfamide|mesh-list
24531543|NCT00636311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25831747|NCT00007995|Interferon-alpha|interferon-alpha|mesh-list
24531553|NCT00636311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24531554|NCT00636311|Tubulin Modulators|tubulin modulators|mesh-ancestor
24531555|NCT00636311|Antimitotic Agents|antimitotic agents|mesh-ancestor
24531556|NCT00636311|Mitosis Modulators|mitosis modulators|mesh-ancestor
24531557|NCT00636311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24531558|NCT00636311|Alkylating Agents|alkylating agents|mesh-ancestor
24531559|NCT00636415|Morphine|morphine|mesh-list
24531560|NCT00636415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24531561|NCT00636415|Narcotics|narcotics|mesh-ancestor
24990019|NCT04269213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046707|NCT00836901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990024|NCT04126733|Nivolumab|nivolumab|mesh-list
25107375|NCT03140410|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24990025|NCT04126733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24990026|NCT04126733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990027|NCT04126733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24990028|NCT04126733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990029|NCT04055116|Lidocaine|lidocaine|mesh-list
24990030|NCT04055116|Anesthetics, Local|anesthetics, local|mesh-ancestor
25658105|NCT01592773|Dopamine Agents|dopamine agents|mesh-ancestor
25658106|NCT01592773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25658107|NCT01592773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658108|NCT01592773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658109|NCT01592773|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25658110|NCT01592773|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25658111|NCT01592786|Memantine|memantine|mesh-list
25658112|NCT01592786|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25658113|NCT01592786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25658114|NCT01592786|Dopamine Agents|dopamine agents|mesh-ancestor
25658115|NCT01592786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24990031|NCT04055116|Anesthetics|anesthetics|mesh-ancestor
24990032|NCT04055116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24990033|NCT04055116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658116|NCT01592786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658117|NCT01592786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658118|NCT01592786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25658119|NCT01592786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25674276|NCT01769508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25674277|NCT01769508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674278|NCT01769586|Diphenhydramine|diphenhydramine|mesh-list
25674279|NCT01769586|Promethazine|promethazine|mesh-list
25674280|NCT01769586|Midazolam|midazolam|mesh-list
25674281|NCT01769586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25674282|NCT01769586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25674283|NCT01769586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25674284|NCT01769586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952394|NCT03894189|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24446087|NCT00303771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446088|NCT00303771|Antidotes|antidotes|mesh-ancestor
24865776|NCT04991350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990034|NCT04055116|Sensory System Agents|sensory system agents|mesh-ancestor
24990035|NCT04055116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24990036|NCT04055116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24990037|NCT04055116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24990038|NCT04055116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24990039|NCT04055116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25140088|NCT02966522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25140089|NCT02966522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140091|NCT02966522|Glucocorticoids|glucocorticoids|mesh-ancestor
24990040|NCT04055116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831748|NCT00007995|Cyclophosphamide|cyclophosphamide|mesh-list
25831749|NCT00007995|Melphalan|melphalan|mesh-list
24990041|NCT04045795|Dexamethasone|dexamethasone|mesh-list
24990042|NCT04045795|Pomalidomide|pomalidomide|mesh-list
24990043|NCT04045795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24990044|NCT04045795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24990045|NCT04045795|Antiemetics|antiemetics|mesh-ancestor
24990046|NCT04045795|Autonomic Agents|autonomic agents|mesh-ancestor
24990047|NCT04045795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24990067|NCT04040946|Choline|choline|mesh-list
24990095|NCT03703050|Nivolumab|nivolumab|mesh-list
24813835|NCT02060604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25140110|NCT02966587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25140111|NCT02966587|Immunologic Factors|immunologic factors|mesh-ancestor
25140112|NCT02966587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531660|NCT00636896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24531661|NCT00636896|Serotonin Agents|serotonin agents|mesh-ancestor
24531662|NCT00636896|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24531663|NCT00636896|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24531664|NCT00636896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24531665|NCT00636896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24531666|NCT00636909|Cyclosporine|cyclosporine|mesh-list
24531667|NCT00636909|Cyclophosphamide|cyclophosphamide|mesh-list
24531668|NCT00636909|Methotrexate|methotrexate|mesh-list
24531669|NCT00636909|Fludarabine|fludarabine|mesh-list
24531670|NCT00636909|Cyclosporins|cyclosporins|mesh-list
24531671|NCT00636909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24531672|NCT00636909|Immunologic Factors|immunologic factors|mesh-ancestor
24531673|NCT00636909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531682|NCT00636909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24990096|NCT03703050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25140128|NCT02966665|Ranitidine|ranitidine|mesh-list
24990097|NCT03703050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990098|NCT03703050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24990099|NCT03703050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990100|NCT03693300|Durvalumab|durvalumab|mesh-list
24990101|NCT03693300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24990102|NCT03693300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990103|NCT03678883|Gemcitabine|gemcitabine|mesh-list
24990104|NCT03678883|Paclitaxel|paclitaxel|mesh-list
25140145|NCT02966665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25140146|NCT02966665|Vitamin B Complex|vitamin b complex|mesh-ancestor
25140147|NCT02966665|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25140148|NCT02966665|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25674285|NCT01769586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25674286|NCT01769586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25674287|NCT01769586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25674288|NCT01769586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25053944|NCT00002411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053945|NCT00002411|Antiviral Agents|antiviral agents|mesh-ancestor
24808258|NCT02025998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24865836|NCT04891991|Dermatologic Agents|dermatologic agents|mesh-ancestor
24865837|NCT04891991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24865838|NCT04891991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24865839|NCT04777851|Nivolumab|nivolumab|mesh-list
24865840|NCT04777851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25831750|NCT00007995|Busulfan|busulfan|mesh-list
25831751|NCT00007995|Sargramostim|sargramostim|mesh-list
25831752|NCT00007995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25831753|NCT00007995|Immunologic Factors|immunologic factors|mesh-ancestor
25053983|NCT00002240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25053984|NCT00002240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25053985|NCT00002240|Protease Inhibitors|protease inhibitors|mesh-ancestor
25053986|NCT00002240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25140149|NCT02966665|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25140150|NCT02966665|Histamine Antagonists|histamine antagonists|mesh-ancestor
25140151|NCT02966665|Histamine Agents|histamine agents|mesh-ancestor
25658121|NCT01592851|Tin Fluorides|tin fluorides|mesh-list
25831754|NCT00007995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831755|NCT00007995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25658122|NCT01592851|Fluorophosphate|fluorophosphate|mesh-list
25140152|NCT02966665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24548242|NCT00708565|Vasodilator Agents|vasodilator agents|mesh-ancestor
24548244|NCT00708578|Insulin Glargine|insulin glargine|mesh-list
24548245|NCT00708578|Glimepiride|glimepiride|mesh-list
24548246|NCT00708578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24548247|NCT00708578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548248|NCT00708578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24990105|NCT03678883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24990106|NCT03678883|Carboplatin|carboplatin|mesh-list
24990107|NCT03678883|Doxorubicin|doxorubicin|mesh-list
24990108|NCT03678883|Irinotecan|irinotecan|mesh-list
24797111|NCT01953952|Cisplatin|cisplatin|mesh-list
24797112|NCT01953952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797113|NCT01953978|Acetaminophen|acetaminophen|mesh-list
24797114|NCT01953978|Dexamethasone|dexamethasone|mesh-list
24531683|NCT00636909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24531684|NCT00636909|Antimetabolites|antimetabolites|mesh-ancestor
24531685|NCT00636909|Dermatologic Agents|dermatologic agents|mesh-ancestor
24531686|NCT00636909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24531720|NCT00636935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531721|NCT00636935|Antimalarials|antimalarials|mesh-ancestor
24531722|NCT00636935|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24531723|NCT00636935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24531724|NCT00636935|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24531779|NCT00637143|Cyclosporine|cyclosporine|mesh-list
24531781|NCT00637143|Cyclosporins|cyclosporins|mesh-list
24531782|NCT00637143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24531783|NCT00637143|Immunologic Factors|immunologic factors|mesh-ancestor
24531784|NCT00637143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531785|NCT00637143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24531786|NCT00637143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24531787|NCT00637143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140153|NCT02966665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25658123|NCT01592851|Cariostatic Agents|cariostatic agents|mesh-ancestor
25658124|NCT01592851|Protective Agents|protective agents|mesh-ancestor
25658125|NCT01592851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658126|NCT01592864|Fluorides|fluorides|mesh-list
25658127|NCT01592864|Tin Fluorides|tin fluorides|mesh-list
25658128|NCT01592864|Fluorophosphate|fluorophosphate|mesh-list
25658129|NCT01592864|Cariostatic Agents|cariostatic agents|mesh-ancestor
25658130|NCT01592864|Protective Agents|protective agents|mesh-ancestor
25658131|NCT01592864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658132|NCT01593020|Paclitaxel|paclitaxel|mesh-list
25658133|NCT01593020|Cyclophosphamide|cyclophosphamide|mesh-list
25658134|NCT01593020|Doxorubicin|doxorubicin|mesh-list
25658135|NCT01593020|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25658136|NCT01593020|Fluorouracil|fluorouracil|mesh-list
25658137|NCT01593020|Epirubicin|epirubicin|mesh-list
25658138|NCT01593020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25658139|NCT01593020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658140|NCT01593020|Tubulin Modulators|tubulin modulators|mesh-ancestor
25658141|NCT01593020|Antimitotic Agents|antimitotic agents|mesh-ancestor
25140154|NCT02966665|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25140155|NCT02966665|Vasodilator Agents|vasodilator agents|mesh-ancestor
24545790|NCT00694967|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
24545791|NCT00694967|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
24545792|NCT00694967|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24545793|NCT00694967|Hormone Antagonists|hormone antagonists|mesh-ancestor
24545796|NCT00694967|Progestins|progestins|mesh-ancestor
25140156|NCT02966665|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25140157|NCT02966665|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25140158|NCT02966665|Protease Inhibitors|protease inhibitors|mesh-ancestor
25140159|NCT02966665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25140160|NCT02966665|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25140161|NCT02966665|Cholinergic Agents|cholinergic agents|mesh-ancestor
24990113|NCT03678883|Antimitotic Agents|antimitotic agents|mesh-ancestor
25140162|NCT02966665|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25140163|NCT02966665|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25140166|NCT02966743|Dexmedetomidine|dexmedetomidine|mesh-list
25831756|NCT00007995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24797117|NCT01953978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24797118|NCT01953978|Antiemetics|antiemetics|mesh-ancestor
24797119|NCT01953978|Autonomic Agents|autonomic agents|mesh-ancestor
24797120|NCT01953978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24590626|NCT00913341|GABA Agents|gaba agents|mesh-ancestor
24797121|NCT01953978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797122|NCT01953978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24797123|NCT01953978|Glucocorticoids|glucocorticoids|mesh-ancestor
24797124|NCT01953978|Hormones|hormones|mesh-ancestor
24797125|NCT01953978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24797126|NCT01953978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24797127|NCT01953978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797128|NCT01953978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24785319|NCT01913444|Protease Inhibitors|protease inhibitors|mesh-ancestor
24785320|NCT01913444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24785321|NCT01913444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785322|NCT01913444|Anticoagulants|anticoagulants|mesh-ancestor
24785323|NCT01913691|Ipilimumab|ipilimumab|mesh-list
24785324|NCT01913691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24785325|NCT01913691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24785326|NCT01913691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24785327|NCT01913691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785328|NCT01913808|Iron|iron|mesh-list
24785329|NCT01913808|Glycine|glycine|mesh-list
24785330|NCT01913808|Trace Elements|trace elements|mesh-ancestor
24785331|NCT01913808|Micronutrients|micronutrients|mesh-ancestor
24785332|NCT01913808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785334|NCT01913808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24785335|NCT01913808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785336|NCT01913834|Teriparatide|teriparatide|mesh-list
25140178|NCT02966743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25140180|NCT02966743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24531791|NCT00637143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24531792|NCT00637182|Anastrozole|anastrozole|mesh-list
24531793|NCT00637182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24797129|NCT01953978|Narcotics|narcotics|mesh-ancestor
24797130|NCT01953978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24797131|NCT01953978|Analgesics|analgesics|mesh-ancestor
24797132|NCT01953978|Sensory System Agents|sensory system agents|mesh-ancestor
24797133|NCT01953978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24797134|NCT01953978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24797135|NCT01953978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24797136|NCT01953978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24797137|NCT01953978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24797138|NCT01953978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797139|NCT01953978|Antipyretics|antipyretics|mesh-ancestor
24797140|NCT01954030|Bevacizumab|bevacizumab|mesh-list
24797141|NCT01954030|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
24797142|NCT01954030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24797143|NCT01954030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797144|NCT01954030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24797145|NCT01954030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24797146|NCT01954030|Growth Substances|growth substances|mesh-ancestor
24797147|NCT01954030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797148|NCT01954030|Growth Inhibitors|growth inhibitors|mesh-ancestor
25658142|NCT01593020|Mitosis Modulators|mitosis modulators|mesh-ancestor
25658143|NCT01593020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658144|NCT01593020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25658145|NCT01593020|Immunologic Factors|immunologic factors|mesh-ancestor
24797149|NCT01954030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24797150|NCT01954030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24797151|NCT01954030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140211|NCT02966288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25140212|NCT02966288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25140213|NCT02966288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25140214|NCT02966288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140215|NCT02966704|Caseins|caseins|mesh-list
25140216|NCT02966704|Chelating Agents|chelating agents|mesh-ancestor
25140217|NCT02966704|Sequestering Agents|sequestering agents|mesh-ancestor
25140218|NCT02966704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140219|NCT02966236|Tranexamic Acid|tranexamic acid|mesh-list
25140220|NCT02966236|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25140221|NCT02966236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25140223|NCT02966236|Hemostatics|hemostatics|mesh-ancestor
24797152|NCT01954030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24864083|NCT01373151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24531794|NCT00637182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531795|NCT00637182|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24531796|NCT00637182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24531797|NCT00637182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24531798|NCT00637182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531799|NCT00637182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25831757|NCT00007995|Alkylating Agents|alkylating agents|mesh-ancestor
24531811|NCT00637286|Zolmitriptan|zolmitriptan|mesh-list
24531812|NCT00637286|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24531813|NCT00637286|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24531814|NCT00637286|Serotonin Agents|serotonin agents|mesh-ancestor
24531815|NCT00637286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24531816|NCT00637286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831758|NCT00007995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831759|NCT00007995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531824|NCT00637403|Megestrol|megestrol|mesh-list
24531825|NCT00637403|Megestrol Acetate|megestrol acetate|mesh-list
24531826|NCT00637403|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24531838|NCT00637442|Galantamine|galantamine|mesh-list
24935378|NCT04051255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24797156|NCT01954043|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24797157|NCT01954043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24797158|NCT01954043|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24797159|NCT01954043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24797160|NCT01954043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797161|NCT01954043|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24797162|NCT01954043|Antitubercular Agents|antitubercular agents|mesh-ancestor
25140238|NCT02966067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140239|NCT02966041|Ondansetron|ondansetron|mesh-list
25140240|NCT02966041|Antiemetics|antiemetics|mesh-ancestor
25140241|NCT02966041|Autonomic Agents|autonomic agents|mesh-ancestor
25140242|NCT02966041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25140243|NCT02966041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140244|NCT02966041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25140245|NCT02966041|Antipruritics|antipruritics|mesh-ancestor
25140246|NCT02966041|Dermatologic Agents|dermatologic agents|mesh-ancestor
25140247|NCT02966041|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24797163|NCT01954043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25107376|NCT03140410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25107387|NCT03140358|Parasympatholytics|parasympatholytics|mesh-ancestor
25107388|NCT03140358|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25107389|NCT03140358|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25107390|NCT03140358|Cholinergic Agents|cholinergic agents|mesh-ancestor
25107391|NCT03140358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25169561|NCT01818076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046730|NCT00836069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25046731|NCT00836069|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25046732|NCT00836069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25046733|NCT00836069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046734|NCT00836056|Clindamycin|clindamycin|mesh-list
25046735|NCT00836056|Clindamycin palmitate|clindamycin palmitate|mesh-list
25046736|NCT00836056|Clindamycin phosphate|clindamycin phosphate|mesh-list
24815468|NCT02070458|Ixazomib|ixazomib|mesh-list
24548391|NCT00709332|Estradiol|estradiol|mesh-list
24868437|NCT04774250|Anticonvulsants|anticonvulsants|mesh-ancestor
24868438|NCT04774250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24868439|NCT04774250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25408578|NCT03434379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808429|NCT02027220|Immunologic Factors|immunologic factors|mesh-ancestor
24808430|NCT02027220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808431|NCT02027220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24808432|NCT02027220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24808433|NCT02027220|Alkylating Agents|alkylating agents|mesh-ancestor
24808434|NCT02027220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865906|NCT04556370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865907|NCT04556370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865908|NCT04556370|Sympathomimetics|sympathomimetics|mesh-ancestor
24868440|NCT04774250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868443|NCT04768569|Zonisamide|zonisamide|mesh-list
25107392|NCT03140358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107394|NCT03140293|Ethyl Chloride|ethyl chloride|mesh-list
25107395|NCT03140293|Anesthetics, Local|anesthetics, local|mesh-ancestor
24797164|NCT01954043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24797165|NCT01954043|Leprostatic Agents|leprostatic agents|mesh-ancestor
24797166|NCT01954043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24797167|NCT01954043|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24797168|NCT01954043|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24927934|NCT04128020|Nivolumab|nivolumab|mesh-list
24990109|NCT03678883|Lomustine|lomustine|mesh-list
24990110|NCT03678883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24990111|NCT03678883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990112|NCT03678883|Tubulin Modulators|tubulin modulators|mesh-ancestor
24990117|NCT03678883|Antimetabolites|antimetabolites|mesh-ancestor
24990118|NCT03678883|Antiviral Agents|antiviral agents|mesh-ancestor
24990119|NCT03678883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24990120|NCT03678883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24990121|NCT03678883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24990122|NCT03678883|Immunologic Factors|immunologic factors|mesh-ancestor
24990123|NCT03678883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990124|NCT03678883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24990125|NCT03678883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24990126|NCT03678883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24990127|NCT03678883|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24990128|NCT03678883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24990129|NCT03678883|Alkylating Agents|alkylating agents|mesh-ancestor
24544085|NCT00687011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24864144|NCT00602667|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24864145|NCT00602667|Topotecan|topotecan|mesh-list
24864146|NCT00602667|Vinblastine|vinblastine|mesh-list
24864148|NCT00602667|Immunologic Factors|immunologic factors|mesh-ancestor
25831760|NCT00007995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25831761|NCT00007995|Antiviral Agents|antiviral agents|mesh-ancestor
25831762|NCT00007995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25831763|NCT00008008|Cyclophosphamide|cyclophosphamide|mesh-list
25831764|NCT00008008|Thiotepa|thiotepa|mesh-list
25831765|NCT00008008|Sargramostim|sargramostim|mesh-list
24531844|NCT00637442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531845|NCT00637442|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24531846|NCT00637442|Autonomic Agents|autonomic agents|mesh-ancestor
24531847|NCT00637442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24531848|NCT00637442|Nootropic Agents|nootropic agents|mesh-ancestor
24531849|NCT00637455|Fexofenadine|fexofenadine|mesh-list
24531850|NCT00637455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24990146|NCT03654768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990147|NCT03610711|Nivolumab|nivolumab|mesh-list
24990148|NCT03610711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24990149|NCT03610711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990150|NCT03610711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24990151|NCT03610711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990152|NCT03604874|Oxytocin|oxytocin|mesh-list
25163036|NCT02900430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25658146|NCT01593020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658147|NCT01593020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25658148|NCT01593020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25658149|NCT01593020|Alkylating Agents|alkylating agents|mesh-ancestor
25658150|NCT01593020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25658151|NCT01593020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25658152|NCT01593020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25658153|NCT01593020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25658154|NCT01593020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658155|NCT01593020|Antimetabolites|antimetabolites|mesh-ancestor
25831766|NCT00008008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25831767|NCT00008008|Immunologic Factors|immunologic factors|mesh-ancestor
25831768|NCT00008008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408903|NCT00180037|Ubiquinone|ubiquinone|mesh-list
24990153|NCT03604874|Oxytocics|oxytocics|mesh-ancestor
24990154|NCT03604874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25140286|NCT02965859|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25140287|NCT02965859|Antiviral Agents|antiviral agents|mesh-ancestor
25140288|NCT02965859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25140289|NCT02965859|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25140290|NCT02965859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24990155|NCT03604874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990156|NCT03584152|Acetaminophen|acetaminophen|mesh-list
24990157|NCT03584152|Ibuprofen|ibuprofen|mesh-list
24990158|NCT03584152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24990159|NCT03584152|Analgesics|analgesics|mesh-ancestor
24990160|NCT03584152|Sensory System Agents|sensory system agents|mesh-ancestor
24990161|NCT03584152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24990162|NCT03584152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990163|NCT03584152|Antipyretics|antipyretics|mesh-ancestor
24990164|NCT03584152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24531860|NCT00637468|Acetazolamide|acetazolamide|mesh-list
24531861|NCT00637468|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24531862|NCT00637468|Anticoagulants|anticoagulants|mesh-ancestor
24531863|NCT00637468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24531867|NCT00637468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24531883|NCT00637468|Adrenergic Agents|adrenergic agents|mesh-ancestor
24531884|NCT00637468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24531885|NCT00637481|Atorvastatin|atorvastatin|mesh-list
24531886|NCT00637481|Calcium|calcium|mesh-list
24990166|NCT03584152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24990167|NCT03584152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24990168|NCT03584152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24990169|NCT03584152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990170|NCT03575572|Colchicine|colchicine|mesh-list
24990171|NCT03575572|Gout Suppressants|gout suppressants|mesh-ancestor
24990172|NCT03575572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24990173|NCT03575572|Tubulin Modulators|tubulin modulators|mesh-ancestor
24990174|NCT03575572|Antimitotic Agents|antimitotic agents|mesh-ancestor
24990182|NCT03557359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927943|NCT04127721|Methotrexate|methotrexate|mesh-list
24990183|NCT03531645|Fulvestrant|fulvestrant|mesh-list
24990184|NCT03531645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24990185|NCT03531645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990186|NCT03531645|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24990187|NCT03531645|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24990188|NCT03531645|Hormone Antagonists|hormone antagonists|mesh-ancestor
24990189|NCT03531645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25140309|NCT02965443|Incretins|incretins|mesh-ancestor
25140331|NCT02965196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24990190|NCT03531645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531887|NCT00637481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24531888|NCT00637481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531889|NCT00637481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24531890|NCT00637481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24531891|NCT00637481|Antimetabolites|antimetabolites|mesh-ancestor
24531894|NCT00637481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24531944|NCT00637637|Indinavir|indinavir|mesh-list
24531945|NCT00637637|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24531946|NCT00637637|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24531947|NCT00637637|Protease Inhibitors|protease inhibitors|mesh-ancestor
24531948|NCT00637637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24531949|NCT00637637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531950|NCT00637637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25140332|NCT02965196|Glucocorticoids|glucocorticoids|mesh-ancestor
24531951|NCT00637637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24531952|NCT00637637|Antiviral Agents|antiviral agents|mesh-ancestor
24531953|NCT00637637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24990191|NCT03522415|Methotrexate|methotrexate|mesh-list
24990192|NCT03522415|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24990193|NCT03522415|Abortifacient Agents|abortifacient agents|mesh-ancestor
24990194|NCT03522415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24990195|NCT03522415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990196|NCT03522415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24990197|NCT03522415|Antimetabolites|antimetabolites|mesh-ancestor
25408776|NCT03420963|Alkylating Agents|alkylating agents|mesh-ancestor
25658156|NCT01593020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24990198|NCT03522415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990199|NCT03522415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990200|NCT03522415|Dermatologic Agents|dermatologic agents|mesh-ancestor
24990201|NCT03522415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24990202|NCT03522415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24990203|NCT03522415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24990204|NCT03522415|Immunologic Factors|immunologic factors|mesh-ancestor
24990205|NCT03522415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25163037|NCT02900430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24990206|NCT03522415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24990208|NCT03521687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24990209|NCT03521687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24864214|NCT05147194|Trimetazidine|trimetazidine|mesh-list
24531974|NCT00637715|Urological Agents|urological agents|mesh-ancestor
24531975|NCT00637767|Melphalan|melphalan|mesh-list
24531976|NCT00637767|Antibodies|antibodies|mesh-list
24531977|NCT00637767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25140372|NCT02965261|Fluoxetine|fluoxetine|mesh-list
24531978|NCT00637767|Immunologic Factors|immunologic factors|mesh-ancestor
24531979|NCT00637767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531980|NCT00637767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24531981|NCT00637767|Alkylating Agents|alkylating agents|mesh-ancestor
25831769|NCT00008008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25831770|NCT00008008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25831771|NCT00008008|Alkylating Agents|alkylating agents|mesh-ancestor
24990211|NCT03521687|Sensory System Agents|sensory system agents|mesh-ancestor
24990212|NCT03521687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24990213|NCT03521687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990214|NCT03521687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24990215|NCT03521687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24990216|NCT03521687|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24990217|NCT03521687|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24990218|NCT03521687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24990219|NCT03521687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990223|NCT03498131|Melatonin|melatonin|mesh-list
24990224|NCT03498131|Antioxidants|antioxidants|mesh-ancestor
24990225|NCT03498131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990226|NCT03498131|Protective Agents|protective agents|mesh-ancestor
24990227|NCT03498131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990228|NCT03498131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24990229|NCT03410901|Antibodies|antibodies|mesh-list
24990230|NCT03410901|Immunologic Factors|immunologic factors|mesh-ancestor
24990231|NCT03410901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140412|NCT02964728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25140413|NCT02964728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140414|NCT02964728|Cholinergic Agents|cholinergic agents|mesh-ancestor
25140415|NCT02964728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25140416|NCT02964728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140417|NCT02964728|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25140418|NCT02964728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25140419|NCT02964689|Pemetrexed|pemetrexed|mesh-list
25140420|NCT02964689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25140421|NCT02964689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25140422|NCT02964689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046765|NCT00835705|Clavulanic Acids|clavulanic acids|mesh-list
25046766|NCT00835705|Clavulanic Acid|clavulanic acid|mesh-list
25046767|NCT00835705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24623262|NCT01070732|Sensory System Agents|sensory system agents|mesh-ancestor
24623263|NCT01070732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24623266|NCT01070745|Ibuprofen|ibuprofen|mesh-list
24623267|NCT01070745|Indomethacin|indomethacin|mesh-list
24813844|NCT02060656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24544142|NCT00687466|Insulin|insulin|mesh-list
25658157|NCT01593215|Yohimbine|yohimbine|mesh-list
25658158|NCT01593215|Mydriatics|mydriatics|mesh-ancestor
25658159|NCT01593215|Autonomic Agents|autonomic agents|mesh-ancestor
25658160|NCT01593215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25658161|NCT01593215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658162|NCT01593215|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25658163|NCT01593215|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25658164|NCT01593215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25658165|NCT01593215|Adrenergic Agents|adrenergic agents|mesh-ancestor
25658166|NCT01593215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25831772|NCT00008008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831773|NCT00008008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831774|NCT00008008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25831775|NCT00008021|Cyclosporine|cyclosporine|mesh-list
24531989|NCT00637793|Cholinergic Agents|cholinergic agents|mesh-ancestor
24531990|NCT00637793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24531991|NCT00637793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655080|NCT01254175|Vaccines|vaccines|mesh-list
24990239|NCT03403205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25046768|NCT00835705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24797197|NCT01954290|Natriuretic Agents|natriuretic agents|mesh-ancestor
24990245|NCT03382730|Chlorhexidine|chlorhexidine|mesh-list
24990246|NCT03382730|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24990247|NCT03382730|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24990248|NCT03382730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24990250|NCT03382730|Dermatologic Agents|dermatologic agents|mesh-ancestor
24990252|NCT03357939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24990253|NCT03357939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24927966|NCT04127396|Sorafenib|sorafenib|mesh-list
24813854|NCT02060656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24813855|NCT02060656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24813856|NCT02060656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24813857|NCT02060656|Growth Substances|growth substances|mesh-ancestor
24813858|NCT02060656|Growth Inhibitors|growth inhibitors|mesh-ancestor
25831776|NCT00008021|Paclitaxel|paclitaxel|mesh-list
25831777|NCT00008021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25046784|NCT00835666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046785|NCT00835666|Hormone Antagonists|hormone antagonists|mesh-ancestor
25046786|NCT00835666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25046787|NCT00835666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046788|NCT00835666|Urological Agents|urological agents|mesh-ancestor
25046789|NCT00835640|Fexofenadine|fexofenadine|mesh-list
25046790|NCT00835640|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25046791|NCT00835640|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25046792|NCT00835640|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24532014|NCT00637858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24532015|NCT00637858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24532016|NCT00637871|Tamoxifen|tamoxifen|mesh-list
24532017|NCT00637871|Bicalutamide|bicalutamide|mesh-list
24532018|NCT00637871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25831778|NCT00008021|Antibodies|antibodies|mesh-list
25831779|NCT00008021|Immunoglobulins|immunoglobulins|mesh-list
25831780|NCT00008021|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25831781|NCT00008021|Cyclosporins|cyclosporins|mesh-list
25831782|NCT00008021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25831783|NCT00008021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831784|NCT00008021|Tubulin Modulators|tubulin modulators|mesh-ancestor
25831785|NCT00008021|Antimitotic Agents|antimitotic agents|mesh-ancestor
25831786|NCT00008021|Mitosis Modulators|mitosis modulators|mesh-ancestor
25831787|NCT00008021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831788|NCT00008021|Immunologic Factors|immunologic factors|mesh-ancestor
25831789|NCT00008021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046806|NCT00835588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046807|NCT00835575|Mirtazapine|mirtazapine|mesh-list
24990304|NCT03306901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990305|NCT03306901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24990306|NCT03306901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24990308|NCT03306901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990309|NCT03256045|Dexamethasone|dexamethasone|mesh-list
24990310|NCT03256045|Dexamethasone acetate|dexamethasone acetate|mesh-list
24990311|NCT03256045|Panobinostat|panobinostat|mesh-list
24990323|NCT03256045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24785338|NCT01913834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785339|NCT01913834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24785341|NCT01913847|Vasodilator Agents|vasodilator agents|mesh-ancestor
24785342|NCT01913847|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25140484|NCT02963896|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25140485|NCT02963896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25140486|NCT02963896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140487|NCT02963402|Adalimumab|adalimumab|mesh-list
25140488|NCT02963402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25140489|NCT02963402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25140490|NCT02963454|Simendan|simendan|mesh-list
25140491|NCT02963454|Dobutamine|dobutamine|mesh-list
25831790|NCT00008021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866034|NCT03817554|Dopamine|dopamine|mesh-list
24866035|NCT03817554|Pramipexole|pramipexole|mesh-list
24866036|NCT03817554|Dopamine Agonists|dopamine agonists|mesh-list
24866037|NCT03817554|Antioxidants|antioxidants|mesh-ancestor
25054276|NCT03530462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054281|NCT03530462|Antiemetics|antiemetics|mesh-ancestor
24785343|NCT01913847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24785344|NCT01913847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24785345|NCT01913847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785346|NCT01913847|Urological Agents|urological agents|mesh-ancestor
24785347|NCT01913860|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24785348|NCT01913860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24852041|NCT02260037|Epinastine|epinastine|mesh-list
24990331|NCT03228693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24928041|NCT04127227|Gemcitabine|gemcitabine|mesh-list
24990332|NCT03228693|Glucocorticoids|glucocorticoids|mesh-ancestor
24990333|NCT03228693|Hormones|hormones|mesh-ancestor
24864242|NCT05118308|Liver Extracts|liver extracts|mesh-list
25831791|NCT00008021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24532019|NCT00637871|Hormone Antagonists|hormone antagonists|mesh-ancestor
24532103|NCT00637988|Sensory System Agents|sensory system agents|mesh-ancestor
24532104|NCT00637988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25831792|NCT00008021|Antifungal Agents|antifungal agents|mesh-ancestor
24532105|NCT00637988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532106|NCT00637988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24532107|NCT00637988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24532108|NCT00637988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24532129|NCT00638066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24532130|NCT00638079|Megestrol|megestrol|mesh-list
24532131|NCT00638079|Megestrol Acetate|megestrol acetate|mesh-list
25831793|NCT00008021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24532139|NCT00638079|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24532140|NCT00638079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24532141|NCT00638079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24532142|NCT00638079|Appetite Stimulants|appetite stimulants|mesh-ancestor
24532143|NCT00638079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24532144|NCT00638118|Fexofenadine|fexofenadine|mesh-list
24532145|NCT00638118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24532146|NCT00638118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24532147|NCT00638118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24990334|NCT03228693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24990335|NCT03228693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990336|NCT03186456|Aspirin|aspirin|mesh-list
24990337|NCT03186456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24990338|NCT03186456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24990339|NCT03186456|Analgesics|analgesics|mesh-ancestor
24990340|NCT03186456|Sensory System Agents|sensory system agents|mesh-ancestor
24797169|NCT01954043|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24797170|NCT01954043|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24797171|NCT01954043|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24797172|NCT01954043|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24797173|NCT01954043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797174|NCT01954043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24797175|NCT01954108|Hyaluronic Acid|hyaluronic acid|mesh-list
24797176|NCT01954108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24797177|NCT01954108|Immunologic Factors|immunologic factors|mesh-ancestor
24797178|NCT01954108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797179|NCT01954108|Viscosupplements|viscosupplements|mesh-ancestor
24797180|NCT01954108|Protective Agents|protective agents|mesh-ancestor
24797182|NCT01954186|Oxytocics|oxytocics|mesh-ancestor
24797183|NCT01954186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24532148|NCT00638118|Histamine Antagonists|histamine antagonists|mesh-ancestor
24532149|NCT00638118|Histamine Agents|histamine agents|mesh-ancestor
24532150|NCT00638118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24532151|NCT00638118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532152|NCT00638118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532153|NCT00638131|Bosentan|bosentan|mesh-list
24532154|NCT00638131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24532182|NCT00638391|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25658167|NCT01593215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658168|NCT01593215|Urological Agents|urological agents|mesh-ancestor
25658169|NCT01593592|Amoxicillin|amoxicillin|mesh-list
25658170|NCT01593592|Clarithromycin|clarithromycin|mesh-list
25658171|NCT01593592|Omeprazole|omeprazole|mesh-list
25658172|NCT01593592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25658173|NCT01593592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25658174|NCT01593592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25658175|NCT01593592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24937528|NCT04027972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24937529|NCT04027972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937530|NCT04027972|Cholinergic Agents|cholinergic agents|mesh-ancestor
24937531|NCT04027972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24937532|NCT04027972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937533|NCT04027972|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24937534|NCT04027972|Autonomic Agents|autonomic agents|mesh-ancestor
24937535|NCT04027972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937536|NCT04027972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25054303|NCT03530436|Antioxidants|antioxidants|mesh-ancestor
25201149|NCT02729766|Empagliflozin|empagliflozin|mesh-list
25054304|NCT03530436|Protective Agents|protective agents|mesh-ancestor
24532183|NCT00638391|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24532184|NCT00638391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532185|NCT00638391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140542|NCT02963181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140543|NCT02963181|Protective Agents|protective agents|mesh-ancestor
25140544|NCT02963181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140545|NCT02963181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25140546|NCT02963181|Mydriatics|mydriatics|mesh-ancestor
25140547|NCT02963181|Autonomic Agents|autonomic agents|mesh-ancestor
25140548|NCT02963181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25140549|NCT02963181|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25140550|NCT02963181|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24797184|NCT01954186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797185|NCT01954238|Rivaroxaban|rivaroxaban|mesh-list
24797186|NCT01954238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24797187|NCT01954238|Antithrombins|antithrombins|mesh-ancestor
24797188|NCT01954238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24797189|NCT01954238|Protease Inhibitors|protease inhibitors|mesh-ancestor
24797190|NCT01954238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590698|NCT00913588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24797191|NCT01954238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797192|NCT01954238|Anticoagulants|anticoagulants|mesh-ancestor
24797193|NCT01954290|Mannitol|mannitol|mesh-list
24797194|NCT01954290|Conivaptan|conivaptan|mesh-list
24797195|NCT01954290|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24797196|NCT01954290|Diuretics|diuretics|mesh-ancestor
25107396|NCT03140293|Anesthetics|anesthetics|mesh-ancestor
24797198|NCT01954290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107397|NCT03140293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25107398|NCT03140293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107399|NCT03140293|Sensory System Agents|sensory system agents|mesh-ancestor
25107400|NCT03140293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25107401|NCT03140293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25107402|NCT03140293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25107403|NCT03140293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25107404|NCT03140293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24544231|NCT00687999|Interferons|interferons|mesh-list
24532186|NCT00638391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24532187|NCT00638391|Hormone Antagonists|hormone antagonists|mesh-ancestor
24532188|NCT00638391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24532189|NCT00638391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532190|NCT00638482|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24532191|NCT00638482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24532227|NCT00638729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24532229|NCT00638729|Anesthetics|anesthetics|mesh-ancestor
24532230|NCT00638729|GABA Modulators|gaba modulators|mesh-ancestor
24532280|NCT00639015|Norepinephrine|norepinephrine|mesh-list
25658176|NCT01593592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25658177|NCT01593592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658178|NCT01593592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658179|NCT01593592|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25658180|NCT01593592|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25658181|NCT01593592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25658182|NCT01593670|Decitabine|decitabine|mesh-list
25658183|NCT01593670|Interleukin-2|interleukin-2|mesh-list
25658184|NCT01593670|Vorinostat|vorinostat|mesh-list
25658185|NCT01593670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25658186|NCT01593670|Antimetabolites|antimetabolites|mesh-ancestor
25674289|NCT01769586|Anesthetics, General|anesthetics, general|mesh-ancestor
24532281|NCT00639015|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24532282|NCT00639015|Mydriatics|mydriatics|mesh-ancestor
24532283|NCT00639015|Autonomic Agents|autonomic agents|mesh-ancestor
25046811|NCT00835575|Histamine Antagonists|histamine antagonists|mesh-ancestor
25046812|NCT00835575|Histamine Agents|histamine agents|mesh-ancestor
25046813|NCT00835575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25046814|NCT00835575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046815|NCT00835575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046816|NCT00835575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24871089|NCT05145101|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24871090|NCT05145101|Immunologic Factors|immunologic factors|mesh-ancestor
24871091|NCT05145101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532284|NCT00639015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24532285|NCT00639015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107405|NCT03140293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107407|NCT03140332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797199|NCT01954290|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24797200|NCT01954290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797201|NCT01954355|Paclitaxel|paclitaxel|mesh-list
25046817|NCT00835575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25046818|NCT00835575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25046819|NCT00835575|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25046821|NCT00835575|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25046822|NCT00835575|Adrenergic Agents|adrenergic agents|mesh-ancestor
24817551|NCT02084472|Glycerol|glycerol|mesh-list
24871513|NCT01633541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871515|NCT01322971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24871516|NCT01322971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24871517|NCT01322971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24871518|NCT01322971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24871519|NCT01285102|Irinotecan|irinotecan|mesh-list
24814855|NCT02067078|Epinephrine|epinephrine|mesh-list
24871533|NCT00424099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24814856|NCT02067078|Racepinephrine|racepinephrine|mesh-list
24814857|NCT02067078|Ropivacaine|ropivacaine|mesh-list
24871534|NCT00424099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24871663|NCT05153590|Incretins|incretins|mesh-ancestor
24871664|NCT05153590|Hormones|hormones|mesh-ancestor
24871665|NCT05153590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24871666|NCT05153135|Palbociclib|palbociclib|mesh-list
24871667|NCT05153135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871668|NCT05153135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24871669|NCT05153135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24871670|NCT05153135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871671|NCT05146479|Fluorides|fluorides|mesh-list
24871732|NCT04952857|Vitamin D|vitamin d|mesh-list
24871733|NCT04952857|Cholecalciferol|cholecalciferol|mesh-list
24871734|NCT04952857|Vitamins|vitamins|mesh-ancestor
24871735|NCT04952857|Micronutrients|micronutrients|mesh-ancestor
24797202|NCT01954355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24797203|NCT01954355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797204|NCT01954355|Tubulin Modulators|tubulin modulators|mesh-ancestor
24797205|NCT01954355|Antimitotic Agents|antimitotic agents|mesh-ancestor
24797206|NCT01954355|Mitosis Modulators|mitosis modulators|mesh-ancestor
24864307|NCT04948463|Ciprofloxacin|ciprofloxacin|mesh-list
24864308|NCT04948463|Tazobactam|tazobactam|mesh-list
24864309|NCT04948463|Piperacillin|piperacillin|mesh-list
24864310|NCT04948463|Amikacin|amikacin|mesh-list
24864311|NCT04948463|Ceftazidime|ceftazidime|mesh-list
24864312|NCT04948463|Cefepime|cefepime|mesh-list
24864313|NCT04948463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24532286|NCT00639015|Sympathomimetics|sympathomimetics|mesh-ancestor
24532287|NCT00639015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24532288|NCT00639015|Nasal Decongestants|nasal decongestants|mesh-ancestor
25831794|NCT00008021|Dermatologic Agents|dermatologic agents|mesh-ancestor
24532289|NCT00639015|Respiratory System Agents|respiratory system agents|mesh-ancestor
24532290|NCT00639015|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24532319|NCT00639327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046823|NCT00835575|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25046824|NCT00835575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25046825|NCT00835575|Serotonin Agents|serotonin agents|mesh-ancestor
25046826|NCT00835575|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24532320|NCT00639327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24532321|NCT00639366|Trastuzumab|trastuzumab|mesh-list
24532322|NCT00639366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24532323|NCT00639366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24532324|NCT00639392|Zoledronic Acid|zoledronic acid|mesh-list
25054375|NCT03530085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25054376|NCT03530085|Immunologic Factors|immunologic factors|mesh-ancestor
25054377|NCT03530085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054378|NCT03530085|Alkylating Agents|alkylating agents|mesh-ancestor
25054379|NCT03530085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24532325|NCT00639392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24532326|NCT00639392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532327|NCT00639483|Celecoxib|celecoxib|mesh-list
24532328|NCT00639483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24532329|NCT00639483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24532330|NCT00639483|Analgesics|analgesics|mesh-ancestor
24532331|NCT00639483|Sensory System Agents|sensory system agents|mesh-ancestor
24532332|NCT00639483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24532333|NCT00639483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532334|NCT00639483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24532335|NCT00639483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24532336|NCT00639483|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24532337|NCT00639483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24532338|NCT00639483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532377|NCT00639587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532378|NCT00639587|Antipruritics|antipruritics|mesh-ancestor
25140603|NCT02962986|Phenylephrine|phenylephrine|mesh-list
24532379|NCT00639587|Dermatologic Agents|dermatologic agents|mesh-ancestor
24532380|NCT00639691|Omalizumab|omalizumab|mesh-list
24532381|NCT00639691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24532382|NCT00639691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24532383|NCT00639691|Respiratory System Agents|respiratory system agents|mesh-ancestor
25831795|NCT00008021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24532432|NCT00639938|gamma-Globulins|gamma-globulins|mesh-list
24797212|NCT01954368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797214|NCT01954368|Sensory System Agents|sensory system agents|mesh-ancestor
24797215|NCT01954368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24797216|NCT01954368|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24797217|NCT01954368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24797218|NCT01954368|Anesthetics, General|anesthetics, general|mesh-ancestor
24797219|NCT01954368|Anesthetics|anesthetics|mesh-ancestor
24797220|NCT01954524|Sildenafil Citrate|sildenafil citrate|mesh-list
24797221|NCT01954524|Vasodilator Agents|vasodilator agents|mesh-ancestor
24797222|NCT01954524|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24797223|NCT01954524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24797224|NCT01954524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864323|NCT04939363|Venetoclax|venetoclax|mesh-list
24532437|NCT00639938|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24532438|NCT00639938|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24532439|NCT00639938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532440|NCT00639938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532441|NCT00639938|Antiviral Agents|antiviral agents|mesh-ancestor
24532442|NCT00639938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24532443|NCT00639938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24532444|NCT00639938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24532445|NCT00639938|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24532446|NCT00639938|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24532448|NCT00640003|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24532449|NCT00640003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532450|NCT00640003|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24532451|NCT00640003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24532452|NCT00640003|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24532453|NCT00640003|GABA Agonists|gaba agonists|mesh-ancestor
24532454|NCT00640003|GABA Agents|gaba agents|mesh-ancestor
24532455|NCT00640003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24532456|NCT00640003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532457|NCT00640029|Meloxicam|meloxicam|mesh-list
25202931|NCT02717871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24532470|NCT00640081|Leucovorin|leucovorin|mesh-list
24532471|NCT00640081|Fluorouracil|fluorouracil|mesh-list
24532472|NCT00640081|Capecitabine|capecitabine|mesh-list
25050110|NCT00540358|Antimetabolites|antimetabolites|mesh-ancestor
24532473|NCT00640081|Oxaliplatin|oxaliplatin|mesh-list
24532474|NCT00640081|Cetuximab|cetuximab|mesh-list
24532475|NCT00640081|Calcium|calcium|mesh-list
25658187|NCT01593670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658188|NCT01593670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658189|NCT01593670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658190|NCT01593670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25658191|NCT01593670|Analgesics|analgesics|mesh-ancestor
24532476|NCT00640081|Levoleucovorin|levoleucovorin|mesh-list
25408857|NCT03415828|Prednisolone acetate|prednisolone acetate|mesh-list
24787497|NCT01925638|Ketoconazole|ketoconazole|mesh-list
24532477|NCT00640081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24532479|NCT00640081|Antimetabolites|antimetabolites|mesh-ancestor
24532483|NCT00640081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24532485|NCT00640081|Antidotes|antidotes|mesh-ancestor
24532486|NCT00640081|Protective Agents|protective agents|mesh-ancestor
24532487|NCT00640081|Vitamin B Complex|vitamin b complex|mesh-ancestor
24532611|NCT00640588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24532612|NCT00640588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532613|NCT00640588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532615|NCT00640627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24532616|NCT00640627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24797225|NCT01954524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797226|NCT01954524|Urological Agents|urological agents|mesh-ancestor
24797227|NCT01954693|Everolimus|everolimus|mesh-list
24797228|NCT01954693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797229|NCT01954693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24532626|NCT00640627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532627|NCT00640640|Bevacizumab|bevacizumab|mesh-list
24532628|NCT00640640|Ranibizumab|ranibizumab|mesh-list
24532629|NCT00640640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24532661|NCT00640744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532662|NCT00640744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24532663|NCT00640744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24532664|NCT00640744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532665|NCT00640796|Aldesleukin|aldesleukin|mesh-list
24532666|NCT00640796|Cyclophosphamide|cyclophosphamide|mesh-list
24532667|NCT00640796|Fludarabine|fludarabine|mesh-list
24532668|NCT00640796|Interleukin-2|interleukin-2|mesh-list
24532669|NCT00640796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24532670|NCT00640796|Immunologic Factors|immunologic factors|mesh-ancestor
24532687|NCT00640809|Celecoxib|celecoxib|mesh-list
24532700|NCT00640809|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24532701|NCT00640809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24532702|NCT00640809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24532703|NCT00640809|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24532704|NCT00640861|Vaccines|vaccines|mesh-list
24532705|NCT00640861|Sargramostim|sargramostim|mesh-list
24532706|NCT00640861|Freund's Adjuvant|freund's adjuvant|mesh-list
24532707|NCT00640861|Immunologic Factors|immunologic factors|mesh-ancestor
24532708|NCT00640861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532709|NCT00640861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24990346|NCT03186456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24532721|NCT00640887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24532722|NCT00640887|Antiviral Agents|antiviral agents|mesh-ancestor
24532723|NCT00640887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25140684|NCT02962258|Diuretics|diuretics|mesh-ancestor
25140685|NCT02962258|Natriuretic Agents|natriuretic agents|mesh-ancestor
25140686|NCT02962258|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25140687|NCT02962492|Dapagliflozin|dapagliflozin|mesh-list
25140688|NCT02962492|Exenatide|exenatide|mesh-list
25140689|NCT02962492|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24532724|NCT00640887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24532725|NCT00640887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24532726|NCT00640887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24532727|NCT00640887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24532728|NCT00640887|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24532729|NCT00640887|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25831796|NCT00008021|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24990370|NCT03176498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24990371|NCT03176498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24990372|NCT03176498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990373|NCT03176498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24990379|NCT03176498|Antimetabolites|antimetabolites|mesh-ancestor
24990380|NCT03176498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24990381|NCT03176498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24990382|NCT03149107|Acetylcysteine|acetylcysteine|mesh-list
24990383|NCT03149107|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24990384|NCT03149107|Antiviral Agents|antiviral agents|mesh-ancestor
25202932|NCT02717871|Glucocorticoids|glucocorticoids|mesh-ancestor
24990385|NCT03149107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24820772|NCT02101567|Oxytocin|oxytocin|mesh-list
24990386|NCT03149107|Expectorants|expectorants|mesh-ancestor
24990387|NCT03149107|Respiratory System Agents|respiratory system agents|mesh-ancestor
25674290|NCT01769586|Anesthetics|anesthetics|mesh-ancestor
25831797|NCT00008034|Cyclophosphamide|cyclophosphamide|mesh-list
25831799|NCT00008034|Epirubicin|epirubicin|mesh-list
25658192|NCT01593670|Sensory System Agents|sensory system agents|mesh-ancestor
25658193|NCT01593670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25054460|NCT03529643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25054461|NCT03529643|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24808772|NCT02029105|Hyaluronic Acid|hyaluronic acid|mesh-list
25207722|NCT03479502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25831800|NCT00008034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25831801|NCT00008034|Immunologic Factors|immunologic factors|mesh-ancestor
25831802|NCT00008034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990388|NCT03149107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24990389|NCT03149107|Antioxidants|antioxidants|mesh-ancestor
24990390|NCT03149107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990391|NCT03149107|Protective Agents|protective agents|mesh-ancestor
24990392|NCT03149107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544282|NCT00688298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544283|NCT00688298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544284|NCT00688363|Chrysarobin|chrysarobin|mesh-list
25831803|NCT00008034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25831804|NCT00008034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24532875|NCT00641446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24532876|NCT00641446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532877|NCT00641446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24532878|NCT00641446|Respiratory System Agents|respiratory system agents|mesh-ancestor
24990393|NCT03149107|Antidotes|antidotes|mesh-ancestor
24990394|NCT03135301|Metformin|metformin|mesh-list
24990395|NCT03135301|Letrozole|letrozole|mesh-list
24990396|NCT03135301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24990397|NCT03135301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990398|NCT03135301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990399|NCT03135301|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24990400|NCT03135301|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24990401|NCT03135301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24990402|NCT03135301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990403|NCT03135301|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24990404|NCT03135301|Hormone Antagonists|hormone antagonists|mesh-ancestor
24990405|NCT03135301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24990406|NCT03117010|Dexamethasone|dexamethasone|mesh-list
24990407|NCT03117010|Etoposide|etoposide|mesh-list
24990408|NCT03117010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24990409|NCT03117010|Antiemetics|antiemetics|mesh-ancestor
24990410|NCT03117010|Autonomic Agents|autonomic agents|mesh-ancestor
24990411|NCT03117010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24990412|NCT03117010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990413|NCT03117010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24990414|NCT03117010|Glucocorticoids|glucocorticoids|mesh-ancestor
24990415|NCT03117010|Hormones|hormones|mesh-ancestor
24990484|NCT02966119|Purinergic Agents|purinergic agents|mesh-ancestor
24990485|NCT02966119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24990492|NCT02870738|Triamcinolone|triamcinolone|mesh-list
25140774|NCT02961998|Celecoxib|celecoxib|mesh-list
24990493|NCT02870738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24990494|NCT02870738|Glucocorticoids|glucocorticoids|mesh-ancestor
25202933|NCT02717871|Hormones|hormones|mesh-ancestor
24990495|NCT02870738|Hormones|hormones|mesh-ancestor
24990504|NCT02859896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990506|NCT02859896|Vitamins|vitamins|mesh-ancestor
24797234|NCT01954732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797235|NCT01954784|Cyclosporine|cyclosporine|mesh-list
24797236|NCT01954784|Mycophenolic Acid|mycophenolic acid|mesh-list
24797237|NCT01954784|Fludarabine|fludarabine|mesh-list
24797238|NCT01954784|Fludarabine phosphate|fludarabine phosphate|mesh-list
24797239|NCT01954784|Lenalidomide|lenalidomide|mesh-list
24797240|NCT01954784|Bortezomib|bortezomib|mesh-list
24797241|NCT01954784|Cyclosporins|cyclosporins|mesh-list
24797242|NCT01954784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797245|NCT01954784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797246|NCT01954784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25658194|NCT01593670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658195|NCT01593670|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25658196|NCT01593722|Ivermectin|ivermectin|mesh-list
25658197|NCT01593722|Diethylcarbamazine|diethylcarbamazine|mesh-list
25658198|NCT01593722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25658199|NCT01593722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25658200|NCT01593722|Filaricides|filaricides|mesh-ancestor
24808803|NCT02029118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25831805|NCT00008034|Alkylating Agents|alkylating agents|mesh-ancestor
25831806|NCT00008034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658201|NCT01593722|Antinematodal Agents|antinematodal agents|mesh-ancestor
24797247|NCT01954784|Immunologic Factors|immunologic factors|mesh-ancestor
24797248|NCT01954784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797249|NCT01954784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24797250|NCT01954784|Antifungal Agents|antifungal agents|mesh-ancestor
24990507|NCT02859896|Micronutrients|micronutrients|mesh-ancestor
24990508|NCT02859896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25140807|NCT02961829|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25140808|NCT02961829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24990509|NCT02832167|Nivolumab|nivolumab|mesh-list
24990510|NCT02832167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24785356|NCT01913990|Ondansetron|ondansetron|mesh-list
24785357|NCT01913990|Aprepitant|aprepitant|mesh-list
24785358|NCT01913990|Antiemetics|antiemetics|mesh-list
24785359|NCT01913990|Emetics|emetics|mesh-list
24577547|NCT00844675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24577548|NCT00844675|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24990511|NCT02832167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990512|NCT02832167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24990513|NCT02832167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813928|NCT02061137|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24686391|NCT04879823|Antipyretics|antipyretics|mesh-ancestor
24864443|NCT04294810|Atezolizumab|atezolizumab|mesh-list
24864444|NCT04294810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864445|NCT04283617|Insulin|insulin|mesh-list
24864446|NCT04283617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24864447|NCT04283617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864448|NCT04192994|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24864450|NCT04182321|Metformin|metformin|mesh-list
24532937|NCT00641680|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24532938|NCT00641680|Glucocorticoids|glucocorticoids|mesh-ancestor
24532939|NCT00641680|Hormones|hormones|mesh-ancestor
24532940|NCT00641680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24532941|NCT00641693|Budesonide|budesonide|mesh-list
24532942|NCT00641693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24532943|NCT00641693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24532944|NCT00641693|Autonomic Agents|autonomic agents|mesh-ancestor
24532945|NCT00641693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24533038|NCT00642122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533039|NCT00642122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24533040|NCT00642122|Respiratory System Agents|respiratory system agents|mesh-ancestor
24533041|NCT00642122|Glucocorticoids|glucocorticoids|mesh-ancestor
25140817|NCT02961842|Anesthetics|anesthetics|mesh-ancestor
24533043|NCT00642122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24533044|NCT00642135|Phenylephrine|phenylephrine|mesh-list
24533045|NCT00642135|Oxymetazoline|oxymetazoline|mesh-list
24533046|NCT00642135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24864462|NCT04124588|Coagulants|coagulants|mesh-ancestor
24544392|NCT00688883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990527|NCT02821026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990528|NCT02821026|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24990529|NCT02821026|Antitubercular Agents|antitubercular agents|mesh-ancestor
25107416|NCT03140397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25107417|NCT03140397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990574|NCT02681237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990575|NCT02681237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990576|NCT02681237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24990578|NCT02674529|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24990579|NCT02674529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24990580|NCT02674529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24990581|NCT02674529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990582|NCT02674529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24990584|NCT02674529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990585|NCT02674529|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24990586|NCT02674529|Antidepressive Agents|antidepressive agents|mesh-ancestor
25658202|NCT01593722|Anthelmintics|anthelmintics|mesh-ancestor
25658203|NCT01593722|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25658204|NCT01593722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658205|NCT01593722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990587|NCT02674529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24990588|NCT02669953|Aflibercept|aflibercept|mesh-list
24990589|NCT02669953|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24990590|NCT02669953|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24990591|NCT02669953|Growth Substances|growth substances|mesh-ancestor
24990592|NCT02669953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990593|NCT02669953|Growth Inhibitors|growth inhibitors|mesh-ancestor
24990594|NCT02669953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990595|NCT02659020|Gemcitabine|gemcitabine|mesh-list
24990596|NCT02659020|Docetaxel|docetaxel|mesh-list
24990597|NCT02659020|Olaratumab|olaratumab|mesh-list
24990598|NCT02659020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24990599|NCT02659020|Antimetabolites|antimetabolites|mesh-ancestor
24990600|NCT02659020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990601|NCT02659020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864500|NCT03872401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24864501|NCT03797261|Venetoclax|venetoclax|mesh-list
24864502|NCT03797261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864503|NCT03719924|Paclitaxel|paclitaxel|mesh-list
24864504|NCT03719924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24533049|NCT00642135|Mydriatics|mydriatics|mesh-ancestor
24533050|NCT00642135|Autonomic Agents|autonomic agents|mesh-ancestor
24533051|NCT00642135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24990602|NCT02659020|Antiviral Agents|antiviral agents|mesh-ancestor
24990603|NCT02659020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24990623|NCT02535832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990624|NCT02513186|Dexamethasone|dexamethasone|mesh-list
24990625|NCT02513186|Cyclophosphamide|cyclophosphamide|mesh-list
24990626|NCT02513186|Lenalidomide|lenalidomide|mesh-list
24990628|NCT02513186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24990629|NCT02513186|Immunologic Factors|immunologic factors|mesh-ancestor
24990630|NCT02513186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990631|NCT02513186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24990632|NCT02513186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24990633|NCT02513186|Alkylating Agents|alkylating agents|mesh-ancestor
24990634|NCT02513186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990635|NCT02513186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544437|NCT00688961|Antipyretics|antipyretics|mesh-ancestor
24533052|NCT00642135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533053|NCT00642135|Sympathomimetics|sympathomimetics|mesh-ancestor
24533054|NCT00642135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24533062|NCT00642135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533063|NCT00642135|Protective Agents|protective agents|mesh-ancestor
24990636|NCT02513186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24990637|NCT02513186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24990638|NCT02513186|Antiemetics|antiemetics|mesh-ancestor
25140889|NCT02961803|Vitamins|vitamins|mesh-ancestor
24990639|NCT02513186|Autonomic Agents|autonomic agents|mesh-ancestor
24990640|NCT02513186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24990641|NCT02513186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24990642|NCT02513186|Glucocorticoids|glucocorticoids|mesh-ancestor
24990643|NCT02513186|Hormones|hormones|mesh-ancestor
24990752|NCT00936936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24990652|NCT02373241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24990705|NCT01684397|Growth Substances|growth substances|mesh-ancestor
24990706|NCT01684397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990707|NCT01684397|Growth Inhibitors|growth inhibitors|mesh-ancestor
24990708|NCT01684397|Immunologic Factors|immunologic factors|mesh-ancestor
24990709|NCT01455597|Estradiol|estradiol|mesh-list
24990710|NCT01455597|Estrogens|estrogens|mesh-ancestor
24990711|NCT01455597|Hormones|hormones|mesh-ancestor
24990712|NCT01455597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24990713|NCT01455597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577549|NCT00844675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577550|NCT00844675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577555|NCT00844688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577558|NCT00844688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24577559|NCT00844688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577560|NCT00844688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24577561|NCT00844688|Immunologic Factors|immunologic factors|mesh-ancestor
25831807|NCT00008034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990948|NCT03436108|Bisphenol A|bisphenol a|mesh-list
24577562|NCT00844688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577563|NCT00844688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24577565|NCT00844727|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24990714|NCT01453088|Bortezomib|bortezomib|mesh-list
24990715|NCT01453088|Melphalan|melphalan|mesh-list
24990716|NCT01453088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990717|NCT01453088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24990718|NCT01453088|Alkylating Agents|alkylating agents|mesh-ancestor
24990719|NCT01453088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990720|NCT01453088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24990721|NCT01453088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24990722|NCT01453088|Immunologic Factors|immunologic factors|mesh-ancestor
24990723|NCT01453088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990724|NCT01400776|Estradiol|estradiol|mesh-list
24990725|NCT01400776|Estrogens|estrogens|mesh-ancestor
24990726|NCT01400776|Hormones|hormones|mesh-ancestor
24990727|NCT01400776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24990728|NCT01400776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990729|NCT01182766|Topiramate|topiramate|mesh-list
24990730|NCT01182766|Anticonvulsants|anticonvulsants|mesh-ancestor
24990731|NCT01182766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24990732|NCT01182766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107428|NCT03139851|Cyclophosphamide|cyclophosphamide|mesh-list
25107429|NCT03139851|Pembrolizumab|pembrolizumab|mesh-list
25107430|NCT03139851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25107431|NCT03139851|Immunologic Factors|immunologic factors|mesh-ancestor
25107432|NCT03139851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107433|NCT03139851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24838253|NCT02196662|Mesalamine|mesalamine|mesh-list
24797259|NCT01954784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24797260|NCT01954784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24797261|NCT01954784|Antitubercular Agents|antitubercular agents|mesh-ancestor
24797262|NCT01954784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24797263|NCT01954914|Plerixafor|plerixafor|mesh-list
24797264|NCT01954914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24797265|NCT01954914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24797266|NCT01954914|Antiviral Agents|antiviral agents|mesh-ancestor
24797267|NCT01954914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24990751|NCT00936936|Mitosis Modulators|mitosis modulators|mesh-ancestor
24990754|NCT00936936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24990755|NCT00936936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24990757|NCT00936936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24990758|NCT00783536|Etanercept|etanercept|mesh-list
24990759|NCT00783536|Methotrexate|methotrexate|mesh-list
24990760|NCT00783536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24990761|NCT00783536|Abortifacient Agents|abortifacient agents|mesh-ancestor
24990762|NCT00783536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24990763|NCT00783536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990765|NCT00783536|Antimetabolites|antimetabolites|mesh-ancestor
24990766|NCT00783536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990767|NCT00783536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990768|NCT00783536|Dermatologic Agents|dermatologic agents|mesh-ancestor
24990769|NCT00783536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24990770|NCT00783536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24990771|NCT00783536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24990772|NCT00783536|Immunologic Factors|immunologic factors|mesh-ancestor
24990773|NCT00783536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24990774|NCT00783536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24990775|NCT00783536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24990776|NCT00783536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24990777|NCT00783536|Analgesics|analgesics|mesh-ancestor
24533065|NCT00642135|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24533066|NCT00642135|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24533067|NCT00642135|Cholinergic Agents|cholinergic agents|mesh-ancestor
24533069|NCT00642161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24533070|NCT00642161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24533071|NCT00642161|Autonomic Agents|autonomic agents|mesh-ancestor
24533072|NCT00642161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25831808|NCT00008034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25831809|NCT00008034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24990790|NCT00511134|Bupropion|bupropion|mesh-list
24990791|NCT00511134|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24990792|NCT00511134|Antidepressive Agents|antidepressive agents|mesh-ancestor
24990793|NCT00511134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24990794|NCT00511134|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24864702|NCT02799641|GABA Agents|gaba agents|mesh-ancestor
25831810|NCT00008034|Antimetabolites|antimetabolites|mesh-ancestor
25831811|NCT00008034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25831812|NCT00008034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25831813|NCT00008034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25831814|NCT00008034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831815|NCT00008047|Paclitaxel|paclitaxel|mesh-list
25831816|NCT00008047|Fluorouracil|fluorouracil|mesh-list
24533147|NCT00642434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24533148|NCT00642434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24533149|NCT00642434|Vasodilator Agents|vasodilator agents|mesh-ancestor
24533150|NCT00642434|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24533178|NCT00642512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533179|NCT00642512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24533180|NCT00642512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24533181|NCT00642512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24533182|NCT00642512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24533183|NCT00642512|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24533184|NCT00642512|Hallucinogens|hallucinogens|mesh-ancestor
24533185|NCT00642512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24533187|NCT00642512|Sensory System Agents|sensory system agents|mesh-ancestor
24533192|NCT00642551|Vitamin K 2|vitamin k 2|mesh-list
24533244|NCT00642733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533245|NCT00642733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24533246|NCT00642733|Immunologic Factors|immunologic factors|mesh-ancestor
25141035|NCT02960113|Cholinergic Agents|cholinergic agents|mesh-ancestor
25831817|NCT00008047|Hydroxyurea|hydroxyurea|mesh-list
25831818|NCT00008047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25831819|NCT00008047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831820|NCT00008047|Tubulin Modulators|tubulin modulators|mesh-ancestor
25831821|NCT00008047|Antimitotic Agents|antimitotic agents|mesh-ancestor
24990799|NCT00511134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24990800|NCT00511134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990802|NCT00511134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24990803|NCT00511134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24990804|NCT00511134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24990805|NCT00511134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25831822|NCT00008047|Mitosis Modulators|mitosis modulators|mesh-ancestor
25831823|NCT00008047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831824|NCT00008047|Antimetabolites|antimetabolites|mesh-ancestor
25831825|NCT00008047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25141057|NCT02959879|Folfirinox|folfirinox|mesh-list
25831826|NCT00008047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25831827|NCT00008047|Immunologic Factors|immunologic factors|mesh-ancestor
25831828|NCT00008047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831829|NCT00008047|Antisickling Agents|antisickling agents|mesh-ancestor
25831830|NCT00008047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831831|NCT00008047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25831832|NCT00008060|Leucovorin|leucovorin|mesh-list
25831833|NCT00008060|Fluorouracil|fluorouracil|mesh-list
25831834|NCT00008060|Oxaliplatin|oxaliplatin|mesh-list
25831835|NCT00008060|Irinotecan|irinotecan|mesh-list
25831836|NCT00008060|Calcium|calcium|mesh-list
25831837|NCT00008060|Levoleucovorin|levoleucovorin|mesh-list
25831838|NCT00008060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25831839|NCT00008060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831840|NCT00008060|Antimetabolites|antimetabolites|mesh-ancestor
25831841|NCT00008060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831842|NCT00008060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25831843|NCT00008060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831844|NCT00008060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25831845|NCT00008060|Immunologic Factors|immunologic factors|mesh-ancestor
25831846|NCT00008060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25831847|NCT00008060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25831848|NCT00008060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831849|NCT00008060|Antidotes|antidotes|mesh-ancestor
25831850|NCT00008060|Protective Agents|protective agents|mesh-ancestor
25831851|NCT00008060|Vitamin B Complex|vitamin b complex|mesh-ancestor
25831852|NCT00008060|Vitamins|vitamins|mesh-ancestor
25831853|NCT00008060|Micronutrients|micronutrients|mesh-ancestor
25831854|NCT00008073|Doxorubicin|doxorubicin|mesh-list
25831855|NCT00008073|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25831856|NCT00008073|Octreotide|octreotide|mesh-list
24990806|NCT04057469|Tulobuterol|tulobuterol|mesh-list
24990807|NCT04057469|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24990808|NCT04057469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25141080|NCT02959762|Vitamins|vitamins|mesh-list
24990809|NCT04057469|Adrenergic Agents|adrenergic agents|mesh-ancestor
24990810|NCT04057469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24990811|NCT04057469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831857|NCT00008073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25831858|NCT00008073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831859|NCT00008073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25658206|NCT01593748|Gemcitabine|gemcitabine|mesh-list
25658207|NCT01593748|Docetaxel|docetaxel|mesh-list
25658208|NCT01593748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25658209|NCT01593748|Antimetabolites|antimetabolites|mesh-ancestor
25658210|NCT01593748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658211|NCT01593748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990812|NCT04057469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990813|NCT04057469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24990814|NCT04057469|Autonomic Agents|autonomic agents|mesh-ancestor
24838331|NCT02197156|Narcotics|narcotics|mesh-ancestor
24990815|NCT04057469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24990816|NCT04057469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24990817|NCT04057469|Respiratory System Agents|respiratory system agents|mesh-ancestor
24990818|NCT04020809|Atezolizumab|atezolizumab|mesh-list
24990819|NCT04020809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990820|NCT04005209|Ketamine|ketamine|mesh-list
24990821|NCT04005209|Analgesics|analgesics|mesh-ancestor
24990822|NCT04005209|Sensory System Agents|sensory system agents|mesh-ancestor
24990823|NCT04005209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24990824|NCT04005209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831860|NCT00008073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25831861|NCT00008073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533276|NCT00642837|Narcotics|narcotics|mesh-ancestor
25163038|NCT02900430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533277|NCT00642837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24533280|NCT00642863|Vitamin A|vitamin a|mesh-list
25831862|NCT00008073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831863|NCT00008073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25831864|NCT00008073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25831865|NCT00008086|Calcitriol|calcitriol|mesh-list
25831866|NCT00008086|Carboplatin|carboplatin|mesh-list
25831867|NCT00008086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831868|NCT00008086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25831869|NCT00008086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831870|NCT00008086|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25831871|NCT00008086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25831872|NCT00008086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831873|NCT00008086|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25831874|NCT00008086|Vitamins|vitamins|mesh-ancestor
25831875|NCT00008086|Micronutrients|micronutrients|mesh-ancestor
25831876|NCT00008086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25831877|NCT00008112|Cisplatin|cisplatin|mesh-list
25831878|NCT00008112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831879|NCT00008125|Gemcitabine|gemcitabine|mesh-list
25831880|NCT00008125|Carboplatin|carboplatin|mesh-list
25831881|NCT00008125|Docetaxel|docetaxel|mesh-list
25831882|NCT00008125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990878|NCT03728179|Aspirin|aspirin|mesh-list
24990879|NCT03728179|Celecoxib|celecoxib|mesh-list
24990880|NCT03728179|Cyclophosphamide|cyclophosphamide|mesh-list
24990881|NCT03728179|Nivolumab|nivolumab|mesh-list
24990882|NCT03728179|Ipilimumab|ipilimumab|mesh-list
24990883|NCT03728179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24990884|NCT03728179|Immunologic Factors|immunologic factors|mesh-ancestor
24990885|NCT03728179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990886|NCT03728179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25046953|NCT00834873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24990887|NCT03728179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24990888|NCT03728179|Alkylating Agents|alkylating agents|mesh-ancestor
24990889|NCT03728179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163039|NCT02900430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24990901|NCT03728179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24864742|NCT02741388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25831883|NCT00008125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24864776|NCT02229136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24864777|NCT02229136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864778|NCT02229136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24990906|NCT03728179|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24990908|NCT03626376|Acyclovir|acyclovir|mesh-list
24990909|NCT03626376|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24990910|NCT03626376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24990911|NCT03626376|Antiviral Agents|antiviral agents|mesh-ancestor
24990912|NCT03626376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24990913|NCT03556358|Paclitaxel|paclitaxel|mesh-list
25658212|NCT01593748|Antiviral Agents|antiviral agents|mesh-ancestor
25658213|NCT01593748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24809005|NCT02030639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486293|NCT00457067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486294|NCT00457067|Growth Inhibitors|growth inhibitors|mesh-ancestor
25201153|NCT02729766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866390|NCT05152901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990914|NCT03556358|Cyclophosphamide|cyclophosphamide|mesh-list
24990915|NCT03556358|Trastuzumab|trastuzumab|mesh-list
24990916|NCT03556358|Epirubicin|epirubicin|mesh-list
24990917|NCT03556358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24990918|NCT03556358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25107434|NCT03139851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24990919|NCT03556358|Tubulin Modulators|tubulin modulators|mesh-ancestor
24990920|NCT03556358|Antimitotic Agents|antimitotic agents|mesh-ancestor
24990921|NCT03556358|Mitosis Modulators|mitosis modulators|mesh-ancestor
24864779|NCT02229136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864785|NCT02050308|Nicotine|nicotine|mesh-list
24864786|NCT02050308|Varenicline|varenicline|mesh-list
24864787|NCT02050308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24864788|NCT02050308|Autonomic Agents|autonomic agents|mesh-ancestor
24864789|NCT02050308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24864790|NCT02050308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864791|NCT02050308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24864792|NCT02050308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24864793|NCT02050308|Cholinergic Agents|cholinergic agents|mesh-ancestor
24990922|NCT03556358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990923|NCT03556358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24990924|NCT03556358|Immunologic Factors|immunologic factors|mesh-ancestor
24990925|NCT03556358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990926|NCT03556358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24990927|NCT03556358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24990928|NCT03556358|Alkylating Agents|alkylating agents|mesh-ancestor
24990929|NCT03556358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24864798|NCT01869361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25831884|NCT00008125|Antimetabolites|antimetabolites|mesh-ancestor
25831885|NCT00008125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141189|NCT02959112|Analgesics|analgesics|mesh-ancestor
25831886|NCT00008125|Antiviral Agents|antiviral agents|mesh-ancestor
25831887|NCT00008125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25831888|NCT00008125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831889|NCT00008125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25831890|NCT00008125|Immunologic Factors|immunologic factors|mesh-ancestor
25831891|NCT00008125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831892|NCT00008125|Tubulin Modulators|tubulin modulators|mesh-ancestor
25831893|NCT00008125|Antimitotic Agents|antimitotic agents|mesh-ancestor
25831894|NCT00008125|Mitosis Modulators|mitosis modulators|mesh-ancestor
25831895|NCT00008151|Cyclosporine|cyclosporine|mesh-list
25831896|NCT00008151|Mycophenolic Acid|mycophenolic acid|mesh-list
25831897|NCT00008151|Methotrexate|methotrexate|mesh-list
25831898|NCT00008151|Fludarabine phosphate|fludarabine phosphate|mesh-list
25831899|NCT00008151|Fludarabine|fludarabine|mesh-list
25831900|NCT00008151|Gemtuzumab|gemtuzumab|mesh-list
25831901|NCT00008151|Cyclosporins|cyclosporins|mesh-list
25831902|NCT00008151|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25163040|NCT02900430|Hormone Antagonists|hormone antagonists|mesh-ancestor
24990937|NCT03555578|Fertility Agents|fertility agents|mesh-ancestor
24990938|NCT03555578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24990939|NCT03555578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990940|NCT03555578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24990941|NCT03555578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990942|NCT03539302|Flecainide|flecainide|mesh-list
24990943|NCT03539302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24990944|NCT03539302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24990945|NCT03539302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24990946|NCT03539302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24990947|NCT03539302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990949|NCT03436108|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24990950|NCT03436108|Estrogens|estrogens|mesh-ancestor
24990951|NCT03436108|Hormones|hormones|mesh-ancestor
25658214|NCT01593748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658215|NCT01593748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25658216|NCT01593748|Immunologic Factors|immunologic factors|mesh-ancestor
25658217|NCT01593748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658218|NCT01593748|Tubulin Modulators|tubulin modulators|mesh-ancestor
25658219|NCT01593748|Antimitotic Agents|antimitotic agents|mesh-ancestor
25658220|NCT01593748|Mitosis Modulators|mitosis modulators|mesh-ancestor
25658221|NCT01593787|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24866542|NCT04702256|Histamine Antagonists|histamine antagonists|mesh-ancestor
24866544|NCT04702256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24866545|NCT04638634|Immunoglobulins|immunoglobulins|mesh-list
24866546|NCT04638634|Immunologic Factors|immunologic factors|mesh-ancestor
24866551|NCT05259319|Atezolizumab|atezolizumab|mesh-list
24990952|NCT03436108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24990953|NCT03436108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864808|NCT01869361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24864809|NCT01869361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774719|NCT01847456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831903|NCT00008151|Abortifacient Agents|abortifacient agents|mesh-ancestor
25831904|NCT00008151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25831905|NCT00008151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141246|NCT02958878|Adrenergic Agents|adrenergic agents|mesh-ancestor
24544714|NCT00689845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24990954|NCT03436108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24990955|NCT03436108|Antioxidants|antioxidants|mesh-ancestor
24990956|NCT03436108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990957|NCT03436108|Protective Agents|protective agents|mesh-ancestor
24990958|NCT03433248|Empagliflozin|empagliflozin|mesh-list
24990959|NCT03433248|Gliclazide|gliclazide|mesh-list
24990960|NCT03433248|Linagliptin|linagliptin|mesh-list
24990961|NCT03433248|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24990962|NCT03433248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990963|NCT03433248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24990964|NCT03433248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990965|NCT03433248|Incretins|incretins|mesh-ancestor
24990966|NCT03433248|Hormones|hormones|mesh-ancestor
24990967|NCT03433248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24990968|NCT03433248|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24990969|NCT03433248|Protease Inhibitors|protease inhibitors|mesh-ancestor
24990970|NCT03433248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24990971|NCT03417999|Dexmedetomidine|dexmedetomidine|mesh-list
24990972|NCT03417999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24990973|NCT03417999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24990974|NCT03417999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990975|NCT03417999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24990976|NCT03417999|Analgesics|analgesics|mesh-ancestor
24533359|NCT00643357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24533361|NCT00643357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24533362|NCT00643357|Analgesics|analgesics|mesh-ancestor
24797270|NCT01954992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797271|NCT01954992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24797273|NCT01954992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24797274|NCT01954992|Immunologic Factors|immunologic factors|mesh-ancestor
24797275|NCT01954992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797276|NCT01955057|Carbon Monoxide|carbon monoxide|mesh-list
25141280|NCT02958566|Ketorolac|ketorolac|mesh-list
24797277|NCT01955057|Antimetabolites|antimetabolites|mesh-ancestor
24797278|NCT01955057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797279|NCT01955057|Gasotransmitters|gasotransmitters|mesh-ancestor
24797280|NCT01955057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24797281|NCT01955057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577566|NCT00844727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24785360|NCT01913990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24785361|NCT01913990|Autonomic Agents|autonomic agents|mesh-ancestor
24785362|NCT01913990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24785363|NCT01913990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785364|NCT01913990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25186129|NCT02823249|Erythritol|erythritol|mesh-list
25658222|NCT01593787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25658223|NCT01593787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658224|NCT01594125|Nintedanib|nintedanib|mesh-list
25658225|NCT01594125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658226|NCT01594125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25658227|NCT01594125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658228|NCT01594125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658229|NCT01594281|Ranibizumab|ranibizumab|mesh-list
25658230|NCT01594281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25658231|NCT01594281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25658232|NCT01594281|Growth Substances|growth substances|mesh-ancestor
25658233|NCT01594281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866694|NCT05195450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866695|NCT05195450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866696|NCT05195450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24866697|NCT05195450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24866698|NCT05189197|Zanubrutinib|zanubrutinib|mesh-list
24866711|NCT05084599|Sympathomimetics|sympathomimetics|mesh-ancestor
24627811|NCT01095016|Fenoterol|fenoterol|mesh-list
24866712|NCT05084599|Autonomic Agents|autonomic agents|mesh-ancestor
24866713|NCT05084599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24866714|NCT05084599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785365|NCT01913990|Glucocorticoids|glucocorticoids|mesh-ancestor
25831906|NCT00008151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25831907|NCT00008151|Antimetabolites|antimetabolites|mesh-ancestor
25831908|NCT00008151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831909|NCT00008151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831910|NCT00008151|Dermatologic Agents|dermatologic agents|mesh-ancestor
25831911|NCT00008151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831912|NCT00008151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25831913|NCT00008151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25831914|NCT00008151|Immunologic Factors|immunologic factors|mesh-ancestor
25831915|NCT00008151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25831916|NCT00008151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25831917|NCT00008151|Antifungal Agents|antifungal agents|mesh-ancestor
25831918|NCT00008151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25831919|NCT00008151|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25831920|NCT00008151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25831921|NCT00008151|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25831922|NCT00008151|Antitubercular Agents|antitubercular agents|mesh-ancestor
25831923|NCT00008151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25831924|NCT00008151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25831925|NCT00008177|Iodine|iodine|mesh-list
24785367|NCT01913990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25141330|NCT02958566|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24785368|NCT01913990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24785369|NCT01913990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24785370|NCT01913990|Antipruritics|antipruritics|mesh-ancestor
24785371|NCT01913990|Dermatologic Agents|dermatologic agents|mesh-ancestor
24785372|NCT01913990|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24785373|NCT01913990|Serotonin Agents|serotonin agents|mesh-ancestor
24785374|NCT01913990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24785375|NCT01913990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785376|NCT01913990|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24785377|NCT01913990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24785378|NCT01913990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24785379|NCT01913990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24785380|NCT01913990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24785381|NCT01913990|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24785383|NCT01914042|Milnacipran|milnacipran|mesh-list
24785384|NCT01914042|Levomilnacipran|levomilnacipran|mesh-list
24785385|NCT01914042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24785386|NCT01914042|Narcotics|narcotics|mesh-ancestor
24785387|NCT01914042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24785388|NCT01914042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141343|NCT02958501|Vitamins|vitamins|mesh-ancestor
25141344|NCT02958501|Micronutrients|micronutrients|mesh-ancestor
25141345|NCT02958501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25141346|NCT02958631|Losartan|losartan|mesh-list
25141347|NCT02958631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24785389|NCT01914042|Analgesics|analgesics|mesh-ancestor
24785390|NCT01914042|Sensory System Agents|sensory system agents|mesh-ancestor
24785391|NCT01914042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24785392|NCT01914042|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24785393|NCT01914042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25107435|NCT03139851|Alkylating Agents|alkylating agents|mesh-ancestor
25658234|NCT01594281|Growth Inhibitors|growth inhibitors|mesh-ancestor
25658235|NCT01594281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658236|NCT01594294|Contact Lens Solutions|contact lens solutions|mesh-list
25658237|NCT01594294|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25658238|NCT01594294|Disinfectants|disinfectants|mesh-ancestor
25658239|NCT01594294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25658240|NCT01594333|Methotrexate|methotrexate|mesh-list
25658241|NCT01594333|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25658242|NCT01594333|Abortifacient Agents|abortifacient agents|mesh-ancestor
25658243|NCT01594333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25408858|NCT03415828|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24866845|NCT04472299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24866846|NCT04468087|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24866847|NCT04468087|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24866848|NCT04468087|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24866849|NCT04468087|Protease Inhibitors|protease inhibitors|mesh-ancestor
24866850|NCT04468087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25054767|NCT03527732|Anticestodal Agents|anticestodal agents|mesh-ancestor
25054768|NCT03527732|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25054769|NCT03527732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25054770|NCT03527732|Tubulin Modulators|tubulin modulators|mesh-ancestor
25054771|NCT03527732|Antimitotic Agents|antimitotic agents|mesh-ancestor
25054772|NCT03527732|Mitosis Modulators|mitosis modulators|mesh-ancestor
25107436|NCT03139851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107437|NCT03139851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25107438|NCT03139851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25107439|NCT03139851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25107440|NCT03140085|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25107441|NCT03140085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24797284|NCT01955070|Sensory System Agents|sensory system agents|mesh-ancestor
24797285|NCT01955070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24797286|NCT01955070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797287|NCT01955070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24797292|NCT01955070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24797294|NCT01955070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25831926|NCT00008177|Cyclosporine|cyclosporine|mesh-list
25831927|NCT00008177|Mycophenolic Acid|mycophenolic acid|mesh-list
25831928|NCT00008177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25831929|NCT00008177|Fludarabine|fludarabine|mesh-list
25831930|NCT00008177|Fludarabine phosphate|fludarabine phosphate|mesh-list
25831931|NCT00008177|Antibodies|antibodies|mesh-list
25831932|NCT00008177|Immunoglobulins|immunoglobulins|mesh-list
25831933|NCT00008177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25831934|NCT00008177|Cyclosporins|cyclosporins|mesh-list
25831935|NCT00008177|Immunologic Factors|immunologic factors|mesh-ancestor
25831936|NCT00008177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831937|NCT00008177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831938|NCT00008177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25831939|NCT00008177|Antimetabolites|antimetabolites|mesh-ancestor
25831940|NCT00008177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831941|NCT00008177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25831942|NCT00008177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831943|NCT00008177|Antifungal Agents|antifungal agents|mesh-ancestor
25831944|NCT00008177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25831945|NCT00008177|Dermatologic Agents|dermatologic agents|mesh-ancestor
25831946|NCT00008177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25831947|NCT00008177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24533411|NCT00643799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24533412|NCT00643799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25831948|NCT00008177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25831949|NCT00008177|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24990985|NCT03348670|BCG Vaccine|bcg vaccine|mesh-list
24990986|NCT03348670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24990987|NCT03348670|Immunologic Factors|immunologic factors|mesh-ancestor
24990988|NCT03348670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990992|NCT03263559|Cyclophosphamide|cyclophosphamide|mesh-list
24990994|NCT03263559|Fludarabine|fludarabine|mesh-list
24990995|NCT03263559|Hydroxyurea|hydroxyurea|mesh-list
24990996|NCT03263559|Thymoglobulin|thymoglobulin|mesh-list
24990997|NCT03263559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24990998|NCT03263559|Immunologic Factors|immunologic factors|mesh-ancestor
24990999|NCT03263559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991000|NCT03263559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24991001|NCT03263559|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25658244|NCT01594333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658245|NCT01594333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25658246|NCT01594333|Antimetabolites|antimetabolites|mesh-ancestor
25658247|NCT01594333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658248|NCT01594333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658249|NCT01594333|Dermatologic Agents|dermatologic agents|mesh-ancestor
25658250|NCT01594333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658251|NCT01594333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25658252|NCT01594333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25658253|NCT01594333|Immunologic Factors|immunologic factors|mesh-ancestor
25658254|NCT01594333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24991002|NCT03263559|Alkylating Agents|alkylating agents|mesh-ancestor
24795851|NCT01946386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24866872|NCT04370418|Immunologic Factors|immunologic factors|mesh-ancestor
24866873|NCT04370418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866888|NCT04127682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24866906|NCT03951025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866907|NCT03951025|Protective Agents|protective agents|mesh-ancestor
24866908|NCT03951025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866909|NCT03951025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24866957|NCT03865940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24952406|NCT03894085|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24952407|NCT03894085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24991003|NCT03263559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991004|NCT03263559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864885|NCT05148689|Adrenergic Agents|adrenergic agents|mesh-ancestor
25658255|NCT01594333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24589807|NCT00909077|Hormones|hormones|mesh-ancestor
25831950|NCT00008177|Antitubercular Agents|antitubercular agents|mesh-ancestor
25831951|NCT00008177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25831952|NCT00008177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25831953|NCT00008177|Trace Elements|trace elements|mesh-ancestor
25831954|NCT00008177|Micronutrients|micronutrients|mesh-ancestor
25831955|NCT00008190|Aldesleukin|aldesleukin|mesh-list
25831956|NCT00008190|Cyclophosphamide|cyclophosphamide|mesh-list
25831957|NCT00008190|Melphalan|melphalan|mesh-list
25831958|NCT00008190|Busulfan|busulfan|mesh-list
25831959|NCT00008190|Etoposide|etoposide|mesh-list
25831960|NCT00008190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24991005|NCT03263559|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24991007|NCT03263559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991008|NCT03263559|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24991009|NCT03228680|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24991010|NCT03228680|Hormones|hormones|mesh-ancestor
24991011|NCT03228680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24991012|NCT03228680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991013|NCT03209479|Glatiramer Acetate|glatiramer acetate|mesh-list
24991014|NCT03209479|(T,G)-A-L|(t,g)-a-l|mesh-list
24991015|NCT03209479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24991016|NCT03209479|Immunologic Factors|immunologic factors|mesh-ancestor
24991017|NCT03209479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991018|NCT03209479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24991019|NCT03209479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24991022|NCT03082729|Apremilast|apremilast|mesh-list
24991023|NCT03082729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24991027|NCT03082729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24864895|NCT05148689|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24864896|NCT05148689|Mydriatics|mydriatics|mesh-ancestor
24864897|NCT05148689|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25831961|NCT00008190|Immunologic Factors|immunologic factors|mesh-ancestor
25831962|NCT00008190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831963|NCT00008190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25831964|NCT00008190|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25831965|NCT00008190|Alkylating Agents|alkylating agents|mesh-ancestor
25831966|NCT00008190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831967|NCT00008190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831968|NCT00008190|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25831969|NCT00008190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25831970|NCT00008190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25831971|NCT00008190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25831972|NCT00008190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991039|NCT03029611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658256|NCT01594424|Immunoglobulins|immunoglobulins|mesh-list
25658257|NCT01594424|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25658258|NCT01594424|Antibodies|antibodies|mesh-list
25658259|NCT01594424|gamma-Globulins|gamma-globulins|mesh-list
25658260|NCT01594424|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25658261|NCT01594424|Immunologic Factors|immunologic factors|mesh-ancestor
25658262|NCT01594424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658263|NCT01594476|Levonorgestrel|levonorgestrel|mesh-list
25658264|NCT01594476|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25658265|NCT01594476|Contraceptive Agents|contraceptive agents|mesh-ancestor
25658266|NCT01594476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25658267|NCT01594476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674291|NCT01769586|GABA Modulators|gaba modulators|mesh-ancestor
25831973|NCT00008190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24952427|NCT03894280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952428|NCT03894280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24952429|NCT03894280|Respiratory System Agents|respiratory system agents|mesh-ancestor
24952430|NCT03894280|Dermatologic Agents|dermatologic agents|mesh-ancestor
24952431|NCT03894280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24814393|NCT02064465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866973|NCT03792750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24867017|NCT03765619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991040|NCT03029611|Tubulin Modulators|tubulin modulators|mesh-ancestor
24991041|NCT03029611|Antimitotic Agents|antimitotic agents|mesh-ancestor
24991042|NCT03029611|Mitosis Modulators|mitosis modulators|mesh-ancestor
24991043|NCT03029611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991044|NCT02914977|Daunorubicin|daunorubicin|mesh-list
24991045|NCT02914977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24991046|NCT02914977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24991047|NCT02914977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24991048|NCT02914977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24991049|NCT02914977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991050|NCT02914977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991051|NCT02891798|Dexamethasone|dexamethasone|mesh-list
24991052|NCT02891798|Dexamethasone acetate|dexamethasone acetate|mesh-list
24991054|NCT02891798|Buprenorphine|buprenorphine|mesh-list
24991055|NCT02891798|Bupivacaine|bupivacaine|mesh-list
24991056|NCT02891798|BB 1101|bb 1101|mesh-list
24991057|NCT02891798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24991058|NCT02891798|Antiemetics|antiemetics|mesh-ancestor
24991059|NCT02891798|Autonomic Agents|autonomic agents|mesh-ancestor
24544802|NCT00690313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24533447|NCT00644033|Serotonin Agents|serotonin agents|mesh-ancestor
25163041|NCT02900430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24991060|NCT02891798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25141430|NCT02957864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24991061|NCT02891798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991062|NCT02891798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24991063|NCT02891798|Glucocorticoids|glucocorticoids|mesh-ancestor
24991064|NCT02891798|Hormones|hormones|mesh-ancestor
24774720|NCT01847495|Irinotecan|irinotecan|mesh-list
24991071|NCT02891798|Anesthetics, Local|anesthetics, local|mesh-ancestor
24991072|NCT02891798|Anesthetics|anesthetics|mesh-ancestor
24991073|NCT02891798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24991074|NCT02891798|Sensory System Agents|sensory system agents|mesh-ancestor
24991075|NCT02891798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24991076|NCT02891798|Narcotics|narcotics|mesh-ancestor
24991077|NCT02891798|Analgesics|analgesics|mesh-ancestor
24991078|NCT02891798|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24991079|NCT02891798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24991080|NCT02891798|Sympatholytics|sympatholytics|mesh-ancestor
24991081|NCT02891798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24991082|NCT02891798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24991083|NCT02891798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24991084|NCT02891798|Adrenergic Agents|adrenergic agents|mesh-ancestor
24991085|NCT02891798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24991086|NCT02870218|Nicotine|nicotine|mesh-list
24991087|NCT02870218|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24991088|NCT02870218|Autonomic Agents|autonomic agents|mesh-ancestor
24991089|NCT02870218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24991090|NCT02870218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991091|NCT02870218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24991092|NCT02870218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24991093|NCT02870218|Cholinergic Agents|cholinergic agents|mesh-ancestor
24991097|NCT02859961|HIV Antibodies|hiv antibodies|mesh-list
24991098|NCT02859961|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24991099|NCT02859961|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25186361|NCT02820987|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24991100|NCT02859961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991101|NCT02859961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24991102|NCT02859961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24991103|NCT02859961|Antiviral Agents|antiviral agents|mesh-ancestor
24991104|NCT02859961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25658268|NCT01594476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25658269|NCT01594476|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25658270|NCT01594476|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25658271|NCT01594749|Dexamethasone|dexamethasone|mesh-list
25658272|NCT01594749|Dexamethasone acetate|dexamethasone acetate|mesh-list
25658273|NCT01594749|Ondansetron|ondansetron|mesh-list
25658274|NCT01594749|Fosaprepitant|fosaprepitant|mesh-list
25658275|NCT01594749|Aprepitant|aprepitant|mesh-list
25658276|NCT01594749|BB 1101|bb 1101|mesh-list
25658277|NCT01594749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24952449|NCT03894046|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24952450|NCT03894046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952451|NCT03894046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952452|NCT03894007|Maytansine|maytansine|mesh-list
24952453|NCT03894007|Docetaxel|docetaxel|mesh-list
25054852|NCT03526770|Chlorhexidine|chlorhexidine|mesh-list
25054853|NCT03526770|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25054854|NCT03526770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24938133|NCT04021992|Gemcitabine|gemcitabine|mesh-list
25054855|NCT03526770|Disinfectants|disinfectants|mesh-ancestor
25054856|NCT03526575|Zaleplon|zaleplon|mesh-list
25054857|NCT03526575|Zolpidem|zolpidem|mesh-list
25054858|NCT03526575|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25054859|NCT03526575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25054860|NCT03526575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25054861|NCT03526575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054862|NCT03526575|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25054863|NCT03526575|GABA Agonists|gaba agonists|mesh-ancestor
25054864|NCT03526575|GABA Agents|gaba agents|mesh-ancestor
25054865|NCT03526575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24991105|NCT02859961|Immunologic Factors|immunologic factors|mesh-ancestor
24991106|NCT02859961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991110|NCT02679781|Midazolam|midazolam|mesh-list
24991111|NCT02679781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24991112|NCT02679781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24991113|NCT02679781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24991114|NCT02679781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785397|NCT01914042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24991115|NCT02679781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24991116|NCT02679781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24864966|NCT05100264|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25831974|NCT00008190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25831975|NCT00008190|Antiviral Agents|antiviral agents|mesh-ancestor
25831976|NCT00008190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25831977|NCT00008203|Interferons|interferons|mesh-list
25831978|NCT00008203|Aldesleukin|aldesleukin|mesh-list
25831979|NCT00008203|Interferon-gamma|interferon-gamma|mesh-list
25831980|NCT00008203|Cyclosporine|cyclosporine|mesh-list
25831981|NCT00008203|Cyclophosphamide|cyclophosphamide|mesh-list
25831982|NCT00008203|Thiotepa|thiotepa|mesh-list
25831983|NCT00008203|Carboplatin|carboplatin|mesh-list
25831984|NCT00008203|Cyclosporins|cyclosporins|mesh-list
25831985|NCT00008203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24991117|NCT02679781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24991118|NCT02679781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24991119|NCT02679781|Anesthetics, General|anesthetics, general|mesh-ancestor
24991120|NCT02679781|Anesthetics|anesthetics|mesh-ancestor
24821363|NCT02104700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24991121|NCT02679781|GABA Modulators|gaba modulators|mesh-ancestor
24991122|NCT02679781|GABA Agents|gaba agents|mesh-ancestor
24991123|NCT02679781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24991124|NCT02679781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991125|NCT02624869|Evolocumab|evolocumab|mesh-list
24991126|NCT02624869|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24991127|NCT02624869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24991128|NCT02624869|Antimetabolites|antimetabolites|mesh-ancestor
24991129|NCT02624869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658278|NCT01594749|Antiemetics|antiemetics|mesh-ancestor
25658279|NCT01594749|Autonomic Agents|autonomic agents|mesh-ancestor
25658280|NCT01594749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25658281|NCT01594749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658282|NCT01594749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25658283|NCT01594749|Glucocorticoids|glucocorticoids|mesh-ancestor
25658284|NCT01594749|Hormones|hormones|mesh-ancestor
25658285|NCT01594749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25658286|NCT01594749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25658287|NCT01594749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658288|NCT01594749|Protease Inhibitors|protease inhibitors|mesh-ancestor
25658289|NCT01594749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658290|NCT01594749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658291|NCT01594749|Antipruritics|antipruritics|mesh-ancestor
25658292|NCT01594749|Dermatologic Agents|dermatologic agents|mesh-ancestor
25658293|NCT01594749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25658294|NCT01594749|Serotonin Agents|serotonin agents|mesh-ancestor
25658295|NCT01594749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25831986|NCT00008203|Immunologic Factors|immunologic factors|mesh-ancestor
25831987|NCT00008203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25831988|NCT00008203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25831990|NCT00008203|Alkylating Agents|alkylating agents|mesh-ancestor
25658296|NCT01594749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24991130|NCT02624869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24991131|NCT02614690|Calpastatin|calpastatin|mesh-list
24991132|NCT02614690|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
24991133|NCT02614690|Protease Inhibitors|protease inhibitors|mesh-ancestor
24991134|NCT02614690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864983|NCT05078931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831991|NCT00008203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25831992|NCT00008203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25831993|NCT00008203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25831994|NCT00008203|Antiviral Agents|antiviral agents|mesh-ancestor
25831995|NCT00008203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25831996|NCT00008203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25831997|NCT00008203|Antifungal Agents|antifungal agents|mesh-ancestor
25831998|NCT00008203|Dermatologic Agents|dermatologic agents|mesh-ancestor
25831999|NCT00008203|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24449559|NCT00315965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449561|NCT00315965|Respiratory System Agents|respiratory system agents|mesh-ancestor
24449562|NCT00315965|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24449563|NCT00315965|Antioxidants|antioxidants|mesh-ancestor
24449564|NCT00315965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449565|NCT00315965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24991150|NCT02435433|Ramucirumab|ramucirumab|mesh-list
24991151|NCT02435433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544871|NCT00690677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864989|NCT05012631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25832000|NCT00008203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25832001|NCT00008203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25832002|NCT00008229|Melphalan|melphalan|mesh-list
25832003|NCT00008229|Immunologic Factors|immunologic factors|mesh-ancestor
25832004|NCT00008229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832005|NCT00008229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25832006|NCT00008229|Alkylating Agents|alkylating agents|mesh-ancestor
25832007|NCT00008229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991165|NCT02417142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24991167|NCT02368886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24991168|NCT02368886|Glucocorticoids|glucocorticoids|mesh-ancestor
24991169|NCT02368886|Hormones|hormones|mesh-ancestor
24991170|NCT02368886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25163042|NCT02900430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991171|NCT02368886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991172|NCT02354703|Ondansetron|ondansetron|mesh-list
24865004|NCT04989322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865005|NCT04989322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24865006|NCT04989322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24865007|NCT04989322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24865008|NCT04965038|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24865009|NCT04965038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24865010|NCT04965038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24865011|NCT04965038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832008|NCT00008229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832009|NCT00008229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25832010|NCT00008229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25832011|NCT00008242|Thalidomide|thalidomide|mesh-list
25832012|NCT00008242|Dexamethasone|dexamethasone|mesh-list
25832013|NCT00008242|Doxorubicin|doxorubicin|mesh-list
25832014|NCT00008242|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25658297|NCT01594749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25658298|NCT01594749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25658299|NCT01594749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25658300|NCT01594749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25658301|NCT01594749|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25832026|NCT00008242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25832027|NCT00008242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25832028|NCT00008242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25832029|NCT00008242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25832030|NCT00008242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832031|NCT00008242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25832032|NCT00008242|Immunologic Factors|immunologic factors|mesh-ancestor
25832033|NCT00008242|Leprostatic Agents|leprostatic agents|mesh-ancestor
25832034|NCT00008242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25832035|NCT00008242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25832036|NCT00008242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25832037|NCT00008242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25832038|NCT00008242|Growth Substances|growth substances|mesh-ancestor
25832039|NCT00008242|Growth Inhibitors|growth inhibitors|mesh-ancestor
25832040|NCT00008268|Melphalan|melphalan|mesh-list
25832041|NCT00008268|Immunologic Factors|immunologic factors|mesh-ancestor
25832042|NCT00008268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832043|NCT00008268|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25832044|NCT00008268|Alkylating Agents|alkylating agents|mesh-ancestor
25832045|NCT00008268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832046|NCT00008268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832047|NCT00008268|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25832048|NCT00008268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25832049|NCT00008281|Leucovorin|leucovorin|mesh-list
24953172|NCT03887650|Glucocorticoids|glucocorticoids|mesh-ancestor
25832050|NCT00008281|Fluorouracil|fluorouracil|mesh-list
25832051|NCT00008281|Oxaliplatin|oxaliplatin|mesh-list
25832052|NCT00008281|Calcium|calcium|mesh-list
25832053|NCT00008281|Levoleucovorin|levoleucovorin|mesh-list
25832054|NCT00008281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25832055|NCT00008281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832056|NCT00008281|Antimetabolites|antimetabolites|mesh-ancestor
25832057|NCT00008281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832058|NCT00008281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25832059|NCT00008281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832060|NCT00008281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24590513|NCT00913029|Timolol|timolol|mesh-list
24991184|NCT02354703|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24991185|NCT02354703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24991186|NCT02354703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24991187|NCT02354703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24991188|NCT02354703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25107442|NCT03139708|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24838736|NCT02200094|Telmisartan|telmisartan|mesh-list
24991189|NCT01442194|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24991190|NCT01442194|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24865030|NCT04931511|Glucocorticoids|glucocorticoids|mesh-ancestor
24449689|NCT00316563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832061|NCT00008281|Immunologic Factors|immunologic factors|mesh-ancestor
25832063|NCT00008281|Protective Agents|protective agents|mesh-ancestor
25832064|NCT00008281|Vitamin B Complex|vitamin b complex|mesh-ancestor
25832065|NCT00008281|Vitamins|vitamins|mesh-ancestor
25832066|NCT00008281|Micronutrients|micronutrients|mesh-ancestor
25832067|NCT00008294|Leucovorin|leucovorin|mesh-list
25832068|NCT00008294|Dexamethasone|dexamethasone|mesh-list
25832069|NCT00008294|Fluorouracil|fluorouracil|mesh-list
25832070|NCT00008294|Oxaliplatin|oxaliplatin|mesh-list
25832071|NCT00008294|Floxuridine|floxuridine|mesh-list
25832072|NCT00008294|Calcium|calcium|mesh-list
25832073|NCT00008294|Levoleucovorin|levoleucovorin|mesh-list
25832074|NCT00008294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25832075|NCT00008294|Antiemetics|antiemetics|mesh-ancestor
25832076|NCT00008294|Autonomic Agents|autonomic agents|mesh-ancestor
25832077|NCT00008294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25832078|NCT00008294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832079|NCT00008294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25832080|NCT00008294|Glucocorticoids|glucocorticoids|mesh-ancestor
25832081|NCT00008294|Hormones|hormones|mesh-ancestor
25832082|NCT00008294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25163043|NCT02900430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25832083|NCT00008294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25832084|NCT00008294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832085|NCT00008294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25832086|NCT00008294|Antimetabolites|antimetabolites|mesh-ancestor
25832087|NCT00008294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832088|NCT00008294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25832089|NCT00008294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25832090|NCT00008294|Immunologic Factors|immunologic factors|mesh-ancestor
25832091|NCT00008294|Antidotes|antidotes|mesh-ancestor
25832092|NCT00008294|Protective Agents|protective agents|mesh-ancestor
25832093|NCT00008294|Vitamin B Complex|vitamin b complex|mesh-ancestor
25658302|NCT01594762|Pexiganan|pexiganan|mesh-list
25658303|NCT01594762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25658304|NCT01594762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25658305|NCT01594827|Chlorhexidine|chlorhexidine|mesh-list
25658306|NCT01594827|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25832094|NCT00008294|Vitamins|vitamins|mesh-ancestor
25832095|NCT00008294|Micronutrients|micronutrients|mesh-ancestor
25832096|NCT00008307|Cyclosporine|cyclosporine|mesh-list
24867675|NCT03194165|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24867676|NCT03194165|Antiviral Agents|antiviral agents|mesh-ancestor
24867677|NCT03194165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24867678|NCT03194165|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24867679|NCT03194165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24867680|NCT03194165|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24867681|NCT03194165|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24867688|NCT03179475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25832097|NCT00008307|Mycophenolic Acid|mycophenolic acid|mesh-list
25832098|NCT00008307|Methylprednisolone|methylprednisolone|mesh-list
25832099|NCT00008307|Fludarabine|fludarabine|mesh-list
25832100|NCT00008307|Fludarabine phosphate|fludarabine phosphate|mesh-list
25832101|NCT00008307|Melphalan|melphalan|mesh-list
25832102|NCT00008307|Cyclosporins|cyclosporins|mesh-list
25832103|NCT00008307|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25832104|NCT00008307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24991221|NCT00796068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24991222|NCT00468130|Aripiprazole|aripiprazole|mesh-list
24991223|NCT00468130|Antidepressive Agents|antidepressive agents|mesh-ancestor
24991224|NCT00468130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24991225|NCT00468130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24991226|NCT00468130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24991227|NCT00468130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25832105|NCT00008307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24991229|NCT00468130|Dopamine Agonists|dopamine agonists|mesh-ancestor
24991230|NCT00468130|Dopamine Agents|dopamine agents|mesh-ancestor
24991231|NCT00468130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24991232|NCT00468130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991233|NCT00468130|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24991234|NCT00468130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24991235|NCT00468130|Serotonin Agents|serotonin agents|mesh-ancestor
24814021|NCT02061800|Hormones|hormones|mesh-ancestor
24991241|NCT05197751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24991242|NCT05197751|Immunologic Factors|immunologic factors|mesh-ancestor
24991243|NCT05197751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991244|NCT05197751|Antacids|antacids|mesh-ancestor
24991245|NCT05197751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991246|NCT05197751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24991247|NCT05197621|Vaccines|vaccines|mesh-list
24991248|NCT05197621|Immunologic Factors|immunologic factors|mesh-ancestor
24991249|NCT05197621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991250|NCT05197504|Bevacizumab|bevacizumab|mesh-list
25107443|NCT03139708|Phenylephrine|phenylephrine|mesh-list
24991251|NCT05197504|Atezolizumab|atezolizumab|mesh-list
24991252|NCT05197504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24991253|NCT05197504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24991254|NCT05197504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24991255|NCT05197504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24991256|NCT05197504|Growth Substances|growth substances|mesh-ancestor
24590724|NCT00913718|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25832106|NCT00008307|Antimetabolites|antimetabolites|mesh-ancestor
25832107|NCT00008307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832108|NCT00008307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25832109|NCT00008307|Immunologic Factors|immunologic factors|mesh-ancestor
25832110|NCT00008307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832111|NCT00008307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25832112|NCT00008307|Antifungal Agents|antifungal agents|mesh-ancestor
25832113|NCT00008307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25832114|NCT00008307|Dermatologic Agents|dermatologic agents|mesh-ancestor
25832115|NCT00008307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25832116|NCT00008307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24991268|NCT05197088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24991269|NCT05197088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991290|NCT05196256|Anesthetics, Local|anesthetics, local|mesh-ancestor
25658307|NCT01594827|Vancomycin|vancomycin|mesh-list
25658308|NCT01594827|Doxycycline|doxycycline|mesh-list
25658309|NCT01594827|Rifampin|rifampin|mesh-list
25658310|NCT01594827|Trimethoprim|trimethoprim|mesh-list
25658311|NCT01594827|Sulfamethoxazole|sulfamethoxazole|mesh-list
25658312|NCT01594827|Mupirocin|mupirocin|mesh-list
25658313|NCT01594827|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25658314|NCT01594827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25658315|NCT01594827|Disinfectants|disinfectants|mesh-ancestor
25658316|NCT01594827|Dermatologic Agents|dermatologic agents|mesh-ancestor
25658317|NCT01594827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25832117|NCT00008307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24867786|NCT00308516|Bevacizumab|bevacizumab|mesh-list
24867787|NCT00308516|Fluorouracil|fluorouracil|mesh-list
24867788|NCT00308516|Oxaliplatin|oxaliplatin|mesh-list
24867789|NCT00308516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24867790|NCT00308516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24867791|NCT00308516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24867792|NCT00308516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24867793|NCT00308516|Growth Substances|growth substances|mesh-ancestor
24991291|NCT05196191|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24991292|NCT05196191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24991293|NCT05196191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24991294|NCT05196191|Dermatologic Agents|dermatologic agents|mesh-ancestor
24991295|NCT05195619|Cyclophosphamide|cyclophosphamide|mesh-list
24991296|NCT05195619|Vaccines|vaccines|mesh-list
24991297|NCT05195619|Immunologic Factors|immunologic factors|mesh-ancestor
24991298|NCT05195619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991299|NCT05195619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24991300|NCT05195619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24991301|NCT05195619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24991302|NCT05195619|Alkylating Agents|alkylating agents|mesh-ancestor
24991303|NCT05195619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991304|NCT05195619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24991305|NCT05195619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24991306|NCT05195294|Lenvatinib|lenvatinib|mesh-list
24991307|NCT05195294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24991308|NCT05195294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24991309|NCT05195294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25832118|NCT00008307|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24449697|NCT00316563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24449698|NCT00316563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449699|NCT00316563|Hormones|hormones|mesh-ancestor
24449700|NCT00316563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24449701|NCT00316680|Vaccines|vaccines|mesh-list
25832119|NCT00008307|Antitubercular Agents|antitubercular agents|mesh-ancestor
25832120|NCT00008307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25832121|NCT00008307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25832122|NCT00008307|Antiemetics|antiemetics|mesh-ancestor
24991333|NCT05195086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24991334|NCT05195086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24991335|NCT05195086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24991336|NCT05195086|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25832123|NCT00008307|Autonomic Agents|autonomic agents|mesh-ancestor
25832124|NCT00008307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25832125|NCT00008307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25832126|NCT00008307|Glucocorticoids|glucocorticoids|mesh-ancestor
25832127|NCT00008307|Hormones|hormones|mesh-ancestor
25832128|NCT00008307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25832129|NCT00008307|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25832130|NCT00008307|Protective Agents|protective agents|mesh-ancestor
25832131|NCT00008307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25832132|NCT00008307|Alkylating Agents|alkylating agents|mesh-ancestor
25832133|NCT00008307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25832134|NCT00008333|Vinorelbine|vinorelbine|mesh-list
25832135|NCT00008333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25832136|NCT00008333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24821527|NCT02106286|Bisoprolol|bisoprolol|mesh-list
25832137|NCT00008333|Tubulin Modulators|tubulin modulators|mesh-ancestor
25832138|NCT00008333|Antimitotic Agents|antimitotic agents|mesh-ancestor
25832139|NCT00008333|Mitosis Modulators|mitosis modulators|mesh-ancestor
24991343|NCT05194904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24991344|NCT05194904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24991345|NCT05194904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991346|NCT05194904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24991347|NCT05194904|Analgesics|analgesics|mesh-ancestor
24991348|NCT05194904|Sensory System Agents|sensory system agents|mesh-ancestor
25658318|NCT01594827|Antimalarials|antimalarials|mesh-ancestor
25658319|NCT01594827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25658320|NCT01594827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25658321|NCT01594827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25658322|NCT01594827|Antitubercular Agents|antitubercular agents|mesh-ancestor
25658323|NCT01594827|Leprostatic Agents|leprostatic agents|mesh-ancestor
25658324|NCT01594827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25658325|NCT01594827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991349|NCT05194904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24991352|NCT05194904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24991353|NCT05194904|Adrenergic Agents|adrenergic agents|mesh-ancestor
24991354|NCT05194904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24991355|NCT05194904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991356|NCT05194904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25832140|NCT00008333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832141|NCT00008359|Amphotericin B|amphotericin b|mesh-list
25832142|NCT00008359|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25832143|NCT00008359|Caspofungin|caspofungin|mesh-list
25832144|NCT00008359|Amebicides|amebicides|mesh-ancestor
25832145|NCT00008359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25832146|NCT00008359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25832147|NCT00008359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25832148|NCT00008359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25832149|NCT00008359|Antifungal Agents|antifungal agents|mesh-ancestor
25832150|NCT00008359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25832151|NCT00008359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832152|NCT00008372|Sulfanilamides|sulfanilamides|mesh-list
25832153|NCT00008372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25832154|NCT00008398|Sargramostim|sargramostim|mesh-list
25832155|NCT00008398|Immunologic Factors|immunologic factors|mesh-ancestor
25832156|NCT00008398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832157|NCT00008411|Docetaxel|docetaxel|mesh-list
25832158|NCT00008411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832159|NCT00008411|Tubulin Modulators|tubulin modulators|mesh-ancestor
25832160|NCT00008411|Antimitotic Agents|antimitotic agents|mesh-ancestor
25832161|NCT00008411|Mitosis Modulators|mitosis modulators|mesh-ancestor
25832162|NCT00008411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832163|NCT00008424|Irinotecan|irinotecan|mesh-list
25832164|NCT00008424|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24991357|NCT05194904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24991358|NCT05194904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24991359|NCT05194904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25832165|NCT00008424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25832166|NCT00008424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25832167|NCT00008424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832168|NCT00008424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832169|NCT00008450|Cyclosporine|cyclosporine|mesh-list
25832170|NCT00008450|Mycophenolic Acid|mycophenolic acid|mesh-list
25832171|NCT00008450|Cyclosporins|cyclosporins|mesh-list
25832172|NCT00008450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25832173|NCT00008450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832174|NCT00008450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25832175|NCT00008450|Immunologic Factors|immunologic factors|mesh-ancestor
25832176|NCT00008450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832177|NCT00008450|Antifungal Agents|antifungal agents|mesh-ancestor
25163044|NCT02900430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25163045|NCT02900105|Letrozole|letrozole|mesh-list
25832178|NCT00008450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25832179|NCT00008450|Dermatologic Agents|dermatologic agents|mesh-ancestor
25832180|NCT00008450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25832181|NCT00008450|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25832182|NCT00008450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25832183|NCT00008450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832184|NCT00008450|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24797319|NCT01955174|Cholinergic Agents|cholinergic agents|mesh-ancestor
24797320|NCT01955174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24797321|NCT01955174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797323|NCT01955187|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24797324|NCT01955187|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24797325|NCT01955187|Prednisolone|prednisolone|mesh-list
24797326|NCT01955187|Prednisolone acetate|prednisolone acetate|mesh-list
24797327|NCT01955187|Cyclophosphamide|cyclophosphamide|mesh-list
24797328|NCT01955187|Rituximab|rituximab|mesh-list
24797329|NCT01955187|Tacrolimus|tacrolimus|mesh-list
24797330|NCT01955187|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24797331|NCT01955187|Prednisolone phosphate|prednisolone phosphate|mesh-list
24797332|NCT01955187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24797333|NCT01955187|Immunologic Factors|immunologic factors|mesh-ancestor
24865127|NCT04388501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865128|NCT04388501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25832190|NCT00008463|Interferon alpha-2|interferon alpha-2|mesh-list
25832191|NCT00008463|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25832192|NCT00008463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832193|NCT00008463|Antiviral Agents|antiviral agents|mesh-ancestor
25832194|NCT00008463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25832195|NCT00008463|Antimetabolites|antimetabolites|mesh-ancestor
25832196|NCT00008463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832197|NCT00008463|Immunologic Factors|immunologic factors|mesh-ancestor
25832198|NCT00008463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875304|NCT04524000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875305|NCT04524000|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25875306|NCT04524000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24797334|NCT01955187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797335|NCT01955187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24797336|NCT01955187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24991367|NCT05194449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
24991368|NCT05194449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24991369|NCT05194449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991370|NCT05194046|Amoxicillin|amoxicillin|mesh-list
24991371|NCT05194046|Clarithromycin|clarithromycin|mesh-list
24991372|NCT05194046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24991373|NCT05194046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24591152|NCT00915408|Dexamethasone|dexamethasone|mesh-list
24865146|NCT04308837|Autonomic Agents|autonomic agents|mesh-ancestor
24865147|NCT04308837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24865148|NCT04308837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865149|NCT04308837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25875307|NCT04524000|Hormone Antagonists|hormone antagonists|mesh-ancestor
25875308|NCT04524000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24411608|NCT00189566|Paclitaxel|paclitaxel|mesh-list
25875309|NCT04524000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875310|NCT04513925|Atezolizumab|atezolizumab|mesh-list
25875311|NCT04513925|Durvalumab|durvalumab|mesh-list
25875312|NCT04513925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875313|NCT04513925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25875314|NCT04504669|Durvalumab|durvalumab|mesh-list
25875315|NCT04504669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25658326|NCT01594827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658327|NCT01594827|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25658328|NCT01594827|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25658329|NCT01594827|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25658330|NCT01594827|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25658331|NCT01594827|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25658332|NCT01594827|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25875316|NCT04504669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875317|NCT04496960|Tofacitinib|tofacitinib|mesh-list
24996660|NCT03023319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24814469|NCT02064621|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24814470|NCT02064621|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25832203|NCT00008476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25832204|NCT00008476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832205|NCT00008489|Didanosine|didanosine|mesh-list
25832206|NCT00008489|Antimetabolites|antimetabolites|mesh-ancestor
25832207|NCT00008489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832208|NCT00008489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25832209|NCT00008489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25832210|NCT00008489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25832211|NCT00008489|Antiviral Agents|antiviral agents|mesh-ancestor
25832212|NCT00008489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25832213|NCT00008489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25832214|NCT00008489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25832215|NCT00008515|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
25832216|NCT00008515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25832217|NCT00008515|Glucocorticoids|glucocorticoids|mesh-ancestor
25832218|NCT00008515|Hormones|hormones|mesh-ancestor
25832219|NCT00008515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24991384|NCT05193838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24991385|NCT05193838|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24991386|NCT05193838|Antioxidants|antioxidants|mesh-ancestor
24865165|NCT04308837|Antipruritics|antipruritics|mesh-ancestor
25832220|NCT00008515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832221|NCT00008528|Enfuvirtide|enfuvirtide|mesh-list
25832222|NCT00008528|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25832223|NCT00008528|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25832224|NCT00008528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832225|NCT00008528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25832226|NCT00008528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25832227|NCT00008528|Antiviral Agents|antiviral agents|mesh-ancestor
25832228|NCT00008528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25832229|NCT00008554|Lamivudine|lamivudine|mesh-list
25832230|NCT00008554|Abacavir|abacavir|mesh-list
25832231|NCT00008554|Nelfinavir|nelfinavir|mesh-list
25832232|NCT00008554|Fosamprenavir|fosamprenavir|mesh-list
25832233|NCT00008554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25832234|NCT00008554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25832235|NCT00008554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25142003|NCT02953210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25142004|NCT02953210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25142005|NCT02953210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25142006|NCT02953210|Narcotics|narcotics|mesh-ancestor
25142007|NCT02953210|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25142008|NCT02953210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25832236|NCT00008554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832237|NCT00008554|Antiviral Agents|antiviral agents|mesh-ancestor
25832238|NCT00008554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25832239|NCT00008554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25832240|NCT00008554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25832241|NCT00008554|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25832242|NCT00008554|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25832243|NCT00008554|Protease Inhibitors|protease inhibitors|mesh-ancestor
25832244|NCT00008697|Arsenic Trioxide|arsenic trioxide|mesh-list
25832245|NCT00008697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832246|NCT00008736|Metoclopramide|metoclopramide|mesh-list
25832247|NCT00008736|Antiemetics|antiemetics|mesh-ancestor
25408859|NCT03415828|Prednisolone phosphate|prednisolone phosphate|mesh-list
25658333|NCT01594827|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25658334|NCT01594827|Renal Agents|renal agents|mesh-ancestor
25658335|NCT01594827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25658336|NCT01594827|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25658337|NCT01594827|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25658338|NCT01594827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25658339|NCT01594827|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25658340|NCT01594931|Artesunate|artesunate|mesh-list
24991388|NCT05193838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107444|NCT03139708|Oxymetazoline|oxymetazoline|mesh-list
24991390|NCT05193747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24991391|NCT05193747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991392|NCT05193734|Hemagglutinins|hemagglutinins|mesh-list
24991393|NCT05193734|Agglutinins|agglutinins|mesh-ancestor
24991394|NCT05193734|Immunologic Factors|immunologic factors|mesh-ancestor
24991395|NCT05193734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991396|NCT05193604|Gemcitabine|gemcitabine|mesh-list
24991397|NCT05193604|Paclitaxel|paclitaxel|mesh-list
24991398|NCT05193604|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24991399|NCT05193604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24991400|NCT05193604|Tubulin Modulators|tubulin modulators|mesh-ancestor
25832254|NCT00008736|Dopamine Agents|dopamine agents|mesh-ancestor
25832255|NCT00008736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25832256|NCT00008736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832257|NCT00008866|Didanosine|didanosine|mesh-list
25832258|NCT00008866|Hydroxyurea|hydroxyurea|mesh-list
25832259|NCT00008866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832260|NCT00008866|Antisickling Agents|antisickling agents|mesh-ancestor
24451487|NCT00323934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24451488|NCT00323934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451489|NCT00323934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451490|NCT00323947|Methylphenidate|methylphenidate|mesh-list
25186884|NCT02817477|Ketamine|ketamine|mesh-list
24451491|NCT00323947|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24451492|NCT00323947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451493|NCT00323947|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24451494|NCT00323947|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24451495|NCT00323947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24451496|NCT00323947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991401|NCT05193604|Antimitotic Agents|antimitotic agents|mesh-ancestor
24991402|NCT05193604|Mitosis Modulators|mitosis modulators|mesh-ancestor
24991403|NCT05193604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991404|NCT05193604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24991405|NCT05193604|Antimetabolites|antimetabolites|mesh-ancestor
24991406|NCT05193604|Antiviral Agents|antiviral agents|mesh-ancestor
25658343|NCT01594931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25658344|NCT01594931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25658345|NCT01594931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24868466|NCT04549051|Anesthetics, Local|anesthetics, local|mesh-list
24975541|NCT03476681|Pembrolizumab|pembrolizumab|mesh-list
24991407|NCT05193604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24991408|NCT05193604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991409|NCT05193604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24991410|NCT05193604|Immunologic Factors|immunologic factors|mesh-ancestor
24991411|NCT05193604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991413|NCT05193253|Hematinics|hematinics|mesh-ancestor
24821713|NCT02107378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24814062|NCT02062203|Moxifloxacin|moxifloxacin|mesh-list
24814063|NCT02062203|Glycine|glycine|mesh-list
25832263|NCT00008866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25832264|NCT00008866|Antimetabolites|antimetabolites|mesh-ancestor
25832265|NCT00008866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25832266|NCT00008866|Antiviral Agents|antiviral agents|mesh-ancestor
25832267|NCT00008866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25832268|NCT00008866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25832269|NCT00008866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25832270|NCT00009009|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25832271|NCT00009009|Complement System Proteins|complement system proteins|mesh-list
25832272|NCT00009009|Immunologic Factors|immunologic factors|mesh-ancestor
25832273|NCT00009009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832274|NCT00009048|Levodopa|levodopa|mesh-list
25832275|NCT00009048|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25832276|NCT00009048|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25832277|NCT00009048|Dopamine Agents|dopamine agents|mesh-ancestor
25832278|NCT00009048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25832279|NCT00009048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832280|NCT00009048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832281|NCT00009061|Ritonavir|ritonavir|mesh-list
25832282|NCT00009061|Nelfinavir|nelfinavir|mesh-list
25832283|NCT00009061|Fosamprenavir|fosamprenavir|mesh-list
25832284|NCT00009061|Lamivudine|lamivudine|mesh-list
25832285|NCT00009061|Abacavir|abacavir|mesh-list
25832286|NCT00009061|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24991438|NCT05170464|Caffeine|caffeine|mesh-list
24797337|NCT01955187|Alkylating Agents|alkylating agents|mesh-ancestor
24991439|NCT05170464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24991440|NCT05170464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991441|NCT05170464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24991442|NCT05170464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991443|NCT05170464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991444|NCT05170464|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24991445|NCT05170464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24991446|NCT05170464|Purinergic Agents|purinergic agents|mesh-ancestor
24991447|NCT05170464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25832287|NCT00009061|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24996662|NCT02921789|Prednisone|prednisone|mesh-list
24591539|NCT00917254|Enoxaparin|enoxaparin|mesh-list
24991458|NCT05165251|Amlodipine|amlodipine|mesh-list
24991459|NCT05165251|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
24991460|NCT05165251|Atorvastatin|atorvastatin|mesh-list
24991461|NCT05165251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24991462|NCT05165251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25163047|NCT02900105|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24991463|NCT05165251|Antimetabolites|antimetabolites|mesh-ancestor
25832288|NCT00009061|Protease Inhibitors|protease inhibitors|mesh-ancestor
25658346|NCT01594931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658347|NCT01594931|Antiviral Agents|antiviral agents|mesh-ancestor
25658348|NCT01594931|Schistosomicides|schistosomicides|mesh-ancestor
25658349|NCT01594931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25658350|NCT01594931|Anthelmintics|anthelmintics|mesh-ancestor
25658351|NCT01594970|Bimatoprost|bimatoprost|mesh-list
25832289|NCT00009061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25832290|NCT00009061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658352|NCT01594970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24868553|NCT04325659|Sensory System Agents|sensory system agents|mesh-ancestor
24868567|NCT04321174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868569|NCT04321174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24868570|NCT04321174|Antiviral Agents|antiviral agents|mesh-ancestor
24868571|NCT04321174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25832291|NCT00009061|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25832292|NCT00009061|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25832293|NCT00009061|Antiviral Agents|antiviral agents|mesh-ancestor
25832294|NCT00009061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25832295|NCT00009061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25832296|NCT00009061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25832297|NCT00009061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25832298|NCT00009061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25832299|NCT00009178|Fluoxetine|fluoxetine|mesh-list
24449771|NCT00316927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24449772|NCT00316927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449773|NCT00316927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24449774|NCT00316927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24449775|NCT00316927|Analgesics|analgesics|mesh-ancestor
24449776|NCT00316927|Sensory System Agents|sensory system agents|mesh-ancestor
24449777|NCT00316927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25832300|NCT00009178|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25832301|NCT00009178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25832302|NCT00009178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24657899|NCT01269515|Analgesics|analgesics|mesh-ancestor
25107462|NCT03139708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25107463|NCT03139708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25832303|NCT00009178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832304|NCT00009178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25832305|NCT00009178|Serotonin Agents|serotonin agents|mesh-ancestor
25832306|NCT00009178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832307|NCT00009178|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25832308|NCT00009178|Antidepressive Agents|antidepressive agents|mesh-ancestor
25832309|NCT00009178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25832310|NCT00009178|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25832311|NCT00009178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25832312|NCT00009178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25832313|NCT00009191|Sertraline|sertraline|mesh-list
25832314|NCT00009191|Antidepressive Agents|antidepressive agents|mesh-ancestor
25832315|NCT00009191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25832316|NCT00009191|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25832317|NCT00009191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25832318|NCT00009191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25832319|NCT00009191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832320|NCT00009191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25832321|NCT00009191|Serotonin Agents|serotonin agents|mesh-ancestor
25163048|NCT02900105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25163049|NCT02900105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163050|NCT02900105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163051|NCT02900105|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24937444|NCT04028804|Deoxyglucose|deoxyglucose|mesh-list
24937445|NCT04028804|Fluorides|fluorides|mesh-list
24937446|NCT04028804|Cariostatic Agents|cariostatic agents|mesh-ancestor
24937447|NCT04028804|Protective Agents|protective agents|mesh-ancestor
24937448|NCT04028804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937449|NCT04028804|Antimetabolites|antimetabolites|mesh-ancestor
24937450|NCT04028804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937451|NCT04028804|Antiviral Agents|antiviral agents|mesh-ancestor
24821791|NCT02107924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24821792|NCT02107950|Gemcitabine|gemcitabine|mesh-list
25658353|NCT01595282|Ibuprofen|ibuprofen|mesh-list
25658354|NCT01595282|Ketorolac|ketorolac|mesh-list
25658355|NCT01595282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25658356|NCT01595282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25658357|NCT01595282|Analgesics|analgesics|mesh-ancestor
25658358|NCT01595282|Sensory System Agents|sensory system agents|mesh-ancestor
25658359|NCT01595282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25658360|NCT01595282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832325|NCT00009204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25832326|NCT00009204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25832327|NCT00009204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25832328|NCT00009204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832329|NCT00009204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25832330|NCT00009204|Serotonin Agents|serotonin agents|mesh-ancestor
25832331|NCT00009204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832332|NCT00009204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25832333|NCT00009204|Antidepressive Agents|antidepressive agents|mesh-ancestor
24785400|NCT01914081|Resveratrol|resveratrol|mesh-list
25107518|NCT03139253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24991464|NCT05165251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991465|NCT05165251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24991466|NCT05165251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24991467|NCT05165251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991468|NCT05165251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24991469|NCT05165251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24991470|NCT05165251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24991471|NCT05165251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24991472|NCT05165251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047197|NCT00830219|Ropinirole|ropinirole|mesh-list
25163052|NCT02900105|Hormone Antagonists|hormone antagonists|mesh-ancestor
25163053|NCT02900105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25163054|NCT02900105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202934|NCT02717871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25202935|NCT02717871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202936|NCT02717871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24991473|NCT05165251|Vasodilator Agents|vasodilator agents|mesh-ancestor
24991474|NCT05154669|Nicotine|nicotine|mesh-list
24991475|NCT05154669|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24991476|NCT05154669|Autonomic Agents|autonomic agents|mesh-ancestor
24865278|NCT04006769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25832334|NCT00009204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25832335|NCT00009204|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25832336|NCT00009204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24991477|NCT05154669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24991478|NCT05154669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991479|NCT05154669|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24991480|NCT05154669|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24991481|NCT05154669|Cholinergic Agents|cholinergic agents|mesh-ancestor
24991482|NCT05154669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24991483|NCT05154669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142259|NCT02951897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25142261|NCT02951637|Carboplatin|carboplatin|mesh-list
24865292|NCT03962894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25832337|NCT00009204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25832338|NCT00009204|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25832339|NCT00009204|Dopamine Agents|dopamine agents|mesh-ancestor
25832340|NCT00009217|Haloperidol|haloperidol|mesh-list
25832341|NCT00009217|Haloperidol decanoate|haloperidol decanoate|mesh-list
25832342|NCT00009217|Antiemetics|antiemetics|mesh-ancestor
25832343|NCT00009217|Autonomic Agents|autonomic agents|mesh-ancestor
25832344|NCT00009217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25832345|NCT00009217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832346|NCT00009217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25832347|NCT00009217|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25832348|NCT00009217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25674292|NCT01769586|GABA Agents|gaba agents|mesh-ancestor
24991548|NCT05139875|Immunologic Factors|immunologic factors|mesh-ancestor
24991549|NCT05139875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991550|NCT05139875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991551|NCT05139875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24592303|NCT00921180|Entecavir|entecavir|mesh-list
25832351|NCT00009217|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25832352|NCT00009217|Dopamine Agents|dopamine agents|mesh-ancestor
25832353|NCT00009217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24991582|NCT05123170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24991583|NCT05123170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24991584|NCT05123170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24991585|NCT05123170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24991586|NCT05123170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24991587|NCT05123170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991588|NCT05123170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24991591|NCT05123170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24991592|NCT05123170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24592358|NCT00921505|Acetaminophen|acetaminophen|mesh-list
25832354|NCT00009217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832355|NCT00009217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25832356|NCT00009230|Celecoxib|celecoxib|mesh-list
25832357|NCT00009230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25832358|NCT00009230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25832359|NCT00009230|Analgesics|analgesics|mesh-ancestor
25832360|NCT00009230|Sensory System Agents|sensory system agents|mesh-ancestor
25832361|NCT00009230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25832362|NCT00009230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832363|NCT00009230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25832364|NCT00009230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25832365|NCT00009230|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25832366|NCT00009230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25832367|NCT00009230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25832368|NCT00009230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832369|NCT00009555|Testosterone|testosterone|mesh-list
24797354|NCT01955187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24797356|NCT01955200|Clopidogrel|clopidogrel|mesh-list
24797357|NCT01955200|Ticagrelor|ticagrelor|mesh-list
24797358|NCT01955200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24797359|NCT01955200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24592440|NCT00921765|Ketamine|ketamine|mesh-list
25832370|NCT00009555|Androgens|androgens|mesh-ancestor
25832371|NCT00009555|Hormones|hormones|mesh-ancestor
25832372|NCT00009555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24797381|NCT01955213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797383|NCT01955213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24797385|NCT01955252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24797386|NCT01955252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24797387|NCT01955317|Chlorhexidine|chlorhexidine|mesh-list
24797389|NCT01955317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25658361|NCT01595282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25658362|NCT01595282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25658363|NCT01595282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25201233|NCT02729467|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25832373|NCT00009555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832375|NCT00009581|Vasodilator Agents|vasodilator agents|mesh-ancestor
25832376|NCT00009581|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25832377|NCT00009581|Cholinergic Agents|cholinergic agents|mesh-ancestor
25832378|NCT00009581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25832379|NCT00009581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832380|NCT00009581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832381|NCT00009620|Phenobarbital|phenobarbital|mesh-list
24785497|NCT01914744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24785498|NCT01914744|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24785499|NCT01914744|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24785500|NCT01914770|Belimumab|belimumab|mesh-list
24785501|NCT01914770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24785502|NCT01914770|Immunologic Factors|immunologic factors|mesh-ancestor
24785503|NCT01914770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785504|NCT01914822|Methylphenidate|methylphenidate|mesh-list
24785505|NCT01914822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24785506|NCT01914822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785507|NCT01914822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24592805|NCT00925327|Riboflavin|riboflavin|mesh-list
25832382|NCT00009620|Anticonvulsants|anticonvulsants|mesh-ancestor
25832383|NCT00009620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24991632|NCT05081089|Lumefantrine|lumefantrine|mesh-list
24991633|NCT05081089|Artemether|artemether|mesh-list
24991634|NCT05081089|Pyrimethamine|pyrimethamine|mesh-list
24991635|NCT05081089|Primaquine|primaquine|mesh-list
24991636|NCT05081089|Sulfadoxine|sulfadoxine|mesh-list
24592921|NCT00926341|Pioglitazone|pioglitazone|mesh-list
24449879|NCT00317408|Prednisolone|prednisolone|mesh-list
24991717|NCT05042505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24991719|NCT05042505|Protease Inhibitors|protease inhibitors|mesh-ancestor
24991720|NCT05042505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991721|NCT05042505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047246|NCT00829868|Zaleplon|zaleplon|mesh-list
24991722|NCT05042505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24991723|NCT05041673|Metformin|metformin|mesh-list
24991724|NCT05041673|Liraglutide|liraglutide|mesh-list
24991725|NCT05041673|Empagliflozin|empagliflozin|mesh-list
24991726|NCT05041673|Vildagliptin|vildagliptin|mesh-list
24449908|NCT00317408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24991728|NCT05041673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991729|NCT05041673|Incretins|incretins|mesh-ancestor
24991730|NCT05041673|Hormones|hormones|mesh-ancestor
24991731|NCT05041673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24991732|NCT05041673|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24991733|NCT05041673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991734|NCT05041673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24991735|NCT05041673|Protease Inhibitors|protease inhibitors|mesh-ancestor
24991736|NCT05041673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991737|NCT05032950|Ritonavir|ritonavir|mesh-list
24991738|NCT05032950|Midazolam|midazolam|mesh-list
25658364|NCT01595282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658365|NCT01595282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658366|NCT01595386|Hydrocortisone|hydrocortisone|mesh-list
25658367|NCT01595386|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25658368|NCT01595386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25658369|NCT01595438|Ciprofloxacin|ciprofloxacin|mesh-list
25658370|NCT01595438|Ceftazidime|ceftazidime|mesh-list
25658371|NCT01595438|Doripenem|doripenem|mesh-list
24991739|NCT05032950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25658372|NCT01595438|Avibactam|avibactam|mesh-list
25142458|NCT02949583|Chlorhexidine|chlorhexidine|mesh-list
25832394|NCT00009620|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25832395|NCT00009646|Indomethacin|indomethacin|mesh-list
25832396|NCT00009646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25832397|NCT00009646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25832398|NCT00009646|Analgesics|analgesics|mesh-ancestor
25832399|NCT00009646|Sensory System Agents|sensory system agents|mesh-ancestor
25832400|NCT00009646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25832401|NCT00009646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774725|NCT01847495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832402|NCT00009646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25832403|NCT00009646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25832404|NCT00009646|Gout Suppressants|gout suppressants|mesh-ancestor
25832405|NCT00009646|Tocolytic Agents|tocolytic agents|mesh-ancestor
25832406|NCT00009646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25832407|NCT00009646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25832408|NCT00009646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25832409|NCT00009646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832410|NCT00009659|Ulipristal acetate|ulipristal acetate|mesh-list
25832411|NCT00009659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25832412|NCT00009659|Contraceptive Agents|contraceptive agents|mesh-ancestor
25832413|NCT00009659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25832414|NCT00009659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832415|NCT00009659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25832417|NCT00009672|Nortriptyline|nortriptyline|mesh-list
25832418|NCT00009672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25832419|NCT00009672|Narcotics|narcotics|mesh-ancestor
25832420|NCT00009672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25832421|NCT00009672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832422|NCT00009672|Analgesics|analgesics|mesh-ancestor
25832423|NCT00009672|Sensory System Agents|sensory system agents|mesh-ancestor
25832424|NCT00009672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25832425|NCT00009672|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25832426|NCT00009672|Antidepressive Agents|antidepressive agents|mesh-ancestor
24797452|NCT01955655|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24785510|NCT01914822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785511|NCT01914822|Dopamine Agents|dopamine agents|mesh-ancestor
24785512|NCT01914822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24785513|NCT01914900|Docetaxel|docetaxel|mesh-list
25832427|NCT00009672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25163055|NCT02899702|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24785537|NCT01914965|Dopamine Agents|dopamine agents|mesh-ancestor
24785538|NCT01914965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24785539|NCT01914965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658373|NCT01595438|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25658374|NCT01595438|Trimethoprim|trimethoprim|mesh-list
25658375|NCT01595438|Sulfamethoxazole|sulfamethoxazole|mesh-list
25658376|NCT01595438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25658377|NCT01595438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25832428|NCT00009672|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25832429|NCT00009672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25055188|NCT03523455|Hematinics|hematinics|mesh-ancestor
25832430|NCT00009672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25832431|NCT00009672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832432|NCT00009672|Adrenergic Agents|adrenergic agents|mesh-ancestor
25832433|NCT00009672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25832434|NCT00009698|Aldesleukin|aldesleukin|mesh-list
25832435|NCT00009698|Interleukin-2|interleukin-2|mesh-list
25832436|NCT00009698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832437|NCT00009698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25832438|NCT00009698|Analgesics|analgesics|mesh-ancestor
25832439|NCT00009698|Sensory System Agents|sensory system agents|mesh-ancestor
25832440|NCT00009698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25832441|NCT00009698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832442|NCT00009698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25832443|NCT00009698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25832444|NCT00009698|Antiviral Agents|antiviral agents|mesh-ancestor
25832445|NCT00009698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25832446|NCT00009750|Cyclosporine|cyclosporine|mesh-list
25832447|NCT00009750|Paclitaxel|paclitaxel|mesh-list
25832448|NCT00009750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25832449|NCT00009750|Antibodies|antibodies|mesh-list
25832450|NCT00009750|Immunoglobulins|immunoglobulins|mesh-list
25832451|NCT00009750|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25832452|NCT00009750|Cyclosporins|cyclosporins|mesh-list
25832453|NCT00009750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25832454|NCT00009750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832455|NCT00009750|Tubulin Modulators|tubulin modulators|mesh-ancestor
25832456|NCT00009750|Antimitotic Agents|antimitotic agents|mesh-ancestor
25832457|NCT00009750|Mitosis Modulators|mitosis modulators|mesh-ancestor
25107542|NCT03139591|Sensory System Agents|sensory system agents|mesh-ancestor
25107543|NCT03139591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25107544|NCT03139591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25107545|NCT03139591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25107546|NCT03139591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25107547|NCT03139591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832458|NCT00009750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832459|NCT00009750|Immunologic Factors|immunologic factors|mesh-ancestor
25142562|NCT02948998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25142563|NCT02948998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142564|NCT02948998|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25142565|NCT02948998|Diuretics|diuretics|mesh-ancestor
25142566|NCT02948998|Natriuretic Agents|natriuretic agents|mesh-ancestor
25142567|NCT02948920|Ephedrine|ephedrine|mesh-list
25142568|NCT02948920|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25142589|NCT02948348|Nivolumab|nivolumab|mesh-list
25832460|NCT00009750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832461|NCT00009750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25832462|NCT00009750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25832463|NCT00009750|Antifungal Agents|antifungal agents|mesh-ancestor
25832464|NCT00009750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25832465|NCT00009750|Dermatologic Agents|dermatologic agents|mesh-ancestor
25832466|NCT00009750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25832467|NCT00009750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25832468|NCT00009763|Cyclosporine|cyclosporine|mesh-list
25832469|NCT00009763|Paclitaxel|paclitaxel|mesh-list
25832470|NCT00009763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24797458|NCT01955655|GABA Agents|gaba agents|mesh-ancestor
25107569|NCT03139565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832471|NCT00009763|Antibodies|antibodies|mesh-list
25832472|NCT00009763|Immunoglobulins|immunoglobulins|mesh-list
25832473|NCT00009763|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25832474|NCT00009763|Cyclosporins|cyclosporins|mesh-list
25832475|NCT00009763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25832476|NCT00009763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832477|NCT00009763|Tubulin Modulators|tubulin modulators|mesh-ancestor
24449950|NCT00317434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449951|NCT00317434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24449952|NCT00317434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25832478|NCT00009763|Antimitotic Agents|antimitotic agents|mesh-ancestor
25658379|NCT01595438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25658380|NCT01595438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25832479|NCT00009763|Mitosis Modulators|mitosis modulators|mesh-ancestor
24991907|NCT04750824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24991908|NCT04750824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24865730|NCT05108740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865731|NCT05076513|Niraparib|niraparib|mesh-list
24865732|NCT05076513|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24865733|NCT05076513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24865734|NCT05076513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832485|NCT00009763|Antifungal Agents|antifungal agents|mesh-ancestor
25832486|NCT00009763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25832487|NCT00009763|Dermatologic Agents|dermatologic agents|mesh-ancestor
25832488|NCT00009763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25832489|NCT00009763|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25832490|NCT00009776|Cyclosporine|cyclosporine|mesh-list
25832491|NCT00009776|Paclitaxel|paclitaxel|mesh-list
25832492|NCT00009776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25832493|NCT00009776|Antibodies|antibodies|mesh-list
25832494|NCT00009776|Immunoglobulins|immunoglobulins|mesh-list
25832495|NCT00009776|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25832496|NCT00009776|Cyclosporins|cyclosporins|mesh-list
25832497|NCT00009776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25832498|NCT00009776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832499|NCT00009776|Tubulin Modulators|tubulin modulators|mesh-ancestor
25832500|NCT00009776|Antimitotic Agents|antimitotic agents|mesh-ancestor
24991909|NCT04750824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991933|NCT04720976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991934|NCT04720976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991935|NCT04717362|Methyltestosterone|methyltestosterone|mesh-list
24991936|NCT04717362|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24991937|NCT04717362|Testosterone|testosterone|mesh-list
24991938|NCT04717362|Testosterone undecanoate|testosterone undecanoate|mesh-list
24991939|NCT04717362|Testosterone enanthate|testosterone enanthate|mesh-list
24991940|NCT04717362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24991941|NCT04717362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24991942|NCT04717362|Anabolic Agents|anabolic agents|mesh-ancestor
24991943|NCT04717362|Hormones|hormones|mesh-ancestor
25832501|NCT00009776|Mitosis Modulators|mitosis modulators|mesh-ancestor
25832502|NCT00009776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832503|NCT00009776|Immunologic Factors|immunologic factors|mesh-ancestor
25832504|NCT00009776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832505|NCT00009776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774727|NCT01847521|Antioxidants|antioxidants|mesh-ancestor
24991966|NCT04703101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24991967|NCT04703101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24797455|NCT01955655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24797456|NCT01955655|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24797457|NCT01955655|GABA Agonists|gaba agonists|mesh-ancestor
24865780|NCT04940572|Valproic Acid|valproic acid|mesh-list
24449963|NCT00317499|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24449964|NCT00317499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25832506|NCT00009776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25832507|NCT00009776|Antifungal Agents|antifungal agents|mesh-ancestor
25832508|NCT00009776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25832509|NCT00009776|Dermatologic Agents|dermatologic agents|mesh-ancestor
25163057|NCT02899702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832510|NCT00009776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25832511|NCT00009776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25832512|NCT00009802|Calcitriol|calcitriol|mesh-list
25832513|NCT00009802|Paclitaxel|paclitaxel|mesh-list
25658381|NCT01595438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832514|NCT00009802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25832515|NCT00009802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832516|NCT00009802|Tubulin Modulators|tubulin modulators|mesh-ancestor
25832517|NCT00009802|Antimitotic Agents|antimitotic agents|mesh-ancestor
25832518|NCT00009802|Mitosis Modulators|mitosis modulators|mesh-ancestor
24797460|NCT01955655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797461|NCT01955694|Eplerenone|eplerenone|mesh-list
24797462|NCT01955694|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24797463|NCT01955694|Hormone Antagonists|hormone antagonists|mesh-ancestor
24797464|NCT01955694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25832519|NCT00009802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832520|NCT00009802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25832521|NCT00009802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832522|NCT00009802|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25832523|NCT00009802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25832524|NCT00009802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25832525|NCT00009802|Vitamins|vitamins|mesh-ancestor
25832526|NCT00009802|Micronutrients|micronutrients|mesh-ancestor
25832527|NCT00009802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25832528|NCT00009815|Leucovorin|leucovorin|mesh-list
25832529|NCT00009815|Etoposide|etoposide|mesh-list
25832530|NCT00009815|Tegafur|tegafur|mesh-list
25832531|NCT00009815|Calcium|calcium|mesh-list
25832532|NCT00009815|Levoleucovorin|levoleucovorin|mesh-list
25832533|NCT00009815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25832534|NCT00009815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832535|NCT00009815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25832536|NCT00009815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832537|NCT00009815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25832538|NCT00009815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25832539|NCT00009815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25832540|NCT00009815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832541|NCT00009815|Antidotes|antidotes|mesh-ancestor
25832542|NCT00009815|Protective Agents|protective agents|mesh-ancestor
25832543|NCT00009815|Vitamin B Complex|vitamin b complex|mesh-ancestor
25832544|NCT00009815|Vitamins|vitamins|mesh-ancestor
25832545|NCT00009815|Micronutrients|micronutrients|mesh-ancestor
25832546|NCT00009815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25832547|NCT00009815|Antimetabolites|antimetabolites|mesh-ancestor
25832548|NCT00009828|Leucovorin|leucovorin|mesh-list
24797486|NCT01955759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24797487|NCT01955759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24797488|NCT01955759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24797489|NCT01955759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24797490|NCT01955759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24797491|NCT01955759|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25142733|NCT02947672|Hormones|hormones|mesh-ancestor
24797492|NCT01955759|Adrenergic Agents|adrenergic agents|mesh-ancestor
24797493|NCT01955759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24797494|NCT01955759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797495|NCT01955759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25832549|NCT00009828|Paclitaxel|paclitaxel|mesh-list
25832550|NCT00009828|Tegafur|tegafur|mesh-list
25832551|NCT00009828|Calcium|calcium|mesh-list
25832552|NCT00009828|Levoleucovorin|levoleucovorin|mesh-list
25832553|NCT00009828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25832554|NCT00009828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832555|NCT00009828|Tubulin Modulators|tubulin modulators|mesh-ancestor
24797498|NCT01955759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25832556|NCT00009828|Antimitotic Agents|antimitotic agents|mesh-ancestor
25832557|NCT00009828|Mitosis Modulators|mitosis modulators|mesh-ancestor
25832558|NCT00009828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832559|NCT00009828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25832560|NCT00009828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832561|NCT00009828|Antidotes|antidotes|mesh-ancestor
25142736|NCT02947672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832562|NCT00009828|Protective Agents|protective agents|mesh-ancestor
25832563|NCT00009828|Vitamin B Complex|vitamin b complex|mesh-ancestor
25832564|NCT00009828|Vitamins|vitamins|mesh-ancestor
25832565|NCT00009828|Micronutrients|micronutrients|mesh-ancestor
25832566|NCT00009828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25832567|NCT00009828|Antimetabolites|antimetabolites|mesh-ancestor
25832568|NCT00009841|Mitogens|mitogens|mesh-list
25832569|NCT00009841|Mitosis Modulators|mitosis modulators|mesh-ancestor
25832570|NCT00009841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055264|NCT03522649|Micronutrients|micronutrients|mesh-ancestor
25055265|NCT03522532|Zinc|zinc|mesh-list
25055266|NCT03522532|Trace Elements|trace elements|mesh-ancestor
25055267|NCT03522532|Micronutrients|micronutrients|mesh-ancestor
25832571|NCT00009854|Ethanol|ethanol|mesh-list
25832572|NCT00009854|Carmustine|carmustine|mesh-list
25832573|NCT00009854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24991979|NCT04690023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991980|NCT04690023|Sensory System Agents|sensory system agents|mesh-ancestor
24991981|NCT04690023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24991988|NCT04653818|Sofosbuvir|sofosbuvir|mesh-list
24991989|NCT04653818|Velpatasvir|velpatasvir|mesh-list
24991990|NCT04653818|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
24991991|NCT04653818|Antiviral Agents|antiviral agents|mesh-ancestor
24991992|NCT04653818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24991993|NCT04646590|Vaccines|vaccines|mesh-list
24991994|NCT04646590|Immunologic Factors|immunologic factors|mesh-ancestor
24991995|NCT04646590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991996|NCT04645667|Tacrolimus|tacrolimus|mesh-list
24991997|NCT04645667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24991998|NCT04645667|Immunologic Factors|immunologic factors|mesh-ancestor
24991999|NCT04645667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992000|NCT04645667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24992001|NCT04645667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24992002|NCT04645667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832574|NCT00009854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25832575|NCT00009854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25832576|NCT00009854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594755|NCT00935467|Saxagliptin|saxagliptin|mesh-list
25832577|NCT00009854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25832578|NCT00009854|Alkylating Agents|alkylating agents|mesh-ancestor
25832579|NCT00009854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832580|NCT00009854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832581|NCT00009867|Arsenic Trioxide|arsenic trioxide|mesh-list
25832582|NCT00009867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832583|NCT00009880|Paclitaxel|paclitaxel|mesh-list
25832584|NCT00009880|Cisplatin|cisplatin|mesh-list
25169563|NCT01818076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25142782|NCT02947243|Analgesics|analgesics|mesh-ancestor
25832585|NCT00009880|Fluorouracil|fluorouracil|mesh-list
25832586|NCT00009880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25832587|NCT00009880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832588|NCT00009880|Tubulin Modulators|tubulin modulators|mesh-ancestor
25832589|NCT00009880|Antimitotic Agents|antimitotic agents|mesh-ancestor
25832590|NCT00009880|Mitosis Modulators|mitosis modulators|mesh-ancestor
25832591|NCT00009880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832592|NCT00009880|Antimetabolites|antimetabolites|mesh-ancestor
25832593|NCT00009880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25832594|NCT00009880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25832595|NCT00009880|Immunologic Factors|immunologic factors|mesh-ancestor
25832596|NCT00009880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992057|NCT04523961|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24992058|NCT04500509|Diclofenac|diclofenac|mesh-list
24992059|NCT04500509|Dinoprostone|dinoprostone|mesh-list
24992061|NCT04500509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24992064|NCT04500509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24992065|NCT04500509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992066|NCT04500509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24992067|NCT04500509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24992068|NCT04500509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24992069|NCT04500509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24992070|NCT04500509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992071|NCT04500509|Oxytocics|oxytocics|mesh-ancestor
24992072|NCT04500509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24992073|NCT04500470|Ketoprofen|ketoprofen|mesh-list
24992074|NCT04500470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24992075|NCT04500470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24992076|NCT04500470|Analgesics|analgesics|mesh-ancestor
25832597|NCT00009893|Leucovorin|leucovorin|mesh-list
25832598|NCT00009893|Gemcitabine|gemcitabine|mesh-list
25658382|NCT01595438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658383|NCT01595438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25658384|NCT01595438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25832599|NCT00009893|Fluorouracil|fluorouracil|mesh-list
25832600|NCT00009893|Calcium|calcium|mesh-list
25832601|NCT00009893|Levoleucovorin|levoleucovorin|mesh-list
25832602|NCT00009893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25055290|NCT03522207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832603|NCT00009893|Antimetabolites|antimetabolites|mesh-ancestor
25832604|NCT00009893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832605|NCT00009893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832606|NCT00009893|Antiviral Agents|antiviral agents|mesh-ancestor
25832607|NCT00009893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25832608|NCT00009893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25832609|NCT00009893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25832610|NCT00009893|Immunologic Factors|immunologic factors|mesh-ancestor
25832611|NCT00009893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832612|NCT00009893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25832613|NCT00009893|Antidotes|antidotes|mesh-ancestor
24992163|NCT04226833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24992164|NCT04226833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24992165|NCT04226833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992167|NCT04214860|Venetoclax|venetoclax|mesh-list
24992168|NCT04214860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24992169|NCT04214860|Antimetabolites|antimetabolites|mesh-ancestor
24992170|NCT04214860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992171|NCT04214860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992172|NCT04214860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25142882|NCT02946437|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25142883|NCT02946814|Listerine|listerine|mesh-list
24992173|NCT04206020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24992174|NCT04206020|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25832614|NCT00009893|Protective Agents|protective agents|mesh-ancestor
25832615|NCT00009893|Vitamin B Complex|vitamin b complex|mesh-ancestor
25832616|NCT00009893|Vitamins|vitamins|mesh-ancestor
25832617|NCT00009893|Micronutrients|micronutrients|mesh-ancestor
24852801|NCT02264145|Norflurane|norflurane|mesh-list
25832618|NCT00009906|Imatinib Mesylate|imatinib mesylate|mesh-list
25142901|NCT02946632|Protease Inhibitors|protease inhibitors|mesh-ancestor
24797533|NCT01956006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832619|NCT00009906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832620|NCT00009906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25832621|NCT00009906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25832622|NCT00009906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832623|NCT00009919|Semaxinib|semaxinib|mesh-list
25832624|NCT00009919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25832625|NCT00009919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25832626|NCT00009919|Growth Substances|growth substances|mesh-ancestor
25832627|NCT00009919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832628|NCT00009919|Growth Inhibitors|growth inhibitors|mesh-ancestor
25142933|NCT02946268|Anesthetics|anesthetics|mesh-ancestor
25142936|NCT02946268|Sensory System Agents|sensory system agents|mesh-ancestor
25832629|NCT00009919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832630|NCT00009919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25832631|NCT00009919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25832632|NCT00009919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832633|NCT00009932|Paclitaxel|paclitaxel|mesh-list
25832634|NCT00009932|Cisplatin|cisplatin|mesh-list
25832635|NCT00009932|Fenretinide|fenretinide|mesh-list
25832636|NCT00009932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25832637|NCT00009932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832638|NCT00009932|Tubulin Modulators|tubulin modulators|mesh-ancestor
25832639|NCT00009932|Antimitotic Agents|antimitotic agents|mesh-ancestor
25832640|NCT00009932|Mitosis Modulators|mitosis modulators|mesh-ancestor
25832641|NCT00009932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832642|NCT00009932|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25832643|NCT00009932|Protective Agents|protective agents|mesh-ancestor
25832644|NCT00009932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797534|NCT01956201|Atorvastatin|atorvastatin|mesh-list
24797535|NCT01956201|Fenofibrate|fenofibrate|mesh-list
24797555|NCT01956487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24797557|NCT01956487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24930045|NCT04106011|Anticonvulsants|anticonvulsants|mesh-ancestor
24992206|NCT04168112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24992215|NCT04103554|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24992216|NCT04103554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24992217|NCT04103554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25832645|NCT00009958|Metronidazole|metronidazole|mesh-list
25832646|NCT00009958|Vaccines|vaccines|mesh-list
25047279|NCT00829686|Renal Agents|renal agents|mesh-ancestor
25658385|NCT01595438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25832647|NCT00009958|Sargramostim|sargramostim|mesh-list
24587104|NCT00893490|Mitomycins|mitomycins|mesh-list
25047280|NCT00829686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25047281|NCT00829686|Antimalarials|antimalarials|mesh-ancestor
25047282|NCT00829686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25047283|NCT00829686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25832648|NCT00009958|Immunologic Factors|immunologic factors|mesh-ancestor
25832649|NCT00009958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832650|NCT00009958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25832651|NCT00009958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25832652|NCT00009958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25832653|NCT00009958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25832654|NCT00009971|Fenretinide|fenretinide|mesh-list
25832655|NCT00009971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832656|NCT00009971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25832657|NCT00009971|Protective Agents|protective agents|mesh-ancestor
25832658|NCT00009971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832659|NCT00009984|Thalidomide|thalidomide|mesh-list
24992218|NCT04103554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24992219|NCT04103554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992220|NCT04088890|Cyclophosphamide|cyclophosphamide|mesh-list
25047307|NCT00829452|Ramipril|ramipril|mesh-list
24992221|NCT04088890|Fludarabine|fludarabine|mesh-list
24992222|NCT04088890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24992223|NCT04088890|Immunologic Factors|immunologic factors|mesh-ancestor
24992224|NCT04088890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107577|NCT03139500|Midazolam|midazolam|mesh-list
24785551|NCT01915069|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24785552|NCT01915069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785553|NCT01915069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25832660|NCT00009984|Fludarabine|fludarabine|mesh-list
25832661|NCT00009984|Fludarabine phosphate|fludarabine phosphate|mesh-list
25832662|NCT00009984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832663|NCT00009984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25832664|NCT00009984|Antimetabolites|antimetabolites|mesh-ancestor
25832665|NCT00009984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832666|NCT00009984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25832667|NCT00009984|Immunologic Factors|immunologic factors|mesh-ancestor
25832668|NCT00009984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832669|NCT00009984|Leprostatic Agents|leprostatic agents|mesh-ancestor
25832670|NCT00009984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25832671|NCT00009984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25832672|NCT00009984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25832673|NCT00009984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25832674|NCT00009984|Growth Substances|growth substances|mesh-ancestor
25832675|NCT00009984|Growth Inhibitors|growth inhibitors|mesh-ancestor
25832676|NCT00009997|Tamoxifen|tamoxifen|mesh-list
25832677|NCT00009997|Paclitaxel|paclitaxel|mesh-list
25832678|NCT00009997|Cyclophosphamide|cyclophosphamide|mesh-list
25832679|NCT00009997|Doxorubicin|doxorubicin|mesh-list
24785555|NCT01915069|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24785556|NCT01915069|Protective Agents|protective agents|mesh-ancestor
24785557|NCT01915069|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24785558|NCT01915069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24785559|NCT01915069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24785564|NCT01915134|Cisplatin|cisplatin|mesh-list
25107578|NCT03139500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25107579|NCT03139500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25107580|NCT03139500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25107581|NCT03139500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107582|NCT03139500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25107583|NCT03139500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25107584|NCT03139500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24595451|NCT00938613|Budesonide|budesonide|mesh-list
25832680|NCT00009997|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25832681|NCT00009997|Trastuzumab|trastuzumab|mesh-list
25832682|NCT00009997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25832683|NCT00009997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832684|NCT00009997|Tubulin Modulators|tubulin modulators|mesh-ancestor
25832685|NCT00009997|Antimitotic Agents|antimitotic agents|mesh-ancestor
25832686|NCT00009997|Mitosis Modulators|mitosis modulators|mesh-ancestor
25832687|NCT00009997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832688|NCT00009997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25413687|NCT03117751|Antiemetics|antiemetics|mesh-ancestor
25658387|NCT01595438|Antimalarials|antimalarials|mesh-ancestor
25832689|NCT00009997|Immunologic Factors|immunologic factors|mesh-ancestor
25832690|NCT00009997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832691|NCT00009997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25832692|NCT00009997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25832693|NCT00009997|Alkylating Agents|alkylating agents|mesh-ancestor
25832694|NCT00009997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25832695|NCT00009997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25832696|NCT00009997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25832697|NCT00009997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25832698|NCT00009997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25832699|NCT00009997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25832700|NCT00009997|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25832701|NCT00009997|Hormone Antagonists|hormone antagonists|mesh-ancestor
25832702|NCT00009997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25832703|NCT00009997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25107592|NCT03139331|Irinotecan|irinotecan|mesh-list
25107593|NCT03139331|Temozolomide|temozolomide|mesh-list
25107594|NCT03139331|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25107595|NCT03139331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25107596|NCT03139331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107597|NCT03139331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107598|NCT03139331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25107599|NCT03139331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25107600|NCT03139331|Alkylating Agents|alkylating agents|mesh-ancestor
25832704|NCT00009997|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25832705|NCT00009997|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25832706|NCT00009997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25832707|NCT00010010|Exemestane|exemestane|mesh-list
25832708|NCT00010010|Goserelin|goserelin|mesh-list
25832709|NCT00010010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832710|NCT00010010|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25832711|NCT00010010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25832712|NCT00010010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25832713|NCT00010010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832714|NCT00010010|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25832715|NCT00010010|Hormone Antagonists|hormone antagonists|mesh-ancestor
25875318|NCT04496960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24866088|NCT03593252|Metronidazole|metronidazole|mesh-list
25107609|NCT03138603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25107610|NCT03138603|Sympatholytics|sympatholytics|mesh-ancestor
25107611|NCT03138603|Autonomic Agents|autonomic agents|mesh-ancestor
25107612|NCT03138603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25107613|NCT03138603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107614|NCT03138603|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25107615|NCT03138603|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25107616|NCT03138603|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25041366|NCT02570490|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25041367|NCT02570490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041368|NCT02570490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041369|NCT02565732|Botulinum Toxins|botulinum toxins|mesh-list
25041370|NCT02565732|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25041371|NCT02565732|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25041372|NCT02565732|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25041373|NCT02565732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25041374|NCT02565732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041375|NCT02565732|Cholinergic Agents|cholinergic agents|mesh-ancestor
25041376|NCT02565732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050340|NCT00517153|Miglustat|miglustat|mesh-list
24595604|NCT00939835|Dexetimide|dexetimide|mesh-list
24992231|NCT04073147|Venetoclax|venetoclax|mesh-list
24992232|NCT04073147|Obinutuzumab|obinutuzumab|mesh-list
24992233|NCT04073147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992234|NCT04073147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24992235|NCT04054375|Prednisone|prednisone|mesh-list
24992236|NCT04054375|Prednisolone|prednisolone|mesh-list
24992237|NCT04054375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24992238|NCT04054375|Glucocorticoids|glucocorticoids|mesh-ancestor
24992239|NCT04054375|Hormones|hormones|mesh-ancestor
24992240|NCT04054375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24992241|NCT04054375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992242|NCT04054375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24992243|NCT04054375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658388|NCT01595438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25658389|NCT01595438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25658390|NCT01595438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25658391|NCT01595438|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24869575|NCT02820961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869577|NCT02820961|Hormone Antagonists|hormone antagonists|mesh-ancestor
24869595|NCT02704390|Methylphenidate|methylphenidate|mesh-list
24869604|NCT02643381|Ketamine|ketamine|mesh-list
25832716|NCT00010010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25832717|NCT00010010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832718|NCT00010010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25832719|NCT00010023|Cisplatin|cisplatin|mesh-list
24992263|NCT04032301|Analgesics|analgesics|mesh-ancestor
24992264|NCT04032301|Sensory System Agents|sensory system agents|mesh-ancestor
24992265|NCT04032301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24992266|NCT04032301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992267|NCT04032301|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24992268|NCT04032301|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24992269|NCT04032301|Anesthetics, General|anesthetics, general|mesh-ancestor
24992270|NCT04032301|Anesthetics|anesthetics|mesh-ancestor
25832720|NCT00010023|Capecitabine|capecitabine|mesh-list
25832721|NCT00010023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832722|NCT00010023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25832723|NCT00010023|Antimetabolites|antimetabolites|mesh-ancestor
25832724|NCT00010023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832725|NCT00010036|Carboplatin|carboplatin|mesh-list
25832726|NCT00010036|Irinotecan|irinotecan|mesh-list
25832727|NCT00010036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832728|NCT00010036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25832729|NCT00010036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24450083|NCT00317785|Sirolimus|sirolimus|mesh-list
24450084|NCT00317785|Mycophenolic Acid|mycophenolic acid|mesh-list
24450099|NCT00317785|Abortifacient Agents|abortifacient agents|mesh-ancestor
25163058|NCT02899611|Valproic Acid|valproic acid|mesh-list
25163059|NCT02899611|Anticonvulsants|anticonvulsants|mesh-ancestor
25163060|NCT02899611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163061|NCT02899611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163062|NCT02899611|GABA Agents|gaba agents|mesh-ancestor
25163063|NCT02899611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25163064|NCT02899611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163065|NCT02899611|Antimanic Agents|antimanic agents|mesh-ancestor
25163066|NCT02899611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25163067|NCT02899611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25163068|NCT02899611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25163069|NCT02899507|Amoxicillin|amoxicillin|mesh-list
25163070|NCT02899507|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24954483|NCT03876548|Iodine|iodine|mesh-list
24450100|NCT00317785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24450102|NCT00317785|Antimetabolites|antimetabolites|mesh-ancestor
25832730|NCT00010036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25832731|NCT00010036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992276|NCT03998319|Tenecteplase|tenecteplase|mesh-list
24992277|NCT03998319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24992278|NCT03998319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24992279|NCT03998319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992281|NCT03984214|Hallucinogens|hallucinogens|mesh-ancestor
24992282|NCT03984214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992283|NCT03984214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24992284|NCT03984214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24992285|NCT03984214|Analgesics|analgesics|mesh-ancestor
24930146|NCT04105023|Estrogens|estrogens|mesh-ancestor
24992286|NCT03984214|Sensory System Agents|sensory system agents|mesh-ancestor
24992287|NCT03984214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24992288|NCT03984214|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24992289|NCT03984214|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24992290|NCT03984214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24992291|NCT03984214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992292|NCT03984214|Hormones|hormones|mesh-ancestor
24992293|NCT03984214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25658392|NCT01595438|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25658393|NCT01595438|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25658394|NCT01595516|Ascorbic Acid|ascorbic acid|mesh-list
25658395|NCT01595516|Metoprolol|metoprolol|mesh-list
24797558|NCT01956487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797559|NCT01956591|Oxybutynin|oxybutynin|mesh-list
24866150|NCT03356483|Niacin|niacin|mesh-list
25658396|NCT01595516|Nebivolol|nebivolol|mesh-list
25658397|NCT01595516|Bradykinin|bradykinin|mesh-list
25832733|NCT00010049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658399|NCT01595516|Vitamins|vitamins|mesh-ancestor
25658400|NCT01595516|Micronutrients|micronutrients|mesh-ancestor
25658401|NCT01595516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658402|NCT01595516|Antioxidants|antioxidants|mesh-ancestor
24952539|NCT03893526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952540|NCT03893526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24952541|NCT03893526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25201287|NCT02728700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25201288|NCT02728700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25832734|NCT00010049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25832735|NCT00010049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952544|NCT03893435|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24952545|NCT03893435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24952546|NCT03893435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24952547|NCT03893435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25832736|NCT00010049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832737|NCT00010062|Fluorouracil|fluorouracil|mesh-list
25832738|NCT00010062|Antimetabolites|antimetabolites|mesh-ancestor
25832739|NCT00010062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832740|NCT00010062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24797560|NCT01956591|Parasympatholytics|parasympatholytics|mesh-ancestor
24797562|NCT01956591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24797563|NCT01956591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797564|NCT01956591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24797565|NCT01956591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24797566|NCT01956591|Cholinergic Agents|cholinergic agents|mesh-ancestor
24797567|NCT01956591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25832741|NCT00010062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832742|NCT00010062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24992317|NCT03953079|Sunitinib|sunitinib|mesh-list
25163071|NCT02899507|Clavulanic Acids|clavulanic acids|mesh-list
24992318|NCT03953079|Aflibercept|aflibercept|mesh-list
24780294|NCT01883323|Cyclophosphamide|cyclophosphamide|mesh-list
24992319|NCT03953079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992320|NCT03953079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24992321|NCT03953079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24992322|NCT03953079|Growth Substances|growth substances|mesh-ancestor
24992323|NCT03953079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992324|NCT03953079|Growth Inhibitors|growth inhibitors|mesh-ancestor
24992325|NCT03953079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24992326|NCT03953079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24992386|NCT03818802|Vitamin B Complex|vitamin b complex|mesh-ancestor
24992327|NCT03953079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992328|NCT03944876|Botulinum Toxins|botulinum toxins|mesh-list
24992329|NCT03944876|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24992330|NCT03944876|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24992331|NCT03944876|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24992332|NCT03944876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24992333|NCT03944876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992334|NCT03944876|Cholinergic Agents|cholinergic agents|mesh-ancestor
24992335|NCT03944876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24992336|NCT03944876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992337|NCT03944876|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24992338|NCT03944876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25408860|NCT03415828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25658403|NCT01595516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658404|NCT01595516|Protective Agents|protective agents|mesh-ancestor
25658405|NCT01595516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25658406|NCT01595516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25658407|NCT01595516|Sympatholytics|sympatholytics|mesh-ancestor
25658408|NCT01595516|Autonomic Agents|autonomic agents|mesh-ancestor
25658409|NCT01595516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25658410|NCT01595516|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25658411|NCT01595516|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25658412|NCT01595516|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25658413|NCT01595516|Adrenergic Agents|adrenergic agents|mesh-ancestor
25658414|NCT01595516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25658415|NCT01595516|Vasodilator Agents|vasodilator agents|mesh-ancestor
25201290|NCT02728700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832743|NCT00010062|Immunologic Factors|immunologic factors|mesh-ancestor
25832744|NCT00010062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832745|NCT00010075|Leucovorin|leucovorin|mesh-list
25832746|NCT00010075|Fluorouracil|fluorouracil|mesh-list
25832747|NCT00010075|Mitoxantrone|mitoxantrone|mesh-list
25832748|NCT00010075|Calcium|calcium|mesh-list
25832749|NCT00010075|Levoleucovorin|levoleucovorin|mesh-list
25832750|NCT00010075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25832751|NCT00010075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143207|NCT02944526|Sensory System Agents|sensory system agents|mesh-ancestor
25143209|NCT02944500|Liraglutide|liraglutide|mesh-list
25832752|NCT00010075|Antimetabolites|antimetabolites|mesh-ancestor
25832753|NCT00010075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832754|NCT00010075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25832755|NCT00010075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832756|NCT00010075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25832757|NCT00010075|Immunologic Factors|immunologic factors|mesh-ancestor
25832758|NCT00010075|Antidotes|antidotes|mesh-ancestor
25832759|NCT00010075|Protective Agents|protective agents|mesh-ancestor
25832760|NCT00010075|Vitamin B Complex|vitamin b complex|mesh-ancestor
25832761|NCT00010075|Vitamins|vitamins|mesh-ancestor
25832762|NCT00010075|Micronutrients|micronutrients|mesh-ancestor
24992341|NCT03944577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24992342|NCT03944577|Antimetabolites|antimetabolites|mesh-ancestor
24992343|NCT03944577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992344|NCT03944577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24992346|NCT03931291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24930218|NCT04103684|Autonomic Agents|autonomic agents|mesh-ancestor
24992347|NCT03931291|Antimetabolites|antimetabolites|mesh-ancestor
24992348|NCT03931291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992349|NCT03931291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992350|NCT03931291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24992351|NCT03922750|Insulin|insulin|mesh-list
24992352|NCT03922750|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24992353|NCT03922750|Insulin Glargine|insulin glargine|mesh-list
24992354|NCT03922750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24992355|NCT03922750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992356|NCT03910673|Fosfomycin|fosfomycin|mesh-list
24992357|NCT03910673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24992358|NCT03910673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24992359|NCT03882970|Tirzepatide|tirzepatide|mesh-list
24992360|NCT03882970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24992361|NCT03882970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992363|NCT03882970|Hormones|hormones|mesh-ancestor
24992364|NCT03882970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24992365|NCT03867734|Aztreonam|aztreonam|mesh-list
24992366|NCT03867734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24992367|NCT03867734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24992368|NCT03854903|Fulvestrant|fulvestrant|mesh-list
24992369|NCT03854903|Palbociclib|palbociclib|mesh-list
24992370|NCT03854903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24992371|NCT03854903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992372|NCT03854903|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24992373|NCT03854903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25163072|NCT02899507|Clavulanic Acid|clavulanic acid|mesh-list
24992374|NCT03854903|Hormone Antagonists|hormone antagonists|mesh-ancestor
24992379|NCT03854903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992381|NCT03829891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24992382|NCT03829891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992383|NCT03818802|Niacinamide|niacinamide|mesh-list
24992384|NCT03818802|Niacin|niacin|mesh-list
24992385|NCT03818802|Nicotinic Acids|nicotinic acids|mesh-list
24992387|NCT03818802|Vitamins|vitamins|mesh-ancestor
24992388|NCT03818802|Micronutrients|micronutrients|mesh-ancestor
24992389|NCT03818802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992390|NCT03818802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24992391|NCT03818802|Antimetabolites|antimetabolites|mesh-ancestor
24992392|NCT03818802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992393|NCT03818802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25832763|NCT00010075|Analgesics|analgesics|mesh-ancestor
25832764|NCT00010075|Sensory System Agents|sensory system agents|mesh-ancestor
25832765|NCT00010075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25832766|NCT00010075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25658416|NCT01595516|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25658417|NCT01595516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25832767|NCT00010075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25055378|NCT03521492|Vitamins|vitamins|mesh-ancestor
25832768|NCT00010075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25832769|NCT00010088|Leucovorin|leucovorin|mesh-list
25832770|NCT00010088|Gemcitabine|gemcitabine|mesh-list
25832771|NCT00010088|Fluorouracil|fluorouracil|mesh-list
25832772|NCT00010088|Calcium|calcium|mesh-list
25832773|NCT00010088|Levoleucovorin|levoleucovorin|mesh-list
25832774|NCT00010088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25832775|NCT00010088|Antimetabolites|antimetabolites|mesh-ancestor
25832776|NCT00010088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832777|NCT00010088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992413|NCT03796156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24992414|NCT03796156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24992415|NCT03796156|Analgesics|analgesics|mesh-ancestor
24992416|NCT03796156|Sensory System Agents|sensory system agents|mesh-ancestor
24992417|NCT03796156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24992418|NCT03796156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832778|NCT00010088|Antiviral Agents|antiviral agents|mesh-ancestor
25832779|NCT00010088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25832780|NCT00010088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25832781|NCT00010088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25832782|NCT00010088|Immunologic Factors|immunologic factors|mesh-ancestor
25832783|NCT00010088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832784|NCT00010088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25832785|NCT00010088|Antidotes|antidotes|mesh-ancestor
25832786|NCT00010088|Protective Agents|protective agents|mesh-ancestor
25832787|NCT00010088|Vitamin B Complex|vitamin b complex|mesh-ancestor
25832788|NCT00010088|Vitamins|vitamins|mesh-ancestor
25832789|NCT00010088|Micronutrients|micronutrients|mesh-ancestor
25832790|NCT00010140|Tamoxifen|tamoxifen|mesh-list
25832791|NCT00010140|Docetaxel|docetaxel|mesh-list
25832792|NCT00010140|Epirubicin|epirubicin|mesh-list
25832793|NCT00010140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832794|NCT00010140|Tubulin Modulators|tubulin modulators|mesh-ancestor
25832795|NCT00010140|Antimitotic Agents|antimitotic agents|mesh-ancestor
25832796|NCT00010140|Mitosis Modulators|mitosis modulators|mesh-ancestor
25832797|NCT00010140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832798|NCT00010140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25143302|NCT02943655|Mefenamic Acid|mefenamic acid|mesh-list
25832799|NCT00010140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25832800|NCT00010140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25832801|NCT00010140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24992419|NCT03796156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24992420|NCT03796156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24992421|NCT03796156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24992422|NCT03796156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24992457|NCT03689712|Avasopasem manganese|avasopasem manganese|mesh-list
24992458|NCT03689712|Antioxidants|antioxidants|mesh-ancestor
24992459|NCT03689712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992460|NCT03689712|Protective Agents|protective agents|mesh-ancestor
24992461|NCT03689712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992462|NCT03631446|Picosulfate sodium|picosulfate sodium|mesh-list
25163073|NCT02899507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25832802|NCT00010140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25832803|NCT00010140|Hormone Antagonists|hormone antagonists|mesh-ancestor
25832804|NCT00010140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24450108|NCT00317785|Antifungal Agents|antifungal agents|mesh-ancestor
24596152|NCT00942136|Omeprazole|omeprazole|mesh-list
25107644|NCT03138785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107645|NCT03138785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25107646|NCT03138785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25107649|NCT03138785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25107650|NCT03138785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25107651|NCT03138785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25107652|NCT03138785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25107653|NCT03138616|Vitamin D|vitamin d|mesh-list
25107654|NCT03138616|Vitamins|vitamins|mesh-ancestor
25107655|NCT03138616|Micronutrients|micronutrients|mesh-ancestor
25107656|NCT03138616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107657|NCT03138616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25107658|NCT03138499|Nivolumab|nivolumab|mesh-list
25107659|NCT03138499|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25107660|NCT03138499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25658418|NCT01595516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25658419|NCT01595516|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25658420|NCT01595516|Protease Inhibitors|protease inhibitors|mesh-ancestor
25658421|NCT01595516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107663|NCT03138499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107664|NCT03138447|Insulin|insulin|mesh-list
25107665|NCT03138447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25107666|NCT03138447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107667|NCT03138356|Metformin|metformin|mesh-list
25832805|NCT00010140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450109|NCT00317785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24450110|NCT00317785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24450111|NCT00317785|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25832806|NCT00010140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25832807|NCT00010140|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25832808|NCT00010140|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25832809|NCT00010140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25832810|NCT00010153|Fulvestrant|fulvestrant|mesh-list
25832811|NCT00010153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25832812|NCT00010153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832813|NCT00010153|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25832814|NCT00010153|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25143358|NCT02943252|Apatinib|apatinib|mesh-list
25832815|NCT00010153|Hormone Antagonists|hormone antagonists|mesh-ancestor
25107668|NCT03138356|Dapagliflozin|dapagliflozin|mesh-list
25107669|NCT03138356|Saxagliptin|saxagliptin|mesh-list
25107670|NCT03138356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25107671|NCT03138356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107672|NCT03138356|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25107673|NCT03138356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107674|NCT03138356|Incretins|incretins|mesh-ancestor
25107675|NCT03138356|Hormones|hormones|mesh-ancestor
25107676|NCT03138356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25107677|NCT03138356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25107678|NCT03138356|Protease Inhibitors|protease inhibitors|mesh-ancestor
25107679|NCT03138356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24992470|NCT03631446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832816|NCT00010153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25832817|NCT00010153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832818|NCT00010166|Gemcitabine|gemcitabine|mesh-list
25832819|NCT00010166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25832820|NCT00010166|Antimetabolites|antimetabolites|mesh-ancestor
25832821|NCT00010166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832822|NCT00010166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832823|NCT00010166|Antiviral Agents|antiviral agents|mesh-ancestor
25832824|NCT00010166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25163074|NCT02899507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25832825|NCT00010166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25832826|NCT00010166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25832827|NCT00010166|Immunologic Factors|immunologic factors|mesh-ancestor
25832828|NCT00010166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832829|NCT00010179|Lurtotecan|lurtotecan|mesh-list
25832830|NCT00010179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832831|NCT00010192|Aldesleukin|aldesleukin|mesh-list
25832832|NCT00010192|Rituximab|rituximab|mesh-list
25832833|NCT00010192|Interleukin-2|interleukin-2|mesh-list
25832834|NCT00010192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25832835|NCT00010192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832836|NCT00010192|Immunologic Factors|immunologic factors|mesh-ancestor
25832837|NCT00010192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832838|NCT00010192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25832839|NCT00010192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25832840|NCT00010192|Analgesics|analgesics|mesh-ancestor
25832841|NCT00010192|Sensory System Agents|sensory system agents|mesh-ancestor
25832842|NCT00010192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25832843|NCT00010192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25832844|NCT00010192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25832845|NCT00010192|Antiviral Agents|antiviral agents|mesh-ancestor
25832846|NCT00010192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25832847|NCT00010231|Calcitriol|calcitriol|mesh-list
25832848|NCT00010231|Dexamethasone|dexamethasone|mesh-list
25832849|NCT00010231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25832850|NCT00010231|Antiemetics|antiemetics|mesh-ancestor
25055430|NCT03521167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25055431|NCT03521167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25055432|NCT03521167|Antimanic Agents|antimanic agents|mesh-ancestor
25055433|NCT03521167|Antipyretics|antipyretics|mesh-ancestor
25055434|NCT03521063|Budesonide|budesonide|mesh-list
25055435|NCT03521063|Poractant alfa|poractant alfa|mesh-list
25055436|NCT03521063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25020862|NCT03676413|Xhance|xhance|mesh-list
25832851|NCT00010231|Autonomic Agents|autonomic agents|mesh-ancestor
25832852|NCT00010231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25832853|NCT00010231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832854|NCT00010231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24992493|NCT03567057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24992495|NCT03567057|Sensory System Agents|sensory system agents|mesh-ancestor
24992496|NCT03567057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24992497|NCT03552068|Clonidine|clonidine|mesh-list
24992498|NCT03552068|Analgesics|analgesics|mesh-ancestor
24992499|NCT03552068|Sensory System Agents|sensory system agents|mesh-ancestor
24992500|NCT03552068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24866333|NCT05153785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832855|NCT00010231|Glucocorticoids|glucocorticoids|mesh-ancestor
25832856|NCT00010231|Hormones|hormones|mesh-ancestor
25832857|NCT00010231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25832858|NCT00010231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25832859|NCT00010231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832860|NCT00010231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25832861|NCT00010231|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25832862|NCT00010231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24992504|NCT03552068|Autonomic Agents|autonomic agents|mesh-ancestor
24992505|NCT03552068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24992506|NCT03552068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24992507|NCT03552068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24992508|NCT03552068|Adrenergic Agents|adrenergic agents|mesh-ancestor
24992509|NCT03552068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24992510|NCT03552068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992511|NCT03548064|Vaccines|vaccines|mesh-list
24992512|NCT03548064|Immunologic Factors|immunologic factors|mesh-ancestor
24992513|NCT03548064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992514|NCT03534635|Pembrolizumab|pembrolizumab|mesh-list
24992515|NCT03534635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24992516|NCT03534635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992517|NCT03527316|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
24992518|NCT03527316|Hallucinogens|hallucinogens|mesh-ancestor
24992519|NCT03527316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992520|NCT03527316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24992521|NCT03527316|Serotonin Agents|serotonin agents|mesh-ancestor
24992522|NCT03527316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24992523|NCT03527316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992524|NCT03527316|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24992525|NCT03527316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25050372|NCT00512317|Neurosteroids|neurosteroids|mesh-ancestor
24822418|NCT02111629|Fluconazole|fluconazole|mesh-list
24866339|NCT05153785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24866340|NCT05153785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866341|NCT05153603|Olaparib|olaparib|mesh-list
24866342|NCT05153603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24866343|NCT05153603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866344|NCT05153603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866345|NCT05153603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832863|NCT00010231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832864|NCT00010231|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25832865|NCT00010231|Vitamins|vitamins|mesh-ancestor
25832866|NCT00010231|Micronutrients|micronutrients|mesh-ancestor
25832867|NCT00010231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24992526|NCT03527316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24992527|NCT03527316|Adrenergic Agents|adrenergic agents|mesh-ancestor
24450155|NCT00317876|Cyclophosphamide|cyclophosphamide|mesh-list
25658422|NCT01595529|Trimethoprim|trimethoprim|mesh-list
25658423|NCT01595529|Sulfamethoxazole|sulfamethoxazole|mesh-list
25658424|NCT01595529|Cephalexin|cephalexin|mesh-list
25658425|NCT01595529|Cefixime|cefixime|mesh-list
25658426|NCT01595529|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25658427|NCT01595529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25658428|NCT01595529|Renal Agents|renal agents|mesh-ancestor
25658429|NCT01595529|Antimalarials|antimalarials|mesh-ancestor
24495347|NCT00499668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495349|NCT00499668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24495351|NCT00499668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24450156|NCT00317876|Methotrexate|methotrexate|mesh-list
24450157|NCT00317876|Cyclosporins|cyclosporins|mesh-list
24450158|NCT00317876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24450159|NCT00317876|Immunologic Factors|immunologic factors|mesh-ancestor
24450160|NCT00317876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143500|NCT02942602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143502|NCT02942329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143503|NCT02942329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25143504|NCT02942329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143505|NCT02942329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143506|NCT02942303|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25143507|NCT02942303|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25143510|NCT02942303|Cholinergic Agents|cholinergic agents|mesh-ancestor
24450161|NCT00317876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24450162|NCT00317876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24450163|NCT00317876|Alkylating Agents|alkylating agents|mesh-ancestor
24450164|NCT00317876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832868|NCT00010270|Immunotoxins|immunotoxins|mesh-list
24450165|NCT00317876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450166|NCT00317876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24450167|NCT00317876|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25832869|NCT00010270|Immunologic Factors|immunologic factors|mesh-ancestor
25832870|NCT00010270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832871|NCT00010283|Beclomethasone|beclomethasone|mesh-list
25832872|NCT00010283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25832873|NCT00010283|Glucocorticoids|glucocorticoids|mesh-ancestor
25832874|NCT00010283|Hormones|hormones|mesh-ancestor
25832875|NCT00010283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25832876|NCT00010283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832877|NCT00010283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25832878|NCT00010283|Respiratory System Agents|respiratory system agents|mesh-ancestor
25832879|NCT00010322|Toremifene|toremifene|mesh-list
25832880|NCT00010322|Atamestane|atamestane|mesh-list
25832881|NCT00010322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25832882|NCT00010322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832883|NCT00010322|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25832884|NCT00010322|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25832885|NCT00010322|Hormone Antagonists|hormone antagonists|mesh-ancestor
25832886|NCT00010322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25832887|NCT00010322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832888|NCT00010322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25832889|NCT00010322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25832890|NCT00010322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832891|NCT00010361|Cyclosporine|cyclosporine|mesh-list
25832892|NCT00010361|Mycophenolic Acid|mycophenolic acid|mesh-list
25832893|NCT00010361|Fludarabine|fludarabine|mesh-list
25832894|NCT00010361|Cyclosporins|cyclosporins|mesh-list
25832895|NCT00010361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832896|NCT00010361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163075|NCT02899507|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25832897|NCT00010361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25658430|NCT01595529|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25658431|NCT01595529|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25658432|NCT01595529|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25658433|NCT01595529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658434|NCT01595529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658435|NCT01595529|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25658436|NCT01595529|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24938739|NCT04016246|Anesthetics, General|anesthetics, general|mesh-ancestor
25658437|NCT01595529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25055487|NCT03520595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25055488|NCT03520595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24822461|NCT02112019|Hydrocortisone|hydrocortisone|mesh-list
25832898|NCT00010361|Immunologic Factors|immunologic factors|mesh-ancestor
25832899|NCT00010361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832900|NCT00010361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24992558|NCT03396692|Anesthetics, Local|anesthetics, local|mesh-ancestor
24797568|NCT01956591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797569|NCT01956591|Urological Agents|urological agents|mesh-ancestor
24797571|NCT01956604|Analgesics|analgesics|mesh-ancestor
24797572|NCT01956604|Sensory System Agents|sensory system agents|mesh-ancestor
24797573|NCT01956604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24797574|NCT01956604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797575|NCT01956604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24797576|NCT01956604|Sympatholytics|sympatholytics|mesh-ancestor
24797577|NCT01956604|Autonomic Agents|autonomic agents|mesh-ancestor
24797578|NCT01956604|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24797579|NCT01956604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25143559|NCT02941562|Antimetabolites|antimetabolites|mesh-ancestor
24797580|NCT01956604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24797581|NCT01956604|Adrenergic Agents|adrenergic agents|mesh-ancestor
24797582|NCT01956604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24992734|NCT03048422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24797583|NCT01956604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797584|NCT01956695|Rituximab|rituximab|mesh-list
24797585|NCT01956695|Lenalidomide|lenalidomide|mesh-list
24797586|NCT01956695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24797587|NCT01956695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797588|NCT01956695|Immunologic Factors|immunologic factors|mesh-ancestor
25832901|NCT00010361|Antifungal Agents|antifungal agents|mesh-ancestor
25832902|NCT00010361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25832903|NCT00010361|Dermatologic Agents|dermatologic agents|mesh-ancestor
25832904|NCT00010361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25832905|NCT00010361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25832906|NCT00010361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25832907|NCT00010361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24992591|NCT03388190|Micronutrients|micronutrients|mesh-ancestor
24992592|NCT03382834|Tamoxifen|tamoxifen|mesh-list
24992593|NCT03382834|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24992594|NCT03382834|Vorinostat|vorinostat|mesh-list
24992595|NCT03382834|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24992596|NCT03382834|Hormone Antagonists|hormone antagonists|mesh-ancestor
24992598|NCT03382834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992611|NCT03353350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107680|NCT03138239|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25107681|NCT03138239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25107682|NCT03138239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107687|NCT03138031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107688|NCT03137927|Vaccines|vaccines|mesh-list
25107689|NCT03137927|Immunologic Factors|immunologic factors|mesh-ancestor
25107690|NCT03137927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992643|NCT03264352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24992644|NCT03264352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992670|NCT03194321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24992671|NCT03194321|Immunologic Factors|immunologic factors|mesh-ancestor
24992672|NCT03194321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992673|NCT03194321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24992674|NCT03194321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24992675|NCT03194321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163076|NCT02899507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202937|NCT02717871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992676|NCT03189693|Anesthetics|anesthetics|mesh-list
24992677|NCT03189693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24992678|NCT03189693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992679|NCT03170206|Palbociclib|palbociclib|mesh-list
24992680|NCT03170206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992681|NCT03170206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24992682|NCT03170206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24992683|NCT03170206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992684|NCT03150173|Buprenorphine|buprenorphine|mesh-list
24992685|NCT03150173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25658438|NCT01595529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25658439|NCT01595646|Insulin|insulin|mesh-list
25832908|NCT00010361|Antitubercular Agents|antitubercular agents|mesh-ancestor
24992686|NCT03150173|Narcotics|narcotics|mesh-ancestor
24992687|NCT03150173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25047410|NCT00817986|Baclofen|baclofen|mesh-list
24992688|NCT03150173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992689|NCT03150173|Analgesics|analgesics|mesh-ancestor
24992690|NCT03150173|Sensory System Agents|sensory system agents|mesh-ancestor
24992709|NCT03065062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992711|NCT03057431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24992712|NCT03057431|Diuretics|diuretics|mesh-ancestor
24992719|NCT03048422|Emtricitabine|emtricitabine|mesh-list
24992720|NCT03048422|Efavirenz|efavirenz|mesh-list
24992721|NCT03048422|Dolutegravir|dolutegravir|mesh-list
24992722|NCT03048422|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24992723|NCT03048422|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
24992724|NCT03048422|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24992725|NCT03048422|Antiviral Agents|antiviral agents|mesh-ancestor
24992726|NCT03048422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24992727|NCT03048422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24992728|NCT03048422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24992729|NCT03048422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24992730|NCT03048422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992731|NCT03048422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24992732|NCT03048422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24992733|NCT03048422|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24993145|NCT00579826|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24992735|NCT03048422|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24992736|NCT03048422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24992737|NCT03048422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25188178|NCT02807298|Carticaine|carticaine|mesh-list
24992738|NCT03048422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24992739|NCT03048422|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24992740|NCT03048422|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25832909|NCT00010361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25832910|NCT00010387|Cyclophosphamide|cyclophosphamide|mesh-list
24450168|NCT00317876|Abortifacient Agents|abortifacient agents|mesh-ancestor
24992741|NCT03022279|Ropivacaine|ropivacaine|mesh-list
24992742|NCT03022279|Anesthetics, Local|anesthetics, local|mesh-ancestor
24992743|NCT03022279|Anesthetics|anesthetics|mesh-ancestor
24992744|NCT03022279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24992745|NCT03022279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992746|NCT03022279|Sensory System Agents|sensory system agents|mesh-ancestor
24596857|NCT00946166|Simvastatin|simvastatin|mesh-list
25832911|NCT00010387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25832912|NCT00010387|Immunologic Factors|immunologic factors|mesh-ancestor
25832913|NCT00010387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832914|NCT00010387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24450179|NCT00317902|Epoetin Alfa|epoetin alfa|mesh-list
24450180|NCT00317902|Hematinics|hematinics|mesh-ancestor
24450181|NCT00317915|Irbesartan|irbesartan|mesh-list
24450182|NCT00317915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24450183|NCT00317915|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24450184|NCT00317915|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25832915|NCT00010387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24992831|NCT02811783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992832|NCT02811783|Sensory System Agents|sensory system agents|mesh-ancestor
24992833|NCT02811783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24992834|NCT02802228|Ifetroban|ifetroban|mesh-list
24785696|NCT01916187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24785697|NCT01916200|Paroxetine|paroxetine|mesh-list
24577889|NCT00846248|Micronutrients|micronutrients|mesh-ancestor
24785698|NCT01916200|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25202938|NCT02717871|Antiemetics|antiemetics|mesh-ancestor
24415030|NCT00199043|Gout Suppressants|gout suppressants|mesh-ancestor
24785699|NCT01916200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24785709|NCT01916200|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24785710|NCT01916200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24785711|NCT01916213|Hyaluronic Acid|hyaluronic acid|mesh-list
24785712|NCT01916213|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24785713|NCT01916213|Immunologic Factors|immunologic factors|mesh-ancestor
24785714|NCT01916213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450196|NCT00317954|Natriuretic Agents|natriuretic agents|mesh-ancestor
25107706|NCT03137498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25107707|NCT03137498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25107708|NCT03137498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25408861|NCT03415828|Glucocorticoids|glucocorticoids|mesh-ancestor
25055550|NCT03520049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809761|NCT02036125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25107709|NCT03137498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25107710|NCT03137498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107711|NCT03137498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25107712|NCT03137498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25107713|NCT03137498|Analgesics|analgesics|mesh-ancestor
25107714|NCT03137498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25107715|NCT03137498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25107716|NCT03137498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25107717|NCT03137498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107718|NCT03137316|Hormones|hormones|mesh-list
25107733|NCT03137368|Exemestane|exemestane|mesh-list
25107734|NCT03137368|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25107735|NCT03137368|Hormone Antagonists|hormone antagonists|mesh-ancestor
25107739|NCT03137368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25107742|NCT03137368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24840736|NCT02212210|Hormones|hormones|mesh-ancestor
24992846|NCT02675790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24992847|NCT02661022|Dexamethasone|dexamethasone|mesh-list
24992848|NCT02661022|Pomalidomide|pomalidomide|mesh-list
24992849|NCT02661022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24992850|NCT02661022|Antiemetics|antiemetics|mesh-ancestor
24992851|NCT02661022|Autonomic Agents|autonomic agents|mesh-ancestor
24992852|NCT02661022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24992853|NCT02661022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992854|NCT02661022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24992855|NCT02661022|Glucocorticoids|glucocorticoids|mesh-ancestor
24992856|NCT02661022|Hormones|hormones|mesh-ancestor
24992857|NCT02661022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24992858|NCT02661022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24992859|NCT02661022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992860|NCT02661022|Immunologic Factors|immunologic factors|mesh-ancestor
24992861|NCT02661022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24992862|NCT02661022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24992863|NCT02661022|Growth Substances|growth substances|mesh-ancestor
24992864|NCT02661022|Growth Inhibitors|growth inhibitors|mesh-ancestor
24992865|NCT02652195|Oxytocin|oxytocin|mesh-list
24992866|NCT02652195|Oxytocics|oxytocics|mesh-ancestor
24992867|NCT02652195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24992868|NCT02652195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992869|NCT02650271|Tenofovir|tenofovir|mesh-list
24992870|NCT02650271|Entecavir|entecavir|mesh-list
24992871|NCT02650271|Antiviral Agents|antiviral agents|mesh-ancestor
24992872|NCT02650271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24992873|NCT02650271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24992887|NCT02570984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24992888|NCT02570984|Respiratory System Agents|respiratory system agents|mesh-ancestor
24992889|NCT02539693|Lidocaine|lidocaine|mesh-list
24992890|NCT02539693|Clonidine|clonidine|mesh-list
24992891|NCT02539693|Anesthetics, Local|anesthetics, local|mesh-ancestor
24992892|NCT02539693|Anesthetics|anesthetics|mesh-ancestor
24992893|NCT02539693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24450200|NCT00317967|Antimetabolites|antimetabolites|mesh-ancestor
24450201|NCT00317967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450206|NCT00317980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24797681|NCT01957293|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24797682|NCT01957293|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24797683|NCT01957293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24797684|NCT01957293|Adrenergic Agents|adrenergic agents|mesh-ancestor
24797685|NCT01957293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24797686|NCT01957293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202939|NCT02717871|Autonomic Agents|autonomic agents|mesh-ancestor
24797687|NCT01957319|Vitamin E|vitamin e|mesh-list
24797688|NCT01957319|Silybin|silybin|mesh-list
24797689|NCT01957319|Vitamins|vitamins|mesh-ancestor
24797690|NCT01957319|Micronutrients|micronutrients|mesh-ancestor
24597223|NCT00947843|Clopidogrel|clopidogrel|mesh-list
24992918|NCT02505204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992919|NCT02505204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24992920|NCT02505204|Sympatholytics|sympatholytics|mesh-ancestor
24992921|NCT02505204|Autonomic Agents|autonomic agents|mesh-ancestor
25658440|NCT01595646|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25658441|NCT01595646|Insulin Detemir|insulin detemir|mesh-list
24992927|NCT02505204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658442|NCT01595646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24809780|NCT02036229|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24992928|NCT02487979|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
24992929|NCT02487979|Immunoconjugates|immunoconjugates|mesh-list
24992931|NCT02487979|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24992932|NCT02487979|Immunologic Factors|immunologic factors|mesh-ancestor
24992933|NCT02487979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992934|NCT02487979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24992935|NCT02487979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992937|NCT02310867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24992938|NCT02310867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992939|NCT02310867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992940|NCT02310867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24992941|NCT02310867|Immunologic Factors|immunologic factors|mesh-ancestor
24992942|NCT02310867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992943|NCT02310867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24992945|NCT02303431|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24992946|NCT02303431|Antithrombins|antithrombins|mesh-ancestor
24992947|NCT02303431|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24992948|NCT02303431|Protease Inhibitors|protease inhibitors|mesh-ancestor
24992949|NCT02303431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450207|NCT00317980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25832916|NCT00010387|Alkylating Agents|alkylating agents|mesh-ancestor
25832917|NCT00010387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832918|NCT00010387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832919|NCT00010387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25832920|NCT00010400|Cyclophosphamide|cyclophosphamide|mesh-list
24597284|NCT00948168|Hormones|hormones|mesh-ancestor
25832921|NCT00010400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24992950|NCT02303431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992951|NCT02303431|Anticoagulants|anticoagulants|mesh-ancestor
24992952|NCT02288897|Temozolomide|temozolomide|mesh-list
24992953|NCT02288897|Dacarbazine|dacarbazine|mesh-list
24992954|NCT02288897|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
24992955|NCT02288897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24992956|NCT02288897|Alkylating Agents|alkylating agents|mesh-ancestor
24992957|NCT02288897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992958|NCT02288897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992959|NCT02288897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24992963|NCT02022982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992964|NCT02022982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24992965|NCT02022982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24993098|NCT00938912|Lacosamide|lacosamide|mesh-list
24992966|NCT02022982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992967|NCT01898312|Mifepristone|mifepristone|mesh-list
24992968|NCT01898312|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24992969|NCT01898312|Abortifacient Agents|abortifacient agents|mesh-ancestor
24992970|NCT01898312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24992971|NCT01898312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992972|NCT01898312|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24992973|NCT01898312|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24992974|NCT01898312|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24992975|NCT01898312|Contraceptive Agents|contraceptive agents|mesh-ancestor
24992976|NCT01898312|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24992977|NCT01898312|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24992978|NCT01898312|Hormone Antagonists|hormone antagonists|mesh-ancestor
24992997|NCT01881048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24992998|NCT01881048|Analgesics|analgesics|mesh-ancestor
24992999|NCT01881048|Sensory System Agents|sensory system agents|mesh-ancestor
24993000|NCT01881048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955045|NCT03868852|Apatinib|apatinib|mesh-list
24993001|NCT01881048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661968|NCT01291615|Gemcitabine|gemcitabine|mesh-list
24993015|NCT01720147|Quercetin|quercetin|mesh-list
24993016|NCT01720147|Antioxidants|antioxidants|mesh-ancestor
24993017|NCT01720147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993018|NCT01720147|Protective Agents|protective agents|mesh-ancestor
24993019|NCT01720147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993020|NCT01694004|Benzocaine|benzocaine|mesh-list
24993021|NCT01694004|Anesthetics, Local|anesthetics, local|mesh-ancestor
24993022|NCT01694004|Anesthetics|anesthetics|mesh-ancestor
24993023|NCT01694004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25658443|NCT01595646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658444|NCT01595854|Dabigatran|dabigatran|mesh-list
25658445|NCT01595854|Ticagrelor|ticagrelor|mesh-list
25055644|NCT03519022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25055645|NCT03519022|Sensory System Agents|sensory system agents|mesh-ancestor
24993024|NCT01694004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993025|NCT01694004|Sensory System Agents|sensory system agents|mesh-ancestor
24993026|NCT01694004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24993027|NCT01491763|Imatinib Mesylate|imatinib mesylate|mesh-list
24993028|NCT01491763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993029|NCT01491763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24993030|NCT01491763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24993032|NCT01366898|Methotrexate|methotrexate|mesh-list
24993035|NCT01366898|Abortifacient Agents|abortifacient agents|mesh-ancestor
24993036|NCT01366898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24993037|NCT01366898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993038|NCT01366898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24993039|NCT01366898|Antimetabolites|antimetabolites|mesh-ancestor
24993040|NCT01366898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993041|NCT01366898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993042|NCT01366898|Dermatologic Agents|dermatologic agents|mesh-ancestor
24993043|NCT01366898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24993044|NCT01366898|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24993045|NCT01366898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24993046|NCT01366898|Immunologic Factors|immunologic factors|mesh-ancestor
24993047|NCT01366898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24993048|NCT01366898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24993049|NCT01366898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24993050|NCT01366898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24993051|NCT01366898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24993053|NCT01358201|Dexamethasone|dexamethasone|mesh-list
24993054|NCT01358201|Methotrexate|methotrexate|mesh-list
24993055|NCT01358201|Vincristine|vincristine|mesh-list
24993056|NCT01358201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24993057|NCT01358201|Antiemetics|antiemetics|mesh-ancestor
24993058|NCT01358201|Autonomic Agents|autonomic agents|mesh-ancestor
24993059|NCT01358201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24993060|NCT01358201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993061|NCT01358201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24993062|NCT01358201|Glucocorticoids|glucocorticoids|mesh-ancestor
24993080|NCT01358201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24993081|NCT01358201|Tubulin Modulators|tubulin modulators|mesh-ancestor
24993082|NCT01358201|Antimitotic Agents|antimitotic agents|mesh-ancestor
24993091|NCT01308034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24993092|NCT01308034|Growth Substances|growth substances|mesh-ancestor
24993093|NCT01308034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993094|NCT01308034|Growth Inhibitors|growth inhibitors|mesh-ancestor
24993095|NCT01308034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24993096|NCT01308034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24993097|NCT01308034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993102|NCT00938912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24993103|NCT00938912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993105|NCT00925652|Bevacizumab|bevacizumab|mesh-list
24993106|NCT00925652|Methotrexate|methotrexate|mesh-list
24993107|NCT00925652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24993108|NCT00925652|Immunologic Factors|immunologic factors|mesh-ancestor
24993109|NCT00925652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993110|NCT00925652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25163077|NCT02899507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822595|NCT02112643|Protective Agents|protective agents|mesh-ancestor
24785764|NCT01916382|Nitisinone|nitisinone|mesh-list
24785765|NCT01916382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24785766|NCT01916382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143849|NCT02940561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143850|NCT02940561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25143851|NCT02940561|Antimetabolites|antimetabolites|mesh-ancestor
24785767|NCT01916395|Sumatriptan|sumatriptan|mesh-list
24785768|NCT01916395|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24785769|NCT01916395|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24785770|NCT01916395|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24785771|NCT01916395|Serotonin Agents|serotonin agents|mesh-ancestor
24785772|NCT01916395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24785773|NCT01916395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658446|NCT01595854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25658447|NCT01595854|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24785774|NCT01916395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785775|NCT01916408|Wobenzym|wobenzym|mesh-list
24785776|NCT01916408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24785777|NCT01916408|Immunologic Factors|immunologic factors|mesh-ancestor
24785778|NCT01916408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785779|NCT01916447|Bevacizumab|bevacizumab|mesh-list
24785780|NCT01916447|Irinotecan|irinotecan|mesh-list
24785781|NCT01916447|Camptothecin|camptothecin|mesh-list
24785782|NCT01916447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24785783|NCT01916447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24785784|NCT01916447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24785785|NCT01916447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24785786|NCT01916447|Growth Substances|growth substances|mesh-ancestor
24785787|NCT01916447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785788|NCT01916447|Growth Inhibitors|growth inhibitors|mesh-ancestor
25107744|NCT03137368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25143870|NCT02940366|Pitavastatin|pitavastatin|mesh-list
25143871|NCT02940366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25107745|NCT03137368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107746|NCT03137368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107747|NCT03137290|Neostigmine|neostigmine|mesh-list
25107753|NCT03137290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107754|NCT03137290|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25107755|NCT03137290|Autonomic Agents|autonomic agents|mesh-ancestor
25107756|NCT03137290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25107757|NCT03137186|Metformin|metformin|mesh-list
25107758|NCT03137186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25107782|NCT03137017|Narcotics|narcotics|mesh-ancestor
24993116|NCT00925652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24993117|NCT00925652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24993118|NCT00925652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24993119|NCT00925652|Growth Substances|growth substances|mesh-ancestor
24993120|NCT00925652|Growth Inhibitors|growth inhibitors|mesh-ancestor
24993121|NCT00925652|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24993122|NCT00925652|Abortifacient Agents|abortifacient agents|mesh-ancestor
25832922|NCT00010400|Immunologic Factors|immunologic factors|mesh-ancestor
24993123|NCT00925652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24993124|NCT00925652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24993125|NCT00925652|Antimetabolites|antimetabolites|mesh-ancestor
24993127|NCT00925652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24993128|NCT00925652|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24797709|NCT01957436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797710|NCT01957436|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24797712|NCT01957449|Propranolol|propranolol|mesh-list
24797713|NCT01957449|Metoprolol|metoprolol|mesh-list
25143893|NCT02940444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24797714|NCT01957449|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25163078|NCT02899325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24797715|NCT01957449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24797716|NCT01957449|Adrenergic Agents|adrenergic agents|mesh-ancestor
24797717|NCT01957449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24797718|NCT01957449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797719|NCT01957449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797720|NCT01957449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24797721|NCT01957449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24797722|NCT01957449|Vasodilator Agents|vasodilator agents|mesh-ancestor
24797724|NCT01957449|Autonomic Agents|autonomic agents|mesh-ancestor
24797725|NCT01957449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24797726|NCT01957449|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24797727|NCT01957540|Ticagrelor|ticagrelor|mesh-list
24797728|NCT01957540|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24797729|NCT01957540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25832923|NCT00010400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832924|NCT00010400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25832925|NCT00010400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25832926|NCT00010400|Alkylating Agents|alkylating agents|mesh-ancestor
25832927|NCT00010400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832928|NCT00010400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832929|NCT00010400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25832930|NCT00010413|Cyclophosphamide|cyclophosphamide|mesh-list
24993168|NCT00186888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24993169|NCT00186888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24993170|NCT00186888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24993171|NCT00186888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24993172|NCT00186888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055705|NCT03518112|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25055706|NCT03518112|Lenograstim|lenograstim|mesh-list
25055707|NCT03518112|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25055708|NCT03518112|BB 1101|bb 1101|mesh-list
25055709|NCT03518112|Calcium|calcium|mesh-list
25055710|NCT03518112|Levoleucovorin|levoleucovorin|mesh-list
25055711|NCT03518112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25055712|NCT03518112|Immunologic Factors|immunologic factors|mesh-ancestor
24809981|NCT02037035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24993173|NCT00186888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24993174|NCT00186888|Tubulin Modulators|tubulin modulators|mesh-ancestor
24993175|NCT00186888|Antimitotic Agents|antimitotic agents|mesh-ancestor
24993176|NCT00186888|Mitosis Modulators|mitosis modulators|mesh-ancestor
24993177|NCT00186888|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24993178|NCT00001563|Rituximab|rituximab|mesh-list
24993179|NCT00001563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24993180|NCT00001563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993181|NCT00001563|Immunologic Factors|immunologic factors|mesh-ancestor
24993182|NCT00001563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993183|NCT00001563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24993184|NCT05200442|Cetuximab|cetuximab|mesh-list
24993185|NCT05200442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24993186|NCT05200442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993187|NCT05200429|Ivacaftor|ivacaftor|mesh-list
24993188|NCT05200429|Elexacaftor|elexacaftor|mesh-list
24993189|NCT05200429|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24993190|NCT05200429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25832931|NCT00010413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25832932|NCT00010413|Immunologic Factors|immunologic factors|mesh-ancestor
24993191|NCT05200429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993192|NCT05200299|Leucovorin|leucovorin|mesh-list
24993193|NCT05200299|Fluorouracil|fluorouracil|mesh-list
24993194|NCT05200299|Capecitabine|capecitabine|mesh-list
24993195|NCT05200299|Oxaliplatin|oxaliplatin|mesh-list
24993196|NCT05200299|Irinotecan|irinotecan|mesh-list
24993197|NCT05200299|Levoleucovorin|levoleucovorin|mesh-list
25832933|NCT00010413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832934|NCT00010413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25832935|NCT00010413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25832936|NCT00010413|Alkylating Agents|alkylating agents|mesh-ancestor
25832937|NCT00010413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832938|NCT00010413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832939|NCT00010413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25832940|NCT00010426|Cysteamine|cysteamine|mesh-list
25832941|NCT00010426|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
25832942|NCT00010426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832943|NCT00010452|Picibanil|picibanil|mesh-list
25832944|NCT00010452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875319|NCT04496960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875320|NCT04496960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875321|NCT04484363|Azacitidine|azacitidine|mesh-list
25875322|NCT04484363|Pevonedistat|pevonedistat|mesh-list
25875323|NCT04484363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25875324|NCT04484363|Antimetabolites|antimetabolites|mesh-ancestor
25875325|NCT04484363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993216|NCT05200260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993218|NCT05200156|Choline|choline|mesh-list
24993219|NCT05200156|Lipotropic Agents|lipotropic agents|mesh-ancestor
24993220|NCT05200156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24993221|NCT05200156|Antimetabolites|antimetabolites|mesh-ancestor
24993222|NCT05200156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993223|NCT05200156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24993260|NCT05198609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24993261|NCT05198609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658448|NCT01595854|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25658449|NCT01595854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25658450|NCT01595854|Purinergic Agents|purinergic agents|mesh-ancestor
25658451|NCT01595854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25658452|NCT01595854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658453|NCT01595854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658454|NCT01595854|Antithrombins|antithrombins|mesh-ancestor
25658455|NCT01595854|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24993262|NCT05198609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993263|NCT05198180|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25832945|NCT00010686|Phytoestrogens|phytoestrogens|mesh-list
25832946|NCT00010686|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24870171|NCT03527186|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24870172|NCT03527186|Serotonin Agents|serotonin agents|mesh-ancestor
24870173|NCT03527186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24870174|NCT03527186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870175|NCT03527186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550206|NCT00719693|Fenofibrate|fenofibrate|mesh-list
25832947|NCT00010686|Estrogens|estrogens|mesh-ancestor
25832948|NCT00010686|Hormones|hormones|mesh-ancestor
24870176|NCT03527186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24870177|NCT03527186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24870178|NCT03527186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24692498|NCT01414816|Interferons|interferons|mesh-list
24993264|NCT05198180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24993265|NCT05198180|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24993266|NCT05198180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24993267|NCT05198141|Letrozole|letrozole|mesh-list
24993268|NCT05198141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993284|NCT05198050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797739|NCT01957631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24797741|NCT01957631|Prednisolone acetate|prednisolone acetate|mesh-list
24797742|NCT01957631|Bupivacaine|bupivacaine|mesh-list
24797743|NCT01957631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24993285|NCT05198050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24993286|NCT05198050|Hormone Antagonists|hormone antagonists|mesh-ancestor
25832949|NCT00010686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25832950|NCT00010686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832951|NCT00010699|Vitamin E|vitamin e|mesh-list
25832952|NCT00010699|Vitamins|vitamins|mesh-ancestor
25832953|NCT00010699|Micronutrients|micronutrients|mesh-ancestor
25832954|NCT00010699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832955|NCT00010699|Antioxidants|antioxidants|mesh-ancestor
25832956|NCT00010699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993287|NCT05198050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24993288|NCT05198050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993289|NCT05198050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24993290|NCT05198050|Abortifacient Agents|abortifacient agents|mesh-ancestor
24993291|NCT05198050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24993292|NCT05198050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24993293|NCT05198050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24993294|NCT05198050|Oxytocics|oxytocics|mesh-ancestor
24993295|NCT05198050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24993296|NCT05198050|Vasodilator Agents|vasodilator agents|mesh-ancestor
24993297|NCT05198050|Urological Agents|urological agents|mesh-ancestor
24993298|NCT05197517|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24993299|NCT05197517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24993300|NCT05197517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24993301|NCT05197517|Antimetabolites|antimetabolites|mesh-ancestor
24993302|NCT05197517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993303|NCT05197517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24993304|NCT05197517|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24993305|NCT05197517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24993306|NCT05188898|Hyaluronic Acid|hyaluronic acid|mesh-list
24993307|NCT05188898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24993308|NCT05188898|Immunologic Factors|immunologic factors|mesh-ancestor
24993309|NCT05188898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993310|NCT05188898|Viscosupplements|viscosupplements|mesh-ancestor
24597885|NCT00952497|Capecitabine|capecitabine|mesh-list
25832957|NCT00010699|Protective Agents|protective agents|mesh-ancestor
25832958|NCT00010725|Vitamins|vitamins|mesh-list
25832959|NCT00010725|Micronutrients|micronutrients|mesh-ancestor
25832960|NCT00010725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832961|NCT00010842|Vitamin E|vitamin e|mesh-list
25658456|NCT01595854|Protease Inhibitors|protease inhibitors|mesh-ancestor
25658457|NCT01595854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658458|NCT01595854|Anticoagulants|anticoagulants|mesh-ancestor
25658459|NCT01596062|Cyclosporine|cyclosporine|mesh-list
25658460|NCT01596062|Mycophenolic Acid|mycophenolic acid|mesh-list
25658461|NCT01596062|Everolimus|everolimus|mesh-list
25658462|NCT01596062|Cyclosporins|cyclosporins|mesh-list
25658463|NCT01596062|Basiliximab|basiliximab|mesh-list
25658464|NCT01596062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658465|NCT01596062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658466|NCT01596062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25658467|NCT01596062|Immunologic Factors|immunologic factors|mesh-ancestor
25055812|NCT03517930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24870261|NCT02896855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870262|NCT02896855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25832962|NCT00010842|Thioctic Acid|thioctic acid|mesh-list
25832963|NCT00010842|Selenium|selenium|mesh-list
25163079|NCT02899325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25832964|NCT00010842|Vitamins|vitamins|mesh-ancestor
25832965|NCT00010842|Micronutrients|micronutrients|mesh-ancestor
25832966|NCT00010842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832967|NCT00010842|Antioxidants|antioxidants|mesh-ancestor
25832968|NCT00010842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832969|NCT00010842|Protective Agents|protective agents|mesh-ancestor
24993311|NCT05188898|Protective Agents|protective agents|mesh-ancestor
24993312|NCT05178225|Ubiquinone|ubiquinone|mesh-list
24993313|NCT05178225|Coenzyme Q10|coenzyme q10|mesh-list
24993314|NCT05178225|Anticoagulants|anticoagulants|mesh-list
24841290|NCT02215213|Vitamin D|vitamin d|mesh-list
24993315|NCT05178225|Micronutrients|micronutrients|mesh-ancestor
24993316|NCT05178225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993317|NCT05178225|Vitamins|vitamins|mesh-ancestor
24993318|NCT05178173|Ethanol|ethanol|mesh-list
24993319|NCT05178173|Cetylpyridinium|cetylpyridinium|mesh-list
24993320|NCT05178173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24993321|NCT05178173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24993322|NCT05178173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24993323|NCT05178173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993324|NCT05162443|Adagrasib|adagrasib|mesh-list
24993325|NCT05162443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993326|NCT05139849|Methylprednisolone|methylprednisolone|mesh-list
24993327|NCT05139849|Hydrocortisone|hydrocortisone|mesh-list
24993328|NCT05139849|Vasopressins|vasopressins|mesh-list
24993329|NCT05139849|Arginine Vasopressin|arginine vasopressin|mesh-list
24993330|NCT05139849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25832970|NCT00010842|Trace Elements|trace elements|mesh-ancestor
25832971|NCT00010842|Vitamin B Complex|vitamin b complex|mesh-ancestor
25832972|NCT00010855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25832973|NCT00010855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25832974|NCT00010855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832975|NCT00010881|Antioxidants|antioxidants|mesh-list
25832976|NCT00010881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25832977|NCT00010881|Protective Agents|protective agents|mesh-ancestor
25832978|NCT00010881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832979|NCT00011076|Pirfenidone|pirfenidone|mesh-list
25832980|NCT00011076|Analgesics|analgesics|mesh-ancestor
25832981|NCT00011076|Sensory System Agents|sensory system agents|mesh-ancestor
25832982|NCT00011076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25047508|NCT00805350|SR 46349B|sr 46349b|mesh-list
25832983|NCT00011076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25832984|NCT00011076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25832985|NCT00011076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25832986|NCT00011076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25832987|NCT00011076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25832988|NCT00011076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25832989|NCT00011089|Tenofovir|tenofovir|mesh-list
25832990|NCT00011089|Antiviral Agents|antiviral agents|mesh-ancestor
25832991|NCT00011089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25832992|NCT00011089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25832993|NCT00011089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25832994|NCT00011089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24993335|NCT05139849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24993336|NCT05139849|Glucocorticoids|glucocorticoids|mesh-ancestor
24993337|NCT05139849|Hormones|hormones|mesh-ancestor
24993338|NCT05139849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24993339|NCT05139849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24993340|NCT05139849|Protective Agents|protective agents|mesh-ancestor
24993341|NCT05139849|Hemostatics|hemostatics|mesh-ancestor
24993342|NCT05139849|Coagulants|coagulants|mesh-ancestor
24993343|NCT05139849|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24993344|NCT05139849|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24993345|NCT05139849|Natriuretic Agents|natriuretic agents|mesh-ancestor
24993346|NCT05131698|Lenvatinib|lenvatinib|mesh-list
24993347|NCT05131698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993348|NCT05131698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25658468|NCT01596062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658469|NCT01596062|Antifungal Agents|antifungal agents|mesh-ancestor
25658470|NCT01596062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25658471|NCT01596062|Dermatologic Agents|dermatologic agents|mesh-ancestor
25832995|NCT00011089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993349|NCT05131698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24993350|NCT05131698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993352|NCT05110781|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24993353|NCT05110781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993354|NCT05110781|Immunologic Factors|immunologic factors|mesh-ancestor
24993356|NCT05099276|Tranexamic Acid|tranexamic acid|mesh-list
24993382|NCT05074485|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24993383|NCT05074485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24993384|NCT05073575|Hyaluronic Acid|hyaluronic acid|mesh-list
24939224|NCT04011930|Vitamin D|vitamin d|mesh-list
24993385|NCT05073575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24993386|NCT05073575|Immunologic Factors|immunologic factors|mesh-ancestor
24993387|NCT05073575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993388|NCT05073575|Viscosupplements|viscosupplements|mesh-ancestor
24993389|NCT05073575|Protective Agents|protective agents|mesh-ancestor
24993390|NCT05062135|Progesterone|progesterone|mesh-list
25107784|NCT03137017|Antitussive Agents|antitussive agents|mesh-ancestor
24785791|NCT01916447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24785792|NCT01916447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144079|NCT02939235|Antiemetics|antiemetics|mesh-ancestor
24785793|NCT01916447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24785794|NCT01916577|Plerixafor|plerixafor|mesh-list
24785795|NCT01916577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24785796|NCT01916577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24785797|NCT01916577|Antiviral Agents|antiviral agents|mesh-ancestor
24785798|NCT01916577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24785799|NCT01916642|Lidocaine|lidocaine|mesh-list
24785800|NCT01916642|Etomidate|etomidate|mesh-list
24785801|NCT01916642|Anesthetics, Local|anesthetics, local|mesh-ancestor
24785802|NCT01916642|Anesthetics|anesthetics|mesh-ancestor
24785803|NCT01916642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24578039|NCT00846703|Vincristine|vincristine|mesh-list
24578040|NCT00846703|Mercaptopurine|mercaptopurine|mesh-list
24578041|NCT00846703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24578042|NCT00846703|Antiemetics|antiemetics|mesh-ancestor
24578043|NCT00846703|Autonomic Agents|autonomic agents|mesh-ancestor
25107785|NCT03137017|Respiratory System Agents|respiratory system agents|mesh-ancestor
25107786|NCT03137082|Guanfacine|guanfacine|mesh-list
25107788|NCT03137082|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25107789|NCT03137082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25107790|NCT03137082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25107791|NCT03137082|Adrenergic Agents|adrenergic agents|mesh-ancestor
25107792|NCT03137082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25107793|NCT03137082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107794|NCT03137082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107796|NCT03137004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25107797|NCT03137004|Tubulin Modulators|tubulin modulators|mesh-ancestor
25107798|NCT03137004|Antimitotic Agents|antimitotic agents|mesh-ancestor
25107799|NCT03137004|Mitosis Modulators|mitosis modulators|mesh-ancestor
25107800|NCT03137004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107801|NCT03136666|Candesartan|candesartan|mesh-list
25107802|NCT03136666|Candesartan cilexetil|candesartan cilexetil|mesh-list
25107803|NCT03136666|Nifedipine|nifedipine|mesh-list
25107804|NCT03136666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25107805|NCT03136666|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25107806|NCT03136666|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25107807|NCT03136666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578047|NCT00846703|Glucocorticoids|glucocorticoids|mesh-ancestor
25107808|NCT03136666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25107809|NCT03136666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25107810|NCT03136666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25107811|NCT03136666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107812|NCT03136666|Vasodilator Agents|vasodilator agents|mesh-ancestor
25107813|NCT03136666|Tocolytic Agents|tocolytic agents|mesh-ancestor
25107814|NCT03136666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25107815|NCT03136705|Niacinamide|niacinamide|mesh-list
25107816|NCT03136705|Niacin|niacin|mesh-list
25107817|NCT03136705|Nicotinic Acids|nicotinic acids|mesh-list
25107818|NCT03136705|Vitamin B Complex|vitamin b complex|mesh-ancestor
25107819|NCT03136705|Vitamins|vitamins|mesh-ancestor
24610155|NCT01000116|Coagulants|coagulants|mesh-ancestor
24867386|NCT00585195|Antitubercular Agents|antitubercular agents|mesh-ancestor
24867387|NCT00585195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25832996|NCT00011089|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25107826|NCT03136705|Vasodilator Agents|vasodilator agents|mesh-ancestor
25107827|NCT03136796|Meropenem|meropenem|mesh-list
25107828|NCT03136796|Piperacillin|piperacillin|mesh-list
25832997|NCT00011089|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25832998|NCT00011128|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25832999|NCT00011128|Antiviral Agents|antiviral agents|mesh-ancestor
24810150|NCT02038335|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24810151|NCT02038335|Levonorgestrel|levonorgestrel|mesh-list
25201332|NCT02728687|Antipruritics|antipruritics|mesh-ancestor
25833000|NCT00011128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833001|NCT00011297|Gabapentin|gabapentin|mesh-list
25833002|NCT00011297|Lorazepam|lorazepam|mesh-list
25055909|NCT03517020|Adrenergic Agents|adrenergic agents|mesh-ancestor
25055910|NCT03517020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25055911|NCT03517020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055912|NCT03517020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055913|NCT03516955|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25107829|NCT03136796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25107830|NCT03136796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25202940|NCT02717871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25107831|NCT03136510|Apixaban|apixaban|mesh-list
25107832|NCT03136510|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25107833|NCT03136510|Antithrombins|antithrombins|mesh-ancestor
24841380|NCT02215538|Methylphenidate|methylphenidate|mesh-list
25144157|NCT02938273|Cetuximab|cetuximab|mesh-list
24867415|NCT04527003|Cannabidiol|cannabidiol|mesh-list
24867416|NCT04527003|Norethindrone|norethindrone|mesh-list
24867417|NCT04527003|Norethindrone Acetate|norethindrone acetate|mesh-list
24993420|NCT04906902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993433|NCT04872686|Povidone-Iodine|povidone-iodine|mesh-list
24993434|NCT04872686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24993435|NCT04872686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24993437|NCT04856293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993438|NCT04856293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24993439|NCT04856293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24993440|NCT04856293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993441|NCT04844619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24993442|NCT04844619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24993443|NCT04783233|Chitosan|chitosan|mesh-list
24867459|NCT04372017|Vitamin D|vitamin d|mesh-list
25833003|NCT00011297|Analgesics|analgesics|mesh-ancestor
25833004|NCT00011297|Sensory System Agents|sensory system agents|mesh-ancestor
25833005|NCT00011297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25833006|NCT00011297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993445|NCT04783233|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24993446|NCT04783233|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24993447|NCT04783233|Antimetabolites|antimetabolites|mesh-ancestor
24993448|NCT04783233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993449|NCT04783233|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24993451|NCT04783233|Sequestering Agents|sequestering agents|mesh-ancestor
24993452|NCT04783233|Hemostatics|hemostatics|mesh-ancestor
24993453|NCT04783233|Coagulants|coagulants|mesh-ancestor
24797744|NCT01957631|Prednisolone phosphate|prednisolone phosphate|mesh-list
24797745|NCT01957631|Anesthetics, Local|anesthetics, local|mesh-ancestor
24797746|NCT01957631|Anesthetics|anesthetics|mesh-ancestor
24797747|NCT01957631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25107834|NCT03136510|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25144194|NCT02937662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24797748|NCT01957631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797749|NCT01957631|Sensory System Agents|sensory system agents|mesh-ancestor
24867478|NCT04339049|Sensory System Agents|sensory system agents|mesh-ancestor
24598179|NCT00954395|Fibrin fragment D|fibrin fragment d|mesh-list
24797750|NCT01957631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24797751|NCT01957631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24797752|NCT01957631|Antiemetics|antiemetics|mesh-ancestor
24601151|NCT00963040|Oxytocics|oxytocics|mesh-ancestor
24797753|NCT01957631|Autonomic Agents|autonomic agents|mesh-ancestor
24797754|NCT01957631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25658472|NCT01596062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25658473|NCT01596062|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25658474|NCT01596062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658475|NCT01596062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25658476|NCT01596062|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25658477|NCT01596062|Antitubercular Agents|antitubercular agents|mesh-ancestor
25658478|NCT01596062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25658479|NCT01596088|Dexrazoxane|dexrazoxane|mesh-list
25658480|NCT01596088|Razoxane|razoxane|mesh-list
25658481|NCT01596088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658482|NCT01596088|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24797755|NCT01957631|Glucocorticoids|glucocorticoids|mesh-ancestor
24797756|NCT01957631|Hormones|hormones|mesh-ancestor
25658483|NCT01596088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24870592|NCT04867798|Tenofovir|tenofovir|mesh-list
24870593|NCT04867798|Lamivudine|lamivudine|mesh-list
24870594|NCT04867798|Antiviral Agents|antiviral agents|mesh-ancestor
24870595|NCT04867798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24870598|NCT04867798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833007|NCT00011297|Anticonvulsants|anticonvulsants|mesh-ancestor
25833008|NCT00011297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25833009|NCT00011297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25833010|NCT00011297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25833011|NCT00011297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24450242|NCT00318201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450279|NCT00318448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450280|NCT00318513|Bevacizumab|bevacizumab|mesh-list
25833012|NCT00011297|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24955513|NCT03864575|Celecoxib|celecoxib|mesh-list
25833013|NCT00011297|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25833014|NCT00011297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25833015|NCT00011297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833016|NCT00011297|Antimanic Agents|antimanic agents|mesh-ancestor
25833017|NCT00011297|Antiemetics|antiemetics|mesh-ancestor
25144232|NCT02937896|Sensory System Agents|sensory system agents|mesh-ancestor
24797775|NCT01957943|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24797776|NCT01957943|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24797778|NCT01957956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24797779|NCT01957956|Alkylating Agents|alkylating agents|mesh-ancestor
24797780|NCT01957956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797781|NCT01957956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797782|NCT01957995|Docetaxel|docetaxel|mesh-list
24797783|NCT01957995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797784|NCT01957995|Tubulin Modulators|tubulin modulators|mesh-ancestor
24797785|NCT01957995|Antimitotic Agents|antimitotic agents|mesh-ancestor
24797786|NCT01957995|Mitosis Modulators|mitosis modulators|mesh-ancestor
25833018|NCT00011297|Autonomic Agents|autonomic agents|mesh-ancestor
24797796|NCT01958138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24797797|NCT01958216|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24797798|NCT01958216|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24797799|NCT01958216|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24797800|NCT01958216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24797801|NCT01958372|Etoposide|etoposide|mesh-list
25833019|NCT00011297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25833020|NCT00011297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25833021|NCT00011297|GABA Modulators|gaba modulators|mesh-ancestor
25833022|NCT00011297|GABA Agents|gaba agents|mesh-ancestor
25833023|NCT00011362|Dexamethasone|dexamethasone|mesh-list
25833024|NCT00011362|Dexamethasone acetate|dexamethasone acetate|mesh-list
25833025|NCT00011362|BB 1101|bb 1101|mesh-list
25833026|NCT00011362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25833027|NCT00011362|Antiemetics|antiemetics|mesh-ancestor
25833028|NCT00011362|Autonomic Agents|autonomic agents|mesh-ancestor
25833029|NCT00011362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25833030|NCT00011362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833031|NCT00011362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25833032|NCT00011362|Glucocorticoids|glucocorticoids|mesh-ancestor
24797802|NCT01958372|Pemetrexed|pemetrexed|mesh-list
24797803|NCT01958372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797804|NCT01958372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24797805|NCT01958372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24993473|NCT04703205|Ivermectin|ivermectin|mesh-list
24993474|NCT04703205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24993475|NCT04703205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24993476|NCT04680598|Antiviral Agents|antiviral agents|mesh-list
24993477|NCT04680598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24993478|NCT04676334|Rucaparib|rucaparib|mesh-list
24993479|NCT04676334|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24993480|NCT04676334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24993481|NCT04676334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993482|NCT04676334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993488|NCT04608903|Sulforaphane|sulforaphane|mesh-list
25107835|NCT03136510|Protease Inhibitors|protease inhibitors|mesh-ancestor
24993489|NCT04608903|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24993490|NCT04608903|Protective Agents|protective agents|mesh-ancestor
24993491|NCT04608903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658484|NCT01596088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25658485|NCT01596088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658486|NCT01596088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658487|NCT01596088|Protective Agents|protective agents|mesh-ancestor
25833033|NCT00011362|Hormones|hormones|mesh-ancestor
24870727|NCT04306510|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24870728|NCT04306510|Immunologic Factors|immunologic factors|mesh-ancestor
24870729|NCT04306510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870730|NCT04132817|Paclitaxel|paclitaxel|mesh-list
24993492|NCT04608903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993493|NCT04560127|Apatinib|apatinib|mesh-list
25833034|NCT00011362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25833035|NCT00011362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25833036|NCT00011362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993499|NCT04544098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25163080|NCT02899325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993500|NCT04544098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993501|NCT04518345|Azacitidine|azacitidine|mesh-list
24993502|NCT04518345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24993503|NCT04518345|Antimetabolites|antimetabolites|mesh-ancestor
24993504|NCT04518345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993506|NCT04518345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24993507|NCT04515472|Hormones|hormones|mesh-list
24993508|NCT04515472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993509|NCT04515472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24993510|NCT04512079|Enoxaparin|enoxaparin|mesh-list
24993511|NCT04512079|Apixaban|apixaban|mesh-list
24993512|NCT04512079|Anticoagulants|anticoagulants|mesh-ancestor
24993513|NCT04512079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24867575|NCT03842696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25833037|NCT00011362|Protease Inhibitors|protease inhibitors|mesh-ancestor
25833038|NCT00011362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833039|NCT00011362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833040|NCT00011375|Rolipram|rolipram|mesh-list
25833041|NCT00011375|Antidepressive Agents|antidepressive agents|mesh-ancestor
25833042|NCT00011375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25833043|NCT00011375|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25833044|NCT00011375|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25833045|NCT00011375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833046|NCT00011375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833047|NCT00011479|Abacavir|abacavir|mesh-list
25833048|NCT00011479|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25833049|NCT00011479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25833050|NCT00011479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833051|NCT00011479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993545|NCT05416827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24993546|NCT05416827|Glucocorticoids|glucocorticoids|mesh-ancestor
24993548|NCT05416827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24993549|NCT05416827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24993550|NCT05416827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24636197|NCT01143831|Hemostatics|hemostatics|mesh-ancestor
25107836|NCT03136510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107837|NCT03136510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785827|NCT01916785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785828|NCT01916798|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24785829|NCT01916798|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24785830|NCT01916798|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25833052|NCT00011479|Antiviral Agents|antiviral agents|mesh-ancestor
25833053|NCT00011479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833054|NCT00011479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25833055|NCT00011479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25833056|NCT00011635|Silymarin|silymarin|mesh-list
25833057|NCT00011635|Antioxidants|antioxidants|mesh-ancestor
25833058|NCT00011635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833059|NCT00011635|Protective Agents|protective agents|mesh-ancestor
25833060|NCT00011635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785831|NCT01916798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24785832|NCT01916850|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
24785833|NCT01916850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24785834|NCT01916850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658488|NCT01596088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658489|NCT01596088|Antimitotic Agents|antimitotic agents|mesh-ancestor
25658490|NCT01596088|Mitosis Modulators|mitosis modulators|mesh-ancestor
25658491|NCT01596127|Rituximab|rituximab|mesh-list
25833061|NCT00011765|Fluoxetine|fluoxetine|mesh-list
24870954|NCT01230242|Contraceptive Agents|contraceptive agents|mesh-ancestor
24870955|NCT01230242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24870956|NCT01230242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870957|NCT01230242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25833062|NCT00011765|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25833063|NCT00011765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24870958|NCT01230242|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24870959|NCT01230242|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24870961|NCT00983437|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24870962|NCT00983437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870963|NCT00983437|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24785835|NCT01916850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24785836|NCT01916850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785838|NCT01916863|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
24785839|NCT01916863|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24785840|NCT01916863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163081|NCT02899364|Sodium thiosulfate|sodium thiosulfate|mesh-list
24417338|NCT00206193|Luteolytic Agents|luteolytic agents|mesh-ancestor
25107842|NCT03136341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25107843|NCT03136341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107844|NCT03136341|Cholinergic Agents|cholinergic agents|mesh-ancestor
25107845|NCT03136341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25107846|NCT03136341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107847|NCT03136341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25107848|NCT03136341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24993561|NCT05416762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993562|NCT05416762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24993563|NCT05416762|Serotonin Agents|serotonin agents|mesh-ancestor
24993564|NCT05416762|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24993569|NCT05416580|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24993570|NCT05416580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24993571|NCT05416580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993572|NCT05416580|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25833064|NCT00011765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25833065|NCT00011765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833066|NCT00011765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25833067|NCT00011765|Serotonin Agents|serotonin agents|mesh-ancestor
25833068|NCT00011765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833069|NCT00011765|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25833070|NCT00011765|Antidepressive Agents|antidepressive agents|mesh-ancestor
25833071|NCT00011765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25833072|NCT00011765|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25833073|NCT00011765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25833074|NCT00011765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25144439|NCT02935933|Narcotics|narcotics|mesh-ancestor
24450289|NCT00318539|Antidepressive Agents|antidepressive agents|mesh-ancestor
24450290|NCT00318539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24450291|NCT00318539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24450292|NCT00318539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24450293|NCT00318539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24450294|NCT00318539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450295|NCT00318552|Meropenem|meropenem|mesh-list
24450296|NCT00318552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24450297|NCT00318552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24450298|NCT00318630|Rosiglitazone|rosiglitazone|mesh-list
24450312|NCT00318669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25658492|NCT01596127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25658493|NCT01596127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658494|NCT01596127|Immunologic Factors|immunologic factors|mesh-ancestor
25658495|NCT01596127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658496|NCT01596127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25658497|NCT01596335|Immunoglobulins|immunoglobulins|mesh-list
25658498|NCT01596335|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25658499|NCT01596335|Antibodies|antibodies|mesh-list
25658500|NCT01596335|Immunologic Factors|immunologic factors|mesh-ancestor
25658501|NCT01596335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658502|NCT01596504|Metformin|metformin|mesh-list
25658503|NCT01596504|Insulin Glargine|insulin glargine|mesh-list
25658504|NCT01596504|Liraglutide|liraglutide|mesh-list
25833075|NCT00011778|Bortezomib|bortezomib|mesh-list
24871038|NCT05163704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24871083|NCT05160727|Irinotecan|irinotecan|mesh-list
24871101|NCT05141422|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25833076|NCT00011778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450313|NCT00318669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25833077|NCT00011804|Topiramate|topiramate|mesh-list
25833078|NCT00011804|Anticonvulsants|anticonvulsants|mesh-ancestor
25833079|NCT00011804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25833080|NCT00011804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833081|NCT00011895|Lamivudine|lamivudine|mesh-list
25833082|NCT00011895|Zidovudine|zidovudine|mesh-list
25833083|NCT00011895|Efavirenz|efavirenz|mesh-list
25833084|NCT00011895|Abacavir|abacavir|mesh-list
25833085|NCT00011895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25833086|NCT00011895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25833087|NCT00011895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417447|NCT00206492|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25833088|NCT00011895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833089|NCT00011895|Antiviral Agents|antiviral agents|mesh-ancestor
25833090|NCT00011895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833091|NCT00011895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25833092|NCT00011895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25833093|NCT00011895|Antimetabolites|antimetabolites|mesh-ancestor
25833094|NCT00011895|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25833095|NCT00011895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24993610|NCT05416073|Anesthetics|anesthetics|mesh-ancestor
24993611|NCT05416073|Antidepressive Agents|antidepressive agents|mesh-ancestor
24993612|NCT05416073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24993651|NCT05415826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24993652|NCT05415826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24993653|NCT05415826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797806|NCT01958372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24797807|NCT01958372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107849|NCT03136237|Cyclosporine|cyclosporine|mesh-list
24797808|NCT01958372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797809|NCT01958372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24797810|NCT01958372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24797811|NCT01958580|Gemcitabine|gemcitabine|mesh-list
24797812|NCT01958580|Docetaxel|docetaxel|mesh-list
24547739|NCT00705510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833096|NCT00011895|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25833097|NCT00011895|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25833098|NCT00011895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25833099|NCT00011895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25833100|NCT00011908|Epratuzumab|epratuzumab|mesh-list
25833101|NCT00011908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25833102|NCT00011908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833103|NCT00011921|Paclitaxel|paclitaxel|mesh-list
25833104|NCT00011921|Etoposide|etoposide|mesh-list
24797813|NCT01958580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24797814|NCT01958580|Antimetabolites|antimetabolites|mesh-ancestor
24797815|NCT01958580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797816|NCT01958580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797817|NCT01958580|Antiviral Agents|antiviral agents|mesh-ancestor
24797818|NCT01958580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24797819|NCT01958580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24993654|NCT05415748|Tamsulosin|tamsulosin|mesh-list
24993655|NCT05415748|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24993656|NCT05415748|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24993657|NCT05415748|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24993658|NCT05415748|Adrenergic Agents|adrenergic agents|mesh-ancestor
24993659|NCT05415748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24993660|NCT05415748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993661|NCT05415748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993662|NCT05415748|Urological Agents|urological agents|mesh-ancestor
25658505|NCT01596504|Lixisenatide|lixisenatide|mesh-list
25658506|NCT01596504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25658507|NCT01596504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658508|NCT01596504|Incretins|incretins|mesh-ancestor
25658509|NCT01596504|Hormones|hormones|mesh-ancestor
25658510|NCT01596504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25658511|NCT01596699|Fludarabine|fludarabine|mesh-list
24871243|NCT04287816|Antithrombins|antithrombins|mesh-list
25658512|NCT01596699|Busulfan|busulfan|mesh-list
24871250|NCT04220489|Analgesics|analgesics|mesh-ancestor
24871251|NCT04220489|Sensory System Agents|sensory system agents|mesh-ancestor
24871252|NCT04220489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24598819|NCT00958386|Irinotecan|irinotecan|mesh-list
25833105|NCT00011921|Carboplatin|carboplatin|mesh-list
25833106|NCT00011921|Etoposide phosphate|etoposide phosphate|mesh-list
24417606|NCT00206947|Cholinergic Agents|cholinergic agents|mesh-ancestor
25833107|NCT00011921|Epirubicin|epirubicin|mesh-list
25833108|NCT00011921|Ifosfamide|ifosfamide|mesh-list
25833109|NCT00011921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25833110|NCT00011921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993683|NCT05415436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24993684|NCT05415436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24993685|NCT05415436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993686|NCT05415436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24993687|NCT05415436|Anesthetics, General|anesthetics, general|mesh-ancestor
24993688|NCT05415436|Anesthetics|anesthetics|mesh-ancestor
24993689|NCT05415267|Vaccines|vaccines|mesh-list
24993690|NCT05415267|Immunologic Factors|immunologic factors|mesh-ancestor
24993691|NCT05415267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993692|NCT05415254|Calcitriol|calcitriol|mesh-list
24993693|NCT05415254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24993694|NCT05415254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833111|NCT00011921|Tubulin Modulators|tubulin modulators|mesh-ancestor
25833112|NCT00011921|Antimitotic Agents|antimitotic agents|mesh-ancestor
25833113|NCT00011921|Mitosis Modulators|mitosis modulators|mesh-ancestor
25833114|NCT00011921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833115|NCT00011921|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25833116|NCT00011921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25833117|NCT00011921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833118|NCT00011921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25833119|NCT00011921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25144614|NCT02935231|Nicotine|nicotine|mesh-list
25833120|NCT00011921|Alkylating Agents|alkylating agents|mesh-ancestor
25833121|NCT00011934|Interferons|interferons|mesh-list
25833122|NCT00011934|Interferon-alpha|interferon-alpha|mesh-list
25833123|NCT00011934|Sargramostim|sargramostim|mesh-list
25833124|NCT00011934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993704|NCT05415228|Chelating Agents|chelating agents|mesh-ancestor
24993705|NCT05415228|Sequestering Agents|sequestering agents|mesh-ancestor
24993706|NCT05415228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993707|NCT05415228|Anticoagulants|anticoagulants|mesh-ancestor
24993708|NCT05415228|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24993709|NCT05415228|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24993716|NCT05410223|Clarithromycin|clarithromycin|mesh-list
24993717|NCT05410223|Doxycycline|doxycycline|mesh-list
24993718|NCT05410223|Furazolidone|furazolidone|mesh-list
24993719|NCT05410223|Bismuth|bismuth|mesh-list
24993720|NCT05410223|Antibodies|antibodies|mesh-list
24993721|NCT05410223|Immunologic Factors|immunologic factors|mesh-ancestor
24993722|NCT05410223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993723|NCT05410223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24993724|NCT05410223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24993725|NCT05410223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24993742|NCT05410197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993743|NCT05410197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24993744|NCT05410197|Antimetabolites|antimetabolites|mesh-ancestor
24993745|NCT05410197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993746|NCT05410197|Antiviral Agents|antiviral agents|mesh-ancestor
24993747|NCT05410197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24993748|NCT05410197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24993756|NCT05409872|Vitamin B 6|vitamin b 6|mesh-list
24993757|NCT05409872|Pyridoxal|pyridoxal|mesh-list
24993758|NCT05409872|Pyridoxine|pyridoxine|mesh-list
25163085|NCT02899364|Antioxidants|antioxidants|mesh-ancestor
24993759|NCT05409872|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24993760|NCT05409872|Micronutrients|micronutrients|mesh-ancestor
24993761|NCT05409872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993762|NCT05409872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24993763|NCT05409872|Vitamin B Complex|vitamin b complex|mesh-ancestor
25658513|NCT01596699|Alemtuzumab|alemtuzumab|mesh-list
25658514|NCT01596699|Clofarabine|clofarabine|mesh-list
25658515|NCT01596699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658516|NCT01596699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25833125|NCT00011934|Antiviral Agents|antiviral agents|mesh-ancestor
24993764|NCT05409872|Antioxidants|antioxidants|mesh-ancestor
25408862|NCT03415828|Hormones|hormones|mesh-ancestor
25833126|NCT00011934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24871379|NCT03161054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24871380|NCT03161054|Immunologic Factors|immunologic factors|mesh-ancestor
24885245|NCT01305460|Azacitidine|azacitidine|mesh-list
24871381|NCT03161054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871382|NCT03161054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24871384|NCT03161054|Alkylating Agents|alkylating agents|mesh-ancestor
24993765|NCT05409872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993766|NCT05409872|Protective Agents|protective agents|mesh-ancestor
25833127|NCT00011934|Immunologic Factors|immunologic factors|mesh-ancestor
25833128|NCT00011934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833130|NCT00011960|Cisplatin|cisplatin|mesh-list
25833131|NCT00011960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25833132|NCT00011960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833133|NCT00011960|Tubulin Modulators|tubulin modulators|mesh-ancestor
25833134|NCT00011960|Antimitotic Agents|antimitotic agents|mesh-ancestor
25833135|NCT00011960|Mitosis Modulators|mitosis modulators|mesh-ancestor
25833136|NCT00011960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833137|NCT00011973|Fenretinide|fenretinide|mesh-list
24993774|NCT05405387|Budesonide|budesonide|mesh-list
24993775|NCT05405387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24993776|NCT05405387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24993777|NCT05405387|Autonomic Agents|autonomic agents|mesh-ancestor
24993778|NCT05405387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24993779|NCT05405387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993780|NCT05405387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24993781|NCT05405387|Respiratory System Agents|respiratory system agents|mesh-ancestor
24993782|NCT05405387|Glucocorticoids|glucocorticoids|mesh-ancestor
24993784|NCT05405387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24993790|NCT05400109|Vidarabine|vidarabine|mesh-list
24993791|NCT05400109|Cyclophosphamide|cyclophosphamide|mesh-list
24993792|NCT05400109|Fludarabine|fludarabine|mesh-list
24785873|NCT01917019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785874|NCT01917032|Folic Acid|folic acid|mesh-list
24785875|NCT01917032|Vitamin A|vitamin a|mesh-list
24785876|NCT01917032|Micronutrients|micronutrients|mesh-list
24785877|NCT01917032|Trace Elements|trace elements|mesh-list
24785878|NCT01917032|Tretinoin|tretinoin|mesh-list
24785879|NCT01917032|Vitamins|vitamins|mesh-ancestor
24785880|NCT01917032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785881|NCT01917032|Hematinics|hematinics|mesh-ancestor
24785882|NCT01917032|Vitamin B Complex|vitamin b complex|mesh-ancestor
24785883|NCT01917032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24785884|NCT01917032|Keratolytic Agents|keratolytic agents|mesh-ancestor
24993793|NCT05400109|Fludarabine phosphate|fludarabine phosphate|mesh-list
24993794|NCT05400109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24993795|NCT05400109|Immunologic Factors|immunologic factors|mesh-ancestor
24993796|NCT05400109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833138|NCT00011973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833139|NCT00011973|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25833140|NCT00011973|Protective Agents|protective agents|mesh-ancestor
25833141|NCT00011973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833142|NCT00011999|Paclitaxel|paclitaxel|mesh-list
25833143|NCT00011999|Cisplatin|cisplatin|mesh-list
24993797|NCT05400109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24993798|NCT05400109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24993799|NCT05400109|Alkylating Agents|alkylating agents|mesh-ancestor
24599053|NCT05350384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993843|NCT05348122|Immunologic Factors|immunologic factors|mesh-ancestor
24993844|NCT05338541|Etoposide|etoposide|mesh-list
24993845|NCT05338541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25107858|NCT03136237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107860|NCT03136237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24993846|NCT05338541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993847|NCT05338541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24993848|NCT05338541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24993849|NCT05338541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24993850|NCT05338541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797820|NCT01958580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24797821|NCT01958580|Immunologic Factors|immunologic factors|mesh-ancestor
25833144|NCT00011999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25658517|NCT01596699|Antimetabolites|antimetabolites|mesh-ancestor
25658518|NCT01596699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658519|NCT01596699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25658520|NCT01596699|Immunologic Factors|immunologic factors|mesh-ancestor
25658521|NCT01596699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871573|NCT05165303|Lidocaine|lidocaine|mesh-list
24993894|NCT05253495|Cytarabine|cytarabine|mesh-list
24993895|NCT05253495|Etoposide|etoposide|mesh-list
24993896|NCT05253495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24993897|NCT05253495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993898|NCT05253495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24993899|NCT05253495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24993900|NCT05253495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24993901|NCT05253495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993902|NCT05253495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24993903|NCT05253495|Antimetabolites|antimetabolites|mesh-ancestor
24993904|NCT05253495|Antiviral Agents|antiviral agents|mesh-ancestor
24993905|NCT05253495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24993906|NCT05253495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24993907|NCT05253495|Immunologic Factors|immunologic factors|mesh-ancestor
24993908|NCT05253495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993931|NCT05188170|Anticestodal Agents|anticestodal agents|mesh-ancestor
24993932|NCT05188170|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24993933|NCT05188170|Anthelmintics|anthelmintics|mesh-ancestor
24993934|NCT05188170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24993935|NCT05188170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24993936|NCT05188170|Antinematodal Agents|antinematodal agents|mesh-ancestor
24993937|NCT05125276|Aspirin|aspirin|mesh-list
24993938|NCT05125276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24993939|NCT05125276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24993940|NCT05125276|Analgesics|analgesics|mesh-ancestor
24993941|NCT05125276|Sensory System Agents|sensory system agents|mesh-ancestor
24993942|NCT05125276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24993943|NCT05125276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993944|NCT05125276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25833145|NCT00011999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833146|NCT00011999|Tubulin Modulators|tubulin modulators|mesh-ancestor
25833147|NCT00011999|Antimitotic Agents|antimitotic agents|mesh-ancestor
25833148|NCT00011999|Mitosis Modulators|mitosis modulators|mesh-ancestor
25833149|NCT00011999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833150|NCT00012025|Fulvestrant|fulvestrant|mesh-list
25833151|NCT00012025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25833152|NCT00012025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833153|NCT00012025|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25833154|NCT00012025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25833155|NCT00012025|Hormone Antagonists|hormone antagonists|mesh-ancestor
25833156|NCT00012025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25833157|NCT00012025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833158|NCT00012038|Irofulven|irofulven|mesh-list
25833159|NCT00012038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25833160|NCT00012038|Alkylating Agents|alkylating agents|mesh-ancestor
25833161|NCT00012038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833162|NCT00012038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833163|NCT00012051|Cytarabine|cytarabine|mesh-list
25833164|NCT00012051|Dexamethasone|dexamethasone|mesh-list
25833165|NCT00012051|Rituximab|rituximab|mesh-list
25833166|NCT00012051|Cisplatin|cisplatin|mesh-list
25833167|NCT00012051|Methotrexate|methotrexate|mesh-list
25833168|NCT00012051|Etoposide|etoposide|mesh-list
25833169|NCT00012051|Melphalan|melphalan|mesh-list
25833170|NCT00012051|Ifosfamide|ifosfamide|mesh-list
25833171|NCT00012051|Carmustine|carmustine|mesh-list
25833172|NCT00012051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24993945|NCT05125276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24993946|NCT05125276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24993947|NCT05125276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24993967|NCT05054751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24993968|NCT05054751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24867938|NCT04765137|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25833173|NCT00012051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833174|NCT00012051|Immunologic Factors|immunologic factors|mesh-ancestor
25833175|NCT00012051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833176|NCT00012051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25833177|NCT00012051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25833178|NCT00012051|Antiemetics|antiemetics|mesh-ancestor
25833179|NCT00012051|Autonomic Agents|autonomic agents|mesh-ancestor
25833180|NCT00012051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25833181|NCT00012051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25833182|NCT00012051|Glucocorticoids|glucocorticoids|mesh-ancestor
25833183|NCT00012051|Hormones|hormones|mesh-ancestor
25875326|NCT04484363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658522|NCT01596699|Alkylating Agents|alkylating agents|mesh-ancestor
24871755|NCT04821830|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24871756|NCT04821830|Dopamine Agents|dopamine agents|mesh-ancestor
25056008|NCT03516188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24871757|NCT04821830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25201346|NCT02728492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24871786|NCT04527289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871802|NCT04518124|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24871803|NCT04518124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24871804|NCT04518124|Adrenergic Agents|adrenergic agents|mesh-ancestor
24871805|NCT04518124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25833184|NCT00012051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25833185|NCT00012051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25833186|NCT00012051|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25833187|NCT00012051|Abortifacient Agents|abortifacient agents|mesh-ancestor
25833188|NCT00012051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25833189|NCT00012051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25833190|NCT00012051|Antimetabolites|antimetabolites|mesh-ancestor
25833191|NCT00012051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833192|NCT00012051|Dermatologic Agents|dermatologic agents|mesh-ancestor
25833193|NCT00012051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833194|NCT00012051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25833195|NCT00012051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25833196|NCT00012051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24993969|NCT05054751|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24993970|NCT05054751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24993971|NCT05054751|Hormone Antagonists|hormone antagonists|mesh-ancestor
24993972|NCT05054751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24993973|NCT05054751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993974|NCT05053867|Tranexamic Acid|tranexamic acid|mesh-list
24993975|NCT05053867|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24993976|NCT05053867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24636291|NCT01144650|Dapsone|dapsone|mesh-list
25833197|NCT00012051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25833198|NCT00012051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25833199|NCT00012051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25833200|NCT00012051|Antiviral Agents|antiviral agents|mesh-ancestor
24993997|NCT05048264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993998|NCT05048264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24993999|NCT05048264|Glucocorticoids|glucocorticoids|mesh-ancestor
24994000|NCT05048264|Hormones|hormones|mesh-ancestor
24994008|NCT05048264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24994009|NCT05048264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994010|NCT05048264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25163086|NCT02899364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994011|NCT05048264|Respiratory System Agents|respiratory system agents|mesh-ancestor
24994012|NCT05038618|Somatomedin B|somatomedin b|mesh-list
24994013|NCT05038618|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24994029|NCT05037487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994049|NCT04987281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24994050|NCT04983940|Methyltestosterone|methyltestosterone|mesh-list
24994051|NCT04983940|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24994052|NCT04983940|Testosterone|testosterone|mesh-list
24994053|NCT04983940|Testosterone undecanoate|testosterone undecanoate|mesh-list
24994054|NCT04983940|Testosterone enanthate|testosterone enanthate|mesh-list
24994055|NCT04983940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24994056|NCT04983940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994057|NCT04983940|Anabolic Agents|anabolic agents|mesh-ancestor
24994058|NCT04983940|Hormones|hormones|mesh-ancestor
24994059|NCT04983940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24994060|NCT04983940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994061|NCT04983940|Androgens|androgens|mesh-ancestor
25408939|NCT03410615|Tremelimumab|tremelimumab|mesh-list
25658523|NCT01596699|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25658524|NCT01596699|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25658525|NCT01596699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25658526|NCT01596842|Cholecalciferol|cholecalciferol|mesh-list
25658527|NCT01596842|Vitamin D|vitamin d|mesh-list
25658528|NCT01596842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25658529|NCT01596842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658530|NCT01596842|Vitamins|vitamins|mesh-ancestor
25658531|NCT01596842|Micronutrients|micronutrients|mesh-ancestor
25658532|NCT01596842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24871925|NCT03592212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871926|NCT03592212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24871927|NCT03592212|Respiratory System Agents|respiratory system agents|mesh-ancestor
24871928|NCT03592212|Tocolytic Agents|tocolytic agents|mesh-ancestor
24871929|NCT03592212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24871930|NCT03592212|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24871931|NCT03592212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24871932|NCT03592212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24797831|NCT01958684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797832|NCT01958684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24797833|NCT01958684|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24797834|NCT01958684|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24797835|NCT01958684|Trace Elements|trace elements|mesh-ancestor
24797836|NCT01958684|Micronutrients|micronutrients|mesh-ancestor
24797838|NCT01958775|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24797839|NCT01958775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24797840|NCT01958775|Hormones|hormones|mesh-ancestor
24797841|NCT01958775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25107861|NCT03136237|Dermatologic Agents|dermatologic agents|mesh-ancestor
24797842|NCT01958775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797843|NCT01958775|Incretins|incretins|mesh-ancestor
24797844|NCT01958814|Albuterol|albuterol|mesh-list
24797845|NCT01958814|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24797846|NCT01958814|Autonomic Agents|autonomic agents|mesh-ancestor
24797847|NCT01958814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24797848|NCT01958814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797849|NCT01958814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24797850|NCT01958814|Respiratory System Agents|respiratory system agents|mesh-ancestor
24797851|NCT01958814|Tocolytic Agents|tocolytic agents|mesh-ancestor
24994080|NCT04930744|Ethambutol|ethambutol|mesh-list
24994088|NCT04930744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24994089|NCT04930744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24994093|NCT04930744|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24994094|NCT04930744|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24994095|NCT04930744|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24994096|NCT04930744|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24994097|NCT04930744|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24994099|NCT04930744|Antimetabolites|antimetabolites|mesh-ancestor
24994100|NCT04930744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24994101|NCT04927052|Lidocaine|lidocaine|mesh-list
24994102|NCT04927052|Anesthetics, Local|anesthetics, local|mesh-ancestor
24994103|NCT04927052|Anesthetics|anesthetics|mesh-ancestor
24994104|NCT04927052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24994105|NCT04927052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994106|NCT04927052|Sensory System Agents|sensory system agents|mesh-ancestor
24994107|NCT04927052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24994108|NCT04927052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24994109|NCT04927052|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24868103|NCT03643965|Budesonide|budesonide|mesh-list
25833201|NCT00012051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24451560|NCT00324194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451561|NCT00324298|Etoposide|etoposide|mesh-list
24451568|NCT00324298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451570|NCT00324324|Moxifloxacin|moxifloxacin|mesh-list
25833202|NCT00012051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25833203|NCT00012051|Alkylating Agents|alkylating agents|mesh-ancestor
25833204|NCT00012051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25833205|NCT00012090|Goserelin|goserelin|mesh-list
25833206|NCT00012090|Bicalutamide|bicalutamide|mesh-list
25833207|NCT00012090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25833208|NCT00012090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833209|NCT00012090|Androgen Antagonists|androgen antagonists|mesh-ancestor
24994110|NCT04927052|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24994111|NCT04927052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25408940|NCT03410615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658533|NCT01597193|Fulvestrant|fulvestrant|mesh-list
25658534|NCT01597193|Anastrozole|anastrozole|mesh-list
25658535|NCT01597193|Exemestane|exemestane|mesh-list
25658536|NCT01597193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25658537|NCT01597193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658538|NCT01597193|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25658539|NCT01597193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25658540|NCT01597193|Hormone Antagonists|hormone antagonists|mesh-ancestor
25674293|NCT01769586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25833210|NCT00012090|Hormone Antagonists|hormone antagonists|mesh-ancestor
24872099|NCT05398861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24872100|NCT05398861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994112|NCT04927052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994113|NCT04892264|Dexamethasone|dexamethasone|mesh-list
24994114|NCT04892264|Dexamethasone acetate|dexamethasone acetate|mesh-list
24994115|NCT04892264|Lenalidomide|lenalidomide|mesh-list
24994116|NCT04892264|Daratumumab|daratumumab|mesh-list
24994118|NCT04892264|BB 1101|bb 1101|mesh-list
24994119|NCT04892264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24994120|NCT04892264|Antiemetics|antiemetics|mesh-ancestor
24994121|NCT04892264|Autonomic Agents|autonomic agents|mesh-ancestor
24994122|NCT04892264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24994123|NCT04892264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994124|NCT04892264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24994125|NCT04892264|Glucocorticoids|glucocorticoids|mesh-ancestor
24994126|NCT04892264|Hormones|hormones|mesh-ancestor
24994127|NCT04892264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24994128|NCT04892264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24994129|NCT04892264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994130|NCT04892264|Protease Inhibitors|protease inhibitors|mesh-ancestor
24994131|NCT04892264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24994132|NCT04892264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994133|NCT04892264|Immunologic Factors|immunologic factors|mesh-ancestor
24994134|NCT04892264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24994135|NCT04892264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24994136|NCT04892264|Growth Substances|growth substances|mesh-ancestor
24994137|NCT04892264|Growth Inhibitors|growth inhibitors|mesh-ancestor
24994138|NCT04892264|Dermatologic Agents|dermatologic agents|mesh-ancestor
24785895|NCT01917045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24994148|NCT04829799|Oxymetazoline|oxymetazoline|mesh-list
24994149|NCT04829799|Anesthetics, Local|anesthetics, local|mesh-ancestor
24994150|NCT04829799|Anesthetics|anesthetics|mesh-ancestor
24994151|NCT04829799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24994152|NCT04829799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144975|NCT02933593|Vasodilator Agents|vasodilator agents|mesh-ancestor
24994189|NCT04824417|Hormone Antagonists|hormone antagonists|mesh-ancestor
24994190|NCT04824417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24994191|NCT04824417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994192|NCT04824417|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25833211|NCT00012090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25833212|NCT00012090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833213|NCT00012103|Dimercaprol|dimercaprol|mesh-list
25833214|NCT00012103|Chelating Agents|chelating agents|mesh-ancestor
24450657|NCT00319878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24450658|NCT00319878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24450659|NCT00319878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833215|NCT00012103|Sequestering Agents|sequestering agents|mesh-ancestor
25833216|NCT00012103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833217|NCT00012116|Temozolomide|temozolomide|mesh-list
25833218|NCT00012116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25833219|NCT00012116|Alkylating Agents|alkylating agents|mesh-ancestor
25833220|NCT00012116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833221|NCT00012116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833222|NCT00012129|Annamycin|annamycin|mesh-list
25833223|NCT00012129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24853043|NCT02265731|Rituximab|rituximab|mesh-list
25833224|NCT00012129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833225|NCT00012142|Sirolimus|sirolimus|mesh-list
24994240|NCT04744831|Camptothecin|camptothecin|mesh-list
24994241|NCT04744831|Immunoconjugates|immunoconjugates|mesh-list
24994242|NCT04744831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24994243|NCT04744831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24548167|NCT00707902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24548168|NCT00707902|Disinfectants|disinfectants|mesh-ancestor
25833226|NCT00012142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25833227|NCT00012142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24599960|NCT02942095|Ixazomib|ixazomib|mesh-list
24994260|NCT04725695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24994261|NCT04725695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994263|NCT04725695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24994264|NCT04725695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25658541|NCT01597193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25658542|NCT01597193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872198|NCT05398653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24872199|NCT05398653|Dermatologic Agents|dermatologic agents|mesh-ancestor
24872206|NCT05398393|Tenofovir|tenofovir|mesh-list
25833228|NCT00012142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25833229|NCT00012142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833230|NCT00012142|Antifungal Agents|antifungal agents|mesh-ancestor
25833231|NCT00012142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24994267|NCT04725695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24994269|NCT04721873|Topiramate|topiramate|mesh-list
24994270|NCT04721873|Phentermine|phentermine|mesh-list
24994271|NCT04721873|Anticonvulsants|anticonvulsants|mesh-ancestor
24994272|NCT04721873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24994279|NCT04721873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24994280|NCT04721873|Adrenergic Agents|adrenergic agents|mesh-ancestor
24994281|NCT04721873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24994282|NCT04721873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994283|NCT04700176|Dexamethasone|dexamethasone|mesh-list
24994284|NCT04700176|Daratumumab|daratumumab|mesh-list
24994285|NCT04700176|Pomalidomide|pomalidomide|mesh-list
24994286|NCT04700176|Tretinoin|tretinoin|mesh-list
24994287|NCT04700176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24994288|NCT04700176|Antiemetics|antiemetics|mesh-ancestor
24994289|NCT04700176|Autonomic Agents|autonomic agents|mesh-ancestor
24994290|NCT04700176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24994291|NCT04700176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994292|NCT04700176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24994293|NCT04700176|Glucocorticoids|glucocorticoids|mesh-ancestor
24994294|NCT04700176|Hormones|hormones|mesh-ancestor
24994295|NCT04700176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24994296|NCT04700176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24994297|NCT04700176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994298|NCT04700176|Immunologic Factors|immunologic factors|mesh-ancestor
25833232|NCT00012142|Immunologic Factors|immunologic factors|mesh-ancestor
25833233|NCT00012142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875327|NCT04484363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24994309|NCT04664829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994310|NCT04664829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994317|NCT04622709|Furosemide|furosemide|mesh-list
24994318|NCT04622709|Diuretics|diuretics|mesh-list
24994319|NCT04622709|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
24994320|NCT04622709|Natriuretic Agents|natriuretic agents|mesh-ancestor
24994321|NCT04622709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994322|NCT04622709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24994323|NCT04622709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994324|NCT04607980|Ustekinumab|ustekinumab|mesh-list
24994325|NCT04607980|Dermatologic Agents|dermatologic agents|mesh-ancestor
24994326|NCT04565015|Immunoglobulins|immunoglobulins|mesh-list
24994327|NCT04565015|gamma-Globulins|gamma-globulins|mesh-list
24994328|NCT04565015|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24994329|NCT04565015|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25875328|NCT04457557|Ropivacaine|ropivacaine|mesh-list
25145090|NCT02932397|Propofol|propofol|mesh-list
25875329|NCT04457557|Anesthetics, Local|anesthetics, local|mesh-list
25875330|NCT04457557|Anesthetics|anesthetics|mesh-list
24994331|NCT04565015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994333|NCT04535362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24994335|NCT04535362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24994336|NCT04535362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994337|NCT04535362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24994338|NCT04535362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24994339|NCT04535362|Cholinergic Agents|cholinergic agents|mesh-ancestor
24994340|NCT04535362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24994341|NCT04535362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797852|NCT01958814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24797853|NCT01958814|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24797854|NCT01958814|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24797855|NCT01958814|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24797856|NCT01958814|Adrenergic Agents|adrenergic agents|mesh-ancestor
24797857|NCT01958814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24797858|NCT01958814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658543|NCT01597193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25658544|NCT01597193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25658545|NCT01597193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658546|NCT01597193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658547|NCT01597245|Etanercept|etanercept|mesh-list
25658548|NCT01597245|Ixekizumab|ixekizumab|mesh-list
25056053|NCT03515707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25056054|NCT03515707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25056055|NCT03515707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25056056|NCT03515707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056057|NCT03515707|Alkylating Agents|alkylating agents|mesh-ancestor
25056058|NCT03515707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25056059|NCT03515707|Immunologic Factors|immunologic factors|mesh-ancestor
24810316|NCT02039518|Antimetabolites|antimetabolites|mesh-ancestor
24872322|NCT05397236|Anesthetics|anesthetics|mesh-ancestor
24797859|NCT01958866|Acetaminophen|acetaminophen|mesh-list
25833234|NCT00012168|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
24797863|NCT01958866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24797864|NCT01958866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797865|NCT01958866|Antipyretics|antipyretics|mesh-ancestor
24797866|NCT01958905|Lumefantrine|lumefantrine|mesh-list
24797867|NCT01958905|Artemether|artemether|mesh-list
24797888|NCT01958996|Idarubicin|idarubicin|mesh-list
24797889|NCT01958996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25107872|NCT03136406|Leucovorin|leucovorin|mesh-list
24797891|NCT01958996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24797892|NCT01958996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24797893|NCT01958996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24797894|NCT01958996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797896|NCT01959022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24797897|NCT01959022|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25833235|NCT00012168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25833236|NCT00012168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833237|NCT00012181|Alvocidib|alvocidib|mesh-list
25833238|NCT00012181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833239|NCT00012181|Growth Inhibitors|growth inhibitors|mesh-ancestor
25833240|NCT00012181|Growth Substances|growth substances|mesh-ancestor
25833241|NCT00012181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833242|NCT00012181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24797902|NCT01959022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797904|NCT01959061|Oxaliplatin|oxaliplatin|mesh-list
24797905|NCT01959061|Raltitrexed|raltitrexed|mesh-list
24797906|NCT01959061|Ethiodized Oil|ethiodized oil|mesh-list
24797907|NCT01959061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797908|NCT01959061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24797909|NCT01959061|Antimetabolites|antimetabolites|mesh-ancestor
24797910|NCT01959061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797911|NCT01959061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24797912|NCT01959061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24797913|NCT01959074|Aceclofenac|aceclofenac|mesh-list
24797914|NCT01959074|Naftopidil|naftopidil|mesh-list
24797915|NCT01959074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25047639|NCT00776373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25833243|NCT00012181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833244|NCT00012181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833245|NCT00012194|Cisplatin|cisplatin|mesh-list
25833246|NCT00012194|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
25833247|NCT00012194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833248|NCT00012194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25833249|NCT00012194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833250|NCT00012194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833251|NCT00012207|Aldesleukin|aldesleukin|mesh-list
25833252|NCT00012207|Prednisone|prednisone|mesh-list
25833253|NCT00012207|Cyclophosphamide|cyclophosphamide|mesh-list
25833254|NCT00012207|Vincristine|vincristine|mesh-list
24994365|NCT04456608|Aspirin|aspirin|mesh-list
24994366|NCT04456608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24994367|NCT04456608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24994368|NCT04456608|Analgesics|analgesics|mesh-ancestor
24994369|NCT04456608|Sensory System Agents|sensory system agents|mesh-ancestor
24994370|NCT04456608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25658549|NCT01597245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25658550|NCT01597245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25658551|NCT01597245|Analgesics|analgesics|mesh-ancestor
25658552|NCT01597245|Sensory System Agents|sensory system agents|mesh-ancestor
25658553|NCT01597245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25658554|NCT01597245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658555|NCT01597245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25658556|NCT01597245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25658557|NCT01597245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24994371|NCT04456608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056084|NCT03515577|Sequestering Agents|sequestering agents|mesh-ancestor
25056085|NCT03515577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056086|NCT03515577|Anticoagulants|anticoagulants|mesh-ancestor
25056087|NCT03515577|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24872457|NCT05385523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25201362|NCT02728440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25201363|NCT02728440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872468|NCT05374954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872470|NCT05370716|Analgesics|analgesics|mesh-ancestor
25023517|NCT03653663|Simvastatin|simvastatin|mesh-list
24872484|NCT05363553|Chelating Agents|chelating agents|mesh-ancestor
25023570|NCT03653052|Durvalumab|durvalumab|mesh-list
24994372|NCT04456608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24994373|NCT04456608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24994374|NCT04456608|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24994375|NCT04456608|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24994376|NCT04456608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994377|NCT04456608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24994378|NCT04456608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25833255|NCT00012207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25833256|NCT00012207|Immunologic Factors|immunologic factors|mesh-ancestor
24994601|NCT03822975|Protease Inhibitors|protease inhibitors|mesh-ancestor
25833257|NCT00012207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833258|NCT00012207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25833259|NCT00012207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25833260|NCT00012207|Alkylating Agents|alkylating agents|mesh-ancestor
25833261|NCT00012207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833262|NCT00012207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833263|NCT00012207|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25833264|NCT00012207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25833265|NCT00012207|Glucocorticoids|glucocorticoids|mesh-ancestor
25833266|NCT00012207|Hormones|hormones|mesh-ancestor
25833267|NCT00012207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25833268|NCT00012207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25833269|NCT00012207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25833270|NCT00012207|Tubulin Modulators|tubulin modulators|mesh-ancestor
25833271|NCT00012207|Antimitotic Agents|antimitotic agents|mesh-ancestor
25833272|NCT00012207|Mitosis Modulators|mitosis modulators|mesh-ancestor
25833273|NCT00012207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25833274|NCT00012207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25833275|NCT00012207|Antiviral Agents|antiviral agents|mesh-ancestor
25833276|NCT00012207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833277|NCT00012220|Gemcitabine|gemcitabine|mesh-list
25833278|NCT00012220|Cisplatin|cisplatin|mesh-list
25833279|NCT00012220|Docetaxel|docetaxel|mesh-list
25833280|NCT00012220|Irinotecan|irinotecan|mesh-list
25833281|NCT00012220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833282|NCT00012220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25833283|NCT00012220|Antimetabolites|antimetabolites|mesh-ancestor
25833284|NCT00012220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833285|NCT00012220|Antiviral Agents|antiviral agents|mesh-ancestor
24994379|NCT04456608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24994380|NCT04456608|Antipyretics|antipyretics|mesh-ancestor
24994381|NCT04450212|Vitamin K|vitamin k|mesh-list
24994382|NCT04450212|Vitamins|vitamins|mesh-ancestor
24994383|NCT04450212|Micronutrients|micronutrients|mesh-ancestor
24994388|NCT04450212|Hemostatics|hemostatics|mesh-ancestor
24994389|NCT04450212|Coagulants|coagulants|mesh-ancestor
24994390|NCT04317300|Varenicline|varenicline|mesh-list
24994391|NCT04317300|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24994392|NCT04317300|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25658558|NCT01597245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25658559|NCT01597245|Immunologic Factors|immunologic factors|mesh-ancestor
25658560|NCT01597245|Dermatologic Agents|dermatologic agents|mesh-ancestor
25658561|NCT01597258|Crizotinib|crizotinib|mesh-list
25658562|NCT01597258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658563|NCT01597258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25658564|NCT01597258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658565|NCT01597258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658566|NCT01597375|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25658567|NCT01597375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25658568|NCT01597479|Anesthetics|anesthetics|mesh-list
25658569|NCT01597479|Levobupivacaine|levobupivacaine|mesh-list
25658570|NCT01597479|Anesthetics, Local|anesthetics, local|mesh-list
25658571|NCT01597479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25658572|NCT01597479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658573|NCT01597479|Sensory System Agents|sensory system agents|mesh-ancestor
25658574|NCT01597479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25658575|NCT01597492|Belimumab|belimumab|mesh-list
24872674|NCT05275738|Micronutrients|micronutrients|mesh-ancestor
24872675|NCT05275738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872676|NCT05275738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24872677|NCT05275738|Antimetabolites|antimetabolites|mesh-ancestor
24872678|NCT05275738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872679|NCT05275738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25056101|NCT03515382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25056102|NCT03515382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872680|NCT05275738|Vasodilator Agents|vasodilator agents|mesh-ancestor
24872681|NCT05271331|Anesthetics|anesthetics|mesh-list
24872682|NCT05271331|Anesthetics, Local|anesthetics, local|mesh-list
24872683|NCT05271331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24872684|NCT05271331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872711|NCT05244109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872712|NCT05238844|Tenofovir|tenofovir|mesh-list
25023785|NCT03651726|Hormones|hormones|mesh-ancestor
24994393|NCT04317300|Cholinergic Agents|cholinergic agents|mesh-ancestor
24994394|NCT04317300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24994395|NCT04317300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994396|NCT04317300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994397|NCT04300231|Hydromorphone|hydromorphone|mesh-list
24994398|NCT04300231|Bupivacaine|bupivacaine|mesh-list
24994399|NCT04300231|Anesthetics, Local|anesthetics, local|mesh-ancestor
24994400|NCT04300231|Anesthetics|anesthetics|mesh-ancestor
24994401|NCT04300231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24994402|NCT04300231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994403|NCT04300231|Sensory System Agents|sensory system agents|mesh-ancestor
25833286|NCT00012220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833287|NCT00012220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833288|NCT00012220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25833289|NCT00012220|Immunologic Factors|immunologic factors|mesh-ancestor
25833290|NCT00012220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833291|NCT00012220|Tubulin Modulators|tubulin modulators|mesh-ancestor
25833292|NCT00012220|Antimitotic Agents|antimitotic agents|mesh-ancestor
25833293|NCT00012220|Mitosis Modulators|mitosis modulators|mesh-ancestor
25833294|NCT00012220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25833295|NCT00012220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25145211|NCT02931877|Sevoflurane|sevoflurane|mesh-list
25833296|NCT00012246|Sargramostim|sargramostim|mesh-list
25833297|NCT00012246|Freund's Adjuvant|freund's adjuvant|mesh-list
25833298|NCT00012246|Immunologic Factors|immunologic factors|mesh-ancestor
25833299|NCT00012246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833300|NCT00012246|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25833301|NCT00012259|Troxacitabine|troxacitabine|mesh-list
25833302|NCT00012259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833303|NCT00012259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25833304|NCT00012259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24994415|NCT04234360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25833305|NCT00012259|Antiviral Agents|antiviral agents|mesh-ancestor
25833306|NCT00012259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833307|NCT00012311|Cyclophosphamide|cyclophosphamide|mesh-list
25833308|NCT00012311|Ifosfamide|ifosfamide|mesh-list
25833309|NCT00012311|Thiotepa|thiotepa|mesh-list
25833310|NCT00012311|Carboplatin|carboplatin|mesh-list
25658576|NCT01597492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25658577|NCT01597492|Immunologic Factors|immunologic factors|mesh-ancestor
25658578|NCT01597492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658579|NCT01597505|Vancomycin|vancomycin|mesh-list
25658580|NCT01597505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25658581|NCT01597505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25658582|NCT01597557|Magnesium Sulfate|magnesium sulfate|mesh-list
25658583|NCT01597557|Analgesics|analgesics|mesh-ancestor
25658584|NCT01597557|Sensory System Agents|sensory system agents|mesh-ancestor
25658585|NCT01597557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25658586|NCT01597557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658587|NCT01597557|Anesthetics|anesthetics|mesh-ancestor
25658588|NCT01597557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25658589|NCT01597557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25658590|NCT01597557|Anticonvulsants|anticonvulsants|mesh-ancestor
25658591|NCT01597557|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25658592|NCT01597557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25833311|NCT00012311|Docetaxel|docetaxel|mesh-list
24872842|NCT05439798|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24872843|NCT05439772|Ondansetron|ondansetron|mesh-list
24872844|NCT05439772|Antiemetics|antiemetics|mesh-ancestor
24872845|NCT05439772|Autonomic Agents|autonomic agents|mesh-ancestor
24872846|NCT05439772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24872847|NCT05439772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833312|NCT00012311|Doxorubicin|doxorubicin|mesh-list
25833313|NCT00012311|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25833314|NCT00012311|Fluorouracil|fluorouracil|mesh-list
25833315|NCT00012311|Methotrexate|methotrexate|mesh-list
25833316|NCT00012311|Etoposide|etoposide|mesh-list
25833317|NCT00012311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25833318|NCT00012311|Immunologic Factors|immunologic factors|mesh-ancestor
25833319|NCT00012311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833320|NCT00012311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25833321|NCT00012311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25833322|NCT00012311|Alkylating Agents|alkylating agents|mesh-ancestor
25833323|NCT00012311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833324|NCT00012311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833325|NCT00012311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24994416|NCT04234360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994417|NCT04234360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24994418|NCT04234360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994427|NCT04224480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24994428|NCT04224480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833326|NCT00012311|Tubulin Modulators|tubulin modulators|mesh-ancestor
25833327|NCT00012311|Antimitotic Agents|antimitotic agents|mesh-ancestor
25833328|NCT00012311|Mitosis Modulators|mitosis modulators|mesh-ancestor
25833329|NCT00012311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25833330|NCT00012311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25833331|NCT00012311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25833332|NCT00012311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833333|NCT00012311|Antimetabolites|antimetabolites|mesh-ancestor
25833334|NCT00012311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25833335|NCT00012311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25833336|NCT00012311|Abortifacient Agents|abortifacient agents|mesh-ancestor
25833337|NCT00012311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25833338|NCT00012311|Dermatologic Agents|dermatologic agents|mesh-ancestor
25833339|NCT00012311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25833340|NCT00012311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25833341|NCT00012311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25833342|NCT00012324|Doxorubicin|doxorubicin|mesh-list
25833343|NCT00012324|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25833344|NCT00012324|Nolatrexed|nolatrexed|mesh-list
25833345|NCT00012324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25833346|NCT00012324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833347|NCT00012324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25163087|NCT02899364|Antitubercular Agents|antitubercular agents|mesh-ancestor
25833348|NCT00012324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25163088|NCT02899364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25833349|NCT00012324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833350|NCT00012324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833351|NCT00012324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25833352|NCT00012324|Antimetabolites|antimetabolites|mesh-ancestor
25833353|NCT00012324|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24994471|NCT04096170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24994472|NCT04096170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24994473|NCT04096170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24994474|NCT04096170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994476|NCT04085887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24994477|NCT04085887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658593|NCT01597557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658594|NCT01597557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25658595|NCT01597557|Tocolytic Agents|tocolytic agents|mesh-ancestor
25658596|NCT01597557|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25658597|NCT01597622|Belimumab|belimumab|mesh-list
25658598|NCT01597622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24994478|NCT04066491|Gemcitabine|gemcitabine|mesh-list
24994479|NCT04066491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994480|NCT04066491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25658599|NCT01597622|Immunologic Factors|immunologic factors|mesh-ancestor
25658600|NCT01597622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658601|NCT01597908|Trametinib|trametinib|mesh-list
25833354|NCT00012337|Gefitinib|gefitinib|mesh-list
25833355|NCT00012337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872952|NCT05438875|Tretinoin|tretinoin|mesh-list
24872953|NCT05438875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872954|NCT05438875|Keratolytic Agents|keratolytic agents|mesh-ancestor
24872955|NCT05438875|Dermatologic Agents|dermatologic agents|mesh-ancestor
24872956|NCT05438758|Ketamine|ketamine|mesh-list
24872957|NCT05438758|Esketamine|esketamine|mesh-list
24872958|NCT05438758|Analgesics|analgesics|mesh-ancestor
24872959|NCT05438758|Sensory System Agents|sensory system agents|mesh-ancestor
24872960|NCT05438758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24872961|NCT05438758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872962|NCT05438758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24872963|NCT05438758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24872964|NCT05438758|Anesthetics, General|anesthetics, general|mesh-ancestor
24994481|NCT04066491|Antimetabolites|antimetabolites|mesh-ancestor
24994482|NCT04066491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833356|NCT00012337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25833357|NCT00012337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833358|NCT00012337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833359|NCT00012350|Tipifarnib|tipifarnib|mesh-list
25833360|NCT00012350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833361|NCT00012363|Gemcitabine|gemcitabine|mesh-list
25833362|NCT00012363|Irinotecan|irinotecan|mesh-list
25833363|NCT00012363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25833364|NCT00012363|Antimetabolites|antimetabolites|mesh-ancestor
25833365|NCT00012363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833366|NCT00012363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833367|NCT00012363|Antiviral Agents|antiviral agents|mesh-ancestor
25833368|NCT00012363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833369|NCT00012363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833370|NCT00012363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25833371|NCT00012363|Immunologic Factors|immunologic factors|mesh-ancestor
25833372|NCT00012363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833373|NCT00012363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25833374|NCT00012363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25833375|NCT00012376|Bryostatin 1|bryostatin 1|mesh-list
25145394|NCT02930031|Protective Agents|protective agents|mesh-ancestor
25833376|NCT00012376|Sargramostim|sargramostim|mesh-list
25833377|NCT00012376|Immunologic Factors|immunologic factors|mesh-ancestor
25833378|NCT00012376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833379|NCT00012376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833380|NCT00012376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25833381|NCT00012389|Oxaliplatin|oxaliplatin|mesh-list
24636416|NCT01145365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785897|NCT01917045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24785898|NCT01917045|Anesthetics, General|anesthetics, general|mesh-ancestor
24785899|NCT01917045|Anesthetics|anesthetics|mesh-ancestor
25833382|NCT00012389|Irinotecan|irinotecan|mesh-list
25833383|NCT00012389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833384|NCT00012389|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25833385|NCT00012389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25833386|NCT00012389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833387|NCT00012389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833388|NCT00012467|Interferons|interferons|mesh-list
25833389|NCT00012467|Interferon-gamma|interferon-gamma|mesh-list
24853144|NCT02266030|Vasodilator Agents|vasodilator agents|mesh-ancestor
25107899|NCT03136406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25107901|NCT03136406|Protective Agents|protective agents|mesh-ancestor
25107902|NCT03136406|Vitamin B Complex|vitamin b complex|mesh-ancestor
25107903|NCT03136406|Vitamins|vitamins|mesh-ancestor
25107904|NCT03136406|Micronutrients|micronutrients|mesh-ancestor
25658602|NCT01597908|Vemurafenib|vemurafenib|mesh-list
25658603|NCT01597908|Dabrafenib|dabrafenib|mesh-list
25658604|NCT01597908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658605|NCT01597908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25658606|NCT01597908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658607|NCT01597908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658608|NCT01597973|Meropenem|meropenem|mesh-list
25658609|NCT01597973|Colistin|colistin|mesh-list
25658610|NCT01597973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25658611|NCT01597973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25658612|NCT01598090|Ribavirin|ribavirin|mesh-list
25658613|NCT01598090|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25658614|NCT01598090|Antimetabolites|antimetabolites|mesh-ancestor
25107905|NCT03135977|Etoposide|etoposide|mesh-list
25107906|NCT03135977|Apatinib|apatinib|mesh-list
25107907|NCT03135977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25107908|NCT03135977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833390|NCT00012467|Itraconazole|itraconazole|mesh-list
25833391|NCT00012467|Fluconazole|fluconazole|mesh-list
25833392|NCT00012467|Amphotericin B|amphotericin b|mesh-list
25833393|NCT00012467|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25833394|NCT00012467|Flucytosine|flucytosine|mesh-list
25833395|NCT00012467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833396|NCT00012467|Antiviral Agents|antiviral agents|mesh-ancestor
25833397|NCT00012467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833398|NCT00012467|Antifungal Agents|antifungal agents|mesh-ancestor
25833399|NCT00012467|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25833400|NCT00012467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25833401|NCT00012467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833402|NCT00012467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833403|NCT00012467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25833404|NCT00012467|Hormone Antagonists|hormone antagonists|mesh-ancestor
25833405|NCT00012467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25833406|NCT00012467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833407|NCT00012467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25833408|NCT00012467|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25833409|NCT00012467|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25833410|NCT00012467|Amebicides|amebicides|mesh-ancestor
25833411|NCT00012467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24873131|NCT05391971|Bupivacaine|bupivacaine|mesh-list
24873132|NCT05391971|Anesthetics, Local|anesthetics, local|mesh-ancestor
25201366|NCT02728323|Levobupivacaine|levobupivacaine|mesh-list
25107909|NCT03135977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25107915|NCT03135912|Antifungal Agents|antifungal agents|mesh-ancestor
25107916|NCT03135912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25107917|NCT03135912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107918|NCT03135912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107919|NCT03136003|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25107920|NCT03136003|Hemostatics|hemostatics|mesh-ancestor
25107921|NCT03136003|Coagulants|coagulants|mesh-ancestor
25107922|NCT03136003|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25107923|NCT03136003|Natriuretic Agents|natriuretic agents|mesh-ancestor
25107924|NCT03136003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107925|NCT03135795|Parecoxib|parecoxib|mesh-list
25107926|NCT03135795|Sufentanil|sufentanil|mesh-list
25107927|NCT03135795|Dexmedetomidine|dexmedetomidine|mesh-list
25107928|NCT03135795|Remifentanil|remifentanil|mesh-list
25107929|NCT03135795|Dsuvia|dsuvia|mesh-list
25107930|NCT03135795|Bromides|bromides|mesh-list
25107945|NCT03135795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24994499|NCT04022980|Nivolumab|nivolumab|mesh-list
25833412|NCT00012467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25833413|NCT00012467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25833414|NCT00012467|Antimetabolites|antimetabolites|mesh-ancestor
25833415|NCT00012506|Etanercept|etanercept|mesh-list
25833416|NCT00012506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25833417|NCT00012506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25833418|NCT00012506|Analgesics|analgesics|mesh-ancestor
25163089|NCT02899364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833419|NCT00012506|Sensory System Agents|sensory system agents|mesh-ancestor
25833420|NCT00012506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25163090|NCT02899364|Chelating Agents|chelating agents|mesh-ancestor
25163091|NCT02899364|Sequestering Agents|sequestering agents|mesh-ancestor
24994506|NCT04022226|Analgesics|analgesics|mesh-ancestor
24994507|NCT04022226|Sensory System Agents|sensory system agents|mesh-ancestor
24994508|NCT04022226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24994509|NCT04022226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994510|NCT04022226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24548435|NCT00709449|Vasodilator Agents|vasodilator agents|mesh-ancestor
24994602|NCT03822975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658615|NCT01598090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658616|NCT01598090|Antiviral Agents|antiviral agents|mesh-ancestor
25658617|NCT01598090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25658618|NCT01598207|Dronabinol|dronabinol|mesh-list
25658619|NCT01598207|Hallucinogens|hallucinogens|mesh-ancestor
25658620|NCT01598207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658621|NCT01598207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25658622|NCT01598207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25658623|NCT01598207|Analgesics|analgesics|mesh-ancestor
25658624|NCT01598207|Sensory System Agents|sensory system agents|mesh-ancestor
25658625|NCT01598207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25658626|NCT01598207|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25658627|NCT01598207|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25658628|NCT01598207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25833421|NCT00012506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833422|NCT00012506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25833423|NCT00012506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25833424|NCT00012506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25833425|NCT00012506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25833426|NCT00012506|Immunologic Factors|immunologic factors|mesh-ancestor
25024211|NCT03648008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24815140|NCT02068287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815141|NCT02068339|Oltipraz|oltipraz|mesh-list
24815142|NCT02068339|Antiviral Agents|antiviral agents|mesh-ancestor
25833427|NCT00012519|Ritonavir|ritonavir|mesh-list
25833428|NCT00012519|Indinavir|indinavir|mesh-list
25833429|NCT00012519|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25833430|NCT00012519|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25833431|NCT00012519|Protease Inhibitors|protease inhibitors|mesh-ancestor
25833432|NCT00012519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833433|NCT00012519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994511|NCT04022226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24994512|NCT04022226|Anesthetics, General|anesthetics, general|mesh-ancestor
24994513|NCT04022226|Anesthetics|anesthetics|mesh-ancestor
24994514|NCT04022226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24994515|NCT04022226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24994516|NCT04022226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24994517|NCT04022226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24994518|NCT04022226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994519|NCT04016818|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24994520|NCT04016818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25189881|NCT02793843|Autonomic Agents|autonomic agents|mesh-ancestor
24994521|NCT04016818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994525|NCT03984578|Pembrolizumab|pembrolizumab|mesh-list
24994526|NCT03984578|Capecitabine|capecitabine|mesh-list
24994527|NCT03984578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24636486|NCT01145846|Cytarabine|cytarabine|mesh-list
24797919|NCT01959074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25833434|NCT00012519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25833435|NCT00012519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25833436|NCT00012519|Antiviral Agents|antiviral agents|mesh-ancestor
25833437|NCT00012519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833438|NCT00012519|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25833439|NCT00012519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25833440|NCT00012558|Inositol|inositol|mesh-list
25833441|NCT00012558|Lamotrigine|lamotrigine|mesh-list
25833442|NCT00012558|Valproic Acid|valproic acid|mesh-list
25833443|NCT00012558|Risperidone|risperidone|mesh-list
25833444|NCT00012558|Tranylcypromine|tranylcypromine|mesh-list
25833445|NCT00012558|Bupropion|bupropion|mesh-list
24797922|NCT01959074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24797923|NCT01959074|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24797924|NCT01959074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24797925|NCT01959074|Adrenergic Agents|adrenergic agents|mesh-ancestor
24797926|NCT01959074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24797927|NCT01959074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797928|NCT01959074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24797929|NCT01959074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24797930|NCT01959074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24797931|NCT01959074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24797932|NCT01959074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24797934|NCT01959100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24797935|NCT01959100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24797937|NCT01959152|Cholinergic Agents|cholinergic agents|mesh-ancestor
24797938|NCT01959152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24797939|NCT01959152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797940|NCT01959152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797941|NCT01959191|Aspirin|aspirin|mesh-list
24797942|NCT01959191|Clopidogrel|clopidogrel|mesh-list
24797943|NCT01959191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24797944|NCT01959191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24797945|NCT01959191|Analgesics|analgesics|mesh-ancestor
24797946|NCT01959191|Sensory System Agents|sensory system agents|mesh-ancestor
24797947|NCT01959191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25658629|NCT01598207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658630|NCT01598207|Hormones|hormones|mesh-ancestor
25658631|NCT01598207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25658632|NCT01598298|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25658633|NCT01598298|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24873273|NCT05312671|Cisplatin|cisplatin|mesh-list
24873274|NCT05312671|Carboplatin|carboplatin|mesh-list
24873275|NCT05312671|Etoposide|etoposide|mesh-list
24873276|NCT05312671|Atezolizumab|atezolizumab|mesh-list
24873277|NCT05312671|Podophyllotoxin|podophyllotoxin|mesh-list
24873278|NCT05312671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24873279|NCT05312671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24873280|NCT05312671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24873281|NCT05312671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24873282|NCT05312671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024293|NCT03647579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25833446|NCT00012558|Paroxetine|paroxetine|mesh-list
24797948|NCT01959191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833447|NCT00012558|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24842663|NCT02222636|Fentanyl|fentanyl|mesh-list
24591639|NCT00918021|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24591640|NCT00918021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24591641|NCT00918021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24622107|NCT01065662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994536|NCT03869268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24994537|NCT03869268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25833448|NCT00012558|Serotonin Agents|serotonin agents|mesh-ancestor
25833449|NCT00012558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25833450|NCT00012558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833451|NCT00012558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833452|NCT00012558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25189942|NCT02793388|Primaquine|primaquine|mesh-list
25833453|NCT00012558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25833454|NCT00012558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25833455|NCT00012558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25833456|NCT00012558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25833457|NCT00012558|Dopamine Agents|dopamine agents|mesh-ancestor
25833458|NCT00012558|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25833459|NCT00012558|Antidepressive Agents|antidepressive agents|mesh-ancestor
25833460|NCT00012558|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25833461|NCT00012558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25833462|NCT00012558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25833463|NCT00012558|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24994539|NCT03869268|Sensory System Agents|sensory system agents|mesh-ancestor
24994540|NCT03869268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24994541|NCT03869268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994542|NCT03869268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24994543|NCT03869268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24994544|NCT03869268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24994545|NCT03869268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24994546|NCT03869268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994547|NCT03869268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24994548|NCT03869268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24994549|NCT03869268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24994550|NCT03869268|Antipyretics|antipyretics|mesh-ancestor
24994551|NCT03869268|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24994552|NCT03869268|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24994553|NCT03869268|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24994554|NCT03869268|Purinergic Agents|purinergic agents|mesh-ancestor
24994555|NCT03869268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24994556|NCT03836014|Dexamethasone|dexamethasone|mesh-list
24994557|NCT03836014|Dexamethasone acetate|dexamethasone acetate|mesh-list
24994558|NCT03836014|Lenalidomide|lenalidomide|mesh-list
24994559|NCT03836014|Daratumumab|daratumumab|mesh-list
24994560|NCT03836014|BB 1101|bb 1101|mesh-list
24994561|NCT03836014|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24994562|NCT03836014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24994581|NCT03831503|Antibodies|antibodies|mesh-list
24994582|NCT03831503|Immunologic Factors|immunologic factors|mesh-ancestor
25658634|NCT01598298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25658635|NCT01598298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25658636|NCT01598298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658637|NCT01598298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25658638|NCT01598298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658639|NCT01598298|Analgesics|analgesics|mesh-ancestor
25658640|NCT01598298|Sensory System Agents|sensory system agents|mesh-ancestor
25658641|NCT01598298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25658642|NCT01598298|Antidepressive Agents|antidepressive agents|mesh-ancestor
25658643|NCT01598298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25658644|NCT01598298|Dopamine Agents|dopamine agents|mesh-ancestor
25833464|NCT00012558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25833465|NCT00012558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833466|NCT00012558|Antimanic Agents|antimanic agents|mesh-ancestor
25833467|NCT00012558|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25833468|NCT00012558|Anticonvulsants|anticonvulsants|mesh-ancestor
25833469|NCT00012558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25833470|NCT00012558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25833471|NCT00012558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25833472|NCT00012558|GABA Agents|gaba agents|mesh-ancestor
25833473|NCT00012558|Vitamin B Complex|vitamin b complex|mesh-ancestor
25201379|NCT02728310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25201380|NCT02728037|Lidocaine|lidocaine|mesh-list
25201381|NCT02728037|Magnesium Sulfate|magnesium sulfate|mesh-list
25201382|NCT02728037|Anesthetics, Local|anesthetics, local|mesh-ancestor
25201383|NCT02728037|Anesthetics|anesthetics|mesh-ancestor
24827399|NCT02138773|Urological Agents|urological agents|mesh-ancestor
24695918|NCT01426399|Metformin|metformin|mesh-list
24873405|NCT05253131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24873406|NCT05253131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24873407|NCT05251090|Factor VIII|factor viii|mesh-list
24994583|NCT03831503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994592|NCT03822975|Heparin|heparin|mesh-list
24994593|NCT03822975|Calcium heparin|calcium heparin|mesh-list
24994594|NCT03822975|Bivalirudin|bivalirudin|mesh-list
24994595|NCT03822975|Anticoagulants|anticoagulants|mesh-ancestor
24994596|NCT03822975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24994597|NCT03822975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24994598|NCT03822975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994599|NCT03822975|Antithrombins|antithrombins|mesh-ancestor
24994600|NCT03822975|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25107950|NCT03135795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25107951|NCT03135795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994631|NCT03668041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25163092|NCT02899286|BCT-100|bct-100|mesh-list
24994632|NCT03668041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24994633|NCT03668041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24994634|NCT03668041|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24994635|NCT03668041|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24994636|NCT03668041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24994637|NCT03668041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994638|NCT03668041|Antimanic Agents|antimanic agents|mesh-ancestor
24994639|NCT03668041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24994640|NCT03668041|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24994641|NCT03668041|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24994642|NCT03668041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24994643|NCT03668041|Serotonin Agents|serotonin agents|mesh-ancestor
24994644|NCT03668041|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24994645|NCT03668041|Antidepressive Agents|antidepressive agents|mesh-ancestor
24994646|NCT03663335|Tacrolimus|tacrolimus|mesh-list
24994647|NCT03663335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24994648|NCT03663335|Immunologic Factors|immunologic factors|mesh-ancestor
24994649|NCT03663335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994650|NCT03663335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24994651|NCT03663335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24994652|NCT03663335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601461|NCT00964288|Lidocaine|lidocaine|mesh-list
25658645|NCT01598506|Hydromorphone|hydromorphone|mesh-list
25658646|NCT01598506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25658647|NCT01598506|Narcotics|narcotics|mesh-ancestor
25658648|NCT01598506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25658649|NCT01598506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658650|NCT01598506|Analgesics|analgesics|mesh-ancestor
25658651|NCT01598506|Sensory System Agents|sensory system agents|mesh-ancestor
25658652|NCT01598506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25658653|NCT01598545|Hydromorphone|hydromorphone|mesh-list
25658654|NCT01598545|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25658655|NCT01598545|Narcotics|narcotics|mesh-ancestor
25658656|NCT01598545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25658657|NCT01598545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658658|NCT01598545|Analgesics|analgesics|mesh-ancestor
25658659|NCT01598545|Sensory System Agents|sensory system agents|mesh-ancestor
25658660|NCT01598545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25658661|NCT01598662|Levonorgestrel|levonorgestrel|mesh-list
25658662|NCT01598662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25658663|NCT01598662|Contraceptive Agents|contraceptive agents|mesh-ancestor
24873449|NCT05222828|Anesthetics, Local|anesthetics, local|mesh-ancestor
24873450|NCT05222828|Anesthetics|anesthetics|mesh-ancestor
24873451|NCT05222828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24873452|NCT05222828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24873455|NCT05215236|Opiate Alkaloids|opiate alkaloids|mesh-list
24873456|NCT05215236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24873457|NCT05215236|Narcotics|narcotics|mesh-ancestor
24873458|NCT05215236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24873459|NCT05215236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24873460|NCT05215236|Analgesics|analgesics|mesh-ancestor
24994713|NCT03315741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145683|NCT02928315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24994723|NCT03259425|Nivolumab|nivolumab|mesh-list
24994724|NCT03259425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24994725|NCT03259425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994726|NCT03259425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24994727|NCT03259425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994743|NCT03175978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24994744|NCT03175978|Abortifacient Agents|abortifacient agents|mesh-ancestor
24994751|NCT03175978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24994752|NCT03175978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24994753|NCT03175978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24994754|NCT03175978|Immunologic Factors|immunologic factors|mesh-ancestor
24994755|NCT03175978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24994765|NCT03010176|Pembrolizumab|pembrolizumab|mesh-list
24994766|NCT03010176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24994767|NCT03010176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994768|NCT02959541|Leucovorin|leucovorin|mesh-list
24994769|NCT02959541|Levoleucovorin|levoleucovorin|mesh-list
24994770|NCT02959541|Antidotes|antidotes|mesh-ancestor
24994771|NCT02959541|Protective Agents|protective agents|mesh-ancestor
24994772|NCT02959541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994773|NCT02959541|Vitamin B Complex|vitamin b complex|mesh-ancestor
24994774|NCT02959541|Vitamins|vitamins|mesh-ancestor
24994775|NCT02959541|Micronutrients|micronutrients|mesh-ancestor
24868711|NCT03393741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25833474|NCT00012558|Vitamins|vitamins|mesh-ancestor
25833475|NCT00012558|Micronutrients|micronutrients|mesh-ancestor
25833476|NCT00012558|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25833477|NCT00012558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25833478|NCT00012584|Fluvoxamine|fluvoxamine|mesh-list
25833479|NCT00012584|Methylphenidate|methylphenidate|mesh-list
25833480|NCT00012584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25833481|NCT00012584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833482|NCT00012584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25833483|NCT00012584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25833484|NCT00012584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25833485|NCT00012584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833486|NCT00012584|Dopamine Agents|dopamine agents|mesh-ancestor
25833487|NCT00012584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25833488|NCT00012584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25833489|NCT00012584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24842944|NCT02224443|GABA Agents|gaba agents|mesh-ancestor
24994784|NCT02684006|Sunitinib|sunitinib|mesh-list
24994785|NCT02684006|Avelumab|avelumab|mesh-list
24994786|NCT02684006|Axitinib|axitinib|mesh-list
24994787|NCT02684006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994788|NCT02684006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24994789|NCT02684006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24868727|NCT03379389|Renal Agents|renal agents|mesh-ancestor
25833490|NCT00012584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25833491|NCT00012584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25658664|NCT01598662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25658665|NCT01598662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658666|NCT01598662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25658667|NCT01598662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25658668|NCT01598662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25658669|NCT01598701|Acetaminophen|acetaminophen|mesh-list
25658670|NCT01598701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25658671|NCT01598701|Analgesics|analgesics|mesh-ancestor
25658672|NCT01598701|Sensory System Agents|sensory system agents|mesh-ancestor
25658673|NCT01598701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25658674|NCT01598701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833492|NCT00012584|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25833493|NCT00012584|Serotonin Agents|serotonin agents|mesh-ancestor
25833494|NCT00012584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25833496|NCT00012584|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25833497|NCT00012584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25833498|NCT00012584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833499|NCT00012584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25833500|NCT00012688|Chlorhexidine|chlorhexidine|mesh-list
25833501|NCT00012688|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25833502|NCT00012688|Doxycycline|doxycycline|mesh-list
25833503|NCT00012688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25833504|NCT00012688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833505|NCT00012688|Disinfectants|disinfectants|mesh-ancestor
25833506|NCT00012688|Dermatologic Agents|dermatologic agents|mesh-ancestor
25833507|NCT00012688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25833508|NCT00012688|Antimalarials|antimalarials|mesh-ancestor
25833509|NCT00012688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25833510|NCT00012688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25833511|NCT00012857|Acetaminophen|acetaminophen|mesh-list
25833512|NCT00012857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25145756|NCT02927379|Analgesics|analgesics|mesh-ancestor
25833513|NCT00012857|Analgesics|analgesics|mesh-ancestor
25833514|NCT00012857|Sensory System Agents|sensory system agents|mesh-ancestor
24451261|NCT00322907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24451262|NCT00322907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24451277|NCT00322985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24451278|NCT00322985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24451279|NCT00322985|Growth Substances|growth substances|mesh-ancestor
24451280|NCT00322985|Growth Inhibitors|growth inhibitors|mesh-ancestor
24451281|NCT00322985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451339|NCT00323219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451341|NCT00323219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451363|NCT00323323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24451364|NCT00323323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24451365|NCT00323323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24451366|NCT00323323|Tubulin Modulators|tubulin modulators|mesh-ancestor
24451367|NCT00323323|Antimitotic Agents|antimitotic agents|mesh-ancestor
24451368|NCT00323323|Mitosis Modulators|mitosis modulators|mesh-ancestor
24451369|NCT00323323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24451371|NCT00323375|Amebicides|amebicides|mesh-ancestor
25833515|NCT00012857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25833516|NCT00012857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994790|NCT02684006|Growth Substances|growth substances|mesh-ancestor
24994791|NCT02684006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994792|NCT02684006|Growth Inhibitors|growth inhibitors|mesh-ancestor
24994793|NCT02684006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24994794|NCT02684006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24994795|NCT02684006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163093|NCT02899286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994798|NCT02675465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24994799|NCT02675465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994800|NCT02675465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24994801|NCT02675465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24994802|NCT02675465|Antiviral Agents|antiviral agents|mesh-ancestor
24994803|NCT02675465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24994804|NCT02675465|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24994805|NCT02675465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24868742|NCT03084718|Beclomethasone|beclomethasone|mesh-list
25833517|NCT00012857|Antipyretics|antipyretics|mesh-ancestor
25833518|NCT00012909|Hormones|hormones|mesh-list
25833519|NCT00012909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25833520|NCT00012909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833521|NCT00013520|Lamivudine|lamivudine|mesh-list
25833522|NCT00013520|Zidovudine|zidovudine|mesh-list
25833523|NCT00013520|Efavirenz|efavirenz|mesh-list
25658675|NCT01598701|Antipyretics|antipyretics|mesh-ancestor
25658676|NCT01598740|Spironolactone|spironolactone|mesh-list
25658677|NCT01598740|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25658678|NCT01598740|Hormone Antagonists|hormone antagonists|mesh-ancestor
25658679|NCT01598740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25658680|NCT01598740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658681|NCT01598740|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25658682|NCT01598740|Diuretics|diuretics|mesh-ancestor
25658683|NCT01598740|Natriuretic Agents|natriuretic agents|mesh-ancestor
25658684|NCT01598753|Tramadol|tramadol|mesh-list
24873643|NCT05101070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24873644|NCT05101070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056202|NCT03514771|Antiviral Agents|antiviral agents|mesh-ancestor
24965991|NCT03772223|Hormones|hormones|mesh-ancestor
24885823|NCT04498780|Valsartan|valsartan|mesh-list
25833524|NCT00013520|Nevirapine|nevirapine|mesh-list
25833525|NCT00013520|Abacavir|abacavir|mesh-list
25047734|NCT00765804|Dexamethasone|dexamethasone|mesh-list
25833526|NCT00013520|Dideoxynucleosides|dideoxynucleosides|mesh-list
25833527|NCT00013520|Stavudine|stavudine|mesh-list
25833528|NCT00013520|Didanosine|didanosine|mesh-list
25833529|NCT00013520|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25833530|NCT00013520|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24994806|NCT02675465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994808|NCT02649673|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24994809|NCT02649673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24994810|NCT02649673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24994811|NCT02649673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994812|NCT02649673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994813|NCT02498951|Obinutuzumab|obinutuzumab|mesh-list
24994814|NCT02498951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24994815|NCT02498951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994816|NCT02454855|Melatonin|melatonin|mesh-list
24994817|NCT02454855|Antioxidants|antioxidants|mesh-ancestor
24994818|NCT02454855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994819|NCT02454855|Protective Agents|protective agents|mesh-ancestor
24994820|NCT02454855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145851|NCT02926326|Acumapimod|acumapimod|mesh-list
24994821|NCT02454855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24994822|NCT02351544|Botulinum Toxins|botulinum toxins|mesh-list
24994823|NCT02351544|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25658685|NCT01598753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25658686|NCT01598753|Narcotics|narcotics|mesh-ancestor
25658687|NCT01598753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25658688|NCT01598753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658689|NCT01598753|Analgesics|analgesics|mesh-ancestor
25658690|NCT01598753|Sensory System Agents|sensory system agents|mesh-ancestor
25658691|NCT01598753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24994824|NCT02351544|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24994825|NCT02351544|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25107990|NCT03136120|Autonomic Agents|autonomic agents|mesh-ancestor
24994827|NCT02351544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994830|NCT02351544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994831|NCT02351544|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24994832|NCT02351544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24994833|NCT02288832|Azithromycin|azithromycin|mesh-list
24994834|NCT02288832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24994835|NCT02288832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25145882|NCT02926053|Fludarabine|fludarabine|mesh-list
24994842|NCT02142738|Paclitaxel|paclitaxel|mesh-list
24994843|NCT02142738|Carboplatin|carboplatin|mesh-list
24994844|NCT02142738|Pembrolizumab|pembrolizumab|mesh-list
24994845|NCT02142738|Pemetrexed|pemetrexed|mesh-list
24994846|NCT02142738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24994847|NCT02142738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994848|NCT02142738|Tubulin Modulators|tubulin modulators|mesh-ancestor
24994849|NCT02142738|Antimitotic Agents|antimitotic agents|mesh-ancestor
24994850|NCT02142738|Mitosis Modulators|mitosis modulators|mesh-ancestor
24994851|NCT02142738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994852|NCT02142738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24994853|NCT02142738|Antimetabolites|antimetabolites|mesh-ancestor
24994854|NCT02142738|Antiviral Agents|antiviral agents|mesh-ancestor
25107962|NCT03135795|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24994855|NCT02142738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24994856|NCT02142738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24994857|NCT02142738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24994858|NCT02142738|Immunologic Factors|immunologic factors|mesh-ancestor
24994871|NCT01931709|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24994872|NCT01931709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994873|NCT01667133|Ponatinib|ponatinib|mesh-list
25658692|NCT01598896|Clonidine|clonidine|mesh-list
25658693|NCT01598896|Dronabinol|dronabinol|mesh-list
25658694|NCT01598896|Analgesics|analgesics|mesh-ancestor
25658695|NCT01598896|Sensory System Agents|sensory system agents|mesh-ancestor
25658696|NCT01598896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25833531|NCT00013520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24873749|NCT05033769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24873750|NCT05033769|Tubulin Modulators|tubulin modulators|mesh-ancestor
24873751|NCT05033769|Antimitotic Agents|antimitotic agents|mesh-ancestor
24873752|NCT05033769|Mitosis Modulators|mitosis modulators|mesh-ancestor
24873753|NCT05033769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24873754|NCT05033756|Pembrolizumab|pembrolizumab|mesh-list
24873755|NCT05033756|Olaparib|olaparib|mesh-list
24873756|NCT05033756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24873757|NCT05033756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24873758|NCT05033756|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24994874|NCT01667133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994875|NCT01667133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24994876|NCT01667133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24994877|NCT01667133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994878|NCT01466686|Temozolomide|temozolomide|mesh-list
24994879|NCT01466686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24994880|NCT01466686|Alkylating Agents|alkylating agents|mesh-ancestor
24994898|NCT00913705|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25145906|NCT02925975|Carvedilol|carvedilol|mesh-list
24994899|NCT00913705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994900|NCT00913705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24994901|NCT00913705|Tubulin Modulators|tubulin modulators|mesh-ancestor
24994902|NCT00913705|Antimitotic Agents|antimitotic agents|mesh-ancestor
24994903|NCT00913705|Mitosis Modulators|mitosis modulators|mesh-ancestor
24994907|NCT00883480|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24994908|NCT00883480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994909|NCT00883480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24994911|NCT00883480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994912|NCT00883480|Antiviral Agents|antiviral agents|mesh-ancestor
24994913|NCT00883480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24994914|NCT00883480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24994915|NCT00883480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24994916|NCT00883480|Immunologic Factors|immunologic factors|mesh-ancestor
24994917|NCT00883480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994924|NCT00446225|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24994925|NCT00446225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994926|NCT00446225|Tubulin Modulators|tubulin modulators|mesh-ancestor
24994927|NCT00446225|Antimitotic Agents|antimitotic agents|mesh-ancestor
24994928|NCT00446225|Mitosis Modulators|mitosis modulators|mesh-ancestor
25107963|NCT03135795|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24785979|NCT01917331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24785981|NCT01917448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24785982|NCT01917448|Narcotics|narcotics|mesh-ancestor
24785983|NCT01917448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24785984|NCT01917448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785985|NCT01917448|Analgesics|analgesics|mesh-ancestor
24785986|NCT01917448|Sensory System Agents|sensory system agents|mesh-ancestor
24785987|NCT01917448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25107964|NCT03135795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25107986|NCT03136120|Bromides|bromides|mesh-list
25107987|NCT03136120|Ipratropium|ipratropium|mesh-list
25107988|NCT03136120|Anticonvulsants|anticonvulsants|mesh-ancestor
25107989|NCT03136120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25833532|NCT00013520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25833533|NCT00013520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833534|NCT00013520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833535|NCT00013520|Antiviral Agents|antiviral agents|mesh-ancestor
25833536|NCT00013520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833537|NCT00013520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25833538|NCT00013520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25833539|NCT00013520|Antimetabolites|antimetabolites|mesh-ancestor
25833540|NCT00013520|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24602253|NCT00967772|Naftopidil|naftopidil|mesh-list
25658697|NCT01598896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658698|NCT01598896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25658699|NCT01598896|Sympatholytics|sympatholytics|mesh-ancestor
25658700|NCT01598896|Autonomic Agents|autonomic agents|mesh-ancestor
25658701|NCT01598896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25658702|NCT01598896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25658703|NCT01598896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25658704|NCT01598896|Adrenergic Agents|adrenergic agents|mesh-ancestor
25658705|NCT01598896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25674592|NCT01774305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25833541|NCT00013520|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25833548|NCT00013520|Protease Inhibitors|protease inhibitors|mesh-ancestor
25875331|NCT04457557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25875332|NCT04457557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108007|NCT03135171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25108008|NCT03135171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108009|NCT03135184|Coal Tar|coal tar|mesh-list
25108010|NCT03135184|Keratolytic Agents|keratolytic agents|mesh-ancestor
25108011|NCT03135184|Dermatologic Agents|dermatologic agents|mesh-ancestor
25108012|NCT03135054|Homoharringtonine|homoharringtonine|mesh-list
25108013|NCT03135054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25108014|NCT03135054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108015|NCT03135054|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25108016|NCT03135054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25108017|NCT03135054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108018|NCT03135106|Itraconazole|itraconazole|mesh-list
25108019|NCT03135106|Fluconazole|fluconazole|mesh-list
25108020|NCT03135106|Antifungal Agents|antifungal agents|mesh-ancestor
24868934|NCT05158647|Tocolytic Agents|tocolytic agents|mesh-ancestor
24868935|NCT05158647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25875333|NCT04457557|Sensory System Agents|sensory system agents|mesh-ancestor
25875334|NCT04457557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25875335|NCT04454658|Navitoclax|navitoclax|mesh-list
25875336|NCT04454658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25146032|NCT02924766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875337|NCT04444921|Paclitaxel|paclitaxel|mesh-list
25875338|NCT04444921|Carboplatin|carboplatin|mesh-list
25875339|NCT04444921|Nivolumab|nivolumab|mesh-list
25875340|NCT04444921|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24622128|NCT01065701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622129|NCT01065727|Mitoxantrone|mitoxantrone|mesh-list
24622130|NCT01065727|Natalizumab|natalizumab|mesh-list
24622131|NCT01065727|Immunologic Factors|immunologic factors|mesh-list
24622132|NCT01065727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
24622133|NCT01065727|Analgesics|analgesics|mesh-ancestor
24622134|NCT01065727|Sensory System Agents|sensory system agents|mesh-ancestor
24622135|NCT01065727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24622136|NCT01065727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622137|NCT01065727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622138|NCT01065727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24994964|NCT05418946|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24994978|NCT05418686|Colchicine|colchicine|mesh-list
24994979|NCT05418686|Gout Suppressants|gout suppressants|mesh-ancestor
24994980|NCT05418686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25146053|NCT02924532|Hormones|hormones|mesh-list
24451859|NCT00325000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24602877|NCT00971581|Omeprazole|omeprazole|mesh-list
24995044|NCT05418361|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24995045|NCT05418361|Protease Inhibitors|protease inhibitors|mesh-ancestor
24995046|NCT05418361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24995047|NCT05418361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995048|NCT05418348|Nimodipine|nimodipine|mesh-list
24995049|NCT05418348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24995050|NCT05418348|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25658706|NCT01598896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658707|NCT01598896|Hallucinogens|hallucinogens|mesh-ancestor
25658708|NCT01598896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25658709|NCT01598896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25658710|NCT01598896|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25658711|NCT01598896|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25658712|NCT01598896|Hormones|hormones|mesh-ancestor
25658713|NCT01598896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25833550|NCT00013585|Antidepressive Agents|antidepressive agents|mesh-ancestor
25833551|NCT00013585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25833552|NCT00013585|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25833553|NCT00013585|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25833554|NCT00013585|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25833555|NCT00013585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024835|NCT03642509|Anticoagulants|anticoagulants|mesh-ancestor
25833556|NCT00013585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833557|NCT00013585|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25833558|NCT00013585|Protective Agents|protective agents|mesh-ancestor
25833559|NCT00013585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833560|NCT00013598|Pioglitazone|pioglitazone|mesh-list
25833561|NCT00013598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24995051|NCT05418348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24995052|NCT05418348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995053|NCT05418348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24995054|NCT05418348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995057|NCT05418309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25833562|NCT00013598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833563|NCT00013624|Levodopa|levodopa|mesh-list
24995089|NCT05418114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24995090|NCT05418114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995091|NCT05418114|Anesthetics|anesthetics|mesh-ancestor
24995092|NCT05418114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24995093|NCT05418114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24995094|NCT05418114|Anticonvulsants|anticonvulsants|mesh-ancestor
24995095|NCT05418114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24995127|NCT05417997|Antiemetics|antiemetics|mesh-ancestor
24995128|NCT05417997|Autonomic Agents|autonomic agents|mesh-ancestor
24995129|NCT05417997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24995130|NCT05417997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995131|NCT05417997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24995132|NCT05417997|Glucocorticoids|glucocorticoids|mesh-ancestor
24995133|NCT05417997|Hormones|hormones|mesh-ancestor
25206390|NCT03586687|Hormones|hormones|mesh-ancestor
24995134|NCT05417997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25833564|NCT00013624|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25833565|NCT00013624|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25833566|NCT00013624|Dopamine Agents|dopamine agents|mesh-ancestor
25833567|NCT00013624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24995142|NCT05417997|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24995143|NCT05417997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24995144|NCT05417997|Anticoagulants|anticoagulants|mesh-ancestor
24995145|NCT05417997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24995146|NCT05417997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24995147|NCT05417997|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24995148|NCT05417997|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24995149|NCT05417997|Antiviral Agents|antiviral agents|mesh-ancestor
24786069|NCT01917877|Dexamethasone|dexamethasone|mesh-list
24786070|NCT01917877|Bevacizumab|bevacizumab|mesh-list
24786071|NCT01917877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24786072|NCT01917877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24786073|NCT01917877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24786074|NCT01917877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24786075|NCT01917877|Growth Substances|growth substances|mesh-ancestor
24643376|NCT01185418|Haloperidol|haloperidol|mesh-list
24786076|NCT01917877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853294|NCT02267239|Chlorhexidine|chlorhexidine|mesh-list
24603620|NCT00974792|Leucovorin|leucovorin|mesh-list
25108055|NCT03134729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108056|NCT03134729|Sensory System Agents|sensory system agents|mesh-ancestor
25108057|NCT03134729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108059|NCT03134651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25146173|NCT02923869|Bupivacaine|bupivacaine|mesh-list
25108060|NCT03134651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25658714|NCT01598987|Cyclosporine|cyclosporine|mesh-list
25658715|NCT01598987|Everolimus|everolimus|mesh-list
25658716|NCT01598987|Tacrolimus|tacrolimus|mesh-list
25658717|NCT01598987|Cyclosporins|cyclosporins|mesh-list
25658718|NCT01598987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25658719|NCT01598987|Immunologic Factors|immunologic factors|mesh-ancestor
25658720|NCT01598987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658721|NCT01598987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25658722|NCT01598987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833568|NCT00013624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833569|NCT00013624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833570|NCT00013663|Aldesleukin|aldesleukin|mesh-list
25833571|NCT00013663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833572|NCT00013663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25833573|NCT00013663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25833574|NCT00013663|Antiviral Agents|antiviral agents|mesh-ancestor
25658723|NCT01598987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658724|NCT01598987|Antifungal Agents|antifungal agents|mesh-ancestor
25658725|NCT01598987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833575|NCT00013663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833576|NCT00013689|Pyrimethamine|pyrimethamine|mesh-list
25833577|NCT00013689|Sulfadoxine|sulfadoxine|mesh-list
25833578|NCT00013689|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25833579|NCT00013689|Antimalarials|antimalarials|mesh-ancestor
25833580|NCT00013689|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25833581|NCT00013689|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25833582|NCT00013689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833583|NCT00013689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25833584|NCT00013689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833585|NCT00013689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833586|NCT00013689|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25833587|NCT00013689|Renal Agents|renal agents|mesh-ancestor
24528218|NCT00620438|Antiviral Agents|antiviral agents|mesh-ancestor
25833588|NCT00013702|Adefovir|adefovir|mesh-list
25833589|NCT00013702|Antiviral Agents|antiviral agents|mesh-ancestor
24995230|NCT05417165|Immunologic Factors|immunologic factors|mesh-ancestor
24995231|NCT05417165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995233|NCT05417087|Antidepressive Agents|antidepressive agents|mesh-ancestor
24995234|NCT05417087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24995235|NCT05417087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24995236|NCT05417087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24995237|NCT05417087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24995238|NCT05417087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995239|NCT05417087|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24995240|NCT05417087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24853335|NCT02267655|Antioxidants|antioxidants|mesh-ancestor
24622139|NCT01065727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24797960|NCT01959191|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24797961|NCT01959191|Purinergic Agents|purinergic agents|mesh-ancestor
24797962|NCT01959191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24797996|NCT01959451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24797997|NCT01959451|Purinergic Agents|purinergic agents|mesh-ancestor
24797998|NCT01959451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24797999|NCT01959451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798000|NCT01959451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798001|NCT01959477|Cyclophosphamide|cyclophosphamide|mesh-list
24798004|NCT01959477|Etoposide phosphate|etoposide phosphate|mesh-list
24798005|NCT01959477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24798006|NCT01959477|Immunologic Factors|immunologic factors|mesh-ancestor
24798007|NCT01959477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798008|NCT01959477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24798009|NCT01959477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24798010|NCT01959477|Alkylating Agents|alkylating agents|mesh-ancestor
24798026|NCT01959828|Antioxidants|antioxidants|mesh-ancestor
24995282|NCT05410496|Antiviral Agents|antiviral agents|mesh-ancestor
24995283|NCT05410496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24995284|NCT05410496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24995285|NCT05410496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24995286|NCT05410496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24995287|NCT05410496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995288|NCT05410496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24995289|NCT05410496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25658726|NCT01598987|Dermatologic Agents|dermatologic agents|mesh-ancestor
25658727|NCT01598987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25658728|NCT01598987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658729|NCT01599104|Olmesartan|olmesartan|mesh-list
25658730|NCT01599104|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25658731|NCT01599104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25658732|NCT01599104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25658733|NCT01599104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25658734|NCT01599104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658735|NCT01599234|Nabiximols|nabiximols|mesh-list
25833590|NCT00013702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833591|NCT00013702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25833592|NCT00013702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25833593|NCT00013702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833594|NCT00013702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833595|NCT00013871|Vaccines|vaccines|mesh-list
25833596|NCT00013871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25833597|NCT00013871|Immunologic Factors|immunologic factors|mesh-ancestor
25833598|NCT00013871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833599|NCT00013962|Vitamin D|vitamin d|mesh-list
25833600|NCT00013962|Vitamins|vitamins|mesh-ancestor
25833601|NCT00013962|Micronutrients|micronutrients|mesh-ancestor
25833602|NCT00013962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833603|NCT00013962|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25833604|NCT00014001|Olanzapine|olanzapine|mesh-list
25833605|NCT00014001|Risperidone|risperidone|mesh-list
25833606|NCT00014001|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25658736|NCT01599234|Analgesics|analgesics|mesh-ancestor
25833607|NCT00014001|Ziprasidone|ziprasidone|mesh-list
25833608|NCT00014001|Clozapine|clozapine|mesh-list
25833609|NCT00014001|Perphenazine|perphenazine|mesh-list
25833610|NCT00014001|Fluphenazine|fluphenazine|mesh-list
25833611|NCT00014001|Fluphenazine depot|fluphenazine depot|mesh-list
25833612|NCT00014001|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
25833613|NCT00014001|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25833614|NCT00014001|Serotonin Agents|serotonin agents|mesh-ancestor
25833615|NCT00014001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25833616|NCT00014001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833617|NCT00014001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833618|NCT00014001|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25201388|NCT02728037|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25833619|NCT00014001|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25833620|NCT00014001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25833621|NCT00014001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25833622|NCT00014001|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25833623|NCT00014001|Dopamine Agents|dopamine agents|mesh-ancestor
24995290|NCT05378763|Docetaxel|docetaxel|mesh-list
24995291|NCT05378763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24995292|NCT05378763|Tubulin Modulators|tubulin modulators|mesh-ancestor
24995293|NCT05378763|Antimitotic Agents|antimitotic agents|mesh-ancestor
24995294|NCT05378763|Mitosis Modulators|mitosis modulators|mesh-ancestor
24995295|NCT05378763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995296|NCT05366192|Ritonavir|ritonavir|mesh-list
24995297|NCT05366192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24869372|NCT04234477|Sympatholytics|sympatholytics|mesh-ancestor
24869373|NCT04234477|Autonomic Agents|autonomic agents|mesh-ancestor
25833624|NCT00014001|Antiemetics|antiemetics|mesh-ancestor
25833625|NCT00014001|Autonomic Agents|autonomic agents|mesh-ancestor
25833626|NCT00014001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24995315|NCT05285566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24995316|NCT05285566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24995317|NCT05285566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24995318|NCT05285566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24995319|NCT05285566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24995320|NCT05285566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163095|NCT02899182|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25146246|NCT02922933|Entinostat|entinostat|mesh-list
24604349|NCT00978718|Micronutrients|micronutrients|mesh-ancestor
25658737|NCT01599234|Sensory System Agents|sensory system agents|mesh-ancestor
25658738|NCT01599234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25658739|NCT01599234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658740|NCT01599325|Azacitidine|azacitidine|mesh-list
25658741|NCT01599325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25658742|NCT01599325|Antimetabolites|antimetabolites|mesh-ancestor
25658743|NCT01599325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658744|NCT01599325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658745|NCT01599325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658746|NCT01599650|Ranibizumab|ranibizumab|mesh-list
25658747|NCT01599650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25658748|NCT01599650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25658749|NCT01599650|Growth Substances|growth substances|mesh-ancestor
25658750|NCT01599650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658751|NCT01599650|Growth Inhibitors|growth inhibitors|mesh-ancestor
25658752|NCT01599650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658753|NCT01599754|Axitinib|axitinib|mesh-list
25658754|NCT01599754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056282|NCT03513822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056283|NCT03513822|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25056284|NCT03513822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25056285|NCT03513822|Anesthetics, General|anesthetics, general|mesh-ancestor
25056286|NCT03513822|Anesthetics|anesthetics|mesh-ancestor
25833627|NCT00014001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25833628|NCT00014001|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25658755|NCT01599754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25833629|NCT00014001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25658756|NCT01599754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833630|NCT00014001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25833631|NCT00014001|Antidepressive Agents|antidepressive agents|mesh-ancestor
25833632|NCT00014001|GABA Antagonists|gaba antagonists|mesh-ancestor
25056292|NCT03513822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25056293|NCT03513822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25056294|NCT03513822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25833633|NCT00014001|GABA Agents|gaba agents|mesh-ancestor
25833634|NCT00014014|Lamivudine|lamivudine|mesh-list
25833635|NCT00014014|Zidovudine|zidovudine|mesh-list
25833636|NCT00014014|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25833637|NCT00014014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24995414|NCT05212025|Adavosertib|adavosertib|mesh-list
24629345|NCT01104597|Nitroglycerin|nitroglycerin|mesh-list
25833638|NCT00014014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25833639|NCT00014014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833640|NCT00014014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108078|NCT03134547|Anesthetics|anesthetics|mesh-ancestor
25108109|NCT03134612|Autonomic Agents|autonomic agents|mesh-ancestor
25108110|NCT03134612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25108111|NCT03134612|Antipruritics|antipruritics|mesh-ancestor
25108112|NCT03134612|Dermatologic Agents|dermatologic agents|mesh-ancestor
25108113|NCT03134612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25108114|NCT03134612|Serotonin Agents|serotonin agents|mesh-ancestor
25108115|NCT03134612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25108116|NCT03134612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25108117|NCT03134612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25108118|NCT03134612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25108119|NCT03134612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25108120|NCT03134573|Interferons|interferons|mesh-list
25108121|NCT03134573|Interferon-beta|interferon-beta|mesh-list
25108122|NCT03134573|Interferon beta-1b|interferon beta-1b|mesh-list
25108123|NCT03134573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108124|NCT03134573|Antiviral Agents|antiviral agents|mesh-ancestor
25108125|NCT03134573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25108126|NCT03134573|Immunologic Factors|immunologic factors|mesh-ancestor
25108127|NCT03134573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108128|NCT03134573|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25108130|NCT03134456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25833641|NCT00014014|Antiviral Agents|antiviral agents|mesh-ancestor
25833642|NCT00014014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833643|NCT00014014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25833644|NCT00014014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25833645|NCT00014014|Antimetabolites|antimetabolites|mesh-ancestor
24798032|NCT01959828|Protective Agents|protective agents|mesh-ancestor
24798033|NCT01959854|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24798034|NCT01959854|Laxatives|laxatives|mesh-ancestor
24798035|NCT01959854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24869581|NCT02804932|Methamphetamine|methamphetamine|mesh-list
24869582|NCT02804932|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25833646|NCT00014040|Nitric Oxide|nitric oxide|mesh-list
25833647|NCT00014040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24995563|NCT05053503|Naltrexone|naltrexone|mesh-list
24995564|NCT05053503|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25833648|NCT00014040|Autonomic Agents|autonomic agents|mesh-ancestor
25658757|NCT01599754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658758|NCT01599806|Ciprofloxacin|ciprofloxacin|mesh-list
25658759|NCT01599806|Ceftazidime|ceftazidime|mesh-list
25658760|NCT01599806|Doripenem|doripenem|mesh-list
25658761|NCT01599806|Avibactam|avibactam|mesh-list
25658762|NCT01599806|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25658763|NCT01599806|Trimethoprim|trimethoprim|mesh-list
25658764|NCT01599806|Sulfamethoxazole|sulfamethoxazole|mesh-list
25658765|NCT01599806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25658766|NCT01599806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25658767|NCT01599806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24843870|NCT02229812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25413688|NCT03117751|Autonomic Agents|autonomic agents|mesh-ancestor
24874247|NCT04860141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24874248|NCT04860141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24874249|NCT04860141|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24874250|NCT04860141|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24874251|NCT04860141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25025350|NCT03638076|Antiviral Agents|antiviral agents|mesh-ancestor
24874369|NCT04777994|Endothelial Growth Factors|endothelial growth factors|mesh-list
25833649|NCT00014040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25833650|NCT00014040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833651|NCT00014040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24605444|NCT00985244|Azithromycin|azithromycin|mesh-list
25146467|NCT02921282|Dopamine Agents|dopamine agents|mesh-ancestor
24869670|NCT01023737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25833652|NCT00014040|Respiratory System Agents|respiratory system agents|mesh-ancestor
24941718|NCT03988452|Ritonavir|ritonavir|mesh-list
24869719|NCT00455403|Chloroquine|chloroquine|mesh-list
25146500|NCT02921165|Aspirin|aspirin|mesh-list
24995683|NCT04870957|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24798077|NCT01960283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24995719|NCT04793646|Acetylcysteine|acetylcysteine|mesh-list
24995720|NCT04793646|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24995721|NCT04793646|Antiviral Agents|antiviral agents|mesh-ancestor
24995722|NCT04793646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24995723|NCT04793646|Expectorants|expectorants|mesh-ancestor
24995724|NCT04793646|Respiratory System Agents|respiratory system agents|mesh-ancestor
24995725|NCT04793646|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24995726|NCT04793646|Antioxidants|antioxidants|mesh-ancestor
24853427|NCT02268149|Prednisone|prednisone|mesh-list
25833653|NCT00014040|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25833654|NCT00014040|Antioxidants|antioxidants|mesh-ancestor
25833655|NCT00014040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833656|NCT00014040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25833657|NCT00014040|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25833658|NCT00014040|Vasodilator Agents|vasodilator agents|mesh-ancestor
25833659|NCT00014040|Gasotransmitters|gasotransmitters|mesh-ancestor
25833660|NCT00014040|Protective Agents|protective agents|mesh-ancestor
25833661|NCT00014066|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
25833662|NCT00014066|Hematoporphyrins|hematoporphyrins|mesh-list
25833663|NCT00014066|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25833664|NCT00014066|Dermatologic Agents|dermatologic agents|mesh-ancestor
25833665|NCT00014066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833666|NCT00014092|Interferons|interferons|mesh-list
25833667|NCT00014092|Interferon-alpha|interferon-alpha|mesh-list
25833668|NCT00014092|Aldesleukin|aldesleukin|mesh-list
24606244|NCT00989651|Veliparib|veliparib|mesh-list
24941564|NCT03989778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24941565|NCT03989830|Endostatins|endostatins|mesh-list
24941566|NCT03989830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24995963|NCT04464174|Antimetabolites|antimetabolites|mesh-ancestor
24941569|NCT03989830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941570|NCT03989830|Growth Inhibitors|growth inhibitors|mesh-ancestor
24941571|NCT03989830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941573|NCT03989336|Paclitaxel|paclitaxel|mesh-list
24869867|NCT05141240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24869869|NCT05141240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833669|NCT00014092|Temozolomide|temozolomide|mesh-list
25833670|NCT00014092|Sargramostim|sargramostim|mesh-list
25833671|NCT00014092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163104|NCT02899169|Tretinoin|tretinoin|mesh-list
25163105|NCT02899169|Hydroxyurea|hydroxyurea|mesh-list
25163106|NCT02899169|Arsenic Trioxide|arsenic trioxide|mesh-list
25163107|NCT02899169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163108|NCT02899169|Keratolytic Agents|keratolytic agents|mesh-ancestor
25163109|NCT02899169|Dermatologic Agents|dermatologic agents|mesh-ancestor
25163110|NCT02899169|Antisickling Agents|antisickling agents|mesh-ancestor
25658768|NCT01599806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25658769|NCT01599806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658770|NCT01599806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658771|NCT01599806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658772|NCT01599806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25658773|NCT01599806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25658774|NCT01599806|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25658775|NCT01599806|Renal Agents|renal agents|mesh-ancestor
25163111|NCT02899169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163112|NCT02899169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163113|NCT02899169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25163114|NCT02899104|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
24874431|NCT04751500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24874433|NCT04751500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24874434|NCT04751500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24874442|NCT04751500|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24874444|NCT04751500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24874445|NCT04751500|Luteolytic Agents|luteolytic agents|mesh-ancestor
24874447|NCT04751500|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25163115|NCT02899104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163116|NCT02899000|Doxycycline|doxycycline|mesh-list
25163117|NCT02899000|Adapalene|adapalene|mesh-list
25163118|NCT02899000|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25163119|NCT02899000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25163120|NCT02899000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25163121|NCT02899000|Antimalarials|antimalarials|mesh-ancestor
25163122|NCT02899000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25163123|NCT02899000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25163124|NCT02899000|Dermatologic Agents|dermatologic agents|mesh-ancestor
24995875|NCT04555837|Pembrolizumab|pembrolizumab|mesh-list
24995876|NCT04555837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24995881|NCT04544995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995882|NCT04544995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24798095|NCT01960543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798096|NCT01960543|Sensory System Agents|sensory system agents|mesh-ancestor
24798097|NCT01960543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24798098|NCT01960543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24798099|NCT01960543|Narcotics|narcotics|mesh-ancestor
24798100|NCT01960543|Analgesics|analgesics|mesh-ancestor
24798101|NCT01960543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24798102|NCT01960543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24798103|NCT01960543|Anesthetics, General|anesthetics, general|mesh-ancestor
24798104|NCT01960569|Hirudins|hirudins|mesh-list
24798105|NCT01960569|Antithrombins|antithrombins|mesh-ancestor
24798106|NCT01960569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24798107|NCT01960569|Protease Inhibitors|protease inhibitors|mesh-ancestor
24798108|NCT01960569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146593|NCT02920658|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24798109|NCT01960569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798110|NCT01960569|Anticoagulants|anticoagulants|mesh-ancestor
24798111|NCT01960569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24798112|NCT01960569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24798113|NCT01960595|Fentanyl|fentanyl|mesh-list
24798114|NCT01960595|Bupivacaine|bupivacaine|mesh-list
24995916|NCT04492072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24995945|NCT04468776|GABA Agonists|gaba agonists|mesh-ancestor
24995946|NCT04468776|GABA Agents|gaba agents|mesh-ancestor
24995947|NCT04468776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24995948|NCT04468776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995949|NCT04468776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24995950|NCT04468776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25833672|NCT00014092|Antiviral Agents|antiviral agents|mesh-ancestor
25833673|NCT00014092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24995951|NCT04468776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24995952|NCT04468776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24995953|NCT04468776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25163125|NCT02899000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25163126|NCT02899000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25163127|NCT02899000|Analgesics|analgesics|mesh-ancestor
25163128|NCT02899000|Sensory System Agents|sensory system agents|mesh-ancestor
24995962|NCT04464174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24995967|NCT04464174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24995968|NCT04464174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24995969|NCT04464174|Immunologic Factors|immunologic factors|mesh-ancestor
24995970|NCT04464174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995972|NCT04455815|Camostat|camostat|mesh-list
25658776|NCT01599806|Antimalarials|antimalarials|mesh-ancestor
25658777|NCT01599806|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25658778|NCT01599806|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25658779|NCT01599806|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25658780|NCT01599806|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25658781|NCT01599806|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25658782|NCT01599806|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25674294|NCT01769586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995973|NCT04455815|Protease Inhibitors|protease inhibitors|mesh-ancestor
25674295|NCT01769586|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24874644|NCT04616547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24874645|NCT04616547|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24874646|NCT04616547|Anticoagulants|anticoagulants|mesh-ancestor
24874647|NCT04616547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25056367|NCT03513276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24810588|NCT02040883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24810589|NCT02040883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24623372|NCT01071122|Vasodilator Agents|vasodilator agents|mesh-ancestor
24623373|NCT01071122|Tocolytic Agents|tocolytic agents|mesh-ancestor
24623374|NCT01071122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24815216|NCT02068859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24815217|NCT02068859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24995974|NCT04455815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24995975|NCT04455815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995976|NCT04455815|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24995977|NCT04455815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24995978|NCT04455815|Anticoagulants|anticoagulants|mesh-ancestor
24995979|NCT04452877|Trametinib|trametinib|mesh-list
25833674|NCT00014092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24786120|NCT01918111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786122|NCT01918124|Cyclophosphamide|cyclophosphamide|mesh-list
24786123|NCT01918124|Cisplatin|cisplatin|mesh-list
24786124|NCT01918124|Carboplatin|carboplatin|mesh-list
24786125|NCT01918124|Doxorubicin|doxorubicin|mesh-list
24786126|NCT01918124|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24786127|NCT01918124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833675|NCT00014092|Alkylating Agents|alkylating agents|mesh-ancestor
25833676|NCT00014092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833677|NCT00014092|Immunologic Factors|immunologic factors|mesh-ancestor
25658783|NCT01600053|Lenalidomide|lenalidomide|mesh-list
25833678|NCT00014092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833679|NCT00014092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25833680|NCT00014092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24786141|NCT01918124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24786142|NCT01918124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24786143|NCT01918150|Cobalt|cobalt|mesh-list
24786144|NCT01918150|Chromium|chromium|mesh-list
24786145|NCT01918150|Trace Elements|trace elements|mesh-ancestor
24786146|NCT01918150|Micronutrients|micronutrients|mesh-ancestor
25833681|NCT00014105|Carboplatin|carboplatin|mesh-list
25108157|NCT03134339|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25108158|NCT03134339|Autonomic Agents|autonomic agents|mesh-ancestor
25108159|NCT03134339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108160|NCT03134339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108161|NCT03134339|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25108162|NCT03134339|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25163129|NCT02899000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108163|NCT03134339|Cholinergic Agents|cholinergic agents|mesh-ancestor
25108164|NCT03134339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24957749|NCT03841773|Cyclobenzaprine|cyclobenzaprine|mesh-list
25833682|NCT00014105|Temozolomide|temozolomide|mesh-list
25833683|NCT00014105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833684|NCT00014105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24996089|NCT04306900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24996090|NCT04306900|Immunologic Factors|immunologic factors|mesh-ancestor
24996105|NCT04249310|Respiratory System Agents|respiratory system agents|mesh-ancestor
24996106|NCT04249310|Parasympatholytics|parasympatholytics|mesh-ancestor
24996107|NCT04249310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24996108|NCT04249310|Cholinergic Agents|cholinergic agents|mesh-ancestor
24996109|NCT04249310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24996110|NCT04249310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658784|NCT01600053|Immunologic Factors|immunologic factors|mesh-ancestor
25658785|NCT01600053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658786|NCT01600053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25658787|NCT01600053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25658788|NCT01600053|Growth Substances|growth substances|mesh-ancestor
25658789|NCT01600053|Growth Inhibitors|growth inhibitors|mesh-ancestor
25658790|NCT01600053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658791|NCT01600170|Atorvastatin|atorvastatin|mesh-list
25658792|NCT01600170|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25658793|NCT01600170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25658794|NCT01600170|Antimetabolites|antimetabolites|mesh-ancestor
25658795|NCT01600170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798117|NCT01960595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24798118|NCT01960595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815242|NCT02069145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815243|NCT02069158|Paclitaxel|paclitaxel|mesh-list
24815244|NCT02069158|Carboplatin|carboplatin|mesh-list
24815245|NCT02069158|Gedatolisib|gedatolisib|mesh-list
24815246|NCT02069158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24815247|NCT02069158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815248|NCT02069158|Tubulin Modulators|tubulin modulators|mesh-ancestor
24815249|NCT02069158|Antimitotic Agents|antimitotic agents|mesh-ancestor
24815250|NCT02069158|Mitosis Modulators|mitosis modulators|mesh-ancestor
24815251|NCT02069158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815252|NCT02069158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24815253|NCT02069158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815254|NCT02069197|Orlistat|orlistat|mesh-list
24815255|NCT02069197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815256|NCT02069197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24874690|NCT04592809|Midazolam|midazolam|mesh-list
24874691|NCT04592809|Ketamine|ketamine|mesh-list
24798119|NCT01960595|Sensory System Agents|sensory system agents|mesh-ancestor
24798120|NCT01960595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24798121|NCT01960595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24798122|NCT01960595|Narcotics|narcotics|mesh-ancestor
24798123|NCT01960595|Analgesics|analgesics|mesh-ancestor
24996119|NCT04203641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24996121|NCT04203641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996123|NCT04188119|Avelumab|avelumab|mesh-list
24996124|NCT04188119|Lansoprazole|lansoprazole|mesh-list
24996125|NCT04188119|Dexlansoprazole|dexlansoprazole|mesh-list
25146834|NCT02918825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24996157|NCT04173325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996158|NCT04173325|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24996159|NCT04173325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24996161|NCT04172597|Loperamide|loperamide|mesh-list
24996162|NCT04172597|Antidiarrheals|antidiarrheals|mesh-list
24996163|NCT04172597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24996164|NCT04172402|Gemcitabine|gemcitabine|mesh-list
24996165|NCT04172402|Nivolumab|nivolumab|mesh-list
24996166|NCT04172402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24996167|NCT04172402|Antimetabolites|antimetabolites|mesh-ancestor
24996168|NCT04172402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996169|NCT04172402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996170|NCT04172402|Antiviral Agents|antiviral agents|mesh-ancestor
24996171|NCT04172402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24996172|NCT04172402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996173|NCT04172402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24996174|NCT04172402|Immunologic Factors|immunologic factors|mesh-ancestor
24996175|NCT04172402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996176|NCT04172402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24996177|NCT04172402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25163130|NCT02899000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163131|NCT02899000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25163132|NCT02899000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25163133|NCT02899143|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25163134|NCT02899143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25163135|NCT02899026|Prednisone|prednisone|mesh-list
25163136|NCT02899026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25163137|NCT02899026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25658796|NCT01600170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25658797|NCT01600170|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25658798|NCT01600170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658799|NCT01600287|Propofol|propofol|mesh-list
25658800|NCT01600287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25658801|NCT01600287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25658802|NCT01600287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658803|NCT01600287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25658804|NCT01600287|Anesthetics, General|anesthetics, general|mesh-ancestor
25658805|NCT01600287|Anesthetics|anesthetics|mesh-ancestor
25658806|NCT01600703|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25658807|NCT01600703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25658808|NCT01600703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658809|NCT01600703|Incretins|incretins|mesh-ancestor
25658810|NCT01600703|Hormones|hormones|mesh-ancestor
25658811|NCT01600703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25833685|NCT00014105|Alkylating Agents|alkylating agents|mesh-ancestor
24996183|NCT04162873|Celecoxib|celecoxib|mesh-list
25833686|NCT00014105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833687|NCT00014118|Paclitaxel|paclitaxel|mesh-list
25833689|NCT00014118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25833690|NCT00014118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833691|NCT00014118|Tubulin Modulators|tubulin modulators|mesh-ancestor
25833692|NCT00014118|Antimitotic Agents|antimitotic agents|mesh-ancestor
25833693|NCT00014118|Mitosis Modulators|mitosis modulators|mesh-ancestor
25833694|NCT00014118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24874774|NCT04563507|Palbociclib|palbociclib|mesh-list
24874775|NCT04563507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24874776|NCT04563507|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24886182|NCT02814695|Ascorbic Acid|ascorbic acid|mesh-list
24874777|NCT04563507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24874778|NCT04563507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24874779|NCT04563507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24874780|NCT04563507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24874781|NCT04563507|Hormone Antagonists|hormone antagonists|mesh-ancestor
25833695|NCT00014144|Gefitinib|gefitinib|mesh-list
25833696|NCT00014144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833697|NCT00014144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25056391|NCT03512990|Anesthetics|anesthetics|mesh-ancestor
25056392|NCT03512990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25056393|NCT03512990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056394|NCT03512990|Sensory System Agents|sensory system agents|mesh-ancestor
25056395|NCT03512990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25056396|NCT03512873|Tranilast|tranilast|mesh-list
25833698|NCT00014144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833699|NCT00014144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833700|NCT00014170|Gefitinib|gefitinib|mesh-list
25833701|NCT00014170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996242|NCT04011475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24996243|NCT04011475|Respiratory System Agents|respiratory system agents|mesh-ancestor
24996244|NCT04011475|Parasympatholytics|parasympatholytics|mesh-ancestor
24996245|NCT04011475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24996246|NCT04011475|Cholinergic Agents|cholinergic agents|mesh-ancestor
24996247|NCT04011475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24996248|NCT04011475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996249|NCT04005352|Aflibercept|aflibercept|mesh-list
24996250|NCT04005352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24996251|NCT04005352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24996252|NCT04005352|Growth Substances|growth substances|mesh-ancestor
24996253|NCT04005352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996254|NCT04005352|Growth Inhibitors|growth inhibitors|mesh-ancestor
24996255|NCT04005352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870288|NCT02421341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163138|NCT02899026|Glucocorticoids|glucocorticoids|mesh-ancestor
24996285|NCT03912064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996286|NCT03912064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24996287|NCT03912064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996288|NCT03895567|Ceftriaxone|ceftriaxone|mesh-list
24996289|NCT03895567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24996290|NCT03895567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24996305|NCT03776071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25658812|NCT01600703|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25658813|NCT01600703|Protease Inhibitors|protease inhibitors|mesh-ancestor
25658814|NCT01600703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658815|NCT01600703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658816|NCT01600716|Botulinum Toxins|botulinum toxins|mesh-list
25658817|NCT01600716|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25658818|NCT01600716|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25658819|NCT01600716|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25658820|NCT01600716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25658821|NCT01600716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658822|NCT01600716|Cholinergic Agents|cholinergic agents|mesh-ancestor
25658823|NCT01600716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25658824|NCT01600716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658825|NCT01600716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25658826|NCT01600716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25658827|NCT01600885|Guanfacine|guanfacine|mesh-list
25658828|NCT01600885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25658829|NCT01600885|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25658830|NCT01600885|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25658831|NCT01600885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25833702|NCT00014170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25833703|NCT00014170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658832|NCT01600885|Adrenergic Agents|adrenergic agents|mesh-ancestor
25658833|NCT01600885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25658834|NCT01600885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833704|NCT00014170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833705|NCT00014183|Gefitinib|gefitinib|mesh-list
24874892|NCT04514484|Nivolumab|nivolumab|mesh-list
24874893|NCT04514484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24874894|NCT04514484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996306|NCT03776071|Alkylating Agents|alkylating agents|mesh-ancestor
24996307|NCT03776071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996308|NCT03776071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996309|NCT03774472|Hydroxychloroquine|hydroxychloroquine|mesh-list
24996311|NCT03774472|Palbociclib|palbociclib|mesh-list
24996312|NCT03774472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996313|NCT03774472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24996314|NCT03774472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24996318|NCT03774472|Hormone Antagonists|hormone antagonists|mesh-ancestor
24996319|NCT03774472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24996320|NCT03774472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996321|NCT03774472|Antimalarials|antimalarials|mesh-ancestor
24996322|NCT03774472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24996323|NCT03774472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24996324|NCT03774472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24996325|NCT03774472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24996326|NCT03774472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24996327|NCT03773822|Hydrocortisone|hydrocortisone|mesh-list
24996328|NCT03773822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24996332|NCT03739476|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24996333|NCT03739476|Antidepressive Agents|antidepressive agents|mesh-ancestor
24996334|NCT03739476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24996335|NCT03739476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24996336|NCT03739476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24870366|NCT01471444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24870367|NCT01471444|Antiviral Agents|antiviral agents|mesh-ancestor
24870368|NCT01471444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24996338|NCT03739476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996339|NCT03711422|Afatinib|afatinib|mesh-list
24996340|NCT03711422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996370|NCT03639558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996371|NCT03639558|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24996372|NCT03639558|Antipruritics|antipruritics|mesh-ancestor
25833706|NCT00014183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996374|NCT03639558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24996375|NCT03639558|Histamine Antagonists|histamine antagonists|mesh-ancestor
24996376|NCT03639558|Histamine Agents|histamine agents|mesh-ancestor
24996377|NCT03639558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24996378|NCT03639558|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24996379|NCT03639558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24786148|NCT01918176|Palbociclib|palbociclib|mesh-list
24786149|NCT01918176|Rabeprazole|rabeprazole|mesh-list
24786150|NCT01918176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24786151|NCT01918176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24786152|NCT01918176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24786153|NCT01918176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833707|NCT00014183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25833708|NCT00014183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833709|NCT00014183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833710|NCT00014196|Cisplatin|cisplatin|mesh-list
25833711|NCT00014196|Docetaxel|docetaxel|mesh-list
25833712|NCT00014196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833713|NCT00014196|Tubulin Modulators|tubulin modulators|mesh-ancestor
25108190|NCT03133845|Sensory System Agents|sensory system agents|mesh-ancestor
25108191|NCT03133845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108192|NCT03133845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25108193|NCT03133845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25108194|NCT03133845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25108195|NCT03133845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25108196|NCT03133845|GABA Modulators|gaba modulators|mesh-ancestor
25658835|NCT01600885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658836|NCT01600950|Insulin Glargine|insulin glargine|mesh-list
25658837|NCT01600950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25658838|NCT01600950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798153|NCT01961180|Citalopram|citalopram|mesh-list
24875019|NCT04481204|Micronutrients|micronutrients|mesh-ancestor
24875020|NCT04480372|Gemcitabine|gemcitabine|mesh-list
24875021|NCT04480372|Atezolizumab|atezolizumab|mesh-list
24875022|NCT04480372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24875023|NCT04480372|Antimetabolites|antimetabolites|mesh-ancestor
24875024|NCT04480372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875037|NCT04460456|Pembrolizumab|pembrolizumab|mesh-list
24875038|NCT04460456|Cemiplimab|cemiplimab|mesh-list
24875039|NCT04460456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24875040|NCT04460456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24798154|NCT01961180|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24798155|NCT01961180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24798156|NCT01961180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25146928|NCT02918331|Growth Substances|growth substances|mesh-ancestor
24798157|NCT01961180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798158|NCT01961180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24798159|NCT01961180|Serotonin Agents|serotonin agents|mesh-ancestor
24798160|NCT01961180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798161|NCT01961180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24798162|NCT01961180|Antidepressive Agents|antidepressive agents|mesh-ancestor
24798163|NCT01961180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24934407|NCT04061512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24934409|NCT04061512|Hormones|hormones|mesh-ancestor
24934410|NCT04061512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24934411|NCT04061512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24934412|NCT04061655|Iron|iron|mesh-list
24996426|NCT03480776|Aspirin|aspirin|mesh-list
24996427|NCT03480776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24996428|NCT03480776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24996429|NCT03480776|Analgesics|analgesics|mesh-ancestor
24823967|NCT02120547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24996430|NCT03480776|Sensory System Agents|sensory system agents|mesh-ancestor
24996431|NCT03480776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24996433|NCT03480776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24996442|NCT03463265|Sirolimus|sirolimus|mesh-list
24996443|NCT03463265|Bevacizumab|bevacizumab|mesh-list
24996444|NCT03463265|Temozolomide|temozolomide|mesh-list
24996445|NCT03463265|Lomustine|lomustine|mesh-list
24996446|NCT03463265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24996447|NCT03463265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833714|NCT00014196|Antimitotic Agents|antimitotic agents|mesh-ancestor
24996505|NCT03387852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24996506|NCT03387852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996514|NCT03387852|Adrenergic Agents|adrenergic agents|mesh-ancestor
24996515|NCT03387852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25146964|NCT02917772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24996516|NCT03387852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996517|NCT03387852|Immunologic Factors|immunologic factors|mesh-ancestor
24996518|NCT03387852|Glucocorticoids|glucocorticoids|mesh-ancestor
24996602|NCT03159702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996603|NCT03159702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24996604|NCT03159702|Immunologic Factors|immunologic factors|mesh-ancestor
24996605|NCT03159702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996606|NCT03159702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24996607|NCT03159702|Alkylating Agents|alkylating agents|mesh-ancestor
24996608|NCT03159702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24996609|NCT03143153|Fluorouracil|fluorouracil|mesh-list
24996610|NCT03143153|Nivolumab|nivolumab|mesh-list
24996611|NCT03143153|Ipilimumab|ipilimumab|mesh-list
24996612|NCT03143153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996613|NCT03143153|Antimetabolites|antimetabolites|mesh-ancestor
24996614|NCT03143153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996615|NCT03143153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24996616|NCT03143153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24996617|NCT03143153|Immunologic Factors|immunologic factors|mesh-ancestor
25658839|NCT01601132|Colchicine|colchicine|mesh-list
25658840|NCT01601132|Theophylline|theophylline|mesh-list
25658841|NCT01601132|Gout Suppressants|gout suppressants|mesh-ancestor
25658842|NCT01601132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25658843|NCT01601132|Tubulin Modulators|tubulin modulators|mesh-ancestor
25658844|NCT01601132|Antimitotic Agents|antimitotic agents|mesh-ancestor
25658845|NCT01601132|Mitosis Modulators|mitosis modulators|mesh-ancestor
25658846|NCT01601132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658847|NCT01601132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658848|NCT01601132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25833717|NCT00014209|Gemcitabine|gemcitabine|mesh-list
25833718|NCT00014209|Dexamethasone|dexamethasone|mesh-list
24875155|NCT04408586|Autonomic Agents|autonomic agents|mesh-ancestor
24875156|NCT04408586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24875157|NCT04408586|Adrenergic Agents|adrenergic agents|mesh-ancestor
24875177|NCT04346654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24875178|NCT04346654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25833719|NCT00014209|Cisplatin|cisplatin|mesh-list
25833720|NCT00014209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833721|NCT00014209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25056445|NCT03512574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056446|NCT03512574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24810649|NCT02041351|Docetaxel|docetaxel|mesh-list
25833722|NCT00014209|Antiemetics|antiemetics|mesh-ancestor
24875205|NCT04329325|Dasatinib|dasatinib|mesh-list
24996618|NCT03143153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996619|NCT03143153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24996620|NCT03143153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24996621|NCT03113643|Azacitidine|azacitidine|mesh-list
24996622|NCT03113643|Venetoclax|venetoclax|mesh-list
24996623|NCT03113643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24996624|NCT03113643|Antimetabolites|antimetabolites|mesh-ancestor
24996625|NCT03113643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996626|NCT03113643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996627|NCT03113643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163139|NCT02899026|Hormones|hormones|mesh-ancestor
25163140|NCT02899026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24996641|NCT03091491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24533612|NCT00644618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25041381|NCT02564744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25041382|NCT02564744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041383|NCT02564744|Immunologic Factors|immunologic factors|mesh-ancestor
25041384|NCT02564744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041385|NCT02564744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25041386|NCT02561442|Ceftriaxone|ceftriaxone|mesh-list
25041387|NCT02561442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25041388|NCT02561442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25041389|NCT02553343|Vaccines|vaccines|mesh-list
25041390|NCT02553343|Immunologic Factors|immunologic factors|mesh-ancestor
25041391|NCT02553343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833723|NCT00014209|Autonomic Agents|autonomic agents|mesh-ancestor
25833724|NCT00014209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25833725|NCT00014209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997007|NCT05419921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24997008|NCT05419921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24997009|NCT05419921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25833726|NCT00014209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25833727|NCT00014209|Glucocorticoids|glucocorticoids|mesh-ancestor
25833728|NCT00014209|Hormones|hormones|mesh-ancestor
25833729|NCT00014209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24997086|NCT05416840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24997087|NCT05416840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658850|NCT01601132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25658851|NCT01601132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658852|NCT01601132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25658853|NCT01601132|Respiratory System Agents|respiratory system agents|mesh-ancestor
25658854|NCT01601132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25658855|NCT01601132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658856|NCT01601132|Vasodilator Agents|vasodilator agents|mesh-ancestor
25658857|NCT01601132|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25658858|NCT01601132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25658859|NCT01601132|Purinergic Agents|purinergic agents|mesh-ancestor
25658860|NCT01601132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25658861|NCT01601236|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25658862|NCT01601236|Hormones|hormones|mesh-ancestor
25658863|NCT01601236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25658864|NCT01601236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24875335|NCT04220827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875346|NCT04220008|Immunoglobulins|immunoglobulins|mesh-list
24875347|NCT04220008|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24875348|NCT04220008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24875349|NCT04220008|Immunologic Factors|immunologic factors|mesh-ancestor
24875350|NCT04220008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24875351|NCT04220008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24875352|NCT04220008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24875353|NCT04220008|Alkylating Agents|alkylating agents|mesh-ancestor
24875354|NCT04220008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875355|NCT04220008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24875356|NCT04220008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24875358|NCT04220008|Antimetabolites|antimetabolites|mesh-ancestor
24997088|NCT05416840|Vasodilator Agents|vasodilator agents|mesh-ancestor
24997097|NCT05416840|Adrenergic Agents|adrenergic agents|mesh-ancestor
24997116|NCT05411991|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24997117|NCT05411991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25163141|NCT02899026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163142|NCT02899026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25163143|NCT02899026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163144|NCT02899026|Immunologic Factors|immunologic factors|mesh-ancestor
25163153|NCT02898792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25163154|NCT02898792|Narcotics|narcotics|mesh-ancestor
25163155|NCT02898792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25833730|NCT00014209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25833731|NCT00014209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25833732|NCT00014209|Antimetabolites|antimetabolites|mesh-ancestor
25833733|NCT00014209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833734|NCT00014209|Antiviral Agents|antiviral agents|mesh-ancestor
25833735|NCT00014209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833736|NCT00014209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833737|NCT00014209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25833738|NCT00014209|Immunologic Factors|immunologic factors|mesh-ancestor
25833739|NCT00014235|Cyclosporine|cyclosporine|mesh-list
24997130|NCT05396690|Sevoflurane|sevoflurane|mesh-list
24997131|NCT05396690|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24997132|NCT05396690|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24997133|NCT05396690|Anesthetics, General|anesthetics, general|mesh-ancestor
24997134|NCT05396690|Anesthetics|anesthetics|mesh-ancestor
24997135|NCT05396690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24997136|NCT05396690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997137|NCT05395494|Cycloserine|cycloserine|mesh-list
24997138|NCT05395494|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24997139|NCT05395494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24997140|NCT05395494|Renal Agents|renal agents|mesh-ancestor
24997141|NCT05395494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24997150|NCT05351151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997151|NCT05351151|Sensory System Agents|sensory system agents|mesh-ancestor
25833740|NCT00014235|Mycophenolic Acid|mycophenolic acid|mesh-list
24997178|NCT05337449|Cariostatic Agents|cariostatic agents|mesh-ancestor
24997179|NCT05337449|Protective Agents|protective agents|mesh-ancestor
24997180|NCT05337449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833741|NCT00014235|Fludarabine|fludarabine|mesh-list
25833742|NCT00014235|Fludarabine phosphate|fludarabine phosphate|mesh-list
25833743|NCT00014235|Cyclosporins|cyclosporins|mesh-list
25833744|NCT00014235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833745|NCT00014235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25833746|NCT00014235|Antimetabolites|antimetabolites|mesh-ancestor
25833747|NCT00014235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833748|NCT00014235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25658865|NCT01601470|Sildenafil Citrate|sildenafil citrate|mesh-list
25658866|NCT01601470|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25658867|NCT01601470|Vasodilator Agents|vasodilator agents|mesh-ancestor
25658868|NCT01601470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25658869|NCT01601470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25658870|NCT01601470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658871|NCT01601470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658872|NCT01601470|Urological Agents|urological agents|mesh-ancestor
25658873|NCT01601470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25658875|NCT01601535|Temozolomide|temozolomide|mesh-list
25658876|NCT01601535|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25658877|NCT01601535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24875489|NCT04163978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24875490|NCT04163978|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24875491|NCT04163978|Vasodilator Agents|vasodilator agents|mesh-ancestor
24875492|NCT04163978|Gasotransmitters|gasotransmitters|mesh-ancestor
24875493|NCT04163978|Protective Agents|protective agents|mesh-ancestor
24875494|NCT04156334|Anesthetics|anesthetics|mesh-list
24875505|NCT04116320|Interferon Inducers|interferon inducers|mesh-ancestor
24875506|NCT04116320|Immunologic Factors|immunologic factors|mesh-ancestor
24875507|NCT04116320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24875508|NCT04112407|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24875509|NCT04112407|Dermatologic Agents|dermatologic agents|mesh-ancestor
25833749|NCT00014235|Immunologic Factors|immunologic factors|mesh-ancestor
25833750|NCT00014235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833751|NCT00014235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833752|NCT00014235|Antifungal Agents|antifungal agents|mesh-ancestor
25833753|NCT00014235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833754|NCT00014235|Dermatologic Agents|dermatologic agents|mesh-ancestor
25833755|NCT00014235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25833756|NCT00014235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25833757|NCT00014235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24997237|NCT05279898|Anesthetics|anesthetics|mesh-ancestor
24997238|NCT05279898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24997239|NCT05279898|Analgesics|analgesics|mesh-ancestor
24997240|NCT05279898|Sensory System Agents|sensory system agents|mesh-ancestor
24997241|NCT05279898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24997242|NCT05279898|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24997243|NCT05279898|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24997244|NCT05279898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24997245|NCT05279898|Adrenergic Agents|adrenergic agents|mesh-ancestor
24997246|NCT05279898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24997254|NCT05279898|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24786187|NCT01918475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786188|NCT01918488|Amiloride|amiloride|mesh-list
24812930|NCT02055300|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24812931|NCT02055300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24812932|NCT02055300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24608442|NCT00992134|Cytarabine|cytarabine|mesh-list
24812933|NCT02055300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812934|NCT02055300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25191133|NCT02784795|Antiviral Agents|antiviral agents|mesh-ancestor
24812935|NCT02055300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812936|NCT02055300|Antidepressive Agents|antidepressive agents|mesh-ancestor
25108205|NCT03133897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108206|NCT03133897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108207|NCT03133897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25108208|NCT03133897|Glucocorticoids|glucocorticoids|mesh-ancestor
25108209|NCT03133897|Hormones|hormones|mesh-ancestor
25047878|NCT00758290|Antimetabolites|antimetabolites|mesh-ancestor
25108210|NCT03133897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24812937|NCT02055300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24812938|NCT02055378|Atropine|atropine|mesh-list
24812939|NCT02055378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24812940|NCT02055378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24812941|NCT02055378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24812942|NCT02055378|Autonomic Agents|autonomic agents|mesh-ancestor
24812943|NCT02055378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812944|NCT02055378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812945|NCT02055378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24857140|NCT02289482|Protease Inhibitors|protease inhibitors|mesh-ancestor
24857141|NCT02289482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857142|NCT02289482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857143|NCT02289482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25658879|NCT01601535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658880|NCT01601535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658881|NCT01601535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25658882|NCT01601535|Alkylating Agents|alkylating agents|mesh-ancestor
25658883|NCT01601626|Pyridoxine|pyridoxine|mesh-list
25658884|NCT01601626|Vitamin B 6|vitamin b 6|mesh-list
25658885|NCT01601626|Ritonavir|ritonavir|mesh-list
25658886|NCT01601626|Lopinavir|lopinavir|mesh-list
25658887|NCT01601626|Raltegravir Potassium|raltegravir potassium|mesh-list
25658888|NCT01601626|Rifampin|rifampin|mesh-list
25658889|NCT01601626|Isoniazid|isoniazid|mesh-list
25658890|NCT01601626|Pyrazinamide|pyrazinamide|mesh-list
24857144|NCT02289482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24875685|NCT03936777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24875686|NCT03936777|Serotonin Agents|serotonin agents|mesh-ancestor
24875687|NCT03936777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201397|NCT02728037|Tocolytic Agents|tocolytic agents|mesh-ancestor
25201398|NCT02728037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25201399|NCT02728245|Dienogest|dienogest|mesh-list
25201400|NCT02728245|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25201401|NCT02728245|Contraceptive Agents|contraceptive agents|mesh-ancestor
25201402|NCT02728245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24875688|NCT03907475|Gemcitabine|gemcitabine|mesh-list
25833758|NCT00014235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24858157|NCT02295709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24858158|NCT02295709|Antiemetics|antiemetics|mesh-ancestor
24858159|NCT02295709|Autonomic Agents|autonomic agents|mesh-ancestor
24858160|NCT02295709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858161|NCT02295709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858162|NCT02295709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24858163|NCT02295709|Glucocorticoids|glucocorticoids|mesh-ancestor
24858164|NCT02295709|Hormones|hormones|mesh-ancestor
25833759|NCT00014235|Antitubercular Agents|antitubercular agents|mesh-ancestor
24858255|NCT02296047|Ipratropium|ipratropium|mesh-list
24858256|NCT02296047|Anticonvulsants|anticonvulsants|mesh-ancestor
24858257|NCT02296047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24858258|NCT02296047|Autonomic Agents|autonomic agents|mesh-ancestor
24858259|NCT02296047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858260|NCT02296047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858261|NCT02296047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24858281|NCT02296073|Sensory System Agents|sensory system agents|mesh-ancestor
24858282|NCT02296073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858283|NCT02296073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24858284|NCT02296073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24858285|NCT02296073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24858286|NCT02296073|Adrenergic Agents|adrenergic agents|mesh-ancestor
24858287|NCT02296073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24858288|NCT02296073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858289|NCT02296073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24858290|NCT02296073|Narcotics|narcotics|mesh-ancestor
25163156|NCT02898792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858291|NCT02296073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24858292|NCT02296073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24858293|NCT02296073|Anesthetics, General|anesthetics, general|mesh-ancestor
24858868|NCT02300038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858869|NCT02300038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25147203|NCT02915354|Etanercept|etanercept|mesh-list
24858870|NCT02300038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24858871|NCT02300038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24858872|NCT02300038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24858873|NCT02300038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858874|NCT02300064|Antioxidants|antioxidants|mesh-list
24858875|NCT02300064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858876|NCT02300064|Protective Agents|protective agents|mesh-ancestor
24858877|NCT02300064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858879|NCT02300194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24858880|NCT02300194|Narcotics|narcotics|mesh-ancestor
24858881|NCT02300194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24858882|NCT02300194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858883|NCT02300194|Analgesics|analgesics|mesh-ancestor
24858884|NCT02300194|Sensory System Agents|sensory system agents|mesh-ancestor
24858885|NCT02300194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858887|NCT02300350|Digoxin|digoxin|mesh-list
24858894|NCT02300350|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24858895|NCT02300350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24858896|NCT02300363|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
24858897|NCT02300363|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25658891|NCT01601626|Ethambutol|ethambutol|mesh-list
25658892|NCT01601626|Rifabutin|rifabutin|mesh-list
25658893|NCT01601626|Vitamins|vitamins|mesh-ancestor
25658894|NCT01601626|Micronutrients|micronutrients|mesh-ancestor
25658895|NCT01601626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658896|NCT01601626|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25658897|NCT01601626|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25658898|NCT01601626|Protease Inhibitors|protease inhibitors|mesh-ancestor
25658899|NCT01601626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25658900|NCT01601626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201409|NCT02728245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25201410|NCT02728245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25201411|NCT02728245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201412|NCT02727712|Anesthetics|anesthetics|mesh-list
25201413|NCT02727712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25056469|NCT03512548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056470|NCT03512548|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24858898|NCT02300363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24858899|NCT02300363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24858958|NCT02300649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24858959|NCT02300649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24858960|NCT02300649|Adrenergic Agents|adrenergic agents|mesh-ancestor
24858961|NCT02300649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24858963|NCT02300688|Maleic acid|maleic acid|mesh-list
24800419|NCT01975480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24800420|NCT01975480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24800555|NCT01976195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24800556|NCT01976195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800557|NCT01976195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24800558|NCT01976195|Immunologic Factors|immunologic factors|mesh-ancestor
24800559|NCT01976195|Leprostatic Agents|leprostatic agents|mesh-ancestor
24800560|NCT01976195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24800561|NCT01976195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24800562|NCT01976195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24800563|NCT01976195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24800564|NCT01976195|Growth Substances|growth substances|mesh-ancestor
24800565|NCT01976195|Growth Inhibitors|growth inhibitors|mesh-ancestor
24800567|NCT01976208|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24800568|NCT01976208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24800569|NCT01976208|Respiratory System Agents|respiratory system agents|mesh-ancestor
24800570|NCT01976520|Vaccines|vaccines|mesh-list
24800571|NCT01976520|Immunologic Factors|immunologic factors|mesh-ancestor
25147258|NCT02914886|Insulin|insulin|mesh-list
24594661|NCT00934895|Mitosis Modulators|mitosis modulators|mesh-ancestor
24594662|NCT00934895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627807|NCT01094990|Hormones|hormones|mesh-ancestor
24594663|NCT00934895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24594664|NCT00934895|Immunologic Factors|immunologic factors|mesh-ancestor
24594665|NCT00934895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800670|NCT01977339|Anesthetics|anesthetics|mesh-ancestor
24800736|NCT01978041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800738|NCT01978301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24800739|NCT01978301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24800740|NCT01978301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24800741|NCT01978301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24800742|NCT01978301|Glucocorticoids|glucocorticoids|mesh-ancestor
24800744|NCT01978301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24800745|NCT01978301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800746|NCT01978301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24800749|NCT01978301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800751|NCT01978405|Antioxidants|antioxidants|mesh-ancestor
24800752|NCT01978405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800753|NCT01978405|Protective Agents|protective agents|mesh-ancestor
24800754|NCT01978405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461734|NCT00353379|Guanfacine|guanfacine|mesh-list
24552113|NCT04176419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24552114|NCT04176419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24552115|NCT04176419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24552117|NCT04176419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24552118|NCT04176419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24552119|NCT04176419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24552122|NCT04176419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800938|NCT01979653|GABA Modulators|gaba modulators|mesh-ancestor
24800940|NCT01979679|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25658901|NCT01601626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25658902|NCT01601626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25658903|NCT01601626|Antiviral Agents|antiviral agents|mesh-ancestor
25658904|NCT01601626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25658905|NCT01601626|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25658906|NCT01601626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25658907|NCT01601626|Vitamin B Complex|vitamin b complex|mesh-ancestor
25658908|NCT01601626|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25658909|NCT01601626|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24454540|NCT03897868|Losartan|losartan|mesh-list
24876020|NCT03776812|Paclitaxel|paclitaxel|mesh-list
24876021|NCT03776812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24876022|NCT03776812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24876023|NCT03776812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24876024|NCT03776812|Tubulin Modulators|tubulin modulators|mesh-ancestor
24800941|NCT01979679|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24800942|NCT01979679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24802799|NCT01992562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24802800|NCT01992562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802801|NCT01992562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25658910|NCT01601626|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25658911|NCT01601626|Antitubercular Agents|antitubercular agents|mesh-ancestor
25658912|NCT01601626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25658913|NCT01601626|Leprostatic Agents|leprostatic agents|mesh-ancestor
24802802|NCT01992562|Protective Agents|protective agents|mesh-ancestor
24802803|NCT01992562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24802804|NCT01992562|Analgesics|analgesics|mesh-ancestor
24597305|NCT00948480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597306|NCT00948493|Insulin|insulin|mesh-list
24597307|NCT00948493|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24597308|NCT00948493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24597309|NCT00948493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622542|NCT01067430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24622543|NCT01067430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573684|NCT00821496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24802937|NCT01993459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24802938|NCT01993459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802939|NCT01993459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25147318|NCT02914015|Morphine|morphine|mesh-list
24802940|NCT01993459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24802941|NCT01993459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24802942|NCT01993459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24802943|NCT01993459|Anesthetics, General|anesthetics, general|mesh-ancestor
24802944|NCT01993459|Anesthetics|anesthetics|mesh-ancestor
24802945|NCT01993459|GABA Modulators|gaba modulators|mesh-ancestor
24802946|NCT01993459|GABA Agents|gaba agents|mesh-ancestor
24802947|NCT01993459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24802948|NCT01993459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802949|NCT01993472|Andrographolide|andrographolide|mesh-list
24802950|NCT01993472|Capecitabine|capecitabine|mesh-list
25191321|NCT02783846|Analgesics|analgesics|mesh-ancestor
24802951|NCT01993472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24802952|NCT01993472|Antimetabolites|antimetabolites|mesh-ancestor
24802953|NCT01993472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802954|NCT01993472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24802955|NCT01993472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24803019|NCT01993810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24803020|NCT01993810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24803021|NCT01993810|Immunologic Factors|immunologic factors|mesh-ancestor
24803022|NCT01993810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786205|NCT01918514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24786206|NCT01918514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24786208|NCT01918514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24786209|NCT01918514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24786210|NCT01918514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846385|NCT02242474|Analgesics|analgesics|mesh-ancestor
24598402|NCT00956059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598403|NCT00956072|Imatinib Mesylate|imatinib mesylate|mesh-list
24598404|NCT00956072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598405|NCT00956072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24598406|NCT00956072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598407|NCT00956072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598409|NCT00956098|Antiviral Agents|antiviral agents|mesh-ancestor
24807622|NCT02022722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807623|NCT02022761|Laninamivir|laninamivir|mesh-list
24807624|NCT02022761|Antiviral Agents|antiviral agents|mesh-ancestor
24807658|NCT02023021|Mitosis Modulators|mitosis modulators|mesh-ancestor
25658914|NCT01601626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25658915|NCT01601626|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25658916|NCT01601626|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25658917|NCT01601626|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25658918|NCT01601626|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24876133|NCT03719001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24876134|NCT03719001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24876135|NCT03719001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24876136|NCT03719001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24876137|NCT03719001|Analgesics|analgesics|mesh-ancestor
24876138|NCT03719001|Sensory System Agents|sensory system agents|mesh-ancestor
24876139|NCT03719001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24876140|NCT03719001|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24807659|NCT02023021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147364|NCT02913859|Androgen Antagonists|androgen antagonists|mesh-list
24807660|NCT02023021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24807661|NCT02023021|Antimetabolites|antimetabolites|mesh-ancestor
24807662|NCT02023021|Antiviral Agents|antiviral agents|mesh-ancestor
24807663|NCT02023021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833760|NCT00014235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25108239|NCT03133780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25108240|NCT03133780|GABA Modulators|gaba modulators|mesh-ancestor
25108241|NCT03133780|GABA Agents|gaba agents|mesh-ancestor
25108242|NCT03133637|Ceftriaxone|ceftriaxone|mesh-list
25108243|NCT03133637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25108244|NCT03133637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25108245|NCT03133234|Osimertinib|osimertinib|mesh-list
24828373|NCT02145338|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24828374|NCT02145338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24828375|NCT02145338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25833761|NCT00014248|Adenosine|adenosine|mesh-list
25833762|NCT00014248|Analgesics|analgesics|mesh-ancestor
25833763|NCT00014248|Sensory System Agents|sensory system agents|mesh-ancestor
25833764|NCT00014248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25833765|NCT00014248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833766|NCT00014248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25833767|NCT00014248|Vasodilator Agents|vasodilator agents|mesh-ancestor
25833768|NCT00014248|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25833769|NCT00014248|Purinergic Agonists|purinergic agonists|mesh-ancestor
25833770|NCT00014248|Purinergic Agents|purinergic agents|mesh-ancestor
25833771|NCT00014248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25833772|NCT00014248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833773|NCT00014261|Interferons|interferons|mesh-list
25191389|NCT02783638|Pregabalin|pregabalin|mesh-list
25833774|NCT00014261|Interferon-alpha|interferon-alpha|mesh-list
25833775|NCT00014261|Interferon alpha-2|interferon alpha-2|mesh-list
25833776|NCT00014261|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25833777|NCT00014261|Temozolomide|temozolomide|mesh-list
25833778|NCT00014261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833779|NCT00014261|Antiviral Agents|antiviral agents|mesh-ancestor
25833780|NCT00014261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833781|NCT00014261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25833782|NCT00014261|Alkylating Agents|alkylating agents|mesh-ancestor
25833783|NCT00014261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833784|NCT00014261|Immunologic Factors|immunologic factors|mesh-ancestor
25833785|NCT00014261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833786|NCT00014274|Gemcitabine|gemcitabine|mesh-list
25833787|NCT00014274|Carboplatin|carboplatin|mesh-list
25833788|NCT00014274|Methotrexate|methotrexate|mesh-list
25833789|NCT00014274|Vinblastine|vinblastine|mesh-list
25833790|NCT00014274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833791|NCT00014274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25833792|NCT00014274|Antimetabolites|antimetabolites|mesh-ancestor
25833793|NCT00014274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833794|NCT00014274|Antiviral Agents|antiviral agents|mesh-ancestor
25833795|NCT00014274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833796|NCT00014274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833797|NCT00014274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25833798|NCT00014274|Immunologic Factors|immunologic factors|mesh-ancestor
25833799|NCT00014274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634914|NCT01135771|Insulin|insulin|mesh-list
25163158|NCT02898792|Sensory System Agents|sensory system agents|mesh-ancestor
25833800|NCT00014274|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25658919|NCT01601626|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25658920|NCT01601626|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25658921|NCT01601626|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25658922|NCT01601626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25658923|NCT01601626|Antimetabolites|antimetabolites|mesh-ancestor
25658924|NCT01601626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25658925|NCT01601704|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
25658926|NCT01601704|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24876276|NCT03623750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24876332|NCT03595982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24876333|NCT03595982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24876334|NCT03595982|Vasodilator Agents|vasodilator agents|mesh-ancestor
24876335|NCT03595982|Tocolytic Agents|tocolytic agents|mesh-ancestor
24876336|NCT03595982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24876337|NCT03594123|Brexpiprazole|brexpiprazole|mesh-list
24876338|NCT03594123|Serotonin Agents|serotonin agents|mesh-ancestor
24876339|NCT03594123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24886393|NCT04526353|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24876340|NCT03594123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24876392|NCT03579446|Oxymorphone|oxymorphone|mesh-list
24876403|NCT03579446|Sensory System Agents|sensory system agents|mesh-ancestor
25147414|NCT02913469|Morphine|morphine|mesh-list
25833801|NCT00014274|Abortifacient Agents|abortifacient agents|mesh-ancestor
25833802|NCT00014274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25833803|NCT00014274|Dermatologic Agents|dermatologic agents|mesh-ancestor
25833804|NCT00014274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25833805|NCT00014274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25833806|NCT00014274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25833807|NCT00014274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24458369|NCT00337623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458370|NCT00337623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24458371|NCT00337623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833808|NCT00014274|Tubulin Modulators|tubulin modulators|mesh-ancestor
25833809|NCT00014274|Antimitotic Agents|antimitotic agents|mesh-ancestor
25833810|NCT00014274|Mitosis Modulators|mitosis modulators|mesh-ancestor
25833811|NCT00014287|Gemcitabine|gemcitabine|mesh-list
25833812|NCT00014287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25833813|NCT00014287|Antimetabolites|antimetabolites|mesh-ancestor
25833814|NCT00014287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833815|NCT00014287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833816|NCT00014287|Antiviral Agents|antiviral agents|mesh-ancestor
25833817|NCT00014287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833818|NCT00014287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833819|NCT00014287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25833820|NCT00014287|Immunologic Factors|immunologic factors|mesh-ancestor
25833821|NCT00014287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833822|NCT00014313|Cisplatin|cisplatin|mesh-list
25833823|NCT00014313|Etoposide|etoposide|mesh-list
24534065|NCT00645918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534066|NCT00645931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25833824|NCT00014313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833825|NCT00014313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25833826|NCT00014313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25833827|NCT00014313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25833828|NCT00014313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833829|NCT00014313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833830|NCT00014339|Prednisone|prednisone|mesh-list
25833831|NCT00014339|Melphalan|melphalan|mesh-list
25833832|NCT00014339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25833833|NCT00014339|Glucocorticoids|glucocorticoids|mesh-ancestor
25833834|NCT00014339|Hormones|hormones|mesh-ancestor
25833835|NCT00014339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25833836|NCT00014339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833837|NCT00014339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25413931|NCT03093064|Immunologic Factors|immunologic factors|mesh-ancestor
25658927|NCT01601821|Sirolimus|sirolimus|mesh-list
25658928|NCT01601821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25658929|NCT01601821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25658930|NCT01601821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25658931|NCT01601821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658932|NCT01601821|Antifungal Agents|antifungal agents|mesh-ancestor
25658933|NCT01601821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25658934|NCT01601821|Immunologic Factors|immunologic factors|mesh-ancestor
25658935|NCT01601821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658936|NCT01601847|Vitamin D|vitamin d|mesh-list
25658937|NCT01601847|Cholecalciferol|cholecalciferol|mesh-list
25658938|NCT01601847|Vitamins|vitamins|mesh-ancestor
25658939|NCT01601847|Micronutrients|micronutrients|mesh-ancestor
25658940|NCT01601847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674296|NCT01769586|Anesthetics, Local|anesthetics, local|mesh-ancestor
25833838|NCT00014339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833839|NCT00014339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24876579|NCT03378479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24876580|NCT03378479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24876582|NCT03367741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24876583|NCT03367741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24876584|NCT03367741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24876585|NCT03367741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24876586|NCT03366103|Navitoclax|navitoclax|mesh-list
24876597|NCT03344965|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24876601|NCT03333343|Gefitinib|gefitinib|mesh-list
25833840|NCT00014339|Alkylating Agents|alkylating agents|mesh-ancestor
25833841|NCT00014339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833842|NCT00014339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25833843|NCT00014339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25833844|NCT00014339|Immunologic Factors|immunologic factors|mesh-ancestor
25833845|NCT00014352|Ketoconazole|ketoconazole|mesh-list
25833846|NCT00014352|Docetaxel|docetaxel|mesh-list
25833847|NCT00014352|Doxorubicin|doxorubicin|mesh-list
25833848|NCT00014352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25833849|NCT00014352|Estramustine|estramustine|mesh-list
25833850|NCT00014352|Warfarin|warfarin|mesh-list
25833851|NCT00014352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833852|NCT00014352|Tubulin Modulators|tubulin modulators|mesh-ancestor
25833853|NCT00014352|Antimitotic Agents|antimitotic agents|mesh-ancestor
25833854|NCT00014352|Mitosis Modulators|mitosis modulators|mesh-ancestor
25833855|NCT00014352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833856|NCT00014352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25833857|NCT00014352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25833858|NCT00014352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25833859|NCT00014352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833860|NCT00014352|Anticoagulants|anticoagulants|mesh-ancestor
25833861|NCT00014352|Antifungal Agents|antifungal agents|mesh-ancestor
25833862|NCT00014352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833863|NCT00014352|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25833864|NCT00014352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25833865|NCT00014352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25833866|NCT00014352|Hormone Antagonists|hormone antagonists|mesh-ancestor
25833867|NCT00014352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25833868|NCT00014352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833869|NCT00014352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25833870|NCT00014352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25833871|NCT00014352|Alkylating Agents|alkylating agents|mesh-ancestor
25833872|NCT00014352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25833873|NCT00014391|Ribavirin|ribavirin|mesh-list
25833874|NCT00014391|Palivizumab|palivizumab|mesh-list
25833875|NCT00014391|Antimetabolites|antimetabolites|mesh-ancestor
25833876|NCT00014391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833877|NCT00014391|Antiviral Agents|antiviral agents|mesh-ancestor
25833878|NCT00014391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833879|NCT00014404|Celecoxib|celecoxib|mesh-list
25833880|NCT00014404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25833881|NCT00014404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25833882|NCT00014404|Analgesics|analgesics|mesh-ancestor
25833883|NCT00014404|Sensory System Agents|sensory system agents|mesh-ancestor
25833884|NCT00014404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25833885|NCT00014404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833886|NCT00014404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25833887|NCT00014404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25833888|NCT00014404|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25833889|NCT00014404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25833890|NCT00014404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833891|NCT00014404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658941|NCT01601847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25658942|NCT01601847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25658943|NCT01601873|Heparin|heparin|mesh-list
25658944|NCT01601873|Anticoagulants|anticoagulants|mesh-ancestor
25658945|NCT01601873|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25658946|NCT01601873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25658947|NCT01601873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658948|NCT01602068|Dexamethasone|dexamethasone|mesh-list
25658949|NCT01602068|Citric Acid|citric acid|mesh-list
25658950|NCT01602068|Sodium Citrate|sodium citrate|mesh-list
25658951|NCT01602068|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25658952|NCT01602068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24876711|NCT03300544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24876712|NCT03300544|Antidotes|antidotes|mesh-ancestor
24876715|NCT03300544|Vitamins|vitamins|mesh-ancestor
24876758|NCT03233204|Olaparib|olaparib|mesh-list
24876759|NCT03233204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
24876760|NCT03233204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24876761|NCT03233204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833892|NCT00014430|Trastuzumab|trastuzumab|mesh-list
24534134|NCT00646126|Antiviral Agents|antiviral agents|mesh-ancestor
25833893|NCT00014430|Vinorelbine|vinorelbine|mesh-list
24450286|NCT00318513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450288|NCT00318539|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25833894|NCT00014430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25833895|NCT00014430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833896|NCT00014430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25833897|NCT00014430|Tubulin Modulators|tubulin modulators|mesh-ancestor
25833898|NCT00014430|Antimitotic Agents|antimitotic agents|mesh-ancestor
25833899|NCT00014430|Mitosis Modulators|mitosis modulators|mesh-ancestor
25833900|NCT00014430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833901|NCT00014443|Thalidomide|thalidomide|mesh-list
25833902|NCT00014443|Topotecan|topotecan|mesh-list
24923195|NCT04171791|Venetoclax|venetoclax|mesh-list
25833903|NCT00014443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25833904|NCT00014443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25833905|NCT00014443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833906|NCT00014443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833907|NCT00014443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833908|NCT00014443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25833909|NCT00014443|Immunologic Factors|immunologic factors|mesh-ancestor
25833910|NCT00014443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833911|NCT00014443|Leprostatic Agents|leprostatic agents|mesh-ancestor
25833912|NCT00014443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25833913|NCT00014443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833914|NCT00014443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25833915|NCT00014443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25833916|NCT00014443|Growth Substances|growth substances|mesh-ancestor
24458385|NCT00337701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24458386|NCT00337701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24458387|NCT00337701|Antiviral Agents|antiviral agents|mesh-ancestor
24635389|NCT01138852|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24635390|NCT01138852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833917|NCT00014443|Growth Inhibitors|growth inhibitors|mesh-ancestor
25833918|NCT00014456|Gemcitabine|gemcitabine|mesh-list
25833919|NCT00014456|Docetaxel|docetaxel|mesh-list
25833920|NCT00014456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25833921|NCT00014456|Antimetabolites|antimetabolites|mesh-ancestor
25833922|NCT00014456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833923|NCT00014456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833924|NCT00014456|Antiviral Agents|antiviral agents|mesh-ancestor
25833925|NCT00014456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833926|NCT00014456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833927|NCT00014456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25833928|NCT00014456|Immunologic Factors|immunologic factors|mesh-ancestor
25833929|NCT00014456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833930|NCT00014456|Tubulin Modulators|tubulin modulators|mesh-ancestor
25833931|NCT00014456|Antimitotic Agents|antimitotic agents|mesh-ancestor
25833932|NCT00014456|Mitosis Modulators|mitosis modulators|mesh-ancestor
24923276|NCT04171674|Ceftobiprole|ceftobiprole|mesh-list
25833933|NCT00014469|Methotrexate|methotrexate|mesh-list
25833934|NCT00014469|Melphalan|melphalan|mesh-list
25833935|NCT00014469|Busulfan|busulfan|mesh-list
25833936|NCT00014469|Tacrolimus|tacrolimus|mesh-list
25833937|NCT00014469|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25833938|NCT00014469|Abortifacient Agents|abortifacient agents|mesh-ancestor
25833939|NCT00014469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25833940|NCT00014469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658953|NCT01602068|Antiemetics|antiemetics|mesh-ancestor
25658954|NCT01602068|Autonomic Agents|autonomic agents|mesh-ancestor
25658955|NCT01602068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25658956|NCT01602068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658957|NCT01602068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25658958|NCT01602068|Glucocorticoids|glucocorticoids|mesh-ancestor
25658959|NCT01602068|Hormones|hormones|mesh-ancestor
25833941|NCT00014469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25833942|NCT00014469|Antimetabolites|antimetabolites|mesh-ancestor
25833943|NCT00014469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056557|NCT03511768|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25056558|NCT03511768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24877018|NCT03023631|Immunologic Factors|immunologic factors|mesh-ancestor
24877041|NCT02974621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24877042|NCT02974621|Olaparib|olaparib|mesh-list
24877043|NCT02974621|Cediranib|cediranib|mesh-list
24877104|NCT02954510|Hematinics|hematinics|mesh-ancestor
24877105|NCT02954510|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24699485|NCT01447069|Tocolytic Agents|tocolytic agents|mesh-ancestor
24877106|NCT02954510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24877107|NCT02953834|Insulin|insulin|mesh-list
24877108|NCT02953834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24877109|NCT02953834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24877110|NCT02935205|Indomethacin|indomethacin|mesh-list
24877111|NCT02935205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24877112|NCT02935205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24877113|NCT02935205|Analgesics|analgesics|mesh-ancestor
24512143|NCT00573001|Antimetabolites|antimetabolites|mesh-ancestor
25833944|NCT00014469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833945|NCT00014469|Dermatologic Agents|dermatologic agents|mesh-ancestor
25833946|NCT00014469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833947|NCT00014469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25833948|NCT00014469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25833949|NCT00014469|Immunologic Factors|immunologic factors|mesh-ancestor
25833950|NCT00014469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25833951|NCT00014469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25833952|NCT00014469|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25833953|NCT00014469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25833954|NCT00014469|Alkylating Agents|alkylating agents|mesh-ancestor
25833955|NCT00014469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25833956|NCT00014508|Cyclosporine|cyclosporine|mesh-list
25833957|NCT00014508|Cyclophosphamide|cyclophosphamide|mesh-list
25833958|NCT00014508|Melphalan|melphalan|mesh-list
25833959|NCT00014508|Fludarabine|fludarabine|mesh-list
25833960|NCT00014508|Fludarabine phosphate|fludarabine phosphate|mesh-list
25833961|NCT00014508|Cyclosporins|cyclosporins|mesh-list
25833962|NCT00014508|Sargramostim|sargramostim|mesh-list
25833963|NCT00014508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25833964|NCT00014508|Immunologic Factors|immunologic factors|mesh-ancestor
25833965|NCT00014508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833966|NCT00014508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25833967|NCT00014508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25833968|NCT00014508|Alkylating Agents|alkylating agents|mesh-ancestor
25833969|NCT00014508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833970|NCT00014508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833971|NCT00014508|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25833972|NCT00014508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25833973|NCT00014508|Antimetabolites|antimetabolites|mesh-ancestor
25833974|NCT00014508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833975|NCT00014508|Antifungal Agents|antifungal agents|mesh-ancestor
25833976|NCT00014508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833977|NCT00014508|Dermatologic Agents|dermatologic agents|mesh-ancestor
25833978|NCT00014508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25833979|NCT00014534|Gemcitabine|gemcitabine|mesh-list
25833980|NCT00014534|Cisplatin|cisplatin|mesh-list
25833981|NCT00014534|Doxorubicin|doxorubicin|mesh-list
25833982|NCT00014534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25833983|NCT00014534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833984|NCT00014534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25658960|NCT01602068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25658961|NCT01602068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25658962|NCT01602068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658963|NCT01602068|Anticoagulants|anticoagulants|mesh-ancestor
25658964|NCT01602068|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25658965|NCT01602068|Chelating Agents|chelating agents|mesh-ancestor
25658966|NCT01602068|Sequestering Agents|sequestering agents|mesh-ancestor
25658967|NCT01602068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658968|NCT01602224|Dexamethasone|dexamethasone|mesh-list
25658969|NCT01602224|Bortezomib|bortezomib|mesh-list
25658970|NCT01602224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25658971|NCT01602224|Antiemetics|antiemetics|mesh-ancestor
25658972|NCT01602224|Autonomic Agents|autonomic agents|mesh-ancestor
25658973|NCT01602224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25658974|NCT01602224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658975|NCT01602224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25658976|NCT01602224|Glucocorticoids|glucocorticoids|mesh-ancestor
25833985|NCT00014534|Antimetabolites|antimetabolites|mesh-ancestor
25060586|NCT03478436|Doxycycline|doxycycline|mesh-list
24699653|NCT01448330|Aspirin|aspirin|mesh-list
25027072|NCT03623048|Chlorhexidine|chlorhexidine|mesh-list
24877361|NCT02798471|Fondaparinux|fondaparinux|mesh-list
24877362|NCT02798471|Anticoagulants|anticoagulants|mesh-ancestor
24877363|NCT02798471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24877364|NCT02798471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24877365|NCT02798471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24877366|NCT02798471|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24877367|NCT02798471|Antithrombins|antithrombins|mesh-ancestor
24877368|NCT02798471|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24815544|NCT02071004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24815545|NCT02071004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24815546|NCT02071004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24815547|NCT02071004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815548|NCT02071004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24815549|NCT02071004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24815550|NCT02071004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815551|NCT02071004|Antipyretics|antipyretics|mesh-ancestor
24815552|NCT02071043|Capecitabine|capecitabine|mesh-list
24815553|NCT02071043|Oxaliplatin|oxaliplatin|mesh-list
25833986|NCT00014534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25833987|NCT00014534|Antiviral Agents|antiviral agents|mesh-ancestor
25833988|NCT00014534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25833989|NCT00014534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25833990|NCT00014534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25833991|NCT00014534|Immunologic Factors|immunologic factors|mesh-ancestor
25833992|NCT00014534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25833993|NCT00014534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24635592|NCT01140412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25833994|NCT00014534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25833995|NCT00014534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25833996|NCT00014547|BBR 3464|bbr 3464|mesh-list
25833997|NCT00014547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25833998|NCT00014573|Aldesleukin|aldesleukin|mesh-list
25833999|NCT00014573|Paclitaxel|paclitaxel|mesh-list
25834000|NCT00014573|Cyclophosphamide|cyclophosphamide|mesh-list
25834001|NCT00014573|Cisplatin|cisplatin|mesh-list
25834002|NCT00014573|Carmustine|carmustine|mesh-list
25834003|NCT00014573|Sargramostim|sargramostim|mesh-list
25834004|NCT00014573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25834005|NCT00014573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834006|NCT00014573|Tubulin Modulators|tubulin modulators|mesh-ancestor
25834007|NCT00014573|Antimitotic Agents|antimitotic agents|mesh-ancestor
25834008|NCT00014573|Mitosis Modulators|mitosis modulators|mesh-ancestor
25834009|NCT00014573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834010|NCT00014573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25834011|NCT00014573|Immunologic Factors|immunologic factors|mesh-ancestor
25834012|NCT00014573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834013|NCT00014573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25834014|NCT00014573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25834015|NCT00014573|Alkylating Agents|alkylating agents|mesh-ancestor
25834016|NCT00014573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25834017|NCT00014573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25658977|NCT01602224|Hormones|hormones|mesh-ancestor
25658978|NCT01602224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25658979|NCT01602224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25658980|NCT01602224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658981|NCT01602315|Cetuximab|cetuximab|mesh-list
25658982|NCT01602315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25658983|NCT01602315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25658984|NCT01602510|Lamotrigine|lamotrigine|mesh-list
25658985|NCT01602510|Anticonvulsants|anticonvulsants|mesh-ancestor
25658986|NCT01602510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25658987|NCT01602510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25658988|NCT01602510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25658989|NCT01602510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25658990|NCT01602510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25658991|NCT01602510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25658992|NCT01602510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25658993|NCT01602510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25658994|NCT01602510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25658995|NCT01602510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25834018|NCT00014573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25834019|NCT00014573|Antiviral Agents|antiviral agents|mesh-ancestor
25834020|NCT00014573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24877396|NCT02718404|Sensory System Agents|sensory system agents|mesh-ancestor
24877397|NCT02718404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24877398|NCT02718404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24877399|NCT02712905|Nivolumab|nivolumab|mesh-list
24877400|NCT02712905|Azacitidine|azacitidine|mesh-list
25056578|NCT03511391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25056579|NCT03511391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056580|NCT03511391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834021|NCT00014586|Goserelin|goserelin|mesh-list
25834022|NCT00014586|Bicalutamide|bicalutamide|mesh-list
25834023|NCT00014586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25834024|NCT00014586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834025|NCT00014586|Androgen Antagonists|androgen antagonists|mesh-ancestor
25834026|NCT00014586|Hormone Antagonists|hormone antagonists|mesh-ancestor
25834027|NCT00014586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25834028|NCT00014586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834029|NCT00014599|Paclitaxel|paclitaxel|mesh-list
25834030|NCT00014599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25834031|NCT00014599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834032|NCT00014599|Tubulin Modulators|tubulin modulators|mesh-ancestor
25834033|NCT00014599|Antimitotic Agents|antimitotic agents|mesh-ancestor
25834034|NCT00014599|Mitosis Modulators|mitosis modulators|mesh-ancestor
25834035|NCT00014599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834036|NCT00014625|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
25834037|NCT00014625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834038|NCT00014625|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25834039|NCT00014625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25834040|NCT00014625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834041|NCT00014638|Letrozole|letrozole|mesh-list
25834042|NCT00014638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834043|NCT00014638|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25834044|NCT00014638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25834045|NCT00014638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25834046|NCT00014638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834047|NCT00014638|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25834048|NCT00014638|Hormone Antagonists|hormone antagonists|mesh-ancestor
24424999|NCT00231582|Tubulin Modulators|tubulin modulators|mesh-ancestor
25834049|NCT00014638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25834050|NCT00014638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834051|NCT00014651|Vapreotide|vapreotide|mesh-list
25834052|NCT00014651|Analgesics|analgesics|mesh-ancestor
25834053|NCT00014651|Sensory System Agents|sensory system agents|mesh-ancestor
25834054|NCT00014651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25834055|NCT00014651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834056|NCT00014651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834057|NCT00014677|Interleukin-4|interleukin-4|mesh-list
25834058|NCT00014677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25834059|NCT00014677|Immunologic Factors|immunologic factors|mesh-ancestor
25834060|NCT00014677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834061|NCT00014677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834062|NCT00014677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25834063|NCT00014690|Topotecan|topotecan|mesh-list
25834064|NCT00014690|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25834065|NCT00014690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25834066|NCT00014690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25834067|NCT00014690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834068|NCT00014690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834069|NCT00014729|Isotretinoin|isotretinoin|mesh-list
25834070|NCT00014729|Dermatologic Agents|dermatologic agents|mesh-ancestor
25834071|NCT00014755|Prednisone|prednisone|mesh-list
25834072|NCT00014755|Cyclophosphamide|cyclophosphamide|mesh-list
25834073|NCT00014755|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25834074|NCT00014755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24635756|NCT01141036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25658996|NCT01602562|Valacyclovir|valacyclovir|mesh-list
25658997|NCT01602562|Antiviral Agents|antiviral agents|mesh-ancestor
25658998|NCT01602562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25658999|NCT01602679|Progesterone|progesterone|mesh-list
25659000|NCT01602679|Progestins|progestins|mesh-ancestor
25659001|NCT01602679|Hormones|hormones|mesh-ancestor
25659002|NCT01602679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25659003|NCT01602679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635758|NCT01141036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25414032|NCT03088813|Irinotecan|irinotecan|mesh-list
25659004|NCT01602692|Lidocaine|lidocaine|mesh-list
24877534|NCT02568553|Antibodies|antibodies|mesh-list
24877535|NCT02568553|Immunoglobulins|immunoglobulins|mesh-list
24877536|NCT02568553|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24877537|NCT02568553|Muromonab-CD3|muromonab-cd3|mesh-list
24877538|NCT02568553|Antibodies, Bispecific|antibodies, bispecific|mesh-list
24699920|NCT01449617|Aspirin|aspirin|mesh-list
24877540|NCT02568553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24877541|NCT02568553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24877553|NCT02535325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24877585|NCT02529852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25834075|NCT00014755|Immunologic Factors|immunologic factors|mesh-ancestor
25834076|NCT00014755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834077|NCT00014755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25834078|NCT00014755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25834079|NCT00014755|Alkylating Agents|alkylating agents|mesh-ancestor
25834080|NCT00014755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834081|NCT00014755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834082|NCT00014755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25834083|NCT00014755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25834084|NCT00014755|Glucocorticoids|glucocorticoids|mesh-ancestor
25834085|NCT00014755|Hormones|hormones|mesh-ancestor
25834086|NCT00014755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25834087|NCT00014755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25834088|NCT00014937|Ritonavir|ritonavir|mesh-list
25834089|NCT00014937|Lopinavir|lopinavir|mesh-list
25834090|NCT00014937|Lamivudine|lamivudine|mesh-list
25834091|NCT00014937|Zidovudine|zidovudine|mesh-list
25834092|NCT00014937|Stavudine|stavudine|mesh-list
25834093|NCT00014937|Didanosine|didanosine|mesh-list
25834094|NCT00014937|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25147685|NCT02911662|Cephalexin|cephalexin|mesh-list
25834095|NCT00014937|Efavirenz|efavirenz|mesh-list
25834096|NCT00014937|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25834097|NCT00014937|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25834098|NCT00014937|Protease Inhibitors|protease inhibitors|mesh-ancestor
24499197|NCT00518245|Enoxaparin|enoxaparin|mesh-list
25834099|NCT00014937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25834100|NCT00014937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834101|NCT00014937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25834102|NCT00014937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25163159|NCT02898792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24534234|NCT00646529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24534235|NCT00646529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25834103|NCT00014937|Antiviral Agents|antiviral agents|mesh-ancestor
25834104|NCT00014937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25834105|NCT00014937|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25834106|NCT00014937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25834107|NCT00014937|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25834108|NCT00014937|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25834109|NCT00014937|Antimetabolites|antimetabolites|mesh-ancestor
25834110|NCT00014937|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25834111|NCT00014937|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25834112|NCT00014937|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25834113|NCT00014937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25834114|NCT00014937|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25834115|NCT00014989|Magnesium Sulfate|magnesium sulfate|mesh-list
25834116|NCT00014989|Analgesics|analgesics|mesh-ancestor
25659005|NCT01602692|Epinephrine|epinephrine|mesh-list
25659006|NCT01602692|Racepinephrine|racepinephrine|mesh-list
25659007|NCT01602692|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25659008|NCT01602692|Epinephryl borate|epinephryl borate|mesh-list
25659009|NCT01602692|Anesthetics, Local|anesthetics, local|mesh-ancestor
25659010|NCT01602692|Anesthetics|anesthetics|mesh-ancestor
25659011|NCT01602692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25659012|NCT01602692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659013|NCT01602692|Sensory System Agents|sensory system agents|mesh-ancestor
25659014|NCT01602692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25659015|NCT01602692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25659016|NCT01602692|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25414033|NCT03088813|Topotecan|topotecan|mesh-list
25027221|NCT03621618|Dobutamine|dobutamine|mesh-list
25056603|NCT03511183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25056604|NCT03511183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056605|NCT03511183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25056606|NCT03511183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25056607|NCT03511183|Growth Substances|growth substances|mesh-ancestor
25056608|NCT03511183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056609|NCT03511183|Growth Inhibitors|growth inhibitors|mesh-ancestor
25056610|NCT03510975|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25056611|NCT03510975|Hemostatics|hemostatics|mesh-ancestor
25056612|NCT03510975|Coagulants|coagulants|mesh-ancestor
25056613|NCT03510975|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24877731|NCT02473042|Hormones|hormones|mesh-ancestor
25834117|NCT00014989|Sensory System Agents|sensory system agents|mesh-ancestor
25834118|NCT00014989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25834119|NCT00014989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834120|NCT00014989|Anesthetics|anesthetics|mesh-ancestor
25834121|NCT00014989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25834122|NCT00014989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25834123|NCT00014989|Anticonvulsants|anticonvulsants|mesh-ancestor
25834124|NCT00014989|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25834125|NCT00014989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25834126|NCT00014989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834127|NCT00014989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25834128|NCT00014989|Tocolytic Agents|tocolytic agents|mesh-ancestor
25834129|NCT00014989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25834130|NCT00015028|Buprenorphine|buprenorphine|mesh-list
24534244|NCT00646594|Budesonide|budesonide|mesh-list
25834131|NCT00015028|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25834132|NCT00015028|Naloxone|naloxone|mesh-list
25834133|NCT00015028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25834134|NCT00015028|Narcotics|narcotics|mesh-ancestor
25834135|NCT00015028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25834136|NCT00015028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834137|NCT00015028|Analgesics|analgesics|mesh-ancestor
25834138|NCT00015028|Sensory System Agents|sensory system agents|mesh-ancestor
25834139|NCT00015028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25834140|NCT00015028|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25834141|NCT00015041|Buprenorphine|buprenorphine|mesh-list
25206626|NCT05344742|Mitoxantrone|mitoxantrone|mesh-list
25834142|NCT00015041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25834143|NCT00015041|Narcotics|narcotics|mesh-ancestor
25834144|NCT00015041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25834145|NCT00015041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834146|NCT00015041|Analgesics|analgesics|mesh-ancestor
25834147|NCT00015041|Sensory System Agents|sensory system agents|mesh-ancestor
25834148|NCT00015041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25834149|NCT00015041|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25834150|NCT00015054|Methylphenidate|methylphenidate|mesh-list
25834151|NCT00015054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25834152|NCT00015054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834153|NCT00015054|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25834154|NCT00015054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25834155|NCT00015054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25834156|NCT00015054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834157|NCT00015054|Dopamine Agents|dopamine agents|mesh-ancestor
25834158|NCT00015054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25834159|NCT00015067|Methylphenidate|methylphenidate|mesh-list
25834160|NCT00015067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25834161|NCT00015067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834162|NCT00015067|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25834163|NCT00015067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25659017|NCT01602692|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25659018|NCT01602692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25659019|NCT01602692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659020|NCT01602692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25659021|NCT01602692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25659022|NCT01602692|Adrenergic Agents|adrenergic agents|mesh-ancestor
25659023|NCT01602692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25659024|NCT01602692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25659025|NCT01602692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25659026|NCT01602692|Autonomic Agents|autonomic agents|mesh-ancestor
25659027|NCT01602692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25659028|NCT01602692|Respiratory System Agents|respiratory system agents|mesh-ancestor
25834164|NCT00015067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25834165|NCT00015067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450323|NCT00318760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24450324|NCT00318760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24450326|NCT00318760|Adrenergic Agents|adrenergic agents|mesh-ancestor
24450345|NCT00318825|Anesthetics, General|anesthetics, general|mesh-ancestor
24450348|NCT00318825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450349|NCT00318825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24450351|NCT00318825|Sensory System Agents|sensory system agents|mesh-ancestor
24450352|NCT00318825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24450353|NCT00318838|Azimilide|azimilide|mesh-list
24450354|NCT00318838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24450355|NCT00318838|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24450356|NCT00318838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25834167|NCT00015067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24635970|NCT01142258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24666167|NCT01317927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875341|NCT04444921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25875342|NCT04444921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875343|NCT04444921|Tubulin Modulators|tubulin modulators|mesh-ancestor
25875344|NCT04444921|Antimitotic Agents|antimitotic agents|mesh-ancestor
25875345|NCT04444921|Mitosis Modulators|mitosis modulators|mesh-ancestor
25875346|NCT04444921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875347|NCT04444921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25875348|NCT04444921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25875349|NCT04438265|Levobupivacaine|levobupivacaine|mesh-list
25875350|NCT04438265|Anesthetics, Local|anesthetics, local|mesh-ancestor
25875351|NCT04438265|Anesthetics|anesthetics|mesh-ancestor
25875352|NCT04438265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25875353|NCT04438265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875354|NCT04438265|Sensory System Agents|sensory system agents|mesh-ancestor
25875355|NCT04438265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25875356|NCT04425018|Paclitaxel|paclitaxel|mesh-list
25875357|NCT04425018|Trastuzumab|trastuzumab|mesh-list
25875358|NCT04425018|Pertuzumab|pertuzumab|mesh-list
25875359|NCT04425018|Margetuximab|margetuximab|mesh-list
25875360|NCT04425018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25875361|NCT04425018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875362|NCT04425018|Tubulin Modulators|tubulin modulators|mesh-ancestor
25875363|NCT04425018|Antimitotic Agents|antimitotic agents|mesh-ancestor
25875364|NCT04425018|Mitosis Modulators|mitosis modulators|mesh-ancestor
25875365|NCT04425018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875366|NCT04425018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25875367|NCT04409873|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25875368|NCT04409873|Listerine|listerine|mesh-list
25875369|NCT04409873|Cetylpyridinium|cetylpyridinium|mesh-list
25875370|NCT04409873|Chlorine dioxide|chlorine dioxide|mesh-list
25875371|NCT04409873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25875372|NCT04409873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25875373|NCT04409873|Dental Disinfectants|dental disinfectants|mesh-ancestor
25875374|NCT04409873|Disinfectants|disinfectants|mesh-ancestor
25875375|NCT04396873|11C-PS13|11c-ps13|mesh-list
25875376|NCT04396873|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25875377|NCT04396873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875378|NCT04396730|Cannabidiol|cannabidiol|mesh-list
25875379|NCT04396730|Contraceptive Agents|contraceptive agents|mesh-list
25875380|NCT04396730|Contraceptives, Oral|contraceptives, oral|mesh-list
25875381|NCT04396730|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25875382|NCT04396730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25875383|NCT04396730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875384|NCT04396730|Anticonvulsants|anticonvulsants|mesh-ancestor
25875385|NCT04396730|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25875386|NCT04394546|Anticoagulants|anticoagulants|mesh-list
25875387|NCT04377308|Fluoxetine|fluoxetine|mesh-list
25875388|NCT04377308|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25875389|NCT04377308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25875390|NCT04377308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25875391|NCT04377308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875392|NCT04377308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25875393|NCT04377308|Serotonin Agents|serotonin agents|mesh-ancestor
25163160|NCT02898779|Primaquine|primaquine|mesh-list
25875394|NCT04377308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875395|NCT04377308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24877929|NCT02227199|Alkylating Agents|alkylating agents|mesh-ancestor
24877930|NCT02227199|Keratolytic Agents|keratolytic agents|mesh-ancestor
24877931|NCT02227199|Dermatologic Agents|dermatologic agents|mesh-ancestor
24877932|NCT02227199|Tubulin Modulators|tubulin modulators|mesh-ancestor
24877933|NCT02227199|Antimitotic Agents|antimitotic agents|mesh-ancestor
24877934|NCT02227199|Mitosis Modulators|mitosis modulators|mesh-ancestor
24940172|NCT04003350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940173|NCT04003350|Antimanic Agents|antimanic agents|mesh-ancestor
24940174|NCT04003350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24940175|NCT04003350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25834168|NCT00015080|Naltrexone|naltrexone|mesh-list
25834169|NCT00015080|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25834170|NCT00015080|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25834171|NCT00015080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834172|NCT00015080|Sensory System Agents|sensory system agents|mesh-ancestor
25834173|NCT00015080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25834174|NCT00015106|Lamotrigine|lamotrigine|mesh-list
25834175|NCT00015106|Anticonvulsants|anticonvulsants|mesh-ancestor
25834176|NCT00015106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25834177|NCT00015106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24636244|NCT01144117|Hematinics|hematinics|mesh-ancestor
24636245|NCT01144156|Adalimumab|adalimumab|mesh-list
24636246|NCT01144156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24636247|NCT01144156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25834178|NCT00015106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834179|NCT00015106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25834180|NCT00015106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834181|NCT00015106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25834182|NCT00015106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25834183|NCT00015106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25834184|NCT00015106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25834185|NCT00015106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25834186|NCT00015132|Sertraline|sertraline|mesh-list
25834187|NCT00015132|Antidepressive Agents|antidepressive agents|mesh-ancestor
25834188|NCT00015132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25834189|NCT00015132|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25834190|NCT00015132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25834191|NCT00015132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25834192|NCT00015132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834193|NCT00015132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25834194|NCT00015132|Serotonin Agents|serotonin agents|mesh-ancestor
25834195|NCT00015132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834196|NCT00015171|Buprenorphine|buprenorphine|mesh-list
25834197|NCT00015171|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25834198|NCT00015171|Naloxone|naloxone|mesh-list
25834199|NCT00015171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25834200|NCT00015171|Narcotics|narcotics|mesh-ancestor
25834201|NCT00015171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25834202|NCT00015171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834203|NCT00015171|Analgesics|analgesics|mesh-ancestor
25834204|NCT00015171|Sensory System Agents|sensory system agents|mesh-ancestor
25834205|NCT00015171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25834206|NCT00015171|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25834207|NCT00015210|Nefazodone|nefazodone|mesh-list
25834208|NCT00015210|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25834209|NCT00015210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25834210|NCT00015210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24458393|NCT00337740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25834211|NCT00015210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834212|NCT00015210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25834213|NCT00015210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834214|NCT00015210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25834215|NCT00015210|Antidepressive Agents|antidepressive agents|mesh-ancestor
25834216|NCT00015210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25659029|NCT01602692|Mydriatics|mydriatics|mesh-ancestor
25659030|NCT01602692|Sympathomimetics|sympathomimetics|mesh-ancestor
25659031|NCT01602692|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25659032|NCT01603082|Clopidogrel|clopidogrel|mesh-list
25659033|NCT01603082|Ticagrelor|ticagrelor|mesh-list
25659034|NCT01603082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25659035|NCT01603082|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25659036|NCT01603082|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25659037|NCT01603082|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25659038|NCT01603082|Purinergic Agents|purinergic agents|mesh-ancestor
24815648|NCT02071407|Anesthetics|anesthetics|mesh-ancestor
24878261|NCT01998529|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24878262|NCT01998529|Protective Agents|protective agents|mesh-ancestor
24878263|NCT01998529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952621|NCT03892928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24952622|NCT03892928|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24952623|NCT03892928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24952625|NCT03892928|Adrenergic Agents|adrenergic agents|mesh-ancestor
24952626|NCT03892928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24952627|NCT03892928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834217|NCT00015210|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25834218|NCT00015210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25834219|NCT00015210|Serotonin Agents|serotonin agents|mesh-ancestor
25834220|NCT00015223|Methylphenidate|methylphenidate|mesh-list
25834221|NCT00015223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25834222|NCT00015223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834223|NCT00015223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25834224|NCT00015223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25834225|NCT00015223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25834226|NCT00015223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834227|NCT00015223|Dopamine Agents|dopamine agents|mesh-ancestor
25834228|NCT00015223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25163161|NCT02898779|Antimalarials|antimalarials|mesh-ancestor
25834229|NCT00015236|Amantadine|amantadine|mesh-list
25834230|NCT00015236|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25834231|NCT00015236|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25834232|NCT00015236|Antiviral Agents|antiviral agents|mesh-ancestor
25834233|NCT00015236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25834234|NCT00015236|Dopamine Agents|dopamine agents|mesh-ancestor
25834235|NCT00015236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25834236|NCT00015236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834237|NCT00015236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534369|NCT00646841|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25834238|NCT00015236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25834239|NCT00015236|Analgesics|analgesics|mesh-ancestor
25834240|NCT00015236|Sensory System Agents|sensory system agents|mesh-ancestor
25834241|NCT00015236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25834242|NCT00015249|Amantadine|amantadine|mesh-list
25834243|NCT00015249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25834244|NCT00015249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25834245|NCT00015249|Antiviral Agents|antiviral agents|mesh-ancestor
25834246|NCT00015249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24450402|NCT00318968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924159|NCT04162522|Citalopram|citalopram|mesh-list
25834247|NCT00015249|Dopamine Agents|dopamine agents|mesh-ancestor
25834248|NCT00015249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25834249|NCT00015249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834250|NCT00015249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834251|NCT00015249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25834252|NCT00015249|Analgesics|analgesics|mesh-ancestor
25834253|NCT00015249|Sensory System Agents|sensory system agents|mesh-ancestor
25834254|NCT00015249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25834255|NCT00015275|Cocaine|cocaine|mesh-list
25834256|NCT00015275|Anesthetics, Local|anesthetics, local|mesh-ancestor
25834257|NCT00015275|Anesthetics|anesthetics|mesh-ancestor
25834258|NCT00015275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25834259|NCT00015275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834260|NCT00015275|Sensory System Agents|sensory system agents|mesh-ancestor
25834261|NCT00015275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25834262|NCT00015275|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25834263|NCT00015275|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25834264|NCT00015275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25659039|NCT01603082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25659040|NCT01603082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659041|NCT01603082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659042|NCT01603277|Antibodies|antibodies|mesh-list
25659043|NCT01603277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25659044|NCT01603277|Immunologic Factors|immunologic factors|mesh-ancestor
25659045|NCT01603277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659046|NCT01603420|Ascorbic Acid|ascorbic acid|mesh-list
25659047|NCT01603420|Docetaxel|docetaxel|mesh-list
25659048|NCT01603420|Methyltestosterone|methyltestosterone|mesh-list
25659049|NCT01603420|Hormones|hormones|mesh-list
25659050|NCT01603420|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25834265|NCT00015275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25834266|NCT00015275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834267|NCT00015275|Dopamine Agents|dopamine agents|mesh-ancestor
25834268|NCT00015275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25834269|NCT00015288|Buprenorphine|buprenorphine|mesh-list
25834270|NCT00015288|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25834271|NCT00015288|Naloxone|naloxone|mesh-list
25834272|NCT00015288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25834273|NCT00015288|Narcotics|narcotics|mesh-ancestor
25834274|NCT00015288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25834275|NCT00015288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834276|NCT00015288|Analgesics|analgesics|mesh-ancestor
25834277|NCT00015288|Sensory System Agents|sensory system agents|mesh-ancestor
25834278|NCT00015288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25834279|NCT00015288|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25834280|NCT00015301|Methylphenidate|methylphenidate|mesh-list
25834281|NCT00015301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25834282|NCT00015301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659051|NCT01603420|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25834283|NCT00015301|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25834284|NCT00015301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25834285|NCT00015301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25834286|NCT00015301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834287|NCT00015301|Dopamine Agents|dopamine agents|mesh-ancestor
25834288|NCT00015301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25834289|NCT00015340|Buprenorphine|buprenorphine|mesh-list
25834290|NCT00015340|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25834291|NCT00015340|Naloxone|naloxone|mesh-list
25834292|NCT00015340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25834293|NCT00015340|Narcotics|narcotics|mesh-ancestor
25834294|NCT00015340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25834295|NCT00015340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834296|NCT00015340|Analgesics|analgesics|mesh-ancestor
24522956|NCT02992522|Venetoclax|venetoclax|mesh-list
24458396|NCT00337740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24458397|NCT00337740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24458398|NCT00337740|Vasodilator Agents|vasodilator agents|mesh-ancestor
24458399|NCT00337766|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24458400|NCT00337766|Hemostatics|hemostatics|mesh-ancestor
24636749|NCT01147146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24636753|NCT01147146|GABA Modulators|gaba modulators|mesh-ancestor
25834297|NCT00015340|Sensory System Agents|sensory system agents|mesh-ancestor
25834298|NCT00015340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25834299|NCT00015340|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25834300|NCT00015548|Olanzapine|olanzapine|mesh-list
25834301|NCT00015548|Risperidone|risperidone|mesh-list
25834302|NCT00015548|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25834303|NCT00015548|Citalopram|citalopram|mesh-list
25834304|NCT00015548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25834305|NCT00015548|Serotonin Agents|serotonin agents|mesh-ancestor
25834306|NCT00015548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25834307|NCT00015548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834308|NCT00015548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834309|NCT00015548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25834310|NCT00015548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25834311|NCT00015548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25834312|NCT00015548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25834313|NCT00015548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25834314|NCT00015548|Dopamine Agents|dopamine agents|mesh-ancestor
25147986|NCT02909257|Bupivacaine|bupivacaine|mesh-list
25834315|NCT00015548|Antiemetics|antiemetics|mesh-ancestor
25834316|NCT00015548|Autonomic Agents|autonomic agents|mesh-ancestor
25834317|NCT00015548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25834318|NCT00015548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25659052|NCT01603420|Androgens|androgens|mesh-list
25659053|NCT01603420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659054|NCT01603420|Tubulin Modulators|tubulin modulators|mesh-ancestor
25659055|NCT01603420|Antimitotic Agents|antimitotic agents|mesh-ancestor
25659056|NCT01603420|Mitosis Modulators|mitosis modulators|mesh-ancestor
25659057|NCT01603420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659058|NCT01603420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25659059|NCT01603420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659060|NCT01603420|Antioxidants|antioxidants|mesh-ancestor
25659061|NCT01603420|Protective Agents|protective agents|mesh-ancestor
25659062|NCT01603420|Vitamins|vitamins|mesh-ancestor
25056673|NCT03510325|Amisulpride|amisulpride|mesh-list
25056674|NCT03510325|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25056675|NCT03510325|Serotonin Agents|serotonin agents|mesh-ancestor
25834319|NCT00015548|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25834320|NCT00015548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25834321|NCT00015548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25834322|NCT00015548|Antidepressive Agents|antidepressive agents|mesh-ancestor
25834323|NCT00015548|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25834324|NCT00015626|Metformin|metformin|mesh-list
25834325|NCT00015626|Pioglitazone|pioglitazone|mesh-list
25834326|NCT00015626|Rosiglitazone|rosiglitazone|mesh-list
25834327|NCT00015626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24636923|NCT01148043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834328|NCT00015626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834329|NCT00015652|Ribavirin|ribavirin|mesh-list
25834330|NCT00015652|Aldesleukin|aldesleukin|mesh-list
25834331|NCT00015652|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25834332|NCT00015652|Antimetabolites|antimetabolites|mesh-ancestor
25834333|NCT00015652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834334|NCT00015652|Antiviral Agents|antiviral agents|mesh-ancestor
25148038|NCT02909335|Antitubercular Agents|antitubercular agents|mesh-ancestor
25834335|NCT00015652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25834336|NCT00015652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834337|NCT00015652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25834338|NCT00015652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25834339|NCT00015665|Voriconazole|voriconazole|mesh-list
25834340|NCT00015665|Antifungal Agents|antifungal agents|mesh-ancestor
25834341|NCT00015665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25834342|NCT00015665|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25834343|NCT00015665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25834344|NCT00015665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924347|NCT04160936|Ropivacaine|ropivacaine|mesh-list
25834345|NCT00015665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834346|NCT00015665|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25834347|NCT00015665|Hormone Antagonists|hormone antagonists|mesh-ancestor
25834348|NCT00015665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25834349|NCT00015665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450227|NCT00318162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450228|NCT00318162|Sensory System Agents|sensory system agents|mesh-ancestor
24450229|NCT00318162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24450230|NCT00318175|Bosentan|bosentan|mesh-list
24450231|NCT00318175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24450232|NCT00318175|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25834350|NCT00015665|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25834351|NCT00015691|Metformin|metformin|mesh-list
25834352|NCT00015691|Rosiglitazone|rosiglitazone|mesh-list
25834353|NCT00015691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25834354|NCT00015691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834355|NCT00015704|Aldesleukin|aldesleukin|mesh-list
24924379|NCT04160598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25834356|NCT00015704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834357|NCT00015704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25834358|NCT00015704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25659063|NCT01603420|Micronutrients|micronutrients|mesh-ancestor
25659064|NCT01603420|Estrogens|estrogens|mesh-ancestor
25659065|NCT01603420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25659066|NCT01603420|Anabolic Agents|anabolic agents|mesh-ancestor
25659067|NCT01603459|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25659068|NCT01603459|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25659069|NCT01603459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25659070|NCT01603459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659071|NCT01603459|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25834359|NCT00015704|Antiviral Agents|antiviral agents|mesh-ancestor
25834360|NCT00015704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25834361|NCT00015769|Levetiracetam|levetiracetam|mesh-list
24878829|NCT00740805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25056695|NCT03510325|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25056696|NCT03510325|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25056697|NCT03510325|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24810993|NCT02044120|Alkylating Agents|alkylating agents|mesh-ancestor
25834362|NCT00015769|Anticonvulsants|anticonvulsants|mesh-ancestor
24878830|NCT00740805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24878833|NCT00669734|Vaccines|vaccines|mesh-list
25163162|NCT02898779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25834363|NCT00015769|Nootropic Agents|nootropic agents|mesh-ancestor
25834364|NCT00015808|Idebenone|idebenone|mesh-list
24534589|NCT00647660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534590|NCT00647660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834365|NCT00015808|Antioxidants|antioxidants|mesh-ancestor
25834366|NCT00015808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834367|NCT00015808|Protective Agents|protective agents|mesh-ancestor
25834368|NCT00015808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834369|NCT00015821|Thalidomide|thalidomide|mesh-list
24637363|NCT01149967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24637364|NCT01149967|Antidepressive Agents|antidepressive agents|mesh-ancestor
24637365|NCT01149967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24637366|NCT01149967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24637367|NCT01149967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24637368|NCT01149967|Parasympatholytics|parasympatholytics|mesh-ancestor
24637369|NCT01149967|Autonomic Agents|autonomic agents|mesh-ancestor
24637370|NCT01149967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24637371|NCT01149967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24637372|NCT01149967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24637373|NCT01149967|Cholinergic Agents|cholinergic agents|mesh-ancestor
25834370|NCT00015821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25834371|NCT00015821|Immunologic Factors|immunologic factors|mesh-ancestor
25834372|NCT00015821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834373|NCT00015821|Leprostatic Agents|leprostatic agents|mesh-ancestor
25834374|NCT00015821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25834375|NCT00015821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24637395|NCT01149993|Thymoglobulin|thymoglobulin|mesh-list
24637396|NCT01149993|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24924429|NCT04160611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25834376|NCT00015821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25834377|NCT00015821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25834378|NCT00015821|Growth Substances|growth substances|mesh-ancestor
25834379|NCT00015821|Growth Inhibitors|growth inhibitors|mesh-ancestor
25834380|NCT00015821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834381|NCT00015834|Cytarabine|cytarabine|mesh-list
25834382|NCT00015834|Imatinib Mesylate|imatinib mesylate|mesh-list
25834383|NCT00015834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25834384|NCT00015834|Antimetabolites|antimetabolites|mesh-ancestor
25834385|NCT00015834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834386|NCT00015834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834387|NCT00015834|Antiviral Agents|antiviral agents|mesh-ancestor
25834388|NCT00015834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25834389|NCT00015834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25834390|NCT00015834|Immunologic Factors|immunologic factors|mesh-ancestor
25834391|NCT00015834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834392|NCT00015834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25834393|NCT00015834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25834394|NCT00015860|Prednisone|prednisone|mesh-list
25834395|NCT00015860|Vincristine|vincristine|mesh-list
24534675|NCT00647816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048073|NCT00743925|Atorvastatin|atorvastatin|mesh-list
24534676|NCT00647816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24534677|NCT00647816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25834396|NCT00015860|Imatinib Mesylate|imatinib mesylate|mesh-list
25834397|NCT00015860|Daunorubicin|daunorubicin|mesh-list
25834398|NCT00015860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25834399|NCT00015860|Glucocorticoids|glucocorticoids|mesh-ancestor
25834400|NCT00015860|Hormones|hormones|mesh-ancestor
25659072|NCT01603459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25659073|NCT01603459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659074|NCT01603459|Cholinergic Agents|cholinergic agents|mesh-ancestor
25659075|NCT01603459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25659076|NCT01603602|Botulinum Toxins|botulinum toxins|mesh-list
25659077|NCT01603602|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25659078|NCT01603602|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25659079|NCT01603602|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24815699|NCT02071615|Methylphenidate|methylphenidate|mesh-list
24815719|NCT02071641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815720|NCT02071641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25834401|NCT00015860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25834402|NCT00015860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834403|NCT00015860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25834404|NCT00015860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834405|NCT00015860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25834406|NCT00015860|Tubulin Modulators|tubulin modulators|mesh-ancestor
25834407|NCT00015860|Antimitotic Agents|antimitotic agents|mesh-ancestor
25834408|NCT00015860|Mitosis Modulators|mitosis modulators|mesh-ancestor
25834409|NCT00015860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834410|NCT00015860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25834411|NCT00015860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458454|NCT00338052|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24458455|NCT00338052|Norethindrone|norethindrone|mesh-list
24458456|NCT00338052|Norethindrone Acetate|norethindrone acetate|mesh-list
24458457|NCT00338052|Estradiol|estradiol|mesh-list
24458458|NCT00338052|Estrogens|estrogens|mesh-ancestor
24458459|NCT00338052|Hormones|hormones|mesh-ancestor
24534678|NCT00647816|Vasodilator Agents|vasodilator agents|mesh-ancestor
24534679|NCT00647829|Valdecoxib|valdecoxib|mesh-list
24534682|NCT00647829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25834412|NCT00015860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25834413|NCT00015860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25834414|NCT00015860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25834415|NCT00015873|Cytarabine|cytarabine|mesh-list
25834416|NCT00015873|Prednisolone|prednisolone|mesh-list
25834417|NCT00015873|Methotrexate|methotrexate|mesh-list
25834418|NCT00015873|Mercaptopurine|mercaptopurine|mesh-list
25834419|NCT00015873|Vincristine|vincristine|mesh-list
25834420|NCT00015873|Asparaginase|asparaginase|mesh-list
25834421|NCT00015873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25834422|NCT00015873|Abortifacient Agents|abortifacient agents|mesh-ancestor
25834423|NCT00015873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24534697|NCT00647842|Analgesics|analgesics|mesh-ancestor
24534698|NCT00647842|Sensory System Agents|sensory system agents|mesh-ancestor
25834424|NCT00015873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834425|NCT00015873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25834426|NCT00015873|Antimetabolites|antimetabolites|mesh-ancestor
25834427|NCT00015873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834428|NCT00015873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834429|NCT00015873|Dermatologic Agents|dermatologic agents|mesh-ancestor
25834430|NCT00015873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25834431|NCT00015873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25834432|NCT00015873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25834433|NCT00015873|Immunologic Factors|immunologic factors|mesh-ancestor
25834434|NCT00015873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25834435|NCT00015873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25834436|NCT00015873|Antiviral Agents|antiviral agents|mesh-ancestor
25834437|NCT00015873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25834438|NCT00015873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25834439|NCT00015873|Tubulin Modulators|tubulin modulators|mesh-ancestor
25834440|NCT00015873|Antimitotic Agents|antimitotic agents|mesh-ancestor
25834441|NCT00015873|Mitosis Modulators|mitosis modulators|mesh-ancestor
25834442|NCT00015873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25834443|NCT00015873|Glucocorticoids|glucocorticoids|mesh-ancestor
25834444|NCT00015873|Hormones|hormones|mesh-ancestor
25834445|NCT00015873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25834446|NCT00015873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25834447|NCT00015886|Docetaxel|docetaxel|mesh-list
25834448|NCT00015886|Fluorouracil|fluorouracil|mesh-list
25834449|NCT00015886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834450|NCT00015886|Tubulin Modulators|tubulin modulators|mesh-ancestor
25834451|NCT00015886|Antimitotic Agents|antimitotic agents|mesh-ancestor
25659080|NCT01603602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25659081|NCT01603602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659082|NCT01603602|Cholinergic Agents|cholinergic agents|mesh-ancestor
25659083|NCT01603602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25659084|NCT01603602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834452|NCT00015886|Mitosis Modulators|mitosis modulators|mesh-ancestor
25834453|NCT00015886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659086|NCT01603602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24879187|NCT04963530|Antimanic Agents|antimanic agents|mesh-ancestor
24879188|NCT04963530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25028077|NCT03613961|Anesthetics|anesthetics|mesh-list
25056721|NCT03510000|Empagliflozin|empagliflozin|mesh-list
25056722|NCT03510000|Pancrelipase|pancrelipase|mesh-list
25834454|NCT00015886|Antimetabolites|antimetabolites|mesh-ancestor
25834455|NCT00015886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25834456|NCT00015886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25834457|NCT00015886|Immunologic Factors|immunologic factors|mesh-ancestor
25834458|NCT00015886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834459|NCT00015899|Lonafarnib|lonafarnib|mesh-list
25834460|NCT00015899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25834461|NCT00015899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637901|NCT01153828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25834462|NCT00015912|Interferons|interferons|mesh-list
25834463|NCT00015912|Interferon-alpha|interferon-alpha|mesh-list
25834464|NCT00015912|Interferon alpha-2|interferon alpha-2|mesh-list
25834465|NCT00015912|Thalidomide|thalidomide|mesh-list
25834466|NCT00015912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834467|NCT00015912|Antiviral Agents|antiviral agents|mesh-ancestor
25834468|NCT00015912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25834469|NCT00015912|Immunologic Factors|immunologic factors|mesh-ancestor
25834470|NCT00015912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834471|NCT00015912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25834472|NCT00015912|Leprostatic Agents|leprostatic agents|mesh-ancestor
25834473|NCT00015912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25834474|NCT00015912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25834475|NCT00015912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25834476|NCT00015912|Growth Substances|growth substances|mesh-ancestor
25834477|NCT00015912|Growth Inhibitors|growth inhibitors|mesh-ancestor
25834478|NCT00015925|Entinostat|entinostat|mesh-list
24405530|NCT00167583|Interferons|interferons|mesh-list
25834479|NCT00015925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834480|NCT00015925|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25834481|NCT00015925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25834482|NCT00015925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834483|NCT00015938|Docetaxel|docetaxel|mesh-list
25834484|NCT00015938|Vinorelbine|vinorelbine|mesh-list
25834485|NCT00015938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834486|NCT00015938|Tubulin Modulators|tubulin modulators|mesh-ancestor
25834487|NCT00015938|Antimitotic Agents|antimitotic agents|mesh-ancestor
25834488|NCT00015938|Mitosis Modulators|mitosis modulators|mesh-ancestor
25834489|NCT00015938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834490|NCT00015938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25834491|NCT00015951|Cytarabine|cytarabine|mesh-list
25834492|NCT00015951|Bevacizumab|bevacizumab|mesh-list
25834493|NCT00015951|Mitoxantrone|mitoxantrone|mesh-list
25834494|NCT00015951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25834495|NCT00015951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458516|NCT00338247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25834496|NCT00015951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25834497|NCT00015951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25834498|NCT00015951|Growth Substances|growth substances|mesh-ancestor
25834499|NCT00015951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834500|NCT00015951|Growth Inhibitors|growth inhibitors|mesh-ancestor
25834501|NCT00015951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25834502|NCT00015951|Antimetabolites|antimetabolites|mesh-ancestor
25834503|NCT00015951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834504|NCT00015951|Antiviral Agents|antiviral agents|mesh-ancestor
25834505|NCT00015951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25834506|NCT00015951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25834507|NCT00015951|Immunologic Factors|immunologic factors|mesh-ancestor
25834508|NCT00015951|Analgesics|analgesics|mesh-ancestor
25659087|NCT01603615|Botulinum Toxins|botulinum toxins|mesh-list
25659088|NCT01603615|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25659089|NCT01603615|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25659090|NCT01603615|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25659091|NCT01603615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25659092|NCT01603615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659093|NCT01603615|Cholinergic Agents|cholinergic agents|mesh-ancestor
24500390|NCT00524095|Xhance|xhance|mesh-list
24879263|NCT04921943|Antitubercular Agents|antitubercular agents|mesh-ancestor
24879264|NCT04921943|Leprostatic Agents|leprostatic agents|mesh-ancestor
25834509|NCT00015951|Sensory System Agents|sensory system agents|mesh-ancestor
25834510|NCT00015951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25834511|NCT00015951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25834512|NCT00015951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25834513|NCT00015951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25834514|NCT00015964|Gefitinib|gefitinib|mesh-list
25834515|NCT00015964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834516|NCT00015964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25834517|NCT00015964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25834518|NCT00015964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834519|NCT00015977|Interleukin-12|interleukin-12|mesh-list
25834520|NCT00015977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25834521|NCT00015977|Immunologic Factors|immunologic factors|mesh-ancestor
25834522|NCT00015977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834523|NCT00015977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25834524|NCT00015977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25834525|NCT00015977|Growth Substances|growth substances|mesh-ancestor
25834526|NCT00015977|Growth Inhibitors|growth inhibitors|mesh-ancestor
25834527|NCT00015977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834528|NCT00015990|Thalidomide|thalidomide|mesh-list
25834529|NCT00015990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25834530|NCT00015990|Immunologic Factors|immunologic factors|mesh-ancestor
25834531|NCT00015990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834532|NCT00015990|Leprostatic Agents|leprostatic agents|mesh-ancestor
25834533|NCT00015990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25834534|NCT00015990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25834535|NCT00015990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25163163|NCT02898779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25834536|NCT00015990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25834537|NCT00015990|Growth Substances|growth substances|mesh-ancestor
25834538|NCT00015990|Growth Inhibitors|growth inhibitors|mesh-ancestor
25834539|NCT00015990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834540|NCT00016016|Cytarabine|cytarabine|mesh-list
25834541|NCT00016016|Mitoxantrone|mitoxantrone|mesh-list
25834542|NCT00016016|Alvocidib|alvocidib|mesh-list
25834543|NCT00016016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25834544|NCT00016016|Antimetabolites|antimetabolites|mesh-ancestor
25834545|NCT00016016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834546|NCT00016016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834547|NCT00016016|Antiviral Agents|antiviral agents|mesh-ancestor
25834548|NCT00016016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25834549|NCT00016016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25834550|NCT00016016|Immunologic Factors|immunologic factors|mesh-ancestor
25834551|NCT00016016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834552|NCT00016016|Analgesics|analgesics|mesh-ancestor
25834553|NCT00016016|Sensory System Agents|sensory system agents|mesh-ancestor
25834554|NCT00016016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25834555|NCT00016016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25834556|NCT00016016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25834557|NCT00016016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25834558|NCT00016016|Growth Inhibitors|growth inhibitors|mesh-ancestor
25834559|NCT00016016|Growth Substances|growth substances|mesh-ancestor
25834560|NCT00016016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24450468|NCT00319267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24450469|NCT00319267|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24450486|NCT00319306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24450487|NCT00319306|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24450488|NCT00319306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24450489|NCT00319306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25834561|NCT00016042|Interferons|interferons|mesh-list
25834562|NCT00016042|Interferon-alpha|interferon-alpha|mesh-list
25834563|NCT00016042|Fluorouracil|fluorouracil|mesh-list
25834564|NCT00016042|Sargramostim|sargramostim|mesh-list
25834565|NCT00016042|Antimetabolites|antimetabolites|mesh-ancestor
25834566|NCT00016042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834567|NCT00016042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25834568|NCT00016042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659094|NCT01603615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25659095|NCT01603615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659096|NCT01603615|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25659097|NCT01603615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25834570|NCT00016042|Immunologic Factors|immunologic factors|mesh-ancestor
25834571|NCT00016042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834572|NCT00016042|Antiviral Agents|antiviral agents|mesh-ancestor
25834573|NCT00016042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25834574|NCT00016055|Temozolomide|temozolomide|mesh-list
25834575|NCT00016055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25834576|NCT00016055|Alkylating Agents|alkylating agents|mesh-ancestor
25834577|NCT00016055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834578|NCT00016055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834579|NCT00016068|Valganciclovir|valganciclovir|mesh-list
25834580|NCT00016068|Ganciclovir|ganciclovir|mesh-list
24879434|NCT04765709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25834581|NCT00016068|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25834582|NCT00016068|Antiviral Agents|antiviral agents|mesh-ancestor
25834583|NCT00016068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25834584|NCT00016068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25834585|NCT00016068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25834586|NCT00016068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834587|NCT00016081|Ribavirin|ribavirin|mesh-list
25201434|NCT02727738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834588|NCT00016081|Antimetabolites|antimetabolites|mesh-ancestor
25834589|NCT00016081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834590|NCT00016081|Antiviral Agents|antiviral agents|mesh-ancestor
25834591|NCT00016081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25834592|NCT00016094|Bevacizumab|bevacizumab|mesh-list
24879451|NCT04752813|Vitamin K 1|vitamin k 1|mesh-list
24879452|NCT04752813|Temozolomide|temozolomide|mesh-list
24879453|NCT04752813|Vitamins|vitamins|mesh-ancestor
24879454|NCT04752813|Micronutrients|micronutrients|mesh-ancestor
24879455|NCT04752813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834593|NCT00016094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25834594|NCT00016094|Antibodies|antibodies|mesh-list
25834595|NCT00016094|Immunoglobulins|immunoglobulins|mesh-list
25834596|NCT00016094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25834597|NCT00016094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834598|NCT00016094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25163164|NCT02898779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24547407|NCT00703755|Metformin|metformin|mesh-list
25834599|NCT00016094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25834600|NCT00016094|Growth Substances|growth substances|mesh-ancestor
25834601|NCT00016094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834602|NCT00016094|Growth Inhibitors|growth inhibitors|mesh-ancestor
25834603|NCT00016094|Immunologic Factors|immunologic factors|mesh-ancestor
25834604|NCT00016107|Bevacizumab|bevacizumab|mesh-list
25834605|NCT00016107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25834606|NCT00016107|Docetaxel|docetaxel|mesh-list
25834607|NCT00016107|Estramustine|estramustine|mesh-list
25834608|NCT00016107|Antibodies|antibodies|mesh-list
25834609|NCT00016107|Immunoglobulins|immunoglobulins|mesh-list
25834610|NCT00016107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25834611|NCT00016107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450305|NCT00318669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450306|NCT00318669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25834612|NCT00016107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25659098|NCT01603628|Botulinum Toxins|botulinum toxins|mesh-list
25659099|NCT01603628|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25659100|NCT01603628|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25659101|NCT01603628|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25659102|NCT01603628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25659103|NCT01603628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659104|NCT01603628|Cholinergic Agents|cholinergic agents|mesh-ancestor
25659105|NCT01603628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25659106|NCT01603628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659107|NCT01603628|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25659108|NCT01603628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25659109|NCT01603641|Botulinum Toxins|botulinum toxins|mesh-list
25659110|NCT01603641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25659111|NCT01603641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25659112|NCT01603641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25659113|NCT01603641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25659114|NCT01603641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659115|NCT01603641|Cholinergic Agents|cholinergic agents|mesh-ancestor
25659116|NCT01603641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25834615|NCT00016107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056792|NCT03509662|Vitamin B Complex|vitamin b complex|mesh-ancestor
25056793|NCT03509584|Nivolumab|nivolumab|mesh-list
25056794|NCT03509584|Ipilimumab|ipilimumab|mesh-list
25056795|NCT03509584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25056796|NCT03509584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201435|NCT02727738|Protective Agents|protective agents|mesh-ancestor
25056798|NCT03509584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056799|NCT03509545|Torsemide|torsemide|mesh-list
25056800|NCT03509545|Furosemide|furosemide|mesh-list
25056801|NCT03509545|Diuretics|diuretics|mesh-ancestor
25056802|NCT03509545|Natriuretic Agents|natriuretic agents|mesh-ancestor
25056803|NCT03509545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056805|NCT03509545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25834617|NCT00016107|Immunologic Factors|immunologic factors|mesh-ancestor
25834618|NCT00016107|Tubulin Modulators|tubulin modulators|mesh-ancestor
25834619|NCT00016107|Antimitotic Agents|antimitotic agents|mesh-ancestor
25834620|NCT00016107|Mitosis Modulators|mitosis modulators|mesh-ancestor
25834621|NCT00016107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834622|NCT00016107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25834623|NCT00016107|Alkylating Agents|alkylating agents|mesh-ancestor
25834624|NCT00016107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24924865|NCT04156152|Fluorides|fluorides|mesh-list
25148356|NCT05148195|Irinotecan|irinotecan|mesh-list
25834625|NCT00016133|Leucovorin|leucovorin|mesh-list
25834626|NCT00016133|Fluorouracil|fluorouracil|mesh-list
25834627|NCT00016133|Vaccines|vaccines|mesh-list
25834628|NCT00016133|BCG Vaccine|bcg vaccine|mesh-list
24451576|NCT00324324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25834629|NCT00016133|Calcium|calcium|mesh-list
25834630|NCT00016133|Levoleucovorin|levoleucovorin|mesh-list
24924901|NCT04155918|Antioxidants|antioxidants|mesh-ancestor
25834631|NCT00016133|Immunologic Factors|immunologic factors|mesh-ancestor
25834632|NCT00016133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834633|NCT00016133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25834634|NCT00016133|Antimetabolites|antimetabolites|mesh-ancestor
25834635|NCT00016133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834636|NCT00016133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25834637|NCT00016133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834638|NCT00016133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25834639|NCT00016133|Antidotes|antidotes|mesh-ancestor
25834640|NCT00016133|Protective Agents|protective agents|mesh-ancestor
25834641|NCT00016133|Vitamin B Complex|vitamin b complex|mesh-ancestor
25163165|NCT02898571|Ascorbic Acid|ascorbic acid|mesh-list
25834642|NCT00016133|Vitamins|vitamins|mesh-ancestor
25834643|NCT00016133|Micronutrients|micronutrients|mesh-ancestor
25163166|NCT02898571|Vitamins|vitamins|mesh-ancestor
25163167|NCT02898571|Micronutrients|micronutrients|mesh-ancestor
25834644|NCT00016133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25834645|NCT00016159|Idarubicin|idarubicin|mesh-list
25834646|NCT00016159|Arsenic Trioxide|arsenic trioxide|mesh-list
25834647|NCT00016159|Tretinoin|tretinoin|mesh-list
25834648|NCT00016159|Lintuzumab|lintuzumab|mesh-list
25834649|NCT00016159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25834650|NCT00016159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834651|NCT00016159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25834652|NCT00016159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25834653|NCT00016159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25659117|NCT01603641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659118|NCT01603641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25659119|NCT01603641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25659120|NCT01603940|Losartan|losartan|mesh-list
25659121|NCT01603940|Benazepril|benazepril|mesh-list
25659122|NCT01603940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25659123|NCT01603940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25659124|NCT01603940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25659125|NCT01603940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25659126|NCT01603940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659127|NCT01603940|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25659128|NCT01603940|Protease Inhibitors|protease inhibitors|mesh-ancestor
25659129|NCT01603940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25834654|NCT00016159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056840|NCT03509168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25056841|NCT03509168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056843|NCT03509168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25056844|NCT03509168|Oxytocics|oxytocics|mesh-ancestor
25056845|NCT03509142|Sirolimus|sirolimus|mesh-list
24879626|NCT04614545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24879627|NCT04614545|Sympathomimetics|sympathomimetics|mesh-ancestor
24879628|NCT04614545|Autonomic Agents|autonomic agents|mesh-ancestor
24879629|NCT04614545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24879630|NCT04614545|Adrenergic Agents|adrenergic agents|mesh-ancestor
24879631|NCT04614545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24879633|NCT04613206|Vaccines|vaccines|mesh-list
25834655|NCT00016159|Keratolytic Agents|keratolytic agents|mesh-ancestor
25834656|NCT00016159|Dermatologic Agents|dermatologic agents|mesh-ancestor
25834657|NCT00016159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25834658|NCT00016172|Doxorubicin|doxorubicin|mesh-list
25834659|NCT00016172|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25834660|NCT00016172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25834661|NCT00016172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924926|NCT04155554|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25834662|NCT00016172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25834663|NCT00016172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25834664|NCT00016172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534861|NCT00648154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24534862|NCT00648154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534863|NCT00648154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534864|NCT00648154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24534865|NCT00648154|Hormone Antagonists|hormone antagonists|mesh-ancestor
24534868|NCT00648180|Doxycycline|doxycycline|mesh-list
25834665|NCT00016172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834666|NCT00016185|Docetaxel|docetaxel|mesh-list
25834667|NCT00016185|Alvocidib|alvocidib|mesh-list
25834668|NCT00016185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834669|NCT00016185|Tubulin Modulators|tubulin modulators|mesh-ancestor
25834670|NCT00016185|Antimitotic Agents|antimitotic agents|mesh-ancestor
25834671|NCT00016185|Mitosis Modulators|mitosis modulators|mesh-ancestor
25834672|NCT00016185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834673|NCT00016185|Growth Inhibitors|growth inhibitors|mesh-ancestor
25834674|NCT00016185|Growth Substances|growth substances|mesh-ancestor
25834675|NCT00016185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834676|NCT00016185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25834677|NCT00016185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25834678|NCT00016198|Leucovorin|leucovorin|mesh-list
25834679|NCT00016198|Fluorouracil|fluorouracil|mesh-list
25834680|NCT00016198|Oxaliplatin|oxaliplatin|mesh-list
25834681|NCT00016198|Calcium|calcium|mesh-list
25834682|NCT00016198|Levoleucovorin|levoleucovorin|mesh-list
25834683|NCT00016198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25834684|NCT00016198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834685|NCT00016198|Antimetabolites|antimetabolites|mesh-ancestor
25834686|NCT00016198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834687|NCT00016198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25834688|NCT00016198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458524|NCT00338273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458525|NCT00338273|Dopamine Agonists|dopamine agonists|mesh-ancestor
25048146|NCT00734435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25834689|NCT00016198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25834690|NCT00016198|Immunologic Factors|immunologic factors|mesh-ancestor
25834691|NCT00016198|Antidotes|antidotes|mesh-ancestor
25834692|NCT00016198|Protective Agents|protective agents|mesh-ancestor
25834693|NCT00016198|Vitamin B Complex|vitamin b complex|mesh-ancestor
25659130|NCT01604109|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
25659131|NCT01604109|Caseins|caseins|mesh-list
25659132|NCT01604109|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25659133|NCT01604109|Serotonin Agents|serotonin agents|mesh-ancestor
25659134|NCT01604109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25659135|NCT01604109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659136|NCT01604109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659137|NCT01604109|Chelating Agents|chelating agents|mesh-ancestor
25659138|NCT01604109|Sequestering Agents|sequestering agents|mesh-ancestor
25659139|NCT01604265|Nabiximols|nabiximols|mesh-list
25659140|NCT01604265|Analgesics|analgesics|mesh-ancestor
25659141|NCT01604265|Sensory System Agents|sensory system agents|mesh-ancestor
25834694|NCT00016198|Vitamins|vitamins|mesh-ancestor
25834695|NCT00016198|Micronutrients|micronutrients|mesh-ancestor
25834696|NCT00016224|Thalidomide|thalidomide|mesh-list
24879727|NCT04511728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24879728|NCT04511728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879729|NCT04511728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24879730|NCT04511728|Anesthetics, General|anesthetics, general|mesh-ancestor
24879731|NCT04511728|Anesthetics|anesthetics|mesh-ancestor
24879732|NCT04510506|Pancrelipase|pancrelipase|mesh-list
24879733|NCT04510506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24879734|NCT04509596|Capecitabine|capecitabine|mesh-list
24879735|NCT04509596|Trastuzumab|trastuzumab|mesh-list
24879736|NCT04509596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25834697|NCT00016224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25834698|NCT00016224|Immunologic Factors|immunologic factors|mesh-ancestor
25834699|NCT00016224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834700|NCT00016224|Leprostatic Agents|leprostatic agents|mesh-ancestor
25834701|NCT00016224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25834702|NCT00016224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25834703|NCT00016224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25834704|NCT00016224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25834705|NCT00016224|Growth Substances|growth substances|mesh-ancestor
25834706|NCT00016224|Growth Inhibitors|growth inhibitors|mesh-ancestor
25834707|NCT00016224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834708|NCT00016263|Dacarbazine|dacarbazine|mesh-list
25834709|NCT00016263|Oblimersen|oblimersen|mesh-list
25834710|NCT00016263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25834711|NCT00016263|Alkylating Agents|alkylating agents|mesh-ancestor
25834712|NCT00016263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834713|NCT00016263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834714|NCT00016276|Tamoxifen|tamoxifen|mesh-list
25834715|NCT00016276|Paclitaxel|paclitaxel|mesh-list
25834716|NCT00016276|Razoxane|razoxane|mesh-list
25834717|NCT00016276|Cyclophosphamide|cyclophosphamide|mesh-list
25834718|NCT00016276|Doxorubicin|doxorubicin|mesh-list
24458540|NCT00338312|Hormones|hormones|mesh-ancestor
24458541|NCT00338312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24458542|NCT00338312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458543|NCT00338338|Amlodipine|amlodipine|mesh-list
24458544|NCT00338338|Lacidipine|lacidipine|mesh-list
25834719|NCT00016276|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25834720|NCT00016276|Trastuzumab|trastuzumab|mesh-list
25834721|NCT00016276|Dexrazoxane|dexrazoxane|mesh-list
25834722|NCT00016276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25834723|NCT00016276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458579|NCT00338390|Didanosine|didanosine|mesh-list
24458580|NCT00338390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24458581|NCT00338390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24458582|NCT00338390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458583|NCT00338390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458584|NCT00338390|Antiviral Agents|antiviral agents|mesh-ancestor
24458585|NCT00338390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24458586|NCT00338390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24458587|NCT00338390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24458588|NCT00338390|Antimetabolites|antimetabolites|mesh-ancestor
24458589|NCT00338416|Epoetin Alfa|epoetin alfa|mesh-list
24458590|NCT00338416|Hematinics|hematinics|mesh-ancestor
24458591|NCT00338468|Epoetin Alfa|epoetin alfa|mesh-list
24458592|NCT00338468|Hematinics|hematinics|mesh-ancestor
25834724|NCT00016276|Tubulin Modulators|tubulin modulators|mesh-ancestor
25659142|NCT01604265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25659143|NCT01604265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659144|NCT01604278|Glycopyrrolate|glycopyrrolate|mesh-list
25659145|NCT01604278|Bromides|bromides|mesh-list
25659146|NCT01604278|Anticonvulsants|anticonvulsants|mesh-ancestor
25659147|NCT01604278|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25659148|NCT01604278|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25659149|NCT01604278|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25659150|NCT01604278|Cholinergic Agents|cholinergic agents|mesh-ancestor
25659151|NCT01604278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25659152|NCT01604278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659153|NCT01604278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659154|NCT01604343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25659155|NCT01604343|Immunologic Factors|immunologic factors|mesh-ancestor
25659156|NCT01604343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659157|NCT01604785|Dopamine|dopamine|mesh-list
25659158|NCT01604785|Propofol|propofol|mesh-list
25659159|NCT01604785|Dopamine Antagonists|dopamine antagonists|mesh-list
25659160|NCT01604785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25659161|NCT01604785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25659162|NCT01604785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815876|NCT02072330|Diuretics|diuretics|mesh-ancestor
25834725|NCT00016276|Antimitotic Agents|antimitotic agents|mesh-ancestor
25834726|NCT00016276|Mitosis Modulators|mitosis modulators|mesh-ancestor
25834727|NCT00016276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834728|NCT00016276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25834729|NCT00016276|Immunologic Factors|immunologic factors|mesh-ancestor
25834730|NCT00016276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834731|NCT00016276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25834732|NCT00016276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25834733|NCT00016276|Alkylating Agents|alkylating agents|mesh-ancestor
25834734|NCT00016276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25834735|NCT00016276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25834736|NCT00016276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24458612|NCT00338546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24458613|NCT00338546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458614|NCT00338546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25834737|NCT00016276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25834738|NCT00016276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25834739|NCT00016276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25834740|NCT00016276|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25834741|NCT00016276|Hormone Antagonists|hormone antagonists|mesh-ancestor
25834742|NCT00016276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25834743|NCT00016276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25834744|NCT00016276|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25834745|NCT00016276|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25834746|NCT00016276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25834747|NCT00016276|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25834748|NCT00016276|Protective Agents|protective agents|mesh-ancestor
25834749|NCT00016289|Interleukin-12|interleukin-12|mesh-list
25834750|NCT00016289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25834751|NCT00016289|Immunologic Factors|immunologic factors|mesh-ancestor
25834752|NCT00016289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834753|NCT00016289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25834754|NCT00016289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25834755|NCT00016289|Growth Substances|growth substances|mesh-ancestor
25834756|NCT00016289|Growth Inhibitors|growth inhibitors|mesh-ancestor
25834757|NCT00016289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834758|NCT00016302|Leucovorin|leucovorin|mesh-list
25834759|NCT00016302|Cytarabine|cytarabine|mesh-list
25834760|NCT00016302|Dexamethasone|dexamethasone|mesh-list
25834761|NCT00016302|Prednisone|prednisone|mesh-list
25834762|NCT00016302|Cyclophosphamide|cyclophosphamide|mesh-list
24523348|NCT01754857|Alkylating Agents|alkylating agents|mesh-ancestor
25834763|NCT00016302|Doxorubicin|doxorubicin|mesh-list
25834764|NCT00016302|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25834765|NCT00016302|Methotrexate|methotrexate|mesh-list
25834766|NCT00016302|Vincristine|vincristine|mesh-list
25834767|NCT00016302|Daunorubicin|daunorubicin|mesh-list
24458645|NCT00338754|Adalimumab|adalimumab|mesh-list
24458646|NCT00338754|Antibodies|antibodies|mesh-list
24458647|NCT00338754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24458648|NCT00338754|Immunologic Factors|immunologic factors|mesh-ancestor
24458649|NCT00338754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458650|NCT00338754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24458651|NCT00338754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24458652|NCT00338767|Fluoxetine|fluoxetine|mesh-list
24458653|NCT00338767|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24458654|NCT00338767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24458655|NCT00338767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24458656|NCT00338767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834768|NCT00016302|Asparaginase|asparaginase|mesh-list
25834769|NCT00016302|Mercaptopurine|mercaptopurine|mesh-list
25834770|NCT00016302|Pegaspargase|pegaspargase|mesh-list
25834771|NCT00016302|Thioguanine|thioguanine|mesh-list
24458658|NCT00338767|Serotonin Agents|serotonin agents|mesh-ancestor
24405770|NCT00168402|Botulinum Toxins|botulinum toxins|mesh-list
25834772|NCT00016302|Levoleucovorin|levoleucovorin|mesh-list
25834773|NCT00016302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25834774|NCT00016302|Immunologic Factors|immunologic factors|mesh-ancestor
25834775|NCT00016302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834776|NCT00016302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25834777|NCT00016302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25834778|NCT00016302|Alkylating Agents|alkylating agents|mesh-ancestor
25834779|NCT00016302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834780|NCT00016302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25674593|NCT01774305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25834781|NCT00016302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25056915|NCT03508869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25056916|NCT03508817|Atropine|atropine|mesh-list
25056917|NCT03508817|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25056918|NCT03508817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25056919|NCT03508817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24811149|NCT02045056|Antimetabolites|antimetabolites|mesh-ancestor
24811151|NCT02045056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24879927|NCT04294225|Anastrozole|anastrozole|mesh-list
24879928|NCT04294225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24879929|NCT04294225|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25834782|NCT00016302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25834783|NCT00016302|Antiemetics|antiemetics|mesh-ancestor
25834784|NCT00016302|Autonomic Agents|autonomic agents|mesh-ancestor
25834785|NCT00016302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25834786|NCT00016302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25834787|NCT00016302|Glucocorticoids|glucocorticoids|mesh-ancestor
25834788|NCT00016302|Hormones|hormones|mesh-ancestor
25834789|NCT00016302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25834790|NCT00016302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25834791|NCT00016302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25834792|NCT00016302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25834793|NCT00016302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25834794|NCT00016302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25834795|NCT00016302|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25834796|NCT00016302|Abortifacient Agents|abortifacient agents|mesh-ancestor
25834797|NCT00016302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25834798|NCT00016302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25834799|NCT00016302|Antimetabolites|antimetabolites|mesh-ancestor
25834800|NCT00016302|Dermatologic Agents|dermatologic agents|mesh-ancestor
25834801|NCT00016302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25834802|NCT00016302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25834803|NCT00016302|Antiviral Agents|antiviral agents|mesh-ancestor
25834804|NCT00016302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25834805|NCT00016302|Antidotes|antidotes|mesh-ancestor
25834806|NCT00016302|Protective Agents|protective agents|mesh-ancestor
25834807|NCT00016302|Vitamin B Complex|vitamin b complex|mesh-ancestor
25834808|NCT00016302|Vitamins|vitamins|mesh-ancestor
25834809|NCT00016302|Micronutrients|micronutrients|mesh-ancestor
25834810|NCT00016302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25163168|NCT02898571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834811|NCT00016302|Tubulin Modulators|tubulin modulators|mesh-ancestor
25834812|NCT00016302|Antimitotic Agents|antimitotic agents|mesh-ancestor
25163169|NCT02898571|Antioxidants|antioxidants|mesh-ancestor
25834813|NCT00016302|Mitosis Modulators|mitosis modulators|mesh-ancestor
25834814|NCT00016315|Gemcitabine|gemcitabine|mesh-list
25834815|NCT00016315|Paclitaxel|paclitaxel|mesh-list
25834816|NCT00016315|Carboplatin|carboplatin|mesh-list
25834817|NCT00016315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25834818|NCT00016315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834819|NCT00016315|Tubulin Modulators|tubulin modulators|mesh-ancestor
25834820|NCT00016315|Antimitotic Agents|antimitotic agents|mesh-ancestor
25834821|NCT00016315|Mitosis Modulators|mitosis modulators|mesh-ancestor
25834822|NCT00016315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834823|NCT00016315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25834824|NCT00016315|Antimetabolites|antimetabolites|mesh-ancestor
25834825|NCT00016315|Antiviral Agents|antiviral agents|mesh-ancestor
25834826|NCT00016315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25834827|NCT00016315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25834828|NCT00016315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25834829|NCT00016315|Immunologic Factors|immunologic factors|mesh-ancestor
25834830|NCT00016315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834831|NCT00016328|Sirolimus|sirolimus|mesh-list
25834832|NCT00016328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25834833|NCT00016328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25834834|NCT00016328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25834835|NCT00016328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659163|NCT01604785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25659164|NCT01604785|Anesthetics, General|anesthetics, general|mesh-ancestor
25659165|NCT01604785|Anesthetics|anesthetics|mesh-ancestor
25659166|NCT01604785|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25659167|NCT01604785|Sympathomimetics|sympathomimetics|mesh-ancestor
25659168|NCT01604785|Autonomic Agents|autonomic agents|mesh-ancestor
25659169|NCT01604785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25659170|NCT01604785|Dopamine Agents|dopamine agents|mesh-ancestor
25659171|NCT01604785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25659172|NCT01604785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834836|NCT00016328|Antifungal Agents|antifungal agents|mesh-ancestor
24879987|NCT04255381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24879988|NCT04251819|Baclofen|baclofen|mesh-list
24879989|NCT04251819|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24879990|NCT04251819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879991|NCT04251819|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24879992|NCT04251819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24879993|NCT04251819|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24879994|NCT04251819|GABA Agonists|gaba agonists|mesh-ancestor
24879995|NCT04251819|GABA Agents|gaba agents|mesh-ancestor
24879996|NCT04251819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24879997|NCT04251819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834837|NCT00016328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25834838|NCT00016328|Immunologic Factors|immunologic factors|mesh-ancestor
25834839|NCT00016328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834840|NCT00016341|Tamoxifen|tamoxifen|mesh-list
24925243|NCT04152161|BCG Vaccine|bcg vaccine|mesh-list
25834841|NCT00016341|Paclitaxel|paclitaxel|mesh-list
25834842|NCT00016341|Cisplatin|cisplatin|mesh-list
25834843|NCT00016341|Doxorubicin|doxorubicin|mesh-list
25834844|NCT00016341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25834845|NCT00016341|Megestrol|megestrol|mesh-list
25834846|NCT00016341|Megestrol Acetate|megestrol acetate|mesh-list
25834847|NCT00016341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25834848|NCT00016341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834849|NCT00016341|Tubulin Modulators|tubulin modulators|mesh-ancestor
25834850|NCT00016341|Antimitotic Agents|antimitotic agents|mesh-ancestor
25834851|NCT00016341|Mitosis Modulators|mitosis modulators|mesh-ancestor
25834852|NCT00016341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834853|NCT00016341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25834854|NCT00016341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25834855|NCT00016341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25834856|NCT00016341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25834857|NCT00016341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834858|NCT00016341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25834859|NCT00016341|Hormone Antagonists|hormone antagonists|mesh-ancestor
25834860|NCT00016341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25834861|NCT00016341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25834862|NCT00016341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25834863|NCT00016341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25834864|NCT00016341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25834865|NCT00016341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25834866|NCT00016341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25834867|NCT00016341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25834868|NCT00016341|Contraceptive Agents|contraceptive agents|mesh-ancestor
25834869|NCT00016341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25834870|NCT00016341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25834871|NCT00016341|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25834872|NCT00016341|Appetite Stimulants|appetite stimulants|mesh-ancestor
25834873|NCT00016341|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24458675|NCT00338793|Prednisolone|prednisolone|mesh-list
24458676|NCT00338793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24458677|NCT00338793|Glucocorticoids|glucocorticoids|mesh-ancestor
24458678|NCT00338793|Hormones|hormones|mesh-ancestor
24458679|NCT00338793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24405882|NCT00168701|Immunologic Factors|immunologic factors|mesh-ancestor
25834874|NCT00016367|Gemcitabine|gemcitabine|mesh-list
25834875|NCT00016367|Cisplatin|cisplatin|mesh-list
25834876|NCT00016367|Trastuzumab|trastuzumab|mesh-list
25834877|NCT00016367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834878|NCT00016367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25834879|NCT00016367|Antimetabolites|antimetabolites|mesh-ancestor
25834880|NCT00016367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547942|NCT00706927|Timolol|timolol|mesh-list
25834881|NCT00016367|Antiviral Agents|antiviral agents|mesh-ancestor
25659173|NCT01604785|Protective Agents|protective agents|mesh-ancestor
25659174|NCT01604850|Sofosbuvir|sofosbuvir|mesh-list
25659175|NCT01604850|Antiviral Agents|antiviral agents|mesh-ancestor
25659176|NCT01604850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25659177|NCT01605032|Bortezomib|bortezomib|mesh-list
25659178|NCT01605032|Melphalan|melphalan|mesh-list
25659179|NCT01605032|Busulfan|busulfan|mesh-list
25659180|NCT01605032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659181|NCT01605032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25659182|NCT01605032|Alkylating Agents|alkylating agents|mesh-ancestor
25659183|NCT01605032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659184|NCT01605032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24952672|NCT03892512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24952673|NCT03892512|Analgesics|analgesics|mesh-ancestor
24952674|NCT03892512|Sensory System Agents|sensory system agents|mesh-ancestor
24778388|NCT01870635|Ondansetron|ondansetron|mesh-list
24880075|NCT04131829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24880076|NCT04131829|Antidepressive Agents|antidepressive agents|mesh-ancestor
24880077|NCT04131829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24880095|NCT04116203|Metformin|metformin|mesh-list
25834882|NCT00016367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25834883|NCT00016367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25834884|NCT00016367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25834885|NCT00016367|Immunologic Factors|immunologic factors|mesh-ancestor
25834886|NCT00016367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834887|NCT00016367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25834888|NCT00016380|Dexamethasone|dexamethasone|mesh-list
25834889|NCT00016380|Ondansetron|ondansetron|mesh-list
25834890|NCT00016380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25834891|NCT00016380|Antiemetics|antiemetics|mesh-ancestor
25834892|NCT00016380|Autonomic Agents|autonomic agents|mesh-ancestor
25834893|NCT00016380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25834894|NCT00016380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834895|NCT00016380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25834896|NCT00016380|Glucocorticoids|glucocorticoids|mesh-ancestor
25834897|NCT00016380|Hormones|hormones|mesh-ancestor
25834898|NCT00016380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25048179|NCT00730665|Esomeprazole|esomeprazole|mesh-list
25834899|NCT00016380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25834900|NCT00016380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834901|NCT00016380|Antipruritics|antipruritics|mesh-ancestor
25834902|NCT00016380|Dermatologic Agents|dermatologic agents|mesh-ancestor
25834903|NCT00016380|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25834904|NCT00016380|Serotonin Agents|serotonin agents|mesh-ancestor
25834905|NCT00016380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25834906|NCT00016380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834907|NCT00016380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25834908|NCT00016380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25834909|NCT00016380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25834910|NCT00016380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25834911|NCT00016380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25834912|NCT00016406|Paclitaxel|paclitaxel|mesh-list
25834913|NCT00016406|Cyclophosphamide|cyclophosphamide|mesh-list
25834914|NCT00016406|Doxorubicin|doxorubicin|mesh-list
25834915|NCT00016406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25834916|NCT00016406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834917|NCT00016406|Tubulin Modulators|tubulin modulators|mesh-ancestor
25834918|NCT00016406|Antimitotic Agents|antimitotic agents|mesh-ancestor
25834919|NCT00016406|Mitosis Modulators|mitosis modulators|mesh-ancestor
25834920|NCT00016406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834921|NCT00016406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25834922|NCT00016406|Immunologic Factors|immunologic factors|mesh-ancestor
25834923|NCT00016406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834924|NCT00016406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25834925|NCT00016406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25834926|NCT00016406|Alkylating Agents|alkylating agents|mesh-ancestor
25834927|NCT00016406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25834928|NCT00016406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25834929|NCT00016406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25834930|NCT00016406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25834931|NCT00016406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25834932|NCT00016419|Cyclosporine|cyclosporine|mesh-list
25834933|NCT00016419|Cyclosporins|cyclosporins|mesh-list
25834934|NCT00016419|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25834935|NCT00016419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25834936|NCT00016419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834937|NCT00016419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25659185|NCT01605032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25659186|NCT01605032|Immunologic Factors|immunologic factors|mesh-ancestor
25659187|NCT01605032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659188|NCT01605071|Estradiol|estradiol|mesh-list
25659189|NCT01605071|Estrogens|estrogens|mesh-ancestor
25659190|NCT01605071|Hormones|hormones|mesh-ancestor
25659191|NCT01605071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25659192|NCT01605071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834938|NCT00016419|Immunologic Factors|immunologic factors|mesh-ancestor
25659193|NCT01605136|Afamelanotide|afamelanotide|mesh-list
25834939|NCT00016419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778459|NCT01870986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24778460|NCT01870986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24778461|NCT01871129|Dexmedetomidine|dexmedetomidine|mesh-list
24778462|NCT01871129|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24778463|NCT01871129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25067425|NCT03443843|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25834940|NCT00016419|Antifungal Agents|antifungal agents|mesh-ancestor
24880245|NCT03960008|Doxorubicin|doxorubicin|mesh-list
24880246|NCT03960008|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24880247|NCT03960008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24880248|NCT03960008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201436|NCT02727738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056942|NCT03508804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25056943|NCT03508804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25056944|NCT03508804|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25056945|NCT03508804|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25056946|NCT03508804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25056947|NCT03508804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056948|NCT03508804|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24880251|NCT03960008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24880252|NCT03960008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880253|NCT03943173|Olaparib|olaparib|mesh-list
25834941|NCT00016419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25834942|NCT00016419|Dermatologic Agents|dermatologic agents|mesh-ancestor
25834943|NCT00016419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25834944|NCT00016419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25834945|NCT00016432|Exemestane|exemestane|mesh-list
25834946|NCT00016432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834947|NCT00016432|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25834948|NCT00016432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24925393|NCT04150731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834949|NCT00016432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25834950|NCT00016432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834951|NCT00016432|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25834952|NCT00016432|Hormone Antagonists|hormone antagonists|mesh-ancestor
25834953|NCT00016432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25834954|NCT00016432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834955|NCT00016445|Hormones|hormones|mesh-list
25834956|NCT00016445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25834957|NCT00016445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834958|NCT00016458|Cyclophosphamide|cyclophosphamide|mesh-list
25834959|NCT00016458|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25834960|NCT00016458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25834961|NCT00016458|Immunologic Factors|immunologic factors|mesh-ancestor
25834962|NCT00016458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834963|NCT00016458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25834964|NCT00016458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25834965|NCT00016458|Alkylating Agents|alkylating agents|mesh-ancestor
25659194|NCT01605136|Dermatologic Agents|dermatologic agents|mesh-ancestor
25659195|NCT01605227|Prednisone|prednisone|mesh-list
25659196|NCT01605227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25659197|NCT01605227|Glucocorticoids|glucocorticoids|mesh-ancestor
25659198|NCT01605227|Hormones|hormones|mesh-ancestor
25659199|NCT01605227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25659200|NCT01605227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659201|NCT01605227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25659202|NCT01605227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659203|NCT01605396|Exemestane|exemestane|mesh-list
25659204|NCT01605396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659205|NCT01605396|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25659206|NCT01605396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25659207|NCT01605396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25659208|NCT01605396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659209|NCT01605396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25659210|NCT01605396|Hormone Antagonists|hormone antagonists|mesh-ancestor
25659211|NCT01605396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25659212|NCT01605396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659213|NCT01605539|Cannabidiol|cannabidiol|mesh-list
25659214|NCT01605539|Anticonvulsants|anticonvulsants|mesh-ancestor
25659215|NCT01605825|4-Aminopyridine|4-aminopyridine|mesh-list
25659216|NCT01605825|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24880304|NCT03874325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880305|NCT03874325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24880306|NCT03874325|Hormone Antagonists|hormone antagonists|mesh-ancestor
24880307|NCT03874325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24880308|NCT03874325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880309|NCT03874325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25056956|NCT03508713|Antirheumatic Agents|antirheumatic agents|mesh-list
25056958|NCT03508635|Cortisone|cortisone|mesh-list
25056959|NCT03508635|Mifepristone|mifepristone|mesh-list
25056960|NCT03508635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25056961|NCT03508635|Glucocorticoids|glucocorticoids|mesh-ancestor
25834966|NCT00016458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834967|NCT00016458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834968|NCT00016458|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25834969|NCT00016523|Nitric Oxide|nitric oxide|mesh-list
25834970|NCT00016523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25834971|NCT00016523|Autonomic Agents|autonomic agents|mesh-ancestor
25834972|NCT00016523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25834973|NCT00016523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834974|NCT00016523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25834975|NCT00016523|Respiratory System Agents|respiratory system agents|mesh-ancestor
25834976|NCT00016523|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25834977|NCT00016523|Antioxidants|antioxidants|mesh-ancestor
25834978|NCT00016523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834979|NCT00016523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25834980|NCT00016523|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25834981|NCT00016523|Vasodilator Agents|vasodilator agents|mesh-ancestor
25834982|NCT00016523|Gasotransmitters|gasotransmitters|mesh-ancestor
25834983|NCT00016523|Protective Agents|protective agents|mesh-ancestor
25834984|NCT00016549|Bevacizumab|bevacizumab|mesh-list
25834985|NCT00016549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25834986|NCT00016549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25834987|NCT00016549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25834988|NCT00016549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25834989|NCT00016549|Growth Substances|growth substances|mesh-ancestor
25834990|NCT00016549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25834991|NCT00016549|Growth Inhibitors|growth inhibitors|mesh-ancestor
25834992|NCT00016588|Tenofovir|tenofovir|mesh-list
25834993|NCT00016588|Antiviral Agents|antiviral agents|mesh-ancestor
25834994|NCT00016588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25834995|NCT00016588|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25834996|NCT00016588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25834997|NCT00016588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25834998|NCT00016588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25834999|NCT00016588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25835000|NCT00016588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25835001|NCT00016601|Ritonavir|ritonavir|mesh-list
25835002|NCT00016601|Nelfinavir|nelfinavir|mesh-list
24458741|NCT00339118|Cyclophosphamide|cyclophosphamide|mesh-list
24458742|NCT00339118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24458753|NCT00339118|Alkylating Agents|alkylating agents|mesh-ancestor
24458754|NCT00339118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24458755|NCT00339131|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24458756|NCT00339131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458757|NCT00339131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535180|NCT00648726|Cefuroxime|cefuroxime|mesh-list
25835003|NCT00016601|Indinavir|indinavir|mesh-list
25835004|NCT00016601|Nevirapine|nevirapine|mesh-list
25835005|NCT00016601|Efavirenz|efavirenz|mesh-list
25163171|NCT02898571|Protective Agents|protective agents|mesh-ancestor
25835006|NCT00016601|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25835007|NCT00016601|Medroxyprogesterone|medroxyprogesterone|mesh-list
25659217|NCT01605825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25659218|NCT01605825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659219|NCT01605890|Tenofovir|tenofovir|mesh-list
25659220|NCT01605890|Emtricitabine|emtricitabine|mesh-list
25659221|NCT01605890|Raltegravir Potassium|raltegravir potassium|mesh-list
25659222|NCT01605890|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25659223|NCT01605890|Antiviral Agents|antiviral agents|mesh-ancestor
25659224|NCT01605890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25659225|NCT01605890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25659226|NCT01605890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25659227|NCT01605890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25835008|NCT00016601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25835009|NCT00016601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24880478|NCT03654274|Contraceptive Agents|contraceptive agents|mesh-ancestor
24880479|NCT03654274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24880480|NCT03654274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24880481|NCT03654274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24880521|NCT03608358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24880522|NCT03605719|Dexamethasone|dexamethasone|mesh-list
24880523|NCT03605719|Nivolumab|nivolumab|mesh-list
24880524|NCT03605719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24880525|NCT03605719|Antiemetics|antiemetics|mesh-ancestor
24880526|NCT03605719|Autonomic Agents|autonomic agents|mesh-ancestor
24880527|NCT03605719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24880528|NCT03605719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880529|NCT03605719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25835010|NCT00016601|Protease Inhibitors|protease inhibitors|mesh-ancestor
25835011|NCT00016601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925456|NCT04149938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24458767|NCT00339196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458768|NCT00339196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458770|NCT00339196|Keratolytic Agents|keratolytic agents|mesh-ancestor
24458771|NCT00339196|Dermatologic Agents|dermatologic agents|mesh-ancestor
24458772|NCT00339196|Anticonvulsants|anticonvulsants|mesh-ancestor
24458773|NCT00339196|GABA Agents|gaba agents|mesh-ancestor
24458774|NCT00339196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24458775|NCT00339196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458776|NCT00339196|Antimanic Agents|antimanic agents|mesh-ancestor
24458777|NCT00339196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24458778|NCT00339196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24405998|NCT00169000|Docetaxel|docetaxel|mesh-list
25835012|NCT00016601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835013|NCT00016601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25835014|NCT00016601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25835015|NCT00016601|Antiviral Agents|antiviral agents|mesh-ancestor
25835016|NCT00016601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25835017|NCT00016601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25835018|NCT00016601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25835019|NCT00016601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25835020|NCT00016601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25835021|NCT00016601|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25835022|NCT00016601|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25835023|NCT00016601|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25835024|NCT00016601|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24640471|NCT01168440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835025|NCT00016601|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25835026|NCT00016601|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25835027|NCT00016601|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25835028|NCT00016601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25835029|NCT00016601|Contraceptive Agents|contraceptive agents|mesh-ancestor
25835030|NCT00016601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24450557|NCT00319566|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24450558|NCT00319566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24450559|NCT00319566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450561|NCT00319566|Hormones|hormones|mesh-ancestor
24450562|NCT00319566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24450563|NCT00319605|Levetiracetam|levetiracetam|mesh-list
24450564|NCT00319605|Anticonvulsants|anticonvulsants|mesh-ancestor
24458791|NCT00339417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458792|NCT00339417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659228|NCT01605890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659229|NCT01605890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25659230|NCT01605890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25659231|NCT01605890|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25659232|NCT01605890|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25659233|NCT01605903|Acetaminophen|acetaminophen|mesh-list
25659234|NCT01605903|Ibuprofen|ibuprofen|mesh-list
25659235|NCT01605903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25659236|NCT01605903|Analgesics|analgesics|mesh-ancestor
25659237|NCT01605903|Sensory System Agents|sensory system agents|mesh-ancestor
25659238|NCT01605903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25659239|NCT01605903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659240|NCT01605903|Antipyretics|antipyretics|mesh-ancestor
24458793|NCT00339586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24458794|NCT00339586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458795|NCT00339586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24880628|NCT03541902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880629|NCT03541902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24880630|NCT03541902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24880631|NCT03541902|Growth Substances|growth substances|mesh-ancestor
24880632|NCT03541902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880633|NCT03541902|Growth Inhibitors|growth inhibitors|mesh-ancestor
24458796|NCT00339586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458797|NCT00339586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458798|NCT00339768|Amoxicillin|amoxicillin|mesh-list
24458799|NCT00339768|Omeprazole|omeprazole|mesh-list
25835031|NCT00016601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835032|NCT00016601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25835033|NCT00016601|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25835034|NCT00016601|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25835035|NCT00016601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25835036|NCT00016601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835037|NCT00016666|Propranolol|propranolol|mesh-list
25835038|NCT00016666|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25835039|NCT00016666|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25835040|NCT00016666|Adrenergic Agents|adrenergic agents|mesh-ancestor
25835041|NCT00016666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25835042|NCT00016666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163172|NCT02898376|Tocopherols|tocopherols|mesh-list
25835043|NCT00016666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163173|NCT02898376|Vitamin E|vitamin e|mesh-list
25835044|NCT00016666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25835045|NCT00016666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25835046|NCT00016666|Vasodilator Agents|vasodilator agents|mesh-ancestor
25835047|NCT00016744|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25835048|NCT00016744|Genistein|genistein|mesh-list
25835049|NCT00016744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835050|NCT00016744|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24458806|NCT00339768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458807|NCT00340080|Abacavir|abacavir|mesh-list
24458808|NCT00340080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25835051|NCT00016744|Protective Agents|protective agents|mesh-ancestor
25835052|NCT00016744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835053|NCT00016744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25835054|NCT00016744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25835055|NCT00016744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835056|NCT00016744|Phytoestrogens|phytoestrogens|mesh-ancestor
25835057|NCT00016744|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25835058|NCT00016744|Estrogens|estrogens|mesh-ancestor
25835059|NCT00016744|Hormones|hormones|mesh-ancestor
24535260|NCT00648856|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24458811|NCT00340080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458813|NCT00340080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24458814|NCT00340080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24458815|NCT00340080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24458816|NCT00340184|Paclitaxel|paclitaxel|mesh-list
24458817|NCT00340184|Carboplatin|carboplatin|mesh-list
24640624|NCT01169389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640625|NCT01169389|Sensory System Agents|sensory system agents|mesh-ancestor
24640626|NCT01169389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24458818|NCT00340184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24458819|NCT00340184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458820|NCT00340184|Tubulin Modulators|tubulin modulators|mesh-ancestor
24458821|NCT00340184|Antimitotic Agents|antimitotic agents|mesh-ancestor
24458822|NCT00340184|Mitosis Modulators|mitosis modulators|mesh-ancestor
24458823|NCT00340184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458824|NCT00340314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
24458825|NCT00340574|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24458826|NCT00340574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24458844|NCT00341250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25835060|NCT00016744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25835061|NCT00016835|Metronidazole|metronidazole|mesh-list
25835062|NCT00016835|Doxycycline|doxycycline|mesh-list
25835063|NCT00016835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25659241|NCT01605903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25659242|NCT01605903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25659243|NCT01605903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25659244|NCT01605903|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25659245|NCT01605903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674594|NCT01774305|Adrenergic Agents|adrenergic agents|mesh-ancestor
25835064|NCT00016835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25835065|NCT00016835|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25835066|NCT00016835|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25835067|NCT00016835|Antimalarials|antimalarials|mesh-ancestor
25875396|NCT04377308|Antidepressive Agents|antidepressive agents|mesh-ancestor
25875397|NCT04377308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25659246|NCT01605903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056987|NCT03508440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25875398|NCT04377308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25875399|NCT04377308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25875400|NCT04377308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875401|NCT04370795|Sirolimus|sirolimus|mesh-list
25875402|NCT04370795|Busulfan|busulfan|mesh-list
25875403|NCT04370795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24880742|NCT03398135|Immunologic Factors|immunologic factors|mesh-ancestor
25029295|NCT03603418|Dexamethasone acetate|dexamethasone acetate|mesh-list
24880757|NCT03395314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24880758|NCT03395314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880759|NCT03395314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24880760|NCT03395314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24880761|NCT03395314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25875404|NCT04370795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25875405|NCT04370795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24458859|NCT00341432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407575|NCT00174720|Hormones|hormones|mesh-ancestor
24458860|NCT00342381|Amifampridine|amifampridine|mesh-list
24458861|NCT00342381|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24458862|NCT00342381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24458863|NCT00342381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535308|NCT00648973|Promethazine|promethazine|mesh-list
25875406|NCT04370795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875407|NCT04370795|Antifungal Agents|antifungal agents|mesh-ancestor
25875408|NCT04370795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25875409|NCT04370795|Immunologic Factors|immunologic factors|mesh-ancestor
24458878|NCT00343005|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24458879|NCT00343005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24458880|NCT00343005|Immunologic Factors|immunologic factors|mesh-ancestor
24458881|NCT00343005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458882|NCT00343005|Antacids|antacids|mesh-ancestor
24458883|NCT00343005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458884|NCT00343005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24458885|NCT00343070|Citalopram|citalopram|mesh-list
24458886|NCT00343070|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25875410|NCT04370795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875411|NCT04370795|Alkylating Agents|alkylating agents|mesh-ancestor
25148894|NCT04414475|Dexamethasone|dexamethasone|mesh-list
25875412|NCT04370795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875413|NCT04370795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25875414|NCT04370795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25875415|NCT04352166|Buprenorphine|buprenorphine|mesh-list
25875416|NCT04352166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25875417|NCT04352166|Narcotics|narcotics|mesh-ancestor
25875418|NCT04352166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25875419|NCT04352166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875420|NCT04352166|Analgesics|analgesics|mesh-ancestor
25875421|NCT04352166|Sensory System Agents|sensory system agents|mesh-ancestor
25875422|NCT04352166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25875423|NCT04352166|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25875424|NCT04339751|Vorinostat|vorinostat|mesh-list
24458917|NCT00343135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446798|NCT00306020|Narcotics|narcotics|mesh-ancestor
24406210|NCT00169247|Cetuximab|cetuximab|mesh-list
25659247|NCT01605942|Dexamethasone|dexamethasone|mesh-list
25659248|NCT01605942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25659249|NCT01605942|Antiemetics|antiemetics|mesh-ancestor
25659250|NCT01605942|Autonomic Agents|autonomic agents|mesh-ancestor
25659251|NCT01605942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25659252|NCT01605942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659253|NCT01605942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25659254|NCT01605942|Glucocorticoids|glucocorticoids|mesh-ancestor
25659255|NCT01605942|Hormones|hormones|mesh-ancestor
25659256|NCT01605942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25659257|NCT01605942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25659258|NCT01605942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659259|NCT01606007|Metformin|metformin|mesh-list
25659260|NCT01606007|Dapagliflozin|dapagliflozin|mesh-list
25835068|NCT00016861|Irinotecan|irinotecan|mesh-list
25835069|NCT00016861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25835070|NCT00016861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25835071|NCT00016861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25835072|NCT00016861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835073|NCT00016861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835074|NCT00016874|Paclitaxel|paclitaxel|mesh-list
25835075|NCT00016874|Cisplatin|cisplatin|mesh-list
25835076|NCT00016874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25835077|NCT00016874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835078|NCT00016874|Tubulin Modulators|tubulin modulators|mesh-ancestor
25835079|NCT00016874|Antimitotic Agents|antimitotic agents|mesh-ancestor
25835080|NCT00016874|Mitosis Modulators|mitosis modulators|mesh-ancestor
25835081|NCT00016874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835082|NCT00016887|Interferons|interferons|mesh-list
25835083|NCT00016887|Cytarabine|cytarabine|mesh-list
25835084|NCT00016887|Interferon-alpha|interferon-alpha|mesh-list
25835085|NCT00016887|Dexamethasone|dexamethasone|mesh-list
25835086|NCT00016887|Cyclophosphamide|cyclophosphamide|mesh-list
25835087|NCT00016887|Melphalan|melphalan|mesh-list
25835088|NCT00016887|Carmustine|carmustine|mesh-list
25835089|NCT00016887|Etoposide|etoposide|mesh-list
25835090|NCT00016887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25835091|NCT00016887|Immunologic Factors|immunologic factors|mesh-ancestor
24458920|NCT00343135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458922|NCT00343161|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24458923|NCT00343161|Magnesium trisilicate|magnesium trisilicate|mesh-list
24458924|NCT00343161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25148943|NCT04356326|Antipyretics|antipyretics|mesh-ancestor
25835092|NCT00016887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835093|NCT00016887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25835094|NCT00016887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25835095|NCT00016887|Alkylating Agents|alkylating agents|mesh-ancestor
25835096|NCT00016887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835097|NCT00016887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835098|NCT00016887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25835099|NCT00016887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25835100|NCT00016887|Antiemetics|antiemetics|mesh-ancestor
25835101|NCT00016887|Autonomic Agents|autonomic agents|mesh-ancestor
25835102|NCT00016887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25835103|NCT00016887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25835104|NCT00016887|Glucocorticoids|glucocorticoids|mesh-ancestor
25835105|NCT00016887|Hormones|hormones|mesh-ancestor
25835106|NCT00016887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25835107|NCT00016887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25835108|NCT00016887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25835109|NCT00016887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25835110|NCT00016887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25835111|NCT00016887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925902|NCT04146376|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25835112|NCT00016887|Antiviral Agents|antiviral agents|mesh-ancestor
25835113|NCT00016887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25835114|NCT00016887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25835115|NCT00016887|Antimetabolites|antimetabolites|mesh-ancestor
25835116|NCT00016900|Paclitaxel|paclitaxel|mesh-list
25835117|NCT00016900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25835118|NCT00016900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835119|NCT00016900|Tubulin Modulators|tubulin modulators|mesh-ancestor
25835120|NCT00016900|Antimitotic Agents|antimitotic agents|mesh-ancestor
25835121|NCT00016900|Mitosis Modulators|mitosis modulators|mesh-ancestor
25835122|NCT00016900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835123|NCT00016926|Capecitabine|capecitabine|mesh-list
25835124|NCT00016926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25835125|NCT00016926|Antimetabolites|antimetabolites|mesh-ancestor
25835126|NCT00016926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835127|NCT00016926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835128|NCT00016939|Alvocidib|alvocidib|mesh-list
25835129|NCT00016939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835130|NCT00016939|Growth Inhibitors|growth inhibitors|mesh-ancestor
25835131|NCT00016939|Growth Substances|growth substances|mesh-ancestor
25835132|NCT00016939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835133|NCT00016939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25835134|NCT00016939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25835135|NCT00016939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835136|NCT00016952|Leucovorin|leucovorin|mesh-list
25835137|NCT00016952|Fluorouracil|fluorouracil|mesh-list
25835138|NCT00016952|Irinotecan|irinotecan|mesh-list
24880980|NCT03173053|Rifampin|rifampin|mesh-list
24450321|NCT00318760|Sympatholytics|sympatholytics|mesh-ancestor
25835139|NCT00016952|Calcium|calcium|mesh-list
25835140|NCT00016952|Levoleucovorin|levoleucovorin|mesh-list
25835141|NCT00016952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25835142|NCT00016952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835143|NCT00016952|Antimetabolites|antimetabolites|mesh-ancestor
25835144|NCT00016952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458965|NCT00343239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458966|NCT00343239|Antimetabolites|antimetabolites|mesh-ancestor
24458967|NCT00343239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24458968|NCT00343239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24458969|NCT00343239|Immunologic Factors|immunologic factors|mesh-ancestor
24535585|NCT00649402|Vasodilator Agents|vasodilator agents|mesh-ancestor
25835145|NCT00016952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25835146|NCT00016952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835147|NCT00016952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25835148|NCT00016952|Immunologic Factors|immunologic factors|mesh-ancestor
25835149|NCT00016952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25835150|NCT00016952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25835151|NCT00016952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25835152|NCT00016952|Antidotes|antidotes|mesh-ancestor
25835153|NCT00016952|Protective Agents|protective agents|mesh-ancestor
25835154|NCT00016952|Vitamin B Complex|vitamin b complex|mesh-ancestor
25835155|NCT00016952|Vitamins|vitamins|mesh-ancestor
25835156|NCT00016952|Micronutrients|micronutrients|mesh-ancestor
25835157|NCT00016978|Leucovorin|leucovorin|mesh-list
25835158|NCT00016978|Fluorouracil|fluorouracil|mesh-list
25835159|NCT00016978|Oxaliplatin|oxaliplatin|mesh-list
25835160|NCT00016978|Calcium|calcium|mesh-list
25835161|NCT00016978|Levoleucovorin|levoleucovorin|mesh-list
25835162|NCT00016978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25835163|NCT00016978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835164|NCT00016978|Antimetabolites|antimetabolites|mesh-ancestor
25835165|NCT00016978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835166|NCT00016978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25835167|NCT00016978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835168|NCT00016978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25835169|NCT00016978|Immunologic Factors|immunologic factors|mesh-ancestor
25835170|NCT00016978|Antidotes|antidotes|mesh-ancestor
25835171|NCT00016978|Protective Agents|protective agents|mesh-ancestor
25835172|NCT00016978|Vitamin B Complex|vitamin b complex|mesh-ancestor
25835173|NCT00016978|Vitamins|vitamins|mesh-ancestor
25835174|NCT00016978|Micronutrients|micronutrients|mesh-ancestor
25835175|NCT00016991|Gefitinib|gefitinib|mesh-list
25835176|NCT00016991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835177|NCT00016991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25835178|NCT00016991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25835179|NCT00016991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835180|NCT00017004|Cisplatin|cisplatin|mesh-list
25835181|NCT00017004|Epoetin Alfa|epoetin alfa|mesh-list
24535605|NCT00649441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25835182|NCT00017004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835183|NCT00017004|Hematinics|hematinics|mesh-ancestor
25835184|NCT00017017|Paclitaxel|paclitaxel|mesh-list
25835185|NCT00017017|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
25835186|NCT00017017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25835187|NCT00017017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835188|NCT00017017|Tubulin Modulators|tubulin modulators|mesh-ancestor
25835189|NCT00017017|Antimitotic Agents|antimitotic agents|mesh-ancestor
25835190|NCT00017017|Mitosis Modulators|mitosis modulators|mesh-ancestor
25835191|NCT00017017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835192|NCT00017030|Trabectedin|trabectedin|mesh-list
25835193|NCT00017030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25835194|NCT00017030|Alkylating Agents|alkylating agents|mesh-ancestor
25835195|NCT00017030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835196|NCT00017030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458981|NCT00343317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25835197|NCT00017069|Dexamethasone|dexamethasone|mesh-list
25835198|NCT00017069|Arsenic Trioxide|arsenic trioxide|mesh-list
25835199|NCT00017069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25835200|NCT00017069|Antiemetics|antiemetics|mesh-ancestor
25835201|NCT00017069|Autonomic Agents|autonomic agents|mesh-ancestor
25835202|NCT00017069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25659261|NCT01606007|Saxagliptin|saxagliptin|mesh-list
25659262|NCT01606007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25835203|NCT00017069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835204|NCT00017069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24881064|NCT03104842|Growth Substances|growth substances|mesh-ancestor
24881065|NCT03104842|Growth Inhibitors|growth inhibitors|mesh-ancestor
24881066|NCT03101475|Durvalumab|durvalumab|mesh-list
24881081|NCT03083405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24881089|NCT03069638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25835205|NCT00017069|Glucocorticoids|glucocorticoids|mesh-ancestor
25835206|NCT00017069|Hormones|hormones|mesh-ancestor
25835207|NCT00017069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25835208|NCT00017069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25835209|NCT00017069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835210|NCT00017082|Oxaliplatin|oxaliplatin|mesh-list
25835211|NCT00017082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835212|NCT00017095|Cyclophosphamide|cyclophosphamide|mesh-list
25835213|NCT00017095|Docetaxel|docetaxel|mesh-list
25835214|NCT00017095|Fluorouracil|fluorouracil|mesh-list
25835215|NCT00017095|Epirubicin|epirubicin|mesh-list
25835216|NCT00017095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24450327|NCT00318760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24450328|NCT00318760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450329|NCT00318773|Sertraline|sertraline|mesh-list
24450330|NCT00318773|Antidepressive Agents|antidepressive agents|mesh-ancestor
24450331|NCT00318773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24450332|NCT00318773|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24450333|NCT00318773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24450334|NCT00318773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24535663|NCT00649532|Dermatologic Agents|dermatologic agents|mesh-ancestor
25835217|NCT00017095|Immunologic Factors|immunologic factors|mesh-ancestor
25835218|NCT00017095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835219|NCT00017095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25835220|NCT00017095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25835221|NCT00017095|Alkylating Agents|alkylating agents|mesh-ancestor
25835222|NCT00017095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835223|NCT00017095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450335|NCT00318773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450337|NCT00318773|Serotonin Agents|serotonin agents|mesh-ancestor
24450338|NCT00318773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450339|NCT00318786|Insulin Aspart|insulin aspart|mesh-list
24450340|NCT00318786|Biphasic Insulins|biphasic insulins|mesh-list
24450341|NCT00318786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24450342|NCT00318786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835224|NCT00017095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25835225|NCT00017095|Tubulin Modulators|tubulin modulators|mesh-ancestor
25835226|NCT00017095|Antimitotic Agents|antimitotic agents|mesh-ancestor
25835227|NCT00017095|Mitosis Modulators|mitosis modulators|mesh-ancestor
24459034|NCT00343408|Fluorouracil|fluorouracil|mesh-list
24459035|NCT00343408|Oxaliplatin|oxaliplatin|mesh-list
24459038|NCT00343408|Levoleucovorin|levoleucovorin|mesh-list
24459039|NCT00343408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459040|NCT00343408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24459041|NCT00343408|Antimetabolites|antimetabolites|mesh-ancestor
24459042|NCT00343408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459043|NCT00343408|Antiviral Agents|antiviral agents|mesh-ancestor
25835228|NCT00017095|Antimetabolites|antimetabolites|mesh-ancestor
25835229|NCT00017095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25835230|NCT00017095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25835231|NCT00017095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25835232|NCT00017095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25835233|NCT00017095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25835234|NCT00017108|Cyclophosphamide|cyclophosphamide|mesh-list
25835235|NCT00017108|Chlorambucil|chlorambucil|mesh-list
25835236|NCT00017108|Fludarabine|fludarabine|mesh-list
25835237|NCT00017108|Fludarabine phosphate|fludarabine phosphate|mesh-list
25835238|NCT00017108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25835239|NCT00017108|Immunologic Factors|immunologic factors|mesh-ancestor
25835240|NCT00017108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835241|NCT00017108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25835242|NCT00017108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25835243|NCT00017108|Alkylating Agents|alkylating agents|mesh-ancestor
24459049|NCT00343408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25659263|NCT01606007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659264|NCT01606007|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25659265|NCT01606007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659266|NCT01606007|Incretins|incretins|mesh-ancestor
25659267|NCT01606007|Hormones|hormones|mesh-ancestor
25659268|NCT01606007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25835244|NCT00017108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835245|NCT00017108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835246|NCT00017108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25835247|NCT00017108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25835248|NCT00017108|Antimetabolites|antimetabolites|mesh-ancestor
25835249|NCT00017121|Sargramostim|sargramostim|mesh-list
25835250|NCT00017121|Immunologic Factors|immunologic factors|mesh-ancestor
25163174|NCT02898376|Tocotrienols|tocotrienols|mesh-list
25835251|NCT00017121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835252|NCT00017134|Fenretinide|fenretinide|mesh-list
25835253|NCT00017134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835254|NCT00017134|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25835255|NCT00017134|Protective Agents|protective agents|mesh-ancestor
25835256|NCT00017134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835257|NCT00017147|Carmustine|carmustine|mesh-list
25835258|NCT00017147|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
25835259|NCT00017147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25835260|NCT00017147|Alkylating Agents|alkylating agents|mesh-ancestor
25835261|NCT00017147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835262|NCT00017147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835263|NCT00017147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25835264|NCT00017160|Doxorubicin|doxorubicin|mesh-list
25835265|NCT00017160|Ifosfamide|ifosfamide|mesh-list
25835266|NCT00017160|Immunologic Factors|immunologic factors|mesh-list
25835267|NCT00017160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25835268|NCT00017160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835269|NCT00017160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25835270|NCT00017160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25835271|NCT00017160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25835272|NCT00017160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835273|NCT00017160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835274|NCT00017160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25835275|NCT00017160|Alkylating Agents|alkylating agents|mesh-ancestor
25835276|NCT00017173|Cisplatin|cisplatin|mesh-list
25835277|NCT00017173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835278|NCT00017186|Gemcitabine|gemcitabine|mesh-list
25835279|NCT00017186|Epirubicin|epirubicin|mesh-list
25835280|NCT00017186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25835281|NCT00017186|Antimetabolites|antimetabolites|mesh-ancestor
25835282|NCT00017186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835283|NCT00017186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835284|NCT00017186|Antiviral Agents|antiviral agents|mesh-ancestor
25835285|NCT00017186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25835286|NCT00017186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25835287|NCT00017186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25835288|NCT00017186|Immunologic Factors|immunologic factors|mesh-ancestor
25835289|NCT00017186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835290|NCT00017186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25835291|NCT00017186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25835292|NCT00017186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25835293|NCT00017199|Bortezomib|bortezomib|mesh-list
25835294|NCT00017199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835295|NCT00017212|Exatecan|exatecan|mesh-list
25835296|NCT00017212|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25835297|NCT00017212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25835298|NCT00017212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25835299|NCT00017212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835300|NCT00017212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835301|NCT00017225|Cyclophosphamide|cyclophosphamide|mesh-list
25835302|NCT00017225|Melphalan|melphalan|mesh-list
25835303|NCT00017225|Ifosfamide|ifosfamide|mesh-list
25835304|NCT00017225|Dacarbazine|dacarbazine|mesh-list
25835305|NCT00017225|Carboplatin|carboplatin|mesh-list
25835306|NCT00017225|Doxorubicin|doxorubicin|mesh-list
25835307|NCT00017225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25835308|NCT00017225|Etoposide|etoposide|mesh-list
25835309|NCT00017225|Vincristine|vincristine|mesh-list
25835310|NCT00017225|Tretinoin|tretinoin|mesh-list
25835311|NCT00017225|Vindesine|vindesine|mesh-list
25835312|NCT00017225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24450607|NCT00319800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450608|NCT00319800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450609|NCT00319800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659269|NCT01606007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25659270|NCT01606007|Protease Inhibitors|protease inhibitors|mesh-ancestor
25835313|NCT00017225|Immunologic Factors|immunologic factors|mesh-ancestor
25414111|NCT03085914|Vitamin B Complex|vitamin b complex|mesh-ancestor
25835314|NCT00017225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835316|NCT00017225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25835317|NCT00017225|Alkylating Agents|alkylating agents|mesh-ancestor
25835318|NCT00017225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835319|NCT00017225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835320|NCT00017225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24881171|NCT02948660|GABA Agents|gaba agents|mesh-ancestor
25029793|NCT03600727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24881197|NCT02935309|Capecitabine|capecitabine|mesh-list
25835321|NCT00017225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25835322|NCT00017225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24450610|NCT00319800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24450612|NCT00319852|Immunologic Factors|immunologic factors|mesh-ancestor
24450613|NCT00319852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450621|NCT00319865|Autonomic Agents|autonomic agents|mesh-ancestor
24450622|NCT00319865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24450623|NCT00319865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450624|NCT00319865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25835323|NCT00017225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25835324|NCT00017225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25835325|NCT00017225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25835326|NCT00017225|Tubulin Modulators|tubulin modulators|mesh-ancestor
25835327|NCT00017225|Antimitotic Agents|antimitotic agents|mesh-ancestor
25835328|NCT00017225|Mitosis Modulators|mitosis modulators|mesh-ancestor
25835329|NCT00017225|Keratolytic Agents|keratolytic agents|mesh-ancestor
25835330|NCT00017225|Dermatologic Agents|dermatologic agents|mesh-ancestor
25835331|NCT00017238|KRN 5500|krn 5500|mesh-list
25835332|NCT00017238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835333|NCT00017238|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25835334|NCT00017238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25835335|NCT00017238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835336|NCT00017251|Carboplatin|carboplatin|mesh-list
25835337|NCT00017251|Etoposide|etoposide|mesh-list
25835338|NCT00017251|Etoposide phosphate|etoposide phosphate|mesh-list
25835339|NCT00017251|Oblimersen|oblimersen|mesh-list
25835340|NCT00017251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459114|NCT00343668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459115|NCT00343707|Paroxetine|paroxetine|mesh-list
25835341|NCT00017251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25835342|NCT00017251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25835343|NCT00017251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25835344|NCT00017251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25835345|NCT00017251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835346|NCT00017264|Atrasentan|atrasentan|mesh-list
25835347|NCT00017264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835348|NCT00017264|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25835349|NCT00017264|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25835350|NCT00017264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835351|NCT00017277|Epoetin Alfa|epoetin alfa|mesh-list
25835352|NCT00017277|Hematinics|hematinics|mesh-ancestor
25835353|NCT00017290|Prednisone|prednisone|mesh-list
25835354|NCT00017290|Cyclophosphamide|cyclophosphamide|mesh-list
25835355|NCT00017290|Vincristine|vincristine|mesh-list
25835356|NCT00017290|Immunoglobulins|immunoglobulins|mesh-list
24459123|NCT00343707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459124|NCT00343707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24459125|NCT00343707|Antidepressive Agents|antidepressive agents|mesh-ancestor
24459131|NCT00343720|Bortezomib|bortezomib|mesh-list
24459162|NCT00343798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459163|NCT00343798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459164|NCT00343798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24459165|NCT00343798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24459166|NCT00343798|Antimetabolites|antimetabolites|mesh-ancestor
24459167|NCT00343798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25835357|NCT00017290|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25835358|NCT00017290|Antibodies|antibodies|mesh-list
25835359|NCT00017290|Sargramostim|sargramostim|mesh-list
25835360|NCT00017290|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
25414112|NCT03085914|Vitamins|vitamins|mesh-ancestor
25659271|NCT01606007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25659272|NCT01606124|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
25659273|NCT01606124|Antioxidants|antioxidants|mesh-ancestor
25659274|NCT01606124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659275|NCT01606124|Protective Agents|protective agents|mesh-ancestor
25659276|NCT01606124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835361|NCT00017290|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
25835362|NCT00017290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25835364|NCT00017290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835365|NCT00017290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25835366|NCT00017290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25659277|NCT01606124|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25659278|NCT01606124|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24888968|NCT04499209|Naproxen|naproxen|mesh-list
25659279|NCT01606124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835367|NCT00017290|Alkylating Agents|alkylating agents|mesh-ancestor
25835368|NCT00017290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835369|NCT00017290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835370|NCT00017290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25835371|NCT00017290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25835372|NCT00017290|Glucocorticoids|glucocorticoids|mesh-ancestor
24430438|NCT00247715|Pantoprazole|pantoprazole|mesh-list
25835373|NCT00017290|Hormones|hormones|mesh-ancestor
25835374|NCT00017290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25835375|NCT00017290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25835376|NCT00017290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25835377|NCT00017290|Tubulin Modulators|tubulin modulators|mesh-ancestor
25835378|NCT00017290|Antimitotic Agents|antimitotic agents|mesh-ancestor
25835379|NCT00017290|Mitosis Modulators|mitosis modulators|mesh-ancestor
25835380|NCT00017290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25835381|NCT00017303|Paclitaxel|paclitaxel|mesh-list
25835382|NCT00017303|Carboplatin|carboplatin|mesh-list
25835383|NCT00017303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25835384|NCT00017303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835385|NCT00017303|Tubulin Modulators|tubulin modulators|mesh-ancestor
25835386|NCT00017303|Antimitotic Agents|antimitotic agents|mesh-ancestor
25835387|NCT00017303|Mitosis Modulators|mitosis modulators|mesh-ancestor
25835388|NCT00017303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835389|NCT00017316|Thalidomide|thalidomide|mesh-list
25835390|NCT00017316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25835391|NCT00017316|Immunologic Factors|immunologic factors|mesh-ancestor
25835392|NCT00017316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149292|NCT03165721|Guadecitabine|guadecitabine|mesh-list
25835393|NCT00017316|Leprostatic Agents|leprostatic agents|mesh-ancestor
24459196|NCT00343876|Clopidogrel|clopidogrel|mesh-list
24459197|NCT00343876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24459198|NCT00343876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24459199|NCT00343876|Analgesics|analgesics|mesh-ancestor
24459200|NCT00343876|Sensory System Agents|sensory system agents|mesh-ancestor
24459201|NCT00343876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24459202|NCT00343876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835394|NCT00017316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25835395|NCT00017316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25835396|NCT00017316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25835397|NCT00017316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25835398|NCT00017316|Growth Substances|growth substances|mesh-ancestor
25835399|NCT00017316|Growth Inhibitors|growth inhibitors|mesh-ancestor
25835400|NCT00017316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835401|NCT00017329|Bortezomib|bortezomib|mesh-list
25835402|NCT00017329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835403|NCT00017342|Cytarabine|cytarabine|mesh-list
25835404|NCT00017342|Bryostatin 1|bryostatin 1|mesh-list
25835405|NCT00017342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25835406|NCT00017342|Antimetabolites|antimetabolites|mesh-ancestor
25835407|NCT00017342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835408|NCT00017342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835409|NCT00017342|Antiviral Agents|antiviral agents|mesh-ancestor
24459203|NCT00343876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24459204|NCT00343876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24459205|NCT00343876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24459206|NCT00343876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24459207|NCT00343876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25414113|NCT03085914|Micronutrients|micronutrients|mesh-ancestor
25659280|NCT01606124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25659281|NCT01606137|Nabiximols|nabiximols|mesh-list
25659282|NCT01606137|Analgesics|analgesics|mesh-ancestor
25659283|NCT01606137|Sensory System Agents|sensory system agents|mesh-ancestor
25659284|NCT01606137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25659285|NCT01606137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674297|NCT01769586|Sensory System Agents|sensory system agents|mesh-ancestor
25835410|NCT00017342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25835411|NCT00017342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25835412|NCT00017342|Immunologic Factors|immunologic factors|mesh-ancestor
25659286|NCT01606176|Nabiximols|nabiximols|mesh-list
25659287|NCT01606176|Analgesics|analgesics|mesh-ancestor
25659288|NCT01606176|Sensory System Agents|sensory system agents|mesh-ancestor
25659289|NCT01606176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25835413|NCT00017342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881293|NCT02774239|Antibodies|antibodies|mesh-list
24881294|NCT02774239|Immunoglobulin G|immunoglobulin g|mesh-list
25835414|NCT00017342|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25835415|NCT00017355|Lenograstim|lenograstim|mesh-list
25835416|NCT00017355|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25835417|NCT00017355|Immunologic Factors|immunologic factors|mesh-ancestor
25163175|NCT02898376|alpha-Tocopherol|alpha-tocopherol|mesh-list
25163176|NCT02898376|Pentoxifylline|pentoxifylline|mesh-list
25163177|NCT02898376|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25163179|NCT02898376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163181|NCT02898376|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25835418|NCT00017355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835419|NCT00017368|Cyclophosphamide|cyclophosphamide|mesh-list
25835420|NCT00017368|Melphalan|melphalan|mesh-list
25835421|NCT00017368|Ifosfamide|ifosfamide|mesh-list
25835422|NCT00017368|Thiotepa|thiotepa|mesh-list
25835423|NCT00017368|Carboplatin|carboplatin|mesh-list
25835424|NCT00017368|Doxorubicin|doxorubicin|mesh-list
25835425|NCT00017368|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25835426|NCT00017368|Etoposide|etoposide|mesh-list
25835427|NCT00017368|Etoposide phosphate|etoposide phosphate|mesh-list
25835428|NCT00017368|Vincristine|vincristine|mesh-list
24536107|NCT00650364|Midodrine|midodrine|mesh-list
25835429|NCT00017368|Isotretinoin|isotretinoin|mesh-list
25835430|NCT00017368|Sargramostim|sargramostim|mesh-list
25835431|NCT00017368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25835432|NCT00017368|Immunologic Factors|immunologic factors|mesh-ancestor
25835433|NCT00017368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835434|NCT00017368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25835435|NCT00017368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25835436|NCT00017368|Alkylating Agents|alkylating agents|mesh-ancestor
25835437|NCT00017368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459215|NCT00343876|Purinergic Agents|purinergic agents|mesh-ancestor
24459216|NCT00343876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24459218|NCT00343980|Glimepiride|glimepiride|mesh-list
24459219|NCT00343980|Rosiglitazone|rosiglitazone|mesh-list
24459220|NCT00343980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24459221|NCT00343980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24459222|NCT00343980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459223|NCT00343980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24459224|NCT00343980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24459225|NCT00343980|Immunologic Factors|immunologic factors|mesh-ancestor
25835438|NCT00017368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835439|NCT00017368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25835440|NCT00017368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25835441|NCT00017368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25835442|NCT00017368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25835443|NCT00017368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25835444|NCT00017368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25835445|NCT00017368|Tubulin Modulators|tubulin modulators|mesh-ancestor
25835446|NCT00017368|Antimitotic Agents|antimitotic agents|mesh-ancestor
25835447|NCT00017368|Mitosis Modulators|mitosis modulators|mesh-ancestor
25835448|NCT00017368|Dermatologic Agents|dermatologic agents|mesh-ancestor
24459226|NCT00344006|Artesunate|artesunate|mesh-list
24459227|NCT00344006|Lumefantrine|lumefantrine|mesh-list
24459228|NCT00344006|Artemether|artemether|mesh-list
24459229|NCT00344006|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24459230|NCT00344006|Dapsone|dapsone|mesh-list
24459231|NCT00344006|Chlorproguanil|chlorproguanil|mesh-list
24459232|NCT00344006|Proguanil|proguanil|mesh-list
24459233|NCT00344006|Antimalarials|antimalarials|mesh-ancestor
24459234|NCT00344006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24459235|NCT00344006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24459236|NCT00344006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25659290|NCT01606176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659291|NCT01606189|Nabiximols|nabiximols|mesh-list
25659292|NCT01606189|Analgesics|analgesics|mesh-ancestor
25659293|NCT01606189|Sensory System Agents|sensory system agents|mesh-ancestor
25659294|NCT01606189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25659295|NCT01606189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835449|NCT00017381|Cyclophosphamide|cyclophosphamide|mesh-list
24459237|NCT00344006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459238|NCT00344006|Antiviral Agents|antiviral agents|mesh-ancestor
25659298|NCT01606202|Sensory System Agents|sensory system agents|mesh-ancestor
24881368|NCT02576574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881369|NCT02576574|Tubulin Modulators|tubulin modulators|mesh-ancestor
24881370|NCT02576574|Antimitotic Agents|antimitotic agents|mesh-ancestor
24881371|NCT02576574|Mitosis Modulators|mitosis modulators|mesh-ancestor
24459239|NCT00344006|Schistosomicides|schistosomicides|mesh-ancestor
24459240|NCT00344006|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24459241|NCT00344006|Anthelmintics|anthelmintics|mesh-ancestor
25835450|NCT00017381|Rituximab|rituximab|mesh-list
25835451|NCT00017381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25835452|NCT00017381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25835453|NCT00017381|Immunologic Factors|immunologic factors|mesh-ancestor
25835454|NCT00017381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835455|NCT00017381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25835456|NCT00017381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25835457|NCT00017381|Alkylating Agents|alkylating agents|mesh-ancestor
25835458|NCT00017381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835459|NCT00017381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835460|NCT00017381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25835461|NCT00017381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25163182|NCT02898376|Protective Agents|protective agents|mesh-ancestor
25835462|NCT00017394|Bevacizumab|bevacizumab|mesh-list
25835463|NCT00017394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25835464|NCT00017394|Vinorelbine|vinorelbine|mesh-list
25835465|NCT00017394|Antibodies|antibodies|mesh-list
25835466|NCT00017394|Immunoglobulins|immunoglobulins|mesh-list
25835467|NCT00017394|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25835468|NCT00017394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835469|NCT00017394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25835470|NCT00017394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25835471|NCT00017394|Growth Substances|growth substances|mesh-ancestor
25835472|NCT00017394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835473|NCT00017394|Growth Inhibitors|growth inhibitors|mesh-ancestor
25835474|NCT00017394|Immunologic Factors|immunologic factors|mesh-ancestor
25835475|NCT00017394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25835476|NCT00017394|Tubulin Modulators|tubulin modulators|mesh-ancestor
25835477|NCT00017394|Antimitotic Agents|antimitotic agents|mesh-ancestor
25835478|NCT00017394|Mitosis Modulators|mitosis modulators|mesh-ancestor
25835479|NCT00017394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835480|NCT00017407|Paclitaxel|paclitaxel|mesh-list
25835481|NCT00017407|Carboplatin|carboplatin|mesh-list
25835482|NCT00017407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25835483|NCT00017407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835484|NCT00017407|Tubulin Modulators|tubulin modulators|mesh-ancestor
25835485|NCT00017407|Antimitotic Agents|antimitotic agents|mesh-ancestor
24459242|NCT00344006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24459243|NCT00344006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25835486|NCT00017407|Mitosis Modulators|mitosis modulators|mesh-ancestor
25835487|NCT00017407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835488|NCT00017433|Arsenic Trioxide|arsenic trioxide|mesh-list
25835489|NCT00017433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450634|NCT00319865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450635|NCT00319865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24450636|NCT00319865|Immunologic Factors|immunologic factors|mesh-ancestor
24450637|NCT00319865|Leprostatic Agents|leprostatic agents|mesh-ancestor
24450638|NCT00319865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24450639|NCT00319865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24450646|NCT00319878|Cyclosporins|cyclosporins|mesh-list
24450647|NCT00319878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450648|NCT00319878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450649|NCT00319878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25835490|NCT00017459|Cisplatin|cisplatin|mesh-list
25835491|NCT00017459|Vinorelbine|vinorelbine|mesh-list
25835492|NCT00017459|Tirapazamine|tirapazamine|mesh-list
25835493|NCT00017459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835494|NCT00017459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25835495|NCT00017459|Tubulin Modulators|tubulin modulators|mesh-ancestor
25659299|NCT01606202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25659300|NCT01606202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659301|NCT01606228|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25659302|NCT01606228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25659303|NCT01606228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25835496|NCT00017459|Antimitotic Agents|antimitotic agents|mesh-ancestor
24881440|NCT02367456|Azacitidine|azacitidine|mesh-list
24881441|NCT02367456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25659304|NCT01606228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25835497|NCT00017459|Mitosis Modulators|mitosis modulators|mesh-ancestor
25835498|NCT00017459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835499|NCT00017472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25835500|NCT00017472|Antibodies|antibodies|mesh-list
25835501|NCT00017472|Immunoglobulins|immunoglobulins|mesh-list
25835502|NCT00017472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25835503|NCT00017472|Immunologic Factors|immunologic factors|mesh-ancestor
25835504|NCT00017472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835505|NCT00017472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835506|NCT00017498|Gemcitabine|gemcitabine|mesh-list
25835507|NCT00017498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25835508|NCT00017498|Antimetabolites|antimetabolites|mesh-ancestor
25835509|NCT00017498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835510|NCT00017498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835511|NCT00017498|Antiviral Agents|antiviral agents|mesh-ancestor
25835512|NCT00017498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25835513|NCT00017498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25835514|NCT00017498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25835515|NCT00017498|Immunologic Factors|immunologic factors|mesh-ancestor
25835516|NCT00017498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643280|NCT01184911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25835517|NCT00017511|Cevimeline|cevimeline|mesh-list
25835518|NCT00017511|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25835519|NCT00017511|Autonomic Agents|autonomic agents|mesh-ancestor
25835520|NCT00017511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25835521|NCT00017511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835522|NCT00017511|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25835523|NCT00017511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25835524|NCT00017511|Cholinergic Agents|cholinergic agents|mesh-ancestor
25835525|NCT00017511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25835526|NCT00017511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835527|NCT00017550|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25835528|NCT00017550|Immunologic Factors|immunologic factors|mesh-ancestor
25835529|NCT00017550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835530|NCT00017550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25835531|NCT00017576|Calcitriol|calcitriol|mesh-list
25835532|NCT00017576|Carboplatin|carboplatin|mesh-list
25835533|NCT00017576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835534|NCT00017576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25835535|NCT00017576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835536|NCT00017576|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25835537|NCT00017576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25835538|NCT00017576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835539|NCT00017576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25835540|NCT00017576|Vitamins|vitamins|mesh-ancestor
25835541|NCT00017576|Micronutrients|micronutrients|mesh-ancestor
25835542|NCT00017576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25835543|NCT00017589|Gemtuzumab|gemtuzumab|mesh-list
25835544|NCT00017589|Oblimersen|oblimersen|mesh-list
25835545|NCT00017589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25835546|NCT00017589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835547|NCT00017602|Dexamethasone|dexamethasone|mesh-list
25835548|NCT00017602|Oblimersen|oblimersen|mesh-list
25835549|NCT00017602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25835550|NCT00017602|Antiemetics|antiemetics|mesh-ancestor
25835551|NCT00017602|Autonomic Agents|autonomic agents|mesh-ancestor
25835552|NCT00017602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25835553|NCT00017602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835554|NCT00017602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25835555|NCT00017602|Glucocorticoids|glucocorticoids|mesh-ancestor
25835556|NCT00017602|Hormones|hormones|mesh-ancestor
25835557|NCT00017602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24524444|NCT04914741|Doxorubicin|doxorubicin|mesh-list
25835558|NCT00017602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25835559|NCT00017602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835560|NCT00017628|Methylprednisolone|methylprednisolone|mesh-list
25835561|NCT00017628|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25835562|NCT00017628|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25835563|NCT00017628|Prednisolone|prednisolone|mesh-list
25659305|NCT01606228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659306|NCT01606228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25659307|NCT01606228|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24816036|NCT02073734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24816037|NCT02073734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24816038|NCT02073734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816039|NCT02073773|Levodopa|levodopa|mesh-list
25835564|NCT00017628|Prednisolone acetate|prednisolone acetate|mesh-list
25835565|NCT00017628|Cyclophosphamide|cyclophosphamide|mesh-list
25835566|NCT00017628|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25835567|NCT00017628|Prednisolone phosphate|prednisolone phosphate|mesh-list
25835568|NCT00017628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25835569|NCT00017628|Immunologic Factors|immunologic factors|mesh-ancestor
24643378|NCT01185418|Aripiprazole|aripiprazole|mesh-list
24643379|NCT01185418|Haloperidol decanoate|haloperidol decanoate|mesh-list
24643380|NCT01185418|Amisulpride|amisulpride|mesh-list
24643381|NCT01185418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24643382|NCT01185418|Serotonin Agents|serotonin agents|mesh-ancestor
24643383|NCT01185418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24643384|NCT01185418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643385|NCT01185418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643386|NCT01185418|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25835570|NCT00017628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835571|NCT00017628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25835572|NCT00017628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25835573|NCT00017628|Alkylating Agents|alkylating agents|mesh-ancestor
25835574|NCT00017628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459293|NCT00344227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24459294|NCT00344227|Growth Substances|growth substances|mesh-ancestor
24459295|NCT00344227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459296|NCT00344227|Growth Inhibitors|growth inhibitors|mesh-ancestor
24459297|NCT00344227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459298|NCT00344253|Interferons|interferons|mesh-list
24459299|NCT00344253|Interferon-beta|interferon-beta|mesh-list
25835575|NCT00017628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835576|NCT00017628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24536247|NCT00650533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835577|NCT00017628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25835578|NCT00017628|Antiemetics|antiemetics|mesh-ancestor
25835579|NCT00017628|Autonomic Agents|autonomic agents|mesh-ancestor
25835580|NCT00017628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24643463|NCT01185769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643464|NCT01185769|Protective Agents|protective agents|mesh-ancestor
25835581|NCT00017628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25835582|NCT00017628|Glucocorticoids|glucocorticoids|mesh-ancestor
25835583|NCT00017628|Hormones|hormones|mesh-ancestor
25835584|NCT00017628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25835585|NCT00017628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25835586|NCT00017628|Protective Agents|protective agents|mesh-ancestor
25835587|NCT00017628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25835588|NCT00017641|Cyclophosphamide|cyclophosphamide|mesh-list
25835589|NCT00017641|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25835590|NCT00017641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25835591|NCT00017641|Immunologic Factors|immunologic factors|mesh-ancestor
25835592|NCT00017641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835593|NCT00017641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25835594|NCT00017641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24524549|NCT04710277|Analgesics, Opioid|analgesics, opioid|mesh-list
25835595|NCT00017641|Alkylating Agents|alkylating agents|mesh-ancestor
25835596|NCT00017641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835597|NCT00017641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835598|NCT00017641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25835599|NCT00017654|Cyclosporine|cyclosporine|mesh-list
25835600|NCT00017654|Methylprednisolone|methylprednisolone|mesh-list
25835601|NCT00017654|Cyclophosphamide|cyclophosphamide|mesh-list
25835602|NCT00017654|Cyclosporins|cyclosporins|mesh-list
25835603|NCT00017654|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25835604|NCT00017654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25659308|NCT01606228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25659309|NCT01606228|Serotonin Agents|serotonin agents|mesh-ancestor
25659310|NCT01606228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25659311|NCT01606228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659312|NCT01606228|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25659313|NCT01606228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25659314|NCT01606228|Dopamine Agents|dopamine agents|mesh-ancestor
25659315|NCT01606254|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25659316|NCT01606254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25659317|NCT01606254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25659318|NCT01606254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25659319|NCT01606254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659320|NCT01606254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25835605|NCT00017654|Immunologic Factors|immunologic factors|mesh-ancestor
25835606|NCT00017654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835607|NCT00017654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25835608|NCT00017654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25835609|NCT00017654|Alkylating Agents|alkylating agents|mesh-ancestor
25835610|NCT00017654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835611|NCT00017654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835612|NCT00017654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25149665|NCT05466279|Anesthetics|anesthetics|mesh-ancestor
25835613|NCT00017654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25835614|NCT00017654|Antifungal Agents|antifungal agents|mesh-ancestor
25835615|NCT00017654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25835616|NCT00017654|Dermatologic Agents|dermatologic agents|mesh-ancestor
25835617|NCT00017654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25835618|NCT00017654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25835619|NCT00017654|Antiemetics|antiemetics|mesh-ancestor
25835620|NCT00017654|Autonomic Agents|autonomic agents|mesh-ancestor
25835621|NCT00017654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25835622|NCT00017654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25835623|NCT00017654|Glucocorticoids|glucocorticoids|mesh-ancestor
25835624|NCT00017654|Hormones|hormones|mesh-ancestor
25835625|NCT00017654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25835626|NCT00017654|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25835627|NCT00017654|Protective Agents|protective agents|mesh-ancestor
25835628|NCT00017680|Melphalan|melphalan|mesh-list
25835629|NCT00017680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25835630|NCT00017680|Alkylating Agents|alkylating agents|mesh-ancestor
25835631|NCT00017680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835632|NCT00017680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835633|NCT00017680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25835634|NCT00017680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25835635|NCT00017680|Immunologic Factors|immunologic factors|mesh-ancestor
25835636|NCT00017680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835637|NCT00017693|Interleukin-4|interleukin-4|mesh-list
25835638|NCT00017693|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25835639|NCT00017693|Immunologic Factors|immunologic factors|mesh-ancestor
25835640|NCT00017693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835641|NCT00017693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835642|NCT00017693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25835643|NCT00017719|Lamivudine|lamivudine|mesh-list
25835644|NCT00017719|Zidovudine|zidovudine|mesh-list
25835645|NCT00017719|Nevirapine|nevirapine|mesh-list
25835646|NCT00017719|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25835647|NCT00017719|Nelfinavir|nelfinavir|mesh-list
25835648|NCT00017719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25835649|NCT00017719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25835650|NCT00017719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25835651|NCT00017719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835652|NCT00017719|Antiviral Agents|antiviral agents|mesh-ancestor
25835653|NCT00017719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25835654|NCT00017719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25835655|NCT00017719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24459300|NCT00344253|Methotrexate|methotrexate|mesh-list
24459301|NCT00344253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24459302|NCT00344253|Abortifacient Agents|abortifacient agents|mesh-ancestor
24459303|NCT00344253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24459304|NCT00344253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459305|NCT00344253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25835656|NCT00017719|Antimetabolites|antimetabolites|mesh-ancestor
25835657|NCT00017719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25835658|NCT00017719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25835659|NCT00017719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25835660|NCT00017719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25835661|NCT00017719|Protease Inhibitors|protease inhibitors|mesh-ancestor
25414190|NCT03081910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25659321|NCT01606254|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25659322|NCT01606254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25659323|NCT01606254|Serotonin Agents|serotonin agents|mesh-ancestor
25659324|NCT01606254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25659325|NCT01606254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659326|NCT01606254|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25659327|NCT01606254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25659328|NCT01606254|Dopamine Agents|dopamine agents|mesh-ancestor
25659329|NCT01606306|Fluticasone|fluticasone|mesh-list
25835662|NCT00017758|Efavirenz|efavirenz|mesh-list
25659330|NCT01606306|Xhance|xhance|mesh-list
25659331|NCT01606306|Montelukast|montelukast|mesh-list
25659332|NCT01606306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25835663|NCT00017758|Nelfinavir|nelfinavir|mesh-list
24881552|NCT02101853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24881553|NCT02101853|Abortifacient Agents|abortifacient agents|mesh-ancestor
24881554|NCT02101853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24881555|NCT02101853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24881556|NCT02101853|Antimetabolites|antimetabolites|mesh-ancestor
24881557|NCT02101853|Dermatologic Agents|dermatologic agents|mesh-ancestor
24881558|NCT02101853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24881559|NCT02101853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24881592|NCT02022059|Lidocaine|lidocaine|mesh-list
25835664|NCT00017758|Atorvastatin|atorvastatin|mesh-list
25835665|NCT00017758|Simvastatin|simvastatin|mesh-list
25835666|NCT00017758|Pravastatin|pravastatin|mesh-list
25835667|NCT00017758|Calcium|calcium|mesh-list
25835668|NCT00017758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25835669|NCT00017758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835670|NCT00017758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25835671|NCT00017758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25835672|NCT00017758|Antimetabolites|antimetabolites|mesh-ancestor
25835673|NCT00017758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835674|NCT00017758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25835675|NCT00017758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25835676|NCT00017758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459306|NCT00344253|Antimetabolites|antimetabolites|mesh-ancestor
24459307|NCT00344253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459308|NCT00344253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459309|NCT00344253|Dermatologic Agents|dermatologic agents|mesh-ancestor
24459310|NCT00344253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459311|NCT00344253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24459312|NCT00344253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24459313|NCT00344253|Immunologic Factors|immunologic factors|mesh-ancestor
24459314|NCT00344253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24926846|NCT04137978|Expectorants|expectorants|mesh-ancestor
25835677|NCT00017758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25835678|NCT00017758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25835679|NCT00017758|Antiviral Agents|antiviral agents|mesh-ancestor
25835680|NCT00017758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25835681|NCT00017758|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25835682|NCT00017758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25835683|NCT00017758|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25835684|NCT00017758|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25835685|NCT00017758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25835686|NCT00017758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25835687|NCT00017758|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25835688|NCT00017758|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25835689|NCT00017758|Protease Inhibitors|protease inhibitors|mesh-ancestor
25835690|NCT00017758|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25835691|NCT00017758|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25835692|NCT00017784|Valganciclovir|valganciclovir|mesh-list
25835693|NCT00017784|Antiviral Agents|antiviral agents|mesh-ancestor
25835694|NCT00017784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25835695|NCT00017862|Reslizumab|reslizumab|mesh-list
25835696|NCT00017862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25835697|NCT00017862|Respiratory System Agents|respiratory system agents|mesh-ancestor
25835698|NCT00017940|Mitogens|mitogens|mesh-list
25835699|NCT00017940|Mitosis Modulators|mitosis modulators|mesh-ancestor
25835700|NCT00017940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659333|NCT01606306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25659334|NCT01606306|Autonomic Agents|autonomic agents|mesh-ancestor
25659335|NCT01606306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25659336|NCT01606306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659337|NCT01606306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25659338|NCT01606306|Respiratory System Agents|respiratory system agents|mesh-ancestor
25659339|NCT01606306|Dermatologic Agents|dermatologic agents|mesh-ancestor
25659340|NCT01606306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25659341|NCT01606306|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25659342|NCT01606306|Hormone Antagonists|hormone antagonists|mesh-ancestor
25659343|NCT01606306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25659344|NCT01606306|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25659345|NCT01606306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25659346|NCT01606306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659348|NCT01606319|Ibuprofen|ibuprofen|mesh-list
25659349|NCT01606319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25659350|NCT01606319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25659351|NCT01606319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25835702|NCT00017992|Lopinavir|lopinavir|mesh-list
25835703|NCT00017992|Emtricitabine|emtricitabine|mesh-list
25835704|NCT00017992|Stavudine|stavudine|mesh-list
25835705|NCT00017992|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25835706|NCT00017992|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25835707|NCT00017992|Protease Inhibitors|protease inhibitors|mesh-ancestor
25835708|NCT00017992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25835709|NCT00017992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835710|NCT00017992|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25835711|NCT00017992|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24536334|NCT00650871|Antiemetics|antiemetics|mesh-ancestor
25835712|NCT00017992|Antiviral Agents|antiviral agents|mesh-ancestor
25835713|NCT00017992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25835714|NCT00017992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25835715|NCT00017992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25835716|NCT00017992|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25835717|NCT00017992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25835718|NCT00017992|Antimetabolites|antimetabolites|mesh-ancestor
25835719|NCT00018018|Zidovudine|zidovudine|mesh-list
25835720|NCT00018018|Antimetabolites|antimetabolites|mesh-ancestor
25835721|NCT00018018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835722|NCT00018018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25835723|NCT00018018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24536335|NCT00650871|Autonomic Agents|autonomic agents|mesh-ancestor
25835724|NCT00018018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25835725|NCT00018018|Antiviral Agents|antiviral agents|mesh-ancestor
25835726|NCT00018018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25835727|NCT00018018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25835728|NCT00018018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25835729|NCT00018083|Efavirenz|efavirenz|mesh-list
25835730|NCT00018083|Isoniazid|isoniazid|mesh-list
25835731|NCT00018083|Rifabutin|rifabutin|mesh-list
25835732|NCT00018083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25835733|NCT00018083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25835734|NCT00018083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25835735|NCT00018083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835736|NCT00018083|Antiviral Agents|antiviral agents|mesh-ancestor
25835737|NCT00018083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25835738|NCT00018083|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25835739|NCT00018083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25835740|NCT00018083|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25835741|NCT00018083|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25835742|NCT00018083|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25835743|NCT00018083|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25835744|NCT00018083|Antitubercular Agents|antitubercular agents|mesh-ancestor
25835745|NCT00018083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25835746|NCT00018083|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25835747|NCT00018083|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25835748|NCT00018083|Antimetabolites|antimetabolites|mesh-ancestor
25835749|NCT00018083|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25835750|NCT00018083|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25835751|NCT00018135|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25835752|NCT00018135|Calcium|calcium|mesh-list
25835753|NCT00018135|Sevelamer|sevelamer|mesh-list
25835754|NCT00018135|Calcium acetate|calcium acetate|mesh-list
25835755|NCT00018135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25835756|NCT00018135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450713|NCT00320099|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24450714|NCT00320099|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24450715|NCT00320099|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24450716|NCT00320099|Fludrocortisone|fludrocortisone|mesh-list
24450717|NCT00320099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25659352|NCT01606319|Analgesics|analgesics|mesh-ancestor
25835757|NCT00018135|Chelating Agents|chelating agents|mesh-ancestor
25835758|NCT00018135|Sequestering Agents|sequestering agents|mesh-ancestor
25659353|NCT01606319|Sensory System Agents|sensory system agents|mesh-ancestor
25659354|NCT01606319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25659355|NCT01606319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835759|NCT00018135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835760|NCT00018135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25659356|NCT01606319|Antipyretics|antipyretics|mesh-ancestor
25835761|NCT00018135|Immunologic Factors|immunologic factors|mesh-ancestor
24881705|NCT01720836|Interferon Inducers|interferon inducers|mesh-ancestor
25835762|NCT00018135|Antacids|antacids|mesh-ancestor
25057137|NCT03507244|Dexamethasone|dexamethasone|mesh-list
25057139|NCT03507244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25057140|NCT03507244|Antiemetics|antiemetics|mesh-ancestor
25057141|NCT03507244|Autonomic Agents|autonomic agents|mesh-ancestor
24811381|NCT02046538|Leucovorin|leucovorin|mesh-list
24450718|NCT00320099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450719|NCT00320099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24450720|NCT00320125|Calcium|calcium|mesh-list
24450721|NCT00320125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25835763|NCT00018135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25835764|NCT00018148|Nortriptyline|nortriptyline|mesh-list
25835765|NCT00018148|Nicotine|nicotine|mesh-list
25835766|NCT00018148|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25835767|NCT00018148|Autonomic Agents|autonomic agents|mesh-ancestor
25835768|NCT00018148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25835769|NCT00018148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835770|NCT00018148|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25835771|NCT00018148|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24926964|NCT04137029|Bromides|bromides|mesh-list
25835772|NCT00018148|Cholinergic Agents|cholinergic agents|mesh-ancestor
25835773|NCT00018148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25835774|NCT00018148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835775|NCT00018148|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24536367|NCT00650923|Alkylating Agents|alkylating agents|mesh-ancestor
24450722|NCT00320125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450724|NCT00320229|Anticoagulants|anticoagulants|mesh-ancestor
24450725|NCT00320229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24450726|NCT00320268|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24450727|NCT00320268|Antidepressive Agents|antidepressive agents|mesh-ancestor
24450728|NCT00320268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24450729|NCT00320268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24450730|NCT00320268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25835776|NCT00018148|Antidepressive Agents|antidepressive agents|mesh-ancestor
25835777|NCT00018148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25835778|NCT00018148|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25835779|NCT00018148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25835780|NCT00018148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25835781|NCT00018148|Adrenergic Agents|adrenergic agents|mesh-ancestor
25835782|NCT00018161|Mecamylamine|mecamylamine|mesh-list
25835783|NCT00018161|Nicotine|nicotine|mesh-list
25835784|NCT00018161|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25835785|NCT00018161|Autonomic Agents|autonomic agents|mesh-ancestor
25835786|NCT00018161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25835787|NCT00018161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536383|NCT00651066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25835788|NCT00018161|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25835789|NCT00018161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25835790|NCT00018161|Cholinergic Agents|cholinergic agents|mesh-ancestor
25835791|NCT00018161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25835792|NCT00018161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835793|NCT00018161|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25835794|NCT00018161|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
25835795|NCT00018161|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24643824|NCT01187589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24643825|NCT01187589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643826|NCT01187589|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25835796|NCT00018161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25835797|NCT00018174|Fluoxetine|fluoxetine|mesh-list
25835798|NCT00018174|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25835799|NCT00018174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25659357|NCT01606319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25659358|NCT01606319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25659359|NCT01606319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25659360|NCT01606319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659361|NCT01606748|Gemcitabine|gemcitabine|mesh-list
25659362|NCT01606748|Cisplatin|cisplatin|mesh-list
25659363|NCT01606748|Necitumumab|necitumumab|mesh-list
25835800|NCT00018174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25835801|NCT00018174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659364|NCT01606748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659365|NCT01606748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25659366|NCT01606748|Antimetabolites|antimetabolites|mesh-ancestor
25659367|NCT01606748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835802|NCT00018174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25835803|NCT00018174|Serotonin Agents|serotonin agents|mesh-ancestor
25835804|NCT00018174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835805|NCT00018174|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25835806|NCT00018174|Antidepressive Agents|antidepressive agents|mesh-ancestor
25835807|NCT00018174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25835808|NCT00018174|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25835809|NCT00018174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25835810|NCT00018174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25835811|NCT00018187|Mecamylamine|mecamylamine|mesh-list
25835812|NCT00018187|Bupropion|bupropion|mesh-list
25835813|NCT00018187|Nicotine|nicotine|mesh-list
25835814|NCT00018187|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25835815|NCT00018187|Autonomic Agents|autonomic agents|mesh-ancestor
25835816|NCT00018187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25835817|NCT00018187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835818|NCT00018187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25835819|NCT00018187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25835820|NCT00018187|Cholinergic Agents|cholinergic agents|mesh-ancestor
25835821|NCT00018187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25835822|NCT00018187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835823|NCT00018187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25835824|NCT00018187|Antidepressive Agents|antidepressive agents|mesh-ancestor
25835825|NCT00018187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25835826|NCT00018187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25835827|NCT00018187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25835828|NCT00018187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25835829|NCT00018187|Dopamine Agents|dopamine agents|mesh-ancestor
25835830|NCT00018187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25835831|NCT00018187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25835832|NCT00018187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25835833|NCT00018187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25835834|NCT00018187|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
25835835|NCT00018187|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25835836|NCT00018187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25835837|NCT00018200|Benztropine|benztropine|mesh-list
25835838|NCT00018200|Fluoxetine|fluoxetine|mesh-list
24459373|NCT00344513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24459374|NCT00344513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25835839|NCT00018200|Desipramine|desipramine|mesh-list
25835840|NCT00018200|Clomipramine|clomipramine|mesh-list
25835841|NCT00018200|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25835842|NCT00018200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25150028|NCT05356104|Exenatide|exenatide|mesh-list
25835843|NCT00018200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24536476|NCT00651352|Autonomic Agents|autonomic agents|mesh-ancestor
24643907|NCT01187888|Rasagiline|rasagiline|mesh-list
25835844|NCT00018200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835845|NCT00018200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25835846|NCT00018200|Serotonin Agents|serotonin agents|mesh-ancestor
25835847|NCT00018200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835848|NCT00018200|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25835849|NCT00018200|Antidepressive Agents|antidepressive agents|mesh-ancestor
25835850|NCT00018200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25835851|NCT00018200|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25835852|NCT00018200|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25835853|NCT00018200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25835854|NCT00018200|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25835855|NCT00018200|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25835856|NCT00018200|Adrenergic Agents|adrenergic agents|mesh-ancestor
25835857|NCT00018200|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25835858|NCT00018200|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25835859|NCT00018200|Parasympatholytics|parasympatholytics|mesh-ancestor
25835860|NCT00018200|Autonomic Agents|autonomic agents|mesh-ancestor
25659368|NCT01606748|Antiviral Agents|antiviral agents|mesh-ancestor
25659369|NCT01606748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25835861|NCT00018200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25835862|NCT00018200|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25835863|NCT00018200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24459375|NCT00344513|Vasodilator Agents|vasodilator agents|mesh-ancestor
24459376|NCT00344513|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24459377|NCT00344513|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24459378|NCT00344513|Protease Inhibitors|protease inhibitors|mesh-ancestor
24524852|NCT04267926|Ubiquinone|ubiquinone|mesh-list
25835864|NCT00018200|Cholinergic Agents|cholinergic agents|mesh-ancestor
25659371|NCT01606748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25659372|NCT01606748|Immunologic Factors|immunologic factors|mesh-ancestor
25659373|NCT01606748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835865|NCT00018200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25835866|NCT00018200|Dopamine Agents|dopamine agents|mesh-ancestor
25835867|NCT00018213|Naltrexone|naltrexone|mesh-list
25835868|NCT00018213|Nicotine|nicotine|mesh-list
25835869|NCT00018213|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25835870|NCT00018213|Autonomic Agents|autonomic agents|mesh-ancestor
25659374|NCT01606748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25659375|NCT01606761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25659376|NCT01606761|Immunologic Factors|immunologic factors|mesh-ancestor
25659377|NCT01606761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659378|NCT01606787|Mannitol|mannitol|mesh-list
25659379|NCT01606787|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25659380|NCT01606787|Diuretics|diuretics|mesh-ancestor
25659381|NCT01606787|Natriuretic Agents|natriuretic agents|mesh-ancestor
25659382|NCT01606787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659383|NCT01606800|Ribavirin|ribavirin|mesh-list
25659384|NCT01606800|Interferon alpha-2|interferon alpha-2|mesh-list
25659385|NCT01606800|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25835871|NCT00018213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25835872|NCT00018213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835873|NCT00018213|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25835874|NCT00018213|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24644024|NCT01188317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24644038|NCT01188707|Belinostat|belinostat|mesh-list
24502952|NCT03981341|Estrogens|estrogens|mesh-list
25835875|NCT00018213|Cholinergic Agents|cholinergic agents|mesh-ancestor
25835876|NCT00018213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24450750|NCT00320320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24450751|NCT00320320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450756|NCT00320359|Topotecan|topotecan|mesh-list
24450757|NCT00320359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450758|NCT00320359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24450759|NCT00320359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24450760|NCT00320359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24450761|NCT00320359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450762|NCT00320359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450763|NCT00320359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24450764|NCT00320476|Bortezomib|bortezomib|mesh-list
24450765|NCT00320476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450766|NCT00320567|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24450767|NCT00320567|Norgestimate|norgestimate|mesh-list
24960695|NCT03814447|Cyclophosphamide|cyclophosphamide|mesh-list
24450768|NCT00320567|Estradiol|estradiol|mesh-list
24450769|NCT00320567|Estrogens|estrogens|mesh-ancestor
24450770|NCT00320567|Hormones|hormones|mesh-ancestor
24450771|NCT00320567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24450772|NCT00320567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450773|NCT00320567|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24450774|NCT00320567|Contraceptive Agents|contraceptive agents|mesh-ancestor
25835877|NCT00018213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835878|NCT00018213|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25835879|NCT00018213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25835880|NCT00018213|Sensory System Agents|sensory system agents|mesh-ancestor
25835881|NCT00018278|Donepezil|donepezil|mesh-list
25835882|NCT00018278|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24927145|NCT04135690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25835883|NCT00018278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875425|NCT04339751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450775|NCT00320567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24450776|NCT00320567|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25659386|NCT01606800|Antimetabolites|antimetabolites|mesh-ancestor
25659387|NCT01606800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659388|NCT01606800|Antiviral Agents|antiviral agents|mesh-ancestor
24881795|NCT01239797|Dexamethasone acetate|dexamethasone acetate|mesh-list
25201448|NCT02727907|Immunologic Factors|immunologic factors|mesh-ancestor
24450788|NCT00320580|Contraceptive Agents|contraceptive agents|mesh-ancestor
25835884|NCT00018278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835885|NCT00018278|Cholinergic Agents|cholinergic agents|mesh-ancestor
25835886|NCT00018278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25835887|NCT00018278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835888|NCT00018278|Nootropic Agents|nootropic agents|mesh-ancestor
25835889|NCT00018291|Gabapentin|gabapentin|mesh-list
25835890|NCT00018291|Risperidone|risperidone|mesh-list
25835891|NCT00018291|Analgesics|analgesics|mesh-ancestor
25835892|NCT00018291|Sensory System Agents|sensory system agents|mesh-ancestor
25835893|NCT00018291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25835894|NCT00018291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835895|NCT00018291|Anticonvulsants|anticonvulsants|mesh-ancestor
25835896|NCT00018291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25835897|NCT00018291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25835898|NCT00018291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25835899|NCT00018291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25835900|NCT00018291|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25835901|NCT00018291|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25835902|NCT00018291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25835903|NCT00018291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835904|NCT00018291|Antimanic Agents|antimanic agents|mesh-ancestor
25835905|NCT00018291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25835906|NCT00018291|Serotonin Agents|serotonin agents|mesh-ancestor
25835907|NCT00018291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25835908|NCT00018291|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25835909|NCT00018291|Dopamine Agents|dopamine agents|mesh-ancestor
25875426|NCT04339751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25875427|NCT04339751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875428|NCT04339751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875429|NCT04334941|Atezolizumab|atezolizumab|mesh-list
25875430|NCT04334941|Talazoparib|talazoparib|mesh-list
25875431|NCT04334941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25875432|NCT04334941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875433|NCT04334941|Immunologic Factors|immunologic factors|mesh-ancestor
25875434|NCT04334941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875435|NCT04334941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25875436|NCT04334941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875437|NCT04334941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875438|NCT04333914|Avdoralimab|avdoralimab|mesh-list
25875439|NCT04333914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25875440|NCT04333914|Antiviral Agents|antiviral agents|mesh-ancestor
24624491|NCT01076556|Antibodies|antibodies|mesh-list
25875441|NCT04333914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25875442|NCT04322305|Pregabalin|pregabalin|mesh-list
25875443|NCT04322305|Analgesics|analgesics|mesh-ancestor
25875444|NCT04322305|Sensory System Agents|sensory system agents|mesh-ancestor
25875445|NCT04322305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25875446|NCT04322305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163183|NCT02898376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875447|NCT04322305|Anticonvulsants|anticonvulsants|mesh-ancestor
25875448|NCT04322305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25875449|NCT04322305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25875450|NCT04322305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875451|NCT04322305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25875452|NCT04322305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25875453|NCT04322305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25875454|NCT04322305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24459453|NCT00344695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459454|NCT00344734|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
24459455|NCT00344734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459456|NCT00344734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659389|NCT01606800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25659390|NCT01606800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659391|NCT01606852|Dexmedetomidine|dexmedetomidine|mesh-list
25659392|NCT01606852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25659393|NCT01606852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25659394|NCT01606852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659395|NCT01606852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25659396|NCT01606852|Analgesics|analgesics|mesh-ancestor
25659397|NCT01606852|Sensory System Agents|sensory system agents|mesh-ancestor
24881828|NCT01103349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881829|NCT01103349|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24952675|NCT03892512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25659398|NCT01606852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25835910|NCT00018343|Estrogens|estrogens|mesh-list
25835911|NCT00018343|Hormones|hormones|mesh-ancestor
25835912|NCT00018343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25835913|NCT00018343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835914|NCT00018356|Testosterone|testosterone|mesh-list
25835915|NCT00018356|Androgens|androgens|mesh-ancestor
25835916|NCT00018356|Hormones|hormones|mesh-ancestor
25835917|NCT00018356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25835918|NCT00018356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835919|NCT00018382|Rosiglitazone|rosiglitazone|mesh-list
25835920|NCT00018382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25835921|NCT00018382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835922|NCT00018447|Fluorides|fluorides|mesh-list
25835923|NCT00018447|Cariostatic Agents|cariostatic agents|mesh-ancestor
25835924|NCT00018447|Protective Agents|protective agents|mesh-ancestor
25835925|NCT00018447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835926|NCT00018460|Vitamins|vitamins|mesh-list
25835927|NCT00018460|Vitamin B Complex|vitamin b complex|mesh-list
25835928|NCT00018460|Micronutrients|micronutrients|mesh-ancestor
24536698|NCT00652106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536699|NCT00652106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459457|NCT00344760|Tenofovir|tenofovir|mesh-list
24459458|NCT00344760|Lamivudine|lamivudine|mesh-list
24459459|NCT00344760|Efavirenz|efavirenz|mesh-list
24459460|NCT00344760|Enfuvirtide|enfuvirtide|mesh-list
24459461|NCT00344760|Antiviral Agents|antiviral agents|mesh-ancestor
24459462|NCT00344760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25150177|NCT05314569|Ketamine|ketamine|mesh-list
24459463|NCT00344760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24459464|NCT00344760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25835929|NCT00018460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835930|NCT00018551|Folic Acid|folic acid|mesh-list
25835931|NCT00018551|Hematinics|hematinics|mesh-ancestor
24525220|NCT03809988|Letrozole|letrozole|mesh-list
25835932|NCT00018551|Vitamin B Complex|vitamin b complex|mesh-ancestor
25835933|NCT00018551|Vitamins|vitamins|mesh-ancestor
25835934|NCT00018551|Micronutrients|micronutrients|mesh-ancestor
25835935|NCT00018551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459470|NCT00344760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24459471|NCT00344760|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24459472|NCT00344760|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24459473|NCT00344760|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24459474|NCT00344760|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24459475|NCT00344760|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24459476|NCT00344760|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24459477|NCT00344812|Buprenorphine|buprenorphine|mesh-list
24459479|NCT00344812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24459480|NCT00344812|Narcotics|narcotics|mesh-ancestor
24459481|NCT00344812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24459482|NCT00344812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644551|NCT01191645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24644552|NCT01191645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644554|NCT01191684|Immunologic Factors|immunologic factors|mesh-ancestor
24644555|NCT01191684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644570|NCT01191710|Progesterone|progesterone|mesh-list
25835936|NCT00018603|Guanfacine|guanfacine|mesh-list
25163184|NCT02898376|Vasodilator Agents|vasodilator agents|mesh-ancestor
25835937|NCT00018603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25835938|NCT00018603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25835939|NCT00018603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25835940|NCT00018603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25835941|NCT00018603|Adrenergic Agents|adrenergic agents|mesh-ancestor
25835942|NCT00018603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25835943|NCT00018603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835944|NCT00018603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835945|NCT00018642|Haloperidol|haloperidol|mesh-list
25835946|NCT00018642|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25835947|NCT00018642|Haloperidol decanoate|haloperidol decanoate|mesh-list
25659399|NCT01606852|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25659400|NCT01606852|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25659401|NCT01606852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25659402|NCT01606852|Adrenergic Agents|adrenergic agents|mesh-ancestor
24881955|NCT00295646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881956|NCT00295646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25835948|NCT00018642|Antidepressive Agents|antidepressive agents|mesh-ancestor
25835949|NCT00018642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25835950|NCT00018642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25835951|NCT00018642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25835952|NCT00018642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25835953|NCT00018642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835954|NCT00018642|Antiemetics|antiemetics|mesh-ancestor
25835955|NCT00018642|Autonomic Agents|autonomic agents|mesh-ancestor
25835956|NCT00018642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25835957|NCT00018642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25835958|NCT00018642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25835959|NCT00018642|Dopamine Agents|dopamine agents|mesh-ancestor
25835960|NCT00018642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25835961|NCT00018642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835962|NCT00018642|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25835963|NCT00018668|Olanzapine|olanzapine|mesh-list
25835964|NCT00018668|Risperidone|risperidone|mesh-list
25835965|NCT00018668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25835966|NCT00018668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25835967|NCT00018668|Serotonin Agents|serotonin agents|mesh-ancestor
25835968|NCT00018668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25835969|NCT00018668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835970|NCT00018668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835971|NCT00018668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25835972|NCT00018668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25835973|NCT00018668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25835974|NCT00018668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25835975|NCT00018668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25835976|NCT00018668|Dopamine Agents|dopamine agents|mesh-ancestor
25835977|NCT00018668|Antiemetics|antiemetics|mesh-ancestor
25835978|NCT00018668|Autonomic Agents|autonomic agents|mesh-ancestor
25835979|NCT00018668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25835980|NCT00018668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25835981|NCT00018668|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25835982|NCT00018668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25835983|NCT00018668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25835984|NCT00018668|Antidepressive Agents|antidepressive agents|mesh-ancestor
25835985|NCT00018694|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
25835986|NCT00018694|Cathartics|cathartics|mesh-ancestor
25835987|NCT00018694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25835988|NCT00018733|Paroxetine|paroxetine|mesh-list
25835989|NCT00018733|Desipramine|desipramine|mesh-list
25835990|NCT00018733|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25835991|NCT00018733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25835992|NCT00018733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25835993|NCT00018733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25835994|NCT00018733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25835995|NCT00018733|Serotonin Agents|serotonin agents|mesh-ancestor
24644639|NCT01192230|Docetaxel|docetaxel|mesh-list
25835996|NCT00018733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25835997|NCT00018733|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24459510|NCT00344916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459512|NCT00344942|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24459528|NCT00344955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459529|NCT00344955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24459530|NCT00344955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24459531|NCT00344955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459533|NCT00344981|Hydroxyurea|hydroxyurea|mesh-list
24459534|NCT00344981|Antiviral Agents|antiviral agents|mesh-ancestor
24459535|NCT00344981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25835998|NCT00018733|Antidepressive Agents|antidepressive agents|mesh-ancestor
25835999|NCT00018733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25836000|NCT00018733|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25836001|NCT00018733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25836002|NCT00018733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836003|NCT00018733|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25836004|NCT00018733|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25836005|NCT00018733|Adrenergic Agents|adrenergic agents|mesh-ancestor
25659403|NCT01606852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25659404|NCT01606852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836006|NCT00018759|Paroxetine|paroxetine|mesh-list
25659406|NCT01607073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25659407|NCT01607073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24952694|NCT03892434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513100|NCT00578721|Antipyretics|antipyretics|mesh-ancestor
25836007|NCT00018759|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25836008|NCT00018759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25836009|NCT00018759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25836010|NCT00018759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836011|NCT00018759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25836012|NCT00018759|Serotonin Agents|serotonin agents|mesh-ancestor
24459538|NCT00344981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536854|NCT00652704|Doxycycline|doxycycline|mesh-list
24644692|NCT01192529|Appetite Depressants|appetite depressants|mesh-ancestor
25836013|NCT00018759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836014|NCT00018759|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24927340|NCT04134026|Hematinics|hematinics|mesh-ancestor
24960994|NCT03812783|Sorafenib|sorafenib|mesh-list
24433336|NCT00258232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24433337|NCT00258232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25836015|NCT00018759|Antidepressive Agents|antidepressive agents|mesh-ancestor
25836016|NCT00018759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25836017|NCT00018759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25836018|NCT00018759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25836019|NCT00018759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836020|NCT00018824|Naltrexone|naltrexone|mesh-list
25836021|NCT00018824|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25836022|NCT00018824|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25836023|NCT00018824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836024|NCT00018824|Sensory System Agents|sensory system agents|mesh-ancestor
25836025|NCT00018824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25836026|NCT00018850|Haloperidol|haloperidol|mesh-list
25836027|NCT00018850|Ondansetron|ondansetron|mesh-list
25836028|NCT00018850|Haloperidol decanoate|haloperidol decanoate|mesh-list
25836029|NCT00018850|Nicotine|nicotine|mesh-list
25836030|NCT00018850|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25836031|NCT00018850|Autonomic Agents|autonomic agents|mesh-ancestor
25836032|NCT00018850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25836033|NCT00018850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836034|NCT00018850|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25836035|NCT00018850|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25836036|NCT00018850|Cholinergic Agents|cholinergic agents|mesh-ancestor
25836037|NCT00018850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24450824|NCT00320697|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24450825|NCT00320697|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24450836|NCT00320697|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24450837|NCT00320697|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24450838|NCT00320697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450840|NCT00320723|Nicotine|nicotine|mesh-list
24450841|NCT00320723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24450842|NCT00320723|Autonomic Agents|autonomic agents|mesh-ancestor
24450843|NCT00320723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24450845|NCT00320723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25836038|NCT00018850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836039|NCT00018850|Antiemetics|antiemetics|mesh-ancestor
25836040|NCT00018850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25836041|NCT00018850|Antipruritics|antipruritics|mesh-ancestor
25836042|NCT00018850|Dermatologic Agents|dermatologic agents|mesh-ancestor
24459539|NCT00344981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459540|NCT00344981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24459541|NCT00344981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24459542|NCT00344981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459543|NCT00344981|Antisickling Agents|antisickling agents|mesh-ancestor
24459545|NCT00344994|Antioxidants|antioxidants|mesh-ancestor
24459546|NCT00344994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836043|NCT00018850|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25836044|NCT00018850|Serotonin Agents|serotonin agents|mesh-ancestor
25836045|NCT00018850|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25659408|NCT01607073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25659409|NCT01607073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659410|NCT01607073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25659411|NCT01607073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659412|NCT01607073|Vasodilator Agents|vasodilator agents|mesh-ancestor
25659413|NCT01607203|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25836046|NCT00018850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25659414|NCT01607203|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25836047|NCT00018850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25836048|NCT00018850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25836049|NCT00018850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25836050|NCT00018850|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25836051|NCT00018850|Dopamine Agents|dopamine agents|mesh-ancestor
25836052|NCT00018850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25836053|NCT00018863|Methylphenidate|methylphenidate|mesh-list
25836054|NCT00018863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25836055|NCT00018863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836056|NCT00018863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25836057|NCT00018863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25836058|NCT00018863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25163185|NCT02898376|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25163186|NCT02898376|Antioxidants|antioxidants|mesh-ancestor
25163187|NCT02898376|Vitamins|vitamins|mesh-ancestor
25836059|NCT00018863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836060|NCT00018863|Dopamine Agents|dopamine agents|mesh-ancestor
25163188|NCT02898376|Micronutrients|micronutrients|mesh-ancestor
25163189|NCT02898610|Colchicine|colchicine|mesh-list
25836061|NCT00018863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25836062|NCT00018902|Fluoxetine|fluoxetine|mesh-list
25836063|NCT00018902|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25836064|NCT00018902|Citalopram|citalopram|mesh-list
25836065|NCT00018902|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25836066|NCT00018902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25836067|NCT00018902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25836068|NCT00018902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836069|NCT00018902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25836070|NCT00018902|Serotonin Agents|serotonin agents|mesh-ancestor
25836071|NCT00018902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836072|NCT00018902|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25836073|NCT00018902|Antidepressive Agents|antidepressive agents|mesh-ancestor
25836074|NCT00018902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25836075|NCT00018902|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25836076|NCT00018902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24459547|NCT00344994|Protective Agents|protective agents|mesh-ancestor
24459548|NCT00344994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836077|NCT00018902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459549|NCT00344994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24459550|NCT00344994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24459551|NCT00344994|Dopamine Agonists|dopamine agonists|mesh-ancestor
24459552|NCT00344994|Dopamine Agents|dopamine agents|mesh-ancestor
24459553|NCT00344994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25836078|NCT00018902|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25836079|NCT00018941|Aldesleukin|aldesleukin|mesh-list
25836080|NCT00018941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836081|NCT00018941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25836082|NCT00018941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25836083|NCT00018941|Antiviral Agents|antiviral agents|mesh-ancestor
25836084|NCT00018941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836085|NCT00018954|Cytarabine|cytarabine|mesh-list
25836086|NCT00018954|Prednisone|prednisone|mesh-list
25836087|NCT00018954|Cyclophosphamide|cyclophosphamide|mesh-list
25836088|NCT00018954|Ifosfamide|ifosfamide|mesh-list
25836089|NCT00018954|Doxorubicin|doxorubicin|mesh-list
25836090|NCT00018954|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25836091|NCT00018954|Methotrexate|methotrexate|mesh-list
25836092|NCT00018954|Etoposide|etoposide|mesh-list
25836093|NCT00018954|Vincristine|vincristine|mesh-list
25836094|NCT00018954|Daunorubicin|daunorubicin|mesh-list
25836095|NCT00018954|Asparaginase|asparaginase|mesh-list
25836096|NCT00018954|Mercaptopurine|mercaptopurine|mesh-list
25836097|NCT00018954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25836098|NCT00018954|Immunologic Factors|immunologic factors|mesh-ancestor
25836099|NCT00018954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836100|NCT00018954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25836101|NCT00018954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25836102|NCT00018954|Alkylating Agents|alkylating agents|mesh-ancestor
25836103|NCT00018954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836104|NCT00018954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836105|NCT00018954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25836106|NCT00018954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25836107|NCT00018954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25163190|NCT02898610|Gout Suppressants|gout suppressants|mesh-ancestor
25659415|NCT01607203|Luteolytic Agents|luteolytic agents|mesh-ancestor
25836108|NCT00018954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25836109|NCT00018954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836110|NCT00018954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25836111|NCT00018954|Glucocorticoids|glucocorticoids|mesh-ancestor
25836112|NCT00018954|Hormones|hormones|mesh-ancestor
25836113|NCT00018954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25836114|NCT00018954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25836115|NCT00018954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25836116|NCT00018954|Abortifacient Agents|abortifacient agents|mesh-ancestor
25836117|NCT00018954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25836118|NCT00018954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25836119|NCT00018954|Antimetabolites|antimetabolites|mesh-ancestor
25836120|NCT00018954|Dermatologic Agents|dermatologic agents|mesh-ancestor
25836121|NCT00018954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25836122|NCT00018954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25836123|NCT00018954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25836124|NCT00018954|Antiviral Agents|antiviral agents|mesh-ancestor
25836125|NCT00018954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836126|NCT00018954|Tubulin Modulators|tubulin modulators|mesh-ancestor
25836127|NCT00018954|Antimitotic Agents|antimitotic agents|mesh-ancestor
24644891|NCT01193595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25836128|NCT00018954|Mitosis Modulators|mitosis modulators|mesh-ancestor
25836129|NCT00019006|Detox adjuvant|detox adjuvant|mesh-list
25836130|NCT00019006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25836131|NCT00019006|Immunologic Factors|immunologic factors|mesh-ancestor
25836132|NCT00019006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836133|NCT00019019|Paclitaxel|paclitaxel|mesh-list
25836134|NCT00019019|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
25836135|NCT00019019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25836136|NCT00019019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836137|NCT00019019|Tubulin Modulators|tubulin modulators|mesh-ancestor
25836138|NCT00019019|Antimitotic Agents|antimitotic agents|mesh-ancestor
25836139|NCT00019019|Mitosis Modulators|mitosis modulators|mesh-ancestor
25836140|NCT00019019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836141|NCT00019019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25836142|NCT00019019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25836143|NCT00019019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25836144|NCT00019019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836145|NCT00019032|Antibodies|antibodies|mesh-list
25836146|NCT00019032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25836147|NCT00019032|Immunologic Factors|immunologic factors|mesh-ancestor
25836148|NCT00019032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836149|NCT00019058|Hydroxyurea|hydroxyurea|mesh-list
25836150|NCT00019058|Pentoxifylline|pentoxifylline|mesh-list
25836151|NCT00019058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836152|NCT00019058|Antisickling Agents|antisickling agents|mesh-ancestor
25836153|NCT00019058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836154|NCT00019058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836155|NCT00019058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25836156|NCT00019058|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25836157|NCT00019058|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25836158|NCT00019058|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25836159|NCT00019058|Protective Agents|protective agents|mesh-ancestor
25836160|NCT00019058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836161|NCT00019058|Vasodilator Agents|vasodilator agents|mesh-ancestor
25836162|NCT00019058|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25836163|NCT00019058|Antioxidants|antioxidants|mesh-ancestor
24459560|NCT00345059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048407|NCT00707889|Leucovorin|leucovorin|mesh-list
24459561|NCT00345059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459563|NCT00345059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24459564|NCT00345059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536912|NCT00652860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25836164|NCT00019071|Cladribine|cladribine|mesh-list
25836165|NCT00019071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836166|NCT00019071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25836167|NCT00019071|Immunologic Factors|immunologic factors|mesh-ancestor
25836168|NCT00019071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836169|NCT00019084|Aldesleukin|aldesleukin|mesh-list
25836170|NCT00019084|Vaccines|vaccines|mesh-list
25836171|NCT00019084|Sargramostim|sargramostim|mesh-list
25836172|NCT00019084|Immunologic Factors|immunologic factors|mesh-ancestor
25836173|NCT00019084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836174|NCT00019084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836175|NCT00019084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24882208|NCT02735707|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
25057171|NCT03506919|Antimetabolites|antimetabolites|mesh-ancestor
25057172|NCT03506919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057173|NCT03506919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836176|NCT00019084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25836177|NCT00019084|Antiviral Agents|antiviral agents|mesh-ancestor
25659416|NCT01607203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25659417|NCT01607203|Contraceptive Agents|contraceptive agents|mesh-ancestor
25659418|NCT01607203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25659419|NCT01607203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659420|NCT01607203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25659421|NCT01607203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25659422|NCT01607203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659423|NCT01607346|Ezogabine|ezogabine|mesh-list
25659424|NCT01607346|Anticonvulsants|anticonvulsants|mesh-ancestor
25659425|NCT01607346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25836178|NCT00019084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836179|NCT00019097|Melphalan|melphalan|mesh-list
25836180|NCT00019097|Sargramostim|sargramostim|mesh-list
25836181|NCT00019097|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
25836182|NCT00019097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25836183|NCT00019097|Alkylating Agents|alkylating agents|mesh-ancestor
25836184|NCT00019097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836185|NCT00019097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836186|NCT00019097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25836187|NCT00019097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25836188|NCT00019097|Immunologic Factors|immunologic factors|mesh-ancestor
25836189|NCT00019097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836190|NCT00019097|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25836191|NCT00019123|Thalidomide|thalidomide|mesh-list
25836192|NCT00019123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25836193|NCT00019123|Immunologic Factors|immunologic factors|mesh-ancestor
25836194|NCT00019123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525530|NCT03188068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24459574|NCT00345098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24459575|NCT00345098|Adrenergic Agents|adrenergic agents|mesh-ancestor
24459576|NCT00345098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24459577|NCT00345098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459578|NCT00345098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536919|NCT00652860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836195|NCT00019123|Leprostatic Agents|leprostatic agents|mesh-ancestor
25836196|NCT00019123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25836197|NCT00019123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836198|NCT00019123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25836199|NCT00019123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25836200|NCT00019123|Growth Substances|growth substances|mesh-ancestor
25836201|NCT00019123|Growth Inhibitors|growth inhibitors|mesh-ancestor
25836202|NCT00019123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836203|NCT00019136|Aldesleukin|aldesleukin|mesh-list
25836204|NCT00019136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836205|NCT00019136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25836206|NCT00019136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25836207|NCT00019136|Antiviral Agents|antiviral agents|mesh-ancestor
25836208|NCT00019136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836209|NCT00019175|Aldesleukin|aldesleukin|mesh-list
25836210|NCT00019175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836211|NCT00019175|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25836212|NCT00019175|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25836213|NCT00019175|Antiviral Agents|antiviral agents|mesh-ancestor
24644997|NCT01194778|Coagulants|coagulants|mesh-ancestor
25836214|NCT00019175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836215|NCT00019188|Interleukin-12|interleukin-12|mesh-list
25836216|NCT00019188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25836217|NCT00019188|Immunologic Factors|immunologic factors|mesh-ancestor
25836218|NCT00019188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459582|NCT00345150|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
24459583|NCT00345150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459584|NCT00345150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459585|NCT00345163|Bevacizumab|bevacizumab|mesh-list
25659426|NCT01607346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659427|NCT01607411|Fluorides|fluorides|mesh-list
25659428|NCT01607411|Cariostatic Agents|cariostatic agents|mesh-ancestor
25659429|NCT01607411|Protective Agents|protective agents|mesh-ancestor
25659430|NCT01607411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836219|NCT00019188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25659431|NCT01607450|Glucagon|glucagon|mesh-list
25659432|NCT01607450|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25659433|NCT01607450|Incretins|incretins|mesh-ancestor
24882261|NCT02109081|Hormones|hormones|mesh-ancestor
24882262|NCT02109081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24882263|NCT02109081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24882264|NCT02109081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882265|NCT01962792|Dexamethasone|dexamethasone|mesh-list
24882266|NCT01962792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24459586|NCT00345163|Irinotecan|irinotecan|mesh-list
24459587|NCT00345163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25836220|NCT00019188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25836221|NCT00019188|Growth Substances|growth substances|mesh-ancestor
25836222|NCT00019188|Growth Inhibitors|growth inhibitors|mesh-ancestor
25836223|NCT00019188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836224|NCT00019214|Aldesleukin|aldesleukin|mesh-list
25836225|NCT00019214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836226|NCT00019214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25836227|NCT00019214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25836228|NCT00019214|Antiviral Agents|antiviral agents|mesh-ancestor
25836229|NCT00019214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836230|NCT00019227|Calcium|calcium|mesh-list
25836231|NCT00019227|Daclizumab|daclizumab|mesh-list
25836232|NCT00019227|Pentetic Acid|pentetic acid|mesh-list
25836233|NCT00019227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25836234|NCT00019227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836235|NCT00019227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25836236|NCT00019227|Immunologic Factors|immunologic factors|mesh-ancestor
25836237|NCT00019227|Antidotes|antidotes|mesh-ancestor
25836238|NCT00019227|Protective Agents|protective agents|mesh-ancestor
25836239|NCT00019227|Chelating Agents|chelating agents|mesh-ancestor
25836240|NCT00019227|Sequestering Agents|sequestering agents|mesh-ancestor
25836241|NCT00019227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836242|NCT00019227|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24927549|NCT04132115|Piperacillin|piperacillin|mesh-list
24459596|NCT00345163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459597|NCT00345163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459598|NCT00345202|Atorvastatin|atorvastatin|mesh-list
24459599|NCT00345202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24459600|NCT00345202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25836243|NCT00019240|Cidofovir|cidofovir|mesh-list
25836244|NCT00019240|Antiviral Agents|antiviral agents|mesh-ancestor
25836245|NCT00019240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836246|NCT00019240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836247|NCT00019240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836248|NCT00019318|Romidepsin|romidepsin|mesh-list
25836249|NCT00019318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25836250|NCT00019318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836251|NCT00019331|Aldesleukin|aldesleukin|mesh-list
25836252|NCT00019331|Sargramostim|sargramostim|mesh-list
25836253|NCT00019331|Immunologic Factors|immunologic factors|mesh-ancestor
25836254|NCT00019331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836255|NCT00019331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836256|NCT00019331|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25836257|NCT00019331|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25836258|NCT00019331|Antiviral Agents|antiviral agents|mesh-ancestor
24525691|NCT02883400|Diuretics|diuretics|mesh-ancestor
25836259|NCT00019331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836260|NCT00019344|Alvocidib|alvocidib|mesh-list
25836261|NCT00019344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836262|NCT00019344|Growth Inhibitors|growth inhibitors|mesh-ancestor
25150757|NCT05060068|Anesthetics, General|anesthetics, general|mesh-ancestor
25836263|NCT00019344|Growth Substances|growth substances|mesh-ancestor
25836264|NCT00019344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836265|NCT00019344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25836266|NCT00019344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459602|NCT00345202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459603|NCT00345202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24459604|NCT00345202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25659434|NCT01607450|Hormones|hormones|mesh-ancestor
25659435|NCT01607450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25659436|NCT01607450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659437|NCT01607450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25659438|NCT01607476|Corticosterone|corticosterone|mesh-list
25659439|NCT01607476|Flutemetamol|flutemetamol|mesh-list
25659440|NCT01607476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24459605|NCT00345202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836267|NCT00019344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836269|NCT00019357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836270|NCT00019357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25836271|NCT00019357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25836272|NCT00019357|Antiviral Agents|antiviral agents|mesh-ancestor
25836273|NCT00019357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836274|NCT00019383|Aldesleukin|aldesleukin|mesh-list
25836275|NCT00019383|Sargramostim|sargramostim|mesh-list
25836276|NCT00019383|Freund's Adjuvant|freund's adjuvant|mesh-list
25836277|NCT00019383|Immunologic Factors|immunologic factors|mesh-ancestor
25836278|NCT00019383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836279|NCT00019383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836280|NCT00019383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25836281|NCT00019383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25836282|NCT00019383|Antiviral Agents|antiviral agents|mesh-ancestor
25836283|NCT00019383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836284|NCT00019383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25836285|NCT00019396|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25836286|NCT00019396|Flt3 ligand protein|flt3 ligand protein|mesh-list
25163191|NCT02898610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24770600|NCT01821261|Fluorides|fluorides|mesh-list
25836287|NCT00019396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25836288|NCT00019396|Immunologic Factors|immunologic factors|mesh-ancestor
25836289|NCT00019396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836290|NCT00019396|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25836291|NCT00019396|Protective Agents|protective agents|mesh-ancestor
25836292|NCT00019409|Cytarabine|cytarabine|mesh-list
25836293|NCT00019409|Prednisone|prednisone|mesh-list
25836294|NCT00019409|Hydrocortisone|hydrocortisone|mesh-list
24459606|NCT00345306|Progesterone|progesterone|mesh-list
24459607|NCT00345306|Progestins|progestins|mesh-ancestor
24459609|NCT00345306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24459610|NCT00345306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459611|NCT00345358|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24459614|NCT00345501|Iloprost|iloprost|mesh-list
25836295|NCT00019409|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25836296|NCT00019409|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25836297|NCT00019409|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25836298|NCT00019409|Cyclophosphamide|cyclophosphamide|mesh-list
25836299|NCT00019409|Methotrexate|methotrexate|mesh-list
25836300|NCT00019409|Vincristine|vincristine|mesh-list
25836301|NCT00019409|Daunorubicin|daunorubicin|mesh-list
25836302|NCT00019409|Asparaginase|asparaginase|mesh-list
25836303|NCT00019409|Mercaptopurine|mercaptopurine|mesh-list
25836304|NCT00019409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25836305|NCT00019409|Immunologic Factors|immunologic factors|mesh-ancestor
25836306|NCT00019409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836307|NCT00019409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25836308|NCT00019409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25836309|NCT00019409|Alkylating Agents|alkylating agents|mesh-ancestor
25836310|NCT00019409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836311|NCT00019409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836312|NCT00019409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25836313|NCT00019409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25836314|NCT00019409|Glucocorticoids|glucocorticoids|mesh-ancestor
25836315|NCT00019409|Hormones|hormones|mesh-ancestor
25836316|NCT00019409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25836317|NCT00019409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25836318|NCT00019409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25836319|NCT00019409|Abortifacient Agents|abortifacient agents|mesh-ancestor
25836320|NCT00019409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25836321|NCT00019409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25836322|NCT00019409|Antimetabolites|antimetabolites|mesh-ancestor
25836323|NCT00019409|Dermatologic Agents|dermatologic agents|mesh-ancestor
25836324|NCT00019409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836325|NCT00019409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25836326|NCT00019409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25836327|NCT00019409|Antiviral Agents|antiviral agents|mesh-ancestor
25836328|NCT00019409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836329|NCT00019409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25836330|NCT00019409|Tubulin Modulators|tubulin modulators|mesh-ancestor
25836331|NCT00019409|Antimitotic Agents|antimitotic agents|mesh-ancestor
25836332|NCT00019409|Mitosis Modulators|mitosis modulators|mesh-ancestor
25836333|NCT00019409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25836334|NCT00019409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24645567|NCT01198665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836337|NCT00019422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836338|NCT00019435|Immunotoxins|immunotoxins|mesh-list
25836339|NCT00019435|Immunologic Factors|immunologic factors|mesh-ancestor
25836340|NCT00019435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836341|NCT00019448|Interleukin-2|interleukin-2|mesh-list
25836342|NCT00019448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836343|NCT00019448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25836344|NCT00019448|Analgesics|analgesics|mesh-ancestor
25836345|NCT00019448|Sensory System Agents|sensory system agents|mesh-ancestor
25836346|NCT00019448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25836347|NCT00019448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836348|NCT00019461|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
25163192|NCT02898610|Tubulin Modulators|tubulin modulators|mesh-ancestor
25836349|NCT00019461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836350|NCT00019461|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25836351|NCT00019461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25836352|NCT00019461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836353|NCT00019461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24459689|NCT00345800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24459690|NCT00345800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24459691|NCT00345800|Anesthetics, General|anesthetics, general|mesh-ancestor
25836354|NCT00019461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836355|NCT00019474|Interferons|interferons|mesh-list
25836356|NCT00019474|Interferon-alpha|interferon-alpha|mesh-list
25836357|NCT00019474|Fluorouracil|fluorouracil|mesh-list
25836358|NCT00019474|Hydroxyurea|hydroxyurea|mesh-list
25836359|NCT00019474|Antimetabolites|antimetabolites|mesh-ancestor
25836360|NCT00019474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836361|NCT00019474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25836362|NCT00019474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836363|NCT00019474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25836364|NCT00019474|Immunologic Factors|immunologic factors|mesh-ancestor
25836365|NCT00019474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836366|NCT00019474|Antiviral Agents|antiviral agents|mesh-ancestor
25836367|NCT00019474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836368|NCT00019474|Antisickling Agents|antisickling agents|mesh-ancestor
25836369|NCT00019474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836370|NCT00019474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25836371|NCT00019487|Aldesleukin|aldesleukin|mesh-list
25836372|NCT00019487|Freund's Adjuvant|freund's adjuvant|mesh-list
25836373|NCT00019487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836374|NCT00019487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25836375|NCT00019487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25836376|NCT00019487|Antiviral Agents|antiviral agents|mesh-ancestor
25836377|NCT00019487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836378|NCT00019487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25836379|NCT00019487|Immunologic Factors|immunologic factors|mesh-ancestor
25836380|NCT00019487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836381|NCT00019500|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25836382|NCT00019500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25836383|NCT00019500|Hormone Antagonists|hormone antagonists|mesh-ancestor
25836384|NCT00019500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25836385|NCT00019500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836386|NCT00019500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25836387|NCT00019500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25836388|NCT00019500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25836389|NCT00019513|Leucovorin|leucovorin|mesh-list
25836390|NCT00019513|Gemcitabine|gemcitabine|mesh-list
25836391|NCT00019513|Fluorouracil|fluorouracil|mesh-list
25836392|NCT00019513|Calcium|calcium|mesh-list
25836393|NCT00019513|Levoleucovorin|levoleucovorin|mesh-list
25836394|NCT00019513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25836395|NCT00019513|Antimetabolites|antimetabolites|mesh-ancestor
25836396|NCT00019513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836397|NCT00019513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836398|NCT00019513|Antiviral Agents|antiviral agents|mesh-ancestor
25836399|NCT00019513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836400|NCT00019513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836401|NCT00019513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25836402|NCT00019513|Immunologic Factors|immunologic factors|mesh-ancestor
25836403|NCT00019513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836404|NCT00019513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25836406|NCT00019513|Protective Agents|protective agents|mesh-ancestor
25836407|NCT00019513|Vitamin B Complex|vitamin b complex|mesh-ancestor
25836408|NCT00019513|Vitamins|vitamins|mesh-ancestor
25836409|NCT00019513|Micronutrients|micronutrients|mesh-ancestor
25836410|NCT00019539|Thalidomide|thalidomide|mesh-list
25836411|NCT00019539|Bevacizumab|bevacizumab|mesh-list
25836412|NCT00019539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25836413|NCT00019539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836414|NCT00019539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25836415|NCT00019539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25836416|NCT00019539|Growth Substances|growth substances|mesh-ancestor
25836417|NCT00019539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836418|NCT00019539|Growth Inhibitors|growth inhibitors|mesh-ancestor
25836419|NCT00019539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25836420|NCT00019539|Immunologic Factors|immunologic factors|mesh-ancestor
25836421|NCT00019539|Leprostatic Agents|leprostatic agents|mesh-ancestor
25836422|NCT00019539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25836423|NCT00019539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836424|NCT00019552|Irofulven|irofulven|mesh-list
25836425|NCT00019552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25836426|NCT00019552|Alkylating Agents|alkylating agents|mesh-ancestor
25836427|NCT00019552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836428|NCT00019552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836429|NCT00019565|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25836430|NCT00019565|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25836431|NCT00019565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836432|NCT00019591|Aldesleukin|aldesleukin|mesh-list
25836433|NCT00019591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836434|NCT00019591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25836435|NCT00019591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25048435|NCT00704483|Ferric Compounds|ferric compounds|mesh-list
25836436|NCT00019591|Antiviral Agents|antiviral agents|mesh-ancestor
25836437|NCT00019591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836438|NCT00019630|Doxorubicin|doxorubicin|mesh-list
24394462|NCT00133341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25836439|NCT00019630|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25836440|NCT00019630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25836441|NCT00019630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836442|NCT00019630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25836443|NCT00019630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25836444|NCT00019630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836445|NCT00019630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836446|NCT00019669|Aldesleukin|aldesleukin|mesh-list
25836447|NCT00019669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836448|NCT00019669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25836449|NCT00019669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25836450|NCT00019669|Antiviral Agents|antiviral agents|mesh-ancestor
25836451|NCT00019669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836452|NCT00019695|Alendronate|alendronate|mesh-list
25836453|NCT00019695|Ketoconazole|ketoconazole|mesh-list
25836454|NCT00019695|Antifungal Agents|antifungal agents|mesh-ancestor
25836455|NCT00019695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836456|NCT00019695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25836457|NCT00019695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25836458|NCT00019695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836459|NCT00019695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836460|NCT00019695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25836461|NCT00019695|Hormone Antagonists|hormone antagonists|mesh-ancestor
25836462|NCT00019695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24537213|NCT00653965|Atorvastatin|atorvastatin|mesh-list
25836463|NCT00019695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836464|NCT00019695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25836465|NCT00019695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25836466|NCT00019721|Aldesleukin|aldesleukin|mesh-list
25836467|NCT00019721|Freund's Adjuvant|freund's adjuvant|mesh-list
25836468|NCT00019721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836469|NCT00019721|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25836470|NCT00019721|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25836471|NCT00019721|Antiviral Agents|antiviral agents|mesh-ancestor
24394260|NCT00132743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394261|NCT00132743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24408167|NCT00176774|Immunologic Factors|immunologic factors|mesh-ancestor
25836472|NCT00019721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24882602|NCT05168176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25836473|NCT00019721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24394270|NCT00132756|Alkylating Agents|alkylating agents|mesh-ancestor
24394271|NCT00132756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394272|NCT00132756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24394273|NCT00132756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24394275|NCT00132821|Nicotine|nicotine|mesh-list
24394276|NCT00132821|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24394277|NCT00132821|Autonomic Agents|autonomic agents|mesh-ancestor
25836474|NCT00019721|Immunologic Factors|immunologic factors|mesh-ancestor
24394286|NCT00132821|Antidepressive Agents|antidepressive agents|mesh-ancestor
24394287|NCT00132821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24394288|NCT00132821|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24537708|NCT00655915|Lidocaine|lidocaine|mesh-list
24394289|NCT00132821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24394290|NCT00132821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24394291|NCT00132821|Dopamine Agents|dopamine agents|mesh-ancestor
24394341|NCT00133042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24394342|NCT00133042|Respiratory System Agents|respiratory system agents|mesh-ancestor
24394343|NCT00133081|Anticonvulsants|anticonvulsants|mesh-list
25836475|NCT00019721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836476|NCT00019734|Aldesleukin|aldesleukin|mesh-list
25836477|NCT00019734|Vaccines|vaccines|mesh-list
25836478|NCT00019734|Immunologic Factors|immunologic factors|mesh-ancestor
25836479|NCT00019734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836480|NCT00019734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836481|NCT00019734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25836482|NCT00019734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25836483|NCT00019734|Antiviral Agents|antiviral agents|mesh-ancestor
25836484|NCT00019734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836485|NCT00019760|Leucovorin|leucovorin|mesh-list
25836486|NCT00019760|Melphalan|melphalan|mesh-list
25836487|NCT00019760|Floxuridine|floxuridine|mesh-list
25836488|NCT00019760|Calcium|calcium|mesh-list
24394348|NCT00133172|Glucocorticoids|glucocorticoids|mesh-ancestor
25836489|NCT00019760|Levoleucovorin|levoleucovorin|mesh-list
25836490|NCT00019760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25836491|NCT00019760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836492|NCT00019760|Antidotes|antidotes|mesh-ancestor
25836493|NCT00019760|Protective Agents|protective agents|mesh-ancestor
25836494|NCT00019760|Vitamin B Complex|vitamin b complex|mesh-ancestor
25836495|NCT00019760|Vitamins|vitamins|mesh-ancestor
25836496|NCT00019760|Micronutrients|micronutrients|mesh-ancestor
25836497|NCT00019760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25836498|NCT00019760|Alkylating Agents|alkylating agents|mesh-ancestor
25836499|NCT00019760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836500|NCT00019760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836501|NCT00019760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25836502|NCT00019760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25836503|NCT00019760|Immunologic Factors|immunologic factors|mesh-ancestor
25836504|NCT00019760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25836505|NCT00019760|Antimetabolites|antimetabolites|mesh-ancestor
25836506|NCT00019773|Capecitabine|capecitabine|mesh-list
25836507|NCT00019773|Oxaliplatin|oxaliplatin|mesh-list
25836508|NCT00019773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25836509|NCT00019773|Antimetabolites|antimetabolites|mesh-ancestor
25836510|NCT00019773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836511|NCT00019773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836512|NCT00019786|Melphalan|melphalan|mesh-list
25836513|NCT00019786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25836514|NCT00019786|Alkylating Agents|alkylating agents|mesh-ancestor
25836515|NCT00019786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836516|NCT00019786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836517|NCT00019786|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25836518|NCT00019786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25836519|NCT00019786|Immunologic Factors|immunologic factors|mesh-ancestor
25836520|NCT00019786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836521|NCT00019812|Paclitaxel|paclitaxel|mesh-list
25836522|NCT00019812|Trastuzumab|trastuzumab|mesh-list
25836523|NCT00019812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25836524|NCT00019812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659441|NCT01607476|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25659442|NCT01607476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659443|NCT01607554|Irinotecan|irinotecan|mesh-list
25659444|NCT01607554|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25659445|NCT01607554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25659446|NCT01607554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836525|NCT00019812|Tubulin Modulators|tubulin modulators|mesh-ancestor
25836526|NCT00019812|Antimitotic Agents|antimitotic agents|mesh-ancestor
25836527|NCT00019812|Mitosis Modulators|mitosis modulators|mesh-ancestor
25836528|NCT00019812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836529|NCT00019812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25836530|NCT00019825|Decitabine|decitabine|mesh-list
25836531|NCT00019825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25836532|NCT00019825|Antimetabolites|antimetabolites|mesh-ancestor
25836533|NCT00019825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836534|NCT00019825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836535|NCT00019825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836536|NCT00019838|Fludarabine|fludarabine|mesh-list
25836537|NCT00019838|Fludarabine phosphate|fludarabine phosphate|mesh-list
25836538|NCT00019838|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
25836539|NCT00019838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836540|NCT00019838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25836541|NCT00019838|Antimetabolites|antimetabolites|mesh-ancestor
25836542|NCT00019838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836543|NCT00019838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25836544|NCT00019838|Immunologic Factors|immunologic factors|mesh-ancestor
25836545|NCT00019838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836546|NCT00019838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25836547|NCT00019838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836548|NCT00019864|Leucovorin|leucovorin|mesh-list
25836549|NCT00019864|Doxorubicin|doxorubicin|mesh-list
25836550|NCT00019864|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25836551|NCT00019864|Methotrexate|methotrexate|mesh-list
25836552|NCT00019864|Dexrazoxane|dexrazoxane|mesh-list
24394437|NCT00133315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24394458|NCT00133341|Sensory System Agents|sensory system agents|mesh-ancestor
24394459|NCT00133341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24394460|NCT00133341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394461|NCT00133341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25836553|NCT00019864|Razoxane|razoxane|mesh-list
25836554|NCT00019864|Levoleucovorin|levoleucovorin|mesh-list
24394464|NCT00133354|Hormones|hormones|mesh-list
24394465|NCT00133354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24394466|NCT00133354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394467|NCT00133354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24394468|NCT00133354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24394469|NCT00133354|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24394470|NCT00133354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24394471|NCT00133354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394472|NCT00133354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394473|NCT00133354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25836555|NCT00019864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836556|NCT00019864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25836557|NCT00019864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24394587|NCT00133692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394588|NCT00133692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24394589|NCT00133692|Sympatholytics|sympatholytics|mesh-ancestor
24394590|NCT00133692|Autonomic Agents|autonomic agents|mesh-ancestor
24394591|NCT00133692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24394592|NCT00133692|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24394593|NCT00133692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24394594|NCT00133692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24394595|NCT00133692|Adrenergic Agents|adrenergic agents|mesh-ancestor
24394596|NCT00133692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24394597|NCT00133692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24394609|NCT00133731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394611|NCT00133731|Antithrombins|antithrombins|mesh-ancestor
24394612|NCT00133731|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25836558|NCT00019864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25836559|NCT00019864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836560|NCT00019864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836561|NCT00019864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836562|NCT00019864|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25836563|NCT00019864|Abortifacient Agents|abortifacient agents|mesh-ancestor
24394705|NCT00134030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24394707|NCT00134030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25836564|NCT00019864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25836565|NCT00019864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25836566|NCT00019864|Antimetabolites|antimetabolites|mesh-ancestor
25659447|NCT01607554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659448|NCT01607554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659449|NCT01607593|Sertraline|sertraline|mesh-list
25659450|NCT01607593|Antidepressive Agents|antidepressive agents|mesh-ancestor
25659451|NCT01607593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25659452|NCT01607593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25659453|NCT01607593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25836567|NCT00019864|Dermatologic Agents|dermatologic agents|mesh-ancestor
25659454|NCT01607593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25659455|NCT01607593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659456|NCT01607593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25836568|NCT00019864|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25836569|NCT00019864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25836570|NCT00019864|Immunologic Factors|immunologic factors|mesh-ancestor
25836571|NCT00019864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25836572|NCT00019864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25836573|NCT00019864|Antidotes|antidotes|mesh-ancestor
25836574|NCT00019864|Protective Agents|protective agents|mesh-ancestor
25836575|NCT00019864|Vitamin B Complex|vitamin b complex|mesh-ancestor
25836576|NCT00019864|Vitamins|vitamins|mesh-ancestor
25836577|NCT00019864|Micronutrients|micronutrients|mesh-ancestor
25836578|NCT00019864|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25836579|NCT00019864|Antimitotic Agents|antimitotic agents|mesh-ancestor
25836580|NCT00019864|Mitosis Modulators|mitosis modulators|mesh-ancestor
25836581|NCT00019890|Sargramostim|sargramostim|mesh-list
25836582|NCT00019890|Immunologic Factors|immunologic factors|mesh-ancestor
25836583|NCT00019890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875455|NCT04322305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25875456|NCT04321408|Ziconotide|ziconotide|mesh-list
25875457|NCT04321408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25875458|NCT04321408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25875459|NCT04321408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875460|NCT04321408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25875461|NCT04321408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875462|NCT04321408|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25875463|NCT04321408|Protective Agents|protective agents|mesh-ancestor
25875464|NCT04321408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25875465|NCT04321408|Analgesics|analgesics|mesh-ancestor
25875466|NCT04321408|Sensory System Agents|sensory system agents|mesh-ancestor
25875467|NCT04321408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25875468|NCT04316117|Deoxyglucose|deoxyglucose|mesh-list
25875469|NCT04316117|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25875470|NCT04316117|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25875471|NCT04316117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875472|NCT04316117|Antimetabolites|antimetabolites|mesh-ancestor
25875473|NCT04316117|Antiviral Agents|antiviral agents|mesh-ancestor
25875474|NCT04316117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25875475|NCT04313881|Azacitidine|azacitidine|mesh-list
25163193|NCT02898610|Antimitotic Agents|antimitotic agents|mesh-ancestor
25875476|NCT04313881|Magrolimab|magrolimab|mesh-list
25875477|NCT04313881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25875478|NCT04313881|Antimetabolites|antimetabolites|mesh-ancestor
25875479|NCT04313881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875480|NCT04313881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875481|NCT04313881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875482|NCT04313881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25875483|NCT04311502|Pyridoxine|pyridoxine|mesh-list
25875484|NCT04311502|Pyridoxal|pyridoxal|mesh-list
25875485|NCT04311502|Vitamin B 6|vitamin b 6|mesh-list
25875486|NCT04311502|Rifampin|rifampin|mesh-list
25875487|NCT04311502|Rifapentine|rifapentine|mesh-list
25875488|NCT04311502|Clofazimine|clofazimine|mesh-list
25875489|NCT04311502|Isoniazid|isoniazid|mesh-list
25875490|NCT04311502|Pyrazinamide|pyrazinamide|mesh-list
25875491|NCT04311502|Ethambutol|ethambutol|mesh-list
25875492|NCT04311502|Vitamins|vitamins|mesh-ancestor
25875493|NCT04311502|Micronutrients|micronutrients|mesh-ancestor
25875494|NCT04311502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875495|NCT04311502|Vitamin B Complex|vitamin b complex|mesh-ancestor
25875496|NCT04311502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25875497|NCT04311502|Antitubercular Agents|antitubercular agents|mesh-ancestor
25875498|NCT04311502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25875499|NCT04311502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25875500|NCT04311502|Leprostatic Agents|leprostatic agents|mesh-ancestor
25875501|NCT04311502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25875502|NCT04311502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875503|NCT04311502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659457|NCT01607593|Serotonin Agents|serotonin agents|mesh-ancestor
25659458|NCT01607593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659460|NCT01607645|Decitabine|decitabine|mesh-list
25659461|NCT01607645|Azacitidine|azacitidine|mesh-list
25659462|NCT01607645|Idarubicin|idarubicin|mesh-list
25836584|NCT00019916|Aldesleukin|aldesleukin|mesh-list
25836585|NCT00019916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836586|NCT00019916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25836587|NCT00019916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25836588|NCT00019916|Antiviral Agents|antiviral agents|mesh-ancestor
25836589|NCT00019916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836590|NCT00019968|Melphalan|melphalan|mesh-list
25836591|NCT00019968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24459720|NCT00346099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836592|NCT00019968|Alkylating Agents|alkylating agents|mesh-ancestor
25836593|NCT00019968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836594|NCT00019968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836595|NCT00019968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25836596|NCT00019968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25836597|NCT00019968|Immunologic Factors|immunologic factors|mesh-ancestor
25836598|NCT00019968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836599|NCT00019994|Aldesleukin|aldesleukin|mesh-list
25836600|NCT00019994|Freund's Adjuvant|freund's adjuvant|mesh-list
25836601|NCT00019994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836602|NCT00019994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25836603|NCT00019994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25836604|NCT00019994|Antiviral Agents|antiviral agents|mesh-ancestor
25836605|NCT00019994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836606|NCT00019994|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25836607|NCT00019994|Immunologic Factors|immunologic factors|mesh-ancestor
25836608|NCT00019994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836609|NCT00020007|Paclitaxel|paclitaxel|mesh-list
25836610|NCT00020007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25836611|NCT00020007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647412|NCT01208766|Hormones|hormones|mesh-ancestor
24647413|NCT01208766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24647414|NCT01208766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24647416|NCT01208766|Immunologic Factors|immunologic factors|mesh-ancestor
25836612|NCT00020007|Tubulin Modulators|tubulin modulators|mesh-ancestor
25836613|NCT00020007|Antimitotic Agents|antimitotic agents|mesh-ancestor
25836614|NCT00020007|Mitosis Modulators|mitosis modulators|mesh-ancestor
25836615|NCT00020007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836616|NCT00020046|Thalidomide|thalidomide|mesh-list
25836617|NCT00020046|Docetaxel|docetaxel|mesh-list
25836618|NCT00020046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836619|NCT00020046|Tubulin Modulators|tubulin modulators|mesh-ancestor
25836620|NCT00020046|Antimitotic Agents|antimitotic agents|mesh-ancestor
25836621|NCT00020046|Mitosis Modulators|mitosis modulators|mesh-ancestor
25836622|NCT00020046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836623|NCT00020046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25836624|NCT00020046|Immunologic Factors|immunologic factors|mesh-ancestor
25836625|NCT00020046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836626|NCT00020046|Leprostatic Agents|leprostatic agents|mesh-ancestor
25836627|NCT00020046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25836628|NCT00020046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836629|NCT00020046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25836630|NCT00020046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25836631|NCT00020046|Growth Substances|growth substances|mesh-ancestor
25836632|NCT00020046|Growth Inhibitors|growth inhibitors|mesh-ancestor
25836633|NCT00020111|Arsenic Trioxide|arsenic trioxide|mesh-list
25836634|NCT00020111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836635|NCT00020124|Doxorubicin|doxorubicin|mesh-list
25836636|NCT00020124|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25836637|NCT00020124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25836638|NCT00020124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836639|NCT00020124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24526793|NCT00613249|Dapivirine|dapivirine|mesh-list
25836640|NCT00020124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25836641|NCT00020124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25659463|NCT01607645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25659464|NCT01607645|Antimetabolites|antimetabolites|mesh-ancestor
25659465|NCT01607645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836642|NCT00020124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836643|NCT00020150|Temozolomide|temozolomide|mesh-list
25836644|NCT00020150|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
25836645|NCT00020150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25836646|NCT00020150|Alkylating Agents|alkylating agents|mesh-ancestor
25836647|NCT00020150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659466|NCT01607645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659467|NCT01607645|Antiviral Agents|antiviral agents|mesh-ancestor
25659468|NCT01607645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25659469|NCT01607645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25659470|NCT01607645|Immunologic Factors|immunologic factors|mesh-ancestor
25659471|NCT01607645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836648|NCT00020150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836649|NCT00020150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836650|NCT00020176|Cyclosporine|cyclosporine|mesh-list
25836651|NCT00020176|Cyclophosphamide|cyclophosphamide|mesh-list
25836652|NCT00020176|Fludarabine|fludarabine|mesh-list
25836653|NCT00020176|Fludarabine phosphate|fludarabine phosphate|mesh-list
25836654|NCT00020176|Cyclosporins|cyclosporins|mesh-list
25836655|NCT00020176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25151488|NCT04622813|Analgesics|analgesics|mesh-ancestor
25151489|NCT04622813|Sensory System Agents|sensory system agents|mesh-ancestor
25836656|NCT00020176|Immunologic Factors|immunologic factors|mesh-ancestor
25836657|NCT00020176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836658|NCT00020176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25836659|NCT00020176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25836660|NCT00020176|Alkylating Agents|alkylating agents|mesh-ancestor
25836661|NCT00020176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836662|NCT00020176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836663|NCT00020176|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25836664|NCT00020176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25836665|NCT00020176|Antimetabolites|antimetabolites|mesh-ancestor
25836666|NCT00020176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836667|NCT00020176|Antifungal Agents|antifungal agents|mesh-ancestor
25836668|NCT00020176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836669|NCT00020176|Dermatologic Agents|dermatologic agents|mesh-ancestor
25836670|NCT00020176|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25836671|NCT00020189|Aspirin|aspirin|mesh-list
25836672|NCT00020189|Alvocidib|alvocidib|mesh-list
25836673|NCT00020189|Clopidogrel|clopidogrel|mesh-list
25836674|NCT00020189|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25836675|NCT00020189|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25836676|NCT00020189|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25836677|NCT00020189|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25836678|NCT00020189|Purinergic Agents|purinergic agents|mesh-ancestor
25836679|NCT00020189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25836680|NCT00020189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836681|NCT00020189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836682|NCT00020189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25836683|NCT00020189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25836684|NCT00020189|Analgesics|analgesics|mesh-ancestor
25836685|NCT00020189|Sensory System Agents|sensory system agents|mesh-ancestor
24459729|NCT00346229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24928334|NCT04123392|Decitabine|decitabine|mesh-list
25836686|NCT00020189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25836687|NCT00020189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25836688|NCT00020189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25836689|NCT00020189|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25836690|NCT00020189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25836691|NCT00020189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25163194|NCT02898610|Mitosis Modulators|mitosis modulators|mesh-ancestor
25836692|NCT00020189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836693|NCT00020189|Antipyretics|antipyretics|mesh-ancestor
25836694|NCT00020189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836695|NCT00020189|Growth Inhibitors|growth inhibitors|mesh-ancestor
25836696|NCT00020189|Growth Substances|growth substances|mesh-ancestor
25836697|NCT00020189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25836698|NCT00020202|Romidepsin|romidepsin|mesh-list
25836699|NCT00020202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25836700|NCT00020202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836701|NCT00020254|Aldesleukin|aldesleukin|mesh-list
24450523|NCT00319488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450524|NCT00319488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24450525|NCT00319488|Respiratory System Agents|respiratory system agents|mesh-ancestor
24450526|NCT00319488|Glucocorticoids|glucocorticoids|mesh-ancestor
24450528|NCT00319488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25659472|NCT01607645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25659473|NCT01607645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25836702|NCT00020254|Nilutamide|nilutamide|mesh-list
24450529|NCT00319488|Hormone Antagonists|hormone antagonists|mesh-ancestor
25659474|NCT01607645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24450530|NCT00319488|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24450531|NCT00319488|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24538161|NCT00657761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25836703|NCT00020254|Vaccines|vaccines|mesh-list
25836704|NCT00020254|Sargramostim|sargramostim|mesh-list
25836705|NCT00020254|Immunologic Factors|immunologic factors|mesh-ancestor
25836706|NCT00020254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836707|NCT00020254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836708|NCT00020254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24450538|NCT00319488|Adrenergic Agents|adrenergic agents|mesh-ancestor
24450539|NCT00319488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24450542|NCT00319514|Tubulin Modulators|tubulin modulators|mesh-ancestor
24450543|NCT00319514|Antimitotic Agents|antimitotic agents|mesh-ancestor
24450544|NCT00319514|Mitosis Modulators|mitosis modulators|mesh-ancestor
24450545|NCT00319514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450546|NCT00319566|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24450547|NCT00319566|Medroxyprogesterone|medroxyprogesterone|mesh-list
24450548|NCT00319566|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25836709|NCT00020254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25836710|NCT00020254|Antiviral Agents|antiviral agents|mesh-ancestor
25836711|NCT00020254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836712|NCT00020254|Androgen Antagonists|androgen antagonists|mesh-ancestor
25151600|NCT04554888|Doxepin|doxepin|mesh-list
25836713|NCT00020254|Hormone Antagonists|hormone antagonists|mesh-ancestor
25836714|NCT00020254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25836715|NCT00020267|Interleukin-2|interleukin-2|mesh-list
25836716|NCT00020267|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25836717|NCT00020267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836718|NCT00020267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25836719|NCT00020267|Analgesics|analgesics|mesh-ancestor
25836720|NCT00020267|Sensory System Agents|sensory system agents|mesh-ancestor
25836721|NCT00020267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25836722|NCT00020267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836723|NCT00020267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25836724|NCT00020267|Immunologic Factors|immunologic factors|mesh-ancestor
25836725|NCT00020332|Docetaxel|docetaxel|mesh-list
25836726|NCT00020332|Alvocidib|alvocidib|mesh-list
25836727|NCT00020332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836728|NCT00020332|Tubulin Modulators|tubulin modulators|mesh-ancestor
25836729|NCT00020332|Antimitotic Agents|antimitotic agents|mesh-ancestor
25836730|NCT00020332|Mitosis Modulators|mitosis modulators|mesh-ancestor
25836731|NCT00020332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836732|NCT00020332|Growth Inhibitors|growth inhibitors|mesh-ancestor
25836733|NCT00020332|Growth Substances|growth substances|mesh-ancestor
25836734|NCT00020332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836735|NCT00020332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25836736|NCT00020332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836737|NCT00020345|Gemcitabine|gemcitabine|mesh-list
25836738|NCT00020345|Fluorouracil|fluorouracil|mesh-list
25836739|NCT00020345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25836740|NCT00020345|Antimetabolites|antimetabolites|mesh-ancestor
25041401|NCT02547818|Sensory System Agents|sensory system agents|mesh-ancestor
25041402|NCT02547818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25041403|NCT02547818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041404|NCT02547818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25041405|NCT02547818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25041406|NCT02547818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25041407|NCT02547818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041408|NCT02547818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041409|NCT02539537|Leucovorin|leucovorin|mesh-list
25041410|NCT02539537|Folic Acid|folic acid|mesh-list
25041411|NCT02539537|Gemcitabine|gemcitabine|mesh-list
25041412|NCT02539537|Fluorouracil|fluorouracil|mesh-list
25041413|NCT02539537|Oxaliplatin|oxaliplatin|mesh-list
25041414|NCT02539537|Irinotecan|irinotecan|mesh-list
25836741|NCT00020345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836742|NCT00020345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836743|NCT00020345|Antiviral Agents|antiviral agents|mesh-ancestor
25836744|NCT00020345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25151653|NCT04547153|Docetaxel|docetaxel|mesh-list
25836745|NCT00020345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836746|NCT00020345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25836747|NCT00020345|Immunologic Factors|immunologic factors|mesh-ancestor
25659475|NCT01607645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25659476|NCT01607853|Calcitriol|calcitriol|mesh-list
25836748|NCT00020345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836749|NCT00020358|Aldesleukin|aldesleukin|mesh-list
25836750|NCT00020358|Freund's Adjuvant|freund's adjuvant|mesh-list
25836751|NCT00020358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647774|NCT01210638|Oxymorphone|oxymorphone|mesh-list
25836752|NCT00020358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25836753|NCT00020358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25836754|NCT00020358|Antiviral Agents|antiviral agents|mesh-ancestor
25836755|NCT00020358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836756|NCT00020358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25836757|NCT00020358|Immunologic Factors|immunologic factors|mesh-ancestor
25836758|NCT00020358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836759|NCT00020371|Lenograstim|lenograstim|mesh-list
25836760|NCT00020371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25163195|NCT02898610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163196|NCT02898610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25202941|NCT02717871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25202942|NCT02717871|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25202943|NCT02717871|Protective Agents|protective agents|mesh-ancestor
25202944|NCT02717871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25202945|NCT02717871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25202946|NCT02717871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25202947|NCT02717871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25202948|NCT02717871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202949|NCT02717871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202950|NCT02717871|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25202951|NCT02717871|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25836761|NCT00020371|Immunologic Factors|immunologic factors|mesh-ancestor
25202953|NCT02717871|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25202954|NCT02717871|Renal Agents|renal agents|mesh-ancestor
25202955|NCT02717871|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25202956|NCT02717871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25202957|NCT02717871|Parasympatholytics|parasympatholytics|mesh-ancestor
25202958|NCT02717871|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25836762|NCT00020371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836763|NCT00020397|Aldesleukin|aldesleukin|mesh-list
25836764|NCT00020397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527016|NCT00614471|Interferon-alpha|interferon-alpha|mesh-list
25836765|NCT00020397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25836766|NCT00020397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25836767|NCT00020397|Antiviral Agents|antiviral agents|mesh-ancestor
25836768|NCT00020397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836769|NCT00020410|Antibodies|antibodies|mesh-list
25836770|NCT00020410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25836771|NCT00020410|Immunologic Factors|immunologic factors|mesh-ancestor
25836772|NCT00020410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836773|NCT00020449|Paclitaxel|paclitaxel|mesh-list
25836774|NCT00020449|Doxorubicin|doxorubicin|mesh-list
25836775|NCT00020449|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25836776|NCT00020449|Interleukin-12|interleukin-12|mesh-list
25836777|NCT00020449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25836778|NCT00020449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836779|NCT00020449|Tubulin Modulators|tubulin modulators|mesh-ancestor
25836780|NCT00020449|Antimitotic Agents|antimitotic agents|mesh-ancestor
25836781|NCT00020449|Mitosis Modulators|mitosis modulators|mesh-ancestor
25836782|NCT00020449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836783|NCT00020449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25836784|NCT00020449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25836785|NCT00020449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25836786|NCT00020449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836787|NCT00020449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25836788|NCT00020449|Immunologic Factors|immunologic factors|mesh-ancestor
25836789|NCT00020449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836790|NCT00020449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25836791|NCT00020449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25836792|NCT00020449|Growth Substances|growth substances|mesh-ancestor
25836793|NCT00020449|Growth Inhibitors|growth inhibitors|mesh-ancestor
25836794|NCT00020462|Aldesleukin|aldesleukin|mesh-list
25836795|NCT00020462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836796|NCT00020462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25836797|NCT00020462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25836798|NCT00020462|Antiviral Agents|antiviral agents|mesh-ancestor
25836799|NCT00020462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836800|NCT00020475|Interleukin-2|interleukin-2|mesh-list
25836801|NCT00020475|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25836802|NCT00020475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836803|NCT00020475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24816170|NCT02074605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24816171|NCT02074605|Immunologic Factors|immunologic factors|mesh-ancestor
24816172|NCT02074605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816174|NCT02074800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24816175|NCT02074800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816176|NCT02074800|Immunologic Factors|immunologic factors|mesh-ancestor
25836804|NCT00020475|Analgesics|analgesics|mesh-ancestor
25836805|NCT00020475|Sensory System Agents|sensory system agents|mesh-ancestor
25836806|NCT00020475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25836807|NCT00020475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527146|NCT00615173|Antimetabolites|antimetabolites|mesh-ancestor
25836808|NCT00020475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25836809|NCT00020475|Immunologic Factors|immunologic factors|mesh-ancestor
25836810|NCT00020488|Leucovorin|leucovorin|mesh-list
25836811|NCT00020488|Fluorouracil|fluorouracil|mesh-list
25836812|NCT00020488|Irinotecan|irinotecan|mesh-list
25836813|NCT00020488|Calcium|calcium|mesh-list
25836814|NCT00020488|Levoleucovorin|levoleucovorin|mesh-list
25836815|NCT00020488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25836816|NCT00020488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836817|NCT00020488|Antimetabolites|antimetabolites|mesh-ancestor
25836818|NCT00020488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836819|NCT00020488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25836820|NCT00020488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836821|NCT00020488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25836822|NCT00020488|Immunologic Factors|immunologic factors|mesh-ancestor
25836823|NCT00020488|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25836824|NCT00020488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25836825|NCT00020488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836826|NCT00020488|Antidotes|antidotes|mesh-ancestor
25836827|NCT00020488|Protective Agents|protective agents|mesh-ancestor
25836828|NCT00020488|Vitamin B Complex|vitamin b complex|mesh-ancestor
25836829|NCT00020488|Vitamins|vitamins|mesh-ancestor
25836830|NCT00020488|Micronutrients|micronutrients|mesh-ancestor
25836831|NCT00020501|Leucovorin|leucovorin|mesh-list
25836832|NCT00020501|Fluorouracil|fluorouracil|mesh-list
25836833|NCT00020501|Floxuridine|floxuridine|mesh-list
25836834|NCT00020501|Irinotecan|irinotecan|mesh-list
25836835|NCT00020501|Melphalan|melphalan|mesh-list
25836836|NCT00020501|Calcium|calcium|mesh-list
25836837|NCT00020501|Levoleucovorin|levoleucovorin|mesh-list
25836838|NCT00020501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24538437|NCT00659386|Immunoglobulins|immunoglobulins|mesh-list
25836839|NCT00020501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836840|NCT00020501|Antimetabolites|antimetabolites|mesh-ancestor
25836841|NCT00020501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836842|NCT00020501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25836843|NCT00020501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836844|NCT00020501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25836845|NCT00020501|Immunologic Factors|immunologic factors|mesh-ancestor
25836846|NCT00020501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25836847|NCT00020501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25836848|NCT00020501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836849|NCT00020501|Antidotes|antidotes|mesh-ancestor
25836850|NCT00020501|Protective Agents|protective agents|mesh-ancestor
25836851|NCT00020501|Vitamin B Complex|vitamin b complex|mesh-ancestor
25836852|NCT00020501|Vitamins|vitamins|mesh-ancestor
25836853|NCT00020501|Micronutrients|micronutrients|mesh-ancestor
25836854|NCT00020501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25836855|NCT00020501|Alkylating Agents|alkylating agents|mesh-ancestor
25836856|NCT00020501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25836857|NCT00020527|Caspofungin|caspofungin|mesh-list
25836858|NCT00020527|Antifungal Agents|antifungal agents|mesh-ancestor
25836859|NCT00020527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836860|NCT00020527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836861|NCT00020527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836862|NCT00020540|Flt3 ligand protein|flt3 ligand protein|mesh-list
25836863|NCT00020540|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25659477|NCT01607853|Betamethasone|betamethasone|mesh-list
25659478|NCT01607853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25659479|NCT01607853|Glucocorticoids|glucocorticoids|mesh-ancestor
25659480|NCT01607853|Hormones|hormones|mesh-ancestor
25659481|NCT01607853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25659482|NCT01607853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836864|NCT00020540|Immunologic Factors|immunologic factors|mesh-ancestor
25836865|NCT00020540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836866|NCT00020540|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24882910|NCT04769206|Galantamine|galantamine|mesh-list
24882911|NCT04769206|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24882912|NCT04769206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24882913|NCT04769206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659483|NCT01607853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25659484|NCT01607853|Respiratory System Agents|respiratory system agents|mesh-ancestor
25659485|NCT01607853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25659486|NCT01607853|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25836867|NCT00020540|Protective Agents|protective agents|mesh-ancestor
25836868|NCT00020566|Dactinomycin|dactinomycin|mesh-list
25836869|NCT00020566|Doxorubicin|doxorubicin|mesh-list
25836870|NCT00020566|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25836871|NCT00020566|Etoposide|etoposide|mesh-list
25836872|NCT00020566|Vincristine|vincristine|mesh-list
25836873|NCT00020566|Melphalan|melphalan|mesh-list
25836874|NCT00020566|Busulfan|busulfan|mesh-list
25836875|NCT00020566|Ifosfamide|ifosfamide|mesh-list
25836876|NCT00020566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25836877|NCT00020566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836878|NCT00020566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25836879|NCT00020566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25836880|NCT00020566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836881|NCT00020566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836882|NCT00020566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25836883|NCT00020566|Tubulin Modulators|tubulin modulators|mesh-ancestor
25836884|NCT00020566|Antimitotic Agents|antimitotic agents|mesh-ancestor
25836885|NCT00020566|Mitosis Modulators|mitosis modulators|mesh-ancestor
25836886|NCT00020566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25836887|NCT00020566|Alkylating Agents|alkylating agents|mesh-ancestor
25836888|NCT00020566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25836889|NCT00020566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25836890|NCT00020566|Immunologic Factors|immunologic factors|mesh-ancestor
25836891|NCT00020566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836892|NCT00020566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25836893|NCT00020566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836894|NCT00020566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25836895|NCT00020566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25836896|NCT00020579|Entinostat|entinostat|mesh-list
25836897|NCT00020579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836898|NCT00020579|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25836899|NCT00020579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836900|NCT00020579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836901|NCT00020605|Naloxone|naloxone|mesh-list
25836902|NCT00020605|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25836903|NCT00020605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836904|NCT00020605|Sensory System Agents|sensory system agents|mesh-ancestor
25836905|NCT00020605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25836906|NCT00020618|Morphine|morphine|mesh-list
25836907|NCT00020618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25836908|NCT00020618|Narcotics|narcotics|mesh-ancestor
25836909|NCT00020618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25836910|NCT00020618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836911|NCT00020618|Analgesics|analgesics|mesh-ancestor
25836912|NCT00020618|Sensory System Agents|sensory system agents|mesh-ancestor
25836913|NCT00020618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25836914|NCT00020631|Pirfenidone|pirfenidone|mesh-list
25151950|NCT04312503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25836915|NCT00020631|Analgesics|analgesics|mesh-ancestor
25836916|NCT00020631|Sensory System Agents|sensory system agents|mesh-ancestor
25836917|NCT00020631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25836918|NCT00020631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836919|NCT00020631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25836920|NCT00020631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25836921|NCT00020631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25836922|NCT00020631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25836923|NCT00020631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836924|NCT00020644|Gemcitabine|gemcitabine|mesh-list
25836925|NCT00020644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25836926|NCT00020644|Antimetabolites|antimetabolites|mesh-ancestor
25836927|NCT00020644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659487|NCT01607853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25659488|NCT01607853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659489|NCT01607853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25195644|NCT02757469|Drospirenone|drospirenone|mesh-list
25836928|NCT00020644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836929|NCT00020644|Antiviral Agents|antiviral agents|mesh-ancestor
25659491|NCT01607853|Micronutrients|micronutrients|mesh-ancestor
25836930|NCT00020644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836931|NCT00020644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836932|NCT00020644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25836933|NCT00020644|Immunologic Factors|immunologic factors|mesh-ancestor
24882988|NCT04673617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882989|NCT04673617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24882990|NCT04673617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24882991|NCT04673617|Alkylating Agents|alkylating agents|mesh-ancestor
24882992|NCT04673617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882993|NCT04673617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882994|NCT04673617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24882995|NCT04673617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25836934|NCT00020644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836935|NCT00020657|Ondansetron|ondansetron|mesh-list
25836936|NCT00020657|Granisetron|granisetron|mesh-list
25836937|NCT00020657|Prochlorperazine|prochlorperazine|mesh-list
25836938|NCT00020657|Dolasetron|dolasetron|mesh-list
25836939|NCT00020657|Antiemetics|antiemetics|mesh-ancestor
25836940|NCT00020657|Autonomic Agents|autonomic agents|mesh-ancestor
25836941|NCT00020657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25836942|NCT00020657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836943|NCT00020657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25836944|NCT00020657|Antipruritics|antipruritics|mesh-ancestor
25836945|NCT00020657|Dermatologic Agents|dermatologic agents|mesh-ancestor
25836946|NCT00020657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24450580|NCT00319683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450581|NCT00319709|Amibegron|amibegron|mesh-list
24450600|NCT00319787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24450601|NCT00319787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450602|NCT00319787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836947|NCT00020657|Serotonin Agents|serotonin agents|mesh-ancestor
25836948|NCT00020657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25836949|NCT00020657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836950|NCT00020657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25836951|NCT00020657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25836952|NCT00020657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25836953|NCT00020657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25836954|NCT00020657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25836955|NCT00020657|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25836956|NCT00020657|Dopamine Agents|dopamine agents|mesh-ancestor
25836957|NCT00020670|Vaccines|vaccines|mesh-list
25836958|NCT00020670|Immunologic Factors|immunologic factors|mesh-ancestor
25836959|NCT00020670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836960|NCT00020696|Cisplatin|cisplatin|mesh-list
25836961|NCT00020696|Tirapazamine|tirapazamine|mesh-list
24459743|NCT00346294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24459744|NCT00346294|Analgesics|analgesics|mesh-ancestor
24459745|NCT00346294|Sensory System Agents|sensory system agents|mesh-ancestor
25836962|NCT00020696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836963|NCT00020709|Cisplatin|cisplatin|mesh-list
25836964|NCT00020709|Docetaxel|docetaxel|mesh-list
25836965|NCT00020709|Etoposide|etoposide|mesh-list
25163197|NCT02897934|Bupivacaine|bupivacaine|mesh-list
25163198|NCT02897934|Anesthetics, Local|anesthetics, local|mesh-ancestor
25836966|NCT00020709|Etoposide phosphate|etoposide phosphate|mesh-list
25836967|NCT00020709|Gefitinib|gefitinib|mesh-list
25836968|NCT00020709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836969|NCT00020709|Tubulin Modulators|tubulin modulators|mesh-ancestor
25836970|NCT00020709|Antimitotic Agents|antimitotic agents|mesh-ancestor
25836971|NCT00020709|Mitosis Modulators|mitosis modulators|mesh-ancestor
25836972|NCT00020709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836973|NCT00020709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25414344|NCT03070886|Nilutamide|nilutamide|mesh-list
25659492|NCT01607853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25659493|NCT01607905|Acetaminophen|acetaminophen|mesh-list
25659494|NCT01607905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25659495|NCT01607905|Analgesics|analgesics|mesh-ancestor
25659496|NCT01607905|Sensory System Agents|sensory system agents|mesh-ancestor
25659497|NCT01607905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25659498|NCT01607905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659499|NCT01607905|Antipyretics|antipyretics|mesh-ancestor
25659500|NCT01608087|Bevacizumab|bevacizumab|mesh-list
25659501|NCT01608087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25659502|NCT01608087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659503|NCT01608087|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25032804|NCT03578263|Oxytocin|oxytocin|mesh-list
25057311|NCT03506178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25057312|NCT03506178|Adrenergic Agents|adrenergic agents|mesh-ancestor
25057313|NCT03506178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25057314|NCT03506178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057315|NCT03506178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057316|NCT03506178|Sympathomimetics|sympathomimetics|mesh-ancestor
25057317|NCT03506178|Autonomic Agents|autonomic agents|mesh-ancestor
24972103|NCT03720067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24972104|NCT03720067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972105|NCT03720067|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24972106|NCT03720067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24972107|NCT03720067|Vasodilator Agents|vasodilator agents|mesh-ancestor
24972108|NCT03720067|Antioxidants|antioxidants|mesh-ancestor
24972109|NCT03720067|Protective Agents|protective agents|mesh-ancestor
24972193|NCT03719625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24972194|NCT03719625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24972319|NCT03719053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25836974|NCT00020709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25836975|NCT00020709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25836976|NCT00020709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836977|NCT00020709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25836978|NCT00020735|Toremifene|toremifene|mesh-list
25836979|NCT00020735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25836980|NCT00020735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836981|NCT00020735|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25836982|NCT00020735|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25836983|NCT00020735|Hormone Antagonists|hormone antagonists|mesh-ancestor
25836984|NCT00020735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25836985|NCT00020735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25836986|NCT00020735|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25836987|NCT00020748|Irinotecan|irinotecan|mesh-list
25836988|NCT00020748|Epirubicin|epirubicin|mesh-list
25836989|NCT00020748|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25163199|NCT02897934|Anesthetics|anesthetics|mesh-ancestor
25836990|NCT00020748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25836991|NCT00020748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25836992|NCT00020748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25836993|NCT00020748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25836994|NCT00020748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25836995|NCT00020748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25836996|NCT00020761|Paclitaxel|paclitaxel|mesh-list
24648311|NCT01213498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459746|NCT00346294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25836997|NCT00020761|Irinotecan|irinotecan|mesh-list
25836998|NCT00020761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25836999|NCT00020761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837000|NCT00020761|Tubulin Modulators|tubulin modulators|mesh-ancestor
25837001|NCT00020761|Antimitotic Agents|antimitotic agents|mesh-ancestor
25837002|NCT00020761|Mitosis Modulators|mitosis modulators|mesh-ancestor
25837003|NCT00020761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837004|NCT00020761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25837005|NCT00020761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25837006|NCT00020761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837007|NCT00020774|Gemcitabine|gemcitabine|mesh-list
25837008|NCT00020774|Lonafarnib|lonafarnib|mesh-list
25659504|NCT01608087|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25659505|NCT01608087|Growth Substances|growth substances|mesh-ancestor
25659506|NCT01608087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659507|NCT01608087|Growth Inhibitors|growth inhibitors|mesh-ancestor
25659508|NCT01608295|Paroxetine|paroxetine|mesh-list
25659509|NCT01608295|Antidepressive Agents|antidepressive agents|mesh-list
25659510|NCT01608295|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
25659511|NCT01608295|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25659512|NCT01608295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25659513|NCT01608295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25659514|NCT01608295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659515|NCT01608295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25659516|NCT01608295|Serotonin Agents|serotonin agents|mesh-ancestor
25659517|NCT01608295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659518|NCT01608295|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25659519|NCT01608295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25195785|NCT02756663|Hormones|hormones|mesh-ancestor
25659520|NCT01608295|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25201467|NCT02727621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25837009|NCT00020774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25837010|NCT00020774|Antimetabolites|antimetabolites|mesh-ancestor
25837011|NCT00020774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837012|NCT00020774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837013|NCT00020774|Antiviral Agents|antiviral agents|mesh-ancestor
25837014|NCT00020774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25837015|NCT00020774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837016|NCT00020774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25837017|NCT00020774|Immunologic Factors|immunologic factors|mesh-ancestor
25837018|NCT00020774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837019|NCT00020787|Cisplatin|cisplatin|mesh-list
25837020|NCT00020787|Fluorouracil|fluorouracil|mesh-list
25837021|NCT00020787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837022|NCT00020787|Antimetabolites|antimetabolites|mesh-ancestor
25837023|NCT00020787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837024|NCT00020787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25837025|NCT00020787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25837026|NCT00020787|Immunologic Factors|immunologic factors|mesh-ancestor
25837027|NCT00020787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837028|NCT00020800|Rituximab|rituximab|mesh-list
25837029|NCT00020800|Fludarabine|fludarabine|mesh-list
25837030|NCT00020800|Fludarabine phosphate|fludarabine phosphate|mesh-list
25837031|NCT00020800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25837032|NCT00020800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837033|NCT00020800|Immunologic Factors|immunologic factors|mesh-ancestor
25837034|NCT00020800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837035|NCT00020800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25837036|NCT00020800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25837037|NCT00020800|Antimetabolites|antimetabolites|mesh-ancestor
25837038|NCT00020800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837039|NCT00020800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25837040|NCT00020839|Temozolomide|temozolomide|mesh-list
25837041|NCT00020839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25837042|NCT00020839|Alkylating Agents|alkylating agents|mesh-ancestor
25837043|NCT00020839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837044|NCT00020839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837045|NCT00020865|Levofloxacin|levofloxacin|mesh-list
25837046|NCT00020865|Ofloxacin|ofloxacin|mesh-list
25837047|NCT00020865|Cefepime|cefepime|mesh-list
25837048|NCT00020865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25837049|NCT00020865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25837050|NCT00020865|Renal Agents|renal agents|mesh-ancestor
25837051|NCT00020865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25837052|NCT00020865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25837053|NCT00020865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25837054|NCT00020865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837055|NCT00020865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837056|NCT00020865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837057|NCT00020865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25837058|NCT00020865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25837059|NCT00020878|Celecoxib|celecoxib|mesh-list
25837060|NCT00020878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25837061|NCT00020878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25837062|NCT00020878|Analgesics|analgesics|mesh-ancestor
25837063|NCT00020878|Sensory System Agents|sensory system agents|mesh-ancestor
25837064|NCT00020878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25837065|NCT00020878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837066|NCT00020878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25837067|NCT00020878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25837068|NCT00020878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25837069|NCT00020878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24538742|NCT00660647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25837070|NCT00020878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837071|NCT00020878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837072|NCT00020917|Leucovorin|leucovorin|mesh-list
25837073|NCT00020917|Fluorouracil|fluorouracil|mesh-list
24527553|NCT00617370|Antimitotic Agents|antimitotic agents|mesh-ancestor
25163200|NCT02897934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25659521|NCT01608295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25659522|NCT01608295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25659523|NCT01608295|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25659524|NCT01608295|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25659525|NCT01608308|Acetaminophen|acetaminophen|mesh-list
25837074|NCT00020917|Irinotecan|irinotecan|mesh-list
25837075|NCT00020917|Cetuximab|cetuximab|mesh-list
25837076|NCT00020917|Calcium|calcium|mesh-list
25837077|NCT00020917|Levoleucovorin|levoleucovorin|mesh-list
25837078|NCT00020917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25837079|NCT00020917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837080|NCT00020917|Antimetabolites|antimetabolites|mesh-ancestor
25837081|NCT00020917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837082|NCT00020917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25837083|NCT00020917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837084|NCT00020917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25837085|NCT00020917|Immunologic Factors|immunologic factors|mesh-ancestor
25837086|NCT00020917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25048455|NCT00698230|Metformin|metformin|mesh-list
25837087|NCT00020917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25837088|NCT00020917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837089|NCT00020917|Antidotes|antidotes|mesh-ancestor
25837090|NCT00020917|Protective Agents|protective agents|mesh-ancestor
25837091|NCT00020917|Vitamin B Complex|vitamin b complex|mesh-ancestor
25837092|NCT00020917|Vitamins|vitamins|mesh-ancestor
25837093|NCT00020917|Micronutrients|micronutrients|mesh-ancestor
25837094|NCT00020917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25837095|NCT00020930|Cetuximab|cetuximab|mesh-list
25837096|NCT00020930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25837097|NCT00020930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837098|NCT00020943|Leucovorin|leucovorin|mesh-list
25837099|NCT00020943|Cytarabine|cytarabine|mesh-list
25837100|NCT00020943|Prednisone|prednisone|mesh-list
25837101|NCT00020943|Cyclophosphamide|cyclophosphamide|mesh-list
25837102|NCT00020943|Carmustine|carmustine|mesh-list
25837103|NCT00020943|Rituximab|rituximab|mesh-list
25837104|NCT00020943|Doxorubicin|doxorubicin|mesh-list
25837105|NCT00020943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25837106|NCT00020943|Methotrexate|methotrexate|mesh-list
25837107|NCT00020943|Etoposide|etoposide|mesh-list
25837108|NCT00020943|Vincristine|vincristine|mesh-list
25152422|NCT04083365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25837109|NCT00020943|Levoleucovorin|levoleucovorin|mesh-list
25837110|NCT00020943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25837111|NCT00020943|Immunologic Factors|immunologic factors|mesh-ancestor
25837112|NCT00020943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837113|NCT00020943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25837114|NCT00020943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25837115|NCT00020943|Alkylating Agents|alkylating agents|mesh-ancestor
25837116|NCT00020943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837117|NCT00020943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837118|NCT00020943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25837119|NCT00020943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25837120|NCT00020943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25837121|NCT00020943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24928722|NCT04119752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25837122|NCT00020943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25837123|NCT00020943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837124|NCT00020943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25837125|NCT00020943|Glucocorticoids|glucocorticoids|mesh-ancestor
25837126|NCT00020943|Hormones|hormones|mesh-ancestor
25837127|NCT00020943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25837128|NCT00020943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25152462|NCT04052139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837129|NCT00020943|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25837130|NCT00020943|Abortifacient Agents|abortifacient agents|mesh-ancestor
25837131|NCT00020943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25837132|NCT00020943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25837133|NCT00020943|Antimetabolites|antimetabolites|mesh-ancestor
25837134|NCT00020943|Dermatologic Agents|dermatologic agents|mesh-ancestor
25837135|NCT00020943|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25837136|NCT00020943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25837137|NCT00020943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25837138|NCT00020943|Antiviral Agents|antiviral agents|mesh-ancestor
25837139|NCT00020943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25837140|NCT00020943|Antidotes|antidotes|mesh-ancestor
25837141|NCT00020943|Protective Agents|protective agents|mesh-ancestor
25837142|NCT00020943|Vitamin B Complex|vitamin b complex|mesh-ancestor
25837143|NCT00020943|Vitamins|vitamins|mesh-ancestor
25837144|NCT00020943|Micronutrients|micronutrients|mesh-ancestor
25837145|NCT00020943|Tubulin Modulators|tubulin modulators|mesh-ancestor
25837146|NCT00020943|Antimitotic Agents|antimitotic agents|mesh-ancestor
25837147|NCT00020943|Mitosis Modulators|mitosis modulators|mesh-ancestor
25057358|NCT03505788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811571|NCT02047175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25837148|NCT00020969|Arsenic Trioxide|arsenic trioxide|mesh-list
25837149|NCT00020969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837151|NCT00021034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25837152|NCT00021034|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25837153|NCT00021034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538822|NCT00660894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25837154|NCT00021047|Carboplatin|carboplatin|mesh-list
25837155|NCT00021047|Capecitabine|capecitabine|mesh-list
25837156|NCT00021047|Epirubicin|epirubicin|mesh-list
25837157|NCT00021047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837158|NCT00021047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25837159|NCT00021047|Antimetabolites|antimetabolites|mesh-ancestor
25837160|NCT00021047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837161|NCT00021047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25837162|NCT00021047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25837163|NCT00021047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25837164|NCT00021047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837165|NCT00021060|Paclitaxel|paclitaxel|mesh-list
25837166|NCT00021060|Bevacizumab|bevacizumab|mesh-list
25837167|NCT00021060|Carboplatin|carboplatin|mesh-list
25837168|NCT00021060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25837169|NCT00021060|Antibodies|antibodies|mesh-list
25837170|NCT00021060|Immunoglobulins|immunoglobulins|mesh-list
25152488|NCT04026880|Androgens|androgens|mesh-ancestor
25837171|NCT00021060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25837172|NCT00021060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25837173|NCT00021060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962561|NCT03797625|Cisplatin|cisplatin|mesh-list
24439917|NCT00280878|Ifosfamide|ifosfamide|mesh-list
25837174|NCT00021060|Tubulin Modulators|tubulin modulators|mesh-ancestor
25837175|NCT00021060|Antimitotic Agents|antimitotic agents|mesh-ancestor
25837176|NCT00021060|Mitosis Modulators|mitosis modulators|mesh-ancestor
25837177|NCT00021060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837178|NCT00021060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25837179|NCT00021060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24450604|NCT00319800|Gefitinib|gefitinib|mesh-list
25837180|NCT00021060|Growth Substances|growth substances|mesh-ancestor
25837181|NCT00021060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837182|NCT00021060|Growth Inhibitors|growth inhibitors|mesh-ancestor
25837183|NCT00021060|Immunologic Factors|immunologic factors|mesh-ancestor
25837184|NCT00021073|Leucovorin|leucovorin|mesh-list
25837185|NCT00021073|Fluorouracil|fluorouracil|mesh-list
25837186|NCT00021073|Irinotecan|irinotecan|mesh-list
25837187|NCT00021073|Alvocidib|alvocidib|mesh-list
25837188|NCT00021073|Calcium|calcium|mesh-list
25837189|NCT00021073|Levoleucovorin|levoleucovorin|mesh-list
25837190|NCT00021073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25837191|NCT00021073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837192|NCT00021073|Antimetabolites|antimetabolites|mesh-ancestor
25837193|NCT00021073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837194|NCT00021073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25837195|NCT00021073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837196|NCT00021073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25837197|NCT00021073|Immunologic Factors|immunologic factors|mesh-ancestor
25837198|NCT00021073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25837199|NCT00021073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25837200|NCT00021073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837201|NCT00021073|Antidotes|antidotes|mesh-ancestor
25837202|NCT00021073|Protective Agents|protective agents|mesh-ancestor
25837203|NCT00021073|Vitamin B Complex|vitamin b complex|mesh-ancestor
25837204|NCT00021073|Vitamins|vitamins|mesh-ancestor
25837205|NCT00021073|Micronutrients|micronutrients|mesh-ancestor
25837206|NCT00021073|Growth Inhibitors|growth inhibitors|mesh-ancestor
25837207|NCT00021073|Growth Substances|growth substances|mesh-ancestor
25837208|NCT00021073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25837209|NCT00021099|Epothilones|epothilones|mesh-list
25837210|NCT00021099|Epothilone B|epothilone b|mesh-list
25837211|NCT00021099|Tubulin Modulators|tubulin modulators|mesh-ancestor
25659526|NCT01608308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25659527|NCT01608308|Analgesics|analgesics|mesh-ancestor
25659528|NCT01608308|Sensory System Agents|sensory system agents|mesh-ancestor
25837212|NCT00021099|Antimitotic Agents|antimitotic agents|mesh-ancestor
25837213|NCT00021099|Mitosis Modulators|mitosis modulators|mesh-ancestor
25659529|NCT01608308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25837214|NCT00021099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837215|NCT00021099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837216|NCT00021112|Cisplatin|cisplatin|mesh-list
25837217|NCT00021112|Etoposide|etoposide|mesh-list
25837218|NCT00021112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837219|NCT00021112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25837220|NCT00021112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25837221|NCT00021112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25659530|NCT01608308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659531|NCT01608308|Antipyretics|antipyretics|mesh-ancestor
25659532|NCT01608659|Botulinum Toxins|botulinum toxins|mesh-list
25837222|NCT00021112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837223|NCT00021112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837224|NCT00021138|Nicotine|nicotine|mesh-list
25837225|NCT00021138|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25837226|NCT00021138|Autonomic Agents|autonomic agents|mesh-ancestor
25837227|NCT00021138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25837228|NCT00021138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459747|NCT00346294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837229|NCT00021138|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25837230|NCT00021138|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24538853|NCT00660972|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25837231|NCT00021138|Cholinergic Agents|cholinergic agents|mesh-ancestor
25837232|NCT00021138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25837233|NCT00021138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837234|NCT00021151|Alemtuzumab|alemtuzumab|mesh-list
25837235|NCT00021151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25837236|NCT00021151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837237|NCT00021164|Aldesleukin|aldesleukin|mesh-list
25837238|NCT00021164|Freund's Adjuvant|freund's adjuvant|mesh-list
25837239|NCT00021164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837240|NCT00021164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25837241|NCT00021164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25837242|NCT00021164|Antiviral Agents|antiviral agents|mesh-ancestor
25837243|NCT00021164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25837244|NCT00021164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25837245|NCT00021164|Immunologic Factors|immunologic factors|mesh-ancestor
25837246|NCT00021164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837247|NCT00021216|Bortezomib|bortezomib|mesh-list
25837248|NCT00021216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163201|NCT02897934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163202|NCT02897934|Sensory System Agents|sensory system agents|mesh-ancestor
25837249|NCT00021242|Docetaxel|docetaxel|mesh-list
25837250|NCT00021242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24946783|NCT03935347|Vidarabine|vidarabine|mesh-list
24440126|NCT00281892|Vidarabine|vidarabine|mesh-list
25837251|NCT00021242|Tubulin Modulators|tubulin modulators|mesh-ancestor
25837252|NCT00021242|Antimitotic Agents|antimitotic agents|mesh-ancestor
25837253|NCT00021242|Mitosis Modulators|mitosis modulators|mesh-ancestor
25837254|NCT00021242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837255|NCT00021268|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
25837256|NCT00021268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837257|NCT00021268|Immunologic Factors|immunologic factors|mesh-ancestor
25837258|NCT00021268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837259|NCT00021281|Leucovorin|leucovorin|mesh-list
25837260|NCT00021281|Fluorouracil|fluorouracil|mesh-list
25837261|NCT00021281|Irinotecan|irinotecan|mesh-list
25837262|NCT00021281|Calcium|calcium|mesh-list
25837263|NCT00021281|Levoleucovorin|levoleucovorin|mesh-list
25837264|NCT00021281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25837265|NCT00021281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837266|NCT00021281|Antimetabolites|antimetabolites|mesh-ancestor
25837267|NCT00021281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837268|NCT00021281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25837269|NCT00021281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837270|NCT00021281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25837271|NCT00021281|Immunologic Factors|immunologic factors|mesh-ancestor
25837272|NCT00021281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25837273|NCT00021281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25837274|NCT00021281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837275|NCT00021281|Antidotes|antidotes|mesh-ancestor
25837276|NCT00021281|Protective Agents|protective agents|mesh-ancestor
25837277|NCT00021281|Vitamin B Complex|vitamin b complex|mesh-ancestor
25837278|NCT00021281|Vitamins|vitamins|mesh-ancestor
25659533|NCT01608659|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25659534|NCT01608659|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25196045|NCT02754726|Antimitotic Agents|antimitotic agents|mesh-ancestor
25659535|NCT01608659|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25659536|NCT01608659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25837279|NCT00021281|Micronutrients|micronutrients|mesh-ancestor
25837280|NCT00021294|Eflornithine|eflornithine|mesh-list
25837281|NCT00021294|Triamcinolone|triamcinolone|mesh-list
25837282|NCT00021294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25837283|NCT00021294|Glucocorticoids|glucocorticoids|mesh-ancestor
25659537|NCT01608659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659538|NCT01608659|Cholinergic Agents|cholinergic agents|mesh-ancestor
25659539|NCT01608659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25659540|NCT01608659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659541|NCT01608659|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24883223|NCT04295863|Pembrolizumab|pembrolizumab|mesh-list
25837284|NCT00021294|Hormones|hormones|mesh-ancestor
25837285|NCT00021294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25837286|NCT00021294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837287|NCT00021294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837288|NCT00021294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837289|NCT00021294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837290|NCT00021294|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25837291|NCT00021294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25837292|NCT00021294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25837293|NCT00021294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25837294|NCT00021294|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
25837295|NCT00021307|Carboplatin|carboplatin|mesh-list
25837296|NCT00021307|Temozolomide|temozolomide|mesh-list
25837297|NCT00021307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837298|NCT00021307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25837299|NCT00021307|Alkylating Agents|alkylating agents|mesh-ancestor
25837300|NCT00021307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837301|NCT00021320|Paclitaxel|paclitaxel|mesh-list
25837302|NCT00021320|Cisplatin|cisplatin|mesh-list
25837303|NCT00021320|Fluorouracil|fluorouracil|mesh-list
25837304|NCT00021320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25837305|NCT00021320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837306|NCT00021320|Tubulin Modulators|tubulin modulators|mesh-ancestor
25837307|NCT00021320|Antimitotic Agents|antimitotic agents|mesh-ancestor
25837308|NCT00021320|Mitosis Modulators|mitosis modulators|mesh-ancestor
25837309|NCT00021320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837310|NCT00021320|Antimetabolites|antimetabolites|mesh-ancestor
25837311|NCT00021320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25837312|NCT00021320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25837313|NCT00021320|Immunologic Factors|immunologic factors|mesh-ancestor
25837314|NCT00021320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837315|NCT00021333|Paclitaxel|paclitaxel|mesh-list
25837316|NCT00021333|Cisplatin|cisplatin|mesh-list
25837317|NCT00021333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24669657|NCT03772314|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24649149|NCT01218711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25163203|NCT02897934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25163204|NCT02897986|Vinorelbine|vinorelbine|mesh-list
25837318|NCT00021333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837319|NCT00021333|Tubulin Modulators|tubulin modulators|mesh-ancestor
25837320|NCT00021333|Antimitotic Agents|antimitotic agents|mesh-ancestor
25837321|NCT00021333|Mitosis Modulators|mitosis modulators|mesh-ancestor
25837322|NCT00021333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837323|NCT00021346|Gemcitabine|gemcitabine|mesh-list
25837324|NCT00021346|Carboplatin|carboplatin|mesh-list
25837325|NCT00021346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837326|NCT00021346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25837327|NCT00021346|Antimetabolites|antimetabolites|mesh-ancestor
25837328|NCT00021346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837329|NCT00021346|Antiviral Agents|antiviral agents|mesh-ancestor
25837330|NCT00021346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25837331|NCT00021346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837332|NCT00021346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25837333|NCT00021346|Immunologic Factors|immunologic factors|mesh-ancestor
25837334|NCT00021346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837335|NCT00021359|Dexamethasone|dexamethasone|mesh-list
25152787|NCT03809442|Anesthetics|anesthetics|mesh-ancestor
25408941|NCT03410615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25659542|NCT01608659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25659543|NCT01608672|Botulinum Toxins|botulinum toxins|mesh-list
25659544|NCT01608672|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25659545|NCT01608672|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25659546|NCT01608672|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25659547|NCT01608672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25057381|NCT03505528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057382|NCT03505528|Antidepressive Agents|antidepressive agents|mesh-ancestor
25837336|NCT00021359|Isotretinoin|isotretinoin|mesh-list
25837337|NCT00021359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25837338|NCT00021359|Antiemetics|antiemetics|mesh-ancestor
25837339|NCT00021359|Autonomic Agents|autonomic agents|mesh-ancestor
25837340|NCT00021359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25837341|NCT00021359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837342|NCT00021359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24883319|NCT03991403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25837343|NCT00021359|Glucocorticoids|glucocorticoids|mesh-ancestor
25837344|NCT00021359|Hormones|hormones|mesh-ancestor
25837345|NCT00021359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25837346|NCT00021359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25837347|NCT00021359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837348|NCT00021359|Dermatologic Agents|dermatologic agents|mesh-ancestor
25837349|NCT00021372|Paclitaxel|paclitaxel|mesh-list
25837350|NCT00021372|Estramustine|estramustine|mesh-list
25837351|NCT00021372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25837352|NCT00021372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837353|NCT00021372|Tubulin Modulators|tubulin modulators|mesh-ancestor
25837354|NCT00021372|Antimitotic Agents|antimitotic agents|mesh-ancestor
25837355|NCT00021372|Mitosis Modulators|mitosis modulators|mesh-ancestor
25837356|NCT00021372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837357|NCT00021372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25837358|NCT00021372|Alkylating Agents|alkylating agents|mesh-ancestor
25837359|NCT00021372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25837360|NCT00021385|Squalamine|squalamine|mesh-list
25837361|NCT00021385|Carboplatin|carboplatin|mesh-list
25837362|NCT00021385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837363|NCT00021385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25837364|NCT00021385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25837365|NCT00021385|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25837366|NCT00021385|Protective Agents|protective agents|mesh-ancestor
25837367|NCT00021385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837368|NCT00021385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25837369|NCT00021385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25837370|NCT00021385|Growth Substances|growth substances|mesh-ancestor
25837371|NCT00021385|Growth Inhibitors|growth inhibitors|mesh-ancestor
25837372|NCT00021398|Leucovorin|leucovorin|mesh-list
24649268|NCT01219101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25837373|NCT00021398|Fluorouracil|fluorouracil|mesh-list
25837374|NCT00021398|Calcium|calcium|mesh-list
25837375|NCT00021398|Levoleucovorin|levoleucovorin|mesh-list
25837376|NCT00021398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25837377|NCT00021398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837378|NCT00021398|Antimetabolites|antimetabolites|mesh-ancestor
25837379|NCT00021398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837380|NCT00021398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25837381|NCT00021398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837382|NCT00021398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25837383|NCT00021398|Immunologic Factors|immunologic factors|mesh-ancestor
25837384|NCT00021398|Antidotes|antidotes|mesh-ancestor
25837385|NCT00021398|Protective Agents|protective agents|mesh-ancestor
25837386|NCT00021398|Vitamin B Complex|vitamin b complex|mesh-ancestor
25837387|NCT00021398|Vitamins|vitamins|mesh-ancestor
25837388|NCT00021398|Micronutrients|micronutrients|mesh-ancestor
25837389|NCT00021450|Goserelin|goserelin|mesh-list
25837390|NCT00021450|Bicalutamide|bicalutamide|mesh-list
25837391|NCT00021450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25837392|NCT00021450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837393|NCT00021450|Androgen Antagonists|androgen antagonists|mesh-ancestor
25837394|NCT00021450|Hormone Antagonists|hormone antagonists|mesh-ancestor
25837395|NCT00021450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25837396|NCT00021450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659548|NCT01608672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659549|NCT01608672|Cholinergic Agents|cholinergic agents|mesh-ancestor
25659550|NCT01608672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25659551|NCT01608672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659552|NCT01608672|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25659553|NCT01608672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25659554|NCT01608724|Saxagliptin|saxagliptin|mesh-list
25659555|NCT01608724|Incretins|incretins|mesh-ancestor
25659556|NCT01608724|Hormones|hormones|mesh-ancestor
25659557|NCT01608724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25837397|NCT00021463|Lamivudine|lamivudine|mesh-list
25837398|NCT00021463|Zidovudine|zidovudine|mesh-list
25837399|NCT00021463|Efavirenz|efavirenz|mesh-list
25837400|NCT00021463|Nevirapine|nevirapine|mesh-list
25837401|NCT00021463|Abacavir|abacavir|mesh-list
25837402|NCT00021463|Dideoxynucleosides|dideoxynucleosides|mesh-list
24816252|NCT02075528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24816253|NCT02075528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25837403|NCT00021463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25837404|NCT00021463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25061810|NCT05390905|Tramadol|tramadol|mesh-list
25837405|NCT00021463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837406|NCT00021463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837407|NCT00021463|Antiviral Agents|antiviral agents|mesh-ancestor
25837408|NCT00021463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25837409|NCT00021463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25837410|NCT00021463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25837411|NCT00021463|Antimetabolites|antimetabolites|mesh-ancestor
25837412|NCT00021463|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24538914|NCT00661180|Sorafenib|sorafenib|mesh-list
25837413|NCT00021463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25837414|NCT00021463|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25837415|NCT00021463|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25837416|NCT00021463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25837417|NCT00021463|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25837418|NCT00021489|Mycophenolic Acid|mycophenolic acid|mesh-list
25837419|NCT00021489|Abacavir|abacavir|mesh-list
25837420|NCT00021489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25837421|NCT00021489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837422|NCT00021489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25837423|NCT00021489|Antitubercular Agents|antitubercular agents|mesh-ancestor
25837424|NCT00021489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25837425|NCT00021489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25837426|NCT00021489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837427|NCT00021489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837428|NCT00021489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25837429|NCT00021489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25837430|NCT00021489|Antiviral Agents|antiviral agents|mesh-ancestor
25837431|NCT00021489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25837432|NCT00021489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25837433|NCT00021502|Chrysarobin|chrysarobin|mesh-list
25837434|NCT00021502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25837435|NCT00021502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25837436|NCT00021502|Analgesics|analgesics|mesh-ancestor
25837437|NCT00021502|Sensory System Agents|sensory system agents|mesh-ancestor
25837438|NCT00021502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25837439|NCT00021502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837440|NCT00021502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25837441|NCT00021502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24527920|NCT00618631|Sensory System Agents|sensory system agents|mesh-ancestor
25837442|NCT00021528|Mirtazapine|mirtazapine|mesh-list
25837443|NCT00021528|Buspirone|buspirone|mesh-list
25837444|NCT00021528|Tranylcypromine|tranylcypromine|mesh-list
25837445|NCT00021528|Sertraline|sertraline|mesh-list
25837446|NCT00021528|Citalopram|citalopram|mesh-list
25837447|NCT00021528|Nortriptyline|nortriptyline|mesh-list
25837448|NCT00021528|Antidepressive Agents|antidepressive agents|mesh-ancestor
25837449|NCT00021528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25837450|NCT00021528|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25837451|NCT00021528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25837452|NCT00021528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25837453|NCT00021528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837454|NCT00021528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25837455|NCT00021528|Serotonin Agents|serotonin agents|mesh-ancestor
25837456|NCT00021528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837457|NCT00021528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837458|NCT00021528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25837459|NCT00021528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25837460|NCT00021528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25659558|NCT01608724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659559|NCT01608724|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25659560|NCT01608724|Protease Inhibitors|protease inhibitors|mesh-ancestor
25659561|NCT01608724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25659562|NCT01608724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659563|NCT01608724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25837461|NCT00021528|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25659564|NCT01609010|Interferons|interferons|mesh-list
25837462|NCT00021528|Histamine Antagonists|histamine antagonists|mesh-ancestor
25837463|NCT00021528|Histamine Agents|histamine agents|mesh-ancestor
25837464|NCT00021528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25837465|NCT00021528|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25837466|NCT00021528|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25837467|NCT00021528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25837468|NCT00021528|Adrenergic Agents|adrenergic agents|mesh-ancestor
25837469|NCT00021528|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25837470|NCT00021528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25837471|NCT00021528|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25837472|NCT00021528|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25837473|NCT00021528|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25837474|NCT00021528|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25837475|NCT00021528|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25837476|NCT00021554|Enfuvirtide|enfuvirtide|mesh-list
25837477|NCT00021554|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25837478|NCT00021554|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25837479|NCT00021554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837480|NCT00021554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25837481|NCT00021554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25837482|NCT00021554|Antiviral Agents|antiviral agents|mesh-ancestor
25837483|NCT00021554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25837484|NCT00021567|Interferons|interferons|mesh-list
25837485|NCT00021567|Interferon-gamma|interferon-gamma|mesh-list
25837486|NCT00021567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837487|NCT00021567|Antiviral Agents|antiviral agents|mesh-ancestor
25837488|NCT00021567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25837489|NCT00021645|Vitamin E|vitamin e|mesh-list
25837490|NCT00021645|Vitamins|vitamins|mesh-ancestor
24527987|NCT00619034|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25837491|NCT00021645|Micronutrients|micronutrients|mesh-ancestor
25837492|NCT00021645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837493|NCT00021645|Antioxidants|antioxidants|mesh-ancestor
25837494|NCT00021645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837495|NCT00021645|Protective Agents|protective agents|mesh-ancestor
25837496|NCT00021671|Metronidazole|metronidazole|mesh-list
25837497|NCT00021671|Nevirapine|nevirapine|mesh-list
25837498|NCT00021671|Erythromycin|erythromycin|mesh-list
25837499|NCT00021671|Erythromycin Estolate|erythromycin estolate|mesh-list
25837500|NCT00021671|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25837501|NCT00021671|Erythromycin stearate|erythromycin stearate|mesh-list
25837502|NCT00021671|Ampicillin|ampicillin|mesh-list
25837503|NCT00021671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25837504|NCT00021671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25837505|NCT00021671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25837506|NCT00021671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25837507|NCT00021671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25837508|NCT00021671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25837509|NCT00021671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837510|NCT00021671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837511|NCT00021671|Antiviral Agents|antiviral agents|mesh-ancestor
25837512|NCT00021671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25837513|NCT00021671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25837514|NCT00021671|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25837515|NCT00021671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25837516|NCT00021671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25837517|NCT00021671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25875504|NCT04311502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24450961|NCT00321178|Clarithromycin|clarithromycin|mesh-list
25875505|NCT04311502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25875506|NCT04311502|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25875507|NCT04311502|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25875508|NCT04311502|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25875509|NCT04311502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25875510|NCT04311502|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25875511|NCT04311502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25875512|NCT04311502|Antimetabolites|antimetabolites|mesh-ancestor
25875513|NCT04311502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25875514|NCT04311502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24929041|NCT04115904|Analgesics|analgesics|mesh-ancestor
25659565|NCT01609010|Interferon alpha-2|interferon alpha-2|mesh-list
25659566|NCT01609010|Rituximab|rituximab|mesh-list
25659567|NCT01609010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25659568|NCT01609010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837518|NCT00021814|Doxazosin|doxazosin|mesh-list
25837519|NCT00021814|Finasteride|finasteride|mesh-list
25837520|NCT00021814|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25837521|NCT00021814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25837522|NCT00021814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837523|NCT00021814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837524|NCT00021814|Hormone Antagonists|hormone antagonists|mesh-ancestor
25837525|NCT00021814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25153095|NCT03502668|Decitabine|decitabine|mesh-list
25837526|NCT00021814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837527|NCT00021814|Urological Agents|urological agents|mesh-ancestor
25837528|NCT00021814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25837529|NCT00021814|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25837530|NCT00021814|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25837531|NCT00021814|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25837532|NCT00021814|Adrenergic Agents|adrenergic agents|mesh-ancestor
25837533|NCT00021814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25837534|NCT00021827|Hormones|hormones|mesh-list
25837535|NCT00021827|Parathyroid Hormone|parathyroid hormone|mesh-list
24450614|NCT00319865|Thalidomide|thalidomide|mesh-list
24450615|NCT00319865|Dexamethasone|dexamethasone|mesh-list
25163205|NCT02897986|Propranolol|propranolol|mesh-list
25163206|NCT02897986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25837536|NCT00021827|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
25837537|NCT00021827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25837538|NCT00021827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837539|NCT00021827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25837540|NCT00021983|Immunotoxins|immunotoxins|mesh-list
25837541|NCT00021983|Immunologic Factors|immunologic factors|mesh-ancestor
25837542|NCT00021983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837543|NCT00021996|Valdecoxib|valdecoxib|mesh-list
25837544|NCT00021996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25837545|NCT00021996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25837546|NCT00021996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837547|NCT00021996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837548|NCT00021996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25837549|NCT00021996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25837550|NCT00021996|Analgesics|analgesics|mesh-ancestor
25837551|NCT00021996|Sensory System Agents|sensory system agents|mesh-ancestor
25837552|NCT00021996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25837553|NCT00021996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837554|NCT00021996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25837555|NCT00021996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25837556|NCT00022009|Gemcitabine|gemcitabine|mesh-list
25837557|NCT00022009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25837558|NCT00022009|Antimetabolites|antimetabolites|mesh-ancestor
25837559|NCT00022009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837560|NCT00022009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837561|NCT00022009|Antiviral Agents|antiviral agents|mesh-ancestor
25837562|NCT00022009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25837563|NCT00022009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837564|NCT00022009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25837565|NCT00022009|Immunologic Factors|immunologic factors|mesh-ancestor
25837566|NCT00022009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837567|NCT00022022|Docetaxel|docetaxel|mesh-list
25837568|NCT00022022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837569|NCT00022022|Tubulin Modulators|tubulin modulators|mesh-ancestor
25837570|NCT00022022|Antimitotic Agents|antimitotic agents|mesh-ancestor
25837571|NCT00022022|Mitosis Modulators|mitosis modulators|mesh-ancestor
25837572|NCT00022022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837573|NCT00022048|Bevacizumab|bevacizumab|mesh-list
25837574|NCT00022048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25837575|NCT00022048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837576|NCT00022048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25837577|NCT00022048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25837578|NCT00022048|Growth Substances|growth substances|mesh-ancestor
25837579|NCT00022048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837580|NCT00022048|Growth Inhibitors|growth inhibitors|mesh-ancestor
25837581|NCT00022074|Gabapentin|gabapentin|mesh-list
25837582|NCT00022074|Analgesics|analgesics|mesh-ancestor
25837583|NCT00022074|Sensory System Agents|sensory system agents|mesh-ancestor
25837584|NCT00022074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25837585|NCT00022074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837586|NCT00022074|Anticonvulsants|anticonvulsants|mesh-ancestor
25163207|NCT02897986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837587|NCT00022074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25837588|NCT00022074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25837589|NCT00022074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25837590|NCT00022074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25837591|NCT00022074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25837592|NCT00022074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25837593|NCT00022074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25837594|NCT00022074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837595|NCT00022074|Antimanic Agents|antimanic agents|mesh-ancestor
25837596|NCT00022087|Vitamin D|vitamin d|mesh-list
25837597|NCT00022087|Cholecalciferol|cholecalciferol|mesh-list
25837598|NCT00022087|Zoledronic Acid|zoledronic acid|mesh-list
25837599|NCT00022087|Calcium|calcium|mesh-list
25837600|NCT00022087|Vitamins|vitamins|mesh-ancestor
25837601|NCT00022087|Micronutrients|micronutrients|mesh-ancestor
25837602|NCT00022087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837603|NCT00022087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25837604|NCT00022087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25837605|NCT00022126|Cytarabine|cytarabine|mesh-list
25837606|NCT00022126|Cyclosporine|cyclosporine|mesh-list
25837607|NCT00022126|Dexamethasone|dexamethasone|mesh-list
25837608|NCT00022126|Methylprednisolone|methylprednisolone|mesh-list
25837609|NCT00022126|Cyclophosphamide|cyclophosphamide|mesh-list
25837610|NCT00022126|Doxorubicin|doxorubicin|mesh-list
25837611|NCT00022126|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25837612|NCT00022126|Methotrexate|methotrexate|mesh-list
25837613|NCT00022126|Vincristine|vincristine|mesh-list
25837614|NCT00022126|Daunorubicin|daunorubicin|mesh-list
25837615|NCT00022126|Asparaginase|asparaginase|mesh-list
25837616|NCT00022126|Mercaptopurine|mercaptopurine|mesh-list
25837617|NCT00022126|Pegaspargase|pegaspargase|mesh-list
25837618|NCT00022126|Thioguanine|thioguanine|mesh-list
25837619|NCT00022126|Cyclosporins|cyclosporins|mesh-list
25837620|NCT00022126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25837621|NCT00022126|Immunologic Factors|immunologic factors|mesh-ancestor
25837622|NCT00022126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837623|NCT00022126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25837624|NCT00022126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25837625|NCT00022126|Alkylating Agents|alkylating agents|mesh-ancestor
25837626|NCT00022126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837627|NCT00022126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837628|NCT00022126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25837629|NCT00022126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25837630|NCT00022126|Antiemetics|antiemetics|mesh-ancestor
25837631|NCT00022126|Autonomic Agents|autonomic agents|mesh-ancestor
25837632|NCT00022126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25837633|NCT00022126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25837634|NCT00022126|Glucocorticoids|glucocorticoids|mesh-ancestor
25837635|NCT00022126|Hormones|hormones|mesh-ancestor
25837636|NCT00022126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25837637|NCT00022126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25837638|NCT00022126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25837639|NCT00022126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25837640|NCT00022126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25837641|NCT00022126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837642|NCT00022126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24528126|NCT00619944|Ritonavir|ritonavir|mesh-list
25837643|NCT00022126|Abortifacient Agents|abortifacient agents|mesh-ancestor
25837644|NCT00022126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25837645|NCT00022126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25837646|NCT00022126|Antimetabolites|antimetabolites|mesh-ancestor
25837647|NCT00022126|Dermatologic Agents|dermatologic agents|mesh-ancestor
24649827|NCT01222052|Fluorouracil|fluorouracil|mesh-list
25837648|NCT00022126|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25837649|NCT00022126|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25163208|NCT02897986|Tubulin Modulators|tubulin modulators|mesh-ancestor
25837650|NCT00022126|Antiviral Agents|antiviral agents|mesh-ancestor
25837651|NCT00022126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25837652|NCT00022126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25837653|NCT00022126|Tubulin Modulators|tubulin modulators|mesh-ancestor
25837654|NCT00022126|Antimitotic Agents|antimitotic agents|mesh-ancestor
25837655|NCT00022126|Mitosis Modulators|mitosis modulators|mesh-ancestor
25837656|NCT00022126|Antifungal Agents|antifungal agents|mesh-ancestor
25837657|NCT00022126|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25837658|NCT00022126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25837659|NCT00022126|Protective Agents|protective agents|mesh-ancestor
25837660|NCT00022139|Paclitaxel|paclitaxel|mesh-list
25837661|NCT00022139|Carboplatin|carboplatin|mesh-list
24883494|NCT05239312|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24883496|NCT05239286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25837662|NCT00022139|Fluorouracil|fluorouracil|mesh-list
25837663|NCT00022139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24539036|NCT00661856|Hormones|hormones|mesh-ancestor
25837664|NCT00022139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837665|NCT00022139|Tubulin Modulators|tubulin modulators|mesh-ancestor
25837666|NCT00022139|Antimitotic Agents|antimitotic agents|mesh-ancestor
25837667|NCT00022139|Mitosis Modulators|mitosis modulators|mesh-ancestor
25153237|NCT03374956|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25837668|NCT00022139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837669|NCT00022139|Antimetabolites|antimetabolites|mesh-ancestor
25837670|NCT00022139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25837671|NCT00022139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24929180|NCT04115111|Durvalumab|durvalumab|mesh-list
25837672|NCT00022139|Immunologic Factors|immunologic factors|mesh-ancestor
25837673|NCT00022139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837674|NCT00022152|Vinorelbine|vinorelbine|mesh-list
25837675|NCT00022152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25837676|NCT00022152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837677|NCT00022152|Tubulin Modulators|tubulin modulators|mesh-ancestor
25837678|NCT00022152|Antimitotic Agents|antimitotic agents|mesh-ancestor
25837679|NCT00022152|Mitosis Modulators|mitosis modulators|mesh-ancestor
25837680|NCT00022152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837681|NCT00022165|Selenium|selenium|mesh-list
25837682|NCT00022165|Antioxidants|antioxidants|mesh-ancestor
25837683|NCT00022165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837684|NCT00022165|Protective Agents|protective agents|mesh-ancestor
25837685|NCT00022165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837686|NCT00022165|Trace Elements|trace elements|mesh-ancestor
25837687|NCT00022165|Micronutrients|micronutrients|mesh-ancestor
25837688|NCT00022178|Cyclophosphamide|cyclophosphamide|mesh-list
25837689|NCT00022178|Cisplatin|cisplatin|mesh-list
25837690|NCT00022178|Doxorubicin|doxorubicin|mesh-list
25837691|NCT00022178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25837692|NCT00022178|Fluorouracil|fluorouracil|mesh-list
25837693|NCT00022178|Vincristine|vincristine|mesh-list
25837694|NCT00022178|Epirubicin|epirubicin|mesh-list
25837695|NCT00022178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25837696|NCT00022178|Immunologic Factors|immunologic factors|mesh-ancestor
25837697|NCT00022178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837698|NCT00022178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25837699|NCT00022178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25837700|NCT00022178|Alkylating Agents|alkylating agents|mesh-ancestor
25837701|NCT00022178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837702|NCT00022178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837703|NCT00022178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25837704|NCT00022178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25837705|NCT00022178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25837706|NCT00022178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25837707|NCT00022178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837708|NCT00022178|Antimetabolites|antimetabolites|mesh-ancestor
25837709|NCT00022178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25837710|NCT00022178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25837711|NCT00022178|Tubulin Modulators|tubulin modulators|mesh-ancestor
25837712|NCT00022178|Antimitotic Agents|antimitotic agents|mesh-ancestor
25837713|NCT00022178|Mitosis Modulators|mitosis modulators|mesh-ancestor
25837714|NCT00022191|Gemcitabine|gemcitabine|mesh-list
25837715|NCT00022191|Paclitaxel|paclitaxel|mesh-list
25837716|NCT00022191|Cisplatin|cisplatin|mesh-list
25837717|NCT00022191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25837718|NCT00022191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837719|NCT00022191|Tubulin Modulators|tubulin modulators|mesh-ancestor
25837720|NCT00022191|Antimitotic Agents|antimitotic agents|mesh-ancestor
24539052|NCT00662220|Ribavirin|ribavirin|mesh-list
25659569|NCT01609010|Immunologic Factors|immunologic factors|mesh-ancestor
25659570|NCT01609010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659571|NCT01609010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25659572|NCT01609010|Antiviral Agents|antiviral agents|mesh-ancestor
25659573|NCT01609010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25659574|NCT01609023|Rituximab|rituximab|mesh-list
25659575|NCT01609023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25659576|NCT01609023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659577|NCT01609023|Immunologic Factors|immunologic factors|mesh-ancestor
25659578|NCT01609023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659579|NCT01609023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25837721|NCT00022191|Mitosis Modulators|mitosis modulators|mesh-ancestor
25837722|NCT00022191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837723|NCT00022191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25837724|NCT00022191|Antimetabolites|antimetabolites|mesh-ancestor
25837725|NCT00022191|Antiviral Agents|antiviral agents|mesh-ancestor
25837726|NCT00022191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24450640|NCT00319865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25837727|NCT00022191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450641|NCT00319865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24450642|NCT00319865|Growth Substances|growth substances|mesh-ancestor
24450643|NCT00319865|Growth Inhibitors|growth inhibitors|mesh-ancestor
24450644|NCT00319878|Cyclosporine|cyclosporine|mesh-list
24450645|NCT00319878|Sirolimus|sirolimus|mesh-list
25837728|NCT00022191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25837729|NCT00022191|Immunologic Factors|immunologic factors|mesh-ancestor
25837730|NCT00022191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837731|NCT00022204|Vitamin E|vitamin e|mesh-list
25837732|NCT00022204|Pentoxifylline|pentoxifylline|mesh-list
25837733|NCT00022204|Vitamins|vitamins|mesh-ancestor
25837734|NCT00022204|Micronutrients|micronutrients|mesh-ancestor
25837735|NCT00022204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837736|NCT00022204|Antioxidants|antioxidants|mesh-ancestor
25837737|NCT00022204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163209|NCT02897986|Antimitotic Agents|antimitotic agents|mesh-ancestor
25837738|NCT00022204|Protective Agents|protective agents|mesh-ancestor
25837739|NCT00022204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25837740|NCT00022204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837741|NCT00022204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25837742|NCT00022204|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25837743|NCT00022204|Vasodilator Agents|vasodilator agents|mesh-ancestor
25837744|NCT00022204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25837745|NCT00022217|Paclitaxel|paclitaxel|mesh-list
25837746|NCT00022217|Cisplatin|cisplatin|mesh-list
24650097|NCT01223820|Capsaicin|capsaicin|mesh-list
25837747|NCT00022217|Carboplatin|carboplatin|mesh-list
25837748|NCT00022217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25837749|NCT00022217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837750|NCT00022217|Tubulin Modulators|tubulin modulators|mesh-ancestor
25837751|NCT00022217|Antimitotic Agents|antimitotic agents|mesh-ancestor
25837752|NCT00022217|Mitosis Modulators|mitosis modulators|mesh-ancestor
25837753|NCT00022217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837754|NCT00022230|Aldesleukin|aldesleukin|mesh-list
25837755|NCT00022230|Paclitaxel|paclitaxel|mesh-list
25837756|NCT00022230|Cyclophosphamide|cyclophosphamide|mesh-list
25837757|NCT00022230|Doxorubicin|doxorubicin|mesh-list
25837758|NCT00022230|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25837759|NCT00022230|Sargramostim|sargramostim|mesh-list
25837760|NCT00022230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25837761|NCT00022230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837762|NCT00022230|Tubulin Modulators|tubulin modulators|mesh-ancestor
24459753|NCT00346359|Methotrexate|methotrexate|mesh-list
24459754|NCT00346359|Fludarabine phosphate|fludarabine phosphate|mesh-list
25837763|NCT00022230|Antimitotic Agents|antimitotic agents|mesh-ancestor
24539120|NCT00662454|Estradiol|estradiol|mesh-list
25837764|NCT00022230|Mitosis Modulators|mitosis modulators|mesh-ancestor
25837765|NCT00022230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837766|NCT00022230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25837767|NCT00022230|Immunologic Factors|immunologic factors|mesh-ancestor
25837768|NCT00022230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837769|NCT00022230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25837770|NCT00022230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25837771|NCT00022230|Alkylating Agents|alkylating agents|mesh-ancestor
25837772|NCT00022230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25837773|NCT00022230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25837774|NCT00022230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25837775|NCT00022230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25163210|NCT02897986|Mitosis Modulators|mitosis modulators|mesh-ancestor
25163211|NCT02897986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163212|NCT02897986|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25163213|NCT02897986|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25163214|NCT02897986|Adrenergic Agents|adrenergic agents|mesh-ancestor
25163215|NCT02897986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25163216|NCT02897986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837776|NCT00022230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837777|NCT00022230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25837778|NCT00022230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25837779|NCT00022230|Antiviral Agents|antiviral agents|mesh-ancestor
24650210|NCT01224509|Contraceptive Agents|contraceptive agents|mesh-ancestor
25837780|NCT00022230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25659580|NCT01609218|Charcoal|charcoal|mesh-list
24650211|NCT01224509|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24650212|NCT01224509|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25837781|NCT00022256|Motexafin gadolinium|motexafin gadolinium|mesh-list
24650214|NCT01224509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24650216|NCT01224509|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24650217|NCT01224509|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25837782|NCT00022256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837783|NCT00022256|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25837784|NCT00022256|Dermatologic Agents|dermatologic agents|mesh-ancestor
25837785|NCT00022308|Cisplatin|cisplatin|mesh-list
25837786|NCT00022308|Irinotecan|irinotecan|mesh-list
25837787|NCT00022308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837788|NCT00022308|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25837789|NCT00022308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25837790|NCT00022308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837791|NCT00022308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837792|NCT00022321|Gemtuzumab|gemtuzumab|mesh-list
25837793|NCT00022321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25837794|NCT00022321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837795|NCT00022360|Taurolidine|taurolidine|mesh-list
25837796|NCT00022360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25837797|NCT00022360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25837798|NCT00022360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837799|NCT00022386|Epoetin Alfa|epoetin alfa|mesh-list
25837800|NCT00022386|Hematinics|hematinics|mesh-ancestor
25837801|NCT00022399|Celecoxib|celecoxib|mesh-list
25837802|NCT00022399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25837803|NCT00022399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25837804|NCT00022399|Analgesics|analgesics|mesh-ancestor
25837805|NCT00022399|Sensory System Agents|sensory system agents|mesh-ancestor
25837806|NCT00022399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25837807|NCT00022399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837808|NCT00022399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25837809|NCT00022399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25837810|NCT00022399|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25837811|NCT00022399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25837812|NCT00022399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837813|NCT00022399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837814|NCT00022412|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
25837815|NCT00022412|Vitamins|vitamins|mesh-ancestor
25837816|NCT00022412|Micronutrients|micronutrients|mesh-ancestor
25837817|NCT00022412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837818|NCT00022412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25837819|NCT00022425|Perillyl alcohol|perillyl alcohol|mesh-list
25837820|NCT00022425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837821|NCT00022425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837822|NCT00022425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837823|NCT00022438|Aldesleukin|aldesleukin|mesh-list
25837824|NCT00022438|Freund's Adjuvant|freund's adjuvant|mesh-list
25837825|NCT00022438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837826|NCT00022438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25837827|NCT00022438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25837828|NCT00022438|Antiviral Agents|antiviral agents|mesh-ancestor
25837829|NCT00022438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25837830|NCT00022438|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25837831|NCT00022438|Immunologic Factors|immunologic factors|mesh-ancestor
24539154|NCT00662467|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25837832|NCT00022438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837833|NCT00022451|Tipifarnib|tipifarnib|mesh-list
25837834|NCT00022451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837835|NCT00022464|Sirolimus|sirolimus|mesh-list
25837836|NCT00022464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25837837|NCT00022464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25837838|NCT00022464|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25837839|NCT00022464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837840|NCT00022464|Antifungal Agents|antifungal agents|mesh-ancestor
25659581|NCT01609218|Antidotes|antidotes|mesh-ancestor
25659582|NCT01609218|Protective Agents|protective agents|mesh-ancestor
25659583|NCT01609218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659584|NCT01609348|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25659585|NCT01609348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25659586|NCT01609348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25659587|NCT01609348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25674298|NCT01769586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25837841|NCT00022464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25837842|NCT00022464|Immunologic Factors|immunologic factors|mesh-ancestor
25837843|NCT00022464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837844|NCT00022529|Trastuzumab|trastuzumab|mesh-list
25837845|NCT00022529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25837846|NCT00022529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837847|NCT00022542|Epothilones|epothilones|mesh-list
25837848|NCT00022542|Epothilone B|epothilone b|mesh-list
24997735|NCT04454684|Hallucinogens|hallucinogens|mesh-ancestor
25837849|NCT00022542|Tubulin Modulators|tubulin modulators|mesh-ancestor
25837850|NCT00022542|Antimitotic Agents|antimitotic agents|mesh-ancestor
25837851|NCT00022542|Mitosis Modulators|mitosis modulators|mesh-ancestor
25837852|NCT00022542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837853|NCT00022542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837854|NCT00022555|Vincristine|vincristine|mesh-list
25837855|NCT00022555|Bryostatin 1|bryostatin 1|mesh-list
25837856|NCT00022555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25837857|NCT00022555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837858|NCT00022555|Tubulin Modulators|tubulin modulators|mesh-ancestor
25837859|NCT00022555|Antimitotic Agents|antimitotic agents|mesh-ancestor
24650359|NCT01225406|Tenofovir|tenofovir|mesh-list
25837860|NCT00022555|Mitosis Modulators|mitosis modulators|mesh-ancestor
25837861|NCT00022555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837862|NCT00022555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25837863|NCT00022555|Immunologic Factors|immunologic factors|mesh-ancestor
25837864|NCT00022555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837865|NCT00022581|Thalidomide|thalidomide|mesh-list
25837866|NCT00022581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25837867|NCT00022581|Immunologic Factors|immunologic factors|mesh-ancestor
25837868|NCT00022581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837869|NCT00022581|Leprostatic Agents|leprostatic agents|mesh-ancestor
25837870|NCT00022581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25837871|NCT00022581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25837872|NCT00022581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25837873|NCT00022581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25837874|NCT00022581|Growth Substances|growth substances|mesh-ancestor
25837875|NCT00022581|Growth Inhibitors|growth inhibitors|mesh-ancestor
25837876|NCT00022581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837877|NCT00022594|Lurtotecan|lurtotecan|mesh-list
25837878|NCT00022594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837879|NCT00022607|Thalidomide|thalidomide|mesh-list
25837880|NCT00022607|Bevacizumab|bevacizumab|mesh-list
25837881|NCT00022607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25837882|NCT00022607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051512|NCT00401011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24704519|NCT01478607|Capsaicin|capsaicin|mesh-list
25837883|NCT00022607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25837884|NCT00022607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25837885|NCT00022607|Growth Substances|growth substances|mesh-ancestor
25837886|NCT00022607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837887|NCT00022607|Growth Inhibitors|growth inhibitors|mesh-ancestor
25837888|NCT00022607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25837889|NCT00022607|Immunologic Factors|immunologic factors|mesh-ancestor
25837890|NCT00022607|Leprostatic Agents|leprostatic agents|mesh-ancestor
25837891|NCT00022607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25837892|NCT00022607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25837893|NCT00022620|Paclitaxel|paclitaxel|mesh-list
25837894|NCT00022620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25837895|NCT00022620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837896|NCT00022620|Tubulin Modulators|tubulin modulators|mesh-ancestor
24539174|NCT00662610|Gout Suppressants|gout suppressants|mesh-ancestor
25837897|NCT00022620|Antimitotic Agents|antimitotic agents|mesh-ancestor
25837898|NCT00022620|Mitosis Modulators|mitosis modulators|mesh-ancestor
25837899|NCT00022620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837900|NCT00022646|Gemcitabine|gemcitabine|mesh-list
25837901|NCT00022646|Pemetrexed|pemetrexed|mesh-list
25837902|NCT00022646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25837903|NCT00022646|Antimetabolites|antimetabolites|mesh-ancestor
25837904|NCT00022646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837905|NCT00022646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837906|NCT00022646|Antiviral Agents|antiviral agents|mesh-ancestor
25837907|NCT00022646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25837908|NCT00022646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837909|NCT00022646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25674299|NCT01769586|Antiemetics|antiemetics|mesh-ancestor
25674300|NCT01769586|Autonomic Agents|autonomic agents|mesh-ancestor
25837910|NCT00022646|Immunologic Factors|immunologic factors|mesh-ancestor
25837911|NCT00022646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837912|NCT00022646|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25837913|NCT00022646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25837914|NCT00022685|Epratuzumab|epratuzumab|mesh-list
25837915|NCT00022685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25837916|NCT00022685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837917|NCT00022711|Temozolomide|temozolomide|mesh-list
25837918|NCT00022711|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25837919|NCT00022711|Alkylating Agents|alkylating agents|mesh-ancestor
25837920|NCT00022711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837921|NCT00022711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837922|NCT00022724|Sirolimus|sirolimus|mesh-list
25837923|NCT00022724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25837924|NCT00022724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25837925|NCT00022724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25837926|NCT00022724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25837927|NCT00022724|Antifungal Agents|antifungal agents|mesh-ancestor
25837928|NCT00022724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25837929|NCT00022724|Immunologic Factors|immunologic factors|mesh-ancestor
25837930|NCT00022724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837931|NCT00022737|Leucovorin|leucovorin|mesh-list
25837932|NCT00022737|Cytarabine|cytarabine|mesh-list
25837933|NCT00022737|Cyclosporine|cyclosporine|mesh-list
25837934|NCT00022737|Dexamethasone|dexamethasone|mesh-list
25837935|NCT00022737|Cyclophosphamide|cyclophosphamide|mesh-list
25837936|NCT00022737|Ifosfamide|ifosfamide|mesh-list
25837937|NCT00022737|Methotrexate|methotrexate|mesh-list
25837938|NCT00022737|Etoposide|etoposide|mesh-list
25837939|NCT00022737|Vincristine|vincristine|mesh-list
25837940|NCT00022737|Etoposide phosphate|etoposide phosphate|mesh-list
25837941|NCT00022737|Imatinib Mesylate|imatinib mesylate|mesh-list
25837942|NCT00022737|Daunorubicin|daunorubicin|mesh-list
25837943|NCT00022737|Asparaginase|asparaginase|mesh-list
25837944|NCT00022737|Mercaptopurine|mercaptopurine|mesh-list
25837945|NCT00022737|Pegaspargase|pegaspargase|mesh-list
25837946|NCT00022737|Cyclosporins|cyclosporins|mesh-list
25837947|NCT00022737|Levoleucovorin|levoleucovorin|mesh-list
25837948|NCT00022737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25837949|NCT00022737|Immunologic Factors|immunologic factors|mesh-ancestor
25837950|NCT00022737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837951|NCT00022737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25837952|NCT00022737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25163217|NCT02897986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25837953|NCT00022737|Alkylating Agents|alkylating agents|mesh-ancestor
25837954|NCT00022737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25837955|NCT00022737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450687|NCT00320047|Baclofen|baclofen|mesh-list
24450688|NCT00320047|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25163218|NCT02897986|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25837956|NCT00022737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25837957|NCT00022737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25837958|NCT00022737|Antiemetics|antiemetics|mesh-ancestor
25837959|NCT00022737|Autonomic Agents|autonomic agents|mesh-ancestor
25837960|NCT00022737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25837961|NCT00022737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25837962|NCT00022737|Glucocorticoids|glucocorticoids|mesh-ancestor
25837963|NCT00022737|Hormones|hormones|mesh-ancestor
25837964|NCT00022737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25837965|NCT00022737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25837966|NCT00022737|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25837967|NCT00022737|Abortifacient Agents|abortifacient agents|mesh-ancestor
24650511|NCT01226056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837968|NCT00022737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25837969|NCT00022737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25837970|NCT00022737|Antimetabolites|antimetabolites|mesh-ancestor
25837971|NCT00022737|Dermatologic Agents|dermatologic agents|mesh-ancestor
25837972|NCT00022737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25837973|NCT00022737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25837974|NCT00022737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25837975|NCT00022737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25837976|NCT00022737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25837977|NCT00022737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25837978|NCT00022737|Antiviral Agents|antiviral agents|mesh-ancestor
25837979|NCT00022737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25837980|NCT00022737|Antidotes|antidotes|mesh-ancestor
25837981|NCT00022737|Protective Agents|protective agents|mesh-ancestor
25837982|NCT00022737|Vitamin B Complex|vitamin b complex|mesh-ancestor
24394070|NCT00131989|Sorafenib|sorafenib|mesh-list
24952749|NCT03892421|Hormones|hormones|mesh-ancestor
25837983|NCT00022737|Vitamins|vitamins|mesh-ancestor
25837984|NCT00022737|Micronutrients|micronutrients|mesh-ancestor
25837985|NCT00022737|Tubulin Modulators|tubulin modulators|mesh-ancestor
25837986|NCT00022737|Antimitotic Agents|antimitotic agents|mesh-ancestor
25837987|NCT00022737|Mitosis Modulators|mitosis modulators|mesh-ancestor
25837988|NCT00022737|Antifungal Agents|antifungal agents|mesh-ancestor
25837989|NCT00022737|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25837990|NCT00022737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25837991|NCT00022737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25837992|NCT00022841|Pamidronate|pamidronate|mesh-list
25837993|NCT00022841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24753930|NCT01718366|Vitamin D|vitamin d|mesh-list
25837994|NCT00022841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837995|NCT00022880|Tositumomab I-131|tositumomab i-131|mesh-list
25837996|NCT00022880|Antibodies|antibodies|mesh-list
25837997|NCT00022880|Immunologic Factors|immunologic factors|mesh-ancestor
25837998|NCT00022880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25837999|NCT00022880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838000|NCT00022893|Tositumomab I-131|tositumomab i-131|mesh-list
25838001|NCT00022893|Antibodies|antibodies|mesh-list
25838002|NCT00022893|Immunologic Factors|immunologic factors|mesh-ancestor
25838003|NCT00022893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838004|NCT00022893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838005|NCT00022906|Tositumomab I-131|tositumomab i-131|mesh-list
25838006|NCT00022906|Antibodies|antibodies|mesh-list
25838007|NCT00022906|Immunologic Factors|immunologic factors|mesh-ancestor
25838008|NCT00022906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838009|NCT00022906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838010|NCT00022932|Tositumomab I-131|tositumomab i-131|mesh-list
25838011|NCT00022932|Antibodies|antibodies|mesh-list
25838012|NCT00022932|Immunologic Factors|immunologic factors|mesh-ancestor
25838013|NCT00022932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838014|NCT00022932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838015|NCT00022945|Prednisone|prednisone|mesh-list
25838016|NCT00022945|Cyclophosphamide|cyclophosphamide|mesh-list
25838017|NCT00022945|Doxorubicin|doxorubicin|mesh-list
25838018|NCT00022945|Vincristine|vincristine|mesh-list
25838019|NCT00022945|Tositumomab I-131|tositumomab i-131|mesh-list
25838020|NCT00022945|Antibodies|antibodies|mesh-list
25838021|NCT00022945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25838022|NCT00022945|Immunologic Factors|immunologic factors|mesh-ancestor
25838023|NCT00022945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838024|NCT00022945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25838025|NCT00022945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25838026|NCT00022945|Alkylating Agents|alkylating agents|mesh-ancestor
24997764|NCT04429685|Anesthetics|anesthetics|mesh-ancestor
25838027|NCT00022945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838028|NCT00022945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838029|NCT00022945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25838030|NCT00022945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25838031|NCT00022945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25838032|NCT00022945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25838033|NCT00022945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838034|NCT00022945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25838035|NCT00022945|Glucocorticoids|glucocorticoids|mesh-ancestor
25838036|NCT00022945|Hormones|hormones|mesh-ancestor
25838037|NCT00022945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25838038|NCT00022945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25838039|NCT00022945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25838040|NCT00022945|Tubulin Modulators|tubulin modulators|mesh-ancestor
25838041|NCT00022945|Antimitotic Agents|antimitotic agents|mesh-ancestor
25838042|NCT00022945|Mitosis Modulators|mitosis modulators|mesh-ancestor
25838043|NCT00022958|Tositumomab I-131|tositumomab i-131|mesh-list
25838044|NCT00022958|Antibodies|antibodies|mesh-list
25838045|NCT00022958|Immunologic Factors|immunologic factors|mesh-ancestor
25838046|NCT00022958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838047|NCT00022958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838048|NCT00022971|Rituximab|rituximab|mesh-list
25838049|NCT00022971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25838050|NCT00022971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838051|NCT00022971|Immunologic Factors|immunologic factors|mesh-ancestor
25838052|NCT00022971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674301|NCT01769586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25838053|NCT00022971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25838054|NCT00023153|Adefovir|adefovir|mesh-list
25674302|NCT01769586|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25838055|NCT00023153|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25838056|NCT00023153|Antiviral Agents|antiviral agents|mesh-ancestor
25838057|NCT00023153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25838058|NCT00023153|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25838059|NCT00023153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25838060|NCT00023153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838061|NCT00023153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838062|NCT00023166|Paclitaxel|paclitaxel|mesh-list
25838063|NCT00023166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25838064|NCT00023166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838065|NCT00023166|Tubulin Modulators|tubulin modulators|mesh-ancestor
25838066|NCT00023166|Antimitotic Agents|antimitotic agents|mesh-ancestor
25838067|NCT00023166|Mitosis Modulators|mitosis modulators|mesh-ancestor
25838068|NCT00023166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875515|NCT04303858|Atezolizumab|atezolizumab|mesh-list
25875516|NCT04303858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875517|NCT04303845|Erenumab|erenumab|mesh-list
25875518|NCT04303845|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25875519|NCT04303845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875520|NCT04303845|Analgesics|analgesics|mesh-ancestor
25875521|NCT04303845|Sensory System Agents|sensory system agents|mesh-ancestor
25875522|NCT04303845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25875523|NCT04303845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875524|NCT04301076|Prednisone|prednisone|mesh-list
25875525|NCT04301076|Cortisone|cortisone|mesh-list
24650696|NCT01227408|Antimetabolites|antimetabolites|mesh-ancestor
24650697|NCT01227408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25163219|NCT02897986|Vasodilator Agents|vasodilator agents|mesh-ancestor
25875526|NCT04301076|Cyclophosphamide|cyclophosphamide|mesh-list
25875527|NCT04301076|Doxorubicin|doxorubicin|mesh-list
25875528|NCT04301076|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25875529|NCT04301076|Etoposide|etoposide|mesh-list
25875530|NCT04301076|Vincristine|vincristine|mesh-list
25875531|NCT04301076|Lenalidomide|lenalidomide|mesh-list
25875532|NCT04301076|Etoposide phosphate|etoposide phosphate|mesh-list
25875533|NCT04301076|Podophyllotoxin|podophyllotoxin|mesh-list
25875534|NCT04301076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25875535|NCT04301076|Immunologic Factors|immunologic factors|mesh-ancestor
25875536|NCT04301076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875537|NCT04301076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25875538|NCT04301076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25875539|NCT04301076|Alkylating Agents|alkylating agents|mesh-ancestor
25875540|NCT04301076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875541|NCT04301076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875542|NCT04301076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25875543|NCT04301076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25875544|NCT04301076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25875545|NCT04301076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24650716|NCT01227603|Candesartan|candesartan|mesh-list
25875546|NCT04301076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875547|NCT04301076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25875548|NCT04301076|Glucocorticoids|glucocorticoids|mesh-ancestor
25875549|NCT04301076|Hormones|hormones|mesh-ancestor
25875550|NCT04301076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25875551|NCT04301076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24539243|NCT00662883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875552|NCT04301076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25875553|NCT04301076|Tubulin Modulators|tubulin modulators|mesh-ancestor
25875554|NCT04301076|Antimitotic Agents|antimitotic agents|mesh-ancestor
25875555|NCT04301076|Mitosis Modulators|mitosis modulators|mesh-ancestor
25875556|NCT04301076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25875557|NCT04301076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25875558|NCT04301076|Growth Substances|growth substances|mesh-ancestor
25163220|NCT02898012|Bevacizumab|bevacizumab|mesh-list
25875559|NCT04301076|Growth Inhibitors|growth inhibitors|mesh-ancestor
25875560|NCT04301076|Keratolytic Agents|keratolytic agents|mesh-ancestor
25875561|NCT04301076|Dermatologic Agents|dermatologic agents|mesh-ancestor
25875562|NCT04300556|Farletuzumab|farletuzumab|mesh-list
25875563|NCT04300556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875564|NCT04272242|Pyridoxine|pyridoxine|mesh-list
25875565|NCT04272242|Pyridoxal|pyridoxal|mesh-list
25875566|NCT04272242|Vitamin B 6|vitamin b 6|mesh-list
25875567|NCT04272242|Isoniazid|isoniazid|mesh-list
25875568|NCT04272242|Rifapentine|rifapentine|mesh-list
25875569|NCT04272242|Dolutegravir|dolutegravir|mesh-list
25875570|NCT04272242|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25875571|NCT04272242|Vitamins|vitamins|mesh-ancestor
25875572|NCT04272242|Micronutrients|micronutrients|mesh-ancestor
25875573|NCT04272242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838069|NCT00023218|Ritonavir|ritonavir|mesh-list
25838070|NCT00023218|Lopinavir|lopinavir|mesh-list
25838071|NCT00023218|Efavirenz|efavirenz|mesh-list
25838072|NCT00023218|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25838073|NCT00023218|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25838074|NCT00023218|Protease Inhibitors|protease inhibitors|mesh-ancestor
25838075|NCT00023218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838076|NCT00023218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838077|NCT00023218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25838078|NCT00023218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25838079|NCT00023218|Antiviral Agents|antiviral agents|mesh-ancestor
25838080|NCT00023218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25838081|NCT00023218|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25838082|NCT00023218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25838083|NCT00023218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25838084|NCT00023218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25838085|NCT00023218|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25838086|NCT00023218|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25838087|NCT00023218|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25838088|NCT00023218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25838089|NCT00023218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24451065|NCT00321724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838090|NCT00023231|Mycophenolic Acid|mycophenolic acid|mesh-list
25838091|NCT00023231|Sirolimus|sirolimus|mesh-list
25838092|NCT00023231|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24650767|NCT01227876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25838093|NCT00023231|Ganciclovir|ganciclovir|mesh-list
25838094|NCT00023231|Prednisone|prednisone|mesh-list
25838095|NCT00023231|Methylprednisolone|methylprednisolone|mesh-list
25838096|NCT00023231|Atorvastatin|atorvastatin|mesh-list
25838097|NCT00023231|Daclizumab|daclizumab|mesh-list
25838098|NCT00023231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25838099|NCT00023231|Glucocorticoids|glucocorticoids|mesh-ancestor
25838100|NCT00023231|Hormones|hormones|mesh-ancestor
25838101|NCT00023231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25838102|NCT00023231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838103|NCT00023231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25838104|NCT00023231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838105|NCT00023231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25838106|NCT00023231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25838107|NCT00023231|Antitubercular Agents|antitubercular agents|mesh-ancestor
25838108|NCT00023231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25838109|NCT00023231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25838110|NCT00023231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838111|NCT00023231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838112|NCT00023231|Antifungal Agents|antifungal agents|mesh-ancestor
25838113|NCT00023231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25838114|NCT00023231|Immunologic Factors|immunologic factors|mesh-ancestor
25838115|NCT00023231|Antiemetics|antiemetics|mesh-ancestor
25838116|NCT00023231|Autonomic Agents|autonomic agents|mesh-ancestor
24929921|NCT04107194|Renal Agents|renal agents|mesh-ancestor
24650804|NCT01228110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24650805|NCT01228136|Tranexamic Acid|tranexamic acid|mesh-list
25838117|NCT00023231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25838118|NCT00023231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25163221|NCT02898012|Temozolomide|temozolomide|mesh-list
25838119|NCT00023231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25838120|NCT00023231|Protective Agents|protective agents|mesh-ancestor
25838121|NCT00023231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25838122|NCT00023231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25838123|NCT00023231|Antimetabolites|antimetabolites|mesh-ancestor
25838124|NCT00023231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25838125|NCT00023231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25838126|NCT00023231|Antiviral Agents|antiviral agents|mesh-ancestor
25838127|NCT00023231|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25838128|NCT00023231|Renal Agents|renal agents|mesh-ancestor
25838129|NCT00023231|Antimalarials|antimalarials|mesh-ancestor
25838130|NCT00023231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25838131|NCT00023231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25838132|NCT00023244|Cyclosporine|cyclosporine|mesh-list
24539336|NCT00663338|Rotigotine|rotigotine|mesh-list
25838133|NCT00023244|Sirolimus|sirolimus|mesh-list
25838134|NCT00023244|Trimethoprim|trimethoprim|mesh-list
24650829|NCT01228214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25838135|NCT00023244|Sulfamethoxazole|sulfamethoxazole|mesh-list
25838136|NCT00023244|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25838137|NCT00023244|Prednisone|prednisone|mesh-list
25838138|NCT00023244|Methylprednisolone|methylprednisolone|mesh-list
25838139|NCT00023244|Tacrolimus|tacrolimus|mesh-list
25838140|NCT00023244|Cyclosporins|cyclosporins|mesh-list
25838141|NCT00023244|Basiliximab|basiliximab|mesh-list
25659588|NCT01609348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659589|NCT01609348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25659590|NCT01609348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659591|NCT01609348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25659592|NCT01609348|Antidepressive Agents|antidepressive agents|mesh-ancestor
25838142|NCT00023244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25838143|NCT00023244|Glucocorticoids|glucocorticoids|mesh-ancestor
25838144|NCT00023244|Hormones|hormones|mesh-ancestor
25838145|NCT00023244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25838146|NCT00023244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930000|NCT04106726|Ivermectin|ivermectin|mesh-list
25838147|NCT00023244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25838148|NCT00023244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838149|NCT00023244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25838150|NCT00023244|Immunologic Factors|immunologic factors|mesh-ancestor
25838151|NCT00023244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25838152|NCT00023244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838153|NCT00023244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838154|NCT00023244|Antifungal Agents|antifungal agents|mesh-ancestor
25838155|NCT00023244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24450782|NCT00320580|Estradiol|estradiol|mesh-list
24450783|NCT00320580|Estrogens|estrogens|mesh-ancestor
24450784|NCT00320580|Hormones|hormones|mesh-ancestor
24450785|NCT00320580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24450786|NCT00320580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539348|NCT00663442|Methylphenidate|methylphenidate|mesh-list
25838156|NCT00023244|Dermatologic Agents|dermatologic agents|mesh-ancestor
25838157|NCT00023244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25838158|NCT00023244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25838159|NCT00023244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25838160|NCT00023244|Antiemetics|antiemetics|mesh-ancestor
25838161|NCT00023244|Autonomic Agents|autonomic agents|mesh-ancestor
25838162|NCT00023244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25838163|NCT00023244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25838164|NCT00023244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25838165|NCT00023244|Protective Agents|protective agents|mesh-ancestor
25838166|NCT00023244|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25838167|NCT00023244|Renal Agents|renal agents|mesh-ancestor
25838168|NCT00023244|Antimalarials|antimalarials|mesh-ancestor
25838169|NCT00023244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25838170|NCT00023244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25838171|NCT00023244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25838172|NCT00023244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25838173|NCT00023244|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25838174|NCT00023244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25838175|NCT00023283|Buprenorphine|buprenorphine|mesh-list
25838176|NCT00023283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25838177|NCT00023283|Narcotics|narcotics|mesh-ancestor
25838178|NCT00023283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25838179|NCT00023283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838180|NCT00023283|Analgesics|analgesics|mesh-ancestor
25838181|NCT00023283|Sensory System Agents|sensory system agents|mesh-ancestor
25838182|NCT00023283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25838183|NCT00023283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25838184|NCT00023296|Nitric Oxide|nitric oxide|mesh-list
25838185|NCT00023296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25838186|NCT00023296|Autonomic Agents|autonomic agents|mesh-ancestor
25838187|NCT00023296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25838188|NCT00023296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838189|NCT00023296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25838190|NCT00023296|Respiratory System Agents|respiratory system agents|mesh-ancestor
25838191|NCT00023296|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25838192|NCT00023296|Antioxidants|antioxidants|mesh-ancestor
25838193|NCT00023296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838194|NCT00023296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25875574|NCT04272242|Vitamin B Complex|vitamin b complex|mesh-ancestor
25659593|NCT01609348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25659594|NCT01609478|Mometasone Furoate|mometasone furoate|mesh-list
25659595|NCT01609478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25659596|NCT01609478|Dermatologic Agents|dermatologic agents|mesh-ancestor
25659597|NCT01609478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25659598|NCT01609543|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25838195|NCT00023296|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25838196|NCT00023296|Vasodilator Agents|vasodilator agents|mesh-ancestor
25838197|NCT00023296|Gasotransmitters|gasotransmitters|mesh-ancestor
25838198|NCT00023296|Protective Agents|protective agents|mesh-ancestor
25838199|NCT00023335|Isoniazid|isoniazid|mesh-list
24811900|NCT02048917|Bupropion|bupropion|mesh-list
25838200|NCT00023335|Rifapentine|rifapentine|mesh-list
25838201|NCT00023335|Antitubercular Agents|antitubercular agents|mesh-ancestor
25838202|NCT00023335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25838203|NCT00023335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25838204|NCT00023335|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24459760|NCT00346359|Abortifacient Agents|abortifacient agents|mesh-ancestor
24459761|NCT00346359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25838205|NCT00023335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25838206|NCT00023335|Antimetabolites|antimetabolites|mesh-ancestor
25838207|NCT00023335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838208|NCT00023335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25838209|NCT00023335|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25838210|NCT00023335|Leprostatic Agents|leprostatic agents|mesh-ancestor
25838211|NCT00023348|Isoniazid|isoniazid|mesh-list
25838212|NCT00023348|Rifabutin|rifabutin|mesh-list
24650975|NCT01228630|Pseudoephedrine|pseudoephedrine|mesh-list
24650976|NCT01228630|Ephedrine|ephedrine|mesh-list
24650977|NCT01228630|Antipruritics|antipruritics|mesh-ancestor
24650978|NCT01228630|Dermatologic Agents|dermatologic agents|mesh-ancestor
24650979|NCT01228630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24650980|NCT01228630|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24650981|NCT01228630|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24650982|NCT01228630|Histamine Antagonists|histamine antagonists|mesh-ancestor
24650983|NCT01228630|Histamine Agents|histamine agents|mesh-ancestor
24650984|NCT01228630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24650985|NCT01228630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650986|NCT01228630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838213|NCT00023348|Antitubercular Agents|antitubercular agents|mesh-ancestor
25838214|NCT00023348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25838215|NCT00023348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25838216|NCT00023348|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25838217|NCT00023348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25838218|NCT00023348|Antimetabolites|antimetabolites|mesh-ancestor
25838219|NCT00023348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838220|NCT00023348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25838221|NCT00023348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25838222|NCT00023361|Rifabutin|rifabutin|mesh-list
25838223|NCT00023361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25838224|NCT00023361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25838225|NCT00023361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25838226|NCT00023361|Antitubercular Agents|antitubercular agents|mesh-ancestor
25838227|NCT00023374|Rifampin|rifampin|mesh-list
25838228|NCT00023374|Pyrazinamide|pyrazinamide|mesh-list
25838229|NCT00023374|Ethambutol|ethambutol|mesh-list
24650998|NCT01228656|Salicylic Acid|salicylic acid|mesh-list
25838230|NCT00023374|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25838231|NCT00023374|Antitubercular Agents|antitubercular agents|mesh-ancestor
25838232|NCT00023374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25838233|NCT00023374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25838234|NCT00023374|Leprostatic Agents|leprostatic agents|mesh-ancestor
25838235|NCT00023374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25838236|NCT00023374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838237|NCT00023374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838238|NCT00023374|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25154119|NCT01462890|Tubulin Modulators|tubulin modulators|mesh-ancestor
25838239|NCT00023374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25838240|NCT00023374|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25838241|NCT00023374|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25838242|NCT00023374|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25838243|NCT00023374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25838244|NCT00023387|Isoniazid|isoniazid|mesh-list
25838245|NCT00023387|Rifapentine|rifapentine|mesh-list
25838246|NCT00023387|Rifampin|rifampin|mesh-list
25838247|NCT00023387|Antitubercular Agents|antitubercular agents|mesh-ancestor
25659599|NCT01609543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659600|NCT01609543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25659601|NCT01609543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25659602|NCT01609543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659603|NCT01609556|Maytansine|maytansine|mesh-list
25659604|NCT01609556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24883881|NCT04631536|Hematinics|hematinics|mesh-ancestor
25838248|NCT00023387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25838249|NCT00023387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25838250|NCT00023387|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25838251|NCT00023387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25838252|NCT00023387|Antimetabolites|antimetabolites|mesh-ancestor
25838253|NCT00023387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838254|NCT00023387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25838255|NCT00023387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25838256|NCT00023387|Leprostatic Agents|leprostatic agents|mesh-ancestor
25838257|NCT00023387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25838258|NCT00023387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838259|NCT00023387|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25838260|NCT00023387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25838261|NCT00023387|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25838262|NCT00023387|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25838263|NCT00023387|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25838264|NCT00023387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25838265|NCT00023400|Nelfinavir|nelfinavir|mesh-list
25838266|NCT00023400|Rifabutin|rifabutin|mesh-list
25838267|NCT00023400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25838268|NCT00023400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25838269|NCT00023400|Protease Inhibitors|protease inhibitors|mesh-ancestor
25838270|NCT00023400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838271|NCT00023400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838272|NCT00023400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25838273|NCT00023400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25838274|NCT00023400|Antiviral Agents|antiviral agents|mesh-ancestor
25838275|NCT00023400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25838276|NCT00023400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25838277|NCT00023400|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25838278|NCT00023400|Antitubercular Agents|antitubercular agents|mesh-ancestor
25838279|NCT00023413|Efavirenz|efavirenz|mesh-list
25838280|NCT00023413|Rifabutin|rifabutin|mesh-list
25838281|NCT00023413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25838282|NCT00023413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25838283|NCT00023413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838284|NCT00023413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838285|NCT00023413|Antiviral Agents|antiviral agents|mesh-ancestor
25838286|NCT00023413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25838287|NCT00023413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25838288|NCT00023413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25163222|NCT02898012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25838289|NCT00023413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25838290|NCT00023413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25838291|NCT00023413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25838292|NCT00023413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25838293|NCT00023413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25838294|NCT00023413|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25838295|NCT00023413|Antitubercular Agents|antitubercular agents|mesh-ancestor
25838296|NCT00023426|Rifapentine|rifapentine|mesh-list
25838297|NCT00023426|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25838298|NCT00023426|Antitubercular Agents|antitubercular agents|mesh-ancestor
25838299|NCT00023426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25838300|NCT00023426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25838301|NCT00023426|Leprostatic Agents|leprostatic agents|mesh-ancestor
25838302|NCT00023504|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25838303|NCT00023504|Immunologic Factors|immunologic factors|mesh-ancestor
25838304|NCT00023504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838305|NCT00023530|Thalidomide|thalidomide|mesh-list
25838306|NCT00023530|Fluconazole|fluconazole|mesh-list
25838307|NCT00023530|Voriconazole|voriconazole|mesh-list
25838308|NCT00023530|Dexamethasone|dexamethasone|mesh-list
25838309|NCT00023530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25838310|NCT00023530|Antiemetics|antiemetics|mesh-ancestor
25838311|NCT00023530|Autonomic Agents|autonomic agents|mesh-ancestor
25838312|NCT00023530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25838313|NCT00023530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459762|NCT00346359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459763|NCT00346359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24410442|NCT00185302|Entinostat|entinostat|mesh-list
25838314|NCT00023530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25838315|NCT00023530|Glucocorticoids|glucocorticoids|mesh-ancestor
25659605|NCT01609556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659606|NCT01609556|Tubulin Modulators|tubulin modulators|mesh-ancestor
25838316|NCT00023530|Hormones|hormones|mesh-ancestor
25838317|NCT00023530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25838318|NCT00023530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25838319|NCT00023530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838320|NCT00023530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25838321|NCT00023530|Immunologic Factors|immunologic factors|mesh-ancestor
25838322|NCT00023530|Leprostatic Agents|leprostatic agents|mesh-ancestor
25838323|NCT00023530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25838324|NCT00023530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25838325|NCT00023530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25838326|NCT00023530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25838327|NCT00023530|Growth Substances|growth substances|mesh-ancestor
25838328|NCT00023530|Growth Inhibitors|growth inhibitors|mesh-ancestor
25838329|NCT00023530|Antifungal Agents|antifungal agents|mesh-ancestor
25838330|NCT00023530|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25838331|NCT00023530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25838332|NCT00023530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838333|NCT00023530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838334|NCT00023530|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25838335|NCT00023530|Hormone Antagonists|hormone antagonists|mesh-ancestor
25838336|NCT00023530|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25838337|NCT00023530|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25838338|NCT00023530|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25838339|NCT00023621|Celecoxib|celecoxib|mesh-list
25838340|NCT00023621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25838341|NCT00023621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25838342|NCT00023621|Analgesics|analgesics|mesh-ancestor
25838343|NCT00023621|Sensory System Agents|sensory system agents|mesh-ancestor
25838344|NCT00023621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25838345|NCT00023621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838346|NCT00023621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25838347|NCT00023621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25838348|NCT00023621|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25838349|NCT00023621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25838350|NCT00023621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838351|NCT00023621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838352|NCT00023634|Sargramostim|sargramostim|mesh-list
25838353|NCT00023634|Immunologic Factors|immunologic factors|mesh-ancestor
25838354|NCT00023634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838355|NCT00023660|Celecoxib|celecoxib|mesh-list
25838356|NCT00023660|Cisplatin|cisplatin|mesh-list
25838357|NCT00023660|Fluorouracil|fluorouracil|mesh-list
25838358|NCT00023660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838359|NCT00023660|Antimetabolites|antimetabolites|mesh-ancestor
25838360|NCT00023660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838361|NCT00023660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25838362|NCT00023660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25838363|NCT00023660|Immunologic Factors|immunologic factors|mesh-ancestor
25838364|NCT00023660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838365|NCT00023660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25838366|NCT00023660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25838367|NCT00023660|Analgesics|analgesics|mesh-ancestor
25838368|NCT00023660|Sensory System Agents|sensory system agents|mesh-ancestor
25838369|NCT00023660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25838370|NCT00023660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25838371|NCT00023660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25838372|NCT00023660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25838373|NCT00023660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25838374|NCT00023660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859060|NCT02301494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24859061|NCT02301494|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24859062|NCT02301650|Tenofovir|tenofovir|mesh-list
24859063|NCT02301650|Lamivudine|lamivudine|mesh-list
24859064|NCT02301650|Telbivudine|telbivudine|mesh-list
24859065|NCT02301650|Antiviral Agents|antiviral agents|mesh-ancestor
24859066|NCT02301650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24859067|NCT02301650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24859068|NCT02301650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24859069|NCT02301650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859070|NCT02301650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859071|NCT02301650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24859072|NCT02301650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24859093|NCT02301676|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24859095|NCT02301715|Oxytocics|oxytocics|mesh-ancestor
24859096|NCT02301715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24859097|NCT02301715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859099|NCT02301780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24859100|NCT02301780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24859101|NCT02301780|Analgesics|analgesics|mesh-ancestor
24859102|NCT02301780|Sensory System Agents|sensory system agents|mesh-ancestor
24859103|NCT02301780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24859105|NCT02301780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24859121|NCT02301806|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24859122|NCT02301806|Protease Inhibitors|protease inhibitors|mesh-ancestor
24859123|NCT02301806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859124|NCT02301806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859125|NCT02301806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24859126|NCT02301806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24859127|NCT02301806|Immunologic Factors|immunologic factors|mesh-ancestor
24859128|NCT02301910|Tenecteplase|tenecteplase|mesh-list
24859129|NCT02301910|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24859130|NCT02301910|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24859131|NCT02301910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859132|NCT02301949|Thalidomide|thalidomide|mesh-list
24859133|NCT02301949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24859134|NCT02301949|Immunologic Factors|immunologic factors|mesh-ancestor
24859135|NCT02301949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859136|NCT02301949|Leprostatic Agents|leprostatic agents|mesh-ancestor
24859137|NCT02301949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24859138|NCT02301949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24859139|NCT02301949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24859140|NCT02301949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25838376|NCT00023699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838377|NCT00023699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25838378|NCT00023699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838379|NCT00023699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838380|NCT00023725|Semaxinib|semaxinib|mesh-list
25838381|NCT00023725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25838382|NCT00023725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25838383|NCT00023725|Growth Substances|growth substances|mesh-ancestor
24859141|NCT02301949|Growth Substances|growth substances|mesh-ancestor
24859142|NCT02301949|Growth Inhibitors|growth inhibitors|mesh-ancestor
24859143|NCT02301949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859144|NCT02301962|Panitumumab|panitumumab|mesh-list
24859145|NCT02301962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24859146|NCT02301962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859147|NCT02302170|Vaccines|vaccines|mesh-list
24859148|NCT02302170|Immunologic Factors|immunologic factors|mesh-ancestor
24859149|NCT02302170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859150|NCT02302209|Oxytocin|oxytocin|mesh-list
24859151|NCT02302209|Oxytocics|oxytocics|mesh-ancestor
24859152|NCT02302209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24859153|NCT02302209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859154|NCT02302274|Flecainide|flecainide|mesh-list
24651364|NCT01231165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24651365|NCT01231165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24651367|NCT01231165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24859163|NCT02302326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24859164|NCT02302326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859166|NCT02302326|Vitamin B Complex|vitamin b complex|mesh-ancestor
24859168|NCT02302326|Micronutrients|micronutrients|mesh-ancestor
24859169|NCT02302378|Bupivacaine|bupivacaine|mesh-list
24859170|NCT02302378|Anesthetics, Local|anesthetics, local|mesh-ancestor
24859171|NCT02302378|Anesthetics|anesthetics|mesh-ancestor
24859172|NCT02302378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25838384|NCT00023725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838385|NCT00023725|Growth Inhibitors|growth inhibitors|mesh-ancestor
25838386|NCT00023725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838387|NCT00023725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24859173|NCT02302378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859174|NCT02302378|Sensory System Agents|sensory system agents|mesh-ancestor
24859175|NCT02302378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24859176|NCT02302404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24859178|NCT02302430|Oxytocics|oxytocics|mesh-ancestor
24859179|NCT02302430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25659607|NCT01609556|Antimitotic Agents|antimitotic agents|mesh-ancestor
25057864|NCT03501212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25057865|NCT03501212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057866|NCT03501212|Sensory System Agents|sensory system agents|mesh-ancestor
25057868|NCT03501056|Antibodies|antibodies|mesh-list
24859180|NCT02302430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859181|NCT02302456|Tranexamic Acid|tranexamic acid|mesh-list
24651384|NCT01231165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24859237|NCT02302547|Tipranavir|tipranavir|mesh-list
24651385|NCT01231165|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24859182|NCT02302456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24859183|NCT02302456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24859184|NCT02302456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859186|NCT02302456|Coagulants|coagulants|mesh-ancestor
24859187|NCT02302469|Lenalidomide|lenalidomide|mesh-list
24859188|NCT02302469|Immunologic Factors|immunologic factors|mesh-ancestor
24859189|NCT02302469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859190|NCT02302469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24859191|NCT02302469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24859192|NCT02302469|Growth Substances|growth substances|mesh-ancestor
24859203|NCT02302495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859211|NCT02302508|Ticagrelor|ticagrelor|mesh-list
24859222|NCT02302547|Lopinavir|lopinavir|mesh-list
25838388|NCT00023725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838389|NCT00023725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838390|NCT00023738|Doxorubicin|doxorubicin|mesh-list
25838391|NCT00023738|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25838392|NCT00023738|Ifosfamide|ifosfamide|mesh-list
25838393|NCT00023738|Dacarbazine|dacarbazine|mesh-list
25838394|NCT00023738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25838395|NCT00023738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838396|NCT00023738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25838397|NCT00023738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24859223|NCT02302547|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24859224|NCT02302547|Darunavir|darunavir|mesh-list
24859225|NCT02302547|Indinavir|indinavir|mesh-list
24859226|NCT02302547|Saquinavir|saquinavir|mesh-list
24859227|NCT02302547|Fosamprenavir|fosamprenavir|mesh-list
24859228|NCT02302547|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
24859229|NCT02302547|Tenofovir|tenofovir|mesh-list
24859230|NCT02302547|Emtricitabine|emtricitabine|mesh-list
24859231|NCT02302547|Raltegravir Potassium|raltegravir potassium|mesh-list
24859232|NCT02302547|Nevirapine|nevirapine|mesh-list
25838398|NCT00023738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838399|NCT00023738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838400|NCT00023738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25838401|NCT00023738|Alkylating Agents|alkylating agents|mesh-ancestor
25838402|NCT00023751|Leucovorin|leucovorin|mesh-list
25838403|NCT00023751|Fluorouracil|fluorouracil|mesh-list
25838404|NCT00023751|Calcium|calcium|mesh-list
25838405|NCT00023751|Levoleucovorin|levoleucovorin|mesh-list
25838406|NCT00023751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25838407|NCT00023751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838408|NCT00023751|Antimetabolites|antimetabolites|mesh-ancestor
25838409|NCT00023751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838410|NCT00023751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25838411|NCT00023751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838412|NCT00023751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25838413|NCT00023751|Immunologic Factors|immunologic factors|mesh-ancestor
25838414|NCT00023751|Antidotes|antidotes|mesh-ancestor
25838415|NCT00023751|Protective Agents|protective agents|mesh-ancestor
25838416|NCT00023751|Vitamin B Complex|vitamin b complex|mesh-ancestor
25838417|NCT00023751|Vitamins|vitamins|mesh-ancestor
25838418|NCT00023751|Micronutrients|micronutrients|mesh-ancestor
25838419|NCT00023777|Cytarabine|cytarabine|mesh-list
25838420|NCT00023777|Daunorubicin|daunorubicin|mesh-list
25838421|NCT00023777|Sargramostim|sargramostim|mesh-list
25838422|NCT00023777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25838423|NCT00023777|Antimetabolites|antimetabolites|mesh-ancestor
25838424|NCT00023777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659608|NCT01609556|Mitosis Modulators|mitosis modulators|mesh-ancestor
25659609|NCT01609556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659610|NCT01609933|Interferons|interferons|mesh-list
24859233|NCT02302547|Maraviroc|maraviroc|mesh-list
24859234|NCT02302547|Dolutegravir|dolutegravir|mesh-list
24859235|NCT02302547|Cobicistat|cobicistat|mesh-list
24859236|NCT02302547|Rilpivirine|rilpivirine|mesh-list
24859239|NCT02302547|Elvitegravir|elvitegravir|mesh-list
24859240|NCT02302547|Efavirenz|efavirenz|mesh-list
24859241|NCT02302547|Etravirine|etravirine|mesh-list
25408942|NCT03410043|Osimertinib|osimertinib|mesh-list
25659611|NCT01609933|Ritonavir|ritonavir|mesh-list
25838425|NCT00023777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838426|NCT00023777|Antiviral Agents|antiviral agents|mesh-ancestor
25838427|NCT00023777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25838428|NCT00023777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25838429|NCT00023777|Immunologic Factors|immunologic factors|mesh-ancestor
25659613|NCT01609933|Interferon-alpha|interferon-alpha|mesh-list
25659614|NCT01609933|Interferon alpha-2|interferon alpha-2|mesh-list
25659615|NCT01609933|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25838430|NCT00023777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838431|NCT00023777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24859242|NCT02302547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
24859243|NCT02302547|Protease Inhibitors|protease inhibitors|mesh-list
24859244|NCT02302547|Integrase Inhibitors|integrase inhibitors|mesh-list
24859245|NCT02302547|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24859293|NCT02302950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859294|NCT02302976|Exenatide|exenatide|mesh-list
24859295|NCT02302976|Cocaine|cocaine|mesh-list
24859296|NCT02302976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24859297|NCT02302976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859298|NCT02302976|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24859299|NCT02302976|Incretins|incretins|mesh-ancestor
25838432|NCT00023777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25838433|NCT00023777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24859300|NCT02302976|Hormones|hormones|mesh-ancestor
24859301|NCT02302976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24859302|NCT02302976|Anesthetics, Local|anesthetics, local|mesh-ancestor
24859303|NCT02302976|Anesthetics|anesthetics|mesh-ancestor
24859304|NCT02302976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24859305|NCT02302976|Sensory System Agents|sensory system agents|mesh-ancestor
24859306|NCT02302976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25838434|NCT00023777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651560|NCT01232075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813230|NCT02057003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813231|NCT02057094|Caseins|caseins|mesh-list
24813232|NCT02057094|Chelating Agents|chelating agents|mesh-ancestor
24813233|NCT02057094|Sequestering Agents|sequestering agents|mesh-ancestor
24813234|NCT02057094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813235|NCT02057107|Docetaxel|docetaxel|mesh-list
24859338|NCT02303106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859339|NCT02303106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24859340|NCT02303106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24859341|NCT02303106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24859342|NCT02303106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24930537|NCT04100655|Molgramostim|molgramostim|mesh-list
24859348|NCT02303119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859349|NCT02303119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24859350|NCT02303171|Enoxaparin|enoxaparin|mesh-list
24859351|NCT02303171|Warfarin|warfarin|mesh-list
24859352|NCT02303171|Anticoagulants|anticoagulants|mesh-ancestor
24859353|NCT02303171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24859354|NCT02303171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24859355|NCT02303171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859356|NCT02303223|Propofol|propofol|mesh-list
24859357|NCT02303223|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24859358|NCT02303223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25838435|NCT00023790|Silicon|silicon|mesh-list
25838436|NCT00023790|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
25838437|NCT00023790|Trace Elements|trace elements|mesh-ancestor
25838438|NCT00023790|Micronutrients|micronutrients|mesh-ancestor
25838439|NCT00023790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838440|NCT00023790|Antimalarials|antimalarials|mesh-ancestor
25838441|NCT00023790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25838442|NCT00023790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25838443|NCT00023790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25838444|NCT00023790|Antiviral Agents|antiviral agents|mesh-ancestor
25838445|NCT00023790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25838446|NCT00023790|Dermatologic Agents|dermatologic agents|mesh-ancestor
25838447|NCT00023816|Carbendazim|carbendazim|mesh-list
25659616|NCT01609933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659617|NCT01609933|Antiviral Agents|antiviral agents|mesh-ancestor
25659618|NCT01609933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25659619|NCT01609933|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25659620|NCT01609933|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25163223|NCT02898012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163224|NCT02898012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25659621|NCT01609933|Protease Inhibitors|protease inhibitors|mesh-ancestor
24816299|NCT02076191|Antimetabolites|antimetabolites|mesh-ancestor
24941591|NCT03989310|Immunoglobulins|immunoglobulins|mesh-list
25057951|NCT03500445|Hormones|hormones|mesh-ancestor
25057953|NCT03500445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25838448|NCT00023816|Antinematodal Agents|antinematodal agents|mesh-ancestor
25838449|NCT00023816|Anthelmintics|anthelmintics|mesh-ancestor
25838450|NCT00023816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25838451|NCT00023816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25838452|NCT00023829|Bicalutamide|bicalutamide|mesh-list
25051666|NCT00389675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25838453|NCT00023829|Flutamide|flutamide|mesh-list
25838454|NCT00023829|Hormones|hormones|mesh-list
25838455|NCT00023829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24859401|NCT02303483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24859402|NCT02303483|Vasodilator Agents|vasodilator agents|mesh-ancestor
24859403|NCT02303587|Methylprednisolone|methylprednisolone|mesh-list
24859404|NCT02303587|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24859405|NCT02303587|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24859406|NCT02303587|Prednisolone|prednisolone|mesh-list
24859407|NCT02303587|Prednisolone acetate|prednisolone acetate|mesh-list
24859408|NCT02303587|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24859409|NCT02303587|Prednisolone phosphate|prednisolone phosphate|mesh-list
24859410|NCT02303587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24859411|NCT02303587|Antiemetics|antiemetics|mesh-ancestor
24859412|NCT02303587|Autonomic Agents|autonomic agents|mesh-ancestor
24859413|NCT02303587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24859414|NCT02303587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859415|NCT02303587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24859416|NCT02303587|Glucocorticoids|glucocorticoids|mesh-ancestor
24859417|NCT02303587|Hormones|hormones|mesh-ancestor
24859418|NCT02303587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24859419|NCT02303587|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24681065|NCT01378039|Hormones|hormones|mesh-ancestor
24859420|NCT02303587|Protective Agents|protective agents|mesh-ancestor
24859421|NCT02303587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24859422|NCT02303587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859423|NCT02303600|Montelukast|montelukast|mesh-list
24859424|NCT02303600|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24859425|NCT02303600|Respiratory System Agents|respiratory system agents|mesh-ancestor
24859426|NCT02303600|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24859442|NCT02303639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24859447|NCT02303639|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24859448|NCT02303639|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24859449|NCT02303639|Adrenergic Agents|adrenergic agents|mesh-ancestor
24859450|NCT02303639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24859451|NCT02303639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859452|NCT02303639|Sympatholytics|sympatholytics|mesh-ancestor
24859453|NCT02303639|Autonomic Agents|autonomic agents|mesh-ancestor
24859454|NCT02303639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24859455|NCT02303730|Insulin Glargine|insulin glargine|mesh-list
24859456|NCT02303730|Exenatide|exenatide|mesh-list
24859457|NCT02303730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24859458|NCT02303730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859459|NCT02303730|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24859460|NCT02303730|Incretins|incretins|mesh-ancestor
24859461|NCT02303730|Hormones|hormones|mesh-ancestor
24859462|NCT02303730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24859463|NCT02303769|Tamsulosin|tamsulosin|mesh-list
24859464|NCT02303769|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24450808|NCT00320632|Adrenergic Agents|adrenergic agents|mesh-ancestor
25838456|NCT00023829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838457|NCT00023829|Androgen Antagonists|androgen antagonists|mesh-ancestor
25838458|NCT00023829|Hormone Antagonists|hormone antagonists|mesh-ancestor
25838459|NCT00023829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859465|NCT02303769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24859466|NCT02303769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24859467|NCT02303769|Adrenergic Agents|adrenergic agents|mesh-ancestor
24859468|NCT02303769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24859476|NCT02303782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859477|NCT02303782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859478|NCT02303847|Ketamine|ketamine|mesh-list
24859479|NCT02303847|Analgesics|analgesics|mesh-ancestor
24859480|NCT02303847|Sensory System Agents|sensory system agents|mesh-ancestor
25659622|NCT01609933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25659623|NCT01609933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659624|NCT01609933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25838460|NCT00023829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25838461|NCT00023842|Mitomycins|mitomycins|mesh-list
24859482|NCT02303847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859483|NCT02303847|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25163225|NCT02898012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24998034|NCT03909607|Anesthetics, General|anesthetics, general|mesh-ancestor
24859484|NCT02303847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24859485|NCT02303847|Anesthetics, General|anesthetics, general|mesh-ancestor
24859486|NCT02303847|Anesthetics|anesthetics|mesh-ancestor
24859487|NCT02303847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24859488|NCT02303847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24859489|NCT02303847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24859490|NCT02303847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24859491|NCT02303847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859492|NCT02303873|Alendronate|alendronate|mesh-list
25838462|NCT00023842|Mitomycin|mitomycin|mesh-list
25838463|NCT00023842|BCG Vaccine|bcg vaccine|mesh-list
25838464|NCT00023842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25838465|NCT00023842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838466|NCT00023842|Alkylating Agents|alkylating agents|mesh-ancestor
25838467|NCT00023842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838468|NCT00023842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25838469|NCT00023842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838470|NCT00023842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25838471|NCT00023842|Immunologic Factors|immunologic factors|mesh-ancestor
25838472|NCT00023842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838473|NCT00023855|Doxorubicin|doxorubicin|mesh-list
25838474|NCT00023855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25838475|NCT00023855|Bortezomib|bortezomib|mesh-list
25838476|NCT00023855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24859493|NCT02303873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24859494|NCT02303873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859502|NCT02303899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859504|NCT02303899|Antiviral Agents|antiviral agents|mesh-ancestor
24859505|NCT02303899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24859506|NCT02303899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859507|NCT02303899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24859508|NCT02303899|Immunologic Factors|immunologic factors|mesh-ancestor
24859509|NCT02303899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859510|NCT02303899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24859511|NCT02303912|Carboplatin|carboplatin|mesh-list
24859512|NCT02303912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859513|NCT02303951|Atezolizumab|atezolizumab|mesh-list
24859514|NCT02303951|Vemurafenib|vemurafenib|mesh-list
24859515|NCT02303951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859516|NCT02303951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24795377|NCT02900560|Cc-486|cc-486|mesh-list
24859517|NCT02303951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859518|NCT02303951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859519|NCT02304042|Oxytocin|oxytocin|mesh-list
24859520|NCT02304042|Carbetocin|carbetocin|mesh-list
24859521|NCT02304042|Oxytocics|oxytocics|mesh-ancestor
24859522|NCT02304042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24859523|NCT02304042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859524|NCT02304055|Oxytocin|oxytocin|mesh-list
24859525|NCT02304055|Carbetocin|carbetocin|mesh-list
24859526|NCT02304055|Oxytocics|oxytocics|mesh-ancestor
24539934|NCT00666055|Ritonavir|ritonavir|mesh-list
25838477|NCT00023855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651774|NCT01233791|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25838478|NCT00023855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25838479|NCT00023855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25838480|NCT00023855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859527|NCT02304055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24859531|NCT02304081|Hormones|hormones|mesh-ancestor
24859532|NCT02304081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24859533|NCT02304081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859534|NCT02304081|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24859535|NCT02304081|Protease Inhibitors|protease inhibitors|mesh-ancestor
24859536|NCT02304081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859537|NCT02304081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859538|NCT02304081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24859539|NCT02304094|Methylprednisolone|methylprednisolone|mesh-list
25163226|NCT02898012|Growth Substances|growth substances|mesh-ancestor
24859540|NCT02304094|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24948543|NCT03918590|Nepafenac|nepafenac|mesh-list
24505163|NCT00540202|Lumefantrine|lumefantrine|mesh-list
24825989|NCT02131480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24826014|NCT02131688|Mitoxantrone|mitoxantrone|mesh-list
25838481|NCT00023855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838482|NCT00023868|Leucovorin|leucovorin|mesh-list
25838483|NCT00023868|Doxorubicin|doxorubicin|mesh-list
25838484|NCT00023868|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25838485|NCT00023868|Fluorouracil|fluorouracil|mesh-list
25838486|NCT00023868|Irinotecan|irinotecan|mesh-list
25838487|NCT00023868|Mitomycins|mitomycins|mesh-list
25838488|NCT00023868|Mitomycin|mitomycin|mesh-list
25838489|NCT00023868|Levoleucovorin|levoleucovorin|mesh-list
25838490|NCT00023868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838491|NCT00023868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25838492|NCT00023868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25838493|NCT00023868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25838494|NCT00023868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838495|NCT00023868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838496|NCT00023868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838497|NCT00023868|Antimetabolites|antimetabolites|mesh-ancestor
24930760|NCT04097444|Leucovorin|leucovorin|mesh-list
25838498|NCT00023868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25838499|NCT00023868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25838500|NCT00023868|Immunologic Factors|immunologic factors|mesh-ancestor
25838501|NCT00023868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24813254|NCT02057328|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24813255|NCT02057328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813256|NCT02057328|Vasodilator Agents|vasodilator agents|mesh-ancestor
24813257|NCT02057328|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24813273|NCT02057484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813274|NCT02057484|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24813275|NCT02057484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813276|NCT02057484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813277|NCT02057601|Levobupivacaine|levobupivacaine|mesh-list
24813278|NCT02057601|Anesthetics, Local|anesthetics, local|mesh-ancestor
24813279|NCT02057601|Anesthetics|anesthetics|mesh-ancestor
24813280|NCT02057601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24813281|NCT02057601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813282|NCT02057601|Sensory System Agents|sensory system agents|mesh-ancestor
24813283|NCT02057601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24813284|NCT02057679|Amoxicillin|amoxicillin|mesh-list
24813285|NCT02057679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24813286|NCT02057679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25838502|NCT00023868|Antidotes|antidotes|mesh-ancestor
25838503|NCT00023868|Protective Agents|protective agents|mesh-ancestor
24859611|NCT02304354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24859612|NCT02304354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859613|NCT02304354|Immunologic Factors|immunologic factors|mesh-ancestor
24859614|NCT02304354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859615|NCT02304354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24859616|NCT02304393|Atezolizumab|atezolizumab|mesh-list
24859617|NCT02304393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859618|NCT02304445|Chlorotrianisene|chlorotrianisene|mesh-list
24859619|NCT02304445|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24859620|NCT02304445|Estrogens|estrogens|mesh-ancestor
24859621|NCT02304445|Hormones|hormones|mesh-ancestor
24859622|NCT02304445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24859623|NCT02304445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859624|NCT02304445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24859625|NCT02304445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859626|NCT02304627|Insulin|insulin|mesh-list
24859627|NCT02304627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24859628|NCT02304627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651969|NCT01234857|Antifungal Agents|antifungal agents|mesh-ancestor
24651970|NCT01234857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25163227|NCT02898012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163228|NCT02898012|Growth Inhibitors|growth inhibitors|mesh-ancestor
25163229|NCT02898012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25163230|NCT02898012|Alkylating Agents|alkylating agents|mesh-ancestor
25163231|NCT02898012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826012|NCT02131545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25198129|NCT02751034|Lidocaine|lidocaine|mesh-list
24826013|NCT02131545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414574|NCT03057600|Antimitotic Agents|antimitotic agents|mesh-ancestor
25838504|NCT00023868|Vitamin B Complex|vitamin b complex|mesh-ancestor
25838505|NCT00023868|Vitamins|vitamins|mesh-ancestor
25838506|NCT00023868|Micronutrients|micronutrients|mesh-ancestor
25659625|NCT01609933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25838507|NCT00023868|Alkylating Agents|alkylating agents|mesh-ancestor
25838508|NCT00023868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25838509|NCT00023881|Bortezomib|bortezomib|mesh-list
25838510|NCT00023881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838511|NCT00023894|Alvocidib|alvocidib|mesh-list
24930844|NCT04096690|Antibodies|antibodies|mesh-list
25838512|NCT00023894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838513|NCT00023894|Growth Inhibitors|growth inhibitors|mesh-ancestor
25838514|NCT00023894|Growth Substances|growth substances|mesh-ancestor
25838515|NCT00023894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838516|NCT00023894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25838517|NCT00023894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838518|NCT00023894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838519|NCT00023907|Paclitaxel|paclitaxel|mesh-list
25838520|NCT00023907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25838521|NCT00023907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838522|NCT00023907|Tubulin Modulators|tubulin modulators|mesh-ancestor
25838523|NCT00023907|Antimitotic Agents|antimitotic agents|mesh-ancestor
25838524|NCT00023907|Mitosis Modulators|mitosis modulators|mesh-ancestor
25838525|NCT00023907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838526|NCT00023920|Cytarabine|cytarabine|mesh-list
25838527|NCT00023920|Bevacizumab|bevacizumab|mesh-list
25838528|NCT00023920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25838529|NCT00023920|Idarubicin|idarubicin|mesh-list
24446339|NCT00304499|Autonomic Agents|autonomic agents|mesh-ancestor
24540090|NCT00666575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24859643|NCT02304822|Ciprofloxacin|ciprofloxacin|mesh-list
24859644|NCT02304822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24859645|NCT02304822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24859647|NCT02304822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24859661|NCT02305030|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24859662|NCT02305030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859663|NCT02305030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859664|NCT02305030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24859665|NCT02305030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24859666|NCT02305069|Pioglitazone|pioglitazone|mesh-list
24859667|NCT02305069|Octreotide|octreotide|mesh-list
24859668|NCT02305069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24859669|NCT02305069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859670|NCT02305069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25163232|NCT02897869|Amikacin|amikacin|mesh-list
25163233|NCT02897869|Murepavadin|murepavadin|mesh-list
25163234|NCT02897869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25163235|NCT02897869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24859671|NCT02305069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24859672|NCT02305069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859675|NCT02305160|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
25163236|NCT02897856|Midazolam|midazolam|mesh-list
24859676|NCT02305160|Respiratory System Agents|respiratory system agents|mesh-ancestor
24859678|NCT02305173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24859679|NCT02305173|Antiemetics|antiemetics|mesh-ancestor
24859680|NCT02305173|Autonomic Agents|autonomic agents|mesh-ancestor
24859681|NCT02305173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24859683|NCT02305173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24859684|NCT02305173|Glucocorticoids|glucocorticoids|mesh-ancestor
24859685|NCT02305173|Hormones|hormones|mesh-ancestor
24859686|NCT02305173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24859737|NCT02305550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859738|NCT02305550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24859739|NCT02305550|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24859740|NCT02305550|Vasodilator Agents|vasodilator agents|mesh-ancestor
24859741|NCT02305550|Gasotransmitters|gasotransmitters|mesh-ancestor
24859742|NCT02305550|Protective Agents|protective agents|mesh-ancestor
24859747|NCT02305615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24859748|NCT02305615|Growth Substances|growth substances|mesh-ancestor
24859749|NCT02305615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859750|NCT02305615|Growth Inhibitors|growth inhibitors|mesh-ancestor
24859752|NCT02305654|Ifosfamide|ifosfamide|mesh-list
24859753|NCT02305654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25838530|NCT00023920|Antibodies|antibodies|mesh-list
25838531|NCT00023920|Immunoglobulins|immunoglobulins|mesh-list
25659626|NCT01609933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25659627|NCT01609933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25838532|NCT00023920|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25838533|NCT00023920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838534|NCT00023920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25838535|NCT00023920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25838536|NCT00023920|Growth Substances|growth substances|mesh-ancestor
25838537|NCT00023920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838538|NCT00023920|Growth Inhibitors|growth inhibitors|mesh-ancestor
24652084|NCT01235819|Hormones|hormones|mesh-ancestor
24652085|NCT01235819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24652086|NCT01235819|Protease Inhibitors|protease inhibitors|mesh-ancestor
24652087|NCT01235819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652088|NCT01235819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838539|NCT00023920|Immunologic Factors|immunologic factors|mesh-ancestor
25838540|NCT00023920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25838541|NCT00023920|Antimetabolites|antimetabolites|mesh-ancestor
25838542|NCT00023920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838543|NCT00023920|Antiviral Agents|antiviral agents|mesh-ancestor
25838544|NCT00023920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24859755|NCT02305654|Tubulin Modulators|tubulin modulators|mesh-ancestor
24859756|NCT02305654|Antimitotic Agents|antimitotic agents|mesh-ancestor
24859757|NCT02305654|Mitosis Modulators|mitosis modulators|mesh-ancestor
24859758|NCT02305654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859759|NCT02305654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24859760|NCT02305654|Alkylating Agents|alkylating agents|mesh-ancestor
24859761|NCT02305693|Letrozole|letrozole|mesh-list
24859762|NCT02305693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859763|NCT02305693|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24859764|NCT02305693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24859765|NCT02305693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859766|NCT02305693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859767|NCT02305693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24859768|NCT02305693|Hormone Antagonists|hormone antagonists|mesh-ancestor
24859769|NCT02305693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24859770|NCT02305693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859771|NCT02305810|Everolimus|everolimus|mesh-list
24859772|NCT02305810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859773|NCT02305810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24859774|NCT02305810|Immunologic Factors|immunologic factors|mesh-ancestor
24859775|NCT02305810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859776|NCT02305823|Aripiprazole|aripiprazole|mesh-list
24859777|NCT02305823|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24859779|NCT02305823|Antidepressive Agents|antidepressive agents|mesh-ancestor
24859780|NCT02305823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25838545|NCT00023920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25838546|NCT00023920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25838547|NCT00023920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25838548|NCT00023920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24826086|NCT02132286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540207|NCT00666991|Paclitaxel|paclitaxel|mesh-list
25838549|NCT00023920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838550|NCT00023933|Antibodies|antibodies|mesh-list
25838551|NCT00023933|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25838552|NCT00023933|Immunologic Factors|immunologic factors|mesh-ancestor
25838553|NCT00023933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838554|NCT00023946|Epothilones|epothilones|mesh-list
25838555|NCT00023946|Epothilone B|epothilone b|mesh-list
25838556|NCT00023946|Tubulin Modulators|tubulin modulators|mesh-ancestor
25838557|NCT00023946|Antimitotic Agents|antimitotic agents|mesh-ancestor
25838558|NCT00023946|Mitosis Modulators|mitosis modulators|mesh-ancestor
25838559|NCT00023946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838560|NCT00023946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24989694|NCT04876781|Tofacitinib|tofacitinib|mesh-list
24859787|NCT02305823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24859788|NCT02305823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859789|NCT02305823|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24859790|NCT02305823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25838561|NCT00023959|Bevacizumab|bevacizumab|mesh-list
25659628|NCT01609933|Antimetabolites|antimetabolites|mesh-ancestor
25659629|NCT01609933|Immunologic Factors|immunologic factors|mesh-ancestor
25659630|NCT01609933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659631|NCT01610011|Glycine|glycine|mesh-list
25198246|NCT02750059|Tenofovir|tenofovir|mesh-list
25659632|NCT01610011|Glycine Agents|glycine agents|mesh-ancestor
25659633|NCT01610011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24941779|NCT03988075|Sensory System Agents|sensory system agents|mesh-ancestor
24941780|NCT03988075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25838562|NCT00023959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25838563|NCT00023959|Fluorouracil|fluorouracil|mesh-list
25838564|NCT00023959|Hydroxyurea|hydroxyurea|mesh-list
25838565|NCT00023959|Antibodies|antibodies|mesh-list
25838566|NCT00023959|Immunoglobulins|immunoglobulins|mesh-list
25838567|NCT00023959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25838568|NCT00023959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838569|NCT00023959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25838570|NCT00023959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25838571|NCT00023959|Growth Substances|growth substances|mesh-ancestor
25838572|NCT00023959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838573|NCT00023959|Growth Inhibitors|growth inhibitors|mesh-ancestor
25838574|NCT00023959|Immunologic Factors|immunologic factors|mesh-ancestor
24930956|NCT04095013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859801|NCT02305836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24859802|NCT02305836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163237|NCT02897856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25163238|NCT02897856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25163239|NCT02897856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25163240|NCT02897856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163241|NCT02897856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25163242|NCT02897856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24859803|NCT02305836|Nootropic Agents|nootropic agents|mesh-ancestor
25163243|NCT02897856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24948852|NCT05401721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948853|NCT05401370|Methylene Blue|methylene blue|mesh-list
24774241|NCT01844674|Tizanidine|tizanidine|mesh-list
24948856|NCT05401292|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24948857|NCT05401292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24948858|NCT05401292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24948859|NCT05401292|Dermatologic Agents|dermatologic agents|mesh-ancestor
24859810|NCT02305862|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24859811|NCT02305862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859812|NCT02305901|Repaglinide|repaglinide|mesh-list
24859813|NCT02305901|Bupropion|bupropion|mesh-list
24859814|NCT02305901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24859815|NCT02305901|Antidepressive Agents|antidepressive agents|mesh-ancestor
24859816|NCT02305901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25838575|NCT00023959|Antimetabolites|antimetabolites|mesh-ancestor
25838576|NCT00023959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838577|NCT00023959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25838578|NCT00023959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25838579|NCT00023959|Antisickling Agents|antisickling agents|mesh-ancestor
25838580|NCT00023959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838581|NCT00023959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25838582|NCT00023972|Gemcitabine|gemcitabine|mesh-list
25838583|NCT00023972|Exatecan|exatecan|mesh-list
25838584|NCT00023972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25838585|NCT00023972|Antimetabolites|antimetabolites|mesh-ancestor
25838586|NCT00023972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838587|NCT00023972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838588|NCT00023972|Antiviral Agents|antiviral agents|mesh-ancestor
25838589|NCT00023972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25838590|NCT00023972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838591|NCT00023972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25838592|NCT00023972|Immunologic Factors|immunologic factors|mesh-ancestor
24859818|NCT02305901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24859819|NCT02305901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24859820|NCT02305901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813299|NCT02057770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24813300|NCT02057770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24813301|NCT02057770|Antimetabolites|antimetabolites|mesh-ancestor
24813302|NCT02057796|Efavirenz|efavirenz|mesh-list
24813303|NCT02057796|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24813304|NCT02057796|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25163244|NCT02897856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25163245|NCT02897856|Anesthetics, General|anesthetics, general|mesh-ancestor
25163246|NCT02897856|Anesthetics|anesthetics|mesh-ancestor
25659634|NCT01610011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659635|NCT01610011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820137|NCT02098889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659636|NCT01610037|Tiotropium Bromide|tiotropium bromide|mesh-list
25838593|NCT00023972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163247|NCT02897856|GABA Modulators|gaba modulators|mesh-ancestor
25163248|NCT02897856|GABA Agents|gaba agents|mesh-ancestor
25163249|NCT02897856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25163250|NCT02897856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163251|NCT02897830|Dexamethasone|dexamethasone|mesh-list
25163252|NCT02897830|Lenalidomide|lenalidomide|mesh-list
25163253|NCT02897830|Ixazomib|ixazomib|mesh-list
25163254|NCT02897830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25163255|NCT02897830|Antiemetics|antiemetics|mesh-ancestor
25163256|NCT02897830|Autonomic Agents|autonomic agents|mesh-ancestor
25163257|NCT02897830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25163258|NCT02897830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163259|NCT02897830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24813305|NCT02057796|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25838594|NCT00023972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24813306|NCT02057796|Rifampin|rifampin|mesh-list
24813307|NCT02057796|Isoniazid|isoniazid|mesh-list
24813308|NCT02057796|Pyrazinamide|pyrazinamide|mesh-list
24813309|NCT02057796|Ethambutol|ethambutol|mesh-list
25838595|NCT00023972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25838596|NCT00023998|Leucovorin|leucovorin|mesh-list
25838597|NCT00023998|Doxorubicin|doxorubicin|mesh-list
25838598|NCT00023998|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25838599|NCT00023998|Methotrexate|methotrexate|mesh-list
25838600|NCT00023998|Trastuzumab|trastuzumab|mesh-list
25838601|NCT00023998|Etoposide|etoposide|mesh-list
25838602|NCT00023998|Etoposide phosphate|etoposide phosphate|mesh-list
24813313|NCT02057796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813315|NCT02057796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24813316|NCT02057796|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24813317|NCT02057796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24813318|NCT02057796|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24813319|NCT02057796|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24813320|NCT02057796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24813321|NCT02057796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24813323|NCT02057796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24859822|NCT02305901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24859823|NCT02305901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540279|NCT00667147|Tubulin Modulators|tubulin modulators|mesh-ancestor
25838603|NCT00023998|Ifosfamide|ifosfamide|mesh-list
25838604|NCT00023998|Levoleucovorin|levoleucovorin|mesh-list
25838605|NCT00023998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838606|NCT00023998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25838607|NCT00023998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25838608|NCT00023998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25838609|NCT00023998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838610|NCT00023998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838611|NCT00023998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838612|NCT00023998|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25838613|NCT00023998|Abortifacient Agents|abortifacient agents|mesh-ancestor
25838614|NCT00023998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25838615|NCT00023998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25838616|NCT00023998|Antimetabolites|antimetabolites|mesh-ancestor
25838617|NCT00023998|Dermatologic Agents|dermatologic agents|mesh-ancestor
25838618|NCT00023998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25838619|NCT00023998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25838620|NCT00023998|Immunologic Factors|immunologic factors|mesh-ancestor
25838621|NCT00023998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25838622|NCT00023998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25838623|NCT00023998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25838624|NCT00023998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25838625|NCT00023998|Antidotes|antidotes|mesh-ancestor
25838626|NCT00023998|Protective Agents|protective agents|mesh-ancestor
25838627|NCT00023998|Vitamin B Complex|vitamin b complex|mesh-ancestor
25838628|NCT00023998|Vitamins|vitamins|mesh-ancestor
25838629|NCT00023998|Micronutrients|micronutrients|mesh-ancestor
25163260|NCT02897830|Glucocorticoids|glucocorticoids|mesh-ancestor
25163261|NCT02897830|Hormones|hormones|mesh-ancestor
25163262|NCT02897830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25163263|NCT02897830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25838630|NCT00023998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25659637|NCT01610037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25659638|NCT01610037|Autonomic Agents|autonomic agents|mesh-ancestor
24884250|NCT02628405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24884251|NCT02628405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24884252|NCT02628405|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24884253|NCT02628405|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24884254|NCT02628405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036088|NCT03550534|Calcium|calcium|mesh-list
24884275|NCT02479646|Lenograstim|lenograstim|mesh-list
25838631|NCT00023998|Alkylating Agents|alkylating agents|mesh-ancestor
24859826|NCT02305901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859827|NCT02305901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24859828|NCT02305927|Vitamin D|vitamin d|mesh-list
24859829|NCT02305927|Cholecalciferol|cholecalciferol|mesh-list
25838632|NCT00024011|Bortezomib|bortezomib|mesh-list
25838633|NCT00024011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838634|NCT00024050|Cyclosporine|cyclosporine|mesh-list
25838635|NCT00024050|Cyclophosphamide|cyclophosphamide|mesh-list
25838636|NCT00024050|Busulfan|busulfan|mesh-list
25838637|NCT00024050|Methotrexate|methotrexate|mesh-list
25838638|NCT00024050|Cyclosporins|cyclosporins|mesh-list
25838639|NCT00024050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25838640|NCT00024050|Immunologic Factors|immunologic factors|mesh-ancestor
25838641|NCT00024050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838642|NCT00024050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25838643|NCT00024050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25838644|NCT00024050|Alkylating Agents|alkylating agents|mesh-ancestor
25838645|NCT00024050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838646|NCT00024050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838647|NCT00024050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25838648|NCT00024050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25838649|NCT00024050|Abortifacient Agents|abortifacient agents|mesh-ancestor
25838650|NCT00024050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25838651|NCT00024050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25838652|NCT00024050|Antimetabolites|antimetabolites|mesh-ancestor
25838653|NCT00024050|Dermatologic Agents|dermatologic agents|mesh-ancestor
24859855|NCT02305992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24859856|NCT02305992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859857|NCT02305992|Sensory System Agents|sensory system agents|mesh-ancestor
24859858|NCT02305992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25838654|NCT00024050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838655|NCT00024050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25838656|NCT00024050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25838657|NCT00024050|Antifungal Agents|antifungal agents|mesh-ancestor
25838658|NCT00024050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25838659|NCT00024050|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25838660|NCT00024063|Orantinib|orantinib|mesh-list
25838661|NCT00024063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25838662|NCT00024063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838663|NCT00024063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838664|NCT00024089|Gefitinib|gefitinib|mesh-list
25838665|NCT00024089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838666|NCT00024089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25838667|NCT00024089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838668|NCT00024089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838669|NCT00024115|Antibodies|antibodies|mesh-list
25838670|NCT00024115|Immunotoxins|immunotoxins|mesh-list
25838671|NCT00024115|Immunologic Factors|immunologic factors|mesh-list
25838672|NCT00024115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838673|NCT00024128|Cyclosporine|cyclosporine|mesh-list
25838674|NCT00024128|Cyclophosphamide|cyclophosphamide|mesh-list
25163268|NCT02897830|Growth Substances|growth substances|mesh-ancestor
25163269|NCT02897830|Growth Inhibitors|growth inhibitors|mesh-ancestor
25163270|NCT02897830|Protease Inhibitors|protease inhibitors|mesh-ancestor
25163271|NCT02897830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25659639|NCT01610037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25659640|NCT01610037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659641|NCT01610037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25659642|NCT01610037|Respiratory System Agents|respiratory system agents|mesh-ancestor
25659643|NCT01610037|Parasympatholytics|parasympatholytics|mesh-ancestor
25659644|NCT01610037|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25659645|NCT01610037|Cholinergic Agents|cholinergic agents|mesh-ancestor
25838675|NCT00024128|Cyclosporins|cyclosporins|mesh-list
24859865|NCT02306031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24859866|NCT02306031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859867|NCT02306031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24859868|NCT02306031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24859869|NCT02306031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24859870|NCT02306031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859871|NCT02306031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859872|NCT02306031|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24859873|NCT02306031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25838676|NCT00024128|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25838677|NCT00024128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25838678|NCT00024128|Immunologic Factors|immunologic factors|mesh-ancestor
25838679|NCT00024128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838680|NCT00024128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25838681|NCT00024128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25838682|NCT00024128|Alkylating Agents|alkylating agents|mesh-ancestor
25838683|NCT00024128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838684|NCT00024128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838685|NCT00024128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25838686|NCT00024128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838687|NCT00024128|Antifungal Agents|antifungal agents|mesh-ancestor
25838688|NCT00024128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25838689|NCT00024128|Dermatologic Agents|dermatologic agents|mesh-ancestor
25838690|NCT00024128|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25838691|NCT00024141|Fluorouracil|fluorouracil|mesh-list
25838692|NCT00024141|Irinotecan|irinotecan|mesh-list
25838693|NCT00024141|Antimetabolites|antimetabolites|mesh-ancestor
25838694|NCT00024141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892050|NCT04465942|Nivolumab|nivolumab|mesh-list
25838695|NCT00024141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25838696|NCT00024141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838697|NCT00024141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25838698|NCT00024141|Immunologic Factors|immunologic factors|mesh-ancestor
25838699|NCT00024141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838700|NCT00024141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25838701|NCT00024141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24859892|NCT02306239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24859893|NCT02306278|Gabapentin|gabapentin|mesh-list
24859894|NCT02306278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859895|NCT02306278|Analgesics|analgesics|mesh-ancestor
25838702|NCT00024141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838703|NCT00024154|Trastuzumab|trastuzumab|mesh-list
25838704|NCT00024154|Gefitinib|gefitinib|mesh-list
25838705|NCT00024154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25838706|NCT00024154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838707|NCT00024154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25838708|NCT00024154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838709|NCT00024154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838710|NCT00024180|Romidepsin|romidepsin|mesh-list
25838711|NCT00024180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24611231|NCT01007864|Ropinirole|ropinirole|mesh-list
25838712|NCT00024180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838713|NCT00024193|Cyclophosphamide|cyclophosphamide|mesh-list
25838714|NCT00024193|Melphalan|melphalan|mesh-list
25838715|NCT00024193|Busulfan|busulfan|mesh-list
25838716|NCT00024193|Cisplatin|cisplatin|mesh-list
25838717|NCT00024193|Doxorubicin|doxorubicin|mesh-list
25838718|NCT00024193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25838719|NCT00024193|Etoposide|etoposide|mesh-list
25838720|NCT00024193|Vincristine|vincristine|mesh-list
25838721|NCT00024193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25838722|NCT00024193|Immunologic Factors|immunologic factors|mesh-ancestor
25838723|NCT00024193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838724|NCT00024193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24859916|NCT02306564|Dopamine Agonists|dopamine agonists|mesh-ancestor
24859917|NCT02306564|Dopamine Agents|dopamine agents|mesh-ancestor
24859918|NCT02306564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25048567|NCT00690456|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24859919|NCT02306564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859920|NCT02306564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859921|NCT02306577|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24859925|NCT02306577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24859926|NCT02306629|Epratuzumab|epratuzumab|mesh-list
24540384|NCT00667771|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24540385|NCT00667771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24540386|NCT00667771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540387|NCT00667771|Sensory System Agents|sensory system agents|mesh-ancestor
24540391|NCT00667797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24540392|NCT00667797|Autonomic Agents|autonomic agents|mesh-ancestor
25838725|NCT00024193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25838726|NCT00024193|Alkylating Agents|alkylating agents|mesh-ancestor
25875575|NCT04272242|Antitubercular Agents|antitubercular agents|mesh-ancestor
25058219|NCT03498326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058221|NCT03498326|Antiviral Agents|antiviral agents|mesh-ancestor
25058222|NCT03498326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25058223|NCT03498326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540393|NCT00667797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25838727|NCT00024193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838728|NCT00024193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838729|NCT00024193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25838730|NCT00024193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25838731|NCT00024193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25838732|NCT00024193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25838733|NCT00024193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838734|NCT00024193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25838735|NCT00024193|Tubulin Modulators|tubulin modulators|mesh-ancestor
25838736|NCT00024193|Antimitotic Agents|antimitotic agents|mesh-ancestor
25838737|NCT00024193|Mitosis Modulators|mitosis modulators|mesh-ancestor
25838738|NCT00024206|Orantinib|orantinib|mesh-list
25838739|NCT00024206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25838740|NCT00024206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838741|NCT00024206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838742|NCT00024232|Antibodies|antibodies|mesh-list
25838743|NCT00024232|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25838744|NCT00024232|Immunologic Factors|immunologic factors|mesh-ancestor
25838745|NCT00024232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838746|NCT00024245|Probenecid|probenecid|mesh-list
25838747|NCT00024245|Uricosuric Agents|uricosuric agents|mesh-ancestor
25163272|NCT02897830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838748|NCT00024245|Gout Suppressants|gout suppressants|mesh-ancestor
24826141|NCT02132546|Disinfectants|disinfectants|mesh-ancestor
24826142|NCT02132559|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24826143|NCT02132559|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24826144|NCT02132559|Immunologic Factors|immunologic factors|mesh-ancestor
24826145|NCT02132559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826146|NCT02132689|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24936270|NCT04042688|Tranexamic Acid|tranexamic acid|mesh-list
24826147|NCT02132689|Fibrinolytic Agents|fibrinolytic agents|mesh-list
24826148|NCT02132689|Heparin|heparin|mesh-list
24826149|NCT02132689|Calcium heparin|calcium heparin|mesh-list
24826150|NCT02132689|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24826151|NCT02132689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838749|NCT00024245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25838750|NCT00024245|Renal Agents|renal agents|mesh-ancestor
25838751|NCT00024271|Gemcitabine|gemcitabine|mesh-list
25838752|NCT00024271|Interferons|interferons|mesh-list
25838753|NCT00024271|Interferon-gamma|interferon-gamma|mesh-list
25838754|NCT00024271|Cisplatin|cisplatin|mesh-list
25838755|NCT00024271|Doxorubicin|doxorubicin|mesh-list
24859927|NCT02306629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24859928|NCT02306629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859929|NCT02306733|Oxytocin|oxytocin|mesh-list
24859930|NCT02306733|Ergonovine|ergonovine|mesh-list
24859931|NCT02306733|Oxytocics|oxytocics|mesh-ancestor
24859932|NCT02306733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24859933|NCT02306733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859934|NCT02306772|Mesalamine|mesalamine|mesh-list
24859935|NCT02306772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24859936|NCT02306772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24859937|NCT02306772|Analgesics|analgesics|mesh-ancestor
24859938|NCT02306772|Sensory System Agents|sensory system agents|mesh-ancestor
24859954|NCT02306798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24859955|NCT02306798|Analgesics|analgesics|mesh-ancestor
24540397|NCT00667797|Tocolytic Agents|tocolytic agents|mesh-ancestor
25838756|NCT00024271|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24859956|NCT02306798|Sensory System Agents|sensory system agents|mesh-ancestor
25659646|NCT01610037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25659647|NCT01610037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659648|NCT01610154|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25659649|NCT01610154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25659650|NCT01610154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859957|NCT02306798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24859958|NCT02306798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859959|NCT02306798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24859960|NCT02306798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25659651|NCT01610154|Incretins|incretins|mesh-ancestor
25659652|NCT01610154|Hormones|hormones|mesh-ancestor
25198628|NCT02747316|Iron|iron|mesh-list
24859962|NCT02306889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24859963|NCT02306889|Antimetabolites|antimetabolites|mesh-ancestor
24859964|NCT02306889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859965|NCT02306889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24859966|NCT02306902|Fenofibrate|fenofibrate|mesh-list
25163273|NCT02897765|Nivolumab|nivolumab|mesh-list
25163274|NCT02897765|Poly ICLC|poly iclc|mesh-list
25163275|NCT02897765|Immunologic Factors|immunologic factors|mesh-ancestor
25163276|NCT02897765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163277|NCT02897765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25163278|NCT02897765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163279|NCT02897765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25163280|NCT02897765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163281|NCT02897765|Interferon Inducers|interferon inducers|mesh-ancestor
25163282|NCT02897557|Pancrelipase|pancrelipase|mesh-list
25163283|NCT02897557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25163284|NCT02897596|Grazoprevir|grazoprevir|mesh-list
25163285|NCT02897596|Antiviral Agents|antiviral agents|mesh-ancestor
25163286|NCT02897596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25163287|NCT02897466|Anti-Infective Agents|anti-infective agents|mesh-list
25163288|NCT02897466|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25163289|NCT02897206|Imipenem|imipenem|mesh-list
25163290|NCT02897206|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
25163291|NCT02897206|Cilastatin|cilastatin|mesh-list
25163292|NCT02897206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25163293|NCT02897206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25163294|NCT02897206|Protease Inhibitors|protease inhibitors|mesh-ancestor
25838757|NCT00024271|Mitomycins|mitomycins|mesh-list
25838758|NCT00024271|Mitomycin|mitomycin|mesh-list
25838759|NCT00024271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838760|NCT00024271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25838761|NCT00024271|Antimetabolites|antimetabolites|mesh-ancestor
25838762|NCT00024271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838763|NCT00024271|Antiviral Agents|antiviral agents|mesh-ancestor
25838764|NCT00024271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25838765|NCT00024271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838766|NCT00024271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24859967|NCT02306902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24540410|NCT00667901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838767|NCT00024271|Immunologic Factors|immunologic factors|mesh-ancestor
25838768|NCT00024271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838769|NCT00024271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25838770|NCT00024271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25838771|NCT00024271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25838772|NCT00024271|Alkylating Agents|alkylating agents|mesh-ancestor
25838773|NCT00024271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25838774|NCT00024284|Carboplatin|carboplatin|mesh-list
25838775|NCT00024284|Irinotecan|irinotecan|mesh-list
25838776|NCT00024284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838777|NCT00024284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25838778|NCT00024284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25838779|NCT00024284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838780|NCT00024284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838781|NCT00024297|Warfarin|warfarin|mesh-list
25838782|NCT00024297|Anticoagulants|anticoagulants|mesh-ancestor
25838783|NCT00024310|Folic Acid|folic acid|mesh-list
25838784|NCT00024310|Paclitaxel|paclitaxel|mesh-list
25838785|NCT00024310|Lometrexol|lometrexol|mesh-list
25838786|NCT00024310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25838787|NCT00024310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838788|NCT00024310|Tubulin Modulators|tubulin modulators|mesh-ancestor
25838789|NCT00024310|Antimitotic Agents|antimitotic agents|mesh-ancestor
25838790|NCT00024310|Mitosis Modulators|mitosis modulators|mesh-ancestor
25838791|NCT00024310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838792|NCT00024310|Hematinics|hematinics|mesh-ancestor
25838793|NCT00024310|Vitamin B Complex|vitamin b complex|mesh-ancestor
25838794|NCT00024310|Vitamins|vitamins|mesh-ancestor
25838795|NCT00024310|Micronutrients|micronutrients|mesh-ancestor
25838796|NCT00024310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838797|NCT00024310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25838798|NCT00024310|Antimetabolites|antimetabolites|mesh-ancestor
25838799|NCT00024310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25838800|NCT00024310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838801|NCT00024323|Cisplatin|cisplatin|mesh-list
25838802|NCT00024323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838803|NCT00024336|Tamoxifen|tamoxifen|mesh-list
25838804|NCT00024336|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25198662|NCT02746185|Heparin|heparin|mesh-list
25838806|NCT00024336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25838807|NCT00024336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838808|NCT00024336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25838809|NCT00024336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163295|NCT02897206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163296|NCT02897206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163297|NCT02897401|Carbon Monoxide|carbon monoxide|mesh-list
25163298|NCT02897401|Antimetabolites|antimetabolites|mesh-ancestor
25163299|NCT02897401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163300|NCT02897401|Gasotransmitters|gasotransmitters|mesh-ancestor
25163301|NCT02897401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25163302|NCT02897401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163303|NCT02897219|Ipragliflozin|ipragliflozin|mesh-list
25163304|NCT02897219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25163305|NCT02897219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163306|NCT02897219|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25163307|NCT02897219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838810|NCT00024336|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25838811|NCT00024336|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25838812|NCT00024336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25838813|NCT00024349|Fluorouracil|fluorouracil|mesh-list
24859980|NCT02307006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24859981|NCT02307006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24859983|NCT02307045|Varenicline|varenicline|mesh-list
24859984|NCT02307045|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24859985|NCT02307045|Autonomic Agents|autonomic agents|mesh-ancestor
24540413|NCT00667901|Protective Agents|protective agents|mesh-ancestor
24540414|NCT00667927|Cyclophosphamide|cyclophosphamide|mesh-list
24540416|NCT00667927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25838814|NCT00024349|Mitomycins|mitomycins|mesh-list
25838815|NCT00024349|Mitomycin|mitomycin|mesh-list
25838816|NCT00024349|Antimetabolites|antimetabolites|mesh-ancestor
25838817|NCT00024349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838818|NCT00024349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25838819|NCT00024349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838820|NCT00024349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25838821|NCT00024349|Immunologic Factors|immunologic factors|mesh-ancestor
24625045|NCT01080079|Antifungal Agents|antifungal agents|mesh-ancestor
25838822|NCT00024349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838823|NCT00024349|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24859986|NCT02307045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24859987|NCT02307045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859989|NCT02307045|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24859990|NCT02307045|Cholinergic Agents|cholinergic agents|mesh-ancestor
24859991|NCT02307045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25838824|NCT00024349|Alkylating Agents|alkylating agents|mesh-ancestor
24859997|NCT02307149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859999|NCT02307201|Analgesics|analgesics|mesh-ancestor
24860000|NCT02307201|Sensory System Agents|sensory system agents|mesh-ancestor
24860001|NCT02307201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24860002|NCT02307201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540429|NCT00667966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540430|NCT00667966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540432|NCT00667979|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24540433|NCT00667979|Vasodilator Agents|vasodilator agents|mesh-ancestor
24540434|NCT00667979|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24540435|NCT00667979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24540436|NCT00667979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860022|NCT02307227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860023|NCT02307227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24860024|NCT02307227|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24860025|NCT02307227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24860026|NCT02307227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24860027|NCT02307227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860028|NCT02307305|Acetaminophen|acetaminophen|mesh-list
24860029|NCT02307305|Celecoxib|celecoxib|mesh-list
24860030|NCT02307305|Naproxen|naproxen|mesh-list
24860031|NCT02307305|Oxycodone|oxycodone|mesh-list
24860032|NCT02307305|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24860033|NCT02307305|Tramadol|tramadol|mesh-list
24860034|NCT02307305|Naloxone|naloxone|mesh-list
24860035|NCT02307305|Esomeprazole|esomeprazole|mesh-list
24860036|NCT02307305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24860038|NCT02307305|Sensory System Agents|sensory system agents|mesh-ancestor
25838825|NCT00024349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25838826|NCT00024349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838827|NCT00024362|BBR 3464|bbr 3464|mesh-list
24860040|NCT02307305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860042|NCT02307305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24860043|NCT02307305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24860044|NCT02307305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24860045|NCT02307305|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24860046|NCT02307305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24860047|NCT02307305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838828|NCT00024362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838829|NCT00024375|Paclitaxel|paclitaxel|mesh-list
25838830|NCT00024375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25838831|NCT00024375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838832|NCT00024375|Tubulin Modulators|tubulin modulators|mesh-ancestor
25838833|NCT00024375|Antimitotic Agents|antimitotic agents|mesh-ancestor
25838834|NCT00024375|Mitosis Modulators|mitosis modulators|mesh-ancestor
25838835|NCT00024375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860056|NCT02307305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24681688|NCT01381536|Belimumab|belimumab|mesh-list
24860057|NCT02307305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24860058|NCT02307305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24860059|NCT02307305|Antidepressive Agents|antidepressive agents|mesh-ancestor
24860060|NCT02307305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24860061|NCT02307305|Dopamine Agents|dopamine agents|mesh-ancestor
24860062|NCT02307305|Gout Suppressants|gout suppressants|mesh-ancestor
24860063|NCT02307305|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24860064|NCT02307383|Lactitol|lactitol|mesh-list
24860065|NCT02307383|Cathartics|cathartics|mesh-ancestor
24860066|NCT02307383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24860067|NCT02307396|Haloperidol|haloperidol|mesh-list
24860068|NCT02307396|Pimozide|pimozide|mesh-list
24860069|NCT02307396|Olanzapine|olanzapine|mesh-list
25838836|NCT00024388|Paclitaxel|paclitaxel|mesh-list
25838837|NCT00024388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25838838|NCT00024388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24945327|NCT03951415|Durvalumab|durvalumab|mesh-list
25838839|NCT00024388|Tubulin Modulators|tubulin modulators|mesh-ancestor
25838840|NCT00024388|Antimitotic Agents|antimitotic agents|mesh-ancestor
25838841|NCT00024388|Mitosis Modulators|mitosis modulators|mesh-ancestor
24860076|NCT02307396|Sertindole|sertindole|mesh-list
24860077|NCT02307396|Fluphenazine|fluphenazine|mesh-list
24860078|NCT02307396|Fluphenazine depot|fluphenazine depot|mesh-list
24860079|NCT02307396|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
24860080|NCT02307396|Sulpiride|sulpiride|mesh-list
24860083|NCT02307396|Fluspirilene|fluspirilene|mesh-list
24860084|NCT02307396|Benperidol|benperidol|mesh-list
24860085|NCT02307396|Bromperidol|bromperidol|mesh-list
24860086|NCT02307396|Perazine|perazine|mesh-list
24540503|NCT00668135|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24540504|NCT00668135|Vasodilator Agents|vasodilator agents|mesh-ancestor
25838842|NCT00024388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838843|NCT00024401|Paclitaxel|paclitaxel|mesh-list
25838844|NCT00024401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25838845|NCT00024401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838846|NCT00024401|Tubulin Modulators|tubulin modulators|mesh-ancestor
25838847|NCT00024401|Antimitotic Agents|antimitotic agents|mesh-ancestor
25838848|NCT00024401|Mitosis Modulators|mitosis modulators|mesh-ancestor
25838849|NCT00024401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838850|NCT00024414|Paclitaxel|paclitaxel|mesh-list
25163308|NCT02897076|Betamethasone|betamethasone|mesh-list
25163309|NCT02897076|Betamethasone Valerate|betamethasone valerate|mesh-list
25163310|NCT02897076|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25163311|NCT02897076|Betamethasone benzoate|betamethasone benzoate|mesh-list
25163312|NCT02897076|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25838851|NCT00024414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25838852|NCT00024414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24860087|NCT02307396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24860088|NCT02307396|Serotonin Agents|serotonin agents|mesh-ancestor
24860089|NCT02307396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24860090|NCT02307396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860091|NCT02307396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860092|NCT02307396|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24860093|NCT02307396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24860094|NCT02307396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24506792|NCT00547053|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24506878|NCT00547352|Tadalafil|tadalafil|mesh-list
24860095|NCT02307396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24860096|NCT02307396|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24860097|NCT02307396|Dopamine Agents|dopamine agents|mesh-ancestor
24860098|NCT02307396|Antiemetics|antiemetics|mesh-ancestor
24860099|NCT02307396|Autonomic Agents|autonomic agents|mesh-ancestor
24860100|NCT02307396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24860101|NCT02307396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24860102|NCT02307396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25838853|NCT00024414|Tubulin Modulators|tubulin modulators|mesh-ancestor
25838854|NCT00024414|Antimitotic Agents|antimitotic agents|mesh-ancestor
25838855|NCT00024414|Mitosis Modulators|mitosis modulators|mesh-ancestor
24860103|NCT02307396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24860104|NCT02307396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24860105|NCT02307396|Antidepressive Agents|antidepressive agents|mesh-ancestor
24860106|NCT02307396|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24860107|NCT02307396|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24860108|NCT02307396|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24860109|NCT02307396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24860110|NCT02307487|Mitomycins|mitomycins|mesh-list
24860111|NCT02307487|Mitomycin|mitomycin|mesh-list
24860112|NCT02307487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24860113|NCT02307487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24860114|NCT02307487|Alkylating Agents|alkylating agents|mesh-ancestor
24860115|NCT02307487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860116|NCT02307487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24860117|NCT02307487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860118|NCT02307565|Midodrine|midodrine|mesh-list
24860119|NCT02307565|Sympathomimetics|sympathomimetics|mesh-ancestor
24860120|NCT02307565|Autonomic Agents|autonomic agents|mesh-ancestor
24860121|NCT02307565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24860122|NCT02307565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540528|NCT00668304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540530|NCT00668304|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24540531|NCT00668304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24540533|NCT00668330|Ibandronic Acid|ibandronic acid|mesh-list
25838856|NCT00024414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838857|NCT00024427|Gemcitabine|gemcitabine|mesh-list
24451145|NCT00322400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451146|NCT00322400|Tubulin Modulators|tubulin modulators|mesh-ancestor
24451151|NCT00322400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451153|NCT00322413|Hematinics|hematinics|mesh-ancestor
24451154|NCT00322543|Pimecrolimus|pimecrolimus|mesh-list
24451155|NCT00322543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25838858|NCT00024427|Fluorouracil|fluorouracil|mesh-list
25838859|NCT00024427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25838860|NCT00024427|Antimetabolites|antimetabolites|mesh-ancestor
25163314|NCT02897076|Glucocorticoids|glucocorticoids|mesh-ancestor
25838861|NCT00024427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838862|NCT00024427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838863|NCT00024427|Antiviral Agents|antiviral agents|mesh-ancestor
25838864|NCT00024427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24964955|NCT03779659|Anesthetics|anesthetics|mesh-list
25838865|NCT00024427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860128|NCT02307565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24860129|NCT02307565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860131|NCT02307591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24681748|NCT01381796|Sumatriptan|sumatriptan|mesh-list
24860132|NCT02307591|Vasodilator Agents|vasodilator agents|mesh-ancestor
24860133|NCT02307591|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24860134|NCT02307591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24860135|NCT02307591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860136|NCT02307591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24860137|NCT02307591|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24540549|NCT00668343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838866|NCT00024427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25838867|NCT00024427|Immunologic Factors|immunologic factors|mesh-ancestor
25838868|NCT00024427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838869|NCT00024440|Cyclophosphamide|cyclophosphamide|mesh-list
25659653|NCT01610154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25659654|NCT01610154|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25838870|NCT00024440|Fludarabine|fludarabine|mesh-list
24506900|NCT00547443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838871|NCT00024440|Fludarabine phosphate|fludarabine phosphate|mesh-list
25838873|NCT00024440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25838874|NCT00024440|Immunologic Factors|immunologic factors|mesh-ancestor
25838875|NCT00024440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838876|NCT00024440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25838877|NCT00024440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25838878|NCT00024440|Alkylating Agents|alkylating agents|mesh-ancestor
25838879|NCT00024440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838880|NCT00024440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838881|NCT00024440|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25838882|NCT00024440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25838883|NCT00024440|Antimetabolites|antimetabolites|mesh-ancestor
25838884|NCT00024453|Teicoplanin|teicoplanin|mesh-list
25838885|NCT00024453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25838886|NCT00024453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25838887|NCT00024466|Vaccines|vaccines|mesh-list
25838888|NCT00024466|Immunologic Factors|immunologic factors|mesh-ancestor
24860138|NCT02307591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24860139|NCT02307591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860140|NCT02307591|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24860143|NCT02307695|Saxagliptin|saxagliptin|mesh-list
25838889|NCT00024466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838890|NCT00024492|Mitoxantrone|mitoxantrone|mesh-list
25838891|NCT00024492|Analgesics|analgesics|mesh-ancestor
25838892|NCT00024492|Sensory System Agents|sensory system agents|mesh-ancestor
24946337|NCT03940235|Androgens|androgens|mesh-list
25838893|NCT00024492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25838894|NCT00024492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838895|NCT00024492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838896|NCT00024492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25838897|NCT00024492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25838898|NCT00024492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838899|NCT00024492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838900|NCT00024518|Interferons|interferons|mesh-list
25838901|NCT00024518|Interferon-alpha|interferon-alpha|mesh-list
25838902|NCT00024518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838903|NCT00024518|Antiviral Agents|antiviral agents|mesh-ancestor
25838904|NCT00024518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25838905|NCT00024518|Immunologic Factors|immunologic factors|mesh-ancestor
25838906|NCT00024518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838907|NCT00024531|Atorvastatin|atorvastatin|mesh-list
24860168|NCT02307864|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24860169|NCT02307864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24860170|NCT02307864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24860171|NCT02307864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24860172|NCT02307864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24860173|NCT02307864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860174|NCT02307864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540577|NCT00668538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540578|NCT00668538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24540579|NCT00668538|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25163313|NCT02897076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24540580|NCT00668538|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24540581|NCT00668603|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24540582|NCT00668603|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24540584|NCT00668603|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24540586|NCT00668603|Hormones|hormones|mesh-ancestor
24540587|NCT00668603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25838908|NCT00024531|Calcium|calcium|mesh-list
25838909|NCT00024531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25838910|NCT00024531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838911|NCT00024531|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24860179|NCT02307864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860180|NCT02307864|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24860181|NCT02307864|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24860182|NCT02307864|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24860183|NCT02307864|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24860184|NCT02307864|Narcotics|narcotics|mesh-ancestor
24860185|NCT02307864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24860186|NCT02307864|Analgesics|analgesics|mesh-ancestor
25659655|NCT01610154|Protease Inhibitors|protease inhibitors|mesh-ancestor
24860187|NCT02307864|Sensory System Agents|sensory system agents|mesh-ancestor
24860188|NCT02307864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24860189|NCT02307955|Fluorophosphate|fluorophosphate|mesh-list
25838912|NCT00024531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25838913|NCT00024531|Antimetabolites|antimetabolites|mesh-ancestor
25838914|NCT00024531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838915|NCT00024531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24860190|NCT02307955|Cariostatic Agents|cariostatic agents|mesh-ancestor
24860191|NCT02307955|Protective Agents|protective agents|mesh-ancestor
24860192|NCT02307955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860193|NCT02307968|Insulin|insulin|mesh-list
25838916|NCT00024531|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25838917|NCT00024531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838918|NCT00024544|Antibodies|antibodies|mesh-list
25838919|NCT00024544|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25838920|NCT00024544|Immunologic Factors|immunologic factors|mesh-ancestor
25838921|NCT00024544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838922|NCT00024687|Immunotoxins|immunotoxins|mesh-list
25838923|NCT00024687|Immunologic Factors|immunologic factors|mesh-ancestor
25838924|NCT00024687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875576|NCT04272242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25875577|NCT04272242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25875578|NCT04272242|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25875579|NCT04272242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25875580|NCT04272242|Antimetabolites|antimetabolites|mesh-ancestor
25875581|NCT04272242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875582|NCT04272242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25875583|NCT04272242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25875584|NCT04272242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25875585|NCT04272242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875586|NCT04272242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25875587|NCT04272242|Antiviral Agents|antiviral agents|mesh-ancestor
25875588|NCT04272242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25875589|NCT04272242|Leprostatic Agents|leprostatic agents|mesh-ancestor
25875590|NCT04269902|Venetoclax|venetoclax|mesh-list
25875591|NCT04269902|Obinutuzumab|obinutuzumab|mesh-list
25875592|NCT04269902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875593|NCT04269902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25875594|NCT04267848|Gemcitabine|gemcitabine|mesh-list
25875595|NCT04267848|Paclitaxel|paclitaxel|mesh-list
25875596|NCT04267848|Cisplatin|cisplatin|mesh-list
25875597|NCT04267848|Carboplatin|carboplatin|mesh-list
25875598|NCT04267848|Pembrolizumab|pembrolizumab|mesh-list
25875599|NCT04267848|Pemetrexed|pemetrexed|mesh-list
25875600|NCT04267848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25875601|NCT04267848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25875602|NCT04267848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875603|NCT04267848|Tubulin Modulators|tubulin modulators|mesh-ancestor
25875604|NCT04267848|Antimitotic Agents|antimitotic agents|mesh-ancestor
25875605|NCT04267848|Mitosis Modulators|mitosis modulators|mesh-ancestor
25875606|NCT04267848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875607|NCT04267848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25875608|NCT04267848|Antimetabolites|antimetabolites|mesh-ancestor
25875609|NCT04267848|Antiviral Agents|antiviral agents|mesh-ancestor
25875610|NCT04267848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25875611|NCT04267848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875612|NCT04267848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25875613|NCT04267848|Immunologic Factors|immunologic factors|mesh-ancestor
25875614|NCT04267848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875615|NCT04267848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24860202|NCT02308098|Formoterol Fumarate|formoterol fumarate|mesh-list
24860203|NCT02308098|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24860204|NCT02308098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24860205|NCT02308098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24860206|NCT02308098|Autonomic Agents|autonomic agents|mesh-ancestor
24860207|NCT02308098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24860208|NCT02308098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860209|NCT02308098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24860210|NCT02308098|Respiratory System Agents|respiratory system agents|mesh-ancestor
24860211|NCT02308098|Glucocorticoids|glucocorticoids|mesh-ancestor
24860213|NCT02308098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24653369|NCT01243697|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25875616|NCT04267848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25875617|NCT04267848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25875618|NCT04263298|Capecitabine|capecitabine|mesh-list
25875619|NCT04263298|Fulvestrant|fulvestrant|mesh-list
25838925|NCT00024986|Tenofovir|tenofovir|mesh-list
25838926|NCT00024986|Antiviral Agents|antiviral agents|mesh-ancestor
24860214|NCT02308098|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24860215|NCT02308098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24860216|NCT02308098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24860217|NCT02308098|Adrenergic Agents|adrenergic agents|mesh-ancestor
24860218|NCT02308098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24860219|NCT02308098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860220|NCT02308137|Domperidone|domperidone|mesh-list
24860221|NCT02308137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860222|NCT02308137|Antiemetics|antiemetics|mesh-ancestor
24860223|NCT02308137|Autonomic Agents|autonomic agents|mesh-ancestor
25838927|NCT00024986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25838928|NCT00024986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25838929|NCT00024986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25838930|NCT00024986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838931|NCT00024986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838932|NCT00024986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25838933|NCT00024986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25838934|NCT00025012|Isotretinoin|isotretinoin|mesh-list
25838935|NCT00025012|Dermatologic Agents|dermatologic agents|mesh-ancestor
25838936|NCT00025038|Cytarabine|cytarabine|mesh-list
25838937|NCT00025038|Cyclophosphamide|cyclophosphamide|mesh-list
25838938|NCT00025038|Fludarabine|fludarabine|mesh-list
25838939|NCT00025038|Fludarabine phosphate|fludarabine phosphate|mesh-list
25838940|NCT00025038|Tipifarnib|tipifarnib|mesh-list
24949242|NCT05086939|Hyaluronic Acid|hyaluronic acid|mesh-list
25838941|NCT00025038|Isotretinoin|isotretinoin|mesh-list
25838942|NCT00025038|Thymoglobulin|thymoglobulin|mesh-list
25838943|NCT00025038|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25838944|NCT00025038|Immunoglobulins|immunoglobulins|mesh-list
25838945|NCT00025038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24860224|NCT02308137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24860225|NCT02308137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860226|NCT02308137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24860227|NCT02308137|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24860228|NCT02308137|Dopamine Agents|dopamine agents|mesh-ancestor
25163315|NCT02897076|Hormones|hormones|mesh-ancestor
24860230|NCT02308254|Lixisenatide|lixisenatide|mesh-list
24860231|NCT02308254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25838946|NCT00025038|Immunologic Factors|immunologic factors|mesh-ancestor
24860235|NCT02308319|Tenofovir|tenofovir|mesh-list
24860236|NCT02308319|Antiviral Agents|antiviral agents|mesh-ancestor
24540645|NCT00668837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25838947|NCT00025038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838948|NCT00025038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25838949|NCT00025038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25838950|NCT00025038|Alkylating Agents|alkylating agents|mesh-ancestor
25838951|NCT00025038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838952|NCT00025038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838953|NCT00025038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25838954|NCT00025038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25838955|NCT00025038|Antimetabolites|antimetabolites|mesh-ancestor
25838956|NCT00025038|Antiviral Agents|antiviral agents|mesh-ancestor
25838957|NCT00025038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25838958|NCT00025038|Dermatologic Agents|dermatologic agents|mesh-ancestor
25838959|NCT00025051|Celecoxib|celecoxib|mesh-list
25838960|NCT00025051|Mitogens|mitogens|mesh-list
25838961|NCT00025051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25838962|NCT00025051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25838963|NCT00025051|Analgesics|analgesics|mesh-ancestor
25838964|NCT00025051|Sensory System Agents|sensory system agents|mesh-ancestor
24949291|NCT05028725|Lugol's solution|lugol's solution|mesh-list
24653432|NCT01243801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25838965|NCT00025051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25838966|NCT00025051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25838967|NCT00025051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25838968|NCT00025051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25838969|NCT00025051|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25838970|NCT00025051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25838971|NCT00025051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838972|NCT00025051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838973|NCT00025051|Mitosis Modulators|mitosis modulators|mesh-ancestor
25838974|NCT00025064|Prednisolone|prednisolone|mesh-list
25838975|NCT00025064|Doxorubicin|doxorubicin|mesh-list
25838976|NCT00025064|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25838977|NCT00025064|Etoposide|etoposide|mesh-list
25838978|NCT00025064|Vincristine|vincristine|mesh-list
25838979|NCT00025064|Melphalan|melphalan|mesh-list
25838980|NCT00025064|Ifosfamide|ifosfamide|mesh-list
25838981|NCT00025064|Dacarbazine|dacarbazine|mesh-list
25838982|NCT00025064|Bleomycin|bleomycin|mesh-list
25838983|NCT00025064|Vinblastine|vinblastine|mesh-list
25838984|NCT00025064|Procarbazine|procarbazine|mesh-list
25838985|NCT00025064|Chlorambucil|chlorambucil|mesh-list
25838986|NCT00025064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25838987|NCT00025064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25838988|NCT00025064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25838989|NCT00025064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25838990|NCT00025064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860237|NCT02308319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24860238|NCT02308319|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24860239|NCT02308319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24860240|NCT02308319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25838991|NCT00025064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25838992|NCT00025064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25838993|NCT00025064|Tubulin Modulators|tubulin modulators|mesh-ancestor
25838994|NCT00025064|Antimitotic Agents|antimitotic agents|mesh-ancestor
24775020|NCT01849666|Vemurafenib|vemurafenib|mesh-list
25838995|NCT00025064|Mitosis Modulators|mitosis modulators|mesh-ancestor
24860241|NCT02308319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860242|NCT02308319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24860243|NCT02308319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24860244|NCT02308332|Tenofovir|tenofovir|mesh-list
24860245|NCT02308332|Emtricitabine|emtricitabine|mesh-list
24860246|NCT02308332|Rilpivirine|rilpivirine|mesh-list
24860247|NCT02308332|Antiviral Agents|antiviral agents|mesh-ancestor
24860248|NCT02308332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25838996|NCT00025064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24540652|NCT00668837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25838997|NCT00025064|Alkylating Agents|alkylating agents|mesh-ancestor
25838998|NCT00025064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25838999|NCT00025064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25839000|NCT00025064|Immunologic Factors|immunologic factors|mesh-ancestor
25839001|NCT00025064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839002|NCT00025064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25839003|NCT00025064|Glucocorticoids|glucocorticoids|mesh-ancestor
25839004|NCT00025064|Hormones|hormones|mesh-ancestor
25839005|NCT00025064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25839006|NCT00025064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25839007|NCT00025077|Cyclophosphamide|cyclophosphamide|mesh-list
25839008|NCT00025077|Thiotepa|thiotepa|mesh-list
25839009|NCT00025077|Carboplatin|carboplatin|mesh-list
25839010|NCT00025077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25839011|NCT00025077|Immunologic Factors|immunologic factors|mesh-ancestor
25839012|NCT00025077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839013|NCT00025077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25839014|NCT00025077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25839015|NCT00025077|Alkylating Agents|alkylating agents|mesh-ancestor
25839016|NCT00025077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839017|NCT00025077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839018|NCT00025077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24860249|NCT02308332|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24860250|NCT02308332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24860251|NCT02308332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860252|NCT02308332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860253|NCT02308332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24860254|NCT02308332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25839019|NCT00025090|Cisplatin|cisplatin|mesh-list
25839020|NCT00025090|Fluorouracil|fluorouracil|mesh-list
25839021|NCT00025090|Mitomycins|mitomycins|mesh-list
25839022|NCT00025090|Mitomycin|mitomycin|mesh-list
25839023|NCT00025090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839024|NCT00025090|Antimetabolites|antimetabolites|mesh-ancestor
25839025|NCT00025090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839026|NCT00025090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25839027|NCT00025090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25839028|NCT00025090|Immunologic Factors|immunologic factors|mesh-ancestor
25839029|NCT00025090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839030|NCT00025090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25839031|NCT00025090|Alkylating Agents|alkylating agents|mesh-ancestor
25839032|NCT00025090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25839033|NCT00025090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839034|NCT00025103|Dactinomycin|dactinomycin|mesh-list
25839035|NCT00025103|Cyclophosphamide|cyclophosphamide|mesh-list
25839036|NCT00025103|Melphalan|melphalan|mesh-list
25839038|NCT00025103|Doxorubicin|doxorubicin|mesh-list
25839039|NCT00025103|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25839040|NCT00025103|Etoposide|etoposide|mesh-list
25839041|NCT00025103|Vincristine|vincristine|mesh-list
25839042|NCT00025103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25839043|NCT00025103|Immunologic Factors|immunologic factors|mesh-ancestor
25839044|NCT00025103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839045|NCT00025103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25839046|NCT00025103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25839047|NCT00025103|Alkylating Agents|alkylating agents|mesh-ancestor
25839048|NCT00025103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839049|NCT00025103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839050|NCT00025103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25839051|NCT00025103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25839052|NCT00025103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25839053|NCT00025103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24860270|NCT02308644|Growth Substances|growth substances|mesh-ancestor
24860271|NCT02308644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860272|NCT02308644|Growth Inhibitors|growth inhibitors|mesh-ancestor
24860273|NCT02308891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24860274|NCT02308930|Vitamin D|vitamin d|mesh-list
24860275|NCT02308930|Vitamins|vitamins|mesh-list
24860276|NCT02308930|Vitamin A|vitamin a|mesh-list
24860277|NCT02308930|Retinol palmitate|retinol palmitate|mesh-list
24860278|NCT02308930|Micronutrients|micronutrients|mesh-ancestor
24529449|NCT00626015|Temozolomide|temozolomide|mesh-list
25839054|NCT00025103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839055|NCT00025103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25839056|NCT00025103|Tubulin Modulators|tubulin modulators|mesh-ancestor
25839057|NCT00025103|Antimitotic Agents|antimitotic agents|mesh-ancestor
25839058|NCT00025103|Mitosis Modulators|mitosis modulators|mesh-ancestor
25839059|NCT00025103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25839060|NCT00025103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25839061|NCT00025103|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25839062|NCT00025103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25839063|NCT00025116|Gefitinib|gefitinib|mesh-list
25839064|NCT00025116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839065|NCT00025116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25839066|NCT00025116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839067|NCT00025116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839068|NCT00025142|Leucovorin|leucovorin|mesh-list
25839069|NCT00025142|Fluorouracil|fluorouracil|mesh-list
25839070|NCT00025142|Oxaliplatin|oxaliplatin|mesh-list
25839071|NCT00025142|Gefitinib|gefitinib|mesh-list
25839072|NCT00025142|Calcium|calcium|mesh-list
25839073|NCT00025142|Levoleucovorin|levoleucovorin|mesh-list
25839074|NCT00025142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25839075|NCT00025142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839076|NCT00025142|Antimetabolites|antimetabolites|mesh-ancestor
25839077|NCT00025142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839078|NCT00025142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25839079|NCT00025142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839080|NCT00025142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24860285|NCT02308930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24860286|NCT02308969|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
24860287|NCT02308969|Hallucinogens|hallucinogens|mesh-ancestor
24860288|NCT02308969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860289|NCT02308969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24540694|NCT00669149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540695|NCT00669149|Antipyretics|antipyretics|mesh-ancestor
24540696|NCT00669149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24540697|NCT00669149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24540698|NCT00669149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25839081|NCT00025142|Immunologic Factors|immunologic factors|mesh-ancestor
25839082|NCT00025142|Antidotes|antidotes|mesh-ancestor
25839083|NCT00025142|Protective Agents|protective agents|mesh-ancestor
25839084|NCT00025142|Vitamin B Complex|vitamin b complex|mesh-ancestor
25839085|NCT00025142|Vitamins|vitamins|mesh-ancestor
25839086|NCT00025142|Micronutrients|micronutrients|mesh-ancestor
25839087|NCT00025142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25659656|NCT01610154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839088|NCT00025142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839089|NCT00025168|Gemcitabine|gemcitabine|mesh-list
25839090|NCT00025168|Irinotecan|irinotecan|mesh-list
25414575|NCT03057600|Mitosis Modulators|mitosis modulators|mesh-ancestor
25839091|NCT00025168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25839092|NCT00025168|Antimetabolites|antimetabolites|mesh-ancestor
24884555|NCT00380705|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25839093|NCT00025168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839094|NCT00025168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839095|NCT00025168|Antiviral Agents|antiviral agents|mesh-ancestor
25839096|NCT00025168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25839097|NCT00025168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839098|NCT00025168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25839099|NCT00025168|Immunologic Factors|immunologic factors|mesh-ancestor
25839100|NCT00025168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839101|NCT00025168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25839102|NCT00025168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25839103|NCT00025181|Ipilimumab|ipilimumab|mesh-list
25839104|NCT00025181|Freund's Adjuvant|freund's adjuvant|mesh-list
25839105|NCT00025181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25839106|NCT00025181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839107|NCT00025181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25839108|NCT00025181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839109|NCT00025181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25839110|NCT00025181|Immunologic Factors|immunologic factors|mesh-ancestor
25839111|NCT00025181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839112|NCT00025194|Estramustine|estramustine|mesh-list
24540700|NCT00669149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24540701|NCT00669149|Anticoagulants|anticoagulants|mesh-ancestor
24860290|NCT02308969|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24860291|NCT02308969|Serotonin Agents|serotonin agents|mesh-ancestor
24860292|NCT02308969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25202959|NCT02717871|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24860293|NCT02308969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860294|NCT02308969|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24860296|NCT02308982|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24860297|NCT02308982|Antibodies|antibodies|mesh-list
24860298|NCT02308982|gamma-Globulins|gamma-globulins|mesh-list
24860299|NCT02308982|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24860300|NCT02308982|Immunologic Factors|immunologic factors|mesh-ancestor
24860301|NCT02308982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860302|NCT02309177|Gemcitabine|gemcitabine|mesh-list
24860303|NCT02309177|Paclitaxel|paclitaxel|mesh-list
24860304|NCT02309177|Carboplatin|carboplatin|mesh-list
24860305|NCT02309177|Nivolumab|nivolumab|mesh-list
25839113|NCT00025194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25839114|NCT00025194|Alkylating Agents|alkylating agents|mesh-ancestor
25839115|NCT00025194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860306|NCT02309177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24860307|NCT02309177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24860308|NCT02309177|Tubulin Modulators|tubulin modulators|mesh-ancestor
24860309|NCT02309177|Antimitotic Agents|antimitotic agents|mesh-ancestor
24860310|NCT02309177|Mitosis Modulators|mitosis modulators|mesh-ancestor
25839116|NCT00025194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839117|NCT00025194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25839118|NCT00025207|Gefitinib|gefitinib|mesh-list
25839119|NCT00025207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839120|NCT00025207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25839121|NCT00025207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839122|NCT00025207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839123|NCT00025220|Thalidomide|thalidomide|mesh-list
25839124|NCT00025220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25839125|NCT00025220|Immunologic Factors|immunologic factors|mesh-ancestor
25839126|NCT00025220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839127|NCT00025220|Leprostatic Agents|leprostatic agents|mesh-ancestor
25839128|NCT00025220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25839129|NCT00025220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25839130|NCT00025220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25839131|NCT00025220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25839132|NCT00025220|Growth Substances|growth substances|mesh-ancestor
25839133|NCT00025220|Growth Inhibitors|growth inhibitors|mesh-ancestor
25839134|NCT00025220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839135|NCT00025246|Imatinib Mesylate|imatinib mesylate|mesh-list
25839136|NCT00025246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839137|NCT00025246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25674303|NCT01769586|Histamine Antagonists|histamine antagonists|mesh-ancestor
25674304|NCT01769586|Histamine Agents|histamine agents|mesh-ancestor
25674305|NCT01769586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25674306|NCT01769586|Antipruritics|antipruritics|mesh-ancestor
25674307|NCT01769586|Dermatologic Agents|dermatologic agents|mesh-ancestor
25674308|NCT01770145|Levodopa|levodopa|mesh-list
25674309|NCT01770145|Carbidopa|carbidopa|mesh-list
24507626|NCT00551122|Antimetabolites|antimetabolites|mesh-ancestor
25839138|NCT00025246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839139|NCT00025246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839140|NCT00025272|Carboplatin|carboplatin|mesh-list
24860317|NCT02309177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24860318|NCT02309177|Immunologic Factors|immunologic factors|mesh-ancestor
24860319|NCT02309177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860320|NCT02309177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24860321|NCT02309177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24860323|NCT02309281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24860324|NCT02309281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24860325|NCT02309281|Growth Substances|growth substances|mesh-ancestor
24860326|NCT02309281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860327|NCT02309281|Growth Inhibitors|growth inhibitors|mesh-ancestor
24860328|NCT02309281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24860329|NCT02309320|Gontivimab|gontivimab|mesh-list
24860330|NCT02309320|Antiviral Agents|antiviral agents|mesh-ancestor
24860331|NCT02309320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24860332|NCT02309346|Clindamycin|clindamycin|mesh-list
24860333|NCT02309346|Clindamycin palmitate|clindamycin palmitate|mesh-list
24860334|NCT02309346|Clindamycin phosphate|clindamycin phosphate|mesh-list
24860335|NCT02309346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24860336|NCT02309346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24540725|NCT00669435|Simvastatin|simvastatin|mesh-list
24540726|NCT00669435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24540727|NCT00669435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24540748|NCT00669487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860337|NCT02309346|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24860338|NCT02309346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860339|NCT02309346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860341|NCT02309385|Dexamethasone acetate|dexamethasone acetate|mesh-list
24860342|NCT02309385|Prednisolone|prednisolone|mesh-list
24860343|NCT02309385|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24860344|NCT02309385|Methylprednisolone|methylprednisolone|mesh-list
24860345|NCT02309385|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24860346|NCT02309385|Prednisolone acetate|prednisolone acetate|mesh-list
24860347|NCT02309385|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24860348|NCT02309385|Prednisolone phosphate|prednisolone phosphate|mesh-list
24860349|NCT02309385|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24860350|NCT02309385|BB 1101|bb 1101|mesh-list
24860351|NCT02309385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24860352|NCT02309385|Antiemetics|antiemetics|mesh-ancestor
24860353|NCT02309385|Autonomic Agents|autonomic agents|mesh-ancestor
24860354|NCT02309385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24860355|NCT02309385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860357|NCT02309385|Glucocorticoids|glucocorticoids|mesh-ancestor
24860363|NCT02309385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860364|NCT02309385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860365|NCT02309385|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24860366|NCT02309385|Protective Agents|protective agents|mesh-ancestor
24860367|NCT02309424|Acetic Acid|acetic acid|mesh-list
24860368|NCT02309424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24860369|NCT02309424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24860370|NCT02309437|Oxycodone|oxycodone|mesh-list
24540753|NCT00669487|Antimetabolites|antimetabolites|mesh-ancestor
24540754|NCT00669565|Bavituximab|bavituximab|mesh-list
24540755|NCT00669565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25839141|NCT00025272|Etoposide|etoposide|mesh-list
24966081|NCT03771677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950878|NCT03910556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24950879|NCT03910556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839142|NCT00025272|Topotecan|topotecan|mesh-list
25839143|NCT00025272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839144|NCT00025272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25839145|NCT00025272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25839146|NCT00025272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24540756|NCT00669565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24540758|NCT00669591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24540759|NCT00669591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24540760|NCT00669643|Rifampin|rifampin|mesh-list
24540761|NCT00669643|Dapsone|dapsone|mesh-list
24446509|NCT00304993|Niacin|niacin|mesh-list
25674310|NCT01770145|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25674311|NCT01770145|Trimethobenzamide|trimethobenzamide|mesh-list
25674312|NCT01770145|Apomorphine|apomorphine|mesh-list
25674313|NCT01770145|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25674314|NCT01770145|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25839147|NCT00025272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839148|NCT00025272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839149|NCT00025272|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25839150|NCT00025285|Thalidomide|thalidomide|mesh-list
25839151|NCT00025285|Carboplatin|carboplatin|mesh-list
25839152|NCT00025285|Irinotecan|irinotecan|mesh-list
25839153|NCT00025285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839154|NCT00025285|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25839155|NCT00025285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25839156|NCT00025285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839157|NCT00025285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839158|NCT00025285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25839159|NCT00025285|Immunologic Factors|immunologic factors|mesh-ancestor
25839160|NCT00025285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839161|NCT00025285|Leprostatic Agents|leprostatic agents|mesh-ancestor
25839162|NCT00025285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25839163|NCT00025285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25839164|NCT00025285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25839165|NCT00025285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25839166|NCT00025285|Growth Substances|growth substances|mesh-ancestor
24653947|NCT01246362|Etoricoxib|etoricoxib|mesh-list
25839167|NCT00025285|Growth Inhibitors|growth inhibitors|mesh-ancestor
25839168|NCT00025298|Paclitaxel|paclitaxel|mesh-list
25839169|NCT00025298|Cisplatin|cisplatin|mesh-list
25839170|NCT00025298|Carboplatin|carboplatin|mesh-list
25839171|NCT00025298|Amifostine|amifostine|mesh-list
25839172|NCT00025298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25839173|NCT00025298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839174|NCT00025298|Tubulin Modulators|tubulin modulators|mesh-ancestor
25839175|NCT00025298|Antimitotic Agents|antimitotic agents|mesh-ancestor
25839176|NCT00025298|Mitosis Modulators|mitosis modulators|mesh-ancestor
25839177|NCT00025298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839178|NCT00025298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25839179|NCT00025298|Protective Agents|protective agents|mesh-ancestor
25839180|NCT00025298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839181|NCT00025311|Topotecan|topotecan|mesh-list
25839182|NCT00025311|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25839183|NCT00025311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25839184|NCT00025311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839185|NCT00025311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839186|NCT00025311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839187|NCT00025324|Cyclophosphamide|cyclophosphamide|mesh-list
25839188|NCT00025324|Thiotepa|thiotepa|mesh-list
25839189|NCT00025324|Carboplatin|carboplatin|mesh-list
25839190|NCT00025324|Etoposide|etoposide|mesh-list
25839191|NCT00025324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25839192|NCT00025324|Immunologic Factors|immunologic factors|mesh-ancestor
25839193|NCT00025324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839194|NCT00025324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25839195|NCT00025324|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25839196|NCT00025324|Alkylating Agents|alkylating agents|mesh-ancestor
25839197|NCT00025324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839198|NCT00025324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24932119|NCT04082858|Anesthetics, General|anesthetics, general|mesh-ancestor
24451249|NCT00322803|GABA Agents|gaba agents|mesh-ancestor
25839199|NCT00025324|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25839200|NCT00025324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25839201|NCT00025324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25839202|NCT00025324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25839203|NCT00025324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839204|NCT00025337|Leucovorin|leucovorin|mesh-list
25839205|NCT00025337|Bevacizumab|bevacizumab|mesh-list
25839206|NCT00025337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24860379|NCT02309450|Protease Inhibitors|protease inhibitors|mesh-ancestor
24860380|NCT02309450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860381|NCT02309450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860382|NCT02309463|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
24860383|NCT02309463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860384|NCT02309554|Nonoxynol|nonoxynol|mesh-list
24860385|NCT02309554|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
25839207|NCT00025337|Fluorouracil|fluorouracil|mesh-list
25839208|NCT00025337|Oxaliplatin|oxaliplatin|mesh-list
24860386|NCT02309554|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
24860387|NCT02309554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839209|NCT00025337|Antibodies|antibodies|mesh-list
25839210|NCT00025337|Immunoglobulins|immunoglobulins|mesh-list
25839211|NCT00025337|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25058687|NCT03493568|Dolutegravir|dolutegravir|mesh-list
24860388|NCT02309554|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24860389|NCT02309554|Contraceptive Agents|contraceptive agents|mesh-ancestor
24860390|NCT02309554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25839212|NCT00025337|Levoleucovorin|levoleucovorin|mesh-list
25839213|NCT00025337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839214|NCT00025337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25839215|NCT00025337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25839216|NCT00025337|Growth Substances|growth substances|mesh-ancestor
25839217|NCT00025337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839218|NCT00025337|Growth Inhibitors|growth inhibitors|mesh-ancestor
25839219|NCT00025337|Immunologic Factors|immunologic factors|mesh-ancestor
25839220|NCT00025337|Antimetabolites|antimetabolites|mesh-ancestor
25839221|NCT00025337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839222|NCT00025337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25839223|NCT00025337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25839224|NCT00025337|Antidotes|antidotes|mesh-ancestor
24935352|NCT04051632|Insulin|insulin|mesh-list
25839225|NCT00025337|Protective Agents|protective agents|mesh-ancestor
25839226|NCT00025337|Vitamin B Complex|vitamin b complex|mesh-ancestor
25839227|NCT00025337|Vitamins|vitamins|mesh-ancestor
25839228|NCT00025337|Micronutrients|micronutrients|mesh-ancestor
24653999|NCT01246752|Cytarabine|cytarabine|mesh-list
25839229|NCT00025350|Gefitinib|gefitinib|mesh-list
25839230|NCT00025350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839231|NCT00025350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25839232|NCT00025350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839233|NCT00025350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839234|NCT00025363|Cyclophosphamide|cyclophosphamide|mesh-list
25839235|NCT00025363|Ifosfamide|ifosfamide|mesh-list
25839236|NCT00025363|Doxorubicin|doxorubicin|mesh-list
25839237|NCT00025363|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25839238|NCT00025363|Irinotecan|irinotecan|mesh-list
25839239|NCT00025363|Etoposide|etoposide|mesh-list
25839240|NCT00025363|Vincristine|vincristine|mesh-list
25839241|NCT00025363|Etoposide phosphate|etoposide phosphate|mesh-list
25839242|NCT00025363|Tirapazamine|tirapazamine|mesh-list
25839243|NCT00025363|Sargramostim|sargramostim|mesh-list
25839244|NCT00025363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25839245|NCT00025363|Immunologic Factors|immunologic factors|mesh-ancestor
25839246|NCT00025363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839247|NCT00025363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25839248|NCT00025363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25839249|NCT00025363|Alkylating Agents|alkylating agents|mesh-ancestor
25839250|NCT00025363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839251|NCT00025363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839252|NCT00025363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25839253|NCT00025363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25839254|NCT00025363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25839255|NCT00025363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25839256|NCT00025363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839257|NCT00025363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25839258|NCT00025363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25839259|NCT00025363|Tubulin Modulators|tubulin modulators|mesh-ancestor
25839260|NCT00025363|Antimitotic Agents|antimitotic agents|mesh-ancestor
25839261|NCT00025363|Mitosis Modulators|mitosis modulators|mesh-ancestor
25839262|NCT00025376|Bortezomib|bortezomib|mesh-list
25839263|NCT00025376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839264|NCT00025389|Paclitaxel|paclitaxel|mesh-list
25839265|NCT00025389|Bevacizumab|bevacizumab|mesh-list
25839266|NCT00025389|Carboplatin|carboplatin|mesh-list
25839267|NCT00025389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25839268|NCT00025389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839269|NCT00025389|Tubulin Modulators|tubulin modulators|mesh-ancestor
25839270|NCT00025389|Antimitotic Agents|antimitotic agents|mesh-ancestor
25839271|NCT00025389|Mitosis Modulators|mitosis modulators|mesh-ancestor
25839272|NCT00025389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860402|NCT02309658|Immunologic Factors|immunologic factors|mesh-ancestor
24860403|NCT02309658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860404|NCT02309801|Daidzin|daidzin|mesh-list
24860405|NCT02309801|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24860406|NCT02309801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202960|NCT02717871|Cholinergic Agents|cholinergic agents|mesh-ancestor
25674315|NCT01770145|Dopamine Agents|dopamine agents|mesh-ancestor
24860407|NCT02309801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674316|NCT01770145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25674317|NCT01770145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674318|NCT01770145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507963|NCT00553618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813326|NCT02057796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24813327|NCT02057796|Leprostatic Agents|leprostatic agents|mesh-ancestor
24813328|NCT02057796|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24813329|NCT02057796|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24813330|NCT02057796|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24813331|NCT02057796|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24860409|NCT02309879|Magnesium Sulfate|magnesium sulfate|mesh-list
24860410|NCT02309879|Remifentanil|remifentanil|mesh-list
24860411|NCT02309879|Anesthetics, Local|anesthetics, local|mesh-ancestor
25839273|NCT00025389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25839274|NCT00025389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25839275|NCT00025389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24540794|NCT00669656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24540795|NCT00669656|Antioxidants|antioxidants|mesh-ancestor
24860419|NCT02309879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24860420|NCT02309879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24654142|NCT01247870|Metformin|metformin|mesh-list
24860422|NCT02309879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24860423|NCT02309879|Narcotics|narcotics|mesh-ancestor
24860424|NCT02309879|Analgesics|analgesics|mesh-ancestor
24860425|NCT02309879|Anticonvulsants|anticonvulsants|mesh-ancestor
24860426|NCT02309879|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24860427|NCT02309879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24860428|NCT02309879|Tocolytic Agents|tocolytic agents|mesh-ancestor
24860429|NCT02309879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24860430|NCT02309931|Antidiarrheals|antidiarrheals|mesh-list
24540796|NCT00669656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540797|NCT00669656|Protective Agents|protective agents|mesh-ancestor
24540798|NCT00669656|Trace Elements|trace elements|mesh-ancestor
24540799|NCT00669656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25839276|NCT00025389|Growth Substances|growth substances|mesh-ancestor
25839277|NCT00025389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839278|NCT00025389|Growth Inhibitors|growth inhibitors|mesh-ancestor
25839279|NCT00025402|Interferons|interferons|mesh-list
25839280|NCT00025402|Cytarabine|cytarabine|mesh-list
25839281|NCT00025402|Interferon-alpha|interferon-alpha|mesh-list
25839282|NCT00025402|Cyclophosphamide|cyclophosphamide|mesh-list
25839283|NCT00025402|Busulfan|busulfan|mesh-list
25839284|NCT00025402|Etoposide|etoposide|mesh-list
25839285|NCT00025402|Idarubicin|idarubicin|mesh-list
25839286|NCT00025402|Hydroxyurea|hydroxyurea|mesh-list
25839287|NCT00025402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24860431|NCT02309931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24860432|NCT02309970|Aspirin|aspirin|mesh-list
24860433|NCT02309970|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24860434|NCT02309970|Warfarin|warfarin|mesh-list
24860435|NCT02309970|Rivaroxaban|rivaroxaban|mesh-list
24860436|NCT02309970|Dabigatran|dabigatran|mesh-list
24860437|NCT02309970|Apixaban|apixaban|mesh-list
24860438|NCT02309970|Clopidogrel|clopidogrel|mesh-list
24654204|NCT01248195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25839288|NCT00025402|Immunologic Factors|immunologic factors|mesh-ancestor
25839289|NCT00025402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839290|NCT00025402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25839291|NCT00025402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25202961|NCT02717871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25839292|NCT00025402|Alkylating Agents|alkylating agents|mesh-ancestor
25839293|NCT00025402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839294|NCT00025402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839295|NCT00025402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25839296|NCT00025402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25839297|NCT00025402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25839298|NCT00025402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25839299|NCT00025402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839300|NCT00025402|Antiviral Agents|antiviral agents|mesh-ancestor
25839301|NCT00025402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25839302|NCT00025402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25839303|NCT00025402|Antimetabolites|antimetabolites|mesh-ancestor
25839304|NCT00025402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25839305|NCT00025402|Antisickling Agents|antisickling agents|mesh-ancestor
25839306|NCT00025402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25839307|NCT00025415|Imatinib Mesylate|imatinib mesylate|mesh-list
24860446|NCT02309970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25839308|NCT00025415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839309|NCT00025415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25839310|NCT00025415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508203|NCT00554502|Immunologic Factors|immunologic factors|mesh-ancestor
24508204|NCT00554502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508206|NCT00554528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24508207|NCT00554528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25058836|NCT03492736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058837|NCT03492736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25058838|NCT03492710|Immunoglobulins|immunoglobulins|mesh-list
25058839|NCT03492710|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25058841|NCT03492710|Immunologic Factors|immunologic factors|mesh-ancestor
25058842|NCT03492710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058861|NCT03492632|Hormones|hormones|mesh-list
25058878|NCT03492580|Dapagliflozin|dapagliflozin|mesh-list
25058879|NCT03492580|Empagliflozin|empagliflozin|mesh-list
25058880|NCT03492580|Canagliflozin|canagliflozin|mesh-list
25058881|NCT03492580|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
25058882|NCT03492580|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25058883|NCT03492580|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25058884|NCT03492580|Glucagon|glucagon|mesh-list
25058885|NCT03492580|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24860447|NCT02309970|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24860448|NCT02309970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24540804|NCT00669656|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25839311|NCT00025415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839312|NCT00025428|Cyclophosphamide|cyclophosphamide|mesh-list
25839313|NCT00025428|Carboplatin|carboplatin|mesh-list
25839314|NCT00025428|Doxorubicin|doxorubicin|mesh-list
25839315|NCT00025428|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25839316|NCT00025428|Etoposide|etoposide|mesh-list
25839317|NCT00025428|Vincristine|vincristine|mesh-list
25839318|NCT00025428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25839319|NCT00025428|Immunologic Factors|immunologic factors|mesh-ancestor
25839320|NCT00025428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839321|NCT00025428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25839322|NCT00025428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25839323|NCT00025428|Alkylating Agents|alkylating agents|mesh-ancestor
25839324|NCT00025428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839325|NCT00025428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839326|NCT00025428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25839327|NCT00025428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25839328|NCT00025428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24860450|NCT02309970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24860451|NCT02309970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24860453|NCT02309970|Antipyretics|antipyretics|mesh-ancestor
24860454|NCT02309970|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24860455|NCT02309970|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25839329|NCT00025428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25839330|NCT00025428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839331|NCT00025428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25839332|NCT00025428|Tubulin Modulators|tubulin modulators|mesh-ancestor
25839333|NCT00025428|Antimitotic Agents|antimitotic agents|mesh-ancestor
25839334|NCT00025428|Mitosis Modulators|mitosis modulators|mesh-ancestor
25839335|NCT00025441|Dactinomycin|dactinomycin|mesh-list
25839336|NCT00025441|Cyclophosphamide|cyclophosphamide|mesh-list
25839337|NCT00025441|Ifosfamide|ifosfamide|mesh-list
25659657|NCT01610154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659658|NCT01610167|Listerine|listerine|mesh-list
25659659|NCT01610167|Fluorides|fluorides|mesh-list
25659660|NCT01610167|Sodium Fluoride|sodium fluoride|mesh-list
25659661|NCT01610167|Cariostatic Agents|cariostatic agents|mesh-ancestor
25659662|NCT01610167|Protective Agents|protective agents|mesh-ancestor
25659663|NCT01610167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659664|NCT01610167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25659665|NCT01610167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25659666|NCT01610206|Gemcitabine|gemcitabine|mesh-list
25659667|NCT01610206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25659668|NCT01610206|Antimetabolites|antimetabolites|mesh-ancestor
25659669|NCT01610206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659670|NCT01610206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659671|NCT01610206|Antiviral Agents|antiviral agents|mesh-ancestor
25659672|NCT01610206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25659673|NCT01610206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25659674|NCT01610206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25659675|NCT01610206|Immunologic Factors|immunologic factors|mesh-ancestor
25839338|NCT00025441|Carboplatin|carboplatin|mesh-list
25839339|NCT00025441|Doxorubicin|doxorubicin|mesh-list
25839340|NCT00025441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25839341|NCT00025441|Etoposide|etoposide|mesh-list
24600324|NCT01026220|Alkylating Agents|alkylating agents|mesh-ancestor
25659676|NCT01610206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839342|NCT00025441|Vincristine|vincristine|mesh-list
25839343|NCT00025441|Epirubicin|epirubicin|mesh-list
25659677|NCT01610284|Fulvestrant|fulvestrant|mesh-list
25839344|NCT00025441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25839345|NCT00025441|Immunologic Factors|immunologic factors|mesh-ancestor
25839346|NCT00025441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839347|NCT00025441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25839348|NCT00025441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25839349|NCT00025441|Alkylating Agents|alkylating agents|mesh-ancestor
24950388|NCT03916250|Petrolatum|petrolatum|mesh-list
25839350|NCT00025441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839351|NCT00025441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839352|NCT00025441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25839353|NCT00025441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25839354|NCT00025441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25839355|NCT00025441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25839356|NCT00025441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839357|NCT00025441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25839358|NCT00025441|Tubulin Modulators|tubulin modulators|mesh-ancestor
25839359|NCT00025441|Antimitotic Agents|antimitotic agents|mesh-ancestor
25839360|NCT00025441|Mitosis Modulators|mitosis modulators|mesh-ancestor
25839361|NCT00025441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25839362|NCT00025441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25839363|NCT00025441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25839364|NCT00025441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25839365|NCT00025454|Tipifarnib|tipifarnib|mesh-list
25839366|NCT00025454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839367|NCT00025467|Thalidomide|thalidomide|mesh-list
25839368|NCT00025467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25839369|NCT00025467|Immunologic Factors|immunologic factors|mesh-ancestor
25839370|NCT00025467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839371|NCT00025467|Leprostatic Agents|leprostatic agents|mesh-ancestor
25839372|NCT00025467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25839373|NCT00025467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25839374|NCT00025467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25839375|NCT00025467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25839376|NCT00025467|Growth Substances|growth substances|mesh-ancestor
25839377|NCT00025467|Growth Inhibitors|growth inhibitors|mesh-ancestor
25839378|NCT00025467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839379|NCT00025480|Paclitaxel|paclitaxel|mesh-list
25839380|NCT00025480|Carboplatin|carboplatin|mesh-list
25839381|NCT00025480|Tipifarnib|tipifarnib|mesh-list
25839382|NCT00025480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25839383|NCT00025480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839384|NCT00025480|Tubulin Modulators|tubulin modulators|mesh-ancestor
24860456|NCT02309970|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24860457|NCT02309970|Purinergic Agents|purinergic agents|mesh-ancestor
24860458|NCT02309970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24860459|NCT02309970|Anticoagulants|anticoagulants|mesh-ancestor
24860460|NCT02309970|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24860461|NCT02309970|Antithrombins|antithrombins|mesh-ancestor
24860462|NCT02309970|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25202962|NCT02717858|Liraglutide|liraglutide|mesh-list
24860463|NCT02309970|Protease Inhibitors|protease inhibitors|mesh-ancestor
24860464|NCT02310009|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24860465|NCT02310009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24965636|NCT03775928|Capecitabine|capecitabine|mesh-list
24860466|NCT02310074|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24860468|NCT02310074|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24860469|NCT02310074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24860470|NCT02310074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860471|NCT02310074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24540827|NCT00669773|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24540828|NCT00669773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659678|NCT01610284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25659679|NCT01610284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659680|NCT01610284|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25659681|NCT01610284|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24540829|NCT00669773|Tubulin Modulators|tubulin modulators|mesh-ancestor
25659682|NCT01610284|Hormone Antagonists|hormone antagonists|mesh-ancestor
25659683|NCT01610284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25659684|NCT01610284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058971|NCT03492047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25058972|NCT03492047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25058973|NCT03492047|Tubulin Modulators|tubulin modulators|mesh-ancestor
24508268|NCT00554710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25839385|NCT00025480|Antimitotic Agents|antimitotic agents|mesh-ancestor
25839386|NCT00025480|Mitosis Modulators|mitosis modulators|mesh-ancestor
24932555|NCT04078880|Micronutrients|micronutrients|mesh-ancestor
25839387|NCT00025480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839388|NCT00025493|Docetaxel|docetaxel|mesh-list
25839389|NCT00025493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839390|NCT00025493|Tubulin Modulators|tubulin modulators|mesh-ancestor
25839391|NCT00025493|Antimitotic Agents|antimitotic agents|mesh-ancestor
25839392|NCT00025493|Mitosis Modulators|mitosis modulators|mesh-ancestor
25839393|NCT00025493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839394|NCT00025519|Mycophenolic Acid|mycophenolic acid|mesh-list
25839395|NCT00025519|Thalidomide|thalidomide|mesh-list
25839396|NCT00025519|Fludarabine|fludarabine|mesh-list
25839397|NCT00025519|Fludarabine phosphate|fludarabine phosphate|mesh-list
25839398|NCT00025519|Tacrolimus|tacrolimus|mesh-list
25839399|NCT00025519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839400|NCT00025519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25839401|NCT00025519|Antimetabolites|antimetabolites|mesh-ancestor
24860489|NCT02310295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24860490|NCT02310295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24540845|NCT00669812|Cytarabine|cytarabine|mesh-list
25839402|NCT00025519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839403|NCT00025519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25839404|NCT00025519|Immunologic Factors|immunologic factors|mesh-ancestor
25839405|NCT00025519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839406|NCT00025519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25839407|NCT00025519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839408|NCT00025519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25839409|NCT00025519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25839410|NCT00025519|Antitubercular Agents|antitubercular agents|mesh-ancestor
25839411|NCT00025519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25839412|NCT00025519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25839413|NCT00025519|Leprostatic Agents|leprostatic agents|mesh-ancestor
25839414|NCT00025519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25839415|NCT00025519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25839416|NCT00025519|Growth Substances|growth substances|mesh-ancestor
25839417|NCT00025519|Growth Inhibitors|growth inhibitors|mesh-ancestor
25839418|NCT00025532|Antibodies|antibodies|mesh-list
25202963|NCT02717858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25839419|NCT00025532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25839420|NCT00025532|Immunologic Factors|immunologic factors|mesh-ancestor
24860496|NCT02310295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24860497|NCT02310295|Glucocorticoids|glucocorticoids|mesh-ancestor
24860499|NCT02310295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24860500|NCT02310295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24860501|NCT02310295|Immunologic Factors|immunologic factors|mesh-ancestor
24860502|NCT02310295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540862|NCT00669812|Alkylating Agents|alkylating agents|mesh-ancestor
25839421|NCT00025532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839422|NCT00025545|Cyclophosphamide|cyclophosphamide|mesh-list
25839423|NCT00025545|Methotrexate|methotrexate|mesh-list
25839424|NCT00025545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25066388|NCT03406247|Ipilimumab|ipilimumab|mesh-list
25839425|NCT00025545|Immunologic Factors|immunologic factors|mesh-ancestor
25839426|NCT00025545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839427|NCT00025545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25839428|NCT00025545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25839429|NCT00025545|Alkylating Agents|alkylating agents|mesh-ancestor
25839430|NCT00025545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839431|NCT00025545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839432|NCT00025545|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25839433|NCT00025545|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25839434|NCT00025545|Abortifacient Agents|abortifacient agents|mesh-ancestor
25839435|NCT00025545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25839436|NCT00025545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25839437|NCT00025545|Antimetabolites|antimetabolites|mesh-ancestor
25659685|NCT01610297|Deferasirox|deferasirox|mesh-list
25659686|NCT01610297|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25659687|NCT01610297|Chelating Agents|chelating agents|mesh-ancestor
25659688|NCT01610297|Sequestering Agents|sequestering agents|mesh-ancestor
24860716|NCT02312115|Furosemide|furosemide|mesh-list
25839438|NCT00025545|Dermatologic Agents|dermatologic agents|mesh-ancestor
25839440|NCT00025545|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25839441|NCT00025545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25839442|NCT00025558|Carboplatin|carboplatin|mesh-list
25839443|NCT00025558|Temozolomide|temozolomide|mesh-list
24860510|NCT02310347|Sensory System Agents|sensory system agents|mesh-ancestor
24860511|NCT02310347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24540874|NCT00669812|Antimetabolites|antimetabolites|mesh-ancestor
24451312|NCT00323011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24451313|NCT00323076|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
24451314|NCT00323076|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24451315|NCT00323076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451319|NCT00323154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25066708|NCT02099175|Ifosfamide|ifosfamide|mesh-list
24451320|NCT00323154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451321|NCT00323154|Analgesics|analgesics|mesh-ancestor
25839444|NCT00025558|Thiotepa|thiotepa|mesh-list
25839445|NCT00025558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839446|NCT00025558|Immunologic Factors|immunologic factors|mesh-ancestor
25839447|NCT00025558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839448|NCT00025558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25839449|NCT00025558|Alkylating Agents|alkylating agents|mesh-ancestor
25839450|NCT00025558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163316|NCT02897076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25839451|NCT00025558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25839452|NCT00025558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25839453|NCT00025584|Bortezomib|bortezomib|mesh-list
24860512|NCT02310347|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24860513|NCT02310347|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24860514|NCT02310347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25839454|NCT00025584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839455|NCT00025597|Cyclophosphamide|cyclophosphamide|mesh-list
25839456|NCT00025597|Carboplatin|carboplatin|mesh-list
25839457|NCT00025597|Doxorubicin|doxorubicin|mesh-list
25839458|NCT00025597|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25839459|NCT00025597|Etoposide|etoposide|mesh-list
25839460|NCT00025597|Vincristine|vincristine|mesh-list
25839461|NCT00025597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25839462|NCT00025597|Immunologic Factors|immunologic factors|mesh-ancestor
25839463|NCT00025597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839464|NCT00025597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25839465|NCT00025597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25839466|NCT00025597|Alkylating Agents|alkylating agents|mesh-ancestor
25839467|NCT00025597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860515|NCT02310347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860517|NCT02310347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24860518|NCT02310360|Fallypride|fallypride|mesh-list
24860519|NCT02310360|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24540881|NCT00669812|Tubulin Modulators|tubulin modulators|mesh-ancestor
24540882|NCT00669812|Antimitotic Agents|antimitotic agents|mesh-ancestor
24540883|NCT00669812|Mitosis Modulators|mitosis modulators|mesh-ancestor
24540884|NCT00669812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24540885|NCT00669812|Glucocorticoids|glucocorticoids|mesh-ancestor
25839468|NCT00025597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839469|NCT00025597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25839470|NCT00025597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25839471|NCT00025597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25067384|NCT03443960|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25839472|NCT00025597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25839473|NCT00025597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839474|NCT00025597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25839475|NCT00025597|Tubulin Modulators|tubulin modulators|mesh-ancestor
25839476|NCT00025597|Antimitotic Agents|antimitotic agents|mesh-ancestor
25839477|NCT00025597|Mitosis Modulators|mitosis modulators|mesh-ancestor
25839478|NCT00025610|Cyclophosphamide|cyclophosphamide|mesh-list
25839479|NCT00025610|Carboplatin|carboplatin|mesh-list
25839480|NCT00025610|Doxorubicin|doxorubicin|mesh-list
25839481|NCT00025610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24654551|NCT01250340|Antipyretics|antipyretics|mesh-ancestor
25839482|NCT00025610|Etoposide|etoposide|mesh-list
25839483|NCT00025610|Vincristine|vincristine|mesh-list
25839484|NCT00025610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25839485|NCT00025610|Immunologic Factors|immunologic factors|mesh-ancestor
25839486|NCT00025610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839487|NCT00025610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25839488|NCT00025610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25839489|NCT00025610|Alkylating Agents|alkylating agents|mesh-ancestor
25839490|NCT00025610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839491|NCT00025610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839492|NCT00025610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25839493|NCT00025610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25839494|NCT00025610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25839495|NCT00025610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25839496|NCT00025610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839497|NCT00025610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25839498|NCT00025610|Tubulin Modulators|tubulin modulators|mesh-ancestor
25839499|NCT00025610|Antimitotic Agents|antimitotic agents|mesh-ancestor
25839500|NCT00025610|Mitosis Modulators|mitosis modulators|mesh-ancestor
25839501|NCT00025623|Cyclophosphamide|cyclophosphamide|mesh-list
25839502|NCT00025623|Carboplatin|carboplatin|mesh-list
25839503|NCT00025623|Doxorubicin|doxorubicin|mesh-list
25839504|NCT00025623|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24860521|NCT02310360|Dopamine Agents|dopamine agents|mesh-ancestor
24860522|NCT02310360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24860523|NCT02310360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860524|NCT02310360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860525|NCT02310373|Nicotine|nicotine|mesh-list
24860526|NCT02310373|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24860527|NCT02310373|Autonomic Agents|autonomic agents|mesh-ancestor
24860528|NCT02310373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24860529|NCT02310373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839505|NCT00025623|Etoposide|etoposide|mesh-list
25839506|NCT00025623|Vincristine|vincristine|mesh-list
25839507|NCT00025623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25839508|NCT00025623|Immunologic Factors|immunologic factors|mesh-ancestor
25839509|NCT00025623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839510|NCT00025623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25839511|NCT00025623|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25839512|NCT00025623|Alkylating Agents|alkylating agents|mesh-ancestor
25839513|NCT00025623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839514|NCT00025623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839515|NCT00025623|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24860530|NCT02310373|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24860531|NCT02310373|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24860532|NCT02310373|Cholinergic Agents|cholinergic agents|mesh-ancestor
24540887|NCT00669812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24540888|NCT00669812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24540889|NCT00669890|Mycophenolic Acid|mycophenolic acid|mesh-list
24540890|NCT00669890|Cyclophosphamide|cyclophosphamide|mesh-list
24540891|NCT00669890|Busulfan|busulfan|mesh-list
24540892|NCT00669890|Methotrexate|methotrexate|mesh-list
24540893|NCT00669890|Gemtuzumab|gemtuzumab|mesh-list
24540894|NCT00669890|Tacrolimus|tacrolimus|mesh-list
24540895|NCT00669890|Thymoglobulin|thymoglobulin|mesh-list
24540896|NCT00669890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24540897|NCT00669890|Immunologic Factors|immunologic factors|mesh-ancestor
24540898|NCT00669890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839516|NCT00025623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25839517|NCT00025623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25839518|NCT00025623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25839519|NCT00025623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25069590|NCT03425552|Serotonin Agents|serotonin agents|mesh-ancestor
25839520|NCT00025623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25839521|NCT00025623|Tubulin Modulators|tubulin modulators|mesh-ancestor
25839522|NCT00025623|Antimitotic Agents|antimitotic agents|mesh-ancestor
25839523|NCT00025623|Mitosis Modulators|mitosis modulators|mesh-ancestor
25839524|NCT00025636|Cytarabine|cytarabine|mesh-list
25839525|NCT00025636|Dexamethasone|dexamethasone|mesh-list
25839526|NCT00025636|Cyclophosphamide|cyclophosphamide|mesh-list
25839527|NCT00025636|Melphalan|melphalan|mesh-list
25839528|NCT00025636|Carmustine|carmustine|mesh-list
25839529|NCT00025636|Cisplatin|cisplatin|mesh-list
25839530|NCT00025636|Methotrexate|methotrexate|mesh-list
25839531|NCT00025636|Etoposide|etoposide|mesh-list
25839532|NCT00025636|Vincristine|vincristine|mesh-list
24860533|NCT02310373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24860572|NCT02311101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24860536|NCT02310490|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24860539|NCT02310490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860541|NCT02310997|Melphalan|melphalan|mesh-list
24860542|NCT02310997|Busulfan|busulfan|mesh-list
24860543|NCT02310997|Fludarabine|fludarabine|mesh-list
24860546|NCT02310997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839533|NCT00025636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24508423|NCT00555399|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24860547|NCT02310997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24860548|NCT02310997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24860549|NCT02310997|Alkylating Agents|alkylating agents|mesh-ancestor
24860550|NCT02310997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540899|NCT00669890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24540900|NCT00669890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25839534|NCT00025636|Immunologic Factors|immunologic factors|mesh-ancestor
25839535|NCT00025636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839536|NCT00025636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25839537|NCT00025636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24932864|NCT04075955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839538|NCT00025636|Alkylating Agents|alkylating agents|mesh-ancestor
25839539|NCT00025636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839540|NCT00025636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839541|NCT00025636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25839542|NCT00025636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25839543|NCT00025636|Antiemetics|antiemetics|mesh-ancestor
25071045|NCT03413371|Bupivacaine|bupivacaine|mesh-list
25839544|NCT00025636|Autonomic Agents|autonomic agents|mesh-ancestor
25839545|NCT00025636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25839546|NCT00025636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25839547|NCT00025636|Glucocorticoids|glucocorticoids|mesh-ancestor
25839548|NCT00025636|Hormones|hormones|mesh-ancestor
25839549|NCT00025636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25839550|NCT00025636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25839551|NCT00025636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25839552|NCT00025636|Abortifacient Agents|abortifacient agents|mesh-ancestor
25839553|NCT00025636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25839554|NCT00025636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25839555|NCT00025636|Antimetabolites|antimetabolites|mesh-ancestor
25839556|NCT00025636|Dermatologic Agents|dermatologic agents|mesh-ancestor
25839557|NCT00025636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839558|NCT00025636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25839559|NCT00025636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25839560|NCT00025636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25839561|NCT00025636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25839562|NCT00025636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25839563|NCT00025636|Antiviral Agents|antiviral agents|mesh-ancestor
25839564|NCT00025636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25839565|NCT00025636|Tubulin Modulators|tubulin modulators|mesh-ancestor
25839566|NCT00025636|Antimitotic Agents|antimitotic agents|mesh-ancestor
24860551|NCT02310997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24860552|NCT02310997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24860553|NCT02311010|Tacrolimus|tacrolimus|mesh-list
24860554|NCT02311010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25839567|NCT00025636|Mitosis Modulators|mitosis modulators|mesh-ancestor
24860558|NCT02311010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540916|NCT00669890|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24540917|NCT00669890|Antitubercular Agents|antitubercular agents|mesh-ancestor
24540918|NCT00669890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24540919|NCT00669890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24540920|NCT00669890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24540921|NCT00669994|Ciprofloxacin|ciprofloxacin|mesh-list
24540922|NCT00669994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24540923|NCT00669994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25839568|NCT00025649|Cyclophosphamide|cyclophosphamide|mesh-list
25839569|NCT00025649|Melphalan|melphalan|mesh-list
25839570|NCT00025649|Busulfan|busulfan|mesh-list
25839571|NCT00025649|Carboplatin|carboplatin|mesh-list
25839572|NCT00025649|Doxorubicin|doxorubicin|mesh-list
25839573|NCT00025649|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25839574|NCT00025649|Etoposide|etoposide|mesh-list
25839575|NCT00025649|Vincristine|vincristine|mesh-list
25839576|NCT00025649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24965917|NCT03773042|Propofol|propofol|mesh-list
24826762|NCT02135887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24860574|NCT02311101|Alkylating Agents|alkylating agents|mesh-ancestor
24860575|NCT02311101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529936|NCT00628316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25839577|NCT00025649|Immunologic Factors|immunologic factors|mesh-ancestor
24860586|NCT02311179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659689|NCT01610297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659690|NCT01610336|Gefitinib|gefitinib|mesh-list
25659691|NCT01610336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25059059|NCT03491410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25059060|NCT03491410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059069|NCT03491410|Antipyretics|antipyretics|mesh-ancestor
24860587|NCT02311179|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24860588|NCT02311179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24860589|NCT02311179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860590|NCT02311205|Sorafenib|sorafenib|mesh-list
24860591|NCT02311205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24860602|NCT02311231|Antithrombins|antithrombins|mesh-ancestor
24860603|NCT02311231|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24860604|NCT02311231|Protease Inhibitors|protease inhibitors|mesh-ancestor
24860605|NCT02311231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860606|NCT02311439|Folfirinox|folfirinox|mesh-list
25071584|NCT03407404|Midazolam|midazolam|mesh-list
24860607|NCT02311439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24860608|NCT02311517|Ropivacaine|ropivacaine|mesh-list
24860609|NCT02311517|Anesthetics, Local|anesthetics, local|mesh-ancestor
24860610|NCT02311517|Anesthetics|anesthetics|mesh-ancestor
24860611|NCT02311517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24860612|NCT02311517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860613|NCT02311517|Sensory System Agents|sensory system agents|mesh-ancestor
24860614|NCT02311517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25839578|NCT00025649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839579|NCT00025649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25839580|NCT00025649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25839581|NCT00025649|Alkylating Agents|alkylating agents|mesh-ancestor
25839582|NCT00025649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839583|NCT00025649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839584|NCT00025649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25839585|NCT00025649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25839586|NCT00025649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25839587|NCT00025649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25839588|NCT00025649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839589|NCT00025649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25839590|NCT00025649|Tubulin Modulators|tubulin modulators|mesh-ancestor
25839591|NCT00025649|Antimitotic Agents|antimitotic agents|mesh-ancestor
25839592|NCT00025649|Mitosis Modulators|mitosis modulators|mesh-ancestor
25839593|NCT00025675|Gefitinib|gefitinib|mesh-list
25839594|NCT00025675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839595|NCT00025675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25839596|NCT00025675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839597|NCT00025675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839598|NCT00025688|Paclitaxel|paclitaxel|mesh-list
25839599|NCT00025688|Carboplatin|carboplatin|mesh-list
24540971|NCT00670345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540973|NCT00670345|Coagulants|coagulants|mesh-ancestor
24540974|NCT00670410|Fludarabine|fludarabine|mesh-list
24540975|NCT00670410|Busulfan|busulfan|mesh-list
24540976|NCT00670410|Thymoglobulin|thymoglobulin|mesh-list
24540977|NCT00670410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24540979|NCT00670410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24860637|NCT02311608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24860638|NCT02311608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654913|NCT01252056|Vasodilator Agents|vasodilator agents|mesh-ancestor
24654914|NCT01252056|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25839600|NCT00025688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25839601|NCT00025688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839602|NCT00025688|Tubulin Modulators|tubulin modulators|mesh-ancestor
25839603|NCT00025688|Antimitotic Agents|antimitotic agents|mesh-ancestor
25163317|NCT02897076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163318|NCT02897076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25839604|NCT00025688|Mitosis Modulators|mitosis modulators|mesh-ancestor
25839605|NCT00025688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839606|NCT00025727|Ritonavir|ritonavir|mesh-list
25839607|NCT00025727|Lopinavir|lopinavir|mesh-list
25839608|NCT00025727|Fosamprenavir|fosamprenavir|mesh-list
25659692|NCT01610336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25659693|NCT01610336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25659694|NCT01610336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659695|NCT01610492|Belimumab|belimumab|mesh-list
25659696|NCT01610492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25659697|NCT01610492|Immunologic Factors|immunologic factors|mesh-ancestor
25659698|NCT01610492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659699|NCT01610557|Bevacizumab|bevacizumab|mesh-list
25659700|NCT01610557|Ranibizumab|ranibizumab|mesh-list
25659701|NCT01610557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25059127|NCT03490994|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25839609|NCT00025727|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25839610|NCT00025727|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25073057|NCT03397706|Valganciclovir|valganciclovir|mesh-list
25839611|NCT00025727|Protease Inhibitors|protease inhibitors|mesh-ancestor
25839612|NCT00025727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839613|NCT00025727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839614|NCT00025727|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25839615|NCT00025727|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25839616|NCT00025727|Antiviral Agents|antiviral agents|mesh-ancestor
25839617|NCT00025727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25839618|NCT00025727|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25839619|NCT00025727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25839620|NCT00025740|Clonazepam|clonazepam|mesh-list
25839621|NCT00025740|Paroxetine|paroxetine|mesh-list
24860645|NCT02311686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24860646|NCT02311686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24860647|NCT02311686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24860648|NCT02311686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860649|NCT02311764|Carboplatin|carboplatin|mesh-list
24860650|NCT02311764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24860651|NCT02311777|Pregabalin|pregabalin|mesh-list
24860652|NCT02311777|Ketamine|ketamine|mesh-list
24860653|NCT02311777|Analgesics|analgesics|mesh-ancestor
24860654|NCT02311777|Sensory System Agents|sensory system agents|mesh-ancestor
24860655|NCT02311777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24860656|NCT02311777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530042|NCT00628810|Antimetabolites|antimetabolites|mesh-ancestor
25839622|NCT00025740|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25839623|NCT00025740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25839624|NCT00025740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25839625|NCT00025740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860666|NCT02311777|Anticonvulsants|anticonvulsants|mesh-ancestor
24860667|NCT02311777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24860668|NCT02311777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24860669|NCT02311777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24860670|NCT02311777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24860671|NCT02311777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24860672|NCT02311777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24860673|NCT02311946|Palbociclib|palbociclib|mesh-list
24860674|NCT02311946|Rabeprazole|rabeprazole|mesh-list
24860675|NCT02311946|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24860676|NCT02311946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24860677|NCT02311946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24860678|NCT02311946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860679|NCT02311946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860680|NCT02311946|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24860681|NCT02311946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24451372|NCT00323375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24966066|NCT03772067|Insulin|insulin|mesh-list
24541049|NCT00670657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24541050|NCT00670657|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24541051|NCT00670657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24541052|NCT00670670|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
24860704|NCT02312089|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24860705|NCT02312089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24860706|NCT02312089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24860707|NCT02312102|Lenalidomide|lenalidomide|mesh-list
24860708|NCT02312102|Bortezomib|bortezomib|mesh-list
24860709|NCT02312102|Immunologic Factors|immunologic factors|mesh-ancestor
24860710|NCT02312102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860711|NCT02312102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24860712|NCT02312102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24860713|NCT02312102|Growth Substances|growth substances|mesh-ancestor
24860714|NCT02312102|Growth Inhibitors|growth inhibitors|mesh-ancestor
24860715|NCT02312102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659702|NCT01610557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659703|NCT01610557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25659704|NCT01610557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25659705|NCT01610557|Growth Substances|growth substances|mesh-ancestor
25659706|NCT01610557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659707|NCT01610557|Growth Inhibitors|growth inhibitors|mesh-ancestor
25659708|NCT01610570|Plicamycin|plicamycin|mesh-list
25659709|NCT01610570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25659710|NCT01610570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038455|NCT05140148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24508607|NCT00556257|Cyclosporins|cyclosporins|mesh-list
24508608|NCT00556257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508609|NCT00556257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508610|NCT00556257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24508611|NCT00556257|Immunologic Factors|immunologic factors|mesh-ancestor
24508612|NCT00556257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508613|NCT00556257|Antifungal Agents|antifungal agents|mesh-ancestor
24860718|NCT02312115|Natriuretic Agents|natriuretic agents|mesh-ancestor
24860719|NCT02312115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541059|NCT00670670|Chelating Agents|chelating agents|mesh-ancestor
25839626|NCT00025740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25839627|NCT00025740|Serotonin Agents|serotonin agents|mesh-ancestor
25839628|NCT00025740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839629|NCT00025740|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25839630|NCT00025740|Antidepressive Agents|antidepressive agents|mesh-ancestor
25839631|NCT00025740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25839632|NCT00025740|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25839633|NCT00025740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25839634|NCT00025740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839635|NCT00025740|Anticonvulsants|anticonvulsants|mesh-ancestor
25839636|NCT00025740|GABA Modulators|gaba modulators|mesh-ancestor
24860723|NCT02312180|Plasminogen|plasminogen|mesh-list
24860724|NCT02312180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24860725|NCT02312180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24860726|NCT02312180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860727|NCT02312232|Levodopa|levodopa|mesh-list
24860740|NCT02312375|Amlodipine|amlodipine|mesh-list
24860741|NCT02312375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24954205|NCT03878667|Antacids|antacids|mesh-ancestor
24860742|NCT02312375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24860743|NCT02312375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24860744|NCT02312375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860745|NCT02312375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24860746|NCT02312375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860747|NCT02312375|Vasodilator Agents|vasodilator agents|mesh-ancestor
24860748|NCT02312427|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24860749|NCT02312427|Protease Inhibitors|protease inhibitors|mesh-ancestor
24541089|NCT00670787|Losartan|losartan|mesh-list
24541090|NCT00670787|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24541091|NCT00670787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24541092|NCT00670787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24541093|NCT00670787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24541094|NCT00670787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25839637|NCT00025740|GABA Agents|gaba agents|mesh-ancestor
24933218|NCT04072640|Voriconazole|voriconazole|mesh-list
24860782|NCT02312635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24860795|NCT02312661|Antimitotic Agents|antimitotic agents|mesh-ancestor
25163319|NCT02897076|Respiratory System Agents|respiratory system agents|mesh-ancestor
24860796|NCT02312661|Mitosis Modulators|mitosis modulators|mesh-ancestor
24860808|NCT02312804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860811|NCT02312908|GABA Modulators|gaba modulators|mesh-ancestor
24860812|NCT02312908|GABA Agents|gaba agents|mesh-ancestor
25839638|NCT00025753|Rosiglitazone|rosiglitazone|mesh-list
25839639|NCT00025753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25839640|NCT00025753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839641|NCT00025779|Guanfacine|guanfacine|mesh-list
25839642|NCT00025779|Methylphenidate|methylphenidate|mesh-list
24860832|NCT02313051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24860833|NCT02313051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25839643|NCT00025779|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25839644|NCT00025779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839645|NCT00025779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25839646|NCT00025779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25839647|NCT00025779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25659711|NCT01610570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25659712|NCT01610570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659713|NCT01610570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25659714|NCT01610570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25659715|NCT01610570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659716|NCT01610570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25659717|NCT01610596|Halobetasol|halobetasol|mesh-list
25659718|NCT01610596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24508711|NCT00556608|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24508712|NCT00556608|Hyaluronic Acid|hyaluronic acid|mesh-list
24508714|NCT00556608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24508715|NCT00556608|Immunologic Factors|immunologic factors|mesh-ancestor
24508716|NCT00556608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508717|NCT00556608|Viscosupplements|viscosupplements|mesh-ancestor
24508718|NCT00556608|Protective Agents|protective agents|mesh-ancestor
24508719|NCT00556621|Gemcitabine|gemcitabine|mesh-list
25839648|NCT00025779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839649|NCT00025779|Dopamine Agents|dopamine agents|mesh-ancestor
25839650|NCT00025779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25839651|NCT00025779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24860860|NCT02313272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25839652|NCT00025779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25839653|NCT00025779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25839654|NCT00025779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25839655|NCT00025779|Adrenergic Agents|adrenergic agents|mesh-ancestor
25839656|NCT00025792|Pramipexole|pramipexole|mesh-list
25839657|NCT00025792|Antioxidants|antioxidants|mesh-ancestor
25839658|NCT00025792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839659|NCT00025792|Protective Agents|protective agents|mesh-ancestor
25839660|NCT00025792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839661|NCT00025792|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25839662|NCT00025792|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25163320|NCT02896829|Imatinib Mesylate|imatinib mesylate|mesh-list
25163321|NCT02896829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163322|NCT02896829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25163323|NCT02896829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163324|NCT02896829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163325|NCT02896842|Imatinib Mesylate|imatinib mesylate|mesh-list
25839663|NCT00025792|Dopamine Agonists|dopamine agonists|mesh-ancestor
25839664|NCT00025792|Dopamine Agents|dopamine agents|mesh-ancestor
25839665|NCT00025792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25839666|NCT00026039|Estrogens|estrogens|mesh-list
25839667|NCT00026039|Hormones|hormones|mesh-ancestor
24860925|NCT02313922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24860926|NCT02313922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24860927|NCT02313922|Immunologic Factors|immunologic factors|mesh-ancestor
24860928|NCT02313922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24860929|NCT02313922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24860930|NCT02313922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25839668|NCT00026039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25839669|NCT00026039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839670|NCT00026052|Riluzole|riluzole|mesh-list
25839671|NCT00026052|Anticonvulsants|anticonvulsants|mesh-ancestor
25839672|NCT00026052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25839673|NCT00026052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25839674|NCT00026052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25839675|NCT00026052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839676|NCT00026052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839677|NCT00026052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25839678|NCT00026052|Protective Agents|protective agents|mesh-ancestor
25839679|NCT00026078|Docetaxel|docetaxel|mesh-list
25839680|NCT00026078|Ifosfamide|ifosfamide|mesh-list
25839681|NCT00026078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839682|NCT00026078|Tubulin Modulators|tubulin modulators|mesh-ancestor
25839683|NCT00026078|Antimitotic Agents|antimitotic agents|mesh-ancestor
25839684|NCT00026078|Mitosis Modulators|mitosis modulators|mesh-ancestor
25839685|NCT00026078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839686|NCT00026078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25839687|NCT00026078|Alkylating Agents|alkylating agents|mesh-ancestor
25839688|NCT00026091|Fenretinide|fenretinide|mesh-list
25839689|NCT00026091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839690|NCT00026091|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25839691|NCT00026091|Protective Agents|protective agents|mesh-ancestor
25839692|NCT00026091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839693|NCT00026104|Gemcitabine|gemcitabine|mesh-list
25659719|NCT01610687|Nabiximols|nabiximols|mesh-list
25659720|NCT01610687|Analgesics|analgesics|mesh-ancestor
25659721|NCT01610687|Sensory System Agents|sensory system agents|mesh-ancestor
25659722|NCT01610687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25659723|NCT01610687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659724|NCT01610700|Nabiximols|nabiximols|mesh-list
25659725|NCT01610700|Analgesics|analgesics|mesh-ancestor
25659726|NCT01610700|Sensory System Agents|sensory system agents|mesh-ancestor
25839694|NCT00026104|Paclitaxel|paclitaxel|mesh-list
24541260|NCT00671697|Antimetabolites|antimetabolites|mesh-ancestor
24860953|NCT02314182|Growth Inhibitors|growth inhibitors|mesh-ancestor
24860954|NCT02314182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24860955|NCT02314182|Antimetabolites|antimetabolites|mesh-ancestor
24860956|NCT02314182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860957|NCT02314182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24860958|NCT02314182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24860959|NCT02314182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860960|NCT02314195|Serotonin|serotonin|mesh-list
24860961|NCT02314195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25839695|NCT00026104|Tipifarnib|tipifarnib|mesh-list
25839696|NCT00026104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25839697|NCT00026104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24933553|NCT04069208|Antimetabolites|antimetabolites|mesh-ancestor
25163326|NCT02896842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163327|NCT02896842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24860977|NCT02314208|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24860978|NCT02314208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860979|NCT02314208|Antioxidants|antioxidants|mesh-ancestor
24860980|NCT02314208|Protective Agents|protective agents|mesh-ancestor
24860981|NCT02314208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860982|NCT02314208|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24860983|NCT02314208|Cathartics|cathartics|mesh-ancestor
24860984|NCT02314208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24860985|NCT02314273|Oprelvekin|oprelvekin|mesh-list
24860986|NCT02314273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541277|NCT00671801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24541278|NCT00671801|Growth Substances|growth substances|mesh-ancestor
24541279|NCT00671801|Growth Inhibitors|growth inhibitors|mesh-ancestor
24541280|NCT00671814|Linezolid|linezolid|mesh-list
24541281|NCT00671814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24541285|NCT00671814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541286|NCT00672022|Miglustat|miglustat|mesh-list
24541287|NCT00672022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541288|NCT00672022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541289|NCT00672022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24541290|NCT00672022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24541291|NCT00672022|Antiviral Agents|antiviral agents|mesh-ancestor
24541292|NCT00672022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24541293|NCT00672022|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24541294|NCT00672022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24541295|NCT00672022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839698|NCT00026104|Tubulin Modulators|tubulin modulators|mesh-ancestor
25839699|NCT00026104|Antimitotic Agents|antimitotic agents|mesh-ancestor
24451407|NCT00323583|Antimitotic Agents|antimitotic agents|mesh-ancestor
24451408|NCT00323583|Mitosis Modulators|mitosis modulators|mesh-ancestor
25839700|NCT00026104|Mitosis Modulators|mitosis modulators|mesh-ancestor
25839701|NCT00026104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451426|NCT00323687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608987|NCT00994734|Contraceptive Agents|contraceptive agents|mesh-ancestor
24608989|NCT00994734|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24608990|NCT00994734|Hormone Antagonists|hormone antagonists|mesh-ancestor
24608991|NCT00994734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24608992|NCT00994734|Luteolytic Agents|luteolytic agents|mesh-ancestor
24608993|NCT00994734|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24608994|NCT00994734|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24623228|NCT01070680|Analgesics|analgesics|mesh-ancestor
24541297|NCT00672113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24933692|NCT04068506|Antimanic Agents|antimanic agents|mesh-ancestor
24860999|NCT02314312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24861000|NCT02314312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861001|NCT02314312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24861002|NCT02314312|Immunologic Factors|immunologic factors|mesh-ancestor
24861003|NCT02314312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839702|NCT00026104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25839703|NCT00026104|Antimetabolites|antimetabolites|mesh-ancestor
25839704|NCT00026104|Antiviral Agents|antiviral agents|mesh-ancestor
25839705|NCT00026104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25839706|NCT00026104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839707|NCT00026104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24861016|NCT02314325|Coagulants|coagulants|mesh-ancestor
24861027|NCT02314351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24861028|NCT02314351|Anesthetics, General|anesthetics, general|mesh-ancestor
24861030|NCT02314351|Antiemetics|antiemetics|mesh-ancestor
25839708|NCT00026104|Immunologic Factors|immunologic factors|mesh-ancestor
24861031|NCT02314351|Autonomic Agents|autonomic agents|mesh-ancestor
24541328|NCT00672347|Morphine|morphine|mesh-list
24541329|NCT00672347|Bupivacaine|bupivacaine|mesh-list
24541330|NCT00672347|Anesthetics, Local|anesthetics, local|mesh-ancestor
24541331|NCT00672347|Anesthetics|anesthetics|mesh-ancestor
24541332|NCT00672347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25839709|NCT00026104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839710|NCT00026130|Gemcitabine|gemcitabine|mesh-list
25839711|NCT00026130|Fluorouracil|fluorouracil|mesh-list
25839712|NCT00026130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24861032|NCT02314351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24861033|NCT02314351|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24861034|NCT02314351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24861036|NCT02314351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24861037|NCT02314351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861038|NCT02314377|Bevacizumab|bevacizumab|mesh-list
24541342|NCT00672347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24541343|NCT00672347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24541344|NCT00672347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24541345|NCT00672347|Adrenergic Agents|adrenergic agents|mesh-ancestor
24541346|NCT00672347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24541347|NCT00672347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839713|NCT00026130|Antimetabolites|antimetabolites|mesh-ancestor
25839714|NCT00026130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839715|NCT00026130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861052|NCT02314481|Atezolizumab|atezolizumab|mesh-list
24861053|NCT02314481|Vemurafenib|vemurafenib|mesh-list
24861054|NCT02314481|Maytansine|maytansine|mesh-list
24861055|NCT02314481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24861056|NCT02314481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861057|NCT02314481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24861058|NCT02314481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24861059|NCT02314481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861060|NCT02314481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24861061|NCT02314481|Tubulin Modulators|tubulin modulators|mesh-ancestor
24861062|NCT02314481|Antimitotic Agents|antimitotic agents|mesh-ancestor
24861063|NCT02314481|Mitosis Modulators|mitosis modulators|mesh-ancestor
24861064|NCT02314533|Fenofibrate|fenofibrate|mesh-list
24861065|NCT02314533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24861066|NCT02314533|Antimetabolites|antimetabolites|mesh-ancestor
24450810|NCT00320632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541349|NCT00672360|Hematinics|hematinics|mesh-ancestor
24541350|NCT00672360|Vitamin B Complex|vitamin b complex|mesh-ancestor
24541351|NCT00672360|Vitamins|vitamins|mesh-ancestor
24541354|NCT00672399|Exenatide|exenatide|mesh-list
24541381|NCT00672464|Antiemetics|antiemetics|mesh-ancestor
25041416|NCT02539537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25041417|NCT02539537|Antimetabolites|antimetabolites|mesh-ancestor
25041418|NCT02539537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839716|NCT00026130|Antiviral Agents|antiviral agents|mesh-ancestor
24861078|NCT02314754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24861079|NCT02314754|Abortifacient Agents|abortifacient agents|mesh-ancestor
24861080|NCT02314754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24861081|NCT02314754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861082|NCT02314754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24861083|NCT02314754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24861084|NCT02314754|Oxytocics|oxytocics|mesh-ancestor
24861085|NCT02314754|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24861086|NCT02314754|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24861087|NCT02314754|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24861088|NCT02314754|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24861089|NCT02314754|Contraceptive Agents|contraceptive agents|mesh-ancestor
24861096|NCT02314754|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24861098|NCT02314806|Clindamycin palmitate|clindamycin palmitate|mesh-list
24936664|NCT04037774|Analgesics|analgesics|mesh-ancestor
24861099|NCT02314806|Clindamycin phosphate|clindamycin phosphate|mesh-list
24541400|NCT00672659|Dexetimide|dexetimide|mesh-list
25839717|NCT00026130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25839718|NCT00026130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839719|NCT00026130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25839720|NCT00026130|Immunologic Factors|immunologic factors|mesh-ancestor
25839721|NCT00026130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839722|NCT00026143|Interferons|interferons|mesh-list
25839723|NCT00026143|Interferon-alpha|interferon-alpha|mesh-list
25839724|NCT00026143|Interferon alpha-2|interferon alpha-2|mesh-list
25839725|NCT00026143|Interleukin-12|interleukin-12|mesh-list
25839726|NCT00026143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839729|NCT00026143|Immunologic Factors|immunologic factors|mesh-ancestor
25839730|NCT00026143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839731|NCT00026143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25839732|NCT00026143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25839733|NCT00026143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25839734|NCT00026143|Growth Substances|growth substances|mesh-ancestor
25839735|NCT00026143|Growth Inhibitors|growth inhibitors|mesh-ancestor
25839736|NCT00026156|Docetaxel|docetaxel|mesh-list
25839737|NCT00026156|Vinorelbine|vinorelbine|mesh-list
25839738|NCT00026156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839739|NCT00026156|Tubulin Modulators|tubulin modulators|mesh-ancestor
25839740|NCT00026156|Antimitotic Agents|antimitotic agents|mesh-ancestor
25839741|NCT00026156|Mitosis Modulators|mitosis modulators|mesh-ancestor
25839742|NCT00026156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839743|NCT00026156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25839744|NCT00026169|Imatinib Mesylate|imatinib mesylate|mesh-list
25839745|NCT00026169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839746|NCT00026169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25839747|NCT00026169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839748|NCT00026169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839749|NCT00026182|Rituximab|rituximab|mesh-list
25839750|NCT00026182|Interleukin-12|interleukin-12|mesh-list
25839751|NCT00026182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25839752|NCT00026182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861100|NCT02314806|Gentamicins|gentamicins|mesh-list
25163328|NCT02896842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163329|NCT02896842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163330|NCT02896803|Fluorouracil|fluorouracil|mesh-list
25839753|NCT00026182|Immunologic Factors|immunologic factors|mesh-ancestor
25839754|NCT00026182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839755|NCT00026182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25839756|NCT00026182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25839757|NCT00026182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25839758|NCT00026182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25839759|NCT00026182|Growth Substances|growth substances|mesh-ancestor
25839760|NCT00026182|Growth Inhibitors|growth inhibitors|mesh-ancestor
25839761|NCT00026195|Irinotecan|irinotecan|mesh-list
25839762|NCT00026195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25839763|NCT00026195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25839764|NCT00026195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839765|NCT00026195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839766|NCT00026195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839767|NCT00026234|Dexamethasone|dexamethasone|mesh-list
25839768|NCT00026234|Capecitabine|capecitabine|mesh-list
25839769|NCT00026234|Oxaliplatin|oxaliplatin|mesh-list
25839770|NCT00026234|Floxuridine|floxuridine|mesh-list
25839771|NCT00026234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25839772|NCT00026234|Antiemetics|antiemetics|mesh-ancestor
25839773|NCT00026234|Autonomic Agents|autonomic agents|mesh-ancestor
25839774|NCT00026234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25839775|NCT00026234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839776|NCT00026234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25839777|NCT00026234|Glucocorticoids|glucocorticoids|mesh-ancestor
24999061|NCT05312762|Chelating Agents|chelating agents|mesh-ancestor
25839778|NCT00026234|Hormones|hormones|mesh-ancestor
25839779|NCT00026234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24656214|NCT01260610|Tenofovir|tenofovir|mesh-list
25839780|NCT00026234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25839781|NCT00026234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839782|NCT00026234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25839783|NCT00026234|Antimetabolites|antimetabolites|mesh-ancestor
25839784|NCT00026234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839785|NCT00026260|Semaxinib|semaxinib|mesh-list
25839786|NCT00026260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24541416|NCT00672659|Autonomic Agents|autonomic agents|mesh-ancestor
24541417|NCT00672659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24541418|NCT00672659|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25839787|NCT00026260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25839788|NCT00026260|Growth Substances|growth substances|mesh-ancestor
25839789|NCT00026260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839790|NCT00026260|Growth Inhibitors|growth inhibitors|mesh-ancestor
25059368|NCT03488810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059369|NCT03488810|Hormone Antagonists|hormone antagonists|mesh-ancestor
25059370|NCT03488719|Metoprolol|metoprolol|mesh-list
25059371|NCT03488719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25059372|NCT03488719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25059373|NCT03488719|Sympatholytics|sympatholytics|mesh-ancestor
25059374|NCT03488719|Autonomic Agents|autonomic agents|mesh-ancestor
25059375|NCT03488719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24821596|NCT02106767|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24821597|NCT02106767|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24821598|NCT02106767|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25839791|NCT00026260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839792|NCT00026260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25839793|NCT00026260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839794|NCT00026260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839795|NCT00026273|Leucovorin|leucovorin|mesh-list
25839796|NCT00026273|Fluorouracil|fluorouracil|mesh-list
25839797|NCT00026273|Irinotecan|irinotecan|mesh-list
25839798|NCT00026273|Calcium|calcium|mesh-list
25839799|NCT00026273|Levoleucovorin|levoleucovorin|mesh-list
25839800|NCT00026273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25839801|NCT00026273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839802|NCT00026273|Antimetabolites|antimetabolites|mesh-ancestor
25839803|NCT00026273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839804|NCT00026273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25839805|NCT00026273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839806|NCT00026273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24542848|NCT00680511|Adrenergic Agents|adrenergic agents|mesh-ancestor
25839807|NCT00026273|Immunologic Factors|immunologic factors|mesh-ancestor
25839808|NCT00026273|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25839809|NCT00026273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25839810|NCT00026273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839811|NCT00026273|Antidotes|antidotes|mesh-ancestor
25839812|NCT00026273|Protective Agents|protective agents|mesh-ancestor
25839813|NCT00026273|Vitamin B Complex|vitamin b complex|mesh-ancestor
25839814|NCT00026273|Vitamins|vitamins|mesh-ancestor
25839815|NCT00026273|Micronutrients|micronutrients|mesh-ancestor
25839816|NCT00026286|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24861115|NCT02314871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24861117|NCT02315001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24861118|NCT02315001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861119|NCT02315001|Incretins|incretins|mesh-ancestor
24861120|NCT02315001|Hormones|hormones|mesh-ancestor
24861121|NCT02315001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24861122|NCT02315118|Rituximab|rituximab|mesh-list
24861123|NCT02315118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24861124|NCT02315118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861125|NCT02315118|Immunologic Factors|immunologic factors|mesh-ancestor
25839817|NCT00026286|Medroxyprogesterone|medroxyprogesterone|mesh-list
25839818|NCT00026286|Estrogens|estrogens|mesh-list
25839819|NCT00026286|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25839820|NCT00026286|Hormones|hormones|mesh-ancestor
25839821|NCT00026286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25839822|NCT00026286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839823|NCT00026286|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25839824|NCT00026286|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25839825|NCT00026286|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25839826|NCT00026286|Contraceptive Agents|contraceptive agents|mesh-ancestor
25839827|NCT00026286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25839828|NCT00026286|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25839829|NCT00026286|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25839830|NCT00026286|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25839831|NCT00026286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25839832|NCT00026286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659727|NCT01610700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25659728|NCT01610700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659729|NCT01610713|Nabiximols|nabiximols|mesh-list
25659730|NCT01610713|Analgesics|analgesics|mesh-ancestor
25659731|NCT01610713|Sensory System Agents|sensory system agents|mesh-ancestor
25659732|NCT01610713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25659733|NCT01610713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659734|NCT01611090|Rituximab|rituximab|mesh-list
25659735|NCT01611090|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25659736|NCT01611090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25839833|NCT00026299|Oxaliplatin|oxaliplatin|mesh-list
25839834|NCT00026299|Gefitinib|gefitinib|mesh-list
25839835|NCT00026299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839836|NCT00026299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25839837|NCT00026299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839838|NCT00026299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839839|NCT00026338|Gemcitabine|gemcitabine|mesh-list
25839840|NCT00026338|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25839841|NCT00026338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25839842|NCT00026338|Antimetabolites|antimetabolites|mesh-ancestor
25839843|NCT00026338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839844|NCT00026338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839845|NCT00026338|Antiviral Agents|antiviral agents|mesh-ancestor
25839846|NCT00026338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25839847|NCT00026338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839848|NCT00026338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25839849|NCT00026338|Immunologic Factors|immunologic factors|mesh-ancestor
25839850|NCT00026338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839851|NCT00026338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24861139|NCT02315196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861140|NCT02315196|Tubulin Modulators|tubulin modulators|mesh-ancestor
24861143|NCT02315196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861144|NCT02315196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24861145|NCT02315196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24861148|NCT02315287|Pioglitazone|pioglitazone|mesh-list
24999596|NCT03831295|Antibodies|antibodies|mesh-list
24861149|NCT02315287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24861150|NCT02315287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861151|NCT02315391|Glycine|glycine|mesh-list
24861152|NCT02315391|Glycine Agents|glycine agents|mesh-ancestor
24861153|NCT02315391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24861154|NCT02315391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861155|NCT02315391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861156|NCT02315495|Saxagliptin|saxagliptin|mesh-list
24861157|NCT02315495|Acarbose|acarbose|mesh-list
24861158|NCT02315495|Incretins|incretins|mesh-ancestor
24861159|NCT02315495|Hormones|hormones|mesh-ancestor
24541449|NCT00672867|Adefovir|adefovir|mesh-list
24541450|NCT00672867|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
24541451|NCT00672867|Clevudine|clevudine|mesh-list
24541452|NCT00672867|Antiviral Agents|antiviral agents|mesh-ancestor
24541453|NCT00672867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24541454|NCT00672867|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24541455|NCT00672867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24541456|NCT00672867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541457|NCT00672867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541458|NCT00672919|Pioglitazone|pioglitazone|mesh-list
24541459|NCT00672919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25839852|NCT00026351|Rituximab|rituximab|mesh-list
25839853|NCT00026351|Pentostatin|pentostatin|mesh-list
24451431|NCT00323687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24861160|NCT02315495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24861161|NCT02315495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839854|NCT00026351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25839855|NCT00026351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839856|NCT00026351|Immunologic Factors|immunologic factors|mesh-ancestor
25839857|NCT00026351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839858|NCT00026351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25839859|NCT00026351|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25839860|NCT00026351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839861|NCT00026351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861169|NCT02315547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24861170|NCT02315573|Lidocaine|lidocaine|mesh-list
24861171|NCT02315573|Epinephrine|epinephrine|mesh-list
24861172|NCT02315573|Racepinephrine|racepinephrine|mesh-list
24861173|NCT02315573|Bupivacaine|bupivacaine|mesh-list
24861174|NCT02315573|Epinephryl borate|epinephryl borate|mesh-list
24861175|NCT02315573|Anesthetics, Local|anesthetics, local|mesh-ancestor
24541470|NCT00673088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541471|NCT00673088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541472|NCT00673205|Bicalutamide|bicalutamide|mesh-list
24541473|NCT00673205|Androgen Antagonists|androgen antagonists|mesh-ancestor
24541474|NCT00673205|Hormone Antagonists|hormone antagonists|mesh-ancestor
24541520|NCT00673556|Immunologic Factors|immunologic factors|mesh-ancestor
24541475|NCT00673205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24541476|NCT00673205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541477|NCT00673205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623484|NCT01071694|Antiviral Agents|antiviral agents|mesh-ancestor
25839863|NCT00026364|Fluorouracil|fluorouracil|mesh-list
25839864|NCT00026364|Irinotecan|irinotecan|mesh-list
25839865|NCT00026364|Gefitinib|gefitinib|mesh-list
25839866|NCT00026364|Calcium|calcium|mesh-list
25839867|NCT00026364|Levoleucovorin|levoleucovorin|mesh-list
24861189|NCT02315573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24861190|NCT02315573|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24861191|NCT02315573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24861192|NCT02315573|Autonomic Agents|autonomic agents|mesh-ancestor
24861193|NCT02315573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24861194|NCT02315573|Respiratory System Agents|respiratory system agents|mesh-ancestor
24861195|NCT02315573|Mydriatics|mydriatics|mesh-ancestor
24541492|NCT00673296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24541494|NCT00673296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541495|NCT00673296|Growth Inhibitors|growth inhibitors|mesh-ancestor
25839868|NCT00026364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25839869|NCT00026364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839870|NCT00026364|Antimetabolites|antimetabolites|mesh-ancestor
25839871|NCT00026364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839872|NCT00026364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25839873|NCT00026364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861196|NCT02315573|Sympathomimetics|sympathomimetics|mesh-ancestor
24861197|NCT02315573|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24861199|NCT02315651|Coenzyme Q10|coenzyme q10|mesh-list
24861200|NCT02315651|Micronutrients|micronutrients|mesh-ancestor
24934386|NCT04062006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24861222|NCT02316197|Peposertib|peposertib|mesh-list
24861223|NCT02316197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24541502|NCT00673504|Sunitinib|sunitinib|mesh-list
24541503|NCT00673504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24541504|NCT00673504|Antimetabolites|antimetabolites|mesh-ancestor
24541505|NCT00673504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541506|NCT00673504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839874|NCT00026364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25839875|NCT00026364|Immunologic Factors|immunologic factors|mesh-ancestor
25839876|NCT00026364|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25839877|NCT00026364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25839878|NCT00026364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839879|NCT00026364|Antidotes|antidotes|mesh-ancestor
25839880|NCT00026364|Protective Agents|protective agents|mesh-ancestor
25839881|NCT00026364|Vitamin B Complex|vitamin b complex|mesh-ancestor
25839882|NCT00026364|Vitamins|vitamins|mesh-ancestor
25839883|NCT00026364|Micronutrients|micronutrients|mesh-ancestor
25839884|NCT00026364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25839885|NCT00026377|Leuprolide|leuprolide|mesh-list
25839886|NCT00026377|Goserelin|goserelin|mesh-list
25839887|NCT00026377|Flutamide|flutamide|mesh-list
25839888|NCT00026377|Bicalutamide|bicalutamide|mesh-list
25839889|NCT00026377|Semaxinib|semaxinib|mesh-list
25839890|NCT00026377|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25839891|NCT00026377|Fertility Agents|fertility agents|mesh-ancestor
25839892|NCT00026377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25839893|NCT00026377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861236|NCT02316301|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24861237|NCT02316301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24861238|NCT02316301|Oxytocics|oxytocics|mesh-ancestor
24861239|NCT02316327|Gemcitabine|gemcitabine|mesh-list
24861240|NCT02316327|Bevacizumab|bevacizumab|mesh-list
24541512|NCT00673504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541513|NCT00673504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24541514|NCT00673504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24541515|NCT00673504|Growth Substances|growth substances|mesh-ancestor
24541516|NCT00673504|Growth Inhibitors|growth inhibitors|mesh-ancestor
24541517|NCT00673504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24541518|NCT00673556|Alefacept|alefacept|mesh-list
24541519|NCT00673556|Dermatologic Agents|dermatologic agents|mesh-ancestor
25839894|NCT00026377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25839895|NCT00026377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839896|NCT00026377|Androgen Antagonists|androgen antagonists|mesh-ancestor
25839897|NCT00026377|Hormone Antagonists|hormone antagonists|mesh-ancestor
25839898|NCT00026377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25839899|NCT00026377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25839900|NCT00026377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25839901|NCT00026377|Growth Substances|growth substances|mesh-ancestor
25839902|NCT00026377|Growth Inhibitors|growth inhibitors|mesh-ancestor
25839903|NCT00026377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25839904|NCT00026377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839905|NCT00026377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839906|NCT00026403|Gemcitabine|gemcitabine|mesh-list
25839908|NCT00026403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839909|NCT00026403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25839910|NCT00026403|Antimetabolites|antimetabolites|mesh-ancestor
25839911|NCT00026403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839912|NCT00026403|Antiviral Agents|antiviral agents|mesh-ancestor
25839913|NCT00026403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25839914|NCT00026403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839915|NCT00026403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25839916|NCT00026403|Immunologic Factors|immunologic factors|mesh-ancestor
25839917|NCT00026403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839918|NCT00026416|Interferons|interferons|mesh-list
25839919|NCT00026416|Interferon-alpha|interferon-alpha|mesh-list
25839920|NCT00026416|Thalidomide|thalidomide|mesh-list
25839921|NCT00026416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25839922|NCT00026416|Antiviral Agents|antiviral agents|mesh-ancestor
25839923|NCT00026416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24861247|NCT02316327|Growth Inhibitors|growth inhibitors|mesh-ancestor
25839924|NCT00026416|Immunologic Factors|immunologic factors|mesh-ancestor
25839925|NCT00026416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839926|NCT00026416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25839927|NCT00026416|Leprostatic Agents|leprostatic agents|mesh-ancestor
25839928|NCT00026416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25839929|NCT00026416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25839930|NCT00026416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25839931|NCT00026416|Growth Substances|growth substances|mesh-ancestor
25839932|NCT00026416|Growth Inhibitors|growth inhibitors|mesh-ancestor
25839933|NCT00026429|Denileukin diftitox|denileukin diftitox|mesh-list
25839934|NCT00026429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875620|NCT04263298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25875621|NCT04263298|Antimetabolites|antimetabolites|mesh-ancestor
25875622|NCT04263298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875623|NCT04263298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875624|NCT04263298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25875625|NCT04263298|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25875626|NCT04263298|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25875627|NCT04263298|Hormone Antagonists|hormone antagonists|mesh-ancestor
24861259|NCT02316340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24861260|NCT02316340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24861261|NCT02316340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24861262|NCT02316340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24861263|NCT02316340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861264|NCT02316340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24861265|NCT02316340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861266|NCT02316340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24541531|NCT00673582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541532|NCT00673582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24541533|NCT00673582|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24541534|NCT00673582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541535|NCT00673608|Deferasirox|deferasirox|mesh-list
24541536|NCT00673608|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24861268|NCT02316379|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24541537|NCT00673608|Chelating Agents|chelating agents|mesh-ancestor
24541538|NCT00673608|Sequestering Agents|sequestering agents|mesh-ancestor
24541539|NCT00673608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541540|NCT00673621|Albuterol|albuterol|mesh-list
24541541|NCT00673621|Methacholine Chloride|methacholine chloride|mesh-list
25875628|NCT04263298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25875629|NCT04263298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875630|NCT04256421|Carboplatin|carboplatin|mesh-list
25875631|NCT04256421|Etoposide|etoposide|mesh-list
25875632|NCT04256421|Atezolizumab|atezolizumab|mesh-list
25875633|NCT04256421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875634|NCT04256421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25875635|NCT04256421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25875636|NCT04256421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25875637|NCT04256421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875638|NCT04256421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875639|NCT04248829|Gefitinib|gefitinib|mesh-list
25875640|NCT04248829|Lazertinib|lazertinib|mesh-list
25875641|NCT04248829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875642|NCT04248829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24813342|NCT02057926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813343|NCT02057926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813344|NCT02057978|Chlorhexidine|chlorhexidine|mesh-list
24813345|NCT02057978|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24813346|NCT02057978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24813347|NCT02057978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24813348|NCT02057978|Disinfectants|disinfectants|mesh-ancestor
24813349|NCT02057978|Dermatologic Agents|dermatologic agents|mesh-ancestor
24656768|NCT01263951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656769|NCT01263951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24656770|NCT01263951|Immunologic Factors|immunologic factors|mesh-ancestor
25839945|NCT00026468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25839946|NCT00026468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25839947|NCT00026468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839948|NCT00026468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25839949|NCT00026468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25839950|NCT00026468|Analgesics|analgesics|mesh-ancestor
25839951|NCT00026468|Sensory System Agents|sensory system agents|mesh-ancestor
25839952|NCT00026468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25839953|NCT00026468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25839954|NCT00026468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25839955|NCT00026520|Interferons|interferons|mesh-list
25839956|NCT00026520|Interferon-alpha|interferon-alpha|mesh-list
25839957|NCT00026520|Thalidomide|thalidomide|mesh-list
25839958|NCT00026520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163333|NCT02896803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25839959|NCT00026520|Antiviral Agents|antiviral agents|mesh-ancestor
25839960|NCT00026520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25839961|NCT00026520|Immunologic Factors|immunologic factors|mesh-ancestor
25839962|NCT00026520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839963|NCT00026520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25839964|NCT00026520|Leprostatic Agents|leprostatic agents|mesh-ancestor
25839965|NCT00026520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25839966|NCT00026520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25839967|NCT00026520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25839968|NCT00026520|Growth Substances|growth substances|mesh-ancestor
25839969|NCT00026520|Growth Inhibitors|growth inhibitors|mesh-ancestor
25839970|NCT00026533|Thalidomide|thalidomide|mesh-list
25839971|NCT00026533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25839972|NCT00026533|Immunologic Factors|immunologic factors|mesh-ancestor
25839973|NCT00026533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839974|NCT00026533|Leprostatic Agents|leprostatic agents|mesh-ancestor
25839975|NCT00026533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25839976|NCT00026533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24813367|NCT02058173|Anthelmintics|anthelmintics|mesh-ancestor
24813368|NCT02058186|Vitamin D|vitamin d|mesh-list
24813369|NCT02058186|Vitamins|vitamins|mesh-ancestor
24813370|NCT02058186|Micronutrients|micronutrients|mesh-ancestor
24813371|NCT02058186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813372|NCT02058186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25049012|NCT00646542|Vildagliptin|vildagliptin|mesh-list
25414803|NCT03038100|Carboplatin|carboplatin|mesh-list
25659748|NCT01611155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659749|NCT01611155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25659750|NCT01611155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659751|NCT01611155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25659752|NCT01611155|Antidepressive Agents|antidepressive agents|mesh-ancestor
25659753|NCT01611155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25659754|NCT01611259|Rituximab|rituximab|mesh-list
25839993|NCT00026624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25839994|NCT00026624|Immunologic Factors|immunologic factors|mesh-ancestor
25839995|NCT00026624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25839996|NCT00026637|Sertraline|sertraline|mesh-list
24861319|NCT02316964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24861320|NCT02316964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861322|NCT02316964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24861324|NCT02316964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24861325|NCT02317146|Magnesium Sulfate|magnesium sulfate|mesh-list
24861326|NCT02317146|Analgesics|analgesics|mesh-ancestor
24541625|NCT00674167|Antimitotic Agents|antimitotic agents|mesh-ancestor
24804385|NCT02002260|Hormones|hormones|mesh-ancestor
24541626|NCT00674167|Mitosis Modulators|mitosis modulators|mesh-ancestor
24861332|NCT02317146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24861334|NCT02317146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25839997|NCT00026637|Antidepressive Agents|antidepressive agents|mesh-ancestor
25839998|NCT00026637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24861335|NCT02317146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24861336|NCT02317146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861337|NCT02317146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24861338|NCT02317146|Tocolytic Agents|tocolytic agents|mesh-ancestor
24861339|NCT02317146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24541636|NCT00674232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25163334|NCT02896803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25163335|NCT02896803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163336|NCT02896803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24541638|NCT00674245|Pantoprazole|pantoprazole|mesh-list
24541639|NCT00674245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25839999|NCT00026637|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24541640|NCT00674245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24541641|NCT00674245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24541642|NCT00674245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541643|NCT00674245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541644|NCT00674310|Ropinirole|ropinirole|mesh-list
24541645|NCT00674310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24541646|NCT00674310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24541647|NCT00674310|Dopamine Agonists|dopamine agonists|mesh-ancestor
24541648|NCT00674310|Dopamine Agents|dopamine agents|mesh-ancestor
25840000|NCT00026637|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24861340|NCT02317159|Imatinib Mesylate|imatinib mesylate|mesh-list
24861341|NCT02317159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541654|NCT00674414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24541655|NCT00674414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541656|NCT00674414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24541657|NCT00674414|Immunologic Factors|immunologic factors|mesh-ancestor
24541658|NCT00674414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861343|NCT02317159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24861344|NCT02317159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861345|NCT02317198|Clopidogrel|clopidogrel|mesh-list
24861346|NCT02317198|Ticagrelor|ticagrelor|mesh-list
24861347|NCT02317198|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24861348|NCT02317198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24861394|NCT02317419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24861395|NCT02317419|Antimetabolites|antimetabolites|mesh-ancestor
24861398|NCT02317419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24861399|NCT02317419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24861400|NCT02317419|Immunologic Factors|immunologic factors|mesh-ancestor
24861401|NCT02317419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861402|NCT02317471|Oxaliplatin|oxaliplatin|mesh-list
24861403|NCT02317471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935067|NCT04054960|Levodopa|levodopa|mesh-list
24861434|NCT02317640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861436|NCT02317679|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24861437|NCT02317679|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24935074|NCT04055194|Tranexamic Acid|tranexamic acid|mesh-list
24541700|NCT00674687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24542851|NCT00680511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25840001|NCT00026637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25840002|NCT00026637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840003|NCT00026637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25840004|NCT00026637|Serotonin Agents|serotonin agents|mesh-ancestor
25840005|NCT00026637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840010|NCT00026819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840011|NCT00026819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25840012|NCT00026819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25840013|NCT00026819|Analgesics|analgesics|mesh-ancestor
25840014|NCT00026819|Sensory System Agents|sensory system agents|mesh-ancestor
25840015|NCT00026819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25840016|NCT00026819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541705|NCT00674713|Antiemetics|antiemetics|mesh-ancestor
25163337|NCT02896803|Immunologic Factors|immunologic factors|mesh-ancestor
25163338|NCT02896803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541712|NCT00674713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24541713|NCT00674713|Serotonin Agents|serotonin agents|mesh-ancestor
25840017|NCT00026819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24861455|NCT02317861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24861456|NCT02317861|Uricosuric Agents|uricosuric agents|mesh-ancestor
24861457|NCT02317861|Renal Agents|renal agents|mesh-ancestor
24861458|NCT02318017|Methylphenidate|methylphenidate|mesh-list
24861459|NCT02318017|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24861460|NCT02318017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861461|NCT02318017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24861462|NCT02318017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24861529|NCT02318290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24861531|NCT02318433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24861532|NCT02318433|Antiemetics|antiemetics|mesh-ancestor
24861533|NCT02318433|Autonomic Agents|autonomic agents|mesh-ancestor
24861534|NCT02318433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24861535|NCT02318433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861536|NCT02318433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24861537|NCT02318433|Glucocorticoids|glucocorticoids|mesh-ancestor
24861538|NCT02318433|Hormones|hormones|mesh-ancestor
24861539|NCT02318433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24861540|NCT02318433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24861541|NCT02318433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861542|NCT02318446|Folic Acid|folic acid|mesh-list
24861575|NCT02318810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861576|NCT02318836|Lofexidine|lofexidine|mesh-list
24861577|NCT02318836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24861578|NCT02318836|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24861579|NCT02318836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861580|NCT02318836|Sensory System Agents|sensory system agents|mesh-ancestor
24861581|NCT02318836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24861582|NCT02318836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24861583|NCT02318836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24861584|NCT02318836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24861585|NCT02318836|Adrenergic Agents|adrenergic agents|mesh-ancestor
24861586|NCT02318836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24541745|NCT00674921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24861598|NCT02319018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24861599|NCT02319018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25003201|NCT03925532|Denosumab|denosumab|mesh-list
24861600|NCT02319018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24861603|NCT02319018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24861625|NCT02319135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24541771|NCT00675194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24541772|NCT00675194|Antimetabolites|antimetabolites|mesh-ancestor
24861627|NCT02319161|Calcium|calcium|mesh-list
24861648|NCT02319265|Antioxidants|antioxidants|mesh-ancestor
24861649|NCT02319265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861650|NCT02319265|Protective Agents|protective agents|mesh-ancestor
24861651|NCT02319265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861652|NCT02319265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24861756|NCT02319941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861757|NCT02319941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861758|NCT02320032|Aripiprazole|aripiprazole|mesh-list
24861759|NCT02320032|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
24861760|NCT02320032|Antidepressive Agents|antidepressive agents|mesh-ancestor
24541813|NCT00675285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25414804|NCT03038100|Atezolizumab|atezolizumab|mesh-list
25659755|NCT01611259|Lenalidomide|lenalidomide|mesh-list
25659756|NCT01611259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25659757|NCT01611259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659758|NCT01611259|Immunologic Factors|immunologic factors|mesh-ancestor
25659759|NCT01611259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659760|NCT01611259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25659761|NCT01611259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24509678|NCT00561587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24509679|NCT00561587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509700|NCT00561717|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24509701|NCT00561717|Histamine Antagonists|histamine antagonists|mesh-ancestor
24509702|NCT00561717|Histamine Agents|histamine agents|mesh-ancestor
24509703|NCT00561717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24509704|NCT00561717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509705|NCT00561717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509706|NCT00561717|Antipruritics|antipruritics|mesh-ancestor
24509707|NCT00561717|Dermatologic Agents|dermatologic agents|mesh-ancestor
24509709|NCT00561717|Autonomic Agents|autonomic agents|mesh-ancestor
24861794|NCT02320240|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24861795|NCT02320240|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24861796|NCT02320240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24813408|NCT02058433|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24813409|NCT02058433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24813410|NCT02058433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813411|NCT02058433|Tubulin Modulators|tubulin modulators|mesh-ancestor
24813412|NCT02058433|Antimitotic Agents|antimitotic agents|mesh-ancestor
24813413|NCT02058433|Mitosis Modulators|mitosis modulators|mesh-ancestor
24813414|NCT02058433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813416|NCT02058446|Valsartan|valsartan|mesh-list
24813417|NCT02058446|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
24813418|NCT02058446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24813419|NCT02058446|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24813420|NCT02058446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24683522|NCT01392755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24861851|NCT02320604|Antifungal Agents|antifungal agents|mesh-ancestor
24861857|NCT02320734|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24861858|NCT02320734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24861859|NCT02320734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24861860|NCT02320734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861862|NCT02320773|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24861863|NCT02320773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24861864|NCT02320773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24861865|NCT02320773|Adrenergic Agents|adrenergic agents|mesh-ancestor
24861866|NCT02320773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24861867|NCT02320773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861868|NCT02320773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861869|NCT02320773|Urological Agents|urological agents|mesh-ancestor
24861870|NCT02320877|Methaqualone|methaqualone|mesh-list
24861871|NCT02320877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24861872|NCT02320877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24861873|NCT02320877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861874|NCT02321176|Resveratrol|resveratrol|mesh-list
24861887|NCT02321241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861888|NCT02321267|Ranibizumab|ranibizumab|mesh-list
25659762|NCT01611259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25659763|NCT01611259|Growth Substances|growth substances|mesh-ancestor
25659764|NCT01611259|Growth Inhibitors|growth inhibitors|mesh-ancestor
25659765|NCT01611298|Vaccines|vaccines|mesh-list
25659766|NCT01611298|Immunologic Factors|immunologic factors|mesh-ancestor
25659767|NCT01611298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659768|NCT01611558|Ipilimumab|ipilimumab|mesh-list
25659769|NCT01611558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25659770|NCT01611558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659771|NCT01611558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25659772|NCT01611558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659773|NCT01611571|Teriparatide|teriparatide|mesh-list
25659774|NCT01611571|Risedronic Acid|risedronic acid|mesh-list
25659775|NCT01611571|Etidronic Acid|etidronic acid|mesh-list
25659776|NCT01611571|Parathyroid Hormone|parathyroid hormone|mesh-list
25659777|NCT01611571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24509756|NCT00562055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25840046|NCT00027040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840047|NCT00027040|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25840048|NCT00027040|Protective Agents|protective agents|mesh-ancestor
25840049|NCT00027040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840051|NCT00027053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24456320|NCT00330902|Antimalarials|antimalarials|mesh-ancestor
24861914|NCT02321293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541843|NCT00675688|Estrogens|estrogens|mesh-list
24541844|NCT00675688|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25659778|NCT01611571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659779|NCT01611571|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25659780|NCT01611571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25659781|NCT01611571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25659782|NCT01611571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659783|NCT01611662|Gemcitabine|gemcitabine|mesh-list
25659784|NCT01611662|Cisplatin|cisplatin|mesh-list
25659785|NCT01611662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659786|NCT01611662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25659787|NCT01611662|Antimetabolites|antimetabolites|mesh-ancestor
25659788|NCT01611662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659789|NCT01611662|Antiviral Agents|antiviral agents|mesh-ancestor
25659790|NCT01611662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25659791|NCT01611662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25659792|NCT01611662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25659793|NCT01611662|Immunologic Factors|immunologic factors|mesh-ancestor
25659794|NCT01611662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659795|NCT01611857|Leucovorin|leucovorin|mesh-list
24541859|NCT00675701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861930|NCT02321384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24861931|NCT02321384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24861932|NCT02321384|Anesthetics, General|anesthetics, general|mesh-ancestor
24861934|NCT02321384|GABA Modulators|gaba modulators|mesh-ancestor
24861935|NCT02321384|GABA Agents|gaba agents|mesh-ancestor
24861936|NCT02321384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24861937|NCT02321384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861938|NCT02321384|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24861939|NCT02321384|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24861940|NCT02321384|Protease Inhibitors|protease inhibitors|mesh-ancestor
24861941|NCT02321384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840052|NCT00027053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25840053|NCT00027053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25840054|NCT00027053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840055|NCT00027053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25840056|NCT00027053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25840057|NCT00027053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25840058|NCT00027053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24541893|NCT00675714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24541894|NCT00675714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24861960|NCT02321501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861961|NCT02321501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24861962|NCT02321501|Immunologic Factors|immunologic factors|mesh-ancestor
24861963|NCT02321501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861964|NCT02321501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24861965|NCT02321501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24861966|NCT02321501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861968|NCT02321579|Pyridoxal|pyridoxal|mesh-list
24861969|NCT02321579|Pyridoxine|pyridoxine|mesh-list
24862009|NCT02322008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24862010|NCT02322008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24862011|NCT02322008|Dermatologic Agents|dermatologic agents|mesh-ancestor
24862012|NCT02322008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24862013|NCT02322203|Niacin|niacin|mesh-list
24862015|NCT02322203|Nicotinic Acids|nicotinic acids|mesh-list
24862016|NCT02322203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24862017|NCT02322203|Antimetabolites|antimetabolites|mesh-ancestor
24862018|NCT02322203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163340|NCT02897037|Bivalirudin|bivalirudin|mesh-list
25840059|NCT00027053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541915|NCT00675779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541916|NCT00675779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24541917|NCT00675779|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24541918|NCT00675779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541919|NCT00675779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24541920|NCT00675779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541921|NCT00675779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24862042|NCT02322502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24862043|NCT02322502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24862044|NCT02322502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862045|NCT02322502|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24862046|NCT02322502|Anesthetics, General|anesthetics, general|mesh-ancestor
24862047|NCT02322502|Anesthetics|anesthetics|mesh-ancestor
24862048|NCT02322502|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24862049|NCT02322502|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24862050|NCT02322580|Etanercept|etanercept|mesh-list
24862051|NCT02322580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24862052|NCT02322580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24862053|NCT02322580|Analgesics|analgesics|mesh-ancestor
24862054|NCT02322580|Sensory System Agents|sensory system agents|mesh-ancestor
24862055|NCT02322580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24862056|NCT02322580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862057|NCT02322580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25840060|NCT00027053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25659796|NCT01611857|Fluorouracil|fluorouracil|mesh-list
24813439|NCT02058485|Adrenergic Agents|adrenergic agents|mesh-ancestor
24813440|NCT02058485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24813441|NCT02058485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813442|NCT02058485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24813443|NCT02058485|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24541962|NCT00676117|Sensory System Agents|sensory system agents|mesh-ancestor
24813454|NCT02058576|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24813455|NCT02058576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24813456|NCT02058576|Adrenergic Agents|adrenergic agents|mesh-ancestor
24813457|NCT02058576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24813458|NCT02058576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004322|NCT02059499|Imiquimod|imiquimod|mesh-list
24813459|NCT02058576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163341|NCT02897037|Anticoagulants|anticoagulants|mesh-ancestor
25163342|NCT02897037|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24813476|NCT02058667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813477|NCT02058693|Amphetamine|amphetamine|mesh-list
24813478|NCT02058693|Adderall|adderall|mesh-list
24813479|NCT02058693|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24813480|NCT02058693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813481|NCT02058693|Sympathomimetics|sympathomimetics|mesh-ancestor
24813482|NCT02058693|Autonomic Agents|autonomic agents|mesh-ancestor
25049599|NCT00580216|Antithrombins|antithrombins|mesh-ancestor
24813483|NCT02058693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24541979|NCT00676221|Antitubercular Agents|antitubercular agents|mesh-ancestor
24541980|NCT00676221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25414805|NCT03038100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25659797|NCT01611857|Oxaliplatin|oxaliplatin|mesh-list
25659798|NCT01611857|Levoleucovorin|levoleucovorin|mesh-list
25659799|NCT01611857|Antimetabolites|antimetabolites|mesh-ancestor
25659800|NCT01611857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850266|NCT02252497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850268|NCT02252497|Coagulants|coagulants|mesh-ancestor
24850269|NCT02252523|Dexmedetomidine|dexmedetomidine|mesh-list
24850272|NCT02252523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850273|NCT02252523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24850275|NCT02252523|Sensory System Agents|sensory system agents|mesh-ancestor
24850279|NCT02252523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25840074|NCT00027066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25840075|NCT00027066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25840080|NCT00027066|Antipyretics|antipyretics|mesh-ancestor
25840081|NCT00027066|Anticoagulants|anticoagulants|mesh-ancestor
25840082|NCT00027079|Naltrexone|naltrexone|mesh-list
25840083|NCT00027079|Ondansetron|ondansetron|mesh-list
25840084|NCT00027079|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25840085|NCT00027079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24850903|NCT02254187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24850904|NCT02254187|Respiratory System Agents|respiratory system agents|mesh-ancestor
24850905|NCT02254187|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24850906|NCT02254187|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24850907|NCT02254187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24850908|NCT02254187|Adrenergic Agents|adrenergic agents|mesh-ancestor
24850909|NCT02254187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24859052|NCT02301494|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24851016|NCT02254967|Vancomycin|vancomycin|mesh-list
24851017|NCT02254967|Fidaxomicin|fidaxomicin|mesh-list
24862263|NCT02324010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24862264|NCT02324010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862265|NCT02324088|Cyclophosphamide|cyclophosphamide|mesh-list
24862266|NCT02324088|Docetaxel|docetaxel|mesh-list
24862267|NCT02324088|Epirubicin|epirubicin|mesh-list
24862268|NCT02324088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24862269|NCT02324088|Immunologic Factors|immunologic factors|mesh-ancestor
24862270|NCT02324088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862271|NCT02324088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24862272|NCT02324088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25163344|NCT02897037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862273|NCT02324088|Alkylating Agents|alkylating agents|mesh-ancestor
24862274|NCT02324088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862275|NCT02324088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542115|NCT00676936|Protective Agents|protective agents|mesh-ancestor
24542116|NCT00676936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24542117|NCT00676936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542118|NCT00677001|R 306465|r 306465|mesh-list
24851018|NCT02254967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25840100|NCT00027079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24444834|NCT00299247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444835|NCT00299247|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25659804|NCT01611857|Immunologic Factors|immunologic factors|mesh-ancestor
25659805|NCT01611857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659806|NCT01611857|Antidotes|antidotes|mesh-ancestor
25659807|NCT01611857|Protective Agents|protective agents|mesh-ancestor
25659808|NCT01611857|Vitamin B Complex|vitamin b complex|mesh-ancestor
25659809|NCT01611857|Vitamins|vitamins|mesh-ancestor
25659810|NCT01611857|Micronutrients|micronutrients|mesh-ancestor
25659811|NCT01611935|Vasopressins|vasopressins|mesh-list
25840101|NCT00027079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25840102|NCT00027079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25840103|NCT00027248|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
25840104|NCT00027248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25840105|NCT00027287|Vitamin E|vitamin e|mesh-list
25840106|NCT00027287|Vitamins|vitamins|mesh-ancestor
25840107|NCT00027287|Micronutrients|micronutrients|mesh-ancestor
25840108|NCT00027287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542128|NCT00677118|Fluorouracil|fluorouracil|mesh-list
24542129|NCT00677118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840114|NCT00027300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659198|NCT01276093|Amiodarone|amiodarone|mesh-list
25840115|NCT00027339|Ritonavir|ritonavir|mesh-list
25163345|NCT02897037|Antithrombins|antithrombins|mesh-ancestor
25052386|NCT00298987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24862325|NCT02324413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24862327|NCT02324413|Adrenergic Agents|adrenergic agents|mesh-ancestor
24684082|NCT01395433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24862328|NCT02324413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24862329|NCT02324413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862332|NCT02324452|Antimetabolites|antimetabolites|mesh-ancestor
25659813|NCT01611935|Hemostatics|hemostatics|mesh-ancestor
25659814|NCT01611935|Coagulants|coagulants|mesh-ancestor
25659815|NCT01611935|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25659816|NCT01611935|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25840116|NCT00027339|Lopinavir|lopinavir|mesh-list
25840117|NCT00027339|Indinavir|indinavir|mesh-list
24862335|NCT02324452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840118|NCT00027339|Fosamprenavir|fosamprenavir|mesh-list
25840119|NCT00027339|Tenofovir|tenofovir|mesh-list
24542155|NCT00677261|Sensory System Agents|sensory system agents|mesh-ancestor
24542156|NCT00677261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24542157|NCT00677300|Ritonavir|ritonavir|mesh-list
24542158|NCT00677300|Darunavir|darunavir|mesh-list
24542159|NCT00677300|Tenofovir|tenofovir|mesh-list
24542160|NCT00677300|Emtricitabine|emtricitabine|mesh-list
24542161|NCT00677300|Raltegravir Potassium|raltegravir potassium|mesh-list
24542164|NCT00677300|Protease Inhibitors|protease inhibitors|mesh-ancestor
24862339|NCT02324491|CKD732|ckd732|mesh-list
24862340|NCT02324491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24862341|NCT02324491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24862342|NCT02324491|Growth Substances|growth substances|mesh-ancestor
24862343|NCT02324491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542168|NCT00677300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24542169|NCT00677300|Antiviral Agents|antiviral agents|mesh-ancestor
24542170|NCT00677300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24532362|NCT00639574|Nefopam|nefopam|mesh-list
24451671|NCT00324467|Histamine Antagonists|histamine antagonists|mesh-ancestor
24451672|NCT00324467|Histamine Agents|histamine agents|mesh-ancestor
24862346|NCT02324582|Pembrolizumab|pembrolizumab|mesh-list
24862347|NCT02324582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24862348|NCT02324582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24862349|NCT02324621|TIC10 compound|tic10 compound|mesh-list
24862350|NCT02324621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24862351|NCT02324686|Vitamin K|vitamin k|mesh-list
24862352|NCT02324686|Vitamin K 1|vitamin k 1|mesh-list
24862353|NCT02324686|Vitamins|vitamins|mesh-ancestor
24862354|NCT02324686|Micronutrients|micronutrients|mesh-ancestor
24862355|NCT02324686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862356|NCT02324686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24542175|NCT00677300|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24542176|NCT00677300|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25163346|NCT02897037|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25041419|NCT02539537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041420|NCT02539537|Antiviral Agents|antiviral agents|mesh-ancestor
25041421|NCT02539537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25041422|NCT02539537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041423|NCT02539537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25041424|NCT02539537|Immunologic Factors|immunologic factors|mesh-ancestor
25041425|NCT02539537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041426|NCT02539537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25041427|NCT02539537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25041428|NCT02539537|Antidotes|antidotes|mesh-ancestor
25041429|NCT02539537|Protective Agents|protective agents|mesh-ancestor
25041430|NCT02539537|Vitamin B Complex|vitamin b complex|mesh-ancestor
25041431|NCT02539537|Vitamins|vitamins|mesh-ancestor
25041432|NCT02539537|Micronutrients|micronutrients|mesh-ancestor
25041433|NCT02539537|Hematinics|hematinics|mesh-ancestor
25163347|NCT02897037|Protease Inhibitors|protease inhibitors|mesh-ancestor
25163348|NCT02897037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163349|NCT02897011|Methotrexate|methotrexate|mesh-list
25163350|NCT02897011|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25163351|NCT02897011|Abortifacient Agents|abortifacient agents|mesh-ancestor
25163352|NCT02897011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25163353|NCT02897011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862368|NCT02324933|Fentanyl|fentanyl|mesh-list
25840120|NCT00027339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25840121|NCT00027339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25840122|NCT00027339|Protease Inhibitors|protease inhibitors|mesh-ancestor
25840123|NCT00027339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840124|NCT00027339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840125|NCT00027339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25840126|NCT00027339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25840127|NCT00027339|Antiviral Agents|antiviral agents|mesh-ancestor
25840128|NCT00027339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25840129|NCT00027339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25840130|NCT00027339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25840131|NCT00027339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25840132|NCT00027339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25840133|NCT00027391|Albuterol|albuterol|mesh-list
25840134|NCT00027391|Oxandrolone|oxandrolone|mesh-list
25163360|NCT02897011|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25163361|NCT02897011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25163362|NCT02897011|Immunologic Factors|immunologic factors|mesh-ancestor
25163363|NCT02897011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25163364|NCT02897011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25163366|NCT02896621|Chlorthalidone|chlorthalidone|mesh-list
25163367|NCT02896621|Amiloride|amiloride|mesh-list
25163368|NCT02896621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25163369|NCT02896621|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25163370|NCT02896621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25163371|NCT02896621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163372|NCT02896621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25163373|NCT02896621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163374|NCT02896621|Vasodilator Agents|vasodilator agents|mesh-ancestor
25163375|NCT02896621|Diuretics|diuretics|mesh-ancestor
25163376|NCT02896621|Natriuretic Agents|natriuretic agents|mesh-ancestor
25163377|NCT02896621|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25163378|NCT02896621|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
25163379|NCT02896621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25163380|NCT02896621|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
25163381|NCT02896621|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25163382|NCT02896582|Cytarabine|cytarabine|mesh-list
25163383|NCT02896582|Dexamethasone|dexamethasone|mesh-list
25163384|NCT02896582|Etoposide|etoposide|mesh-list
25163385|NCT02896582|Melphalan|melphalan|mesh-list
25163386|NCT02896582|Cisplatin|cisplatin|mesh-list
25163387|NCT02896582|Obinutuzumab|obinutuzumab|mesh-list
25163388|NCT02896582|Carmustine|carmustine|mesh-list
25163389|NCT02896582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25163390|NCT02896582|Antiemetics|antiemetics|mesh-ancestor
25041434|NCT02527707|Ritonavir|ritonavir|mesh-list
25041435|NCT02527707|Lonafarnib|lonafarnib|mesh-list
25163391|NCT02896582|Autonomic Agents|autonomic agents|mesh-ancestor
25163394|NCT02896582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25163396|NCT02896582|Hormones|hormones|mesh-ancestor
25163397|NCT02896582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25163398|NCT02896582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25163399|NCT02896582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163400|NCT02896582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25163401|NCT02896582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25163402|NCT02896582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25163403|NCT02896582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163404|NCT02896582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163405|NCT02896582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24982380|NCT02889133|Dextrans|dextrans|mesh-list
24542177|NCT00677339|Vitamin D|vitamin d|mesh-list
24542178|NCT00677339|Ergocalciferols|ergocalciferols|mesh-list
24542179|NCT00677339|Cholecalciferol|cholecalciferol|mesh-list
24542180|NCT00677339|Vitamins|vitamins|mesh-list
24542181|NCT00677339|Micronutrients|micronutrients|mesh-ancestor
24862357|NCT02324686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24862358|NCT02324686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862359|NCT02324686|Hemostatics|hemostatics|mesh-ancestor
24862360|NCT02324686|Coagulants|coagulants|mesh-ancestor
24862361|NCT02324738|Piperaquine|piperaquine|mesh-list
24862362|NCT02324738|Artenimol|artenimol|mesh-list
24862363|NCT02324738|Mefloquine|mefloquine|mesh-list
24862364|NCT02324738|Antimalarials|antimalarials|mesh-ancestor
24862365|NCT02324738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24862366|NCT02324738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24862367|NCT02324738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25659817|NCT01611935|Natriuretic Agents|natriuretic agents|mesh-ancestor
24862369|NCT02324933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25840139|NCT00027391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25840140|NCT00027391|Respiratory System Agents|respiratory system agents|mesh-ancestor
25840141|NCT00027391|Tocolytic Agents|tocolytic agents|mesh-ancestor
25840142|NCT00027391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25840143|NCT00027391|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24542244|NCT00677755|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24862467|NCT02325557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24862468|NCT02325557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24862469|NCT02325583|Midazolam|midazolam|mesh-list
24862470|NCT02325583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24862471|NCT02325583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24862472|NCT02325583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24862473|NCT02325583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659819|NCT01611948|Aprepitant|aprepitant|mesh-list
25659820|NCT01611948|Antiemetics|antiemetics|mesh-ancestor
25659821|NCT01611948|Autonomic Agents|autonomic agents|mesh-ancestor
25659822|NCT01611948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25659823|NCT01611948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659824|NCT01611948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25659825|NCT01611948|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25659826|NCT01611948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25840165|NCT00027404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25840166|NCT00027404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840167|NCT00027443|Cyclosporine|cyclosporine|mesh-list
24862494|NCT02325882|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24659993|NCT01281514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24659994|NCT01281514|Immunologic Factors|immunologic factors|mesh-ancestor
24659995|NCT01281514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659996|NCT01281527|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24659997|NCT01281527|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24862495|NCT02325882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24862496|NCT02325882|Adrenergic Agents|adrenergic agents|mesh-ancestor
24862497|NCT02325882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24542289|NCT00678145|Autonomic Agents|autonomic agents|mesh-ancestor
24542290|NCT00678145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24542291|NCT00678145|Respiratory System Agents|respiratory system agents|mesh-ancestor
24542292|NCT00678145|Mydriatics|mydriatics|mesh-ancestor
25840168|NCT00027443|Cyclosporins|cyclosporins|mesh-list
25840169|NCT00027443|Muromonab-CD3|muromonab-cd3|mesh-list
25840170|NCT00027443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163408|NCT02896582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25840171|NCT00027443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840172|NCT00027443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25840173|NCT00027443|Immunologic Factors|immunologic factors|mesh-ancestor
25840174|NCT00027443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840175|NCT00027443|Antifungal Agents|antifungal agents|mesh-ancestor
25840176|NCT00027443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25840177|NCT00027443|Dermatologic Agents|dermatologic agents|mesh-ancestor
25840178|NCT00027443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25840179|NCT00027443|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25840180|NCT00027495|Curcumin|curcumin|mesh-list
25840181|NCT00027495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25840182|NCT00027495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25840183|NCT00027495|Analgesics|analgesics|mesh-ancestor
25840184|NCT00027495|Sensory System Agents|sensory system agents|mesh-ancestor
25840185|NCT00027495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25840186|NCT00027495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840187|NCT00027495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25840188|NCT00027495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25840189|NCT00027495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163412|NCT02896582|Alkylating Agents|alkylating agents|mesh-ancestor
25163413|NCT02896582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24451675|NCT00324480|Alvocidib|alvocidib|mesh-list
25840192|NCT00027508|Trabectedin|trabectedin|mesh-list
25840193|NCT00027508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25840194|NCT00027508|Alkylating Agents|alkylating agents|mesh-ancestor
25840195|NCT00027508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840196|NCT00027508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840197|NCT00027521|Bleomycin|bleomycin|mesh-list
25840198|NCT00027521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25840199|NCT00027521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840200|NCT00027534|Metronidazole|metronidazole|mesh-list
25840201|NCT00027534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25840202|NCT00027534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24542322|NCT00678275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542323|NCT00678275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25840203|NCT00027534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25840204|NCT00027534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24660121|NCT01281787|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24660126|NCT01281800|Gemcitabine|gemcitabine|mesh-list
25840205|NCT00027547|Cytarabine|cytarabine|mesh-list
25840206|NCT00027547|Cyclosporine|cyclosporine|mesh-list
25840207|NCT00027547|Mycophenolic Acid|mycophenolic acid|mesh-list
25840208|NCT00027547|Methotrexate|methotrexate|mesh-list
24862528|NCT05143281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25659828|NCT01611974|Maribavir|maribavir|mesh-list
25659829|NCT01611974|Antiviral Agents|antiviral agents|mesh-ancestor
25659830|NCT01611974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25659831|NCT01612000|Hemagglutinins|hemagglutinins|mesh-list
25659832|NCT01612000|Agglutinins|agglutinins|mesh-ancestor
25659833|NCT01612000|Immunologic Factors|immunologic factors|mesh-ancestor
25659834|NCT01612000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659835|NCT01612156|Lidocaine|lidocaine|mesh-list
25659836|NCT01612156|Anesthetics, Local|anesthetics, local|mesh-ancestor
25659837|NCT01612156|Anesthetics|anesthetics|mesh-ancestor
25659838|NCT01612156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25840209|NCT00027547|Fludarabine phosphate|fludarabine phosphate|mesh-list
24862542|NCT05142904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24862543|NCT05142904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24862545|NCT05142904|Micronutrients|micronutrients|mesh-ancestor
24862546|NCT05142904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862547|NCT05142865|Carboplatin|carboplatin|mesh-list
24862549|NCT05142865|Apatinib|apatinib|mesh-list
24862550|NCT05142865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542336|NCT00678327|Etoposide|etoposide|mesh-list
24542337|NCT00678327|Vincristine|vincristine|mesh-list
24862554|NCT05142865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24862555|NCT05142865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862556|NCT05142865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24660230|NCT01282333|Veliparib|veliparib|mesh-list
25840212|NCT00027547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25840213|NCT00027547|Abortifacient Agents|abortifacient agents|mesh-ancestor
24533107|NCT00642291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24660258|NCT01282502|Midostaurin|midostaurin|mesh-list
24542365|NCT00678431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542366|NCT00678431|Protective Agents|protective agents|mesh-ancestor
24542367|NCT00678431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542368|NCT00678431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542376|NCT00678457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24542377|NCT00678457|Antipruritics|antipruritics|mesh-ancestor
24542378|NCT00678457|Dermatologic Agents|dermatologic agents|mesh-ancestor
24542379|NCT00678457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24862589|NCT05021926|Hyaluronic Acid|hyaluronic acid|mesh-list
24862590|NCT05021926|Anesthetics, Local|anesthetics, local|mesh-ancestor
24862591|NCT05021926|Anesthetics|anesthetics|mesh-ancestor
24862592|NCT05021926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24862593|NCT05021926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862594|NCT05021926|Sensory System Agents|sensory system agents|mesh-ancestor
24862595|NCT05021926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24862596|NCT05021926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24862597|NCT05021926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24862598|NCT05021926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24862599|NCT05021926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24862600|NCT05021926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862601|NCT05021926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24862602|NCT05021926|Immunologic Factors|immunologic factors|mesh-ancestor
24862619|NCT05021913|Immunologic Factors|immunologic factors|mesh-ancestor
24862620|NCT05021913|Viscosupplements|viscosupplements|mesh-ancestor
24862621|NCT05021913|Protective Agents|protective agents|mesh-ancestor
24862622|NCT04987931|Talazoparib|talazoparib|mesh-list
24862623|NCT04987931|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24862624|NCT04987931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796332|NCT01949363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24862625|NCT04987931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840214|NCT00027547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25840215|NCT00027547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840216|NCT00027547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25659839|NCT01612156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659840|NCT01612156|Sensory System Agents|sensory system agents|mesh-ancestor
25659841|NCT01612156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25659842|NCT01612156|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24862631|NCT04929834|Dermatologic Agents|dermatologic agents|mesh-ancestor
24862632|NCT04881955|Ecopipam|ecopipam|mesh-list
24862633|NCT04881955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25659843|NCT01612156|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25659844|NCT01612156|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25840217|NCT00027547|Antimetabolites|antimetabolites|mesh-ancestor
25840218|NCT00027547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862652|NCT04850222|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24862654|NCT04850222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24862655|NCT04850222|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24862656|NCT04850222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24660488|NCT01283841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24660489|NCT01283841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840219|NCT00027547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840220|NCT00027547|Dermatologic Agents|dermatologic agents|mesh-ancestor
25840221|NCT00027547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840222|NCT00027547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25840223|NCT00027547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25840224|NCT00027547|Immunologic Factors|immunologic factors|mesh-ancestor
25840225|NCT00027547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24542452|NCT00678756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24542453|NCT00678756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542454|NCT00678756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25840226|NCT00027547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24862682|NCT04722952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24862683|NCT04722952|Immunologic Factors|immunologic factors|mesh-ancestor
24862684|NCT04722952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862685|NCT04722952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24862686|NCT04722952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24862687|NCT04722952|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24862705|NCT04715191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24862706|NCT04715191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24862707|NCT04715191|Alkylating Agents|alkylating agents|mesh-ancestor
24862708|NCT04715191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862709|NCT04715191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24862710|NCT04715191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24862711|NCT04715191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24862712|NCT04715191|Antimetabolites|antimetabolites|mesh-ancestor
24862714|NCT04703361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24542471|NCT00678782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542472|NCT00678782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24542473|NCT00678782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24542474|NCT00678782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24542475|NCT00678782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24542476|NCT00678782|Immunologic Factors|immunologic factors|mesh-ancestor
24542477|NCT00678964|Carboplatin|carboplatin|mesh-list
25840227|NCT00027547|Antiviral Agents|antiviral agents|mesh-ancestor
25840228|NCT00027547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25840229|NCT00027547|Antifungal Agents|antifungal agents|mesh-ancestor
25840230|NCT00027547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25840231|NCT00027547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25840232|NCT00027547|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25840233|NCT00027547|Antitubercular Agents|antitubercular agents|mesh-ancestor
25840234|NCT00027547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25840235|NCT00027573|Cyclophosphamide|cyclophosphamide|mesh-list
25415216|NCT03012529|Vitamin B Complex|vitamin b complex|mesh-ancestor
25659845|NCT01612156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25674595|NCT01774305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25840236|NCT00027573|Methotrexate|methotrexate|mesh-list
24885716|NCT04671030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24885718|NCT04671030|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24885719|NCT04671030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24885720|NCT04660890|Moxifloxacin|moxifloxacin|mesh-list
24885721|NCT04660890|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25840237|NCT00027573|Fludarabine|fludarabine|mesh-list
25840238|NCT00027573|Fludarabine phosphate|fludarabine phosphate|mesh-list
25840239|NCT00027573|Tacrolimus|tacrolimus|mesh-list
25840240|NCT00027573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25840241|NCT00027573|Immunologic Factors|immunologic factors|mesh-ancestor
25840242|NCT00027573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840243|NCT00027573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24998076|NCT03841565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24998151|NCT03590821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24998152|NCT03590821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24998153|NCT03590821|Analgesics|analgesics|mesh-ancestor
24998154|NCT03590821|Sensory System Agents|sensory system agents|mesh-ancestor
24998155|NCT03590821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24998156|NCT03590821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998157|NCT03590821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24998158|NCT03590821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24998159|NCT03590821|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24998160|NCT03590821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24998161|NCT03590821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998162|NCT03590821|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24998163|NCT03590821|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24998164|NCT03590821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998165|NCT03590821|Antipyretics|antipyretics|mesh-ancestor
25163414|NCT02896582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25202964|NCT02717858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202965|NCT02717858|Incretins|incretins|mesh-ancestor
25202966|NCT02717858|Hormones|hormones|mesh-ancestor
25202967|NCT02717858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25202968|NCT02717572|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25202969|NCT02717572|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25202970|NCT02717572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202971|NCT02717819|Vitamin D|vitamin d|mesh-list
25202972|NCT02717819|Vitamins|vitamins|mesh-ancestor
25202973|NCT02717819|Micronutrients|micronutrients|mesh-ancestor
25202974|NCT02717819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202975|NCT02717819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25202976|NCT02717780|Fentanyl|fentanyl|mesh-list
25202977|NCT02717780|Remifentanil|remifentanil|mesh-list
25202978|NCT02717780|Sevoflurane|sevoflurane|mesh-list
25202979|NCT02717780|Desflurane|desflurane|mesh-list
25202980|NCT02717780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25202981|NCT02717780|Narcotics|narcotics|mesh-ancestor
24986816|NCT05160896|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25202982|NCT02717780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25202983|NCT02717780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202984|NCT02717780|Analgesics|analgesics|mesh-ancestor
25202985|NCT02717780|Sensory System Agents|sensory system agents|mesh-ancestor
25202986|NCT02717780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202987|NCT02717780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25202988|NCT02717780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25202989|NCT02717780|Anesthetics, General|anesthetics, general|mesh-ancestor
25202990|NCT02717780|Anesthetics|anesthetics|mesh-ancestor
25202991|NCT02717780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25202992|NCT02717780|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25202993|NCT02717052|Ketamine|ketamine|mesh-list
25202994|NCT02717052|Esketamine|esketamine|mesh-list
25202995|NCT02717052|Analgesics|analgesics|mesh-ancestor
25202996|NCT02717052|Sensory System Agents|sensory system agents|mesh-ancestor
25202997|NCT02717052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202998|NCT02717052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862758|NCT04532502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25659846|NCT01612156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659847|NCT01612221|Acetylcysteine|acetylcysteine|mesh-list
25659848|NCT01612221|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25659849|NCT01612221|Antiviral Agents|antiviral agents|mesh-ancestor
25659850|NCT01612221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25659851|NCT01612221|Expectorants|expectorants|mesh-ancestor
25659852|NCT01612221|Respiratory System Agents|respiratory system agents|mesh-ancestor
25659853|NCT01612221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24862779|NCT04382924|Adrenergic Agents|adrenergic agents|mesh-ancestor
24862806|NCT04364997|Antidepressive Agents|antidepressive agents|mesh-ancestor
24862807|NCT04364997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24862808|NCT04364997|Dopamine Agents|dopamine agents|mesh-ancestor
24862810|NCT04356196|Bisoprolol|bisoprolol|mesh-list
24862811|NCT04356196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24862812|NCT04356196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24542642|NCT00679653|Felodipine|felodipine|mesh-list
24542643|NCT00679653|Ramipril|ramipril|mesh-list
24542644|NCT00679653|Trandolapril|trandolapril|mesh-list
24542645|NCT00679653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24542646|NCT00679653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24542647|NCT00679653|Sympatholytics|sympatholytics|mesh-ancestor
24542648|NCT00679653|Autonomic Agents|autonomic agents|mesh-ancestor
24987025|NCT04501120|Antimetabolites|antimetabolites|mesh-ancestor
25163415|NCT02896413|Dexmedetomidine|dexmedetomidine|mesh-list
25163416|NCT02896413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24862898|NCT04097730|Vitamins|vitamins|mesh-ancestor
24862899|NCT04097730|Micronutrients|micronutrients|mesh-ancestor
24862900|NCT04097730|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24862901|NCT04097730|Dermatologic Agents|dermatologic agents|mesh-ancestor
24862902|NCT04097730|Glucocorticoids|glucocorticoids|mesh-ancestor
24862903|NCT04097730|Hormones|hormones|mesh-ancestor
24862911|NCT04034459|Levoleucovorin|levoleucovorin|mesh-list
24862912|NCT04034459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24542704|NCT00679770|Tavaborole|tavaborole|mesh-list
24862923|NCT04034459|Antidotes|antidotes|mesh-ancestor
24862924|NCT04034459|Protective Agents|protective agents|mesh-ancestor
24862925|NCT04034459|Vitamin B Complex|vitamin b complex|mesh-ancestor
24862926|NCT04034459|Vitamins|vitamins|mesh-ancestor
25659855|NCT01612221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659856|NCT01612221|Protective Agents|protective agents|mesh-ancestor
25659857|NCT01612221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659858|NCT01612221|Antidotes|antidotes|mesh-ancestor
24863011|NCT03757013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24863012|NCT03757013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24863013|NCT03757013|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24863014|NCT03757013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25840246|NCT00027573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840247|NCT00027573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840248|NCT00027573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25840249|NCT00027573|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25840250|NCT00027573|Abortifacient Agents|abortifacient agents|mesh-ancestor
25840251|NCT00027573|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25840252|NCT00027573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25840253|NCT00027573|Antimetabolites|antimetabolites|mesh-ancestor
25840254|NCT00027573|Dermatologic Agents|dermatologic agents|mesh-ancestor
25840255|NCT00027573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840257|NCT00027573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25659859|NCT01612546|Camptothecin|camptothecin|mesh-list
25840258|NCT00027573|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25840259|NCT00027586|Imatinib Mesylate|imatinib mesylate|mesh-list
25840260|NCT00027586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840261|NCT00027586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25840262|NCT00027586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840263|NCT00027586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840264|NCT00027599|Bevacizumab|bevacizumab|mesh-list
25840265|NCT00027599|Sargramostim|sargramostim|mesh-list
25840266|NCT00027599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25840267|NCT00027599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840268|NCT00027599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24863015|NCT03757013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24863016|NCT03757013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163417|NCT02896413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24661454|NCT01289561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840269|NCT00027599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25840270|NCT00027599|Growth Substances|growth substances|mesh-ancestor
25840271|NCT00027599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840272|NCT00027599|Growth Inhibitors|growth inhibitors|mesh-ancestor
25840273|NCT00027599|Immunologic Factors|immunologic factors|mesh-ancestor
25840274|NCT00027612|Irinotecan|irinotecan|mesh-list
25840275|NCT00027612|Carmustine|carmustine|mesh-list
25840276|NCT00027612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25840277|NCT00027612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25840278|NCT00027612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840279|NCT00027612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840280|NCT00027612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840281|NCT00027612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24542831|NCT00680485|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24863041|NCT03646162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24863042|NCT03646162|Hormone Antagonists|hormone antagonists|mesh-ancestor
24863043|NCT03646162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24863044|NCT03646162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863045|NCT03646162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24863053|NCT03635788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25840282|NCT00027612|Alkylating Agents|alkylating agents|mesh-ancestor
25840283|NCT00027625|Temozolomide|temozolomide|mesh-list
25840284|NCT00027625|Gefitinib|gefitinib|mesh-list
25840285|NCT00027625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24474760|NCT00407264|Respiratory System Agents|respiratory system agents|mesh-ancestor
24806088|NCT02013570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806089|NCT02013570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24806090|NCT02013570|Analgesics|analgesics|mesh-ancestor
24806091|NCT02013570|Sensory System Agents|sensory system agents|mesh-ancestor
24806092|NCT02013570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24806093|NCT02013570|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24474802|NCT00407433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24474803|NCT00407433|Immunologic Factors|immunologic factors|mesh-ancestor
24474804|NCT00407433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474805|NCT00407446|Sildenafil Citrate|sildenafil citrate|mesh-list
24474806|NCT00407446|Vasodilator Agents|vasodilator agents|mesh-ancestor
24474807|NCT00407446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24474808|NCT00407446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24474809|NCT00407446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474810|NCT00407446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474811|NCT00407446|Urological Agents|urological agents|mesh-ancestor
24474813|NCT00407459|Carboplatin|carboplatin|mesh-list
24474814|NCT00407459|Pemetrexed|pemetrexed|mesh-list
24474815|NCT00407459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24474816|NCT00407459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474817|NCT00407459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24474818|NCT00407459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24474819|NCT00407459|Growth Substances|growth substances|mesh-ancestor
24474820|NCT00407459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474821|NCT00407459|Growth Inhibitors|growth inhibitors|mesh-ancestor
24670434|NCT02575404|Pembrolizumab|pembrolizumab|mesh-list
24474938|NCT00408187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25659860|NCT01612546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24474939|NCT00408213|Mycophenolic Acid|mycophenolic acid|mesh-list
24885922|NCT04132427|Magnesium citrate|magnesium citrate|mesh-list
24885923|NCT04132427|Citric Acid|citric acid|mesh-list
24885924|NCT04132427|Sodium Citrate|sodium citrate|mesh-list
24885947|NCT04097470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885948|NCT04097470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816518|NCT02077556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24885952|NCT04054999|Vitamin B 12|vitamin b 12|mesh-list
24474940|NCT00408213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24474941|NCT00408213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987440|NCT01936480|Moxifloxacin|moxifloxacin|mesh-list
24474950|NCT00408226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474951|NCT00408226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474952|NCT00408226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24474953|NCT00408226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24474978|NCT00408278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840286|NCT00027625|Alkylating Agents|alkylating agents|mesh-ancestor
24475075|NCT00408785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24475076|NCT00408785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475078|NCT00408785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24475079|NCT00408785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475080|NCT00408785|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24475109|NCT00408941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24475110|NCT00408941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446632|NCT00305500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25840287|NCT00027625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475181|NCT00409318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24475182|NCT00409318|Analgesics|analgesics|mesh-ancestor
24806179|NCT02014337|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24806180|NCT02014337|Hormone Antagonists|hormone antagonists|mesh-ancestor
24806181|NCT02014337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24806182|NCT02014337|Luteolytic Agents|luteolytic agents|mesh-ancestor
24806183|NCT02014337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24806184|NCT02014337|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24806185|NCT02014428|Hyaluronic Acid|hyaluronic acid|mesh-list
24475183|NCT00409318|Sensory System Agents|sensory system agents|mesh-ancestor
24475184|NCT00409318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24475185|NCT00409318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475186|NCT00409318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25840288|NCT00027625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840289|NCT00027625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25840290|NCT00027625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446633|NCT00305500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446634|NCT00305500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24446635|NCT00305500|Serotonin Agents|serotonin agents|mesh-ancestor
24446636|NCT00305500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446637|NCT00305500|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24446638|NCT00305500|Antidepressive Agents|antidepressive agents|mesh-ancestor
24446639|NCT00305500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24600963|NCT00961467|Alkylating Agents|alkylating agents|mesh-ancestor
24600964|NCT00961467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600965|NCT00961467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24600966|NCT00961467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24475276|NCT00409695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475277|NCT00409695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24475279|NCT00409721|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24475280|NCT00409721|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24475281|NCT00409721|Dopamine Agents|dopamine agents|mesh-ancestor
25840291|NCT00027638|Thalidomide|thalidomide|mesh-list
24475301|NCT00409851|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24475302|NCT00409851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24475303|NCT00409851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475304|NCT00409851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25659861|NCT01612546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659862|NCT01612546|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25659863|NCT01612546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25659864|NCT01612546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25659865|NCT01612546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659866|NCT01612702|Dexamethasone|dexamethasone|mesh-list
25659867|NCT01612702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25659868|NCT01612702|Antiemetics|antiemetics|mesh-ancestor
24464937|NCT00367315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24464938|NCT00367315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24464939|NCT00367393|Pimecrolimus|pimecrolimus|mesh-list
24464940|NCT00367393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24822838|NCT02113800|Everolimus|everolimus|mesh-list
24475305|NCT00409851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475306|NCT00409851|Vasodilator Agents|vasodilator agents|mesh-ancestor
24475307|NCT00409851|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24475308|NCT00409851|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24475309|NCT00409890|Scopolamine|scopolamine|mesh-list
24475311|NCT00409890|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24475312|NCT00409890|Anticonvulsants|anticonvulsants|mesh-ancestor
24475313|NCT00409890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24475314|NCT00409890|Antiemetics|antiemetics|mesh-ancestor
24806194|NCT02014454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24806195|NCT02014454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24806196|NCT02014454|Adrenergic Agents|adrenergic agents|mesh-ancestor
24806197|NCT02014454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24475358|NCT00410033|Insulin Aspart|insulin aspart|mesh-list
24475359|NCT00410033|Isophane Insulin, Human|isophane insulin, human|mesh-list
24475360|NCT00410033|Insulin, Isophane|insulin, isophane|mesh-list
24475361|NCT00410033|Isophane insulin, beef|isophane insulin, beef|mesh-list
24475362|NCT00410033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24475363|NCT00410033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475364|NCT00410215|Bisacodyl|bisacodyl|mesh-list
24475365|NCT00410215|Cathartics|cathartics|mesh-ancestor
24475366|NCT00410215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24475367|NCT00410215|Laxatives|laxatives|mesh-ancestor
24475368|NCT00410254|Midazolam|midazolam|mesh-list
24475369|NCT00410254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24475370|NCT00410254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25840292|NCT00027638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24806200|NCT02014454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24806201|NCT02014454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24806202|NCT02014454|Vasodilator Agents|vasodilator agents|mesh-ancestor
24806203|NCT02014506|Cyclophosphamide|cyclophosphamide|mesh-list
24806205|NCT02014506|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24806206|NCT02014506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24806207|NCT02014506|Immunologic Factors|immunologic factors|mesh-ancestor
24806208|NCT02014506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475373|NCT00410254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24475374|NCT00410254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24475375|NCT00410254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24475376|NCT00410254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24475472|NCT00410592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24475473|NCT00410592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24475482|NCT00410631|Doxorubicin|doxorubicin|mesh-list
24475483|NCT00410631|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24475484|NCT00410631|Etoposide|etoposide|mesh-list
24475485|NCT00410631|Vincristine|vincristine|mesh-list
24475486|NCT00410631|Topotecan|topotecan|mesh-list
24475487|NCT00410631|Etoposide phosphate|etoposide phosphate|mesh-list
24475488|NCT00410631|Vindesine|vindesine|mesh-list
24475489|NCT00410631|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24475490|NCT00410631|Isotretinoin|isotretinoin|mesh-list
24475491|NCT00410631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24475492|NCT00410631|Immunologic Factors|immunologic factors|mesh-ancestor
24475493|NCT00410631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475494|NCT00410631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24475495|NCT00410631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24475496|NCT00410631|Alkylating Agents|alkylating agents|mesh-ancestor
24475497|NCT00410631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475498|NCT00410631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24475499|NCT00410631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24475500|NCT00410631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24475503|NCT00410631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24475504|NCT00410631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24475505|NCT00410631|Tubulin Modulators|tubulin modulators|mesh-ancestor
25840293|NCT00027638|Immunologic Factors|immunologic factors|mesh-ancestor
25659869|NCT01612702|Autonomic Agents|autonomic agents|mesh-ancestor
25659870|NCT01612702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25659871|NCT01612702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659872|NCT01612702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25659873|NCT01612702|Glucocorticoids|glucocorticoids|mesh-ancestor
24475511|NCT00410644|Hydromorphone|hydromorphone|mesh-list
25659874|NCT01612702|Hormones|hormones|mesh-ancestor
25659875|NCT01612702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25840294|NCT00027638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886090|NCT03387774|Protease Inhibitors|protease inhibitors|mesh-ancestor
24886091|NCT03387774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886092|NCT03387774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840295|NCT00027638|Leprostatic Agents|leprostatic agents|mesh-ancestor
24511263|NCT00568048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511264|NCT00568048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24511265|NCT00568048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24511266|NCT00568048|Growth Substances|growth substances|mesh-ancestor
24475512|NCT00410644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24475513|NCT00410644|Narcotics|narcotics|mesh-ancestor
24475528|NCT00410657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24475529|NCT00410657|Glucocorticoids|glucocorticoids|mesh-ancestor
24475531|NCT00410657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25163418|NCT02896413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475548|NCT00410735|Respiratory System Agents|respiratory system agents|mesh-ancestor
24475549|NCT00410735|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24475550|NCT00410735|Hormone Antagonists|hormone antagonists|mesh-ancestor
24475551|NCT00410735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24475552|NCT00410735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840296|NCT00027638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25840297|NCT00027638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24475602|NCT00410943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475604|NCT00410943|Sensory System Agents|sensory system agents|mesh-ancestor
24475605|NCT00410943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25840298|NCT00027638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25840299|NCT00027638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25840300|NCT00027638|Growth Substances|growth substances|mesh-ancestor
25840301|NCT00027638|Growth Inhibitors|growth inhibitors|mesh-ancestor
25840302|NCT00027638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840303|NCT00027664|Interferons|interferons|mesh-list
25840304|NCT00027664|Interferon-alpha|interferon-alpha|mesh-list
25840305|NCT00027664|Thalidomide|thalidomide|mesh-list
25840306|NCT00027664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840307|NCT00027664|Antiviral Agents|antiviral agents|mesh-ancestor
25840308|NCT00027664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25840309|NCT00027664|Immunologic Factors|immunologic factors|mesh-ancestor
25840310|NCT00027664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840311|NCT00027664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25840312|NCT00027664|Leprostatic Agents|leprostatic agents|mesh-ancestor
25840313|NCT00027664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25840314|NCT00027664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24806257|NCT02014558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24806258|NCT02014623|Histamine Antagonists|histamine antagonists|mesh-list
24806259|NCT02014623|Histamine Agents|histamine agents|mesh-ancestor
24806260|NCT02014623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24806261|NCT02014623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806262|NCT02014623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806263|NCT02014636|Pembrolizumab|pembrolizumab|mesh-list
24806264|NCT02014636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25840315|NCT00027664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25840316|NCT00027664|Growth Substances|growth substances|mesh-ancestor
25840317|NCT00027664|Growth Inhibitors|growth inhibitors|mesh-ancestor
25840318|NCT00027677|Halofuginone|halofuginone|mesh-list
25840319|NCT00027677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840320|NCT00027677|Coccidiostats|coccidiostats|mesh-ancestor
25840321|NCT00027677|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24475715|NCT00411203|Hormone Antagonists|hormone antagonists|mesh-ancestor
24475716|NCT00411203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24475717|NCT00411203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659876|NCT01612702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25659877|NCT01612702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25674319|NCT01770145|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25674320|NCT01770145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674321|NCT01770145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25674322|NCT01770145|Immunologic Factors|immunologic factors|mesh-ancestor
25674323|NCT01770145|Dopamine Agonists|dopamine agonists|mesh-ancestor
25674324|NCT01770145|Emetics|emetics|mesh-ancestor
25674325|NCT01770145|Autonomic Agents|autonomic agents|mesh-ancestor
25674326|NCT01770145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24511394|NCT00568503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511395|NCT00568503|Anticonvulsants|anticonvulsants|mesh-ancestor
24475718|NCT00411203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24475719|NCT00411203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24475720|NCT00411203|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24475721|NCT00411203|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25840322|NCT00027677|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24806362|NCT02015403|Antiviral Agents|antiviral agents|mesh-ancestor
24806270|NCT02014714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24806271|NCT02014714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806296|NCT02014831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24475725|NCT00411229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24475726|NCT00411229|Antimetabolites|antimetabolites|mesh-ancestor
24475727|NCT00411229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990556|NCT02754154|Antithrombins|antithrombins|mesh-ancestor
24475728|NCT00411229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24475729|NCT00411268|Hydromorphone|hydromorphone|mesh-list
24475730|NCT00411268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24475731|NCT00411268|Narcotics|narcotics|mesh-ancestor
24475732|NCT00411268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24475733|NCT00411268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475734|NCT00411268|Analgesics|analgesics|mesh-ancestor
24475735|NCT00411268|Sensory System Agents|sensory system agents|mesh-ancestor
24475736|NCT00411268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24475737|NCT00411281|Cytarabine|cytarabine|mesh-list
24475738|NCT00411281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24475739|NCT00411281|Antimetabolites|antimetabolites|mesh-ancestor
24475740|NCT00411281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475741|NCT00411281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24475742|NCT00411281|Antiviral Agents|antiviral agents|mesh-ancestor
24475743|NCT00411281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24475744|NCT00411281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25840323|NCT00027677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24475750|NCT00411307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24475751|NCT00411307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475753|NCT00411307|Sensory System Agents|sensory system agents|mesh-ancestor
25840324|NCT00027677|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24475785|NCT00411372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24475787|NCT00411372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24475788|NCT00411372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475789|NCT00411372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24475790|NCT00411372|Respiratory System Agents|respiratory system agents|mesh-ancestor
24475791|NCT00411372|Dermatologic Agents|dermatologic agents|mesh-ancestor
24475792|NCT00411372|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24415917|NCT00201422|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24475838|NCT00411541|Tubulin Modulators|tubulin modulators|mesh-ancestor
24475839|NCT00411541|Antimitotic Agents|antimitotic agents|mesh-ancestor
24475840|NCT00411541|Mitosis Modulators|mitosis modulators|mesh-ancestor
24475841|NCT00411541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475842|NCT00411593|Bevacizumab|bevacizumab|mesh-list
24475843|NCT00411593|Bortezomib|bortezomib|mesh-list
24475851|NCT00411736|Azithromycin|azithromycin|mesh-list
25840325|NCT00027677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24475932|NCT00412022|Luteolytic Agents|luteolytic agents|mesh-ancestor
24806344|NCT02015312|Silicon|silicon|mesh-list
24806345|NCT02015312|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24806346|NCT02015312|Mannitol|mannitol|mesh-list
24806347|NCT02015312|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24806348|NCT02015312|Diuretics|diuretics|mesh-ancestor
24806349|NCT02015312|Natriuretic Agents|natriuretic agents|mesh-ancestor
24806350|NCT02015312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806352|NCT02015312|Micronutrients|micronutrients|mesh-ancestor
24806353|NCT02015312|Antioxidants|antioxidants|mesh-ancestor
24806354|NCT02015312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806355|NCT02015312|Protective Agents|protective agents|mesh-ancestor
24806356|NCT02015312|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24806357|NCT02015312|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24806358|NCT02015312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806359|NCT02015312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24806360|NCT02015403|Acetylcysteine|acetylcysteine|mesh-list
25659878|NCT01612858|Metformin|metformin|mesh-list
25659879|NCT01612858|Pioglitazone|pioglitazone|mesh-list
25659880|NCT01612858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25840326|NCT00027677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806363|NCT02015403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24806364|NCT02015403|Expectorants|expectorants|mesh-ancestor
24806365|NCT02015403|Respiratory System Agents|respiratory system agents|mesh-ancestor
24806366|NCT02015403|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24806367|NCT02015403|Antioxidants|antioxidants|mesh-ancestor
24806368|NCT02015403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806369|NCT02015403|Protective Agents|protective agents|mesh-ancestor
24806370|NCT02015403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475969|NCT00412191|Lamotrigine|lamotrigine|mesh-list
24475970|NCT00412191|Anticonvulsants|anticonvulsants|mesh-ancestor
24806375|NCT02015494|Agglutinins|agglutinins|mesh-ancestor
25163419|NCT02896413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24806376|NCT02015507|Ciprofloxacin|ciprofloxacin|mesh-list
24806377|NCT02015507|Ivacaftor|ivacaftor|mesh-list
25163420|NCT02896413|Analgesics|analgesics|mesh-ancestor
24998174|NCT03469284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589223|NCT00906139|Anesthetics|anesthetics|mesh-ancestor
24589224|NCT00906139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24589225|NCT00906139|Narcotics|narcotics|mesh-ancestor
24589240|NCT00906269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24589241|NCT00906269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589242|NCT00906269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589243|NCT00906269|Urological Agents|urological agents|mesh-ancestor
24589246|NCT00906295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25840327|NCT00027677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25840328|NCT00027677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25840329|NCT00027677|Growth Substances|growth substances|mesh-ancestor
25840330|NCT00027677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840331|NCT00027677|Growth Inhibitors|growth inhibitors|mesh-ancestor
24806434|NCT02015728|Alkylating Agents|alkylating agents|mesh-ancestor
24827591|NCT02140268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24827592|NCT02140268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840332|NCT00027690|Gefitinib|gefitinib|mesh-list
25840333|NCT00027690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840334|NCT00027690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25840335|NCT00027690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840336|NCT00027690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163421|NCT02896413|Sensory System Agents|sensory system agents|mesh-ancestor
25163422|NCT02896413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25163423|NCT02896413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25163424|NCT02896413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25163425|NCT02896413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25163426|NCT02896413|Adrenergic Agents|adrenergic agents|mesh-ancestor
25163427|NCT02896413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25163428|NCT02896413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163429|NCT02896270|Valproic Acid|valproic acid|mesh-list
25163430|NCT02896270|Anticonvulsants|anticonvulsants|mesh-ancestor
25163431|NCT02896270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163432|NCT02896270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163433|NCT02896270|GABA Agents|gaba agents|mesh-ancestor
25163434|NCT02896270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25163435|NCT02896270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163436|NCT02896270|Antimanic Agents|antimanic agents|mesh-ancestor
25163437|NCT02896270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25163438|NCT02896270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25163439|NCT02896270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25163440|NCT02896205|Mycophenolic Acid|mycophenolic acid|mesh-list
25163441|NCT02896205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25163442|NCT02896205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163443|NCT02896205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25163444|NCT02896205|Antitubercular Agents|antitubercular agents|mesh-ancestor
25163445|NCT02896205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25163446|NCT02896205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25163447|NCT02896205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163448|NCT02896205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163449|NCT02896101|Pimecrolimus|pimecrolimus|mesh-list
25163450|NCT02896101|Tacrolimus|tacrolimus|mesh-list
25163451|NCT02896101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25163452|NCT02896101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25163453|NCT02896101|Analgesics|analgesics|mesh-ancestor
25163454|NCT02896101|Sensory System Agents|sensory system agents|mesh-ancestor
25163455|NCT02896101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25163456|NCT02896101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163457|NCT02896101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25163458|NCT02896101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25163459|NCT02896101|Dermatologic Agents|dermatologic agents|mesh-ancestor
25163460|NCT02896101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25163461|NCT02896101|Immunologic Factors|immunologic factors|mesh-ancestor
25163462|NCT02896101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25163463|NCT02896101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24806407|NCT02015650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24806409|NCT02015650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24806410|NCT02015650|Immunologic Factors|immunologic factors|mesh-ancestor
24806411|NCT02015650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806412|NCT02015650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24806413|NCT02015650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24806414|NCT02015650|Alkylating Agents|alkylating agents|mesh-ancestor
24806415|NCT02015650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24992985|NCT01883804|Sympatholytics|sympatholytics|mesh-ancestor
24806416|NCT02015650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24806417|NCT02015728|Etoposide|etoposide|mesh-list
24806418|NCT02015728|Everolimus|everolimus|mesh-list
24806419|NCT02015728|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24806420|NCT02015728|Temozolomide|temozolomide|mesh-list
24806421|NCT02015728|Sorafenib|sorafenib|mesh-list
24806422|NCT02015728|Dasatinib|dasatinib|mesh-list
24806423|NCT02015728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24806424|NCT02015728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806491|NCT02016261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806492|NCT02016261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24806493|NCT02016261|Serotonin Agents|serotonin agents|mesh-ancestor
24806494|NCT02016261|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24806495|NCT02016261|Antidepressive Agents|antidepressive agents|mesh-ancestor
24806496|NCT02016261|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24806497|NCT02016261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24806526|NCT02016391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24806527|NCT02016391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806528|NCT02016391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24806529|NCT02016391|Analgesics|analgesics|mesh-ancestor
24806530|NCT02016391|Sensory System Agents|sensory system agents|mesh-ancestor
24806531|NCT02016391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24806532|NCT02016391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24806533|NCT02016391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24806534|NCT02016391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24806535|NCT02016391|Adrenergic Agents|adrenergic agents|mesh-ancestor
24806536|NCT02016391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24806537|NCT02016391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806538|NCT02016417|Gemcitabine|gemcitabine|mesh-list
24806539|NCT02016417|Cisplatin|cisplatin|mesh-list
24806540|NCT02016417|Docetaxel|docetaxel|mesh-list
24806541|NCT02016417|Fluorouracil|fluorouracil|mesh-list
24806542|NCT02016417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806543|NCT02016417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24806544|NCT02016417|Antimetabolites|antimetabolites|mesh-ancestor
24806545|NCT02016417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806546|NCT02016417|Antiviral Agents|antiviral agents|mesh-ancestor
24806547|NCT02016417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24806548|NCT02016417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24806639|NCT02016976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24806640|NCT02016976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806641|NCT02016976|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24806642|NCT02016976|Narcotics|narcotics|mesh-ancestor
24806643|NCT02017119|Lactulose|lactulose|mesh-list
24806644|NCT02017119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24806651|NCT02017314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806652|NCT02017314|Analgesics|analgesics|mesh-ancestor
24806653|NCT02017314|Sensory System Agents|sensory system agents|mesh-ancestor
25840337|NCT00027703|Gemcitabine|gemcitabine|mesh-list
25840338|NCT00027703|Bevacizumab|bevacizumab|mesh-list
25840339|NCT00027703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25840340|NCT00027703|Cisplatin|cisplatin|mesh-list
25840341|NCT00027703|Antibodies|antibodies|mesh-list
25840342|NCT00027703|Immunoglobulins|immunoglobulins|mesh-list
25840343|NCT00027703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25840344|NCT00027703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840345|NCT00027703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25840346|NCT00027703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25840347|NCT00027703|Growth Substances|growth substances|mesh-ancestor
25840348|NCT00027703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806692|NCT02017600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24806693|NCT02017600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24806694|NCT02017600|Immunologic Factors|immunologic factors|mesh-ancestor
24806695|NCT02017600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806711|NCT02017704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24806722|NCT02017873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25840349|NCT00027703|Growth Inhibitors|growth inhibitors|mesh-ancestor
25840350|NCT00027703|Immunologic Factors|immunologic factors|mesh-ancestor
25840351|NCT00027703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25840352|NCT00027703|Antimetabolites|antimetabolites|mesh-ancestor
25840353|NCT00027703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840354|NCT00027703|Antiviral Agents|antiviral agents|mesh-ancestor
25840355|NCT00027703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25840356|NCT00027703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476025|NCT00412555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476026|NCT00412581|Lenalidomide|lenalidomide|mesh-list
24476027|NCT00412581|Dacarbazine|dacarbazine|mesh-list
24476028|NCT00412581|Immunologic Factors|immunologic factors|mesh-ancestor
24476029|NCT00412581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476030|NCT00412581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24476031|NCT00412581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24476032|NCT00412581|Growth Substances|growth substances|mesh-ancestor
24476033|NCT00412581|Growth Inhibitors|growth inhibitors|mesh-ancestor
24476053|NCT00412633|Sulfamethazine|sulfamethazine|mesh-list
24476054|NCT00412633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24476055|NCT00412646|Etravirine|etravirine|mesh-list
24476056|NCT00412646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24476057|NCT00412646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24476058|NCT00412646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476059|NCT00412646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476060|NCT00412646|Antiviral Agents|antiviral agents|mesh-ancestor
24476061|NCT00412646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24476062|NCT00412698|Rimonabant|rimonabant|mesh-list
24476063|NCT00412698|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25840357|NCT00027703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25840358|NCT00027716|Bortezomib|bortezomib|mesh-list
25840359|NCT00027716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840360|NCT00027742|Interferons|interferons|mesh-list
25840361|NCT00027742|Interferon-alpha|interferon-alpha|mesh-list
25840362|NCT00027742|Temozolomide|temozolomide|mesh-list
25840363|NCT00027742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840364|NCT00027742|Antiviral Agents|antiviral agents|mesh-ancestor
25840365|NCT00027742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24806831|NCT02018276|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24806832|NCT02018276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24806833|NCT02018276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806834|NCT02018289|Triclosan|triclosan|mesh-list
24806835|NCT02018289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24806836|NCT02018289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24806837|NCT02018289|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24806838|NCT02018289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24806839|NCT02018289|Antimetabolites|antimetabolites|mesh-ancestor
24806840|NCT02018289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806841|NCT02018289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24806842|NCT02018328|Curcumin|curcumin|mesh-list
24806843|NCT02018328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25840366|NCT00027742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25840367|NCT00027742|Alkylating Agents|alkylating agents|mesh-ancestor
25840368|NCT00027742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840369|NCT00027742|Immunologic Factors|immunologic factors|mesh-ancestor
25840370|NCT00027742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840371|NCT00027768|Ethiodized Oil|ethiodized oil|mesh-list
25840372|NCT00027768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840373|NCT00027807|Aldesleukin|aldesleukin|mesh-list
25840374|NCT00027807|Molgramostim|molgramostim|mesh-list
25840375|NCT00027807|Sargramostim|sargramostim|mesh-list
24993841|NCT05348122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25840376|NCT00027807|Immunologic Factors|immunologic factors|mesh-ancestor
25840377|NCT00027807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840378|NCT00027807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840379|NCT00027807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25840380|NCT00027807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24447250|NCT00307671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25840381|NCT00027807|Antiviral Agents|antiviral agents|mesh-ancestor
25840382|NCT00027807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25840383|NCT00027820|Cyclosporine|cyclosporine|mesh-list
24511789|NCT00570895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840385|NCT00027820|Fludarabine|fludarabine|mesh-list
25840386|NCT00027820|Fludarabine phosphate|fludarabine phosphate|mesh-list
25840387|NCT00027820|Cyclosporins|cyclosporins|mesh-list
25840388|NCT00027820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476091|NCT00412919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476092|NCT00412919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476093|NCT00412919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476094|NCT00412997|Panobinostat|panobinostat|mesh-list
25840389|NCT00027820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25840390|NCT00027820|Antimetabolites|antimetabolites|mesh-ancestor
25840391|NCT00027820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806844|NCT02018328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24806845|NCT02018328|Analgesics|analgesics|mesh-ancestor
24806846|NCT02018328|Sensory System Agents|sensory system agents|mesh-ancestor
24806847|NCT02018328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24806848|NCT02018328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806849|NCT02018328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24806850|NCT02018328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24806851|NCT02018328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806852|NCT02018328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24806853|NCT02018328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806854|NCT02018367|Proflavine|proflavine|mesh-list
24806855|NCT02018367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24806856|NCT02018367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24806862|NCT02018523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840392|NCT00027820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24797957|NCT01959191|Antipyretics|antipyretics|mesh-ancestor
25840393|NCT00027820|Immunologic Factors|immunologic factors|mesh-ancestor
25840394|NCT00027820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840395|NCT00027820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840396|NCT00027820|Antifungal Agents|antifungal agents|mesh-ancestor
25840397|NCT00027820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25840398|NCT00027820|Dermatologic Agents|dermatologic agents|mesh-ancestor
25840399|NCT00027820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25840400|NCT00027820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25840401|NCT00027820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25840402|NCT00027820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25840403|NCT00027820|Antitubercular Agents|antitubercular agents|mesh-ancestor
25840404|NCT00027820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25840405|NCT00027833|Leucovorin|leucovorin|mesh-list
25840406|NCT00027833|Fluorouracil|fluorouracil|mesh-list
25840407|NCT00027833|Irinotecan|irinotecan|mesh-list
25840408|NCT00027833|Calcium|calcium|mesh-list
25840409|NCT00027833|Levoleucovorin|levoleucovorin|mesh-list
25840410|NCT00027833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25840411|NCT00027833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840412|NCT00027833|Antimetabolites|antimetabolites|mesh-ancestor
24806863|NCT02018523|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24806864|NCT02018523|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24806865|NCT02018523|Growth Substances|growth substances|mesh-ancestor
24806866|NCT02018523|Growth Inhibitors|growth inhibitors|mesh-ancestor
24806867|NCT02018523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806868|NCT02018536|Simeprevir|simeprevir|mesh-list
24806869|NCT02018536|Antiviral Agents|antiviral agents|mesh-ancestor
24806870|NCT02018536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24806871|NCT02018536|Protease Inhibitors|protease inhibitors|mesh-ancestor
24806872|NCT02018536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24806873|NCT02018536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806874|NCT02018588|Tryptophan|tryptophan|mesh-list
24806875|NCT02018588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24806876|NCT02018588|Antidepressive Agents|antidepressive agents|mesh-ancestor
24806877|NCT02018588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24806878|NCT02018601|Acetaminophen|acetaminophen|mesh-list
24806879|NCT02018601|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
24806923|NCT02018796|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24806924|NCT02018796|Hormone Antagonists|hormone antagonists|mesh-ancestor
25659881|NCT01612858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659882|NCT01612884|Clopidogrel|clopidogrel|mesh-list
25659883|NCT01612884|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25659884|NCT01612884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25659885|NCT01612884|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25659886|NCT01612884|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25659887|NCT01612884|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25840413|NCT00027833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203004|NCT02717052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24663505|NCT01301820|Antimetabolites|antimetabolites|mesh-ancestor
25840414|NCT00027833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25840415|NCT00027833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840416|NCT00027833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25840417|NCT00027833|Immunologic Factors|immunologic factors|mesh-ancestor
24806925|NCT02018796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24806927|NCT02018796|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24806928|NCT02018796|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24806929|NCT02018874|Gemcitabine|gemcitabine|mesh-list
24806930|NCT02018874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24806931|NCT02018874|Antimetabolites|antimetabolites|mesh-ancestor
24806932|NCT02018874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806933|NCT02018874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806934|NCT02018874|Antiviral Agents|antiviral agents|mesh-ancestor
24806935|NCT02018874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24806936|NCT02018874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24806937|NCT02018874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24476120|NCT00413127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25840418|NCT00027833|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25840419|NCT00027833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25840420|NCT00027833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840421|NCT00027833|Antidotes|antidotes|mesh-ancestor
25840422|NCT00027833|Protective Agents|protective agents|mesh-ancestor
25840423|NCT00027833|Vitamin B Complex|vitamin b complex|mesh-ancestor
25840424|NCT00027833|Vitamins|vitamins|mesh-ancestor
24994906|NCT00883480|Docetaxel|docetaxel|mesh-list
24806939|NCT02018874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806942|NCT02018965|Niacinamide|niacinamide|mesh-list
24806943|NCT02018965|Nicotinic Acids|nicotinic acids|mesh-list
24806944|NCT02018965|Vitamin B Complex|vitamin b complex|mesh-list
24806945|NCT02018965|Micronutrients|micronutrients|mesh-ancestor
24806946|NCT02018965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806947|NCT02018965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24806948|NCT02018965|Antimetabolites|antimetabolites|mesh-ancestor
24806949|NCT02018965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806950|NCT02018965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24806951|NCT02018965|Vasodilator Agents|vasodilator agents|mesh-ancestor
24806952|NCT02018991|Everolimus|everolimus|mesh-list
24806953|NCT02018991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806954|NCT02018991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24806955|NCT02018991|Immunologic Factors|immunologic factors|mesh-ancestor
24806956|NCT02018991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806957|NCT02019017|Botulinum Toxins|botulinum toxins|mesh-list
24806958|NCT02019017|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24806959|NCT02019017|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24806960|NCT02019017|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24806961|NCT02019017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24806962|NCT02019017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806963|NCT02019017|Cholinergic Agents|cholinergic agents|mesh-ancestor
24806965|NCT02019017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806966|NCT02019017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24806967|NCT02019017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24806968|NCT02019056|Pyridoxine|pyridoxine|mesh-list
24806969|NCT02019056|Metadoxine|metadoxine|mesh-list
24806970|NCT02019056|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24806971|NCT02019056|Vitamin B Complex|vitamin b complex|mesh-ancestor
24806972|NCT02019056|Vitamins|vitamins|mesh-ancestor
24806973|NCT02019056|Micronutrients|micronutrients|mesh-ancestor
24806974|NCT02019056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840425|NCT00027833|Micronutrients|micronutrients|mesh-ancestor
24806975|NCT02019095|Dimercaprol|dimercaprol|mesh-list
24807003|NCT02019290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24807004|NCT02019290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24807005|NCT02019290|Anesthetics, General|anesthetics, general|mesh-ancestor
24807006|NCT02019290|Anesthetics|anesthetics|mesh-ancestor
24807007|NCT02019290|GABA Modulators|gaba modulators|mesh-ancestor
24807008|NCT02019290|GABA Agents|gaba agents|mesh-ancestor
24807009|NCT02019290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24807010|NCT02019290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840426|NCT00027859|Ketoconazole|ketoconazole|mesh-list
25840427|NCT00027859|Hydrocortisone|hydrocortisone|mesh-list
25840428|NCT00027859|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24807041|NCT02019381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24465097|NCT00367913|Clarithromycin|clarithromycin|mesh-list
24807042|NCT02019381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24601897|NCT00966368|Insulin|insulin|mesh-list
24807044|NCT02019446|Antifungal Agents|antifungal agents|mesh-ancestor
24807045|NCT02019446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24807046|NCT02019446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24807047|NCT02019446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476129|NCT00413179|Metformin|metformin|mesh-list
25840429|NCT00027859|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25840430|NCT00027859|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25840431|NCT00027859|Docetaxel|docetaxel|mesh-list
24807070|NCT02019485|Adrenergic Agents|adrenergic agents|mesh-ancestor
24807071|NCT02019485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24807072|NCT02019524|Folic Acid|folic acid|mesh-list
24807073|NCT02019524|Vitamin B Complex|vitamin b complex|mesh-list
24807074|NCT02019524|Molgramostim|molgramostim|mesh-list
24807075|NCT02019524|Vaccines|vaccines|mesh-list
24476243|NCT00413686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476244|NCT00413699|Tofacitinib|tofacitinib|mesh-list
24476245|NCT00413699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24476246|NCT00413699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476247|NCT00413699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476248|NCT00413712|Adenosine|adenosine|mesh-list
24476249|NCT00413712|Calcium Channel Blockers|calcium channel blockers|mesh-list
24476250|NCT00413712|Calcium|calcium|mesh-list
25840432|NCT00027859|Estramustine|estramustine|mesh-list
25840433|NCT00027859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840434|NCT00027859|Tubulin Modulators|tubulin modulators|mesh-ancestor
24996507|NCT03387852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24807095|NCT02019810|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24807096|NCT02019810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25840435|NCT00027859|Antimitotic Agents|antimitotic agents|mesh-ancestor
25840436|NCT00027859|Mitosis Modulators|mitosis modulators|mesh-ancestor
25203005|NCT02717052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25203006|NCT02717052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25203007|NCT02717052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203008|NCT02717052|Antidepressive Agents|antidepressive agents|mesh-ancestor
25203009|NCT02717052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25203010|NCT02717091|Gemcitabine|gemcitabine|mesh-list
25203011|NCT02717091|Paclitaxel|paclitaxel|mesh-list
25203012|NCT02717091|Folfirinox|folfirinox|mesh-list
24447263|NCT00307723|Growth Inhibitors|growth inhibitors|mesh-ancestor
24447264|NCT00307723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24447265|NCT00307723|Antimetabolites|antimetabolites|mesh-ancestor
24447266|NCT00307723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447267|NCT00307723|Antiviral Agents|antiviral agents|mesh-ancestor
25840437|NCT00027859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840438|NCT00027859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25840439|NCT00027859|Antifungal Agents|antifungal agents|mesh-ancestor
24446763|NCT00305825|Growth Inhibitors|growth inhibitors|mesh-ancestor
24476371|NCT00414414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24476374|NCT00414414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24476375|NCT00414414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476376|NCT00414414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24476377|NCT00414414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807099|NCT02019810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807100|NCT02019810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476403|NCT00414921|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24476404|NCT00414921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476405|NCT00414921|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24476406|NCT00414921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24476407|NCT00414921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24476460|NCT00415103|Antiemetics|antiemetics|mesh-ancestor
25163464|NCT02896101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163465|NCT02895958|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25163472|NCT02896023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163473|NCT02895659|Norepinephrine|norepinephrine|mesh-list
25163474|NCT02895659|Epinephrine|epinephrine|mesh-list
25163475|NCT02895659|Racepinephrine|racepinephrine|mesh-list
25163476|NCT02895659|Epinephryl borate|epinephryl borate|mesh-list
25163477|NCT02895659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25415217|NCT03012529|Vitamins|vitamins|mesh-ancestor
25659888|NCT01612884|Purinergic Agents|purinergic agents|mesh-ancestor
25659889|NCT01612884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25659890|NCT01612884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886390|NCT04526353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24886391|NCT04526353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886392|NCT04526353|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24886402|NCT04526210|Antidepressive Agents|antidepressive agents|mesh-ancestor
24886403|NCT04526210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24886404|NCT04526210|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25840440|NCT00027859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25840441|NCT00027859|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25840442|NCT00027859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25840443|NCT00027859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840444|NCT00027859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25840445|NCT00027859|Hormone Antagonists|hormone antagonists|mesh-ancestor
25840446|NCT00027859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25840447|NCT00027859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476528|NCT00415584|Cinacalcet|cinacalcet|mesh-list
24476529|NCT00415584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24476530|NCT00415584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786184|NCT01918475|Carbetocin|carbetocin|mesh-list
24476531|NCT00415584|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25840448|NCT00027859|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25840449|NCT00027859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24807108|NCT02019810|Protective Agents|protective agents|mesh-ancestor
24807109|NCT02019836|Vitamin D|vitamin d|mesh-list
24807110|NCT02019836|Vitamins|vitamins|mesh-ancestor
24807111|NCT02019836|Micronutrients|micronutrients|mesh-ancestor
24807112|NCT02019836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807113|NCT02019836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24476616|NCT00415883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476617|NCT00415922|Levodopa|levodopa|mesh-list
24476618|NCT00415922|Carbidopa|carbidopa|mesh-list
24476619|NCT00415922|Entacapone|entacapone|mesh-list
24476623|NCT00415922|Dopamine Agents|dopamine agents|mesh-ancestor
24476624|NCT00415922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24476625|NCT00415922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476626|NCT00415922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664193|NCT01305707|Antidepressive Agents|antidepressive agents|mesh-list
24664194|NCT01305707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24664195|NCT01305707|Serotonin Agents|serotonin agents|mesh-ancestor
24664196|NCT01305707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24476628|NCT00415922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476629|NCT00415922|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24476630|NCT00415922|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24476631|NCT00415922|Immunologic Factors|immunologic factors|mesh-ancestor
24476632|NCT00415922|Dopamine Agonists|dopamine agonists|mesh-ancestor
24476634|NCT00415935|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24476672|NCT00416130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476673|NCT00416130|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24858892|NCT02300350|Protective Agents|protective agents|mesh-ancestor
24476675|NCT00416130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476676|NCT00416143|Prednisone|prednisone|mesh-list
24476677|NCT00416143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24476678|NCT00416143|Glucocorticoids|glucocorticoids|mesh-ancestor
24476679|NCT00416143|Hormones|hormones|mesh-ancestor
24476680|NCT00416143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24476681|NCT00416143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476682|NCT00416143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25163478|NCT02895659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25840450|NCT00027859|Alkylating Agents|alkylating agents|mesh-ancestor
24664296|NCT01305837|Hormones|hormones|mesh-ancestor
24664297|NCT01305837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24664298|NCT01305837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24476836|NCT00416676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24476837|NCT00416676|Alkylating Agents|alkylating agents|mesh-ancestor
24476838|NCT00416676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477006|NCT00416962|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25659891|NCT01612884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659892|NCT01613027|Rituximab|rituximab|mesh-list
25659893|NCT01613027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25659894|NCT01613027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659895|NCT01613027|Immunologic Factors|immunologic factors|mesh-ancestor
25659896|NCT01613027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659897|NCT01613027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25659898|NCT01613131|Estradiol|estradiol|mesh-list
24886527|NCT04525235|Anesthetics, General|anesthetics, general|mesh-ancestor
24886528|NCT04525235|Anesthetics|anesthetics|mesh-ancestor
24886529|NCT04525235|GABA Modulators|gaba modulators|mesh-ancestor
24477007|NCT00416962|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24477008|NCT00416962|Dopamine Agents|dopamine agents|mesh-ancestor
24477009|NCT00416962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24477010|NCT00416962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477011|NCT00416962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24477012|NCT00416962|Analgesics|analgesics|mesh-ancestor
24477013|NCT00416962|Sensory System Agents|sensory system agents|mesh-ancestor
24477014|NCT00416962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24477015|NCT00417014|Prednisolone|prednisolone|mesh-list
24477033|NCT00417053|Cyclophosphamide|cyclophosphamide|mesh-list
24477035|NCT00417053|Busulfan|busulfan|mesh-list
24477036|NCT00417053|Carboplatin|carboplatin|mesh-list
24477037|NCT00417053|Doxorubicin|doxorubicin|mesh-list
24477038|NCT00417053|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24477039|NCT00417053|Etoposide|etoposide|mesh-list
24477040|NCT00417053|Vincristine|vincristine|mesh-list
24477041|NCT00417053|Etoposide phosphate|etoposide phosphate|mesh-list
24477042|NCT00417053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24477043|NCT00417053|Immunologic Factors|immunologic factors|mesh-ancestor
25163479|NCT02895659|Adrenergic Agents|adrenergic agents|mesh-ancestor
25840451|NCT00027859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24477044|NCT00417053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477045|NCT00417053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24477046|NCT00417053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24477047|NCT00417053|Alkylating Agents|alkylating agents|mesh-ancestor
24477048|NCT00417053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477049|NCT00417053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477051|NCT00417053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24477052|NCT00417053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25099203|NCT03192878|Infliximab|infliximab|mesh-list
24477053|NCT00417053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24477054|NCT00417053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477055|NCT00417053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24477056|NCT00417053|Tubulin Modulators|tubulin modulators|mesh-ancestor
24602136|NCT00967382|Tinzaparin|tinzaparin|mesh-list
24602137|NCT00967382|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24602138|NCT00967382|Anticoagulants|anticoagulants|mesh-ancestor
24602139|NCT00967382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25840452|NCT00027872|Tipifarnib|tipifarnib|mesh-list
24477057|NCT00417053|Antimitotic Agents|antimitotic agents|mesh-ancestor
24477058|NCT00417053|Mitosis Modulators|mitosis modulators|mesh-ancestor
24477059|NCT00417066|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24477060|NCT00417066|Ganirelix|ganirelix|mesh-list
24477061|NCT00417066|Luteolytic Agents|luteolytic agents|mesh-ancestor
24477124|NCT00417404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477125|NCT00417404|Antioxidants|antioxidants|mesh-ancestor
24477126|NCT00417404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477127|NCT00417404|Protective Agents|protective agents|mesh-ancestor
24477128|NCT00417404|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24477129|NCT00417404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477130|NCT00417430|Fulvestrant|fulvestrant|mesh-list
24477132|NCT00417430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477139|NCT00417443|Analgesics|analgesics|mesh-ancestor
24477140|NCT00417443|Sensory System Agents|sensory system agents|mesh-ancestor
24477141|NCT00417443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24477142|NCT00417443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840453|NCT00027872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477187|NCT00417729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477188|NCT00417729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477189|NCT00417729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24477190|NCT00417729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477191|NCT00417768|Plasminogen|plasminogen|mesh-list
24477192|NCT00417768|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24477243|NCT00417937|Dermatologic Agents|dermatologic agents|mesh-ancestor
24477244|NCT00417950|Acarbose|acarbose|mesh-list
24477245|NCT00417950|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24477246|NCT00417950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477247|NCT00417950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477248|NCT00417950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24804805|NCT02005315|Antimetabolites|antimetabolites|mesh-ancestor
25659899|NCT01613131|Estrogens|estrogens|mesh-ancestor
25659900|NCT01613131|Hormones|hormones|mesh-ancestor
24477249|NCT00417950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477250|NCT00418054|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24477251|NCT00418054|Interferon-alpha|interferon-alpha|mesh-list
24512164|NCT00573404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24477252|NCT00418054|Nitazoxanide|nitazoxanide|mesh-list
24477253|NCT00418054|Antiviral Agents|antiviral agents|mesh-ancestor
24477254|NCT00418054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24602140|NCT00967382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24602141|NCT00967382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602143|NCT00967408|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24602144|NCT00967408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24602145|NCT00967408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24602146|NCT00967408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602147|NCT00967408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24602148|NCT00967408|Serotonin Agents|serotonin agents|mesh-ancestor
24602149|NCT00967408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602150|NCT00967408|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24602151|NCT00967408|Antidepressive Agents|antidepressive agents|mesh-ancestor
24477255|NCT00418054|Immunologic Factors|immunologic factors|mesh-ancestor
24477256|NCT00418054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477257|NCT00418054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24477258|NCT00418067|Sirolimus|sirolimus|mesh-list
24477259|NCT00418067|Paclitaxel|paclitaxel|mesh-list
24477260|NCT00418067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24477261|NCT00418067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163480|NCT02895659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24447269|NCT00307723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24447270|NCT00307723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24447271|NCT00307723|Immunologic Factors|immunologic factors|mesh-ancestor
24447272|NCT00307775|Estradiol|estradiol|mesh-list
24447276|NCT00307775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447278|NCT00307814|Hematinics|hematinics|mesh-ancestor
24447279|NCT00307827|Visilizumab|visilizumab|mesh-list
24447280|NCT00307827|Immunologic Factors|immunologic factors|mesh-ancestor
25840454|NCT00027885|Cyclophosphamide|cyclophosphamide|mesh-list
25840455|NCT00027885|Bevacizumab|bevacizumab|mesh-list
25840456|NCT00027885|Docetaxel|docetaxel|mesh-list
25840457|NCT00027885|Doxorubicin|doxorubicin|mesh-list
25840458|NCT00027885|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25840459|NCT00027885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25840460|NCT00027885|Immunologic Factors|immunologic factors|mesh-ancestor
24807617|NCT02022722|Hormones|hormones|mesh-ancestor
25840461|NCT00027885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840462|NCT00027885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25840463|NCT00027885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25840464|NCT00027885|Alkylating Agents|alkylating agents|mesh-ancestor
25840465|NCT00027885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840466|NCT00027885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840467|NCT00027885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25840468|NCT00027885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25840469|NCT00027885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25840470|NCT00027885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25840471|NCT00027885|Growth Substances|growth substances|mesh-ancestor
25041528|NCT02502669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477262|NCT00418067|Tubulin Modulators|tubulin modulators|mesh-ancestor
24477281|NCT00418132|Thalidomide|thalidomide|mesh-list
24477282|NCT00418132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24477283|NCT00418132|Immunologic Factors|immunologic factors|mesh-ancestor
24477284|NCT00418132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477293|NCT00418171|Olanzapine|olanzapine|mesh-list
24477294|NCT00418171|Ziprasidone|ziprasidone|mesh-list
24477295|NCT00418171|Antiemetics|antiemetics|mesh-ancestor
24477296|NCT00418171|Autonomic Agents|autonomic agents|mesh-ancestor
24477297|NCT00418171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24477298|NCT00418171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477299|NCT00418171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24477300|NCT00418171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24622713|NCT01068093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477337|NCT00418327|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24477338|NCT00418327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477339|NCT00418327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24477340|NCT00418327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477341|NCT00418327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163481|NCT02895659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163482|NCT02895659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163483|NCT02895659|Sympathomimetics|sympathomimetics|mesh-ancestor
25659901|NCT01613131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24886646|NCT04524026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816564|NCT02077712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24816565|NCT02077712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816567|NCT02077751|Vitamin B Complex|vitamin b complex|mesh-ancestor
25163484|NCT02895659|Autonomic Agents|autonomic agents|mesh-ancestor
25163485|NCT02895659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25163486|NCT02895659|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25163487|NCT02895659|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25163488|NCT02895659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25163489|NCT02895659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25163490|NCT02895659|Respiratory System Agents|respiratory system agents|mesh-ancestor
25163491|NCT02895659|Mydriatics|mydriatics|mesh-ancestor
25163492|NCT02895529|Itraconazole|itraconazole|mesh-list
25163493|NCT02895529|Caspofungin|caspofungin|mesh-list
25163494|NCT02895529|Antifungal Agents|antifungal agents|mesh-ancestor
25163495|NCT02895529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25163496|NCT02895529|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25163497|NCT02895529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25163498|NCT02895529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163499|NCT02895529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163500|NCT02895529|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25163501|NCT02895529|Hormone Antagonists|hormone antagonists|mesh-ancestor
25163502|NCT02895529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25163503|NCT02895529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163504|NCT02895529|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25163505|NCT02895672|Exenatide|exenatide|mesh-list
25163506|NCT02895672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24477354|NCT00418353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25840472|NCT00027885|Growth Inhibitors|growth inhibitors|mesh-ancestor
24446768|NCT00305825|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24446769|NCT00305825|Hormone Antagonists|hormone antagonists|mesh-ancestor
24446770|NCT00305825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24477358|NCT00418353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24477359|NCT00418353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477360|NCT00418353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24477361|NCT00418353|Respiratory System Agents|respiratory system agents|mesh-ancestor
24477362|NCT00418353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24477363|NCT00418366|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24477364|NCT00418366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24477365|NCT00418366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477366|NCT00418366|Incretins|incretins|mesh-ancestor
24477368|NCT00418366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24477369|NCT00418366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24477370|NCT00418366|Protease Inhibitors|protease inhibitors|mesh-ancestor
24477371|NCT00418366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477372|NCT00418366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477373|NCT00418392|Minocycline|minocycline|mesh-list
25840473|NCT00027885|Tubulin Modulators|tubulin modulators|mesh-ancestor
25840474|NCT00027885|Antimitotic Agents|antimitotic agents|mesh-ancestor
25840475|NCT00027885|Mitosis Modulators|mitosis modulators|mesh-ancestor
24456739|NCT00332085|Chromium|chromium|mesh-list
24477440|NCT00418587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24477458|NCT00418678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24477459|NCT00418678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24477460|NCT00418678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24477472|NCT00418730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477473|NCT00418730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477474|NCT00418782|Naproxen|naproxen|mesh-list
24477475|NCT00418782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24477476|NCT00418782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24477477|NCT00418782|Analgesics|analgesics|mesh-ancestor
24477478|NCT00418782|Sensory System Agents|sensory system agents|mesh-ancestor
24840409|NCT02210104|Ipilimumab|ipilimumab|mesh-list
24477479|NCT00418782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24535721|NCT00649610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415218|NCT03012529|Micronutrients|micronutrients|mesh-ancestor
25659902|NCT01613131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659903|NCT01613326|Glycopyrrolate|glycopyrrolate|mesh-list
25659904|NCT01613326|Albuterol|albuterol|mesh-list
25659905|NCT01613326|Tiotropium Bromide|tiotropium bromide|mesh-list
25659906|NCT01613326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25659907|NCT01613326|Autonomic Agents|autonomic agents|mesh-ancestor
24465316|NCT00368914|Sirolimus|sirolimus|mesh-list
24465317|NCT00368914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24465318|NCT00368914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25659908|NCT01613326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25840476|NCT00027885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25840477|NCT00027885|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24512309|NCT00574015|Antipyretics|antipyretics|mesh-ancestor
24477515|NCT00418860|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25840478|NCT00027885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25659909|NCT01613326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840479|NCT00027885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840480|NCT00027898|Carboplatin|carboplatin|mesh-list
24477516|NCT00418860|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24477517|NCT00418860|Purinergic Agents|purinergic agents|mesh-ancestor
24477518|NCT00418860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24477519|NCT00418873|Risperidone|risperidone|mesh-list
24477520|NCT00418873|Zotepine|zotepine|mesh-list
24477595|NCT00419172|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24477596|NCT00419172|Chelating Agents|chelating agents|mesh-ancestor
24477597|NCT00419172|Sequestering Agents|sequestering agents|mesh-ancestor
24477598|NCT00419250|Lenalidomide|lenalidomide|mesh-list
24477599|NCT00419250|Immunologic Factors|immunologic factors|mesh-ancestor
24477600|NCT00419250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477601|NCT00419250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24477602|NCT00419250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24477603|NCT00419250|Growth Substances|growth substances|mesh-ancestor
24477604|NCT00419250|Growth Inhibitors|growth inhibitors|mesh-ancestor
24477605|NCT00419250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477606|NCT00419302|Insulin|insulin|mesh-list
24477607|NCT00419302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24477672|NCT00419653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24477673|NCT00419653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25108330|NCT03132714|Clarithromycin|clarithromycin|mesh-list
24477674|NCT00419653|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24477675|NCT00419653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24477676|NCT00419653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24807158|NCT02020122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24807159|NCT02020122|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24807160|NCT02020122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24807161|NCT02020122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25840481|NCT00027898|Etoposide|etoposide|mesh-list
25840482|NCT00027898|Bortezomib|bortezomib|mesh-list
25840483|NCT00027898|Etoposide phosphate|etoposide phosphate|mesh-list
24807173|NCT02020161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807174|NCT02020161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25840484|NCT00027898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477732|NCT00419783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24477733|NCT00419796|Lumiracoxib|lumiracoxib|mesh-list
24477734|NCT00419796|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24477735|NCT00419796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24477736|NCT00419796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477737|NCT00419796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477738|NCT00419796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24537432|NCT00654576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24477768|NCT00419887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477769|NCT00419887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477770|NCT00419913|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24477771|NCT00419913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24477772|NCT00419913|Immunologic Factors|immunologic factors|mesh-ancestor
24477773|NCT00419913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477775|NCT00419991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24477776|NCT00419991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25840485|NCT00027898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25840486|NCT00027898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25840487|NCT00027898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25840488|NCT00027898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840489|NCT00027898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840490|NCT00027911|Sargramostim|sargramostim|mesh-list
24449585|NCT00316160|Bupropion|bupropion|mesh-list
25659910|NCT01613326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25659911|NCT01613326|Respiratory System Agents|respiratory system agents|mesh-ancestor
25659912|NCT01613326|Parasympatholytics|parasympatholytics|mesh-ancestor
25659913|NCT01613326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25659914|NCT01613326|Cholinergic Agents|cholinergic agents|mesh-ancestor
25659915|NCT01613326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24886825|NCT04522297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25840491|NCT00027911|Immunologic Factors|immunologic factors|mesh-ancestor
25840492|NCT00027911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840493|NCT00027924|Cyclosporine|cyclosporine|mesh-list
25840494|NCT00027924|Methotrexate|methotrexate|mesh-list
25840495|NCT00027924|Fludarabine phosphate|fludarabine phosphate|mesh-list
25840496|NCT00027924|Fludarabine|fludarabine|mesh-list
25840497|NCT00027924|Busulfan|busulfan|mesh-list
25840498|NCT00027924|Cyclosporins|cyclosporins|mesh-list
25840499|NCT00027924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25840500|NCT00027924|Abortifacient Agents|abortifacient agents|mesh-ancestor
25840501|NCT00027924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25840502|NCT00027924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840503|NCT00027924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25840504|NCT00027924|Antimetabolites|antimetabolites|mesh-ancestor
25840505|NCT00027924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840506|NCT00027924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840507|NCT00027924|Dermatologic Agents|dermatologic agents|mesh-ancestor
25840508|NCT00027924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840509|NCT00027924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25840510|NCT00027924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25840511|NCT00027924|Immunologic Factors|immunologic factors|mesh-ancestor
25840512|NCT00027924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25840513|NCT00027924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25840514|NCT00027924|Antifungal Agents|antifungal agents|mesh-ancestor
25840515|NCT00027924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25840516|NCT00027924|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25840517|NCT00027924|Alkylating Agents|alkylating agents|mesh-ancestor
25840518|NCT00027924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25840519|NCT00027924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25659916|NCT01613326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477883|NCT00420589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24477884|NCT00420589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477885|NCT00420615|Epothilone B|epothilone b|mesh-list
24477886|NCT00420615|Epothilones|epothilones|mesh-list
24477888|NCT00420615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24477889|NCT00420615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24477890|NCT00420615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24477891|NCT00420615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477892|NCT00420615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807193|NCT02020200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24807194|NCT02020200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807195|NCT02020200|Dopamine Agents|dopamine agents|mesh-ancestor
24807196|NCT02020200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24807197|NCT02020213|Posaconazole|posaconazole|mesh-list
24807198|NCT02020213|Antifungal Agents|antifungal agents|mesh-ancestor
24807199|NCT02020213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24807200|NCT02020213|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24807201|NCT02020213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24807202|NCT02020213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24807203|NCT02020213|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24807204|NCT02020213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24587901|NCT00898508|Antibodies|antibodies|mesh-list
24477948|NCT00420953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24477949|NCT00420953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477950|NCT00420953|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25659917|NCT01613326|Tocolytic Agents|tocolytic agents|mesh-ancestor
25659918|NCT01613326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25659919|NCT01613326|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25659920|NCT01613326|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25659921|NCT01613326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25659922|NCT01613326|Adrenergic Agents|adrenergic agents|mesh-ancestor
25659923|NCT01613326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25659924|NCT01613326|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25659925|NCT01613599|Rituximab|rituximab|mesh-list
25659926|NCT01613599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25659927|NCT01613599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659928|NCT01613599|Immunologic Factors|immunologic factors|mesh-ancestor
25659929|NCT01613599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659930|NCT01613599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25659931|NCT01613716|Dexamethasone|dexamethasone|mesh-list
25659932|NCT01613716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25659933|NCT01613716|Antiemetics|antiemetics|mesh-ancestor
25659934|NCT01613716|Autonomic Agents|autonomic agents|mesh-ancestor
24886965|NCT04521491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24477951|NCT00420953|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24477952|NCT00420953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24477954|NCT00421018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25840520|NCT00027937|Aldesleukin|aldesleukin|mesh-list
25840521|NCT00027937|Paclitaxel|paclitaxel|mesh-list
25840522|NCT00027937|Cyclophosphamide|cyclophosphamide|mesh-list
25840523|NCT00027937|Melphalan|melphalan|mesh-list
24478003|NCT00421122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478004|NCT00421122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24478005|NCT00421122|Respiratory System Agents|respiratory system agents|mesh-ancestor
24478006|NCT00421122|Glucocorticoids|glucocorticoids|mesh-ancestor
24478007|NCT00421122|Hormones|hormones|mesh-ancestor
24537652|NCT00655616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25840524|NCT00027937|Busulfan|busulfan|mesh-list
25840525|NCT00027937|Thiotepa|thiotepa|mesh-list
25840526|NCT00027937|Sargramostim|sargramostim|mesh-list
25840527|NCT00027937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25840528|NCT00027937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840529|NCT00027937|Tubulin Modulators|tubulin modulators|mesh-ancestor
25840530|NCT00027937|Antimitotic Agents|antimitotic agents|mesh-ancestor
25840531|NCT00027937|Mitosis Modulators|mitosis modulators|mesh-ancestor
24665196|NCT01310738|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
24665197|NCT01310738|Meglumine Antimoniate|meglumine antimoniate|mesh-list
25840532|NCT00027937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840533|NCT00027937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25840534|NCT00027937|Immunologic Factors|immunologic factors|mesh-ancestor
25840535|NCT00027937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840536|NCT00027937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25840537|NCT00027937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25840538|NCT00027937|Alkylating Agents|alkylating agents|mesh-ancestor
25840539|NCT00027937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25840540|NCT00027937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25840541|NCT00027937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25840542|NCT00027937|Antiviral Agents|antiviral agents|mesh-ancestor
25840543|NCT00027937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25840544|NCT00027963|Gabapentin|gabapentin|mesh-list
25840545|NCT00027963|Analgesics|analgesics|mesh-ancestor
25840546|NCT00027963|Sensory System Agents|sensory system agents|mesh-ancestor
25840547|NCT00027963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25041553|NCT02488408|Immunologic Factors|immunologic factors|mesh-ancestor
25840548|NCT00027963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840549|NCT00027963|Anticonvulsants|anticonvulsants|mesh-ancestor
25840550|NCT00027963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25840551|NCT00027963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25840552|NCT00027963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25840553|NCT00027963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25840554|NCT00027963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25840555|NCT00027963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25840556|NCT00027963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25840557|NCT00027963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840558|NCT00027963|Antimanic Agents|antimanic agents|mesh-ancestor
25840559|NCT00027976|Celecoxib|celecoxib|mesh-list
25840560|NCT00027976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25840561|NCT00027976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25840562|NCT00027976|Analgesics|analgesics|mesh-ancestor
25840563|NCT00027976|Sensory System Agents|sensory system agents|mesh-ancestor
24478067|NCT00421421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478069|NCT00421434|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25840564|NCT00027976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25840565|NCT00027976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659935|NCT01613716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25659936|NCT01613716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659937|NCT01613716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25659938|NCT01613716|Glucocorticoids|glucocorticoids|mesh-ancestor
25659939|NCT01613716|Hormones|hormones|mesh-ancestor
25659940|NCT01613716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25659941|NCT01613716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25659942|NCT01613716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659943|NCT01614093|Oxytocin|oxytocin|mesh-list
25659944|NCT01614093|Oxytocics|oxytocics|mesh-ancestor
25659945|NCT01614093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25659946|NCT01614093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659947|NCT01614210|Tamoxifen|tamoxifen|mesh-list
24816604|NCT02077933|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24816605|NCT02077933|Hormone Antagonists|hormone antagonists|mesh-ancestor
24816607|NCT02077946|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25840566|NCT00027976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25840567|NCT00027976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25840568|NCT00027976|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25840569|NCT00027976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25840570|NCT00027976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840571|NCT00027976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840572|NCT00027989|Gemcitabine|gemcitabine|mesh-list
25840573|NCT00027989|Doxorubicin|doxorubicin|mesh-list
25840574|NCT00027989|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24478083|NCT00421447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24478084|NCT00421447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478085|NCT00421447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478086|NCT00421447|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24807207|NCT02020213|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24807208|NCT02020213|Hormone Antagonists|hormone antagonists|mesh-ancestor
24807209|NCT02020213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24807210|NCT02020213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807211|NCT02020330|Lumefantrine|lumefantrine|mesh-list
24807212|NCT02020330|Artemether|artemether|mesh-list
25163508|NCT02895672|Incretins|incretins|mesh-ancestor
25163510|NCT02895672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25163511|NCT02895672|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25163513|NCT02895750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25163514|NCT02895750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163515|NCT02895191|Urinastatin|urinastatin|mesh-list
25163516|NCT02895191|Trypsin Inhibitors|trypsin inhibitors|mesh-list
25004820|NCT01416935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25004821|NCT01416935|Vasodilator Agents|vasodilator agents|mesh-ancestor
25004822|NCT01416935|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24845866|NCT02239835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845867|NCT02239835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24845868|NCT02239835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24845869|NCT02239835|Antiviral Agents|antiviral agents|mesh-ancestor
25163517|NCT02895191|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25163518|NCT02895191|Protease Inhibitors|protease inhibitors|mesh-ancestor
25163519|NCT02895191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478105|NCT00421473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24478106|NCT00421473|Antimalarials|antimalarials|mesh-ancestor
24478107|NCT00421473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24478108|NCT00421473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24478109|NCT00421473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478110|NCT00421473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478111|NCT00421473|Antimetabolites|antimetabolites|mesh-ancestor
24478112|NCT00421512|Bevacizumab|bevacizumab|mesh-list
24478114|NCT00421512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24478115|NCT00421512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478116|NCT00421512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24478124|NCT00421538|Nadroparin|nadroparin|mesh-list
24478125|NCT00421538|Calcium|calcium|mesh-list
24478126|NCT00421538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24478127|NCT00421538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537891|NCT00656695|Cyclosporins|cyclosporins|mesh-list
25840575|NCT00027989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25840576|NCT00027989|Antimetabolites|antimetabolites|mesh-ancestor
25840577|NCT00027989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478151|NCT00421694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24478152|NCT00421694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478153|NCT00421694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478155|NCT00421720|Remifentanil|remifentanil|mesh-list
24478156|NCT00421720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24478157|NCT00421720|Narcotics|narcotics|mesh-ancestor
24478158|NCT00421720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25659948|NCT01614210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25659949|NCT01614210|Hormone Antagonists|hormone antagonists|mesh-ancestor
25659950|NCT01614210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25659951|NCT01614210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659952|NCT01614210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25659953|NCT01614210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659954|NCT01614210|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25659955|NCT01614210|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25060698|NCT03477929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25060699|NCT03477864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25060701|NCT03477864|Cemiplimab|cemiplimab|mesh-list
24887162|NCT04519125|Emtricitabine|emtricitabine|mesh-list
24887163|NCT04519125|Antiviral Agents|antiviral agents|mesh-ancestor
24887164|NCT04519125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24672739|NCT01333423|Roscovitine|roscovitine|mesh-list
24478159|NCT00421720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478160|NCT00421720|Analgesics|analgesics|mesh-ancestor
24478161|NCT00421720|Sensory System Agents|sensory system agents|mesh-ancestor
24478162|NCT00421720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24478163|NCT00421720|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24478164|NCT00421720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24478165|NCT00421720|Anesthetics, General|anesthetics, general|mesh-ancestor
24478166|NCT00421720|Anesthetics|anesthetics|mesh-ancestor
24478167|NCT00421785|Acetylcysteine|acetylcysteine|mesh-list
24478168|NCT00421785|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24478169|NCT00421785|Antiviral Agents|antiviral agents|mesh-ancestor
24478170|NCT00421785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24478171|NCT00421785|Expectorants|expectorants|mesh-ancestor
24478172|NCT00421785|Respiratory System Agents|respiratory system agents|mesh-ancestor
24478173|NCT00421785|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25840578|NCT00027989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840579|NCT00027989|Antiviral Agents|antiviral agents|mesh-ancestor
25840580|NCT00027989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25840581|NCT00027989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478181|NCT00421811|Alkylating Agents|alkylating agents|mesh-ancestor
24478182|NCT00421811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478183|NCT00421811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478184|NCT00421811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24478185|NCT00421811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24478186|NCT00421811|Immunologic Factors|immunologic factors|mesh-ancestor
25163520|NCT02895191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478187|NCT00421811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478188|NCT00421824|Capecitabine|capecitabine|mesh-list
24478189|NCT00421824|Oxaliplatin|oxaliplatin|mesh-list
24478212|NCT00421863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25840582|NCT00027989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24478213|NCT00421863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24478214|NCT00421863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24478215|NCT00421863|Adrenergic Agents|adrenergic agents|mesh-ancestor
24478216|NCT00421863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24478217|NCT00421863|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24478218|NCT00421863|Protease Inhibitors|protease inhibitors|mesh-ancestor
24478219|NCT00421863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478220|NCT00421915|Etanercept|etanercept|mesh-list
24478221|NCT00421915|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24478222|NCT00421915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24478224|NCT00421915|Sensory System Agents|sensory system agents|mesh-ancestor
24478225|NCT00421915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24478226|NCT00421915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807227|NCT02020551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24807229|NCT02020551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24807230|NCT02020551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24807231|NCT02020551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807232|NCT02020603|Epinephrine|epinephrine|mesh-list
24807233|NCT02020603|Racepinephrine|racepinephrine|mesh-list
24807235|NCT02020603|Epinephryl borate|epinephryl borate|mesh-list
24807236|NCT02020603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24807237|NCT02020603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24807238|NCT02020603|Adrenergic Agents|adrenergic agents|mesh-ancestor
25840583|NCT00027989|Immunologic Factors|immunologic factors|mesh-ancestor
24478345|NCT00422435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478346|NCT00422435|Tubulin Modulators|tubulin modulators|mesh-ancestor
24478484|NCT00423059|Growth Inhibitors|growth inhibitors|mesh-ancestor
24478485|NCT00423163|Voriconazole|voriconazole|mesh-list
24478486|NCT00423163|Micafungin|micafungin|mesh-list
24478487|NCT00423163|Antifungal Agents|antifungal agents|mesh-ancestor
25659956|NCT01614210|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25659957|NCT01614457|Ivacaftor|ivacaftor|mesh-list
25659958|NCT01614457|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25659959|NCT01614457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25659960|NCT01614457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659961|NCT01614470|Ivacaftor|ivacaftor|mesh-list
25659962|NCT01614470|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24887327|NCT04517292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24887328|NCT04517292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887329|NCT04517292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24887330|NCT04517292|Immunologic Factors|immunologic factors|mesh-ancestor
25060723|NCT03477422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060724|NCT03477344|Dexmedetomidine|dexmedetomidine|mesh-list
24823139|NCT02115204|Tubulin Modulators|tubulin modulators|mesh-ancestor
24672913|NCT01334424|Propofol|propofol|mesh-list
24478488|NCT00423163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25840584|NCT00027989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840585|NCT00027989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25840586|NCT00027989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25840587|NCT00027989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25840588|NCT00028028|Sirolimus|sirolimus|mesh-list
25840589|NCT00028028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25840590|NCT00028028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25840591|NCT00028028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24807244|NCT02020603|Autonomic Agents|autonomic agents|mesh-ancestor
24807248|NCT02020603|Mydriatics|mydriatics|mesh-ancestor
24807259|NCT02020694|Vitamin D|vitamin d|mesh-list
24807260|NCT02020694|Ergocalciferols|ergocalciferols|mesh-list
24807261|NCT02020694|Cholecalciferol|cholecalciferol|mesh-list
24807262|NCT02020694|Vitamins|vitamins|mesh-list
24807263|NCT02020694|Micronutrients|micronutrients|mesh-ancestor
24807264|NCT02020694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807265|NCT02020694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24807266|NCT02020694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24807267|NCT02020720|Fluorides|fluorides|mesh-list
24807268|NCT02020720|Cariostatic Agents|cariostatic agents|mesh-ancestor
24807269|NCT02020720|Protective Agents|protective agents|mesh-ancestor
24807270|NCT02020720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807271|NCT02020980|Botulinum Toxins|botulinum toxins|mesh-list
24807272|NCT02020980|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24807273|NCT02020980|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24807274|NCT02020980|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24807275|NCT02020980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24807276|NCT02020980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807277|NCT02020980|Cholinergic Agents|cholinergic agents|mesh-ancestor
24807278|NCT02020980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24807279|NCT02020980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478490|NCT00423163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24478491|NCT00423163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478492|NCT00423163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478493|NCT00423163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24478494|NCT00423163|Hormone Antagonists|hormone antagonists|mesh-ancestor
24478495|NCT00423163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24478496|NCT00423163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478497|NCT00423163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24478498|NCT00423202|Ambrisentan|ambrisentan|mesh-list
24478499|NCT00423202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25163521|NCT02895061|Alfacalcidol|alfacalcidol|mesh-list
25163522|NCT02895061|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
25840592|NCT00028028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840593|NCT00028028|Antifungal Agents|antifungal agents|mesh-ancestor
25840594|NCT00028028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25840595|NCT00028028|Immunologic Factors|immunologic factors|mesh-ancestor
24448081|NCT00310154|Docetaxel|docetaxel|mesh-list
25840596|NCT00028028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840597|NCT00028106|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
25840598|NCT00028106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840599|NCT00028106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25108557|NCT03131973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24861387|NCT02317419|Paclitaxel|paclitaxel|mesh-list
25659963|NCT01614470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25659964|NCT01614470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659965|NCT01614509|Triamcinolone|triamcinolone|mesh-list
25659966|NCT01614509|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25659967|NCT01614509|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25659968|NCT01614509|Bevacizumab|bevacizumab|mesh-list
25659969|NCT01614509|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25659970|NCT01614509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25659971|NCT01614509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25659972|NCT01614509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25659973|NCT01614509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25659974|NCT01614509|Growth Substances|growth substances|mesh-ancestor
25840600|NCT00028106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887509|NCT04515966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887512|NCT04515979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840601|NCT00028106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24673105|NCT01335334|Antacids|antacids|mesh-ancestor
24887549|NCT04515641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24887552|NCT04515238|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24887553|NCT04515238|Venetoclax|venetoclax|mesh-list
24887554|NCT04515238|Obinutuzumab|obinutuzumab|mesh-list
24887555|NCT04515238|Zanubrutinib|zanubrutinib|mesh-list
24887556|NCT04515238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24887565|NCT04514835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25840602|NCT00028132|Tenofovir|tenofovir|mesh-list
25840603|NCT00028132|Antiviral Agents|antiviral agents|mesh-ancestor
25840604|NCT00028132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25840605|NCT00028132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25840606|NCT00028132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25840607|NCT00028132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840608|NCT00028132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840609|NCT00028132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25840610|NCT00028132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25875644|NCT04248829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875645|NCT04245514|Durvalumab|durvalumab|mesh-list
25875646|NCT04245514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25875647|NCT04245514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875648|NCT04244552|Doxorubicin|doxorubicin|mesh-list
25875649|NCT04244552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25875650|NCT04244552|Pembrolizumab|pembrolizumab|mesh-list
24807294|NCT02021097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24807295|NCT02021097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24807296|NCT02021097|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24807297|NCT02021097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24807332|NCT02021240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24807333|NCT02021240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807334|NCT02021240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24807335|NCT02021240|Glucocorticoids|glucocorticoids|mesh-ancestor
24807337|NCT02021240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24807338|NCT02021240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24807339|NCT02021240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807340|NCT02021240|Analgesics|analgesics|mesh-ancestor
24807341|NCT02021240|Sensory System Agents|sensory system agents|mesh-ancestor
24807342|NCT02021240|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24478538|NCT00423501|Hormones|hormones|mesh-ancestor
24478542|NCT00423514|Melphalan|melphalan|mesh-list
24478543|NCT00423514|Thiotepa|thiotepa|mesh-list
24478544|NCT00423514|Clofarabine|clofarabine|mesh-list
24478545|NCT00423514|Tacrolimus|tacrolimus|mesh-list
24478546|NCT00423514|Immunologic Factors|immunologic factors|mesh-ancestor
24478547|NCT00423514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478548|NCT00423514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24478549|NCT00423514|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24478550|NCT00423514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478551|NCT00423514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478552|NCT00423514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24478553|NCT00423514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478554|NCT00423514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24478555|NCT00423514|Antitubercular Agents|antitubercular agents|mesh-ancestor
24478556|NCT00423514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24807361|NCT02021422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24807362|NCT02021422|Immunologic Factors|immunologic factors|mesh-ancestor
25163523|NCT02895061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25659975|NCT01614509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659976|NCT01614509|Growth Inhibitors|growth inhibitors|mesh-ancestor
25659977|NCT01614509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25659978|NCT01614509|Glucocorticoids|glucocorticoids|mesh-ancestor
25659979|NCT01614509|Hormones|hormones|mesh-ancestor
25659980|NCT01614509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25659981|NCT01614509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25659982|NCT01614509|Immunologic Factors|immunologic factors|mesh-ancestor
25659983|NCT01614509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25659984|NCT01614509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163524|NCT02895061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163525|NCT02895061|Vitamins|vitamins|mesh-ancestor
25060736|NCT03477344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25060737|NCT03477344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060738|NCT03477292|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25060739|NCT03477292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25060740|NCT03477266|Mosapride|mosapride|mesh-list
25060741|NCT03477266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25060742|NCT03477266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25060743|NCT03477266|Serotonin Agents|serotonin agents|mesh-ancestor
25163526|NCT02895061|Micronutrients|micronutrients|mesh-ancestor
24807363|NCT02021422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807364|NCT02021422|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24807365|NCT02021422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25163528|NCT02895113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24827595|NCT02140281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24827596|NCT02140333|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24719115|NCT01559285|Ropivacaine|ropivacaine|mesh-list
25840611|NCT00028171|Tacrolimus|tacrolimus|mesh-list
25840612|NCT00028171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25840613|NCT00028171|Immunologic Factors|immunologic factors|mesh-ancestor
25840614|NCT00028171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840615|NCT00028171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25840616|NCT00028171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840617|NCT00028171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840618|NCT00028275|Interferons|interferons|mesh-list
25840619|NCT00028275|Interferon-gamma|interferon-gamma|mesh-list
25840620|NCT00028275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840621|NCT00028275|Antiviral Agents|antiviral agents|mesh-ancestor
25840622|NCT00028275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25840623|NCT00028288|Daclizumab|daclizumab|mesh-list
25840624|NCT00028288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25840625|NCT00028288|Immunologic Factors|immunologic factors|mesh-ancestor
25840626|NCT00028288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840627|NCT00028314|Ritonavir|ritonavir|mesh-list
25840628|NCT00028314|Lopinavir|lopinavir|mesh-list
24447301|NCT00308048|Antimetabolites|antimetabolites|mesh-ancestor
25840629|NCT00028314|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25840630|NCT00028314|Nevirapine|nevirapine|mesh-list
25840631|NCT00028314|Abacavir|abacavir|mesh-list
25840632|NCT00028314|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25840633|NCT00028314|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25840634|NCT00028314|Protease Inhibitors|protease inhibitors|mesh-ancestor
25840635|NCT00028314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24807366|NCT02021422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24807367|NCT02021422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24478615|NCT00423709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478616|NCT00423709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24478617|NCT00423709|Alkylating Agents|alkylating agents|mesh-ancestor
24478618|NCT00423709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24478619|NCT00423748|Ambrisentan|ambrisentan|mesh-list
24478620|NCT00423748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24807393|NCT02021825|Sensory System Agents|sensory system agents|mesh-ancestor
24807394|NCT02021825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24807395|NCT02021825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807396|NCT02021825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807400|NCT02021825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840636|NCT00028314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840637|NCT00028314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25840638|NCT00028314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25840639|NCT00028314|Antiviral Agents|antiviral agents|mesh-ancestor
25163529|NCT02895113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25163530|NCT02895113|Analgesics|analgesics|mesh-ancestor
24868546|NCT04334174|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25163531|NCT02895113|Sensory System Agents|sensory system agents|mesh-ancestor
25163532|NCT02895113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25415369|NCT03007147|Cytarabine|cytarabine|mesh-list
25659985|NCT01614743|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25659986|NCT01614743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25659987|NCT01614743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25659988|NCT01614743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659989|NCT01614743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25659990|NCT01614743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25659991|NCT01614743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25659992|NCT01614743|Cholinergic Agents|cholinergic agents|mesh-ancestor
25840640|NCT00028314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24887801|NCT04512105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887835|NCT04511715|Bevacizumab|bevacizumab|mesh-list
25163533|NCT02895113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163534|NCT02895113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25163535|NCT02895113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25163536|NCT02895113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25163537|NCT02895113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25163538|NCT02895113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163539|NCT02895113|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25163540|NCT02895113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25163541|NCT02895113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163542|NCT02895113|Antipyretics|antipyretics|mesh-ancestor
25163543|NCT02895321|Listerine|listerine|mesh-list
25163544|NCT02895321|Sodium Fluoride|sodium fluoride|mesh-list
25163545|NCT02895321|Cariostatic Agents|cariostatic agents|mesh-ancestor
25163546|NCT02895321|Protective Agents|protective agents|mesh-ancestor
25163547|NCT02895321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163548|NCT02895321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25163549|NCT02895321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25163550|NCT02894983|Calpastatin|calpastatin|mesh-list
25163551|NCT02894983|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25163552|NCT02894983|Protease Inhibitors|protease inhibitors|mesh-ancestor
25163553|NCT02894983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163554|NCT02894983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163555|NCT02895022|Lidocaine|lidocaine|mesh-list
25163556|NCT02895022|Anesthetics, Local|anesthetics, local|mesh-ancestor
24478702|NCT00424034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24478703|NCT00424060|Sagopilone|sagopilone|mesh-list
24478704|NCT00424060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478705|NCT00424086|Vaccines|vaccines|mesh-list
24478706|NCT00424086|Immunologic Factors|immunologic factors|mesh-ancestor
24478707|NCT00424086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478708|NCT00424138|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24478709|NCT00424138|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24478710|NCT00424138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478711|NCT00424151|Rituximab|rituximab|mesh-list
24478712|NCT00424151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25840641|NCT00028314|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25840642|NCT00028314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25840643|NCT00028314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25840644|NCT00028314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24807448|NCT02022228|Luteolytic Agents|luteolytic agents|mesh-ancestor
24807449|NCT02022228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24807450|NCT02022228|Contraceptive Agents|contraceptive agents|mesh-ancestor
24807451|NCT02022228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24807452|NCT02022228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807453|NCT02022228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25840645|NCT00028314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24478840|NCT00424801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478861|NCT00424801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24478863|NCT00424801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24478881|NCT00424814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24478882|NCT00424814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24478883|NCT00424814|Antimetabolites|antimetabolites|mesh-ancestor
24478885|NCT00424853|Cisplatin|cisplatin|mesh-list
24478886|NCT00424853|Docetaxel|docetaxel|mesh-list
24478887|NCT00424853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478888|NCT00424853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24478889|NCT00424853|Antimetabolites|antimetabolites|mesh-ancestor
24479109|NCT00425568|Androgens|androgens|mesh-ancestor
24479110|NCT00425568|Hormones|hormones|mesh-ancestor
24479111|NCT00425568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24479116|NCT00425594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24479117|NCT00425594|Laxatives|laxatives|mesh-ancestor
24479118|NCT00425620|Amphotericin B|amphotericin b|mesh-list
25659993|NCT01614743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24479119|NCT00425620|Amebicides|amebicides|mesh-ancestor
24479120|NCT00425620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25659994|NCT01614769|Glimepiride|glimepiride|mesh-list
25659995|NCT01614769|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25659996|NCT01614769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25659997|NCT01614769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25659998|NCT01614769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25659999|NCT01614769|Immunologic Factors|immunologic factors|mesh-ancestor
25660000|NCT01614795|Sirolimus|sirolimus|mesh-list
24512603|NCT00575861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24512606|NCT00575861|Sensory System Agents|sensory system agents|mesh-ancestor
24887928|NCT04510649|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24887929|NCT04510649|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24887934|NCT04510818|Antimetabolites|antimetabolites|mesh-ancestor
24479121|NCT00425620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24479122|NCT00425620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24479123|NCT00425620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24479124|NCT00425620|Antifungal Agents|antifungal agents|mesh-ancestor
24479125|NCT00425646|Bevacizumab|bevacizumab|mesh-list
24479126|NCT00425646|Imatinib Mesylate|imatinib mesylate|mesh-list
24479127|NCT00425646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24479128|NCT00425646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479129|NCT00425646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24479130|NCT00425646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24479131|NCT00425646|Growth Substances|growth substances|mesh-ancestor
24807497|NCT02022358|Dermatologic Agents|dermatologic agents|mesh-ancestor
24807498|NCT02022358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24807499|NCT02022358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24807500|NCT02022358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24807501|NCT02022358|Immunologic Factors|immunologic factors|mesh-ancestor
24807502|NCT02022358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25840646|NCT00028314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24479277|NCT00426179|Imatinib Mesylate|imatinib mesylate|mesh-list
24479278|NCT00426179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602525|NCT00969176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24602526|NCT00969176|Analgesics|analgesics|mesh-ancestor
24479473|NCT00426998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24479474|NCT00426998|Growth Substances|growth substances|mesh-ancestor
24479475|NCT00426998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479476|NCT00426998|Growth Inhibitors|growth inhibitors|mesh-ancestor
24479477|NCT00426998|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24479478|NCT00426998|Dermatologic Agents|dermatologic agents|mesh-ancestor
24666275|NCT01318265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24479480|NCT00427076|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24479481|NCT00427076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24479482|NCT00427076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24479483|NCT00427076|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24479484|NCT00427076|Renal Agents|renal agents|mesh-ancestor
24479485|NCT00427076|Antimalarials|antimalarials|mesh-ancestor
24479486|NCT00427076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24479487|NCT00427076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24479488|NCT00427089|Ascorbic Acid|ascorbic acid|mesh-list
24479489|NCT00427089|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24479490|NCT00427089|Antioxidants|antioxidants|mesh-ancestor
25840647|NCT00028327|Lamivudine|lamivudine|mesh-list
25840648|NCT00028327|Zidovudine|zidovudine|mesh-list
25840649|NCT00028327|Efavirenz|efavirenz|mesh-list
25840650|NCT00028327|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
24814948|NCT02067442|Sensory System Agents|sensory system agents|mesh-ancestor
25840651|NCT00028327|Nelfinavir|nelfinavir|mesh-list
25840652|NCT00028327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25163559|NCT02895022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163560|NCT02895022|Sensory System Agents|sensory system agents|mesh-ancestor
25163561|NCT02895022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25163562|NCT02895022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25163563|NCT02895022|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25163564|NCT02895022|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25163565|NCT02895022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25163566|NCT02895022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163568|NCT02894957|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25163569|NCT02894957|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25163570|NCT02894957|Cholinergic Agents|cholinergic agents|mesh-ancestor
25163571|NCT02894957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25163572|NCT02894957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163573|NCT02894957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415370|NCT03007147|Dexamethasone|dexamethasone|mesh-list
25660001|NCT01614795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25660002|NCT01614795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25660003|NCT01614795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25660004|NCT01614795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25660005|NCT01614795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25660006|NCT01614795|Antifungal Agents|antifungal agents|mesh-ancestor
24887943|NCT04510662|Telmisartan|telmisartan|mesh-list
24887944|NCT04510662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24887945|NCT04510662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24887946|NCT04510662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25660007|NCT01614795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25203013|NCT02717091|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25203014|NCT02717091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25203015|NCT02717091|Tubulin Modulators|tubulin modulators|mesh-ancestor
25203016|NCT02717091|Antimitotic Agents|antimitotic agents|mesh-ancestor
25203017|NCT02717091|Mitosis Modulators|mitosis modulators|mesh-ancestor
25203018|NCT02717091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203019|NCT02717091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25203020|NCT02717091|Antimetabolites|antimetabolites|mesh-ancestor
25203021|NCT02717091|Antiviral Agents|antiviral agents|mesh-ancestor
25203022|NCT02717091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25203023|NCT02717091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203024|NCT02717091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25203025|NCT02717091|Immunologic Factors|immunologic factors|mesh-ancestor
25203026|NCT02717091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203043|NCT02716961|Gemcitabine|gemcitabine|mesh-list
25203044|NCT02716961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25203045|NCT02716961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25203046|NCT02716961|Antimetabolites|antimetabolites|mesh-ancestor
25203047|NCT02716961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203048|NCT02716961|Antiviral Agents|antiviral agents|mesh-ancestor
25203049|NCT02716961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25203050|NCT02716961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203051|NCT02716961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25203052|NCT02716961|Immunologic Factors|immunologic factors|mesh-ancestor
24807657|NCT02023021|Antimitotic Agents|antimitotic agents|mesh-ancestor
25203053|NCT02716961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203055|NCT02716857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25203056|NCT02716857|Narcotics|narcotics|mesh-ancestor
25203057|NCT02716857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25203058|NCT02716857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203059|NCT02716857|Analgesics|analgesics|mesh-ancestor
25203060|NCT02716857|Sensory System Agents|sensory system agents|mesh-ancestor
25203061|NCT02716857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24622744|NCT01068327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479520|NCT00427167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24479521|NCT00427206|Acetaminophen|acetaminophen|mesh-list
24479522|NCT00427206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24479523|NCT00427206|Analgesics|analgesics|mesh-ancestor
24479524|NCT00427206|Sensory System Agents|sensory system agents|mesh-ancestor
24479525|NCT00427206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24479526|NCT00427206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479527|NCT00427206|Antipyretics|antipyretics|mesh-ancestor
24479531|NCT00427232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479532|NCT00427232|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
24479533|NCT00427245|Cyclophosphamide|cyclophosphamide|mesh-list
25840653|NCT00028327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25840654|NCT00028327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840655|NCT00028327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840656|NCT00028327|Antiviral Agents|antiviral agents|mesh-ancestor
25840657|NCT00028327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25840658|NCT00028327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24479546|NCT00427271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24479547|NCT00427271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24479548|NCT00427271|Analgesics|analgesics|mesh-ancestor
24479549|NCT00427271|Sensory System Agents|sensory system agents|mesh-ancestor
24479550|NCT00427271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24479632|NCT00427570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479633|NCT00427570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24479634|NCT00427570|Tubulin Modulators|tubulin modulators|mesh-ancestor
24479635|NCT00427570|Antimitotic Agents|antimitotic agents|mesh-ancestor
24479636|NCT00427570|Mitosis Modulators|mitosis modulators|mesh-ancestor
25660008|NCT01614795|Immunologic Factors|immunologic factors|mesh-ancestor
25660009|NCT01614795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660010|NCT01614847|Lubricant Eye Drops|lubricant eye drops|mesh-list
25660011|NCT01614847|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25660012|NCT01614847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25660013|NCT01614886|Rivastigmine|rivastigmine|mesh-list
25660014|NCT01614886|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24479637|NCT00427570|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24479638|NCT00427570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24479640|NCT00427583|Imatinib Mesylate|imatinib mesylate|mesh-list
24479641|NCT00427583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622749|NCT01068327|Antidotes|antidotes|mesh-ancestor
24479648|NCT00427596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24479649|NCT00427596|Adrenergic Agents|adrenergic agents|mesh-ancestor
24479669|NCT00427882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479670|NCT00427882|Urological Agents|urological agents|mesh-ancestor
24479671|NCT00427947|Ropivacaine|ropivacaine|mesh-list
24479672|NCT00427947|Anesthetics, Local|anesthetics, local|mesh-ancestor
24479679|NCT00428025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24479694|NCT00428064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479695|NCT00428064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24479696|NCT00428064|Immunologic Factors|immunologic factors|mesh-ancestor
24622761|NCT01068353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24622762|NCT01068353|Analgesics|analgesics|mesh-ancestor
24622763|NCT01068353|Sensory System Agents|sensory system agents|mesh-ancestor
24622764|NCT01068353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24622765|NCT01068353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622766|NCT01068353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24622767|NCT01068353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24622768|NCT01068353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24622799|NCT01068587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24622800|NCT01068587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24471883|NCT00397241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622801|NCT01068587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24622802|NCT01068587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589321|NCT00906828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479697|NCT00428064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447296|NCT00308048|Interferon alpha-2|interferon alpha-2|mesh-list
24479698|NCT00428064|Antifungal Agents|antifungal agents|mesh-ancestor
24479699|NCT00428064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24479700|NCT00428064|Dermatologic Agents|dermatologic agents|mesh-ancestor
24479701|NCT00428064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24479702|NCT00428064|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24479747|NCT00428194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479748|NCT00428194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24479749|NCT00428194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479750|NCT00428194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479751|NCT00428272|Interferons|interferons|mesh-list
24479752|NCT00428272|Interferon-gamma|interferon-gamma|mesh-list
24479753|NCT00428272|Lexatumumab|lexatumumab|mesh-list
24622803|NCT01068587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622804|NCT01068756|Dapagliflozin|dapagliflozin|mesh-list
24622805|NCT01068756|Rifampin|rifampin|mesh-list
24622806|NCT01068756|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24622807|NCT01068756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622808|NCT01068756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24622809|NCT01068756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622810|NCT01068756|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24622811|NCT01068756|Antitubercular Agents|antitubercular agents|mesh-ancestor
24479773|NCT00428311|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24479774|NCT00428311|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24479775|NCT00428311|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24479776|NCT00428311|Androgen Antagonists|androgen antagonists|mesh-ancestor
24539974|NCT00666107|Vaccines|vaccines|mesh-list
24479809|NCT00428454|Immunologic Factors|immunologic factors|mesh-ancestor
24479810|NCT00428454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479811|NCT00428480|Methamphetamine|methamphetamine|mesh-list
24479812|NCT00428480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24479813|NCT00428480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479814|NCT00428480|Sympathomimetics|sympathomimetics|mesh-ancestor
24479815|NCT00428480|Autonomic Agents|autonomic agents|mesh-ancestor
24807513|NCT02022475|Micronutrients|micronutrients|mesh-ancestor
24807514|NCT02022475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807516|NCT02022475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24807517|NCT02022488|Midazolam|midazolam|mesh-list
24807518|NCT02022488|Ketamine|ketamine|mesh-list
24807519|NCT02022488|Alfentanil|alfentanil|mesh-list
24807520|NCT02022488|Analgesics|analgesics|mesh-ancestor
24807521|NCT02022488|Sensory System Agents|sensory system agents|mesh-ancestor
24807522|NCT02022488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24807523|NCT02022488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888279|NCT04507217|Pemetrexed|pemetrexed|mesh-list
24807524|NCT02022488|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24807525|NCT02022488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24807526|NCT02022488|Anesthetics, General|anesthetics, general|mesh-ancestor
24807528|NCT02022488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24807529|NCT02022488|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24807530|NCT02022488|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24807531|NCT02022488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24807532|NCT02022488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807533|NCT02022488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24807534|NCT02022488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24807535|NCT02022488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24479853|NCT00428558|Immunologic Factors|immunologic factors|mesh-ancestor
24807549|NCT02022527|Sensory System Agents|sensory system agents|mesh-ancestor
24807550|NCT02022527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24807551|NCT02022527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807552|NCT02022527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24807553|NCT02022527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24807554|NCT02022527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24807555|NCT02022527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24807556|NCT02022527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807557|NCT02022527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24807558|NCT02022527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24807559|NCT02022527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24807560|NCT02022527|Antipyretics|antipyretics|mesh-ancestor
24807561|NCT02022527|Anticoagulants|anticoagulants|mesh-ancestor
24807562|NCT02022527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24807563|NCT02022527|Antifungal Agents|antifungal agents|mesh-ancestor
25163574|NCT02895074|Proxymetacaine|proxymetacaine|mesh-list
24447297|NCT00308048|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24447298|NCT00308048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447299|NCT00308048|Antiviral Agents|antiviral agents|mesh-ancestor
24447300|NCT00308048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25840659|NCT00028327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25840660|NCT00028327|Antimetabolites|antimetabolites|mesh-ancestor
25840661|NCT00028327|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25840662|NCT00028327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25840663|NCT00028327|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25840664|NCT00028327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25840665|NCT00028327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25840666|NCT00028327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25840667|NCT00028327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25840668|NCT00028327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25840669|NCT00028327|Protease Inhibitors|protease inhibitors|mesh-ancestor
25840670|NCT00028353|Toremifene|toremifene|mesh-list
25840671|NCT00028353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25840672|NCT00028353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840673|NCT00028353|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25840674|NCT00028353|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25840675|NCT00028353|Hormone Antagonists|hormone antagonists|mesh-ancestor
25840676|NCT00028353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25041657|NCT01604889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807564|NCT02022527|Keratolytic Agents|keratolytic agents|mesh-ancestor
24807565|NCT02022527|Dermatologic Agents|dermatologic agents|mesh-ancestor
24807568|NCT02022540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24807569|NCT02022540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24807570|NCT02022540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24807571|NCT02022540|Growth Substances|growth substances|mesh-ancestor
24807572|NCT02022540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807652|NCT02023021|Gemcitabine|gemcitabine|mesh-list
24807653|NCT02023021|Paclitaxel|paclitaxel|mesh-list
24807654|NCT02023021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24807655|NCT02023021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807656|NCT02023021|Tubulin Modulators|tubulin modulators|mesh-ancestor
25163575|NCT02895074|Tropicamide|tropicamide|mesh-list
25163576|NCT02895074|Mydriatics|mydriatics|mesh-ancestor
25163577|NCT02895074|Autonomic Agents|autonomic agents|mesh-ancestor
25163578|NCT02895074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25163579|NCT02895074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163580|NCT02895074|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25163581|NCT02895074|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25163582|NCT02895074|Cholinergic Agents|cholinergic agents|mesh-ancestor
25163583|NCT02895074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25408943|NCT03410043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24888352|NCT04505943|Abortifacient Agents|abortifacient agents|mesh-ancestor
24888353|NCT04505943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25163584|NCT02895074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163585|NCT02895074|Anesthetics, Local|anesthetics, local|mesh-ancestor
25163586|NCT02895074|Anesthetics|anesthetics|mesh-ancestor
25163587|NCT02895074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25163588|NCT02895074|Sensory System Agents|sensory system agents|mesh-ancestor
25163589|NCT02894892|Esomeprazole|esomeprazole|mesh-list
25163590|NCT02894892|Bismuth|bismuth|mesh-list
25163591|NCT02894892|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25163592|NCT02894892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25163593|NCT02894892|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25163594|NCT02894892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163595|NCT02894892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163596|NCT02894892|Antacids|antacids|mesh-ancestor
25163597|NCT02894905|Adafosbuvir|adafosbuvir|mesh-list
25163598|NCT02894905|Antiviral Agents|antiviral agents|mesh-ancestor
25163599|NCT02894905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25163600|NCT02894918|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25163601|NCT02894918|Antiviral Agents|antiviral agents|mesh-ancestor
25163602|NCT02894918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25163603|NCT02894593|Ethanol|ethanol|mesh-list
25163604|NCT02894593|Chlorhexidine|chlorhexidine|mesh-list
25163605|NCT02894593|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25163606|NCT02894593|Listerine|listerine|mesh-list
25163607|NCT02894593|Sodium Fluoride|sodium fluoride|mesh-list
25840677|NCT00028353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840678|NCT00028353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25840679|NCT00028366|Ritonavir|ritonavir|mesh-list
25840680|NCT00028366|Lopinavir|lopinavir|mesh-list
25840681|NCT00028366|Fosamprenavir|fosamprenavir|mesh-list
25840682|NCT00028366|Tenofovir|tenofovir|mesh-list
25840683|NCT00028366|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24807665|NCT02023021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24807666|NCT02023021|Immunologic Factors|immunologic factors|mesh-ancestor
24807667|NCT02023021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807669|NCT02023047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24807670|NCT02023047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24807671|NCT02023047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807672|NCT02023047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24807673|NCT02023047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807674|NCT02023047|Vasodilator Agents|vasodilator agents|mesh-ancestor
24807675|NCT02023047|Tocolytic Agents|tocolytic agents|mesh-ancestor
24807676|NCT02023047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24807677|NCT02023086|Tropicamide|tropicamide|mesh-list
24479911|NCT00428883|Respiratory System Agents|respiratory system agents|mesh-ancestor
24479912|NCT00428883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24479913|NCT00428883|Antioxidants|antioxidants|mesh-ancestor
24479914|NCT00428883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479915|NCT00428883|Protective Agents|protective agents|mesh-ancestor
24479916|NCT00428883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479981|NCT00429377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479982|NCT00429442|Simvastatin|simvastatin|mesh-list
24807713|NCT02023359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807714|NCT02023359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24807715|NCT02023359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24807716|NCT02023359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24807717|NCT02023359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807718|NCT02023359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24807719|NCT02023359|Hormone Antagonists|hormone antagonists|mesh-ancestor
24589672|NCT00908362|Glucocorticoids|glucocorticoids|mesh-ancestor
24479983|NCT00429442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24479984|NCT00429442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24479985|NCT00429442|Antimetabolites|antimetabolites|mesh-ancestor
24480050|NCT00429676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24480051|NCT00429676|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24480052|NCT00429676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24480053|NCT00429676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24480054|NCT00429676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24480055|NCT00429676|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24480056|NCT00429676|Dopamine Agents|dopamine agents|mesh-ancestor
24480057|NCT00429676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24480058|NCT00429676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660015|NCT01614886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25660016|NCT01614886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840684|NCT00028366|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25840685|NCT00028366|Protease Inhibitors|protease inhibitors|mesh-ancestor
25840686|NCT00028366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840687|NCT00028366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840688|NCT00028366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25840689|NCT00028366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25840690|NCT00028366|Antiviral Agents|antiviral agents|mesh-ancestor
25840691|NCT00028366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25840692|NCT00028366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25840693|NCT00028366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25840694|NCT00028366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25840695|NCT00028366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25840697|NCT00028405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480059|NCT00429676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24480060|NCT00429715|Aluminum sulfate|aluminum sulfate|mesh-list
24480061|NCT00429715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24480062|NCT00429715|Immunologic Factors|immunologic factors|mesh-ancestor
24480063|NCT00429715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480064|NCT00429754|Aprepitant|aprepitant|mesh-list
24480089|NCT00429832|Antipruritics|antipruritics|mesh-ancestor
24480090|NCT00429832|Dermatologic Agents|dermatologic agents|mesh-ancestor
24480091|NCT00429832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24480092|NCT00429832|Serotonin Agents|serotonin agents|mesh-ancestor
24480093|NCT00429832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24480101|NCT00429832|Histamine Antagonists|histamine antagonists|mesh-ancestor
24480102|NCT00429832|Histamine Agents|histamine agents|mesh-ancestor
24480103|NCT00429832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24807720|NCT02023359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25163608|NCT02894593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25163609|NCT02894593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25163610|NCT02894593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25163611|NCT02894593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163612|NCT02894593|Disinfectants|disinfectants|mesh-ancestor
25163613|NCT02894593|Dermatologic Agents|dermatologic agents|mesh-ancestor
25163614|NCT02894593|Cariostatic Agents|cariostatic agents|mesh-ancestor
25163615|NCT02894593|Protective Agents|protective agents|mesh-ancestor
24480121|NCT00429871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24480122|NCT00429871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480123|NCT00429897|Bendroflumethiazide|bendroflumethiazide|mesh-list
24480124|NCT00429897|Amiloride|amiloride|mesh-list
24480125|NCT00429897|Spironolactone|spironolactone|mesh-list
24480126|NCT00429897|Furosemide|furosemide|mesh-list
24480127|NCT00429897|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24430377|NCT00247507|Acetylcysteine|acetylcysteine|mesh-list
24480128|NCT00429897|Hormone Antagonists|hormone antagonists|mesh-ancestor
24480553|NCT00431249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24480185|NCT00430079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480186|NCT00430079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807749|NCT02023554|Azithromycin|azithromycin|mesh-list
24807750|NCT02023554|Theophylline|theophylline|mesh-list
24807751|NCT02023554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24807752|NCT02023554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24807761|NCT02023554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807762|NCT02023554|Vasodilator Agents|vasodilator agents|mesh-ancestor
24807763|NCT02023554|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24807764|NCT02023554|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24807765|NCT02023554|Purinergic Agents|purinergic agents|mesh-ancestor
24807766|NCT02023554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24480295|NCT00430261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480296|NCT00430261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24480302|NCT00430261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25660017|NCT01614886|Cholinergic Agents|cholinergic agents|mesh-ancestor
25660018|NCT01614886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25660019|NCT01614886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660020|NCT01614886|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25660021|NCT01614886|Protective Agents|protective agents|mesh-ancestor
25660022|NCT01615198|Olmesartan|olmesartan|mesh-list
25660023|NCT01615198|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25660024|NCT01615198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25660025|NCT01615198|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25660026|NCT01615198|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24480303|NCT00430261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480304|NCT00430365|Lenalidomide|lenalidomide|mesh-list
24480305|NCT00430365|Immunologic Factors|immunologic factors|mesh-ancestor
24888641|NCT04501991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888642|NCT04501900|Clopidogrel|clopidogrel|mesh-list
24888643|NCT04501900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24888669|NCT04501224|Entecavir|entecavir|mesh-list
24480306|NCT00430365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480307|NCT00430365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24480308|NCT00430365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24480309|NCT00430365|Growth Substances|growth substances|mesh-ancestor
24480310|NCT00430365|Growth Inhibitors|growth inhibitors|mesh-ancestor
24480311|NCT00430365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480313|NCT00430443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24480314|NCT00430443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480315|NCT00430469|Lactoferrin|lactoferrin|mesh-list
24480316|NCT00430469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24480317|NCT00430547|Carbimazole|carbimazole|mesh-list
25163616|NCT02894554|Lamivudine|lamivudine|mesh-list
25163617|NCT02894554|Telbivudine|telbivudine|mesh-list
25203062|NCT02716766|Capecitabine|capecitabine|mesh-list
25840698|NCT00028405|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25840699|NCT00028405|Dermatologic Agents|dermatologic agents|mesh-ancestor
24480318|NCT00430547|Antithyroid Agents|antithyroid agents|mesh-ancestor
24480319|NCT00430547|Hormone Antagonists|hormone antagonists|mesh-ancestor
24480321|NCT00430547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840700|NCT00028418|Clofarabine|clofarabine|mesh-list
24480338|NCT00430651|Antimitotic Agents|antimitotic agents|mesh-ancestor
24807769|NCT02023567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24807770|NCT02023567|Serotonin Agents|serotonin agents|mesh-ancestor
24807771|NCT02023567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24807772|NCT02023567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807773|NCT02023567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807774|NCT02023567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24807775|NCT02023567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25840701|NCT00028418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25840702|NCT00028418|Antimetabolites|antimetabolites|mesh-ancestor
25840703|NCT00028418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840704|NCT00028418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840705|NCT00028431|Ipilimumab|ipilimumab|mesh-list
25840706|NCT00028431|Antibodies|antibodies|mesh-list
25840707|NCT00028431|Immunologic Factors|immunologic factors|mesh-ancestor
25840708|NCT00028431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480519|NCT00431197|Hormones|hormones|mesh-ancestor
24480520|NCT00431236|Dexamethasone|dexamethasone|mesh-list
24480521|NCT00431236|Ondansetron|ondansetron|mesh-list
24480522|NCT00431236|Casopitant|casopitant|mesh-list
24480523|NCT00431236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24480555|NCT00431249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480556|NCT00431249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24480557|NCT00431249|Vasodilator Agents|vasodilator agents|mesh-ancestor
24480558|NCT00431249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24480609|NCT00431392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24547887|NCT00706277|Anesthetics|anesthetics|mesh-ancestor
24807786|NCT02023593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24807787|NCT02023593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24807788|NCT02023593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24807789|NCT02023593|Antidotes|antidotes|mesh-ancestor
24807790|NCT02023593|Protective Agents|protective agents|mesh-ancestor
24807791|NCT02023593|Vitamin B Complex|vitamin b complex|mesh-ancestor
24807792|NCT02023593|Vitamins|vitamins|mesh-ancestor
24807793|NCT02023593|Micronutrients|micronutrients|mesh-ancestor
24807795|NCT02023684|Ropivacaine|ropivacaine|mesh-list
24807796|NCT02023684|Anesthetics, Local|anesthetics, local|mesh-ancestor
24807797|NCT02023684|Anesthetics|anesthetics|mesh-ancestor
24807798|NCT02023684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24807799|NCT02023684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807800|NCT02023684|Sensory System Agents|sensory system agents|mesh-ancestor
24628743|NCT01101204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24807801|NCT02023684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24480671|NCT00431665|Anticoagulants|anticoagulants|mesh-ancestor
24480672|NCT00431665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24482993|NCT00441246|Appetite Depressants|appetite depressants|mesh-ancestor
25660027|NCT01615198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660028|NCT01615484|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25660029|NCT01615731|Digoxin|digoxin|mesh-list
25415371|NCT03007147|Methylprednisolone|methylprednisolone|mesh-list
25660030|NCT01615731|Misoprostol|misoprostol|mesh-list
25660031|NCT01615731|Mifepristone|mifepristone|mesh-list
25660032|NCT01615731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25660033|NCT01615731|Abortifacient Agents|abortifacient agents|mesh-ancestor
25840709|NCT00028431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25840710|NCT00028431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840711|NCT00028431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25840712|NCT00028431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840713|NCT00028483|Docetaxel|docetaxel|mesh-list
25840714|NCT00028483|Doxorubicin|doxorubicin|mesh-list
24480812|NCT00432315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807832|NCT02023853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24807833|NCT02023853|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24807834|NCT02023853|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24807835|NCT02023853|Vasodilator Agents|vasodilator agents|mesh-ancestor
24807836|NCT02023892|Atorvastatin|atorvastatin|mesh-list
24807837|NCT02023892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24807838|NCT02023892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24807839|NCT02023892|Antimetabolites|antimetabolites|mesh-ancestor
24807840|NCT02023892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163618|NCT02894554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25203063|NCT02716766|Oxaliplatin|oxaliplatin|mesh-list
25840715|NCT00028483|Immunoconjugates|immunoconjugates|mesh-list
25840716|NCT00028483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840717|NCT00028483|Tubulin Modulators|tubulin modulators|mesh-ancestor
25840718|NCT00028483|Antimitotic Agents|antimitotic agents|mesh-ancestor
25840719|NCT00028483|Mitosis Modulators|mitosis modulators|mesh-ancestor
25840720|NCT00028483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840721|NCT00028483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25840722|NCT00028483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25840723|NCT00028483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24807841|NCT02023892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24807842|NCT02023892|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24807843|NCT02023892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24807844|NCT02023931|Sulforaphane|sulforaphane|mesh-list
24807845|NCT02023931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24807846|NCT02023931|Protective Agents|protective agents|mesh-ancestor
24807847|NCT02023931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807848|NCT02023931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807849|NCT02024009|Gemcitabine|gemcitabine|mesh-list
24807850|NCT02024009|Nelfinavir|nelfinavir|mesh-list
24807873|NCT02024022|Magnesium citrate|magnesium citrate|mesh-list
24807874|NCT02024022|Cathartics|cathartics|mesh-ancestor
24807875|NCT02024022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24807876|NCT02024152|Cetirizine|cetirizine|mesh-list
25840724|NCT00028483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840725|NCT00028483|Immunologic Factors|immunologic factors|mesh-ancestor
25840726|NCT00028483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590256|NCT00911339|Atorvastatin|atorvastatin|mesh-list
24590257|NCT00911339|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24590258|NCT00911339|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24590259|NCT00911339|Antimetabolites|antimetabolites|mesh-ancestor
24590260|NCT00911339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590261|NCT00911339|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24590262|NCT00911339|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24480893|NCT00432575|Hormones|hormones|mesh-ancestor
24480908|NCT00432614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24480948|NCT00432861|Pancrelipase|pancrelipase|mesh-list
25840727|NCT00028496|Metronidazole|metronidazole|mesh-list
25840728|NCT00028496|Molgramostim|molgramostim|mesh-list
25840729|NCT00028496|Vaccines|vaccines|mesh-list
25840730|NCT00028496|Sargramostim|sargramostim|mesh-list
25840731|NCT00028496|Immunologic Factors|immunologic factors|mesh-ancestor
25840732|NCT00028496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840733|NCT00028496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840734|NCT00028496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25840735|NCT00028496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25840736|NCT00028496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25840737|NCT00028496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25840738|NCT00028535|Paclitaxel|paclitaxel|mesh-list
24480950|NCT00432861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24480951|NCT00432887|Caffeine|caffeine|mesh-list
24480952|NCT00432887|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24480953|NCT00432887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480954|NCT00432887|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24480955|NCT00432887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480956|NCT00432887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480957|NCT00432887|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24481022|NCT00433121|Dopamine Agents|dopamine agents|mesh-ancestor
24481023|NCT00433121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24888879|NCT04499586|Raltitrexed|raltitrexed|mesh-list
24888896|NCT04499573|Cytarabine|cytarabine|mesh-list
24481024|NCT00433121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24481025|NCT00433121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24481026|NCT00433121|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24481027|NCT00433121|Antidepressive Agents|antidepressive agents|mesh-ancestor
25840739|NCT00028535|Trastuzumab|trastuzumab|mesh-list
25840740|NCT00028535|Interleukin-12|interleukin-12|mesh-list
25840741|NCT00028535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25163619|NCT02894554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25163620|NCT02894554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163621|NCT02894554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163622|NCT02894554|Antiviral Agents|antiviral agents|mesh-ancestor
25163623|NCT02894554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25163624|NCT02894554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25163625|NCT02894554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25163626|NCT02894606|Thymoglobulin|thymoglobulin|mesh-list
25163627|NCT02894606|Basiliximab|basiliximab|mesh-list
25163628|NCT02894606|Immunologic Factors|immunologic factors|mesh-ancestor
24807893|NCT02024256|Sensory System Agents|sensory system agents|mesh-ancestor
24807894|NCT02024256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24807895|NCT02024256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807896|NCT02024256|Anesthetics|anesthetics|mesh-ancestor
24807897|NCT02024256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24807898|NCT02024256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24807899|NCT02024256|Anticonvulsants|anticonvulsants|mesh-ancestor
24590310|NCT00911716|Alkylating Agents|alkylating agents|mesh-ancestor
25840742|NCT00028535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481028|NCT00433121|Autonomic Agents|autonomic agents|mesh-ancestor
24481029|NCT00433121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24481030|NCT00433121|Antiemetics|antiemetics|mesh-ancestor
24481031|NCT00433121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24481032|NCT00433173|Anastrozole|anastrozole|mesh-list
24481033|NCT00433173|Goserelin|goserelin|mesh-list
24481034|NCT00433173|Testosterone|testosterone|mesh-list
24481035|NCT00433173|Androgens|androgens|mesh-ancestor
24481036|NCT00433173|Hormones|hormones|mesh-ancestor
24481037|NCT00433173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24481038|NCT00433173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807901|NCT02024256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24807902|NCT02024256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807903|NCT02024256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24807904|NCT02024256|Tocolytic Agents|tocolytic agents|mesh-ancestor
24481170|NCT00433498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24481171|NCT00433498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481173|NCT00433498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24481198|NCT00433719|Antiviral Agents|antiviral agents|mesh-ancestor
24481199|NCT00433719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24481200|NCT00433719|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25840743|NCT00028535|Tubulin Modulators|tubulin modulators|mesh-ancestor
25840744|NCT00028535|Antimitotic Agents|antimitotic agents|mesh-ancestor
25840745|NCT00028535|Mitosis Modulators|mitosis modulators|mesh-ancestor
25840746|NCT00028535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840747|NCT00028535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24481211|NCT00433732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24481212|NCT00433732|Analgesics|analgesics|mesh-ancestor
24481213|NCT00433732|Sensory System Agents|sensory system agents|mesh-ancestor
24481214|NCT00433732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24481215|NCT00433732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481216|NCT00433732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24807924|NCT02024308|Antiviral Agents|antiviral agents|mesh-ancestor
24807925|NCT02024308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24807926|NCT02024334|Leflunomide|leflunomide|mesh-list
24807927|NCT02024334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24807928|NCT02024334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807929|NCT02024334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24807930|NCT02024334|Immunologic Factors|immunologic factors|mesh-ancestor
25108745|NCT03130426|Lixisenatide|lixisenatide|mesh-list
24807931|NCT02024334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807932|NCT02024373|Atorvastatin|atorvastatin|mesh-list
24807933|NCT02024373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24481421|NCT00434382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25840748|NCT00028535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25840749|NCT00028535|Immunologic Factors|immunologic factors|mesh-ancestor
25660034|NCT01615731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25840750|NCT00028535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840751|NCT00028535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25840752|NCT00028535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25840753|NCT00028535|Growth Substances|growth substances|mesh-ancestor
25840754|NCT00028535|Growth Inhibitors|growth inhibitors|mesh-ancestor
25840756|NCT00028561|Epothilone B|epothilone b|mesh-list
25840757|NCT00028561|Epothilones|epothilones|mesh-list
25840758|NCT00028561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840759|NCT00028561|Tubulin Modulators|tubulin modulators|mesh-ancestor
25840760|NCT00028561|Antimitotic Agents|antimitotic agents|mesh-ancestor
25840761|NCT00028561|Mitosis Modulators|mitosis modulators|mesh-ancestor
25840762|NCT00028561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481429|NCT00434668|Cisplatin|cisplatin|mesh-list
24481430|NCT00434668|Docetaxel|docetaxel|mesh-list
24807950|NCT02024555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24807951|NCT02024555|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24807953|NCT02024555|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24807954|NCT02024555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24807955|NCT02024555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24807956|NCT02024555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807957|NCT02024555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807958|NCT02024555|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24807959|NCT02024555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24807966|NCT02024555|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24807967|NCT02024555|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24807968|NCT02024555|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24807969|NCT02024555|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24807971|NCT02024568|Analgesics|analgesics|mesh-ancestor
24807972|NCT02024568|Sensory System Agents|sensory system agents|mesh-ancestor
24807973|NCT02024568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24807974|NCT02024568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807975|NCT02024568|Anticonvulsants|anticonvulsants|mesh-ancestor
24481485|NCT00435058|Adrenergic Agents|adrenergic agents|mesh-ancestor
24481519|NCT00435292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24481520|NCT00435292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24877916|NCT02227199|Antibodies|antibodies|mesh-list
24481521|NCT00435292|Gout Suppressants|gout suppressants|mesh-ancestor
24481522|NCT00435292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24481523|NCT00435292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481524|NCT00435292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481525|NCT00435305|Vancomycin|vancomycin|mesh-list
24481526|NCT00435305|Meropenem|meropenem|mesh-list
24481527|NCT00435305|Tazobactam|tazobactam|mesh-list
24481528|NCT00435305|Linezolid|linezolid|mesh-list
24481529|NCT00435305|Piperacillin|piperacillin|mesh-list
24481530|NCT00435305|Ceftazidime|ceftazidime|mesh-list
24481531|NCT00435305|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24808200|NCT02025712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481532|NCT00435305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24481537|NCT00435305|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24481539|NCT00435331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24481540|NCT00435331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24481541|NCT00435331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24481554|NCT00435448|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
24481555|NCT00435448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481556|NCT00435448|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25840763|NCT00028574|Gabapentin|gabapentin|mesh-list
24807978|NCT02024568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807979|NCT02024568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24807981|NCT02024568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24807982|NCT02024568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24807983|NCT02024568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24807984|NCT02024594|Nitrous Oxide|nitrous oxide|mesh-list
24807985|NCT02024594|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24807986|NCT02024594|Anesthetics, General|anesthetics, general|mesh-ancestor
24807987|NCT02024594|Anesthetics|anesthetics|mesh-ancestor
25840764|NCT00028574|Analgesics|analgesics|mesh-ancestor
25840765|NCT00028574|Sensory System Agents|sensory system agents|mesh-ancestor
25840766|NCT00028574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25840767|NCT00028574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481563|NCT00435500|Fluorides|fluorides|mesh-list
24667722|NCT05320107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667723|NCT05320107|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25163635|NCT02894710|Anesthetics, Local|anesthetics, local|mesh-ancestor
24667728|NCT05320107|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24667729|NCT05320107|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24481758|NCT00436761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481759|NCT00436761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24481760|NCT00436761|Immunologic Factors|immunologic factors|mesh-ancestor
24481761|NCT00436761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481762|NCT00436761|Antifungal Agents|antifungal agents|mesh-ancestor
24481763|NCT00436761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24481764|NCT00436761|Dermatologic Agents|dermatologic agents|mesh-ancestor
24481765|NCT00436761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25840768|NCT00028574|Anticonvulsants|anticonvulsants|mesh-ancestor
25840769|NCT00028574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25840770|NCT00028574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25840771|NCT00028574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25840772|NCT00028574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25840773|NCT00028574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25840774|NCT00028574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24808064|NCT02025010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24808065|NCT02025010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808066|NCT02025010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24808067|NCT02025010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24482048|NCT00437762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24482049|NCT00437762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24482050|NCT00437762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24482051|NCT00437762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482052|NCT00437762|Cholinergic Agents|cholinergic agents|mesh-ancestor
24482053|NCT00437762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24482054|NCT00437762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482055|NCT00437762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24482056|NCT00437762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24482058|NCT00437814|Analgesics|analgesics|mesh-ancestor
24482105|NCT00437957|GABA Agents|gaba agents|mesh-ancestor
24482106|NCT00437957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24482107|NCT00437957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482109|NCT00437957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24603584|NCT00974584|Mitosis Modulators|mitosis modulators|mesh-ancestor
24482110|NCT00437957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24432566|NCT00255437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24482111|NCT00437957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24482148|NCT00438048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24482149|NCT00438048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482164|NCT00438087|Hormones|hormones|mesh-ancestor
25840775|NCT00028574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24808075|NCT02025023|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24808076|NCT02025023|Antimetabolites|antimetabolites|mesh-ancestor
24808077|NCT02025023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482317|NCT00438607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482331|NCT00438737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482333|NCT00438737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24482334|NCT00438737|Antimetabolites|antimetabolites|mesh-ancestor
24482335|NCT00438737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482336|NCT00438737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24482337|NCT00438737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24482368|NCT00438828|Autonomic Agents|autonomic agents|mesh-ancestor
24482369|NCT00438828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24482370|NCT00438828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482371|NCT00438828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24482372|NCT00438828|Glucocorticoids|glucocorticoids|mesh-ancestor
24482387|NCT00438841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482388|NCT00438841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24482389|NCT00438841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24482390|NCT00438841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24482392|NCT00438841|Autonomic Agents|autonomic agents|mesh-ancestor
24482400|NCT00438841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24482401|NCT00438841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24482402|NCT00438841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24482403|NCT00438841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24622827|NCT01068795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622829|NCT01068847|Verapamil|verapamil|mesh-list
24622830|NCT01068847|Nifedipine|nifedipine|mesh-list
24482599|NCT00439972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482631|NCT00440102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482634|NCT00440128|Casopitant|casopitant|mesh-list
24482635|NCT00440128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24482636|NCT00440128|Tubulin Modulators|tubulin modulators|mesh-ancestor
24482637|NCT00440128|Antimitotic Agents|antimitotic agents|mesh-ancestor
24482638|NCT00440128|Mitosis Modulators|mitosis modulators|mesh-ancestor
24419282|NCT00211614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24482670|NCT00440167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24482671|NCT00440167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24482672|NCT00440167|Antimetabolites|antimetabolites|mesh-ancestor
24482683|NCT00440219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24808177|NCT02025491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24808178|NCT02025491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24808179|NCT02025491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24808180|NCT02025491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24808181|NCT02025491|Antifungal Agents|antifungal agents|mesh-ancestor
24808182|NCT02025608|Pramipexole|pramipexole|mesh-list
24808183|NCT02025608|Antioxidants|antioxidants|mesh-ancestor
24482701|NCT00440245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24482702|NCT00440245|Adrenergic Agents|adrenergic agents|mesh-ancestor
24482703|NCT00440245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24482704|NCT00440245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482705|NCT00440258|Cabergoline|cabergoline|mesh-list
24482706|NCT00440258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24808193|NCT02025712|Exemestane|exemestane|mesh-list
24808194|NCT02025712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808195|NCT02025712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24808196|NCT02025712|Immunologic Factors|immunologic factors|mesh-ancestor
24808197|NCT02025712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808198|NCT02025712|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25103432|NCT03161509|Antipyretics|antipyretics|mesh-ancestor
24808199|NCT02025712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24878516|NCT01585805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24808201|NCT02025712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808202|NCT02025712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24808203|NCT02025712|Hormone Antagonists|hormone antagonists|mesh-ancestor
24808204|NCT02025712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24808205|NCT02025803|Capecitabine|capecitabine|mesh-list
24808206|NCT02025803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24482727|NCT00440336|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24482728|NCT00440336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24482729|NCT00440349|Tamoxifen|tamoxifen|mesh-list
24482730|NCT00440349|Prednisone|prednisone|mesh-list
24482731|NCT00440349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24482732|NCT00440349|Glucocorticoids|glucocorticoids|mesh-ancestor
24482733|NCT00440349|Hormones|hormones|mesh-ancestor
24482734|NCT00440349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24482845|NCT00440739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24482982|NCT00441246|Respiratory System Agents|respiratory system agents|mesh-ancestor
24482984|NCT00441246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24482985|NCT00441246|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24482986|NCT00441246|Sympathomimetics|sympathomimetics|mesh-ancestor
24482987|NCT00441246|Adrenergic Agents|adrenergic agents|mesh-ancestor
24482988|NCT00441246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24482989|NCT00441246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482990|NCT00441246|Expectorants|expectorants|mesh-ancestor
24482991|NCT00441246|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24482992|NCT00441246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24482994|NCT00441246|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24482995|NCT00441298|Tenofovir|tenofovir|mesh-list
25840776|NCT00028574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840777|NCT00028574|Antimanic Agents|antimanic agents|mesh-ancestor
24483120|NCT00441922|Mitosis Modulators|mitosis modulators|mesh-ancestor
24483121|NCT00441922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483122|NCT00441922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24483125|NCT00441961|Abortifacient Agents|abortifacient agents|mesh-ancestor
24483126|NCT00441961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24483127|NCT00441961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483128|NCT00441961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24483129|NCT00441961|Antimetabolites|antimetabolites|mesh-ancestor
24483130|NCT00441961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483131|NCT00441961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25060967|NCT03475160|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24889201|NCT04495881|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24889202|NCT04495881|Protease Inhibitors|protease inhibitors|mesh-ancestor
24889203|NCT04495881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516643|NCT00602693|Cyclophosphamide|cyclophosphamide|mesh-list
25060973|NCT03475121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25060974|NCT03475121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25060977|NCT03475017|Curcumin|curcumin|mesh-list
24483132|NCT00441961|Dermatologic Agents|dermatologic agents|mesh-ancestor
24483133|NCT00441961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483134|NCT00441961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24483135|NCT00441961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24483161|NCT00442052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483162|NCT00442052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24483163|NCT00442052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24483164|NCT00442052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24483165|NCT00442052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24483166|NCT00442052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483167|NCT00442052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24483168|NCT00442052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24483169|NCT00442052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483170|NCT00442052|Antipyretics|antipyretics|mesh-ancestor
24483171|NCT00442052|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24483172|NCT00442052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24483173|NCT00442052|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24483174|NCT00442182|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
24483200|NCT00442234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483201|NCT00442273|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24483202|NCT00442273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24483203|NCT00442312|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
24483204|NCT00442312|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24483205|NCT00442312|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24483206|NCT00442312|Adrenergic Agents|adrenergic agents|mesh-ancestor
24483207|NCT00442312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24483208|NCT00442312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483222|NCT00442390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24808216|NCT02025855|Sensory System Agents|sensory system agents|mesh-ancestor
24808217|NCT02025855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24808218|NCT02025855|Antitussive Agents|antitussive agents|mesh-ancestor
24483239|NCT00442481|Citalopram|citalopram|mesh-list
24483240|NCT00442481|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24483274|NCT00442585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25163636|NCT02894710|Anesthetics|anesthetics|mesh-ancestor
25840778|NCT00028587|Paclitaxel|paclitaxel|mesh-list
24483275|NCT00442585|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24483276|NCT00442585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483277|NCT00442585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483279|NCT00442637|Capecitabine|capecitabine|mesh-list
24483288|NCT00442637|Antimetabolites|antimetabolites|mesh-ancestor
25840779|NCT00028587|Carboplatin|carboplatin|mesh-list
24483308|NCT00442741|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24483325|NCT00442819|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
24483326|NCT00442819|Vasodilator Agents|vasodilator agents|mesh-ancestor
24894148|NCT04443556|Analgesics|analgesics|mesh-ancestor
24879289|NCT04910061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879290|NCT04910061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24879291|NCT04910061|Antimetabolites|antimetabolites|mesh-ancestor
24483327|NCT00442819|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24483328|NCT00442819|Protective Agents|protective agents|mesh-ancestor
24483329|NCT00442819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483330|NCT00442832|Vancomycin|vancomycin|mesh-list
24483331|NCT00442832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24483332|NCT00442832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24483333|NCT00442845|Atorvastatin|atorvastatin|mesh-list
24483334|NCT00442845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24483335|NCT00442845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24483336|NCT00442845|Antimetabolites|antimetabolites|mesh-ancestor
25660035|NCT01615731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660036|NCT01615731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25660037|NCT01615731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25660038|NCT01615731|Oxytocics|oxytocics|mesh-ancestor
25660039|NCT01615731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25660040|NCT01615731|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25660041|NCT01615731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415372|NCT03007147|Prednisolone|prednisolone|mesh-list
25674327|NCT01770145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24889236|NCT04495504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889237|NCT04495504|Sensory System Agents|sensory system agents|mesh-ancestor
24483337|NCT00442845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483420|NCT00443482|Autonomic Agents|autonomic agents|mesh-ancestor
24483421|NCT00443482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24483422|NCT00443482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483423|NCT00443482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24483424|NCT00443482|Respiratory System Agents|respiratory system agents|mesh-ancestor
24483425|NCT00443482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24483426|NCT00443482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24483427|NCT00443482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24808233|NCT02025881|Cyclophosphamide|cyclophosphamide|mesh-list
24808234|NCT02025881|Thiotepa|thiotepa|mesh-list
24808235|NCT02025881|Carboplatin|carboplatin|mesh-list
24808236|NCT02025881|Etoposide|etoposide|mesh-list
24808237|NCT02025881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24808238|NCT02025881|Immunologic Factors|immunologic factors|mesh-ancestor
24808239|NCT02025881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591830|NCT00919282|Leucovorin|leucovorin|mesh-list
24483454|NCT00443573|Anticoagulants|anticoagulants|mesh-list
24483455|NCT00443573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24483456|NCT00443573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24483457|NCT00443573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483458|NCT00443612|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24483459|NCT00443612|Irbesartan|irbesartan|mesh-list
24483460|NCT00443612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24483461|NCT00443612|Diuretics|diuretics|mesh-ancestor
24483462|NCT00443612|Natriuretic Agents|natriuretic agents|mesh-ancestor
24483463|NCT00443612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483464|NCT00443612|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24483465|NCT00443612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24575310|NCT00830531|Natriuretic Agents|natriuretic agents|mesh-ancestor
24483466|NCT00443612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483467|NCT00443612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24483483|NCT00443794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24483485|NCT00443794|Sensory System Agents|sensory system agents|mesh-ancestor
24483502|NCT00443794|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24483503|NCT00443794|Protease Inhibitors|protease inhibitors|mesh-ancestor
24483504|NCT00443794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24483505|NCT00443794|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24483506|NCT00443794|Sympatholytics|sympatholytics|mesh-ancestor
24483507|NCT00443794|Autonomic Agents|autonomic agents|mesh-ancestor
25163637|NCT02894710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24483723|NCT00444665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24483764|NCT00444834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24483765|NCT00444834|Vasodilator Agents|vasodilator agents|mesh-ancestor
25840780|NCT00028587|Bortezomib|bortezomib|mesh-list
24592046|NCT00920153|Gemcitabine|gemcitabine|mesh-list
24483892|NCT00445796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24483893|NCT00445796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25840781|NCT00028587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24483991|NCT00446043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24808325|NCT02026492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24808326|NCT02026492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808327|NCT02026505|Bortezomib|bortezomib|mesh-list
24808328|NCT02026505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808329|NCT02026518|Vitamin D|vitamin d|mesh-list
24808330|NCT02026518|Cholecalciferol|cholecalciferol|mesh-list
25840782|NCT00028587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484026|NCT00446303|Azacitidine|azacitidine|mesh-list
24484027|NCT00446303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24484028|NCT00446303|Antimetabolites|antimetabolites|mesh-ancestor
24484029|NCT00446303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484030|NCT00446303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484031|NCT00446303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484032|NCT00446316|Imatinib Mesylate|imatinib mesylate|mesh-list
24484034|NCT00446316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484035|NCT00446316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24484036|NCT00446316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808438|NCT02027220|Antiemetics|antiemetics|mesh-ancestor
24808439|NCT02027220|Autonomic Agents|autonomic agents|mesh-ancestor
24808440|NCT02027220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25660042|NCT01615731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660043|NCT01615731|Protective Agents|protective agents|mesh-ancestor
24808441|NCT02027220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25660044|NCT01615731|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25061095|NCT03473691|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
25061099|NCT03473639|Entinostat|entinostat|mesh-list
24808442|NCT02027220|Glucocorticoids|glucocorticoids|mesh-ancestor
24808443|NCT02027220|Hormones|hormones|mesh-ancestor
25840783|NCT00028587|Tubulin Modulators|tubulin modulators|mesh-ancestor
24808477|NCT02027337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24808478|NCT02027337|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24808479|NCT02027337|Hormone Antagonists|hormone antagonists|mesh-ancestor
24808480|NCT02027337|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24808481|NCT02027337|Diuretics|diuretics|mesh-ancestor
24484348|NCT00447915|Ibandronic Acid|ibandronic acid|mesh-list
24484349|NCT00447915|Calcium|calcium|mesh-list
24484350|NCT00447915|Vitamins|vitamins|mesh-ancestor
24484351|NCT00447915|Micronutrients|micronutrients|mesh-ancestor
24484352|NCT00447915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484353|NCT00447915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24484354|NCT00447915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24484355|NCT00447928|Nitroglycerin|nitroglycerin|mesh-list
24808482|NCT02027337|Natriuretic Agents|natriuretic agents|mesh-ancestor
24808483|NCT02027337|Androgen Antagonists|androgen antagonists|mesh-ancestor
24808484|NCT02027337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808485|NCT02027337|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24808486|NCT02027363|Capecitabine|capecitabine|mesh-list
24808487|NCT02027363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24808488|NCT02027363|Antimetabolites|antimetabolites|mesh-ancestor
24603582|NCT00974584|Tubulin Modulators|tubulin modulators|mesh-ancestor
24603583|NCT00974584|Antimitotic Agents|antimitotic agents|mesh-ancestor
25163638|NCT02894710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840784|NCT00028587|Antimitotic Agents|antimitotic agents|mesh-ancestor
25840785|NCT00028587|Mitosis Modulators|mitosis modulators|mesh-ancestor
25840786|NCT00028587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840787|NCT00028600|Cyclophosphamide|cyclophosphamide|mesh-list
25840788|NCT00028600|Melphalan|melphalan|mesh-list
25840789|NCT00028600|Methotrexate|methotrexate|mesh-list
25840790|NCT00028600|Fludarabine|fludarabine|mesh-list
25840791|NCT00028600|Fludarabine phosphate|fludarabine phosphate|mesh-list
25840792|NCT00028600|Tacrolimus|tacrolimus|mesh-list
25840793|NCT00028600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25840794|NCT00028600|Immunologic Factors|immunologic factors|mesh-ancestor
25840795|NCT00028600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840796|NCT00028600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25840797|NCT00028600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25840798|NCT00028600|Alkylating Agents|alkylating agents|mesh-ancestor
25840799|NCT00028600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840800|NCT00028600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840801|NCT00028600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25840802|NCT00028600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25840803|NCT00028600|Abortifacient Agents|abortifacient agents|mesh-ancestor
25840804|NCT00028600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25840805|NCT00028600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24900150|NCT04397549|Analgesics|analgesics|mesh-ancestor
25840806|NCT00028600|Antimetabolites|antimetabolites|mesh-ancestor
25840807|NCT00028600|Dermatologic Agents|dermatologic agents|mesh-ancestor
25840808|NCT00028600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840809|NCT00028600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25840810|NCT00028600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24827615|NCT02140450|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24827616|NCT02140450|Mannitol|mannitol|mesh-list
24827617|NCT02140450|Acetazolamide|acetazolamide|mesh-list
24827618|NCT02140450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25840811|NCT00028600|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25840812|NCT00028613|Antibodies|antibodies|mesh-list
25840813|NCT00028613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24603585|NCT00974584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603586|NCT00974584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24603587|NCT00974584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24603588|NCT00974584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25660045|NCT01615731|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25660046|NCT01615731|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24603589|NCT00974584|Growth Substances|growth substances|mesh-ancestor
25163639|NCT02894710|Sensory System Agents|sensory system agents|mesh-ancestor
25163641|NCT02894710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25163642|NCT02894710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25163643|NCT02894710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24858659|NCT02298985|Curcumin|curcumin|mesh-list
25163644|NCT02894710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25163645|NCT02894710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163646|NCT02894645|Cytarabine|cytarabine|mesh-list
25163647|NCT02894645|Dexamethasone|dexamethasone|mesh-list
25163648|NCT02894645|Prednisolone|prednisolone|mesh-list
25163649|NCT02894645|Cyclophosphamide|cyclophosphamide|mesh-list
25163650|NCT02894645|Doxorubicin|doxorubicin|mesh-list
25163651|NCT02894645|Methotrexate|methotrexate|mesh-list
25163652|NCT02894645|Fludarabine|fludarabine|mesh-list
25163653|NCT02894645|Vincristine|vincristine|mesh-list
25163654|NCT02894645|Daunorubicin|daunorubicin|mesh-list
25163655|NCT02894645|Asparaginase|asparaginase|mesh-list
25163656|NCT02894645|Mercaptopurine|mercaptopurine|mesh-list
25163657|NCT02894645|Thioguanine|thioguanine|mesh-list
25163658|NCT02894645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25163659|NCT02894645|Immunologic Factors|immunologic factors|mesh-ancestor
25163660|NCT02894645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163661|NCT02894645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25163662|NCT02894645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25163663|NCT02894645|Alkylating Agents|alkylating agents|mesh-ancestor
25163664|NCT02894645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163665|NCT02894645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163666|NCT02894645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25163667|NCT02894645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25163668|NCT02894645|Antiemetics|antiemetics|mesh-ancestor
25163669|NCT02894645|Autonomic Agents|autonomic agents|mesh-ancestor
25163670|NCT02894645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25163671|NCT02894645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25163672|NCT02894645|Glucocorticoids|glucocorticoids|mesh-ancestor
25163673|NCT02894645|Hormones|hormones|mesh-ancestor
25203064|NCT02716766|Sorafenib|sorafenib|mesh-list
24603590|NCT00974584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603591|NCT00974584|Growth Inhibitors|growth inhibitors|mesh-ancestor
24603592|NCT00974584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603593|NCT00974584|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24533606|NCT00644618|Gemcitabine|gemcitabine|mesh-list
25840814|NCT00028613|Immunologic Factors|immunologic factors|mesh-ancestor
25840815|NCT00028613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603594|NCT00974584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24622848|NCT01068847|Antitubercular Agents|antitubercular agents|mesh-ancestor
24622849|NCT01068847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24622850|NCT01068847|Antimetabolites|antimetabolites|mesh-ancestor
24622851|NCT01068847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24484382|NCT00448097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484424|NCT00448266|Alkylating Agents|alkylating agents|mesh-ancestor
24484425|NCT00448266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484426|NCT00448266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484427|NCT00448266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24484428|NCT00448292|Naluzotan|naluzotan|mesh-list
24484429|NCT00448292|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24484453|NCT00448409|Immunologic Factors|immunologic factors|mesh-ancestor
24484454|NCT00448409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484455|NCT00448461|Heparin|heparin|mesh-list
24484456|NCT00448461|Bivalirudin|bivalirudin|mesh-list
24484457|NCT00448461|Anticoagulants|anticoagulants|mesh-ancestor
24484458|NCT00448461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24484459|NCT00448461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24484474|NCT00448578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24484475|NCT00448578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24484476|NCT00448578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24484477|NCT00448578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484478|NCT00448643|Cisplatin|cisplatin|mesh-list
24419890|NCT00214331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484515|NCT00448903|Anticoagulants|anticoagulants|mesh-ancestor
24484516|NCT00448942|Chlorhexidine|chlorhexidine|mesh-list
24484517|NCT00448942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24484594|NCT00449397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24484595|NCT00449397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484596|NCT00449410|Atorvastatin|atorvastatin|mesh-list
24484601|NCT00449410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484603|NCT00449410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24484613|NCT00449436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24484614|NCT00449436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484615|NCT00449436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484616|NCT00449436|Antiviral Agents|antiviral agents|mesh-ancestor
25840816|NCT00028652|Interleukin-12|interleukin-12|mesh-list
24889439|NCT04493463|Prednisolone|prednisolone|mesh-list
24889440|NCT04493463|Prednisolone acetate|prednisolone acetate|mesh-list
24889441|NCT04493463|Ropivacaine|ropivacaine|mesh-list
24889442|NCT04493463|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24889443|NCT04493463|Prednisolone phosphate|prednisolone phosphate|mesh-list
25061245|NCT03472872|Antipyretics|antipyretics|mesh-ancestor
24484617|NCT00449436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24484618|NCT00449436|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24484619|NCT00449436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24484620|NCT00449436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24484621|NCT00449449|Lidocaine|lidocaine|mesh-list
24484622|NCT00449449|Anesthetics, Local|anesthetics, local|mesh-ancestor
25840817|NCT00028652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25840818|NCT00028652|Immunologic Factors|immunologic factors|mesh-ancestor
25840819|NCT00028652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840820|NCT00028652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25840821|NCT00028652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25840822|NCT00028652|Growth Substances|growth substances|mesh-ancestor
25840823|NCT00028652|Growth Inhibitors|growth inhibitors|mesh-ancestor
25840824|NCT00028652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840825|NCT00028665|Cyclophosphamide|cyclophosphamide|mesh-list
24484671|NCT00449527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24808537|NCT02027792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24808538|NCT02027792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484776|NCT00450008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484777|NCT00450008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24484778|NCT00450008|Immunologic Factors|immunologic factors|mesh-ancestor
25163674|NCT02894645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24484779|NCT00450008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484780|NCT00450008|Leprostatic Agents|leprostatic agents|mesh-ancestor
24484781|NCT00450008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24484782|NCT00450008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24484783|NCT00450008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24484784|NCT00450008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24484785|NCT00450008|Growth Substances|growth substances|mesh-ancestor
24484786|NCT00450008|Growth Inhibitors|growth inhibitors|mesh-ancestor
24484789|NCT00450086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24484790|NCT00450086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24484791|NCT00450086|Autonomic Agents|autonomic agents|mesh-ancestor
24484792|NCT00450086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24484793|NCT00450086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484794|NCT00450086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24484795|NCT00450086|Respiratory System Agents|respiratory system agents|mesh-ancestor
24484802|NCT00450086|Sensory System Agents|sensory system agents|mesh-ancestor
24484803|NCT00450086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24484804|NCT00450099|Bupivacaine|bupivacaine|mesh-list
24484805|NCT00450099|Anesthetics, Local|anesthetics, local|mesh-ancestor
24484806|NCT00450099|Anesthetics|anesthetics|mesh-ancestor
24484807|NCT00450099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24484808|NCT00450099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484809|NCT00450099|Sensory System Agents|sensory system agents|mesh-ancestor
24484847|NCT00450203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24484848|NCT00450203|Antimetabolites|antimetabolites|mesh-ancestor
24484849|NCT00450203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808564|NCT02027961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808566|NCT02027987|Anticonvulsants|anticonvulsants|mesh-ancestor
24808567|NCT02027987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808568|NCT02027987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808569|NCT02027987|GABA Agents|gaba agents|mesh-ancestor
24808570|NCT02027987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24808571|NCT02027987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808572|NCT02027987|Antimanic Agents|antimanic agents|mesh-ancestor
24808573|NCT02027987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24808574|NCT02027987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24808575|NCT02027987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24603595|NCT00974740|Atorvastatin|atorvastatin|mesh-list
24808576|NCT02028026|Citalopram|citalopram|mesh-list
24808577|NCT02028026|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
24808578|NCT02028026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25660047|NCT01615731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25660048|NCT01615731|Contraceptive Agents|contraceptive agents|mesh-ancestor
25660049|NCT01615731|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25660050|NCT01615731|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25840826|NCT00028665|Carmustine|carmustine|mesh-list
25840827|NCT00028665|Rituximab|rituximab|mesh-list
24889527|NCT04492709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889528|NCT04492514|Mavrilimumab|mavrilimumab|mesh-list
24889529|NCT04492514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24825701|NCT02129699|Denosumab|denosumab|mesh-list
24474495|NCT00406250|Bevacizumab|bevacizumab|mesh-list
24889530|NCT04492319|Neostigmine|neostigmine|mesh-list
25061280|NCT03472508|Folic Acid|folic acid|mesh-list
25061281|NCT03472508|Vitamin B Complex|vitamin b complex|mesh-list
25061282|NCT03472508|Enalapril|enalapril|mesh-list
25061283|NCT03472508|Enalaprilat|enalaprilat|mesh-list
25061284|NCT03472508|Hematinics|hematinics|mesh-ancestor
25061285|NCT03472508|Vitamins|vitamins|mesh-ancestor
25061286|NCT03472508|Micronutrients|micronutrients|mesh-ancestor
25061287|NCT03472508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061288|NCT03472508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889539|NCT04492319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24889540|NCT04492280|Hydrocortisone|hydrocortisone|mesh-list
24889541|NCT04492280|Fludrocortisone|fludrocortisone|mesh-list
24889542|NCT04492280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24889543|NCT04492566|Pancrelipase|pancrelipase|mesh-list
24889558|NCT04492358|Mitosis Modulators|mitosis modulators|mesh-ancestor
25201596|NCT02726555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24808579|NCT02028026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24484888|NCT00450515|Capecitabine|capecitabine|mesh-list
24484889|NCT00450515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24484890|NCT00450515|Antimetabolites|antimetabolites|mesh-ancestor
24484968|NCT00450892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484969|NCT00450944|Immunotoxins|immunotoxins|mesh-list
24485003|NCT00451100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24485004|NCT00451100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485006|NCT00451100|Autonomic Agents|autonomic agents|mesh-ancestor
24485007|NCT00451100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24485008|NCT00451100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24485009|NCT00451100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24485010|NCT00451100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24485011|NCT00451113|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24485012|NCT00451113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24485013|NCT00451113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24485014|NCT00451113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485015|NCT00451113|Incretins|incretins|mesh-ancestor
25840828|NCT00028665|Cisplatin|cisplatin|mesh-list
25840829|NCT00028665|Etoposide|etoposide|mesh-list
25840830|NCT00028665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25840831|NCT00028665|Immunologic Factors|immunologic factors|mesh-ancestor
25840832|NCT00028665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840833|NCT00028665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25840834|NCT00028665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25840835|NCT00028665|Alkylating Agents|alkylating agents|mesh-ancestor
25840836|NCT00028665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840837|NCT00028665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840838|NCT00028665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25163676|NCT02894645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25163677|NCT02894645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25163678|NCT02894645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25163679|NCT02894645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25660051|NCT01615731|Hormone Antagonists|hormone antagonists|mesh-ancestor
25660052|NCT01615731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25660053|NCT01615731|Luteolytic Agents|luteolytic agents|mesh-ancestor
25660054|NCT01615731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25660055|NCT01615731|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25660056|NCT01615809|Amphotericin B|amphotericin b|mesh-list
25660057|NCT01615809|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25660058|NCT01615809|Amebicides|amebicides|mesh-ancestor
25660059|NCT01615809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25660060|NCT01615809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25660061|NCT01615809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25660062|NCT01615809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25660063|NCT01615809|Antifungal Agents|antifungal agents|mesh-ancestor
25660064|NCT01615822|Artefenomel|artefenomel|mesh-list
25660065|NCT01615822|Antimalarials|antimalarials|mesh-ancestor
25660066|NCT01615822|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25660067|NCT01615822|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25660068|NCT01615822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25660069|NCT01615939|Bupivacaine|bupivacaine|mesh-list
25660070|NCT01615939|Ropivacaine|ropivacaine|mesh-list
25660071|NCT01615939|Anesthetics, Local|anesthetics, local|mesh-ancestor
25163680|NCT02894645|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25163681|NCT02894645|Abortifacient Agents|abortifacient agents|mesh-ancestor
24513078|NCT00578526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513079|NCT00578591|Rituximab|rituximab|mesh-list
24513080|NCT00578591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24467260|NCT00376818|Hormones|hormones|mesh-list
24513081|NCT00578591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513082|NCT00578591|Immunologic Factors|immunologic factors|mesh-ancestor
24513083|NCT00578591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513084|NCT00578591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24513085|NCT00578721|Aspirin|aspirin|mesh-list
24513086|NCT00578721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24513087|NCT00578721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24513088|NCT00578721|Analgesics|analgesics|mesh-ancestor
25163682|NCT02894645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25163683|NCT02894645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25163684|NCT02894645|Antimetabolites|antimetabolites|mesh-ancestor
25163685|NCT02894645|Dermatologic Agents|dermatologic agents|mesh-ancestor
25163686|NCT02894645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25163687|NCT02894645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25163688|NCT02894645|Antiviral Agents|antiviral agents|mesh-ancestor
25163689|NCT02894645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25163690|NCT02894645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25163691|NCT02894645|Tubulin Modulators|tubulin modulators|mesh-ancestor
25163692|NCT02894645|Antimitotic Agents|antimitotic agents|mesh-ancestor
25163693|NCT02894645|Mitosis Modulators|mitosis modulators|mesh-ancestor
25163694|NCT05428072|Aspirin|aspirin|mesh-list
25163695|NCT05428072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25163696|NCT05428072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25163697|NCT05428072|Analgesics|analgesics|mesh-ancestor
25163698|NCT05428072|Sensory System Agents|sensory system agents|mesh-ancestor
25163699|NCT05428072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25163700|NCT05428072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163701|NCT05428072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25163702|NCT05428072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25163703|NCT05428072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25163704|NCT05428072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25163705|NCT05428072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163706|NCT05428072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25163707|NCT05428072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25163708|NCT05428072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163709|NCT05428072|Antipyretics|antipyretics|mesh-ancestor
25163725|NCT05427942|Adalimumab|adalimumab|mesh-list
25163726|NCT05427942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25163727|NCT05427942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25163728|NCT05427903|Epinephrine|epinephrine|mesh-list
25163729|NCT05427903|Anesthetics|anesthetics|mesh-list
25163730|NCT05427903|Carticaine|carticaine|mesh-list
25163731|NCT05427903|Anesthetics, Local|anesthetics, local|mesh-list
25840839|NCT00028665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24485241|NCT00452192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24485242|NCT00452192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485244|NCT00452218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485245|NCT00452218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24485246|NCT00452218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485247|NCT00452218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840840|NCT00028665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25840841|NCT00028665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25840842|NCT00028665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25840843|NCT00028665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840844|NCT00028678|Dalteparin|dalteparin|mesh-list
25840845|NCT00028678|Tinzaparin|tinzaparin|mesh-list
25840846|NCT00028678|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25840847|NCT00028678|Anticoagulants|anticoagulants|mesh-ancestor
25840848|NCT00028678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25660072|NCT01615939|Anesthetics|anesthetics|mesh-ancestor
25660073|NCT01615939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25660074|NCT01615939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660075|NCT01615939|Sensory System Agents|sensory system agents|mesh-ancestor
25660076|NCT01615939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25660077|NCT01616082|Phentermine|phentermine|mesh-list
25660078|NCT01616082|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25660079|NCT01616082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660080|NCT01616082|Appetite Depressants|appetite depressants|mesh-ancestor
25660081|NCT01616082|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25660082|NCT01616082|Sympathomimetics|sympathomimetics|mesh-ancestor
25660083|NCT01616082|Autonomic Agents|autonomic agents|mesh-ancestor
24676542|NCT01350882|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25840849|NCT00028678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24485249|NCT00452231|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24485250|NCT00452231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24485251|NCT00452231|Renal Agents|renal agents|mesh-ancestor
24485252|NCT00452231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24485253|NCT00452231|Antitubercular Agents|antitubercular agents|mesh-ancestor
24485254|NCT00452231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24485255|NCT00452231|Antimetabolites|antimetabolites|mesh-ancestor
24485316|NCT00452569|Immunologic Factors|immunologic factors|mesh-ancestor
24485317|NCT00452569|Leprostatic Agents|leprostatic agents|mesh-ancestor
24808644|NCT02028507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24808645|NCT02028507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24808646|NCT02028507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24808647|NCT02028507|Hormone Antagonists|hormone antagonists|mesh-ancestor
24808648|NCT02028507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24808649|NCT02028507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808681|NCT02028663|Esomeprazole|esomeprazole|mesh-list
24808682|NCT02028663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24808683|NCT02028663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24808684|NCT02028663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24808685|NCT02028663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808686|NCT02028663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808688|NCT02028689|Lesinurad|lesinurad|mesh-list
24808689|NCT02028689|Furosemide|furosemide|mesh-list
24808690|NCT02028689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24808691|NCT02028689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840850|NCT00028678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840851|NCT00028691|Chlorambucil|chlorambucil|mesh-list
24449787|NCT00316940|Bortezomib|bortezomib|mesh-list
24808714|NCT02028806|Micronutrients|micronutrients|mesh-ancestor
24808715|NCT02028819|Dolutegravir|dolutegravir|mesh-list
24808716|NCT02028819|Ibalizumab|ibalizumab|mesh-list
24808717|NCT02028819|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24808718|NCT02028819|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24808719|NCT02028819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808720|NCT02028819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808721|NCT02028819|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25163732|NCT05427903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24485517|NCT00453401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485518|NCT00453401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956063|NCT03857672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
24485520|NCT00453414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24485522|NCT00453427|Alemtuzumab|alemtuzumab|mesh-list
24485523|NCT00453427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24485524|NCT00453427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485525|NCT00453453|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24485526|NCT00453453|Natriuretic Agents|natriuretic agents|mesh-ancestor
24485564|NCT00453765|Respiratory System Agents|respiratory system agents|mesh-ancestor
24485565|NCT00453765|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24485566|NCT00453765|Hormone Antagonists|hormone antagonists|mesh-ancestor
24485568|NCT00453765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485569|NCT00453765|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24485570|NCT00453765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24485571|NCT00453765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485574|NCT00453778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24485575|NCT00453778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24485576|NCT00453778|Autonomic Agents|autonomic agents|mesh-ancestor
24485577|NCT00453778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24485578|NCT00453778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485579|NCT00453778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24485580|NCT00453778|Respiratory System Agents|respiratory system agents|mesh-ancestor
24485581|NCT00453778|Dermatologic Agents|dermatologic agents|mesh-ancestor
24808753|NCT02028949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24808755|NCT02028949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808756|NCT02028949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808757|NCT02029001|Everolimus|everolimus|mesh-list
24808758|NCT02029001|Sorafenib|sorafenib|mesh-list
24808760|NCT02029001|Olaparib|olaparib|mesh-list
25660084|NCT01616082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24808761|NCT02029001|Lapatinib|lapatinib|mesh-list
25660085|NCT01616082|Adrenergic Agents|adrenergic agents|mesh-ancestor
25660086|NCT01616082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25660087|NCT01616082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061331|NCT03472261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24808762|NCT02029001|Tremelimumab|tremelimumab|mesh-list
24808763|NCT02029001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808764|NCT02029001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24808765|NCT02029001|Immunologic Factors|immunologic factors|mesh-ancestor
24485598|NCT00453856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485599|NCT00453856|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24485600|NCT00453856|Renal Agents|renal agents|mesh-ancestor
24485601|NCT00453908|Alfuzosin|alfuzosin|mesh-list
24485603|NCT00453908|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25840852|NCT00028691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25840853|NCT00028691|Alkylating Agents|alkylating agents|mesh-ancestor
24808779|NCT02029118|Metoprolol|metoprolol|mesh-list
24808780|NCT02029118|Ramipril|ramipril|mesh-list
24808781|NCT02029118|Atorvastatin|atorvastatin|mesh-list
24808782|NCT02029118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24808783|NCT02029118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24808784|NCT02029118|Analgesics|analgesics|mesh-ancestor
24808785|NCT02029118|Sensory System Agents|sensory system agents|mesh-ancestor
24808786|NCT02029118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24808787|NCT02029118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808788|NCT02029118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24808789|NCT02029118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24485633|NCT00454259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24456806|NCT00332306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24485692|NCT00454519|Mitomycins|mitomycins|mesh-list
24485693|NCT00454519|Mitomycin|mitomycin|mesh-list
24485694|NCT00454519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485695|NCT00454519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24485696|NCT00454519|Alkylating Agents|alkylating agents|mesh-ancestor
24485697|NCT00454519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485705|NCT00454545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25840854|NCT00028691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485732|NCT00454714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485733|NCT00454714|Urological Agents|urological agents|mesh-ancestor
24485734|NCT00454740|Solifenacin Succinate|solifenacin succinate|mesh-list
24808790|NCT02029118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24808791|NCT02029118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24808792|NCT02029118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485783|NCT00455026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485784|NCT00455026|Analgesics|analgesics|mesh-ancestor
24485785|NCT00455026|Sensory System Agents|sensory system agents|mesh-ancestor
24485786|NCT00455026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24485788|NCT00455039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485789|NCT00455039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24485790|NCT00455039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485791|NCT00455039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485792|NCT00455091|Lamivudine|lamivudine|mesh-list
24485793|NCT00455091|Adefovir|adefovir|mesh-list
24485794|NCT00455091|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
24485795|NCT00455091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24808804|NCT02029118|Sympatholytics|sympatholytics|mesh-ancestor
24808805|NCT02029118|Autonomic Agents|autonomic agents|mesh-ancestor
24808806|NCT02029118|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24808807|NCT02029118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24808808|NCT02029118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24808809|NCT02029118|Adrenergic Agents|adrenergic agents|mesh-ancestor
24808810|NCT02029118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24808811|NCT02029118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24808812|NCT02029118|Protease Inhibitors|protease inhibitors|mesh-ancestor
24808814|NCT02029313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24808815|NCT02029313|Respiratory System Agents|respiratory system agents|mesh-ancestor
24485796|NCT00455091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25840855|NCT00028691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485858|NCT00455286|Prednisolone phosphate|prednisolone phosphate|mesh-list
24485859|NCT00455286|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25840856|NCT00028717|Prednisone|prednisone|mesh-list
24485949|NCT00455572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24485951|NCT00455572|Antimitotic Agents|antimitotic agents|mesh-ancestor
24485952|NCT00455572|Mitosis Modulators|mitosis modulators|mesh-ancestor
25660088|NCT01616160|Mometasone Furoate|mometasone furoate|mesh-list
25660089|NCT01616160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24953103|NCT03888677|Immunologic Factors|immunologic factors|mesh-ancestor
24953125|NCT03888534|Protease Inhibitors|protease inhibitors|mesh-ancestor
25061362|NCT03471988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25061363|NCT03471988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25061364|NCT03471988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676835|NCT01352572|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25061384|NCT03471585|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24823889|NCT02119884|Octreotide|octreotide|mesh-list
24889851|NCT04488705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24889852|NCT04488705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889853|NCT04488705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24467411|NCT00377546|Sensory System Agents|sensory system agents|mesh-ancestor
24485953|NCT00455572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485954|NCT00455585|Lamivudine|lamivudine|mesh-list
24485955|NCT00455585|Nevirapine|nevirapine|mesh-list
24485956|NCT00455585|Stavudine|stavudine|mesh-list
25840857|NCT00028717|Cyclophosphamide|cyclophosphamide|mesh-list
24485988|NCT00455715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486008|NCT00455806|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24486010|NCT00455832|Antimetabolites|antimetabolites|mesh-ancestor
24622903|NCT01069081|Cisplatin|cisplatin|mesh-list
24486032|NCT00455897|Rituximab|rituximab|mesh-list
24486033|NCT00455897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24486034|NCT00455897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486035|NCT00455897|Immunologic Factors|immunologic factors|mesh-ancestor
24486036|NCT00455897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622931|NCT01069159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622933|NCT01069159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24622934|NCT01069159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24957528|NCT03844243|Mitogens|mitogens|mesh-list
24622935|NCT01069159|Vasodilator Agents|vasodilator agents|mesh-ancestor
24622936|NCT01069198|Vitamin A|vitamin a|mesh-list
24622937|NCT01069198|Albendazole|albendazole|mesh-list
24622938|NCT01069198|Vitamins|vitamins|mesh-ancestor
24622939|NCT01069198|Micronutrients|micronutrients|mesh-ancestor
24622940|NCT01069198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622941|NCT01069198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622942|NCT01069198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622943|NCT01069198|Anthelmintics|anthelmintics|mesh-ancestor
24622944|NCT01069198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24622945|NCT01069198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24486042|NCT00455910|Leprostatic Agents|leprostatic agents|mesh-ancestor
24486043|NCT00455910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24486044|NCT00455910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24486045|NCT00455910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24486046|NCT00455910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24486047|NCT00455910|Growth Substances|growth substances|mesh-ancestor
24486048|NCT00455910|Growth Inhibitors|growth inhibitors|mesh-ancestor
24486049|NCT00455910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486050|NCT00455936|Gefitinib|gefitinib|mesh-list
24486051|NCT00455936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827627|NCT02140450|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25840858|NCT00028717|Rituximab|rituximab|mesh-list
25840859|NCT00028717|Doxorubicin|doxorubicin|mesh-list
25163733|NCT05427903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163734|NCT05427903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25163735|NCT05427903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25163736|NCT05427903|Adrenergic Agents|adrenergic agents|mesh-ancestor
25163737|NCT05427903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25163738|NCT05427903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660090|NCT01616160|Dermatologic Agents|dermatologic agents|mesh-ancestor
25660091|NCT01616160|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25660092|NCT01616173|Dexamethasone|dexamethasone|mesh-list
25660093|NCT01616173|Dexamethasone acetate|dexamethasone acetate|mesh-list
25660094|NCT01616173|BB 1101|bb 1101|mesh-list
25660095|NCT01616173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25660096|NCT01616173|Antiemetics|antiemetics|mesh-ancestor
25660097|NCT01616173|Autonomic Agents|autonomic agents|mesh-ancestor
25660098|NCT01616173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25660099|NCT01616173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660100|NCT01616173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25660101|NCT01616173|Glucocorticoids|glucocorticoids|mesh-ancestor
25163739|NCT05427903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25163740|NCT05427903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25660102|NCT01616173|Hormones|hormones|mesh-ancestor
25674328|NCT01770145|Antiemetics|antiemetics|mesh-ancestor
25840860|NCT00028717|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25061434|NCT03471351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061435|NCT03471325|Methamphetamine|methamphetamine|mesh-list
25061436|NCT03471325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25061437|NCT03471325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061438|NCT03471325|Sympathomimetics|sympathomimetics|mesh-ancestor
25840861|NCT00028717|Vincristine|vincristine|mesh-list
24823961|NCT02120404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823962|NCT02120547|Cenicriviroc|cenicriviroc|mesh-list
24823971|NCT02120599|Folic Acid|folic acid|mesh-list
24889912|NCT04488107|Hormone Antagonists|hormone antagonists|mesh-ancestor
24889913|NCT04488107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24889914|NCT04488107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889921|NCT04488081|Cyclosporine|cyclosporine|mesh-list
24889922|NCT04488081|Remdesivir|remdesivir|mesh-list
24889923|NCT04488081|Celecoxib|celecoxib|mesh-list
24889924|NCT04488081|Famotidine|famotidine|mesh-list
24889925|NCT04488081|Cyclosporins|cyclosporins|mesh-list
24889926|NCT04488081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889927|NCT04488081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889928|NCT04488081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25163741|NCT05427903|Autonomic Agents|autonomic agents|mesh-ancestor
25163742|NCT05427903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25163743|NCT05427903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25163744|NCT05427903|Respiratory System Agents|respiratory system agents|mesh-ancestor
25163745|NCT05427903|Mydriatics|mydriatics|mesh-ancestor
25163746|NCT05427903|Sympathomimetics|sympathomimetics|mesh-ancestor
25163747|NCT05427903|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25163748|NCT05427903|Sensory System Agents|sensory system agents|mesh-ancestor
25163765|NCT05427721|Antifungal Agents|antifungal agents|mesh-ancestor
25163766|NCT05427669|Leucovorin|leucovorin|mesh-list
25163767|NCT05427669|Fluorouracil|fluorouracil|mesh-list
25163768|NCT05427669|Oxaliplatin|oxaliplatin|mesh-list
25163769|NCT05427669|Irinotecan|irinotecan|mesh-list
25163770|NCT05427669|Levoleucovorin|levoleucovorin|mesh-list
25163771|NCT05427669|Antimetabolites|antimetabolites|mesh-ancestor
25163772|NCT05427669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163773|NCT05427669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25163774|NCT05427669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163775|NCT05427669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25163776|NCT05427669|Immunologic Factors|immunologic factors|mesh-ancestor
25163777|NCT05427669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163778|NCT05427669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25163779|NCT05427669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25163780|NCT05427669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163781|NCT05427669|Antidotes|antidotes|mesh-ancestor
25163782|NCT05427669|Protective Agents|protective agents|mesh-ancestor
25163783|NCT05427669|Vitamin B Complex|vitamin b complex|mesh-ancestor
25163784|NCT05427669|Vitamins|vitamins|mesh-ancestor
25163785|NCT05427669|Micronutrients|micronutrients|mesh-ancestor
25163786|NCT05427630|Dronabinol|dronabinol|mesh-list
25163787|NCT05427630|Hallucinogens|hallucinogens|mesh-ancestor
25163788|NCT05427630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163789|NCT05427630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24957803|NCT03841305|Liver Extracts|liver extracts|mesh-list
25163790|NCT05427630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25163791|NCT05427630|Analgesics|analgesics|mesh-ancestor
25163792|NCT05427630|Sensory System Agents|sensory system agents|mesh-ancestor
25660103|NCT01616173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25660104|NCT01616173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25660105|NCT01616173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25660106|NCT01616173|Protease Inhibitors|protease inhibitors|mesh-ancestor
25660107|NCT01616173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25660108|NCT01616173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660109|NCT01616459|Vaccines|vaccines|mesh-list
25660110|NCT01616459|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25660111|NCT01616459|Immunologic Factors|immunologic factors|mesh-ancestor
25660112|NCT01616459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660113|NCT01616654|Tazarotene|tazarotene|mesh-list
25660114|NCT01616654|Trifarotene|trifarotene|mesh-list
25660115|NCT01616654|Dermatologic Agents|dermatologic agents|mesh-ancestor
25660116|NCT01616654|Keratolytic Agents|keratolytic agents|mesh-ancestor
25660117|NCT01616693|Zinc|zinc|mesh-list
25660118|NCT01616693|Vaccines|vaccines|mesh-list
25660119|NCT01616693|Immunologic Factors|immunologic factors|mesh-ancestor
25660120|NCT01616693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660121|NCT01616693|Trace Elements|trace elements|mesh-ancestor
25660122|NCT01616693|Micronutrients|micronutrients|mesh-ancestor
25163793|NCT05427630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24889957|NCT04487951|Micronutrients|micronutrients|mesh-ancestor
24889958|NCT04487951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889984|NCT04487236|Antimetabolites|antimetabolites|mesh-ancestor
24467478|NCT00377910|Anesthetics|anesthetics|mesh-ancestor
24513207|NCT00579969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24513239|NCT00580112|Glucocorticoids|glucocorticoids|mesh-ancestor
25163794|NCT05427630|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25163795|NCT05427630|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25163796|NCT05427630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25163797|NCT05427630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163798|NCT05427630|Hormones|hormones|mesh-ancestor
25163799|NCT05427630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25163800|NCT05427617|Fulvestrant|fulvestrant|mesh-list
25163801|NCT05427617|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25163802|NCT05427617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25163803|NCT05427617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163804|NCT05427617|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25163805|NCT05427617|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24486052|NCT00455936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24486077|NCT00456235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24486078|NCT00456235|Antitubercular Agents|antitubercular agents|mesh-ancestor
24486079|NCT00456235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24486080|NCT00456235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24486082|NCT00456235|Dermatologic Agents|dermatologic agents|mesh-ancestor
24486083|NCT00456235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24486085|NCT00456248|Interferon alfacon-1|interferon alfacon-1|mesh-list
24486086|NCT00456248|Antimetabolites|antimetabolites|mesh-ancestor
24486172|NCT00456716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24486173|NCT00456716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486174|NCT00456716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486175|NCT00456729|Metronidazole|metronidazole|mesh-list
24486176|NCT00456729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24486177|NCT00456729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24486178|NCT00456729|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24486179|NCT00456729|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24486180|NCT00456794|Istradefylline|istradefylline|mesh-list
24486201|NCT00456820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486204|NCT00456833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840862|NCT00028717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25840863|NCT00028717|Immunologic Factors|immunologic factors|mesh-ancestor
24808949|NCT02029950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808950|NCT02029950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24808951|NCT02029950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24808952|NCT02029950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24808953|NCT02029950|Growth Substances|growth substances|mesh-ancestor
24808954|NCT02029950|Growth Inhibitors|growth inhibitors|mesh-ancestor
24808955|NCT02029950|Keratolytic Agents|keratolytic agents|mesh-ancestor
24808956|NCT02029950|Dermatologic Agents|dermatologic agents|mesh-ancestor
24808957|NCT02029950|Tubulin Modulators|tubulin modulators|mesh-ancestor
24808958|NCT02029950|Antimitotic Agents|antimitotic agents|mesh-ancestor
24808959|NCT02029950|Mitosis Modulators|mitosis modulators|mesh-ancestor
24808960|NCT02030054|Atorvastatin|atorvastatin|mesh-list
24808961|NCT02030054|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24808962|NCT02030054|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24808963|NCT02030054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24808964|NCT02030054|Antimetabolites|antimetabolites|mesh-ancestor
24486205|NCT00456833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24486206|NCT00456833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486207|NCT00456833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808969|NCT02030314|Chlorthalidone|chlorthalidone|mesh-list
24808970|NCT02030314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24808971|NCT02030314|Diuretics|diuretics|mesh-ancestor
24808972|NCT02030314|Natriuretic Agents|natriuretic agents|mesh-ancestor
24808973|NCT02030314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808974|NCT02030314|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24808975|NCT02030314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24808976|NCT02030314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808977|NCT02030483|Dexamethasone|dexamethasone|mesh-list
24808978|NCT02030483|Lenalidomide|lenalidomide|mesh-list
24808979|NCT02030483|Palbociclib|palbociclib|mesh-list
25660123|NCT01617083|Azithromycin|azithromycin|mesh-list
25660124|NCT01617083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25660125|NCT01617083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25660126|NCT01617148|Aflibercept|aflibercept|mesh-list
25660127|NCT01617148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25674329|NCT01770353|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25061503|NCT03470597|Trace Elements|trace elements|mesh-ancestor
24808980|NCT02030483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24808981|NCT02030483|Antiemetics|antiemetics|mesh-ancestor
24808982|NCT02030483|Autonomic Agents|autonomic agents|mesh-ancestor
24594260|NCT00933283|Methadone|methadone|mesh-list
25840864|NCT00028717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420591|NCT00216385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486241|NCT00456898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24486242|NCT00456898|Analgesics|analgesics|mesh-ancestor
24486248|NCT00456937|Citalopram|citalopram|mesh-list
24486253|NCT00456937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24486254|NCT00456937|Serotonin Agents|serotonin agents|mesh-ancestor
24486255|NCT00456937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486256|NCT00456937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24486257|NCT00456937|Antidepressive Agents|antidepressive agents|mesh-ancestor
25840865|NCT00028717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25840866|NCT00028717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25840867|NCT00028717|Alkylating Agents|alkylating agents|mesh-ancestor
24533792|NCT00645190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486284|NCT00457054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486286|NCT00457054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25163806|NCT05427617|Hormone Antagonists|hormone antagonists|mesh-ancestor
24486331|NCT00457145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486332|NCT00457223|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25840868|NCT00028717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840869|NCT00028717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486363|NCT00457483|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24486364|NCT00457483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24486365|NCT00457509|Vaccines|vaccines|mesh-list
24486366|NCT00457509|Immunologic Factors|immunologic factors|mesh-ancestor
25840870|NCT00028717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24420669|NCT00216554|Risperidone|risperidone|mesh-list
24486395|NCT00457678|Dermatologic Agents|dermatologic agents|mesh-ancestor
24486396|NCT00457717|Atropine|atropine|mesh-list
24486397|NCT00457717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24486401|NCT00457717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24486402|NCT00457717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486403|NCT00457717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24486404|NCT00457717|Respiratory System Agents|respiratory system agents|mesh-ancestor
24486405|NCT00457717|Mydriatics|mydriatics|mesh-ancestor
24486406|NCT00457717|Parasympatholytics|parasympatholytics|mesh-ancestor
24486407|NCT00457717|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24486408|NCT00457717|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24486409|NCT00457717|Cholinergic Agents|cholinergic agents|mesh-ancestor
24486410|NCT00457717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24486414|NCT00457769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24784329|NCT01907529|Cyclophosphamide|cyclophosphamide|mesh-list
24486415|NCT00457769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486416|NCT00457769|Cholinergic Agents|cholinergic agents|mesh-ancestor
24486417|NCT00457769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24486452|NCT00458055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24486473|NCT00458185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24486474|NCT00458185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24486475|NCT00458185|Analgesics|analgesics|mesh-ancestor
24486503|NCT00458250|Antimetabolites|antimetabolites|mesh-ancestor
24486504|NCT00458250|Dermatologic Agents|dermatologic agents|mesh-ancestor
24486505|NCT00458250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486530|NCT00458315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24486531|NCT00458315|Antimetabolites|antimetabolites|mesh-ancestor
24486532|NCT00458315|Antiviral Agents|antiviral agents|mesh-ancestor
24486533|NCT00458315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24486534|NCT00458315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486535|NCT00458315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24486810|NCT00460174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25660128|NCT01617148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25660129|NCT01617148|Growth Substances|growth substances|mesh-ancestor
25660130|NCT01617148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660131|NCT01617148|Growth Inhibitors|growth inhibitors|mesh-ancestor
25660132|NCT01617148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25660133|NCT01617434|Liraglutide|liraglutide|mesh-list
25660134|NCT01617434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25660135|NCT01617434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660136|NCT01617434|Incretins|incretins|mesh-ancestor
25660137|NCT01617434|Hormones|hormones|mesh-ancestor
25660138|NCT01617434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25660139|NCT01617447|Aripiprazole|aripiprazole|mesh-list
25061538|NCT03470480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061539|NCT03470480|Adrenergic Agents|adrenergic agents|mesh-ancestor
25061540|NCT03470480|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24486811|NCT00460174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24486812|NCT00460174|Immunologic Factors|immunologic factors|mesh-ancestor
24486814|NCT00460213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24486815|NCT00460213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24486816|NCT00460213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24486817|NCT00460213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486819|NCT00460226|Anticonvulsants|anticonvulsants|mesh-ancestor
24486820|NCT00460226|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24486873|NCT00460382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24486874|NCT00460382|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24486875|NCT00460382|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24958382|NCT03833895|Protective Agents|protective agents|mesh-ancestor
24486876|NCT00460382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24486877|NCT00460382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24809012|NCT02030678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809013|NCT02030717|Clonidine|clonidine|mesh-list
24486983|NCT00460785|Analgesics|analgesics|mesh-ancestor
24486984|NCT00460785|Sensory System Agents|sensory system agents|mesh-ancestor
24486985|NCT00460785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24486986|NCT00460837|Picosulfate sodium|picosulfate sodium|mesh-list
24486987|NCT00460837|Cathartics|cathartics|mesh-ancestor
24486988|NCT00460837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24486989|NCT00460850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24437999|NCT00274872|Oxaliplatin|oxaliplatin|mesh-list
24486998|NCT00460876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486999|NCT00460876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487000|NCT00460915|Amlodipine|amlodipine|mesh-list
24487001|NCT00460915|Lacidipine|lacidipine|mesh-list
24487002|NCT00460915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24487003|NCT00460915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24487004|NCT00460915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24487005|NCT00460915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840871|NCT00028717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25840872|NCT00028717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25840873|NCT00028717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25840874|NCT00028717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25840875|NCT00028717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840876|NCT00028717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24487011|NCT00460928|gamma-Globulins|gamma-globulins|mesh-list
24487012|NCT00460928|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24487013|NCT00460928|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24487014|NCT00460928|Immunologic Factors|immunologic factors|mesh-ancestor
24487015|NCT00460928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487083|NCT00461578|Chlorproguanil|chlorproguanil|mesh-list
24487084|NCT00461578|Antimalarials|antimalarials|mesh-ancestor
24487085|NCT00461578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24487086|NCT00461578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24487087|NCT00461578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24487088|NCT00461578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25203065|NCT02716766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25840877|NCT00028717|Glucocorticoids|glucocorticoids|mesh-ancestor
25840878|NCT00028717|Hormones|hormones|mesh-ancestor
25163807|NCT05427617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25163808|NCT05427617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163809|NCT05427617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163810|NCT05427617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163821|NCT05427500|Bupivacaine|bupivacaine|mesh-list
25163822|NCT05427500|Anesthetics, Local|anesthetics, local|mesh-ancestor
25660141|NCT01617447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25660142|NCT01617447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25660143|NCT01617447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25660144|NCT01617447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25163823|NCT05427500|Anesthetics|anesthetics|mesh-ancestor
25660145|NCT01617447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660146|NCT01617447|Dopamine Agonists|dopamine agonists|mesh-ancestor
25660147|NCT01617447|Dopamine Agents|dopamine agents|mesh-ancestor
25660148|NCT01617447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25674330|NCT01770353|Hematinics|hematinics|mesh-ancestor
25061577|NCT03470337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25061578|NCT03470337|Immunologic Factors|immunologic factors|mesh-ancestor
25061579|NCT03470337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163824|NCT05427500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25163825|NCT05427500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163826|NCT05427500|Sensory System Agents|sensory system agents|mesh-ancestor
25163827|NCT05427500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25163828|NCT05427383|Paclitaxel|paclitaxel|mesh-list
25163829|NCT05427383|Docetaxel|docetaxel|mesh-list
25163830|NCT05427383|Irinotecan|irinotecan|mesh-list
25163831|NCT05427383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25163832|NCT05427383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163833|NCT05427383|Tubulin Modulators|tubulin modulators|mesh-ancestor
25163834|NCT05427383|Antimitotic Agents|antimitotic agents|mesh-ancestor
25163835|NCT05427383|Mitosis Modulators|mitosis modulators|mesh-ancestor
25163836|NCT05427383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163837|NCT05427383|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25163838|NCT05427383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25163839|NCT05427383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163840|NCT05427305|Bevacizumab|bevacizumab|mesh-list
25163841|NCT05427305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25163842|NCT05427305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163843|NCT05427305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25163844|NCT05427305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25163845|NCT05427305|Growth Substances|growth substances|mesh-ancestor
25163846|NCT05427305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163847|NCT05427305|Growth Inhibitors|growth inhibitors|mesh-ancestor
25163848|NCT05427175|Methotrexate|methotrexate|mesh-list
25163849|NCT05427175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25163850|NCT05427175|Abortifacient Agents|abortifacient agents|mesh-ancestor
25163851|NCT05427175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25163852|NCT05427175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163853|NCT05427175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25163854|NCT05427175|Antimetabolites|antimetabolites|mesh-ancestor
25163855|NCT05427175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163856|NCT05427175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163857|NCT05427175|Dermatologic Agents|dermatologic agents|mesh-ancestor
25163858|NCT05427175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163859|NCT05427175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25163860|NCT05427175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25163861|NCT05427175|Immunologic Factors|immunologic factors|mesh-ancestor
25163862|NCT05427175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25163863|NCT05427175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25203066|NCT02716766|Antimetabolites|antimetabolites|mesh-ancestor
24487090|NCT00461578|Schistosomicides|schistosomicides|mesh-ancestor
24487091|NCT00461578|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24487092|NCT00461578|Anthelmintics|anthelmintics|mesh-ancestor
24487093|NCT00461578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24487094|NCT00461578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487095|NCT00461578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487096|NCT00461578|Leprostatic Agents|leprostatic agents|mesh-ancestor
24487097|NCT00461578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24487098|NCT00461617|Mitiglinide|mitiglinide|mesh-list
24487099|NCT00461617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24809063|NCT02030977|Antioxidants|antioxidants|mesh-ancestor
24809064|NCT02030977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809065|NCT02030977|Protective Agents|protective agents|mesh-ancestor
24809066|NCT02030977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809068|NCT02030977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25840879|NCT00028717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25840880|NCT00028717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25840881|NCT00028717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25840882|NCT00028717|Tubulin Modulators|tubulin modulators|mesh-ancestor
25840883|NCT00028717|Antimitotic Agents|antimitotic agents|mesh-ancestor
25840884|NCT00028717|Mitosis Modulators|mitosis modulators|mesh-ancestor
25840885|NCT00028730|Cyclophosphamide|cyclophosphamide|mesh-list
25840886|NCT00028730|Thiotepa|thiotepa|mesh-list
25660149|NCT01617447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660150|NCT01617447|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25660151|NCT01617447|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25660152|NCT01617447|Serotonin Agents|serotonin agents|mesh-ancestor
25660153|NCT01617447|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25660154|NCT01617447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25840887|NCT00028730|Fludarabine|fludarabine|mesh-list
25840888|NCT00028730|Fludarabine phosphate|fludarabine phosphate|mesh-list
25840889|NCT00028730|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25840890|NCT00028730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24809070|NCT02031016|Remifentanil|remifentanil|mesh-list
24809071|NCT02031016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24809072|NCT02031016|Narcotics|narcotics|mesh-ancestor
24809073|NCT02031016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24420820|NCT00216866|Dalteparin|dalteparin|mesh-list
24487262|NCT00462540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487263|NCT00462540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24487264|NCT00462540|Respiratory System Agents|respiratory system agents|mesh-ancestor
24487265|NCT00462540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24487305|NCT00462592|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25840891|NCT00028730|Immunologic Factors|immunologic factors|mesh-ancestor
25840892|NCT00028730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840893|NCT00028730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25840894|NCT00028730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25840895|NCT00028730|Alkylating Agents|alkylating agents|mesh-ancestor
25840896|NCT00028730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840897|NCT00028730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487306|NCT00462592|Hormone Antagonists|hormone antagonists|mesh-ancestor
24487307|NCT00462592|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24487308|NCT00462592|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24487309|NCT00462592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809136|NCT02031510|Dexmedetomidine|dexmedetomidine|mesh-list
24809137|NCT02031510|Bupivacaine|bupivacaine|mesh-list
24809138|NCT02031510|Anesthetics, Local|anesthetics, local|mesh-ancestor
24809139|NCT02031510|Anesthetics|anesthetics|mesh-ancestor
24809140|NCT02031510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24809141|NCT02031510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809142|NCT02031510|Sensory System Agents|sensory system agents|mesh-ancestor
24809143|NCT02031510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24809144|NCT02031510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24809145|NCT02031510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25840898|NCT00028730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25840899|NCT00028730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25840900|NCT00028730|Antimetabolites|antimetabolites|mesh-ancestor
25840901|NCT00028743|Paclitaxel|paclitaxel|mesh-list
25840902|NCT00028743|Cisplatin|cisplatin|mesh-list
25840903|NCT00028743|Carboplatin|carboplatin|mesh-list
24827654|NCT02140632|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25840904|NCT00028743|Topotecan|topotecan|mesh-list
25840905|NCT00028743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25840906|NCT00028743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840907|NCT00028743|Tubulin Modulators|tubulin modulators|mesh-ancestor
25840908|NCT00028743|Antimitotic Agents|antimitotic agents|mesh-ancestor
25840909|NCT00028743|Mitosis Modulators|mitosis modulators|mesh-ancestor
25840910|NCT00028743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809146|NCT02031510|Analgesics|analgesics|mesh-ancestor
24595063|NCT00936689|Hormones|hormones|mesh-ancestor
24487310|NCT00462618|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24487311|NCT00462618|Antidepressive Agents|antidepressive agents|mesh-ancestor
24487312|NCT00462618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24487313|NCT00462618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24487391|NCT00462852|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24487392|NCT00462852|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24487393|NCT00462878|Vancomycin|vancomycin|mesh-list
24487394|NCT00462878|Meropenem|meropenem|mesh-list
24487395|NCT00462878|Teicoplanin|teicoplanin|mesh-list
24487431|NCT00463073|Irinotecan|irinotecan|mesh-list
24487461|NCT00463203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25840911|NCT00028743|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24487509|NCT00463671|Acetylcysteine|acetylcysteine|mesh-list
24487510|NCT00463671|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24487514|NCT00463671|Respiratory System Agents|respiratory system agents|mesh-ancestor
24487515|NCT00463671|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24487516|NCT00463671|Antioxidants|antioxidants|mesh-ancestor
24487517|NCT00463671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487518|NCT00463671|Protective Agents|protective agents|mesh-ancestor
24487519|NCT00463671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487520|NCT00463671|Antidotes|antidotes|mesh-ancestor
24487521|NCT00463710|Interferon beta-1a|interferon beta-1a|mesh-list
24487522|NCT00463710|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24487523|NCT00463710|Immunologic Factors|immunologic factors|mesh-ancestor
24487524|NCT00463710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809147|NCT02031510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25660155|NCT01617447|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25840912|NCT00028743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24513330|NCT00580619|Adrenergic Agents|adrenergic agents|mesh-ancestor
24513331|NCT00580619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25840913|NCT00028743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809148|NCT02031510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24809149|NCT02031510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24809150|NCT02031510|Adrenergic Agents|adrenergic agents|mesh-ancestor
24809151|NCT02031510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24809152|NCT02031510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604276|NCT00978211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604278|NCT00978211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24604279|NCT00978211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604280|NCT00978263|Metformin|metformin|mesh-list
24604281|NCT00978263|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24604282|NCT00978263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604283|NCT00978315|Cholecalciferol|cholecalciferol|mesh-list
24604284|NCT00978315|Vitamin D|vitamin d|mesh-list
24487564|NCT00463827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24487565|NCT00463827|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24487566|NCT00463827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487568|NCT00463879|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24487605|NCT00464165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487607|NCT00464165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24487651|NCT00464347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487652|NCT00464347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24487653|NCT00464347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24487654|NCT00464347|Growth Substances|growth substances|mesh-ancestor
24487655|NCT00464347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487656|NCT00464347|Growth Inhibitors|growth inhibitors|mesh-ancestor
24487657|NCT00464347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24604296|NCT00978328|Sensory System Agents|sensory system agents|mesh-ancestor
24604297|NCT00978328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24604299|NCT00978354|Diuretics|diuretics|mesh-ancestor
24604300|NCT00978354|Natriuretic Agents|natriuretic agents|mesh-ancestor
24604305|NCT00978393|Liraglutide|liraglutide|mesh-list
24809153|NCT02031523|Analgesics|analgesics|mesh-list
24809154|NCT02031523|Sensory System Agents|sensory system agents|mesh-ancestor
24809155|NCT02031523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24809156|NCT02031523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163864|NCT05427084|Canagliflozin|canagliflozin|mesh-list
24809157|NCT02031601|Carboplatin|carboplatin|mesh-list
24809158|NCT02031601|Docetaxel|docetaxel|mesh-list
24809159|NCT02031601|Pemetrexed|pemetrexed|mesh-list
24809160|NCT02031601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24809161|NCT02031601|Gefitinib|gefitinib|mesh-list
24809162|NCT02031601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809216|NCT02031965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24809217|NCT02031965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809219|NCT02031991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24809220|NCT02031991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809221|NCT02031991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24809222|NCT02031991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24809223|NCT02031991|Growth Substances|growth substances|mesh-ancestor
24809224|NCT02031991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809225|NCT02031991|Growth Inhibitors|growth inhibitors|mesh-ancestor
24809226|NCT02032043|Ivermectin|ivermectin|mesh-list
24487815|NCT00465231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24487817|NCT00465231|Narcotics|narcotics|mesh-ancestor
24487868|NCT00465439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24487869|NCT00465439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487870|NCT00465439|Sensory System Agents|sensory system agents|mesh-ancestor
24487871|NCT00465439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24487872|NCT00465439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24487874|NCT00465439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24487881|NCT00465439|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24487882|NCT00465439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24487884|NCT00465439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24487885|NCT00465439|Respiratory System Agents|respiratory system agents|mesh-ancestor
24487886|NCT00465439|Mydriatics|mydriatics|mesh-ancestor
24487887|NCT00465439|Sympathomimetics|sympathomimetics|mesh-ancestor
24487888|NCT00465439|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25660156|NCT01617447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25660157|NCT01617460|Aripiprazole|aripiprazole|mesh-list
25660158|NCT01617460|Antidepressive Agents|antidepressive agents|mesh-ancestor
24890372|NCT04483427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24890373|NCT04483427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24890374|NCT04483427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24890375|NCT04483427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24890376|NCT04483427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890377|NCT04483427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24890378|NCT04483427|Narcotics|narcotics|mesh-ancestor
24816822|NCT02079194|Aspirin|aspirin|mesh-list
24816823|NCT02079194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24816824|NCT02079194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24816825|NCT02079194|Analgesics|analgesics|mesh-ancestor
24816826|NCT02079194|Sensory System Agents|sensory system agents|mesh-ancestor
24487889|NCT00465452|Dopamine|dopamine|mesh-list
24487890|NCT00465452|Dopamine Agonists|dopamine agonists|mesh-list
24487891|NCT00465452|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24487892|NCT00465452|Sympathomimetics|sympathomimetics|mesh-ancestor
24487893|NCT00465452|Autonomic Agents|autonomic agents|mesh-ancestor
24487894|NCT00465452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24487895|NCT00465452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487896|NCT00465452|Dopamine Agents|dopamine agents|mesh-ancestor
24487897|NCT00465452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24487898|NCT00465452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487899|NCT00465452|Protective Agents|protective agents|mesh-ancestor
24487900|NCT00465543|Rosmarinic acid|rosmarinic acid|mesh-list
24487901|NCT00465543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24487937|NCT00465751|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
24488016|NCT00466219|Interferons|interferons|mesh-list
24488018|NCT00466219|Interferon-alpha|interferon-alpha|mesh-list
24488019|NCT00466219|Interferon alpha-2|interferon alpha-2|mesh-list
24488020|NCT00466219|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24488021|NCT00466219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488022|NCT00466219|Antiviral Agents|antiviral agents|mesh-ancestor
24488023|NCT00466219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24488024|NCT00466219|Antimetabolites|antimetabolites|mesh-ancestor
24488025|NCT00466219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488026|NCT00466219|Immunologic Factors|immunologic factors|mesh-ancestor
24488027|NCT00466219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488028|NCT00466232|Sorafenib|sorafenib|mesh-list
24446906|NCT00306475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488039|NCT00466284|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24488040|NCT00466284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488041|NCT00466284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24488042|NCT00466284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488043|NCT00466284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488044|NCT00466388|Cevimeline|cevimeline|mesh-list
24488045|NCT00466388|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24488046|NCT00466388|Autonomic Agents|autonomic agents|mesh-ancestor
25840914|NCT00028756|Gemcitabine|gemcitabine|mesh-list
25840915|NCT00028756|Cisplatin|cisplatin|mesh-list
25840916|NCT00028756|Doxorubicin|doxorubicin|mesh-list
24488047|NCT00466388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24488048|NCT00466388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488049|NCT00466388|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24488050|NCT00466388|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24488086|NCT00466518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488088|NCT00466570|Gatifloxacin|gatifloxacin|mesh-list
24827655|NCT02140632|Prednisolone phosphate|prednisolone phosphate|mesh-list
24827656|NCT02140632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24827657|NCT02140632|Antiemetics|antiemetics|mesh-ancestor
24827658|NCT02140632|Autonomic Agents|autonomic agents|mesh-ancestor
24827659|NCT02140632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24447366|NCT00308321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24447367|NCT00308321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25660159|NCT01617460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25660160|NCT01617460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25660161|NCT01617460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25660162|NCT01617460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25660163|NCT01617460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660164|NCT01617460|Dopamine Agonists|dopamine agonists|mesh-ancestor
25660165|NCT01617460|Dopamine Agents|dopamine agents|mesh-ancestor
25660166|NCT01617460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25660167|NCT01617460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660168|NCT01617460|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25660169|NCT01617460|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25840917|NCT00028756|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24447370|NCT00308334|Domperidone|domperidone|mesh-list
24890426|NCT04483674|Tenofovir|tenofovir|mesh-list
24890460|NCT04483284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24890462|NCT04483219|Antibodies|antibodies|mesh-list
25840918|NCT00028756|Methotrexate|methotrexate|mesh-list
24890463|NCT04483219|Immunologic Factors|immunologic factors|mesh-ancestor
24890464|NCT04483219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890465|NCT04483063|Chlorhexidine|chlorhexidine|mesh-list
24890466|NCT04483063|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24890467|NCT04483063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24890468|NCT04483063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24890469|NCT04483063|Disinfectants|disinfectants|mesh-ancestor
24890470|NCT04483063|Dermatologic Agents|dermatologic agents|mesh-ancestor
24890471|NCT04482907|Hormones|hormones|mesh-list
25061675|NCT03469167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25061676|NCT03469167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061677|NCT03469167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061678|NCT03469167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25061679|NCT03469167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25840919|NCT00028756|Vinblastine|vinblastine|mesh-list
24447377|NCT00308334|Dopamine Agents|dopamine agents|mesh-ancestor
24447378|NCT00308334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24447379|NCT00308334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447380|NCT00308360|Valproic Acid|valproic acid|mesh-list
24447381|NCT00308360|Risperidone|risperidone|mesh-list
24447382|NCT00308360|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24447383|NCT00308360|Serotonin Agents|serotonin agents|mesh-ancestor
24447384|NCT00308360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24447385|NCT00308360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447386|NCT00308360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447387|NCT00308360|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25840920|NCT00028756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840921|NCT00028756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25840922|NCT00028756|Antimetabolites|antimetabolites|mesh-ancestor
25840923|NCT00028756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809365|NCT02033408|Amoxicillin|amoxicillin|mesh-list
24829863|NCT02155049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24809258|NCT02032290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24809259|NCT02032290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24809260|NCT02032290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24809261|NCT02032290|Purinergic Agents|purinergic agents|mesh-ancestor
24809262|NCT02032290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24809263|NCT02032290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809264|NCT02032290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840924|NCT00028756|Antiviral Agents|antiviral agents|mesh-ancestor
24488127|NCT00466609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488128|NCT00466609|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24488130|NCT00466622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24488131|NCT00466622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488133|NCT00466713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24488134|NCT00466713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840925|NCT00028756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25840926|NCT00028756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488155|NCT00466856|Octreotide|octreotide|mesh-list
24488156|NCT00466856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24488157|NCT00466856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24488158|NCT00466856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25660170|NCT01617460|Serotonin Agents|serotonin agents|mesh-ancestor
25660171|NCT01617460|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25660172|NCT01617460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25660173|NCT01617460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25660174|NCT01617460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25660175|NCT01617577|Lenograstim|lenograstim|mesh-list
25660176|NCT01617577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25660177|NCT01617577|Immunologic Factors|immunologic factors|mesh-ancestor
25660178|NCT01617577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660179|NCT01617655|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25660180|NCT01617655|Immunologic Factors|immunologic factors|mesh-ancestor
25660181|NCT01617655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660182|NCT01617668|Paclitaxel|paclitaxel|mesh-list
25660183|NCT01617668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25660184|NCT01617668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25660185|NCT01617668|Tubulin Modulators|tubulin modulators|mesh-ancestor
25660186|NCT01617668|Antimitotic Agents|antimitotic agents|mesh-ancestor
25660187|NCT01617668|Mitosis Modulators|mitosis modulators|mesh-ancestor
24488159|NCT00466869|Betahistine|betahistine|mesh-list
24488160|NCT00466869|Vasodilator Agents|vasodilator agents|mesh-ancestor
24488161|NCT00466869|Histamine Agonists|histamine agonists|mesh-ancestor
24488162|NCT00466869|Histamine Agents|histamine agents|mesh-ancestor
25163865|NCT05427084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25163866|NCT05427084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163867|NCT05427084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25163869|NCT05426824|Pegaspargase|pegaspargase|mesh-list
25163870|NCT05426824|Asparaginase|asparaginase|mesh-list
25163871|NCT05426824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163872|NCT05426798|Azacitidine|azacitidine|mesh-list
25163874|NCT05426798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25163875|NCT05426798|Antimetabolites|antimetabolites|mesh-ancestor
25163876|NCT05426798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163877|NCT05426798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163878|NCT05426798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163879|NCT05426499|Fluconazole|fluconazole|mesh-list
25163880|NCT05426499|Isavuconazole|isavuconazole|mesh-list
25163881|NCT05426499|Anidulafungin|anidulafungin|mesh-list
25163882|NCT05426499|Meropenem|meropenem|mesh-list
25163883|NCT05426499|Cefotaxime|cefotaxime|mesh-list
25163884|NCT05426499|Cefoxitin|cefoxitin|mesh-list
25163885|NCT05426499|Antifungal Agents|antifungal agents|mesh-ancestor
25163886|NCT05426499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25163887|NCT05426499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25163888|NCT05426499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25163889|NCT05426499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488163|NCT00466869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24488202|NCT00467116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488203|NCT00467116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488204|NCT00467116|Antiviral Agents|antiviral agents|mesh-ancestor
24488205|NCT00467116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25840927|NCT00028756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24488230|NCT00467194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24488231|NCT00467194|Antifungal Agents|antifungal agents|mesh-ancestor
24488232|NCT00467194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25840928|NCT00028756|Immunologic Factors|immunologic factors|mesh-ancestor
24449862|NCT00317330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24488271|NCT00467493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488272|NCT00467493|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24488273|NCT00467493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24488274|NCT00467493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488275|NCT00467493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488280|NCT00467506|Antibodies|antibodies|mesh-list
24488382|NCT00468260|Tubulin Modulators|tubulin modulators|mesh-ancestor
24488383|NCT00468260|Antimitotic Agents|antimitotic agents|mesh-ancestor
24488384|NCT00468260|Mitosis Modulators|mitosis modulators|mesh-ancestor
24488401|NCT00468351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25840929|NCT00028756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488436|NCT00468533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488437|NCT00468533|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24488438|NCT00468533|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24488439|NCT00468533|Serotonin Agents|serotonin agents|mesh-ancestor
24488441|NCT00468533|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24488442|NCT00468533|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24488443|NCT00468533|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24488444|NCT00468689|Ketoconazole|ketoconazole|mesh-list
24488445|NCT00468689|Antifungal Agents|antifungal agents|mesh-ancestor
24488446|NCT00468689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24488447|NCT00468689|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24488448|NCT00468689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24488449|NCT00468689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488450|NCT00468689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488451|NCT00468689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24488452|NCT00468689|Hormone Antagonists|hormone antagonists|mesh-ancestor
24488453|NCT00468689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24488454|NCT00468689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488502|NCT00469053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24488503|NCT00469053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488505|NCT00469053|Sensory System Agents|sensory system agents|mesh-ancestor
24488506|NCT00469053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24446909|NCT00306475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25840930|NCT00028756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25840931|NCT00028756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24488576|NCT00469430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24488577|NCT00469430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24488578|NCT00469430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24488579|NCT00469430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24488581|NCT00469443|Bevacizumab|bevacizumab|mesh-list
24488582|NCT00469443|Fluorouracil|fluorouracil|mesh-list
24488583|NCT00469443|Capecitabine|capecitabine|mesh-list
25840933|NCT00028756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25840934|NCT00028756|Abortifacient Agents|abortifacient agents|mesh-ancestor
25840935|NCT00028756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25840936|NCT00028756|Dermatologic Agents|dermatologic agents|mesh-ancestor
25840937|NCT00028756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24488607|NCT00469469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488608|NCT00469469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24488609|NCT00469469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24488610|NCT00469469|Growth Substances|growth substances|mesh-ancestor
24488887|NCT00470483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25840938|NCT00028756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24488938|NCT00470665|Sirolimus|sirolimus|mesh-list
24488939|NCT00470665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24488940|NCT00470665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25840939|NCT00028756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24488941|NCT00470665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24488942|NCT00470665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488943|NCT00470665|Antifungal Agents|antifungal agents|mesh-ancestor
24488944|NCT00470665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24488945|NCT00470665|Immunologic Factors|immunologic factors|mesh-ancestor
24488946|NCT00470665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488948|NCT00470678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24488949|NCT00470678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24488950|NCT00470678|Growth Substances|growth substances|mesh-ancestor
24488951|NCT00470678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488952|NCT00470678|Growth Inhibitors|growth inhibitors|mesh-ancestor
24488953|NCT00470678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488954|NCT00470743|Ibuprofen|ibuprofen|mesh-list
24488969|NCT00470743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24488971|NCT00470821|Antioxidants|antioxidants|mesh-ancestor
24488973|NCT00470821|Protective Agents|protective agents|mesh-ancestor
24489030|NCT00471094|Lansoprazole|lansoprazole|mesh-list
24489031|NCT00471094|Dexlansoprazole|dexlansoprazole|mesh-list
24489032|NCT00471094|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24809338|NCT02033096|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
24809339|NCT02033096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809340|NCT02033096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809341|NCT02033187|Chlorhexidine|chlorhexidine|mesh-list
24809342|NCT02033187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24809343|NCT02033187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24489241|NCT00471952|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24489242|NCT00471952|Serotonin Agents|serotonin agents|mesh-ancestor
24489243|NCT00471965|Leucovorin|leucovorin|mesh-list
24489244|NCT00471965|Doxorubicin|doxorubicin|mesh-list
24489245|NCT00471965|Fluorouracil|fluorouracil|mesh-list
24489246|NCT00471965|Oxaliplatin|oxaliplatin|mesh-list
24489247|NCT00471965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24489251|NCT00471965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24489304|NCT00472134|Sensory System Agents|sensory system agents|mesh-ancestor
24489305|NCT00472134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489348|NCT00472550|Esomeprazole|esomeprazole|mesh-list
24489349|NCT00472550|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24489350|NCT00472550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24489484|NCT00473551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489485|NCT00473551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24489486|NCT00473551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24489487|NCT00473551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24489488|NCT00473551|Antimetabolites|antimetabolites|mesh-ancestor
24489503|NCT00473616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489504|NCT00473616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489506|NCT00473707|Oxytocics|oxytocics|mesh-ancestor
24489507|NCT00473707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24489508|NCT00473707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489509|NCT00473720|Paclitaxel|paclitaxel|mesh-list
24489510|NCT00473720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24489511|NCT00473720|Satraplatin|satraplatin|mesh-list
24489512|NCT00473720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24891098|NCT04476121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24891103|NCT04476121|Antipyretics|antipyretics|mesh-ancestor
24489514|NCT00473720|Tubulin Modulators|tubulin modulators|mesh-ancestor
24489515|NCT00473720|Antimitotic Agents|antimitotic agents|mesh-ancestor
24489516|NCT00473720|Mitosis Modulators|mitosis modulators|mesh-ancestor
24489517|NCT00473720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489518|NCT00473915|Fluticasone|fluticasone|mesh-list
24489520|NCT00473915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24809355|NCT02033356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24809356|NCT02033356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809357|NCT02033356|Sensory System Agents|sensory system agents|mesh-ancestor
24809358|NCT02033356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24809359|NCT02033356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24809360|NCT02033356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24889840|NCT04489381|Nitazoxanide|nitazoxanide|mesh-list
24809361|NCT02033356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24489541|NCT00473980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24489542|NCT00473980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24489543|NCT00473980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489595|NCT00474136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24489628|NCT00474591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24489629|NCT00474591|Protease Inhibitors|protease inhibitors|mesh-ancestor
24489630|NCT00474591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24489631|NCT00474591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489632|NCT00474591|Anticoagulants|anticoagulants|mesh-ancestor
24489633|NCT00474591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24489634|NCT00474591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24489635|NCT00474669|Docetaxel|docetaxel|mesh-list
24489636|NCT00474669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489637|NCT00474669|Tubulin Modulators|tubulin modulators|mesh-ancestor
24489638|NCT00474669|Antimitotic Agents|antimitotic agents|mesh-ancestor
24489639|NCT00474669|Mitosis Modulators|mitosis modulators|mesh-ancestor
24489640|NCT00474669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489641|NCT00474695|Ranibizumab|ranibizumab|mesh-list
24489650|NCT00474721|Codeine|codeine|mesh-list
24489651|NCT00474721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24489652|NCT00474721|Analgesics|analgesics|mesh-ancestor
24489653|NCT00474721|Sensory System Agents|sensory system agents|mesh-ancestor
24489654|NCT00474721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489655|NCT00474721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489665|NCT00474721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24489667|NCT00474721|Respiratory System Agents|respiratory system agents|mesh-ancestor
24489668|NCT00474773|Celecoxib|celecoxib|mesh-list
24489669|NCT00474773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24489670|NCT00474773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24489671|NCT00474773|Analgesics|analgesics|mesh-ancestor
24489672|NCT00474773|Sensory System Agents|sensory system agents|mesh-ancestor
24489673|NCT00474773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489674|NCT00474773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489675|NCT00474773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24809366|NCT02033408|Metronidazole|metronidazole|mesh-list
24809367|NCT02033408|Vancomycin|vancomycin|mesh-list
25840940|NCT00028756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24489782|NCT00475397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489783|NCT00475397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24489920|NCT00475930|Chlorhexidine|chlorhexidine|mesh-list
24489921|NCT00475930|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24489922|NCT00475930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24440885|NCT00285181|Simvastatin|simvastatin|mesh-list
24489923|NCT00475930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24489924|NCT00475930|Disinfectants|disinfectants|mesh-ancestor
24489925|NCT00475930|Dermatologic Agents|dermatologic agents|mesh-ancestor
24489937|NCT00475969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24489997|NCT00476138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489998|NCT00476138|Protective Agents|protective agents|mesh-ancestor
24489999|NCT00476138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490000|NCT00476138|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24490004|NCT00476164|Rituximab|rituximab|mesh-list
24490061|NCT00476216|Antithrombins|antithrombins|mesh-ancestor
24490062|NCT00476216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24490063|NCT00476216|Protease Inhibitors|protease inhibitors|mesh-ancestor
24490064|NCT00476216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490065|NCT00476216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660188|NCT01617668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891423|NCT04470908|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24891424|NCT04470908|Antitubercular Agents|antitubercular agents|mesh-ancestor
24490067|NCT00476268|Beclomethasone|beclomethasone|mesh-list
24490068|NCT00476268|Formoterol Fumarate|formoterol fumarate|mesh-list
24490069|NCT00476268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24490070|NCT00476268|Autonomic Agents|autonomic agents|mesh-ancestor
24490095|NCT00476359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24490096|NCT00476359|Protease Inhibitors|protease inhibitors|mesh-ancestor
24490097|NCT00476359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840941|NCT00028756|Tubulin Modulators|tubulin modulators|mesh-ancestor
25840942|NCT00028756|Antimitotic Agents|antimitotic agents|mesh-ancestor
25840943|NCT00028756|Mitosis Modulators|mitosis modulators|mesh-ancestor
24490098|NCT00476359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490099|NCT00476359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24490100|NCT00476359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24490101|NCT00476359|Antiviral Agents|antiviral agents|mesh-ancestor
24490102|NCT00476359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24490103|NCT00476359|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24490104|NCT00476359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25840944|NCT00028782|Etanidazole|etanidazole|mesh-list
25840945|NCT00028782|Imidazole|imidazole|mesh-list
25840946|NCT00028782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840947|NCT00028782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840948|NCT00028782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840949|NCT00028795|Temozolomide|temozolomide|mesh-list
25840950|NCT00028795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25840951|NCT00028795|Alkylating Agents|alkylating agents|mesh-ancestor
25840952|NCT00028795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840953|NCT00028795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840954|NCT00028821|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
25840955|NCT00028821|Estradiol|estradiol|mesh-list
25840956|NCT00028821|Estrogens|estrogens|mesh-ancestor
25840957|NCT00028821|Hormones|hormones|mesh-ancestor
25041956|NCT01535508|Vitamins|vitamins|mesh-ancestor
24490105|NCT00476424|Efavirenz|efavirenz|mesh-list
24490106|NCT00476424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24490107|NCT00476424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24490108|NCT00476424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490109|NCT00476424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490110|NCT00476424|Antiviral Agents|antiviral agents|mesh-ancestor
24490111|NCT00476424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24490112|NCT00476424|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24490113|NCT00476424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24490114|NCT00476424|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24490115|NCT00476424|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24490116|NCT00476424|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24490117|NCT00476424|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25163890|NCT05426499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163891|NCT05426499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25163892|NCT05426499|Hormone Antagonists|hormone antagonists|mesh-ancestor
25163893|NCT05426499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25163894|NCT05426499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163895|NCT05426499|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25163896|NCT05426499|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25415373|NCT03007147|Hydrocortisone|hydrocortisone|mesh-list
25660189|NCT01617681|Valsartan|valsartan|mesh-list
25660190|NCT01617681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25660191|NCT01617681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25660192|NCT01617681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25660193|NCT01617681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660194|NCT01618162|Liraglutide|liraglutide|mesh-list
25660195|NCT01618162|Xultophy|xultophy|mesh-list
25660196|NCT01618162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25660197|NCT01618162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660198|NCT01618162|Incretins|incretins|mesh-ancestor
25660199|NCT01618162|Hormones|hormones|mesh-ancestor
25660200|NCT01618162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25660201|NCT01618214|Insulin Aspart|insulin aspart|mesh-list
25660202|NCT01618214|Biphasic Insulins|biphasic insulins|mesh-list
25660203|NCT01618214|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
25660204|NCT01618214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24891850|NCT04467463|Anesthetics, Local|anesthetics, local|mesh-ancestor
25163897|NCT05426499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25163899|NCT05426486|Docetaxel|docetaxel|mesh-list
25163900|NCT05426486|Trastuzumab|trastuzumab|mesh-list
25163901|NCT05426486|Pertuzumab|pertuzumab|mesh-list
25163902|NCT05426486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163903|NCT05426486|Tubulin Modulators|tubulin modulators|mesh-ancestor
24809378|NCT02033408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490157|NCT00476853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24490225|NCT00477048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24490226|NCT00477048|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24490227|NCT00477048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24490228|NCT00477061|Morphine|morphine|mesh-list
24490229|NCT00477061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24490230|NCT00477061|Narcotics|narcotics|mesh-ancestor
24490239|NCT00477074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490241|NCT00477126|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24490242|NCT00477126|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24490243|NCT00477126|Protease Inhibitors|protease inhibitors|mesh-ancestor
24490244|NCT00477126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490245|NCT00477126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490246|NCT00477126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24490283|NCT00477516|Calcium|calcium|mesh-list
24490284|NCT00477516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24490285|NCT00477516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490286|NCT00477516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24490287|NCT00477542|Clofarabine|clofarabine|mesh-list
24961944|NCT03803553|Fluorouracil|fluorouracil|mesh-list
24490288|NCT00477542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24490289|NCT00477542|Antimetabolites|antimetabolites|mesh-ancestor
24490290|NCT00477542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490291|NCT00477542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490292|NCT00477581|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25840958|NCT00028821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24490311|NCT00477737|Propofol|propofol|mesh-list
24490312|NCT00477737|Sevoflurane|sevoflurane|mesh-list
24490350|NCT00477789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24490351|NCT00477789|Antioxidants|antioxidants|mesh-ancestor
24490352|NCT00477789|Protective Agents|protective agents|mesh-ancestor
24490353|NCT00477789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490354|NCT00477802|Botulinum Toxins|botulinum toxins|mesh-list
24490355|NCT00477802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24490356|NCT00477802|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24490357|NCT00477802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24490358|NCT00477802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24490359|NCT00477802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490360|NCT00477802|Cholinergic Agents|cholinergic agents|mesh-ancestor
24490361|NCT00477802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24490362|NCT00477802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490363|NCT00477802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24490364|NCT00477802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24490410|NCT00478049|Tubulin Modulators|tubulin modulators|mesh-ancestor
24490411|NCT00478049|Antimitotic Agents|antimitotic agents|mesh-ancestor
24490412|NCT00478049|Mitosis Modulators|mitosis modulators|mesh-ancestor
24490413|NCT00478049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490414|NCT00478049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24490415|NCT00478049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490416|NCT00478075|Bortezomib|bortezomib|mesh-list
24490417|NCT00478075|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
24490418|NCT00478075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809386|NCT02033434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24490437|NCT00478114|Sorafenib|sorafenib|mesh-list
25840959|NCT00028821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490455|NCT00478452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24490456|NCT00478452|Immunologic Factors|immunologic factors|mesh-ancestor
24490457|NCT00478452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490458|NCT00478452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24490459|NCT00478452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24490460|NCT00478452|Alkylating Agents|alkylating agents|mesh-ancestor
24490461|NCT00478452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490462|NCT00478452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490463|NCT00478452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24490501|NCT00478634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24892143|NCT04465357|Sensory System Agents|sensory system agents|mesh-ancestor
24892144|NCT04465357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24490502|NCT00478634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24490503|NCT00478634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24490504|NCT00478634|Immunologic Factors|immunologic factors|mesh-ancestor
24490509|NCT00478699|Gemcitabine|gemcitabine|mesh-list
24490637|NCT00479362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24490638|NCT00479362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490639|NCT00479362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24490640|NCT00479362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24490641|NCT00479362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24490642|NCT00479362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24490643|NCT00479362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490644|NCT00479362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24490645|NCT00479362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24490757|NCT00480064|Lomustine|lomustine|mesh-list
24490758|NCT00480064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24490759|NCT00480064|Antimetabolites|antimetabolites|mesh-ancestor
24490760|NCT00480064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490761|NCT00480064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490762|NCT00480064|Antiviral Agents|antiviral agents|mesh-ancestor
24490763|NCT00480064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24490764|NCT00480064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24490765|NCT00480064|Immunologic Factors|immunologic factors|mesh-ancestor
24490766|NCT00480064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840960|NCT00028821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490809|NCT00480194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24490810|NCT00480194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490811|NCT00480194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24490812|NCT00480194|Respiratory System Agents|respiratory system agents|mesh-ancestor
24490813|NCT00480194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24490814|NCT00480194|Cholinergic Agents|cholinergic agents|mesh-ancestor
24490815|NCT00480194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24490816|NCT00480194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490817|NCT00480194|Nasal Decongestants|nasal decongestants|mesh-ancestor
24490818|NCT00480194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24490819|NCT00480207|Folic Acid|folic acid|mesh-list
24490820|NCT00480207|Vitamin B Complex|vitamin b complex|mesh-list
24490821|NCT00480207|Hematinics|hematinics|mesh-ancestor
24490822|NCT00480207|Vitamins|vitamins|mesh-ancestor
24490823|NCT00480207|Micronutrients|micronutrients|mesh-ancestor
24809392|NCT02033434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24809393|NCT02033434|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24809394|NCT02033434|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24809396|NCT02033434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809397|NCT02033512|Hormones|hormones|mesh-list
24809398|NCT02033512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24809399|NCT02033512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809400|NCT02033538|Paclitaxel|paclitaxel|mesh-list
24490824|NCT00480207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490825|NCT00480246|Perphenazine|perphenazine|mesh-list
24490826|NCT00480246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24490827|NCT00480246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24490828|NCT00480246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24490830|NCT00480246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24490841|NCT00480272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490842|NCT00480272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24490843|NCT00480272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490844|NCT00480272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24490846|NCT00480298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25840961|NCT00028821|Tubulin Modulators|tubulin modulators|mesh-ancestor
24490847|NCT00480298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24490894|NCT00480376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490895|NCT00480376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24491130|NCT00481312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24490896|NCT00480376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24490898|NCT00480389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490899|NCT00480389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25660205|NCT01618214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660206|NCT01618266|Dexamethasone|dexamethasone|mesh-list
25660207|NCT01618266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25660208|NCT01618266|Antiemetics|antiemetics|mesh-ancestor
24446813|NCT00306124|Levodopa|levodopa|mesh-list
24715265|NCT01535495|Propranolol|propranolol|mesh-list
24892623|NCT04461340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24892624|NCT04461340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24892625|NCT04461340|Antifungal Agents|antifungal agents|mesh-ancestor
24892626|NCT04461340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24892627|NCT04461340|Immunologic Factors|immunologic factors|mesh-ancestor
25061822|NCT05390749|Rituximab|rituximab|mesh-list
25061823|NCT05390749|Methotrexate|methotrexate|mesh-list
25061824|NCT05390749|Pomalidomide|pomalidomide|mesh-list
24892656|NCT04460807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24892658|NCT04460807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892659|NCT04460807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24892660|NCT04460807|Hormone Antagonists|hormone antagonists|mesh-ancestor
25840962|NCT00028821|Antimitotic Agents|antimitotic agents|mesh-ancestor
24490900|NCT00480389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490901|NCT00480389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490902|NCT00480402|Progesterone|progesterone|mesh-list
24490903|NCT00480402|Progestins|progestins|mesh-ancestor
24490905|NCT00480402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24490906|NCT00480402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490907|NCT00480454|Vaccines|vaccines|mesh-list
24490908|NCT00480454|Immunologic Factors|immunologic factors|mesh-ancestor
25163920|NCT05425914|Lubricant Eye Drops|lubricant eye drops|mesh-list
25840963|NCT00028821|Mitosis Modulators|mitosis modulators|mesh-ancestor
24490909|NCT00480454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490911|NCT00480558|Immunologic Factors|immunologic factors|mesh-ancestor
24490962|NCT00480610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840964|NCT00028821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490963|NCT00480623|Satraplatin|satraplatin|mesh-list
24809402|NCT02033538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24809403|NCT02033538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809404|NCT02033538|Tubulin Modulators|tubulin modulators|mesh-ancestor
24809405|NCT02033538|Antimitotic Agents|antimitotic agents|mesh-ancestor
24809406|NCT02033538|Mitosis Modulators|mitosis modulators|mesh-ancestor
24490964|NCT00480623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490965|NCT00480649|Fluticasone|fluticasone|mesh-list
24490967|NCT00480649|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24490968|NCT00480649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24490969|NCT00480649|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24490971|NCT00480649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24490972|NCT00480649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491002|NCT00480675|Hormones|hormones|mesh-ancestor
24491007|NCT00480675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491036|NCT00480883|Gout Suppressants|gout suppressants|mesh-ancestor
24491037|NCT00480883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24491038|NCT00480883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24491039|NCT00480883|Antioxidants|antioxidants|mesh-ancestor
24491040|NCT00480883|Protective Agents|protective agents|mesh-ancestor
24491041|NCT00480883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491042|NCT00480883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24491043|NCT00480883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24491044|NCT00480883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24491045|NCT00480896|Tacrolimus|tacrolimus|mesh-list
24491046|NCT00480896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24491047|NCT00480896|Immunologic Factors|immunologic factors|mesh-ancestor
24491048|NCT00480896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491082|NCT00481169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24491083|NCT00481169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491084|NCT00481169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24491086|NCT00481182|Fosamprenavir|fosamprenavir|mesh-list
25660209|NCT01618266|Autonomic Agents|autonomic agents|mesh-ancestor
25660210|NCT01618266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25660211|NCT01618266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660212|NCT01618266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25660213|NCT01618266|Glucocorticoids|glucocorticoids|mesh-ancestor
25660214|NCT01618266|Hormones|hormones|mesh-ancestor
25660215|NCT01618266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25660216|NCT01618266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25660217|NCT01618266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25660218|NCT01618305|Lamivudine|lamivudine|mesh-list
25660219|NCT01618305|Zidovudine|zidovudine|mesh-list
25660220|NCT01618305|Efavirenz|efavirenz|mesh-list
25660221|NCT01618305|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25660222|NCT01618305|Raltegravir Potassium|raltegravir potassium|mesh-list
24816974|NCT02080104|Oxytocin|oxytocin|mesh-list
24491088|NCT00481182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24491089|NCT00481182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24491090|NCT00481182|Protease Inhibitors|protease inhibitors|mesh-ancestor
24491091|NCT00481182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840965|NCT00028834|Gemcitabine|gemcitabine|mesh-list
25840966|NCT00028834|Bevacizumab|bevacizumab|mesh-list
24491092|NCT00481182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491093|NCT00481182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24491094|NCT00481182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24491095|NCT00481182|Antiviral Agents|antiviral agents|mesh-ancestor
24491096|NCT00481182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24491097|NCT00481182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24491119|NCT00481312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24491120|NCT00481312|Analgesics|analgesics|mesh-ancestor
24491121|NCT00481312|Sensory System Agents|sensory system agents|mesh-ancestor
24491122|NCT00481312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24491123|NCT00481312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24491124|NCT00481312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24491125|NCT00481312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24491126|NCT00481312|Adrenergic Agents|adrenergic agents|mesh-ancestor
24491127|NCT00481312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24491128|NCT00481312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491129|NCT00481312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24491131|NCT00481312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24491132|NCT00481312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24491133|NCT00481312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24491134|NCT00481312|Anesthetics, General|anesthetics, general|mesh-ancestor
24809409|NCT02033551|Carboplatin|carboplatin|mesh-list
24491272|NCT00481819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24491273|NCT00481819|Glucocorticoids|glucocorticoids|mesh-ancestor
24491275|NCT00481819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25163921|NCT05425914|Vitamins|vitamins|mesh-ancestor
25163922|NCT05425914|Micronutrients|micronutrients|mesh-ancestor
24491276|NCT00481819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24491277|NCT00481819|Protective Agents|protective agents|mesh-ancestor
24491283|NCT00481923|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24491284|NCT00481923|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24491312|NCT00482066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491313|NCT00482066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24491314|NCT00482066|Immunologic Factors|immunologic factors|mesh-ancestor
24491316|NCT00482066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24491318|NCT00482079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24491366|NCT00482222|Antidotes|antidotes|mesh-ancestor
24491367|NCT00482222|Protective Agents|protective agents|mesh-ancestor
24491368|NCT00482222|Vitamin B Complex|vitamin b complex|mesh-ancestor
24491370|NCT00482222|Micronutrients|micronutrients|mesh-ancestor
24491371|NCT00482222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24491372|NCT00482248|Omalizumab|omalizumab|mesh-list
24491373|NCT00482248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24491378|NCT00482261|Lenalidomide|lenalidomide|mesh-list
24491379|NCT00482261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24491380|NCT00482261|Antiemetics|antiemetics|mesh-ancestor
24491381|NCT00482261|Autonomic Agents|autonomic agents|mesh-ancestor
24491382|NCT00482261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24491383|NCT00482261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491384|NCT00482261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24491385|NCT00482261|Glucocorticoids|glucocorticoids|mesh-ancestor
24491386|NCT00482261|Hormones|hormones|mesh-ancestor
24491387|NCT00482261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24491388|NCT00482261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24491389|NCT00482261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491390|NCT00482261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24491392|NCT00482261|Analgesics|analgesics|mesh-ancestor
24491568|NCT00483054|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24491569|NCT00483054|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24491570|NCT00483054|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24491571|NCT00483054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24491572|NCT00483054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24491573|NCT00483067|Cytarabine|cytarabine|mesh-list
24491574|NCT00483067|Cladribine|cladribine|mesh-list
24491575|NCT00483067|Lenograstim|lenograstim|mesh-list
24491576|NCT00483067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24491617|NCT00483158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660223|NCT01618305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25660224|NCT01618305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24892873|NCT04457648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24892874|NCT04457765|Povidone-Iodine|povidone-iodine|mesh-list
24892875|NCT04457765|Povidone|povidone|mesh-list
24491618|NCT00483158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491619|NCT00483210|Fenofibrate|fenofibrate|mesh-list
24491620|NCT00483210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24491621|NCT00483210|Antimetabolites|antimetabolites|mesh-ancestor
24442762|NCT00292526|Enalapril|enalapril|mesh-list
24626898|NCT01089140|Hemostatics|hemostatics|mesh-ancestor
24491622|NCT00483210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491623|NCT00483210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24491624|NCT00483275|Alfacalcidol|alfacalcidol|mesh-list
24491625|NCT00483275|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
24491626|NCT00483275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24491627|NCT00483275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491628|NCT00483275|Vitamins|vitamins|mesh-ancestor
24491629|NCT00483275|Micronutrients|micronutrients|mesh-ancestor
25840967|NCT00028834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24491640|NCT00483314|Expectorants|expectorants|mesh-ancestor
24491665|NCT00483392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840968|NCT00028834|Antibodies|antibodies|mesh-list
24491667|NCT00483431|Hemostatics|hemostatics|mesh-ancestor
24491668|NCT00483431|Coagulants|coagulants|mesh-ancestor
24491669|NCT00483457|Enzyme Inhibitors|enzyme inhibitors|mesh-list
24491670|NCT00483457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491672|NCT00483470|Immunologic Factors|immunologic factors|mesh-ancestor
24491673|NCT00483470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491675|NCT00483600|Fondaparinux|fondaparinux|mesh-list
24491676|NCT00483600|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24491677|NCT00483600|Antithrombins|antithrombins|mesh-ancestor
24491678|NCT00483600|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24491745|NCT00483834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491746|NCT00483834|Growth Inhibitors|growth inhibitors|mesh-ancestor
24491773|NCT00483964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24491774|NCT00483964|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24491775|NCT00483964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25163923|NCT05425914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840969|NCT00028834|Immunoglobulins|immunoglobulins|mesh-list
25840970|NCT00028834|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25840971|NCT00028834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840972|NCT00028834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25840973|NCT00028834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25840974|NCT00028834|Growth Substances|growth substances|mesh-ancestor
25041987|NCT01520545|GABA Agonists|gaba agonists|mesh-ancestor
24491776|NCT00483964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24491777|NCT00483964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24491778|NCT00483964|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24491779|NCT00483964|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24491780|NCT00483964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24491781|NCT00483964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491782|NCT00483964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25840975|NCT00028834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840976|NCT00028834|Growth Inhibitors|growth inhibitors|mesh-ancestor
25840977|NCT00028834|Immunologic Factors|immunologic factors|mesh-ancestor
25840978|NCT00028834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24491796|NCT00484003|Sensory System Agents|sensory system agents|mesh-ancestor
24891984|NCT04466176|Xhance|xhance|mesh-list
24491797|NCT00484003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24491798|NCT00484003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840979|NCT00028834|Antimetabolites|antimetabolites|mesh-ancestor
24491817|NCT00484068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491819|NCT00484107|Estrogens|estrogens|mesh-list
24491820|NCT00484107|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24491821|NCT00484107|Hormones|hormones|mesh-ancestor
24491822|NCT00484107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24491823|NCT00484107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491824|NCT00484120|Diclofenac|diclofenac|mesh-list
24491828|NCT00484120|Sensory System Agents|sensory system agents|mesh-ancestor
24491852|NCT00484133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491853|NCT00484133|Protective Agents|protective agents|mesh-ancestor
24491877|NCT00484250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24491878|NCT00484250|Antimalarials|antimalarials|mesh-ancestor
24491879|NCT00484328|Ribavirin|ribavirin|mesh-list
24491880|NCT00484328|Antimetabolites|antimetabolites|mesh-ancestor
25660225|NCT01618305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25660226|NCT01618305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491881|NCT00484328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840980|NCT00028834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840981|NCT00028834|Antiviral Agents|antiviral agents|mesh-ancestor
24491882|NCT00484328|Antiviral Agents|antiviral agents|mesh-ancestor
24491883|NCT00484328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24491884|NCT00484341|Doxorubicin|doxorubicin|mesh-list
24491885|NCT00484341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24491886|NCT00484341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491887|NCT00484341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24491888|NCT00484341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24491889|NCT00484341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491890|NCT00484341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491891|NCT00484432|Doxorubicin|doxorubicin|mesh-list
24809446|NCT02033733|Cisatracurium|cisatracurium|mesh-list
24809447|NCT02033733|Atracurium|atracurium|mesh-list
24491892|NCT00484432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24491893|NCT00484432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491894|NCT00484432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25840982|NCT00028834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24491895|NCT00484432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24491896|NCT00484432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492330|NCT00485888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24491897|NCT00484432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491899|NCT00484484|Analgesics|analgesics|mesh-ancestor
24491900|NCT00484484|Sensory System Agents|sensory system agents|mesh-ancestor
24963199|NCT03792347|Pembrolizumab|pembrolizumab|mesh-list
24491901|NCT00484484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24491902|NCT00484484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163924|NCT05425914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25163925|NCT05425914|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25163926|NCT05425914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25163928|NCT05425875|Chelating Agents|chelating agents|mesh-ancestor
25163929|NCT05425875|Sequestering Agents|sequestering agents|mesh-ancestor
25163930|NCT05425875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163931|NCT05425862|Talazoparib|talazoparib|mesh-list
24491904|NCT00484484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24491905|NCT00484484|Anesthetics, General|anesthetics, general|mesh-ancestor
24491906|NCT00484484|Anesthetics|anesthetics|mesh-ancestor
24491907|NCT00484484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25840983|NCT00028834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491937|NCT00484601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24491981|NCT00484809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24491982|NCT00484809|Analgesics|analgesics|mesh-ancestor
25840984|NCT00028834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24491999|NCT00484900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24492000|NCT00484900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24492001|NCT00484900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24492002|NCT00484926|Aspirin|aspirin|mesh-list
24492003|NCT00484926|Clopidogrel|clopidogrel|mesh-list
24492004|NCT00484926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24492005|NCT00484926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24492006|NCT00484926|Analgesics|analgesics|mesh-ancestor
24492007|NCT00484926|Sensory System Agents|sensory system agents|mesh-ancestor
24492008|NCT00484926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24492009|NCT00484926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492010|NCT00484926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24492011|NCT00484926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24492012|NCT00484926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24492013|NCT00484926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24492036|NCT00485004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24492037|NCT00485004|Antifungal Agents|antifungal agents|mesh-ancestor
24492038|NCT00485004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24492039|NCT00485004|Immunologic Factors|immunologic factors|mesh-ancestor
24492040|NCT00485004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492041|NCT00485030|Sirolimus|sirolimus|mesh-list
24492130|NCT00485407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492131|NCT00485459|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24492132|NCT00485459|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24492133|NCT00485459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25840985|NCT00028847|Cytarabine|cytarabine|mesh-list
25840986|NCT00028847|Imatinib Mesylate|imatinib mesylate|mesh-list
25840987|NCT00028847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24492245|NCT00485771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492246|NCT00485771|Anticonvulsants|anticonvulsants|mesh-ancestor
24492247|NCT00485771|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25415528|NCT03004287|Glucocorticoids|glucocorticoids|mesh-ancestor
24492248|NCT00485771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24492250|NCT00485797|Methylphenidate|methylphenidate|mesh-list
24492251|NCT00485797|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24492252|NCT00485797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492253|NCT00485797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24809453|NCT02033733|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24492298|NCT00485849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492314|NCT00485875|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24492315|NCT00485875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24492316|NCT00485875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492318|NCT00485875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492319|NCT00485875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492322|NCT00485888|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24492323|NCT00485888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24492324|NCT00485888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492325|NCT00485888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492327|NCT00485888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492328|NCT00485888|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24492329|NCT00485888|Antidepressive Agents|antidepressive agents|mesh-ancestor
24492331|NCT00485901|Haloperidol|haloperidol|mesh-list
24492332|NCT00485901|Olanzapine|olanzapine|mesh-list
24492333|NCT00485901|Haloperidol decanoate|haloperidol decanoate|mesh-list
24492470|NCT00486421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492473|NCT00486421|Glucocorticoids|glucocorticoids|mesh-ancestor
24492481|NCT00486460|Antimetabolites|antimetabolites|mesh-ancestor
24492482|NCT00486460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492483|NCT00486460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24492485|NCT00486460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24492529|NCT00486668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24492530|NCT00486668|Alkylating Agents|alkylating agents|mesh-ancestor
24492531|NCT00486668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24492532|NCT00486668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24492533|NCT00486668|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24622958|NCT01069263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622960|NCT01069302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24492604|NCT00487032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24492605|NCT00487032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24492606|NCT00487032|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24492607|NCT00487032|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24492608|NCT00487032|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24492609|NCT00487032|Adrenergic Agents|adrenergic agents|mesh-ancestor
24492610|NCT00487032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492611|NCT00487032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492612|NCT00487032|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24492613|NCT00487032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24492614|NCT00487032|Sympathomimetics|sympathomimetics|mesh-ancestor
24492615|NCT00487032|Nasal Decongestants|nasal decongestants|mesh-ancestor
25840988|NCT00028847|Antimetabolites|antimetabolites|mesh-ancestor
24492621|NCT00487110|Acetaminophen|acetaminophen|mesh-list
24492622|NCT00487110|Tropisetron|tropisetron|mesh-list
24492623|NCT00487110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24492624|NCT00487110|Analgesics|analgesics|mesh-ancestor
24492625|NCT00487110|Sensory System Agents|sensory system agents|mesh-ancestor
24492626|NCT00487110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24492627|NCT00487110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492628|NCT00487110|Antipyretics|antipyretics|mesh-ancestor
24492629|NCT00487110|Antiemetics|antiemetics|mesh-ancestor
24492630|NCT00487110|Autonomic Agents|autonomic agents|mesh-ancestor
24492633|NCT00487110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24492634|NCT00487110|Serotonin Agents|serotonin agents|mesh-ancestor
24492635|NCT00487110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492636|NCT00487110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492638|NCT00487123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24492639|NCT00487123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24492640|NCT00487123|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24492641|NCT00487123|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24492642|NCT00487123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492805|NCT00488137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492806|NCT00488137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893171|NCT04453345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24893172|NCT04453345|Growth Substances|growth substances|mesh-ancestor
24893173|NCT04453345|Growth Inhibitors|growth inhibitors|mesh-ancestor
24893174|NCT04453436|Tenofovir|tenofovir|mesh-list
24893175|NCT04453436|Lamivudine|lamivudine|mesh-list
24893176|NCT04453436|Dolutegravir|dolutegravir|mesh-list
24893177|NCT04453436|Antiviral Agents|antiviral agents|mesh-ancestor
24893178|NCT04453436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24492807|NCT00488137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492808|NCT00488163|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24492809|NCT00488163|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24492810|NCT00488163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24492811|NCT00488163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24492888|NCT00488566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24492894|NCT00488566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24492895|NCT00488566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24492896|NCT00488566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24492897|NCT00488605|Leucovorin|leucovorin|mesh-list
24492898|NCT00488605|Prednisone|prednisone|mesh-list
24492899|NCT00488605|Methotrexate|methotrexate|mesh-list
24492900|NCT00488605|Vinblastine|vinblastine|mesh-list
24492901|NCT00488605|Levoleucovorin|levoleucovorin|mesh-list
24492957|NCT00488722|Goserelin|goserelin|mesh-list
24492958|NCT00488722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24492959|NCT00488722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24492960|NCT00488761|Tigecycline|tigecycline|mesh-list
24492961|NCT00488761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24492962|NCT00488761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24492963|NCT00488761|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24492964|NCT00488761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492965|NCT00488761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492966|NCT00488787|Ketamine|ketamine|mesh-list
24492967|NCT00488787|Analgesics|analgesics|mesh-ancestor
24492968|NCT00488787|Sensory System Agents|sensory system agents|mesh-ancestor
24492969|NCT00488787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24493138|NCT00489658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493139|NCT00489710|Enzyme Inhibitors|enzyme inhibitors|mesh-list
24493140|NCT00489710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493141|NCT00489723|Tamsulosin|tamsulosin|mesh-list
24493464|NCT00490997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493466|NCT00491049|Ofloxacin|ofloxacin|mesh-list
25840989|NCT00028847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25840990|NCT00028847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25840991|NCT00028847|Antiviral Agents|antiviral agents|mesh-ancestor
25840992|NCT00028847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25840993|NCT00028847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25840994|NCT00028847|Immunologic Factors|immunologic factors|mesh-ancestor
25840995|NCT00028847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25840996|NCT00028847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25840997|NCT00028847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25840998|NCT00028860|Gemcitabine|gemcitabine|mesh-list
25840999|NCT00028860|Paclitaxel|paclitaxel|mesh-list
24963783|NCT03788733|Melatonin|melatonin|mesh-list
25841000|NCT00028860|Carboplatin|carboplatin|mesh-list
25841001|NCT00028860|Ifosfamide|ifosfamide|mesh-list
25841002|NCT00028860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25841003|NCT00028860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841004|NCT00028860|Tubulin Modulators|tubulin modulators|mesh-ancestor
24493502|NCT00491127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24493503|NCT00491127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24493504|NCT00491127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24493505|NCT00491127|Antimetabolites|antimetabolites|mesh-ancestor
24493506|NCT00491127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493507|NCT00491127|Antiviral Agents|antiviral agents|mesh-ancestor
24493508|NCT00491127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493509|NCT00491127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25660227|NCT01618305|Antiviral Agents|antiviral agents|mesh-ancestor
25660228|NCT01618305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25660229|NCT01618305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25660230|NCT01618305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25660231|NCT01618305|Antimetabolites|antimetabolites|mesh-ancestor
25660232|NCT01618305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25660233|NCT01618305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24493510|NCT00491127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24493511|NCT00491127|Immunologic Factors|immunologic factors|mesh-ancestor
24493513|NCT00491166|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24893296|NCT04452214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24893297|NCT04452214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24893304|NCT04451655|Insulin|insulin|mesh-list
24893309|NCT04451395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893311|NCT04451447|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24470363|NCT00389935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24470364|NCT00389935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24893312|NCT04451447|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24881710|NCT01559363|XL647|xl647|mesh-list
24893313|NCT04451447|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24893314|NCT04451200|Busulfan|busulfan|mesh-list
24622987|NCT01069536|Antiemetics|antiemetics|mesh-ancestor
24622988|NCT01069536|Autonomic Agents|autonomic agents|mesh-ancestor
24622989|NCT01069536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24809468|NCT02033941|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24809469|NCT02033941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24809470|NCT02033941|Disinfectants|disinfectants|mesh-ancestor
24809471|NCT02033941|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
24809472|NCT02033941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24809473|NCT02033967|Milrinone|milrinone|mesh-list
24809474|NCT02033967|Vasodilator Agents|vasodilator agents|mesh-list
24809475|NCT02033967|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24809476|NCT02033967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24809477|NCT02033967|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24493621|NCT00491790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493674|NCT00491946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25841005|NCT00028860|Antimitotic Agents|antimitotic agents|mesh-ancestor
25841006|NCT00028860|Mitosis Modulators|mitosis modulators|mesh-ancestor
25841007|NCT00028860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841008|NCT00028860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25841009|NCT00028860|Antimetabolites|antimetabolites|mesh-ancestor
25841010|NCT00028860|Antiviral Agents|antiviral agents|mesh-ancestor
25841011|NCT00028860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493703|NCT00492128|Amlodipine|amlodipine|mesh-list
24963988|NCT03787030|Vitamin E|vitamin e|mesh-list
24493704|NCT00492128|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24493705|NCT00492128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24494021|NCT00493402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24494022|NCT00493402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494023|NCT00493402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24494028|NCT00493428|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24494043|NCT00493480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494044|NCT00493480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494045|NCT00493480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24494046|NCT00493480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24494047|NCT00493480|Vasodilator Agents|vasodilator agents|mesh-ancestor
24494049|NCT00493480|Protective Agents|protective agents|mesh-ancestor
24494050|NCT00493480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24494051|NCT00493480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24494054|NCT00493480|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24494071|NCT00493610|Protective Agents|protective agents|mesh-ancestor
24494072|NCT00493610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494073|NCT00493610|Antidotes|antidotes|mesh-ancestor
24494074|NCT00493623|Ibandronic Acid|ibandronic acid|mesh-list
24494177|NCT00494156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494178|NCT00494156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24494179|NCT00494156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24494180|NCT00494156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841012|NCT00028860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841013|NCT00028860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25408944|NCT03410043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25660234|NCT01618305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25660235|NCT01618305|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25660236|NCT01618305|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25660237|NCT01618305|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25660238|NCT01618305|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25660239|NCT01618305|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25660240|NCT01618669|Regadenoson|regadenoson|mesh-list
25660241|NCT01618669|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25660242|NCT01618669|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25660243|NCT01618669|Purinergic Agonists|purinergic agonists|mesh-ancestor
25660244|NCT01618669|Purinergic Agents|purinergic agents|mesh-ancestor
24893417|NCT04449718|Vitamins|vitamins|mesh-ancestor
24893418|NCT04449718|Micronutrients|micronutrients|mesh-ancestor
25841014|NCT00028860|Immunologic Factors|immunologic factors|mesh-ancestor
25841015|NCT00028860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841016|NCT00028860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25841017|NCT00028860|Alkylating Agents|alkylating agents|mesh-ancestor
25841018|NCT00028873|Paclitaxel|paclitaxel|mesh-list
25841019|NCT00028873|Docetaxel|docetaxel|mesh-list
24494464|NCT00495326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25841020|NCT00028873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24494477|NCT00495326|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24809505|NCT02034201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809506|NCT02034201|Dopamine Agents|dopamine agents|mesh-ancestor
24598792|NCT00958204|Fluoxetine|fluoxetine|mesh-list
24494501|NCT00495352|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24494502|NCT00495352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24494503|NCT00495352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24494504|NCT00495352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494505|NCT00495352|Dopamine Agents|dopamine agents|mesh-ancestor
24494506|NCT00495352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24494507|NCT00495352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494508|NCT00495352|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24494544|NCT00495651|Antiviral Agents|antiviral agents|mesh-ancestor
24494545|NCT00495729|Simvastatin|simvastatin|mesh-list
25841021|NCT00028873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841022|NCT00028873|Tubulin Modulators|tubulin modulators|mesh-ancestor
25841023|NCT00028873|Antimitotic Agents|antimitotic agents|mesh-ancestor
25841024|NCT00028873|Mitosis Modulators|mitosis modulators|mesh-ancestor
25841025|NCT00028873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841026|NCT00028886|Interferons|interferons|mesh-list
25841027|NCT00028886|Interferon-alpha|interferon-alpha|mesh-list
25841028|NCT00028886|Thalidomide|thalidomide|mesh-list
25841029|NCT00028886|Dexamethasone|dexamethasone|mesh-list
24494546|NCT00495729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24494547|NCT00495729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24494548|NCT00495729|Antimetabolites|antimetabolites|mesh-ancestor
24494549|NCT00495729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494550|NCT00495729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24494551|NCT00495729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24809553|NCT02034500|Vaccines|vaccines|mesh-list
24809554|NCT02034500|Immunologic Factors|immunologic factors|mesh-ancestor
24494593|NCT00495898|Immunologic Factors|immunologic factors|mesh-ancestor
24494594|NCT00495898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494595|NCT00496002|Adefovir|adefovir|mesh-list
24494596|NCT00496002|Clevudine|clevudine|mesh-list
24494597|NCT00496002|Antiviral Agents|antiviral agents|mesh-ancestor
24494598|NCT00496002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24494599|NCT00496002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24494600|NCT00496002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24494601|NCT00496002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24494602|NCT00496002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494603|NCT00496028|Paclitaxel|paclitaxel|mesh-list
24494604|NCT00496028|Carboplatin|carboplatin|mesh-list
24494605|NCT00496028|Saracatinib|saracatinib|mesh-list
24494606|NCT00496028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24494607|NCT00496028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494608|NCT00496028|Tubulin Modulators|tubulin modulators|mesh-ancestor
24494609|NCT00496028|Antimitotic Agents|antimitotic agents|mesh-ancestor
24494610|NCT00496028|Mitosis Modulators|mitosis modulators|mesh-ancestor
25841030|NCT00028886|Cyclophosphamide|cyclophosphamide|mesh-list
24494631|NCT00496184|Tocolytic Agents|tocolytic agents|mesh-ancestor
24494632|NCT00496184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24494634|NCT00496223|Dacarbazine|dacarbazine|mesh-list
24494635|NCT00496223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494636|NCT00496223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24827661|NCT02140632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24827662|NCT02140632|Glucocorticoids|glucocorticoids|mesh-ancestor
25841031|NCT00028886|Melphalan|melphalan|mesh-list
25841032|NCT00028886|Doxorubicin|doxorubicin|mesh-list
25841033|NCT00028886|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25841034|NCT00028886|Vincristine|vincristine|mesh-list
24964431|NCT03783429|Digoxin|digoxin|mesh-list
25841035|NCT00028886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25660245|NCT01618669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25841036|NCT00028886|Immunologic Factors|immunologic factors|mesh-ancestor
25408945|NCT03410043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841037|NCT00028886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841038|NCT00028886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25061873|NCT05390359|Respiratory System Agents|respiratory system agents|mesh-ancestor
25061874|NCT05390307|Liraglutide|liraglutide|mesh-list
25061875|NCT05390307|Dapagliflozin|dapagliflozin|mesh-list
25061877|NCT05390307|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25061879|NCT05390307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061880|NCT05390307|Incretins|incretins|mesh-ancestor
25061881|NCT05390307|Hormones|hormones|mesh-ancestor
25061882|NCT05390307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25061883|NCT05390307|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25061884|NCT05390307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061885|NCT05390307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25061886|NCT05390255|Mometasone Furoate|mometasone furoate|mesh-list
25841039|NCT00028886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25841040|NCT00028886|Alkylating Agents|alkylating agents|mesh-ancestor
25841041|NCT00028886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841042|NCT00028886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841043|NCT00028886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25841044|NCT00028886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25841045|NCT00028886|Antiemetics|antiemetics|mesh-ancestor
25841046|NCT00028886|Autonomic Agents|autonomic agents|mesh-ancestor
25841047|NCT00028886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25841048|NCT00028886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25841049|NCT00028886|Glucocorticoids|glucocorticoids|mesh-ancestor
25841050|NCT00028886|Hormones|hormones|mesh-ancestor
25841051|NCT00028886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25841052|NCT00028886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25163932|NCT05425862|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25163933|NCT05425862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163934|NCT05425862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163935|NCT05425862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163936|NCT05425654|Cyclophosphamide|cyclophosphamide|mesh-list
25163937|NCT05425654|Busulfan|busulfan|mesh-list
25163938|NCT05425654|Carmustine|carmustine|mesh-list
25163939|NCT05425654|Rituximab|rituximab|mesh-list
25163940|NCT05425654|Methotrexate|methotrexate|mesh-list
25163941|NCT05425654|Vincristine|vincristine|mesh-list
25163942|NCT05425654|Lenalidomide|lenalidomide|mesh-list
25163943|NCT05425654|Procarbazine|procarbazine|mesh-list
25163944|NCT05425654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25163945|NCT05425654|Immunologic Factors|immunologic factors|mesh-ancestor
25163946|NCT05425654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163947|NCT05425654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25163948|NCT05425654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25163949|NCT05425654|Alkylating Agents|alkylating agents|mesh-ancestor
25163950|NCT05425654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25163951|NCT05425654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163952|NCT05425654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25163953|NCT05425654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25163954|NCT05425654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25163955|NCT05425654|Abortifacient Agents|abortifacient agents|mesh-ancestor
25163956|NCT05425654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25163957|NCT05425654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25163958|NCT05425654|Antimetabolites|antimetabolites|mesh-ancestor
25163959|NCT05425654|Dermatologic Agents|dermatologic agents|mesh-ancestor
25163960|NCT05425654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25163961|NCT05425654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25163962|NCT05425654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25163963|NCT05425654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25163964|NCT05425654|Tubulin Modulators|tubulin modulators|mesh-ancestor
25163965|NCT05425654|Antimitotic Agents|antimitotic agents|mesh-ancestor
25163966|NCT05425654|Mitosis Modulators|mitosis modulators|mesh-ancestor
25660246|NCT01618669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660247|NCT01618669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660248|NCT01618708|Hylan|hylan|mesh-list
25660249|NCT01618708|Viscosupplements|viscosupplements|mesh-ancestor
25660250|NCT01618708|Protective Agents|protective agents|mesh-ancestor
25660251|NCT01618708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660252|NCT01619059|Metformin|metformin|mesh-list
25660253|NCT01619059|Dapagliflozin|dapagliflozin|mesh-list
25660254|NCT01619059|Saxagliptin|saxagliptin|mesh-list
25660255|NCT01619059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25660256|NCT01619059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660257|NCT01619059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25674331|NCT01770353|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25163967|NCT05425654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25163968|NCT05425654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25163969|NCT05425654|Growth Substances|growth substances|mesh-ancestor
25163970|NCT05425654|Growth Inhibitors|growth inhibitors|mesh-ancestor
25163972|NCT05425576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25163973|NCT05425576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163974|NCT05425420|Methadone|methadone|mesh-list
25163975|NCT05425420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25163976|NCT05425420|Narcotics|narcotics|mesh-ancestor
25163977|NCT05425420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25163978|NCT05425420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25163979|NCT05425420|Analgesics|analgesics|mesh-ancestor
25163980|NCT05425420|Sensory System Agents|sensory system agents|mesh-ancestor
25163981|NCT05425420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25163982|NCT05425420|Antitussive Agents|antitussive agents|mesh-ancestor
25163983|NCT05425420|Respiratory System Agents|respiratory system agents|mesh-ancestor
24918586|NCT04218149|Bupivacaine|bupivacaine|mesh-list
24494637|NCT00496223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24494721|NCT00496600|Antimitotic Agents|antimitotic agents|mesh-ancestor
24494722|NCT00496600|Mitosis Modulators|mitosis modulators|mesh-ancestor
24494723|NCT00496600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494725|NCT00496652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24495005|NCT00497913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24809606|NCT02035072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809607|NCT02035072|Antiviral Agents|antiviral agents|mesh-ancestor
24809608|NCT02035072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24495044|NCT00498225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495045|NCT00498225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495046|NCT00498225|Antiviral Agents|antiviral agents|mesh-ancestor
24495047|NCT00498225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24495048|NCT00498225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495050|NCT00498225|Immunologic Factors|immunologic factors|mesh-ancestor
24495051|NCT00498225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495052|NCT00498251|Albuterol|albuterol|mesh-list
24495053|NCT00498251|Ipratropium|ipratropium|mesh-list
24495054|NCT00498251|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24495202|NCT00498979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24495218|NCT00498992|Lidocaine|lidocaine|mesh-list
24495219|NCT00498992|Vitamins|vitamins|mesh-ancestor
24964745|NCT03780933|Vitamins|vitamins|mesh-ancestor
24495220|NCT00498992|Micronutrients|micronutrients|mesh-ancestor
24495221|NCT00498992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495222|NCT00498992|Anesthetics, Local|anesthetics, local|mesh-ancestor
24495223|NCT00498992|Anesthetics|anesthetics|mesh-ancestor
25841053|NCT00028886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25841054|NCT00028886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25841055|NCT00028886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24495230|NCT00498992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24495231|NCT00498992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495233|NCT00498992|Protective Agents|protective agents|mesh-ancestor
24495234|NCT00499005|Carbetocin|carbetocin|mesh-list
24495235|NCT00499005|Oxytocin|oxytocin|mesh-list
24495236|NCT00499005|Oxytocics|oxytocics|mesh-ancestor
24495237|NCT00499005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24495238|NCT00499005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495239|NCT00499018|Cytarabine|cytarabine|mesh-list
24495240|NCT00499018|Prednisone|prednisone|mesh-list
24495241|NCT00499018|Rituximab|rituximab|mesh-list
24495242|NCT00499018|Mitoxantrone|mitoxantrone|mesh-list
24495243|NCT00499018|Cyclophosphamide|cyclophosphamide|mesh-list
24495244|NCT00499018|Vincristine|vincristine|mesh-list
24495384|NCT00499850|Fluorouracil|fluorouracil|mesh-list
24495385|NCT00499850|Oxaliplatin|oxaliplatin|mesh-list
24495386|NCT00499850|Antimetabolites|antimetabolites|mesh-ancestor
24495387|NCT00499850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495388|NCT00499850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24495389|NCT00499850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495390|NCT00499850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24495400|NCT00499876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24495401|NCT00499876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24495403|NCT00499993|Lanreotide|lanreotide|mesh-list
24495506|NCT00500604|Valsartan|valsartan|mesh-list
24495507|NCT00500604|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24495508|NCT00500604|Irbesartan|irbesartan|mesh-list
24495509|NCT00500604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24495636|NCT00501397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24495637|NCT00501397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495638|NCT00501397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893805|NCT04446234|Aripiprazole|aripiprazole|mesh-list
24893806|NCT04446234|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24893807|NCT04446234|Ziprasidone|ziprasidone|mesh-list
24893808|NCT04446234|Amisulpride|amisulpride|mesh-list
24893809|NCT04446234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24893810|NCT04446234|Serotonin Agents|serotonin agents|mesh-ancestor
24893811|NCT04446234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24893812|NCT04446234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893813|NCT04446234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893835|NCT04446065|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24893836|NCT04445948|Amoxicillin|amoxicillin|mesh-list
24680334|NCT01374282|Antidotes|antidotes|mesh-ancestor
24817037|NCT02080416|Protease Inhibitors|protease inhibitors|mesh-ancestor
24817038|NCT02080416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817040|NCT02080416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24495639|NCT00501397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24495640|NCT00501397|Hormone Antagonists|hormone antagonists|mesh-ancestor
25205335|NCT04899791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495641|NCT00501397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25841056|NCT00028886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495703|NCT00501618|Serotonin Agents|serotonin agents|mesh-ancestor
24495704|NCT00501618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24495705|NCT00501618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495706|NCT00501618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495707|NCT00501618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24495708|NCT00501618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24495709|NCT00501618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24495710|NCT00501618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24495711|NCT00501618|GABA Antagonists|gaba antagonists|mesh-ancestor
24495713|NCT00501657|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24827690|NCT02140814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495714|NCT00501657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24495719|NCT00501657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24495773|NCT00501904|Metformin|metformin|mesh-list
24495778|NCT00501982|Poractant alfa|poractant alfa|mesh-list
24495779|NCT00501982|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
24495798|NCT00502060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495799|NCT00502060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495800|NCT00502073|Cyclosporine|cyclosporine|mesh-list
24495801|NCT00502073|Cyclosporins|cyclosporins|mesh-list
24495802|NCT00502073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495803|NCT00502073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495804|NCT00502073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24495805|NCT00502073|Immunologic Factors|immunologic factors|mesh-ancestor
24495806|NCT00502073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841057|NCT00028886|Antiviral Agents|antiviral agents|mesh-ancestor
25841058|NCT00028886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25841059|NCT00028886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25841060|NCT00028886|Tubulin Modulators|tubulin modulators|mesh-ancestor
25841061|NCT00028886|Antimitotic Agents|antimitotic agents|mesh-ancestor
25841062|NCT00028886|Mitosis Modulators|mitosis modulators|mesh-ancestor
25841063|NCT00028886|Leprostatic Agents|leprostatic agents|mesh-ancestor
25841064|NCT00028886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25841065|NCT00028886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25841066|NCT00028886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25841067|NCT00028886|Growth Substances|growth substances|mesh-ancestor
25841068|NCT00028886|Growth Inhibitors|growth inhibitors|mesh-ancestor
24964948|NCT03779568|Bupivacaine|bupivacaine|mesh-list
25841069|NCT00028899|Cytarabine|cytarabine|mesh-list
25841070|NCT00028899|Asparaginase|asparaginase|mesh-list
25841071|NCT00028899|Mitoxantrone|mitoxantrone|mesh-list
24534770|NCT00647972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25660258|NCT01619059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660259|NCT01619059|Incretins|incretins|mesh-ancestor
25660260|NCT01619059|Hormones|hormones|mesh-ancestor
25660261|NCT01619059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25660262|NCT01619059|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25660263|NCT01619059|Protease Inhibitors|protease inhibitors|mesh-ancestor
25660264|NCT01619059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25660265|NCT01619410|Clindamycin|clindamycin|mesh-list
25660266|NCT01619410|Clindamycin palmitate|clindamycin palmitate|mesh-list
25660267|NCT01619410|Clindamycin phosphate|clindamycin phosphate|mesh-list
25660268|NCT01619410|Linezolid|linezolid|mesh-list
25660269|NCT01619410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25660270|NCT01619410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25660271|NCT01619410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25841072|NCT00028899|Gemtuzumab|gemtuzumab|mesh-list
24893948|NCT04445857|Katacalcin|katacalcin|mesh-list
24534772|NCT00647972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25841073|NCT00028899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25841074|NCT00028899|Antimetabolites|antimetabolites|mesh-ancestor
25841075|NCT00028899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495807|NCT00502073|Antifungal Agents|antifungal agents|mesh-ancestor
25841076|NCT00028899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495858|NCT00502229|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24809705|NCT02035956|Vaccines|vaccines|mesh-list
24495904|NCT00502528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24495905|NCT00502528|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24422483|NCT00222573|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24495961|NCT00502684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25841077|NCT00028899|Antiviral Agents|antiviral agents|mesh-ancestor
25841078|NCT00028899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24809756|NCT02036125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809757|NCT02036125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24809758|NCT02036125|Glucocorticoids|glucocorticoids|mesh-ancestor
25841079|NCT00028899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25841080|NCT00028899|Immunologic Factors|immunologic factors|mesh-ancestor
24495962|NCT00502684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24495963|NCT00502684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24495964|NCT00502684|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24495965|NCT00502684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24495966|NCT00502684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495967|NCT00502736|Ibandronic Acid|ibandronic acid|mesh-list
24495968|NCT00502736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24495969|NCT00502736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495970|NCT00502762|Topotecan|topotecan|mesh-list
24495971|NCT00502762|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24451059|NCT00321633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163984|NCT05425368|Fluorides|fluorides|mesh-list
25163985|NCT05425368|Cariostatic Agents|cariostatic agents|mesh-ancestor
24827691|NCT02140814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24827692|NCT02140814|Vasodilator Agents|vasodilator agents|mesh-ancestor
24827693|NCT02140840|Trametinib|trametinib|mesh-list
24827694|NCT02140840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496046|NCT00503321|polysaccharide-K|polysaccharide-k|mesh-list
25841081|NCT00028899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770170|NCT01818908|Prednisone|prednisone|mesh-list
25841082|NCT00028899|Analgesics|analgesics|mesh-ancestor
25841083|NCT00028899|Sensory System Agents|sensory system agents|mesh-ancestor
25841084|NCT00028899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25164039|NCT05424393|Analgesics|analgesics|mesh-ancestor
25841085|NCT00028899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25841086|NCT00028899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25841087|NCT00028899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841088|NCT00028899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25841089|NCT00028912|Carboplatin|carboplatin|mesh-list
25841090|NCT00028912|Bortezomib|bortezomib|mesh-list
25841091|NCT00028912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841092|NCT00028925|Carboplatin|carboplatin|mesh-list
25841093|NCT00028925|Topotecan|topotecan|mesh-list
25841094|NCT00028925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25163986|NCT05425368|Protective Agents|protective agents|mesh-ancestor
25163987|NCT05425368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203067|NCT02716766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203068|NCT02716766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25203069|NCT02716766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25203070|NCT02716766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203071|NCT02716792|Ibandronic Acid|ibandronic acid|mesh-list
25203072|NCT02716792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25203073|NCT02716792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203074|NCT02716610|Insulin Lispro|insulin lispro|mesh-list
25203075|NCT02716610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25203076|NCT02716610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203077|NCT02716415|Menthol|menthol|mesh-list
25203078|NCT02716415|Petrolatum|petrolatum|mesh-list
25203079|NCT02716415|Zinc Oxide|zinc oxide|mesh-list
25203080|NCT02716415|Antipruritics|antipruritics|mesh-ancestor
25203081|NCT02716415|Dermatologic Agents|dermatologic agents|mesh-ancestor
25203082|NCT02716415|Emollients|emollients|mesh-ancestor
25203083|NCT02716415|Sunscreening Agents|sunscreening agents|mesh-ancestor
25203084|NCT02716415|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25660272|NCT01619410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203085|NCT02716415|Protective Agents|protective agents|mesh-ancestor
25203086|NCT02716415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203087|NCT02716428|Ribavirin|ribavirin|mesh-list
25203088|NCT02716428|Antimetabolites|antimetabolites|mesh-ancestor
25203089|NCT02716428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203090|NCT02716428|Antiviral Agents|antiviral agents|mesh-ancestor
25203091|NCT02716428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25203099|NCT02716285|Peppermint oil|peppermint oil|mesh-list
25203100|NCT02716285|Antiemetics|antiemetics|mesh-ancestor
25203101|NCT02716285|Autonomic Agents|autonomic agents|mesh-ancestor
25203102|NCT02716285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25203103|NCT02716285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203104|NCT02716285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25203105|NCT02716285|Parasympatholytics|parasympatholytics|mesh-ancestor
25203106|NCT02716129|Morphine|morphine|mesh-list
25203107|NCT02716129|Nalbuphine|nalbuphine|mesh-list
24496045|NCT00503243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24604941|NCT00982527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25841095|NCT00028925|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24604942|NCT00982527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604943|NCT00982527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496055|NCT00503321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25841096|NCT00028925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25841097|NCT00028925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841098|NCT00028925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841099|NCT00028938|Paclitaxel|paclitaxel|mesh-list
24496062|NCT00503347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24496063|NCT00503347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496064|NCT00503386|Palonosetron|palonosetron|mesh-list
24496065|NCT00503386|Granisetron|granisetron|mesh-list
24496066|NCT00503386|Antiemetics|antiemetics|mesh-ancestor
24496067|NCT00503386|Autonomic Agents|autonomic agents|mesh-ancestor
24496068|NCT00503386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24496069|NCT00503386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496070|NCT00503386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25841100|NCT00028938|Carboplatin|carboplatin|mesh-list
25841101|NCT00028938|Epoetin Alfa|epoetin alfa|mesh-list
24496117|NCT00503516|Megestrol Acetate|megestrol acetate|mesh-list
24496118|NCT00503516|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24496119|NCT00503516|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24496120|NCT00503516|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24496121|NCT00503516|Contraceptive Agents|contraceptive agents|mesh-ancestor
24496122|NCT00503516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24496123|NCT00503516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496124|NCT00503516|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24496125|NCT00503516|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24809800|NCT02036255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24809801|NCT02036255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809802|NCT02036255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24809803|NCT02036255|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24809804|NCT02036255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809806|NCT02036281|Neurokinin A|neurokinin a|mesh-list
24809807|NCT02036281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24809808|NCT02036281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809809|NCT02036281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809810|NCT02036359|Docetaxel|docetaxel|mesh-list
24809811|NCT02036359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24809812|NCT02036359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496176|NCT00503594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24496177|NCT00503594|Tubulin Modulators|tubulin modulators|mesh-ancestor
24496178|NCT00503594|Antimitotic Agents|antimitotic agents|mesh-ancestor
24496179|NCT00503594|Mitosis Modulators|mitosis modulators|mesh-ancestor
25841102|NCT00028938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24534804|NCT00648024|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24534805|NCT00648024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534806|NCT00648024|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24534807|NCT00648050|Verapamil|verapamil|mesh-list
24534808|NCT00648050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25841103|NCT00028938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496214|NCT00503763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24496215|NCT00503763|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24496216|NCT00503763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496217|NCT00503815|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24496218|NCT00503815|Laxatives|laxatives|mesh-ancestor
24496219|NCT00503815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25841104|NCT00028938|Tubulin Modulators|tubulin modulators|mesh-ancestor
25409023|NCT03404193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25061963|NCT05389722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25061964|NCT05389722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25061965|NCT05389722|Antifungal Agents|antifungal agents|mesh-ancestor
24894145|NCT04443556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894147|NCT04443556|Narcotics|narcotics|mesh-ancestor
24809832|NCT02036437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809833|NCT02036437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24809834|NCT02036437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24809835|NCT02036437|Oxytocics|oxytocics|mesh-ancestor
24809836|NCT02036463|Prednisone|prednisone|mesh-list
24809837|NCT02036463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24809838|NCT02036463|Glucocorticoids|glucocorticoids|mesh-ancestor
24809839|NCT02036463|Hormones|hormones|mesh-ancestor
24809840|NCT02036463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24809841|NCT02036463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965985|NCT03772223|Autonomic Agents|autonomic agents|mesh-ancestor
24600824|NCT00960817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24809842|NCT02036463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24809843|NCT02036463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496288|NCT00504140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24496289|NCT00504140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496290|NCT00504140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24496291|NCT00504140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24496294|NCT00504140|Antiviral Agents|antiviral agents|mesh-ancestor
24496318|NCT00504244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496319|NCT00504244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24496320|NCT00504244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24496321|NCT00504244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24496322|NCT00504244|Antitubercular Agents|antitubercular agents|mesh-ancestor
24809848|NCT02036489|Mercaptopurine|mercaptopurine|mesh-list
24809849|NCT02036489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24465659|NCT00370422|Hormones|hormones|mesh-ancestor
24809880|NCT02036528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809881|NCT02036528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809882|NCT02036528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809883|NCT02036528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24496403|NCT00504491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24496404|NCT00504491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496405|NCT00504491|Immunologic Factors|immunologic factors|mesh-ancestor
24496406|NCT00504491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496407|NCT00504491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24496409|NCT00504543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24496410|NCT00504543|Immunologic Factors|immunologic factors|mesh-ancestor
24496411|NCT00504543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496412|NCT00504543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496444|NCT00504933|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24496445|NCT00504933|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25841105|NCT00028938|Antimitotic Agents|antimitotic agents|mesh-ancestor
24809972|NCT02037035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24809973|NCT02037035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809974|NCT02037035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24809975|NCT02037035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24809976|NCT02037035|Anesthetics, General|anesthetics, general|mesh-ancestor
24809977|NCT02037035|Anesthetics|anesthetics|mesh-ancestor
24809978|NCT02037035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24809979|NCT02037035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24809980|NCT02037035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24496492|NCT00505089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24496493|NCT00505089|Immunologic Factors|immunologic factors|mesh-ancestor
24496494|NCT00505089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496496|NCT00505102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809991|NCT02037191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809992|NCT02037191|Dermatologic Agents|dermatologic agents|mesh-ancestor
24809993|NCT02037191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809994|NCT02037191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24809995|NCT02037191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24810014|NCT02037412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24810015|NCT02037412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25660273|NCT01619410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660274|NCT01619423|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
25660275|NCT01619423|Edetic Acid|edetic acid|mesh-list
25660276|NCT01619423|Anticoagulants|anticoagulants|mesh-ancestor
25660277|NCT01619423|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24894349|NCT04442633|Hormone Antagonists|hormone antagonists|mesh-ancestor
24894351|NCT04442633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810029|NCT02037503|Sensory System Agents|sensory system agents|mesh-ancestor
24810030|NCT02037503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24810031|NCT02037503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810032|NCT02037503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24810033|NCT02037503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24810034|NCT02037503|Anesthetics, General|anesthetics, general|mesh-ancestor
24496524|NCT00505232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496525|NCT00505258|Ceftobiprole|ceftobiprole|mesh-list
25841106|NCT00028938|Mitosis Modulators|mitosis modulators|mesh-ancestor
25841107|NCT00028938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841108|NCT00028938|Hematinics|hematinics|mesh-ancestor
25841109|NCT00028951|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25841110|NCT00028951|Hemostatics|hemostatics|mesh-ancestor
25841111|NCT00028951|Coagulants|coagulants|mesh-ancestor
24447456|NCT00308529|Carboplatin|carboplatin|mesh-list
24447457|NCT00308529|Irinotecan|irinotecan|mesh-list
25079223|NCT03349346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447458|NCT00308529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24447459|NCT00308529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447460|NCT00308529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24447468|NCT00308529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447470|NCT00308542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25164009|NCT05424692|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
25164010|NCT05424692|Fluorouracil|fluorouracil|mesh-list
25164011|NCT05424692|Oxaliplatin|oxaliplatin|mesh-list
25164012|NCT05424692|Irinotecan|irinotecan|mesh-list
25164013|NCT05424692|Cetuximab|cetuximab|mesh-list
25164014|NCT05424692|Antimetabolites|antimetabolites|mesh-ancestor
25164015|NCT05424692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164016|NCT05424692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25164017|NCT05424692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25164018|NCT05424692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25164019|NCT05424692|Immunologic Factors|immunologic factors|mesh-ancestor
25164020|NCT05424692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164021|NCT05424692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25164022|NCT05424692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25164023|NCT05424692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25164024|NCT05424692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25164025|NCT05424692|Vitamin B Complex|vitamin b complex|mesh-ancestor
25164026|NCT05424692|Vitamins|vitamins|mesh-ancestor
25164027|NCT05424692|Micronutrients|micronutrients|mesh-ancestor
25164028|NCT05424445|Misoprostol|misoprostol|mesh-list
25164029|NCT05424445|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25164030|NCT05424445|Abortifacient Agents|abortifacient agents|mesh-ancestor
25164031|NCT05424445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25164032|NCT05424445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164033|NCT05424445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25164034|NCT05424445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25164035|NCT05424445|Oxytocics|oxytocics|mesh-ancestor
25164036|NCT05424393|Etanercept|etanercept|mesh-list
25164037|NCT05424393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25164038|NCT05424393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25164040|NCT05424393|Sensory System Agents|sensory system agents|mesh-ancestor
25164041|NCT05424393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25164042|NCT05424393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164043|NCT05424393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25164044|NCT05424393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25164045|NCT05424393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25164046|NCT05424393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24496587|NCT00505531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496588|NCT00505531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24810038|NCT02037503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24810039|NCT02037503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24496597|NCT00505700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24496598|NCT00505700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25660278|NCT01619423|Chelating Agents|chelating agents|mesh-ancestor
24496599|NCT00505700|Immunologic Factors|immunologic factors|mesh-ancestor
24496600|NCT00505700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496601|NCT00505700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25660279|NCT01619423|Sequestering Agents|sequestering agents|mesh-ancestor
25660280|NCT01619423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660281|NCT01619423|Vitamin B Complex|vitamin b complex|mesh-ancestor
25660282|NCT01619423|Vitamins|vitamins|mesh-ancestor
25841112|NCT00028964|Cyclophosphamide|cyclophosphamide|mesh-list
25841113|NCT00028964|Doxorubicin|doxorubicin|mesh-list
24496603|NCT00505700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24496604|NCT00505700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496605|NCT00505739|Mifepristone|mifepristone|mesh-list
24496606|NCT00505739|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24496607|NCT00505739|Abortifacient Agents|abortifacient agents|mesh-ancestor
24496608|NCT00505739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24496609|NCT00505739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496610|NCT00505739|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24496611|NCT00505739|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24496612|NCT00505739|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24496613|NCT00505739|Contraceptive Agents|contraceptive agents|mesh-ancestor
24496614|NCT00505739|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24496615|NCT00505739|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24496616|NCT00505739|Hormone Antagonists|hormone antagonists|mesh-ancestor
24496617|NCT00505739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24496634|NCT00505804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24496635|NCT00505804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24496642|NCT00505804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24496643|NCT00505804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24496644|NCT00505804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24496645|NCT00505804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24496646|NCT00505804|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24496647|NCT00505804|Dopamine Agents|dopamine agents|mesh-ancestor
24496648|NCT00505804|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24496649|NCT00505817|Leuprolide|leuprolide|mesh-list
24496650|NCT00505817|Cetrorelix|cetrorelix|mesh-list
24496651|NCT00505817|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24496652|NCT00505817|Fertility Agents|fertility agents|mesh-ancestor
24496729|NCT00506298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24496754|NCT00506545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496767|NCT00506623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496772|NCT00506701|Tadalafil|tadalafil|mesh-list
24496773|NCT00506701|Vasodilator Agents|vasodilator agents|mesh-ancestor
24496774|NCT00506701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24496775|NCT00506701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24496776|NCT00506701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841114|NCT00028964|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24496805|NCT00506844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24496807|NCT00506935|Anticonvulsants|anticonvulsants|mesh-ancestor
24496808|NCT00506935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496809|NCT00506935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496811|NCT00506935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24496813|NCT00506961|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24496825|NCT00506974|Anesthetics, General|anesthetics, general|mesh-ancestor
24496826|NCT00506974|Anesthetics|anesthetics|mesh-ancestor
24496827|NCT00506974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24496828|NCT00506974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496829|NCT00507000|Vitamin D|vitamin d|mesh-list
24496830|NCT00507000|Cholecalciferol|cholecalciferol|mesh-list
24496831|NCT00507000|Vitamins|vitamins|mesh-ancestor
24496832|NCT00507000|Micronutrients|micronutrients|mesh-ancestor
24496833|NCT00507000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496834|NCT00507000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24497354|NCT00509613|Antifungal Agents|antifungal agents|mesh-ancestor
25841115|NCT00028964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25841116|NCT00028964|Immunologic Factors|immunologic factors|mesh-ancestor
25841117|NCT00028964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841118|NCT00028964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24622996|NCT01069536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622997|NCT01069757|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24622998|NCT01069757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622999|NCT01069757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24623000|NCT01069757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623001|NCT01069757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623002|NCT01069770|Sunitinib|sunitinib|mesh-list
24623003|NCT01069770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623004|NCT01069770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24623005|NCT01069770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25660283|NCT01619423|Micronutrients|micronutrients|mesh-ancestor
25062037|NCT05382806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25062038|NCT05382806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062102|NCT05307770|Melatonin|melatonin|mesh-list
25062103|NCT05307770|Antioxidants|antioxidants|mesh-ancestor
25062104|NCT05307770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062105|NCT05307770|Protective Agents|protective agents|mesh-ancestor
25062106|NCT05307770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062107|NCT05307770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25062108|NCT05303805|Sevoflurane|sevoflurane|mesh-list
24623013|NCT01069796|Bevacizumab|bevacizumab|mesh-list
24496884|NCT00507117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496885|NCT00507143|Irinotecan|irinotecan|mesh-list
24496886|NCT00507143|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24496887|NCT00507143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24496888|NCT00507143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496889|NCT00507143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496890|NCT00507143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496891|NCT00507195|Midazolam|midazolam|mesh-list
24496892|NCT00507195|Propofol|propofol|mesh-list
25205336|NCT04899791|Protective Agents|protective agents|mesh-ancestor
24496893|NCT00507195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
24496894|NCT00507195|Sevoflurane|sevoflurane|mesh-list
24496895|NCT00507195|Desflurane|desflurane|mesh-list
24496896|NCT00507195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24496897|NCT00507195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496898|NCT00507195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24496899|NCT00507195|Anesthetics, General|anesthetics, general|mesh-ancestor
24496900|NCT00507195|Anesthetics|anesthetics|mesh-ancestor
24496901|NCT00507195|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24496902|NCT00507195|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24496903|NCT00507195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25841119|NCT00028964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24496999|NCT00507793|Cyclosporins|cyclosporins|mesh-list
24761181|NCT01761513|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24497011|NCT00507793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24497012|NCT00507793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841120|NCT00028964|Alkylating Agents|alkylating agents|mesh-ancestor
24497079|NCT00507962|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24497114|NCT00508092|Sensory System Agents|sensory system agents|mesh-ancestor
24497115|NCT00508092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24497117|NCT00508209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497118|NCT00508287|Exenatide|exenatide|mesh-list
25841121|NCT00028964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497246|NCT00508976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497247|NCT00509015|Artesunate|artesunate|mesh-list
24497248|NCT00509015|Pyrimethamine|pyrimethamine|mesh-list
24497249|NCT00509015|Primaquine|primaquine|mesh-list
24497250|NCT00509015|Sulfadoxine|sulfadoxine|mesh-list
24497251|NCT00509015|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24497252|NCT00509015|Antimalarials|antimalarials|mesh-ancestor
24497253|NCT00509015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24497254|NCT00509015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24497338|NCT00509561|Capecitabine|capecitabine|mesh-list
24497339|NCT00509561|Cetuximab|cetuximab|mesh-list
24497340|NCT00509561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497341|NCT00509561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24497342|NCT00509561|Antimetabolites|antimetabolites|mesh-ancestor
24497343|NCT00509561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497344|NCT00509561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24497345|NCT00509613|Sirolimus|sirolimus|mesh-list
24497346|NCT00509613|Sorafenib|sorafenib|mesh-list
24497347|NCT00509613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497348|NCT00509613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24497349|NCT00509613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497350|NCT00509613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497351|NCT00509613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25164047|NCT05424393|Immunologic Factors|immunologic factors|mesh-ancestor
24497352|NCT00509613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25660284|NCT01619423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660285|NCT01619774|Trametinib|trametinib|mesh-list
25660286|NCT01619774|Dabrafenib|dabrafenib|mesh-list
25660287|NCT01619774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25660288|NCT01619774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25660289|NCT01619774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25660290|NCT01619774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660291|NCT01619852|Lidocaine|lidocaine|mesh-list
25660292|NCT01619852|Anesthetics, Local|anesthetics, local|mesh-ancestor
25660293|NCT01619852|Anesthetics|anesthetics|mesh-ancestor
24476107|NCT00413023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894471|NCT04440267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24894472|NCT04440267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24946506|NCT03938662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946507|NCT03938662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24953169|NCT03887650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953170|NCT03887650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953171|NCT03887650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24953176|NCT03887650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24953177|NCT03887650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953178|NCT03887650|Anesthetics, Local|anesthetics, local|mesh-ancestor
24953179|NCT03887650|Anesthetics|anesthetics|mesh-ancestor
24953181|NCT03887650|Sensory System Agents|sensory system agents|mesh-ancestor
24497353|NCT00509613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24497356|NCT00509613|Immunologic Factors|immunologic factors|mesh-ancestor
24497371|NCT00509743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24497397|NCT00509964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497398|NCT00509964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810174|NCT02038452|Prednisolone acetate|prednisolone acetate|mesh-list
24810175|NCT02038452|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24810176|NCT02038452|Prednisolone phosphate|prednisolone phosphate|mesh-list
24810177|NCT02038452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24810178|NCT02038452|Antiemetics|antiemetics|mesh-ancestor
24810179|NCT02038452|Autonomic Agents|autonomic agents|mesh-ancestor
24497399|NCT00509990|Pimecrolimus|pimecrolimus|mesh-list
24497400|NCT00509990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24497401|NCT00509990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24497402|NCT00509990|Analgesics|analgesics|mesh-ancestor
24497403|NCT00509990|Sensory System Agents|sensory system agents|mesh-ancestor
24497476|NCT00510211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24497477|NCT00510211|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24497478|NCT00510211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24497493|NCT00510263|Prednisolone acetate|prednisolone acetate|mesh-list
24497494|NCT00510263|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24497495|NCT00510263|Prednisolone phosphate|prednisolone phosphate|mesh-list
24497502|NCT00510263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497503|NCT00510263|Antiemetics|antiemetics|mesh-ancestor
24497504|NCT00510263|Autonomic Agents|autonomic agents|mesh-ancestor
24497505|NCT00510263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24497506|NCT00510263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24497507|NCT00510263|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24497508|NCT00510263|Protective Agents|protective agents|mesh-ancestor
24497509|NCT00510263|Antiviral Agents|antiviral agents|mesh-ancestor
24497510|NCT00510263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24497511|NCT00510354|Imatinib Mesylate|imatinib mesylate|mesh-list
25841122|NCT00028964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841123|NCT00028964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25841124|NCT00028964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25841125|NCT00028964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25841126|NCT00028964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25841127|NCT00028964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841128|NCT00028990|Paclitaxel|paclitaxel|mesh-list
25841129|NCT00028990|Bevacizumab|bevacizumab|mesh-list
24762103|NCT01766089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25841130|NCT00028990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25841131|NCT00028990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841132|NCT00028990|Tubulin Modulators|tubulin modulators|mesh-ancestor
25841133|NCT00028990|Antimitotic Agents|antimitotic agents|mesh-ancestor
25660294|NCT01619852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25660295|NCT01619852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660296|NCT01619852|Sensory System Agents|sensory system agents|mesh-ancestor
25660297|NCT01619852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25660298|NCT01619852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25660299|NCT01619852|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25660300|NCT01619852|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25660301|NCT01619852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25660302|NCT01619852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660303|NCT01619865|Edotreotide|edotreotide|mesh-list
25660304|NCT01619865|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25660305|NCT01619865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660306|NCT01619878|Lumefantrine|lumefantrine|mesh-list
25660307|NCT01619878|Artemether|artemether|mesh-list
24513835|NCT00585520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24513836|NCT00585520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513838|NCT00585559|Acetylcysteine|acetylcysteine|mesh-list
24894480|NCT04440267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24894482|NCT04440267|Dermatologic Agents|dermatologic agents|mesh-ancestor
24894483|NCT04440267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24894484|NCT04440267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24894485|NCT04440267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24894486|NCT04440267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24894487|NCT04440267|Tubulin Modulators|tubulin modulators|mesh-ancestor
24894488|NCT04440267|Antimitotic Agents|antimitotic agents|mesh-ancestor
24894489|NCT04440267|Mitosis Modulators|mitosis modulators|mesh-ancestor
24894490|NCT04440267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24894491|NCT04440267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24894492|NCT04440267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25841134|NCT00028990|Mitosis Modulators|mitosis modulators|mesh-ancestor
25841135|NCT00028990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841136|NCT00028990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25841137|NCT00028990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25841138|NCT00028990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25841139|NCT00028990|Growth Substances|growth substances|mesh-ancestor
25841140|NCT00028990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841141|NCT00028990|Growth Inhibitors|growth inhibitors|mesh-ancestor
25841142|NCT00029003|Gefitinib|gefitinib|mesh-list
25841143|NCT00029003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841144|NCT00029003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25841145|NCT00029003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25164048|NCT05424263|Calcium, Dietary|calcium, dietary|mesh-list
25841146|NCT00029003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841147|NCT00029042|Infliximab|infliximab|mesh-list
25841148|NCT00029042|Dermatologic Agents|dermatologic agents|mesh-ancestor
25841149|NCT00029042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25841150|NCT00029042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25841151|NCT00029159|Estrogens|estrogens|mesh-list
25841152|NCT00029159|Androgens|androgens|mesh-list
25841153|NCT00029159|Hormones|hormones|mesh-ancestor
24497628|NCT00510913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497629|NCT00510926|Imatinib Mesylate|imatinib mesylate|mesh-list
24497630|NCT00510926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497631|NCT00510926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24497632|NCT00510926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497633|NCT00510926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497635|NCT00510939|Tipifarnib|tipifarnib|mesh-list
24497636|NCT00510939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497637|NCT00510965|Ranibizumab|ranibizumab|mesh-list
24497638|NCT00510965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24498778|NCT00516243|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24497639|NCT00510965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24497641|NCT00510965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497642|NCT00510965|Growth Inhibitors|growth inhibitors|mesh-ancestor
24497643|NCT00510965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497645|NCT00511017|Vitamins|vitamins|mesh-ancestor
24810187|NCT02038452|Protective Agents|protective agents|mesh-ancestor
24810188|NCT02038452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24810189|NCT02038452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497695|NCT00511446|Docetaxel|docetaxel|mesh-list
25660308|NCT01619878|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25660309|NCT01619878|Antimalarials|antimalarials|mesh-ancestor
25660310|NCT01619878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25660311|NCT01619878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25660312|NCT01619878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25674332|NCT01770353|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25674333|NCT01770392|Rifampin|rifampin|mesh-list
25674334|NCT01770392|Nintedanib|nintedanib|mesh-list
25674335|NCT01770392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25674336|NCT01770392|Antitubercular Agents|antitubercular agents|mesh-ancestor
25674337|NCT01770392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25674338|NCT01770392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25674339|NCT01770392|Leprostatic Agents|leprostatic agents|mesh-ancestor
25674340|NCT01770392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25674341|NCT01770392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674342|NCT01770392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674343|NCT01770392|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25841154|NCT00029159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25841155|NCT00029159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841156|NCT00029224|Zoledronic Acid|zoledronic acid|mesh-list
25841157|NCT00029224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25841158|NCT00029224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841159|NCT00029250|Allicin|allicin|mesh-list
25841160|NCT00029250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25841161|NCT00029250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24497785|NCT00511849|Antimitotic Agents|antimitotic agents|mesh-ancestor
24497786|NCT00511849|Mitosis Modulators|mitosis modulators|mesh-ancestor
25164066|NCT05424016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497791|NCT00511849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497792|NCT00511849|Growth Inhibitors|growth inhibitors|mesh-ancestor
24497793|NCT00511849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24810190|NCT02038491|Anesthetics|anesthetics|mesh-list
24810191|NCT02038491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24810192|NCT02038491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497794|NCT00511849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497795|NCT00511940|Acamprosate|acamprosate|mesh-list
24497796|NCT00511940|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24497800|NCT00511953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24497801|NCT00511953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497802|NCT00511953|Anticonvulsants|anticonvulsants|mesh-ancestor
24497816|NCT00511966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841162|NCT00029250|Antimetabolites|antimetabolites|mesh-ancestor
24497858|NCT00512265|Expectorants|expectorants|mesh-ancestor
24497859|NCT00512265|Respiratory System Agents|respiratory system agents|mesh-ancestor
24497860|NCT00512265|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24497861|NCT00512265|Antioxidants|antioxidants|mesh-ancestor
24497862|NCT00512265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497863|NCT00512265|Protective Agents|protective agents|mesh-ancestor
24497864|NCT00512265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497865|NCT00512265|Antidotes|antidotes|mesh-ancestor
24497868|NCT00512291|Antiemetics|antiemetics|mesh-ancestor
25841163|NCT00029250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841164|NCT00029250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25841165|NCT00029250|Antioxidants|antioxidants|mesh-ancestor
25164049|NCT05424263|Calcium Carbonate|calcium carbonate|mesh-list
24827755|NCT02141178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24827756|NCT02141178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827757|NCT02141178|Sensory System Agents|sensory system agents|mesh-ancestor
24827758|NCT02141178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24827759|NCT02141321|Alprostadil|alprostadil|mesh-list
24827760|NCT02141321|Misoprostol|misoprostol|mesh-list
24720767|NCT01570582|Gemcitabine|gemcitabine|mesh-list
25841166|NCT00029250|Protective Agents|protective agents|mesh-ancestor
25841167|NCT00029250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841168|NCT00029250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25841169|NCT00029250|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25841170|NCT00029315|Plasminogen|plasminogen|mesh-list
25841171|NCT00029315|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25841172|NCT00029315|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24827821|NCT02141737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25841173|NCT00029315|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25841174|NCT00029315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841175|NCT00029328|Etanercept|etanercept|mesh-list
25841176|NCT00029328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25164050|NCT05424263|Calcium|calcium|mesh-list
25164051|NCT05424263|Calcium acetate|calcium acetate|mesh-list
25164052|NCT05424263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25164053|NCT05424263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164054|NCT05424263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25164055|NCT05424263|Antacids|antacids|mesh-ancestor
25164056|NCT05424263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164057|NCT05424263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25164058|NCT05424263|Chelating Agents|chelating agents|mesh-ancestor
25164059|NCT05424263|Sequestering Agents|sequestering agents|mesh-ancestor
25164060|NCT05424016|Propranolol|propranolol|mesh-list
25164061|NCT05424016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25164062|NCT05424016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25164063|NCT05424016|Adrenergic Agents|adrenergic agents|mesh-ancestor
25409024|NCT03404180|Dexmedetomidine|dexmedetomidine|mesh-list
24894623|NCT04438733|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24894624|NCT04438733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24894625|NCT04438733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24894626|NCT04438733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894627|NCT04438733|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25164064|NCT05424016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25164065|NCT05424016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164081|NCT05423834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25164082|NCT05423834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25164084|NCT05423834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164085|NCT05423834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25164086|NCT05423834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25164087|NCT05423821|Anesthetics|anesthetics|mesh-list
25164088|NCT05423821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25164089|NCT05423821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164090|NCT05423769|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25164091|NCT05423769|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25164092|NCT05423769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164093|NCT05423769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25164094|NCT05423769|Immunologic Factors|immunologic factors|mesh-ancestor
25058172|NCT03498820|Remifentanil|remifentanil|mesh-list
25841177|NCT00029328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25841178|NCT00029328|Analgesics|analgesics|mesh-ancestor
25841179|NCT00029328|Sensory System Agents|sensory system agents|mesh-ancestor
25841180|NCT00029328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24498175|NCT00513487|Methacholine Chloride|methacholine chloride|mesh-list
24498176|NCT00513487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24810221|NCT02038816|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24810222|NCT02038816|Chelating Agents|chelating agents|mesh-ancestor
24498255|NCT00513786|Antimitotic Agents|antimitotic agents|mesh-ancestor
24498256|NCT00513786|Mitosis Modulators|mitosis modulators|mesh-ancestor
24498257|NCT00513786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498258|NCT00513786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24498259|NCT00513786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24810268|NCT02039323|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24810269|NCT02039336|Docetaxel|docetaxel|mesh-list
24810270|NCT02039336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498260|NCT00513786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24498261|NCT00513786|Growth Substances|growth substances|mesh-ancestor
25841181|NCT00029328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841182|NCT00029328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25841183|NCT00029328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25841184|NCT00029328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25841185|NCT00029328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25841186|NCT00029328|Immunologic Factors|immunologic factors|mesh-ancestor
24498335|NCT00513981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24810271|NCT02039336|Tubulin Modulators|tubulin modulators|mesh-ancestor
24810272|NCT02039336|Antimitotic Agents|antimitotic agents|mesh-ancestor
24498341|NCT00513981|Antidotes|antidotes|mesh-ancestor
24498363|NCT00514163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498364|NCT00514163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498365|NCT00514163|Antiviral Agents|antiviral agents|mesh-ancestor
24498366|NCT00514163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24498367|NCT00514163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498368|NCT00514163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24498369|NCT00514163|Immunologic Factors|immunologic factors|mesh-ancestor
24498370|NCT00514163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467398|NCT00377468|Hormones|hormones|mesh-ancestor
24498383|NCT00514228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24498384|NCT00514228|Growth Substances|growth substances|mesh-ancestor
24498385|NCT00514228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498386|NCT00514228|Growth Inhibitors|growth inhibitors|mesh-ancestor
24498432|NCT00514605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498433|NCT00514618|Misoprostol|misoprostol|mesh-list
24498434|NCT00514618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25660313|NCT01619982|Vancomycin|vancomycin|mesh-list
25660314|NCT01619982|Cefazolin|cefazolin|mesh-list
25660315|NCT01619982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25660316|NCT01619982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25660317|NCT01620047|Fentanyl|fentanyl|mesh-list
25660318|NCT01620047|Ropivacaine|ropivacaine|mesh-list
25660319|NCT01620047|Anesthetics, Local|anesthetics, local|mesh-ancestor
25660320|NCT01620047|Anesthetics|anesthetics|mesh-ancestor
25660321|NCT01620047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24894713|NCT05388448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24894714|NCT05388448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24894715|NCT05388448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24810313|NCT02039492|Natriuretic Agents|natriuretic agents|mesh-ancestor
24498439|NCT00514618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24498442|NCT00514657|Mitosis Modulators|mitosis modulators|mesh-ancestor
24810273|NCT02039336|Mitosis Modulators|mitosis modulators|mesh-ancestor
24810274|NCT02039336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810275|NCT02039362|Tenofovir|tenofovir|mesh-list
24810276|NCT02039362|Antiviral Agents|antiviral agents|mesh-ancestor
24498443|NCT00514657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498444|NCT00514670|Hand Sanitizers|hand sanitizers|mesh-list
24498445|NCT00514670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24498446|NCT00514670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24498447|NCT00514670|Disinfectants|disinfectants|mesh-ancestor
24498448|NCT00514748|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
24498487|NCT00514982|Dermatologic Agents|dermatologic agents|mesh-ancestor
24498488|NCT00514982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24498489|NCT00514982|Antimetabolites|antimetabolites|mesh-ancestor
24498490|NCT00514982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25164095|NCT05423769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498491|NCT00514982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498492|NCT00514982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24498493|NCT00514982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25164096|NCT05423535|Fibrin Foam|fibrin foam|mesh-list
25841187|NCT00029380|Cyclosporine|cyclosporine|mesh-list
24498494|NCT00514982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24498495|NCT00514982|Analgesics|analgesics|mesh-ancestor
24498496|NCT00514982|Sensory System Agents|sensory system agents|mesh-ancestor
24498497|NCT00514982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24498498|NCT00514995|Sodium Oxybate|sodium oxybate|mesh-list
24498499|NCT00514995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24498500|NCT00514995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24498501|NCT00514995|Anesthetics, General|anesthetics, general|mesh-ancestor
24498502|NCT00514995|Anesthetics|anesthetics|mesh-ancestor
24498503|NCT00514995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24498504|NCT00514995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498505|NCT00515138|Rituximab|rituximab|mesh-list
24498513|NCT00515138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498514|NCT00515138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24498515|NCT00515138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24498516|NCT00515138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24498517|NCT00515138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24602933|NCT00971724|Prednisolone|prednisolone|mesh-list
24498518|NCT00515138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841188|NCT00029380|Mycophenolic Acid|mycophenolic acid|mesh-list
24535103|NCT00648570|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24498535|NCT00515229|Analgesics|analgesics|mesh-ancestor
24498536|NCT00515229|Sensory System Agents|sensory system agents|mesh-ancestor
24498537|NCT00515229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24498538|NCT00515229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498539|NCT00515229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24498540|NCT00515229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24498541|NCT00515229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24498542|NCT00515229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498543|NCT00515229|Adrenergic Agents|adrenergic agents|mesh-ancestor
24498544|NCT00515229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24498545|NCT00515255|Minocycline|minocycline|mesh-list
24498546|NCT00515255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25841189|NCT00029380|Cyclophosphamide|cyclophosphamide|mesh-list
25841190|NCT00029380|Busulfan|busulfan|mesh-list
25841191|NCT00029380|Cyclosporins|cyclosporins|mesh-list
24498574|NCT00515320|Serotonin Agents|serotonin agents|mesh-ancestor
24498575|NCT00515320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498576|NCT00515320|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24498577|NCT00515320|Antidepressive Agents|antidepressive agents|mesh-ancestor
24498578|NCT00515320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25660322|NCT01620047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660323|NCT01620047|Sensory System Agents|sensory system agents|mesh-ancestor
25660324|NCT01620047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25660325|NCT01620047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25660326|NCT01620047|Narcotics|narcotics|mesh-ancestor
25660327|NCT01620047|Analgesics|analgesics|mesh-ancestor
25660328|NCT01620047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24894863|NCT05379855|Cholinergic Agents|cholinergic agents|mesh-ancestor
24894864|NCT05379855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24894865|NCT05379855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717377|NCT01547416|Fentanyl|fentanyl|mesh-list
25201633|NCT02726646|Doxycycline|doxycycline|mesh-list
25201634|NCT02726646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25201635|NCT02726646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24894916|NCT05374057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24498579|NCT00515320|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24498580|NCT00515320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24498582|NCT00515359|Propofol|propofol|mesh-list
24763098|NCT01771406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763099|NCT01771432|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24763100|NCT01771432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24763101|NCT01771445|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24763102|NCT01771445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24763104|NCT01771458|Trastuzumab|trastuzumab|mesh-list
24498585|NCT00515359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498587|NCT00515359|Anesthetics, General|anesthetics, general|mesh-ancestor
24498588|NCT00515359|Anesthetics|anesthetics|mesh-ancestor
24498589|NCT00515450|Immunoglobulins|immunoglobulins|mesh-list
24498590|NCT00515450|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24498591|NCT00515450|Antibodies|antibodies|mesh-list
24498592|NCT00515450|gamma-Globulins|gamma-globulins|mesh-list
24498593|NCT00515450|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24498594|NCT00515450|Immunologic Factors|immunologic factors|mesh-ancestor
24498595|NCT00515450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498596|NCT00515489|Risperidone|risperidone|mesh-list
24498597|NCT00515489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24498598|NCT00515489|Serotonin Agents|serotonin agents|mesh-ancestor
24498599|NCT00515489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24498614|NCT00515593|Hormones|hormones|mesh-list
24498615|NCT00515593|Parathyroid Hormone|parathyroid hormone|mesh-list
24498616|NCT00515593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24498617|NCT00515593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498618|NCT00515593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24498619|NCT00515684|Bevacizumab|bevacizumab|mesh-list
25164097|NCT05423535|Hemostatics|hemostatics|mesh-ancestor
25164098|NCT05423535|Coagulants|coagulants|mesh-ancestor
24498620|NCT00515684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24498621|NCT00515684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810277|NCT02039362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24810278|NCT02039362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24498669|NCT00515892|Antibodies|antibodies|mesh-list
24498670|NCT00515892|Immunoglobulins|immunoglobulins|mesh-list
24498671|NCT00515892|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24498672|NCT00515892|Immunotoxins|immunotoxins|mesh-list
24498673|NCT00515892|Immunologic Factors|immunologic factors|mesh-ancestor
24498674|NCT00515892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498675|NCT00515892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498676|NCT00515905|Propofol|propofol|mesh-list
24498677|NCT00515905|Sevoflurane|sevoflurane|mesh-list
24763105|NCT01771458|Everolimus|everolimus|mesh-list
24498678|NCT00515905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24498679|NCT00515905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24498680|NCT00515905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498681|NCT00515905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24498682|NCT00515905|Anesthetics, General|anesthetics, general|mesh-ancestor
24498683|NCT00515905|Anesthetics|anesthetics|mesh-ancestor
24498684|NCT00515905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24498685|NCT00515905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24498721|NCT00516113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24498722|NCT00516113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24444584|NCT00298545|Micronutrients|micronutrients|mesh-ancestor
24498723|NCT00516113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660329|NCT01620047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25660330|NCT01620047|Anesthetics, General|anesthetics, general|mesh-ancestor
25660331|NCT01620060|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25660332|NCT01620060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25660333|NCT01620060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25660334|NCT01620060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25660335|NCT01620060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660336|NCT01620060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25660337|NCT01620060|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24498724|NCT00516113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24498725|NCT00516113|Serotonin Agents|serotonin agents|mesh-ancestor
24810281|NCT02039362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841192|NCT00029380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24810282|NCT02039362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24498726|NCT00516113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498727|NCT00516113|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25841193|NCT00029380|Immunologic Factors|immunologic factors|mesh-ancestor
25841194|NCT00029380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841195|NCT00029380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25841196|NCT00029380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25841197|NCT00029380|Alkylating Agents|alkylating agents|mesh-ancestor
25841198|NCT00029380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498763|NCT00516191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24498764|NCT00516191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24498765|NCT00516191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498767|NCT00516191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24498777|NCT00516243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498779|NCT00516243|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24498780|NCT00516243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498781|NCT00516243|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24498783|NCT00516282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24498784|NCT00516282|Alkylating Agents|alkylating agents|mesh-ancestor
24498785|NCT00516282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498786|NCT00516282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498787|NCT00516360|Chlorhexidine|chlorhexidine|mesh-list
24498788|NCT00516360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
24498789|NCT00516360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24498790|NCT00516360|Disinfectants|disinfectants|mesh-ancestor
24498803|NCT00516412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498804|NCT00516412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24498805|NCT00516412|Immunologic Factors|immunologic factors|mesh-ancestor
24498812|NCT00516425|Immunologic Factors|immunologic factors|mesh-ancestor
24498813|NCT00516425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498814|NCT00516425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24498815|NCT00516425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24498816|NCT00516425|Alkylating Agents|alkylating agents|mesh-ancestor
24498817|NCT00516425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498818|NCT00516425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25164099|NCT05423392|Lidocaine|lidocaine|mesh-list
25164100|NCT05423392|Carticaine|carticaine|mesh-list
24827973|NCT02142595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24827974|NCT02142595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24827975|NCT02142595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827976|NCT02142595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24827978|NCT02142595|Sensory System Agents|sensory system agents|mesh-ancestor
24827979|NCT02142595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24827980|NCT02142595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24827981|NCT02142595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24827982|NCT02142595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24827983|NCT02142595|Adrenergic Agents|adrenergic agents|mesh-ancestor
24827984|NCT02142595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24721226|NCT01572597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25841199|NCT00029380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589251|NCT00906295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24589252|NCT00906295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24589253|NCT00906360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24589254|NCT00906360|Cetuximab|cetuximab|mesh-list
24589255|NCT00906360|Sunitinib|sunitinib|mesh-list
24589256|NCT00906360|Antibodies|antibodies|mesh-list
24589257|NCT00906360|Immunoglobulins|immunoglobulins|mesh-list
24589258|NCT00906360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24589259|NCT00906360|Immunologic Factors|immunologic factors|mesh-ancestor
24589260|NCT00906360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164101|NCT05423392|Anesthetics|anesthetics|mesh-list
25164102|NCT05423392|Anesthetics, Local|anesthetics, local|mesh-ancestor
25164103|NCT05423392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25164104|NCT05423392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164105|NCT05423392|Sensory System Agents|sensory system agents|mesh-ancestor
25164106|NCT05423392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25164107|NCT05423392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25164108|NCT05423392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24514299|NCT00589394|Immunologic Factors|immunologic factors|mesh-ancestor
24514300|NCT00589394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514302|NCT00589485|Trace Elements|trace elements|mesh-ancestor
24514303|NCT00589485|Micronutrients|micronutrients|mesh-ancestor
24514304|NCT00589485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514305|NCT00589732|Valsartan|valsartan|mesh-list
24514306|NCT00589732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25062291|NCT04991324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062294|NCT04936399|Nivolumab|nivolumab|mesh-list
25164109|NCT05423392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25164110|NCT05423392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25164111|NCT05423392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164112|NCT05423379|Everolimus|everolimus|mesh-list
25164113|NCT05423379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24763351|NCT01773044|Anesthetics|anesthetics|mesh-ancestor
25164114|NCT05423379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25164115|NCT05423379|Immunologic Factors|immunologic factors|mesh-ancestor
25164116|NCT05423379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203116|NCT02716259|Sodium Fluoride|sodium fluoride|mesh-list
25203117|NCT02716259|Cariostatic Agents|cariostatic agents|mesh-ancestor
25203118|NCT02716259|Protective Agents|protective agents|mesh-ancestor
25203119|NCT02716259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203120|NCT02716233|Pegaspargase|pegaspargase|mesh-list
25203121|NCT02716233|Asparaginase|asparaginase|mesh-list
25203122|NCT02716233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207781|NCT03387657|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25207782|NCT03387657|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25207783|NCT03387657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25207784|NCT03387657|Diuretics|diuretics|mesh-ancestor
25207785|NCT03387657|Natriuretic Agents|natriuretic agents|mesh-ancestor
24498820|NCT00516425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24498821|NCT00516425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24498822|NCT00516425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24498823|NCT00516425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498824|NCT00516438|Topotecan|topotecan|mesh-list
24498825|NCT00516438|Olaparib|olaparib|mesh-list
24498826|NCT00516438|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
24763475|NCT01773837|Dopamine Agents|dopamine agents|mesh-ancestor
24498827|NCT00516438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24498828|NCT00516438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24498829|NCT00516438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498830|NCT00516438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498831|NCT00516438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498919|NCT00516828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24498920|NCT00516828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24498921|NCT00516828|Immunologic Factors|immunologic factors|mesh-ancestor
24810290|NCT02039453|Analgesics|analgesics|mesh-ancestor
24810291|NCT02039453|Sensory System Agents|sensory system agents|mesh-ancestor
24810292|NCT02039453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24810293|NCT02039453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24810294|NCT02039453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24498982|NCT00517114|Rabeprazole|rabeprazole|mesh-list
24499019|NCT00517309|Immunologic Factors|immunologic factors|mesh-ancestor
24499065|NCT00517582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24499066|NCT00517582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499068|NCT00517582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24499069|NCT00517582|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
24499070|NCT00517582|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
24499071|NCT00517582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499072|NCT00517582|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24499073|NCT00517582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24499074|NCT00517582|Immunologic Factors|immunologic factors|mesh-ancestor
24499075|NCT00517621|Paclitaxel|paclitaxel|mesh-list
24499076|NCT00517621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24499077|NCT00517621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24499078|NCT00517621|Tubulin Modulators|tubulin modulators|mesh-ancestor
25660338|NCT01620060|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25660339|NCT01620060|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25660340|NCT01620060|Adrenergic Agents|adrenergic agents|mesh-ancestor
25660341|NCT01620060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25660342|NCT01620060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660343|NCT01620060|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25660344|NCT01620060|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25660345|NCT01620060|Serotonin Agents|serotonin agents|mesh-ancestor
24472044|NCT00397800|Immunologic Factors|immunologic factors|mesh-ancestor
24499079|NCT00517621|Antimitotic Agents|antimitotic agents|mesh-ancestor
24499080|NCT00517621|Mitosis Modulators|mitosis modulators|mesh-ancestor
24499081|NCT00517621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499082|NCT00517712|Arsenic Trioxide|arsenic trioxide|mesh-list
24499145|NCT00517985|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24499146|NCT00517985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24499147|NCT00517985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24499148|NCT00517985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499149|NCT00517985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24499153|NCT00517985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24499154|NCT00517985|Antidepressive Agents|antidepressive agents|mesh-ancestor
24499156|NCT00517985|Dopamine Agents|dopamine agents|mesh-ancestor
24499157|NCT00518102|Becaplermin|becaplermin|mesh-list
24499158|NCT00518102|Anticoagulants|anticoagulants|mesh-ancestor
24499159|NCT00518102|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
24499179|NCT00518141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499180|NCT00518141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499181|NCT00518141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24499182|NCT00518141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24499221|NCT00518297|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24499222|NCT00518297|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24499223|NCT00518297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499224|NCT00518297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499225|NCT00518297|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24499226|NCT00518297|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24499227|NCT00518297|Protease Inhibitors|protease inhibitors|mesh-ancestor
24499228|NCT00518375|Cyclosporine|cyclosporine|mesh-list
24499261|NCT00518479|Amlodipine|amlodipine|mesh-list
24499262|NCT00518479|Valsartan|valsartan|mesh-list
24499263|NCT00518479|Moxonidine|moxonidine|mesh-list
24499264|NCT00518479|Bendroflumethiazide|bendroflumethiazide|mesh-list
24499265|NCT00518479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24499266|NCT00518479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24499267|NCT00518479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25164127|NCT05423210|Atezolizumab|atezolizumab|mesh-list
24810314|NCT02039518|Gemcitabine|gemcitabine|mesh-list
25164128|NCT05423210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24499268|NCT00518479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499269|NCT00518479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24499270|NCT00518479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499271|NCT00518479|Vasodilator Agents|vasodilator agents|mesh-ancestor
24499272|NCT00518479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24499273|NCT00518479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24499274|NCT00518479|Diuretics|diuretics|mesh-ancestor
24499275|NCT00518479|Natriuretic Agents|natriuretic agents|mesh-ancestor
24499276|NCT00518479|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24499277|NCT00518570|Levetiracetam|levetiracetam|mesh-list
24499278|NCT00518570|Anticonvulsants|anticonvulsants|mesh-ancestor
24499279|NCT00518570|Nootropic Agents|nootropic agents|mesh-ancestor
24499280|NCT00518583|Paclitaxel|paclitaxel|mesh-list
24499281|NCT00518583|Doxorubicin|doxorubicin|mesh-list
24499282|NCT00518583|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24499295|NCT00518635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24499296|NCT00518635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499297|NCT00518635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24499298|NCT00518895|Dacarbazine|dacarbazine|mesh-list
24499299|NCT00518895|Oblimersen|oblimersen|mesh-list
24499302|NCT00518895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499303|NCT00518895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24499304|NCT00518908|Sevoflurane|sevoflurane|mesh-list
24499305|NCT00518908|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24499306|NCT00518908|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24499307|NCT00518908|Anesthetics, General|anesthetics, general|mesh-ancestor
24499308|NCT00518908|Anesthetics|anesthetics|mesh-ancestor
24499309|NCT00518908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24499310|NCT00518908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499311|NCT00518947|Verapamil|verapamil|mesh-list
24499312|NCT00518947|Lithium Carbonate|lithium carbonate|mesh-list
24499313|NCT00518947|Antidepressive Agents|antidepressive agents|mesh-ancestor
25660346|NCT01620060|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25660347|NCT01620060|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25660348|NCT01620060|Dopamine Agents|dopamine agents|mesh-ancestor
24499314|NCT00518947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24499315|NCT00518947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499316|NCT00518947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499317|NCT00518947|Antimanic Agents|antimanic agents|mesh-ancestor
24499318|NCT00518947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24499319|NCT00518947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24499334|NCT00519012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24499335|NCT00519012|Serotonin Agents|serotonin agents|mesh-ancestor
24499336|NCT00519012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499337|NCT00519012|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24499338|NCT00519012|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24499339|NCT00519012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24499344|NCT00519051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24499345|NCT00519051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25841200|NCT00029380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24499369|NCT00519181|Anticonvulsants|anticonvulsants|mesh-ancestor
24499370|NCT00519181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499371|NCT00519181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499372|NCT00519181|GABA Agents|gaba agents|mesh-ancestor
24499373|NCT00519181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24499374|NCT00519181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499375|NCT00519181|Antimanic Agents|antimanic agents|mesh-ancestor
24499376|NCT00519181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24499377|NCT00519181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24499378|NCT00519181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24499379|NCT00519207|Lidocaine|lidocaine|mesh-list
24499380|NCT00519207|Anesthetics, Local|anesthetics, local|mesh-ancestor
24499381|NCT00519207|Anesthetics|anesthetics|mesh-ancestor
24499382|NCT00519207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24499383|NCT00519207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499384|NCT00519207|Sensory System Agents|sensory system agents|mesh-ancestor
24499385|NCT00519207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24499386|NCT00519207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24499387|NCT00519207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24499388|NCT00519207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24499389|NCT00519207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24535235|NCT00648817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535236|NCT00648817|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25841201|NCT00029380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841202|NCT00029380|Antifungal Agents|antifungal agents|mesh-ancestor
25841203|NCT00029380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25841204|NCT00029380|Dermatologic Agents|dermatologic agents|mesh-ancestor
25841205|NCT00029380|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25841206|NCT00029380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25841207|NCT00029380|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25841208|NCT00029380|Antitubercular Agents|antitubercular agents|mesh-ancestor
25841209|NCT00029380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24499390|NCT00519207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499391|NCT00519246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
24499400|NCT00519246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24499401|NCT00519246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25841210|NCT00029458|Clozapine|clozapine|mesh-list
24499419|NCT00519298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499420|NCT00519298|Nootropic Agents|nootropic agents|mesh-ancestor
24764555|NCT01782599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24499422|NCT00519324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24499423|NCT00519324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24499424|NCT00519324|Immunologic Factors|immunologic factors|mesh-ancestor
24499425|NCT00519324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499426|NCT00519337|Ascorbic Acid|ascorbic acid|mesh-list
24499427|NCT00519337|Vitamins|vitamins|mesh-ancestor
24499428|NCT00519337|Micronutrients|micronutrients|mesh-ancestor
24499429|NCT00519337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499430|NCT00519337|Antioxidants|antioxidants|mesh-ancestor
24499431|NCT00519337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499432|NCT00519337|Protective Agents|protective agents|mesh-ancestor
25841211|NCT00029458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25841212|NCT00029458|Serotonin Agents|serotonin agents|mesh-ancestor
25841213|NCT00029458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25164130|NCT05423197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25164131|NCT05423197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25164132|NCT05423132|Ropivacaine|ropivacaine|mesh-list
25164133|NCT05423132|Anesthetics, Local|anesthetics, local|mesh-ancestor
25841214|NCT00029458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841215|NCT00029458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841216|NCT00029458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25841217|NCT00029458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25841218|NCT00029458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25841219|NCT00029458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24514532|NCT00591383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24514533|NCT00591383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514537|NCT00591487|Lidocaine|lidocaine|mesh-list
25164134|NCT05423132|Anesthetics|anesthetics|mesh-ancestor
25164135|NCT05423132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25164136|NCT05423132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164137|NCT05423132|Sensory System Agents|sensory system agents|mesh-ancestor
25164138|NCT05423132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25164140|NCT05423015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25164141|NCT05422911|Abiraterone Acetate|abiraterone acetate|mesh-list
25164142|NCT05422911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25164143|NCT05422911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24499433|NCT00519363|Atorvastatin|atorvastatin|mesh-list
24499434|NCT00519363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24499435|NCT00519363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24810309|NCT02039492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24810310|NCT02039492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810311|NCT02039492|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24810312|NCT02039492|Diuretics|diuretics|mesh-ancestor
24764560|NCT01782612|Analgesics|analgesics|mesh-list
24603511|NCT00974155|Antidepressive Agents|antidepressive agents|mesh-ancestor
24499436|NCT00519363|Antimetabolites|antimetabolites|mesh-ancestor
25181774|NCT04793568|Interferon-gamma|interferon-gamma|mesh-list
24499437|NCT00519363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499438|NCT00519363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24499439|NCT00519363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24499440|NCT00519363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499441|NCT00519467|Artesunate|artesunate|mesh-list
24499442|NCT00519467|Dapsone|dapsone|mesh-list
24499443|NCT00519467|Chlorproguanil|chlorproguanil|mesh-list
24499444|NCT00519467|Antimalarials|antimalarials|mesh-ancestor
24499445|NCT00519467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24499517|NCT00519870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499518|NCT00519870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24499519|NCT00519870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24469614|NCT00386529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499718|NCT00520650|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24499719|NCT00520754|Levocetirizine|levocetirizine|mesh-list
24499749|NCT00520949|Esomeprazole|esomeprazole|mesh-list
24499750|NCT00520949|Bismuth|bismuth|mesh-list
24499751|NCT00520949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24499752|NCT00520949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24810326|NCT02039531|Hyaluronic Acid|hyaluronic acid|mesh-list
24810327|NCT02039531|Mitosis Modulators|mitosis modulators|mesh-ancestor
24810328|NCT02039531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810329|NCT02039531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24810330|NCT02039531|Immunologic Factors|immunologic factors|mesh-ancestor
24810331|NCT02039531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810332|NCT02039531|Viscosupplements|viscosupplements|mesh-ancestor
24499756|NCT00520949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499757|NCT00520949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499758|NCT00520949|Antacids|antacids|mesh-ancestor
24499759|NCT00520949|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24499760|NCT00520949|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24499761|NCT00520949|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24499762|NCT00520949|Renal Agents|renal agents|mesh-ancestor
24499763|NCT00520949|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
24499764|NCT00520949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24499765|NCT00520949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24499766|NCT00520949|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24499767|NCT00521040|Levocetirizine|levocetirizine|mesh-list
24499768|NCT00521040|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25660349|NCT01620138|Cabergoline|cabergoline|mesh-list
25660350|NCT01620138|Pasireotide|pasireotide|mesh-list
25660351|NCT01620138|Hormones|hormones|mesh-ancestor
25660352|NCT01620138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25660353|NCT01620138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660354|NCT01620138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25660355|NCT01620138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25660356|NCT01620138|Dopamine Agonists|dopamine agonists|mesh-ancestor
25660357|NCT01620138|Dopamine Agents|dopamine agents|mesh-ancestor
24514643|NCT00592111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24514644|NCT00592111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24514645|NCT00592111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25841220|NCT00029458|GABA Antagonists|gaba antagonists|mesh-ancestor
24514646|NCT00592111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24499769|NCT00521040|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24499817|NCT00521222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24499818|NCT00521222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499819|NCT00521222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24499820|NCT00521222|Respiratory System Agents|respiratory system agents|mesh-ancestor
24499821|NCT00521222|Dermatologic Agents|dermatologic agents|mesh-ancestor
24810339|NCT02039661|Sensory System Agents|sensory system agents|mesh-ancestor
24810340|NCT02039661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24810341|NCT02039661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25164144|NCT05422911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24810342|NCT02039661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24810343|NCT02039661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24499863|NCT00521430|Cyclosporins|cyclosporins|mesh-list
25841221|NCT00029458|GABA Agents|gaba agents|mesh-ancestor
25841222|NCT00029497|Amitriptyline|amitriptyline|mesh-list
25841223|NCT00029497|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25841224|NCT00029497|Antidepressive Agents|antidepressive agents|mesh-ancestor
25841225|NCT00029497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25841226|NCT00029497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25841227|NCT00029497|Analgesics|analgesics|mesh-ancestor
25841228|NCT00029497|Sensory System Agents|sensory system agents|mesh-ancestor
25841229|NCT00029497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25841230|NCT00029497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841231|NCT00029497|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25841232|NCT00029497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25841233|NCT00029497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24499864|NCT00521430|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24499865|NCT00521430|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24499866|NCT00521430|Abortifacient Agents|abortifacient agents|mesh-ancestor
24499867|NCT00521430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24499868|NCT00521430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499869|NCT00521430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24499870|NCT00521430|Antimetabolites|antimetabolites|mesh-ancestor
24499871|NCT00521430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499872|NCT00521430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24499873|NCT00521430|Dermatologic Agents|dermatologic agents|mesh-ancestor
24499874|NCT00521430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841234|NCT00029497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470549|NCT00390520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841235|NCT00029497|Adrenergic Agents|adrenergic agents|mesh-ancestor
25841236|NCT00029497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25841237|NCT00029523|Cytarabine|cytarabine|mesh-list
25841238|NCT00029523|Methotrexate|methotrexate|mesh-list
25841239|NCT00029523|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24499875|NCT00521430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24499876|NCT00521430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24499877|NCT00521430|Immunologic Factors|immunologic factors|mesh-ancestor
24499878|NCT00521430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24499879|NCT00521430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24499880|NCT00521430|Antifungal Agents|antifungal agents|mesh-ancestor
24499894|NCT00521430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24499895|NCT00521430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24499896|NCT00521482|Thalidomide|thalidomide|mesh-list
24499897|NCT00521482|Temozolomide|temozolomide|mesh-list
24499899|NCT00521482|Alkylating Agents|alkylating agents|mesh-ancestor
24765084|NCT01785979|Antimalarials|antimalarials|mesh-ancestor
24499915|NCT00521521|Antimitotic Agents|antimitotic agents|mesh-ancestor
24499916|NCT00521521|Mitosis Modulators|mitosis modulators|mesh-ancestor
24810348|NCT02039700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24810349|NCT02039700|Uricosuric Agents|uricosuric agents|mesh-ancestor
24810350|NCT02039700|Renal Agents|renal agents|mesh-ancestor
24810351|NCT02039765|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25660358|NCT01620138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25660359|NCT01620138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660360|NCT01620177|Ethanol|ethanol|mesh-list
25660361|NCT01620177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25660362|NCT01620177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25660363|NCT01620177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24895286|NCT04594213|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24810352|NCT02039765|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24603784|NCT00975663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499917|NCT00521521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499918|NCT00521612|Sevoflurane|sevoflurane|mesh-list
24499920|NCT00521612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24499921|NCT00521612|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24499922|NCT00521612|Anesthetics, General|anesthetics, general|mesh-ancestor
24499923|NCT00521612|Anesthetics|anesthetics|mesh-ancestor
24499924|NCT00521612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25841240|NCT00029523|Abortifacient Agents|abortifacient agents|mesh-ancestor
25841241|NCT00029523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25841242|NCT00029523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841243|NCT00029523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25841244|NCT00029523|Antimetabolites|antimetabolites|mesh-ancestor
25841245|NCT00029523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841246|NCT00029523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841247|NCT00029523|Dermatologic Agents|dermatologic agents|mesh-ancestor
25841248|NCT00029523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841249|NCT00029523|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25841250|NCT00029523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25841251|NCT00029523|Immunologic Factors|immunologic factors|mesh-ancestor
25841252|NCT00029523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25841253|NCT00029523|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25841254|NCT00029523|Antiviral Agents|antiviral agents|mesh-ancestor
25841255|NCT00029523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24535344|NCT00648999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24535345|NCT00648999|Protease Inhibitors|protease inhibitors|mesh-ancestor
24535346|NCT00648999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841256|NCT00029614|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25841257|NCT00029614|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24499989|NCT00521963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24499990|NCT00521963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24499991|NCT00522015|Rivastigmine|rivastigmine|mesh-list
24499992|NCT00522015|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25841258|NCT00029614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25841259|NCT00029614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25841260|NCT00029614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841261|NCT00029614|Adrenergic Agents|adrenergic agents|mesh-ancestor
24810353|NCT02039765|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24810354|NCT02039765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24810356|NCT02039765|Adrenergic Agents|adrenergic agents|mesh-ancestor
24603880|NCT00975988|Lapatinib|lapatinib|mesh-list
25841262|NCT00029614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25841263|NCT00029614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841264|NCT00029627|Yohimbine|yohimbine|mesh-list
25841265|NCT00029627|Mydriatics|mydriatics|mesh-ancestor
25841266|NCT00029627|Autonomic Agents|autonomic agents|mesh-ancestor
24500026|NCT00522184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24500027|NCT00522184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24500028|NCT00522184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24500029|NCT00522184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24500030|NCT00522184|Immunologic Factors|immunologic factors|mesh-ancestor
24500031|NCT00522210|Insulin|insulin|mesh-list
24500032|NCT00522210|Isophane Insulin, Human|isophane insulin, human|mesh-list
24500033|NCT00522210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24500034|NCT00522210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500035|NCT00522249|Interferons|interferons|mesh-list
24500036|NCT00522249|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24500040|NCT00522249|Sunitinib|sunitinib|mesh-list
24810358|NCT02039765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810359|NCT02039765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500087|NCT00522587|Sensory System Agents|sensory system agents|mesh-ancestor
25660364|NCT01620177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660365|NCT01620190|Paclitaxel|paclitaxel|mesh-list
25660366|NCT01620190|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25660367|NCT01620190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25660368|NCT01620190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25660369|NCT01620190|Tubulin Modulators|tubulin modulators|mesh-ancestor
25660370|NCT01620190|Antimitotic Agents|antimitotic agents|mesh-ancestor
25660371|NCT01620190|Mitosis Modulators|mitosis modulators|mesh-ancestor
25660372|NCT01620190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660373|NCT01620216|Sorafenib|sorafenib|mesh-list
25660374|NCT01620216|Sunitinib|sunitinib|mesh-list
25841267|NCT00029627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24500088|NCT00522587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25841268|NCT00029627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500090|NCT00522639|Antimetabolites|antimetabolites|mesh-ancestor
24500091|NCT00522639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203123|NCT02716272|Nivolumab|nivolumab|mesh-list
24828009|NCT02142751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24828010|NCT02142751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24828011|NCT02142751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24828013|NCT02142777|Phytoestrogens|phytoestrogens|mesh-ancestor
24828014|NCT02142777|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24828015|NCT02142777|Estrogens|estrogens|mesh-ancestor
24828016|NCT02142777|Hormones|hormones|mesh-ancestor
25841269|NCT00029627|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25841270|NCT00029627|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25841271|NCT00029627|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25841272|NCT00029627|Adrenergic Agents|adrenergic agents|mesh-ancestor
25841273|NCT00029627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25841274|NCT00029627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447563|NCT00308971|Vitamins|vitamins|mesh-ancestor
24447564|NCT00308971|Micronutrients|micronutrients|mesh-ancestor
24447565|NCT00308971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447566|NCT00308971|Antioxidants|antioxidants|mesh-ancestor
24447567|NCT00308971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447576|NCT00309088|Tacrolimus|tacrolimus|mesh-list
24828047|NCT02142920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24828048|NCT02142920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828049|NCT02142920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828050|NCT02143050|Metformin|metformin|mesh-list
24828051|NCT02143050|Trametinib|trametinib|mesh-list
24828052|NCT02143050|Dabrafenib|dabrafenib|mesh-list
24828053|NCT02143050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24828054|NCT02143050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828055|NCT02143050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828056|NCT02143050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24828057|NCT02143050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828058|NCT02143050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164145|NCT05422911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164146|NCT05422911|Hormone Antagonists|hormone antagonists|mesh-ancestor
25164147|NCT05422911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25164148|NCT05422911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164149|NCT05422911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25164150|NCT05422885|Dasatinib|dasatinib|mesh-list
25164151|NCT05422885|Quercetin|quercetin|mesh-list
25164152|NCT05422885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25164153|NCT05422885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25164154|NCT05422885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25164155|NCT05422885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164156|NCT05422885|Antioxidants|antioxidants|mesh-ancestor
25164157|NCT05422885|Protective Agents|protective agents|mesh-ancestor
25164158|NCT05422885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164159|NCT05421962|Fentanyl|fentanyl|mesh-list
25164160|NCT05421962|Ketamine|ketamine|mesh-list
25164161|NCT05421962|Analgesics|analgesics|mesh-ancestor
25164162|NCT05421962|Sensory System Agents|sensory system agents|mesh-ancestor
25164163|NCT05421962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25164164|NCT05421962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164165|NCT05421962|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25164166|NCT05421962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25164167|NCT05421962|Anesthetics, General|anesthetics, general|mesh-ancestor
25164168|NCT05421962|Anesthetics|anesthetics|mesh-ancestor
25164169|NCT05421962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25164170|NCT05421962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25164171|NCT05421962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25164172|NCT05421962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25164173|NCT05421962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164174|NCT05421962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25164175|NCT05421962|Narcotics|narcotics|mesh-ancestor
25164176|NCT05421962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25164177|NCT05420805|Zinc Oxide|zinc oxide|mesh-list
25164178|NCT05420805|Butyric Acid|butyric acid|mesh-list
25164179|NCT05420805|Dermatologic Agents|dermatologic agents|mesh-ancestor
25164180|NCT05420805|Sunscreening Agents|sunscreening agents|mesh-ancestor
25660375|NCT01620216|Dasatinib|dasatinib|mesh-list
25660376|NCT01620216|Ponatinib|ponatinib|mesh-list
24514838|NCT00593125|Levetiracetam|levetiracetam|mesh-list
24514839|NCT00593125|Anticonvulsants|anticonvulsants|mesh-ancestor
24514840|NCT00593125|Nootropic Agents|nootropic agents|mesh-ancestor
24514841|NCT00593138|Methylphenidate|methylphenidate|mesh-list
24514842|NCT00593138|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
24514843|NCT00593138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25164181|NCT05420805|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25164182|NCT05420805|Protective Agents|protective agents|mesh-ancestor
25164183|NCT05420805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164184|NCT05420805|Histamine Antagonists|histamine antagonists|mesh-ancestor
25164185|NCT05420805|Histamine Agents|histamine agents|mesh-ancestor
24500092|NCT00522639|Antiviral Agents|antiviral agents|mesh-ancestor
24500093|NCT00522639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24500095|NCT00522665|Cetuximab|cetuximab|mesh-list
24500096|NCT00522665|Everolimus|everolimus|mesh-list
24500097|NCT00522665|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24500098|NCT00522665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25841275|NCT00029627|Urological Agents|urological agents|mesh-ancestor
24500099|NCT00522665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24500100|NCT00522665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500101|NCT00522665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24500102|NCT00522665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24500157|NCT00523055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24500158|NCT00523055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500161|NCT00523068|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24500162|NCT00523068|Cholinergic Agents|cholinergic agents|mesh-ancestor
24500163|NCT00523068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24500164|NCT00523068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500165|NCT00523068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500166|NCT00523068|Urological Agents|urological agents|mesh-ancestor
24500167|NCT00523120|Diclofenac|diclofenac|mesh-list
24500169|NCT00523120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24500170|NCT00523120|Analgesics|analgesics|mesh-ancestor
24500171|NCT00523120|Sensory System Agents|sensory system agents|mesh-ancestor
24500172|NCT00523120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24500173|NCT00523120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841276|NCT00029679|Borage oil|borage oil|mesh-list
25841277|NCT00029679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25841278|NCT00029757|Estrogens|estrogens|mesh-list
24500183|NCT00523133|Sensory System Agents|sensory system agents|mesh-ancestor
24500184|NCT00523133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24500185|NCT00523159|Sargramostim|sargramostim|mesh-list
25841279|NCT00029757|Hormones|hormones|mesh-ancestor
25841280|NCT00029757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25841281|NCT00029757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841282|NCT00029770|Acetaminophen|acetaminophen|mesh-list
24810360|NCT02039791|Paclitaxel|paclitaxel|mesh-list
24810361|NCT02039791|Carboplatin|carboplatin|mesh-list
24810362|NCT02039791|Nimotuzumab|nimotuzumab|mesh-list
24810363|NCT02039791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25841283|NCT00029770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24444635|NCT00298675|Irinotecan|irinotecan|mesh-list
25841284|NCT00029770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25841285|NCT00029770|Codeine|codeine|mesh-list
25841286|NCT00029770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25841287|NCT00029770|Analgesics|analgesics|mesh-ancestor
25841288|NCT00029770|Sensory System Agents|sensory system agents|mesh-ancestor
25841289|NCT00029770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25841290|NCT00029770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841291|NCT00029770|Antipyretics|antipyretics|mesh-ancestor
24500204|NCT00523185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500205|NCT00523185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24500232|NCT00523380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24500233|NCT00523380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24500234|NCT00523380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24500235|NCT00523380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500278|NCT00523458|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24500279|NCT00523458|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25660377|NCT01620216|Idelalisib|idelalisib|mesh-list
25660378|NCT01620216|Antineoplastic Agents|antineoplastic agents|mesh-list
25660379|NCT01620216|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
25660380|NCT01620216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25660381|NCT01620216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25660382|NCT01620216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660383|NCT01620216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25660384|NCT01620216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25841292|NCT00029770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25841293|NCT00029770|Narcotics|narcotics|mesh-ancestor
25841294|NCT00029770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25841295|NCT00029770|Antitussive Agents|antitussive agents|mesh-ancestor
25841296|NCT00029770|Respiratory System Agents|respiratory system agents|mesh-ancestor
25841297|NCT00029770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25875651|NCT04244552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25875652|NCT04244552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514911|NCT00593463|Sensory System Agents|sensory system agents|mesh-ancestor
24854871|NCT02275975|Hormone Antagonists|hormone antagonists|mesh-ancestor
24514917|NCT00593463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25875653|NCT04244552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25875654|NCT04244552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25875655|NCT04244552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875656|NCT04244552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875657|NCT04244552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25875658|NCT04244058|Amantadine|amantadine|mesh-list
25875659|NCT04244058|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25875660|NCT04244058|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24500280|NCT00523458|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25875661|NCT04244058|Antiviral Agents|antiviral agents|mesh-ancestor
24500282|NCT00523458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24500283|NCT00523666|Galantamine|galantamine|mesh-list
24500284|NCT00523666|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24500285|NCT00523666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24500286|NCT00523666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500287|NCT00523666|Cholinergic Agents|cholinergic agents|mesh-ancestor
24500605|NCT00525200|Immunologic Factors|immunologic factors|mesh-ancestor
24500288|NCT00523666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24500289|NCT00523666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164186|NCT05420805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24500290|NCT00523666|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24500291|NCT00523666|Autonomic Agents|autonomic agents|mesh-ancestor
24500292|NCT00523666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24500293|NCT00523666|Nootropic Agents|nootropic agents|mesh-ancestor
25875662|NCT04244058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25875663|NCT04244058|Dopamine Agents|dopamine agents|mesh-ancestor
25875664|NCT04244058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24810364|NCT02039791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810365|NCT02039791|Tubulin Modulators|tubulin modulators|mesh-ancestor
24810366|NCT02039791|Antimitotic Agents|antimitotic agents|mesh-ancestor
25875665|NCT04244058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875666|NCT04244058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875667|NCT04244058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25875668|NCT04244058|Analgesics|analgesics|mesh-ancestor
25875669|NCT04244058|Sensory System Agents|sensory system agents|mesh-ancestor
25875670|NCT04244058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24500294|NCT00523692|Etanercept|etanercept|mesh-list
24500295|NCT00523692|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24500296|NCT00523692|Methotrexate|methotrexate|mesh-list
24500297|NCT00523692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24500298|NCT00523692|Abortifacient Agents|abortifacient agents|mesh-ancestor
24500299|NCT00523692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25875671|NCT04232553|Mirikizumab|mirikizumab|mesh-list
25875672|NCT04232553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24500300|NCT00523692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500301|NCT00523692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24500302|NCT00523692|Antimetabolites|antimetabolites|mesh-ancestor
24500303|NCT00523692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500304|NCT00523692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24500305|NCT00523692|Dermatologic Agents|dermatologic agents|mesh-ancestor
24500306|NCT00523692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25660385|NCT01620216|Growth Substances|growth substances|mesh-ancestor
25660386|NCT01620216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660387|NCT01620216|Growth Inhibitors|growth inhibitors|mesh-ancestor
25660388|NCT01620489|Liraglutide|liraglutide|mesh-list
25660389|NCT01620489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25660390|NCT01620489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660391|NCT01620489|Incretins|incretins|mesh-ancestor
25660392|NCT01620489|Hormones|hormones|mesh-ancestor
25660393|NCT01620489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25660394|NCT01620593|Metformin|metformin|mesh-list
25660395|NCT01620593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24946800|NCT03935347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24946801|NCT03935347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24946802|NCT03935347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24946803|NCT03935347|Antimetabolites|antimetabolites|mesh-ancestor
24946804|NCT03935347|Antiviral Agents|antiviral agents|mesh-ancestor
24946805|NCT03935347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24514965|NCT00593658|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24514966|NCT00593658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24514967|NCT00593658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514968|NCT00593658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24514969|NCT00593658|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25841298|NCT00029822|Alfuzosin|alfuzosin|mesh-list
25841299|NCT00029822|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25841300|NCT00029822|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25841301|NCT00029822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25841302|NCT00029822|Adrenergic Agents|adrenergic agents|mesh-ancestor
25841303|NCT00029822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25841304|NCT00029822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841305|NCT00029822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841306|NCT00029822|Urological Agents|urological agents|mesh-ancestor
25841307|NCT00029835|Rimonabant|rimonabant|mesh-list
24500314|NCT00523692|Analgesics|analgesics|mesh-ancestor
24500315|NCT00523692|Sensory System Agents|sensory system agents|mesh-ancestor
24500316|NCT00523692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24500317|NCT00523692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24500318|NCT00523692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24500319|NCT00523757|Spironolactone|spironolactone|mesh-list
24500320|NCT00523757|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24500321|NCT00523757|Hormone Antagonists|hormone antagonists|mesh-ancestor
24500322|NCT00523757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24500323|NCT00523757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500324|NCT00523757|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24500325|NCT00523757|Diuretics|diuretics|mesh-ancestor
24500326|NCT00523757|Natriuretic Agents|natriuretic agents|mesh-ancestor
24500327|NCT00523887|Fentanyl|fentanyl|mesh-list
24500328|NCT00523887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24500329|NCT00523887|Narcotics|narcotics|mesh-ancestor
24500330|NCT00523887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24500331|NCT00523887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500332|NCT00523887|Analgesics|analgesics|mesh-ancestor
24605706|NCT00986817|Terlipressin|terlipressin|mesh-list
24500337|NCT00523887|Anesthetics, General|anesthetics, general|mesh-ancestor
25841308|NCT00029835|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25841309|NCT00029835|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
25841310|NCT00029835|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25841311|NCT00029835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24500385|NCT00524069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24500387|NCT00524069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24500388|NCT00524069|Immunologic Factors|immunologic factors|mesh-ancestor
25841312|NCT00029835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841313|NCT00029835|Hormones|hormones|mesh-ancestor
25841314|NCT00029835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25841315|NCT00029835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841316|NCT00029848|Rimonabant|rimonabant|mesh-list
25841317|NCT00029848|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25841318|NCT00029848|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
25841319|NCT00029848|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25841320|NCT00029848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25841321|NCT00029848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841322|NCT00029848|Hormones|hormones|mesh-ancestor
25875673|NCT04232553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25660396|NCT01620593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660397|NCT01621009|Bupropion|bupropion|mesh-list
25660398|NCT01621009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25660399|NCT01621009|Antidepressive Agents|antidepressive agents|mesh-ancestor
25660400|NCT01621009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25660401|NCT01621009|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25660402|NCT01621009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25660403|NCT01621009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25660404|NCT01621009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660405|NCT01621009|Dopamine Agents|dopamine agents|mesh-ancestor
25660406|NCT01621009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24824978|NCT02126527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824979|NCT02126527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24824980|NCT02126579|Poly ICLC|poly iclc|mesh-list
24824981|NCT02126579|Interferon Inducers|interferon inducers|mesh-ancestor
24895504|NCT04006210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24895505|NCT04006210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895509|NCT04003805|Nicotine|nicotine|mesh-list
25841323|NCT00029848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25841324|NCT00029848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841325|NCT00029861|Rimonabant|rimonabant|mesh-list
25841326|NCT00029861|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25841327|NCT00029861|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
25841328|NCT00029861|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25841329|NCT00029861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25841330|NCT00029861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841331|NCT00029861|Hormones|hormones|mesh-ancestor
24810373|NCT02039804|Immunologic Factors|immunologic factors|mesh-ancestor
24810374|NCT02039804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810375|NCT02039804|Viscosupplements|viscosupplements|mesh-ancestor
24810376|NCT02039804|Protective Agents|protective agents|mesh-ancestor
24810377|NCT02039804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24810379|NCT02039869|Sucralfate|sucralfate|mesh-list
25841332|NCT00029861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25841333|NCT00029861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841334|NCT00029874|Minocycline|minocycline|mesh-list
24500430|NCT00524186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24500431|NCT00524186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24500432|NCT00524186|Antidotes|antidotes|mesh-ancestor
24500433|NCT00524186|Protective Agents|protective agents|mesh-ancestor
24500434|NCT00524186|Vitamin B Complex|vitamin b complex|mesh-ancestor
24500435|NCT00524186|Vitamins|vitamins|mesh-ancestor
24500436|NCT00524186|Micronutrients|micronutrients|mesh-ancestor
24500437|NCT00524186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24500438|NCT00524186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24765679|NCT01789892|Antiemetics|antiemetics|mesh-ancestor
24500439|NCT00524186|Growth Substances|growth substances|mesh-ancestor
24500440|NCT00524186|Growth Inhibitors|growth inhibitors|mesh-ancestor
24500451|NCT00524381|Etanercept|etanercept|mesh-list
24500452|NCT00524381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24500453|NCT00524381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24500454|NCT00524381|Analgesics|analgesics|mesh-ancestor
24500455|NCT00524381|Sensory System Agents|sensory system agents|mesh-ancestor
24500477|NCT00524615|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24500478|NCT00524615|Hormone Antagonists|hormone antagonists|mesh-ancestor
24500479|NCT00524615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25841335|NCT00029874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25841336|NCT00029874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24500480|NCT00524615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500481|NCT00524615|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24500482|NCT00524615|Diuretics|diuretics|mesh-ancestor
24500483|NCT00524615|Natriuretic Agents|natriuretic agents|mesh-ancestor
24500484|NCT00524667|Fludarabine|fludarabine|mesh-list
24500485|NCT00524667|Valproic Acid|valproic acid|mesh-list
24500486|NCT00524667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24500494|NCT00524667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24500496|NCT00524667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25841337|NCT00030004|Midazolam|midazolam|mesh-list
25841338|NCT00030004|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25841339|NCT00030004|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25841340|NCT00030004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25841341|NCT00030004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841342|NCT00030004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25841343|NCT00030004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25841344|NCT00030004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25841345|NCT00030004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25841346|NCT00030004|Anesthetics, General|anesthetics, general|mesh-ancestor
25841347|NCT00030004|Anesthetics|anesthetics|mesh-ancestor
24765840|NCT01790997|Aspirin|aspirin|mesh-list
25409025|NCT03404180|Propofol|propofol|mesh-list
25660407|NCT01621009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660408|NCT01621009|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25660409|NCT01621009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25660410|NCT01621009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25660411|NCT01621178|Insulin|insulin|mesh-list
25660412|NCT01621178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25660413|NCT01621178|Insulin Glargine|insulin glargine|mesh-list
25660414|NCT01621178|Insulin Lispro|insulin lispro|mesh-list
25841348|NCT00030004|GABA Modulators|gaba modulators|mesh-ancestor
25841349|NCT00030004|GABA Agents|gaba agents|mesh-ancestor
25841350|NCT00030004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24810383|NCT02039869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24810384|NCT02039869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810385|NCT02039960|Bupropion|bupropion|mesh-list
24810386|NCT02039960|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24810387|NCT02039960|Antidepressive Agents|antidepressive agents|mesh-ancestor
24810388|NCT02039960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24810389|NCT02039960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24500570|NCT00525005|Tubulin Modulators|tubulin modulators|mesh-ancestor
24500571|NCT00525005|Antimitotic Agents|antimitotic agents|mesh-ancestor
24500572|NCT00525005|Mitosis Modulators|mitosis modulators|mesh-ancestor
24500573|NCT00525005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500574|NCT00525096|Celecoxib|celecoxib|mesh-list
24500575|NCT00525096|Exemestane|exemestane|mesh-list
24500576|NCT00525096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24500577|NCT00525096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24500578|NCT00525096|Analgesics|analgesics|mesh-ancestor
24500579|NCT00525096|Sensory System Agents|sensory system agents|mesh-ancestor
24500580|NCT00525096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24828093|NCT02143362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24828094|NCT02143362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24680411|NCT01374698|Aspirin|aspirin|mesh-list
24828095|NCT02143362|Anesthetics, General|anesthetics, general|mesh-ancestor
24828096|NCT02143362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24828097|NCT02143362|Narcotics|narcotics|mesh-ancestor
24500581|NCT00525096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500582|NCT00525096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25841351|NCT00030004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500600|NCT00525200|Mitosis Modulators|mitosis modulators|mesh-ancestor
24500601|NCT00525200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500603|NCT00525200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24500604|NCT00525200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24500606|NCT00525200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841352|NCT00030030|Silymarin|silymarin|mesh-list
24810395|NCT02039960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810396|NCT02039960|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24671164|NCT01324089|Resveratrol|resveratrol|mesh-list
24477176|NCT00417716|Bevacizumab|bevacizumab|mesh-list
24765900|NCT01791296|Analgesics|analgesics|mesh-ancestor
25841353|NCT00030030|Antioxidants|antioxidants|mesh-ancestor
25841354|NCT00030030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841355|NCT00030030|Protective Agents|protective agents|mesh-ancestor
25841356|NCT00030030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841357|NCT00030056|Molgramostim|molgramostim|mesh-list
25841358|NCT00030056|Sargramostim|sargramostim|mesh-list
25841359|NCT00030056|Immunologic Factors|immunologic factors|mesh-ancestor
25841360|NCT00030056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841361|NCT00030056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841362|NCT00030069|Calcitriol|calcitriol|mesh-list
25841363|NCT00030069|Dexamethasone|dexamethasone|mesh-list
24500672|NCT00525447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24500673|NCT00525447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24500674|NCT00525447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24500675|NCT00525447|Immunologic Factors|immunologic factors|mesh-ancestor
24500676|NCT00525447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24500677|NCT00525447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24500678|NCT00525447|Growth Substances|growth substances|mesh-ancestor
24500679|NCT00525447|Growth Inhibitors|growth inhibitors|mesh-ancestor
24500680|NCT00525447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24810397|NCT02039960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24810398|NCT02039960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605692|NCT00986778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24500692|NCT00525486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24500693|NCT00525486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500694|NCT00525486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24500695|NCT00525486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500696|NCT00525486|Vasodilator Agents|vasodilator agents|mesh-ancestor
24500697|NCT00525486|Tocolytic Agents|tocolytic agents|mesh-ancestor
24500698|NCT00525486|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24500699|NCT00525551|Acetylcysteine|acetylcysteine|mesh-list
24500700|NCT00525551|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25841364|NCT00030069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25841365|NCT00030069|Antiemetics|antiemetics|mesh-ancestor
24500701|NCT00525551|Antiviral Agents|antiviral agents|mesh-ancestor
24500702|NCT00525551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24500703|NCT00525551|Expectorants|expectorants|mesh-ancestor
24766036|NCT01792037|Antiemetics|antiemetics|mesh-ancestor
24500704|NCT00525551|Respiratory System Agents|respiratory system agents|mesh-ancestor
24500705|NCT00525551|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25841366|NCT00030069|Autonomic Agents|autonomic agents|mesh-ancestor
25841367|NCT00030069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25164188|NCT05420350|Lamotrigine|lamotrigine|mesh-list
25164190|NCT05420350|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25164191|NCT05420350|Antidepressive Agents|antidepressive agents|mesh-ancestor
25164192|NCT05420350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25164193|NCT05420350|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25164194|NCT05420350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25164195|NCT05420350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25164196|NCT05420350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841368|NCT00030069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500707|NCT00525551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500708|NCT00525551|Protective Agents|protective agents|mesh-ancestor
24500709|NCT00525551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500710|NCT00525551|Antidotes|antidotes|mesh-ancestor
24500711|NCT00525564|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24500712|NCT00525564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24500713|NCT00525564|Autonomic Agents|autonomic agents|mesh-ancestor
24500714|NCT00525564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24500715|NCT00525564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605699|NCT00986778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24605701|NCT00986804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24605702|NCT00986804|Antimetabolites|antimetabolites|mesh-ancestor
24605703|NCT00986804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605704|NCT00986804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605705|NCT00986804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841369|NCT00030069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25841370|NCT00030069|Glucocorticoids|glucocorticoids|mesh-ancestor
25841371|NCT00030069|Hormones|hormones|mesh-ancestor
25841372|NCT00030069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25841373|NCT00030069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25841374|NCT00030069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841375|NCT00030069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25841376|NCT00030069|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25841377|NCT00030069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25841378|NCT00030069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605708|NCT00986817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24605710|NCT00986843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24605711|NCT00986843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24605712|NCT00986843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605713|NCT00986843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841379|NCT00030069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25841380|NCT00030069|Vitamins|vitamins|mesh-ancestor
25841381|NCT00030069|Micronutrients|micronutrients|mesh-ancestor
24535574|NCT00649376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24500852|NCT00525967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24500869|NCT00525993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500871|NCT00526006|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24500872|NCT00526006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24500873|NCT00526006|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24500874|NCT00526006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24500875|NCT00526006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500877|NCT00526175|Prednisone|prednisone|mesh-list
24500878|NCT00526175|Cyclophosphamide|cyclophosphamide|mesh-list
24500902|NCT00526175|Antimetabolites|antimetabolites|mesh-ancestor
25841382|NCT00030069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24535582|NCT00649402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605714|NCT00986843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623032|NCT01069822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24623033|NCT01069822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623034|NCT01069822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24623035|NCT01069822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24623036|NCT01069822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24623037|NCT01069822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24623038|NCT01069822|Anesthetics, General|anesthetics, general|mesh-ancestor
24500920|NCT00526214|Sensory System Agents|sensory system agents|mesh-ancestor
24500922|NCT00526214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500923|NCT00526214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24500924|NCT00526214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24500925|NCT00526214|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24500926|NCT00526214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24500927|NCT00526214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24500928|NCT00526214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500929|NCT00526305|Cytarabine|cytarabine|mesh-list
24500930|NCT00526305|Dexamethasone|dexamethasone|mesh-list
24500931|NCT00526305|Prednisone|prednisone|mesh-list
24500932|NCT00526305|Hydrocortisone|hydrocortisone|mesh-list
24500933|NCT00526305|Cyclophosphamide|cyclophosphamide|mesh-list
24500934|NCT00526305|Vincristine|vincristine|mesh-list
24500951|NCT00526305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24500952|NCT00526305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24500953|NCT00526305|Glucocorticoids|glucocorticoids|mesh-ancestor
24500955|NCT00526305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24500956|NCT00526305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24500957|NCT00526305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24623040|NCT01069822|GABA Modulators|gaba modulators|mesh-ancestor
24500970|NCT00526305|Sensory System Agents|sensory system agents|mesh-ancestor
24500971|NCT00526305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24500972|NCT00526318|Cyclophosphamide|cyclophosphamide|mesh-list
24500973|NCT00526318|Melphalan|melphalan|mesh-list
24500974|NCT00526318|Ifosfamide|ifosfamide|mesh-list
24500975|NCT00526318|Dacarbazine|dacarbazine|mesh-list
24500976|NCT00526318|Carboplatin|carboplatin|mesh-list
24500988|NCT00526318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500989|NCT00526318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24500994|NCT00526318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24500995|NCT00526318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24623043|NCT01069822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623045|NCT01069874|Cholecalciferol|cholecalciferol|mesh-list
24501015|NCT00526396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24501016|NCT00526396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501032|NCT00526409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501033|NCT00526409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24501034|NCT00526409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24828098|NCT02143362|Analgesics|analgesics|mesh-ancestor
24501035|NCT00526409|Abortifacient Agents|abortifacient agents|mesh-ancestor
24501036|NCT00526409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24501037|NCT00526409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24501038|NCT00526409|Antimetabolites|antimetabolites|mesh-ancestor
24501039|NCT00526409|Dermatologic Agents|dermatologic agents|mesh-ancestor
24501040|NCT00526409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501041|NCT00526409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24501042|NCT00526409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24501043|NCT00526409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24501044|NCT00526409|Tubulin Modulators|tubulin modulators|mesh-ancestor
24501045|NCT00526409|Antimitotic Agents|antimitotic agents|mesh-ancestor
24501056|NCT00526409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24501057|NCT00526448|Ribavirin|ribavirin|mesh-list
24501058|NCT00526448|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24501059|NCT00526448|Antimetabolites|antimetabolites|mesh-ancestor
24501060|NCT00526448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501078|NCT00526643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501079|NCT00526643|Antiviral Agents|antiviral agents|mesh-ancestor
24501080|NCT00526643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24501081|NCT00526643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501082|NCT00526643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24501083|NCT00526643|Immunologic Factors|immunologic factors|mesh-ancestor
24501084|NCT00526643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501800|NCT00531128|Antimetabolites|antimetabolites|mesh-ancestor
24501088|NCT00526695|Anesthetics, General|anesthetics, general|mesh-ancestor
24501089|NCT00526695|Anesthetics|anesthetics|mesh-ancestor
24501090|NCT00526695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24501091|NCT00526695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501093|NCT00526734|Immunologic Factors|immunologic factors|mesh-ancestor
24501094|NCT00526734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501095|NCT00526734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24501096|NCT00526734|Alkylating Agents|alkylating agents|mesh-ancestor
24501097|NCT00526734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501098|NCT00526734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501099|NCT00526734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24501100|NCT00526734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25841383|NCT00030082|Melphalan|melphalan|mesh-list
25841384|NCT00030082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25841385|NCT00030082|Alkylating Agents|alkylating agents|mesh-ancestor
25841386|NCT00030082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501101|NCT00526760|Dexmedetomidine|dexmedetomidine|mesh-list
24501102|NCT00526760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24501103|NCT00526760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24501104|NCT00526760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623050|NCT01069874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24623051|NCT01069913|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25164197|NCT05420350|Dopamine Agents|dopamine agents|mesh-ancestor
25164198|NCT05420350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24828099|NCT02143362|Sensory System Agents|sensory system agents|mesh-ancestor
24828100|NCT02143362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24828101|NCT02143362|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24828103|NCT02143362|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24828104|NCT02143362|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24828105|NCT02143362|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24828106|NCT02143362|Cholinergic Agents|cholinergic agents|mesh-ancestor
24828107|NCT02143362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24828108|NCT02143362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828109|NCT02143440|Insulin|insulin|mesh-list
24828110|NCT02143440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24828111|NCT02143440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828112|NCT02143479|Tacrolimus|tacrolimus|mesh-list
24828113|NCT02143479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24828256|NCT02144415|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24828257|NCT02144415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828258|NCT02144415|Sympathomimetics|sympathomimetics|mesh-ancestor
24828259|NCT02144415|Autonomic Agents|autonomic agents|mesh-ancestor
24828260|NCT02144415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24828261|NCT02144415|Dopamine Agents|dopamine agents|mesh-ancestor
24828262|NCT02144415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24828263|NCT02144415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828264|NCT02144415|Adrenergic Agents|adrenergic agents|mesh-ancestor
24828265|NCT02144415|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24501119|NCT00526877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501121|NCT00526877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24501122|NCT00526877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24501123|NCT00526877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24501124|NCT00526877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24501125|NCT00526877|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24501126|NCT00526877|Dopamine Agents|dopamine agents|mesh-ancestor
24501127|NCT00526929|Darbepoetin alfa|darbepoetin alfa|mesh-list
24501128|NCT00526929|Hematinics|hematinics|mesh-ancestor
24501129|NCT00527020|Nicotine|nicotine|mesh-list
24501130|NCT00527020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24501131|NCT00527020|Autonomic Agents|autonomic agents|mesh-ancestor
24501132|NCT00527020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24501133|NCT00527020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501134|NCT00527020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24501135|NCT00527020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24501136|NCT00527020|Cholinergic Agents|cholinergic agents|mesh-ancestor
24501137|NCT00527020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24501138|NCT00527020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164199|NCT05420350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164200|NCT05420350|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25164201|NCT05420350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25164202|NCT05420350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25164203|NCT05420350|Anticonvulsants|anticonvulsants|mesh-ancestor
25164204|NCT05420350|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24501338|NCT00528151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164209|NCT05420350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25164210|NCT05420220|Axitinib|axitinib|mesh-list
25164211|NCT05420220|Antibodies|antibodies|mesh-list
25164212|NCT05420220|Immunologic Factors|immunologic factors|mesh-ancestor
25660415|NCT01621178|Dulaglutide|dulaglutide|mesh-list
25660416|NCT01621178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25660417|NCT01621178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660418|NCT01621191|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25660419|NCT01621191|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25660420|NCT01621191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25660421|NCT01621191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25164213|NCT05420220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164214|NCT05420220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25164215|NCT05420220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25164216|NCT05420220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25164217|NCT05420220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164218|NCT05419830|Antihypertensive Agents|antihypertensive agents|mesh-list
25164219|NCT05419583|Aspirin|aspirin|mesh-list
25164220|NCT05419583|Warfarin|warfarin|mesh-list
25164221|NCT05419583|Apixaban|apixaban|mesh-list
25164222|NCT05419583|Edoxaban|edoxaban|mesh-list
25164223|NCT05419583|Anticoagulants|anticoagulants|mesh-list
25164224|NCT05419583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25164225|NCT05419583|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
24501158|NCT00527059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24623056|NCT01069965|BGP 15|bgp 15|mesh-list
24623057|NCT01069965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859017|NCT02301091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24501159|NCT00527059|Adrenergic Agents|adrenergic agents|mesh-ancestor
24501160|NCT00527059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24766698|NCT01796132|Antidepressive Agents|antidepressive agents|mesh-ancestor
24501161|NCT00527059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501162|NCT00527059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24501163|NCT00527059|Vasodilator Agents|vasodilator agents|mesh-ancestor
24501164|NCT00527059|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24501165|NCT00527059|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24501166|NCT00527059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501167|NCT00527059|Protective Agents|protective agents|mesh-ancestor
24501168|NCT00527085|Cinacalcet|cinacalcet|mesh-list
24501169|NCT00527085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24501170|NCT00527085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501180|NCT00527150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24501181|NCT00527150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501182|NCT00527150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501183|NCT00527202|Botulinum Toxins|botulinum toxins|mesh-list
24501184|NCT00527202|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24501185|NCT00527202|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24501186|NCT00527202|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24501187|NCT00527202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24535747|NCT00649649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623058|NCT01069965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501242|NCT00527657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501243|NCT00527657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501244|NCT00527657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24501245|NCT00527657|Immunologic Factors|immunologic factors|mesh-ancestor
24501246|NCT00527657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501247|NCT00527657|Leprostatic Agents|leprostatic agents|mesh-ancestor
24501248|NCT00527657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24501249|NCT00527657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24501250|NCT00527657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24501251|NCT00527657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24766822|NCT01796951|Aspirin|aspirin|mesh-list
24501252|NCT00527657|Growth Substances|growth substances|mesh-ancestor
24501253|NCT00527657|Growth Inhibitors|growth inhibitors|mesh-ancestor
24501254|NCT00527683|Vigabatrin|vigabatrin|mesh-list
24501255|NCT00527683|Anticonvulsants|anticonvulsants|mesh-ancestor
24501256|NCT00527683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501257|NCT00527683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841387|NCT00030082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841388|NCT00030082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24605262|NCT00984347|Oxytocin|oxytocin|mesh-list
24501335|NCT00528151|Analgesics|analgesics|mesh-ancestor
24501336|NCT00528151|Sensory System Agents|sensory system agents|mesh-ancestor
24501337|NCT00528151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25841389|NCT00030082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25841390|NCT00030082|Immunologic Factors|immunologic factors|mesh-ancestor
25841391|NCT00030082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841392|NCT00030095|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
25841393|NCT00030095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841394|NCT00030095|Tubulin Modulators|tubulin modulators|mesh-ancestor
25841395|NCT00030095|Antimitotic Agents|antimitotic agents|mesh-ancestor
25841396|NCT00030095|Mitosis Modulators|mitosis modulators|mesh-ancestor
25841397|NCT00030095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841398|NCT00030121|Cardiodilatin|cardiodilatin|mesh-list
25841399|NCT00030121|Vasodilator Agents|vasodilator agents|mesh-ancestor
25415529|NCT03004287|Hormones|hormones|mesh-ancestor
24895852|NCT02960763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841400|NCT00030173|Epothilones|epothilones|mesh-list
25841401|NCT00030173|Desoxyepothilone B|desoxyepothilone b|mesh-list
25841402|NCT00030173|Tubulin Modulators|tubulin modulators|mesh-ancestor
25841403|NCT00030173|Antimitotic Agents|antimitotic agents|mesh-ancestor
25841404|NCT00030173|Mitosis Modulators|mitosis modulators|mesh-ancestor
25841405|NCT00030173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841406|NCT00030173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841407|NCT00030238|Calcium|calcium|mesh-list
25841408|NCT00030238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25841409|NCT00030238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841410|NCT00030342|Interferons|interferons|mesh-list
25841411|NCT00030342|Interferon-alpha|interferon-alpha|mesh-list
25841412|NCT00030342|Fluorouracil|fluorouracil|mesh-list
25841413|NCT00030342|Sargramostim|sargramostim|mesh-list
25841414|NCT00030342|Antimetabolites|antimetabolites|mesh-ancestor
25841415|NCT00030342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841416|NCT00030342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24479253|NCT00426101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24501348|NCT00528177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24501349|NCT00528177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501351|NCT00528177|Sensory System Agents|sensory system agents|mesh-ancestor
24501352|NCT00528177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24501353|NCT00528216|Capsaicin|capsaicin|mesh-list
24501354|NCT00528216|Antipruritics|antipruritics|mesh-ancestor
24501355|NCT00528216|Dermatologic Agents|dermatologic agents|mesh-ancestor
24501356|NCT00528216|Sensory System Agents|sensory system agents|mesh-ancestor
24501357|NCT00528216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24501358|NCT00528216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501359|NCT00528255|Misoprostol|misoprostol|mesh-list
24501360|NCT00528255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24501361|NCT00528255|Abortifacient Agents|abortifacient agents|mesh-ancestor
24501362|NCT00528255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24501363|NCT00528255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501364|NCT00528255|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24501365|NCT00528255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25841417|NCT00030342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841418|NCT00030342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25841419|NCT00030342|Immunologic Factors|immunologic factors|mesh-ancestor
25841420|NCT00030342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841421|NCT00030342|Antiviral Agents|antiviral agents|mesh-ancestor
25841422|NCT00030342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25841423|NCT00030355|Homoharringtonine|homoharringtonine|mesh-list
24535803|NCT00649727|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24501366|NCT00528255|Oxytocics|oxytocics|mesh-ancestor
24501368|NCT00528281|Lapatinib|lapatinib|mesh-list
24501369|NCT00528281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501370|NCT00528281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501371|NCT00528281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501372|NCT00528281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24501373|NCT00528281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24501374|NCT00528281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24501376|NCT00528359|Risperidone|risperidone|mesh-list
24501377|NCT00528359|Aripiprazole|aripiprazole|mesh-list
24810412|NCT02040064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501380|NCT00528359|Serotonin Agents|serotonin agents|mesh-ancestor
24501381|NCT00528359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24501382|NCT00528359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501457|NCT00528658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24501458|NCT00528658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24501459|NCT00528658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501553|NCT00529425|Sensory System Agents|sensory system agents|mesh-ancestor
24501645|NCT00530361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501648|NCT00530387|Ketoprofen|ketoprofen|mesh-list
24501649|NCT00530387|Piroxicam|piroxicam|mesh-list
24501650|NCT00530387|Salicylates|salicylates|mesh-list
24501651|NCT00530387|Etofenamate|etofenamate|mesh-list
25660422|NCT01621191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660423|NCT01621191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25660424|NCT01621191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660425|NCT01621191|Analgesics|analgesics|mesh-ancestor
25660426|NCT01621191|Sensory System Agents|sensory system agents|mesh-ancestor
25660427|NCT01621191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25660428|NCT01621191|Antidepressive Agents|antidepressive agents|mesh-ancestor
25660429|NCT01621191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24895906|NCT02871297|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24501652|NCT00530387|Sunscreening Agents|sunscreening agents|mesh-list
24501653|NCT00530387|Homosalate|homosalate|mesh-list
24501654|NCT00530387|Octylmethoxycinnamate|octylmethoxycinnamate|mesh-list
24501655|NCT00530387|Benzophenone|benzophenone|mesh-list
24810422|NCT02040220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24810423|NCT02040220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24810424|NCT02040220|Growth Substances|growth substances|mesh-ancestor
24810425|NCT02040220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810426|NCT02040220|Growth Inhibitors|growth inhibitors|mesh-ancestor
24810427|NCT02040220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810428|NCT02040246|Metformin|metformin|mesh-list
24810429|NCT02040246|Repaglinide|repaglinide|mesh-list
24501662|NCT00530387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24501663|NCT00530387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25841424|NCT00030355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24501665|NCT00530387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501666|NCT00530387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501667|NCT00530387|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24501668|NCT00530387|Protective Agents|protective agents|mesh-ancestor
24501669|NCT00530387|Dermatologic Agents|dermatologic agents|mesh-ancestor
24501670|NCT00530387|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24501671|NCT00530400|Cefuroxime|cefuroxime|mesh-list
24501672|NCT00530400|Cefuroxime axetil|cefuroxime axetil|mesh-list
24501673|NCT00530400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24501681|NCT00530413|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24501796|NCT00531115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24501798|NCT00531128|Gamma-sitosterol|gamma-sitosterol|mesh-list
24501799|NCT00531128|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24501806|NCT00531167|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24501807|NCT00531167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24810430|NCT02040246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24810431|NCT02040246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810432|NCT02040285|Metoclopramide|metoclopramide|mesh-list
24810433|NCT02040285|Bisacodyl|bisacodyl|mesh-list
25841425|NCT00030355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501809|NCT00531167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841426|NCT00030355|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25841427|NCT00030355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841428|NCT00030355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841429|NCT00030368|Paclitaxel|paclitaxel|mesh-list
25841430|NCT00030368|Bortezomib|bortezomib|mesh-list
24501919|NCT00531596|Selegiline|selegiline|mesh-list
24501920|NCT00531596|Antidepressive Agents|antidepressive agents|mesh-ancestor
24501921|NCT00531596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24501922|NCT00531596|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24501923|NCT00531596|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24501924|NCT00531596|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24501925|NCT00531596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501926|NCT00531596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501927|NCT00531596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25875674|NCT04232553|Analgesics|analgesics|mesh-ancestor
24828267|NCT02144415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24828268|NCT02144415|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24828269|NCT02144441|Insulin Glargine|insulin glargine|mesh-list
24828270|NCT02144441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24828271|NCT02144441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828272|NCT02144623|Valproic Acid|valproic acid|mesh-list
25164226|NCT05419583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25164227|NCT05419583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25164228|NCT05419583|Analgesics|analgesics|mesh-ancestor
25164229|NCT05419583|Sensory System Agents|sensory system agents|mesh-ancestor
25164230|NCT05419583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25164231|NCT05419583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164232|NCT05419583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25164233|NCT05419583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25164234|NCT05419583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25164235|NCT05419583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25164236|NCT05419583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164237|NCT05419583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25164238|NCT05419583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25164239|NCT05419583|Antipyretics|antipyretics|mesh-ancestor
25164240|NCT05419583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25164241|NCT05419583|Antithrombins|antithrombins|mesh-ancestor
25415605|NCT03000387|Autonomic Agents|autonomic agents|mesh-ancestor
25660430|NCT01621191|Dopamine Agents|dopamine agents|mesh-ancestor
25841431|NCT00030368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24515392|NCT00596596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660431|NCT01621230|Fentanyl|fentanyl|mesh-list
25164242|NCT05419583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25164243|NCT05419583|Protease Inhibitors|protease inhibitors|mesh-ancestor
25164244|NCT05419583|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25164245|NCT05419583|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25164246|NCT05419583|Antimetabolites|antimetabolites|mesh-ancestor
25164247|NCT05419583|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25164277|NCT05414487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767256|NCT01799486|Telbivudine|telbivudine|mesh-list
24501973|NCT00531856|Gasotransmitters|gasotransmitters|mesh-ancestor
24501974|NCT00531856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24501975|NCT00531856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501976|NCT00531895|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24502045|NCT05319912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24502046|NCT05319912|Nootropic Agents|nootropic agents|mesh-ancestor
24810435|NCT02040285|Autonomic Agents|autonomic agents|mesh-ancestor
24810436|NCT02040285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24810437|NCT02040285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810438|NCT02040285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24810439|NCT02040285|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24810440|NCT02040285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25841432|NCT00030368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841433|NCT00030368|Tubulin Modulators|tubulin modulators|mesh-ancestor
25841434|NCT00030368|Antimitotic Agents|antimitotic agents|mesh-ancestor
25841435|NCT00030368|Mitosis Modulators|mitosis modulators|mesh-ancestor
25841436|NCT00030368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841437|NCT00030381|Esorubicin|esorubicin|mesh-list
25841438|NCT00030381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25841439|NCT00030381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841440|NCT00030394|Imatinib Mesylate|imatinib mesylate|mesh-list
25841441|NCT00030394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841442|NCT00030394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24767445|NCT01800799|Celecoxib|celecoxib|mesh-list
25841443|NCT00030394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841444|NCT00030394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841445|NCT00030407|Celecoxib|celecoxib|mesh-list
24502049|NCT05319912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24502099|NCT05319756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502101|NCT05319756|Sensory System Agents|sensory system agents|mesh-ancestor
24502102|NCT05319756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24502103|NCT05319756|Anticonvulsants|anticonvulsants|mesh-ancestor
24502104|NCT05319756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24502105|NCT05319756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24502106|NCT05319756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24502107|NCT05319756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24502108|NCT05319756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24502109|NCT05319756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24502110|NCT05319756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502111|NCT05319756|Antimanic Agents|antimanic agents|mesh-ancestor
24502112|NCT05319639|Leucovorin|leucovorin|mesh-list
24502113|NCT05319639|Paclitaxel|paclitaxel|mesh-list
24502114|NCT05319639|Fluorouracil|fluorouracil|mesh-list
24502115|NCT05319639|Oxaliplatin|oxaliplatin|mesh-list
24443500|NCT00295282|Antibodies|antibodies|mesh-list
24502127|NCT05319639|Immunologic Factors|immunologic factors|mesh-ancestor
24502128|NCT05319639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660432|NCT01621230|Bupivacaine|bupivacaine|mesh-list
25660433|NCT01621230|Anesthetics, Local|anesthetics, local|mesh-ancestor
24535856|NCT00649844|Ziprasidone|ziprasidone|mesh-list
24535857|NCT00649844|Clozapine|clozapine|mesh-list
24535858|NCT00649844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25660434|NCT01621230|Anesthetics|anesthetics|mesh-ancestor
25660435|NCT01621230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25660436|NCT01621230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660437|NCT01621230|Sensory System Agents|sensory system agents|mesh-ancestor
25660438|NCT01621230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25660439|NCT01621230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25660440|NCT01621230|Narcotics|narcotics|mesh-ancestor
25660441|NCT01621230|Analgesics|analgesics|mesh-ancestor
25660442|NCT01621230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25660443|NCT01621230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25660444|NCT01621230|Anesthetics, General|anesthetics, general|mesh-ancestor
25660445|NCT01621477|Cytarabine|cytarabine|mesh-list
25660446|NCT01621477|Plerixafor|plerixafor|mesh-list
25660447|NCT01621477|Mycophenolic Acid|mycophenolic acid|mesh-list
25660448|NCT01621477|Cyclophosphamide|cyclophosphamide|mesh-list
24895967|NCT02728531|Cytarabine|cytarabine|mesh-list
25841446|NCT00030407|Docetaxel|docetaxel|mesh-list
25841447|NCT00030407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841448|NCT00030407|Tubulin Modulators|tubulin modulators|mesh-ancestor
25080479|NCT03337932|Doxycycline|doxycycline|mesh-list
25841449|NCT00030407|Antimitotic Agents|antimitotic agents|mesh-ancestor
25841450|NCT00030407|Mitosis Modulators|mitosis modulators|mesh-ancestor
25841451|NCT00030407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841452|NCT00030407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24502142|NCT05319340|Anticoagulants|anticoagulants|mesh-list
24502198|NCT05318248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841453|NCT00030407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24502287|NCT05302388|Diphenhydramine|diphenhydramine|mesh-list
24502288|NCT05302388|Promethazine|promethazine|mesh-list
24502289|NCT05302388|Dexamethasone|dexamethasone|mesh-list
24502290|NCT05302388|Prednisolone|prednisolone|mesh-list
24502291|NCT05302388|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24502292|NCT05302388|Methylprednisolone|methylprednisolone|mesh-list
25841454|NCT00030407|Analgesics|analgesics|mesh-ancestor
24502500|NCT05034536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24502501|NCT05013892|Memantine|memantine|mesh-list
24502502|NCT05013892|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24502523|NCT04988685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24502524|NCT04988685|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24502525|NCT04988685|Antifungal Agents|antifungal agents|mesh-ancestor
24502526|NCT04988685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24502527|NCT04988685|Immunologic Factors|immunologic factors|mesh-ancestor
25164301|NCT05411380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25164302|NCT05411380|Antimetabolites|antimetabolites|mesh-ancestor
25164303|NCT05411380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164304|NCT05411380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25164305|NCT05411380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25164306|NCT05411380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25164307|NCT05411380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25164308|NCT05411380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25164309|NCT05411380|Hormone Antagonists|hormone antagonists|mesh-ancestor
25164310|NCT05411380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25164311|NCT05411380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164312|NCT05411380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25164313|NCT05411380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25164315|NCT05400031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25164316|NCT05395052|Cyclophosphamide|cyclophosphamide|mesh-list
25164317|NCT05395052|Pembrolizumab|pembrolizumab|mesh-list
25164318|NCT05395052|Nivolumab|nivolumab|mesh-list
25164319|NCT05395052|Trastuzumab|trastuzumab|mesh-list
25164320|NCT05395052|Fludarabine|fludarabine|mesh-list
25164321|NCT05395052|Cetuximab|cetuximab|mesh-list
25164322|NCT05395052|Atezolizumab|atezolizumab|mesh-list
25164323|NCT05395052|Interleukin-2|interleukin-2|mesh-list
25164324|NCT05395052|Avelumab|avelumab|mesh-list
25164325|NCT05395052|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
25164326|NCT05395052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25164327|NCT05395052|Immunologic Factors|immunologic factors|mesh-ancestor
25164328|NCT05395052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164329|NCT05395052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25164330|NCT05395052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25164331|NCT05395052|Alkylating Agents|alkylating agents|mesh-ancestor
25164332|NCT05395052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164333|NCT05395052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25164334|NCT05395052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25415960|NCT02980510|Irinotecan|irinotecan|mesh-list
25660449|NCT01621477|Busulfan|busulfan|mesh-list
25660450|NCT01621477|Clofarabine|clofarabine|mesh-list
25660451|NCT01621477|Tacrolimus|tacrolimus|mesh-list
25660452|NCT01621477|Thymoglobulin|thymoglobulin|mesh-list
25660453|NCT01621477|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25660454|NCT01621477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25660455|NCT01621477|Immunologic Factors|immunologic factors|mesh-ancestor
25660456|NCT01621477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660457|NCT01621477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25660458|NCT01621477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25660459|NCT01621477|Alkylating Agents|alkylating agents|mesh-ancestor
25660460|NCT01621477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660461|NCT01621477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25660462|NCT01621477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25660463|NCT01621477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25660464|NCT01621477|Antimetabolites|antimetabolites|mesh-ancestor
25660465|NCT01621477|Antiviral Agents|antiviral agents|mesh-ancestor
24896029|NCT02601313|Immunologic Factors|immunologic factors|mesh-ancestor
24684498|NCT05268068|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24515491|NCT00598013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24515492|NCT00598013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515494|NCT00598052|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24515495|NCT00598052|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24515496|NCT00598052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24515497|NCT00598052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515498|NCT00598052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24473065|NCT00401674|Carboplatin|carboplatin|mesh-list
24473066|NCT00401674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24896036|NCT02601313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25164335|NCT05395052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25164336|NCT05395052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25164337|NCT05395052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25164338|NCT05395052|Analgesics|analgesics|mesh-ancestor
25164339|NCT05395052|Sensory System Agents|sensory system agents|mesh-ancestor
25164340|NCT05395052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25203124|NCT02716272|Ipilimumab|ipilimumab|mesh-list
25203125|NCT02716272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25203126|NCT02716272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767889|NCT01804218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25203127|NCT02716272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25203128|NCT02716272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203129|NCT02716142|Misoprostol|misoprostol|mesh-list
25203130|NCT02716142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25203131|NCT02716142|Abortifacient Agents|abortifacient agents|mesh-ancestor
25203132|NCT02716142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25203133|NCT02716142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207786|NCT03387657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810464|NCT02040402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810466|NCT02040415|Anticonvulsants|anticonvulsants|mesh-ancestor
24502720|NCT04630886|Coagulants|coagulants|mesh-ancestor
24502721|NCT04549168|Lemborexant|lemborexant|mesh-list
24502722|NCT04549168|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
24502723|NCT04549168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24502724|NCT04549168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502725|NCT04549168|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24502726|NCT04549168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24502727|NCT04549168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24502784|NCT04447040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24502785|NCT04447040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24502809|NCT04288323|Edetic Acid|edetic acid|mesh-list
24502810|NCT04288323|Pentetic Acid|pentetic acid|mesh-list
24502811|NCT04288323|Antidotes|antidotes|mesh-ancestor
24502812|NCT04288323|Protective Agents|protective agents|mesh-ancestor
24502813|NCT04288323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502814|NCT04288323|Chelating Agents|chelating agents|mesh-ancestor
24502815|NCT04288323|Sequestering Agents|sequestering agents|mesh-ancestor
24502816|NCT04288323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502817|NCT04288323|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24502818|NCT04288323|Anticoagulants|anticoagulants|mesh-ancestor
24535997|NCT00650169|Clopidogrel|clopidogrel|mesh-list
24502838|NCT04152551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24502839|NCT04152551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502840|NCT04152551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24502841|NCT04152551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660466|NCT01621477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25660467|NCT01621477|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25660468|NCT01621477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25660469|NCT01621477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25660470|NCT01621477|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25660471|NCT01621477|Antitubercular Agents|antitubercular agents|mesh-ancestor
25660472|NCT01621477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25660473|NCT01621477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25660474|NCT01621477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25660475|NCT01621490|Nivolumab|nivolumab|mesh-list
25660476|NCT01621490|Ipilimumab|ipilimumab|mesh-list
25660477|NCT01621490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25660478|NCT01621490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25660479|NCT01621490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25062572|NCT04347122|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25062573|NCT04347122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25062574|NCT04347122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062575|NCT04347122|Hemostatics|hemostatics|mesh-ancestor
25062576|NCT04347122|Coagulants|coagulants|mesh-ancestor
25062577|NCT04341116|Plonmarlimab|plonmarlimab|mesh-list
24431464|NCT00251797|Irinotecan|irinotecan|mesh-list
24826274|NCT02133820|Analgesics|analgesics|mesh-list
24502842|NCT04152551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24502844|NCT04151667|Lenalidomide|lenalidomide|mesh-list
24502845|NCT04151667|Bortezomib|bortezomib|mesh-list
24502846|NCT04151667|Daratumumab|daratumumab|mesh-list
24502847|NCT04151667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24502848|NCT04151667|Antiemetics|antiemetics|mesh-ancestor
24502849|NCT04151667|Autonomic Agents|autonomic agents|mesh-ancestor
24502850|NCT04151667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24502851|NCT04151667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502852|NCT04151667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24502853|NCT04151667|Glucocorticoids|glucocorticoids|mesh-ancestor
24502854|NCT04151667|Hormones|hormones|mesh-ancestor
24480706|NCT00431704|Carboplatin|carboplatin|mesh-list
24502889|NCT04093167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24502890|NCT04067726|Vitamin D|vitamin d|mesh-list
24810473|NCT02040415|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24810475|NCT02040415|Parasympatholytics|parasympatholytics|mesh-ancestor
24810476|NCT02040415|Autonomic Agents|autonomic agents|mesh-ancestor
24810477|NCT02040415|Vasodilator Agents|vasodilator agents|mesh-ancestor
24810478|NCT02040441|Spironolactone|spironolactone|mesh-list
24810479|NCT02040441|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24810480|NCT02040441|Hormone Antagonists|hormone antagonists|mesh-ancestor
24536049|NCT00650234|Metformin|metformin|mesh-list
25841457|NCT00030407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841458|NCT00030407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25841459|NCT00030407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25841460|NCT00030407|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25841461|NCT00030407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25841462|NCT00030407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841463|NCT00030420|Celecoxib|celecoxib|mesh-list
25841464|NCT00030420|Docetaxel|docetaxel|mesh-list
25841465|NCT00030420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841466|NCT00030420|Tubulin Modulators|tubulin modulators|mesh-ancestor
25841467|NCT00030420|Antimitotic Agents|antimitotic agents|mesh-ancestor
25841468|NCT00030420|Mitosis Modulators|mitosis modulators|mesh-ancestor
25841469|NCT00030420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841470|NCT00030420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25841471|NCT00030420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25841472|NCT00030420|Analgesics|analgesics|mesh-ancestor
24503121|NCT03200379|Antiviral Agents|antiviral agents|mesh-list
24503122|NCT03200379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24503127|NCT03160638|Azithromycin|azithromycin|mesh-list
24503128|NCT03160638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24503129|NCT03160638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25164341|NCT05393674|Nivolumab|nivolumab|mesh-list
24828543|NCT02145975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828544|NCT02145975|Analgesics|analgesics|mesh-ancestor
24503131|NCT03153150|Rivaroxaban|rivaroxaban|mesh-list
24810489|NCT02040454|Tubulin Modulators|tubulin modulators|mesh-ancestor
24810490|NCT02040454|Antimitotic Agents|antimitotic agents|mesh-ancestor
24810491|NCT02040454|Mitosis Modulators|mitosis modulators|mesh-ancestor
24810492|NCT02040454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810493|NCT02040571|Insulin|insulin|mesh-list
24503132|NCT03153150|Dabigatran|dabigatran|mesh-list
25660480|NCT01621490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660481|NCT01621633|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25660482|NCT01621633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25660483|NCT01621633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660484|NCT01621672|Lenalidomide|lenalidomide|mesh-list
25660485|NCT01621672|Immunologic Factors|immunologic factors|mesh-ancestor
25660486|NCT01621672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503133|NCT03153150|Apixaban|apixaban|mesh-list
24503134|NCT03153150|Edoxaban|edoxaban|mesh-list
24503135|NCT03153150|Acenocoumarol|acenocoumarol|mesh-list
24503136|NCT03153150|Phenindione|phenindione|mesh-list
24503137|NCT03153150|Anticoagulants|anticoagulants|mesh-ancestor
24503138|NCT03153150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25660487|NCT01621672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24515552|NCT00598169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515553|NCT00598169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201661|NCT02726269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24896095|NCT02382445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24896096|NCT02382445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24503139|NCT03153150|Antithrombins|antithrombins|mesh-ancestor
24503147|NCT03126331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503148|NCT03126331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24503149|NCT03126331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841473|NCT00030420|Sensory System Agents|sensory system agents|mesh-ancestor
24503170|NCT02978391|Adrenergic Agents|adrenergic agents|mesh-ancestor
24503175|NCT02978391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24503176|NCT02978391|Autonomic Agents|autonomic agents|mesh-ancestor
24503182|NCT02978391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24503259|NCT02384850|Vitamin B Complex|vitamin b complex|mesh-ancestor
24503261|NCT02384850|Micronutrients|micronutrients|mesh-ancestor
24503262|NCT02384850|Hematinics|hematinics|mesh-ancestor
24503320|NCT02143830|Thymoglobulin|thymoglobulin|mesh-list
24503321|NCT02143830|Lenograstim|lenograstim|mesh-list
24503332|NCT02042287|Metronidazole|metronidazole|mesh-list
24503333|NCT02042287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24503334|NCT02042287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24503335|NCT02042287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24457212|NCT00333450|Immunologic Factors|immunologic factors|mesh-ancestor
25164342|NCT05393674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25164343|NCT05393674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25164344|NCT05393674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24828545|NCT02145975|Sensory System Agents|sensory system agents|mesh-ancestor
25841474|NCT00030420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25841475|NCT00030420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841476|NCT00030420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25841477|NCT00030420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24828546|NCT02145975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24828547|NCT02145975|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24828548|NCT02145975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24828549|NCT02145975|Anesthetics, General|anesthetics, general|mesh-ancestor
24828550|NCT02145975|Anesthetics|anesthetics|mesh-ancestor
24828551|NCT02146118|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24828552|NCT02146118|Silybin|silybin|mesh-list
24828553|NCT02146118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828554|NCT02146118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24828555|NCT02146118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828556|NCT02146118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828557|NCT02146118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24828558|NCT02146118|Protective Agents|protective agents|mesh-ancestor
24828559|NCT02146118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828560|NCT02146209|Metronidazole|metronidazole|mesh-list
24828561|NCT02146209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24828562|NCT02146209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24722060|NCT01578434|Vitamin D|vitamin d|mesh-list
24447652|NCT00309322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24559724|NCT04448886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447653|NCT00309322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164345|NCT05393674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164346|NCT05393505|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25164347|NCT05393505|Amoxicillin|amoxicillin|mesh-list
25164348|NCT05393505|Levofloxacin|levofloxacin|mesh-list
25164349|NCT05393505|Ofloxacin|ofloxacin|mesh-list
25164350|NCT05393505|Meropenem|meropenem|mesh-list
25164351|NCT05393505|Clavulanic Acid|clavulanic acid|mesh-list
25164352|NCT05393505|Clavulanic Acids|clavulanic acids|mesh-list
25164353|NCT05393505|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25164354|NCT05393505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25164355|NCT05393505|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25164356|NCT05393505|Renal Agents|renal agents|mesh-ancestor
25164357|NCT05393505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25660488|NCT01621672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25660489|NCT01621672|Growth Substances|growth substances|mesh-ancestor
25660490|NCT01621672|Growth Inhibitors|growth inhibitors|mesh-ancestor
25660491|NCT01621672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25660492|NCT01621776|Insulin|insulin|mesh-list
25660493|NCT01621776|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25660494|NCT01621776|Insulin Aspart|insulin aspart|mesh-list
25660495|NCT01621776|Insulin Lispro|insulin lispro|mesh-list
25841478|NCT00030420|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25841479|NCT00030420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25841480|NCT00030420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841481|NCT00030433|Gemcitabine|gemcitabine|mesh-list
25841482|NCT00030433|Irinotecan|irinotecan|mesh-list
25062592|NCT04311489|Ularitide|ularitide|mesh-list
25062593|NCT04311489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25062594|NCT04311489|Autonomic Agents|autonomic agents|mesh-ancestor
24684969|NCT03121534|Hormones|hormones|mesh-ancestor
25841483|NCT00030433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25841484|NCT00030433|Antimetabolites|antimetabolites|mesh-ancestor
25841485|NCT00030433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841486|NCT00030433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841487|NCT00030433|Antiviral Agents|antiviral agents|mesh-ancestor
25164358|NCT05393505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25164359|NCT05393505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25164360|NCT05393505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164361|NCT05393505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25164362|NCT05393505|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25164371|NCT05392699|Growth Substances|growth substances|mesh-ancestor
25164372|NCT05392699|Growth Inhibitors|growth inhibitors|mesh-ancestor
25164373|NCT05392699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25164374|NCT05388656|Estradiol|estradiol|mesh-list
25164375|NCT05388656|Progesterone|progesterone|mesh-list
25164376|NCT05388656|Estrogens|estrogens|mesh-ancestor
25164377|NCT05388656|Hormones|hormones|mesh-ancestor
25164378|NCT05388656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25164379|NCT05388656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164380|NCT05388656|Progestins|progestins|mesh-ancestor
25164381|NCT05387408|Analgesics, Opioid|analgesics, opioid|mesh-list
25164382|NCT05387408|Narcotics|narcotics|mesh-ancestor
25164383|NCT05387408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25164384|NCT05387408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164385|NCT05387408|Analgesics|analgesics|mesh-ancestor
25164386|NCT05387408|Sensory System Agents|sensory system agents|mesh-ancestor
25164387|NCT05387408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25164388|NCT05386576|Venetoclax|venetoclax|mesh-list
24503375|NCT01655225|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24503376|NCT01655225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24503406|NCT01582776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25841488|NCT00030433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24768899|NCT01811160|Protective Agents|protective agents|mesh-ancestor
25841489|NCT00030433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841490|NCT00030433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25841491|NCT00030433|Immunologic Factors|immunologic factors|mesh-ancestor
25841492|NCT00030433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841493|NCT00030433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24810561|NCT02040818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503511|NCT00532142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24503512|NCT00532142|Glucocorticoids|glucocorticoids|mesh-ancestor
24503514|NCT00532142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24503526|NCT00532168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503563|NCT00532272|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24503564|NCT00532272|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24503565|NCT00532272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503566|NCT00532272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503567|NCT00532272|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24503568|NCT00532272|Hormone Antagonists|hormone antagonists|mesh-ancestor
24503569|NCT00532272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24503570|NCT00532272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503571|NCT00532272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24503573|NCT00532285|Paclitaxel|paclitaxel|mesh-list
24503574|NCT00532285|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24503575|NCT00532285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24810568|NCT02040831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810570|NCT02040883|Risperidone|risperidone|mesh-list
25660496|NCT01621776|Insulin glulisine|insulin glulisine|mesh-list
25660497|NCT01621776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25660498|NCT01621776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660499|NCT01621880|Methylprednisolone|methylprednisolone|mesh-list
25660500|NCT01621880|Bevacizumab|bevacizumab|mesh-list
25660501|NCT01621880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25660502|NCT01621880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25660503|NCT01621880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24810571|NCT02040883|Aripiprazole|aripiprazole|mesh-list
24810572|NCT02040883|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24810573|NCT02040883|Ziprasidone|ziprasidone|mesh-list
24503602|NCT00532350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503603|NCT00532350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24503604|NCT00532350|Respiratory System Agents|respiratory system agents|mesh-ancestor
24503606|NCT00532350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24503607|NCT00532350|Cholinergic Agents|cholinergic agents|mesh-ancestor
24503608|NCT00532350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24503609|NCT00532350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503610|NCT00532389|Panobinostat|panobinostat|mesh-list
24503611|NCT00532389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503618|NCT00532415|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24503619|NCT00532415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25841494|NCT00030433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25841495|NCT00030446|Carboplatin|carboplatin|mesh-list
25841496|NCT00030446|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25841497|NCT00030446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841498|NCT00030446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25841499|NCT00030446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841500|NCT00030446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841501|NCT00030459|Cisplatin|cisplatin|mesh-list
25841502|NCT00030459|Vinorelbine|vinorelbine|mesh-list
25841503|NCT00030459|Mitomycins|mitomycins|mesh-list
25841504|NCT00030459|Mitomycin|mitomycin|mesh-list
25841505|NCT00030459|Vinblastine|vinblastine|mesh-list
25841506|NCT00030459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503653|NCT00532519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810577|NCT02040883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24810578|NCT02040883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810579|NCT02040883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810580|NCT02040883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24810581|NCT02040883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24810582|NCT02040883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24810583|NCT02040883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24810584|NCT02040883|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24810585|NCT02040883|Dopamine Agents|dopamine agents|mesh-ancestor
24810586|NCT02040883|Antiemetics|antiemetics|mesh-ancestor
24810587|NCT02040883|Autonomic Agents|autonomic agents|mesh-ancestor
25841507|NCT00030459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25841508|NCT00030459|Tubulin Modulators|tubulin modulators|mesh-ancestor
25841509|NCT00030459|Antimitotic Agents|antimitotic agents|mesh-ancestor
25841510|NCT00030459|Mitosis Modulators|mitosis modulators|mesh-ancestor
25841511|NCT00030459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841512|NCT00030459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25841513|NCT00030459|Alkylating Agents|alkylating agents|mesh-ancestor
25841514|NCT00030459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25841515|NCT00030459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841516|NCT00030472|Doxorubicin|doxorubicin|mesh-list
25841517|NCT00030472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25841518|NCT00030472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25841519|NCT00030472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841520|NCT00030472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25841521|NCT00030472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25841522|NCT00030472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841523|NCT00030472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841524|NCT00030485|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25841525|NCT00030485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841526|NCT00030485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24503666|NCT00532571|Coenzyme Q10|coenzyme q10|mesh-list
24503667|NCT00532571|Vitamins|vitamins|mesh-ancestor
24503668|NCT00532571|Micronutrients|micronutrients|mesh-ancestor
24503669|NCT00532571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503670|NCT00532584|Beclomethasone|beclomethasone|mesh-list
24503678|NCT00532623|Gemcitabine|gemcitabine|mesh-list
24503679|NCT00532623|Vinorelbine|vinorelbine|mesh-list
24503680|NCT00532623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24503681|NCT00532623|Antimetabolites|antimetabolites|mesh-ancestor
24503682|NCT00532623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503683|NCT00532623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503684|NCT00532623|Antiviral Agents|antiviral agents|mesh-ancestor
24503685|NCT00532623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24810590|NCT02040883|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25164389|NCT05386576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25164393|NCT05379790|Irinotecan|irinotecan|mesh-list
24769298|NCT01813617|Immunologic Factors|immunologic factors|mesh-ancestor
25841527|NCT00030485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817418|NCT02083575|Micronutrients|micronutrients|mesh-ancestor
25841528|NCT00030485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810591|NCT02040883|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24503687|NCT00532623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24482181|NCT00438113|Sympatholytics|sympatholytics|mesh-ancestor
24810596|NCT02040883|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24689189|NCT02293109|Antimetabolites|antimetabolites|mesh-ancestor
24810597|NCT02040883|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24810598|NCT02040883|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24810600|NCT02040909|Propofol|propofol|mesh-list
24810601|NCT02040909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24606672|NCT00991744|Cytarabine|cytarabine|mesh-list
24503764|NCT00532818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906640|NCT04338620|Paclitaxel|paclitaxel|mesh-list
24503765|NCT00532818|Antimanic Agents|antimanic agents|mesh-ancestor
24503766|NCT00532818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25841529|NCT00030498|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25841530|NCT00030498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841531|NCT00030498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25841532|NCT00030498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841533|NCT00030498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503830|NCT00533026|Sensory System Agents|sensory system agents|mesh-ancestor
24503831|NCT00533026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24503832|NCT00533026|Antidepressive Agents|antidepressive agents|mesh-ancestor
24503833|NCT00533026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24810604|NCT02040909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24810611|NCT02040987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24606736|NCT05408988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606737|NCT05408936|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
24503834|NCT00533026|Dopamine Agents|dopamine agents|mesh-ancestor
24503835|NCT00533039|Varespladib methyl|varespladib methyl|mesh-list
24503848|NCT00533091|Immunologic Factors|immunologic factors|mesh-ancestor
24503853|NCT00533169|Keratolytic Agents|keratolytic agents|mesh-ancestor
24503854|NCT00533169|Dermatologic Agents|dermatologic agents|mesh-ancestor
24503881|NCT00533299|Antimanic Agents|antimanic agents|mesh-ancestor
24503882|NCT00533299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24503883|NCT00533299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24503884|NCT00533299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24503885|NCT00533299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24503886|NCT00533299|Vasodilator Agents|vasodilator agents|mesh-ancestor
24503888|NCT00533312|Niacinamide|niacinamide|mesh-list
24503889|NCT00533312|Nicotinic Acids|nicotinic acids|mesh-list
24503890|NCT00533312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24503891|NCT00533312|Antimetabolites|antimetabolites|mesh-ancestor
24503892|NCT00533312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810612|NCT02040987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24810613|NCT02040987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24810614|NCT02040987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24810615|NCT02040987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503893|NCT00533312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24503894|NCT00533312|Vasodilator Agents|vasodilator agents|mesh-ancestor
24503895|NCT00533312|Vitamin B Complex|vitamin b complex|mesh-ancestor
24503896|NCT00533312|Vitamins|vitamins|mesh-ancestor
24503897|NCT00533312|Micronutrients|micronutrients|mesh-ancestor
24503898|NCT00533312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503899|NCT00533390|Efavirenz|efavirenz|mesh-list
24503920|NCT00533455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24503921|NCT00533455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503922|NCT00533455|Anticonvulsants|anticonvulsants|mesh-ancestor
24503923|NCT00533455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24503924|NCT00533455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24503925|NCT00533455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24769491|NCT01814449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24504009|NCT00533676|Adrenergic Agents|adrenergic agents|mesh-ancestor
24504010|NCT00533676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24504011|NCT00533676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504012|NCT00533676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504013|NCT00533676|Sympathomimetics|sympathomimetics|mesh-ancestor
25660504|NCT01621880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25660505|NCT01621880|Growth Substances|growth substances|mesh-ancestor
25660506|NCT01621880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660507|NCT01621880|Growth Inhibitors|growth inhibitors|mesh-ancestor
25660508|NCT01621880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25660509|NCT01621880|Antiemetics|antiemetics|mesh-ancestor
25660510|NCT01621880|Autonomic Agents|autonomic agents|mesh-ancestor
25660511|NCT01621880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24690024|NCT01398501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25062607|NCT04308304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062608|NCT04308304|Nootropic Agents|nootropic agents|mesh-ancestor
24825156|NCT02127697|Tocolytic Agents|tocolytic agents|mesh-ancestor
24525721|NCT02823574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24896346|NCT04437693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896349|NCT04437654|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24896350|NCT04437654|Antithrombins|antithrombins|mesh-ancestor
24896351|NCT04437654|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24896352|NCT04437654|Protease Inhibitors|protease inhibitors|mesh-ancestor
24896353|NCT04437654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896354|NCT04437654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515666|NCT00598637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515667|NCT00598676|Sirolimus|sirolimus|mesh-list
24515668|NCT00598676|Everolimus|everolimus|mesh-list
24515669|NCT00598676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24515670|NCT00598676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24504014|NCT00533676|Autonomic Agents|autonomic agents|mesh-ancestor
24504015|NCT00533676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24504016|NCT00533676|Nasal Decongestants|nasal decongestants|mesh-ancestor
24504017|NCT00533676|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24504018|NCT00533676|Respiratory System Agents|respiratory system agents|mesh-ancestor
24504019|NCT00533741|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24504020|NCT00533741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24504021|NCT00533741|Immunologic Factors|immunologic factors|mesh-ancestor
24504022|NCT00533741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504024|NCT00533741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504025|NCT00533741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24504026|NCT00533858|Losartan|losartan|mesh-list
24504027|NCT00533858|Lacidipine|lacidipine|mesh-list
24504028|NCT00533858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24504029|NCT00533858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24504030|NCT00533858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24504036|NCT00533858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504037|NCT00533923|Cyclosporine|cyclosporine|mesh-list
24504038|NCT00533923|Cyclophosphamide|cyclophosphamide|mesh-list
24504039|NCT00533923|Fludarabine|fludarabine|mesh-list
24504040|NCT00533923|Alemtuzumab|alemtuzumab|mesh-list
25841534|NCT00030511|Fluorouracil|fluorouracil|mesh-list
25841535|NCT00030511|Antimetabolites|antimetabolites|mesh-ancestor
25841536|NCT00030511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841537|NCT00030511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25841538|NCT00030511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841539|NCT00030511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25841540|NCT00030511|Immunologic Factors|immunologic factors|mesh-ancestor
25841541|NCT00030511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841542|NCT00030524|Gefitinib|gefitinib|mesh-list
25841543|NCT00030524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841544|NCT00030524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25841545|NCT00030524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841546|NCT00030524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841547|NCT00030537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25841548|NCT00030537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841549|NCT00030537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25841550|NCT00030537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841551|NCT00030537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769699|NCT01815255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25841552|NCT00030550|Thalidomide|thalidomide|mesh-list
25660512|NCT01621880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25660513|NCT01621880|Glucocorticoids|glucocorticoids|mesh-ancestor
25660514|NCT01621880|Hormones|hormones|mesh-ancestor
25660515|NCT01621880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25660516|NCT01621880|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25660517|NCT01621880|Protective Agents|protective agents|mesh-ancestor
25660518|NCT01622231|Fluticasone|fluticasone|mesh-list
25660519|NCT01622231|Xhance|xhance|mesh-list
25660520|NCT01622231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25660521|NCT01622231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25660522|NCT01622231|Autonomic Agents|autonomic agents|mesh-ancestor
25660523|NCT01622231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24690647|NCT01403285|Sargramostim|sargramostim|mesh-list
25660524|NCT01622231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660525|NCT01622231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25660526|NCT01622231|Respiratory System Agents|respiratory system agents|mesh-ancestor
25660527|NCT01622231|Dermatologic Agents|dermatologic agents|mesh-ancestor
25660528|NCT01622231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25660529|NCT01622257|Metformin|metformin|mesh-list
24825169|NCT02127736|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25841553|NCT00030550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25841554|NCT00030550|Immunologic Factors|immunologic factors|mesh-ancestor
25841555|NCT00030550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841556|NCT00030550|Leprostatic Agents|leprostatic agents|mesh-ancestor
25841557|NCT00030550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25841558|NCT00030550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25841559|NCT00030550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25841560|NCT00030550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25841561|NCT00030550|Growth Substances|growth substances|mesh-ancestor
25841562|NCT00030550|Growth Inhibitors|growth inhibitors|mesh-ancestor
25841563|NCT00030550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841564|NCT00030563|Irinotecan|irinotecan|mesh-list
25841565|NCT00030563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25164412|NCT05376761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164413|NCT05373901|Tretinoin|tretinoin|mesh-list
25164414|NCT05373901|Dinutuximab|dinutuximab|mesh-list
25164415|NCT05373901|Isotretinoin|isotretinoin|mesh-list
25164416|NCT05373901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25164417|NCT05373901|Keratolytic Agents|keratolytic agents|mesh-ancestor
25164418|NCT05373901|Dermatologic Agents|dermatologic agents|mesh-ancestor
25164429|NCT05368857|Afamelanotide|afamelanotide|mesh-list
25164430|NCT05368857|Dermatologic Agents|dermatologic agents|mesh-ancestor
24504109|NCT00534183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504110|NCT00534183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504111|NCT00534183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24504112|NCT00534183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24504113|NCT00534183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24504114|NCT00534183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24504115|NCT00534183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24504117|NCT00534183|Antiemetics|antiemetics|mesh-ancestor
24504118|NCT00534183|Autonomic Agents|autonomic agents|mesh-ancestor
24810640|NCT02041338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810641|NCT02041338|Tubulin Modulators|tubulin modulators|mesh-ancestor
24810642|NCT02041338|Antimitotic Agents|antimitotic agents|mesh-ancestor
24810643|NCT02041338|Mitosis Modulators|mitosis modulators|mesh-ancestor
24810644|NCT02041338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810645|NCT02041338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24810646|NCT02041338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24607107|NCT05213481|Analgesics|analgesics|mesh-ancestor
25841566|NCT00030563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24504157|NCT00534378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24504158|NCT00534378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24504159|NCT00534378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24504166|NCT00534391|Polymyxins|polymyxins|mesh-list
25841567|NCT00030563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841568|NCT00030563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841569|NCT00030563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841570|NCT00030576|Cisplatin|cisplatin|mesh-list
25841571|NCT00030576|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25841572|NCT00030576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841573|NCT00030576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24504238|NCT00534625|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24504240|NCT00534625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504241|NCT00534625|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24504242|NCT00534625|Hormone Antagonists|hormone antagonists|mesh-ancestor
24504243|NCT00534625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24504244|NCT00534625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504245|NCT00534625|Antisickling Agents|antisickling agents|mesh-ancestor
24504246|NCT00534625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24504247|NCT00534651|Acetaminophen|acetaminophen|mesh-list
24810664|NCT02041455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24810665|NCT02041455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24810666|NCT02041455|Analgesics|analgesics|mesh-ancestor
24769882|NCT01816646|Renal Agents|renal agents|mesh-ancestor
25660530|NCT01622257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25660531|NCT01622257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504322|NCT00535340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504323|NCT00535353|Irinotecan|irinotecan|mesh-list
25660532|NCT01622296|Lidocaine|lidocaine|mesh-list
25660533|NCT01622296|Epinephrine|epinephrine|mesh-list
25660534|NCT01622296|Anesthetics, Local|anesthetics, local|mesh-list
25660535|NCT01622296|Anesthetics|anesthetics|mesh-list
25660536|NCT01622296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25660537|NCT01622296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504324|NCT00535353|Olaparib|olaparib|mesh-list
24504325|NCT00535353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24504326|NCT00535353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24504327|NCT00535353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504328|NCT00535353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810671|NCT02041455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24810672|NCT02041455|Adrenergic Agents|adrenergic agents|mesh-ancestor
24810673|NCT02041455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24810674|NCT02041481|Leucovorin|leucovorin|mesh-list
24810675|NCT02041481|Fluorouracil|fluorouracil|mesh-list
24810676|NCT02041481|Oxaliplatin|oxaliplatin|mesh-list
24810677|NCT02041481|Calcium|calcium|mesh-list
24810678|NCT02041481|Levoleucovorin|levoleucovorin|mesh-list
24504329|NCT00535353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504330|NCT00535353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24504331|NCT00535379|Sunitinib|sunitinib|mesh-list
25841574|NCT00030576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841575|NCT00030576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841576|NCT00030589|Bexarotene|bexarotene|mesh-list
25841577|NCT00030589|Methoxsalen|methoxsalen|mesh-list
25841578|NCT00030589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841579|NCT00030589|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25841580|NCT00030589|Dermatologic Agents|dermatologic agents|mesh-ancestor
25841581|NCT00030602|Freund's Adjuvant|freund's adjuvant|mesh-list
25841582|NCT00030602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25841583|NCT00030602|Immunologic Factors|immunologic factors|mesh-ancestor
24504338|NCT00535379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24504339|NCT00535379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504340|NCT00535379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841584|NCT00030602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841585|NCT00030615|Decitabine|decitabine|mesh-list
25841586|NCT00030615|Azacitidine|azacitidine|mesh-list
25841587|NCT00030615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25841588|NCT00030615|Antimetabolites|antimetabolites|mesh-ancestor
25841589|NCT00030615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841590|NCT00030615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841591|NCT00030615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24810683|NCT02041481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25841592|NCT00030641|Docetaxel|docetaxel|mesh-list
24504353|NCT00535470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504354|NCT00535470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24504355|NCT00535470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504356|NCT00535509|Cisplatin|cisplatin|mesh-list
24504357|NCT00535509|Docetaxel|docetaxel|mesh-list
24504358|NCT00535509|Trastuzumab|trastuzumab|mesh-list
24504359|NCT00535509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504360|NCT00535509|Tubulin Modulators|tubulin modulators|mesh-ancestor
24504361|NCT00535509|Antimitotic Agents|antimitotic agents|mesh-ancestor
24504362|NCT00535509|Mitosis Modulators|mitosis modulators|mesh-ancestor
25841593|NCT00030641|Oblimersen|oblimersen|mesh-list
25841594|NCT00030641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841595|NCT00030641|Tubulin Modulators|tubulin modulators|mesh-ancestor
25841596|NCT00030641|Antimitotic Agents|antimitotic agents|mesh-ancestor
25841597|NCT00030641|Mitosis Modulators|mitosis modulators|mesh-ancestor
25841598|NCT00030641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504380|NCT00535808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24504382|NCT00535808|Anesthetics, General|anesthetics, general|mesh-ancestor
24504383|NCT00535808|Anesthetics|anesthetics|mesh-ancestor
24504384|NCT00535808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24504385|NCT00535808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504386|NCT00535808|Vasodilator Agents|vasodilator agents|mesh-ancestor
24504387|NCT00535808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24504388|NCT00535808|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24810688|NCT02041481|Protective Agents|protective agents|mesh-ancestor
24810689|NCT02041481|Vitamin B Complex|vitamin b complex|mesh-ancestor
25841599|NCT00030654|Ketoconazole|ketoconazole|mesh-list
25841600|NCT00030654|Vinblastine|vinblastine|mesh-list
25841601|NCT00030654|Docetaxel|docetaxel|mesh-list
25841602|NCT00030654|Doxorubicin|doxorubicin|mesh-list
24692142|NCT01411436|Sorafenib|sorafenib|mesh-list
25841603|NCT00030654|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25841604|NCT00030654|Bicalutamide|bicalutamide|mesh-list
25841605|NCT00030654|Flutamide|flutamide|mesh-list
25841606|NCT00030654|Estramustine|estramustine|mesh-list
25841607|NCT00030654|Hormones|hormones|mesh-list
25841608|NCT00030654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25841609|NCT00030654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841610|NCT00030654|Tubulin Modulators|tubulin modulators|mesh-ancestor
25841611|NCT00030654|Antimitotic Agents|antimitotic agents|mesh-ancestor
25841612|NCT00030654|Mitosis Modulators|mitosis modulators|mesh-ancestor
25660538|NCT01622296|Sensory System Agents|sensory system agents|mesh-ancestor
25660539|NCT01622296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25841613|NCT00030654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841614|NCT00030654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25841615|NCT00030654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25841616|NCT00030654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25841617|NCT00030654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504438|NCT00536237|Vasodilator Agents|vasodilator agents|mesh-ancestor
24504439|NCT00536237|Vitamin B Complex|vitamin b complex|mesh-ancestor
24504441|NCT00536237|Micronutrients|micronutrients|mesh-ancestor
24504443|NCT00536276|Ergocalciferols|ergocalciferols|mesh-list
24504444|NCT00536276|Cholecalciferol|cholecalciferol|mesh-list
24504445|NCT00536276|Vitamins|vitamins|mesh-list
24504446|NCT00536276|Micronutrients|micronutrients|mesh-ancestor
24504447|NCT00536276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624259|NCT01075529|Fluoxetine|fluoxetine|mesh-list
24810691|NCT02041481|Micronutrients|micronutrients|mesh-ancestor
24810692|NCT02041546|Pulmonary Surfactants|pulmonary surfactants|mesh-list
24810693|NCT02041546|Poractant alfa|poractant alfa|mesh-list
24771112|NCT01824758|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24810694|NCT02041546|Respiratory System Agents|respiratory system agents|mesh-ancestor
24810695|NCT02041650|Ticagrelor|ticagrelor|mesh-list
24810696|NCT02041650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24810697|NCT02041650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24810698|NCT02041650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24810699|NCT02041650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25841618|NCT00030654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25841619|NCT00030654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841620|NCT00030654|Antifungal Agents|antifungal agents|mesh-ancestor
25841621|NCT00030654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25841622|NCT00030654|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25841623|NCT00030654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25841624|NCT00030654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25841625|NCT00030654|Hormone Antagonists|hormone antagonists|mesh-ancestor
25841626|NCT00030654|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24504473|NCT00536640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24966869|NCT03764527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24966870|NCT03764527|Antiviral Agents|antiviral agents|mesh-ancestor
24784880|NCT01910766|Vitamins|vitamins|mesh-ancestor
24504474|NCT00536640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504475|NCT00536640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24504476|NCT00536640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24504477|NCT00536640|Growth Substances|growth substances|mesh-ancestor
24504490|NCT00536653|Vitamin D|vitamin d|mesh-list
24504491|NCT00536653|Ergocalciferols|ergocalciferols|mesh-list
24504492|NCT00536653|Cholecalciferol|cholecalciferol|mesh-list
24504493|NCT00536653|Vitamins|vitamins|mesh-list
24504494|NCT00536653|Goserelin|goserelin|mesh-list
24504495|NCT00536653|Bicalutamide|bicalutamide|mesh-list
24504496|NCT00536653|Calcium|calcium|mesh-list
24504497|NCT00536653|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24504498|NCT00536653|Micronutrients|micronutrients|mesh-ancestor
24504499|NCT00536653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504500|NCT00536653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24504501|NCT00536653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24504502|NCT00536653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24504503|NCT00536653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504507|NCT00536653|Hormones|hormones|mesh-ancestor
24504508|NCT00536692|Mecamylamine|mecamylamine|mesh-list
24483404|NCT00443235|Alkylating Agents|alkylating agents|mesh-ancestor
24504530|NCT00536770|Gemcitabine|gemcitabine|mesh-list
24504531|NCT00536770|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24504532|NCT00536770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24504533|NCT00536770|Antimetabolites|antimetabolites|mesh-ancestor
24504534|NCT00536770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504535|NCT00536770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504536|NCT00536770|Antiviral Agents|antiviral agents|mesh-ancestor
24504544|NCT00536770|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24504545|NCT00536770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24504546|NCT00536770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25660540|NCT01622296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25660541|NCT01622296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25660542|NCT01622296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25660543|NCT01622296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25660544|NCT01622296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515794|NCT00599287|Antiemetics|antiemetics|mesh-ancestor
24515795|NCT00599287|Autonomic Agents|autonomic agents|mesh-ancestor
24515796|NCT00599287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24515797|NCT00599287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24896466|NCT04435912|Hydrocortisone|hydrocortisone|mesh-list
24896467|NCT04435912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24896468|NCT04435925|Fentanyl|fentanyl|mesh-list
24896469|NCT04435925|Remifentanil|remifentanil|mesh-list
24896470|NCT04435925|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24896471|NCT04435925|Narcotics|narcotics|mesh-ancestor
25841627|NCT00030654|Androgen Antagonists|androgen antagonists|mesh-ancestor
25841628|NCT00030654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25841629|NCT00030654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24828612|NCT02146547|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24828613|NCT02146547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24828614|NCT02146547|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24828615|NCT02146547|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24828617|NCT02146638|Morphine|morphine|mesh-list
24828618|NCT02146638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24828619|NCT02146638|Narcotics|narcotics|mesh-ancestor
24828620|NCT02146638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24828621|NCT02146638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828622|NCT02146638|Analgesics|analgesics|mesh-ancestor
24828623|NCT02146638|Sensory System Agents|sensory system agents|mesh-ancestor
24828624|NCT02146638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24828625|NCT02146638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24828626|NCT02146638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24828627|NCT02146638|Anesthetics, General|anesthetics, general|mesh-ancestor
24447689|NCT00309478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447691|NCT00309478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24447692|NCT00309478|Alkylating Agents|alkylating agents|mesh-ancestor
24504557|NCT00536848|Metronidazole|metronidazole|mesh-list
24504558|NCT00536848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24504559|NCT00536848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24504560|NCT00536848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24504561|NCT00536848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24504562|NCT00536861|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24504563|NCT00536861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504564|NCT00536861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24504565|NCT00536861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504566|NCT00536861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504567|NCT00536887|Atorvastatin|atorvastatin|mesh-list
25841630|NCT00030654|Alkylating Agents|alkylating agents|mesh-ancestor
25841631|NCT00030667|Imatinib Mesylate|imatinib mesylate|mesh-list
25841632|NCT00030667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841633|NCT00030667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25841634|NCT00030667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841635|NCT00030667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841636|NCT00030693|Metronidazole|metronidazole|mesh-list
25841637|NCT00030693|Vaccines|vaccines|mesh-list
25841638|NCT00030693|Immunologic Factors|immunologic factors|mesh-ancestor
25841639|NCT00030693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841640|NCT00030693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25841641|NCT00030693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25841642|NCT00030693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25841643|NCT00030693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25841644|NCT00030719|Cyclophosphamide|cyclophosphamide|mesh-list
25841645|NCT00030719|Melphalan|melphalan|mesh-list
25841646|NCT00030719|Busulfan|busulfan|mesh-list
24504634|NCT00537524|Immunologic Factors|immunologic factors|mesh-ancestor
24504635|NCT00537524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841647|NCT00030719|Carboplatin|carboplatin|mesh-list
24770607|NCT01821274|Diltiazem|diltiazem|mesh-list
24606015|NCT00988663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24606016|NCT00988663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841648|NCT00030719|Etoposide|etoposide|mesh-list
25660545|NCT01622296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25660546|NCT01622296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25660547|NCT01622296|Adrenergic Agents|adrenergic agents|mesh-ancestor
25660548|NCT01622296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25660549|NCT01622296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25660550|NCT01622296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25660551|NCT01622296|Autonomic Agents|autonomic agents|mesh-ancestor
25660552|NCT01622296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25660553|NCT01622296|Respiratory System Agents|respiratory system agents|mesh-ancestor
25660554|NCT01622296|Mydriatics|mydriatics|mesh-ancestor
25841649|NCT00030719|Vincristine|vincristine|mesh-list
25841650|NCT00030719|Dinutuximab|dinutuximab|mesh-list
24515822|NCT00599534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606017|NCT00988663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606018|NCT00988663|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24606019|NCT00988663|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24606021|NCT00988715|Mycophenolic Acid|mycophenolic acid|mesh-list
24606022|NCT00988715|Fludarabine|fludarabine|mesh-list
25841651|NCT00030719|Isotretinoin|isotretinoin|mesh-list
25841652|NCT00030719|Antibodies|antibodies|mesh-list
25841653|NCT00030719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25841654|NCT00030719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25841655|NCT00030719|Immunologic Factors|immunologic factors|mesh-ancestor
25841656|NCT00030719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841657|NCT00030719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25841658|NCT00030719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25841659|NCT00030719|Alkylating Agents|alkylating agents|mesh-ancestor
25841660|NCT00030719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841661|NCT00030719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841662|NCT00030719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24504645|NCT00537550|Daunorubicin|daunorubicin|mesh-list
24504646|NCT00537550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24504647|NCT00537550|Abortifacient Agents|abortifacient agents|mesh-ancestor
24504648|NCT00537550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24504649|NCT00537550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504650|NCT00537550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24504651|NCT00537550|Antimetabolites|antimetabolites|mesh-ancestor
24504652|NCT00537550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504653|NCT00537550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504654|NCT00537550|Dermatologic Agents|dermatologic agents|mesh-ancestor
24504655|NCT00537550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504656|NCT00537550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24504657|NCT00537550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24606024|NCT00988715|Cyclosporins|cyclosporins|mesh-list
24606025|NCT00988715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24606026|NCT00988715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24607767|NCT03735979|Anticoagulants|anticoagulants|mesh-ancestor
24504658|NCT00537550|Immunologic Factors|immunologic factors|mesh-ancestor
25841663|NCT00030719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25841664|NCT00030719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25841665|NCT00030719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25841666|NCT00030719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841667|NCT00030719|Tubulin Modulators|tubulin modulators|mesh-ancestor
24504662|NCT00537550|Tubulin Modulators|tubulin modulators|mesh-ancestor
24504663|NCT00537550|Antimitotic Agents|antimitotic agents|mesh-ancestor
24504664|NCT00537550|Mitosis Modulators|mitosis modulators|mesh-ancestor
24504665|NCT00537550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24504666|NCT00537550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24504667|NCT00537550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25841668|NCT00030719|Antimitotic Agents|antimitotic agents|mesh-ancestor
25841669|NCT00030719|Mitosis Modulators|mitosis modulators|mesh-ancestor
25841670|NCT00030719|Dermatologic Agents|dermatologic agents|mesh-ancestor
25841671|NCT00030732|Gemcitabine|gemcitabine|mesh-list
25841672|NCT00030732|Capecitabine|capecitabine|mesh-list
25841673|NCT00030732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25841674|NCT00030732|Antimetabolites|antimetabolites|mesh-ancestor
25841675|NCT00030732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504679|NCT00537602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24504680|NCT00537602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504681|NCT00537667|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24504682|NCT00537667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24504683|NCT00537732|Omeprazole|omeprazole|mesh-list
24504684|NCT00537732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24504685|NCT00537732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24504698|NCT00537862|Antitubercular Agents|antitubercular agents|mesh-ancestor
24504699|NCT00537862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25660555|NCT01622296|Sympathomimetics|sympathomimetics|mesh-ancestor
25660556|NCT01622296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25660557|NCT01622543|Leucovorin|leucovorin|mesh-list
25660558|NCT01622543|Bevacizumab|bevacizumab|mesh-list
25660559|NCT01622543|Fluorouracil|fluorouracil|mesh-list
25660560|NCT01622543|Oxaliplatin|oxaliplatin|mesh-list
25660561|NCT01622543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25660562|NCT01622543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25660563|NCT01622543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25660564|NCT01622543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24896581|NCT04434378|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25062664|NCT04231877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25062665|NCT04231877|Glucocorticoids|glucocorticoids|mesh-ancestor
25062667|NCT04231877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24896582|NCT04434378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24896583|NCT04434378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24896584|NCT04434378|Adrenergic Agents|adrenergic agents|mesh-ancestor
24896585|NCT04434378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25841676|NCT00030732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841677|NCT00030732|Antiviral Agents|antiviral agents|mesh-ancestor
25841678|NCT00030732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25841679|NCT00030732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606028|NCT00988715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606029|NCT00988715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24606030|NCT00988715|Immunologic Factors|immunologic factors|mesh-ancestor
24606031|NCT00988715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606032|NCT00988715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606033|NCT00988715|Antifungal Agents|antifungal agents|mesh-ancestor
24606034|NCT00988715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24606035|NCT00988715|Dermatologic Agents|dermatologic agents|mesh-ancestor
24606036|NCT00988715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24606038|NCT00988715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24606039|NCT00988715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24810717|NCT02042196|Estradiol|estradiol|mesh-list
24810718|NCT02042196|Estrogens|estrogens|mesh-ancestor
25841680|NCT00030732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25841681|NCT00030732|Immunologic Factors|immunologic factors|mesh-ancestor
25841682|NCT00030732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841683|NCT00030745|Gemcitabine|gemcitabine|mesh-list
25841684|NCT00030745|Cisplatin|cisplatin|mesh-list
25841685|NCT00030745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841686|NCT00030745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25841687|NCT00030745|Antimetabolites|antimetabolites|mesh-ancestor
25841688|NCT00030745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841689|NCT00030745|Antiviral Agents|antiviral agents|mesh-ancestor
24504706|NCT00537888|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24504707|NCT00537888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24504708|NCT00537888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504709|NCT00537888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504710|NCT00537888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24504711|NCT00537888|Hormone Antagonists|hormone antagonists|mesh-ancestor
24504712|NCT00537888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24810720|NCT02042196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24810721|NCT02042196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810722|NCT02042196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24810723|NCT02042196|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24810724|NCT02042196|Fertility Agents|fertility agents|mesh-ancestor
24504713|NCT00537888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504714|NCT00537888|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24504715|NCT00537888|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24504716|NCT00537901|Bevacizumab|bevacizumab|mesh-list
24504717|NCT00537901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24504718|NCT00537901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504719|NCT00537901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24504720|NCT00537901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24504721|NCT00537901|Growth Substances|growth substances|mesh-ancestor
24966945|NCT03764202|Anesthetics, General|anesthetics, general|mesh-ancestor
24504732|NCT00537966|Darunavir|darunavir|mesh-list
24504733|NCT00537966|Tenofovir|tenofovir|mesh-list
24504734|NCT00537966|Lamivudine|lamivudine|mesh-list
24504735|NCT00537966|Emtricitabine|emtricitabine|mesh-list
24504736|NCT00537966|Raltegravir Potassium|raltegravir potassium|mesh-list
25660565|NCT01622543|Growth Substances|growth substances|mesh-ancestor
25660566|NCT01622543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660567|NCT01622543|Growth Inhibitors|growth inhibitors|mesh-ancestor
25660568|NCT01622543|Antimetabolites|antimetabolites|mesh-ancestor
25660569|NCT01622543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660570|NCT01622543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25660571|NCT01622543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25660572|NCT01622543|Immunologic Factors|immunologic factors|mesh-ancestor
25660573|NCT01622543|Antidotes|antidotes|mesh-ancestor
25660574|NCT01622543|Protective Agents|protective agents|mesh-ancestor
25841690|NCT00030745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25841691|NCT00030745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25054111|NCT03531931|Apatinib|apatinib|mesh-list
25841692|NCT00030745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25841693|NCT00030745|Immunologic Factors|immunologic factors|mesh-ancestor
25841694|NCT00030745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841695|NCT00030758|Lenograstim|lenograstim|mesh-list
25841696|NCT00030758|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25841697|NCT00030758|Immunologic Factors|immunologic factors|mesh-ancestor
25841698|NCT00030758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770917|NCT01823081|Vasodilator Agents|vasodilator agents|mesh-ancestor
25841699|NCT00030784|Doxorubicin|doxorubicin|mesh-list
25841700|NCT00030784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25841701|NCT00030784|Ifosfamide|ifosfamide|mesh-list
25841702|NCT00030784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25164481|NCT05361837|Dexmedetomidine|dexmedetomidine|mesh-list
25164482|NCT05361837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25164483|NCT05361837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25164484|NCT05361837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164485|NCT05361837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25164486|NCT05361837|Analgesics|analgesics|mesh-ancestor
25164487|NCT05361837|Sensory System Agents|sensory system agents|mesh-ancestor
25164488|NCT05361837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25164489|NCT05361837|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25164490|NCT05361837|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25164491|NCT05361837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25164492|NCT05361837|Adrenergic Agents|adrenergic agents|mesh-ancestor
25164493|NCT05361837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25164494|NCT05361837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164495|NCT05360615|Empagliflozin|empagliflozin|mesh-list
25164496|NCT05360615|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25164497|NCT05360615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164498|NCT05360615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25164499|NCT05360615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164521|NCT05349448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164523|NCT05349448|Analgesics|analgesics|mesh-ancestor
25164524|NCT05349448|Sensory System Agents|sensory system agents|mesh-ancestor
25164525|NCT05349448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25164526|NCT05349448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25164527|NCT05349448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25164528|NCT05349448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25164529|NCT05349448|Adrenergic Agents|adrenergic agents|mesh-ancestor
25841703|NCT00030784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841704|NCT00030784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25841705|NCT00030784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25841706|NCT00030784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841707|NCT00030784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841708|NCT00030784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25841709|NCT00030784|Alkylating Agents|alkylating agents|mesh-ancestor
25841710|NCT00030797|Irinotecan|irinotecan|mesh-list
25841711|NCT00030797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25841712|NCT00030797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24810727|NCT02042222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810728|NCT02042222|Antisickling Agents|antisickling agents|mesh-ancestor
24810729|NCT02042222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24810730|NCT02042222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810731|NCT02042222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24810732|NCT02042326|Sirolimus|sirolimus|mesh-list
24810733|NCT02042326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24864221|NCT05146895|Interferon Inducers|interferon inducers|mesh-ancestor
24810734|NCT02042326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24810735|NCT02042326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24607960|NCT03077698|Megestrol|megestrol|mesh-list
25841713|NCT00030797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841714|NCT00030797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841715|NCT00030797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841716|NCT00030810|Cisplatin|cisplatin|mesh-list
24771157|NCT01825031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841717|NCT00030810|Docetaxel|docetaxel|mesh-list
25841718|NCT00030810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841719|NCT00030810|Tubulin Modulators|tubulin modulators|mesh-ancestor
25841720|NCT00030810|Antimitotic Agents|antimitotic agents|mesh-ancestor
25841721|NCT00030810|Mitosis Modulators|mitosis modulators|mesh-ancestor
25841722|NCT00030810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841723|NCT00030849|Interferons|interferons|mesh-list
25841724|NCT00030849|Interferon-alpha|interferon-alpha|mesh-list
25841726|NCT00030849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841727|NCT00030849|Antiviral Agents|antiviral agents|mesh-ancestor
25841728|NCT00030849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24536812|NCT00652600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25841729|NCT00030849|Immunologic Factors|immunologic factors|mesh-ancestor
25841730|NCT00030849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841731|NCT00030862|Cisplatin|cisplatin|mesh-list
25841732|NCT00030862|Irinotecan|irinotecan|mesh-list
25841733|NCT00030862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841734|NCT00030862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25841735|NCT00030862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25841736|NCT00030862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841737|NCT00030862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841738|NCT00030875|Bortezomib|bortezomib|mesh-list
25841739|NCT00030875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841740|NCT00030888|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
24504758|NCT00538005|Oxaliplatin|oxaliplatin|mesh-list
24504759|NCT00538005|Sorafenib|sorafenib|mesh-list
24771210|NCT01825421|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24504760|NCT00538005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24504761|NCT00538005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504762|NCT00538005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24504763|NCT00538005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24504764|NCT00538005|Growth Substances|growth substances|mesh-ancestor
24504765|NCT00538005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504766|NCT00538005|Growth Inhibitors|growth inhibitors|mesh-ancestor
24504767|NCT00538005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24504768|NCT00538005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504769|NCT00538005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504770|NCT00538018|Telithromycin|telithromycin|mesh-list
25041524|NCT02502669|Finasteride|finasteride|mesh-list
24504771|NCT00538018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24504772|NCT00538018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24504773|NCT00538044|Simvastatin|simvastatin|mesh-list
24504774|NCT00538044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24504775|NCT00538044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24504776|NCT00538044|Antimetabolites|antimetabolites|mesh-ancestor
24504777|NCT00538044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504778|NCT00538044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24504779|NCT00538044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24504780|NCT00538044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841741|NCT00030888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841742|NCT00030888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25841743|NCT00030888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841744|NCT00030888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841745|NCT00030914|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25841746|NCT00030914|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25841747|NCT00030914|Medroxyprogesterone|medroxyprogesterone|mesh-list
25841748|NCT00030914|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25841749|NCT00030914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24504837|NCT00538330|Hormone Antagonists|hormone antagonists|mesh-ancestor
24504838|NCT00538330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24504839|NCT00538330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504840|NCT00538330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24504841|NCT00538330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504842|NCT00538330|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24504843|NCT00538330|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24504844|NCT00538330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24504859|NCT00538395|Immunologic Factors|immunologic factors|mesh-ancestor
25841750|NCT00030914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25841751|NCT00030914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841752|NCT00030914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25841753|NCT00030914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841754|NCT00030914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25841755|NCT00030914|Antidepressive Agents|antidepressive agents|mesh-ancestor
25841756|NCT00030914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25841757|NCT00030914|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25841758|NCT00030914|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24953222|NCT03887858|Urological Agents|urological agents|mesh-ancestor
24953224|NCT03887416|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25062674|NCT04231877|Antimitotic Agents|antimitotic agents|mesh-ancestor
25062675|NCT04231877|Mitosis Modulators|mitosis modulators|mesh-ancestor
25062676|NCT04211272|Sildenafil Citrate|sildenafil citrate|mesh-list
25062677|NCT04211272|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25062678|NCT04211272|Macitentan|macitentan|mesh-list
25062679|NCT04211272|Riociguat|riociguat|mesh-list
25062680|NCT04211272|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25062681|NCT04211272|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25062682|NCT04211272|Antimetabolites|antimetabolites|mesh-ancestor
25841759|NCT00030914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25841760|NCT00030914|Contraceptive Agents|contraceptive agents|mesh-ancestor
25841761|NCT00030914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25841762|NCT00030914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24810782|NCT02042495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24810783|NCT02042495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810784|NCT02042573|Sertraline|sertraline|mesh-list
24810785|NCT02042573|Antidepressive Agents|antidepressive agents|mesh-ancestor
24810786|NCT02042573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24608163|NCT02044497|Oxycodone|oxycodone|mesh-list
24504877|NCT00538421|Anesthetics, General|anesthetics, general|mesh-ancestor
24504878|NCT00538421|Anesthetics|anesthetics|mesh-ancestor
24771447|NCT01827293|Diphenhydramine|diphenhydramine|mesh-list
25841763|NCT00030914|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25841764|NCT00030914|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25841765|NCT00030914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25841766|NCT00030914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841767|NCT00030966|Natalizumab|natalizumab|mesh-list
24504907|NCT00538499|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24504908|NCT00538499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24504909|NCT00538499|Anesthetics, General|anesthetics, general|mesh-ancestor
24504910|NCT00538525|Docetaxel|docetaxel|mesh-list
24504911|NCT00538525|Doxorubicin|doxorubicin|mesh-list
24504912|NCT00538525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504913|NCT00538525|Tubulin Modulators|tubulin modulators|mesh-ancestor
25841768|NCT00030966|Immunologic Factors|immunologic factors|mesh-ancestor
25841769|NCT00030966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841770|NCT00030979|Donepezil|donepezil|mesh-list
25841771|NCT00030979|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25841772|NCT00030979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841773|NCT00030979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841774|NCT00030979|Cholinergic Agents|cholinergic agents|mesh-ancestor
24504954|NCT00538655|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24504955|NCT00538655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967012|NCT03763396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24908927|NCT04315155|Nivolumab|nivolumab|mesh-list
24504957|NCT00538694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24504958|NCT00538694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24504960|NCT00538720|Ergocalciferols|ergocalciferols|mesh-list
24810787|NCT02042573|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24810788|NCT02042573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24504962|NCT00538720|Micronutrients|micronutrients|mesh-ancestor
24504963|NCT00538720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504964|NCT00538720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24504966|NCT00538811|Interferons|interferons|mesh-list
25841775|NCT00030979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25841776|NCT00030979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841777|NCT00030979|Nootropic Agents|nootropic agents|mesh-ancestor
25841778|NCT00031018|Interferon alpha-2|interferon alpha-2|mesh-list
25841779|NCT00031018|Donepezil|donepezil|mesh-list
25841780|NCT00031018|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25660575|NCT01622543|Vitamin B Complex|vitamin b complex|mesh-ancestor
25660576|NCT01622543|Vitamins|vitamins|mesh-ancestor
25660577|NCT01622543|Micronutrients|micronutrients|mesh-ancestor
25660578|NCT01622569|Fluticasone|fluticasone|mesh-list
25660579|NCT01622569|Xhance|xhance|mesh-list
25660580|NCT01622569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25660581|NCT01622569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25660582|NCT01622569|Autonomic Agents|autonomic agents|mesh-ancestor
25660583|NCT01622569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25660584|NCT01622569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660585|NCT01622569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25660586|NCT01622569|Respiratory System Agents|respiratory system agents|mesh-ancestor
25841781|NCT00031018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841782|NCT00031018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062716|NCT04155203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25062717|NCT04155203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25062718|NCT04155203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25062719|NCT04155203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25062720|NCT04155203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25062721|NCT04155203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062727|NCT04099836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25062728|NCT04099836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25062729|NCT04099836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25062730|NCT04099836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24504988|NCT00538876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24504990|NCT00538876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504991|NCT00538876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504992|NCT00538876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505000|NCT00538889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505001|NCT00538889|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24505002|NCT00538889|Antidepressive Agents|antidepressive agents|mesh-ancestor
24505003|NCT00538889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25841783|NCT00031018|Cholinergic Agents|cholinergic agents|mesh-ancestor
24505004|NCT00538954|Magnesium Oxide|magnesium oxide|mesh-list
24505005|NCT00538954|Antacids|antacids|mesh-ancestor
24505006|NCT00538954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505007|NCT00538954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24505008|NCT00538967|Doxycycline|doxycycline|mesh-list
24505022|NCT00539071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24505023|NCT00539071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25841784|NCT00031018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25841785|NCT00031018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841786|NCT00031018|Nootropic Agents|nootropic agents|mesh-ancestor
25841787|NCT00031018|Antiviral Agents|antiviral agents|mesh-ancestor
25841788|NCT00031018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25841789|NCT00031018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810789|NCT02042573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24810790|NCT02042573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810791|NCT02042573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24810792|NCT02042573|Serotonin Agents|serotonin agents|mesh-ancestor
25841790|NCT00031044|Enfuvirtide|enfuvirtide|mesh-list
25841791|NCT00031044|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25841792|NCT00031044|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25841793|NCT00031044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841794|NCT00031044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25841795|NCT00031044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25841796|NCT00031044|Antiviral Agents|antiviral agents|mesh-ancestor
25841797|NCT00031044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25841798|NCT00031057|Riboflavin|riboflavin|mesh-list
25841799|NCT00031057|Thiamine|thiamine|mesh-list
25841800|NCT00031057|Vitamin B Complex|vitamin b complex|mesh-ancestor
25841801|NCT00031057|Vitamins|vitamins|mesh-ancestor
25841802|NCT00031057|Micronutrients|micronutrients|mesh-ancestor
25841803|NCT00031057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841804|NCT00031057|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25841805|NCT00031057|Dermatologic Agents|dermatologic agents|mesh-ancestor
24828794|NCT02147730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828795|NCT02147808|Midazolam|midazolam|mesh-list
24828796|NCT02147808|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25041515|NCT02508038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041516|NCT02504580|Bupivacaine|bupivacaine|mesh-list
25041517|NCT02504580|Anesthetics, Local|anesthetics, local|mesh-ancestor
25041518|NCT02504580|Anesthetics|anesthetics|mesh-ancestor
25041519|NCT02504580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25041520|NCT02504580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660587|NCT01622569|Dermatologic Agents|dermatologic agents|mesh-ancestor
25660588|NCT01622569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25660589|NCT01622660|Gemcitabine|gemcitabine|mesh-list
25660590|NCT01622660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25660591|NCT01622660|Antimetabolites|antimetabolites|mesh-ancestor
25660592|NCT01622660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660593|NCT01622660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25660594|NCT01622660|Antiviral Agents|antiviral agents|mesh-ancestor
25660595|NCT01622660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25660596|NCT01622660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25660597|NCT01622660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25841806|NCT00031070|Cyclosporine|cyclosporine|mesh-list
24516054|NCT00600405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24516055|NCT00600405|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24516056|NCT00600405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24516057|NCT00600405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24516058|NCT00600405|Adrenergic Agents|adrenergic agents|mesh-ancestor
24516059|NCT00600405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24516060|NCT00600405|Urological Agents|urological agents|mesh-ancestor
24516061|NCT00600509|Levetiracetam|levetiracetam|mesh-list
24516062|NCT00600509|Anticonvulsants|anticonvulsants|mesh-ancestor
24516063|NCT00600509|Nootropic Agents|nootropic agents|mesh-ancestor
25062817|NCT03912831|Cyclophosphamide|cyclophosphamide|mesh-list
25062818|NCT03912831|Fludarabine|fludarabine|mesh-list
24817538|NCT02084446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24817539|NCT02084446|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24817540|NCT02084446|Antitubercular Agents|antitubercular agents|mesh-ancestor
24817541|NCT02084446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25041521|NCT02504580|Sensory System Agents|sensory system agents|mesh-ancestor
25041522|NCT02504580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25041523|NCT02503137|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25041525|NCT02502669|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25841807|NCT00031070|Lamivudine|lamivudine|mesh-list
25841808|NCT00031070|Zidovudine|zidovudine|mesh-list
25841809|NCT00031070|Efavirenz|efavirenz|mesh-list
24505032|NCT00539123|Sensory System Agents|sensory system agents|mesh-ancestor
24505033|NCT00539123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24505034|NCT00539123|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24505035|NCT00539149|Amoxicillin|amoxicillin|mesh-list
24505036|NCT00539149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24505037|NCT00539149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24505038|NCT00539331|Paclitaxel|paclitaxel|mesh-list
24505039|NCT00539331|Carboplatin|carboplatin|mesh-list
24505040|NCT00539331|Cediranib|cediranib|mesh-list
25841810|NCT00031070|Abacavir|abacavir|mesh-list
25841811|NCT00031070|Vaccines|vaccines|mesh-list
24505053|NCT00539409|Insulin Aspart|insulin aspart|mesh-list
24505054|NCT00539409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24505055|NCT00539409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24505056|NCT00539409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810793|NCT02042573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810795|NCT02042599|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24810796|NCT02042599|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25164531|NCT05349448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164532|NCT05349448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25164533|NCT05349448|Glucocorticoids|glucocorticoids|mesh-ancestor
25164534|NCT05349448|Hormones|hormones|mesh-ancestor
25164535|NCT05349448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25164536|NCT05349448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25164537|NCT05349448|Immunologic Factors|immunologic factors|mesh-ancestor
25164538|NCT05349448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25164539|NCT05349383|Antineoplastic Agents|antineoplastic agents|mesh-list
25164540|NCT05349383|Antibodies|antibodies|mesh-list
25164541|NCT05349383|Immunoglobulins|immunoglobulins|mesh-list
25164542|NCT05349383|Immunoconjugates|immunoconjugates|mesh-list
25164543|NCT05349383|Immunologic Factors|immunologic factors|mesh-ancestor
25164544|NCT05349383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771881|NCT01830361|Midostaurin|midostaurin|mesh-list
25041526|NCT02502669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24859020|NCT02301130|Tremelimumab|tremelimumab|mesh-list
24505057|NCT00539435|Insulin|insulin|mesh-list
24505058|NCT00539435|Insulin Aspart|insulin aspart|mesh-list
24505059|NCT00539435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25660598|NCT01622660|Immunologic Factors|immunologic factors|mesh-ancestor
25660599|NCT01622660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660600|NCT01622673|Raltegravir Potassium|raltegravir potassium|mesh-list
25660601|NCT01622673|Calcium Carbonate|calcium carbonate|mesh-list
25660602|NCT01622673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25660603|NCT01622673|Antacids|antacids|mesh-list
25660604|NCT01622673|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
25660605|NCT01622673|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
25660606|NCT01622673|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
25660607|NCT01622673|TEMPO|tempo|mesh-list
25660608|NCT01622673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660609|NCT01622673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25660610|NCT01622673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25660611|NCT01622673|Antiviral Agents|antiviral agents|mesh-ancestor
25660612|NCT01622673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25841812|NCT00031070|Cyclosporins|cyclosporins|mesh-list
25841813|NCT00031070|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24505060|NCT00539435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505061|NCT00539448|Insulin|insulin|mesh-list
24505062|NCT00539448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24505063|NCT00539448|Insulin Glargine|insulin glargine|mesh-list
24505064|NCT00539448|Insulin glulisine|insulin glulisine|mesh-list
24505065|NCT00539448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24505066|NCT00539448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505067|NCT00539565|Prednisolone|prednisolone|mesh-list
24505068|NCT00539565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24759055|NCT01749111|Alkylating Agents|alkylating agents|mesh-ancestor
24759056|NCT01749111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759057|NCT01749111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759058|NCT01749111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24759059|NCT01749111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24759060|NCT01749111|Abortifacient Agents|abortifacient agents|mesh-ancestor
24759061|NCT01749111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24759062|NCT01749111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24759063|NCT01749111|Antimetabolites|antimetabolites|mesh-ancestor
24759064|NCT01749111|Dermatologic Agents|dermatologic agents|mesh-ancestor
24759065|NCT01749111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759066|NCT01749111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24759067|NCT01749111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24759068|NCT01749150|Ritonavir|ritonavir|mesh-list
24759069|NCT01749150|Ribavirin|ribavirin|mesh-list
24759070|NCT01749150|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24759071|NCT01749150|Interferon-alpha|interferon-alpha|mesh-list
24759158|NCT01749423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759159|NCT01749423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24759160|NCT01749423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24759162|NCT01749475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24759163|NCT01749475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24759164|NCT01749475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24759165|NCT01749475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759166|NCT01749475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24759167|NCT01749475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24759168|NCT01749475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24759169|NCT01749475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24759170|NCT01749475|Anesthetics, General|anesthetics, general|mesh-ancestor
24759234|NCT01750099|Sensory System Agents|sensory system agents|mesh-ancestor
24759235|NCT01750099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24759236|NCT01750099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24759237|NCT01750099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24759238|NCT01750099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24759239|NCT01750099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24759240|NCT01750099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759241|NCT01750099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24759242|NCT01750099|Narcotics|narcotics|mesh-ancestor
24759253|NCT01750099|Autonomic Agents|autonomic agents|mesh-ancestor
24759254|NCT01750099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24759255|NCT01750099|Respiratory System Agents|respiratory system agents|mesh-ancestor
24759256|NCT01750099|Mydriatics|mydriatics|mesh-ancestor
24759257|NCT01750099|Sympathomimetics|sympathomimetics|mesh-ancestor
24759258|NCT01750099|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24759259|NCT01750359|Curcumin|curcumin|mesh-list
24759260|NCT01750359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24759261|NCT01750359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24759262|NCT01750359|Analgesics|analgesics|mesh-ancestor
24759263|NCT01750359|Sensory System Agents|sensory system agents|mesh-ancestor
24759264|NCT01750359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24759265|NCT01750359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759266|NCT01750359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24759267|NCT01750359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24759268|NCT01750359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759269|NCT01750359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759270|NCT01750359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759271|NCT01750385|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24945133|NCT03953716|Hormones|hormones|mesh-ancestor
24759272|NCT01750385|Cephalosporins|cephalosporins|mesh-list
24810804|NCT02042612|Anesthetics, General|anesthetics, general|mesh-ancestor
24810805|NCT02042612|Anesthetics|anesthetics|mesh-ancestor
24810806|NCT02042612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24810808|NCT02042638|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25660613|NCT01622673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24772034|NCT01831193|Curcumin|curcumin|mesh-list
25660614|NCT01622673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25660615|NCT01622673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759298|NCT01750476|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24759299|NCT01750476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24759300|NCT01750476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759301|NCT01750476|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24759302|NCT01750541|Valproic Acid|valproic acid|mesh-list
24759303|NCT01750541|Haloperidol|haloperidol|mesh-list
24759304|NCT01750541|Haloperidol decanoate|haloperidol decanoate|mesh-list
24759305|NCT01750541|Antiemetics|antiemetics|mesh-ancestor
24759306|NCT01750541|Autonomic Agents|autonomic agents|mesh-ancestor
24759307|NCT01750541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24759308|NCT01750541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759309|NCT01750541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24759310|NCT01750541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24759311|NCT01750541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24759312|NCT01750541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24759313|NCT01750541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24759314|NCT01750541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24759315|NCT01750541|Dopamine Agents|dopamine agents|mesh-ancestor
24759316|NCT01750541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24759357|NCT01750788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759374|NCT01750866|Immunologic Factors|immunologic factors|mesh-ancestor
24759402|NCT01751074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759404|NCT01751074|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24759405|NCT01751074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759406|NCT01751074|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
24759407|NCT01751204|Calcium, Dietary|calcium, dietary|mesh-list
24759408|NCT01751204|Calcium|calcium|mesh-list
24759412|NCT01751269|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
24759434|NCT01751321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759435|NCT01751347|Lidocaine|lidocaine|mesh-list
24759436|NCT01751347|Bupivacaine|bupivacaine|mesh-list
24759437|NCT01751347|Anesthetics, Local|anesthetics, local|mesh-ancestor
24759438|NCT01751347|Anesthetics|anesthetics|mesh-ancestor
24759439|NCT01751347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24772377|NCT01833312|Analgesics|analgesics|mesh-ancestor
24759440|NCT01751347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759441|NCT01751347|Sensory System Agents|sensory system agents|mesh-ancestor
24759442|NCT01751347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24759443|NCT01751347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24759444|NCT01751347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24759445|NCT01751347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24759446|NCT01751347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24759447|NCT01751347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759448|NCT01751373|Botulinum Toxins|botulinum toxins|mesh-list
24759449|NCT01751373|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24759450|NCT01751373|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24759451|NCT01751373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24759452|NCT01751373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759453|NCT01751373|Cholinergic Agents|cholinergic agents|mesh-ancestor
24759454|NCT01751373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24759455|NCT01751373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759456|NCT01751373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24759457|NCT01751373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24759458|NCT01751425|Imatinib Mesylate|imatinib mesylate|mesh-list
24759459|NCT01751425|Dasatinib|dasatinib|mesh-list
24759460|NCT01751425|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
24759461|NCT01751425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759462|NCT01751425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24759463|NCT01751425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759464|NCT01751425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759465|NCT01751763|Sorafenib|sorafenib|mesh-list
24759466|NCT01751763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759476|NCT01751828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759478|NCT01751828|Serotonin Agents|serotonin agents|mesh-ancestor
24759479|NCT01751828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759481|NCT01751854|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24505121|NCT00539968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25660616|NCT01622673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660617|NCT01622673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24519096|NCT03432949|BB 1101|bb 1101|mesh-list
25062863|NCT03664024|Carboplatin|carboplatin|mesh-list
25062864|NCT03664024|Pembrolizumab|pembrolizumab|mesh-list
25062885|NCT03530995|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24759493|NCT01751919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24759494|NCT01751919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759495|NCT01751919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759496|NCT01752010|Immunologic Factors|immunologic factors|mesh-list
24759497|NCT01752010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759499|NCT01752075|Immunologic Factors|immunologic factors|mesh-ancestor
24759500|NCT01752075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759501|NCT01752075|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24759502|NCT01752075|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24759503|NCT01752075|Growth Substances|growth substances|mesh-ancestor
24759504|NCT01752075|Growth Inhibitors|growth inhibitors|mesh-ancestor
24759505|NCT01752075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759506|NCT01752153|Silymarin|silymarin|mesh-list
24759507|NCT01752153|Deferoxamine|deferoxamine|mesh-list
24759508|NCT01752153|Antioxidants|antioxidants|mesh-ancestor
24759509|NCT01752153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810823|NCT02042690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24810824|NCT02042690|Alkylating Agents|alkylating agents|mesh-ancestor
24810826|NCT02042690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759510|NCT01752153|Protective Agents|protective agents|mesh-ancestor
24759511|NCT01752153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759512|NCT01752153|Siderophores|siderophores|mesh-ancestor
24759513|NCT01752153|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24759514|NCT01752153|Chelating Agents|chelating agents|mesh-ancestor
24759515|NCT01752153|Sequestering Agents|sequestering agents|mesh-ancestor
24759516|NCT01752205|Paclitaxel|paclitaxel|mesh-list
24759517|NCT01752205|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24759518|NCT01752205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24759519|NCT01752205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759520|NCT01752205|Tubulin Modulators|tubulin modulators|mesh-ancestor
24759521|NCT01752205|Antimitotic Agents|antimitotic agents|mesh-ancestor
24759522|NCT01752205|Mitosis Modulators|mitosis modulators|mesh-ancestor
24759523|NCT01752205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759524|NCT01752205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24759525|NCT01752205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759526|NCT01752244|Alfacalcidol|alfacalcidol|mesh-list
24759527|NCT01752244|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
24759528|NCT01752244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24759529|NCT01752244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759530|NCT01752244|Vitamins|vitamins|mesh-ancestor
24759531|NCT01752244|Micronutrients|micronutrients|mesh-ancestor
24759577|NCT01752699|Analgesics|analgesics|mesh-ancestor
24810830|NCT02042690|Autonomic Agents|autonomic agents|mesh-ancestor
24759592|NCT01752881|Immunologic Factors|immunologic factors|mesh-ancestor
24759593|NCT01752881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759594|NCT01752959|Remifentanil|remifentanil|mesh-list
24759633|NCT01753128|Adrenergic Agents|adrenergic agents|mesh-ancestor
24759634|NCT01753128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24759635|NCT01753128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620098|NCT01055405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620099|NCT01055405|Urological Agents|urological agents|mesh-ancestor
24620100|NCT01055418|Ascorbic Acid|ascorbic acid|mesh-list
24620101|NCT01055418|Vitamins|vitamins|mesh-ancestor
24620102|NCT01055418|Micronutrients|micronutrients|mesh-ancestor
24620103|NCT01055418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620104|NCT01055418|Antioxidants|antioxidants|mesh-ancestor
24550390|NCT00720512|Leucovorin|leucovorin|mesh-list
24457482|NCT00334503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457483|NCT00334503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24457484|NCT00334503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457485|NCT00334503|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24457486|NCT00334529|Oseltamivir|oseltamivir|mesh-list
24457487|NCT00334529|Antiviral Agents|antiviral agents|mesh-ancestor
24457488|NCT00334529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24457489|NCT00334529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457490|NCT00334529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457491|NCT00334568|Rosiglitazone|rosiglitazone|mesh-list
25660618|NCT01622673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25660619|NCT01622673|Immunologic Factors|immunologic factors|mesh-ancestor
25660620|NCT01622673|Antioxidants|antioxidants|mesh-ancestor
24457492|NCT00334568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24457493|NCT00334568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457494|NCT00334581|Irbesartan|irbesartan|mesh-list
24896815|NCT04432688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24896816|NCT04432688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24473930|NCT00404482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24516175|NCT00600847|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25054166|NCT03531437|Contraceptive Agents|contraceptive agents|mesh-ancestor
24828797|NCT02147808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24828798|NCT02147808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24828799|NCT02147808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828800|NCT02147808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24828801|NCT02147808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25841815|NCT00031070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841816|NCT00031070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841817|NCT00031070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841818|NCT00031070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25841819|NCT00031070|Antifungal Agents|antifungal agents|mesh-ancestor
25841820|NCT00031070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25841821|NCT00031070|Dermatologic Agents|dermatologic agents|mesh-ancestor
25841822|NCT00031070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25841823|NCT00031070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25841824|NCT00031070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24828834|NCT02147938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25042580|NCT01416064|Molindone|molindone|mesh-list
24457495|NCT00334581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24457496|NCT00334581|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24457497|NCT00334581|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25164586|NCT05321043|Riboflavin|riboflavin|mesh-list
25164587|NCT05321043|Vitamins|vitamins|mesh-ancestor
25164588|NCT05321043|Micronutrients|micronutrients|mesh-ancestor
25164589|NCT05321043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164590|NCT05321043|Vitamin B Complex|vitamin b complex|mesh-ancestor
25164591|NCT05321043|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25164592|NCT05321043|Dermatologic Agents|dermatologic agents|mesh-ancestor
25164593|NCT05316493|Megestrol|megestrol|mesh-list
25164594|NCT05316493|Megestrol Acetate|megestrol acetate|mesh-list
25164595|NCT05316493|Contraceptive Agents|contraceptive agents|mesh-list
24457498|NCT00334581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505122|NCT00540072|Daptomycin|daptomycin|mesh-list
24458594|NCT00338481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24458595|NCT00338481|Narcotics|narcotics|mesh-ancestor
25841825|NCT00031070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24458602|NCT00338494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24458604|NCT00338494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458743|NCT00339118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458744|NCT00339118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24458745|NCT00339118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24458746|NCT00339118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458747|NCT00339118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458748|NCT00339118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24458749|NCT00339118|Immunologic Factors|immunologic factors|mesh-ancestor
24458750|NCT00339118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458751|NCT00339118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24461723|NCT00353340|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24458908|NCT00343096|GABA Modulators|gaba modulators|mesh-ancestor
24458909|NCT00343096|GABA Agents|gaba agents|mesh-ancestor
24459346|NCT00344422|Glucocorticoids|glucocorticoids|mesh-ancestor
24459347|NCT00344422|Hormones|hormones|mesh-ancestor
24459348|NCT00344422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24459349|NCT00344422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24459656|NCT00345735|Narcotics|narcotics|mesh-ancestor
24459657|NCT00345735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24459658|NCT00345735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459659|NCT00345735|Analgesics|analgesics|mesh-ancestor
24459660|NCT00345735|Sensory System Agents|sensory system agents|mesh-ancestor
24459661|NCT00345735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24459662|NCT00345735|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24459663|NCT00345735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24459664|NCT00345735|Anesthetics, General|anesthetics, general|mesh-ancestor
24459665|NCT00345735|Anesthetics|anesthetics|mesh-ancestor
25660621|NCT01622673|Protective Agents|protective agents|mesh-ancestor
25660622|NCT01623115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25660623|NCT01623115|Immunologic Factors|immunologic factors|mesh-ancestor
25660624|NCT01623115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459666|NCT00345761|Bevacizumab|bevacizumab|mesh-list
24459667|NCT00345761|Capecitabine|capecitabine|mesh-list
24459668|NCT00345761|Oxaliplatin|oxaliplatin|mesh-list
25415961|NCT02980510|Panitumumab|panitumumab|mesh-list
25062918|NCT03449901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24901991|NCT04378972|Vitamin D|vitamin d|mesh-list
24902064|NCT04378283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24902065|NCT04378283|Adrenergic Agents|adrenergic agents|mesh-ancestor
24902066|NCT04378283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24902067|NCT04378283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25062919|NCT03449901|Antimetabolites|antimetabolites|mesh-ancestor
25062920|NCT03449901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062921|NCT03449901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25062922|NCT03449901|Antiviral Agents|antiviral agents|mesh-ancestor
24459669|NCT00345761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24459670|NCT00345761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841826|NCT00031070|Antiviral Agents|antiviral agents|mesh-ancestor
25841827|NCT00031070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24773698|NCT01841411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25841828|NCT00031070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25841829|NCT00031070|Antimetabolites|antimetabolites|mesh-ancestor
25841830|NCT00031070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25841831|NCT00031070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25841832|NCT00031070|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25841833|NCT00031070|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24810841|NCT02042690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24810843|NCT02042690|Dermatologic Agents|dermatologic agents|mesh-ancestor
24810844|NCT02042690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24810845|NCT02042690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24810846|NCT02042690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24606132|NCT00989027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24810847|NCT02042690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24460596|NCT00348998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460597|NCT00348998|Growth Inhibitors|growth inhibitors|mesh-ancestor
24460598|NCT00348998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24460599|NCT00348998|Androgen Antagonists|androgen antagonists|mesh-ancestor
24460600|NCT00348998|Hormone Antagonists|hormone antagonists|mesh-ancestor
24460601|NCT00348998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24460602|NCT00349024|Povidone|povidone|mesh-list
24460603|NCT00349024|Hyaluronic Acid|hyaluronic acid|mesh-list
24460604|NCT00349024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25164596|NCT05316493|Levonorgestrel|levonorgestrel|mesh-list
24460612|NCT00349076|Fluorouracil|fluorouracil|mesh-list
24460613|NCT00349076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460614|NCT00349076|Antimetabolites|antimetabolites|mesh-ancestor
25841834|NCT00031070|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24460619|NCT00349076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460621|NCT00349089|Vinorelbine|vinorelbine|mesh-list
24460622|NCT00349089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460623|NCT00349089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460683|NCT00349219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24460684|NCT00349245|Dexmedetomidine|dexmedetomidine|mesh-list
24460685|NCT00349245|Remifentanil|remifentanil|mesh-list
24460686|NCT00349245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24460687|NCT00349245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24460688|NCT00349245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460689|NCT00349245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24460690|NCT00349245|Analgesics|analgesics|mesh-ancestor
24460691|NCT00349245|Sensory System Agents|sensory system agents|mesh-ancestor
24460692|NCT00349245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24460693|NCT00349245|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24460694|NCT00349245|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24460696|NCT00349245|Adrenergic Agents|adrenergic agents|mesh-ancestor
24460697|NCT00349245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24460698|NCT00349245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460699|NCT00349245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24460700|NCT00349245|Narcotics|narcotics|mesh-ancestor
25660625|NCT01623271|Gabapentin|gabapentin|mesh-list
25660626|NCT01623271|Analgesics|analgesics|mesh-ancestor
25660627|NCT01623271|Sensory System Agents|sensory system agents|mesh-ancestor
25660628|NCT01623271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25660629|NCT01623271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660630|NCT01623271|Anticonvulsants|anticonvulsants|mesh-ancestor
25660631|NCT01623271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25660632|NCT01623271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25660633|NCT01623271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25660634|NCT01623271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24460702|NCT00349258|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24460703|NCT00349258|Fertility Agents|fertility agents|mesh-ancestor
24460704|NCT00349258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24460705|NCT00349258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460706|NCT00349258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24460707|NCT00349258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460708|NCT00349284|Ezetimibe|ezetimibe|mesh-list
24460709|NCT00349284|Fenofibrate|fenofibrate|mesh-list
24460710|NCT00349284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24460711|NCT00349284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24460712|NCT00349284|Antimetabolites|antimetabolites|mesh-ancestor
24810848|NCT02042690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24810849|NCT02042742|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
25841835|NCT00031070|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25841836|NCT00031083|Interferons|interferons|mesh-list
25841837|NCT00031083|Interferon-beta|interferon-beta|mesh-list
24810850|NCT02042742|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
24810851|NCT02042742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24810852|NCT02042742|Antioxidants|antioxidants|mesh-ancestor
24810853|NCT02042742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810854|NCT02042742|Protective Agents|protective agents|mesh-ancestor
24810855|NCT02042742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810856|NCT02042742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24810857|NCT02042742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24810858|NCT02042742|Disinfectants|disinfectants|mesh-ancestor
25841838|NCT00031083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461349|NCT00352079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24461350|NCT00352079|Immunologic Factors|immunologic factors|mesh-ancestor
24461351|NCT00352079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461352|NCT00352092|Mycophenolic Acid|mycophenolic acid|mesh-list
24461353|NCT00352092|Sirolimus|sirolimus|mesh-list
24461354|NCT00352092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
25164597|NCT05316493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24828835|NCT02147938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461355|NCT00352092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24461356|NCT00352092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461357|NCT00352092|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24461358|NCT00352092|Antitubercular Agents|antitubercular agents|mesh-ancestor
24461359|NCT00352092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24461374|NCT00352170|Cholecalciferol|cholecalciferol|mesh-list
24810869|NCT02043054|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24810870|NCT02043054|Protease Inhibitors|protease inhibitors|mesh-ancestor
24810871|NCT02043054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24810872|NCT02043054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810873|NCT02043171|Vitamin D|vitamin d|mesh-list
24810874|NCT02043171|Ergocalciferols|ergocalciferols|mesh-list
24609025|NCT00994799|Ranibizumab|ranibizumab|mesh-list
24461447|NCT00352339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24461448|NCT00352378|Cyclophosphamide|cyclophosphamide|mesh-list
24461449|NCT00352378|Docetaxel|docetaxel|mesh-list
24461450|NCT00352378|Doxorubicin|doxorubicin|mesh-list
24461451|NCT00352378|Capecitabine|capecitabine|mesh-list
24461452|NCT00352378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24461453|NCT00352378|Immunologic Factors|immunologic factors|mesh-ancestor
24461454|NCT00352378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461455|NCT00352378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24461456|NCT00352378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24461457|NCT00352378|Alkylating Agents|alkylating agents|mesh-ancestor
24461458|NCT00352378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461459|NCT00352378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461460|NCT00352378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24461461|NCT00352378|Tubulin Modulators|tubulin modulators|mesh-ancestor
24461462|NCT00352378|Antimitotic Agents|antimitotic agents|mesh-ancestor
24774476|NCT01845701|Lumefantrine|lumefantrine|mesh-list
24461463|NCT00352378|Mitosis Modulators|mitosis modulators|mesh-ancestor
24461464|NCT00352378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24429649|NCT00244608|Budesonide|budesonide|mesh-list
24461499|NCT00352469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24461500|NCT00352469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461501|NCT00352482|Sildenafil Citrate|sildenafil citrate|mesh-list
24410393|NCT00185185|Diuretics|diuretics|mesh-ancestor
24461502|NCT00352482|Vasodilator Agents|vasodilator agents|mesh-ancestor
24461503|NCT00352482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24461504|NCT00352482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24461505|NCT00352482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841839|NCT00031083|Antiviral Agents|antiviral agents|mesh-ancestor
24461550|NCT00352625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810887|NCT02043223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810889|NCT02043223|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24810890|NCT02043223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810891|NCT02043288|Gemcitabine|gemcitabine|mesh-list
24810892|NCT02043288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24810893|NCT02043288|Antimetabolites|antimetabolites|mesh-ancestor
24810894|NCT02043288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810895|NCT02043288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24430013|NCT00245791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461556|NCT00352651|Anticonvulsants|anticonvulsants|mesh-ancestor
24461557|NCT00352651|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24461558|NCT00352651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24461559|NCT00352651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461568|NCT00352677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461571|NCT00352742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461572|NCT00352742|Chelating Agents|chelating agents|mesh-ancestor
24461573|NCT00352742|Sequestering Agents|sequestering agents|mesh-ancestor
24461574|NCT00352742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461575|NCT00352742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461576|NCT00352742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24461577|NCT00352742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24461579|NCT00352742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461580|NCT00352742|Growth Inhibitors|growth inhibitors|mesh-ancestor
24461581|NCT00352768|Fluvoxamine|fluvoxamine|mesh-list
24461582|NCT00352768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430088|NCT00246155|Botulinum Toxins|botulinum toxins|mesh-list
25164598|NCT05316493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461583|NCT00352768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461584|NCT00352768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24461585|NCT00352768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24461586|NCT00352768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24774652|NCT01847157|Anesthetics|anesthetics|mesh-list
24461587|NCT00352768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461588|NCT00352768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24461589|NCT00352768|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24430125|NCT00246207|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24461590|NCT00352768|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24461591|NCT00352768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24461592|NCT00352768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24810906|NCT02043314|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24810907|NCT02043314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24810908|NCT02043314|Antimetabolites|antimetabolites|mesh-ancestor
24461593|NCT00352768|Serotonin Agents|serotonin agents|mesh-ancestor
24461594|NCT00352768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24461595|NCT00352768|Antidepressive Agents|antidepressive agents|mesh-ancestor
24461596|NCT00352768|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24461597|NCT00352768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24461598|NCT00352768|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24461599|NCT00352807|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25841840|NCT00031083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24461600|NCT00352807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24461601|NCT00352807|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24461602|NCT00352807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24461603|NCT00352807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24461604|NCT00352807|Adrenergic Agents|adrenergic agents|mesh-ancestor
24461606|NCT00352807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461607|NCT00352807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461608|NCT00352833|Catumaxomab|catumaxomab|mesh-list
24774878|NCT01848613|Vinorelbine|vinorelbine|mesh-list
24461609|NCT00352833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24461610|NCT00352859|Gemcitabine|gemcitabine|mesh-list
24461611|NCT00352859|Interferons|interferons|mesh-list
24461612|NCT00352859|Sorafenib|sorafenib|mesh-list
24430245|NCT00246636|Fenofibrate|fenofibrate|mesh-list
25841841|NCT00031083|Immunologic Factors|immunologic factors|mesh-ancestor
25841842|NCT00031083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841843|NCT00031096|Azelaic acid|azelaic acid|mesh-list
25841844|NCT00031096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841845|NCT00031096|Dermatologic Agents|dermatologic agents|mesh-ancestor
25841846|NCT00031109|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25660635|NCT01623271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24896935|NCT04432233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24896936|NCT04432233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24896937|NCT04432233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841847|NCT00031109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24461613|NCT00352859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24461614|NCT00352859|Antimetabolites|antimetabolites|mesh-ancestor
24461615|NCT00352859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461616|NCT00352859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461617|NCT00352859|Antiviral Agents|antiviral agents|mesh-ancestor
24461618|NCT00352859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24461619|NCT00352859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461620|NCT00352859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24461630|NCT00353002|Anesthetics|anesthetics|mesh-ancestor
24461631|NCT00353002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24461632|NCT00353002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461633|NCT00353002|Sensory System Agents|sensory system agents|mesh-ancestor
24461634|NCT00353002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24461635|NCT00353002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24461636|NCT00353002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24461637|NCT00353002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24461638|NCT00353002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24461639|NCT00353002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461641|NCT00353015|Irinotecan|irinotecan|mesh-list
24461642|NCT00353015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461643|NCT00353015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24461644|NCT00353015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24461645|NCT00353015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461646|NCT00353015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461647|NCT00353028|Fluvoxamine|fluvoxamine|mesh-list
24810909|NCT02043314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810910|NCT02043314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25164599|NCT05316493|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24828836|NCT02147951|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
24828839|NCT02147964|Ketoconazole|ketoconazole|mesh-list
25164600|NCT05316493|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25164601|NCT05316493|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25164602|NCT05316493|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25164603|NCT05316493|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25164604|NCT05316493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24620781|NCT01059058|Protective Agents|protective agents|mesh-ancestor
25164605|NCT05316493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25164606|NCT05316493|Appetite Stimulants|appetite stimulants|mesh-ancestor
25164607|NCT05316493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25203145|NCT02716038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203146|NCT02716090|Adapalene|adapalene|mesh-list
25203147|NCT02716090|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25203148|NCT02716090|Dermatologic Agents|dermatologic agents|mesh-ancestor
25203149|NCT02716090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25203150|NCT02716090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25203151|NCT02716090|Analgesics|analgesics|mesh-ancestor
25203152|NCT02716090|Sensory System Agents|sensory system agents|mesh-ancestor
25203153|NCT02716090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25203154|NCT02716090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203155|NCT02716090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25203156|NCT02716090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25203157|NCT02715869|Sevoflurane|sevoflurane|mesh-list
25203158|NCT02715869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25203159|NCT02715869|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25203160|NCT02715869|Anesthetics, General|anesthetics, general|mesh-ancestor
25203161|NCT02715869|Anesthetics|anesthetics|mesh-ancestor
25203162|NCT02715869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25203165|NCT02715687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25203166|NCT02715687|Vasodilator Agents|vasodilator agents|mesh-ancestor
25203167|NCT02715687|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25203168|NCT02715687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25203169|NCT02715687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203170|NCT02715687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25203171|NCT02715687|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25660636|NCT01623271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25660637|NCT01623271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25841848|NCT00031109|Immunologic Factors|immunologic factors|mesh-ancestor
25660638|NCT01623271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660639|NCT01623271|Antimanic Agents|antimanic agents|mesh-ancestor
25660640|NCT01623310|Fluticasone|fluticasone|mesh-list
25841849|NCT00031109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660641|NCT01623310|Xhance|xhance|mesh-list
25203172|NCT02715687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25203173|NCT02715687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203174|NCT02715687|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25203175|NCT02715687|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25203176|NCT02715687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25203177|NCT02715947|Methotrexate|methotrexate|mesh-list
25203178|NCT02715947|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25203179|NCT02715947|Abortifacient Agents|abortifacient agents|mesh-ancestor
25203180|NCT02715947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25203181|NCT02715947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203182|NCT02715947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25203183|NCT02715947|Antimetabolites|antimetabolites|mesh-ancestor
25203184|NCT02715947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203185|NCT02715947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25203186|NCT02715947|Dermatologic Agents|dermatologic agents|mesh-ancestor
25203187|NCT02715947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203188|NCT02715947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25203189|NCT02715947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25203190|NCT02715947|Immunologic Factors|immunologic factors|mesh-ancestor
25203191|NCT02715947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25203192|NCT02715947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25203193|NCT02715960|Vitamin A|vitamin a|mesh-list
25203194|NCT02715960|Tretinoin|tretinoin|mesh-list
25203195|NCT02715960|Acitretin|acitretin|mesh-list
25203196|NCT02715960|Vitamins|vitamins|mesh-ancestor
25203197|NCT02715960|Micronutrients|micronutrients|mesh-ancestor
25203198|NCT02715960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203199|NCT02715960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25203200|NCT02715960|Keratolytic Agents|keratolytic agents|mesh-ancestor
25203201|NCT02715960|Dermatologic Agents|dermatologic agents|mesh-ancestor
25203202|NCT02715492|Enoxaparin|enoxaparin|mesh-list
25203203|NCT02715492|Anticoagulants|anticoagulants|mesh-ancestor
25203204|NCT02715492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25203205|NCT02715492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25203206|NCT02715492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203207|NCT02715531|Leucovorin|leucovorin|mesh-list
25203208|NCT02715531|Gemcitabine|gemcitabine|mesh-list
24451239|NCT00322751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841850|NCT00031109|Antacids|antacids|mesh-ancestor
25841851|NCT00031109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841852|NCT00031109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25841853|NCT00031135|Choline|choline|mesh-list
25841854|NCT00031135|Lipotropic Agents|lipotropic agents|mesh-ancestor
25841855|NCT00031135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25841856|NCT00031135|Antimetabolites|antimetabolites|mesh-ancestor
25841857|NCT00031135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841858|NCT00031135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25841859|NCT00031135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25841860|NCT00031135|Nootropic Agents|nootropic agents|mesh-ancestor
25841861|NCT00031148|Mitogens|mitogens|mesh-list
24810911|NCT02043340|Photosensitizing Agents|photosensitizing agents|mesh-list
24810912|NCT02043340|Dermatologic Agents|dermatologic agents|mesh-ancestor
24461649|NCT00353028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461650|NCT00353028|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24461651|NCT00353028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24461652|NCT00353028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24461653|NCT00353028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461654|NCT00353028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24461655|NCT00353028|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24461656|NCT00353028|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24461715|NCT00353184|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24462064|NCT00354757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461718|NCT00353184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810916|NCT02043665|Pembrolizumab|pembrolizumab|mesh-list
24810917|NCT02043665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24810918|NCT02043665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810919|NCT02043717|Vitamin D|vitamin d|mesh-list
24810920|NCT02043717|Vitamins|vitamins|mesh-ancestor
24810921|NCT02043717|Micronutrients|micronutrients|mesh-ancestor
25660642|NCT01623310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25660643|NCT01623310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25841863|NCT00031148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841864|NCT00031161|Nitisinone|nitisinone|mesh-list
25841865|NCT00031161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841866|NCT00031161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841867|NCT00031187|Docetaxel|docetaxel|mesh-list
25841868|NCT00031187|Doxorubicin|doxorubicin|mesh-list
25841869|NCT00031187|Immunoconjugates|immunoconjugates|mesh-list
25841870|NCT00031187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841871|NCT00031187|Tubulin Modulators|tubulin modulators|mesh-ancestor
25841872|NCT00031187|Antimitotic Agents|antimitotic agents|mesh-ancestor
24516323|NCT00601536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24516327|NCT00601562|Antimetabolites|antimetabolites|mesh-ancestor
24461719|NCT00353184|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24461720|NCT00353184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24461721|NCT00353184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461722|NCT00353340|Acetylcysteine|acetylcysteine|mesh-list
24491919|NCT00484575|Propofol|propofol|mesh-list
24461724|NCT00353340|Antiviral Agents|antiviral agents|mesh-ancestor
24461725|NCT00353340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24461727|NCT00353340|Respiratory System Agents|respiratory system agents|mesh-ancestor
24461728|NCT00353340|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24461729|NCT00353340|Antioxidants|antioxidants|mesh-ancestor
24461730|NCT00353340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461731|NCT00353340|Protective Agents|protective agents|mesh-ancestor
24461732|NCT00353340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461733|NCT00353340|Antidotes|antidotes|mesh-ancestor
24461735|NCT00353379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24461736|NCT00353379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24461737|NCT00353379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24461738|NCT00353379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24461739|NCT00353379|Adrenergic Agents|adrenergic agents|mesh-ancestor
24461740|NCT00353379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24461741|NCT00353379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461764|NCT00353665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24461765|NCT00353665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24461766|NCT00353665|Anticonvulsants|anticonvulsants|mesh-ancestor
24461767|NCT00353665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24461768|NCT00353665|Protective Agents|protective agents|mesh-ancestor
24461770|NCT00353678|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25164608|NCT05310786|Analgesics, Opioid|analgesics, opioid|mesh-list
24461771|NCT00353678|Antithrombins|antithrombins|mesh-ancestor
24461772|NCT00353678|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24461773|NCT00353678|Protease Inhibitors|protease inhibitors|mesh-ancestor
24461774|NCT00353678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461775|NCT00353678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461776|NCT00353678|Anticoagulants|anticoagulants|mesh-ancestor
24461777|NCT00353691|Metformin|metformin|mesh-list
24461778|NCT00353691|Glimepiride|glimepiride|mesh-list
24461779|NCT00353691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24461780|NCT00353691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461781|NCT00353691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24461784|NCT00353717|Paclitaxel|paclitaxel|mesh-list
24461785|NCT00353717|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24461786|NCT00353717|Cetuximab|cetuximab|mesh-list
24461787|NCT00353717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24461788|NCT00353717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461789|NCT00353717|Tubulin Modulators|tubulin modulators|mesh-ancestor
24461790|NCT00353717|Antimitotic Agents|antimitotic agents|mesh-ancestor
24461791|NCT00353717|Mitosis Modulators|mitosis modulators|mesh-ancestor
24505090|NCT00539773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24461799|NCT00353743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24461800|NCT00353743|Antimalarials|antimalarials|mesh-ancestor
24461801|NCT00353808|Reboxetine|reboxetine|mesh-list
24461802|NCT00353808|Antidepressive Agents|antidepressive agents|mesh-ancestor
24461803|NCT00353808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24775974|NCT01855971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660644|NCT01623310|Autonomic Agents|autonomic agents|mesh-ancestor
25660645|NCT01623310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25660646|NCT01623310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660647|NCT01623310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25660648|NCT01623310|Respiratory System Agents|respiratory system agents|mesh-ancestor
25660649|NCT01623310|Dermatologic Agents|dermatologic agents|mesh-ancestor
25660650|NCT01623310|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25660651|NCT01623323|Fluticasone|fluticasone|mesh-list
25660652|NCT01623323|Xhance|xhance|mesh-list
24775975|NCT01855971|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24776041|NCT01856166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24776044|NCT01856166|Anesthetics|anesthetics|mesh-ancestor
24461804|NCT00353808|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24461805|NCT00353808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24461806|NCT00353808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24461807|NCT00353808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461809|NCT00353808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24810922|NCT02043717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810923|NCT02043717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24606205|NCT00989469|Irinotecan|irinotecan|mesh-list
24810924|NCT02043730|Gemcitabine|gemcitabine|mesh-list
24810942|NCT02043756|Sensory System Agents|sensory system agents|mesh-ancestor
24609323|NCT00996060|Hydralazine|hydralazine|mesh-list
24461810|NCT00353808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461811|NCT00353912|Amlodipine|amlodipine|mesh-list
24461812|NCT00353912|Valsartan|valsartan|mesh-list
24461813|NCT00353912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24461814|NCT00353912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24430813|NCT00249366|Lorazepam|lorazepam|mesh-list
24461815|NCT00353912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24461816|NCT00353912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461817|NCT00353912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24461818|NCT00353912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461819|NCT00353912|Vasodilator Agents|vasodilator agents|mesh-ancestor
24461820|NCT00353912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24461822|NCT00353990|Insulin Aspart|insulin aspart|mesh-list
24461823|NCT00353990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24461824|NCT00353990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461825|NCT00354068|Temozolomide|temozolomide|mesh-list
24461826|NCT00354068|Imatinib Mesylate|imatinib mesylate|mesh-list
24461827|NCT00354068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24461828|NCT00354068|Alkylating Agents|alkylating agents|mesh-ancestor
24461829|NCT00354068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461830|NCT00354068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24430948|NCT00249860|Interferons|interferons|mesh-list
24461831|NCT00354068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24461832|NCT00354068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461834|NCT00354081|Folic Acid|folic acid|mesh-list
24461835|NCT00354081|Hydroxocobalamin|hydroxocobalamin|mesh-list
24461836|NCT00354081|Vitamin B 12|vitamin b 12|mesh-list
24461837|NCT00354081|Pyridoxine|pyridoxine|mesh-list
24810943|NCT02043756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24810944|NCT02043756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810945|NCT02043756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810946|NCT02043756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24810947|NCT02043756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24810948|NCT02043756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25164609|NCT05310786|Narcotics|narcotics|mesh-ancestor
24810949|NCT02043756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810950|NCT02043821|Capecitabine|capecitabine|mesh-list
25841873|NCT00031187|Mitosis Modulators|mitosis modulators|mesh-ancestor
25841874|NCT00031187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841875|NCT00031187|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25841876|NCT00031187|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25841877|NCT00031187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25841878|NCT00031187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841879|NCT00031187|Immunologic Factors|immunologic factors|mesh-ancestor
25841880|NCT00031187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841881|NCT00031278|Trastuzumab|trastuzumab|mesh-list
25841882|NCT00031278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25841883|NCT00031278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841884|NCT00031291|Immunoglobulins|immunoglobulins|mesh-list
25841885|NCT00031291|Antibodies|antibodies|mesh-list
25841886|NCT00031291|gamma-Globulins|gamma-globulins|mesh-list
25841887|NCT00031291|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25841888|NCT00031291|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25841889|NCT00031291|Immunologic Factors|immunologic factors|mesh-ancestor
24828940|NCT02148432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24828941|NCT02148432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24828942|NCT02148432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828943|NCT02148432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24828944|NCT02148432|Analgesics|analgesics|mesh-ancestor
24828945|NCT02148432|Sensory System Agents|sensory system agents|mesh-ancestor
24828946|NCT02148432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25841890|NCT00031291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875675|NCT04232553|Sensory System Agents|sensory system agents|mesh-ancestor
25875676|NCT04232553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25660653|NCT01623323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25660654|NCT01623323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25660655|NCT01623323|Autonomic Agents|autonomic agents|mesh-ancestor
25164610|NCT05310786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25164611|NCT05310786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164612|NCT05310786|Analgesics|analgesics|mesh-ancestor
24461853|NCT00354094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461855|NCT00354146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461856|NCT00354185|Belinostat|belinostat|mesh-list
24461857|NCT00354185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461871|NCT00354198|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24461872|NCT00354198|Antioxidants|antioxidants|mesh-ancestor
24461874|NCT00354198|Glucocorticoids|glucocorticoids|mesh-ancestor
24461885|NCT00354276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461886|NCT00354276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461887|NCT00354276|Antiviral Agents|antiviral agents|mesh-ancestor
24461888|NCT00354276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24461889|NCT00354276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24461890|NCT00354276|Immunologic Factors|immunologic factors|mesh-ancestor
24461891|NCT00354276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461892|NCT00354302|Calcium, Dietary|calcium, dietary|mesh-list
24461893|NCT00354302|Cholecalciferol|cholecalciferol|mesh-list
24461895|NCT00354302|Risedronic Acid|risedronic acid|mesh-list
24461896|NCT00354302|Calcium Carbonate|calcium carbonate|mesh-list
24461897|NCT00354302|Calcium|calcium|mesh-list
24461898|NCT00354302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24431131|NCT00250536|Nandrolone|nandrolone|mesh-list
24461900|NCT00354302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24462063|NCT00354757|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24461901|NCT00354302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461902|NCT00354302|Vitamins|vitamins|mesh-ancestor
24461903|NCT00354302|Micronutrients|micronutrients|mesh-ancestor
24461904|NCT00354302|Antacids|antacids|mesh-ancestor
24461905|NCT00354302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25875677|NCT04232553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875678|NCT04232553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25875679|NCT04232553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24537214|NCT00653965|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24537215|NCT00653965|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24537216|NCT00653965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25875680|NCT04232553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25875681|NCT04232553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25875682|NCT04224493|Rituximab|rituximab|mesh-list
25875683|NCT04224493|Lenalidomide|lenalidomide|mesh-list
25875684|NCT04224493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25875685|NCT04224493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875686|NCT04224493|Immunologic Factors|immunologic factors|mesh-ancestor
25875687|NCT04224493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875688|NCT04224493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25875689|NCT04224493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25875690|NCT04224493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25875691|NCT04224493|Growth Substances|growth substances|mesh-ancestor
25875692|NCT04224493|Growth Inhibitors|growth inhibitors|mesh-ancestor
25875693|NCT04216290|Gemcitabine|gemcitabine|mesh-list
25875694|NCT04216290|Cisplatin|cisplatin|mesh-list
24461937|NCT00354380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461939|NCT00354393|Vinorelbine|vinorelbine|mesh-list
24461940|NCT00354393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461941|NCT00354393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24461942|NCT00354393|Abortifacient Agents|abortifacient agents|mesh-ancestor
24461943|NCT00354393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24461944|NCT00354393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461945|NCT00354393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24461946|NCT00354393|Antimetabolites|antimetabolites|mesh-ancestor
24828984|NCT02148861|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24537228|NCT00654017|Urological Agents|urological agents|mesh-ancestor
24537229|NCT00654043|Torsemide|torsemide|mesh-list
24537230|NCT00654043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24537231|NCT00654043|Diuretics|diuretics|mesh-ancestor
24537232|NCT00654043|Natriuretic Agents|natriuretic agents|mesh-ancestor
25660656|NCT01623323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25660657|NCT01623323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660658|NCT01623323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25660659|NCT01623323|Respiratory System Agents|respiratory system agents|mesh-ancestor
25201735|NCT02725398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201736|NCT02725398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25201737|NCT02725398|Mydriatics|mydriatics|mesh-ancestor
25201738|NCT02725398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25201739|NCT02725398|Cholinergic Agents|cholinergic agents|mesh-ancestor
25660660|NCT01623323|Dermatologic Agents|dermatologic agents|mesh-ancestor
25841891|NCT00031317|Clozapine|clozapine|mesh-list
25841892|NCT00031317|Paroxetine|paroxetine|mesh-list
25841893|NCT00031317|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25841894|NCT00031317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25841895|NCT00031317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24461947|NCT00354393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461948|NCT00354393|Dermatologic Agents|dermatologic agents|mesh-ancestor
24461949|NCT00354393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461950|NCT00354393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24461951|NCT00354393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24461952|NCT00354393|Immunologic Factors|immunologic factors|mesh-ancestor
24461953|NCT00354393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24461954|NCT00354393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24461955|NCT00354393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24461956|NCT00354393|Tubulin Modulators|tubulin modulators|mesh-ancestor
24461957|NCT00354393|Antimitotic Agents|antimitotic agents|mesh-ancestor
24461958|NCT00354393|Mitosis Modulators|mitosis modulators|mesh-ancestor
24461959|NCT00354406|Abciximab|abciximab|mesh-list
24461960|NCT00354406|Anticoagulants|anticoagulants|mesh-ancestor
24462023|NCT00354549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24462025|NCT00354562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24462026|NCT00354562|Tubulin Modulators|tubulin modulators|mesh-ancestor
24462027|NCT00354562|Antimitotic Agents|antimitotic agents|mesh-ancestor
24664879|NCT01309126|Cetuximab|cetuximab|mesh-list
24462028|NCT00354562|Mitosis Modulators|mitosis modulators|mesh-ancestor
24462029|NCT00354562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462030|NCT00354627|Etravirine|etravirine|mesh-list
24462031|NCT00354627|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24462032|NCT00354627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24462059|NCT00354731|Antioxidants|antioxidants|mesh-ancestor
24462060|NCT00354757|Rabeprazole|rabeprazole|mesh-list
24462061|NCT00354757|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24462062|NCT00354757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24462065|NCT00354757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462068|NCT00354809|Autonomic Agents|autonomic agents|mesh-ancestor
24462069|NCT00354809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24462070|NCT00354809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462071|NCT00354809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24777085|NCT01861990|Antimanic Agents|antimanic agents|mesh-ancestor
24462072|NCT00354809|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24462073|NCT00354809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24462074|NCT00354809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810965|NCT02043912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24810966|NCT02043912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810967|NCT02043912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24810968|NCT02043912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24810969|NCT02043912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24810970|NCT02043912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24810971|NCT02043912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24810972|NCT02043912|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24810973|NCT02043912|Dopamine Agents|dopamine agents|mesh-ancestor
24810974|NCT02043912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24810975|NCT02043912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810976|NCT02043912|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25841896|NCT00031317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841897|NCT00031317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24810977|NCT02043977|Propofol|propofol|mesh-list
24810978|NCT02043977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24810979|NCT02043977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24810980|NCT02043977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462075|NCT00354861|Aluminum sulfate|aluminum sulfate|mesh-list
24462076|NCT00354861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24462077|NCT00354861|Immunologic Factors|immunologic factors|mesh-ancestor
25660661|NCT01623323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25660662|NCT01623466|Contraceptive Agents|contraceptive agents|mesh-list
25660663|NCT01623466|Levonorgestrel|levonorgestrel|mesh-list
25660664|NCT01623466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25660665|NCT01623466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841898|NCT00031317|Serotonin Agents|serotonin agents|mesh-ancestor
24462078|NCT00354861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777242|NCT01863173|Sympatholytics|sympatholytics|mesh-ancestor
24462080|NCT00354874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24462081|NCT00354874|Autonomic Agents|autonomic agents|mesh-ancestor
24462082|NCT00354874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24462083|NCT00354874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462084|NCT00354874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24462096|NCT00354900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24462115|NCT00354965|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24462116|NCT00354965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24462117|NCT00354965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24462118|NCT00354965|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24462126|NCT00354991|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24462127|NCT00354991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462128|NCT00354991|Diuretics|diuretics|mesh-ancestor
24462129|NCT00354991|Natriuretic Agents|natriuretic agents|mesh-ancestor
24462130|NCT00354991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462131|NCT00354991|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24462132|NCT00354991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24462133|NCT00355043|Zinc Sulfate|zinc sulfate|mesh-list
24810981|NCT02043977|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24810982|NCT02043977|Anesthetics, General|anesthetics, general|mesh-ancestor
24810983|NCT02043977|Anesthetics|anesthetics|mesh-ancestor
24810985|NCT02044120|Temozolomide|temozolomide|mesh-list
24810986|NCT02044120|Niraparib|niraparib|mesh-list
24810987|NCT02044120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24810988|NCT02044120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24462134|NCT00355043|Astringents|astringents|mesh-ancestor
24462135|NCT00355043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462136|NCT00355043|Dermatologic Agents|dermatologic agents|mesh-ancestor
24462137|NCT00355095|Epoetin Alfa|epoetin alfa|mesh-list
24462138|NCT00355095|Hematinics|hematinics|mesh-ancestor
24462139|NCT00355108|Tranexamic Acid|tranexamic acid|mesh-list
24462140|NCT00355108|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24462141|NCT00355108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24462142|NCT00355108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462143|NCT00355108|Hemostatics|hemostatics|mesh-ancestor
24462144|NCT00355108|Coagulants|coagulants|mesh-ancestor
24462145|NCT00355251|Atorvastatin|atorvastatin|mesh-list
24462146|NCT00355251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24462147|NCT00355251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24462148|NCT00355251|Antimetabolites|antimetabolites|mesh-ancestor
24777333|NCT01863511|Natriuretic Agents|natriuretic agents|mesh-ancestor
24462182|NCT00355303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462264|NCT00355602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24462265|NCT00355602|Antimalarials|antimalarials|mesh-ancestor
25841899|NCT00031317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462266|NCT00355602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24462267|NCT00355602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24462268|NCT00355602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810989|NCT02044120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24810990|NCT02044120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914872|NCT04251364|Acetazolamide|acetazolamide|mesh-list
24810991|NCT02044120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680637|NCT01375699|Doxorubicin|doxorubicin|mesh-list
24462269|NCT00355602|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24828985|NCT02148861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24828986|NCT02148861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828987|NCT02148913|Melphalan|melphalan|mesh-list
24828988|NCT02148913|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24828989|NCT02148913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24829030|NCT02149329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24829031|NCT02149329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24829032|NCT02149329|Protease Inhibitors|protease inhibitors|mesh-ancestor
24829033|NCT02149329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829034|NCT02149329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829035|NCT02149407|Glycerol|glycerol|mesh-list
24829036|NCT02149407|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25841900|NCT00031317|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25841901|NCT00031317|Antidepressive Agents|antidepressive agents|mesh-ancestor
25841902|NCT00031317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25841903|NCT00031317|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25841904|NCT00031317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25660666|NCT01623466|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25660667|NCT01623466|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25841905|NCT00031317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841906|NCT00031317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25841907|NCT00031317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25841908|NCT00031317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25841909|NCT00031317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25841910|NCT00031317|GABA Antagonists|gaba antagonists|mesh-ancestor
25841912|NCT00031343|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25841913|NCT00031343|Antiviral Agents|antiviral agents|mesh-ancestor
25841914|NCT00031343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25201759|NCT02725255|Albendazole|albendazole|mesh-list
24516455|NCT00602017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841915|NCT00031395|Clonidine|clonidine|mesh-list
25841916|NCT00031395|Methylphenidate|methylphenidate|mesh-list
25841917|NCT00031395|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25841918|NCT00031395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841919|NCT00031395|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25164664|NCT05265052|Oxycodone|oxycodone|mesh-list
25164665|NCT05265052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25164666|NCT05265052|Narcotics|narcotics|mesh-ancestor
25164667|NCT05265052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25164668|NCT05265052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164669|NCT05265052|Analgesics|analgesics|mesh-ancestor
25164670|NCT05265052|Sensory System Agents|sensory system agents|mesh-ancestor
25164671|NCT05265052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24462270|NCT00355602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24462271|NCT00355602|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24462273|NCT00355602|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24462275|NCT00355628|Citric Acid|citric acid|mesh-list
24462276|NCT00355628|Sodium Citrate|sodium citrate|mesh-list
24462277|NCT00355628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24462278|NCT00355628|Narcotics|narcotics|mesh-ancestor
24462279|NCT00355628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24462280|NCT00355628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462281|NCT00355628|Analgesics|analgesics|mesh-ancestor
24462282|NCT00355628|Sensory System Agents|sensory system agents|mesh-ancestor
24462283|NCT00355628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24462284|NCT00355628|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24462285|NCT00355628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24462286|NCT00355628|Anesthetics, General|anesthetics, general|mesh-ancestor
24462287|NCT00355628|Anesthetics|anesthetics|mesh-ancestor
24462288|NCT00355628|Anticoagulants|anticoagulants|mesh-ancestor
24462412|NCT00356070|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24462413|NCT00356070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24462414|NCT00356070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24462443|NCT00356226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462444|NCT00356226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24462445|NCT00356226|Sympatholytics|sympatholytics|mesh-ancestor
24462446|NCT00356226|Autonomic Agents|autonomic agents|mesh-ancestor
24462447|NCT00356226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24462448|NCT00356226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24462449|NCT00356226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24462450|NCT00356226|Adrenergic Agents|adrenergic agents|mesh-ancestor
24462451|NCT00356226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24462452|NCT00356226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462453|NCT00356252|Carotenoids|carotenoids|mesh-list
24462454|NCT00356252|Antioxidants|antioxidants|mesh-ancestor
24462455|NCT00356252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462456|NCT00356252|Protective Agents|protective agents|mesh-ancestor
24505093|NCT00539786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24810992|NCT02044120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25660668|NCT01623466|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25660669|NCT01623466|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25660670|NCT01623479|Bimatoprost|bimatoprost|mesh-list
25660671|NCT01623479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25660672|NCT01623596|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25660673|NCT01623596|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25660674|NCT01623596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660675|NCT01623596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25660676|NCT01623596|Immunologic Factors|immunologic factors|mesh-ancestor
25660677|NCT01623596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660678|NCT01623752|Etanercept|etanercept|mesh-list
25660679|NCT01623752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25841921|NCT00031395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25841922|NCT00031395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516514|NCT00602186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516515|NCT00602186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810994|NCT02044120|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24462493|NCT00356460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462494|NCT00356473|Atorvastatin|atorvastatin|mesh-list
24462495|NCT00356473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24462496|NCT00356473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24462497|NCT00356473|Antimetabolites|antimetabolites|mesh-ancestor
24462498|NCT00356473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462499|NCT00356473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24462522|NCT00356720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24462523|NCT00356720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24462524|NCT00356733|Epoetin Alfa|epoetin alfa|mesh-list
24462525|NCT00356733|Hematinics|hematinics|mesh-ancestor
24462526|NCT00356772|Azithromycin|azithromycin|mesh-list
24462527|NCT00356772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24462528|NCT00356772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24462530|NCT00356824|Amodiaquine|amodiaquine|mesh-list
24462531|NCT00356824|Antimalarials|antimalarials|mesh-ancestor
24462532|NCT00356824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24462533|NCT00356824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24462534|NCT00356824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24462535|NCT00356824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24462536|NCT00356824|Antiviral Agents|antiviral agents|mesh-ancestor
24462537|NCT00356824|Schistosomicides|schistosomicides|mesh-ancestor
24462538|NCT00356824|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24462539|NCT00356824|Anthelmintics|anthelmintics|mesh-ancestor
24462540|NCT00356850|Azithromycin|azithromycin|mesh-list
24462541|NCT00356850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24462542|NCT00356850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24462592|NCT00357045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24462593|NCT00357045|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24436180|NCT00269243|Protease Inhibitors|protease inhibitors|mesh-ancestor
24462594|NCT00357045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24462595|NCT00357045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24437047|NCT00272558|Tubulin Modulators|tubulin modulators|mesh-ancestor
24462627|NCT00357084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24462629|NCT00357084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24462630|NCT00357084|Protective Agents|protective agents|mesh-ancestor
24462631|NCT00357123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24462670|NCT00357188|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24462671|NCT00357188|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24462672|NCT00357188|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24462673|NCT00357240|Ritonavir|ritonavir|mesh-list
24462674|NCT00357240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24462675|NCT00357240|Omeprazole|omeprazole|mesh-list
25841924|NCT00031395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24462680|NCT00357240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462682|NCT00357240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24462683|NCT00357240|Antiviral Agents|antiviral agents|mesh-ancestor
24462684|NCT00357240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24664945|NCT01309438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24440780|NCT00284778|Docetaxel|docetaxel|mesh-list
24462722|NCT00357318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24462723|NCT00357318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24462731|NCT00357318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462732|NCT00357383|Azithromycin|azithromycin|mesh-list
24462733|NCT00357383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24462734|NCT00357383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25841925|NCT00031395|Analgesics|analgesics|mesh-ancestor
25841926|NCT00031395|Sensory System Agents|sensory system agents|mesh-ancestor
25841927|NCT00031395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25841928|NCT00031395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25841929|NCT00031395|Sympatholytics|sympatholytics|mesh-ancestor
25660680|NCT01623752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25660681|NCT01623752|Analgesics|analgesics|mesh-ancestor
25660682|NCT01623752|Sensory System Agents|sensory system agents|mesh-ancestor
25660683|NCT01623752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25660684|NCT01623752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897158|NCT04428268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897159|NCT04428268|Amebicides|amebicides|mesh-ancestor
24897160|NCT04428268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24897161|NCT04428268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24897162|NCT04428268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24897163|NCT04428268|Antimalarials|antimalarials|mesh-ancestor
24897164|NCT04428268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24897165|NCT04428268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24897166|NCT04428268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25841930|NCT00031395|Autonomic Agents|autonomic agents|mesh-ancestor
25841931|NCT00031395|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24462736|NCT00357422|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24462737|NCT00357422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24441271|NCT00286923|Topiramate|topiramate|mesh-list
24441341|NCT00287209|Amiodarone|amiodarone|mesh-list
24462739|NCT00357422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462740|NCT00357448|Interleukin-2|interleukin-2|mesh-list
24606434|NCT00990418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24606435|NCT00990418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24606436|NCT00990418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24606437|NCT00990418|Anesthetics, General|anesthetics, general|mesh-ancestor
24462769|NCT00357604|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24462771|NCT00357604|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24462772|NCT00357604|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24462773|NCT00357604|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24462774|NCT00357604|Norgestimate|norgestimate|mesh-list
24462775|NCT00357604|Norgestrel|norgestrel|mesh-list
24442223|NCT00290602|Hormones|hormones|mesh-ancestor
24462776|NCT00357604|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24462777|NCT00357604|Estradiol|estradiol|mesh-list
24462780|NCT00357604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24462781|NCT00357604|Protease Inhibitors|protease inhibitors|mesh-ancestor
24462808|NCT00357617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24462809|NCT00357617|Analgesics|analgesics|mesh-ancestor
24462810|NCT00357617|Sensory System Agents|sensory system agents|mesh-ancestor
24462811|NCT00357617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24462812|NCT00357617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462813|NCT00357617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24462814|NCT00357617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25841932|NCT00031395|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25841933|NCT00031395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25841934|NCT00031395|Adrenergic Agents|adrenergic agents|mesh-ancestor
25841935|NCT00031434|Valganciclovir|valganciclovir|mesh-list
24462815|NCT00357617|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24462816|NCT00357617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24462817|NCT00357617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462818|NCT00357617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442533|NCT00291382|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24462820|NCT00357630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24628910|NCT01101815|Sensory System Agents|sensory system agents|mesh-ancestor
24628911|NCT01101815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24628912|NCT01101893|Raltegravir Potassium|raltegravir potassium|mesh-list
24628913|NCT01101893|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24628914|NCT01101893|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24628915|NCT01101893|Antiviral Agents|antiviral agents|mesh-ancestor
24628916|NCT01101893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24628917|NCT01101893|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24628918|NCT01101893|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24628958|NCT01102335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628959|NCT01102335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628960|NCT01102387|Octenidine|octenidine|mesh-list
24628961|NCT01102387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24606438|NCT00990418|Anesthetics|anesthetics|mesh-ancestor
24606439|NCT00990444|Insulin|insulin|mesh-list
24628962|NCT01102387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24628963|NCT01102439|Aspirin|aspirin|mesh-list
25660685|NCT01623752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25660686|NCT01623752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25660687|NCT01623752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25660688|NCT01623752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25660689|NCT01623752|Immunologic Factors|immunologic factors|mesh-ancestor
25660690|NCT01623869|Trebananib|trebananib|mesh-list
25660691|NCT01623869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25660692|NCT01623869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25660693|NCT01623869|Growth Substances|growth substances|mesh-ancestor
24628964|NCT01102439|Clopidogrel|clopidogrel|mesh-list
24629009|NCT01102595|Bevacizumab|bevacizumab|mesh-list
25841936|NCT00031434|Ganciclovir|ganciclovir|mesh-list
24629010|NCT01102595|Temozolomide|temozolomide|mesh-list
24629011|NCT01102595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24629012|NCT01102595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629013|NCT01102595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24629014|NCT01102595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25841937|NCT00031434|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
24629015|NCT01102595|Growth Substances|growth substances|mesh-ancestor
25841938|NCT00031434|Antiviral Agents|antiviral agents|mesh-ancestor
25841939|NCT00031434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24629019|NCT01102595|Alkylating Agents|alkylating agents|mesh-ancestor
24629020|NCT01102595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629021|NCT01102608|Ifosfamide|ifosfamide|mesh-list
24629022|NCT01102608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24629024|NCT01102608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462829|NCT00357630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462830|NCT00357643|Vitamin D|vitamin d|mesh-list
24629026|NCT01102673|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
24629028|NCT01102673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629029|NCT01102686|Leucovorin|leucovorin|mesh-list
24629030|NCT01102686|Pyrimethamine|pyrimethamine|mesh-list
24629041|NCT01102686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24629042|NCT01102686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462831|NCT00357643|Calcium|calcium|mesh-list
24462832|NCT00357643|Vitamins|vitamins|mesh-ancestor
24462833|NCT00357643|Micronutrients|micronutrients|mesh-ancestor
24505095|NCT00539786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24629069|NCT01103115|Calcium Carbonate|calcium carbonate|mesh-list
25841940|NCT00031434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25841941|NCT00031434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841942|NCT00031434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841943|NCT00031473|Ribavirin|ribavirin|mesh-list
25841944|NCT00031473|Antimetabolites|antimetabolites|mesh-ancestor
25841945|NCT00031473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841946|NCT00031473|Antiviral Agents|antiviral agents|mesh-ancestor
25841947|NCT00031473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25841948|NCT00031499|Azithromycin|azithromycin|mesh-list
24829116|NCT02149927|Anesthetics|anesthetics|mesh-ancestor
24829117|NCT02149927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24829118|NCT02149927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829124|NCT02149992|Inositol|inositol|mesh-list
25164730|NCT05233228|Nicotine|nicotine|mesh-list
25164731|NCT05233228|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25164732|NCT05233228|Autonomic Agents|autonomic agents|mesh-ancestor
25164733|NCT05233228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25164734|NCT05233228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164735|NCT05233228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25164736|NCT05233228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25164737|NCT05233228|Cholinergic Agents|cholinergic agents|mesh-ancestor
25164738|NCT05233228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25164739|NCT05233228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164740|NCT05228314|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25164741|NCT05228314|Vaccines|vaccines|mesh-list
25164742|NCT05228314|Aluminum sulfate|aluminum sulfate|mesh-list
25164743|NCT05228314|Immunologic Factors|immunologic factors|mesh-ancestor
25164744|NCT05228314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164745|NCT05228314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25164746|NCT05228314|Antacids|antacids|mesh-ancestor
25164747|NCT05228314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164748|NCT05228314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25164749|NCT05223478|Phentolamine|phentolamine|mesh-list
25164750|NCT05223478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25164751|NCT05223478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25164752|NCT05223478|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25164753|NCT05223478|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25164754|NCT05223478|Adrenergic Agents|adrenergic agents|mesh-ancestor
24916070|NCT04245046|Antimetabolites|antimetabolites|mesh-ancestor
25164755|NCT05223478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25164756|NCT05223478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164757|NCT05223478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164758|NCT05223478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25164759|NCT05220046|Psilocybin|psilocybin|mesh-list
25164763|NCT05219409|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24629074|NCT01103115|Vitamins|vitamins|mesh-ancestor
24629075|NCT01103115|Micronutrients|micronutrients|mesh-ancestor
25841949|NCT00031499|Doxycycline|doxycycline|mesh-list
25415962|NCT02980510|Fluorouracil|fluorouracil|mesh-list
25660694|NCT01623869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841950|NCT00031499|Penicillins|penicillins|mesh-list
25841951|NCT00031499|Penicillin G Benzathine|penicillin g benzathine|mesh-list
25841952|NCT00031499|Penicillin G|penicillin g|mesh-list
25841953|NCT00031499|Penicillin G Procaine|penicillin g procaine|mesh-list
25841954|NCT00031499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24462834|NCT00357643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629077|NCT01103115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629078|NCT01103115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24629079|NCT01103154|Nadolol|nadolol|mesh-list
24629080|NCT01103154|Carvedilol|carvedilol|mesh-list
24629097|NCT01103154|Sympatholytics|sympatholytics|mesh-ancestor
24629098|NCT01103154|Autonomic Agents|autonomic agents|mesh-ancestor
24629100|NCT01103193|Remifentanil|remifentanil|mesh-list
24629105|NCT01103193|Anesthetics|anesthetics|mesh-ancestor
24629106|NCT01103193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24629107|NCT01103193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629108|NCT01103193|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24606441|NCT00990444|Dextrans|dextrans|mesh-list
24606442|NCT00990444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24606443|NCT00990444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606444|NCT00990444|Anticoagulants|anticoagulants|mesh-ancestor
24606445|NCT00990444|Plasma Substitutes|plasma substitutes|mesh-ancestor
24623060|NCT01070030|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24623061|NCT01070030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24623062|NCT01070030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24629109|NCT01103193|Narcotics|narcotics|mesh-ancestor
24629110|NCT01103193|Analgesics|analgesics|mesh-ancestor
24629111|NCT01103193|Sensory System Agents|sensory system agents|mesh-ancestor
24629114|NCT01103206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24629115|NCT01103206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629116|NCT01103206|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24629117|NCT01103206|Hormone Antagonists|hormone antagonists|mesh-ancestor
24629118|NCT01103206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24629120|NCT01103336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24629121|NCT01103336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24629122|NCT01103336|Vasodilator Agents|vasodilator agents|mesh-ancestor
24629123|NCT01103336|Vitamin B Complex|vitamin b complex|mesh-ancestor
25841955|NCT00031499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25841956|NCT00031499|Antimalarials|antimalarials|mesh-ancestor
24629132|NCT01103375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629133|NCT01103375|Dermatologic Agents|dermatologic agents|mesh-ancestor
24629135|NCT01103388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24629196|NCT01103609|Anticoagulants|anticoagulants|mesh-ancestor
24629197|NCT01103622|Digoxin|digoxin|mesh-list
24629198|NCT01103622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24629199|NCT01103622|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24629200|NCT01103622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24629201|NCT01103622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629202|NCT01103622|Protective Agents|protective agents|mesh-ancestor
24629203|NCT01103622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629204|NCT01103635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24629205|NCT01103635|Ipilimumab|ipilimumab|mesh-list
24629206|NCT01103635|Tremelimumab|tremelimumab|mesh-list
24629207|NCT01103635|Antibodies|antibodies|mesh-list
24629208|NCT01103635|Immunoglobulins|immunoglobulins|mesh-list
24629209|NCT01103635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24629210|NCT01103635|Immunologic Factors|immunologic factors|mesh-ancestor
24778761|NCT01872403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629211|NCT01103635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629212|NCT01103635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629213|NCT01103635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24629214|NCT01103635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660695|NCT01623869|Growth Inhibitors|growth inhibitors|mesh-ancestor
25660696|NCT01623869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25660697|NCT01624090|Plicamycin|plicamycin|mesh-list
25660698|NCT01624090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25660699|NCT01624090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660700|NCT01624090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25660701|NCT01624090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25660702|NCT01624090|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25660703|NCT01624090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25660704|NCT01624090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660705|NCT01624090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25660706|NCT01624142|Evolocumab|evolocumab|mesh-list
24474336|NCT00405717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516626|NCT00602615|Torsemide|torsemide|mesh-list
25841957|NCT00031499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24503031|NCT03539614|Prazosin|prazosin|mesh-list
24623072|NCT01070108|Analgesics|analgesics|mesh-ancestor
24623073|NCT01070108|Sensory System Agents|sensory system agents|mesh-ancestor
24623074|NCT01070108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24623075|NCT01070108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623076|NCT01070108|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24623077|NCT01070108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24623078|NCT01070108|Anesthetics, General|anesthetics, general|mesh-ancestor
24623079|NCT01070108|Anesthetics|anesthetics|mesh-ancestor
24623080|NCT01070108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24859021|NCT02301130|Mogamulizumab|mogamulizumab|mesh-list
24629258|NCT01103830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24537635|NCT00655603|Pancrelipase|pancrelipase|mesh-list
25841958|NCT00031499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24629259|NCT01103830|Contraceptive Agents|contraceptive agents|mesh-ancestor
24505311|NCT00540891|Alfuzosin|alfuzosin|mesh-list
24629299|NCT01104298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24778909|NCT01872884|Anesthetics|anesthetics|mesh-ancestor
24629300|NCT01104298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505123|NCT00540072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24629325|NCT01104519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629326|NCT01104532|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24629328|NCT01104532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24629329|NCT01104532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629330|NCT01104532|Incretins|incretins|mesh-ancestor
24629331|NCT01104532|Hormones|hormones|mesh-ancestor
24629332|NCT01104532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24629333|NCT01104532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24629334|NCT01104532|Protease Inhibitors|protease inhibitors|mesh-ancestor
24623081|NCT01070108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24623082|NCT01070108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25841959|NCT00031564|Aldesleukin|aldesleukin|mesh-list
25841960|NCT00031564|Interleukin-2|interleukin-2|mesh-list
25841961|NCT00031564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841962|NCT00031564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841963|NCT00031564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24623083|NCT01070108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24623084|NCT01070108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623085|NCT01070160|Metformin|metformin|mesh-list
24623086|NCT01070160|Progesterone|progesterone|mesh-list
24623087|NCT01070160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24623088|NCT01070160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164764|NCT05219409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24623089|NCT01070160|Progestins|progestins|mesh-ancestor
24629335|NCT01104532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24629336|NCT01104532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629337|NCT01104532|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24629338|NCT01104571|Trastuzumab|trastuzumab|mesh-list
24629339|NCT01104571|Lapatinib|lapatinib|mesh-list
24629340|NCT01104571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25841964|NCT00031564|Analgesics|analgesics|mesh-ancestor
24629341|NCT01104571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629342|NCT01104571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24629343|NCT01104571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505124|NCT00540072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24629371|NCT01104883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24629372|NCT01104883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24629373|NCT01104883|Trace Elements|trace elements|mesh-ancestor
24629374|NCT01104883|Micronutrients|micronutrients|mesh-ancestor
24629375|NCT01104883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629376|NCT01104896|Nicotine|nicotine|mesh-list
24629377|NCT01104896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24629378|NCT01104896|Autonomic Agents|autonomic agents|mesh-ancestor
24629379|NCT01104896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24629380|NCT01104896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629381|NCT01104896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24629382|NCT01104896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24629384|NCT01104896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25660707|NCT01624142|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25660708|NCT01624142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25841965|NCT00031564|Sensory System Agents|sensory system agents|mesh-ancestor
25660709|NCT01624142|Antimetabolites|antimetabolites|mesh-ancestor
25063134|NCT03112044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25063142|NCT03042143|Plasma-lyte 148|plasma-lyte 148|mesh-list
25063143|NCT03042143|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24825692|NCT02129634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24825693|NCT02129634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825694|NCT02129634|Tubulin Modulators|tubulin modulators|mesh-ancestor
24825695|NCT02129634|Antimitotic Agents|antimitotic agents|mesh-ancestor
25660710|NCT01624142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439802|NCT00280423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24629386|NCT01104935|Trastuzumab|trastuzumab|mesh-list
24629534|NCT01106001|Anesthetics, Local|anesthetics, local|mesh-ancestor
24629535|NCT01106001|Anesthetics|anesthetics|mesh-ancestor
24629536|NCT01106001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24629537|NCT01106001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629538|NCT01106001|Sensory System Agents|sensory system agents|mesh-ancestor
24623091|NCT01070160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24623092|NCT01070186|Sunitinib|sunitinib|mesh-list
24623093|NCT01070186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623094|NCT01070186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24623095|NCT01070186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24623117|NCT01070277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24623118|NCT01070277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24623119|NCT01070277|Anticestodal Agents|anticestodal agents|mesh-ancestor
24629539|NCT01106001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24629540|NCT01106053|Pramipexole|pramipexole|mesh-list
24629541|NCT01106053|Antioxidants|antioxidants|mesh-ancestor
24629542|NCT01106053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629543|NCT01106053|Protective Agents|protective agents|mesh-ancestor
25841966|NCT00031564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25841967|NCT00031564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25841968|NCT00031564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25841969|NCT00031564|Antiviral Agents|antiviral agents|mesh-ancestor
25841970|NCT00031564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25841971|NCT00031577|Paclitaxel|paclitaxel|mesh-list
24629544|NCT01106053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629545|NCT01106053|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24629546|NCT01106053|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24629547|NCT01106053|Dopamine Agonists|dopamine agonists|mesh-ancestor
24629548|NCT01106053|Dopamine Agents|dopamine agents|mesh-ancestor
24629549|NCT01106053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24629550|NCT01106066|Oxaliplatin|oxaliplatin|mesh-list
24629551|NCT01106066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629552|NCT01106118|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24629553|NCT01106118|Vasodilator Agents|vasodilator agents|mesh-ancestor
24629554|NCT01106118|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24629555|NCT01106118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24629556|NCT01106118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24629589|NCT01106495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24629591|NCT01106547|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24629592|NCT01106547|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24629593|NCT01106547|Prednisolone|prednisolone|mesh-list
24629594|NCT01106547|Prednisolone acetate|prednisolone acetate|mesh-list
24629595|NCT01106547|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24629596|NCT01106547|Prednisolone phosphate|prednisolone phosphate|mesh-list
24629665|NCT01107093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24629666|NCT01107093|Contraceptive Agents|contraceptive agents|mesh-ancestor
24629667|NCT01107093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24629668|NCT01107093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841972|NCT00031577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25841973|NCT00031577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841974|NCT00031577|Tubulin Modulators|tubulin modulators|mesh-ancestor
25041529|NCT02502669|Hormone Antagonists|hormone antagonists|mesh-ancestor
24811057|NCT02044549|Oxytocics|oxytocics|mesh-ancestor
25041530|NCT02502669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25660711|NCT01624142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25660712|NCT01624194|Oxytocin|oxytocin|mesh-list
25660713|NCT01624194|Oxytocics|oxytocics|mesh-ancestor
25660714|NCT01624194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25660715|NCT01624194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660716|NCT01624233|Ixekizumab|ixekizumab|mesh-list
25660717|NCT01624233|Dermatologic Agents|dermatologic agents|mesh-ancestor
25660718|NCT01624259|Metformin|metformin|mesh-list
25660719|NCT01624259|Liraglutide|liraglutide|mesh-list
25660720|NCT01624259|Dulaglutide|dulaglutide|mesh-list
25064208|NCT03462212|Mitosis Modulators|mitosis modulators|mesh-ancestor
25063149|NCT03029234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25041531|NCT02502669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041532|NCT02502669|Urological Agents|urological agents|mesh-ancestor
25041533|NCT02490488|Gemcitabine|gemcitabine|mesh-list
25041534|NCT02490488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25041535|NCT02490488|Antimetabolites|antimetabolites|mesh-ancestor
25041536|NCT02490488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041537|NCT02490488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041538|NCT02490488|Antiviral Agents|antiviral agents|mesh-ancestor
25041539|NCT02490488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25041540|NCT02490488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041541|NCT02490488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25041542|NCT02490488|Immunologic Factors|immunologic factors|mesh-ancestor
25041543|NCT02490488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041545|NCT02488408|Decitabine|decitabine|mesh-list
25041546|NCT02488408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25054447|NCT03529929|Hormones|hormones|mesh-ancestor
25164765|NCT05219409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164766|NCT05219409|Incretins|incretins|mesh-ancestor
25164767|NCT05219409|Hormones|hormones|mesh-ancestor
25164768|NCT05219409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25164769|NCT05219409|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25164770|NCT05219409|Protease Inhibitors|protease inhibitors|mesh-ancestor
25164771|NCT05219409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25164772|NCT05219409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203210|NCT02715531|Bevacizumab|bevacizumab|mesh-list
25203211|NCT02715531|Capecitabine|capecitabine|mesh-list
25203212|NCT02715531|Oxaliplatin|oxaliplatin|mesh-list
25203213|NCT02715531|Atezolizumab|atezolizumab|mesh-list
25203214|NCT02715531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25203215|NCT02715531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25203216|NCT02715531|Tubulin Modulators|tubulin modulators|mesh-ancestor
25203217|NCT02715531|Antimitotic Agents|antimitotic agents|mesh-ancestor
25203218|NCT02715531|Mitosis Modulators|mitosis modulators|mesh-ancestor
25203219|NCT02715531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203220|NCT02715531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25203221|NCT02715531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25203222|NCT02715531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25203223|NCT02715531|Growth Substances|growth substances|mesh-ancestor
25203224|NCT02715531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203225|NCT02715531|Growth Inhibitors|growth inhibitors|mesh-ancestor
25203226|NCT02715531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25203227|NCT02715531|Antimetabolites|antimetabolites|mesh-ancestor
25203228|NCT02715531|Antiviral Agents|antiviral agents|mesh-ancestor
25203229|NCT02715531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25203230|NCT02715531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203231|NCT02715531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25203232|NCT02715531|Immunologic Factors|immunologic factors|mesh-ancestor
25203234|NCT02715531|Protective Agents|protective agents|mesh-ancestor
25203235|NCT02715531|Vitamin B Complex|vitamin b complex|mesh-ancestor
25203236|NCT02715531|Vitamins|vitamins|mesh-ancestor
25203237|NCT02715531|Micronutrients|micronutrients|mesh-ancestor
25203238|NCT02715479|Dolutegravir|dolutegravir|mesh-list
25203239|NCT02715479|BMS-955176|bms-955176|mesh-list
25203240|NCT02715479|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25203241|NCT02715479|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25203242|NCT02715479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203243|NCT02715479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203244|NCT02715479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25203245|NCT02715479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25203246|NCT02715479|Antiviral Agents|antiviral agents|mesh-ancestor
25203247|NCT02715479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25203248|NCT02715336|Leuprolide|leuprolide|mesh-list
25203249|NCT02715336|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25203250|NCT02715336|Fertility Agents|fertility agents|mesh-ancestor
25203251|NCT02715336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25203252|NCT02715336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203253|NCT02715336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25203254|NCT02715336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629669|NCT01107093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24629670|NCT01107106|Ulipristal acetate|ulipristal acetate|mesh-list
24629671|NCT01107106|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25660721|NCT01624259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25660722|NCT01624259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629672|NCT01107106|Contraceptive Agents|contraceptive agents|mesh-ancestor
24629673|NCT01107106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24629674|NCT01107106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629675|NCT01107106|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24629677|NCT01107145|Chloroquine|chloroquine|mesh-list
24629678|NCT01107145|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24629679|NCT01107145|Lumefantrine|lumefantrine|mesh-list
24629680|NCT01107145|Artemether|artemether|mesh-list
24629681|NCT01107145|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24629751|NCT01107574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629753|NCT01107639|Docetaxel|docetaxel|mesh-list
24629754|NCT01107639|Cetuximab|cetuximab|mesh-list
24629755|NCT01107639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629756|NCT01107639|Tubulin Modulators|tubulin modulators|mesh-ancestor
24629757|NCT01107639|Antimitotic Agents|antimitotic agents|mesh-ancestor
24623120|NCT01070277|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24811011|NCT02044224|Dexmedetomidine|dexmedetomidine|mesh-list
24811012|NCT02044224|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24811013|NCT02044224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24811014|NCT02044224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811015|NCT02044224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24811016|NCT02044224|Analgesics|analgesics|mesh-ancestor
24859022|NCT02301130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24610288|NCT01001130|Autonomic Agents|autonomic agents|mesh-ancestor
24780241|NCT01882660|Decitabine|decitabine|mesh-list
24610289|NCT01001130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24629758|NCT01107639|Mitosis Modulators|mitosis modulators|mesh-ancestor
24629759|NCT01107639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629779|NCT01107808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629780|NCT01107808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24629781|NCT01107808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24629782|NCT01107808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24629783|NCT01107938|Esomeprazole|esomeprazole|mesh-list
24629784|NCT01107938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24629796|NCT01107951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24629799|NCT01107951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24629800|NCT01107951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24629801|NCT01107951|Glucocorticoids|glucocorticoids|mesh-ancestor
24629802|NCT01107951|Hormones|hormones|mesh-ancestor
24629803|NCT01107951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24629804|NCT01107951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24629805|NCT01108029|Memantine|memantine|mesh-list
24629806|NCT01108029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24629807|NCT01108029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24629841|NCT01108133|Dexamethasone|dexamethasone|mesh-list
24629842|NCT01108133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24629843|NCT01108133|Antiemetics|antiemetics|mesh-ancestor
24629844|NCT01108133|Autonomic Agents|autonomic agents|mesh-ancestor
24629845|NCT01108133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24629846|NCT01108133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629847|NCT01108133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24629848|NCT01108133|Glucocorticoids|glucocorticoids|mesh-ancestor
24811017|NCT02044224|Sensory System Agents|sensory system agents|mesh-ancestor
24811018|NCT02044224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24811019|NCT02044224|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24811020|NCT02044224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24811021|NCT02044224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24811022|NCT02044224|Adrenergic Agents|adrenergic agents|mesh-ancestor
24811023|NCT02044224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24811024|NCT02044224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811025|NCT02044250|Aspirin|aspirin|mesh-list
24811026|NCT02044250|Clopidogrel|clopidogrel|mesh-list
24811027|NCT02044250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24811028|NCT02044250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24780451|NCT01884441|Vinorelbine|vinorelbine|mesh-list
24811030|NCT02044250|Sensory System Agents|sensory system agents|mesh-ancestor
24811031|NCT02044250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24811032|NCT02044250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811033|NCT02044250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24811034|NCT02044250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24811035|NCT02044250|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24811036|NCT02044250|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24811037|NCT02044250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811038|NCT02044250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24811039|NCT02044250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24817664|NCT02085005|Antimetabolites|antimetabolites|mesh-ancestor
24817665|NCT02085005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817666|NCT02085005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24817667|NCT02085005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24817668|NCT02085005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24817669|NCT02085005|Growth Substances|growth substances|mesh-ancestor
24516785|NCT00603356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516786|NCT00603356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516787|NCT00603434|Methylphenidate|methylphenidate|mesh-list
24817693|NCT02085239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897489|NCT04425135|Carboplatin|carboplatin|mesh-list
24897491|NCT04425135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24897492|NCT04425135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24897493|NCT04425135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063205|NCT02835534|Plasminogen|plasminogen|mesh-list
24811040|NCT02044250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24630319|NCT01110824|Protective Agents|protective agents|mesh-ancestor
24629850|NCT01108133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24629851|NCT01108133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25841975|NCT00031577|Antimitotic Agents|antimitotic agents|mesh-ancestor
25841976|NCT00031577|Mitosis Modulators|mitosis modulators|mesh-ancestor
25875695|NCT04216290|Fluorouracil|fluorouracil|mesh-list
24629852|NCT01108133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629865|NCT01108289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629866|NCT01108302|Oxytocin|oxytocin|mesh-list
24629867|NCT01108302|Oxytocics|oxytocics|mesh-ancestor
24629868|NCT01108302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24629869|NCT01108302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629870|NCT01108393|S 20098|s 20098|mesh-list
24629872|NCT01108393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24629873|NCT01108393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629874|NCT01108562|Lidocaine|lidocaine|mesh-list
24629875|NCT01108562|Anesthetics, Local|anesthetics, local|mesh-ancestor
24780620|NCT01885338|Protective Agents|protective agents|mesh-ancestor
24629876|NCT01108562|Anesthetics|anesthetics|mesh-ancestor
24629877|NCT01108562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24811041|NCT02044250|Antipyretics|antipyretics|mesh-ancestor
24811042|NCT02044250|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24811043|NCT02044250|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24811044|NCT02044250|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24811045|NCT02044250|Purinergic Agents|purinergic agents|mesh-ancestor
24811047|NCT02044354|Docetaxel|docetaxel|mesh-list
24629991|NCT01108939|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24629992|NCT01108939|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24629993|NCT01108939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24629994|NCT01109030|Pioglitazone|pioglitazone|mesh-list
24629995|NCT01109030|Chlordiazepoxide|chlordiazepoxide|mesh-list
24629998|NCT01109030|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24629999|NCT01109030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630000|NCT01109030|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24630001|NCT01109030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24630031|NCT01109043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24630032|NCT01109043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24630033|NCT01109043|Adrenergic Agents|adrenergic agents|mesh-ancestor
24630034|NCT01109043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24630035|NCT01109043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630036|NCT01109121|Allopurinol|allopurinol|mesh-list
24630037|NCT01109121|Antimetabolites|antimetabolites|mesh-ancestor
24630038|NCT01109121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660723|NCT01624259|Incretins|incretins|mesh-ancestor
25660724|NCT01624259|Hormones|hormones|mesh-ancestor
25660725|NCT01624259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25660726|NCT01624467|Necitumumab|necitumumab|mesh-list
25660727|NCT01624467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25660728|NCT01624467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25660729|NCT01624662|Fluticasone|fluticasone|mesh-list
25660730|NCT01624662|Xhance|xhance|mesh-list
25660731|NCT01624662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25660732|NCT01624662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25660733|NCT01624662|Autonomic Agents|autonomic agents|mesh-ancestor
25660734|NCT01624662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25660735|NCT01624662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660736|NCT01624662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25660737|NCT01624662|Respiratory System Agents|respiratory system agents|mesh-ancestor
25660738|NCT01624662|Dermatologic Agents|dermatologic agents|mesh-ancestor
24897560|NCT04424459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897561|NCT04424459|Analgesics|analgesics|mesh-ancestor
25063221|NCT02616055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063222|NCT02611830|Vedolizumab|vedolizumab|mesh-list
25063223|NCT02611830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25063224|NCT02611817|Vedolizumab|vedolizumab|mesh-list
25063225|NCT02611817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24697960|NCT01438021|Immunologic Factors|immunologic factors|mesh-ancestor
24897571|NCT04424381|Anticoagulants|anticoagulants|mesh-ancestor
24897572|NCT04423926|Prednisolone|prednisolone|mesh-list
25063253|NCT02477826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25063254|NCT02477826|Antimetabolites|antimetabolites|mesh-ancestor
24630039|NCT01109121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24630040|NCT01109121|Gout Suppressants|gout suppressants|mesh-ancestor
24780763|NCT01886209|Autonomic Agents|autonomic agents|mesh-ancestor
24780765|NCT01886209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24630041|NCT01109121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24630042|NCT01109121|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24537783|NCT00656123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24537784|NCT00656123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24537785|NCT00656188|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24537786|NCT00656188|Vasodilator Agents|vasodilator agents|mesh-ancestor
24537787|NCT00656188|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24537788|NCT00656188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25841977|NCT00031577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841978|NCT00031616|Brivudine|brivudine|mesh-list
25841979|NCT00031616|Phosphoramidic acid|phosphoramidic acid|mesh-list
25841980|NCT00031616|Antiviral Agents|antiviral agents|mesh-ancestor
25841981|NCT00031616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25841982|NCT00031616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25841983|NCT00031616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506859|NCT00547209|Nitrous Oxide|nitrous oxide|mesh-list
24630043|NCT01109121|Antioxidants|antioxidants|mesh-ancestor
24630044|NCT01109121|Protective Agents|protective agents|mesh-ancestor
24630045|NCT01109121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630079|NCT01109485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24630080|NCT01109485|Histamine Antagonists|histamine antagonists|mesh-ancestor
24630081|NCT01109485|Histamine Agents|histamine agents|mesh-ancestor
24630082|NCT01109485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25164773|NCT05209360|Carbon Fiber|carbon fiber|mesh-list
24630114|NCT01109615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24630115|NCT01109615|Antimetabolites|antimetabolites|mesh-ancestor
24630116|NCT01109615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630117|NCT01109615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24811058|NCT02044549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24811059|NCT02044549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811061|NCT02044601|Carboplatin|carboplatin|mesh-list
24811062|NCT02044601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24811063|NCT02044601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24811064|NCT02044601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24811065|NCT02044601|Tubulin Modulators|tubulin modulators|mesh-ancestor
24811066|NCT02044601|Antimitotic Agents|antimitotic agents|mesh-ancestor
24811067|NCT02044601|Mitosis Modulators|mitosis modulators|mesh-ancestor
24811068|NCT02044601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841984|NCT00031629|Gemcitabine|gemcitabine|mesh-list
25841985|NCT00031629|Docetaxel|docetaxel|mesh-list
25841986|NCT00031629|Lenograstim|lenograstim|mesh-list
25841987|NCT00031629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25841988|NCT00031629|Antimetabolites|antimetabolites|mesh-ancestor
24918421|NCT04219865|Edaravone|edaravone|mesh-list
25841989|NCT00031629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25841990|NCT00031629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25841991|NCT00031629|Antiviral Agents|antiviral agents|mesh-ancestor
25660739|NCT01624662|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25660740|NCT01624948|Mycophenolic Acid|mycophenolic acid|mesh-list
25660741|NCT01624948|Everolimus|everolimus|mesh-list
25660742|NCT01624948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25660743|NCT01624948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25660744|NCT01624948|Immunologic Factors|immunologic factors|mesh-ancestor
25660745|NCT01624948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660746|NCT01624948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25660747|NCT01624948|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25660748|NCT01624948|Antitubercular Agents|antitubercular agents|mesh-ancestor
25660749|NCT01624948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25841992|NCT00031629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25841993|NCT00031629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25660750|NCT01624948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25660751|NCT01624948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25660752|NCT01624948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660753|NCT01624974|Montelukast|montelukast|mesh-list
25841994|NCT00031629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25841995|NCT00031629|Immunologic Factors|immunologic factors|mesh-ancestor
25841996|NCT00031629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25841997|NCT00031629|Tubulin Modulators|tubulin modulators|mesh-ancestor
25841998|NCT00031629|Antimitotic Agents|antimitotic agents|mesh-ancestor
25841999|NCT00031629|Mitosis Modulators|mitosis modulators|mesh-ancestor
24811069|NCT02044601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24811070|NCT02044601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811071|NCT02044627|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
24811072|NCT02044627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24811073|NCT02044627|Antimetabolites|antimetabolites|mesh-ancestor
24811074|NCT02044627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811075|NCT02044627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24811076|NCT02044627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811077|NCT02044627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24507299|NCT00549666|Adrenergic Agents|adrenergic agents|mesh-ancestor
24630125|NCT01109615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24630127|NCT01109654|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24630129|NCT01109654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24630130|NCT01109654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630131|NCT01109654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24630132|NCT01109654|Fertility Agents|fertility agents|mesh-ancestor
24630133|NCT01109654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24630134|NCT01109654|Hormone Antagonists|hormone antagonists|mesh-ancestor
24630135|NCT01109693|Mirtazapine|mirtazapine|mesh-list
24630277|NCT01110616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630278|NCT01110616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25842000|NCT00031629|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25842001|NCT00031642|Rituximab|rituximab|mesh-list
25842002|NCT00031642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25164774|NCT05209360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25164775|NCT05209360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24630314|NCT01110824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24630315|NCT01110824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630316|NCT01110824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811084|NCT02044952|Triptolide|triptolide|mesh-list
24811085|NCT02044952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24811086|NCT02044952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24811087|NCT02044952|Analgesics|analgesics|mesh-ancestor
24811088|NCT02044952|Sensory System Agents|sensory system agents|mesh-ancestor
24811089|NCT02044952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24811090|NCT02044952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811091|NCT02044952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24811092|NCT02044952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24859023|NCT02301130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24630317|NCT01110824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24630318|NCT01110824|Antioxidants|antioxidants|mesh-ancestor
24630320|NCT01110824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24630380|NCT01111422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630381|NCT01111422|Protective Agents|protective agents|mesh-ancestor
24630382|NCT01111422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630383|NCT01111422|Antidotes|antidotes|mesh-ancestor
24630384|NCT01111448|Sirolimus|sirolimus|mesh-list
24796284|NCT01949038|GABA Agents|gaba agents|mesh-ancestor
24630385|NCT01111448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24630386|NCT01111448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24630387|NCT01111448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24630388|NCT01111448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630389|NCT01111448|Antifungal Agents|antifungal agents|mesh-ancestor
24630391|NCT01111448|Immunologic Factors|immunologic factors|mesh-ancestor
24630430|NCT01111656|Immunologic Factors|immunologic factors|mesh-ancestor
24630474|NCT01111890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24630476|NCT01111903|Immunologic Factors|immunologic factors|mesh-ancestor
25660754|NCT01624974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25660755|NCT01624974|Respiratory System Agents|respiratory system agents|mesh-ancestor
25660756|NCT01624974|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25660757|NCT01624974|Hormone Antagonists|hormone antagonists|mesh-ancestor
25660758|NCT01624974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25660759|NCT01624974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817706|NCT02085291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817734|NCT02085408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063263|NCT02477826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24630477|NCT01111903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630478|NCT01111903|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24630479|NCT01111903|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24630480|NCT01111903|Growth Substances|growth substances|mesh-ancestor
24630481|NCT01111903|Growth Inhibitors|growth inhibitors|mesh-ancestor
24630482|NCT01111903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630484|NCT01111942|Carboplatin|carboplatin|mesh-list
24630485|NCT01111942|Docetaxel|docetaxel|mesh-list
24630520|NCT01112085|Ranibizumab|ranibizumab|mesh-list
24630521|NCT01112085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24630522|NCT01112085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24811093|NCT02044952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811094|NCT02044952|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
24811095|NCT02044952|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24811096|NCT02044952|Contraceptive Agents|contraceptive agents|mesh-ancestor
25842003|NCT00031642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842004|NCT00031642|Immunologic Factors|immunologic factors|mesh-ancestor
25842005|NCT00031642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842006|NCT00031642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24630585|NCT01112540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24630586|NCT01112540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630587|NCT01112540|Analgesics|analgesics|mesh-ancestor
24630625|NCT01112813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630626|NCT01112813|Antimanic Agents|antimanic agents|mesh-ancestor
24630654|NCT01112878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24630655|NCT01112878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24630656|NCT01112878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24630657|NCT01112878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24630658|NCT01112878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665220|NCT01310985|Capecitabine|capecitabine|mesh-list
24630659|NCT01112878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630660|NCT01112878|Antimanic Agents|antimanic agents|mesh-ancestor
24630661|NCT01112878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24630662|NCT01112878|Sympatholytics|sympatholytics|mesh-ancestor
24630663|NCT01112878|Autonomic Agents|autonomic agents|mesh-ancestor
25050669|NCT00478972|Hormones|hormones|mesh-ancestor
24630664|NCT01112878|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24630665|NCT01112878|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24833727|NCT02175394|Hormones|hormones|mesh-ancestor
24630666|NCT01112878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24630667|NCT01112878|Adrenergic Agents|adrenergic agents|mesh-ancestor
24630668|NCT01112891|Vitamin D|vitamin d|mesh-list
24630669|NCT01112891|Ergocalciferols|ergocalciferols|mesh-list
24630670|NCT01112891|Cholecalciferol|cholecalciferol|mesh-list
24630671|NCT01112891|Vitamins|vitamins|mesh-list
24630672|NCT01112891|Micronutrients|micronutrients|mesh-ancestor
24630673|NCT01112891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630709|NCT01113164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24630710|NCT01113164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630711|NCT01113164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24630712|NCT01113164|Antipruritics|antipruritics|mesh-ancestor
24630713|NCT01113164|Dermatologic Agents|dermatologic agents|mesh-ancestor
24811117|NCT02044965|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24811118|NCT02044965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24811120|NCT02044978|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24811121|NCT02044978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630714|NCT01113164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24630715|NCT01113164|Serotonin Agents|serotonin agents|mesh-ancestor
24630716|NCT01113164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24630717|NCT01113164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630718|NCT01113164|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24630746|NCT01113372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630748|NCT01113424|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24630749|NCT01113424|Autonomic Agents|autonomic agents|mesh-ancestor
25660760|NCT01624974|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25660761|NCT01624974|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25660762|NCT01624974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630750|NCT01113424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24630761|NCT01113489|Beclomethasone|beclomethasone|mesh-list
25842007|NCT00031655|Cyclosporine|cyclosporine|mesh-list
25063299|NCT02186847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063300|NCT02186847|Tubulin Modulators|tubulin modulators|mesh-ancestor
25063301|NCT02186847|Antimitotic Agents|antimitotic agents|mesh-ancestor
25063302|NCT02186847|Mitosis Modulators|mitosis modulators|mesh-ancestor
25063303|NCT02186847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063304|NCT02186847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25063305|NCT02186847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630762|NCT01113489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24630763|NCT01113489|Glucocorticoids|glucocorticoids|mesh-ancestor
24630765|NCT01113489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24630797|NCT01113671|Micronutrients|micronutrients|mesh-ancestor
24630798|NCT01113671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630800|NCT01113671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630801|NCT01113671|Protective Agents|protective agents|mesh-ancestor
24630802|NCT01113762|Cimetidine|cimetidine|mesh-list
24630803|NCT01113762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24630804|NCT01113762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24630805|NCT01113762|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24630806|NCT01113762|Histamine Antagonists|histamine antagonists|mesh-ancestor
24630821|NCT01114048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24630822|NCT01114048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24630823|NCT01114048|Alkylating Agents|alkylating agents|mesh-ancestor
24630824|NCT01114048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630825|NCT01114048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630826|NCT01114048|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24630827|NCT01114048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24811123|NCT02045017|Pomalidomide|pomalidomide|mesh-list
24811124|NCT02045017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24811125|NCT02045017|Antiemetics|antiemetics|mesh-ancestor
24811126|NCT02045017|Autonomic Agents|autonomic agents|mesh-ancestor
24811127|NCT02045017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24811128|NCT02045017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811129|NCT02045017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24630828|NCT01114048|Antiemetics|antiemetics|mesh-ancestor
24630833|NCT01114048|Hormones|hormones|mesh-ancestor
24630844|NCT01114087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630845|NCT01114087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24630846|NCT01114087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24630847|NCT01114087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630849|NCT01114100|Antidepressive Agents|antidepressive agents|mesh-ancestor
24630850|NCT01114100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24508843|NCT00557219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24630860|NCT01114191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24630861|NCT01114191|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24630862|NCT01114191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24630863|NCT01114191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24630888|NCT01114490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630890|NCT01114542|Insulin|insulin|mesh-list
24630891|NCT01114542|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24630892|NCT01114542|Insulin Glargine|insulin glargine|mesh-list
24630893|NCT01114542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24630894|NCT01114542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630895|NCT01114568|Ertugliflozin|ertugliflozin|mesh-list
24630896|NCT01114568|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24630897|NCT01114568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630898|NCT01114568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24811130|NCT02045017|Glucocorticoids|glucocorticoids|mesh-ancestor
24811132|NCT02045017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24811133|NCT02045017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24811134|NCT02045017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24811135|NCT02045017|Immunologic Factors|immunologic factors|mesh-ancestor
25660763|NCT01625000|Risperidone|risperidone|mesh-list
25660764|NCT01625000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25660765|NCT01625000|Serotonin Agents|serotonin agents|mesh-ancestor
25660766|NCT01625000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25660767|NCT01625000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660768|NCT01625000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660769|NCT01625000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25660770|NCT01625000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25660771|NCT01625000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24516947|NCT00604942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811136|NCT02045017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24811137|NCT02045017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24811138|NCT02045017|Growth Substances|growth substances|mesh-ancestor
24811139|NCT02045017|Growth Inhibitors|growth inhibitors|mesh-ancestor
24630974|NCT01115426|Ramipril|ramipril|mesh-list
24630975|NCT01115426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24630976|NCT01115426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24630977|NCT01115426|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24630978|NCT01115426|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24631275|NCT01116700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630979|NCT01115426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630980|NCT01115426|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24630982|NCT01115426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24630983|NCT01115439|Artesunate|artesunate|mesh-list
24630984|NCT01115439|Pyrimethamine|pyrimethamine|mesh-list
24630985|NCT01115439|Sulfadoxine|sulfadoxine|mesh-list
24630986|NCT01115439|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24630987|NCT01115439|Antimalarials|antimalarials|mesh-ancestor
24630988|NCT01115439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25842008|NCT00031655|Mycophenolic Acid|mycophenolic acid|mesh-list
25842009|NCT00031655|Fludarabine|fludarabine|mesh-list
24631071|NCT01116050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24631073|NCT01116050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24631074|NCT01116050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631075|NCT01116050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24631076|NCT01116050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24631077|NCT01116050|Oxytocics|oxytocics|mesh-ancestor
24631078|NCT01116063|Iloprost|iloprost|mesh-list
24631079|NCT01116063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24631080|NCT01116063|Vasodilator Agents|vasodilator agents|mesh-ancestor
24631084|NCT01116128|Prednisone|prednisone|mesh-list
24631085|NCT01116128|Melphalan|melphalan|mesh-list
24631086|NCT01116128|Dasatinib|dasatinib|mesh-list
24631087|NCT01116128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24631119|NCT01116167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631120|NCT01116167|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24631121|NCT01116167|Hormone Antagonists|hormone antagonists|mesh-ancestor
24631161|NCT01116206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631162|NCT01116206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811141|NCT02045030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24811142|NCT02045030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24811145|NCT02045030|Growth Inhibitors|growth inhibitors|mesh-ancestor
24631173|NCT01116219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631174|NCT01116219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631175|NCT01116219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24631176|NCT01116219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24631177|NCT01116219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24631178|NCT01116271|Irinotecan|irinotecan|mesh-list
24631179|NCT01116271|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24631180|NCT01116271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24631214|NCT01116531|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24631231|NCT01116583|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24631232|NCT01116583|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24631233|NCT01116583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24631234|NCT01116583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631235|NCT01116583|Antimanic Agents|antimanic agents|mesh-ancestor
24631237|NCT01116596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24631241|NCT01116596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631242|NCT01116596|Antipyretics|antipyretics|mesh-ancestor
24631243|NCT01116609|Epinephrine|epinephrine|mesh-list
24631244|NCT01116609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24631245|NCT01116609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24631246|NCT01116609|Adrenergic Agents|adrenergic agents|mesh-ancestor
24631247|NCT01116609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24631248|NCT01116609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631249|NCT01116609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631250|NCT01116609|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24631251|NCT01116609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24631252|NCT01116609|Autonomic Agents|autonomic agents|mesh-ancestor
24631253|NCT01116609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24631270|NCT01116635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25660772|NCT01625000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25842010|NCT00031655|Fludarabine phosphate|fludarabine phosphate|mesh-list
24898011|NCT04419038|Alkylating Agents|alkylating agents|mesh-ancestor
24475127|NCT00409019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24905199|NCT04350086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24905200|NCT04350086|Adrenergic Agents|adrenergic agents|mesh-ancestor
24905201|NCT04350086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24905202|NCT04350086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905203|NCT04350190|Apatinib|apatinib|mesh-list
24905204|NCT04350190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905205|NCT04350190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24905206|NCT04350190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24475128|NCT00409071|Sinomenine|sinomenine|mesh-list
24475129|NCT00409071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24631271|NCT01116635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842011|NCT00031655|Cyclosporins|cyclosporins|mesh-list
24811160|NCT02045290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811162|NCT02045368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24811163|NCT02045368|Abortifacient Agents|abortifacient agents|mesh-ancestor
24811164|NCT02045368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24811165|NCT02045368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811166|NCT02045368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24631272|NCT01116700|Dexmedetomidine|dexmedetomidine|mesh-list
24631273|NCT01116700|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24631274|NCT01116700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24631433|NCT01117662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24631308|NCT01116817|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24631309|NCT01116817|Antiviral Agents|antiviral agents|mesh-ancestor
24631310|NCT01116817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24631311|NCT01116817|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24631312|NCT01116817|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24631313|NCT01116830|Antipsychotic Agents|antipsychotic agents|mesh-list
24631314|NCT01116830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24631315|NCT01116830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24631316|NCT01116830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631317|NCT01116830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24631318|NCT01117038|Amlodipine|amlodipine|mesh-list
24631319|NCT01117038|Enalapril|enalapril|mesh-list
24631320|NCT01117038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24451712|NCT00324597|Imetelstat|imetelstat|mesh-list
24631374|NCT01117220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24784186|NCT01906788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24631375|NCT01117220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631376|NCT01117220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631377|NCT01117220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24631378|NCT01117220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24631379|NCT01117220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24811167|NCT02045368|Antimetabolites|antimetabolites|mesh-ancestor
24811168|NCT02045368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811169|NCT02045368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24811170|NCT02045368|Dermatologic Agents|dermatologic agents|mesh-ancestor
24811171|NCT02045368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811172|NCT02045368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24811173|NCT02045368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24606543|NCT00990847|Procaterol|procaterol|mesh-list
24811175|NCT02045368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24811176|NCT02045368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24811177|NCT02045589|Gemcitabine|gemcitabine|mesh-list
24811178|NCT02045589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24811179|NCT02045589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24811180|NCT02045589|Antimetabolites|antimetabolites|mesh-ancestor
24811181|NCT02045589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811182|NCT02045589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24631401|NCT01117376|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25660773|NCT01625000|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25660774|NCT01625000|Dopamine Agents|dopamine agents|mesh-ancestor
25660775|NCT01625013|Hylan|hylan|mesh-list
25660776|NCT01625013|Viscosupplements|viscosupplements|mesh-ancestor
25660777|NCT01625013|Protective Agents|protective agents|mesh-ancestor
25660778|NCT01625013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660779|NCT01625091|Naltrexone|naltrexone|mesh-list
25660780|NCT01625091|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25660781|NCT01625091|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25660782|NCT01625091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660783|NCT01625091|Sensory System Agents|sensory system agents|mesh-ancestor
25660784|NCT01625091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25660785|NCT01625169|Etravirine|etravirine|mesh-list
24517065|NCT00605774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24517066|NCT00605774|Autonomic Agents|autonomic agents|mesh-ancestor
25064294|NCT03461328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25064295|NCT03461328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064297|NCT03461328|Tocolytic Agents|tocolytic agents|mesh-ancestor
24517067|NCT00605774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24517068|NCT00605774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24631402|NCT01117376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631403|NCT01117376|Sensory System Agents|sensory system agents|mesh-ancestor
24631404|NCT01117376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24631405|NCT01117610|Ropivacaine|ropivacaine|mesh-list
24631406|NCT01117610|Anesthetics, Local|anesthetics, local|mesh-ancestor
24631407|NCT01117610|Anesthetics|anesthetics|mesh-ancestor
24631422|NCT01117636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25842012|NCT00031655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842013|NCT00031655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25842014|NCT00031655|Antimetabolites|antimetabolites|mesh-ancestor
24829182|NCT02150161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829184|NCT02150161|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24829185|NCT02150161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24829186|NCT02150161|Anesthetics, General|anesthetics, general|mesh-ancestor
24829187|NCT02150161|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24829188|NCT02150161|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24829189|NCT02150161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24829190|NCT02150161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24586548|NCT00891267|Amlodipine|amlodipine|mesh-list
25164784|NCT05184192|Gabapentin|gabapentin|mesh-list
25164785|NCT05184192|Analgesics|analgesics|mesh-ancestor
25164786|NCT05184192|Sensory System Agents|sensory system agents|mesh-ancestor
25164787|NCT05184192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24811186|NCT02045589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24811187|NCT02045589|Immunologic Factors|immunologic factors|mesh-ancestor
24811188|NCT02045589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811189|NCT02045602|Gemcitabine|gemcitabine|mesh-list
24811190|NCT02045602|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24811192|NCT02045602|Antimetabolites|antimetabolites|mesh-ancestor
24811193|NCT02045602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811194|NCT02045602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24811195|NCT02045602|Antiviral Agents|antiviral agents|mesh-ancestor
24811196|NCT02045602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24811197|NCT02045602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631430|NCT01117662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24631431|NCT01117662|Immunologic Factors|immunologic factors|mesh-ancestor
25875696|NCT04216290|Durvalumab|durvalumab|mesh-list
24631432|NCT01117662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631435|NCT01118039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24631436|NCT01118039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24631437|NCT01118039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24631438|NCT01118039|Growth Substances|growth substances|mesh-ancestor
24631439|NCT01118039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631440|NCT01118039|Growth Inhibitors|growth inhibitors|mesh-ancestor
24631441|NCT01118039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24631442|NCT01118039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631500|NCT01118572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24631502|NCT01118572|Sensory System Agents|sensory system agents|mesh-ancestor
24631503|NCT01118572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24631504|NCT01118572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631505|NCT01118572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24631506|NCT01118572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24811198|NCT02045602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24811199|NCT02045602|Immunologic Factors|immunologic factors|mesh-ancestor
24811200|NCT02045602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811202|NCT02045667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24811203|NCT02045667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24811204|NCT02045667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24811205|NCT02045667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24811206|NCT02045667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660786|NCT01625169|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25660787|NCT01625169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25660788|NCT01625169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25660789|NCT01625169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660790|NCT01625169|Antiviral Agents|antiviral agents|mesh-ancestor
25660791|NCT01625169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24517098|NCT00605930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842016|NCT00031655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24898270|NCT04416035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24898271|NCT04416035|Growth Substances|growth substances|mesh-ancestor
24898296|NCT04415567|Lenvatinib|lenvatinib|mesh-list
24898297|NCT04415567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25660792|NCT01625182|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24898298|NCT04415567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24898340|NCT04414995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898341|NCT04414995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24811207|NCT02045693|Buprenorphine|buprenorphine|mesh-list
24811209|NCT02045693|Naloxone|naloxone|mesh-list
24811210|NCT02045693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24811211|NCT02045693|Narcotics|narcotics|mesh-ancestor
24811212|NCT02045693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24811213|NCT02045693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811214|NCT02045693|Analgesics|analgesics|mesh-ancestor
24811215|NCT02045693|Sensory System Agents|sensory system agents|mesh-ancestor
24811216|NCT02045693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24811217|NCT02045693|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24811219|NCT02045693|Respiratory System Agents|respiratory system agents|mesh-ancestor
24811220|NCT02045810|Levobupivacaine|levobupivacaine|mesh-list
24631509|NCT01118572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631626|NCT01119079|Anesthetics|anesthetics|mesh-list
24631627|NCT01119079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24631628|NCT01119079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631629|NCT01119144|Calcium, Dietary|calcium, dietary|mesh-list
24631630|NCT01119144|Calcium|calcium|mesh-list
24631631|NCT01119144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24631632|NCT01119144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631633|NCT01119144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24631635|NCT01119157|Immunologic Factors|immunologic factors|mesh-ancestor
24811229|NCT02045849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24940582|NCT03999580|Vitamin D|vitamin d|mesh-list
24811230|NCT02045849|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24811231|NCT02045849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24811232|NCT02045849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811233|NCT02045849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631636|NCT01119157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631645|NCT01119209|Sensory System Agents|sensory system agents|mesh-ancestor
24631646|NCT01119209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24631647|NCT01119417|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
24631648|NCT01119417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24631649|NCT01119417|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24631650|NCT01119417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631652|NCT01119430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24631653|NCT01119430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24631654|NCT01119430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24631655|NCT01119430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631656|NCT01119430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24631658|NCT01119430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505128|NCT00540085|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24631683|NCT01119534|Antipruritics|antipruritics|mesh-ancestor
24631684|NCT01119534|Dermatologic Agents|dermatologic agents|mesh-ancestor
24631685|NCT01119534|Expectorants|expectorants|mesh-ancestor
24631686|NCT01119534|Respiratory System Agents|respiratory system agents|mesh-ancestor
24631687|NCT01119534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24631688|NCT01119534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24631689|NCT01119534|Adrenergic Agents|adrenergic agents|mesh-ancestor
24631690|NCT01119534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24631691|NCT01119534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660793|NCT01625182|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25660794|NCT01625182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660795|NCT01625182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25660796|NCT01625182|Immunologic Factors|immunologic factors|mesh-ancestor
25660797|NCT01625182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660798|NCT01625338|Sofosbuvir|sofosbuvir|mesh-list
25660799|NCT01625338|Antiviral Agents|antiviral agents|mesh-ancestor
25660800|NCT01625338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25660801|NCT01625377|Mycophenolic Acid|mycophenolic acid|mesh-list
25660802|NCT01625377|Everolimus|everolimus|mesh-list
25063367|NCT01938261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25063368|NCT01938261|Analgesics|analgesics|mesh-ancestor
25063369|NCT01938261|Sensory System Agents|sensory system agents|mesh-ancestor
25063370|NCT01938261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24898423|NCT04414540|Metformin|metformin|mesh-list
24898424|NCT04414540|Pembrolizumab|pembrolizumab|mesh-list
24631692|NCT01119534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631693|NCT01119534|Appetite Depressants|appetite depressants|mesh-ancestor
24631694|NCT01119534|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24631695|NCT01119534|Sympathomimetics|sympathomimetics|mesh-ancestor
24631696|NCT01119534|Autonomic Agents|autonomic agents|mesh-ancestor
24631697|NCT01119534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24631698|NCT01119534|Nasal Decongestants|nasal decongestants|mesh-ancestor
24631699|NCT01119534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24631700|NCT01119534|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24631701|NCT01119534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24631702|NCT01119534|Antitussive Agents|antitussive agents|mesh-ancestor
24631703|NCT01119534|Insect Repellents|insect repellents|mesh-ancestor
24631704|NCT01119534|Protective Agents|protective agents|mesh-ancestor
24631705|NCT01119599|Temozolomide|temozolomide|mesh-list
24631706|NCT01119599|R04929097|r04929097|mesh-list
24631707|NCT01119599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24631708|NCT01119599|Alkylating Agents|alkylating agents|mesh-ancestor
24631709|NCT01119599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631770|NCT01120119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24631776|NCT01120158|Paclitaxel|paclitaxel|mesh-list
24631802|NCT01120171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24631803|NCT01120171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24811234|NCT02045849|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24811236|NCT02045849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24811237|NCT02045849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811238|NCT02045849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24811239|NCT02045914|Calcium|calcium|mesh-list
24811241|NCT02045914|Ionomycin|ionomycin|mesh-list
24811242|NCT02045914|Calcium Ionophores|calcium ionophores|mesh-list
24811243|NCT02045914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24811244|NCT02045914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811245|NCT02045914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24787365|NCT01924624|Immunologic Factors|immunologic factors|mesh-ancestor
24811246|NCT02045914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631804|NCT01120171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24631859|NCT01120561|Trastuzumab|trastuzumab|mesh-list
24631860|NCT01120561|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24631861|NCT01120561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24631862|NCT01120561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24631863|NCT01120561|Tubulin Modulators|tubulin modulators|mesh-ancestor
24631864|NCT01120561|Antimitotic Agents|antimitotic agents|mesh-ancestor
24631865|NCT01120561|Mitosis Modulators|mitosis modulators|mesh-ancestor
25164842|NCT05166876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842017|NCT00031655|Immunologic Factors|immunologic factors|mesh-ancestor
24631866|NCT01120561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631867|NCT01120665|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24631868|NCT01120665|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24631870|NCT01120665|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24811247|NCT02045940|GSK2881078|gsk2881078|mesh-list
24811248|NCT02045940|Anabolic Agents|anabolic agents|mesh-ancestor
24811249|NCT02045940|Hormones|hormones|mesh-ancestor
24811250|NCT02045940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24811251|NCT02045940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811252|NCT02045953|Albuterol|albuterol|mesh-list
24811253|NCT02045953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24811254|NCT02045953|Autonomic Agents|autonomic agents|mesh-ancestor
24632098|NCT01122004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632099|NCT01122004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24632100|NCT01122004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24514034|NCT00587444|Heparin|heparin|mesh-list
24632328|NCT01123408|Clozapine|clozapine|mesh-list
24632329|NCT01123408|Antiemetics|antiemetics|mesh-ancestor
24632330|NCT01123408|Autonomic Agents|autonomic agents|mesh-ancestor
25660803|NCT01625377|Tacrolimus|tacrolimus|mesh-list
25660804|NCT01625377|Basiliximab|basiliximab|mesh-list
25660805|NCT01625377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25660806|NCT01625377|Immunologic Factors|immunologic factors|mesh-ancestor
25660807|NCT01625377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660808|NCT01625377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24475570|NCT00410774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24517156|NCT00606242|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24517157|NCT00606268|Micafungin|micafungin|mesh-list
24635014|NCT01136421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24898559|NCT04412850|Tocolytic Agents|tocolytic agents|mesh-ancestor
24632331|NCT01123408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24632332|NCT01123408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632333|NCT01123408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24632334|NCT01123408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24632335|NCT01123408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24632336|NCT01123408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24632337|NCT01123408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24632338|NCT01123408|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25082287|NCT03323671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24632339|NCT01123408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24632340|NCT01123408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24632341|NCT01123408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632342|NCT01123408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24632343|NCT01123408|Serotonin Agents|serotonin agents|mesh-ancestor
24632344|NCT01123408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24632345|NCT01123408|Dopamine Agents|dopamine agents|mesh-ancestor
24632346|NCT01123408|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24632347|NCT01123408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24632348|NCT01123408|GABA Antagonists|gaba antagonists|mesh-ancestor
24632349|NCT01123408|GABA Agents|gaba agents|mesh-ancestor
24632350|NCT01123473|Fluorouracil|fluorouracil|mesh-list
24632351|NCT01123473|Capecitabine|capecitabine|mesh-list
24632352|NCT01123473|Epirubicin|epirubicin|mesh-list
24632353|NCT01123473|Lapatinib|lapatinib|mesh-list
24632354|NCT01123473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632355|NCT01123473|Antimetabolites|antimetabolites|mesh-ancestor
24632397|NCT01123538|Contraceptive Agents|contraceptive agents|mesh-ancestor
24632398|NCT01123538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24811269|NCT02045992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811270|NCT02045992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24811271|NCT02045992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811272|NCT02045992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811273|NCT02045992|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24811274|NCT02045992|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24811275|NCT02045992|Purinergic Agents|purinergic agents|mesh-ancestor
24811276|NCT02045992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24811278|NCT02046044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24811279|NCT02046044|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24632399|NCT01123538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24632400|NCT01123538|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24632402|NCT01123551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24632403|NCT01123551|Narcotics|narcotics|mesh-ancestor
24632404|NCT01123551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24538334|NCT00658918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842018|NCT00031655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632405|NCT01123551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632406|NCT01123551|Analgesics|analgesics|mesh-ancestor
24632407|NCT01123551|Sensory System Agents|sensory system agents|mesh-ancestor
24632408|NCT01123551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24632409|NCT01123564|Ranibizumab|ranibizumab|mesh-list
24632452|NCT01124032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632453|NCT01124032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25164843|NCT05166876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24632454|NCT01124032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24632455|NCT01124032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24632456|NCT01124032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632499|NCT01124383|Sensory System Agents|sensory system agents|mesh-ancestor
24632551|NCT01124500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24632552|NCT01124500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24462836|NCT00357643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24632553|NCT01124500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660809|NCT01625377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25660810|NCT01625377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660811|NCT01625377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25660812|NCT01625377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25660813|NCT01625377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24475774|NCT00411333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24475775|NCT00411333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475776|NCT00411333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24475778|NCT00411333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632555|NCT01124500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24632556|NCT01124526|Cyclophosphamide|cyclophosphamide|mesh-list
24632557|NCT01124526|Rituximab|rituximab|mesh-list
24632558|NCT01124526|Fludarabine|fludarabine|mesh-list
24632565|NCT01124526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632566|NCT01124526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632567|NCT01124526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24811280|NCT02046044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811281|NCT02046044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811282|NCT02046044|Protective Agents|protective agents|mesh-ancestor
24811283|NCT02046044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811284|NCT02046109|Chlorhexidine|chlorhexidine|mesh-list
24672371|NCT01331785|Adrenergic Agents|adrenergic agents|mesh-ancestor
24632568|NCT01124526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24632575|NCT01124539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632576|NCT01124539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632577|NCT01124630|Leucovorin|leucovorin|mesh-list
24632578|NCT01124630|Fluorouracil|fluorouracil|mesh-list
24632579|NCT01124630|Irinotecan|irinotecan|mesh-list
24462838|NCT00357669|Anticonvulsants|anticonvulsants|mesh-ancestor
24632612|NCT01124760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24632613|NCT01124760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632614|NCT01124760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24632615|NCT01124760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24632616|NCT01124760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24632617|NCT01124760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24632648|NCT01125020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632649|NCT01125020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24632692|NCT01125215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24632693|NCT01125215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632695|NCT01125254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24632696|NCT01125254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24632717|NCT01125423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632720|NCT01125423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24632721|NCT01125423|Analgesics|analgesics|mesh-ancestor
25842019|NCT00031655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632722|NCT01125423|Sensory System Agents|sensory system agents|mesh-ancestor
24632723|NCT01125423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24632724|NCT01125423|Antidepressive Agents|antidepressive agents|mesh-ancestor
24632725|NCT01125423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24632733|NCT01125449|Ascorbic Acid|ascorbic acid|mesh-list
24632734|NCT01125449|Vitamins|vitamins|mesh-ancestor
24632735|NCT01125449|Micronutrients|micronutrients|mesh-ancestor
24632736|NCT01125449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624167|NCT01074970|Cisplatin|cisplatin|mesh-list
24632737|NCT01125449|Antioxidants|antioxidants|mesh-ancestor
24632738|NCT01125449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632739|NCT01125449|Protective Agents|protective agents|mesh-ancestor
24632740|NCT01125488|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25842020|NCT00031655|Antifungal Agents|antifungal agents|mesh-ancestor
25842021|NCT00031655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25842022|NCT00031655|Dermatologic Agents|dermatologic agents|mesh-ancestor
25842023|NCT00031655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24829289|NCT02151084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586708|NCT00891761|Dexamethasone|dexamethasone|mesh-list
24829290|NCT02151240|Acyclovir|acyclovir|mesh-list
24829291|NCT02151240|Foscarnet|foscarnet|mesh-list
25842024|NCT00031655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24632741|NCT01125488|Luteolytic Agents|luteolytic agents|mesh-ancestor
24632742|NCT01125488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24632743|NCT01125488|Contraceptive Agents|contraceptive agents|mesh-ancestor
24632744|NCT01125488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25660814|NCT01625377|Antitubercular Agents|antitubercular agents|mesh-ancestor
25660815|NCT01625377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25660816|NCT01625377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25660817|NCT01625455|Aprepitant|aprepitant|mesh-list
25660818|NCT01625455|Antiemetics|antiemetics|mesh-ancestor
25660819|NCT01625455|Autonomic Agents|autonomic agents|mesh-ancestor
25842025|NCT00031655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25875697|NCT04216290|Mitomycins|mitomycins|mesh-list
24475975|NCT00412191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475976|NCT00412191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24898995|NCT04408235|Anticoagulants|anticoagulants|mesh-ancestor
24898996|NCT04408235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24898997|NCT04408235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24898998|NCT04408235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632745|NCT01125488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842026|NCT00031655|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24632770|NCT01125670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632771|NCT01125670|Anticoagulants|anticoagulants|mesh-ancestor
24632773|NCT01125683|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24665546|NCT01313390|Docetaxel|docetaxel|mesh-list
24632774|NCT01125683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632775|NCT01125683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632776|NCT01125683|Cholinergic Agents|cholinergic agents|mesh-ancestor
24632777|NCT01125683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24632778|NCT01125683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632779|NCT01125683|Nootropic Agents|nootropic agents|mesh-ancestor
24632780|NCT01125696|Ritonavir|ritonavir|mesh-list
24632781|NCT01125696|Lopinavir|lopinavir|mesh-list
24632782|NCT01125696|Tenofovir|tenofovir|mesh-list
24632783|NCT01125696|Lamivudine|lamivudine|mesh-list
24632784|NCT01125696|Zidovudine|zidovudine|mesh-list
24632785|NCT01125696|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24632786|NCT01125696|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24632793|NCT01125696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24632794|NCT01125696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25842027|NCT00031655|Antitubercular Agents|antitubercular agents|mesh-ancestor
25842028|NCT00031655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25842029|NCT00031681|Irinotecan|irinotecan|mesh-list
25842030|NCT00031681|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
25842031|NCT00031681|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25842032|NCT00031681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25842033|NCT00031681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842034|NCT00031681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538476|NCT00659451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24538477|NCT00659451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538478|NCT00659451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24632795|NCT01125696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24632796|NCT01125696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24632797|NCT01125696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24632798|NCT01125696|Antimetabolites|antimetabolites|mesh-ancestor
24632866|NCT01125943|Cholinergic Agents|cholinergic agents|mesh-ancestor
24632867|NCT01125943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24632868|NCT01125982|Propofol|propofol|mesh-list
24632869|NCT01125982|Desflurane|desflurane|mesh-list
24632870|NCT01125982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24632871|NCT01125982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24632872|NCT01125982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632873|NCT01125982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24632875|NCT01125982|Anesthetics|anesthetics|mesh-ancestor
24632876|NCT01125982|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24632877|NCT01126008|Docetaxel|docetaxel|mesh-list
24632878|NCT01126008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632880|NCT01126008|Antimitotic Agents|antimitotic agents|mesh-ancestor
24632881|NCT01126008|Mitosis Modulators|mitosis modulators|mesh-ancestor
24632882|NCT01126008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632884|NCT01126073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24632885|NCT01126073|Antimetabolites|antimetabolites|mesh-ancestor
25164844|NCT05166876|Vasodilator Agents|vasodilator agents|mesh-ancestor
25164845|NCT05166876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25164846|NCT05166876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25164847|NCT05166876|Immunologic Factors|immunologic factors|mesh-ancestor
25164848|NCT05166876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164849|NCT05162742|Colchicine|colchicine|mesh-list
25164850|NCT05162742|Gout Suppressants|gout suppressants|mesh-ancestor
25660820|NCT01625455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25660821|NCT01625455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660822|NCT01625455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25660823|NCT01625455|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25660824|NCT01625455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25660825|NCT01625455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660826|NCT01625845|Pentoxifylline|pentoxifylline|mesh-list
25660827|NCT01625845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24899070|NCT04407078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899071|NCT04407078|Cholinergic Agents|cholinergic agents|mesh-ancestor
24632887|NCT01126073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24632888|NCT01126073|Vasodilator Agents|vasodilator agents|mesh-ancestor
24632896|NCT01126086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24632897|NCT01126086|Protease Inhibitors|protease inhibitors|mesh-ancestor
24632898|NCT01126086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842035|NCT00031681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842036|NCT00031681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25842037|NCT00031707|Megestrol|megestrol|mesh-list
25842038|NCT00031707|Megestrol Acetate|megestrol acetate|mesh-list
25842039|NCT00031707|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25842040|NCT00031707|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25842041|NCT00031707|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25842042|NCT00031707|Contraceptive Agents|contraceptive agents|mesh-ancestor
24632904|NCT01126138|Docetaxel|docetaxel|mesh-list
24632905|NCT01126138|Capecitabine|capecitabine|mesh-list
24632906|NCT01126138|Vinorelbine|vinorelbine|mesh-list
24632907|NCT01126138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632908|NCT01126138|Tubulin Modulators|tubulin modulators|mesh-ancestor
24632909|NCT01126138|Antimitotic Agents|antimitotic agents|mesh-ancestor
24632927|NCT01126216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632928|NCT01126216|Tubulin Modulators|tubulin modulators|mesh-ancestor
24632929|NCT01126216|Antimitotic Agents|antimitotic agents|mesh-ancestor
24632935|NCT01126229|Protective Agents|protective agents|mesh-ancestor
24811285|NCT02046109|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24811286|NCT02046109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24811287|NCT02046109|Disinfectants|disinfectants|mesh-ancestor
24811288|NCT02046187|Temozolomide|temozolomide|mesh-list
24811289|NCT02046187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24811290|NCT02046187|Alkylating Agents|alkylating agents|mesh-ancestor
24632936|NCT01126229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632937|NCT01126229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632938|NCT01126229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24632939|NCT01126294|Melatonin|melatonin|mesh-list
24632940|NCT01126294|Antioxidants|antioxidants|mesh-ancestor
24632941|NCT01126294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632942|NCT01126294|Protective Agents|protective agents|mesh-ancestor
24632943|NCT01126294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632944|NCT01126294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24632945|NCT01126307|Verapamil|verapamil|mesh-list
24632946|NCT01126307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24632947|NCT01126307|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24632948|NCT01126307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24538492|NCT00659503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25842043|NCT00031707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25842044|NCT00031707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842045|NCT00031707|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24632949|NCT01126307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632950|NCT01126307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24632951|NCT01126307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632952|NCT01126307|Vasodilator Agents|vasodilator agents|mesh-ancestor
24632964|NCT01126450|Growth Substances|growth substances|mesh-ancestor
24632965|NCT01126450|Growth Inhibitors|growth inhibitors|mesh-ancestor
24632966|NCT01126463|Ethiodized Oil|ethiodized oil|mesh-list
24632967|NCT01126463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632969|NCT01126528|Cholecalciferol|cholecalciferol|mesh-list
24632970|NCT01126528|Vitamins|vitamins|mesh-ancestor
24632971|NCT01126528|Micronutrients|micronutrients|mesh-ancestor
24632980|NCT01126645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632981|NCT01126645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24632982|NCT01126645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632983|NCT01126645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632984|NCT01126684|Atorvastatin|atorvastatin|mesh-list
24632985|NCT01126684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24633157|NCT01127477|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24633158|NCT01127477|Plasma Substitutes|plasma substitutes|mesh-ancestor
24633159|NCT01127477|Blood Substitutes|blood substitutes|mesh-ancestor
24633160|NCT01127490|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24790037|NCT01940250|Tocolytic Agents|tocolytic agents|mesh-ancestor
25409026|NCT03404180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25660828|NCT01625845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25660829|NCT01625845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660830|NCT01625845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25660831|NCT01625845|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24519451|NCT01208662|Hormones|hormones|mesh-ancestor
24633161|NCT01127490|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24633163|NCT01127490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24829292|NCT02151240|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
24829293|NCT02151240|Antiviral Agents|antiviral agents|mesh-ancestor
24829294|NCT02151240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24829295|NCT02151240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24829296|NCT02151240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24829297|NCT02151240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842046|NCT00031707|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25842047|NCT00031707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25842048|NCT00031707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842049|NCT00031707|Appetite Stimulants|appetite stimulants|mesh-ancestor
24706410|NCT01489943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25842050|NCT00031707|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25842051|NCT00031720|Tamoxifen|tamoxifen|mesh-list
25842052|NCT00031720|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25842053|NCT00031720|Hormone Antagonists|hormone antagonists|mesh-ancestor
25842054|NCT00031720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25842055|NCT00031720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842056|NCT00031720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25842057|NCT00031720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842058|NCT00031720|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25842059|NCT00031720|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25842060|NCT00031720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25842061|NCT00031733|Interleukin-12|interleukin-12|mesh-list
25842062|NCT00031733|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25842063|NCT00031733|Sargramostim|sargramostim|mesh-list
25842064|NCT00031733|Freund's Adjuvant|freund's adjuvant|mesh-list
25842065|NCT00031733|Aluminum sulfate|aluminum sulfate|mesh-list
24633164|NCT01127490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633165|NCT01127490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24633166|NCT01127490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633167|NCT01127490|Analgesics|analgesics|mesh-ancestor
24633168|NCT01127490|Sensory System Agents|sensory system agents|mesh-ancestor
25164851|NCT05162742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25164852|NCT05162742|Tubulin Modulators|tubulin modulators|mesh-ancestor
25164853|NCT05162742|Antimitotic Agents|antimitotic agents|mesh-ancestor
25164854|NCT05162742|Mitosis Modulators|mitosis modulators|mesh-ancestor
25164855|NCT05162742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164856|NCT05162742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25164857|NCT05159050|Paclitaxel|paclitaxel|mesh-list
25164858|NCT05159050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25164859|NCT05159050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25164860|NCT05159050|Tubulin Modulators|tubulin modulators|mesh-ancestor
25164861|NCT05159050|Antimitotic Agents|antimitotic agents|mesh-ancestor
25164862|NCT05159050|Mitosis Modulators|mitosis modulators|mesh-ancestor
25164863|NCT05159050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164864|NCT05153525|Cisatracurium|cisatracurium|mesh-list
25164865|NCT05153525|Atracurium|atracurium|mesh-list
25164866|NCT05153525|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25164867|NCT05153525|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25164868|NCT05153525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25164869|NCT05153525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164870|NCT05153525|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25164871|NCT05153525|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25164872|NCT05153525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25164873|NCT05153525|Cholinergic Agents|cholinergic agents|mesh-ancestor
25164874|NCT05153525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25164875|NCT05153525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063199|NCT02862171|Dapivirine|dapivirine|mesh-list
24633406|NCT01129323|Thymoglobulin|thymoglobulin|mesh-list
24633407|NCT01129323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24633408|NCT01129323|Immunologic Factors|immunologic factors|mesh-ancestor
24633409|NCT01129323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633424|NCT01129375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811291|NCT02046187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633624|NCT01130376|Immunologic Factors|immunologic factors|mesh-ancestor
24633628|NCT01130376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24633629|NCT01130467|Methylphenidate|methylphenidate|mesh-list
24633630|NCT01130467|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25415963|NCT02980510|Levoleucovorin|levoleucovorin|mesh-list
25660832|NCT01625845|Protective Agents|protective agents|mesh-ancestor
24633631|NCT01130467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24633632|NCT01130467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633633|NCT01130467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24633667|NCT01130662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24633668|NCT01130688|Zileuton|zileuton|mesh-list
24633669|NCT01130688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24633670|NCT01130688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24706681|NCT01491191|Analgesics|analgesics|mesh-ancestor
24394846|NCT00134394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24394847|NCT00134394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24394848|NCT00134394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24394849|NCT00134420|Clonidine|clonidine|mesh-list
24394850|NCT00134420|Mitogens|mitogens|mesh-list
24394881|NCT00134498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24394882|NCT00134498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394884|NCT00134511|Torcetrapib|torcetrapib|mesh-list
24394885|NCT00134511|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24394886|NCT00134511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24394887|NCT00134511|Antimetabolites|antimetabolites|mesh-ancestor
24394888|NCT00134511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394889|NCT00134511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24394890|NCT00134511|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24394891|NCT00134511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394892|NCT00134550|Atorvastatin|atorvastatin|mesh-list
24394893|NCT00134550|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24394894|NCT00134550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24394895|NCT00134550|Antimetabolites|antimetabolites|mesh-ancestor
24394896|NCT00134550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394897|NCT00134550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24394898|NCT00134550|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24394899|NCT00134550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394900|NCT00134641|Gemcitabine|gemcitabine|mesh-list
24394916|NCT00134654|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24394917|NCT00134654|Estrogens|estrogens|mesh-ancestor
24394918|NCT00134654|Hormones|hormones|mesh-ancestor
24394919|NCT00134654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24394920|NCT00134654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394921|NCT00134667|Verteporfin|verteporfin|mesh-list
24394922|NCT00134667|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24394923|NCT00134667|Dermatologic Agents|dermatologic agents|mesh-ancestor
24394924|NCT00134680|Trastuzumab|trastuzumab|mesh-list
24811293|NCT02046304|Gemcitabine|gemcitabine|mesh-list
24394927|NCT00134680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24394928|NCT00134680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24394929|NCT00134680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24394930|NCT00134680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394968|NCT00134758|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24394976|NCT00134810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394977|NCT00134810|Cholinergic Agents|cholinergic agents|mesh-ancestor
24394978|NCT00134810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24394979|NCT00134810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394980|NCT00134810|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24394981|NCT00134810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24394982|NCT00134875|Buprenorphine|buprenorphine|mesh-list
24394985|NCT00134875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24395014|NCT00134953|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24395015|NCT00134953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395016|NCT00134953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395017|NCT00134953|Cholinergic Agents|cholinergic agents|mesh-ancestor
24395018|NCT00134953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24835248|NCT02182531|Epinastine|epinastine|mesh-list
24395019|NCT00134953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395020|NCT00134953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24395021|NCT00134953|Protective Agents|protective agents|mesh-ancestor
24395022|NCT00134966|Levodopa|levodopa|mesh-list
24395023|NCT00134966|Carbidopa|carbidopa|mesh-list
24395024|NCT00134966|Entacapone|entacapone|mesh-list
24395025|NCT00134966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24395026|NCT00134966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24395027|NCT00134966|Dopamine Agents|dopamine agents|mesh-ancestor
24395028|NCT00134966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24395029|NCT00134966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395031|NCT00134966|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24395032|NCT00134966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395050|NCT00134992|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24395051|NCT00134992|Prednisolone acetate|prednisolone acetate|mesh-list
24517831|NCT00610142|Sensory System Agents|sensory system agents|mesh-ancestor
24449687|NCT00316563|Dronabinol|dronabinol|mesh-list
24395052|NCT00134992|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24395053|NCT00134992|Prednisolone phosphate|prednisolone phosphate|mesh-list
24395054|NCT00134992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24395055|NCT00134992|Glucocorticoids|glucocorticoids|mesh-ancestor
24395060|NCT00134992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24395061|NCT00134992|Antiemetics|antiemetics|mesh-ancestor
24395062|NCT00134992|Autonomic Agents|autonomic agents|mesh-ancestor
24395063|NCT00134992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24395064|NCT00134992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24395065|NCT00134992|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24395066|NCT00134992|Protective Agents|protective agents|mesh-ancestor
24395068|NCT00135005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24395069|NCT00135005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24395146|NCT00135135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24395147|NCT00135135|Keratolytic Agents|keratolytic agents|mesh-ancestor
24395148|NCT00135135|Dermatologic Agents|dermatologic agents|mesh-ancestor
24395149|NCT00135187|Dexamethasone|dexamethasone|mesh-list
24395151|NCT00135187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24395152|NCT00135187|Antiemetics|antiemetics|mesh-ancestor
24395153|NCT00135187|Autonomic Agents|autonomic agents|mesh-ancestor
24395154|NCT00135187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24395155|NCT00135187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395156|NCT00135187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24395157|NCT00135187|Glucocorticoids|glucocorticoids|mesh-ancestor
25842066|NCT00031733|Immunologic Factors|immunologic factors|mesh-ancestor
24395306|NCT00135720|Analgesics|analgesics|mesh-ancestor
24395307|NCT00135720|Sensory System Agents|sensory system agents|mesh-ancestor
24455343|NCT01691833|Micronutrients|micronutrients|mesh-ancestor
24395308|NCT00135720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24395309|NCT00135720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520584|NCT05337085|Anesthetics|anesthetics|mesh-ancestor
24395341|NCT00135785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24395379|NCT00135837|Dermatologic Agents|dermatologic agents|mesh-ancestor
24395381|NCT00135863|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24395382|NCT00135863|Dalteparin|dalteparin|mesh-list
24395383|NCT00135863|Anticoagulants|anticoagulants|mesh-ancestor
24395384|NCT00135863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24395385|NCT00135863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24395386|NCT00135863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395388|NCT00135876|Tinzaparin|tinzaparin|mesh-list
24395389|NCT00135876|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24395390|NCT00135876|Anticoagulants|anticoagulants|mesh-ancestor
24395391|NCT00135876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24395392|NCT00135876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24395393|NCT00135876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395394|NCT00135902|Progesterone|progesterone|mesh-list
24395423|NCT00135954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25203255|NCT02714998|Methotrexate|methotrexate|mesh-list
24395424|NCT00135954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24395425|NCT00135954|Glucocorticoids|glucocorticoids|mesh-ancestor
24395426|NCT00135954|Hormones|hormones|mesh-ancestor
24395432|NCT00135967|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24395433|NCT00135967|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24395434|NCT00135967|Prednisolone|prednisolone|mesh-list
24395435|NCT00135967|Prednisolone acetate|prednisolone acetate|mesh-list
24395436|NCT00135967|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24395437|NCT00135967|Prednisolone phosphate|prednisolone phosphate|mesh-list
24395438|NCT00135967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24395439|NCT00135967|Glucocorticoids|glucocorticoids|mesh-ancestor
24395440|NCT00135967|Hormones|hormones|mesh-ancestor
24395441|NCT00135967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24395442|NCT00135967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395452|NCT00135967|Antiemetics|antiemetics|mesh-ancestor
24811302|NCT02046304|Immunologic Factors|immunologic factors|mesh-ancestor
24811303|NCT02046304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811304|NCT02046421|Gemcitabine|gemcitabine|mesh-list
24811305|NCT02046421|Carboplatin|carboplatin|mesh-list
24811306|NCT02046421|Mifepristone|mifepristone|mesh-list
24395458|NCT00135993|Rotigotine|rotigotine|mesh-list
24395459|NCT00135993|Dopamine Agonists|dopamine agonists|mesh-ancestor
24395460|NCT00135993|Dopamine Agents|dopamine agents|mesh-ancestor
25660833|NCT01625845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395461|NCT00135993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24520750|NCT05333640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24395500|NCT00136175|Antiviral Agents|antiviral agents|mesh-ancestor
25660834|NCT01625845|Vasodilator Agents|vasodilator agents|mesh-ancestor
25660835|NCT01625845|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25842067|NCT00031733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707516|NCT01496261|Purinergic Agents|purinergic agents|mesh-ancestor
25842068|NCT00031733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842069|NCT00031733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24899371|NCT04404439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24899373|NCT04404439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24899374|NCT04404439|Antidepressive Agents|antidepressive agents|mesh-ancestor
24899375|NCT04404439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24476260|NCT00413712|Purinergic Agents|purinergic agents|mesh-ancestor
24906151|NCT04342065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24906152|NCT04342065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24906153|NCT04342065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24395501|NCT00136175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24395502|NCT00136175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395554|NCT00136383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24395555|NCT00136383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395556|NCT00136383|Analgesics|analgesics|mesh-ancestor
24395557|NCT00136383|Sensory System Agents|sensory system agents|mesh-ancestor
24395590|NCT00136448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395591|NCT00136448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24395593|NCT00136448|Sensory System Agents|sensory system agents|mesh-ancestor
24395594|NCT00136448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24395595|NCT00136448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24395596|NCT00136448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24395597|NCT00136448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24395630|NCT00136526|Mitosis Modulators|mitosis modulators|mesh-ancestor
24811307|NCT02046421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24811308|NCT02046421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24811309|NCT02046421|Antimetabolites|antimetabolites|mesh-ancestor
24811310|NCT02046421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811311|NCT02046421|Antiviral Agents|antiviral agents|mesh-ancestor
24859025|NCT02301130|Immunologic Factors|immunologic factors|mesh-ancestor
24395631|NCT00136526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395632|NCT00136526|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24395633|NCT00136526|Estrogens|estrogens|mesh-ancestor
24395634|NCT00136526|Hormones|hormones|mesh-ancestor
24395635|NCT00136526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24395638|NCT00136539|Cyclophosphamide|cyclophosphamide|mesh-list
24395644|NCT00136539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395645|NCT00136539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24395646|NCT00136539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24395647|NCT00136539|Alkylating Agents|alkylating agents|mesh-ancestor
24395648|NCT00136539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395649|NCT00136539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24395650|NCT00136539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24395651|NCT00136539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24811312|NCT02046421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24811319|NCT02046421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24811320|NCT02046421|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24395716|NCT00136734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395718|NCT00136734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24395719|NCT00136747|Memantine|memantine|mesh-list
24395720|NCT00136747|Bupropion|bupropion|mesh-list
24395721|NCT00136747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24395744|NCT00136773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24395745|NCT00136773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395746|NCT00136773|Vasodilator Agents|vasodilator agents|mesh-ancestor
24395747|NCT00136773|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24395748|NCT00136773|Protease Inhibitors|protease inhibitors|mesh-ancestor
24395749|NCT00136773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395750|NCT00136786|Memantine|memantine|mesh-list
24395751|NCT00136786|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24395752|NCT00136786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24395753|NCT00136786|Dopamine Agents|dopamine agents|mesh-ancestor
24395754|NCT00136786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25660836|NCT01625845|Antioxidants|antioxidants|mesh-ancestor
25660837|NCT01625897|Risperidone|risperidone|mesh-list
25660838|NCT01625897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25660839|NCT01625897|Serotonin Agents|serotonin agents|mesh-ancestor
25660840|NCT01625897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25660841|NCT01625897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660842|NCT01625897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660843|NCT01625897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25660844|NCT01625897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24395755|NCT00136786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395756|NCT00136786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395757|NCT00136786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24395759|NCT00136825|Acetylcysteine|acetylcysteine|mesh-list
24395767|NCT00136825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395768|NCT00136825|Protective Agents|protective agents|mesh-ancestor
24395769|NCT00136825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395770|NCT00136825|Antidotes|antidotes|mesh-ancestor
24395771|NCT00136851|Amlodipine|amlodipine|mesh-list
24395772|NCT00136851|Benazepril|benazepril|mesh-list
24395773|NCT00136851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24395785|NCT00136929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395788|NCT00136942|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24395789|NCT00136942|Antimetabolites|antimetabolites|mesh-ancestor
24606745|NCT05408845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24606746|NCT05408845|Trastuzumab|trastuzumab|mesh-list
24606747|NCT05408845|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24606749|NCT05408845|Maytansine|maytansine|mesh-list
24395793|NCT00136942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395794|NCT00136968|Voriconazole|voriconazole|mesh-list
25842070|NCT00031733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25842071|NCT00031733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25842072|NCT00031733|Growth Substances|growth substances|mesh-ancestor
24395795|NCT00136968|Antifungal Agents|antifungal agents|mesh-ancestor
24395796|NCT00136968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24395797|NCT00136968|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24395798|NCT00136968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24395799|NCT00136968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395800|NCT00136968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395801|NCT00136968|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24395802|NCT00136968|Hormone Antagonists|hormone antagonists|mesh-ancestor
24395803|NCT00136968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24896694|NCT04433533|Antimetabolites|antimetabolites|mesh-ancestor
24395804|NCT00136968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395806|NCT00136981|Atorvastatin|atorvastatin|mesh-list
24395807|NCT00136981|Torcetrapib|torcetrapib|mesh-list
24395808|NCT00136981|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24395809|NCT00136981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24395810|NCT00136981|Antimetabolites|antimetabolites|mesh-ancestor
24395835|NCT00137007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395836|NCT00137020|Ziprasidone|ziprasidone|mesh-list
24395837|NCT00137020|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24395838|NCT00137020|Serotonin Agents|serotonin agents|mesh-ancestor
24395839|NCT00137020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24395840|NCT00137020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395841|NCT00137020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395842|NCT00137020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24395843|NCT00137020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24395844|NCT00137020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24395845|NCT00137020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24395846|NCT00137020|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24395847|NCT00137020|Dopamine Agents|dopamine agents|mesh-ancestor
24395849|NCT00137033|Naproxen|naproxen|mesh-list
24395850|NCT00137033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25842073|NCT00031733|Growth Inhibitors|growth inhibitors|mesh-ancestor
24395868|NCT00137059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395869|NCT00137059|Antipyretics|antipyretics|mesh-ancestor
24395870|NCT00137072|Sildenafil Citrate|sildenafil citrate|mesh-list
24395906|NCT00137202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24395907|NCT00137202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395908|NCT00137202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24395909|NCT00137202|Antipruritics|antipruritics|mesh-ancestor
24395910|NCT00137202|Dermatologic Agents|dermatologic agents|mesh-ancestor
24395911|NCT00137202|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24395912|NCT00137202|Serotonin Agents|serotonin agents|mesh-ancestor
24606751|NCT05408845|Antibodies|antibodies|mesh-list
24606752|NCT05408845|Immunoglobulins|immunoglobulins|mesh-list
24606753|NCT05408845|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24606754|NCT05408845|Immunoconjugates|immunoconjugates|mesh-list
24606755|NCT05408845|Immunologic Factors|immunologic factors|mesh-ancestor
24606756|NCT05408845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606757|NCT05408845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24395913|NCT00137202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24395936|NCT00137345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24395937|NCT00137345|Antifungal Agents|antifungal agents|mesh-ancestor
25063543|NCT03468062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24899433|NCT04403568|Sensory System Agents|sensory system agents|mesh-ancestor
24899436|NCT04403568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24395938|NCT00137345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24395939|NCT00137345|Immunologic Factors|immunologic factors|mesh-ancestor
24395940|NCT00137345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395941|NCT00137358|Amifostine|amifostine|mesh-list
24538801|NCT00660855|Analgesics|analgesics|mesh-ancestor
24395947|NCT00137397|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24395948|NCT00137397|Cholinergic Agents|cholinergic agents|mesh-ancestor
24395949|NCT00137397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24623143|NCT01070446|Lipotropic Agents|lipotropic agents|mesh-ancestor
24395979|NCT00137501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24395980|NCT00137501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395981|NCT00137501|Vasodilator Agents|vasodilator agents|mesh-ancestor
24395982|NCT00137501|Tocolytic Agents|tocolytic agents|mesh-ancestor
24395983|NCT00137501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25082674|NCT03321110|Ubiquinone|ubiquinone|mesh-list
24829298|NCT02151240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829299|NCT02151279|Chitosan|chitosan|mesh-list
24829300|NCT02151279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24829301|NCT02151279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24829302|NCT02151279|Antimetabolites|antimetabolites|mesh-ancestor
24829303|NCT02151279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829304|NCT02151279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24829305|NCT02151279|Chelating Agents|chelating agents|mesh-ancestor
24829306|NCT02151279|Sequestering Agents|sequestering agents|mesh-ancestor
24829307|NCT02151279|Hemostatics|hemostatics|mesh-ancestor
25842074|NCT00031733|Antacids|antacids|mesh-ancestor
25842075|NCT00031733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842076|NCT00031733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25842077|NCT00031746|Caseins|caseins|mesh-list
25842078|NCT00031746|Chelating Agents|chelating agents|mesh-ancestor
25842079|NCT00031746|Sequestering Agents|sequestering agents|mesh-ancestor
25842080|NCT00031746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842081|NCT00031759|Imiquimod|imiquimod|mesh-list
25842082|NCT00031759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25842083|NCT00031759|Immunologic Factors|immunologic factors|mesh-ancestor
24829331|NCT02151604|Anesthetics|anesthetics|mesh-ancestor
25842084|NCT00031759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842085|NCT00031759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842086|NCT00031759|Interferon Inducers|interferon inducers|mesh-ancestor
25842087|NCT00031785|Megestrol|megestrol|mesh-list
25842088|NCT00031785|Megestrol Acetate|megestrol acetate|mesh-list
25164898|NCT05138068|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25164899|NCT05138068|Hallucinogens|hallucinogens|mesh-ancestor
25164900|NCT05138068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164901|NCT05138068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25164902|NCT05138068|Serotonin Agents|serotonin agents|mesh-ancestor
25164903|NCT05138068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25164904|NCT05138068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164905|NCT05138068|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25164906|NCT05138068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25164907|NCT05138068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25164916|NCT05134974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164917|NCT05134974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164918|NCT05134974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24395986|NCT00137514|Amebicides|amebicides|mesh-ancestor
24395987|NCT00137514|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24396021|NCT00137657|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24396023|NCT00137657|Renal Agents|renal agents|mesh-ancestor
24396032|NCT00137657|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24396033|NCT00137657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24396054|NCT00137735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24396055|NCT00137735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396056|NCT00137735|Anticonvulsants|anticonvulsants|mesh-ancestor
24396057|NCT00137735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24396058|NCT00137735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25660845|NCT01625897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25660846|NCT01625897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25660847|NCT01625897|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25416116|NCT02969798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25842089|NCT00031785|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25842090|NCT00031785|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25063551|NCT03468062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25063552|NCT03468062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24817850|NCT02085902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25201835|NCT02725164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201836|NCT02725164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24817851|NCT02085967|Itraconazole|itraconazole|mesh-list
24817853|NCT02085967|Midazolam|midazolam|mesh-list
24817854|NCT02085967|Bupropion|bupropion|mesh-list
24476363|NCT00414336|Antacids|antacids|mesh-ancestor
24396059|NCT00137735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24396060|NCT00137735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24396061|NCT00137735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24396062|NCT00137735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24396094|NCT00137787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396095|NCT00137787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396096|NCT00137787|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24396097|NCT00137787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24396098|NCT00137800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24396131|NCT00137852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24396133|NCT00137852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396134|NCT00137852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396135|NCT00137852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24396136|NCT00137852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24396138|NCT00137852|Sensory System Agents|sensory system agents|mesh-ancestor
24396139|NCT00137852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24396140|NCT00137852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396141|NCT00137852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24396142|NCT00137852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25842091|NCT00031785|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24396143|NCT00137852|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24396144|NCT00137852|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24396145|NCT00137995|Cytarabine|cytarabine|mesh-list
24396146|NCT00137995|Dexamethasone|dexamethasone|mesh-list
24396147|NCT00137995|Rituximab|rituximab|mesh-list
24396148|NCT00137995|Etoposide|etoposide|mesh-list
24396149|NCT00137995|Etoposide phosphate|etoposide phosphate|mesh-list
24396150|NCT00137995|Melphalan|melphalan|mesh-list
24396151|NCT00137995|Ifosfamide|ifosfamide|mesh-list
24396152|NCT00137995|Carboplatin|carboplatin|mesh-list
24396153|NCT00137995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24396154|NCT00137995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396155|NCT00137995|Immunologic Factors|immunologic factors|mesh-ancestor
24967996|NCT03755427|Immunologic Factors|immunologic factors|mesh-ancestor
24396156|NCT00137995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396157|NCT00137995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24396158|NCT00137995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24396159|NCT00137995|Antiemetics|antiemetics|mesh-ancestor
24396160|NCT00137995|Autonomic Agents|autonomic agents|mesh-ancestor
24451413|NCT00323583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25842092|NCT00031785|Contraceptive Agents|contraceptive agents|mesh-ancestor
24396172|NCT00137995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24396174|NCT00137995|Antiviral Agents|antiviral agents|mesh-ancestor
24396175|NCT00137995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24396176|NCT00137995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24396214|NCT00138177|Fluorouracil|fluorouracil|mesh-list
24396215|NCT00138177|Oxaliplatin|oxaliplatin|mesh-list
24396216|NCT00138177|Vorinostat|vorinostat|mesh-list
24396217|NCT00138177|Calcium|calcium|mesh-list
24396218|NCT00138177|Levoleucovorin|levoleucovorin|mesh-list
24396219|NCT00138177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24396220|NCT00138177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396221|NCT00138177|Antimetabolites|antimetabolites|mesh-ancestor
24396222|NCT00138177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396223|NCT00138177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24396224|NCT00138177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396225|NCT00138177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24396226|NCT00138177|Immunologic Factors|immunologic factors|mesh-ancestor
24396227|NCT00138177|Antidotes|antidotes|mesh-ancestor
25660848|NCT01625897|Dopamine Agents|dopamine agents|mesh-ancestor
25660849|NCT01625923|Olanzapine|olanzapine|mesh-list
25660850|NCT01625923|Antiemetics|antiemetics|mesh-ancestor
25660851|NCT01625923|Autonomic Agents|autonomic agents|mesh-ancestor
25660852|NCT01625923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25660853|NCT01625923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660854|NCT01625923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25660855|NCT01625923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25875698|NCT04216290|Mitomycin|mitomycin|mesh-list
25660856|NCT01625923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24519471|NCT01198522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899495|NCT04403282|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24899496|NCT04403282|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24396261|NCT00138229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24396264|NCT00138229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24396266|NCT00138229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24396267|NCT00138242|Carboplatin|carboplatin|mesh-list
24396268|NCT00138242|Docetaxel|docetaxel|mesh-list
24396269|NCT00138242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396270|NCT00138242|Tubulin Modulators|tubulin modulators|mesh-ancestor
24396307|NCT00138554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24396308|NCT00138554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396309|NCT00138554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24396310|NCT00138554|Protease Inhibitors|protease inhibitors|mesh-ancestor
24396311|NCT00138554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842093|NCT00031785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25842094|NCT00031785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842095|NCT00031785|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25842096|NCT00031785|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25842097|NCT00031785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25842098|NCT00031785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842099|NCT00031785|Appetite Stimulants|appetite stimulants|mesh-ancestor
25842100|NCT00031785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24396312|NCT00138554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396313|NCT00138567|Vildagliptin|vildagliptin|mesh-list
24396314|NCT00138567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24396315|NCT00138567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396316|NCT00138567|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24623122|NCT01070277|Tubulin Modulators|tubulin modulators|mesh-ancestor
24623123|NCT01070277|Antimitotic Agents|antimitotic agents|mesh-ancestor
24623124|NCT01070277|Mitosis Modulators|mitosis modulators|mesh-ancestor
24623125|NCT01070277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623126|NCT01070277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623127|NCT01070277|Alkylating Agents|alkylating agents|mesh-ancestor
24623128|NCT01070277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24623129|NCT01070277|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
24396317|NCT00138567|Protease Inhibitors|protease inhibitors|mesh-ancestor
24396318|NCT00138567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396319|NCT00138567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396320|NCT00138580|Vildagliptin|vildagliptin|mesh-list
24396321|NCT00138580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24396322|NCT00138580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396323|NCT00138580|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24396363|NCT00138736|Agglutinins|agglutinins|mesh-ancestor
24396364|NCT00138736|Immunologic Factors|immunologic factors|mesh-ancestor
24396365|NCT00138736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396366|NCT00138736|Coagulants|coagulants|mesh-ancestor
24396395|NCT00138970|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24396396|NCT00138970|Prednisolone acetate|prednisolone acetate|mesh-list
24396397|NCT00138970|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24396435|NCT00139009|Cyclosporins|cyclosporins|mesh-list
24396436|NCT00139009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842101|NCT00031798|Methylphenidate|methylphenidate|mesh-list
24968674|NCT03749590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24396437|NCT00139009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396438|NCT00139009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24396439|NCT00139009|Immunologic Factors|immunologic factors|mesh-ancestor
24396493|NCT00139165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396494|NCT00139165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24396495|NCT00139165|Respiratory System Agents|respiratory system agents|mesh-ancestor
24396496|NCT00139165|Glucocorticoids|glucocorticoids|mesh-ancestor
24396497|NCT00139165|Hormones|hormones|mesh-ancestor
24396498|NCT00139165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24396502|NCT00139217|Nitric Oxide|nitric oxide|mesh-list
24396505|NCT00139217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25842102|NCT00031798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25842103|NCT00031798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25416342|NCT02956590|Antimetabolites|antimetabolites|mesh-ancestor
25660857|NCT01625923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25660858|NCT01625923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25660859|NCT01625923|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24899606|NCT04402411|Analgesics|analgesics|mesh-ancestor
25201839|NCT02725164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25842104|NCT00031798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25842105|NCT00031798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25842106|NCT00031798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25842107|NCT00031798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842108|NCT00031798|Dopamine Agents|dopamine agents|mesh-ancestor
25842109|NCT00031798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25842110|NCT00031811|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25842111|NCT00031811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25842112|NCT00031811|Hormone Antagonists|hormone antagonists|mesh-ancestor
25842113|NCT00031811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25842114|NCT00031811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842115|NCT00031811|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25842116|NCT00031811|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24396546|NCT00139243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396547|NCT00139243|Antimetabolites|antimetabolites|mesh-ancestor
24396548|NCT00139243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623131|NCT01070290|Oxaliplatin|oxaliplatin|mesh-list
24623132|NCT01070290|Irinotecan|irinotecan|mesh-list
24623133|NCT01070290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24623134|NCT01070290|Antimetabolites|antimetabolites|mesh-ancestor
24623135|NCT01070290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623136|NCT01070290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623140|NCT01070407|Cloricromen|cloricromen|mesh-list
24623141|NCT01070407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24623142|NCT01070446|Choline|choline|mesh-list
24396549|NCT00139243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24396550|NCT00139243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24396551|NCT00139243|Immunologic Factors|immunologic factors|mesh-ancestor
24396552|NCT00139243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396553|NCT00139243|Antidotes|antidotes|mesh-ancestor
24396554|NCT00139243|Protective Agents|protective agents|mesh-ancestor
24396555|NCT00139243|Vitamin B Complex|vitamin b complex|mesh-ancestor
24396556|NCT00139243|Vitamins|vitamins|mesh-ancestor
24396557|NCT00139243|Micronutrients|micronutrients|mesh-ancestor
24396558|NCT00139243|Tubulin Modulators|tubulin modulators|mesh-ancestor
24396559|NCT00139243|Antimitotic Agents|antimitotic agents|mesh-ancestor
24396560|NCT00139243|Mitosis Modulators|mitosis modulators|mesh-ancestor
24396561|NCT00139256|Betamethasone|betamethasone|mesh-list
24396595|NCT00139360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24396596|NCT00139360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24396597|NCT00139360|Growth Substances|growth substances|mesh-ancestor
24396598|NCT00139360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396599|NCT00139360|Growth Inhibitors|growth inhibitors|mesh-ancestor
24396601|NCT00139373|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24396602|NCT00139373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396603|NCT00139373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396604|NCT00139373|Cholinergic Agents|cholinergic agents|mesh-ancestor
24396605|NCT00139373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24396606|NCT00139373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396607|NCT00139373|Nootropic Agents|nootropic agents|mesh-ancestor
24396608|NCT00139386|Candesartan|candesartan|mesh-list
24396609|NCT00139386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24396611|NCT00139386|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24396613|NCT00139516|Nicotine|nicotine|mesh-list
24396639|NCT00139568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396640|NCT00139568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396641|NCT00139581|Pimecrolimus|pimecrolimus|mesh-list
25660860|NCT01625923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25660861|NCT01625923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25660862|NCT01625923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660863|NCT01625923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25660864|NCT01625923|Serotonin Agents|serotonin agents|mesh-ancestor
25660865|NCT01626092|Cyclosporine|cyclosporine|mesh-list
25660866|NCT01626092|Mycophenolic Acid|mycophenolic acid|mesh-list
25660867|NCT01626092|Melphalan|melphalan|mesh-list
25660868|NCT01626092|Alemtuzumab|alemtuzumab|mesh-list
25660869|NCT01626092|Clofarabine|clofarabine|mesh-list
25660870|NCT01626092|Cyclosporins|cyclosporins|mesh-list
25660871|NCT01626092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25660872|NCT01626092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660873|NCT01626092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24899743|NCT04400890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899744|NCT04400890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24899745|NCT04400890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24899747|NCT04400890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899748|NCT04400890|Protective Agents|protective agents|mesh-ancestor
24906949|NCT04334824|Diuretics|diuretics|mesh-ancestor
24906950|NCT04334824|Natriuretic Agents|natriuretic agents|mesh-ancestor
25842117|NCT00031811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25842118|NCT00031824|Cyclosporine|cyclosporine|mesh-list
25842119|NCT00031824|Hydroxychloroquine|hydroxychloroquine|mesh-list
25842120|NCT00031824|Prednisone|prednisone|mesh-list
25842121|NCT00031824|Tacrolimus|tacrolimus|mesh-list
25842122|NCT00031824|Cyclosporins|cyclosporins|mesh-list
25842123|NCT00031824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25842124|NCT00031824|Glucocorticoids|glucocorticoids|mesh-ancestor
25842125|NCT00031824|Hormones|hormones|mesh-ancestor
25842126|NCT00031824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25842127|NCT00031824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842128|NCT00031824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25842129|NCT00031824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842130|NCT00031824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25042972|NCT01344187|Vitamins|vitamins|mesh-ancestor
24396647|NCT00139581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24396648|NCT00139581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396649|NCT00139581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24396650|NCT00139581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24396651|NCT00139581|Dermatologic Agents|dermatologic agents|mesh-ancestor
24396652|NCT00139581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24396653|NCT00139581|Immunologic Factors|immunologic factors|mesh-ancestor
24396654|NCT00139581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24396655|NCT00139581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396736|NCT00139815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24396737|NCT00139815|Protease Inhibitors|protease inhibitors|mesh-ancestor
24623145|NCT01070446|Antimetabolites|antimetabolites|mesh-ancestor
24970761|NCT03731091|Vitamins|vitamins|mesh-ancestor
24859026|NCT02301130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396738|NCT00139815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396739|NCT00139841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25842131|NCT00031824|Immunologic Factors|immunologic factors|mesh-ancestor
24396749|NCT00139854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24396750|NCT00139854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24396751|NCT00139854|GABA Modulators|gaba modulators|mesh-ancestor
24396752|NCT00139854|GABA Agents|gaba agents|mesh-ancestor
24396753|NCT00139854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24396754|NCT00139854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396755|NCT00139867|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24396756|NCT00139867|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24396774|NCT00139880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396775|NCT00139893|Metoclopramide|metoclopramide|mesh-list
24396776|NCT00139893|Antiemetics|antiemetics|mesh-ancestor
24396777|NCT00139893|Autonomic Agents|autonomic agents|mesh-ancestor
24396778|NCT00139893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24396779|NCT00139893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396780|NCT00139893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24396781|NCT00139893|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24396783|NCT00139893|Dopamine Agents|dopamine agents|mesh-ancestor
25164928|NCT05125796|Acetaminophen|acetaminophen|mesh-list
25164929|NCT05125796|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
25164930|NCT05125796|Ketoprofen|ketoprofen|mesh-list
25164931|NCT05125796|Lidocaine|lidocaine|mesh-list
25164932|NCT05125796|Anesthetics, Local|anesthetics, local|mesh-ancestor
25164933|NCT05125796|Anesthetics|anesthetics|mesh-ancestor
25164934|NCT05125796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25164935|NCT05125796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164936|NCT05125796|Sensory System Agents|sensory system agents|mesh-ancestor
25417390|NCT02879695|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25660874|NCT01626092|Immunologic Factors|immunologic factors|mesh-ancestor
25660875|NCT01626092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660876|NCT01626092|Antifungal Agents|antifungal agents|mesh-ancestor
25660877|NCT01626092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25660878|NCT01626092|Dermatologic Agents|dermatologic agents|mesh-ancestor
25660879|NCT01626092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25660880|NCT01626092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25660881|NCT01626092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25842132|NCT00031824|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24899940|NCT04398771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25164937|NCT05125796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25164938|NCT05125796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25164939|NCT05125796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25164940|NCT05125796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25164942|NCT05125796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164943|NCT05125796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25164944|NCT05125796|Analgesics|analgesics|mesh-ancestor
25164945|NCT05125796|Antipyretics|antipyretics|mesh-ancestor
25164946|NCT05125796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25164947|NCT05125796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24396835|NCT00140101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24396836|NCT00140101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396837|NCT00140101|Tubulin Modulators|tubulin modulators|mesh-ancestor
24396872|NCT00140218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24396873|NCT00140218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24396874|NCT00140218|Dopamine Agonists|dopamine agonists|mesh-ancestor
24396875|NCT00140218|Dopamine Agents|dopamine agents|mesh-ancestor
24396876|NCT00140218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24396877|NCT00140257|Citalopram|citalopram|mesh-list
24396878|NCT00140257|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24396879|NCT00140257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24396880|NCT00140257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24396881|NCT00140257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396882|NCT00140257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24396883|NCT00140257|Serotonin Agents|serotonin agents|mesh-ancestor
24396884|NCT00140257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396885|NCT00140257|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24396886|NCT00140257|Antidepressive Agents|antidepressive agents|mesh-ancestor
24396887|NCT00140257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24396889|NCT00140296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24396890|NCT00140296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396891|NCT00140309|Moxifloxacin|moxifloxacin|mesh-list
24396903|NCT00140309|Antitubercular Agents|antitubercular agents|mesh-ancestor
24396905|NCT00140309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24396906|NCT00140309|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24623146|NCT01070446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623147|NCT01070446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24623148|NCT01070446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24623149|NCT01070446|Nootropic Agents|nootropic agents|mesh-ancestor
24623150|NCT01070472|Misoprostol|misoprostol|mesh-list
25842133|NCT00031824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842134|NCT00031824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842135|NCT00031824|Antifungal Agents|antifungal agents|mesh-ancestor
25842136|NCT00031824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25842137|NCT00031824|Dermatologic Agents|dermatologic agents|mesh-ancestor
25842138|NCT00031824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25842139|NCT00031824|Antimalarials|antimalarials|mesh-ancestor
24970869|NCT03730363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25842140|NCT00031824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25842141|NCT00031824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25842142|NCT00031837|Gemcitabine|gemcitabine|mesh-list
25842143|NCT00031837|Dalteparin|dalteparin|mesh-list
25842144|NCT00031837|Tinzaparin|tinzaparin|mesh-list
25842145|NCT00031837|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25842146|NCT00031837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25842147|NCT00031837|Antimetabolites|antimetabolites|mesh-ancestor
25842148|NCT00031837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842149|NCT00031837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842150|NCT00031837|Antiviral Agents|antiviral agents|mesh-ancestor
24396910|NCT00140309|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24396911|NCT00140309|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24396912|NCT00140309|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24396913|NCT00140309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24396914|NCT00140309|Antimetabolites|antimetabolites|mesh-ancestor
24396915|NCT00140309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24396916|NCT00140361|Artesunate|artesunate|mesh-list
24396917|NCT00140361|Lumefantrine|lumefantrine|mesh-list
25660882|NCT01626092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25660883|NCT01626092|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25660884|NCT01626092|Antitubercular Agents|antitubercular agents|mesh-ancestor
25660885|NCT01626092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24396918|NCT00140361|Artemether|artemether|mesh-list
24396919|NCT00140361|Pyrimethamine|pyrimethamine|mesh-list
24396920|NCT00140361|Sulfadoxine|sulfadoxine|mesh-list
24396921|NCT00140361|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24396922|NCT00140361|Antimalarials|antimalarials|mesh-ancestor
24396923|NCT00140361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24396924|NCT00140361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24396951|NCT00140465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24396952|NCT00140465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24396953|NCT00140465|Purinergic Agents|purinergic agents|mesh-ancestor
24396954|NCT00140465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25164948|NCT05125796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24396956|NCT00140465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396958|NCT00140478|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24396959|NCT00140478|Abortifacient Agents|abortifacient agents|mesh-ancestor
24396960|NCT00140478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24396961|NCT00140478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396962|NCT00140478|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25842151|NCT00031837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25842152|NCT00031837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842153|NCT00031837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25842154|NCT00031837|Immunologic Factors|immunologic factors|mesh-ancestor
25842155|NCT00031837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842156|NCT00031837|Anticoagulants|anticoagulants|mesh-ancestor
24396965|NCT00140478|Contraceptive Agents|contraceptive agents|mesh-ancestor
24396966|NCT00140478|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24396967|NCT00140478|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24396968|NCT00140478|Hormone Antagonists|hormone antagonists|mesh-ancestor
24396969|NCT00140478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24396970|NCT00140478|Luteolytic Agents|luteolytic agents|mesh-ancestor
24396971|NCT00140478|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24396972|NCT00140478|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24396973|NCT00140517|Chloroquine|chloroquine|mesh-list
24397015|NCT00140543|Immunologic Factors|immunologic factors|mesh-ancestor
24397016|NCT00140543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397017|NCT00140569|Interferons|interferons|mesh-list
24397018|NCT00140569|Fludarabine|fludarabine|mesh-list
24397019|NCT00140569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24397020|NCT00140569|Antiviral Agents|antiviral agents|mesh-ancestor
24397021|NCT00140569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24397022|NCT00140582|Rituximab|rituximab|mesh-list
24397025|NCT00140582|Immunologic Factors|immunologic factors|mesh-ancestor
24397037|NCT00140595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397038|NCT00140595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842157|NCT00031837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24397130|NCT00140868|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24397131|NCT00140894|Rofecoxib|rofecoxib|mesh-list
24397132|NCT00140894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397133|NCT00140894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397134|NCT00140894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24623151|NCT01070472|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24623153|NCT01070472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24623154|NCT01070472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623155|NCT01070472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24538902|NCT00661115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538903|NCT00661115|Urological Agents|urological agents|mesh-ancestor
24397204|NCT00141063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397205|NCT00141063|Dopamine Agents|dopamine agents|mesh-ancestor
24397206|NCT00141063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24397240|NCT00141167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24397241|NCT00141167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397242|NCT00141167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397244|NCT00141193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24397245|NCT00141193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24397247|NCT00141193|Sensory System Agents|sensory system agents|mesh-ancestor
24397248|NCT00141193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24397249|NCT00141193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397250|NCT00141193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24397251|NCT00141193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24397252|NCT00141193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25842158|NCT00031837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24907207|NCT04331626|Gemcitabine|gemcitabine|mesh-list
24397253|NCT00141193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24397287|NCT00141258|Sensory System Agents|sensory system agents|mesh-ancestor
24397297|NCT00141258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24397298|NCT00141258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25842159|NCT00031850|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25842160|NCT00031850|Goserelin|goserelin|mesh-list
25842161|NCT00031850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25842162|NCT00031850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842163|NCT00031850|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25842164|NCT00031850|Hormone Antagonists|hormone antagonists|mesh-ancestor
25842165|NCT00031850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25842166|NCT00031850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842167|NCT00031850|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25842168|NCT00031850|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25164949|NCT05125796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25164950|NCT05125796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25164951|NCT05103904|Lenvatinib|lenvatinib|mesh-list
25164952|NCT05103904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25164953|NCT05103904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25164954|NCT05103904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25164955|NCT05103904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808386|NCT02026869|Metformin|metformin|mesh-list
25164978|NCT05096117|ASP8062|asp8062|mesh-list
25164979|NCT05096117|Analgesics|analgesics|mesh-ancestor
25164980|NCT05096117|Sensory System Agents|sensory system agents|mesh-ancestor
25164981|NCT05096117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25164982|NCT05096117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164983|NCT05096117|GABA Modulators|gaba modulators|mesh-ancestor
25164984|NCT05096117|GABA Agents|gaba agents|mesh-ancestor
25164985|NCT05096117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25164986|NCT05096117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164989|NCT05087381|Cyproheptadine|cyproheptadine|mesh-list
25164990|NCT05087381|Niclosamide|niclosamide|mesh-list
25164991|NCT05087381|Fluvoxamine|fluvoxamine|mesh-list
25164992|NCT05087381|Bromhexine|bromhexine|mesh-list
25164993|NCT05087381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25164994|NCT05087381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25164995|NCT05087381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25164996|NCT05087381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25164997|NCT05087381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25164998|NCT05087381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25164999|NCT05087381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25165000|NCT05087381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25165001|NCT05087381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25842169|NCT00031850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24971496|NCT03725878|Folic Acid|folic acid|mesh-list
25842170|NCT00031863|Rofecoxib|rofecoxib|mesh-list
25842171|NCT00031863|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24397299|NCT00141310|Sildenafil Citrate|sildenafil citrate|mesh-list
24397300|NCT00141310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397301|NCT00141310|Vasodilator Agents|vasodilator agents|mesh-ancestor
24397302|NCT00141310|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24397325|NCT00141362|Anticonvulsants|anticonvulsants|mesh-ancestor
24397326|NCT00141362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24397327|NCT00141362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24397328|NCT00141362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397329|NCT00141362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24397330|NCT00141362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24397331|NCT00141362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24397332|NCT00141362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24397333|NCT00141362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24397334|NCT00141375|Pregabalin|pregabalin|mesh-list
24397335|NCT00141375|Analgesics|analgesics|mesh-ancestor
24397336|NCT00141375|Sensory System Agents|sensory system agents|mesh-ancestor
24397337|NCT00141375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24397338|NCT00141375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811325|NCT02046421|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24811326|NCT02046421|Hormone Antagonists|hormone antagonists|mesh-ancestor
24811327|NCT02046421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24397388|NCT00141414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24397389|NCT00141414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24397390|NCT00141427|Pregabalin|pregabalin|mesh-list
24397391|NCT00141427|Analgesics|analgesics|mesh-ancestor
24518599|NCT04785651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24900573|NCT04392700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24900574|NCT04392700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24397392|NCT00141427|Sensory System Agents|sensory system agents|mesh-ancestor
24397393|NCT00141427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24397406|NCT00141492|Hormones|hormones|mesh-ancestor
24397407|NCT00141492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24397408|NCT00141492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397409|NCT00141531|Apaziquone|apaziquone|mesh-list
24397410|NCT00141531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24397411|NCT00141544|Methyltestosterone|methyltestosterone|mesh-list
24397412|NCT00141544|Estrogens|estrogens|mesh-list
24397413|NCT00141544|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
24397414|NCT00141544|Estrone|estrone|mesh-list
24397415|NCT00141544|Testosterone|testosterone|mesh-list
24397416|NCT00141544|Testosterone undecanoate|testosterone undecanoate|mesh-list
24397417|NCT00141544|Testosterone enanthate|testosterone enanthate|mesh-list
24397418|NCT00141544|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24397419|NCT00141544|Hormones|hormones|mesh-ancestor
24526268|NCT00290511|Antiemetics|antiemetics|mesh-ancestor
25842172|NCT00031863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25842173|NCT00031863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842174|NCT00031863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842175|NCT00031863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25842176|NCT00031863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25842177|NCT00031863|Analgesics|analgesics|mesh-ancestor
24397426|NCT00141557|Methyltestosterone|methyltestosterone|mesh-list
24397427|NCT00141557|Estrogens|estrogens|mesh-list
24397428|NCT00141557|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
24397429|NCT00141557|Estrone|estrone|mesh-list
24397430|NCT00141557|Testosterone|testosterone|mesh-list
24397431|NCT00141557|Testosterone undecanoate|testosterone undecanoate|mesh-list
24397434|NCT00141557|Hormones|hormones|mesh-ancestor
24397444|NCT00141570|Testosterone|testosterone|mesh-list
24397445|NCT00141570|Testosterone undecanoate|testosterone undecanoate|mesh-list
24397446|NCT00141570|Testosterone enanthate|testosterone enanthate|mesh-list
24397447|NCT00141570|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24811331|NCT02046447|Trihexyphenidyl|trihexyphenidyl|mesh-list
24811332|NCT02046447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24397448|NCT00141570|Hormones|hormones|mesh-ancestor
24397449|NCT00141570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24397450|NCT00141570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397451|NCT00141570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24397453|NCT00141570|Anabolic Agents|anabolic agents|mesh-ancestor
24397454|NCT00141570|Androgens|androgens|mesh-ancestor
24397455|NCT00141583|Candesartan|candesartan|mesh-list
24397456|NCT00141583|Enalapril|enalapril|mesh-list
24397457|NCT00141583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24397458|NCT00141583|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24397459|NCT00141583|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24397732|NCT00142467|Immunologic Factors|immunologic factors|mesh-ancestor
24455447|NCT00945724|Antiviral Agents|antiviral agents|mesh-ancestor
24455448|NCT00945724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24455449|NCT00945724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24455459|NCT00554515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24455460|NCT00554515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24455461|NCT00554515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24455462|NCT00554515|Antiviral Agents|antiviral agents|mesh-ancestor
24455463|NCT00554515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24455464|NCT00107198|Prednisone|prednisone|mesh-list
24397464|NCT00141596|Amiloride|amiloride|mesh-list
25660886|NCT01626092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25660887|NCT01626092|Alkylating Agents|alkylating agents|mesh-ancestor
25660888|NCT01626092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25660889|NCT01626092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25660890|NCT01626092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24397518|NCT00141713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24397519|NCT00141713|Immunologic Factors|immunologic factors|mesh-ancestor
24397520|NCT00141791|Etanercept|etanercept|mesh-list
24397521|NCT00141791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25417391|NCT02879695|Muromonab-CD3|muromonab-cd3|mesh-list
25660891|NCT01626092|Antimetabolites|antimetabolites|mesh-ancestor
25660892|NCT01626118|Indomethacin|indomethacin|mesh-list
25660893|NCT01626118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25842178|NCT00031863|Sensory System Agents|sensory system agents|mesh-ancestor
24900695|NCT04391998|Mitosis Modulators|mitosis modulators|mesh-ancestor
24397522|NCT00141791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24397523|NCT00141791|Analgesics|analgesics|mesh-ancestor
24397524|NCT00141791|Sensory System Agents|sensory system agents|mesh-ancestor
24397525|NCT00141791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24397563|NCT00141882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24397564|NCT00141882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397565|NCT00141882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397566|NCT00141882|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24397567|NCT00141882|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24397568|NCT00141895|Misoprostol|misoprostol|mesh-list
24397569|NCT00141895|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24397570|NCT00141895|Abortifacient Agents|abortifacient agents|mesh-ancestor
24397571|NCT00141895|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24397572|NCT00141895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397573|NCT00141895|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24397574|NCT00141895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24397575|NCT00141895|Oxytocics|oxytocics|mesh-ancestor
24397577|NCT00141908|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
24397578|NCT00141908|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
24397579|NCT00141908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24397580|NCT00141908|Hormone Antagonists|hormone antagonists|mesh-ancestor
24397581|NCT00141908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24397582|NCT00141908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397583|NCT00141908|Progestins|progestins|mesh-ancestor
24397584|NCT00141908|Hormones|hormones|mesh-ancestor
24397585|NCT00141908|Cathartics|cathartics|mesh-ancestor
24397586|NCT00141908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24397587|NCT00141947|Bexarotene|bexarotene|mesh-list
24397588|NCT00141947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24397589|NCT00141960|Famotidine|famotidine|mesh-list
24397590|NCT00141960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24397591|NCT00141960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24397592|NCT00141960|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24397593|NCT00141960|Histamine Antagonists|histamine antagonists|mesh-ancestor
24397646|NCT00142155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24397647|NCT00142155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25842179|NCT00031863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25842180|NCT00031863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842181|NCT00031863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24397649|NCT00142181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24811338|NCT02046447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397731|NCT00142467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24397755|NCT00142493|Anesthetics|anesthetics|mesh-ancestor
24397756|NCT00142493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24397757|NCT00142493|Analgesics|analgesics|mesh-ancestor
24397758|NCT00142493|Sensory System Agents|sensory system agents|mesh-ancestor
24397759|NCT00142493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24397803|NCT00142610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972442|NCT03717740|Esomeprazole|esomeprazole|mesh-list
24397804|NCT00142610|Protective Agents|protective agents|mesh-ancestor
24397805|NCT00142727|Analgesics, Opioid|analgesics, opioid|mesh-list
24397807|NCT00142727|Narcotic Antagonists|narcotic antagonists|mesh-list
24397808|NCT00142727|Narcotics|narcotics|mesh-ancestor
24397809|NCT00142727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24397810|NCT00142727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397811|NCT00142727|Analgesics|analgesics|mesh-ancestor
24397812|NCT00142727|Sensory System Agents|sensory system agents|mesh-ancestor
24397813|NCT00142727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24397814|NCT00142727|Antitussive Agents|antitussive agents|mesh-ancestor
24397815|NCT00142727|Respiratory System Agents|respiratory system agents|mesh-ancestor
24397816|NCT00142779|Fluoxetine|fluoxetine|mesh-list
24397817|NCT00142779|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25417392|NCT02879695|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25660894|NCT01626118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25660895|NCT01626118|Analgesics|analgesics|mesh-ancestor
25660896|NCT01626118|Sensory System Agents|sensory system agents|mesh-ancestor
25660897|NCT01626118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25660898|NCT01626118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660899|NCT01626118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24818082|NCT02086929|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24818083|NCT02086929|Serotonin Agents|serotonin agents|mesh-ancestor
24818084|NCT02086942|Dexamethasone|dexamethasone|mesh-list
24818085|NCT02086942|Cyclophosphamide|cyclophosphamide|mesh-list
24818086|NCT02086942|Bortezomib|bortezomib|mesh-list
24818087|NCT02086942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24818088|NCT02086942|Immunologic Factors|immunologic factors|mesh-ancestor
24818089|NCT02086942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818090|NCT02086942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24818091|NCT02086942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24818092|NCT02086942|Alkylating Agents|alkylating agents|mesh-ancestor
24518672|NCT04559906|Ethyl Chloride|ethyl chloride|mesh-list
24397818|NCT00142779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24397819|NCT00142779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24397820|NCT00142779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397821|NCT00142779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24397822|NCT00142779|Serotonin Agents|serotonin agents|mesh-ancestor
24397823|NCT00142779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397824|NCT00142779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24397825|NCT00142779|Antidepressive Agents|antidepressive agents|mesh-ancestor
24397826|NCT00142779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25842182|NCT00031863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25041554|NCT02488408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041555|NCT02488408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041556|NCT02486042|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25041557|NCT02486042|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25041558|NCT02486042|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25041559|NCT02486042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25041561|NCT02471222|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25041562|NCT02471222|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25041563|NCT02471222|Antiviral Agents|antiviral agents|mesh-ancestor
25842183|NCT00031876|Paclitaxel|paclitaxel|mesh-list
25842184|NCT00031876|Capecitabine|capecitabine|mesh-list
25842185|NCT00031876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25842186|NCT00031876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25165002|NCT05087381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25165003|NCT05087381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25165004|NCT05087381|Serotonin Agents|serotonin agents|mesh-ancestor
25165005|NCT05087381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25165006|NCT05087381|Antidepressive Agents|antidepressive agents|mesh-ancestor
25165007|NCT05087381|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25165008|NCT05087381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25165009|NCT05087381|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25165025|NCT05087381|Respiratory System Agents|respiratory system agents|mesh-ancestor
25165040|NCT05077254|Mycophenolic Acid|mycophenolic acid|mesh-list
25165041|NCT05077254|Vaccines|vaccines|mesh-list
25165042|NCT05077254|Tacrolimus|tacrolimus|mesh-list
24973212|NCT03711240|Vitamins|vitamins|mesh-ancestor
25165043|NCT05077254|Immunologic Factors|immunologic factors|mesh-ancestor
25165044|NCT05077254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165045|NCT05077254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25165046|NCT05077254|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25165047|NCT05077254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25165048|NCT05077254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25165049|NCT05077254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25165050|NCT05077254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25165051|NCT05077254|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25165059|NCT05076838|Autonomic Agents|autonomic agents|mesh-ancestor
25165060|NCT05076838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25842187|NCT00031876|Tubulin Modulators|tubulin modulators|mesh-ancestor
24397827|NCT00142779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25417393|NCT02879695|Immunologic Factors|immunologic factors|mesh-ancestor
25660900|NCT01626118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25660901|NCT01626118|Gout Suppressants|gout suppressants|mesh-ancestor
25660902|NCT01626118|Tocolytic Agents|tocolytic agents|mesh-ancestor
25660903|NCT01626118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25660904|NCT01626118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25660905|NCT01626118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25660906|NCT01626118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660907|NCT01626352|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25660908|NCT01626352|Ofatumumab|ofatumumab|mesh-list
25660909|NCT01626352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25660910|NCT01626352|Alkylating Agents|alkylating agents|mesh-ancestor
25842188|NCT00031876|Antimitotic Agents|antimitotic agents|mesh-ancestor
24901027|NCT04389424|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24901028|NCT04389424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901029|NCT04389424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901030|NCT04389359|Hydroxychloroquine|hydroxychloroquine|mesh-list
24901031|NCT04389359|Antimalarials|antimalarials|mesh-ancestor
24397828|NCT00142779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24397829|NCT00142779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24397831|NCT00142844|Disulfiram|disulfiram|mesh-list
24397832|NCT00142844|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24397854|NCT00142883|Pregabalin|pregabalin|mesh-list
24397855|NCT00142883|Analgesics|analgesics|mesh-ancestor
24397856|NCT00142883|Sensory System Agents|sensory system agents|mesh-ancestor
24397857|NCT00142883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24397858|NCT00142883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397859|NCT00142883|Anticonvulsants|anticonvulsants|mesh-ancestor
24397860|NCT00142883|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24397861|NCT00142883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24397862|NCT00142883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397864|NCT00142883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24397874|NCT00142896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397876|NCT00142896|Sensory System Agents|sensory system agents|mesh-ancestor
24399167|NCT00146731|Antiviral Agents|antiviral agents|mesh-ancestor
24811342|NCT02046460|Warfarin|warfarin|mesh-list
24811343|NCT02046460|Phenprocoumon|phenprocoumon|mesh-list
24811344|NCT02046460|Acenocoumarol|acenocoumarol|mesh-list
24811345|NCT02046460|Vitamins|vitamins|mesh-ancestor
24811346|NCT02046460|Micronutrients|micronutrients|mesh-ancestor
24811347|NCT02046460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811348|NCT02046460|Anticoagulants|anticoagulants|mesh-ancestor
24811349|NCT02046460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24811350|NCT02046460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24811351|NCT02046460|Analgesics|analgesics|mesh-ancestor
24673901|NCT01341041|Chlorine dioxide|chlorine dioxide|mesh-list
24397878|NCT00142896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24397879|NCT00142948|Naltrexone|naltrexone|mesh-list
25842189|NCT00031876|Mitosis Modulators|mitosis modulators|mesh-ancestor
25842190|NCT00031876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842191|NCT00031876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25842192|NCT00031876|Antimetabolites|antimetabolites|mesh-ancestor
25842193|NCT00031889|Exemestane|exemestane|mesh-list
25842194|NCT00031889|Bicalutamide|bicalutamide|mesh-list
25842195|NCT00031889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842196|NCT00031889|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25842197|NCT00031889|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25842198|NCT00031889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24397880|NCT00142948|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24397881|NCT00142948|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24397882|NCT00142948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397883|NCT00142948|Sensory System Agents|sensory system agents|mesh-ancestor
24397978|NCT00143156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24397979|NCT00143156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25842199|NCT00031889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455466|NCT00107198|Cyclophosphamide|cyclophosphamide|mesh-list
24397980|NCT00143156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397981|NCT00143156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24397992|NCT00143169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24455475|NCT00107198|Alkylating Agents|alkylating agents|mesh-ancestor
24455476|NCT00107198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455477|NCT00107198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24455478|NCT00107198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24455479|NCT00107198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24455481|NCT00107198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24398012|NCT00143221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398013|NCT00143221|Urological Agents|urological agents|mesh-ancestor
24398015|NCT00143234|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
24398016|NCT00143234|Atorvastatin|atorvastatin|mesh-list
24398017|NCT00143234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24398018|NCT00143234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25660911|NCT01626352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660912|NCT01626352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25660913|NCT01626664|Gemcitabine|gemcitabine|mesh-list
25660914|NCT01626664|Oxaliplatin|oxaliplatin|mesh-list
25660915|NCT01626664|Mogamulizumab|mogamulizumab|mesh-list
24398019|NCT00143234|Antimetabolites|antimetabolites|mesh-ancestor
25660916|NCT01626664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25063965|NCT03464435|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25063967|NCT03464435|Tacrolimus|tacrolimus|mesh-list
25063968|NCT03464435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25063969|NCT03464435|Immunologic Factors|immunologic factors|mesh-ancestor
25063970|NCT03464435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063971|NCT03464435|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24398020|NCT00143234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398021|NCT00143234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24398022|NCT00143234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24398023|NCT00143234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398024|NCT00143234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24398025|NCT00143234|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24811352|NCT02046460|Sensory System Agents|sensory system agents|mesh-ancestor
24811353|NCT02046460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24811354|NCT02046460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24811355|NCT02046460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24811356|NCT02046460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24811357|NCT02046460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24811358|NCT02046460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811359|NCT02046460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24811360|NCT02046460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24811363|NCT02046460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24398072|NCT00143351|Dopamine Agents|dopamine agents|mesh-ancestor
24398073|NCT00143364|Varenicline|varenicline|mesh-list
24398074|NCT00143364|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24398075|NCT00143364|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24398076|NCT00143364|Cholinergic Agents|cholinergic agents|mesh-ancestor
24398077|NCT00143364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24398078|NCT00143364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842200|NCT00031889|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24398079|NCT00143364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398080|NCT00143377|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24398081|NCT00143377|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24398082|NCT00143377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24398085|NCT00143377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398086|NCT00143377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398087|NCT00143377|Urological Agents|urological agents|mesh-ancestor
24398089|NCT00143429|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24398149|NCT00143689|Lamivudine|lamivudine|mesh-list
24398150|NCT00143689|Zidovudine|zidovudine|mesh-list
24398151|NCT00143689|Nevirapine|nevirapine|mesh-list
24398152|NCT00143689|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24398153|NCT00143689|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24398154|NCT00143689|Protease Inhibitors|protease inhibitors|mesh-ancestor
24398155|NCT00143689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398156|NCT00143689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398157|NCT00143689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24398158|NCT00143689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24398159|NCT00143689|Antiviral Agents|antiviral agents|mesh-ancestor
24398160|NCT00143689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24398161|NCT00143689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24398162|NCT00143689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24398185|NCT00143715|Vitamin K|vitamin k|mesh-list
24398294|NCT00144131|Hematinics|hematinics|mesh-ancestor
24398295|NCT00144144|Calcium Channel Blockers|calcium channel blockers|mesh-list
24398296|NCT00144144|Angiotensin II|angiotensin ii|mesh-list
24398297|NCT00144144|Giapreza|giapreza|mesh-list
24811364|NCT02046460|Hemostatics|hemostatics|mesh-ancestor
24811365|NCT02046460|Coagulants|coagulants|mesh-ancestor
24811366|NCT02046486|Ticagrelor|ticagrelor|mesh-list
24811367|NCT02046486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24859027|NCT02301208|Nedaplatin|nedaplatin|mesh-list
24973821|NCT03706703|Growth Substances|growth substances|mesh-ancestor
24398301|NCT00144144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24398302|NCT00144144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398303|NCT00144144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24398304|NCT00144144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24398305|NCT00144144|Protease Inhibitors|protease inhibitors|mesh-ancestor
25660917|NCT01626664|Antimetabolites|antimetabolites|mesh-ancestor
25660918|NCT01626664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660919|NCT01626664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25660920|NCT01626664|Antiviral Agents|antiviral agents|mesh-ancestor
25660921|NCT01626664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25660922|NCT01626664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901307|NCT04386499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398306|NCT00144144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527730|NCT00618176|Antiviral Agents|antiviral agents|mesh-ancestor
24398361|NCT00144222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24398392|NCT00144287|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24398393|NCT00144287|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24398394|NCT00144287|Protease Inhibitors|protease inhibitors|mesh-ancestor
24398395|NCT00144287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398397|NCT00144287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24398399|NCT00144287|Antiviral Agents|antiviral agents|mesh-ancestor
24398448|NCT00144417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398451|NCT00144417|Antitubercular Agents|antitubercular agents|mesh-ancestor
25842201|NCT00031889|Hormone Antagonists|hormone antagonists|mesh-ancestor
24398453|NCT00144417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24398454|NCT00144417|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24398455|NCT00144417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24398456|NCT00144417|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24398457|NCT00144417|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24398458|NCT00144417|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24398478|NCT00144469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24398480|NCT00144482|Hematinics|hematinics|mesh-ancestor
24398481|NCT00144495|Epoetin Alfa|epoetin alfa|mesh-list
24398482|NCT00144495|Hematinics|hematinics|mesh-ancestor
24398483|NCT00144677|Sirolimus|sirolimus|mesh-list
24398484|NCT00144677|Tacrolimus|tacrolimus|mesh-list
24398485|NCT00144677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24398486|NCT00144677|Immunologic Factors|immunologic factors|mesh-ancestor
24398487|NCT00144677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398488|NCT00144677|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24398510|NCT00144716|Protective Agents|protective agents|mesh-ancestor
24398511|NCT00144716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398512|NCT00144755|Darbepoetin alfa|darbepoetin alfa|mesh-list
24398516|NCT00144807|Doxorubicin|doxorubicin|mesh-list
24398517|NCT00144807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24398518|NCT00144807|Immunologic Factors|immunologic factors|mesh-ancestor
24398519|NCT00144807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398520|NCT00144807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24398521|NCT00144807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24398522|NCT00144807|Alkylating Agents|alkylating agents|mesh-ancestor
24398523|NCT00144807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398524|NCT00144807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527881|NCT00618501|Glucocorticoids|glucocorticoids|mesh-ancestor
24398573|NCT00144872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24398574|NCT00144872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24398575|NCT00144872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24398576|NCT00144872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24398577|NCT00144872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24398578|NCT00144911|Fluticasone|fluticasone|mesh-list
24398580|NCT00144911|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25842202|NCT00031889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24973944|NCT05177666|Trastuzumab|trastuzumab|mesh-list
25842203|NCT00031889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398581|NCT00144911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24398582|NCT00144911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24398583|NCT00144911|Autonomic Agents|autonomic agents|mesh-ancestor
24398584|NCT00144911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24398585|NCT00144911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398586|NCT00144911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24398587|NCT00144911|Respiratory System Agents|respiratory system agents|mesh-ancestor
24398588|NCT00144911|Dermatologic Agents|dermatologic agents|mesh-ancestor
24398589|NCT00144911|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24398590|NCT00144911|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24398591|NCT00144911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24398599|NCT00144976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398600|NCT00144976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398601|NCT00144989|Cisplatin|cisplatin|mesh-list
24398602|NCT00144989|Irinotecan|irinotecan|mesh-list
24398603|NCT00144989|Etoposide|etoposide|mesh-list
25660923|NCT01626664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25660924|NCT01626664|Immunologic Factors|immunologic factors|mesh-ancestor
25660925|NCT01626664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660926|NCT01626872|Risperidone|risperidone|mesh-list
25660927|NCT01626872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25660928|NCT01626872|Serotonin Agents|serotonin agents|mesh-ancestor
25660929|NCT01626872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25842204|NCT00031889|Androgen Antagonists|androgen antagonists|mesh-ancestor
25842205|NCT00031902|Prednisolone|prednisolone|mesh-list
25842206|NCT00031902|Rituximab|rituximab|mesh-list
24901401|NCT04385290|Midostaurin|midostaurin|mesh-list
24901402|NCT04385290|Staurosporine|staurosporine|mesh-list
24901403|NCT04385290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25842207|NCT00031902|Vincristine|vincristine|mesh-list
25842208|NCT00031902|Bleomycin|bleomycin|mesh-list
25842209|NCT00031902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24398604|NCT00144989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24398605|NCT00144989|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24398606|NCT00144989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24398656|NCT00145210|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24811374|NCT02046486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811375|NCT02046499|Oxytocin|oxytocin|mesh-list
24811376|NCT02046499|Ergonovine|ergonovine|mesh-list
24398660|NCT00145236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25842210|NCT00031902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842211|NCT00031902|Immunologic Factors|immunologic factors|mesh-ancestor
25842212|NCT00031902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043057|NCT01332812|Protease Inhibitors|protease inhibitors|mesh-ancestor
24398661|NCT00145236|Vasodilator Agents|vasodilator agents|mesh-ancestor
24398662|NCT00145236|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24974221|NCT05095831|Pancreatin|pancreatin|mesh-list
24398663|NCT00145236|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24398664|NCT00145236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24398665|NCT00145236|Adrenergic Agents|adrenergic agents|mesh-ancestor
24398666|NCT00145236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24398667|NCT00145236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528009|NCT00619203|Antipyretics|antipyretics|mesh-ancestor
24398712|NCT00145379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24398713|NCT00145379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398714|NCT00145405|Octreotide|octreotide|mesh-list
24398715|NCT00145405|Lanreotide|lanreotide|mesh-list
24398716|NCT00145405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24398717|NCT00145405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24398718|NCT00145405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24398719|NCT00145444|Olanzapine|olanzapine|mesh-list
24398720|NCT00145444|Ziprasidone|ziprasidone|mesh-list
24398721|NCT00145444|Antiemetics|antiemetics|mesh-ancestor
24398742|NCT00145483|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24398743|NCT00145483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538996|NCT00661635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24538997|NCT00661635|Analgesics|analgesics|mesh-ancestor
25842213|NCT00031902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25165071|NCT05076838|Anesthetics, General|anesthetics, general|mesh-ancestor
25842214|NCT00031902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25842215|NCT00031902|Tubulin Modulators|tubulin modulators|mesh-ancestor
25842216|NCT00031902|Antimitotic Agents|antimitotic agents|mesh-ancestor
25842217|NCT00031902|Mitosis Modulators|mitosis modulators|mesh-ancestor
25842218|NCT00031902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842219|NCT00031902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25842220|NCT00031902|Glucocorticoids|glucocorticoids|mesh-ancestor
25842221|NCT00031902|Hormones|hormones|mesh-ancestor
25875699|NCT04216290|Immunoglobulins|immunoglobulins|mesh-list
24398744|NCT00145483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398745|NCT00145483|Urological Agents|urological agents|mesh-ancestor
24398747|NCT00145522|Estradiol|estradiol|mesh-list
24398748|NCT00145522|Dydrogesterone|dydrogesterone|mesh-list
24398749|NCT00145522|Estrogens|estrogens|mesh-ancestor
24398750|NCT00145522|Hormones|hormones|mesh-ancestor
24398751|NCT00145522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24398752|NCT00145522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398753|NCT00145522|Progestins|progestins|mesh-ancestor
24398754|NCT00145522|Androgen Antagonists|androgen antagonists|mesh-ancestor
24398755|NCT00145522|Hormone Antagonists|hormone antagonists|mesh-ancestor
24811379|NCT02046499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24811380|NCT02046499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398769|NCT00145561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25660930|NCT01626872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660931|NCT01626872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660932|NCT01626872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25660933|NCT01626872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25660934|NCT01626872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25660935|NCT01626872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24398770|NCT00145561|Antiviral Agents|antiviral agents|mesh-ancestor
25660936|NCT01626872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25660937|NCT01626872|Dopamine Agents|dopamine agents|mesh-ancestor
24901737|NCT04382014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24398771|NCT00145561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24398772|NCT00145561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24398773|NCT00145561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24398774|NCT00145613|Antibodies|antibodies|mesh-list
24398775|NCT00145613|Immunologic Factors|immunologic factors|mesh-ancestor
24398776|NCT00145613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398777|NCT00145639|Carboplatin|carboplatin|mesh-list
24398801|NCT00145691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398802|NCT00145691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24398803|NCT00145691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24398804|NCT00145730|Ibuprofen|ibuprofen|mesh-list
24398805|NCT00145730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24398806|NCT00145730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24398807|NCT00145730|Analgesics|analgesics|mesh-ancestor
25165061|NCT05076838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165062|NCT05076838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25165063|NCT05076838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25165064|NCT05076838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24398810|NCT00145730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398811|NCT00145730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24398813|NCT00145730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24398819|NCT00145847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398820|NCT00145847|Sensory System Agents|sensory system agents|mesh-ancestor
24398821|NCT00145847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24398884|NCT00146042|Antimitotic Agents|antimitotic agents|mesh-ancestor
24398885|NCT00146042|Mitosis Modulators|mitosis modulators|mesh-ancestor
24398886|NCT00146042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398887|NCT00146042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24398888|NCT00146042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24398897|NCT00146068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24398898|NCT00146068|Antiviral Agents|antiviral agents|mesh-ancestor
24398899|NCT00146068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24398900|NCT00146120|Etoposide|etoposide|mesh-list
24398901|NCT00146120|Idarubicin|idarubicin|mesh-list
24398902|NCT00146120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24398903|NCT00146120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24398904|NCT00146120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24398905|NCT00146120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24398906|NCT00146120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398907|NCT00146120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398958|NCT00146250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398959|NCT00146250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24398961|NCT00146250|Sensory System Agents|sensory system agents|mesh-ancestor
24399166|NCT00146731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24398985|NCT00146380|Zidovudine|zidovudine|mesh-list
24398986|NCT00146380|Nevirapine|nevirapine|mesh-list
24398987|NCT00146380|Nelfinavir|nelfinavir|mesh-list
24398988|NCT00146380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24398989|NCT00146380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24398990|NCT00146380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933402|NCT04071106|Calcipotriene|calcipotriene|mesh-list
24398991|NCT00146380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398992|NCT00146380|Antiviral Agents|antiviral agents|mesh-ancestor
24398993|NCT00146380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24398994|NCT00146380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24398995|NCT00146380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24398996|NCT00146380|Antimetabolites|antimetabolites|mesh-ancestor
24539033|NCT00661856|Phytoestrogens|phytoestrogens|mesh-ancestor
25842222|NCT00031902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25842223|NCT00031902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25842224|NCT00031902|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25842225|NCT00031915|Imatinib Mesylate|imatinib mesylate|mesh-list
25842226|NCT00031915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842227|NCT00031915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25842228|NCT00031915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842229|NCT00031915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842230|NCT00031928|Mafosfamide|mafosfamide|mesh-list
25842231|NCT00031928|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25842232|NCT00031928|Immunologic Factors|immunologic factors|mesh-ancestor
25842233|NCT00031928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417699|NCT02856893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25660938|NCT01627067|Metformin|metformin|mesh-list
25660939|NCT01627067|Everolimus|everolimus|mesh-list
24901849|NCT04380376|Alkylating Agents|alkylating agents|mesh-ancestor
25842234|NCT00031928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842235|NCT00031941|Lenalidomide|lenalidomide|mesh-list
25842236|NCT00031941|Immunologic Factors|immunologic factors|mesh-ancestor
25842237|NCT00031941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842238|NCT00031941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25842239|NCT00031941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25842240|NCT00031941|Growth Substances|growth substances|mesh-ancestor
25842241|NCT00031941|Growth Inhibitors|growth inhibitors|mesh-ancestor
25842242|NCT00031941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842243|NCT00031954|Gemcitabine|gemcitabine|mesh-list
25842244|NCT00031954|Paclitaxel|paclitaxel|mesh-list
25165065|NCT05076838|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25165066|NCT05076838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25842245|NCT00031954|Carboplatin|carboplatin|mesh-list
24399054|NCT00146562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24399118|NCT00146614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24399119|NCT00146614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399120|NCT00146614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24399121|NCT00146614|Antimetabolites|antimetabolites|mesh-ancestor
24399162|NCT00146731|Antimalarials|antimalarials|mesh-ancestor
24399163|NCT00146731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24399164|NCT00146731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24399165|NCT00146731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24399274|NCT00147355|Codeine|codeine|mesh-list
24811387|NCT02046538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24811389|NCT02046538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24811390|NCT02046538|Immunologic Factors|immunologic factors|mesh-ancestor
24811391|NCT02046538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811392|NCT02046538|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24811393|NCT02046538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24811394|NCT02046538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811395|NCT02046538|Antidotes|antidotes|mesh-ancestor
24811396|NCT02046538|Protective Agents|protective agents|mesh-ancestor
24811397|NCT02046538|Vitamin B Complex|vitamin b complex|mesh-ancestor
24811398|NCT02046538|Vitamins|vitamins|mesh-ancestor
24811399|NCT02046538|Micronutrients|micronutrients|mesh-ancestor
24811400|NCT02046551|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24399275|NCT00147355|Ondansetron|ondansetron|mesh-list
24399341|NCT00147524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399343|NCT00147563|Eplerenone|eplerenone|mesh-list
24399344|NCT00147563|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24399345|NCT00147563|Hormone Antagonists|hormone antagonists|mesh-ancestor
24399346|NCT00147563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24399347|NCT00147563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399348|NCT00147563|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24399349|NCT00147563|Diuretics|diuretics|mesh-ancestor
24399350|NCT00147563|Natriuretic Agents|natriuretic agents|mesh-ancestor
24399351|NCT00147563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24399352|NCT00147589|Eplerenone|eplerenone|mesh-list
24399353|NCT00147589|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24399354|NCT00147589|Hormone Antagonists|hormone antagonists|mesh-ancestor
25660940|NCT01627067|Exemestane|exemestane|mesh-list
25660941|NCT01627067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25660942|NCT01627067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660943|NCT01627067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25660944|NCT01627067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25660945|NCT01627067|Immunologic Factors|immunologic factors|mesh-ancestor
25660946|NCT01627067|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25660947|NCT01627067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25660948|NCT01627067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25660949|NCT01627067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660950|NCT01627067|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25660951|NCT01627067|Hormone Antagonists|hormone antagonists|mesh-ancestor
25660952|NCT01627067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25660953|NCT01627249|Bevacizumab|bevacizumab|mesh-list
25660954|NCT01627249|Ranibizumab|ranibizumab|mesh-list
25660955|NCT01627249|Aflibercept|aflibercept|mesh-list
25660956|NCT01627249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25660957|NCT01627249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25660958|NCT01627249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25660959|NCT01627249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25660960|NCT01627249|Growth Substances|growth substances|mesh-ancestor
25660961|NCT01627249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660962|NCT01627249|Growth Inhibitors|growth inhibitors|mesh-ancestor
25842246|NCT00031954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25842247|NCT00031954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842248|NCT00031954|Tubulin Modulators|tubulin modulators|mesh-ancestor
25842249|NCT00031954|Antimitotic Agents|antimitotic agents|mesh-ancestor
25842250|NCT00031954|Mitosis Modulators|mitosis modulators|mesh-ancestor
25842251|NCT00031954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842252|NCT00031954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25842253|NCT00031954|Antimetabolites|antimetabolites|mesh-ancestor
25842254|NCT00031954|Antiviral Agents|antiviral agents|mesh-ancestor
25842255|NCT00031954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25083828|NCT03312257|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25842256|NCT00031954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842257|NCT00031954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25842258|NCT00031954|Immunologic Factors|immunologic factors|mesh-ancestor
25842259|NCT00031954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842260|NCT00031967|Melatonin|melatonin|mesh-list
25842261|NCT00031967|Antioxidants|antioxidants|mesh-ancestor
25842262|NCT00031967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842263|NCT00031967|Protective Agents|protective agents|mesh-ancestor
25842264|NCT00031967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842265|NCT00031967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25842266|NCT00031980|Cyclosporine|cyclosporine|mesh-list
25165067|NCT05076838|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25165068|NCT05076838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25165069|NCT05076838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25165070|NCT05076838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25165072|NCT05076838|Anesthetics|anesthetics|mesh-ancestor
25165073|NCT05076838|GABA Modulators|gaba modulators|mesh-ancestor
25165074|NCT05076838|GABA Agents|gaba agents|mesh-ancestor
25165075|NCT05076838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25165076|NCT05076838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203256|NCT02714998|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25203257|NCT02714998|Abortifacient Agents|abortifacient agents|mesh-ancestor
25203258|NCT02714998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25203259|NCT02714998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203260|NCT02714998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25203261|NCT02714998|Antimetabolites|antimetabolites|mesh-ancestor
25203262|NCT02714998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203263|NCT02714998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25203264|NCT02714998|Dermatologic Agents|dermatologic agents|mesh-ancestor
25203265|NCT02714998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203266|NCT02714998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25203267|NCT02714998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25203268|NCT02714998|Immunologic Factors|immunologic factors|mesh-ancestor
25203269|NCT02714998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25203270|NCT02714998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25203272|NCT02715024|Solifenacin Succinate|solifenacin succinate|mesh-list
25203273|NCT02715024|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25203274|NCT02715024|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25203275|NCT02715024|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25203276|NCT02715024|Adrenergic Agents|adrenergic agents|mesh-ancestor
25203277|NCT02715024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25203278|NCT02715024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203279|NCT02715024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203280|NCT02715024|Urological Agents|urological agents|mesh-ancestor
25203281|NCT02715024|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25203282|NCT02715024|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25203283|NCT02715024|Cholinergic Agents|cholinergic agents|mesh-ancestor
24399355|NCT00147589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24399396|NCT00147654|Adrenergic Agents|adrenergic agents|mesh-ancestor
24399397|NCT00147654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24399398|NCT00147654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399399|NCT00147654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399400|NCT00147654|Urological Agents|urological agents|mesh-ancestor
24811401|NCT02046551|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24811402|NCT02046551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24811403|NCT02046551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24399401|NCT00147654|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24399402|NCT00147654|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24399418|NCT00147680|Tubulin Modulators|tubulin modulators|mesh-ancestor
24399461|NCT00147862|Coagulants|coagulants|mesh-ancestor
24399462|NCT00147875|Gemcitabine|gemcitabine|mesh-list
24399463|NCT00147875|Prednisone|prednisone|mesh-list
24399509|NCT00147914|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24399510|NCT00147914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24399511|NCT00147914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399512|NCT00147953|Rituximab|rituximab|mesh-list
24399513|NCT00147953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24399514|NCT00147953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399515|NCT00147953|Immunologic Factors|immunologic factors|mesh-ancestor
24399565|NCT00148083|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24399566|NCT00148083|Serotonin Agents|serotonin agents|mesh-ancestor
24399591|NCT00148148|Caspofungin|caspofungin|mesh-list
24399592|NCT00148148|Amebicides|amebicides|mesh-ancestor
24399593|NCT00148148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24399594|NCT00148148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24399595|NCT00148148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24399596|NCT00148148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24399597|NCT00148148|Antifungal Agents|antifungal agents|mesh-ancestor
24399598|NCT00148148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24399599|NCT00148148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399600|NCT00148252|Mycophenolic Acid|mycophenolic acid|mesh-list
24399601|NCT00148252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24399602|NCT00148252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399795|NCT00148681|Cyclophosphamide|cyclophosphamide|mesh-list
24399603|NCT00148252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24399604|NCT00148252|Antitubercular Agents|antitubercular agents|mesh-ancestor
24399605|NCT00148252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24399606|NCT00148252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24399607|NCT00148252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24399608|NCT00148252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399610|NCT00148265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24399611|NCT00148265|Glucocorticoids|glucocorticoids|mesh-ancestor
25842267|NCT00031980|Cyclosporins|cyclosporins|mesh-list
25084709|NCT03303677|Vancomycin|vancomycin|mesh-list
24399613|NCT00148265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24811404|NCT02046551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674521|NCT05148312|Hormones|hormones|mesh-ancestor
24399614|NCT00148265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399615|NCT00148278|Dobutamine|dobutamine|mesh-list
24399616|NCT00148278|Epinephrine|epinephrine|mesh-list
24399617|NCT00148278|Norepinephrine|norepinephrine|mesh-list
24399678|NCT00148395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24399679|NCT00148395|Alkylating Agents|alkylating agents|mesh-ancestor
24399680|NCT00148395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24399681|NCT00148395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24399682|NCT00148395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24399683|NCT00148395|Tubulin Modulators|tubulin modulators|mesh-ancestor
24399694|NCT00148408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24399695|NCT00148408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399697|NCT00148421|Darbepoetin alfa|darbepoetin alfa|mesh-list
24399701|NCT00148447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24399702|NCT00148447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24399703|NCT00148447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399758|NCT00148564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24399759|NCT00148564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842268|NCT00031980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842269|NCT00031980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842270|NCT00031980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25842271|NCT00031980|Immunologic Factors|immunologic factors|mesh-ancestor
25842272|NCT00031980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25417855|NCT02839642|Cholinergic Agents|cholinergic agents|mesh-ancestor
25660963|NCT01627327|Fluticasone|fluticasone|mesh-list
25660964|NCT01627327|Xhance|xhance|mesh-list
25660965|NCT01627327|Bromides|bromides|mesh-list
25660966|NCT01627327|Tiotropium Bromide|tiotropium bromide|mesh-list
25660967|NCT01627327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25660968|NCT01627327|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25064163|NCT03462836|Anesthetics, General|anesthetics, general|mesh-ancestor
25064164|NCT03462836|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25064165|NCT03462836|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24827053|NCT02137239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24827054|NCT02137239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24827055|NCT02137239|Antiemetics|antiemetics|mesh-ancestor
25064166|NCT03462836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25064167|NCT03462810|Cabotegravir|cabotegravir|mesh-list
25842273|NCT00031980|Antifungal Agents|antifungal agents|mesh-ancestor
25842274|NCT00031980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25084998|NCT03302065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25842275|NCT00031980|Dermatologic Agents|dermatologic agents|mesh-ancestor
25842276|NCT00031980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25842277|NCT00031980|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25842278|NCT00031993|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25842279|NCT00031993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842280|NCT00031993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25842281|NCT00031993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842282|NCT00031993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399760|NCT00148564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24399762|NCT00148564|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24399763|NCT00148564|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24399765|NCT00148590|Memantine|memantine|mesh-list
24399766|NCT00148590|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24399767|NCT00148590|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24399768|NCT00148590|Dopamine Agents|dopamine agents|mesh-ancestor
24399779|NCT00148603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24399780|NCT00148603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399789|NCT00148616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399790|NCT00148616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399791|NCT00148616|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24399792|NCT00148616|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24399793|NCT00148681|Paclitaxel|paclitaxel|mesh-list
24399794|NCT00148681|Vinorelbine|vinorelbine|mesh-list
24399797|NCT00148681|Trastuzumab|trastuzumab|mesh-list
24399798|NCT00148681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24399799|NCT00148681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399800|NCT00148681|Tubulin Modulators|tubulin modulators|mesh-ancestor
24399801|NCT00148681|Antimitotic Agents|antimitotic agents|mesh-ancestor
24399832|NCT00148746|Immunologic Factors|immunologic factors|mesh-ancestor
24399833|NCT00148746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399834|NCT00148746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24399835|NCT00148746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24399837|NCT00148746|Antifungal Agents|antifungal agents|mesh-ancestor
24399902|NCT00148863|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24399903|NCT00148863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399904|NCT00148863|Antiviral Agents|antiviral agents|mesh-ancestor
24399906|NCT00148863|Antimetabolites|antimetabolites|mesh-ancestor
24399916|NCT00148876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24399918|NCT00148902|Lapatinib|lapatinib|mesh-list
24399919|NCT00148902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399920|NCT00148902|Tubulin Modulators|tubulin modulators|mesh-ancestor
24399921|NCT00148902|Antimitotic Agents|antimitotic agents|mesh-ancestor
24399922|NCT00148902|Mitosis Modulators|mitosis modulators|mesh-ancestor
24399923|NCT00148902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399924|NCT00148902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24399925|NCT00148902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24399926|NCT00148915|Ibandronic Acid|ibandronic acid|mesh-list
24399927|NCT00148915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24399928|NCT00148915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399930|NCT00149019|Antibodies, Bispecific|antibodies, bispecific|mesh-list
24399931|NCT00149019|Immunologic Factors|immunologic factors|mesh-ancestor
24399932|NCT00149019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399933|NCT00149058|Epoetin Alfa|epoetin alfa|mesh-list
24399934|NCT00149058|Hematinics|hematinics|mesh-ancestor
24399935|NCT00149084|Amoxicillin|amoxicillin|mesh-list
24399944|NCT00149084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25660969|NCT01627327|Autonomic Agents|autonomic agents|mesh-ancestor
25660970|NCT01627327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25660971|NCT01627327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660972|NCT01627327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25660973|NCT01627327|Respiratory System Agents|respiratory system agents|mesh-ancestor
25660974|NCT01627327|Dermatologic Agents|dermatologic agents|mesh-ancestor
25660975|NCT01627327|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25660976|NCT01627327|Parasympatholytics|parasympatholytics|mesh-ancestor
24903773|NCT04361318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25842283|NCT00032019|Prednisone|prednisone|mesh-list
25842284|NCT00032019|Cyclophosphamide|cyclophosphamide|mesh-list
25842285|NCT00032019|Rituximab|rituximab|mesh-list
25842286|NCT00032019|Doxorubicin|doxorubicin|mesh-list
25842287|NCT00032019|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25842288|NCT00032019|Etoposide|etoposide|mesh-list
25842289|NCT00032019|Vincristine|vincristine|mesh-list
24829345|NCT02151630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829346|NCT02151630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24829347|NCT02151630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24724101|NCT01591122|Prednisone|prednisone|mesh-list
25842290|NCT00032019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25842291|NCT00032019|Immunologic Factors|immunologic factors|mesh-ancestor
25842292|NCT00032019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842293|NCT00032019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25842294|NCT00032019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25085459|NCT03298191|Analgesics|analgesics|mesh-ancestor
25842295|NCT00032019|Alkylating Agents|alkylating agents|mesh-ancestor
25842296|NCT00032019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432854|NCT00256542|Lidocaine|lidocaine|mesh-list
24399967|NCT00149136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842297|NCT00032019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842298|NCT00032019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25842299|NCT00032019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25842300|NCT00032019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25842301|NCT00032019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25842302|NCT00032019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25842303|NCT00032019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842304|NCT00032019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25842305|NCT00032019|Glucocorticoids|glucocorticoids|mesh-ancestor
24399968|NCT00149136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399969|NCT00149149|Polaprezinc|polaprezinc|mesh-list
24399970|NCT00149149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24399973|NCT00149162|Interleukin-2|interleukin-2|mesh-list
24399974|NCT00149162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399975|NCT00149162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24399976|NCT00149162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24399977|NCT00149162|Antiviral Agents|antiviral agents|mesh-ancestor
24399987|NCT00149201|Antimetabolites|antimetabolites|mesh-ancestor
24399988|NCT00149201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399989|NCT00149201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24400005|NCT00149253|Etoricoxib|etoricoxib|mesh-list
24400006|NCT00149253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400007|NCT00149253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25165085|NCT05054023|Piroxicam|piroxicam|mesh-list
25165086|NCT05054023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25165087|NCT05054023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25165088|NCT05054023|Analgesics|analgesics|mesh-ancestor
25165089|NCT05054023|Sensory System Agents|sensory system agents|mesh-ancestor
25165090|NCT05054023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25165091|NCT05054023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165092|NCT05054023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25165093|NCT05054023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25165094|NCT05054023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25165095|NCT05054023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400008|NCT00149253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24400010|NCT00149253|Sensory System Agents|sensory system agents|mesh-ancestor
24400011|NCT00149253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24400012|NCT00149253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25085854|NCT03294525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25660977|NCT01627327|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25660978|NCT01627327|Cholinergic Agents|cholinergic agents|mesh-ancestor
25660979|NCT01627327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25660980|NCT01627327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660981|NCT01627327|Anticonvulsants|anticonvulsants|mesh-ancestor
25660982|NCT01627782|Ketamine|ketamine|mesh-list
25660983|NCT01627782|Analgesics|analgesics|mesh-ancestor
25660984|NCT01627782|Sensory System Agents|sensory system agents|mesh-ancestor
25660985|NCT01627782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25660986|NCT01627782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25660987|NCT01627782|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25660988|NCT01627782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25660989|NCT01627782|Anesthetics, General|anesthetics, general|mesh-ancestor
25660990|NCT01627782|Anesthetics|anesthetics|mesh-ancestor
25660991|NCT01627782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24953286|NCT03886779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085856|NCT03294525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25842306|NCT00032019|Hormones|hormones|mesh-ancestor
25842307|NCT00032019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25842308|NCT00032019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25842309|NCT00032019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25842310|NCT00032019|Tubulin Modulators|tubulin modulators|mesh-ancestor
25842311|NCT00032019|Antimitotic Agents|antimitotic agents|mesh-ancestor
24443712|NCT00295893|Carboplatin|carboplatin|mesh-list
24400013|NCT00149253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24400014|NCT00149253|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24400025|NCT00149292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24400026|NCT00149292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24400027|NCT00149292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24400028|NCT00149292|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24400029|NCT00149292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24400030|NCT00149292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24400031|NCT00149292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400055|NCT00149578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24400057|NCT00149578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400058|NCT00149578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24400059|NCT00149578|Antiviral Agents|antiviral agents|mesh-ancestor
24400060|NCT00149578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24400061|NCT00149578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400244|NCT00150137|Hormone Antagonists|hormone antagonists|mesh-ancestor
25842312|NCT00032019|Mitosis Modulators|mitosis modulators|mesh-ancestor
24539159|NCT00662519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24539160|NCT00662519|Immunologic Factors|immunologic factors|mesh-ancestor
24400062|NCT00149578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24400063|NCT00149578|Immunologic Factors|immunologic factors|mesh-ancestor
24400064|NCT00149578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400066|NCT00149578|Protective Agents|protective agents|mesh-ancestor
24400067|NCT00149578|Vitamin B Complex|vitamin b complex|mesh-ancestor
24400069|NCT00149578|Micronutrients|micronutrients|mesh-ancestor
24400093|NCT00149656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400094|NCT00149656|Protective Agents|protective agents|mesh-ancestor
24400095|NCT00149656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400097|NCT00149656|Micronutrients|micronutrients|mesh-ancestor
24400098|NCT00149708|Hormones|hormones|mesh-list
24400099|NCT00149708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24400100|NCT00149708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400101|NCT00149851|Tegaserod|tegaserod|mesh-list
24400102|NCT00149851|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24400103|NCT00149851|Serotonin Agents|serotonin agents|mesh-ancestor
25165096|NCT05054023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25165097|NCT05053737|Atezolizumab|atezolizumab|mesh-list
24400154|NCT00149942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24400155|NCT00149942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24400156|NCT00149942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400157|NCT00149942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400158|NCT00149968|Mycophenolic Acid|mycophenolic acid|mesh-list
24400159|NCT00149968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24400160|NCT00149968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24400161|NCT00149968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24400162|NCT00149968|Antitubercular Agents|antitubercular agents|mesh-ancestor
24400167|NCT00149981|Everolimus|everolimus|mesh-list
24400179|NCT00150007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400180|NCT00150007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400181|NCT00150020|Mycophenolic Acid|mycophenolic acid|mesh-list
24400182|NCT00150020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24400183|NCT00150020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24400184|NCT00150020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24400185|NCT00150020|Antitubercular Agents|antitubercular agents|mesh-ancestor
24400186|NCT00150020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25660992|NCT01627782|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25660993|NCT01627782|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25660994|NCT01627782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25660995|NCT01627782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25660996|NCT01627860|Topiramate|topiramate|mesh-list
25660997|NCT01627860|Anticonvulsants|anticonvulsants|mesh-ancestor
25660998|NCT01627860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25660999|NCT01627860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400187|NCT00150020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25842313|NCT00032032|Paclitaxel|paclitaxel|mesh-list
25842314|NCT00032032|Carboplatin|carboplatin|mesh-list
25842315|NCT00032032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24400194|NCT00150046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400195|NCT00150059|Pimecrolimus|pimecrolimus|mesh-list
24400196|NCT00150059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24400197|NCT00150059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24400198|NCT00150059|Analgesics|analgesics|mesh-ancestor
24400199|NCT00150059|Sensory System Agents|sensory system agents|mesh-ancestor
24400200|NCT00150059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24400201|NCT00150059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530462|NCT00630474|Xylometazoline|xylometazoline|mesh-list
24400218|NCT00150085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400219|NCT00150085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24400220|NCT00150085|Immunologic Factors|immunologic factors|mesh-ancestor
24400221|NCT00150085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400222|NCT00150085|Antifungal Agents|antifungal agents|mesh-ancestor
24400223|NCT00150085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24400241|NCT00150124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400242|NCT00150137|Methimazole|methimazole|mesh-list
24400243|NCT00150137|Antithyroid Agents|antithyroid agents|mesh-ancestor
24400269|NCT00150228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400271|NCT00150241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24400272|NCT00150241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24400273|NCT00150241|Cholinergic Agents|cholinergic agents|mesh-ancestor
24400274|NCT00150241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24400275|NCT00150241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400276|NCT00150241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400277|NCT00150254|Varenicline|varenicline|mesh-list
24400278|NCT00150254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24400279|NCT00150254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24400280|NCT00150254|Cholinergic Agents|cholinergic agents|mesh-ancestor
24400281|NCT00150254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24400282|NCT00150254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400283|NCT00150254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400285|NCT00150280|Celecoxib|celecoxib|mesh-list
24400286|NCT00150280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24400287|NCT00150280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24400288|NCT00150280|Analgesics|analgesics|mesh-ancestor
24400289|NCT00150280|Sensory System Agents|sensory system agents|mesh-ancestor
24400298|NCT00150293|Pregabalin|pregabalin|mesh-list
24400306|NCT00150293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400307|NCT00150293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24400308|NCT00150293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24400309|NCT00150293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24400310|NCT00150293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25842316|NCT00032032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842317|NCT00032032|Tubulin Modulators|tubulin modulators|mesh-ancestor
25842318|NCT00032032|Antimitotic Agents|antimitotic agents|mesh-ancestor
25842319|NCT00032032|Mitosis Modulators|mitosis modulators|mesh-ancestor
25842320|NCT00032032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842321|NCT00032045|Ipilimumab|ipilimumab|mesh-list
25842322|NCT00032045|Freund's Adjuvant|freund's adjuvant|mesh-list
25842323|NCT00032045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25842324|NCT00032045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24938130|NCT04022135|Vitamins|vitamins|mesh-ancestor
25842325|NCT00032045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25842326|NCT00032045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842327|NCT00032045|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25842328|NCT00032045|Immunologic Factors|immunologic factors|mesh-ancestor
25842329|NCT00032045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400311|NCT00150293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24400329|NCT00150358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400331|NCT00150358|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24400332|NCT00150358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24400343|NCT00150384|Amlodipine|amlodipine|mesh-list
24400349|NCT00150384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400350|NCT00150384|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24400351|NCT00150384|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25086869|NCT03285165|Anesthetics|anesthetics|mesh-ancestor
24400352|NCT00150384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842330|NCT00032084|Bupropion|bupropion|mesh-list
25842335|NCT00032084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842336|NCT00032084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25064236|NCT03461718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25064237|NCT03461718|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25064238|NCT03461718|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25064239|NCT03461718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24480792|NCT00432146|Hemostatics|hemostatics|mesh-ancestor
24400353|NCT00150384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24530582|NCT00631085|Vitamins|vitamins|mesh-ancestor
24811430|NCT02046629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24811431|NCT02046629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24811432|NCT02046629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24811433|NCT02046629|Immunologic Factors|immunologic factors|mesh-ancestor
24400369|NCT00150423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24400370|NCT00150423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842337|NCT00032084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25842338|NCT00032084|Cholinergic Agents|cholinergic agents|mesh-ancestor
25842339|NCT00032084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25842340|NCT00032084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842341|NCT00032084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25842342|NCT00032084|Antidepressive Agents|antidepressive agents|mesh-ancestor
24811436|NCT02046629|Antimetabolites|antimetabolites|mesh-ancestor
25842343|NCT00032084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25875700|NCT04216290|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24400371|NCT00150423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24400372|NCT00150423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24400373|NCT00150423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24400374|NCT00150423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24400375|NCT00150423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24400376|NCT00150436|Pregabalin|pregabalin|mesh-list
24400377|NCT00150436|Analgesics|analgesics|mesh-ancestor
24400378|NCT00150436|Sensory System Agents|sensory system agents|mesh-ancestor
25165098|NCT05053737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25165099|NCT05051449|Ketamine|ketamine|mesh-list
25165100|NCT05051449|Analgesics|analgesics|mesh-ancestor
25165101|NCT05051449|Sensory System Agents|sensory system agents|mesh-ancestor
25165102|NCT05051449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25165103|NCT05051449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165105|NCT05051449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25165106|NCT05051449|Anesthetics, General|anesthetics, general|mesh-ancestor
25165107|NCT05051449|Anesthetics|anesthetics|mesh-ancestor
25165108|NCT05051449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25165109|NCT05051449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25165110|NCT05051449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25165111|NCT05051449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25087033|NCT03283176|Vitamin B 12|vitamin b 12|mesh-list
25165112|NCT05051449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400387|NCT00150436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24400388|NCT00150436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24400389|NCT00150436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24400391|NCT00150449|Analgesics|analgesics|mesh-ancestor
24400392|NCT00150449|Sensory System Agents|sensory system agents|mesh-ancestor
24400393|NCT00150449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24400394|NCT00150449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400395|NCT00150449|Anticonvulsants|anticonvulsants|mesh-ancestor
24400426|NCT00150553|Carbamazepine|carbamazepine|mesh-list
24400427|NCT00150553|Anticonvulsants|anticonvulsants|mesh-ancestor
24400428|NCT00150553|Antimanic Agents|antimanic agents|mesh-ancestor
24400429|NCT00150553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25661000|NCT01628107|Epoetin Alfa|epoetin alfa|mesh-list
25661001|NCT01628107|Hematinics|hematinics|mesh-ancestor
25661002|NCT01628120|Epoetin Alfa|epoetin alfa|mesh-list
25661003|NCT01628120|Hematinics|hematinics|mesh-ancestor
25661004|NCT01628393|Ozanimod|ozanimod|mesh-list
25661005|NCT01628393|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25661006|NCT01628393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661007|NCT01628393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25661008|NCT01628393|Immunologic Factors|immunologic factors|mesh-ancestor
25064288|NCT03461328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064289|NCT03461328|Anesthetics|anesthetics|mesh-ancestor
24400430|NCT00150553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24400431|NCT00150553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400432|NCT00150553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25842344|NCT00032084|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24400439|NCT00150553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400441|NCT00150553|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24400443|NCT00150579|Dextroamphetamine|dextroamphetamine|mesh-list
24400444|NCT00150579|Adderall|adderall|mesh-list
24400445|NCT00150579|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24400446|NCT00150579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400463|NCT00150605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400464|NCT00150605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24400465|NCT00150605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24400467|NCT00150605|Sensory System Agents|sensory system agents|mesh-ancestor
24400468|NCT00150605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24400469|NCT00150605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24400470|NCT00150605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24400471|NCT00150605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400472|NCT00150605|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24400473|NCT00150605|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24400474|NCT00150631|Candesartan|candesartan|mesh-list
24400475|NCT00150631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24400476|NCT00150631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24400477|NCT00150631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24400478|NCT00150631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400480|NCT00150657|Bevacizumab|bevacizumab|mesh-list
24400481|NCT00150657|Carboplatin|carboplatin|mesh-list
24811434|NCT02046629|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24811435|NCT02046629|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24811437|NCT02046629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400482|NCT00150657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24400484|NCT00150657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24539207|NCT00662805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24539208|NCT00662805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24400523|NCT00150761|Levocetirizine|levocetirizine|mesh-list
24400524|NCT00150761|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24400525|NCT00150761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24531129|NCT00634205|Doxorubicin|doxorubicin|mesh-list
25842345|NCT00032084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24400598|NCT00150891|Antimetabolites|antimetabolites|mesh-ancestor
24400599|NCT00150891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24400638|NCT00151047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24400639|NCT00151047|Tubulin Modulators|tubulin modulators|mesh-ancestor
24400640|NCT00151047|Antimitotic Agents|antimitotic agents|mesh-ancestor
24400655|NCT00151060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24400656|NCT00151060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400657|NCT00151060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24400658|NCT00151060|Alkylating Agents|alkylating agents|mesh-ancestor
24400659|NCT00151060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24400661|NCT00151073|Docetaxel|docetaxel|mesh-list
24400662|NCT00151073|Estramustine|estramustine|mesh-list
24400664|NCT00151073|Tubulin Modulators|tubulin modulators|mesh-ancestor
24400665|NCT00151073|Antimitotic Agents|antimitotic agents|mesh-ancestor
25661009|NCT01628393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661010|NCT01628549|Sarecycline|sarecycline|mesh-list
25661011|NCT01628549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25661012|NCT01628549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25661013|NCT01628549|Dermatologic Agents|dermatologic agents|mesh-ancestor
25661014|NCT01628588|Bimatoprost|bimatoprost|mesh-list
25661015|NCT01628588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25661016|NCT01628601|Timolol|timolol|mesh-list
25661017|NCT01628601|Bimatoprost|bimatoprost|mesh-list
25661018|NCT01628601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25661019|NCT01628601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25661020|NCT01628601|Adrenergic Agents|adrenergic agents|mesh-ancestor
25661021|NCT01628601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25661022|NCT01628601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661023|NCT01628601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661024|NCT01628601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25661025|NCT01628601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25661026|NCT01628692|Ribavirin|ribavirin|mesh-list
25201858|NCT02724904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201860|NCT02724904|Dermatologic Agents|dermatologic agents|mesh-ancestor
24400670|NCT00151073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24400672|NCT00151073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24400673|NCT00151086|Vinorelbine|vinorelbine|mesh-list
24400674|NCT00151086|Estramustine|estramustine|mesh-list
24400675|NCT00151086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24400676|NCT00151086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24400677|NCT00151086|Tubulin Modulators|tubulin modulators|mesh-ancestor
24811438|NCT02046629|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24811440|NCT02046668|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24811441|NCT02046668|Hormone Antagonists|hormone antagonists|mesh-ancestor
24811442|NCT02046668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24811443|NCT02046668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400678|NCT00151086|Antimitotic Agents|antimitotic agents|mesh-ancestor
24400679|NCT00151086|Mitosis Modulators|mitosis modulators|mesh-ancestor
24400680|NCT00151086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400767|NCT00151255|Analgesics|analgesics|mesh-ancestor
24719732|NCT01563718|Naltrexone|naltrexone|mesh-list
24400768|NCT00151255|Sensory System Agents|sensory system agents|mesh-ancestor
24400769|NCT00151255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24400770|NCT00151255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24400771|NCT00151255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24400772|NCT00151255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400782|NCT00151294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400784|NCT00151294|Serotonin Agents|serotonin agents|mesh-ancestor
24400785|NCT00151294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400786|NCT00151294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24400787|NCT00151294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24400788|NCT00151294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24400789|NCT00151294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24811454|NCT02046733|Nivolumab|nivolumab|mesh-list
24811455|NCT02046733|Ipilimumab|ipilimumab|mesh-list
24811456|NCT02046733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24400885|NCT00151541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400886|NCT00151541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24400913|NCT00151619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24532564|NCT00640458|Sildenafil Citrate|sildenafil citrate|mesh-list
24400977|NCT00151801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24400978|NCT00151801|Immunologic Factors|immunologic factors|mesh-ancestor
24400979|NCT00151801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400980|NCT00151801|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25842346|NCT00032084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25842347|NCT00032084|Dopamine Agents|dopamine agents|mesh-ancestor
25842348|NCT00032084|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25842349|NCT00032084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25842350|NCT00032084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842351|NCT00032097|Motexafin gadolinium|motexafin gadolinium|mesh-list
25842352|NCT00032097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448020|NCT00310089|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25842353|NCT00032097|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25087537|NCT03278808|Amebicides|amebicides|mesh-ancestor
25842354|NCT00032097|Dermatologic Agents|dermatologic agents|mesh-ancestor
25842355|NCT00032110|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25842356|NCT00032110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24829372|NCT02151812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829374|NCT02151916|Fluorides, Topical|fluorides, topical|mesh-list
24829375|NCT02151916|Cariostatic Agents|cariostatic agents|mesh-ancestor
24829376|NCT02151916|Protective Agents|protective agents|mesh-ancestor
24829377|NCT02151916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842357|NCT00032110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25842358|NCT00032110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842359|NCT00032110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842360|NCT00032123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25842361|NCT00032123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842362|NCT00032123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25661027|NCT01628692|Simeprevir|simeprevir|mesh-list
25661028|NCT01628692|Antimetabolites|antimetabolites|mesh-ancestor
25661029|NCT01628692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661030|NCT01628692|Antiviral Agents|antiviral agents|mesh-ancestor
24484331|NCT00447759|Gout Suppressants|gout suppressants|mesh-ancestor
24484332|NCT00447863|Levonorgestrel|levonorgestrel|mesh-list
24484333|NCT00447863|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24484334|NCT00447863|Estradiol|estradiol|mesh-list
24484335|NCT00447863|Estrogens|estrogens|mesh-ancestor
24519630|NCT05332028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25842363|NCT00032123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842364|NCT00032123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842365|NCT00032136|Tamoxifen|tamoxifen|mesh-list
25842366|NCT00032136|Exemestane|exemestane|mesh-list
25842367|NCT00032136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842368|NCT00032136|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25842369|NCT00032136|Hormone Antagonists|hormone antagonists|mesh-ancestor
25842370|NCT00032136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25842371|NCT00032136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165123|NCT05046132|Moxifloxacin|moxifloxacin|mesh-list
25165124|NCT05046132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25165125|NCT05046132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25165126|NCT05046132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25165127|NCT05046132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25165128|NCT05046132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25165129|NCT05046132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25165130|NCT05046132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25165131|NCT05045612|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25165132|NCT05045612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24401118|NCT00152191|Cyclophosphamide|cyclophosphamide|mesh-list
24401055|NCT00152035|Dopamine Agents|dopamine agents|mesh-ancestor
24401056|NCT00152035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24401057|NCT00152035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401058|NCT00152035|Adrenergic Agents|adrenergic agents|mesh-ancestor
24401059|NCT00152035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24401060|NCT00152035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24401061|NCT00152035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24401062|NCT00152035|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24401063|NCT00152048|Eflornithine|eflornithine|mesh-list
24401064|NCT00152048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24401065|NCT00152048|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24401066|NCT00152048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24401067|NCT00152048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24401068|NCT00152048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24401069|NCT00152048|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
24401070|NCT00152048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24401071|NCT00152048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401072|NCT00152100|Alemtuzumab|alemtuzumab|mesh-list
24401073|NCT00152100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24401075|NCT00152126|Melphalan|melphalan|mesh-list
24401092|NCT00152178|Tegafur|tegafur|mesh-list
24401093|NCT00152178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24401094|NCT00152178|Immunologic Factors|immunologic factors|mesh-ancestor
24433538|NCT00258791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24401104|NCT00152178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24401105|NCT00152178|Abortifacient Agents|abortifacient agents|mesh-ancestor
24401106|NCT00152178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24401107|NCT00152178|Dermatologic Agents|dermatologic agents|mesh-ancestor
24811461|NCT02046850|Rifampin|rifampin|mesh-list
24811462|NCT02046850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24811463|NCT02046850|Antitubercular Agents|antitubercular agents|mesh-ancestor
25661031|NCT01628692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25661032|NCT01628692|Protease Inhibitors|protease inhibitors|mesh-ancestor
25661033|NCT01628692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661034|NCT01628874|Lidocaine|lidocaine|mesh-list
25661035|NCT01628874|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25661036|NCT01628874|Anesthetics, Local|anesthetics, local|mesh-ancestor
25661037|NCT01628874|Anesthetics|anesthetics|mesh-ancestor
25661038|NCT01628874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25661039|NCT01628874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610710|NCT01004575|Cobalt|cobalt|mesh-list
24401108|NCT00152178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733000|NCT01642862|Antimetabolites|antimetabolites|mesh-ancestor
24909967|NCT04303520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201870|NCT02725112|Pregabalin|pregabalin|mesh-list
24401109|NCT00152178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24401110|NCT00152178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24401111|NCT00152178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24401112|NCT00152178|Hormone Antagonists|hormone antagonists|mesh-ancestor
24401113|NCT00152178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24401114|NCT00152178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24401115|NCT00152178|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24401117|NCT00152178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24401120|NCT00152191|Methotrexate|methotrexate|mesh-list
24401121|NCT00152191|Tegafur|tegafur|mesh-list
24401141|NCT00152204|Sulfadoxine|sulfadoxine|mesh-list
24401142|NCT00152204|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24401143|NCT00152204|Antimalarials|antimalarials|mesh-ancestor
24401149|NCT00152204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401150|NCT00152204|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24401151|NCT00152204|Renal Agents|renal agents|mesh-ancestor
24401152|NCT00152230|Tegafur|tegafur|mesh-list
24401153|NCT00152230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24401154|NCT00152230|Antimetabolites|antimetabolites|mesh-ancestor
24401155|NCT00152230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401156|NCT00152230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842372|NCT00032136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25842373|NCT00032136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842374|NCT00032136|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25842375|NCT00032136|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25842376|NCT00032136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25842377|NCT00032136|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25842378|NCT00032136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25842379|NCT00032136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842380|NCT00032149|Prednisolone|prednisolone|mesh-list
25842381|NCT00032149|Cyclophosphamide|cyclophosphamide|mesh-list
25842382|NCT00032149|Etoposide|etoposide|mesh-list
25842383|NCT00032149|Vincristine|vincristine|mesh-list
25087863|NCT03276143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25842384|NCT00032149|Mitoxantrone|mitoxantrone|mesh-list
25842385|NCT00032149|Bleomycin|bleomycin|mesh-list
24401165|NCT00152282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24401166|NCT00152282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401171|NCT00152295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401173|NCT00152308|Ethanol|ethanol|mesh-list
24401174|NCT00152308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24401175|NCT00152308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24401176|NCT00152308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24401177|NCT00152308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24401178|NCT00152308|Antifungal Agents|antifungal agents|mesh-ancestor
24401179|NCT00152308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24539347|NCT00663377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539349|NCT00663442|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24401195|NCT00152386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401196|NCT00152386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24401197|NCT00152399|Somatostatin|somatostatin|mesh-list
24401198|NCT00152399|Hormones|hormones|mesh-ancestor
25661040|NCT01628874|Sensory System Agents|sensory system agents|mesh-ancestor
25661041|NCT01628874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25661042|NCT01628874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25661043|NCT01628874|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25661044|NCT01628874|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25661045|NCT01628874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25661046|NCT01628874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661047|NCT01628874|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25661048|NCT01628913|Everolimus|everolimus|mesh-list
25661049|NCT01628913|Dactolisib|dactolisib|mesh-list
25661050|NCT01628913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25661051|NCT01628913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25661052|NCT01628913|Immunologic Factors|immunologic factors|mesh-ancestor
25661053|NCT01628913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661054|NCT01628926|Ropinirole|ropinirole|mesh-list
25661055|NCT01628926|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25661056|NCT01628926|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25661057|NCT01628926|Dopamine Agonists|dopamine agonists|mesh-ancestor
25661058|NCT01628926|Dopamine Agents|dopamine agents|mesh-ancestor
25842386|NCT00032149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25842387|NCT00032149|Immunologic Factors|immunologic factors|mesh-ancestor
25842388|NCT00032149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842389|NCT00032149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25842390|NCT00032149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24655073|NCT01254123|Exenatide|exenatide|mesh-list
24655169|NCT00660673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24401199|NCT00152399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24811464|NCT02046850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24610713|NCT01004575|Micronutrients|micronutrients|mesh-ancestor
24401213|NCT00152425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24401214|NCT00152438|Progesterone|progesterone|mesh-list
24401215|NCT00152438|Progestins|progestins|mesh-ancestor
24401217|NCT00152438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24401219|NCT00152490|Certolizumab Pegol|certolizumab pegol|mesh-list
24401220|NCT00152490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24401221|NCT00152490|Immunologic Factors|immunologic factors|mesh-ancestor
24401222|NCT00152490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401223|NCT00152490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24401225|NCT00152542|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24401226|NCT00152542|Autonomic Agents|autonomic agents|mesh-ancestor
24401227|NCT00152542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24401228|NCT00152542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401229|NCT00152542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25203284|NCT02715193|Volagidemab|volagidemab|mesh-list
25087953|NCT03275116|Anticonvulsants|anticonvulsants|mesh-ancestor
25088251|NCT05074602|Fluconazole|fluconazole|mesh-list
25203285|NCT02715193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25203286|NCT02715193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203287|NCT02715154|Dexmedetomidine|dexmedetomidine|mesh-list
25203288|NCT02715154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24401230|NCT00152542|Respiratory System Agents|respiratory system agents|mesh-ancestor
24401231|NCT00152542|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24401234|NCT00152542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24401235|NCT00152542|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24401236|NCT00152542|Vasodilator Agents|vasodilator agents|mesh-ancestor
24401237|NCT00152542|Gasotransmitters|gasotransmitters|mesh-ancestor
24401238|NCT00152542|Protective Agents|protective agents|mesh-ancestor
24401239|NCT00152581|Interferons|interferons|mesh-list
24401240|NCT00152581|Ribavirin|ribavirin|mesh-list
24401241|NCT00152581|Interferon-alpha|interferon-alpha|mesh-list
24401248|NCT00152581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401250|NCT00152581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401251|NCT00152594|Voriconazole|voriconazole|mesh-list
24401252|NCT00152594|Antifungal Agents|antifungal agents|mesh-ancestor
24401253|NCT00152594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24401254|NCT00152594|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24401255|NCT00152594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24401256|NCT00152594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24401257|NCT00152594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401258|NCT00152594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24401259|NCT00152594|Hormone Antagonists|hormone antagonists|mesh-ancestor
24401260|NCT00152594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24401261|NCT00152594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401262|NCT00152594|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24401263|NCT00152620|Dexamethasone|dexamethasone|mesh-list
24401264|NCT00152620|Methylprednisolone|methylprednisolone|mesh-list
24401269|NCT00152620|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25088252|NCT05074602|Antifungal Agents|antifungal agents|mesh-ancestor
24401271|NCT00152620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24401272|NCT00152620|Antiemetics|antiemetics|mesh-ancestor
24401273|NCT00152620|Autonomic Agents|autonomic agents|mesh-ancestor
24401274|NCT00152620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24401275|NCT00152620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401290|NCT00152633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401291|NCT00152633|Sympatholytics|sympatholytics|mesh-ancestor
24401292|NCT00152633|Autonomic Agents|autonomic agents|mesh-ancestor
24401293|NCT00152633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25661059|NCT01628926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25661060|NCT01628926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661061|NCT01628926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661062|NCT01628965|Rotigotine|rotigotine|mesh-list
25661063|NCT01628965|Dopamine Agonists|dopamine agonists|mesh-ancestor
25661064|NCT01628965|Dopamine Agents|dopamine agents|mesh-ancestor
24827384|NCT02138708|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24827385|NCT02138708|Purinergic Agonists|purinergic agonists|mesh-ancestor
24827386|NCT02138708|Purinergic Agents|purinergic agents|mesh-ancestor
24827387|NCT02138708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24401294|NCT00152633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401295|NCT00152633|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24401296|NCT00152633|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25842391|NCT00032149|Alkylating Agents|alkylating agents|mesh-ancestor
25842392|NCT00032149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842393|NCT00032149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842394|NCT00032149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25842395|NCT00032149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25842396|NCT00032149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25842397|NCT00032149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25842398|NCT00032149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842399|NCT00032149|Tubulin Modulators|tubulin modulators|mesh-ancestor
25842400|NCT00032149|Antimitotic Agents|antimitotic agents|mesh-ancestor
25842401|NCT00032149|Mitosis Modulators|mitosis modulators|mesh-ancestor
25842402|NCT00032149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24401566|NCT00153270|Valproic Acid|valproic acid|mesh-list
25165163|NCT05024552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25165164|NCT05024552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25165166|NCT05024552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25165167|NCT05024552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25165168|NCT05024552|Immunologic Factors|immunologic factors|mesh-ancestor
25165169|NCT05024552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165170|NCT05024552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25165171|NCT05024552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25165172|NCT05024552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25165173|NCT05024552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25165193|NCT05011123|Immunologic Factors|immunologic factors|mesh-ancestor
25165194|NCT05011123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165195|NCT05005299|Cyclophosphamide|cyclophosphamide|mesh-list
25165196|NCT05005299|Fludarabine|fludarabine|mesh-list
25165197|NCT05005299|Venetoclax|venetoclax|mesh-list
25165198|NCT05005299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25165199|NCT05005299|Immunologic Factors|immunologic factors|mesh-ancestor
25165200|NCT05005299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165201|NCT05005299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25165202|NCT05005299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25165203|NCT05005299|Alkylating Agents|alkylating agents|mesh-ancestor
25165204|NCT05005299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25165205|NCT05005299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25165206|NCT05005299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25165207|NCT05004259|Daratumumab|daratumumab|mesh-list
25165208|NCT05004259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25165209|NCT04996823|Ipilimumab|ipilimumab|mesh-list
25165210|NCT04996823|Axitinib|axitinib|mesh-list
25165211|NCT04996823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25165212|NCT04996823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25165213|NCT04996823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25165214|NCT04996823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25165215|NCT04996823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25165216|NCT04996823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24401341|NCT00152724|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24401342|NCT00152724|Antipruritics|antipruritics|mesh-ancestor
24401343|NCT00152724|Dermatologic Agents|dermatologic agents|mesh-ancestor
24401344|NCT00152724|Gout Suppressants|gout suppressants|mesh-ancestor
24401392|NCT00152841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401393|NCT00152841|Antioxidants|antioxidants|mesh-ancestor
24401394|NCT00152841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401395|NCT00152841|Protective Agents|protective agents|mesh-ancestor
25661065|NCT01628965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25661066|NCT01628965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661067|NCT01628965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661068|NCT01629134|Hyaluronic Acid|hyaluronic acid|mesh-list
25661069|NCT01629134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25661070|NCT01629134|Immunologic Factors|immunologic factors|mesh-ancestor
25661071|NCT01629134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661072|NCT01629134|Viscosupplements|viscosupplements|mesh-ancestor
25661073|NCT01629134|Protective Agents|protective agents|mesh-ancestor
25661074|NCT01629290|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
24911420|NCT04288349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24911422|NCT04288349|Autonomic Agents|autonomic agents|mesh-ancestor
24401396|NCT00152854|Acetaminophen|acetaminophen|mesh-list
24401397|NCT00152854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24401398|NCT00152854|Analgesics|analgesics|mesh-ancestor
24401399|NCT00152854|Sensory System Agents|sensory system agents|mesh-ancestor
24401402|NCT00152854|Antipyretics|antipyretics|mesh-ancestor
24401409|NCT00152867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24401410|NCT00152867|Glucocorticoids|glucocorticoids|mesh-ancestor
24401411|NCT00152867|Hormones|hormones|mesh-ancestor
24401412|NCT00152867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24401413|NCT00152867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24401443|NCT00152932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24401445|NCT00152945|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24401446|NCT00152945|Glycerol|glycerol|mesh-list
24401447|NCT00152945|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24401448|NCT00152945|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25842403|NCT00032149|Glucocorticoids|glucocorticoids|mesh-ancestor
24401451|NCT00152945|Protective Agents|protective agents|mesh-ancestor
24401452|NCT00152945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401454|NCT00152958|Antioxidants|antioxidants|mesh-ancestor
24401455|NCT00152958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401456|NCT00152958|Protective Agents|protective agents|mesh-ancestor
24401457|NCT00152958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811467|NCT02046850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24811468|NCT02046850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811469|NCT02046850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721509|NCT01575301|Exenatide|exenatide|mesh-list
24401477|NCT00152997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401478|NCT00152997|Protective Agents|protective agents|mesh-ancestor
24401479|NCT00152997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401480|NCT00152997|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24401481|NCT00152997|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24401482|NCT00152997|Dopamine Agonists|dopamine agonists|mesh-ancestor
24401483|NCT00152997|Dopamine Agents|dopamine agents|mesh-ancestor
24401484|NCT00152997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24401486|NCT00153023|Telmisartan|telmisartan|mesh-list
24401487|NCT00153023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24401488|NCT00153023|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24401489|NCT00153023|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25842404|NCT00032149|Hormones|hormones|mesh-ancestor
25842405|NCT00032149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25842406|NCT00032149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25842407|NCT00032149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25842408|NCT00032149|Analgesics|analgesics|mesh-ancestor
24401490|NCT00153023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401535|NCT00153140|Laxatives|laxatives|mesh-ancestor
25842409|NCT00032149|Sensory System Agents|sensory system agents|mesh-ancestor
25842410|NCT00032149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25842411|NCT00032162|Carboplatin|carboplatin|mesh-list
25842412|NCT00032162|Doxorubicin|doxorubicin|mesh-list
25842413|NCT00032162|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25842414|NCT00032162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842415|NCT00032162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25842416|NCT00032162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25842417|NCT00032162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25842418|NCT00032162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842419|NCT00032162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842420|NCT00032175|Gemcitabine|gemcitabine|mesh-list
25661075|NCT01629290|Cariostatic Agents|cariostatic agents|mesh-ancestor
25661076|NCT01629290|Protective Agents|protective agents|mesh-ancestor
25661077|NCT01629290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661078|NCT01629381|Rivaroxaban|rivaroxaban|mesh-list
25661079|NCT01629381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25661080|NCT01629381|Antithrombins|antithrombins|mesh-ancestor
25661081|NCT01629381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25661082|NCT01629381|Protease Inhibitors|protease inhibitors|mesh-ancestor
25661083|NCT01629381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661084|NCT01629381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661085|NCT01629381|Anticoagulants|anticoagulants|mesh-ancestor
25661086|NCT01629563|Ulipristal acetate|ulipristal acetate|mesh-list
25661087|NCT01629563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24909768|NCT04305028|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24909769|NCT04305028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909770|NCT04305028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24909771|NCT04305028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25065158|NCT03452657|Ranibizumab|ranibizumab|mesh-list
24827487|NCT02139657|Immunologic Factors|immunologic factors|mesh-ancestor
24827488|NCT02139657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827489|NCT02139761|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
25842421|NCT00032175|Capecitabine|capecitabine|mesh-list
25842422|NCT00032175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25842423|NCT00032175|Antimetabolites|antimetabolites|mesh-ancestor
25842424|NCT00032175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842425|NCT00032175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842426|NCT00032175|Antiviral Agents|antiviral agents|mesh-ancestor
25842427|NCT00032175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25091105|NCT03251222|Analgesics|analgesics|mesh-ancestor
25842428|NCT00032175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842429|NCT00032175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24401536|NCT00153140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24401537|NCT00153153|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24401538|NCT00153153|Laxatives|laxatives|mesh-ancestor
24401563|NCT00153244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24401564|NCT00153244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24401565|NCT00153244|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24401602|NCT00153296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24401604|NCT00153296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24401605|NCT00153296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811470|NCT02046850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24722063|NCT01578434|Vitamins|vitamins|mesh-list
24811471|NCT02046850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25842430|NCT00032175|Immunologic Factors|immunologic factors|mesh-ancestor
25842431|NCT00032175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842432|NCT00032188|Aldesleukin|aldesleukin|mesh-list
25842433|NCT00032188|Interleukin-2|interleukin-2|mesh-list
25842434|NCT00032188|Bryostatin 1|bryostatin 1|mesh-list
25842435|NCT00032188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24811472|NCT02046850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24811473|NCT02046850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24401606|NCT00153296|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24401607|NCT00153296|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24401610|NCT00153491|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24401611|NCT00153491|Antimalarials|antimalarials|mesh-ancestor
24401612|NCT00153491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24401613|NCT00153491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24401614|NCT00153491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24401615|NCT00153517|Metronidazole|metronidazole|mesh-list
24401616|NCT00153517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24401617|NCT00153517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24401618|NCT00153517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24401619|NCT00153517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24401620|NCT00153530|Methotrexate|methotrexate|mesh-list
24401621|NCT00153530|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24401622|NCT00153530|Abortifacient Agents|abortifacient agents|mesh-ancestor
24401623|NCT00153530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24401624|NCT00153530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401625|NCT00153530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24401654|NCT00153634|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
24401655|NCT00153634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24401656|NCT00153634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24401657|NCT00153634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24401662|NCT00153634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24401663|NCT00153634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24401664|NCT00153634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24401694|NCT00153699|Anticonvulsants|anticonvulsants|mesh-ancestor
25661088|NCT01629563|Contraceptive Agents|contraceptive agents|mesh-ancestor
25661089|NCT01629563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25661090|NCT01629563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661091|NCT01629563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25661092|NCT01629589|Vaccines|vaccines|mesh-list
25661093|NCT01629589|Immunologic Factors|immunologic factors|mesh-ancestor
25661094|NCT01629589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661095|NCT01629667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25661096|NCT01629667|Immunologic Factors|immunologic factors|mesh-ancestor
25842436|NCT00032188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25065189|NCT03452475|Piperaquine|piperaquine|mesh-list
25065191|NCT03452475|Mefloquine|mefloquine|mesh-list
24401695|NCT00153699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24401696|NCT00153699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401698|NCT00153725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24401699|NCT00153725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24401700|NCT00153725|Analgesics|analgesics|mesh-ancestor
24401701|NCT00153725|Sensory System Agents|sensory system agents|mesh-ancestor
24401702|NCT00153725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24401703|NCT00153725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401704|NCT00153725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24401705|NCT00153725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24401706|NCT00153725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24401707|NCT00153725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24401708|NCT00153725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401709|NCT00153725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24401715|NCT00153764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401718|NCT00153881|Carboplatin|carboplatin|mesh-list
24401719|NCT00153881|Docetaxel|docetaxel|mesh-list
24401720|NCT00153881|Capecitabine|capecitabine|mesh-list
24401721|NCT00153881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24401722|NCT00153881|Tubulin Modulators|tubulin modulators|mesh-ancestor
24401731|NCT00153907|Antimetabolites|antimetabolites|mesh-ancestor
24811474|NCT02046850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24811475|NCT02046850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24811476|NCT02046915|Dexamethasone|dexamethasone|mesh-list
24811477|NCT02046915|Cyclophosphamide|cyclophosphamide|mesh-list
24811478|NCT02046915|Pomalidomide|pomalidomide|mesh-list
24401732|NCT00153907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401733|NCT00153907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24401734|NCT00153907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24401735|NCT00153907|Tubulin Modulators|tubulin modulators|mesh-ancestor
24401736|NCT00153907|Antimitotic Agents|antimitotic agents|mesh-ancestor
24401737|NCT00153907|Mitosis Modulators|mitosis modulators|mesh-ancestor
24401761|NCT00153972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401762|NCT00153972|Dopamine Agonists|dopamine agonists|mesh-ancestor
24401764|NCT00153998|Folic Acid|folic acid|mesh-list
24401765|NCT00153998|Fluorouracil|fluorouracil|mesh-list
24401766|NCT00153998|Oxaliplatin|oxaliplatin|mesh-list
24401767|NCT00153998|Irinotecan|irinotecan|mesh-list
25842437|NCT00032188|Analgesics|analgesics|mesh-ancestor
25842438|NCT00032188|Sensory System Agents|sensory system agents|mesh-ancestor
25842439|NCT00032188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25842440|NCT00032188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842441|NCT00032188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25842442|NCT00032188|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24401775|NCT00153998|Immunologic Factors|immunologic factors|mesh-ancestor
24401776|NCT00153998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401777|NCT00153998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24401791|NCT00154024|Atorvastatin|atorvastatin|mesh-list
24401792|NCT00154024|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24401793|NCT00154024|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24401794|NCT00154024|Antimetabolites|antimetabolites|mesh-ancestor
24401797|NCT00154024|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25842443|NCT00032188|Antiviral Agents|antiviral agents|mesh-ancestor
25842444|NCT00032188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24539460|NCT00663949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539461|NCT00663949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539462|NCT00663949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24539463|NCT00663949|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24539464|NCT00663949|Protective Agents|protective agents|mesh-ancestor
24539465|NCT00663949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539468|NCT00663949|Antioxidants|antioxidants|mesh-ancestor
25842445|NCT00032188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25842446|NCT00032188|Immunologic Factors|immunologic factors|mesh-ancestor
24401798|NCT00154024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24401799|NCT00154024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24401800|NCT00154024|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24401801|NCT00154024|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24401802|NCT00154037|Pioglitazone|pioglitazone|mesh-list
24401803|NCT00154037|Candesartan|candesartan|mesh-list
25661097|NCT01629667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842447|NCT00032279|Visilizumab|visilizumab|mesh-list
24401804|NCT00154037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25842448|NCT00032279|Immunologic Factors|immunologic factors|mesh-ancestor
24911828|NCT04284007|Anesthetics|anesthetics|mesh-ancestor
25092848|NCT03238430|Narcotics|narcotics|mesh-ancestor
25842449|NCT00032279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842450|NCT00032292|Visilizumab|visilizumab|mesh-list
25842451|NCT00032292|Immunologic Factors|immunologic factors|mesh-ancestor
25842452|NCT00032292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842453|NCT00032305|Visilizumab|visilizumab|mesh-list
25842454|NCT00032305|Immunologic Factors|immunologic factors|mesh-ancestor
25842455|NCT00032305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041564|NCT02471222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25041565|NCT02471222|Dopamine Agents|dopamine agents|mesh-ancestor
25041566|NCT02471222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25041567|NCT02471222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041568|NCT02471222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041569|NCT02471222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25041570|NCT02471222|Analgesics|analgesics|mesh-ancestor
25165231|NCT04958122|Penicillin G|penicillin g|mesh-list
25165232|NCT04958122|Penicillin G Procaine|penicillin g procaine|mesh-list
25165233|NCT04958122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25165234|NCT04958122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24539477|NCT00664014|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24539478|NCT00664014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539479|NCT00664014|Natriuretic Agents|natriuretic agents|mesh-ancestor
24539480|NCT00664014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842456|NCT00032396|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
25842457|NCT00032396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25842458|NCT00032396|Glucocorticoids|glucocorticoids|mesh-ancestor
25842459|NCT00032396|Hormones|hormones|mesh-ancestor
24401817|NCT00154050|Protease Inhibitors|protease inhibitors|mesh-ancestor
24401831|NCT00154089|Protective Agents|protective agents|mesh-ancestor
24811479|NCT02046915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24811480|NCT02046915|Immunologic Factors|immunologic factors|mesh-ancestor
24811481|NCT02046915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811482|NCT02046915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24401832|NCT00154089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401833|NCT00154089|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24401834|NCT00154089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24401835|NCT00154089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25842460|NCT00032396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25842461|NCT00032396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842462|NCT00032734|Satavaptan|satavaptan|mesh-list
25842463|NCT00032734|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25842464|NCT00032734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842465|NCT00032734|Natriuretic Agents|natriuretic agents|mesh-ancestor
25842466|NCT00032734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842467|NCT00032747|Vasopressins|vasopressins|mesh-list
25842468|NCT00032747|Arginine Vasopressin|arginine vasopressin|mesh-list
25842469|NCT00032747|Hemostatics|hemostatics|mesh-ancestor
25842470|NCT00032747|Coagulants|coagulants|mesh-ancestor
25842471|NCT00032747|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25842472|NCT00032747|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25842473|NCT00032747|Natriuretic Agents|natriuretic agents|mesh-ancestor
25842474|NCT00032747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842475|NCT00032773|Pentostatin|pentostatin|mesh-list
25842476|NCT00032773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842477|NCT00032773|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25842478|NCT00032773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842479|NCT00032773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401836|NCT00154089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24401837|NCT00154089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24401839|NCT00154089|Sensory System Agents|sensory system agents|mesh-ancestor
24401840|NCT00154089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24401841|NCT00154089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24401842|NCT00154089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24401843|NCT00154115|Simendan|simendan|mesh-list
24401844|NCT00154115|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24401845|NCT00154115|Vasodilator Agents|vasodilator agents|mesh-ancestor
24401846|NCT00154115|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24401873|NCT00154180|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25661098|NCT01629966|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
25661099|NCT01629966|Antidepressive Agents|antidepressive agents|mesh-ancestor
25661100|NCT01629966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25661101|NCT01629966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25661102|NCT01629966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25842481|NCT00032786|Immunologic Factors|immunologic factors|mesh-ancestor
25842482|NCT00032786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401881|NCT00154180|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24401882|NCT00154180|Progestins|progestins|mesh-ancestor
24401883|NCT00154193|Cyclosporine|cyclosporine|mesh-list
24401884|NCT00154193|Cyclosporins|cyclosporins|mesh-list
24401885|NCT00154193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24401886|NCT00154193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401887|NCT00154193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24401888|NCT00154193|Immunologic Factors|immunologic factors|mesh-ancestor
24401898|NCT00154206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24401899|NCT00154206|Antitubercular Agents|antitubercular agents|mesh-ancestor
24401900|NCT00154206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24401901|NCT00154206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24401902|NCT00154206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24401903|NCT00154206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401904|NCT00154219|Lumiracoxib|lumiracoxib|mesh-list
24401905|NCT00154219|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24401906|NCT00154219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24401907|NCT00154219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24401908|NCT00154219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811483|NCT02046915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24723836|NCT01589393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24811484|NCT02046915|Alkylating Agents|alkylating agents|mesh-ancestor
24811485|NCT02046915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401916|NCT00154219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25842483|NCT00032799|Natalizumab|natalizumab|mesh-list
24401917|NCT00154232|Mycophenolic Acid|mycophenolic acid|mesh-list
24401918|NCT00154232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24401919|NCT00154232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24401920|NCT00154232|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24401921|NCT00154232|Antitubercular Agents|antitubercular agents|mesh-ancestor
24401922|NCT00154232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24401923|NCT00154232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24401924|NCT00154232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24401925|NCT00154232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401926|NCT00154245|Mycophenolic Acid|mycophenolic acid|mesh-list
24401927|NCT00154245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24401928|NCT00154245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24401929|NCT00154245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24401930|NCT00154245|Antitubercular Agents|antitubercular agents|mesh-ancestor
24401931|NCT00154245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24401932|NCT00154245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24401933|NCT00154245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24401934|NCT00154245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842484|NCT00032799|Immunologic Factors|immunologic factors|mesh-ancestor
25842485|NCT00032799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165281|NCT04934449|Keratolytic Agents|keratolytic agents|mesh-ancestor
24829390|NCT02152059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24829391|NCT02152059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24829392|NCT02152059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829393|NCT02152059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829395|NCT02152176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25842486|NCT00032812|Raclopride|raclopride|mesh-list
25842487|NCT00032812|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25842488|NCT00032812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25842489|NCT00032812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25842490|NCT00032812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842491|NCT00032812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25661103|NCT01629966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24912345|NCT04276636|Calcium Carbonate|calcium carbonate|mesh-list
24912362|NCT04276376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912363|NCT04276480|Tazobactam|tazobactam|mesh-list
24912364|NCT04276480|Piperacillin|piperacillin|mesh-list
24912389|NCT04276545|GABA Agents|gaba agents|mesh-ancestor
24912390|NCT04276545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25842492|NCT00032812|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25842493|NCT00032812|Dopamine Agents|dopamine agents|mesh-ancestor
25842494|NCT00032812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25842495|NCT00032812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842496|NCT00032825|Ketoconazole|ketoconazole|mesh-list
25043299|NCT01279590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539501|NCT00664144|Rasburicase|rasburicase|mesh-list
24401942|NCT00154258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24401943|NCT00154258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24401944|NCT00154258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24401945|NCT00154258|GABA Antagonists|gaba antagonists|mesh-ancestor
25165282|NCT04934449|Dermatologic Agents|dermatologic agents|mesh-ancestor
25165283|NCT04934228|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25165284|NCT04934228|Clonidine|clonidine|mesh-list
25165285|NCT04934228|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25165286|NCT04934228|Diuretics|diuretics|mesh-ancestor
25165287|NCT04934228|Natriuretic Agents|natriuretic agents|mesh-ancestor
25165288|NCT04934228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165289|NCT04934228|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25165290|NCT04934228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25165291|NCT04934228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25165292|NCT04934228|Analgesics|analgesics|mesh-ancestor
25165293|NCT04934228|Sensory System Agents|sensory system agents|mesh-ancestor
25165294|NCT04934228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25165295|NCT04934228|Sympatholytics|sympatholytics|mesh-ancestor
25165296|NCT04934228|Autonomic Agents|autonomic agents|mesh-ancestor
25165297|NCT04934228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25165298|NCT04934228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25165299|NCT04934228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25165300|NCT04934228|Adrenergic Agents|adrenergic agents|mesh-ancestor
25165301|NCT04934228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25165302|NCT04927780|Leucovorin|leucovorin|mesh-list
25165304|NCT04927780|Oxaliplatin|oxaliplatin|mesh-list
25165305|NCT04927780|Irinotecan|irinotecan|mesh-list
25165306|NCT04927780|Calcium|calcium|mesh-list
25165307|NCT04927780|Levoleucovorin|levoleucovorin|mesh-list
25165308|NCT04927780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25165309|NCT04927780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165310|NCT04927780|Antimetabolites|antimetabolites|mesh-ancestor
25165311|NCT04927780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25165312|NCT04927780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24401951|NCT00154271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401952|NCT00154323|Oxcarbazepine|oxcarbazepine|mesh-list
24401953|NCT00154323|Anticonvulsants|anticonvulsants|mesh-ancestor
24401954|NCT00154323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24401955|NCT00154323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24401956|NCT00154323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24606918|NCT05407155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24606919|NCT05407155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24606920|NCT05407155|Tubulin Modulators|tubulin modulators|mesh-ancestor
24401967|NCT00154336|Antimetabolites|antimetabolites|mesh-ancestor
24401972|NCT00154336|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24401973|NCT00154336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24401974|NCT00154336|Immunologic Factors|immunologic factors|mesh-ancestor
24401975|NCT00154336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25661104|NCT01629966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661105|NCT01629966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25661106|NCT01629966|Serotonin Agents|serotonin agents|mesh-ancestor
25661107|NCT01629966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661108|NCT01629966|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25661109|NCT01629966|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25842497|NCT00032825|Docetaxel|docetaxel|mesh-list
25842498|NCT00032825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24401976|NCT00154336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24401977|NCT00154336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24401978|NCT00154349|Imatinib Mesylate|imatinib mesylate|mesh-list
24912483|NCT04275115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24912484|NCT04275115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24912485|NCT04275115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24912486|NCT04275115|Anesthetics, General|anesthetics, general|mesh-ancestor
24912487|NCT04275115|Anesthetics|anesthetics|mesh-ancestor
24486990|NCT00460850|Antiviral Agents|antiviral agents|mesh-ancestor
24486991|NCT00460850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24401979|NCT00154349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24401980|NCT00154349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24401981|NCT00154349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24401982|NCT00154349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401983|NCT00154362|Oxcarbazepine|oxcarbazepine|mesh-list
24401984|NCT00154362|Anticonvulsants|anticonvulsants|mesh-ancestor
24401985|NCT00154362|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24401986|NCT00154362|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24401987|NCT00154362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24401988|NCT00154362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401989|NCT00154362|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24401990|NCT00154362|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24401991|NCT00154388|Imatinib Mesylate|imatinib mesylate|mesh-list
24539540|NCT00664287|Vasodilator Agents|vasodilator agents|mesh-ancestor
24539541|NCT00664287|Vitamin B Complex|vitamin b complex|mesh-ancestor
24539542|NCT00664287|Vitamins|vitamins|mesh-ancestor
24539543|NCT00664287|Micronutrients|micronutrients|mesh-ancestor
24539544|NCT00664287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539545|NCT00664313|Linezolid|linezolid|mesh-list
24539546|NCT00664313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25842499|NCT00032825|Tubulin Modulators|tubulin modulators|mesh-ancestor
25842500|NCT00032825|Antimitotic Agents|antimitotic agents|mesh-ancestor
25842501|NCT00032825|Mitosis Modulators|mitosis modulators|mesh-ancestor
25842502|NCT00032825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842503|NCT00032825|Antifungal Agents|antifungal agents|mesh-ancestor
24401992|NCT00154388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842504|NCT00032825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402017|NCT00154440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402018|NCT00154440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402019|NCT00154440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24402022|NCT00154661|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24402023|NCT00154661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402024|NCT00154661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402025|NCT00154661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24402026|NCT00154661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24402027|NCT00154661|Protective Agents|protective agents|mesh-ancestor
24606925|NCT05407155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24606926|NCT05407155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24606927|NCT05407155|Growth Substances|growth substances|mesh-ancestor
24606928|NCT05407155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606929|NCT05407155|Growth Inhibitors|growth inhibitors|mesh-ancestor
24623156|NCT01070472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24623157|NCT01070472|Oxytocics|oxytocics|mesh-ancestor
24623158|NCT01070485|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25842505|NCT00032825|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25842506|NCT00032825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25842507|NCT00032825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842508|NCT00032825|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25842509|NCT00032825|Hormone Antagonists|hormone antagonists|mesh-ancestor
25842510|NCT00032825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25093995|NCT03230058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402028|NCT00154661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402029|NCT00154661|Vasodilator Agents|vasodilator agents|mesh-ancestor
24402030|NCT00154661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24402031|NCT00154661|Antioxidants|antioxidants|mesh-ancestor
24402033|NCT00154687|Fluorouracil|fluorouracil|mesh-list
24402034|NCT00154687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25661110|NCT01630109|Metoclopramide|metoclopramide|mesh-list
25661111|NCT01630109|Antiemetics|antiemetics|mesh-ancestor
25661112|NCT01630109|Autonomic Agents|autonomic agents|mesh-ancestor
25661113|NCT01630109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25661114|NCT01630109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661115|NCT01630109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25661116|NCT01630109|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24402035|NCT00154687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402036|NCT00154687|Tubulin Modulators|tubulin modulators|mesh-ancestor
24912640|NCT04273321|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24912641|NCT04273321|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24912642|NCT04273321|Prednisolone|prednisolone|mesh-list
25842511|NCT00032825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402037|NCT00154687|Antimitotic Agents|antimitotic agents|mesh-ancestor
24402038|NCT00154687|Mitosis Modulators|mitosis modulators|mesh-ancestor
24402039|NCT00154687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402040|NCT00154687|Antimetabolites|antimetabolites|mesh-ancestor
24402050|NCT00154700|Antimitotic Agents|antimitotic agents|mesh-ancestor
24402051|NCT00154700|Mitosis Modulators|mitosis modulators|mesh-ancestor
24402052|NCT00154700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402053|NCT00154700|Hematinics|hematinics|mesh-ancestor
24402054|NCT00154700|Vitamin B Complex|vitamin b complex|mesh-ancestor
24402055|NCT00154700|Vitamins|vitamins|mesh-ancestor
24402056|NCT00154700|Micronutrients|micronutrients|mesh-ancestor
24402057|NCT00154700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402058|NCT00154726|Paclitaxel|paclitaxel|mesh-list
24402059|NCT00154726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25842512|NCT00032825|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25842513|NCT00032838|Yohimbine|yohimbine|mesh-list
25842514|NCT00032838|Mydriatics|mydriatics|mesh-ancestor
25842515|NCT00032838|Autonomic Agents|autonomic agents|mesh-ancestor
25842516|NCT00032838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24793289|NCT03581370|Cephalosporins|cephalosporins|mesh-list
25842517|NCT00032838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402060|NCT00154726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402061|NCT00154726|Tubulin Modulators|tubulin modulators|mesh-ancestor
24402062|NCT00154726|Antimitotic Agents|antimitotic agents|mesh-ancestor
24402063|NCT00154726|Mitosis Modulators|mitosis modulators|mesh-ancestor
24402064|NCT00154726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402065|NCT00154739|Gemcitabine|gemcitabine|mesh-list
24402066|NCT00154739|Epirubicin|epirubicin|mesh-list
24402067|NCT00154739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402068|NCT00154739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24402069|NCT00154739|Antimetabolites|antimetabolites|mesh-ancestor
24402070|NCT00154739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402071|NCT00154739|Antiviral Agents|antiviral agents|mesh-ancestor
24402072|NCT00154739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402073|NCT00154739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402074|NCT00154739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24402075|NCT00154739|Immunologic Factors|immunologic factors|mesh-ancestor
24402091|NCT00154791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842518|NCT00032838|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25842519|NCT00032838|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25842520|NCT00032838|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25842521|NCT00032838|Adrenergic Agents|adrenergic agents|mesh-ancestor
25842522|NCT00032838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25842523|NCT00032838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842524|NCT00032838|Urological Agents|urological agents|mesh-ancestor
25875701|NCT04216290|Immunoglobulin G|immunoglobulin g|mesh-list
25875702|NCT04216290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875703|NCT04216290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25875704|NCT04216290|Antimetabolites|antimetabolites|mesh-ancestor
25875705|NCT04216290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539586|NCT00664677|Masoprocol|masoprocol|mesh-list
24539587|NCT00664677|Antioxidants|antioxidants|mesh-ancestor
24402110|NCT00154843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623159|NCT01070485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623160|NCT01070511|Tadalafil|tadalafil|mesh-list
24623161|NCT01070511|Vasodilator Agents|vasodilator agents|mesh-ancestor
25875706|NCT04216290|Antiviral Agents|antiviral agents|mesh-ancestor
25875707|NCT04216290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25875708|NCT04216290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875709|NCT04216290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25875710|NCT04216290|Immunologic Factors|immunologic factors|mesh-ancestor
25875711|NCT04216290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875712|NCT04216290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24402119|NCT00154869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402120|NCT00154869|Antiviral Agents|antiviral agents|mesh-ancestor
24402121|NCT00154869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25661117|NCT01630109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25661118|NCT01630109|Dopamine Agents|dopamine agents|mesh-ancestor
25661119|NCT01630109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25661120|NCT01630109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912785|NCT04272086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24912787|NCT04272320|Anesthetics, Local|anesthetics, local|mesh-ancestor
24912788|NCT04272320|Anesthetics|anesthetics|mesh-ancestor
24912789|NCT04272320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24402165|NCT00155259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402166|NCT00155259|Tubulin Modulators|tubulin modulators|mesh-ancestor
24402167|NCT00155259|Antimitotic Agents|antimitotic agents|mesh-ancestor
24402168|NCT00155259|Mitosis Modulators|mitosis modulators|mesh-ancestor
24402169|NCT00155259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402170|NCT00155259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24402171|NCT00155259|Antimetabolites|antimetabolites|mesh-ancestor
24402173|NCT00155272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24402174|NCT00155272|Immunologic Factors|immunologic factors|mesh-ancestor
24402175|NCT00155272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842525|NCT00032890|Celecoxib|celecoxib|mesh-list
25842526|NCT00032890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25842527|NCT00032890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25842528|NCT00032890|Analgesics|analgesics|mesh-ancestor
25842529|NCT00032890|Sensory System Agents|sensory system agents|mesh-ancestor
25842530|NCT00032890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25842531|NCT00032890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842532|NCT00032890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25842533|NCT00032890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25842534|NCT00032890|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24402176|NCT00155272|Leprostatic Agents|leprostatic agents|mesh-ancestor
24402177|NCT00155272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24402178|NCT00155272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402179|NCT00155272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24402180|NCT00155272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24402181|NCT00155272|Growth Substances|growth substances|mesh-ancestor
24402182|NCT00155272|Growth Inhibitors|growth inhibitors|mesh-ancestor
24402183|NCT00155272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402184|NCT00155350|Pioglitazone|pioglitazone|mesh-list
24402185|NCT00155350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24402186|NCT00155350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402187|NCT00155376|Morphine|morphine|mesh-list
24402188|NCT00155376|Glucagon|glucagon|mesh-list
24402189|NCT00155376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24402190|NCT00155376|Narcotics|narcotics|mesh-ancestor
24402191|NCT00155376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24402192|NCT00155376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402193|NCT00155376|Analgesics|analgesics|mesh-ancestor
24402194|NCT00155376|Sensory System Agents|sensory system agents|mesh-ancestor
24402199|NCT00155402|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24402200|NCT00155402|Hemostatics|hemostatics|mesh-ancestor
24402201|NCT00155402|Coagulants|coagulants|mesh-ancestor
24402202|NCT00155558|Leucovorin|leucovorin|mesh-list
24402203|NCT00155558|Fluorouracil|fluorouracil|mesh-list
24402204|NCT00155558|Antimetabolites|antimetabolites|mesh-ancestor
24402205|NCT00155558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402206|NCT00155558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24402207|NCT00155558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403393|NCT00160186|Pancreatin|pancreatin|mesh-list
24402208|NCT00155558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24402209|NCT00155558|Immunologic Factors|immunologic factors|mesh-ancestor
24402210|NCT00155558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402211|NCT00155558|Antidotes|antidotes|mesh-ancestor
24623165|NCT01070511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402213|NCT00155558|Vitamin B Complex|vitamin b complex|mesh-ancestor
24402227|NCT00155883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24402228|NCT00155883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402229|NCT00155883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24402230|NCT00155883|Immunologic Factors|immunologic factors|mesh-ancestor
24402231|NCT00155883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402232|NCT00155883|Antidotes|antidotes|mesh-ancestor
24402233|NCT00155883|Protective Agents|protective agents|mesh-ancestor
24402234|NCT00155883|Vitamin B Complex|vitamin b complex|mesh-ancestor
24402235|NCT00155883|Vitamins|vitamins|mesh-ancestor
24402236|NCT00155883|Micronutrients|micronutrients|mesh-ancestor
24402239|NCT00156078|Sensory System Agents|sensory system agents|mesh-ancestor
25661121|NCT01630135|Fluticasone|fluticasone|mesh-list
25661122|NCT01630135|Xhance|xhance|mesh-list
25661123|NCT01630135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25661124|NCT01630135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25661125|NCT01630135|Autonomic Agents|autonomic agents|mesh-ancestor
25661126|NCT01630135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25065297|NCT03451435|Acetylcysteine|acetylcysteine|mesh-list
25065298|NCT03451435|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25065299|NCT03451435|Antiviral Agents|antiviral agents|mesh-ancestor
25065300|NCT03451435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25065301|NCT03451435|Expectorants|expectorants|mesh-ancestor
25065302|NCT03451435|Respiratory System Agents|respiratory system agents|mesh-ancestor
25065303|NCT03451435|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25065304|NCT03451435|Antioxidants|antioxidants|mesh-ancestor
24913382|NCT04265612|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25842535|NCT00032890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25842536|NCT00032890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842537|NCT00032890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842538|NCT00032929|Selegiline|selegiline|mesh-list
25842539|NCT00032929|Antidepressive Agents|antidepressive agents|mesh-ancestor
25842540|NCT00032929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25842541|NCT00032929|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25842542|NCT00032929|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25842543|NCT00032929|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24402240|NCT00156078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24402241|NCT00156078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402242|NCT00156078|Anticonvulsants|anticonvulsants|mesh-ancestor
24402243|NCT00156078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24402244|NCT00156078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24402245|NCT00156078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402246|NCT00156078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24402247|NCT00156078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24402248|NCT00156078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24402249|NCT00156078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24402250|NCT00156078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24402251|NCT00156286|Imatinib Mesylate|imatinib mesylate|mesh-list
24402252|NCT00156286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402253|NCT00156286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24458130|NCT00336765|XL647|xl647|mesh-list
25842544|NCT00032929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842545|NCT00032929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842546|NCT00032929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25842547|NCT00032929|Protective Agents|protective agents|mesh-ancestor
25842548|NCT00032929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842549|NCT00032942|Lofexidine|lofexidine|mesh-list
25842550|NCT00032942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25842551|NCT00032942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25842552|NCT00032942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842553|NCT00032942|Sensory System Agents|sensory system agents|mesh-ancestor
25842554|NCT00032942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25842555|NCT00032942|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25842556|NCT00032942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25842557|NCT00032942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25842558|NCT00032942|Adrenergic Agents|adrenergic agents|mesh-ancestor
25842559|NCT00032942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25842560|NCT00032942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402262|NCT00156299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24402263|NCT00156299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402264|NCT00156299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24402265|NCT00156299|Glucocorticoids|glucocorticoids|mesh-ancestor
24402267|NCT00156299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25165313|NCT04927780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842561|NCT00032955|Buprenorphine|buprenorphine|mesh-list
25842562|NCT00032955|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25842563|NCT00032955|Naloxone|naloxone|mesh-list
25842564|NCT00032955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24829399|NCT02152176|Analgesics|analgesics|mesh-ancestor
24829400|NCT02152176|Sensory System Agents|sensory system agents|mesh-ancestor
24829401|NCT02152176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25165314|NCT04927780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25165315|NCT04927780|Immunologic Factors|immunologic factors|mesh-ancestor
25661127|NCT01630135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661128|NCT01630135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25661129|NCT01630135|Respiratory System Agents|respiratory system agents|mesh-ancestor
25661130|NCT01630135|Dermatologic Agents|dermatologic agents|mesh-ancestor
25661131|NCT01630135|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25661132|NCT01630811|Quinidine|quinidine|mesh-list
25661133|NCT01630811|Dextromethorphan|dextromethorphan|mesh-list
25661134|NCT01630811|Antitussive Agents|antitussive agents|mesh-ancestor
25661135|NCT01630811|Respiratory System Agents|respiratory system agents|mesh-ancestor
24913576|NCT04262999|Nootropic Agents|nootropic agents|mesh-ancestor
24913577|NCT04262999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24913578|NCT04262999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913579|NCT04262999|GABA Agents|gaba agents|mesh-ancestor
24913580|NCT04262999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24913581|NCT04262999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913582|NCT04262999|Antimanic Agents|antimanic agents|mesh-ancestor
25165316|NCT04927780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25165317|NCT04927780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25165318|NCT04927780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25165319|NCT04927780|Antidotes|antidotes|mesh-ancestor
25094801|NCT03222518|Acetaminophen|acetaminophen|mesh-list
25165320|NCT04927780|Protective Agents|protective agents|mesh-ancestor
25165321|NCT04927780|Vitamin B Complex|vitamin b complex|mesh-ancestor
25165323|NCT04927780|Micronutrients|micronutrients|mesh-ancestor
25203289|NCT02715154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25203290|NCT02715154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203291|NCT02715154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25203292|NCT02715154|Analgesics|analgesics|mesh-ancestor
25203293|NCT02715154|Sensory System Agents|sensory system agents|mesh-ancestor
25203294|NCT02715154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25203295|NCT02715154|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25203296|NCT02715154|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25203297|NCT02715154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25203298|NCT02715154|Adrenergic Agents|adrenergic agents|mesh-ancestor
25203299|NCT02715154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25203300|NCT02715154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203301|NCT02715232|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25203302|NCT02715232|Cyproterone Acetate|cyproterone acetate|mesh-list
25203303|NCT02715232|Lynestrenol|lynestrenol|mesh-list
25203304|NCT02715232|Estradiol|estradiol|mesh-list
25203305|NCT02715232|Testosterone|testosterone|mesh-list
25203306|NCT02715232|Cyproterone|cyproterone|mesh-list
25203307|NCT02715232|Estrogens|estrogens|mesh-ancestor
25203308|NCT02715232|Hormones|hormones|mesh-ancestor
25203309|NCT02715232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25203310|NCT02715232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203311|NCT02715232|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25203312|NCT02715232|Contraceptive Agents|contraceptive agents|mesh-ancestor
25203313|NCT02715232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25203314|NCT02715232|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25203315|NCT02715232|Androgens|androgens|mesh-ancestor
25203316|NCT02715232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25203317|NCT02715232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25203318|NCT02715232|Luteolytic Agents|luteolytic agents|mesh-ancestor
25203319|NCT02715232|Androgen Antagonists|androgen antagonists|mesh-ancestor
25203320|NCT02715232|Hormone Antagonists|hormone antagonists|mesh-ancestor
25203321|NCT02715232|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25203322|NCT02715232|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25203323|NCT02715232|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25203324|NCT02715232|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25203325|NCT02715167|Budesonide|budesonide|mesh-list
25203326|NCT02715167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25203327|NCT02715167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25203328|NCT02715167|Autonomic Agents|autonomic agents|mesh-ancestor
25203329|NCT02715167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25203330|NCT02715167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203331|NCT02715167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25203332|NCT02715167|Respiratory System Agents|respiratory system agents|mesh-ancestor
25203333|NCT02715167|Glucocorticoids|glucocorticoids|mesh-ancestor
25203334|NCT02715167|Hormones|hormones|mesh-ancestor
25203335|NCT02715167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25203336|NCT02714959|Aldesleukin|aldesleukin|mesh-list
25203337|NCT02714959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25203338|NCT02714959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25661136|NCT01630811|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25661137|NCT01630811|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25661138|NCT01630811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25661139|NCT01630811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661140|NCT01630811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661141|NCT01630811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25661142|NCT01630811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25842565|NCT00032955|Narcotics|narcotics|mesh-ancestor
24913708|NCT04261907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25661143|NCT01630811|Adrenergic Agents|adrenergic agents|mesh-ancestor
25842566|NCT00032955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24819338|NCT02094807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203339|NCT02714959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25203340|NCT02714959|Antiviral Agents|antiviral agents|mesh-ancestor
25203341|NCT02714959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25203342|NCT02714725|Dexmedetomidine|dexmedetomidine|mesh-list
25203343|NCT02714725|Propofol|propofol|mesh-list
25203344|NCT02714725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25203345|NCT02714725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25203346|NCT02714725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402269|NCT00156299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402270|NCT00156299|Lipotropic Agents|lipotropic agents|mesh-ancestor
24402271|NCT00156299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24402272|NCT00156299|Antimetabolites|antimetabolites|mesh-ancestor
24402276|NCT00156299|Analgesics|analgesics|mesh-ancestor
25095020|NCT03221166|Leprostatic Agents|leprostatic agents|mesh-ancestor
24402277|NCT00156299|Sensory System Agents|sensory system agents|mesh-ancestor
25842567|NCT00032955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842568|NCT00032955|Analgesics|analgesics|mesh-ancestor
25842569|NCT00032955|Sensory System Agents|sensory system agents|mesh-ancestor
24458162|NCT00336882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25842570|NCT00032955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25842571|NCT00032955|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25842572|NCT00032968|Buprenorphine|buprenorphine|mesh-list
25842573|NCT00032968|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25842574|NCT00032968|Naloxone|naloxone|mesh-list
25842575|NCT00032968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25842576|NCT00032968|Narcotics|narcotics|mesh-ancestor
25842577|NCT00032968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25842578|NCT00032968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842579|NCT00032968|Analgesics|analgesics|mesh-ancestor
25842580|NCT00032968|Sensory System Agents|sensory system agents|mesh-ancestor
24623176|NCT01070524|Glucocorticoids|glucocorticoids|mesh-ancestor
24623177|NCT01070524|Hormones|hormones|mesh-ancestor
24675982|NCT01347268|Hormones|hormones|mesh-ancestor
24402300|NCT00156325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24402301|NCT00156377|Mupirocin|mupirocin|mesh-list
24402302|NCT00156377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24402303|NCT00156377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402304|NCT00156377|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24402305|NCT00156377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402307|NCT00156403|Amlodipine|amlodipine|mesh-list
24402318|NCT00156520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402319|NCT00156520|Hemostatics|hemostatics|mesh-ancestor
24402320|NCT00156520|Coagulants|coagulants|mesh-ancestor
24402321|NCT00156546|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24402322|NCT00156546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402324|NCT00156611|Anticoagulants|anticoagulants|mesh-ancestor
24402325|NCT00156611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24402326|NCT00156650|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24402327|NCT00156650|Medroxyprogesterone|medroxyprogesterone|mesh-list
24402328|NCT00156650|Testosterone|testosterone|mesh-list
24402329|NCT00156650|Acyline|acyline|mesh-list
24402330|NCT00156650|Androgens|androgens|mesh-ancestor
24402331|NCT00156650|Hormones|hormones|mesh-ancestor
24402332|NCT00156650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24402333|NCT00156650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402334|NCT00156650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24402335|NCT00156650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402336|NCT00156650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24402337|NCT00156650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24402338|NCT00156650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24402339|NCT00156650|Contraceptive Agents|contraceptive agents|mesh-ancestor
25842581|NCT00032968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25842582|NCT00032968|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24539722|NCT00665327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24539723|NCT00665327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24539724|NCT00665327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25661144|NCT01630811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25661145|NCT01630811|Antimalarials|antimalarials|mesh-ancestor
25661146|NCT01630811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25842583|NCT00033033|Reserpine|reserpine|mesh-list
25842584|NCT00033033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25842585|NCT00033033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25842586|NCT00033033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24914155|NCT04257812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914408|NCT04255017|Lopinavir|lopinavir|mesh-list
25842587|NCT00033033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25842588|NCT00033033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842589|NCT00033033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25842590|NCT00033033|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25842591|NCT00033033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25842592|NCT00033033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25842593|NCT00033033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842594|NCT00033033|Adrenergic Agents|adrenergic agents|mesh-ancestor
25842595|NCT00033033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25043397|NCT01265901|Cyclophosphamide|cyclophosphamide|mesh-list
25043398|NCT01265901|Sunitinib|sunitinib|mesh-list
25842596|NCT00033046|Modafinil|modafinil|mesh-list
25842597|NCT00033046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25842598|NCT00033046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842599|NCT00033046|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25842600|NCT00033046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25842601|NCT00033046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25842602|NCT00033046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402390|NCT00157066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402391|NCT00157066|Vitamins|vitamins|mesh-ancestor
24402404|NCT00157092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25165335|NCT04881929|Docetaxel|docetaxel|mesh-list
25165336|NCT04881929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25165337|NCT04881929|Tubulin Modulators|tubulin modulators|mesh-ancestor
25165338|NCT04881929|Antimitotic Agents|antimitotic agents|mesh-ancestor
25165339|NCT04881929|Mitosis Modulators|mitosis modulators|mesh-ancestor
25165340|NCT04881929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25165341|NCT04881032|Temozolomide|temozolomide|mesh-list
25165342|NCT04881032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25165343|NCT04881032|Alkylating Agents|alkylating agents|mesh-ancestor
25165344|NCT04881032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25165345|NCT04881032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25165346|NCT04878432|Azacitidine|azacitidine|mesh-list
25165347|NCT04878432|Decitabine|decitabine|mesh-list
25165348|NCT04878432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25165349|NCT04878432|Antimetabolites|antimetabolites|mesh-ancestor
25165350|NCT04878432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25165351|NCT04878432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25165352|NCT04878432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402411|NCT00157118|Anticoagulants|anticoagulants|mesh-ancestor
24481265|NCT00433927|Vitamins|vitamins|mesh-ancestor
24402412|NCT00157118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24402413|NCT00157118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24402414|NCT00157118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842603|NCT00033059|Tolcapone|tolcapone|mesh-list
25842604|NCT00033059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25842605|NCT00033059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25842606|NCT00033059|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25842607|NCT00033059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842608|NCT00033059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842609|NCT00033072|Selegiline|selegiline|mesh-list
25842610|NCT00033072|Antidepressive Agents|antidepressive agents|mesh-ancestor
25842611|NCT00033072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25842612|NCT00033072|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25842613|NCT00033072|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25842614|NCT00033072|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24402417|NCT00157131|Coagulants|coagulants|mesh-ancestor
24402453|NCT00157378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24402454|NCT00157378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402455|NCT00157378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402456|NCT00157378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24402457|NCT00157378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24402458|NCT00157378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25095727|NCT03216941|Anesthetics, General|anesthetics, general|mesh-ancestor
24623178|NCT01070524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24623179|NCT01070524|Sympathomimetics|sympathomimetics|mesh-ancestor
24402459|NCT00157378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24402460|NCT00157378|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24402461|NCT00157378|Dopamine Agents|dopamine agents|mesh-ancestor
25661147|NCT01630811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25661148|NCT01630811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24831521|NCT02166554|Hyaluronic Acid|hyaluronic acid|mesh-list
24831522|NCT02166554|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24831523|NCT02166554|Immunologic Factors|immunologic factors|mesh-ancestor
24831524|NCT02166554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831525|NCT02166554|Viscosupplements|viscosupplements|mesh-ancestor
24402462|NCT00157378|Antiemetics|antiemetics|mesh-ancestor
24402463|NCT00157378|Autonomic Agents|autonomic agents|mesh-ancestor
24402464|NCT00157378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24402465|NCT00157378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24402466|NCT00157378|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24402467|NCT00157482|Simvastatin|simvastatin|mesh-list
24402469|NCT00157482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24402470|NCT00157482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24402471|NCT00157482|Antimetabolites|antimetabolites|mesh-ancestor
24402472|NCT00157482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402473|NCT00157482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24402487|NCT00157508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402488|NCT00157508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24402489|NCT00157508|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
24402490|NCT00157508|Protease Inhibitors|protease inhibitors|mesh-ancestor
24402491|NCT00157508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402492|NCT00157547|Fluvoxamine|fluvoxamine|mesh-list
24402494|NCT00157547|Fluoxetine|fluoxetine|mesh-list
25842615|NCT00033072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842616|NCT00033072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842617|NCT00033072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25842618|NCT00033072|Protective Agents|protective agents|mesh-ancestor
25842619|NCT00033072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842620|NCT00033085|Ondansetron|ondansetron|mesh-list
24402503|NCT00157547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24402504|NCT00157547|Serotonin Agents|serotonin agents|mesh-ancestor
24402505|NCT00157547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402506|NCT00157547|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24402507|NCT00157547|Antidepressive Agents|antidepressive agents|mesh-ancestor
24402508|NCT00157547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24402509|NCT00157547|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25095883|NCT03215693|Ensartinib|ensartinib|mesh-list
24402510|NCT00157547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24402511|NCT00157547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402527|NCT00157586|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24402528|NCT00157586|Protease Inhibitors|protease inhibitors|mesh-ancestor
24402529|NCT00157586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402531|NCT00157651|Anticoagulants|anticoagulants|mesh-ancestor
25842621|NCT00033085|Antiemetics|antiemetics|mesh-ancestor
24402570|NCT00157859|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24402571|NCT00157859|Renal Agents|renal agents|mesh-ancestor
24402572|NCT00157872|Naproxen|naproxen|mesh-list
24402573|NCT00157872|Rofecoxib|rofecoxib|mesh-list
24402574|NCT00157872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24402575|NCT00157872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25842622|NCT00033085|Autonomic Agents|autonomic agents|mesh-ancestor
24402577|NCT00157872|Sensory System Agents|sensory system agents|mesh-ancestor
24402578|NCT00157872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24402579|NCT00157872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402580|NCT00157872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24402581|NCT00157872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24402583|NCT00157872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24402584|NCT00157872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402585|NCT00157872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402586|NCT00157872|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24402587|NCT00157885|Artesunate|artesunate|mesh-list
24402588|NCT00157885|Amodiaquine|amodiaquine|mesh-list
24402589|NCT00157885|Antimalarials|antimalarials|mesh-ancestor
24623180|NCT01070615|Prucalopride|prucalopride|mesh-list
24623181|NCT01070615|Laxatives|laxatives|mesh-ancestor
24623182|NCT01070615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24676096|NCT01348204|Quercetin|quercetin|mesh-list
24402590|NCT00157885|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24402591|NCT00157885|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24402592|NCT00157885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402773|NCT00158457|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24482201|NCT00438139|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25661149|NCT01630811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661150|NCT01630811|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25661151|NCT01630811|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25661152|NCT01630811|Cholinergic Agents|cholinergic agents|mesh-ancestor
24833789|NCT02175602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24833790|NCT02175602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833791|NCT02175602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24833792|NCT02175602|Serotonin Agents|serotonin agents|mesh-ancestor
24833793|NCT02175602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833794|NCT02175602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24833795|NCT02175602|Antidepressive Agents|antidepressive agents|mesh-ancestor
24402774|NCT00158457|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24402795|NCT00158483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402796|NCT00158496|Interferons|interferons|mesh-list
24402797|NCT00158496|Ribavirin|ribavirin|mesh-list
24402798|NCT00158496|Interferon-alpha|interferon-alpha|mesh-list
24402799|NCT00158496|Interferon alpha-2|interferon alpha-2|mesh-list
24402800|NCT00158496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24402801|NCT00158496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402802|NCT00158496|Antiviral Agents|antiviral agents|mesh-ancestor
24402803|NCT00158496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402804|NCT00158496|Antimetabolites|antimetabolites|mesh-ancestor
24402805|NCT00158496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402806|NCT00158496|Immunologic Factors|immunologic factors|mesh-ancestor
24402807|NCT00158496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402808|NCT00158509|Valacyclovir|valacyclovir|mesh-list
24402809|NCT00158509|Antiviral Agents|antiviral agents|mesh-ancestor
24402810|NCT00158509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402811|NCT00158522|Interferons|interferons|mesh-list
24402812|NCT00158522|Interferon-alpha|interferon-alpha|mesh-list
24402851|NCT00158574|Pyrimethamine|pyrimethamine|mesh-list
24402852|NCT00158574|Sulfadoxine|sulfadoxine|mesh-list
24402853|NCT00158574|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24402854|NCT00158574|Dapsone|dapsone|mesh-list
24402855|NCT00158574|Mefloquine|mefloquine|mesh-list
24402857|NCT00158574|Proguanil|proguanil|mesh-list
25842623|NCT00033085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24539823|NCT00665743|Naproxen|naproxen|mesh-list
25842624|NCT00033085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842625|NCT00033085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25842626|NCT00033085|Antipruritics|antipruritics|mesh-ancestor
25842627|NCT00033085|Dermatologic Agents|dermatologic agents|mesh-ancestor
24402881|NCT00158691|Protective Agents|protective agents|mesh-ancestor
24402882|NCT00158691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402883|NCT00158704|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
24402884|NCT00158704|Antiviral Agents|antiviral agents|mesh-ancestor
24402885|NCT00158704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402886|NCT00158704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24402887|NCT00158704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24402957|NCT00158847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24402958|NCT00158847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24402959|NCT00158847|Adrenergic Agents|adrenergic agents|mesh-ancestor
25842628|NCT00033085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24402977|NCT00158873|Sensory System Agents|sensory system agents|mesh-ancestor
24402978|NCT00158873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25096316|NCT03212677|Iron|iron|mesh-list
24402979|NCT00158873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24402980|NCT00158873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24402981|NCT00158873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24402982|NCT00158873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24402983|NCT00158873|GABA Modulators|gaba modulators|mesh-ancestor
24402984|NCT00158873|GABA Agents|gaba agents|mesh-ancestor
24402985|NCT00158873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24403002|NCT00158990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24539844|NCT00665808|Insulin|insulin|mesh-list
25842629|NCT00033085|Serotonin Agents|serotonin agents|mesh-ancestor
25842630|NCT00033085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25842631|NCT00033085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842632|NCT00033085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25661153|NCT01630811|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25661154|NCT01630811|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25661155|NCT01630811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25661156|NCT01630811|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25661157|NCT01630811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25661158|NCT01631110|Vaccines|vaccines|mesh-list
25661159|NCT01631110|Immunologic Factors|immunologic factors|mesh-ancestor
25842633|NCT00033085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25842634|NCT00033085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25842635|NCT00033085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25842636|NCT00033085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25661160|NCT01631110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835283|NCT02182557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24835284|NCT02182557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835285|NCT02182557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835497|NCT02183025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24835498|NCT02183025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25842638|NCT00033098|Antimetabolites|antimetabolites|mesh-ancestor
24623184|NCT01070615|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24623186|NCT01070615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24460420|NCT00348413|Methylprednisolone|methylprednisolone|mesh-list
24403004|NCT00158990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24403005|NCT00158990|Serotonin Agents|serotonin agents|mesh-ancestor
24403006|NCT00158990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403018|NCT00159081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403019|NCT00159081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403020|NCT00159081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24403021|NCT00159081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24403022|NCT00159081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24403023|NCT00159081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24403024|NCT00159081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24403027|NCT00159081|Autonomic Agents|autonomic agents|mesh-ancestor
24403028|NCT00159081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24403029|NCT00159081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24403030|NCT00159081|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24403031|NCT00159094|Vinorelbine|vinorelbine|mesh-list
24403032|NCT00159094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24403033|NCT00159094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403034|NCT00159094|Tubulin Modulators|tubulin modulators|mesh-ancestor
24403035|NCT00159094|Antimitotic Agents|antimitotic agents|mesh-ancestor
24403036|NCT00159094|Mitosis Modulators|mitosis modulators|mesh-ancestor
24403037|NCT00159094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403038|NCT00159107|Acamprosate|acamprosate|mesh-list
24403039|NCT00159107|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24403040|NCT00159120|Antipsychotic Agents|antipsychotic agents|mesh-list
24403041|NCT00159120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24403042|NCT00159120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24403043|NCT00159120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539862|NCT00665873|Amoxicillin|amoxicillin|mesh-list
25842639|NCT00033098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842640|NCT00033098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842641|NCT00033111|Cabergoline|cabergoline|mesh-list
25842642|NCT00033111|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25842643|NCT00033111|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25165353|NCT04871607|Cytarabine|cytarabine|mesh-list
25842644|NCT00033111|Dopamine Agonists|dopamine agonists|mesh-ancestor
25842645|NCT00033111|Dopamine Agents|dopamine agents|mesh-ancestor
25842646|NCT00033111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25842647|NCT00033111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842648|NCT00033111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842649|NCT00033163|Tenofovir|tenofovir|mesh-list
25842650|NCT00033163|Adefovir|adefovir|mesh-list
25842651|NCT00033163|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25842652|NCT00033163|Antiviral Agents|antiviral agents|mesh-ancestor
25066269|NCT03819088|Zinc|zinc|mesh-list
24403044|NCT00159120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24403046|NCT00159133|Antipsychotic Agents|antipsychotic agents|mesh-list
24403047|NCT00159133|Anticonvulsants|anticonvulsants|mesh-ancestor
24403063|NCT00159146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24403064|NCT00159146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24403065|NCT00159146|Adrenergic Agents|adrenergic agents|mesh-ancestor
24403066|NCT00159146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24403067|NCT00159146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403068|NCT00159146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403069|NCT00159146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24403070|NCT00159146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24403091|NCT00159224|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24403092|NCT00159224|Protease Inhibitors|protease inhibitors|mesh-ancestor
24403093|NCT00159224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25417933|NCT02829931|Ipilimumab|ipilimumab|mesh-list
25661161|NCT01631149|Rocuronium|rocuronium|mesh-list
25661162|NCT01631149|Atracurium|atracurium|mesh-list
25661163|NCT01631149|Mivacurium|mivacurium|mesh-list
25661164|NCT01631149|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25661165|NCT01631149|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25661166|NCT01631149|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25842653|NCT00033163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25842655|NCT00033163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25842656|NCT00033163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842657|NCT00033163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842658|NCT00033163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25842659|NCT00033163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25842661|NCT00033176|Antioxidants|antioxidants|mesh-ancestor
25842662|NCT00033176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842663|NCT00033176|Protective Agents|protective agents|mesh-ancestor
25842664|NCT00033176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842665|NCT00033176|Vitamin B Complex|vitamin b complex|mesh-ancestor
25842666|NCT00033176|Vitamins|vitamins|mesh-ancestor
25842667|NCT00033176|Micronutrients|micronutrients|mesh-ancestor
25842668|NCT00033189|Ubiquinone|ubiquinone|mesh-list
24403095|NCT00159224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24403096|NCT00159224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24403097|NCT00159224|Antiviral Agents|antiviral agents|mesh-ancestor
24403098|NCT00159224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25842669|NCT00033189|Coenzyme Q10|coenzyme q10|mesh-list
24403109|NCT00159302|Antioxidants|antioxidants|mesh-ancestor
24403110|NCT00159302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403111|NCT00159302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24403112|NCT00159302|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24403113|NCT00159302|Vasodilator Agents|vasodilator agents|mesh-ancestor
24403114|NCT00159302|Gasotransmitters|gasotransmitters|mesh-ancestor
24623187|NCT01070615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676239|NCT01349205|Analgesics|analgesics|mesh-ancestor
24403115|NCT00159302|Protective Agents|protective agents|mesh-ancestor
24403116|NCT00159380|Pimagedine|pimagedine|mesh-list
24403117|NCT00159380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403118|NCT00159380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403119|NCT00159445|Gemcitabine|gemcitabine|mesh-list
24403120|NCT00159445|Capecitabine|capecitabine|mesh-list
25842670|NCT00033189|Micronutrients|micronutrients|mesh-ancestor
25842671|NCT00033189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165354|NCT04871607|Etoposide|etoposide|mesh-list
25165355|NCT04871607|Podophyllotoxin|podophyllotoxin|mesh-list
25165356|NCT04871607|Etoposide phosphate|etoposide phosphate|mesh-list
25165357|NCT04871607|Carmustine|carmustine|mesh-list
25165358|NCT04871607|Basiliximab|basiliximab|mesh-list
25165359|NCT04871607|Lenograstim|lenograstim|mesh-list
25165360|NCT04871607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25165361|NCT04871607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25165362|NCT04871607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25165363|NCT04871607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25165364|NCT04871607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403153|NCT00159471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24403154|NCT00159471|Immunologic Factors|immunologic factors|mesh-ancestor
24403155|NCT00159471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403156|NCT00159471|Tubulin Modulators|tubulin modulators|mesh-ancestor
24403157|NCT00159471|Antimitotic Agents|antimitotic agents|mesh-ancestor
24403158|NCT00159471|Mitosis Modulators|mitosis modulators|mesh-ancestor
24403159|NCT00159484|Celecoxib|celecoxib|mesh-list
24403160|NCT00159484|Epothilone B|epothilone b|mesh-list
24403161|NCT00159484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24403162|NCT00159484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24403164|NCT00159484|Sensory System Agents|sensory system agents|mesh-ancestor
25842672|NCT00033189|Vitamins|vitamins|mesh-ancestor
25842673|NCT00033215|S 3304|s 3304|mesh-list
25842674|NCT00033215|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
25661167|NCT01631149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25661168|NCT01631149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661169|NCT01631149|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25842675|NCT00033215|Protease Inhibitors|protease inhibitors|mesh-ancestor
25842676|NCT00033215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842677|NCT00033215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842678|NCT00033241|Gemcitabine|gemcitabine|mesh-list
24403168|NCT00159484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24403169|NCT00159484|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24403170|NCT00159484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24403171|NCT00159484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403212|NCT00159653|Adrenergic Agents|adrenergic agents|mesh-ancestor
24403213|NCT00159653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24403214|NCT00159653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403215|NCT00159653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403216|NCT00159653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24403217|NCT00159653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24403218|NCT00159653|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24403219|NCT00159653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24403220|NCT00159666|Pregabalin|pregabalin|mesh-list
24403221|NCT00159666|Analgesics|analgesics|mesh-ancestor
24403222|NCT00159666|Sensory System Agents|sensory system agents|mesh-ancestor
24403223|NCT00159666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24403224|NCT00159666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403225|NCT00159666|Anticonvulsants|anticonvulsants|mesh-ancestor
24403226|NCT00159666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24403227|NCT00159666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24403280|NCT00159718|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24403281|NCT00159718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24403282|NCT00159718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24403283|NCT00159718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403284|NCT00159718|Vasodilator Agents|vasodilator agents|mesh-ancestor
24403285|NCT00159731|Pregabalin|pregabalin|mesh-list
24403286|NCT00159731|Analgesics|analgesics|mesh-ancestor
24403287|NCT00159731|Sensory System Agents|sensory system agents|mesh-ancestor
24403288|NCT00159731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24484597|NCT00449410|Ezetimibe|ezetimibe|mesh-list
24403322|NCT00159770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24403323|NCT00159770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24403324|NCT00159770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24403325|NCT00159770|Dopamine Agents|dopamine agents|mesh-ancestor
24403326|NCT00159770|Antiemetics|antiemetics|mesh-ancestor
24403327|NCT00159770|Autonomic Agents|autonomic agents|mesh-ancestor
24403328|NCT00159770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24403329|NCT00159770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24539956|NCT00666055|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24539957|NCT00666055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24539958|NCT00666055|Antimetabolites|antimetabolites|mesh-ancestor
24539959|NCT00666055|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24540002|NCT00666185|Hormone Antagonists|hormone antagonists|mesh-ancestor
24403348|NCT00159835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24403350|NCT00159887|Sildenafil Citrate|sildenafil citrate|mesh-list
24403351|NCT00159887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403352|NCT00159887|Vasodilator Agents|vasodilator agents|mesh-ancestor
24403353|NCT00159887|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24403354|NCT00159887|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24403355|NCT00159887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403356|NCT00159887|Urological Agents|urological agents|mesh-ancestor
24403357|NCT00159900|Sildenafil Citrate|sildenafil citrate|mesh-list
25181775|NCT04793568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403358|NCT00159900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403359|NCT00159900|Vasodilator Agents|vasodilator agents|mesh-ancestor
24403360|NCT00159900|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24403387|NCT00160160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403397|NCT00160238|Vasodilator Agents|vasodilator agents|mesh-ancestor
24403398|NCT00160238|Histamine Agonists|histamine agonists|mesh-ancestor
24403399|NCT00160238|Histamine Agents|histamine agents|mesh-ancestor
24403400|NCT00160238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24403401|NCT00160238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403402|NCT00160238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403403|NCT00160264|Vitamin D|vitamin d|mesh-list
24403404|NCT00160264|Lactulose|lactulose|mesh-list
24403405|NCT00160264|Calcium|calcium|mesh-list
24403406|NCT00160264|Vitamins|vitamins|mesh-ancestor
24403407|NCT00160264|Micronutrients|micronutrients|mesh-ancestor
24403408|NCT00160264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661170|NCT01631149|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25661171|NCT01631149|Cholinergic Agents|cholinergic agents|mesh-ancestor
25661172|NCT01631149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25842679|NCT00033241|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25842680|NCT00033241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25842682|NCT00033241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842683|NCT00033241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842684|NCT00033241|Antiviral Agents|antiviral agents|mesh-ancestor
24838569|NCT02198482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24838570|NCT02198482|Immunologic Factors|immunologic factors|mesh-ancestor
24838571|NCT02198482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838572|NCT02198482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24403409|NCT00160264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24403410|NCT00160264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24403411|NCT00160264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24403412|NCT00160277|Moxonidine|moxonidine|mesh-list
24403413|NCT00160277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24403414|NCT00160290|Lactulose|lactulose|mesh-list
24403415|NCT00160290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24811489|NCT02046915|Antiemetics|antiemetics|mesh-ancestor
24811490|NCT02046915|Autonomic Agents|autonomic agents|mesh-ancestor
25842685|NCT00033241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25842686|NCT00033241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842687|NCT00033241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25842688|NCT00033241|Immunologic Factors|immunologic factors|mesh-ancestor
24403438|NCT00160342|Testosterone undecanoate|testosterone undecanoate|mesh-list
24403439|NCT00160342|Testosterone enanthate|testosterone enanthate|mesh-list
24403440|NCT00160342|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24403441|NCT00160342|Hormones|hormones|mesh-ancestor
24403442|NCT00160342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24403443|NCT00160342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403445|NCT00160342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403449|NCT00160355|Melphalan|melphalan|mesh-list
24403450|NCT00160355|Thiotepa|thiotepa|mesh-list
24403451|NCT00160355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403452|NCT00160355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403453|NCT00160355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24403454|NCT00160355|Immunologic Factors|immunologic factors|mesh-ancestor
24403455|NCT00160355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403456|NCT00160355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24403457|NCT00160355|Alkylating Agents|alkylating agents|mesh-ancestor
24403458|NCT00160355|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24403459|NCT00160394|Adapalene|adapalene|mesh-list
24403460|NCT00160394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24403461|NCT00160394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24403462|NCT00160394|Analgesics|analgesics|mesh-ancestor
24403495|NCT00160550|Levetiracetam|levetiracetam|mesh-list
24403496|NCT00160550|Anticonvulsants|anticonvulsants|mesh-ancestor
24540025|NCT00666354|Methotrexate|methotrexate|mesh-list
25842689|NCT00033241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842690|NCT00033241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25842691|NCT00033254|Thalidomide|thalidomide|mesh-list
25842692|NCT00033254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25842693|NCT00033254|Immunologic Factors|immunologic factors|mesh-ancestor
25842694|NCT00033254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842695|NCT00033254|Leprostatic Agents|leprostatic agents|mesh-ancestor
25842696|NCT00033254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25842697|NCT00033254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25842698|NCT00033254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25181776|NCT04793568|Antiviral Agents|antiviral agents|mesh-ancestor
25842699|NCT00033254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25842700|NCT00033254|Growth Substances|growth substances|mesh-ancestor
25842701|NCT00033254|Growth Inhibitors|growth inhibitors|mesh-ancestor
25842702|NCT00033254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842703|NCT00033267|Sirolimus|sirolimus|mesh-list
25842704|NCT00033267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25842705|NCT00033267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25165367|NCT04871607|Antimetabolites|antimetabolites|mesh-ancestor
25165368|NCT04871607|Antiviral Agents|antiviral agents|mesh-ancestor
24403587|NCT00161018|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
24811493|NCT02046915|Glucocorticoids|glucocorticoids|mesh-ancestor
24811494|NCT02046915|Hormones|hormones|mesh-ancestor
25661173|NCT01631149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661174|NCT01631214|Alendronate|alendronate|mesh-list
25661175|NCT01631214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25661176|NCT01631214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25661177|NCT01631214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661178|NCT01631214|Immunologic Factors|immunologic factors|mesh-ancestor
25661179|NCT01631227|Eprosartan|eprosartan|mesh-list
24839389|NCT02203643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24811495|NCT02046915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24811496|NCT02046915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24811497|NCT02046915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24811498|NCT02046915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24403610|NCT00161070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24403611|NCT00161070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24403612|NCT00161070|Analgesics|analgesics|mesh-ancestor
24403613|NCT00161070|Sensory System Agents|sensory system agents|mesh-ancestor
24403614|NCT00161070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24403615|NCT00161070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403623|NCT00161070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403632|NCT00161096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24403633|NCT00161096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24403634|NCT00161096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403635|NCT00161096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403637|NCT00161122|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24540067|NCT00666484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24540068|NCT00666484|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24540069|NCT00666484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24540070|NCT00666484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24403638|NCT00161122|Immunologic Factors|immunologic factors|mesh-ancestor
24403639|NCT00161122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403641|NCT00161200|Ranitidine|ranitidine|mesh-list
24403642|NCT00161200|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
24403643|NCT00161200|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24403644|NCT00161200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24403669|NCT00161239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24403670|NCT00161239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403671|NCT00161239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24403672|NCT00161239|Abortifacient Agents|abortifacient agents|mesh-ancestor
24403673|NCT00161239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24403674|NCT00161239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24403676|NCT00161239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403677|NCT00161239|Dermatologic Agents|dermatologic agents|mesh-ancestor
24403678|NCT00161239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403679|NCT00161239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24403680|NCT00161239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24403681|NCT00161239|Immunologic Factors|immunologic factors|mesh-ancestor
24403682|NCT00161239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24403683|NCT00161239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24403685|NCT00161278|Carboplatin|carboplatin|mesh-list
24451585|NCT00324324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24451586|NCT00324363|Exenatide|exenatide|mesh-list
24451622|NCT00324467|Mesna|mesna|mesh-list
25842706|NCT00033267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25098162|NCT03199170|Analgesics|analgesics|mesh-ancestor
25842707|NCT00033267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25165369|NCT04871607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25842708|NCT00033267|Antifungal Agents|antifungal agents|mesh-ancestor
24403746|NCT00161421|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24403747|NCT00161421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24403748|NCT00161421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842709|NCT00033267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25842710|NCT00033267|Immunologic Factors|immunologic factors|mesh-ancestor
25842711|NCT00033267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842712|NCT00033280|Temozolomide|temozolomide|mesh-list
25842713|NCT00033280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25842714|NCT00033280|Alkylating Agents|alkylating agents|mesh-ancestor
25842715|NCT00033280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842716|NCT00033280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842717|NCT00033306|Irinotecan|irinotecan|mesh-list
25842718|NCT00033306|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25842719|NCT00033306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25842720|NCT00033306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403749|NCT00161421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403758|NCT00161447|Androgens|androgens|mesh-ancestor
24403759|NCT00161447|Hormones|hormones|mesh-ancestor
24403760|NCT00161447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25661180|NCT01631227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25661181|NCT01631227|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
25661182|NCT01631227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24403761|NCT00161447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403781|NCT00161486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24403782|NCT00161486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403783|NCT00161486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24403784|NCT00161486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403786|NCT00161486|Hormone Antagonists|hormone antagonists|mesh-ancestor
24403787|NCT00161564|Rituximab|rituximab|mesh-list
24403788|NCT00161564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24403804|NCT00161577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403806|NCT00161590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24403807|NCT00161590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403808|NCT00161655|Etanercept|etanercept|mesh-list
24403809|NCT00161655|Methotrexate|methotrexate|mesh-list
24403810|NCT00161655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24403811|NCT00161655|Abortifacient Agents|abortifacient agents|mesh-ancestor
24403812|NCT00161655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24403813|NCT00161655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403814|NCT00161655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24403815|NCT00161655|Antimetabolites|antimetabolites|mesh-ancestor
24403882|NCT00161980|Coagulants|coagulants|mesh-ancestor
24403883|NCT00161993|Immunoglobulins|immunoglobulins|mesh-list
24403884|NCT00161993|Antibodies|antibodies|mesh-list
24403885|NCT00161993|gamma-Globulins|gamma-globulins|mesh-list
24403886|NCT00161993|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24403887|NCT00161993|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24403888|NCT00161993|Immunologic Factors|immunologic factors|mesh-ancestor
24403889|NCT00161993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403890|NCT00162006|Immunoglobulins|immunoglobulins|mesh-list
24403891|NCT00162006|Antibodies|antibodies|mesh-list
24403892|NCT00162006|gamma-Globulins|gamma-globulins|mesh-list
25165377|NCT04871607|Dermatologic Agents|dermatologic agents|mesh-ancestor
25165378|NCT04871607|Tubulin Modulators|tubulin modulators|mesh-ancestor
25165379|NCT04871607|Antimitotic Agents|antimitotic agents|mesh-ancestor
25165380|NCT04871607|Mitosis Modulators|mitosis modulators|mesh-ancestor
25165381|NCT04865731|Esomeprazole|esomeprazole|mesh-list
25165382|NCT04865731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25165383|NCT04865731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25165384|NCT04865731|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25165385|NCT04865731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25165386|NCT04865731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25165387|NCT04864431|Vitamin D|vitamin d|mesh-list
25165388|NCT04864431|Cholecalciferol|cholecalciferol|mesh-list
25165389|NCT04864431|Vitamins|vitamins|mesh-ancestor
25165390|NCT04864431|Micronutrients|micronutrients|mesh-ancestor
25165391|NCT04864431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165392|NCT04864431|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25165393|NCT04864431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25165394|NCT04863638|Vaccines|vaccines|mesh-list
25165395|NCT04863638|Immunologic Factors|immunologic factors|mesh-ancestor
25165396|NCT04863638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165397|NCT04856904|Trifarotene|trifarotene|mesh-list
25165398|NCT04856904|Dermatologic Agents|dermatologic agents|mesh-ancestor
25165402|NCT04833959|Panitumumab|panitumumab|mesh-list
25165403|NCT04833959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25165404|NCT04833959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25165410|NCT04798287|Adalimumab|adalimumab|mesh-list
25165411|NCT04798287|Etanercept|etanercept|mesh-list
25165412|NCT04798287|Golimumab|golimumab|mesh-list
25165413|NCT04798287|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
25165414|NCT04798287|Infliximab|infliximab|mesh-list
25165415|NCT04798287|Certolizumab Pegol|certolizumab pegol|mesh-list
25165416|NCT04798287|Tofacitinib|tofacitinib|mesh-list
25165417|NCT04798287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25165418|NCT04798287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25165419|NCT04798287|Dermatologic Agents|dermatologic agents|mesh-ancestor
25165420|NCT04798287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25165421|NCT04798287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25165422|NCT04798287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25165423|NCT04798287|Analgesics|analgesics|mesh-ancestor
25165424|NCT04798287|Sensory System Agents|sensory system agents|mesh-ancestor
25165426|NCT04798287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165427|NCT04798287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25165428|NCT04798287|Immunologic Factors|immunologic factors|mesh-ancestor
25165429|NCT04798287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25165430|NCT04798287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409027|NCT03404180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25842721|NCT00033306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661183|NCT01631227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661184|NCT01631630|Pioglitazone|pioglitazone|mesh-list
25661185|NCT01631630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24841005|NCT02213627|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25842722|NCT00033306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25165431|NCT04798287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25165437|NCT04792424|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25165438|NCT04792424|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25165439|NCT04792424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25165440|NCT04790786|Bamlanivimab|bamlanivimab|mesh-list
25165441|NCT04790786|Antiviral Agents|antiviral agents|mesh-ancestor
25165442|NCT04790786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24403897|NCT00162019|Factor VIII|factor viii|mesh-list
24403898|NCT00162019|Coagulants|coagulants|mesh-ancestor
24403899|NCT00162045|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
24403901|NCT00162045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403903|NCT00162110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24403904|NCT00162110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403905|NCT00162149|Ritonavir|ritonavir|mesh-list
24403906|NCT00162149|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24403943|NCT00162201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24403946|NCT00162214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403947|NCT00162214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24403948|NCT00162214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403949|NCT00162214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403950|NCT00162214|Antifungal Agents|antifungal agents|mesh-ancestor
24403951|NCT00162214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24403952|NCT00162214|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24403953|NCT00162214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24403954|NCT00162214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24403955|NCT00162214|Hormone Antagonists|hormone antagonists|mesh-ancestor
24811510|NCT02047019|Candesartan cilexetil|candesartan cilexetil|mesh-list
24811511|NCT02047019|Nifedipine|nifedipine|mesh-list
24811512|NCT02047019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24811513|NCT02047019|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24811514|NCT02047019|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24859028|NCT02301208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403961|NCT00162227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24403962|NCT00162227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842723|NCT00033319|Aspirin|aspirin|mesh-list
25842724|NCT00033319|Folic Acid|folic acid|mesh-list
25842725|NCT00033319|Hematinics|hematinics|mesh-ancestor
25842726|NCT00033319|Vitamin B Complex|vitamin b complex|mesh-ancestor
25842727|NCT00033319|Vitamins|vitamins|mesh-ancestor
25842728|NCT00033319|Micronutrients|micronutrients|mesh-ancestor
25842729|NCT00033319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842730|NCT00033319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25842731|NCT00033319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25842732|NCT00033319|Analgesics|analgesics|mesh-ancestor
24403963|NCT00162227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403965|NCT00162227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24403966|NCT00162227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25842733|NCT00033319|Sensory System Agents|sensory system agents|mesh-ancestor
25842734|NCT00033319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25842735|NCT00033319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25842736|NCT00033319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25842737|NCT00033319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25842738|NCT00033319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25842739|NCT00033319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842740|NCT00033319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25842741|NCT00033319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25842742|NCT00033319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842743|NCT00033319|Antipyretics|antipyretics|mesh-ancestor
25842744|NCT00033332|Zoledronic Acid|zoledronic acid|mesh-list
25842745|NCT00033332|Pamidronate|pamidronate|mesh-list
25842746|NCT00033332|Thalidomide|thalidomide|mesh-list
25842747|NCT00033332|Dexamethasone|dexamethasone|mesh-list
25842748|NCT00033332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25842749|NCT00033332|Antiemetics|antiemetics|mesh-ancestor
25661186|NCT01631630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661187|NCT01631656|Azelaic acid|azelaic acid|mesh-list
25661188|NCT01631656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25661189|NCT01631656|Dermatologic Agents|dermatologic agents|mesh-ancestor
24841400|NCT02215733|Telmisartan|telmisartan|mesh-list
24404049|NCT00162422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24404050|NCT00162422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24404051|NCT00162422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24404052|NCT00162422|Adrenergic Agents|adrenergic agents|mesh-ancestor
24404053|NCT00162422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24404054|NCT00162422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811518|NCT02047019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24811519|NCT02047019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811520|NCT02047019|Vasodilator Agents|vasodilator agents|mesh-ancestor
24811521|NCT02047019|Tocolytic Agents|tocolytic agents|mesh-ancestor
24811522|NCT02047019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24811524|NCT02047136|Histamine Agonists|histamine agonists|mesh-ancestor
24811525|NCT02047136|Histamine Agents|histamine agents|mesh-ancestor
24676667|NCT01351948|Antacids|antacids|mesh-ancestor
24404062|NCT00162461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404063|NCT00162461|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24404064|NCT00162461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24404065|NCT00162474|Phenytoin|phenytoin|mesh-list
24404066|NCT00162474|Warfarin|warfarin|mesh-list
24404067|NCT00162474|Anticoagulants|anticoagulants|mesh-ancestor
24404068|NCT00162474|Anticonvulsants|anticonvulsants|mesh-ancestor
24404069|NCT00162474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24404070|NCT00162474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24404071|NCT00162474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25098719|NCT03195569|Carboplatin|carboplatin|mesh-list
24404072|NCT00162474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404073|NCT00162474|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24404074|NCT00162474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25842750|NCT00033332|Autonomic Agents|autonomic agents|mesh-ancestor
25842751|NCT00033332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25842752|NCT00033332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404089|NCT00162487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404092|NCT00162526|Tocotrienols|tocotrienols|mesh-list
24404093|NCT00162526|alpha-Tocopherol|alpha-tocopherol|mesh-list
24404094|NCT00162526|Antioxidants|antioxidants|mesh-ancestor
24404095|NCT00162526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404096|NCT00162526|Protective Agents|protective agents|mesh-ancestor
25842753|NCT00033332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25842754|NCT00033332|Glucocorticoids|glucocorticoids|mesh-ancestor
25842755|NCT00033332|Hormones|hormones|mesh-ancestor
25842756|NCT00033332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25842757|NCT00033332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25842758|NCT00033332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842759|NCT00033332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25842760|NCT00033332|Immunologic Factors|immunologic factors|mesh-ancestor
25842761|NCT00033332|Leprostatic Agents|leprostatic agents|mesh-ancestor
25842762|NCT00033332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25842763|NCT00033332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25842764|NCT00033332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25842765|NCT00033332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25842766|NCT00033332|Growth Substances|growth substances|mesh-ancestor
25842767|NCT00033332|Growth Inhibitors|growth inhibitors|mesh-ancestor
25842768|NCT00033332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25842769|NCT00033345|Indole-3-carbinol|indole-3-carbinol|mesh-list
25842770|NCT00033345|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25842771|NCT00033345|Protective Agents|protective agents|mesh-ancestor
25098849|NCT03195309|Fentanyl|fentanyl|mesh-list
25842772|NCT00033345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842773|NCT00033345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842774|NCT00033358|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24404103|NCT00162552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404104|NCT00162552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24404105|NCT00162552|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24404106|NCT00162552|Protective Agents|protective agents|mesh-ancestor
24404107|NCT00162552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404108|NCT00162552|Vasodilator Agents|vasodilator agents|mesh-ancestor
24404109|NCT00162552|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24404110|NCT00162552|Antioxidants|antioxidants|mesh-ancestor
24404111|NCT00162565|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24404112|NCT00162565|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24404113|NCT00162565|Adrenergic Agents|adrenergic agents|mesh-ancestor
24404114|NCT00162565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25661190|NCT01631682|Propranolol|propranolol|mesh-list
24811528|NCT02047136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811530|NCT02047149|Dasatinib|dasatinib|mesh-list
24811531|NCT02047149|Hydroxyurea|hydroxyurea|mesh-list
24811532|NCT02047149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24811533|NCT02047149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24436919|NCT00272064|Insulin glulisine|insulin glulisine|mesh-list
24404173|NCT00162682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24404175|NCT00162695|Vincristine|vincristine|mesh-list
24811535|NCT02047149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811536|NCT02047149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24811537|NCT02047149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24811538|NCT02047149|Analgesics|analgesics|mesh-ancestor
24811539|NCT02047149|Sensory System Agents|sensory system agents|mesh-ancestor
24404217|NCT00162760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24404218|NCT00162760|Growth Substances|growth substances|mesh-ancestor
24404219|NCT00162760|Growth Inhibitors|growth inhibitors|mesh-ancestor
24404220|NCT00162760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24404221|NCT00162786|Hydroxyzine|hydroxyzine|mesh-list
24404222|NCT00162786|Antipruritics|antipruritics|mesh-ancestor
24404223|NCT00162786|Dermatologic Agents|dermatologic agents|mesh-ancestor
24404224|NCT00162786|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24540283|NCT00667160|Pimecrolimus|pimecrolimus|mesh-list
24404229|NCT00162786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404230|NCT00162799|Triflusal|triflusal|mesh-list
24404231|NCT00162799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25842775|NCT00033358|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24404232|NCT00162812|Epirubicin|epirubicin|mesh-list
24404233|NCT00162812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24404234|NCT00162812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24404235|NCT00162812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24404236|NCT00162812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24404237|NCT00162812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404238|NCT00162812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404239|NCT00162851|Alemtuzumab|alemtuzumab|mesh-list
25098983|NCT03194204|Antimalarials|antimalarials|mesh-ancestor
25098984|NCT03194204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24404244|NCT00162864|Respiratory System Agents|respiratory system agents|mesh-ancestor
24404286|NCT00163046|Gabapentin|gabapentin|mesh-list
24404287|NCT00163046|Analgesics|analgesics|mesh-ancestor
24404288|NCT00163046|Sensory System Agents|sensory system agents|mesh-ancestor
24404289|NCT00163046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24404290|NCT00163046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404291|NCT00163046|Anticonvulsants|anticonvulsants|mesh-ancestor
24404292|NCT00163046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24404293|NCT00163046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24404294|NCT00163046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24404295|NCT00163046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24404296|NCT00163046|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24404297|NCT00163046|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24404298|NCT00163046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24811540|NCT02047149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24811541|NCT02047149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811542|NCT02047149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25842776|NCT00033358|Medroxyprogesterone|medroxyprogesterone|mesh-list
24404300|NCT00163046|Antimanic Agents|antimanic agents|mesh-ancestor
24404301|NCT00163072|Megestrol Acetate|megestrol acetate|mesh-list
24404302|NCT00163072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24404303|NCT00163072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24404304|NCT00163072|Appetite Stimulants|appetite stimulants|mesh-ancestor
24404313|NCT00163111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24404317|NCT00163111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24404318|NCT00163111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842777|NCT00033358|Norgestrel|norgestrel|mesh-list
24404453|NCT00163488|Ciclesonide|ciclesonide|mesh-list
24404454|NCT00163488|Glucocorticoids|glucocorticoids|mesh-ancestor
25418182|NCT02797470|Antimetabolites|antimetabolites|mesh-ancestor
25842778|NCT00033358|Estradiol|estradiol|mesh-list
25842779|NCT00033358|Estrogens|estrogens|mesh-ancestor
25842780|NCT00033358|Hormones|hormones|mesh-ancestor
25842781|NCT00033358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25842782|NCT00033358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842783|NCT00033358|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25842785|NCT00033358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25842786|NCT00033358|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25842787|NCT00033358|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25842788|NCT00033358|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25842789|NCT00033358|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25661191|NCT01631682|Oxytocin|oxytocin|mesh-list
25661192|NCT01631682|Mifepristone|mifepristone|mesh-list
25661193|NCT01631682|Oxytocics|oxytocics|mesh-ancestor
25661194|NCT01631682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25842790|NCT00033358|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25842791|NCT00033358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25842792|NCT00033358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842793|NCT00033410|Paclitaxel|paclitaxel|mesh-list
24404620|NCT00164242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404621|NCT00164242|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24404622|NCT00164242|Autonomic Agents|autonomic agents|mesh-ancestor
24404623|NCT00164242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24404624|NCT00164242|Nootropic Agents|nootropic agents|mesh-ancestor
24404626|NCT00164255|Pyrimethamine|pyrimethamine|mesh-list
25842794|NCT00033410|Carboplatin|carboplatin|mesh-list
25842795|NCT00033410|Tirapazamine|tirapazamine|mesh-list
25842796|NCT00033410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25842797|NCT00033410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842798|NCT00033410|Tubulin Modulators|tubulin modulators|mesh-ancestor
25842799|NCT00033410|Antimitotic Agents|antimitotic agents|mesh-ancestor
25842800|NCT00033410|Mitosis Modulators|mitosis modulators|mesh-ancestor
25842801|NCT00033410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842802|NCT00033423|Rituximab|rituximab|mesh-list
25165466|NCT04785924|Imipenem|imipenem|mesh-list
25165467|NCT04785924|Relebactam|relebactam|mesh-list
25165468|NCT04785924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25165469|NCT04785924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25099182|NCT03193281|Dasatinib|dasatinib|mesh-list
25165470|NCT04785924|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25165471|NCT04785924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25165472|NCT04785924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203347|NCT02714725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25203348|NCT02714725|Anesthetics, General|anesthetics, general|mesh-ancestor
25203349|NCT02714725|Anesthetics|anesthetics|mesh-ancestor
25203350|NCT02714725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25203351|NCT02714725|Analgesics|analgesics|mesh-ancestor
25203352|NCT02714725|Sensory System Agents|sensory system agents|mesh-ancestor
25203353|NCT02714725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25203354|NCT02714725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25203355|NCT02714725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25203356|NCT02714725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25203357|NCT02714725|Adrenergic Agents|adrenergic agents|mesh-ancestor
25203358|NCT02714725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25203359|NCT02714725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203360|NCT02714842|Diclofenac|diclofenac|mesh-list
25203361|NCT02714842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25203362|NCT02714842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25203363|NCT02714842|Analgesics|analgesics|mesh-ancestor
25203364|NCT02714842|Sensory System Agents|sensory system agents|mesh-ancestor
25203365|NCT02714842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25203366|NCT02714842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203367|NCT02714842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25203368|NCT02714842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25203369|NCT02714842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25203370|NCT02714842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203371|NCT02714842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203372|NCT02714712|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25203373|NCT02714712|Antiviral Agents|antiviral agents|mesh-ancestor
25203374|NCT02714712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25203375|NCT02714699|Diclofenac|diclofenac|mesh-list
25203376|NCT02714699|Scopolamine|scopolamine|mesh-list
25203377|NCT02714699|Bromides|bromides|mesh-list
25203378|NCT02714699|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25661195|NCT01631682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661196|NCT01631682|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25661197|NCT01631682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25661198|NCT01631682|Adrenergic Agents|adrenergic agents|mesh-ancestor
25661199|NCT01631682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25661200|NCT01631682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203379|NCT02714699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25203380|NCT02714699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25203382|NCT02714699|Sensory System Agents|sensory system agents|mesh-ancestor
25203383|NCT02714699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25203384|NCT02714699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203385|NCT02714699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25203386|NCT02714699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25842803|NCT00033423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25842804|NCT00033423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842805|NCT00033423|Immunologic Factors|immunologic factors|mesh-ancestor
24404628|NCT00164255|Antimalarials|antimalarials|mesh-ancestor
24404629|NCT00164255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24404630|NCT00164255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24404631|NCT00164255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24404632|NCT00164255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24404633|NCT00164255|Antiviral Agents|antiviral agents|mesh-ancestor
24404634|NCT00164255|Schistosomicides|schistosomicides|mesh-ancestor
24404635|NCT00164255|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24404636|NCT00164255|Anthelmintics|anthelmintics|mesh-ancestor
24404637|NCT00164255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24404638|NCT00164255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404639|NCT00164255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404640|NCT00164255|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24404641|NCT00164255|Renal Agents|renal agents|mesh-ancestor
24404642|NCT00164281|Isoniazid|isoniazid|mesh-list
24404643|NCT00164281|Antitubercular Agents|antitubercular agents|mesh-ancestor
24404644|NCT00164281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24404645|NCT00164281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25842806|NCT00033423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842807|NCT00033423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25099409|NCT03191903|Hormones|hormones|mesh-ancestor
24811592|NCT02047292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811593|NCT02047292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811594|NCT02047292|Cholinergic Agents|cholinergic agents|mesh-ancestor
24404662|NCT00164359|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24404663|NCT00164359|Anthelmintics|anthelmintics|mesh-ancestor
24404664|NCT00164359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24404665|NCT00164359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404666|NCT00164359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404667|NCT00164359|Leprostatic Agents|leprostatic agents|mesh-ancestor
25842808|NCT00033436|Niacinamide|niacinamide|mesh-list
24404674|NCT00164424|Antiviral Agents|antiviral agents|mesh-ancestor
24404675|NCT00164424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24404676|NCT00164450|Isoniazid|isoniazid|mesh-list
24404678|NCT00164450|Antitubercular Agents|antitubercular agents|mesh-ancestor
24404690|NCT00164463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24404691|NCT00164463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24404692|NCT00164463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24404693|NCT00164463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25842809|NCT00033436|Niacin|niacin|mesh-list
25842810|NCT00033436|Nicotinic Acids|nicotinic acids|mesh-list
25842811|NCT00033436|Vitamin B Complex|vitamin b complex|mesh-ancestor
24404694|NCT00164463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404695|NCT00164463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404696|NCT00164463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24404697|NCT00164463|Antitubercular Agents|antitubercular agents|mesh-ancestor
24404698|NCT00164463|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24404699|NCT00164463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24404700|NCT00164463|Antimetabolites|antimetabolites|mesh-ancestor
25661201|NCT01631682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25661202|NCT01631682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25661203|NCT01631682|Vasodilator Agents|vasodilator agents|mesh-ancestor
24404701|NCT00164463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25661204|NCT01631682|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25661205|NCT01631682|Abortifacient Agents|abortifacient agents|mesh-ancestor
24843792|NCT02229617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24843793|NCT02229617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24404702|NCT00164710|Artesunate|artesunate|mesh-list
24404703|NCT00164710|Lumefantrine|lumefantrine|mesh-list
24404704|NCT00164710|Artemether|artemether|mesh-list
24404705|NCT00164710|Pyrimethamine|pyrimethamine|mesh-list
24404706|NCT00164710|Sulfadoxine|sulfadoxine|mesh-list
24404707|NCT00164710|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24811599|NCT02047292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24811600|NCT02047292|Nootropic Agents|nootropic agents|mesh-ancestor
24811602|NCT02047422|Furosemide|furosemide|mesh-list
24677307|NCT01355614|Infliximab|infliximab|mesh-list
24404742|NCT00164736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24404743|NCT00164736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24404744|NCT00164736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24404745|NCT00164736|Antimetabolites|antimetabolites|mesh-ancestor
25842812|NCT00033436|Vitamins|vitamins|mesh-ancestor
24404775|NCT00164788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404776|NCT00164788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404835|NCT00165035|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24404836|NCT00165035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24404837|NCT00165035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24404838|NCT00165035|Tubulin Modulators|tubulin modulators|mesh-ancestor
24404839|NCT00165035|Antimitotic Agents|antimitotic agents|mesh-ancestor
24404840|NCT00165035|Mitosis Modulators|mitosis modulators|mesh-ancestor
24404932|NCT00165178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25842813|NCT00033436|Micronutrients|micronutrients|mesh-ancestor
25842814|NCT00033436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404933|NCT00165178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25842815|NCT00033436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24404985|NCT00165217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24404986|NCT00165217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24404987|NCT00165217|Growth Substances|growth substances|mesh-ancestor
24404988|NCT00165217|Growth Inhibitors|growth inhibitors|mesh-ancestor
24404989|NCT00165230|Thalidomide|thalidomide|mesh-list
24404990|NCT00165230|Temozolomide|temozolomide|mesh-list
24404991|NCT00165230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24540446|NCT00668018|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24540447|NCT00668018|Vasodilator Agents|vasodilator agents|mesh-ancestor
24540448|NCT00668018|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24540453|NCT00668031|Aprotinin|aprotinin|mesh-list
25842816|NCT00033436|Antimetabolites|antimetabolites|mesh-ancestor
25842817|NCT00033436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842818|NCT00033436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25842819|NCT00033436|Vasodilator Agents|vasodilator agents|mesh-ancestor
24405056|NCT00165399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25842820|NCT00033449|Cisplatin|cisplatin|mesh-list
25842821|NCT00033449|Gefitinib|gefitinib|mesh-list
25842822|NCT00033449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842823|NCT00033449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25842824|NCT00033449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875713|NCT04216290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24540588|NCT00668603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540589|NCT00668603|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24540590|NCT00668603|Contraceptive Agents|contraceptive agents|mesh-ancestor
24405280|NCT00166413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811629|NCT02047474|Immunologic Factors|immunologic factors|mesh-ancestor
24540593|NCT00668616|Paclitaxel|paclitaxel|mesh-list
24540594|NCT00668616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24540595|NCT00668616|Cyclophosphamide|cyclophosphamide|mesh-list
24811647|NCT02047539|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24811648|NCT02047539|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24811649|NCT02047539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829445|NCT02152410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829446|NCT02152410|Analgesics|analgesics|mesh-ancestor
24829447|NCT02152410|Sensory System Agents|sensory system agents|mesh-ancestor
24829448|NCT02152410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24829449|NCT02152423|Enoxaparin|enoxaparin|mesh-list
25661206|NCT01631682|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25661207|NCT01631682|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24829450|NCT02152423|Anticoagulants|anticoagulants|mesh-ancestor
24829451|NCT02152423|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24829452|NCT02152423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24829453|NCT02152423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829454|NCT02152475|Curcumin|curcumin|mesh-list
25661208|NCT01631682|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25661209|NCT01631682|Contraceptive Agents|contraceptive agents|mesh-ancestor
24844612|NCT02233452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25842825|NCT00033449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842826|NCT00033462|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25842827|NCT00033462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842828|NCT00033462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25842829|NCT00033462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448274|NCT00310934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448275|NCT00310934|Analgesics|analgesics|mesh-ancestor
24448276|NCT00310934|Sensory System Agents|sensory system agents|mesh-ancestor
24448277|NCT00310934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24448278|NCT00310934|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24448279|NCT00310934|Antitussive Agents|antitussive agents|mesh-ancestor
24448280|NCT00310934|Respiratory System Agents|respiratory system agents|mesh-ancestor
24811650|NCT02047539|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24405333|NCT00166478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24405335|NCT00166491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24701730|NCT01460602|Rituximab|rituximab|mesh-list
25842830|NCT00033462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842831|NCT00033553|Gemcitabine|gemcitabine|mesh-list
25842832|NCT00033553|Paclitaxel|paclitaxel|mesh-list
25842833|NCT00033553|Carboplatin|carboplatin|mesh-list
25842834|NCT00033553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25842835|NCT00033553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24811683|NCT02047630|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24811684|NCT02047630|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24811685|NCT02047773|Meropenem|meropenem|mesh-list
24811686|NCT02047773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24811687|NCT02047773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24811688|NCT02047799|Calcitriol|calcitriol|mesh-list
24811689|NCT02047799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24405396|NCT00166816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405397|NCT00166816|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24405398|NCT00166816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405399|NCT00166816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405400|NCT00166816|Antifungal Agents|antifungal agents|mesh-ancestor
24405401|NCT00166816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25842836|NCT00033553|Tubulin Modulators|tubulin modulators|mesh-ancestor
24405402|NCT00166816|Dermatologic Agents|dermatologic agents|mesh-ancestor
25165473|NCT04766996|Aspirin|aspirin|mesh-list
25165474|NCT04766996|Acetaminophen|acetaminophen|mesh-list
25165475|NCT04766996|Prednisone|prednisone|mesh-list
25165476|NCT04766996|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25165477|NCT04766996|Meloxicam|meloxicam|mesh-list
25165478|NCT04766996|Diclofenac|diclofenac|mesh-list
25165479|NCT04766996|Lidocaine|lidocaine|mesh-list
25165480|NCT04766996|Pregabalin|pregabalin|mesh-list
25165481|NCT04766996|Tramadol|tramadol|mesh-list
25165482|NCT04766996|Bupivacaine|bupivacaine|mesh-list
25165483|NCT04766996|Propofol|propofol|mesh-list
25165484|NCT04766996|Omeprazole|omeprazole|mesh-list
25165485|NCT04766996|Tranexamic Acid|tranexamic acid|mesh-list
25165486|NCT04766996|Anesthetics, Local|anesthetics, local|mesh-ancestor
25165487|NCT04766996|Anesthetics|anesthetics|mesh-ancestor
25165488|NCT04766996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25165489|NCT04766996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165490|NCT04766996|Sensory System Agents|sensory system agents|mesh-ancestor
25165491|NCT04766996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25165492|NCT04766996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25165493|NCT04766996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25165494|NCT04766996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25165495|NCT04766996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25165496|NCT04766996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25165497|NCT04766996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25165498|NCT04766996|Glucocorticoids|glucocorticoids|mesh-ancestor
25165499|NCT04766996|Hormones|hormones|mesh-ancestor
24405410|NCT00166829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24540643|NCT00668837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24540644|NCT00668837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540646|NCT00668837|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25661210|NCT01631682|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24540647|NCT00668837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24540648|NCT00668837|Serotonin Agents|serotonin agents|mesh-ancestor
24540649|NCT00668837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24405455|NCT00166881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661211|NCT01631682|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24621374|NCT01062048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24734749|NCT01653470|Vitamin B Complex|vitamin b complex|mesh-ancestor
24621375|NCT01062048|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24405456|NCT00167141|Contraceptive Agents|contraceptive agents|mesh-list
24811696|NCT02047799|Micronutrients|micronutrients|mesh-ancestor
25099777|NCT03187457|Metronidazole|metronidazole|mesh-list
24811700|NCT02047838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24811701|NCT02047838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607154|NCT05162690|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24607155|NCT05162690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607156|NCT05162690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24607157|NCT05162690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607159|NCT05129358|Diuretics|diuretics|mesh-ancestor
24607160|NCT05129358|Natriuretic Agents|natriuretic agents|mesh-ancestor
24607161|NCT05129358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607162|NCT05129358|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24607163|NCT05129358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25842837|NCT00033553|Antimitotic Agents|antimitotic agents|mesh-ancestor
25842838|NCT00033553|Mitosis Modulators|mitosis modulators|mesh-ancestor
25842839|NCT00033553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842840|NCT00033553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25842841|NCT00033553|Antimetabolites|antimetabolites|mesh-ancestor
25842842|NCT00033553|Antiviral Agents|antiviral agents|mesh-ancestor
25842843|NCT00033553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25842844|NCT00033553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540653|NCT00668837|Dopamine Agents|dopamine agents|mesh-ancestor
24540654|NCT00668850|Insulin|insulin|mesh-list
24540655|NCT00668850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24540656|NCT00668850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24540657|NCT00668850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540658|NCT00668941|Vitamin D|vitamin d|mesh-list
24540659|NCT00668941|Cholecalciferol|cholecalciferol|mesh-list
24540660|NCT00668941|Alendronate|alendronate|mesh-list
24607164|NCT05129358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405457|NCT00167141|Contraceptive Agents, Male|contraceptive agents, male|mesh-list
24405458|NCT00167141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24405459|NCT00167141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405461|NCT00167154|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24405463|NCT00167154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24405464|NCT00167154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405476|NCT00167232|Sensory System Agents|sensory system agents|mesh-ancestor
24405477|NCT00167232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24405478|NCT00167297|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24623195|NCT01070628|Dopamine Agents|dopamine agents|mesh-ancestor
24701837|NCT01461616|Insulin|insulin|mesh-list
24405500|NCT00167479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405501|NCT00167479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405503|NCT00167479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24405504|NCT00167479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24405505|NCT00167479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24405510|NCT00167492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405511|NCT00167492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24405512|NCT00167492|Antitubercular Agents|antitubercular agents|mesh-ancestor
24405513|NCT00167492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24405514|NCT00167492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25661212|NCT01631682|Hormone Antagonists|hormone antagonists|mesh-ancestor
25661213|NCT01631682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25661214|NCT01631682|Luteolytic Agents|luteolytic agents|mesh-ancestor
25661215|NCT01631682|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25661216|NCT01631682|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25661217|NCT01631825|Rotigotine|rotigotine|mesh-list
25661218|NCT01631825|Dopamine Agonists|dopamine agonists|mesh-ancestor
25842846|NCT00033553|Immunologic Factors|immunologic factors|mesh-ancestor
25108462|NCT03132025|Capecitabine|capecitabine|mesh-list
25108463|NCT03132025|Apatinib|apatinib|mesh-list
25108464|NCT03132025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24623209|NCT01070641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25099992|NCT03186443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623210|NCT01070641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623211|NCT01070641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623212|NCT01070641|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24623213|NCT01070641|Antioxidants|antioxidants|mesh-ancestor
24405538|NCT00167583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24942646|NCT03979209|Mometasone Furoate|mometasone furoate|mesh-list
24405539|NCT00167583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842847|NCT00033553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842848|NCT00033566|S 3304|s 3304|mesh-list
25842849|NCT00033566|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
25842850|NCT00033566|Protease Inhibitors|protease inhibitors|mesh-ancestor
25842851|NCT00033566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842852|NCT00033566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842853|NCT00033592|Bupropion|bupropion|mesh-list
25842854|NCT00033592|Nicotine|nicotine|mesh-list
24701966|NCT01463163|Ticagrelor|ticagrelor|mesh-list
24811707|NCT02048020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24811708|NCT02048020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24811709|NCT02048020|Tubulin Modulators|tubulin modulators|mesh-ancestor
24811710|NCT02048020|Antimitotic Agents|antimitotic agents|mesh-ancestor
24811711|NCT02048020|Mitosis Modulators|mitosis modulators|mesh-ancestor
24811712|NCT02048020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811715|NCT02048085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24811716|NCT02048085|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24811717|NCT02048085|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24811718|NCT02048085|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24811719|NCT02048085|Purinergic Agents|purinergic agents|mesh-ancestor
24811720|NCT02048085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25100050|NCT03185988|Trastuzumab|trastuzumab|mesh-list
24811721|NCT02048085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811722|NCT02048085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811723|NCT02048098|Misoprostol|misoprostol|mesh-list
24540686|NCT00669149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540687|NCT00669149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24811728|NCT02048098|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24448281|NCT00311038|Landiolol|landiolol|mesh-list
24448282|NCT00311038|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24448283|NCT00311038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25842855|NCT00033592|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25842856|NCT00033592|Autonomic Agents|autonomic agents|mesh-ancestor
25842857|NCT00033592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25842858|NCT00033592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842859|NCT00033592|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25165500|NCT04766996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25165501|NCT04766996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25165502|NCT04766996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25661227|NCT01631864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25661228|NCT01631864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25165504|NCT04766996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25165505|NCT04766996|Anesthetics, General|anesthetics, general|mesh-ancestor
25165506|NCT04766996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25165507|NCT04766996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25165508|NCT04766996|Analgesics|analgesics|mesh-ancestor
25165509|NCT04766996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25165510|NCT04766996|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25165511|NCT04766996|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25165512|NCT04766996|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25165513|NCT04766996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25165514|NCT04766996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25165515|NCT04766996|Antipyretics|antipyretics|mesh-ancestor
25165516|NCT04766996|Anticonvulsants|anticonvulsants|mesh-ancestor
25165517|NCT04766996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25165518|NCT04766996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25165519|NCT04766996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25165520|NCT04766996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25165521|NCT04766996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25165522|NCT04766996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25165523|NCT04766996|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25165524|NCT04766996|Hemostatics|hemostatics|mesh-ancestor
25165526|NCT04766996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25165528|NCT04766996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25165529|NCT04766996|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25165530|NCT04766996|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25165544|NCT04752696|Fluorouracil|fluorouracil|mesh-list
25165545|NCT04752696|Irinotecan|irinotecan|mesh-list
25165546|NCT04752696|Onvansertib|onvansertib|mesh-list
25165547|NCT04752696|Antimetabolites|antimetabolites|mesh-ancestor
25165548|NCT04752696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25165549|NCT04752696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25165550|NCT04752696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25165551|NCT04752696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25165552|NCT04752696|Immunologic Factors|immunologic factors|mesh-ancestor
25165553|NCT04752696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165554|NCT04752696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25165555|NCT04752696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25165556|NCT04752696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25165558|NCT04752696|Protective Agents|protective agents|mesh-ancestor
25165559|NCT04752696|Vitamin B Complex|vitamin b complex|mesh-ancestor
25165560|NCT04752696|Vitamins|vitamins|mesh-ancestor
25165561|NCT04752696|Micronutrients|micronutrients|mesh-ancestor
25165562|NCT04752696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24451637|NCT00324467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24811736|NCT02048215|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24811737|NCT02048215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811738|NCT02048215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24811739|NCT02048215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842860|NCT00033592|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24405575|NCT00167674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24405576|NCT00167687|Prazosin|prazosin|mesh-list
24405577|NCT00167687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24405578|NCT00167687|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24405579|NCT00167687|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24405583|NCT00167687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405584|NCT00167687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405585|NCT00167713|Ibuprofen|ibuprofen|mesh-list
24405586|NCT00167713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24405587|NCT00167713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24405588|NCT00167713|Analgesics|analgesics|mesh-ancestor
24405589|NCT00167713|Sensory System Agents|sensory system agents|mesh-ancestor
24405590|NCT00167713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24811747|NCT02048215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24811748|NCT02048215|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24811749|NCT02048215|Adrenergic Agents|adrenergic agents|mesh-ancestor
24811750|NCT02048228|Clopidogrel|clopidogrel|mesh-list
24811751|NCT02048228|Ticagrelor|ticagrelor|mesh-list
25842861|NCT00033592|Cholinergic Agents|cholinergic agents|mesh-ancestor
25842862|NCT00033592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25842863|NCT00033592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875714|NCT04216290|Alkylating Agents|alkylating agents|mesh-ancestor
24845910|NCT02239952|Growth Substances|growth substances|mesh-ancestor
24811752|NCT02048228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24811753|NCT02048228|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24811754|NCT02048228|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24405598|NCT00167739|Sulfadoxine|sulfadoxine|mesh-list
24405599|NCT00167739|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24405600|NCT00167739|Quinine|quinine|mesh-list
24405601|NCT00167739|Antimalarials|antimalarials|mesh-ancestor
24405602|NCT00167739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24405603|NCT00167739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24405604|NCT00167739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24405605|NCT00167739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24405606|NCT00167739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405607|NCT00167739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405622|NCT00167791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405623|NCT00167791|Immunologic Factors|immunologic factors|mesh-ancestor
24405624|NCT00167791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405625|NCT00167791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25100513|NCT03182257|ONO-7579|ono-7579|mesh-list
24405627|NCT00167817|Antidepressive Agents|antidepressive agents|mesh-ancestor
24405628|NCT00167817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24405629|NCT00167817|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24405630|NCT00167817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24405631|NCT00167817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24405632|NCT00167817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405633|NCT00167817|Dopamine Agonists|dopamine agonists|mesh-ancestor
24405634|NCT00167817|Dopamine Agents|dopamine agents|mesh-ancestor
24405635|NCT00167817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24405744|NCT00168181|Autonomic Agents|autonomic agents|mesh-ancestor
24405636|NCT00167817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405637|NCT00167817|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24405638|NCT00167817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24405639|NCT00167817|Serotonin Agents|serotonin agents|mesh-ancestor
24405640|NCT00167817|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24405641|NCT00167817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25842864|NCT00033592|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25842865|NCT00033592|Antidepressive Agents|antidepressive agents|mesh-ancestor
25842866|NCT00033592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24540699|NCT00669149|Purinergic Agents|purinergic agents|mesh-ancestor
25842867|NCT00033592|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25842868|NCT00033592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24702069|NCT01463956|Ribavirin|ribavirin|mesh-list
24540719|NCT00669370|Mitosis Modulators|mitosis modulators|mesh-ancestor
24540720|NCT00669370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405658|NCT00167856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24540740|NCT00669435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24540741|NCT00669435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24540742|NCT00669487|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24405665|NCT00167856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24405667|NCT00167882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24405668|NCT00167882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24405669|NCT00167882|Analgesics|analgesics|mesh-ancestor
24405670|NCT00167882|Sensory System Agents|sensory system agents|mesh-ancestor
24405671|NCT00167882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24405672|NCT00167882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405673|NCT00167882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24405674|NCT00167882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24405675|NCT00167908|Amifostine|amifostine|mesh-list
24405676|NCT00167908|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24405677|NCT00167908|Protective Agents|protective agents|mesh-ancestor
24405678|NCT00167908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811765|NCT02048293|Analgesics|analgesics|mesh-ancestor
25661229|NCT01631864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25661230|NCT01631864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661231|NCT01631864|Vasodilator Agents|vasodilator agents|mesh-ancestor
25661232|NCT01631864|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25842869|NCT00033592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25842870|NCT00033592|Dopamine Agents|dopamine agents|mesh-ancestor
24405713|NCT00167999|Tazobactam|tazobactam|mesh-list
25842871|NCT00033592|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25842872|NCT00033592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25100709|NCT03180632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25100732|NCT03180229|Granisetron|granisetron|mesh-list
24405715|NCT00167999|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24405739|NCT00168168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24405740|NCT00168168|Immunologic Factors|immunologic factors|mesh-ancestor
24405741|NCT00168168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405759|NCT00168350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24405760|NCT00168350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24405761|NCT00168363|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24405762|NCT00168363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24405763|NCT00168363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24405764|NCT00168363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24405765|NCT00168363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24405766|NCT00168363|Adrenergic Agents|adrenergic agents|mesh-ancestor
24613392|NCT01018836|Riluzole|riluzole|mesh-list
24811782|NCT02048358|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24811783|NCT02048358|Prednisolone phosphate|prednisolone phosphate|mesh-list
24811784|NCT02048358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24811785|NCT02048358|Antiemetics|antiemetics|mesh-ancestor
24811786|NCT02048358|Autonomic Agents|autonomic agents|mesh-ancestor
24811787|NCT02048358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24405796|NCT00168441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25661233|NCT01632150|Thalidomide|thalidomide|mesh-list
25661234|NCT01632150|Dexamethasone|dexamethasone|mesh-list
25661235|NCT01632150|Dexamethasone acetate|dexamethasone acetate|mesh-list
25842873|NCT00033592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661236|NCT01632150|Cyclophosphamide|cyclophosphamide|mesh-list
25842874|NCT00033605|Octreotide|octreotide|mesh-list
25842875|NCT00033605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25842876|NCT00033605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25842877|NCT00033605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842878|NCT00033618|Epothilones|epothilones|mesh-list
24405848|NCT00168532|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24405849|NCT00168532|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24405850|NCT00168532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24405851|NCT00168532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24405853|NCT00168584|Vitamins|vitamins|mesh-ancestor
24405875|NCT00168649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405876|NCT00168688|Micronutrients|micronutrients|mesh-list
25842884|NCT00033618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842885|NCT00033644|Cisplatin|cisplatin|mesh-list
25842886|NCT00033644|Doxorubicin|doxorubicin|mesh-list
25842887|NCT00033644|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25842888|NCT00033644|Mitomycins|mitomycins|mesh-list
24405878|NCT00168688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405879|NCT00168701|Dimethyl Fumarate|dimethyl fumarate|mesh-list
24405880|NCT00168701|Dermatologic Agents|dermatologic agents|mesh-ancestor
24405881|NCT00168701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24405883|NCT00168701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405884|NCT00168714|Interferons|interferons|mesh-list
24405885|NCT00168714|Interferon-beta|interferon-beta|mesh-list
24405886|NCT00168714|Interferon beta-1a|interferon beta-1a|mesh-list
24405889|NCT00168714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24405890|NCT00168714|Immunologic Factors|immunologic factors|mesh-ancestor
25661237|NCT01632150|Elotuzumab|elotuzumab|mesh-list
25661238|NCT01632150|BB 1101|bb 1101|mesh-list
25661239|NCT01632150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24811811|NCT02048423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25842897|NCT00033644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842898|NCT00033644|Immunologic Factors|immunologic factors|mesh-ancestor
25842899|NCT00033644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811821|NCT02048423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811822|NCT02048475|Desflurane|desflurane|mesh-list
24811823|NCT02048475|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24811824|NCT02048475|Anesthetics, General|anesthetics, general|mesh-ancestor
24811825|NCT02048475|Anesthetics|anesthetics|mesh-ancestor
24811826|NCT02048475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24811827|NCT02048475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811828|NCT02048488|Belizatinib|belizatinib|mesh-list
24811829|NCT02048488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24811830|NCT02048488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811831|NCT02048488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405926|NCT00168779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24405927|NCT00168779|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24405928|NCT00168779|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24405929|NCT00168779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405930|NCT00168779|Diuretics|diuretics|mesh-ancestor
25842900|NCT00033644|Alkylating Agents|alkylating agents|mesh-ancestor
25842901|NCT00033644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25842902|NCT00033644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24405977|NCT00168896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24405978|NCT00168896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24405979|NCT00168909|Alfacalcidol|alfacalcidol|mesh-list
24405980|NCT00168909|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
24405981|NCT00168909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24405982|NCT00168909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405984|NCT00168909|Micronutrients|micronutrients|mesh-ancestor
24405985|NCT00168922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24406067|NCT00169065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406068|NCT00169065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24406069|NCT00169065|Serotonin Agents|serotonin agents|mesh-ancestor
24406070|NCT00169065|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25661240|NCT01632150|Immunologic Factors|immunologic factors|mesh-ancestor
25101343|NCT03175705|Analgesics|analgesics|mesh-ancestor
24811896|NCT02048865|Protease Inhibitors|protease inhibitors|mesh-ancestor
24811897|NCT02048865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811898|NCT02048865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811899|NCT02048865|Anticoagulants|anticoagulants|mesh-ancestor
24406071|NCT00169065|GABA Antagonists|gaba antagonists|mesh-ancestor
24406072|NCT00169065|GABA Agents|gaba agents|mesh-ancestor
24406073|NCT00169078|Chloroquine|chloroquine|mesh-list
24406074|NCT00169078|Amebicides|amebicides|mesh-ancestor
24406075|NCT00169078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24406076|NCT00169078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24406077|NCT00169078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24406078|NCT00169078|Antimalarials|antimalarials|mesh-ancestor
25101420|NCT03175016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25101421|NCT03174938|Flutemetamol|flutemetamol|mesh-list
25101422|NCT03174938|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25101423|NCT03174938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101449|NCT03174561|Silymarin|silymarin|mesh-list
25101450|NCT03174561|Lipotropic Agents|lipotropic agents|mesh-ancestor
25101451|NCT03174561|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25101452|NCT03174561|Antimetabolites|antimetabolites|mesh-ancestor
25101453|NCT03174561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101454|NCT03174561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25101456|NCT03174561|Nootropic Agents|nootropic agents|mesh-ancestor
24406079|NCT00169078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24406080|NCT00169091|Haloperidol|haloperidol|mesh-list
24406081|NCT00169091|Haloperidol decanoate|haloperidol decanoate|mesh-list
24406083|NCT00169091|Antiemetics|antiemetics|mesh-ancestor
24406089|NCT00169091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24406090|NCT00169091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24406091|NCT00169091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24406092|NCT00169091|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24406094|NCT00169091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24406095|NCT00169091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406096|NCT00169091|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24406097|NCT00169091|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25842903|NCT00033683|Tamoxifen|tamoxifen|mesh-list
24406115|NCT00169130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24406116|NCT00169143|Rituximab|rituximab|mesh-list
24406117|NCT00169143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24406118|NCT00169143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406119|NCT00169143|Immunologic Factors|immunologic factors|mesh-ancestor
24406120|NCT00169143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406121|NCT00169143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24406122|NCT00169156|Prednisone|prednisone|mesh-list
24406123|NCT00169156|Cyclophosphamide|cyclophosphamide|mesh-list
24406124|NCT00169156|Rituximab|rituximab|mesh-list
24811901|NCT02048917|Varenicline|varenicline|mesh-list
24811902|NCT02048917|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24811903|NCT02048917|Antidepressive Agents|antidepressive agents|mesh-ancestor
24811904|NCT02048917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24811905|NCT02048917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24811906|NCT02048917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24811907|NCT02048917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24811908|NCT02048917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811909|NCT02048917|Dopamine Agents|dopamine agents|mesh-ancestor
24811910|NCT02048917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24811911|NCT02048917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811912|NCT02048917|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24811913|NCT02048917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24811914|NCT02048917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811915|NCT02048917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24811916|NCT02048917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24811917|NCT02048917|Cholinergic Agents|cholinergic agents|mesh-ancestor
24811918|NCT02048930|Budesonide|budesonide|mesh-list
24811919|NCT02048930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24811920|NCT02048930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24811921|NCT02048930|Autonomic Agents|autonomic agents|mesh-ancestor
25842904|NCT00033683|Cyclophosphamide|cyclophosphamide|mesh-list
24406144|NCT00169156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25842905|NCT00033683|Docetaxel|docetaxel|mesh-list
24859329|NCT02303002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406145|NCT00169156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24552289|NCT03635164|Durvalumab|durvalumab|mesh-list
24552747|NCT00727207|Everolimus|everolimus|mesh-list
24553049|NCT00729222|Rolofylline|rolofylline|mesh-list
24553471|NCT00731302|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24553472|NCT00731302|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24703054|NCT01469507|Hyaluronic Acid|hyaluronic acid|mesh-list
24406194|NCT00169208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25842906|NCT00033683|Fluorouracil|fluorouracil|mesh-list
25842907|NCT00033683|Methotrexate|methotrexate|mesh-list
25842908|NCT00033683|Epirubicin|epirubicin|mesh-list
25842909|NCT00033683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25842910|NCT00033683|Immunologic Factors|immunologic factors|mesh-ancestor
25842911|NCT00033683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842912|NCT00033683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24779105|NCT01873820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406195|NCT00169208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406196|NCT00169208|Analgesics|analgesics|mesh-ancestor
25842913|NCT00033683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25842914|NCT00033683|Alkylating Agents|alkylating agents|mesh-ancestor
25842915|NCT00033683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842916|NCT00033683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842917|NCT00033683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25165641|NCT04731844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25165642|NCT04731844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25165643|NCT04731844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25165644|NCT04731844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25165645|NCT04731844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25165646|NCT04731844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25165648|NCT04725812|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25165649|NCT04725812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25165650|NCT04725812|Immunologic Factors|immunologic factors|mesh-ancestor
25165651|NCT04725812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165652|NCT04713371|Cyclophosphamide|cyclophosphamide|mesh-list
25165653|NCT04713371|Pembrolizumab|pembrolizumab|mesh-list
25165654|NCT04713371|Ipilimumab|ipilimumab|mesh-list
25165655|NCT04713371|Sargramostim|sargramostim|mesh-list
25165656|NCT04713371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25165657|NCT04713371|Immunologic Factors|immunologic factors|mesh-ancestor
25165658|NCT04713371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165659|NCT04713371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25165660|NCT04713371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25101697|NCT03172988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25101699|NCT03172988|Autonomic Agents|autonomic agents|mesh-ancestor
25101700|NCT03172988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101701|NCT03172988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101702|NCT03172988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25165691|NCT04683614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25165692|NCT04683614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25165693|NCT04683614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165694|NCT04683614|Sympathomimetics|sympathomimetics|mesh-ancestor
25165695|NCT04683614|Autonomic Agents|autonomic agents|mesh-ancestor
25165696|NCT04683614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25165697|NCT04683614|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25165698|NCT04676087|Mogamulizumab|mogamulizumab|mesh-list
25165699|NCT04676087|Immunoglobulins|immunoglobulins|mesh-list
25165700|NCT04676087|Immunoglobulin G|immunoglobulin g|mesh-list
25165701|NCT04676087|Immunologic Factors|immunologic factors|mesh-ancestor
24406198|NCT00169208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24406199|NCT00169208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24406200|NCT00169208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24406201|NCT00169208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703122|NCT01469884|Cyclosporine|cyclosporine|mesh-list
24406245|NCT00169520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607404|NCT04665037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24607405|NCT04665037|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24607406|NCT04665037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24554598|NCT00737191|Olanzapine|olanzapine|mesh-list
24554599|NCT00737191|Antiemetics|antiemetics|mesh-ancestor
24554729|NCT00737815|Cathartics|cathartics|mesh-ancestor
24554789|NCT00738192|Sodium Citrate|sodium citrate|mesh-list
24554791|NCT00738192|Narcotics|narcotics|mesh-ancestor
24555011|NCT00739388|Azacitidine|azacitidine|mesh-list
25842918|NCT00033683|Tubulin Modulators|tubulin modulators|mesh-ancestor
25661241|NCT01632150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842919|NCT00033683|Antimitotic Agents|antimitotic agents|mesh-ancestor
24541360|NCT00672399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541361|NCT00672399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842920|NCT00033683|Mitosis Modulators|mitosis modulators|mesh-ancestor
24555081|NCT00739830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24555515|NCT00741884|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24555516|NCT00741884|Cholinergic Agents|cholinergic agents|mesh-ancestor
24555726|NCT00742846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556011|NCT00744640|Antiviral Agents|antiviral agents|mesh-ancestor
24406247|NCT00169533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406384|NCT00169988|Antidepressive Agents|antidepressive agents|mesh-ancestor
25842921|NCT00033683|Antimetabolites|antimetabolites|mesh-ancestor
25842922|NCT00033683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25842923|NCT00033683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25842924|NCT00033683|Abortifacient Agents|abortifacient agents|mesh-ancestor
25842925|NCT00033683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24406248|NCT00169533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24406249|NCT00169533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24406250|NCT00169533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406251|NCT00169546|Fluticasone|fluticasone|mesh-list
24406253|NCT00169546|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24406254|NCT00169546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24703188|NCT01470092|Tibolone|tibolone|mesh-list
24406293|NCT00169572|Serotonin Agents|serotonin agents|mesh-ancestor
24406294|NCT00169572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24406295|NCT00169572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406296|NCT00169572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24406297|NCT00169572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24406299|NCT00169572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24406315|NCT00169611|Methylphenidate|methylphenidate|mesh-list
24406316|NCT00169611|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24406317|NCT00169611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406318|NCT00169611|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24406319|NCT00169611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24406320|NCT00169611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24406321|NCT00169611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406322|NCT00169611|Dopamine Agents|dopamine agents|mesh-ancestor
24406323|NCT00169611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24406326|NCT00169624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25101873|NCT03172052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24406344|NCT00169845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406345|NCT00169845|Protective Agents|protective agents|mesh-ancestor
24541016|NCT00670475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24406346|NCT00169845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406348|NCT00169845|Micronutrients|micronutrients|mesh-ancestor
24406349|NCT00169845|Provitamins|provitamins|mesh-ancestor
24406350|NCT00169923|Rosiglitazone|rosiglitazone|mesh-list
24406351|NCT00169923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24406363|NCT00169949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829484|NCT02152579|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
24829485|NCT02152579|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24829487|NCT02152579|Natriuretic Agents|natriuretic agents|mesh-ancestor
24829488|NCT02152579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829489|NCT02152579|Vasodilator Agents|vasodilator agents|mesh-ancestor
24829490|NCT02152579|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25842926|NCT00033683|Dermatologic Agents|dermatologic agents|mesh-ancestor
25842927|NCT00033683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661242|NCT01632150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25661243|NCT01632150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25661244|NCT01632150|Alkylating Agents|alkylating agents|mesh-ancestor
25661245|NCT01632150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661246|NCT01632150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25661247|NCT01632150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25661248|NCT01632150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25661249|NCT01632150|Antiemetics|antiemetics|mesh-ancestor
25842928|NCT00033683|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25842929|NCT00033683|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25842930|NCT00033683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24827446|NCT02139098|Analgesics|analgesics|mesh-ancestor
24861519|NCT02318225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24861520|NCT02318225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842931|NCT00033683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25201947|NCT02724358|Estrogens|estrogens|mesh-ancestor
24861602|NCT02319018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861604|NCT02319018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861605|NCT02319018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25842932|NCT00033683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24861606|NCT02319018|Immunologic Factors|immunologic factors|mesh-ancestor
25055399|NCT03521167|Acetaminophen|acetaminophen|mesh-list
25842933|NCT00033683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25842934|NCT00033683|Hormone Antagonists|hormone antagonists|mesh-ancestor
25842935|NCT00033683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25842936|NCT00033683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25842937|NCT00033683|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25842938|NCT00033683|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25842939|NCT00033683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25842940|NCT00033696|Paclitaxel|paclitaxel|mesh-list
25842941|NCT00033696|Etoposide|etoposide|mesh-list
25842942|NCT00033696|Carboplatin|carboplatin|mesh-list
25101924|NCT03171727|Heparin|heparin|mesh-list
24829867|NCT02155088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406364|NCT00169949|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24406365|NCT00169949|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24406367|NCT00169949|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24406368|NCT00169949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24406369|NCT00169949|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24406370|NCT00169949|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24406371|NCT00169988|Risperidone|risperidone|mesh-list
24406372|NCT00169988|Sertraline|sertraline|mesh-list
24406381|NCT00169988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24406382|NCT00169988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24406387|NCT00169988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24406388|NCT00170001|Esomeprazole|esomeprazole|mesh-list
24406389|NCT00170001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24406390|NCT00170001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24406391|NCT00170001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24406392|NCT00170001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24406393|NCT00170001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406394|NCT00170053|Sirolimus|sirolimus|mesh-list
24406395|NCT00170053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24406396|NCT00170053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24406397|NCT00170053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24406402|NCT00170053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406403|NCT00170183|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24406404|NCT00170183|Natriuretic Agents|natriuretic agents|mesh-ancestor
24406405|NCT00170183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406406|NCT00170196|Prednisone|prednisone|mesh-list
24406407|NCT00170196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24406408|NCT00170196|Glucocorticoids|glucocorticoids|mesh-ancestor
25165702|NCT04676087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101952|NCT03171740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25165703|NCT04676087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25165704|NCT04675151|Phentolamine|phentolamine|mesh-list
25165705|NCT04675151|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25165706|NCT04675151|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25165707|NCT04675151|Pilocarpine|pilocarpine|mesh-list
25165708|NCT04675151|Miotics|miotics|mesh-ancestor
25165709|NCT04675151|Autonomic Agents|autonomic agents|mesh-ancestor
25165710|NCT04675151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25165711|NCT04675151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165712|NCT04675151|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25165713|NCT04675151|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25165714|NCT04675151|Cholinergic Agents|cholinergic agents|mesh-ancestor
25165715|NCT04675151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25409028|NCT03404180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661250|NCT01632150|Autonomic Agents|autonomic agents|mesh-ancestor
25661251|NCT01632150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25661252|NCT01632150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25661253|NCT01632150|Glucocorticoids|glucocorticoids|mesh-ancestor
25661254|NCT01632150|Hormones|hormones|mesh-ancestor
25661255|NCT01632150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25661256|NCT01632150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25661257|NCT01632150|Protease Inhibitors|protease inhibitors|mesh-ancestor
25661258|NCT01632150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24861746|NCT02319915|Hemostatics|hemostatics|mesh-ancestor
24861776|NCT02320032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24861778|NCT02320045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24861779|NCT02320045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861780|NCT02320045|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24861781|NCT02320045|Incretins|incretins|mesh-ancestor
24861782|NCT02320045|Hormones|hormones|mesh-ancestor
24861783|NCT02320045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24861784|NCT02320084|Nitisinone|nitisinone|mesh-list
24861785|NCT02320084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24861805|NCT02320240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24623727|NCT01073501|Pregabalin|pregabalin|mesh-list
25165716|NCT04675151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25165717|NCT04675151|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25165718|NCT04675151|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25165719|NCT04675151|Adrenergic Agents|adrenergic agents|mesh-ancestor
25165720|NCT04675151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24541069|NCT00670696|Sensory System Agents|sensory system agents|mesh-ancestor
24541070|NCT00670696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24558552|NCT00757835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703377|NCT01471470|Growth Substances|growth substances|mesh-ancestor
24406429|NCT00170209|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24406430|NCT00170209|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24406431|NCT00170209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24406433|NCT00170209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24406434|NCT00170222|Doxycycline|doxycycline|mesh-list
24406435|NCT00170222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24406436|NCT00170222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24406437|NCT00170222|Antimalarials|antimalarials|mesh-ancestor
24406438|NCT00170222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24406439|NCT00170222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24406441|NCT00170378|Anticoagulants|anticoagulants|mesh-ancestor
24406442|NCT00170378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24406473|NCT00170456|Immunologic Factors|immunologic factors|mesh-ancestor
24406474|NCT00170456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406475|NCT00170456|Antacids|antacids|mesh-ancestor
24406476|NCT00170456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406477|NCT00170456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24406478|NCT00170469|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24406479|NCT00170469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24406480|NCT00170469|Immunologic Factors|immunologic factors|mesh-ancestor
24406481|NCT00170469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406482|NCT00170469|Antacids|antacids|mesh-ancestor
24562186|NCT00764907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24562187|NCT00764907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24562188|NCT00764907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562350|NCT00766155|Antimetabolites|antimetabolites|mesh-ancestor
24562638|NCT00767546|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24562639|NCT00767546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24562640|NCT00767546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406486|NCT00170547|Immunologic Factors|immunologic factors|mesh-ancestor
24406487|NCT00170547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406488|NCT00170573|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25842943|NCT00033696|Topotecan|topotecan|mesh-list
25842944|NCT00033696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25842945|NCT00033696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842946|NCT00033696|Tubulin Modulators|tubulin modulators|mesh-ancestor
24406498|NCT00170664|Tubulin Modulators|tubulin modulators|mesh-ancestor
24406499|NCT00170664|Antimitotic Agents|antimitotic agents|mesh-ancestor
24406500|NCT00170664|Mitosis Modulators|mitosis modulators|mesh-ancestor
24406501|NCT00170664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661259|NCT01632150|Leprostatic Agents|leprostatic agents|mesh-ancestor
25661260|NCT01632150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25661261|NCT01632150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25661262|NCT01632150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25661263|NCT01632150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25661264|NCT01632150|Growth Substances|growth substances|mesh-ancestor
25661265|NCT01632150|Growth Inhibitors|growth inhibitors|mesh-ancestor
25661266|NCT01632215|Gabapentin|gabapentin|mesh-list
25661267|NCT01632215|Anticonvulsants|anticonvulsants|mesh-list
25661268|NCT01632215|Analgesics|analgesics|mesh-ancestor
25661269|NCT01632215|Sensory System Agents|sensory system agents|mesh-ancestor
25661270|NCT01632215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25842947|NCT00033696|Antimitotic Agents|antimitotic agents|mesh-ancestor
24406506|NCT00170677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406508|NCT00170690|Treosulfan|treosulfan|mesh-list
24406509|NCT00170690|Busulfan|busulfan|mesh-list
24406510|NCT00170690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24406511|NCT00170690|Alkylating Agents|alkylating agents|mesh-ancestor
24406512|NCT00170690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406513|NCT00170690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406514|NCT00170690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25102173|NCT03169751|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25102176|NCT03169764|Leucovorin|leucovorin|mesh-list
24406515|NCT00170690|Immunologic Factors|immunologic factors|mesh-ancestor
25842948|NCT00033696|Mitosis Modulators|mitosis modulators|mesh-ancestor
25842949|NCT00033696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842950|NCT00033696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25842951|NCT00033696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25842952|NCT00033696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24406546|NCT00170755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24406547|NCT00170755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406548|NCT00170755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564200|NCT00775580|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24564391|NCT00776217|Dermatologic Agents|dermatologic agents|mesh-ancestor
24564466|NCT00776503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564535|NCT00776672|Protease Inhibitors|protease inhibitors|mesh-ancestor
24564713|NCT00777569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24564929|NCT00778193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564930|NCT00778193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24564931|NCT00778193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24564932|NCT00778193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564933|NCT00778193|Antipyretics|antipyretics|mesh-ancestor
24564934|NCT00778193|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24564995|NCT00778401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24859032|NCT02301286|Aspirin|aspirin|mesh-list
24406558|NCT00170768|Cholinergic Agents|cholinergic agents|mesh-ancestor
25842953|NCT00033696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24406559|NCT00170768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25102217|NCT03169738|Oxaliplatin|oxaliplatin|mesh-list
24406560|NCT00170768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406561|NCT00170768|Urological Agents|urological agents|mesh-ancestor
24406562|NCT00170781|Lumiracoxib|lumiracoxib|mesh-list
24406563|NCT00170781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24406564|NCT00170781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24406565|NCT00170781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24406566|NCT00170781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406567|NCT00170781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24541160|NCT00671281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24541161|NCT00671281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541162|NCT00671281|Hemostatics|hemostatics|mesh-ancestor
24541163|NCT00671281|Coagulants|coagulants|mesh-ancestor
24541164|NCT00671320|Diclofenac|diclofenac|mesh-list
24541165|NCT00671320|Valdecoxib|valdecoxib|mesh-list
24541166|NCT00671320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24541167|NCT00671320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24541168|NCT00671320|Analgesics|analgesics|mesh-ancestor
24406593|NCT00170859|Immunologic Factors|immunologic factors|mesh-ancestor
25661271|NCT01632215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409029|NCT03404180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25661272|NCT01632215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25842954|NCT00033709|Thalidomide|thalidomide|mesh-list
25842955|NCT00033709|Temozolomide|temozolomide|mesh-list
25842956|NCT00033709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25842964|NCT00033709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25102403|NCT03169335|Paclitaxel|paclitaxel|mesh-list
24406648|NCT00170963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24406649|NCT00170963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406650|NCT00170963|Vasodilator Agents|vasodilator agents|mesh-ancestor
24406651|NCT00170963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24406652|NCT00170963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24406653|NCT00170976|Amlodipine|amlodipine|mesh-list
24406654|NCT00170976|Valsartan|valsartan|mesh-list
24406662|NCT00170976|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25661273|NCT01632215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25661274|NCT01632215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25661275|NCT01632215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25661276|NCT01632215|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25661277|NCT01632215|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25661278|NCT01632215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25661279|NCT01632215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661280|NCT01632215|Antimanic Agents|antimanic agents|mesh-ancestor
25842965|NCT00033709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24864636|NCT03072628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864637|NCT02955966|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24864638|NCT02955966|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24864639|NCT02955966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544514|NCT00689208|Parasympatholytics|parasympatholytics|mesh-ancestor
25842966|NCT00033709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24866207|NCT03030222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24426968|NCT00236925|Hydrocortisone|hydrocortisone|mesh-list
24866208|NCT03030222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814302|NCT02063802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24406663|NCT00170976|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24406664|NCT00170989|Valsartan|valsartan|mesh-list
24406665|NCT00170989|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24406666|NCT00170989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24406668|NCT00170989|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24406669|NCT00170989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406670|NCT00170989|Diuretics|diuretics|mesh-ancestor
24406671|NCT00170989|Natriuretic Agents|natriuretic agents|mesh-ancestor
24703712|NCT01473303|Vitamins|vitamins|mesh-ancestor
25842967|NCT00033709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25842968|NCT00033709|Growth Substances|growth substances|mesh-ancestor
24406723|NCT00171080|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24572487|NCT00815048|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24572665|NCT00816205|Nifedipine|nifedipine|mesh-list
24573227|NCT00818610|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24573296|NCT00819104|Metoprolol|metoprolol|mesh-list
24573419|NCT00819845|Antioxidants|antioxidants|mesh-ancestor
24679790|NCT01370707|Metformin|metformin|mesh-list
24406728|NCT00171093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24406729|NCT00171093|Antimetabolites|antimetabolites|mesh-ancestor
24406730|NCT00171093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406731|NCT00171093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24406732|NCT00171093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24406733|NCT00171093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24406734|NCT00171093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24406812|NCT00171366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550688|NCT00721747|Alkylating Agents|alkylating agents|mesh-ancestor
24550689|NCT00721747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550690|NCT00721747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550691|NCT00721747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24573729|NCT00821782|Ofloxacin|ofloxacin|mesh-list
24573786|NCT00822081|Timolol|timolol|mesh-list
24574022|NCT00823030|Lidocaine|lidocaine|mesh-list
24550692|NCT00721747|Tubulin Modulators|tubulin modulators|mesh-ancestor
24550693|NCT00721747|Antimitotic Agents|antimitotic agents|mesh-ancestor
24574627|NCT00826566|Caffeine|caffeine|mesh-list
24550695|NCT00721747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24574686|NCT00826852|Carboplatin|carboplatin|mesh-list
24575271|NCT00830466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575272|NCT00830492|Clomiphene|clomiphene|mesh-list
24575273|NCT00830492|Enclomiphene|enclomiphene|mesh-list
24575274|NCT00830492|Zuclomiphene|zuclomiphene|mesh-list
24575275|NCT00830492|Buserelin|buserelin|mesh-list
24575276|NCT00830492|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24671107|NCT01323569|Sensory System Agents|sensory system agents|mesh-ancestor
24406820|NCT00171379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24406821|NCT00171379|Antitubercular Agents|antitubercular agents|mesh-ancestor
24406822|NCT00171379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24406823|NCT00171379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24406824|NCT00171379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24406825|NCT00171379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406846|NCT00171431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406847|NCT00171457|Tegaserod|tegaserod|mesh-list
25661281|NCT01632241|Belimumab|belimumab|mesh-list
25661282|NCT01632241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25661283|NCT01632241|Immunologic Factors|immunologic factors|mesh-ancestor
25661284|NCT01632241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661285|NCT01632306|Leucovorin|leucovorin|mesh-list
25661286|NCT01632306|Gemcitabine|gemcitabine|mesh-list
25661287|NCT01632306|Paclitaxel|paclitaxel|mesh-list
25661288|NCT01632306|Fluorouracil|fluorouracil|mesh-list
25661289|NCT01632306|Oxaliplatin|oxaliplatin|mesh-list
24406848|NCT00171457|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25661290|NCT01632306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25661291|NCT01632306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25661292|NCT01632306|Tubulin Modulators|tubulin modulators|mesh-ancestor
24406849|NCT00171457|Serotonin Agents|serotonin agents|mesh-ancestor
24406850|NCT00171457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24406853|NCT00171470|Tegaserod|tegaserod|mesh-list
24406864|NCT00171483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406865|NCT00171496|Cyclosporine|cyclosporine|mesh-list
24406866|NCT00171496|Tacrolimus|tacrolimus|mesh-list
24406867|NCT00171496|Cyclosporins|cyclosporins|mesh-list
24406868|NCT00171496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24406869|NCT00171496|Immunologic Factors|immunologic factors|mesh-ancestor
24406870|NCT00171496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406871|NCT00171496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24406872|NCT00171496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24406873|NCT00171496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406874|NCT00171496|Antifungal Agents|antifungal agents|mesh-ancestor
24406875|NCT00171496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24406888|NCT00171509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24406889|NCT00171509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24406890|NCT00171522|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24406895|NCT00171522|Serotonin Agents|serotonin agents|mesh-ancestor
24406896|NCT00171522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24406897|NCT00171522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406898|NCT00171522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406908|NCT00171535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24406954|NCT00171626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25842969|NCT00033709|Growth Inhibitors|growth inhibitors|mesh-ancestor
25842970|NCT00033722|Folic Acid|folic acid|mesh-list
25842971|NCT00033722|Lometrexol|lometrexol|mesh-list
25842972|NCT00033722|Hematinics|hematinics|mesh-ancestor
25842973|NCT00033722|Vitamin B Complex|vitamin b complex|mesh-ancestor
25842974|NCT00033722|Vitamins|vitamins|mesh-ancestor
25842975|NCT00033722|Micronutrients|micronutrients|mesh-ancestor
25842976|NCT00033722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25842977|NCT00033722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25842978|NCT00033722|Antimetabolites|antimetabolites|mesh-ancestor
25842979|NCT00033722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25842980|NCT00033722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406955|NCT00171626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24406956|NCT00171626|Analgesics|analgesics|mesh-ancestor
24406957|NCT00171626|Sensory System Agents|sensory system agents|mesh-ancestor
24406958|NCT00171626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24406959|NCT00171626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406960|NCT00171626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24406961|NCT00171626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24406962|NCT00171626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24406963|NCT00171626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24406964|NCT00171626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820007|NCT02098460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24820008|NCT02098460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24820009|NCT02098460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24820010|NCT02098460|Vasodilator Agents|vasodilator agents|mesh-ancestor
24820011|NCT02098460|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24703968|NCT01475760|Chitosan|chitosan|mesh-list
24406976|NCT00171652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24406977|NCT00171652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24406978|NCT00171652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24406979|NCT00171652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406981|NCT00171665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24406982|NCT00171665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24406984|NCT00171665|Sensory System Agents|sensory system agents|mesh-ancestor
24406985|NCT00171665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24406986|NCT00171665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406987|NCT00171665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24406988|NCT00171665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24406989|NCT00171665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24406990|NCT00171665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407011|NCT00171691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24407012|NCT00171691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24407013|NCT00171691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24407014|NCT00171691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407015|NCT00171691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407051|NCT00171756|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24407052|NCT00171756|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24407053|NCT00171756|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25842981|NCT00033722|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24868810|NCT02259517|Dopamine Agents|dopamine agents|mesh-ancestor
24868811|NCT02259517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24868812|NCT02259517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24868813|NCT02259517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24868814|NCT02259517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24868815|NCT02259517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24868816|NCT02259517|Adrenergic Agents|adrenergic agents|mesh-ancestor
24911695|NCT04284839|Apixaban|apixaban|mesh-list
24911696|NCT04284839|Edoxaban|edoxaban|mesh-list
24911697|NCT04284839|Anticoagulants|anticoagulants|mesh-ancestor
24911698|NCT04284839|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24820037|NCT02098499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24820039|NCT02098499|Autonomic Agents|autonomic agents|mesh-ancestor
24820040|NCT02098499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24739942|NCT01685281|Metadoxine|metadoxine|mesh-list
24820041|NCT02098499|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24820042|NCT02098499|Histamine Antagonists|histamine antagonists|mesh-ancestor
24820043|NCT02098499|Histamine Agents|histamine agents|mesh-ancestor
24820044|NCT02098499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24820045|NCT02098499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820046|NCT02098499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24820047|NCT02098499|Antipruritics|antipruritics|mesh-ancestor
24407054|NCT00171756|Adrenergic Agents|adrenergic agents|mesh-ancestor
24407128|NCT00171938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407129|NCT00171964|Zoledronic Acid|zoledronic acid|mesh-list
24407130|NCT00171964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24407131|NCT00171964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407132|NCT00171977|Imatinib Mesylate|imatinib mesylate|mesh-list
24407133|NCT00171977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407134|NCT00171977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24407135|NCT00171977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407136|NCT00171977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407138|NCT00171990|Antiviral Agents|antiviral agents|mesh-ancestor
24407139|NCT00171990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24407140|NCT00171990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24407164|NCT00172107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24407165|NCT00172107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407167|NCT00172172|Parathyroid Hormone|parathyroid hormone|mesh-list
24820053|NCT02098499|Dopamine Agents|dopamine agents|mesh-ancestor
24820054|NCT02098499|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25842982|NCT00033722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25842983|NCT00033735|Fluorouracil|fluorouracil|mesh-list
25842984|NCT00033735|Irofulven|irofulven|mesh-list
24407168|NCT00172172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24407172|NCT00172302|Micronutrients|micronutrients|mesh-ancestor
24407173|NCT00172302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407174|NCT00172302|Antioxidants|antioxidants|mesh-ancestor
24407175|NCT00172302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407176|NCT00172302|Protective Agents|protective agents|mesh-ancestor
24407177|NCT00172354|Hydrocortisone|hydrocortisone|mesh-list
24407178|NCT00172354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24407179|NCT00172367|Lycopene|lycopene|mesh-list
24407180|NCT00172367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24407181|NCT00172367|Antioxidants|antioxidants|mesh-ancestor
24407182|NCT00172367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407183|NCT00172367|Protective Agents|protective agents|mesh-ancestor
24407184|NCT00172367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407185|NCT00172367|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24407186|NCT00172367|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24407187|NCT00172367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407188|NCT00172380|Docetaxel|docetaxel|mesh-list
24407189|NCT00172380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407190|NCT00172380|Tubulin Modulators|tubulin modulators|mesh-ancestor
25103080|NCT03164421|Antidotes|antidotes|mesh-ancestor
25661293|NCT01632306|Antimitotic Agents|antimitotic agents|mesh-ancestor
25661294|NCT01632306|Mitosis Modulators|mitosis modulators|mesh-ancestor
25661295|NCT01632306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661296|NCT01632306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25661297|NCT01632306|Antimetabolites|antimetabolites|mesh-ancestor
25661298|NCT01632306|Antiviral Agents|antiviral agents|mesh-ancestor
25661299|NCT01632306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25661300|NCT01632306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661301|NCT01632306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25661302|NCT01632306|Immunologic Factors|immunologic factors|mesh-ancestor
25842985|NCT00033735|Antimetabolites|antimetabolites|mesh-ancestor
25842986|NCT00033735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407191|NCT00172380|Antimitotic Agents|antimitotic agents|mesh-ancestor
25842987|NCT00033735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25842988|NCT00033735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25842989|NCT00033735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25842990|NCT00033735|Immunologic Factors|immunologic factors|mesh-ancestor
25842991|NCT00033735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451693|NCT00324519|Misoprostol|misoprostol|mesh-list
24451694|NCT00324519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24451695|NCT00324519|Abortifacient Agents|abortifacient agents|mesh-ancestor
24451696|NCT00324519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24451697|NCT00324519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451698|NCT00324519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24451699|NCT00324519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24451700|NCT00324519|Oxytocics|oxytocics|mesh-ancestor
24451701|NCT00324558|Bemiparin|bemiparin|mesh-list
24407192|NCT00172380|Mitosis Modulators|mitosis modulators|mesh-ancestor
24407193|NCT00172380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407194|NCT00172419|Atorvastatin|atorvastatin|mesh-list
24407195|NCT00172419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24407196|NCT00172419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25842992|NCT00033735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24407203|NCT00172809|Interferon-alpha|interferon-alpha|mesh-list
24407204|NCT00172809|Interferon alpha-2|interferon alpha-2|mesh-list
24407205|NCT00172809|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24407206|NCT00172809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407207|NCT00172809|Antiviral Agents|antiviral agents|mesh-ancestor
24407208|NCT00172809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24407209|NCT00172809|Immunologic Factors|immunologic factors|mesh-ancestor
24407210|NCT00172809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407211|NCT00173667|Nifedipine|nifedipine|mesh-list
24407212|NCT00173667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24407213|NCT00173667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24407227|NCT00173745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24407228|NCT00173745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407229|NCT00173745|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24407244|NCT00173862|Alkylating Agents|alkylating agents|mesh-ancestor
24407245|NCT00173875|Gefitinib|gefitinib|mesh-list
24407246|NCT00173875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407247|NCT00173875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24407248|NCT00173875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407249|NCT00173875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407250|NCT00173888|Gemcitabine|gemcitabine|mesh-list
24407251|NCT00173888|Cisplatin|cisplatin|mesh-list
24407252|NCT00173888|Docetaxel|docetaxel|mesh-list
24407253|NCT00173888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407254|NCT00173888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25842993|NCT00033735|Alkylating Agents|alkylating agents|mesh-ancestor
25842994|NCT00033748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25842995|NCT00033748|Antibodies|antibodies|mesh-list
25842996|NCT00033748|Immunoglobulins|immunoglobulins|mesh-list
24407284|NCT00174200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24407285|NCT00174200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24407286|NCT00174200|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24407287|NCT00174200|Dopamine Agents|dopamine agents|mesh-ancestor
24407288|NCT00174226|Buspirone|buspirone|mesh-list
24407306|NCT00174239|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24407307|NCT00174239|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24407308|NCT00174239|Dopamine Agents|dopamine agents|mesh-ancestor
24407309|NCT00174239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25842997|NCT00033748|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25842998|NCT00033748|Immunologic Factors|immunologic factors|mesh-ancestor
25842999|NCT00033748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843000|NCT00033748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407312|NCT00174239|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24407313|NCT00174239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407314|NCT00174239|Dopamine Agonists|dopamine agonists|mesh-ancestor
24407315|NCT00174304|Amlodipine|amlodipine|mesh-list
24407316|NCT00174304|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
24407317|NCT00174304|Atorvastatin|atorvastatin|mesh-list
24407318|NCT00174304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24407319|NCT00174304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24407324|NCT00174304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820065|NCT02098590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24820066|NCT02098590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24820067|NCT02098590|Antimalarials|antimalarials|mesh-ancestor
24407325|NCT00174304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25843001|NCT00033813|Oxatomide|oxatomide|mesh-list
25843002|NCT00033813|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24870819|NCT03462290|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24870820|NCT03462290|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24870821|NCT03462290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24407326|NCT00174304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24407327|NCT00174304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24820070|NCT02098590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820071|NCT02098590|Antimetabolites|antimetabolites|mesh-ancestor
24820072|NCT02098616|Asunaprevir|asunaprevir|mesh-list
24541551|NCT00673621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24541552|NCT00673621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24541553|NCT00673621|Adrenergic Agents|adrenergic agents|mesh-ancestor
24541554|NCT00673621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25103276|NCT03163576|Vitamins|vitamins|mesh-ancestor
24541555|NCT00673621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843003|NCT00033813|Histamine Antagonists|histamine antagonists|mesh-ancestor
25843004|NCT00033813|Histamine Agents|histamine agents|mesh-ancestor
25843005|NCT00033813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25843006|NCT00033813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843007|NCT00033813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843008|NCT00033813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25843009|NCT00033813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25165743|NCT04656184|Immunologic Factors|immunologic factors|mesh-ancestor
25165744|NCT04656184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165745|NCT04656184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24829869|NCT02155088|Antimitotic Agents|antimitotic agents|mesh-ancestor
25843010|NCT00033813|Respiratory System Agents|respiratory system agents|mesh-ancestor
25843011|NCT00033891|Infliximab|infliximab|mesh-list
24407431|NCT00174512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24407432|NCT00174512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24407433|NCT00174512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407434|NCT00174512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407435|NCT00174512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407437|NCT00174538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24407438|NCT00174538|Narcotics|narcotics|mesh-ancestor
24407439|NCT00174538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24407440|NCT00174538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407443|NCT00174538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24407444|NCT00174538|Antitussive Agents|antitussive agents|mesh-ancestor
24407445|NCT00174538|Respiratory System Agents|respiratory system agents|mesh-ancestor
24407446|NCT00174551|Prazosin|prazosin|mesh-list
24407447|NCT00174551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24407470|NCT00174590|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24407471|NCT00174590|Serotonin Agents|serotonin agents|mesh-ancestor
24407480|NCT00174590|Dopamine Agents|dopamine agents|mesh-ancestor
24407481|NCT00174603|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24407482|NCT00174603|Antidepressive Agents|antidepressive agents|mesh-ancestor
24407483|NCT00174603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24407484|NCT00174603|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24407485|NCT00174603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24407486|NCT00174603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24407487|NCT00174603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407579|NCT00174733|Ciclesonide|ciclesonide|mesh-list
24407580|NCT00174733|Glucocorticoids|glucocorticoids|mesh-ancestor
24820088|NCT02098629|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24820089|NCT02098629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24820090|NCT02098629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820091|NCT02098629|Protective Agents|protective agents|mesh-ancestor
24820092|NCT02098785|Caffeine|caffeine|mesh-list
24820093|NCT02098785|Caffeine citrate|caffeine citrate|mesh-list
24820094|NCT02098785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820095|NCT02098785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24820096|NCT02098785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820097|NCT02098785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24820098|NCT02098785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680501|NCT01375023|Immunologic Factors|immunologic factors|mesh-ancestor
24407625|NCT00174876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24407626|NCT00174876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24407627|NCT00174876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407635|NCT00174876|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24407636|NCT00174876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24407637|NCT00174876|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25661303|NCT01632306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661304|NCT01632306|Antidotes|antidotes|mesh-ancestor
25661305|NCT01632306|Protective Agents|protective agents|mesh-ancestor
24872214|NCT05398393|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24950000|NCT03095612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950001|NCT03063203|Decitabine|decitabine|mesh-list
24950003|NCT03063203|Antimetabolites|antimetabolites|mesh-ancestor
24872215|NCT05398393|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24872216|NCT05398393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24872219|NCT05398393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24872220|NCT05398393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24742013|NCT05294393|Anticonvulsants|anticonvulsants|mesh-ancestor
24815011|NCT02067949|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25201963|NCT02724202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407639|NCT00174902|Aspirin|aspirin|mesh-list
24407640|NCT00174902|Propranolol|propranolol|mesh-list
25103421|NCT03161509|Acetaminophen|acetaminophen|mesh-list
24407641|NCT00174902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24407642|NCT00174902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24407643|NCT00174902|Analgesics|analgesics|mesh-ancestor
24407644|NCT00174902|Sensory System Agents|sensory system agents|mesh-ancestor
24407645|NCT00174902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24407646|NCT00174902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541577|NCT00674011|Growth Substances|growth substances|mesh-ancestor
24407658|NCT00174902|Adrenergic Agents|adrenergic agents|mesh-ancestor
24407659|NCT00174902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24407660|NCT00174902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24407661|NCT00174902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25103474|NCT03161210|Anesthetics|anesthetics|mesh-list
24407662|NCT00174902|Vasodilator Agents|vasodilator agents|mesh-ancestor
24407663|NCT00174928|Lansoprazole|lansoprazole|mesh-list
24407664|NCT00174928|Dexlansoprazole|dexlansoprazole|mesh-list
24407666|NCT00174928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24407672|NCT00174993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407673|NCT00175032|Aspirin|aspirin|mesh-list
24407745|NCT00175357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24407746|NCT00175357|Narcotics|narcotics|mesh-ancestor
24843808|NCT02229747|Diclofenac|diclofenac|mesh-list
24843809|NCT02229747|Meloxicam|meloxicam|mesh-list
24843810|NCT02229747|Nimesulide|nimesulide|mesh-list
24407747|NCT00175357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24407748|NCT00175357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407749|NCT00175357|Analgesics|analgesics|mesh-ancestor
24407750|NCT00175357|Sensory System Agents|sensory system agents|mesh-ancestor
24407751|NCT00175357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24407752|NCT00175357|Antitussive Agents|antitussive agents|mesh-ancestor
24407753|NCT00175357|Respiratory System Agents|respiratory system agents|mesh-ancestor
24407755|NCT00175370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24407756|NCT00175370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24407757|NCT00175383|Hormones|hormones|mesh-list
24407758|NCT00175383|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24407759|NCT00175383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24820108|NCT02098824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24820109|NCT02098824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24820110|NCT02098824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407762|NCT00175396|Leuprolide|leuprolide|mesh-list
24407763|NCT00175396|Methyltestosterone|methyltestosterone|mesh-list
24407782|NCT00175396|Protective Agents|protective agents|mesh-ancestor
24407783|NCT00175396|Vitamins|vitamins|mesh-ancestor
24407784|NCT00175396|Micronutrients|micronutrients|mesh-ancestor
24407785|NCT00175396|Estrogens|estrogens|mesh-ancestor
24407786|NCT00175396|Anabolic Agents|anabolic agents|mesh-ancestor
24407840|NCT00175682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24407841|NCT00175682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407842|NCT00175682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407843|NCT00175695|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
24407845|NCT00175695|Anticoagulants|anticoagulants|mesh-ancestor
24407846|NCT00175695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24541589|NCT00674050|Dermatologic Agents|dermatologic agents|mesh-ancestor
25661306|NCT01632306|Vitamin B Complex|vitamin b complex|mesh-ancestor
25661307|NCT01632306|Vitamins|vitamins|mesh-ancestor
25661308|NCT01632306|Micronutrients|micronutrients|mesh-ancestor
25661309|NCT01632345|Efavirenz|efavirenz|mesh-list
25661310|NCT01632345|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25661311|NCT01632345|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25661312|NCT01632345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25661313|NCT01632345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661314|NCT01632345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661315|NCT01632345|Antiviral Agents|antiviral agents|mesh-ancestor
25661316|NCT01632345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24874706|NCT04592809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24874707|NCT04592809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24874708|NCT04592809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24874754|NCT04576104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24874755|NCT04576104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24874756|NCT04576104|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24874757|NCT04576104|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24874759|NCT04576104|Contraceptive Agents|contraceptive agents|mesh-ancestor
24541590|NCT00674050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24541591|NCT00674050|Tocolytic Agents|tocolytic agents|mesh-ancestor
25843012|NCT00033891|Dermatologic Agents|dermatologic agents|mesh-ancestor
25843013|NCT00033891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25843014|NCT00033891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25843015|NCT00033982|Posaconazole|posaconazole|mesh-list
25843016|NCT00033982|Antifungal Agents|antifungal agents|mesh-ancestor
25843017|NCT00033982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25843018|NCT00033982|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25843019|NCT00033982|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24407847|NCT00175695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24407848|NCT00175695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407849|NCT00175695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24407850|NCT00175734|Chrysarobin|chrysarobin|mesh-list
24704548|NCT01478685|Antimetabolites|antimetabolites|mesh-ancestor
25843020|NCT00033982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25843021|NCT00033982|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25843022|NCT00033982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25843023|NCT00033982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843024|NCT00033982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843025|NCT00033982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24451732|NCT00324623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24451733|NCT00324623|Immunologic Factors|immunologic factors|mesh-ancestor
24451734|NCT00324623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451735|NCT00324623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24407948|NCT00175981|Vasodilator Agents|vasodilator agents|mesh-ancestor
24407949|NCT00175981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24407950|NCT00175981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24407951|NCT00175981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407952|NCT00175981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407953|NCT00175981|Urological Agents|urological agents|mesh-ancestor
24407954|NCT00175981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24407955|NCT00175981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24407960|NCT00175981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24408017|NCT00176267|Tubulin Modulators|tubulin modulators|mesh-ancestor
24541618|NCT00674141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24541619|NCT00674141|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24541620|NCT00674141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843026|NCT00033982|Hormone Antagonists|hormone antagonists|mesh-ancestor
25843027|NCT00033982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24446031|NCT00303615|Anabolic Agents|anabolic agents|mesh-ancestor
24408041|NCT00176293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408042|NCT00176293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24408043|NCT00176293|Glucocorticoids|glucocorticoids|mesh-ancestor
24408044|NCT00176293|Hormones|hormones|mesh-ancestor
24408045|NCT00176293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24408046|NCT00176293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24408047|NCT00176293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408048|NCT00176293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24408049|NCT00176293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24408050|NCT00176293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24408051|NCT00176293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408198|NCT00176813|Immunologic Factors|immunologic factors|mesh-ancestor
25103678|NCT03159754|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24408199|NCT00176813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408200|NCT00176813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25661317|NCT01632345|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25661318|NCT01632345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25661319|NCT01632345|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25661320|NCT01632345|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25661321|NCT01632345|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25661322|NCT01632345|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25661323|NCT01632345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24875790|NCT03839823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24875792|NCT03839823|Antiviral Agents|antiviral agents|mesh-ancestor
24875793|NCT03839823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24875794|NCT03839823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24875795|NCT03839823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24408201|NCT00176813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24408202|NCT00176813|Analgesics|analgesics|mesh-ancestor
25843028|NCT00033982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408304|NCT00177281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408305|NCT00177281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408306|NCT00177281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408307|NCT00177333|Doxycycline|doxycycline|mesh-list
24408308|NCT00177333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24408309|NCT00177333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24408310|NCT00177333|Antimalarials|antimalarials|mesh-ancestor
24408311|NCT00177333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24408312|NCT00177333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24408313|NCT00177372|Misoprostol|misoprostol|mesh-list
24408314|NCT00177372|Mifepristone|mifepristone|mesh-list
24541681|NCT00674596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24541683|NCT00674674|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24541684|NCT00674674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24704724|NCT01479920|Fluoxetine|fluoxetine|mesh-list
24820178|NCT02099136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24820179|NCT02099136|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24680938|NCT01377155|Insulin Detemir|insulin detemir|mesh-list
24408350|NCT00177424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24408351|NCT00177424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408352|NCT00177424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24408353|NCT00177424|Serotonin Agents|serotonin agents|mesh-ancestor
24408354|NCT00177424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408391|NCT00177567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24408392|NCT00177567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24408393|NCT00177567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24451740|NCT00324623|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24451741|NCT00324623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24451742|NCT00324623|Antimetabolites|antimetabolites|mesh-ancestor
24451744|NCT00324688|Antiviral Agents|antiviral agents|mesh-ancestor
24451745|NCT00324688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24451746|NCT00324688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24820182|NCT02099136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820183|NCT02099240|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25843029|NCT00034047|Nafarelin|nafarelin|mesh-list
25843030|NCT00034047|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25843031|NCT00034047|Fertility Agents|fertility agents|mesh-ancestor
25843032|NCT00034047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25843033|NCT00034047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843034|NCT00034060|Etanercept|etanercept|mesh-list
25843035|NCT00034060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25843036|NCT00034060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25843037|NCT00034060|Analgesics|analgesics|mesh-ancestor
25843038|NCT00034060|Sensory System Agents|sensory system agents|mesh-ancestor
25843039|NCT00034060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25843040|NCT00034060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408419|NCT00177580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24408420|NCT00177580|Antimetabolites|antimetabolites|mesh-ancestor
25661324|NCT01632345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25661325|NCT01632423|Bimatoprost|bimatoprost|mesh-list
25661326|NCT01632423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25661327|NCT01632566|Celecoxib|celecoxib|mesh-list
25661328|NCT01632566|Simvastatin|simvastatin|mesh-list
25661329|NCT01632566|LY3031207|ly3031207|mesh-list
25661330|NCT01632566|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25661331|NCT01632566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25661332|NCT01632566|Antimetabolites|antimetabolites|mesh-ancestor
25661333|NCT01632566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446982|NCT00306813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25409030|NCT03404180|Anesthetics, General|anesthetics, general|mesh-ancestor
25661334|NCT01632566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24876727|NCT03263078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24876728|NCT03263078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24876730|NCT03263078|Anesthetics, General|anesthetics, general|mesh-ancestor
24876731|NCT03263078|Anesthetics|anesthetics|mesh-ancestor
24876732|NCT03263078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24876733|NCT03263078|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24786628|NCT01921010|Antimetabolites|antimetabolites|mesh-ancestor
24786629|NCT01921010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786630|NCT01921010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24786631|NCT01921010|Vasodilator Agents|vasodilator agents|mesh-ancestor
24786634|NCT01921010|Micronutrients|micronutrients|mesh-ancestor
24578935|NCT00852436|Anticonvulsants|anticonvulsants|mesh-ancestor
24408421|NCT00177580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408422|NCT00177580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25181777|NCT04793568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24408423|NCT00177580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24408424|NCT00177580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408426|NCT00177619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24408447|NCT00177749|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24408448|NCT00177749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24408449|NCT00177749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24408450|NCT00177749|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24408451|NCT00177749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24408452|NCT00177749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408453|NCT00177749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408455|NCT00177749|Hormone Antagonists|hormone antagonists|mesh-ancestor
24408457|NCT00177749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408458|NCT00177853|Celecoxib|celecoxib|mesh-list
24408468|NCT00177853|Sensory System Agents|sensory system agents|mesh-ancestor
24408469|NCT00177853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24408470|NCT00177853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408471|NCT00177853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25843041|NCT00034060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25843042|NCT00034060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25843043|NCT00034060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25843044|NCT00034060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24820214|NCT02099240|Pyrazinamide|pyrazinamide|mesh-list
24820215|NCT02099240|Ceftazidime|ceftazidime|mesh-list
24820216|NCT02099240|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24820217|NCT02099240|Colistin|colistin|mesh-list
24820218|NCT02099240|Clavulanic Acids|clavulanic acids|mesh-list
24820219|NCT02099240|Clavulanic Acid|clavulanic acid|mesh-list
25165762|NCT04633213|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25843045|NCT00034060|Immunologic Factors|immunologic factors|mesh-ancestor
25843046|NCT00034086|Ritonavir|ritonavir|mesh-list
25843047|NCT00034086|Lopinavir|lopinavir|mesh-list
25843048|NCT00034086|Tenofovir|tenofovir|mesh-list
25843049|NCT00034086|Lamivudine|lamivudine|mesh-list
25843050|NCT00034086|Zidovudine|zidovudine|mesh-list
25843051|NCT00034086|Stavudine|stavudine|mesh-list
25843052|NCT00034086|Didanosine|didanosine|mesh-list
25843053|NCT00034086|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25843054|NCT00034086|Vaccines|vaccines|mesh-list
25843055|NCT00034086|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25843056|NCT00034086|Immunologic Factors|immunologic factors|mesh-ancestor
25843057|NCT00034086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843058|NCT00034086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24827554|NCT02140242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24827555|NCT02140242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661335|NCT01632566|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25661336|NCT01632566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661337|NCT01632566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25661338|NCT01632566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25661339|NCT01632566|Analgesics|analgesics|mesh-ancestor
25661340|NCT01632566|Sensory System Agents|sensory system agents|mesh-ancestor
25661341|NCT01632566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25661342|NCT01632566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661343|NCT01632566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25661344|NCT01632566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25661345|NCT01632566|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25661346|NCT01632566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25661347|NCT01632566|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
25843059|NCT00034086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25843060|NCT00034086|Protease Inhibitors|protease inhibitors|mesh-ancestor
24877908|NCT02227199|Carboplatin|carboplatin|mesh-list
24877910|NCT02227199|Etoposide phosphate|etoposide phosphate|mesh-list
24877911|NCT02227199|Ifosfamide|ifosfamide|mesh-list
24877912|NCT02227199|Isophosphamide mustard|isophosphamide mustard|mesh-list
25843061|NCT00034086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843062|NCT00034086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878471|NCT01709123|Chromium|chromium|mesh-list
24878668|NCT01281176|Vorinostat|vorinostat|mesh-list
24827556|NCT02140242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827558|NCT02140255|Lopinavir|lopinavir|mesh-list
24827559|NCT02140255|Raltegravir Potassium|raltegravir potassium|mesh-list
24827560|NCT02140255|Nevirapine|nevirapine|mesh-list
24718261|NCT01553357|Antiemetics|antiemetics|mesh-ancestor
25843063|NCT00034086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25843064|NCT00034086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25843065|NCT00034086|Antiviral Agents|antiviral agents|mesh-ancestor
25843066|NCT00034086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25843067|NCT00034086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25843068|NCT00034086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25843069|NCT00034086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25843070|NCT00034086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25843071|NCT00034086|Antimetabolites|antimetabolites|mesh-ancestor
25843072|NCT00034125|Tamoxifen|tamoxifen|mesh-list
25843073|NCT00034125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25843074|NCT00034125|Hormone Antagonists|hormone antagonists|mesh-ancestor
25843075|NCT00034125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25843076|NCT00034125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843077|NCT00034125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25843078|NCT00034125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843079|NCT00034125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25843080|NCT00034125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25843081|NCT00034125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25843082|NCT00034138|Oregovomab|oregovomab|mesh-list
25843083|NCT00034138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25843084|NCT00034138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843085|NCT00034151|Paclitaxel|paclitaxel|mesh-list
24446981|NCT00306813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24446984|NCT00306813|Growth Inhibitors|growth inhibitors|mesh-ancestor
24446985|NCT00306813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446986|NCT00306826|Pioglitazone|pioglitazone|mesh-list
24827561|NCT02140255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
24827562|NCT02140255|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24827563|NCT02140255|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24827564|NCT02140255|Protease Inhibitors|protease inhibitors|mesh-ancestor
24827565|NCT02140255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446987|NCT00306826|Simvastatin|simvastatin|mesh-list
24446988|NCT00306826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24446989|NCT00306826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24446990|NCT00306826|Antimetabolites|antimetabolites|mesh-ancestor
24446991|NCT00306826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446992|NCT00306826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24446993|NCT00306826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24446994|NCT00306826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446995|NCT00306826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24446996|NCT00306826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446997|NCT00306878|Abatacept|abatacept|mesh-list
24446998|NCT00306878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25165763|NCT04633213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25165764|NCT04632316|Cyclophosphamide|cyclophosphamide|mesh-list
25165765|NCT04632316|Fludarabine|fludarabine|mesh-list
25165766|NCT04632316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25165767|NCT04632316|Immunologic Factors|immunologic factors|mesh-ancestor
25165768|NCT04632316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165769|NCT04632316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25165770|NCT04632316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25409031|NCT03404180|Anesthetics|anesthetics|mesh-ancestor
25661348|NCT01632566|Hormone Antagonists|hormone antagonists|mesh-ancestor
25661349|NCT01632566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25661350|NCT01632579|Celecoxib|celecoxib|mesh-list
25661351|NCT01632579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25661352|NCT01632579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25661353|NCT01632579|Analgesics|analgesics|mesh-ancestor
25661354|NCT01632579|Sensory System Agents|sensory system agents|mesh-ancestor
25661355|NCT01632579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24880435|NCT03784066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24880473|NCT03654274|Estrogens|estrogens|mesh-ancestor
24880474|NCT03654274|Hormones|hormones|mesh-ancestor
24880578|NCT03590054|Abexinostat|abexinostat|mesh-list
24880579|NCT03590054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24880580|NCT03590054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446999|NCT00306878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447000|NCT00306878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447001|NCT00306878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24447002|NCT00306878|Immunologic Factors|immunologic factors|mesh-ancestor
24447003|NCT00306878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843086|NCT00034151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25843087|NCT00034151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843088|NCT00034151|Tubulin Modulators|tubulin modulators|mesh-ancestor
25843089|NCT00034151|Antimitotic Agents|antimitotic agents|mesh-ancestor
25843090|NCT00034151|Mitosis Modulators|mitosis modulators|mesh-ancestor
25843091|NCT00034151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843092|NCT00034164|Paclitaxel|paclitaxel|mesh-list
25843093|NCT00034164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25843094|NCT00034164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843095|NCT00034164|Tubulin Modulators|tubulin modulators|mesh-ancestor
25843096|NCT00034164|Antimitotic Agents|antimitotic agents|mesh-ancestor
25843097|NCT00034164|Mitosis Modulators|mitosis modulators|mesh-ancestor
25843098|NCT00034164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843099|NCT00034177|Paclitaxel|paclitaxel|mesh-list
25843100|NCT00034177|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25843101|NCT00034177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25843102|NCT00034177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843103|NCT00034177|Tubulin Modulators|tubulin modulators|mesh-ancestor
25843104|NCT00034177|Antimitotic Agents|antimitotic agents|mesh-ancestor
25843105|NCT00034177|Mitosis Modulators|mitosis modulators|mesh-ancestor
25843106|NCT00034177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843107|NCT00034190|Paclitaxel|paclitaxel|mesh-list
25843108|NCT00034190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25843109|NCT00034190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843110|NCT00034190|Tubulin Modulators|tubulin modulators|mesh-ancestor
25843111|NCT00034190|Antimitotic Agents|antimitotic agents|mesh-ancestor
25843112|NCT00034190|Mitosis Modulators|mitosis modulators|mesh-ancestor
25843113|NCT00034190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843114|NCT00034229|Felbamate|felbamate|mesh-list
25843115|NCT00034229|Anticonvulsants|anticonvulsants|mesh-ancestor
25843116|NCT00034229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25843117|NCT00034229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25843118|NCT00034229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25843119|NCT00034229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843120|NCT00034229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843121|NCT00034242|Immunoglobulins|immunoglobulins|mesh-list
25843122|NCT00034242|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25843123|NCT00034242|Antibodies|antibodies|mesh-list
25843124|NCT00034242|gamma-Globulins|gamma-globulins|mesh-list
25843125|NCT00034242|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25843126|NCT00034242|Immunologic Factors|immunologic factors|mesh-ancestor
25843127|NCT00034242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843128|NCT00034307|Sitaxsentan|sitaxsentan|mesh-list
25843129|NCT00034307|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25843130|NCT00034307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843131|NCT00034346|Paclitaxel|paclitaxel|mesh-list
25843132|NCT00034346|Carboplatin|carboplatin|mesh-list
25843133|NCT00034346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25843134|NCT00034346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843135|NCT00034346|Tubulin Modulators|tubulin modulators|mesh-ancestor
25843136|NCT00034346|Antimitotic Agents|antimitotic agents|mesh-ancestor
25843137|NCT00034346|Mitosis Modulators|mitosis modulators|mesh-ancestor
25875715|NCT04216290|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25661356|NCT01632579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661357|NCT01632579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25661358|NCT01632579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25661359|NCT01632579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25661360|NCT01632579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25661361|NCT01632579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661362|NCT01632579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875716|NCT04214262|Atezolizumab|atezolizumab|mesh-list
24886556|NCT04525235|Protective Agents|protective agents|mesh-ancestor
24886557|NCT04525235|Antitussive Agents|antitussive agents|mesh-ancestor
25843138|NCT00034346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843139|NCT00034359|Lamivudine|lamivudine|mesh-list
25843140|NCT00034359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25843141|NCT00034359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25843142|NCT00034359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843143|NCT00034359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843144|NCT00034359|Antiviral Agents|antiviral agents|mesh-ancestor
25843145|NCT00034359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25843146|NCT00034359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25843147|NCT00034359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25843148|NCT00034372|Oregovomab|oregovomab|mesh-list
25843149|NCT00034372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25843150|NCT00034372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843151|NCT00034385|Valganciclovir|valganciclovir|mesh-list
25843152|NCT00034385|Antiviral Agents|antiviral agents|mesh-ancestor
25843153|NCT00034385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25875717|NCT04214262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25875718|NCT04214262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875719|NCT04214262|Immunologic Factors|immunologic factors|mesh-ancestor
25875720|NCT04214262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875721|NCT04200313|Pancrelipase|pancrelipase|mesh-list
25875722|NCT04200313|Pancreatin|pancreatin|mesh-list
25875723|NCT04200313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25875724|NCT04188405|Decitabine|decitabine|mesh-list
25875725|NCT04188405|Venetoclax|venetoclax|mesh-list
25875726|NCT04188405|Ponatinib|ponatinib|mesh-list
25875727|NCT04188405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25875728|NCT04188405|Antimetabolites|antimetabolites|mesh-ancestor
24827570|NCT02140255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24827571|NCT02140255|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24827572|NCT02140255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24827573|NCT02140255|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25875729|NCT04188405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875730|NCT04188405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875731|NCT04188405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875732|NCT04188405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25875733|NCT04181060|Bevacizumab|bevacizumab|mesh-list
25875734|NCT04181060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25875735|NCT04181060|Osimertinib|osimertinib|mesh-list
25875736|NCT04181060|Endothelial Growth Factors|endothelial growth factors|mesh-list
25875737|NCT04181060|Antibodies|antibodies|mesh-list
25875738|NCT04181060|Immunoglobulins|immunoglobulins|mesh-list
25875739|NCT04181060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25875740|NCT04181060|Immunoglobulin G|immunoglobulin g|mesh-list
25875741|NCT04181060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875742|NCT04181060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25875743|NCT04181060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25875744|NCT04181060|Growth Substances|growth substances|mesh-ancestor
25875745|NCT04181060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875746|NCT04181060|Growth Inhibitors|growth inhibitors|mesh-ancestor
25875747|NCT04181060|Immunologic Factors|immunologic factors|mesh-ancestor
25875748|NCT04181060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875749|NCT04181060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25875750|NCT04181060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875751|NCT04166409|Carboplatin|carboplatin|mesh-list
25875752|NCT04166409|Vincristine|vincristine|mesh-list
25875753|NCT04166409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875754|NCT04166409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25875755|NCT04166409|Tubulin Modulators|tubulin modulators|mesh-ancestor
24827574|NCT02140255|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24827575|NCT02140255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24827576|NCT02140255|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24827577|NCT02140255|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24827578|NCT02140268|Midazolam|midazolam|mesh-list
25875756|NCT04166409|Antimitotic Agents|antimitotic agents|mesh-ancestor
25875757|NCT04166409|Mitosis Modulators|mitosis modulators|mesh-ancestor
24447074|NCT00307450|Levetiracetam|levetiracetam|mesh-list
24447075|NCT00307450|Anticonvulsants|anticonvulsants|mesh-ancestor
25661363|NCT01632709|Bupivacaine|bupivacaine|mesh-list
25661364|NCT01632709|Anesthetics, Local|anesthetics, local|mesh-ancestor
25661365|NCT01632709|Anesthetics|anesthetics|mesh-ancestor
24447076|NCT00307450|Nootropic Agents|nootropic agents|mesh-ancestor
25875758|NCT04166409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887046|NCT04520503|Anesthetics, General|anesthetics, general|mesh-ancestor
24887048|NCT04520230|Budesonide|budesonide|mesh-list
24887049|NCT04520230|Formoterol Fumarate|formoterol fumarate|mesh-list
24887050|NCT04520230|Tiotropium Bromide|tiotropium bromide|mesh-list
24465450|NCT00369603|Autonomic Agents|autonomic agents|mesh-ancestor
25843155|NCT00034463|Vitamins|vitamins|mesh-ancestor
24887308|NCT04517526|Pemetrexed|pemetrexed|mesh-list
24447077|NCT00307463|Antihypertensive Agents|antihypertensive agents|mesh-list
24447079|NCT00307502|Lopinavir|lopinavir|mesh-list
24447080|NCT00307502|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24447081|NCT00307502|Darunavir|darunavir|mesh-list
24447082|NCT00307502|Nelfinavir|nelfinavir|mesh-list
24447083|NCT00307502|Indinavir|indinavir|mesh-list
24447084|NCT00307502|Saquinavir|saquinavir|mesh-list
24447085|NCT00307502|Amprenavir|amprenavir|mesh-list
24447086|NCT00307502|Fosamprenavir|fosamprenavir|mesh-list
24447087|NCT00307502|Nevirapine|nevirapine|mesh-list
24447088|NCT00307502|Tipranavir|tipranavir|mesh-list
24447089|NCT00307502|Efavirenz|efavirenz|mesh-list
25843156|NCT00034463|Micronutrients|micronutrients|mesh-ancestor
25843157|NCT00034463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843158|NCT00034463|Hematinics|hematinics|mesh-ancestor
25843159|NCT00034463|Vitamin B Complex|vitamin b complex|mesh-ancestor
25843160|NCT00034489|Gemcitabine|gemcitabine|mesh-list
25843161|NCT00034489|Pemetrexed|pemetrexed|mesh-list
25843162|NCT00034489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25843163|NCT00034489|Antimetabolites|antimetabolites|mesh-ancestor
25843164|NCT00034489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843165|NCT00034489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827579|NCT02140268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24827580|NCT02140268|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25843166|NCT00034489|Antiviral Agents|antiviral agents|mesh-ancestor
25165771|NCT04632316|Alkylating Agents|alkylating agents|mesh-ancestor
25843167|NCT00034489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25843168|NCT00034489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843169|NCT00034489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25843170|NCT00034489|Immunologic Factors|immunologic factors|mesh-ancestor
25104473|NCT03152370|Leucovorin|leucovorin|mesh-list
25843171|NCT00034489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447164|NCT00307632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24447165|NCT00307632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24447166|NCT00307645|Mycophenolic Acid|mycophenolic acid|mesh-list
24447168|NCT00307645|Methylprednisolone|methylprednisolone|mesh-list
24447169|NCT00307645|Cyclophosphamide|cyclophosphamide|mesh-list
24447171|NCT00307645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24447172|NCT00307645|Immunologic Factors|immunologic factors|mesh-ancestor
24447173|NCT00307645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843172|NCT00034489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25843173|NCT00034489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25843174|NCT00034502|Irinotecan|irinotecan|mesh-list
25843175|NCT00034502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25843176|NCT00034502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25843177|NCT00034502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843178|NCT00034502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843179|NCT00034502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843180|NCT00034528|Prednisone|prednisone|mesh-list
25843181|NCT00034528|Fludarabine|fludarabine|mesh-list
25843182|NCT00034528|Busulfan|busulfan|mesh-list
25843183|NCT00034528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25843184|NCT00034528|Glucocorticoids|glucocorticoids|mesh-ancestor
25843185|NCT00034528|Hormones|hormones|mesh-ancestor
25843186|NCT00034528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25843187|NCT00034528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843188|NCT00034528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25843189|NCT00034528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843190|NCT00034528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661366|NCT01632709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25661367|NCT01632709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661368|NCT01632709|Sensory System Agents|sensory system agents|mesh-ancestor
25661369|NCT01632709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25661370|NCT01632891|Ritonavir|ritonavir|mesh-list
25661371|NCT01632891|Lopinavir|lopinavir|mesh-list
25661372|NCT01632891|Tenofovir|tenofovir|mesh-list
25661373|NCT01632891|Emtricitabine|emtricitabine|mesh-list
25843191|NCT00034528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25843192|NCT00034528|Immunologic Factors|immunologic factors|mesh-ancestor
24786659|NCT01921218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786660|NCT01921218|Antifungal Agents|antifungal agents|mesh-ancestor
24786661|NCT01921218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25843193|NCT00034528|Alkylating Agents|alkylating agents|mesh-ancestor
25843194|NCT00034528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25843195|NCT00034528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25843196|NCT00034541|Paclitaxel|paclitaxel|mesh-list
25165772|NCT04632316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843197|NCT00034541|Carboplatin|carboplatin|mesh-list
25165773|NCT04632316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25165774|NCT04632316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25165775|NCT04631601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25165776|NCT04631601|Androgens|androgens|mesh-list
25165777|NCT04631601|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
25165778|NCT04631601|Hormones|hormones|mesh-ancestor
25165779|NCT04631601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25165780|NCT04631601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165781|NCT04631601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25165782|NCT04631601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25165783|NCT04631601|Androgen Antagonists|androgen antagonists|mesh-ancestor
25165784|NCT04631601|Hormone Antagonists|hormone antagonists|mesh-ancestor
25165801|NCT04622865|Quercetin|quercetin|mesh-list
25165802|NCT04622865|Antioxidants|antioxidants|mesh-ancestor
25104701|NCT03151460|Dopamine|dopamine|mesh-list
25165803|NCT04622865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25165804|NCT04622865|Protective Agents|protective agents|mesh-ancestor
25165805|NCT04622865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165828|NCT04610671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25165829|NCT04610671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25165830|NCT04609397|Hemay005|hemay005|mesh-list
25165831|NCT04609397|Dermatologic Agents|dermatologic agents|mesh-ancestor
25165832|NCT04609397|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25165833|NCT04609397|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25165834|NCT04609397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25165835|NCT04609397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104825|NCT03150706|Avelumab|avelumab|mesh-list
25843198|NCT00034541|Cetuximab|cetuximab|mesh-list
25843199|NCT00034541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25843200|NCT00034541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843201|NCT00034541|Tubulin Modulators|tubulin modulators|mesh-ancestor
25843202|NCT00034541|Antimitotic Agents|antimitotic agents|mesh-ancestor
25843203|NCT00034541|Mitosis Modulators|mitosis modulators|mesh-ancestor
25843204|NCT00034541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843205|NCT00034541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25843206|NCT00034580|Olanzapine|olanzapine|mesh-list
24447231|NCT00307671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25843207|NCT00034580|Risperidone|risperidone|mesh-list
25843208|NCT00034580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25843209|NCT00034580|Serotonin Agents|serotonin agents|mesh-ancestor
25843210|NCT00034580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25843211|NCT00034580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843212|NCT00034580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998166|NCT03590821|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25843213|NCT00034580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25843214|NCT00034580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25843215|NCT00034580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25843216|NCT00034580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25843217|NCT00034580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25843218|NCT00034580|Dopamine Agents|dopamine agents|mesh-ancestor
25843219|NCT00034580|Antiemetics|antiemetics|mesh-ancestor
25843220|NCT00034580|Autonomic Agents|autonomic agents|mesh-ancestor
25843221|NCT00034580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25843222|NCT00034580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25843223|NCT00034580|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25843224|NCT00034580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25843225|NCT00034580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25843226|NCT00034593|Gemcitabine|gemcitabine|mesh-list
25661374|NCT01632891|Nevirapine|nevirapine|mesh-list
25661375|NCT01632891|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25661376|NCT01632891|Efavirenz|efavirenz|mesh-list
25661377|NCT01632891|Trimethoprim|trimethoprim|mesh-list
25661378|NCT01632891|Sulfamethoxazole|sulfamethoxazole|mesh-list
24888660|NCT04501783|Favipiravir|favipiravir|mesh-list
24888661|NCT04501783|Antiviral Agents|antiviral agents|mesh-ancestor
24888662|NCT04501783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24888663|NCT04501523|Capecitabine|capecitabine|mesh-list
24888664|NCT04501523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24888701|NCT04501367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888702|NCT04501367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24888703|NCT04501367|Glucocorticoids|glucocorticoids|mesh-ancestor
24816745|NCT02078596|Valproic Acid|valproic acid|mesh-list
24816746|NCT02078596|Anticonvulsants|anticonvulsants|mesh-ancestor
24816747|NCT02078596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816749|NCT02078596|GABA Agents|gaba agents|mesh-ancestor
24816765|NCT02078648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24816766|NCT02078648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816767|NCT02078648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24497482|NCT00510211|Serotonin Agents|serotonin agents|mesh-ancestor
24888761|NCT04500704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24888763|NCT04500743|Dienogest|dienogest|mesh-list
24888802|NCT04499989|Isoniazid|isoniazid|mesh-list
25843227|NCT00034593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25843228|NCT00034593|Antimetabolites|antimetabolites|mesh-ancestor
25843229|NCT00034593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843230|NCT00034593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843231|NCT00034593|Antiviral Agents|antiviral agents|mesh-ancestor
25843232|NCT00034593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25843233|NCT00034593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843234|NCT00034593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25843235|NCT00034593|Immunologic Factors|immunologic factors|mesh-ancestor
25843236|NCT00034593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843237|NCT00034606|Gemcitabine|gemcitabine|mesh-list
25843238|NCT00034606|Pemetrexed|pemetrexed|mesh-list
25843239|NCT00034606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25843240|NCT00034606|Antimetabolites|antimetabolites|mesh-ancestor
24827597|NCT02140333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827598|NCT02140333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25843241|NCT00034606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843242|NCT00034606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843243|NCT00034606|Antiviral Agents|antiviral agents|mesh-ancestor
25843244|NCT00034606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25843245|NCT00034606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843246|NCT00034606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25843247|NCT00034606|Immunologic Factors|immunologic factors|mesh-ancestor
25843248|NCT00034606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843249|NCT00034606|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25843250|NCT00034606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25843251|NCT00034619|Oxaliplatin|oxaliplatin|mesh-list
25843252|NCT00034619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843253|NCT00034632|Posaconazole|posaconazole|mesh-list
25843254|NCT00034632|Antifungal Agents|antifungal agents|mesh-ancestor
25843255|NCT00034632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25843256|NCT00034632|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25843257|NCT00034632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25843258|NCT00034632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25843259|NCT00034632|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25843260|NCT00034632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25843261|NCT00034632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843262|NCT00034632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843263|NCT00034632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25661379|NCT01632891|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25661380|NCT01632891|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25661381|NCT01632891|Protease Inhibitors|protease inhibitors|mesh-ancestor
25661382|NCT01632891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661383|NCT01632891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661384|NCT01632891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25661385|NCT01632891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25661386|NCT01632891|Antiviral Agents|antiviral agents|mesh-ancestor
25661387|NCT01632891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25661388|NCT01632891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25661389|NCT01632891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25661390|NCT01632891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25661391|NCT01632891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25661392|NCT01632891|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25661393|NCT01632891|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25661394|NCT01632891|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24889322|NCT04494321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24889323|NCT04494321|Respiratory System Agents|respiratory system agents|mesh-ancestor
24889324|NCT04494321|Glucocorticoids|glucocorticoids|mesh-ancestor
24889326|NCT04494321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24889327|NCT04494321|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24889328|NCT04494321|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24889329|NCT04494321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24889330|NCT04494321|Adrenergic Agents|adrenergic agents|mesh-ancestor
24877986|NCT02181413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843264|NCT00034632|Hormone Antagonists|hormone antagonists|mesh-ancestor
25843265|NCT00034632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25843266|NCT00034632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843267|NCT00034645|Posaconazole|posaconazole|mesh-list
25843268|NCT00034645|Antifungal Agents|antifungal agents|mesh-ancestor
25843269|NCT00034645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25843270|NCT00034645|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25843271|NCT00034645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25843272|NCT00034645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25843273|NCT00034645|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25843274|NCT00034645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25843275|NCT00034645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24447293|NCT00308048|Interferons|interferons|mesh-list
24447294|NCT00308048|Ribavirin|ribavirin|mesh-list
24447295|NCT00308048|Interferon-alpha|interferon-alpha|mesh-list
25843276|NCT00034645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843277|NCT00034645|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25843278|NCT00034645|Hormone Antagonists|hormone antagonists|mesh-ancestor
25843279|NCT00034645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25843280|NCT00034645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843281|NCT00034658|Posaconazole|posaconazole|mesh-list
25843282|NCT00034658|Antifungal Agents|antifungal agents|mesh-ancestor
25843283|NCT00034658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25843284|NCT00034658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25843285|NCT00034658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25843286|NCT00034658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25843287|NCT00034658|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25843288|NCT00034658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25843289|NCT00034658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843290|NCT00034658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843291|NCT00034658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25843292|NCT00034658|Hormone Antagonists|hormone antagonists|mesh-ancestor
25843293|NCT00034658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25843294|NCT00034658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843295|NCT00034671|Posaconazole|posaconazole|mesh-list
25843296|NCT00034671|Antifungal Agents|antifungal agents|mesh-ancestor
25843297|NCT00034671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25843298|NCT00034671|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25843299|NCT00034671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25843300|NCT00034671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25843301|NCT00034671|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25843302|NCT00034671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25843303|NCT00034671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843304|NCT00034671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843305|NCT00034671|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25843306|NCT00034671|Hormone Antagonists|hormone antagonists|mesh-ancestor
24827619|NCT02140450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24827620|NCT02140450|Adrenergic Agents|adrenergic agents|mesh-ancestor
24827621|NCT02140450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25843307|NCT00034671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25661395|NCT01632891|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25661396|NCT01632891|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25661397|NCT01632891|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25661398|NCT01632891|Renal Agents|renal agents|mesh-ancestor
25661399|NCT01632891|Antimalarials|antimalarials|mesh-ancestor
25661400|NCT01632891|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25661401|NCT01632891|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25661402|NCT01632891|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25661403|NCT01632891|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25661404|NCT01632891|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25661405|NCT01632904|Hydroxyurea|hydroxyurea|mesh-list
24890217|NCT04485156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24890218|NCT04485156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24890219|NCT04485156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890220|NCT04485156|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24890221|NCT04485156|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24890222|NCT04485156|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24890223|NCT04485156|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25843308|NCT00034671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843309|NCT00034697|Temozolomide|temozolomide|mesh-list
25843310|NCT00034697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25843311|NCT00034697|Alkylating Agents|alkylating agents|mesh-ancestor
25843312|NCT00034697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843313|NCT00034697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843314|NCT00034710|Capsaicin|capsaicin|mesh-list
25843315|NCT00034710|Antipruritics|antipruritics|mesh-ancestor
25083079|NCT03318159|Posaconazole|posaconazole|mesh-list
25843316|NCT00034710|Dermatologic Agents|dermatologic agents|mesh-ancestor
25843317|NCT00034710|Sensory System Agents|sensory system agents|mesh-ancestor
25843318|NCT00034710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25843319|NCT00034710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843320|NCT00034736|Levofloxacin|levofloxacin|mesh-list
25843321|NCT00034736|Ofloxacin|ofloxacin|mesh-list
25843322|NCT00034736|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25843323|NCT00034736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25843324|NCT00034736|Renal Agents|renal agents|mesh-ancestor
25843325|NCT00034736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25843326|NCT00034736|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25843327|NCT00034736|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25843328|NCT00034736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843329|NCT00034736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843330|NCT00034736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843331|NCT00034736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25843332|NCT00034736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25843333|NCT00034749|Risperidone|risperidone|mesh-list
25843334|NCT00034749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25843335|NCT00034749|Serotonin Agents|serotonin agents|mesh-ancestor
25843336|NCT00034749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25843337|NCT00034749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843338|NCT00034749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843339|NCT00034749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25843340|NCT00034749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25843341|NCT00034749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25843342|NCT00034749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25843343|NCT00034749|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25843344|NCT00034749|Dopamine Agents|dopamine agents|mesh-ancestor
25843345|NCT00034762|Risperidone|risperidone|mesh-list
25843346|NCT00034762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25843347|NCT00034762|Serotonin Agents|serotonin agents|mesh-ancestor
25843348|NCT00034762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25843349|NCT00034762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843350|NCT00034762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843351|NCT00034762|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25843352|NCT00034762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25843353|NCT00034762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25843354|NCT00034762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25843355|NCT00034762|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25843356|NCT00034762|Dopamine Agents|dopamine agents|mesh-ancestor
25843357|NCT00034775|Risperidone|risperidone|mesh-list
25843358|NCT00034775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25843359|NCT00034775|Serotonin Agents|serotonin agents|mesh-ancestor
25843360|NCT00034775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25843361|NCT00034775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843362|NCT00034775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843363|NCT00034775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25843364|NCT00034775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25661406|NCT01632904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25661407|NCT01632904|Antisickling Agents|antisickling agents|mesh-ancestor
25661408|NCT01632904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661409|NCT01632904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661410|NCT01632904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25661411|NCT01632995|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25661412|NCT01632995|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24890575|NCT04481815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24890576|NCT04481815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24890577|NCT04481815|Immunologic Factors|immunologic factors|mesh-ancestor
24890578|NCT04481815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890579|NCT04481815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24890580|NCT04481815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24890581|NCT04481815|Abortifacient Agents|abortifacient agents|mesh-ancestor
24890582|NCT04481815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25843365|NCT00034775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25105305|NCT03146793|Antioxidants|antioxidants|mesh-ancestor
25165873|NCT04589325|Dermatologic Agents|dermatologic agents|mesh-ancestor
25165874|NCT04587947|Valsartan|valsartan|mesh-list
25165875|NCT04587947|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25165876|NCT04587947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25843366|NCT00034775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25165877|NCT04587947|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25165879|NCT04587947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203387|NCT02714699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25203388|NCT02714699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843367|NCT00034775|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25203389|NCT02714699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203390|NCT02714699|Anticonvulsants|anticonvulsants|mesh-ancestor
25203391|NCT02714699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25203392|NCT02714699|Antiemetics|antiemetics|mesh-ancestor
25203393|NCT02714699|Autonomic Agents|autonomic agents|mesh-ancestor
25203394|NCT02714699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25203395|NCT02714699|Mydriatics|mydriatics|mesh-ancestor
25203396|NCT02714699|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25203397|NCT02714699|Cholinergic Agents|cholinergic agents|mesh-ancestor
25203398|NCT02714699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25203399|NCT02714699|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25203400|NCT02714699|Parasympatholytics|parasympatholytics|mesh-ancestor
25203401|NCT02714855|Apixaban|apixaban|mesh-list
25203402|NCT02714855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25203403|NCT02714855|Antithrombins|antithrombins|mesh-ancestor
25105358|NCT03146481|Aceclofenac|aceclofenac|mesh-list
25203404|NCT02714855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25203405|NCT02714855|Protease Inhibitors|protease inhibitors|mesh-ancestor
25203406|NCT02714855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203407|NCT02714855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203408|NCT02714855|Anticoagulants|anticoagulants|mesh-ancestor
25203409|NCT02714543|Hydrocortisone|hydrocortisone|mesh-list
25203410|NCT02714543|Hyaluronic Acid|hyaluronic acid|mesh-list
25203411|NCT02714543|Antioxidants|antioxidants|mesh-list
25203412|NCT02714543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25203413|NCT02714543|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25203414|NCT02714543|Immunologic Factors|immunologic factors|mesh-ancestor
25203415|NCT02714543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843368|NCT00034775|Dopamine Agents|dopamine agents|mesh-ancestor
25843369|NCT00034788|Becaplermin|becaplermin|mesh-list
25843370|NCT00034788|Anticoagulants|anticoagulants|mesh-ancestor
25843371|NCT00034788|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
25843372|NCT00034788|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25843373|NCT00034788|Growth Substances|growth substances|mesh-ancestor
25843374|NCT00034788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843375|NCT00034801|Olanzapine|olanzapine|mesh-list
25843376|NCT00034801|Ziprasidone|ziprasidone|mesh-list
25843377|NCT00034801|Antiemetics|antiemetics|mesh-ancestor
25843378|NCT00034801|Autonomic Agents|autonomic agents|mesh-ancestor
25843379|NCT00034801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25843380|NCT00034801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843381|NCT00034801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24447365|NCT00308321|Autonomic Agents|autonomic agents|mesh-ancestor
24827653|NCT02140632|Prednisolone acetate|prednisolone acetate|mesh-list
25843382|NCT00034801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25661413|NCT01632995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25661414|NCT01632995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661415|NCT01632995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661416|NCT01632995|Antiviral Agents|antiviral agents|mesh-ancestor
25661417|NCT01632995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25661418|NCT01632995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25661419|NCT01632995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25661420|NCT01633060|Fulvestrant|fulvestrant|mesh-list
25843383|NCT00034801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25843384|NCT00034801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24819218|NCT02094222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819221|NCT02094274|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25843385|NCT00034801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25843386|NCT00034801|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25843387|NCT00034801|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25843388|NCT00034801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25843389|NCT00034801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843390|NCT00034801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25843391|NCT00034801|Serotonin Agents|serotonin agents|mesh-ancestor
25843392|NCT00034801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25843393|NCT00034801|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25843394|NCT00034801|Dopamine Agents|dopamine agents|mesh-ancestor
25843395|NCT00034840|Valsartan|valsartan|mesh-list
25843396|NCT00034840|Telmisartan|telmisartan|mesh-list
25843397|NCT00034840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24716843|NCT01544192|Vitamins|vitamins|mesh-ancestor
25843398|NCT00034840|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25843399|NCT00034840|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25843400|NCT00034840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843401|NCT00034853|Naproxen|naproxen|mesh-list
25843402|NCT00034853|Meloxicam|meloxicam|mesh-list
25843403|NCT00034853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25843404|NCT00034853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25843405|NCT00034853|Analgesics|analgesics|mesh-ancestor
25843406|NCT00034853|Sensory System Agents|sensory system agents|mesh-ancestor
25843407|NCT00034853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24975131|NCT04698031|Aspirin|aspirin|mesh-list
24829866|NCT02155088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25843408|NCT00034853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843409|NCT00034853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24827701|NCT02140983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24827702|NCT02140983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827703|NCT02140983|Incretins|incretins|mesh-ancestor
24827704|NCT02140983|Hormones|hormones|mesh-ancestor
24827705|NCT02140983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25843410|NCT00034853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25843411|NCT00034853|Gout Suppressants|gout suppressants|mesh-ancestor
24447471|NCT00308542|Antiemetics|antiemetics|mesh-ancestor
24447472|NCT00308542|Autonomic Agents|autonomic agents|mesh-ancestor
24447473|NCT00308542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24447474|NCT00308542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975177|NCT04689347|Micronutrients|micronutrients|mesh-ancestor
24447475|NCT00308542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24447476|NCT00308542|Glucocorticoids|glucocorticoids|mesh-ancestor
24447478|NCT00308542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24447479|NCT00308542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24447480|NCT00308542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447481|NCT00308594|Dexamethasone|dexamethasone|mesh-list
25843412|NCT00034853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25843413|NCT00034853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24827716|NCT02141087|Analgesics|analgesics|mesh-ancestor
24827717|NCT02141087|Sensory System Agents|sensory system agents|mesh-ancestor
24827718|NCT02141087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25843414|NCT00034853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843415|NCT00034853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25843416|NCT00034866|Tipranavir|tipranavir|mesh-list
25843417|NCT00034866|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
25843418|NCT00034866|Protease Inhibitors|protease inhibitors|mesh-list
25843419|NCT00034866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25843420|NCT00034866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25843421|NCT00034866|Antiviral Agents|antiviral agents|mesh-ancestor
25843422|NCT00034866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042052|NCT01516203|Antimetabolites|antimetabolites|mesh-ancestor
24975234|NCT04546581|Antibodies|antibodies|mesh-list
25661421|NCT01633060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25661422|NCT01633060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25661423|NCT01633060|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25661424|NCT01633060|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25843423|NCT00034866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843424|NCT00034866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843425|NCT00034866|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25843426|NCT00034879|Gefitinib|gefitinib|mesh-list
25843427|NCT00034879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843428|NCT00034879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25843429|NCT00034879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843430|NCT00034879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843431|NCT00034892|Olanzapine|olanzapine|mesh-list
24827928|NCT02142309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24827929|NCT02142309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827930|NCT02142309|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24584971|NCT00882401|Vitamin D|vitamin d|mesh-list
24827932|NCT02142335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24827933|NCT02142335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827934|NCT02142335|Immunologic Factors|immunologic factors|mesh-ancestor
24827967|NCT02142569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24827968|NCT02142569|Antimetabolites|antimetabolites|mesh-ancestor
24827969|NCT02142569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24827970|NCT02142569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25041489|NCT02513303|Sirolimus|sirolimus|mesh-list
25041497|NCT02513303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041498|NCT02511886|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
25041504|NCT02511886|GABA Agonists|gaba agonists|mesh-ancestor
24828059|NCT02143167|4-Aminopyridine|4-aminopyridine|mesh-list
24828060|NCT02143167|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24828061|NCT02143167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24828062|NCT02143167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828273|NCT02144623|Anticonvulsants|anticonvulsants|mesh-ancestor
24828274|NCT02144623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828275|NCT02144623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828276|NCT02144623|GABA Agents|gaba agents|mesh-ancestor
24828277|NCT02144623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24828278|NCT02144623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843432|NCT00034892|Risperidone|risperidone|mesh-list
24828279|NCT02144623|Antimanic Agents|antimanic agents|mesh-ancestor
24828280|NCT02144623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24828281|NCT02144623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25843433|NCT00034892|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25843434|NCT00034892|Serotonin Agents|serotonin agents|mesh-ancestor
25843435|NCT00034892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25843436|NCT00034892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843437|NCT00034892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843438|NCT00034892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25843439|NCT00034892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24975424|NCT03729245|Sunitinib|sunitinib|mesh-list
25843440|NCT00034892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25843441|NCT00034892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25843442|NCT00034892|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25843443|NCT00034892|Dopamine Agents|dopamine agents|mesh-ancestor
24828314|NCT02144818|Luteolytic Agents|luteolytic agents|mesh-ancestor
24828315|NCT02144818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24828316|NCT02144818|Contraceptive Agents|contraceptive agents|mesh-ancestor
24828317|NCT02144818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24828318|NCT02144818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828319|NCT02144818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24828320|NCT02144818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24828321|NCT02144818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828322|NCT02144922|Pitavastatin|pitavastatin|mesh-list
24828323|NCT02144922|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24828324|NCT02144922|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24828325|NCT02144922|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24828326|NCT02144922|Antimetabolites|antimetabolites|mesh-ancestor
24828327|NCT02144922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828328|NCT02144922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828329|NCT02144922|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24828330|NCT02145065|Paclitaxel|paclitaxel|mesh-list
24828331|NCT02145065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24937132|NCT04032834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24828332|NCT02145065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828333|NCT02145065|Tubulin Modulators|tubulin modulators|mesh-ancestor
24828334|NCT02145065|Antimitotic Agents|antimitotic agents|mesh-ancestor
24828335|NCT02145065|Mitosis Modulators|mitosis modulators|mesh-ancestor
24828336|NCT02145065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828337|NCT02145091|Psilocybin|psilocybin|mesh-list
24828338|NCT02145091|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
25843444|NCT00034892|Antiemetics|antiemetics|mesh-ancestor
25843445|NCT00034892|Autonomic Agents|autonomic agents|mesh-ancestor
24892646|NCT04460820|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24828339|NCT02145091|Hallucinogens|hallucinogens|mesh-ancestor
24828340|NCT02145091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828341|NCT02145091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24828343|NCT02145091|Serotonin Agents|serotonin agents|mesh-ancestor
24828344|NCT02145091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24828345|NCT02145091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843446|NCT00034892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25843447|NCT00034892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25843448|NCT00034892|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25843449|NCT00034892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25843450|NCT00034892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25843451|NCT00034905|Risperidone|risperidone|mesh-list
25843452|NCT00034905|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24828433|NCT02145585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24828435|NCT02145598|Lenalidomide|lenalidomide|mesh-list
25843453|NCT00034905|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25843454|NCT00034905|Serotonin Agents|serotonin agents|mesh-ancestor
25843455|NCT00034905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25843456|NCT00034905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843457|NCT00034905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843458|NCT00034905|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25843459|NCT00034905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25843460|NCT00034905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25843461|NCT00034905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25843462|NCT00034905|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24828446|NCT02145611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828447|NCT02145611|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24828449|NCT02145611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828450|NCT02145611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828451|NCT02145624|Vaccines|vaccines|mesh-list
24828452|NCT02145624|Immunologic Factors|immunologic factors|mesh-ancestor
24828453|NCT02145624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828454|NCT02145637|Afatinib|afatinib|mesh-list
24828455|NCT02145637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828456|NCT02145637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24828457|NCT02145637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828458|NCT02145637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828459|NCT02145689|Botulinum Toxins|botulinum toxins|mesh-list
24828460|NCT02145689|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24828461|NCT02145689|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24828462|NCT02145689|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24828463|NCT02145689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25843463|NCT00034905|Dopamine Agents|dopamine agents|mesh-ancestor
25843464|NCT00034905|Antidepressive Agents|antidepressive agents|mesh-ancestor
25843465|NCT00034944|Aprepitant|aprepitant|mesh-list
25843466|NCT00034944|Antiemetics|antiemetics|mesh-ancestor
25843467|NCT00034944|Autonomic Agents|autonomic agents|mesh-ancestor
25843468|NCT00034944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25843469|NCT00034944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843470|NCT00034944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25843471|NCT00034944|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25843472|NCT00034944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25843473|NCT00034944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843474|NCT00034983|Aprepitant|aprepitant|mesh-list
25843475|NCT00034983|Paroxetine|paroxetine|mesh-list
25843476|NCT00034983|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25843477|NCT00034983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25843478|NCT00034983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25843479|NCT00034983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843480|NCT00034983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25843481|NCT00034983|Serotonin Agents|serotonin agents|mesh-ancestor
24975607|NCT03440112|Antidotes|antidotes|mesh-ancestor
25843482|NCT00034983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843483|NCT00034983|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25843484|NCT00034983|Antidepressive Agents|antidepressive agents|mesh-ancestor
25843485|NCT00034983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25843486|NCT00034983|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24447654|NCT00309322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25661425|NCT01633060|Hormone Antagonists|hormone antagonists|mesh-ancestor
25661426|NCT01633060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25661427|NCT01633060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893342|NCT04451382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893343|NCT04451382|Cholinergic Agents|cholinergic agents|mesh-ancestor
24893344|NCT04451382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24893346|NCT04451174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24893347|NCT04451174|Glucocorticoids|glucocorticoids|mesh-ancestor
25843487|NCT00034983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25843488|NCT00034983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843489|NCT00034983|Antiemetics|antiemetics|mesh-ancestor
25843490|NCT00034983|Autonomic Agents|autonomic agents|mesh-ancestor
25843491|NCT00034983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25843492|NCT00034983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25843493|NCT00034983|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25843494|NCT00035009|Aprepitant|aprepitant|mesh-list
24975678|NCT03286114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24828643|NCT02146703|Immunologic Factors|immunologic factors|mesh-ancestor
24828644|NCT02146703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165885|NCT04569877|Molgramostim|molgramostim|mesh-list
25165886|NCT04569877|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25165887|NCT04569877|Sargramostim|sargramostim|mesh-list
25165888|NCT04569877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25165889|NCT04569877|Immunologic Factors|immunologic factors|mesh-ancestor
25165890|NCT04569877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165891|NCT04551352|Adalimumab|adalimumab|mesh-list
25165892|NCT04551352|Obinutuzumab|obinutuzumab|mesh-list
25165893|NCT04551352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25165894|NCT04551352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25165895|NCT04551352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25165896|NCT04551352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828645|NCT02146846|Imatinib Mesylate|imatinib mesylate|mesh-list
24828646|NCT02146846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828647|NCT02146846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24828648|NCT02146846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828649|NCT02146846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828650|NCT02146911|Bupropion|bupropion|mesh-list
24828651|NCT02146911|Varenicline|varenicline|mesh-list
25843495|NCT00035009|Paroxetine|paroxetine|mesh-list
25843496|NCT00035009|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25843497|NCT00035009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25843498|NCT00035009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25843499|NCT00035009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843500|NCT00035009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25843501|NCT00035009|Serotonin Agents|serotonin agents|mesh-ancestor
25843502|NCT00035009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795049|NCT03831113|Sensory System Agents|sensory system agents|mesh-ancestor
25843503|NCT00035009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24828656|NCT02146911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24828657|NCT02146911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24828658|NCT02146911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828659|NCT02146911|Dopamine Agents|dopamine agents|mesh-ancestor
24828660|NCT02146911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24828661|NCT02146911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828662|NCT02146911|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24828663|NCT02146911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24828664|NCT02146911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828665|NCT02146911|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24828666|NCT02146911|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24828667|NCT02146911|Cholinergic Agents|cholinergic agents|mesh-ancestor
24828668|NCT02146937|Bicalutamide|bicalutamide|mesh-list
24828669|NCT02146937|Finasteride|finasteride|mesh-list
24828670|NCT02146937|Androgen Antagonists|androgen antagonists|mesh-ancestor
24828671|NCT02146937|Hormone Antagonists|hormone antagonists|mesh-ancestor
24828672|NCT02146937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24828673|NCT02146937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722309|NCT01579539|Hormones|hormones|mesh-ancestor
25661428|NCT01633112|Glatiramer Acetate|glatiramer acetate|mesh-list
25661429|NCT01633112|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25661430|NCT01633112|(T,G)-A-L|(t,g)-a-l|mesh-list
25661431|NCT01633112|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25661432|NCT01633112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828676|NCT02146937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25661433|NCT01633112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25661434|NCT01633112|Immunologic Factors|immunologic factors|mesh-ancestor
25661435|NCT01633112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843505|NCT00035009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25661436|NCT01633112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25661437|NCT01633112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25661438|NCT01633827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25661439|NCT01633827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25843506|NCT00035009|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25843507|NCT00035009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25108805|NCT03130218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108835|NCT03130270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24878901|NCT00336063|Antimetabolites|antimetabolites|mesh-ancestor
24828677|NCT02146937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828678|NCT02146937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828679|NCT02146937|Urological Agents|urological agents|mesh-ancestor
25843508|NCT00035009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843509|NCT00035009|Antiemetics|antiemetics|mesh-ancestor
25843510|NCT00035009|Autonomic Agents|autonomic agents|mesh-ancestor
25843511|NCT00035009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25843512|NCT00035009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25843513|NCT00035009|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25843514|NCT00035035|Gemcitabine|gemcitabine|mesh-list
25843515|NCT00035035|Pemetrexed|pemetrexed|mesh-list
25843516|NCT00035035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25843517|NCT00035035|Antimetabolites|antimetabolites|mesh-ancestor
25843518|NCT00035035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843519|NCT00035035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843520|NCT00035035|Antiviral Agents|antiviral agents|mesh-ancestor
25843521|NCT00035035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25843522|NCT00035035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843523|NCT00035035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25843524|NCT00035035|Immunologic Factors|immunologic factors|mesh-ancestor
25843525|NCT00035035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105486|NCT03146104|Isoflurane|isoflurane|mesh-list
25843526|NCT00035035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25843527|NCT00035035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25843528|NCT00035048|Aprepitant|aprepitant|mesh-list
25843529|NCT00035048|Antiemetics|antiemetics|mesh-ancestor
25843530|NCT00035048|Autonomic Agents|autonomic agents|mesh-ancestor
25843531|NCT00035048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25843532|NCT00035048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843533|NCT00035048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25843534|NCT00035048|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24828884|NCT02148016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828885|NCT02148016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24828886|NCT02148016|Respiratory System Agents|respiratory system agents|mesh-ancestor
24828888|NCT02148094|Emtricitabine|emtricitabine|mesh-list
24828889|NCT02148094|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24828890|NCT02148094|Antiviral Agents|antiviral agents|mesh-ancestor
24828891|NCT02148094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25843535|NCT00035048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25843536|NCT00035048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843537|NCT00035061|Pemetrexed|pemetrexed|mesh-list
24829129|NCT02150031|Chlorhexidine|chlorhexidine|mesh-list
25843538|NCT00035061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843539|NCT00035061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843540|NCT00035061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843541|NCT00035061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25843542|NCT00035061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25843543|NCT00035074|Methotrexate|methotrexate|mesh-list
25042626|NCT01408082|Hormones|hormones|mesh-ancestor
24828947|NCT02148432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24828948|NCT02148432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24828949|NCT02148432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24828950|NCT02148432|Adrenergic Agents|adrenergic agents|mesh-ancestor
24828952|NCT02148432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828953|NCT02148549|Oxaliplatin|oxaliplatin|mesh-list
24828954|NCT02148549|Irinotecan|irinotecan|mesh-list
25661440|NCT01633827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661441|NCT01633853|Vitamin D|vitamin d|mesh-list
25661442|NCT01633853|Ergocalciferols|ergocalciferols|mesh-list
25661443|NCT01633853|Cholecalciferol|cholecalciferol|mesh-list
25661444|NCT01633853|Vitamins|vitamins|mesh-list
25661445|NCT01633853|Micronutrients|micronutrients|mesh-ancestor
25661446|NCT01633853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893737|NCT04446715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24893738|NCT04446715|Anesthetics, General|anesthetics, general|mesh-ancestor
24893739|NCT04446598|Tadalafil|tadalafil|mesh-list
24893740|NCT04446598|Vasodilator Agents|vasodilator agents|mesh-ancestor
24893741|NCT04446598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24520073|NCT03936192|Analgesics|analgesics|mesh-ancestor
24828955|NCT02148549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828956|NCT02148549|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24828957|NCT02148549|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24828958|NCT02148549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828959|NCT02148549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828960|NCT02148601|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24828961|NCT02148601|Vancomycin|vancomycin|mesh-list
24828976|NCT02148848|Risedronic Acid|risedronic acid|mesh-list
24828977|NCT02148848|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24828978|NCT02148848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24828979|NCT02148848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975956|NCT02367846|NuvaRing|nuvaring|mesh-list
24828980|NCT02148848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24828981|NCT02148848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828982|NCT02148848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25843544|NCT00035074|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25843545|NCT00035074|Abortifacient Agents|abortifacient agents|mesh-ancestor
25843546|NCT00035074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24829063|NCT02149706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829065|NCT02149758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24829088|NCT02149888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829089|NCT02149888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25843547|NCT00035074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843548|NCT00035074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25843549|NCT00035074|Antimetabolites|antimetabolites|mesh-ancestor
25843550|NCT00035074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843551|NCT00035074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843552|NCT00035074|Dermatologic Agents|dermatologic agents|mesh-ancestor
25843553|NCT00035074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843554|NCT00035074|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25843555|NCT00035074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25843556|NCT00035074|Immunologic Factors|immunologic factors|mesh-ancestor
25843557|NCT00035074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25843558|NCT00035074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25843559|NCT00035087|Epothilones|epothilones|mesh-list
25843560|NCT00035087|Epothilone B|epothilone b|mesh-list
25843561|NCT00035087|Tubulin Modulators|tubulin modulators|mesh-ancestor
25843562|NCT00035087|Antimitotic Agents|antimitotic agents|mesh-ancestor
25843563|NCT00035087|Mitosis Modulators|mitosis modulators|mesh-ancestor
25843564|NCT00035087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843565|NCT00035087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843566|NCT00035100|Epothilones|epothilones|mesh-list
25843567|NCT00035100|Epothilone B|epothilone b|mesh-list
25843568|NCT00035100|Tubulin Modulators|tubulin modulators|mesh-ancestor
25042685|NCT01390545|Veltuzumab|veltuzumab|mesh-list
24829120|NCT02149953|Glycine Agents|glycine agents|mesh-ancestor
24829121|NCT02149953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24829122|NCT02149953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829123|NCT02149953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829125|NCT02149992|Vitamin B Complex|vitamin b complex|mesh-ancestor
24829126|NCT02149992|Vitamins|vitamins|mesh-ancestor
24829127|NCT02149992|Micronutrients|micronutrients|mesh-ancestor
24829128|NCT02149992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829148|NCT02150031|Disinfectants|disinfectants|mesh-ancestor
24829149|NCT02150031|Dermatologic Agents|dermatologic agents|mesh-ancestor
24829150|NCT02150031|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24829151|NCT02150031|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24829152|NCT02150031|Adrenergic Agents|adrenergic agents|mesh-ancestor
24829153|NCT02150031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24829154|NCT02150031|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24829155|NCT02150031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24829156|NCT02150031|Autonomic Agents|autonomic agents|mesh-ancestor
24829157|NCT02150031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25418183|NCT02797470|Antiviral Agents|antiviral agents|mesh-ancestor
25661447|NCT01633853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25661448|NCT01633853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25661449|NCT01633944|Buprenorphine|buprenorphine|mesh-list
25661450|NCT01633944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25661451|NCT01633944|Narcotics|narcotics|mesh-ancestor
24829158|NCT02150031|Respiratory System Agents|respiratory system agents|mesh-ancestor
24829159|NCT02150031|Mydriatics|mydriatics|mesh-ancestor
24829160|NCT02150031|Sympathomimetics|sympathomimetics|mesh-ancestor
24829161|NCT02150031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25041551|NCT02488408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25041552|NCT02488408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25843569|NCT00035100|Antimitotic Agents|antimitotic agents|mesh-ancestor
25843570|NCT00035100|Mitosis Modulators|mitosis modulators|mesh-ancestor
25843571|NCT00035100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843572|NCT00035100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843573|NCT00035113|Epothilones|epothilones|mesh-list
25843574|NCT00035113|Epothilone B|epothilone b|mesh-list
25843575|NCT00035113|Tubulin Modulators|tubulin modulators|mesh-ancestor
25843576|NCT00035113|Antimitotic Agents|antimitotic agents|mesh-ancestor
25843577|NCT00035113|Mitosis Modulators|mitosis modulators|mesh-ancestor
25843578|NCT00035113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843579|NCT00035113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843580|NCT00035126|Epothilones|epothilones|mesh-list
25843581|NCT00035126|Epothilone B|epothilone b|mesh-list
24795112|NCT03626922|Hormones|hormones|mesh-ancestor
25843582|NCT00035126|Tubulin Modulators|tubulin modulators|mesh-ancestor
25843583|NCT00035126|Antimitotic Agents|antimitotic agents|mesh-ancestor
25843584|NCT00035126|Mitosis Modulators|mitosis modulators|mesh-ancestor
25165897|NCT04546633|Lumefantrine|lumefantrine|mesh-list
25843585|NCT00035126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843586|NCT00035126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843587|NCT00035139|Methylphenidate|methylphenidate|mesh-list
25843588|NCT00035139|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25843589|NCT00035139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843590|NCT00035139|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25042784|NCT01369095|Serotonin Agents|serotonin agents|mesh-ancestor
24829191|NCT02150161|Narcotics|narcotics|mesh-ancestor
24829192|NCT02150161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24829193|NCT02150291|Folic Acid|folic acid|mesh-list
24829194|NCT02150291|Vitamin B Complex|vitamin b complex|mesh-list
24829195|NCT02150291|Hematinics|hematinics|mesh-ancestor
24829196|NCT02150291|Vitamins|vitamins|mesh-ancestor
24829197|NCT02150291|Micronutrients|micronutrients|mesh-ancestor
24829198|NCT02150291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829199|NCT02150317|Sorafenib|sorafenib|mesh-list
24829200|NCT02150317|Chlorotrianisene|chlorotrianisene|mesh-list
24829201|NCT02150317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24829202|NCT02150317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24829203|NCT02150317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829204|NCT02150317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843591|NCT00035139|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25843592|NCT00035139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25843593|NCT00035139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447829|NCT00309686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24447830|NCT00309686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24829261|NCT02150993|Raltegravir Potassium|raltegravir potassium|mesh-list
25843594|NCT00035139|Dopamine Agents|dopamine agents|mesh-ancestor
25843595|NCT00035139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25843596|NCT00035152|Paclitaxel|paclitaxel|mesh-list
24829262|NCT02150993|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
24829263|NCT02150993|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24829264|NCT02150993|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24829265|NCT02150993|Protease Inhibitors|protease inhibitors|mesh-ancestor
24829266|NCT02150993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829267|NCT02150993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843597|NCT00035152|Carboplatin|carboplatin|mesh-list
25843598|NCT00035152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25843599|NCT00035152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843600|NCT00035152|Tubulin Modulators|tubulin modulators|mesh-ancestor
25843601|NCT00035152|Antimitotic Agents|antimitotic agents|mesh-ancestor
25165899|NCT04546633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25165900|NCT04546633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25165901|NCT04546633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25165907|NCT04534270|Dapagliflozin|dapagliflozin|mesh-list
25165908|NCT04534270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25843602|NCT00035152|Mitosis Modulators|mitosis modulators|mesh-ancestor
25843603|NCT00035152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843604|NCT00035165|Epothilones|epothilones|mesh-list
25843605|NCT00035165|Epothilone B|epothilone b|mesh-list
25843606|NCT00035165|Tubulin Modulators|tubulin modulators|mesh-ancestor
25843607|NCT00035165|Antimitotic Agents|antimitotic agents|mesh-ancestor
25843608|NCT00035165|Mitosis Modulators|mitosis modulators|mesh-ancestor
25661452|NCT01633944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25661453|NCT01633944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661454|NCT01633944|Analgesics|analgesics|mesh-ancestor
25661455|NCT01633944|Sensory System Agents|sensory system agents|mesh-ancestor
25661456|NCT01633944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25661457|NCT01633944|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25661458|NCT01634100|Empagliflozin|empagliflozin|mesh-list
25661459|NCT01634100|Rifampin|rifampin|mesh-list
25661460|NCT01634100|Probenecid|probenecid|mesh-list
24894275|NCT04442919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25843609|NCT00035165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843610|NCT00035165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843611|NCT00035178|Argatroban|argatroban|mesh-list
25843612|NCT00035178|Antithrombins|antithrombins|mesh-ancestor
25843613|NCT00035178|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25843614|NCT00035178|Protease Inhibitors|protease inhibitors|mesh-ancestor
25843615|NCT00035178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843616|NCT00035178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843617|NCT00035178|Anticoagulants|anticoagulants|mesh-ancestor
25843618|NCT00035178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25042831|NCT01361802|Ambroxol|ambroxol|mesh-list
25843619|NCT00035191|Galantamine|galantamine|mesh-list
25843620|NCT00035191|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25843621|NCT00035191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843622|NCT00035191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843623|NCT00035191|Cholinergic Agents|cholinergic agents|mesh-ancestor
25843624|NCT00035191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25843625|NCT00035191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976677|NCT05275699|Glycine|glycine|mesh-list
25843626|NCT00035191|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25843627|NCT00035191|Autonomic Agents|autonomic agents|mesh-ancestor
25843628|NCT00035191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25843629|NCT00035191|Nootropic Agents|nootropic agents|mesh-ancestor
25843630|NCT00035204|Galantamine|galantamine|mesh-list
25843631|NCT00035204|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25843632|NCT00035204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843633|NCT00035204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843634|NCT00035204|Cholinergic Agents|cholinergic agents|mesh-ancestor
24447950|NCT00309894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447951|NCT00309894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24829333|NCT02151604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829334|NCT02151630|Salicylic Acid|salicylic acid|mesh-list
24447952|NCT00309894|Hormone Antagonists|hormone antagonists|mesh-ancestor
25843635|NCT00035204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25843636|NCT00035204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843637|NCT00035204|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25843638|NCT00035204|Autonomic Agents|autonomic agents|mesh-ancestor
25843639|NCT00035204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25843640|NCT00035204|Nootropic Agents|nootropic agents|mesh-ancestor
25843641|NCT00035230|Topiramate|topiramate|mesh-list
25843642|NCT00035230|Anticonvulsants|anticonvulsants|mesh-ancestor
25843643|NCT00035230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25843644|NCT00035230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843645|NCT00035243|Epothilones|epothilones|mesh-list
25843646|NCT00035243|Epothilone B|epothilone b|mesh-list
25843647|NCT00035243|Tubulin Modulators|tubulin modulators|mesh-ancestor
25041589|NCT01621243|Antiviral Agents|antiviral agents|mesh-ancestor
25843648|NCT00035243|Antimitotic Agents|antimitotic agents|mesh-ancestor
25843649|NCT00035243|Mitosis Modulators|mitosis modulators|mesh-ancestor
25843650|NCT00035243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843651|NCT00035243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843652|NCT00035256|Teriparatide|teriparatide|mesh-list
25043006|NCT01337752|Bortezomib|bortezomib|mesh-list
25843653|NCT00035256|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25843654|NCT00035256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25843655|NCT00035256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843656|NCT00035256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25843657|NCT00035256|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25843658|NCT00035256|Hormone Antagonists|hormone antagonists|mesh-ancestor
25843659|NCT00035256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25843660|NCT00035256|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25843661|NCT00035256|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25661461|NCT01634100|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25661462|NCT01634100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879144|NCT05006599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24786774|NCT01921790|Oxaliplatin|oxaliplatin|mesh-list
24786784|NCT01921790|Hormones|hormones|mesh-ancestor
25843662|NCT00035269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25843663|NCT00035269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25843664|NCT00035282|Aprepitant|aprepitant|mesh-list
25843665|NCT00035282|Antiemetics|antiemetics|mesh-ancestor
25843666|NCT00035282|Autonomic Agents|autonomic agents|mesh-ancestor
25843667|NCT00035282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25843668|NCT00035282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843669|NCT00035282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25843670|NCT00035282|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25843671|NCT00035282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25843672|NCT00035282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843673|NCT00035295|Aprepitant|aprepitant|mesh-list
25843674|NCT00035295|Antiemetics|antiemetics|mesh-ancestor
25843675|NCT00035295|Autonomic Agents|autonomic agents|mesh-ancestor
25843676|NCT00035295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25843677|NCT00035295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843678|NCT00035295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25843679|NCT00035295|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25843680|NCT00035295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25843681|NCT00035295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843682|NCT00035308|Abetimus|abetimus|mesh-list
25843683|NCT00035308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24829338|NCT02151630|Keratolytic Agents|keratolytic agents|mesh-ancestor
24829339|NCT02151630|Dermatologic Agents|dermatologic agents|mesh-ancestor
25843684|NCT00035308|Immunologic Factors|immunologic factors|mesh-ancestor
25843685|NCT00035308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843686|NCT00035321|Olanzapine|olanzapine|mesh-list
25843687|NCT00035321|Fluoxetine|fluoxetine|mesh-list
25843688|NCT00035321|Antiemetics|antiemetics|mesh-ancestor
25843689|NCT00035321|Autonomic Agents|autonomic agents|mesh-ancestor
25843690|NCT00035321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25843691|NCT00035321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843692|NCT00035321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25843693|NCT00035321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25843694|NCT00035321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25843695|NCT00035321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25843696|NCT00035321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25843697|NCT00035321|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25843698|NCT00035321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24976731|NCT05274672|Antimalarials|antimalarials|mesh-ancestor
25843699|NCT00035321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25843700|NCT00035321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843701|NCT00035321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25843702|NCT00035321|Serotonin Agents|serotonin agents|mesh-ancestor
24829380|NCT02151929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24829382|NCT02151929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829384|NCT02151968|Anesthetics, Local|anesthetics, local|mesh-list
25843703|NCT00035321|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25843704|NCT00035321|Antidepressive Agents|antidepressive agents|mesh-ancestor
25843705|NCT00035321|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25843706|NCT00035321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25843707|NCT00035321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843708|NCT00035347|Azithromycin|azithromycin|mesh-list
25843709|NCT00035347|Levofloxacin|levofloxacin|mesh-list
25843710|NCT00035347|Ofloxacin|ofloxacin|mesh-list
25843711|NCT00035347|Ceftriaxone|ceftriaxone|mesh-list
25843712|NCT00035347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25843713|NCT00035347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25843714|NCT00035347|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25843715|NCT00035347|Renal Agents|renal agents|mesh-ancestor
25843716|NCT00035347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25843717|NCT00035347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25843718|NCT00035347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843719|NCT00035347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843720|NCT00035347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843721|NCT00035347|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25843722|NCT00035347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25661463|NCT01634100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25661464|NCT01634100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661465|NCT01634100|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25418483|NCT02773030|Bortezomib|bortezomib|mesh-list
24894605|NCT04438655|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24894606|NCT04438655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24894607|NCT04438837|Hydroxychloroquine|hydroxychloroquine|mesh-list
24894608|NCT04438837|Antimalarials|antimalarials|mesh-ancestor
24894609|NCT04438837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24520150|NCT03736863|Apatinib|apatinib|mesh-list
24894610|NCT04438837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24894611|NCT04438837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24894766|NCT05387941|Autonomic Agents|autonomic agents|mesh-ancestor
25843723|NCT00035360|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25843724|NCT00035360|Antiviral Agents|antiviral agents|mesh-ancestor
25843725|NCT00035360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25843726|NCT00035425|Vancomycin|vancomycin|mesh-list
25843727|NCT00035425|Linezolid|linezolid|mesh-list
25843728|NCT00035425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25843729|NCT00035425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24448080|NCT00310141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829385|NCT02151968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24829386|NCT02151968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829387|NCT02151968|Sensory System Agents|sensory system agents|mesh-ancestor
25843730|NCT00035425|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25843731|NCT00035425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843732|NCT00035425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843733|NCT00035451|Sotalol|sotalol|mesh-list
25843734|NCT00035451|Azimilide|azimilide|mesh-list
25843735|NCT00035451|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25843736|NCT00035451|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25843737|NCT00035451|Adrenergic Agents|adrenergic agents|mesh-ancestor
25843738|NCT00035451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25843739|NCT00035451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843740|NCT00035451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843741|NCT00035451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25843742|NCT00035451|Sympatholytics|sympatholytics|mesh-ancestor
25843743|NCT00035451|Autonomic Agents|autonomic agents|mesh-ancestor
25843744|NCT00035451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25843745|NCT00035451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25843746|NCT00035451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25843747|NCT00035451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25843748|NCT00035464|Azimilide|azimilide|mesh-list
25843749|NCT00035464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25843750|NCT00035464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25843751|NCT00035464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25843752|NCT00035464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843753|NCT00035464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25041571|NCT02471222|Sensory System Agents|sensory system agents|mesh-ancestor
25041572|NCT02471222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25041573|NCT01625234|Ensartinib|ensartinib|mesh-list
25041574|NCT01625234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041575|NCT01625234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25041576|NCT01625234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041577|NCT01625234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041579|NCT01621243|Paclitaxel|paclitaxel|mesh-list
25041580|NCT01621243|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25041581|NCT01621243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25041582|NCT01621243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041583|NCT01621243|Tubulin Modulators|tubulin modulators|mesh-ancestor
25041584|NCT01621243|Antimitotic Agents|antimitotic agents|mesh-ancestor
25041585|NCT01621243|Mitosis Modulators|mitosis modulators|mesh-ancestor
25041586|NCT01621243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041587|NCT01621243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25041588|NCT01621243|Antimetabolites|antimetabolites|mesh-ancestor
25843754|NCT00035464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843755|NCT00035477|Azimilide|azimilide|mesh-list
25843756|NCT00035477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25843757|NCT00035477|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25418484|NCT02773030|Daratumumab|daratumumab|mesh-list
25661466|NCT01634100|Antitubercular Agents|antitubercular agents|mesh-ancestor
25661467|NCT01634100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25661468|NCT01634100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25661469|NCT01634100|Leprostatic Agents|leprostatic agents|mesh-ancestor
25661470|NCT01634100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25661471|NCT01634100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661472|NCT01634100|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25843758|NCT00035477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25843759|NCT00035477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843760|NCT00035477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24475025|NCT00408551|Levoleucovorin|levoleucovorin|mesh-list
24475026|NCT00408551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24475027|NCT00408551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843761|NCT00035477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843762|NCT00035490|Azimilide|azimilide|mesh-list
24879365|NCT04796454|Gemcitabine|gemcitabine|mesh-list
24879366|NCT04796454|Oxaliplatin|oxaliplatin|mesh-list
24815757|NCT02071888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24815774|NCT02071966|Clopidogrel|clopidogrel|mesh-list
25843763|NCT00035490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25843764|NCT00035490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25843765|NCT00035490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25843766|NCT00035490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843767|NCT00035490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25843768|NCT00035490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843769|NCT00035516|Epothilones|epothilones|mesh-list
25843770|NCT00035516|Tubulin Modulators|tubulin modulators|mesh-ancestor
25843771|NCT00035516|Antimitotic Agents|antimitotic agents|mesh-ancestor
25165967|NCT04501653|Psilocybin|psilocybin|mesh-list
25165968|NCT04501653|Psilocin|psilocin|mesh-list
25165969|NCT04501653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25165970|NCT04501653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25165971|NCT04501653|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25165972|NCT04501653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25165973|NCT04501653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25165974|NCT04501653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25165975|NCT04501653|Dopamine Agents|dopamine agents|mesh-ancestor
25165976|NCT04501653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25165977|NCT04501653|Hallucinogens|hallucinogens|mesh-ancestor
25165978|NCT04501653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25165979|NCT04493164|Cytarabine|cytarabine|mesh-list
25165980|NCT04493164|Daunorubicin|daunorubicin|mesh-list
25843772|NCT00035516|Mitosis Modulators|mitosis modulators|mesh-ancestor
25843773|NCT00035516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829405|NCT02152228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24829406|NCT02152228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843774|NCT00035516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843775|NCT00035581|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
25843776|NCT00035581|Poly I-C|poly i-c|mesh-list
24448143|NCT00310505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25843777|NCT00035581|Antiviral Agents|antiviral agents|mesh-ancestor
24829412|NCT02152306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24829413|NCT02152306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843778|NCT00035581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25843779|NCT00035581|Interferon Inducers|interferon inducers|mesh-ancestor
25843780|NCT00035581|Immunologic Factors|immunologic factors|mesh-ancestor
24977488|NCT02988401|Insulin|insulin|mesh-list
25843781|NCT00035581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843782|NCT00035607|Darbepoetin alfa|darbepoetin alfa|mesh-list
25843783|NCT00035607|Hematinics|hematinics|mesh-ancestor
25843784|NCT00035620|Lenograstim|lenograstim|mesh-list
25843785|NCT00035620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25843786|NCT00035620|Immunologic Factors|immunologic factors|mesh-ancestor
25843787|NCT00035620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843788|NCT00035802|Topiramate|topiramate|mesh-list
25843789|NCT00035802|Anticonvulsants|anticonvulsants|mesh-ancestor
25843790|NCT00035802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25843791|NCT00035802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843792|NCT00035854|Linezolid|linezolid|mesh-list
24829414|NCT02152306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25041592|NCT01621243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25041593|NCT01621243|Immunologic Factors|immunologic factors|mesh-ancestor
25041594|NCT01621243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661473|NCT01634100|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25661474|NCT01634100|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25661475|NCT01634100|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25661476|NCT01634100|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25661477|NCT01634100|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25661478|NCT01634100|Uricosuric Agents|uricosuric agents|mesh-ancestor
25661479|NCT01634100|Gout Suppressants|gout suppressants|mesh-ancestor
25661480|NCT01634100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25268749|NCT02414581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24475917|NCT00412022|Letrozole|letrozole|mesh-list
24475937|NCT00412035|Botulinum Toxins|botulinum toxins|mesh-list
24475938|NCT00412035|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25041595|NCT01619332|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25041596|NCT01619332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25041597|NCT01619332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829424|NCT02152332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843793|NCT00035854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25843794|NCT00035854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25843795|NCT00035854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25165981|NCT04493164|Ivosidenib|ivosidenib|mesh-list
25843796|NCT00035854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843797|NCT00035854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875759|NCT04162210|Dexamethasone|dexamethasone|mesh-list
25875760|NCT04162210|Pomalidomide|pomalidomide|mesh-list
25875761|NCT04162210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25875762|NCT04162210|Antiemetics|antiemetics|mesh-ancestor
25875763|NCT04162210|Autonomic Agents|autonomic agents|mesh-ancestor
25875764|NCT04162210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25875765|NCT04162210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829427|NCT02152332|Contraceptive Agents|contraceptive agents|mesh-ancestor
25043428|NCT01261312|Guadecitabine|guadecitabine|mesh-list
25875766|NCT04162210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25875767|NCT04162210|Glucocorticoids|glucocorticoids|mesh-ancestor
25875768|NCT04162210|Hormones|hormones|mesh-ancestor
25875769|NCT04162210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25875770|NCT04162210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25875771|NCT04162210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875772|NCT04162210|Immunologic Factors|immunologic factors|mesh-ancestor
24829437|NCT02152358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24829438|NCT02152358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24829439|NCT02152358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829440|NCT02152358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829441|NCT02152410|Morphine|morphine|mesh-list
24829442|NCT02152410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24829443|NCT02152410|Narcotics|narcotics|mesh-ancestor
24829444|NCT02152410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24977771|NCT02177695|Tubulin Modulators|tubulin modulators|mesh-ancestor
25875773|NCT04162210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25875774|NCT04162210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25875775|NCT04162210|Growth Substances|growth substances|mesh-ancestor
25875776|NCT04162210|Growth Inhibitors|growth inhibitors|mesh-ancestor
25875777|NCT04154787|Rituximab|rituximab|mesh-list
25875778|NCT04154787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25875779|NCT04154787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875780|NCT04154787|Immunologic Factors|immunologic factors|mesh-ancestor
25875781|NCT04154787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875782|NCT04154787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25055194|NCT03523221|Dexamethasone|dexamethasone|mesh-list
25875783|NCT04153565|Cisplatin|cisplatin|mesh-list
25875784|NCT04153565|Pembrolizumab|pembrolizumab|mesh-list
25875785|NCT04153565|Pemetrexed|pemetrexed|mesh-list
25875786|NCT04153565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448211|NCT00310765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24448212|NCT00310765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24448213|NCT00310765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24448214|NCT00310765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24448215|NCT00310765|Antimanic Agents|antimanic agents|mesh-ancestor
24448216|NCT00310778|Atenolol|atenolol|mesh-list
24448217|NCT00310778|Valsartan|valsartan|mesh-list
24448218|NCT00310778|Candesartan|candesartan|mesh-list
24448219|NCT00310778|Ramipril|ramipril|mesh-list
24977890|NCT01670409|Antimetabolites|antimetabolites|mesh-ancestor
25105693|NCT05178823|Cariostatic Agents|cariostatic agents|mesh-ancestor
25105700|NCT05166304|Rebamipide|rebamipide|mesh-list
25875787|NCT04153565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24829516|NCT02152943|Letrozole|letrozole|mesh-list
24820220|NCT02099240|Rifapentine|rifapentine|mesh-list
25875788|NCT04153565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875789|NCT04153565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041658|NCT01604889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25418636|NCT02761057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661482|NCT01634113|Bromides|bromides|mesh-list
25661483|NCT01634113|Tiotropium Bromide|tiotropium bromide|mesh-list
25661484|NCT01634113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25661485|NCT01634113|Autonomic Agents|autonomic agents|mesh-ancestor
24815820|NCT02072135|Sensory System Agents|sensory system agents|mesh-ancestor
24815822|NCT02072213|Tamsulosin|tamsulosin|mesh-list
25041659|NCT01604889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041671|NCT01602393|Flurbiprofen|flurbiprofen|mesh-list
25041672|NCT01602393|Analgesics|analgesics|mesh-ancestor
25041673|NCT01602393|Sensory System Agents|sensory system agents|mesh-ancestor
25041674|NCT01602393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25041675|NCT01602393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041676|NCT01602393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25041677|NCT01602393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25041678|NCT01602393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25041679|NCT01602393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25041680|NCT01602393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25041681|NCT01602393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041682|NCT01602393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041683|NCT01594983|Fenofibrate|fenofibrate|mesh-list
25041684|NCT01594983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24829455|NCT02152475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24829456|NCT02152475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24829457|NCT02152475|Analgesics|analgesics|mesh-ancestor
24829458|NCT02152475|Sensory System Agents|sensory system agents|mesh-ancestor
24829459|NCT02152475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24829460|NCT02152475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829461|NCT02152475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24829462|NCT02152475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25043584|NCT01235754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843798|NCT00035893|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
25843799|NCT00035893|Poly I-C|poly i-c|mesh-list
25843800|NCT00035893|Antiviral Agents|antiviral agents|mesh-ancestor
25843801|NCT00035893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24829464|NCT02152475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843802|NCT00035893|Interferon Inducers|interferon inducers|mesh-ancestor
25843803|NCT00035893|Immunologic Factors|immunologic factors|mesh-ancestor
24407469|NCT00174590|Risperidone|risperidone|mesh-list
25843804|NCT00035893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843805|NCT00035958|Prednisone|prednisone|mesh-list
25843806|NCT00035958|Etanercept|etanercept|mesh-list
25843807|NCT00035958|Methotrexate|methotrexate|mesh-list
25843808|NCT00035958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25843809|NCT00035958|Glucocorticoids|glucocorticoids|mesh-ancestor
25843810|NCT00035958|Hormones|hormones|mesh-ancestor
25843811|NCT00035958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25843812|NCT00035958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843813|NCT00035958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25843814|NCT00035958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843815|NCT00035958|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25843816|NCT00035958|Abortifacient Agents|abortifacient agents|mesh-ancestor
24448318|NCT00311129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24448332|NCT00311337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448333|NCT00311389|Timolol|timolol|mesh-list
24448334|NCT00311389|Travoprost|travoprost|mesh-list
25843817|NCT00035958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25843818|NCT00035958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25843819|NCT00035958|Antimetabolites|antimetabolites|mesh-ancestor
25843820|NCT00035958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843821|NCT00035958|Dermatologic Agents|dermatologic agents|mesh-ancestor
25843822|NCT00035958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829476|NCT02152514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24829477|NCT02152514|Anesthetics, General|anesthetics, general|mesh-ancestor
24829478|NCT02152514|Anesthetics|anesthetics|mesh-ancestor
25843823|NCT00035958|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25843824|NCT00035958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25843825|NCT00035958|Immunologic Factors|immunologic factors|mesh-ancestor
25843826|NCT00035958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25843827|NCT00035958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25843828|NCT00035958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25843829|NCT00035958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25843830|NCT00035958|Analgesics|analgesics|mesh-ancestor
25661486|NCT01634113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25661487|NCT01634113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661488|NCT01634113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25661489|NCT01634113|Respiratory System Agents|respiratory system agents|mesh-ancestor
25661490|NCT01634113|Parasympatholytics|parasympatholytics|mesh-ancestor
25843831|NCT00035958|Sensory System Agents|sensory system agents|mesh-ancestor
25843832|NCT00035958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25843833|NCT00035958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25843834|NCT00035971|Alendronate|alendronate|mesh-list
25843835|NCT00035971|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25843836|NCT00035971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25843837|NCT00035971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843838|NCT00035971|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25843839|NCT00035971|Hormone Antagonists|hormone antagonists|mesh-ancestor
25843840|NCT00035971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25843841|NCT00035971|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25843842|NCT00035971|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25843843|NCT00035984|Exenatide|exenatide|mesh-list
25843844|NCT00035984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25165982|NCT04493164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25165983|NCT04493164|Antimetabolites|antimetabolites|mesh-ancestor
25843845|NCT00035984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843846|NCT00035984|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25843847|NCT00035984|Incretins|incretins|mesh-ancestor
25843848|NCT00035984|Hormones|hormones|mesh-ancestor
25843849|NCT00035984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25843850|NCT00035997|Zoledronic Acid|zoledronic acid|mesh-list
24829508|NCT02152917|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24829509|NCT02152917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24829510|NCT02152917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829512|NCT02152917|Coagulants|coagulants|mesh-ancestor
25843851|NCT00035997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25843852|NCT00035997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041685|NCT01594983|Antimetabolites|antimetabolites|mesh-ancestor
25041686|NCT01594983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041687|NCT01594983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25041688|NCT01594216|Exemestane|exemestane|mesh-list
25041689|NCT01594216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041690|NCT01594216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25041691|NCT01594216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25041692|NCT01594216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055471|NCT03520985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25843853|NCT00036023|Darbepoetin alfa|darbepoetin alfa|mesh-list
25843854|NCT00036023|Hematinics|hematinics|mesh-ancestor
25843855|NCT00036062|Sivelestat|sivelestat|mesh-list
25843856|NCT00036062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25843857|NCT00036062|Protease Inhibitors|protease inhibitors|mesh-ancestor
25843858|NCT00036062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843859|NCT00036062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843860|NCT00036088|Olanzapine|olanzapine|mesh-list
25843861|NCT00036088|Antiemetics|antiemetics|mesh-ancestor
25843862|NCT00036088|Autonomic Agents|autonomic agents|mesh-ancestor
25843863|NCT00036088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25843864|NCT00036088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843865|NCT00036088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25843866|NCT00036088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24829514|NCT02152943|Trastuzumab|trastuzumab|mesh-list
24829515|NCT02152943|Everolimus|everolimus|mesh-list
24829517|NCT02152943|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
24829518|NCT02152943|Antibodies|antibodies|mesh-list
24829519|NCT02152943|Immunoglobulins|immunoglobulins|mesh-list
24829520|NCT02152943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24829521|NCT02152943|Immunologic Factors|immunologic factors|mesh-ancestor
24829522|NCT02152943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843867|NCT00036088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25843868|NCT00036088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25843869|NCT00036088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25843870|NCT00036088|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25843871|NCT00036088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25843872|NCT00036088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25843873|NCT00036088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843874|NCT00036088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25843875|NCT00036088|Serotonin Agents|serotonin agents|mesh-ancestor
25843876|NCT00036101|Aripiprazole|aripiprazole|mesh-list
24829577|NCT02153177|Oxycodone|oxycodone|mesh-list
25843877|NCT00036101|Antidepressive Agents|antidepressive agents|mesh-ancestor
25843878|NCT00036101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25843879|NCT00036101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24726792|NCT01605929|Anesthetics|anesthetics|mesh-ancestor
25843880|NCT00036101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25843881|NCT00036101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25843882|NCT00036101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899871|NCT04399343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899873|NCT04399148|Aprepitant|aprepitant|mesh-list
24899874|NCT04399148|Desloratadine|desloratadine|mesh-list
24899875|NCT04399148|Antiemetics|antiemetics|mesh-ancestor
24899876|NCT04399148|Autonomic Agents|autonomic agents|mesh-ancestor
25843883|NCT00036101|Dopamine Agonists|dopamine agonists|mesh-ancestor
24899877|NCT04399148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24899878|NCT04399148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899879|NCT04399148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24722817|NCT01582711|Isoniazid|isoniazid|mesh-list
25843884|NCT00036101|Dopamine Agents|dopamine agents|mesh-ancestor
25843885|NCT00036101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25843886|NCT00036101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843887|NCT00036101|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25843888|NCT00036101|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25843889|NCT00036101|Serotonin Agents|serotonin agents|mesh-ancestor
25843890|NCT00036101|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25843891|NCT00036101|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25843892|NCT00036101|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24829523|NCT02152943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24829524|NCT02152943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25843893|NCT00036101|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25843894|NCT00036114|Aripiprazole|aripiprazole|mesh-list
25843895|NCT00036114|Antidepressive Agents|antidepressive agents|mesh-ancestor
25843896|NCT00036114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25843897|NCT00036114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25843898|NCT00036114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25843899|NCT00036114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25843900|NCT00036114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843901|NCT00036114|Dopamine Agonists|dopamine agonists|mesh-ancestor
25843902|NCT00036114|Dopamine Agents|dopamine agents|mesh-ancestor
25843903|NCT00036114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25843904|NCT00036114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843905|NCT00036114|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24829535|NCT02152969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24829536|NCT02152969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24829537|NCT02152969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24829538|NCT02152969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843906|NCT00036114|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25843907|NCT00036114|Serotonin Agents|serotonin agents|mesh-ancestor
25843908|NCT00036114|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25843909|NCT00036114|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25843910|NCT00036114|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25843911|NCT00036114|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25843912|NCT00036127|Aripiprazole|aripiprazole|mesh-list
25843913|NCT00036127|Antidepressive Agents|antidepressive agents|mesh-ancestor
25843914|NCT00036127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24448444|NCT00311870|Nisoldipine|nisoldipine|mesh-list
25843915|NCT00036127|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25843916|NCT00036127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24448477|NCT00311961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24448478|NCT00311961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448479|NCT00311961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24448481|NCT00311961|Antiemetics|antiemetics|mesh-ancestor
24448482|NCT00311961|Autonomic Agents|autonomic agents|mesh-ancestor
24448483|NCT00311961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24448484|NCT00311961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24448485|NCT00311961|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24448486|NCT00311961|Protective Agents|protective agents|mesh-ancestor
24448487|NCT00311974|Dihydralazine|dihydralazine|mesh-list
25661491|NCT01634113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25661492|NCT01634113|Cholinergic Agents|cholinergic agents|mesh-ancestor
25661493|NCT01634113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25661494|NCT01634113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661495|NCT01634113|Anticonvulsants|anticonvulsants|mesh-ancestor
25674344|NCT01770392|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24756173|NCT01731457|Analgesics|analgesics|mesh-ancestor
25674345|NCT01770392|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25674346|NCT01770392|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25674347|NCT01770392|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24954632|NCT03874130|Scopolamine|scopolamine|mesh-list
24845280|NCT02237339|Antioxidants|antioxidants|mesh-ancestor
24900122|NCT04397393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24900123|NCT04397393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900124|NCT04397393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24786873|NCT01922193|Hormones|hormones|mesh-ancestor
25268750|NCT02414581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24819436|NCT02095509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843917|NCT00036127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25843918|NCT00036127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843919|NCT00036127|Dopamine Agonists|dopamine agonists|mesh-ancestor
25843920|NCT00036127|Dopamine Agents|dopamine agents|mesh-ancestor
25843921|NCT00036127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25843922|NCT00036127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843923|NCT00036127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25843924|NCT00036127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25843925|NCT00036127|Serotonin Agents|serotonin agents|mesh-ancestor
25041693|NCT01594216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041694|NCT01594216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25041695|NCT01594216|Hormone Antagonists|hormone antagonists|mesh-ancestor
25041696|NCT01594216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25041697|NCT01594216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041698|NCT01593228|Gemcitabine|gemcitabine|mesh-list
24448565|NCT00312260|Anticonvulsants|anticonvulsants|mesh-ancestor
24448566|NCT00312260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24448567|NCT00312260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24448568|NCT00312260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24448569|NCT00312260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24448570|NCT00312260|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25843926|NCT00036127|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25843927|NCT00036127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25843928|NCT00036127|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25843929|NCT00036127|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25843930|NCT00036153|Methotrexate|methotrexate|mesh-list
25843931|NCT00036153|Tacrolimus|tacrolimus|mesh-list
25843932|NCT00036153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25843933|NCT00036153|Abortifacient Agents|abortifacient agents|mesh-ancestor
24780846|NCT01886573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843934|NCT00036153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25843935|NCT00036153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843936|NCT00036153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25843937|NCT00036153|Antimetabolites|antimetabolites|mesh-ancestor
25843938|NCT00036153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843939|NCT00036153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25843940|NCT00036153|Dermatologic Agents|dermatologic agents|mesh-ancestor
25843941|NCT00036153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843942|NCT00036153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25843943|NCT00036153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24820221|NCT02099240|Ampicillin|ampicillin|mesh-list
25044031|NCT01168713|Ofloxacin|ofloxacin|mesh-list
24845817|NCT02239458|Hormones|hormones|mesh-ancestor
25843944|NCT00036153|Immunologic Factors|immunologic factors|mesh-ancestor
25843945|NCT00036153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25843946|NCT00036153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25843947|NCT00036153|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25843948|NCT00036166|Micafungin|micafungin|mesh-list
25843949|NCT00036166|Antifungal Agents|antifungal agents|mesh-ancestor
25843950|NCT00036166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25843951|NCT00036179|Micafungin|micafungin|mesh-list
25843952|NCT00036179|Antifungal Agents|antifungal agents|mesh-ancestor
24846009|NCT02240602|Oxycodone|oxycodone|mesh-list
25843953|NCT00036179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25843954|NCT00036218|Ropinirole|ropinirole|mesh-list
25843955|NCT00036218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24702799|NCT01467804|Serotonin Agents|serotonin agents|mesh-ancestor
25843956|NCT00036218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25661496|NCT01634139|Tiotropium Bromide|tiotropium bromide|mesh-list
25661497|NCT01634139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25661498|NCT01634139|Autonomic Agents|autonomic agents|mesh-ancestor
25661499|NCT01634139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25661500|NCT01634139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661501|NCT01634139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25661502|NCT01634139|Respiratory System Agents|respiratory system agents|mesh-ancestor
25843957|NCT00036218|Dopamine Agonists|dopamine agonists|mesh-ancestor
25661503|NCT01634139|Parasympatholytics|parasympatholytics|mesh-ancestor
25165996|NCT04491968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25165997|NCT04491968|Narcotics|narcotics|mesh-ancestor
25165998|NCT04491968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25165999|NCT04491968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166000|NCT04491968|Analgesics|analgesics|mesh-ancestor
25166001|NCT04491968|Sensory System Agents|sensory system agents|mesh-ancestor
25166002|NCT04491968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25166003|NCT04491968|Antitussive Agents|antitussive agents|mesh-ancestor
25843959|NCT00036218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25843960|NCT00036218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843961|NCT00036218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843962|NCT00036231|Secretin|secretin|mesh-list
25843963|NCT00036231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25843964|NCT00036231|Hormones|hormones|mesh-ancestor
25843965|NCT00036231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25843966|NCT00036231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843967|NCT00036244|Secretin|secretin|mesh-list
25843968|NCT00036244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25843969|NCT00036244|Hormones|hormones|mesh-ancestor
24448597|NCT00312273|Protective Agents|protective agents|mesh-ancestor
24448598|NCT00312299|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
24448599|NCT00312299|Vasodilator Agents|vasodilator agents|mesh-ancestor
24448600|NCT00312299|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24829600|NCT02153281|Antidepressive Agents|antidepressive agents|mesh-ancestor
24829601|NCT02153281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24616159|NCT01034410|Cytarabine|cytarabine|mesh-list
24448601|NCT00312299|Protective Agents|protective agents|mesh-ancestor
24448602|NCT00312299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448603|NCT00312325|Prednisolone|prednisolone|mesh-list
24448604|NCT00312325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24448605|NCT00312325|Glucocorticoids|glucocorticoids|mesh-ancestor
24448639|NCT00312520|Prednisolone acetate|prednisolone acetate|mesh-list
24448640|NCT00312520|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25843970|NCT00036244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25843971|NCT00036244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843972|NCT00036283|Celecoxib|celecoxib|mesh-list
25843973|NCT00036283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25843974|NCT00036283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25843975|NCT00036283|Analgesics|analgesics|mesh-ancestor
25843976|NCT00036283|Sensory System Agents|sensory system agents|mesh-ancestor
25843977|NCT00036283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25843978|NCT00036283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25843979|NCT00036283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25843980|NCT00036283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25843981|NCT00036283|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25843982|NCT00036283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25843983|NCT00036283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25843984|NCT00036283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829609|NCT02153424|Protease Inhibitors|protease inhibitors|mesh-ancestor
25843985|NCT00036309|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25843986|NCT00036309|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25843987|NCT00036309|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25843988|NCT00036309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25843989|NCT00036309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25843990|NCT00036309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25843991|NCT00036309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166004|NCT04491968|Respiratory System Agents|respiratory system agents|mesh-ancestor
25843992|NCT00036309|Analgesics|analgesics|mesh-ancestor
25843993|NCT00036309|Sensory System Agents|sensory system agents|mesh-ancestor
24448650|NCT00312520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24448651|NCT00312520|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24448652|NCT00312520|Protective Agents|protective agents|mesh-ancestor
24448653|NCT00312520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24448654|NCT00312520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448656|NCT00312533|Viscosupplements|viscosupplements|mesh-ancestor
25843994|NCT00036309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25843995|NCT00036309|Antidepressive Agents|antidepressive agents|mesh-ancestor
25843996|NCT00036309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25843997|NCT00036309|Dopamine Agents|dopamine agents|mesh-ancestor
25843998|NCT00036335|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24900175|NCT04396938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829658|NCT02153593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829659|NCT02153593|Hemostatics|hemostatics|mesh-ancestor
24829660|NCT02153593|Coagulants|coagulants|mesh-ancestor
25843999|NCT00036335|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24829687|NCT02153879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844000|NCT00036335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25844001|NCT00036335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25844002|NCT00036335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844003|NCT00036335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25844004|NCT00036335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844005|NCT00036335|Analgesics|analgesics|mesh-ancestor
25844006|NCT00036335|Sensory System Agents|sensory system agents|mesh-ancestor
25844007|NCT00036335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25844008|NCT00036335|Antidepressive Agents|antidepressive agents|mesh-ancestor
25844009|NCT00036335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25844010|NCT00036335|Dopamine Agents|dopamine agents|mesh-ancestor
25844011|NCT00036348|Aripiprazole|aripiprazole|mesh-list
25844012|NCT00036348|Antidepressive Agents|antidepressive agents|mesh-ancestor
25844013|NCT00036348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25041699|NCT01593228|Paclitaxel|paclitaxel|mesh-list
25041700|NCT01593228|Carboplatin|carboplatin|mesh-list
25041701|NCT01593228|Doxorubicin|doxorubicin|mesh-list
25041702|NCT01593228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25041703|NCT01593228|Irinotecan|irinotecan|mesh-list
25041704|NCT01593228|Topotecan|topotecan|mesh-list
25041705|NCT01593228|Iniparib|iniparib|mesh-list
25844014|NCT00036348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25844015|NCT00036348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25844016|NCT00036348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25844017|NCT00036348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844018|NCT00036348|Dopamine Agonists|dopamine agonists|mesh-ancestor
25844019|NCT00036348|Dopamine Agents|dopamine agents|mesh-ancestor
25844020|NCT00036348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24637380|NCT01149980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25844021|NCT00036348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844022|NCT00036348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25844023|NCT00036348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25844024|NCT00036348|Serotonin Agents|serotonin agents|mesh-ancestor
25844025|NCT00036348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25844026|NCT00036348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25844027|NCT00036348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25844028|NCT00036348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25844029|NCT00036361|Aripiprazole|aripiprazole|mesh-list
25844030|NCT00036361|Antidepressive Agents|antidepressive agents|mesh-ancestor
25844031|NCT00036361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25844032|NCT00036361|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25844033|NCT00036361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25844034|NCT00036361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25844035|NCT00036361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844036|NCT00036361|Dopamine Agonists|dopamine agonists|mesh-ancestor
25844037|NCT00036361|Dopamine Agents|dopamine agents|mesh-ancestor
25844038|NCT00036361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25844039|NCT00036361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844040|NCT00036361|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25844041|NCT00036361|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25844042|NCT00036361|Serotonin Agents|serotonin agents|mesh-ancestor
25844043|NCT00036361|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25844044|NCT00036361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25844045|NCT00036361|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25844046|NCT00036361|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25844047|NCT00036374|Infliximab|infliximab|mesh-list
24534798|NCT00648011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534799|NCT00648011|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25661504|NCT01634139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25661505|NCT01634139|Cholinergic Agents|cholinergic agents|mesh-ancestor
25661506|NCT01634139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25661507|NCT01634139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661508|NCT01634152|Tiotropium Bromide|tiotropium bromide|mesh-list
25661509|NCT01634152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25661510|NCT01634152|Autonomic Agents|autonomic agents|mesh-ancestor
25661511|NCT01634152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24900476|NCT04393610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24900477|NCT04393610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24900478|NCT04393610|Tocolytic Agents|tocolytic agents|mesh-ancestor
24900479|NCT04393610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24534800|NCT00648011|Protease Inhibitors|protease inhibitors|mesh-ancestor
24534801|NCT00648011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534802|NCT00648024|Anagrelide|anagrelide|mesh-list
25844048|NCT00036374|Dermatologic Agents|dermatologic agents|mesh-ancestor
25844049|NCT00036374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25844050|NCT00036374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25844051|NCT00036387|Infliximab|infliximab|mesh-list
25844052|NCT00036387|Dermatologic Agents|dermatologic agents|mesh-ancestor
25844053|NCT00036387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25844054|NCT00036387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25844055|NCT00036400|Epoetin Alfa|epoetin alfa|mesh-list
25844056|NCT00036400|Hematinics|hematinics|mesh-ancestor
25844057|NCT00036439|Infliximab|infliximab|mesh-list
25844058|NCT00036439|Dermatologic Agents|dermatologic agents|mesh-ancestor
25844059|NCT00036439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25166005|NCT04485273|Anesthetics|anesthetics|mesh-list
25166006|NCT04485273|Sevoflurane|sevoflurane|mesh-list
25166007|NCT04485273|Bupivacaine|bupivacaine|mesh-list
25166008|NCT04485273|Anesthetics, Local|anesthetics, local|mesh-list
25166009|NCT04485273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25166010|NCT04485273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25166011|NCT04485273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166012|NCT04485273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25166013|NCT04485273|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25166014|NCT04485273|Anesthetics, General|anesthetics, general|mesh-ancestor
25166015|NCT04485273|Sensory System Agents|sensory system agents|mesh-ancestor
25166016|NCT04485273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25166017|NCT04484012|Acalabrutinib|acalabrutinib|mesh-list
25166018|NCT04484012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166019|NCT04465643|Nivolumab|nivolumab|mesh-list
25166020|NCT04465643|Ipilimumab|ipilimumab|mesh-list
25166021|NCT04465643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25166022|NCT04465643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844060|NCT00036439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25844061|NCT00036452|Ritonavir|ritonavir|mesh-list
25166023|NCT04465643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25166024|NCT04465643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166025|NCT04465487|Cemiplimab|cemiplimab|mesh-list
25166026|NCT04465487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25166027|NCT04465487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166028|NCT04461015|Insulin|insulin|mesh-list
25166029|NCT04461015|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25166030|NCT04461015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25166031|NCT04461015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166037|NCT04447989|Sildenafil Citrate|sildenafil citrate|mesh-list
25166038|NCT04447989|Vasodilator Agents|vasodilator agents|mesh-ancestor
25166039|NCT04447989|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25166040|NCT04447989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25166041|NCT04447989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25166042|NCT04447989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166043|NCT04447989|Urological Agents|urological agents|mesh-ancestor
25166044|NCT04447768|Venetoclax|venetoclax|mesh-list
25166047|NCT04447768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25166048|NCT04424602|Cyclophosphamide|cyclophosphamide|mesh-list
25844062|NCT00036452|Lopinavir|lopinavir|mesh-list
25844063|NCT00036452|Tenofovir|tenofovir|mesh-list
25844064|NCT00036452|Emtricitabine|emtricitabine|mesh-list
25844065|NCT00036452|Stavudine|stavudine|mesh-list
25844066|NCT00036452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25844067|NCT00036452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25844068|NCT00036452|Protease Inhibitors|protease inhibitors|mesh-ancestor
25844069|NCT00036452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25181778|NCT04793490|Acetaminophen|acetaminophen|mesh-list
25844070|NCT00036452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844071|NCT00036452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25844072|NCT00036452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25844073|NCT00036452|Antiviral Agents|antiviral agents|mesh-ancestor
25844074|NCT00036452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25844075|NCT00036452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25661512|NCT01634152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661513|NCT01634152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25661514|NCT01634152|Respiratory System Agents|respiratory system agents|mesh-ancestor
25661515|NCT01634152|Parasympatholytics|parasympatholytics|mesh-ancestor
25844076|NCT00036452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25844077|NCT00036452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25844078|NCT00036452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25844079|NCT00036452|Antimetabolites|antimetabolites|mesh-ancestor
25844080|NCT00036491|Rituximab|rituximab|mesh-list
24637397|NCT01149993|Immunologic Factors|immunologic factors|mesh-ancestor
25844081|NCT00036491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25844082|NCT00036491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844083|NCT00036491|Immunologic Factors|immunologic factors|mesh-ancestor
25844084|NCT00036491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844085|NCT00036491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25844086|NCT00036504|Insulin Lispro|insulin lispro|mesh-list
25844087|NCT00036504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24857549|NCT02292303|Dermatologic Agents|dermatologic agents|mesh-ancestor
24857550|NCT02292303|Sunscreening Agents|sunscreening agents|mesh-ancestor
25844088|NCT00036504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844089|NCT00036543|Atrasentan|atrasentan|mesh-list
25844090|NCT00036543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844091|NCT00036543|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25844092|NCT00036543|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25844093|NCT00036543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844094|NCT00036556|Atrasentan|atrasentan|mesh-list
25844095|NCT00036556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844096|NCT00036556|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25844097|NCT00036556|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25844098|NCT00036556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844099|NCT00036582|Clozapine|clozapine|mesh-list
25844100|NCT00036582|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25844101|NCT00036582|Serotonin Agents|serotonin agents|mesh-ancestor
25844102|NCT00036582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25844103|NCT00036582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844104|NCT00036582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844105|NCT00036582|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25844106|NCT00036582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25844107|NCT00036582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25844108|NCT00036582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25844109|NCT00036582|GABA Antagonists|gaba antagonists|mesh-ancestor
25844110|NCT00036582|GABA Agents|gaba agents|mesh-ancestor
25844111|NCT00036634|Tenofovir|tenofovir|mesh-list
25844112|NCT00036634|Antiviral Agents|antiviral agents|mesh-ancestor
25844113|NCT00036634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25844114|NCT00036634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25844115|NCT00036634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25844116|NCT00036634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844117|NCT00036634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844118|NCT00036634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25844119|NCT00036634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25844120|NCT00036647|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25844121|NCT00036647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24742233|NCT05296005|Protective Agents|protective agents|mesh-ancestor
24742234|NCT05296005|Vitamin B Complex|vitamin b complex|mesh-ancestor
24742236|NCT05296005|Micronutrients|micronutrients|mesh-ancestor
24742237|NCT05295836|Glycerol|glycerol|mesh-list
25844122|NCT00036647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25844123|NCT00036647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844124|NCT00036647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844125|NCT00036751|Imatinib Mesylate|imatinib mesylate|mesh-list
25844126|NCT00036751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844127|NCT00036751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25844128|NCT00036751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844129|NCT00036751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844130|NCT00036764|Epothilones|epothilones|mesh-list
25844131|NCT00036764|Epothilone B|epothilone b|mesh-list
25844132|NCT00036764|Tubulin Modulators|tubulin modulators|mesh-ancestor
25844133|NCT00036764|Antimitotic Agents|antimitotic agents|mesh-ancestor
25844134|NCT00036764|Mitosis Modulators|mitosis modulators|mesh-ancestor
24534635|NCT00647738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24534636|NCT00647738|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25844135|NCT00036764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844136|NCT00036764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844137|NCT00036777|Carboplatin|carboplatin|mesh-list
25844138|NCT00036777|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
25844139|NCT00036777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844140|NCT00036777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24637540|NCT01151254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24637541|NCT01151254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24637542|NCT01151267|Anesthetics|anesthetics|mesh-list
24637543|NCT01151267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25844141|NCT00036777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844142|NCT00036777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844144|NCT00036790|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25844145|NCT00036790|Motexafin gadolinium|motexafin gadolinium|mesh-list
25844146|NCT00036790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25844147|NCT00036790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844148|NCT00036790|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25844149|NCT00036790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25844150|NCT00036790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844151|NCT00036790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844152|NCT00036790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25844153|NCT00036790|Dermatologic Agents|dermatologic agents|mesh-ancestor
25844154|NCT00036842|Arsenic Trioxide|arsenic trioxide|mesh-list
25844155|NCT00036842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844156|NCT00036855|Rituximab|rituximab|mesh-list
25844157|NCT00036855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25844158|NCT00036855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25844159|NCT00036855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451120|NCT00322075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25844160|NCT00036855|Immunologic Factors|immunologic factors|mesh-ancestor
25844161|NCT00036855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844162|NCT00036855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25844163|NCT00036868|Cyclophosphamide|cyclophosphamide|mesh-list
25844164|NCT00036868|Fluorouracil|fluorouracil|mesh-list
25844165|NCT00036868|Methotrexate|methotrexate|mesh-list
25844166|NCT00036868|Trastuzumab|trastuzumab|mesh-list
25844167|NCT00036868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25844168|NCT00036868|Immunologic Factors|immunologic factors|mesh-ancestor
25844169|NCT00036868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844170|NCT00036868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24458426|NCT00337792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24458435|NCT00337883|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24458436|NCT00337883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458437|NCT00337883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24458438|NCT00337883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458439|NCT00337883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458441|NCT00337922|Abacavir|abacavir|mesh-list
24458442|NCT00337922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24534670|NCT00647816|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24534671|NCT00647816|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24534672|NCT00647816|Adrenergic Agents|adrenergic agents|mesh-ancestor
24534673|NCT00647816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25844171|NCT00036868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25844172|NCT00036868|Alkylating Agents|alkylating agents|mesh-ancestor
25844173|NCT00036868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844174|NCT00036868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844175|NCT00036868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25844176|NCT00036868|Antimetabolites|antimetabolites|mesh-ancestor
25844177|NCT00036868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25844178|NCT00036868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25844179|NCT00036868|Abortifacient Agents|abortifacient agents|mesh-ancestor
25844180|NCT00036868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25844181|NCT00036868|Dermatologic Agents|dermatologic agents|mesh-ancestor
25844182|NCT00036868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844183|NCT00036868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25844184|NCT00036868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25844185|NCT00036868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25844186|NCT00036881|Zinc Sulfate|zinc sulfate|mesh-list
25844187|NCT00036881|Astringents|astringents|mesh-ancestor
25055667|NCT03518489|Lappaconitine|lappaconitine|mesh-list
25844188|NCT00036881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844189|NCT00036881|Dermatologic Agents|dermatologic agents|mesh-ancestor
25844190|NCT00036894|Lenalidomide|lenalidomide|mesh-list
25844191|NCT00036894|Immunologic Factors|immunologic factors|mesh-ancestor
25844192|NCT00036894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844193|NCT00036894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24458443|NCT00337922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24458444|NCT00337922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458445|NCT00337922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458446|NCT00337922|Antiviral Agents|antiviral agents|mesh-ancestor
24458447|NCT00337922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24458448|NCT00337922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24458449|NCT00337922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24458450|NCT00337948|Epoetin Alfa|epoetin alfa|mesh-list
24458451|NCT00337948|Hematinics|hematinics|mesh-ancestor
24458452|NCT00338000|Epoetin Alfa|epoetin alfa|mesh-list
24458453|NCT00338000|Hematinics|hematinics|mesh-ancestor
25844194|NCT00036894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25844195|NCT00036894|Growth Substances|growth substances|mesh-ancestor
25844196|NCT00036894|Growth Inhibitors|growth inhibitors|mesh-ancestor
25844197|NCT00036894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844198|NCT00036946|Aflibercept|aflibercept|mesh-list
25844199|NCT00036946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25844200|NCT00036946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25844201|NCT00036946|Growth Substances|growth substances|mesh-ancestor
25844202|NCT00036946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844203|NCT00036946|Growth Inhibitors|growth inhibitors|mesh-ancestor
25844204|NCT00036946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844205|NCT00036985|Cyclophosphamide|cyclophosphamide|mesh-list
25844206|NCT00036985|Doxorubicin|doxorubicin|mesh-list
25844207|NCT00036985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25844208|NCT00036985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25844209|NCT00036985|Immunologic Factors|immunologic factors|mesh-ancestor
25844210|NCT00036985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844211|NCT00036985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25844212|NCT00036985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25844213|NCT00036985|Alkylating Agents|alkylating agents|mesh-ancestor
25844214|NCT00036985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844215|NCT00036985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844216|NCT00036985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25844217|NCT00036985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25844218|NCT00036985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25844219|NCT00036985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25844220|NCT00036985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25120786|NCT02639650|Paclitaxel|paclitaxel|mesh-list
25844221|NCT00037011|Antibodies|antibodies|mesh-list
25844222|NCT00037011|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25844223|NCT00037011|Immunologic Factors|immunologic factors|mesh-ancestor
25844224|NCT00037011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844225|NCT00037037|Sargramostim|sargramostim|mesh-list
25844226|NCT00037037|Immunologic Factors|immunologic factors|mesh-ancestor
25844227|NCT00037037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844228|NCT00037050|Vancomycin|vancomycin|mesh-list
25844229|NCT00037050|Linezolid|linezolid|mesh-list
25844230|NCT00037050|Oxacillin|oxacillin|mesh-list
25844231|NCT00037050|Dicloxacillin|dicloxacillin|mesh-list
25844232|NCT00037050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25844233|NCT00037050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25844234|NCT00037050|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25844235|NCT00037050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444585|NCT00298545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24742662|NCT05202561|Vaccines|vaccines|mesh-list
24458480|NCT00338117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24458481|NCT00338117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405472|NCT00167232|Naltrexone|naltrexone|mesh-list
25844236|NCT00037050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844237|NCT00037063|Ascorbic Acid|ascorbic acid|mesh-list
25844238|NCT00037063|Vitamin E|vitamin e|mesh-list
25844239|NCT00037063|Riboflavin|riboflavin|mesh-list
25844240|NCT00037063|Thiamine|thiamine|mesh-list
25844241|NCT00037063|Vitamins|vitamins|mesh-ancestor
25844242|NCT00037063|Micronutrients|micronutrients|mesh-ancestor
24534709|NCT00647881|Paroxetine|paroxetine|mesh-list
25844243|NCT00037063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844244|NCT00037063|Antioxidants|antioxidants|mesh-ancestor
25844245|NCT00037063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844246|NCT00037063|Protective Agents|protective agents|mesh-ancestor
25844247|NCT00037063|Vitamin B Complex|vitamin b complex|mesh-ancestor
25844248|NCT00037063|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25844249|NCT00037063|Dermatologic Agents|dermatologic agents|mesh-ancestor
25844250|NCT00037089|Tegafur|tegafur|mesh-list
25844251|NCT00037089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25844252|NCT00037089|Antimetabolites|antimetabolites|mesh-ancestor
25844253|NCT00037089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844254|NCT00037089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844255|NCT00037102|Interferons|interferons|mesh-list
25844256|NCT00037102|Interferon-beta|interferon-beta|mesh-list
25844257|NCT00037102|Interferon beta-1a|interferon beta-1a|mesh-list
25844258|NCT00037102|Methotrexate|methotrexate|mesh-list
25844259|NCT00037102|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25844260|NCT00037102|Abortifacient Agents|abortifacient agents|mesh-ancestor
25844261|NCT00037102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25844262|NCT00037102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229214|NCT02603822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844263|NCT00037102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24535261|NCT00648856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24535267|NCT00648869|Metformin|metformin|mesh-list
25844264|NCT00037102|Antimetabolites|antimetabolites|mesh-ancestor
25166049|NCT04424602|Dimethoate|dimethoate|mesh-list
25166050|NCT04424602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166051|NCT04424602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25166052|NCT04424602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166053|NCT04424602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25166054|NCT04424602|Immunologic Factors|immunologic factors|mesh-ancestor
25166055|NCT04424602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166056|NCT04424602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25166057|NCT04424602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25166058|NCT04424602|Alkylating Agents|alkylating agents|mesh-ancestor
25166059|NCT04424602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25166060|NCT04424602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25166061|NCT04424602|Cholinergic Agents|cholinergic agents|mesh-ancestor
25166062|NCT04424602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25166068|NCT04410796|Carboplatin|carboplatin|mesh-list
25166069|NCT04410796|Pemetrexed|pemetrexed|mesh-list
25166070|NCT04410796|Osimertinib|osimertinib|mesh-list
25166071|NCT04410796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166072|NCT04410796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25166073|NCT04410796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166074|NCT04410796|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25166075|NCT04410796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25166076|NCT04410796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25166077|NCT04401176|Lidocaine|lidocaine|mesh-list
25166078|NCT04401176|Heparin|heparin|mesh-list
25166079|NCT04401176|Anesthetics, Local|anesthetics, local|mesh-ancestor
25166080|NCT04401176|Anesthetics|anesthetics|mesh-ancestor
25166081|NCT04401176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25166082|NCT04401176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166083|NCT04401176|Sensory System Agents|sensory system agents|mesh-ancestor
25166084|NCT04401176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25166085|NCT04401176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25166086|NCT04401176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25166087|NCT04401176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25166088|NCT04401176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25166089|NCT04401176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166090|NCT04401176|Anticoagulants|anticoagulants|mesh-ancestor
25166091|NCT04401176|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25166092|NCT04401176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25166100|NCT04395079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166101|NCT04395079|Immunologic Factors|immunologic factors|mesh-ancestor
25166102|NCT04395079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166103|NCT04395079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25166104|NCT04395079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844265|NCT00037102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844266|NCT00037102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844267|NCT00037102|Dermatologic Agents|dermatologic agents|mesh-ancestor
25844268|NCT00037102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844269|NCT00037102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25844270|NCT00037102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24534740|NCT00647907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534741|NCT00647907|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24534743|NCT00647907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25844271|NCT00037102|Immunologic Factors|immunologic factors|mesh-ancestor
25844272|NCT00037102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25844273|NCT00037102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25844274|NCT00037102|Antiviral Agents|antiviral agents|mesh-ancestor
25844275|NCT00037102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25844276|NCT00037102|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25844277|NCT00037115|Interferons|interferons|mesh-list
25844278|NCT00037115|Interferon-beta|interferon-beta|mesh-list
25844279|NCT00037115|Interferon beta-1a|interferon beta-1a|mesh-list
25844280|NCT00037115|Methylprednisolone|methylprednisolone|mesh-list
24536136|NCT00650403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25844281|NCT00037115|Methotrexate|methotrexate|mesh-list
25661516|NCT01634152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25844282|NCT00037115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25844283|NCT00037115|Abortifacient Agents|abortifacient agents|mesh-ancestor
25844284|NCT00037115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25844285|NCT00037115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844286|NCT00037115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25844287|NCT00037115|Antimetabolites|antimetabolites|mesh-ancestor
25844288|NCT00037115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844289|NCT00037115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844290|NCT00037115|Dermatologic Agents|dermatologic agents|mesh-ancestor
25844291|NCT00037115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844292|NCT00037115|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25844293|NCT00037115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25844294|NCT00037115|Immunologic Factors|immunologic factors|mesh-ancestor
25844295|NCT00037115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25844296|NCT00037115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25844297|NCT00037115|Antiviral Agents|antiviral agents|mesh-ancestor
25844298|NCT00037115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25844299|NCT00037115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25844300|NCT00037115|Antiemetics|antiemetics|mesh-ancestor
25844301|NCT00037115|Autonomic Agents|autonomic agents|mesh-ancestor
25844302|NCT00037115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25844303|NCT00037115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25844304|NCT00037115|Glucocorticoids|glucocorticoids|mesh-ancestor
25844305|NCT00037115|Hormones|hormones|mesh-ancestor
25844306|NCT00037115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25844307|NCT00037115|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25844308|NCT00037115|Protective Agents|protective agents|mesh-ancestor
25844309|NCT00037115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25844310|NCT00037141|Ethanol|ethanol|mesh-list
25844311|NCT00037141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25844312|NCT00037141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25844313|NCT00037141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25844314|NCT00037141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844315|NCT00037154|Saw palmetto extract|saw palmetto extract|mesh-list
25844316|NCT00037154|Urological Agents|urological agents|mesh-ancestor
24458494|NCT00338130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458495|NCT00338195|Caffeine|caffeine|mesh-list
24458496|NCT00338195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24534750|NCT00647946|Abacavir|abacavir|mesh-list
25844317|NCT00037180|Leucovorin|leucovorin|mesh-list
25844318|NCT00037180|Celecoxib|celecoxib|mesh-list
25844319|NCT00037180|Fluorouracil|fluorouracil|mesh-list
24537264|NCT00654121|Insulin|insulin|mesh-list
25844320|NCT00037180|Irinotecan|irinotecan|mesh-list
25844321|NCT00037180|Antimetabolites|antimetabolites|mesh-ancestor
25844322|NCT00037180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844323|NCT00037180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25844324|NCT00037180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844325|NCT00037180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25844326|NCT00037180|Immunologic Factors|immunologic factors|mesh-ancestor
25844327|NCT00037180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844328|NCT00037180|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25844329|NCT00037180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25844330|NCT00037180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844331|NCT00037180|Antidotes|antidotes|mesh-ancestor
25844332|NCT00037180|Protective Agents|protective agents|mesh-ancestor
25844333|NCT00037180|Vitamin B Complex|vitamin b complex|mesh-ancestor
25844334|NCT00037180|Vitamins|vitamins|mesh-ancestor
24637985|NCT01154439|Cytarabine|cytarabine|mesh-list
25844335|NCT00037180|Micronutrients|micronutrients|mesh-ancestor
25844336|NCT00037180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25844337|NCT00037180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25844338|NCT00037180|Analgesics|analgesics|mesh-ancestor
25844339|NCT00037180|Sensory System Agents|sensory system agents|mesh-ancestor
25844340|NCT00037180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25844341|NCT00037180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25844342|NCT00037180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25844343|NCT00037180|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25844344|NCT00037180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25844345|NCT00037206|Anidulafungin|anidulafungin|mesh-list
25844346|NCT00037206|Antifungal Agents|antifungal agents|mesh-ancestor
25844347|NCT00037206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25844348|NCT00037219|Anidulafungin|anidulafungin|mesh-list
25844349|NCT00037219|Antifungal Agents|antifungal agents|mesh-ancestor
25844350|NCT00037219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25875790|NCT04153565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25875791|NCT04153565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25875792|NCT04145115|Nivolumab|nivolumab|mesh-list
25875793|NCT04145115|Ipilimumab|ipilimumab|mesh-list
25875794|NCT04145115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25229256|NCT02603575|Sulfanilamide|sulfanilamide|mesh-list
25844351|NCT00037479|Ceftriaxone|ceftriaxone|mesh-list
24613806|NCT01020864|Cetuximab|cetuximab|mesh-list
25844352|NCT00037479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24538741|NCT00660647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25844353|NCT00037479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25844354|NCT00037518|Cinacalcet|cinacalcet|mesh-list
25844355|NCT00037518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25844356|NCT00037518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844357|NCT00037518|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25844358|NCT00037518|Hormone Antagonists|hormone antagonists|mesh-ancestor
25844359|NCT00037518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25844360|NCT00037531|Sirolimus|sirolimus|mesh-list
25844361|NCT00037531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25844362|NCT00037531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25844363|NCT00037531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25844364|NCT00037531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844365|NCT00037531|Antifungal Agents|antifungal agents|mesh-ancestor
25844366|NCT00037531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25844367|NCT00037531|Immunologic Factors|immunologic factors|mesh-ancestor
25844368|NCT00037531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844369|NCT00037544|Factor VIII|factor viii|mesh-list
25844370|NCT00037544|Coagulants|coagulants|mesh-ancestor
25844371|NCT00037570|Pantoprazole|pantoprazole|mesh-list
25844372|NCT00037570|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25844373|NCT00037570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25844374|NCT00037570|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25844375|NCT00037570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844376|NCT00037570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844377|NCT00037583|Gemtuzumab|gemtuzumab|mesh-list
25844378|NCT00037583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25844379|NCT00037583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844380|NCT00037596|Cytarabine|cytarabine|mesh-list
25844381|NCT00037596|Gemtuzumab|gemtuzumab|mesh-list
25844382|NCT00037596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25844383|NCT00037596|Antimetabolites|antimetabolites|mesh-ancestor
25844384|NCT00037596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844385|NCT00037596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844386|NCT00037596|Antiviral Agents|antiviral agents|mesh-ancestor
25844387|NCT00037596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25844388|NCT00037596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25844389|NCT00037596|Immunologic Factors|immunologic factors|mesh-ancestor
24538968|NCT00661349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25844390|NCT00037596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844391|NCT00037596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25844392|NCT00037609|Sulindac sulfone|sulindac sulfone|mesh-list
25844393|NCT00037609|Capecitabine|capecitabine|mesh-list
25844394|NCT00037609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25844395|NCT00037609|Antimetabolites|antimetabolites|mesh-ancestor
25844396|NCT00037609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844397|NCT00037609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844398|NCT00037609|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25844399|NCT00037609|Protective Agents|protective agents|mesh-ancestor
25844400|NCT00037609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844401|NCT00037609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25844402|NCT00037609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844403|NCT00037609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25844404|NCT00037609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25844405|NCT00037609|Analgesics|analgesics|mesh-ancestor
25844406|NCT00037609|Sensory System Agents|sensory system agents|mesh-ancestor
25844407|NCT00037609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25844408|NCT00037609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25844409|NCT00037609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25844410|NCT00037622|Dexelvucitabine|dexelvucitabine|mesh-list
24638086|NCT01154829|Aripiprazole|aripiprazole|mesh-list
25844411|NCT00037622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25844412|NCT00037622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25844413|NCT00037622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844414|NCT00037622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844415|NCT00037622|Antiviral Agents|antiviral agents|mesh-ancestor
25844416|NCT00037622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25844417|NCT00037622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25661517|NCT01634152|Cholinergic Agents|cholinergic agents|mesh-ancestor
25661518|NCT01634152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25844418|NCT00037622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25844419|NCT00037635|Cinacalcet|cinacalcet|mesh-list
25844420|NCT00037635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25844421|NCT00037635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844422|NCT00037635|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25844423|NCT00037635|Hormone Antagonists|hormone antagonists|mesh-ancestor
25844424|NCT00037635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25844425|NCT00037648|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24707538|NCT01496443|Glimepiride|glimepiride|mesh-list
25844426|NCT00037648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24707579|NCT01496742|Paclitaxel|paclitaxel|mesh-list
24743316|NCT04897802|Incretins|incretins|mesh-ancestor
24857842|NCT02294266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844427|NCT00037661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25844428|NCT00037661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25844429|NCT00037674|Topiramate|topiramate|mesh-list
25844430|NCT00037674|Anticonvulsants|anticonvulsants|mesh-ancestor
25844431|NCT00037674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25844432|NCT00037674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203419|NCT02714530|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25203420|NCT02714530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25203421|NCT02714530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25203422|NCT02714530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203423|NCT02714530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844433|NCT00037700|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25844434|NCT00037700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25844435|NCT00037752|Sibutramine|sibutramine|mesh-list
25844436|NCT00037752|Antidepressive Agents|antidepressive agents|mesh-ancestor
25844437|NCT00037752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24857843|NCT02294266|Adrenergic Agents|adrenergic agents|mesh-ancestor
25844438|NCT00037752|Appetite Depressants|appetite depressants|mesh-ancestor
25844439|NCT00037752|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25844440|NCT00037804|Irinotecan|irinotecan|mesh-list
25844441|NCT00037804|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25844442|NCT00037804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25844443|NCT00037804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844444|NCT00037804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458512|NCT00338247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24458513|NCT00338247|Antimetabolites|antimetabolites|mesh-ancestor
24458514|NCT00338247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844445|NCT00037804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844446|NCT00037817|Celecoxib|celecoxib|mesh-list
25844447|NCT00037817|Decitabine|decitabine|mesh-list
25844448|NCT00037817|Romidepsin|romidepsin|mesh-list
25844449|NCT00037817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25844450|NCT00037817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25844451|NCT00037817|Analgesics|analgesics|mesh-ancestor
25844452|NCT00037817|Sensory System Agents|sensory system agents|mesh-ancestor
25844453|NCT00037817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25844454|NCT00037817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844455|NCT00037817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25844456|NCT00037817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25844457|NCT00037817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25844458|NCT00037817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25844459|NCT00037817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844460|NCT00037817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844461|NCT00037817|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25844462|NCT00037817|Antimetabolites|antimetabolites|mesh-ancestor
25844463|NCT00037817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844464|NCT00037817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25844465|NCT00037869|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
25844466|NCT00037869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844467|NCT00037869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844468|NCT00037869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844469|NCT00037869|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25844470|NCT00037882|Interferons|interferons|mesh-list
25844471|NCT00037882|Interferon-alpha|interferon-alpha|mesh-list
25844472|NCT00037882|Interferon alpha-2|interferon alpha-2|mesh-list
25844473|NCT00037882|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25844474|NCT00037882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844475|NCT00037882|Antiviral Agents|antiviral agents|mesh-ancestor
25844476|NCT00037882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25844477|NCT00037882|Immunologic Factors|immunologic factors|mesh-ancestor
25844478|NCT00037882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844479|NCT00037999|Testosterone|testosterone|mesh-list
25844480|NCT00037999|Androgens|androgens|mesh-ancestor
25844481|NCT00037999|Hormones|hormones|mesh-ancestor
25844482|NCT00037999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25844483|NCT00037999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844484|NCT00038012|Carboplatin|carboplatin|mesh-list
25844485|NCT00038012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844486|NCT00038025|Pentostatin|pentostatin|mesh-list
25844487|NCT00038025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844488|NCT00038025|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25844489|NCT00038025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844490|NCT00038025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844491|NCT00038051|Lintuzumab|lintuzumab|mesh-list
25844492|NCT00038051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25844493|NCT00038051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844494|NCT00038064|Darbepoetin alfa|darbepoetin alfa|mesh-list
25844495|NCT00038064|Hematinics|hematinics|mesh-ancestor
25844496|NCT00038077|Metoprolol|metoprolol|mesh-list
25844497|NCT00038077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25844498|NCT00038077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25844499|NCT00038077|Sympatholytics|sympatholytics|mesh-ancestor
25844500|NCT00038077|Autonomic Agents|autonomic agents|mesh-ancestor
25844501|NCT00038077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25844502|NCT00038077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844503|NCT00038077|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24450299|NCT00318630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25844504|NCT00038077|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25844505|NCT00038077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25844506|NCT00038077|Adrenergic Agents|adrenergic agents|mesh-ancestor
25844507|NCT00038077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25844508|NCT00038077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844509|NCT00038090|Thalidomide|thalidomide|mesh-list
25844510|NCT00038090|Dexamethasone|dexamethasone|mesh-list
24638410|NCT01156389|Schistosomicides|schistosomicides|mesh-ancestor
25844511|NCT00038090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24450302|NCT00318669|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24450303|NCT00318669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24450304|NCT00318669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25844512|NCT00038090|Antiemetics|antiemetics|mesh-ancestor
25844513|NCT00038090|Autonomic Agents|autonomic agents|mesh-ancestor
25844514|NCT00038090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25844515|NCT00038090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844516|NCT00038090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25844517|NCT00038090|Glucocorticoids|glucocorticoids|mesh-ancestor
25844518|NCT00038090|Hormones|hormones|mesh-ancestor
25844519|NCT00038090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25844520|NCT00038090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25844521|NCT00038090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844522|NCT00038090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25844523|NCT00038090|Immunologic Factors|immunologic factors|mesh-ancestor
25844524|NCT00038090|Leprostatic Agents|leprostatic agents|mesh-ancestor
25661519|NCT01634152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661520|NCT01634165|Insulin Glargine|insulin glargine|mesh-list
25661521|NCT01634165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25661522|NCT01634165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661523|NCT01634178|Apremilast|apremilast|mesh-list
25661524|NCT01634178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25661525|NCT01634178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25661526|NCT01634178|Analgesics|analgesics|mesh-ancestor
25844525|NCT00038090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25844528|NCT00038090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25844529|NCT00038090|Growth Substances|growth substances|mesh-ancestor
25844530|NCT00038090|Growth Inhibitors|growth inhibitors|mesh-ancestor
25844531|NCT00038116|Dopamine|dopamine|mesh-list
25844532|NCT00038116|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25844533|NCT00038116|Sympathomimetics|sympathomimetics|mesh-ancestor
25844534|NCT00038116|Autonomic Agents|autonomic agents|mesh-ancestor
25844535|NCT00038116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25844536|NCT00038116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844537|NCT00038116|Dopamine Agents|dopamine agents|mesh-ancestor
25844538|NCT00038116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25844539|NCT00038116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844540|NCT00038116|Protective Agents|protective agents|mesh-ancestor
25844541|NCT00038168|Paclitaxel|paclitaxel|mesh-list
25844542|NCT00038168|Estramustine|estramustine|mesh-list
25844543|NCT00038168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25844544|NCT00038168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844545|NCT00038168|Tubulin Modulators|tubulin modulators|mesh-ancestor
25844546|NCT00038168|Antimitotic Agents|antimitotic agents|mesh-ancestor
25844547|NCT00038168|Mitosis Modulators|mitosis modulators|mesh-ancestor
25844548|NCT00038168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844549|NCT00038168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24450307|NCT00318669|Serotonin Agents|serotonin agents|mesh-ancestor
24450308|NCT00318669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450309|NCT00318669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24450311|NCT00318669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25844550|NCT00038168|Alkylating Agents|alkylating agents|mesh-ancestor
25844551|NCT00038168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25844552|NCT00038181|Thalidomide|thalidomide|mesh-list
25844553|NCT00038181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25844554|NCT00038181|Immunologic Factors|immunologic factors|mesh-ancestor
25844555|NCT00038181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844556|NCT00038181|Leprostatic Agents|leprostatic agents|mesh-ancestor
25844557|NCT00038181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25844558|NCT00038181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25844559|NCT00038181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25844560|NCT00038181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25844561|NCT00038181|Growth Substances|growth substances|mesh-ancestor
25844562|NCT00038181|Growth Inhibitors|growth inhibitors|mesh-ancestor
25844563|NCT00038181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844564|NCT00038194|Docetaxel|docetaxel|mesh-list
25844565|NCT00038194|Imatinib Mesylate|imatinib mesylate|mesh-list
25844566|NCT00038194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844567|NCT00038194|Tubulin Modulators|tubulin modulators|mesh-ancestor
25844568|NCT00038194|Antimitotic Agents|antimitotic agents|mesh-ancestor
25844569|NCT00038194|Mitosis Modulators|mitosis modulators|mesh-ancestor
25844570|NCT00038194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844571|NCT00038194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25844572|NCT00038194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844573|NCT00038207|Vincristine|vincristine|mesh-list
25844574|NCT00038207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25844575|NCT00038207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844576|NCT00038207|Tubulin Modulators|tubulin modulators|mesh-ancestor
25844577|NCT00038207|Antimitotic Agents|antimitotic agents|mesh-ancestor
25844578|NCT00038207|Mitosis Modulators|mitosis modulators|mesh-ancestor
25844579|NCT00038207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844580|NCT00038220|Ritonavir|ritonavir|mesh-list
25844581|NCT00038220|Lopinavir|lopinavir|mesh-list
25844582|NCT00038220|Tenofovir|tenofovir|mesh-list
25844583|NCT00038220|Lamivudine|lamivudine|mesh-list
25844584|NCT00038220|Efavirenz|efavirenz|mesh-list
25844585|NCT00038220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25844586|NCT00038220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25844587|NCT00038220|Protease Inhibitors|protease inhibitors|mesh-ancestor
25844588|NCT00038220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844589|NCT00038220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844590|NCT00038220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25844591|NCT00038220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25844592|NCT00038220|Antiviral Agents|antiviral agents|mesh-ancestor
25844593|NCT00038220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25844594|NCT00038220|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25844595|NCT00038220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24545539|NCT00693732|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25844596|NCT00038220|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25844597|NCT00038220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25166157|NCT04332068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398975|NCT00146289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25844598|NCT00038220|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25844599|NCT00038220|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25844600|NCT00038220|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25844601|NCT00038220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25844602|NCT00038220|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25844603|NCT00038233|Thalidomide|thalidomide|mesh-list
25844604|NCT00038233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25844605|NCT00038233|Immunologic Factors|immunologic factors|mesh-ancestor
25844606|NCT00038233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844607|NCT00038233|Leprostatic Agents|leprostatic agents|mesh-ancestor
25844608|NCT00038233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25844609|NCT00038233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25166125|NCT04357873|Pembrolizumab|pembrolizumab|mesh-list
25844610|NCT00038233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25844611|NCT00038233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25844612|NCT00038233|Growth Substances|growth substances|mesh-ancestor
25844613|NCT00038233|Growth Inhibitors|growth inhibitors|mesh-ancestor
25844614|NCT00038233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844615|NCT00038246|Thalidomide|thalidomide|mesh-list
25844617|NCT00038246|Estramustine|estramustine|mesh-list
25844618|NCT00038246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25844619|NCT00038246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844620|NCT00038246|Tubulin Modulators|tubulin modulators|mesh-ancestor
25844621|NCT00038246|Antimitotic Agents|antimitotic agents|mesh-ancestor
25844622|NCT00038246|Mitosis Modulators|mitosis modulators|mesh-ancestor
25844623|NCT00038246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844624|NCT00038246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25844625|NCT00038246|Immunologic Factors|immunologic factors|mesh-ancestor
25844626|NCT00038246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844627|NCT00038246|Leprostatic Agents|leprostatic agents|mesh-ancestor
25844628|NCT00038246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25844629|NCT00038246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25844630|NCT00038246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24829608|NCT02153424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25166126|NCT04357873|Vorinostat|vorinostat|mesh-list
25166127|NCT04357873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25166128|NCT04357873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166129|NCT04357873|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25166130|NCT04357873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25166131|NCT04357873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166142|NCT04341441|Hydroxychloroquine|hydroxychloroquine|mesh-list
25166143|NCT04341441|Antimalarials|antimalarials|mesh-ancestor
25166144|NCT04341441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25166145|NCT04341441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25166146|NCT04341441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25166147|NCT04341441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25166153|NCT04332068|Ivermectin|ivermectin|mesh-list
25166154|NCT04332068|Permethrin|permethrin|mesh-list
25166155|NCT04332068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25166156|NCT04332068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25166159|NCT04329975|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25166160|NCT04329975|Hemostatics|hemostatics|mesh-ancestor
25166161|NCT04329975|Coagulants|coagulants|mesh-ancestor
25166162|NCT04329975|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25166163|NCT04329975|Natriuretic Agents|natriuretic agents|mesh-ancestor
25166164|NCT04329975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166165|NCT04317430|Niclosamide|niclosamide|mesh-list
25166166|NCT04317430|Anticestodal Agents|anticestodal agents|mesh-ancestor
25166167|NCT04317430|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25166168|NCT04317430|Anthelmintics|anthelmintics|mesh-ancestor
25166169|NCT04317430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25166170|NCT04317430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25166171|NCT04317430|Antinematodal Agents|antinematodal agents|mesh-ancestor
25166174|NCT04306393|Nitric Oxide|nitric oxide|mesh-list
25166175|NCT04306393|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25166176|NCT04306393|Autonomic Agents|autonomic agents|mesh-ancestor
25661527|NCT01634178|Sensory System Agents|sensory system agents|mesh-ancestor
25166177|NCT04306393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25166178|NCT04306393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25418791|NCT02747004|Tamoxifen|tamoxifen|mesh-list
25661528|NCT01634178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25844634|NCT00038246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24543792|NCT00685529|Autonomic Agents|autonomic agents|mesh-ancestor
25844635|NCT00038246|Alkylating Agents|alkylating agents|mesh-ancestor
25844636|NCT00038246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25844637|NCT00038259|Aldesleukin|aldesleukin|mesh-list
25844638|NCT00038259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844639|NCT00038259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24638774|NCT01158014|Coagulants|coagulants|mesh-ancestor
24458529|NCT00338273|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24458530|NCT00338273|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24458531|NCT00338273|Serotonin Agents|serotonin agents|mesh-ancestor
24458532|NCT00338273|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24458533|NCT00338273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24458534|NCT00338273|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24458535|NCT00338273|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24458536|NCT00338299|Epoetin Alfa|epoetin alfa|mesh-list
24458537|NCT00338299|Hematinics|hematinics|mesh-ancestor
24458538|NCT00338312|Testosterone|testosterone|mesh-list
24458539|NCT00338312|Androgens|androgens|mesh-ancestor
25844640|NCT00038259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25844641|NCT00038259|Antiviral Agents|antiviral agents|mesh-ancestor
25844642|NCT00038259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25844643|NCT00038272|Mycophenolic Acid|mycophenolic acid|mesh-list
25844644|NCT00038272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25844645|NCT00038272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844646|NCT00038272|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25844647|NCT00038272|Antitubercular Agents|antitubercular agents|mesh-ancestor
25844648|NCT00038272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25844649|NCT00038272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25844650|NCT00038272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844651|NCT00038272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844652|NCT05434104|Metronidazole|metronidazole|mesh-list
25844653|NCT05434104|Fluconazole|fluconazole|mesh-list
25844654|NCT05434104|Lactoferrin|lactoferrin|mesh-list
25844655|NCT05434104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25844656|NCT05434104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25844657|NCT05434104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25844658|NCT05434104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25844659|NCT05434104|Antifungal Agents|antifungal agents|mesh-ancestor
25844660|NCT05434104|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25844661|NCT05434104|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25844662|NCT05434104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844663|NCT05434104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844664|NCT05434104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25844665|NCT05434104|Hormone Antagonists|hormone antagonists|mesh-ancestor
25844666|NCT05434104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25844667|NCT05434104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166179|NCT04306393|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25844668|NCT05434104|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25844669|NCT05434104|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25844670|NCT05434000|Hydroxyurea|hydroxyurea|mesh-list
25844671|NCT05434000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844672|NCT05434000|Antisickling Agents|antisickling agents|mesh-ancestor
25844673|NCT05434000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844674|NCT05434000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844675|NCT05434000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25844676|NCT05433896|Dasatinib|dasatinib|mesh-list
25844677|NCT05433896|Omeprazole|omeprazole|mesh-list
25844678|NCT05433896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25844679|NCT05433896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25844680|NCT05433896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25844681|NCT05433896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844682|NCT05433896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844683|NCT05433896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844684|NCT05433896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25844685|NCT05433597|Cisplatin|cisplatin|mesh-list
25844686|NCT05433597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844687|NCT05433532|Azacitidine|azacitidine|mesh-list
25844688|NCT05433532|Venetoclax|venetoclax|mesh-list
25844689|NCT05433532|HH-GV-678|hh-gv-678|mesh-list
25844695|NCT05433532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25875795|NCT04145115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875796|NCT04145115|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25875797|NCT04145115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875798|NCT04128683|Bromocriptine|bromocriptine|mesh-list
25875799|NCT04128683|Amisulpride|amisulpride|mesh-list
25875800|NCT04128683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25875801|NCT04128683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25875802|NCT04128683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25875803|NCT04128683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875804|NCT04128683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25875805|NCT04128683|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25875806|NCT04128683|Dopamine Agents|dopamine agents|mesh-ancestor
25875807|NCT04128683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25875808|NCT04128683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875809|NCT04128683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25875810|NCT04128683|Antidepressive Agents|antidepressive agents|mesh-ancestor
25875811|NCT04128683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25875812|NCT04128683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25875813|NCT04128683|Hormone Antagonists|hormone antagonists|mesh-ancestor
25875814|NCT04128683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25875815|NCT04128683|Dopamine Agonists|dopamine agonists|mesh-ancestor
25875816|NCT04104672|Gemcitabine|gemcitabine|mesh-list
25875817|NCT04104672|Paclitaxel|paclitaxel|mesh-list
25875818|NCT04104672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25875819|NCT04104672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875820|NCT04104672|Tubulin Modulators|tubulin modulators|mesh-ancestor
25875821|NCT04104672|Antimitotic Agents|antimitotic agents|mesh-ancestor
25875822|NCT04104672|Mitosis Modulators|mitosis modulators|mesh-ancestor
24458605|NCT00338494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458606|NCT00338507|Erdosteine|erdosteine|mesh-list
24458607|NCT00338507|Expectorants|expectorants|mesh-ancestor
24534923|NCT00648297|Nadolol|nadolol|mesh-list
25875823|NCT04104672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875824|NCT04104672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25875825|NCT04104672|Antimetabolites|antimetabolites|mesh-ancestor
24997429|NCT04964622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25875826|NCT04104672|Antiviral Agents|antiviral agents|mesh-ancestor
25875827|NCT04104672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25875828|NCT04104672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875829|NCT04104672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25875830|NCT04104672|Immunologic Factors|immunologic factors|mesh-ancestor
25875831|NCT04104672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875832|NCT04102436|Aldesleukin|aldesleukin|mesh-list
25875833|NCT04102436|Cyclophosphamide|cyclophosphamide|mesh-list
24820222|NCT02099240|Rifabutin|rifabutin|mesh-list
25166180|NCT04306393|Respiratory System Agents|respiratory system agents|mesh-ancestor
25166181|NCT04306393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25875834|NCT04102436|Fludarabine|fludarabine|mesh-list
25875835|NCT04102436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25875836|NCT04102436|Immunologic Factors|immunologic factors|mesh-ancestor
25875837|NCT04102436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875838|NCT04102436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25875839|NCT04102436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24639046|NCT01159821|Paroxetine|paroxetine|mesh-list
25875840|NCT04102436|Alkylating Agents|alkylating agents|mesh-ancestor
25875841|NCT04102436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875842|NCT04102436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875843|NCT04102436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24544196|NCT00687700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25875844|NCT04102436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25875845|NCT04102436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25875846|NCT04102436|Antiviral Agents|antiviral agents|mesh-ancestor
25844699|NCT05433480|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25844700|NCT05433480|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25844701|NCT05433480|Hormone Antagonists|hormone antagonists|mesh-ancestor
25844702|NCT05433480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25844703|NCT05433480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844704|NCT05433428|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24458608|NCT00338507|Respiratory System Agents|respiratory system agents|mesh-ancestor
24458609|NCT00338546|Cocaine|cocaine|mesh-list
24458610|NCT00338546|Dexmedetomidine|dexmedetomidine|mesh-list
24458611|NCT00338546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24639086|NCT01160185|Tubulin Modulators|tubulin modulators|mesh-ancestor
25844705|NCT05433428|Lubricant Eye Drops|lubricant eye drops|mesh-list
25844706|NCT05433428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25844707|NCT05433402|Chlorpromazine|chlorpromazine|mesh-list
25844708|NCT05433402|Antiemetics|antiemetics|mesh-ancestor
25844709|NCT05433402|Autonomic Agents|autonomic agents|mesh-ancestor
25844710|NCT05433402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25844711|NCT05433402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844712|NCT05433402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25844713|NCT05433402|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25844714|NCT05433402|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25844715|NCT05433402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25844716|NCT05433402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25844717|NCT05433402|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25844718|NCT05433402|Dopamine Agents|dopamine agents|mesh-ancestor
25844719|NCT05433402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25844720|NCT05433402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844721|NCT05433272|Vaccines|vaccines|mesh-list
25844722|NCT05433272|Immunologic Factors|immunologic factors|mesh-ancestor
24820223|NCT02099240|Mupirocin|mupirocin|mesh-list
25844723|NCT05433272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844724|NCT05433207|Eldecalcitol|eldecalcitol|mesh-list
25844725|NCT05433207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25844726|NCT05433207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844727|NCT05433116|Pembrolizumab|pembrolizumab|mesh-list
25844728|NCT05433116|Lenvatinib|lenvatinib|mesh-list
25844729|NCT05433116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25844730|NCT05433116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844731|NCT05433116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25844732|NCT05433116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844733|NCT05433116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844734|NCT05432934|Dexamethasone|dexamethasone|mesh-list
25844735|NCT05432934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24829610|NCT02153424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829611|NCT02153424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829612|NCT02153424|Anticoagulants|anticoagulants|mesh-ancestor
25844736|NCT05432934|Antiemetics|antiemetics|mesh-ancestor
24794459|NCT05150236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844737|NCT05432934|Autonomic Agents|autonomic agents|mesh-ancestor
25844738|NCT05432934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25844739|NCT05432934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844740|NCT05432934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25844741|NCT05432934|Glucocorticoids|glucocorticoids|mesh-ancestor
25844742|NCT05432934|Hormones|hormones|mesh-ancestor
25844743|NCT05432934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25844744|NCT05432934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25844745|NCT05432934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844746|NCT05432778|Letermovir|letermovir|mesh-list
25844747|NCT05432778|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24393199|NCT00129142|Toremifene|toremifene|mesh-list
25044255|NCT01124552|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25844748|NCT05432778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844749|NCT05432778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844750|NCT05432778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24820224|NCT02099240|Fosfomycin|fosfomycin|mesh-list
25166182|NCT04306393|Antioxidants|antioxidants|mesh-ancestor
25166183|NCT04306393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166184|NCT04306393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25844751|NCT05432778|Antiviral Agents|antiviral agents|mesh-ancestor
25844752|NCT05432778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25844753|NCT05432427|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25844754|NCT05432427|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25844755|NCT05432427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844756|NCT05432414|Dexamethasone|dexamethasone|mesh-list
25844757|NCT05432414|Bortezomib|bortezomib|mesh-list
25844758|NCT05432414|Pomalidomide|pomalidomide|mesh-list
25844759|NCT05432414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25844760|NCT05432414|Antiemetics|antiemetics|mesh-ancestor
25844761|NCT05432414|Autonomic Agents|autonomic agents|mesh-ancestor
24458625|NCT00338546|Anesthetics|anesthetics|mesh-ancestor
24458626|NCT00338546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25121509|NCT03101579|Hematinics|hematinics|mesh-ancestor
24458627|NCT00338546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24544444|NCT00689000|Glycine Agents|glycine agents|mesh-ancestor
24458628|NCT00338546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24458629|NCT00338546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24458630|NCT00338546|Dopamine Agents|dopamine agents|mesh-ancestor
24458632|NCT00338624|Parasympatholytics|parasympatholytics|mesh-ancestor
24458633|NCT00338624|Autonomic Agents|autonomic agents|mesh-ancestor
24458634|NCT00338624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24458639|NCT00338624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25181779|NCT04793490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24458640|NCT00338624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458641|NCT00338624|Urological Agents|urological agents|mesh-ancestor
24458642|NCT00338650|Adalimumab|adalimumab|mesh-list
24458643|NCT00338650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25844762|NCT05432414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25844763|NCT05432414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844764|NCT05432414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24639230|NCT01160731|Etoposide|etoposide|mesh-list
25844765|NCT05432414|Glucocorticoids|glucocorticoids|mesh-ancestor
25844766|NCT05432414|Hormones|hormones|mesh-ancestor
25844767|NCT05432414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25844768|NCT05432414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25844769|NCT05432414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844770|NCT05432414|Immunologic Factors|immunologic factors|mesh-ancestor
25844771|NCT05432414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25844772|NCT05432414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25844773|NCT05432414|Growth Substances|growth substances|mesh-ancestor
25844774|NCT05432414|Growth Inhibitors|growth inhibitors|mesh-ancestor
25844775|NCT05432141|Vaccines|vaccines|mesh-list
25844776|NCT05432141|Immunologic Factors|immunologic factors|mesh-ancestor
25844777|NCT05432141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844778|NCT05432115|Amoxicillin|amoxicillin|mesh-list
25844779|NCT05432115|Tetracycline|tetracycline|mesh-list
25844780|NCT05432115|Esomeprazole|esomeprazole|mesh-list
25844781|NCT05432115|Bismuth|bismuth|mesh-list
25844782|NCT05432115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25844783|NCT05432115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25844784|NCT05432115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25844785|NCT05432115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25844786|NCT05432115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25844787|NCT05432115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844788|NCT05432115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844789|NCT05432115|Antacids|antacids|mesh-ancestor
25844790|NCT05432115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25844791|NCT05428683|Moxifloxacin|moxifloxacin|mesh-list
25844792|NCT05428683|Triamcinolone|triamcinolone|mesh-list
25844794|NCT05428683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24544630|NCT00689715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25844795|NCT05428683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25844796|NCT05428683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25844797|NCT05428683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844798|NCT05428683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844799|NCT05428683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844800|NCT05428683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844801|NCT05428683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25844802|NCT05428683|Glucocorticoids|glucocorticoids|mesh-ancestor
25844804|NCT05428683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25844805|NCT05424549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25844806|NCT05424549|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25844807|NCT05417646|Empagliflozin|empagliflozin|mesh-list
25844808|NCT05417646|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25844809|NCT05417646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844810|NCT05417646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25844811|NCT05417646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844812|NCT05403450|Decitabine|decitabine|mesh-list
25844813|NCT05403450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25844814|NCT05403450|Antimetabolites|antimetabolites|mesh-ancestor
25844815|NCT05403450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844816|NCT05403450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166218|NCT04262817|Nicotine|nicotine|mesh-list
25166219|NCT04262817|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25166220|NCT04262817|Autonomic Agents|autonomic agents|mesh-ancestor
25166221|NCT04262817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25166222|NCT04262817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166223|NCT04262817|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25166224|NCT04262817|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25166225|NCT04262817|Cholinergic Agents|cholinergic agents|mesh-ancestor
25166226|NCT04262817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25166227|NCT04262817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166228|NCT04239872|Calcium, Dietary|calcium, dietary|mesh-list
25166229|NCT04239872|Calcium|calcium|mesh-list
25166230|NCT04239872|Fluorides|fluorides|mesh-list
25166231|NCT04239872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25166232|NCT04239872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166233|NCT04239872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25166234|NCT04239872|Cariostatic Agents|cariostatic agents|mesh-ancestor
25166235|NCT04239872|Protective Agents|protective agents|mesh-ancestor
25166236|NCT04230187|Leucovorin|leucovorin|mesh-list
25166237|NCT04230187|Bevacizumab|bevacizumab|mesh-list
25166238|NCT04230187|Fluorouracil|fluorouracil|mesh-list
25166239|NCT04230187|Oxaliplatin|oxaliplatin|mesh-list
25166240|NCT04230187|Irinotecan|irinotecan|mesh-list
25166241|NCT04230187|Levoleucovorin|levoleucovorin|mesh-list
25166242|NCT04230187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25166243|NCT04230187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166244|NCT04230187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25166245|NCT04230187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25166246|NCT04230187|Growth Substances|growth substances|mesh-ancestor
25166247|NCT04230187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166248|NCT04230187|Growth Inhibitors|growth inhibitors|mesh-ancestor
25166249|NCT04230187|Antimetabolites|antimetabolites|mesh-ancestor
25166250|NCT04230187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166251|NCT04230187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25844817|NCT05403450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844818|NCT05402891|Lithium Carbonate|lithium carbonate|mesh-list
25844819|NCT05402891|Antidepressive Agents|antidepressive agents|mesh-ancestor
24458657|NCT00338767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25844820|NCT05402891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25844821|NCT05402891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844822|NCT05402891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844823|NCT05402891|Antimanic Agents|antimanic agents|mesh-ancestor
25844824|NCT05402891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25844825|NCT05402891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25844826|NCT05402891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844827|NCT05382546|Ketorolac|ketorolac|mesh-list
25844828|NCT05382546|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25844829|NCT05382546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25844832|NCT05382546|Sensory System Agents|sensory system agents|mesh-ancestor
25844833|NCT05382546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25844834|NCT05382546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844835|NCT05382546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25844837|NCT05382546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25844838|NCT05382546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844839|NCT05382546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844840|NCT05377333|Dulaglutide|dulaglutide|mesh-list
25844841|NCT05377333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25844842|NCT05377333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844843|NCT05347654|Sulfadiazine|sulfadiazine|mesh-list
25844844|NCT05347654|Silver Sulfadiazine|silver sulfadiazine|mesh-list
25844845|NCT05347654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25844846|NCT05347654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25844847|NCT05347654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25844848|NCT05347654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25844849|NCT05347654|Coccidiostats|coccidiostats|mesh-ancestor
25844850|NCT05347654|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25844851|NCT05330013|Dapagliflozin|dapagliflozin|mesh-list
25844852|NCT05330013|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25844853|NCT05330013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844854|NCT05330013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25844855|NCT05330013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844856|NCT05324332|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25844857|NCT05324332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25844858|NCT05324332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844859|NCT05322148|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25844860|NCT05322148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25875847|NCT04102436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25875848|NCT04102020|Azacitidine|azacitidine|mesh-list
25875849|NCT04102020|Venetoclax|venetoclax|mesh-list
25875850|NCT04102020|Cc-486|cc-486|mesh-list
25875851|NCT04102020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25875852|NCT04102020|Antimetabolites|antimetabolites|mesh-ancestor
25875853|NCT04102020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875854|NCT04102020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875855|NCT04102020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875856|NCT04086485|Olaparib|olaparib|mesh-list
25875857|NCT04086485|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25875858|NCT04086485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875859|NCT04086485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875860|NCT04086485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875861|NCT04071223|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25875862|NCT04071223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875863|NCT04065451|Epinephrine|epinephrine|mesh-list
25875864|NCT04065451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25875865|NCT04065451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25875866|NCT04065451|Adrenergic Agents|adrenergic agents|mesh-ancestor
25044325|NCT01113957|Veliparib|veliparib|mesh-list
25875867|NCT04065451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25875868|NCT04065451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875869|NCT04065451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875870|NCT04065451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25875871|NCT04065451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25875872|NCT04065451|Autonomic Agents|autonomic agents|mesh-ancestor
25875873|NCT04065451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25875874|NCT04065451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25875875|NCT04065451|Respiratory System Agents|respiratory system agents|mesh-ancestor
25875876|NCT04065451|Mydriatics|mydriatics|mesh-ancestor
25875877|NCT04065451|Sympathomimetics|sympathomimetics|mesh-ancestor
25875878|NCT04065451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25875879|NCT04063163|Carboplatin|carboplatin|mesh-list
25875880|NCT04063163|Etoposide|etoposide|mesh-list
25875881|NCT04063163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875882|NCT04063163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25875883|NCT04063163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25875884|NCT04063163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25875885|NCT04063163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875886|NCT04063163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875887|NCT04054752|Vaccines|vaccines|mesh-list
25229451|NCT02602509|Sensory System Agents|sensory system agents|mesh-ancestor
25844861|NCT05310422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25844862|NCT05310422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25844863|NCT05306223|Levofloxacin|levofloxacin|mesh-list
25844864|NCT05306223|Ofloxacin|ofloxacin|mesh-list
25844865|NCT05306223|Cycloserine|cycloserine|mesh-list
25844866|NCT05306223|Linezolid|linezolid|mesh-list
25844867|NCT05306223|Pyrazinamide|pyrazinamide|mesh-list
25844868|NCT05306223|Bedaquiline|bedaquiline|mesh-list
25844869|NCT05306223|Clofazimine|clofazimine|mesh-list
25844870|NCT05306223|Prothionamide|prothionamide|mesh-list
25844871|NCT05306223|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25844872|NCT05306223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25844873|NCT05306223|Renal Agents|renal agents|mesh-ancestor
25844874|NCT05306223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25844875|NCT05306223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25844876|NCT05306223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25844877|NCT05306223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844878|NCT05306223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844879|NCT05306223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458659|NCT00338767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534994|NCT00648388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25844880|NCT05306223|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25844881|NCT05306223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25844882|NCT05306223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25844883|NCT05306223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25844884|NCT05306223|Antitubercular Agents|antitubercular agents|mesh-ancestor
25844885|NCT05306223|Antimetabolites|antimetabolites|mesh-ancestor
25844886|NCT05306223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25844887|NCT05306223|Leprostatic Agents|leprostatic agents|mesh-ancestor
25844888|NCT05285917|Hydroxyurea|hydroxyurea|mesh-list
24458660|NCT00338767|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24458661|NCT00338767|Antidepressive Agents|antidepressive agents|mesh-ancestor
25844889|NCT05285917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844890|NCT05285917|Antisickling Agents|antisickling agents|mesh-ancestor
25844891|NCT05285917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25166252|NCT04230187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25166253|NCT04230187|Immunologic Factors|immunologic factors|mesh-ancestor
25166254|NCT04230187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25166255|NCT04230187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25166256|NCT04230187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25166257|NCT04230187|Antidotes|antidotes|mesh-ancestor
25166258|NCT04230187|Protective Agents|protective agents|mesh-ancestor
25844892|NCT05285917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844893|NCT05285917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25844894|NCT05259046|Vitamin K 2|vitamin k 2|mesh-list
25844895|NCT05259046|Vitamin K|vitamin k|mesh-list
25844896|NCT05259046|Vitamin MK 7|vitamin mk 7|mesh-list
25844897|NCT05259046|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25844898|NCT05259046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25844899|NCT05259046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844900|NCT05259046|Hemostatics|hemostatics|mesh-ancestor
25844901|NCT05259046|Coagulants|coagulants|mesh-ancestor
24639731|NCT01164046|Hemostatics|hemostatics|mesh-ancestor
25844902|NCT05259046|Vitamins|vitamins|mesh-ancestor
25844903|NCT05259046|Micronutrients|micronutrients|mesh-ancestor
25844904|NCT05259046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844905|NCT05257824|Aspirin|aspirin|mesh-list
25844906|NCT05257824|Clopidogrel|clopidogrel|mesh-list
25844907|NCT05257824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25844908|NCT05257824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25844909|NCT05257824|Analgesics|analgesics|mesh-ancestor
25844910|NCT05257824|Sensory System Agents|sensory system agents|mesh-ancestor
25844911|NCT05257824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25844912|NCT05257824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844913|NCT05257824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25844914|NCT05257824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25844915|NCT05257824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25844916|NCT05257824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25844917|NCT05257824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844918|NCT05257824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25661529|NCT01634178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844919|NCT05257824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25844920|NCT05257824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25844921|NCT05257824|Antipyretics|antipyretics|mesh-ancestor
25844922|NCT05257824|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25844923|NCT05257824|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25844924|NCT05257824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24450496|NCT00319319|Autonomic Agents|autonomic agents|mesh-ancestor
24450497|NCT00319319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24450498|NCT00319319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450499|NCT00319319|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24450500|NCT00319319|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24450501|NCT00319319|Cholinergic Agents|cholinergic agents|mesh-ancestor
24450502|NCT00319319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24450503|NCT00319319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450504|NCT00319332|Tositumomab I-131|tositumomab i-131|mesh-list
24450505|NCT00319332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450506|NCT00319345|Mannitol|mannitol|mesh-list
24450507|NCT00319345|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24450508|NCT00319345|Diuretics|diuretics|mesh-ancestor
24450509|NCT00319345|Natriuretic Agents|natriuretic agents|mesh-ancestor
24450510|NCT00319345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450511|NCT00319358|Antioxidants|antioxidants|mesh-list
24450512|NCT00319358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450513|NCT00319358|Protective Agents|protective agents|mesh-ancestor
24450514|NCT00319358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450515|NCT00319488|Budesonide|budesonide|mesh-list
24450516|NCT00319488|Albuterol|albuterol|mesh-list
24450517|NCT00319488|Montelukast|montelukast|mesh-list
24450518|NCT00319488|Leukotriene Antagonists|leukotriene antagonists|mesh-list
24450519|NCT00319488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24450520|NCT00319488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25844925|NCT05257824|Purinergic Agents|purinergic agents|mesh-ancestor
25844926|NCT05257824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25844927|NCT05217498|Istradefylline|istradefylline|mesh-list
25844928|NCT05217498|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
25844929|NCT05217498|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25844930|NCT05217498|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25844931|NCT05217498|Purinergic Agents|purinergic agents|mesh-ancestor
25844932|NCT05217498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25844933|NCT05217498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844934|NCT05217498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844935|NCT05195242|Dexamethasone|dexamethasone|mesh-list
25844936|NCT05195242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25166259|NCT04230187|Vitamin B Complex|vitamin b complex|mesh-ancestor
25844937|NCT05195242|Antiemetics|antiemetics|mesh-ancestor
25844938|NCT05195242|Autonomic Agents|autonomic agents|mesh-ancestor
25844939|NCT05195242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25844940|NCT05195242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844941|NCT05195242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25844942|NCT05195242|Glucocorticoids|glucocorticoids|mesh-ancestor
25844943|NCT05195242|Hormones|hormones|mesh-ancestor
25844944|NCT05195242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25844945|NCT05195242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25844946|NCT05195242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25844947|NCT05194397|Niacinamide|niacinamide|mesh-list
25844948|NCT05194397|Niacin|niacin|mesh-list
25844949|NCT05194397|Nicotinic Acids|nicotinic acids|mesh-list
25844950|NCT05194397|Vitamin B Complex|vitamin b complex|mesh-ancestor
25844951|NCT05194397|Vitamins|vitamins|mesh-ancestor
25844952|NCT05194397|Micronutrients|micronutrients|mesh-ancestor
25844953|NCT05194397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844954|NCT05194397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25844955|NCT05194397|Antimetabolites|antimetabolites|mesh-ancestor
25844956|NCT05194397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844957|NCT05194397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25844958|NCT05194397|Vasodilator Agents|vasodilator agents|mesh-ancestor
25844959|NCT05184920|Nicotine|nicotine|mesh-list
25844960|NCT05184920|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25844961|NCT05184920|Autonomic Agents|autonomic agents|mesh-ancestor
25844962|NCT05184920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25844963|NCT05184920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844964|NCT05184920|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25844965|NCT05184920|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25844966|NCT05184920|Cholinergic Agents|cholinergic agents|mesh-ancestor
25844967|NCT05184920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25844968|NCT05184920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844969|NCT05116059|Amphotericin B|amphotericin b|mesh-list
25844970|NCT05116059|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25844971|NCT05116059|Amebicides|amebicides|mesh-ancestor
25844972|NCT05116059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25844973|NCT05116059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25844974|NCT05116059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25844978|NCT05098704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25844979|NCT05098704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25844980|NCT05098704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25844981|NCT05098704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25844982|NCT05098704|Purinergic Agents|purinergic agents|mesh-ancestor
25844983|NCT05098704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25844984|NCT05098704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25844985|NCT05098704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450522|NCT00319488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25844987|NCT05083975|Anesthetics, Local|anesthetics, local|mesh-list
25844988|NCT05083975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25844989|NCT05083975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844990|NCT05083975|Sensory System Agents|sensory system agents|mesh-ancestor
25844991|NCT05083975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25844992|NCT05082285|Vaccines|vaccines|mesh-list
25844993|NCT05082285|Immunologic Factors|immunologic factors|mesh-ancestor
25844994|NCT05082285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25844995|NCT05076877|Metformin|metformin|mesh-list
25844996|NCT05076877|Midazolam|midazolam|mesh-list
25844997|NCT05076877|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25844998|NCT05076877|Lazertinib|lazertinib|mesh-list
25844999|NCT05076877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25845000|NCT05076877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845001|NCT05076877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25845002|NCT05076877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25166260|NCT04230187|Vitamins|vitamins|mesh-ancestor
25845003|NCT05076877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25845004|NCT05076877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25845005|NCT05076877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25845006|NCT05076877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25845007|NCT05076877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25845008|NCT05076877|Anesthetics, General|anesthetics, general|mesh-ancestor
25845009|NCT05076877|Anesthetics|anesthetics|mesh-ancestor
25845010|NCT05076877|GABA Modulators|gaba modulators|mesh-ancestor
25845011|NCT05076877|GABA Agents|gaba agents|mesh-ancestor
25845012|NCT05076877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25845013|NCT05076877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845014|NCT05076877|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25845015|NCT05076877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25845016|NCT05076877|Antimetabolites|antimetabolites|mesh-ancestor
25845017|NCT05076877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25845018|NCT05076877|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25845019|NCT05076877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845020|NCT05076877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25845021|NCT05029999|Doxorubicin|doxorubicin|mesh-list
25845022|NCT05029999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25845023|NCT05029999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25845024|NCT05029999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845025|NCT05029999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25845026|NCT05029999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25845027|NCT05029999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845028|NCT05029999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845029|NCT05019794|Infigratinib|infigratinib|mesh-list
25845030|NCT05019794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845031|NCT04961190|Paroxetine|paroxetine|mesh-list
25845032|NCT04961190|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25845033|NCT04961190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25845034|NCT04961190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25845035|NCT04961190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25845036|NCT04961190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845037|NCT04961190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25409032|NCT03404180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25661530|NCT01634178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25661531|NCT01634178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25661532|NCT01634178|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25661533|NCT01634178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25845038|NCT04961190|Serotonin Agents|serotonin agents|mesh-ancestor
25845039|NCT04961190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845040|NCT04961190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25845041|NCT04961190|Antidepressive Agents|antidepressive agents|mesh-ancestor
25845042|NCT04961190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25845043|NCT04961190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25845044|NCT04961190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25845045|NCT04961190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845046|NCT04961190|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25845047|NCT04941521|Exenatide|exenatide|mesh-list
25845048|NCT04941521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25845049|NCT04941521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845050|NCT04941521|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25845051|NCT04941521|Incretins|incretins|mesh-ancestor
25845052|NCT04941521|Hormones|hormones|mesh-ancestor
25845053|NCT04941521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25845054|NCT04888377|Aspirin|aspirin|mesh-list
25845055|NCT04888377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25845056|NCT04888377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25845057|NCT04888377|Analgesics|analgesics|mesh-ancestor
25845058|NCT04888377|Sensory System Agents|sensory system agents|mesh-ancestor
25845059|NCT04888377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25845060|NCT04888377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845061|NCT04888377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25845062|NCT04888377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25845063|NCT04888377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25845064|NCT04888377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25845065|NCT04888377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845066|NCT04888377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25845067|NCT04888377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25845068|NCT04888377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845069|NCT04888377|Antipyretics|antipyretics|mesh-ancestor
25845070|NCT04768296|Topotecan|topotecan|mesh-list
25845071|NCT04768296|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25845072|NCT04768296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25845073|NCT04768296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845074|NCT04768296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845075|NCT04768296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845076|NCT04760782|Abaloparatide|abaloparatide|mesh-list
25845077|NCT04760782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25845078|NCT04760782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845079|NCT04750772|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
25845080|NCT04750772|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25845081|NCT04750772|Chelating Agents|chelating agents|mesh-ancestor
24413882|NCT00195559|Levonorgestrel|levonorgestrel|mesh-list
25845082|NCT04750772|Sequestering Agents|sequestering agents|mesh-ancestor
25845083|NCT04750772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448714|NCT00312754|Protease Inhibitors|protease inhibitors|mesh-ancestor
24448715|NCT00312754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448716|NCT00312754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448717|NCT00312754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24448718|NCT00312754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24448719|NCT00312754|Antiviral Agents|antiviral agents|mesh-ancestor
24448720|NCT00312754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25845084|NCT04750772|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25845085|NCT04733118|Trastuzumab|trastuzumab|mesh-list
25845086|NCT04733118|Pertuzumab|pertuzumab|mesh-list
25845087|NCT04733118|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25845088|NCT04733118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25845089|NCT04733118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845090|NCT04733118|Tubulin Modulators|tubulin modulators|mesh-ancestor
25845091|NCT04733118|Antimitotic Agents|antimitotic agents|mesh-ancestor
25845092|NCT04733118|Mitosis Modulators|mitosis modulators|mesh-ancestor
25845093|NCT04733118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845094|NCT04680442|Trastuzumab|trastuzumab|mesh-list
25845095|NCT04680442|Pertuzumab|pertuzumab|mesh-list
25845096|NCT04680442|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25845097|NCT04680442|Maytansine|maytansine|mesh-list
25845098|NCT04680442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25845099|NCT04680442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845100|NCT04680442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25845101|NCT04680442|Tubulin Modulators|tubulin modulators|mesh-ancestor
25166262|NCT04224272|Fulvestrant|fulvestrant|mesh-list
25166263|NCT04224272|Palbociclib|palbociclib|mesh-list
25166265|NCT04224272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845102|NCT04680442|Antimitotic Agents|antimitotic agents|mesh-ancestor
25845103|NCT04680442|Mitosis Modulators|mitosis modulators|mesh-ancestor
24545765|NCT00694733|Androgens|androgens|mesh-ancestor
24545766|NCT00694733|Anabolic Agents|anabolic agents|mesh-ancestor
24545768|NCT00694759|Pioglitazone|pioglitazone|mesh-list
24545769|NCT00694759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24545770|NCT00694759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545771|NCT00694837|Nelfinavir|nelfinavir|mesh-list
24545777|NCT00694837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24545778|NCT00694837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24545779|NCT00694837|Antiviral Agents|antiviral agents|mesh-ancestor
25845104|NCT04680442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845105|NCT04678401|Cyclophosphamide|cyclophosphamide|mesh-list
25166266|NCT04224272|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25166267|NCT04224272|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25166268|NCT04224272|Hormone Antagonists|hormone antagonists|mesh-ancestor
25166269|NCT04224272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25166270|NCT04224272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166271|NCT04224272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25166272|NCT04224272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25166273|NCT04224272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166274|NCT04207190|Talazoparib|talazoparib|mesh-list
25166275|NCT04207190|Gemtuzumab|gemtuzumab|mesh-list
25166276|NCT04207190|Calicheamicins|calicheamicins|mesh-list
25166277|NCT04207190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25166278|NCT04207190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25166279|NCT04207190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166280|NCT04207190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166281|NCT04207190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25166282|NCT04207190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25845106|NCT04678401|Thiotepa|thiotepa|mesh-list
25845107|NCT04678401|Fludarabine|fludarabine|mesh-list
25845108|NCT04678401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25845109|NCT04678401|Immunologic Factors|immunologic factors|mesh-ancestor
25845110|NCT04678401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845111|NCT04678401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25181780|NCT04793490|Analgesics|analgesics|mesh-ancestor
25845112|NCT04678401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25845113|NCT04678401|Alkylating Agents|alkylating agents|mesh-ancestor
25845114|NCT04678401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845115|NCT04678401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458707|NCT00338936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458708|NCT00338936|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24458709|NCT00338936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24458710|NCT00339001|Epoetin Alfa|epoetin alfa|mesh-list
24458711|NCT00339001|Hematinics|hematinics|mesh-ancestor
25845116|NCT04678401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24794524|NCT05067387|Sensory System Agents|sensory system agents|mesh-ancestor
25845117|NCT04677114|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25845118|NCT04677114|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25845119|NCT04677114|Buprenorphine|buprenorphine|mesh-list
25845120|NCT04677114|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25845121|NCT04677114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25845122|NCT04677114|Antitubercular Agents|antitubercular agents|mesh-ancestor
25845123|NCT04677114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25845124|NCT04677114|Narcotics|narcotics|mesh-ancestor
25845125|NCT04677114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25845126|NCT04677114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845127|NCT04677114|Analgesics|analgesics|mesh-ancestor
25845128|NCT04677114|Sensory System Agents|sensory system agents|mesh-ancestor
25845129|NCT04677114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25845130|NCT04677114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25845131|NCT04659161|Xanomeline|xanomeline|mesh-list
25845132|NCT04659161|Trospium chloride|trospium chloride|mesh-list
25661534|NCT01634178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661535|NCT01634178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661536|NCT01634191|Apremilast|apremilast|mesh-list
25661537|NCT01634191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25661538|NCT01634191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25661539|NCT01634191|Analgesics|analgesics|mesh-ancestor
25661540|NCT01634191|Sensory System Agents|sensory system agents|mesh-ancestor
25661541|NCT01634191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25661542|NCT01634191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661543|NCT01634191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24548866|NCT00712465|Digoxin|digoxin|mesh-list
25845133|NCT04659161|Parasympatholytics|parasympatholytics|mesh-ancestor
24458712|NCT00339014|Zonisamide|zonisamide|mesh-list
24458713|NCT00339014|Bupropion|bupropion|mesh-list
24458714|NCT00339014|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24458715|NCT00339014|Antidepressive Agents|antidepressive agents|mesh-ancestor
24458716|NCT00339014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24458717|NCT00339014|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25845134|NCT04659161|Autonomic Agents|autonomic agents|mesh-ancestor
25845135|NCT04659161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25845136|NCT04659161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845137|NCT04659161|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25845138|NCT04659161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25845139|NCT04659161|Cholinergic Agents|cholinergic agents|mesh-ancestor
25845140|NCT04659161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25845141|NCT04659161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845142|NCT04659161|Urological Agents|urological agents|mesh-ancestor
25845143|NCT04659161|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25845144|NCT04659161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25845145|NCT04659161|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25845146|NCT04659161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25845147|NCT04604548|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
25845148|NCT04604548|Antioxidants|antioxidants|mesh-ancestor
25845149|NCT04604548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845150|NCT04604548|Protective Agents|protective agents|mesh-ancestor
25845151|NCT04604548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845152|NCT04597411|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25845153|NCT04597411|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25845154|NCT04597411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875888|NCT04054752|Immunologic Factors|immunologic factors|mesh-ancestor
25875889|NCT04054752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875890|NCT04053881|Certolizumab Pegol|certolizumab pegol|mesh-list
24640267|NCT01167101|Antioxidants|antioxidants|mesh-ancestor
25875891|NCT04053881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25875892|NCT04053881|Immunologic Factors|immunologic factors|mesh-ancestor
25875893|NCT04053881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875894|NCT04053881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25875895|NCT04050462|Nivolumab|nivolumab|mesh-list
25875896|NCT04050462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25875897|NCT04050462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458718|NCT00339014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24458719|NCT00339014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24458720|NCT00339014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458722|NCT00339014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24458723|NCT00339014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458724|NCT00339014|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24458725|NCT00339014|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24458726|NCT00339014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458727|NCT00339014|Anticonvulsants|anticonvulsants|mesh-ancestor
24458728|NCT00339014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24458729|NCT00339014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24458730|NCT00339066|Sertraline|sertraline|mesh-list
24535165|NCT00648661|Autonomic Agents|autonomic agents|mesh-ancestor
25875898|NCT04050462|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25875899|NCT04050462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875900|NCT04045028|Rituximab|rituximab|mesh-list
25875901|NCT04045028|Atezolizumab|atezolizumab|mesh-list
25875902|NCT04045028|Daratumumab|daratumumab|mesh-list
25875903|NCT04045028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25875904|NCT04045028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875905|NCT04045028|Immunologic Factors|immunologic factors|mesh-ancestor
25875906|NCT04045028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875907|NCT04045028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25875908|NCT04041050|Celecoxib|celecoxib|mesh-list
25875909|NCT04041050|Navitoclax|navitoclax|mesh-list
25875910|NCT04041050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25875911|NCT04041050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25875912|NCT04041050|Analgesics|analgesics|mesh-ancestor
25875913|NCT04041050|Sensory System Agents|sensory system agents|mesh-ancestor
25875914|NCT04041050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25875915|NCT04041050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875916|NCT04041050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24458731|NCT00339066|Antidepressive Agents|antidepressive agents|mesh-ancestor
25661544|NCT01634191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24458732|NCT00339066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24458733|NCT00339066|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24458734|NCT00339066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24458735|NCT00339066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24458736|NCT00339066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458737|NCT00339066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24458738|NCT00339066|Serotonin Agents|serotonin agents|mesh-ancestor
24458739|NCT00339066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458740|NCT00339118|Doxorubicin|doxorubicin|mesh-list
25845155|NCT04541589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25845156|NCT04541589|Immunologic Factors|immunologic factors|mesh-ancestor
25845157|NCT04541589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845158|NCT04518319|Olanzapine|olanzapine|mesh-list
25845159|NCT04518319|Antiemetics|antiemetics|mesh-ancestor
25845160|NCT04518319|Autonomic Agents|autonomic agents|mesh-ancestor
25845161|NCT04518319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25845162|NCT04518319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845163|NCT04518319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25845164|NCT04518319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25845165|NCT04518319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25845166|NCT04518319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25845167|NCT04518319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25845168|NCT04518319|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25845169|NCT04518319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25845170|NCT04518319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25845171|NCT04518319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845172|NCT04518319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24858389|NCT02296749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24858390|NCT02296749|Immunologic Factors|immunologic factors|mesh-ancestor
24458782|NCT00339417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24458783|NCT00339417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24458784|NCT00339417|Anthelmintics|anthelmintics|mesh-ancestor
24458785|NCT00339417|Anticestodal Agents|anticestodal agents|mesh-ancestor
24458786|NCT00339417|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24458787|NCT00339417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24458788|NCT00339417|Tubulin Modulators|tubulin modulators|mesh-ancestor
24458789|NCT00339417|Antimitotic Agents|antimitotic agents|mesh-ancestor
24458790|NCT00339417|Mitosis Modulators|mitosis modulators|mesh-ancestor
24535224|NCT00648804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25845173|NCT04518319|Serotonin Agents|serotonin agents|mesh-ancestor
25845174|NCT04436744|Palbociclib|palbociclib|mesh-list
25845175|NCT04436744|Anastrozole|anastrozole|mesh-list
25845176|NCT04436744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845177|NCT04436744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25845178|NCT04436744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845179|NCT04436744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845180|NCT04436744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25845181|NCT04436744|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25845182|NCT04436744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25845183|NCT04436744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25845184|NCT04436744|Hormone Antagonists|hormone antagonists|mesh-ancestor
25845185|NCT04436744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25845186|NCT04436744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845187|NCT04430790|Doxapram|doxapram|mesh-list
25845188|NCT04430790|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25845189|NCT04430790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845190|NCT04430790|Respiratory System Agents|respiratory system agents|mesh-ancestor
25845191|NCT04393389|Paclitaxel|paclitaxel|mesh-list
25845192|NCT04393389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25845193|NCT04393389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845194|NCT04393389|Tubulin Modulators|tubulin modulators|mesh-ancestor
24458800|NCT00339768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24458801|NCT00339768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24458802|NCT00339768|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24458803|NCT00339768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24458804|NCT00339768|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24458805|NCT00339768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24406042|NCT00169039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24450565|NCT00319605|Nootropic Agents|nootropic agents|mesh-ancestor
24450566|NCT00319618|Docetaxel|docetaxel|mesh-list
24450567|NCT00319618|Gefitinib|gefitinib|mesh-list
25845195|NCT04393389|Antimitotic Agents|antimitotic agents|mesh-ancestor
25845196|NCT04393389|Mitosis Modulators|mitosis modulators|mesh-ancestor
25845197|NCT04393389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845198|NCT04319757|Cyclophosphamide|cyclophosphamide|mesh-list
25845199|NCT04319757|Fludarabine|fludarabine|mesh-list
25845200|NCT04319757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25845201|NCT04319757|Immunologic Factors|immunologic factors|mesh-ancestor
25845202|NCT04319757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845203|NCT04319757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25845204|NCT04319757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25845205|NCT04319757|Alkylating Agents|alkylating agents|mesh-ancestor
25845206|NCT04319757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845207|NCT04319757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845208|NCT04319757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25845209|NCT04245722|Cyclophosphamide|cyclophosphamide|mesh-list
25845210|NCT04245722|Rituximab|rituximab|mesh-list
25845211|NCT04245722|Fludarabine|fludarabine|mesh-list
25845212|NCT04245722|Obinutuzumab|obinutuzumab|mesh-list
25845213|NCT04245722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25845214|NCT04245722|Immunologic Factors|immunologic factors|mesh-ancestor
25845215|NCT04245722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640627|NCT01169402|Fluconazole|fluconazole|mesh-list
24640628|NCT01169402|Antifungal Agents|antifungal agents|mesh-ancestor
25845216|NCT04245722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25845217|NCT04245722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25845218|NCT04245722|Alkylating Agents|alkylating agents|mesh-ancestor
25845219|NCT04245722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845220|NCT04245722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845221|NCT04245722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25845222|NCT04245722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25845223|NCT04231643|Dronabinol|dronabinol|mesh-list
25845224|NCT04231643|Cannabidiol|cannabidiol|mesh-list
25845225|NCT04231643|Hallucinogens|hallucinogens|mesh-ancestor
25845226|NCT04231643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845227|NCT04231643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25166296|NCT04180488|Histamine Antagonists|histamine antagonists|mesh-list
25166297|NCT04180488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25845228|NCT04231643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25845229|NCT04231643|Analgesics|analgesics|mesh-ancestor
25845230|NCT04231643|Sensory System Agents|sensory system agents|mesh-ancestor
25845231|NCT04231643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25845232|NCT04231643|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25845233|NCT04231643|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25845234|NCT04231643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25845235|NCT04231643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458834|NCT00340613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845236|NCT04231643|Hormones|hormones|mesh-ancestor
25845237|NCT04231643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25845238|NCT04231643|Anticonvulsants|anticonvulsants|mesh-ancestor
25845239|NCT04201665|Oxytocin|oxytocin|mesh-list
25845240|NCT04201665|Carbetocin|carbetocin|mesh-list
25845241|NCT04201665|Oxytocics|oxytocics|mesh-ancestor
25845242|NCT04201665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25845243|NCT04201665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845244|NCT04198662|Epinephrine|epinephrine|mesh-list
25845245|NCT04198662|Ropivacaine|ropivacaine|mesh-list
25845246|NCT04198662|Anesthetics, Local|anesthetics, local|mesh-ancestor
25845247|NCT04198662|Anesthetics|anesthetics|mesh-ancestor
25845248|NCT04198662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25845249|NCT04198662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845250|NCT04198662|Sensory System Agents|sensory system agents|mesh-ancestor
25845251|NCT04198662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25845252|NCT04198662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25845253|NCT04198662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24858534|NCT02298166|Immunologic Factors|immunologic factors|mesh-ancestor
24458853|NCT00341432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24458854|NCT00341432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458855|NCT00341432|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24458856|NCT00341432|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24458857|NCT00341432|Cholinergic Agents|cholinergic agents|mesh-ancestor
24458858|NCT00341432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24640703|NCT01169688|Adrenergic Agents|adrenergic agents|mesh-ancestor
25845254|NCT04198662|Adrenergic Agents|adrenergic agents|mesh-ancestor
25845255|NCT04198662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25845256|NCT04198662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845257|NCT04198662|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25845258|NCT04198662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24640755|NCT01169870|Paclitaxel|paclitaxel|mesh-list
25845259|NCT04198662|Autonomic Agents|autonomic agents|mesh-ancestor
25845260|NCT04198662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25845261|NCT04198662|Respiratory System Agents|respiratory system agents|mesh-ancestor
25845263|NCT04198662|Sympathomimetics|sympathomimetics|mesh-ancestor
25845264|NCT04198662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25845265|NCT04170348|Vitamin D|vitamin d|mesh-list
25845266|NCT04170348|Ergocalciferols|ergocalciferols|mesh-list
25845267|NCT04170348|Cholecalciferol|cholecalciferol|mesh-list
25845268|NCT04170348|Vitamins|vitamins|mesh-list
25845269|NCT04170348|Trientine|trientine|mesh-list
25845270|NCT04170348|Micronutrients|micronutrients|mesh-ancestor
25845271|NCT04170348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845272|NCT04170348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25845273|NCT04170348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25845274|NCT04170348|Chelating Agents|chelating agents|mesh-ancestor
25845275|NCT04170348|Sequestering Agents|sequestering agents|mesh-ancestor
25845276|NCT04170348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845277|NCT04149210|Fluorometholone|fluorometholone|mesh-list
25845278|NCT04149210|Lubricant Eye Drops|lubricant eye drops|mesh-list
24640793|NCT01170104|Sorafenib|sorafenib|mesh-list
25845279|NCT04149210|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25845280|NCT04149210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25166298|NCT04180488|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
25845281|NCT04149210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25845282|NCT04149210|Glucocorticoids|glucocorticoids|mesh-ancestor
25845283|NCT04149210|Hormones|hormones|mesh-ancestor
25845284|NCT04149210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25845285|NCT04149210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845286|NCT04149210|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25845287|NCT04094701|Analgesics, Opioid|analgesics, opioid|mesh-list
24640885|NCT01170468|Micronutrients|micronutrients|mesh-ancestor
24640886|NCT01170468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640889|NCT01170494|Cholecalciferol|cholecalciferol|mesh-list
25845288|NCT04094701|Narcotics|narcotics|mesh-ancestor
25845289|NCT04094701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25845290|NCT04094701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845291|NCT04094701|Analgesics|analgesics|mesh-ancestor
25845292|NCT04094701|Sensory System Agents|sensory system agents|mesh-ancestor
25845293|NCT04094701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25845294|NCT04088188|Gemcitabine|gemcitabine|mesh-list
25845295|NCT04088188|Cisplatin|cisplatin|mesh-list
25845296|NCT04088188|Ivosidenib|ivosidenib|mesh-list
25845297|NCT04088188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845298|NCT04088188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25845299|NCT04088188|Antimetabolites|antimetabolites|mesh-ancestor
25845300|NCT04088188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845301|NCT04088188|Antiviral Agents|antiviral agents|mesh-ancestor
25845302|NCT04088188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25845303|NCT04088188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845304|NCT04088188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25845305|NCT04088188|Immunologic Factors|immunologic factors|mesh-ancestor
25845306|NCT04088188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845307|NCT04083144|Varenicline|varenicline|mesh-list
25845308|NCT04083144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25845309|NCT04083144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25122330|NCT03094663|Cefazolin|cefazolin|mesh-list
25845310|NCT04083144|Cholinergic Agents|cholinergic agents|mesh-ancestor
25845311|NCT04083144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25845312|NCT04083144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845313|NCT04083144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845314|NCT04078295|Nivolumab|nivolumab|mesh-list
25845315|NCT04078295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25845316|NCT04078295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845317|NCT04078295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25845318|NCT04078295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845319|NCT04061421|Decitabine|decitabine|mesh-list
25845320|NCT04061421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25845321|NCT04061421|Antimetabolites|antimetabolites|mesh-ancestor
25845322|NCT04061421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845323|NCT04061421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845324|NCT04061421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845325|NCT04008797|Lenvatinib|lenvatinib|mesh-list
25845326|NCT04008797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845327|NCT04008797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25845328|NCT04008797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845329|NCT04008797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845330|NCT04002258|Antipsychotic Agents|antipsychotic agents|mesh-list
25845334|NCT04002258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25845335|NCT03957057|Iron|iron|mesh-list
25845336|NCT03957057|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25845337|NCT03957057|Trace Elements|trace elements|mesh-ancestor
25845338|NCT03957057|Micronutrients|micronutrients|mesh-ancestor
25845339|NCT03957057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845340|NCT03957057|Hematinics|hematinics|mesh-ancestor
25845341|NCT03828201|Levofloxacin|levofloxacin|mesh-list
25845342|NCT03828201|Ofloxacin|ofloxacin|mesh-list
25166299|NCT04180488|Histamine Agents|histamine agents|mesh-ancestor
25845343|NCT03828201|Linezolid|linezolid|mesh-list
25845344|NCT03828201|Bedaquiline|bedaquiline|mesh-list
25845345|NCT03828201|Clofazimine|clofazimine|mesh-list
25845346|NCT03828201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25845347|NCT03828201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25845348|NCT03828201|Renal Agents|renal agents|mesh-ancestor
25845349|NCT03828201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25845350|NCT03828201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25845351|NCT03828201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25845352|NCT03828201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845353|NCT03828201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845354|NCT03828201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845355|NCT03828201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25845356|NCT03828201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25845357|NCT03828201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24858632|NCT02298582|Fentanyl|fentanyl|mesh-list
25845358|NCT03828201|Antitubercular Agents|antitubercular agents|mesh-ancestor
25845359|NCT03828201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25845360|NCT03828201|Leprostatic Agents|leprostatic agents|mesh-ancestor
24640982|NCT01171092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845361|NCT03783923|Deflazacort|deflazacort|mesh-list
25845362|NCT03783923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25845363|NCT03783923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25845364|NCT03783923|Immunologic Factors|immunologic factors|mesh-ancestor
25845365|NCT03783923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845366|NCT03718429|Rivaroxaban|rivaroxaban|mesh-list
25845367|NCT03718429|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25845368|NCT03718429|Antithrombins|antithrombins|mesh-ancestor
25845369|NCT03718429|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25845370|NCT03718429|Protease Inhibitors|protease inhibitors|mesh-ancestor
24450317|NCT00318760|Sensory System Agents|sensory system agents|mesh-ancestor
25845371|NCT03718429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845372|NCT03718429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845373|NCT03718429|Anticoagulants|anticoagulants|mesh-ancestor
25845374|NCT03668431|Trametinib|trametinib|mesh-list
25845375|NCT03668431|Dabrafenib|dabrafenib|mesh-list
25845376|NCT03668431|Spartalizumab|spartalizumab|mesh-list
25845377|NCT03668431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845378|NCT03668431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25845379|NCT03668431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845380|NCT03668431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845381|NCT03668431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25845382|NCT03636958|Anticonvulsants|anticonvulsants|mesh-list
25845383|NCT03603223|Pembrolizumab|pembrolizumab|mesh-list
25845384|NCT03603223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25845385|NCT03603223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845386|NCT03533946|Rucaparib|rucaparib|mesh-list
25845387|NCT03533946|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25845388|NCT03533946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845389|NCT03533946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845390|NCT03533946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845391|NCT03439865|Ivacaftor|ivacaftor|mesh-list
25845392|NCT03439865|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25845393|NCT03439865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25845394|NCT03439865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845395|NCT03430596|Pramipexole|pramipexole|mesh-list
25845396|NCT03430596|Trihexyphenidyl|trihexyphenidyl|mesh-list
25845397|NCT03430596|Antioxidants|antioxidants|mesh-ancestor
25845398|NCT03430596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845399|NCT03430596|Protective Agents|protective agents|mesh-ancestor
25875917|NCT04041050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25845400|NCT03430596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845402|NCT03430596|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25845403|NCT03430596|Dopamine Agonists|dopamine agonists|mesh-ancestor
25845404|NCT03430596|Dopamine Agents|dopamine agents|mesh-ancestor
25845405|NCT03430596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25845406|NCT03430596|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25845407|NCT03430596|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25845408|NCT03430596|Cholinergic Agents|cholinergic agents|mesh-ancestor
25845409|NCT03358875|Docetaxel|docetaxel|mesh-list
25845410|NCT03358875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845411|NCT03358875|Tubulin Modulators|tubulin modulators|mesh-ancestor
25845412|NCT03358875|Antimitotic Agents|antimitotic agents|mesh-ancestor
25845413|NCT03358875|Mitosis Modulators|mitosis modulators|mesh-ancestor
25845414|NCT03358875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845415|NCT03338621|Moxifloxacin|moxifloxacin|mesh-list
25845416|NCT03338621|Rifampin|rifampin|mesh-list
25845417|NCT03338621|Isoniazid|isoniazid|mesh-list
25845418|NCT03338621|Pyrazinamide|pyrazinamide|mesh-list
25845419|NCT03338621|Ethambutol|ethambutol|mesh-list
25845420|NCT03338621|Bedaquiline|bedaquiline|mesh-list
25845421|NCT03338621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25845422|NCT03338621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25845423|NCT03338621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25845424|NCT03338621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25845425|NCT03338621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845426|NCT03338621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845427|NCT03338621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845428|NCT03338621|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25845429|NCT03338621|Antitubercular Agents|antitubercular agents|mesh-ancestor
25845430|NCT03338621|Leprostatic Agents|leprostatic agents|mesh-ancestor
24535466|NCT00649181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535467|NCT00649181|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24535468|NCT00649181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24535469|NCT00649181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535470|NCT00649194|Rabeprazole|rabeprazole|mesh-list
25845431|NCT03338621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25845432|NCT03338621|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25845433|NCT03338621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25845434|NCT03338621|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25845435|NCT03338621|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25845436|NCT03338621|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25845437|NCT03338621|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25845438|NCT03338621|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25845439|NCT03338621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25845440|NCT03338621|Antimetabolites|antimetabolites|mesh-ancestor
25845441|NCT03338621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25875918|NCT04041050|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25875919|NCT04041050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25875920|NCT04041050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875921|NCT04041050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875922|NCT04041050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875923|NCT04040088|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
25875924|NCT04040088|Chelating Agents|chelating agents|mesh-ancestor
24458925|NCT00343161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24458926|NCT00343161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24458927|NCT00343161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458928|NCT00343161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458929|NCT00343161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24458930|NCT00343161|Immunologic Factors|immunologic factors|mesh-ancestor
24458931|NCT00343161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535474|NCT00649194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535475|NCT00649194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535477|NCT00649207|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25875925|NCT04040088|Sequestering Agents|sequestering agents|mesh-ancestor
25875926|NCT04040088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875927|NCT04038515|Menthol|menthol|mesh-list
25875928|NCT04038515|Nicotine|nicotine|mesh-list
24641260|NCT01172652|Ziprasidone|ziprasidone|mesh-list
25166300|NCT04180488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24829635|NCT02153541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24829638|NCT02153541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24829639|NCT02153541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24829640|NCT02153541|Analgesics|analgesics|mesh-ancestor
24829641|NCT02153541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24829642|NCT02153541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24829643|NCT02153567|Citalopram|citalopram|mesh-list
24461292|NCT00351871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24829644|NCT02153567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24829645|NCT02153567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24726407|NCT01603108|Rifaximin|rifaximin|mesh-list
25845442|NCT03336333|Rituximab|rituximab|mesh-list
25845443|NCT03336333|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25845444|NCT03336333|Venetoclax|venetoclax|mesh-list
25845445|NCT03336333|Zanubrutinib|zanubrutinib|mesh-list
25845446|NCT03336333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25845447|NCT03336333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845448|NCT03336333|Immunologic Factors|immunologic factors|mesh-ancestor
25845449|NCT03336333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845450|NCT03336333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25845451|NCT03336333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25166322|NCT04171453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24460138|NCT00347490|Enoxaparin|enoxaparin|mesh-list
25166323|NCT04171453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25166324|NCT04171453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25166348|NCT04152980|Pentoxifylline|pentoxifylline|mesh-list
25166349|NCT04152980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25166350|NCT04152980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25166351|NCT04152980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845452|NCT03336333|Alkylating Agents|alkylating agents|mesh-ancestor
25845453|NCT03336333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845454|NCT03336333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25845455|NCT03336333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845456|NCT03238248|Azacitidine|azacitidine|mesh-list
25845457|NCT03238248|Pevonedistat|pevonedistat|mesh-list
25845458|NCT03238248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25845459|NCT03238248|Antimetabolites|antimetabolites|mesh-ancestor
25845460|NCT03238248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845461|NCT03238248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845462|NCT03238248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845463|NCT03208179|Azithromycin|azithromycin|mesh-list
25845464|NCT03208179|Pyrimethamine|pyrimethamine|mesh-list
25845465|NCT03208179|Piperaquine|piperaquine|mesh-list
25845466|NCT03208179|Sulfadoxine|sulfadoxine|mesh-list
25845467|NCT03208179|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25845468|NCT03208179|Artenimol|artenimol|mesh-list
25845469|NCT03208179|Artemisinins|artemisinins|mesh-list
25845470|NCT03208179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25845471|NCT03208179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25845472|NCT03208179|Antimalarials|antimalarials|mesh-ancestor
25845473|NCT03208179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25845474|NCT03208179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25845475|NCT03208179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25845476|NCT03208179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845477|NCT03208179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845478|NCT03208179|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25845479|NCT03208179|Renal Agents|renal agents|mesh-ancestor
25845480|NCT03062826|Aspirin|aspirin|mesh-list
25845481|NCT03062826|Clopidogrel|clopidogrel|mesh-list
25845482|NCT03062826|Ticagrelor|ticagrelor|mesh-list
25845483|NCT03062826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25845484|NCT03062826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24458948|NCT00343200|Sildenafil Citrate|sildenafil citrate|mesh-list
24458949|NCT00343200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458950|NCT00343200|Vasodilator Agents|vasodilator agents|mesh-ancestor
24458951|NCT00343200|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24458952|NCT00343200|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24458953|NCT00343200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458954|NCT00343200|Urological Agents|urological agents|mesh-ancestor
24458955|NCT00343226|Basiliximab|basiliximab|mesh-list
25845485|NCT03062826|Analgesics|analgesics|mesh-ancestor
25845486|NCT03062826|Sensory System Agents|sensory system agents|mesh-ancestor
25845487|NCT03062826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25845488|NCT03062826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845489|NCT03062826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25845490|NCT03062826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25845491|NCT03062826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25845492|NCT03062826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25845493|NCT03062826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845494|NCT03062826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24546054|NCT00696566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25845495|NCT03062826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25845496|NCT03062826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458956|NCT00343226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24458957|NCT00343226|Immunologic Factors|immunologic factors|mesh-ancestor
24458958|NCT00343226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845498|NCT03062826|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25845499|NCT03062826|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25845500|NCT03062826|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25845501|NCT03062826|Purinergic Agents|purinergic agents|mesh-ancestor
25845502|NCT03062826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25845503|NCT03058289|Pembrolizumab|pembrolizumab|mesh-list
24641401|NCT01173315|Vitamins|vitamins|mesh-list
25845504|NCT03058289|Ipilimumab|ipilimumab|mesh-list
25845505|NCT03058289|Antibodies|antibodies|mesh-list
25845506|NCT03058289|Immunoglobulins|immunoglobulins|mesh-list
25845507|NCT03058289|Immunologic Factors|immunologic factors|mesh-ancestor
25845508|NCT03058289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845509|NCT03058289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25845510|NCT03058289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166352|NCT04152980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25845511|NCT03058289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25845512|NCT03058289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845513|NCT03057106|Durvalumab|durvalumab|mesh-list
25845514|NCT03057106|Tremelimumab|tremelimumab|mesh-list
25845515|NCT03057106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25845516|NCT03057106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845517|NCT02971748|Pembrolizumab|pembrolizumab|mesh-list
25845518|NCT02971748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25845519|NCT02971748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845520|NCT02942355|Palbociclib|palbociclib|mesh-list
25845521|NCT02942355|Anastrozole|anastrozole|mesh-list
25845522|NCT02942355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845523|NCT02942355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25845524|NCT02942355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845525|NCT02942355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845526|NCT02942355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25845527|NCT02942355|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25845528|NCT02942355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25845529|NCT02942355|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25845530|NCT02942355|Hormone Antagonists|hormone antagonists|mesh-ancestor
25845531|NCT02942355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25845532|NCT02942355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845533|NCT02734771|Prednisone|prednisone|mesh-list
25845534|NCT02734771|Cyclophosphamide|cyclophosphamide|mesh-list
25845535|NCT02734771|Rituximab|rituximab|mesh-list
25845536|NCT02734771|Doxorubicin|doxorubicin|mesh-list
25845537|NCT02734771|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25845538|NCT02734771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25845539|NCT02734771|Immunologic Factors|immunologic factors|mesh-ancestor
25845540|NCT02734771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845541|NCT02734771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25845542|NCT02734771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24535536|NCT00649311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845543|NCT02734771|Alkylating Agents|alkylating agents|mesh-ancestor
25845544|NCT02734771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845545|NCT02734771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450576|NCT00319670|Laxatives|laxatives|mesh-ancestor
24450586|NCT00319709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450587|NCT00319709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450588|NCT00319761|Calcitriol|calcitriol|mesh-list
24450589|NCT00319761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24450590|NCT00319761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450591|NCT00319761|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24450592|NCT00319761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24450593|NCT00319761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450594|NCT00319761|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24450595|NCT00319761|Vitamins|vitamins|mesh-ancestor
24450596|NCT00319761|Micronutrients|micronutrients|mesh-ancestor
24450597|NCT00319761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24450598|NCT00319787|Gefitinib|gefitinib|mesh-list
25661545|NCT01634191|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24450599|NCT00319787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845546|NCT02734771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25845547|NCT02734771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25845548|NCT02734771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25845549|NCT02734771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25845550|NCT02734771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25845551|NCT02734771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845552|NCT02734771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25845553|NCT02734771|Glucocorticoids|glucocorticoids|mesh-ancestor
25845554|NCT02734771|Hormones|hormones|mesh-ancestor
25845555|NCT02734771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25845556|NCT02734771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25845557|NCT02680574|Darbepoetin alfa|darbepoetin alfa|mesh-list
25845558|NCT02680574|Hematinics|hematinics|mesh-ancestor
25845559|NCT02648347|Darbepoetin alfa|darbepoetin alfa|mesh-list
25845560|NCT02648347|Hematinics|hematinics|mesh-ancestor
25845561|NCT02544815|Digoxin|digoxin|mesh-list
25845562|NCT02544815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25845563|NCT02544815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25845564|NCT02544815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845565|NCT02544815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845566|NCT02544815|Protective Agents|protective agents|mesh-ancestor
25845567|NCT02544815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845568|NCT02347111|Sotalol|sotalol|mesh-list
24641516|NCT01174017|Cadexomer iodine|cadexomer iodine|mesh-list
25845569|NCT02347111|Flecainide|flecainide|mesh-list
25845570|NCT02347111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25845571|NCT02347111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25845572|NCT02347111|Adrenergic Agents|adrenergic agents|mesh-ancestor
25845573|NCT02347111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25845574|NCT02347111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845575|NCT02347111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845576|NCT02347111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25845577|NCT02347111|Sympatholytics|sympatholytics|mesh-ancestor
25845578|NCT02347111|Autonomic Agents|autonomic agents|mesh-ancestor
25845579|NCT02347111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25845580|NCT02347111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25845581|NCT02347111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25845582|NCT02347111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25845583|NCT02334865|Lenalidomide|lenalidomide|mesh-list
25845584|NCT02334865|Sargramostim|sargramostim|mesh-list
25845585|NCT02334865|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25845586|NCT02334865|Freund's Adjuvant|freund's adjuvant|mesh-list
25845587|NCT02334865|Immunologic Factors|immunologic factors|mesh-ancestor
25845588|NCT02334865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845589|NCT02334865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25122733|NCT03090971|Diclofenac|diclofenac|mesh-list
25845590|NCT02334865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25845591|NCT02334865|Growth Substances|growth substances|mesh-ancestor
25845592|NCT02334865|Growth Inhibitors|growth inhibitors|mesh-ancestor
25845593|NCT02334865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845594|NCT02334865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25845595|NCT02090114|Methyltestosterone|methyltestosterone|mesh-list
25845596|NCT02090114|Abiraterone Acetate|abiraterone acetate|mesh-list
25845597|NCT02090114|Testosterone|testosterone|mesh-list
24535566|NCT00649363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24535567|NCT00649363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24535568|NCT00649376|Fexofenadine|fexofenadine|mesh-list
24535577|NCT00649402|Amlodipine|amlodipine|mesh-list
25845598|NCT02090114|Testosterone undecanoate|testosterone undecanoate|mesh-list
25845599|NCT02090114|Testosterone enanthate|testosterone enanthate|mesh-list
25845600|NCT02090114|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25845601|NCT02090114|Androgens|androgens|mesh-ancestor
25845602|NCT02090114|Hormones|hormones|mesh-ancestor
25845603|NCT02090114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25845604|NCT02090114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845605|NCT02090114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25845606|NCT02090114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845607|NCT02090114|Anabolic Agents|anabolic agents|mesh-ancestor
25845608|NCT02090114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25845609|NCT02090114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845610|NCT02090114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845611|NCT02090114|Hormone Antagonists|hormone antagonists|mesh-ancestor
25845612|NCT02090114|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25845613|NCT01331018|Plerixafor|plerixafor|mesh-list
25845614|NCT01331018|Prednisone|prednisone|mesh-list
25845615|NCT01331018|Methylprednisolone|methylprednisolone|mesh-list
25845616|NCT01331018|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25845622|NCT01331018|Prednisolone phosphate|prednisolone phosphate|mesh-list
25845623|NCT01331018|Lenograstim|lenograstim|mesh-list
25845624|NCT01331018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25845625|NCT01331018|Glucocorticoids|glucocorticoids|mesh-ancestor
25845626|NCT01331018|Hormones|hormones|mesh-ancestor
25845627|NCT01331018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25845628|NCT01331018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845629|NCT01331018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25845630|NCT01331018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845631|NCT01331018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25845632|NCT01331018|Immunologic Factors|immunologic factors|mesh-ancestor
25845633|NCT01331018|Antiemetics|antiemetics|mesh-ancestor
25845634|NCT01331018|Autonomic Agents|autonomic agents|mesh-ancestor
25845635|NCT01331018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25845636|NCT01331018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24480625|NCT00431418|Sildenafil Citrate|sildenafil citrate|mesh-list
24453162|NCT05238831|Maytansine|maytansine|mesh-list
24453163|NCT05238831|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25845637|NCT01331018|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25845638|NCT01331018|Protective Agents|protective agents|mesh-ancestor
24547599|NCT00704756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25845639|NCT01331018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25845640|NCT01331018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25845641|NCT01331018|Antiviral Agents|antiviral agents|mesh-ancestor
25845642|NCT01331018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25845643|NCT00712881|Cyclophosphamide|cyclophosphamide|mesh-list
25845644|NCT00712881|Docetaxel|docetaxel|mesh-list
25845645|NCT00712881|Doxorubicin|doxorubicin|mesh-list
25845646|NCT00712881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25845647|NCT00712881|Trastuzumab|trastuzumab|mesh-list
25845648|NCT00712881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25845649|NCT00712881|Immunologic Factors|immunologic factors|mesh-ancestor
25845650|NCT00712881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845651|NCT00712881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25845652|NCT00712881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25845653|NCT00712881|Alkylating Agents|alkylating agents|mesh-ancestor
25845654|NCT00712881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845655|NCT00712881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845656|NCT00712881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25845657|NCT00712881|Tubulin Modulators|tubulin modulators|mesh-ancestor
25845658|NCT00712881|Antimitotic Agents|antimitotic agents|mesh-ancestor
25845659|NCT00712881|Mitosis Modulators|mitosis modulators|mesh-ancestor
25845660|NCT00712881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25845661|NCT00712881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25845662|NCT00712881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25845663|NCT00712881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845664|NCT00712881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25845665|NCT00470223|Zoledronic Acid|zoledronic acid|mesh-list
25845666|NCT00470223|Cisplatin|cisplatin|mesh-list
25845667|NCT00470223|Doxorubicin|doxorubicin|mesh-list
25845668|NCT00470223|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25845669|NCT00470223|Methotrexate|methotrexate|mesh-list
25845670|NCT00470223|Etoposide|etoposide|mesh-list
25845671|NCT00470223|Ifosfamide|ifosfamide|mesh-list
25845672|NCT00470223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845673|NCT00470223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25845674|NCT00470223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25845675|NCT00470223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25845676|NCT00470223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547850|NCT00706069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25845677|NCT00470223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845678|NCT00470223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25845679|NCT00470223|Abortifacient Agents|abortifacient agents|mesh-ancestor
25845680|NCT00470223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25661547|NCT01634191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845681|NCT00470223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845682|NCT00470223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24858681|NCT02299024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858682|NCT02299063|Dexmedetomidine|dexmedetomidine|mesh-list
25845683|NCT00470223|Antimetabolites|antimetabolites|mesh-ancestor
25845684|NCT00470223|Dermatologic Agents|dermatologic agents|mesh-ancestor
25845685|NCT00470223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25845686|NCT00470223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25845687|NCT00470223|Immunologic Factors|immunologic factors|mesh-ancestor
25845688|NCT00470223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25845689|NCT00470223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25845690|NCT00470223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25166353|NCT04152980|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25166354|NCT04152980|Protective Agents|protective agents|mesh-ancestor
25166355|NCT04152980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166356|NCT04152980|Vasodilator Agents|vasodilator agents|mesh-ancestor
25166357|NCT04152980|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25166358|NCT04152980|Antioxidants|antioxidants|mesh-ancestor
25845691|NCT00470223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25845692|NCT00470223|Alkylating Agents|alkylating agents|mesh-ancestor
25845693|NCT00470223|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25845694|NCT00103389|Docetaxel|docetaxel|mesh-list
25845695|NCT00103389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845696|NCT00103389|Tubulin Modulators|tubulin modulators|mesh-ancestor
25845697|NCT00103389|Antimitotic Agents|antimitotic agents|mesh-ancestor
25845698|NCT00103389|Mitosis Modulators|mitosis modulators|mesh-ancestor
25845699|NCT00103389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845700|NCT00097851|Docetaxel|docetaxel|mesh-list
25845701|NCT00097851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845702|NCT00097851|Tubulin Modulators|tubulin modulators|mesh-ancestor
25845703|NCT00097851|Antimitotic Agents|antimitotic agents|mesh-ancestor
25845704|NCT00097851|Mitosis Modulators|mitosis modulators|mesh-ancestor
25845705|NCT00097851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845706|NCT00038376|Interferons|interferons|mesh-list
25845707|NCT00038376|Interferon-alpha|interferon-alpha|mesh-list
25845708|NCT00038376|Interferon alpha-2|interferon alpha-2|mesh-list
25845709|NCT00038376|Isotretinoin|isotretinoin|mesh-list
25845710|NCT00038376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845711|NCT00038376|Antiviral Agents|antiviral agents|mesh-ancestor
25845712|NCT00038376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25845713|NCT00038376|Immunologic Factors|immunologic factors|mesh-ancestor
25845714|NCT00038376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845715|NCT00038376|Dermatologic Agents|dermatologic agents|mesh-ancestor
25845716|NCT00038389|Rofecoxib|rofecoxib|mesh-list
25845717|NCT00038389|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25845718|NCT00038389|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25845719|NCT00038389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845720|NCT00038389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845721|NCT00038389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25845722|NCT00038389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25845723|NCT00038389|Analgesics|analgesics|mesh-ancestor
25845724|NCT00038389|Sensory System Agents|sensory system agents|mesh-ancestor
25845725|NCT00038389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25845726|NCT00038389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845727|NCT00038389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25845728|NCT00038389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25845729|NCT00038402|Paclitaxel|paclitaxel|mesh-list
25845730|NCT00038402|Cyclophosphamide|cyclophosphamide|mesh-list
25845731|NCT00038402|Fluorouracil|fluorouracil|mesh-list
25845732|NCT00038402|Trastuzumab|trastuzumab|mesh-list
25845733|NCT00038402|Epirubicin|epirubicin|mesh-list
25845734|NCT00038402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25845735|NCT00038402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845736|NCT00038402|Tubulin Modulators|tubulin modulators|mesh-ancestor
25845737|NCT00038402|Antimitotic Agents|antimitotic agents|mesh-ancestor
25845738|NCT00038402|Mitosis Modulators|mitosis modulators|mesh-ancestor
25845739|NCT00038402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845740|NCT00038402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25845741|NCT00038402|Immunologic Factors|immunologic factors|mesh-ancestor
25845742|NCT00038402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535634|NCT00649493|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24535635|NCT00649493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24535636|NCT00649493|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24535637|NCT00649493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661548|NCT01634191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661549|NCT01634243|Rotigotine|rotigotine|mesh-list
25661550|NCT01634243|Dopamine Agonists|dopamine agonists|mesh-ancestor
25845743|NCT00038402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25845744|NCT00038402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25845745|NCT00038402|Alkylating Agents|alkylating agents|mesh-ancestor
25845746|NCT00038402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25845747|NCT00038402|Antimetabolites|antimetabolites|mesh-ancestor
25845748|NCT00038402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25845749|NCT00038402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24641920|NCT01176747|Autonomic Agents|autonomic agents|mesh-ancestor
25845750|NCT00038402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25845751|NCT00038402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25845752|NCT00038402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25845753|NCT00038402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845755|NCT00038454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25845756|NCT00038454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25845757|NCT00038454|Analgesics|analgesics|mesh-ancestor
25845758|NCT00038454|Sensory System Agents|sensory system agents|mesh-ancestor
25845759|NCT00038454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25845760|NCT00038454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845761|NCT00038454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25845762|NCT00038454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25845763|NCT00038480|Ritonavir|ritonavir|mesh-list
25845764|NCT00038480|Lopinavir|lopinavir|mesh-list
25845765|NCT00038480|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25845766|NCT00038480|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25845767|NCT00038480|Protease Inhibitors|protease inhibitors|mesh-ancestor
25845768|NCT00038480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845769|NCT00038480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845770|NCT00038480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25845771|NCT00038480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25845772|NCT00038480|Antiviral Agents|antiviral agents|mesh-ancestor
25845773|NCT00038480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25845774|NCT00038480|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25845775|NCT00038480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25845776|NCT00038493|Temozolomide|temozolomide|mesh-list
25845777|NCT00038493|Lonafarnib|lonafarnib|mesh-list
25845778|NCT00038493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25845779|NCT00038493|Alkylating Agents|alkylating agents|mesh-ancestor
24450343|NCT00318825|Nitrous Oxide|nitrous oxide|mesh-list
24450344|NCT00318825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24450376|NCT00318903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450377|NCT00318903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24450378|NCT00318903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25845780|NCT00038493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845781|NCT00038493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845782|NCT00038493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845783|NCT00038506|Tenofovir|tenofovir|mesh-list
25845784|NCT00038506|Lamivudine|lamivudine|mesh-list
24458991|NCT00343369|Asparaginase|asparaginase|mesh-list
24458992|NCT00343369|Mercaptopurine|mercaptopurine|mesh-list
24458993|NCT00343369|Pegaspargase|pegaspargase|mesh-list
24458994|NCT00343369|Thioguanine|thioguanine|mesh-list
24458995|NCT00343369|Teniposide|teniposide|mesh-list
24458996|NCT00343369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24458997|NCT00343369|Immunologic Factors|immunologic factors|mesh-ancestor
24458998|NCT00343369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458999|NCT00343369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24459000|NCT00343369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24459001|NCT00343369|Alkylating Agents|alkylating agents|mesh-ancestor
24459002|NCT00343369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845785|NCT00038506|Zidovudine|zidovudine|mesh-list
25845786|NCT00038506|Abacavir|abacavir|mesh-list
25845787|NCT00038506|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25845788|NCT00038506|Antiviral Agents|antiviral agents|mesh-ancestor
25845789|NCT00038506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25845790|NCT00038506|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25845791|NCT00038506|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25845792|NCT00038506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845793|NCT00038506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459018|NCT00343369|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24459019|NCT00343369|Abortifacient Agents|abortifacient agents|mesh-ancestor
24459020|NCT00343369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24459021|NCT00343369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24459022|NCT00343369|Antimetabolites|antimetabolites|mesh-ancestor
25409033|NCT03404180|Analgesics|analgesics|mesh-ancestor
25845794|NCT00038506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24459044|NCT00343408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24459045|NCT00343408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459046|NCT00343408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24407780|NCT00175396|Antioxidants|antioxidants|mesh-ancestor
24459047|NCT00343408|Immunologic Factors|immunologic factors|mesh-ancestor
24459048|NCT00343408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535750|NCT00649662|Ciprofloxacin|ciprofloxacin|mesh-list
25845795|NCT00038506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25845796|NCT00038506|Antimetabolites|antimetabolites|mesh-ancestor
25845798|NCT00038519|Saquinavir|saquinavir|mesh-list
25845799|NCT00038519|Amprenavir|amprenavir|mesh-list
25845800|NCT00038519|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25845801|NCT00038519|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25845802|NCT00038519|Protease Inhibitors|protease inhibitors|mesh-ancestor
25845803|NCT00038519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845804|NCT00038519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845805|NCT00038519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25845806|NCT00038519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25845807|NCT00038519|Antiviral Agents|antiviral agents|mesh-ancestor
24459052|NCT00343408|Vitamin B Complex|vitamin b complex|mesh-ancestor
24459053|NCT00343408|Vitamins|vitamins|mesh-ancestor
24459054|NCT00343408|Micronutrients|micronutrients|mesh-ancestor
24459055|NCT00343408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24459056|NCT00343421|Vaccines|vaccines|mesh-list
24459057|NCT00343421|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24459058|NCT00343421|Immunologic Factors|immunologic factors|mesh-ancestor
24459059|NCT00343421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459060|NCT00343447|Cyclophosphamide|cyclophosphamide|mesh-list
24459061|NCT00343447|Rituximab|rituximab|mesh-list
25122975|NCT03088371|Lidocaine|lidocaine|mesh-list
25845808|NCT00038519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25845809|NCT00038519|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25845810|NCT00038519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25845811|NCT00038519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25845812|NCT00038519|Antitubercular Agents|antitubercular agents|mesh-ancestor
25845813|NCT00038519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25845814|NCT00038532|Ritonavir|ritonavir|mesh-list
25845815|NCT00038532|Saquinavir|saquinavir|mesh-list
25845816|NCT00038532|Amprenavir|amprenavir|mesh-list
25845817|NCT00038532|Efavirenz|efavirenz|mesh-list
25845818|NCT00038532|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25845819|NCT00038532|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25845820|NCT00038532|Protease Inhibitors|protease inhibitors|mesh-ancestor
25845821|NCT00038532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845822|NCT00038532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845823|NCT00038532|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25845824|NCT00038532|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25845825|NCT00038532|Antiviral Agents|antiviral agents|mesh-ancestor
25845826|NCT00038532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25845827|NCT00038532|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25845828|NCT00038532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25845829|NCT00038532|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25845830|NCT00038532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25845831|NCT00038532|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25845832|NCT00038532|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25845833|NCT00038532|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25845834|NCT00038532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25845835|NCT00038532|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25845836|NCT00038532|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25845837|NCT00038532|Antitubercular Agents|antitubercular agents|mesh-ancestor
25845838|NCT00038532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25845839|NCT00038545|Paclitaxel|paclitaxel|mesh-list
25845840|NCT00038545|Topotecan|topotecan|mesh-list
25845841|NCT00038545|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25845842|NCT00038545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845843|NCT00038545|Tubulin Modulators|tubulin modulators|mesh-ancestor
25845844|NCT00038545|Antimitotic Agents|antimitotic agents|mesh-ancestor
25845845|NCT00038545|Mitosis Modulators|mitosis modulators|mesh-ancestor
25845846|NCT00038545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845847|NCT00038545|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25845848|NCT00038545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25845849|NCT00038545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845850|NCT00038558|Doxorubicin|doxorubicin|mesh-list
25845851|NCT00038558|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25845852|NCT00038558|Bleomycin|bleomycin|mesh-list
25845853|NCT00038558|Dacarbazine|dacarbazine|mesh-list
25845854|NCT00038558|Vinblastine|vinblastine|mesh-list
25845855|NCT00038558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25845856|NCT00038558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845857|NCT00038558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25845858|NCT00038558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25845859|NCT00038558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845860|NCT00038558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845861|NCT00038558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25845862|NCT00038558|Alkylating Agents|alkylating agents|mesh-ancestor
25845863|NCT00038558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25845864|NCT00038558|Tubulin Modulators|tubulin modulators|mesh-ancestor
25845865|NCT00038558|Antimitotic Agents|antimitotic agents|mesh-ancestor
25845866|NCT00038558|Mitosis Modulators|mitosis modulators|mesh-ancestor
25845867|NCT00038571|Bortezomib|bortezomib|mesh-list
25845868|NCT00038571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481364|NCT00434135|Pemetrexed|pemetrexed|mesh-list
25845869|NCT00038584|Lonafarnib|lonafarnib|mesh-list
25845870|NCT00038584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845871|NCT00038584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845872|NCT00038597|Lonafarnib|lonafarnib|mesh-list
25845873|NCT00038597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845874|NCT00038597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845875|NCT00038623|Rituximab|rituximab|mesh-list
25845876|NCT00038623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25845877|NCT00038623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845878|NCT00038623|Immunologic Factors|immunologic factors|mesh-ancestor
25845879|NCT00038623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845880|NCT00038623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25845881|NCT00038636|Ritonavir|ritonavir|mesh-list
25845882|NCT00038636|Lopinavir|lopinavir|mesh-list
25845883|NCT00038636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25845884|NCT00038636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25845885|NCT00038636|Protease Inhibitors|protease inhibitors|mesh-ancestor
25845886|NCT00038636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535812|NCT00649740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845887|NCT00038636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845888|NCT00038636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25845889|NCT00038636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25845890|NCT00038636|Antiviral Agents|antiviral agents|mesh-ancestor
25845891|NCT00038636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25845892|NCT00038636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25845893|NCT00038636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25845894|NCT00038662|Atrasentan|atrasentan|mesh-list
25845895|NCT00038662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845896|NCT00038662|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
24715159|NCT01534845|Temozolomide|temozolomide|mesh-list
25845897|NCT00038662|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25845898|NCT00038662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845899|NCT00038701|O-(Chloroacetylcarbamoyl)fumagillol|o-(chloroacetylcarbamoyl)fumagillol|mesh-list
25845900|NCT00038701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25845901|NCT00038701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845902|NCT00038701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25845903|NCT00038701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25845904|NCT00038701|Growth Substances|growth substances|mesh-ancestor
25845905|NCT00038701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845906|NCT00038701|Growth Inhibitors|growth inhibitors|mesh-ancestor
25845907|NCT00038766|Semapimod|semapimod|mesh-list
25845908|NCT00038766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25845909|NCT00038766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25845910|NCT00038766|Analgesics|analgesics|mesh-ancestor
24642281|NCT01178658|Alkylating Agents|alkylating agents|mesh-ancestor
25661551|NCT01634243|Dopamine Agents|dopamine agents|mesh-ancestor
25661552|NCT01634243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25661553|NCT01634243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661554|NCT01634243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661555|NCT01634555|Leucovorin|leucovorin|mesh-list
25661556|NCT01634555|Folic Acid|folic acid|mesh-list
25661557|NCT01634555|Fluorouracil|fluorouracil|mesh-list
25661558|NCT01634555|Irinotecan|irinotecan|mesh-list
25661559|NCT01634555|Ramucirumab|ramucirumab|mesh-list
25661560|NCT01634555|Levoleucovorin|levoleucovorin|mesh-list
25661561|NCT01634555|Antimetabolites|antimetabolites|mesh-ancestor
25661562|NCT01634555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845911|NCT00038766|Sensory System Agents|sensory system agents|mesh-ancestor
25845912|NCT00038766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25845913|NCT00038766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845914|NCT00038766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25845915|NCT00038766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25845916|NCT00038766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25845917|NCT00038766|Immunologic Factors|immunologic factors|mesh-ancestor
25845918|NCT00038792|Mitogens|mitogens|mesh-list
25845919|NCT00038792|Mitosis Modulators|mitosis modulators|mesh-ancestor
25845920|NCT00038792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845921|NCT00038805|Gemtuzumab|gemtuzumab|mesh-list
25845922|NCT00038805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24459067|NCT00343447|Alkylating Agents|alkylating agents|mesh-ancestor
24459068|NCT00343447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459069|NCT00343447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459070|NCT00343447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24459071|NCT00343447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24459072|NCT00343486|Solabegron|solabegron|mesh-list
24535828|NCT00649805|Verapamil|verapamil|mesh-list
25845923|NCT00038805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845924|NCT00038831|Vidarabine|vidarabine|mesh-list
25845925|NCT00038831|Fludarabine|fludarabine|mesh-list
25845926|NCT00038831|Fludarabine phosphate|fludarabine phosphate|mesh-list
25845927|NCT00038831|Melphalan|melphalan|mesh-list
25845928|NCT00038831|Gemtuzumab|gemtuzumab|mesh-list
25845929|NCT00038831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25845930|NCT00038831|Thymoglobulin|thymoglobulin|mesh-list
25845931|NCT00038831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845932|NCT00038831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25845933|NCT00038831|Antimetabolites|antimetabolites|mesh-ancestor
25845934|NCT00038831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845935|NCT00038831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25845936|NCT00038831|Immunologic Factors|immunologic factors|mesh-ancestor
25845937|NCT00038831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845938|NCT00038831|Antiviral Agents|antiviral agents|mesh-ancestor
25845939|NCT00038831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25845940|NCT00038831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25845941|NCT00038831|Alkylating Agents|alkylating agents|mesh-ancestor
25845942|NCT00038831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25845943|NCT00038831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25845944|NCT00038844|Vidarabine|vidarabine|mesh-list
24459074|NCT00343486|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24459075|NCT00343486|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24459076|NCT00343486|Adrenergic Agents|adrenergic agents|mesh-ancestor
24459077|NCT00343486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24459078|NCT00343486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459079|NCT00343486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459081|NCT00343499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24459082|NCT00343499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24459083|NCT00343499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24459084|NCT00343499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459085|NCT00343525|Bavituximab|bavituximab|mesh-list
24459086|NCT00343525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24459087|NCT00343525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459088|NCT00343629|Sulindac|sulindac|mesh-list
24459089|NCT00343629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24459090|NCT00343629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24459091|NCT00343629|Analgesics|analgesics|mesh-ancestor
24459092|NCT00343629|Sensory System Agents|sensory system agents|mesh-ancestor
24459093|NCT00343629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24459094|NCT00343629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459095|NCT00343629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24459096|NCT00343629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25845945|NCT00038844|Cyclophosphamide|cyclophosphamide|mesh-list
25845946|NCT00038844|Rituximab|rituximab|mesh-list
25845947|NCT00038844|Fludarabine|fludarabine|mesh-list
24406697|NCT00171028|Valsartan|valsartan|mesh-list
25845948|NCT00038844|Fludarabine phosphate|fludarabine phosphate|mesh-list
25845949|NCT00038844|Alemtuzumab|alemtuzumab|mesh-list
25845950|NCT00038844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25845951|NCT00038844|Immunologic Factors|immunologic factors|mesh-ancestor
25845952|NCT00038844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845953|NCT00038844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24459097|NCT00343629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459098|NCT00343629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25845954|NCT00038844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24459099|NCT00343629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459100|NCT00343629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459102|NCT00343655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24459103|NCT00343655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24459104|NCT00343655|Antimetabolites|antimetabolites|mesh-ancestor
24459105|NCT00343655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459106|NCT00343655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24459107|NCT00343655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24459108|NCT00343655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459109|NCT00343668|Irinotecan|irinotecan|mesh-list
24459110|NCT00343668|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24459111|NCT00343668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24459112|NCT00343668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459113|NCT00343668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535868|NCT00649844|Dopamine Agents|dopamine agents|mesh-ancestor
25845956|NCT00038844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845957|NCT00038844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845958|NCT00038844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25845959|NCT00038844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25845960|NCT00038844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25845961|NCT00038844|Antimetabolites|antimetabolites|mesh-ancestor
25845962|NCT00038844|Antiviral Agents|antiviral agents|mesh-ancestor
25845963|NCT00038844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25875929|NCT04038515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25875930|NCT04038515|Autonomic Agents|autonomic agents|mesh-ancestor
25875931|NCT04038515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25875932|NCT04038515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875933|NCT04038515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25875934|NCT04038515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25875935|NCT04038515|Cholinergic Agents|cholinergic agents|mesh-ancestor
25875936|NCT04038515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25875937|NCT04038515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875938|NCT04038515|Antipruritics|antipruritics|mesh-ancestor
25875939|NCT04038515|Dermatologic Agents|dermatologic agents|mesh-ancestor
25875940|NCT03990467|Tazobactam|tazobactam|mesh-list
25875941|NCT03990467|Piperacillin|piperacillin|mesh-list
25875942|NCT03990467|Amikacin|amikacin|mesh-list
25875943|NCT03990467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25875944|NCT03990467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25875945|NCT03990467|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25875946|NCT03990467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875947|NCT03990467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875948|NCT03983954|Durvalumab|durvalumab|mesh-list
25875949|NCT03983954|Obinutuzumab|obinutuzumab|mesh-list
25875950|NCT03983954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25875951|NCT03983954|Immunoconjugates|immunoconjugates|mesh-list
25875952|NCT03983954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25875953|NCT03983954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875954|NCT03983954|Immunologic Factors|immunologic factors|mesh-ancestor
25875955|NCT03983954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875956|NCT03981146|Nivolumab|nivolumab|mesh-list
25875957|NCT03981146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25875958|NCT03981146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875959|NCT03981146|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25875960|NCT03981146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875961|NCT03975231|Trametinib|trametinib|mesh-list
25875962|NCT03975231|Dabrafenib|dabrafenib|mesh-list
25875963|NCT03975231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875964|NCT03975231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25875965|NCT03975231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875966|NCT03975231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875967|NCT03968653|Carboplatin|carboplatin|mesh-list
25875968|NCT03968653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875969|NCT03953131|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
25875970|NCT03953131|Chelating Agents|chelating agents|mesh-ancestor
25875971|NCT03953131|Sequestering Agents|sequestering agents|mesh-ancestor
25875972|NCT03953131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875973|NCT03952585|Cisplatin|cisplatin|mesh-list
25875974|NCT03952585|Nivolumab|nivolumab|mesh-list
25875975|NCT03952585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875976|NCT03952585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25875977|NCT03952585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25845964|NCT00038883|Alemtuzumab|alemtuzumab|mesh-list
25845965|NCT00038883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25845966|NCT00038883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845967|NCT00038896|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25845968|NCT00038896|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24801182|NCT01981499|Histamine Agents|histamine agents|mesh-ancestor
25845969|NCT00038896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25845970|NCT00038896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25845971|NCT00038896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845972|NCT00038896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25845973|NCT00038896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25845974|NCT00038896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25845975|NCT00038896|Antidepressive Agents|antidepressive agents|mesh-ancestor
24459126|NCT00343707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24459127|NCT00343707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24459128|NCT00343707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24459129|NCT00343707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459130|NCT00343707|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24459132|NCT00343720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459133|NCT00343733|Fentanyl|fentanyl|mesh-list
24459134|NCT00343733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24459135|NCT00343733|Narcotics|narcotics|mesh-ancestor
25845976|NCT00038896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24459137|NCT00343733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459138|NCT00343733|Analgesics|analgesics|mesh-ancestor
24459139|NCT00343733|Sensory System Agents|sensory system agents|mesh-ancestor
24459140|NCT00343733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24459141|NCT00343733|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24459142|NCT00343733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24459143|NCT00343733|Anesthetics, General|anesthetics, general|mesh-ancestor
24459144|NCT00343733|Anesthetics|anesthetics|mesh-ancestor
24459145|NCT00343759|Lapatinib|lapatinib|mesh-list
24459146|NCT00343759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845977|NCT00038922|Oprelvekin|oprelvekin|mesh-list
25845978|NCT00038922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25845979|NCT00038935|Factor VIII|factor viii|mesh-list
25845980|NCT00038935|Coagulants|coagulants|mesh-ancestor
25845981|NCT00038961|PENTA|penta|mesh-list
25845982|NCT00038961|Fondaparinux|fondaparinux|mesh-list
25845983|NCT00038961|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25845984|NCT00038961|Antithrombins|antithrombins|mesh-ancestor
25845985|NCT00038961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25845986|NCT00038961|Protease Inhibitors|protease inhibitors|mesh-ancestor
24459147|NCT00343759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25845987|NCT00038961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25845988|NCT00038961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845989|NCT00038961|Anticoagulants|anticoagulants|mesh-ancestor
25845990|NCT00038961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25845991|NCT00038961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24459148|NCT00343759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459149|NCT00343759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459151|NCT00343798|Mycophenolic Acid|mycophenolic acid|mesh-list
24459152|NCT00343798|Cyclophosphamide|cyclophosphamide|mesh-list
24459153|NCT00343798|Fludarabine|fludarabine|mesh-list
24459154|NCT00343798|Fludarabine phosphate|fludarabine phosphate|mesh-list
24459155|NCT00343798|Cyclosporins|cyclosporins|mesh-list
24459156|NCT00343798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24459157|NCT00343798|Immunologic Factors|immunologic factors|mesh-ancestor
24459158|NCT00343798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459159|NCT00343798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24459160|NCT00343798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24459161|NCT00343798|Alkylating Agents|alkylating agents|mesh-ancestor
24459173|NCT00343798|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24459174|NCT00343798|Antitubercular Agents|antitubercular agents|mesh-ancestor
24459175|NCT00343798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25845992|NCT00038974|Ribavirin|ribavirin|mesh-list
25845993|NCT00038974|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25845994|NCT00038974|Antimetabolites|antimetabolites|mesh-ancestor
25845995|NCT00038974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25845996|NCT00038974|Antiviral Agents|antiviral agents|mesh-ancestor
25845997|NCT00038974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25845998|NCT00039013|Exenatide|exenatide|mesh-list
25845999|NCT00039013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24535971|NCT00650117|Narcotics|narcotics|mesh-ancestor
25846000|NCT00039013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846001|NCT00039013|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25418792|NCT02747004|Loperamide|loperamide|mesh-list
25846002|NCT00039013|Incretins|incretins|mesh-ancestor
25846003|NCT00039013|Hormones|hormones|mesh-ancestor
25846004|NCT00039013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25846005|NCT00039026|Exenatide|exenatide|mesh-list
25846006|NCT00039026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25846007|NCT00039026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846008|NCT00039026|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25846009|NCT00039026|Incretins|incretins|mesh-ancestor
25846010|NCT00039026|Hormones|hormones|mesh-ancestor
25846011|NCT00039026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25846012|NCT00039039|Paclitaxel|paclitaxel|mesh-list
25846013|NCT00039039|Cisplatin|cisplatin|mesh-list
25846014|NCT00039039|Carboplatin|carboplatin|mesh-list
24459177|NCT00343811|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24459178|NCT00343811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459180|NCT00343811|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24459181|NCT00343811|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25181781|NCT04793490|Sensory System Agents|sensory system agents|mesh-ancestor
24459182|NCT00343811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459183|NCT00343824|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24459184|NCT00343824|Laxatives|laxatives|mesh-ancestor
24459186|NCT00343850|Mesalamine|mesalamine|mesh-list
24459187|NCT00343850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24459188|NCT00343850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24459189|NCT00343850|Analgesics|analgesics|mesh-ancestor
24459190|NCT00343850|Sensory System Agents|sensory system agents|mesh-ancestor
25846015|NCT00039039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25846016|NCT00039039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846017|NCT00039039|Tubulin Modulators|tubulin modulators|mesh-ancestor
25846018|NCT00039039|Antimitotic Agents|antimitotic agents|mesh-ancestor
25846019|NCT00039039|Mitosis Modulators|mitosis modulators|mesh-ancestor
25846020|NCT00039039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846021|NCT00039052|Interleukin-4|interleukin-4|mesh-list
25846022|NCT00039052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25846023|NCT00039052|Immunologic Factors|immunologic factors|mesh-ancestor
25846024|NCT00039052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846025|NCT00039052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846026|NCT00039052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24642695|NCT01180959|Bevacizumab|bevacizumab|mesh-list
24459191|NCT00343850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24459192|NCT00343850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459193|NCT00343850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24459195|NCT00343876|Aspirin|aspirin|mesh-list
25846027|NCT00039091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25846028|NCT00039091|Ipilimumab|ipilimumab|mesh-list
25846029|NCT00039091|Antibodies|antibodies|mesh-list
25846030|NCT00039091|Immunoglobulins|immunoglobulins|mesh-list
25846031|NCT00039091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25846032|NCT00039091|Immunologic Factors|immunologic factors|mesh-ancestor
25846033|NCT00039091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846034|NCT00039091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846035|NCT00039091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25846036|NCT00039091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846037|NCT00039104|Zoledronic Acid|zoledronic acid|mesh-list
25846038|NCT00039104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25846039|NCT00039104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846040|NCT00039117|Cytarabine|cytarabine|mesh-list
25846041|NCT00039117|Daunorubicin|daunorubicin|mesh-list
25846042|NCT00039117|Oblimersen|oblimersen|mesh-list
25846043|NCT00039117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25846044|NCT00039117|Antimetabolites|antimetabolites|mesh-ancestor
25846045|NCT00039117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846046|NCT00039117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846047|NCT00039117|Antiviral Agents|antiviral agents|mesh-ancestor
25846048|NCT00039117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25846049|NCT00039117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25846050|NCT00039117|Immunologic Factors|immunologic factors|mesh-ancestor
25846051|NCT00039117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846052|NCT00039117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25846053|NCT00039117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24536039|NCT00650208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24536040|NCT00650208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25846054|NCT00039117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25846055|NCT00039117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846056|NCT00039156|IDN 5109|idn 5109|mesh-list
25661563|NCT01634555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25661564|NCT01634555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846057|NCT00039156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846058|NCT00039169|IDN 5109|idn 5109|mesh-list
25846059|NCT00039169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846060|NCT00039182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25846061|NCT00039182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846062|NCT00039182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25846063|NCT00039182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846064|NCT00039182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974306|NCT04976790|Flurbiprofen|flurbiprofen|mesh-list
25846065|NCT00039208|Leucovorin|leucovorin|mesh-list
25846066|NCT00039208|Fluorouracil|fluorouracil|mesh-list
25846067|NCT00039208|Oxaliplatin|oxaliplatin|mesh-list
25846068|NCT00039208|Irinotecan|irinotecan|mesh-list
25846069|NCT00039208|Calcium|calcium|mesh-list
25846070|NCT00039208|Levoleucovorin|levoleucovorin|mesh-list
25846071|NCT00039208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25846072|NCT00039208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846073|NCT00039208|Antimetabolites|antimetabolites|mesh-ancestor
25846074|NCT00039208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846075|NCT00039208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25846076|NCT00039208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642807|NCT01181414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25846077|NCT00039208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25846078|NCT00039208|Immunologic Factors|immunologic factors|mesh-ancestor
25846079|NCT00039208|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25846080|NCT00039208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25846081|NCT00039208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846082|NCT00039208|Antidotes|antidotes|mesh-ancestor
25846083|NCT00039208|Protective Agents|protective agents|mesh-ancestor
25846084|NCT00039208|Vitamin B Complex|vitamin b complex|mesh-ancestor
25846085|NCT00039208|Vitamins|vitamins|mesh-ancestor
25846086|NCT00039208|Micronutrients|micronutrients|mesh-ancestor
25846087|NCT00039234|Aldesleukin|aldesleukin|mesh-list
25846088|NCT00039234|Histamine|histamine|mesh-list
25846089|NCT00039234|Histamine phosphate|histamine phosphate|mesh-list
25846090|NCT00039234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846091|NCT00039234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25846092|NCT00039234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25846093|NCT00039234|Antiviral Agents|antiviral agents|mesh-ancestor
25846094|NCT00039234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25846095|NCT00039234|Histamine Agonists|histamine agonists|mesh-ancestor
25846096|NCT00039234|Histamine Agents|histamine agents|mesh-ancestor
24459208|NCT00343876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24459209|NCT00343876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24459211|NCT00343876|Antipyretics|antipyretics|mesh-ancestor
24459212|NCT00343876|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24459213|NCT00343876|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24459214|NCT00343876|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25846097|NCT00039234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25846098|NCT00039234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846099|NCT00039234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846100|NCT00039273|Panitumumab|panitumumab|mesh-list
25846101|NCT00039273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25846102|NCT00039273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846103|NCT00039286|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25846104|NCT00039286|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25846105|NCT00039286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846106|NCT00039338|Cisplatin|cisplatin|mesh-list
25846107|NCT00039338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846108|NCT00039351|Prednisone|prednisone|mesh-list
25846109|NCT00039351|Cyclophosphamide|cyclophosphamide|mesh-list
25846110|NCT00039351|Vincristine|vincristine|mesh-list
25846111|NCT00039351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25846112|NCT00039351|Immunologic Factors|immunologic factors|mesh-ancestor
25846113|NCT00039351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846114|NCT00039351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25846115|NCT00039351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25846116|NCT00039351|Alkylating Agents|alkylating agents|mesh-ancestor
25846117|NCT00039351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846118|NCT00039351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846119|NCT00039351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24549314|NCT00714558|Anesthetics|anesthetics|mesh-ancestor
25846120|NCT00039351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25661565|NCT01634555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25846121|NCT00039351|Glucocorticoids|glucocorticoids|mesh-ancestor
25846122|NCT00039351|Hormones|hormones|mesh-ancestor
24858839|NCT02299765|Antimetabolites|antimetabolites|mesh-ancestor
25846123|NCT00039351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25846124|NCT00039351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25846125|NCT00039351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25846126|NCT00039351|Tubulin Modulators|tubulin modulators|mesh-ancestor
25846127|NCT00039351|Antimitotic Agents|antimitotic agents|mesh-ancestor
25846128|NCT00039351|Mitosis Modulators|mitosis modulators|mesh-ancestor
25846129|NCT00039364|Imatinib Mesylate|imatinib mesylate|mesh-list
25846130|NCT00039364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846131|NCT00039364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25846132|NCT00039364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846133|NCT00039364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846134|NCT00039390|Capecitabine|capecitabine|mesh-list
25846135|NCT00039390|Gefitinib|gefitinib|mesh-list
25846136|NCT00039390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25846137|NCT00039390|Antimetabolites|antimetabolites|mesh-ancestor
25846138|NCT00039390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846139|NCT00039390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846140|NCT00039390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25846141|NCT00039390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846142|NCT00039403|Gemcitabine|gemcitabine|mesh-list
25846143|NCT00039403|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
25846144|NCT00039403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25846145|NCT00039403|Antimetabolites|antimetabolites|mesh-ancestor
25846146|NCT00039403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846147|NCT00039403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846148|NCT00039403|Antiviral Agents|antiviral agents|mesh-ancestor
25846149|NCT00039403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24450627|NCT00319865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24450628|NCT00319865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24450629|NCT00319865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450630|NCT00319865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24450631|NCT00319865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24450632|NCT00319865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24450633|NCT00319865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643082|NCT01183663|Leucovorin|leucovorin|mesh-list
25846150|NCT00039403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846151|NCT00039403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24536156|NCT00650416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24536157|NCT00650416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24536159|NCT00650416|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24536160|NCT00650416|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24536161|NCT00650429|Ziprasidone|ziprasidone|mesh-list
24536175|NCT00650442|Estradiol|estradiol|mesh-list
24450650|NCT00319878|Immunologic Factors|immunologic factors|mesh-ancestor
24450651|NCT00319878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643132|NCT01183806|Rivastigmine|rivastigmine|mesh-list
25846152|NCT00039403|Immunologic Factors|immunologic factors|mesh-ancestor
25846153|NCT00039403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846154|NCT00039403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25846155|NCT00039416|Imatinib Mesylate|imatinib mesylate|mesh-list
25846156|NCT00039416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846157|NCT00039416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25846158|NCT00039416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846159|NCT00039416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846160|NCT00039429|Atrasentan|atrasentan|mesh-list
25846161|NCT00039429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846162|NCT00039429|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25846163|NCT00039429|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25846164|NCT00039429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846165|NCT00039442|Capecitabine|capecitabine|mesh-list
25846166|NCT00039442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25846167|NCT00039442|Antimetabolites|antimetabolites|mesh-ancestor
25846168|NCT00039442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846169|NCT00039442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846170|NCT00039455|Trastuzumab|trastuzumab|mesh-list
25846171|NCT00039455|Alvocidib|alvocidib|mesh-list
25846172|NCT00039455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25846173|NCT00039455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846174|NCT00039455|Growth Inhibitors|growth inhibitors|mesh-ancestor
25846175|NCT00039455|Growth Substances|growth substances|mesh-ancestor
25846176|NCT00039455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661566|NCT01634555|Immunologic Factors|immunologic factors|mesh-ancestor
25846177|NCT00039455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25846178|NCT00039455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846179|NCT00039455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846180|NCT00039468|Thalidomide|thalidomide|mesh-list
25846181|NCT00039468|Irinotecan|irinotecan|mesh-list
25846182|NCT00039468|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25846183|NCT00039468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25846184|NCT00039468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846185|NCT00039468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846186|NCT00039468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846187|NCT00039468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25846188|NCT00039468|Immunologic Factors|immunologic factors|mesh-ancestor
25846189|NCT00039468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846190|NCT00039468|Leprostatic Agents|leprostatic agents|mesh-ancestor
25846191|NCT00039468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25846192|NCT00039468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25846193|NCT00039468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25846194|NCT00039468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25846195|NCT00039468|Growth Substances|growth substances|mesh-ancestor
25846196|NCT00039468|Growth Inhibitors|growth inhibitors|mesh-ancestor
25846197|NCT00039481|Cyclophosphamide|cyclophosphamide|mesh-list
24459273|NCT00344123|Antiviral Agents|antiviral agents|mesh-ancestor
24459274|NCT00344123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24459275|NCT00344123|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25846198|NCT00039481|Doxorubicin|doxorubicin|mesh-list
24459276|NCT00344123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24459277|NCT00344123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24459278|NCT00344123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24459279|NCT00344123|Antimetabolites|antimetabolites|mesh-ancestor
24459280|NCT00344123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24459281|NCT00344123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24459282|NCT00344149|Rituximab|rituximab|mesh-list
25846199|NCT00039481|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25846200|NCT00039481|Dexrazoxane|dexrazoxane|mesh-list
25846201|NCT00039481|Razoxane|razoxane|mesh-list
25846202|NCT00039481|Oblimersen|oblimersen|mesh-list
25846203|NCT00039481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25846204|NCT00039481|Immunologic Factors|immunologic factors|mesh-ancestor
25846205|NCT00039481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846206|NCT00039481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24450398|NCT00318968|Esomeprazole|esomeprazole|mesh-list
24450399|NCT00318968|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24450400|NCT00318968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25846207|NCT00039481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25846208|NCT00039481|Alkylating Agents|alkylating agents|mesh-ancestor
25846209|NCT00039481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846210|NCT00039481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846211|NCT00039481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25846212|NCT00039481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25846213|NCT00039481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24450703|NCT00320073|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24450704|NCT00320073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450705|NCT00320073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450706|NCT00320073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450707|NCT00320073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24450708|NCT00320073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24450709|NCT00320073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24450710|NCT00320099|Insulin|insulin|mesh-list
24450711|NCT00320099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25846214|NCT00039481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25846215|NCT00039481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846216|NCT00039481|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25846217|NCT00039481|Protective Agents|protective agents|mesh-ancestor
25846218|NCT00039481|Antimitotic Agents|antimitotic agents|mesh-ancestor
25846219|NCT00039481|Mitosis Modulators|mitosis modulators|mesh-ancestor
25846220|NCT00039494|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25846221|NCT00039494|Temozolomide|temozolomide|mesh-list
25846222|NCT00039494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846223|NCT00039494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25846224|NCT00039494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846225|NCT00039494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846226|NCT00039494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25846227|NCT00039494|Alkylating Agents|alkylating agents|mesh-ancestor
25846228|NCT00039520|Sulindac|sulindac|mesh-list
25846229|NCT00039520|Docetaxel|docetaxel|mesh-list
25846230|NCT00039520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24546425|NCT00698334|Pyrazinamide|pyrazinamide|mesh-list
25846231|NCT00039520|Tubulin Modulators|tubulin modulators|mesh-ancestor
25846232|NCT00039520|Antimitotic Agents|antimitotic agents|mesh-ancestor
25846233|NCT00039520|Mitosis Modulators|mitosis modulators|mesh-ancestor
25846234|NCT00039520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846235|NCT00039520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25846236|NCT00039520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25846237|NCT00039520|Analgesics|analgesics|mesh-ancestor
25846238|NCT00039520|Sensory System Agents|sensory system agents|mesh-ancestor
24643410|NCT01185470|Morphine|morphine|mesh-list
25846239|NCT00039520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25846240|NCT00039520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846241|NCT00039520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25846242|NCT00039520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25846243|NCT00039520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25846244|NCT00039520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846245|NCT00039546|Gemcitabine|gemcitabine|mesh-list
25846246|NCT00039546|Paclitaxel|paclitaxel|mesh-list
25846247|NCT00039546|Cyclophosphamide|cyclophosphamide|mesh-list
25846248|NCT00039546|Epirubicin|epirubicin|mesh-list
25846249|NCT00039546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25846250|NCT00039546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846251|NCT00039546|Tubulin Modulators|tubulin modulators|mesh-ancestor
25846252|NCT00039546|Antimitotic Agents|antimitotic agents|mesh-ancestor
25846253|NCT00039546|Mitosis Modulators|mitosis modulators|mesh-ancestor
25846254|NCT00039546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846255|NCT00039546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25846256|NCT00039546|Immunologic Factors|immunologic factors|mesh-ancestor
25846257|NCT00039546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846258|NCT00039546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25846259|NCT00039546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25846260|NCT00039546|Alkylating Agents|alkylating agents|mesh-ancestor
25846261|NCT00039546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25846262|NCT00039546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25846263|NCT00039546|Antimetabolites|antimetabolites|mesh-ancestor
24549676|NCT00716911|Ganciclovir|ganciclovir|mesh-list
24549727|NCT00717379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549774|NCT00717561|Amoxicillin|amoxicillin|mesh-list
25846264|NCT00039546|Antiviral Agents|antiviral agents|mesh-ancestor
25846265|NCT00039546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25846266|NCT00039546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846267|NCT00039546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24643645|NCT01186471|Cholinergic Agents|cholinergic agents|mesh-ancestor
25846268|NCT00039546|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24450731|NCT00320268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24450732|NCT00320268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450743|NCT00320307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846269|NCT00039546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25846270|NCT00039585|Imatinib Mesylate|imatinib mesylate|mesh-list
24450744|NCT00320307|Antiviral Agents|antiviral agents|mesh-ancestor
24450745|NCT00320307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24450746|NCT00320307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24450747|NCT00320307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24450748|NCT00320320|Irinotecan|irinotecan|mesh-list
24450749|NCT00320320|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25846271|NCT00039585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846272|NCT00039585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25846273|NCT00039585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846274|NCT00039585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846275|NCT00039611|Leucovorin|leucovorin|mesh-list
25846276|NCT00039611|Fluorouracil|fluorouracil|mesh-list
25846277|NCT00039611|Oxaliplatin|oxaliplatin|mesh-list
25846278|NCT00039611|Calcium|calcium|mesh-list
25846279|NCT00039611|Levoleucovorin|levoleucovorin|mesh-list
25846280|NCT00039611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25846281|NCT00039611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846282|NCT00039611|Antimetabolites|antimetabolites|mesh-ancestor
25846283|NCT00039611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846284|NCT00039611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25846285|NCT00039611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846286|NCT00039611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24442753|NCT00292448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24442755|NCT00292448|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25661567|NCT01634555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661568|NCT01634555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24594453|NCT00933998|Pyridoxal|pyridoxal|mesh-list
25846287|NCT00039611|Immunologic Factors|immunologic factors|mesh-ancestor
25846288|NCT00039611|Antidotes|antidotes|mesh-ancestor
25846289|NCT00039611|Protective Agents|protective agents|mesh-ancestor
25846290|NCT00039611|Vitamin B Complex|vitamin b complex|mesh-ancestor
25846291|NCT00039611|Vitamins|vitamins|mesh-ancestor
25846292|NCT00039611|Micronutrients|micronutrients|mesh-ancestor
25846293|NCT00039663|Rosiglitazone|rosiglitazone|mesh-list
25846294|NCT00039663|Pravastatin|pravastatin|mesh-list
25846295|NCT00039663|Gemfibrozil|gemfibrozil|mesh-list
25846296|NCT00039663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25846297|NCT00039663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846298|NCT00039663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25846299|NCT00039663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25846300|NCT00039663|Antimetabolites|antimetabolites|mesh-ancestor
25846301|NCT00039663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846302|NCT00039663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25846303|NCT00039663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25846304|NCT00039663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846305|NCT00039663|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25846306|NCT00039663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25846307|NCT00039767|Lepirudin|lepirudin|mesh-list
25846308|NCT00039767|Antithrombins|antithrombins|mesh-ancestor
25846309|NCT00039767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24459355|NCT00344422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24459356|NCT00344422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24459357|NCT00344422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24459358|NCT00344422|Tubulin Modulators|tubulin modulators|mesh-ancestor
24459359|NCT00344422|Antimitotic Agents|antimitotic agents|mesh-ancestor
24459360|NCT00344422|Mitosis Modulators|mitosis modulators|mesh-ancestor
24459361|NCT00344513|Carvedilol|carvedilol|mesh-list
24459362|NCT00344513|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24459363|NCT00344513|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24459364|NCT00344513|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24459365|NCT00344513|Adrenergic Agents|adrenergic agents|mesh-ancestor
24459366|NCT00344513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24459367|NCT00344513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459368|NCT00344513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459369|NCT00344513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24459370|NCT00344513|Antioxidants|antioxidants|mesh-ancestor
24459371|NCT00344513|Protective Agents|protective agents|mesh-ancestor
24459372|NCT00344513|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25846310|NCT00039767|Protease Inhibitors|protease inhibitors|mesh-ancestor
25846311|NCT00039767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846312|NCT00039767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846313|NCT00039767|Anticoagulants|anticoagulants|mesh-ancestor
25846314|NCT00039767|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25846315|NCT00039767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25846316|NCT00039832|Reteplase|reteplase|mesh-list
25846317|NCT00039832|Abciximab|abciximab|mesh-list
25846318|NCT00039832|Anticoagulants|anticoagulants|mesh-ancestor
25846319|NCT00039832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25846320|NCT00039832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24643983|NCT01188265|Antitussive Agents|antitussive agents|mesh-ancestor
25846321|NCT00039832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25846322|NCT00039832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846323|NCT00039858|Argatroban|argatroban|mesh-list
25846324|NCT00039858|Antithrombins|antithrombins|mesh-ancestor
25846325|NCT00039858|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25846326|NCT00039858|Protease Inhibitors|protease inhibitors|mesh-ancestor
25846327|NCT00039858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846328|NCT00039858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846329|NCT00039858|Anticoagulants|anticoagulants|mesh-ancestor
25846330|NCT00039858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25846331|NCT00039884|Darbepoetin alfa|darbepoetin alfa|mesh-list
25846332|NCT00039884|Hematinics|hematinics|mesh-ancestor
25846333|NCT00039962|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25846334|NCT00039962|Thymalfasin|thymalfasin|mesh-list
25846335|NCT00039962|Antiviral Agents|antiviral agents|mesh-ancestor
25846336|NCT00039962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25846337|NCT00039962|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25846338|NCT00039962|Immunologic Factors|immunologic factors|mesh-ancestor
25846339|NCT00039962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846340|NCT00039975|Ritonavir|ritonavir|mesh-list
25846341|NCT00039975|Indinavir|indinavir|mesh-list
25661569|NCT01634555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25846342|NCT00039975|Amlodipine|amlodipine|mesh-list
25846343|NCT00039975|Diltiazem|diltiazem|mesh-list
25846345|NCT00039975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25846346|NCT00039975|Protease Inhibitors|protease inhibitors|mesh-ancestor
25846347|NCT00039975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846348|NCT00039975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846349|NCT00039975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25846350|NCT00039975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25846351|NCT00039975|Antiviral Agents|antiviral agents|mesh-ancestor
25846352|NCT00039975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25846353|NCT00039975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25846354|NCT00039975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25846355|NCT00039975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25846356|NCT00039975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25846357|NCT00039975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25846358|NCT00039975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25846359|NCT00039975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846360|NCT00039975|Vasodilator Agents|vasodilator agents|mesh-ancestor
25846361|NCT00039988|Glatiramer Acetate|glatiramer acetate|mesh-list
25846362|NCT00039988|Albuterol|albuterol|mesh-list
25846363|NCT00039988|(T,G)-A-L|(t,g)-a-l|mesh-list
25846364|NCT00039988|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25846365|NCT00039988|Autonomic Agents|autonomic agents|mesh-ancestor
25846366|NCT00039988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25846367|NCT00039988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846368|NCT00039988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25846369|NCT00039988|Respiratory System Agents|respiratory system agents|mesh-ancestor
25846370|NCT00039988|Tocolytic Agents|tocolytic agents|mesh-ancestor
25846371|NCT00039988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25846372|NCT00039988|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25846373|NCT00039988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25846374|NCT00039988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25846375|NCT00039988|Adrenergic Agents|adrenergic agents|mesh-ancestor
25846376|NCT00039988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24459414|NCT00344565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24459415|NCT00344565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459416|NCT00344565|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24459417|NCT00344565|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24459418|NCT00344565|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24459419|NCT00344565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459421|NCT00344617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24459422|NCT00344617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459423|NCT00344617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24459424|NCT00344617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24459425|NCT00344617|Growth Substances|growth substances|mesh-ancestor
24459426|NCT00344617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407455|NCT00174564|Oxaliplatin|oxaliplatin|mesh-list
25846377|NCT00039988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846378|NCT00039988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25846379|NCT00039988|Immunologic Factors|immunologic factors|mesh-ancestor
25846380|NCT00039988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25846381|NCT00039988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25846382|NCT00040014|Exemestane|exemestane|mesh-list
25846383|NCT00040014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846384|NCT00040014|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25846385|NCT00040014|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25846386|NCT00040014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846387|NCT00040014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044501|NCT01086748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25846388|NCT00040014|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25846389|NCT00040014|Hormone Antagonists|hormone antagonists|mesh-ancestor
25846390|NCT00040014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24459428|NCT00344669|Albendazole|albendazole|mesh-list
24459429|NCT00344669|Anthelmintics|anthelmintics|mesh-ancestor
24459430|NCT00344669|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24459431|NCT00344669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24459432|NCT00344669|Anticestodal Agents|anticestodal agents|mesh-ancestor
24459433|NCT00344669|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24459434|NCT00344669|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24459435|NCT00344669|Tubulin Modulators|tubulin modulators|mesh-ancestor
24459436|NCT00344669|Antimitotic Agents|antimitotic agents|mesh-ancestor
24459437|NCT00344669|Mitosis Modulators|mitosis modulators|mesh-ancestor
24459438|NCT00344669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459439|NCT00344669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459440|NCT00344695|Bupropion|bupropion|mesh-list
24459441|NCT00344695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24459442|NCT00344695|Antidepressive Agents|antidepressive agents|mesh-ancestor
24459443|NCT00344695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25846391|NCT00040014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459444|NCT00344695|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24459445|NCT00344695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24459446|NCT00344695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25846392|NCT00040027|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25846393|NCT00040027|Interferon-alpha|interferon-alpha|mesh-list
25846394|NCT00040027|Thymalfasin|thymalfasin|mesh-list
25846395|NCT00040027|Antiviral Agents|antiviral agents|mesh-ancestor
25846396|NCT00040027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24550176|NCT00719459|Iron|iron|mesh-list
25846397|NCT00040027|Immunologic Factors|immunologic factors|mesh-ancestor
25846398|NCT00040027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846399|NCT00040027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24644247|NCT01189864|Autonomic Agents|autonomic agents|mesh-ancestor
25846400|NCT00040040|Bupropion|bupropion|mesh-list
25846401|NCT00040040|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25846402|NCT00040040|Antidepressive Agents|antidepressive agents|mesh-ancestor
25846403|NCT00040040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25846404|NCT00040040|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25846405|NCT00040040|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25846406|NCT00040040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25846407|NCT00040040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846408|NCT00040040|Dopamine Agents|dopamine agents|mesh-ancestor
25846409|NCT00040040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25846410|NCT00040040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846411|NCT00040040|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25846412|NCT00040040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25846413|NCT00040040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846414|NCT00040053|Ondansetron|ondansetron|mesh-list
25846415|NCT00040053|Antiemetics|antiemetics|mesh-ancestor
25846416|NCT00040053|Autonomic Agents|autonomic agents|mesh-ancestor
25846417|NCT00040053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25846418|NCT00040053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846419|NCT00040053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25846420|NCT00040053|Antipruritics|antipruritics|mesh-ancestor
25846421|NCT00040053|Dermatologic Agents|dermatologic agents|mesh-ancestor
25846422|NCT00040053|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25846423|NCT00040053|Serotonin Agents|serotonin agents|mesh-ancestor
25846424|NCT00040053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25846425|NCT00040053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846426|NCT00040053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25846427|NCT00040053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25846428|NCT00040053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25846429|NCT00040053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25846430|NCT00040053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25846431|NCT00040066|Cocaine|cocaine|mesh-list
24847225|NCT02245490|Tamsulosin|tamsulosin|mesh-list
24644331|NCT01190371|Artesunate|artesunate|mesh-list
24459465|NCT00344760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459466|NCT00344760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459467|NCT00344760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24459468|NCT00344760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24459469|NCT00344760|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24407543|NCT00174681|Insulin Glargine|insulin glargine|mesh-list
25846432|NCT00040066|Anesthetics, Local|anesthetics, local|mesh-ancestor
25846433|NCT00040066|Anesthetics|anesthetics|mesh-ancestor
25846434|NCT00040066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25846435|NCT00040066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846436|NCT00040066|Sensory System Agents|sensory system agents|mesh-ancestor
25846437|NCT00040066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25846438|NCT00040066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25846439|NCT00040066|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25846440|NCT00040066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25846441|NCT00040066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25846442|NCT00040066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846443|NCT00040066|Dopamine Agents|dopamine agents|mesh-ancestor
25846444|NCT00040066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25846445|NCT00040105|Imatinib Mesylate|imatinib mesylate|mesh-list
25846446|NCT00040105|Tipifarnib|tipifarnib|mesh-list
25846447|NCT00040105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846448|NCT00040105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25846449|NCT00040105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846450|NCT00040105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846451|NCT00040144|Dexelvucitabine|dexelvucitabine|mesh-list
25846452|NCT00040144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25846453|NCT00040144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25124158|NCT03079271|Benzocaine|benzocaine|mesh-list
25846454|NCT00040144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846455|NCT00040144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846456|NCT00040144|Antiviral Agents|antiviral agents|mesh-ancestor
25846457|NCT00040144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25846458|NCT00040144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25846459|NCT00040144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25846460|NCT00040157|Dexelvucitabine|dexelvucitabine|mesh-list
25846461|NCT00040157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24450437|NCT00319072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24450439|NCT00319150|Epoetin Alfa|epoetin alfa|mesh-list
25846462|NCT00040157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24459483|NCT00344812|Analgesics|analgesics|mesh-ancestor
24459484|NCT00344812|Sensory System Agents|sensory system agents|mesh-ancestor
24459485|NCT00344812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24459486|NCT00344812|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24459487|NCT00344812|Antitussive Agents|antitussive agents|mesh-ancestor
24459488|NCT00344812|Respiratory System Agents|respiratory system agents|mesh-ancestor
24459489|NCT00344825|Fludarabine|fludarabine|mesh-list
24459490|NCT00344825|Fludarabine phosphate|fludarabine phosphate|mesh-list
24459491|NCT00344825|Alemtuzumab|alemtuzumab|mesh-list
24459492|NCT00344825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459493|NCT00344825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25846463|NCT00040157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846464|NCT00040157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846465|NCT00040157|Antiviral Agents|antiviral agents|mesh-ancestor
25846466|NCT00040157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25846467|NCT00040157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25846468|NCT00040157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25846469|NCT00040183|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25846470|NCT00040183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846471|NCT00040183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24459496|NCT00344825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25846472|NCT00040183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846473|NCT00040183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846474|NCT00040209|Levodopa|levodopa|mesh-list
25846475|NCT00040209|Apomorphine|apomorphine|mesh-list
25846476|NCT00040209|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25846477|NCT00040209|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25846478|NCT00040209|Dopamine Agents|dopamine agents|mesh-ancestor
25846479|NCT00040209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25846480|NCT00040209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846481|NCT00040209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846482|NCT00040209|Emetics|emetics|mesh-ancestor
25846483|NCT00040209|Autonomic Agents|autonomic agents|mesh-ancestor
25846484|NCT00040209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25846485|NCT00040209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25846486|NCT00040209|Dopamine Agonists|dopamine agonists|mesh-ancestor
24644493|NCT01191216|Antidepressive Agents|antidepressive agents|mesh-ancestor
25846487|NCT00040248|Daclizumab|daclizumab|mesh-list
25846488|NCT00040248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25846489|NCT00040248|Immunologic Factors|immunologic factors|mesh-ancestor
25846490|NCT00040248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846491|NCT00040261|Memantine|memantine|mesh-list
25846492|NCT00040261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24947611|NCT03927170|Protease Inhibitors|protease inhibitors|mesh-ancestor
25846493|NCT00040261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25846494|NCT00040261|Dopamine Agents|dopamine agents|mesh-ancestor
25846495|NCT00040261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25846496|NCT00040261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846497|NCT00040261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846498|NCT00040261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25846499|NCT00040261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25846500|NCT00040274|Dexelvucitabine|dexelvucitabine|mesh-list
25846501|NCT00040274|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25846502|NCT00040274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25846503|NCT00040274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846504|NCT00040274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846505|NCT00040274|Antiviral Agents|antiviral agents|mesh-ancestor
25846506|NCT00040274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24459497|NCT00344825|Immunologic Factors|immunologic factors|mesh-ancestor
24459498|NCT00344825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846507|NCT00040274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24459499|NCT00344825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24459502|NCT00344851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24459503|NCT00344851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459504|NCT00344851|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24459506|NCT00344851|Hormones|hormones|mesh-ancestor
24459507|NCT00344851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24459508|NCT00344916|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
24459509|NCT00344916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24794837|NCT04354103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407638|NCT00174876|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25846508|NCT00040274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25846509|NCT00040300|Racivir|racivir|mesh-list
25846510|NCT00040300|Antiviral Agents|antiviral agents|mesh-ancestor
25846511|NCT00040300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25846512|NCT00040326|Anticonvulsants|anticonvulsants|mesh-list
25846513|NCT00040378|Vitamins|vitamins|mesh-list
25846514|NCT00040378|Vitamin E|vitamin e|mesh-list
25846515|NCT00040378|Tocopherols|tocopherols|mesh-list
25846516|NCT00040378|Tocotrienols|tocotrienols|mesh-list
25846517|NCT00040378|alpha-Tocopherol|alpha-tocopherol|mesh-list
25846518|NCT00040378|Selenium|selenium|mesh-list
25846519|NCT00040378|Micronutrients|micronutrients|mesh-ancestor
25846520|NCT00040378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846521|NCT00040378|Antioxidants|antioxidants|mesh-ancestor
25846522|NCT00040378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846523|NCT00040378|Protective Agents|protective agents|mesh-ancestor
24450844|NCT00320723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450846|NCT00320723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24450847|NCT00320723|Cholinergic Agents|cholinergic agents|mesh-ancestor
24450848|NCT00320723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24450849|NCT00320723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450850|NCT00320723|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24450851|NCT00320723|Antidepressive Agents|antidepressive agents|mesh-ancestor
24450852|NCT00320723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24450853|NCT00320723|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24450854|NCT00320723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24450855|NCT00320723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25846524|NCT00040378|Trace Elements|trace elements|mesh-ancestor
24450856|NCT00320723|Dopamine Agents|dopamine agents|mesh-ancestor
25846525|NCT00040391|Leucovorin|leucovorin|mesh-list
25846526|NCT00040391|Fluorouracil|fluorouracil|mesh-list
25846527|NCT00040391|Irinotecan|irinotecan|mesh-list
25846528|NCT00040391|Antimetabolites|antimetabolites|mesh-ancestor
24644753|NCT01192854|Adefovir|adefovir|mesh-list
25846529|NCT00040391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846530|NCT00040391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25846531|NCT00040391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846532|NCT00040391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25846533|NCT00040391|Immunologic Factors|immunologic factors|mesh-ancestor
25846534|NCT00040391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846535|NCT00040391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25846536|NCT00040391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25846537|NCT00040391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846538|NCT00040391|Antidotes|antidotes|mesh-ancestor
25846539|NCT00040391|Protective Agents|protective agents|mesh-ancestor
25846540|NCT00040391|Vitamin B Complex|vitamin b complex|mesh-ancestor
25846541|NCT00040391|Vitamins|vitamins|mesh-ancestor
25846542|NCT00040391|Micronutrients|micronutrients|mesh-ancestor
25846543|NCT00040417|Fludarabine|fludarabine|mesh-list
25846544|NCT00040417|Alemtuzumab|alemtuzumab|mesh-list
25846545|NCT00040417|Lenograstim|lenograstim|mesh-list
25846546|NCT00040417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846547|NCT00040417|Immunologic Factors|immunologic factors|mesh-ancestor
24407766|NCT00175396|Nilutamide|nilutamide|mesh-list
25846548|NCT00040417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846549|NCT00040417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25846550|NCT00040417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25846551|NCT00040469|Cyclophosphamide|cyclophosphamide|mesh-list
25846552|NCT00040469|Busulfan|busulfan|mesh-list
25846553|NCT00040469|Alemtuzumab|alemtuzumab|mesh-list
25846554|NCT00040469|Phenytoin|phenytoin|mesh-list
25846555|NCT00040469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25846556|NCT00040469|Immunologic Factors|immunologic factors|mesh-ancestor
25846557|NCT00040469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846558|NCT00040469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24459613|NCT00345358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459615|NCT00345501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25846559|NCT00040469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25846560|NCT00040469|Alkylating Agents|alkylating agents|mesh-ancestor
25846561|NCT00040469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846562|NCT00040469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846563|NCT00040469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25846564|NCT00040469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25846565|NCT00040469|Anticonvulsants|anticonvulsants|mesh-ancestor
25846566|NCT00040469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25846567|NCT00040469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25846568|NCT00040469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25846569|NCT00040469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25846570|NCT00040469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25846571|NCT00040482|Cyclophosphamide|cyclophosphamide|mesh-list
25846572|NCT00040482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25846573|NCT00040482|Immunologic Factors|immunologic factors|mesh-ancestor
25846574|NCT00040482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846575|NCT00040482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25846576|NCT00040482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25846577|NCT00040482|Alkylating Agents|alkylating agents|mesh-ancestor
25846578|NCT00040482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846579|NCT00040482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846580|NCT00040482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25846581|NCT00040495|Pantoprazole|pantoprazole|mesh-list
25846582|NCT00040495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25846583|NCT00040495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25846584|NCT00040495|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25124351|NCT03077516|Meloxicam|meloxicam|mesh-list
25846585|NCT00040495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846586|NCT00040495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24668649|NCT04681677|Bevacizumab|bevacizumab|mesh-list
25846587|NCT00040508|Sirolimus|sirolimus|mesh-list
25846588|NCT00040508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25846589|NCT00040508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25846590|NCT00040508|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25846591|NCT00040508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846592|NCT00040508|Antifungal Agents|antifungal agents|mesh-ancestor
24645269|NCT01197040|Prednisone|prednisone|mesh-list
25846593|NCT00040508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25846594|NCT00040508|Immunologic Factors|immunologic factors|mesh-ancestor
25846595|NCT00040508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846596|NCT00040521|Oprelvekin|oprelvekin|mesh-list
24645314|NCT01197235|Hematinics|hematinics|mesh-ancestor
25846597|NCT00040521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875978|NCT03952585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875979|NCT03948568|Tamoxifen|tamoxifen|mesh-list
25875980|NCT03948568|Letrozole|letrozole|mesh-list
25875981|NCT03948568|Anastrozole|anastrozole|mesh-list
25875982|NCT03948568|Exemestane|exemestane|mesh-list
25875983|NCT03948568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875984|NCT03948568|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25875985|NCT03948568|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25875986|NCT03948568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875987|NCT03948568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875988|NCT03948568|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25875989|NCT03948568|Hormone Antagonists|hormone antagonists|mesh-ancestor
25875990|NCT03948568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25875991|NCT03948568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875992|NCT03948568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25875993|NCT03948568|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25875994|NCT03948568|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25875995|NCT03948568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25875996|NCT03929718|Spironolactone|spironolactone|mesh-list
25875997|NCT03929718|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25875998|NCT03929718|Hormone Antagonists|hormone antagonists|mesh-ancestor
25875999|NCT03929718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25876000|NCT03929718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876001|NCT03929718|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25876002|NCT03929718|Diuretics|diuretics|mesh-ancestor
25876003|NCT03929718|Natriuretic Agents|natriuretic agents|mesh-ancestor
24547347|NCT00703482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547349|NCT00703586|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25846598|NCT00040586|Interleukin-2|interleukin-2|mesh-list
25846599|NCT00040586|Antibodies|antibodies|mesh-list
25846600|NCT00040586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25846601|NCT00040586|Immunologic Factors|immunologic factors|mesh-ancestor
25846602|NCT00040586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846603|NCT00040586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846604|NCT00040586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25846605|NCT00040586|Analgesics|analgesics|mesh-ancestor
25846606|NCT00040586|Sensory System Agents|sensory system agents|mesh-ancestor
25846607|NCT00040586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25846608|NCT00040599|Labetuzumab|labetuzumab|mesh-list
25846609|NCT00040599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25846610|NCT00040599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846611|NCT00040625|Cisplatin|cisplatin|mesh-list
25846612|NCT00040625|Pemetrexed|pemetrexed|mesh-list
25846613|NCT00040625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846614|NCT00040625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846615|NCT00040625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846616|NCT00040625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25846617|NCT00040625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25846618|NCT00040651|Cyclophosphamide|cyclophosphamide|mesh-list
25846619|NCT00040651|Fludarabine|fludarabine|mesh-list
25846620|NCT00040651|Thymoglobulin|thymoglobulin|mesh-list
25846621|NCT00040651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25846622|NCT00040651|Immunologic Factors|immunologic factors|mesh-ancestor
25846623|NCT00040651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846624|NCT00040651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25846625|NCT00040651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25846626|NCT00040651|Alkylating Agents|alkylating agents|mesh-ancestor
25846627|NCT00040651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846628|NCT00040651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846629|NCT00040651|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25846630|NCT00040690|Leucovorin|leucovorin|mesh-list
25846631|NCT00040690|Cytarabine|cytarabine|mesh-list
25846632|NCT00040690|Cyclophosphamide|cyclophosphamide|mesh-list
25846633|NCT00040690|Ifosfamide|ifosfamide|mesh-list
25846634|NCT00040690|Doxorubicin|doxorubicin|mesh-list
25846635|NCT00040690|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25846636|NCT00040690|Methotrexate|methotrexate|mesh-list
25846637|NCT00040690|Etoposide|etoposide|mesh-list
25846638|NCT00040690|Vincristine|vincristine|mesh-list
25846639|NCT00040690|Levoleucovorin|levoleucovorin|mesh-list
25846640|NCT00040690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25846641|NCT00040690|Immunologic Factors|immunologic factors|mesh-ancestor
25846642|NCT00040690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846643|NCT00040690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25846644|NCT00040690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25846645|NCT00040690|Alkylating Agents|alkylating agents|mesh-ancestor
25846646|NCT00040690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846647|NCT00040690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846648|NCT00040690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25846649|NCT00040690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25846650|NCT00040690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25846651|NCT00040690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25846652|NCT00040690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846653|NCT00040690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25846654|NCT00040690|Abortifacient Agents|abortifacient agents|mesh-ancestor
25846655|NCT00040690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25846656|NCT00040690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25846657|NCT00040690|Antimetabolites|antimetabolites|mesh-ancestor
25846658|NCT00040690|Dermatologic Agents|dermatologic agents|mesh-ancestor
25846659|NCT00040690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25846660|NCT00040690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25846661|NCT00040690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25846662|NCT00040690|Antiviral Agents|antiviral agents|mesh-ancestor
25846663|NCT00040690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25846664|NCT00040690|Antidotes|antidotes|mesh-ancestor
25661570|NCT01634555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661571|NCT01634555|Antidotes|antidotes|mesh-ancestor
25661572|NCT01634555|Protective Agents|protective agents|mesh-ancestor
25661573|NCT01634555|Vitamin B Complex|vitamin b complex|mesh-ancestor
25846665|NCT00040690|Protective Agents|protective agents|mesh-ancestor
25846666|NCT00040690|Vitamin B Complex|vitamin b complex|mesh-ancestor
25846667|NCT00040690|Vitamins|vitamins|mesh-ancestor
25846668|NCT00040690|Micronutrients|micronutrients|mesh-ancestor
25846669|NCT00040690|Tubulin Modulators|tubulin modulators|mesh-ancestor
25846670|NCT00040690|Antimitotic Agents|antimitotic agents|mesh-ancestor
25846671|NCT00040690|Mitosis Modulators|mitosis modulators|mesh-ancestor
25846672|NCT00040768|Bortezomib|bortezomib|mesh-list
25846673|NCT00040768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846674|NCT00040781|Gefitinib|gefitinib|mesh-list
25846675|NCT00040781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846676|NCT00040781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25846677|NCT00040781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846678|NCT00040781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846679|NCT00040794|Paclitaxel|paclitaxel|mesh-list
25846680|NCT00040794|Carboplatin|carboplatin|mesh-list
25846681|NCT00040794|Gefitinib|gefitinib|mesh-list
25846682|NCT00040794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25846683|NCT00040794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846684|NCT00040794|Tubulin Modulators|tubulin modulators|mesh-ancestor
24459688|NCT00345800|Sodium Oxybate|sodium oxybate|mesh-list
25846685|NCT00040794|Antimitotic Agents|antimitotic agents|mesh-ancestor
25846686|NCT00040794|Mitosis Modulators|mitosis modulators|mesh-ancestor
25846687|NCT00040794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846688|NCT00040794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25846689|NCT00040794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846690|NCT00040807|Docetaxel|docetaxel|mesh-list
25846691|NCT00040807|Irinotecan|irinotecan|mesh-list
25846692|NCT00040807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846693|NCT00040807|Tubulin Modulators|tubulin modulators|mesh-ancestor
25846694|NCT00040807|Antimitotic Agents|antimitotic agents|mesh-ancestor
25846695|NCT00040807|Mitosis Modulators|mitosis modulators|mesh-ancestor
25846696|NCT00040807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846697|NCT00040807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25846698|NCT00040807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25846699|NCT00040807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846700|NCT00040820|Oxaliplatin|oxaliplatin|mesh-list
25846701|NCT00040820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846702|NCT00040859|Capecitabine|capecitabine|mesh-list
25846703|NCT00040859|Oxaliplatin|oxaliplatin|mesh-list
25846704|NCT00040859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25846705|NCT00040859|Antimetabolites|antimetabolites|mesh-ancestor
25846706|NCT00040859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846707|NCT00040859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846708|NCT00040872|Cyclophosphamide|cyclophosphamide|mesh-list
25846709|NCT00040872|Thiotepa|thiotepa|mesh-list
25846710|NCT00040872|Carboplatin|carboplatin|mesh-list
25846711|NCT00040872|Doxorubicin|doxorubicin|mesh-list
25846712|NCT00040872|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25846713|NCT00040872|Etoposide|etoposide|mesh-list
25846714|NCT00040872|Vincristine|vincristine|mesh-list
25846715|NCT00040872|Topotecan|topotecan|mesh-list
25846716|NCT00040872|Isotretinoin|isotretinoin|mesh-list
25846717|NCT00040872|Antibodies|antibodies|mesh-list
25846718|NCT00040872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25846719|NCT00040872|Sargramostim|sargramostim|mesh-list
25846720|NCT00040872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25846721|NCT00040872|Immunologic Factors|immunologic factors|mesh-ancestor
25846722|NCT00040872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846723|NCT00040872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25846724|NCT00040872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25846725|NCT00040872|Alkylating Agents|alkylating agents|mesh-ancestor
25846726|NCT00040872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846727|NCT00040872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846728|NCT00040872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25846729|NCT00040872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25846730|NCT00040872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25846731|NCT00040872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25846732|NCT00040872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846733|NCT00040872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25846734|NCT00040872|Tubulin Modulators|tubulin modulators|mesh-ancestor
25846735|NCT00040872|Antimitotic Agents|antimitotic agents|mesh-ancestor
25846736|NCT00040872|Mitosis Modulators|mitosis modulators|mesh-ancestor
25846737|NCT00040872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25846738|NCT00040872|Dermatologic Agents|dermatologic agents|mesh-ancestor
25846739|NCT00040885|Docetaxel|docetaxel|mesh-list
25846740|NCT00040885|Infliximab|infliximab|mesh-list
25846741|NCT00040885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846742|NCT00040885|Tubulin Modulators|tubulin modulators|mesh-ancestor
25409034|NCT03404180|Sensory System Agents|sensory system agents|mesh-ancestor
25846743|NCT00040885|Antimitotic Agents|antimitotic agents|mesh-ancestor
25846744|NCT00040885|Mitosis Modulators|mitosis modulators|mesh-ancestor
25846745|NCT00040885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846747|NCT00040885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25846748|NCT00040885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25846749|NCT00040950|Rituximab|rituximab|mesh-list
25846750|NCT00040950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25846751|NCT00040950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846752|NCT00040950|Immunologic Factors|immunologic factors|mesh-ancestor
25846753|NCT00040950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846754|NCT00040950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25846755|NCT00040989|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25846756|NCT00040989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846757|NCT00041015|Cisplatin|cisplatin|mesh-list
25846758|NCT00041015|Etoposide|etoposide|mesh-list
25846759|NCT00041015|Topotecan|topotecan|mesh-list
25846760|NCT00041015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846761|NCT00041015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25846762|NCT00041015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25846763|NCT00041015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25846764|NCT00041015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846765|NCT00041015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846766|NCT00041015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25846767|NCT00041041|Imatinib Mesylate|imatinib mesylate|mesh-list
25846768|NCT00041041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846769|NCT00041041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25846770|NCT00041041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846771|NCT00041041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846772|NCT00041054|Sulindac sulfone|sulindac sulfone|mesh-list
25846773|NCT00041054|Carboplatin|carboplatin|mesh-list
25846774|NCT00041054|Etoposide|etoposide|mesh-list
25846775|NCT00041054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846776|NCT00041054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25846777|NCT00041054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25846778|NCT00041054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25846779|NCT00041054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846780|NCT00041054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846781|NCT00041054|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25846782|NCT00041054|Protective Agents|protective agents|mesh-ancestor
25846783|NCT00041054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846784|NCT00041054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25846785|NCT00041054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25846786|NCT00041054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25846787|NCT00041054|Analgesics|analgesics|mesh-ancestor
25846788|NCT00041054|Sensory System Agents|sensory system agents|mesh-ancestor
25846789|NCT00041054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25846790|NCT00041054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25846791|NCT00041054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25846792|NCT00041093|Docetaxel|docetaxel|mesh-list
25846793|NCT00041093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450897|NCT00320879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450898|NCT00320892|Atropine|atropine|mesh-list
24450899|NCT00320892|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24450910|NCT00320892|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24450911|NCT00320892|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24450912|NCT00320892|Cholinergic Agents|cholinergic agents|mesh-ancestor
24450913|NCT00320892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24450914|NCT00320892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450915|NCT00320892|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24450916|NCT00320970|Candesartan|candesartan|mesh-list
24450917|NCT00320970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25846794|NCT00041093|Tubulin Modulators|tubulin modulators|mesh-ancestor
25846795|NCT00041093|Antimitotic Agents|antimitotic agents|mesh-ancestor
25846796|NCT00041093|Mitosis Modulators|mitosis modulators|mesh-ancestor
25846797|NCT00041093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846798|NCT00041106|Gemcitabine|gemcitabine|mesh-list
25846799|NCT00041106|Cisplatin|cisplatin|mesh-list
25846800|NCT00041106|Gefitinib|gefitinib|mesh-list
24537192|NCT00653926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25846801|NCT00041106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846802|NCT00041106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25846803|NCT00041106|Antimetabolites|antimetabolites|mesh-ancestor
25846804|NCT00041106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846805|NCT00041106|Antiviral Agents|antiviral agents|mesh-ancestor
25846806|NCT00041106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25418793|NCT02747004|Antidiarrheals|antidiarrheals|mesh-list
25846807|NCT00041106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846808|NCT00041106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25846809|NCT00041106|Immunologic Factors|immunologic factors|mesh-ancestor
25846810|NCT00041106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846811|NCT00041106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25846812|NCT00041171|Docetaxel|docetaxel|mesh-list
25846813|NCT00041171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846814|NCT00041171|Tubulin Modulators|tubulin modulators|mesh-ancestor
25846815|NCT00041171|Antimitotic Agents|antimitotic agents|mesh-ancestor
25846816|NCT00041171|Mitosis Modulators|mitosis modulators|mesh-ancestor
25846817|NCT00041171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846818|NCT00041197|Imatinib Mesylate|imatinib mesylate|mesh-list
25846819|NCT00041197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846820|NCT00041197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25846821|NCT00041197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846822|NCT00041197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846823|NCT00041210|Prednisone|prednisone|mesh-list
25846824|NCT00041210|Doxorubicin|doxorubicin|mesh-list
25846825|NCT00041210|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25846826|NCT00041210|Bleomycin|bleomycin|mesh-list
25846827|NCT00041210|Etoposide|etoposide|mesh-list
25846828|NCT00041210|Vincristine|vincristine|mesh-list
25846829|NCT00041210|Dacarbazine|dacarbazine|mesh-list
25846830|NCT00041210|Vinblastine|vinblastine|mesh-list
25846831|NCT00041210|Mechlorethamine|mechlorethamine|mesh-list
25846832|NCT00041210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25846833|NCT00041210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846834|NCT00041210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25846835|NCT00041210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24408093|NCT00176527|Antiviral Agents|antiviral agents|mesh-ancestor
25846836|NCT00041210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846837|NCT00041210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846838|NCT00041210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25846839|NCT00041210|Glucocorticoids|glucocorticoids|mesh-ancestor
25846840|NCT00041210|Hormones|hormones|mesh-ancestor
25846841|NCT00041210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25846842|NCT00041210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846843|NCT00041210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25846844|NCT00041210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25846845|NCT00041210|Tubulin Modulators|tubulin modulators|mesh-ancestor
25846846|NCT00041210|Antimitotic Agents|antimitotic agents|mesh-ancestor
25846847|NCT00041210|Mitosis Modulators|mitosis modulators|mesh-ancestor
25846848|NCT00041210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25846849|NCT00041210|Alkylating Agents|alkylating agents|mesh-ancestor
25846850|NCT00041223|Proanthocyanidin|proanthocyanidin|mesh-list
24450465|NCT00319215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24450466|NCT00319215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846851|NCT00041223|Procyanidin|procyanidin|mesh-list
25846852|NCT00041223|Antioxidants|antioxidants|mesh-ancestor
25846853|NCT00041223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846854|NCT00041223|Protective Agents|protective agents|mesh-ancestor
25846855|NCT00041223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846856|NCT00041223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25846857|NCT00041223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25846858|NCT00041223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25846859|NCT00041236|Exatecan|exatecan|mesh-list
25846860|NCT00041236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25846861|NCT00041236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24646099|NCT01202084|Fluticasone|fluticasone|mesh-list
25846862|NCT00041236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846863|NCT00041236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846864|NCT00041236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846865|NCT00041262|Cisplatin|cisplatin|mesh-list
25846866|NCT00041262|Fluorouracil|fluorouracil|mesh-list
25846867|NCT00041262|Epirubicin|epirubicin|mesh-list
25846868|NCT00041262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846869|NCT00041262|Antimetabolites|antimetabolites|mesh-ancestor
25846870|NCT00041262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846871|NCT00041262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24394263|NCT00132743|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24394264|NCT00132743|Protective Agents|protective agents|mesh-ancestor
24394265|NCT00132743|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24394266|NCT00132743|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25661574|NCT01634555|Vitamins|vitamins|mesh-ancestor
25661575|NCT01634555|Micronutrients|micronutrients|mesh-ancestor
25661576|NCT01634555|Hematinics|hematinics|mesh-ancestor
25661577|NCT01634854|Misoprostol|misoprostol|mesh-list
24551909|NCT04620304|UB-421|ub-421|mesh-list
24394267|NCT00132743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394268|NCT00132756|Estramustine|estramustine|mesh-list
24394269|NCT00132756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24394344|NCT00133172|Mycophenolic Acid|mycophenolic acid|mesh-list
24394345|NCT00133172|Prednisone|prednisone|mesh-list
24394346|NCT00133172|Tacrolimus|tacrolimus|mesh-list
24394347|NCT00133172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25846872|NCT00041262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25846873|NCT00041262|Immunologic Factors|immunologic factors|mesh-ancestor
25846874|NCT00041262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846875|NCT00041262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24394349|NCT00133172|Hormones|hormones|mesh-ancestor
25846876|NCT00041262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25846877|NCT00041262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24394350|NCT00133172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24394351|NCT00133172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394352|NCT00133172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24394353|NCT00133172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24394354|NCT00133172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24394355|NCT00133172|Immunologic Factors|immunologic factors|mesh-ancestor
24394356|NCT00133172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24394357|NCT00133172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394358|NCT00133172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394359|NCT00133172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24394360|NCT00133172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24394361|NCT00133172|Antitubercular Agents|antitubercular agents|mesh-ancestor
24394362|NCT00133172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24394363|NCT00133172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24394365|NCT00133185|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24394366|NCT00133185|Telmisartan|telmisartan|mesh-list
24394367|NCT00133185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24394372|NCT00133185|Diuretics|diuretics|mesh-ancestor
24394373|NCT00133185|Natriuretic Agents|natriuretic agents|mesh-ancestor
24394374|NCT00133185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394375|NCT00133185|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24394376|NCT00133185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24394377|NCT00133198|Pramipexole|pramipexole|mesh-list
24394378|NCT00133198|Antioxidants|antioxidants|mesh-ancestor
24394379|NCT00133198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394380|NCT00133198|Protective Agents|protective agents|mesh-ancestor
24394381|NCT00133198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394382|NCT00133198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24394383|NCT00133198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24394384|NCT00133198|Dopamine Agonists|dopamine agonists|mesh-ancestor
25846878|NCT00041262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846879|NCT00041275|Megestrol|megestrol|mesh-list
25846880|NCT00041275|Megestrol Acetate|megestrol acetate|mesh-list
25846881|NCT00041275|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25846882|NCT00041275|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25846883|NCT00041275|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25846884|NCT00041275|Contraceptive Agents|contraceptive agents|mesh-ancestor
25846885|NCT00041275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25846886|NCT00041275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846887|NCT00041275|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25846888|NCT00041275|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25846889|NCT00041275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25846890|NCT00041275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846891|NCT00041275|Appetite Stimulants|appetite stimulants|mesh-ancestor
25846892|NCT00041275|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25846893|NCT00041288|Cyclosporine|cyclosporine|mesh-list
25846894|NCT00041288|Mycophenolic Acid|mycophenolic acid|mesh-list
25846895|NCT00041288|Cyclophosphamide|cyclophosphamide|mesh-list
25846896|NCT00041288|Methotrexate|methotrexate|mesh-list
25846897|NCT00041288|Fludarabine|fludarabine|mesh-list
25846898|NCT00041288|Fludarabine phosphate|fludarabine phosphate|mesh-list
25846899|NCT00041288|Tacrolimus|tacrolimus|mesh-list
25846900|NCT00041288|Cyclosporins|cyclosporins|mesh-list
25846901|NCT00041288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25846902|NCT00041288|Immunologic Factors|immunologic factors|mesh-ancestor
25846903|NCT00041288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846904|NCT00041288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25846905|NCT00041288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25846906|NCT00041288|Alkylating Agents|alkylating agents|mesh-ancestor
25846907|NCT00041288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846908|NCT00041288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846910|NCT00041288|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25846911|NCT00041288|Abortifacient Agents|abortifacient agents|mesh-ancestor
25846912|NCT00041288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25846913|NCT00041288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25846914|NCT00041288|Antimetabolites|antimetabolites|mesh-ancestor
25846915|NCT00041288|Dermatologic Agents|dermatologic agents|mesh-ancestor
25846916|NCT00041288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846917|NCT00041288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25846918|NCT00041288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25846919|NCT00041288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25846920|NCT00041288|Antifungal Agents|antifungal agents|mesh-ancestor
25846921|NCT00041288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25846922|NCT00041288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25846923|NCT00041288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25846924|NCT00041288|Antitubercular Agents|antitubercular agents|mesh-ancestor
25846925|NCT00041288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25846926|NCT00041314|Gemcitabine|gemcitabine|mesh-list
25846927|NCT00041314|Sulindac sulfone|sulindac sulfone|mesh-list
25846928|NCT00041314|Carboplatin|carboplatin|mesh-list
25846929|NCT00041314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846930|NCT00041314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25846931|NCT00041314|Antimetabolites|antimetabolites|mesh-ancestor
25846932|NCT00041314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846933|NCT00041314|Antiviral Agents|antiviral agents|mesh-ancestor
25846934|NCT00041314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24394385|NCT00133198|Dopamine Agents|dopamine agents|mesh-ancestor
24394386|NCT00133198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24394387|NCT00133224|Prednisone|prednisone|mesh-list
24394416|NCT00133250|Calcium heparin|calcium heparin|mesh-list
24394418|NCT00133250|Anticoagulants|anticoagulants|mesh-ancestor
24394419|NCT00133250|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24394420|NCT00133250|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24394421|NCT00133250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394422|NCT00133250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24394424|NCT00133276|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24394425|NCT00133276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24394426|NCT00133276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24394427|NCT00133276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846935|NCT00041314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846936|NCT00041314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25846937|NCT00041314|Immunologic Factors|immunologic factors|mesh-ancestor
24408454|NCT00177749|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25846938|NCT00041314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846939|NCT00041314|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25846940|NCT00041314|Protective Agents|protective agents|mesh-ancestor
24537550|NCT00655148|Vaccines|vaccines|mesh-list
24394474|NCT00133354|Hormone Antagonists|hormone antagonists|mesh-ancestor
24394475|NCT00133367|Sirolimus|sirolimus|mesh-list
24394476|NCT00133367|Fludarabine|fludarabine|mesh-list
24394477|NCT00133367|Melphalan|melphalan|mesh-list
24394478|NCT00133367|Tacrolimus|tacrolimus|mesh-list
24394479|NCT00133367|Thymoglobulin|thymoglobulin|mesh-list
24394480|NCT00133367|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24394481|NCT00133367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24394501|NCT00133380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24394503|NCT00133393|Pentoxifylline|pentoxifylline|mesh-list
24394504|NCT00133393|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24394505|NCT00133393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394506|NCT00133393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846941|NCT00041314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25846942|NCT00041314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25846943|NCT00041314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24537575|NCT00655252|Everolimus|everolimus|mesh-list
24394520|NCT00133406|Glycine Agents|glycine agents|mesh-ancestor
24394521|NCT00133406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24394522|NCT00133419|Vitamins|vitamins|mesh-list
24394523|NCT00133419|Vitamin A|vitamin a|mesh-list
24394524|NCT00133419|Zinc|zinc|mesh-list
24394525|NCT00133419|Trace Elements|trace elements|mesh-list
24394526|NCT00133419|Micronutrients|micronutrients|mesh-list
24394527|NCT00133419|Retinol palmitate|retinol palmitate|mesh-list
24394528|NCT00133419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394529|NCT00133419|Antioxidants|antioxidants|mesh-ancestor
24394530|NCT00133419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394534|NCT00133445|Vaccines|vaccines|mesh-list
24394541|NCT00133458|Anticestodal Agents|anticestodal agents|mesh-ancestor
24394542|NCT00133458|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24394543|NCT00133458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24394544|NCT00133458|Tubulin Modulators|tubulin modulators|mesh-ancestor
24394545|NCT00133458|Antimitotic Agents|antimitotic agents|mesh-ancestor
24394546|NCT00133458|Mitosis Modulators|mitosis modulators|mesh-ancestor
24394547|NCT00133458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846944|NCT00041314|Analgesics|analgesics|mesh-ancestor
25846945|NCT00041314|Sensory System Agents|sensory system agents|mesh-ancestor
24394586|NCT00133692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24646504|NCT01204138|Apremilast|apremilast|mesh-list
25074120|NCT03390608|Estrogens|estrogens|mesh-list
24394614|NCT00133731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394616|NCT00133744|Vitamin B Complex|vitamin b complex|mesh-list
24394617|NCT00133744|Vitamins|vitamins|mesh-ancestor
24394618|NCT00133744|Micronutrients|micronutrients|mesh-ancestor
24394619|NCT00133744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846946|NCT00041314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25846947|NCT00041314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25846948|NCT00041314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25846949|NCT00041327|Interferons|interferons|mesh-list
25846950|NCT00041327|Interferon-alpha|interferon-alpha|mesh-list
25846951|NCT00041327|Lamivudine|lamivudine|mesh-list
25846952|NCT00041327|Zidovudine|zidovudine|mesh-list
25846953|NCT00041327|Prednisone|prednisone|mesh-list
25846954|NCT00041327|Cyclophosphamide|cyclophosphamide|mesh-list
25846955|NCT00041327|Doxorubicin|doxorubicin|mesh-list
25846956|NCT00041327|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25846957|NCT00041327|Etoposide|etoposide|mesh-list
25846958|NCT00041327|Vincristine|vincristine|mesh-list
25846959|NCT00041327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25846960|NCT00041327|Immunologic Factors|immunologic factors|mesh-ancestor
25846961|NCT00041327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846962|NCT00041327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25846963|NCT00041327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25846964|NCT00041327|Alkylating Agents|alkylating agents|mesh-ancestor
24394620|NCT00133744|Hematinics|hematinics|mesh-ancestor
24394621|NCT00133757|Bupropion|bupropion|mesh-list
24394622|NCT00133757|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24394623|NCT00133757|Antidepressive Agents|antidepressive agents|mesh-ancestor
24394624|NCT00133757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24394625|NCT00133757|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24394626|NCT00133757|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24394627|NCT00133757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24394628|NCT00133757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394629|NCT00133757|Dopamine Agents|dopamine agents|mesh-ancestor
24394630|NCT00133757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24394631|NCT00133757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394632|NCT00133757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24394633|NCT00133757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24646555|NCT01204268|Anesthetics|anesthetics|mesh-ancestor
24394706|NCT00134030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25846965|NCT00041327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846966|NCT00041327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846967|NCT00041327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25846968|NCT00041327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25846969|NCT00041327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25846970|NCT00041327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25846971|NCT00041327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846972|NCT00041327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25846973|NCT00041327|Glucocorticoids|glucocorticoids|mesh-ancestor
25846974|NCT00041327|Hormones|hormones|mesh-ancestor
25846975|NCT00041327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25846976|NCT00041327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25846977|NCT00041327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25846978|NCT00041327|Antiviral Agents|antiviral agents|mesh-ancestor
25846979|NCT00041327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25846980|NCT00041327|Tubulin Modulators|tubulin modulators|mesh-ancestor
25846981|NCT00041327|Antimitotic Agents|antimitotic agents|mesh-ancestor
24459709|NCT00346047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24459710|NCT00346047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846982|NCT00041327|Mitosis Modulators|mitosis modulators|mesh-ancestor
25846983|NCT00041327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25846984|NCT00041327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25846985|NCT00041327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25846986|NCT00041327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24548179|NCT00708149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25846987|NCT00041327|Antimetabolites|antimetabolites|mesh-ancestor
25846988|NCT00041340|Imatinib Mesylate|imatinib mesylate|mesh-list
25846989|NCT00041340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25846990|NCT00041340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25846991|NCT00041340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25846992|NCT00041340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25846993|NCT00041431|Hormones|hormones|mesh-list
25846994|NCT00041431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25846995|NCT00041431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25846996|NCT00041483|Anecortave|anecortave|mesh-list
25846997|NCT00041483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25846998|NCT00041483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25846999|NCT00041483|Growth Substances|growth substances|mesh-ancestor
25847000|NCT00041483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847001|NCT00041483|Growth Inhibitors|growth inhibitors|mesh-ancestor
25847002|NCT00041483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847003|NCT00041535|Miglustat|miglustat|mesh-list
25847004|NCT00041535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847005|NCT00041535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459711|NCT00346047|Analgesics|analgesics|mesh-ancestor
24459712|NCT00346047|Sensory System Agents|sensory system agents|mesh-ancestor
24459713|NCT00346047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25847006|NCT00041535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25847007|NCT00041535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25847008|NCT00041535|Antiviral Agents|antiviral agents|mesh-ancestor
25847009|NCT00041535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25847010|NCT00041535|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25847011|NCT00041535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25847012|NCT00041535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847013|NCT00041548|Nitric Oxide|nitric oxide|mesh-list
25847014|NCT00041548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25847015|NCT00041548|Autonomic Agents|autonomic agents|mesh-ancestor
25847016|NCT00041548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24537699|NCT00655837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25847017|NCT00041548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847018|NCT00041548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25847019|NCT00041548|Respiratory System Agents|respiratory system agents|mesh-ancestor
25847020|NCT00041548|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25847021|NCT00041548|Antioxidants|antioxidants|mesh-ancestor
25847022|NCT00041548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847023|NCT00041548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25847024|NCT00041548|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25847025|NCT00041548|Vasodilator Agents|vasodilator agents|mesh-ancestor
25847026|NCT00041548|Gasotransmitters|gasotransmitters|mesh-ancestor
25847027|NCT00041548|Protective Agents|protective agents|mesh-ancestor
25847028|NCT00041561|Nitric Oxide|nitric oxide|mesh-list
25847029|NCT00041561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25847030|NCT00041561|Autonomic Agents|autonomic agents|mesh-ancestor
25847031|NCT00041561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25847032|NCT00041561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847033|NCT00041561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25847034|NCT00041561|Respiratory System Agents|respiratory system agents|mesh-ancestor
25847035|NCT00041561|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25847036|NCT00041561|Antioxidants|antioxidants|mesh-ancestor
25847037|NCT00041561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847038|NCT00041561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25847039|NCT00041561|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25847040|NCT00041561|Vasodilator Agents|vasodilator agents|mesh-ancestor
25847041|NCT00041561|Gasotransmitters|gasotransmitters|mesh-ancestor
25847042|NCT00041561|Protective Agents|protective agents|mesh-ancestor
25847043|NCT00041574|Nitric Oxide|nitric oxide|mesh-list
25847044|NCT00041574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25847045|NCT00041574|Autonomic Agents|autonomic agents|mesh-ancestor
25418794|NCT02747004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25661578|NCT01634854|Oxytocin|oxytocin|mesh-list
25661579|NCT01634854|Oxytocics|oxytocics|mesh-ancestor
25661580|NCT01634854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25661581|NCT01634854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661582|NCT01634854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25661583|NCT01634854|Abortifacient Agents|abortifacient agents|mesh-ancestor
25661584|NCT01634854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25661585|NCT01634854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25661586|NCT01635062|Calcitriol|calcitriol|mesh-list
25661587|NCT01635062|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
25847046|NCT00041574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25847047|NCT00041574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847048|NCT00041574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25847049|NCT00041574|Respiratory System Agents|respiratory system agents|mesh-ancestor
25847050|NCT00041574|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25847051|NCT00041574|Antioxidants|antioxidants|mesh-ancestor
25847052|NCT00041574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847053|NCT00041574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24647030|NCT01205997|Anesthetics|anesthetics|mesh-ancestor
25847054|NCT00041574|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25847055|NCT00041574|Vasodilator Agents|vasodilator agents|mesh-ancestor
25847056|NCT00041574|Gasotransmitters|gasotransmitters|mesh-ancestor
25847057|NCT00041574|Protective Agents|protective agents|mesh-ancestor
25847058|NCT00041639|Labetuzumab|labetuzumab|mesh-list
25847059|NCT00041639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25847060|NCT00041639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847061|NCT00041652|Labetuzumab|labetuzumab|mesh-list
25847062|NCT00041652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25847063|NCT00041652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847064|NCT00041665|Mitogens|mitogens|mesh-list
25847065|NCT00041665|Mitosis Modulators|mitosis modulators|mesh-ancestor
25847066|NCT00041665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847067|NCT00041678|Aripiprazole|aripiprazole|mesh-list
25847068|NCT00041678|Antidepressive Agents|antidepressive agents|mesh-ancestor
25847069|NCT00041678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25847070|NCT00041678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25847071|NCT00041678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24459717|NCT00346099|Panitumumab|panitumumab|mesh-list
24459718|NCT00346099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25847072|NCT00041678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25847073|NCT00041678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847074|NCT00041678|Dopamine Agonists|dopamine agonists|mesh-ancestor
25847075|NCT00041678|Dopamine Agents|dopamine agents|mesh-ancestor
25847076|NCT00041678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25847077|NCT00041678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847078|NCT00041678|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25847079|NCT00041678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25847080|NCT00041678|Serotonin Agents|serotonin agents|mesh-ancestor
25847081|NCT00041678|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25847082|NCT00041678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25847083|NCT00041678|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25847084|NCT00041678|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25847085|NCT00041691|Labetuzumab|labetuzumab|mesh-list
25847086|NCT00041691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25847087|NCT00041691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847088|NCT00041704|Anidulafungin|anidulafungin|mesh-list
25847089|NCT00041704|Antifungal Agents|antifungal agents|mesh-ancestor
25847090|NCT00041704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25847091|NCT00041782|Dalteparin|dalteparin|mesh-list
25847092|NCT00041782|Tinzaparin|tinzaparin|mesh-list
25847093|NCT00041782|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25847094|NCT00041782|Anticoagulants|anticoagulants|mesh-ancestor
25847095|NCT00041782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25847096|NCT00041782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24647112|NCT01206348|Minocycline|minocycline|mesh-list
25847097|NCT00041782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847098|NCT00041899|Ulipristal acetate|ulipristal acetate|mesh-list
25847099|NCT00041899|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25847100|NCT00041899|Contraceptive Agents|contraceptive agents|mesh-ancestor
25847101|NCT00041899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25847102|NCT00041899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847103|NCT00041899|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25847104|NCT00041977|Doxycycline|doxycycline|mesh-list
25847105|NCT00041977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25847106|NCT00041977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25847107|NCT00041977|Antimalarials|antimalarials|mesh-ancestor
25847108|NCT00041977|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25847109|NCT00041977|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25847110|NCT00041990|Decitabine|decitabine|mesh-list
25847111|NCT00041990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25847112|NCT00041990|Antimetabolites|antimetabolites|mesh-ancestor
25847113|NCT00041990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847114|NCT00041990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847115|NCT00041990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847116|NCT00042003|Decitabine|decitabine|mesh-list
25876004|NCT03928366|Remifentanil|remifentanil|mesh-list
25847118|NCT00042003|Antimetabolites|antimetabolites|mesh-ancestor
25847119|NCT00042003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847120|NCT00042003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847121|NCT00042003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847122|NCT00042016|Decitabine|decitabine|mesh-list
25847123|NCT00042016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25847124|NCT00042016|Antimetabolites|antimetabolites|mesh-ancestor
25847125|NCT00042016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847126|NCT00042016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847127|NCT00042016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847128|NCT00042029|Aprepitant|aprepitant|mesh-list
25847129|NCT00042029|Antiemetics|antiemetics|mesh-ancestor
25847130|NCT00042029|Autonomic Agents|autonomic agents|mesh-ancestor
25847131|NCT00042029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25847132|NCT00042029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847133|NCT00042029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25847134|NCT00042029|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25847135|NCT00042029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25847136|NCT00042029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847137|NCT00042068|Meloxicam|meloxicam|mesh-list
25847138|NCT00042068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25847139|NCT00042068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25847140|NCT00042068|Analgesics|analgesics|mesh-ancestor
25847141|NCT00042068|Sensory System Agents|sensory system agents|mesh-ancestor
25847142|NCT00042068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25847143|NCT00042068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847144|NCT00042068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25847145|NCT00042068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25847146|NCT00042068|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25847147|NCT00042068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25847148|NCT00042068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847149|NCT00042068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847150|NCT00042146|Zolpidem|zolpidem|mesh-list
25847151|NCT00042146|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25847152|NCT00042146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25847153|NCT00042146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25847154|NCT00042146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847155|NCT00042146|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25847156|NCT00042146|GABA Agonists|gaba agonists|mesh-ancestor
25847157|NCT00042146|GABA Agents|gaba agents|mesh-ancestor
25847158|NCT00042146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25847159|NCT00042146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847160|NCT00042172|Donepezil|donepezil|mesh-list
25847161|NCT00042172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25847162|NCT00042172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847163|NCT00042172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847164|NCT00042172|Cholinergic Agents|cholinergic agents|mesh-ancestor
25847165|NCT00042172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25847166|NCT00042172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847167|NCT00042172|Nootropic Agents|nootropic agents|mesh-ancestor
25876005|NCT03928366|Propofol|propofol|mesh-list
25876006|NCT03928366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25876007|NCT03928366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25876008|NCT03928366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876009|NCT03928366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25876010|NCT03928366|Anesthetics, General|anesthetics, general|mesh-ancestor
25876011|NCT03928366|Anesthetics|anesthetics|mesh-ancestor
25876012|NCT03928366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24450532|NCT00319488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450534|NCT00319488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24450535|NCT00319488|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24450536|NCT00319488|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24450537|NCT00319488|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24450549|NCT00319566|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24450550|NCT00319566|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25876013|NCT03928366|Narcotics|narcotics|mesh-ancestor
25876014|NCT03928366|Analgesics|analgesics|mesh-ancestor
25876015|NCT03928366|Sensory System Agents|sensory system agents|mesh-ancestor
25876016|NCT03928366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25876017|NCT03914625|Calcium, Dietary|calcium, dietary|mesh-list
25876018|NCT03914625|Leucovorin|leucovorin|mesh-list
25876019|NCT03914625|Folic Acid|folic acid|mesh-list
25847169|NCT00042302|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25847170|NCT00042302|Carboplatin|carboplatin|mesh-list
25847171|NCT00042302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25847172|NCT00042302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847173|NCT00042302|Tubulin Modulators|tubulin modulators|mesh-ancestor
25847174|NCT00042302|Antimitotic Agents|antimitotic agents|mesh-ancestor
25847175|NCT00042302|Mitosis Modulators|mitosis modulators|mesh-ancestor
25847176|NCT00042302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847177|NCT00042315|Vinorelbine|vinorelbine|mesh-list
25847178|NCT00042315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25847179|NCT00042315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847180|NCT00042315|Tubulin Modulators|tubulin modulators|mesh-ancestor
25847181|NCT00042315|Antimitotic Agents|antimitotic agents|mesh-ancestor
25847182|NCT00042315|Mitosis Modulators|mitosis modulators|mesh-ancestor
25847183|NCT00042315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847184|NCT00042328|Valacyclovir|valacyclovir|mesh-list
25847185|NCT00042328|Antiviral Agents|antiviral agents|mesh-ancestor
25847186|NCT00042328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25847187|NCT00042354|Clofarabine|clofarabine|mesh-list
25847188|NCT00042354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25847189|NCT00042354|Antimetabolites|antimetabolites|mesh-ancestor
25847190|NCT00042354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847191|NCT00042354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847192|NCT00042367|Mafosfamide|mafosfamide|mesh-list
25847193|NCT00042367|Cyclophosphamide|cyclophosphamide|mesh-list
25847194|NCT00042367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25847195|NCT00042367|Immunologic Factors|immunologic factors|mesh-ancestor
25847196|NCT00042367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847197|NCT00042367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847198|NCT00042367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25847199|NCT00042367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25847200|NCT00042367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25847201|NCT00042367|Alkylating Agents|alkylating agents|mesh-ancestor
25847202|NCT00042367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847203|NCT00042367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25847204|NCT00042393|Adefovir|adefovir|mesh-list
25847205|NCT00042393|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25847206|NCT00042393|Antiviral Agents|antiviral agents|mesh-ancestor
25847207|NCT00042393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25847208|NCT00042393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25847209|NCT00042393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25847210|NCT00042393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847211|NCT00042393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847212|NCT00042406|Zanolimumab|zanolimumab|mesh-list
25847213|NCT00042406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25847214|NCT00042406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847215|NCT00042458|Pramlintide|pramlintide|mesh-list
25847216|NCT00042458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25847217|NCT00042458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847218|NCT00042471|Pramlintide|pramlintide|mesh-list
25847219|NCT00042471|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
25847220|NCT00042471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25847221|NCT00042471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847222|NCT00042471|Appetite Depressants|appetite depressants|mesh-ancestor
25847223|NCT00042471|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24459733|NCT00346229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847224|NCT00042471|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
25847225|NCT00042471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847226|NCT00042536|Naltrexone|naltrexone|mesh-list
25847227|NCT00042536|Yohimbine|yohimbine|mesh-list
25847228|NCT00042536|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25847229|NCT00042536|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25847230|NCT00042536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847231|NCT00042536|Sensory System Agents|sensory system agents|mesh-ancestor
25847232|NCT00042536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25847233|NCT00042536|Mydriatics|mydriatics|mesh-ancestor
25847234|NCT00042536|Autonomic Agents|autonomic agents|mesh-ancestor
25847235|NCT00042536|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25847236|NCT00042536|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25847237|NCT00042536|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25847238|NCT00042536|Adrenergic Agents|adrenergic agents|mesh-ancestor
25847239|NCT00042536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25847240|NCT00042536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847241|NCT00042536|Urological Agents|urological agents|mesh-ancestor
25847242|NCT00042549|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25847243|NCT00042549|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25847244|NCT00042549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25847245|NCT00042562|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25847246|NCT00042562|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25847247|NCT00042562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25847248|NCT00042562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25847249|NCT00042562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847250|NCT00042562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25847251|NCT00042562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847252|NCT00042562|Analgesics|analgesics|mesh-ancestor
25847253|NCT00042562|Sensory System Agents|sensory system agents|mesh-ancestor
25847254|NCT00042562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25847255|NCT00042562|Antidepressive Agents|antidepressive agents|mesh-ancestor
25847256|NCT00042562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25847257|NCT00042562|Dopamine Agents|dopamine agents|mesh-ancestor
25847258|NCT00042575|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25847259|NCT00042575|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25847260|NCT00042575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25847261|NCT00042575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25847262|NCT00042575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847263|NCT00042575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25847264|NCT00042575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847265|NCT00042575|Analgesics|analgesics|mesh-ancestor
25847266|NCT00042575|Sensory System Agents|sensory system agents|mesh-ancestor
24820226|NCT02099240|Cefuroxime axetil|cefuroxime axetil|mesh-list
25847267|NCT00042575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25847268|NCT00042575|Antidepressive Agents|antidepressive agents|mesh-ancestor
25847269|NCT00042575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25847270|NCT00042575|Dopamine Agents|dopamine agents|mesh-ancestor
25847271|NCT00042588|Antibodies|antibodies|mesh-list
25847272|NCT00042588|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25847273|NCT00042588|Immunologic Factors|immunologic factors|mesh-ancestor
25847274|NCT00042588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847275|NCT00042601|Pramlintide|pramlintide|mesh-list
25847276|NCT00042601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25847277|NCT00042601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847278|NCT00042653|Cinacalcet|cinacalcet|mesh-list
25847279|NCT00042653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25847280|NCT00042653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847281|NCT00042653|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25847282|NCT00042653|Hormone Antagonists|hormone antagonists|mesh-ancestor
25847283|NCT00042653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24459735|NCT00346242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24459736|NCT00346242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847284|NCT00042679|Gemcitabine|gemcitabine|mesh-list
25847285|NCT00042679|Carboplatin|carboplatin|mesh-list
25847286|NCT00042679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847287|NCT00042679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25847288|NCT00042679|Antimetabolites|antimetabolites|mesh-ancestor
25847289|NCT00042679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847290|NCT00042679|Antiviral Agents|antiviral agents|mesh-ancestor
25847291|NCT00042679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25847292|NCT00042679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847293|NCT00042679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25847294|NCT00042679|Immunologic Factors|immunologic factors|mesh-ancestor
25847295|NCT00042679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847296|NCT00042718|Amoxicillin|amoxicillin|mesh-list
25847297|NCT00042718|Azithromycin|azithromycin|mesh-list
25847298|NCT00042718|Levofloxacin|levofloxacin|mesh-list
25847299|NCT00042718|Ofloxacin|ofloxacin|mesh-list
25847300|NCT00042718|Clavulanic Acid|clavulanic acid|mesh-list
25847301|NCT00042718|Clavulanic Acids|clavulanic acids|mesh-list
25847302|NCT00042718|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25847303|NCT00042718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25847304|NCT00042718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25847305|NCT00042718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25847306|NCT00042718|Renal Agents|renal agents|mesh-ancestor
25847307|NCT00042718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25847308|NCT00042718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25847309|NCT00042718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876020|NCT03914625|Cytarabine|cytarabine|mesh-list
25230073|NCT02598791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230074|NCT02598791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25847310|NCT00042718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847311|NCT00042718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847312|NCT00042718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25847313|NCT00042718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25847314|NCT00042718|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25847315|NCT00042731|Lycopene|lycopene|mesh-list
25847316|NCT00042731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25847317|NCT00042731|Antioxidants|antioxidants|mesh-ancestor
25847318|NCT00042731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847319|NCT00042731|Protective Agents|protective agents|mesh-ancestor
25847320|NCT00042731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648208|NCT01213095|Rituximab|rituximab|mesh-list
24648312|NCT01213498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25847321|NCT00042731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25847322|NCT00042731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25847323|NCT00042731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847324|NCT00042796|Decitabine|decitabine|mesh-list
25847325|NCT00042796|Azacitidine|azacitidine|mesh-list
25847326|NCT00042796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25847327|NCT00042796|Antimetabolites|antimetabolites|mesh-ancestor
25847328|NCT00042796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847329|NCT00042796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847330|NCT00042796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847331|NCT00042809|Paclitaxel|paclitaxel|mesh-list
25847332|NCT00042809|Trastuzumab|trastuzumab|mesh-list
25847333|NCT00042809|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25847334|NCT00042809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25847335|NCT00042809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847336|NCT00042809|Tubulin Modulators|tubulin modulators|mesh-ancestor
25847337|NCT00042809|Antimitotic Agents|antimitotic agents|mesh-ancestor
24648354|NCT01213719|Betaine|betaine|mesh-list
25847338|NCT00042809|Mitosis Modulators|mitosis modulators|mesh-ancestor
25847339|NCT00042809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847340|NCT00042809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25847341|NCT00042809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25847342|NCT00042809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847343|NCT00042822|Romidepsin|romidepsin|mesh-list
25847344|NCT00042822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25847345|NCT00042822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847346|NCT00042835|Paclitaxel|paclitaxel|mesh-list
25847347|NCT00042835|Etoposide|etoposide|mesh-list
25847348|NCT00042835|Docetaxel|docetaxel|mesh-list
25847349|NCT00042835|Cisplatin|cisplatin|mesh-list
25847350|NCT00042835|Carboplatin|carboplatin|mesh-list
25847351|NCT00042835|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25847352|NCT00042835|Etoposide phosphate|etoposide phosphate|mesh-list
25847353|NCT00042835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25847354|NCT00042835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24551728|NCT05072236|Lidocaine|lidocaine|mesh-list
25847355|NCT00042835|Tubulin Modulators|tubulin modulators|mesh-ancestor
25847356|NCT00042835|Antimitotic Agents|antimitotic agents|mesh-ancestor
25847357|NCT00042835|Mitosis Modulators|mitosis modulators|mesh-ancestor
25847358|NCT00042835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847359|NCT00042835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25847360|NCT00042835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25847361|NCT00042835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847362|NCT00042835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24636172|NCT01143584|Autonomic Agents|autonomic agents|mesh-ancestor
24636173|NCT01143584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25847363|NCT00042848|Modafinil|modafinil|mesh-list
25661588|NCT01635062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25661589|NCT01635062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661590|NCT01635062|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25661591|NCT01635062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25661592|NCT01635062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847364|NCT00042848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25847365|NCT00042848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847369|NCT00042848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847370|NCT00042861|Leucovorin|leucovorin|mesh-list
25847371|NCT00042861|Fluorouracil|fluorouracil|mesh-list
25847372|NCT00042861|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
25847373|NCT00042861|Calcium|calcium|mesh-list
25847374|NCT00042861|Levoleucovorin|levoleucovorin|mesh-list
25847375|NCT00042861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25847376|NCT00042861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847377|NCT00042861|Antimetabolites|antimetabolites|mesh-ancestor
25847378|NCT00042861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847379|NCT00042861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25847380|NCT00042861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847381|NCT00042861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25847382|NCT00042861|Immunologic Factors|immunologic factors|mesh-ancestor
25847383|NCT00042861|Antidotes|antidotes|mesh-ancestor
25847384|NCT00042861|Protective Agents|protective agents|mesh-ancestor
25203427|NCT02714166|Sunscreening Agents|sunscreening agents|mesh-list
25203428|NCT02714166|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25203429|NCT02714166|Protective Agents|protective agents|mesh-ancestor
25203430|NCT02714166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203431|NCT02714166|Dermatologic Agents|dermatologic agents|mesh-ancestor
25203433|NCT02714231|Scopolamine|scopolamine|mesh-list
25203434|NCT02714231|Bromides|bromides|mesh-list
25847385|NCT00042861|Vitamin B Complex|vitamin b complex|mesh-ancestor
25847386|NCT00042861|Vitamins|vitamins|mesh-ancestor
25847387|NCT00042861|Micronutrients|micronutrients|mesh-ancestor
25847388|NCT00042861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25847389|NCT00042861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847390|NCT00042874|Leucovorin|leucovorin|mesh-list
25847391|NCT00042874|Fluorouracil|fluorouracil|mesh-list
25847392|NCT00042874|Irinotecan|irinotecan|mesh-list
25847393|NCT00042874|Alvocidib|alvocidib|mesh-list
25847394|NCT00042874|Calcium|calcium|mesh-list
25847395|NCT00042874|Levoleucovorin|levoleucovorin|mesh-list
25847396|NCT00042874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25847397|NCT00042874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847398|NCT00042874|Antimetabolites|antimetabolites|mesh-ancestor
25847399|NCT00042874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847400|NCT00042874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25847401|NCT00042874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847402|NCT00042874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25847403|NCT00042874|Immunologic Factors|immunologic factors|mesh-ancestor
25847404|NCT00042874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25847405|NCT00042874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25847406|NCT00042874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847407|NCT00042874|Antidotes|antidotes|mesh-ancestor
25847408|NCT00042874|Protective Agents|protective agents|mesh-ancestor
25847409|NCT00042874|Vitamin B Complex|vitamin b complex|mesh-ancestor
25847410|NCT00042874|Vitamins|vitamins|mesh-ancestor
25847411|NCT00042874|Micronutrients|micronutrients|mesh-ancestor
25847412|NCT00042874|Growth Inhibitors|growth inhibitors|mesh-ancestor
25847413|NCT00042874|Growth Substances|growth substances|mesh-ancestor
25847414|NCT00042874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24538807|NCT00660868|Pentoxifylline|pentoxifylline|mesh-list
25847415|NCT00042887|Mitomycins|mitomycins|mesh-list
25847416|NCT00042887|Mitomycin|mitomycin|mesh-list
25847417|NCT00042887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24648883|NCT01217138|Respiratory System Agents|respiratory system agents|mesh-ancestor
24648934|NCT01217450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847418|NCT00042887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847419|NCT00042887|Alkylating Agents|alkylating agents|mesh-ancestor
25847420|NCT00042887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847421|NCT00042887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25847422|NCT00042887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847423|NCT00042913|Epratuzumab|epratuzumab|mesh-list
25418795|NCT02747004|Hormone Antagonists|hormone antagonists|mesh-ancestor
25847424|NCT00042913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25847425|NCT00042913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847426|NCT00042926|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
25847427|NCT00042926|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25847428|NCT00042926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847429|NCT00042952|Imatinib Mesylate|imatinib mesylate|mesh-list
25847430|NCT00042952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24801769|NCT01985724|Mitogens|mitogens|mesh-list
25847431|NCT00042952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25847432|NCT00042952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847433|NCT00042952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847434|NCT00042965|Gemcitabine|gemcitabine|mesh-list
25847435|NCT00042965|Capecitabine|capecitabine|mesh-list
25847436|NCT00042965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25847437|NCT00042965|Antimetabolites|antimetabolites|mesh-ancestor
25847438|NCT00042965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847439|NCT00042965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847440|NCT00042965|Antiviral Agents|antiviral agents|mesh-ancestor
25847441|NCT00042965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25847442|NCT00042965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847443|NCT00042965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25847444|NCT00042965|Immunologic Factors|immunologic factors|mesh-ancestor
25847445|NCT00042965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847446|NCT00042978|Carboplatin|carboplatin|mesh-list
25847447|NCT00042978|Etoposide|etoposide|mesh-list
25847448|NCT00042978|Etoposide phosphate|etoposide phosphate|mesh-list
25847449|NCT00042978|Oblimersen|oblimersen|mesh-list
25847450|NCT00042978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847451|NCT00042978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25847452|NCT00042978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25847453|NCT00042978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25847454|NCT00042978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847455|NCT00042978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847456|NCT00043004|Leucovorin|leucovorin|mesh-list
25847457|NCT00043004|Bevacizumab|bevacizumab|mesh-list
25847458|NCT00043004|Fluorouracil|fluorouracil|mesh-list
25847459|NCT00043004|Oxaliplatin|oxaliplatin|mesh-list
25847460|NCT00043004|Calcium|calcium|mesh-list
25847461|NCT00043004|Levoleucovorin|levoleucovorin|mesh-list
25847462|NCT00043004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25847463|NCT00043004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847464|NCT00043004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25847465|NCT00043004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25847466|NCT00043004|Growth Substances|growth substances|mesh-ancestor
25847467|NCT00043004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847468|NCT00043004|Growth Inhibitors|growth inhibitors|mesh-ancestor
25847469|NCT00043004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25847470|NCT00043004|Antimetabolites|antimetabolites|mesh-ancestor
25847471|NCT00043004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847472|NCT00043004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25847473|NCT00043004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25847474|NCT00043004|Immunologic Factors|immunologic factors|mesh-ancestor
25847475|NCT00043004|Antidotes|antidotes|mesh-ancestor
25847476|NCT00043004|Protective Agents|protective agents|mesh-ancestor
25847477|NCT00043004|Vitamin B Complex|vitamin b complex|mesh-ancestor
25847478|NCT00043004|Vitamins|vitamins|mesh-ancestor
25847479|NCT00043004|Micronutrients|micronutrients|mesh-ancestor
25847480|NCT00043043|Celecoxib|celecoxib|mesh-list
25847481|NCT00043043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25847482|NCT00043043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24649068|NCT01218568|Rifaximin|rifaximin|mesh-list
25847483|NCT00043043|Analgesics|analgesics|mesh-ancestor
25847484|NCT00043043|Sensory System Agents|sensory system agents|mesh-ancestor
25847485|NCT00043043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25847486|NCT00043043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847487|NCT00043043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25847488|NCT00043043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25847489|NCT00043043|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25847490|NCT00043043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25847491|NCT00043043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847492|NCT00043043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847493|NCT00043069|Cholecalciferol|cholecalciferol|mesh-list
25847494|NCT00043069|Risedronic Acid|risedronic acid|mesh-list
25847495|NCT00043069|Calcium Carbonate|calcium carbonate|mesh-list
25847496|NCT00043069|Estrogens|estrogens|mesh-list
25847497|NCT00043069|Estrogen Antagonists|estrogen antagonists|mesh-list
25847498|NCT00043069|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
25847499|NCT00043069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25419104|NCT02723994|Antiemetics|antiemetics|mesh-ancestor
25847500|NCT00043069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847501|NCT00043069|Vitamins|vitamins|mesh-ancestor
25847502|NCT00043069|Micronutrients|micronutrients|mesh-ancestor
25847503|NCT00043069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25847504|NCT00043069|Hormones|hormones|mesh-ancestor
25847505|NCT00043069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25847506|NCT00043069|Antacids|antacids|mesh-ancestor
25847507|NCT00043069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847508|NCT00043069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24548679|NCT00711308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847509|NCT00043069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25847510|NCT00043069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25847511|NCT00043069|Hormone Antagonists|hormone antagonists|mesh-ancestor
25230093|NCT02598466|Abatacept|abatacept|mesh-list
25230094|NCT02598466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25230095|NCT02598466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847512|NCT00043082|Carboplatin|carboplatin|mesh-list
25847513|NCT00043082|Doxorubicin|doxorubicin|mesh-list
25847514|NCT00043082|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25847515|NCT00043082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847516|NCT00043082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25847517|NCT00043082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25847518|NCT00043082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25847519|NCT00043082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847520|NCT00043082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847521|NCT00043095|Gemcitabine|gemcitabine|mesh-list
25847522|NCT00043095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25847523|NCT00043095|Antimetabolites|antimetabolites|mesh-ancestor
25847524|NCT00043095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847525|NCT00043095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847526|NCT00043095|Antiviral Agents|antiviral agents|mesh-ancestor
24459748|NCT00346294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24459749|NCT00346294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24459750|NCT00346294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25847527|NCT00043095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25847528|NCT00043095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847529|NCT00043095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25847530|NCT00043095|Immunologic Factors|immunologic factors|mesh-ancestor
25847531|NCT00043095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847532|NCT00043121|Leucovorin|leucovorin|mesh-list
25847533|NCT00043121|Fluorouracil|fluorouracil|mesh-list
25847534|NCT00043121|Capecitabine|capecitabine|mesh-list
25847535|NCT00043121|Oxaliplatin|oxaliplatin|mesh-list
25847536|NCT00043121|Calcium|calcium|mesh-list
25847537|NCT00043121|Levoleucovorin|levoleucovorin|mesh-list
24450955|NCT00321126|Micronutrients|micronutrients|mesh-ancestor
24450956|NCT00321126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450958|NCT00321165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24450959|NCT00321165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24450960|NCT00321165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847538|NCT00043121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25847539|NCT00043121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847540|NCT00043121|Antimetabolites|antimetabolites|mesh-ancestor
25847541|NCT00043121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847542|NCT00043121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25847543|NCT00043121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847544|NCT00043121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25847545|NCT00043121|Immunologic Factors|immunologic factors|mesh-ancestor
25847546|NCT00043121|Antidotes|antidotes|mesh-ancestor
25847547|NCT00043121|Protective Agents|protective agents|mesh-ancestor
25847548|NCT00043121|Vitamin B Complex|vitamin b complex|mesh-ancestor
25847549|NCT00043121|Vitamins|vitamins|mesh-ancestor
25847550|NCT00043121|Micronutrients|micronutrients|mesh-ancestor
25847551|NCT00043134|Decitabine|decitabine|mesh-list
25847552|NCT00043134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25847553|NCT00043134|Antimetabolites|antimetabolites|mesh-ancestor
25661593|NCT01635062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25661594|NCT01635062|Vitamins|vitamins|mesh-ancestor
25661595|NCT01635062|Micronutrients|micronutrients|mesh-ancestor
25661596|NCT01635062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25661597|NCT01635101|Acetaminophen|acetaminophen|mesh-list
25661598|NCT01635101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25661599|NCT01635101|Analgesics|analgesics|mesh-ancestor
25661600|NCT01635101|Sensory System Agents|sensory system agents|mesh-ancestor
25661601|NCT01635101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25661602|NCT01635101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847555|NCT00043134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847556|NCT00043134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847557|NCT00043147|Prednisone|prednisone|mesh-list
25847558|NCT00043147|Methylprednisolone|methylprednisolone|mesh-list
25847559|NCT00043147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25847560|NCT00043147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25847561|NCT00043147|Prednisolone|prednisolone|mesh-list
25847562|NCT00043147|Prednisolone acetate|prednisolone acetate|mesh-list
25847563|NCT00043147|Beclomethasone|beclomethasone|mesh-list
25847564|NCT00043147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25847565|NCT00043147|Prednisolone phosphate|prednisolone phosphate|mesh-list
25847566|NCT00043147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25847567|NCT00043147|Glucocorticoids|glucocorticoids|mesh-ancestor
25847568|NCT00043147|Hormones|hormones|mesh-ancestor
25847569|NCT00043147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25847570|NCT00043147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847571|NCT00043147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25847572|NCT00043147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450617|NCT00319865|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24450618|NCT00319865|Bortezomib|bortezomib|mesh-list
24450619|NCT00319865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25847573|NCT00043147|Antiemetics|antiemetics|mesh-ancestor
25847574|NCT00043147|Autonomic Agents|autonomic agents|mesh-ancestor
25847575|NCT00043147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125881|NCT03066154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25847576|NCT00043147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25847577|NCT00043147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25847578|NCT00043147|Protective Agents|protective agents|mesh-ancestor
25847579|NCT00043147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25847580|NCT00043147|Respiratory System Agents|respiratory system agents|mesh-ancestor
25847581|NCT00043199|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
25847582|NCT00043199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847583|NCT00043264|Azithromycin|azithromycin|mesh-list
25847584|NCT00043264|Rifampin|rifampin|mesh-list
25847585|NCT00043264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25847586|NCT00043264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25847587|NCT00043264|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25847588|NCT00043264|Antitubercular Agents|antitubercular agents|mesh-ancestor
24649700|NCT01221558|Lycopene|lycopene|mesh-list
25847589|NCT00043264|Leprostatic Agents|leprostatic agents|mesh-ancestor
25847590|NCT00043264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25847591|NCT00043264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847592|NCT00043264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847593|NCT00043264|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25847594|NCT00043264|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25847595|NCT00043264|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25847596|NCT00043264|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25847597|NCT00043264|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25847598|NCT00043264|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25847599|NCT00043277|Bivalirudin|bivalirudin|mesh-list
25847600|NCT00043277|Antithrombins|antithrombins|mesh-ancestor
25847601|NCT00043277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25847602|NCT00043277|Protease Inhibitors|protease inhibitors|mesh-ancestor
25847603|NCT00043277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847604|NCT00043277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847605|NCT00043277|Anticoagulants|anticoagulants|mesh-ancestor
25847606|NCT00043303|Interferons|interferons|mesh-list
25847607|NCT00043303|Interferon-gamma|interferon-gamma|mesh-list
24649742|NCT01221792|Antioxidants|antioxidants|mesh-ancestor
25847608|NCT00043303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847609|NCT00043303|Antiviral Agents|antiviral agents|mesh-ancestor
25847610|NCT00043303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25847611|NCT00043316|Interferons|interferons|mesh-list
25847612|NCT00043316|Interferon-gamma|interferon-gamma|mesh-list
25847613|NCT00043316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847614|NCT00043316|Antiviral Agents|antiviral agents|mesh-ancestor
25847615|NCT00043316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24820227|NCT02099240|Cefepime|cefepime|mesh-list
25847616|NCT00043329|Interferon-gamma|interferon-gamma|mesh-list
25847617|NCT00043329|Antiviral Agents|antiviral agents|mesh-ancestor
25847618|NCT00043329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24723230|NCT01586143|Antipyretics|antipyretics|mesh-ancestor
25847619|NCT00043342|Interferons|interferons|mesh-list
25847620|NCT00043342|Interferon-gamma|interferon-gamma|mesh-list
25847621|NCT00043342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847622|NCT00043342|Antiviral Agents|antiviral agents|mesh-ancestor
25847623|NCT00043342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25847624|NCT00043355|Interferons|interferons|mesh-list
25847625|NCT00043355|Interferon-gamma|interferon-gamma|mesh-list
25847626|NCT00043355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847627|NCT00043355|Antiviral Agents|antiviral agents|mesh-ancestor
25847628|NCT00043355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25847629|NCT00043381|Decitabine|decitabine|mesh-list
25847630|NCT00043381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25847631|NCT00043381|Antimetabolites|antimetabolites|mesh-ancestor
25847632|NCT00043381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847633|NCT00043381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847634|NCT00043381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847635|NCT00043394|Trastuzumab|trastuzumab|mesh-list
25847636|NCT00043394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25847637|NCT00043394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847638|NCT00043537|Fluoxetine|fluoxetine|mesh-list
25847639|NCT00043537|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25847640|NCT00043537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24459751|NCT00346294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24459752|NCT00346294|Immunologic Factors|immunologic factors|mesh-ancestor
25847641|NCT00043537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25847642|NCT00043537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847643|NCT00043537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25847644|NCT00043537|Serotonin Agents|serotonin agents|mesh-ancestor
25847645|NCT00043537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847646|NCT00043537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25847647|NCT00043537|Antidepressive Agents|antidepressive agents|mesh-ancestor
25847648|NCT00043537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25847649|NCT00043537|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25847650|NCT00043537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25847651|NCT00043537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847652|NCT00043576|Calcitriol|calcitriol|mesh-list
25847653|NCT00043576|Docetaxel|docetaxel|mesh-list
25847654|NCT00043576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847655|NCT00043576|Tubulin Modulators|tubulin modulators|mesh-ancestor
25847656|NCT00043576|Antimitotic Agents|antimitotic agents|mesh-ancestor
25847657|NCT00043576|Mitosis Modulators|mitosis modulators|mesh-ancestor
25847658|NCT00043576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847659|NCT00043576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25847660|NCT00043576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847661|NCT00043576|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25847662|NCT00043576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25847663|NCT00043576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25847664|NCT00043576|Vitamins|vitamins|mesh-ancestor
25847665|NCT00043576|Micronutrients|micronutrients|mesh-ancestor
25847666|NCT00043576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25847667|NCT00043589|Donepezil|donepezil|mesh-list
25847668|NCT00043589|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25847669|NCT00043589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847670|NCT00043589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847671|NCT00043589|Cholinergic Agents|cholinergic agents|mesh-ancestor
25847672|NCT00043589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25847673|NCT00043589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847674|NCT00043589|Nootropic Agents|nootropic agents|mesh-ancestor
25847675|NCT00043654|Mifepristone|mifepristone|mesh-list
25847676|NCT00043654|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25847677|NCT00043654|Abortifacient Agents|abortifacient agents|mesh-ancestor
25847678|NCT00043654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25847679|NCT00043654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847680|NCT00043654|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25847681|NCT00043654|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25847682|NCT00043654|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25847683|NCT00043654|Contraceptive Agents|contraceptive agents|mesh-ancestor
25847684|NCT00043654|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25847685|NCT00043654|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25847686|NCT00043654|Hormone Antagonists|hormone antagonists|mesh-ancestor
25847687|NCT00043654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25661603|NCT01635101|Antipyretics|antipyretics|mesh-ancestor
25661604|NCT01635153|Micronutrients|micronutrients|mesh-list
25661605|NCT01635153|Trace Elements|trace elements|mesh-list
25661606|NCT01635153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661607|NCT01635218|Fluoxetine|fluoxetine|mesh-list
25847688|NCT00043654|Luteolytic Agents|luteolytic agents|mesh-ancestor
25847689|NCT00043654|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25847690|NCT00043654|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25847691|NCT00043667|Daclizumab|daclizumab|mesh-list
25847692|NCT00043667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25847693|NCT00043667|Immunologic Factors|immunologic factors|mesh-ancestor
25847694|NCT00043667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847695|NCT00043680|Celecoxib|celecoxib|mesh-list
24650223|NCT01224652|Paclitaxel|paclitaxel|mesh-list
25847696|NCT00043680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25847697|NCT00043680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25847698|NCT00043680|Analgesics|analgesics|mesh-ancestor
25847699|NCT00043680|Sensory System Agents|sensory system agents|mesh-ancestor
25847700|NCT00043680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25847701|NCT00043680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847702|NCT00043680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25847703|NCT00043680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25847704|NCT00043680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25847705|NCT00043680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25847706|NCT00043680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847707|NCT00043680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847708|NCT00043706|Antibodies|antibodies|mesh-list
25847709|NCT00043706|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25847710|NCT00043706|Mitogens|mitogens|mesh-list
25847711|NCT00043706|Immunologic Factors|immunologic factors|mesh-ancestor
25847712|NCT00043706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847713|NCT00043706|Mitosis Modulators|mitosis modulators|mesh-ancestor
25847714|NCT00043706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847715|NCT00043719|Vitamin D|vitamin d|mesh-list
25847716|NCT00043719|Nitroglycerin|nitroglycerin|mesh-list
25847717|NCT00043719|Calcium|calcium|mesh-list
25847718|NCT00043719|Vitamins|vitamins|mesh-ancestor
25847719|NCT00043719|Micronutrients|micronutrients|mesh-ancestor
25847720|NCT00043719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847721|NCT00043719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25847722|NCT00043719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25847723|NCT00043719|Vasodilator Agents|vasodilator agents|mesh-ancestor
25847724|NCT00043758|Tolvaptan|tolvaptan|mesh-list
25847725|NCT00043758|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25847726|NCT00043758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847727|NCT00043758|Natriuretic Agents|natriuretic agents|mesh-ancestor
25847728|NCT00043758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847729|NCT00043771|Tolvaptan|tolvaptan|mesh-list
25847730|NCT00043771|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25847731|NCT00043771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847732|NCT00043771|Natriuretic Agents|natriuretic agents|mesh-ancestor
25847733|NCT00043771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847734|NCT00043784|Enoxaparin|enoxaparin|mesh-list
25847735|NCT00043784|Anticoagulants|anticoagulants|mesh-ancestor
25847736|NCT00043784|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24650313|NCT01225094|Analgesics|analgesics|mesh-ancestor
25847737|NCT00043784|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25847738|NCT00043784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876021|NCT03914625|Dexamethasone|dexamethasone|mesh-list
25876022|NCT03914625|Dexamethasone acetate|dexamethasone acetate|mesh-list
25876023|NCT03914625|Prednisone|prednisone|mesh-list
25876024|NCT03914625|Prednisolone|prednisolone|mesh-list
25876025|NCT03914625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25876026|NCT03914625|Methylprednisolone|methylprednisolone|mesh-list
25876027|NCT03914625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25876028|NCT03914625|Prednisolone acetate|prednisolone acetate|mesh-list
25876029|NCT03914625|Hydrocortisone|hydrocortisone|mesh-list
25876030|NCT03914625|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25876031|NCT03914625|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25876032|NCT03914625|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25876033|NCT03914625|Cortisone|cortisone|mesh-list
25876034|NCT03914625|Cyclophosphamide|cyclophosphamide|mesh-list
24650578|NCT01226667|Anticonvulsants|anticonvulsants|mesh-ancestor
25876035|NCT03914625|Doxorubicin|doxorubicin|mesh-list
25876036|NCT03914625|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25876037|NCT03914625|Methotrexate|methotrexate|mesh-list
25876038|NCT03914625|Vincristine|vincristine|mesh-list
25876039|NCT03914625|Asparaginase|asparaginase|mesh-list
25876040|NCT03914625|Mercaptopurine|mercaptopurine|mesh-list
25876041|NCT03914625|Pegaspargase|pegaspargase|mesh-list
25876042|NCT03914625|Thioguanine|thioguanine|mesh-list
25876043|NCT03914625|Blinatumomab|blinatumomab|mesh-list
25876044|NCT03914625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25847740|NCT00043810|Fludarabine|fludarabine|mesh-list
25847741|NCT00043810|Fludarabine phosphate|fludarabine phosphate|mesh-list
25847742|NCT00043810|Busulfan|busulfan|mesh-list
25847743|NCT00043810|GEL protein, Gelonium multiflorum|gel protein, gelonium multiflorum|mesh-list
24417941|NCT00208195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25847744|NCT00043810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847745|NCT00043810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25847746|NCT00043810|Antimetabolites|antimetabolites|mesh-ancestor
25847747|NCT00043810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847748|NCT00043810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25847749|NCT00043810|Immunologic Factors|immunologic factors|mesh-ancestor
25847750|NCT00043810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847751|NCT00043810|Antiviral Agents|antiviral agents|mesh-ancestor
25847752|NCT00043810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25847753|NCT00043810|Alkylating Agents|alkylating agents|mesh-ancestor
25847754|NCT00043810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25847755|NCT00043810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25847756|NCT00043810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24450777|NCT00320567|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24450778|NCT00320567|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24450779|NCT00320567|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24450780|NCT00320580|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25847757|NCT00043810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25847758|NCT00043810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847759|NCT00043823|Bevacizumab|bevacizumab|mesh-list
24650899|NCT01228357|Histamine Agents|histamine agents|mesh-ancestor
25847760|NCT00043823|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25847761|NCT00043823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25847762|NCT00043823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847763|NCT00043823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25847764|NCT00043823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25847765|NCT00043823|Growth Substances|growth substances|mesh-ancestor
25847766|NCT00043823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847767|NCT00043823|Growth Inhibitors|growth inhibitors|mesh-ancestor
25847768|NCT00043823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25847769|NCT00043823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847770|NCT00043823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847771|NCT00043849|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25847772|NCT00043849|Antidepressive Agents|antidepressive agents|mesh-ancestor
25847773|NCT00043849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25847774|NCT00043849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25847775|NCT00043849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25847776|NCT00043849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25847777|NCT00043849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847778|NCT00043862|Topotecan|topotecan|mesh-list
25847779|NCT00043862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25847780|NCT00043862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24650990|NCT01228630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24859110|NCT02301780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24859111|NCT02301780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24859112|NCT02301780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859114|NCT02301806|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24859115|NCT02301806|Glimepiride|glimepiride|mesh-list
24859116|NCT02301806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24859117|NCT02301806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859118|NCT02301806|Incretins|incretins|mesh-ancestor
24859120|NCT02301806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25847781|NCT00043862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847782|NCT00043862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847783|NCT00043862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847784|NCT00043875|Lamotrigine|lamotrigine|mesh-list
25847785|NCT00043875|Anticonvulsants|anticonvulsants|mesh-ancestor
25847786|NCT00043875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25847787|NCT00043875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25847788|NCT00043875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847789|NCT00043875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25847790|NCT00043875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847791|NCT00043875|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25847792|NCT00043875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25847793|NCT00043875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25847794|NCT00043875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25419105|NCT02723994|Autonomic Agents|autonomic agents|mesh-ancestor
25847795|NCT00043875|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25847796|NCT00043888|Ritonavir|ritonavir|mesh-list
25847797|NCT00043888|Fosamprenavir|fosamprenavir|mesh-list
25847798|NCT00043888|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25847799|NCT00043888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25847800|NCT00043888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25847801|NCT00043888|Protease Inhibitors|protease inhibitors|mesh-ancestor
25847802|NCT00043888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847803|NCT00043888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847804|NCT00043888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25847805|NCT00043888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25847806|NCT00043888|Antiviral Agents|antiviral agents|mesh-ancestor
25847807|NCT00043888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25847808|NCT00043888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25847809|NCT00043888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25847810|NCT00043888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25847811|NCT00043888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25847812|NCT00043901|Lamotrigine|lamotrigine|mesh-list
25847813|NCT00043901|Anticonvulsants|anticonvulsants|mesh-ancestor
25847814|NCT00043901|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25847815|NCT00043901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25847816|NCT00043901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651319|NCT01230996|Cisplatin|cisplatin|mesh-list
24651366|NCT01231165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651368|NCT01231165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24651369|NCT01231165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651386|NCT01231165|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24651387|NCT01231191|Acetaminophen|acetaminophen|mesh-list
24651388|NCT01231191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24651389|NCT01231191|Analgesics|analgesics|mesh-ancestor
24651390|NCT01231191|Sensory System Agents|sensory system agents|mesh-ancestor
24651391|NCT01231191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24651392|NCT01231191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651393|NCT01231191|Antipyretics|antipyretics|mesh-ancestor
24859246|NCT02302547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859247|NCT02302547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859249|NCT02302547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24859250|NCT02302547|Antiviral Agents|antiviral agents|mesh-ancestor
24859251|NCT02302547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24859252|NCT02302547|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24859253|NCT02302547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24859254|NCT02302547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24859255|NCT02302547|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24859285|NCT02302950|Raltegravir Potassium|raltegravir potassium|mesh-list
24859286|NCT02302950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24859287|NCT02302950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24859288|NCT02302950|Antiviral Agents|antiviral agents|mesh-ancestor
24859289|NCT02302950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24859290|NCT02302950|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24859291|NCT02302950|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24859292|NCT02302950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859307|NCT02302976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24859308|NCT02302976|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24859309|NCT02302976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24859310|NCT02302976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24859311|NCT02302976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859312|NCT02302976|Dopamine Agents|dopamine agents|mesh-ancestor
24859313|NCT02302976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24859314|NCT02302989|Ranibizumab|ranibizumab|mesh-list
24859315|NCT02302989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24859316|NCT02302989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24859317|NCT02302989|Growth Substances|growth substances|mesh-ancestor
24859318|NCT02302989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859319|NCT02302989|Growth Inhibitors|growth inhibitors|mesh-ancestor
24859320|NCT02302989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859321|NCT02303002|Botulinum Toxins|botulinum toxins|mesh-list
24859322|NCT02303002|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24859323|NCT02303002|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24859324|NCT02303002|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24859325|NCT02303002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24859326|NCT02303002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813211|NCT02056899|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25876045|NCT03914625|Muromonab-CD3|muromonab-cd3|mesh-list
25847817|NCT00043901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25847818|NCT00043901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813212|NCT02056899|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24813213|NCT02056899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24813214|NCT02056899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813215|NCT02056899|Antimanic Agents|antimanic agents|mesh-ancestor
24813216|NCT02056938|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24813217|NCT02056938|Basiliximab|basiliximab|mesh-list
24813218|NCT02056938|Immunologic Factors|immunologic factors|mesh-ancestor
24813219|NCT02056938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813220|NCT02056938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24813221|NCT02057003|Sofosbuvir|sofosbuvir|mesh-list
24813222|NCT02057003|Grazoprevir|grazoprevir|mesh-list
24813223|NCT02057003|Ledipasvir|ledipasvir|mesh-list
24813224|NCT02057003|Velpatasvir|velpatasvir|mesh-list
24813225|NCT02057003|Simeprevir|simeprevir|mesh-list
24813226|NCT02057003|Antiviral Agents|antiviral agents|mesh-ancestor
24813227|NCT02057003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24813228|NCT02057003|Protease Inhibitors|protease inhibitors|mesh-ancestor
24813229|NCT02057003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847819|NCT00043901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25847820|NCT00043901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25847821|NCT00043901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25847822|NCT00043901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25847823|NCT00043901|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25847824|NCT00043914|Lamotrigine|lamotrigine|mesh-list
25847825|NCT00043914|Anticonvulsants|anticonvulsants|mesh-ancestor
25847826|NCT00043914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24539796|NCT00665678|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24539798|NCT00665678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539800|NCT00665678|Serotonin Agents|serotonin agents|mesh-ancestor
24859359|NCT02303223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859360|NCT02303223|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24859361|NCT02303223|Anesthetics, General|anesthetics, general|mesh-ancestor
24859362|NCT02303223|Anesthetics|anesthetics|mesh-ancestor
24859363|NCT02303327|Androgens|androgens|mesh-list
24859364|NCT02303327|Hormones|hormones|mesh-ancestor
24859365|NCT02303327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24859366|NCT02303327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859367|NCT02303366|Pembrolizumab|pembrolizumab|mesh-list
24859368|NCT02303366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24859369|NCT02303366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859370|NCT02303405|Pioglitazone|pioglitazone|mesh-list
24859371|NCT02303405|Hydroxychloroquine|hydroxychloroquine|mesh-list
24859372|NCT02303405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24859373|NCT02303405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859374|NCT02303405|Antimalarials|antimalarials|mesh-ancestor
24859375|NCT02303405|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24859376|NCT02303405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24859377|NCT02303405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24859378|NCT02303405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859379|NCT02303405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859380|NCT02303405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24859381|NCT02303418|Oxytocin|oxytocin|mesh-list
24859382|NCT02303418|Carbetocin|carbetocin|mesh-list
24859383|NCT02303418|Oxytocics|oxytocics|mesh-ancestor
24859384|NCT02303418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24859386|NCT02303444|Sorafenib|sorafenib|mesh-list
24859400|NCT02303483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651600|NCT01232270|Anesthetics|anesthetics|mesh-ancestor
24859427|NCT02303600|Hormone Antagonists|hormone antagonists|mesh-ancestor
24859428|NCT02303600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24859429|NCT02303600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859430|NCT02303600|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24859431|NCT02303600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24450807|NCT00320632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25847827|NCT00043914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25847828|NCT00043914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859432|NCT02303600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859434|NCT02303639|Sotalol|sotalol|mesh-list
24859435|NCT02303639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
24859436|NCT02303639|Vasodilator Agents|vasodilator agents|mesh-ancestor
24859437|NCT02303639|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24859438|NCT02303639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25409035|NCT03404180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24859439|NCT02303639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859441|NCT02303639|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24859470|NCT02303769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859472|NCT02303782|Azacitidine|azacitidine|mesh-list
24859473|NCT02303782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24859474|NCT02303782|Antimetabolites|antimetabolites|mesh-ancestor
24859496|NCT02303886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859541|NCT02304094|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24859542|NCT02304094|Prednisolone|prednisolone|mesh-list
24859543|NCT02304094|Prednisolone acetate|prednisolone acetate|mesh-list
24859544|NCT02304094|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24859545|NCT02304094|Prednisolone phosphate|prednisolone phosphate|mesh-list
24859546|NCT02304094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24859547|NCT02304094|Antiemetics|antiemetics|mesh-ancestor
24859548|NCT02304094|Autonomic Agents|autonomic agents|mesh-ancestor
24859549|NCT02304094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24859550|NCT02304094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859576|NCT02304211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847829|NCT00043914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24859577|NCT02304237|Progesterone|progesterone|mesh-list
24859578|NCT02304237|Progestins|progestins|mesh-ancestor
24859579|NCT02304237|Hormones|hormones|mesh-ancestor
24813239|NCT02057107|Antimitotic Agents|antimitotic agents|mesh-ancestor
24813240|NCT02057107|Mitosis Modulators|mitosis modulators|mesh-ancestor
24813241|NCT02057107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813242|NCT02057107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24813243|NCT02057263|Alendronate|alendronate|mesh-list
24813244|NCT02057263|Diphosphonates|diphosphonates|mesh-list
24813245|NCT02057263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24813246|NCT02057263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813247|NCT02057289|Micafungin|micafungin|mesh-list
24813248|NCT02057289|Antifungal Agents|antifungal agents|mesh-ancestor
24813249|NCT02057289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24813251|NCT02057328|Nebivolol|nebivolol|mesh-list
24813252|NCT02057328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24813253|NCT02057328|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24540007|NCT00666302|Pimecrolimus|pimecrolimus|mesh-list
25847830|NCT00043914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847831|NCT00043914|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25847832|NCT00043914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25847833|NCT00043914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25847834|NCT00043914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25847835|NCT00043914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25847836|NCT00043927|Cisplatin|cisplatin|mesh-list
25847837|NCT00043927|Etoposide|etoposide|mesh-list
25847838|NCT00043927|Topotecan|topotecan|mesh-list
25847839|NCT00043927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813258|NCT02057328|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24813259|NCT02057328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24813260|NCT02057328|Adrenergic Agents|adrenergic agents|mesh-ancestor
24813261|NCT02057328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24813262|NCT02057328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813264|NCT02057367|Anesthetics, Local|anesthetics, local|mesh-ancestor
24813266|NCT02057367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24813267|NCT02057367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813268|NCT02057367|Sensory System Agents|sensory system agents|mesh-ancestor
24813269|NCT02057367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24813271|NCT02057484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24813272|NCT02057484|Immunologic Factors|immunologic factors|mesh-ancestor
24651866|NCT01234285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25847840|NCT00043927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25847841|NCT00043927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25847842|NCT00043927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25847843|NCT00043927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847844|NCT00043927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813287|NCT02057770|Cyclophosphamide|cyclophosphamide|mesh-list
24813288|NCT02057770|Busulfan|busulfan|mesh-list
24813289|NCT02057770|Fludarabine|fludarabine|mesh-list
24813290|NCT02057770|Fludarabine phosphate|fludarabine phosphate|mesh-list
24813291|NCT02057770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24813292|NCT02057770|Immunologic Factors|immunologic factors|mesh-ancestor
24813293|NCT02057770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813294|NCT02057770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24813295|NCT02057770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24846081|NCT02241096|Anesthetics|anesthetics|mesh-ancestor
24846082|NCT02241096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24846083|NCT02241096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846084|NCT02241096|Sensory System Agents|sensory system agents|mesh-ancestor
24846085|NCT02241096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24846086|NCT02241096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24622311|NCT01066598|Rituximab|rituximab|mesh-list
24813296|NCT02057770|Alkylating Agents|alkylating agents|mesh-ancestor
24813297|NCT02057770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813298|NCT02057770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859580|NCT02304237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24859581|NCT02304237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859582|NCT02304250|Dexamethasone|dexamethasone|mesh-list
24859583|NCT02304250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24859584|NCT02304250|Antiemetics|antiemetics|mesh-ancestor
24859585|NCT02304250|Autonomic Agents|autonomic agents|mesh-ancestor
24859586|NCT02304250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24859587|NCT02304250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859588|NCT02304250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24859589|NCT02304250|Glucocorticoids|glucocorticoids|mesh-ancestor
24859591|NCT02304250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24859592|NCT02304250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24859593|NCT02304250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859594|NCT02304276|Calcium|calcium|mesh-list
24859595|NCT02304276|Fluorides|fluorides|mesh-list
24859596|NCT02304276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24859597|NCT02304276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859598|NCT02304276|Cariostatic Agents|cariostatic agents|mesh-ancestor
24859599|NCT02304276|Protective Agents|protective agents|mesh-ancestor
24859600|NCT02304289|Artesunate|artesunate|mesh-list
24859601|NCT02304289|Antimalarials|antimalarials|mesh-ancestor
24540083|NCT00666575|Analgesics|analgesics|mesh-ancestor
24540084|NCT00666575|Sensory System Agents|sensory system agents|mesh-ancestor
24859609|NCT02304289|Anthelmintics|anthelmintics|mesh-ancestor
24859646|NCT02304822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24859648|NCT02304822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859649|NCT02304822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859650|NCT02304822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859651|NCT02304822|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24859652|NCT02304822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24859654|NCT02304887|Teriparatide|teriparatide|mesh-list
24859655|NCT02304887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25847845|NCT00043927|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24859660|NCT02305030|Anticoagulants|anticoagulants|mesh-ancestor
24651995|NCT01234974|Everolimus|everolimus|mesh-list
24859687|NCT02305173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25126553|NCT03061253|Nicotine|nicotine|mesh-list
24859689|NCT02305186|Pembrolizumab|pembrolizumab|mesh-list
24859690|NCT02305186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24859691|NCT02305186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859692|NCT02305199|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24859696|NCT02305355|Atorvastatin|atorvastatin|mesh-list
24859697|NCT02305355|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24859698|NCT02305355|Simvastatin|simvastatin|mesh-list
24540173|NCT00666796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24859725|NCT02305485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24859726|NCT02305485|Immunologic Factors|immunologic factors|mesh-ancestor
24859727|NCT02305485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859728|NCT02305550|Nitric Oxide|nitric oxide|mesh-list
24859729|NCT02305550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24859730|NCT02305550|Autonomic Agents|autonomic agents|mesh-ancestor
24859731|NCT02305550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24859732|NCT02305550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859733|NCT02305550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24859734|NCT02305550|Respiratory System Agents|respiratory system agents|mesh-ancestor
24859735|NCT02305550|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24859736|NCT02305550|Antioxidants|antioxidants|mesh-ancestor
25847846|NCT00043940|Bivalirudin|bivalirudin|mesh-list
25661608|NCT01635218|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25661609|NCT01635218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25661610|NCT01635218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25661611|NCT01635218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661612|NCT01635218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25661613|NCT01635218|Serotonin Agents|serotonin agents|mesh-ancestor
25847847|NCT00043940|Antithrombins|antithrombins|mesh-ancestor
25847848|NCT00043940|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25847849|NCT00043940|Protease Inhibitors|protease inhibitors|mesh-ancestor
25847850|NCT00043940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847851|NCT00043940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847852|NCT00043940|Anticoagulants|anticoagulants|mesh-ancestor
25847853|NCT00043953|Ritonavir|ritonavir|mesh-list
25847854|NCT00043953|Lopinavir|lopinavir|mesh-list
25847855|NCT00043953|Saquinavir|saquinavir|mesh-list
25847856|NCT00043953|Lamivudine|lamivudine|mesh-list
25847857|NCT00043953|Zidovudine|zidovudine|mesh-list
25847858|NCT00043953|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25847859|NCT00043953|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25847860|NCT00043953|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25847861|NCT00043953|Protease Inhibitors|protease inhibitors|mesh-ancestor
25847862|NCT00043953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847863|NCT00043953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847864|NCT00043953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25847865|NCT00043953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25847866|NCT00043953|Antiviral Agents|antiviral agents|mesh-ancestor
25847867|NCT00043953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24859791|NCT02305823|Serotonin Agents|serotonin agents|mesh-ancestor
24859792|NCT02305823|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24859793|NCT02305823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24859794|NCT02305823|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24859795|NCT02305823|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24859797|NCT02305836|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24859798|NCT02305836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859799|NCT02305836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859800|NCT02305836|Cholinergic Agents|cholinergic agents|mesh-ancestor
25847868|NCT00043953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25847869|NCT00043953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25847870|NCT00043953|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24540262|NCT00667108|Sensory System Agents|sensory system agents|mesh-ancestor
24859817|NCT02305901|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24652245|NCT01237262|Adalimumab|adalimumab|mesh-list
25847871|NCT00043953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25847872|NCT00043953|Antimetabolites|antimetabolites|mesh-ancestor
25847873|NCT00043966|Ritonavir|ritonavir|mesh-list
25847874|NCT00043966|Lopinavir|lopinavir|mesh-list
25847875|NCT00043966|Tenofovir|tenofovir|mesh-list
25847876|NCT00043966|Emtricitabine|emtricitabine|mesh-list
25847877|NCT00043966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25847878|NCT00043966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25847879|NCT00043966|Protease Inhibitors|protease inhibitors|mesh-ancestor
25847880|NCT00043966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847881|NCT00043966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847882|NCT00043966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25847883|NCT00043966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25847884|NCT00043966|Antiviral Agents|antiviral agents|mesh-ancestor
25847885|NCT00043966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25847886|NCT00043966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25847887|NCT00043966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25847888|NCT00043966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25847889|NCT00043966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24652275|NCT01237275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847890|NCT00044057|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24859830|NCT02305927|Vitamins|vitamins|mesh-ancestor
24859831|NCT02305927|Micronutrients|micronutrients|mesh-ancestor
24859832|NCT02305927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859833|NCT02305927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24859834|NCT02305927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24859835|NCT02305940|Doxycycline|doxycycline|mesh-list
24859836|NCT02305940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24859837|NCT02305940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24859838|NCT02305940|Antimalarials|antimalarials|mesh-ancestor
24859839|NCT02305940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25847891|NCT00044057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25847892|NCT00044057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25847893|NCT00044057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847894|NCT00044135|Clevudine|clevudine|mesh-list
25847895|NCT00044135|Antiviral Agents|antiviral agents|mesh-ancestor
25847896|NCT00044135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25847897|NCT00044148|Ruboxistaurin|ruboxistaurin|mesh-list
25847898|NCT00044148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847899|NCT00044148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847901|NCT00044187|Antidepressive Agents|antidepressive agents|mesh-ancestor
25847902|NCT00044187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25847903|NCT00044187|Appetite Depressants|appetite depressants|mesh-ancestor
25847904|NCT00044187|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25847905|NCT00044265|Ramipril|ramipril|mesh-list
25847906|NCT00044265|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25847907|NCT00044265|Protease Inhibitors|protease inhibitors|mesh-ancestor
25847908|NCT00044265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847909|NCT00044265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847910|NCT00044265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25847911|NCT00044278|Lamotrigine|lamotrigine|mesh-list
24859847|NCT02305979|Histamine Antagonists|histamine antagonists|mesh-ancestor
24859848|NCT02305979|Histamine Agents|histamine agents|mesh-ancestor
24859849|NCT02305979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24859850|NCT02305979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859852|NCT02305992|Bupivacaine|bupivacaine|mesh-list
24859853|NCT02305992|Anesthetics, Local|anesthetics, local|mesh-list
25847912|NCT00044278|Anticonvulsants|anticonvulsants|mesh-ancestor
25847913|NCT00044278|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25847914|NCT00044278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25847915|NCT00044278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847916|NCT00044278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25847917|NCT00044278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847918|NCT00044278|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25847919|NCT00044278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25847920|NCT00044278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25847921|NCT00044278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25847922|NCT00044278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25847923|NCT00044291|Toremifene|toremifene|mesh-list
25847924|NCT00044291|Letrozole|letrozole|mesh-list
25847925|NCT00044291|Hormones|hormones|mesh-list
25847926|NCT00044291|Atamestane|atamestane|mesh-list
25847927|NCT00044291|Estrogen Antagonists|estrogen antagonists|mesh-list
25847928|NCT00044291|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
24859859|NCT02306031|Diclofenac|diclofenac|mesh-list
24859860|NCT02306031|Lubricant Eye Drops|lubricant eye drops|mesh-list
25847929|NCT00044291|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
25847930|NCT00044291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25847931|NCT00044291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847932|NCT00044291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847933|NCT00044291|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25847934|NCT00044291|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25847935|NCT00044291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847936|NCT00044291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847937|NCT00044291|Hormone Antagonists|hormone antagonists|mesh-ancestor
25847938|NCT00044291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25847939|NCT00044291|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25847940|NCT00044291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25847941|NCT00044343|Lapatinib|lapatinib|mesh-list
24652474|NCT01238627|Nicotine|nicotine|mesh-list
25847942|NCT00044343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847943|NCT00044343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25847944|NCT00044343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876046|NCT03914625|Antibodies|antibodies|mesh-list
24652541|NCT01238926|Folic Acid|folic acid|mesh-list
24652588|NCT01239017|Fasinumab|fasinumab|mesh-list
24859896|NCT02306278|Sensory System Agents|sensory system agents|mesh-ancestor
24859897|NCT02306278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24859898|NCT02306278|Anticonvulsants|anticonvulsants|mesh-ancestor
24859899|NCT02306278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24859900|NCT02306278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24859901|NCT02306278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24859902|NCT02306278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24859903|NCT02306278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24859904|NCT02306278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24859905|NCT02306278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24859906|NCT02306278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859907|NCT02306278|Antimanic Agents|antimanic agents|mesh-ancestor
24859909|NCT02306473|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24859910|NCT02306473|Diuretics|diuretics|mesh-ancestor
24859911|NCT02306473|Natriuretic Agents|natriuretic agents|mesh-ancestor
24859912|NCT02306473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859913|NCT02306564|Cabergoline|cabergoline|mesh-list
24859914|NCT02306564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24540363|NCT00667498|Metformin|metformin|mesh-list
24540368|NCT00667641|Paclitaxel|paclitaxel|mesh-list
25847945|NCT00044343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847946|NCT00044382|Lenalidomide|lenalidomide|mesh-list
25847947|NCT00044382|Immunologic Factors|immunologic factors|mesh-ancestor
25847948|NCT00044382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847949|NCT00044382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25847950|NCT00044382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25847951|NCT00044382|Growth Substances|growth substances|mesh-ancestor
25847952|NCT00044382|Growth Inhibitors|growth inhibitors|mesh-ancestor
25847953|NCT00044382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847954|NCT00044395|Ruboxistaurin|ruboxistaurin|mesh-list
24859992|NCT02307045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859994|NCT02307149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24859995|NCT02307149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859996|NCT02307149|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24652841|NCT01240538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25847955|NCT00044395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847956|NCT00044395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847957|NCT00044408|Ruboxistaurin|ruboxistaurin|mesh-list
25847958|NCT00044408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847959|NCT00044408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847960|NCT00044421|Ruboxistaurin|ruboxistaurin|mesh-list
25847961|NCT00044421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847962|NCT00044421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847963|NCT00044434|Bupropion|bupropion|mesh-list
25847964|NCT00044434|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25847965|NCT00044434|Antidepressive Agents|antidepressive agents|mesh-ancestor
25847966|NCT00044434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25847967|NCT00044434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25847968|NCT00044434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25847969|NCT00044434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25847970|NCT00044434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860003|NCT02307201|Anesthetics|anesthetics|mesh-ancestor
24860004|NCT02307201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24860005|NCT02307201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24860006|NCT02307201|Anticonvulsants|anticonvulsants|mesh-ancestor
24860007|NCT02307201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24860008|NCT02307201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24860009|NCT02307201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860010|NCT02307201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24860011|NCT02307201|Tocolytic Agents|tocolytic agents|mesh-ancestor
24860012|NCT02307201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24860013|NCT02307227|Paclitaxel|paclitaxel|mesh-list
24860014|NCT02307227|Docetaxel|docetaxel|mesh-list
24860015|NCT02307227|Trastuzumab|trastuzumab|mesh-list
24860016|NCT02307227|Epirubicin|epirubicin|mesh-list
24860017|NCT02307227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24860018|NCT02307227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24860019|NCT02307227|Tubulin Modulators|tubulin modulators|mesh-ancestor
24860020|NCT02307227|Antimitotic Agents|antimitotic agents|mesh-ancestor
24860021|NCT02307227|Mitosis Modulators|mitosis modulators|mesh-ancestor
24860081|NCT02307396|Thioridazine|thioridazine|mesh-list
24860082|NCT02307396|Clopenthixol|clopenthixol|mesh-list
25847971|NCT00044434|Dopamine Agents|dopamine agents|mesh-ancestor
25847972|NCT00044434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25847973|NCT00044434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847974|NCT00044434|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25847975|NCT00044434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25847976|NCT00044434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652995|NCT01241175|Anesthetics|anesthetics|mesh-ancestor
24540514|NCT00668239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24540516|NCT00668304|Moxifloxacin|moxifloxacin|mesh-list
25847977|NCT00044447|Glimepiride|glimepiride|mesh-list
25847978|NCT00044447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25847979|NCT00044447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25847980|NCT00044447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847981|NCT00044447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25847982|NCT00044447|Immunologic Factors|immunologic factors|mesh-ancestor
25847983|NCT00044460|Rosiglitazone|rosiglitazone|mesh-list
25661614|NCT01635218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653036|NCT01241500|ON 01910|on 01910|mesh-list
25847984|NCT00044460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25847985|NCT00044460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25847986|NCT00044473|Levofloxacin|levofloxacin|mesh-list
25847988|NCT00044473|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25847989|NCT00044473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24860141|NCT02307591|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24860142|NCT02307591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24860144|NCT02307695|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24860145|NCT02307695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24860146|NCT02307695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860149|NCT02307695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24860150|NCT02307695|Protease Inhibitors|protease inhibitors|mesh-ancestor
24860151|NCT02307695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540565|NCT00668499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24540566|NCT00668538|Miconazole|miconazole|mesh-list
24540567|NCT00668538|Clotrimazole|clotrimazole|mesh-list
24540568|NCT00668538|Antifungal Agents|antifungal agents|mesh-ancestor
24540569|NCT00668538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25847990|NCT00044473|Renal Agents|renal agents|mesh-ancestor
25847991|NCT00044473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25847992|NCT00044473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25847993|NCT00044473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24860152|NCT02307695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860153|NCT02307721|Remifentanil|remifentanil|mesh-list
24860155|NCT02307721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24860156|NCT02307721|Narcotics|narcotics|mesh-ancestor
24860157|NCT02307721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24860158|NCT02307721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860159|NCT02307721|Analgesics|analgesics|mesh-ancestor
24860160|NCT02307721|Sensory System Agents|sensory system agents|mesh-ancestor
24860161|NCT02307721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24860162|NCT02307721|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24860163|NCT02307825|Azithromycin|azithromycin|mesh-list
24860164|NCT02307825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24860165|NCT02307825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24860166|NCT02307864|Moxifloxacin|moxifloxacin|mesh-list
24860167|NCT02307864|Tramadol|tramadol|mesh-list
24653206|NCT01242332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25847994|NCT00044473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25847995|NCT00044473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25847996|NCT00044473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25847997|NCT00044473|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25847998|NCT00044473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25847999|NCT00044486|Posaconazole|posaconazole|mesh-list
24860194|NCT02307968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24860195|NCT02307968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860197|NCT02308072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24860198|NCT02308072|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24860199|NCT02308072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860200|NCT02308072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540616|NCT00668642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24540617|NCT00668642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848000|NCT00044486|Antifungal Agents|antifungal agents|mesh-ancestor
25848001|NCT00044486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25848002|NCT00044486|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25848003|NCT00044486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24653292|NCT01243086|Hormones|hormones|mesh-ancestor
25848004|NCT00044486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25848005|NCT00044486|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25848006|NCT00044486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25848007|NCT00044486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848008|NCT00044486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848009|NCT00044486|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25848010|NCT00044486|Hormone Antagonists|hormone antagonists|mesh-ancestor
25848011|NCT00044486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25848012|NCT00044486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848013|NCT00044525|Taxane|taxane|mesh-list
25848014|NCT00044525|IDN 5109|idn 5109|mesh-list
25848015|NCT00044525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848016|NCT00044538|Taxane|taxane|mesh-list
25848017|NCT00044538|IDN 5109|idn 5109|mesh-list
25848018|NCT00044538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848019|NCT00044551|Taxane|taxane|mesh-list
25848020|NCT00044551|IDN 5109|idn 5109|mesh-list
25848021|NCT00044551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848023|NCT00044564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848024|NCT00044577|Tenofovir|tenofovir|mesh-list
25848025|NCT00044577|Lamivudine|lamivudine|mesh-list
25848026|NCT00044577|Abacavir|abacavir|mesh-list
25848027|NCT00044577|Dideoxynucleosides|dideoxynucleosides|mesh-list
25848028|NCT00044577|Antiviral Agents|antiviral agents|mesh-ancestor
25848029|NCT00044577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25848030|NCT00044577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25848031|NCT00044577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25848032|NCT00044577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848033|NCT00044577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848034|NCT00044577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25848035|NCT00044577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24860257|NCT02308553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24860258|NCT02308553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24860259|NCT02308553|Tubulin Modulators|tubulin modulators|mesh-ancestor
24860260|NCT02308553|Antimitotic Agents|antimitotic agents|mesh-ancestor
24860261|NCT02308553|Mitosis Modulators|mitosis modulators|mesh-ancestor
24860262|NCT02308553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860263|NCT02308553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24860264|NCT02308553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860265|NCT02308644|Bevacizumab|bevacizumab|mesh-list
24860266|NCT02308644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24860267|NCT02308644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24860268|NCT02308644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24860269|NCT02308644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25848036|NCT00044577|Antimetabolites|antimetabolites|mesh-ancestor
25848037|NCT00044616|Fluoxetine|fluoxetine|mesh-list
25848038|NCT00044616|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25848039|NCT00044616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25848040|NCT00044616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25848041|NCT00044616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848042|NCT00044616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25848043|NCT00044616|Serotonin Agents|serotonin agents|mesh-ancestor
25848044|NCT00044616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848045|NCT00044616|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25848046|NCT00044616|Antidepressive Agents|antidepressive agents|mesh-ancestor
25848047|NCT00044616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25848048|NCT00044616|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25848049|NCT00044616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25848050|NCT00044616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848051|NCT00044629|Zolpidem|zolpidem|mesh-list
25848052|NCT00044629|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25848053|NCT00044629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25848054|NCT00044629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25848055|NCT00044629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848056|NCT00044629|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25848057|NCT00044629|GABA Agonists|gaba agonists|mesh-ancestor
25848058|NCT00044629|GABA Agents|gaba agents|mesh-ancestor
25848059|NCT00044629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25848060|NCT00044629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848061|NCT00044642|Lorazepam|lorazepam|mesh-list
25848062|NCT00044642|Anticonvulsants|anticonvulsants|mesh-ancestor
25848063|NCT00044642|Antiemetics|antiemetics|mesh-ancestor
25848064|NCT00044642|Autonomic Agents|autonomic agents|mesh-ancestor
25848065|NCT00044642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25848066|NCT00044642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848067|NCT00044642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25848068|NCT00044642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25848069|NCT00044642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25848070|NCT00044642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25848071|NCT00044642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25848072|NCT00044642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25848073|NCT00044642|GABA Modulators|gaba modulators|mesh-ancestor
25848074|NCT00044642|GABA Agents|gaba agents|mesh-ancestor
25848075|NCT00044642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25127042|NCT03058536|Hormones|hormones|mesh-ancestor
25848076|NCT00044642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848077|NCT00044668|Exenatide|exenatide|mesh-list
25848078|NCT00044668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25848079|NCT00044668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848080|NCT00044668|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25419261|NCT02717507|Adrenergic Agents|adrenergic agents|mesh-ancestor
24549568|NCT00716001|Acetylcysteine|acetylcysteine|mesh-list
25848081|NCT00044668|Incretins|incretins|mesh-ancestor
24540743|NCT00669487|Lamivudine|lamivudine|mesh-list
24540744|NCT00669487|Stavudine|stavudine|mesh-list
25848082|NCT00044668|Hormones|hormones|mesh-ancestor
24540745|NCT00669487|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24653835|NCT01245946|Adapalene|adapalene|mesh-list
25848083|NCT00044668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25848084|NCT00044681|Risperidone|risperidone|mesh-list
25848085|NCT00044681|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25848086|NCT00044681|Serotonin Agents|serotonin agents|mesh-ancestor
25848087|NCT00044681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25848088|NCT00044681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848089|NCT00044681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848090|NCT00044681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24860371|NCT02309437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24860372|NCT02309437|Narcotics|narcotics|mesh-ancestor
24860373|NCT02309437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24860374|NCT02309437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860375|NCT02309437|Analgesics|analgesics|mesh-ancestor
24860376|NCT02309437|Sensory System Agents|sensory system agents|mesh-ancestor
24860377|NCT02309437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24860378|NCT02309450|Asunaprevir|asunaprevir|mesh-list
25848091|NCT00044681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25848092|NCT00044681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25848093|NCT00044681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25848094|NCT00044681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25848095|NCT00044681|Dopamine Agents|dopamine agents|mesh-ancestor
25848096|NCT00044694|Exenatide|exenatide|mesh-list
25848097|NCT00044694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25848098|NCT00044694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860391|NCT02309554|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24860392|NCT02309658|Gemcitabine|gemcitabine|mesh-list
24860393|NCT02309658|Cisplatin|cisplatin|mesh-list
24860394|NCT02309658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24860395|NCT02309658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24860396|NCT02309658|Antimetabolites|antimetabolites|mesh-ancestor
24860397|NCT02309658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860398|NCT02309658|Antiviral Agents|antiviral agents|mesh-ancestor
25848099|NCT00044694|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25848100|NCT00044694|Incretins|incretins|mesh-ancestor
25848101|NCT00044694|Hormones|hormones|mesh-ancestor
25848102|NCT00044694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25848103|NCT00044707|Pramlintide|pramlintide|mesh-list
25848104|NCT00044707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25848105|NCT00044707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848106|NCT00044720|Sirolimus|sirolimus|mesh-list
25848107|NCT00044720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25848108|NCT00044720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25848109|NCT00044720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25848110|NCT00044720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848111|NCT00044720|Antifungal Agents|antifungal agents|mesh-ancestor
25848112|NCT00044720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25848113|NCT00044720|Immunologic Factors|immunologic factors|mesh-ancestor
25848114|NCT00044720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848115|NCT00044733|Gemtuzumab|gemtuzumab|mesh-list
25848116|NCT00044733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25848117|NCT00044733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848118|NCT00044746|Tazobactam|tazobactam|mesh-list
24540782|NCT00669656|Vitamin D|vitamin d|mesh-list
24860400|NCT02309658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860401|NCT02309658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24860421|NCT02309879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848119|NCT00044746|Piperacillin|piperacillin|mesh-list
25848120|NCT00044746|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25848121|NCT00044746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25848122|NCT00044746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25848123|NCT00044746|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25848124|NCT00044746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848125|NCT00044746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848126|NCT00044759|Tazobactam|tazobactam|mesh-list
25848127|NCT00044759|Piperacillin|piperacillin|mesh-list
25848128|NCT00044759|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25848129|NCT00044759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25848130|NCT00044759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25848131|NCT00044759|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25848132|NCT00044759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848133|NCT00044759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848134|NCT00044772|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25848135|NCT00044772|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25848136|NCT00044772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25848137|NCT00044772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24860473|NCT02310087|Vitamins|vitamins|mesh-ancestor
24860474|NCT02310087|Micronutrients|micronutrients|mesh-ancestor
25848138|NCT00044772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860475|NCT02310087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860476|NCT02310087|Antioxidants|antioxidants|mesh-ancestor
24557295|NCT00752141|Cholinergic Agents|cholinergic agents|mesh-ancestor
24860477|NCT02310087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860478|NCT02310087|Protective Agents|protective agents|mesh-ancestor
24860479|NCT02310243|Palbociclib|palbociclib|mesh-list
24860480|NCT02310243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654358|NCT01248923|Immunologic Factors|immunologic factors|mesh-ancestor
25848139|NCT00044772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25848140|NCT00044772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848141|NCT00044772|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25848142|NCT00044772|Antidepressive Agents|antidepressive agents|mesh-ancestor
25848143|NCT00044772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25848144|NCT00044785|Leucovorin|leucovorin|mesh-list
25848145|NCT00044785|Fluorouracil|fluorouracil|mesh-list
25848146|NCT00044785|Irinotecan|irinotecan|mesh-list
25848147|NCT00044785|Antimetabolites|antimetabolites|mesh-ancestor
25848148|NCT00044785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848149|NCT00044785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25848150|NCT00044785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848151|NCT00044785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25848152|NCT00044785|Immunologic Factors|immunologic factors|mesh-ancestor
25848153|NCT00044785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848154|NCT00044785|Antidotes|antidotes|mesh-ancestor
25848155|NCT00044785|Protective Agents|protective agents|mesh-ancestor
25848156|NCT00044785|Vitamin B Complex|vitamin b complex|mesh-ancestor
25848157|NCT00044785|Vitamins|vitamins|mesh-ancestor
25848158|NCT00044785|Micronutrients|micronutrients|mesh-ancestor
25848159|NCT00044785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25848160|NCT00044785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25848161|NCT00044785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848162|NCT00044798|Citalopram|citalopram|mesh-list
24654483|NCT01249690|Immunologic Factors|immunologic factors|mesh-ancestor
24860555|NCT02311010|Immunologic Factors|immunologic factors|mesh-ancestor
24860556|NCT02311010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860557|NCT02311010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25848163|NCT00044798|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25848164|NCT00044798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25848165|NCT00044798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25848166|NCT00044798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860594|NCT02311205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860596|NCT02311231|Calcium heparin|calcium heparin|mesh-list
24860597|NCT02311231|Bivalirudin|bivalirudin|mesh-list
24860598|NCT02311231|Anticoagulants|anticoagulants|mesh-ancestor
24860599|NCT02311231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24860600|NCT02311231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24654807|NCT01251627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24608898|NCT00994344|Ritonavir|ritonavir|mesh-list
24608980|NCT00994734|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24608981|NCT00994734|Abortifacient Agents|abortifacient agents|mesh-ancestor
24608982|NCT00994734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24682257|NCT01385020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24540957|NCT00670293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24860619|NCT02311530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24860620|NCT02311530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860621|NCT02311530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24860622|NCT02311530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860623|NCT02311530|Vasodilator Agents|vasodilator agents|mesh-ancestor
24860624|NCT02311569|Mirabegron|mirabegron|mesh-list
24860625|NCT02311569|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24860626|NCT02311569|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24860627|NCT02311569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24860628|NCT02311569|Adrenergic Agents|adrenergic agents|mesh-ancestor
24860629|NCT02311569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24654872|NCT01251848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25848167|NCT00044798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25848168|NCT00044798|Serotonin Agents|serotonin agents|mesh-ancestor
25848169|NCT00044798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848170|NCT00044798|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25848171|NCT00044798|Antidepressive Agents|antidepressive agents|mesh-ancestor
25848172|NCT00044798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25848173|NCT00044811|Fexofenadine|fexofenadine|mesh-list
25848174|NCT00044811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25848175|NCT00044811|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25848176|NCT00044811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24860643|NCT02311608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860644|NCT02311686|Ethanol|ethanol|mesh-list
24654931|NCT01252069|Hormones|hormones|mesh-ancestor
24860694|NCT02312076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860695|NCT02312076|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24860696|NCT02312076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24860698|NCT02312089|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24860699|NCT02312089|Luteolytic Agents|luteolytic agents|mesh-ancestor
24860700|NCT02312089|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24860701|NCT02312089|Contraceptive Agents|contraceptive agents|mesh-ancestor
24860702|NCT02312089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24860703|NCT02312089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541039|NCT00670566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24541040|NCT00670566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860720|NCT02312115|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24860721|NCT02312115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24860722|NCT02312115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541057|NCT00670670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541058|NCT00670670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541060|NCT00670670|Sequestering Agents|sequestering agents|mesh-ancestor
24541061|NCT00670683|Insulin Detemir|insulin detemir|mesh-list
24541062|NCT00670683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24541063|NCT00670683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541064|NCT00670696|Tetracaine|tetracaine|mesh-list
24541065|NCT00670696|Anesthetics, Local|anesthetics, local|mesh-ancestor
24541066|NCT00670696|Anesthetics|anesthetics|mesh-ancestor
24541067|NCT00670696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25848177|NCT00044811|Histamine Antagonists|histamine antagonists|mesh-ancestor
25848178|NCT00044811|Histamine Agents|histamine agents|mesh-ancestor
24860739|NCT02312297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24541077|NCT00670722|Biphasic Insulins|biphasic insulins|mesh-list
25848179|NCT00044811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24655290|NCT01255579|Dermatologic Agents|dermatologic agents|mesh-ancestor
24860831|NCT02313051|Hormone Antagonists|hormone antagonists|mesh-ancestor
24541125|NCT00671008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25848180|NCT00044811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860835|NCT02313064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24860836|NCT02313103|Lofexidine|lofexidine|mesh-list
24860837|NCT02313103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24860838|NCT02313103|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24860839|NCT02313103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860840|NCT02313103|Sensory System Agents|sensory system agents|mesh-ancestor
24860841|NCT02313103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24860842|NCT02313103|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24860843|NCT02313103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24860844|NCT02313103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24860845|NCT02313103|Adrenergic Agents|adrenergic agents|mesh-ancestor
24860846|NCT02313103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24860847|NCT02313103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860848|NCT02313220|Dapagliflozin|dapagliflozin|mesh-list
24860849|NCT02313220|Exenatide|exenatide|mesh-list
24860850|NCT02313220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24860851|NCT02313220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860852|NCT02313220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24860853|NCT02313220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860854|NCT02313220|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24860855|NCT02313220|Incretins|incretins|mesh-ancestor
24860856|NCT02313220|Hormones|hormones|mesh-ancestor
24860857|NCT02313220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24860858|NCT02313272|Bevacizumab|bevacizumab|mesh-list
24557652|NCT00753207|Epirubicin|epirubicin|mesh-list
25848181|NCT00044811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848182|NCT00044824|Fexofenadine|fexofenadine|mesh-list
25848183|NCT00044824|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25848184|NCT00044824|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25848185|NCT00044824|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25848186|NCT00044824|Histamine Antagonists|histamine antagonists|mesh-ancestor
25848187|NCT00044824|Histamine Agents|histamine agents|mesh-ancestor
25848188|NCT00044824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24860891|NCT02313337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24860892|NCT02313337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24860893|NCT02313337|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24655517|NCT01257048|Hormones|hormones|mesh-ancestor
25848189|NCT00044824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848190|NCT00044824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860941|NCT02314013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24860942|NCT02314013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24860944|NCT02314182|Capecitabine|capecitabine|mesh-list
24860945|NCT02314182|Oxaliplatin|oxaliplatin|mesh-list
24860946|NCT02314182|Irinotecan|irinotecan|mesh-list
24860947|NCT02314182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24860948|NCT02314182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24860949|NCT02314182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24860950|NCT02314182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24860951|NCT02314182|Growth Substances|growth substances|mesh-ancestor
24860952|NCT02314182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541241|NCT00671632|GABA Modulators|gaba modulators|mesh-ancestor
24541242|NCT00671632|GABA Agents|gaba agents|mesh-ancestor
24860962|NCT02314195|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24860963|NCT02314195|Serotonin Agents|serotonin agents|mesh-ancestor
24541261|NCT00671697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541267|NCT00671801|Irinotecan|irinotecan|mesh-list
24655631|NCT01257464|Incretins|incretins|mesh-ancestor
24451406|NCT00323583|Tubulin Modulators|tubulin modulators|mesh-ancestor
24860987|NCT02314286|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24860988|NCT02314286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24860989|NCT02314286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24860990|NCT02314286|Antimetabolites|antimetabolites|mesh-ancestor
24608988|NCT00994734|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25848191|NCT00044837|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25848192|NCT00044837|Medroxyprogesterone|medroxyprogesterone|mesh-list
25848193|NCT00044837|Estradiol|estradiol|mesh-list
25848194|NCT00044837|Estrogens|estrogens|mesh-ancestor
24802062|NCT01987076|Prednisone|prednisone|mesh-list
25848195|NCT00044837|Hormones|hormones|mesh-ancestor
25848196|NCT00044837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25848197|NCT00044837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848198|NCT00044837|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25848199|NCT00044837|Contraceptive Agents|contraceptive agents|mesh-ancestor
25848200|NCT00044837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25848201|NCT00044837|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25848202|NCT00044837|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24655895|NCT01258634|Antidotes|antidotes|mesh-ancestor
25848203|NCT00044837|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25848204|NCT00044837|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25848205|NCT00044837|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25848206|NCT00044837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24861043|NCT02314377|Growth Substances|growth substances|mesh-ancestor
24861044|NCT02314377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861045|NCT02314377|Growth Inhibitors|growth inhibitors|mesh-ancestor
24861046|NCT02314468|Glycerol|glycerol|mesh-list
24861047|NCT02314468|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24861048|NCT02314468|Protective Agents|protective agents|mesh-ancestor
25848207|NCT00044837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848208|NCT00044863|Cetuximab|cetuximab|mesh-list
25848209|NCT00044863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25848210|NCT00044863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848211|NCT00044876|Ulipristal acetate|ulipristal acetate|mesh-list
25848212|NCT00044876|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25848213|NCT00044876|Contraceptive Agents|contraceptive agents|mesh-ancestor
25848214|NCT00044876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25848215|NCT00044876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848216|NCT00044876|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25848217|NCT00044889|Clofarabine|clofarabine|mesh-list
25848218|NCT00044889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25848219|NCT00044889|Antimetabolites|antimetabolites|mesh-ancestor
25661615|NCT01635218|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24861076|NCT02314754|Misoprostol|misoprostol|mesh-list
24861077|NCT02314754|Mifepristone|mifepristone|mesh-list
25848220|NCT00044889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656010|NCT01259336|Itraconazole|itraconazole|mesh-list
25848221|NCT00044889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848222|NCT00044902|Epratuzumab|epratuzumab|mesh-list
25848223|NCT00044902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25848224|NCT00044902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848225|NCT00044915|Repinotan hydrochloride|repinotan hydrochloride|mesh-list
25848226|NCT00044915|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25848227|NCT00044915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25848228|NCT00044915|Serotonin Agents|serotonin agents|mesh-ancestor
25848229|NCT00044915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25848230|NCT00044915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848231|NCT00044915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848232|NCT00044928|Tazobactam|tazobactam|mesh-list
25848233|NCT00044928|Piperacillin|piperacillin|mesh-list
25848234|NCT00044928|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25848235|NCT00044928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25848236|NCT00044928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25848237|NCT00044928|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25848238|NCT00044928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848239|NCT00044928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542847|NCT00680511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848240|NCT00044954|Cyclosporine|cyclosporine|mesh-list
24656180|NCT01260376|Acipimox|acipimox|mesh-list
24656317|NCT01261078|Epinephrine|epinephrine|mesh-list
25848241|NCT00044954|Mycophenolic Acid|mycophenolic acid|mesh-list
25848242|NCT00044954|Fludarabine|fludarabine|mesh-list
25848243|NCT00044954|Fludarabine phosphate|fludarabine phosphate|mesh-list
24861176|NCT02315573|Anesthetics|anesthetics|mesh-ancestor
24861177|NCT02315573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24861178|NCT02315573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861179|NCT02315573|Sensory System Agents|sensory system agents|mesh-ancestor
24861180|NCT02315573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24542849|NCT00680511|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25848244|NCT00044954|Cyclosporins|cyclosporins|mesh-list
24861181|NCT02315573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24861182|NCT02315573|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24861183|NCT02315573|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24861184|NCT02315573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24861185|NCT02315573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861186|NCT02315573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24541482|NCT00673270|Hydrocortisone|hydrocortisone|mesh-list
24541483|NCT00673270|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24541484|NCT00673270|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24541485|NCT00673270|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24541486|NCT00673270|Fludrocortisone|fludrocortisone|mesh-list
24541487|NCT00673270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24541488|NCT00673296|Bevacizumab|bevacizumab|mesh-list
25848245|NCT00044954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848246|NCT00044954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25848247|NCT00044954|Antimetabolites|antimetabolites|mesh-ancestor
25848248|NCT00044954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848249|NCT00044954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25848250|NCT00044954|Immunologic Factors|immunologic factors|mesh-ancestor
25848251|NCT00044954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848252|NCT00044954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848253|NCT00044954|Antifungal Agents|antifungal agents|mesh-ancestor
25848254|NCT00044954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24558128|NCT00755521|Etoricoxib|etoricoxib|mesh-list
25848255|NCT00044954|Dermatologic Agents|dermatologic agents|mesh-ancestor
25848256|NCT00044954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25848257|NCT00044954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25848258|NCT00044954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25848259|NCT00044954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24861210|NCT02315950|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24861211|NCT02315950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24656513|NCT01262274|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24541511|NCT00673504|Immunologic Factors|immunologic factors|mesh-ancestor
25848260|NCT00044954|Antitubercular Agents|antitubercular agents|mesh-ancestor
25848261|NCT00044954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25661616|NCT01635218|Antidepressive Agents|antidepressive agents|mesh-ancestor
25661617|NCT01635218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25661618|NCT01635218|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25661619|NCT01635218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25848264|NCT00044993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25848265|NCT00044993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541521|NCT00673556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541522|NCT00673569|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24541523|NCT00673569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541524|NCT00673569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24541525|NCT00673569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541526|NCT00673569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541527|NCT00673582|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25848266|NCT00044993|Tubulin Modulators|tubulin modulators|mesh-ancestor
25848267|NCT00044993|Antimitotic Agents|antimitotic agents|mesh-ancestor
24861248|NCT02316327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24541528|NCT00673582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24541529|NCT00673582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24541530|NCT00673582|Antimetabolites|antimetabolites|mesh-ancestor
24861250|NCT02316327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861251|NCT02316327|Antiviral Agents|antiviral agents|mesh-ancestor
24861252|NCT02316327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24861253|NCT02316327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24861254|NCT02316327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24861255|NCT02316327|Immunologic Factors|immunologic factors|mesh-ancestor
24861256|NCT02316340|Hydroxychloroquine|hydroxychloroquine|mesh-list
24861257|NCT02316340|Vorinostat|vorinostat|mesh-list
24861258|NCT02316340|Antimalarials|antimalarials|mesh-ancestor
24861276|NCT02316496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24623233|NCT01070680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24623234|NCT01070680|Adrenergic Agents|adrenergic agents|mesh-ancestor
24623235|NCT01070680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24813332|NCT02057796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24813334|NCT02057796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24813335|NCT02057887|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24813336|NCT02057887|Antiviral Agents|antiviral agents|mesh-ancestor
24541543|NCT00673621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25848268|NCT00044993|Mitosis Modulators|mitosis modulators|mesh-ancestor
25848269|NCT00044993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813354|NCT02058173|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24813355|NCT02058173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24813356|NCT02058173|Antimalarials|antimalarials|mesh-ancestor
24813357|NCT02058173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24813358|NCT02058173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24813359|NCT02058173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24813360|NCT02058173|Analgesics|analgesics|mesh-ancestor
24813361|NCT02058173|Sensory System Agents|sensory system agents|mesh-ancestor
24813362|NCT02058173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24541558|NCT00673621|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
25848270|NCT00044993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25848271|NCT00044993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25848272|NCT00044993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25848273|NCT00044993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848274|NCT00045006|Vorinostat|vorinostat|mesh-list
25848275|NCT00045006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848276|NCT00045006|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25848277|NCT00045006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876047|NCT03914625|Immunoglobulins|immunoglobulins|mesh-list
24656878|NCT01264497|Tesamorelin|tesamorelin|mesh-list
24813385|NCT02058212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813387|NCT02058212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813388|NCT02058212|Protective Agents|protective agents|mesh-ancestor
24813389|NCT02058212|Trace Elements|trace elements|mesh-ancestor
24813390|NCT02058277|Aprepitant|aprepitant|mesh-list
24813391|NCT02058277|Antiemetics|antiemetics|mesh-ancestor
24541576|NCT00674011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24541581|NCT00674050|Albuterol|albuterol|mesh-list
25661620|NCT01635218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876048|NCT03914625|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25661621|NCT01635439|Dinoprostone|dinoprostone|mesh-list
25876049|NCT03914625|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25876050|NCT03914625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25876051|NCT03914625|Prednisolone phosphate|prednisolone phosphate|mesh-list
25876052|NCT03914625|BB 1101|bb 1101|mesh-list
25876053|NCT03914625|Calcium|calcium|mesh-list
25876054|NCT03914625|2-Aminopurine|2-aminopurine|mesh-list
25876055|NCT03914625|Levoleucovorin|levoleucovorin|mesh-list
25876056|NCT03914625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25876057|NCT03914625|Immunologic Factors|immunologic factors|mesh-ancestor
24541693|NCT00674687|Anticonvulsants|anticonvulsants|mesh-ancestor
24861422|NCT02317601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24861423|NCT02317601|Glucocorticoids|glucocorticoids|mesh-ancestor
24861424|NCT02317601|Hormones|hormones|mesh-ancestor
24861425|NCT02317601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24861426|NCT02317601|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24861427|NCT02317601|Protective Agents|protective agents|mesh-ancestor
24861428|NCT02317601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24861429|NCT02317601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861430|NCT02317640|Testosterone|testosterone|mesh-list
24861431|NCT02317640|Androgens|androgens|mesh-ancestor
24861432|NCT02317640|Hormones|hormones|mesh-ancestor
24861433|NCT02317640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24861487|NCT02318043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24861550|NCT02318511|Immunologic Factors|immunologic factors|mesh-ancestor
24861551|NCT02318511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861552|NCT02318511|Viscosupplements|viscosupplements|mesh-ancestor
24657486|NCT01267604|Inositol|inositol|mesh-list
24861565|NCT02318758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541737|NCT00674856|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24541738|NCT00674856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541739|NCT00674921|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24541740|NCT00674921|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24541741|NCT00674921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24541742|NCT00674921|Renal Agents|renal agents|mesh-ancestor
24541743|NCT00674921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24541744|NCT00674921|Antimalarials|antimalarials|mesh-ancestor
24813403|NCT02058303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541759|NCT00675012|Antimetabolites|antimetabolites|mesh-ancestor
24542852|NCT00680511|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24861626|NCT02319161|Calcium Channel Blockers|calcium channel blockers|mesh-list
24861628|NCT02319161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24861629|NCT02319161|Esmolol|esmolol|mesh-list
24861630|NCT02319161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24861631|NCT02319161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861632|NCT02319161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24861633|NCT02319161|Adrenergic Agents|adrenergic agents|mesh-ancestor
24861634|NCT02319161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24861635|NCT02319161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861636|NCT02319161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24861637|NCT02319161|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24861638|NCT02319187|Irinotecan|irinotecan|mesh-list
24861639|NCT02319187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24861640|NCT02319187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24861641|NCT02319187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24861642|NCT02319187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876059|NCT03914625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25876060|NCT03914625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25876061|NCT03914625|Alkylating Agents|alkylating agents|mesh-ancestor
25876062|NCT03914625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876063|NCT03914625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876064|NCT03914625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25876065|NCT03914625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25876066|NCT03914625|Antiemetics|antiemetics|mesh-ancestor
25876067|NCT03914625|Autonomic Agents|autonomic agents|mesh-ancestor
25876068|NCT03914625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25876069|NCT03914625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25876070|NCT03914625|Glucocorticoids|glucocorticoids|mesh-ancestor
25876071|NCT03914625|Hormones|hormones|mesh-ancestor
25876072|NCT03914625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25876073|NCT03914625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25876074|NCT03914625|Protease Inhibitors|protease inhibitors|mesh-ancestor
25876075|NCT03914625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876076|NCT03914625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25876077|NCT03914625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25876078|NCT03914625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25876079|NCT03914625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25876080|NCT03914625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25876081|NCT03914625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24550044|NCT00718796|Coenzyme Q10|coenzyme q10|mesh-list
24550045|NCT00718796|Ubiquinone|ubiquinone|mesh-list
24550046|NCT00718796|Atorvastatin|atorvastatin|mesh-list
24550047|NCT00718796|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24550048|NCT00718796|Simvastatin|simvastatin|mesh-list
24550049|NCT00718796|Pravastatin|pravastatin|mesh-list
24550050|NCT00718796|Lovastatin|lovastatin|mesh-list
24861643|NCT02319187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861644|NCT02319200|Metformin|metformin|mesh-list
24861645|NCT02319200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24861646|NCT02319200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861647|NCT02319265|Melatonin|melatonin|mesh-list
24861710|NCT02319577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861764|NCT02320032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24861765|NCT02320032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861850|NCT02320604|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24861852|NCT02320604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24861853|NCT02320604|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24861854|NCT02320604|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24861855|NCT02320734|Rocuronium|rocuronium|mesh-list
25127786|NCT03053284|Pasireotide|pasireotide|mesh-list
24861856|NCT02320734|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24541834|NCT00675545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541845|NCT00675688|Hormones|hormones|mesh-ancestor
24861916|NCT02321293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24861917|NCT02321371|Rifaximin|rifaximin|mesh-list
24861918|NCT02321371|Lactulose|lactulose|mesh-list
24861919|NCT02321371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24861920|NCT02321371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24861921|NCT02321371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24861922|NCT02321384|Ritonavir|ritonavir|mesh-list
24861923|NCT02321384|Midazolam|midazolam|mesh-list
24861924|NCT02321384|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24861925|NCT02321384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24861926|NCT02321384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24861927|NCT02321384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861928|NCT02321384|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24862014|NCT02322203|Niacinamide|niacinamide|mesh-list
24862058|NCT02322580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24862059|NCT02322580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24862060|NCT02322580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24862061|NCT02322580|Immunologic Factors|immunologic factors|mesh-ancestor
24862062|NCT02322619|Moxifloxacin|moxifloxacin|mesh-list
24862063|NCT02322619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24862064|NCT02322619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24862065|NCT02322619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24862066|NCT02322619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24541932|NCT00675896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541933|NCT00675961|Naltrexone|naltrexone|mesh-list
24541934|NCT00675961|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24541935|NCT00675961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24541936|NCT00675961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541937|NCT00675961|Sensory System Agents|sensory system agents|mesh-ancestor
25848285|NCT00045136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446694|NCT00305708|Antimetabolites|antimetabolites|mesh-ancestor
24658053|NCT01270165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661622|NCT01635439|Oxytocics|oxytocics|mesh-ancestor
25661623|NCT01635439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25661624|NCT01635439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661625|NCT01635504|Botulinum Toxins|botulinum toxins|mesh-list
25661626|NCT01635504|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25661627|NCT01635504|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25661628|NCT01635504|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25661629|NCT01635504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25848286|NCT00045136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848287|NCT00045136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25848288|NCT00045136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25848289|NCT00045136|Immunologic Factors|immunologic factors|mesh-ancestor
25848290|NCT00045136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848291|NCT00045149|Aldesleukin|aldesleukin|mesh-list
25848292|NCT00045149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848293|NCT00045149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25876082|NCT03914625|Abortifacient Agents|abortifacient agents|mesh-ancestor
24541972|NCT00676156|Vitamin B Complex|vitamin b complex|mesh-ancestor
24541974|NCT00676156|Micronutrients|micronutrients|mesh-ancestor
24541975|NCT00676221|Mycophenolic Acid|mycophenolic acid|mesh-list
24541976|NCT00676221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24541978|NCT00676221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24813484|NCT02058693|Dopamine Agents|dopamine agents|mesh-ancestor
25661630|NCT01635504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813485|NCT02058693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24862280|NCT02324088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24394112|NCT00132158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24601771|NCT00965900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24601772|NCT00965900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24601774|NCT00965913|Nicotine|nicotine|mesh-list
24601779|NCT00965913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24601780|NCT00965913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24601781|NCT00965913|Cholinergic Agents|cholinergic agents|mesh-ancestor
24601782|NCT00965913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24862281|NCT02324088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24862282|NCT02324088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25661631|NCT01635504|Cholinergic Agents|cholinergic agents|mesh-ancestor
24542109|NCT00676936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848330|NCT00045279|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25848331|NCT00045279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848332|NCT00045279|Antiviral Agents|antiviral agents|mesh-ancestor
25848333|NCT00045279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25848334|NCT00045279|Immunologic Factors|immunologic factors|mesh-ancestor
25848335|NCT00045279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848336|NCT00045292|Valacyclovir|valacyclovir|mesh-list
24542165|NCT00677300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542166|NCT00677300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451646|NCT00324467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24451647|NCT00324467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24451648|NCT00324467|Tubulin Modulators|tubulin modulators|mesh-ancestor
24451649|NCT00324467|Antimitotic Agents|antimitotic agents|mesh-ancestor
24455257|NCT02062944|Sirolimus|sirolimus|mesh-list
24451650|NCT00324467|Mitosis Modulators|mitosis modulators|mesh-ancestor
24451651|NCT00324467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24451652|NCT00324467|Analgesics|analgesics|mesh-ancestor
24451653|NCT00324467|Sensory System Agents|sensory system agents|mesh-ancestor
24451655|NCT00324467|Antipruritics|antipruritics|mesh-ancestor
24659354|NCT01277016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24862461|NCT02325479|Enoxaparin|enoxaparin|mesh-list
24862463|NCT02325479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24862464|NCT02325479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24862465|NCT02325479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862466|NCT02325557|Pembrolizumab|pembrolizumab|mesh-list
24862475|NCT02325583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24862476|NCT02325583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24862477|NCT02325583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24862478|NCT02325583|Anesthetics, General|anesthetics, general|mesh-ancestor
25848346|NCT00045370|Interferons|interferons|mesh-list
25848347|NCT00045370|Interferon-alpha|interferon-alpha|mesh-list
25848348|NCT00045370|Sirolimus|sirolimus|mesh-list
25848349|NCT00045370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419338|NCT02713997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661634|NCT01635504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25848350|NCT00045370|Antiviral Agents|antiviral agents|mesh-ancestor
25848351|NCT00045370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25848352|NCT00045370|Immunologic Factors|immunologic factors|mesh-ancestor
25848353|NCT00045370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848354|NCT00045370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25848355|NCT00045370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25848356|NCT00045370|Antifungal Agents|antifungal agents|mesh-ancestor
25848357|NCT00045370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25848358|NCT00045396|Tipifarnib|tipifarnib|mesh-list
24542384|NCT00678457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24542387|NCT00678457|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24542388|NCT00678457|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24542389|NCT00678457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24542390|NCT00678457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24542391|NCT00678483|Rimonabant|rimonabant|mesh-list
24542392|NCT00678483|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24542393|NCT00678483|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24542394|NCT00678483|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24542397|NCT00678483|Hormones|hormones|mesh-ancestor
24660410|NCT01283256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542413|NCT00678613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24542414|NCT00678613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24542415|NCT00678613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24542416|NCT00678613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24542417|NCT00678613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542419|NCT00678613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542420|NCT00678613|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24862676|NCT04722952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24862677|NCT04722952|Antimetabolites|antimetabolites|mesh-ancestor
24862678|NCT04722952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862679|NCT04722952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24862680|NCT04722952|Antiviral Agents|antiviral agents|mesh-ancestor
24542441|NCT00678743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24542442|NCT00678743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542443|NCT00678756|Ketoconazole|ketoconazole|mesh-list
24542444|NCT00678756|Antifungal Agents|antifungal agents|mesh-ancestor
24542445|NCT00678756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24542446|NCT00678756|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24542447|NCT00678756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25848373|NCT00045448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24862787|NCT04371640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24862788|NCT04371640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24862789|NCT04371640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24862790|NCT04371640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24862792|NCT04371640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24862793|NCT04371640|Immunologic Factors|immunologic factors|mesh-ancestor
24862794|NCT04371640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862795|NCT04364997|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24862796|NCT04364997|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24542577|NCT00679458|Buprenorphine|buprenorphine|mesh-list
24542578|NCT00679458|Naloxone|naloxone|mesh-list
24660880|NCT01286896|Sunitinib|sunitinib|mesh-list
24862813|NCT04356196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24862814|NCT04356196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862815|NCT04356196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24862816|NCT04356196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542604|NCT00679523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24542605|NCT00679523|Antifungal Agents|antifungal agents|mesh-ancestor
24862817|NCT04356196|Vasodilator Agents|vasodilator agents|mesh-ancestor
24862818|NCT04356196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24862819|NCT04356196|Sympatholytics|sympatholytics|mesh-ancestor
24862820|NCT04356196|Autonomic Agents|autonomic agents|mesh-ancestor
24862821|NCT04356196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24862822|NCT04356196|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24862823|NCT04356196|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24862824|NCT04356196|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24862825|NCT04356196|Adrenergic Agents|adrenergic agents|mesh-ancestor
24862826|NCT04356196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24862831|NCT04218123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24862832|NCT04218123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24862833|NCT04218123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862834|NCT04218123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24862835|NCT04218123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862836|NCT04218123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24862837|NCT04218123|Antidepressive Agents|antidepressive agents|mesh-ancestor
24862838|NCT04218123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24542615|NCT00679536|Alkylating Agents|alkylating agents|mesh-ancestor
24542616|NCT00679536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24542617|NCT00679536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24542619|NCT00679601|Antifungal Agents|antifungal agents|mesh-ancestor
24542620|NCT00679601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25848382|NCT00045448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24862874|NCT04107168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24862876|NCT04107168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24862877|NCT04107168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24862878|NCT04107168|Growth Substances|growth substances|mesh-ancestor
24862882|NCT04107168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862886|NCT04097730|Riboflavin|riboflavin|mesh-list
24862887|NCT04097730|Moxifloxacin|moxifloxacin|mesh-list
24862888|NCT04097730|Difluprednate|difluprednate|mesh-list
24542674|NCT00679666|Dermatologic Agents|dermatologic agents|mesh-ancestor
24542676|NCT00679679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24542677|NCT00679679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542678|NCT00679705|Atosiban|atosiban|mesh-list
24542679|NCT00679705|Ritodrine|ritodrine|mesh-list
25848384|NCT00045461|Ifosfamide|ifosfamide|mesh-list
25848385|NCT00045461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661049|NCT01287689|Antibodies|antibodies|mesh-list
24813575|NCT02059031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24813576|NCT02059031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24813577|NCT02059031|Antiviral Agents|antiviral agents|mesh-ancestor
24813578|NCT02059031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24813579|NCT02059330|Palbociclib|palbociclib|mesh-list
24813580|NCT02059330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813581|NCT02059330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24813582|NCT02059330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813583|NCT02059330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813584|NCT02059460|Terlipressin|terlipressin|mesh-list
24813585|NCT02059460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24813586|NCT02059460|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24813587|NCT02059564|Liraglutide|liraglutide|mesh-list
24862889|NCT04097730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24862890|NCT04097730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24862891|NCT04097730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24862892|NCT04097730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24862894|NCT04097730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862895|NCT04097730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542685|NCT00679705|Sympathomimetics|sympathomimetics|mesh-ancestor
24542686|NCT00679705|Autonomic Agents|autonomic agents|mesh-ancestor
24542687|NCT00679705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24862913|NCT04034459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25661636|NCT01635764|Adalimumab|adalimumab|mesh-list
25661637|NCT01635764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25661638|NCT01635764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24862914|NCT04034459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25661639|NCT01636063|Misoprostol|misoprostol|mesh-list
25848386|NCT00045461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25848387|NCT00045461|Alkylating Agents|alkylating agents|mesh-ancestor
25848388|NCT00045461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876083|NCT03914625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25876084|NCT03914625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25876085|NCT03914625|Antimetabolites|antimetabolites|mesh-ancestor
25876086|NCT03914625|Dermatologic Agents|dermatologic agents|mesh-ancestor
25876087|NCT03914625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25876088|NCT03914625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25876089|NCT03914625|Antiviral Agents|antiviral agents|mesh-ancestor
25876090|NCT03914625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25876091|NCT03914625|Antidotes|antidotes|mesh-ancestor
25876092|NCT03914625|Protective Agents|protective agents|mesh-ancestor
24862919|NCT04034459|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24862920|NCT04034459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24862921|NCT04034459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24862922|NCT04034459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661203|NCT01288404|Hormones|hormones|mesh-ancestor
24862937|NCT04005729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24862938|NCT04005729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862939|NCT04005729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862940|NCT03950076|Edoxaban|edoxaban|mesh-list
24862941|NCT03950076|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24862942|NCT03950076|Antithrombins|antithrombins|mesh-ancestor
24542716|NCT00679900|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24542746|NCT00680173|Immunologic Factors|immunologic factors|mesh-ancestor
24862943|NCT03950076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24862944|NCT03950076|Protease Inhibitors|protease inhibitors|mesh-ancestor
24542749|NCT00680212|Carotenoids|carotenoids|mesh-list
24542750|NCT00680212|Antioxidants|antioxidants|mesh-ancestor
24542751|NCT00680212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542752|NCT00680212|Protective Agents|protective agents|mesh-ancestor
24542753|NCT00680212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542754|NCT00680212|Provitamins|provitamins|mesh-ancestor
24542755|NCT00680212|Vitamins|vitamins|mesh-ancestor
24542756|NCT00680212|Micronutrients|micronutrients|mesh-ancestor
25848389|NCT00045500|Prednisone|prednisone|mesh-list
24542757|NCT00680277|Carotenoids|carotenoids|mesh-list
24542758|NCT00680277|Antioxidants|antioxidants|mesh-ancestor
24451727|NCT00324610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451729|NCT00324623|Cyclophosphamide|cyclophosphamide|mesh-list
24451730|NCT00324623|Fludarabine|fludarabine|mesh-list
24451731|NCT00324623|Fludarabine phosphate|fludarabine phosphate|mesh-list
24451743|NCT00324688|Tenofovir|tenofovir|mesh-list
24451756|NCT00324714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24463940|NCT00362778|Insulin|insulin|mesh-list
24451757|NCT00324714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451758|NCT00324714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24451760|NCT00324727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24451761|NCT00324727|Alkylating Agents|alkylating agents|mesh-ancestor
24451762|NCT00324727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451763|NCT00324727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451764|NCT00324727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24451765|NCT00324727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24451766|NCT00324727|Immunologic Factors|immunologic factors|mesh-ancestor
24451767|NCT00324727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451768|NCT00324766|Simendan|simendan|mesh-list
24862983|NCT03823534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24862984|NCT03823534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24862985|NCT03823534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24863002|NCT03779243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661346|NCT01288963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661348|NCT01288963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24463941|NCT00362778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24661380|NCT01289236|Analgesics|analgesics|mesh-ancestor
24806095|NCT02013570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24806096|NCT02013570|Adrenergic Agents|adrenergic agents|mesh-ancestor
25661640|NCT01636063|Mifepristone|mifepristone|mesh-list
25661641|NCT01636063|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24806097|NCT02013570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25848390|NCT00045500|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
25848391|NCT00045500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25848392|NCT00045500|Glucocorticoids|glucocorticoids|mesh-ancestor
25848393|NCT00045500|Hormones|hormones|mesh-ancestor
25848394|NCT00045500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25848395|NCT00045500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848396|NCT00045500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24806098|NCT02013570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583898|NCT00877539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24474764|NCT00407277|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24474765|NCT00407277|Autonomic Agents|autonomic agents|mesh-ancestor
24474766|NCT00407277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24474767|NCT00407277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474768|NCT00407277|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24474769|NCT00407277|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24474770|NCT00407277|Cholinergic Agents|cholinergic agents|mesh-ancestor
24474791|NCT00407407|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24474792|NCT00407407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474793|NCT00407433|Gemcitabine|gemcitabine|mesh-list
24474794|NCT00407433|Oxaliplatin|oxaliplatin|mesh-list
24474795|NCT00407433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24474796|NCT00407433|Antimetabolites|antimetabolites|mesh-ancestor
24474797|NCT00407433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474798|NCT00407433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474799|NCT00407433|Antiviral Agents|antiviral agents|mesh-ancestor
24474800|NCT00407433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24474801|NCT00407433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848397|NCT00045500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848398|NCT00045500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25848399|NCT00045500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24806131|NCT02013960|Abortifacient Agents|abortifacient agents|mesh-ancestor
24806132|NCT02013960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24806133|NCT02013960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474955|NCT00408239|Anticoagulants|anticoagulants|mesh-ancestor
25848400|NCT00045500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848401|NCT00045513|Fludarabine|fludarabine|mesh-list
24474962|NCT00408252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24806136|NCT02013960|Oxytocics|oxytocics|mesh-ancestor
24806139|NCT02013986|Etomidate|etomidate|mesh-list
24806140|NCT02013986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24806141|NCT02013986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24806142|NCT02013986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806144|NCT02013986|Anesthetics, General|anesthetics, general|mesh-ancestor
24806145|NCT02013986|Anesthetics|anesthetics|mesh-ancestor
24806146|NCT02013986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24806147|NCT02013986|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24806148|NCT02013986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24806149|NCT02013986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24806150|NCT02013986|GABA Modulators|gaba modulators|mesh-ancestor
24806151|NCT02013986|GABA Agents|gaba agents|mesh-ancestor
24806152|NCT02013986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25848402|NCT00045513|Fludarabine phosphate|fludarabine phosphate|mesh-list
25848403|NCT00045513|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
25848404|NCT00045513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474981|NCT00408330|Dermatologic Agents|dermatologic agents|mesh-ancestor
24474982|NCT00408369|Pafuramidine|pafuramidine|mesh-list
24474983|NCT00408369|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24474984|NCT00408369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24474985|NCT00408369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24474993|NCT00408382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24474994|NCT00408382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848405|NCT00045513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25848406|NCT00045513|Antimetabolites|antimetabolites|mesh-ancestor
24446697|NCT00305708|Immunologic Factors|immunologic factors|mesh-ancestor
24446698|NCT00305708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446699|NCT00305708|Alkylating Agents|alkylating agents|mesh-ancestor
24600956|NCT00961467|Glucocorticoids|glucocorticoids|mesh-ancestor
24600957|NCT00961467|Hormones|hormones|mesh-ancestor
24600958|NCT00961467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24600959|NCT00961467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600960|NCT00961467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24600961|NCT00961467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661979|NCT01291628|Copper|copper|mesh-list
24475250|NCT00409630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24475251|NCT00409630|Autonomic Agents|autonomic agents|mesh-ancestor
24475252|NCT00409630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24475253|NCT00409630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475254|NCT00409630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24475255|NCT00409630|Respiratory System Agents|respiratory system agents|mesh-ancestor
24475259|NCT00409643|Valsartan|valsartan|mesh-list
24475260|NCT00409643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24475261|NCT00409643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25044099|NCT01150695|Vaccines|vaccines|mesh-list
25044100|NCT01150695|Immunologic Factors|immunologic factors|mesh-ancestor
25044101|NCT01150695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044102|NCT01143246|Terlipressin|terlipressin|mesh-list
25044103|NCT01143246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25044104|NCT01143246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25044105|NCT01143064|Progesterone|progesterone|mesh-list
25044106|NCT01143064|Progestins|progestins|mesh-ancestor
24475262|NCT00409643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24475263|NCT00409643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475264|NCT00409643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24563105|NCT00770107|Thiamine|thiamine|mesh-list
24475265|NCT00409643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475266|NCT00409643|Vasodilator Agents|vasodilator agents|mesh-ancestor
24475267|NCT00409643|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24475268|NCT00409643|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24475269|NCT00409656|Basiliximab|basiliximab|mesh-list
24475270|NCT00409656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24475271|NCT00409656|Immunologic Factors|immunologic factors|mesh-ancestor
25848407|NCT00045513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848408|NCT00045513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25848409|NCT00045513|Immunologic Factors|immunologic factors|mesh-ancestor
25848410|NCT00045513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848411|NCT00045513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25848412|NCT00045513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848413|NCT00045526|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25848414|NCT00045526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24475338|NCT00409942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475339|NCT00409942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24475340|NCT00409981|Paclitaxel|paclitaxel|mesh-list
24475341|NCT00409981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24475342|NCT00409981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24475343|NCT00409981|Tubulin Modulators|tubulin modulators|mesh-ancestor
24475344|NCT00409981|Antimitotic Agents|antimitotic agents|mesh-ancestor
24475345|NCT00409981|Mitosis Modulators|mitosis modulators|mesh-ancestor
24475346|NCT00409981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475347|NCT00409994|Sirolimus|sirolimus|mesh-list
24475348|NCT00409994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24475349|NCT00409994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24475350|NCT00409994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24475371|NCT00410254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24475372|NCT00410254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806198|NCT02014454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806199|NCT02014454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475390|NCT00410306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24475391|NCT00410306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475392|NCT00410306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24475393|NCT00410306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24475394|NCT00410306|Anabolic Agents|anabolic agents|mesh-ancestor
24475396|NCT00410345|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24475397|NCT00410345|Abortifacient Agents|abortifacient agents|mesh-ancestor
24475398|NCT00410345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24475399|NCT00410345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475400|NCT00410345|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24475401|NCT00410345|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24475402|NCT00410345|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24475403|NCT00410345|Contraceptive Agents|contraceptive agents|mesh-ancestor
24475404|NCT00410345|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24475405|NCT00410345|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24475406|NCT00410345|Hormone Antagonists|hormone antagonists|mesh-ancestor
25041727|NCT01591473|Antiviral Agents|antiviral agents|mesh-ancestor
24475828|NCT00411541|Autonomic Agents|autonomic agents|mesh-ancestor
25661642|NCT01636063|Abortifacient Agents|abortifacient agents|mesh-ancestor
25661643|NCT01636063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25661644|NCT01636063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661645|NCT01636063|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25661646|NCT01636063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25661647|NCT01636063|Oxytocics|oxytocics|mesh-ancestor
25661648|NCT01636063|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25661649|NCT01636063|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25848416|NCT00045526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848417|NCT00045526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475442|NCT00410527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24475443|NCT00410527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24475444|NCT00410540|Morphine|morphine|mesh-list
24475445|NCT00410540|Hydromorphone|hydromorphone|mesh-list
24475446|NCT00410540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24475447|NCT00410540|Narcotics|narcotics|mesh-ancestor
24806217|NCT02014532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24802492|NCT01990586|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24475464|NCT00410553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475465|NCT00410553|Tubulin Modulators|tubulin modulators|mesh-ancestor
24475466|NCT00410553|Antimitotic Agents|antimitotic agents|mesh-ancestor
24475467|NCT00410553|Mitosis Modulators|mitosis modulators|mesh-ancestor
24475468|NCT00410592|Esomeprazole|esomeprazole|mesh-list
24475469|NCT00410592|Pantoprazole|pantoprazole|mesh-list
24662363|NCT01294215|Tocolytic Agents|tocolytic agents|mesh-ancestor
24475558|NCT00410748|Analgesics|analgesics|mesh-ancestor
24475559|NCT00410748|Sensory System Agents|sensory system agents|mesh-ancestor
24475560|NCT00410748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24475561|NCT00410774|Gemcitabine|gemcitabine|mesh-list
24475562|NCT00410774|Bevacizumab|bevacizumab|mesh-list
24475563|NCT00410774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24475564|NCT00410774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24475565|NCT00410774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24475566|NCT00410774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24475567|NCT00410774|Growth Substances|growth substances|mesh-ancestor
24475580|NCT00410787|Narcotics|narcotics|mesh-ancestor
24475581|NCT00410787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24475582|NCT00410787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475583|NCT00410787|Analgesics|analgesics|mesh-ancestor
24475584|NCT00410787|Sensory System Agents|sensory system agents|mesh-ancestor
24475585|NCT00410787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24475587|NCT00410852|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24475588|NCT00410852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24806232|NCT02014558|Cephalexin|cephalexin|mesh-list
24464407|NCT00364754|Tesmilifene|tesmilifene|mesh-list
24464408|NCT00364754|Histamine Antagonists|histamine antagonists|mesh-ancestor
24464409|NCT00364754|Histamine Agents|histamine agents|mesh-ancestor
24464410|NCT00364754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24464411|NCT00364754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731375|NCT01634412|Amitriptyline|amitriptyline|mesh-list
25848418|NCT00045539|Leucovorin|leucovorin|mesh-list
24806240|NCT02014558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24806241|NCT02014558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24806242|NCT02014558|Anesthetics, General|anesthetics, general|mesh-ancestor
24806243|NCT02014558|Anesthetics|anesthetics|mesh-ancestor
24806244|NCT02014558|GABA Modulators|gaba modulators|mesh-ancestor
24806245|NCT02014558|GABA Agents|gaba agents|mesh-ancestor
24806246|NCT02014558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24806247|NCT02014558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848419|NCT00045539|Methotrexate|methotrexate|mesh-list
25041728|NCT01591473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24475628|NCT00410982|Gemcitabine|gemcitabine|mesh-list
25848420|NCT00045539|Thiotepa|thiotepa|mesh-list
24806249|NCT02014558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24806250|NCT02014558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24584915|NCT00882193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24475630|NCT00410982|Melphalan|melphalan|mesh-list
24475631|NCT00410982|Busulfan|busulfan|mesh-list
24475632|NCT00410982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24475633|NCT00410982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24475634|NCT00410982|Immunologic Factors|immunologic factors|mesh-ancestor
24475635|NCT00410982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446839|NCT00306254|Enoxaparin|enoxaparin|mesh-list
25848421|NCT00045539|Calcium|calcium|mesh-list
24446840|NCT00306254|N-(4-chlorophenyl)-N-(2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide|n-(4-chlorophenyl)-n-(2-fluoro-4-(2-oxopyridin-1(2h)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide|mesh-list
24446841|NCT00306254|Anticoagulants|anticoagulants|mesh-ancestor
24446842|NCT00306254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25848422|NCT00045539|Levoleucovorin|levoleucovorin|mesh-list
25848423|NCT00045539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25848424|NCT00045539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848425|NCT00045539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25848426|NCT00045539|Abortifacient Agents|abortifacient agents|mesh-ancestor
25848427|NCT00045539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24622502|NCT01067365|Zuclomiphene|zuclomiphene|mesh-list
24622503|NCT01067365|Anticoagulants|anticoagulants|mesh-ancestor
24464564|NCT00365339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25848428|NCT00045539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25848430|NCT00045539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848431|NCT00045539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848432|NCT00045539|Dermatologic Agents|dermatologic agents|mesh-ancestor
25848433|NCT00045539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848434|NCT00045539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24446709|NCT00305734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24475723|NCT00411229|Capecitabine|capecitabine|mesh-list
24475724|NCT00411229|Oxaliplatin|oxaliplatin|mesh-list
24806266|NCT02014714|Fentanyl|fentanyl|mesh-list
24806267|NCT02014714|Morphine|morphine|mesh-list
24806268|NCT02014714|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24806269|NCT02014714|Narcotics|narcotics|mesh-ancestor
24806297|NCT02014831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806298|NCT02014922|Vitamin E|vitamin e|mesh-list
24806299|NCT02014922|alpha-Tocopherol|alpha-tocopherol|mesh-list
24806300|NCT02014922|Tocopherols|tocopherols|mesh-list
24806301|NCT02014922|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24806302|NCT02014922|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24662657|NCT01296074|Hormones|hormones|mesh-ancestor
24475798|NCT00411372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806324|NCT02015182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24806325|NCT02015182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806326|NCT02015182|Sensory System Agents|sensory system agents|mesh-ancestor
24475810|NCT00411437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475811|NCT00411437|Urological Agents|urological agents|mesh-ancestor
24475812|NCT00411437|Parasympatholytics|parasympatholytics|mesh-ancestor
24475813|NCT00411437|Autonomic Agents|autonomic agents|mesh-ancestor
24475814|NCT00411437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24475815|NCT00411515|Mycophenolic Acid|mycophenolic acid|mesh-list
24475816|NCT00411515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24475817|NCT00411515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24475818|NCT00411515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24475819|NCT00411515|Antitubercular Agents|antitubercular agents|mesh-ancestor
24475820|NCT00411515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24475821|NCT00411515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24475822|NCT00411515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24475823|NCT00411515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475824|NCT00411541|Dexamethasone|dexamethasone|mesh-list
24475825|NCT00411541|Vincristine|vincristine|mesh-list
24475826|NCT00411541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24475827|NCT00411541|Antiemetics|antiemetics|mesh-ancestor
24475829|NCT00411541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24475830|NCT00411541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475831|NCT00411541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24475832|NCT00411541|Glucocorticoids|glucocorticoids|mesh-ancestor
24475844|NCT00411593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24475845|NCT00411593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24475846|NCT00411593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24475847|NCT00411593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24475848|NCT00411593|Growth Substances|growth substances|mesh-ancestor
24475849|NCT00411593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475850|NCT00411593|Growth Inhibitors|growth inhibitors|mesh-ancestor
24475852|NCT00411736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24475853|NCT00411736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24475854|NCT00411866|Ketoconazole|ketoconazole|mesh-list
24475855|NCT00411866|Antifungal Agents|antifungal agents|mesh-ancestor
24475885|NCT00411879|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24475887|NCT00411879|Coagulants|coagulants|mesh-ancestor
24475888|NCT00411879|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24806327|NCT02015182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25661650|NCT01636063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25661651|NCT01636063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25661652|NCT01636063|Contraceptive Agents|contraceptive agents|mesh-ancestor
25661653|NCT01636063|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25661654|NCT01636063|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25661655|NCT01636063|Hormone Antagonists|hormone antagonists|mesh-ancestor
25661656|NCT01636063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25661657|NCT01636063|Luteolytic Agents|luteolytic agents|mesh-ancestor
25661658|NCT01636063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25661659|NCT01636063|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24806331|NCT02015260|Chelating Agents|chelating agents|mesh-ancestor
24806332|NCT02015260|Sequestering Agents|sequestering agents|mesh-ancestor
24806333|NCT02015260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806334|NCT02015299|Linagliptin|linagliptin|mesh-list
24806335|NCT02015299|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24806336|NCT02015299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24806337|NCT02015299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806338|NCT02015299|Incretins|incretins|mesh-ancestor
24806339|NCT02015299|Hormones|hormones|mesh-ancestor
24806340|NCT02015299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24475889|NCT00411879|Natriuretic Agents|natriuretic agents|mesh-ancestor
24475890|NCT00411905|Bortezomib|bortezomib|mesh-list
24475891|NCT00411905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24475892|NCT00411957|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24475893|NCT00411957|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24475894|NCT00411957|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24475895|NCT00411957|Protease Inhibitors|protease inhibitors|mesh-ancestor
24475896|NCT00411957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24806622|NCT02016976|Midazolam|midazolam|mesh-list
24475897|NCT00411957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475898|NCT00411957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24475899|NCT00411957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24475900|NCT00411957|Antiviral Agents|antiviral agents|mesh-ancestor
24475901|NCT00411957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24475902|NCT00411996|Ritonavir|ritonavir|mesh-list
24475903|NCT00411996|Indinavir|indinavir|mesh-list
24475904|NCT00411996|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24475905|NCT00411996|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24475906|NCT00411996|Protease Inhibitors|protease inhibitors|mesh-ancestor
24475907|NCT00411996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24475908|NCT00411996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848435|NCT00045539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25848436|NCT00045539|Immunologic Factors|immunologic factors|mesh-ancestor
25848437|NCT00045539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25848438|NCT00045539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24662823|NCT01297023|Vitamins|vitamins|mesh-list
24806395|NCT02015598|Respiratory System Agents|respiratory system agents|mesh-ancestor
24806396|NCT02015611|Vitamin D|vitamin d|mesh-list
24806397|NCT02015611|Vitamins|vitamins|mesh-ancestor
24806398|NCT02015611|Micronutrients|micronutrients|mesh-ancestor
24806399|NCT02015611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806400|NCT02015611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24806401|NCT02015650|Fluorouracil|fluorouracil|mesh-list
24806402|NCT02015650|Cetuximab|cetuximab|mesh-list
24601252|NCT00963664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24601253|NCT00963664|Antimetabolites|antimetabolites|mesh-ancestor
24601254|NCT00963664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662889|NCT01297452|Paclitaxel|paclitaxel|mesh-list
24806436|NCT02015780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806437|NCT02015923|Panitumumab|panitumumab|mesh-list
24806438|NCT02015923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24806439|NCT02015923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806440|NCT02015949|Methylphenidate|methylphenidate|mesh-list
24464735|NCT00366418|Rituximab|rituximab|mesh-list
24464977|NCT00367471|Mitosis Modulators|mitosis modulators|mesh-ancestor
24464978|NCT00367471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806441|NCT02015949|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25041709|NCT01593228|Antimitotic Agents|antimitotic agents|mesh-ancestor
24806442|NCT02015949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806443|NCT02015949|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24806444|NCT02015949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24806445|NCT02015949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24806446|NCT02015949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806447|NCT02015949|Dopamine Agents|dopamine agents|mesh-ancestor
24806448|NCT02015949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24806449|NCT02015988|Simvastatin|simvastatin|mesh-list
24806450|NCT02015988|Fenofibrate|fenofibrate|mesh-list
24806451|NCT02015988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24806452|NCT02015988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24806453|NCT02015988|Antimetabolites|antimetabolites|mesh-ancestor
24806486|NCT02016261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806487|NCT02016261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24806488|NCT02016261|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24806490|NCT02016261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24662924|NCT01297686|Hormones|hormones|mesh-ancestor
24662981|NCT01297842|Meropenem|meropenem|mesh-list
24806564|NCT02016443|Autonomic Agents|autonomic agents|mesh-ancestor
24806565|NCT02016443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24806566|NCT02016443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24806567|NCT02016443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24601372|NCT00964106|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24806568|NCT02016443|Adrenergic Agents|adrenergic agents|mesh-ancestor
24806569|NCT02016443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24806570|NCT02016443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806571|NCT02016495|Thioctic Acid|thioctic acid|mesh-list
24806572|NCT02016495|Antioxidants|antioxidants|mesh-ancestor
24806586|NCT02016664|Ketamine|ketamine|mesh-list
24806587|NCT02016664|Analgesics|analgesics|mesh-ancestor
24806617|NCT02016846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24806618|NCT02016846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806619|NCT02016846|Incretins|incretins|mesh-ancestor
24806620|NCT02016846|Hormones|hormones|mesh-ancestor
24806621|NCT02016846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24806665|NCT02017392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25848439|NCT00045539|Antidotes|antidotes|mesh-ancestor
24806713|NCT02017704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806714|NCT02017704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806715|NCT02017704|Antidotes|antidotes|mesh-ancestor
24806716|NCT02017704|Protective Agents|protective agents|mesh-ancestor
24806717|NCT02017704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806718|NCT02017704|Vitamin B Complex|vitamin b complex|mesh-ancestor
24806720|NCT02017704|Micronutrients|micronutrients|mesh-ancestor
24806743|NCT02018055|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24476018|NCT00412503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24476019|NCT00412503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24476020|NCT00412503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476021|NCT00412555|Oseltamivir|oseltamivir|mesh-list
24476022|NCT00412555|Antiviral Agents|antiviral agents|mesh-ancestor
25848440|NCT00045539|Protective Agents|protective agents|mesh-ancestor
25848441|NCT00045539|Vitamin B Complex|vitamin b complex|mesh-ancestor
24806744|NCT02018055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24806745|NCT02018055|Purinergic Agents|purinergic agents|mesh-ancestor
24806746|NCT02018055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24806747|NCT02018081|Levofloxacin|levofloxacin|mesh-list
24806748|NCT02018081|Ofloxacin|ofloxacin|mesh-list
24806749|NCT02018081|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24806750|NCT02018081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24806751|NCT02018081|Renal Agents|renal agents|mesh-ancestor
24806752|NCT02018081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24806753|NCT02018081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24806754|NCT02018081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24806755|NCT02018081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24806756|NCT02018081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806757|NCT02018081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806758|NCT02018081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24806759|NCT02018081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24806761|NCT02018094|Chlorhexidine|chlorhexidine|mesh-list
24806762|NCT02018094|Povidone-Iodine|povidone-iodine|mesh-list
24806763|NCT02018094|Metronidazole|metronidazole|mesh-list
24806768|NCT02018094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24806770|NCT02018094|Disinfectants|disinfectants|mesh-ancestor
24806771|NCT02018094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24806772|NCT02018094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24806773|NCT02018094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24806774|NCT02018094|Trace Elements|trace elements|mesh-ancestor
24601674|NCT00965406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24601675|NCT00965406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601676|NCT00965549|Insulin|insulin|mesh-list
24601677|NCT00965549|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24601678|NCT00965549|Insulin Glargine|insulin glargine|mesh-list
24601679|NCT00965549|Insulin Aspart|insulin aspart|mesh-list
24601680|NCT00965549|Insulin glulisine|insulin glulisine|mesh-list
24806779|NCT02018094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661660|NCT01636076|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25661661|NCT01636076|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25661662|NCT01636076|Autonomic Agents|autonomic agents|mesh-ancestor
25661663|NCT01636076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25661664|NCT01636076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806782|NCT02018094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24806784|NCT02018133|Ergocalciferols|ergocalciferols|mesh-list
24806785|NCT02018133|Vitamins|vitamins|mesh-ancestor
24806786|NCT02018133|Micronutrients|micronutrients|mesh-ancestor
24806787|NCT02018133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806788|NCT02018133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24806789|NCT02018133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24806790|NCT02018159|Menotropins|menotropins|mesh-list
24806791|NCT02018159|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24806792|NCT02018159|Fertility Agents|fertility agents|mesh-ancestor
24806826|NCT02018276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663316|NCT01300364|Serotonin Agents|serotonin agents|mesh-ancestor
24806857|NCT02018419|Vaccines|vaccines|mesh-list
24806858|NCT02018419|Immunologic Factors|immunologic factors|mesh-ancestor
24806859|NCT02018419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806860|NCT02018523|Lenalidomide|lenalidomide|mesh-list
24806861|NCT02018523|Immunologic Factors|immunologic factors|mesh-ancestor
24806880|NCT02018601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24806881|NCT02018601|Analgesics|analgesics|mesh-ancestor
24806882|NCT02018601|Sensory System Agents|sensory system agents|mesh-ancestor
24806883|NCT02018601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24806884|NCT02018601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806885|NCT02018601|Antipyretics|antipyretics|mesh-ancestor
24806886|NCT02018601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24806887|NCT02018601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24806888|NCT02018601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24806889|NCT02018731|Metformin|metformin|mesh-list
24806890|NCT02018731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24806891|NCT02018731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806892|NCT02018757|Chlorotrianisene|chlorotrianisene|mesh-list
24806893|NCT02018757|Arsenic Trioxide|arsenic trioxide|mesh-list
24806894|NCT02018757|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24806895|NCT02018757|Estrogens|estrogens|mesh-ancestor
24601795|NCT00965991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24601797|NCT00966004|Mirabegron|mirabegron|mesh-list
24806896|NCT02018757|Hormones|hormones|mesh-ancestor
25848442|NCT00045539|Vitamins|vitamins|mesh-ancestor
25848443|NCT00045539|Micronutrients|micronutrients|mesh-ancestor
25848444|NCT00045539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25848445|NCT00045539|Alkylating Agents|alkylating agents|mesh-ancestor
25848446|NCT00045539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25848447|NCT00045565|Arsenic Trioxide|arsenic trioxide|mesh-list
24806897|NCT02018757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25848448|NCT00045565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806964|NCT02019017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24807029|NCT02019355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807030|NCT02019355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24807031|NCT02019355|Immunologic Factors|immunologic factors|mesh-ancestor
24807032|NCT02019355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476135|NCT00413179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24476136|NCT00413179|Hormone Antagonists|hormone antagonists|mesh-ancestor
24476137|NCT00413179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24476138|NCT00413179|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24476171|NCT00413387|Budesonide|budesonide|mesh-list
24476172|NCT00413387|Beclomethasone|beclomethasone|mesh-list
24807049|NCT02019459|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24807050|NCT02019459|Autonomic Agents|autonomic agents|mesh-ancestor
24807051|NCT02019459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24807052|NCT02019459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807053|NCT02019459|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24807054|NCT02019459|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24807055|NCT02019459|Cholinergic Agents|cholinergic agents|mesh-ancestor
24807056|NCT02019459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25041729|NCT01591473|Interferon Inducers|interferon inducers|mesh-ancestor
24465134|NCT00367965|Zopiclone|zopiclone|mesh-list
24663875|NCT01303926|Tubulin Modulators|tubulin modulators|mesh-ancestor
25848449|NCT00045591|Celecoxib|celecoxib|mesh-list
25848450|NCT00045591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25848451|NCT00045591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24752241|NCT01709370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848452|NCT00045591|Analgesics|analgesics|mesh-ancestor
24802659|NCT01991327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24476378|NCT00414531|Atorvastatin|atorvastatin|mesh-list
24476387|NCT00414648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24476388|NCT00414648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24476389|NCT00414648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24476390|NCT00414648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807097|NCT02019810|Adrenergic Agents|adrenergic agents|mesh-ancestor
24663977|NCT01304316|Mydriatics|mydriatics|mesh-ancestor
24807103|NCT02019810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24476734|NCT00416377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25848453|NCT00045591|Sensory System Agents|sensory system agents|mesh-ancestor
25848454|NCT00045591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25848455|NCT00045591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848456|NCT00045591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25848457|NCT00045591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25848458|NCT00045591|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25848459|NCT00045591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25848460|NCT00045591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24664224|NCT01305707|Analgesics|analgesics|mesh-ancestor
24476913|NCT00416832|Doxorubicin|doxorubicin|mesh-list
24476914|NCT00416832|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24476916|NCT00416832|Vincristine|vincristine|mesh-list
24476918|NCT00416832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24476919|NCT00416832|Immunologic Factors|immunologic factors|mesh-ancestor
24476920|NCT00416832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476921|NCT00416832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24476922|NCT00416832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24476923|NCT00416832|Alkylating Agents|alkylating agents|mesh-ancestor
24476924|NCT00416832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476925|NCT00416832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476958|NCT00416871|Antiviral Agents|antiviral agents|mesh-ancestor
24476959|NCT00416871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24476960|NCT00416871|Immunologic Factors|immunologic factors|mesh-ancestor
24476961|NCT00416871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476962|NCT00416871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24476963|NCT00416871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24602131|NCT00967291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602132|NCT00967291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24602133|NCT00967291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24602134|NCT00967291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476965|NCT00416897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24476985|NCT00416910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476986|NCT00416910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848461|NCT00045591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848462|NCT00045604|Cisplatin|cisplatin|mesh-list
24477050|NCT00417053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24477237|NCT00417898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477276|NCT00418080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24477277|NCT00418080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477278|NCT00418080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477279|NCT00418119|Epoetin Alfa|epoetin alfa|mesh-list
25848463|NCT00045604|Irinotecan|irinotecan|mesh-list
25848464|NCT00045604|Imatinib Mesylate|imatinib mesylate|mesh-list
25848465|NCT00045604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848466|NCT00045604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25848467|NCT00045604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24802662|NCT01991327|Fertility Agents|fertility agents|mesh-ancestor
24802664|NCT01991327|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25848468|NCT00045604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848469|NCT00045604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848470|NCT00045604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25848471|NCT00045617|Cisplatin|cisplatin|mesh-list
25848472|NCT00045617|Etoposide|etoposide|mesh-list
25848473|NCT00045617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24477374|NCT00418392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24477375|NCT00418392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24477376|NCT00418431|Bevacizumab|bevacizumab|mesh-list
24477377|NCT00418431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24622714|NCT01068093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24622715|NCT01068132|Cetuximab|cetuximab|mesh-list
24622716|NCT01068132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24477461|NCT00418704|Docetaxel|docetaxel|mesh-list
25848474|NCT00045617|Vaccines|vaccines|mesh-list
25848475|NCT00045617|Antibodies|antibodies|mesh-list
25848476|NCT00045617|Immunoglobulins|immunoglobulins|mesh-list
24477464|NCT00418704|Tubulin Modulators|tubulin modulators|mesh-ancestor
24477465|NCT00418704|Antimitotic Agents|antimitotic agents|mesh-ancestor
24477466|NCT00418704|Mitosis Modulators|mitosis modulators|mesh-ancestor
24477467|NCT00418704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477468|NCT00418704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24477469|NCT00418704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477470|NCT00418730|Proteasome Inhibitors|proteasome inhibitors|mesh-list
24477471|NCT00418730|Protease Inhibitors|protease inhibitors|mesh-ancestor
25848477|NCT00045617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24477546|NCT00419042|Gemcitabine|gemcitabine|mesh-list
24477547|NCT00419042|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24477548|NCT00419042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24477549|NCT00419042|Antimetabolites|antimetabolites|mesh-ancestor
24477550|NCT00419042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477551|NCT00419042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477559|NCT00419068|Cholecalciferol|cholecalciferol|mesh-list
24477560|NCT00419068|Vitamin D|vitamin d|mesh-list
24477561|NCT00419068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24477562|NCT00419068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477563|NCT00419068|Vitamins|vitamins|mesh-ancestor
24477564|NCT00419068|Micronutrients|micronutrients|mesh-ancestor
24477565|NCT00419068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24477614|NCT00419419|Nitroglycerin|nitroglycerin|mesh-list
24477617|NCT00419471|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24477618|NCT00419471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24477677|NCT00419653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414502|NCT00197834|Valproic Acid|valproic acid|mesh-list
24465305|NCT00368862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465306|NCT00368862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24477678|NCT00419653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24807157|NCT02020122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477708|NCT00419731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24477709|NCT00419731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24477710|NCT00419731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848478|NCT00045617|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
25848479|NCT00045617|Immunologic Factors|immunologic factors|mesh-ancestor
25848480|NCT00045617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848481|NCT00045617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477778|NCT00419991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477806|NCT00420355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24477807|NCT00420355|Protease Inhibitors|protease inhibitors|mesh-ancestor
24477808|NCT00420355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477809|NCT00420355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477810|NCT00420355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24477811|NCT00420355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25848482|NCT00045617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25848483|NCT00045617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24477835|NCT00420524|Tubulin Modulators|tubulin modulators|mesh-ancestor
25848484|NCT00045617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25848485|NCT00045617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848486|NCT00045617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848487|NCT00045669|Imatinib Mesylate|imatinib mesylate|mesh-list
24807179|NCT02020161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24807180|NCT02020161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24807181|NCT02020161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24807183|NCT02020161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24807184|NCT02020161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24807185|NCT02020161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25848488|NCT00045669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848489|NCT00045669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25848490|NCT00045669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848491|NCT00045669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848492|NCT00045682|Paclitaxel|paclitaxel|mesh-list
25848493|NCT00045682|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25848494|NCT00045682|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
25848495|NCT00045682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25848496|NCT00045682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848498|NCT00045682|Antimitotic Agents|antimitotic agents|mesh-ancestor
25848499|NCT00045682|Mitosis Modulators|mitosis modulators|mesh-ancestor
25848500|NCT00045682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848501|NCT00045695|Bortezomib|bortezomib|mesh-list
24477897|NCT00420654|Hormones|hormones|mesh-list
24477907|NCT00420693|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24477908|NCT00420693|Anesthetics, General|anesthetics, general|mesh-ancestor
24477909|NCT00420693|Anesthetics|anesthetics|mesh-ancestor
24477910|NCT00420693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25848502|NCT00045695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848503|NCT00045721|Carmustine|carmustine|mesh-list
25848504|NCT00045721|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
24477919|NCT00420797|Sympathomimetics|sympathomimetics|mesh-ancestor
24477920|NCT00420797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25041730|NCT01591473|Immunologic Factors|immunologic factors|mesh-ancestor
24807186|NCT02020161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24807187|NCT02020161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24807188|NCT02020200|Methylphenidate|methylphenidate|mesh-list
25848505|NCT00045721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25848506|NCT00045721|Alkylating Agents|alkylating agents|mesh-ancestor
25848507|NCT00045721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477928|NCT00420797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477930|NCT00420836|Tobramycin|tobramycin|mesh-list
25848508|NCT00045721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848509|NCT00045721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848510|NCT00045747|Fluorouracil|fluorouracil|mesh-list
25848511|NCT00045747|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
25848512|NCT00045747|Antimetabolites|antimetabolites|mesh-ancestor
25848513|NCT00045747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848514|NCT00045747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25848515|NCT00045747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848516|NCT00045747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25848517|NCT00045747|Immunologic Factors|immunologic factors|mesh-ancestor
25848518|NCT00045747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848519|NCT00045747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25848520|NCT00045747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848521|NCT00045760|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
25848522|NCT00045760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25848523|NCT00045773|Sertraline|sertraline|mesh-list
25848524|NCT00045773|Antidepressive Agents|antidepressive agents|mesh-ancestor
25848525|NCT00045773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24477937|NCT00420901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477938|NCT00420901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477939|NCT00420901|Urological Agents|urological agents|mesh-ancestor
24477941|NCT00420953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24477942|NCT00420953|Vasodilator Agents|vasodilator agents|mesh-ancestor
24477943|NCT00420953|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24477944|NCT00420953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24477945|NCT00420953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477946|NCT00420953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24477947|NCT00420953|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24587982|NCT00899821|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24478027|NCT00421200|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24478028|NCT00421200|Plasma Substitutes|plasma substitutes|mesh-ancestor
24478031|NCT00421252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24478032|NCT00421252|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24478033|NCT00421252|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24478034|NCT00421252|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24478035|NCT00421252|Purinergic Agents|purinergic agents|mesh-ancestor
24478036|NCT00421252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24478037|NCT00421252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478038|NCT00421252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478040|NCT00421317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478041|NCT00421317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24478042|NCT00421317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478043|NCT00421317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478044|NCT00421369|Sertraline|sertraline|mesh-list
24478045|NCT00421369|Reboxetine|reboxetine|mesh-list
24478278|NCT00422123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24478279|NCT00422123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24478280|NCT00422123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24478281|NCT00422123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24802775|NCT01992328|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24478285|NCT00422175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478286|NCT00422175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24478287|NCT00422175|Immunologic Factors|immunologic factors|mesh-ancestor
24478288|NCT00422175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478289|NCT00422188|Deoxycholic Acid|deoxycholic acid|mesh-list
24478290|NCT00422188|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24478316|NCT00422331|Lithium Carbonate|lithium carbonate|mesh-list
24478317|NCT00422331|Antidepressive Agents|antidepressive agents|mesh-ancestor
24478318|NCT00422331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24478319|NCT00422331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478320|NCT00422331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478321|NCT00422331|Antimanic Agents|antimanic agents|mesh-ancestor
24478322|NCT00422331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24478323|NCT00422331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24478324|NCT00422331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478348|NCT00422435|Mitosis Modulators|mitosis modulators|mesh-ancestor
24478391|NCT00422604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24478392|NCT00422604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24478393|NCT00422604|Adrenergic Agents|adrenergic agents|mesh-ancestor
24478395|NCT00422617|Dermatologic Agents|dermatologic agents|mesh-ancestor
24478396|NCT00422617|Immunologic Factors|immunologic factors|mesh-ancestor
24478397|NCT00422617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478398|NCT00422643|Hyaluronic Acid|hyaluronic acid|mesh-list
24478399|NCT00422643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24478400|NCT00422643|Immunologic Factors|immunologic factors|mesh-ancestor
24478401|NCT00422643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478402|NCT00422643|Viscosupplements|viscosupplements|mesh-ancestor
24478403|NCT00422643|Protective Agents|protective agents|mesh-ancestor
24465567|NCT00370097|Xhance|xhance|mesh-list
24478404|NCT00422682|Gemcitabine|gemcitabine|mesh-list
24478405|NCT00422682|Paclitaxel|paclitaxel|mesh-list
24478406|NCT00422682|Carboplatin|carboplatin|mesh-list
24478407|NCT00422682|Temozolomide|temozolomide|mesh-list
24478408|NCT00422682|Topotecan|topotecan|mesh-list
24478409|NCT00422682|Iniparib|iniparib|mesh-list
24478410|NCT00422682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24478411|NCT00422682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478412|NCT00422682|Tubulin Modulators|tubulin modulators|mesh-ancestor
24478413|NCT00422682|Antimitotic Agents|antimitotic agents|mesh-ancestor
24478414|NCT00422682|Mitosis Modulators|mitosis modulators|mesh-ancestor
24478415|NCT00422682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478416|NCT00422682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24478417|NCT00422682|Antimetabolites|antimetabolites|mesh-ancestor
24478428|NCT00422682|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24478429|NCT00422708|Anesthetics|anesthetics|mesh-list
24478430|NCT00422708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24807245|NCT02020603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24807246|NCT02020603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24807247|NCT02020603|Respiratory System Agents|respiratory system agents|mesh-ancestor
24807249|NCT02020603|Sympathomimetics|sympathomimetics|mesh-ancestor
24807250|NCT02020603|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24807251|NCT02020603|Coagulants|coagulants|mesh-ancestor
24807252|NCT02020629|Lixisenatide|lixisenatide|mesh-list
24807253|NCT02020629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24807254|NCT02020629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807255|NCT02020681|Fluorides|fluorides|mesh-list
24807256|NCT02020681|Cariostatic Agents|cariostatic agents|mesh-ancestor
24807257|NCT02020681|Protective Agents|protective agents|mesh-ancestor
24807258|NCT02020681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848526|NCT00045773|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25848527|NCT00045773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25848528|NCT00045773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25876093|NCT03914625|Vitamin B Complex|vitamin b complex|mesh-ancestor
24807309|NCT02021201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24807310|NCT02021201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807311|NCT02021201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807312|NCT02021201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25661665|NCT01636076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24807313|NCT02021201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24807314|NCT02021201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25848529|NCT00045773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848530|NCT00045773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25848531|NCT00045773|Serotonin Agents|serotonin agents|mesh-ancestor
25848532|NCT00045773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478509|NCT00423228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478510|NCT00423228|Nootropic Agents|nootropic agents|mesh-ancestor
24478511|NCT00423371|Hyaluronic Acid|hyaluronic acid|mesh-list
24478512|NCT00423371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24478513|NCT00423371|Immunologic Factors|immunologic factors|mesh-ancestor
24478514|NCT00423371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478515|NCT00423371|Viscosupplements|viscosupplements|mesh-ancestor
24478528|NCT00423397|Immunologic Factors|immunologic factors|mesh-ancestor
24478529|NCT00423397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478530|NCT00423397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24478531|NCT00423397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478532|NCT00423397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478534|NCT00423475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25848533|NCT00045799|Omeprazole|omeprazole|mesh-list
25848534|NCT00045799|Cimetidine|cimetidine|mesh-list
25848535|NCT00045799|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
25848536|NCT00045799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25848537|NCT00045799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25848538|NCT00045799|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25848539|NCT00045799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24807315|NCT02021201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24807316|NCT02021201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24807317|NCT02021201|Dopamine Agents|dopamine agents|mesh-ancestor
24807343|NCT02021240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24807344|NCT02021240|Anesthetics, General|anesthetics, general|mesh-ancestor
24807345|NCT02021240|Anesthetics|anesthetics|mesh-ancestor
24807346|NCT02021240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24807347|NCT02021240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24807348|NCT02021240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24807349|NCT02021240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25848540|NCT00045799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848541|NCT00045799|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25848542|NCT00045799|Histamine Antagonists|histamine antagonists|mesh-ancestor
25848543|NCT00045799|Histamine Agents|histamine agents|mesh-ancestor
24807350|NCT02021240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807351|NCT02021409|Darbepoetin alfa|darbepoetin alfa|mesh-list
24807352|NCT02021409|Hematinics|hematinics|mesh-ancestor
24807353|NCT02021422|Fluorouracil|fluorouracil|mesh-list
25848544|NCT00045799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24807708|NCT02023359|Everolimus|everolimus|mesh-list
24478535|NCT00423475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478536|NCT00423501|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24478539|NCT00423501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24478540|NCT00423501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478541|NCT00423514|Mycophenolic Acid|mycophenolic acid|mesh-list
24478572|NCT00423540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24478573|NCT00423540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24478574|NCT00423540|Anticonvulsants|anticonvulsants|mesh-ancestor
24478575|NCT00423540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24478576|NCT00423540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24478577|NCT00423540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478578|NCT00423540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24478579|NCT00423540|Tocolytic Agents|tocolytic agents|mesh-ancestor
24478580|NCT00423540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24478582|NCT00423696|Bevacizumab|bevacizumab|mesh-list
24478583|NCT00423696|Fluorouracil|fluorouracil|mesh-list
24478584|NCT00423696|Capecitabine|capecitabine|mesh-list
24478586|NCT00423696|Calcium|calcium|mesh-list
24478587|NCT00423696|Levoleucovorin|levoleucovorin|mesh-list
24478588|NCT00423696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24478589|NCT00423696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24803128|NCT01994733|Antacids|antacids|mesh-ancestor
24807397|NCT02021825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24807398|NCT02021825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24807399|NCT02021825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478667|NCT00423969|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24478668|NCT00423969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25848545|NCT00045799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478670|NCT00423969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478671|NCT00423969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24478673|NCT00423969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478674|NCT00423969|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24807432|NCT02021864|Cholecalciferol|cholecalciferol|mesh-list
24807433|NCT02021864|Vitamins|vitamins|mesh-ancestor
24807434|NCT02021864|Micronutrients|micronutrients|mesh-ancestor
24807435|NCT02021864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807436|NCT02021864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24807437|NCT02021864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24807438|NCT02022163|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24807439|NCT02022163|Vaccines|vaccines|mesh-list
24807440|NCT02022163|Immunologic Factors|immunologic factors|mesh-ancestor
24588789|NCT00904293|Warfarin|warfarin|mesh-list
24478675|NCT00423969|Antidepressive Agents|antidepressive agents|mesh-ancestor
24478676|NCT00423969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24478677|NCT00423969|Autonomic Agents|autonomic agents|mesh-ancestor
24478678|NCT00423969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24478679|NCT00423969|Cholinergic Agents|cholinergic agents|mesh-ancestor
24478680|NCT00423969|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24478681|NCT00423969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478682|NCT00423969|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24478683|NCT00423969|Nootropic Agents|nootropic agents|mesh-ancestor
24478684|NCT00423982|Vancomycin|vancomycin|mesh-list
24478690|NCT00423982|Antitubercular Agents|antitubercular agents|mesh-ancestor
24478691|NCT00423982|Leprostatic Agents|leprostatic agents|mesh-ancestor
24478692|NCT00423982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24478693|NCT00423982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478694|NCT00423982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848546|NCT00045799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24807441|NCT02022163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807442|NCT02022163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24807444|NCT02022163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807445|NCT02022163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24807446|NCT02022215|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24807447|NCT02022228|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24478774|NCT00424333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25848547|NCT00045799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25848548|NCT00045812|Ezetimibe|ezetimibe|mesh-list
25848549|NCT00045812|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25848550|NCT00045812|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25848551|NCT00045812|Antimetabolites|antimetabolites|mesh-ancestor
24803281|NCT01995344|Analgesics|analgesics|mesh-ancestor
25848552|NCT00045812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848553|NCT00045812|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25848554|NCT00045864|Aldesleukin|aldesleukin|mesh-list
25848555|NCT00045864|Rituximab|rituximab|mesh-list
25848556|NCT00045864|Interleukin-2|interleukin-2|mesh-list
25848557|NCT00045864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25848558|NCT00045864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848559|NCT00045864|Immunologic Factors|immunologic factors|mesh-ancestor
24478997|NCT00425191|Antimitotic Agents|antimitotic agents|mesh-ancestor
24478998|NCT00425191|Mitosis Modulators|mitosis modulators|mesh-ancestor
24666119|NCT01317511|Caseins|caseins|mesh-list
24479132|NCT00425646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479133|NCT00425646|Growth Inhibitors|growth inhibitors|mesh-ancestor
24479134|NCT00425646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24479137|NCT00425711|Acamprosate|acamprosate|mesh-list
24479188|NCT00425932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25661666|NCT01636076|Respiratory System Agents|respiratory system agents|mesh-ancestor
25661667|NCT01636076|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25661668|NCT01636076|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25661669|NCT01636076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25661670|NCT01636076|Adrenergic Agents|adrenergic agents|mesh-ancestor
25661671|NCT01636076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25661672|NCT01636076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661673|NCT01636206|Lifitegrast|lifitegrast|mesh-list
25661674|NCT01636206|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25661675|NCT01636206|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25661676|NCT01636687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25661677|NCT01636687|Immunologic Factors|immunologic factors|mesh-ancestor
25661678|NCT01636687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661679|NCT01636934|Minocycline|minocycline|mesh-list
24479279|NCT00426179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24479280|NCT00426179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479281|NCT00426179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479282|NCT00426192|Mannitol|mannitol|mesh-list
24479283|NCT00426192|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24479284|NCT00426192|Diuretics|diuretics|mesh-ancestor
24479285|NCT00426192|Natriuretic Agents|natriuretic agents|mesh-ancestor
24479286|NCT00426192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479479|NCT00427076|Vancomycin|vancomycin|mesh-list
24479642|NCT00427583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24479643|NCT00427583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479644|NCT00427583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622745|NCT01068327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24622746|NCT01068327|Immunologic Factors|immunologic factors|mesh-ancestor
24622747|NCT01068327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803429|NCT01996423|Vitamin D|vitamin d|mesh-list
24622748|NCT01068327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24622750|NCT01068327|Protective Agents|protective agents|mesh-ancestor
24622751|NCT01068327|Vitamin B Complex|vitamin b complex|mesh-ancestor
24622752|NCT01068327|Vitamins|vitamins|mesh-ancestor
24622753|NCT01068327|Micronutrients|micronutrients|mesh-ancestor
24622754|NCT01068327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24622755|NCT01068327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24622756|NCT01068327|Protease Inhibitors|protease inhibitors|mesh-ancestor
24622757|NCT01068327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24622758|NCT01068327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24479645|NCT00427596|Solabegron|solabegron|mesh-list
24479646|NCT00427596|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24479682|NCT00428025|Sensory System Agents|sensory system agents|mesh-ancestor
24479683|NCT00428025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24479684|NCT00428025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479685|NCT00428025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24479686|NCT00428025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24479687|NCT00428025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24479688|NCT00428025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479689|NCT00428025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479690|NCT00428064|Cyclosporine|cyclosporine|mesh-list
24479691|NCT00428064|Sirolimus|sirolimus|mesh-list
24479692|NCT00428064|Cyclosporins|cyclosporins|mesh-list
24479693|NCT00428064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666364|NCT01318681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24479724|NCT00428142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24479757|NCT00428272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24479758|NCT00428272|Immunologic Factors|immunologic factors|mesh-ancestor
24479760|NCT00428311|Metformin|metformin|mesh-list
24479764|NCT00428311|Cyproterone|cyproterone|mesh-list
24479765|NCT00428311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24807945|NCT02024555|Levofloxacin|levofloxacin|mesh-list
24479818|NCT00428480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24479849|NCT00428558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479850|NCT00428558|Antiviral Agents|antiviral agents|mesh-ancestor
24479851|NCT00428558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24479852|NCT00428558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24807511|NCT02022475|Cholecalciferol|cholecalciferol|mesh-list
25876094|NCT03914625|Vitamins|vitamins|mesh-ancestor
24803533|NCT01996761|Cerebrolysin|cerebrolysin|mesh-list
24479861|NCT00428649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479862|NCT00428649|Protective Agents|protective agents|mesh-ancestor
24479863|NCT00428649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479864|NCT00428649|Trace Elements|trace elements|mesh-ancestor
24479865|NCT00428649|Micronutrients|micronutrients|mesh-ancestor
24479866|NCT00428701|Esomeprazole|esomeprazole|mesh-list
24479867|NCT00428701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24479868|NCT00428701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24807566|NCT02022540|Ranibizumab|ranibizumab|mesh-list
24807567|NCT02022540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24807625|NCT02022761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24807626|NCT02022852|Capecitabine|capecitabine|mesh-list
24807627|NCT02022852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24807628|NCT02022852|Antimetabolites|antimetabolites|mesh-ancestor
24807632|NCT02022917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24807634|NCT02022917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24807635|NCT02022917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24807636|NCT02022917|Growth Substances|growth substances|mesh-ancestor
24807637|NCT02022917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807638|NCT02022917|Growth Inhibitors|growth inhibitors|mesh-ancestor
24807639|NCT02022930|Triamcinolone|triamcinolone|mesh-list
24807640|NCT02022930|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24807680|NCT02023086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24807681|NCT02023086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807682|NCT02023086|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24807683|NCT02023086|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24807684|NCT02023086|Cholinergic Agents|cholinergic agents|mesh-ancestor
24807685|NCT02023086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24807686|NCT02023086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807687|NCT02023164|Diphenhydramine|diphenhydramine|mesh-list
24807689|NCT02023164|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24807690|NCT02023164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24479876|NCT00428727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479877|NCT00428727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24807698|NCT02023164|Autonomic Agents|autonomic agents|mesh-ancestor
24807699|NCT02023164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24807700|NCT02023164|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24807701|NCT02023164|Histamine Antagonists|histamine antagonists|mesh-ancestor
24807702|NCT02023164|Histamine Agents|histamine agents|mesh-ancestor
24807703|NCT02023164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24807704|NCT02023164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807705|NCT02023164|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24807706|NCT02023164|Antipruritics|antipruritics|mesh-ancestor
24807707|NCT02023164|Dermatologic Agents|dermatologic agents|mesh-ancestor
25848560|NCT00045864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480020|NCT00429533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480094|NCT00429832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480096|NCT00429832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24803776|NCT01998503|Dexamethasone|dexamethasone|mesh-list
24480097|NCT00429832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24480098|NCT00429832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24480099|NCT00429832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24480100|NCT00429832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24480130|NCT00429897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666806|NCT01321021|Antipruritics|antipruritics|mesh-ancestor
24807757|NCT02023554|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24807758|NCT02023554|Respiratory System Agents|respiratory system agents|mesh-ancestor
24807759|NCT02023554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24480452|NCT00431106|Capecitabine|capecitabine|mesh-list
24480453|NCT00431106|Vinorelbine|vinorelbine|mesh-list
24480454|NCT00431106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24480455|NCT00431106|Antimetabolites|antimetabolites|mesh-ancestor
24480456|NCT00431106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480457|NCT00431106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807767|NCT02023567|Serotonin|serotonin|mesh-list
24480573|NCT00431275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480574|NCT00431340|Belinostat|belinostat|mesh-list
24480575|NCT00431340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807779|NCT02023593|Antimetabolites|antimetabolites|mesh-ancestor
24807780|NCT02023593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807781|NCT02023593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24807782|NCT02023593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807783|NCT02023593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24807784|NCT02023593|Immunologic Factors|immunologic factors|mesh-ancestor
24602756|NCT00970905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24602757|NCT00970905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24602758|NCT00970905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24602759|NCT00970905|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24602760|NCT00970931|Chlorthalidone|chlorthalidone|mesh-list
25661680|NCT01636934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25661681|NCT01636934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25661682|NCT01636947|Dexamethasone|dexamethasone|mesh-list
25661683|NCT01636947|Dexamethasone acetate|dexamethasone acetate|mesh-list
25661684|NCT01636947|Ondansetron|ondansetron|mesh-list
25661685|NCT01636947|Aprepitant|aprepitant|mesh-list
24602761|NCT00970931|Amiloride|amiloride|mesh-list
24602762|NCT00970931|Diuretics|diuretics|mesh-list
24602763|NCT00970931|Natriuretic Agents|natriuretic agents|mesh-ancestor
24602764|NCT00970931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602765|NCT00970931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24807808|NCT02023710|Bevacizumab|bevacizumab|mesh-list
24807809|NCT02023710|Carboplatin|carboplatin|mesh-list
24480650|NCT00431613|Gemcitabine|gemcitabine|mesh-list
24480651|NCT00431613|Carboplatin|carboplatin|mesh-list
24480652|NCT00431613|Docetaxel|docetaxel|mesh-list
24480653|NCT00431613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480654|NCT00431613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24598398|NCT00956059|Hormones|hormones|mesh-ancestor
24480655|NCT00431613|Antimetabolites|antimetabolites|mesh-ancestor
25848561|NCT00045864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25130441|NCT03033836|Antiviral Agents|antiviral agents|mesh-ancestor
25848562|NCT00045864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25848563|NCT00045864|Analgesics|analgesics|mesh-ancestor
24807822|NCT02023840|Metronidazole|metronidazole|mesh-list
24807823|NCT02023840|Erythritol|erythritol|mesh-list
24807824|NCT02023840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24807825|NCT02023840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24807826|NCT02023840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24807827|NCT02023840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24807828|NCT02023840|Vasodilator Agents|vasodilator agents|mesh-ancestor
24807829|NCT02023853|Metronidazole|metronidazole|mesh-list
24807830|NCT02023853|Erythritol|erythritol|mesh-list
25848564|NCT00045864|Sensory System Agents|sensory system agents|mesh-ancestor
24807856|NCT02024009|Antimitotic Agents|antimitotic agents|mesh-ancestor
24807857|NCT02024009|Mitosis Modulators|mitosis modulators|mesh-ancestor
24807858|NCT02024009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807859|NCT02024009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24807860|NCT02024009|Antimetabolites|antimetabolites|mesh-ancestor
24807861|NCT02024009|Antiviral Agents|antiviral agents|mesh-ancestor
24667196|NCT05461053|Lidocaine|lidocaine|mesh-list
25848565|NCT00045864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25848566|NCT00045864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25848567|NCT00045864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25848568|NCT00045864|Antiviral Agents|antiviral agents|mesh-ancestor
25848569|NCT00045864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25848570|NCT00045877|Aldesleukin|aldesleukin|mesh-list
25848571|NCT00045877|Rituximab|rituximab|mesh-list
25848572|NCT00045877|Interleukin-2|interleukin-2|mesh-list
25848573|NCT00045877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24480840|NCT00432393|Levodopa|levodopa|mesh-list
24480841|NCT00432393|Carbidopa|carbidopa|mesh-list
24480842|NCT00432393|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24480843|NCT00432393|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24480844|NCT00432393|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24480879|NCT00432549|Topiramate|topiramate|mesh-list
24481048|NCT00433186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25848574|NCT00045877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481085|NCT00433225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481086|NCT00433225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24481087|NCT00433225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24807905|NCT02024256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24807906|NCT02024295|Choline|choline|mesh-list
24807907|NCT02024295|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
24807908|NCT02024295|Lipotropic Agents|lipotropic agents|mesh-ancestor
24807909|NCT02024295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24807910|NCT02024295|Antimetabolites|antimetabolites|mesh-ancestor
24807911|NCT02024295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804129|NCT02001259|Anesthetics|anesthetics|mesh-ancestor
24481152|NCT00433459|Mitosis Modulators|mitosis modulators|mesh-ancestor
24481153|NCT00433459|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24481154|NCT00433485|Sirolimus|sirolimus|mesh-list
24481155|NCT00433485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24481156|NCT00433485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24481157|NCT00433485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24481158|NCT00433485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481159|NCT00433485|Antifungal Agents|antifungal agents|mesh-ancestor
24481160|NCT00433485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24481161|NCT00433485|Immunologic Factors|immunologic factors|mesh-ancestor
24481162|NCT00433485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481163|NCT00433498|Carboplatin|carboplatin|mesh-list
24481164|NCT00433498|Etoposide|etoposide|mesh-list
24481165|NCT00433498|Etoposide phosphate|etoposide phosphate|mesh-list
24481166|NCT00433498|Pravastatin|pravastatin|mesh-list
24481167|NCT00433498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848575|NCT00045877|Immunologic Factors|immunologic factors|mesh-ancestor
25848576|NCT00045877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848577|NCT00045877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24481169|NCT00433498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24667385|NCT05455697|Hormones|hormones|mesh-ancestor
24481311|NCT00434031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807912|NCT02024295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24807913|NCT02024295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24807916|NCT02024308|Fludarabine|fludarabine|mesh-list
24807917|NCT02024308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807918|NCT02024308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24807919|NCT02024308|Antimetabolites|antimetabolites|mesh-ancestor
24807920|NCT02024308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807921|NCT02024308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24807922|NCT02024308|Immunologic Factors|immunologic factors|mesh-ancestor
24807923|NCT02024308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481412|NCT00434382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848578|NCT00045877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25848579|NCT00045877|Analgesics|analgesics|mesh-ancestor
24807934|NCT02024373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24807935|NCT02024373|Antimetabolites|antimetabolites|mesh-ancestor
24807936|NCT02024373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807937|NCT02024373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24807938|NCT02024373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24807939|NCT02024373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24807940|NCT02024425|Antioxidants|antioxidants|mesh-list
24807941|NCT02024425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807943|NCT02024425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807948|NCT02024555|Ethambutol|ethambutol|mesh-list
24807949|NCT02024555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25848580|NCT00045877|Sensory System Agents|sensory system agents|mesh-ancestor
24431784|NCT00252863|Hormone Antagonists|hormone antagonists|mesh-ancestor
24481414|NCT00434382|Anesthetics, General|anesthetics, general|mesh-ancestor
24481415|NCT00434382|Anesthetics|anesthetics|mesh-ancestor
24481416|NCT00434382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24492218|NCT00485706|Dialysis Solutions|dialysis solutions|mesh-list
24481417|NCT00434382|Narcotics|narcotics|mesh-ancestor
24481418|NCT00434382|Analgesics|analgesics|mesh-ancestor
24481419|NCT00434382|Sensory System Agents|sensory system agents|mesh-ancestor
24481420|NCT00434382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24807960|NCT02024555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24807961|NCT02024555|Antitubercular Agents|antitubercular agents|mesh-ancestor
24807962|NCT02024555|Leprostatic Agents|leprostatic agents|mesh-ancestor
24807963|NCT02024555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24807964|NCT02024555|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24481431|NCT00434668|Vinorelbine|vinorelbine|mesh-list
24481432|NCT00434668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481433|NCT00434668|Tubulin Modulators|tubulin modulators|mesh-ancestor
24481434|NCT00434668|Antimitotic Agents|antimitotic agents|mesh-ancestor
24481435|NCT00434668|Mitosis Modulators|mitosis modulators|mesh-ancestor
24481436|NCT00434668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481437|NCT00434668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24481438|NCT00434681|Acetaminophen|acetaminophen|mesh-list
24481439|NCT00434681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24481440|NCT00434681|Analgesics|analgesics|mesh-ancestor
24481441|NCT00434681|Sensory System Agents|sensory system agents|mesh-ancestor
24481442|NCT00434681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24481443|NCT00434681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481444|NCT00434681|Antipyretics|antipyretics|mesh-ancestor
24481445|NCT00434746|Fezakinumab|fezakinumab|mesh-list
24481446|NCT00434746|Dermatologic Agents|dermatologic agents|mesh-ancestor
24481447|NCT00434772|Glucagon|glucagon|mesh-list
24481448|NCT00434772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24481449|NCT00434772|Hormones|hormones|mesh-ancestor
24481450|NCT00434772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24481451|NCT00434772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481452|NCT00434824|Methyltestosterone|methyltestosterone|mesh-list
24481462|NCT00434824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481463|NCT00434824|Anabolic Agents|anabolic agents|mesh-ancestor
24807976|NCT02024568|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24807977|NCT02024568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24481483|NCT00435058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24481484|NCT00435058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24481486|NCT00435058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25661686|NCT01636947|Fosaprepitant|fosaprepitant|mesh-list
25661687|NCT01636947|Metoclopramide|metoclopramide|mesh-list
25848581|NCT00045877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25848582|NCT00045877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25848583|NCT00045877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25848584|NCT00045877|Antiviral Agents|antiviral agents|mesh-ancestor
25848585|NCT00045877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25848586|NCT00045916|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25230920|NCT02592941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230921|NCT02593227|Cyclophosphamide|cyclophosphamide|mesh-list
24481515|NCT00435292|Analgesics|analgesics|mesh-ancestor
24481516|NCT00435292|Sensory System Agents|sensory system agents|mesh-ancestor
24481517|NCT00435292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24481518|NCT00435292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848588|NCT00045916|Antidepressive Agents|antidepressive agents|mesh-ancestor
24481564|NCT00435500|Fluorides, Topical|fluorides, topical|mesh-list
24481565|NCT00435500|Cariostatic Agents|cariostatic agents|mesh-ancestor
24481566|NCT00435500|Protective Agents|protective agents|mesh-ancestor
24481567|NCT00435500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481568|NCT00435747|Parecoxib|parecoxib|mesh-list
24481569|NCT00435747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24481570|NCT00435747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24481571|NCT00435747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481572|NCT00435747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481573|NCT00435747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24481574|NCT00435747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24481576|NCT00435747|Sensory System Agents|sensory system agents|mesh-ancestor
24481577|NCT00435747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24481578|NCT00435747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481579|NCT00435747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24481580|NCT00435747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24481581|NCT00435760|Bromides|bromides|mesh-list
24481612|NCT00435955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24481613|NCT00435955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848589|NCT00045916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25848590|NCT00045916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848591|NCT00045916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481623|NCT00435981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24481624|NCT00436033|Milnacipran|milnacipran|mesh-list
24481625|NCT00436033|Levomilnacipran|levomilnacipran|mesh-list
24807988|NCT02024594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24807989|NCT02024594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807990|NCT02024594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24807991|NCT02024594|Analgesics|analgesics|mesh-ancestor
24807992|NCT02024594|Sensory System Agents|sensory system agents|mesh-ancestor
24807993|NCT02024594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24807994|NCT02024633|Gemcitabine|gemcitabine|mesh-list
24807995|NCT02024633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24807996|NCT02024633|Antimetabolites|antimetabolites|mesh-ancestor
24807997|NCT02024633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807998|NCT02024633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807999|NCT02024633|Antiviral Agents|antiviral agents|mesh-ancestor
24466459|NCT00373581|Anticonvulsants|anticonvulsants|mesh-ancestor
24466460|NCT00373581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466461|NCT00373581|GABA Agents|gaba agents|mesh-ancestor
24466479|NCT00373607|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24808000|NCT02024633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24808001|NCT02024633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808002|NCT02024633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24808003|NCT02024633|Immunologic Factors|immunologic factors|mesh-ancestor
24808004|NCT02024633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808005|NCT02024659|Budesonide|budesonide|mesh-list
24808006|NCT02024659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24808007|NCT02024659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24808008|NCT02024659|Autonomic Agents|autonomic agents|mesh-ancestor
24808009|NCT02024659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24590728|NCT00913718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25661688|NCT01636947|Granisetron|granisetron|mesh-list
25661689|NCT01636947|Tropisetron|tropisetron|mesh-list
25661690|NCT01636947|Dolasetron|dolasetron|mesh-list
25661691|NCT01636947|Alizapride|alizapride|mesh-list
25661692|NCT01636947|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25661693|NCT01636947|BB 1101|bb 1101|mesh-list
25661694|NCT01636947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25661695|NCT01636947|Antiemetics|antiemetics|mesh-ancestor
25661696|NCT01636947|Autonomic Agents|autonomic agents|mesh-ancestor
25661697|NCT01636947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25848592|NCT00045916|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25848593|NCT00045916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24481642|NCT00436072|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24481643|NCT00436072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24481644|NCT00436072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808015|NCT02024659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24808016|NCT02024841|Docetaxel|docetaxel|mesh-list
24808017|NCT02024841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808018|NCT02024841|Tubulin Modulators|tubulin modulators|mesh-ancestor
24808019|NCT02024841|Antimitotic Agents|antimitotic agents|mesh-ancestor
24808020|NCT02024841|Mitosis Modulators|mitosis modulators|mesh-ancestor
24808021|NCT02024841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808022|NCT02024906|Caseins|caseins|mesh-list
24808023|NCT02024906|Chelating Agents|chelating agents|mesh-ancestor
24590778|NCT00913848|Valproic Acid|valproic acid|mesh-list
24481651|NCT00436124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481652|NCT00436124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432117|NCT00253578|Sorafenib|sorafenib|mesh-list
24481654|NCT00436241|Oxaliplatin|oxaliplatin|mesh-list
24481655|NCT00436241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24481656|NCT00436241|Antimetabolites|antimetabolites|mesh-ancestor
25848594|NCT00045916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25848595|NCT00045916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25848596|NCT00045916|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25848597|NCT00045916|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24481750|NCT00436761|Cyclosporine|cyclosporine|mesh-list
24808031|NCT02024919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24808032|NCT02024919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808033|NCT02024919|Vasodilator Agents|vasodilator agents|mesh-ancestor
24808035|NCT02024945|Parasympatholytics|parasympatholytics|mesh-ancestor
25848598|NCT00045916|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25848599|NCT00045916|Adrenergic Agents|adrenergic agents|mesh-ancestor
25848600|NCT00045955|Fexofenadine|fexofenadine|mesh-list
25848601|NCT00045955|Montelukast|montelukast|mesh-list
25848602|NCT00045955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25848603|NCT00045955|Respiratory System Agents|respiratory system agents|mesh-ancestor
25848604|NCT00045955|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24808042|NCT02024945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24808043|NCT02024945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808044|NCT02024945|Urological Agents|urological agents|mesh-ancestor
24808050|NCT02024984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24808051|NCT02024984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481904|NCT00437229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24481905|NCT00437229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481906|NCT00437229|Protease Inhibitors|protease inhibitors|mesh-ancestor
24481907|NCT00437229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481908|NCT00437229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481909|NCT00437229|Antipruritics|antipruritics|mesh-ancestor
24481910|NCT00437229|Dermatologic Agents|dermatologic agents|mesh-ancestor
24481911|NCT00437229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24481912|NCT00437229|Serotonin Agents|serotonin agents|mesh-ancestor
24481913|NCT00437229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24481914|NCT00437229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24481915|NCT00437229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24481917|NCT00437229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24482047|NCT00437762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24808058|NCT02025010|Abiraterone Acetate|abiraterone acetate|mesh-list
24808059|NCT02025010|Glucocorticoids|glucocorticoids|mesh-list
24808060|NCT02025010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24808062|NCT02025010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24667929|NCT05242484|Golimumab|golimumab|mesh-list
24482151|NCT00438087|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24482152|NCT00438087|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24482153|NCT00438087|Prednisolone|prednisolone|mesh-list
24482154|NCT00438087|Prednisolone acetate|prednisolone acetate|mesh-list
24482155|NCT00438087|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24482156|NCT00438087|Prednisolone phosphate|prednisolone phosphate|mesh-list
24482157|NCT00438087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24482158|NCT00438087|Antiemetics|antiemetics|mesh-ancestor
24482159|NCT00438087|Autonomic Agents|autonomic agents|mesh-ancestor
24482160|NCT00438087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24482161|NCT00438087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482162|NCT00438087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24482163|NCT00438087|Glucocorticoids|glucocorticoids|mesh-ancestor
24482173|NCT00438113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24482174|NCT00438113|Diuretics|diuretics|mesh-ancestor
24482175|NCT00438113|Natriuretic Agents|natriuretic agents|mesh-ancestor
24482176|NCT00438113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482177|NCT00438113|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24482178|NCT00438113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24482215|NCT00438152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24482217|NCT00438152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24482218|NCT00438152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24482219|NCT00438152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24482221|NCT00438178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24804881|NCT02005718|Cholecalciferol|cholecalciferol|mesh-list
24482222|NCT00438178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482223|NCT00438217|Leuprolide|leuprolide|mesh-list
24482224|NCT00438217|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24482225|NCT00438217|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24482226|NCT00438217|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24482227|NCT00438217|Fertility Agents|fertility agents|mesh-ancestor
24482228|NCT00438217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24482229|NCT00438217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482230|NCT00438217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24482231|NCT00438217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848605|NCT00045955|Hormone Antagonists|hormone antagonists|mesh-ancestor
24432788|NCT00256178|Antimetabolites|antimetabolites|mesh-ancestor
24482279|NCT00438321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24482280|NCT00438321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848606|NCT00045955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25848607|NCT00045955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848608|NCT00045955|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24808079|NCT02025023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808080|NCT02025023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24808081|NCT02025023|Immunologic Factors|immunologic factors|mesh-ancestor
24808082|NCT02025023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808083|NCT02025023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24808084|NCT02025023|Glucocorticoids|glucocorticoids|mesh-ancestor
24808086|NCT02025023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24603190|NCT00972842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603192|NCT00972855|Androgen Antagonists|androgen antagonists|mesh-ancestor
24603193|NCT00972855|Hormone Antagonists|hormone antagonists|mesh-ancestor
24603194|NCT00972855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24591096|NCT00914953|Oxytocin|oxytocin|mesh-list
25848609|NCT00045955|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25848610|NCT00045955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482314|NCT00438607|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24482315|NCT00438607|Purinergic Agents|purinergic agents|mesh-ancestor
24482316|NCT00438607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25848611|NCT00045955|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24482357|NCT00438776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482359|NCT00438776|Serotonin Agents|serotonin agents|mesh-ancestor
24735375|NCT01656720|Methoxamine|methoxamine|mesh-list
24603196|NCT00972855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603197|NCT00972881|Capecitabine|capecitabine|mesh-list
24603198|NCT00972881|Irinotecan|irinotecan|mesh-list
24603199|NCT00972881|Cetuximab|cetuximab|mesh-list
24603200|NCT00972881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24603201|NCT00972881|Antimetabolites|antimetabolites|mesh-ancestor
24603202|NCT00972881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603203|NCT00972881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603204|NCT00972881|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24603205|NCT00972881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24603206|NCT00972881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603207|NCT00972881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25848612|NCT00045955|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24622812|NCT01068756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24622813|NCT01068756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24482404|NCT00438841|Growth Substances|growth substances|mesh-ancestor
25848613|NCT00045955|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25848614|NCT00045955|Histamine Antagonists|histamine antagonists|mesh-ancestor
25848618|NCT00046020|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24482427|NCT00438984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24482428|NCT00438984|Alkylating Agents|alkylating agents|mesh-ancestor
24482429|NCT00438984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622817|NCT01068756|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24622818|NCT01068756|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24622819|NCT01068756|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24622820|NCT01068756|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24622821|NCT01068756|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24622822|NCT01068756|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24622823|NCT01068795|Enoxaparin|enoxaparin|mesh-list
24622824|NCT01068795|Anticoagulants|anticoagulants|mesh-ancestor
24622825|NCT01068795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24622826|NCT01068795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24482439|NCT00438984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24482440|NCT00439049|Naltrexone|naltrexone|mesh-list
24482472|NCT00439166|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24482473|NCT00439166|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24482474|NCT00439166|Antitubercular Agents|antitubercular agents|mesh-ancestor
24482475|NCT00439166|Leprostatic Agents|leprostatic agents|mesh-ancestor
24482476|NCT00439166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24482477|NCT00439166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24482478|NCT00439166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482479|NCT00439166|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24482480|NCT00439166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24482481|NCT00439166|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24482482|NCT00439166|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24482483|NCT00439166|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24482484|NCT00439166|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24808149|NCT02025374|Levobupivacaine|levobupivacaine|mesh-list
24808150|NCT02025374|Anesthetics, Local|anesthetics, local|mesh-ancestor
24808151|NCT02025374|Anesthetics|anesthetics|mesh-ancestor
24591299|NCT00915811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24482533|NCT00439426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482534|NCT00439426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24482536|NCT00439504|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24482537|NCT00439504|Autonomic Agents|autonomic agents|mesh-ancestor
24482538|NCT00439504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24482539|NCT00439504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482540|NCT00439504|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24482541|NCT00439504|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24482542|NCT00439504|Cholinergic Agents|cholinergic agents|mesh-ancestor
24482543|NCT00439504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24482544|NCT00439504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482546|NCT00439530|Oseltamivir|oseltamivir|mesh-list
24482547|NCT00439530|Probenecid|probenecid|mesh-list
24482548|NCT00439530|Antiviral Agents|antiviral agents|mesh-ancestor
24482549|NCT00439530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24482550|NCT00439530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24482551|NCT00439530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482552|NCT00439530|Uricosuric Agents|uricosuric agents|mesh-ancestor
24433156|NCT00257712|Hormones|hormones|mesh-list
24482593|NCT00439972|Moxifloxacin|moxifloxacin|mesh-list
24482594|NCT00439972|Ortho Evra|ortho evra|mesh-list
25848619|NCT00046020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24482595|NCT00439972|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24482680|NCT00440167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482681|NCT00440167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24482684|NCT00440219|Glucocorticoids|glucocorticoids|mesh-ancestor
24482685|NCT00440219|Hormones|hormones|mesh-ancestor
25166395|NCT04117659|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25166396|NCT04117659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433293|NCT00258089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24482695|NCT00440245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24482696|NCT00440245|Respiratory System Agents|respiratory system agents|mesh-ancestor
24482697|NCT00440245|Tocolytic Agents|tocolytic agents|mesh-ancestor
24482698|NCT00440245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24482699|NCT00440245|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24482700|NCT00440245|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24808170|NCT02025465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24808171|NCT02025465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24808172|NCT02025465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24808173|NCT02025465|Vasodilator Agents|vasodilator agents|mesh-ancestor
24808174|NCT02025491|Amphotericin B|amphotericin b|mesh-list
24808175|NCT02025491|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24808176|NCT02025491|Amebicides|amebicides|mesh-ancestor
24808190|NCT02025608|Dopamine Agents|dopamine agents|mesh-ancestor
24482781|NCT00440622|Antimetabolites|antimetabolites|mesh-ancestor
24482782|NCT00440622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482783|NCT00440622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24482784|NCT00440622|Antiviral Agents|antiviral agents|mesh-ancestor
24482789|NCT00440622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482790|NCT00440622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24482792|NCT00440635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24482793|NCT00440648|Sevelamer|sevelamer|mesh-list
24482864|NCT00440804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24482865|NCT00440804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24482866|NCT00440804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24482867|NCT00440804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482868|NCT00440843|Olanzapine|olanzapine|mesh-list
24482895|NCT00440869|Antidotes|antidotes|mesh-ancestor
24482897|NCT00440895|Anticoagulants|anticoagulants|mesh-ancestor
24482898|NCT00440895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24482899|NCT00440921|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24482902|NCT00440960|Lidocaine|lidocaine|mesh-list
24482903|NCT00440960|Midazolam|midazolam|mesh-list
24482904|NCT00440960|Alfentanil|alfentanil|mesh-list
24482905|NCT00440960|Propofol|propofol|mesh-list
24482906|NCT00440960|Anesthetics, Local|anesthetics, local|mesh-ancestor
24482907|NCT00440960|Anesthetics|anesthetics|mesh-ancestor
24482908|NCT00440960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24482909|NCT00440960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482943|NCT00441025|Alemtuzumab|alemtuzumab|mesh-list
24482944|NCT00441025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24482945|NCT00441025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24482947|NCT00441051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24482973|NCT00441246|Pseudoephedrine|pseudoephedrine|mesh-list
24482974|NCT00441246|Ephedrine|ephedrine|mesh-list
24482975|NCT00441246|Guaifenesin|guaifenesin|mesh-list
24482976|NCT00441246|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
24482977|NCT00441246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24482978|NCT00441246|Autonomic Agents|autonomic agents|mesh-ancestor
24483282|NCT00442637|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24483283|NCT00442637|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24483284|NCT00442637|Growth Substances|growth substances|mesh-ancestor
24483285|NCT00442637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483286|NCT00442637|Growth Inhibitors|growth inhibitors|mesh-ancestor
24483287|NCT00442637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25848620|NCT00046020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25848621|NCT00046020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848622|NCT00046020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25848623|NCT00046020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848624|NCT00046020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24808225|NCT02025868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24808226|NCT02025868|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24808227|NCT02025868|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24808228|NCT02025868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808229|NCT02025868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808230|NCT02025868|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24808231|NCT02025868|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24808232|NCT02025868|Protease Inhibitors|protease inhibitors|mesh-ancestor
24483409|NCT00443235|Leprostatic Agents|leprostatic agents|mesh-ancestor
24483410|NCT00443235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24467344|NCT00377104|Alvocidib|alvocidib|mesh-list
24483493|NCT00443794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24483494|NCT00443794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24483495|NCT00443794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483496|NCT00443794|Antipyretics|antipyretics|mesh-ancestor
24483497|NCT00443794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24483498|NCT00443794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24483501|NCT00443794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24483518|NCT00443937|Mycophenolic Acid|mycophenolic acid|mesh-list
24483519|NCT00443937|Everolimus|everolimus|mesh-list
24483520|NCT00443937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24483533|NCT00443950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24483534|NCT00443950|Analgesics|analgesics|mesh-ancestor
24483535|NCT00443950|Sensory System Agents|sensory system agents|mesh-ancestor
24483536|NCT00443950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24483537|NCT00443950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483538|NCT00443950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24483539|NCT00443950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24483540|NCT00443950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24483541|NCT00443950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24483542|NCT00443950|Immunologic Factors|immunologic factors|mesh-ancestor
24483543|NCT00443963|Esomeprazole|esomeprazole|mesh-list
24483544|NCT00443963|Ranitidine|ranitidine|mesh-list
24808241|NCT02025881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24808243|NCT02025881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808244|NCT02025881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808245|NCT02025881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24808246|NCT02025881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24808247|NCT02025881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25203437|NCT02714231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25203438|NCT02714231|Analgesics|analgesics|mesh-ancestor
25203439|NCT02714231|Sensory System Agents|sensory system agents|mesh-ancestor
24808248|NCT02025881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24808249|NCT02025881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808251|NCT02025998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24808252|NCT02025998|Autonomic Agents|autonomic agents|mesh-ancestor
24808253|NCT02025998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24467512|NCT00377975|Ephedrine|ephedrine|mesh-list
24808254|NCT02025998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808255|NCT02025998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24808256|NCT02025998|Respiratory System Agents|respiratory system agents|mesh-ancestor
24808257|NCT02025998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24483545|NCT00443963|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24483546|NCT00443963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24483547|NCT00443963|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24483548|NCT00443963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483583|NCT00444171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24483584|NCT00444171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483585|NCT00444184|Timolol|timolol|mesh-list
24483586|NCT00444184|Travoprost|travoprost|mesh-list
24483587|NCT00444184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24483588|NCT00444184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24483589|NCT00444184|Adrenergic Agents|adrenergic agents|mesh-ancestor
24483590|NCT00444184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24808261|NCT02025998|Vasodilator Agents|vasodilator agents|mesh-ancestor
24808262|NCT02026050|Dexamethasone|dexamethasone|mesh-list
24808263|NCT02026050|Dexamethasone acetate|dexamethasone acetate|mesh-list
24808264|NCT02026050|BB 1101|bb 1101|mesh-list
24808265|NCT02026050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24808266|NCT02026050|Antiemetics|antiemetics|mesh-ancestor
24808267|NCT02026050|Autonomic Agents|autonomic agents|mesh-ancestor
24808268|NCT02026050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24808269|NCT02026050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808270|NCT02026050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24808271|NCT02026050|Glucocorticoids|glucocorticoids|mesh-ancestor
24808272|NCT02026050|Hormones|hormones|mesh-ancestor
24808273|NCT02026050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24808274|NCT02026050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24808275|NCT02026050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808276|NCT02026050|Protease Inhibitors|protease inhibitors|mesh-ancestor
24483685|NCT00444548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24467605|NCT00378183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24483686|NCT00444548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24483687|NCT00444548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483688|NCT00444548|Adrenergic Agents|adrenergic agents|mesh-ancestor
24483870|NCT00445510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24808278|NCT02026050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876095|NCT03914625|Micronutrients|micronutrients|mesh-ancestor
24752242|NCT01709370|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24808281|NCT02026219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24808282|NCT02026219|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24808283|NCT02026219|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24808284|NCT02026219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24808285|NCT02026219|Purinergic Agents|purinergic agents|mesh-ancestor
24808286|NCT02026219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24808287|NCT02026219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808288|NCT02026219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808290|NCT02026310|Glimepiride|glimepiride|mesh-list
24790648|NCT01944085|Ibuprofen|ibuprofen|mesh-list
24808291|NCT02026310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24483894|NCT00445796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24483895|NCT00445796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24483896|NCT00445796|Antiviral Agents|antiviral agents|mesh-ancestor
24483897|NCT00445796|Schistosomicides|schistosomicides|mesh-ancestor
24483898|NCT00445796|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24483915|NCT00445874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483916|NCT00445874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483917|NCT00445874|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24483919|NCT00445900|Prednisone|prednisone|mesh-list
24483920|NCT00445900|Cyclophosphamide|cyclophosphamide|mesh-list
24483921|NCT00445900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24483922|NCT00445900|Immunologic Factors|immunologic factors|mesh-ancestor
24483923|NCT00445900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483925|NCT00445900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24808302|NCT02026479|Autonomic Agents|autonomic agents|mesh-ancestor
24808303|NCT02026479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24808309|NCT02026479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24808310|NCT02026479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808311|NCT02026479|Protease Inhibitors|protease inhibitors|mesh-ancestor
24808312|NCT02026479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808313|NCT02026479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808314|NCT02026492|Methacholine Chloride|methacholine chloride|mesh-list
24808315|NCT02026492|Miotics|miotics|mesh-ancestor
24808316|NCT02026492|Autonomic Agents|autonomic agents|mesh-ancestor
24808317|NCT02026492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24808318|NCT02026492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808319|NCT02026492|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24808320|NCT02026492|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
24808321|NCT02026492|Respiratory System Agents|respiratory system agents|mesh-ancestor
24808322|NCT02026492|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24808323|NCT02026492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24808324|NCT02026492|Cholinergic Agents|cholinergic agents|mesh-ancestor
24808336|NCT02026583|Simvastatin|simvastatin|mesh-list
24592153|NCT00920465|Misoprostol|misoprostol|mesh-list
25848625|NCT00046020|Antidepressive Agents|antidepressive agents|mesh-ancestor
24484054|NCT00446420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24484055|NCT00446420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484056|NCT00446420|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24484057|NCT00446420|Anesthetics, General|anesthetics, general|mesh-ancestor
24484058|NCT00446420|Anesthetics|anesthetics|mesh-ancestor
24484059|NCT00446420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24484060|NCT00446420|Narcotics|narcotics|mesh-ancestor
24484091|NCT00446524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484092|NCT00446524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24484105|NCT00446537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24484108|NCT00446589|Teriparatide|teriparatide|mesh-list
24484109|NCT00446589|Ibandronic Acid|ibandronic acid|mesh-list
24484110|NCT00446589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24484177|NCT00446901|Micronutrients|micronutrients|mesh-ancestor
24484227|NCT00447070|Protease Inhibitors|protease inhibitors|mesh-ancestor
24484228|NCT00447070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484229|NCT00447070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484230|NCT00447070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24484231|NCT00447070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24484232|NCT00447070|Antiviral Agents|antiviral agents|mesh-ancestor
24484233|NCT00447070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24467990|NCT00379431|Autonomic Agents|autonomic agents|mesh-ancestor
24467991|NCT00379431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24467993|NCT00379431|Glucocorticoids|glucocorticoids|mesh-ancestor
24484234|NCT00447213|Insulin|insulin|mesh-list
24484259|NCT00447369|Analgesics|analgesics|mesh-ancestor
24484260|NCT00447369|Sensory System Agents|sensory system agents|mesh-ancestor
24484261|NCT00447369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24484262|NCT00447369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484263|NCT00447369|Anticonvulsants|anticonvulsants|mesh-ancestor
24484264|NCT00447369|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24484265|NCT00447369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25848626|NCT00046020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25848627|NCT00046033|Ritonavir|ritonavir|mesh-list
24808353|NCT02026778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24808354|NCT02026778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808357|NCT02026778|Dermatologic Agents|dermatologic agents|mesh-ancestor
24808404|NCT02026973|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24808405|NCT02026973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24808406|NCT02026973|Hormone Antagonists|hormone antagonists|mesh-ancestor
24468074|NCT00379691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24808407|NCT02026973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24808408|NCT02026973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808409|NCT02026973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24808410|NCT02026973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25848628|NCT00046033|Lopinavir|lopinavir|mesh-list
24808445|NCT02027220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24808446|NCT02027298|Abatacept|abatacept|mesh-list
24808447|NCT02027298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24808448|NCT02027298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808449|NCT02027298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484337|NCT00447863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24484338|NCT00447863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484339|NCT00447863|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25848629|NCT00046033|Saquinavir|saquinavir|mesh-list
25848630|NCT00046033|Amprenavir|amprenavir|mesh-list
25848631|NCT00046033|Tenofovir|tenofovir|mesh-list
25848632|NCT00046033|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25848633|NCT00046033|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24484343|NCT00447863|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24484344|NCT00447863|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24484345|NCT00447863|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24484347|NCT00447915|Cholecalciferol|cholecalciferol|mesh-list
24808450|NCT02027298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24808451|NCT02027298|Immunologic Factors|immunologic factors|mesh-ancestor
24808452|NCT02027298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808453|NCT02027298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24808455|NCT02027324|Povidone-Iodine|povidone-iodine|mesh-list
24808456|NCT02027324|Povidone|povidone|mesh-list
24808457|NCT02027324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24484363|NCT00447967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24484364|NCT00447967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484365|NCT00447967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24484366|NCT00447967|Immunologic Factors|immunologic factors|mesh-ancestor
24484367|NCT00447967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484368|NCT00447967|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24484369|NCT00447967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24484370|NCT00447967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484371|NCT00447967|Antidotes|antidotes|mesh-ancestor
24622883|NCT01069042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24622884|NCT01069042|Protease Inhibitors|protease inhibitors|mesh-ancestor
24622885|NCT01069042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622886|NCT01069042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622887|NCT01069042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24622894|NCT01069055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24808489|NCT02027363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808490|NCT02027363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808491|NCT02027454|Moxifloxacin|moxifloxacin|mesh-list
24808492|NCT02027454|Cabotegravir|cabotegravir|mesh-list
24592572|NCT00922896|Gemcitabine|gemcitabine|mesh-list
24484397|NCT00448149|Everolimus|everolimus|mesh-list
24484398|NCT00448149|Sorafenib|sorafenib|mesh-list
24484399|NCT00448149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468346|NCT00381147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468347|NCT00381147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24468348|NCT00381147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24468350|NCT00381173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24468351|NCT00381173|Immunologic Factors|immunologic factors|mesh-ancestor
24805248|NCT02008214|Pentoxifylline|pentoxifylline|mesh-list
24805249|NCT02008214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25848634|NCT00046033|Protease Inhibitors|protease inhibitors|mesh-ancestor
25848635|NCT00046033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848636|NCT00046033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805251|NCT02008214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848637|NCT00046033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24484430|NCT00448292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24484431|NCT00448292|Serotonin Agents|serotonin agents|mesh-ancestor
24484432|NCT00448292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24808494|NCT02027454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24808495|NCT02027454|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24808496|NCT02027454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24808502|NCT02027454|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24484436|NCT00448305|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24484437|NCT00448305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24484438|NCT00448305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484439|NCT00448305|Tubulin Modulators|tubulin modulators|mesh-ancestor
24484440|NCT00448305|Antimitotic Agents|antimitotic agents|mesh-ancestor
24484441|NCT00448305|Mitosis Modulators|mitosis modulators|mesh-ancestor
24484442|NCT00448305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484444|NCT00448383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24484445|NCT00448383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24484446|NCT00448396|Epothilone B|epothilone b|mesh-list
24484447|NCT00448396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484448|NCT00448396|Tubulin Modulators|tubulin modulators|mesh-ancestor
24484449|NCT00448396|Antimitotic Agents|antimitotic agents|mesh-ancestor
24484450|NCT00448396|Mitosis Modulators|mitosis modulators|mesh-ancestor
24484451|NCT00448396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808511|NCT02027493|Antiviral Agents|antiviral agents|mesh-ancestor
24808512|NCT02027493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24484573|NCT00449280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484574|NCT00449280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484575|NCT00449280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24484576|NCT00449280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24484577|NCT00449280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24484578|NCT00449280|Antifungal Agents|antifungal agents|mesh-ancestor
24484587|NCT00449319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484588|NCT00449319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484674|NCT00449527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24484675|NCT00449527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484676|NCT00449527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25848638|NCT00046033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24446855|NCT00306319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24484721|NCT00449657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24484722|NCT00449657|Immunologic Factors|immunologic factors|mesh-ancestor
24484741|NCT00449722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24484742|NCT00449774|Lamotrigine|lamotrigine|mesh-list
24484743|NCT00449774|Anticonvulsants|anticonvulsants|mesh-list
24484744|NCT00449774|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24484974|NCT00450957|Antioxidants|antioxidants|mesh-ancestor
24484745|NCT00449774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24484746|NCT00449774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484747|NCT00449774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24484748|NCT00449774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484749|NCT00449774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24484750|NCT00449774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24484751|NCT00449774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24484752|NCT00449774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24484753|NCT00449774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24484754|NCT00449800|Ceftriaxone|ceftriaxone|mesh-list
24484755|NCT00449800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24484772|NCT00450008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484773|NCT00450008|Tubulin Modulators|tubulin modulators|mesh-ancestor
24484774|NCT00450008|Antimitotic Agents|antimitotic agents|mesh-ancestor
24484775|NCT00450008|Mitosis Modulators|mitosis modulators|mesh-ancestor
25166397|NCT04117659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166398|NCT04111315|Dipyrone|dipyrone|mesh-list
24808535|NCT02027792|Analgesics|analgesics|mesh-ancestor
24808536|NCT02027792|Sensory System Agents|sensory system agents|mesh-ancestor
25419413|NCT02707042|Amoxicillin|amoxicillin|mesh-list
25661698|NCT01636947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661699|NCT01636947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25661700|NCT01636947|Glucocorticoids|glucocorticoids|mesh-ancestor
25661701|NCT01636947|Hormones|hormones|mesh-ancestor
24484810|NCT00450099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24484811|NCT00450138|Cisplatin|cisplatin|mesh-list
24484812|NCT00450138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484813|NCT00450164|Nadolol|nadolol|mesh-list
24484814|NCT00450164|Prazosin|prazosin|mesh-list
24484815|NCT00450164|Isosorbide|isosorbide|mesh-list
24484816|NCT00450164|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24484817|NCT00450164|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
24484818|NCT00450164|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24484819|NCT00450164|Diuretics|diuretics|mesh-ancestor
25089195|NCT03268226|Beclomethasone|beclomethasone|mesh-list
24805298|NCT02008747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24484820|NCT00450164|Natriuretic Agents|natriuretic agents|mesh-ancestor
24484821|NCT00450164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484822|NCT00450164|Vasodilator Agents|vasodilator agents|mesh-ancestor
24484845|NCT00450203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484846|NCT00450203|Growth Inhibitors|growth inhibitors|mesh-ancestor
24484876|NCT00450320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484878|NCT00450398|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24484879|NCT00450398|Immunologic Factors|immunologic factors|mesh-ancestor
24484882|NCT00450398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484883|NCT00450398|Antiviral Agents|antiviral agents|mesh-ancestor
24484884|NCT00450398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24484885|NCT00450398|Interferon Inducers|interferon inducers|mesh-ancestor
24484886|NCT00450398|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24484887|NCT00450398|Protective Agents|protective agents|mesh-ancestor
24808560|NCT02027961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24808561|NCT02027961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808562|NCT02027961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24808563|NCT02027961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484905|NCT00450736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24484906|NCT00450736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24484908|NCT00450736|Sensory System Agents|sensory system agents|mesh-ancestor
24484916|NCT00450736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484918|NCT00450762|Carboplatin|carboplatin|mesh-list
24484919|NCT00450762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484920|NCT00450762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24484921|NCT00450762|Antimetabolites|antimetabolites|mesh-ancestor
24484922|NCT00450762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484923|NCT00450762|Antiviral Agents|antiviral agents|mesh-ancestor
24805311|NCT02008786|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24469993|NCT00388271|Urological Agents|urological agents|mesh-ancestor
24484924|NCT00450762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24484925|NCT00450762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484926|NCT00450762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24484927|NCT00450762|Immunologic Factors|immunologic factors|mesh-ancestor
24484928|NCT00450762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484929|NCT00450827|Bevacizumab|bevacizumab|mesh-list
24484930|NCT00450827|Antibodies|antibodies|mesh-list
24484970|NCT00450944|Immunologic Factors|immunologic factors|mesh-ancestor
24484971|NCT00450944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484972|NCT00450957|Lycopene|lycopene|mesh-list
24484973|NCT00450957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24484986|NCT00451061|Adrenergic Agents|adrenergic agents|mesh-ancestor
24484987|NCT00451061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24470186|NCT00389090|Alkylating Agents|alkylating agents|mesh-ancestor
24484988|NCT00451061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484989|NCT00451061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848639|NCT00046033|Antiviral Agents|antiviral agents|mesh-ancestor
25848640|NCT00046033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25848641|NCT00046033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25848642|NCT00046033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25848643|NCT00046033|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25848644|NCT00046033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25848645|NCT00046033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25848646|NCT00046033|Antitubercular Agents|antitubercular agents|mesh-ancestor
25848647|NCT00046033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25848648|NCT00046111|Topotecan|topotecan|mesh-list
24808594|NCT02028234|Omeprazole|omeprazole|mesh-list
24808595|NCT02028234|Pantoprazole|pantoprazole|mesh-list
24808596|NCT02028234|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24808597|NCT02028234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24808598|NCT02028234|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24808599|NCT02028234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808600|NCT02028234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470465|NCT00390208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24485042|NCT00451230|Hydrocortisone|hydrocortisone|mesh-list
25848649|NCT00046111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24485047|NCT00451230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24485048|NCT00451230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485049|NCT00451230|Sensory System Agents|sensory system agents|mesh-ancestor
24485050|NCT00451230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24485051|NCT00451230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24485052|NCT00451230|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24485054|NCT00451230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24485055|NCT00451230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485056|NCT00451230|Dopamine Agents|dopamine agents|mesh-ancestor
24485057|NCT00451230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24485059|NCT00451360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24808611|NCT02028312|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24808612|NCT02028312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24808613|NCT02028312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24808615|NCT02028403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25848650|NCT00046111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25848651|NCT00046111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848652|NCT00046111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848653|NCT00046111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848654|NCT00046137|Teriparatide|teriparatide|mesh-list
25848655|NCT00046137|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25848656|NCT00046137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24485180|NCT00451867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24485181|NCT00451867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485182|NCT00451867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808621|NCT02028416|Immunologic Factors|immunologic factors|mesh-ancestor
24808622|NCT02028416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808623|NCT02028416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24808624|NCT02028429|Sildenafil Citrate|sildenafil citrate|mesh-list
24808625|NCT02028429|Vasodilator Agents|vasodilator agents|mesh-ancestor
24808626|NCT02028429|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24808627|NCT02028429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24808628|NCT02028429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808629|NCT02028429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808630|NCT02028429|Urological Agents|urological agents|mesh-ancestor
24808631|NCT02028494|Capecitabine|capecitabine|mesh-list
24808632|NCT02028494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24808633|NCT02028494|Antimetabolites|antimetabolites|mesh-ancestor
24808692|NCT02028689|Diuretics|diuretics|mesh-ancestor
24808693|NCT02028689|Natriuretic Agents|natriuretic agents|mesh-ancestor
24808694|NCT02028689|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24808695|NCT02028689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24485331|NCT00452595|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24485332|NCT00452595|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24485333|NCT00452595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24485334|NCT00452595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24485335|NCT00452595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485378|NCT00452855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24485379|NCT00452855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485380|NCT00452855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25661702|NCT01636947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25661703|NCT01636947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25661704|NCT01636947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25661705|NCT01636947|Protease Inhibitors|protease inhibitors|mesh-ancestor
25661706|NCT01636947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661707|NCT01636947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485381|NCT00452855|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24485382|NCT00452855|Anesthetics, General|anesthetics, general|mesh-ancestor
24485392|NCT00452881|Antimetabolites|antimetabolites|mesh-ancestor
25848661|NCT00046137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24485461|NCT00453115|Antiviral Agents|antiviral agents|mesh-ancestor
24485479|NCT00453167|Tubulin Modulators|tubulin modulators|mesh-ancestor
24485480|NCT00453167|Antimitotic Agents|antimitotic agents|mesh-ancestor
24485481|NCT00453167|Mitosis Modulators|mitosis modulators|mesh-ancestor
24485482|NCT00453167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485483|NCT00453167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24485484|NCT00453167|Antimetabolites|antimetabolites|mesh-ancestor
24808744|NCT02028923|Narcotics|narcotics|mesh-ancestor
24446857|NCT00306319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848662|NCT00046137|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25848663|NCT00046137|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25848664|NCT00046150|Insulin glulisine|insulin glulisine|mesh-list
24446862|NCT00306358|Vitamins|vitamins|mesh-ancestor
24446863|NCT00306358|Micronutrients|micronutrients|mesh-ancestor
24446864|NCT00306358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485629|NCT00454259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24485630|NCT00454259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485632|NCT00454259|Sensory System Agents|sensory system agents|mesh-ancestor
24808771|NCT02029001|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24808773|NCT02029105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24471965|NCT00397657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808774|NCT02029105|Immunologic Factors|immunologic factors|mesh-ancestor
24808775|NCT02029105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808776|NCT02029105|Viscosupplements|viscosupplements|mesh-ancestor
24808777|NCT02029105|Protective Agents|protective agents|mesh-ancestor
24808778|NCT02029118|Aspirin|aspirin|mesh-list
24485680|NCT00454480|Immunologic Factors|immunologic factors|mesh-ancestor
24485681|NCT00454480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485682|NCT00454480|Antiviral Agents|antiviral agents|mesh-ancestor
24485684|NCT00454480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485685|NCT00454480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24485686|NCT00454480|Alkylating Agents|alkylating agents|mesh-ancestor
24485687|NCT00454480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24485688|NCT00454480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24485689|NCT00454480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24485690|NCT00454480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24485691|NCT00454480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24808794|NCT02029118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24471972|NCT00397709|Rifampin|rifampin|mesh-list
24808795|NCT02029118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808796|NCT02029118|Antipyretics|antipyretics|mesh-ancestor
24808797|NCT02029118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24808798|NCT02029118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24808799|NCT02029118|Antimetabolites|antimetabolites|mesh-ancestor
24808800|NCT02029118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24808801|NCT02029118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24808802|NCT02029118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24593726|NCT00930722|Quinapril|quinapril|mesh-list
24485735|NCT00454740|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24485736|NCT00454740|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24485737|NCT00454740|Cholinergic Agents|cholinergic agents|mesh-ancestor
24485742|NCT00454831|Chitosan|chitosan|mesh-list
24485743|NCT00454831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24485744|NCT00454831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24485745|NCT00454831|Antimetabolites|antimetabolites|mesh-ancestor
24485746|NCT00454831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485747|NCT00454831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24485748|NCT00454831|Chelating Agents|chelating agents|mesh-ancestor
24485749|NCT00454831|Sequestering Agents|sequestering agents|mesh-ancestor
25661708|NCT01636947|Antipruritics|antipruritics|mesh-ancestor
25661709|NCT01636947|Dermatologic Agents|dermatologic agents|mesh-ancestor
24485750|NCT00454831|Hemostatics|hemostatics|mesh-ancestor
25661710|NCT01636947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25848665|NCT00046150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25848666|NCT00046150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485751|NCT00454831|Coagulants|coagulants|mesh-ancestor
24485752|NCT00454883|Ziprasidone|ziprasidone|mesh-list
24485753|NCT00454883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24485754|NCT00454883|Serotonin Agents|serotonin agents|mesh-ancestor
24471992|NCT00397722|Paroxetine|paroxetine|mesh-list
24485755|NCT00454883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25848667|NCT00046163|Midodrine|midodrine|mesh-list
24485765|NCT00454896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24485766|NCT00454896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24485767|NCT00454896|Cholinergic Agents|cholinergic agents|mesh-ancestor
24485768|NCT00454896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25166399|NCT04111315|Ibuprofen|ibuprofen|mesh-list
24485769|NCT00454896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485770|NCT00454896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485771|NCT00454896|Urological Agents|urological agents|mesh-ancestor
24485774|NCT00454961|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24485775|NCT00454961|Antimalarials|antimalarials|mesh-ancestor
24485776|NCT00454961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24485777|NCT00454961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24485778|NCT00454961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24485779|NCT00455026|Remifentanil|remifentanil|mesh-list
24485780|NCT00455026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24485781|NCT00455026|Narcotics|narcotics|mesh-ancestor
24485797|NCT00455091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485798|NCT00455091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485799|NCT00455091|Antiviral Agents|antiviral agents|mesh-ancestor
24485800|NCT00455091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24485801|NCT00455091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24485802|NCT00455091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24485804|NCT00455117|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24485805|NCT00455117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24485806|NCT00455117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24805501|NCT02009709|Vitamin B Complex|vitamin b complex|mesh-ancestor
24485807|NCT00455117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485808|NCT00455117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24485809|NCT00455117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24485810|NCT00455117|Analgesics|analgesics|mesh-ancestor
24485811|NCT00455117|Sensory System Agents|sensory system agents|mesh-ancestor
24485812|NCT00455117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24485813|NCT00455117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485825|NCT00455234|Antiemetics|antiemetics|mesh-ancestor
24485826|NCT00455234|Autonomic Agents|autonomic agents|mesh-ancestor
24485827|NCT00455234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24485907|NCT00455416|Resveratrol|resveratrol|mesh-list
24485908|NCT00455416|Quercetin|quercetin|mesh-list
24485909|NCT00455416|Antioxidants|antioxidants|mesh-ancestor
24485910|NCT00455416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485911|NCT00455416|Protective Agents|protective agents|mesh-ancestor
24485912|NCT00455416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808816|NCT02029313|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24808817|NCT02029313|Hormone Antagonists|hormone antagonists|mesh-ancestor
24808818|NCT02029313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24808819|NCT02029313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805506|NCT02009709|Dermatologic Agents|dermatologic agents|mesh-ancestor
24808820|NCT02029313|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24808821|NCT02029313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24808822|NCT02029313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808823|NCT02029378|Eculizumab|eculizumab|mesh-list
24808824|NCT02029378|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24808825|NCT02029378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24808826|NCT02029378|Immunologic Factors|immunologic factors|mesh-ancestor
24808827|NCT02029378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808828|NCT02029456|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24808829|NCT02029456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24808830|NCT02029456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24603892|NCT00976066|Sensory System Agents|sensory system agents|mesh-ancestor
24603965|NCT00976300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24603966|NCT00976300|Dermatologic Agents|dermatologic agents|mesh-ancestor
24603967|NCT00976300|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24603969|NCT00976326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24485913|NCT00455416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485914|NCT00455416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25661711|NCT01636947|Serotonin Agents|serotonin agents|mesh-ancestor
24485918|NCT00455416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24485919|NCT00455416|Antimetabolites|antimetabolites|mesh-ancestor
24485920|NCT00455416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24485921|NCT00455416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24485922|NCT00455416|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24485923|NCT00455442|Mifepristone|mifepristone|mesh-list
24485924|NCT00455442|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25166400|NCT04111315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24486012|NCT00455832|Antiviral Agents|antiviral agents|mesh-ancestor
24486013|NCT00455832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24486015|NCT00455845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24486016|NCT00455845|Contraceptive Agents|contraceptive agents|mesh-ancestor
24486017|NCT00455845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24486018|NCT00455845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486019|NCT00455845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24603973|NCT00976469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622895|NCT01069055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622897|NCT01069055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24622909|NCT01069081|Mitosis Modulators|mitosis modulators|mesh-ancestor
24622910|NCT01069081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622911|NCT01069081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24622912|NCT01069081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24622913|NCT01069081|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24622914|NCT01069081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622916|NCT01069094|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24622917|NCT01069094|Fertility Agents|fertility agents|mesh-ancestor
24622918|NCT01069094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24622919|NCT01069094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622920|NCT01069094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24486020|NCT00455845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24486022|NCT00455871|Ranibizumab|ranibizumab|mesh-list
24486023|NCT00455871|Verteporfin|verteporfin|mesh-list
24486024|NCT00455871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24486025|NCT00455871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25848669|NCT00046163|Autonomic Agents|autonomic agents|mesh-ancestor
24486031|NCT00455871|Dermatologic Agents|dermatologic agents|mesh-ancestor
24486054|NCT00455936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486055|NCT00456027|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24486056|NCT00456027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24622951|NCT01069198|Mitosis Modulators|mitosis modulators|mesh-ancestor
24622952|NCT01069263|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
24808833|NCT02029482|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24808834|NCT02029482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808835|NCT02029482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24808836|NCT02029482|Immunologic Factors|immunologic factors|mesh-ancestor
24808837|NCT02029482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808838|NCT02029534|Atorvastatin|atorvastatin|mesh-list
24808839|NCT02029534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24808840|NCT02029534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24808852|NCT02029573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24808853|NCT02029573|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24808855|NCT02029573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24808856|NCT02029573|Alkylating Agents|alkylating agents|mesh-ancestor
24808857|NCT02029573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472738|NCT00400387|Riboflavin|riboflavin|mesh-list
24472906|NCT00401115|Immunologic Factors|immunologic factors|mesh-ancestor
24472907|NCT00401115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472909|NCT00401128|Irinotecan|irinotecan|mesh-list
24738723|NCT01677065|Oxycodone|oxycodone|mesh-list
24808858|NCT02029586|Beta-lapachone|beta-lapachone|mesh-list
24808859|NCT02029586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24808860|NCT02029586|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24808861|NCT02029586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24808862|NCT02029586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808863|NCT02029586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661712|NCT01636947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24808865|NCT02029599|Acetaminophen|acetaminophen|mesh-list
24808866|NCT02029599|Methotrexate|methotrexate|mesh-list
24808867|NCT02029599|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24808868|NCT02029599|Abortifacient Agents|abortifacient agents|mesh-ancestor
24808869|NCT02029599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24808870|NCT02029599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808871|NCT02029599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24808872|NCT02029599|Antimetabolites|antimetabolites|mesh-ancestor
25131854|NCT03023059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808873|NCT02029599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808874|NCT02029599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808875|NCT02029599|Dermatologic Agents|dermatologic agents|mesh-ancestor
24808882|NCT02029599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24808884|NCT02029599|Sensory System Agents|sensory system agents|mesh-ancestor
24808885|NCT02029599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24808888|NCT02029612|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24486102|NCT00456313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24486103|NCT00456313|Dermatologic Agents|dermatologic agents|mesh-ancestor
24486104|NCT00456313|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24486105|NCT00456339|Amoxicillin|amoxicillin|mesh-list
24486106|NCT00456339|Clavulanic Acid|clavulanic acid|mesh-list
24461328|NCT00351910|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24473218|NCT00402415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24486107|NCT00456339|Clavulanic Acids|clavulanic acids|mesh-list
24486108|NCT00456339|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24486109|NCT00456339|Prednisolone|prednisolone|mesh-list
24486110|NCT00456339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24486111|NCT00456339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24486112|NCT00456339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24486113|NCT00456339|Glucocorticoids|glucocorticoids|mesh-ancestor
24486114|NCT00456339|Hormones|hormones|mesh-ancestor
25848670|NCT00046163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24486115|NCT00456339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24486117|NCT00456339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24486118|NCT00456339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486119|NCT00456339|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24486120|NCT00456339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486121|NCT00456339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486122|NCT00456430|Citalopram|citalopram|mesh-list
24486123|NCT00456430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24486164|NCT00456586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24486165|NCT00456586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486166|NCT00456586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473643|NCT00403663|Anesthetics, Local|anesthetics, local|mesh-ancestor
24473644|NCT00403663|Anesthetics|anesthetics|mesh-ancestor
24473645|NCT00403663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24473646|NCT00403663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473663|NCT00403728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473664|NCT00403728|Antifungal Agents|antifungal agents|mesh-ancestor
24473665|NCT00403728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24808890|NCT02029612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24808891|NCT02029612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808892|NCT02029612|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24808893|NCT02029612|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24808894|NCT02029612|Cholinergic Agents|cholinergic agents|mesh-ancestor
24808895|NCT02029612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24808896|NCT02029612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808897|NCT02029625|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24808899|NCT02029625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24808900|NCT02029625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24808901|NCT02029625|Antimetabolites|antimetabolites|mesh-ancestor
24808902|NCT02029625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808903|NCT02029625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24667631|NCT05359224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24673969|NCT01341340|Everolimus|everolimus|mesh-list
24473667|NCT00403728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24473668|NCT00403728|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24473669|NCT00403780|Pregabalin|pregabalin|mesh-list
24473670|NCT00403780|Analgesics|analgesics|mesh-ancestor
24739197|NCT01679743|Trastuzumab|trastuzumab|mesh-list
24473707|NCT00403897|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25181782|NCT04793490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24808904|NCT02029625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24808907|NCT02029794|Retinol acetate|retinol acetate|mesh-list
24808908|NCT02029794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24808909|NCT02029794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24808910|NCT02029794|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24808911|NCT02029794|Immunologic Factors|immunologic factors|mesh-ancestor
24603974|NCT00976651|Menotropins|menotropins|mesh-list
24603979|NCT00976690|Mesalamine|mesalamine|mesh-list
24808923|NCT02029898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25848671|NCT00046163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808983|NCT02030483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24808984|NCT02030483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486208|NCT00456833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24486209|NCT00456833|Immunologic Factors|immunologic factors|mesh-ancestor
24486243|NCT00456898|Sensory System Agents|sensory system agents|mesh-ancestor
24486244|NCT00456898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24486245|NCT00456898|Antitussive Agents|antitussive agents|mesh-ancestor
24486246|NCT00456898|Respiratory System Agents|respiratory system agents|mesh-ancestor
24486247|NCT00456898|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24486249|NCT00456937|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24486250|NCT00456937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24473708|NCT00403897|Laxatives|laxatives|mesh-ancestor
24473709|NCT00403897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24486251|NCT00456937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25848672|NCT00046163|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25848673|NCT00046163|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25848674|NCT00046163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25848675|NCT00046163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25848676|NCT00046163|Adrenergic Agents|adrenergic agents|mesh-ancestor
25848677|NCT00046163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24486261|NCT00456963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24486262|NCT00456963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24486263|NCT00456963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25848678|NCT00046163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848679|NCT00046176|Lamivudine|lamivudine|mesh-list
25848680|NCT00046176|Abacavir|abacavir|mesh-list
25848681|NCT00046176|Dideoxynucleosides|dideoxynucleosides|mesh-list
25848682|NCT00046176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25848683|NCT00046176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25848684|NCT00046176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848685|NCT00046176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848686|NCT00046176|Antiviral Agents|antiviral agents|mesh-ancestor
25848687|NCT00046176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25848688|NCT00046176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25848689|NCT00046176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25848690|NCT00046176|Antimetabolites|antimetabolites|mesh-ancestor
25848691|NCT00046241|Bupropion|bupropion|mesh-list
24486279|NCT00456976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486281|NCT00457054|Antidepressive Agents|antidepressive agents|mesh-ancestor
24486282|NCT00457054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24486283|NCT00457054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486326|NCT00457145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24486327|NCT00457145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24486329|NCT00457145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486330|NCT00457145|Growth Inhibitors|growth inhibitors|mesh-ancestor
24486453|NCT00458055|Antimetabolites|antimetabolites|mesh-ancestor
25661713|NCT01636947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25661714|NCT01636947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25661715|NCT01636947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25661716|NCT01636947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25661717|NCT01636947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25661718|NCT01636947|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25661719|NCT01636947|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25661720|NCT01636947|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25661721|NCT01636947|Dopamine Agents|dopamine agents|mesh-ancestor
25661722|NCT01636947|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25661723|NCT01636960|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25661724|NCT01636960|Antiviral Agents|antiviral agents|mesh-ancestor
25848694|NCT00046241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25848695|NCT00046241|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24486454|NCT00458055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486455|NCT00458055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24486456|NCT00458055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24486457|NCT00458055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486458|NCT00458055|Vasodilator Agents|vasodilator agents|mesh-ancestor
24486459|NCT00458055|Vitamin B Complex|vitamin b complex|mesh-ancestor
24486460|NCT00458055|Vitamins|vitamins|mesh-ancestor
24486461|NCT00458055|Micronutrients|micronutrients|mesh-ancestor
24486462|NCT00458055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486463|NCT00458081|Rimonabant|rimonabant|mesh-list
24445689|NCT00302289|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24445690|NCT00302289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445691|NCT00302289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24486464|NCT00458081|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24486465|NCT00458081|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24486466|NCT00458081|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25131999|NCT03021772|Hormones|hormones|mesh-ancestor
24486467|NCT00458081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24486468|NCT00458081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486469|NCT00458081|Hormones|hormones|mesh-ancestor
24486470|NCT00458081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24486471|NCT00458081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486472|NCT00458185|Etanercept|etanercept|mesh-list
24486593|NCT00458614|Dexlansoprazole|dexlansoprazole|mesh-list
24486597|NCT00458614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486598|NCT00458614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486599|NCT00458718|Rimonabant|rimonabant|mesh-list
24486605|NCT00458718|Hormones|hormones|mesh-ancestor
24486606|NCT00458718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24486635|NCT00458913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486636|NCT00458991|Dextromethorphan|dextromethorphan|mesh-list
24486637|NCT00458991|Caffeine|caffeine|mesh-list
24473813|NCT00404261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486648|NCT00458991|Respiratory System Agents|respiratory system agents|mesh-ancestor
24486649|NCT00458991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24486650|NCT00458991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24486651|NCT00459004|Rimonabant|rimonabant|mesh-list
24486652|NCT00459004|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24486653|NCT00459004|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24486654|NCT00459004|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24486655|NCT00459004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24486656|NCT00459004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486658|NCT00459004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24486659|NCT00459004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486660|NCT00459160|Antihypertensive Agents|antihypertensive agents|mesh-list
24486661|NCT00459173|Rimonabant|rimonabant|mesh-list
24486707|NCT00459563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24486708|NCT00459563|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24486709|NCT00459563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24486710|NCT00459563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486711|NCT00459563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24486749|NCT00459836|Antimitotic Agents|antimitotic agents|mesh-ancestor
24486750|NCT00459836|Mitosis Modulators|mitosis modulators|mesh-ancestor
24486783|NCT00460083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24486821|NCT00460226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24486822|NCT00460226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486823|NCT00460226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24486824|NCT00460226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486825|NCT00460226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24486826|NCT00460226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25661725|NCT01636960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25661726|NCT01637077|Pregabalin|pregabalin|mesh-list
25661727|NCT01637077|Analgesics|analgesics|mesh-ancestor
25661728|NCT01637077|Sensory System Agents|sensory system agents|mesh-ancestor
25661729|NCT01637077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25848705|NCT00046254|Zoledronic Acid|zoledronic acid|mesh-list
24676689|NCT01352130|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
24676691|NCT01352130|Autonomic Agents|autonomic agents|mesh-ancestor
24486828|NCT00460226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24486829|NCT00460226|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24486830|NCT00460252|Insulin|insulin|mesh-list
24486831|NCT00460252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24486857|NCT00460369|Renal Agents|renal agents|mesh-ancestor
24486858|NCT00460382|Ritonavir|ritonavir|mesh-list
24486859|NCT00460382|Darunavir|darunavir|mesh-list
24486860|NCT00460382|Raltegravir Potassium|raltegravir potassium|mesh-list
24486861|NCT00460382|Enfuvirtide|enfuvirtide|mesh-list
24486862|NCT00460382|Etravirine|etravirine|mesh-list
24486863|NCT00460382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24486864|NCT00460382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24486865|NCT00460382|Protease Inhibitors|protease inhibitors|mesh-ancestor
24486866|NCT00460382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486867|NCT00460382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486868|NCT00460382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24486869|NCT00460382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24486870|NCT00460382|Antiviral Agents|antiviral agents|mesh-ancestor
24486871|NCT00460382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24486872|NCT00460382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24486892|NCT00460473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24486893|NCT00460473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24809032|NCT02030912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24474058|NCT00404794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474060|NCT00404794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676853|NCT01352572|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24676855|NCT01352611|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24676856|NCT01352611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676857|NCT01352611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24676858|NCT01352611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24676859|NCT01352611|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24809095|NCT02031211|Analgesics|analgesics|mesh-ancestor
24809096|NCT02031211|Sensory System Agents|sensory system agents|mesh-ancestor
24809097|NCT02031211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24809098|NCT02031211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809099|NCT02031211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24809100|NCT02031211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24809109|NCT02031289|Micronutrients|micronutrients|mesh-ancestor
25661730|NCT01637077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661731|NCT01637077|Anticonvulsants|anticonvulsants|mesh-ancestor
25661732|NCT01637077|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25661733|NCT01637077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25661734|NCT01637077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661735|NCT01637077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25661736|NCT01637077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25661737|NCT01637077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25661738|NCT01637077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25661739|NCT01637077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25661740|NCT01637090|Everolimus|everolimus|mesh-list
25661741|NCT01637090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487196|NCT00461916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24487198|NCT00461916|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24809116|NCT02031367|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24809117|NCT02031367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24809118|NCT02031367|Glucocorticoids|glucocorticoids|mesh-ancestor
24474257|NCT00405366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24809120|NCT02031367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24809121|NCT02031367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809122|NCT02031367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24809123|NCT02031367|Immunologic Factors|immunologic factors|mesh-ancestor
24809124|NCT02031367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809125|NCT02031367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848706|NCT00046254|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25848707|NCT00046254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848708|NCT00046267|Niacin|niacin|mesh-list
25848709|NCT00046267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25848710|NCT00046267|Antimetabolites|antimetabolites|mesh-ancestor
25848711|NCT00046267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604201|NCT00977756|Maraviroc|maraviroc|mesh-list
24595024|NCT00936546|Rituximab|rituximab|mesh-list
24487268|NCT00462540|Adrenergic Agents|adrenergic agents|mesh-ancestor
24487297|NCT00462592|Autonomic Agents|autonomic agents|mesh-ancestor
24487298|NCT00462592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24487511|NCT00463671|Antiviral Agents|antiviral agents|mesh-ancestor
24487512|NCT00463671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24487513|NCT00463671|Expectorants|expectorants|mesh-ancestor
24487658|NCT00464347|Glucocorticoids|glucocorticoids|mesh-ancestor
24487660|NCT00464347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24487661|NCT00464347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24487676|NCT00464399|Everolimus|everolimus|mesh-list
24487677|NCT00464399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604285|NCT00978315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25848712|NCT00046267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24740506|NCT01688700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474399|NCT00405925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24474400|NCT00405925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25848713|NCT00046267|Vasodilator Agents|vasodilator agents|mesh-ancestor
24678131|NCT01359930|Sensory System Agents|sensory system agents|mesh-ancestor
24809330|NCT02033031|Ranibizumab|ranibizumab|mesh-list
25848714|NCT00046267|Vitamin B Complex|vitamin b complex|mesh-ancestor
25848715|NCT00046267|Vitamins|vitamins|mesh-ancestor
25848716|NCT00046267|Micronutrients|micronutrients|mesh-ancestor
24474536|NCT00406432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24604286|NCT00978315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604288|NCT00978315|Micronutrients|micronutrients|mesh-ancestor
24604289|NCT00978315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24604293|NCT00978328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24604294|NCT00978328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604295|NCT00978328|Analgesics|analgesics|mesh-ancestor
24809169|NCT02031601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24809170|NCT02031601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24809171|NCT02031692|Cholecalciferol|cholecalciferol|mesh-list
24809172|NCT02031692|Vitamin D|vitamin d|mesh-list
24809173|NCT02031692|Calcium Carbonate|calcium carbonate|mesh-list
24809174|NCT02031692|Calcium|calcium|mesh-list
24487678|NCT00464399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24809175|NCT02031692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24809176|NCT02031692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809183|NCT02031731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24809184|NCT02031731|Immunologic Factors|immunologic factors|mesh-ancestor
24809185|NCT02031731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809186|NCT02031744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24809187|NCT02031744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809188|NCT02031744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24809189|NCT02031744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809190|NCT02031744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809191|NCT02031861|Nifedipine|nifedipine|mesh-list
24809192|NCT02031861|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24809193|NCT02031861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24809194|NCT02031861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809195|NCT02031861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25419414|NCT02707042|Azithromycin|azithromycin|mesh-list
24809196|NCT02031861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809197|NCT02031861|Vasodilator Agents|vasodilator agents|mesh-ancestor
24809198|NCT02031861|Tocolytic Agents|tocolytic agents|mesh-ancestor
24809199|NCT02031861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24809201|NCT02031939|Oxaliplatin|oxaliplatin|mesh-list
24809202|NCT02031939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24906040|NCT04343001|Antipyretics|antipyretics|mesh-ancestor
24809203|NCT02031939|Antimetabolites|antimetabolites|mesh-ancestor
24809204|NCT02031939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809205|NCT02031939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809206|NCT02031965|Dexamethasone|dexamethasone|mesh-list
24809227|NCT02032043|Albendazole|albendazole|mesh-list
25848717|NCT00046267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487818|NCT00465231|Analgesics|analgesics|mesh-ancestor
24809238|NCT02032043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809239|NCT02032095|Immunoglobulins|immunoglobulins|mesh-list
24809240|NCT02032095|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24809241|NCT02032095|gamma-Globulins|gamma-globulins|mesh-list
24809242|NCT02032095|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24809243|NCT02032095|Immunologic Factors|immunologic factors|mesh-ancestor
24809244|NCT02032095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604326|NCT00978588|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24809245|NCT02032134|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
24809246|NCT02032134|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24809247|NCT02032134|Protective Agents|protective agents|mesh-ancestor
24809248|NCT02032134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809249|NCT02032134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24595339|NCT00938184|Paroxetine|paroxetine|mesh-list
24487819|NCT00465231|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24487820|NCT00465231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24487821|NCT00465231|Anesthetics, General|anesthetics, general|mesh-ancestor
24487822|NCT00465244|Levetiracetam|levetiracetam|mesh-list
24487823|NCT00465244|Lorazepam|lorazepam|mesh-list
24487862|NCT00465439|Lidocaine|lidocaine|mesh-list
24487863|NCT00465439|Epinephrine|epinephrine|mesh-list
24487864|NCT00465439|Racepinephrine|racepinephrine|mesh-list
24487865|NCT00465439|Epinephryl borate|epinephryl borate|mesh-list
24487866|NCT00465439|Anesthetics, Local|anesthetics, local|mesh-ancestor
24487867|NCT00465439|Anesthetics|anesthetics|mesh-ancestor
24489366|NCT00472823|Cholecalciferol|cholecalciferol|mesh-list
25848718|NCT00046293|Abciximab|abciximab|mesh-list
24487960|NCT00466076|Immunologic Factors|immunologic factors|mesh-ancestor
24487961|NCT00466076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487962|NCT00466076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24487963|NCT00466076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24487966|NCT00466089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24487968|NCT00466089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487969|NCT00466102|Everolimus|everolimus|mesh-list
24487970|NCT00466102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809280|NCT02032394|Povidone-Iodine|povidone-iodine|mesh-list
24809281|NCT02032394|Povidone|povidone|mesh-list
24809282|NCT02032394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24809283|NCT02032394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24809284|NCT02032394|Disinfectants|disinfectants|mesh-ancestor
24809285|NCT02032394|Dermatologic Agents|dermatologic agents|mesh-ancestor
24809286|NCT02032394|Plasma Substitutes|plasma substitutes|mesh-ancestor
24809287|NCT02032394|Blood Substitutes|blood substitutes|mesh-ancestor
24809288|NCT02032654|Floxacillin|floxacillin|mesh-list
24488089|NCT00466570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24488091|NCT00466570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24488092|NCT00466570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24488093|NCT00466570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488233|NCT00467194|Immunologic Factors|immunologic factors|mesh-ancestor
24488234|NCT00467207|Botulinum Toxins|botulinum toxins|mesh-list
24488235|NCT00467207|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24488236|NCT00467207|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24488237|NCT00467207|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24488238|NCT00467207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24488276|NCT00467493|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24488277|NCT00467493|Hormone Antagonists|hormone antagonists|mesh-ancestor
24488278|NCT00467493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24488279|NCT00467493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488281|NCT00467506|Antibodies, Bispecific|antibodies, bispecific|mesh-list
24488282|NCT00467506|Immunologic Factors|immunologic factors|mesh-ancestor
24488283|NCT00467506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488284|NCT00467545|Telbivudine|telbivudine|mesh-list
24488285|NCT00467545|Antiviral Agents|antiviral agents|mesh-ancestor
24488286|NCT00467545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24488329|NCT00467909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488330|NCT00467935|Ranibizumab|ranibizumab|mesh-list
24488331|NCT00467935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24488332|NCT00467935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24488333|NCT00467935|Growth Substances|growth substances|mesh-ancestor
24488334|NCT00467935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488335|NCT00467935|Growth Inhibitors|growth inhibitors|mesh-ancestor
24488336|NCT00467935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488337|NCT00467948|Cefazolin|cefazolin|mesh-list
24488338|NCT00467948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24488339|NCT00467948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24488340|NCT00467987|Testosterone|testosterone|mesh-list
24488341|NCT00467987|Androgens|androgens|mesh-ancestor
24488342|NCT00467987|Hormones|hormones|mesh-ancestor
25848719|NCT00046293|Anticoagulants|anticoagulants|mesh-ancestor
24488584|NCT00469443|Irinotecan|irinotecan|mesh-list
24809315|NCT02032927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24809316|NCT02032927|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24809317|NCT02032927|Antitussive Agents|antitussive agents|mesh-ancestor
24488585|NCT00469443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24488586|NCT00469443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848720|NCT00046293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25848721|NCT00046306|Antioxidants|antioxidants|mesh-list
25848722|NCT00046306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488626|NCT00469560|Sequestering Agents|sequestering agents|mesh-ancestor
24488627|NCT00469560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488628|NCT00469586|Insulin|insulin|mesh-list
24488629|NCT00469586|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24488630|NCT00469586|Metformin|metformin|mesh-list
24488667|NCT00469690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488668|NCT00469703|Thalidomide|thalidomide|mesh-list
24488669|NCT00469703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24488670|NCT00469703|Immunologic Factors|immunologic factors|mesh-ancestor
24488671|NCT00469703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488672|NCT00469703|Leprostatic Agents|leprostatic agents|mesh-ancestor
24488673|NCT00469703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24488674|NCT00469703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24488675|NCT00469703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24488676|NCT00469703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24488677|NCT00469703|Growth Substances|growth substances|mesh-ancestor
24488738|NCT00469885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24488739|NCT00469885|Autonomic Agents|autonomic agents|mesh-ancestor
24488740|NCT00469885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24488741|NCT00469885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488742|NCT00469885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24488743|NCT00469885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24604402|NCT00979056|Rifaximin|rifaximin|mesh-list
24488814|NCT00470197|Antiviral Agents|antiviral agents|mesh-ancestor
24488815|NCT00470197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24488816|NCT00470197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24488817|NCT00470197|Immunologic Factors|immunologic factors|mesh-ancestor
24488818|NCT00470197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488820|NCT00470197|Sensory System Agents|sensory system agents|mesh-ancestor
24488821|NCT00470197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24488822|NCT00470197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24488823|NCT00470197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24488824|NCT00470197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661742|NCT01637090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25661743|NCT01637090|Immunologic Factors|immunologic factors|mesh-ancestor
25661744|NCT01637090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661745|NCT01637272|Pasireotide|pasireotide|mesh-list
25661746|NCT01637272|Hormones|hormones|mesh-ancestor
24488825|NCT00470197|Growth Inhibitors|growth inhibitors|mesh-ancestor
24488826|NCT00470197|Growth Substances|growth substances|mesh-ancestor
25674348|NCT01770392|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25848723|NCT00046306|Protective Agents|protective agents|mesh-ancestor
25848724|NCT00046306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801681|NCT01984931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24488827|NCT00470197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24488829|NCT00470210|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24488830|NCT00470210|Antimetabolites|antimetabolites|mesh-ancestor
24488831|NCT00470210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488832|NCT00470210|Antiviral Agents|antiviral agents|mesh-ancestor
24488833|NCT00470210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24488863|NCT00470340|Immunologic Factors|immunologic factors|mesh-ancestor
24488864|NCT00470340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488865|NCT00470353|Cholecalciferol|cholecalciferol|mesh-list
24488866|NCT00470353|Vitamin D|vitamin d|mesh-list
24488867|NCT00470353|Calcium Carbonate|calcium carbonate|mesh-list
24488868|NCT00470353|Calcium|calcium|mesh-list
24488869|NCT00470353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24488870|NCT00470353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488871|NCT00470353|Vitamins|vitamins|mesh-ancestor
24488872|NCT00470353|Micronutrients|micronutrients|mesh-ancestor
24488873|NCT00470353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24488874|NCT00470353|Antacids|antacids|mesh-ancestor
24488875|NCT00470353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488972|NCT00470821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488974|NCT00470821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488975|NCT00470821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24488976|NCT00470873|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24488977|NCT00470873|Vasodilator Agents|vasodilator agents|mesh-ancestor
24488978|NCT00470873|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24488979|NCT00470873|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24488980|NCT00470873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488981|NCT00470873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488982|NCT00470873|Urological Agents|urological agents|mesh-ancestor
24488983|NCT00470886|Telmisartan|telmisartan|mesh-list
24488984|NCT00470886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24488985|NCT00470886|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24488986|NCT00470886|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24488987|NCT00470886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488988|NCT00470912|Sunscreening Agents|sunscreening agents|mesh-list
24489003|NCT00470990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489004|NCT00471003|Telmisartan|telmisartan|mesh-list
24489005|NCT00471003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24489006|NCT00471003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24489007|NCT00471003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24489015|NCT00471042|Buprenorphine|buprenorphine|mesh-list
24489016|NCT00471042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24489017|NCT00471042|Narcotics|narcotics|mesh-ancestor
24489018|NCT00471042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24489019|NCT00471042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489020|NCT00471042|Analgesics|analgesics|mesh-ancestor
24809331|NCT02033031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24809332|NCT02033031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489021|NCT00471042|Sensory System Agents|sensory system agents|mesh-ancestor
24489022|NCT00471042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489023|NCT00471042|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24489024|NCT00471055|Capsaicin|capsaicin|mesh-list
24489025|NCT00471055|Antipruritics|antipruritics|mesh-ancestor
24489026|NCT00471055|Dermatologic Agents|dermatologic agents|mesh-ancestor
24489027|NCT00471055|Sensory System Agents|sensory system agents|mesh-ancestor
24489028|NCT00471055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489029|NCT00471055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489129|NCT00471523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24489130|NCT00471523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489131|NCT00471523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24489134|NCT00471523|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24489167|NCT00471588|Antidepressive Agents|antidepressive agents|mesh-ancestor
24489168|NCT00471627|Pancrelipase|pancrelipase|mesh-list
24489174|NCT00471640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489175|NCT00471640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489177|NCT00471640|Glucocorticoids|glucocorticoids|mesh-ancestor
24489179|NCT00471640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25661747|NCT01637272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25661748|NCT01637272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489200|NCT00471809|Azithromycin|azithromycin|mesh-list
24489201|NCT00471809|Budesonide|budesonide|mesh-list
24489202|NCT00471809|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24489203|NCT00471809|Montelukast|montelukast|mesh-list
24489219|NCT00471809|Adrenergic Agents|adrenergic agents|mesh-ancestor
24489220|NCT00471809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24489221|NCT00471809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489222|NCT00471809|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24489223|NCT00471809|Hormone Antagonists|hormone antagonists|mesh-ancestor
24489224|NCT00471809|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24489225|NCT00471809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24908283|NCT04321967|Nitroglycerin|nitroglycerin|mesh-list
24489226|NCT00471900|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24489227|NCT00471900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24489228|NCT00471900|Immunologic Factors|immunologic factors|mesh-ancestor
24489229|NCT00471900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489230|NCT00471952|Caffeine|caffeine|mesh-list
24489231|NCT00471952|Rizatriptan|rizatriptan|mesh-list
24489232|NCT00471952|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24489233|NCT00471952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489234|NCT00471952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24489235|NCT00471952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24489248|NCT00471965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489249|NCT00471965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24489250|NCT00471965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24489252|NCT00471965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489283|NCT00472004|Hormones|hormones|mesh-ancestor
24489284|NCT00472004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24489285|NCT00472004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489286|NCT00472004|Androgen Antagonists|androgen antagonists|mesh-ancestor
24489287|NCT00472004|Hormone Antagonists|hormone antagonists|mesh-ancestor
24489288|NCT00472004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24489289|NCT00472004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24489290|NCT00472004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489291|NCT00472004|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24489292|NCT00472004|Anabolic Agents|anabolic agents|mesh-ancestor
24489293|NCT00472043|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
24489294|NCT00472043|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24489295|NCT00472043|Dermatologic Agents|dermatologic agents|mesh-ancestor
24489296|NCT00472108|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
24489297|NCT00472108|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24489298|NCT00472108|Dermatologic Agents|dermatologic agents|mesh-ancestor
24489299|NCT00472134|Bupivacaine|bupivacaine|mesh-list
24580734|NCT00863460|Cyclophosphamide|cyclophosphamide|mesh-list
24489300|NCT00472134|Anesthetics, Local|anesthetics, local|mesh-ancestor
24489301|NCT00472134|Anesthetics|anesthetics|mesh-ancestor
24489302|NCT00472134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24489303|NCT00472134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809351|NCT02033239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809352|NCT02033356|Lidocaine|lidocaine|mesh-list
24809353|NCT02033356|Anesthetics, Local|anesthetics, local|mesh-ancestor
24956335|NCT03855267|Etomidate|etomidate|mesh-list
24809354|NCT02033356|Anesthetics|anesthetics|mesh-ancestor
24489368|NCT00472823|Vitamins|vitamins|mesh-ancestor
24489369|NCT00472823|Micronutrients|micronutrients|mesh-ancestor
24489370|NCT00472823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489371|NCT00472823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24489372|NCT00472823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24489373|NCT00472875|Glyburide|glyburide|mesh-list
24489374|NCT00472875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24489375|NCT00472875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489376|NCT00472901|Afamelanotide|afamelanotide|mesh-list
24489377|NCT00472901|Dermatologic Agents|dermatologic agents|mesh-ancestor
24489378|NCT00472927|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24489379|NCT00472927|Estrogens|estrogens|mesh-ancestor
24489424|NCT00473174|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24489425|NCT00473174|Protease Inhibitors|protease inhibitors|mesh-ancestor
24489427|NCT00473174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489428|NCT00473174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24489429|NCT00473213|Interferons|interferons|mesh-list
24489430|NCT00473213|Interferon-beta|interferon-beta|mesh-list
25661749|NCT01637402|Prednisone|prednisone|mesh-list
25661750|NCT01637402|Abiraterone Acetate|abiraterone acetate|mesh-list
24902611|NCT04372082|Vasodilator Agents|vasodilator agents|mesh-ancestor
24489431|NCT00473213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489432|NCT00473213|Antiviral Agents|antiviral agents|mesh-ancestor
24489433|NCT00473213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24489434|NCT00473213|Immunologic Factors|immunologic factors|mesh-ancestor
24489435|NCT00473213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489436|NCT00473239|Vitamin D|vitamin d|mesh-list
24489642|NCT00474695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24489643|NCT00474695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24489644|NCT00474695|Growth Substances|growth substances|mesh-ancestor
24489645|NCT00474695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489646|NCT00474695|Growth Inhibitors|growth inhibitors|mesh-ancestor
24489647|NCT00474695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489648|NCT00474721|Acetaminophen|acetaminophen|mesh-list
24489649|NCT00474721|Ibuprofen|ibuprofen|mesh-list
24809368|NCT02033408|Doxycycline|doxycycline|mesh-list
24809369|NCT02033408|Ciprofloxacin|ciprofloxacin|mesh-list
24809370|NCT02033408|Gentamicins|gentamicins|mesh-list
24809371|NCT02033408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24489676|NCT00474773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24489677|NCT00474773|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24489678|NCT00474773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24489679|NCT00474773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24489680|NCT00474773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489681|NCT00474838|Metformin|metformin|mesh-list
24489682|NCT00474838|Glimepiride|glimepiride|mesh-list
24489683|NCT00474838|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24489684|NCT00474838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489685|NCT00474838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24489686|NCT00474838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24489687|NCT00474838|Immunologic Factors|immunologic factors|mesh-ancestor
24489688|NCT00474890|Pseudoephedrine|pseudoephedrine|mesh-list
24489689|NCT00474890|Ephedrine|ephedrine|mesh-list
24489690|NCT00474890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24818893|NCT02091505|Ranibizumab|ranibizumab|mesh-list
24489691|NCT00474890|Autonomic Agents|autonomic agents|mesh-ancestor
24489692|NCT00474890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489723|NCT00475072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489725|NCT00475072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24489726|NCT00475098|Tinzaparin|tinzaparin|mesh-list
24489727|NCT00475098|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24489728|NCT00475098|Dalteparin|dalteparin|mesh-list
24489729|NCT00475098|Anticoagulants|anticoagulants|mesh-ancestor
24489730|NCT00475098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24489731|NCT00475098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24489732|NCT00475098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489733|NCT00475137|Lamotrigine|lamotrigine|mesh-list
24489734|NCT00475137|Anticonvulsants|anticonvulsants|mesh-list
24489735|NCT00475137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24489740|NCT00475137|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24489741|NCT00475137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24489742|NCT00475137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25166401|NCT04111315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24534142|NCT00646126|Renal Agents|renal agents|mesh-ancestor
25132577|NCT03018015|Ibuprofen|ibuprofen|mesh-list
24489900|NCT00475813|Adrenergic Agents|adrenergic agents|mesh-ancestor
24489901|NCT00475813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24489905|NCT00475826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24489907|NCT00475826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491140|NCT00481364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24489910|NCT00475917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24489912|NCT00475917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489913|NCT00475917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489914|NCT00475917|Antiviral Agents|antiviral agents|mesh-ancestor
24489915|NCT00475917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24489936|NCT00475969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489938|NCT00475969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489940|NCT00475969|Sensory System Agents|sensory system agents|mesh-ancestor
24489941|NCT00475969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489942|NCT00475969|Antidepressive Agents|antidepressive agents|mesh-ancestor
24489943|NCT00475969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24489945|NCT00476034|Lumiracoxib|lumiracoxib|mesh-list
24489946|NCT00476034|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24489947|NCT00476034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24489948|NCT00476034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409036|NCT03404180|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25848725|NCT00046319|Ambrisentan|ambrisentan|mesh-list
24818274|NCT02087579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24614484|NCT01024491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24489949|NCT00476034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489950|NCT00476034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24489951|NCT00476034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24489952|NCT00476034|Analgesics|analgesics|mesh-ancestor
24489953|NCT00476034|Sensory System Agents|sensory system agents|mesh-ancestor
24909053|NCT04313374|Narcotics|narcotics|mesh-ancestor
24489954|NCT00476034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489955|NCT00476034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489956|NCT00476034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24489974|NCT00476073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24489975|NCT00476073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489976|NCT00476099|Budesonide|budesonide|mesh-list
24489977|NCT00476099|Beclomethasone|beclomethasone|mesh-list
24489978|NCT00476099|Formoterol Fumarate|formoterol fumarate|mesh-list
24489979|NCT00476099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24489980|NCT00476099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24489981|NCT00476099|Autonomic Agents|autonomic agents|mesh-ancestor
24489982|NCT00476099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489983|NCT00476099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489984|NCT00476099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24489985|NCT00476099|Respiratory System Agents|respiratory system agents|mesh-ancestor
24489986|NCT00476099|Glucocorticoids|glucocorticoids|mesh-ancestor
24489987|NCT00476099|Hormones|hormones|mesh-ancestor
24809375|NCT02033408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24809376|NCT02033408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24809377|NCT02033408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596404|NCT00943462|Temozolomide|temozolomide|mesh-list
24489988|NCT00476099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24489989|NCT00476099|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24489990|NCT00476099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24489991|NCT00476099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24489992|NCT00476099|Adrenergic Agents|adrenergic agents|mesh-ancestor
24489993|NCT00476099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24489994|NCT00476099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489995|NCT00476138|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24489996|NCT00476138|Antioxidants|antioxidants|mesh-ancestor
24809379|NCT02033408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809380|NCT02033408|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24809381|NCT02033408|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24809382|NCT02033408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24809383|NCT02033434|Ketamine|ketamine|mesh-list
24446929|NCT00306683|Vasodilator Agents|vasodilator agents|mesh-ancestor
24446930|NCT00306696|Rosiglitazone|rosiglitazone|mesh-list
24446931|NCT00306696|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25166402|NCT04111315|Analgesics|analgesics|mesh-ancestor
24490123|NCT00476437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490125|NCT00476463|Antiviral Agents|antiviral agents|mesh-ancestor
24490126|NCT00476463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24490127|NCT00476463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24490128|NCT00476463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24490129|NCT00476463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490130|NCT00476463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490131|NCT00476463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24490153|NCT00476853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490154|NCT00476853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490155|NCT00476853|Antiviral Agents|antiviral agents|mesh-ancestor
24909414|NCT04309240|Rivaroxaban|rivaroxaban|mesh-list
24490156|NCT00476853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24490231|NCT00477061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24490232|NCT00477061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490233|NCT00477061|Analgesics|analgesics|mesh-ancestor
24490234|NCT00477061|Sensory System Agents|sensory system agents|mesh-ancestor
24490235|NCT00477061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24490236|NCT00477074|Dimercaprol|dimercaprol|mesh-list
24490237|NCT00477074|Chelating Agents|chelating agents|mesh-ancestor
24490238|NCT00477074|Sequestering Agents|sequestering agents|mesh-ancestor
24809384|NCT02033434|Analgesics|analgesics|mesh-ancestor
24809385|NCT02033434|Sensory System Agents|sensory system agents|mesh-ancestor
24490313|NCT00477737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25661751|NCT01637402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25661752|NCT01637402|Glucocorticoids|glucocorticoids|mesh-ancestor
24490314|NCT00477737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24490343|NCT00477776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490345|NCT00477789|Antimetabolites|antimetabolites|mesh-ancestor
24490346|NCT00477789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490347|NCT00477789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490348|NCT00477789|Gout Suppressants|gout suppressants|mesh-ancestor
24490349|NCT00477789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24809387|NCT02033434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809388|NCT02033434|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24909942|NCT04303819|Hormones|hormones|mesh-ancestor
24490438|NCT00478114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490439|NCT00478114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24490440|NCT00478114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490441|NCT00478114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490442|NCT00478270|Ibandronic Acid|ibandronic acid|mesh-list
24490443|NCT00478270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24490444|NCT00478270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490445|NCT00478374|Doxorubicin|doxorubicin|mesh-list
24490446|NCT00478374|Sorafenib|sorafenib|mesh-list
24490447|NCT00478374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24490448|NCT00478374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490449|NCT00478374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24490450|NCT00478374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24490451|NCT00478374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490452|NCT00478374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490453|NCT00478374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24490454|NCT00478452|Cyclophosphamide|cyclophosphamide|mesh-list
24485024|NCT00451139|Atovaquone|atovaquone|mesh-list
25848726|NCT00046319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24490505|NCT00478634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490507|NCT00478660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24490508|NCT00478660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24490510|NCT00478699|Cisplatin|cisplatin|mesh-list
24490511|NCT00478699|Docetaxel|docetaxel|mesh-list
24490512|NCT00478699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490513|NCT00478699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24490515|NCT00478699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490516|NCT00478699|Antiviral Agents|antiviral agents|mesh-ancestor
24490552|NCT00478907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24490553|NCT00478907|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24490554|NCT00478907|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24490555|NCT00478907|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25041731|NCT01591473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490569|NCT00478959|Immunologic Factors|immunologic factors|mesh-ancestor
24490570|NCT00478959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490571|NCT00478959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24809389|NCT02033434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24809390|NCT02033434|Anesthetics, General|anesthetics, general|mesh-ancestor
24809391|NCT02033434|Anesthetics|anesthetics|mesh-ancestor
24490582|NCT00478998|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24490583|NCT00478998|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24490584|NCT00478998|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24490585|NCT00478998|Adrenergic Agents|adrenergic agents|mesh-ancestor
24490586|NCT00478998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24490587|NCT00478998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490588|NCT00478998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490589|NCT00478998|Urological Agents|urological agents|mesh-ancestor
24490591|NCT00479076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24490636|NCT00479362|Sensory System Agents|sensory system agents|mesh-ancestor
24490798|NCT00480181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24490799|NCT00480181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24490800|NCT00480181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24490801|NCT00480181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24490802|NCT00480181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24485368|NCT00452829|Folic Acid|folic acid|mesh-list
24911005|NCT04292314|Chelating Agents|chelating agents|mesh-ancestor
24490805|NCT00480194|Ipratropium|ipratropium|mesh-list
24490806|NCT00480194|Anticonvulsants|anticonvulsants|mesh-ancestor
24490807|NCT00480194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24490808|NCT00480194|Autonomic Agents|autonomic agents|mesh-ancestor
25661753|NCT01637402|Hormones|hormones|mesh-ancestor
25674349|NCT01770392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490934|NCT00480584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490935|NCT00480584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24490936|NCT00480584|Immunologic Factors|immunologic factors|mesh-ancestor
24490937|NCT00480584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490938|NCT00480584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24490939|NCT00480597|Gemcitabine|gemcitabine|mesh-list
24490940|NCT00480597|Capecitabine|capecitabine|mesh-list
24490941|NCT00480597|Vinorelbine|vinorelbine|mesh-list
24490942|NCT00480597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490961|NCT00480610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490973|NCT00480649|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24490974|NCT00480649|Respiratory System Agents|respiratory system agents|mesh-ancestor
24490975|NCT00480649|Dermatologic Agents|dermatologic agents|mesh-ancestor
24490976|NCT00480649|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24490977|NCT00480649|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24490978|NCT00480649|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24490979|NCT00480649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24911354|NCT04289090|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24911355|NCT04289090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24911356|NCT04289194|Hydrogen Peroxide|hydrogen peroxide|mesh-list
24490980|NCT00480649|Adrenergic Agents|adrenergic agents|mesh-ancestor
24490981|NCT00480649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24490982|NCT00480649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446934|NCT00306696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24446935|NCT00306696|Diuretics|diuretics|mesh-ancestor
24446936|NCT00306696|Natriuretic Agents|natriuretic agents|mesh-ancestor
24446937|NCT00306696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446938|NCT00306696|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24446939|NCT00306696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24446940|NCT00306696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446941|NCT00306696|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24490987|NCT00480675|Prednisolone acetate|prednisolone acetate|mesh-list
24490988|NCT00480675|Bupivacaine|bupivacaine|mesh-list
24490989|NCT00480675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24490990|NCT00480675|Prednisolone phosphate|prednisolone phosphate|mesh-list
24490991|NCT00480675|Anesthetics, Local|anesthetics, local|mesh-ancestor
24490992|NCT00480675|Anesthetics|anesthetics|mesh-ancestor
24490993|NCT00480675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24490994|NCT00480675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490995|NCT00480675|Sensory System Agents|sensory system agents|mesh-ancestor
24490996|NCT00480675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24490997|NCT00480675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24490998|NCT00480675|Antiemetics|antiemetics|mesh-ancestor
24490999|NCT00480675|Autonomic Agents|autonomic agents|mesh-ancestor
24491000|NCT00480675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24491001|NCT00480675|Glucocorticoids|glucocorticoids|mesh-ancestor
24491003|NCT00480675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24491005|NCT00480675|Protective Agents|protective agents|mesh-ancestor
24491006|NCT00480675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24491135|NCT00481312|Anesthetics|anesthetics|mesh-ancestor
25045174|NCT00990327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24491136|NCT00481312|GABA Modulators|gaba modulators|mesh-ancestor
24491137|NCT00481312|GABA Agents|gaba agents|mesh-ancestor
24491138|NCT00481364|Atorvastatin|atorvastatin|mesh-list
24491139|NCT00481364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24491141|NCT00481364|Antimetabolites|antimetabolites|mesh-ancestor
24491146|NCT00481429|Rosiglitazone|rosiglitazone|mesh-list
24491150|NCT00481442|Oxymetazoline|oxymetazoline|mesh-list
24911358|NCT04289194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24491151|NCT00481442|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24491152|NCT00481442|Mydriatics|mydriatics|mesh-ancestor
24491153|NCT00481442|Autonomic Agents|autonomic agents|mesh-ancestor
24491154|NCT00481442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24491155|NCT00481442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491156|NCT00481442|Sympathomimetics|sympathomimetics|mesh-ancestor
24491157|NCT00481442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24491158|NCT00481442|Nasal Decongestants|nasal decongestants|mesh-ancestor
24491159|NCT00481442|Respiratory System Agents|respiratory system agents|mesh-ancestor
24491160|NCT00481442|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24491161|NCT00481442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24491262|NCT00481819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24491263|NCT00481819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491264|NCT00481819|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25674350|NCT01770392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24491268|NCT00481819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24491270|NCT00481819|Autonomic Agents|autonomic agents|mesh-ancestor
24491271|NCT00481819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24809408|NCT02033551|Paclitaxel|paclitaxel|mesh-list
24491374|NCT00482248|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24491375|NCT00482248|Respiratory System Agents|respiratory system agents|mesh-ancestor
24491376|NCT00482261|Aspirin|aspirin|mesh-list
24491377|NCT00482261|Dexamethasone|dexamethasone|mesh-list
24491391|NCT00482261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24451034|NCT00321516|Aripiprazole|aripiprazole|mesh-list
24491417|NCT00482378|Pamidronate|pamidronate|mesh-list
24491418|NCT00482378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24491419|NCT00482378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491420|NCT00482456|Nitrous Oxide|nitrous oxide|mesh-list
24491423|NCT00482456|Anesthetics|anesthetics|mesh-ancestor
24491451|NCT00482573|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
24491452|NCT00482573|Anesthetics|anesthetics|mesh-list
24442574|NCT00291720|Spironolactone|spironolactone|mesh-list
24491454|NCT00482573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491455|NCT00482573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24491456|NCT00482573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24491457|NCT00482573|Adrenergic Agents|adrenergic agents|mesh-ancestor
24491458|NCT00482573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24491459|NCT00482573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491460|NCT00482573|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24491461|NCT00482573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24491462|NCT00482573|Autonomic Agents|autonomic agents|mesh-ancestor
24491463|NCT00482573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24491518|NCT00482846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24491519|NCT00482846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24491521|NCT00482846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491522|NCT00482963|Efavirenz|efavirenz|mesh-list
24491523|NCT00482963|Levonorgestrel|levonorgestrel|mesh-list
24491524|NCT00482963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24491525|NCT00482963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24491526|NCT00482963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491527|NCT00482963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491528|NCT00482963|Antiviral Agents|antiviral agents|mesh-ancestor
24491529|NCT00482963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24491530|NCT00482963|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24491531|NCT00482963|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24491532|NCT00482963|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24491533|NCT00482963|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24491534|NCT00482963|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24491535|NCT00482963|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24491562|NCT00483054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661755|NCT01637402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661756|NCT01637402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25661757|NCT01637402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25661758|NCT01637402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25661759|NCT01637402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661760|NCT01637402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661761|NCT01637402|Hormone Antagonists|hormone antagonists|mesh-ancestor
25661762|NCT01637402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25661763|NCT01637584|Prazosin|prazosin|mesh-list
25661764|NCT01637584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25661765|NCT01637584|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24491563|NCT00483054|Antiviral Agents|antiviral agents|mesh-ancestor
24491564|NCT00483054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25166403|NCT04111315|Sensory System Agents|sensory system agents|mesh-ancestor
24491565|NCT00483054|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24491566|NCT00483054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24491567|NCT00483054|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25848730|NCT00046345|Protease Inhibitors|protease inhibitors|mesh-ancestor
25848731|NCT00046345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809415|NCT02033551|Mitosis Modulators|mitosis modulators|mesh-ancestor
24809416|NCT02033551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848732|NCT00046345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491631|NCT00483301|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24491632|NCT00483301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914369|NCT04255498|Hormone Antagonists|hormone antagonists|mesh-ancestor
24491633|NCT00483301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24491634|NCT00483301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491679|NCT00483600|Protease Inhibitors|protease inhibitors|mesh-ancestor
24491680|NCT00483600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491681|NCT00483600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491682|NCT00483600|Anticoagulants|anticoagulants|mesh-ancestor
24491683|NCT00483600|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24491684|NCT00483600|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24491685|NCT00483626|Sildenafil Citrate|sildenafil citrate|mesh-list
24491686|NCT00483626|Vasodilator Agents|vasodilator agents|mesh-ancestor
24491687|NCT00483626|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24491688|NCT00483626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24491689|NCT00483626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491690|NCT00483626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451052|NCT00321581|Cediranib|cediranib|mesh-list
24491718|NCT00483782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24491719|NCT00483782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491720|NCT00483782|Tubulin Modulators|tubulin modulators|mesh-ancestor
24491721|NCT00483782|Antimitotic Agents|antimitotic agents|mesh-ancestor
24491722|NCT00483782|Mitosis Modulators|mitosis modulators|mesh-ancestor
24491723|NCT00483782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491724|NCT00483782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24491725|NCT00483782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24491726|NCT00483782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24491727|NCT00483782|Growth Substances|growth substances|mesh-ancestor
24491728|NCT00483782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491729|NCT00483782|Growth Inhibitors|growth inhibitors|mesh-ancestor
24491730|NCT00483795|Citric Acid|citric acid|mesh-list
24491731|NCT00483795|Sodium Citrate|sodium citrate|mesh-list
24491732|NCT00483795|Anticoagulants|anticoagulants|mesh-ancestor
24491733|NCT00483795|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24491734|NCT00483795|Chelating Agents|chelating agents|mesh-ancestor
24491735|NCT00483795|Sequestering Agents|sequestering agents|mesh-ancestor
24491966|NCT00484744|Sensory System Agents|sensory system agents|mesh-ancestor
24491967|NCT00484744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24491968|NCT00484744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491969|NCT00484744|Antipyretics|antipyretics|mesh-ancestor
24491970|NCT00484744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24491971|NCT00484744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24491972|NCT00484744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24491973|NCT00484744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24491974|NCT00484744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848733|NCT00046345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25848734|NCT00046345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25848735|NCT00046345|Antiviral Agents|antiviral agents|mesh-ancestor
24492021|NCT00484926|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24492022|NCT00484926|Purinergic Agents|purinergic agents|mesh-ancestor
24492023|NCT00484926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492024|NCT00484991|Verapamil|verapamil|mesh-list
24492025|NCT00484991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25132955|NCT03016039|Curcumin|curcumin|mesh-list
24492095|NCT00485160|Tocolytic Agents|tocolytic agents|mesh-ancestor
24492124|NCT00485407|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24492125|NCT00485407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24492126|NCT00485407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24534301|NCT00646620|Hormones|hormones|mesh-ancestor
24809452|NCT02033733|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24492254|NCT00485797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24492255|NCT00485797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24492257|NCT00485797|Dopamine Agents|dopamine agents|mesh-ancestor
24492258|NCT00485797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492260|NCT00485810|Antiemetics|antiemetics|mesh-ancestor
24492261|NCT00485810|Autonomic Agents|autonomic agents|mesh-ancestor
24492262|NCT00485810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24492263|NCT00485810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492264|NCT00485810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24492265|NCT00485810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24492266|NCT00485810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24787236|NCT01924104|Aspirin|aspirin|mesh-list
24492267|NCT00485810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24492268|NCT00485810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24492269|NCT00485810|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24492270|NCT00485810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24492271|NCT00485810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24492287|NCT00485823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24492288|NCT00485823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492289|NCT00485823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492290|NCT00485823|Serotonin Agents|serotonin agents|mesh-ancestor
24492291|NCT00485849|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24492292|NCT00485849|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24492293|NCT00485849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24492294|NCT00485849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24492295|NCT00485849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492296|NCT00485849|Adrenergic Agents|adrenergic agents|mesh-ancestor
24492297|NCT00485849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492334|NCT00485901|Antiemetics|antiemetics|mesh-ancestor
24492335|NCT00485901|Autonomic Agents|autonomic agents|mesh-ancestor
24492336|NCT00485901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24492337|NCT00485901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492338|NCT00485901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24492339|NCT00485901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24492340|NCT00485901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24492341|NCT00485901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24492342|NCT00485901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24492343|NCT00485901|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24492344|NCT00485901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24492345|NCT00485901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24492346|NCT00485901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492347|NCT00485901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492348|NCT00485901|Serotonin Agents|serotonin agents|mesh-ancestor
24492349|NCT00485901|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24492350|NCT00485901|Dopamine Agents|dopamine agents|mesh-ancestor
24492365|NCT00485979|Antimitotic Agents|antimitotic agents|mesh-ancestor
24492366|NCT00485979|Mitosis Modulators|mitosis modulators|mesh-ancestor
24492367|NCT00485979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809454|NCT02033733|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24492368|NCT00485979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24492369|NCT00486005|Olanzapine|olanzapine|mesh-list
24492370|NCT00486005|Nizatidine|nizatidine|mesh-list
24492382|NCT00486005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24492383|NCT00486005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492384|NCT00486005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492385|NCT00486005|Serotonin Agents|serotonin agents|mesh-ancestor
24492386|NCT00486005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24492387|NCT00486005|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24492388|NCT00486005|Histamine Antagonists|histamine antagonists|mesh-ancestor
24492389|NCT00486005|Histamine Agents|histamine agents|mesh-ancestor
24492390|NCT00486083|Methylphenidate|methylphenidate|mesh-list
24492391|NCT00486083|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24492392|NCT00486083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24492413|NCT00486187|Metformin|metformin|mesh-list
24492414|NCT00486187|Rosiglitazone|rosiglitazone|mesh-list
24492415|NCT00486187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24492416|NCT00486187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492417|NCT00486213|Pyridoxine|pyridoxine|mesh-list
24492418|NCT00486213|Vitamin B 6|vitamin b 6|mesh-list
24914342|NCT04255576|Vitamins|vitamins|mesh-ancestor
24914343|NCT04255576|Micronutrients|micronutrients|mesh-ancestor
25674351|NCT01770483|Interferons|interferons|mesh-list
24488965|NCT00470743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492419|NCT00486213|Vitamin B Complex|vitamin b complex|mesh-ancestor
24492424|NCT00486317|Salmon calcitonin|salmon calcitonin|mesh-list
24492425|NCT00486317|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
24492426|NCT00486317|Katacalcin|katacalcin|mesh-list
24492427|NCT00486317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24914362|NCT04255498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24914363|NCT04255498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24914364|NCT04255498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24914365|NCT04255498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24914366|NCT04255498|Contraceptive Agents|contraceptive agents|mesh-ancestor
24492429|NCT00486317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24492430|NCT00486317|Vasodilator Agents|vasodilator agents|mesh-ancestor
24492431|NCT00486343|Zileuton|zileuton|mesh-list
24492432|NCT00486343|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24492433|NCT00486343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24492434|NCT00486343|Analgesics|analgesics|mesh-ancestor
24492435|NCT00486343|Sensory System Agents|sensory system agents|mesh-ancestor
24492436|NCT00486343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24492437|NCT00486343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848736|NCT00046345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25848737|NCT00046358|Ibuprofen|ibuprofen|mesh-list
24492450|NCT00486356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24492451|NCT00486356|Antimetabolites|antimetabolites|mesh-ancestor
24492452|NCT00486356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492453|NCT00486356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25109276|NCT03126123|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24492454|NCT00486356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24492455|NCT00486356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24492456|NCT00486356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492457|NCT00486369|Calcitonin|calcitonin|mesh-list
24492458|NCT00486369|Salmon calcitonin|salmon calcitonin|mesh-list
24492459|NCT00486369|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
24492460|NCT00486369|Katacalcin|katacalcin|mesh-list
24492461|NCT00486369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24914420|NCT04255017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24914421|NCT04254835|Chlorhexidine, thymol drug combination|chlorhexidine, thymol drug combination|mesh-list
24914634|NCT04253873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24914635|NCT04253132|Tolfenamic acid|tolfenamic acid|mesh-list
24914636|NCT04253132|Analgesics|analgesics|mesh-ancestor
24688924|NCT02575963|Immunologic Factors|immunologic factors|mesh-ancestor
24688925|NCT02575963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688927|NCT02575963|Natriuretic Agents|natriuretic agents|mesh-ancestor
24492462|NCT00486369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492463|NCT00486369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24492464|NCT00486369|Vasodilator Agents|vasodilator agents|mesh-ancestor
24492465|NCT00486421|Prednisone|prednisone|mesh-list
24809455|NCT02033733|Cholinergic Agents|cholinergic agents|mesh-ancestor
24809456|NCT02033733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492486|NCT00486460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492487|NCT00486460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24492488|NCT00486460|Immunologic Factors|immunologic factors|mesh-ancestor
24492489|NCT00486460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492490|NCT00486460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24492491|NCT00486460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24492492|NCT00486460|Analgesics|analgesics|mesh-ancestor
24492493|NCT00486460|Sensory System Agents|sensory system agents|mesh-ancestor
24492494|NCT00486460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24492495|NCT00486460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24914637|NCT04253132|Sensory System Agents|sensory system agents|mesh-ancestor
24914638|NCT04253132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24492496|NCT00486460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24492497|NCT00486460|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24492498|NCT00486460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24492499|NCT00486486|Timolol|timolol|mesh-list
24492500|NCT00486486|Bimatoprost|bimatoprost|mesh-list
24492501|NCT00486486|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25661766|NCT01637584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25661767|NCT01637584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25661768|NCT01637584|Adrenergic Agents|adrenergic agents|mesh-ancestor
24492521|NCT00486668|Tubulin Modulators|tubulin modulators|mesh-ancestor
24492522|NCT00486668|Antimitotic Agents|antimitotic agents|mesh-ancestor
24492523|NCT00486668|Mitosis Modulators|mitosis modulators|mesh-ancestor
25181783|NCT04793490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492524|NCT00486668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492525|NCT00486668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24492526|NCT00486668|Immunologic Factors|immunologic factors|mesh-ancestor
24492527|NCT00486668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492528|NCT00486668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24604632|NCT00980551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604633|NCT00980551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24787235|NCT01924091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24915509|NCT01822288|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24915510|NCT01822288|Anabolic Agents|anabolic agents|mesh-ancestor
24915511|NCT01583283|Dexamethasone|dexamethasone|mesh-list
24402945|NCT00158847|Xhance|xhance|mesh-list
24492556|NCT00486694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492559|NCT00486772|Calcium|calcium|mesh-list
24492560|NCT00486772|Sevelamer|sevelamer|mesh-list
25848739|NCT00046358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24492590|NCT00486980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492593|NCT00487032|Prazosin|prazosin|mesh-list
24492594|NCT00487032|Phenylephrine|phenylephrine|mesh-list
24492595|NCT00487032|Oxymetazoline|oxymetazoline|mesh-list
24492596|NCT00487032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24492597|NCT00487032|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24492598|NCT00487032|Autonomic Agents|autonomic agents|mesh-ancestor
24492599|NCT00487032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24492600|NCT00487032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492601|NCT00487032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24915743|NCT04249037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915744|NCT04249037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24915786|NCT04248205|Ketamine|ketamine|mesh-list
24492631|NCT00487110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24492632|NCT00487110|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24492675|NCT00487227|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24492676|NCT00487227|Purinergic Agents|purinergic agents|mesh-ancestor
24492677|NCT00487227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492678|NCT00487253|Miltefosine|miltefosine|mesh-list
24492679|NCT00487253|Meglumine Antimoniate|meglumine antimoniate|mesh-list
24622961|NCT01069302|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24622962|NCT01069302|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24492680|NCT00487253|Antifungal Agents|antifungal agents|mesh-ancestor
24492694|NCT00487448|Cytarabine|cytarabine|mesh-list
24492695|NCT00487448|Fludarabine|fludarabine|mesh-list
24492697|NCT00487448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24492698|NCT00487448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24492699|NCT00487448|Antimetabolites|antimetabolites|mesh-ancestor
24492700|NCT00487448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492701|NCT00487448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24492702|NCT00487448|Immunologic Factors|immunologic factors|mesh-ancestor
24492703|NCT00487448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492704|NCT00487448|Antiviral Agents|antiviral agents|mesh-ancestor
24492705|NCT00487448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24492706|NCT00487448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24492729|NCT00487734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492730|NCT00487734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24492731|NCT00487734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24492732|NCT00487734|Anabolic Agents|anabolic agents|mesh-ancestor
24492733|NCT00487773|Cholecalciferol|cholecalciferol|mesh-list
24492735|NCT00487773|Albuterol|albuterol|mesh-list
25661769|NCT01637584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25661770|NCT01637584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661771|NCT01637584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661772|NCT01637623|Allopurinol|allopurinol|mesh-list
24492736|NCT00487773|Montelukast|montelukast|mesh-list
24492737|NCT00487773|Vitamins|vitamins|mesh-ancestor
24492738|NCT00487773|Micronutrients|micronutrients|mesh-ancestor
24492739|NCT00487773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492740|NCT00487773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25848740|NCT00046358|Analgesics|analgesics|mesh-ancestor
24492766|NCT00487786|Antimitotic Agents|antimitotic agents|mesh-ancestor
24492767|NCT00487786|Mitosis Modulators|mitosis modulators|mesh-ancestor
24492768|NCT00487786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492770|NCT00487799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24492771|NCT00487799|Autonomic Agents|autonomic agents|mesh-ancestor
24492772|NCT00487799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24492773|NCT00487799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492774|NCT00487799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25181784|NCT04793490|Antipyretics|antipyretics|mesh-ancestor
24492775|NCT00487799|Respiratory System Agents|respiratory system agents|mesh-ancestor
24492812|NCT00488163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492813|NCT00488163|Adrenergic Agents|adrenergic agents|mesh-ancestor
24492815|NCT00488163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492816|NCT00488176|Cetirizine|cetirizine|mesh-list
24492817|NCT00488176|Montelukast|montelukast|mesh-list
24622967|NCT01069302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848741|NCT00046358|Sensory System Agents|sensory system agents|mesh-ancestor
25848742|NCT00046358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25848743|NCT00046358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848744|NCT00046358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25848745|NCT00046358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25848746|NCT00046358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25848747|NCT00046358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492881|NCT00488540|Sensory System Agents|sensory system agents|mesh-ancestor
24492882|NCT00488540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24492883|NCT00488540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492884|NCT00488540|Antipyretics|antipyretics|mesh-ancestor
24492885|NCT00488566|Lamotrigine|lamotrigine|mesh-list
24492886|NCT00488566|Anticonvulsants|anticonvulsants|mesh-ancestor
24492887|NCT00488566|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24493027|NCT00489138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24493028|NCT00489138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493030|NCT00489151|Adefovir|adefovir|mesh-list
24493031|NCT00489151|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
24493032|NCT00489151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24493033|NCT00489151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24493034|NCT00489151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622972|NCT01069328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24622973|NCT01069328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622974|NCT01069328|Tubulin Modulators|tubulin modulators|mesh-ancestor
24493035|NCT00489151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493146|NCT00489723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24493147|NCT00489723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493148|NCT00489723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493149|NCT00489723|Urological Agents|urological agents|mesh-ancestor
24493163|NCT00489775|Dopamine Agents|dopamine agents|mesh-ancestor
25848748|NCT00046358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848749|NCT00046384|Aripiprazole|aripiprazole|mesh-list
24493204|NCT00489944|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24493205|NCT00489944|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24493246|NCT00490178|Fenofibrate|fenofibrate|mesh-list
24493296|NCT00490308|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24493298|NCT00490360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24918622|NCT04217668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493299|NCT00490360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24493300|NCT00490360|Antimetabolites|antimetabolites|mesh-ancestor
24493301|NCT00490360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493302|NCT00490360|Antiviral Agents|antiviral agents|mesh-ancestor
24493303|NCT00490360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493304|NCT00490360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493305|NCT00490360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24493306|NCT00490360|Immunologic Factors|immunologic factors|mesh-ancestor
24493344|NCT00490633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24493345|NCT00490633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493346|NCT00490633|Disinfectants|disinfectants|mesh-ancestor
24493347|NCT00490659|Gemcitabine|gemcitabine|mesh-list
24493348|NCT00490659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493349|NCT00490659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24493350|NCT00490659|Antimetabolites|antimetabolites|mesh-ancestor
24493351|NCT00490659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493354|NCT00490659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493355|NCT00490659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24493356|NCT00490659|Immunologic Factors|immunologic factors|mesh-ancestor
24918623|NCT04217668|Vasodilator Agents|vasodilator agents|mesh-ancestor
24493357|NCT00490659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493359|NCT00490685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493360|NCT00490685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25848750|NCT00046384|Antidepressive Agents|antidepressive agents|mesh-ancestor
25848751|NCT00046384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25848752|NCT00046384|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24493962|NCT00493194|Dermatologic Agents|dermatologic agents|mesh-ancestor
24493395|NCT00490828|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24493396|NCT00490828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25848753|NCT00046384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25848754|NCT00046384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24493462|NCT00490997|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24534402|NCT00646880|Propiverine|propiverine|mesh-list
25848755|NCT00046384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493470|NCT00491049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493471|NCT00491049|Renal Agents|renal agents|mesh-ancestor
24493472|NCT00491049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24493473|NCT00491049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24493474|NCT00491049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24493476|NCT00491049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493477|NCT00491049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493478|NCT00491049|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24493479|NCT00491049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24493480|NCT00491114|Gemcitabine|gemcitabine|mesh-list
24493481|NCT00491114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25848756|NCT00046384|Dopamine Agonists|dopamine agonists|mesh-ancestor
25848757|NCT00046384|Dopamine Agents|dopamine agents|mesh-ancestor
25848758|NCT00046384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25848759|NCT00046384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848760|NCT00046384|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25848761|NCT00046384|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25848762|NCT00046384|Serotonin Agents|serotonin agents|mesh-ancestor
25848763|NCT00046384|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24622983|NCT01069328|Growth Inhibitors|growth inhibitors|mesh-ancestor
24493489|NCT00491114|Immunologic Factors|immunologic factors|mesh-ancestor
24493490|NCT00491114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493491|NCT00491127|Gemcitabine|gemcitabine|mesh-list
24493492|NCT00491127|Dexamethasone|dexamethasone|mesh-list
24493493|NCT00491127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493494|NCT00491127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24493495|NCT00491127|Antiemetics|antiemetics|mesh-ancestor
24493496|NCT00491127|Autonomic Agents|autonomic agents|mesh-ancestor
24493497|NCT00491127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24493498|NCT00491127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493499|NCT00491127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24493500|NCT00491127|Glucocorticoids|glucocorticoids|mesh-ancestor
24493501|NCT00491127|Hormones|hormones|mesh-ancestor
24493563|NCT00491426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24493582|NCT00491517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493583|NCT00491517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24493584|NCT00491517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493585|NCT00491517|Antifungal Agents|antifungal agents|mesh-ancestor
24493586|NCT00491517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24493587|NCT00491517|Immunologic Factors|immunologic factors|mesh-ancestor
24493607|NCT00491712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493608|NCT00491725|Metformin|metformin|mesh-list
24493609|NCT00491725|Repaglinide|repaglinide|mesh-list
24493610|NCT00491725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24493611|NCT00491725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493612|NCT00491790|Montelukast|montelukast|mesh-list
25661775|NCT01637623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25661776|NCT01637623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25661777|NCT01637623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24493613|NCT00491790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25661778|NCT01637623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493614|NCT00491790|Respiratory System Agents|respiratory system agents|mesh-ancestor
24493615|NCT00491790|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24493622|NCT00491803|Sildenafil Citrate|sildenafil citrate|mesh-list
24493623|NCT00491803|Vasodilator Agents|vasodilator agents|mesh-ancestor
24493624|NCT00491803|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24493625|NCT00491803|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24493626|NCT00491803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493627|NCT00491803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493628|NCT00491803|Urological Agents|urological agents|mesh-ancestor
24493629|NCT00491816|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24493630|NCT00491816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493631|NCT00491816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24493632|NCT00491816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493633|NCT00491816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493635|NCT00491855|Bevacizumab|bevacizumab|mesh-list
24493636|NCT00491855|Oxaliplatin|oxaliplatin|mesh-list
24493662|NCT00491920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24493963|NCT00493194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24493663|NCT00491920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24493664|NCT00491946|Dactinomycin|dactinomycin|mesh-list
24493665|NCT00491946|Vincristine|vincristine|mesh-list
24493666|NCT00491946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24493667|NCT00491946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493668|NCT00491946|Tubulin Modulators|tubulin modulators|mesh-ancestor
24493669|NCT00491946|Antimitotic Agents|antimitotic agents|mesh-ancestor
24493670|NCT00491946|Mitosis Modulators|mitosis modulators|mesh-ancestor
24493671|NCT00491946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493672|NCT00491946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24493673|NCT00491946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493717|NCT00492128|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24493718|NCT00492141|Temozolomide|temozolomide|mesh-list
24493720|NCT00492141|Rubitecan|rubitecan|mesh-list
24493721|NCT00492141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24493741|NCT00492245|Mitomycins|mitomycins|mesh-list
24493742|NCT00492245|Mitomycin|mitomycin|mesh-list
24493743|NCT00492245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24493744|NCT00492245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493745|NCT00492245|Alkylating Agents|alkylating agents|mesh-ancestor
24493746|NCT00492245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493747|NCT00492245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24493748|NCT00492245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493749|NCT00492258|Sorafenib|sorafenib|mesh-list
24493750|NCT00492258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493751|NCT00492258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24493752|NCT00492258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493753|NCT00492258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493754|NCT00492388|Ketamine|ketamine|mesh-list
24921200|NCT04193501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24493755|NCT00492388|Analgesics|analgesics|mesh-ancestor
24493756|NCT00492388|Sensory System Agents|sensory system agents|mesh-ancestor
24493757|NCT00492388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24493758|NCT00492388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493759|NCT00492388|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24493760|NCT00492388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24493761|NCT00492388|Anesthetics, General|anesthetics, general|mesh-ancestor
24493762|NCT00492388|Anesthetics|anesthetics|mesh-ancestor
24493763|NCT00492388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24921796|NCT04186702|Growth Substances|growth substances|mesh-ancestor
24493764|NCT00492388|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24493765|NCT00492388|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24493766|NCT00492388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24493767|NCT00492388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493768|NCT00492414|Paroxetine|paroxetine|mesh-list
24493769|NCT00492414|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24493770|NCT00492414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24493771|NCT00492414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24493824|NCT00492518|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24493825|NCT00492518|Antiviral Agents|antiviral agents|mesh-ancestor
24493830|NCT00492518|Antioxidants|antioxidants|mesh-ancestor
24493831|NCT00492518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493832|NCT00492518|Protective Agents|protective agents|mesh-ancestor
24493910|NCT00492986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493911|NCT00492986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24809482|NCT02033967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809483|NCT02034071|Diazoxide|diazoxide|mesh-list
24493912|NCT00492986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493913|NCT00492986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493914|NCT00493077|Interferons|interferons|mesh-list
24493915|NCT00493077|Interferon-beta|interferon-beta|mesh-list
24493916|NCT00493077|Interferon beta-1a|interferon beta-1a|mesh-list
24493917|NCT00493077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493918|NCT00493077|Antiviral Agents|antiviral agents|mesh-ancestor
24493919|NCT00493077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493961|NCT00493194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493964|NCT00493194|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24493965|NCT00493194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24493966|NCT00493194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25181785|NCT04782700|Prednisone|prednisone|mesh-list
24493967|NCT00493194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497912|NCT00512486|Respiratory System Agents|respiratory system agents|mesh-ancestor
24493969|NCT00493233|Risperidone|risperidone|mesh-list
24493970|NCT00493233|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24493971|NCT00493233|Antipsychotic Agents|antipsychotic agents|mesh-list
24493972|NCT00493233|Clozapine|clozapine|mesh-list
24493973|NCT00493233|Perphenazine|perphenazine|mesh-list
24493974|NCT00493233|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24493975|NCT00493233|Serotonin Agents|serotonin agents|mesh-ancestor
24493976|NCT00493233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24493979|NCT00493233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24493980|NCT00493233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24494076|NCT00493623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494077|NCT00493662|Hyaluronic Acid|hyaluronic acid|mesh-list
24494078|NCT00493662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24494079|NCT00493662|Immunologic Factors|immunologic factors|mesh-ancestor
24494080|NCT00493662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494081|NCT00493662|Viscosupplements|viscosupplements|mesh-ancestor
24494082|NCT00493662|Protective Agents|protective agents|mesh-ancestor
24494083|NCT00493727|Acetylcysteine|acetylcysteine|mesh-list
24494084|NCT00493727|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24494085|NCT00493727|Antiviral Agents|antiviral agents|mesh-ancestor
24494086|NCT00493727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24494087|NCT00493727|Expectorants|expectorants|mesh-ancestor
24494088|NCT00493727|Respiratory System Agents|respiratory system agents|mesh-ancestor
24494089|NCT00493727|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24494090|NCT00493727|Antioxidants|antioxidants|mesh-ancestor
24494091|NCT00493727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494092|NCT00493727|Protective Agents|protective agents|mesh-ancestor
24494093|NCT00493727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661779|NCT01637623|Antimetabolites|antimetabolites|mesh-ancestor
25661780|NCT01637623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661781|NCT01637623|Gout Suppressants|gout suppressants|mesh-ancestor
25661782|NCT01637623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25661783|NCT01637623|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25661784|NCT01637623|Antioxidants|antioxidants|mesh-ancestor
25661785|NCT01637623|Protective Agents|protective agents|mesh-ancestor
25661786|NCT01637623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661787|NCT01637935|Pioglitazone|pioglitazone|mesh-list
25661788|NCT01637935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25661789|NCT01637935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494094|NCT00493727|Antidotes|antidotes|mesh-ancestor
24454784|NCT03690544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24454785|NCT03690544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24454786|NCT03690544|Analgesics|analgesics|mesh-ancestor
24494095|NCT00493766|Panobinostat|panobinostat|mesh-list
24494098|NCT00493766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24494099|NCT00493766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494101|NCT00493831|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24494102|NCT00493831|Autonomic Agents|autonomic agents|mesh-ancestor
24494115|NCT00493857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24494116|NCT00493857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494117|NCT00493870|Cyclophosphamide|cyclophosphamide|mesh-list
24494119|NCT00493870|Doxorubicin|doxorubicin|mesh-list
24494176|NCT00494156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24494190|NCT00494208|Hormones|hormones|mesh-ancestor
24494191|NCT00494208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24494192|NCT00494208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494193|NCT00494247|Antibodies|antibodies|mesh-list
24494194|NCT00494247|Immunologic Factors|immunologic factors|mesh-ancestor
24494195|NCT00494247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494196|NCT00494312|Pioglitazone|pioglitazone|mesh-list
24923371|NCT04170751|Sympathomimetics|sympathomimetics|mesh-ancestor
24494241|NCT00494559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494242|NCT00494572|Montelukast|montelukast|mesh-list
24494243|NCT00494572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25848765|NCT00046384|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25848766|NCT00046384|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25848767|NCT00046423|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25848768|NCT00046423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848769|NCT00046462|Metformin|metformin|mesh-list
25848770|NCT00046462|Insulin Glargine|insulin glargine|mesh-list
25848771|NCT00046462|Glyburide|glyburide|mesh-list
25848772|NCT00046462|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
25848773|NCT00046462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25848774|NCT00046462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848775|NCT00046501|Insulin|insulin|mesh-list
25848776|NCT00046501|Insulin Glargine|insulin glargine|mesh-list
25848777|NCT00046501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24494276|NCT00494663|Antifungal Agents|antifungal agents|mesh-ancestor
24494277|NCT00494663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24494278|NCT00494663|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24494279|NCT00494663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24923425|NCT04170439|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24499151|NCT00517985|Analgesics|analgesics|mesh-ancestor
24494281|NCT00494663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494282|NCT00494663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24494284|NCT00494663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24494285|NCT00494663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494286|NCT00494663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24494287|NCT00494715|Valsartan|valsartan|mesh-list
24494288|NCT00494715|Benazepril|benazepril|mesh-list
24494289|NCT00494715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24494312|NCT00494832|Dexmedetomidine|dexmedetomidine|mesh-list
24494313|NCT00494832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25848778|NCT00046501|Insulin, Isophane|insulin, isophane|mesh-list
24494314|NCT00494832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24923608|NCT04168723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24494315|NCT00494832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494316|NCT00494832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24494317|NCT00494832|Analgesics|analgesics|mesh-ancestor
24494318|NCT00494832|Sensory System Agents|sensory system agents|mesh-ancestor
24534484|NCT00647166|Azathioprine|azathioprine|mesh-list
24494336|NCT00494897|Methotrexate|methotrexate|mesh-list
24494337|NCT00494897|Vincristine|vincristine|mesh-list
24494378|NCT00494988|Insulin, Isophane|insulin, isophane|mesh-list
25848779|NCT00046501|Isophane Insulin, Human|isophane insulin, human|mesh-list
25848780|NCT00046501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24809498|NCT02034097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809500|NCT02034201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24809501|NCT02034201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809502|NCT02034201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24809503|NCT02034201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24809504|NCT02034201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25661790|NCT01638000|Solifenacin Succinate|solifenacin succinate|mesh-list
25661791|NCT01638000|Mirabegron|mirabegron|mesh-list
25661792|NCT01638000|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25661793|NCT01638000|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25848781|NCT00046501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848782|NCT00046514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25848783|NCT00046514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494384|NCT00495066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494385|NCT00495066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24494386|NCT00495066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494388|NCT00495092|Caffeine|caffeine|mesh-list
24494389|NCT00495092|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24494390|NCT00495092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494391|NCT00495092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24494392|NCT00495092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24494393|NCT00495092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494394|NCT00495092|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24494395|NCT00495092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24494396|NCT00495092|Purinergic Agents|purinergic agents|mesh-ancestor
24494397|NCT00495092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24494398|NCT00495092|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24494399|NCT00495092|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24494400|NCT00495092|Parasympatholytics|parasympatholytics|mesh-ancestor
24494401|NCT00495092|Autonomic Agents|autonomic agents|mesh-ancestor
24494402|NCT00495092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24494403|NCT00495092|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24494404|NCT00495092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24494405|NCT00495092|Cholinergic Agents|cholinergic agents|mesh-ancestor
24494406|NCT00495118|Risperidone|risperidone|mesh-list
24494407|NCT00495118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24494408|NCT00495118|Serotonin Agents|serotonin agents|mesh-ancestor
24494409|NCT00495118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25848784|NCT00046527|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24494410|NCT00495118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494411|NCT00495118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494412|NCT00495118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24809507|NCT02034201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24809508|NCT02034253|Risperidone|risperidone|mesh-list
24809509|NCT02034253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24494478|NCT00495326|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24494479|NCT00495326|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24494480|NCT00495326|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24494482|NCT00495326|Antimetabolites|antimetabolites|mesh-ancestor
25848785|NCT00046527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494483|NCT00495326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24494484|NCT00495339|Levofloxacin|levofloxacin|mesh-list
24494485|NCT00495339|Ofloxacin|ofloxacin|mesh-list
24494486|NCT00495339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24494487|NCT00495339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25848786|NCT00046553|Mifepristone|mifepristone|mesh-list
25848787|NCT00046553|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25848788|NCT00046553|Abortifacient Agents|abortifacient agents|mesh-ancestor
25848789|NCT00046553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25848790|NCT00046553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848791|NCT00046553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25848792|NCT00046553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25848793|NCT00046553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25848794|NCT00046553|Contraceptive Agents|contraceptive agents|mesh-ancestor
25848795|NCT00046553|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25848796|NCT00046553|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25848797|NCT00046553|Hormone Antagonists|hormone antagonists|mesh-ancestor
24494493|NCT00495339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494494|NCT00495339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494495|NCT00495339|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24494496|NCT00495339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24494497|NCT00495352|Bupropion|bupropion|mesh-list
24494498|NCT00495352|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24494499|NCT00495352|Antidepressive Agents|antidepressive agents|mesh-ancestor
24494500|NCT00495352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24494532|NCT00495573|Antiviral Agents|antiviral agents|mesh-ancestor
24494533|NCT00495573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24494535|NCT00495651|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24494536|NCT00495651|Antitubercular Agents|antitubercular agents|mesh-ancestor
24494537|NCT00495651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25661794|NCT01638000|Cholinergic Agents|cholinergic agents|mesh-ancestor
25848799|NCT00046553|Luteolytic Agents|luteolytic agents|mesh-ancestor
25848800|NCT00046553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25848801|NCT00046553|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25848802|NCT00046683|Alemtuzumab|alemtuzumab|mesh-list
25848803|NCT00046683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25848804|NCT00046683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848805|NCT00046735|Lenalidomide|lenalidomide|mesh-list
25848806|NCT00046735|Immunologic Factors|immunologic factors|mesh-ancestor
25848807|NCT00046735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848808|NCT00046735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25848809|NCT00046735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25848810|NCT00046735|Growth Substances|growth substances|mesh-ancestor
24494538|NCT00495651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24494539|NCT00495651|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24494540|NCT00495651|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24494541|NCT00495651|Antimetabolites|antimetabolites|mesh-ancestor
24809510|NCT02034253|Serotonin Agents|serotonin agents|mesh-ancestor
24809511|NCT02034253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24809512|NCT02034253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809513|NCT02034253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809515|NCT02034253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24809516|NCT02034253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24809517|NCT02034253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24809518|NCT02034253|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24809519|NCT02034253|Dopamine Agents|dopamine agents|mesh-ancestor
24809520|NCT02034292|Aspirin|aspirin|mesh-list
24809521|NCT02034292|Clopidogrel|clopidogrel|mesh-list
24809523|NCT02034292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24809524|NCT02034292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24809525|NCT02034292|Analgesics|analgesics|mesh-ancestor
24809526|NCT02034292|Sensory System Agents|sensory system agents|mesh-ancestor
24809527|NCT02034292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24809528|NCT02034292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809529|NCT02034292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24809530|NCT02034292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24494542|NCT00495651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494552|NCT00495729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24494553|NCT00495781|Iron|iron|mesh-list
24494554|NCT00495781|Trace Elements|trace elements|mesh-ancestor
24494555|NCT00495781|Micronutrients|micronutrients|mesh-ancestor
24494556|NCT00495781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494558|NCT00495846|Lanreotide|lanreotide|mesh-list
24494583|NCT00495872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24494584|NCT00495872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24494585|NCT00495872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24494586|NCT00495898|Sirolimus|sirolimus|mesh-list
24494587|NCT00495898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24494588|NCT00495898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24494589|NCT00495898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24494590|NCT00495898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494591|NCT00495898|Antifungal Agents|antifungal agents|mesh-ancestor
24494592|NCT00495898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24809531|NCT02034292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24809532|NCT02034292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24809533|NCT02034292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809534|NCT02034292|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24809535|NCT02034292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25661795|NCT01638000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25661796|NCT01638000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661797|NCT01638000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661798|NCT01638000|Urological Agents|urological agents|mesh-ancestor
25661799|NCT01638000|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25661800|NCT01638000|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25661801|NCT01638000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25661802|NCT01638000|Adrenergic Agents|adrenergic agents|mesh-ancestor
25661803|NCT01638013|Peficitinib|peficitinib|mesh-list
25661804|NCT01638013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661805|NCT01638013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661806|NCT01638013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25661807|NCT01638013|Immunologic Factors|immunologic factors|mesh-ancestor
24809540|NCT02034292|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24809541|NCT02034292|Purinergic Agents|purinergic agents|mesh-ancestor
24809542|NCT02034292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24809543|NCT02034292|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24809544|NCT02034292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24809545|NCT02034292|Serotonin Agents|serotonin agents|mesh-ancestor
24494711|NCT00496444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25848811|NCT00046735|Growth Inhibitors|growth inhibitors|mesh-ancestor
24494719|NCT00496600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494720|NCT00496600|Tubulin Modulators|tubulin modulators|mesh-ancestor
24494731|NCT00496665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494732|NCT00496665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24494733|NCT00496665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24494734|NCT00496665|Alkylating Agents|alkylating agents|mesh-ancestor
24494735|NCT00496665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494736|NCT00496665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848812|NCT00046735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494738|NCT00496665|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24809586|NCT02034838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24809588|NCT02034890|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24494739|NCT00496665|Abortifacient Agents|abortifacient agents|mesh-ancestor
24494740|NCT00496665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24494741|NCT00496665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24494742|NCT00496665|Antimetabolites|antimetabolites|mesh-ancestor
24494743|NCT00496665|Dermatologic Agents|dermatologic agents|mesh-ancestor
24494744|NCT00496665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24494763|NCT00497003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25133756|NCT03011021|Hormones|hormones|mesh-ancestor
24494765|NCT00497003|Autonomic Agents|autonomic agents|mesh-ancestor
24494766|NCT00497003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25848813|NCT00046748|Omalizumab|omalizumab|mesh-list
25848814|NCT00046748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24494775|NCT00497003|Protective Agents|protective agents|mesh-ancestor
24494776|NCT00497003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24494777|NCT00497003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24494778|NCT00497003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24494779|NCT00497003|Vasodilator Agents|vasodilator agents|mesh-ancestor
24787534|NCT01925729|Histamine Agents|histamine agents|mesh-ancestor
24494780|NCT00497003|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24494781|NCT00497003|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24494783|NCT00497016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24494784|NCT00497016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24494785|NCT00497016|Antimetabolites|antimetabolites|mesh-ancestor
24494786|NCT00497016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494787|NCT00497016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24494788|NCT00497016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24494789|NCT00497016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24494791|NCT00497029|Fluorides, Topical|fluorides, topical|mesh-list
24494792|NCT00497029|Cariostatic Agents|cariostatic agents|mesh-ancestor
24494793|NCT00497029|Protective Agents|protective agents|mesh-ancestor
25848815|NCT00046748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24494915|NCT00497523|Albuterol|albuterol|mesh-list
24494916|NCT00497523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24494917|NCT00497523|Autonomic Agents|autonomic agents|mesh-ancestor
24494918|NCT00497523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24494919|NCT00497523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494920|NCT00497523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24494921|NCT00497523|Respiratory System Agents|respiratory system agents|mesh-ancestor
24494922|NCT00497523|Tocolytic Agents|tocolytic agents|mesh-ancestor
25848816|NCT00046748|Respiratory System Agents|respiratory system agents|mesh-ancestor
25848817|NCT00046787|Lurtotecan|lurtotecan|mesh-list
25848818|NCT00046787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25661808|NCT01638013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661809|NCT01638052|Clonidine|clonidine|mesh-list
25661810|NCT01638052|Bupivacaine|bupivacaine|mesh-list
25661811|NCT01638052|Anesthetics, Local|anesthetics, local|mesh-ancestor
25661812|NCT01638052|Anesthetics|anesthetics|mesh-ancestor
24494955|NCT00497562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24494956|NCT00497562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494957|NCT00497562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24494958|NCT00497562|Serotonin Agents|serotonin agents|mesh-ancestor
24494959|NCT00497562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24494960|NCT00497562|Antidepressive Agents|antidepressive agents|mesh-ancestor
24624974|NCT01079676|Immunologic Factors|immunologic factors|mesh-ancestor
24931220|NCT04091763|Polidocanol|polidocanol|mesh-list
24931221|NCT04091763|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
24494961|NCT00497562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24494962|NCT00497562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24494963|NCT00497562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24494964|NCT00497562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24494965|NCT00497562|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24494966|NCT00497562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24494978|NCT00497601|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24494979|NCT00497601|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24494980|NCT00497601|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24494982|NCT00497614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24494983|NCT00497614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24494984|NCT00497744|Cefepime|cefepime|mesh-list
24494985|NCT00497744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24494986|NCT00497744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24494987|NCT00497809|Lenograstim|lenograstim|mesh-list
24494988|NCT00497809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24494989|NCT00497809|Immunologic Factors|immunologic factors|mesh-ancestor
24494990|NCT00497809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848822|NCT00046813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25848823|NCT00046813|Autonomic Agents|autonomic agents|mesh-ancestor
24494991|NCT00497900|Vitamin D|vitamin d|mesh-list
24494992|NCT00497900|Vitamins|vitamins|mesh-ancestor
24494993|NCT00497900|Micronutrients|micronutrients|mesh-ancestor
24494994|NCT00497900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809609|NCT02035072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809610|NCT02035072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24809611|NCT02035072|Immunologic Factors|immunologic factors|mesh-ancestor
24809612|NCT02035072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848824|NCT00046813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24495006|NCT00497913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24495007|NCT00497939|Saw palmetto extract|saw palmetto extract|mesh-list
24495008|NCT00497939|Urological Agents|urological agents|mesh-ancestor
24495009|NCT00498004|Risperidone|risperidone|mesh-list
24495010|NCT00498004|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24495011|NCT00498004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24495012|NCT00498004|Serotonin Agents|serotonin agents|mesh-ancestor
24495013|NCT00498004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24495014|NCT00498004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495015|NCT00498004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848825|NCT00046813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848826|NCT00046813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25848827|NCT00046813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25848828|NCT00046813|Cholinergic Agents|cholinergic agents|mesh-ancestor
25848829|NCT00046813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25661813|NCT01638052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25661814|NCT01638052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661815|NCT01638052|Sensory System Agents|sensory system agents|mesh-ancestor
25661816|NCT01638052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25661817|NCT01638052|Analgesics|analgesics|mesh-ancestor
25661818|NCT01638052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25848830|NCT00046813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848831|NCT00046826|Thalidomide|thalidomide|mesh-list
25848834|NCT00046826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848835|NCT00046826|Tubulin Modulators|tubulin modulators|mesh-ancestor
24495016|NCT00498004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24495017|NCT00498004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24495018|NCT00498004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24495019|NCT00498004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24495020|NCT00498004|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24495021|NCT00498004|Dopamine Agents|dopamine agents|mesh-ancestor
24495022|NCT00498004|Antidepressive Agents|antidepressive agents|mesh-ancestor
24495024|NCT00498108|Dopamine Agonists|dopamine agonists|mesh-ancestor
24495025|NCT00498108|Dopamine Agents|dopamine agents|mesh-ancestor
24495026|NCT00498108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24495027|NCT00498108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495033|NCT00498134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24495034|NCT00498134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24495035|NCT00498134|Analgesics|analgesics|mesh-ancestor
24495036|NCT00498134|Sensory System Agents|sensory system agents|mesh-ancestor
24495042|NCT00498225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24495043|NCT00498225|Antimetabolites|antimetabolites|mesh-ancestor
24495059|NCT00498251|Respiratory System Agents|respiratory system agents|mesh-ancestor
24495061|NCT00498251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24495062|NCT00498251|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24495063|NCT00498251|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24495064|NCT00498251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24495065|NCT00498251|Adrenergic Agents|adrenergic agents|mesh-ancestor
24495066|NCT00498251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24495067|NCT00498251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495068|NCT00498251|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24495069|NCT00498251|Cholinergic Agents|cholinergic agents|mesh-ancestor
24495070|NCT00498316|Mycophenolic Acid|mycophenolic acid|mesh-list
25848836|NCT00046826|Antimitotic Agents|antimitotic agents|mesh-ancestor
24932608|NCT04077957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24932609|NCT04077957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625171|NCT01080651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24589414|NCT00907400|Naproxen|naproxen|mesh-list
25848837|NCT00046826|Mitosis Modulators|mitosis modulators|mesh-ancestor
25848838|NCT00046826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848839|NCT00046826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25848840|NCT00046826|Immunologic Factors|immunologic factors|mesh-ancestor
24495071|NCT00498316|Cyclophosphamide|cyclophosphamide|mesh-list
24495072|NCT00498316|Melphalan|melphalan|mesh-list
24495073|NCT00498316|Busulfan|busulfan|mesh-list
24495074|NCT00498316|Rituximab|rituximab|mesh-list
24495075|NCT00498316|Fludarabine|fludarabine|mesh-list
24495076|NCT00498316|Fludarabine phosphate|fludarabine phosphate|mesh-list
24495084|NCT00498316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24587021|NCT00893061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24495085|NCT00498316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24495086|NCT00498316|Alkylating Agents|alkylating agents|mesh-ancestor
24495087|NCT00498316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495088|NCT00498316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495089|NCT00498316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24495090|NCT00498316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24495091|NCT00498316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24495092|NCT00498316|Antimetabolites|antimetabolites|mesh-ancestor
24495093|NCT00498316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24495094|NCT00498316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24495095|NCT00498316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495096|NCT00498316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24933895|NCT04066257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24933896|NCT04066257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24495097|NCT00498316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24495098|NCT00498316|Antitubercular Agents|antitubercular agents|mesh-ancestor
24495099|NCT00498316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24495100|NCT00498342|Acetylcysteine|acetylcysteine|mesh-list
24495101|NCT00498342|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24495102|NCT00498342|Antiviral Agents|antiviral agents|mesh-ancestor
24495103|NCT00498342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24495104|NCT00498342|Expectorants|expectorants|mesh-ancestor
24495105|NCT00498342|Respiratory System Agents|respiratory system agents|mesh-ancestor
24495106|NCT00498342|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24495107|NCT00498342|Antioxidants|antioxidants|mesh-ancestor
25848841|NCT00046826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661819|NCT01638052|Sympatholytics|sympatholytics|mesh-ancestor
24454841|NCT03474029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24454842|NCT03474029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25848842|NCT00046826|Leprostatic Agents|leprostatic agents|mesh-ancestor
25848843|NCT00046826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25848844|NCT00046826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25848845|NCT00046826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24495123|NCT00498589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24495124|NCT00498589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934129|NCT04063540|Natriuretic Agents|natriuretic agents|mesh-ancestor
24934130|NCT04063540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934131|NCT04063540|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24934132|NCT04063540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24934424|NCT04061447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24934425|NCT04061447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24934427|NCT04061265|Epinephrine|epinephrine|mesh-list
24934429|NCT04061265|Anesthetics, Local|anesthetics, local|mesh-ancestor
24934576|NCT04060719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934577|NCT04060719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24934578|NCT04060719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24934754|NCT04058899|Dexmedetomidine|dexmedetomidine|mesh-list
24934755|NCT04058899|Nalbuphine|nalbuphine|mesh-list
24934756|NCT04058899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24934759|NCT04058899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24495130|NCT00498589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495131|NCT00498589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24495132|NCT00498589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24495133|NCT00498589|Immunologic Factors|immunologic factors|mesh-ancestor
24495142|NCT00498680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495146|NCT00498784|Contraceptive Agents|contraceptive agents|mesh-ancestor
24495147|NCT00498784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24495148|NCT00498784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495149|NCT00498784|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24495150|NCT00498784|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24495151|NCT00498784|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24495152|NCT00498888|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25848846|NCT00046826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25848847|NCT00046826|Growth Substances|growth substances|mesh-ancestor
25848848|NCT00046826|Growth Inhibitors|growth inhibitors|mesh-ancestor
24809658|NCT02035709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809660|NCT02035709|Sensory System Agents|sensory system agents|mesh-ancestor
24809661|NCT02035709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24495182|NCT00498953|Tubulin Modulators|tubulin modulators|mesh-ancestor
24495183|NCT00498953|Antimitotic Agents|antimitotic agents|mesh-ancestor
24495184|NCT00498953|Mitosis Modulators|mitosis modulators|mesh-ancestor
24495185|NCT00498953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495187|NCT00498953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24495188|NCT00498953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24495189|NCT00498953|Immunologic Factors|immunologic factors|mesh-ancestor
25848849|NCT00046826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25848850|NCT00046826|Alkylating Agents|alkylating agents|mesh-ancestor
25848851|NCT00046826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25848852|NCT00046852|Cyclophosphamide|cyclophosphamide|mesh-list
25848853|NCT00046852|Melphalan|melphalan|mesh-list
25848854|NCT00046852|Carmustine|carmustine|mesh-list
25848855|NCT00046852|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24495283|NCT00499135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24495284|NCT00499135|Growth Substances|growth substances|mesh-ancestor
24495285|NCT00499135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495291|NCT00499135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24495292|NCT00499265|Gemcitabine|gemcitabine|mesh-list
25661820|NCT01638052|Autonomic Agents|autonomic agents|mesh-ancestor
25661821|NCT01638052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25661822|NCT01638052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25661823|NCT01638052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25661824|NCT01638052|Adrenergic Agents|adrenergic agents|mesh-ancestor
24495293|NCT00499265|Protease Inhibitors|protease inhibitors|mesh-list
25661825|NCT01638052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25661826|NCT01638052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661827|NCT01638429|Rifaximin|rifaximin|mesh-list
25848856|NCT00046852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25848857|NCT00046852|Immunologic Factors|immunologic factors|mesh-ancestor
25848858|NCT00046852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848859|NCT00046852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25848860|NCT00046852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25848861|NCT00046852|Alkylating Agents|alkylating agents|mesh-ancestor
25848862|NCT00046852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848863|NCT00046852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848864|NCT00046852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25848865|NCT00046878|Carmustine|carmustine|mesh-list
25848866|NCT00046878|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
25848867|NCT00046878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25848868|NCT00046878|Alkylating Agents|alkylating agents|mesh-ancestor
25848869|NCT00046878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495294|NCT00499265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-list
24495295|NCT00499265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24495302|NCT00499265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24495303|NCT00499265|Immunologic Factors|immunologic factors|mesh-ancestor
25848870|NCT00046878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848871|NCT00046878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848872|NCT00046904|Etanercept|etanercept|mesh-list
25848873|NCT00046904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25848874|NCT00046904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24495308|NCT00499291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495309|NCT00499291|Tubulin Modulators|tubulin modulators|mesh-ancestor
24495310|NCT00499291|Antimitotic Agents|antimitotic agents|mesh-ancestor
24495311|NCT00499291|Mitosis Modulators|mitosis modulators|mesh-ancestor
24495312|NCT00499291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495313|NCT00499525|Paclitaxel|paclitaxel|mesh-list
24495314|NCT00499525|Sorafenib|sorafenib|mesh-list
24495315|NCT00499525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24495316|NCT00499525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495317|NCT00499525|Tubulin Modulators|tubulin modulators|mesh-ancestor
24495318|NCT00499525|Antimitotic Agents|antimitotic agents|mesh-ancestor
25848875|NCT00046904|Analgesics|analgesics|mesh-ancestor
25848876|NCT00046904|Sensory System Agents|sensory system agents|mesh-ancestor
25848877|NCT00046904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25848878|NCT00046904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848879|NCT00046904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24809677|NCT02035904|Levobupivacaine|levobupivacaine|mesh-list
24809678|NCT02035904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24809679|NCT02035904|Narcotics|narcotics|mesh-ancestor
24809680|NCT02035904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24495358|NCT00499720|Aztreonam|aztreonam|mesh-list
24495359|NCT00499720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24495360|NCT00499720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24495361|NCT00499733|Cyclophosphamide|cyclophosphamide|mesh-list
24495362|NCT00499733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24495363|NCT00499733|Immunologic Factors|immunologic factors|mesh-ancestor
24957625|NCT03843515|Nivolumab|nivolumab|mesh-list
24495364|NCT00499733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495365|NCT00499733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24495366|NCT00499733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24495367|NCT00499733|Alkylating Agents|alkylating agents|mesh-ancestor
24495368|NCT00499733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495369|NCT00499733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495370|NCT00499733|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24495371|NCT00499811|Vorinostat|vorinostat|mesh-list
24495372|NCT00499811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495373|NCT00499811|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24495374|NCT00499811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495375|NCT00499811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091348|NCT03249259|Choline|choline|mesh-list
24495376|NCT00499837|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
24495402|NCT00499876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24495404|NCT00499993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25661828|NCT01638429|Neomycin|neomycin|mesh-list
25661829|NCT01638429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25661830|NCT01638429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25661831|NCT01638429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25661832|NCT01638429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25661833|NCT01638429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661834|NCT01638429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495405|NCT00500006|Dasatinib|dasatinib|mesh-list
24495406|NCT00500006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495434|NCT00500253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24495437|NCT00500253|Antioxidants|antioxidants|mesh-ancestor
24495438|NCT00500253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495439|NCT00500253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24495440|NCT00500253|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24495441|NCT00500253|Vasodilator Agents|vasodilator agents|mesh-ancestor
24495442|NCT00500253|Gasotransmitters|gasotransmitters|mesh-ancestor
24495443|NCT00500253|Protective Agents|protective agents|mesh-ancestor
24495444|NCT00500253|Miotics|miotics|mesh-ancestor
24495445|NCT00500253|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24495446|NCT00500253|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
24495447|NCT00500253|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24495448|NCT00500253|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24495449|NCT00500253|Cholinergic Agents|cholinergic agents|mesh-ancestor
24455493|NCT00327522|Immunologic Factors|immunologic factors|mesh-ancestor
24455494|NCT00327522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455495|NCT00327535|Epoetin Alfa|epoetin alfa|mesh-list
24495450|NCT00500279|Celecoxib|celecoxib|mesh-list
24495451|NCT00500279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24495452|NCT00500279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24495453|NCT00500279|Analgesics|analgesics|mesh-ancestor
24495454|NCT00500279|Sensory System Agents|sensory system agents|mesh-ancestor
24495455|NCT00500279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25848880|NCT00046904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24495492|NCT00500552|Perhexiline|perhexiline|mesh-list
24495493|NCT00500552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24809681|NCT02035904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495494|NCT00500552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24495495|NCT00500552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495496|NCT00500552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24495497|NCT00500552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495498|NCT00500552|Vasodilator Agents|vasodilator agents|mesh-ancestor
24495499|NCT00500565|Bupivacaine|bupivacaine|mesh-list
24495500|NCT00500565|Anesthetics, Local|anesthetics, local|mesh-ancestor
24495501|NCT00500565|Anesthetics|anesthetics|mesh-ancestor
24495502|NCT00500565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24587849|NCT00897871|Etoposide|etoposide|mesh-list
24495503|NCT00500565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495504|NCT00500565|Sensory System Agents|sensory system agents|mesh-ancestor
24495505|NCT00500565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24495567|NCT00501124|Clevudine|clevudine|mesh-list
24495568|NCT00501124|Antiviral Agents|antiviral agents|mesh-ancestor
24495569|NCT00501124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25848881|NCT00046904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24495581|NCT00501215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495583|NCT00501241|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24495584|NCT00501241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24495585|NCT00501241|Serotonin Agents|serotonin agents|mesh-ancestor
24495586|NCT00501241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24495587|NCT00501241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495588|NCT00501241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495589|NCT00501254|Aspirin|aspirin|mesh-list
24495590|NCT00501254|Salicylic Acid|salicylic acid|mesh-list
24495591|NCT00501254|Salicylates|salicylates|mesh-list
24495592|NCT00501254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25166404|NCT04111315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24495593|NCT00501254|Antifungal Agents|antifungal agents|mesh-ancestor
24495594|NCT00501254|Keratolytic Agents|keratolytic agents|mesh-ancestor
24495595|NCT00501254|Dermatologic Agents|dermatologic agents|mesh-ancestor
24495596|NCT00501254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24495597|NCT00501254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24495598|NCT00501254|Analgesics|analgesics|mesh-ancestor
24495599|NCT00501254|Sensory System Agents|sensory system agents|mesh-ancestor
25848882|NCT00046904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25848883|NCT00046904|Immunologic Factors|immunologic factors|mesh-ancestor
24495615|NCT00501267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24495616|NCT00501267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495617|NCT00501267|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24495618|NCT00501267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24495619|NCT00501267|Cholinergic Agents|cholinergic agents|mesh-ancestor
25848884|NCT00046917|Cisplatin|cisplatin|mesh-list
25661835|NCT01638546|Temozolomide|temozolomide|mesh-list
25661836|NCT01638546|Veliparib|veliparib|mesh-list
25661837|NCT01638546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25848886|NCT00046917|Alvocidib|alvocidib|mesh-list
25848887|NCT00046917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848888|NCT00046917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25848889|NCT00046917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25848890|NCT00046917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848891|NCT00046917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848892|NCT00046917|Growth Inhibitors|growth inhibitors|mesh-ancestor
25848893|NCT00046917|Growth Substances|growth substances|mesh-ancestor
25848894|NCT00046917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495659|NCT00501410|Vitamins|vitamins|mesh-ancestor
24495660|NCT00501410|Micronutrients|micronutrients|mesh-ancestor
24495661|NCT00501410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24495662|NCT00501410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24495663|NCT00501410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495664|NCT00501488|Rosiglitazone|rosiglitazone|mesh-list
24495665|NCT00501488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24495666|NCT00501488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495681|NCT00501579|Prednisolone phosphate|prednisolone phosphate|mesh-list
24495682|NCT00501579|Difluprednate|difluprednate|mesh-list
24495683|NCT00501579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24495684|NCT00501579|Glucocorticoids|glucocorticoids|mesh-ancestor
24495686|NCT00501579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24495687|NCT00501579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495688|NCT00501579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24495689|NCT00501579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495690|NCT00501579|Antiemetics|antiemetics|mesh-ancestor
24495691|NCT00501579|Autonomic Agents|autonomic agents|mesh-ancestor
24495692|NCT00501579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24495693|NCT00501579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25848895|NCT00046917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24495694|NCT00501579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24495695|NCT00501579|Protective Agents|protective agents|mesh-ancestor
24495697|NCT00501605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495698|NCT00501605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24495699|NCT00501605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495700|NCT00501605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809690|NCT02035930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809691|NCT02035930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25848896|NCT00046943|Atrasentan|atrasentan|mesh-list
25848897|NCT00046943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848898|NCT00046943|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
24470791|NCT00391911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470792|NCT00391911|Antidotes|antidotes|mesh-ancestor
24470793|NCT00391924|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24470794|NCT00391924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24470795|NCT00391924|Immunologic Factors|immunologic factors|mesh-ancestor
24470796|NCT00391924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470797|NCT00391950|Zoledronic Acid|zoledronic acid|mesh-list
24518906|NCT03992443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24470912|NCT00392457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24470922|NCT00392457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24470923|NCT00392470|Irinotecan|irinotecan|mesh-list
24470957|NCT00392691|Vinorelbine|vinorelbine|mesh-list
25848899|NCT00046943|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24495739|NCT00501748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24495740|NCT00501787|Metformin|metformin|mesh-list
24495741|NCT00501787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24495742|NCT00501787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495743|NCT00501839|Clomiphene|clomiphene|mesh-list
24495744|NCT00501839|Enclomiphene|enclomiphene|mesh-list
24495745|NCT00501839|Zuclomiphene|zuclomiphene|mesh-list
24495746|NCT00501839|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24495747|NCT00501839|Hormone Antagonists|hormone antagonists|mesh-ancestor
24495767|NCT00501878|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24495768|NCT00501878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24495769|NCT00501878|Adrenergic Agents|adrenergic agents|mesh-ancestor
24495770|NCT00501878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24495771|NCT00501878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848900|NCT00046943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495859|NCT00502229|Hormone Antagonists|hormone antagonists|mesh-ancestor
25041732|NCT01591447|Solithromycin|solithromycin|mesh-list
24495895|NCT00502437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24495896|NCT00502437|Serotonin Agents|serotonin agents|mesh-ancestor
24748665|NCT02283281|Hormones|hormones|mesh-ancestor
24495897|NCT00502437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24495898|NCT00502437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495899|NCT00502476|Chlorhexidine|chlorhexidine|mesh-list
24495900|NCT00502476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24495901|NCT00502476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24495902|NCT00502476|Disinfectants|disinfectants|mesh-ancestor
24495903|NCT00502528|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
25848901|NCT00046969|Cisplatin|cisplatin|mesh-list
25848902|NCT00046969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848903|NCT00046995|Leucovorin|leucovorin|mesh-list
25848904|NCT00046995|Carboplatin|carboplatin|mesh-list
25848905|NCT00046995|Fluorouracil|fluorouracil|mesh-list
25848906|NCT00046995|Calcium|calcium|mesh-list
24495950|NCT00502684|Adrenergic Agents|adrenergic agents|mesh-ancestor
24495951|NCT00502684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24495952|NCT00502684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495953|NCT00502684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495954|NCT00502684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24495955|NCT00502684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24495956|NCT00502684|Vasodilator Agents|vasodilator agents|mesh-ancestor
24495957|NCT00502684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24495958|NCT00502684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24495959|NCT00502684|Analgesics|analgesics|mesh-ancestor
24495972|NCT00502762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24495973|NCT00502762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495974|NCT00502762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495975|NCT00502762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495976|NCT00502788|Ribavirin|ribavirin|mesh-list
24495977|NCT00502788|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24495979|NCT00502788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495981|NCT00502788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24495982|NCT00502879|Etanercept|etanercept|mesh-list
24495983|NCT00502879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24495984|NCT00502879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25848907|NCT00046995|Levoleucovorin|levoleucovorin|mesh-list
25848908|NCT00046995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848909|NCT00046995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24495985|NCT00502879|Analgesics|analgesics|mesh-ancestor
24495986|NCT00502879|Sensory System Agents|sensory system agents|mesh-ancestor
24495987|NCT00502879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24495988|NCT00502879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495989|NCT00502879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25848910|NCT00046995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848911|NCT00046995|Antimetabolites|antimetabolites|mesh-ancestor
25848912|NCT00046995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848913|NCT00046995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25848914|NCT00046995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24496003|NCT00502892|Alkylating Agents|alkylating agents|mesh-ancestor
24496004|NCT00502970|Interferons|interferons|mesh-list
24496005|NCT00502970|Ribavirin|ribavirin|mesh-list
24496006|NCT00502970|Iron-Dextran Complex|iron-dextran complex|mesh-list
24496007|NCT00502970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496008|NCT00502970|Antiviral Agents|antiviral agents|mesh-ancestor
24496009|NCT00502970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24496010|NCT00502970|Antimetabolites|antimetabolites|mesh-ancestor
24496047|NCT00503321|Tegafur|tegafur|mesh-list
24496048|NCT00503321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24496049|NCT00503321|Antimetabolites|antimetabolites|mesh-ancestor
24496050|NCT00503321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496051|NCT00503321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496052|NCT00503321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24496053|NCT00503321|Immunologic Factors|immunologic factors|mesh-ancestor
24496054|NCT00503321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809771|NCT02036164|Cisplatin|cisplatin|mesh-list
24809772|NCT02036164|Carboplatin|carboplatin|mesh-list
24480637|NCT00431522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24480638|NCT00431522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809773|NCT02036164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24809774|NCT02036164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809775|NCT02036164|Tubulin Modulators|tubulin modulators|mesh-ancestor
24809776|NCT02036164|Antimitotic Agents|antimitotic agents|mesh-ancestor
25661838|NCT01638546|Alkylating Agents|alkylating agents|mesh-ancestor
24809777|NCT02036164|Mitosis Modulators|mitosis modulators|mesh-ancestor
24809778|NCT02036164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661839|NCT01638546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044316|NCT01114308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25044317|NCT01114308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604936|NCT00982527|Fenoldopam|fenoldopam|mesh-list
24604937|NCT00982527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24604938|NCT00982527|Vasodilator Agents|vasodilator agents|mesh-ancestor
24604939|NCT00982527|Dopamine Agonists|dopamine agonists|mesh-ancestor
24604940|NCT00982527|Dopamine Agents|dopamine agents|mesh-ancestor
24496071|NCT00503386|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24496072|NCT00503386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24496074|NCT00503386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24496075|NCT00503386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496076|NCT00503412|Cediranib|cediranib|mesh-list
24496077|NCT00503412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496078|NCT00503412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24496079|NCT00503412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496080|NCT00503412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496081|NCT00503451|Panobinostat|panobinostat|mesh-list
24496082|NCT00503451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496083|NCT00503451|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24496084|NCT00503451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496085|NCT00503451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496086|NCT00503477|Cediranib|cediranib|mesh-list
24496087|NCT00503477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809790|NCT02036242|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24809791|NCT02036242|Narcotics|narcotics|mesh-ancestor
24809792|NCT02036242|Analgesics|analgesics|mesh-ancestor
24600746|NCT00960349|Cisplatin|cisplatin|mesh-list
25848915|NCT00046995|Immunologic Factors|immunologic factors|mesh-ancestor
24480639|NCT00431522|Antimanic Agents|antimanic agents|mesh-ancestor
24482430|NCT00438984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25004943|NCT05201352|Antimetabolites|antimetabolites|mesh-ancestor
24496088|NCT00503477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24496089|NCT00503477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496090|NCT00503477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496091|NCT00503490|Levofloxacin|levofloxacin|mesh-list
24496092|NCT00503490|Ofloxacin|ofloxacin|mesh-list
24805632|NCT02011347|Ketamine|ketamine|mesh-list
24496114|NCT00503503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24496115|NCT00503503|Immunologic Factors|immunologic factors|mesh-ancestor
25848916|NCT00046995|Antidotes|antidotes|mesh-ancestor
24600786|NCT00960544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496127|NCT00503516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496128|NCT00503516|Appetite Stimulants|appetite stimulants|mesh-ancestor
24496174|NCT00503594|Antiviral Agents|antiviral agents|mesh-ancestor
24496175|NCT00503594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24496220|NCT00503828|Naproxen|naproxen|mesh-list
24496221|NCT00503828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24496222|NCT00503828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24496223|NCT00503828|Analgesics|analgesics|mesh-ancestor
24496283|NCT00504127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496284|NCT00504127|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24496287|NCT00504140|Etoposide|etoposide|mesh-list
24809813|NCT02036359|Tubulin Modulators|tubulin modulators|mesh-ancestor
24809814|NCT02036359|Antimitotic Agents|antimitotic agents|mesh-ancestor
24809815|NCT02036359|Mitosis Modulators|mitosis modulators|mesh-ancestor
24809816|NCT02036359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004944|NCT05201352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004945|NCT05201352|Antiviral Agents|antiviral agents|mesh-ancestor
24483015|NCT00441428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24483016|NCT00441428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24483017|NCT00441428|Cholinergic Agents|cholinergic agents|mesh-ancestor
24483018|NCT00441428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24483019|NCT00441428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483021|NCT00441428|Urological Agents|urological agents|mesh-ancestor
24809817|NCT02036359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24809818|NCT02036359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809819|NCT02036372|Insulin|insulin|mesh-list
24809820|NCT02036372|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24809821|NCT02036372|Liraglutide|liraglutide|mesh-list
24809822|NCT02036372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24809826|NCT02036372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24809827|NCT02036437|Misoprostol|misoprostol|mesh-list
24809828|NCT02036437|Dinoprostone|dinoprostone|mesh-list
24809829|NCT02036437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25661840|NCT01638546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25661841|NCT01638546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25661842|NCT01638546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809857|NCT02036489|Tubulin Modulators|tubulin modulators|mesh-ancestor
24496323|NCT00504244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24496324|NCT00504244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24496325|NCT00504244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496326|NCT00504283|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24496328|NCT00504283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24496329|NCT00504283|Narcotics|narcotics|mesh-ancestor
25848917|NCT00046995|Protective Agents|protective agents|mesh-ancestor
24496359|NCT00504413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496360|NCT00504413|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24496361|NCT00504413|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24496362|NCT00504413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25134402|NCT03006380|Oxytocin|oxytocin|mesh-list
24496363|NCT00504413|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24496365|NCT00504413|Anesthetics|anesthetics|mesh-ancestor
24496366|NCT00504413|GABA Modulators|gaba modulators|mesh-ancestor
24496367|NCT00504413|GABA Agents|gaba agents|mesh-ancestor
24496368|NCT00504413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24496369|NCT00504413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496370|NCT00504413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24496371|NCT00504413|Antidepressive Agents|antidepressive agents|mesh-ancestor
24496398|NCT00504465|Oxytocics|oxytocics|mesh-ancestor
24496399|NCT00504465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24496400|NCT00504465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496402|NCT00504491|Alemtuzumab|alemtuzumab|mesh-list
24809863|NCT02036489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24809864|NCT02036489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809865|NCT02036489|Antimetabolites|antimetabolites|mesh-ancestor
24809866|NCT02036489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24809867|NCT02036489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24809872|NCT02036528|Gentamicins|gentamicins|mesh-list
24809873|NCT02036528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24809874|NCT02036528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24809875|NCT02036528|Antimalarials|antimalarials|mesh-ancestor
24809876|NCT02036528|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25005022|NCT05074121|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24496907|NCT00507195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24749896|NCT01694576|Paclitaxel|paclitaxel|mesh-list
24497138|NCT00508365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497139|NCT00508365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497233|NCT00508963|Anthelmintics|anthelmintics|mesh-ancestor
24809877|NCT02036528|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24809900|NCT02036554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24809902|NCT02036697|Morphine|morphine|mesh-list
24809903|NCT02036697|Bupivacaine|bupivacaine|mesh-list
24809904|NCT02036697|Anesthetics, Local|anesthetics, local|mesh-ancestor
24809905|NCT02036697|Anesthetics|anesthetics|mesh-ancestor
24809906|NCT02036697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24809907|NCT02036697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848918|NCT00046995|Vitamin B Complex|vitamin b complex|mesh-ancestor
25848919|NCT00046995|Vitamins|vitamins|mesh-ancestor
25848920|NCT00046995|Micronutrients|micronutrients|mesh-ancestor
25848921|NCT00047021|Cytarabine|cytarabine|mesh-list
25848922|NCT00047021|Mitoxantrone|mitoxantrone|mesh-list
25661843|NCT01639001|Cisplatin|cisplatin|mesh-list
25661844|NCT01639001|Carboplatin|carboplatin|mesh-list
25661845|NCT01639001|Pemetrexed|pemetrexed|mesh-list
25661846|NCT01639001|Crizotinib|crizotinib|mesh-list
25661847|NCT01639001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25661848|NCT01639001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661849|NCT01639001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661850|NCT01639001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25848923|NCT00047021|Sargramostim|sargramostim|mesh-list
25848924|NCT00047021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25848925|NCT00047021|Antimetabolites|antimetabolites|mesh-ancestor
25661851|NCT01639001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25661852|NCT01639001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25848927|NCT00047021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496434|NCT00504816|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24809908|NCT02036697|Sensory System Agents|sensory system agents|mesh-ancestor
24809909|NCT02036697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24809910|NCT02036697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24809911|NCT02036697|Narcotics|narcotics|mesh-ancestor
24809912|NCT02036697|Analgesics|analgesics|mesh-ancestor
24809913|NCT02036697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24809914|NCT02036697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24809915|NCT02036697|Anesthetics, General|anesthetics, general|mesh-ancestor
24809916|NCT02036723|Bevacizumab|bevacizumab|mesh-list
24809917|NCT02036723|Ranibizumab|ranibizumab|mesh-list
24809918|NCT02036723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24809919|NCT02036723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809920|NCT02036723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24451064|NCT00321724|Cediranib|cediranib|mesh-list
24496446|NCT00504933|Histamine Antagonists|histamine antagonists|mesh-ancestor
24496447|NCT00504933|Histamine Agents|histamine agents|mesh-ancestor
24496448|NCT00504933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24496482|NCT00504959|Growth Inhibitors|growth inhibitors|mesh-ancestor
24496483|NCT00504959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496484|NCT00505037|Sevelamer|sevelamer|mesh-list
24496485|NCT00505037|Chelating Agents|chelating agents|mesh-ancestor
24496486|NCT00505037|Sequestering Agents|sequestering agents|mesh-ancestor
24496487|NCT00505037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809958|NCT02036879|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24809959|NCT02036879|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
24809962|NCT02036983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24809963|NCT02036983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809964|NCT02036983|Sensory System Agents|sensory system agents|mesh-ancestor
24809965|NCT02036983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24809967|NCT02037009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24809968|NCT02037009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809970|NCT02037035|Analgesics|analgesics|mesh-ancestor
24809971|NCT02037035|Sensory System Agents|sensory system agents|mesh-ancestor
24809996|NCT02037191|Immunologic Factors|immunologic factors|mesh-ancestor
24809997|NCT02037191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24809998|NCT02037191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24809999|NCT02037399|Dexamethasone|dexamethasone|mesh-list
24810000|NCT02037399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24810001|NCT02037399|Antiemetics|antiemetics|mesh-ancestor
25848928|NCT00047021|Antiviral Agents|antiviral agents|mesh-ancestor
24503952|NCT00533533|Oxaliplatin|oxaliplatin|mesh-list
24496512|NCT00505167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496513|NCT00505167|Cholinergic Agents|cholinergic agents|mesh-ancestor
24496514|NCT00505167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24496515|NCT00505167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496516|NCT00505167|Nootropic Agents|nootropic agents|mesh-ancestor
24496517|NCT00505167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24496518|NCT00505167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24496519|NCT00505167|Dopamine Agents|dopamine agents|mesh-ancestor
24496520|NCT00505167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24496521|NCT00505167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24496522|NCT00505232|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24496523|NCT00505232|Immunologic Factors|immunologic factors|mesh-ancestor
24810006|NCT02037399|Glucocorticoids|glucocorticoids|mesh-ancestor
24810007|NCT02037399|Hormones|hormones|mesh-ancestor
24810008|NCT02037399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25661853|NCT01639040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25661854|NCT01639040|Immunologic Factors|immunologic factors|mesh-ancestor
25661855|NCT01639040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661856|NCT01639157|Buspirone|buspirone|mesh-list
25661857|NCT01639157|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25661858|NCT01639157|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25661859|NCT01639157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24810009|NCT02037399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25231646|NCT02587390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25848929|NCT00047021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25848930|NCT00047021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25848931|NCT00047021|Immunologic Factors|immunologic factors|mesh-ancestor
25848932|NCT00047021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810010|NCT02037399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810011|NCT02037412|Clopidogrel|clopidogrel|mesh-list
24810012|NCT02037412|Ticagrelor|ticagrelor|mesh-list
24810013|NCT02037412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24810040|NCT02037503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504034|NCT00533858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24525249|NCT03737253|Menotropins|menotropins|mesh-list
24810042|NCT02037516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24810043|NCT02037516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24810044|NCT02037516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810045|NCT02037516|Cholinergic Agents|cholinergic agents|mesh-ancestor
24810046|NCT02037516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24810047|NCT02037516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810048|NCT02037516|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24810049|NCT02037516|Autonomic Agents|autonomic agents|mesh-ancestor
24810050|NCT02037516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24496590|NCT00505700|Bortezomib|bortezomib|mesh-list
24496591|NCT00505700|Idarubicin|idarubicin|mesh-list
24496592|NCT00505700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24496593|NCT00505700|Antimetabolites|antimetabolites|mesh-ancestor
24506192|NCT00544232|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24496594|NCT00505700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496595|NCT00505700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496596|NCT00505700|Antiviral Agents|antiviral agents|mesh-ancestor
24496618|NCT00505739|Luteolytic Agents|luteolytic agents|mesh-ancestor
24496619|NCT00505739|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24496620|NCT00505739|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24496621|NCT00505791|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24496622|NCT00505791|Natriuretic Agents|natriuretic agents|mesh-ancestor
24810052|NCT02037633|Ropivacaine|ropivacaine|mesh-list
24810053|NCT02037633|Anesthetics, Local|anesthetics, local|mesh-ancestor
24810054|NCT02037633|Anesthetics|anesthetics|mesh-ancestor
24605235|NCT00983996|Alendronate|alendronate|mesh-list
24810055|NCT02037633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24810056|NCT02037633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810057|NCT02037633|Sensory System Agents|sensory system agents|mesh-ancestor
24496655|NCT00505817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24496656|NCT00505817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496669|NCT00505882|Pramlintide|pramlintide|mesh-list
24496670|NCT00505882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24496671|NCT00505882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496673|NCT00505947|Dermatologic Agents|dermatologic agents|mesh-ancestor
24496674|NCT00505947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24496675|NCT00505947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24496680|NCT00506051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24496681|NCT00506051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24496683|NCT00506168|Irinotecan|irinotecan|mesh-list
24496684|NCT00506168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24496685|NCT00506168|Antimetabolites|antimetabolites|mesh-ancestor
24496686|NCT00506168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496687|NCT00506168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496688|NCT00506168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24496689|NCT00506168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24496690|NCT00506168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496691|NCT00506194|Gliclazide|gliclazide|mesh-list
24496692|NCT00506194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24496693|NCT00506194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496694|NCT00506207|Oxaliplatin|oxaliplatin|mesh-list
24496695|NCT00506207|Irinotecan|irinotecan|mesh-list
24496696|NCT00506207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496697|NCT00506207|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24496698|NCT00506207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24810060|NCT02037633|Narcotics|narcotics|mesh-ancestor
24810061|NCT02037633|Analgesics|analgesics|mesh-ancestor
24810062|NCT02037633|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24810063|NCT02037633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25661860|NCT01639157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661861|NCT01639157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25661862|NCT01639157|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25661863|NCT01639157|Serotonin Agents|serotonin agents|mesh-ancestor
24810064|NCT02037633|Anesthetics, General|anesthetics, general|mesh-ancestor
24810067|NCT02037672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810068|NCT02037711|Levobupivacaine|levobupivacaine|mesh-list
24810069|NCT02037711|Anesthetics, Local|anesthetics, local|mesh-ancestor
24810070|NCT02037711|Anesthetics|anesthetics|mesh-ancestor
24810071|NCT02037711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24810072|NCT02037711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810073|NCT02037711|Sensory System Agents|sensory system agents|mesh-ancestor
24810074|NCT02037711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24810075|NCT02037724|Iron|iron|mesh-list
24510762|NCT00565539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496770|NCT00506623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24810102|NCT02037802|Analgesics|analgesics|mesh-ancestor
24810103|NCT02037802|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24810104|NCT02037815|Mannitol|mannitol|mesh-list
24810105|NCT02037815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24810106|NCT02037815|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24810107|NCT02037815|Diuretics|diuretics|mesh-ancestor
24810108|NCT02037815|Natriuretic Agents|natriuretic agents|mesh-ancestor
24601413|NCT00964106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24496796|NCT00506844|Irinotecan|irinotecan|mesh-list
24496797|NCT00506844|Cetuximab|cetuximab|mesh-list
24496798|NCT00506844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24496799|NCT00506844|Antimetabolites|antimetabolites|mesh-ancestor
24496800|NCT00506844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496801|NCT00506844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496802|NCT00506844|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24496803|NCT00506844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24496804|NCT00506844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848933|NCT00047021|Analgesics|analgesics|mesh-ancestor
25848934|NCT00047021|Sensory System Agents|sensory system agents|mesh-ancestor
25848935|NCT00047021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25848936|NCT00047021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24510763|NCT00565539|Antiviral Agents|antiviral agents|mesh-ancestor
24511417|NCT00568672|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24496843|NCT00507052|Antioxidants|antioxidants|mesh-ancestor
24496844|NCT00507052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496845|NCT00507052|Protective Agents|protective agents|mesh-ancestor
24496846|NCT00507052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496847|NCT00507052|Antidotes|antidotes|mesh-ancestor
24496848|NCT00507065|Amphetamine|amphetamine|mesh-list
24496849|NCT00507065|Adderall|adderall|mesh-list
24810109|NCT02037815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810110|NCT02037919|Etonogestrel|etonogestrel|mesh-list
24810111|NCT02037919|Desogestrel|desogestrel|mesh-list
24810112|NCT02037919|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24810131|NCT02037997|Tubulin Modulators|tubulin modulators|mesh-ancestor
24810132|NCT02037997|Antimitotic Agents|antimitotic agents|mesh-ancestor
25661864|NCT01639157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25661865|NCT01639157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661866|NCT01639222|Calcium, Dietary|calcium, dietary|mesh-list
25661867|NCT01639222|Vitamin D|vitamin d|mesh-list
25661868|NCT01639222|Cholecalciferol|cholecalciferol|mesh-list
25661869|NCT01639222|Calcium|calcium|mesh-list
25661870|NCT01639222|Vitamins|vitamins|mesh-ancestor
25661871|NCT01639222|Micronutrients|micronutrients|mesh-ancestor
25661872|NCT01639222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661873|NCT01639222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25661874|NCT01639222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25661875|NCT01639339|Belimumab|belimumab|mesh-list
24496850|NCT00507065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24496851|NCT00507065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661876|NCT01639339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25661877|NCT01639339|Immunologic Factors|immunologic factors|mesh-ancestor
25231670|NCT02587273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25231671|NCT02587273|Anesthetics, General|anesthetics, general|mesh-ancestor
24496854|NCT00507065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24496855|NCT00507065|Dopamine Agents|dopamine agents|mesh-ancestor
24496856|NCT00507065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24496857|NCT00507065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496858|NCT00507065|Adrenergic Agents|adrenergic agents|mesh-ancestor
24511501|NCT00569101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24526418|NCT00611650|Protective Agents|protective agents|mesh-ancestor
24511573|NCT00569712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24512925|NCT00577668|Glucocorticoids|glucocorticoids|mesh-ancestor
24496859|NCT00507065|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24496860|NCT00507065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24496861|NCT00507065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24496862|NCT00507065|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24496863|NCT00507091|Leucovorin|leucovorin|mesh-list
24496864|NCT00507091|Fluorouracil|fluorouracil|mesh-list
24496865|NCT00507091|Irinotecan|irinotecan|mesh-list
24496866|NCT00507091|Antimetabolites|antimetabolites|mesh-ancestor
24496867|NCT00507091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848937|NCT00047021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25848938|NCT00047021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605377|NCT00984789|Femovan|femovan|mesh-list
24605378|NCT00984789|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24605379|NCT00984789|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24605380|NCT00984789|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24605381|NCT00984789|Contraceptive Agents|contraceptive agents|mesh-ancestor
24605382|NCT00984789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24605383|NCT00984789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605384|NCT00984789|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24605386|NCT00984789|Hormones|hormones|mesh-ancestor
24605387|NCT00984789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24605388|NCT00984789|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24605389|NCT00984789|Progestins|progestins|mesh-ancestor
25166405|NCT04111315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605390|NCT00984789|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24512926|NCT00577668|Hormones|hormones|mesh-ancestor
24515275|NCT00596128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605392|NCT00984828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623006|NCT01069770|Growth Substances|growth substances|mesh-ancestor
24623007|NCT01069770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623011|NCT01069770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623014|NCT01069796|Capecitabine|capecitabine|mesh-list
24623015|NCT01069796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24623016|NCT01069796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623017|NCT01069796|Tubulin Modulators|tubulin modulators|mesh-ancestor
24623018|NCT01069796|Antimitotic Agents|antimitotic agents|mesh-ancestor
24623019|NCT01069796|Mitosis Modulators|mitosis modulators|mesh-ancestor
24623020|NCT01069796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623021|NCT01069796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24623022|NCT01069796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24623023|NCT01069796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24623024|NCT01069796|Growth Substances|growth substances|mesh-ancestor
24623025|NCT01069796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601549|NCT00964691|Chloroquine|chloroquine|mesh-list
25848939|NCT00047047|Gemcitabine|gemcitabine|mesh-list
24497027|NCT00507832|Dermatologic Agents|dermatologic agents|mesh-ancestor
25848940|NCT00047047|Cisplatin|cisplatin|mesh-list
25848941|NCT00047047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848942|NCT00047047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25848943|NCT00047047|Antimetabolites|antimetabolites|mesh-ancestor
24496868|NCT00507091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24496869|NCT00507091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496870|NCT00507091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24496871|NCT00507091|Immunologic Factors|immunologic factors|mesh-ancestor
24496872|NCT00507091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496873|NCT00507091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24496874|NCT00507091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24496875|NCT00507091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496876|NCT00507091|Antidotes|antidotes|mesh-ancestor
24496877|NCT00507091|Protective Agents|protective agents|mesh-ancestor
25661878|NCT01639339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661879|NCT01639352|Pasireotide|pasireotide|mesh-list
24496920|NCT00507221|Antimitotic Agents|antimitotic agents|mesh-ancestor
24496923|NCT00507221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496924|NCT00507234|Formoterol Fumarate|formoterol fumarate|mesh-list
24496925|NCT00507234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24496945|NCT00507403|Dermatologic Agents|dermatologic agents|mesh-ancestor
24496946|NCT00507403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24496947|NCT00507403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24496948|NCT00507494|Pioglitazone|pioglitazone|mesh-list
24496949|NCT00507494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24496950|NCT00507494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496951|NCT00507585|Leucovorin|leucovorin|mesh-list
24496952|NCT00507585|Bevacizumab|bevacizumab|mesh-list
24496953|NCT00507585|Fluorouracil|fluorouracil|mesh-list
24496954|NCT00507585|Oxaliplatin|oxaliplatin|mesh-list
24496955|NCT00507585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24496956|NCT00507585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496957|NCT00507585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24496958|NCT00507585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24496959|NCT00507585|Growth Substances|growth substances|mesh-ancestor
24496960|NCT00507585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496961|NCT00507585|Growth Inhibitors|growth inhibitors|mesh-ancestor
24496962|NCT00507585|Antimetabolites|antimetabolites|mesh-ancestor
24496963|NCT00507585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496964|NCT00507585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24496966|NCT00507585|Immunologic Factors|immunologic factors|mesh-ancestor
24496967|NCT00507585|Antidotes|antidotes|mesh-ancestor
24496968|NCT00507585|Protective Agents|protective agents|mesh-ancestor
24496969|NCT00507585|Vitamin B Complex|vitamin b complex|mesh-ancestor
24496970|NCT00507585|Vitamins|vitamins|mesh-ancestor
24496971|NCT00507585|Micronutrients|micronutrients|mesh-ancestor
24496972|NCT00507637|Botulinum Toxins|botulinum toxins|mesh-list
25166406|NCT04111315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24496973|NCT00507637|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24496986|NCT00507663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24496987|NCT00507663|Sympatholytics|sympatholytics|mesh-ancestor
24496988|NCT00507663|Autonomic Agents|autonomic agents|mesh-ancestor
24496989|NCT00507663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24496990|NCT00507663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521326|NCT04876937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24496991|NCT00507663|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24810133|NCT02037997|Mitosis Modulators|mitosis modulators|mesh-ancestor
24810134|NCT02037997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810135|NCT02037997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24810136|NCT02037997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24810137|NCT02037997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24810138|NCT02037997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24810139|NCT02038062|Sevoflurane|sevoflurane|mesh-list
25661880|NCT01639352|Hormones|hormones|mesh-ancestor
25661881|NCT01639352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25661882|NCT01639352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661883|NCT01639560|Varenicline|varenicline|mesh-list
25661884|NCT01639560|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25661885|NCT01639560|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25661886|NCT01639560|Cholinergic Agents|cholinergic agents|mesh-ancestor
25661887|NCT01639560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25661888|NCT01639560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810140|NCT02038062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24810141|NCT02038062|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24497022|NCT00507832|Analgesics|analgesics|mesh-ancestor
25419493|NCT02705196|Mitosis Modulators|mitosis modulators|mesh-ancestor
24586152|NCT00889356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848944|NCT00047047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497023|NCT00507832|Sensory System Agents|sensory system agents|mesh-ancestor
24497024|NCT00507832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24497025|NCT00507832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497026|NCT00507832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24497028|NCT00507832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24588910|NCT00904644|Antiviral Agents|antiviral agents|mesh-ancestor
24497029|NCT00507832|Immunologic Factors|immunologic factors|mesh-ancestor
24497030|NCT00507832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24497031|NCT00507832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497032|NCT00507832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497035|NCT00507845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24497036|NCT00507845|Protease Inhibitors|protease inhibitors|mesh-ancestor
24497037|NCT00507845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24522422|NCT03853044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24522423|NCT03853044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24497038|NCT00507845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497039|NCT00507845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24497040|NCT00507845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24497041|NCT00507845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24497042|NCT00507845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24497043|NCT00507845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24497044|NCT00507845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497045|NCT00507845|Vasodilator Agents|vasodilator agents|mesh-ancestor
24497046|NCT00507858|Dexamethasone|dexamethasone|mesh-list
24497047|NCT00507858|Pemetrexed|pemetrexed|mesh-list
24497048|NCT00507858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24497049|NCT00507858|Antiemetics|antiemetics|mesh-ancestor
24497050|NCT00507858|Autonomic Agents|autonomic agents|mesh-ancestor
24497051|NCT00507858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24522757|NCT03254654|Tubulin Modulators|tubulin modulators|mesh-ancestor
24522758|NCT03254654|Antimitotic Agents|antimitotic agents|mesh-ancestor
24497052|NCT00507858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497053|NCT00507858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24810143|NCT02038062|Anesthetics|anesthetics|mesh-ancestor
24810144|NCT02038062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24497080|NCT00507962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497081|NCT00507962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24497082|NCT00507962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24497083|NCT00507962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24497097|NCT00508040|Interferon-alpha|interferon-alpha|mesh-list
24497098|NCT00508040|Interferon alpha-2|interferon alpha-2|mesh-list
24497099|NCT00508040|Prednisone|prednisone|mesh-list
24497100|NCT00508040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24523123|NCT02584309|Antimitotic Agents|antimitotic agents|mesh-ancestor
24523124|NCT02584309|Mitosis Modulators|mitosis modulators|mesh-ancestor
24523125|NCT02512926|Cyclophosphamide|cyclophosphamide|mesh-list
25661889|NCT01639560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661890|NCT01639599|Dexamethasone|dexamethasone|mesh-list
25661891|NCT01639599|Dexamethasone acetate|dexamethasone acetate|mesh-list
25661892|NCT01639599|Haloperidol|haloperidol|mesh-list
25661893|NCT01639599|Haloperidol decanoate|haloperidol decanoate|mesh-list
25661894|NCT01639599|BB 1101|bb 1101|mesh-list
25661895|NCT01639599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25661896|NCT01639599|Antiemetics|antiemetics|mesh-ancestor
25661897|NCT01639599|Autonomic Agents|autonomic agents|mesh-ancestor
25661898|NCT01639599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25661899|NCT01639599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661900|NCT01639599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25661901|NCT01639599|Glucocorticoids|glucocorticoids|mesh-ancestor
25661902|NCT01639599|Hormones|hormones|mesh-ancestor
25661903|NCT01639599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25848946|NCT00047047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25231688|NCT02587741|Acarbose|acarbose|mesh-list
25231689|NCT02587741|Gliclazide|gliclazide|mesh-list
25231690|NCT02587741|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
25231691|NCT02587741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25848947|NCT00047047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274032|NCT02381470|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24904971|NCT04351919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24904972|NCT04351919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24904973|NCT04351919|Antimalarials|antimalarials|mesh-ancestor
24523127|NCT02512926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24497101|NCT00508040|Glucocorticoids|glucocorticoids|mesh-ancestor
24497102|NCT00508040|Hormones|hormones|mesh-ancestor
24497103|NCT00508040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24497104|NCT00508040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497105|NCT00508040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24497106|NCT00508040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497107|NCT00508040|Antiviral Agents|antiviral agents|mesh-ancestor
24497108|NCT00508040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24497110|NCT00508092|Anesthetics|anesthetics|mesh-list
24497111|NCT00508092|Anesthetics, Local|anesthetics, local|mesh-list
24497112|NCT00508092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24497113|NCT00508092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497164|NCT00508495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497165|NCT00508495|Antipyretics|antipyretics|mesh-ancestor
24497167|NCT00508664|Fluorouracil|fluorouracil|mesh-list
24497169|NCT00508664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497170|NCT00508664|Tubulin Modulators|tubulin modulators|mesh-ancestor
24497171|NCT00508664|Antimitotic Agents|antimitotic agents|mesh-ancestor
24497172|NCT00508664|Mitosis Modulators|mitosis modulators|mesh-ancestor
24497173|NCT00508664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497174|NCT00508664|Antimetabolites|antimetabolites|mesh-ancestor
24497186|NCT00508690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24497187|NCT00508690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24497188|NCT00508690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497189|NCT00508690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555553|NCT00742014|Urological Agents|urological agents|mesh-ancestor
24497191|NCT00508859|Antidepressive Agents|antidepressive agents|mesh-ancestor
24497213|NCT00508898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24497214|NCT00508898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497215|NCT00508898|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24497216|NCT00508898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24497217|NCT00508898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497220|NCT00508898|Micronutrients|micronutrients|mesh-ancestor
24497221|NCT00508898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24497222|NCT00508911|Contraceptive Agents|contraceptive agents|mesh-list
24497223|NCT00508911|Contraceptives, Oral|contraceptives, oral|mesh-list
24810157|NCT02038335|Hormones|hormones|mesh-ancestor
24810158|NCT02038335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24810159|NCT02038335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810160|NCT02038335|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24810161|NCT02038335|Contraceptive Agents|contraceptive agents|mesh-ancestor
24810162|NCT02038335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24810163|NCT02038335|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24810164|NCT02038335|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24810165|NCT02038335|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24601849|NCT00966160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24497224|NCT00508911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24497225|NCT00508911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497226|NCT00508911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24497227|NCT00508963|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
25661904|NCT01639599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25661905|NCT01639599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25661906|NCT01639599|Protease Inhibitors|protease inhibitors|mesh-ancestor
25661907|NCT01639599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661908|NCT01639599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661909|NCT01639599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25661910|NCT01639599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25661911|NCT01639599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25661912|NCT01639599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25661913|NCT01639599|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24497231|NCT00508963|Schistosomicides|schistosomicides|mesh-ancestor
24497255|NCT00509015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24497256|NCT00509015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497257|NCT00509015|Antiviral Agents|antiviral agents|mesh-ancestor
24497258|NCT00509015|Schistosomicides|schistosomicides|mesh-ancestor
24497259|NCT00509015|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24497260|NCT00509015|Anthelmintics|anthelmintics|mesh-ancestor
24497261|NCT00509015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24497262|NCT00509015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497263|NCT00509015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497264|NCT00509015|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24497265|NCT00509015|Renal Agents|renal agents|mesh-ancestor
24497266|NCT00509158|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25848948|NCT00047047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24497296|NCT00509353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24497299|NCT00509379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24497300|NCT00509379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497301|NCT00509379|Immunologic Factors|immunologic factors|mesh-ancestor
24497302|NCT00509379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497310|NCT00509431|Sirolimus|sirolimus|mesh-list
24497331|NCT00509470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497332|NCT00509470|Vasodilator Agents|vasodilator agents|mesh-ancestor
24497334|NCT00509470|Natriuretic Agents|natriuretic agents|mesh-ancestor
24497335|NCT00509470|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24810166|NCT02038335|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24810167|NCT02038335|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24810168|NCT02038335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24810172|NCT02038452|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24654593|NCT01250535|Warfarin|warfarin|mesh-list
25005280|NCT04320940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24524926|NCT04200417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497336|NCT00509470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24497337|NCT00509470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24497370|NCT00509743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24497373|NCT00509743|Sensory System Agents|sensory system agents|mesh-ancestor
24497374|NCT00509743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24497375|NCT00509743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497376|NCT00509743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24497377|NCT00509743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24497378|NCT00509743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24497379|NCT00509743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497580|NCT00510588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24497381|NCT00509834|Lactoferrin|lactoferrin|mesh-list
24497382|NCT00509834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24497383|NCT00509847|Lactoferrin|lactoferrin|mesh-list
24497384|NCT00509847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24497385|NCT00509860|Irinotecan|irinotecan|mesh-list
24497386|NCT00509860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24497387|NCT00509860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24497388|NCT00509860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497389|NCT00509860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497390|NCT00509860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497391|NCT00509938|Lactoferrin|lactoferrin|mesh-list
24497392|NCT00509938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24497393|NCT00509964|Irinotecan|irinotecan|mesh-list
24497394|NCT00509964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24497395|NCT00509964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24497396|NCT00509964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497449|NCT00510159|Sulfalene|sulfalene|mesh-list
24497461|NCT00510159|Renal Agents|renal agents|mesh-ancestor
24497462|NCT00510172|Epoprostenol|epoprostenol|mesh-list
24497463|NCT00510172|Tezosentan|tezosentan|mesh-list
25661914|NCT01639599|Dopamine Agents|dopamine agents|mesh-ancestor
25661915|NCT01639599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25661916|NCT01639599|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24751995|NCT01707615|Antioxidants|antioxidants|mesh-ancestor
24497464|NCT00510172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24497465|NCT00510172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24534951|NCT00648323|Doxazosin|doxazosin|mesh-list
25661917|NCT01639729|Sufentanil|sufentanil|mesh-list
25848949|NCT00047047|Immunologic Factors|immunologic factors|mesh-ancestor
25848950|NCT00047047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848952|NCT00047073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25848953|NCT00047073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24801958|NCT01986556|Renal Agents|renal agents|mesh-ancestor
24801959|NCT01986582|Phenylephrine|phenylephrine|mesh-list
24563635|NCT00772655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25848954|NCT00047073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24497514|NCT00510354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497515|NCT00510354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497516|NCT00510367|Cyclophosphamide|cyclophosphamide|mesh-list
24497518|NCT00510367|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24497519|NCT00510367|Fluorouracil|fluorouracil|mesh-list
24497520|NCT00510367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24497521|NCT00510367|Immunologic Factors|immunologic factors|mesh-ancestor
24497522|NCT00510367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497523|NCT00510367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24497524|NCT00510367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24497525|NCT00510367|Alkylating Agents|alkylating agents|mesh-ancestor
24497526|NCT00510367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497531|NCT00510367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25166408|NCT04111315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25166409|NCT04111315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25166410|NCT04111315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166411|NCT04111315|Antipyretics|antipyretics|mesh-ancestor
24810183|NCT02038452|Glucocorticoids|glucocorticoids|mesh-ancestor
24810184|NCT02038452|Hormones|hormones|mesh-ancestor
25203440|NCT02714231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851937|NCT02259855|Tipranavir|tipranavir|mesh-list
24851939|NCT02259855|Antiviral Agents|antiviral agents|mesh-ancestor
24859016|NCT02301091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497532|NCT00510367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497533|NCT00510367|Antimetabolites|antimetabolites|mesh-ancestor
24497534|NCT00510367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24497536|NCT00510393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497537|NCT00510393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24497538|NCT00510393|Immunologic Factors|immunologic factors|mesh-ancestor
24497539|NCT00510393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497540|NCT00510406|Tamsulosin|tamsulosin|mesh-list
24497541|NCT00510406|Solifenacin Succinate|solifenacin succinate|mesh-list
24497542|NCT00510406|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24497552|NCT00510406|Cholinergic Agents|cholinergic agents|mesh-ancestor
24497553|NCT00510419|Sumatriptan|sumatriptan|mesh-list
24497554|NCT00510419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24497555|NCT00510419|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24497570|NCT00510471|Immunologic Factors|immunologic factors|mesh-ancestor
24497571|NCT00510471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497572|NCT00510536|Acetaminophen|acetaminophen|mesh-list
24497573|NCT00510536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24497574|NCT00510536|Analgesics|analgesics|mesh-ancestor
24497575|NCT00510536|Sensory System Agents|sensory system agents|mesh-ancestor
24497576|NCT00510536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24497577|NCT00510536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497578|NCT00510536|Antipyretics|antipyretics|mesh-ancestor
24497579|NCT00510588|Metformin|metformin|mesh-list
24497584|NCT00510614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497585|NCT00510614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24497586|NCT00510614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24497587|NCT00510614|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
24497588|NCT00510614|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24497589|NCT00510614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24497590|NCT00510627|Oxaliplatin|oxaliplatin|mesh-list
24497591|NCT00510627|Irinotecan|irinotecan|mesh-list
24497592|NCT00510627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526073|NCT01845441|Fentanyl|fentanyl|mesh-list
24497593|NCT00510627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24497594|NCT00510627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25661918|NCT01639729|Dsuvia|dsuvia|mesh-list
25661919|NCT01639729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25661920|NCT01639729|Narcotics|narcotics|mesh-ancestor
25661921|NCT01639729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25661922|NCT01639729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661923|NCT01639729|Analgesics|analgesics|mesh-ancestor
25661924|NCT01639729|Sensory System Agents|sensory system agents|mesh-ancestor
25661925|NCT01639729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25231707|NCT02587130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231708|NCT02587130|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25231710|NCT02587130|Anesthetics, General|anesthetics, general|mesh-ancestor
25231711|NCT02587130|Anesthetics|anesthetics|mesh-ancestor
25231712|NCT02587130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25231713|NCT02587130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25231717|NCT02587195|Teriflunomide|teriflunomide|mesh-list
24497595|NCT00510627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497596|NCT00510627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497597|NCT00510640|Sunitinib|sunitinib|mesh-list
24497598|NCT00510640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497599|NCT00510640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25848955|NCT00047073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848956|NCT00047073|Antifungal Agents|antifungal agents|mesh-ancestor
25848957|NCT00047073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24497625|NCT00510913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497626|NCT00510913|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25848958|NCT00047073|Immunologic Factors|immunologic factors|mesh-ancestor
24497644|NCT00511017|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
24497646|NCT00511017|Micronutrients|micronutrients|mesh-ancestor
24497647|NCT00511017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497648|NCT00511017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24497649|NCT00511069|Bortezomib|bortezomib|mesh-list
24497650|NCT00511069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497651|NCT00511121|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24497652|NCT00511121|Imatinib Mesylate|imatinib mesylate|mesh-list
24497653|NCT00511121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497654|NCT00511121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24497655|NCT00511121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497656|NCT00511121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497657|NCT00511121|Antiviral Agents|antiviral agents|mesh-ancestor
24497658|NCT00511121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24497659|NCT00511212|Immunoglobulins|immunoglobulins|mesh-list
24497660|NCT00511212|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24497661|NCT00511212|Antibodies|antibodies|mesh-list
24497663|NCT00511212|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24497678|NCT00511277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24497748|NCT00511654|GABA Agents|gaba agents|mesh-ancestor
24497749|NCT00511654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24497761|NCT00511771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24497762|NCT00511771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497763|NCT00511771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497764|NCT00511823|Rosiglitazone|rosiglitazone|mesh-list
24497765|NCT00511823|Granisetron|granisetron|mesh-list
24497766|NCT00511823|Casopitant|casopitant|mesh-list
24497767|NCT00511823|Dolasetron|dolasetron|mesh-list
24497768|NCT00511823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24497769|NCT00511823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497770|NCT00511823|Antiemetics|antiemetics|mesh-ancestor
24497771|NCT00511823|Autonomic Agents|autonomic agents|mesh-ancestor
24497803|NCT00511953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24497804|NCT00511953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24497805|NCT00511953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24497807|NCT00511953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24497808|NCT00511953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24497809|NCT00511953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24497810|NCT00511953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497811|NCT00511953|Antimanic Agents|antimanic agents|mesh-ancestor
24497813|NCT00511966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24497814|NCT00511966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24497815|NCT00511966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24497871|NCT00512291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527498|NCT00616889|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24527499|NCT00616889|Antidepressive Agents|antidepressive agents|mesh-ancestor
24527500|NCT00616889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24527501|NCT00616889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25661926|NCT01639729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25661927|NCT01639729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25661928|NCT01639729|Anesthetics, General|anesthetics, general|mesh-ancestor
25661929|NCT01639729|Anesthetics|anesthetics|mesh-ancestor
25661930|NCT01639833|Hemostatics|hemostatics|mesh-list
25661931|NCT01639833|Coagulants|coagulants|mesh-ancestor
25661932|NCT01639872|Risperidone|risperidone|mesh-list
25661933|NCT01639872|Clozapine|clozapine|mesh-list
25661934|NCT01639872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24818535|NCT02089308|Nicotine|nicotine|mesh-list
24818536|NCT02089308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24818537|NCT02089308|Autonomic Agents|autonomic agents|mesh-ancestor
25231734|NCT02587169|Doxorubicin|doxorubicin|mesh-list
24497873|NCT00512291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24497874|NCT00512291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25848959|NCT00047073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25848960|NCT00047099|Tamoxifen|tamoxifen|mesh-list
25848961|NCT00047099|Cyclophosphamide|cyclophosphamide|mesh-list
24497913|NCT00512616|Ceftriaxone|ceftriaxone|mesh-list
24497914|NCT00512616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24497915|NCT00512616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24497916|NCT00512629|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24497917|NCT00512629|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24497918|NCT00512629|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25848962|NCT00047099|Docetaxel|docetaxel|mesh-list
25848963|NCT00047099|Fluorouracil|fluorouracil|mesh-list
25848964|NCT00047099|Epirubicin|epirubicin|mesh-list
25848965|NCT00047099|Goserelin|goserelin|mesh-list
25848966|NCT00047099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24497938|NCT00512668|Androgen Antagonists|androgen antagonists|mesh-ancestor
24497939|NCT00512668|Hormone Antagonists|hormone antagonists|mesh-ancestor
24497940|NCT00512668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24497941|NCT00512681|Oxaliplatin|oxaliplatin|mesh-list
24497942|NCT00512681|Irinotecan|irinotecan|mesh-list
24497943|NCT00512681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497944|NCT00512681|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24497945|NCT00512681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24497946|NCT00512681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497947|NCT00512681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497948|NCT00512759|Nitroglycerin|nitroglycerin|mesh-list
24497949|NCT00512759|Vasodilator Agents|vasodilator agents|mesh-ancestor
24497950|NCT00512811|Furosemide|furosemide|mesh-list
24497951|NCT00512811|Diuretics|diuretics|mesh-ancestor
24497952|NCT00512811|Natriuretic Agents|natriuretic agents|mesh-ancestor
24810193|NCT02038621|Paclitaxel|paclitaxel|mesh-list
24810198|NCT02038621|Tubulin Modulators|tubulin modulators|mesh-ancestor
24810199|NCT02038621|Antimitotic Agents|antimitotic agents|mesh-ancestor
24810200|NCT02038621|Mitosis Modulators|mitosis modulators|mesh-ancestor
24810201|NCT02038621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810202|NCT02038621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24497953|NCT00512811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166416|NCT04093024|Nintedanib|nintedanib|mesh-list
24497972|NCT00512863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24497974|NCT00512928|Vitamin K|vitamin k|mesh-list
24497988|NCT00512980|Doxorubicin|doxorubicin|mesh-list
24497989|NCT00512980|Vinblastine|vinblastine|mesh-list
24497990|NCT00512980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24497991|NCT00512980|Antimetabolites|antimetabolites|mesh-ancestor
24497999|NCT00512980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498000|NCT00512980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24498001|NCT00512980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24498002|NCT00512980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24498003|NCT00512980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24498004|NCT00512980|Glucocorticoids|glucocorticoids|mesh-ancestor
24498006|NCT00512980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24498007|NCT00512980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24498008|NCT00512980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24498009|NCT00512980|Tubulin Modulators|tubulin modulators|mesh-ancestor
24498010|NCT00512980|Antimitotic Agents|antimitotic agents|mesh-ancestor
24498011|NCT00512980|Mitosis Modulators|mitosis modulators|mesh-ancestor
24498012|NCT00512993|Zoledronic Acid|zoledronic acid|mesh-list
24498013|NCT00512993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24498016|NCT00513032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498017|NCT00513032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498018|NCT00513058|Vinorelbine|vinorelbine|mesh-list
24498020|NCT00513058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24498021|NCT00513058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498022|NCT00513058|Tubulin Modulators|tubulin modulators|mesh-ancestor
25661935|NCT01639872|Serotonin Agents|serotonin agents|mesh-ancestor
25661936|NCT01639872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25661937|NCT01639872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661938|NCT01639872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498023|NCT00513058|Antimitotic Agents|antimitotic agents|mesh-ancestor
24498024|NCT00513058|Mitosis Modulators|mitosis modulators|mesh-ancestor
25661939|NCT01639872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25661940|NCT01639872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25231768|NCT02586961|Autonomic Agents|autonomic agents|mesh-ancestor
24498025|NCT00513058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498026|NCT00513058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24498027|NCT00513058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498054|NCT00513162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498061|NCT00513162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24498062|NCT00513162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24498065|NCT00513188|Prednisone|prednisone|mesh-list
24498066|NCT00513188|Cyclophosphamide|cyclophosphamide|mesh-list
24498067|NCT00513188|Doxorubicin|doxorubicin|mesh-list
24498068|NCT00513188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24498069|NCT00513188|Methotrexate|methotrexate|mesh-list
24498070|NCT00513188|Vincristine|vincristine|mesh-list
24498071|NCT00513188|Denileukin diftitox|denileukin diftitox|mesh-list
24498072|NCT00513188|Levoleucovorin|levoleucovorin|mesh-list
24498073|NCT00513188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24498074|NCT00513188|Immunologic Factors|immunologic factors|mesh-ancestor
24498075|NCT00513188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498076|NCT00513188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24498077|NCT00513188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24498078|NCT00513188|Alkylating Agents|alkylating agents|mesh-ancestor
24498079|NCT00513188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498080|NCT00513188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498081|NCT00513188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24498082|NCT00513188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24498083|NCT00513188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24498084|NCT00513188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24498085|NCT00513188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498086|NCT00513188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24498087|NCT00513188|Glucocorticoids|glucocorticoids|mesh-ancestor
24498088|NCT00513188|Hormones|hormones|mesh-ancestor
24498089|NCT00513188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24498090|NCT00513188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25848967|NCT00047099|Immunologic Factors|immunologic factors|mesh-ancestor
24498091|NCT00513188|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24498093|NCT00513188|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24498094|NCT00513188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24498095|NCT00513188|Antimetabolites|antimetabolites|mesh-ancestor
24498096|NCT00513188|Dermatologic Agents|dermatologic agents|mesh-ancestor
24498097|NCT00513188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24703160|NCT01470040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25166417|NCT04093024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810214|NCT02038816|Azacitidine|azacitidine|mesh-list
24810215|NCT02038816|Deferasirox|deferasirox|mesh-list
24810216|NCT02038816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24498113|NCT00513201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498114|NCT00513253|Lapatinib|lapatinib|mesh-list
24498115|NCT00513253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498116|NCT00513253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24498128|NCT00513266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498129|NCT00513266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24498130|NCT00513266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24498132|NCT00513266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498133|NCT00513266|Growth Inhibitors|growth inhibitors|mesh-ancestor
24498134|NCT00513266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24498135|NCT00513266|Antimetabolites|antimetabolites|mesh-ancestor
24498158|NCT00513383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498159|NCT00513383|Antimetabolites|antimetabolites|mesh-ancestor
24498160|NCT00513383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24498161|NCT00513383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24498162|NCT00513383|Immunologic Factors|immunologic factors|mesh-ancestor
24498163|NCT00513383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498164|NCT00513383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24498165|NCT00513396|Isoniazid|isoniazid|mesh-list
25848968|NCT00047099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810223|NCT02038816|Sequestering Agents|sequestering agents|mesh-ancestor
24810251|NCT02039063|Quetmolimab|quetmolimab|mesh-list
24810252|NCT02039063|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24810253|NCT02039063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24810254|NCT02039063|Immunologic Factors|immunologic factors|mesh-ancestor
24810255|NCT02039063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810256|NCT02039323|Tenofovir|tenofovir|mesh-list
24810257|NCT02039323|Maraviroc|maraviroc|mesh-list
24810258|NCT02039323|Antiviral Agents|antiviral agents|mesh-ancestor
24810259|NCT02039323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25231815|NCT02586259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25231816|NCT02586259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24810260|NCT02039323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24810261|NCT02039323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24810262|NCT02039323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703162|NCT01470040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24810263|NCT02039323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810264|NCT02039323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24810265|NCT02039323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24810266|NCT02039323|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24810267|NCT02039323|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24498177|NCT00513487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24498178|NCT00513487|Autonomic Agents|autonomic agents|mesh-ancestor
24498179|NCT00513487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24498180|NCT00513487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498181|NCT00513487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24498182|NCT00513487|Respiratory System Agents|respiratory system agents|mesh-ancestor
24498183|NCT00513487|Dermatologic Agents|dermatologic agents|mesh-ancestor
24498184|NCT00513487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24498186|NCT00513487|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24498187|NCT00513487|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
24498188|NCT00513487|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24498189|NCT00513487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24498190|NCT00513487|Cholinergic Agents|cholinergic agents|mesh-ancestor
24498191|NCT00513487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24498192|NCT00513487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498193|NCT00513513|Ritonavir|ritonavir|mesh-list
24498194|NCT00513513|Darunavir|darunavir|mesh-list
24498195|NCT00513513|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25848969|NCT00047099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25848970|NCT00047099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25848971|NCT00047099|Alkylating Agents|alkylating agents|mesh-ancestor
25848972|NCT00047099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498232|NCT00513630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24498248|NCT00513656|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24498250|NCT00513786|Bevacizumab|bevacizumab|mesh-list
24498251|NCT00513786|Carboplatin|carboplatin|mesh-list
24498252|NCT00513786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24498253|NCT00513786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498254|NCT00513786|Tubulin Modulators|tubulin modulators|mesh-ancestor
24498272|NCT00513864|Sensory System Agents|sensory system agents|mesh-ancestor
24498273|NCT00513864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24498274|NCT00513864|Antitussive Agents|antitussive agents|mesh-ancestor
24498283|NCT00513929|Astringents|astringents|mesh-ancestor
24498284|NCT00513929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498285|NCT00513929|Dermatologic Agents|dermatologic agents|mesh-ancestor
24498286|NCT00513955|Prednisolone|prednisolone|mesh-list
24498287|NCT00513955|Cyclophosphamide|cyclophosphamide|mesh-list
24498288|NCT00513955|Doxorubicin|doxorubicin|mesh-list
24498289|NCT00513955|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24498290|NCT00513955|Vincristine|vincristine|mesh-list
24498291|NCT00513955|Bortezomib|bortezomib|mesh-list
24498292|NCT00513955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24498293|NCT00513955|Immunologic Factors|immunologic factors|mesh-ancestor
24498294|NCT00513955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498311|NCT00513955|Hormones|hormones|mesh-ancestor
24498312|NCT00513955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24498313|NCT00513955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24498314|NCT00513968|Adefovir|adefovir|mesh-list
24498315|NCT00513968|Antiviral Agents|antiviral agents|mesh-ancestor
24498336|NCT00513981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24498338|NCT00513981|Immunologic Factors|immunologic factors|mesh-ancestor
24498339|NCT00513981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24498340|NCT00513981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25661941|NCT01639872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25661942|NCT01639872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24498342|NCT00513981|Protective Agents|protective agents|mesh-ancestor
24498343|NCT00513981|Vitamin B Complex|vitamin b complex|mesh-ancestor
24498344|NCT00513981|Vitamins|vitamins|mesh-ancestor
25661943|NCT01639872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25661944|NCT01639872|Dopamine Agents|dopamine agents|mesh-ancestor
25661945|NCT01639872|GABA Antagonists|gaba antagonists|mesh-ancestor
25661946|NCT01639872|GABA Agents|gaba agents|mesh-ancestor
25661947|NCT01640171|Ketorolac|ketorolac|mesh-list
25661948|NCT01640171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25661949|NCT01640171|Lidocaine|lidocaine|mesh-list
25231844|NCT02586454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231845|NCT02586454|Analgesics|analgesics|mesh-ancestor
25231846|NCT02586454|Sensory System Agents|sensory system agents|mesh-ancestor
25231847|NCT02586454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25231848|NCT02586454|Anesthetics, Local|anesthetics, local|mesh-ancestor
25231849|NCT02586454|Anesthetics|anesthetics|mesh-ancestor
25231850|NCT02586363|Entecavir|entecavir|mesh-list
25231851|NCT02586363|Antiviral Agents|antiviral agents|mesh-ancestor
25231852|NCT02586363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25231853|NCT02586246|Certolizumab Pegol|certolizumab pegol|mesh-list
25231854|NCT02586246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24498345|NCT00513981|Micronutrients|micronutrients|mesh-ancestor
24498346|NCT00513994|Nitroglycerin|nitroglycerin|mesh-list
24498347|NCT00513994|Vasodilator Agents|vasodilator agents|mesh-ancestor
24498348|NCT00514072|Vaccines|vaccines|mesh-list
24498349|NCT00514072|BCG Vaccine|bcg vaccine|mesh-list
24498350|NCT00514072|Immunologic Factors|immunologic factors|mesh-ancestor
25848973|NCT00047099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498387|NCT00514228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24498388|NCT00514228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498390|NCT00514293|Carboplatin|carboplatin|mesh-list
24498399|NCT00514293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498400|NCT00514293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24498401|NCT00514293|Antimetabolites|antimetabolites|mesh-ancestor
24498402|NCT00514293|Keratolytic Agents|keratolytic agents|mesh-ancestor
24498403|NCT00514293|Dermatologic Agents|dermatologic agents|mesh-ancestor
24498404|NCT00514397|Temozolomide|temozolomide|mesh-list
24498405|NCT00514397|Motexafin gadolinium|motexafin gadolinium|mesh-list
24498406|NCT00514397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24498407|NCT00514397|Alkylating Agents|alkylating agents|mesh-ancestor
24498408|NCT00514397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498409|NCT00514397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498410|NCT00514397|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24498411|NCT00514397|Dermatologic Agents|dermatologic agents|mesh-ancestor
24498412|NCT00514410|Folic Acid|folic acid|mesh-list
24498413|NCT00514410|Hematinics|hematinics|mesh-ancestor
24498414|NCT00514410|Vitamin B Complex|vitamin b complex|mesh-ancestor
24498415|NCT00514410|Vitamins|vitamins|mesh-ancestor
24498416|NCT00514410|Micronutrients|micronutrients|mesh-ancestor
24498417|NCT00514410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498418|NCT00514475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24498419|NCT00514475|Immunologic Factors|immunologic factors|mesh-ancestor
24498449|NCT00514748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24498450|NCT00514748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24498451|NCT00514748|Analgesics|analgesics|mesh-ancestor
24498452|NCT00514748|Sensory System Agents|sensory system agents|mesh-ancestor
24498453|NCT00514748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24958738|NCT03830034|Iron|iron|mesh-list
24498454|NCT00514748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498455|NCT00514748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24498456|NCT00514748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24498457|NCT00514761|Capecitabine|capecitabine|mesh-list
24498458|NCT00514761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24498459|NCT00514761|Antimetabolites|antimetabolites|mesh-ancestor
24498460|NCT00514761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498461|NCT00514761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498462|NCT00514774|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24498463|NCT00514774|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24498464|NCT00514774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24498465|NCT00514891|Vitamin A|vitamin a|mesh-list
24498466|NCT00514891|Vitamins|vitamins|mesh-ancestor
24498467|NCT00514891|Micronutrients|micronutrients|mesh-ancestor
24498468|NCT00514891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498469|NCT00514969|Imatinib Mesylate|imatinib mesylate|mesh-list
24498470|NCT00514969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25848974|NCT00047099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25848975|NCT00047099|Tubulin Modulators|tubulin modulators|mesh-ancestor
25848976|NCT00047099|Antimitotic Agents|antimitotic agents|mesh-ancestor
25661950|NCT01640171|Proxymetacaine|proxymetacaine|mesh-list
25661951|NCT01640171|Anesthetics|anesthetics|mesh-list
25661952|NCT01640171|Anesthetics, Local|anesthetics, local|mesh-ancestor
25661953|NCT01640171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25661954|NCT01640171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661955|NCT01640171|Sensory System Agents|sensory system agents|mesh-ancestor
25661956|NCT01640171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25661957|NCT01640171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25661958|NCT01640171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25674352|NCT01770483|Ribavirin|ribavirin|mesh-list
25848981|NCT00047099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25848982|NCT00047099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24498471|NCT00514969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24498472|NCT00514969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498473|NCT00514969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498475|NCT00514982|Mesalamine|mesalamine|mesh-list
24498476|NCT00514982|Mercaptopurine|mercaptopurine|mesh-list
24498477|NCT00514982|Infliximab|infliximab|mesh-list
24498478|NCT00514982|Tacrolimus|tacrolimus|mesh-list
24498479|NCT00514982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24498480|NCT00514982|Immunologic Factors|immunologic factors|mesh-ancestor
24498524|NCT00515151|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24498525|NCT00515151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24499060|NCT00517582|Icatibant|icatibant|mesh-list
24498526|NCT00515151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24498527|NCT00515151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498529|NCT00515190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498531|NCT00515229|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24498532|NCT00515229|Antidepressive Agents|antidepressive agents|mesh-ancestor
24498533|NCT00515229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24498534|NCT00515229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24498584|NCT00515359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24499498|NCT00519753|Adrenergic Agents|adrenergic agents|mesh-ancestor
24498586|NCT00515359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25848983|NCT00047099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848984|NCT00047099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25848985|NCT00047099|Hormone Antagonists|hormone antagonists|mesh-ancestor
25848986|NCT00047099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24498622|NCT00515684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25200636|NCT02732795|Narcotics|narcotics|mesh-ancestor
24498623|NCT00515684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24498624|NCT00515684|Growth Substances|growth substances|mesh-ancestor
24498625|NCT00515684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498686|NCT00515944|Botulinum Toxins|botulinum toxins|mesh-list
24498687|NCT00515944|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24498688|NCT00515944|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24498689|NCT00515944|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24498690|NCT00515944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24498691|NCT00515944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498692|NCT00515944|Cholinergic Agents|cholinergic agents|mesh-ancestor
24498693|NCT00515944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24498694|NCT00515944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498695|NCT00515944|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24498696|NCT00515944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24498698|NCT00515957|Immunologic Factors|immunologic factors|mesh-ancestor
24498699|NCT00515957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498700|NCT00516009|Dexamethasone|dexamethasone|mesh-list
24498720|NCT00516113|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24498753|NCT00516152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25661959|NCT01640171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25661960|NCT01640171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25661961|NCT01640171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661962|NCT01640171|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25661963|NCT01640171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25661964|NCT01640171|Analgesics|analgesics|mesh-ancestor
25661965|NCT01640171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25661966|NCT01640171|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25661967|NCT01640171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661968|NCT01640184|Vitamin D|vitamin d|mesh-list
25661969|NCT01640184|Vitamins|vitamins|mesh-ancestor
25661970|NCT01640184|Micronutrients|micronutrients|mesh-ancestor
24498754|NCT00516152|Alkylating Agents|alkylating agents|mesh-ancestor
24498755|NCT00516152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25166418|NCT04093024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24498756|NCT00516152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24498758|NCT00516191|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24498760|NCT00516191|Melphalan|melphalan|mesh-list
24498761|NCT00516191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25848987|NCT00047099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25848988|NCT00047099|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25848989|NCT00047099|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25848990|NCT00047099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25848991|NCT00047112|Cisplatin|cisplatin|mesh-list
25848992|NCT00047112|Fluorouracil|fluorouracil|mesh-list
25848993|NCT00047112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24535134|NCT00648622|Carvedilol|carvedilol|mesh-list
24499024|NCT00517322|Protease Inhibitors|protease inhibitors|mesh-ancestor
24499025|NCT00517322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709405|NCT01505426|Ipragliflozin|ipragliflozin|mesh-list
24499026|NCT00517322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499027|NCT00517322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24499035|NCT00517387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24499037|NCT00517426|Acetazolamide|acetazolamide|mesh-list
24499038|NCT00517426|Anticonvulsants|anticonvulsants|mesh-ancestor
24499039|NCT00517426|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24499040|NCT00517426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499041|NCT00517426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499042|NCT00517426|Diuretics|diuretics|mesh-ancestor
24499043|NCT00517426|Natriuretic Agents|natriuretic agents|mesh-ancestor
24499044|NCT00517426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499046|NCT00517491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24499047|NCT00517504|Methylphenidate|methylphenidate|mesh-list
24499048|NCT00517504|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24499049|NCT00517504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499057|NCT00517517|Agglutinins|agglutinins|mesh-ancestor
24499058|NCT00517517|Immunologic Factors|immunologic factors|mesh-ancestor
24499059|NCT00517517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499061|NCT00517582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24499062|NCT00517582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24499063|NCT00517582|Analgesics|analgesics|mesh-ancestor
24499064|NCT00517582|Sensory System Agents|sensory system agents|mesh-ancestor
24499083|NCT00517712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24499084|NCT00517725|Carvedilol|carvedilol|mesh-list
24499085|NCT00517725|Nebivolol|nebivolol|mesh-list
24499086|NCT00517725|Bisoprolol|bisoprolol|mesh-list
24499097|NCT00517725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24499098|NCT00517725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24499100|NCT00517725|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24810296|NCT02039453|Anesthetics|anesthetics|mesh-ancestor
24810297|NCT02039479|Lithium Carbonate|lithium carbonate|mesh-list
24810298|NCT02039479|Antidepressive Agents|antidepressive agents|mesh-ancestor
24810299|NCT02039479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24810300|NCT02039479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499101|NCT00517725|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25005797|NCT02560805|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24499102|NCT00517725|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24499103|NCT00517725|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24499104|NCT00517725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24499105|NCT00517725|Sympatholytics|sympatholytics|mesh-ancestor
24499106|NCT00517725|Autonomic Agents|autonomic agents|mesh-ancestor
24499107|NCT00517725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24499108|NCT00517725|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24499109|NCT00517764|Citalopram|citalopram|mesh-list
24499133|NCT00517946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499134|NCT00517946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24499136|NCT00517946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24499137|NCT00517946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24499138|NCT00517946|Respiratory System Agents|respiratory system agents|mesh-ancestor
24499139|NCT00517946|Nasal Decongestants|nasal decongestants|mesh-ancestor
24499140|NCT00517946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24499141|NCT00517946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24499142|NCT00517946|Sympathomimetics|sympathomimetics|mesh-ancestor
24499143|NCT00517946|Adrenergic Agents|adrenergic agents|mesh-ancestor
24499144|NCT00517985|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24499183|NCT00518141|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25848994|NCT00047112|Antimetabolites|antimetabolites|mesh-ancestor
25848995|NCT00047112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25848996|NCT00047112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24499184|NCT00518141|Antipyretics|antipyretics|mesh-ancestor
24499185|NCT00518193|Cetuximab|cetuximab|mesh-list
24499207|NCT00518271|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24499209|NCT00518271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499210|NCT00518271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24499211|NCT00518271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24499212|NCT00518271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24499213|NCT00518271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24499214|NCT00518271|Antifungal Agents|antifungal agents|mesh-ancestor
24499215|NCT00518297|Raltegravir Potassium|raltegravir potassium|mesh-list
24499216|NCT00518297|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24499217|NCT00518297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24499218|NCT00518297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24499219|NCT00518297|Antiviral Agents|antiviral agents|mesh-ancestor
24710427|NCT01510548|Adalimumab|adalimumab|mesh-list
24499220|NCT00518297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24810302|NCT02039479|Antimanic Agents|antimanic agents|mesh-ancestor
24810303|NCT02039479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24810304|NCT02039479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24810305|NCT02039479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603387|NCT00973583|Vitamin D|vitamin d|mesh-list
24499300|NCT00518895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24499301|NCT00518895|Alkylating Agents|alkylating agents|mesh-ancestor
24444589|NCT00298571|Anesthetics|anesthetics|mesh-ancestor
24499340|NCT00519012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499341|NCT00519051|Fluoxetine|fluoxetine|mesh-list
24499342|NCT00519051|Antidepressive Agents|antidepressive agents|mesh-list
24499343|NCT00519051|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24499446|NCT00519467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24499447|NCT00519467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24499448|NCT00519467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24499449|NCT00519467|Antiviral Agents|antiviral agents|mesh-ancestor
24499450|NCT00519467|Schistosomicides|schistosomicides|mesh-ancestor
24499451|NCT00519467|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24499452|NCT00519467|Anthelmintics|anthelmintics|mesh-ancestor
24499453|NCT00519467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24499454|NCT00519467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499455|NCT00519467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499456|NCT00519467|Leprostatic Agents|leprostatic agents|mesh-ancestor
24499495|NCT00519753|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24499496|NCT00519753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24499497|NCT00519753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24499510|NCT00519805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499511|NCT00519870|Losartan|losartan|mesh-list
24499512|NCT00519870|Nifedipine|nifedipine|mesh-list
24499513|NCT00519870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24499514|NCT00519870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24499515|NCT00519870|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24499516|NCT00519870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24499538|NCT00519987|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24499539|NCT00519987|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24499540|NCT00519987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24499541|NCT00519987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810315|NCT02039518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24810317|NCT02039518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810318|NCT02039518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810319|NCT02039518|Antiviral Agents|antiviral agents|mesh-ancestor
24810320|NCT02039518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24810321|NCT02039518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24810322|NCT02039518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24810323|NCT02039518|Immunologic Factors|immunologic factors|mesh-ancestor
24499542|NCT00520000|Carboplatin|carboplatin|mesh-list
24499543|NCT00520000|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24499544|NCT00520000|Paclitaxel|paclitaxel|mesh-list
24499545|NCT00520000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24499546|NCT00520000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24499547|NCT00520000|Tubulin Modulators|tubulin modulators|mesh-ancestor
24499563|NCT00520091|Celecoxib|celecoxib|mesh-list
25661971|NCT01640184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25661972|NCT01640184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24499589|NCT00520104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25661973|NCT01640197|Resveratrol|resveratrol|mesh-list
24499590|NCT00520104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24499591|NCT00520104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24499592|NCT00520104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24499593|NCT00520104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499594|NCT00520169|Ketamine|ketamine|mesh-list
24499595|NCT00520169|Analgesics|analgesics|mesh-ancestor
24499596|NCT00520169|Sensory System Agents|sensory system agents|mesh-ancestor
24499597|NCT00520169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24499598|NCT00520169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499599|NCT00520169|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24499600|NCT00520169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24499601|NCT00520169|Anesthetics, General|anesthetics, general|mesh-ancestor
24499602|NCT00520169|Anesthetics|anesthetics|mesh-ancestor
24499603|NCT00520169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24499604|NCT00520169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25848997|NCT00047112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24499807|NCT00521183|Tetrahydrouridine|tetrahydrouridine|mesh-list
24499808|NCT00521183|Antimetabolites|antimetabolites|mesh-ancestor
24499809|NCT00521183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499810|NCT00521222|Fluticasone|fluticasone|mesh-list
24499811|NCT00521222|Xhance|xhance|mesh-list
24499812|NCT00521222|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24810344|NCT02039661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24810345|NCT02039661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810346|NCT02039700|Lesinurad|lesinurad|mesh-list
24810347|NCT02039700|Gout Suppressants|gout suppressants|mesh-ancestor
24603731|NCT00975299|Bombesin|bombesin|mesh-list
24499855|NCT00521300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24499856|NCT00521300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24499857|NCT00521430|Cyclosporine|cyclosporine|mesh-list
24499858|NCT00521430|Methylprednisolone|methylprednisolone|mesh-list
24499859|NCT00521430|Methotrexate|methotrexate|mesh-list
24499860|NCT00521430|Fludarabine phosphate|fludarabine phosphate|mesh-list
24499861|NCT00521430|Fludarabine|fludarabine|mesh-list
24499937|NCT00521703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24499938|NCT00521703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24499939|NCT00521703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24499940|NCT00521703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499941|NCT00521742|Pioglitazone|pioglitazone|mesh-list
24499942|NCT00521742|Glyburide|glyburide|mesh-list
24499943|NCT00521742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24500910|NCT00526175|Mitosis Modulators|mitosis modulators|mesh-ancestor
24443305|NCT00294463|Estradiol|estradiol|mesh-list
24499974|NCT00521859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24499976|NCT00521950|Azathioprine|azathioprine|mesh-list
24499977|NCT00521950|Antimetabolites|antimetabolites|mesh-ancestor
24499978|NCT00521950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499979|NCT00521950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24500037|NCT00522249|Interferon-alpha|interferon-alpha|mesh-list
24500038|NCT00522249|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
24500039|NCT00522249|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24500041|NCT00522249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24500042|NCT00522249|Antiviral Agents|antiviral agents|mesh-ancestor
24500043|NCT00522249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24500044|NCT00522249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24500045|NCT00522249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24500046|NCT00522249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500047|NCT00522249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24500048|NCT00522249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24500049|NCT00522249|Growth Substances|growth substances|mesh-ancestor
24500050|NCT00522249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500051|NCT00522249|Growth Inhibitors|growth inhibitors|mesh-ancestor
24500052|NCT00522249|Immunologic Factors|immunologic factors|mesh-ancestor
24500053|NCT00522444|Magnesium Sulfate|magnesium sulfate|mesh-list
24500054|NCT00522444|Analgesics|analgesics|mesh-ancestor
24500055|NCT00522444|Sensory System Agents|sensory system agents|mesh-ancestor
24500056|NCT00522444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24500057|NCT00522444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500074|NCT00522509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500075|NCT00522509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24500076|NCT00522587|Remifentanil|remifentanil|mesh-list
24500077|NCT00522587|Sevoflurane|sevoflurane|mesh-list
24500078|NCT00522587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24500079|NCT00522587|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25166419|NCT04093024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25848998|NCT00047112|Immunologic Factors|immunologic factors|mesh-ancestor
25661975|NCT01640197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25661976|NCT01640197|Protective Agents|protective agents|mesh-ancestor
25661977|NCT01640197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500114|NCT00522782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24500115|NCT00522782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500116|NCT00522782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24500117|NCT00522782|Respiratory System Agents|respiratory system agents|mesh-ancestor
24500118|NCT00522782|Glucocorticoids|glucocorticoids|mesh-ancestor
24500119|NCT00522782|Hormones|hormones|mesh-ancestor
24500120|NCT00522782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25848999|NCT00047112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849000|NCT00047138|Dactinomycin|dactinomycin|mesh-list
25849001|NCT00047138|Cyclophosphamide|cyclophosphamide|mesh-list
25849002|NCT00047138|Carboplatin|carboplatin|mesh-list
24500237|NCT00523393|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24500238|NCT00523393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24500239|NCT00523393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500240|NCT00523406|Triamcinolone|triamcinolone|mesh-list
24500256|NCT00523432|Antifungal Agents|antifungal agents|mesh-ancestor
24500257|NCT00523432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24500258|NCT00523432|Immunologic Factors|immunologic factors|mesh-ancestor
24500259|NCT00523432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500260|NCT00523445|Varenicline|varenicline|mesh-list
25849003|NCT00047138|Doxorubicin|doxorubicin|mesh-list
25849004|NCT00047138|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25849005|NCT00047138|Etoposide|etoposide|mesh-list
24500275|NCT00523458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24500276|NCT00523458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24500277|NCT00523458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24500338|NCT00523887|Anesthetics|anesthetics|mesh-ancestor
24500359|NCT00523965|Amebicides|amebicides|mesh-ancestor
24500360|NCT00523965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24500361|NCT00523965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24500362|NCT00523965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24500363|NCT00523965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24500364|NCT00523965|Antifungal Agents|antifungal agents|mesh-ancestor
24500365|NCT00523965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24500366|NCT00523965|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24500367|NCT00523965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24500368|NCT00524004|Immunoglobulin G|immunoglobulin g|mesh-list
24500369|NCT00524004|Immunologic Factors|immunologic factors|mesh-ancestor
24500911|NCT00526175|Antiviral Agents|antiviral agents|mesh-ancestor
25849006|NCT00047138|Vincristine|vincristine|mesh-list
24500495|NCT00524667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24500497|NCT00524693|Montelukast|montelukast|mesh-list
24500498|NCT00524693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24500499|NCT00524693|Respiratory System Agents|respiratory system agents|mesh-ancestor
24443378|NCT00294619|Hormones|hormones|mesh-list
24500839|NCT00525928|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24500508|NCT00524706|Oxaliplatin|oxaliplatin|mesh-list
25166420|NCT04093024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166421|NCT04090775|Cyclophosphamide|cyclophosphamide|mesh-list
25166422|NCT04090775|Nivolumab|nivolumab|mesh-list
25166423|NCT04090775|Ipilimumab|ipilimumab|mesh-list
25166424|NCT04090775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25166425|NCT04090775|Immunologic Factors|immunologic factors|mesh-ancestor
24500509|NCT00524706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24500510|NCT00524706|Antidotes|antidotes|mesh-ancestor
24500511|NCT00524706|Protective Agents|protective agents|mesh-ancestor
24500512|NCT00524706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500513|NCT00524706|Vitamin B Complex|vitamin b complex|mesh-ancestor
24500514|NCT00524706|Vitamins|vitamins|mesh-ancestor
24500515|NCT00524706|Micronutrients|micronutrients|mesh-ancestor
24500516|NCT00524810|Docetaxel|docetaxel|mesh-list
24500517|NCT00524810|Doxorubicin|doxorubicin|mesh-list
24500518|NCT00524810|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24500519|NCT00524810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24500520|NCT00524810|Tubulin Modulators|tubulin modulators|mesh-ancestor
24500521|NCT00524810|Antimitotic Agents|antimitotic agents|mesh-ancestor
24500522|NCT00524810|Mitosis Modulators|mitosis modulators|mesh-ancestor
24500523|NCT00524810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500524|NCT00524810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24500525|NCT00524810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25661978|NCT01640197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661979|NCT01640197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24500526|NCT00524810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24500527|NCT00524810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24500528|NCT00524836|Levocetirizine|levocetirizine|mesh-list
24500529|NCT00524836|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25849007|NCT00047138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25849008|NCT00047138|Immunologic Factors|immunologic factors|mesh-ancestor
25849009|NCT00047138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849010|NCT00047138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24604370|NCT00978913|Vaccines|vaccines|mesh-list
25849011|NCT00047138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25849012|NCT00047138|Alkylating Agents|alkylating agents|mesh-ancestor
25849013|NCT00047138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849014|NCT00047138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849015|NCT00047138|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25849016|NCT00047138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25849017|NCT00047138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25849018|NCT00047138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24500567|NCT00525005|Docetaxel|docetaxel|mesh-list
24500568|NCT00525005|Oxaliplatin|oxaliplatin|mesh-list
24500569|NCT00525005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849019|NCT00047138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849020|NCT00047138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24500630|NCT00525252|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24500631|NCT00525252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500632|NCT00525252|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24500633|NCT00525252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24500634|NCT00525252|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24500635|NCT00525252|GABA Agonists|gaba agonists|mesh-ancestor
24500636|NCT00525252|GABA Agents|gaba agents|mesh-ancestor
24500637|NCT00525252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24500638|NCT00525252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500639|NCT00525278|Levocetirizine|levocetirizine|mesh-list
24810390|NCT02039960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24810391|NCT02039960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24810392|NCT02039960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810393|NCT02039960|Dopamine Agents|dopamine agents|mesh-ancestor
24810394|NCT02039960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25849021|NCT00047138|Tubulin Modulators|tubulin modulators|mesh-ancestor
25849022|NCT00047138|Antimitotic Agents|antimitotic agents|mesh-ancestor
25849023|NCT00047138|Mitosis Modulators|mitosis modulators|mesh-ancestor
25849024|NCT00047138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25849025|NCT00047138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24500651|NCT00525382|Histamine Agents|histamine agents|mesh-ancestor
24500652|NCT00525382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24500654|NCT00525382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500656|NCT00525408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24500657|NCT00525408|Tubulin Modulators|tubulin modulators|mesh-ancestor
24500658|NCT00525408|Antimitotic Agents|antimitotic agents|mesh-ancestor
24500660|NCT00525408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500661|NCT00525447|Dexamethasone|dexamethasone|mesh-list
24500662|NCT00525447|Lenalidomide|lenalidomide|mesh-list
24500663|NCT00525447|Dacetuzumab|dacetuzumab|mesh-list
24500664|NCT00525447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24500665|NCT00525447|Antiemetics|antiemetics|mesh-ancestor
24500666|NCT00525447|Autonomic Agents|autonomic agents|mesh-ancestor
24500667|NCT00525447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24500668|NCT00525447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500669|NCT00525447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24500670|NCT00525447|Glucocorticoids|glucocorticoids|mesh-ancestor
24500746|NCT00525642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500748|NCT00525642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24605693|NCT00986778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24500750|NCT00525642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500752|NCT00525642|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24500753|NCT00525642|Tubulin Modulators|tubulin modulators|mesh-ancestor
24500754|NCT00525642|Antimitotic Agents|antimitotic agents|mesh-ancestor
24500755|NCT00525642|Mitosis Modulators|mitosis modulators|mesh-ancestor
25849026|NCT00047138|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25849027|NCT00047138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25849028|NCT00047164|Ipilimumab|ipilimumab|mesh-list
25849029|NCT00047164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25849030|NCT00047164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849031|NCT00047164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25849032|NCT00047164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500783|NCT00525694|Anesthetics, Local|anesthetics, local|mesh-ancestor
24500789|NCT00525694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25849033|NCT00047177|Oxaliplatin|oxaliplatin|mesh-list
25849034|NCT00047177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849035|NCT00047190|Tipifarnib|tipifarnib|mesh-list
25849036|NCT00047190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24500805|NCT00525759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500806|NCT00525759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24500807|NCT00525759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24500808|NCT00525759|Alkylating Agents|alkylating agents|mesh-ancestor
25876096|NCT03914625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25876097|NCT03914625|Tubulin Modulators|tubulin modulators|mesh-ancestor
25876098|NCT03914625|Antimitotic Agents|antimitotic agents|mesh-ancestor
24605707|NCT00986817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24604655|NCT00980707|Xhance|xhance|mesh-list
25876099|NCT03914625|Mitosis Modulators|mitosis modulators|mesh-ancestor
25876100|NCT03914625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25876101|NCT03914625|Hematinics|hematinics|mesh-ancestor
25876102|NCT03914612|Paclitaxel|paclitaxel|mesh-list
25876103|NCT03914612|Carboplatin|carboplatin|mesh-list
25876104|NCT03914612|Pembrolizumab|pembrolizumab|mesh-list
25876105|NCT03914612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25876106|NCT03914612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25876107|NCT03914612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876108|NCT03914612|Tubulin Modulators|tubulin modulators|mesh-ancestor
25876109|NCT03914612|Antimitotic Agents|antimitotic agents|mesh-ancestor
25876110|NCT03914612|Mitosis Modulators|mitosis modulators|mesh-ancestor
24500836|NCT00525889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500838|NCT00525928|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24500900|NCT00526175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24500901|NCT00526175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24500905|NCT00526175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24500906|NCT00526175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24500907|NCT00526175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24500908|NCT00526175|Tubulin Modulators|tubulin modulators|mesh-ancestor
24500909|NCT00526175|Antimitotic Agents|antimitotic agents|mesh-ancestor
24500939|NCT00526305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24500940|NCT00526305|Immunologic Factors|immunologic factors|mesh-ancestor
24500941|NCT00526305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876111|NCT03914612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623041|NCT01069822|GABA Agents|gaba agents|mesh-ancestor
24623042|NCT01069822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24604838|NCT00981890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876112|NCT03914612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25166426|NCT04090775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715630|NCT01537770|Lidocaine|lidocaine|mesh-list
24501072|NCT00526617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24501073|NCT00526617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501105|NCT00526760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24501106|NCT00526760|Analgesics|analgesics|mesh-ancestor
24501107|NCT00526760|Sensory System Agents|sensory system agents|mesh-ancestor
24501108|NCT00526760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24501140|NCT00527033|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25661980|NCT01640340|Dexamethasone|dexamethasone|mesh-list
25661981|NCT01640340|Ondansetron|ondansetron|mesh-list
25661982|NCT01640340|Aprepitant|aprepitant|mesh-list
25661983|NCT01640340|Palonosetron|palonosetron|mesh-list
25661984|NCT01640340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25661985|NCT01640340|Antiemetics|antiemetics|mesh-ancestor
25661986|NCT01640340|Autonomic Agents|autonomic agents|mesh-ancestor
25661987|NCT01640340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25661988|NCT01640340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876113|NCT03907488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24846703|NCT02243553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24501141|NCT00527033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24501142|NCT00527033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24501143|NCT00527033|Adrenergic Agents|adrenergic agents|mesh-ancestor
24501144|NCT00527033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24501145|NCT00527033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501146|NCT00527033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501147|NCT00527033|Urological Agents|urological agents|mesh-ancestor
24501149|NCT00527059|Spironolactone|spironolactone|mesh-list
24501150|NCT00527059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24501151|NCT00527059|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24501152|NCT00527059|Hormone Antagonists|hormone antagonists|mesh-ancestor
24501192|NCT00527202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24501193|NCT00527202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24501194|NCT00527215|Darbepoetin alfa|darbepoetin alfa|mesh-list
24501196|NCT00527228|Deflazacort|deflazacort|mesh-list
24501197|NCT00527228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24501198|NCT00527228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24501199|NCT00527228|Immunologic Factors|immunologic factors|mesh-ancestor
24501200|NCT00527228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623059|NCT01070030|Amlodipine|amlodipine|mesh-list
24810399|NCT02039999|Citric Acid|citric acid|mesh-list
24810400|NCT02039999|Sodium Citrate|sodium citrate|mesh-list
24810401|NCT02039999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24810402|NCT02039999|Anticoagulants|anticoagulants|mesh-ancestor
24810403|NCT02039999|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24810404|NCT02039999|Chelating Agents|chelating agents|mesh-ancestor
24501234|NCT00527540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501235|NCT00527540|Immunologic Factors|immunologic factors|mesh-ancestor
24501236|NCT00527540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501238|NCT00527657|Temozolomide|temozolomide|mesh-list
24501239|NCT00527657|Lomustine|lomustine|mesh-list
24501240|NCT00527657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24501241|NCT00527657|Alkylating Agents|alkylating agents|mesh-ancestor
25849037|NCT00047203|Alvocidib|alvocidib|mesh-list
24501291|NCT00527800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25849038|NCT00047203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501292|NCT00527930|Oxaliplatin|oxaliplatin|mesh-list
24501293|NCT00527930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501294|NCT00527995|Sildenafil Citrate|sildenafil citrate|mesh-list
24501295|NCT00527995|Vasodilator Agents|vasodilator agents|mesh-ancestor
24501296|NCT00527995|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24501317|NCT00528060|Protease Inhibitors|protease inhibitors|mesh-ancestor
24501318|NCT00528060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501319|NCT00528060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501320|NCT00528060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24501321|NCT00528060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24501322|NCT00528060|Antiviral Agents|antiviral agents|mesh-ancestor
24501323|NCT00528060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24501324|NCT00528060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24501325|NCT00528060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24501326|NCT00528060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24501327|NCT00528060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24501328|NCT00528073|Rifaximin|rifaximin|mesh-list
24501329|NCT00528073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24501330|NCT00528073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24501331|NCT00528073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24501332|NCT00528151|Curcumin|curcumin|mesh-list
24501333|NCT00528151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24501334|NCT00528151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24810405|NCT02039999|Sequestering Agents|sequestering agents|mesh-ancestor
24810406|NCT02039999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810407|NCT02040064|Gefitinib|gefitinib|mesh-list
24810408|NCT02040064|Tremelimumab|tremelimumab|mesh-list
24810409|NCT02040064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810410|NCT02040064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24501460|NCT00528658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501461|NCT00528658|Antipyretics|antipyretics|mesh-ancestor
24501462|NCT00528671|Phenprocoumon|phenprocoumon|mesh-list
24501551|NCT00529425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25661989|NCT01640340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24501552|NCT00529425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501656|NCT00530387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25661990|NCT01640340|Glucocorticoids|glucocorticoids|mesh-ancestor
24501658|NCT00530387|Analgesics|analgesics|mesh-ancestor
25166427|NCT04090775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24785476|NCT01914627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24501659|NCT00530387|Sensory System Agents|sensory system agents|mesh-ancestor
24501660|NCT00530387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24501661|NCT00530387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810418|NCT02040142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810419|NCT02040142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24810420|NCT02040142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501682|NCT00530413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24501727|NCT00530595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24501728|NCT00530868|Bevacizumab|bevacizumab|mesh-list
25849039|NCT00047203|Growth Inhibitors|growth inhibitors|mesh-ancestor
24501793|NCT00531089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501794|NCT00531089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24501989|NCT00531908|Furosemide|furosemide|mesh-list
24502004|NCT00531973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502006|NCT00531986|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24502007|NCT00531986|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24443505|NCT00295308|Analgesics|analgesics|mesh-ancestor
24502554|NCT04836910|Metformin|metformin|mesh-list
24502555|NCT04836910|Contraceptive Agents|contraceptive agents|mesh-list
24502556|NCT04836910|Contraceptives, Oral|contraceptives, oral|mesh-list
24502557|NCT04836910|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
24502558|NCT04836910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24810455|NCT02040350|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
24810456|NCT02040350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810457|NCT02040350|Cholinergic Agents|cholinergic agents|mesh-ancestor
24810458|NCT02040350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24502559|NCT04836910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502560|NCT04836910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24502561|NCT04836910|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24502650|NCT04724044|Moxifloxacin|moxifloxacin|mesh-list
24502651|NCT04724044|Clarithromycin|clarithromycin|mesh-list
24502712|NCT04630886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24502713|NCT04630886|Respiratory System Agents|respiratory system agents|mesh-ancestor
25166428|NCT04090775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24502714|NCT04630886|Mydriatics|mydriatics|mesh-ancestor
24502715|NCT04630886|Sympathomimetics|sympathomimetics|mesh-ancestor
24502716|NCT04630886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24852338|NCT02262156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24852340|NCT02262156|Serotonin Agents|serotonin agents|mesh-ancestor
24502717|NCT04630886|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24502718|NCT04630886|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25849040|NCT00047203|Growth Substances|growth substances|mesh-ancestor
24718285|NCT01553500|Cathartics|cathartics|mesh-ancestor
24810467|NCT02040415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24502878|NCT04107675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502879|NCT04107675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24810483|NCT02040441|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24810484|NCT02040441|Diuretics|diuretics|mesh-ancestor
24502891|NCT04067726|Cholecalciferol|cholecalciferol|mesh-list
24502892|NCT04067726|Denosumab|denosumab|mesh-list
24502893|NCT04067726|Calcium|calcium|mesh-list
24502894|NCT04067726|Vitamins|vitamins|mesh-ancestor
24502895|NCT04067726|Micronutrients|micronutrients|mesh-ancestor
24502896|NCT04067726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502897|NCT04067726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24502898|NCT04067726|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24502899|NCT04049799|Analgesics, Opioid|analgesics, opioid|mesh-list
24502900|NCT04049799|Narcotics|narcotics|mesh-ancestor
24502901|NCT04049799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24502906|NCT04049084|Adenosine|adenosine|mesh-list
24502907|NCT04049084|Analgesics|analgesics|mesh-ancestor
24502908|NCT04049084|Sensory System Agents|sensory system agents|mesh-ancestor
24502909|NCT04049084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24502931|NCT04020172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24502932|NCT04020172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136086|NCT02995096|Sirolimus|sirolimus|mesh-list
25166429|NCT04090775|Alkylating Agents|alkylating agents|mesh-ancestor
25203441|NCT02714231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503141|NCT03153150|Protease Inhibitors|protease inhibitors|mesh-ancestor
24503142|NCT03153150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503143|NCT03153150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503146|NCT03126331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24503193|NCT02843230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24503196|NCT02843230|Growth Inhibitors|growth inhibitors|mesh-ancestor
24503197|NCT02843230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24503198|NCT02843230|Alkylating Agents|alkylating agents|mesh-ancestor
24503233|NCT02503839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24503236|NCT02503839|Sensory System Agents|sensory system agents|mesh-ancestor
25849041|NCT00047203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849042|NCT00047203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24503354|NCT01840566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24503355|NCT01840566|Alkylating Agents|alkylating agents|mesh-ancestor
25166430|NCT04090775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503356|NCT01840566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24503358|NCT01824537|Immunologic Factors|immunologic factors|mesh-ancestor
24503359|NCT01824537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503361|NCT01730937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503362|NCT01730937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24503363|NCT01730937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503364|NCT01730937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503366|NCT01655225|Letrozole|letrozole|mesh-list
24503367|NCT01655225|Fulvestrant|fulvestrant|mesh-list
24503368|NCT01655225|Midazolam|midazolam|mesh-list
24503369|NCT01655225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503370|NCT01655225|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24810547|NCT02040818|Tigecycline|tigecycline|mesh-list
24810548|NCT02040818|Heparin|heparin|mesh-list
24810549|NCT02040818|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24810550|NCT02040818|Anticoagulants|anticoagulants|mesh-ancestor
24810551|NCT02040818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24810552|NCT02040818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24859018|NCT02301091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503371|NCT01655225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24503372|NCT01655225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24720316|NCT01567657|Anesthetics|anesthetics|mesh-ancestor
24503373|NCT01655225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503374|NCT01655225|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25849043|NCT00047203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849044|NCT00047203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849045|NCT00047216|Tipifarnib|tipifarnib|mesh-list
24810556|NCT02040818|Expectorants|expectorants|mesh-ancestor
24810557|NCT02040818|Respiratory System Agents|respiratory system agents|mesh-ancestor
24810558|NCT02040818|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24503515|NCT00532142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503516|NCT00532168|Ritonavir|ritonavir|mesh-list
24503517|NCT00532168|Lopinavir|lopinavir|mesh-list
24503519|NCT00532168|Tenofovir|tenofovir|mesh-list
24503520|NCT00532168|Emtricitabine|emtricitabine|mesh-list
24503521|NCT00532168|Efavirenz|efavirenz|mesh-list
24503522|NCT00532168|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24503523|NCT00532168|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24503525|NCT00532168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503688|NCT00532623|Immunologic Factors|immunologic factors|mesh-ancestor
24503689|NCT00532623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503748|NCT00532714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24503749|NCT00532714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503750|NCT00532727|Carboplatin|carboplatin|mesh-list
24721013|NCT01571882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24503753|NCT00532727|Tubulin Modulators|tubulin modulators|mesh-ancestor
24503754|NCT00532727|Antimitotic Agents|antimitotic agents|mesh-ancestor
24503755|NCT00532727|Mitosis Modulators|mitosis modulators|mesh-ancestor
24503756|NCT00532727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503757|NCT00532818|Hydralazine|hydralazine|mesh-list
24503758|NCT00532818|Valproic Acid|valproic acid|mesh-list
24503759|NCT00532818|Anticonvulsants|anticonvulsants|mesh-ancestor
24503760|NCT00532818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25661991|NCT01640340|Hormones|hormones|mesh-ancestor
24810602|NCT02040909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25661992|NCT01640340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25661993|NCT01640340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25661994|NCT01640340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25661995|NCT01640340|Antipruritics|antipruritics|mesh-ancestor
25661996|NCT01640340|Dermatologic Agents|dermatologic agents|mesh-ancestor
25661997|NCT01640340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25661998|NCT01640340|Serotonin Agents|serotonin agents|mesh-ancestor
25661999|NCT01640340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24810603|NCT02040909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810606|NCT02040909|Anesthetics|anesthetics|mesh-ancestor
24810607|NCT02040935|Trastuzumab|trastuzumab|mesh-list
24810608|NCT02040935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24810609|NCT02040935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810610|NCT02040987|Moxifloxacin|moxifloxacin|mesh-list
24503855|NCT00533195|5-Methoxypsoralen|5-methoxypsoralen|mesh-list
24503856|NCT00533195|Methoxsalen|methoxsalen|mesh-list
24503857|NCT00533195|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24503858|NCT00533195|Dermatologic Agents|dermatologic agents|mesh-ancestor
25849046|NCT00047216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503859|NCT00533195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24503860|NCT00533247|Celecoxib|celecoxib|mesh-list
24503880|NCT00533299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849047|NCT00047229|Doxorubicin|doxorubicin|mesh-list
25849048|NCT00047229|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25849049|NCT00047229|Oblimersen|oblimersen|mesh-list
25849050|NCT00047229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25849051|NCT00047229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849052|NCT00047229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25849053|NCT00047229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25849054|NCT00047229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849055|NCT00047229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849056|NCT00047242|Irinotecan|irinotecan|mesh-list
24503926|NCT00533455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24503927|NCT00533455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24503928|NCT00533455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24503929|NCT00533455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24503930|NCT00533455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849057|NCT00047242|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
24503931|NCT00533455|Antimanic Agents|antimanic agents|mesh-ancestor
24503932|NCT00533468|Lidocaine|lidocaine|mesh-list
24503933|NCT00533468|Anesthetics, Local|anesthetics, local|mesh-ancestor
25849058|NCT00047242|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24503934|NCT00533468|Anesthetics|anesthetics|mesh-ancestor
24503992|NCT00533624|Antitubercular Agents|antitubercular agents|mesh-ancestor
24503993|NCT00533624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24503994|NCT00533624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24503995|NCT00533624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503996|NCT00533624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504003|NCT00533637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24504004|NCT00533637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504005|NCT00533637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849059|NCT00047242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25849060|NCT00047242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849061|NCT00047242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849062|NCT00047242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849063|NCT00047242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25849064|NCT00047255|Carboplatin|carboplatin|mesh-list
25849065|NCT00047255|Docetaxel|docetaxel|mesh-list
25849066|NCT00047255|Trastuzumab|trastuzumab|mesh-list
25849067|NCT00047255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849068|NCT00047255|Tubulin Modulators|tubulin modulators|mesh-ancestor
25849069|NCT00047255|Antimitotic Agents|antimitotic agents|mesh-ancestor
25849070|NCT00047255|Mitosis Modulators|mitosis modulators|mesh-ancestor
25849071|NCT00047255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849072|NCT00047255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25849073|NCT00047268|Cytarabine|cytarabine|mesh-list
25849074|NCT00047268|Mercaptopurine|mercaptopurine|mesh-list
25136350|NCT02991768|Hormones|hormones|mesh-ancestor
24810622|NCT02041117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810623|NCT02041117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24810624|NCT02041117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25662000|NCT01640340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662001|NCT01640340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25662002|NCT01640340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25662003|NCT01640340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25662004|NCT01640340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25662005|NCT01640340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25662006|NCT01640340|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25662007|NCT01640340|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25674353|NCT01770483|Interferon-alpha|interferon-alpha|mesh-list
25674354|NCT01770483|Nitazoxanide|nitazoxanide|mesh-list
24810630|NCT02041273|Palbociclib|palbociclib|mesh-list
24810631|NCT02041273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810632|NCT02041273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24810633|NCT02041273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849075|NCT00047268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24504126|NCT00534261|Interferon-beta|interferon-beta|mesh-list
24504127|NCT00534261|Interferon beta-1a|interferon beta-1a|mesh-list
24504128|NCT00534261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504129|NCT00534261|Antiviral Agents|antiviral agents|mesh-ancestor
24504130|NCT00534261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24504131|NCT00534261|Immunologic Factors|immunologic factors|mesh-ancestor
24504132|NCT00534261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504133|NCT00534261|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24504134|NCT00534287|Moxifloxacin|moxifloxacin|mesh-list
24504136|NCT00534287|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24504137|NCT00534287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24504138|NCT00534287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24504139|NCT00534287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24504160|NCT00534378|Anesthetics, General|anesthetics, general|mesh-ancestor
24504161|NCT00534378|Anesthetics|anesthetics|mesh-ancestor
24504162|NCT00534378|GABA Modulators|gaba modulators|mesh-ancestor
24504163|NCT00534378|GABA Agents|gaba agents|mesh-ancestor
24504164|NCT00534378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25006384|NCT05123365|Acetylcysteine|acetylcysteine|mesh-list
24504165|NCT00534378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504168|NCT00534391|Polymyxin B|polymyxin b|mesh-list
24504169|NCT00534391|Gramicidin|gramicidin|mesh-list
24504170|NCT00534391|Lubricant Eye Drops|lubricant eye drops|mesh-list
24504171|NCT00534391|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24504172|NCT00534391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24504173|NCT00534391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24504174|NCT00534391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24504178|NCT00534391|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24504180|NCT00534456|Hematinics|hematinics|mesh-ancestor
24504183|NCT00534508|Immunologic Factors|immunologic factors|mesh-ancestor
24504184|NCT00534508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504185|NCT00534508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24504186|NCT00534508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504187|NCT00534508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504188|NCT00534573|Amisulpride|amisulpride|mesh-list
24504189|NCT00534573|Moclobemide|moclobemide|mesh-list
24504190|NCT00534573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24504191|NCT00534573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24504192|NCT00534573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24504202|NCT00534573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504203|NCT00534586|Ketamine|ketamine|mesh-list
24504204|NCT00534586|Remifentanil|remifentanil|mesh-list
24504205|NCT00534586|Propofol|propofol|mesh-list
24504206|NCT00534586|Sevoflurane|sevoflurane|mesh-list
24504207|NCT00534586|Esketamine|esketamine|mesh-list
24810647|NCT02041338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24810648|NCT02041338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24810650|NCT02041351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810651|NCT02041351|Tubulin Modulators|tubulin modulators|mesh-ancestor
24810652|NCT02041351|Antimitotic Agents|antimitotic agents|mesh-ancestor
24810653|NCT02041351|Mitosis Modulators|mitosis modulators|mesh-ancestor
24810654|NCT02041351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810655|NCT02041455|Amitriptyline|amitriptyline|mesh-list
24810657|NCT02041455|Antioxidants|antioxidants|mesh-ancestor
24810658|NCT02041455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810659|NCT02041455|Protective Agents|protective agents|mesh-ancestor
24810660|NCT02041455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662008|NCT01640834|Glucagon|glucagon|mesh-list
25662009|NCT01640834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25662010|NCT01640834|Hormones|hormones|mesh-ancestor
24810661|NCT02041455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24810662|NCT02041455|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24810663|NCT02041455|Antidepressive Agents|antidepressive agents|mesh-ancestor
25181786|NCT04782700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25662011|NCT01640834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24504208|NCT00534586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24504209|NCT00534586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24504210|NCT00534586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504211|NCT00534586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24504212|NCT00534586|Anesthetics, General|anesthetics, general|mesh-ancestor
24504214|NCT00534586|Analgesics|analgesics|mesh-ancestor
24504215|NCT00534586|Sensory System Agents|sensory system agents|mesh-ancestor
24504216|NCT00534586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24504217|NCT00534586|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24504218|NCT00534586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24504219|NCT00534586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25849076|NCT00047268|Antimetabolites|antimetabolites|mesh-ancestor
25849077|NCT00047268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849078|NCT00047268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849079|NCT00047268|Antiviral Agents|antiviral agents|mesh-ancestor
25849080|NCT00047268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25849081|NCT00047268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25849082|NCT00047268|Immunologic Factors|immunologic factors|mesh-ancestor
25849083|NCT00047268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849084|NCT00047268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24504230|NCT00534625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24504231|NCT00534625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24504232|NCT00534625|Analgesics|analgesics|mesh-ancestor
24504233|NCT00534625|Sensory System Agents|sensory system agents|mesh-ancestor
24504234|NCT00534625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24504235|NCT00534625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504236|NCT00534625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24504237|NCT00534625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25849085|NCT00047268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849086|NCT00047281|Thalidomide|thalidomide|mesh-list
25849087|NCT00047281|Celecoxib|celecoxib|mesh-list
24504250|NCT00534651|Sensory System Agents|sensory system agents|mesh-ancestor
24504251|NCT00534651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24504252|NCT00534651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504253|NCT00534651|Antipyretics|antipyretics|mesh-ancestor
24504254|NCT00534677|Octreotide|octreotide|mesh-list
24504255|NCT00534677|Terlipressin|terlipressin|mesh-list
24504256|NCT00534677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24504257|NCT00534677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24504258|NCT00534677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504259|NCT00534677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24504260|NCT00534677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24504261|NCT00534729|Carboplatin|carboplatin|mesh-list
24504262|NCT00534729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504263|NCT00534807|Rifampin|rifampin|mesh-list
24723186|NCT01585753|Maraviroc|maraviroc|mesh-list
24504264|NCT00534807|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24504265|NCT00534807|Antitubercular Agents|antitubercular agents|mesh-ancestor
24504266|NCT00534807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24504267|NCT00534807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24504268|NCT00534807|Leprostatic Agents|leprostatic agents|mesh-ancestor
24504269|NCT00534807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24504295|NCT00535080|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24504296|NCT00535080|Dermatologic Agents|dermatologic agents|mesh-ancestor
24504298|NCT00535119|Carboplatin|carboplatin|mesh-list
24504299|NCT00535119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24504300|NCT00535119|Veliparib|veliparib|mesh-list
24504301|NCT00535119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24504302|NCT00535119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504303|NCT00535119|Tubulin Modulators|tubulin modulators|mesh-ancestor
24504304|NCT00535119|Antimitotic Agents|antimitotic agents|mesh-ancestor
24504305|NCT00535119|Mitosis Modulators|mitosis modulators|mesh-ancestor
24504306|NCT00535119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849088|NCT00047281|Cyclophosphamide|cyclophosphamide|mesh-list
24504332|NCT00535379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504333|NCT00535379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25849089|NCT00047281|Etoposide|etoposide|mesh-list
25849090|NCT00047281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25849091|NCT00047281|Immunologic Factors|immunologic factors|mesh-ancestor
24536511|NCT00651547|Hormones|hormones|mesh-ancestor
25849092|NCT00047281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849093|NCT00047281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25849094|NCT00047281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25849095|NCT00047281|Alkylating Agents|alkylating agents|mesh-ancestor
25849096|NCT00047281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876114|NCT03907488|Nivolumab|nivolumab|mesh-list
24504363|NCT00535509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504364|NCT00535509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25849097|NCT00047281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24536549|NCT00651612|Adrenergic Agents|adrenergic agents|mesh-ancestor
24504389|NCT00535808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504390|NCT00535860|Teriparatide|teriparatide|mesh-list
24504391|NCT00535860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24504392|NCT00535860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504393|NCT00535860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24504394|NCT00535951|Panobinostat|panobinostat|mesh-list
24504395|NCT00535951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504396|NCT00535951|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24504397|NCT00535951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504398|NCT00535951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504399|NCT00536003|Progesterone|progesterone|mesh-list
25849098|NCT00047281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24810684|NCT02041481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810685|NCT02041481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24810686|NCT02041481|Immunologic Factors|immunologic factors|mesh-ancestor
24504403|NCT00536003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504404|NCT00536042|Minocycline|minocycline|mesh-list
24504405|NCT00536042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24504406|NCT00536042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24504407|NCT00536068|Acetaminophen|acetaminophen|mesh-list
24504408|NCT00536068|Aspirin|aspirin|mesh-list
24504409|NCT00536068|Diclofenac|diclofenac|mesh-list
24504410|NCT00536068|Naproxen|naproxen|mesh-list
24504411|NCT00536068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24504412|NCT00536068|Analgesics|analgesics|mesh-ancestor
24504413|NCT00536068|Sensory System Agents|sensory system agents|mesh-ancestor
24504414|NCT00536068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24504415|NCT00536068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504416|NCT00536068|Antipyretics|antipyretics|mesh-ancestor
24504417|NCT00536068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24504418|NCT00536068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24504419|NCT00536068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24504420|NCT00536068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24504421|NCT00536068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504422|NCT00536068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504423|NCT00536068|Gout Suppressants|gout suppressants|mesh-ancestor
24852445|NCT02262546|Dopamine Agents|dopamine agents|mesh-ancestor
24504424|NCT00536068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24504425|NCT00536068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24504426|NCT00536068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24504427|NCT00536211|Metformin|metformin|mesh-list
24504428|NCT00536211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24504429|NCT00536211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849099|NCT00047281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25849100|NCT00047281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25849101|NCT00047281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25849102|NCT00047281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849103|NCT00047281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25849104|NCT00047281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25849105|NCT00047281|Analgesics|analgesics|mesh-ancestor
25849106|NCT00047281|Sensory System Agents|sensory system agents|mesh-ancestor
25849107|NCT00047281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25849108|NCT00047281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25849109|NCT00047281|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25849110|NCT00047281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25849111|NCT00047281|Leprostatic Agents|leprostatic agents|mesh-ancestor
25849112|NCT00047281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25849113|NCT00047281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25849114|NCT00047281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25849115|NCT00047281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25849116|NCT00047281|Growth Substances|growth substances|mesh-ancestor
25849117|NCT00047281|Growth Inhibitors|growth inhibitors|mesh-ancestor
25849118|NCT00047294|Thalidomide|thalidomide|mesh-list
24504478|NCT00536640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504479|NCT00536640|Growth Inhibitors|growth inhibitors|mesh-ancestor
24810701|NCT02041650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24810702|NCT02041650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810703|NCT02041650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810704|NCT02041767|Ertapenem|ertapenem|mesh-list
24810705|NCT02041767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24810706|NCT02041767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24607569|NCT04420299|Bemiparin|bemiparin|mesh-list
24504480|NCT00536640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24504481|NCT00536640|Antimetabolites|antimetabolites|mesh-ancestor
24504482|NCT00536640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504483|NCT00536640|Antiviral Agents|antiviral agents|mesh-ancestor
24504484|NCT00536640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24504485|NCT00536640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504486|NCT00536640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24504487|NCT00536640|Immunologic Factors|immunologic factors|mesh-ancestor
24504488|NCT00536640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24504489|NCT00536653|Calcium, Dietary|calcium, dietary|mesh-list
24504537|NCT00536770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24504538|NCT00536770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504539|NCT00536770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25849119|NCT00047294|Celecoxib|celecoxib|mesh-list
25849120|NCT00047294|Temozolomide|temozolomide|mesh-list
25849121|NCT00047294|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24504543|NCT00536770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24504579|NCT00537121|Calcium|calcium|mesh-list
24504580|NCT00537121|Levoleucovorin|levoleucovorin|mesh-list
24504581|NCT00537121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24504582|NCT00537121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504583|NCT00537121|Antimetabolites|antimetabolites|mesh-ancestor
24504584|NCT00537121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504585|NCT00537121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24504586|NCT00537121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504587|NCT00537121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24504588|NCT00537121|Immunologic Factors|immunologic factors|mesh-ancestor
24504589|NCT00537121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24504590|NCT00537121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24504591|NCT00537121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849122|NCT00047294|Alkylating Agents|alkylating agents|mesh-ancestor
25849123|NCT00047294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849124|NCT00047294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849125|NCT00047294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25849126|NCT00047294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25849127|NCT00047294|Analgesics|analgesics|mesh-ancestor
25849128|NCT00047294|Sensory System Agents|sensory system agents|mesh-ancestor
25849129|NCT00047294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25849130|NCT00047294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849131|NCT00047294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25849132|NCT00047294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25849133|NCT00047294|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25849134|NCT00047294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25849135|NCT00047294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849136|NCT00047294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25849137|NCT00047294|Immunologic Factors|immunologic factors|mesh-ancestor
25849138|NCT00047294|Leprostatic Agents|leprostatic agents|mesh-ancestor
25849139|NCT00047294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24536705|NCT00652119|Paclitaxel|paclitaxel|mesh-list
25849140|NCT00047294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25849141|NCT00047294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25849142|NCT00047294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25849143|NCT00047294|Growth Substances|growth substances|mesh-ancestor
25849144|NCT00047294|Growth Inhibitors|growth inhibitors|mesh-ancestor
25849145|NCT00047307|Gemcitabine|gemcitabine|mesh-list
25849146|NCT00047307|Alvocidib|alvocidib|mesh-list
25849147|NCT00047307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25849148|NCT00047307|Antimetabolites|antimetabolites|mesh-ancestor
25849149|NCT00047307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849150|NCT00047307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849151|NCT00047307|Antiviral Agents|antiviral agents|mesh-ancestor
25849152|NCT00047307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25849153|NCT00047307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849154|NCT00047307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24504724|NCT00537953|Miltefosine|miltefosine|mesh-list
25849155|NCT00047307|Immunologic Factors|immunologic factors|mesh-ancestor
25849156|NCT00047307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849157|NCT00047307|Growth Inhibitors|growth inhibitors|mesh-ancestor
25849158|NCT00047307|Growth Substances|growth substances|mesh-ancestor
25849159|NCT00047307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25849160|NCT00047333|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25849161|NCT00047333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504756|NCT00537966|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24504757|NCT00538005|Bevacizumab|bevacizumab|mesh-list
24810736|NCT02042326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810737|NCT02042326|Antifungal Agents|antifungal agents|mesh-ancestor
24810738|NCT02042326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24810739|NCT02042326|Immunologic Factors|immunologic factors|mesh-ancestor
24536819|NCT00652639|Anticonvulsants|anticonvulsants|mesh-ancestor
24504784|NCT00538070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504785|NCT00538070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849162|NCT00047333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25849163|NCT00047333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849164|NCT00047333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849165|NCT00047346|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25166432|NCT04090775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25849166|NCT00047346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504805|NCT00538187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504807|NCT00538239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24504829|NCT00538265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24504831|NCT00538317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24504832|NCT00538317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24810777|NCT02042482|Coenzyme Q10|coenzyme q10|mesh-list
24810778|NCT02042482|Micronutrients|micronutrients|mesh-ancestor
24810779|NCT02042482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849167|NCT00047346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25849168|NCT00047346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849169|NCT00047346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849170|NCT00047450|Citalopram|citalopram|mesh-list
24504833|NCT00538317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504834|NCT00538317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24504835|NCT00538330|Tamoxifen|tamoxifen|mesh-list
24504836|NCT00538330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25849171|NCT00047450|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25849172|NCT00047450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25849173|NCT00047450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25849174|NCT00047450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504861|NCT00538395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24504862|NCT00538395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24504863|NCT00538395|Alkylating Agents|alkylating agents|mesh-ancestor
24504864|NCT00538395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504865|NCT00538395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504866|NCT00538395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24504867|NCT00538395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24504868|NCT00538395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24504869|NCT00538395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24504870|NCT00538395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504871|NCT00538421|Propofol|propofol|mesh-list
24504872|NCT00538421|Sevoflurane|sevoflurane|mesh-list
24504873|NCT00538421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24724256|NCT01592032|Vancomycin|vancomycin|mesh-list
24504874|NCT00538421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24504875|NCT00538421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504876|NCT00538421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24810781|NCT02042495|Metformin|metformin|mesh-list
24504891|NCT00538486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504892|NCT00538486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24504893|NCT00538486|Vasodilator Agents|vasodilator agents|mesh-ancestor
24504894|NCT00538486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24504895|NCT00538486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24504896|NCT00538499|Fentanyl|fentanyl|mesh-list
24504897|NCT00538499|Bupivacaine|bupivacaine|mesh-list
24504898|NCT00538499|Anesthetics, Local|anesthetics, local|mesh-ancestor
24504899|NCT00538499|Anesthetics|anesthetics|mesh-ancestor
24810822|NCT02042690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24504900|NCT00538499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24504901|NCT00538499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504902|NCT00538499|Sensory System Agents|sensory system agents|mesh-ancestor
24504903|NCT00538499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24504965|NCT00538720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25849175|NCT00047450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24504968|NCT00538811|Interferon-alpha|interferon-alpha|mesh-list
24504969|NCT00538811|Interferon alpha-2|interferon alpha-2|mesh-list
24504970|NCT00538811|Interferon-gamma|interferon-gamma|mesh-list
24504971|NCT00538811|Amantadine|amantadine|mesh-list
24504972|NCT00538811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504973|NCT00538811|Antiviral Agents|antiviral agents|mesh-ancestor
24504974|NCT00538811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24504975|NCT00538811|Antimetabolites|antimetabolites|mesh-ancestor
24504976|NCT00538811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504977|NCT00538811|Immunologic Factors|immunologic factors|mesh-ancestor
24504978|NCT00538811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849176|NCT00047450|Serotonin Agents|serotonin agents|mesh-ancestor
25849177|NCT00047450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849178|NCT00047450|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25849179|NCT00047450|Antidepressive Agents|antidepressive agents|mesh-ancestor
25849180|NCT00047450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25849181|NCT00047476|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
25849182|NCT00047476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25849183|NCT00047476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849184|NCT00047476|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24505027|NCT00539123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24505028|NCT00539123|Narcotics|narcotics|mesh-ancestor
24505029|NCT00539123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24505030|NCT00539123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505031|NCT00539123|Analgesics|analgesics|mesh-ancestor
24759072|NCT01749150|Lactams|lactams|mesh-list
24759073|NCT01749150|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24759074|NCT01749150|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24759075|NCT01749150|Protease Inhibitors|protease inhibitors|mesh-ancestor
24759076|NCT01749150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759077|NCT01749150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759078|NCT01749150|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24759079|NCT01749150|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24759080|NCT01749150|Antiviral Agents|antiviral agents|mesh-ancestor
24759081|NCT01749150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24759082|NCT01749150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24759083|NCT01749150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24759084|NCT01749150|Antimetabolites|antimetabolites|mesh-ancestor
24759085|NCT01749150|Immunologic Factors|immunologic factors|mesh-ancestor
24759086|NCT01749150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759121|NCT01749371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759122|NCT01749371|Protective Agents|protective agents|mesh-ancestor
24759124|NCT01749384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24759125|NCT01749384|Endothelial Growth Factors|endothelial growth factors|mesh-list
24810799|NCT02042599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24810800|NCT02042599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810801|NCT02042612|Sevoflurane|sevoflurane|mesh-list
24810802|NCT02042612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24810803|NCT02042612|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24759126|NCT01749384|Antibodies|antibodies|mesh-list
24759127|NCT01749384|Immunoglobulins|immunoglobulins|mesh-list
24759157|NCT01749423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24759243|NCT01750099|Analgesics|analgesics|mesh-ancestor
24759244|NCT01750099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24759245|NCT01750099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24759246|NCT01750099|Anesthetics, General|anesthetics, general|mesh-ancestor
24759247|NCT01750099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24759248|NCT01750099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24759249|NCT01750099|Adrenergic Agents|adrenergic agents|mesh-ancestor
24759250|NCT01750099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24759251|NCT01750099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24759252|NCT01750099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24810807|NCT02042612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810809|NCT02042638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24620096|NCT01055405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24759276|NCT01750437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24759277|NCT01750437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25006505|NCT04949022|Insulin|insulin|mesh-list
24759278|NCT01750437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24810821|NCT02042690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759281|NCT01750463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24759282|NCT01750463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24759283|NCT01750463|Analgesics|analgesics|mesh-ancestor
24759284|NCT01750463|Sensory System Agents|sensory system agents|mesh-ancestor
24759285|NCT01750463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24759286|NCT01750463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759287|NCT01750463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24759288|NCT01750463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24960225|NCT03818919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759289|NCT01750476|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24759290|NCT01750476|Medroxyprogesterone|medroxyprogesterone|mesh-list
24759291|NCT01750476|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24759292|NCT01750476|Contraceptive Agents|contraceptive agents|mesh-ancestor
24759293|NCT01750476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24759294|NCT01750476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759295|NCT01750476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24759296|NCT01750476|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24759297|NCT01750476|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24759317|NCT01750541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759318|NCT01750541|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24759337|NCT01750723|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24759338|NCT01750723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759339|NCT01750723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759340|NCT01750723|Diuretics|diuretics|mesh-ancestor
24759341|NCT01750723|Natriuretic Agents|natriuretic agents|mesh-ancestor
24759342|NCT01750723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759343|NCT01750762|Lenalidomide|lenalidomide|mesh-list
24759344|NCT01750762|Immunologic Factors|immunologic factors|mesh-ancestor
24759345|NCT01750762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759346|NCT01750762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24759347|NCT01750762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24759348|NCT01750762|Growth Substances|growth substances|mesh-ancestor
24759349|NCT01750762|Growth Inhibitors|growth inhibitors|mesh-ancestor
24550014|NCT00718601|Imetelstat|imetelstat|mesh-list
24759350|NCT01750762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810810|NCT02042638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810811|NCT02042664|Metformin|metformin|mesh-list
24810813|NCT02042664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810815|NCT02042690|Cyclophosphamide|cyclophosphamide|mesh-list
24810816|NCT02042690|Methotrexate|methotrexate|mesh-list
24810817|NCT02042690|Epirubicin|epirubicin|mesh-list
24810818|NCT02042690|Mercaptopurine|mercaptopurine|mesh-list
24810819|NCT02042690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24608558|NCT00992537|Insulin, Long-Acting|insulin, long-acting|mesh-list
24608559|NCT00992537|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24608560|NCT00992537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24759351|NCT01750788|Rivaroxaban|rivaroxaban|mesh-list
24759352|NCT01750788|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24759353|NCT01750788|Antithrombins|antithrombins|mesh-ancestor
24759354|NCT01750788|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24759355|NCT01750788|Protease Inhibitors|protease inhibitors|mesh-ancestor
24759356|NCT01750788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759409|NCT01751204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24759410|NCT01751204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759411|NCT01751204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24759413|NCT01751269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759414|NCT01751269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759415|NCT01751269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24759416|NCT01751269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24759417|NCT01751295|Atorvastatin|atorvastatin|mesh-list
24759418|NCT01751295|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24759419|NCT01751295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24759420|NCT01751295|Antimetabolites|antimetabolites|mesh-ancestor
24505089|NCT00539773|Antiviral Agents|antiviral agents|mesh-ancestor
24759427|NCT01751321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759429|NCT01751321|Hormones|hormones|mesh-ancestor
24759430|NCT01751321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24759431|NCT01751321|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24759432|NCT01751321|Protease Inhibitors|protease inhibitors|mesh-ancestor
24759433|NCT01751321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24810820|NCT02042690|Immunologic Factors|immunologic factors|mesh-ancestor
24810825|NCT02042690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166433|NCT04090775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24759532|NCT01752270|Cyproterone Acetate|cyproterone acetate|mesh-list
24759534|NCT01752270|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
24759535|NCT01752270|Androgen Antagonists|androgen antagonists|mesh-ancestor
24759536|NCT01752270|Hormone Antagonists|hormone antagonists|mesh-ancestor
24759537|NCT01752270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24759538|NCT01752270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759539|NCT01752270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759540|NCT01752270|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24759541|NCT01752270|Contraceptive Agents|contraceptive agents|mesh-ancestor
24759542|NCT01752270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24759562|NCT01752517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759563|NCT01752517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24759565|NCT01752543|Conivaptan|conivaptan|mesh-list
24759566|NCT01752543|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24759567|NCT01752543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759568|NCT01752543|Natriuretic Agents|natriuretic agents|mesh-ancestor
24550317|NCT00720265|Tacrolimus|tacrolimus|mesh-list
24759569|NCT01752543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759570|NCT01752686|Carboplatin|carboplatin|mesh-list
24759571|NCT01752686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759572|NCT01752699|Methadone|methadone|mesh-list
24759573|NCT01752699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24759574|NCT01752699|Narcotics|narcotics|mesh-ancestor
24759575|NCT01752699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24759576|NCT01752699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759596|NCT01752959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24759597|NCT01752959|Narcotics|narcotics|mesh-ancestor
24759605|NCT01752959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24759606|NCT01752959|Adrenergic Agents|adrenergic agents|mesh-ancestor
24759607|NCT01752959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24759608|NCT01752959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759609|NCT01752998|Analgesics, Opioid|analgesics, opioid|mesh-list
24759610|NCT01752998|Narcotics|narcotics|mesh-ancestor
24759611|NCT01752998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24759612|NCT01752998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759613|NCT01752998|Analgesics|analgesics|mesh-ancestor
24759614|NCT01752998|Sensory System Agents|sensory system agents|mesh-ancestor
24759615|NCT01752998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24759616|NCT01753037|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24759617|NCT01753037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24759618|NCT01753037|Immunologic Factors|immunologic factors|mesh-ancestor
24759619|NCT01753037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759621|NCT01753102|Estrogens|estrogens|mesh-ancestor
24759622|NCT01753102|Hormones|hormones|mesh-ancestor
24664768|NCT01308606|Antiviral Agents|antiviral agents|mesh-ancestor
24759623|NCT01753102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24759624|NCT01753102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759626|NCT01753128|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24759627|NCT01753128|Antidepressive Agents|antidepressive agents|mesh-ancestor
24759628|NCT01753128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24759629|NCT01753128|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24759630|NCT01753128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24759631|NCT01753128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24759632|NCT01753128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458910|NCT00343096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24459339|NCT00344422|BB 1101|bb 1101|mesh-list
24459340|NCT00344422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24459341|NCT00344422|Antiemetics|antiemetics|mesh-ancestor
24459342|NCT00344422|Autonomic Agents|autonomic agents|mesh-ancestor
24459343|NCT00344422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24459344|NCT00344422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459345|NCT00344422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24461506|NCT00352482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461669|NCT00353041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461671|NCT00353041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24461672|NCT00353041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24461673|NCT00353041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24461674|NCT00353041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24461675|NCT00353041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24461676|NCT00353041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461677|NCT00353054|Calcium Carbonate|calcium carbonate|mesh-list
24461679|NCT00353054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461680|NCT00353054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25409037|NCT03404180|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24461681|NCT00353067|2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid|2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid|mesh-list
24725547|NCT01598259|Antioxidants|antioxidants|mesh-ancestor
24725825|NCT01599936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461682|NCT00353067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24461683|NCT00353067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24461684|NCT00353067|Analgesics|analgesics|mesh-ancestor
24461697|NCT00353080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24461698|NCT00353080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461699|NCT00353080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24461701|NCT00353145|Oxaliplatin|oxaliplatin|mesh-list
24461782|NCT00353691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24461783|NCT00353691|Immunologic Factors|immunologic factors|mesh-ancestor
24810937|NCT02043730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24810938|NCT02043730|Immunologic Factors|immunologic factors|mesh-ancestor
24810939|NCT02043730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461838|NCT00354081|Pyridoxal|pyridoxal|mesh-list
24461839|NCT00354081|Vitamin B 6|vitamin b 6|mesh-list
24461840|NCT00354081|Vitamin B Complex|vitamin b complex|mesh-list
24461841|NCT00354081|Micronutrients|micronutrients|mesh-ancestor
25849185|NCT00047476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25849186|NCT00047476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25849187|NCT00047476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849188|NCT00047476|Dopamine Agents|dopamine agents|mesh-ancestor
25849189|NCT00047476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24461873|NCT00354198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24461876|NCT00354198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24461877|NCT00354198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24461878|NCT00354198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24461879|NCT00354198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461880|NCT00354237|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24461881|NCT00354237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461882|NCT00354276|Cytarabine|cytarabine|mesh-list
24461883|NCT00354276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24461884|NCT00354276|Antimetabolites|antimetabolites|mesh-ancestor
24461992|NCT00354458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461993|NCT00354523|Capecitabine|capecitabine|mesh-list
24461994|NCT00354523|Imatinib Mesylate|imatinib mesylate|mesh-list
24461995|NCT00354523|Dacarbazine|dacarbazine|mesh-list
24461996|NCT00354523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24461997|NCT00354523|Antimetabolites|antimetabolites|mesh-ancestor
24461998|NCT00354523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461999|NCT00354523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24462000|NCT00354523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24462001|NCT00354523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24810961|NCT02043912|Haloperidol|haloperidol|mesh-list
24810962|NCT02043912|Haloperidol decanoate|haloperidol decanoate|mesh-list
24810963|NCT02043912|Antiemetics|antiemetics|mesh-ancestor
24810964|NCT02043912|Autonomic Agents|autonomic agents|mesh-ancestor
24609533|NCT00997087|Flumazenil|flumazenil|mesh-list
24462002|NCT00354523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24462003|NCT00354523|Alkylating Agents|alkylating agents|mesh-ancestor
24462004|NCT00354549|Gemcitabine|gemcitabine|mesh-list
24462005|NCT00354549|Bevacizumab|bevacizumab|mesh-list
24462047|NCT00354692|Ferric gluconate|ferric gluconate|mesh-list
24462048|NCT00354692|Hematinics|hematinics|mesh-ancestor
24462049|NCT00354731|Pentoxifylline|pentoxifylline|mesh-list
24462050|NCT00354731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24537287|NCT00654160|Vitamins|vitamins|mesh-ancestor
24462119|NCT00354965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462120|NCT00354965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462122|NCT00354991|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24462123|NCT00354991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24462124|NCT00354991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25041733|NCT01591447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24462125|NCT00354991|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24462292|NCT00355628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432760|NCT00255996|Linezolid|linezolid|mesh-list
24462294|NCT00355641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24462296|NCT00355641|Dopamine Agonists|dopamine agonists|mesh-ancestor
24462297|NCT00355641|Dopamine Agents|dopamine agents|mesh-ancestor
24462298|NCT00355641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24462331|NCT00355719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24462332|NCT00355719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24462333|NCT00355719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24462396|NCT00355966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24462398|NCT00355966|Oxytocics|oxytocics|mesh-ancestor
24462399|NCT00356005|Azithromycin|azithromycin|mesh-list
24810995|NCT02044133|Vitamin D|vitamin d|mesh-list
24462491|NCT00356460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24462492|NCT00356460|Mitosis Modulators|mitosis modulators|mesh-ancestor
24537416|NCT00654537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537417|NCT00654576|Olanzapine|olanzapine|mesh-list
24616224|NCT01035190|Budesonide|budesonide|mesh-list
24537418|NCT00654576|Chlorpromazine|chlorpromazine|mesh-list
24537419|NCT00654576|Risperidone|risperidone|mesh-list
24537420|NCT00654576|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24537421|NCT00654576|Clozapine|clozapine|mesh-list
24537422|NCT00654576|Sulpiride|sulpiride|mesh-list
24537498|NCT00654914|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24537500|NCT00654914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537501|NCT00654914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537502|NCT00654914|Urological Agents|urological agents|mesh-ancestor
24537503|NCT00655018|Ascorbic Acid|ascorbic acid|mesh-list
24537504|NCT00655018|Tocopherols|tocopherols|mesh-list
24537505|NCT00655018|Vitamin E|vitamin e|mesh-list
24462676|NCT00357240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24462677|NCT00357240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24462678|NCT00357240|Protease Inhibitors|protease inhibitors|mesh-ancestor
24462679|NCT00357240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438247|NCT00275184|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24537524|NCT00655109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24628919|NCT01101893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628920|NCT01101893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628951|NCT01102244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628952|NCT01102244|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24628953|NCT01102244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24628954|NCT01102335|Telbivudine|telbivudine|mesh-list
24628955|NCT01102335|Antiviral Agents|antiviral agents|mesh-ancestor
24628956|NCT01102335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24630582|NCT01112540|Morphine|morphine|mesh-list
24628957|NCT01102335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24629099|NCT01103154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24629102|NCT01103193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24629103|NCT01103193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24629104|NCT01103193|Anesthetics, General|anesthetics, general|mesh-ancestor
24629385|NCT01104896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629387|NCT01104935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24629388|NCT01104935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629389|NCT01104961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24629390|NCT01104987|Alendronate|alendronate|mesh-list
24629391|NCT01104987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24629392|NCT01104987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849190|NCT00047502|Imatinib Mesylate|imatinib mesylate|mesh-list
24629393|NCT01105013|Clotrimazole|clotrimazole|mesh-list
24629428|NCT01105273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629760|NCT01107639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25849191|NCT00047502|Lonafarnib|lonafarnib|mesh-list
24629808|NCT01108029|Dopamine Agents|dopamine agents|mesh-ancestor
24629809|NCT01108029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24629810|NCT01108029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629811|NCT01108029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629812|NCT01108029|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24629813|NCT01108029|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24629815|NCT01108042|Fluorouracil|fluorouracil|mesh-list
24629816|NCT01108042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629817|NCT01108042|Tubulin Modulators|tubulin modulators|mesh-ancestor
24629818|NCT01108042|Antimitotic Agents|antimitotic agents|mesh-ancestor
25166434|NCT04090775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24629819|NCT01108042|Mitosis Modulators|mitosis modulators|mesh-ancestor
24629820|NCT01108042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629840|NCT01108107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25849192|NCT00047502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24811046|NCT02044250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24811048|NCT02044354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24811049|NCT02044354|Tubulin Modulators|tubulin modulators|mesh-ancestor
24811050|NCT02044354|Antimitotic Agents|antimitotic agents|mesh-ancestor
24811051|NCT02044354|Mitosis Modulators|mitosis modulators|mesh-ancestor
25181787|NCT04782700|Glucocorticoids|glucocorticoids|mesh-ancestor
24811052|NCT02044354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811053|NCT02044549|Oxytocin|oxytocin|mesh-list
24811054|NCT02044549|Carbetocin|carbetocin|mesh-list
24629878|NCT01108562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629986|NCT01108926|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24629987|NCT01108926|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24629988|NCT01108926|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24629989|NCT01108926|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24630390|NCT01111448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24630392|NCT01111448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630393|NCT01111513|Analgesics|analgesics|mesh-list
24630394|NCT01111513|Ropivacaine|ropivacaine|mesh-list
24630395|NCT01111513|Anesthetics, Local|anesthetics, local|mesh-ancestor
24630424|NCT01111656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24630425|NCT01111656|Antimetabolites|antimetabolites|mesh-ancestor
24630426|NCT01111656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630427|NCT01111656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24630428|NCT01111656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24630429|NCT01111656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811097|NCT02044952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24811098|NCT02044952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24811099|NCT02044952|Immunologic Factors|immunologic factors|mesh-ancestor
24811100|NCT02044952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24811101|NCT02044952|Alkylating Agents|alkylating agents|mesh-ancestor
24811102|NCT02044952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24811103|NCT02044965|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24811104|NCT02044965|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24630523|NCT01112085|Growth Substances|growth substances|mesh-ancestor
24630524|NCT01112085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630525|NCT01112085|Growth Inhibitors|growth inhibitors|mesh-ancestor
24630526|NCT01112085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630583|NCT01112540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24630584|NCT01112540|Narcotics|narcotics|mesh-ancestor
24537865|NCT00656591|Methotrexate|methotrexate|mesh-list
24630674|NCT01112891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24630702|NCT01113138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24630703|NCT01113138|Tocolytic Agents|tocolytic agents|mesh-ancestor
24630704|NCT01113138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24630705|NCT01113164|Ondansetron|ondansetron|mesh-list
24630706|NCT01113164|Sertraline|sertraline|mesh-list
24630707|NCT01113164|Antiemetics|antiemetics|mesh-ancestor
24630708|NCT01113164|Autonomic Agents|autonomic agents|mesh-ancestor
25849193|NCT00047502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24630751|NCT01113424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630752|NCT01113424|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24630753|NCT01113424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24630754|NCT01113424|Cholinergic Agents|cholinergic agents|mesh-ancestor
24630755|NCT01113424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24630756|NCT01113424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630757|NCT01113437|Omalizumab|omalizumab|mesh-list
24630758|NCT01113437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24630759|NCT01113437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24630760|NCT01113437|Respiratory System Agents|respiratory system agents|mesh-ancestor
24537923|NCT00656773|Sufentanil|sufentanil|mesh-list
24630910|NCT01114854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630911|NCT01114958|Cisplatin|cisplatin|mesh-list
24631081|NCT01116115|Palmitic Acid|palmitic acid|mesh-list
24631082|NCT01116115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631083|NCT01116115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811144|NCT02045030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811146|NCT02045030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24811147|NCT02045056|Gemfibrozil|gemfibrozil|mesh-list
24811148|NCT02045056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24631165|NCT01116219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24631166|NCT01116219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24631168|NCT01116219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24631169|NCT01116219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24631170|NCT01116219|Growth Substances|growth substances|mesh-ancestor
24631171|NCT01116219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631172|NCT01116219|Growth Inhibitors|growth inhibitors|mesh-ancestor
24537991|NCT00657059|Antiemetics|antiemetics|mesh-ancestor
24631254|NCT01116609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24631255|NCT01116609|Respiratory System Agents|respiratory system agents|mesh-ancestor
24631256|NCT01116609|Mydriatics|mydriatics|mesh-ancestor
25849194|NCT00047502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849195|NCT00047502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849197|NCT00047554|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24631257|NCT01116609|Sympathomimetics|sympathomimetics|mesh-ancestor
24631258|NCT01116609|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24631259|NCT01116622|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24631261|NCT01116622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24631262|NCT01116622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24631263|NCT01116622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631264|NCT01116622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631266|NCT01116635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24631267|NCT01116635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24631268|NCT01116635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24811184|NCT02045589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24811185|NCT02045589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631380|NCT01117220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24631381|NCT01117220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24631382|NCT01117220|Dopamine Agents|dopamine agents|mesh-ancestor
24631383|NCT01117298|Tadalafil|tadalafil|mesh-list
24631384|NCT01117298|Vasodilator Agents|vasodilator agents|mesh-ancestor
24811191|NCT02045602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24631452|NCT01118234|Immunologic Factors|immunologic factors|mesh-ancestor
24631453|NCT01118234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631454|NCT01118234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24631455|NCT01118260|Anesthetics|anesthetics|mesh-list
24631456|NCT01118260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24631457|NCT01118260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631458|NCT01118286|Nifedipine|nifedipine|mesh-list
24631459|NCT01118286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24631460|NCT01118286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24631461|NCT01118286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631462|NCT01118286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24631463|NCT01118286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631492|NCT01118559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24631493|NCT01118559|Protease Inhibitors|protease inhibitors|mesh-ancestor
24631494|NCT01118559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631495|NCT01118559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811221|NCT02045810|Anesthetics, Local|anesthetics, local|mesh-ancestor
24811223|NCT02045810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24811224|NCT02045810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811225|NCT02045810|Sensory System Agents|sensory system agents|mesh-ancestor
24811226|NCT02045810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24631507|NCT01118572|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24631508|NCT01118572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24538165|NCT00657774|Prednisone|prednisone|mesh-list
24631771|NCT01120119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631772|NCT01120119|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24631774|NCT01120119|Micronutrients|micronutrients|mesh-ancestor
24631775|NCT01120119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24631777|NCT01120158|Bevacizumab|bevacizumab|mesh-list
24631801|NCT01120171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24631820|NCT01120327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631822|NCT01120340|Mesalamine|mesalamine|mesh-list
24631823|NCT01120340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24631824|NCT01120340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24631825|NCT01120340|Analgesics|analgesics|mesh-ancestor
24631847|NCT01120418|Besifloxacin|besifloxacin|mesh-list
24631848|NCT01120418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25166437|NCT04082442|Evolocumab|evolocumab|mesh-list
24631849|NCT01120418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24811255|NCT02045953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24811256|NCT02045953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811257|NCT02045953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25181788|NCT04782700|Hormones|hormones|mesh-ancestor
24811258|NCT02045953|Respiratory System Agents|respiratory system agents|mesh-ancestor
24811259|NCT02045953|Tocolytic Agents|tocolytic agents|mesh-ancestor
24811260|NCT02045953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24672248|NCT01330810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24631872|NCT01120665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24631873|NCT01120665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631874|NCT01120665|Estrogens|estrogens|mesh-ancestor
25409038|NCT03404180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25662012|NCT01640834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662013|NCT01640925|Chlorhexidine|chlorhexidine|mesh-list
24632097|NCT01122004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24632257|NCT01122940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632258|NCT01122940|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24632259|NCT01122940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24632260|NCT01122953|Phenytoin|phenytoin|mesh-list
24632261|NCT01122953|Anticonvulsants|anticonvulsants|mesh-ancestor
24632262|NCT01122953|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24632263|NCT01122953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24632300|NCT01123265|Methotrexate|methotrexate|mesh-list
24632301|NCT01123265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24665501|NCT01312714|Vitamin D|vitamin d|mesh-list
24632302|NCT01123265|Abortifacient Agents|abortifacient agents|mesh-ancestor
24811262|NCT02045953|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24811263|NCT02045953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24811264|NCT02045953|Adrenergic Agents|adrenergic agents|mesh-ancestor
24811265|NCT02045953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24811266|NCT02045953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811267|NCT02045992|Caffeine|caffeine|mesh-list
24632319|NCT01123278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24632321|NCT01123317|Oxytocin|oxytocin|mesh-list
24632322|NCT01123317|Oxytocics|oxytocics|mesh-ancestor
24632323|NCT01123317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24632324|NCT01123317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849198|NCT00047554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24632559|NCT01124526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24632560|NCT01124526|Immunologic Factors|immunologic factors|mesh-ancestor
24632561|NCT01124526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632562|NCT01124526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24632563|NCT01124526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24632564|NCT01124526|Alkylating Agents|alkylating agents|mesh-ancestor
24538389|NCT00659074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24729312|NCT01621100|Narcotics|narcotics|mesh-ancestor
24633410|NCT01129323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24633411|NCT01129323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24633412|NCT01129323|Alkylating Agents|alkylating agents|mesh-ancestor
24633413|NCT01129323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633414|NCT01129323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633671|NCT01130688|Analgesics|analgesics|mesh-ancestor
24633672|NCT01130688|Sensory System Agents|sensory system agents|mesh-ancestor
24633673|NCT01130688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24633674|NCT01130688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633675|NCT01130688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24394761|NCT00134160|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24394762|NCT00134160|Calcium Channel Blockers|calcium channel blockers|mesh-list
24394763|NCT00134160|Calcium|calcium|mesh-list
24394764|NCT00134160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24394765|NCT00134160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394766|NCT00134160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24394767|NCT00134160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24394768|NCT00134160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394769|NCT00134160|Vasodilator Agents|vasodilator agents|mesh-ancestor
24394770|NCT00134160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24394784|NCT00134186|Dermatologic Agents|dermatologic agents|mesh-ancestor
24394785|NCT00134199|Sibutramine|sibutramine|mesh-list
24394786|NCT00134199|Antidepressive Agents|antidepressive agents|mesh-ancestor
24394787|NCT00134199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24394788|NCT00134199|Appetite Depressants|appetite depressants|mesh-ancestor
24394789|NCT00134199|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24394790|NCT00134212|Epinephrine|epinephrine|mesh-list
25153878|NCT02115724|Vitamins|vitamins|mesh-list
24394845|NCT00134394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24811292|NCT02046187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24811294|NCT02046304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24672647|NCT01332786|Tigecycline|tigecycline|mesh-list
24394925|NCT00134680|Letrozole|letrozole|mesh-list
24394926|NCT00134680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25409039|NCT03404180|Adrenergic Agents|adrenergic agents|mesh-ancestor
25662014|NCT01640925|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25662015|NCT01640925|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24395030|NCT00134966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538682|NCT00660283|Alkylating Agents|alkylating agents|mesh-ancestor
24395070|NCT00135005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395071|NCT00135005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395072|NCT00135018|Celecoxib|celecoxib|mesh-list
24395073|NCT00135018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24811295|NCT02046304|Antimetabolites|antimetabolites|mesh-ancestor
24859024|NCT02301130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24395074|NCT00135018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24395075|NCT00135018|Analgesics|analgesics|mesh-ancestor
24395076|NCT00135018|Sensory System Agents|sensory system agents|mesh-ancestor
24395094|NCT00135083|Insulin glulisine|insulin glulisine|mesh-list
24395095|NCT00135083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24395096|NCT00135083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395097|NCT00135096|Insulin|insulin|mesh-list
24395098|NCT00135096|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24395099|NCT00135096|Insulin Glargine|insulin glargine|mesh-list
24395100|NCT00135096|Insulin glulisine|insulin glulisine|mesh-list
24395101|NCT00135096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24395102|NCT00135096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395103|NCT00135122|Prednisolone|prednisolone|mesh-list
24395104|NCT00135122|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24395105|NCT00135122|Methylprednisolone|methylprednisolone|mesh-list
24395106|NCT00135122|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24395107|NCT00135122|Prednisolone acetate|prednisolone acetate|mesh-list
24395140|NCT00135135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24395141|NCT00135135|Alkylating Agents|alkylating agents|mesh-ancestor
24395142|NCT00135135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24395143|NCT00135135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24395144|NCT00135135|Immunologic Factors|immunologic factors|mesh-ancestor
24395145|NCT00135135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849199|NCT00047554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24395255|NCT00135525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24395256|NCT00135525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395257|NCT00135551|Benidipine|benidipine|mesh-list
24395258|NCT00135551|Diuretics|diuretics|mesh-list
24395259|NCT00135551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24395260|NCT00135551|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
24395261|NCT00135551|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24395262|NCT00135551|Natriuretic Agents|natriuretic agents|mesh-ancestor
24395263|NCT00135551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395264|NCT00135551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395265|NCT00135551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24451265|NCT00322920|Topotecan|topotecan|mesh-list
24395504|NCT00136175|Immunologic Factors|immunologic factors|mesh-ancestor
24395505|NCT00136175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395507|NCT00136188|Hematinics|hematinics|mesh-ancestor
24395508|NCT00136188|Vitamin B Complex|vitamin b complex|mesh-ancestor
24395509|NCT00136188|Vitamins|vitamins|mesh-ancestor
24395510|NCT00136188|Micronutrients|micronutrients|mesh-ancestor
24395511|NCT00136188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395512|NCT00136201|Tigecycline|tigecycline|mesh-list
24395513|NCT00136201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24395514|NCT00136201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24395515|NCT00136201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24395516|NCT00136201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395517|NCT00136201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731804|NCT01636557|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24731806|NCT01636557|Purinergic Agents|purinergic agents|mesh-ancestor
24395518|NCT00136266|Vitamin D|vitamin d|mesh-list
24395519|NCT00136266|Vitamins|vitamins|mesh-list
24395520|NCT00136266|Vitamin A|vitamin a|mesh-list
24395549|NCT00136383|Paroxetine|paroxetine|mesh-list
24395550|NCT00136383|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24395551|NCT00136383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24395552|NCT00136383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24395553|NCT00136383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395636|NCT00136526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395637|NCT00136526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24395639|NCT00136539|Doxorubicin|doxorubicin|mesh-list
24395640|NCT00136539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24395641|NCT00136539|Trastuzumab|trastuzumab|mesh-list
24395642|NCT00136539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24395643|NCT00136539|Immunologic Factors|immunologic factors|mesh-ancestor
24395687|NCT00136565|Tubulin Modulators|tubulin modulators|mesh-ancestor
24395688|NCT00136565|Antimitotic Agents|antimitotic agents|mesh-ancestor
24395689|NCT00136565|Mitosis Modulators|mitosis modulators|mesh-ancestor
24395690|NCT00136578|Carboplatin|carboplatin|mesh-list
24395691|NCT00136578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24395693|NCT00136591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24395694|NCT00136617|Chlordiazepoxide|chlordiazepoxide|mesh-list
24395695|NCT00136617|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24395696|NCT00136617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24395697|NCT00136617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24395698|NCT00136617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395699|NCT00136617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24395700|NCT00136617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24395701|NCT00136617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24395707|NCT00136656|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24395708|NCT00136656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24395709|NCT00136656|Antitubercular Agents|antitubercular agents|mesh-ancestor
24395711|NCT00136734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24395712|NCT00136734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395713|NCT00136734|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24395714|NCT00136734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24395715|NCT00136734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24395758|NCT00136786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24395760|NCT00136825|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24395761|NCT00136825|Antiviral Agents|antiviral agents|mesh-ancestor
24395762|NCT00136825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24395763|NCT00136825|Expectorants|expectorants|mesh-ancestor
24395764|NCT00136825|Respiratory System Agents|respiratory system agents|mesh-ancestor
24395765|NCT00136825|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24395766|NCT00136825|Antioxidants|antioxidants|mesh-ancestor
25849202|NCT00047567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24395856|NCT00137033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24395857|NCT00137033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24395858|NCT00137033|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24395859|NCT00137033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24395860|NCT00137033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395942|NCT00137358|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24395943|NCT00137358|Protective Agents|protective agents|mesh-ancestor
24395944|NCT00137358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395945|NCT00137397|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24395946|NCT00137397|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24395988|NCT00137514|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24395989|NCT00137514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24395991|NCT00137514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24395992|NCT00137527|Anesthetics|anesthetics|mesh-list
24395993|NCT00137527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24395994|NCT00137527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396015|NCT00137605|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24396016|NCT00137605|Immunologic Factors|immunologic factors|mesh-ancestor
24396017|NCT00137605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396018|NCT00137657|Trimethoprim|trimethoprim|mesh-list
24396019|NCT00137657|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24396020|NCT00137657|Sulfamethoxazole|sulfamethoxazole|mesh-list
24396099|NCT00137800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396100|NCT00137800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24396101|NCT00137800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396102|NCT00137800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396104|NCT00137813|Docetaxel|docetaxel|mesh-list
24396117|NCT00137826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24396118|NCT00137826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24396228|NCT00138177|Protective Agents|protective agents|mesh-ancestor
24396229|NCT00138177|Vitamin B Complex|vitamin b complex|mesh-ancestor
24396231|NCT00138177|Micronutrients|micronutrients|mesh-ancestor
24396232|NCT00138177|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24592480|NCT00921973|Vaccines|vaccines|mesh-list
24396234|NCT00138216|Irinotecan|irinotecan|mesh-list
24396258|NCT00138229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396260|NCT00138229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24396423|NCT00138970|Immunologic Factors|immunologic factors|mesh-ancestor
24396424|NCT00138970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24396782|NCT00139893|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25662016|NCT01640925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25662017|NCT01640925|Disinfectants|disinfectants|mesh-ancestor
25662018|NCT01640925|Dermatologic Agents|dermatologic agents|mesh-ancestor
25849203|NCT00047567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24396888|NCT00140296|Contraceptive Agents|contraceptive agents|mesh-list
25849204|NCT00047567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811321|NCT02046421|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24811322|NCT02046421|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24811323|NCT02046421|Contraceptive Agents|contraceptive agents|mesh-ancestor
24397183|NCT00140998|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24397185|NCT00141011|Anticoagulants|anticoagulants|mesh-ancestor
24397186|NCT00141011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24397187|NCT00141011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24397188|NCT00141011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137464|NCT02985554|Nivolumab|nivolumab|mesh-list
24397373|NCT00141401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24397374|NCT00141401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24397375|NCT00141401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24397377|NCT00141414|Analgesics|analgesics|mesh-ancestor
24397378|NCT00141414|Sensory System Agents|sensory system agents|mesh-ancestor
24397379|NCT00141414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24397380|NCT00141414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397381|NCT00141414|Anticonvulsants|anticonvulsants|mesh-ancestor
24397382|NCT00141414|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24397383|NCT00141414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24397384|NCT00141414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397385|NCT00141414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24397386|NCT00141414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24397387|NCT00141414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24397461|NCT00141583|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24397462|NCT00141583|Protease Inhibitors|protease inhibitors|mesh-ancestor
24397463|NCT00141583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24455414|NCT01370486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455430|NCT00945724|Alkylating Agents|alkylating agents|mesh-ancestor
24455431|NCT00945724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455432|NCT00945724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24455433|NCT00945724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24455434|NCT00945724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24455435|NCT00945724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24455436|NCT00945724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24455437|NCT00945724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24455438|NCT00945724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24455439|NCT00945724|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24455440|NCT00945724|Abortifacient Agents|abortifacient agents|mesh-ancestor
24455441|NCT00945724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24455442|NCT00945724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24455443|NCT00945724|Antimetabolites|antimetabolites|mesh-ancestor
24397526|NCT00141791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397527|NCT00141791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24397528|NCT00141791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24397560|NCT00141882|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24397561|NCT00141882|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24811333|NCT02046447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24811334|NCT02046447|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24811335|NCT02046447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24397562|NCT00141882|Dopamine Agents|dopamine agents|mesh-ancestor
24538921|NCT00661206|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24398009|NCT00143221|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24398011|NCT00143221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451458|NCT00323817|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24398163|NCT00143689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24398164|NCT00143689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24398165|NCT00143689|Antimetabolites|antimetabolites|mesh-ancestor
24398166|NCT00143689|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24543120|NCT00681980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24398182|NCT00143702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398183|NCT00143702|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25166438|NCT04082442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24398184|NCT00143702|Dermatologic Agents|dermatologic agents|mesh-ancestor
24398396|NCT00144287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398398|NCT00144287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24398489|NCT00144677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398490|NCT00144677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398491|NCT00144677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25662019|NCT01640951|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24398492|NCT00144677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24398493|NCT00144677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24398494|NCT00144677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24398495|NCT00144677|Antifungal Agents|antifungal agents|mesh-ancestor
24398498|NCT00144703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24398499|NCT00144703|Immunologic Factors|immunologic factors|mesh-ancestor
24398500|NCT00144703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398501|NCT00144703|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24811368|NCT02046486|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24811369|NCT02046486|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24811370|NCT02046486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24811371|NCT02046486|Purinergic Agents|purinergic agents|mesh-ancestor
24811372|NCT02046486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24811373|NCT02046486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398502|NCT00144703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398503|NCT00144703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398504|NCT00144703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24398505|NCT00144703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24398506|NCT00144703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24398507|NCT00144703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24398508|NCT00144703|Antifungal Agents|antifungal agents|mesh-ancestor
24398509|NCT00144716|Insect Repellents|insect repellents|mesh-list
24398669|NCT00145275|Zoledronic Acid|zoledronic acid|mesh-list
24398670|NCT00145275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24398671|NCT00145275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398672|NCT00145301|Lumiracoxib|lumiracoxib|mesh-list
24398673|NCT00145301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24398674|NCT00145301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24398675|NCT00145301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876115|NCT03907488|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24398778|NCT00145639|Doxorubicin|doxorubicin|mesh-list
24398781|NCT00145639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24398822|NCT00145873|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24398824|NCT00145873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398825|NCT00145886|Parathyroid Hormone|parathyroid hormone|mesh-list
24398826|NCT00145886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398827|NCT00145886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24398828|NCT00145925|Gliclazide|gliclazide|mesh-list
24398829|NCT00145925|Perindopril|perindopril|mesh-list
24398830|NCT00145925|Indapamide|indapamide|mesh-list
24398831|NCT00145925|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
24735833|NCT01658891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24398832|NCT00145925|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24398833|NCT00145925|Protease Inhibitors|protease inhibitors|mesh-ancestor
24398834|NCT00145925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398835|NCT00145925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398836|NCT00145925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24398837|NCT00145925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24398838|NCT00145925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398862|NCT00145990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398863|NCT00146016|Amantadine|amantadine|mesh-list
24398864|NCT00146016|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24398865|NCT00146016|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24398866|NCT00146016|Antiviral Agents|antiviral agents|mesh-ancestor
24398867|NCT00146016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24398870|NCT00146016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398871|NCT00146016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398872|NCT00146016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24398873|NCT00146016|Analgesics|analgesics|mesh-ancestor
24398874|NCT00146016|Sensory System Agents|sensory system agents|mesh-ancestor
24398875|NCT00146016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24398876|NCT00146042|Erythromycin|erythromycin|mesh-list
24398877|NCT00146042|Erythromycin Estolate|erythromycin estolate|mesh-list
24398878|NCT00146042|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24398879|NCT00146042|Erythromycin stearate|erythromycin stearate|mesh-list
24398880|NCT00146042|Docetaxel|docetaxel|mesh-list
24398881|NCT00146042|Trastuzumab|trastuzumab|mesh-list
24398882|NCT00146042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24398938|NCT00146159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398939|NCT00146159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398940|NCT00146211|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
24398942|NCT00146211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24398944|NCT00146224|Hematinics|hematinics|mesh-ancestor
24398945|NCT00146237|Phenytoin|phenytoin|mesh-list
25849208|NCT00047580|Analgesics|analgesics|mesh-ancestor
24398946|NCT00146237|Anticonvulsants|anticonvulsants|mesh-ancestor
24398947|NCT00146237|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24398948|NCT00146237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24398949|NCT00146237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24398950|NCT00146237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398951|NCT00146237|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24398952|NCT00146237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25094764|NCT03223025|Hormones|hormones|mesh-list
24398953|NCT00146250|Nitrous Oxide|nitrous oxide|mesh-list
24398954|NCT00146250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24399168|NCT00146731|Schistosomicides|schistosomicides|mesh-ancestor
24399169|NCT00146731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24399170|NCT00146731|Anthelmintics|anthelmintics|mesh-ancestor
24399195|NCT00146900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24399196|NCT00146900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399198|NCT00146900|Serotonin Agents|serotonin agents|mesh-ancestor
24399199|NCT00146900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399200|NCT00146900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24399285|NCT00147355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24399286|NCT00147355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24399287|NCT00147355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399288|NCT00147355|Antipyretics|antipyretics|mesh-ancestor
24399289|NCT00147355|Antiemetics|antiemetics|mesh-ancestor
24399292|NCT00147355|Antipruritics|antipruritics|mesh-ancestor
24399293|NCT00147355|Dermatologic Agents|dermatologic agents|mesh-ancestor
24399294|NCT00147355|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24399295|NCT00147355|Serotonin Agents|serotonin agents|mesh-ancestor
24399296|NCT00147355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24399416|NCT00147680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24399417|NCT00147680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399618|NCT00148278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24399619|NCT00148278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24399620|NCT00148278|Adrenergic Agents|adrenergic agents|mesh-ancestor
24399621|NCT00148278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24399622|NCT00148278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399623|NCT00148278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399624|NCT00148278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24399625|NCT00148278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24399672|NCT00148395|Antiviral Agents|antiviral agents|mesh-ancestor
24399673|NCT00148395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24399674|NCT00148395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24399675|NCT00148395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24399677|NCT00148395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399803|NCT00148681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399804|NCT00148681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24736412|NCT01662037|Bosentan|bosentan|mesh-list
24399805|NCT00148681|Immunologic Factors|immunologic factors|mesh-ancestor
24399806|NCT00148681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399808|NCT00148681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24399809|NCT00148681|Alkylating Agents|alkylating agents|mesh-ancestor
24399836|NCT00148746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399838|NCT00148746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24399839|NCT00148746|Dermatologic Agents|dermatologic agents|mesh-ancestor
24399840|NCT00148746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24399841|NCT00148746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24399842|NCT00148746|Glucocorticoids|glucocorticoids|mesh-ancestor
24399844|NCT00148746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24399878|NCT00148837|Interferon alpha-2|interferon alpha-2|mesh-list
24399879|NCT00148837|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24399880|NCT00148837|Prazosin|prazosin|mesh-list
25662020|NCT01640951|Immunologic Factors|immunologic factors|mesh-ancestor
25662021|NCT01640951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662022|NCT01640964|Terlipressin|terlipressin|mesh-list
25662023|NCT01640964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25662024|NCT01640964|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25662025|NCT01641081|Formoterol Fumarate|formoterol fumarate|mesh-list
25849209|NCT00047580|Sensory System Agents|sensory system agents|mesh-ancestor
25849210|NCT00047580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25849211|NCT00047580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849212|NCT00047580|Anticonvulsants|anticonvulsants|mesh-ancestor
25849213|NCT00047580|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24399881|NCT00148837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24961060|NCT03812354|Nicotine|nicotine|mesh-list
24399882|NCT00148837|Antiviral Agents|antiviral agents|mesh-ancestor
24399883|NCT00148837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24399884|NCT00148837|Antimetabolites|antimetabolites|mesh-ancestor
24399885|NCT00148837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399886|NCT00148837|Immunologic Factors|immunologic factors|mesh-ancestor
24399887|NCT00148837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399888|NCT00148837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24399889|NCT00148837|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24399890|NCT00148837|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24399891|NCT00148837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24399892|NCT00148837|Adrenergic Agents|adrenergic agents|mesh-ancestor
24399893|NCT00148837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24399894|NCT00148850|Pioglitazone|pioglitazone|mesh-list
24399895|NCT00148850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24399896|NCT00148850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399897|NCT00148863|Interferons|interferons|mesh-list
24399898|NCT00148863|Ribavirin|ribavirin|mesh-list
24399899|NCT00148863|Interferon-alpha|interferon-alpha|mesh-list
24399900|NCT00148863|Interferon alpha-2|interferon alpha-2|mesh-list
24811413|NCT02046577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24811414|NCT02046577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24811415|NCT02046590|Propofol|propofol|mesh-list
24811416|NCT02046590|Anesthetics|anesthetics|mesh-ancestor
24811417|NCT02046590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24674619|NCT05027919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24400111|NCT00149864|Antitubercular Agents|antitubercular agents|mesh-ancestor
24400112|NCT00149864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24400113|NCT00149864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24400114|NCT00149864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400115|NCT00149864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400117|NCT00149877|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24400118|NCT00149877|Serotonin Agents|serotonin agents|mesh-ancestor
24400119|NCT00149877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24400140|NCT00149929|Mycophenolic Acid|mycophenolic acid|mesh-list
24400141|NCT00149929|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24400142|NCT00149929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24400143|NCT00149929|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24400144|NCT00149929|Antitubercular Agents|antitubercular agents|mesh-ancestor
24539162|NCT00662571|Acamprosate|acamprosate|mesh-list
24400188|NCT00150020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400189|NCT00150020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400191|NCT00150046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24400192|NCT00150046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24400193|NCT00150046|Immunologic Factors|immunologic factors|mesh-ancestor
24400264|NCT00150228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24400265|NCT00150228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24811427|NCT02046629|Sensory System Agents|sensory system agents|mesh-ancestor
24811428|NCT02046629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24811429|NCT02046629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400312|NCT00150306|Sertraline|sertraline|mesh-list
24400320|NCT00150306|Serotonin Agents|serotonin agents|mesh-ancestor
24405023|NCT00165334|Vinorelbine|vinorelbine|mesh-list
24400802|NCT00151346|Sensory System Agents|sensory system agents|mesh-ancestor
24400803|NCT00151346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24539238|NCT00662883|Anesthetics|anesthetics|mesh-ancestor
24400825|NCT00151450|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24400826|NCT00151450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24400838|NCT00151489|Analgesics|analgesics|mesh-ancestor
24400839|NCT00151489|Sensory System Agents|sensory system agents|mesh-ancestor
24400840|NCT00151489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24400841|NCT00151489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400842|NCT00151489|Anticonvulsants|anticonvulsants|mesh-ancestor
24400843|NCT00151489|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24400844|NCT00151489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25662026|NCT01641081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25662027|NCT01641081|Autonomic Agents|autonomic agents|mesh-ancestor
25662028|NCT01641081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25419568|NCT02696096|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25232254|NCT02583698|Carvedilol|carvedilol|mesh-list
24400845|NCT00151489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166439|NCT04082442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24400891|NCT00151541|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24400892|NCT00151541|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24400893|NCT00151541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400894|NCT00151541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400895|NCT00151541|Leprostatic Agents|leprostatic agents|mesh-ancestor
24400896|NCT00151541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24400898|NCT00151567|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24400899|NCT00151567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24400900|NCT00151567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24400902|NCT00151567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24401019|NCT00151970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401026|NCT00151983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24401144|NCT00152204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24401145|NCT00152204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24401146|NCT00152204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24401147|NCT00152204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24401148|NCT00152204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24401276|NCT00152620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24401277|NCT00152620|Glucocorticoids|glucocorticoids|mesh-ancestor
24401278|NCT00152620|Hormones|hormones|mesh-ancestor
24401279|NCT00152620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24401286|NCT00152633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24401287|NCT00152633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24401288|NCT00152633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24401289|NCT00152633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24606916|NCT05407155|Paclitaxel|paclitaxel|mesh-list
24606917|NCT05407155|Bevacizumab|bevacizumab|mesh-list
24401909|NCT00154219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24401910|NCT00154219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25849214|NCT00047580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25849215|NCT00047580|Parasympatholytics|parasympatholytics|mesh-ancestor
25849216|NCT00047580|Autonomic Agents|autonomic agents|mesh-ancestor
25849217|NCT00047580|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25849218|NCT00047580|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25849219|NCT00047580|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25849220|NCT00047580|Adrenergic Agents|adrenergic agents|mesh-ancestor
25849221|NCT00047580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25849222|NCT00047580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849223|NCT00047632|Interferons|interferons|mesh-list
25849224|NCT00047632|Interferon-gamma|interferon-gamma|mesh-list
24623171|NCT01070524|Autonomic Agents|autonomic agents|mesh-ancestor
25849225|NCT00047632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849226|NCT00047632|Antiviral Agents|antiviral agents|mesh-ancestor
25849227|NCT00047632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25849228|NCT00047645|Interferons|interferons|mesh-list
25849229|NCT00047645|Interferon-gamma|interferon-gamma|mesh-list
25849230|NCT00047645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849231|NCT00047645|Antiviral Agents|antiviral agents|mesh-ancestor
24540045|NCT00666393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540046|NCT00666393|Analgesics|analgesics|mesh-ancestor
24540047|NCT00666393|Sensory System Agents|sensory system agents|mesh-ancestor
24540048|NCT00666393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24540049|NCT00666393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24540050|NCT00666393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24540051|NCT00666393|Anesthetics, General|anesthetics, general|mesh-ancestor
24540071|NCT00666484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24540072|NCT00666484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403862|NCT00161733|Hemostatics|hemostatics|mesh-ancestor
24403863|NCT00161733|Coagulants|coagulants|mesh-ancestor
24403864|NCT00161759|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24404055|NCT00162435|Warfarin|warfarin|mesh-list
24404061|NCT00162461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24811515|NCT02047019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811517|NCT02047019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24540257|NCT00667082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540258|NCT00667082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540259|NCT00667082|Protease Inhibitors|protease inhibitors|mesh-ancestor
24540261|NCT00667108|Analgesics|analgesics|mesh-ancestor
24404182|NCT00162695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25849232|NCT00047645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25849233|NCT00047658|Interferons|interferons|mesh-list
25849234|NCT00047658|Interferon-gamma|interferon-gamma|mesh-list
25849235|NCT00047658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849237|NCT00047658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24540263|NCT00667108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24540264|NCT00667108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540265|NCT00667108|Anticonvulsants|anticonvulsants|mesh-ancestor
24540266|NCT00667108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24540267|NCT00667108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24540268|NCT00667108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24540276|NCT00667147|Paclitaxel|paclitaxel|mesh-list
24404225|NCT00162786|Histamine Antagonists|histamine antagonists|mesh-ancestor
24404226|NCT00162786|Histamine Agents|histamine agents|mesh-ancestor
24404227|NCT00162786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24404228|NCT00162786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849238|NCT00047671|Citalopram|citalopram|mesh-list
24404646|NCT00164281|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24404647|NCT00164281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24404648|NCT00164281|Antimetabolites|antimetabolites|mesh-ancestor
24404649|NCT00164281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404650|NCT00164281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24404651|NCT00164359|Artesunate|artesunate|mesh-list
24404652|NCT00164359|Amodiaquine|amodiaquine|mesh-list
24404653|NCT00164359|Dapsone|dapsone|mesh-list
24404654|NCT00164359|Chlorproguanil|chlorproguanil|mesh-list
24404655|NCT00164359|Antimalarials|antimalarials|mesh-ancestor
24404656|NCT00164359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24404657|NCT00164359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25137849|NCT02982161|Celecoxib|celecoxib|mesh-list
24404794|NCT00164840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24404795|NCT00164840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24404796|NCT00164840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24404797|NCT00164840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404798|NCT00164840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404799|NCT00164866|Omeprazole|omeprazole|mesh-list
24404800|NCT00164866|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24404801|NCT00164866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24404802|NCT00164866|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24404803|NCT00164866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811607|NCT02047422|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24404856|NCT00165074|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
24404857|NCT00165074|Respiratory System Agents|respiratory system agents|mesh-ancestor
24404858|NCT00165087|Doxorubicin|doxorubicin|mesh-list
24404859|NCT00165087|Dexrazoxane|dexrazoxane|mesh-list
24404860|NCT00165087|Asparaginase|asparaginase|mesh-list
24404861|NCT00165087|Razoxane|razoxane|mesh-list
24404862|NCT00165087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24404863|NCT00165087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24404864|NCT00165087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24404865|NCT00165087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24404866|NCT00165087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849239|NCT00047671|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24404885|NCT00165139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24594632|NCT00934739|Analgesics|analgesics|mesh-ancestor
24404886|NCT00165139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24404887|NCT00165139|Alkylating Agents|alkylating agents|mesh-ancestor
24404896|NCT00165139|Antimitotic Agents|antimitotic agents|mesh-ancestor
24404897|NCT00165139|Mitosis Modulators|mitosis modulators|mesh-ancestor
24404898|NCT00165139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24404899|NCT00165139|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24404902|NCT00165178|Dexamethasone|dexamethasone|mesh-list
24404903|NCT00165178|Prednisone|prednisone|mesh-list
24404904|NCT00165178|Hydrocortisone|hydrocortisone|mesh-list
24404905|NCT00165178|Doxorubicin|doxorubicin|mesh-list
24404906|NCT00165178|Methotrexate|methotrexate|mesh-list
24404907|NCT00165178|Vincristine|vincristine|mesh-list
24404908|NCT00165178|Asparaginase|asparaginase|mesh-list
24404909|NCT00165178|Dexrazoxane|dexrazoxane|mesh-list
24404910|NCT00165178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24404911|NCT00165178|Antiemetics|antiemetics|mesh-ancestor
24404912|NCT00165178|Autonomic Agents|autonomic agents|mesh-ancestor
24404913|NCT00165178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24404914|NCT00165178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404915|NCT00165178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24404916|NCT00165178|Glucocorticoids|glucocorticoids|mesh-ancestor
25849240|NCT00047671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25849241|NCT00047671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25876116|NCT03907488|Doxorubicin|doxorubicin|mesh-list
24404918|NCT00165178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24404926|NCT00165178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24404928|NCT00165178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24404929|NCT00165178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24404930|NCT00165178|Antimetabolites|antimetabolites|mesh-ancestor
24404931|NCT00165178|Dermatologic Agents|dermatologic agents|mesh-ancestor
24404948|NCT00165178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24404950|NCT00165191|Fluorouracil|fluorouracil|mesh-list
24404951|NCT00165191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24404952|NCT00165191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24404953|NCT00165191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24404954|NCT00165191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24404955|NCT00165191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404956|NCT00165191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404958|NCT00165191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24404967|NCT00165204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25849242|NCT00047671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849243|NCT00047671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25849244|NCT00047671|Serotonin Agents|serotonin agents|mesh-ancestor
25849245|NCT00047671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849246|NCT00047671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24405014|NCT00165308|Hormone Antagonists|hormone antagonists|mesh-ancestor
24405015|NCT00165308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24405016|NCT00165308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405017|NCT00165308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24405018|NCT00165308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405019|NCT00165308|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24425339|NCT00232700|Citalopram|citalopram|mesh-list
24405020|NCT00165308|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24405021|NCT00165308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25166440|NCT04082442|Antimetabolites|antimetabolites|mesh-ancestor
24405022|NCT00165334|Cetuximab|cetuximab|mesh-list
24405024|NCT00165334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24405025|NCT00165334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405026|NCT00165334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25041711|NCT01593228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405027|NCT00165334|Tubulin Modulators|tubulin modulators|mesh-ancestor
24405028|NCT00165334|Antimitotic Agents|antimitotic agents|mesh-ancestor
24405029|NCT00165334|Mitosis Modulators|mitosis modulators|mesh-ancestor
24405030|NCT00165334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405032|NCT00165347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24405033|NCT00165347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405034|NCT00165347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405035|NCT00165360|Temozolomide|temozolomide|mesh-list
24405036|NCT00165360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24405037|NCT00165360|Alkylating Agents|alkylating agents|mesh-ancestor
24540500|NCT00668122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405059|NCT00165399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24405106|NCT00165477|Immunologic Factors|immunologic factors|mesh-ancestor
24405107|NCT00165477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405147|NCT00165568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24405148|NCT00165568|Growth Substances|growth substances|mesh-ancestor
25662030|NCT01641081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25662031|NCT01641081|Respiratory System Agents|respiratory system agents|mesh-ancestor
25849247|NCT00047671|Antidepressive Agents|antidepressive agents|mesh-ancestor
25849248|NCT00047671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25849249|NCT00047710|Bevacizumab|bevacizumab|mesh-list
25849250|NCT00047710|Capecitabine|capecitabine|mesh-list
25849251|NCT00047710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25849252|NCT00047710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849253|NCT00047710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25849254|NCT00047710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25849255|NCT00047710|Growth Substances|growth substances|mesh-ancestor
25849256|NCT00047710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849257|NCT00047710|Growth Inhibitors|growth inhibitors|mesh-ancestor
24405166|NCT00165659|Donepezil|donepezil|mesh-list
24405167|NCT00165659|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24405168|NCT00165659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405169|NCT00165659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405170|NCT00165659|Cholinergic Agents|cholinergic agents|mesh-ancestor
24405171|NCT00165659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24405172|NCT00165659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405173|NCT00165659|Nootropic Agents|nootropic agents|mesh-ancestor
24405174|NCT00165685|Sibutramine|sibutramine|mesh-list
24405175|NCT00165685|Antidepressive Agents|antidepressive agents|mesh-ancestor
24405176|NCT00165685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24405177|NCT00165685|Appetite Depressants|appetite depressants|mesh-ancestor
24405178|NCT00165685|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24405179|NCT00165737|Donepezil|donepezil|mesh-list
24811627|NCT02047474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405204|NCT00165815|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24405205|NCT00165815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405206|NCT00165815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405207|NCT00165815|Cholinergic Agents|cholinergic agents|mesh-ancestor
24405208|NCT00165815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24405209|NCT00165815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405210|NCT00165815|Nootropic Agents|nootropic agents|mesh-ancestor
24405211|NCT00165828|Zonisamide|zonisamide|mesh-list
24405212|NCT00165828|Anticonvulsants|anticonvulsants|mesh-ancestor
24405213|NCT00165828|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24405214|NCT00165828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24405215|NCT00165828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405216|NCT00165828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24405217|NCT00165828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405218|NCT00165854|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
24405219|NCT00165854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405220|NCT00165854|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24405221|NCT00165854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405222|NCT00165854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405223|NCT00165867|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
24405224|NCT00165867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166441|NCT04082442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405246|NCT00166153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24407415|NCT00174486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405247|NCT00166153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405249|NCT00166153|Antitubercular Agents|antitubercular agents|mesh-ancestor
24405250|NCT00166153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24405251|NCT00166153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24405252|NCT00166153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540556|NCT00668356|Antiviral Agents|antiviral agents|mesh-ancestor
24540557|NCT00668356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24811628|NCT02047474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24811630|NCT02047474|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24811631|NCT02047474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24811632|NCT02047474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811633|NCT02047474|Antidotes|antidotes|mesh-ancestor
24811634|NCT02047474|Protective Agents|protective agents|mesh-ancestor
24811635|NCT02047474|Vitamin B Complex|vitamin b complex|mesh-ancestor
24811637|NCT02047474|Micronutrients|micronutrients|mesh-ancestor
24811638|NCT02047539|Aspirin|aspirin|mesh-list
24811639|NCT02047539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24405282|NCT00166413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24405283|NCT00166413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24405284|NCT00166413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25052607|NCT00250822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405285|NCT00166413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24405286|NCT00166413|Growth Substances|growth substances|mesh-ancestor
24405303|NCT00166426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24405305|NCT00166465|Fluorouracil|fluorouracil|mesh-list
24405306|NCT00166465|Oxaliplatin|oxaliplatin|mesh-list
24540591|NCT00668603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24405332|NCT00166478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24811640|NCT02047539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24811642|NCT02047539|Sensory System Agents|sensory system agents|mesh-ancestor
24811643|NCT02047539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24811644|NCT02047539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811645|NCT02047539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24811646|NCT02047539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24405371|NCT00166686|Sensory System Agents|sensory system agents|mesh-ancestor
24405372|NCT00166686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24405373|NCT00166686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405374|NCT00166686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24405376|NCT00166686|Autonomic Agents|autonomic agents|mesh-ancestor
24540614|NCT00668642|Dutasteride|dutasteride|mesh-list
24540615|NCT00668642|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25849258|NCT00047710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25849259|NCT00047710|Antimetabolites|antimetabolites|mesh-ancestor
25849260|NCT00047710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849261|NCT00047723|Minocycline|minocycline|mesh-list
25849262|NCT00047723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25849263|NCT00047723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25849264|NCT00047736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25849265|NCT00047736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849266|NCT00047736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24811681|NCT02047578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25849267|NCT00047736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849268|NCT00047736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849269|NCT00047749|Ziconotide|ziconotide|mesh-list
25849270|NCT00047749|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25849271|NCT00047749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25849272|NCT00047749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405404|NCT00166816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24405405|NCT00166816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24405406|NCT00166816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405407|NCT00166829|Mycophenolic Acid|mycophenolic acid|mesh-list
24405421|NCT00166829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24405422|NCT00166829|Antifungal Agents|antifungal agents|mesh-ancestor
24405423|NCT00166842|Cyclosporine|cyclosporine|mesh-list
24405424|NCT00166842|Sirolimus|sirolimus|mesh-list
24405425|NCT00166842|Tacrolimus|tacrolimus|mesh-list
24405426|NCT00166842|Cyclosporins|cyclosporins|mesh-list
24405427|NCT00166842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24405428|NCT00166842|Immunologic Factors|immunologic factors|mesh-ancestor
24408102|NCT00176540|Antitussive Agents|antitussive agents|mesh-ancestor
24540663|NCT00668941|Vitamins|vitamins|mesh-ancestor
24540664|NCT00668941|Micronutrients|micronutrients|mesh-ancestor
25849274|NCT00047749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849275|NCT00047749|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24405507|NCT00167479|Dopamine Agents|dopamine agents|mesh-ancestor
24405508|NCT00167492|Mycophenolic Acid|mycophenolic acid|mesh-list
24405509|NCT00167492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25849276|NCT00047749|Protective Agents|protective agents|mesh-ancestor
25849277|NCT00047749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25849278|NCT00047749|Analgesics|analgesics|mesh-ancestor
24540668|NCT00668967|Verapamil|verapamil|mesh-list
25849279|NCT00047749|Sensory System Agents|sensory system agents|mesh-ancestor
25849280|NCT00047749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25849281|NCT00047762|Bevacizumab|bevacizumab|mesh-list
25849282|NCT00047762|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25849283|NCT00047762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24811725|NCT02048098|Abortifacient Agents|abortifacient agents|mesh-ancestor
24811726|NCT02048098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24811727|NCT02048098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849284|NCT00047762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405662|NCT00167856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405663|NCT00167856|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24405664|NCT00167856|Antidepressive Agents|antidepressive agents|mesh-ancestor
25849294|NCT00047801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405683|NCT00167921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138301|NCT02979223|Vitamins|vitamins|mesh-ancestor
24811796|NCT02048358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24811799|NCT02048384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24811800|NCT02048384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811801|NCT02048384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24811802|NCT02048384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24405893|NCT00168740|Rituximab|rituximab|mesh-list
24405894|NCT00168740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25849295|NCT00047801|Tubulin Modulators|tubulin modulators|mesh-ancestor
24406147|NCT00169156|Tubulin Modulators|tubulin modulators|mesh-ancestor
24406148|NCT00169156|Antimitotic Agents|antimitotic agents|mesh-ancestor
24406149|NCT00169156|Mitosis Modulators|mitosis modulators|mesh-ancestor
24406151|NCT00169169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24406152|NCT00169169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406153|NCT00169169|Immunologic Factors|immunologic factors|mesh-ancestor
24406154|NCT00169169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406167|NCT00169182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552097|NCT04176419|Anesthetics, Local|anesthetics, local|mesh-ancestor
24811943|NCT02048943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24811944|NCT02048943|Immunologic Factors|immunologic factors|mesh-ancestor
24406256|NCT00169546|Autonomic Agents|autonomic agents|mesh-ancestor
24406257|NCT00169546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24406258|NCT00169546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406259|NCT00169546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24406260|NCT00169546|Respiratory System Agents|respiratory system agents|mesh-ancestor
24406261|NCT00169546|Dermatologic Agents|dermatologic agents|mesh-ancestor
24406262|NCT00169546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24406263|NCT00169546|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25849296|NCT00047801|Antimitotic Agents|antimitotic agents|mesh-ancestor
25849297|NCT00047801|Mitosis Modulators|mitosis modulators|mesh-ancestor
25849298|NCT00047801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849299|NCT00047827|Amphotericin B|amphotericin b|mesh-list
25849300|NCT00047827|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25849302|NCT00047827|Amebicides|amebicides|mesh-ancestor
24406298|NCT00169572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24406300|NCT00169572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24406301|NCT00169572|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24406302|NCT00169585|Levofloxacin|levofloxacin|mesh-list
25849303|NCT00047827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25849304|NCT00047827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25849309|NCT00047840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849310|NCT00047840|Tubulin Modulators|tubulin modulators|mesh-ancestor
25849311|NCT00047840|Antimitotic Agents|antimitotic agents|mesh-ancestor
24406398|NCT00170053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406399|NCT00170053|Antifungal Agents|antifungal agents|mesh-ancestor
24406400|NCT00170053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24406401|NCT00170053|Immunologic Factors|immunologic factors|mesh-ancestor
24561892|NCT00763620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561965|NCT00763880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24561966|NCT00763880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562035|NCT00764244|Glucocorticoids|glucocorticoids|mesh-ancestor
24789955|NCT01939743|Analgesics|analgesics|mesh-ancestor
24562108|NCT00764595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562110|NCT00764712|Insulin|insulin|mesh-list
24562183|NCT00764907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25052746|NCT00162292|Abortifacient Agents|abortifacient agents|mesh-ancestor
24562184|NCT00764907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24541085|NCT00670761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406516|NCT00170690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406517|NCT00170690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24562837|NCT00768508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24406553|NCT00170768|Autonomic Agents|autonomic agents|mesh-ancestor
24406554|NCT00170768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24406555|NCT00170768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406556|NCT00170768|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24564199|NCT00775580|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24564996|NCT00778401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564997|NCT00778401|Antimanic Agents|antimanic agents|mesh-ancestor
24564998|NCT00778414|Amoxicillin|amoxicillin|mesh-list
24565007|NCT00778427|Metformin|metformin|mesh-list
24565069|NCT00778674|Benazepril|benazepril|mesh-list
24565148|NCT00779012|Infliximab|infliximab|mesh-list
24565149|NCT00779012|Dermatologic Agents|dermatologic agents|mesh-ancestor
24565150|NCT00779012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24565151|NCT00779012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24565223|NCT00779350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24565224|NCT00779350|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24565297|NCT00779714|Mitosis Modulators|mitosis modulators|mesh-ancestor
24565298|NCT00779714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24747984|NCT03003065|Temoporfin|temoporfin|mesh-list
24748072|NCT02975934|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24565370|NCT00779922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25849312|NCT00047840|Mitosis Modulators|mitosis modulators|mesh-ancestor
24679553|NCT01369212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25849313|NCT00047840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406580|NCT00170820|Everolimus|everolimus|mesh-list
24406581|NCT00170820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406582|NCT00170820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24406583|NCT00170820|Immunologic Factors|immunologic factors|mesh-ancestor
24406584|NCT00170820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406585|NCT00170833|Everolimus|everolimus|mesh-list
24541169|NCT00671320|Sensory System Agents|sensory system agents|mesh-ancestor
25849314|NCT00048087|Docetaxel|docetaxel|mesh-list
24406618|NCT00170898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24406621|NCT00170898|Sensory System Agents|sensory system agents|mesh-ancestor
24406622|NCT00170898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24406623|NCT00170898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567138|NCT00789646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24671045|NCT01323335|Antioxidants|antioxidants|mesh-ancestor
24568352|NCT00795756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568563|NCT00796432|Serotonin Agents|serotonin agents|mesh-ancestor
24568803|NCT00797693|Misoprostol|misoprostol|mesh-list
24569183|NCT00799175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24569257|NCT00799760|Antiviral Agents|antiviral agents|mesh-ancestor
24569258|NCT00799760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24569259|NCT00799760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24569348|NCT00800293|Hormones|hormones|mesh-ancestor
24569421|NCT00800527|Diclofenac|diclofenac|mesh-list
24569639|NCT00801411|Cyclophosphamide|cyclophosphamide|mesh-list
24569713|NCT00801528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24569950|NCT00802451|Mesalamine|mesalamine|mesh-list
24406624|NCT00170898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24406625|NCT00170898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24406627|NCT00170924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24406628|NCT00170924|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24406630|NCT00170924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406631|NCT00170937|Valsartan|valsartan|mesh-list
24406632|NCT00170937|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24406633|NCT00170937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24748097|NCT02943785|Protease Inhibitors|protease inhibitors|mesh-ancestor
24406634|NCT00170937|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24406655|NCT00170976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24406656|NCT00170976|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24406657|NCT00170976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24406658|NCT00170976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406659|NCT00170976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24406660|NCT00170976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570087|NCT00803218|Fluticasone|fluticasone|mesh-list
24570735|NCT00806299|Loperamide|loperamide|mesh-list
24571041|NCT00807872|Antibodies|antibodies|mesh-list
24571121|NCT00808184|Midazolam|midazolam|mesh-list
24571564|NCT00810862|Pimecrolimus|pimecrolimus|mesh-list
24571881|NCT00812123|Glucocorticoids|glucocorticoids|mesh-ancestor
24571955|NCT00812370|Anticoagulants|anticoagulants|mesh-ancestor
24572026|NCT00812760|Dopamine Agents|dopamine agents|mesh-ancestor
24572206|NCT00813722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24572344|NCT00814281|Montelukast|montelukast|mesh-list
24572414|NCT00814645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24572415|NCT00814723|Ezetimibe|ezetimibe|mesh-list
24406661|NCT00170976|Vasodilator Agents|vasodilator agents|mesh-ancestor
24573472|NCT00820118|Antiviral Agents|antiviral agents|mesh-ancestor
24406727|NCT00171093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24406769|NCT00171145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24406770|NCT00171145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24406771|NCT00171145|Cholinergic Agents|cholinergic agents|mesh-ancestor
24406772|NCT00171145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24406773|NCT00171145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406774|NCT00171145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406775|NCT00171145|Urological Agents|urological agents|mesh-ancestor
24406776|NCT00171171|Deferasirox|deferasirox|mesh-list
24406777|NCT00171171|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25849315|NCT00048087|Gefitinib|gefitinib|mesh-list
25849316|NCT00048087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849317|NCT00048087|Tubulin Modulators|tubulin modulators|mesh-ancestor
25849318|NCT00048087|Antimitotic Agents|antimitotic agents|mesh-ancestor
25849319|NCT00048087|Mitosis Modulators|mitosis modulators|mesh-ancestor
25849320|NCT00048087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849321|NCT00048087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25232373|NCT02582996|Sensory System Agents|sensory system agents|mesh-ancestor
25232374|NCT02582996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24406778|NCT00171171|Chelating Agents|chelating agents|mesh-ancestor
24406779|NCT00171171|Sequestering Agents|sequestering agents|mesh-ancestor
24406780|NCT00171171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406781|NCT00171184|Darifenacin|darifenacin|mesh-list
24406782|NCT00171184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24406783|NCT00171184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24406784|NCT00171184|Cholinergic Agents|cholinergic agents|mesh-ancestor
24406785|NCT00171184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24406786|NCT00171184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406797|NCT00171327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25849322|NCT00048087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24406826|NCT00171392|Mycophenolic Acid|mycophenolic acid|mesh-list
24406827|NCT00171392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24406834|NCT00171392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406835|NCT00171418|Tegaserod|tegaserod|mesh-list
24406836|NCT00171418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24406837|NCT00171418|Serotonin Agents|serotonin agents|mesh-ancestor
24406838|NCT00171418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24406839|NCT00171418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406840|NCT00171418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406841|NCT00171431|Tegaserod|tegaserod|mesh-list
24406842|NCT00171431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24406843|NCT00171431|Serotonin Agents|serotonin agents|mesh-ancestor
24406844|NCT00171431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24406845|NCT00171431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671108|NCT01323569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24575353|NCT00830856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24575354|NCT00830856|Antifungal Agents|antifungal agents|mesh-ancestor
24575355|NCT00830856|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24575356|NCT00830856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24575358|NCT00830856|Hormone Antagonists|hormone antagonists|mesh-ancestor
24575706|NCT00833378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24575707|NCT00833378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24575708|NCT00833404|Nicotine|nicotine|mesh-list
24575709|NCT00833404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24550696|NCT00721747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24550699|NCT00721773|Valsartan|valsartan|mesh-list
24550700|NCT00721773|Benazepril|benazepril|mesh-list
24550701|NCT00721773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24819987|NCT02098421|Oxytocin|oxytocin|mesh-list
24819988|NCT02098421|Oxytocics|oxytocics|mesh-ancestor
24819989|NCT02098421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24819990|NCT02098421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819991|NCT02098460|Cilostazol|cilostazol|mesh-list
24819992|NCT02098460|Atorvastatin|atorvastatin|mesh-list
24406892|NCT00171522|Laxatives|laxatives|mesh-ancestor
24406893|NCT00171522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24819994|NCT02098460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24819995|NCT02098460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24819996|NCT02098460|Antimetabolites|antimetabolites|mesh-ancestor
24819997|NCT02098460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819998|NCT02098460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24819999|NCT02098460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24820000|NCT02098460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820001|NCT02098460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24820002|NCT02098460|Autonomic Agents|autonomic agents|mesh-ancestor
24820003|NCT02098460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24820004|NCT02098460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820005|NCT02098460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24820006|NCT02098460|Respiratory System Agents|respiratory system agents|mesh-ancestor
24679949|NCT01371968|Alfentanil|alfentanil|mesh-list
24820028|NCT02098499|Metoclopramide|metoclopramide|mesh-list
24820029|NCT02098499|Haloperidol decanoate|haloperidol decanoate|mesh-list
24820030|NCT02098499|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24820031|NCT02098499|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24820032|NCT02098499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24820033|NCT02098499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820035|NCT02098499|Anesthetics|anesthetics|mesh-ancestor
24407001|NCT00171678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24407023|NCT00171717|Antifungal Agents|antifungal agents|mesh-ancestor
25662032|NCT01641081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25662033|NCT01641081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24407026|NCT00171717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24407027|NCT00171717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24407028|NCT00171743|Cyclosporine|cyclosporine|mesh-list
24407029|NCT00171743|Cyclosporins|cyclosporins|mesh-list
24407036|NCT00171743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24407037|NCT00171743|Dermatologic Agents|dermatologic agents|mesh-ancestor
24407038|NCT00171743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24451692|NCT00324506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407042|NCT00171756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24407043|NCT00171756|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24407044|NCT00171756|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24407045|NCT00171756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407046|NCT00171756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24407047|NCT00171756|Sympatholytics|sympatholytics|mesh-ancestor
24407048|NCT00171756|Autonomic Agents|autonomic agents|mesh-ancestor
24407049|NCT00171756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24407103|NCT00171847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25849323|NCT00048113|Alicaforsen|alicaforsen|mesh-list
25849324|NCT00048113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24407350|NCT00174330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407351|NCT00174330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24407352|NCT00174330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24407354|NCT00174330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24407355|NCT00174330|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24407356|NCT00174330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24407357|NCT00174330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24407408|NCT00174473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24407409|NCT00174473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407410|NCT00174473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24407411|NCT00174486|Tadalafil|tadalafil|mesh-list
24407412|NCT00174486|Vasodilator Agents|vasodilator agents|mesh-ancestor
24407413|NCT00174486|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24407414|NCT00174486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24407420|NCT00174499|Autonomic Agents|autonomic agents|mesh-ancestor
24407421|NCT00174499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24407594|NCT00174772|Cisplatin|cisplatin|mesh-list
24407596|NCT00174772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407597|NCT00174772|Tubulin Modulators|tubulin modulators|mesh-ancestor
24407598|NCT00174772|Antimitotic Agents|antimitotic agents|mesh-ancestor
24407599|NCT00174772|Mitosis Modulators|mitosis modulators|mesh-ancestor
24407605|NCT00174798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24407606|NCT00174798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407607|NCT00174798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751817|NCT01706471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24407608|NCT00174798|Urological Agents|urological agents|mesh-ancestor
24407610|NCT00174811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24407611|NCT00174811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24407612|NCT00174824|Insulin Glargine|insulin glargine|mesh-list
24407613|NCT00174824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24407614|NCT00174824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407615|NCT00174863|SR 31747|sr 31747|mesh-list
24407616|NCT00174863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407617|NCT00174863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407618|NCT00174863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24407619|NCT00174863|Immunologic Factors|immunologic factors|mesh-ancestor
24407620|NCT00174863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407621|NCT00174876|Aripiprazole|aripiprazole|mesh-list
24407622|NCT00174876|Antidepressive Agents|antidepressive agents|mesh-ancestor
24407647|NCT00174902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24407648|NCT00174902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24407649|NCT00174902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24407650|NCT00174902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24407651|NCT00174902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407652|NCT00174902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24407653|NCT00174902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24407654|NCT00174902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407655|NCT00174902|Antipyretics|antipyretics|mesh-ancestor
25849325|NCT00048113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24407656|NCT00174902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24407657|NCT00174902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25849326|NCT00048113|Immunologic Factors|immunologic factors|mesh-ancestor
24407719|NCT00175162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407722|NCT00175227|Diuretics|diuretics|mesh-ancestor
24407723|NCT00175227|Natriuretic Agents|natriuretic agents|mesh-ancestor
24407728|NCT00175227|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24407736|NCT00175266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24407737|NCT00175266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24407738|NCT00175266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407739|NCT00175305|Octreotide|octreotide|mesh-list
24407740|NCT00175305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24541578|NCT00674011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541579|NCT00674011|Growth Inhibitors|growth inhibitors|mesh-ancestor
24541580|NCT00674050|Fluticasone|fluticasone|mesh-list
24541582|NCT00674050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541583|NCT00674050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25849327|NCT00048113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849328|NCT00048126|Capecitabine|capecitabine|mesh-list
25849329|NCT00048126|Irinotecan|irinotecan|mesh-list
25849330|NCT00048126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24820112|NCT02098824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24820113|NCT02098824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24820114|NCT02098824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820115|NCT02098824|Cholinergic Agents|cholinergic agents|mesh-ancestor
24820116|NCT02098824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24820117|NCT02098824|Autonomic Agents|autonomic agents|mesh-ancestor
24407906|NCT00175838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24407907|NCT00175838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24407908|NCT00175838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408103|NCT00176540|Respiratory System Agents|respiratory system agents|mesh-ancestor
24820124|NCT02098837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820125|NCT02098837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24820126|NCT02098837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24407976|NCT00176020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24407977|NCT00176020|Antimetabolites|antimetabolites|mesh-ancestor
24407978|NCT00176020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407979|NCT00176020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24407980|NCT00176020|Vasodilator Agents|vasodilator agents|mesh-ancestor
24407981|NCT00176046|Viscum album peptide|viscum album peptide|mesh-list
24407982|NCT00176046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407983|NCT00176046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24407984|NCT00176046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24407985|NCT00176046|Antiviral Agents|antiviral agents|mesh-ancestor
24407986|NCT00176046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24407987|NCT00176059|Immunoglobulins|immunoglobulins|mesh-list
24407988|NCT00176059|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24407989|NCT00176059|Antibodies|antibodies|mesh-list
24407990|NCT00176059|gamma-Globulins|gamma-globulins|mesh-list
24407991|NCT00176059|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24407992|NCT00176059|Immunologic Factors|immunologic factors|mesh-ancestor
24407993|NCT00176059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407994|NCT00176098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
24407995|NCT00176098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24408018|NCT00176267|Antimitotic Agents|antimitotic agents|mesh-ancestor
24408019|NCT00176267|Mitosis Modulators|mitosis modulators|mesh-ancestor
24408020|NCT00176267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408021|NCT00176280|Dexamethasone|dexamethasone|mesh-list
24408022|NCT00176280|Sargramostim|sargramostim|mesh-list
24408023|NCT00176280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24408024|NCT00176280|Antiemetics|antiemetics|mesh-ancestor
24408025|NCT00176280|Autonomic Agents|autonomic agents|mesh-ancestor
24408026|NCT00176280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24408027|NCT00176280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408028|NCT00176280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24408029|NCT00176280|Glucocorticoids|glucocorticoids|mesh-ancestor
24408031|NCT00176280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24408032|NCT00176280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24408033|NCT00176280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408034|NCT00176280|Immunologic Factors|immunologic factors|mesh-ancestor
24408036|NCT00176293|Doxorubicin|doxorubicin|mesh-list
24408037|NCT00176293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24820127|NCT02098837|Antiviral Agents|antiviral agents|mesh-ancestor
24820128|NCT02098837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24820129|NCT02098889|Scopolamine|scopolamine|mesh-list
24820130|NCT02098889|Bromides|bromides|mesh-list
25849331|NCT00048126|Antimetabolites|antimetabolites|mesh-ancestor
24820132|NCT02098889|Anticonvulsants|anticonvulsants|mesh-ancestor
24820133|NCT02098889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24820134|NCT02098889|Antiemetics|antiemetics|mesh-ancestor
24820135|NCT02098889|Autonomic Agents|autonomic agents|mesh-ancestor
24820136|NCT02098889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24408038|NCT00176293|Antiemetics|antiemetics|mesh-ancestor
24408039|NCT00176293|Autonomic Agents|autonomic agents|mesh-ancestor
24408040|NCT00176293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24541617|NCT00674141|Hormones|hormones|mesh-ancestor
24408087|NCT00176527|Isotretinoin|isotretinoin|mesh-list
24408088|NCT00176527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408089|NCT00176527|Tubulin Modulators|tubulin modulators|mesh-ancestor
24408090|NCT00176527|Antimitotic Agents|antimitotic agents|mesh-ancestor
24408091|NCT00176527|Mitosis Modulators|mitosis modulators|mesh-ancestor
25849332|NCT00048126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408092|NCT00176527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408094|NCT00176527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24408095|NCT00176527|Immunologic Factors|immunologic factors|mesh-ancestor
24408096|NCT00176527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408097|NCT00176527|Dermatologic Agents|dermatologic agents|mesh-ancestor
24408098|NCT00176527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24408099|NCT00176527|Alkylating Agents|alkylating agents|mesh-ancestor
24408100|NCT00176527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24408101|NCT00176540|Dextromethorphan|dextromethorphan|mesh-list
24408106|NCT00176540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24408107|NCT00176540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408137|NCT00176670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24820144|NCT02098889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24820145|NCT02098889|Parasympatholytics|parasympatholytics|mesh-ancestor
24820146|NCT02098915|Metoclopramide|metoclopramide|mesh-list
24820147|NCT02098915|Antiemetics|antiemetics|mesh-ancestor
24820148|NCT02098915|Autonomic Agents|autonomic agents|mesh-ancestor
24820149|NCT02098915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24820150|NCT02098915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820151|NCT02098915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24820152|NCT02098915|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24820153|NCT02098915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24820154|NCT02098915|Dopamine Agents|dopamine agents|mesh-ancestor
24820155|NCT02098915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24820156|NCT02098915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820157|NCT02098980|Vitamin D|vitamin d|mesh-list
24820158|NCT02098980|Vitamins|vitamins|mesh-ancestor
24820159|NCT02098980|Micronutrients|micronutrients|mesh-ancestor
24820160|NCT02098980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820161|NCT02098980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24408248|NCT00177008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408249|NCT00177008|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24408250|NCT00177008|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24408251|NCT00177008|Serotonin Agents|serotonin agents|mesh-ancestor
24408252|NCT00177008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24408253|NCT00177008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24408254|NCT00177008|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24408256|NCT00177021|Imiquimod|imiquimod|mesh-list
24408292|NCT00177138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408300|NCT00177242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408315|NCT00177372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24408316|NCT00177372|Abortifacient Agents|abortifacient agents|mesh-ancestor
24408317|NCT00177372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24408318|NCT00177372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408319|NCT00177372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24408320|NCT00177372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24408321|NCT00177372|Oxytocics|oxytocics|mesh-ancestor
24408322|NCT00177372|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24408323|NCT00177372|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24408324|NCT00177372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24408325|NCT00177372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24408326|NCT00177372|Contraceptive Agents|contraceptive agents|mesh-ancestor
24408329|NCT00177372|Hormone Antagonists|hormone antagonists|mesh-ancestor
24408330|NCT00177372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25849333|NCT00048126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25419569|NCT02693535|Pembrolizumab|pembrolizumab|mesh-list
25662034|NCT01641081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24408348|NCT00177424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24408349|NCT00177424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24820170|NCT02099136|Celecoxib|celecoxib|mesh-list
24820171|NCT02099136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24820172|NCT02099136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24820173|NCT02099136|Analgesics|analgesics|mesh-ancestor
24820174|NCT02099136|Sensory System Agents|sensory system agents|mesh-ancestor
24820175|NCT02099136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24820176|NCT02099136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820177|NCT02099136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24408355|NCT00177528|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24408356|NCT00177528|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24408357|NCT00177528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24408374|NCT00177567|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24408375|NCT00177567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24408376|NCT00177567|Serotonin Agents|serotonin agents|mesh-ancestor
24408377|NCT00177567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24408378|NCT00177567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408379|NCT00177567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408380|NCT00177567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24408381|NCT00177567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24408382|NCT00177567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24408383|NCT00177567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24408384|NCT00177567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24408385|NCT00177567|Dopamine Agents|dopamine agents|mesh-ancestor
24408386|NCT00177567|Antiemetics|antiemetics|mesh-ancestor
24408387|NCT00177567|Autonomic Agents|autonomic agents|mesh-ancestor
24408388|NCT00177567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24451747|NCT00324688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24451748|NCT00324688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451749|NCT00324688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451750|NCT00324688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24451751|NCT00324688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24451752|NCT00324714|Risedronic Acid|risedronic acid|mesh-list
24451753|NCT00324714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24451754|NCT00324714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24451755|NCT00324714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408394|NCT00177567|Antidepressive Agents|antidepressive agents|mesh-ancestor
24408395|NCT00177567|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24408396|NCT00177567|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24408397|NCT00177567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24408398|NCT00177567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820180|NCT02099136|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24820181|NCT02099136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820184|NCT02099240|Amoxicillin|amoxicillin|mesh-list
24820185|NCT02099240|Azithromycin|azithromycin|mesh-list
24820186|NCT02099240|Moxifloxacin|moxifloxacin|mesh-list
24408399|NCT00177567|Antimanic Agents|antimanic agents|mesh-ancestor
24408400|NCT00177567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24408401|NCT00177567|Anticonvulsants|anticonvulsants|mesh-ancestor
24408402|NCT00177567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24408403|NCT00177567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24408404|NCT00177567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24408405|NCT00177567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24408406|NCT00177567|Histamine Antagonists|histamine antagonists|mesh-ancestor
24408407|NCT00177567|Histamine Agents|histamine agents|mesh-ancestor
24408408|NCT00177567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24408409|NCT00177567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24408410|NCT00177567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24408481|NCT00177996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408482|NCT00177996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24408483|NCT00177996|Serotonin Agents|serotonin agents|mesh-ancestor
24408504|NCT00178048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24408531|NCT00178113|Protective Agents|protective agents|mesh-ancestor
24408532|NCT00178113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408533|NCT00178113|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24408534|NCT00178113|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24408535|NCT00178113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408536|NCT00178269|Docetaxel|docetaxel|mesh-list
24408537|NCT00178269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408538|NCT00178269|Tubulin Modulators|tubulin modulators|mesh-ancestor
24408539|NCT00178269|Antimitotic Agents|antimitotic agents|mesh-ancestor
24408540|NCT00178269|Mitosis Modulators|mitosis modulators|mesh-ancestor
24820232|NCT02099240|Aztreonam|aztreonam|mesh-list
25849335|NCT00048126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25849336|NCT00048126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849337|NCT00048139|Capecitabine|capecitabine|mesh-list
24820260|NCT02099240|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
24820261|NCT02099240|Ceftizoxime|ceftizoxime|mesh-list
24820262|NCT02099240|Kanamycin|kanamycin|mesh-list
24820263|NCT02099240|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
24820264|NCT02099240|Cefoperazone|cefoperazone|mesh-list
24820265|NCT02099240|Lincomycin|lincomycin|mesh-list
24820266|NCT02099240|Dirithromycin|dirithromycin|mesh-list
24820267|NCT02099240|Cefotetan|cefotetan|mesh-list
24820268|NCT02099240|Ethionamide|ethionamide|mesh-list
24820269|NCT02099240|Demeclocycline|demeclocycline|mesh-list
24820270|NCT02099240|Cefaclor|cefaclor|mesh-list
24820271|NCT02099240|Capreomycin|capreomycin|mesh-list
24820272|NCT02099240|Mafenide|mafenide|mesh-list
24820273|NCT02099240|Ceftibuten|ceftibuten|mesh-list
24820274|NCT02099240|Tobramycin|tobramycin|mesh-list
24820275|NCT02099240|Chloramphenicol|chloramphenicol|mesh-list
24820276|NCT02099240|Chloramphenicol succinate|chloramphenicol succinate|mesh-list
24820277|NCT02099240|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
24681176|NCT01378741|Analgesics|analgesics|mesh-ancestor
25849338|NCT00048139|Irinotecan|irinotecan|mesh-list
24408592|NCT00178802|Antimetabolites|antimetabolites|mesh-ancestor
24408593|NCT00178802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24820278|NCT02099240|Oxytetracycline|oxytetracycline|mesh-list
24820280|NCT02099240|Enoxacin|enoxacin|mesh-list
24820281|NCT02099240|Quinupristin-dalfopristin|quinupristin-dalfopristin|mesh-list
24820282|NCT02099240|Virginiamycin|virginiamycin|mesh-list
24820283|NCT02099240|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25849339|NCT00048139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25849340|NCT00048139|Antimetabolites|antimetabolites|mesh-ancestor
25849341|NCT00048139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849342|NCT00048139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849343|NCT00048139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24820289|NCT02099240|Mezlocillin|mezlocillin|mesh-list
24820290|NCT02099240|Benzathine benzylpenicillin, procaine benzylpenicillin, drug combination|benzathine benzylpenicillin, procaine benzylpenicillin, drug combination|mesh-list
24820291|NCT02099240|Cefamandole|cefamandole|mesh-list
24820292|NCT02099240|Cefamandole nafate|cefamandole nafate|mesh-list
24820293|NCT02099240|Cefonicid|cefonicid|mesh-list
24820294|NCT02099240|Cefmetazole|cefmetazole|mesh-list
24820295|NCT02099240|Loracarbef|loracarbef|mesh-list
24820296|NCT02099240|Grepafloxacin|grepafloxacin|mesh-list
24820297|NCT02099240|Fluoroquinolones|fluoroquinolones|mesh-list
24820298|NCT02099240|Lomefloxacin|lomefloxacin|mesh-list
24820299|NCT02099240|Nalidixic Acid|nalidixic acid|mesh-list
24820300|NCT02099240|Sparfloxacin|sparfloxacin|mesh-list
25849346|NCT00048152|Mycophenolic Acid|mycophenolic acid|mesh-list
25849347|NCT00048152|Cyclosporine|cyclosporine|mesh-list
25849348|NCT00048152|Cyclosporins|cyclosporins|mesh-list
25849349|NCT00048152|Daclizumab|daclizumab|mesh-list
25849350|NCT00048152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25849351|NCT00048152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849352|NCT00048152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25849353|NCT00048152|Antitubercular Agents|antitubercular agents|mesh-ancestor
25849354|NCT00048152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25849355|NCT00048152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24408630|NCT00178945|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24408634|NCT00178945|Cholinergic Agents|cholinergic agents|mesh-ancestor
24820301|NCT02099240|Methacycline|methacycline|mesh-list
24820302|NCT02099240|Tetracycline|tetracycline|mesh-list
24820303|NCT02099240|Chlortetracycline|chlortetracycline|mesh-list
24820304|NCT02099240|Dalfopristin|dalfopristin|mesh-list
24820305|NCT02099240|Novobiocin|novobiocin|mesh-list
24820306|NCT02099240|Spectinomycin|spectinomycin|mesh-list
24820307|NCT02099240|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24820308|NCT02099240|Sulfamethoxazole|sulfamethoxazole|mesh-list
24820309|NCT02099240|Sulfasalazine|sulfasalazine|mesh-list
24820310|NCT02099240|Silver Sulfadiazine|silver sulfadiazine|mesh-list
24820311|NCT02099240|Methenamine|methenamine|mesh-list
24820312|NCT02099240|Sulperazone|sulperazone|mesh-list
24820313|NCT02099240|Sulfisoxazole|sulfisoxazole|mesh-list
24820314|NCT02099240|Cinoxacin|cinoxacin|mesh-list
24820315|NCT02099240|Nitrofurazone|nitrofurazone|mesh-list
24820316|NCT02099240|Trimethoprim|trimethoprim|mesh-list
24820317|NCT02099240|Sulfamethizole|sulfamethizole|mesh-list
24820318|NCT02099240|Procaine|procaine|mesh-list
24820319|NCT02099240|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24820320|NCT02099240|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25849356|NCT00048152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408641|NCT00178971|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24408642|NCT00178971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24408643|NCT00178971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408644|NCT00178971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24408645|NCT00178971|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24408648|NCT00178971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662035|NCT01641081|Adrenergic Agents|adrenergic agents|mesh-ancestor
25662036|NCT01641081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25662037|NCT01641081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662038|NCT01641120|Interferons|interferons|mesh-list
25662039|NCT01641120|Interferon-beta|interferon-beta|mesh-list
25662040|NCT01641120|Interferon beta-1a|interferon beta-1a|mesh-list
25662041|NCT01641120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662042|NCT01641120|Antiviral Agents|antiviral agents|mesh-ancestor
25662043|NCT01641120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25662044|NCT01641120|Immunologic Factors|immunologic factors|mesh-ancestor
24408650|NCT00179023|Pseudoephedrine|pseudoephedrine|mesh-list
24408652|NCT00179023|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
24408653|NCT00179023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24408654|NCT00179023|Autonomic Agents|autonomic agents|mesh-ancestor
24408655|NCT00179023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24408684|NCT00179062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24408685|NCT00179062|Dopamine Agents|dopamine agents|mesh-ancestor
24408686|NCT00179062|Antiemetics|antiemetics|mesh-ancestor
24408687|NCT00179062|Autonomic Agents|autonomic agents|mesh-ancestor
24408688|NCT00179062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24408690|NCT00179062|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24408698|NCT00179114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24820322|NCT02099240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24820323|NCT02099240|Antitubercular Agents|antitubercular agents|mesh-ancestor
24820324|NCT02099240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24541839|NCT00675649|Immunologic Factors|immunologic factors|mesh-ancestor
24408710|NCT00179231|Clozapine|clozapine|mesh-list
24408711|NCT00179231|Antiemetics|antiemetics|mesh-ancestor
24408712|NCT00179231|Autonomic Agents|autonomic agents|mesh-ancestor
24408713|NCT00179231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24408714|NCT00179231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849357|NCT00048152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849358|NCT00048152|Antifungal Agents|antifungal agents|mesh-ancestor
24408777|NCT00179465|GABA Agents|gaba agents|mesh-ancestor
24408778|NCT00179465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24408779|NCT00179608|Lenalidomide|lenalidomide|mesh-list
24408780|NCT00179608|Immunologic Factors|immunologic factors|mesh-ancestor
24408781|NCT00179608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408782|NCT00179608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24408783|NCT00179608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24408784|NCT00179608|Growth Substances|growth substances|mesh-ancestor
24408785|NCT00179608|Growth Inhibitors|growth inhibitors|mesh-ancestor
24408786|NCT00179608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849359|NCT00048152|Dermatologic Agents|dermatologic agents|mesh-ancestor
25849360|NCT00048152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25849361|NCT00048152|Immunologic Factors|immunologic factors|mesh-ancestor
25849362|NCT00048152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820381|NCT02099253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24820382|NCT02099253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576215|NCT00837655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24820383|NCT02099253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24820384|NCT02099253|Analgesics|analgesics|mesh-ancestor
24820385|NCT02099253|Sensory System Agents|sensory system agents|mesh-ancestor
24820386|NCT02099253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24820390|NCT02099253|Adrenergic Agents|adrenergic agents|mesh-ancestor
24820391|NCT02099253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24820392|NCT02099253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820393|NCT02099292|Rituximab|rituximab|mesh-list
24820394|NCT02099292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24820395|NCT02099292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24820396|NCT02099292|Immunologic Factors|immunologic factors|mesh-ancestor
24820397|NCT02099292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820398|NCT02099292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24820399|NCT02099331|Melatonin|melatonin|mesh-list
24820400|NCT02099331|Antioxidants|antioxidants|mesh-ancestor
24611287|NCT01008293|Lactulose|lactulose|mesh-list
25662045|NCT01641120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662046|NCT01641120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25674355|NCT01770483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849363|NCT00048152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25849364|NCT00048152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25849365|NCT00048204|Paroxetine|paroxetine|mesh-list
25849366|NCT00048204|Vestipitant|vestipitant|mesh-list
24820407|NCT02099357|Micronutrients|micronutrients|mesh-ancestor
25849367|NCT00048204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24820408|NCT02099357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820409|NCT02099357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24820410|NCT02099396|Gemcitabine|gemcitabine|mesh-list
24820411|NCT02099396|Docetaxel|docetaxel|mesh-list
24820412|NCT02099396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24820413|NCT02099396|Antimetabolites|antimetabolites|mesh-ancestor
24408804|NCT00179699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24408806|NCT00179699|Growth Substances|growth substances|mesh-ancestor
24408818|NCT00179712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24408822|NCT00179725|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24408823|NCT00179725|Lenalidomide|lenalidomide|mesh-list
25849368|NCT00048204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25849369|NCT00048204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24408824|NCT00179725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24408825|NCT00179725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408826|NCT00179725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24408827|NCT00179725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24408828|NCT00179725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408829|NCT00179725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408830|NCT00179725|Immunologic Factors|immunologic factors|mesh-ancestor
24408831|NCT00179725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408832|NCT00179725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24408833|NCT00179725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24408834|NCT00179725|Growth Substances|growth substances|mesh-ancestor
24408835|NCT00179725|Growth Inhibitors|growth inhibitors|mesh-ancestor
24408836|NCT00179738|Lenalidomide|lenalidomide|mesh-list
24408837|NCT00179738|Immunologic Factors|immunologic factors|mesh-ancestor
24408838|NCT00179738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820414|NCT02099396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820416|NCT02099396|Antiviral Agents|antiviral agents|mesh-ancestor
24820417|NCT02099396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24408854|NCT00179751|Immunologic Factors|immunologic factors|mesh-ancestor
24408855|NCT00179751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408856|NCT00179751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24408857|NCT00179751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24408858|NCT00179751|Growth Substances|growth substances|mesh-ancestor
24408859|NCT00179751|Growth Inhibitors|growth inhibitors|mesh-ancestor
24408860|NCT00179764|Busulfan|busulfan|mesh-list
24408861|NCT00179764|Alkylating Agents|alkylating agents|mesh-ancestor
24408862|NCT00179764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408863|NCT00179764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24408864|NCT00179764|Immunologic Factors|immunologic factors|mesh-ancestor
25041735|NCT01590719|Leucovorin|leucovorin|mesh-list
24408865|NCT00179764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408866|NCT00179764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24408867|NCT00179764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408868|NCT00179764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24408869|NCT00179816|Cyclophosphamide|cyclophosphamide|mesh-list
24408870|NCT00179816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24408871|NCT00179816|Immunologic Factors|immunologic factors|mesh-ancestor
24408879|NCT00179881|Thalidomide|thalidomide|mesh-list
25876117|NCT03907488|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24463374|NCT00360438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24408880|NCT00179881|Carboplatin|carboplatin|mesh-list
24408881|NCT00179881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408882|NCT00179881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24408883|NCT00179881|Immunologic Factors|immunologic factors|mesh-ancestor
24408884|NCT00179881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408885|NCT00179881|Leprostatic Agents|leprostatic agents|mesh-ancestor
24408886|NCT00179881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25849370|NCT00048204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849371|NCT00048204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24408891|NCT00179881|Growth Inhibitors|growth inhibitors|mesh-ancestor
24408893|NCT00179920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849372|NCT00048204|Serotonin Agents|serotonin agents|mesh-ancestor
25849373|NCT00048204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408895|NCT00180011|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24820423|NCT02099396|Antimitotic Agents|antimitotic agents|mesh-ancestor
24820424|NCT02099396|Mitosis Modulators|mitosis modulators|mesh-ancestor
24820425|NCT02099474|Raltegravir Potassium|raltegravir potassium|mesh-list
24820427|NCT02099474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24820428|NCT02099474|Antiviral Agents|antiviral agents|mesh-ancestor
24820429|NCT02099474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24820430|NCT02099474|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24408896|NCT00180011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24408897|NCT00180011|Respiratory System Agents|respiratory system agents|mesh-ancestor
24408899|NCT00180024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24408900|NCT00180024|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24409164|NCT00181116|Anticonvulsants|anticonvulsants|mesh-ancestor
24408901|NCT00180024|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24408902|NCT00180024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408906|NCT00180037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408909|NCT00180050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24408910|NCT00180050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24408911|NCT00180050|Autonomic Agents|autonomic agents|mesh-ancestor
24408912|NCT00180050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24408913|NCT00180050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408914|NCT00180050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24408915|NCT00180050|Respiratory System Agents|respiratory system agents|mesh-ancestor
24408916|NCT00180050|Glucocorticoids|glucocorticoids|mesh-ancestor
24408917|NCT00180050|Hormones|hormones|mesh-ancestor
24408925|NCT00180076|Autonomic Agents|autonomic agents|mesh-ancestor
24408926|NCT00180076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24408927|NCT00180076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408928|NCT00180076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24408929|NCT00180076|Respiratory System Agents|respiratory system agents|mesh-ancestor
24408930|NCT00180076|Glucocorticoids|glucocorticoids|mesh-ancestor
24408931|NCT00180076|Hormones|hormones|mesh-ancestor
24408932|NCT00180076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24408940|NCT00180089|Respiratory System Agents|respiratory system agents|mesh-ancestor
24408941|NCT00180089|Glucocorticoids|glucocorticoids|mesh-ancestor
24408960|NCT00180102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24408961|NCT00180102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408962|NCT00180115|Cytarabine|cytarabine|mesh-list
24408963|NCT00180115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24408964|NCT00180115|Antimetabolites|antimetabolites|mesh-ancestor
24820431|NCT02099474|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24820432|NCT02099474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820433|NCT02099474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820435|NCT02099604|Interferons|interferons|mesh-list
24820436|NCT02099604|Ribavirin|ribavirin|mesh-list
24820437|NCT02099604|Interferon-alpha|interferon-alpha|mesh-list
24820438|NCT02099604|Interferon alpha-2|interferon alpha-2|mesh-list
24820439|NCT02099604|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24820440|NCT02099604|Vitamins|vitamins|mesh-ancestor
24820441|NCT02099604|Micronutrients|micronutrients|mesh-ancestor
24820442|NCT02099604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820443|NCT02099604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24820444|NCT02099604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24820445|NCT02099604|Antiviral Agents|antiviral agents|mesh-ancestor
24820446|NCT02099604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24820447|NCT02099604|Antimetabolites|antimetabolites|mesh-ancestor
24681758|NCT01381835|Simeprevir|simeprevir|mesh-list
24408965|NCT00180115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408966|NCT00180115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408967|NCT00180115|Antiviral Agents|antiviral agents|mesh-ancestor
25662047|NCT01641133|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25876118|NCT03907488|Dacarbazine|dacarbazine|mesh-list
25849374|NCT00048204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24408968|NCT00180115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24408969|NCT00180115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24408983|NCT00180128|Immunologic Factors|immunologic factors|mesh-ancestor
24408984|NCT00180128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408990|NCT00180128|Sensory System Agents|sensory system agents|mesh-ancestor
24408991|NCT00180128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24408992|NCT00180141|Pimecrolimus|pimecrolimus|mesh-list
24408993|NCT00180141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24408994|NCT00180141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24408995|NCT00180141|Analgesics|analgesics|mesh-ancestor
24408996|NCT00180141|Sensory System Agents|sensory system agents|mesh-ancestor
24408997|NCT00180141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24408998|NCT00180141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408999|NCT00180141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24409000|NCT00180141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24409001|NCT00180141|Dermatologic Agents|dermatologic agents|mesh-ancestor
24820450|NCT02099617|Oxymetazoline|oxymetazoline|mesh-list
24820451|NCT02099617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24820452|NCT02099617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24820453|NCT02099617|Adrenergic Agents|adrenergic agents|mesh-ancestor
24820454|NCT02099617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24820455|NCT02099617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542007|NCT00676416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24409013|NCT00180310|Antimitotic Agents|antimitotic agents|mesh-ancestor
24409014|NCT00180310|Mitosis Modulators|mitosis modulators|mesh-ancestor
24409015|NCT00180310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397501|NCT00141648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24409016|NCT00180310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24409017|NCT00180310|Immunologic Factors|immunologic factors|mesh-ancestor
24409018|NCT00180310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409020|NCT00180622|Carbon Monoxide|carbon monoxide|mesh-list
25849375|NCT00048204|Antidepressive Agents|antidepressive agents|mesh-ancestor
24409021|NCT00180622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24409023|NCT00180622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24409024|NCT00180622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409025|NCT00180622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24409026|NCT00180622|Respiratory System Agents|respiratory system agents|mesh-ancestor
24409027|NCT00180622|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24409028|NCT00180622|Antioxidants|antioxidants|mesh-ancestor
24409029|NCT00180622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409030|NCT00180622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24409031|NCT00180622|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24409032|NCT00180622|Vasodilator Agents|vasodilator agents|mesh-ancestor
24409033|NCT00180622|Gasotransmitters|gasotransmitters|mesh-ancestor
24820467|NCT02099695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820468|NCT02099695|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24820469|NCT02099695|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24820470|NCT02099695|Cholinergic Agents|cholinergic agents|mesh-ancestor
24820471|NCT02099695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24820472|NCT02099695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820473|NCT02099695|Urological Agents|urological agents|mesh-ancestor
24820474|NCT02099825|Cycloserine|cycloserine|mesh-list
24820475|NCT02099825|Mifepristone|mifepristone|mesh-list
24820476|NCT02099825|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24820477|NCT02099825|Abortifacient Agents|abortifacient agents|mesh-ancestor
24820478|NCT02099825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24820479|NCT02099825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820480|NCT02099825|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24820481|NCT02099825|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24820482|NCT02099825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24820483|NCT02099825|Contraceptive Agents|contraceptive agents|mesh-ancestor
25849376|NCT00048204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25849377|NCT00048204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25849378|NCT00048204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25849379|NCT00048204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849380|NCT00048204|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25849381|NCT00048230|Bortezomib|bortezomib|mesh-list
25849382|NCT00048230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849383|NCT00048334|Romidepsin|romidepsin|mesh-list
24820484|NCT02099825|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24820485|NCT02099825|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24820486|NCT02099825|Hormone Antagonists|hormone antagonists|mesh-ancestor
24820487|NCT02099825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24820488|NCT02099825|Luteolytic Agents|luteolytic agents|mesh-ancestor
24820489|NCT02099825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24820490|NCT02099825|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24820491|NCT02099825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24820555|NCT02100202|Antioxidants|antioxidants|mesh-ancestor
24409049|NCT00180791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24409050|NCT00180791|Alkylating Agents|alkylating agents|mesh-ancestor
24409051|NCT00180791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24409052|NCT00180791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24409053|NCT00180791|Immunologic Factors|immunologic factors|mesh-ancestor
24409054|NCT00180791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409055|NCT00180830|Imatinib Mesylate|imatinib mesylate|mesh-list
24409056|NCT00180830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409057|NCT00180830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24409058|NCT00180830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820495|NCT02099825|Antitubercular Agents|antitubercular agents|mesh-ancestor
24820496|NCT02099825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24820497|NCT02099825|Antimetabolites|antimetabolites|mesh-ancestor
24820498|NCT02099825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820500|NCT02099877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24820501|NCT02099877|Narcotics|narcotics|mesh-ancestor
24820502|NCT02099877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24409059|NCT00180830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409078|NCT00180843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24409079|NCT00180843|Cholinergic Agents|cholinergic agents|mesh-ancestor
24409080|NCT00180882|Rituximab|rituximab|mesh-list
24409081|NCT00180882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24409082|NCT00180882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409083|NCT00180882|Immunologic Factors|immunologic factors|mesh-ancestor
24409084|NCT00180882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409085|NCT00180882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24409087|NCT00180895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24409088|NCT00180895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409089|NCT00180895|Immunologic Factors|immunologic factors|mesh-ancestor
24409090|NCT00180895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409091|NCT00180895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24409093|NCT00180908|Etoposide|etoposide|mesh-list
24409094|NCT00180908|Methotrexate|methotrexate|mesh-list
24409095|NCT00180908|Ifosfamide|ifosfamide|mesh-list
25849384|NCT00048334|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25849385|NCT00048334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409127|NCT00180947|Mitosis Modulators|mitosis modulators|mesh-ancestor
24409128|NCT00180947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409129|NCT00180960|Oxaliplatin|oxaliplatin|mesh-list
24409131|NCT00180960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409132|NCT00180960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24820503|NCT02099877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409135|NCT00180960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409136|NCT00180973|Hydroxyurea|hydroxyurea|mesh-list
24409137|NCT00180973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409139|NCT00180973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409140|NCT00180973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409141|NCT00180973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24409142|NCT00181012|Lidocaine|lidocaine|mesh-list
24409143|NCT00181012|Anesthetics, Local|anesthetics, local|mesh-ancestor
24409144|NCT00181012|Anesthetics|anesthetics|mesh-ancestor
24409145|NCT00181012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24409146|NCT00181012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409147|NCT00181012|Sensory System Agents|sensory system agents|mesh-ancestor
24820537|NCT02099981|Pimagedine|pimagedine|mesh-list
24820538|NCT02099981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820539|NCT02099981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820540|NCT02100046|Ethosuximide|ethosuximide|mesh-list
24820541|NCT02100046|Anticonvulsants|anticonvulsants|mesh-ancestor
24576360|NCT00838214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24576361|NCT00838214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820542|NCT02100176|Dopamine|dopamine|mesh-list
24820543|NCT02100176|Rotigotine|rotigotine|mesh-list
24820544|NCT02100176|Dopamine Agonists|dopamine agonists|mesh-list
25849386|NCT00048360|Bupropion|bupropion|mesh-list
24463620|NCT00361621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24463621|NCT00361621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24463622|NCT00361621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24820545|NCT02100176|Dopamine Agents|dopamine agents|mesh-ancestor
24820546|NCT02100176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24820547|NCT02100176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820548|NCT02100176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820549|NCT02100176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24820550|NCT02100176|Sympathomimetics|sympathomimetics|mesh-ancestor
24820551|NCT02100176|Autonomic Agents|autonomic agents|mesh-ancestor
24820552|NCT02100176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24820553|NCT02100176|Protective Agents|protective agents|mesh-ancestor
24820554|NCT02100202|Turmeric extract|turmeric extract|mesh-list
24820556|NCT02100202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820557|NCT02100202|Protective Agents|protective agents|mesh-ancestor
24682026|NCT01383460|Epoetin Alfa|epoetin alfa|mesh-list
24409150|NCT00181012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24409151|NCT00181012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24409152|NCT00181012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24409153|NCT00181012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409155|NCT00181025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24409156|NCT00181025|Alkylating Agents|alkylating agents|mesh-ancestor
24409157|NCT00181025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409158|NCT00181025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409159|NCT00181025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24409160|NCT00181025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24409161|NCT00181025|Immunologic Factors|immunologic factors|mesh-ancestor
24409162|NCT00181025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409163|NCT00181116|Levetiracetam|levetiracetam|mesh-list
24820558|NCT02100202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820562|NCT02100267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24820563|NCT02100267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820564|NCT02100267|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24820565|NCT02100267|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
24820566|NCT02100267|Respiratory System Agents|respiratory system agents|mesh-ancestor
24820567|NCT02100267|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24820568|NCT02100267|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24820592|NCT02100423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820593|NCT02100423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24820594|NCT02100423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24820595|NCT02100423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24820596|NCT02100423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24820597|NCT02100423|Analgesics|analgesics|mesh-ancestor
24820598|NCT02100423|Sensory System Agents|sensory system agents|mesh-ancestor
24820599|NCT02100423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24820600|NCT02100423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24820601|NCT02100423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24820602|NCT02100423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407802|NCT00175565|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24409172|NCT00181181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24409174|NCT00181181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409175|NCT00181181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24409176|NCT00181181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24409177|NCT00181181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409179|NCT00181220|Anticonvulsants|anticonvulsants|mesh-ancestor
24409180|NCT00181220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409181|NCT00181220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409183|NCT00181220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24409184|NCT00181220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820622|NCT02100462|Antipyretics|antipyretics|mesh-ancestor
24820623|NCT02100462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24820624|NCT02100462|Diuretics|diuretics|mesh-ancestor
25662048|NCT01641133|Immunologic Factors|immunologic factors|mesh-ancestor
25662049|NCT01641133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662050|NCT01641159|Buspirone|buspirone|mesh-list
25662051|NCT01641159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25662052|NCT01641159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24409193|NCT00181246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409195|NCT00181246|Sensory System Agents|sensory system agents|mesh-ancestor
24409196|NCT00181246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24409197|NCT00181246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24409198|NCT00181246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24409199|NCT00181246|Anesthetics, General|anesthetics, general|mesh-ancestor
24409200|NCT00181246|Anesthetics|anesthetics|mesh-ancestor
24409203|NCT00181272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24409204|NCT00181298|Memantine|memantine|mesh-list
24409205|NCT00181298|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24409206|NCT00181298|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24409207|NCT00181298|Dopamine Agents|dopamine agents|mesh-ancestor
24409208|NCT00181298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24820648|NCT02100605|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24598858|NCT05352191|Hormones|hormones|mesh-ancestor
24820649|NCT02100605|Respiratory System Agents|respiratory system agents|mesh-ancestor
24820650|NCT02100605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24820651|NCT02100605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820652|NCT02100605|Sympathomimetics|sympathomimetics|mesh-ancestor
24682210|NCT01384773|Vitamins|vitamins|mesh-ancestor
24409220|NCT00181532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24820653|NCT02100605|Autonomic Agents|autonomic agents|mesh-ancestor
24820654|NCT02100605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24820655|NCT02100605|Adrenergic Agents|adrenergic agents|mesh-ancestor
24820656|NCT02100605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24820657|NCT02100605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820658|NCT02100605|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24820659|NCT02100605|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24820660|NCT02100761|Voriconazole|voriconazole|mesh-list
24820661|NCT02100761|Antifungal Agents|antifungal agents|mesh-ancestor
24820662|NCT02100761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24820663|NCT02100761|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24820664|NCT02100761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24820665|NCT02100761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820666|NCT02100761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576497|NCT00838955|Antifungal Agents|antifungal agents|mesh-ancestor
25201037|NCT02730364|Acetaminophen|acetaminophen|mesh-list
24576588|NCT00839358|Adrenergic Agents|adrenergic agents|mesh-ancestor
24820681|NCT02100852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820682|NCT02100917|Trastuzumab|trastuzumab|mesh-list
24820683|NCT02100917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24820684|NCT02100917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24820685|NCT02101047|Phenylephrine|phenylephrine|mesh-list
24415209|NCT00199095|Hormones|hormones|mesh-ancestor
24820686|NCT02101047|Oxymetazoline|oxymetazoline|mesh-list
24820687|NCT02101047|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24820688|NCT02101047|Mydriatics|mydriatics|mesh-ancestor
24820689|NCT02101047|Autonomic Agents|autonomic agents|mesh-ancestor
24820690|NCT02101047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24820691|NCT02101047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662053|NCT01641159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25662054|NCT01641159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662055|NCT01641159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24409324|NCT00181779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24409325|NCT00181779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24409326|NCT00181779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24409327|NCT00181779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24409328|NCT00181779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820694|NCT02101047|Nasal Decongestants|nasal decongestants|mesh-ancestor
24820695|NCT02101047|Respiratory System Agents|respiratory system agents|mesh-ancestor
24820696|NCT02101047|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24820697|NCT02101047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25203442|NCT02714231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24820700|NCT02101047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24820701|NCT02101047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820702|NCT02101047|Protective Agents|protective agents|mesh-ancestor
24820703|NCT02101125|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24820704|NCT02101125|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24820705|NCT02101125|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24820706|NCT02101125|Antimetabolites|antimetabolites|mesh-ancestor
24820707|NCT02101125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820708|NCT02101125|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24409329|NCT00181779|Dopamine Agonists|dopamine agonists|mesh-ancestor
24409330|NCT00181779|Dopamine Agents|dopamine agents|mesh-ancestor
24409331|NCT00181779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24409332|NCT00181779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409333|NCT00181779|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24409334|NCT00181779|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24409335|NCT00181779|Serotonin Agents|serotonin agents|mesh-ancestor
24409336|NCT00181779|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24409356|NCT00181870|Antimanic Agents|antimanic agents|mesh-ancestor
24409357|NCT00181870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24409358|NCT00181870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24409359|NCT00181870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409360|NCT00181870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24409361|NCT00181870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24409362|NCT00181870|Analgesics|analgesics|mesh-ancestor
24409363|NCT00181870|Sensory System Agents|sensory system agents|mesh-ancestor
24820720|NCT02101138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24820721|NCT02101151|Vitamin D|vitamin d|mesh-list
24820722|NCT02101151|Cholecalciferol|cholecalciferol|mesh-list
24820723|NCT02101151|Vitamins|vitamins|mesh-ancestor
24820724|NCT02101151|Micronutrients|micronutrients|mesh-ancestor
24820725|NCT02101151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820726|NCT02101151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24820727|NCT02101151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24820728|NCT02101164|Denosumab|denosumab|mesh-list
24820729|NCT02101164|Pamidronate|pamidronate|mesh-list
24820730|NCT02101164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24409364|NCT00181870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24409365|NCT00181870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25053215|NCT00084253|Lamivudine|lamivudine|mesh-list
24409366|NCT00181870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24409367|NCT00181870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409368|NCT00181870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24409429|NCT00181987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409441|NCT00182013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24409444|NCT00182013|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24409445|NCT00182013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24409446|NCT00182013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24409447|NCT00182013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24409448|NCT00182013|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24820737|NCT02101203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24820738|NCT02101203|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24820739|NCT02101203|Serotonin Agents|serotonin agents|mesh-ancestor
24820740|NCT02101203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24820741|NCT02101203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820743|NCT02101216|Dideoxynucleosides|dideoxynucleosides|mesh-list
24820744|NCT02101216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24820745|NCT02101216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24820746|NCT02101216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820747|NCT02101216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820748|NCT02101216|Antiviral Agents|antiviral agents|mesh-ancestor
24820749|NCT02101216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24820750|NCT02101216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24820751|NCT02101216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24409456|NCT00182013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24409457|NCT00182013|Antidepressive Agents|antidepressive agents|mesh-ancestor
24409459|NCT00182039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24409460|NCT00182039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24409461|NCT00182039|Sympatholytics|sympatholytics|mesh-ancestor
24409462|NCT00182039|Autonomic Agents|autonomic agents|mesh-ancestor
24409495|NCT00182260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849389|NCT00048360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24409499|NCT00182312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409501|NCT00182312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409502|NCT00182312|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24820752|NCT02101216|Antimetabolites|antimetabolites|mesh-ancestor
24576589|NCT00839358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24820753|NCT02101229|Insulin|insulin|mesh-list
24820754|NCT02101229|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24820755|NCT02101229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24820756|NCT02101229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820757|NCT02101255|Fluorides|fluorides|mesh-list
24820758|NCT02101255|Cariostatic Agents|cariostatic agents|mesh-ancestor
24820759|NCT02101255|Protective Agents|protective agents|mesh-ancestor
24820760|NCT02101255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409519|NCT00182364|Anticoagulants|anticoagulants|mesh-ancestor
24409520|NCT00182364|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24409521|NCT00182364|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24409522|NCT00182364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409523|NCT00182377|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24409524|NCT00182377|Plasma Substitutes|plasma substitutes|mesh-ancestor
24409525|NCT00182377|Blood Substitutes|blood substitutes|mesh-ancestor
24409526|NCT00182429|Metronidazole|metronidazole|mesh-list
25849390|NCT00048360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25849391|NCT00048360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25849392|NCT00048360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24409527|NCT00182429|Rifampin|rifampin|mesh-list
24409528|NCT00182429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24409529|NCT00182429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24409530|NCT00182429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24409531|NCT00182429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24409532|NCT00182429|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24820765|NCT02101476|Sensory System Agents|sensory system agents|mesh-ancestor
24820766|NCT02101476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24820767|NCT02101476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820768|NCT02101476|Antipyretics|antipyretics|mesh-ancestor
24820769|NCT02101476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24820770|NCT02101476|Narcotics|narcotics|mesh-ancestor
24820771|NCT02101476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24820773|NCT02101567|Carbetocin|carbetocin|mesh-list
24451822|NCT00324831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25849393|NCT00048360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849394|NCT00048360|Dopamine Agents|dopamine agents|mesh-ancestor
24451823|NCT00324831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24451824|NCT00324831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24451825|NCT00324831|Tubulin Modulators|tubulin modulators|mesh-ancestor
24451826|NCT00324831|Antimitotic Agents|antimitotic agents|mesh-ancestor
24451827|NCT00324831|Mitosis Modulators|mitosis modulators|mesh-ancestor
25849395|NCT00048360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24409558|NCT00182442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409559|NCT00182442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24409560|NCT00182442|Serotonin Agents|serotonin agents|mesh-ancestor
24409561|NCT00182442|Antidepressive Agents|antidepressive agents|mesh-ancestor
24409562|NCT00182455|Topiramate|topiramate|mesh-list
24409563|NCT00182455|Anticonvulsants|anticonvulsants|mesh-ancestor
24409580|NCT00182507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24409581|NCT00182507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24409582|NCT00182507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409583|NCT00182507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24409584|NCT00182507|Serotonin Agents|serotonin agents|mesh-ancestor
24409585|NCT00182520|Topiramate|topiramate|mesh-list
24409586|NCT00182520|Anticonvulsants|anticonvulsants|mesh-ancestor
24409587|NCT00182520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24409588|NCT00182520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409589|NCT00182533|Sertraline|sertraline|mesh-list
24409590|NCT00182533|Antidepressive Agents|antidepressive agents|mesh-ancestor
24409591|NCT00182533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25203443|NCT02714231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24409592|NCT00182533|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24820782|NCT02101632|Emollients|emollients|mesh-ancestor
24820783|NCT02101632|Dermatologic Agents|dermatologic agents|mesh-ancestor
24820784|NCT02101710|Isosorbide|isosorbide|mesh-list
24820785|NCT02101710|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24820786|NCT02101710|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
24820787|NCT02101710|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24820788|NCT02101710|Diuretics|diuretics|mesh-ancestor
24820789|NCT02101710|Natriuretic Agents|natriuretic agents|mesh-ancestor
24820790|NCT02101710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820791|NCT02101710|Vasodilator Agents|vasodilator agents|mesh-ancestor
24820792|NCT02101710|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24820793|NCT02101710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820794|NCT02101840|Oxycodone|oxycodone|mesh-list
24409598|NCT00182533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409599|NCT00182559|Cyclosporine|cyclosporine|mesh-list
24409600|NCT00182559|Tacrolimus|tacrolimus|mesh-list
24409601|NCT00182559|Cyclosporins|cyclosporins|mesh-list
24409943|NCT00183911|Protective Agents|protective agents|mesh-ancestor
24409602|NCT00182559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24409603|NCT00182559|Immunologic Factors|immunologic factors|mesh-ancestor
24409604|NCT00182559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425533|NCT00233584|Hormones|hormones|mesh-ancestor
24409605|NCT00182559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24409606|NCT00182559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409607|NCT00182559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409608|NCT00182559|Antifungal Agents|antifungal agents|mesh-ancestor
24409609|NCT00182559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24409610|NCT00182559|Dermatologic Agents|dermatologic agents|mesh-ancestor
24409611|NCT00182559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24409612|NCT00182572|Naltrexone|naltrexone|mesh-list
24409613|NCT00182572|Buprenorphine|buprenorphine|mesh-list
24409616|NCT00182572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24409617|NCT00182572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409618|NCT00182572|Analgesics|analgesics|mesh-ancestor
24409619|NCT00182572|Sensory System Agents|sensory system agents|mesh-ancestor
24409620|NCT00182572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24409621|NCT00182572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24409622|NCT00182572|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24409639|NCT00182650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409640|NCT00182650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24409641|NCT00182650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24409642|NCT00182650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24820803|NCT02101892|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24820847|NCT02102295|Protective Agents|protective agents|mesh-ancestor
24820848|NCT02102295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820849|NCT02102295|Antioxidants|antioxidants|mesh-ancestor
24820850|NCT02102295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820851|NCT02102295|Vitamins|vitamins|mesh-ancestor
24820852|NCT02102295|Micronutrients|micronutrients|mesh-ancestor
25419570|NCT02693535|Nivolumab|nivolumab|mesh-list
24820855|NCT02102321|Anthelmintics|anthelmintics|mesh-ancestor
24409657|NCT00182663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24409658|NCT00182663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409659|NCT00182663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24409660|NCT00182663|Immunologic Factors|immunologic factors|mesh-ancestor
24409661|NCT00182663|Leprostatic Agents|leprostatic agents|mesh-ancestor
24409662|NCT00182663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24409663|NCT00182663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24409664|NCT00182663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24426336|NCT00235859|Antimetabolites|antimetabolites|mesh-ancestor
24409665|NCT00182663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24409666|NCT00182663|Growth Substances|growth substances|mesh-ancestor
24409667|NCT00182663|Growth Inhibitors|growth inhibitors|mesh-ancestor
24409668|NCT00182663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24409669|NCT00182663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409670|NCT00182663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409671|NCT00182663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24409672|NCT00182663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24409673|NCT00182702|Epothilones|epothilones|mesh-list
24409674|NCT00182702|Epothilone B|epothilone b|mesh-list
24409675|NCT00182702|Tubulin Modulators|tubulin modulators|mesh-ancestor
24409676|NCT00182702|Antimitotic Agents|antimitotic agents|mesh-ancestor
24409677|NCT00182702|Mitosis Modulators|mitosis modulators|mesh-ancestor
24409678|NCT00182702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820876|NCT02102438|Mitosis Modulators|mitosis modulators|mesh-ancestor
24411042|NCT00187499|Autonomic Agents|autonomic agents|mesh-ancestor
24599456|NCT04562129|Sensory System Agents|sensory system agents|mesh-ancestor
24820878|NCT02102438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24820880|NCT02102516|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24820881|NCT02102516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24820882|NCT02102516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24820883|NCT02102516|Analgesics|analgesics|mesh-ancestor
24820884|NCT02102516|Sensory System Agents|sensory system agents|mesh-ancestor
24820885|NCT02102516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24409682|NCT00182715|Capecitabine|capecitabine|mesh-list
24409683|NCT00182715|Oxaliplatin|oxaliplatin|mesh-list
24409684|NCT00182715|Cetuximab|cetuximab|mesh-list
24409685|NCT00182715|Calcium|calcium|mesh-list
24409686|NCT00182715|Levoleucovorin|levoleucovorin|mesh-list
24409687|NCT00182715|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24409688|NCT00182715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409701|NCT00182741|Calcitriol|calcitriol|mesh-list
24409702|NCT00182741|Prednisone|prednisone|mesh-list
24409703|NCT00182741|Mitoxantrone|mitoxantrone|mesh-list
24409704|NCT00182741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24409706|NCT00182741|Hormones|hormones|mesh-ancestor
24409707|NCT00182741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24820902|NCT02102620|Anesthetics, Local|anesthetics, local|mesh-ancestor
24820903|NCT02102620|Anesthetics|anesthetics|mesh-ancestor
24820904|NCT02102620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24820905|NCT02102620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820906|NCT02102620|Sensory System Agents|sensory system agents|mesh-ancestor
24820907|NCT02102620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24427130|NCT00237497|Zopiclone|zopiclone|mesh-list
24820908|NCT02102620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24820909|NCT02102620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24409708|NCT00182741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409709|NCT00182741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24409710|NCT00182741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409712|NCT00182741|Sensory System Agents|sensory system agents|mesh-ancestor
24409713|NCT00182741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24409714|NCT00182741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24409715|NCT00182741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24409716|NCT00182741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409717|NCT00182741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409718|NCT00182741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24409719|NCT00182741|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24409720|NCT00182741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24409721|NCT00182741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24409722|NCT00182741|Vitamins|vitamins|mesh-ancestor
24409723|NCT00182741|Micronutrients|micronutrients|mesh-ancestor
24409725|NCT00182806|Gemcitabine|gemcitabine|mesh-list
25674356|NCT01770483|Antiviral Agents|antiviral agents|mesh-ancestor
24452683|NCT05457829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24452684|NCT05457829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24409738|NCT00182806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24409740|NCT00182819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24409741|NCT00182819|Alkylating Agents|alkylating agents|mesh-ancestor
24409742|NCT00182819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409743|NCT00182819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409745|NCT00182845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24409746|NCT00182845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820910|NCT02102620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24409757|NCT00182884|Donepezil|donepezil|mesh-list
24409758|NCT00182884|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24409759|NCT00182884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409760|NCT00182884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409761|NCT00182884|Cholinergic Agents|cholinergic agents|mesh-ancestor
24409762|NCT00182884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24409763|NCT00182884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409764|NCT00182884|Nootropic Agents|nootropic agents|mesh-ancestor
24409765|NCT00183001|Vitamin K|vitamin k|mesh-list
24409766|NCT00183001|Vitamins|vitamins|mesh-ancestor
24409767|NCT00183001|Micronutrients|micronutrients|mesh-ancestor
24409768|NCT00183001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409769|NCT00183001|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24409807|NCT00183235|Dopamine Agonists|dopamine agonists|mesh-ancestor
24409808|NCT00183235|Dopamine Agents|dopamine agents|mesh-ancestor
24451831|NCT00324922|Sulfamethoxazole|sulfamethoxazole|mesh-list
24451833|NCT00324922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24451834|NCT00324922|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25849396|NCT00048360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849397|NCT00048360|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25849398|NCT00048360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24409889|NCT00183820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409890|NCT00183820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24409891|NCT00183820|Antimetabolites|antimetabolites|mesh-ancestor
24409892|NCT00183820|Antiviral Agents|antiviral agents|mesh-ancestor
24409893|NCT00183820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24409894|NCT00183820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409895|NCT00183820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24409896|NCT00183820|Immunologic Factors|immunologic factors|mesh-ancestor
24409897|NCT00183820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409898|NCT00183833|Capecitabine|capecitabine|mesh-list
24820920|NCT02102646|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24820921|NCT02102646|Luteolytic Agents|luteolytic agents|mesh-ancestor
24820922|NCT02102646|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24820923|NCT02102646|Contraceptive Agents|contraceptive agents|mesh-ancestor
24820924|NCT02102646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24820929|NCT02102672|Trimetazidine|trimetazidine|mesh-list
24820930|NCT02102672|Vasodilator Agents|vasodilator agents|mesh-ancestor
24820932|NCT02102698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24820933|NCT02102698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24814083|NCT02062255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24820934|NCT02102698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24820935|NCT02102698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820936|NCT02102698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24820937|NCT02102698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24820938|NCT02102698|Dopamine Agents|dopamine agents|mesh-ancestor
24820939|NCT02102698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24820940|NCT02102698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820942|NCT02102711|Vitamins|vitamins|mesh-ancestor
24820943|NCT02102711|Micronutrients|micronutrients|mesh-ancestor
24820944|NCT02102711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820945|NCT02102776|Mitomycins|mitomycins|mesh-list
24409899|NCT00183833|Imatinib Mesylate|imatinib mesylate|mesh-list
24409900|NCT00183833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24409901|NCT00183833|Antimetabolites|antimetabolites|mesh-ancestor
24430572|NCT00248261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409902|NCT00183833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409903|NCT00183833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409904|NCT00183833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24409905|NCT00183833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409906|NCT00183846|Irinotecan|irinotecan|mesh-list
25662056|NCT01641159|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25662057|NCT01641159|Serotonin Agents|serotonin agents|mesh-ancestor
25419571|NCT02693535|Trastuzumab|trastuzumab|mesh-list
25662058|NCT01641159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25849399|NCT00048360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464309|NCT00364195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464310|NCT00364195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464311|NCT00364195|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24464312|NCT00364221|Rosiglitazone|rosiglitazone|mesh-list
24464313|NCT00364221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24464314|NCT00364221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849400|NCT00048373|Etanercept|etanercept|mesh-list
24409907|NCT00183846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24409908|NCT00183846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24409909|NCT00183846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409910|NCT00183846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409911|NCT00183846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451855|NCT00324974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451873|NCT00325000|Adrenergic Agents|adrenergic agents|mesh-ancestor
24451874|NCT00325026|Misoprostol|misoprostol|mesh-list
24409912|NCT00183859|Irinotecan|irinotecan|mesh-list
24409913|NCT00183859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25876119|NCT03907488|Vinblastine|vinblastine|mesh-list
24820946|NCT02102776|Mitomycin|mitomycin|mesh-list
24820947|NCT02102776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24820948|NCT02102776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24820949|NCT02102776|Alkylating Agents|alkylating agents|mesh-ancestor
24820950|NCT02102776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820951|NCT02102776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24820952|NCT02102776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820953|NCT02102789|Leucovorin|leucovorin|mesh-list
24820954|NCT02102789|Dexamethasone|dexamethasone|mesh-list
24820955|NCT02102789|Fluorouracil|fluorouracil|mesh-list
24820956|NCT02102789|Oxaliplatin|oxaliplatin|mesh-list
24820957|NCT02102789|Floxuridine|floxuridine|mesh-list
24820958|NCT02102789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24820959|NCT02102789|Antiemetics|antiemetics|mesh-ancestor
24820960|NCT02102789|Autonomic Agents|autonomic agents|mesh-ancestor
24820961|NCT02102789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24411460|NCT00189072|Analgesics|analgesics|mesh-ancestor
24820962|NCT02102789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820963|NCT02102789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24820964|NCT02102789|Glucocorticoids|glucocorticoids|mesh-ancestor
24820965|NCT02102789|Hormones|hormones|mesh-ancestor
24791764|NCT03118232|Disinfectants|disinfectants|mesh-ancestor
24820966|NCT02102789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24820967|NCT02102789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24820968|NCT02102789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24820969|NCT02102789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820970|NCT02102789|Antimetabolites|antimetabolites|mesh-ancestor
24820971|NCT02102789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24820972|NCT02102789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24820973|NCT02102789|Immunologic Factors|immunologic factors|mesh-ancestor
24820974|NCT02102789|Antidotes|antidotes|mesh-ancestor
24409917|NCT00183859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409918|NCT00183885|Mitomycins|mitomycins|mesh-list
24409936|NCT00183911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409937|NCT00183911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24409938|NCT00183911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409939|NCT00183911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24409942|NCT00183911|Antidotes|antidotes|mesh-ancestor
24409945|NCT00183911|Vitamins|vitamins|mesh-ancestor
24409946|NCT00183911|Micronutrients|micronutrients|mesh-ancestor
24451875|NCT00325026|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24451876|NCT00325026|Abortifacient Agents|abortifacient agents|mesh-ancestor
24451877|NCT00325026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24820976|NCT02102789|Vitamin B Complex|vitamin b complex|mesh-ancestor
24820977|NCT02102789|Vitamins|vitamins|mesh-ancestor
24820978|NCT02102789|Micronutrients|micronutrients|mesh-ancestor
24820979|NCT02102815|Dexamethasone|dexamethasone|mesh-list
24820980|NCT02102815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24820981|NCT02102815|Antiemetics|antiemetics|mesh-ancestor
25662059|NCT01641159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662060|NCT01641237|Listerine|listerine|mesh-list
25662061|NCT01641237|Fluorides|fluorides|mesh-list
25662062|NCT01641237|Sodium Fluoride|sodium fluoride|mesh-list
25662063|NCT01641237|Cariostatic Agents|cariostatic agents|mesh-ancestor
25662064|NCT01641237|Protective Agents|protective agents|mesh-ancestor
25662065|NCT01641237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576870|NCT00840684|Analgesics|analgesics|mesh-ancestor
25662066|NCT01641237|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24464402|NCT00364702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24464403|NCT00364702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24464404|NCT00364702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464405|NCT00364702|Dopamine Agents|dopamine agents|mesh-ancestor
24464406|NCT00364702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25077374|NCT03365466|Anticoagulants|anticoagulants|mesh-ancestor
25077375|NCT03365388|Hyaluronic Acid|hyaluronic acid|mesh-list
24576871|NCT00840684|Sensory System Agents|sensory system agents|mesh-ancestor
24820982|NCT02102815|Autonomic Agents|autonomic agents|mesh-ancestor
24820983|NCT02102815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24576970|NCT00841256|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24820984|NCT02102815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820985|NCT02102815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24820986|NCT02102815|Glucocorticoids|glucocorticoids|mesh-ancestor
24820987|NCT02102815|Hormones|hormones|mesh-ancestor
24431804|NCT00252928|Antifungal Agents|antifungal agents|mesh-ancestor
24820988|NCT02102815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24820989|NCT02102815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24682943|NCT01389401|Omeprazole|omeprazole|mesh-list
24451878|NCT00325026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409961|NCT00183937|Tubulin Modulators|tubulin modulators|mesh-ancestor
24409962|NCT00183937|Antimitotic Agents|antimitotic agents|mesh-ancestor
24409963|NCT00183937|Mitosis Modulators|mitosis modulators|mesh-ancestor
24409964|NCT00183937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409966|NCT00183950|Antitussive Agents|antitussive agents|mesh-ancestor
24409967|NCT00183950|Respiratory System Agents|respiratory system agents|mesh-ancestor
24409969|NCT00183976|Doxorubicin|doxorubicin|mesh-list
24409970|NCT00183976|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24409971|NCT00183976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24409972|NCT00183976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409973|NCT00183976|Immunologic Factors|immunologic factors|mesh-ancestor
24409974|NCT00183976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409975|NCT00183976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24409976|NCT00183976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24409977|NCT00183976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24409978|NCT00183976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24409979|NCT00183976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409980|NCT00183976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410033|NCT00184041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24410034|NCT00184041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24410082|NCT00184197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24410083|NCT00184197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410084|NCT00184197|Cholinergic Agents|cholinergic agents|mesh-ancestor
24410085|NCT00184197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25166449|NCT04080895|Lumefantrine|lumefantrine|mesh-list
24410089|NCT00184496|Narcotics|narcotics|mesh-ancestor
24410090|NCT00184496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24410091|NCT00184496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820991|NCT02102828|Aspirin|aspirin|mesh-list
24820992|NCT02102828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24820993|NCT02102828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24820994|NCT02102828|Analgesics|analgesics|mesh-ancestor
24820995|NCT02102828|Sensory System Agents|sensory system agents|mesh-ancestor
24820996|NCT02102828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24820997|NCT02102828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432329|NCT00254436|Epoetin Alfa|epoetin alfa|mesh-list
24820998|NCT02102828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24820999|NCT02102828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24410092|NCT00184496|Analgesics|analgesics|mesh-ancestor
24410093|NCT00184496|Sensory System Agents|sensory system agents|mesh-ancestor
24410094|NCT00184496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24410144|NCT00184665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25419572|NCT02693535|Ipilimumab|ipilimumab|mesh-list
25662067|NCT01641237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25662068|NCT01641367|Tenofovir|tenofovir|mesh-list
25662069|NCT01641367|Emtricitabine|emtricitabine|mesh-list
25662070|NCT01641367|Raltegravir Potassium|raltegravir potassium|mesh-list
25662071|NCT01641367|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25662072|NCT01641367|Darunavir|darunavir|mesh-list
25662073|NCT01641367|Etravirine|etravirine|mesh-list
25662074|NCT01641367|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
25662075|NCT01641367|Protease Inhibitors|protease inhibitors|mesh-list
25662076|NCT01641367|Antiviral Agents|antiviral agents|mesh-ancestor
24410145|NCT00184665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410146|NCT00184795|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24410148|NCT00184795|Norethindrone|norethindrone|mesh-list
24410149|NCT00184795|Norethindrone Acetate|norethindrone acetate|mesh-list
24410151|NCT00184795|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24410152|NCT00184795|Estrogens|estrogens|mesh-ancestor
24410156|NCT00184795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24410157|NCT00184795|Contraceptive Agents|contraceptive agents|mesh-ancestor
24410158|NCT00184795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24410159|NCT00184795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24410160|NCT00184795|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24410163|NCT00184821|Glyburide|glyburide|mesh-list
25849401|NCT00048373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25849402|NCT00048373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25849403|NCT00048373|Analgesics|analgesics|mesh-ancestor
25849404|NCT00048373|Sensory System Agents|sensory system agents|mesh-ancestor
25849405|NCT00048373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24410193|NCT00184847|Analgesics|analgesics|mesh-ancestor
24410194|NCT00184847|Sensory System Agents|sensory system agents|mesh-ancestor
24410195|NCT00184847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24821005|NCT02102828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821007|NCT02102854|Thymoglobulin|thymoglobulin|mesh-list
24821008|NCT02102854|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24821009|NCT02102854|Immunologic Factors|immunologic factors|mesh-ancestor
25053642|NCT00004899|Etoposide|etoposide|mesh-list
24821010|NCT02102854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821011|NCT02102854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24821012|NCT02102971|Liver Extracts|liver extracts|mesh-list
24821013|NCT02102971|Hematinics|hematinics|mesh-ancestor
24821014|NCT02103023|Imiquimod|imiquimod|mesh-list
24821015|NCT02103023|Vaccines|vaccines|mesh-list
24821016|NCT02103023|Immunologic Factors|immunologic factors|mesh-ancestor
24821017|NCT02103023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821018|NCT02103023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24821019|NCT02103023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24821020|NCT02103023|Interferon Inducers|interferon inducers|mesh-ancestor
24821021|NCT02103049|Ezetimibe|ezetimibe|mesh-list
24821022|NCT02103049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24821023|NCT02103049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24821024|NCT02103049|Antimetabolites|antimetabolites|mesh-ancestor
24821025|NCT02103049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821039|NCT02103166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24821040|NCT02103166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821041|NCT02103166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24821043|NCT02103192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821044|NCT02103192|Protective Agents|protective agents|mesh-ancestor
24963452|NCT03790605|Curcumin|curcumin|mesh-list
24410206|NCT00184886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410207|NCT00184886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24410208|NCT00184886|Antimetabolites|antimetabolites|mesh-ancestor
24410209|NCT00184886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411596|NCT00189553|Doxorubicin|doxorubicin|mesh-list
24410210|NCT00184886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24410211|NCT00184886|Dermatologic Agents|dermatologic agents|mesh-ancestor
24821060|NCT02103335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821061|NCT02103335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24821062|NCT02103335|Glucocorticoids|glucocorticoids|mesh-ancestor
24821063|NCT02103335|Hormones|hormones|mesh-ancestor
24821064|NCT02103335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24821065|NCT02103335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24821066|NCT02103335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24821067|NCT02103335|Immunologic Factors|immunologic factors|mesh-ancestor
24821068|NCT02103335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24821069|NCT02103335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24821070|NCT02103335|Growth Substances|growth substances|mesh-ancestor
24821071|NCT02103335|Growth Inhibitors|growth inhibitors|mesh-ancestor
24821072|NCT02103361|Ustekinumab|ustekinumab|mesh-list
24821073|NCT02103361|Dermatologic Agents|dermatologic agents|mesh-ancestor
24821074|NCT02103374|Terbutaline|terbutaline|mesh-list
24821075|NCT02103374|Ipratropium|ipratropium|mesh-list
24821076|NCT02103374|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24821077|NCT02103374|Autonomic Agents|autonomic agents|mesh-ancestor
24821078|NCT02103374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25419573|NCT02693535|Pertuzumab|pertuzumab|mesh-list
25849406|NCT00048373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876121|NCT03907488|Immunoglobulins|immunoglobulins|mesh-list
24821080|NCT02103374|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24410212|NCT00184886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24410242|NCT00184912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24410244|NCT00184938|Naloxone|naloxone|mesh-list
24410245|NCT00184938|Annexin A5|annexin a5|mesh-list
25046664|NCT00838279|Lamotrigine|lamotrigine|mesh-list
24410246|NCT00184938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24410274|NCT00184977|Respiratory System Agents|respiratory system agents|mesh-ancestor
24410308|NCT00185068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410309|NCT00185068|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24410310|NCT00185068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24445979|NCT00303407|Anticoagulants|anticoagulants|mesh-ancestor
24821081|NCT02103374|Respiratory System Agents|respiratory system agents|mesh-ancestor
24821082|NCT02103374|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24821083|NCT02103374|Cholinergic Agents|cholinergic agents|mesh-ancestor
24821084|NCT02103374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24821085|NCT02103374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821086|NCT02103374|Sympathomimetics|sympathomimetics|mesh-ancestor
24821087|NCT02103374|Tocolytic Agents|tocolytic agents|mesh-ancestor
24821088|NCT02103374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24821089|NCT02103374|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24821090|NCT02103374|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24821091|NCT02103374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24821092|NCT02103374|Adrenergic Agents|adrenergic agents|mesh-ancestor
24821093|NCT02103465|Rotigotine|rotigotine|mesh-list
24821094|NCT02103465|Dopamine Agonists|dopamine agonists|mesh-ancestor
24821095|NCT02103465|Dopamine Agents|dopamine agents|mesh-ancestor
24821096|NCT02103465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24821097|NCT02103465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821098|NCT02103465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821099|NCT02103556|Mineral Oil|mineral oil|mesh-list
24821100|NCT02103556|Emollients|emollients|mesh-ancestor
24821101|NCT02103556|Dermatologic Agents|dermatologic agents|mesh-ancestor
24821102|NCT02103569|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24542260|NCT00678132|Olaparib|olaparib|mesh-list
24821115|NCT02103569|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24821116|NCT02103569|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24821117|NCT02103569|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24821118|NCT02103569|Protease Inhibitors|protease inhibitors|mesh-ancestor
24821119|NCT02103569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25166450|NCT04080895|Artemether|artemether|mesh-list
24542274|NCT00678145|Naloxone|naloxone|mesh-list
24821128|NCT02103647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24821129|NCT02103647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821130|NCT02103647|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24821132|NCT02103647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24410350|NCT00185120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24410351|NCT00185120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410352|NCT00185120|Vasodilator Agents|vasodilator agents|mesh-ancestor
24410353|NCT00185120|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24410354|NCT00185120|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24411597|NCT00189553|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24410385|NCT00185172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410386|NCT00185172|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24410387|NCT00185172|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24410396|NCT00185185|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24410397|NCT00185185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24410398|NCT00185185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410399|NCT00185185|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24410400|NCT00185185|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24410401|NCT00185185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24821133|NCT02103647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24821134|NCT02103647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24821135|NCT02103660|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24821136|NCT02103660|Contraceptive Agents|contraceptive agents|mesh-list
24821137|NCT02103660|Medroxyprogesterone|medroxyprogesterone|mesh-list
24821138|NCT02103660|Progestins|progestins|mesh-list
24821139|NCT02103660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24683289|NCT01391052|Contraceptive Agents|contraceptive agents|mesh-ancestor
24410402|NCT00185185|Sympatholytics|sympatholytics|mesh-ancestor
24410403|NCT00185185|Autonomic Agents|autonomic agents|mesh-ancestor
24410404|NCT00185185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24410510|NCT00185575|Antidepressive Agents|antidepressive agents|mesh-ancestor
24410512|NCT00185575|Dopamine Agents|dopamine agents|mesh-ancestor
24410514|NCT00185705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24410515|NCT00185705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24410516|NCT00185705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24410517|NCT00185705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410518|NCT00185783|Hydrocortisone|hydrocortisone|mesh-list
24410519|NCT00185783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24410520|NCT00185796|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24410521|NCT00185796|Immunologic Factors|immunologic factors|mesh-ancestor
24410522|NCT00185796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410523|NCT00185796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24410524|NCT00185835|Gefitinib|gefitinib|mesh-list
24410525|NCT00185835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24410560|NCT00185952|Tocolytic Agents|tocolytic agents|mesh-ancestor
24821148|NCT02103660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24821149|NCT02103660|Hormones|hormones|mesh-ancestor
24821150|NCT02103660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24821151|NCT02103686|Pregabalin|pregabalin|mesh-list
24821152|NCT02103686|Analgesics|analgesics|mesh-ancestor
24821153|NCT02103686|Sensory System Agents|sensory system agents|mesh-ancestor
24821154|NCT02103686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24821155|NCT02103686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821156|NCT02103686|Anticonvulsants|anticonvulsants|mesh-ancestor
24821157|NCT02103686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24821158|NCT02103686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24821159|NCT02103686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821160|NCT02103686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24821161|NCT02103686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24821162|NCT02103686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24821163|NCT02103686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24821164|NCT02103686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24821165|NCT02103725|Pimecrolimus|pimecrolimus|mesh-list
24821166|NCT02103725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24821167|NCT02103725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24821168|NCT02103725|Analgesics|analgesics|mesh-ancestor
24821169|NCT02103725|Sensory System Agents|sensory system agents|mesh-ancestor
24821170|NCT02103725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24821171|NCT02103725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821185|NCT02103738|Growth Inhibitors|growth inhibitors|mesh-ancestor
24821186|NCT02103738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24821187|NCT02103764|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24821188|NCT02103764|Medroxyprogesterone|medroxyprogesterone|mesh-list
24821190|NCT02103764|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24821191|NCT02103764|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24821192|NCT02103764|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24821193|NCT02103764|Contraceptive Agents|contraceptive agents|mesh-ancestor
25849407|NCT00048373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25849408|NCT00048373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24410561|NCT00185952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24410567|NCT00185991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410568|NCT00186082|Cefoxitin|cefoxitin|mesh-list
24410569|NCT00186082|Cefotetan|cefotetan|mesh-list
24410570|NCT00186082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24410571|NCT00186082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24410572|NCT00186264|Hydrocortisone|hydrocortisone|mesh-list
24410573|NCT00186264|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24410574|NCT00186264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24410575|NCT00186264|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24410576|NCT00186264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24410577|NCT00186264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24410578|NCT00186264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410579|NCT00186264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24410582|NCT00186264|Antidepressive Agents|antidepressive agents|mesh-ancestor
24410590|NCT00186277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410591|NCT00186316|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
24410592|NCT00186316|Immunologic Factors|immunologic factors|mesh-ancestor
24410593|NCT00186316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410594|NCT00186329|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24410595|NCT00186329|Natriuretic Agents|natriuretic agents|mesh-ancestor
24410596|NCT00186329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410598|NCT00186420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24410599|NCT00186420|Tubulin Modulators|tubulin modulators|mesh-ancestor
24410600|NCT00186420|Antimitotic Agents|antimitotic agents|mesh-ancestor
24410601|NCT00186420|Mitosis Modulators|mitosis modulators|mesh-ancestor
24410602|NCT00186420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410603|NCT00186589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24542311|NCT00678236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25849409|NCT00048373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24410632|NCT00186810|Busulfan|busulfan|mesh-list
24410633|NCT00186810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24410634|NCT00186810|Immunologic Factors|immunologic factors|mesh-ancestor
24410673|NCT00186940|Rasburicase|rasburicase|mesh-list
24410674|NCT00186940|Gout Suppressants|gout suppressants|mesh-ancestor
24410675|NCT00186940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24410676|NCT00186966|Cytarabine|cytarabine|mesh-list
24410677|NCT00186966|Cyclophosphamide|cyclophosphamide|mesh-list
24410678|NCT00186966|Melphalan|melphalan|mesh-list
24410679|NCT00186966|Busulfan|busulfan|mesh-list
24410680|NCT00186966|Fludarabine|fludarabine|mesh-list
24410681|NCT00186966|Etoposide|etoposide|mesh-list
24410682|NCT00186966|Daunorubicin|daunorubicin|mesh-list
24410683|NCT00186966|Thioguanine|thioguanine|mesh-list
24410684|NCT00186966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24410685|NCT00186966|Immunologic Factors|immunologic factors|mesh-ancestor
24410686|NCT00186966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410687|NCT00186966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24410688|NCT00186966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24410689|NCT00186966|Alkylating Agents|alkylating agents|mesh-ancestor
24821194|NCT02103764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24821195|NCT02103764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821196|NCT02103764|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24821197|NCT02103764|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24821198|NCT02103764|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24821199|NCT02103764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24821200|NCT02103764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24821202|NCT02103764|Hormones|hormones|mesh-ancestor
24821203|NCT02103764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24821204|NCT02103777|Caffeine|caffeine|mesh-list
24821205|NCT02103777|Caffeine citrate|caffeine citrate|mesh-list
24821206|NCT02103777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821207|NCT02103777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24821208|NCT02103777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821209|NCT02103777|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24821211|NCT02103777|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24821212|NCT02103777|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24821213|NCT02103777|Purinergic Agents|purinergic agents|mesh-ancestor
24410695|NCT00186966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24410696|NCT00186966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24410697|NCT00186966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25849410|NCT00048373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24821223|NCT02103881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24821224|NCT02103881|Anesthetics, General|anesthetics, general|mesh-ancestor
24821225|NCT02103881|Anesthetics|anesthetics|mesh-ancestor
24821226|NCT02103881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24821227|NCT02103881|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24821228|NCT02103881|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24821229|NCT02103881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24821230|NCT02103881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821231|NCT02103881|Antiemetics|antiemetics|mesh-ancestor
24821232|NCT02103881|Autonomic Agents|autonomic agents|mesh-ancestor
24821233|NCT02103881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24821234|NCT02103881|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24821235|NCT02103881|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24821236|NCT02103881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24821237|NCT02103881|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24821238|NCT02103881|Dopamine Agents|dopamine agents|mesh-ancestor
24821239|NCT02103881|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24410713|NCT00186979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24410714|NCT00186979|Tubulin Modulators|tubulin modulators|mesh-ancestor
24410715|NCT00186979|Antimitotic Agents|antimitotic agents|mesh-ancestor
24410716|NCT00186979|Mitosis Modulators|mitosis modulators|mesh-ancestor
24410717|NCT00186979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24410718|NCT00186979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24410719|NCT00186979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24410720|NCT00187005|Cytarabine|cytarabine|mesh-list
24410721|NCT00187005|Dexamethasone|dexamethasone|mesh-list
24410722|NCT00187005|Prednisone|prednisone|mesh-list
24410723|NCT00187005|Cyclophosphamide|cyclophosphamide|mesh-list
24410724|NCT00187005|Methotrexate|methotrexate|mesh-list
24410725|NCT00187005|Etoposide|etoposide|mesh-list
24410735|NCT00187005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24410736|NCT00187005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24410737|NCT00187005|Alkylating Agents|alkylating agents|mesh-ancestor
24410738|NCT00187005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410739|NCT00187005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24410740|NCT00187005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24410741|NCT00187005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24410747|NCT00187005|Hormones|hormones|mesh-ancestor
24410748|NCT00187005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24410749|NCT00187005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24410750|NCT00187005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24410751|NCT00187005|Abortifacient Agents|abortifacient agents|mesh-ancestor
24410752|NCT00187005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24410753|NCT00187005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24410755|NCT00187005|Dermatologic Agents|dermatologic agents|mesh-ancestor
24410756|NCT00187005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24410757|NCT00187005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24821240|NCT02103998|Iodine|iodine|mesh-list
24821241|NCT02103998|Hormones|hormones|mesh-list
24821242|NCT02103998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24821243|NCT02103998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821244|NCT02103998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24821245|NCT02103998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24821246|NCT02103998|Trace Elements|trace elements|mesh-ancestor
24821247|NCT02103998|Micronutrients|micronutrients|mesh-ancestor
24821248|NCT02104011|Propranolol|propranolol|mesh-list
24821249|NCT02104011|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24821250|NCT02104011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24821251|NCT02104011|Adrenergic Agents|adrenergic agents|mesh-ancestor
24821252|NCT02104011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24577196|NCT00842491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24410758|NCT00187005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25662077|NCT01641367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24410778|NCT00187057|Doxorubicin|doxorubicin|mesh-list
25849411|NCT00048373|Immunologic Factors|immunologic factors|mesh-ancestor
25849412|NCT00048399|Fludarabine|fludarabine|mesh-list
25849413|NCT00048399|Alemtuzumab|alemtuzumab|mesh-list
25849414|NCT00048399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849415|NCT00048399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25849416|NCT00048412|Fludarabine|fludarabine|mesh-list
25849417|NCT00048412|Alemtuzumab|alemtuzumab|mesh-list
24802648|NCT01991288|Autonomic Agents|autonomic agents|mesh-ancestor
24802649|NCT01991288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24802650|NCT01991288|Respiratory System Agents|respiratory system agents|mesh-ancestor
24410779|NCT00187057|Methotrexate|methotrexate|mesh-list
24410780|NCT00187057|Etoposide|etoposide|mesh-list
24410781|NCT00187057|Vincristine|vincristine|mesh-list
24410782|NCT00187057|Daunorubicin|daunorubicin|mesh-list
24410783|NCT00187057|Asparaginase|asparaginase|mesh-list
24410784|NCT00187057|Mercaptopurine|mercaptopurine|mesh-list
24410785|NCT00187057|Vinblastine|vinblastine|mesh-list
24410786|NCT00187057|Procarbazine|procarbazine|mesh-list
24410787|NCT00187057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24410788|NCT00187057|Immunologic Factors|immunologic factors|mesh-ancestor
24410789|NCT00187057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410790|NCT00187057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25007578|NCT03221751|Prazosin|prazosin|mesh-list
24410791|NCT00187057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24410792|NCT00187057|Alkylating Agents|alkylating agents|mesh-ancestor
24821253|NCT02104011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821254|NCT02104011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821255|NCT02104011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24821256|NCT02104011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24821257|NCT02104011|Vasodilator Agents|vasodilator agents|mesh-ancestor
24821259|NCT02104128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24821260|NCT02104128|Antidepressive Agents|antidepressive agents|mesh-ancestor
24821261|NCT02104128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24821262|NCT02104128|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24821263|NCT02104128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24821264|NCT02104128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24821265|NCT02104128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821266|NCT02104128|Dopamine Agents|dopamine agents|mesh-ancestor
24821267|NCT02104128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24821268|NCT02104128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821269|NCT02104128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24821270|NCT02104128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24821271|NCT02104128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821272|NCT02104193|Simvastatin|simvastatin|mesh-list
24821273|NCT02104193|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24821274|NCT02104193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24821275|NCT02104193|Antimetabolites|antimetabolites|mesh-ancestor
24821276|NCT02104193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821277|NCT02104193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24821278|NCT02104193|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24821279|NCT02104193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849418|NCT00048412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24410793|NCT00187057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410794|NCT00187057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24410795|NCT00187057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24410796|NCT00187057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24410797|NCT00187057|Antiemetics|antiemetics|mesh-ancestor
24410798|NCT00187057|Autonomic Agents|autonomic agents|mesh-ancestor
24410799|NCT00187057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24410800|NCT00187057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24410801|NCT00187057|Glucocorticoids|glucocorticoids|mesh-ancestor
24410803|NCT00187057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24410804|NCT00187057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24410805|NCT00187057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24410806|NCT00187057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24410807|NCT00187057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24410808|NCT00187057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24410809|NCT00187057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24410810|NCT00187057|Abortifacient Agents|abortifacient agents|mesh-ancestor
24410811|NCT00187057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24410812|NCT00187057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24410813|NCT00187057|Antimetabolites|antimetabolites|mesh-ancestor
25662079|NCT01641367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25662080|NCT01641367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674357|NCT01770483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24821315|NCT02104323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821316|NCT02104323|Growth Inhibitors|growth inhibitors|mesh-ancestor
24821317|NCT02104609|Levonorgestrel|levonorgestrel|mesh-list
24821319|NCT02104609|Contraceptive Agents|contraceptive agents|mesh-ancestor
24821320|NCT02104609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24821321|NCT02104609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821322|NCT02104609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24821323|NCT02104609|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24821324|NCT02104609|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24821325|NCT02104648|Moxifloxacin|moxifloxacin|mesh-list
24821326|NCT02104648|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24410817|NCT00187057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24410818|NCT00187057|Antiviral Agents|antiviral agents|mesh-ancestor
24410819|NCT00187057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24410820|NCT00187057|Tubulin Modulators|tubulin modulators|mesh-ancestor
24410821|NCT00187057|Antimitotic Agents|antimitotic agents|mesh-ancestor
24410822|NCT00187057|Mitosis Modulators|mitosis modulators|mesh-ancestor
24410823|NCT00187070|Cytarabine|cytarabine|mesh-list
24410824|NCT00187070|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24410825|NCT00187070|Dexamethasone|dexamethasone|mesh-list
24410826|NCT00187070|Prednisone|prednisone|mesh-list
24410827|NCT00187070|Cyclophosphamide|cyclophosphamide|mesh-list
24410828|NCT00187070|Ifosfamide|ifosfamide|mesh-list
25849419|NCT00048412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25849420|NCT00048425|Simendan|simendan|mesh-list
24410829|NCT00187070|Carboplatin|carboplatin|mesh-list
24410830|NCT00187070|Doxorubicin|doxorubicin|mesh-list
24410831|NCT00187070|Methotrexate|methotrexate|mesh-list
24410832|NCT00187070|Etoposide|etoposide|mesh-list
24410833|NCT00187070|Vincristine|vincristine|mesh-list
24410834|NCT00187070|Vinblastine|vinblastine|mesh-list
24410835|NCT00187070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24410838|NCT00187070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24410839|NCT00187070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24410840|NCT00187070|Alkylating Agents|alkylating agents|mesh-ancestor
24410841|NCT00187070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410842|NCT00187070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24410843|NCT00187070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24410844|NCT00187070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24410845|NCT00187070|Antiemetics|antiemetics|mesh-ancestor
24410846|NCT00187070|Autonomic Agents|autonomic agents|mesh-ancestor
24821336|NCT02104648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24821337|NCT02104648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821338|NCT02104648|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24821339|NCT02104648|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24821340|NCT02104648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24821341|NCT02104661|Oxcarbazepine|oxcarbazepine|mesh-list
24821342|NCT02104661|Anticonvulsants|anticonvulsants|mesh-ancestor
24821343|NCT02104661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24821344|NCT02104661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25849421|NCT00048425|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24821349|NCT02104674|Montelukast|montelukast|mesh-list
24821350|NCT02104674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24821351|NCT02104674|Respiratory System Agents|respiratory system agents|mesh-ancestor
24821352|NCT02104674|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24821353|NCT02104674|Hormone Antagonists|hormone antagonists|mesh-ancestor
24683751|NCT01393925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821987|NCT02109315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24410848|NCT00187070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24410851|NCT00187070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24410852|NCT00187070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24410879|NCT00187083|Fludarabine|fludarabine|mesh-list
24410880|NCT00187083|Etoposide|etoposide|mesh-list
24410882|NCT00187083|Topotecan|topotecan|mesh-list
24410883|NCT00187083|Asparaginase|asparaginase|mesh-list
24410884|NCT00187083|Mercaptopurine|mercaptopurine|mesh-list
24410885|NCT00187083|Idarubicin|idarubicin|mesh-list
24410886|NCT00187083|Pegaspargase|pegaspargase|mesh-list
24410887|NCT00187083|Teniposide|teniposide|mesh-list
24952389|NCT03894189|Vasodilator Agents|vasodilator agents|mesh-ancestor
25662081|NCT01641367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662082|NCT01641367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24410888|NCT00187083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24410889|NCT00187083|Antiemetics|antiemetics|mesh-ancestor
24410890|NCT00187083|Autonomic Agents|autonomic agents|mesh-ancestor
24410891|NCT00187083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24410892|NCT00187083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410893|NCT00187083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24410894|NCT00187083|Glucocorticoids|glucocorticoids|mesh-ancestor
24410895|NCT00187083|Hormones|hormones|mesh-ancestor
24410896|NCT00187083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24410897|NCT00187083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24410898|NCT00187083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24410899|NCT00187083|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24410901|NCT00187083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24410902|NCT00187083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24410903|NCT00187083|Antimetabolites|antimetabolites|mesh-ancestor
24410904|NCT00187083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410905|NCT00187083|Dermatologic Agents|dermatologic agents|mesh-ancestor
24410906|NCT00187083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24410907|NCT00187083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24410917|NCT00187083|Mitosis Modulators|mitosis modulators|mesh-ancestor
24821354|NCT02104674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24821356|NCT02104674|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24821357|NCT02104674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24821358|NCT02104674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821359|NCT02104700|Tenofovir|tenofovir|mesh-list
24821360|NCT02104700|Emtricitabine|emtricitabine|mesh-list
24821361|NCT02104700|Rilpivirine|rilpivirine|mesh-list
24821362|NCT02104700|Antiviral Agents|antiviral agents|mesh-ancestor
24821364|NCT02104700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24821365|NCT02104700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24821366|NCT02104700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821367|NCT02104700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821368|NCT02104700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24821369|NCT02104700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24821370|NCT02104778|Dexamethasone|dexamethasone|mesh-list
24821371|NCT02104778|Epinephrine|epinephrine|mesh-list
24821372|NCT02104778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24821373|NCT02104778|Antiemetics|antiemetics|mesh-ancestor
24821374|NCT02104778|Autonomic Agents|autonomic agents|mesh-ancestor
24821375|NCT02104778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24821376|NCT02104778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821377|NCT02104778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24821378|NCT02104778|Glucocorticoids|glucocorticoids|mesh-ancestor
24821379|NCT02104778|Hormones|hormones|mesh-ancestor
24821380|NCT02104778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24410974|NCT00187161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410975|NCT00187161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24410976|NCT00187161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24410977|NCT00187161|Alkylating Agents|alkylating agents|mesh-ancestor
24410978|NCT00187161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410979|NCT00187161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24410980|NCT00187161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24410981|NCT00187161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24410982|NCT00187161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24410983|NCT00187161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24410984|NCT00187161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24410985|NCT00187161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24410986|NCT00187161|Abortifacient Agents|abortifacient agents|mesh-ancestor
24410987|NCT00187161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24821394|NCT02104778|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24821395|NCT02104843|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24821397|NCT02104843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24821399|NCT02104843|Antimetabolites|antimetabolites|mesh-ancestor
24821400|NCT02104843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821401|NCT02104843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24821402|NCT02104843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24821403|NCT02104843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821404|NCT02104843|Protease Inhibitors|protease inhibitors|mesh-ancestor
24821405|NCT02104960|Dermatologic Agents|dermatologic agents|mesh-list
24821414|NCT02105077|Anesthetics|anesthetics|mesh-list
24821415|NCT02105077|Xenon|xenon|mesh-list
24821416|NCT02105077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24683861|NCT01394445|Miotics|miotics|mesh-ancestor
24410991|NCT00187161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24410992|NCT00187161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24821417|NCT02105077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821418|NCT02105077|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24821419|NCT02105077|Anesthetics, General|anesthetics, general|mesh-ancestor
24821420|NCT02105090|Anesthetics|anesthetics|mesh-list
24821422|NCT02105090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24821423|NCT02105090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821424|NCT02105090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24821425|NCT02105090|Sensory System Agents|sensory system agents|mesh-ancestor
24821427|NCT02105103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24821428|NCT02105103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821430|NCT02105155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24683897|NCT01394653|Antiemetics|antiemetics|mesh-ancestor
24410993|NCT00187161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24410994|NCT00187161|Antiviral Agents|antiviral agents|mesh-ancestor
24410995|NCT00187161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24410996|NCT00187161|Tubulin Modulators|tubulin modulators|mesh-ancestor
24410997|NCT00187161|Antimitotic Agents|antimitotic agents|mesh-ancestor
24410998|NCT00187161|Mitosis Modulators|mitosis modulators|mesh-ancestor
24411000|NCT00187174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411007|NCT00187330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24411009|NCT00187330|Respiratory System Agents|respiratory system agents|mesh-ancestor
24411010|NCT00187330|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24411011|NCT00187330|Antioxidants|antioxidants|mesh-ancestor
24411012|NCT00187330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411013|NCT00187330|Protective Agents|protective agents|mesh-ancestor
24411014|NCT00187330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411015|NCT00187330|Antidotes|antidotes|mesh-ancestor
24411016|NCT00187408|Heparin|heparin|mesh-list
24411017|NCT00187408|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24411018|NCT00187408|Tinzaparin|tinzaparin|mesh-list
24411019|NCT00187408|Dalteparin|dalteparin|mesh-list
24411021|NCT00187408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24411022|NCT00187408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24411023|NCT00187408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411025|NCT00187447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24411026|NCT00187447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24411027|NCT00187447|Analgesics|analgesics|mesh-ancestor
24411040|NCT00187499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24411041|NCT00187499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24411043|NCT00187499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24411044|NCT00187499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411045|NCT00187499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24411046|NCT00187499|Respiratory System Agents|respiratory system agents|mesh-ancestor
24411047|NCT00187499|Dermatologic Agents|dermatologic agents|mesh-ancestor
24411048|NCT00187499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24411049|NCT00187525|Memantine|memantine|mesh-list
24411050|NCT00187525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24411051|NCT00187525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24411052|NCT00187525|Dopamine Agents|dopamine agents|mesh-ancestor
24411053|NCT00187525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24411059|NCT00187551|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25849422|NCT00048425|Vasodilator Agents|vasodilator agents|mesh-ancestor
25849423|NCT00048425|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25849424|NCT00048425|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24411060|NCT00187551|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25849425|NCT00048425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411061|NCT00187551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411062|NCT00187551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24411072|NCT00187564|Vitamins|vitamins|mesh-ancestor
24411073|NCT00187564|Micronutrients|micronutrients|mesh-ancestor
24411074|NCT00187577|Bimatoprost|bimatoprost|mesh-list
24411075|NCT00187577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24411076|NCT00187577|Latanoprost|latanoprost|mesh-list
24411077|NCT00187577|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24411078|NCT00187577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24411079|NCT00187707|Gabapentin|gabapentin|mesh-list
24411080|NCT00187707|Analgesics|analgesics|mesh-ancestor
24411081|NCT00187707|Sensory System Agents|sensory system agents|mesh-ancestor
24411082|NCT00187707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24411083|NCT00187707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411100|NCT00187746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25007634|NCT03104400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443433|NCT00294931|Irinotecan|irinotecan|mesh-list
25876122|NCT03907488|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25419574|NCT02693535|Atezolizumab|atezolizumab|mesh-list
25674358|NCT01770483|Antimetabolites|antimetabolites|mesh-ancestor
25662085|NCT01641367|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25849429|NCT00048477|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
24411101|NCT00187746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411102|NCT00187759|Cephalexin|cephalexin|mesh-list
24411103|NCT00187759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24411104|NCT00187759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24411105|NCT00187798|Metformin|metformin|mesh-list
24411106|NCT00187798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24411107|NCT00187798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411109|NCT00187915|Mycophenolic Acid|mycophenolic acid|mesh-list
24411110|NCT00187915|Tacrolimus|tacrolimus|mesh-list
24411111|NCT00187915|Cyclosporins|cyclosporins|mesh-list
24411112|NCT00187915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24411113|NCT00187915|Immunologic Factors|immunologic factors|mesh-ancestor
24411114|NCT00187915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411115|NCT00187915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24411116|NCT00187915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411117|NCT00187915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411118|NCT00187915|Antifungal Agents|antifungal agents|mesh-ancestor
24411119|NCT00187915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24411121|NCT00187915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24411122|NCT00187915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24411123|NCT00187915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411124|NCT00187915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24411125|NCT00187915|Antitubercular Agents|antitubercular agents|mesh-ancestor
24411165|NCT00188071|Acetaminophen|acetaminophen|mesh-list
24411166|NCT00188071|Ketoprofen|ketoprofen|mesh-list
24411167|NCT00188071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24411168|NCT00188071|Analgesics|analgesics|mesh-ancestor
24411169|NCT00188071|Sensory System Agents|sensory system agents|mesh-ancestor
24411170|NCT00188071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25203444|NCT02714231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24821432|NCT02105155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411182|NCT00188136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411184|NCT00188136|Immunologic Factors|immunologic factors|mesh-ancestor
24411185|NCT00188136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411225|NCT00188383|Antiviral Agents|antiviral agents|mesh-ancestor
24411226|NCT00188383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24411227|NCT00188383|Dopamine Agents|dopamine agents|mesh-ancestor
24411228|NCT00188383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25849430|NCT00048477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25054099|NCT03531970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25849431|NCT00048477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849432|NCT00048503|Tipifarnib|tipifarnib|mesh-list
24411229|NCT00188383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411230|NCT00188383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411231|NCT00188383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24411232|NCT00188383|Analgesics|analgesics|mesh-ancestor
24411233|NCT00188383|Sensory System Agents|sensory system agents|mesh-ancestor
24411234|NCT00188383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24411235|NCT00188396|Citalopram|citalopram|mesh-list
25662086|NCT01641367|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25662087|NCT01641445|Topiramate|topiramate|mesh-list
25662088|NCT01641445|Anticonvulsants|anticonvulsants|mesh-ancestor
25662089|NCT01641445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25662090|NCT01641445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662091|NCT01641640|Sofosbuvir|sofosbuvir|mesh-list
24411236|NCT00188396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25662092|NCT01641640|Ribavirin|ribavirin|mesh-list
25662093|NCT01641640|Antiviral Agents|antiviral agents|mesh-ancestor
24802897|NCT01993212|Hormones|hormones|mesh-ancestor
24411237|NCT00188396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24411238|NCT00188396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24411239|NCT00188396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411240|NCT00188396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24411241|NCT00188396|Serotonin Agents|serotonin agents|mesh-ancestor
24411242|NCT00188396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411243|NCT00188396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24411244|NCT00188396|Antidepressive Agents|antidepressive agents|mesh-ancestor
24411272|NCT00188565|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24411273|NCT00188565|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24411274|NCT00188565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411275|NCT00188565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411276|NCT00188604|Selenious Acid|selenious acid|mesh-list
24411305|NCT00188643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821435|NCT02105155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849433|NCT00048503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24821436|NCT02105311|Benzalkonium Compounds|benzalkonium compounds|mesh-list
24821438|NCT02105311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24821439|NCT02105311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24821440|NCT02105311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24821442|NCT02105350|Oxaliplatin|oxaliplatin|mesh-list
24821443|NCT02105350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24821444|NCT02105350|Antimetabolites|antimetabolites|mesh-ancestor
24821445|NCT02105350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821446|NCT02105350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24821447|NCT02105350|Antiviral Agents|antiviral agents|mesh-ancestor
25097979|NCT03200002|Immunologic Factors|immunologic factors|mesh-ancestor
24821448|NCT02105350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24821449|NCT02105350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821450|NCT02105350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24821451|NCT02105350|Immunologic Factors|immunologic factors|mesh-ancestor
24821452|NCT02105350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577442|NCT00844168|Sorafenib|sorafenib|mesh-list
24821453|NCT02105493|Nitroglycerin|nitroglycerin|mesh-list
24821454|NCT02105493|Vasodilator Agents|vasodilator agents|mesh-ancestor
24821455|NCT02105610|Anesthetics|anesthetics|mesh-list
24821456|NCT02105610|Sevoflurane|sevoflurane|mesh-list
24821457|NCT02105610|Desflurane|desflurane|mesh-list
24821458|NCT02105610|Isoflurane|isoflurane|mesh-list
24821459|NCT02105610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
24821460|NCT02105610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24821461|NCT02105610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821462|NCT02105610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25203445|NCT02714231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821463|NCT02105610|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24821464|NCT02105610|Anesthetics, General|anesthetics, general|mesh-ancestor
24821465|NCT02105623|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24821466|NCT02105623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24821467|NCT02105623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24611494|NCT01009853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24411338|NCT00188773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24411339|NCT00188773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24821989|NCT02109315|Hormones|hormones|mesh-ancestor
24821470|NCT02105623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24821471|NCT02105623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24821472|NCT02105623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821473|NCT02105675|Docetaxel|docetaxel|mesh-list
24821474|NCT02105675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24821475|NCT02105675|Tubulin Modulators|tubulin modulators|mesh-ancestor
24821476|NCT02105675|Antimitotic Agents|antimitotic agents|mesh-ancestor
24821477|NCT02105675|Mitosis Modulators|mitosis modulators|mesh-ancestor
24821478|NCT02105675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821479|NCT02105714|Formaldehyde|formaldehyde|mesh-list
24821480|NCT02105714|Disinfectants|disinfectants|mesh-ancestor
24821486|NCT02105792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411343|NCT00188773|Expectorants|expectorants|mesh-ancestor
24411344|NCT00188773|Respiratory System Agents|respiratory system agents|mesh-ancestor
25097996|NCT03199976|Xhance|xhance|mesh-list
24411345|NCT00188773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25849434|NCT00048555|Galiximab|galiximab|mesh-list
24411358|NCT00188812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24411359|NCT00188812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411360|NCT00188812|Nootropic Agents|nootropic agents|mesh-ancestor
24411361|NCT00188825|Basiliximab|basiliximab|mesh-list
25419575|NCT02693535|Sunitinib|sunitinib|mesh-list
25849435|NCT00048555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25232647|NCT02581982|Paclitaxel|paclitaxel|mesh-list
24411362|NCT00188825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24411363|NCT00188825|Immunologic Factors|immunologic factors|mesh-ancestor
24411364|NCT00188825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411365|NCT00188864|Dexamethasone|dexamethasone|mesh-list
24411366|NCT00188864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24411367|NCT00188864|Antiemetics|antiemetics|mesh-ancestor
24411368|NCT00188864|Autonomic Agents|autonomic agents|mesh-ancestor
24411369|NCT00188864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24411370|NCT00188864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849436|NCT00048555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411376|NCT00188864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411377|NCT00188877|Fluorouracil|fluorouracil|mesh-list
24411378|NCT00188877|Antimetabolites|antimetabolites|mesh-ancestor
24411379|NCT00188877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411380|NCT00188877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24411381|NCT00188877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411382|NCT00188877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24411383|NCT00188877|Immunologic Factors|immunologic factors|mesh-ancestor
24411384|NCT00188877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411385|NCT00188929|Deoxyglucose|deoxyglucose|mesh-list
24411386|NCT00188929|Antimetabolites|antimetabolites|mesh-ancestor
24411387|NCT00188929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411388|NCT00188929|Antiviral Agents|antiviral agents|mesh-ancestor
24411389|NCT00188929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24411391|NCT00188942|Fluoxetine|fluoxetine|mesh-list
24411392|NCT00188942|Antiemetics|antiemetics|mesh-ancestor
24411393|NCT00188942|Autonomic Agents|autonomic agents|mesh-ancestor
24411394|NCT00188942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25007684|NCT02909452|Pembrolizumab|pembrolizumab|mesh-list
25007685|NCT02909452|Entinostat|entinostat|mesh-list
25007706|NCT02880293|Mycophenolic Acid|mycophenolic acid|mesh-list
25007707|NCT02880293|Cyclophosphamide|cyclophosphamide|mesh-list
25007708|NCT02880293|Melphalan|melphalan|mesh-list
25849437|NCT00048594|Aprepitant|aprepitant|mesh-list
24821487|NCT02105792|Protease Inhibitors|protease inhibitors|mesh-ancestor
24821488|NCT02105792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821489|NCT02105870|Abciximab|abciximab|mesh-list
24821490|NCT02105870|Anticoagulants|anticoagulants|mesh-ancestor
24821491|NCT02105870|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24821492|NCT02106104|Glimepiride|glimepiride|mesh-list
24821494|NCT02106104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24821495|NCT02106104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24821496|NCT02106104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821497|NCT02106104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24821498|NCT02106104|Immunologic Factors|immunologic factors|mesh-ancestor
24821499|NCT02106104|Incretins|incretins|mesh-ancestor
24821500|NCT02106104|Hormones|hormones|mesh-ancestor
24821501|NCT02106104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24821502|NCT02106104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24821503|NCT02106104|Protease Inhibitors|protease inhibitors|mesh-ancestor
24821505|NCT02106104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821507|NCT02106130|Mosapride|mosapride|mesh-list
24821508|NCT02106130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821509|NCT02106130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24821510|NCT02106130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24821511|NCT02106130|Antioxidants|antioxidants|mesh-ancestor
24821512|NCT02106130|Protective Agents|protective agents|mesh-ancestor
24821513|NCT02106130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821514|NCT02106130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821515|NCT02106130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24821516|NCT02106130|Serotonin Agents|serotonin agents|mesh-ancestor
24411395|NCT00188942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411396|NCT00188942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24411397|NCT00188942|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24411398|NCT00188942|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24411399|NCT00188942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24411400|NCT00188942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24411401|NCT00188942|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24411402|NCT00188942|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24411403|NCT00188942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24411404|NCT00188942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849438|NCT00048594|Antiemetics|antiemetics|mesh-ancestor
24821518|NCT02106182|Silodosin|silodosin|mesh-list
24821519|NCT02106182|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24821520|NCT02106182|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25849439|NCT00048594|Autonomic Agents|autonomic agents|mesh-ancestor
25232666|NCT02581761|Misoprostol|misoprostol|mesh-list
24821521|NCT02106182|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24821522|NCT02106182|Adrenergic Agents|adrenergic agents|mesh-ancestor
25849440|NCT00048594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24821523|NCT02106182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24821524|NCT02106182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821525|NCT02106182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577501|NCT00844350|Oxytocics|oxytocics|mesh-ancestor
24821526|NCT02106182|Urological Agents|urological agents|mesh-ancestor
24821528|NCT02106286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24821529|NCT02106286|Sympatholytics|sympatholytics|mesh-ancestor
24411420|NCT00188955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411422|NCT00188994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24411423|NCT00188994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411424|NCT00189007|Allopurinol|allopurinol|mesh-list
24411426|NCT00189007|Antimetabolites|antimetabolites|mesh-ancestor
24411427|NCT00189007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411428|NCT00189007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411429|NCT00189007|Gout Suppressants|gout suppressants|mesh-ancestor
24411430|NCT00189007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24411431|NCT00189007|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24411432|NCT00189007|Antioxidants|antioxidants|mesh-ancestor
24411433|NCT00189007|Protective Agents|protective agents|mesh-ancestor
24411434|NCT00189007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411435|NCT00189007|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24411437|NCT00189007|Natriuretic Agents|natriuretic agents|mesh-ancestor
24411438|NCT00189020|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24411439|NCT00189020|Immunologic Factors|immunologic factors|mesh-ancestor
24411440|NCT00189020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411443|NCT00189033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24411444|NCT00189059|Amitriptyline|amitriptyline|mesh-list
24411445|NCT00189059|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24411446|NCT00189059|Antidepressive Agents|antidepressive agents|mesh-ancestor
24411447|NCT00189059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24411448|NCT00189059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24411449|NCT00189059|Analgesics|analgesics|mesh-ancestor
24411450|NCT00189059|Sensory System Agents|sensory system agents|mesh-ancestor
24411451|NCT00189059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24411452|NCT00189059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411453|NCT00189059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24411454|NCT00189059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24411455|NCT00189059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24411456|NCT00189059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411457|NCT00189059|Adrenergic Agents|adrenergic agents|mesh-ancestor
24411458|NCT00189059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24411459|NCT00189072|Gabapentin|gabapentin|mesh-list
24821531|NCT02106286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24821532|NCT02106286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821533|NCT02106286|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24821535|NCT02106286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24821536|NCT02106286|Adrenergic Agents|adrenergic agents|mesh-ancestor
24821537|NCT02106286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24821538|NCT02106286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821540|NCT02106364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24821541|NCT02106364|Insulin Glargine|insulin glargine|mesh-list
24821542|NCT02106364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24821543|NCT02106364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821544|NCT02106468|Prednisone|prednisone|mesh-list
24821545|NCT02106468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24821546|NCT02106468|Glucocorticoids|glucocorticoids|mesh-ancestor
24821547|NCT02106468|Hormones|hormones|mesh-ancestor
24821548|NCT02106468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24821549|NCT02106468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821550|NCT02106468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24411465|NCT00189072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24411466|NCT00189072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24411473|NCT00189072|Antimanic Agents|antimanic agents|mesh-ancestor
24411474|NCT00189085|Simvastatin|simvastatin|mesh-list
24411475|NCT00189085|Ezetimibe|ezetimibe|mesh-list
24411476|NCT00189085|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
24411481|NCT00189085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24411482|NCT00189085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25662094|NCT01641640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25662095|NCT01641640|Antimetabolites|antimetabolites|mesh-ancestor
24411483|NCT00189085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411484|NCT00189124|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24411485|NCT00189124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24411486|NCT00189124|Immunologic Factors|immunologic factors|mesh-ancestor
24411487|NCT00189124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411488|NCT00189150|Mycophenolic Acid|mycophenolic acid|mesh-list
24411489|NCT00189150|Valganciclovir|valganciclovir|mesh-list
24411490|NCT00189150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24411491|NCT00189150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411492|NCT00189150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24411493|NCT00189150|Antitubercular Agents|antitubercular agents|mesh-ancestor
24411494|NCT00189150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24411495|NCT00189150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24411496|NCT00189150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411497|NCT00189150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411498|NCT00189150|Antiviral Agents|antiviral agents|mesh-ancestor
24411499|NCT00189163|Pioglitazone|pioglitazone|mesh-list
24411500|NCT00189163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24411501|NCT00189163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411502|NCT00189176|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
24821557|NCT02106481|Sensory System Agents|sensory system agents|mesh-ancestor
24821558|NCT02106481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24821559|NCT02106507|Everolimus|everolimus|mesh-list
24821560|NCT02106507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24821561|NCT02106507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24821562|NCT02106507|Immunologic Factors|immunologic factors|mesh-ancestor
24821563|NCT02106507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821564|NCT02106520|Bevacizumab|bevacizumab|mesh-list
24821565|NCT02106520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24821566|NCT02106520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866046|NCT03817554|Sympathomimetics|sympathomimetics|mesh-ancestor
24821567|NCT02106520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24821568|NCT02106520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24821569|NCT02106520|Growth Substances|growth substances|mesh-ancestor
24821570|NCT02106520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684313|NCT01396707|Capecitabine|capecitabine|mesh-list
24411506|NCT00189176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411507|NCT00189176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24821585|NCT02106650|Folic Acid|folic acid|mesh-list
24542701|NCT00679744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24821594|NCT02106650|Hematinics|hematinics|mesh-ancestor
24821595|NCT02106767|Rifampin|rifampin|mesh-list
24411532|NCT00189358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411533|NCT00189371|Paclitaxel|paclitaxel|mesh-list
24411534|NCT00189371|Carboplatin|carboplatin|mesh-list
24411535|NCT00189371|Epoetin Alfa|epoetin alfa|mesh-list
24411536|NCT00189371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24411593|NCT00189514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411595|NCT00189553|Carboplatin|carboplatin|mesh-list
25140891|NCT02961803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411599|NCT00189553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411601|NCT00189553|Antimitotic Agents|antimitotic agents|mesh-ancestor
24411602|NCT00189553|Mitosis Modulators|mitosis modulators|mesh-ancestor
24411603|NCT00189553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411604|NCT00189553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24411605|NCT00189553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24411606|NCT00189553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24411607|NCT00189553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411609|NCT00189566|Carboplatin|carboplatin|mesh-list
24411610|NCT00189566|Topotecan|topotecan|mesh-list
24411611|NCT00189566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24411612|NCT00189566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411613|NCT00189566|Tubulin Modulators|tubulin modulators|mesh-ancestor
24411614|NCT00189566|Antimitotic Agents|antimitotic agents|mesh-ancestor
24411615|NCT00189566|Mitosis Modulators|mitosis modulators|mesh-ancestor
25849441|NCT00048594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849442|NCT00048594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24821600|NCT02106767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821601|NCT02106767|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24821602|NCT02106767|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24821603|NCT02106767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821605|NCT02106767|Antitubercular Agents|antitubercular agents|mesh-ancestor
24821606|NCT02106767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24821607|NCT02106767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24821608|NCT02106767|Leprostatic Agents|leprostatic agents|mesh-ancestor
25007728|NCT02853500|Doxorubicin|doxorubicin|mesh-list
24821609|NCT02106767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25232717|NCT02581553|Renal Agents|renal agents|mesh-ancestor
24821610|NCT02106767|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24821611|NCT02106767|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24821612|NCT02106767|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24821613|NCT02106767|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24821614|NCT02106767|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24821615|NCT02106767|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24821616|NCT02106793|Mitomycins|mitomycins|mesh-list
24821617|NCT02106793|Mitomycin|mitomycin|mesh-list
24821618|NCT02106793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24821619|NCT02106793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849443|NCT00048594|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25849444|NCT00048594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25849445|NCT00048594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411641|NCT00189618|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24411642|NCT00189618|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24411643|NCT00189618|Purinergic Agents|purinergic agents|mesh-ancestor
24411644|NCT00189618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24411645|NCT00189644|Cyclophosphamide|cyclophosphamide|mesh-list
24411647|NCT00189644|Epirubicin|epirubicin|mesh-list
24411648|NCT00189644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24411672|NCT00189657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24411674|NCT00189657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411676|NCT00189683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24411677|NCT00189683|Antimetabolites|antimetabolites|mesh-ancestor
24411678|NCT00189683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411679|NCT00189683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24821620|NCT02106793|Alkylating Agents|alkylating agents|mesh-ancestor
24821621|NCT02106793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821622|NCT02106793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24821623|NCT02106793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821624|NCT02106806|Zinc|zinc|mesh-list
24821625|NCT02106806|Zinc Sulfate|zinc sulfate|mesh-list
24821626|NCT02106806|Trace Elements|trace elements|mesh-ancestor
24821627|NCT02106806|Micronutrients|micronutrients|mesh-ancestor
24821628|NCT02106806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821629|NCT02106806|Astringents|astringents|mesh-ancestor
24821630|NCT02106806|Dermatologic Agents|dermatologic agents|mesh-ancestor
24821631|NCT02106845|Digoxin|digoxin|mesh-list
24821632|NCT02106845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24821633|NCT02106845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24821634|NCT02106845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24821635|NCT02106845|Antimetabolites|antimetabolites|mesh-ancestor
24413261|NCT00193362|Antimetabolites|antimetabolites|mesh-ancestor
24821636|NCT02106845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821637|NCT02106845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24821638|NCT02106845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24821639|NCT02106845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821640|NCT02106845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24821641|NCT02106845|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24821642|NCT02106845|Protective Agents|protective agents|mesh-ancestor
24821643|NCT02106845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821644|NCT02106871|Sildenafil Citrate|sildenafil citrate|mesh-list
24821645|NCT02106871|Vasodilator Agents|vasodilator agents|mesh-ancestor
24821646|NCT02106871|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24821647|NCT02106871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24821648|NCT02106871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821649|NCT02106871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821650|NCT02106871|Urological Agents|urological agents|mesh-ancestor
24821651|NCT02107079|Melatonin|melatonin|mesh-list
24821652|NCT02107079|Antioxidants|antioxidants|mesh-ancestor
24821653|NCT02107079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821654|NCT02107079|Protective Agents|protective agents|mesh-ancestor
24821666|NCT02107170|Sevoflurane|sevoflurane|mesh-list
24821667|NCT02107170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24821683|NCT02107235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821684|NCT02107235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411698|NCT00189722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24411699|NCT00189722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411700|NCT00189722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411701|NCT00189748|Tacrolimus|tacrolimus|mesh-list
24411702|NCT00189748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24411703|NCT00189748|Immunologic Factors|immunologic factors|mesh-ancestor
24411704|NCT00189748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803156|NCT01994941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24411705|NCT00189748|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24411706|NCT00189748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411707|NCT00189748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821689|NCT02107365|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24821690|NCT02107365|Asunaprevir|asunaprevir|mesh-list
24821691|NCT02107365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24821692|NCT02107365|Antiviral Agents|antiviral agents|mesh-ancestor
24821693|NCT02107365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24821694|NCT02107365|Antimetabolites|antimetabolites|mesh-ancestor
24821695|NCT02107365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821696|NCT02107365|Immunologic Factors|immunologic factors|mesh-ancestor
24821697|NCT02107365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821698|NCT02107365|Protease Inhibitors|protease inhibitors|mesh-ancestor
24821699|NCT02107365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849446|NCT00048607|Aprepitant|aprepitant|mesh-list
24821701|NCT02107378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24821702|NCT02107378|Doxorubicin|doxorubicin|mesh-list
24821703|NCT02107378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24821704|NCT02107378|Topotecan|topotecan|mesh-list
24821705|NCT02107378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24821707|NCT02107378|Tubulin Modulators|tubulin modulators|mesh-ancestor
24821708|NCT02107378|Antimitotic Agents|antimitotic agents|mesh-ancestor
24821709|NCT02107378|Mitosis Modulators|mitosis modulators|mesh-ancestor
24821710|NCT02107378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821715|NCT02107378|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24821717|NCT02107391|Goserelin|goserelin|mesh-list
24821718|NCT02107391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24821719|NCT02107391|Fertility Agents|fertility agents|mesh-ancestor
24821720|NCT02107391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24821721|NCT02107391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821722|NCT02107391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24821723|NCT02107391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24821724|NCT02107690|Lidocaine|lidocaine|mesh-list
24821725|NCT02107690|Anesthetics, Local|anesthetics, local|mesh-ancestor
24821726|NCT02107690|Anesthetics|anesthetics|mesh-ancestor
24411746|NCT00189839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411747|NCT00189878|Methotrexate|methotrexate|mesh-list
24411748|NCT00189878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24411749|NCT00189878|Abortifacient Agents|abortifacient agents|mesh-ancestor
24411753|NCT00189878|Antimetabolites|antimetabolites|mesh-ancestor
24411754|NCT00189878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411755|NCT00189878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411799|NCT00190034|Acetylcysteine|acetylcysteine|mesh-list
24411800|NCT00190034|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24411801|NCT00190034|Antiviral Agents|antiviral agents|mesh-ancestor
25849447|NCT00048607|Paroxetine|paroxetine|mesh-list
25849448|NCT00048607|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25849449|NCT00048607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24411802|NCT00190034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24411803|NCT00190034|Expectorants|expectorants|mesh-ancestor
24411804|NCT00190034|Respiratory System Agents|respiratory system agents|mesh-ancestor
24411805|NCT00190034|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24411806|NCT00190034|Antioxidants|antioxidants|mesh-ancestor
24411807|NCT00190034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821727|NCT02107690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24821728|NCT02107690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821729|NCT02107690|Sensory System Agents|sensory system agents|mesh-ancestor
24821730|NCT02107690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24821731|NCT02107690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24821732|NCT02107690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24821733|NCT02107690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24821734|NCT02107690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24821735|NCT02107690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821736|NCT02107716|Lidocaine|lidocaine|mesh-list
24821737|NCT02107716|Anesthetics, Local|anesthetics, local|mesh-ancestor
24821738|NCT02107716|Anesthetics|anesthetics|mesh-ancestor
24821739|NCT02107716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24821740|NCT02107716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821741|NCT02107716|Sensory System Agents|sensory system agents|mesh-ancestor
24821742|NCT02107716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24821743|NCT02107716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24821744|NCT02107716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25662096|NCT01641640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232774|NCT02581176|Antithrombins|antithrombins|mesh-ancestor
25232776|NCT02581176|Protease Inhibitors|protease inhibitors|mesh-ancestor
24821745|NCT02107716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24821746|NCT02107716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24821747|NCT02107716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821748|NCT02107729|Lidocaine|lidocaine|mesh-list
24821749|NCT02107729|Anesthetics, Local|anesthetics, local|mesh-ancestor
24821750|NCT02107729|Anesthetics|anesthetics|mesh-ancestor
24684620|NCT04941937|Thalidomide|thalidomide|mesh-list
24411808|NCT00190034|Protective Agents|protective agents|mesh-ancestor
24411809|NCT00190034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411810|NCT00190034|Antidotes|antidotes|mesh-ancestor
24411811|NCT00190060|Testosterone|testosterone|mesh-list
24411812|NCT00190060|Androgens|androgens|mesh-ancestor
24411813|NCT00190060|Hormones|hormones|mesh-ancestor
25166451|NCT04080895|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25166452|NCT04080895|Amodiaquine|amodiaquine|mesh-list
24411814|NCT00190060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24411815|NCT00190060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411816|NCT00190099|Dexamethasone|dexamethasone|mesh-list
24411817|NCT00190099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24411904|NCT00190372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24411907|NCT00190411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24411916|NCT00190411|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24411917|NCT00190411|Adrenergic Agents|adrenergic agents|mesh-ancestor
24411918|NCT00190411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24411919|NCT00190411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411920|NCT00190424|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
24411921|NCT00190424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24411922|NCT00190424|Immunologic Factors|immunologic factors|mesh-ancestor
25849450|NCT00048607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24411923|NCT00190424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411924|NCT00190437|Amoxicillin|amoxicillin|mesh-list
24411925|NCT00190437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24411971|NCT00190567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411973|NCT00190567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411975|NCT00190567|Sensory System Agents|sensory system agents|mesh-ancestor
24411976|NCT00190567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24411977|NCT00190567|Antidepressive Agents|antidepressive agents|mesh-ancestor
24821764|NCT02107742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821765|NCT02107742|Sensory System Agents|sensory system agents|mesh-ancestor
24821766|NCT02107742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24821767|NCT02107742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24821768|NCT02107742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24821769|NCT02107742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24821770|NCT02107742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24577807|NCT00845910|Growth Inhibitors|growth inhibitors|mesh-ancestor
24821771|NCT02107742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821772|NCT02107755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24821775|NCT02107755|Immunoglobulins|immunoglobulins|mesh-list
24821776|NCT02107755|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24821777|NCT02107755|Immunologic Factors|immunologic factors|mesh-ancestor
24821778|NCT02107755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821779|NCT02107755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24821780|NCT02107755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24821781|NCT02107755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821783|NCT02107807|Vaccines|vaccines|mesh-list
24821784|NCT02107807|Immunologic Factors|immunologic factors|mesh-ancestor
24821785|NCT02107807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821786|NCT02107807|Cathartics|cathartics|mesh-ancestor
24821787|NCT02107807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24821788|NCT02107924|Vancomycin|vancomycin|mesh-list
24821789|NCT02107924|Tobramycin|tobramycin|mesh-list
24821790|NCT02107924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24411981|NCT00190580|Antihypertensive Agents|antihypertensive agents|mesh-list
24412012|NCT00190619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412013|NCT00190619|Analgesics|analgesics|mesh-ancestor
24412014|NCT00190619|Sensory System Agents|sensory system agents|mesh-ancestor
24461168|NCT00351169|Citalopram|citalopram|mesh-list
24412015|NCT00190619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24412016|NCT00190619|Antidepressive Agents|antidepressive agents|mesh-ancestor
24412017|NCT00190619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24412018|NCT00190619|Dopamine Agents|dopamine agents|mesh-ancestor
25662097|NCT01641653|Midazolam|midazolam|mesh-list
25662098|NCT01641653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24821801|NCT02107950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24821803|NCT02107950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412019|NCT00190632|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24412056|NCT00190710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412057|NCT00190736|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24412061|NCT00190736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412062|NCT00190736|Adrenergic Agents|adrenergic agents|mesh-ancestor
24412063|NCT00190736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412089|NCT00190814|Antidepressive Agents|antidepressive agents|mesh-ancestor
24412090|NCT00190814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24412113|NCT00190853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412114|NCT00190853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412115|NCT00190853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412116|NCT00190853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412125|NCT00190866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25849451|NCT00048607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821820|NCT02108210|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24821821|NCT02108210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24821822|NCT02108301|Cyclosporine|cyclosporine|mesh-list
24821823|NCT02108301|Tacrolimus|tacrolimus|mesh-list
24821824|NCT02108301|Cyclosporins|cyclosporins|mesh-list
24412156|NCT00190892|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24412157|NCT00190892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412158|NCT00190892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412159|NCT00190892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412160|NCT00190892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412161|NCT00190892|Serotonin Agents|serotonin agents|mesh-ancestor
24412162|NCT00190892|Anticonvulsants|anticonvulsants|mesh-ancestor
24412163|NCT00190892|Antimanic Agents|antimanic agents|mesh-ancestor
24412187|NCT00190918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24412188|NCT00190918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24412189|NCT00190931|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24412190|NCT00190931|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24412191|NCT00190931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412192|NCT00190931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412193|NCT00190931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412194|NCT00190931|Adrenergic Agents|adrenergic agents|mesh-ancestor
24412195|NCT00190931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25849452|NCT00048607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25849453|NCT00048607|Serotonin Agents|serotonin agents|mesh-ancestor
24412206|NCT00190957|Adrenergic Agents|adrenergic agents|mesh-ancestor
24412207|NCT00190957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25849454|NCT00048607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412249|NCT00191035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24821826|NCT02108301|Immunologic Factors|immunologic factors|mesh-ancestor
24821827|NCT02108301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821828|NCT02108301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24821829|NCT02108301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821830|NCT02108301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821831|NCT02108301|Antifungal Agents|antifungal agents|mesh-ancestor
24821832|NCT02108301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24821833|NCT02108301|Dermatologic Agents|dermatologic agents|mesh-ancestor
24821834|NCT02108301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24821836|NCT02108353|Antioxidants|antioxidants|mesh-ancestor
24821837|NCT02108353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821840|NCT02108353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24821841|NCT02108366|Oseltamivir|oseltamivir|mesh-list
24821842|NCT02108366|Celecoxib|celecoxib|mesh-list
24821843|NCT02108366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24821844|NCT02108366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24821845|NCT02108366|Analgesics|analgesics|mesh-ancestor
24412250|NCT00191035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412251|NCT00191035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412253|NCT00191035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412272|NCT00191061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24412273|NCT00191061|Antidepressive Agents|antidepressive agents|mesh-ancestor
24412275|NCT00191061|Dopamine Agents|dopamine agents|mesh-ancestor
24412276|NCT00191087|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25849455|NCT00048607|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25054500|NCT03529331|Sensory System Agents|sensory system agents|mesh-ancestor
24803319|NCT01995695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803320|NCT01995734|Pasireotide|pasireotide|mesh-list
24412277|NCT00191087|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24821847|NCT02108366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24821848|NCT02108366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821849|NCT02108366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24821851|NCT02108366|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24821852|NCT02108366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24821853|NCT02108366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821854|NCT02108366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821855|NCT02108366|Antiviral Agents|antiviral agents|mesh-ancestor
24821856|NCT02108366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24821857|NCT02108483|Dapsone|dapsone|mesh-list
24821858|NCT02108483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24821859|NCT02108483|Antimalarials|antimalarials|mesh-ancestor
24821860|NCT02108483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24821861|NCT02108483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24821862|NCT02108483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24821863|NCT02108483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821864|NCT02108483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821865|NCT02108483|Leprostatic Agents|leprostatic agents|mesh-ancestor
24412294|NCT00191126|Antiviral Agents|antiviral agents|mesh-ancestor
24412295|NCT00191126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24412296|NCT00191126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412297|NCT00191126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24412298|NCT00191126|Immunologic Factors|immunologic factors|mesh-ancestor
25007814|NCT02703714|Pembrolizumab|pembrolizumab|mesh-list
24412299|NCT00191126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412301|NCT00191178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24412302|NCT00191178|Insulin Glargine|insulin glargine|mesh-list
24412303|NCT00191178|Insulin Lispro|insulin lispro|mesh-list
24412304|NCT00191178|Protamines|protamines|mesh-list
24412305|NCT00191178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24412306|NCT00191178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412307|NCT00191178|Heparin Antagonists|heparin antagonists|mesh-ancestor
24412308|NCT00191178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412309|NCT00191178|Coagulants|coagulants|mesh-ancestor
24412310|NCT00191204|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24412311|NCT00191204|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24412312|NCT00191204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412313|NCT00191204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412314|NCT00191204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166453|NCT04080895|Antimalarials|antimalarials|mesh-ancestor
24412317|NCT00191204|Analgesics|analgesics|mesh-ancestor
24412318|NCT00191204|Sensory System Agents|sensory system agents|mesh-ancestor
24412319|NCT00191204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24412320|NCT00191204|Antidepressive Agents|antidepressive agents|mesh-ancestor
24412321|NCT00191204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24412322|NCT00191204|Dopamine Agents|dopamine agents|mesh-ancestor
24412323|NCT00191230|Gemcitabine|gemcitabine|mesh-list
24412355|NCT00191256|Tubulin Modulators|tubulin modulators|mesh-ancestor
24412356|NCT00191256|Antimitotic Agents|antimitotic agents|mesh-ancestor
24412357|NCT00191256|Mitosis Modulators|mitosis modulators|mesh-ancestor
24412360|NCT00191256|Antimetabolites|antimetabolites|mesh-ancestor
24412370|NCT00191295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24821866|NCT02108483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24821867|NCT02108535|Sulfadiazine|sulfadiazine|mesh-list
24821868|NCT02108535|Silver Sulfadiazine|silver sulfadiazine|mesh-list
24821869|NCT02108535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24821870|NCT02108535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24821871|NCT02108535|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24821872|NCT02108535|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24821873|NCT02108535|Coccidiostats|coccidiostats|mesh-ancestor
24821874|NCT02108535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24821875|NCT02108548|Naproxen|naproxen|mesh-list
25054564|NCT03529149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24821876|NCT02108548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24821877|NCT02108548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24821878|NCT02108548|Analgesics|analgesics|mesh-ancestor
24821879|NCT02108548|Sensory System Agents|sensory system agents|mesh-ancestor
24821880|NCT02108548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24821881|NCT02108548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821882|NCT02108548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24821883|NCT02108548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25662099|NCT01641653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25876123|NCT03907488|Lenograstim|lenograstim|mesh-list
25419576|NCT02693535|Olaparib|olaparib|mesh-list
24821885|NCT02108548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24821886|NCT02108548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821887|NCT02108548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849456|NCT00048607|Antidepressive Agents|antidepressive agents|mesh-ancestor
25849457|NCT00048607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24550999|NCT00723515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25007886|NCT02582775|Antiviral Agents|antiviral agents|mesh-ancestor
24821888|NCT02108626|Nicotine|nicotine|mesh-list
24821889|NCT02108626|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24821890|NCT02108626|Autonomic Agents|autonomic agents|mesh-ancestor
24821891|NCT02108626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24611566|NCT01009970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24412371|NCT00191295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412372|NCT00191295|Adrenergic Agents|adrenergic agents|mesh-ancestor
24412373|NCT00191295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412374|NCT00191295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412375|NCT00191321|Teriparatide|teriparatide|mesh-list
24412376|NCT00191321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24412377|NCT00191321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412378|NCT00191321|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24412379|NCT00191347|Gemcitabine|gemcitabine|mesh-list
24412380|NCT00191347|Pemetrexed|pemetrexed|mesh-list
24412381|NCT00191347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24412417|NCT00191399|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24412418|NCT00191399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412419|NCT00191399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412420|NCT00191399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412421|NCT00191399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412422|NCT00191399|Serotonin Agents|serotonin agents|mesh-ancestor
24412423|NCT00191399|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24412424|NCT00191399|Antidepressive Agents|antidepressive agents|mesh-ancestor
24821892|NCT02108626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821893|NCT02108626|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24821894|NCT02108626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24821895|NCT02108626|Cholinergic Agents|cholinergic agents|mesh-ancestor
24821896|NCT02108626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24821897|NCT02108626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821898|NCT02108639|Asunaprevir|asunaprevir|mesh-list
24821899|NCT02108639|Protease Inhibitors|protease inhibitors|mesh-ancestor
24821900|NCT02108639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412432|NCT00191412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24412433|NCT00191412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24412434|NCT00191425|Teriparatide|teriparatide|mesh-list
24412435|NCT00191425|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
24604606|NCT00980408|Dopamine Agents|dopamine agents|mesh-ancestor
24412497|NCT00191516|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24412498|NCT00191516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412499|NCT00191516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412500|NCT00191516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412501|NCT00191516|Adrenergic Agents|adrenergic agents|mesh-ancestor
24412519|NCT00191555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24412521|NCT00191555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24412522|NCT00191555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24412523|NCT00191555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24412524|NCT00191555|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24412525|NCT00191555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24821915|NCT02108743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24821916|NCT02108743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821918|NCT02108756|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24821919|NCT02108756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24821920|NCT02108756|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24821921|NCT02108756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821922|NCT02108756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821925|NCT02108795|Narcotics|narcotics|mesh-ancestor
24412538|NCT00191568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412539|NCT00191568|Antiviral Agents|antiviral agents|mesh-ancestor
24412540|NCT00191568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24412541|NCT00191568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412542|NCT00191568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24412543|NCT00191568|Immunologic Factors|immunologic factors|mesh-ancestor
25419577|NCT02693535|Palbociclib|palbociclib|mesh-list
24412544|NCT00191568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412547|NCT00191581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24412548|NCT00191581|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
24412567|NCT00191607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24412568|NCT00191607|Antimetabolites|antimetabolites|mesh-ancestor
24412569|NCT00191607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412570|NCT00191607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412571|NCT00191607|Antiviral Agents|antiviral agents|mesh-ancestor
24412572|NCT00191607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24412573|NCT00191607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412574|NCT00191607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24412575|NCT00191607|Immunologic Factors|immunologic factors|mesh-ancestor
24551235|NCT00724672|Dermatologic Agents|dermatologic agents|mesh-ancestor
24412576|NCT00191607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412577|NCT00191607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24412578|NCT00191607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24412579|NCT00191607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24412580|NCT00191620|Gemcitabine|gemcitabine|mesh-list
24412581|NCT00191620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412582|NCT00191620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24821930|NCT02108795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24821931|NCT02108808|Clopidogrel|clopidogrel|mesh-list
24821933|NCT02108808|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24821934|NCT02108808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24821935|NCT02108808|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24821936|NCT02108808|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24821937|NCT02108808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24412611|NCT00191672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412612|NCT00191672|Tubulin Modulators|tubulin modulators|mesh-ancestor
24412613|NCT00191672|Antimitotic Agents|antimitotic agents|mesh-ancestor
24412614|NCT00191672|Mitosis Modulators|mitosis modulators|mesh-ancestor
24412615|NCT00191672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412616|NCT00191672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24412618|NCT00191672|Antiviral Agents|antiviral agents|mesh-ancestor
24412619|NCT00191672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24412620|NCT00191672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821958|NCT02108886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821959|NCT02108990|Acetaminophen|acetaminophen|mesh-list
24821960|NCT02108990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24821961|NCT02108990|Analgesics|analgesics|mesh-ancestor
24821962|NCT02108990|Sensory System Agents|sensory system agents|mesh-ancestor
24821963|NCT02108990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25166454|NCT04080895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24629512|NCT01105793|Danazol|danazol|mesh-list
24821964|NCT02108990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821965|NCT02108990|Antipyretics|antipyretics|mesh-ancestor
24821966|NCT02109185|Mometasone Furoate|mometasone furoate|mesh-list
24821967|NCT02109185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24821968|NCT02109185|Dermatologic Agents|dermatologic agents|mesh-ancestor
24821969|NCT02109185|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25849458|NCT00048607|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25876124|NCT03907488|Immunoconjugates|immunoconjugates|mesh-list
24412688|NCT00191828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24412689|NCT00191828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412690|NCT00191828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24412691|NCT00191828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24412692|NCT00191828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24412693|NCT00191828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24821990|NCT02109315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24821991|NCT02109315|Antioxidants|antioxidants|mesh-ancestor
24551338|NCT00725478|Dopamine Agonists|dopamine agonists|mesh-ancestor
24821992|NCT02109315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821993|NCT02109315|Protective Agents|protective agents|mesh-ancestor
24821994|NCT02109328|Paclitaxel|paclitaxel|mesh-list
24821995|NCT02109328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24821997|NCT02109328|Tubulin Modulators|tubulin modulators|mesh-ancestor
24821998|NCT02109328|Antimitotic Agents|antimitotic agents|mesh-ancestor
24821999|NCT02109328|Mitosis Modulators|mitosis modulators|mesh-ancestor
24822000|NCT02109328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822001|NCT02109341|Paclitaxel|paclitaxel|mesh-list
24412711|NCT00191841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412712|NCT00191867|Teriparatide|teriparatide|mesh-list
24412713|NCT00191867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24412714|NCT00191867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412715|NCT00191867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24412716|NCT00191880|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24412717|NCT00191880|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24412718|NCT00191880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412724|NCT00191893|Teriparatide|teriparatide|mesh-list
24412726|NCT00191893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822007|NCT02109341|Mitosis Modulators|mitosis modulators|mesh-ancestor
24822008|NCT02109341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822009|NCT02109354|Vaccines|vaccines|mesh-list
24822010|NCT02109354|Immunologic Factors|immunologic factors|mesh-ancestor
24822011|NCT02109354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822012|NCT02109510|Lidocaine|lidocaine|mesh-list
24412859|NCT00192595|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24412860|NCT00192595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24412861|NCT00192595|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24412862|NCT00192595|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24412863|NCT00192595|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24412864|NCT00192595|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24412866|NCT00192608|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24412867|NCT00192608|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24412868|NCT00192608|Protease Inhibitors|protease inhibitors|mesh-ancestor
24412903|NCT00192634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412904|NCT00192634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412905|NCT00192634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24412906|NCT00192634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24412907|NCT00192660|Ritonavir|ritonavir|mesh-list
24412908|NCT00192660|Nelfinavir|nelfinavir|mesh-list
24412909|NCT00192660|Indinavir|indinavir|mesh-list
24412910|NCT00192660|Saquinavir|saquinavir|mesh-list
24412911|NCT00192660|Amprenavir|amprenavir|mesh-list
24412912|NCT00192660|Tenofovir|tenofovir|mesh-list
24412938|NCT00192660|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24412939|NCT00192660|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24412940|NCT00192660|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24412942|NCT00192660|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24412943|NCT00192660|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24412944|NCT00192660|Antitubercular Agents|antitubercular agents|mesh-ancestor
24412945|NCT00192660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24412981|NCT00192777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166455|NCT04080895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24412982|NCT00192803|Candesartan|candesartan|mesh-list
24413015|NCT00192959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413016|NCT00192959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24413018|NCT00192959|Anesthetics|anesthetics|mesh-ancestor
24413019|NCT00193011|Cyclophosphamide|cyclophosphamide|mesh-list
24413020|NCT00193011|Docetaxel|docetaxel|mesh-list
24413021|NCT00193011|Fluorouracil|fluorouracil|mesh-list
24413022|NCT00193011|Methotrexate|methotrexate|mesh-list
24413023|NCT00193011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24413045|NCT00193024|Epirubicin|epirubicin|mesh-list
24413055|NCT00193076|Gemcitabine|gemcitabine|mesh-list
24543030|NCT00681733|Pioglitazone|pioglitazone|mesh-list
24413061|NCT00193076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413063|NCT00193076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24413065|NCT00193076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24413066|NCT00193076|Immunologic Factors|immunologic factors|mesh-ancestor
24413067|NCT00193076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413793|NCT00195299|Sirolimus|sirolimus|mesh-list
24413078|NCT00193089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24413079|NCT00193102|Thalidomide|thalidomide|mesh-list
24413080|NCT00193102|Capecitabine|capecitabine|mesh-list
24413081|NCT00193102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24413082|NCT00193102|Antimetabolites|antimetabolites|mesh-ancestor
24413083|NCT00193102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849459|NCT00048607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25849460|NCT00048607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413087|NCT00193102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413088|NCT00193102|Leprostatic Agents|leprostatic agents|mesh-ancestor
24413089|NCT00193102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24413090|NCT00193102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24413091|NCT00193102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24413092|NCT00193102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24413097|NCT00193115|Doxorubicin|doxorubicin|mesh-list
24413098|NCT00193115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24413099|NCT00193115|Immunologic Factors|immunologic factors|mesh-ancestor
24822036|NCT02109510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24822037|NCT02109510|Adrenergic Agents|adrenergic agents|mesh-ancestor
24822038|NCT02109510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24822039|NCT02109510|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24822040|NCT02109510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24822041|NCT02109510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24822042|NCT02109510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24822043|NCT02109510|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24413100|NCT00193115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413101|NCT00193115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24413102|NCT00193115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24413103|NCT00193115|Alkylating Agents|alkylating agents|mesh-ancestor
24413167|NCT00193245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413168|NCT00193245|Tubulin Modulators|tubulin modulators|mesh-ancestor
24413169|NCT00193245|Antimitotic Agents|antimitotic agents|mesh-ancestor
24413174|NCT00193245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413177|NCT00193271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413178|NCT00193271|Tubulin Modulators|tubulin modulators|mesh-ancestor
24413179|NCT00193271|Antimitotic Agents|antimitotic agents|mesh-ancestor
24413180|NCT00193271|Mitosis Modulators|mitosis modulators|mesh-ancestor
24413223|NCT00193323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24413224|NCT00193323|Antimetabolites|antimetabolites|mesh-ancestor
24413225|NCT00193323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413226|NCT00193323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413227|NCT00193323|Antiviral Agents|antiviral agents|mesh-ancestor
24413228|NCT00193323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24413229|NCT00193323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413230|NCT00193323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24413231|NCT00193323|Immunologic Factors|immunologic factors|mesh-ancestor
24413232|NCT00193323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413243|NCT00193349|Imatinib Mesylate|imatinib mesylate|mesh-list
24413244|NCT00193349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413245|NCT00193349|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24413246|NCT00193349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24413247|NCT00193349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413248|NCT00193349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413249|NCT00193349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24413250|NCT00193362|Gemcitabine|gemcitabine|mesh-list
24413252|NCT00193362|Vinorelbine|vinorelbine|mesh-list
24413253|NCT00193362|Carboplatin|carboplatin|mesh-list
25141475|NCT02957435|Eplerenone|eplerenone|mesh-list
24413255|NCT00193362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413256|NCT00193362|Tubulin Modulators|tubulin modulators|mesh-ancestor
24413257|NCT00193362|Antimitotic Agents|antimitotic agents|mesh-ancestor
24413258|NCT00193362|Mitosis Modulators|mitosis modulators|mesh-ancestor
24413259|NCT00193362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413260|NCT00193362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24413301|NCT00193505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24413302|NCT00193505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24413303|NCT00193505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24413304|NCT00193505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24413305|NCT00193505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413342|NCT00193570|Antimitotic Agents|antimitotic agents|mesh-ancestor
24413347|NCT00193570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413348|NCT00193583|Carboplatin|carboplatin|mesh-list
24413349|NCT00193583|Topotecan|topotecan|mesh-list
24413350|NCT00193583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413351|NCT00193583|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24413352|NCT00193583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24413353|NCT00193583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413354|NCT00193583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413355|NCT00193622|Bevacizumab|bevacizumab|mesh-list
24413356|NCT00193622|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24413357|NCT00193622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24413358|NCT00193622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413359|NCT00193622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24413360|NCT00193622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25849462|NCT00048607|Autonomic Agents|autonomic agents|mesh-ancestor
24413373|NCT00193635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24413374|NCT00193635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413375|NCT00193635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413376|NCT00193648|Rosiglitazone|rosiglitazone|mesh-list
24413377|NCT00193648|Adalimumab|adalimumab|mesh-list
24413378|NCT00193648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24413379|NCT00193648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24822064|NCT02109627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24822065|NCT02109627|Immunologic Factors|immunologic factors|mesh-ancestor
24822066|NCT02109627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822067|NCT02109666|Abatacept|abatacept|mesh-list
24685559|NCT05271058|Glucocorticoids|glucocorticoids|mesh-ancestor
24413380|NCT00193648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24413381|NCT00193648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413382|NCT00193661|Testosterone|testosterone|mesh-list
24413383|NCT00193661|Androgens|androgens|mesh-ancestor
24413384|NCT00193661|Hormones|hormones|mesh-ancestor
24413385|NCT00193661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24413386|NCT00193661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413387|NCT00193674|Dydrogesterone|dydrogesterone|mesh-list
24413388|NCT00193674|Progestins|progestins|mesh-ancestor
24413389|NCT00193674|Hormones|hormones|mesh-ancestor
24413390|NCT00193674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24413391|NCT00193674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413392|NCT00193700|Testosterone|testosterone|mesh-list
24822068|NCT02109666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24822069|NCT02109666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822070|NCT02109666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822071|NCT02109666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24822073|NCT02109666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822074|NCT02109666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24822075|NCT02109679|Metformin|metformin|mesh-list
24822076|NCT02109679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24822077|NCT02109679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822078|NCT02109718|Sulfadiazine|sulfadiazine|mesh-list
24822079|NCT02109718|Silver Sulfadiazine|silver sulfadiazine|mesh-list
24822080|NCT02109718|Petrolatum|petrolatum|mesh-list
24822081|NCT02109718|Emollients|emollients|mesh-ancestor
24822082|NCT02109718|Dermatologic Agents|dermatologic agents|mesh-ancestor
24822083|NCT02109718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24822084|NCT02109718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24822085|NCT02109718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24822086|NCT02109718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24822087|NCT02109718|Coccidiostats|coccidiostats|mesh-ancestor
24822088|NCT02109718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24822089|NCT02109783|Caffeine|caffeine|mesh-list
24413549|NCT00194272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24413551|NCT00194324|Clotrimazole|clotrimazole|mesh-list
24413552|NCT00194324|Antifungal Agents|antifungal agents|mesh-ancestor
24413553|NCT00194324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24413554|NCT00194324|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24413555|NCT00194324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24413556|NCT00194324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24822112|NCT02109861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822113|NCT02109861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24822114|NCT02109861|Alkylating Agents|alkylating agents|mesh-ancestor
24822115|NCT02109861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822116|NCT02109861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25141607|NCT02956408|Vitamin D|vitamin d|mesh-list
24822118|NCT02109861|Immunologic Factors|immunologic factors|mesh-ancestor
24822119|NCT02109900|Progesterone|progesterone|mesh-list
24822120|NCT02109900|Progestins|progestins|mesh-ancestor
24413557|NCT00194324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413558|NCT00194324|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24413559|NCT00194324|Hormone Antagonists|hormone antagonists|mesh-ancestor
24413561|NCT00194324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849463|NCT00048607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24413563|NCT00194324|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24413564|NCT00194324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24413566|NCT00194402|Niacinamide|niacinamide|mesh-list
24822132|NCT02109913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24822133|NCT02109913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413606|NCT00194623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413607|NCT00194623|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24413608|NCT00194623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24413610|NCT00194649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413611|NCT00194649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413612|NCT00194649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24413613|NCT00194649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24413614|NCT00194649|Antiviral Agents|antiviral agents|mesh-ancestor
24413623|NCT00194727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413624|NCT00194727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413625|NCT00194727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24413636|NCT00194740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24413649|NCT00194753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24413650|NCT00194753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24413651|NCT00194753|Alkylating Agents|alkylating agents|mesh-ancestor
24413652|NCT00194753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24413653|NCT00194753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24413654|NCT00194753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24413655|NCT00194753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24413656|NCT00194753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849464|NCT00048607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25849465|NCT00048607|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25849466|NCT00048646|Progesterone|progesterone|mesh-list
25849467|NCT00048646|Progestins|progestins|mesh-ancestor
24822138|NCT02109965|Dexmedetomidine|dexmedetomidine|mesh-list
24822140|NCT02109965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24822141|NCT02109965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24413719|NCT00194974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413722|NCT00194974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24413723|NCT00194974|Vasodilator Agents|vasodilator agents|mesh-ancestor
24413724|NCT00194974|Tocolytic Agents|tocolytic agents|mesh-ancestor
24413725|NCT00194974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24413726|NCT00194974|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24413727|NCT00194974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24413728|NCT00194974|Sympathomimetics|sympathomimetics|mesh-ancestor
24413729|NCT00194974|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24413730|NCT00194974|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24413731|NCT00195000|Cytarabine|cytarabine|mesh-list
24413732|NCT00195000|Gemtuzumab|gemtuzumab|mesh-list
24413733|NCT00195000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24413734|NCT00195000|Antimetabolites|antimetabolites|mesh-ancestor
24413772|NCT00195195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24413773|NCT00195195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24413787|NCT00195286|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24413789|NCT00195286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24413790|NCT00195286|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24413791|NCT00195286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413792|NCT00195286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822144|NCT02109965|Anesthetics, General|anesthetics, general|mesh-ancestor
24822145|NCT02109965|Anesthetics|anesthetics|mesh-ancestor
24822146|NCT02109965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24822147|NCT02109965|Analgesics|analgesics|mesh-ancestor
24822148|NCT02109965|Sensory System Agents|sensory system agents|mesh-ancestor
24413794|NCT00195299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24413795|NCT00195299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24413796|NCT00195299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24413797|NCT00195299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413798|NCT00195299|Antifungal Agents|antifungal agents|mesh-ancestor
24413799|NCT00195299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24413854|NCT00195468|Cyclosporins|cyclosporins|mesh-list
24413855|NCT00195468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413856|NCT00195468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413857|NCT00195468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24413858|NCT00195468|Immunologic Factors|immunologic factors|mesh-ancestor
24413859|NCT00195468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413909|NCT00195585|Vitamin B Complex|vitamin b complex|mesh-ancestor
24413910|NCT00195585|Vitamins|vitamins|mesh-ancestor
24413911|NCT00195585|Micronutrients|micronutrients|mesh-ancestor
24822156|NCT02109965|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24413924|NCT00195598|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24413928|NCT00195611|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24413929|NCT00195611|Immunologic Factors|immunologic factors|mesh-ancestor
24413930|NCT00195611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413932|NCT00195637|Antibodies|antibodies|mesh-list
24413933|NCT00195637|gamma-Globulins|gamma-globulins|mesh-list
24413944|NCT00195689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24413945|NCT00195728|Acetaminophen|acetaminophen|mesh-list
24413946|NCT00195728|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
24413947|NCT00195728|Hydrocodone|hydrocodone|mesh-list
24413948|NCT00195728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24413949|NCT00195728|Analgesics|analgesics|mesh-ancestor
24413950|NCT00195728|Sensory System Agents|sensory system agents|mesh-ancestor
25849468|NCT00048646|Hormones|hormones|mesh-ancestor
24413951|NCT00195728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24413952|NCT00195728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413953|NCT00195728|Antipyretics|antipyretics|mesh-ancestor
24413954|NCT00195728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24413955|NCT00195728|Narcotics|narcotics|mesh-ancestor
24413956|NCT00195728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24413957|NCT00195728|Antitussive Agents|antitussive agents|mesh-ancestor
24413958|NCT00195728|Respiratory System Agents|respiratory system agents|mesh-ancestor
24413959|NCT00195728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24413960|NCT00195728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24413961|NCT00195728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24413962|NCT00195741|Valproic Acid|valproic acid|mesh-list
24413963|NCT00195741|Anticonvulsants|anticonvulsants|mesh-ancestor
24413964|NCT00195741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413965|NCT00195741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413966|NCT00195741|GABA Agents|gaba agents|mesh-ancestor
24413967|NCT00195741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24413968|NCT00195741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413969|NCT00195741|Antimanic Agents|antimanic agents|mesh-ancestor
24414008|NCT00195793|Fenofibrate|fenofibrate|mesh-list
24414009|NCT00195793|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24414010|NCT00195793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24414080|NCT00195910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24552963|NCT00728559|Anesthetics|anesthetics|mesh-ancestor
24414081|NCT00195910|Narcotics|narcotics|mesh-ancestor
24414082|NCT00195910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24414083|NCT00195910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414084|NCT00195910|Analgesics|analgesics|mesh-ancestor
24414085|NCT00195910|Sensory System Agents|sensory system agents|mesh-ancestor
24414086|NCT00195910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24414087|NCT00195923|Clindamycin|clindamycin|mesh-list
24414088|NCT00195923|Clindamycin palmitate|clindamycin palmitate|mesh-list
24414089|NCT00195923|Clindamycin phosphate|clindamycin phosphate|mesh-list
24414091|NCT00195923|Ceftazidime|ceftazidime|mesh-list
24414102|NCT00195936|Hormone Antagonists|hormone antagonists|mesh-ancestor
24414103|NCT00195936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24414105|NCT00195988|Tacrolimus|tacrolimus|mesh-list
24414106|NCT00195988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24822183|NCT02110316|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24822184|NCT02110316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24822185|NCT02110316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24822186|NCT02110316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822187|NCT02110316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24822188|NCT02110316|Hormone Antagonists|hormone antagonists|mesh-ancestor
24822189|NCT02110316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24822190|NCT02110316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822191|NCT02110316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24578321|NCT00848562|Nicorandil|nicorandil|mesh-list
24822192|NCT02110355|Trametinib|trametinib|mesh-list
24822193|NCT02110355|Dabrafenib|dabrafenib|mesh-list
24822194|NCT02110355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822195|NCT02110355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24822196|NCT02110355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24822197|NCT02110355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822198|NCT02110394|Rituximab|rituximab|mesh-list
24822199|NCT02110394|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24822200|NCT02110394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24822201|NCT02110394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822202|NCT02110394|Immunologic Factors|immunologic factors|mesh-ancestor
24822203|NCT02110394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822204|NCT02110394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24822205|NCT02110394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24822206|NCT02110394|Alkylating Agents|alkylating agents|mesh-ancestor
24822207|NCT02110394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822208|NCT02110459|Murepavadin|murepavadin|mesh-list
24822209|NCT02110459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25876125|NCT03907488|Imidazole|imidazole|mesh-list
24822217|NCT02110524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822219|NCT02110537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24822220|NCT02110537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24822221|NCT02110537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24822222|NCT02110537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24552968|NCT00728585|Mitogens|mitogens|mesh-list
25008068|NCT02097680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804157|NCT02001298|Remifentanil|remifentanil|mesh-list
25008069|NCT02097680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24553121|NCT00729638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553123|NCT00729638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24553124|NCT00729638|Growth Substances|growth substances|mesh-ancestor
24553125|NCT00729638|Growth Inhibitors|growth inhibitors|mesh-ancestor
24822223|NCT02110537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822224|NCT02110654|Mometasone Furoate|mometasone furoate|mesh-list
24822225|NCT02110654|Montelukast|montelukast|mesh-list
24822226|NCT02110654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24822227|NCT02110654|Respiratory System Agents|respiratory system agents|mesh-ancestor
24822228|NCT02110654|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24822229|NCT02110654|Hormone Antagonists|hormone antagonists|mesh-ancestor
24822230|NCT02110654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24822231|NCT02110654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822232|NCT02110654|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24822233|NCT02110654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24822234|NCT02110654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822244|NCT02110719|Gabapentin|gabapentin|mesh-list
24822245|NCT02110719|Hydromorphone|hydromorphone|mesh-list
24822246|NCT02110719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24822247|NCT02110719|Antiemetics|antiemetics|mesh-ancestor
24822248|NCT02110719|Autonomic Agents|autonomic agents|mesh-ancestor
24822249|NCT02110719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24822250|NCT02110719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822252|NCT02110719|Glucocorticoids|glucocorticoids|mesh-ancestor
24822254|NCT02110719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24822255|NCT02110719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24822256|NCT02110719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822259|NCT02110719|Sensory System Agents|sensory system agents|mesh-ancestor
24822260|NCT02110719|Antipyretics|antipyretics|mesh-ancestor
24822261|NCT02110719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24822262|NCT02110719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24432079|NCT00253552|Cyclosporine|cyclosporine|mesh-list
24553268|NCT00730197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24553292|NCT00730223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24553293|NCT00730223|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24822263|NCT02110719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24578336|NCT00848679|Anesthetics|anesthetics|mesh-ancestor
24822264|NCT02110719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24822265|NCT02110719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054901|NCT03526224|Teriflunomide|teriflunomide|mesh-list
24822266|NCT02110719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24822267|NCT02110719|Narcotics|narcotics|mesh-ancestor
25849469|NCT00048646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24414117|NCT00195988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24414118|NCT00196131|Morphine|morphine|mesh-list
24414119|NCT00196131|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24414120|NCT00196131|Narcotics|narcotics|mesh-ancestor
24414121|NCT00196131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24414122|NCT00196131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414123|NCT00196131|Analgesics|analgesics|mesh-ancestor
24414124|NCT00196131|Sensory System Agents|sensory system agents|mesh-ancestor
24414125|NCT00196131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24414126|NCT00196352|Levonorgestrel|levonorgestrel|mesh-list
24414127|NCT00196352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24414128|NCT00196352|Contraceptive Agents|contraceptive agents|mesh-ancestor
24414129|NCT00196352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24414130|NCT00196352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414131|NCT00196352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24414132|NCT00196352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24414133|NCT00196352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24414134|NCT00196365|Levonorgestrel|levonorgestrel|mesh-list
24414135|NCT00196365|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24414136|NCT00196365|Contraceptive Agents|contraceptive agents|mesh-ancestor
24414137|NCT00196365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24414138|NCT00196365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822273|NCT02110719|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24822274|NCT02110719|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24822275|NCT02110719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24822277|NCT02110719|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24822278|NCT02110745|Propofol|propofol|mesh-list
24822279|NCT02110745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24822280|NCT02110745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24822281|NCT02110745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414162|NCT00196469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24414163|NCT00196469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24414164|NCT00196469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414165|NCT00196534|Thrombin|thrombin|mesh-list
24414166|NCT00196534|Hemostatics|hemostatics|mesh-ancestor
24822287|NCT02110784|Antimalarials|antimalarials|mesh-ancestor
24822288|NCT02110784|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24822289|NCT02110784|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24822290|NCT02110784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24822291|NCT02110810|Indomethacin|indomethacin|mesh-list
24822292|NCT02110810|Glycerol|glycerol|mesh-list
24446520|NCT00304993|Vitamins|vitamins|mesh-ancestor
24822304|NCT02110810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24822305|NCT02110810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24822306|NCT02110810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414173|NCT00196547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24414174|NCT00196547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414175|NCT00196547|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24414176|NCT00196547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24414177|NCT00196547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414207|NCT00196599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24414210|NCT00196599|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24414211|NCT00196599|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24414212|NCT00196599|Antimetabolites|antimetabolites|mesh-ancestor
24414213|NCT00196612|Emtricitabine|emtricitabine|mesh-list
24414214|NCT00196612|Efavirenz|efavirenz|mesh-list
24414215|NCT00196612|Didanosine|didanosine|mesh-list
24414216|NCT00196612|Antiviral Agents|antiviral agents|mesh-ancestor
24414217|NCT00196612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24414218|NCT00196612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24551060|NCT00723879|Ribavirin|ribavirin|mesh-list
24554147|NCT00734682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24554148|NCT00734682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24554149|NCT00734682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569808|NCT00801944|Cholinergic Agents|cholinergic agents|mesh-ancestor
24554150|NCT00734682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24554176|NCT00734773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24554177|NCT00734773|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24554178|NCT00734773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24414219|NCT00196612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24414220|NCT00196612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414221|NCT00196612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414237|NCT00196625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414238|NCT00196625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24414239|NCT00196625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24414240|NCT00196625|Antiviral Agents|antiviral agents|mesh-ancestor
24414241|NCT00196625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24414242|NCT00196625|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24822307|NCT02110810|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24822308|NCT02110810|Protective Agents|protective agents|mesh-ancestor
24822309|NCT02110953|Irinotecan|irinotecan|mesh-list
24822310|NCT02110953|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24822311|NCT02110953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24822312|NCT02110953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24822314|NCT02110953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822316|NCT02110966|Mepivacaine|mepivacaine|mesh-list
24822317|NCT02110966|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24822318|NCT02110966|Narcotics|narcotics|mesh-ancestor
24822322|NCT02110966|Sensory System Agents|sensory system agents|mesh-ancestor
24822323|NCT02110966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24822324|NCT02110966|Anesthetics, Local|anesthetics, local|mesh-ancestor
24822325|NCT02110966|Anesthetics|anesthetics|mesh-ancestor
24822327|NCT02110992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24686374|NCT04879823|Acetaminophen|acetaminophen|mesh-list
24414243|NCT00196625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24414244|NCT00196625|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24414245|NCT00196625|Antitubercular Agents|antitubercular agents|mesh-ancestor
24414246|NCT00196625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24414247|NCT00196638|Interferons|interferons|mesh-list
24414248|NCT00196638|Interferon-alpha|interferon-alpha|mesh-list
24414249|NCT00196638|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24414250|NCT00196638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849470|NCT00048646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849471|NCT00048659|N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|n-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|mesh-list
25849472|NCT00048659|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25849473|NCT00048659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849474|NCT00048672|Imatinib Mesylate|imatinib mesylate|mesh-list
25849475|NCT00048672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849476|NCT00048672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25849477|NCT00048672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414262|NCT00196664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414263|NCT00196664|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24414265|NCT00196664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24414266|NCT00196664|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24414267|NCT00196664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24414268|NCT00196664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414269|NCT00196677|Vitamins|vitamins|mesh-list
24414270|NCT00196677|Micronutrients|micronutrients|mesh-ancestor
24414271|NCT00196677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414272|NCT00196690|Donepezil|donepezil|mesh-list
24822328|NCT02110992|Tubulin Modulators|tubulin modulators|mesh-ancestor
24822329|NCT02110992|Antimitotic Agents|antimitotic agents|mesh-ancestor
24822330|NCT02110992|Mitosis Modulators|mitosis modulators|mesh-ancestor
24822331|NCT02110992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414273|NCT00196690|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24414274|NCT00196690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414275|NCT00196690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414311|NCT00196859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414313|NCT00196859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24414314|NCT00196859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414315|NCT00196872|Cyclophosphamide|cyclophosphamide|mesh-list
24414316|NCT00196872|Epirubicin|epirubicin|mesh-list
24414317|NCT00196872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24414351|NCT00197080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414353|NCT00197132|Rosiglitazone|rosiglitazone|mesh-list
24414354|NCT00197132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24414355|NCT00197132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414356|NCT00197197|Aplaviroc|aplaviroc|mesh-list
24414397|NCT00197418|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24414398|NCT00197418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24414399|NCT00197418|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24414400|NCT00197418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414401|NCT00197418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414402|NCT00197418|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24414403|NCT00197418|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24414404|NCT00197418|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24414405|NCT00197418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24414406|NCT00197418|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24414407|NCT00197444|Nedaplatin|nedaplatin|mesh-list
24414408|NCT00197444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24414409|NCT00197483|Pergolide|pergolide|mesh-list
24414410|NCT00197483|Dopamine Agonists|dopamine agonists|mesh-ancestor
24414411|NCT00197483|Dopamine Agents|dopamine agents|mesh-ancestor
24414414|NCT00197483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822344|NCT02111122|Anesthetics|anesthetics|mesh-ancestor
24414422|NCT00197561|Antioxidants|antioxidants|mesh-ancestor
24414423|NCT00197561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414424|NCT00197561|Protective Agents|protective agents|mesh-ancestor
24414425|NCT00197561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414442|NCT00197613|Nevirapine|nevirapine|mesh-list
24414443|NCT00197613|Stavudine|stavudine|mesh-list
24414444|NCT00197613|Didanosine|didanosine|mesh-list
24414445|NCT00197613|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24414446|NCT00197613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24414447|NCT00197613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414448|NCT00197613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414449|NCT00197613|Antiviral Agents|antiviral agents|mesh-ancestor
24414450|NCT00197613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24414451|NCT00197613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24414452|NCT00197613|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24414463|NCT00197639|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24414464|NCT00197639|Protease Inhibitors|protease inhibitors|mesh-ancestor
24822345|NCT02111122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24822346|NCT02111122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822348|NCT02111161|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24822349|NCT02111161|Immunoglobulin G|immunoglobulin g|mesh-list
24822350|NCT02111161|gamma-Globulins|gamma-globulins|mesh-list
24822351|NCT02111161|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24822352|NCT02111161|Immunologic Factors|immunologic factors|mesh-ancestor
24822353|NCT02111161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822355|NCT02111265|Remifentanil|remifentanil|mesh-list
24822356|NCT02111265|Cisatracurium|cisatracurium|mesh-list
24822357|NCT02111265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24822358|NCT02111265|Narcotics|narcotics|mesh-ancestor
24822359|NCT02111265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24822360|NCT02111265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822361|NCT02111265|Analgesics|analgesics|mesh-ancestor
24822362|NCT02111265|Sensory System Agents|sensory system agents|mesh-ancestor
24822363|NCT02111265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24822364|NCT02111265|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24822365|NCT02111265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24822366|NCT02111265|Anesthetics, General|anesthetics, general|mesh-ancestor
24822367|NCT02111265|Anesthetics|anesthetics|mesh-ancestor
24822368|NCT02111265|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24822369|NCT02111265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24822370|NCT02111317|Verapamil|verapamil|mesh-list
24822371|NCT02111317|Peficitinib|peficitinib|mesh-list
24822372|NCT02111317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24822373|NCT02111317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24822374|NCT02111317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24822375|NCT02111317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822376|NCT02111317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24822377|NCT02111317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822378|NCT02111317|Vasodilator Agents|vasodilator agents|mesh-ancestor
24822379|NCT02111317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24822380|NCT02111317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24822381|NCT02111317|Immunologic Factors|immunologic factors|mesh-ancestor
24822383|NCT02111421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24822384|NCT02111421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24822385|NCT02111421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822397|NCT02111434|Androgens|androgens|mesh-ancestor
24822398|NCT02111434|Hormones|hormones|mesh-ancestor
24822399|NCT02111434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24822401|NCT02111473|Testosterone|testosterone|mesh-list
24822402|NCT02111473|Androgens|androgens|mesh-ancestor
24822403|NCT02111473|Hormones|hormones|mesh-ancestor
24822404|NCT02111473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24822405|NCT02111473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822406|NCT02111551|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
24822407|NCT02111551|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24822408|NCT02111551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24822409|NCT02111551|Cholinergic Agents|cholinergic agents|mesh-ancestor
24414481|NCT00197743|Carotenoids|carotenoids|mesh-list
24414483|NCT00197743|Micronutrients|micronutrients|mesh-ancestor
24414484|NCT00197743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414485|NCT00197743|Antioxidants|antioxidants|mesh-ancestor
24414486|NCT00197743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414487|NCT00197743|Protective Agents|protective agents|mesh-ancestor
24414489|NCT00197756|Vitamins|vitamins|mesh-list
24414490|NCT00197756|Vitamin A|vitamin a|mesh-list
24414491|NCT00197756|Retinol palmitate|retinol palmitate|mesh-list
24414492|NCT00197756|Micronutrients|micronutrients|mesh-ancestor
24414493|NCT00197756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414494|NCT00197756|Antioxidants|antioxidants|mesh-ancestor
24822411|NCT02111551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822412|NCT02111551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822413|NCT02111590|Immunoglobulins|immunoglobulins|mesh-list
24822415|NCT02111590|Antibodies|antibodies|mesh-list
24822416|NCT02111590|Immunologic Factors|immunologic factors|mesh-ancestor
24822417|NCT02111590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822419|NCT02111629|Secnidazole|secnidazole|mesh-list
24822420|NCT02111629|Antifungal Agents|antifungal agents|mesh-ancestor
24822421|NCT02111629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24822422|NCT02111629|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24554539|NCT00736931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24822423|NCT02111629|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24414495|NCT00197756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414496|NCT00197756|Protective Agents|protective agents|mesh-ancestor
24414497|NCT00197756|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25876126|NCT03907488|Immunologic Factors|immunologic factors|mesh-ancestor
24466516|NCT00373776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24466517|NCT00373776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466529|NCT00373789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25154465|NCT05471427|Taxane|taxane|mesh-list
24414498|NCT00197756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24414531|NCT00197912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24414532|NCT00197912|Alkylating Agents|alkylating agents|mesh-ancestor
24414533|NCT00197912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414534|NCT00197912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24414535|NCT00197912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24414536|NCT00197912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24414537|NCT00197912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24414538|NCT00197912|Analgesics|analgesics|mesh-ancestor
24414565|NCT00198094|Antidepressive Agents|antidepressive agents|mesh-ancestor
24414566|NCT00198094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24414567|NCT00198094|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24414568|NCT00198094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24414569|NCT00198094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24414570|NCT00198094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414571|NCT00198094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24414574|NCT00198094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24414575|NCT00198094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24414576|NCT00198094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24414577|NCT00198094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24414595|NCT00198159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24414596|NCT00198159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414597|NCT00198159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414598|NCT00198172|Epirubicin|epirubicin|mesh-list
24414599|NCT00198172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822424|NCT02111629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24822425|NCT02111629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822426|NCT02111629|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24822427|NCT02111629|Hormone Antagonists|hormone antagonists|mesh-ancestor
24822428|NCT02111629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24822429|NCT02111629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822430|NCT02111629|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24822431|NCT02111629|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24822432|NCT02111629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24822433|NCT02111629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24822434|NCT02111707|Indomethacin|indomethacin|mesh-list
24414925|NCT00199004|Vincristine|vincristine|mesh-list
24414603|NCT00198172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414604|NCT00198172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822457|NCT02112006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24822458|NCT02112006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822459|NCT02112006|Sensory System Agents|sensory system agents|mesh-ancestor
24822460|NCT02112006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24822462|NCT02112019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24414605|NCT00198198|Aripiprazole|aripiprazole|mesh-list
24414606|NCT00198198|Antidepressive Agents|antidepressive agents|mesh-ancestor
24414607|NCT00198198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24414608|NCT00198198|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24414609|NCT00198198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24414610|NCT00198198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24414630|NCT00198237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24414631|NCT00198237|Antimetabolites|antimetabolites|mesh-ancestor
24414632|NCT00198250|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24414633|NCT00198250|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24414634|NCT00198250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24414635|NCT00198250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24414636|NCT00198250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414654|NCT00198354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24414655|NCT00198354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414656|NCT00198354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24414657|NCT00198354|Immunologic Factors|immunologic factors|mesh-ancestor
24414658|NCT00198354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414659|NCT00198367|Cisplatin|cisplatin|mesh-list
24414660|NCT00198367|Carboplatin|carboplatin|mesh-list
25662100|NCT01641653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25662101|NCT01641653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662102|NCT01641653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25849478|NCT00048672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466544|NCT00373802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24466545|NCT00373802|Adrenergic Agents|adrenergic agents|mesh-ancestor
24466546|NCT00373802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24466547|NCT00373802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414661|NCT00198367|Vinorelbine|vinorelbine|mesh-list
24414662|NCT00198367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24554679|NCT00737685|Cyclophosphamide|cyclophosphamide|mesh-list
24414663|NCT00198367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414664|NCT00198367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24414665|NCT00198367|Tubulin Modulators|tubulin modulators|mesh-ancestor
24414666|NCT00198367|Antimitotic Agents|antimitotic agents|mesh-ancestor
24414667|NCT00198367|Mitosis Modulators|mitosis modulators|mesh-ancestor
24414852|NCT00198978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24414854|NCT00198978|Dermatologic Agents|dermatologic agents|mesh-ancestor
24414855|NCT00198978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414856|NCT00198978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24414857|NCT00198978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24414858|NCT00198978|Antiviral Agents|antiviral agents|mesh-ancestor
25166456|NCT04080895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24414919|NCT00199004|Cytarabine|cytarabine|mesh-list
24414920|NCT00199004|Dexamethasone|dexamethasone|mesh-list
24414921|NCT00199004|Prednisolone|prednisolone|mesh-list
24414922|NCT00199004|Cyclophosphamide|cyclophosphamide|mesh-list
24414923|NCT00199004|Rituximab|rituximab|mesh-list
24414924|NCT00199004|Methotrexate|methotrexate|mesh-list
24414931|NCT00199004|Vindesine|vindesine|mesh-list
24414932|NCT00199004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24414933|NCT00199004|Immunologic Factors|immunologic factors|mesh-ancestor
24414934|NCT00199004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414935|NCT00199004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24822465|NCT02112032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24822466|NCT02112032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822467|NCT02112032|Antiviral Agents|antiviral agents|mesh-ancestor
24822468|NCT02112032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24822469|NCT02112097|Etanercept|etanercept|mesh-list
24822470|NCT02112097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24414962|NCT00199004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24414998|NCT00199017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24414999|NCT00199017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24415031|NCT00199043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24415032|NCT00199043|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24415035|NCT00199043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415037|NCT00199056|Dexamethasone|dexamethasone|mesh-list
24415038|NCT00199056|Prednisolone|prednisolone|mesh-list
24415039|NCT00199056|Cyclophosphamide|cyclophosphamide|mesh-list
24415040|NCT00199056|Ifosfamide|ifosfamide|mesh-list
24415041|NCT00199056|Methotrexate|methotrexate|mesh-list
24415042|NCT00199056|Fludarabine|fludarabine|mesh-list
24415043|NCT00199056|Vincristine|vincristine|mesh-list
24415044|NCT00199056|Doxorubicin|doxorubicin|mesh-list
24415045|NCT00199056|Daunorubicin|daunorubicin|mesh-list
24415046|NCT00199056|Asparaginase|asparaginase|mesh-list
24415047|NCT00199056|Mercaptopurine|mercaptopurine|mesh-list
24415051|NCT00199056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24415052|NCT00199056|Immunologic Factors|immunologic factors|mesh-ancestor
24415053|NCT00199056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415054|NCT00199056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24415055|NCT00199056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24415056|NCT00199056|Alkylating Agents|alkylating agents|mesh-ancestor
25142328|NCT02951117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24415057|NCT00199056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415058|NCT00199056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415059|NCT00199056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24415060|NCT00199056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24415061|NCT00199056|Antiemetics|antiemetics|mesh-ancestor
24415062|NCT00199056|Autonomic Agents|autonomic agents|mesh-ancestor
24415063|NCT00199056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24415064|NCT00199056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25662103|NCT01641653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25662104|NCT01641653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25662105|NCT01641653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25662106|NCT01641653|Anesthetics, General|anesthetics, general|mesh-ancestor
25662107|NCT01641653|Anesthetics|anesthetics|mesh-ancestor
24415065|NCT00199056|Glucocorticoids|glucocorticoids|mesh-ancestor
24415066|NCT00199056|Hormones|hormones|mesh-ancestor
25419578|NCT02693535|Afatinib|afatinib|mesh-list
25662108|NCT01641653|GABA Modulators|gaba modulators|mesh-ancestor
24415067|NCT00199056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24415068|NCT00199056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25166457|NCT04028401|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24415070|NCT00199056|Abortifacient Agents|abortifacient agents|mesh-ancestor
24415071|NCT00199056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24415072|NCT00199056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24415073|NCT00199056|Antimetabolites|antimetabolites|mesh-ancestor
24415089|NCT00199069|Prednisolone|prednisolone|mesh-list
24415090|NCT00199069|Cyclophosphamide|cyclophosphamide|mesh-list
24415091|NCT00199069|Ifosfamide|ifosfamide|mesh-list
24415092|NCT00199069|Methotrexate|methotrexate|mesh-list
24415093|NCT00199069|Vincristine|vincristine|mesh-list
24415094|NCT00199069|Doxorubicin|doxorubicin|mesh-list
24415095|NCT00199069|Daunorubicin|daunorubicin|mesh-list
24415096|NCT00199069|Asparaginase|asparaginase|mesh-list
24415097|NCT00199069|Mitoxantrone|mitoxantrone|mesh-list
24415132|NCT00199069|Mitosis Modulators|mitosis modulators|mesh-ancestor
24415133|NCT00199069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24415134|NCT00199069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24415135|NCT00199069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24415136|NCT00199069|Analgesics|analgesics|mesh-ancestor
24415137|NCT00199069|Sensory System Agents|sensory system agents|mesh-ancestor
24555746|NCT00742976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24555747|NCT00742976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555748|NCT00743028|Navitoclax|navitoclax|mesh-list
24555749|NCT00743028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415322|NCT00199186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24415323|NCT00199186|Tubulin Modulators|tubulin modulators|mesh-ancestor
24415324|NCT00199186|Antimitotic Agents|antimitotic agents|mesh-ancestor
24415325|NCT00199186|Mitosis Modulators|mitosis modulators|mesh-ancestor
24415332|NCT00199212|Trastuzumab|trastuzumab|mesh-list
24415338|NCT00199225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24415388|NCT00199355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849479|NCT00048750|Micafungin|micafungin|mesh-list
24415389|NCT00199368|Istradefylline|istradefylline|mesh-list
25008249|NCT00710970|Tamoxifen|tamoxifen|mesh-list
24415390|NCT00199368|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
24415391|NCT00199368|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24415392|NCT00199368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24415393|NCT00199368|Purinergic Agents|purinergic agents|mesh-ancestor
24415394|NCT00199368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24415395|NCT00199368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415396|NCT00199368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415397|NCT00199394|Istradefylline|istradefylline|mesh-list
24415398|NCT00199394|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
24415399|NCT00199394|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24415653|NCT00200447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24822578|NCT02112630|Ribavirin|ribavirin|mesh-list
24687225|NCT04223037|Vaccines|vaccines|mesh-list
24415496|NCT00199745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24415497|NCT00199745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24415518|NCT00199784|Autonomic Agents|autonomic agents|mesh-ancestor
24415519|NCT00199784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24415520|NCT00199784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415536|NCT00199940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415537|NCT00199940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415538|NCT00199940|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24415539|NCT00199940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24415541|NCT00199940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24415542|NCT00199940|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24415544|NCT00199953|Rabeprazole|rabeprazole|mesh-list
24415545|NCT00199953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24415546|NCT00199953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24415547|NCT00199953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24415548|NCT00199953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24415549|NCT00199953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415550|NCT00199966|Valproic Acid|valproic acid|mesh-list
24415551|NCT00199966|Anticonvulsants|anticonvulsants|mesh-ancestor
25166459|NCT04026958|Clarithromycin|clarithromycin|mesh-list
24415552|NCT00199966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24415553|NCT00199966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415554|NCT00199966|GABA Agents|gaba agents|mesh-ancestor
24415555|NCT00199966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24415556|NCT00199966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415557|NCT00199966|Antimanic Agents|antimanic agents|mesh-ancestor
24415558|NCT00199966|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25419579|NCT02693535|Vemurafenib|vemurafenib|mesh-list
24415559|NCT00199966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24415582|NCT00200174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415583|NCT00200174|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24415584|NCT00200174|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24415585|NCT00200174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24415586|NCT00200187|Anesthetics|anesthetics|mesh-list
24415587|NCT00200187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24415588|NCT00200187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415589|NCT00200226|Vitamin B 6|vitamin b 6|mesh-list
24415602|NCT00200226|Vitamin B Complex|vitamin b complex|mesh-ancestor
24415606|NCT00200252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415608|NCT00200382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415609|NCT00200395|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24415610|NCT00200395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415623|NCT00200421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24415625|NCT00200421|Adrenergic Agents|adrenergic agents|mesh-ancestor
24415626|NCT00200421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24415627|NCT00200421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415628|NCT00200421|Vasodilator Agents|vasodilator agents|mesh-ancestor
24415629|NCT00200421|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24415630|NCT00200421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24415646|NCT00200447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24415647|NCT00200447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24415648|NCT00200447|Dopamine Agents|dopamine agents|mesh-ancestor
24415649|NCT00200447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24415650|NCT00200447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415651|NCT00200447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415652|NCT00200447|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24822592|NCT02112643|Selenic Acid|selenic acid|mesh-list
24822593|NCT02112643|Antioxidants|antioxidants|mesh-ancestor
24822594|NCT02112643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822596|NCT02112643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822597|NCT02112643|Trace Elements|trace elements|mesh-ancestor
24822598|NCT02112643|Micronutrients|micronutrients|mesh-ancestor
24822599|NCT02112695|Diprenorphine|diprenorphine|mesh-list
24822600|NCT02112695|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24822601|NCT02112695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822602|NCT02112695|Sensory System Agents|sensory system agents|mesh-ancestor
24822603|NCT02112695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24578721|NCT00851175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24822606|NCT02112721|Micronutrients|micronutrients|mesh-ancestor
24822607|NCT02112721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822608|NCT02112721|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24822609|NCT02112799|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24415654|NCT00200447|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24415655|NCT00200460|Nebivolol|nebivolol|mesh-list
24415656|NCT00200460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24415657|NCT00200460|Vasodilator Agents|vasodilator agents|mesh-ancestor
24415692|NCT00200512|Dopamine Agents|dopamine agents|mesh-ancestor
24415693|NCT00200512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24415742|NCT00200564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24415743|NCT00200564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24415744|NCT00200564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24415745|NCT00200564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24415746|NCT00200564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415747|NCT00200590|Acetaminophen|acetaminophen|mesh-list
24415748|NCT00200590|Morphine|morphine|mesh-list
24822610|NCT02112799|Antiviral Agents|antiviral agents|mesh-ancestor
24822611|NCT02112799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24822612|NCT02112864|Dexamethasone|dexamethasone|mesh-list
24822613|NCT02112864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24966289|NCT03769818|Dexamethasone|dexamethasone|mesh-list
24923395|NCT04170790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24822614|NCT02112864|Antiemetics|antiemetics|mesh-ancestor
24822615|NCT02112864|Autonomic Agents|autonomic agents|mesh-ancestor
24822616|NCT02112864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24822617|NCT02112864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822618|NCT02112864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24822619|NCT02112864|Glucocorticoids|glucocorticoids|mesh-ancestor
24822620|NCT02112864|Hormones|hormones|mesh-ancestor
24822621|NCT02112864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24822622|NCT02112864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24822628|NCT02112903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24822629|NCT02112903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24822630|NCT02112903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822631|NCT02112903|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24822632|NCT02112903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24822633|NCT02112903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24822634|NCT02112903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822635|NCT02112903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24822636|NCT02112903|Serotonin Agents|serotonin agents|mesh-ancestor
24822637|NCT02112903|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24822638|NCT02112903|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24822639|NCT02112903|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24415781|NCT00200655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24415782|NCT00200655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24822656|NCT02112916|Methotrexate|methotrexate|mesh-list
24822657|NCT02112916|Etoposide|etoposide|mesh-list
24822658|NCT02112916|Vincristine|vincristine|mesh-list
24822659|NCT02112916|Bortezomib|bortezomib|mesh-list
24822660|NCT02112916|Etoposide phosphate|etoposide phosphate|mesh-list
24822661|NCT02112916|Daunorubicin|daunorubicin|mesh-list
24822662|NCT02112916|Asparaginase|asparaginase|mesh-list
24822663|NCT02112916|Mercaptopurine|mercaptopurine|mesh-list
24822664|NCT02112916|Pegaspargase|pegaspargase|mesh-list
24822665|NCT02112916|Podophyllotoxin|podophyllotoxin|mesh-list
24822666|NCT02112916|Thioguanine|thioguanine|mesh-list
24822667|NCT02112916|BB 1101|bb 1101|mesh-list
24415792|NCT00200694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24415793|NCT00200694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24415794|NCT00200694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24415829|NCT00201318|Lamivudine|lamivudine|mesh-list
24415830|NCT00201318|Cyclophosphamide|cyclophosphamide|mesh-list
24415831|NCT00201318|Doxorubicin|doxorubicin|mesh-list
24415832|NCT00201318|Vincristine|vincristine|mesh-list
24415833|NCT00201318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24415834|NCT00201318|Immunologic Factors|immunologic factors|mesh-ancestor
24415837|NCT00201318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24415838|NCT00201318|Alkylating Agents|alkylating agents|mesh-ancestor
24822690|NCT02112916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24822691|NCT02112916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24415867|NCT00201344|Vitamin B Complex|vitamin b complex|mesh-ancestor
24415868|NCT00201344|Vitamins|vitamins|mesh-ancestor
24415869|NCT00201344|Micronutrients|micronutrients|mesh-ancestor
24415870|NCT00201357|Thalidomide|thalidomide|mesh-list
24415871|NCT00201357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24415872|NCT00201357|Immunologic Factors|immunologic factors|mesh-ancestor
24415873|NCT00201357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415911|NCT00201422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24415912|NCT00201422|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24415913|NCT00201422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24822696|NCT02112916|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25166460|NCT04026958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25166461|NCT04026958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24822698|NCT02112916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25662109|NCT01641653|GABA Agents|gaba agents|mesh-ancestor
25662110|NCT01641653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25662111|NCT01641653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662112|NCT01641692|Albuterol|albuterol|mesh-list
25662113|NCT01641692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25662114|NCT01641692|Autonomic Agents|autonomic agents|mesh-ancestor
25662115|NCT01641692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24822699|NCT02112916|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24822701|NCT02112916|Dermatologic Agents|dermatologic agents|mesh-ancestor
24822702|NCT02112916|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24822703|NCT02112916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24822706|NCT02112916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24822708|NCT02112916|Protective Agents|protective agents|mesh-ancestor
24822709|NCT02112916|Vitamin B Complex|vitamin b complex|mesh-ancestor
24822710|NCT02112916|Vitamins|vitamins|mesh-ancestor
24822711|NCT02112916|Micronutrients|micronutrients|mesh-ancestor
24415914|NCT00201422|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24415915|NCT00201422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24415951|NCT00201669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415952|NCT00201669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415954|NCT00201682|Rituximab|rituximab|mesh-list
24415955|NCT00201682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24416006|NCT00201708|Mitosis Modulators|mitosis modulators|mesh-ancestor
24416007|NCT00201708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24416008|NCT00201708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24416009|NCT00201708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24416010|NCT00201708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416011|NCT00201721|Cyclophosphamide|cyclophosphamide|mesh-list
24416012|NCT00201721|Rituximab|rituximab|mesh-list
24416013|NCT00201721|Pentostatin|pentostatin|mesh-list
24416014|NCT00201721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24416042|NCT00201799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24416043|NCT00201812|Dexamethasone|dexamethasone|mesh-list
24416044|NCT00201812|Etanercept|etanercept|mesh-list
24416045|NCT00201812|Docetaxel|docetaxel|mesh-list
24416046|NCT00201812|Glucocorticoids|glucocorticoids|mesh-list
24416047|NCT00201812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24416048|NCT00201812|Antiemetics|antiemetics|mesh-ancestor
24416049|NCT00201812|Autonomic Agents|autonomic agents|mesh-ancestor
24416050|NCT00201812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24416051|NCT00201812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416052|NCT00201812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24416053|NCT00201812|Hormones|hormones|mesh-ancestor
24822721|NCT02112929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24822722|NCT02112929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822724|NCT02112981|Everolimus|everolimus|mesh-list
24822725|NCT02112981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822726|NCT02112981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24822727|NCT02112981|Immunologic Factors|immunologic factors|mesh-ancestor
24416090|NCT00202007|Aripiprazole|aripiprazole|mesh-list
24416147|NCT00202176|Ipratropium|ipratropium|mesh-list
24416181|NCT00202241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24416182|NCT00202241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416183|NCT00202280|Folic Acid|folic acid|mesh-list
25849480|NCT00048750|Antifungal Agents|antifungal agents|mesh-ancestor
24416184|NCT00202280|Vitamin B 12|vitamin b 12|mesh-list
24416185|NCT00202280|Hydroxocobalamin|hydroxocobalamin|mesh-list
24416186|NCT00202280|Vitamins|vitamins|mesh-ancestor
24416187|NCT00202280|Micronutrients|micronutrients|mesh-ancestor
24416188|NCT00202280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416189|NCT00202280|Hematinics|hematinics|mesh-ancestor
24416198|NCT00202293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24822739|NCT02113072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24822740|NCT02113072|Respiratory System Agents|respiratory system agents|mesh-ancestor
24416248|NCT00202462|Testosterone|testosterone|mesh-list
24416249|NCT00202462|Androgens|androgens|mesh-ancestor
24416250|NCT00202462|Hormones|hormones|mesh-ancestor
24416251|NCT00202462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24416253|NCT00202514|Valproic Acid|valproic acid|mesh-list
24416254|NCT00202514|Anticonvulsants|anticonvulsants|mesh-ancestor
24416255|NCT00202514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416256|NCT00202514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416257|NCT00202514|GABA Agents|gaba agents|mesh-ancestor
24416503|NCT00203281|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24416504|NCT00203281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25662116|NCT01641692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662117|NCT01641692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25662118|NCT01641692|Respiratory System Agents|respiratory system agents|mesh-ancestor
25662119|NCT01641692|Tocolytic Agents|tocolytic agents|mesh-ancestor
24416505|NCT00203281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416564|NCT00203385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416566|NCT00203385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24416567|NCT00203385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467059|NCT00376077|Antiemetics|antiemetics|mesh-ancestor
24416568|NCT00203385|Antimanic Agents|antimanic agents|mesh-ancestor
24822741|NCT02113137|Chlorine dioxide|chlorine dioxide|mesh-list
24822742|NCT02113137|Dental Disinfectants|dental disinfectants|mesh-ancestor
24822743|NCT02113137|Disinfectants|disinfectants|mesh-ancestor
24822744|NCT02113137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24822746|NCT02113150|Remifentanil|remifentanil|mesh-list
24416581|NCT00203463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24416582|NCT00203463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416583|NCT00203528|Valproic Acid|valproic acid|mesh-list
24416584|NCT00203528|Risperidone|risperidone|mesh-list
24416585|NCT00203528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24416586|NCT00203528|Serotonin Agents|serotonin agents|mesh-ancestor
25849481|NCT00048750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24416595|NCT00203528|Dopamine Agents|dopamine agents|mesh-ancestor
24416596|NCT00203528|Anticonvulsants|anticonvulsants|mesh-ancestor
24416597|NCT00203528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416598|NCT00203528|GABA Agents|gaba agents|mesh-ancestor
24416599|NCT00203528|Antimanic Agents|antimanic agents|mesh-ancestor
24416600|NCT00203554|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
24416601|NCT00203554|Vasodilator Agents|vasodilator agents|mesh-ancestor
24416613|NCT00203567|Analgesics|analgesics|mesh-ancestor
24416614|NCT00203567|Sensory System Agents|sensory system agents|mesh-ancestor
24416615|NCT00203567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24416616|NCT00203567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24416624|NCT00203580|Anticoagulants|anticoagulants|mesh-ancestor
24416625|NCT00203580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24416626|NCT00203580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24416627|NCT00203580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416628|NCT00203606|Interferons|interferons|mesh-list
25849482|NCT00048763|Cilostazol|cilostazol|mesh-list
24558237|NCT00755872|Etidronic Acid|etidronic acid|mesh-list
24822808|NCT02113566|Acetaminophen|acetaminophen|mesh-list
24822809|NCT02113566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24822810|NCT02113566|Analgesics|analgesics|mesh-ancestor
24543933|NCT00685971|Vitamins|vitamins|mesh-ancestor
24416739|NCT00203814|Antimalarials|antimalarials|mesh-ancestor
24416740|NCT00203814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24416741|NCT00203814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24416742|NCT00203814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24416743|NCT00203814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24416744|NCT00203814|Antiviral Agents|antiviral agents|mesh-ancestor
24416745|NCT00203814|Schistosomicides|schistosomicides|mesh-ancestor
24416746|NCT00203814|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24416747|NCT00203814|Anthelmintics|anthelmintics|mesh-ancestor
24416748|NCT00203814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24416749|NCT00203814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24822850|NCT02113813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24822851|NCT02113813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24822852|NCT02113813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24416788|NCT00204022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416789|NCT00204022|Antimetabolites|antimetabolites|mesh-ancestor
24416790|NCT00204022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24416791|NCT00204022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24416792|NCT00204022|Immunologic Factors|immunologic factors|mesh-ancestor
24416793|NCT00204022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416794|NCT00204022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24416795|NCT00204061|Amisulpride|amisulpride|mesh-list
24416796|NCT00204061|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24416846|NCT00204243|Antitussive Agents|antitussive agents|mesh-ancestor
24416847|NCT00204243|Respiratory System Agents|respiratory system agents|mesh-ancestor
24416848|NCT00204256|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24416849|NCT00204256|Hematinics|hematinics|mesh-ancestor
24416850|NCT00204269|Testosterone|testosterone|mesh-list
24416851|NCT00204269|Androgens|androgens|mesh-ancestor
24416852|NCT00204269|Hormones|hormones|mesh-ancestor
24416853|NCT00204269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24416854|NCT00204269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416855|NCT00204308|Tenofovir|tenofovir|mesh-list
24416856|NCT00204308|Emtricitabine|emtricitabine|mesh-list
24416857|NCT00204308|Antiviral Agents|antiviral agents|mesh-ancestor
24416858|NCT00204308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25849483|NCT00048763|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24416908|NCT00204451|Estrogens|estrogens|mesh-ancestor
24416909|NCT00204451|Hormones|hormones|mesh-ancestor
24416910|NCT00204451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24416916|NCT00204451|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24416917|NCT00204451|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24416941|NCT00204542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24416942|NCT00204542|Analgesics|analgesics|mesh-ancestor
25849484|NCT00048763|Autonomic Agents|autonomic agents|mesh-ancestor
25849485|NCT00048763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25849486|NCT00048763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849487|NCT00048763|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24822853|NCT02113813|Anesthetics, General|anesthetics, general|mesh-ancestor
24822855|NCT02113813|GABA Modulators|gaba modulators|mesh-ancestor
24822856|NCT02113813|GABA Agents|gaba agents|mesh-ancestor
24822857|NCT02113813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24822858|NCT02113813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822859|NCT02113813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822860|NCT02113813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24822861|NCT02113813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24822862|NCT02113891|Eculizumab|eculizumab|mesh-list
24822863|NCT02113891|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24822864|NCT02113891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24416990|NCT00204646|Carboplatin|carboplatin|mesh-list
24416993|NCT00204646|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24416994|NCT00204646|Ifosfamide|ifosfamide|mesh-list
24416995|NCT00204646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24416996|NCT00204646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24416997|NCT00204646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24417000|NCT00204646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417001|NCT00204646|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24417002|NCT00204646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24417003|NCT00204646|Alkylating Agents|alkylating agents|mesh-ancestor
24417004|NCT00204659|Rituximab|rituximab|mesh-list
24417046|NCT00204906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24417048|NCT00204919|Ergocalciferols|ergocalciferols|mesh-list
24417049|NCT00204919|Vitamins|vitamins|mesh-ancestor
24822875|NCT02113943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24822876|NCT02113943|Serotonin Agents|serotonin agents|mesh-ancestor
24822877|NCT02113943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822878|NCT02113943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24417062|NCT00204984|Vasodilator Agents|vasodilator agents|mesh-ancestor
24417063|NCT00205166|Caffeine|caffeine|mesh-list
24417064|NCT00205166|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24417065|NCT00205166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417066|NCT00205166|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24417067|NCT00205166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417068|NCT00205166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417069|NCT00205166|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24417070|NCT00205166|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24417071|NCT00205166|Purinergic Agents|purinergic agents|mesh-ancestor
24417072|NCT00205166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24417073|NCT00205231|Etanercept|etanercept|mesh-list
24417074|NCT00205231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24417105|NCT00205322|Vitamin B Complex|vitamin b complex|mesh-ancestor
24417107|NCT00205322|Micronutrients|micronutrients|mesh-ancestor
24417108|NCT00205426|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24417109|NCT00205426|Natriuretic Agents|natriuretic agents|mesh-ancestor
24417110|NCT00205426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417111|NCT00205491|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24417112|NCT00205491|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24417113|NCT00205491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24417114|NCT00205491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24417115|NCT00205491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417116|NCT00205491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24417117|NCT00205491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417118|NCT00205491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24417119|NCT00205491|Antidepressive Agents|antidepressive agents|mesh-ancestor
24417120|NCT00205491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24417124|NCT00205634|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24417125|NCT00205634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417126|NCT00205634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417127|NCT00205634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24417167|NCT00205738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24822887|NCT02114021|Sensory System Agents|sensory system agents|mesh-ancestor
24822888|NCT02114021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24822889|NCT02114021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24822890|NCT02114021|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25662120|NCT01641692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24467380|NCT00377442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24467381|NCT00377442|Antimetabolites|antimetabolites|mesh-ancestor
24467383|NCT00377442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24822891|NCT02114021|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24822892|NCT02114021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24822893|NCT02114021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688160|NCT03289325|Dexmedetomidine|dexmedetomidine|mesh-list
25849488|NCT00048763|Respiratory System Agents|respiratory system agents|mesh-ancestor
24417240|NCT00206050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417262|NCT00206115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417264|NCT00206128|Antidepressive Agents|antidepressive agents|mesh-ancestor
24417266|NCT00206128|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24417267|NCT00206128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24417268|NCT00206128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24417269|NCT00206128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417270|NCT00206141|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24417271|NCT00206141|Antidepressive Agents|antidepressive agents|mesh-ancestor
24417272|NCT00206141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24417273|NCT00206141|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24417274|NCT00206141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24417275|NCT00206141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24822895|NCT02114021|Glucocorticoids|glucocorticoids|mesh-ancestor
24822896|NCT02114021|Hormones|hormones|mesh-ancestor
24822897|NCT02114021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24822898|NCT02114021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24822899|NCT02114021|Respiratory System Agents|respiratory system agents|mesh-ancestor
24822900|NCT02114073|Cyclosporine|cyclosporine|mesh-list
24822901|NCT02114073|Betamethasone|betamethasone|mesh-list
24822902|NCT02114073|Cyclosporins|cyclosporins|mesh-list
25166462|NCT04026958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25166463|NCT04026958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849489|NCT00048763|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24822903|NCT02114073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24822904|NCT02114073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822905|NCT02114073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24822906|NCT02114073|Immunologic Factors|immunologic factors|mesh-ancestor
24822907|NCT02114073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822908|NCT02114073|Antifungal Agents|antifungal agents|mesh-ancestor
24822909|NCT02114073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24822910|NCT02114073|Dermatologic Agents|dermatologic agents|mesh-ancestor
25849490|NCT00048763|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25849491|NCT00048763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849492|NCT00048763|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25849493|NCT00048763|Vasodilator Agents|vasodilator agents|mesh-ancestor
25849494|NCT00048763|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25849495|NCT00048763|Protective Agents|protective agents|mesh-ancestor
24822912|NCT02114073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24822913|NCT02114073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24822914|NCT02114073|Glucocorticoids|glucocorticoids|mesh-ancestor
24822915|NCT02114073|Hormones|hormones|mesh-ancestor
24822916|NCT02114073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24822917|NCT02114073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24822918|NCT02114073|Respiratory System Agents|respiratory system agents|mesh-ancestor
25849496|NCT00048763|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24417346|NCT00206219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417347|NCT00206219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24822919|NCT02114099|Atorvastatin|atorvastatin|mesh-list
24822920|NCT02114099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24822921|NCT02114099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24417453|NCT00206505|Mitosis Modulators|mitosis modulators|mesh-ancestor
24417454|NCT00206505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417455|NCT00206544|Tamoxifen|tamoxifen|mesh-list
24417456|NCT00206544|Progesterone|progesterone|mesh-list
24417457|NCT00206544|Progestins|progestins|mesh-ancestor
24417458|NCT00206544|Hormones|hormones|mesh-ancestor
24417459|NCT00206544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24544206|NCT00687817|Paclitaxel|paclitaxel|mesh-list
24417535|NCT00206739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24417536|NCT00206739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417537|NCT00206739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662121|NCT01641692|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25662122|NCT01641692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25662123|NCT01641692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24467533|NCT00377988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467534|NCT00377988|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24417538|NCT00206739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24417539|NCT00206739|Renal Agents|renal agents|mesh-ancestor
24417575|NCT00206778|GABA Agents|gaba agents|mesh-ancestor
24417577|NCT00206778|Antimanic Agents|antimanic agents|mesh-ancestor
24822934|NCT02114346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822935|NCT02114346|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24822936|NCT02114346|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24822937|NCT02114346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24822938|NCT02114359|Cisplatin|cisplatin|mesh-list
24822939|NCT02114359|Fluorouracil|fluorouracil|mesh-list
24822940|NCT02114359|Capecitabine|capecitabine|mesh-list
24822941|NCT02114359|Oxaliplatin|oxaliplatin|mesh-list
24417578|NCT00206856|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24417579|NCT00206856|Natriuretic Agents|natriuretic agents|mesh-ancestor
24417580|NCT00206856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417582|NCT00206934|Citalopram|citalopram|mesh-list
24417583|NCT00206934|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24417584|NCT00206934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24417585|NCT00206934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24417586|NCT00206934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417587|NCT00206934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24417588|NCT00206934|Serotonin Agents|serotonin agents|mesh-ancestor
24417589|NCT00206934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417590|NCT00206934|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24417607|NCT00206947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24417608|NCT00206947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417627|NCT00206960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24417628|NCT00206960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24417629|NCT00206960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24417630|NCT00206960|Dopamine Agents|dopamine agents|mesh-ancestor
24417631|NCT00206973|Mannitol|mannitol|mesh-list
24417632|NCT00206973|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24417633|NCT00206973|Diuretics|diuretics|mesh-ancestor
24417634|NCT00206973|Natriuretic Agents|natriuretic agents|mesh-ancestor
24417635|NCT00206973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417648|NCT00206986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24417649|NCT00206986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417651|NCT00206999|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24417656|NCT00206999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24822943|NCT02114359|Antimetabolites|antimetabolites|mesh-ancestor
24822944|NCT02114359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822945|NCT02114359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24822946|NCT02114359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24822947|NCT02114359|Immunologic Factors|immunologic factors|mesh-ancestor
24822948|NCT02114359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579119|NCT00853320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24579120|NCT00853411|Prednisone|prednisone|mesh-list
24579121|NCT00853411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24579122|NCT00853411|Glucocorticoids|glucocorticoids|mesh-ancestor
24417664|NCT00207064|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24417665|NCT00207064|Antidepressive Agents|antidepressive agents|mesh-ancestor
24417666|NCT00207064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24417667|NCT00207064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24417668|NCT00207064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24417669|NCT00207064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24417670|NCT00207064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417671|NCT00207077|Cetuximab|cetuximab|mesh-list
24417672|NCT00207077|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24417673|NCT00207077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24417674|NCT00207077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417675|NCT00207077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24417676|NCT00207077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417677|NCT00207077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417678|NCT00207116|Cetuximab|cetuximab|mesh-list
24417679|NCT00207116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24417680|NCT00207116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417681|NCT00207129|Capecitabine|capecitabine|mesh-list
24417682|NCT00207129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24417683|NCT00207129|Antimetabolites|antimetabolites|mesh-ancestor
25662124|NCT01641692|Adrenergic Agents|adrenergic agents|mesh-ancestor
25662125|NCT01641692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25419580|NCT02693535|Crizotinib|crizotinib|mesh-list
24805168|NCT02007928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24417684|NCT00207129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417685|NCT00207129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579125|NCT00853411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822949|NCT02114463|Flurbiprofen|flurbiprofen|mesh-list
24822951|NCT02114463|Ropivacaine|ropivacaine|mesh-list
24822952|NCT02114463|Anesthetics, Local|anesthetics, local|mesh-ancestor
24822954|NCT02114463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24417686|NCT00207155|Cetuximab|cetuximab|mesh-list
24417687|NCT00207155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24417688|NCT00207155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417689|NCT00207311|Interferons|interferons|mesh-list
24417690|NCT00207311|Interferon-alpha|interferon-alpha|mesh-list
24417691|NCT00207311|Interferon alpha-2|interferon alpha-2|mesh-list
24417692|NCT00207311|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24417693|NCT00207311|Orlistat|orlistat|mesh-list
24417726|NCT00207428|Carbamazepine|carbamazepine|mesh-list
24417727|NCT00207428|Anticonvulsants|anticonvulsants|mesh-ancestor
24417728|NCT00207428|Antimanic Agents|antimanic agents|mesh-ancestor
25849497|NCT00048763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24417729|NCT00207428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24417730|NCT00207428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24417731|NCT00207428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417732|NCT00207428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24417733|NCT00207428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24417735|NCT00207428|Sensory System Agents|sensory system agents|mesh-ancestor
24417736|NCT00207428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24417737|NCT00207428|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24417738|NCT00207428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24417739|NCT00207428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417740|NCT00207428|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24417741|NCT00207428|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24417743|NCT00207532|Hematinics|hematinics|mesh-ancestor
24417744|NCT00207532|Vitamin B Complex|vitamin b complex|mesh-ancestor
24417745|NCT00207532|Vitamins|vitamins|mesh-ancestor
24417785|NCT00207753|Antimitotic Agents|antimitotic agents|mesh-ancestor
24417786|NCT00207753|Mitosis Modulators|mitosis modulators|mesh-ancestor
24417787|NCT00207753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417788|NCT00207753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417789|NCT00207766|Infliximab|infliximab|mesh-list
24417790|NCT00207766|Dermatologic Agents|dermatologic agents|mesh-ancestor
24417791|NCT00207766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24417792|NCT00207766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24417793|NCT00207779|Heparin|heparin|mesh-list
24417794|NCT00207779|Anticoagulants|anticoagulants|mesh-ancestor
24822967|NCT02114476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24562287|NCT00765427|Protective Agents|protective agents|mesh-ancestor
25849498|NCT00048763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417903|NCT00208169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24417904|NCT00208169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24417905|NCT00208169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24417906|NCT00208169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24417907|NCT00208169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417908|NCT00208169|Dopamine Agonists|dopamine agonists|mesh-ancestor
24417910|NCT00208169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24417911|NCT00208169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417912|NCT00208169|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24417913|NCT00208169|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24417914|NCT00208169|Serotonin Agents|serotonin agents|mesh-ancestor
24417922|NCT00208182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24417923|NCT00208182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417924|NCT00208182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417925|NCT00208182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24417926|NCT00208182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24417927|NCT00208182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24417928|NCT00208182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24417929|NCT00208182|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24417956|NCT00208221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25849499|NCT00048776|Cilostazol|cilostazol|mesh-list
24417976|NCT00208260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24417977|NCT00208260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417978|NCT00208260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24417979|NCT00208260|Immunologic Factors|immunologic factors|mesh-ancestor
24562290|NCT00765557|Laxatives|laxatives|mesh-ancestor
25849500|NCT00048776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24599839|NCT03559192|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24599840|NCT03559192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599841|NCT03559192|Sensory System Agents|sensory system agents|mesh-ancestor
24599843|NCT03549715|Durvalumab|durvalumab|mesh-list
24822968|NCT02114476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822969|NCT02114489|Ibandronic Acid|ibandronic acid|mesh-list
24822970|NCT02114489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24822971|NCT02114489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688797|NCT02642094|Sirolimus|sirolimus|mesh-list
24417982|NCT00208260|Protective Agents|protective agents|mesh-ancestor
24417983|NCT00208260|Vitamin B Complex|vitamin b complex|mesh-ancestor
24417985|NCT00208260|Micronutrients|micronutrients|mesh-ancestor
24417986|NCT00208273|Letrozole|letrozole|mesh-list
24418030|NCT00208442|Diuretics|diuretics|mesh-ancestor
24418031|NCT00208442|Natriuretic Agents|natriuretic agents|mesh-ancestor
24418042|NCT00208520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24418043|NCT00208520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418044|NCT00208520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24418052|NCT00208520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24418053|NCT00208520|Analgesics|analgesics|mesh-ancestor
24418054|NCT00208520|Sensory System Agents|sensory system agents|mesh-ancestor
24418055|NCT00208520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24418056|NCT00208520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24418057|NCT00208520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24418058|NCT00208533|Aripiprazole|aripiprazole|mesh-list
24822974|NCT02114502|Dexamethasone|dexamethasone|mesh-list
24822975|NCT02114502|Melphalan|melphalan|mesh-list
24822976|NCT02114502|Busulfan|busulfan|mesh-list
24822977|NCT02114502|Vorinostat|vorinostat|mesh-list
24822978|NCT02114502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24822979|NCT02114502|Antiemetics|antiemetics|mesh-ancestor
24822980|NCT02114502|Autonomic Agents|autonomic agents|mesh-ancestor
25109861|NCT03121352|Paclitaxel|paclitaxel|mesh-list
24822981|NCT02114502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24418059|NCT00208533|Antidepressive Agents|antidepressive agents|mesh-ancestor
24418060|NCT00208533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24418061|NCT00208533|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24418062|NCT00208533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24418063|NCT00208533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24418064|NCT00208533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418065|NCT00208533|Dopamine Agonists|dopamine agonists|mesh-ancestor
24418066|NCT00208533|Dopamine Agents|dopamine agents|mesh-ancestor
24418067|NCT00208533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24418068|NCT00208533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418069|NCT00208533|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24418070|NCT00208533|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24418071|NCT00208533|Serotonin Agents|serotonin agents|mesh-ancestor
24418072|NCT00208533|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24418073|NCT00208533|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24418074|NCT00208533|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24544376|NCT00688857|Diazoxide|diazoxide|mesh-list
24418164|NCT00208793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24418165|NCT00208793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24418166|NCT00208819|Valproic Acid|valproic acid|mesh-list
24418167|NCT00208819|Olanzapine|olanzapine|mesh-list
24822982|NCT02114502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822983|NCT02114502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24822985|NCT02114502|Hormones|hormones|mesh-ancestor
24822986|NCT02114502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24822987|NCT02114502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24822988|NCT02114502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24418180|NCT00208819|Dopamine Agents|dopamine agents|mesh-ancestor
24418181|NCT00208819|Antiemetics|antiemetics|mesh-ancestor
25849501|NCT00048776|Autonomic Agents|autonomic agents|mesh-ancestor
24563143|NCT00770354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24563144|NCT00770354|Hormone Antagonists|hormone antagonists|mesh-ancestor
24418182|NCT00208819|Autonomic Agents|autonomic agents|mesh-ancestor
24418222|NCT00208923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24418223|NCT00208936|Fluorouracil|fluorouracil|mesh-list
24418224|NCT00208936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24418225|NCT00208936|Antimetabolites|antimetabolites|mesh-ancestor
24418226|NCT00208936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662126|NCT01641692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662127|NCT01641809|Tenofovir|tenofovir|mesh-list
25662128|NCT01641809|Lamivudine|lamivudine|mesh-list
25662129|NCT01641809|Emtricitabine|emtricitabine|mesh-list
25662130|NCT01641809|Efavirenz|efavirenz|mesh-list
24467846|NCT00378937|Levopropoxyphene|levopropoxyphene|mesh-list
24418227|NCT00208936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24418228|NCT00208936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24418229|NCT00208936|Immunologic Factors|immunologic factors|mesh-ancestor
24418230|NCT00208936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418232|NCT00209014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24418233|NCT00209014|Immunologic Factors|immunologic factors|mesh-ancestor
24418234|NCT00209014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418235|NCT00209014|Leprostatic Agents|leprostatic agents|mesh-ancestor
24418236|NCT00209014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24418237|NCT00209014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24418238|NCT00209014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24418239|NCT00209014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24418240|NCT00209014|Growth Substances|growth substances|mesh-ancestor
24418241|NCT00209014|Growth Inhibitors|growth inhibitors|mesh-ancestor
24418242|NCT00209014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24418255|NCT00209118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24418256|NCT00209118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418257|NCT00209118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24418259|NCT00209118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822999|NCT02114502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24823000|NCT02114502|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24823001|NCT02114502|Vitamin B Complex|vitamin b complex|mesh-ancestor
24791564|NCT03920007|Hormones|hormones|mesh-ancestor
24418282|NCT00209209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24418283|NCT00209209|Alkylating Agents|alkylating agents|mesh-ancestor
24418284|NCT00209209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418285|NCT00209209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24418286|NCT00209209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24418287|NCT00209209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24418288|NCT00209209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24418316|NCT00209222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24418317|NCT00209222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24418318|NCT00209222|Alkylating Agents|alkylating agents|mesh-ancestor
25849502|NCT00048776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24418330|NCT00209222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24418331|NCT00209222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24418332|NCT00209222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24418333|NCT00209222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24418334|NCT00209222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24418363|NCT00209352|Antiviral Agents|antiviral agents|mesh-ancestor
24418364|NCT00209352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24418366|NCT00209469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24418367|NCT00209469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418368|NCT00209482|Metformin|metformin|mesh-list
24418369|NCT00209482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24418370|NCT00209482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418371|NCT00209495|Dexamethasone|dexamethasone|mesh-list
24418373|NCT00209495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24418374|NCT00209495|Antiemetics|antiemetics|mesh-ancestor
24418375|NCT00209495|Autonomic Agents|autonomic agents|mesh-ancestor
24418376|NCT00209495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24418377|NCT00209495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008642|NCT04879368|Antimitotic Agents|antimitotic agents|mesh-ancestor
24418413|NCT00209573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24418414|NCT00209573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418422|NCT00209599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418462|NCT00209651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418463|NCT00209651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24418471|NCT00209677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24418472|NCT00209677|Antimetabolites|antimetabolites|mesh-ancestor
24418473|NCT00209677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418474|NCT00209677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24418475|NCT00209677|Antiviral Agents|antiviral agents|mesh-ancestor
24418476|NCT00209677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24418477|NCT00209677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24418478|NCT00209677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24418479|NCT00209677|Immunologic Factors|immunologic factors|mesh-ancestor
24418480|NCT00209677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418481|NCT00209690|Cisplatin|cisplatin|mesh-list
25662131|NCT01641809|Abacavir|abacavir|mesh-list
24823018|NCT02114528|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24823019|NCT02114528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24823020|NCT02114528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24823023|NCT02114528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24823024|NCT02114528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823026|NCT02114528|Autonomic Agents|autonomic agents|mesh-ancestor
24418482|NCT00209690|Docetaxel|docetaxel|mesh-list
24418483|NCT00209690|Fluorouracil|fluorouracil|mesh-list
24823028|NCT02114528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24823029|NCT02114645|Leuprolide|leuprolide|mesh-list
24419000|NCT00210782|Phenytoin|phenytoin|mesh-list
24689252|NCT01940809|Dabrafenib|dabrafenib|mesh-list
24418600|NCT00209833|Antimetabolites|antimetabolites|mesh-ancestor
24418601|NCT00209833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418602|NCT00209833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24418603|NCT00209833|Immunologic Factors|immunologic factors|mesh-ancestor
24418604|NCT00209833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418605|NCT00209833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24418606|NCT00209833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24418648|NCT00209859|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24418649|NCT00209859|Respiratory System Agents|respiratory system agents|mesh-ancestor
24418651|NCT00209872|Ketamine|ketamine|mesh-list
24418652|NCT00209872|Gabapentin|gabapentin|mesh-list
24418653|NCT00209872|Esketamine|esketamine|mesh-list
24418654|NCT00209872|Anesthetics, Local|anesthetics, local|mesh-ancestor
24418655|NCT00209872|Anesthetics|anesthetics|mesh-ancestor
24418656|NCT00209872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24418657|NCT00209872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418658|NCT00209872|Sensory System Agents|sensory system agents|mesh-ancestor
24418659|NCT00209872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24418660|NCT00209872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24418661|NCT00209872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24418662|NCT00209872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24418663|NCT00209872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24418664|NCT00209872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418665|NCT00209872|Analgesics|analgesics|mesh-ancestor
24418666|NCT00209872|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24418667|NCT00209872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24418668|NCT00209872|Anesthetics, General|anesthetics, general|mesh-ancestor
24418669|NCT00209872|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24418670|NCT00209872|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24418671|NCT00209872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24418672|NCT00209872|Anticonvulsants|anticonvulsants|mesh-ancestor
24418673|NCT00209872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24418674|NCT00209872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24418769|NCT00210028|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24418770|NCT00210028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24418771|NCT00210041|Gemcitabine|gemcitabine|mesh-list
24418772|NCT00210041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24418773|NCT00210041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24418774|NCT00210041|Antimetabolites|antimetabolites|mesh-ancestor
24418802|NCT00210210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24418827|NCT00210314|Antimetabolites|antimetabolites|mesh-ancestor
24418828|NCT00210314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418829|NCT00210314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24418830|NCT00210314|Dermatologic Agents|dermatologic agents|mesh-ancestor
24418831|NCT00210314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24418832|NCT00210314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24418833|NCT00210314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24418834|NCT00210314|Immunologic Factors|immunologic factors|mesh-ancestor
24418835|NCT00210314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24418836|NCT00210314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24418837|NCT00210314|Antiviral Agents|antiviral agents|mesh-ancestor
24418838|NCT00210314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24418840|NCT00210327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24418842|NCT00210340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24418843|NCT00210340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24418859|NCT00210379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166464|NCT04026958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418864|NCT00210379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24418865|NCT00210379|Antimetabolites|antimetabolites|mesh-ancestor
24418866|NCT00210379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418890|NCT00210483|Almotriptan|almotriptan|mesh-list
24418891|NCT00210483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24418893|NCT00210483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24418904|NCT00210496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823039|NCT02114645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24823040|NCT02114645|Contraceptive Agents|contraceptive agents|mesh-ancestor
24689395|NCT01591629|Hormones|hormones|mesh-ancestor
24418906|NCT00210509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24418907|NCT00210509|Serotonin Agents|serotonin agents|mesh-ancestor
24418908|NCT00210509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24418909|NCT00210509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418910|NCT00210509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418911|NCT00210535|Topiramate|topiramate|mesh-list
24418912|NCT00210535|Anticonvulsants|anticonvulsants|mesh-ancestor
24418913|NCT00210535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24418914|NCT00210535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418938|NCT00210561|Narcotics|narcotics|mesh-ancestor
24418939|NCT00210561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24418940|NCT00210574|Topiramate|topiramate|mesh-list
24418941|NCT00210574|Anticonvulsants|anticonvulsants|mesh-ancestor
24418942|NCT00210574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24418943|NCT00210574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418944|NCT00210587|Epoetin Alfa|epoetin alfa|mesh-list
24418945|NCT00210587|Hematinics|hematinics|mesh-ancestor
24418946|NCT00210600|Epoetin Alfa|epoetin alfa|mesh-list
24418947|NCT00210600|Hematinics|hematinics|mesh-ancestor
24418948|NCT00210665|Trabectedin|trabectedin|mesh-list
24418949|NCT00210665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24418950|NCT00210665|Alkylating Agents|alkylating agents|mesh-ancestor
24418951|NCT00210665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823049|NCT02114658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823050|NCT02114658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24823051|NCT02114658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24418973|NCT00210717|Serotonin Agents|serotonin agents|mesh-ancestor
24418974|NCT00210717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24418975|NCT00210717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418976|NCT00210717|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24418977|NCT00210717|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24418978|NCT00210717|Dopamine Agents|dopamine agents|mesh-ancestor
24418979|NCT00210730|Epoetin Alfa|epoetin alfa|mesh-list
24418980|NCT00210730|Hematinics|hematinics|mesh-ancestor
24418981|NCT00210743|Epoetin Alfa|epoetin alfa|mesh-list
24418998|NCT00210769|Dopamine Agents|dopamine agents|mesh-ancestor
24419001|NCT00210782|Anticonvulsants|anticonvulsants|mesh-ancestor
24419002|NCT00210782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24564431|NCT00776438|Vaccines|vaccines|mesh-list
24419093|NCT00211224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419094|NCT00211224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419095|NCT00211224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24419096|NCT00211224|Protective Agents|protective agents|mesh-ancestor
24419100|NCT00211250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823052|NCT02114658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823053|NCT02114671|Ciprofloxacin|ciprofloxacin|mesh-list
24823054|NCT02114671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24823055|NCT02114671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24823056|NCT02114671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24823057|NCT02114671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24823058|NCT02114671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823059|NCT02114671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823060|NCT02114671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823061|NCT02114671|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24823062|NCT02114671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24419155|NCT00211367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24419156|NCT00211367|Growth Substances|growth substances|mesh-ancestor
24419157|NCT00211367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419158|NCT00211367|Growth Inhibitors|growth inhibitors|mesh-ancestor
24419159|NCT00211367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419161|NCT00211380|Antidepressive Agents|antidepressive agents|mesh-ancestor
24419162|NCT00211380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24419163|NCT00211380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24419164|NCT00211380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24419165|NCT00211380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24419166|NCT00211380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419167|NCT00211380|Dopamine Agonists|dopamine agonists|mesh-ancestor
24419168|NCT00211380|Dopamine Agents|dopamine agents|mesh-ancestor
24419169|NCT00211380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24419170|NCT00211380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419199|NCT00211419|Verteporfin|verteporfin|mesh-list
24419200|NCT00211419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24419201|NCT00211419|Glucocorticoids|glucocorticoids|mesh-ancestor
24419202|NCT00211419|Hormones|hormones|mesh-ancestor
24419203|NCT00211419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24419204|NCT00211419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419205|NCT00211419|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24419206|NCT00211419|Dermatologic Agents|dermatologic agents|mesh-ancestor
24419207|NCT00211419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24419240|NCT00211484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419241|NCT00211484|Growth Inhibitors|growth inhibitors|mesh-ancestor
24419242|NCT00211484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419243|NCT00211497|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
24419245|NCT00211523|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
24419246|NCT00211523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24419248|NCT00211562|Olanzapine|olanzapine|mesh-list
24419249|NCT00211562|Vitamins|vitamins|mesh-ancestor
24419250|NCT00211562|Micronutrients|micronutrients|mesh-ancestor
24419251|NCT00211562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419252|NCT00211562|Antiemetics|antiemetics|mesh-ancestor
24419253|NCT00211562|Autonomic Agents|autonomic agents|mesh-ancestor
24419254|NCT00211562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24419255|NCT00211562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24419256|NCT00211562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24419257|NCT00211562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24419258|NCT00211562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24419259|NCT00211562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24419260|NCT00211562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24419261|NCT00211562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24823070|NCT02114697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823071|NCT02114710|Hydrocortisone|hydrocortisone|mesh-list
24419267|NCT00211562|Protective Agents|protective agents|mesh-ancestor
24419268|NCT00211588|Galantamine|galantamine|mesh-list
24823079|NCT02114736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24419322|NCT00211718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419323|NCT00211718|Cholinergic Agents|cholinergic agents|mesh-ancestor
24419364|NCT00211939|Sequestering Agents|sequestering agents|mesh-ancestor
24419366|NCT00211952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24419367|NCT00211952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24419368|NCT00211952|Analgesics|analgesics|mesh-ancestor
24419369|NCT00211952|Sensory System Agents|sensory system agents|mesh-ancestor
24419370|NCT00211952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24419371|NCT00211952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419372|NCT00211952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24419373|NCT00211952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24419374|NCT00211952|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24419375|NCT00211952|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24419376|NCT00211952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419377|NCT00211952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419405|NCT00212043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24419410|NCT00212043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419411|NCT00212043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24419412|NCT00212043|Immunologic Factors|immunologic factors|mesh-ancestor
24419413|NCT00212043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419414|NCT00212069|Gemcitabine|gemcitabine|mesh-list
24419415|NCT00212069|Carboplatin|carboplatin|mesh-list
24419416|NCT00212069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419417|NCT00212069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24419418|NCT00212069|Antimetabolites|antimetabolites|mesh-ancestor
24419419|NCT00212069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419420|NCT00212069|Antiviral Agents|antiviral agents|mesh-ancestor
24419421|NCT00212069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24564794|NCT00777985|Bosentan|bosentan|mesh-list
24419422|NCT00212069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419423|NCT00212069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24419424|NCT00212069|Immunologic Factors|immunologic factors|mesh-ancestor
24419425|NCT00212069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419426|NCT00212082|Docetaxel|docetaxel|mesh-list
24823089|NCT02114775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24419434|NCT00212082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24419435|NCT00212082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24419436|NCT00212082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419437|NCT00212095|Ketoconazole|ketoconazole|mesh-list
25849503|NCT00048776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419439|NCT00212095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419440|NCT00212095|Tubulin Modulators|tubulin modulators|mesh-ancestor
24419441|NCT00212095|Antimitotic Agents|antimitotic agents|mesh-ancestor
24419442|NCT00212095|Mitosis Modulators|mitosis modulators|mesh-ancestor
24419443|NCT00212095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419444|NCT00212095|Antifungal Agents|antifungal agents|mesh-ancestor
24419445|NCT00212095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24419446|NCT00212095|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24419447|NCT00212095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24419448|NCT00212095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419449|NCT00212095|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24419450|NCT00212095|Hormone Antagonists|hormone antagonists|mesh-ancestor
24419451|NCT00212095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24419452|NCT00212095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849504|NCT00048776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25849505|NCT00048776|Respiratory System Agents|respiratory system agents|mesh-ancestor
24419476|NCT00212173|Appetite Depressants|appetite depressants|mesh-ancestor
24419477|NCT00212173|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24419479|NCT00212186|Antioxidants|antioxidants|mesh-ancestor
24419480|NCT00212186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419481|NCT00212186|Protective Agents|protective agents|mesh-ancestor
24823090|NCT02114775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823091|NCT02114775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823092|NCT02114775|Urological Agents|urological agents|mesh-ancestor
24823093|NCT02115035|Vemurafenib|vemurafenib|mesh-list
24823094|NCT02115035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823097|NCT02115035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823099|NCT02115087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24823100|NCT02115087|Narcotics|narcotics|mesh-ancestor
24823101|NCT02115087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24823102|NCT02115087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823103|NCT02115087|Analgesics|analgesics|mesh-ancestor
24823104|NCT02115087|Sensory System Agents|sensory system agents|mesh-ancestor
24823105|NCT02115087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24823106|NCT02115152|Cyclophosphamide|cyclophosphamide|mesh-list
24823107|NCT02115152|Fluorouracil|fluorouracil|mesh-list
24823108|NCT02115152|Capecitabine|capecitabine|mesh-list
24823109|NCT02115152|Epirubicin|epirubicin|mesh-list
24823110|NCT02115152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24823111|NCT02115152|Immunologic Factors|immunologic factors|mesh-ancestor
24823112|NCT02115152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823113|NCT02115152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24823114|NCT02115152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25166465|NCT04026958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24823116|NCT02115152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419482|NCT00212186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419484|NCT00212186|Micronutrients|micronutrients|mesh-ancestor
24419485|NCT00212199|Orlistat|orlistat|mesh-list
24419486|NCT00212199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419487|NCT00212199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419488|NCT00212199|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24419490|NCT00212212|Selenium|selenium|mesh-list
24419508|NCT00212277|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24419509|NCT00212277|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24823122|NCT02115152|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24823123|NCT02115152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24823124|NCT02115152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823125|NCT02115204|Cyclophosphamide|cyclophosphamide|mesh-list
24419534|NCT00212589|Leucovorin|leucovorin|mesh-list
24419535|NCT00212589|Folic Acid|folic acid|mesh-list
24419536|NCT00212589|Fluorouracil|fluorouracil|mesh-list
24419537|NCT00212589|Capecitabine|capecitabine|mesh-list
24419538|NCT00212589|Levoleucovorin|levoleucovorin|mesh-list
24419539|NCT00212589|Antimetabolites|antimetabolites|mesh-ancestor
24419540|NCT00212589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419541|NCT00212589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24419542|NCT00212589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419543|NCT00212589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24419544|NCT00212589|Immunologic Factors|immunologic factors|mesh-ancestor
24419545|NCT00212589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419546|NCT00212589|Antidotes|antidotes|mesh-ancestor
24419550|NCT00212589|Micronutrients|micronutrients|mesh-ancestor
24419551|NCT00212589|Hematinics|hematinics|mesh-ancestor
24419552|NCT00212602|Aprepitant|aprepitant|mesh-list
24419554|NCT00212602|Antiemetics|antiemetics|mesh-ancestor
24419555|NCT00212602|Autonomic Agents|autonomic agents|mesh-ancestor
24419556|NCT00212602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24419557|NCT00212602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419558|NCT00212602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24419559|NCT00212602|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24419560|NCT00212602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24419561|NCT00212602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419562|NCT00212615|Capecitabine|capecitabine|mesh-list
24419563|NCT00212615|Oxaliplatin|oxaliplatin|mesh-list
24419564|NCT00212615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24419565|NCT00212615|Antimetabolites|antimetabolites|mesh-ancestor
24419566|NCT00212615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419567|NCT00212615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419568|NCT00212654|Landiolol|landiolol|mesh-list
24419569|NCT00212654|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24419570|NCT00212654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24419571|NCT00212654|Adrenergic Agents|adrenergic agents|mesh-ancestor
24419572|NCT00212654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24419573|NCT00212654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419574|NCT00212654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823136|NCT02115204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823137|NCT02115204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419628|NCT00213122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419638|NCT00213200|Analgesics|analgesics|mesh-ancestor
24419639|NCT00213200|Sensory System Agents|sensory system agents|mesh-ancestor
24419640|NCT00213200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24584454|NCT00880412|Etazolate|etazolate|mesh-list
24419641|NCT00213200|Anesthetics, Local|anesthetics, local|mesh-ancestor
24419642|NCT00213200|Anesthetics|anesthetics|mesh-ancestor
24419643|NCT00213226|Dexamethasone|dexamethasone|mesh-list
24419644|NCT00213226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24419645|NCT00213226|Antiemetics|antiemetics|mesh-ancestor
24419646|NCT00213226|Autonomic Agents|autonomic agents|mesh-ancestor
24419647|NCT00213226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24419763|NCT00213590|Dermatologic Agents|dermatologic agents|mesh-ancestor
24419764|NCT00213590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24419765|NCT00213590|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24419767|NCT00213694|Docetaxel|docetaxel|mesh-list
24419832|NCT00214240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419833|NCT00214253|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
24419834|NCT00214253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24419835|NCT00214253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419836|NCT00214266|Mycophenolic Acid|mycophenolic acid|mesh-list
24419838|NCT00214266|Alemtuzumab|alemtuzumab|mesh-list
24419839|NCT00214266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24419840|NCT00214266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419841|NCT00214266|Immunologic Factors|immunologic factors|mesh-ancestor
24419918|NCT00214552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419919|NCT00214578|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24419920|NCT00214578|Antidepressive Agents|antidepressive agents|mesh-ancestor
24419921|NCT00214578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24419922|NCT00214578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24419923|NCT00214578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24419924|NCT00214578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24419925|NCT00214578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419926|NCT00214604|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24419928|NCT00214604|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24419929|NCT00214604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24419930|NCT00214604|Antimetabolites|antimetabolites|mesh-ancestor
24419962|NCT00214643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419963|NCT00214643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419983|NCT00214825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419984|NCT00214825|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24419985|NCT00214825|Hormone Antagonists|hormone antagonists|mesh-ancestor
24419999|NCT00214877|Methylene Blue|methylene blue|mesh-list
24420000|NCT00214877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420001|NCT00214877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420002|NCT00214942|Fentanyl|fentanyl|mesh-list
24420003|NCT00214942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24420004|NCT00214942|Narcotics|narcotics|mesh-ancestor
24420005|NCT00214942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25419581|NCT02693535|Talazoparib|talazoparib|mesh-list
24469295|NCT00385398|Temozolomide|temozolomide|mesh-list
24420006|NCT00214942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420007|NCT00214942|Analgesics|analgesics|mesh-ancestor
24420017|NCT00214955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24420035|NCT00214994|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
24420036|NCT00214994|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24420037|NCT00214994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24823145|NCT02115204|Abortifacient Agents|abortifacient agents|mesh-ancestor
24823146|NCT02115204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24823147|NCT02115204|Dermatologic Agents|dermatologic agents|mesh-ancestor
24420044|NCT00215007|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24420045|NCT00215007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24420046|NCT00215007|Renal Agents|renal agents|mesh-ancestor
24420047|NCT00215007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24420048|NCT00215007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24420049|NCT00215007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24420050|NCT00215007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420051|NCT00215007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420052|NCT00215007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420053|NCT00215007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24420054|NCT00215007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24420062|NCT00215046|Antimetabolites|antimetabolites|mesh-ancestor
24420112|NCT00215228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24420114|NCT00215228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823148|NCT02115204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823149|NCT02115204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24823150|NCT02115204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24565169|NCT00779064|Anticoagulants|anticoagulants|mesh-ancestor
24420153|NCT00215280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24420154|NCT00215280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24420155|NCT00215280|Anthelmintics|anthelmintics|mesh-ancestor
24420156|NCT00215280|Anticestodal Agents|anticestodal agents|mesh-ancestor
24420157|NCT00215280|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24420162|NCT00215280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420163|NCT00215280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420165|NCT00215345|Docetaxel|docetaxel|mesh-list
24420166|NCT00215345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420167|NCT00215345|Tubulin Modulators|tubulin modulators|mesh-ancestor
24420168|NCT00215345|Antimitotic Agents|antimitotic agents|mesh-ancestor
24420169|NCT00215345|Mitosis Modulators|mitosis modulators|mesh-ancestor
24420170|NCT00215345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420171|NCT00215345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24420172|NCT00215345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24420173|NCT00215345|Analgesics|analgesics|mesh-ancestor
24420174|NCT00215345|Sensory System Agents|sensory system agents|mesh-ancestor
24420214|NCT00215384|Respiratory System Agents|respiratory system agents|mesh-ancestor
24420215|NCT00215384|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24420216|NCT00215384|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24420217|NCT00215384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24420218|NCT00215384|Adrenergic Agents|adrenergic agents|mesh-ancestor
24420219|NCT00215384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24420220|NCT00215384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420221|NCT00215397|Formoterol Fumarate|formoterol fumarate|mesh-list
24420222|NCT00215397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24420223|NCT00215397|Autonomic Agents|autonomic agents|mesh-ancestor
24420224|NCT00215397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24420225|NCT00215397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420226|NCT00215397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24420227|NCT00215397|Respiratory System Agents|respiratory system agents|mesh-ancestor
25849506|NCT00048776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25849507|NCT00048776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24420413|NCT00215982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420415|NCT00215995|Irinotecan|irinotecan|mesh-list
24420416|NCT00215995|Gefitinib|gefitinib|mesh-list
24420417|NCT00215995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420434|NCT00216021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420435|NCT00216034|polysaccharide-K|polysaccharide-k|mesh-list
24420436|NCT00216034|Tegafur|tegafur|mesh-list
24420437|NCT00216034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24420438|NCT00216034|Antimetabolites|antimetabolites|mesh-ancestor
24823175|NCT02115360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24823176|NCT02115360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25662132|NCT01641809|Rilpivirine|rilpivirine|mesh-list
24823177|NCT02115360|Vasodilator Agents|vasodilator agents|mesh-ancestor
24823178|NCT02115464|Metformin|metformin|mesh-list
24823179|NCT02115464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24823180|NCT02115464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823181|NCT02115490|Diphosphonates|diphosphonates|mesh-list
24823182|NCT02115490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24823183|NCT02115490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823184|NCT02115529|Nabilone|nabilone|mesh-list
24823185|NCT02115529|Antiemetics|antiemetics|mesh-ancestor
24823186|NCT02115529|Autonomic Agents|autonomic agents|mesh-ancestor
24823187|NCT02115529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24823188|NCT02115529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823189|NCT02115529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24823190|NCT02115529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24823191|NCT02115529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24420439|NCT00216034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25166466|NCT04026958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24420443|NCT00216034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420444|NCT00216034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24420445|NCT00216034|Antiviral Agents|antiviral agents|mesh-ancestor
24420446|NCT00216034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24420447|NCT00216034|Interferon Inducers|interferon inducers|mesh-ancestor
24420448|NCT00216034|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24420449|NCT00216034|Protective Agents|protective agents|mesh-ancestor
24420450|NCT00216047|Trastuzumab|trastuzumab|mesh-list
24420451|NCT00216047|Vatalanib|vatalanib|mesh-list
24420452|NCT00216047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24420453|NCT00216047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420454|NCT00216047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24420455|NCT00216047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420456|NCT00216047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420500|NCT00216177|Adalimumab|adalimumab|mesh-list
24420501|NCT00216177|Infliximab|infliximab|mesh-list
24420502|NCT00216177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24420503|NCT00216177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24420504|NCT00216177|Dermatologic Agents|dermatologic agents|mesh-ancestor
24420505|NCT00216177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24420506|NCT00216190|Midazolam|midazolam|mesh-list
24420507|NCT00216190|Dexmedetomidine|dexmedetomidine|mesh-list
24420508|NCT00216190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24420509|NCT00216190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24420510|NCT00216190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823192|NCT02115529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24823193|NCT02115529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24823194|NCT02115594|Fulvestrant|fulvestrant|mesh-list
24823196|NCT02115594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24420511|NCT00216190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24420512|NCT00216190|Analgesics|analgesics|mesh-ancestor
24420513|NCT00216190|Sensory System Agents|sensory system agents|mesh-ancestor
24420514|NCT00216190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24565880|NCT00783172|Mitogens|mitogens|mesh-list
24420515|NCT00216190|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24420548|NCT00216281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24420549|NCT00216281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420550|NCT00216281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24420551|NCT00216281|Serotonin Agents|serotonin agents|mesh-ancestor
24420609|NCT00216424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420610|NCT00216437|Capecitabine|capecitabine|mesh-list
24420611|NCT00216437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24420612|NCT00216437|Antimetabolites|antimetabolites|mesh-ancestor
25166467|NCT04024761|Cyclophosphamide|cyclophosphamide|mesh-list
25849508|NCT00048776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772714|NCT01835236|Paclitaxel|paclitaxel|mesh-list
25849509|NCT00048776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24823197|NCT02115594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823198|NCT02115594|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24823199|NCT02115594|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24823200|NCT02115594|Hormone Antagonists|hormone antagonists|mesh-ancestor
24565930|NCT00783484|Maraviroc|maraviroc|mesh-list
24420613|NCT00216437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420614|NCT00216437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420615|NCT00216450|Rabeprazole|rabeprazole|mesh-list
24420616|NCT00216450|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24420617|NCT00216450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24420650|NCT00216515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420651|NCT00216515|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24420652|NCT00216515|Autonomic Agents|autonomic agents|mesh-ancestor
24420653|NCT00216515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24420654|NCT00216515|Nootropic Agents|nootropic agents|mesh-ancestor
24420655|NCT00216528|Risperidone|risperidone|mesh-list
24420656|NCT00216528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24420657|NCT00216528|Serotonin Agents|serotonin agents|mesh-ancestor
24420700|NCT00216606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420702|NCT00216619|Anticonvulsants|anticonvulsants|mesh-ancestor
24420703|NCT00216619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24420704|NCT00216619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420705|NCT00216632|Risperidone|risperidone|mesh-list
24420717|NCT00216645|Doxorubicin|doxorubicin|mesh-list
24420718|NCT00216645|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24420719|NCT00216645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24420720|NCT00216645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420721|NCT00216645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24420722|NCT00216645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24420723|NCT00216645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422005|NCT00220896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823216|NCT02115659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420952|NCT00217373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24420982|NCT00217451|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24420993|NCT00217477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24420994|NCT00217477|Immunologic Factors|immunologic factors|mesh-ancestor
24420995|NCT00217477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849510|NCT00048776|Vasodilator Agents|vasodilator agents|mesh-ancestor
24420997|NCT00217503|Valganciclovir|valganciclovir|mesh-list
24420998|NCT00217503|Ganciclovir|ganciclovir|mesh-list
24420999|NCT00217503|Cyclophosphamide|cyclophosphamide|mesh-list
24421000|NCT00217503|Bevacizumab|bevacizumab|mesh-list
24421001|NCT00217503|Doxorubicin|doxorubicin|mesh-list
24421002|NCT00217503|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24421003|NCT00217503|Etoposide|etoposide|mesh-list
24421004|NCT00217503|Bortezomib|bortezomib|mesh-list
24421005|NCT00217503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24421006|NCT00217503|Immunologic Factors|immunologic factors|mesh-ancestor
24421007|NCT00217503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421008|NCT00217503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25166469|NCT04024761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25166470|NCT04024761|Immunologic Factors|immunologic factors|mesh-ancestor
24421009|NCT00217503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24421010|NCT00217503|Alkylating Agents|alkylating agents|mesh-ancestor
24421011|NCT00217503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421012|NCT00217503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421128|NCT00217711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421129|NCT00217711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24421130|NCT00217711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24421158|NCT00217932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421159|NCT00217932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421160|NCT00217932|GABA Agents|gaba agents|mesh-ancestor
24421161|NCT00217932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24421162|NCT00217932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421163|NCT00217932|Antimanic Agents|antimanic agents|mesh-ancestor
24421209|NCT00218127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421211|NCT00218127|Sensory System Agents|sensory system agents|mesh-ancestor
24421212|NCT00218127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24823242|NCT02115776|Chlorhexidine|chlorhexidine|mesh-list
24823243|NCT02115776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24823244|NCT02115776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24823245|NCT02115776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24823246|NCT02115776|Disinfectants|disinfectants|mesh-ancestor
24823247|NCT02115776|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24823248|NCT02115776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823249|NCT02115776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421213|NCT00218140|Nicotine|nicotine|mesh-list
24421214|NCT00218140|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24421232|NCT00218166|GABA Agonists|gaba agonists|mesh-list
24421233|NCT00218166|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24421234|NCT00218166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421303|NCT00218244|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24421304|NCT00218244|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24823251|NCT02116010|Silver Sulfadiazine|silver sulfadiazine|mesh-list
24823252|NCT02116010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24421305|NCT00218244|Cholinergic Agents|cholinergic agents|mesh-ancestor
24421306|NCT00218244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25419582|NCT02693535|Tucatinib|tucatinib|mesh-list
24421307|NCT00218244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421308|NCT00218244|Respiratory System Agents|respiratory system agents|mesh-ancestor
24421309|NCT00218283|Nicotine|nicotine|mesh-list
24421310|NCT00218283|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24421311|NCT00218283|Autonomic Agents|autonomic agents|mesh-ancestor
24421312|NCT00218283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24421318|NCT00218283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421319|NCT00218309|Hydromorphone|hydromorphone|mesh-list
24421320|NCT00218309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24421321|NCT00218309|Narcotics|narcotics|mesh-ancestor
24421322|NCT00218309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24421323|NCT00218309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421324|NCT00218309|Analgesics|analgesics|mesh-ancestor
24421325|NCT00218309|Sensory System Agents|sensory system agents|mesh-ancestor
24421326|NCT00218309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24421327|NCT00218322|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24421328|NCT00218322|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24421329|NCT00218322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25849511|NCT00048776|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24421378|NCT00218504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421379|NCT00218504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24421380|NCT00218504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24421381|NCT00218504|Analgesics|analgesics|mesh-ancestor
24421382|NCT00218504|Sensory System Agents|sensory system agents|mesh-ancestor
24421383|NCT00218504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24823267|NCT02116231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823268|NCT02116257|Propacetamol|propacetamol|mesh-list
24823269|NCT02116257|Analgesics|analgesics|mesh-ancestor
24823270|NCT02116257|Sensory System Agents|sensory system agents|mesh-ancestor
24421432|NCT00218621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24421433|NCT00218621|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24421434|NCT00218621|Antitussive Agents|antitussive agents|mesh-ancestor
24421435|NCT00218621|Respiratory System Agents|respiratory system agents|mesh-ancestor
24421436|NCT00218660|Naltrexone|naltrexone|mesh-list
24421437|NCT00218660|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24421438|NCT00218660|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24823425|NCT02117219|Azacitidine|azacitidine|mesh-list
24421440|NCT00218660|Sensory System Agents|sensory system agents|mesh-ancestor
24421441|NCT00218660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24421442|NCT00218790|Dialysis Solutions|dialysis solutions|mesh-list
24421443|NCT00218790|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24421444|NCT00218855|Thalidomide|thalidomide|mesh-list
24421445|NCT00218855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24421446|NCT00218855|Immunologic Factors|immunologic factors|mesh-ancestor
24421447|NCT00218855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421448|NCT00218855|Leprostatic Agents|leprostatic agents|mesh-ancestor
24421449|NCT00218855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24421450|NCT00218855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24823279|NCT02116348|Mitosis Modulators|mitosis modulators|mesh-ancestor
24421497|NCT00219375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421498|NCT00219375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421499|NCT00219375|Glycine Agents|glycine agents|mesh-ancestor
24421500|NCT00219375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24421501|NCT00219375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421502|NCT00219388|Simendan|simendan|mesh-list
24421503|NCT00219388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24421510|NCT00219388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421511|NCT00219401|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24421512|NCT00219401|Immunologic Factors|immunologic factors|mesh-ancestor
24421513|NCT00219401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421514|NCT00219440|Metformin|metformin|mesh-list
24421515|NCT00219440|Pioglitazone|pioglitazone|mesh-list
24421516|NCT00219440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24421517|NCT00219440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421519|NCT00219466|Tocopherols|tocopherols|mesh-list
24421520|NCT00219466|Vitamin E|vitamin e|mesh-list
24421521|NCT00219466|Tocotrienols|tocotrienols|mesh-list
24421522|NCT00219466|alpha-Tocopherol|alpha-tocopherol|mesh-list
25166471|NCT04024761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421523|NCT00219466|Zinc Oxide|zinc oxide|mesh-list
24421524|NCT00219466|Trace Elements|trace elements|mesh-ancestor
24421525|NCT00219466|Micronutrients|micronutrients|mesh-ancestor
24421526|NCT00219466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421527|NCT00219466|Antioxidants|antioxidants|mesh-ancestor
24421528|NCT00219466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421529|NCT00219466|Protective Agents|protective agents|mesh-ancestor
24421530|NCT00219466|Vitamins|vitamins|mesh-ancestor
24470127|NCT00388882|Anticonvulsants|anticonvulsants|mesh-ancestor
24421550|NCT00219570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823285|NCT02116400|Lithium Carbonate|lithium carbonate|mesh-list
24823286|NCT02116400|Antidepressive Agents|antidepressive agents|mesh-ancestor
24823287|NCT02116400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24823288|NCT02116400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421646|NCT00219804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24421647|NCT00219804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24421648|NCT00219804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24421649|NCT00219804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421650|NCT00219804|Adrenergic Agents|adrenergic agents|mesh-ancestor
24421651|NCT00219804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24421652|NCT00219804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421655|NCT00219856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24421656|NCT00219856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24421657|NCT00219856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421658|NCT00219856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24421659|NCT00219856|Anesthetics, General|anesthetics, general|mesh-ancestor
24421660|NCT00219856|Anesthetics|anesthetics|mesh-ancestor
24421661|NCT00219856|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24421669|NCT00219869|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24421670|NCT00219869|Autonomic Agents|autonomic agents|mesh-ancestor
24823297|NCT02116465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24823298|NCT02116465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24421767|NCT00220155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421768|NCT00220155|Antiviral Agents|antiviral agents|mesh-ancestor
24421769|NCT00220155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24421770|NCT00220155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421771|NCT00220155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24421772|NCT00220155|Immunologic Factors|immunologic factors|mesh-ancestor
24421773|NCT00220155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421775|NCT00220168|Irinotecan|irinotecan|mesh-list
24421776|NCT00220168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25849512|NCT00048776|Protective Agents|protective agents|mesh-ancestor
24545140|NCT00692055|Gout Suppressants|gout suppressants|mesh-ancestor
24421797|NCT00220220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24568231|NCT00795314|Fentanyl|fentanyl|mesh-list
24421798|NCT00220220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545157|NCT00692159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24421799|NCT00220220|Vasodilator Agents|vasodilator agents|mesh-ancestor
24421800|NCT00220220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24421801|NCT00220220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24421802|NCT00220233|Amlodipine|amlodipine|mesh-list
24421803|NCT00220233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24421804|NCT00220233|Olmesartan|olmesartan|mesh-list
25849513|NCT00048776|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24823304|NCT02116465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823305|NCT02116465|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24823306|NCT02116465|Immunologic Factors|immunologic factors|mesh-ancestor
24823307|NCT02116465|Dopamine Agonists|dopamine agonists|mesh-ancestor
24823308|NCT02116556|Rifaximin|rifaximin|mesh-list
24823309|NCT02116556|Prednisone|prednisone|mesh-list
24823310|NCT02116556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24823311|NCT02116556|Glucocorticoids|glucocorticoids|mesh-ancestor
24823312|NCT02116556|Hormones|hormones|mesh-ancestor
24421808|NCT00220233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24545158|NCT00692172|Alefacept|alefacept|mesh-list
24421861|NCT00220324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24421862|NCT00220324|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
24421863|NCT00220324|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24823426|NCT02117219|Durvalumab|durvalumab|mesh-list
24823321|NCT02116569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823322|NCT02116712|Saracatinib|saracatinib|mesh-list
24823323|NCT02116712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823324|NCT02116712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823325|NCT02116712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823326|NCT02116790|Naproxen|naproxen|mesh-list
24823327|NCT02116790|Levodopa|levodopa|mesh-list
24421894|NCT00220493|Methylphenidate|methylphenidate|mesh-list
24421896|NCT00220493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421897|NCT00220493|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24421898|NCT00220493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25166472|NCT04024761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24823330|NCT02116790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25662133|NCT01641809|Cabotegravir|cabotegravir|mesh-list
24847081|NCT02245126|Anesthetics|anesthetics|mesh-ancestor
24823331|NCT02116790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24823332|NCT02116790|Analgesics|analgesics|mesh-ancestor
24823333|NCT02116790|Sensory System Agents|sensory system agents|mesh-ancestor
24823334|NCT02116790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24823335|NCT02116790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823336|NCT02116790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24823337|NCT02116790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24421907|NCT00220506|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24421908|NCT00220506|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24421909|NCT00220506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421910|NCT00220532|Folic Acid|folic acid|mesh-list
24421911|NCT00220532|Riboflavin|riboflavin|mesh-list
24421912|NCT00220532|Hematinics|hematinics|mesh-ancestor
24421913|NCT00220532|Vitamin B Complex|vitamin b complex|mesh-ancestor
25849514|NCT00048776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25849515|NCT00048776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849516|NCT00048802|Valproic Acid|valproic acid|mesh-list
25849517|NCT00048802|Olanzapine|olanzapine|mesh-list
25849518|NCT00048802|Risperidone|risperidone|mesh-list
24421954|NCT00220714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24421955|NCT00220714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24421956|NCT00220714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421957|NCT00220714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24421958|NCT00220766|Immunoglobulins|immunoglobulins|mesh-list
24421960|NCT00220766|gamma-Globulins|gamma-globulins|mesh-list
24421961|NCT00220766|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24421962|NCT00220766|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24421963|NCT00220766|Immunoglobulin G|immunoglobulin g|mesh-list
25849519|NCT00048802|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24421992|NCT00220844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24421993|NCT00220844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421994|NCT00220844|Adrenergic Agents|adrenergic agents|mesh-ancestor
24421995|NCT00220844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24421996|NCT00220844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421997|NCT00220857|Rabeprazole|rabeprazole|mesh-list
24421998|NCT00220857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25166473|NCT04024761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24422004|NCT00220896|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24422016|NCT00220909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422017|NCT00220909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823362|NCT02116842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24823364|NCT02116868|Antihypertensive Agents|antihypertensive agents|mesh-list
24823365|NCT02116868|Nicardipine|nicardipine|mesh-list
24823367|NCT02116868|Remifentanil|remifentanil|mesh-list
24823368|NCT02116868|Esmolol|esmolol|mesh-list
24823369|NCT02116868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24691397|NCT01406431|Valsartan|valsartan|mesh-list
24422042|NCT00221052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422065|NCT00221286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25849520|NCT00048802|Ziprasidone|ziprasidone|mesh-list
24422076|NCT00221312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422078|NCT00221325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24422079|NCT00221325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24422080|NCT00221325|Immunologic Factors|immunologic factors|mesh-ancestor
24422081|NCT00221325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422082|NCT00221325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24422083|NCT00221364|Azithromycin|azithromycin|mesh-list
24422084|NCT00221364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24422085|NCT00221364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24422086|NCT00221390|Ropinirole|ropinirole|mesh-list
24422087|NCT00221390|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24422088|NCT00221390|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24422089|NCT00221390|Dopamine Agonists|dopamine agonists|mesh-ancestor
24422090|NCT00221390|Dopamine Agents|dopamine agents|mesh-ancestor
24422132|NCT00221468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24422133|NCT00221468|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24422134|NCT00221468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24422135|NCT00221468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24422136|NCT00221468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422137|NCT00221481|Valproic Acid|valproic acid|mesh-list
24422138|NCT00221481|Olanzapine|olanzapine|mesh-list
24422139|NCT00221481|Antiemetics|antiemetics|mesh-ancestor
24422140|NCT00221481|Autonomic Agents|autonomic agents|mesh-ancestor
24823371|NCT02116868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24823372|NCT02116868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823373|NCT02116868|Analgesics|analgesics|mesh-ancestor
25849521|NCT00048802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24823374|NCT02116868|Sensory System Agents|sensory system agents|mesh-ancestor
24823375|NCT02116868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24823376|NCT02116868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24823377|NCT02116868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24823378|NCT02116868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25166474|NCT04024761|Alkylating Agents|alkylating agents|mesh-ancestor
24422190|NCT00221520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422211|NCT00221624|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24422213|NCT00221624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24422214|NCT00221624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422215|NCT00221624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24422216|NCT00221624|Analgesics|analgesics|mesh-ancestor
24422217|NCT00221624|Sensory System Agents|sensory system agents|mesh-ancestor
24422218|NCT00221624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24422219|NCT00221637|Valproic Acid|valproic acid|mesh-list
24422220|NCT00221637|Anticonvulsants|anticonvulsants|mesh-ancestor
24422221|NCT00221637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422222|NCT00221637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422223|NCT00221637|GABA Agents|gaba agents|mesh-ancestor
24422225|NCT00221637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422226|NCT00221637|Antimanic Agents|antimanic agents|mesh-ancestor
24422227|NCT00221637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24422228|NCT00221637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24422229|NCT00221637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24422230|NCT00221650|Ribavirin|ribavirin|mesh-list
24422231|NCT00221650|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24823380|NCT02116868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24823381|NCT02116868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849522|NCT00048802|Serotonin Agents|serotonin agents|mesh-ancestor
24422301|NCT00221975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24422302|NCT00221975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422303|NCT00221975|Anticonvulsants|anticonvulsants|mesh-ancestor
24422304|NCT00221975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24823382|NCT02116868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24823383|NCT02116868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24823384|NCT02116868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24823385|NCT02116868|Vasodilator Agents|vasodilator agents|mesh-ancestor
24823386|NCT02116868|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24823387|NCT02116868|Serotonin Agents|serotonin agents|mesh-ancestor
24823388|NCT02116868|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24823389|NCT02116868|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24823390|NCT02116959|Carboplatin|carboplatin|mesh-list
24823391|NCT02116959|Etoposide|etoposide|mesh-list
24823392|NCT02116959|Vincristine|vincristine|mesh-list
24823393|NCT02116959|Melphalan|melphalan|mesh-list
24823394|NCT02116959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823395|NCT02116959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24823396|NCT02116959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24823397|NCT02116959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24823398|NCT02116959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823399|NCT02116959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823400|NCT02116959|Tubulin Modulators|tubulin modulators|mesh-ancestor
24823401|NCT02116959|Antimitotic Agents|antimitotic agents|mesh-ancestor
24422356|NCT00222183|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24422357|NCT00222183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422358|NCT00222183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422359|NCT00222235|Cycloserine|cycloserine|mesh-list
24422360|NCT00222235|Glycine|glycine|mesh-list
24422361|NCT00222235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24422362|NCT00222235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24422363|NCT00222235|Renal Agents|renal agents|mesh-ancestor
24422364|NCT00222235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24422365|NCT00222235|Antitubercular Agents|antitubercular agents|mesh-ancestor
24422366|NCT00222235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24422367|NCT00222235|Antimetabolites|antimetabolites|mesh-ancestor
24422368|NCT00222235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849523|NCT00048802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25849524|NCT00048802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422396|NCT00222443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24422397|NCT00222443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422398|NCT00222443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419583|NCT02693535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24422399|NCT00222443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24422401|NCT00222469|Bevacizumab|bevacizumab|mesh-list
24422402|NCT00222469|Oxaliplatin|oxaliplatin|mesh-list
25849525|NCT00048802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849526|NCT00048802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24422409|NCT00222469|Growth Inhibitors|growth inhibitors|mesh-ancestor
25201326|NCT02728687|Mannitol|mannitol|mesh-list
24422410|NCT00222469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24823412|NCT02117128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823413|NCT02117128|Hemostatics|hemostatics|mesh-ancestor
24823414|NCT02117128|Coagulants|coagulants|mesh-ancestor
24823415|NCT02117141|Hydrocodone|hydrocodone|mesh-list
24823416|NCT02117141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24823417|NCT02117141|Narcotics|narcotics|mesh-ancestor
24823418|NCT02117141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24823419|NCT02117141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823420|NCT02117141|Analgesics|analgesics|mesh-ancestor
24823421|NCT02117141|Sensory System Agents|sensory system agents|mesh-ancestor
24823422|NCT02117141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24823423|NCT02117141|Antitussive Agents|antitussive agents|mesh-ancestor
24823424|NCT02117141|Respiratory System Agents|respiratory system agents|mesh-ancestor
24823433|NCT02117219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24823435|NCT02117362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24823436|NCT02117362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823437|NCT02117362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24691716|NCT01408836|Prednisolone phosphate|prednisolone phosphate|mesh-list
24422417|NCT00222469|Immunologic Factors|immunologic factors|mesh-ancestor
24422419|NCT00222482|Anticonvulsants|anticonvulsants|mesh-ancestor
24422420|NCT00222482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422421|NCT00222482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823438|NCT02117362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823440|NCT02117401|Ketamine|ketamine|mesh-list
24823441|NCT02117401|Remifentanil|remifentanil|mesh-list
24823442|NCT02117401|Propofol|propofol|mesh-list
24823443|NCT02117401|Mivacurium|mivacurium|mesh-list
24823444|NCT02117401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24823445|NCT02117401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24823446|NCT02117401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823447|NCT02117401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24823448|NCT02117401|Anesthetics, General|anesthetics, general|mesh-ancestor
24823449|NCT02117401|Anesthetics|anesthetics|mesh-ancestor
24823450|NCT02117401|Analgesics|analgesics|mesh-ancestor
24823451|NCT02117401|Sensory System Agents|sensory system agents|mesh-ancestor
24823452|NCT02117401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24823453|NCT02117401|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24823454|NCT02117401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24823455|NCT02117401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24823456|NCT02117401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24823457|NCT02117401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823458|NCT02117401|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24823459|NCT02117401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24823460|NCT02117401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24823461|NCT02117401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24823462|NCT02117401|GABA Modulators|gaba modulators|mesh-ancestor
24823463|NCT02117401|GABA Agents|gaba agents|mesh-ancestor
24823464|NCT02117401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24823465|NCT02117401|Narcotics|narcotics|mesh-ancestor
24823466|NCT02117401|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24823467|NCT02117401|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24823468|NCT02117401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24823469|NCT02117453|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24823470|NCT02117453|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24823471|NCT02117453|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24823472|NCT02117453|Antimetabolites|antimetabolites|mesh-ancestor
24691765|NCT01408979|Anesthetics|anesthetics|mesh-ancestor
24422422|NCT00222482|GABA Agents|gaba agents|mesh-ancestor
24422423|NCT00222482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24422424|NCT00222482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422486|NCT00222573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422489|NCT00222573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24422490|NCT00222573|Sympatholytics|sympatholytics|mesh-ancestor
24422491|NCT00222573|Autonomic Agents|autonomic agents|mesh-ancestor
24422492|NCT00222573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24823493|NCT02117596|Antifungal Agents|antifungal agents|mesh-ancestor
24823494|NCT02117596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25145120|NCT02932007|Chloroquine|chloroquine|mesh-list
24823495|NCT02117596|Immunologic Factors|immunologic factors|mesh-ancestor
24823496|NCT02117596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823498|NCT02117622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24823499|NCT02117622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823501|NCT02117700|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24823502|NCT02117700|Antiviral Agents|antiviral agents|mesh-ancestor
24823503|NCT02117700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24823510|NCT02117700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823511|NCT02117700|Antidotes|antidotes|mesh-ancestor
24823513|NCT02117726|Dexmedetomidine|dexmedetomidine|mesh-list
24823514|NCT02117726|Propofol|propofol|mesh-list
24823515|NCT02117726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24823516|NCT02117726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24823517|NCT02117726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823518|NCT02117726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24422499|NCT00222651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24823519|NCT02117726|Anesthetics, General|anesthetics, general|mesh-ancestor
24823520|NCT02117726|Anesthetics|anesthetics|mesh-ancestor
24823521|NCT02117726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24823522|NCT02117726|Analgesics|analgesics|mesh-ancestor
24823523|NCT02117726|Sensory System Agents|sensory system agents|mesh-ancestor
24823524|NCT02117726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24823525|NCT02117726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24823526|NCT02117726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24823527|NCT02117726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24823528|NCT02117726|Adrenergic Agents|adrenergic agents|mesh-ancestor
24823529|NCT02117726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24823530|NCT02117726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823531|NCT02117726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24823532|NCT02117726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24823533|NCT02117726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24823534|NCT02117726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24823535|NCT02117726|GABA Modulators|gaba modulators|mesh-ancestor
24823536|NCT02117726|GABA Agents|gaba agents|mesh-ancestor
24823537|NCT02117739|Dapsone|dapsone|mesh-list
24823538|NCT02117739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24823600|NCT02118064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823601|NCT02118064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823602|NCT02118064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823604|NCT02118090|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24823605|NCT02118090|Amebicides|amebicides|mesh-ancestor
24823606|NCT02118090|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24823607|NCT02118090|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24823608|NCT02118090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24422500|NCT00222651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422501|NCT00222677|Aspirin|aspirin|mesh-list
24422502|NCT00222677|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24422503|NCT00222677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24422504|NCT00222677|Analgesics|analgesics|mesh-ancestor
24422505|NCT00222677|Sensory System Agents|sensory system agents|mesh-ancestor
24422506|NCT00222677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24422507|NCT00222677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422508|NCT00222677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24422510|NCT00222677|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24422511|NCT00222677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24422512|NCT00222677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422513|NCT00222677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25849527|NCT00048802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24422538|NCT00222833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24422539|NCT00222833|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24422540|NCT00222833|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24422541|NCT00222833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24422542|NCT00222833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422543|NCT00222833|Dopamine Agonists|dopamine agonists|mesh-ancestor
24422544|NCT00222833|Dopamine Agents|dopamine agents|mesh-ancestor
24823609|NCT02118090|Antimalarials|antimalarials|mesh-ancestor
24823610|NCT02118090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24823611|NCT02118090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24823612|NCT02118090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24823616|NCT02118090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823617|NCT02118090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24823618|NCT02118090|Filaricides|filaricides|mesh-ancestor
24823619|NCT02118090|Antinematodal Agents|antinematodal agents|mesh-ancestor
24823620|NCT02118090|Anthelmintics|anthelmintics|mesh-ancestor
24422550|NCT00222833|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24422551|NCT00222833|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24632374|NCT01123525|Adenosine|adenosine|mesh-list
24422552|NCT00222833|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24422553|NCT00222833|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24422554|NCT00222872|Hormones|hormones|mesh-list
24422555|NCT00222872|Parathyroid Hormone|parathyroid hormone|mesh-list
24422556|NCT00222872|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
24422557|NCT00222872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24422558|NCT00222872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422577|NCT00223015|Tacrolimus|tacrolimus|mesh-list
24422578|NCT00223015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24422579|NCT00223015|Immunologic Factors|immunologic factors|mesh-ancestor
24422580|NCT00223015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422581|NCT00223015|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24422582|NCT00223015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422583|NCT00223015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422584|NCT00223028|Sirolimus|sirolimus|mesh-list
24422585|NCT00223028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24422586|NCT00223028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25849528|NCT00048802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25849529|NCT00048802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25849530|NCT00048802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24422600|NCT00223054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422602|NCT00223054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422603|NCT00223054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545506|NCT00693589|Folic Acid|folic acid|mesh-list
24422627|NCT00223249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422628|NCT00223275|Naltrexone|naltrexone|mesh-list
24422629|NCT00223275|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24422630|NCT00223275|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24422631|NCT00223275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422632|NCT00223275|Sensory System Agents|sensory system agents|mesh-ancestor
24422633|NCT00223275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24422635|NCT00223288|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24422636|NCT00223288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24941574|NCT03989336|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24422651|NCT00223301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24422652|NCT00223301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422653|NCT00223301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422654|NCT00223418|Aripiprazole|aripiprazole|mesh-list
24823632|NCT02118285|Immunologic Factors|immunologic factors|mesh-ancestor
24823633|NCT02118285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823634|NCT02118285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24823635|NCT02118285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24823636|NCT02118285|Alkylating Agents|alkylating agents|mesh-ancestor
24823637|NCT02118285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823638|NCT02118285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823639|NCT02118285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24823640|NCT02118285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24823641|NCT02118285|Analgesics|analgesics|mesh-ancestor
24823642|NCT02118285|Sensory System Agents|sensory system agents|mesh-ancestor
24823643|NCT02118285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24823644|NCT02118311|Cyclophosphamide|cyclophosphamide|mesh-list
24823645|NCT02118311|Fludarabine|fludarabine|mesh-list
24422702|NCT00223626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422704|NCT00223639|Anticonvulsants|anticonvulsants|mesh-ancestor
24422705|NCT00223639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24422706|NCT00223639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422707|NCT00223691|Acarbose|acarbose|mesh-list
24422708|NCT00223691|Diphenhydramine|diphenhydramine|mesh-list
24422709|NCT00223691|Promethazine|promethazine|mesh-list
24422710|NCT00223691|Ibuprofen|ibuprofen|mesh-list
24422711|NCT00223691|Celecoxib|celecoxib|mesh-list
24422712|NCT00223691|Indomethacin|indomethacin|mesh-list
24823727|NCT02118727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24423070|NCT00224549|Vasodilator Agents|vasodilator agents|mesh-ancestor
24823729|NCT02118727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823730|NCT02118727|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24823732|NCT02118753|Eplerenone|eplerenone|mesh-list
24612142|NCT01012193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24422734|NCT00223691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24422735|NCT00223691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25849531|NCT00048802|Dopamine Agents|dopamine agents|mesh-ancestor
25849532|NCT00048802|Antiemetics|antiemetics|mesh-ancestor
25849533|NCT00048802|Autonomic Agents|autonomic agents|mesh-ancestor
25849534|NCT00048802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25662134|NCT01641809|Antiviral Agents|antiviral agents|mesh-ancestor
24823735|NCT02118753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24823736|NCT02118753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823737|NCT02118753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24823738|NCT02118753|Diuretics|diuretics|mesh-ancestor
24823739|NCT02118753|Natriuretic Agents|natriuretic agents|mesh-ancestor
24823740|NCT02118753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24823741|NCT02118844|Rocuronium|rocuronium|mesh-list
24823742|NCT02118844|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24823743|NCT02118844|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24823744|NCT02118844|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24823745|NCT02118844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24823746|NCT02118844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823769|NCT02118870|Purinergic Agents|purinergic agents|mesh-ancestor
24823770|NCT02118870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24823771|NCT02118909|Itraconazole|itraconazole|mesh-list
24823772|NCT02118909|Ciprofloxacin|ciprofloxacin|mesh-list
24823773|NCT02118909|Antifungal Agents|antifungal agents|mesh-ancestor
24823774|NCT02118909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24823775|NCT02118909|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24823776|NCT02118909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24823777|NCT02118909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823778|NCT02118909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823779|NCT02118909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24422881|NCT00223717|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24422882|NCT00223717|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24422883|NCT00223717|Dopamine Agents|dopamine agents|mesh-ancestor
24422884|NCT00223717|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24422885|NCT00223717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24422890|NCT00223717|Hormone Antagonists|hormone antagonists|mesh-ancestor
24422891|NCT00223717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24422892|NCT00223717|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24422893|NCT00223717|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24422894|NCT00223717|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24422895|NCT00223717|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24422896|NCT00223717|Hemostatics|hemostatics|mesh-ancestor
24422897|NCT00223717|Coagulants|coagulants|mesh-ancestor
24422906|NCT00223743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24422907|NCT00223743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422908|NCT00223769|Oxandrolone|oxandrolone|mesh-list
24422909|NCT00223769|Androgens|androgens|mesh-ancestor
24422910|NCT00223769|Hormones|hormones|mesh-ancestor
24422911|NCT00223769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24823780|NCT02118909|Hormone Antagonists|hormone antagonists|mesh-ancestor
24823781|NCT02118909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24422985|NCT00224354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24423066|NCT00224549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24824026|NCT02120872|Simvastatin|simvastatin|mesh-list
24423069|NCT00224549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423072|NCT00224549|Natriuretic Agents|natriuretic agents|mesh-ancestor
24423073|NCT00224549|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24423125|NCT00224809|Spironolactone|spironolactone|mesh-list
24423126|NCT00224809|Clopidogrel|clopidogrel|mesh-list
24423127|NCT00224809|Enzyme Inhibitors|enzyme inhibitors|mesh-list
24423128|NCT00224809|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24423150|NCT00224809|Hormone Antagonists|hormone antagonists|mesh-ancestor
24423151|NCT00224809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24423152|NCT00224809|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24823782|NCT02118909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823783|NCT02118909|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24823784|NCT02118909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24423153|NCT00224809|Diuretics|diuretics|mesh-ancestor
24423154|NCT00224809|Natriuretic Agents|natriuretic agents|mesh-ancestor
24423155|NCT00224809|Protease Inhibitors|protease inhibitors|mesh-ancestor
24423157|NCT00224822|Antidepressive Agents|antidepressive agents|mesh-ancestor
24423158|NCT00224822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24423159|NCT00224822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24423160|NCT00224822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24423161|NCT00224822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24423166|NCT00224822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25419584|NCT02693535|Entrectinib|entrectinib|mesh-list
24423167|NCT00224822|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24870275|NCT02621151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24423168|NCT00224822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24423169|NCT00224822|Serotonin Agents|serotonin agents|mesh-ancestor
24423170|NCT00224822|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24423171|NCT00224822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24423172|NCT00224822|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24423173|NCT00224822|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24423174|NCT00224978|Chloroquine|chloroquine|mesh-list
24423175|NCT00224978|Amebicides|amebicides|mesh-ancestor
24423176|NCT00224978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24423177|NCT00224978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25849535|NCT00048802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24823789|NCT02118987|Omalizumab|omalizumab|mesh-list
24823790|NCT02118987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24823791|NCT02118987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24823792|NCT02118987|Respiratory System Agents|respiratory system agents|mesh-ancestor
24423203|NCT00225043|Protective Agents|protective agents|mesh-ancestor
24423205|NCT00225056|Capecitabine|capecitabine|mesh-list
24423206|NCT00225056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24423207|NCT00225056|Tubulin Modulators|tubulin modulators|mesh-ancestor
24423208|NCT00225056|Antimitotic Agents|antimitotic agents|mesh-ancestor
24423209|NCT00225056|Mitosis Modulators|mitosis modulators|mesh-ancestor
24423210|NCT00225056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423211|NCT00225056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24423212|NCT00225056|Antimetabolites|antimetabolites|mesh-ancestor
24423214|NCT00225108|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24423215|NCT00225108|Dalteparin|dalteparin|mesh-list
24423216|NCT00225108|Anticoagulants|anticoagulants|mesh-ancestor
24423217|NCT00225108|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24423218|NCT00225108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25849536|NCT00048802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24423267|NCT00225238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24423268|NCT00225238|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24423270|NCT00225238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423271|NCT00225264|Pioglitazone|pioglitazone|mesh-list
24423272|NCT00225264|Glimepiride|glimepiride|mesh-list
24423273|NCT00225264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24423274|NCT00225264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423275|NCT00225264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24423276|NCT00225264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24423277|NCT00225264|Immunologic Factors|immunologic factors|mesh-ancestor
24423278|NCT00225290|Thalidomide|thalidomide|mesh-list
24423279|NCT00225290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24423280|NCT00225290|Immunologic Factors|immunologic factors|mesh-ancestor
24423281|NCT00225290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423282|NCT00225290|Leprostatic Agents|leprostatic agents|mesh-ancestor
24423283|NCT00225290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24423285|NCT00225290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24423286|NCT00225290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24423287|NCT00225290|Growth Substances|growth substances|mesh-ancestor
24823794|NCT02119000|Cathartics|cathartics|mesh-ancestor
24823795|NCT02119000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24823796|NCT02119000|Laxatives|laxatives|mesh-ancestor
24692546|NCT01415128|Omeprazole|omeprazole|mesh-list
24423311|NCT00225433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423312|NCT00225433|Hormone Antagonists|hormone antagonists|mesh-ancestor
24423313|NCT00225485|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24423314|NCT00225485|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24423315|NCT00225485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25849537|NCT00048802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24423316|NCT00225485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24423317|NCT00225485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423319|NCT00225485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423320|NCT00225485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24423321|NCT00225485|Antidepressive Agents|antidepressive agents|mesh-ancestor
24423322|NCT00225485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24423323|NCT00225511|Milnacipran|milnacipran|mesh-list
24423327|NCT00225511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24423339|NCT00225524|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24423340|NCT00225524|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24423341|NCT00225524|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24423342|NCT00225524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25409040|NCT03404180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24423343|NCT00225524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423344|NCT00225524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24423345|NCT00225524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423346|NCT00225524|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24423347|NCT00225524|Antidepressive Agents|antidepressive agents|mesh-ancestor
24423348|NCT00225524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24423349|NCT00225589|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24423351|NCT00225589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24423352|NCT00225589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423353|NCT00225589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24423354|NCT00225589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24423356|NCT00225589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423357|NCT00225589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24423358|NCT00225589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24423359|NCT00225589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423360|NCT00225615|Verapamil|verapamil|mesh-list
24423361|NCT00225615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24423362|NCT00225615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24423363|NCT00225615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24423364|NCT00225615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423365|NCT00225615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24823797|NCT02119039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24423395|NCT00225849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24423396|NCT00225849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24423398|NCT00225849|Sensory System Agents|sensory system agents|mesh-ancestor
24423399|NCT00225849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24423400|NCT00225849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423401|NCT00225849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24423402|NCT00225849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24423403|NCT00225849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24423404|NCT00225849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24423405|NCT00225849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423406|NCT00225849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24823820|NCT02119234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823821|NCT02119234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24823822|NCT02119234|Respiratory System Agents|respiratory system agents|mesh-ancestor
24823823|NCT02119234|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25849538|NCT00048802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24823861|NCT02119520|Antimetabolites|antimetabolites|mesh-ancestor
24823862|NCT02119520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823863|NCT02119520|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24426521|NCT00236249|Lidocaine|lidocaine|mesh-list
24823864|NCT02119520|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24823865|NCT02119520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580198|NCT00861016|Sympatholytics|sympatholytics|mesh-ancestor
24823866|NCT02119806|Fentanyl|fentanyl|mesh-list
24823867|NCT02119806|Midazolam|midazolam|mesh-list
24823868|NCT02119806|Propofol|propofol|mesh-list
24823869|NCT02119806|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24423435|NCT00225914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24823892|NCT02119884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24823893|NCT02119884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823894|NCT02119884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24823895|NCT02119884|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24823896|NCT02120066|Plasminogen|plasminogen|mesh-list
24823897|NCT02120066|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24823898|NCT02120066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24823899|NCT02120066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24823910|NCT02120092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823911|NCT02120118|Docetaxel|docetaxel|mesh-list
24823912|NCT02120118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823913|NCT02120118|Tubulin Modulators|tubulin modulators|mesh-ancestor
24823914|NCT02120118|Antimitotic Agents|antimitotic agents|mesh-ancestor
24823915|NCT02120118|Mitosis Modulators|mitosis modulators|mesh-ancestor
24823916|NCT02120118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823917|NCT02120196|Rifaximin|rifaximin|mesh-list
24823918|NCT02120196|Norfloxacin|norfloxacin|mesh-list
24823919|NCT02120196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24823920|NCT02120196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24823921|NCT02120196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24823922|NCT02120196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24823923|NCT02120196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24938661|NCT04017598|Iron|iron|mesh-list
24823924|NCT02120196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823925|NCT02120196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823926|NCT02120196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24423496|NCT00226096|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24423497|NCT00226096|Serotonin Agents|serotonin agents|mesh-ancestor
24423499|NCT00226096|Protease Inhibitors|protease inhibitors|mesh-ancestor
24423531|NCT00226135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24423532|NCT00226135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24423533|NCT00226135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24423534|NCT00226135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24423535|NCT00226135|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24423536|NCT00226200|Omalizumab|omalizumab|mesh-list
24423537|NCT00226200|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24423538|NCT00226200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24423539|NCT00226200|Respiratory System Agents|respiratory system agents|mesh-ancestor
24423540|NCT00226317|Aripiprazole|aripiprazole|mesh-list
24423541|NCT00226317|Antidepressive Agents|antidepressive agents|mesh-ancestor
24423542|NCT00226317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24423543|NCT00226317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24423544|NCT00226317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24423545|NCT00226317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24423546|NCT00226317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823931|NCT02120274|Vitamin B 12|vitamin b 12|mesh-list
24823932|NCT02120274|Hydroxocobalamin|hydroxocobalamin|mesh-list
24823933|NCT02120274|Micronutrients|micronutrients|mesh-ancestor
24823934|NCT02120274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823935|NCT02120274|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24823936|NCT02120274|Vitamin B Complex|vitamin b complex|mesh-ancestor
24823937|NCT02120274|Hematinics|hematinics|mesh-ancestor
24823938|NCT02120339|Carvedilol|carvedilol|mesh-list
24823939|NCT02120339|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24823940|NCT02120339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24823941|NCT02120339|Adrenergic Agents|adrenergic agents|mesh-ancestor
24823942|NCT02120339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24823943|NCT02120339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823944|NCT02120339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823945|NCT02120339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24823946|NCT02120339|Antioxidants|antioxidants|mesh-ancestor
24823947|NCT02120339|Protective Agents|protective agents|mesh-ancestor
24823948|NCT02120339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24823949|NCT02120339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24823950|NCT02120339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24823951|NCT02120339|Vasodilator Agents|vasodilator agents|mesh-ancestor
24823952|NCT02120339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25166475|NCT04024761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823972|NCT02120599|Hematinics|hematinics|mesh-ancestor
24823973|NCT02120599|Vitamin B Complex|vitamin b complex|mesh-ancestor
24545745|NCT00694733|Estradiol|estradiol|mesh-list
24423589|NCT00226395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24423590|NCT00226395|Narcotics|narcotics|mesh-ancestor
24423591|NCT00226395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24423592|NCT00226395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423593|NCT00226395|Analgesics|analgesics|mesh-ancestor
25849539|NCT00048802|Antidepressive Agents|antidepressive agents|mesh-ancestor
24423594|NCT00226395|Sensory System Agents|sensory system agents|mesh-ancestor
24423595|NCT00226395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24823984|NCT02120638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24823985|NCT02120638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24823986|NCT02120651|Hemostatics|hemostatics|mesh-list
24823987|NCT02120651|Coagulants|coagulants|mesh-ancestor
24823988|NCT02120677|Itraconazole|itraconazole|mesh-list
24823989|NCT02120677|Antifungal Agents|antifungal agents|mesh-ancestor
24823990|NCT02120677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24823991|NCT02120677|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24823992|NCT02120677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24823993|NCT02120677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823994|NCT02120677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823995|NCT02120677|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24823996|NCT02120677|Hormone Antagonists|hormone antagonists|mesh-ancestor
24823997|NCT02120677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24823998|NCT02120677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823999|NCT02120677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24824001|NCT02120703|Gabapentin|gabapentin|mesh-list
25849540|NCT00048802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233282|NCT02577770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233283|NCT02577770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824002|NCT02120703|Analgesics|analgesics|mesh-ancestor
24824003|NCT02120703|Sensory System Agents|sensory system agents|mesh-ancestor
24824004|NCT02120703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24824005|NCT02120703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423608|NCT00226421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24423621|NCT00226447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24423622|NCT00226447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24423623|NCT00226447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24423632|NCT00226473|Alkylating Agents|alkylating agents|mesh-ancestor
24423633|NCT00226473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423634|NCT00226473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24423635|NCT00226473|Tubulin Modulators|tubulin modulators|mesh-ancestor
24423636|NCT00226473|Antimitotic Agents|antimitotic agents|mesh-ancestor
24423637|NCT00226473|Mitosis Modulators|mitosis modulators|mesh-ancestor
24423638|NCT00226512|Alemtuzumab|alemtuzumab|mesh-list
24423639|NCT00226512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24423640|NCT00226512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24423641|NCT00226538|Fluconazole|fluconazole|mesh-list
24423642|NCT00226538|Rifampin|rifampin|mesh-list
24423643|NCT00226538|Diclofenac|diclofenac|mesh-list
24423644|NCT00226538|Phenytoin|phenytoin|mesh-list
24423645|NCT00226538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24545781|NCT00694863|Cosyntropin|cosyntropin|mesh-list
24423672|NCT00226538|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24423673|NCT00226538|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24423674|NCT00226538|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24423675|NCT00226538|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24423677|NCT00226538|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24423678|NCT00226538|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24423679|NCT00226538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24423680|NCT00226538|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24423681|NCT00226551|Isoproterenol|isoproterenol|mesh-list
24423728|NCT00226707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423729|NCT00226707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24423730|NCT00226707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24423731|NCT00226707|Dermatologic Agents|dermatologic agents|mesh-ancestor
24423732|NCT00226707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25849541|NCT00048802|Antimanic Agents|antimanic agents|mesh-ancestor
24423733|NCT00226707|Immunologic Factors|immunologic factors|mesh-ancestor
24423734|NCT00226707|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24423735|NCT00226707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423736|NCT00226707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423738|NCT00226746|Paclitaxel|paclitaxel|mesh-list
24824025|NCT02120859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423754|NCT00226785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24423755|NCT00226785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24423756|NCT00226785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423757|NCT00226785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24423758|NCT00226785|Analgesics|analgesics|mesh-ancestor
24423759|NCT00226785|Sensory System Agents|sensory system agents|mesh-ancestor
24423760|NCT00226785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24423761|NCT00226785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24423762|NCT00226785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24423763|NCT00226785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24423764|NCT00226785|Adrenergic Agents|adrenergic agents|mesh-ancestor
24423765|NCT00226785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24423766|NCT00226785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423767|NCT00226798|Capecitabine|capecitabine|mesh-list
24824034|NCT02120911|Trastuzumab|trastuzumab|mesh-list
24824036|NCT02120911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24824037|NCT02120911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24824038|NCT02121119|Lidocaine|lidocaine|mesh-list
24824039|NCT02121119|Bupivacaine|bupivacaine|mesh-list
24824040|NCT02121119|Anesthetics, Local|anesthetics, local|mesh-ancestor
24824041|NCT02121119|Anesthetics|anesthetics|mesh-ancestor
25849542|NCT00048802|Anticonvulsants|anticonvulsants|mesh-ancestor
25849543|NCT00048802|GABA Agents|gaba agents|mesh-ancestor
24423777|NCT00226824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24423778|NCT00226824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662135|NCT01641809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25662136|NCT01641809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25849544|NCT00048828|Olanzapine|olanzapine|mesh-list
24423779|NCT00226824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24423784|NCT00226837|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24423785|NCT00226837|Anesthetics, General|anesthetics, general|mesh-ancestor
24423786|NCT00226837|Anesthetics|anesthetics|mesh-ancestor
24423787|NCT00226837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24423788|NCT00226837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423789|NCT00226837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24423790|NCT00226837|Analgesics|analgesics|mesh-ancestor
24423791|NCT00226837|Sensory System Agents|sensory system agents|mesh-ancestor
24423792|NCT00226837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24571565|NCT00810862|Lactitol|lactitol|mesh-list
24423794|NCT00226889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24423795|NCT00226889|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24423796|NCT00226889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423797|NCT00226902|Chrysarobin|chrysarobin|mesh-list
24423831|NCT00226980|Leprostatic Agents|leprostatic agents|mesh-ancestor
24824056|NCT02121197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824057|NCT02121197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24824058|NCT02121197|Glucocorticoids|glucocorticoids|mesh-ancestor
24824059|NCT02121197|Hormones|hormones|mesh-ancestor
24423869|NCT00227188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24423870|NCT00227188|Immunologic Factors|immunologic factors|mesh-ancestor
24423871|NCT00227188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423872|NCT00227253|Hormones|hormones|mesh-list
24423873|NCT00227253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24423874|NCT00227253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423875|NCT00227292|Citalopram|citalopram|mesh-list
24423876|NCT00227292|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24423877|NCT00227292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24423878|NCT00227292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25849545|NCT00048828|Clozapine|clozapine|mesh-list
25849546|NCT00048828|Antiemetics|antiemetics|mesh-ancestor
25849547|NCT00048828|Autonomic Agents|autonomic agents|mesh-ancestor
25849548|NCT00048828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25849549|NCT00048828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849550|NCT00048828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25849551|NCT00048828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25849552|NCT00048828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25849553|NCT00048828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24927930|NCT04127916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927931|NCT04127916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24927932|NCT04127916|Alkylating Agents|alkylating agents|mesh-ancestor
25849554|NCT00048828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24423898|NCT00227357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24423899|NCT00227357|Narcotics|narcotics|mesh-ancestor
24423900|NCT00227357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24693276|NCT01419353|Estradiol|estradiol|mesh-list
24423917|NCT00227409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423918|NCT00227409|Antidotes|antidotes|mesh-ancestor
24423919|NCT00227409|Protective Agents|protective agents|mesh-ancestor
24423920|NCT00227409|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24423921|NCT00227448|Phenylephrine|phenylephrine|mesh-list
24423922|NCT00227448|Oxymetazoline|oxymetazoline|mesh-list
24423923|NCT00227448|Midodrine|midodrine|mesh-list
24423924|NCT00227448|Norepinephrine|norepinephrine|mesh-list
24423925|NCT00227448|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24423926|NCT00227448|Mydriatics|mydriatics|mesh-ancestor
24423927|NCT00227448|Autonomic Agents|autonomic agents|mesh-ancestor
24423928|NCT00227448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24423929|NCT00227448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423964|NCT00227565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423965|NCT00227565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423966|NCT00227565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24423967|NCT00227565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24423968|NCT00227630|Pemetrexed|pemetrexed|mesh-list
24423969|NCT00227630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24423970|NCT00227630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824112|NCT02121782|Immunologic Factors|immunologic factors|mesh-ancestor
24824113|NCT02121782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824115|NCT02121951|Fentanyl|fentanyl|mesh-list
24824116|NCT02121951|Midazolam|midazolam|mesh-list
24824117|NCT02121951|Anesthetics|anesthetics|mesh-list
24824118|NCT02121951|Levobupivacaine|levobupivacaine|mesh-list
24824119|NCT02121951|Anesthetics, Local|anesthetics, local|mesh-list
24824120|NCT02121951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24824121|NCT02121951|Narcotics|narcotics|mesh-ancestor
25849555|NCT00048828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24824122|NCT02121951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24693334|NCT01419691|Auranofin|auranofin|mesh-list
24423971|NCT00227630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423972|NCT00227630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24423973|NCT00227630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24423974|NCT00227656|Interferons|interferons|mesh-list
24824125|NCT02121951|Sensory System Agents|sensory system agents|mesh-ancestor
24824126|NCT02121951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24824127|NCT02121951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24424079|NCT00227812|Dopamine Agents|dopamine agents|mesh-ancestor
24424080|NCT00227812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25849556|NCT00048828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25849557|NCT00048828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25849558|NCT00048828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849559|NCT00048828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25849560|NCT00048828|Serotonin Agents|serotonin agents|mesh-ancestor
25849561|NCT00048828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24424112|NCT00227981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24424113|NCT00227981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424114|NCT00227981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25166476|NCT04024761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25166477|NCT04024761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24424115|NCT00227981|Serotonin Agents|serotonin agents|mesh-ancestor
24424117|NCT00227981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24424156|NCT00228033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24424157|NCT00228046|Valproic Acid|valproic acid|mesh-list
24424158|NCT00228046|Methylphenidate|methylphenidate|mesh-list
24424159|NCT00228046|Amphetamine|amphetamine|mesh-list
24424160|NCT00228046|Dextroamphetamine|dextroamphetamine|mesh-list
25849562|NCT00048828|GABA Antagonists|gaba antagonists|mesh-ancestor
25849563|NCT00048828|GABA Agents|gaba agents|mesh-ancestor
25849564|NCT00048841|Alendronate|alendronate|mesh-list
25849565|NCT00048841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25849566|NCT00048841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424162|NCT00228046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424163|NCT00228046|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24424164|NCT00228046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24424168|NCT00228046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24424169|NCT00228046|Sympathomimetics|sympathomimetics|mesh-ancestor
24424170|NCT00228046|Autonomic Agents|autonomic agents|mesh-ancestor
24424171|NCT00228046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24424172|NCT00228046|Adrenergic Agents|adrenergic agents|mesh-ancestor
24424173|NCT00228046|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24424175|NCT00228046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24424176|NCT00228046|GABA Agents|gaba agents|mesh-ancestor
25849567|NCT00048854|Sertraline|sertraline|mesh-list
25849568|NCT00048854|Antidepressive Agents|antidepressive agents|mesh-ancestor
24424201|NCT00228267|Anesthetics, General|anesthetics, general|mesh-ancestor
24424202|NCT00228267|Anesthetics|anesthetics|mesh-ancestor
24424203|NCT00228319|Vitamins|vitamins|mesh-list
24424204|NCT00228319|Ascorbic Acid|ascorbic acid|mesh-list
24424205|NCT00228319|Vitamin E|vitamin e|mesh-list
24424206|NCT00228319|Vitamin A|vitamin a|mesh-list
24424207|NCT00228319|Carboplatin|carboplatin|mesh-list
24424208|NCT00228319|Carotenoids|carotenoids|mesh-list
24424209|NCT00228319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424210|NCT00228319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424211|NCT00228319|Micronutrients|micronutrients|mesh-ancestor
24424212|NCT00228319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824174|NCT02122055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24824175|NCT02122055|Analgesics|analgesics|mesh-ancestor
24580603|NCT00862472|Timolol|timolol|mesh-list
24824176|NCT02122055|Sensory System Agents|sensory system agents|mesh-ancestor
24824177|NCT02122055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24824178|NCT02122055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24824180|NCT02122055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24824181|NCT02122055|Adrenergic Agents|adrenergic agents|mesh-ancestor
24693507|NCT01420900|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25849569|NCT00048854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24424242|NCT00228410|Tigecycline|tigecycline|mesh-list
24424243|NCT00228410|Aztreonam|aztreonam|mesh-list
24424254|NCT00228462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24424255|NCT00228462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424256|NCT00228475|Budesonide|budesonide|mesh-list
24424257|NCT00228475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24424258|NCT00228475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24424259|NCT00228475|Autonomic Agents|autonomic agents|mesh-ancestor
25233305|NCT02577250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25233306|NCT02577250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424260|NCT00228475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24424261|NCT00228475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424262|NCT00228475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24424264|NCT00228475|Glucocorticoids|glucocorticoids|mesh-ancestor
24424277|NCT00228514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24824195|NCT02122081|Thymoglobulin|thymoglobulin|mesh-list
24824196|NCT02122081|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24824197|NCT02122081|Immunoglobulins|immunoglobulins|mesh-list
24824198|NCT02122081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24824199|NCT02122081|Immunologic Factors|immunologic factors|mesh-ancestor
24824200|NCT02122081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824201|NCT02122081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24824202|NCT02122081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24824203|NCT02122081|Alkylating Agents|alkylating agents|mesh-ancestor
24824204|NCT02122081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824205|NCT02122081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24824206|NCT02122081|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24824207|NCT02122081|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24824208|NCT02122081|Abortifacient Agents|abortifacient agents|mesh-ancestor
24824209|NCT02122081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24824210|NCT02122081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24824211|NCT02122081|Antimetabolites|antimetabolites|mesh-ancestor
24824212|NCT02122081|Dermatologic Agents|dermatologic agents|mesh-ancestor
24824216|NCT02122081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24824217|NCT02122172|Afatinib|afatinib|mesh-list
24824218|NCT02122172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24824219|NCT02122172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24824220|NCT02122172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824221|NCT02122172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824253|NCT02122510|Sensory System Agents|sensory system agents|mesh-ancestor
24426522|NCT00236249|Anesthetics, Local|anesthetics, local|mesh-ancestor
24824257|NCT02122510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24824258|NCT02122510|Adrenergic Agents|adrenergic agents|mesh-ancestor
24424278|NCT00228514|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24424279|NCT00228514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24424280|NCT00228527|Esomeprazole|esomeprazole|mesh-list
24424281|NCT00228527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24424348|NCT00228930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24424349|NCT00228930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424350|NCT00228930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24424352|NCT00228930|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24424353|NCT00228930|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24424354|NCT00228930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25849570|NCT00048854|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24424356|NCT00228982|Ceftobiprole|ceftobiprole|mesh-list
24424357|NCT00228982|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
24424358|NCT00228982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24424359|NCT00228982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24424360|NCT00228995|Epoetin Alfa|epoetin alfa|mesh-list
24424361|NCT00228995|Hematinics|hematinics|mesh-ancestor
24424362|NCT00229060|Doripenem|doripenem|mesh-list
24424363|NCT00229060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24424364|NCT00229060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24424365|NCT00229112|Tazobactam|tazobactam|mesh-list
24424366|NCT00229112|Piperacillin|piperacillin|mesh-list
24424367|NCT00229112|Ertapenem|ertapenem|mesh-list
24424368|NCT00229112|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24424369|NCT00229112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424370|NCT00229112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24424371|NCT00229112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24424379|NCT00229125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424380|NCT00229125|Anticonvulsants|anticonvulsants|mesh-ancestor
24424381|NCT00229125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24424382|NCT00229125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25849571|NCT00048854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25849572|NCT00048854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24424383|NCT00229125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24424384|NCT00229125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24424385|NCT00229125|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25662137|NCT01641809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25662138|NCT01641809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876129|NCT03907488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25876130|NCT03907488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24424386|NCT00229125|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24424387|NCT00229125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24424388|NCT00229125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424389|NCT00229125|Antimanic Agents|antimanic agents|mesh-ancestor
24424390|NCT00229125|Antiemetics|antiemetics|mesh-ancestor
24424391|NCT00229125|Autonomic Agents|autonomic agents|mesh-ancestor
24424392|NCT00229125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24424393|NCT00229125|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24424394|NCT00229125|GABA Modulators|gaba modulators|mesh-ancestor
24424395|NCT00229125|GABA Agents|gaba agents|mesh-ancestor
24424396|NCT00229138|Tacrolimus|tacrolimus|mesh-list
24424397|NCT00229138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24424398|NCT00229138|Immunologic Factors|immunologic factors|mesh-ancestor
24424399|NCT00229138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424400|NCT00229138|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24424445|NCT00229424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424446|NCT00229424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424448|NCT00229450|Hormones|hormones|mesh-ancestor
24424449|NCT00229450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24424450|NCT00229450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424451|NCT00229476|Sertraline|sertraline|mesh-list
24424452|NCT00229476|Antidepressive Agents|antidepressive agents|mesh-ancestor
24424453|NCT00229476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24424454|NCT00229476|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24424455|NCT00229476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24424489|NCT00229528|Serotonin Agents|serotonin agents|mesh-ancestor
24424490|NCT00229528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424493|NCT00229528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24424494|NCT00229528|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24424495|NCT00229528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25876131|NCT03907488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24424518|NCT00229593|Testosterone|testosterone|mesh-list
24424519|NCT00229593|Androgens|androgens|mesh-ancestor
24424520|NCT00229593|Hormones|hormones|mesh-ancestor
24424521|NCT00229593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24424522|NCT00229593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424695|NCT00230451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24424696|NCT00230451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24424697|NCT00230451|Immunologic Factors|immunologic factors|mesh-ancestor
24424698|NCT00230451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424699|NCT00230464|Vildagliptin|vildagliptin|mesh-list
24424700|NCT00230464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24824296|NCT02122692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24824297|NCT02122692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24824298|NCT02122692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824299|NCT02122692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824300|NCT02122692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24824301|NCT02122692|Hormone Antagonists|hormone antagonists|mesh-ancestor
24824302|NCT02122692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24694050|NCT01423539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24424701|NCT00230464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166485|NCT03993132|Empagliflozin|empagliflozin|mesh-list
24424705|NCT00230464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424707|NCT00230477|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
24424708|NCT00230477|Adefovir|adefovir|mesh-list
24424709|NCT00230477|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24424710|NCT00230477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25662139|NCT01641809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662140|NCT01641809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25662141|NCT01641809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25662142|NCT01641809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25662143|NCT01641809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25662144|NCT01641809|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25662145|NCT01641809|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25662146|NCT01641809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24424711|NCT00230477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24871698|NCT05072444|QPX7728|qpx7728|mesh-list
24424712|NCT00230477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009334|NCT02054104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24424714|NCT00230477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24424715|NCT00230477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24424716|NCT00230477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24424717|NCT00230490|Adefovir|adefovir|mesh-list
24424718|NCT00230490|Pradefovir|pradefovir|mesh-list
24424719|NCT00230490|Antiviral Agents|antiviral agents|mesh-ancestor
24424720|NCT00230490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24424721|NCT00230490|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24424722|NCT00230490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24424723|NCT00230490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849573|NCT00048854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849574|NCT00048854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25849575|NCT00048854|Serotonin Agents|serotonin agents|mesh-ancestor
25849576|NCT00048854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424746|NCT00230542|Pemetrexed|pemetrexed|mesh-list
24424747|NCT00230542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424748|NCT00230542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24424749|NCT00230542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424750|NCT00230542|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24424770|NCT00230763|Timolol|timolol|mesh-list
24424771|NCT00230763|Latanoprost|latanoprost|mesh-list
24424772|NCT00230763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24424773|NCT00230763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24424774|NCT00230763|Adrenergic Agents|adrenergic agents|mesh-ancestor
24424775|NCT00230763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24424776|NCT00230763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849577|NCT00048880|Antibodies|antibodies|mesh-list
24824307|NCT02122705|Narcotics|narcotics|mesh-ancestor
24824308|NCT02122705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24824309|NCT02122705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824310|NCT02122705|Analgesics|analgesics|mesh-ancestor
24824311|NCT02122705|Sensory System Agents|sensory system agents|mesh-ancestor
24824312|NCT02122705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24824313|NCT02122731|Amiloride|amiloride|mesh-list
24424825|NCT00230958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424826|NCT00230984|Methyltestosterone|methyltestosterone|mesh-list
24424827|NCT00230984|Testosterone|testosterone|mesh-list
24424828|NCT00230984|Testosterone undecanoate|testosterone undecanoate|mesh-list
24424829|NCT00230984|Testosterone enanthate|testosterone enanthate|mesh-list
24424830|NCT00230984|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24424848|NCT00230997|Nootropic Agents|nootropic agents|mesh-ancestor
24424849|NCT00231023|Triamcinolone|triamcinolone|mesh-list
24424850|NCT00231023|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24424851|NCT00231023|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24424852|NCT00231023|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24424853|NCT00231023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24424854|NCT00231023|Glucocorticoids|glucocorticoids|mesh-ancestor
24424855|NCT00231023|Hormones|hormones|mesh-ancestor
24424856|NCT00231023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24424857|NCT00231023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424858|NCT00231023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24424859|NCT00231023|Immunologic Factors|immunologic factors|mesh-ancestor
24424860|NCT00231023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24424861|NCT00231023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424862|NCT00231075|Paclitaxel|paclitaxel|mesh-list
24424863|NCT00231075|Carboplatin|carboplatin|mesh-list
24424864|NCT00231075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24824315|NCT02122731|Natriuretic Agents|natriuretic agents|mesh-ancestor
24824316|NCT02122731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824317|NCT02122731|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24824318|NCT02122731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24424878|NCT00231140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24424879|NCT00231140|Immunologic Factors|immunologic factors|mesh-ancestor
24424880|NCT00231140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424881|NCT00231140|Leprostatic Agents|leprostatic agents|mesh-ancestor
24424882|NCT00231140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24424883|NCT00231140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24424884|NCT00231140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24424885|NCT00231140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24424886|NCT00231140|Growth Substances|growth substances|mesh-ancestor
24424887|NCT00231140|Growth Inhibitors|growth inhibitors|mesh-ancestor
24424888|NCT00231140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424889|NCT00231192|Repaglinide|repaglinide|mesh-list
24424890|NCT00231192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24424891|NCT00231192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424892|NCT00231218|Ascorbic Acid|ascorbic acid|mesh-list
24424894|NCT00231218|Vitamins|vitamins|mesh-ancestor
24424895|NCT00231218|Micronutrients|micronutrients|mesh-ancestor
24424896|NCT00231218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424950|NCT00231452|Antiviral Agents|antiviral agents|mesh-ancestor
24424970|NCT00231517|Morphine|morphine|mesh-list
25849578|NCT00048880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24824320|NCT02122731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580725|NCT00863395|Sensory System Agents|sensory system agents|mesh-ancestor
24580732|NCT00863460|Cytarabine|cytarabine|mesh-list
24824321|NCT02122731|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24824322|NCT02122731|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24824323|NCT02122809|Chiauranib|chiauranib|mesh-list
24824324|NCT02122809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694241|NCT01424618|Fertility Agents|fertility agents|mesh-ancestor
24424989|NCT00231569|Antimetabolites|antimetabolites|mesh-ancestor
24424990|NCT00231569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573112|NCT00817895|Immunologic Factors|immunologic factors|mesh-ancestor
24424991|NCT00231569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24424992|NCT00231582|Paclitaxel|paclitaxel|mesh-list
24424993|NCT00231582|Etoposide|etoposide|mesh-list
24424994|NCT00231582|Carboplatin|carboplatin|mesh-list
24424995|NCT00231582|Epirubicin|epirubicin|mesh-list
24424996|NCT00231582|Ifosfamide|ifosfamide|mesh-list
24424997|NCT00231582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24424998|NCT00231582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24425049|NCT00231829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24425050|NCT00231829|Analgesics|analgesics|mesh-ancestor
24425051|NCT00231829|Sensory System Agents|sensory system agents|mesh-ancestor
24425052|NCT00231829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24425053|NCT00231829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425054|NCT00231829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24425055|NCT00231829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24425068|NCT00231855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24425069|NCT00231855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24425096|NCT00232011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24425097|NCT00232011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24425098|NCT00232011|Analgesics|analgesics|mesh-ancestor
24425099|NCT00232011|Sensory System Agents|sensory system agents|mesh-ancestor
24425100|NCT00232011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24425101|NCT00232011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425102|NCT00232011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24425103|NCT00232011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24425104|NCT00232011|Dermatologic Agents|dermatologic agents|mesh-ancestor
24425105|NCT00232011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24425106|NCT00232011|Immunologic Factors|immunologic factors|mesh-ancestor
24425131|NCT00232063|Immunologic Factors|immunologic factors|mesh-ancestor
24425132|NCT00232063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425133|NCT00232063|Antifungal Agents|antifungal agents|mesh-ancestor
24425134|NCT00232063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24425135|NCT00232063|Dermatologic Agents|dermatologic agents|mesh-ancestor
24425136|NCT00232063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24425137|NCT00232063|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24824325|NCT02122809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24824327|NCT02122809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824328|NCT02122939|Citalopram|citalopram|mesh-list
24824329|NCT02122939|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24824330|NCT02122939|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24824331|NCT02122939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24824332|NCT02122939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694381|NCT01425320|Analgesics|analgesics|mesh-ancestor
24425215|NCT00232284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425216|NCT00232336|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24425217|NCT00232336|Antidepressive Agents|antidepressive agents|mesh-ancestor
24425218|NCT00232336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24425219|NCT00232336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24425220|NCT00232336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24425221|NCT00232336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24425222|NCT00232336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425223|NCT00232349|Galantamine|galantamine|mesh-list
24425224|NCT00232349|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24425225|NCT00232349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24425226|NCT00232349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425227|NCT00232349|Cholinergic Agents|cholinergic agents|mesh-ancestor
24472278|NCT00398697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24425228|NCT00232349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25849579|NCT00048880|Immunologic Factors|immunologic factors|mesh-ancestor
24425281|NCT00232622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24425282|NCT00232622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24425283|NCT00232622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425285|NCT00232648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24425286|NCT00232648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24425293|NCT00232648|Hormones|hormones|mesh-ancestor
25849580|NCT00048880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876132|NCT03907488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876133|NCT03907488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876134|NCT03907488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24425448|NCT00233038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24425449|NCT00233038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24425450|NCT00233038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425451|NCT00233051|Fluticasone|fluticasone|mesh-list
24425452|NCT00233051|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24425453|NCT00233051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24425454|NCT00233051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24425455|NCT00233051|Autonomic Agents|autonomic agents|mesh-ancestor
24425456|NCT00233051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24425473|NCT00233155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425474|NCT00233337|Artemether|artemether|mesh-list
24425521|NCT00233571|Adalimumab|adalimumab|mesh-list
24425522|NCT00233571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24425523|NCT00233571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24425524|NCT00233584|Budesonide|budesonide|mesh-list
24824336|NCT02122939|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24694492|NCT01425736|Cisplatin|cisplatin|mesh-list
24426523|NCT00236249|Anesthetics|anesthetics|mesh-ancestor
24425555|NCT00233623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24425556|NCT00233623|Immunologic Factors|immunologic factors|mesh-ancestor
24425606|NCT00233779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24425607|NCT00233779|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24425608|NCT00233779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24425609|NCT00233779|Antifungal Agents|antifungal agents|mesh-ancestor
24425610|NCT00233779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24425611|NCT00233779|Immunologic Factors|immunologic factors|mesh-ancestor
24425612|NCT00233779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425613|NCT00233779|Anticoagulants|anticoagulants|mesh-ancestor
24425614|NCT00233779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24425646|NCT00233883|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24425647|NCT00233883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425649|NCT00233883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24425650|NCT00233883|Antiviral Agents|antiviral agents|mesh-ancestor
24425651|NCT00233883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24425652|NCT00233896|Beclomethasone|beclomethasone|mesh-list
24425653|NCT00233896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24425654|NCT00233896|Glucocorticoids|glucocorticoids|mesh-ancestor
24425655|NCT00233896|Hormones|hormones|mesh-ancestor
24425656|NCT00233896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24425657|NCT00233896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425658|NCT00233896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24425659|NCT00233896|Respiratory System Agents|respiratory system agents|mesh-ancestor
24425660|NCT00233909|Gemtuzumab|gemtuzumab|mesh-list
24425661|NCT00233909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24425662|NCT00233909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24425663|NCT00233935|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24425664|NCT00233935|Antioxidants|antioxidants|mesh-ancestor
24425665|NCT00233935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425666|NCT00233935|Protective Agents|protective agents|mesh-ancestor
24425734|NCT00234182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24425736|NCT00234182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409188|NCT03395197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25662147|NCT01641809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25662148|NCT01641809|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25662149|NCT01641809|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25662150|NCT01641822|Tobramycin|tobramycin|mesh-list
25662151|NCT01641822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25662152|NCT01641822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25662153|NCT01641900|Eszopiclone|eszopiclone|mesh-list
25662154|NCT01641900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25662155|NCT01641900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25662156|NCT01641900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425738|NCT00234195|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24425739|NCT00234195|Antidepressive Agents|antidepressive agents|mesh-ancestor
24425740|NCT00234195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24425741|NCT00234195|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24425742|NCT00234195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24425743|NCT00234195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24425744|NCT00234195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824341|NCT02123004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24824342|NCT02123004|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24425831|NCT00234429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24425832|NCT00234429|Antimetabolites|antimetabolites|mesh-ancestor
24425833|NCT00234429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24425834|NCT00234442|Gefitinib|gefitinib|mesh-list
25849581|NCT00048945|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25849582|NCT00048945|Antiviral Agents|antiviral agents|mesh-ancestor
24425852|NCT00234468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425853|NCT00234507|Botulinum Toxins|botulinum toxins|mesh-list
24425854|NCT00234507|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24425855|NCT00234507|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24425856|NCT00234507|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24425857|NCT00234507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24425858|NCT00234507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425873|NCT00234546|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24425874|NCT00234546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24425875|NCT00234572|Lanreotide|lanreotide|mesh-list
24425876|NCT00234572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24425877|NCT00234598|Chlorhexidine|chlorhexidine|mesh-list
24824347|NCT02123004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824348|NCT02123004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425893|NCT00234637|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24425894|NCT00234637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24425895|NCT00234637|Cholinergic Agents|cholinergic agents|mesh-ancestor
24425896|NCT00234637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24425897|NCT00234637|Protective Agents|protective agents|mesh-ancestor
24425898|NCT00234676|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24425899|NCT00234676|Estrogens|estrogens|mesh-ancestor
24425900|NCT00234676|Hormones|hormones|mesh-ancestor
24425913|NCT00234819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24425915|NCT00234819|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24425916|NCT00234819|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24425917|NCT00234819|Hormone Antagonists|hormone antagonists|mesh-ancestor
24425918|NCT00234819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24425920|NCT00234845|Methotrexate|methotrexate|mesh-list
24425921|NCT00234845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24425922|NCT00234845|Abortifacient Agents|abortifacient agents|mesh-ancestor
24425923|NCT00234845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24425924|NCT00234845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425925|NCT00234845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24425926|NCT00234845|Antimetabolites|antimetabolites|mesh-ancestor
24425927|NCT00234845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425928|NCT00234845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24425929|NCT00234845|Dermatologic Agents|dermatologic agents|mesh-ancestor
24425943|NCT00234858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24425944|NCT00234858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24425945|NCT00234858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425947|NCT00234858|Natriuretic Agents|natriuretic agents|mesh-ancestor
24824360|NCT02123056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24425963|NCT00234871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24425964|NCT00234871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425965|NCT00234871|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24425967|NCT00234871|Vasodilator Agents|vasodilator agents|mesh-ancestor
24425968|NCT00234871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24425969|NCT00234871|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24425970|NCT00234871|Protease Inhibitors|protease inhibitors|mesh-ancestor
24425971|NCT00234871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24425973|NCT00234897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24425974|NCT00234897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24425975|NCT00234910|Ritonavir|ritonavir|mesh-list
24425976|NCT00234910|Lopinavir|lopinavir|mesh-list
24425977|NCT00234910|Tenofovir|tenofovir|mesh-list
24425978|NCT00234910|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24425979|NCT00234910|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24425980|NCT00234910|Protease Inhibitors|protease inhibitors|mesh-ancestor
24425981|NCT00234910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24426005|NCT00234923|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24426006|NCT00234923|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24426007|NCT00234923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24426008|NCT00234923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24426009|NCT00234923|Antimetabolites|antimetabolites|mesh-ancestor
24426010|NCT00234936|Adalimumab|adalimumab|mesh-list
24426011|NCT00234936|Methotrexate|methotrexate|mesh-list
24426085|NCT00235014|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24426086|NCT00235014|Protease Inhibitors|protease inhibitors|mesh-ancestor
24426087|NCT00235014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24426088|NCT00235014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24426089|NCT00235053|Fluticasone|fluticasone|mesh-list
24426090|NCT00235053|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24426091|NCT00235053|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24426092|NCT00235053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24426093|NCT00235053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24426094|NCT00235053|Autonomic Agents|autonomic agents|mesh-ancestor
24426095|NCT00235053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24426204|NCT00235248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24426205|NCT00235248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24426206|NCT00235248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24426207|NCT00235248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24426208|NCT00235248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426229|NCT00235261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24426230|NCT00235261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24426231|NCT00235261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24426233|NCT00235261|Sensory System Agents|sensory system agents|mesh-ancestor
24426234|NCT00235261|Anticonvulsants|anticonvulsants|mesh-ancestor
24426235|NCT00235261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24426236|NCT00235261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24426237|NCT00235261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426238|NCT00235261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24426239|NCT00235261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24426240|NCT00235261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24426241|NCT00235261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24426242|NCT00235261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24426244|NCT00235274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24426245|NCT00235274|Hormones|hormones|mesh-ancestor
24426246|NCT00235274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24426247|NCT00235274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849583|NCT00048945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25849584|NCT00049023|Octreotide|octreotide|mesh-list
25849585|NCT00049023|Edotreotide|edotreotide|mesh-list
24426430|NCT00236015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24426431|NCT00236015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426433|NCT00236028|Dermatologic Agents|dermatologic agents|mesh-ancestor
24426434|NCT00236028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24426435|NCT00236028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24426436|NCT00236054|Tiagabine|tiagabine|mesh-list
24426437|NCT00236054|Anticonvulsants|anticonvulsants|mesh-ancestor
24426438|NCT00236054|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
24426451|NCT00236067|GABA Agents|gaba agents|mesh-ancestor
24426452|NCT00236067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24426453|NCT00236067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426454|NCT00236093|Fentanyl|fentanyl|mesh-list
24426455|NCT00236093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24426456|NCT00236093|Narcotics|narcotics|mesh-ancestor
24426457|NCT00236093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24426458|NCT00236093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426459|NCT00236093|Analgesics|analgesics|mesh-ancestor
24426460|NCT00236093|Sensory System Agents|sensory system agents|mesh-ancestor
24426461|NCT00236093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24426462|NCT00236093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24426463|NCT00236093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24426464|NCT00236093|Anesthetics, General|anesthetics, general|mesh-ancestor
24426465|NCT00236093|Anesthetics|anesthetics|mesh-ancestor
24426466|NCT00236106|Mometasone Furoate|mometasone furoate|mesh-list
24426467|NCT00236106|Tacrolimus|tacrolimus|mesh-list
24426468|NCT00236106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24426469|NCT00236106|Immunologic Factors|immunologic factors|mesh-ancestor
24426470|NCT00236106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849586|NCT00049023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24426472|NCT00236106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24426473|NCT00236106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426474|NCT00236106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24426508|NCT00236223|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24426509|NCT00236223|Anesthetics, General|anesthetics, general|mesh-ancestor
24426510|NCT00236223|Anesthetics|anesthetics|mesh-ancestor
24426511|NCT00236223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24426512|NCT00236223|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24426513|NCT00236223|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24426514|NCT00236223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24426515|NCT00236223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426516|NCT00236223|Anticonvulsants|anticonvulsants|mesh-ancestor
24426517|NCT00236223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24426518|NCT00236223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24426519|NCT00236223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24426520|NCT00236223|Antimanic Agents|antimanic agents|mesh-ancestor
24426524|NCT00236249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24426545|NCT00236288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24426556|NCT00236301|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24426559|NCT00236301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24426560|NCT00236301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426561|NCT00236301|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24426567|NCT00236327|Narcotics|narcotics|mesh-ancestor
24426568|NCT00236327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24426569|NCT00236327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426570|NCT00236327|Analgesics|analgesics|mesh-ancestor
24426571|NCT00236327|Sensory System Agents|sensory system agents|mesh-ancestor
24426572|NCT00236327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24426573|NCT00236327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24426574|NCT00236327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24426575|NCT00236327|Anesthetics, General|anesthetics, general|mesh-ancestor
24426576|NCT00236327|Anesthetics|anesthetics|mesh-ancestor
24426577|NCT00236353|Risperidone|risperidone|mesh-list
24426578|NCT00236353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24426579|NCT00236353|Serotonin Agents|serotonin agents|mesh-ancestor
24426580|NCT00236353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24426581|NCT00236353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426582|NCT00236353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426583|NCT00236353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24426584|NCT00236353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24426585|NCT00236353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24426586|NCT00236353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24426587|NCT00236353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24426588|NCT00236353|Dopamine Agents|dopamine agents|mesh-ancestor
24426589|NCT00236366|Fentanyl|fentanyl|mesh-list
24426624|NCT00236392|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24426625|NCT00236392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24426626|NCT00236392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426627|NCT00236405|Epoetin Alfa|epoetin alfa|mesh-list
24426628|NCT00236405|Hematinics|hematinics|mesh-ancestor
24426630|NCT00236418|Anticonvulsants|anticonvulsants|mesh-ancestor
24426631|NCT00236418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24426632|NCT00236418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426633|NCT00236431|Galantamine|galantamine|mesh-list
24426660|NCT00236457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426661|NCT00236457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426662|NCT00236457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24426663|NCT00236457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24426664|NCT00236457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24426665|NCT00236457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24426666|NCT00236457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24426667|NCT00236457|Dopamine Agents|dopamine agents|mesh-ancestor
24426668|NCT00236470|Risperidone|risperidone|mesh-list
24426694|NCT00236496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426701|NCT00236522|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24824392|NCT02123121|Resveratrol|resveratrol|mesh-list
24580797|NCT00863668|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24580803|NCT00863733|Acetic Acid|acetic acid|mesh-list
24824393|NCT02123121|Antioxidants|antioxidants|mesh-ancestor
24824394|NCT02123121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824395|NCT02123121|Protective Agents|protective agents|mesh-ancestor
24824396|NCT02123121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580870|NCT00863902|Histamine Agents|histamine agents|mesh-ancestor
24824399|NCT02123264|Zoledronic Acid|zoledronic acid|mesh-list
24824400|NCT02123264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24824401|NCT02123264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824402|NCT02123355|Dexmedetomidine|dexmedetomidine|mesh-list
24824403|NCT02123355|Remifentanil|remifentanil|mesh-list
24426744|NCT00236561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426745|NCT00236561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426746|NCT00236561|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24426747|NCT00236561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24426748|NCT00236561|Vasodilator Agents|vasodilator agents|mesh-ancestor
24426749|NCT00236561|Anticonvulsants|anticonvulsants|mesh-ancestor
24426750|NCT00236561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24426751|NCT00236574|Galantamine|galantamine|mesh-list
24426752|NCT00236574|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24426753|NCT00236574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427303|NCT00237913|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24426797|NCT00236652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24426798|NCT00236652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24426799|NCT00236652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426800|NCT00236652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24426801|NCT00236652|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24426802|NCT00236652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24426804|NCT00236665|Anticonvulsants|anticonvulsants|mesh-ancestor
24426805|NCT00236665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24426806|NCT00236665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426807|NCT00236678|Epoetin Alfa|epoetin alfa|mesh-list
24426810|NCT00236691|Anticonvulsants|anticonvulsants|mesh-ancestor
24426811|NCT00236691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24426812|NCT00236691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426813|NCT00236704|Topiramate|topiramate|mesh-list
24824414|NCT02123355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24824415|NCT02123355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24824416|NCT02123355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24824417|NCT02123355|Adrenergic Agents|adrenergic agents|mesh-ancestor
24426815|NCT00236704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24426816|NCT00236704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426817|NCT00236717|Topiramate|topiramate|mesh-list
24426818|NCT00236717|Carbamazepine|carbamazepine|mesh-list
24426819|NCT00236717|Valproic Acid|valproic acid|mesh-list
24426820|NCT00236717|Anticonvulsants|anticonvulsants|mesh-ancestor
24426821|NCT00236717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24426822|NCT00236717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426823|NCT00236717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24426824|NCT00236717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849587|NCT00049023|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24426825|NCT00236717|GABA Agents|gaba agents|mesh-ancestor
24426846|NCT00236743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426847|NCT00236756|Topiramate|topiramate|mesh-list
24426848|NCT00236756|Anticonvulsants|anticonvulsants|mesh-ancestor
24426849|NCT00236756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24426850|NCT00236756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426851|NCT00236769|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24426852|NCT00236769|Norelgestromin|norelgestromin|mesh-list
24426853|NCT00236769|Estradiol|estradiol|mesh-list
24426854|NCT00236769|Estrogens|estrogens|mesh-ancestor
24426855|NCT00236769|Hormones|hormones|mesh-ancestor
24695332|NCT03771612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24426888|NCT00236795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24426889|NCT00236795|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24426890|NCT00236795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24426891|NCT00236795|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24426892|NCT00236795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24426893|NCT00236795|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
24426894|NCT00236795|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24426895|NCT00236795|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24426896|NCT00236808|Levofloxacin|levofloxacin|mesh-list
24426897|NCT00236808|Ofloxacin|ofloxacin|mesh-list
24426898|NCT00236808|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24426899|NCT00236808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24426900|NCT00236808|Renal Agents|renal agents|mesh-ancestor
25662157|NCT01641926|Interferons|interferons|mesh-list
25662158|NCT01641926|Interferon-alpha|interferon-alpha|mesh-list
24426904|NCT00236808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849588|NCT00049023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24426998|NCT00237133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426999|NCT00237133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24427000|NCT00237133|Hormone Antagonists|hormone antagonists|mesh-ancestor
24427001|NCT00237133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24427002|NCT00237133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427003|NCT00237146|Zoledronic Acid|zoledronic acid|mesh-list
24427004|NCT00237146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24427005|NCT00237146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427006|NCT00237159|Zoledronic Acid|zoledronic acid|mesh-list
24427007|NCT00237159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24427017|NCT00237198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24427020|NCT00237198|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25849589|NCT00049023|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25849590|NCT00049023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427031|NCT00237211|Hormone Antagonists|hormone antagonists|mesh-ancestor
24427032|NCT00237211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24427033|NCT00237211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427035|NCT00237224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427036|NCT00237224|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24427037|NCT00237224|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24427038|NCT00237224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146902|NCT02918591|Empagliflozin|empagliflozin|mesh-list
24427039|NCT00237224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427040|NCT00237224|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24427041|NCT00237224|Hormone Antagonists|hormone antagonists|mesh-ancestor
24427042|NCT00237224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24427043|NCT00237224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427156|NCT00237536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24427158|NCT00237536|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24427159|NCT00237536|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24427160|NCT00237536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24427218|NCT00237705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24824463|NCT02123524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824464|NCT02123524|Anticoagulants|anticoagulants|mesh-ancestor
24427219|NCT00237705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427221|NCT00237731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24427223|NCT00237731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24427237|NCT00237861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427253|NCT00237874|Antidepressive Agents|antidepressive agents|mesh-ancestor
24427254|NCT00237874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24427255|NCT00237874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24427256|NCT00237874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24427257|NCT00237874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24427258|NCT00237874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427259|NCT00237874|Dopamine Agonists|dopamine agonists|mesh-ancestor
24427260|NCT00237874|Dopamine Agents|dopamine agents|mesh-ancestor
24427261|NCT00237874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24427262|NCT00237874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427263|NCT00237874|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24427280|NCT00237900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24427281|NCT00237900|Immunologic Factors|immunologic factors|mesh-ancestor
24824466|NCT02123563|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24824467|NCT02123563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24824469|NCT02123589|Midazolam|midazolam|mesh-list
24824470|NCT02123589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24824471|NCT02123589|Narcotics|narcotics|mesh-ancestor
24824472|NCT02123589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24580937|NCT00864045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25662159|NCT01641926|Interferon alpha-2|interferon alpha-2|mesh-list
25662160|NCT01641926|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25662161|NCT01641926|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25662162|NCT01641926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063318|NCT02097121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063319|NCT02097121|Cholinergic Agents|cholinergic agents|mesh-ancestor
24805604|NCT02010970|Antifungal Agents|antifungal agents|mesh-ancestor
24805605|NCT02010970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24805606|NCT02010970|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24805607|NCT02010970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24427297|NCT00237913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427298|NCT00237913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427299|NCT00237913|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24427300|NCT00237913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24427301|NCT00237913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24427302|NCT00237913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24427308|NCT00237913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24427309|NCT00237913|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24427310|NCT00237913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24427311|NCT00237913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24427312|NCT00237913|Antidepressive Agents|antidepressive agents|mesh-ancestor
24427313|NCT00237913|Dopamine Agonists|dopamine agonists|mesh-ancestor
24427314|NCT00237913|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24427315|NCT00237913|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24427316|NCT00237913|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24547359|NCT00703625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427470|NCT00238225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24824481|NCT02123589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24427553|NCT00238368|Immunologic Factors|immunologic factors|mesh-ancestor
24427554|NCT00238368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427558|NCT00238368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824505|NCT02123628|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24824506|NCT02123628|Cefotaxime|cefotaxime|mesh-list
24824507|NCT02123628|Fusidic Acid|fusidic acid|mesh-list
24824508|NCT02123628|Trimethoprim|trimethoprim|mesh-list
24427644|NCT00238667|Warfarin|warfarin|mesh-list
24427645|NCT00238667|Anticoagulants|anticoagulants|mesh-list
24427680|NCT00238732|Estrogens|estrogens|mesh-list
24427681|NCT00238732|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24427682|NCT00238732|Hormones|hormones|mesh-ancestor
24427683|NCT00238732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24427684|NCT00238732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427685|NCT00238732|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24824542|NCT02123979|Dopamine Agonists|dopamine agonists|mesh-ancestor
24824543|NCT02123979|Dopamine Agents|dopamine agents|mesh-ancestor
24824544|NCT02123979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24824545|NCT02123979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824546|NCT02123979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824547|NCT02124005|Bupivacaine|bupivacaine|mesh-list
24824548|NCT02124005|Anesthetics, Local|anesthetics, local|mesh-ancestor
24824549|NCT02124005|Anesthetics|anesthetics|mesh-ancestor
24824550|NCT02124005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24427691|NCT00238745|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24427692|NCT00238745|Hormone Antagonists|hormone antagonists|mesh-ancestor
24427693|NCT00238745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24427694|NCT00238745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427695|NCT00238745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24427697|NCT00238784|Formoterol Fumarate|formoterol fumarate|mesh-list
24427698|NCT00238784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24427699|NCT00238784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24427700|NCT00238784|Autonomic Agents|autonomic agents|mesh-ancestor
25662163|NCT01641926|Antiviral Agents|antiviral agents|mesh-ancestor
25662164|NCT01641926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25662165|NCT01641926|Immunologic Factors|immunologic factors|mesh-ancestor
25662166|NCT01641926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662167|NCT01641939|Trastuzumab|trastuzumab|mesh-list
25662168|NCT01641939|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25662169|NCT01641939|Maytansine|maytansine|mesh-list
25662170|NCT01641939|Taxane|taxane|mesh-list
25662171|NCT01641939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25662172|NCT01641939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849591|NCT00049062|Gefitinib|gefitinib|mesh-list
24473196|NCT00402376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24427701|NCT00238784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24824637|NCT02124369|Tubulin Modulators|tubulin modulators|mesh-ancestor
24824638|NCT02124369|Antimitotic Agents|antimitotic agents|mesh-ancestor
24824639|NCT02124369|Mitosis Modulators|mitosis modulators|mesh-ancestor
24824640|NCT02124369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824641|NCT02124369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24824642|NCT02124369|Antimetabolites|antimetabolites|mesh-ancestor
24824643|NCT02124369|Antiviral Agents|antiviral agents|mesh-ancestor
24824644|NCT02124369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24824645|NCT02124369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824646|NCT02124369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24824647|NCT02124369|Immunologic Factors|immunologic factors|mesh-ancestor
24824648|NCT02124369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824658|NCT02124525|Acetylcysteine|acetylcysteine|mesh-list
24824659|NCT02124525|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24824667|NCT02124525|Protective Agents|protective agents|mesh-ancestor
24824668|NCT02124525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824669|NCT02124525|Antidotes|antidotes|mesh-ancestor
24824670|NCT02124642|Folic Acid|folic acid|mesh-list
24824671|NCT02124642|Vitamin B Complex|vitamin b complex|mesh-list
24824672|NCT02124642|Hematinics|hematinics|mesh-ancestor
24792731|NCT04755244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24824675|NCT02124642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824677|NCT02124655|Listerine|listerine|mesh-list
24824679|NCT02124655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24824680|NCT02124655|Disinfectants|disinfectants|mesh-ancestor
24824681|NCT02124681|Hydroxychloroquine|hydroxychloroquine|mesh-list
24824682|NCT02124681|Antimalarials|antimalarials|mesh-ancestor
24824683|NCT02124681|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24824684|NCT02124681|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24824685|NCT02124681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24824686|NCT02124681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824687|NCT02124681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824688|NCT02124681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24824724|NCT02125188|Hemostatics|hemostatics|mesh-ancestor
24824725|NCT02125188|Coagulants|coagulants|mesh-ancestor
24824726|NCT02125188|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24824727|NCT02125188|Natriuretic Agents|natriuretic agents|mesh-ancestor
24824728|NCT02125188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824729|NCT02125201|Fentanyl|fentanyl|mesh-list
24824730|NCT02125201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24824731|NCT02125201|Narcotics|narcotics|mesh-ancestor
24824732|NCT02125201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24824733|NCT02125201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824734|NCT02125201|Analgesics|analgesics|mesh-ancestor
24427760|NCT00238966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24427761|NCT00238966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427762|NCT00238966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24427763|NCT00238966|Antitubercular Agents|antitubercular agents|mesh-ancestor
24427764|NCT00238966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24427765|NCT00238966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24427766|NCT00238966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427767|NCT00238966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427768|NCT00238979|Mycophenolic Acid|mycophenolic acid|mesh-list
24427769|NCT00238979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24427770|NCT00238979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427771|NCT00238979|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24427772|NCT00238979|Antitubercular Agents|antitubercular agents|mesh-ancestor
24427773|NCT00238979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24427774|NCT00238979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24427775|NCT00238979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427776|NCT00238979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427795|NCT00239031|Mycophenolic Acid|mycophenolic acid|mesh-list
24824753|NCT02125305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24824754|NCT02125305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824755|NCT02125318|Anagrelide|anagrelide|mesh-list
24824756|NCT02125318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24824757|NCT02125318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24824758|NCT02125318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849592|NCT00049062|Anastrozole|anastrozole|mesh-list
24824759|NCT02125318|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25662173|NCT01641939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24427922|NCT00239291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24427924|NCT00239291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427925|NCT00239304|Gefitinib|gefitinib|mesh-list
24427927|NCT00239304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24427928|NCT00239304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849593|NCT00049062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849594|NCT00049062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24427929|NCT00239304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427930|NCT00239330|Atorvastatin|atorvastatin|mesh-list
24427931|NCT00239330|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24427932|NCT00239330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24427933|NCT00239330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24427934|NCT00239330|Antimetabolites|antimetabolites|mesh-ancestor
24427935|NCT00239330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427936|NCT00239330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24427937|NCT00239330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24427938|NCT00239330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427939|NCT00239343|Gefitinib|gefitinib|mesh-list
24427940|NCT00239343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427941|NCT00239343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24427942|NCT00239343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427943|NCT00239343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427944|NCT00239369|Telmisartan|telmisartan|mesh-list
24427945|NCT00239369|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24427946|NCT00239369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24824760|NCT02125344|Paclitaxel|paclitaxel|mesh-list
24427991|NCT00239408|Cholinergic Agents|cholinergic agents|mesh-ancestor
24427992|NCT00239408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25849595|NCT00049062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428018|NCT00239434|Bromides|bromides|mesh-list
24428019|NCT00239434|Tiotropium Bromide|tiotropium bromide|mesh-list
24428020|NCT00239434|Ipratropium|ipratropium|mesh-list
24428021|NCT00239434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24428022|NCT00239434|Autonomic Agents|autonomic agents|mesh-ancestor
24428023|NCT00239434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24428024|NCT00239434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428025|NCT00239434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24428026|NCT00239434|Respiratory System Agents|respiratory system agents|mesh-ancestor
24428027|NCT00239434|Parasympatholytics|parasympatholytics|mesh-ancestor
24428028|NCT00239434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24428029|NCT00239434|Cholinergic Agents|cholinergic agents|mesh-ancestor
24824774|NCT02125344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24824775|NCT02125344|Immunologic Factors|immunologic factors|mesh-ancestor
24824776|NCT02125344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824777|NCT02125344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24824778|NCT02125344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24824779|NCT02125344|Alkylating Agents|alkylating agents|mesh-ancestor
24824780|NCT02125344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24428057|NCT00239473|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24428058|NCT00239473|Tiotropium Bromide|tiotropium bromide|mesh-list
24428059|NCT00239473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24428060|NCT00239473|Autonomic Agents|autonomic agents|mesh-ancestor
24428061|NCT00239473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24428062|NCT00239473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428063|NCT00239473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24428066|NCT00239473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24428067|NCT00239473|Cholinergic Agents|cholinergic agents|mesh-ancestor
24428068|NCT00239473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24428069|NCT00239473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428070|NCT00239486|Pramipexole|pramipexole|mesh-list
24428071|NCT00239486|Antioxidants|antioxidants|mesh-ancestor
24428072|NCT00239486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428073|NCT00239486|Protective Agents|protective agents|mesh-ancestor
24428074|NCT00239486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428075|NCT00239486|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24428076|NCT00239486|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24428077|NCT00239486|Dopamine Agonists|dopamine agonists|mesh-ancestor
24428078|NCT00239486|Dopamine Agents|dopamine agents|mesh-ancestor
24428079|NCT00239486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24428087|NCT00239499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428088|NCT00239499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24581316|NCT00864890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24428164|NCT00239785|Immunologic Factors|immunologic factors|mesh-ancestor
24428165|NCT00239785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428166|NCT00239798|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24428167|NCT00239798|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24428168|NCT00239798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428169|NCT00239798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24428170|NCT00239798|Immunologic Factors|immunologic factors|mesh-ancestor
24428171|NCT00239798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428172|NCT00239811|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24576409|NCT00838305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24428173|NCT00239811|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24428174|NCT00239811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428175|NCT00239811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24428176|NCT00239811|Immunologic Factors|immunologic factors|mesh-ancestor
24428177|NCT00239811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428186|NCT00239876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428187|NCT00239876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24428188|NCT00239876|Immunologic Factors|immunologic factors|mesh-ancestor
24428202|NCT00239902|Immunologic Factors|immunologic factors|mesh-ancestor
24428203|NCT00239902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428204|NCT00239954|Citalopram|citalopram|mesh-list
24428205|NCT00239954|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24428206|NCT00239954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24428207|NCT00239954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24428210|NCT00239954|Serotonin Agents|serotonin agents|mesh-ancestor
24428212|NCT00239954|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24428213|NCT00239954|Antidepressive Agents|antidepressive agents|mesh-ancestor
24428214|NCT00239954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24428216|NCT00239967|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24428217|NCT00239967|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24428218|NCT00239967|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24428219|NCT00239967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24428220|NCT00239967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428221|NCT00239967|Hormones|hormones|mesh-ancestor
24428222|NCT00239967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25849596|NCT00049062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428282|NCT00240058|Autonomic Agents|autonomic agents|mesh-ancestor
24428283|NCT00240058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24428284|NCT00240058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428285|NCT00240058|Sympathomimetics|sympathomimetics|mesh-ancestor
24428286|NCT00240058|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24428287|NCT00240058|Nasal Decongestants|nasal decongestants|mesh-ancestor
24428288|NCT00240058|Respiratory System Agents|respiratory system agents|mesh-ancestor
24428289|NCT00240058|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24576508|NCT00839059|Lenalidomide|lenalidomide|mesh-list
24428290|NCT00240058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24428299|NCT00240058|Antioxidants|antioxidants|mesh-ancestor
24428320|NCT00240123|Histamine Agents|histamine agents|mesh-ancestor
24428321|NCT00240123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24428322|NCT00240123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428323|NCT00240123|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24428324|NCT00240149|Insulin|insulin|mesh-list
24428325|NCT00240149|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24428326|NCT00240149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25849597|NCT00049062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24824838|NCT02125578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24824840|NCT02125578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24428337|NCT00240253|Pramlintide|pramlintide|mesh-list
24428338|NCT00240253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24428339|NCT00240253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428340|NCT00240266|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24428357|NCT00240292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24428358|NCT00240292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24428359|NCT00240292|Antimetabolites|antimetabolites|mesh-ancestor
24547858|NCT00706173|Hydrocortisone|hydrocortisone|mesh-list
24824841|NCT02125578|Immunologic Factors|immunologic factors|mesh-ancestor
24824842|NCT02125578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824843|NCT02125578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24824845|NCT02125617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24824846|NCT02125617|Glucocorticoids|glucocorticoids|mesh-ancestor
24428385|NCT00240396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428386|NCT00240396|Analgesics|analgesics|mesh-ancestor
24428387|NCT00240396|Sensory System Agents|sensory system agents|mesh-ancestor
24428388|NCT00240396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24428389|NCT00240409|Pramipexole|pramipexole|mesh-list
24428390|NCT00240409|Bromocriptine|bromocriptine|mesh-list
24428391|NCT00240409|Antioxidants|antioxidants|mesh-ancestor
24428392|NCT00240409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428393|NCT00240409|Protective Agents|protective agents|mesh-ancestor
24428394|NCT00240409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428395|NCT00240409|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24428396|NCT00240409|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24428397|NCT00240409|Dopamine Agonists|dopamine agonists|mesh-ancestor
24428398|NCT00240409|Dopamine Agents|dopamine agents|mesh-ancestor
24428399|NCT00240409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24428400|NCT00240409|Hormone Antagonists|hormone antagonists|mesh-ancestor
25009778|NCT05188417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24428401|NCT00240409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24428402|NCT00240422|Telmisartan|telmisartan|mesh-list
24428405|NCT00240422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24428406|NCT00240422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24428407|NCT00240422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428408|NCT00240422|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24428427|NCT00240448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24696829|NCT01431326|Anesthetics|anesthetics|mesh-ancestor
24428475|NCT00240617|Analgesics|analgesics|mesh-ancestor
24428476|NCT00240617|Sensory System Agents|sensory system agents|mesh-ancestor
24428477|NCT00240617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24428523|NCT00240656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428524|NCT00240656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24428526|NCT00240656|Protective Agents|protective agents|mesh-ancestor
24428527|NCT00240656|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24428528|NCT00240656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24428529|NCT00240656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24428530|NCT00240656|Vasodilator Agents|vasodilator agents|mesh-ancestor
24428531|NCT00240656|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24428532|NCT00240656|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24428533|NCT00240656|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24428534|NCT00240656|Protease Inhibitors|protease inhibitors|mesh-ancestor
24428535|NCT00240656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428537|NCT00240682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25849598|NCT00049062|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24428540|NCT00240695|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24428559|NCT00240708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24428560|NCT00240708|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24428561|NCT00240708|Dopamine Agents|dopamine agents|mesh-ancestor
24428562|NCT00240721|Topiramate|topiramate|mesh-list
24428563|NCT00240721|Anticonvulsants|anticonvulsants|mesh-ancestor
24428564|NCT00240721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24428593|NCT00240773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24428594|NCT00240773|Gout Suppressants|gout suppressants|mesh-ancestor
24428595|NCT00240773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24428596|NCT00240773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428597|NCT00240773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428599|NCT00240786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24428600|NCT00240786|Analgesics|analgesics|mesh-ancestor
24428601|NCT00240786|Sensory System Agents|sensory system agents|mesh-ancestor
24428602|NCT00240786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24428603|NCT00240786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428604|NCT00240786|Antipyretics|antipyretics|mesh-ancestor
24428605|NCT00240799|Acetaminophen|acetaminophen|mesh-list
24428606|NCT00240799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24428607|NCT00240799|Analgesics|analgesics|mesh-ancestor
24428608|NCT00240799|Sensory System Agents|sensory system agents|mesh-ancestor
24824852|NCT02125630|Hormones|hormones|mesh-list
24824853|NCT02125630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24824854|NCT02125630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824855|NCT02125643|Caffeine|caffeine|mesh-list
24824856|NCT02125643|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24824857|NCT02125643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824858|NCT02125643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24824859|NCT02125643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428609|NCT00240799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24428610|NCT00240799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428611|NCT00240799|Antipyretics|antipyretics|mesh-ancestor
24428612|NCT00240812|Ibuprofen|ibuprofen|mesh-list
24428613|NCT00240812|Pseudoephedrine|pseudoephedrine|mesh-list
24428614|NCT00240812|Ephedrine|ephedrine|mesh-list
24428615|NCT00240812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24428616|NCT00240812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25166487|NCT03993132|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24428632|NCT00240812|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24428670|NCT00240864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428671|NCT00240864|Antipyretics|antipyretics|mesh-ancestor
24428672|NCT00240864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24428673|NCT00240864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24428693|NCT00240955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24428694|NCT00240955|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24428695|NCT00240955|Antitubercular Agents|antitubercular agents|mesh-ancestor
24428696|NCT00240955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24428697|NCT00240955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24428698|NCT00240955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428699|NCT00240955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824864|NCT02125643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24824866|NCT02125682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24824867|NCT02125682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24824868|NCT02125682|Antimetabolites|antimetabolites|mesh-ancestor
24824869|NCT02125682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824870|NCT02125682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24824871|NCT02125682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24824872|NCT02125682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824873|NCT02125786|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24824874|NCT02125786|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24824875|NCT02125786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824876|NCT02125812|Moxifloxacin|moxifloxacin|mesh-list
24824877|NCT02125812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24824878|NCT02125812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24824879|NCT02125812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24824880|NCT02125812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24824881|NCT02125812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824882|NCT02125812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824883|NCT02125812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697031|NCT01432249|Etanercept|etanercept|mesh-list
24428700|NCT00241007|Valsartan|valsartan|mesh-list
24428701|NCT00241007|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24428702|NCT00241007|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24428703|NCT00241007|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24428704|NCT00241007|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24428705|NCT00241007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428706|NCT00241007|Diuretics|diuretics|mesh-ancestor
24428707|NCT00241007|Natriuretic Agents|natriuretic agents|mesh-ancestor
24428708|NCT00241007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428709|NCT00241007|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24428710|NCT00241007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24428712|NCT00241020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24429659|NCT00244608|Glucocorticoids|glucocorticoids|mesh-ancestor
24428787|NCT00241189|Dermatologic Agents|dermatologic agents|mesh-ancestor
24428788|NCT00241189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428789|NCT00241189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24428790|NCT00241189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24428791|NCT00241189|Immunologic Factors|immunologic factors|mesh-ancestor
24428792|NCT00241189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24428793|NCT00241189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24428794|NCT00241189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24428796|NCT00241189|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24428797|NCT00241189|Antifungal Agents|antifungal agents|mesh-ancestor
24428798|NCT00241215|Botulinum Toxins|botulinum toxins|mesh-list
24428824|NCT00241254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428826|NCT00241254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24428827|NCT00241254|Alkylating Agents|alkylating agents|mesh-ancestor
25849599|NCT00049062|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24824902|NCT02125968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824904|NCT02125968|Sympathomimetics|sympathomimetics|mesh-ancestor
24824905|NCT02125968|Autonomic Agents|autonomic agents|mesh-ancestor
24428929|NCT00241540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24428930|NCT00241540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24428931|NCT00241540|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24428932|NCT00241540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428933|NCT00241540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428935|NCT00241553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24428936|NCT00241553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24428937|NCT00241553|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24428938|NCT00241553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428939|NCT00241553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824916|NCT02126137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24824917|NCT02126137|Antimetabolites|antimetabolites|mesh-ancestor
24428988|NCT00242190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428989|NCT00242190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24428990|NCT00242190|Immunologic Factors|immunologic factors|mesh-ancestor
24428991|NCT00242190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428993|NCT00242203|Docetaxel|docetaxel|mesh-list
24428994|NCT00242203|Trastuzumab|trastuzumab|mesh-list
24428995|NCT00242203|Epirubicin|epirubicin|mesh-list
24428996|NCT00242203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24428997|NCT00242203|Tubulin Modulators|tubulin modulators|mesh-ancestor
24428998|NCT00242203|Antimitotic Agents|antimitotic agents|mesh-ancestor
24428999|NCT00242203|Mitosis Modulators|mitosis modulators|mesh-ancestor
24429000|NCT00242203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429001|NCT00242203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24429010|NCT00242268|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24429011|NCT00242268|Antimetabolites|antimetabolites|mesh-ancestor
24429012|NCT00242268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429013|NCT00242268|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24429014|NCT00242268|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24429015|NCT00242268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429016|NCT00242346|Candesartan|candesartan|mesh-list
24429017|NCT00242346|Candesartan cilexetil|candesartan cilexetil|mesh-list
24429018|NCT00242346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24429019|NCT00242346|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24429020|NCT00242346|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24429021|NCT00242346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429022|NCT00242359|Omalizumab|omalizumab|mesh-list
24429023|NCT00242359|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24429024|NCT00242359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24429025|NCT00242359|Respiratory System Agents|respiratory system agents|mesh-ancestor
24429026|NCT00242372|Insulin|insulin|mesh-list
24429027|NCT00242372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24429028|NCT00242372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429029|NCT00242411|Budesonide|budesonide|mesh-list
24429031|NCT00242411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24429032|NCT00242411|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24429033|NCT00242411|Autonomic Agents|autonomic agents|mesh-ancestor
24429034|NCT00242411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24429035|NCT00242411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429060|NCT00242450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824921|NCT02126267|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24824922|NCT02126267|Azithromycin|azithromycin|mesh-list
24697469|NCT01435083|Hemostatics|hemostatics|mesh-ancestor
24429061|NCT00242463|Nandrolone Decanoate|nandrolone decanoate|mesh-list
24429062|NCT00242463|Nandrolone|nandrolone|mesh-list
24429063|NCT00242463|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
24429067|NCT00242463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24429077|NCT00242541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429078|NCT00242554|Zoledronic Acid|zoledronic acid|mesh-list
24429079|NCT00242554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24429080|NCT00242554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429082|NCT00242593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24429109|NCT00242749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24429110|NCT00242749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429111|NCT00242749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429112|NCT00242762|Docetaxel|docetaxel|mesh-list
24429113|NCT00242762|Gefitinib|gefitinib|mesh-list
24429114|NCT00242762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429115|NCT00242762|Tubulin Modulators|tubulin modulators|mesh-ancestor
24429116|NCT00242762|Antimitotic Agents|antimitotic agents|mesh-ancestor
24429117|NCT00242762|Mitosis Modulators|mitosis modulators|mesh-ancestor
24429118|NCT00242762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429119|NCT00242762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24429120|NCT00242762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429121|NCT00242775|Fluticasone|fluticasone|mesh-list
24429122|NCT00242775|Budesonide|budesonide|mesh-list
24824925|NCT02126267|Disinfectants|disinfectants|mesh-ancestor
24824926|NCT02126267|Dermatologic Agents|dermatologic agents|mesh-ancestor
24824927|NCT02126267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24824929|NCT02126293|Trace Elements|trace elements|mesh-ancestor
24824930|NCT02126293|Micronutrients|micronutrients|mesh-ancestor
25419659|NCT02688140|Immunologic Factors|immunologic factors|mesh-ancestor
25662174|NCT01641939|Tubulin Modulators|tubulin modulators|mesh-ancestor
25849601|NCT00049062|Hormone Antagonists|hormone antagonists|mesh-ancestor
25662175|NCT01641939|Antimitotic Agents|antimitotic agents|mesh-ancestor
25662176|NCT01641939|Mitosis Modulators|mitosis modulators|mesh-ancestor
24473819|NCT00404261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25849602|NCT00049062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25662177|NCT01641939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662178|NCT01641952|Rituximab|rituximab|mesh-list
24824931|NCT02126293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824932|NCT02126332|Acetaminophen|acetaminophen|mesh-list
24429155|NCT00242801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429157|NCT00242814|Telmisartan|telmisartan|mesh-list
25047951|NCT00751803|Eletriptan|eletriptan|mesh-list
24429159|NCT00242814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24429160|NCT00242814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24429161|NCT00242814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429162|NCT00242814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24429171|NCT00242853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429172|NCT00242853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24429173|NCT00242853|Respiratory System Agents|respiratory system agents|mesh-ancestor
25009848|NCT05155137|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25009849|NCT05155137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25009850|NCT05155137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24792850|NCT04493333|Psyllium|psyllium|mesh-list
25009851|NCT05155137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25009862|NCT05134857|Zonisamide|zonisamide|mesh-list
25009863|NCT05134857|Anticonvulsants|anticonvulsants|mesh-ancestor
25009864|NCT05134857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24429174|NCT00242853|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24429175|NCT00242853|Antioxidants|antioxidants|mesh-ancestor
24429187|NCT00242879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429189|NCT00242879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24429190|NCT00242879|Antiviral Agents|antiviral agents|mesh-ancestor
24429191|NCT00242879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24429192|NCT00242879|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24430231|NCT00246597|Epoetin Alfa|epoetin alfa|mesh-list
24429193|NCT00242879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24429194|NCT00242918|Docetaxel|docetaxel|mesh-list
24429195|NCT00242918|Gefitinib|gefitinib|mesh-list
24429196|NCT00242918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429197|NCT00242918|Tubulin Modulators|tubulin modulators|mesh-ancestor
24429198|NCT00242918|Antimitotic Agents|antimitotic agents|mesh-ancestor
24548280|NCT00708747|Antibodies|antibodies|mesh-list
24429221|NCT00242996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24429223|NCT00242996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429224|NCT00242996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429225|NCT00242996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24429226|NCT00242996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24429227|NCT00242996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24429228|NCT00242996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24429229|NCT00242996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24429230|NCT00242996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429232|NCT00243009|Mycophenolic Acid|mycophenolic acid|mesh-list
24429233|NCT00243009|Fludarabine|fludarabine|mesh-list
24429234|NCT00243009|Fludarabine phosphate|fludarabine phosphate|mesh-list
24429235|NCT00243009|Cyclosporins|cyclosporins|mesh-list
24429236|NCT00243009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429252|NCT00243009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24429254|NCT00243035|Tipifarnib|tipifarnib|mesh-list
24429255|NCT00243035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429256|NCT00243100|Gemcitabine|gemcitabine|mesh-list
24429257|NCT00243100|Vorinostat|vorinostat|mesh-list
24429266|NCT00243100|Immunologic Factors|immunologic factors|mesh-ancestor
24429267|NCT00243100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429268|NCT00243100|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24429269|NCT00243113|Docetaxel|docetaxel|mesh-list
24429270|NCT00243113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429271|NCT00243113|Tubulin Modulators|tubulin modulators|mesh-ancestor
25662179|NCT01641952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25662180|NCT01641952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662181|NCT01641952|Immunologic Factors|immunologic factors|mesh-ancestor
25662182|NCT01641952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662183|NCT01641952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24429272|NCT00243113|Antimitotic Agents|antimitotic agents|mesh-ancestor
24429273|NCT00243113|Mitosis Modulators|mitosis modulators|mesh-ancestor
24548292|NCT00708812|Paclitaxel|paclitaxel|mesh-list
24429315|NCT00243464|Respiratory System Agents|respiratory system agents|mesh-ancestor
24824935|NCT02126332|Tramadol|tramadol|mesh-list
24824936|NCT02126332|Ropivacaine|ropivacaine|mesh-list
24824937|NCT02126332|Anesthetics, Local|anesthetics, local|mesh-ancestor
24824938|NCT02126332|Anesthetics|anesthetics|mesh-ancestor
24824939|NCT02126332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24824940|NCT02126332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697673|NCT01436422|Vaccines|vaccines|mesh-list
24577657|NCT00845546|Loratadine|loratadine|mesh-list
24577739|NCT00845754|Sensory System Agents|sensory system agents|mesh-ancestor
24429316|NCT00243464|Dermatologic Agents|dermatologic agents|mesh-ancestor
24429317|NCT00243477|Citalopram|citalopram|mesh-list
24429318|NCT00243477|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24429319|NCT00243477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24429320|NCT00243477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24429321|NCT00243477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429334|NCT00243672|Atorvastatin|atorvastatin|mesh-list
24429340|NCT00243672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25849603|NCT00049062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429341|NCT00243672|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24429342|NCT00243672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429343|NCT00243672|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24429398|NCT00243815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24429400|NCT00243815|Sensory System Agents|sensory system agents|mesh-ancestor
24429412|NCT00243854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429420|NCT00243880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24429421|NCT00243880|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24429422|NCT00243880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429423|NCT00243893|Doxycycline|doxycycline|mesh-list
24429424|NCT00243893|Minocycline|minocycline|mesh-list
25849604|NCT00049075|Fludarabine|fludarabine|mesh-list
24429454|NCT00244075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429455|NCT00244127|Prednisone|prednisone|mesh-list
24429459|NCT00244127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24429460|NCT00244127|Immunologic Factors|immunologic factors|mesh-ancestor
25166488|NCT03993132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24429461|NCT00244127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429462|NCT00244127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24429463|NCT00244127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24429464|NCT00244127|Alkylating Agents|alkylating agents|mesh-ancestor
24429465|NCT00244127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429466|NCT00244127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429467|NCT00244127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24429660|NCT00244608|Hormones|hormones|mesh-ancestor
24429468|NCT00244127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24429469|NCT00244127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24429470|NCT00244127|Glucocorticoids|glucocorticoids|mesh-ancestor
24429472|NCT00244127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24429473|NCT00244127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24429474|NCT00244127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24429475|NCT00244127|Tubulin Modulators|tubulin modulators|mesh-ancestor
24429476|NCT00244127|Antimitotic Agents|antimitotic agents|mesh-ancestor
24429477|NCT00244127|Mitosis Modulators|mitosis modulators|mesh-ancestor
24429479|NCT00244153|Morphine|morphine|mesh-list
24429480|NCT00244153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24429481|NCT00244153|Antiemetics|antiemetics|mesh-ancestor
24824953|NCT02126358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24824954|NCT02126358|Antimetabolites|antimetabolites|mesh-ancestor
24824955|NCT02126358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824956|NCT02126358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24577836|NCT00845988|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24577837|NCT00845988|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24875146|NCT04408586|Topiramate|topiramate|mesh-list
24577838|NCT00845988|Serotonin Agents|serotonin agents|mesh-ancestor
24429524|NCT00244296|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24429525|NCT00244296|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24429533|NCT00244296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24429534|NCT00244296|Antidepressive Agents|antidepressive agents|mesh-ancestor
24429535|NCT00244296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24429536|NCT00244296|Dopamine Agents|dopamine agents|mesh-ancestor
24429537|NCT00244309|Tamsulosin|tamsulosin|mesh-list
24429538|NCT00244309|Dutasteride|dutasteride|mesh-list
24429539|NCT00244309|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24473892|NCT00404404|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24805823|NCT02012140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24429540|NCT00244309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24429541|NCT00244309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24429542|NCT00244309|Adrenergic Agents|adrenergic agents|mesh-ancestor
24429543|NCT00244309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24429544|NCT00244309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429545|NCT00244309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429580|NCT00244426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24429581|NCT00244426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24429582|NCT00244426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429585|NCT00244439|Malathion|malathion|mesh-list
24429586|NCT00244439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429587|NCT00244439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429588|NCT00244439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24429589|NCT00244439|Cholinergic Agents|cholinergic agents|mesh-ancestor
24429590|NCT00244439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24429591|NCT00244439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429593|NCT00244452|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24429594|NCT00244452|Fertility Agents|fertility agents|mesh-ancestor
24429595|NCT00244452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24824957|NCT02126358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24577839|NCT00845988|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24824958|NCT02126358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824959|NCT02126384|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24824960|NCT02126384|Immunologic Factors|immunologic factors|mesh-ancestor
24824961|NCT02126384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824962|NCT02126462|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24824963|NCT02126462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24824964|NCT02126462|Immunologic Factors|immunologic factors|mesh-ancestor
24824965|NCT02126462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824967|NCT02126462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824968|NCT02126462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24824969|NCT02126527|Sirolimus|sirolimus|mesh-list
24824970|NCT02126527|Auranofin|auranofin|mesh-list
24824971|NCT02126527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24824972|NCT02126527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24429625|NCT00244556|Etanercept|etanercept|mesh-list
24429626|NCT00244556|Methotrexate|methotrexate|mesh-list
24429627|NCT00244556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24429628|NCT00244556|Abortifacient Agents|abortifacient agents|mesh-ancestor
24429629|NCT00244556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24429630|NCT00244556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429656|NCT00244608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429657|NCT00244608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24429658|NCT00244608|Respiratory System Agents|respiratory system agents|mesh-ancestor
24824982|NCT02126579|Immunologic Factors|immunologic factors|mesh-ancestor
24824983|NCT02126579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824984|NCT02126644|Glycolic acid|glycolic acid|mesh-list
24824985|NCT02126644|Keratolytic Agents|keratolytic agents|mesh-ancestor
24824986|NCT02126644|Dermatologic Agents|dermatologic agents|mesh-ancestor
24824987|NCT02126657|Glycolic acid|glycolic acid|mesh-list
24824988|NCT02126657|Keratolytic Agents|keratolytic agents|mesh-ancestor
24824989|NCT02126657|Dermatologic Agents|dermatologic agents|mesh-ancestor
24824990|NCT02126683|Hydroxychloroquine|hydroxychloroquine|mesh-list
24429661|NCT00244608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24548366|NCT00709254|Fentanyl|fentanyl|mesh-list
24429683|NCT00244907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429684|NCT00244907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24429685|NCT00244907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429686|NCT00244907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24429687|NCT00244907|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24429688|NCT00244907|Protective Agents|protective agents|mesh-ancestor
24429689|NCT00244907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429690|NCT00244907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24577968|NCT00846443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577969|NCT00846443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577971|NCT00846443|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24429691|NCT00244907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429692|NCT00244907|Phytoestrogens|phytoestrogens|mesh-ancestor
25662184|NCT01642082|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
25662185|NCT01642082|Immunologic Factors|immunologic factors|mesh-ancestor
24446226|NCT00304135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446227|NCT00304135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24446228|NCT00304135|Immunologic Factors|immunologic factors|mesh-ancestor
24446229|NCT00304135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429693|NCT00244907|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24429696|NCT00244907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24429697|NCT00244920|Squalamine|squalamine|mesh-list
24429698|NCT00244920|Leuprolide|leuprolide|mesh-list
24429699|NCT00244920|Bicalutamide|bicalutamide|mesh-list
24429700|NCT00244920|Hormones|hormones|mesh-list
25849605|NCT00049075|Fludarabine phosphate|fludarabine phosphate|mesh-list
24429810|NCT00245141|Cyclophosphamide|cyclophosphamide|mesh-list
24429811|NCT00245141|Vincristine|vincristine|mesh-list
24429812|NCT00245141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24429813|NCT00245141|Immunologic Factors|immunologic factors|mesh-ancestor
24429814|NCT00245141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429815|NCT00245141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24429816|NCT00245141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24429846|NCT00245206|Serotonin Agents|serotonin agents|mesh-ancestor
24429847|NCT00245206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24429848|NCT00245206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429850|NCT00245206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24429867|NCT00245206|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24429868|NCT00245206|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24429869|NCT00245245|Factor VIII|factor viii|mesh-list
24429870|NCT00245245|Coagulants|coagulants|mesh-ancestor
24429871|NCT00245258|Sildenafil Citrate|sildenafil citrate|mesh-list
24429918|NCT00245440|Azithromycin|azithromycin|mesh-list
24429919|NCT00245440|Telithromycin|telithromycin|mesh-list
24429920|NCT00245440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24429921|NCT00245440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24429922|NCT00245453|Azithromycin|azithromycin|mesh-list
24429923|NCT00245453|Clarithromycin|clarithromycin|mesh-list
24429924|NCT00245453|Telithromycin|telithromycin|mesh-list
24429925|NCT00245453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24429926|NCT00245453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24429927|NCT00245453|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24429928|NCT00245453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429929|NCT00245453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429930|NCT00245453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24430028|NCT00245921|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24430030|NCT00245921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24430031|NCT00245921|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24430049|NCT00246064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24578030|NCT00846690|Respiratory System Agents|respiratory system agents|mesh-ancestor
24578033|NCT00846690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24430051|NCT00246103|Cyclophosphamide|cyclophosphamide|mesh-list
24430052|NCT00246103|Fluorouracil|fluorouracil|mesh-list
24430053|NCT00246103|Epirubicin|epirubicin|mesh-list
24430054|NCT00246103|Valproic Acid|valproic acid|mesh-list
24430055|NCT00246103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24430056|NCT00246103|Immunologic Factors|immunologic factors|mesh-ancestor
24430057|NCT00246103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430059|NCT00246103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24430061|NCT00246103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430600|NCT00248430|Aldesleukin|aldesleukin|mesh-list
24430084|NCT00246142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430085|NCT00246142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430086|NCT00246142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24430087|NCT00246142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24430089|NCT00246155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24430090|NCT00246155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24430091|NCT00246155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24430092|NCT00246155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24430135|NCT00246220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24430136|NCT00246220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24430137|NCT00246220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430138|NCT00246220|Dopamine Agents|dopamine agents|mesh-ancestor
24430139|NCT00246220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25662186|NCT01642082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662187|NCT01642147|Anesthetics|anesthetics|mesh-list
25662188|NCT01642147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24430140|NCT00246233|Methylphenidate|methylphenidate|mesh-list
24430141|NCT00246233|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25849606|NCT00049075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849607|NCT00049075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24430142|NCT00246233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430143|NCT00246233|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24430144|NCT00246233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24430145|NCT00246233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24430146|NCT00246233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430147|NCT00246233|Dopamine Agents|dopamine agents|mesh-ancestor
24578135|NCT00846976|Androgen Antagonists|androgen antagonists|mesh-ancestor
24578136|NCT00846976|Hormone Antagonists|hormone antagonists|mesh-ancestor
24430148|NCT00246233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430149|NCT00246246|Risperidone|risperidone|mesh-list
24825020|NCT02126956|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24825021|NCT02126956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825022|NCT02126956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24825023|NCT02126956|Immunologic Factors|immunologic factors|mesh-ancestor
24825024|NCT02126956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825025|NCT02126995|Metadoxine|metadoxine|mesh-list
24825026|NCT02126995|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24430150|NCT00246246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24430151|NCT00246246|Serotonin Agents|serotonin agents|mesh-ancestor
24430213|NCT00246415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430214|NCT00246415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24430215|NCT00246415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24430217|NCT00246467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24430218|NCT00246467|Immunologic Factors|immunologic factors|mesh-ancestor
24430219|NCT00246467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430220|NCT00246467|Antacids|antacids|mesh-ancestor
24430221|NCT00246467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430222|NCT00246467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24430223|NCT00246532|Morphine|morphine|mesh-list
24430224|NCT00246532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24430225|NCT00246532|Narcotics|narcotics|mesh-ancestor
24430226|NCT00246532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24430227|NCT00246532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430228|NCT00246532|Analgesics|analgesics|mesh-ancestor
24430230|NCT00246532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24430232|NCT00246597|Hematinics|hematinics|mesh-ancestor
24430233|NCT00246610|Nelfinavir|nelfinavir|mesh-list
24430234|NCT00246610|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24430267|NCT00246909|Pantoprazole|pantoprazole|mesh-list
24430268|NCT00246909|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24430272|NCT00246909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430273|NCT00246974|Gemcitabine|gemcitabine|mesh-list
24430274|NCT00246974|Gefitinib|gefitinib|mesh-list
24430275|NCT00246974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24430276|NCT00246974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24430277|NCT00246974|Antimetabolites|antimetabolites|mesh-ancestor
24430278|NCT00246974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430279|NCT00246974|Antiviral Agents|antiviral agents|mesh-ancestor
24430417|NCT00247650|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24430418|NCT00247650|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24430419|NCT00247650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430420|NCT00247650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430421|NCT00247650|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24430422|NCT00247650|Hormone Antagonists|hormone antagonists|mesh-ancestor
24430423|NCT00247650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24430424|NCT00247650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430425|NCT00247650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24430427|NCT00247663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24430428|NCT00247663|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24430429|NCT00247663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24430430|NCT00247663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430431|NCT00247663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825039|NCT02127034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24825040|NCT02127034|Urological Agents|urological agents|mesh-ancestor
24825041|NCT02127034|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24825042|NCT02127034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24825043|NCT02127034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24825045|NCT02127047|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24825046|NCT02127047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24430432|NCT00247663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24430433|NCT00247663|Hormone Antagonists|hormone antagonists|mesh-ancestor
24430518|NCT00248118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430519|NCT00248131|Octreotide|octreotide|mesh-list
24430520|NCT00248131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24430521|NCT00248131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24430522|NCT00248131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24430523|NCT00248144|Famciclovir|famciclovir|mesh-list
24430524|NCT00248144|Antiviral Agents|antiviral agents|mesh-ancestor
24430525|NCT00248144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24430526|NCT00248144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24430527|NCT00248144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430528|NCT00248144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430529|NCT00248157|Octreotide|octreotide|mesh-list
24430530|NCT00248157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24825047|NCT02127047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825048|NCT02127047|Incretins|incretins|mesh-ancestor
24430534|NCT00248183|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24430535|NCT00248183|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24430536|NCT00248183|Serotonin Agents|serotonin agents|mesh-ancestor
24430537|NCT00248183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430538|NCT00248183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430542|NCT00248209|Antidepressive Agents|antidepressive agents|mesh-ancestor
24430593|NCT00248339|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24430594|NCT00248339|Epoetin Alfa|epoetin alfa|mesh-list
24430595|NCT00248339|Antimetabolites|antimetabolites|mesh-ancestor
24430596|NCT00248339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430597|NCT00248339|Antiviral Agents|antiviral agents|mesh-ancestor
24430598|NCT00248339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24430599|NCT00248339|Hematinics|hematinics|mesh-ancestor
24430604|NCT00248430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430605|NCT00248430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24430606|NCT00248430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24430607|NCT00248430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24430614|NCT00248443|Dimercaprol|dimercaprol|mesh-list
24430633|NCT00248482|Irinotecan|irinotecan|mesh-list
24430634|NCT00248482|Imatinib Mesylate|imatinib mesylate|mesh-list
24430635|NCT00248482|Camptothecin|camptothecin|mesh-list
24430657|NCT00248729|GABA Modulators|gaba modulators|mesh-ancestor
24430658|NCT00248729|GABA Agents|gaba agents|mesh-ancestor
24430659|NCT00248729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430678|NCT00248989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430679|NCT00249041|Etanercept|etanercept|mesh-list
24430680|NCT00249041|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24430681|NCT00249041|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24430682|NCT00249041|Analgesics|analgesics|mesh-ancestor
24430683|NCT00249041|Sensory System Agents|sensory system agents|mesh-ancestor
24430684|NCT00249041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24430685|NCT00249041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430686|NCT00249041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24430687|NCT00249041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24430688|NCT00249041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24430689|NCT00249041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25662189|NCT01642147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662190|NCT01642212|Budesonide|budesonide|mesh-list
25662191|NCT01642212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25662192|NCT01642212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25662193|NCT01642212|Autonomic Agents|autonomic agents|mesh-ancestor
25662194|NCT01642212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25662195|NCT01642212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430690|NCT00249041|Immunologic Factors|immunologic factors|mesh-ancestor
24430691|NCT00249106|Vaccines|vaccines|mesh-list
24430692|NCT00249106|Immunologic Factors|immunologic factors|mesh-ancestor
24430693|NCT00249106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430695|NCT00249119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24430696|NCT00249119|Serotonin Agents|serotonin agents|mesh-ancestor
24430697|NCT00249119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430700|NCT00249119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24548685|NCT00711503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24430727|NCT00249145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24430728|NCT00249145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24430729|NCT00249145|Dopamine Agents|dopamine agents|mesh-ancestor
24430730|NCT00249158|Risperidone|risperidone|mesh-list
24430731|NCT00249158|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24430732|NCT00249158|Serotonin Agents|serotonin agents|mesh-ancestor
24430733|NCT00249158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430734|NCT00249158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430735|NCT00249158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430736|NCT00249158|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24430737|NCT00249158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24825070|NCT02127138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825071|NCT02127138|Antifungal Agents|antifungal agents|mesh-ancestor
24825072|NCT02127138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24825073|NCT02127138|Immunologic Factors|immunologic factors|mesh-ancestor
24825074|NCT02127138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825075|NCT02127151|Talazoparib|talazoparib|mesh-list
24825076|NCT02127151|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24825077|NCT02127151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825078|NCT02127151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825079|NCT02127151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825080|NCT02127164|Sodium Hypochlorite|sodium hypochlorite|mesh-list
24825082|NCT02127164|Disinfectants|disinfectants|mesh-ancestor
24825083|NCT02127164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24825085|NCT02127190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24430738|NCT00249158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24430739|NCT00249158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24430740|NCT00249158|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24430741|NCT00249158|Dopamine Agents|dopamine agents|mesh-ancestor
24430742|NCT00249171|Risperidone|risperidone|mesh-list
24430743|NCT00249171|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24430744|NCT00249171|Serotonin Agents|serotonin agents|mesh-ancestor
24430745|NCT00249171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24548698|NCT00711789|Giapreza|giapreza|mesh-list
24430761|NCT00249197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24430762|NCT00249197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430763|NCT00249197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430764|NCT00249197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24430778|NCT00249210|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25849608|NCT00049075|Antimetabolites|antimetabolites|mesh-ancestor
24430779|NCT00249210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24430780|NCT00249223|Risperidone|risperidone|mesh-list
24430781|NCT00249223|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24430782|NCT00249223|Serotonin Agents|serotonin agents|mesh-ancestor
24430783|NCT00249223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430784|NCT00249223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430785|NCT00249223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430786|NCT00249223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24430787|NCT00249223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24430788|NCT00249223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24430789|NCT00249223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24430831|NCT00249405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24430832|NCT00249405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24430833|NCT00249405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430834|NCT00249405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430835|NCT00249405|Serotonin Agents|serotonin agents|mesh-ancestor
24430836|NCT00249405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612883|NCT01015664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24430864|NCT00249509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24430865|NCT00249509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24430866|NCT00249509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24430867|NCT00249509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24430868|NCT00249509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430870|NCT00249509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430871|NCT00249509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430872|NCT00249509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24430906|NCT00249704|Cholecalciferol|cholecalciferol|mesh-list
24430908|NCT00249704|Micronutrients|micronutrients|mesh-ancestor
24430909|NCT00249704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430910|NCT00249704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24430911|NCT00249704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24430912|NCT00249730|Sildenafil Citrate|sildenafil citrate|mesh-list
24430913|NCT00249730|Vasodilator Agents|vasodilator agents|mesh-ancestor
24430914|NCT00249730|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24430915|NCT00249730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24430916|NCT00249730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430917|NCT00249730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430918|NCT00249730|Urological Agents|urological agents|mesh-ancestor
24430919|NCT00249782|Metronidazole|metronidazole|mesh-list
24430920|NCT00249782|Dapsone|dapsone|mesh-list
24430921|NCT00249782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24430922|NCT00249782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24430923|NCT00249782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24430924|NCT00249782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24430925|NCT00249782|Antimalarials|antimalarials|mesh-ancestor
24430926|NCT00249782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24430927|NCT00249782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849609|NCT00049075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431001|NCT00249964|Tubulin Modulators|tubulin modulators|mesh-ancestor
24431002|NCT00249964|Antimitotic Agents|antimitotic agents|mesh-ancestor
24431003|NCT00249964|Mitosis Modulators|mitosis modulators|mesh-ancestor
24431004|NCT00249964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431006|NCT00249964|Alkylating Agents|alkylating agents|mesh-ancestor
24431008|NCT00249977|Irinotecan|irinotecan|mesh-list
24431009|NCT00249977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431010|NCT00249977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24431011|NCT00249977|Antimetabolites|antimetabolites|mesh-ancestor
24431012|NCT00249977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431013|NCT00249977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24431014|NCT00249977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24431015|NCT00249977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431016|NCT00250029|Capecitabine|capecitabine|mesh-list
25849610|NCT00049075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25849611|NCT00049075|Immunologic Factors|immunologic factors|mesh-ancestor
25849612|NCT00049075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431026|NCT00250042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825116|NCT02127593|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24825093|NCT02127320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24825094|NCT02127320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825095|NCT02127437|Lanreotide|lanreotide|mesh-list
24825096|NCT02127437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825098|NCT02127463|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24825099|NCT02127489|Bupivacaine|bupivacaine|mesh-list
24431027|NCT00250042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431028|NCT00250068|Rubitecan|rubitecan|mesh-list
24431029|NCT00250068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431086|NCT00250315|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24431134|NCT00250536|Hormones|hormones|mesh-ancestor
24431135|NCT00250536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24431136|NCT00250536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431137|NCT00250536|Anabolic Agents|anabolic agents|mesh-ancestor
24431138|NCT00250536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24431139|NCT00250562|Valsartan|valsartan|mesh-list
24431140|NCT00250562|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24431141|NCT00250562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24431142|NCT00250562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24431143|NCT00250562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24431144|NCT00250562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431150|NCT00250575|Clozapine|clozapine|mesh-list
25849613|NCT00049088|Bevacizumab|bevacizumab|mesh-list
24431187|NCT00250744|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24431188|NCT00250744|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24431189|NCT00250744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431190|NCT00250744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431191|NCT00250744|Antimanic Agents|antimanic agents|mesh-ancestor
24431202|NCT00250796|Antiviral Agents|antiviral agents|mesh-ancestor
24578597|NCT00849615|Immunologic Factors|immunologic factors|mesh-ancestor
24431203|NCT00250796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24611339|NCT01008709|beta-Endorphin|beta-endorphin|mesh-list
24431204|NCT00250796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24431205|NCT00250796|Immunologic Factors|immunologic factors|mesh-ancestor
24431206|NCT00250796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431236|NCT00250874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24431237|NCT00250874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24431238|NCT00250874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431239|NCT00250874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24431240|NCT00250952|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24431241|NCT00250952|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24431242|NCT00250952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24431243|NCT00250952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24431244|NCT00250952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431245|NCT00250952|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24431246|NCT00250952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24431247|NCT00250952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825100|NCT02127489|Anesthetics, Local|anesthetics, local|mesh-ancestor
24431272|NCT00251030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431273|NCT00251030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431274|NCT00251030|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24431275|NCT00251030|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24431276|NCT00251030|Protease Inhibitors|protease inhibitors|mesh-ancestor
24431277|NCT00251030|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24431278|NCT00251030|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24431279|NCT00251030|Antiviral Agents|antiviral agents|mesh-ancestor
25045349|NCT00966953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24431280|NCT00251030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24431281|NCT00251056|Mannitol|mannitol|mesh-list
24431282|NCT00251056|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24431283|NCT00251056|Diuretics|diuretics|mesh-ancestor
24431284|NCT00251056|Natriuretic Agents|natriuretic agents|mesh-ancestor
24431285|NCT00251056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849614|NCT00049088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24431310|NCT00251186|Antimetabolites|antimetabolites|mesh-ancestor
24431311|NCT00251186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431312|NCT00251186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431313|NCT00251186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24431314|NCT00251277|Rituximab|rituximab|mesh-list
24825113|NCT02127593|Moxifloxacin|moxifloxacin|mesh-list
24825114|NCT02127593|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24825115|NCT02127593|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24825117|NCT02127593|Norgestimate|norgestimate|mesh-list
24825118|NCT02127593|Norgestrel|norgestrel|mesh-list
24825119|NCT02127593|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24825120|NCT02127593|Estradiol|estradiol|mesh-list
24825121|NCT02127593|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24825122|NCT02127593|Estrogens|estrogens|mesh-ancestor
24825123|NCT02127593|Hormones|hormones|mesh-ancestor
24825124|NCT02127593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24825125|NCT02127593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825126|NCT02127593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24431364|NCT00251485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24431365|NCT00251485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431366|NCT00251498|Cetuximab|cetuximab|mesh-list
24431367|NCT00251498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24431368|NCT00251498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431369|NCT00251511|Arsenic Trioxide|arsenic trioxide|mesh-list
25849615|NCT00049088|Docetaxel|docetaxel|mesh-list
24431405|NCT00251602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24431406|NCT00251602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24431407|NCT00251602|Respiratory System Agents|respiratory system agents|mesh-ancestor
24431408|NCT00251602|Mydriatics|mydriatics|mesh-ancestor
24431484|NCT00251849|Antitubercular Agents|antitubercular agents|mesh-ancestor
24431485|NCT00251849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24431486|NCT00251849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24431487|NCT00251849|Leprostatic Agents|leprostatic agents|mesh-ancestor
25849616|NCT00049088|Antibodies|antibodies|mesh-list
24431488|NCT00251888|Irinotecan|irinotecan|mesh-list
24431489|NCT00251888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431490|NCT00251888|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24431491|NCT00251888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24431492|NCT00251888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431493|NCT00251888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431494|NCT00251901|Esomeprazole|esomeprazole|mesh-list
24431497|NCT00251901|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24431498|NCT00251901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431499|NCT00251901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431500|NCT00251914|Esomeprazole|esomeprazole|mesh-list
24825132|NCT02127593|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24825133|NCT02127593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24825134|NCT02127593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24431538|NCT00252122|Anesthetics|anesthetics|mesh-ancestor
24431562|NCT00252291|Methacholine Chloride|methacholine chloride|mesh-list
24431564|NCT00252291|Autonomic Agents|autonomic agents|mesh-ancestor
24431565|NCT00252291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24431566|NCT00252291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431567|NCT00252291|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24825142|NCT02127684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24825143|NCT02127684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24699023|NCT01444469|Azithromycin|azithromycin|mesh-list
24431595|NCT00252343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24431600|NCT00252356|Amibegron|amibegron|mesh-list
24431601|NCT00252356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24431602|NCT00252356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24431603|NCT00252356|Adrenergic Agents|adrenergic agents|mesh-ancestor
24431604|NCT00252356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431605|NCT00252356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431606|NCT00252356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25166489|NCT03993132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431608|NCT00252369|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24431609|NCT00252369|Dermatologic Agents|dermatologic agents|mesh-ancestor
24431610|NCT00252369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24431611|NCT00252369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24431612|NCT00252369|Hemostatics|hemostatics|mesh-ancestor
24431613|NCT00252369|Coagulants|coagulants|mesh-ancestor
24431614|NCT00252408|Hormones|hormones|mesh-list
24431615|NCT00252408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24431616|NCT00252408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431617|NCT00252421|Nitroglycerin|nitroglycerin|mesh-list
24431618|NCT00252421|Vasodilator Agents|vasodilator agents|mesh-ancestor
24431619|NCT00252434|Methamphetamine|methamphetamine|mesh-list
24431620|NCT00252434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24431621|NCT00252434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431622|NCT00252434|Sympathomimetics|sympathomimetics|mesh-ancestor
24431623|NCT00252434|Autonomic Agents|autonomic agents|mesh-ancestor
24431624|NCT00252434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24431625|NCT00252434|Dopamine Agents|dopamine agents|mesh-ancestor
24431626|NCT00252434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431686|NCT00252707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431687|NCT00252707|Tubulin Modulators|tubulin modulators|mesh-ancestor
24431688|NCT00252707|Antimitotic Agents|antimitotic agents|mesh-ancestor
24431689|NCT00252707|Mitosis Modulators|mitosis modulators|mesh-ancestor
24431690|NCT00252707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431691|NCT00252707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24431692|NCT00252707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825144|NCT02127684|Growth Substances|growth substances|mesh-ancestor
24431711|NCT00252785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431713|NCT00252785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431714|NCT00252785|Vasodilator Agents|vasodilator agents|mesh-ancestor
24431715|NCT00252785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24431716|NCT00252785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24431717|NCT00252785|Purinergic Agents|purinergic agents|mesh-ancestor
24431718|NCT00252798|Paclitaxel|paclitaxel|mesh-list
24431719|NCT00252798|Carboplatin|carboplatin|mesh-list
24431720|NCT00252798|Gefitinib|gefitinib|mesh-list
24431721|NCT00252798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24431722|NCT00252798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431731|NCT00252811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24431732|NCT00252811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431733|NCT00252811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431735|NCT00252824|Formoterol Fumarate|formoterol fumarate|mesh-list
24431736|NCT00252824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24431737|NCT00252824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24431738|NCT00252824|Autonomic Agents|autonomic agents|mesh-ancestor
24431739|NCT00252824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24431740|NCT00252824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431741|NCT00252824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24431742|NCT00252824|Respiratory System Agents|respiratory system agents|mesh-ancestor
24549000|NCT00712790|Sorafenib|sorafenib|mesh-list
24431766|NCT00252863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24431767|NCT00252863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431768|NCT00252863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24431769|NCT00252863|Respiratory System Agents|respiratory system agents|mesh-ancestor
24474276|NCT00405405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431770|NCT00252863|Dermatologic Agents|dermatologic agents|mesh-ancestor
24431771|NCT00252863|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24431772|NCT00252863|Glucocorticoids|glucocorticoids|mesh-ancestor
24431773|NCT00252863|Hormones|hormones|mesh-ancestor
24431774|NCT00252863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24431775|NCT00252863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24431776|NCT00252863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24431778|NCT00252863|Adrenergic Agents|adrenergic agents|mesh-ancestor
24431779|NCT00252863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25849617|NCT00049088|Immunoglobulins|immunoglobulins|mesh-list
25849618|NCT00049088|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25849619|NCT00049088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849620|NCT00049088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25849621|NCT00049088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25849622|NCT00049088|Growth Substances|growth substances|mesh-ancestor
25849623|NCT00049088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849624|NCT00049088|Growth Inhibitors|growth inhibitors|mesh-ancestor
25849625|NCT00049088|Immunologic Factors|immunologic factors|mesh-ancestor
25849626|NCT00049088|Tubulin Modulators|tubulin modulators|mesh-ancestor
25849627|NCT00049088|Antimitotic Agents|antimitotic agents|mesh-ancestor
25849628|NCT00049088|Mitosis Modulators|mitosis modulators|mesh-ancestor
25849629|NCT00049088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849630|NCT00049101|Leucovorin|leucovorin|mesh-list
25849631|NCT00049101|Fluorouracil|fluorouracil|mesh-list
24431833|NCT00253110|Dopamine Agents|dopamine agents|mesh-ancestor
24431834|NCT00253110|Antiemetics|antiemetics|mesh-ancestor
24431835|NCT00253110|Autonomic Agents|autonomic agents|mesh-ancestor
24431839|NCT00253123|Risperidone|risperidone|mesh-list
25849632|NCT00049101|Oxaliplatin|oxaliplatin|mesh-list
25849633|NCT00049101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25849634|NCT00049101|Calcium|calcium|mesh-list
24431887|NCT00253175|Topiramate|topiramate|mesh-list
24431888|NCT00253175|Anticonvulsants|anticonvulsants|mesh-ancestor
24431889|NCT00253175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24431890|NCT00253175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431891|NCT00253188|Galantamine|galantamine|mesh-list
24431911|NCT00253201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24431912|NCT00253201|Nootropic Agents|nootropic agents|mesh-ancestor
24431913|NCT00253214|Galantamine|galantamine|mesh-list
24432070|NCT00253539|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24431914|NCT00253214|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24579037|NCT00853008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24431915|NCT00253214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431918|NCT00253214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431919|NCT00253214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431920|NCT00253214|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24431921|NCT00253214|Autonomic Agents|autonomic agents|mesh-ancestor
24431922|NCT00253214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24431923|NCT00253214|Nootropic Agents|nootropic agents|mesh-ancestor
24431924|NCT00253227|Galantamine|galantamine|mesh-list
24431925|NCT00253227|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24431926|NCT00253227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431928|NCT00253227|Cholinergic Agents|cholinergic agents|mesh-ancestor
24825151|NCT02127697|Autonomic Agents|autonomic agents|mesh-ancestor
24825152|NCT02127697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25849635|NCT00049101|Levoleucovorin|levoleucovorin|mesh-list
25849636|NCT00049101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25849637|NCT00049101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849638|NCT00049101|Antimetabolites|antimetabolites|mesh-ancestor
25849639|NCT00049101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849640|NCT00049101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25849641|NCT00049101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849642|NCT00049101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24431954|NCT00253305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431956|NCT00253318|Docetaxel|docetaxel|mesh-list
24431957|NCT00253318|Everolimus|everolimus|mesh-list
24431958|NCT00253318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24431959|NCT00253318|Antiemetics|antiemetics|mesh-ancestor
24431960|NCT00253318|Autonomic Agents|autonomic agents|mesh-ancestor
24431961|NCT00253318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24952611|NCT03892928|Propofol|propofol|mesh-list
25849643|NCT00049101|Immunologic Factors|immunologic factors|mesh-ancestor
24432012|NCT00253461|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24432013|NCT00253461|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24432014|NCT00253461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24432015|NCT00253461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432016|NCT00253461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393416|NCT00129948|Antiviral Agents|antiviral agents|mesh-ancestor
24432017|NCT00253461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432035|NCT00253487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24432036|NCT00253487|Immunologic Factors|immunologic factors|mesh-ancestor
24432037|NCT00253487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432038|NCT00253487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24432039|NCT00253487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432040|NCT00253500|Epirubicin|epirubicin|mesh-list
24432041|NCT00253500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24432042|NCT00253500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432043|NCT00253500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24432044|NCT00253500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24432045|NCT00253500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432046|NCT00253500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432047|NCT00253526|Gemcitabine|gemcitabine|mesh-list
24432048|NCT00253526|Bevacizumab|bevacizumab|mesh-list
24432049|NCT00253526|Antibodies|antibodies|mesh-list
24432050|NCT00253526|Immunoglobulins|immunoglobulins|mesh-list
24432051|NCT00253526|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24432052|NCT00253526|Mitogens|mitogens|mesh-list
24432053|NCT00253526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24432054|NCT00253526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432055|NCT00253526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24432056|NCT00253526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24432057|NCT00253526|Growth Substances|growth substances|mesh-ancestor
24432058|NCT00253526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432059|NCT00253526|Growth Inhibitors|growth inhibitors|mesh-ancestor
24432060|NCT00253526|Immunologic Factors|immunologic factors|mesh-ancestor
24432061|NCT00253526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24432062|NCT00253526|Antimetabolites|antimetabolites|mesh-ancestor
24432063|NCT00253526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432064|NCT00253526|Antiviral Agents|antiviral agents|mesh-ancestor
24432065|NCT00253526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24432066|NCT00253526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432067|NCT00253526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24432068|NCT00253526|Mitosis Modulators|mitosis modulators|mesh-ancestor
24432069|NCT00253539|Tamoxifen|tamoxifen|mesh-list
24432073|NCT00253539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432074|NCT00253539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24432075|NCT00253539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432076|NCT00253539|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24432077|NCT00253539|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24432078|NCT00253539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24432080|NCT00253552|Cyclophosphamide|cyclophosphamide|mesh-list
24432081|NCT00253552|Busulfan|busulfan|mesh-list
24432082|NCT00253552|Methotrexate|methotrexate|mesh-list
24432083|NCT00253552|Etoposide|etoposide|mesh-list
24432084|NCT00253552|Cyclosporins|cyclosporins|mesh-list
24432085|NCT00253552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24432086|NCT00253552|Immunologic Factors|immunologic factors|mesh-ancestor
24432088|NCT00253552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24432109|NCT00253565|Capecitabine|capecitabine|mesh-list
24432110|NCT00253565|Imatinib Mesylate|imatinib mesylate|mesh-list
24432111|NCT00253565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24432274|NCT00254189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24432275|NCT00254189|Contraceptive Agents|contraceptive agents|mesh-ancestor
24432276|NCT00254189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24432277|NCT00254189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24432278|NCT00254189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24432279|NCT00254189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24432280|NCT00254189|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24432281|NCT00254202|Iloperidone|iloperidone|mesh-list
24432282|NCT00254202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24432283|NCT00254202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24432284|NCT00254202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24432285|NCT00254202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432286|NCT00254202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24432287|NCT00254241|Risperidone|risperidone|mesh-list
24432289|NCT00254241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24432290|NCT00254241|Serotonin Agents|serotonin agents|mesh-ancestor
25662196|NCT01642212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25662197|NCT01642212|Respiratory System Agents|respiratory system agents|mesh-ancestor
25662198|NCT01642212|Glucocorticoids|glucocorticoids|mesh-ancestor
24432291|NCT00254241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24432294|NCT00254241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25849644|NCT00049101|Antidotes|antidotes|mesh-ancestor
25849645|NCT00049101|Protective Agents|protective agents|mesh-ancestor
25849646|NCT00049101|Vitamin B Complex|vitamin b complex|mesh-ancestor
25662200|NCT01642212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25662201|NCT01642238|Aspirin|aspirin|mesh-list
25662202|NCT01642238|Hirudins|hirudins|mesh-list
25662203|NCT01642238|Bivalirudin|bivalirudin|mesh-list
24955498|NCT03864250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24955509|NCT03864588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24432303|NCT00254254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432304|NCT00254254|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24432305|NCT00254254|Incretins|incretins|mesh-ancestor
24432306|NCT00254254|Hormones|hormones|mesh-ancestor
24432307|NCT00254254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24432308|NCT00254267|Motesanib diphosphate|motesanib diphosphate|mesh-list
24432309|NCT00254267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24432310|NCT00254267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432311|NCT00254267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432353|NCT00254553|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24432355|NCT00254553|Hormones|hormones|mesh-ancestor
25849647|NCT00049101|Vitamins|vitamins|mesh-ancestor
24432370|NCT00254631|Oxycodone|oxycodone|mesh-list
24432371|NCT00254631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24432372|NCT00254631|Narcotics|narcotics|mesh-ancestor
24432373|NCT00254631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24432374|NCT00254631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825165|NCT02127697|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24825166|NCT02127697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24432399|NCT00254735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24432400|NCT00254735|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24432401|NCT00254735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24579133|NCT00853450|Purinergic Agents|purinergic agents|mesh-ancestor
24432402|NCT00254735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24432403|NCT00254735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432404|NCT00254735|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24432405|NCT00254735|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24432406|NCT00254735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24432407|NCT00254735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24432408|NCT00254735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432422|NCT00254774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24432423|NCT00254774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24432424|NCT00254774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25849648|NCT00049101|Micronutrients|micronutrients|mesh-ancestor
25849649|NCT00049101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24432436|NCT00254787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24432437|NCT00254787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24432438|NCT00254787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432440|NCT00254800|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24432441|NCT00254800|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24432442|NCT00254800|Levonorgestrel|levonorgestrel|mesh-list
24432443|NCT00254800|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24432444|NCT00254800|Estradiol|estradiol|mesh-list
24432728|NCT00255788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24825170|NCT02127736|Antidepressive Agents|antidepressive agents|mesh-ancestor
24432524|NCT00255242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432525|NCT00255242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24432526|NCT00255242|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24432527|NCT00255242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432528|NCT00255255|Budesonide|budesonide|mesh-list
24432529|NCT00255255|Formoterol Fumarate|formoterol fumarate|mesh-list
24432530|NCT00255255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24432531|NCT00255255|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24432532|NCT00255255|Autonomic Agents|autonomic agents|mesh-ancestor
24432533|NCT00255255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24432534|NCT00255255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432535|NCT00255255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24432536|NCT00255255|Respiratory System Agents|respiratory system agents|mesh-ancestor
24432537|NCT00255255|Glucocorticoids|glucocorticoids|mesh-ancestor
24432538|NCT00255255|Hormones|hormones|mesh-ancestor
25662204|NCT01642238|Clopidogrel|clopidogrel|mesh-list
25662205|NCT01642238|Ticagrelor|ticagrelor|mesh-list
25662206|NCT01642238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25662207|NCT01642238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25662208|NCT01642238|Analgesics|analgesics|mesh-ancestor
25849650|NCT00049101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849652|NCT00049114|Doxorubicin|doxorubicin|mesh-list
24432609|NCT00255515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24432610|NCT00255515|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24432611|NCT00255515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24432612|NCT00255515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24432613|NCT00255515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432614|NCT00255528|Metoprolol|metoprolol|mesh-list
24432615|NCT00255528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24432617|NCT00255528|Sympatholytics|sympatholytics|mesh-ancestor
24432618|NCT00255528|Autonomic Agents|autonomic agents|mesh-ancestor
24432619|NCT00255528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24432620|NCT00255528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432621|NCT00255528|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24432622|NCT00255528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24432642|NCT00255567|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
24432643|NCT00255567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24432644|NCT00255567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24432645|NCT00255567|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24432646|NCT00255567|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24432647|NCT00255567|Schistosomicides|schistosomicides|mesh-ancestor
24432648|NCT00255567|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24825172|NCT02127736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24825173|NCT02127736|Analgesics|analgesics|mesh-ancestor
24825174|NCT02127736|Sensory System Agents|sensory system agents|mesh-ancestor
24432649|NCT00255567|Anthelmintics|anthelmintics|mesh-ancestor
24432702|NCT00255710|Antitubercular Agents|antitubercular agents|mesh-ancestor
24432703|NCT00255710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24432704|NCT00255710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24579276|NCT00854178|Isoflurane|isoflurane|mesh-list
24579406|NCT00854841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432709|NCT00255762|Carboplatin|carboplatin|mesh-list
24432710|NCT00255762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24432711|NCT00255762|Antibodies|antibodies|mesh-list
24432712|NCT00255762|Immunoglobulins|immunoglobulins|mesh-list
24432713|NCT00255762|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24432714|NCT00255762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24432715|NCT00255762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432716|NCT00255762|Tubulin Modulators|tubulin modulators|mesh-ancestor
24432717|NCT00255762|Antimitotic Agents|antimitotic agents|mesh-ancestor
24432718|NCT00255762|Mitosis Modulators|mitosis modulators|mesh-ancestor
24432719|NCT00255762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432720|NCT00255762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24432721|NCT00255762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24432722|NCT00255762|Growth Substances|growth substances|mesh-ancestor
24825176|NCT02127736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825177|NCT02127736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24485365|NCT00452725|Hormones|hormones|mesh-list
25849653|NCT00049114|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25849654|NCT00049114|Tipifarnib|tipifarnib|mesh-list
24432725|NCT00255762|Immunologic Factors|immunologic factors|mesh-ancestor
24432727|NCT00255788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432763|NCT00255996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24432764|NCT00255996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432765|NCT00255996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432766|NCT00256009|Misoprostol|misoprostol|mesh-list
24432767|NCT00256009|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24432768|NCT00256009|Abortifacient Agents|abortifacient agents|mesh-ancestor
24432769|NCT00256009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24432770|NCT00256009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432818|NCT00256321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432819|NCT00256321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24432820|NCT00256321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24432821|NCT00256321|Analgesics|analgesics|mesh-ancestor
24432822|NCT00256321|Sensory System Agents|sensory system agents|mesh-ancestor
24432823|NCT00256321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24432824|NCT00256321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432825|NCT00256321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24432826|NCT00256321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24825178|NCT02127736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25166490|NCT03993132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24825179|NCT02127736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24432827|NCT00256321|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24432828|NCT00256321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24432829|NCT00256321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432830|NCT00256334|Resveratrol|resveratrol|mesh-list
24432831|NCT00256334|Antioxidants|antioxidants|mesh-ancestor
24432832|NCT00256334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432833|NCT00256334|Protective Agents|protective agents|mesh-ancestor
24432834|NCT00256334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432835|NCT00256334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432836|NCT00256334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24432868|NCT00256542|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24432869|NCT00256542|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24432870|NCT00256646|Rosiglitazone|rosiglitazone|mesh-list
24432871|NCT00256646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24432872|NCT00256646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432873|NCT00256711|Vinorelbine|vinorelbine|mesh-list
24432875|NCT00256711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24432876|NCT00256711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432877|NCT00256711|Tubulin Modulators|tubulin modulators|mesh-ancestor
24432879|NCT00256711|Mitosis Modulators|mitosis modulators|mesh-ancestor
24432880|NCT00256711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432881|NCT00256711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24432882|NCT00256711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432883|NCT00256737|Omeprazole|omeprazole|mesh-list
24432884|NCT00256737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24432886|NCT00256737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24432887|NCT00256737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432888|NCT00256737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432890|NCT00256828|Efavirenz|efavirenz|mesh-list
24432891|NCT00256828|Didanosine|didanosine|mesh-list
24432892|NCT00256828|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24432893|NCT00256828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24432894|NCT00256828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432895|NCT00256828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432896|NCT00256828|Antiviral Agents|antiviral agents|mesh-ancestor
24432897|NCT00256828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24432898|NCT00256828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24432899|NCT00256828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24432901|NCT00256828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24432902|NCT00256828|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24432903|NCT00256828|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24432904|NCT00256828|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24432905|NCT00256828|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24432906|NCT00256828|Antimetabolites|antimetabolites|mesh-ancestor
24432908|NCT00256893|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24432909|NCT00256893|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24432910|NCT00256893|Dopamine Agonists|dopamine agonists|mesh-ancestor
24432911|NCT00256893|Dopamine Agents|dopamine agents|mesh-ancestor
24432912|NCT00256893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24825182|NCT02127736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24825183|NCT02127749|Metronidazole|metronidazole|mesh-list
24825184|NCT02127749|Vancomycin|vancomycin|mesh-list
24825185|NCT02127749|Ciprofloxacin|ciprofloxacin|mesh-list
24825186|NCT02127749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24432913|NCT00256893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432914|NCT00256893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432915|NCT00256932|Alvimopan|alvimopan|mesh-list
24432978|NCT00257075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24432979|NCT00257075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24432980|NCT00257075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24432981|NCT00257075|Dopamine Agents|dopamine agents|mesh-ancestor
24432982|NCT00257114|Bortezomib|bortezomib|mesh-list
24432983|NCT00257114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432984|NCT00257127|Vaccines|vaccines|mesh-list
24432985|NCT00257127|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24432986|NCT00257127|Immunologic Factors|immunologic factors|mesh-ancestor
24432987|NCT00257127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432988|NCT00257140|Levofloxacin|levofloxacin|mesh-list
24432989|NCT00257140|Ofloxacin|ofloxacin|mesh-list
24825187|NCT02127749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24825188|NCT02127749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24825189|NCT02127749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24825190|NCT02127749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24825191|NCT02127749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24825192|NCT02127749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432990|NCT00257140|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24432991|NCT00257140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25849656|NCT00049114|Immunologic Factors|immunologic factors|mesh-ancestor
25662209|NCT01642238|Sensory System Agents|sensory system agents|mesh-ancestor
25662210|NCT01642238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25849657|NCT00049114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849658|NCT00049114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25849659|NCT00049114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25849660|NCT00049114|Alkylating Agents|alkylating agents|mesh-ancestor
25233607|NCT02576119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233612|NCT02575924|Imidacloprid|imidacloprid|mesh-list
24432992|NCT00257140|Renal Agents|renal agents|mesh-ancestor
24432993|NCT00257140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24432994|NCT00257140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24432995|NCT00257140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24432996|NCT00257140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432997|NCT00257140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432998|NCT00257140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432999|NCT00257140|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24433000|NCT00257140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24433001|NCT00257257|Rimonabant|rimonabant|mesh-list
24433002|NCT00257257|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24433003|NCT00257257|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
25148656|NCT04823845|Adapalene|adapalene|mesh-list
24433005|NCT00257257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24433006|NCT00257257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433008|NCT00257257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24433198|NCT00257855|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24433009|NCT00257257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433022|NCT00257270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24433023|NCT00257270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433024|NCT00257270|Antimanic Agents|antimanic agents|mesh-ancestor
24433026|NCT00257348|Capecitabine|capecitabine|mesh-list
24433027|NCT00257348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433028|NCT00257348|Tubulin Modulators|tubulin modulators|mesh-ancestor
24433029|NCT00257348|Antimitotic Agents|antimitotic agents|mesh-ancestor
24433030|NCT00257348|Mitosis Modulators|mitosis modulators|mesh-ancestor
24433031|NCT00257348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433032|NCT00257348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24433033|NCT00257348|Antimetabolites|antimetabolites|mesh-ancestor
24433062|NCT00257452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24433063|NCT00257452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24433064|NCT00257452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24433065|NCT00257452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825195|NCT02127749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24825196|NCT02127749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24825197|NCT02127775|Lesinurad|lesinurad|mesh-list
24825198|NCT02127775|Gout Suppressants|gout suppressants|mesh-ancestor
24825199|NCT02127775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24825200|NCT02127775|Uricosuric Agents|uricosuric agents|mesh-ancestor
24825201|NCT02127775|Renal Agents|renal agents|mesh-ancestor
24433268|NCT00258050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24433066|NCT00257452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433067|NCT00257452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433068|NCT00257452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433069|NCT00257452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24433070|NCT00257452|Autonomic Agents|autonomic agents|mesh-ancestor
24433071|NCT00257452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24433072|NCT00257452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24433073|NCT00257452|Respiratory System Agents|respiratory system agents|mesh-ancestor
24433074|NCT00257452|Parasympatholytics|parasympatholytics|mesh-ancestor
24433075|NCT00257452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24433076|NCT00257452|Cholinergic Agents|cholinergic agents|mesh-ancestor
24433077|NCT00257452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24433082|NCT00257491|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24433083|NCT00257491|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25662211|NCT01642238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662212|NCT01642238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25662213|NCT01642238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25662214|NCT01642238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25662215|NCT01642238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25662216|NCT01642238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233641|NCT02575768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25233642|NCT02575768|Vasodilator Agents|vasodilator agents|mesh-ancestor
25233643|NCT02575768|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25849661|NCT00049114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433084|NCT00257491|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25166491|NCT03993132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433085|NCT00257491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433128|NCT00257621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24433129|NCT00257621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24825202|NCT02127788|Micafungin|micafungin|mesh-list
24825203|NCT02127788|Antifungal Agents|antifungal agents|mesh-ancestor
24825204|NCT02127788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24825205|NCT02127840|Epinephrine|epinephrine|mesh-list
24433130|NCT00257621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24433131|NCT00257634|Dexamethasone|dexamethasone|mesh-list
24433132|NCT00257634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24433133|NCT00257634|Antiemetics|antiemetics|mesh-ancestor
24433134|NCT00257634|Autonomic Agents|autonomic agents|mesh-ancestor
24433135|NCT00257634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24433148|NCT00257699|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24433149|NCT00257699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24433150|NCT00257699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24433151|NCT00257699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433152|NCT00257699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433153|NCT00257699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433154|NCT00257699|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24433155|NCT00257699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24433157|NCT00257712|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
24433159|NCT00257712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24433161|NCT00257712|Growth Substances|growth substances|mesh-ancestor
24433162|NCT00257751|Aprotinin|aprotinin|mesh-list
24433163|NCT00257751|Hemostatics|hemostatics|mesh-ancestor
24433164|NCT00257751|Coagulants|coagulants|mesh-ancestor
24433197|NCT00257855|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24433200|NCT00257855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24433201|NCT00257855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24433203|NCT00257868|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24433204|NCT00257868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433205|NCT00257868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433206|NCT00257868|Cholinergic Agents|cholinergic agents|mesh-ancestor
24433207|NCT00257868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24433208|NCT00257868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433209|NCT00257868|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24433210|NCT00257868|Protective Agents|protective agents|mesh-ancestor
24433212|NCT00257959|Sotalol|sotalol|mesh-list
24433213|NCT00257959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24433214|NCT00257959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24433215|NCT00257959|Vasodilator Agents|vasodilator agents|mesh-ancestor
24433216|NCT00257959|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24433217|NCT00257959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24433218|NCT00257959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433219|NCT00257959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24433220|NCT00257959|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24433221|NCT00257959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24433223|NCT00257959|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24433224|NCT00257959|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25849662|NCT00049114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433258|NCT00258050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24433259|NCT00258050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24433266|NCT00258050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433267|NCT00258050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24879694|NCT04528680|Paclitaxel|paclitaxel|mesh-list
24433322|NCT00258193|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
24433323|NCT00258193|Enzyme Activators|enzyme activators|mesh-ancestor
24433324|NCT00258193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433325|NCT00258193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24433327|NCT00258232|Capecitabine|capecitabine|mesh-list
24433328|NCT00258232|Irinotecan|irinotecan|mesh-list
24433329|NCT00258232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25662217|NCT01642238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25662218|NCT01642238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25662219|NCT01642238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25662220|NCT01642238|Antipyretics|antipyretics|mesh-ancestor
24433331|NCT00258232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433332|NCT00258232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433333|NCT00258232|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24433334|NCT00258232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24433335|NCT00258232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433338|NCT00258232|Analgesics|analgesics|mesh-ancestor
24433339|NCT00258232|Sensory System Agents|sensory system agents|mesh-ancestor
24433340|NCT00258232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24433341|NCT00258232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849663|NCT00049114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24825207|NCT02127840|Epinephryl borate|epinephryl borate|mesh-list
24825208|NCT02127840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24825209|NCT02127840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24825210|NCT02127840|Adrenergic Agents|adrenergic agents|mesh-ancestor
24433485|NCT00258596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24433486|NCT00258596|Immunologic Factors|immunologic factors|mesh-ancestor
24433487|NCT00258596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433488|NCT00258609|Botulinum Toxins|botulinum toxins|mesh-list
24433489|NCT00258609|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24433490|NCT00258609|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24433491|NCT00258609|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24433492|NCT00258609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24433493|NCT00258609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433494|NCT00258609|Cholinergic Agents|cholinergic agents|mesh-ancestor
24433495|NCT00258609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24433496|NCT00258609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433497|NCT00258609|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24433498|NCT00258609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24433499|NCT00258622|Lidocaine|lidocaine|mesh-list
24433529|NCT00258765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433531|NCT00258765|Antimitotic Agents|antimitotic agents|mesh-ancestor
24433532|NCT00258765|Mitosis Modulators|mitosis modulators|mesh-ancestor
24433533|NCT00258765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433534|NCT00258765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24433535|NCT00258765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433536|NCT00258791|Ibuprofen|ibuprofen|mesh-list
24433537|NCT00258791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24433563|NCT00259064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433564|NCT00259064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433566|NCT00259077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24579966|NCT00859079|Incretins|incretins|mesh-ancestor
24433567|NCT00259077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24433568|NCT00259077|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24433569|NCT00259077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433570|NCT00259077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433571|NCT00259116|Methocarbamol|methocarbamol|mesh-list
24433572|NCT00259116|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24433590|NCT00259142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24434248|NCT00261820|Tacrolimus|tacrolimus|mesh-list
24433591|NCT00259142|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24433592|NCT00259142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433593|NCT00259142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433594|NCT00259142|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24433595|NCT00259142|Renal Agents|renal agents|mesh-ancestor
24433596|NCT00259155|Rifaximin|rifaximin|mesh-list
24433597|NCT00259155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24433598|NCT00259155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24433630|NCT00259402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433632|NCT00259402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433633|NCT00259402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24433634|NCT00259402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24433635|NCT00259402|Immunologic Factors|immunologic factors|mesh-ancestor
24433636|NCT00259402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825211|NCT02127840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24825212|NCT02127840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825213|NCT02127840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433637|NCT00259428|Dronedarone|dronedarone|mesh-list
24433638|NCT00259428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24433639|NCT00259441|Simvastatin|simvastatin|mesh-list
24433640|NCT00259441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24433641|NCT00259441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24433642|NCT00259441|Antimetabolites|antimetabolites|mesh-ancestor
25233683|NCT02575443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24433643|NCT00259441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433644|NCT00259441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24433645|NCT00259441|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24433646|NCT00259441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433647|NCT00259636|Zonisamide|zonisamide|mesh-list
24433648|NCT00259636|Anticonvulsants|anticonvulsants|mesh-ancestor
24433649|NCT00259636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24433650|NCT00259636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24433651|NCT00259636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433652|NCT00259636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24433653|NCT00259636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433654|NCT00259662|Atorvastatin|atorvastatin|mesh-list
25849664|NCT00049114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24433701|NCT00259766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24433702|NCT00259766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433703|NCT00259766|Sympathomimetics|sympathomimetics|mesh-ancestor
24433704|NCT00259766|Tocolytic Agents|tocolytic agents|mesh-ancestor
24433705|NCT00259766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24433706|NCT00259779|Prednisolone|prednisolone|mesh-list
24433707|NCT00259779|Budesonide|budesonide|mesh-list
24433708|NCT00259779|Formoterol Fumarate|formoterol fumarate|mesh-list
24433709|NCT00259779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24433710|NCT00259779|Glucocorticoids|glucocorticoids|mesh-ancestor
24433711|NCT00259779|Hormones|hormones|mesh-ancestor
24433712|NCT00259779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24433713|NCT00259779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433714|NCT00259779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24433715|NCT00259779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433716|NCT00259779|Autonomic Agents|autonomic agents|mesh-ancestor
24433717|NCT00259779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24433718|NCT00259779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24433719|NCT00259779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24433720|NCT00259779|Respiratory System Agents|respiratory system agents|mesh-ancestor
24433787|NCT00259896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24433788|NCT00259922|Alvimopan|alvimopan|mesh-list
24433789|NCT00259922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24433790|NCT00259935|Topotecan|topotecan|mesh-list
24433791|NCT00259935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24433792|NCT00259935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24433793|NCT00259935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433794|NCT00259935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433795|NCT00259935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433796|NCT00259974|Rituximab|rituximab|mesh-list
24433797|NCT00259974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24433798|NCT00259974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433799|NCT00259974|Immunologic Factors|immunologic factors|mesh-ancestor
24433800|NCT00259974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433801|NCT00259974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24433802|NCT00259987|Lapatinib|lapatinib|mesh-list
24433803|NCT00259987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435004|NCT00264680|Lamotrigine|lamotrigine|mesh-list
24433804|NCT00259987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24433805|NCT00259987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433832|NCT00260247|Anticonvulsants|anticonvulsants|mesh-ancestor
25849665|NCT00049114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24433849|NCT00260260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24433850|NCT00260260|Narcotics|narcotics|mesh-ancestor
24433851|NCT00260260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24433852|NCT00260260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433853|NCT00260260|Analgesics|analgesics|mesh-ancestor
24825224|NCT02127853|Analgesics|analgesics|mesh-ancestor
24825225|NCT02127853|Sensory System Agents|sensory system agents|mesh-ancestor
24825226|NCT02127853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24433854|NCT00260260|Sensory System Agents|sensory system agents|mesh-ancestor
24433855|NCT00260260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24433856|NCT00260325|Valdecoxib|valdecoxib|mesh-list
24433857|NCT00260325|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24433869|NCT00260351|Vaccines|vaccines|mesh-list
24433870|NCT00260351|Immunologic Factors|immunologic factors|mesh-ancestor
24433871|NCT00260351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433872|NCT00260364|Gemcitabine|gemcitabine|mesh-list
24433873|NCT00260364|Bevacizumab|bevacizumab|mesh-list
24433874|NCT00260364|Capecitabine|capecitabine|mesh-list
24433875|NCT00260364|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24433876|NCT00260364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24433877|NCT00260364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433878|NCT00260364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24433879|NCT00260364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24433880|NCT00260364|Growth Substances|growth substances|mesh-ancestor
24433881|NCT00260364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433925|NCT00260624|Antidepressive Agents|antidepressive agents|mesh-ancestor
24433927|NCT00260702|Omalizumab|omalizumab|mesh-list
24433928|NCT00260702|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24433929|NCT00260702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24433930|NCT00260702|Respiratory System Agents|respiratory system agents|mesh-ancestor
24433937|NCT00260793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433939|NCT00260819|Bosentan|bosentan|mesh-list
24433940|NCT00260819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24433941|NCT00260819|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24433942|NCT00260819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433943|NCT00260988|Dalteparin|dalteparin|mesh-list
24433944|NCT00260988|Tinzaparin|tinzaparin|mesh-list
24433945|NCT00260988|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24433946|NCT00260988|Anticoagulants|anticoagulants|mesh-ancestor
24433947|NCT00260988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24434173|NCT00261599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24433961|NCT00261053|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24433962|NCT00261053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24433963|NCT00261053|Immunologic Factors|immunologic factors|mesh-ancestor
24433964|NCT00261053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433965|NCT00261079|Fexofenadine|fexofenadine|mesh-list
24433966|NCT00261079|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24433967|NCT00261079|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24433968|NCT00261079|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24433969|NCT00261079|Histamine Antagonists|histamine antagonists|mesh-ancestor
24433970|NCT00261079|Histamine Agents|histamine agents|mesh-ancestor
24433971|NCT00261079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24433972|NCT00261079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433973|NCT00261079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433974|NCT00261092|Oxaliplatin|oxaliplatin|mesh-list
24433975|NCT00261092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433976|NCT00261105|Telithromycin|telithromycin|mesh-list
24433977|NCT00261105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24433978|NCT00261105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24433979|NCT00261118|Rituximab|rituximab|mesh-list
24433990|NCT00261131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433991|NCT00261131|Cholinergic Agents|cholinergic agents|mesh-ancestor
24433992|NCT00261131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24433993|NCT00261131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433994|NCT00261131|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24433995|NCT00261131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24433996|NCT00261170|Bupropion|bupropion|mesh-list
24433997|NCT00261170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24433998|NCT00261170|Antidepressive Agents|antidepressive agents|mesh-ancestor
24433999|NCT00261170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24434000|NCT00261170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24434001|NCT00261170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24434002|NCT00261170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24434004|NCT00261170|Dopamine Agents|dopamine agents|mesh-ancestor
24434095|NCT00261482|Estrogens|estrogens|mesh-ancestor
24434096|NCT00261482|Hormones|hormones|mesh-ancestor
24434097|NCT00261482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24434111|NCT00261508|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24434112|NCT00261508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24434113|NCT00261508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24434114|NCT00261508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24434115|NCT00261508|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24434116|NCT00261508|Dopamine Agents|dopamine agents|mesh-ancestor
24434117|NCT00261521|Epoetin Alfa|epoetin alfa|mesh-list
24434118|NCT00261521|Hematinics|hematinics|mesh-ancestor
24434119|NCT00261547|Rituximab|rituximab|mesh-list
24434120|NCT00261547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24434121|NCT00261547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24434122|NCT00261547|Immunologic Factors|immunologic factors|mesh-ancestor
24434123|NCT00261547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434124|NCT00261547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24434125|NCT00261560|Acetaminophen|acetaminophen|mesh-list
24434126|NCT00261560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25849666|NCT00049114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25849667|NCT00049114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25662221|NCT01642238|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25849668|NCT00049166|Cisplatin|cisplatin|mesh-list
25849669|NCT00049166|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25233740|NCT02575508|Irinotecan|irinotecan|mesh-list
24434127|NCT00261560|Analgesics|analgesics|mesh-ancestor
24580507|NCT00862095|Topiramate|topiramate|mesh-list
24825231|NCT02127853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24825232|NCT02127853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24825233|NCT02127853|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24825235|NCT02127853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24825236|NCT02127853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825237|NCT02127853|Antimanic Agents|antimanic agents|mesh-ancestor
24825238|NCT02127866|Beclomethasone|beclomethasone|mesh-list
24825239|NCT02127866|Glycopyrrolate|glycopyrrolate|mesh-list
24825240|NCT02127866|Formoterol Fumarate|formoterol fumarate|mesh-list
24700444|NCT01452568|Anticoagulants|anticoagulants|mesh-ancestor
24434128|NCT00261560|Sensory System Agents|sensory system agents|mesh-ancestor
24434135|NCT00261573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434136|NCT00261573|Cholinergic Agents|cholinergic agents|mesh-ancestor
24434137|NCT00261573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24434138|NCT00261573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434139|NCT00261573|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24434140|NCT00261573|Autonomic Agents|autonomic agents|mesh-ancestor
24434141|NCT00261573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24434142|NCT00261573|Nootropic Agents|nootropic agents|mesh-ancestor
24434143|NCT00261586|Aspirin|aspirin|mesh-list
24434144|NCT00261586|Acetaminophen|acetaminophen|mesh-list
24434145|NCT00261586|Ibuprofen|ibuprofen|mesh-list
24434183|NCT00261612|Rituximab|rituximab|mesh-list
24434184|NCT00261612|Bortezomib|bortezomib|mesh-list
24434185|NCT00261612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24434186|NCT00261612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24434187|NCT00261612|Immunologic Factors|immunologic factors|mesh-ancestor
24434229|NCT00261729|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24434230|NCT00261729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24434231|NCT00261729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434232|NCT00261729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24434233|NCT00261729|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24434234|NCT00261729|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24434235|NCT00261729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24434236|NCT00261729|Adrenergic Agents|adrenergic agents|mesh-ancestor
24825241|NCT02127866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24825242|NCT02127866|Autonomic Agents|autonomic agents|mesh-ancestor
24825243|NCT02127866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24825244|NCT02127866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825245|NCT02127866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24825246|NCT02127866|Respiratory System Agents|respiratory system agents|mesh-ancestor
24613092|NCT01016990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434237|NCT00261742|Penicillins|penicillins|mesh-list
24434238|NCT00261742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24434239|NCT00261742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24434240|NCT00261755|Analgesics|analgesics|mesh-list
24434241|NCT00261755|Sensory System Agents|sensory system agents|mesh-ancestor
25166492|NCT03993132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24434242|NCT00261755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24434243|NCT00261755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434244|NCT00261820|Mycophenolic Acid|mycophenolic acid|mesh-list
24434245|NCT00261820|Sirolimus|sirolimus|mesh-list
24434246|NCT00261820|Methylprednisolone|methylprednisolone|mesh-list
24434247|NCT00261820|Prednisolone|prednisolone|mesh-list
24434250|NCT00261820|Immunologic Factors|immunologic factors|mesh-ancestor
24434251|NCT00261820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434291|NCT00261937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24434293|NCT00261937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434295|NCT00261976|Dermatologic Agents|dermatologic agents|mesh-ancestor
24434296|NCT00261976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24434297|NCT00261976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24434298|NCT00262015|Vaccines|vaccines|mesh-list
24434323|NCT00262210|Etoposide|etoposide|mesh-list
24434324|NCT00262210|Epirubicin|epirubicin|mesh-list
24434325|NCT00262210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25409340|NCT03384914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662222|NCT01642238|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25662223|NCT01642238|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25662224|NCT01642238|Purinergic Agents|purinergic agents|mesh-ancestor
25233769|NCT02575248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25233775|NCT02575183|Varenicline|varenicline|mesh-list
24434341|NCT00262210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24434342|NCT00262210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24434343|NCT00262210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24434373|NCT00262288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825247|NCT02127866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24825248|NCT02127866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24825249|NCT02127866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24825250|NCT02127866|Adrenergic Agents|adrenergic agents|mesh-ancestor
24825251|NCT02127866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24825252|NCT02127866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825253|NCT02127866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24549624|NCT00716391|Cisplatin|cisplatin|mesh-list
24825280|NCT02128022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825282|NCT02128061|Lenalidomide|lenalidomide|mesh-list
24825283|NCT02128061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24434495|NCT00262483|Ribavirin|ribavirin|mesh-list
24434496|NCT00262483|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24434497|NCT00262483|Antimetabolites|antimetabolites|mesh-ancestor
24434498|NCT00262483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434499|NCT00262483|Antiviral Agents|antiviral agents|mesh-ancestor
24434501|NCT00262548|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24434510|NCT00262561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24434511|NCT00262561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24434512|NCT00262561|Analgesics|analgesics|mesh-ancestor
24434513|NCT00262561|Sensory System Agents|sensory system agents|mesh-ancestor
25849670|NCT00049166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24434514|NCT00262561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24434515|NCT00262561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434516|NCT00262561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24434517|NCT00262561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24434518|NCT00262561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24434519|NCT00262561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24434520|NCT00262561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434521|NCT00262561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24434522|NCT00262561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24434523|NCT00262561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434524|NCT00262561|Antipyretics|antipyretics|mesh-ancestor
24434525|NCT00262574|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24434526|NCT00262574|Natriuretic Agents|natriuretic agents|mesh-ancestor
24434527|NCT00262574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434528|NCT00262587|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24434529|NCT00262587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24434530|NCT00262587|Autonomic Agents|autonomic agents|mesh-ancestor
24825305|NCT02128100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24825307|NCT02128100|Antidotes|antidotes|mesh-ancestor
24825308|NCT02128100|Protective Agents|protective agents|mesh-ancestor
24434533|NCT00262587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24434534|NCT00262587|Respiratory System Agents|respiratory system agents|mesh-ancestor
24434535|NCT00262587|Glucocorticoids|glucocorticoids|mesh-ancestor
24434536|NCT00262587|Hormones|hormones|mesh-ancestor
24434537|NCT00262587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24434538|NCT00262587|Sympathomimetics|sympathomimetics|mesh-ancestor
24434547|NCT00262769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434548|NCT00262769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24434549|NCT00262769|Immunologic Factors|immunologic factors|mesh-ancestor
24434550|NCT00262769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434551|NCT00262782|Fludarabine|fludarabine|mesh-list
24434552|NCT00262782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24434553|NCT00262795|Fludarabine|fludarabine|mesh-list
24434554|NCT00262795|Chlorambucil|chlorambucil|mesh-list
24434555|NCT00262795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435005|NCT00264680|Anticonvulsants|anticonvulsants|mesh-list
24434556|NCT00262795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434557|NCT00262795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24434558|NCT00262795|Alkylating Agents|alkylating agents|mesh-ancestor
24434559|NCT00262808|Leucovorin|leucovorin|mesh-list
24434562|NCT00262808|Calcium|calcium|mesh-list
24434589|NCT00262886|Alkylating Agents|alkylating agents|mesh-ancestor
24434590|NCT00262886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434591|NCT00262886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662225|NCT01642238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25662226|NCT01642238|Antithrombins|antithrombins|mesh-ancestor
24434592|NCT00262886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24825310|NCT02128100|Vitamins|vitamins|mesh-ancestor
24825311|NCT02128100|Micronutrients|micronutrients|mesh-ancestor
24581911|NCT00866645|Dopamine Agents|dopamine agents|mesh-ancestor
24825312|NCT02128126|Vaccines|vaccines|mesh-list
24825313|NCT02128126|Immunologic Factors|immunologic factors|mesh-ancestor
24825342|NCT02128204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24825358|NCT02128243|Antimetabolites|antimetabolites|mesh-ancestor
24825359|NCT02128243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24434603|NCT00262977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24434604|NCT00262977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24434606|NCT00262977|Sensory System Agents|sensory system agents|mesh-ancestor
24434607|NCT00262977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24434608|NCT00262977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434609|NCT00262977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24434610|NCT00262977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24434611|NCT00262977|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24434612|NCT00262977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24434613|NCT00262977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434614|NCT00262977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24434615|NCT00262977|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24434616|NCT00262977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434617|NCT00262977|Antipyretics|antipyretics|mesh-ancestor
24434618|NCT00263003|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24434625|NCT00263003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24434626|NCT00263003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434627|NCT00263003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24434628|NCT00263003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24434629|NCT00263016|Docetaxel|docetaxel|mesh-list
24434630|NCT00263016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24434631|NCT00263016|Tubulin Modulators|tubulin modulators|mesh-ancestor
24434633|NCT00263016|Mitosis Modulators|mitosis modulators|mesh-ancestor
24434634|NCT00263016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434635|NCT00263029|Capecitabine|capecitabine|mesh-list
24434636|NCT00263029|Oxaliplatin|oxaliplatin|mesh-list
24434637|NCT00263029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24434638|NCT00263029|Antimetabolites|antimetabolites|mesh-ancestor
24434639|NCT00263029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434640|NCT00263029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24434641|NCT00263055|Oxaliplatin|oxaliplatin|mesh-list
24434643|NCT00263068|Rotigotine|rotigotine|mesh-list
24434671|NCT00263133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434672|NCT00263185|Vitamin D|vitamin d|mesh-list
24434673|NCT00263185|Ergocalciferols|ergocalciferols|mesh-list
24580912|NCT00864019|Sertraline|sertraline|mesh-list
24825360|NCT02128243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24434675|NCT00263185|Vitamins|vitamins|mesh-list
24434676|NCT00263185|Calcium Carbonate|calcium carbonate|mesh-list
24434677|NCT00263185|Micronutrients|micronutrients|mesh-ancestor
24434678|NCT00263185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434679|NCT00263185|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24434680|NCT00263185|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24434681|NCT00263185|Antacids|antacids|mesh-ancestor
24434682|NCT00263185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434683|NCT00263185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24434684|NCT00263198|Letrozole|letrozole|mesh-list
24434685|NCT00263198|Vatalanib|vatalanib|mesh-list
24434686|NCT00263198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24434687|NCT00263198|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24434688|NCT00263198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24434689|NCT00263198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434691|NCT00263198|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24434724|NCT00263315|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24434725|NCT00263315|Amebicides|amebicides|mesh-ancestor
24434726|NCT00263315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24434727|NCT00263315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24434728|NCT00263315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24434729|NCT00263315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24434730|NCT00263315|Antifungal Agents|antifungal agents|mesh-ancestor
24434731|NCT00263354|Oxaliplatin|oxaliplatin|mesh-list
24434732|NCT00263354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24434733|NCT00263393|Atenolol|atenolol|mesh-list
24434745|NCT00263393|Autonomic Agents|autonomic agents|mesh-ancestor
24825385|NCT02128308|Ofloxacin|ofloxacin|mesh-list
24825386|NCT02128308|Cycloserine|cycloserine|mesh-list
24434747|NCT00263393|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24434749|NCT00263393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24434750|NCT00263393|Adrenergic Agents|adrenergic agents|mesh-ancestor
24434751|NCT00263393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24434752|NCT00263393|Protease Inhibitors|protease inhibitors|mesh-ancestor
24434770|NCT00263484|Dexamethasone acetate|dexamethasone acetate|mesh-list
24434771|NCT00263484|BB 1101|bb 1101|mesh-list
24434772|NCT00263484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24434773|NCT00263484|Antiemetics|antiemetics|mesh-ancestor
24434774|NCT00263484|Autonomic Agents|autonomic agents|mesh-ancestor
24434775|NCT00263484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24434776|NCT00263484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931055|NCT04094142|Acalabrutinib|acalabrutinib|mesh-list
24434777|NCT00263484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24434778|NCT00263484|Glucocorticoids|glucocorticoids|mesh-ancestor
24434779|NCT00263484|Hormones|hormones|mesh-ancestor
24434780|NCT00263484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24434781|NCT00263484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24434782|NCT00263484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24434783|NCT00263484|Protease Inhibitors|protease inhibitors|mesh-ancestor
24434784|NCT00263484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434785|NCT00263484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434786|NCT00263484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24434787|NCT00263484|Immunologic Factors|immunologic factors|mesh-ancestor
24434788|NCT00263484|Leprostatic Agents|leprostatic agents|mesh-ancestor
24434789|NCT00263484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24434790|NCT00263484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25849671|NCT00049166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24434810|NCT00263718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24434812|NCT00263718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24434813|NCT00263718|Respiratory System Agents|respiratory system agents|mesh-ancestor
24434895|NCT00264212|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24434896|NCT00264212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24434897|NCT00264212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434898|NCT00264212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24434899|NCT00264212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24434901|NCT00264225|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24434920|NCT00264277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434921|NCT00264277|Hemostatics|hemostatics|mesh-ancestor
24434922|NCT00264277|Coagulants|coagulants|mesh-ancestor
25849672|NCT00049166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434955|NCT00264472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434956|NCT00264485|Fentanyl|fentanyl|mesh-list
24434957|NCT00264485|Morphine|morphine|mesh-list
24434958|NCT00264485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24434959|NCT00264485|Narcotics|narcotics|mesh-ancestor
24434960|NCT00264485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24434961|NCT00264485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434962|NCT00264485|Analgesics|analgesics|mesh-ancestor
24434963|NCT00264485|Sensory System Agents|sensory system agents|mesh-ancestor
24434964|NCT00264485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24434965|NCT00264485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24434966|NCT00264485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24434967|NCT00264485|Anesthetics, General|anesthetics, general|mesh-ancestor
24434968|NCT00264485|Anesthetics|anesthetics|mesh-ancestor
24434969|NCT00264615|Lamotrigine|lamotrigine|mesh-list
24434970|NCT00264615|Anticonvulsants|anticonvulsants|mesh-ancestor
24434971|NCT00264615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24434997|NCT00264654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434998|NCT00264654|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24434999|NCT00264654|Antidepressive Agents|antidepressive agents|mesh-ancestor
24435000|NCT00264654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24435001|NCT00264654|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24435002|NCT00264654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24435003|NCT00264654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435006|NCT00264680|Valproic Acid|valproic acid|mesh-list
24435007|NCT00264680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24435008|NCT00264680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24435009|NCT00264680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435010|NCT00264680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24435011|NCT00264680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435012|NCT00264680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24906136|NCT04342065|Pregabalin|pregabalin|mesh-list
24435013|NCT00264680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24435014|NCT00264680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24435015|NCT00264680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24435016|NCT00264680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24435017|NCT00264680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435018|NCT00264680|GABA Agents|gaba agents|mesh-ancestor
24435019|NCT00264680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24435032|NCT00264901|Insulin Detemir|insulin detemir|mesh-list
25203446|NCT02714231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045356|NCT00961675|Ciprofloxacin|ciprofloxacin|mesh-list
24435033|NCT00264901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24825426|NCT02128321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24825427|NCT02128321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24825428|NCT02128321|Antifungal Agents|antifungal agents|mesh-ancestor
24825429|NCT02128321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24825431|NCT02128334|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24825432|NCT02128334|Fertility Agents|fertility agents|mesh-ancestor
25849673|NCT00049166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435040|NCT00264927|Satavaptan|satavaptan|mesh-list
24435041|NCT00264927|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24435042|NCT00264927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435043|NCT00264927|Natriuretic Agents|natriuretic agents|mesh-ancestor
24435044|NCT00264927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435045|NCT00264953|Prednisone|prednisone|mesh-list
24435046|NCT00264953|Etoposide|etoposide|mesh-list
24435090|NCT00265031|Vincristine|vincristine|mesh-list
24435091|NCT00265031|Doxorubicin|doxorubicin|mesh-list
24435092|NCT00265031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24435130|NCT00265265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24435131|NCT00265265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435132|NCT00265265|Adrenergic Agents|adrenergic agents|mesh-ancestor
24435156|NCT00265291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435157|NCT00265291|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24435158|NCT00265291|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24435159|NCT00265291|Adrenergic Agents|adrenergic agents|mesh-ancestor
24435160|NCT00265304|Ketoprofen|ketoprofen|mesh-list
24435167|NCT00265304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24435168|NCT00265304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24435169|NCT00265304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24435170|NCT00265304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435171|NCT00265304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435172|NCT00265408|Aspirin|aspirin|mesh-list
24435173|NCT00265408|Warfarin|warfarin|mesh-list
24435174|NCT00265408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24435175|NCT00265408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24435187|NCT00265408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435188|NCT00265408|Antipyretics|antipyretics|mesh-ancestor
24435189|NCT00265408|Anticoagulants|anticoagulants|mesh-ancestor
24435190|NCT00265460|Lobeline|lobeline|mesh-list
24435191|NCT00265460|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24435192|NCT00265460|Autonomic Agents|autonomic agents|mesh-ancestor
24435193|NCT00265460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24435194|NCT00265460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435195|NCT00265460|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24435196|NCT00265460|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24435197|NCT00265460|Cholinergic Agents|cholinergic agents|mesh-ancestor
24435198|NCT00265460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24435199|NCT00265460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435200|NCT00265460|Respiratory System Agents|respiratory system agents|mesh-ancestor
24435207|NCT00265551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435208|NCT00265551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24825438|NCT02128360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435210|NCT00265551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24435211|NCT00265551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24435212|NCT00265551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24435213|NCT00265551|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24435214|NCT00265551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24435215|NCT00265551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24435216|NCT00265551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435218|NCT00265551|Serotonin Agents|serotonin agents|mesh-ancestor
24435219|NCT00265642|Irbesartan|irbesartan|mesh-list
24435220|NCT00265642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24435221|NCT00265642|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25409341|NCT03384836|Pembrolizumab|pembrolizumab|mesh-list
24435222|NCT00265642|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24435223|NCT00265642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435224|NCT00265694|Gemcitabine|gemcitabine|mesh-list
24435225|NCT00265694|Carboplatin|carboplatin|mesh-list
24435226|NCT00265694|Vinorelbine|vinorelbine|mesh-list
24435227|NCT00265694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435228|NCT00265694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24435229|NCT00265694|Antimetabolites|antimetabolites|mesh-ancestor
25203447|NCT02714231|Anticonvulsants|anticonvulsants|mesh-ancestor
24435230|NCT00265694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435231|NCT00265694|Antiviral Agents|antiviral agents|mesh-ancestor
24435232|NCT00265694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24435233|NCT00265694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435234|NCT00265694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24435235|NCT00265694|Immunologic Factors|immunologic factors|mesh-ancestor
24435236|NCT00265694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435237|NCT00265694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24435241|NCT00265733|Paclitaxel|paclitaxel|mesh-list
24435242|NCT00265733|Capecitabine|capecitabine|mesh-list
24435244|NCT00265733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24435245|NCT00265733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435246|NCT00265733|Tubulin Modulators|tubulin modulators|mesh-ancestor
24435247|NCT00265733|Antimitotic Agents|antimitotic agents|mesh-ancestor
24435248|NCT00265733|Mitosis Modulators|mitosis modulators|mesh-ancestor
24435249|NCT00265733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435250|NCT00265733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24435251|NCT00265733|Antimetabolites|antimetabolites|mesh-ancestor
24435252|NCT00265746|Metformin|metformin|mesh-list
24435253|NCT00265746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24435254|NCT00265746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435255|NCT00265772|Prednisolone|prednisolone|mesh-list
24435256|NCT00265772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24435257|NCT00265772|Glucocorticoids|glucocorticoids|mesh-ancestor
24435258|NCT00265772|Hormones|hormones|mesh-ancestor
25849674|NCT00049179|Cytarabine|cytarabine|mesh-list
25849675|NCT00049179|Gemtuzumab|gemtuzumab|mesh-list
24435344|NCT00266058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24435345|NCT00266058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24435346|NCT00266058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24435348|NCT00266058|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24435387|NCT00266136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435389|NCT00266136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24435390|NCT00266136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24435391|NCT00266136|Antimetabolites|antimetabolites|mesh-ancestor
24435392|NCT00266136|Antiviral Agents|antiviral agents|mesh-ancestor
24435393|NCT00266136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24435394|NCT00266136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24435395|NCT00266136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24435396|NCT00266136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24435397|NCT00266136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435398|NCT00266149|Lamotrigine|lamotrigine|mesh-list
24435400|NCT00266149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24435401|NCT00266149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24435402|NCT00266149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435403|NCT00266149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24435404|NCT00266149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435405|NCT00266149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24435406|NCT00266149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24435407|NCT00266149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24435408|NCT00266149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24435409|NCT00266149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24435411|NCT00266162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24435412|NCT00266162|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24435413|NCT00266162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435414|NCT00266214|Lidocaine|lidocaine|mesh-list
24435415|NCT00266214|Anesthetics, Local|anesthetics, local|mesh-ancestor
24435416|NCT00266214|Anesthetics|anesthetics|mesh-ancestor
24529256|NCT00625196|Autonomic Agents|autonomic agents|mesh-ancestor
24435458|NCT00266448|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24435459|NCT00266448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24435460|NCT00266448|Disinfectants|disinfectants|mesh-ancestor
24435461|NCT00266487|Vitamins|vitamins|mesh-list
24435462|NCT00266487|Folic Acid|folic acid|mesh-list
24435463|NCT00266487|Vitamin B 12|vitamin b 12|mesh-list
24435464|NCT00266487|Vitamin B 6|vitamin b 6|mesh-list
24435465|NCT00266487|Pyridoxal|pyridoxal|mesh-list
25233829|NCT02574975|Respiratory System Agents|respiratory system agents|mesh-ancestor
25233830|NCT02574975|Glucocorticoids|glucocorticoids|mesh-ancestor
25233831|NCT02574975|Hormones|hormones|mesh-ancestor
25233832|NCT02574975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24906468|NCT04340388|Darunavir|darunavir|mesh-list
24906469|NCT04340388|Abacavir|abacavir|mesh-list
24906470|NCT04340388|Dolutegravir|dolutegravir|mesh-list
24435466|NCT00266487|Pyridoxine|pyridoxine|mesh-list
24549815|NCT00717652|Tretinoin|tretinoin|mesh-list
24825486|NCT02128633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24825488|NCT02128646|Bupivacaine|bupivacaine|mesh-list
24825489|NCT02128646|Anesthetics, Local|anesthetics, local|mesh-ancestor
24825490|NCT02128646|Anesthetics|anesthetics|mesh-ancestor
24825491|NCT02128646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24435564|NCT00266838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24435566|NCT00266838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435567|NCT00267163|Donepezil|donepezil|mesh-list
24435568|NCT00267163|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24435569|NCT00267163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435587|NCT00267176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24435588|NCT00267215|Lumiracoxib|lumiracoxib|mesh-list
24435589|NCT00267215|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24435590|NCT00267215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24435591|NCT00267215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849676|NCT00049179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25849677|NCT00049179|Antimetabolites|antimetabolites|mesh-ancestor
24435616|NCT00267267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24435617|NCT00267267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24435618|NCT00267267|Antimetabolites|antimetabolites|mesh-ancestor
24435619|NCT00267267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435620|NCT00267267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24435621|NCT00267267|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24435622|NCT00267267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435623|NCT00267306|Visilizumab|visilizumab|mesh-list
24825498|NCT02128646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24825499|NCT02128646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24825500|NCT02128646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24825501|NCT02128646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825502|NCT02128646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825503|NCT02128685|Dydrogesterone|dydrogesterone|mesh-list
24825504|NCT02128685|Progestins|progestins|mesh-ancestor
24825505|NCT02128685|Hormones|hormones|mesh-ancestor
24825506|NCT02128685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24825507|NCT02128685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825508|NCT02128841|Rivaroxaban|rivaroxaban|mesh-list
24825509|NCT02128841|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24825510|NCT02128841|Antithrombins|antithrombins|mesh-ancestor
24435628|NCT00267319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24435629|NCT00267319|Immunologic Factors|immunologic factors|mesh-ancestor
25203449|NCT02714231|Antiemetics|antiemetics|mesh-ancestor
24435631|NCT00267319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24435632|NCT00267319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25849678|NCT00049179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825519|NCT02128893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24825520|NCT02128893|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24701427|NCT01458977|Tenofovir|tenofovir|mesh-list
24435633|NCT00267332|Modafinil|modafinil|mesh-list
24435634|NCT00267332|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24435635|NCT00267332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435636|NCT00267332|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24435637|NCT00267332|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24435638|NCT00267332|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24435639|NCT00267332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435640|NCT00267384|Acetylcysteine|acetylcysteine|mesh-list
24435641|NCT00267384|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24435642|NCT00267384|Antiviral Agents|antiviral agents|mesh-ancestor
25662227|NCT01642238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25662228|NCT01642238|Protease Inhibitors|protease inhibitors|mesh-ancestor
25662229|NCT01642238|Anticoagulants|anticoagulants|mesh-ancestor
25662230|NCT01642251|Cisplatin|cisplatin|mesh-list
25662231|NCT01642251|Etoposide|etoposide|mesh-list
25662232|NCT01642251|Etoposide phosphate|etoposide phosphate|mesh-list
25662233|NCT01642251|Veliparib|veliparib|mesh-list
25662234|NCT01642251|Podophyllotoxin|podophyllotoxin|mesh-list
25662235|NCT01642251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24906569|NCT04339348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24906570|NCT04339348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24906604|NCT04338906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24435643|NCT00267384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24435644|NCT00267384|Expectorants|expectorants|mesh-ancestor
24435645|NCT00267384|Respiratory System Agents|respiratory system agents|mesh-ancestor
24435646|NCT00267384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24435647|NCT00267384|Antioxidants|antioxidants|mesh-ancestor
24435648|NCT00267384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435649|NCT00267384|Protective Agents|protective agents|mesh-ancestor
24435650|NCT00267384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435651|NCT00267384|Antidotes|antidotes|mesh-ancestor
24435652|NCT00267514|Sevelamer|sevelamer|mesh-list
24435653|NCT00267514|Chelating Agents|chelating agents|mesh-ancestor
24435654|NCT00267514|Sequestering Agents|sequestering agents|mesh-ancestor
24435655|NCT00267514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435656|NCT00267540|Cholecalciferol|cholecalciferol|mesh-list
24435657|NCT00267540|Vitamin D|vitamin d|mesh-list
24435658|NCT00267540|Vitamins|vitamins|mesh-ancestor
24435659|NCT00267540|Micronutrients|micronutrients|mesh-ancestor
24435661|NCT00267540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24435662|NCT00267540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24435663|NCT00267553|Toremifene|toremifene|mesh-list
24435664|NCT00267553|Letrozole|letrozole|mesh-list
24435665|NCT00267553|Atamestane|atamestane|mesh-list
24435666|NCT00267553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849679|NCT00049179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435679|NCT00267657|Reserpine|reserpine|mesh-list
24435680|NCT00267657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24435681|NCT00267657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24435682|NCT00267657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24435684|NCT00267657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435685|NCT00267657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24435686|NCT00267657|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24435687|NCT00267657|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24435688|NCT00267657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24435707|NCT00267813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24435708|NCT00267813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24825521|NCT02128893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435709|NCT00267813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435711|NCT00267813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24435712|NCT00267813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435713|NCT00267813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24435714|NCT00267813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24435715|NCT00267813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435716|NCT00267826|Rituximab|rituximab|mesh-list
24435717|NCT00267826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24435718|NCT00267826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435719|NCT00267826|Immunologic Factors|immunologic factors|mesh-ancestor
25849680|NCT00049179|Antiviral Agents|antiviral agents|mesh-ancestor
24435720|NCT00267826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435733|NCT00267917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24435734|NCT00267917|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24435735|NCT00267917|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24435736|NCT00267917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24435737|NCT00267917|Adrenergic Agents|adrenergic agents|mesh-ancestor
24435738|NCT00267917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24435739|NCT00267917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435775|NCT00268177|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24435776|NCT00268177|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24435777|NCT00268177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24435779|NCT00268177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24435780|NCT00268177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435781|NCT00268216|Fluticasone|fluticasone|mesh-list
24435782|NCT00268216|Xhance|xhance|mesh-list
24435783|NCT00268216|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24435784|NCT00268216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24435785|NCT00268216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24435786|NCT00268216|Autonomic Agents|autonomic agents|mesh-ancestor
24435787|NCT00268216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24435788|NCT00268216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662236|NCT01642251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25662237|NCT01642251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25662238|NCT01642251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24435789|NCT00268216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24435790|NCT00268216|Respiratory System Agents|respiratory system agents|mesh-ancestor
24435792|NCT00268216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24435793|NCT00268216|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24435794|NCT00268216|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24435795|NCT00268216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24435796|NCT00268216|Adrenergic Agents|adrenergic agents|mesh-ancestor
24435797|NCT00268216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24435798|NCT00268216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825523|NCT02128893|Antifungal Agents|antifungal agents|mesh-ancestor
24825524|NCT02128893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24825525|NCT02128906|Docetaxel|docetaxel|mesh-list
24825526|NCT02128906|Cetuximab|cetuximab|mesh-list
24825527|NCT02128906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825528|NCT02128906|Tubulin Modulators|tubulin modulators|mesh-ancestor
24825529|NCT02128906|Antimitotic Agents|antimitotic agents|mesh-ancestor
24825530|NCT02128906|Mitosis Modulators|mitosis modulators|mesh-ancestor
24825531|NCT02128906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825532|NCT02128906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24825533|NCT02128945|Fludarabine|fludarabine|mesh-list
24825534|NCT02128945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825535|NCT02128971|Ferrous fumarate|ferrous fumarate|mesh-list
24825536|NCT02128971|Trace Elements|trace elements|mesh-ancestor
24435799|NCT00268229|Cytarabine|cytarabine|mesh-list
24435880|NCT00268398|Antidotes|antidotes|mesh-ancestor
24435881|NCT00268398|Protective Agents|protective agents|mesh-ancestor
24435882|NCT00268398|Vitamin B Complex|vitamin b complex|mesh-ancestor
24435883|NCT00268398|Vitamins|vitamins|mesh-ancestor
24435884|NCT00268398|Micronutrients|micronutrients|mesh-ancestor
24435885|NCT00268398|Hematinics|hematinics|mesh-ancestor
24435888|NCT00268411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24435915|NCT00268515|Cyclosporins|cyclosporins|mesh-list
24435916|NCT00268515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24435917|NCT00268515|Glucocorticoids|glucocorticoids|mesh-ancestor
24435918|NCT00268515|Hormones|hormones|mesh-ancestor
24435919|NCT00268515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24435921|NCT00268515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24435922|NCT00268515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435923|NCT00268515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24435924|NCT00268515|Immunologic Factors|immunologic factors|mesh-ancestor
24435925|NCT00268515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24435926|NCT00268515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435927|NCT00268515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435928|NCT00268515|Antifungal Agents|antifungal agents|mesh-ancestor
24435929|NCT00268515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24435930|NCT00268515|Dermatologic Agents|dermatologic agents|mesh-ancestor
24825537|NCT02128971|Micronutrients|micronutrients|mesh-ancestor
24825538|NCT02128971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825539|NCT02128984|Antioxidants|antioxidants|mesh-list
24825540|NCT02128984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435943|NCT00268528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435952|NCT00268554|Caffeine|caffeine|mesh-list
24435953|NCT00268554|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24435954|NCT00268554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435955|NCT00268554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24435956|NCT00268554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435957|NCT00268554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435958|NCT00268554|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24435959|NCT00268554|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24435960|NCT00268554|Purinergic Agents|purinergic agents|mesh-ancestor
24435961|NCT00268554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24435962|NCT00268554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24435963|NCT00268554|Vasodilator Agents|vasodilator agents|mesh-ancestor
24435964|NCT00268567|Prednisone|prednisone|mesh-list
24435965|NCT00268567|Leflunomide|leflunomide|mesh-list
24435966|NCT00268567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24435967|NCT00268567|Glucocorticoids|glucocorticoids|mesh-ancestor
24435968|NCT00268567|Hormones|hormones|mesh-ancestor
24435969|NCT00268567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24435970|NCT00268567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435971|NCT00268567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24436011|NCT00268671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436012|NCT00268684|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24436014|NCT00268684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24436015|NCT00268684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25662239|NCT01642251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906860|NCT04336332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906861|NCT04336332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24906862|NCT04336488|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24906893|NCT04336228|Autonomic Agents|autonomic agents|mesh-ancestor
24906894|NCT04336228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24906895|NCT04336228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24906896|NCT04336228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24906897|NCT04336228|Cholinergic Agents|cholinergic agents|mesh-ancestor
24436016|NCT00268684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24436017|NCT00268684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436018|NCT00268684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24436019|NCT00268684|Alkylating Agents|alkylating agents|mesh-ancestor
24436020|NCT00268697|Ezetimibe|ezetimibe|mesh-list
24436021|NCT00268697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24436022|NCT00268697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24436023|NCT00268697|Antimetabolites|antimetabolites|mesh-ancestor
24436025|NCT00268697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24436045|NCT00268723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24436046|NCT00268723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436047|NCT00268749|Glycine|glycine|mesh-list
24436058|NCT00268788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436059|NCT00268814|Methadone|methadone|mesh-list
24436060|NCT00268814|Heroin|heroin|mesh-list
24436061|NCT00268814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24436062|NCT00268814|Narcotics|narcotics|mesh-ancestor
24436063|NCT00268814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24436064|NCT00268814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436065|NCT00268814|Analgesics|analgesics|mesh-ancestor
24436066|NCT00268814|Sensory System Agents|sensory system agents|mesh-ancestor
24436067|NCT00268814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24436097|NCT00268918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436098|NCT00268918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24436099|NCT00268918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24436101|NCT00268957|Chelating Agents|chelating agents|mesh-ancestor
24436102|NCT00268957|Sequestering Agents|sequestering agents|mesh-ancestor
24436110|NCT00268970|Mitosis Modulators|mitosis modulators|mesh-ancestor
24436111|NCT00268970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436112|NCT00269035|Risperidone|risperidone|mesh-list
24436113|NCT00269035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24436114|NCT00269035|Serotonin Agents|serotonin agents|mesh-ancestor
24436115|NCT00269035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24436116|NCT00269035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436117|NCT00269035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436118|NCT00269035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24436119|NCT00269035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24436120|NCT00269035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24436122|NCT00269035|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24436124|NCT00269061|Pioglitazone|pioglitazone|mesh-list
24436125|NCT00269061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24436126|NCT00269061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436127|NCT00269126|Fluticasone|fluticasone|mesh-list
24436129|NCT00269126|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24436136|NCT00269126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24436151|NCT00269204|Niacinamide|niacinamide|mesh-list
24436152|NCT00269204|Nicotinic Acids|nicotinic acids|mesh-list
24436153|NCT00269204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24436154|NCT00269204|Antimetabolites|antimetabolites|mesh-ancestor
24825553|NCT02129114|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24825554|NCT02129114|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24825555|NCT02129114|Estradiol|estradiol|mesh-list
24825556|NCT02129114|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24825557|NCT02129114|Estrogens|estrogens|mesh-ancestor
24825558|NCT02129114|Hormones|hormones|mesh-ancestor
24825559|NCT02129114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24825560|NCT02129114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409342|NCT03384836|Propranolol|propranolol|mesh-list
25662240|NCT01642251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662241|NCT01642251|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25662242|NCT01642251|Keratolytic Agents|keratolytic agents|mesh-ancestor
25662243|NCT01642251|Dermatologic Agents|dermatologic agents|mesh-ancestor
25662244|NCT01642251|Tubulin Modulators|tubulin modulators|mesh-ancestor
25662245|NCT01642251|Antimitotic Agents|antimitotic agents|mesh-ancestor
25662246|NCT01642251|Mitosis Modulators|mitosis modulators|mesh-ancestor
25662247|NCT01642277|Solifenacin Succinate|solifenacin succinate|mesh-list
25233862|NCT02574741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25233863|NCT02574741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233864|NCT02574741|Dopamine Agonists|dopamine agonists|mesh-ancestor
24825561|NCT02129114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24825562|NCT02129114|Contraceptive Agents|contraceptive agents|mesh-ancestor
24825563|NCT02129114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24825564|NCT02129114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24436155|NCT00269204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436156|NCT00269204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24436157|NCT00269204|Vasodilator Agents|vasodilator agents|mesh-ancestor
24436158|NCT00269204|Vitamin B Complex|vitamin b complex|mesh-ancestor
24436159|NCT00269204|Vitamins|vitamins|mesh-ancestor
24436160|NCT00269204|Micronutrients|micronutrients|mesh-ancestor
24436161|NCT00269204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436163|NCT00269217|Niacinamide|niacinamide|mesh-list
24436166|NCT00269217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24436167|NCT00269217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24436168|NCT00269217|Antimetabolites|antimetabolites|mesh-ancestor
24436169|NCT00269217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849681|NCT00049179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24436170|NCT00269217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24436171|NCT00269217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24436172|NCT00269217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24436174|NCT00269217|Vitamin B Complex|vitamin b complex|mesh-ancestor
24436176|NCT00269217|Micronutrients|micronutrients|mesh-ancestor
24436177|NCT00269217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436178|NCT00269243|Quinapril|quinapril|mesh-list
24436179|NCT00269243|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24436181|NCT00269243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24436735|NCT00271271|Gemcitabine|gemcitabine|mesh-list
24436183|NCT00269243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24436184|NCT00269269|Antihypertensive Agents|antihypertensive agents|mesh-list
24436185|NCT00269334|Paroxetine|paroxetine|mesh-list
24436243|NCT00269568|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24436244|NCT00269568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24436245|NCT00269568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24436246|NCT00269568|Contraceptive Agents|contraceptive agents|mesh-ancestor
24436247|NCT00269568|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24436248|NCT00269568|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24436249|NCT00269568|Hormone Antagonists|hormone antagonists|mesh-ancestor
24436250|NCT00269568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24436251|NCT00269568|Luteolytic Agents|luteolytic agents|mesh-ancestor
24436253|NCT00269568|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24436254|NCT00269594|Lamotrigine|lamotrigine|mesh-list
24436255|NCT00269594|Anticonvulsants|anticonvulsants|mesh-ancestor
24436256|NCT00269594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24436257|NCT00269594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24436258|NCT00269594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436259|NCT00269594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24436260|NCT00269594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436261|NCT00269594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24436262|NCT00269594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24436283|NCT00269620|Hormones|hormones|mesh-ancestor
24436284|NCT00269620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24436285|NCT00269620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436309|NCT00269724|Cholinergic Agents|cholinergic agents|mesh-ancestor
24436310|NCT00269724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24436311|NCT00269724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436312|NCT00269724|Urological Agents|urological agents|mesh-ancestor
24436314|NCT00269737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24436315|NCT00269737|Narcotics|narcotics|mesh-ancestor
24825579|NCT02129179|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25662248|NCT01642277|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25662249|NCT01642277|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25662250|NCT01642277|Cholinergic Agents|cholinergic agents|mesh-ancestor
25662251|NCT01642277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25662252|NCT01642277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662253|NCT01642277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662254|NCT01642277|Urological Agents|urological agents|mesh-ancestor
25849682|NCT00049179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25849683|NCT00049179|Immunologic Factors|immunologic factors|mesh-ancestor
25849684|NCT00049179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849685|NCT00049179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25849686|NCT00049192|Imatinib Mesylate|imatinib mesylate|mesh-list
24907235|NCT04331600|Chloroquine|chloroquine|mesh-list
24907236|NCT04331600|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24907237|NCT04331600|Amebicides|amebicides|mesh-ancestor
24907261|NCT04331418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24907262|NCT04331418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24976326|NCT04154800|Hormone Antagonists|hormone antagonists|mesh-ancestor
24825580|NCT02129179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24825581|NCT02129179|Hormones|hormones|mesh-ancestor
24825582|NCT02129179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24436316|NCT00269737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24436317|NCT00269737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436318|NCT00269737|Analgesics|analgesics|mesh-ancestor
24436319|NCT00269737|Sensory System Agents|sensory system agents|mesh-ancestor
24436320|NCT00269737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24436321|NCT00269737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24436322|NCT00269737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24436323|NCT00269737|Anesthetics, General|anesthetics, general|mesh-ancestor
24436324|NCT00269737|Anesthetics|anesthetics|mesh-ancestor
24436325|NCT00269750|Oxybutynin|oxybutynin|mesh-list
24436326|NCT00269750|Parasympatholytics|parasympatholytics|mesh-ancestor
24436327|NCT00269750|Autonomic Agents|autonomic agents|mesh-ancestor
24825617|NCT02129257|Growth Substances|growth substances|mesh-ancestor
24436328|NCT00269750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24436337|NCT00269763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24436339|NCT00269763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24436340|NCT00269763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436341|NCT00269763|Analgesics|analgesics|mesh-ancestor
24436342|NCT00269763|Sensory System Agents|sensory system agents|mesh-ancestor
24436343|NCT00269763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24436360|NCT00269789|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24436361|NCT00269789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24436362|NCT00269789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24436363|NCT00269789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436364|NCT00269789|Dopamine Agents|dopamine agents|mesh-ancestor
24436365|NCT00269789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24436366|NCT00269802|Methylphenidate|methylphenidate|mesh-list
24436367|NCT00269802|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24436369|NCT00269802|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24436391|NCT00269828|Mitosis Modulators|mitosis modulators|mesh-ancestor
25203452|NCT02714231|Mydriatics|mydriatics|mesh-ancestor
25203451|NCT02714231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24931700|NCT04085913|Sensory System Agents|sensory system agents|mesh-ancestor
24436392|NCT00269828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436393|NCT00269841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24436394|NCT00269841|Infliximab|infliximab|mesh-list
24632861|NCT01125943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24436395|NCT00269841|Antibodies|antibodies|mesh-list
24436396|NCT00269841|Immunoglobulins|immunoglobulins|mesh-list
24436397|NCT00269841|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24436398|NCT00269841|Immunologic Factors|immunologic factors|mesh-ancestor
24825583|NCT02129179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825584|NCT02129179|Incretins|incretins|mesh-ancestor
24825585|NCT02129231|Magnesium Oxide|magnesium oxide|mesh-list
24825586|NCT02129231|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24825587|NCT02129231|Simvastatin|simvastatin|mesh-list
24825589|NCT02129231|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
24825590|NCT02129231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24825591|NCT02129231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24436399|NCT00269841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436400|NCT00269841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24436401|NCT00269841|Dermatologic Agents|dermatologic agents|mesh-ancestor
24436402|NCT00269841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25662255|NCT01642407|Sildenafil Citrate|sildenafil citrate|mesh-list
25662256|NCT01642407|Vasodilator Agents|vasodilator agents|mesh-ancestor
25662257|NCT01642407|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25662258|NCT01642407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25662259|NCT01642407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25662260|NCT01642407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662261|NCT01642407|Urological Agents|urological agents|mesh-ancestor
25662262|NCT01642485|Moxifloxacin|moxifloxacin|mesh-list
24907562|NCT04329858|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24436403|NCT00269841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24436404|NCT00269854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24436405|NCT00269854|Infliximab|infliximab|mesh-list
24436406|NCT00269854|Antibodies|antibodies|mesh-list
24436407|NCT00269854|Immunoglobulins|immunoglobulins|mesh-list
24436408|NCT00269854|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24436409|NCT00269854|Immunologic Factors|immunologic factors|mesh-ancestor
24436474|NCT00270088|Epoetin Alfa|epoetin alfa|mesh-list
24436475|NCT00270088|Hematinics|hematinics|mesh-ancestor
24436476|NCT00270101|Epoetin Alfa|epoetin alfa|mesh-list
24436477|NCT00270101|Hematinics|hematinics|mesh-ancestor
24436478|NCT00270114|Epoetin Alfa|epoetin alfa|mesh-list
24436479|NCT00270114|Hematinics|hematinics|mesh-ancestor
24436480|NCT00270127|Epoetin Alfa|epoetin alfa|mesh-list
24436481|NCT00270127|Hematinics|hematinics|mesh-ancestor
24436482|NCT00270140|Epoetin Alfa|epoetin alfa|mesh-list
24436483|NCT00270140|Hematinics|hematinics|mesh-ancestor
24436485|NCT00270153|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24436486|NCT00270153|Protease Inhibitors|protease inhibitors|mesh-ancestor
24436487|NCT00270153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24436488|NCT00270153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436489|NCT00270153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24436490|NCT00270166|Epoetin Alfa|epoetin alfa|mesh-list
24436491|NCT00270166|Hematinics|hematinics|mesh-ancestor
24436492|NCT00270179|Epoetin Alfa|epoetin alfa|mesh-list
24436493|NCT00270179|Hematinics|hematinics|mesh-ancestor
24436568|NCT00270491|Mitosis Modulators|mitosis modulators|mesh-ancestor
24436627|NCT00270582|Immunologic Factors|immunologic factors|mesh-ancestor
24436628|NCT00270582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436629|NCT00270582|Tubulin Modulators|tubulin modulators|mesh-ancestor
24436630|NCT00270582|Antimitotic Agents|antimitotic agents|mesh-ancestor
24436631|NCT00270582|Mitosis Modulators|mitosis modulators|mesh-ancestor
24436633|NCT00270647|Ascorbic Acid|ascorbic acid|mesh-list
24436634|NCT00270647|Vitamin E|vitamin e|mesh-list
24436635|NCT00270647|Beta Carotene|beta carotene|mesh-list
24436636|NCT00270647|Carotenoids|carotenoids|mesh-list
24436637|NCT00270647|Micronutrients|micronutrients|mesh-ancestor
24436638|NCT00270647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436639|NCT00270647|Antioxidants|antioxidants|mesh-ancestor
24436640|NCT00270647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436641|NCT00270647|Protective Agents|protective agents|mesh-ancestor
24436642|NCT00270647|Provitamins|provitamins|mesh-ancestor
24436643|NCT00270751|Minocycline|minocycline|mesh-list
24436663|NCT00270777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24436664|NCT00270777|Respiratory System Agents|respiratory system agents|mesh-ancestor
24436665|NCT00270777|Mydriatics|mydriatics|mesh-ancestor
24436666|NCT00270777|Sympathomimetics|sympathomimetics|mesh-ancestor
24436667|NCT00270777|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24436668|NCT00270777|Antipruritics|antipruritics|mesh-ancestor
24436669|NCT00270777|Dermatologic Agents|dermatologic agents|mesh-ancestor
24436670|NCT00270777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24436671|NCT00270777|Histamine Antagonists|histamine antagonists|mesh-ancestor
24436672|NCT00270777|Histamine Agents|histamine agents|mesh-ancestor
24436673|NCT00270777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24436674|NCT00270777|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24436675|NCT00270777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24436676|NCT00270777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24436679|NCT00270777|Sensory System Agents|sensory system agents|mesh-ancestor
24436680|NCT00270777|Antiemetics|antiemetics|mesh-ancestor
24825612|NCT02129257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24437056|NCT00272584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437058|NCT00272584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24437059|NCT00272584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24437060|NCT00272584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24437061|NCT00272584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24437062|NCT00272584|Dopamine Agents|dopamine agents|mesh-ancestor
24437064|NCT00272597|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24437065|NCT00272597|Serotonin Agents|serotonin agents|mesh-ancestor
24437066|NCT00272597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24825615|NCT02129257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24825616|NCT02129257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25662263|NCT01642485|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24437155|NCT00272805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24437156|NCT00272805|Antioxidants|antioxidants|mesh-ancestor
25849687|NCT00049192|Oblimersen|oblimersen|mesh-list
24437205|NCT00272948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24437206|NCT00272948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25409343|NCT03384836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24437207|NCT00272948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437238|NCT00273039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24437239|NCT00273039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24437240|NCT00273039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24437241|NCT00273039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437242|NCT00273039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24437244|NCT00273039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849688|NCT00049192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849689|NCT00049192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25849690|NCT00049192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849691|NCT00049192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825618|NCT02129257|Growth Inhibitors|growth inhibitors|mesh-ancestor
24825619|NCT02129257|Antidotes|antidotes|mesh-ancestor
24825620|NCT02129257|Protective Agents|protective agents|mesh-ancestor
24825621|NCT02129257|Vitamin B Complex|vitamin b complex|mesh-ancestor
24582530|NCT00870272|Oxytocics|oxytocics|mesh-ancestor
24437651|NCT00274079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437652|NCT00274092|Tiotropium Bromide|tiotropium bromide|mesh-list
24437653|NCT00274092|Ipratropium|ipratropium|mesh-list
24437654|NCT00274092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24437655|NCT00274092|Autonomic Agents|autonomic agents|mesh-ancestor
24437656|NCT00274092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24437657|NCT00274092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437658|NCT00274092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24437659|NCT00274092|Respiratory System Agents|respiratory system agents|mesh-ancestor
25849693|NCT00049218|Etoposide|etoposide|mesh-list
25849694|NCT00049218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24437662|NCT00274092|Cholinergic Agents|cholinergic agents|mesh-ancestor
24437732|NCT00274391|Diuretics|diuretics|mesh-ancestor
24437733|NCT00274391|Natriuretic Agents|natriuretic agents|mesh-ancestor
24437754|NCT00274430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24437790|NCT00274508|Respiratory System Agents|respiratory system agents|mesh-ancestor
24437791|NCT00274508|Parasympatholytics|parasympatholytics|mesh-ancestor
24437792|NCT00274508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24437793|NCT00274508|Cholinergic Agents|cholinergic agents|mesh-ancestor
24437794|NCT00274508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24437795|NCT00274508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437796|NCT00274508|Anticonvulsants|anticonvulsants|mesh-ancestor
24437797|NCT00274521|Tiotropium Bromide|tiotropium bromide|mesh-list
24437798|NCT00274521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24437799|NCT00274521|Autonomic Agents|autonomic agents|mesh-ancestor
24437845|NCT00274560|Respiratory System Agents|respiratory system agents|mesh-ancestor
25849695|NCT00049218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24437876|NCT00274599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437877|NCT00274599|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24437878|NCT00274599|Protease Inhibitors|protease inhibitors|mesh-ancestor
24437879|NCT00274599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24437880|NCT00274612|Telmisartan|telmisartan|mesh-list
24437882|NCT00274612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24437883|NCT00274612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24438146|NCT00275067|Alkylating Agents|alkylating agents|mesh-ancestor
24816099|NCT02074189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438147|NCT00275067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438148|NCT00275067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438150|NCT00275080|Azacitidine|azacitidine|mesh-list
24550436|NCT00720577|Pioglitazone|pioglitazone|mesh-list
25849696|NCT00049218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24438270|NCT00275249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24438271|NCT00275249|Narcotics|narcotics|mesh-ancestor
24438272|NCT00275249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24438273|NCT00275249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438275|NCT00275249|Sensory System Agents|sensory system agents|mesh-ancestor
24438276|NCT00275249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24438277|NCT00275314|Valganciclovir|valganciclovir|mesh-list
24438278|NCT00275314|Antiviral Agents|antiviral agents|mesh-ancestor
24438279|NCT00275314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24438280|NCT00275405|Allyl sulfide|allyl sulfide|mesh-list
24438281|NCT00275405|Antioxidants|antioxidants|mesh-ancestor
24825677|NCT02129595|Antioxidants|antioxidants|mesh-ancestor
24438346|NCT00275548|Ribavirin|ribavirin|mesh-list
24438389|NCT00275730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24438390|NCT00275730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438391|NCT00275730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24438392|NCT00275730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24908116|NCT04324060|Danazol|danazol|mesh-list
24908201|NCT04322760|Bupivacaine|bupivacaine|mesh-list
24438393|NCT00275730|Gout Suppressants|gout suppressants|mesh-ancestor
24438394|NCT00275730|Tocolytic Agents|tocolytic agents|mesh-ancestor
24438395|NCT00275730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24825656|NCT02129582|Immunoglobulins|immunoglobulins|mesh-list
24438400|NCT00275756|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24438401|NCT00275756|Dorzolamide|dorzolamide|mesh-list
24438402|NCT00275756|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24438403|NCT00275756|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24438404|NCT00275756|Adrenergic Agents|adrenergic agents|mesh-ancestor
24438405|NCT00275756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24438406|NCT00275756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438407|NCT00275756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438408|NCT00275756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24438409|NCT00275756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24438410|NCT00275756|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24438476|NCT00276029|Immunologic Factors|immunologic factors|mesh-ancestor
24438477|NCT00276055|Gemcitabine|gemcitabine|mesh-list
24438478|NCT00276055|Bevacizumab|bevacizumab|mesh-list
24438479|NCT00276055|Docetaxel|docetaxel|mesh-list
24438480|NCT00276055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24438481|NCT00276055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438482|NCT00276055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24438494|NCT00276055|Immunologic Factors|immunologic factors|mesh-ancestor
24438495|NCT00276055|Tubulin Modulators|tubulin modulators|mesh-ancestor
24438496|NCT00276055|Antimitotic Agents|antimitotic agents|mesh-ancestor
24438497|NCT00276055|Mitosis Modulators|mitosis modulators|mesh-ancestor
24438500|NCT00276068|Anesthetics, Local|anesthetics, local|mesh-ancestor
24438514|NCT00276068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438515|NCT00276068|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24438516|NCT00276068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24438517|NCT00276068|Adrenergic Agents|adrenergic agents|mesh-ancestor
24438518|NCT00276068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24438520|NCT00276081|Estrogens|estrogens|mesh-list
24438572|NCT00276198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881801|NCT01239797|Autonomic Agents|autonomic agents|mesh-ancestor
24438573|NCT00276198|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24438574|NCT00276276|Topotecan|topotecan|mesh-list
24438575|NCT00276276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24881802|NCT01239797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24438576|NCT00276276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24438577|NCT00276276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438578|NCT00276276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438579|NCT00276276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438580|NCT00276289|Spironolactone|spironolactone|mesh-list
24438581|NCT00276289|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24438582|NCT00276289|Hormone Antagonists|hormone antagonists|mesh-ancestor
24438840|NCT00276809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438648|NCT00276588|Mitosis Modulators|mitosis modulators|mesh-ancestor
24438649|NCT00276588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438650|NCT00276588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24438651|NCT00276588|Antimetabolites|antimetabolites|mesh-ancestor
24438652|NCT00276588|Antiviral Agents|antiviral agents|mesh-ancestor
24438653|NCT00276588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24438654|NCT00276588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438655|NCT00276588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24438656|NCT00276588|Immunologic Factors|immunologic factors|mesh-ancestor
24438657|NCT00276588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438658|NCT00276601|Cytarabine|cytarabine|mesh-list
24438659|NCT00276601|Methotrexate|methotrexate|mesh-list
24438660|NCT00276601|Mercaptopurine|mercaptopurine|mesh-list
24438662|NCT00276601|Arsenic Trioxide|arsenic trioxide|mesh-list
24438663|NCT00276601|Tretinoin|tretinoin|mesh-list
24438664|NCT00276601|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24438665|NCT00276601|Abortifacient Agents|abortifacient agents|mesh-ancestor
25662265|NCT01642485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25662266|NCT01642485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25662267|NCT01642485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25662268|NCT01642485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24438666|NCT00276601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24438667|NCT00276601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662269|NCT01642485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25662270|NCT01642485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438668|NCT00276601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24438669|NCT00276601|Antimetabolites|antimetabolites|mesh-ancestor
24438674|NCT00276601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24438675|NCT00276601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24438676|NCT00276601|Immunologic Factors|immunologic factors|mesh-ancestor
24438677|NCT00276601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24438678|NCT00276601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24438726|NCT00276705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24438727|NCT00276705|Alkylating Agents|alkylating agents|mesh-ancestor
24438822|NCT00276796|Tubulin Modulators|tubulin modulators|mesh-ancestor
24438823|NCT00276796|Antimitotic Agents|antimitotic agents|mesh-ancestor
24438824|NCT00276796|Mitosis Modulators|mitosis modulators|mesh-ancestor
24438825|NCT00276796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438826|NCT00276796|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24438827|NCT00276796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24438828|NCT00276796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438830|NCT00276809|Dexamethasone|dexamethasone|mesh-list
24438831|NCT00276809|Cyclophosphamide|cyclophosphamide|mesh-list
24438832|NCT00276809|Melphalan|melphalan|mesh-list
24438833|NCT00276809|Carmustine|carmustine|mesh-list
24438834|NCT00276809|Fludarabine|fludarabine|mesh-list
24438835|NCT00276809|Fludarabine phosphate|fludarabine phosphate|mesh-list
24438836|NCT00276809|Etoposide|etoposide|mesh-list
24438837|NCT00276809|Alemtuzumab|alemtuzumab|mesh-list
24438838|NCT00276809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24438839|NCT00276809|Immunologic Factors|immunologic factors|mesh-ancestor
24825674|NCT02129582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24825675|NCT02129582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24825676|NCT02129595|Resveratrol|resveratrol|mesh-list
25849697|NCT00049218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25849698|NCT00049218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849699|NCT00049218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438933|NCT00276926|Imatinib Mesylate|imatinib mesylate|mesh-list
25849700|NCT00049244|Capecitabine|capecitabine|mesh-list
25849701|NCT00049244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25849702|NCT00049244|Antimetabolites|antimetabolites|mesh-ancestor
25849703|NCT00049244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849704|NCT00049244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849705|NCT00049283|Docetaxel|docetaxel|mesh-list
25849706|NCT00049283|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25849707|NCT00049283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849708|NCT00049283|Tubulin Modulators|tubulin modulators|mesh-ancestor
25849709|NCT00049283|Antimitotic Agents|antimitotic agents|mesh-ancestor
25849710|NCT00049283|Mitosis Modulators|mitosis modulators|mesh-ancestor
25849711|NCT00049283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849712|NCT00049283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24793447|NCT03485534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24439063|NCT00277472|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24439064|NCT00277472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439066|NCT00277472|Natriuretic Agents|natriuretic agents|mesh-ancestor
24439067|NCT00277472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439474|NCT00278941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24439163|NCT00277706|Micronutrients|micronutrients|mesh-ancestor
24439164|NCT00277706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439165|NCT00277706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24439166|NCT00277706|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24439167|NCT00277758|Interferons|interferons|mesh-list
24439168|NCT00277758|Ribavirin|ribavirin|mesh-list
24439169|NCT00277758|Interferon-alpha|interferon-alpha|mesh-list
24439170|NCT00277758|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24439171|NCT00277758|Interleukin-2|interleukin-2|mesh-list
24439212|NCT00278083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24439213|NCT00278083|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24439214|NCT00278083|Vasodilator Agents|vasodilator agents|mesh-ancestor
25849713|NCT00049283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24439247|NCT00278213|Fludarabine|fludarabine|mesh-list
24439248|NCT00278213|Fludarabine phosphate|fludarabine phosphate|mesh-list
24825686|NCT02129621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24825687|NCT02129621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607413|NCT04665037|Hormone Antagonists|hormone antagonists|mesh-ancestor
24439251|NCT00278213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24439252|NCT00278213|Immunologic Factors|immunologic factors|mesh-ancestor
24439253|NCT00278213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439254|NCT00278213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24439255|NCT00278213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24439257|NCT00278213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439258|NCT00278213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439259|NCT00278213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24439260|NCT00278213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24439262|NCT00278213|Analgesics|analgesics|mesh-ancestor
24439263|NCT00278213|Sensory System Agents|sensory system agents|mesh-ancestor
24439264|NCT00278213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24439265|NCT00278213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24439266|NCT00278213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24439267|NCT00278213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24439268|NCT00278213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24439269|NCT00278252|Etoposide|etoposide|mesh-list
24583293|NCT00874003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24583295|NCT00874003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24439342|NCT00278343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24439343|NCT00278343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439344|NCT00278343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439345|NCT00278343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24439346|NCT00278369|Aldesleukin|aldesleukin|mesh-list
24439347|NCT00278369|Interleukin-2|interleukin-2|mesh-list
24439351|NCT00278369|Analgesics|analgesics|mesh-ancestor
24439369|NCT00278408|Vincristine|vincristine|mesh-list
24439370|NCT00278408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24439371|NCT00278408|Immunologic Factors|immunologic factors|mesh-ancestor
24439391|NCT00278408|Antimitotic Agents|antimitotic agents|mesh-ancestor
24439392|NCT00278408|Mitosis Modulators|mitosis modulators|mesh-ancestor
25849714|NCT00049296|Thalidomide|thalidomide|mesh-list
24439414|NCT00278421|Glucocorticoids|glucocorticoids|mesh-ancestor
24439416|NCT00278421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24439417|NCT00278421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24439418|NCT00278421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24439419|NCT00278421|Tubulin Modulators|tubulin modulators|mesh-ancestor
24439473|NCT00278941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24439916|NCT00280878|Vinorelbine|vinorelbine|mesh-list
24439475|NCT00278941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439476|NCT00278967|Bisacodyl|bisacodyl|mesh-list
24439477|NCT00278967|Cathartics|cathartics|mesh-ancestor
24439478|NCT00278967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24439481|NCT00279019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24439482|NCT00279019|Autonomic Agents|autonomic agents|mesh-ancestor
24439483|NCT00279019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24439484|NCT00279019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439485|NCT00279019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24439486|NCT00279019|Respiratory System Agents|respiratory system agents|mesh-ancestor
24439487|NCT00279019|Parasympatholytics|parasympatholytics|mesh-ancestor
24439488|NCT00279019|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24439489|NCT00279019|Cholinergic Agents|cholinergic agents|mesh-ancestor
24439490|NCT00279019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24439491|NCT00279019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439492|NCT00279045|Metformin|metformin|mesh-list
24439493|NCT00279045|Rosiglitazone|rosiglitazone|mesh-list
24439494|NCT00279045|Glyburide|glyburide|mesh-list
24439495|NCT00279045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25849715|NCT00049296|Docetaxel|docetaxel|mesh-list
25849716|NCT00049296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439550|NCT00279344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24825689|NCT02129621|Diuretics|diuretics|mesh-ancestor
24825690|NCT02129621|Natriuretic Agents|natriuretic agents|mesh-ancestor
24702904|NCT01468441|Cetrorelix|cetrorelix|mesh-list
24439574|NCT00279448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24583341|NCT00874133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24439630|NCT00279565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24439631|NCT00279565|Analgesics|analgesics|mesh-ancestor
24439632|NCT00279565|Sensory System Agents|sensory system agents|mesh-ancestor
24439633|NCT00279565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24439634|NCT00279565|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24439635|NCT00279565|Antitussive Agents|antitussive agents|mesh-ancestor
24439636|NCT00279565|Respiratory System Agents|respiratory system agents|mesh-ancestor
24439674|NCT00279760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439675|NCT00279760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24439676|NCT00279760|Immunologic Factors|immunologic factors|mesh-ancestor
24439729|NCT00280098|Mitosis Modulators|mitosis modulators|mesh-ancestor
25849717|NCT00049296|Tubulin Modulators|tubulin modulators|mesh-ancestor
24787180|NCT01923948|Sensory System Agents|sensory system agents|mesh-ancestor
24439730|NCT00280098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439731|NCT00280176|Fluorouracil|fluorouracil|mesh-list
24439733|NCT00280176|Antimetabolites|antimetabolites|mesh-ancestor
24439734|NCT00280176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439735|NCT00280176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24439736|NCT00280176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439737|NCT00280176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24439738|NCT00280176|Immunologic Factors|immunologic factors|mesh-ancestor
24882057|NCT02855229|Methylphenidate|methylphenidate|mesh-list
24439739|NCT00280176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439740|NCT00280215|Losartan|losartan|mesh-list
24439741|NCT00280215|Lisinopril|lisinopril|mesh-list
24439742|NCT00280215|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24439786|NCT00280371|Formoterol Fumarate|formoterol fumarate|mesh-list
24439787|NCT00280371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24439789|NCT00280371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24439790|NCT00280371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439791|NCT00280371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24439792|NCT00280371|Respiratory System Agents|respiratory system agents|mesh-ancestor
24439820|NCT00280462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439821|NCT00280462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24439822|NCT00280462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439823|NCT00280462|Vasodilator Agents|vasodilator agents|mesh-ancestor
24439871|NCT00280605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24439872|NCT00280605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439873|NCT00280605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439919|NCT00280878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439920|NCT00280878|Immunologic Factors|immunologic factors|mesh-ancestor
24439921|NCT00280878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439922|NCT00280878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24439923|NCT00280878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24439986|NCT00281125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24439987|NCT00281125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24439989|NCT00281190|Chelating Agents|chelating agents|mesh-ancestor
24439990|NCT00281190|Sequestering Agents|sequestering agents|mesh-ancestor
24439991|NCT00281190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439994|NCT00281255|Antimetabolites|antimetabolites|mesh-ancestor
24440011|NCT00281255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24440012|NCT00281281|Vancomycin|vancomycin|mesh-list
24440013|NCT00281281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24440014|NCT00281281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24440015|NCT00281307|Tocopherols|tocopherols|mesh-list
24440016|NCT00281307|Vitamin E|vitamin e|mesh-list
24440017|NCT00281307|Tocotrienols|tocotrienols|mesh-list
24440018|NCT00281307|alpha-Tocopherol|alpha-tocopherol|mesh-list
24440019|NCT00281307|Antioxidants|antioxidants|mesh-ancestor
24440020|NCT00281307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440021|NCT00281307|Protective Agents|protective agents|mesh-ancestor
24440022|NCT00281307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440023|NCT00281307|Vitamins|vitamins|mesh-ancestor
24440024|NCT00281307|Micronutrients|micronutrients|mesh-ancestor
24440026|NCT00281476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24440027|NCT00281476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24440028|NCT00281476|Antimetabolites|antimetabolites|mesh-ancestor
24440029|NCT00281476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440030|NCT00281476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24440031|NCT00281476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24440032|NCT00281476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24440033|NCT00281489|Anesthetics|anesthetics|mesh-list
24440058|NCT00281593|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24440059|NCT00281593|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25849718|NCT00049296|Antimitotic Agents|antimitotic agents|mesh-ancestor
24440080|NCT00281619|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24440090|NCT00281710|Methylprednisolone|methylprednisolone|mesh-list
24440091|NCT00281710|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24440092|NCT00281710|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24440093|NCT00281710|Prednisolone|prednisolone|mesh-list
24440094|NCT00281710|Prednisolone acetate|prednisolone acetate|mesh-list
24440095|NCT00281710|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24440096|NCT00281710|Prednisolone phosphate|prednisolone phosphate|mesh-list
25849719|NCT00049296|Mitosis Modulators|mitosis modulators|mesh-ancestor
24825702|NCT02129699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24825703|NCT02129699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909171|NCT04312282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583461|NCT00874601|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24825704|NCT02129764|Prednisone|prednisone|mesh-list
24825705|NCT02129764|Allopurinol|allopurinol|mesh-list
24825706|NCT02129764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24825707|NCT02129764|Glucocorticoids|glucocorticoids|mesh-ancestor
24825709|NCT02129764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24825711|NCT02129764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24825712|NCT02129764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440097|NCT00281710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24440098|NCT00281710|Antiemetics|antiemetics|mesh-ancestor
24440099|NCT00281710|Autonomic Agents|autonomic agents|mesh-ancestor
24440100|NCT00281710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24440101|NCT00281710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440102|NCT00281710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24440103|NCT00281710|Glucocorticoids|glucocorticoids|mesh-ancestor
24440104|NCT00281710|Hormones|hormones|mesh-ancestor
24440105|NCT00281710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24440106|NCT00281710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24440107|NCT00281710|Protective Agents|protective agents|mesh-ancestor
24440117|NCT00281788|Mitosis Modulators|mitosis modulators|mesh-ancestor
24440118|NCT00281788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440119|NCT00281788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24440120|NCT00281788|Antimetabolites|antimetabolites|mesh-ancestor
24440121|NCT00281866|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24440122|NCT00281866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440123|NCT00281866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24440129|NCT00281892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440130|NCT00281892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24440131|NCT00281892|Antimetabolites|antimetabolites|mesh-ancestor
24440132|NCT00281892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440177|NCT00281931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24440178|NCT00281931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24440181|NCT00281944|Fluorouracil|fluorouracil|mesh-list
24440182|NCT00281944|Oxaliplatin|oxaliplatin|mesh-list
24440183|NCT00281944|Calcium|calcium|mesh-list
24440184|NCT00281944|Levoleucovorin|levoleucovorin|mesh-list
24440185|NCT00281944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25849720|NCT00049296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849721|NCT00049296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24440191|NCT00281944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24440192|NCT00281944|Immunologic Factors|immunologic factors|mesh-ancestor
24440193|NCT00281944|Antidotes|antidotes|mesh-ancestor
24440194|NCT00281944|Protective Agents|protective agents|mesh-ancestor
24440195|NCT00281944|Vitamin B Complex|vitamin b complex|mesh-ancestor
24440196|NCT00281944|Vitamins|vitamins|mesh-ancestor
24825714|NCT02129764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825716|NCT02129764|Gout Suppressants|gout suppressants|mesh-ancestor
24825717|NCT02129764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24825718|NCT02129764|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24825719|NCT02129764|Antioxidants|antioxidants|mesh-ancestor
24825720|NCT02129764|Protective Agents|protective agents|mesh-ancestor
24825721|NCT02129829|Tenofovir|tenofovir|mesh-list
24825722|NCT02129829|Antiviral Agents|antiviral agents|mesh-ancestor
24440217|NCT00281983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440219|NCT00281983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24440243|NCT00281996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24440245|NCT00281996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849722|NCT00049296|Immunologic Factors|immunologic factors|mesh-ancestor
25849723|NCT00049296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440303|NCT00282178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24440304|NCT00282178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24440305|NCT00282178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440306|NCT00282178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24440307|NCT00282178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24440308|NCT00282217|Sirolimus|sirolimus|mesh-list
24440309|NCT00282217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24440310|NCT00282217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24440311|NCT00282217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25662271|NCT01642485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662272|NCT01642485|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24909371|NCT04309838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24909374|NCT04310293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909418|NCT04309240|Protease Inhibitors|protease inhibitors|mesh-ancestor
24909419|NCT04309240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24440312|NCT00282217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440313|NCT00282217|Antifungal Agents|antifungal agents|mesh-ancestor
24440314|NCT00282217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24440315|NCT00282217|Immunologic Factors|immunologic factors|mesh-ancestor
24440316|NCT00282217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440318|NCT00282360|Vasodilator Agents|vasodilator agents|mesh-ancestor
24440320|NCT00282386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440321|NCT00282386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440322|NCT00282386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24440323|NCT00282386|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24440332|NCT00282399|Decitabine|decitabine|mesh-list
24440341|NCT00282451|Insulin, Long-Acting|insulin, long-acting|mesh-list
24440342|NCT00282451|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24440390|NCT00282932|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24825731|NCT02129933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24825732|NCT02129933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825733|NCT02129933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24703232|NCT01470339|Analgesics|analgesics|mesh-ancestor
24440391|NCT00282932|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24440407|NCT00282958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440408|NCT00282958|Cholinergic Agents|cholinergic agents|mesh-ancestor
24440409|NCT00282958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24625156|NCT01080638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24440410|NCT00282958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440411|NCT00282958|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24440413|NCT00282997|Pregabalin|pregabalin|mesh-list
24440414|NCT00282997|Analgesics|analgesics|mesh-ancestor
24440415|NCT00282997|Sensory System Agents|sensory system agents|mesh-ancestor
24440416|NCT00282997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24440456|NCT00283179|Antidepressive Agents|antidepressive agents|mesh-ancestor
24440457|NCT00283179|Dopamine Agonists|dopamine agonists|mesh-ancestor
24440458|NCT00283179|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24440459|NCT00283179|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24440460|NCT00283179|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24825734|NCT02129933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24583630|NCT00875849|Cetuximab|cetuximab|mesh-list
24825735|NCT02129933|Growth Substances|growth substances|mesh-ancestor
24825736|NCT02129933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825737|NCT02129933|Growth Inhibitors|growth inhibitors|mesh-ancestor
24440468|NCT00283192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440470|NCT00283192|Serotonin Agents|serotonin agents|mesh-ancestor
24440471|NCT00283192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440472|NCT00283218|Insulin Aspart|insulin aspart|mesh-list
24440494|NCT00283335|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24440495|NCT00283335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24440496|NCT00283335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24440497|NCT00283465|Epoetin Alfa|epoetin alfa|mesh-list
24440498|NCT00283465|Hematinics|hematinics|mesh-ancestor
24440499|NCT00283478|Gemcitabine|gemcitabine|mesh-list
24440500|NCT00283478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24440501|NCT00283478|Antimetabolites|antimetabolites|mesh-ancestor
24440502|NCT00283478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440503|NCT00283478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440504|NCT00283478|Antiviral Agents|antiviral agents|mesh-ancestor
24440543|NCT00283634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25849724|NCT00049296|Leprostatic Agents|leprostatic agents|mesh-ancestor
24945529|NCT03949686|Anesthetics|anesthetics|mesh-ancestor
24440545|NCT00283634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440547|NCT00283660|Dermatologic Agents|dermatologic agents|mesh-ancestor
24440548|NCT00283660|Sunscreening Agents|sunscreening agents|mesh-ancestor
24440593|NCT00283829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440594|NCT00283829|Tubulin Modulators|tubulin modulators|mesh-ancestor
24440595|NCT00283829|Antimitotic Agents|antimitotic agents|mesh-ancestor
24440596|NCT00283829|Mitosis Modulators|mitosis modulators|mesh-ancestor
25662273|NCT01642485|Contraceptive Agents|contraceptive agents|mesh-ancestor
25662274|NCT01642485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25662275|NCT01642485|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25662276|NCT01642485|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25662277|NCT01642485|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25662279|NCT01642589|Immunologic Factors|immunologic factors|mesh-ancestor
25662280|NCT01642589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662281|NCT01642602|Dexlansoprazole|dexlansoprazole|mesh-list
25154591|NCT05470530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24818952|NCT02092012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24484360|NCT00447967|Irinotecan|irinotecan|mesh-list
24484416|NCT00448266|Cyclophosphamide|cyclophosphamide|mesh-list
24440597|NCT00283829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440598|NCT00283946|Zolpidem|zolpidem|mesh-list
24440599|NCT00283946|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24440600|NCT00283946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24440601|NCT00283946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24440602|NCT00283946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440603|NCT00283946|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24440604|NCT00283946|GABA Agonists|gaba agonists|mesh-ancestor
24440605|NCT00283946|GABA Agents|gaba agents|mesh-ancestor
24440606|NCT00283946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24440607|NCT00283946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440608|NCT00283985|Dexamethasone|dexamethasone|mesh-list
24440610|NCT00283985|Asparaginase|asparaginase|mesh-list
24440651|NCT00284206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24440652|NCT00284206|Serotonin Agents|serotonin agents|mesh-ancestor
24440653|NCT00284206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24440778|NCT00284765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24440779|NCT00284765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24440781|NCT00284778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440782|NCT00284778|Tubulin Modulators|tubulin modulators|mesh-ancestor
24440783|NCT00284778|Antimitotic Agents|antimitotic agents|mesh-ancestor
24440784|NCT00284778|Mitosis Modulators|mitosis modulators|mesh-ancestor
24440785|NCT00284778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440786|NCT00284791|Lamotrigine|lamotrigine|mesh-list
24440787|NCT00284791|Sertraline|sertraline|mesh-list
24440788|NCT00284791|Fluoxetine|fluoxetine|mesh-list
24440789|NCT00284791|Antidepressive Agents|antidepressive agents|mesh-ancestor
24440790|NCT00284791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24440791|NCT00284791|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24440792|NCT00284791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24440980|NCT00285519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440981|NCT00285519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440983|NCT00285597|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24440984|NCT00285597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24440986|NCT00285623|Hemostatics|hemostatics|mesh-ancestor
24440987|NCT00285623|Coagulants|coagulants|mesh-ancestor
24440988|NCT00285662|Artesunate|artesunate|mesh-list
24440989|NCT00285662|Pyrimethamine|pyrimethamine|mesh-list
24440990|NCT00285662|Sulfadoxine|sulfadoxine|mesh-list
24440991|NCT00285662|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24440992|NCT00285662|Amodiaquine|amodiaquine|mesh-list
24440993|NCT00285662|Antimalarials|antimalarials|mesh-ancestor
24440994|NCT00285662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24440995|NCT00285662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25849725|NCT00049296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24441001|NCT00285662|Anthelmintics|anthelmintics|mesh-ancestor
24441002|NCT00285662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24441003|NCT00285662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441004|NCT00285662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849726|NCT00049296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24441076|NCT00286013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441078|NCT00286013|Antiviral Agents|antiviral agents|mesh-ancestor
24441079|NCT00286013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24441080|NCT00286013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825764|NCT02130167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825766|NCT02130323|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24825767|NCT02130323|Immunologic Factors|immunologic factors|mesh-ancestor
24825768|NCT02130323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825769|NCT02130323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825770|NCT02130323|Interferon Inducers|interferon inducers|mesh-ancestor
25662282|NCT01642602|Lansoprazole|lansoprazole|mesh-list
25662283|NCT01642602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25662284|NCT01642602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25662285|NCT01642602|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25662286|NCT01642602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825771|NCT02130414|Cyclosporine|cyclosporine|mesh-list
24825772|NCT02130414|Cyclosporins|cyclosporins|mesh-list
25154606|NCT05470465|Citalopram|citalopram|mesh-list
24441081|NCT00286013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24441082|NCT00286013|Immunologic Factors|immunologic factors|mesh-ancestor
24441083|NCT00286013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441084|NCT00286026|Azithromycin|azithromycin|mesh-list
24441085|NCT00286026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24441086|NCT00286026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24441087|NCT00286052|Naloxone|naloxone|mesh-list
24441088|NCT00286052|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24441089|NCT00286052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441090|NCT00286052|Sensory System Agents|sensory system agents|mesh-ancestor
24441097|NCT00286117|Hormone Antagonists|hormone antagonists|mesh-ancestor
24825780|NCT02130414|Dermatologic Agents|dermatologic agents|mesh-ancestor
24825781|NCT02130414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24825782|NCT02130414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24825783|NCT02130440|Resveratrol|resveratrol|mesh-list
24825784|NCT02130440|Antioxidants|antioxidants|mesh-ancestor
24825785|NCT02130440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825786|NCT02130440|Protective Agents|protective agents|mesh-ancestor
24825787|NCT02130440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825788|NCT02130440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441098|NCT00286117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24441125|NCT00286143|Fentanyl|fentanyl|mesh-list
24441126|NCT00286143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24441127|NCT00286143|Narcotics|narcotics|mesh-ancestor
25849727|NCT00049296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24441226|NCT00286585|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
24441227|NCT00286585|Anesthetics|anesthetics|mesh-list
24441228|NCT00286585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24441229|NCT00286585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24441230|NCT00286585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441231|NCT00286585|Anesthetics, General|anesthetics, general|mesh-ancestor
24441312|NCT00287157|Anticonvulsants|anticonvulsants|mesh-ancestor
24441383|NCT00287313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441384|NCT00287313|Hemostatics|hemostatics|mesh-ancestor
24441385|NCT00287313|Coagulants|coagulants|mesh-ancestor
24441386|NCT00287326|Clonidine|clonidine|mesh-list
24441387|NCT00287326|Morphine|morphine|mesh-list
24441388|NCT00287326|Bupivacaine|bupivacaine|mesh-list
24441390|NCT00287326|Anesthetics|anesthetics|mesh-ancestor
24441391|NCT00287326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24441392|NCT00287326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441393|NCT00287326|Sensory System Agents|sensory system agents|mesh-ancestor
24441434|NCT00287378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24441435|NCT00287378|Respiratory System Agents|respiratory system agents|mesh-ancestor
24441443|NCT00287430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24441444|NCT00287430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441446|NCT00287443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24583785|NCT00876889|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24583858|NCT00877175|Respiratory System Agents|respiratory system agents|mesh-ancestor
24441447|NCT00287443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849728|NCT00049296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24441448|NCT00287456|Insulin|insulin|mesh-list
24441449|NCT00287456|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24441450|NCT00287456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24441486|NCT00287560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24441487|NCT00287560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441509|NCT00287742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24441510|NCT00287742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24441511|NCT00287742|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24441512|NCT00287742|Dopamine Agents|dopamine agents|mesh-ancestor
24441513|NCT00287768|Docetaxel|docetaxel|mesh-list
24441514|NCT00287768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441515|NCT00287768|Tubulin Modulators|tubulin modulators|mesh-ancestor
24441516|NCT00287768|Antimitotic Agents|antimitotic agents|mesh-ancestor
24441517|NCT00287768|Mitosis Modulators|mitosis modulators|mesh-ancestor
24441518|NCT00287768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441519|NCT00287781|Lidocaine|lidocaine|mesh-list
24441520|NCT00287781|Anesthetics, Local|anesthetics, local|mesh-ancestor
24441521|NCT00287781|Anesthetics|anesthetics|mesh-ancestor
24441523|NCT00287781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441524|NCT00287781|Sensory System Agents|sensory system agents|mesh-ancestor
24441525|NCT00287781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25849729|NCT00049296|Growth Substances|growth substances|mesh-ancestor
25849730|NCT00049296|Growth Inhibitors|growth inhibitors|mesh-ancestor
24441543|NCT00287794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24441544|NCT00287794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24441545|NCT00287794|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24441546|NCT00287794|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24441548|NCT00287794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24441549|NCT00287794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24441550|NCT00287794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24441551|NCT00287794|Anesthetics, General|anesthetics, general|mesh-ancestor
24583958|NCT00877760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825798|NCT02130518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24825799|NCT02130661|Itraconazole|itraconazole|mesh-list
24825800|NCT02130661|Antifungal Agents|antifungal agents|mesh-ancestor
24825801|NCT02130661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24441552|NCT00287794|Anesthetics|anesthetics|mesh-ancestor
24441553|NCT00287794|GABA Modulators|gaba modulators|mesh-ancestor
24441554|NCT00287794|GABA Agents|gaba agents|mesh-ancestor
24441555|NCT00287794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24441556|NCT00287820|Olanzapine|olanzapine|mesh-list
24441565|NCT00287820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24441569|NCT00287820|Antiemetics|antiemetics|mesh-ancestor
24441570|NCT00287820|Autonomic Agents|autonomic agents|mesh-ancestor
24441571|NCT00287820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24441572|NCT00287820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24441576|NCT00287846|Imatinib Mesylate|imatinib mesylate|mesh-list
24441595|NCT00287911|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24441596|NCT00287911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24441597|NCT00287911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441645|NCT00287950|Mitosis Modulators|mitosis modulators|mesh-ancestor
24441666|NCT00288002|Trastuzumab|trastuzumab|mesh-list
24441668|NCT00288002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24441669|NCT00288002|Immunologic Factors|immunologic factors|mesh-ancestor
24441670|NCT00288002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441671|NCT00288002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24441672|NCT00288002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24441673|NCT00288002|Alkylating Agents|alkylating agents|mesh-ancestor
24441674|NCT00288002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441675|NCT00288002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441676|NCT00288002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24441677|NCT00288002|Tubulin Modulators|tubulin modulators|mesh-ancestor
24441678|NCT00288002|Antimitotic Agents|antimitotic agents|mesh-ancestor
24441685|NCT00288002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24825802|NCT02130661|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24825803|NCT02130661|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24825804|NCT02130661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825805|NCT02130661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825806|NCT02130661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24825807|NCT02130661|Hormone Antagonists|hormone antagonists|mesh-ancestor
24882519|NCT05169801|Growth Substances|growth substances|mesh-ancestor
24882520|NCT05169801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825808|NCT02130661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24882521|NCT05169801|Growth Inhibitors|growth inhibitors|mesh-ancestor
24825809|NCT02130661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703698|NCT01473303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24441686|NCT00288002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441688|NCT00288028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441689|NCT00288041|Paclitaxel|paclitaxel|mesh-list
24441690|NCT00288041|Carboplatin|carboplatin|mesh-list
24441691|NCT00288041|Bortezomib|bortezomib|mesh-list
24441692|NCT00288041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24441701|NCT00288158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441703|NCT00288158|Gout Suppressants|gout suppressants|mesh-ancestor
24441704|NCT00288158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24441705|NCT00288158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24441706|NCT00288158|Antioxidants|antioxidants|mesh-ancestor
24441707|NCT00288158|Protective Agents|protective agents|mesh-ancestor
24441708|NCT00288158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441709|NCT00288158|Uricosuric Agents|uricosuric agents|mesh-ancestor
24441754|NCT00288236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441755|NCT00288249|Sagopilone|sagopilone|mesh-list
24441756|NCT00288249|Epothilones|epothilones|mesh-list
24441757|NCT00288249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441812|NCT00288431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441827|NCT00288470|Hylan|hylan|mesh-list
24441828|NCT00288470|Viscosupplements|viscosupplements|mesh-ancestor
24441829|NCT00288470|Protective Agents|protective agents|mesh-ancestor
24441830|NCT00288470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441831|NCT00288483|Policosanol|policosanol|mesh-list
24441832|NCT00288483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24441852|NCT00288548|Sympatholytics|sympatholytics|mesh-ancestor
24441853|NCT00288548|Autonomic Agents|autonomic agents|mesh-ancestor
24441854|NCT00288548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24441855|NCT00288548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441856|NCT00288548|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24441857|NCT00288548|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24441858|NCT00288548|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24441859|NCT00288548|Adrenergic Agents|adrenergic agents|mesh-ancestor
24441860|NCT00288548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24441861|NCT00288548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584085|NCT00878514|Alprazolam|alprazolam|mesh-list
24977124|NCT03469492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441863|NCT00288561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24932722|NCT04077580|Methenamine|methenamine|mesh-list
24441864|NCT00288561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24825810|NCT02130661|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24825811|NCT02130700|Seviteronel|seviteronel|mesh-list
24825812|NCT02130700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825815|NCT02130700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825816|NCT02130713|Fluoroquinolones|fluoroquinolones|mesh-list
24825817|NCT02130713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24441982|NCT00289419|Ropivacaine|ropivacaine|mesh-list
24441983|NCT00289419|Epinephryl borate|epinephryl borate|mesh-list
24441984|NCT00289419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24441985|NCT00289419|Narcotics|narcotics|mesh-ancestor
24441986|NCT00289419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24441987|NCT00289419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441988|NCT00289419|Analgesics|analgesics|mesh-ancestor
24441989|NCT00289419|Sensory System Agents|sensory system agents|mesh-ancestor
24441990|NCT00289419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24442017|NCT00289445|Antidotes|antidotes|mesh-ancestor
24442018|NCT00289445|Protective Agents|protective agents|mesh-ancestor
24442019|NCT00289445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442020|NCT00289445|Vitamin B Complex|vitamin b complex|mesh-ancestor
24442022|NCT00289445|Micronutrients|micronutrients|mesh-ancestor
24442023|NCT00289445|Hematinics|hematinics|mesh-ancestor
25057228|NCT03506789|Dexamethasone|dexamethasone|mesh-list
24442024|NCT00289445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24442025|NCT00289445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442026|NCT00289445|Alkylating Agents|alkylating agents|mesh-ancestor
24442080|NCT00289952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24442081|NCT00289952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442082|NCT00289952|Antimanic Agents|antimanic agents|mesh-ancestor
24442083|NCT00289952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24442084|NCT00289952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24442085|NCT00289952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24442086|NCT00290004|Motexafin gadolinium|motexafin gadolinium|mesh-list
24442087|NCT00290004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442088|NCT00290004|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24442089|NCT00290004|Dermatologic Agents|dermatologic agents|mesh-ancestor
24442091|NCT00290017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442163|NCT00290173|Ritodrine|ritodrine|mesh-list
24442164|NCT00290173|Sympathomimetics|sympathomimetics|mesh-ancestor
24442165|NCT00290173|Autonomic Agents|autonomic agents|mesh-ancestor
24442166|NCT00290173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24442167|NCT00290173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442168|NCT00290173|Tocolytic Agents|tocolytic agents|mesh-ancestor
24442169|NCT00290173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24442170|NCT00290173|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24442171|NCT00290173|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24442172|NCT00290173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24825822|NCT02130739|Fentanyl|fentanyl|mesh-list
24825823|NCT02130739|Propofol|propofol|mesh-list
24825824|NCT02130739|Ropivacaine|ropivacaine|mesh-list
24825825|NCT02130739|Anesthetics|anesthetics|mesh-ancestor
24825826|NCT02130739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24825827|NCT02130739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825828|NCT02130739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24825829|NCT02130739|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24825830|NCT02130739|Anesthetics, General|anesthetics, general|mesh-ancestor
24825831|NCT02130739|Anesthetics, Local|anesthetics, local|mesh-ancestor
24825832|NCT02130739|Sensory System Agents|sensory system agents|mesh-ancestor
24825833|NCT02130739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24825834|NCT02130739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24442174|NCT00290173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25419660|NCT02688140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24442175|NCT00290173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442177|NCT00290264|Formoterol Fumarate|formoterol fumarate|mesh-list
24442253|NCT00290628|Antitubercular Agents|antitubercular agents|mesh-ancestor
24442254|NCT00290628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24442255|NCT00290628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24442257|NCT00290628|Autonomic Agents|autonomic agents|mesh-ancestor
24442258|NCT00290628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24442259|NCT00290628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24442260|NCT00290628|Glucocorticoids|glucocorticoids|mesh-ancestor
24442261|NCT00290628|Hormones|hormones|mesh-ancestor
24442262|NCT00290628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24570012|NCT00802802|Efavirenz|efavirenz|mesh-list
24442346|NCT00290758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442352|NCT00290758|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24442353|NCT00290758|Estrogens|estrogens|mesh-ancestor
24442354|NCT00290758|Hormones|hormones|mesh-ancestor
24442355|NCT00290758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24442356|NCT00290823|Albendazole|albendazole|mesh-list
24442357|NCT00290823|Dexamethasone|dexamethasone|mesh-list
24442358|NCT00290823|Omeprazole|omeprazole|mesh-list
24442359|NCT00290823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24442360|NCT00290823|Antiemetics|antiemetics|mesh-ancestor
24442361|NCT00290823|Autonomic Agents|autonomic agents|mesh-ancestor
24442362|NCT00290823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24442363|NCT00290823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442364|NCT00290823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24442365|NCT00290823|Glucocorticoids|glucocorticoids|mesh-ancestor
24442366|NCT00290823|Hormones|hormones|mesh-ancestor
24442367|NCT00290823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24442370|NCT00290823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24442403|NCT00290901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24505702|NCT00542074|Ethanol|ethanol|mesh-list
24442404|NCT00290901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442405|NCT00290901|Analgesics|analgesics|mesh-ancestor
24825836|NCT02130739|Analgesics|analgesics|mesh-ancestor
24825837|NCT02130739|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24442419|NCT00290914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25849731|NCT00049335|Capecitabine|capecitabine|mesh-list
24442420|NCT00290914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25849732|NCT00049335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24442473|NCT00291148|Sensory System Agents|sensory system agents|mesh-ancestor
24442474|NCT00291148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24442475|NCT00291148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584252|NCT00879164|Anesthetics|anesthetics|mesh-ancestor
24442476|NCT00291148|Anticonvulsants|anticonvulsants|mesh-ancestor
24442477|NCT00291148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24442478|NCT00291148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24442479|NCT00291148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442480|NCT00291148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24442481|NCT00291148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24442482|NCT00291148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24442529|NCT00291382|Respiratory System Agents|respiratory system agents|mesh-ancestor
24442530|NCT00291382|Dermatologic Agents|dermatologic agents|mesh-ancestor
24442531|NCT00291382|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24442532|NCT00291382|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24442534|NCT00291382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24442538|NCT00291408|Nitric Oxide|nitric oxide|mesh-list
24442565|NCT00291616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24442567|NCT00291707|Cetuximab|cetuximab|mesh-list
24442568|NCT00291707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442569|NCT00291707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442570|NCT00291707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442571|NCT00291707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24442572|NCT00291707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24442643|NCT00291863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442645|NCT00291863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24442646|NCT00291863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442684|NCT00292123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24442686|NCT00292123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24442687|NCT00292123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442688|NCT00292123|Analgesics|analgesics|mesh-ancestor
24442689|NCT00292123|Sensory System Agents|sensory system agents|mesh-ancestor
24442690|NCT00292123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24911959|NCT04283110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24911960|NCT04283110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24911961|NCT04283110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24911962|NCT04283110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24911963|NCT04283110|Anesthetics, General|anesthetics, general|mesh-ancestor
24442692|NCT00292123|Respiratory System Agents|respiratory system agents|mesh-ancestor
24442693|NCT00292201|Atorvastatin|atorvastatin|mesh-list
24442694|NCT00292201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24442695|NCT00292201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24442823|NCT00292799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24442824|NCT00292799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442825|NCT00292799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442826|NCT00292799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442827|NCT00292799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24442828|NCT00292799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24442830|NCT00292838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24442831|NCT00292838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24442832|NCT00292838|Autonomic Agents|autonomic agents|mesh-ancestor
24442833|NCT00292838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24442834|NCT00292838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442836|NCT00292838|Respiratory System Agents|respiratory system agents|mesh-ancestor
24442837|NCT00292838|Dermatologic Agents|dermatologic agents|mesh-ancestor
24442838|NCT00292838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24442839|NCT00292890|Insulin|insulin|mesh-list
24442840|NCT00292890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24442841|NCT00292890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442842|NCT00292929|Artesunate|artesunate|mesh-list
24442849|NCT00292929|Schistosomicides|schistosomicides|mesh-ancestor
24442850|NCT00292929|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24442851|NCT00292929|Anthelmintics|anthelmintics|mesh-ancestor
24442852|NCT00292955|Cetuximab|cetuximab|mesh-list
24442853|NCT00292955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24442854|NCT00292955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442855|NCT00293072|Rituximab|rituximab|mesh-list
24442856|NCT00293072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24442857|NCT00293072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442858|NCT00293072|Immunologic Factors|immunologic factors|mesh-ancestor
24442862|NCT00293085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442863|NCT00293085|Tubulin Modulators|tubulin modulators|mesh-ancestor
24442864|NCT00293085|Antimitotic Agents|antimitotic agents|mesh-ancestor
24442865|NCT00293085|Mitosis Modulators|mitosis modulators|mesh-ancestor
24442866|NCT00293085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442867|NCT00293098|Deferiprone|deferiprone|mesh-list
24442868|NCT00293098|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24442869|NCT00293098|Chelating Agents|chelating agents|mesh-ancestor
24442870|NCT00293098|Sequestering Agents|sequestering agents|mesh-ancestor
24442871|NCT00293098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825858|NCT02130817|Immunoglobulins|immunoglobulins|mesh-list
24442872|NCT00293111|Etodolac|etodolac|mesh-list
24442873|NCT00293111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24442874|NCT00293111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24442921|NCT00293280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24442922|NCT00293280|Alkylating Agents|alkylating agents|mesh-ancestor
24442923|NCT00293280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442924|NCT00293280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442925|NCT00293319|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24442926|NCT00293319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442927|NCT00293319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442928|NCT00293319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442929|NCT00293319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24442931|NCT00293332|Carboplatin|carboplatin|mesh-list
24442932|NCT00293332|Docetaxel|docetaxel|mesh-list
25662287|NCT01642602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662288|NCT01642615|Dexlansoprazole|dexlansoprazole|mesh-list
25662289|NCT01642615|Lansoprazole|lansoprazole|mesh-list
25662290|NCT01642615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25662291|NCT01642615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25662292|NCT01642615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25662293|NCT01642615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25662294|NCT01642615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662295|NCT01642914|Linaclotide|linaclotide|mesh-list
25849736|NCT00049348|Gemcitabine|gemcitabine|mesh-list
25849737|NCT00049348|Cisplatin|cisplatin|mesh-list
25849738|NCT00049348|Fluorouracil|fluorouracil|mesh-list
25849739|NCT00049348|Epoetin Alfa|epoetin alfa|mesh-list
25849740|NCT00049348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584623|NCT00881140|Luteolytic Agents|luteolytic agents|mesh-ancestor
24584624|NCT00881140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24584625|NCT00881140|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25849741|NCT00049348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25849742|NCT00049348|Antimetabolites|antimetabolites|mesh-ancestor
25849743|NCT00049348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849744|NCT00049348|Antiviral Agents|antiviral agents|mesh-ancestor
25849745|NCT00049348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25849746|NCT00049348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849747|NCT00049348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24882765|NCT05002244|Antimetabolites|antimetabolites|mesh-ancestor
25849748|NCT00049348|Immunologic Factors|immunologic factors|mesh-ancestor
24825861|NCT02130817|Immunoglobulin G|immunoglobulin g|mesh-list
25849749|NCT00049348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849750|NCT00049348|Hematinics|hematinics|mesh-ancestor
25849751|NCT00049361|Thalidomide|thalidomide|mesh-list
25849752|NCT00049361|Temozolomide|temozolomide|mesh-list
25849753|NCT00049361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25849754|NCT00049361|Alkylating Agents|alkylating agents|mesh-ancestor
25849755|NCT00049361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849756|NCT00049361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849757|NCT00049361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25849758|NCT00049361|Immunologic Factors|immunologic factors|mesh-ancestor
25849759|NCT00049361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849760|NCT00049361|Leprostatic Agents|leprostatic agents|mesh-ancestor
25849761|NCT00049361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25849762|NCT00049361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25849763|NCT00049361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25849764|NCT00049361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25849765|NCT00049361|Growth Substances|growth substances|mesh-ancestor
25849766|NCT00049361|Growth Inhibitors|growth inhibitors|mesh-ancestor
25849767|NCT00049374|Thalidomide|thalidomide|mesh-list
25849768|NCT00049374|Dexamethasone|dexamethasone|mesh-list
25849769|NCT00049374|Oblimersen|oblimersen|mesh-list
25849770|NCT00049374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25849771|NCT00049374|Antiemetics|antiemetics|mesh-ancestor
25849772|NCT00049374|Autonomic Agents|autonomic agents|mesh-ancestor
25849773|NCT00049374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24584626|NCT00881153|Cefprozil|cefprozil|mesh-list
25849774|NCT00049374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849775|NCT00049374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25849776|NCT00049374|Glucocorticoids|glucocorticoids|mesh-ancestor
25849777|NCT00049374|Hormones|hormones|mesh-ancestor
25849778|NCT00049374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25849779|NCT00049374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25662296|NCT01642914|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25662297|NCT01642914|Enzyme Activators|enzyme activators|mesh-ancestor
25662298|NCT01642914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662299|NCT01642914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25662300|NCT01643382|Insulin|insulin|mesh-list
25662301|NCT01643382|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25662302|NCT01643382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25662303|NCT01643382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662304|NCT01643408|Asparaginase|asparaginase|mesh-list
25662305|NCT01643408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662306|NCT01643616|Midazolam|midazolam|mesh-list
25234162|NCT02573168|Psychotropic Drugs|psychotropic drugs|mesh-list
25234164|NCT02573064|Colistin|colistin|mesh-list
25849780|NCT00049374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849781|NCT00049374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25849782|NCT00049374|Immunologic Factors|immunologic factors|mesh-ancestor
25849783|NCT00049374|Leprostatic Agents|leprostatic agents|mesh-ancestor
25849784|NCT00049374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25849785|NCT00049374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25849786|NCT00049374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25203453|NCT02714231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25849787|NCT00049374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25849788|NCT00049374|Growth Substances|growth substances|mesh-ancestor
25849789|NCT00049374|Growth Inhibitors|growth inhibitors|mesh-ancestor
25849790|NCT00049387|Temozolomide|temozolomide|mesh-list
25849791|NCT00049387|Tipifarnib|tipifarnib|mesh-list
25849792|NCT00049387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25849793|NCT00049387|Alkylating Agents|alkylating agents|mesh-ancestor
24882814|NCT04933682|Fluconazole|fluconazole|mesh-list
25849794|NCT00049387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849795|NCT00049387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849796|NCT00049413|Cyclophosphamide|cyclophosphamide|mesh-list
25849797|NCT00049413|Rituximab|rituximab|mesh-list
25849798|NCT00049413|Pentostatin|pentostatin|mesh-list
25849799|NCT00049413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25849800|NCT00049413|Immunologic Factors|immunologic factors|mesh-ancestor
25849801|NCT00049413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849802|NCT00049413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25849803|NCT00049413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24633215|NCT01127594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849804|NCT00049413|Alkylating Agents|alkylating agents|mesh-ancestor
25849805|NCT00049413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849806|NCT00049413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849807|NCT00049413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25849808|NCT00049413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25849809|NCT00049413|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
25849810|NCT00049413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849811|NCT00049439|Cyclophosphamide|cyclophosphamide|mesh-list
25849812|NCT00049439|Lomustine|lomustine|mesh-list
25849813|NCT00049439|Etoposide|etoposide|mesh-list
25849814|NCT00049439|Procarbazine|procarbazine|mesh-list
25849815|NCT00049439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25849816|NCT00049439|Immunologic Factors|immunologic factors|mesh-ancestor
25849817|NCT00049439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849818|NCT00049439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25849819|NCT00049439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25849820|NCT00049439|Alkylating Agents|alkylating agents|mesh-ancestor
25849821|NCT00049439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849822|NCT00049439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849823|NCT00049439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25849824|NCT00049439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25849825|NCT00049439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25849826|NCT00049439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25849827|NCT00049439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849828|NCT00049452|Zoledronic Acid|zoledronic acid|mesh-list
25849829|NCT00049452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25849830|NCT00049452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849831|NCT00049556|Gefitinib|gefitinib|mesh-list
25849832|NCT00049556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849833|NCT00049556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25849834|NCT00049556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849835|NCT00049556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849836|NCT00049569|Leucovorin|leucovorin|mesh-list
25849837|NCT00049569|Cytarabine|cytarabine|mesh-list
25849838|NCT00049569|Prednisone|prednisone|mesh-list
25849839|NCT00049569|Hydrocortisone|hydrocortisone|mesh-list
25849840|NCT00049569|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25662307|NCT01643616|Ropivacaine|ropivacaine|mesh-list
25662308|NCT01643616|Prilocaine|prilocaine|mesh-list
25662309|NCT01643616|Anesthetics, Local|anesthetics, local|mesh-ancestor
25662310|NCT01643616|Anesthetics|anesthetics|mesh-ancestor
25662311|NCT01643616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25662312|NCT01643616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662313|NCT01643616|Sensory System Agents|sensory system agents|mesh-ancestor
25662314|NCT01643616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25662315|NCT01643616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25662316|NCT01643616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25234172|NCT02573220|Fluorouracil|fluorouracil|mesh-list
25234173|NCT02573220|Irinotecan|irinotecan|mesh-list
25234174|NCT02573220|Cetuximab|cetuximab|mesh-list
25234175|NCT02573220|Camptothecin|camptothecin|mesh-list
25849841|NCT00049569|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25849842|NCT00049569|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25849843|NCT00049569|Cyclophosphamide|cyclophosphamide|mesh-list
25849844|NCT00049569|Doxorubicin|doxorubicin|mesh-list
25849845|NCT00049569|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25849846|NCT00049569|Methotrexate|methotrexate|mesh-list
25849847|NCT00049569|Etoposide|etoposide|mesh-list
24442989|NCT00293410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25849848|NCT00049569|Vincristine|vincristine|mesh-list
25849849|NCT00049569|Imatinib Mesylate|imatinib mesylate|mesh-list
24825876|NCT02130817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825877|NCT02130817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24825879|NCT02130817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25849850|NCT00049569|Asparaginase|asparaginase|mesh-list
25849851|NCT00049569|Pegaspargase|pegaspargase|mesh-list
25849852|NCT00049569|Levoleucovorin|levoleucovorin|mesh-list
25849853|NCT00049569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25849854|NCT00049569|Immunologic Factors|immunologic factors|mesh-ancestor
25849855|NCT00049569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849856|NCT00049569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25849857|NCT00049569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25849858|NCT00049569|Alkylating Agents|alkylating agents|mesh-ancestor
25849859|NCT00049569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849860|NCT00049569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849861|NCT00049569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25849862|NCT00049569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25849863|NCT00049569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25849864|NCT00049569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25849865|NCT00049569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849866|NCT00049569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25849867|NCT00049569|Glucocorticoids|glucocorticoids|mesh-ancestor
25849868|NCT00049569|Hormones|hormones|mesh-ancestor
25849869|NCT00049569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25849870|NCT00049569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25849871|NCT00049569|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25849872|NCT00049569|Abortifacient Agents|abortifacient agents|mesh-ancestor
25849873|NCT00049569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25849874|NCT00049569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25849875|NCT00049569|Antimetabolites|antimetabolites|mesh-ancestor
25849876|NCT00049569|Dermatologic Agents|dermatologic agents|mesh-ancestor
25849877|NCT00049569|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25849878|NCT00049569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25849879|NCT00049569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25849880|NCT00049569|Antiviral Agents|antiviral agents|mesh-ancestor
25849881|NCT00049569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25849882|NCT00049569|Antidotes|antidotes|mesh-ancestor
25849883|NCT00049569|Protective Agents|protective agents|mesh-ancestor
25849884|NCT00049569|Vitamin B Complex|vitamin b complex|mesh-ancestor
25849885|NCT00049569|Vitamins|vitamins|mesh-ancestor
25849886|NCT00049569|Micronutrients|micronutrients|mesh-ancestor
25849887|NCT00049569|Tubulin Modulators|tubulin modulators|mesh-ancestor
24584833|NCT00881725|Metformin|metformin|mesh-list
25849888|NCT00049569|Antimitotic Agents|antimitotic agents|mesh-ancestor
24442990|NCT00293410|Alkylating Agents|alkylating agents|mesh-ancestor
25849889|NCT00049569|Mitosis Modulators|mitosis modulators|mesh-ancestor
25849890|NCT00049569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25849891|NCT00049582|Decitabine|decitabine|mesh-list
24825880|NCT02130817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24825881|NCT02130817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24704436|NCT01478282|Rivaroxaban|rivaroxaban|mesh-list
25849892|NCT00049582|Azacitidine|azacitidine|mesh-list
25849893|NCT00049582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25849894|NCT00049582|Antimetabolites|antimetabolites|mesh-ancestor
25662317|NCT01643616|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25662318|NCT01643616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25662319|NCT01643616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25662320|NCT01643616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25662321|NCT01643616|Anesthetics, General|anesthetics, general|mesh-ancestor
25662322|NCT01643616|GABA Modulators|gaba modulators|mesh-ancestor
25662323|NCT01643616|GABA Agents|gaba agents|mesh-ancestor
25662324|NCT01643616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25662325|NCT01643616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662326|NCT01643668|Busulfan|busulfan|mesh-list
25234194|NCT02573220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25849895|NCT00049582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849896|NCT00049582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849897|NCT00049582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849899|NCT00049595|Cyclophosphamide|cyclophosphamide|mesh-list
25849900|NCT00049595|Dacarbazine|dacarbazine|mesh-list
25849901|NCT00049595|Doxorubicin|doxorubicin|mesh-list
25849902|NCT00049595|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25849903|NCT00049595|Etoposide|etoposide|mesh-list
25849904|NCT00049595|Vincristine|vincristine|mesh-list
25849905|NCT00049595|Bleomycin|bleomycin|mesh-list
25849906|NCT00049595|Vinblastine|vinblastine|mesh-list
25849907|NCT00049595|Procarbazine|procarbazine|mesh-list
25849908|NCT00049595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25849909|NCT00049595|Immunologic Factors|immunologic factors|mesh-ancestor
25849910|NCT00049595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849911|NCT00049595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25849912|NCT00049595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25849913|NCT00049595|Alkylating Agents|alkylating agents|mesh-ancestor
24933740|NCT04067856|Antiemetics|antiemetics|mesh-ancestor
24633306|NCT01128257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25849914|NCT00049595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849915|NCT00049595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849916|NCT00049595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25849917|NCT00049595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25849918|NCT00049595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25849919|NCT00049595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25849920|NCT00049595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849921|NCT00049595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25849922|NCT00049595|Glucocorticoids|glucocorticoids|mesh-ancestor
25849923|NCT00049595|Hormones|hormones|mesh-ancestor
25849924|NCT00049595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25849925|NCT00049595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25849926|NCT00049595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25849927|NCT00049595|Tubulin Modulators|tubulin modulators|mesh-ancestor
25849928|NCT00049595|Antimitotic Agents|antimitotic agents|mesh-ancestor
25849929|NCT00049595|Mitosis Modulators|mitosis modulators|mesh-ancestor
25849930|NCT00049608|Gemcitabine|gemcitabine|mesh-list
25849931|NCT00049608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25849932|NCT00049608|Antimetabolites|antimetabolites|mesh-ancestor
25849933|NCT00049608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849934|NCT00049608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849935|NCT00049608|Antiviral Agents|antiviral agents|mesh-ancestor
24825892|NCT02130830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825893|NCT02130830|Sensory System Agents|sensory system agents|mesh-ancestor
25849936|NCT00049608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25849937|NCT00049608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849938|NCT00049608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25849939|NCT00049608|Immunologic Factors|immunologic factors|mesh-ancestor
25849940|NCT00049608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849941|NCT00049634|Cyclosporine|cyclosporine|mesh-list
25849942|NCT00049634|Cyclophosphamide|cyclophosphamide|mesh-list
25849943|NCT00049634|Busulfan|busulfan|mesh-list
24442991|NCT00293410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442992|NCT00293410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442993|NCT00293410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24443011|NCT00293436|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24443012|NCT00293475|Sodium thiosulfate|sodium thiosulfate|mesh-list
24443014|NCT00293475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25849944|NCT00049634|Methotrexate|methotrexate|mesh-list
25849945|NCT00049634|Cyclosporins|cyclosporins|mesh-list
25849946|NCT00049634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25849947|NCT00049634|Immunologic Factors|immunologic factors|mesh-ancestor
25849948|NCT00049634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849949|NCT00049634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24585394|NCT00885326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24585395|NCT00885326|Growth Substances|growth substances|mesh-ancestor
25662327|NCT01643668|Clofarabine|clofarabine|mesh-list
25662328|NCT01643668|Alkylating Agents|alkylating agents|mesh-ancestor
25662329|NCT01643668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662330|NCT01643668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25662331|NCT01643668|Immunologic Factors|immunologic factors|mesh-ancestor
25662332|NCT01643668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662333|NCT01643668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25849951|NCT00049634|Alkylating Agents|alkylating agents|mesh-ancestor
25849952|NCT00049634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849953|NCT00049634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849954|NCT00049634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25849955|NCT00049634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25849956|NCT00049634|Abortifacient Agents|abortifacient agents|mesh-ancestor
25849957|NCT00049634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25849958|NCT00049634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25849959|NCT00049634|Antimetabolites|antimetabolites|mesh-ancestor
25203454|NCT02714231|Cholinergic Agents|cholinergic agents|mesh-ancestor
25849960|NCT00049634|Dermatologic Agents|dermatologic agents|mesh-ancestor
25849961|NCT00049634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25849962|NCT00049634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25849963|NCT00049634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25849964|NCT00049634|Antifungal Agents|antifungal agents|mesh-ancestor
25849965|NCT00049634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25849966|NCT00049634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25849967|NCT00049660|Capecitabine|capecitabine|mesh-list
24825898|NCT02130830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24825899|NCT02130830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825900|NCT02130869|Cytarabine|cytarabine|mesh-list
24825901|NCT02130869|Aldesleukin|aldesleukin|mesh-list
24825902|NCT02130869|Carboplatin|carboplatin|mesh-list
24825903|NCT02130869|Etoposide|etoposide|mesh-list
24825904|NCT02130869|Etoposide phosphate|etoposide phosphate|mesh-list
24825905|NCT02130869|Melphalan|melphalan|mesh-list
24825906|NCT02130869|Busulfan|busulfan|mesh-list
24825907|NCT02130869|Interleukin-2|interleukin-2|mesh-list
24825908|NCT02130869|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24825909|NCT02130869|Mechlorethamine|mechlorethamine|mesh-list
25849968|NCT00049660|Vinorelbine|vinorelbine|mesh-list
25849969|NCT00049660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25849970|NCT00049660|Antimetabolites|antimetabolites|mesh-ancestor
25849971|NCT00049660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849972|NCT00049660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25849973|NCT00049660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25849974|NCT00049660|Tubulin Modulators|tubulin modulators|mesh-ancestor
25849975|NCT00049660|Antimitotic Agents|antimitotic agents|mesh-ancestor
24585401|NCT00885443|Propofol|propofol|mesh-list
25849976|NCT00049660|Mitosis Modulators|mitosis modulators|mesh-ancestor
25849977|NCT00049725|Daclizumab|daclizumab|mesh-list
25849978|NCT00049725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25849979|NCT00049725|Immunologic Factors|immunologic factors|mesh-ancestor
25849980|NCT00049725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25849981|NCT00049751|Adalimumab|adalimumab|mesh-list
25849982|NCT00049751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25849983|NCT00049751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25849984|NCT00049764|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
25849985|NCT00049764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25849986|NCT00049777|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
25849987|NCT00049777|Heparin|heparin|mesh-list
25849988|NCT00049777|Calcium heparin|calcium heparin|mesh-list
25849989|NCT00049777|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25849990|NCT00049777|Tinzaparin|tinzaparin|mesh-list
25849991|NCT00049777|Dalteparin|dalteparin|mesh-list
25849992|NCT00049777|Anticoagulants|anticoagulants|mesh-ancestor
25010650|NCT03428958|Levoleucovorin|levoleucovorin|mesh-list
25849993|NCT00049777|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25849994|NCT00049777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25849995|NCT00049777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25849996|NCT00049777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25849997|NCT00049790|Paclitaxel|paclitaxel|mesh-list
25849998|NCT00049790|Carboplatin|carboplatin|mesh-list
25849999|NCT00049790|Angiostatins|angiostatins|mesh-list
25850000|NCT00049790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25850001|NCT00049790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24883041|NCT04632706|Ivermectin|ivermectin|mesh-list
25850002|NCT00049790|Tubulin Modulators|tubulin modulators|mesh-ancestor
24825910|NCT02130869|Sargramostim|sargramostim|mesh-list
24825911|NCT02130869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825912|NCT02130869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24825913|NCT02130869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24825914|NCT02130869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25850003|NCT00049790|Antimitotic Agents|antimitotic agents|mesh-ancestor
25850004|NCT00049790|Mitosis Modulators|mitosis modulators|mesh-ancestor
25419845|NCT02670707|Antimetabolites|antimetabolites|mesh-ancestor
25850005|NCT00049790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850009|NCT00049790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850011|NCT00049803|Sodium Oxybate|sodium oxybate|mesh-list
25850012|NCT00049803|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25850013|NCT00049803|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25850014|NCT00049803|Anesthetics, General|anesthetics, general|mesh-ancestor
24585593|NCT00886275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25850015|NCT00049803|Anesthetics|anesthetics|mesh-ancestor
25850016|NCT00049803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25850017|NCT00049803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850018|NCT00049829|Zoledronic Acid|zoledronic acid|mesh-list
25850019|NCT00049829|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24443028|NCT00293475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25850020|NCT00049829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850021|NCT00049946|Risperidone|risperidone|mesh-list
25850022|NCT00049946|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25850023|NCT00049946|Serotonin Agents|serotonin agents|mesh-ancestor
25850024|NCT00049946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25850025|NCT00049946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850026|NCT00049946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850027|NCT00049946|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25850028|NCT00049946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25850029|NCT00049946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24585668|NCT00886574|Antipyretics|antipyretics|mesh-ancestor
24825915|NCT02130869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850030|NCT00049946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25850031|NCT00049946|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25850032|NCT00049946|Dopamine Agents|dopamine agents|mesh-ancestor
25850033|NCT00049972|Paroxetine|paroxetine|mesh-list
25850034|NCT00049972|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25850035|NCT00049972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25850036|NCT00049972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25850037|NCT00049972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850038|NCT00049972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25850039|NCT00049972|Serotonin Agents|serotonin agents|mesh-ancestor
25850040|NCT00049972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850041|NCT00049972|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25850042|NCT00049972|Antidepressive Agents|antidepressive agents|mesh-ancestor
25850043|NCT00049972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25850044|NCT00049972|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25850045|NCT00049972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25850046|NCT00049972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850047|NCT00049985|Darbepoetin alfa|darbepoetin alfa|mesh-list
25850048|NCT00049985|Hematinics|hematinics|mesh-ancestor
25850049|NCT00049998|Topotecan|topotecan|mesh-list
25850050|NCT00049998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25850051|NCT00049998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25850052|NCT00049998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850053|NCT00049998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850054|NCT00049998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850055|NCT00050141|Tipifarnib|tipifarnib|mesh-list
25850056|NCT00050141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662334|NCT01643668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662335|NCT01643668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25662336|NCT01643668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25662337|NCT01643668|Antimetabolites|antimetabolites|mesh-ancestor
25662338|NCT01643772|Oxycodone|oxycodone|mesh-list
25662339|NCT01643772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25662340|NCT01643772|Narcotics|narcotics|mesh-ancestor
25662341|NCT01643772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25662342|NCT01643772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662343|NCT01643772|Analgesics|analgesics|mesh-ancestor
25662344|NCT01643772|Sensory System Agents|sensory system agents|mesh-ancestor
24825918|NCT02130869|Antimetabolites|antimetabolites|mesh-ancestor
24825919|NCT02130869|Antiviral Agents|antiviral agents|mesh-ancestor
24490691|NCT00479726|Dopamine Agents|dopamine agents|mesh-ancestor
25850060|NCT00050180|Saquinavir|saquinavir|mesh-list
25850061|NCT00050180|Midazolam|midazolam|mesh-list
25850062|NCT00050180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25850063|NCT00050180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25850064|NCT00050180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25850065|NCT00050180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850066|NCT00050180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25850067|NCT00050180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25850068|NCT00050180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25850069|NCT00050180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25850070|NCT00050180|Anesthetics, General|anesthetics, general|mesh-ancestor
25850071|NCT00050180|Anesthetics|anesthetics|mesh-ancestor
25850072|NCT00050180|GABA Modulators|gaba modulators|mesh-ancestor
25850073|NCT00050180|GABA Agents|gaba agents|mesh-ancestor
25850074|NCT00050180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25850075|NCT00050180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850076|NCT00050180|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25850077|NCT00050180|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25850078|NCT00050180|Protease Inhibitors|protease inhibitors|mesh-ancestor
25850079|NCT00050180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203455|NCT02714231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25850080|NCT00050180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25850081|NCT00050180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25850082|NCT00050180|Antiviral Agents|antiviral agents|mesh-ancestor
25850083|NCT00050180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25850084|NCT00050180|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25850085|NCT00050180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25850086|NCT00050206|Olanzapine|olanzapine|mesh-list
25850087|NCT00050206|Antiemetics|antiemetics|mesh-ancestor
25850088|NCT00050206|Autonomic Agents|autonomic agents|mesh-ancestor
25850089|NCT00050206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25850090|NCT00050206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850091|NCT00050206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25850092|NCT00050206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25850093|NCT00050206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25850094|NCT00050206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25850095|NCT00050206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25850096|NCT00050206|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25850097|NCT00050206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25850098|NCT00050206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25850099|NCT00050206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850100|NCT00050206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25850101|NCT00050206|Serotonin Agents|serotonin agents|mesh-ancestor
25850102|NCT00050245|Rituximab|rituximab|mesh-list
25850103|NCT00050245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25850104|NCT00050245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850105|NCT00050245|Immunologic Factors|immunologic factors|mesh-ancestor
24585819|NCT00887211|Sirolimus|sirolimus|mesh-list
25850106|NCT00050245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850107|NCT00050245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25850108|NCT00050271|Acetylcarnitine|acetylcarnitine|mesh-list
25850109|NCT00050271|Vitamin B Complex|vitamin b complex|mesh-ancestor
25850110|NCT00050271|Vitamins|vitamins|mesh-ancestor
25850111|NCT00050271|Micronutrients|micronutrients|mesh-ancestor
24825922|NCT02130869|Immunologic Factors|immunologic factors|mesh-ancestor
24825923|NCT02130869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662345|NCT01643772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25662346|NCT01643902|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25662347|NCT01643902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25662348|NCT01643902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25662349|NCT01643902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662350|NCT01643928|Rituximab|rituximab|mesh-list
25662351|NCT01643928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25662352|NCT01643928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662353|NCT01643928|Immunologic Factors|immunologic factors|mesh-ancestor
25662354|NCT01643928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662355|NCT01643928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25662356|NCT01644175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25850114|NCT00050297|N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|n-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|mesh-list
25850115|NCT00050297|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24585858|NCT00887367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057345|NCT03506009|Antithrombins|antithrombins|mesh-ancestor
25850116|NCT00050297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850117|NCT00050336|Lonafarnib|lonafarnib|mesh-list
25850118|NCT00050336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850119|NCT00050336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850120|NCT00050349|Epothilones|epothilones|mesh-list
25850121|NCT00050349|Epothilone B|epothilone b|mesh-list
25850122|NCT00050349|Tubulin Modulators|tubulin modulators|mesh-ancestor
25850123|NCT00050349|Antimitotic Agents|antimitotic agents|mesh-ancestor
25010522|NCT03855046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010523|NCT03855046|Cholinergic Agents|cholinergic agents|mesh-ancestor
25010524|NCT03855046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25010525|NCT03854110|Gemcitabine|gemcitabine|mesh-list
25010526|NCT03854110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25010527|NCT03854110|Antimetabolites|antimetabolites|mesh-ancestor
25850124|NCT00050349|Mitosis Modulators|mitosis modulators|mesh-ancestor
25850125|NCT00050349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850126|NCT00050349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850127|NCT00050362|Rofecoxib|rofecoxib|mesh-list
25850128|NCT00050362|Bupivacaine|bupivacaine|mesh-list
25850129|NCT00050362|Anesthetics, Local|anesthetics, local|mesh-ancestor
25850130|NCT00050362|Anesthetics|anesthetics|mesh-ancestor
24825924|NCT02130869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24825925|NCT02130869|Alkylating Agents|alkylating agents|mesh-ancestor
25850131|NCT00050362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25850132|NCT00050362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850133|NCT00050362|Sensory System Agents|sensory system agents|mesh-ancestor
25850134|NCT00050362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25850135|NCT00050362|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25850136|NCT00050362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25850137|NCT00050362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850138|NCT00050362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850139|NCT00050362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25850140|NCT00050362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25850141|NCT00050362|Analgesics|analgesics|mesh-ancestor
25850142|NCT00050362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25850143|NCT00050362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25850144|NCT00050375|Oregovomab|oregovomab|mesh-list
25850145|NCT00050375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25850146|NCT00050375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850147|NCT00050401|Vancomycin|vancomycin|mesh-list
25850148|NCT00050401|Tobramycin|tobramycin|mesh-list
25850149|NCT00050401|Meropenem|meropenem|mesh-list
25850150|NCT00050401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25850151|NCT00050401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25850152|NCT00050414|Dexamethasone|dexamethasone|mesh-list
25850153|NCT00050414|Trabectedin|trabectedin|mesh-list
25850154|NCT00050414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25850155|NCT00050414|Antiemetics|antiemetics|mesh-ancestor
25850156|NCT00050414|Autonomic Agents|autonomic agents|mesh-ancestor
25850157|NCT00050414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25850158|NCT00050414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825932|NCT02130869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24825933|NCT02130973|Denosumab|denosumab|mesh-list
24825934|NCT02130973|Teriparatide|teriparatide|mesh-list
25010617|NCT03617731|Growth Inhibitors|growth inhibitors|mesh-ancestor
25110169|NCT05464979|Ketamine|ketamine|mesh-list
25110170|NCT05464979|Esketamine|esketamine|mesh-list
25110171|NCT05464979|Analgesics|analgesics|mesh-ancestor
25110172|NCT05464979|Sensory System Agents|sensory system agents|mesh-ancestor
25662357|NCT01644175|Immunologic Factors|immunologic factors|mesh-ancestor
25662358|NCT01644175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662359|NCT01644188|Ezetimibe|ezetimibe|mesh-list
25662360|NCT01644188|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25662361|NCT01644188|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25662362|NCT01644188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25662363|NCT01644188|Antimetabolites|antimetabolites|mesh-ancestor
25662364|NCT01644188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915880|NCT04247087|Vitamins|vitamins|mesh-ancestor
24915881|NCT04247087|Micronutrients|micronutrients|mesh-ancestor
24915882|NCT04247087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915883|NCT04247087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24915884|NCT04247087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24915885|NCT04247087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915886|NCT04247087|Hemostatics|hemostatics|mesh-ancestor
24915887|NCT04247087|Coagulants|coagulants|mesh-ancestor
24915922|NCT04246723|Antiviral Agents|antiviral agents|mesh-ancestor
24868114|NCT03595566|Vancomycin|vancomycin|mesh-list
24915945|NCT04246567|Fentanyl|fentanyl|mesh-list
25850159|NCT00050414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25850160|NCT00050414|Glucocorticoids|glucocorticoids|mesh-ancestor
25850161|NCT00050414|Hormones|hormones|mesh-ancestor
25850162|NCT00050414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25850163|NCT00050414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25850164|NCT00050414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850165|NCT00050414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25850166|NCT00050414|Alkylating Agents|alkylating agents|mesh-ancestor
25850167|NCT00050414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110174|NCT05464979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110175|NCT05464979|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25110178|NCT05464979|Anesthetics|anesthetics|mesh-ancestor
25850168|NCT00050427|Trabectedin|trabectedin|mesh-list
25850169|NCT00050427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25850170|NCT00050427|Alkylating Agents|alkylating agents|mesh-ancestor
25110198|NCT05464953|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25110199|NCT05464953|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25110200|NCT05464953|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25110201|NCT05464953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25110202|NCT05464953|Glucocorticoids|glucocorticoids|mesh-ancestor
25110203|NCT05464953|Hormones|hormones|mesh-ancestor
25110204|NCT05464953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24415804|NCT00200941|Topiramate|topiramate|mesh-list
24612783|NCT01015391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612784|NCT01015391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24612785|NCT01015391|Immunologic Factors|immunologic factors|mesh-ancestor
24697465|NCT01434914|Octenidine|octenidine|mesh-list
24697482|NCT01435161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25010618|NCT03596164|Teduglutide|teduglutide|mesh-list
25010619|NCT03596164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25010620|NCT03596164|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25010621|NCT03596164|Protective Agents|protective agents|mesh-ancestor
24977934|NCT01261728|Antimetabolites|antimetabolites|mesh-ancestor
24697588|NCT01435707|Immunologic Factors|immunologic factors|mesh-ancestor
24697589|NCT01435707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24697590|NCT01435707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697591|NCT01435837|Caffeine|caffeine|mesh-list
25850171|NCT00050427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850172|NCT00050427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850173|NCT00050440|Dexamethasone|dexamethasone|mesh-list
25850174|NCT00050440|Trabectedin|trabectedin|mesh-list
25850175|NCT00050440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25850176|NCT00050440|Antiemetics|antiemetics|mesh-ancestor
25850177|NCT00050440|Autonomic Agents|autonomic agents|mesh-ancestor
25010622|NCT03596164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010623|NCT03505710|Trastuzumab|trastuzumab|mesh-list
25010624|NCT03505710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25010625|NCT03505710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010627|NCT03482479|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25010628|NCT03482479|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25010629|NCT03482479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662365|NCT01644188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25662366|NCT01644188|Immunologic Factors|immunologic factors|mesh-ancestor
25662367|NCT01644188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662368|NCT01644331|Tolvaptan|tolvaptan|mesh-list
25662369|NCT01644331|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25662370|NCT01644331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662371|NCT01644331|Natriuretic Agents|natriuretic agents|mesh-ancestor
25662372|NCT01644331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662373|NCT01644396|Adalimumab|adalimumab|mesh-list
25662374|NCT01644396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25662375|NCT01644396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25662376|NCT01644474|Ezetimibe|ezetimibe|mesh-list
24697791|NCT01437306|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24697792|NCT01437306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697793|NCT01437306|Sensory System Agents|sensory system agents|mesh-ancestor
24697794|NCT01437306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24697795|NCT01437306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24697796|NCT01437306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24697797|NCT01437306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24697798|NCT01437306|Adrenergic Agents|adrenergic agents|mesh-ancestor
24697799|NCT01437306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24697802|NCT01437371|Enalapril|enalapril|mesh-list
25850178|NCT00050440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25850179|NCT00050440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850180|NCT00050440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25850181|NCT00050440|Glucocorticoids|glucocorticoids|mesh-ancestor
25850182|NCT00050440|Hormones|hormones|mesh-ancestor
25850183|NCT00050440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25850184|NCT00050440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25850185|NCT00050440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850186|NCT00050440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25850187|NCT00050440|Alkylating Agents|alkylating agents|mesh-ancestor
25850188|NCT00050440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850189|NCT00050479|Celecoxib|celecoxib|mesh-list
25850190|NCT00050479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25850191|NCT00050479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25850192|NCT00050479|Analgesics|analgesics|mesh-ancestor
25850193|NCT00050479|Sensory System Agents|sensory system agents|mesh-ancestor
25850194|NCT00050479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25850195|NCT00050479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850196|NCT00050479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25850197|NCT00050479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25850198|NCT00050479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25850199|NCT00050479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25850200|NCT00050479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25010630|NCT03482479|Sensory System Agents|sensory system agents|mesh-ancestor
25010631|NCT03482479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25010637|NCT03446157|Cetuximab|cetuximab|mesh-list
25010638|NCT03446157|Palbociclib|palbociclib|mesh-list
25010639|NCT03446157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25010640|NCT03446157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010641|NCT03446157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25010642|NCT03446157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25010643|NCT03446157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010644|NCT03428958|Leucovorin|leucovorin|mesh-list
25010645|NCT03428958|Bevacizumab|bevacizumab|mesh-list
25010646|NCT03428958|Cetuximab|cetuximab|mesh-list
25010647|NCT03428958|Panitumumab|panitumumab|mesh-list
25010648|NCT03428958|Oxaliplatin|oxaliplatin|mesh-list
25010649|NCT03428958|Irinotecan|irinotecan|mesh-list
24825939|NCT02131012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24825940|NCT02131012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25850201|NCT00050479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850202|NCT00050505|Vaccines|vaccines|mesh-list
25850203|NCT00050505|Immunologic Factors|immunologic factors|mesh-ancestor
25850204|NCT00050505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850205|NCT00050531|Interferons|interferons|mesh-list
25850206|NCT00050531|Interferon-alpha|interferon-alpha|mesh-list
25850207|NCT00050531|Interferon alpha-2|interferon alpha-2|mesh-list
25850208|NCT00050531|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25850209|NCT00050531|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
25010654|NCT03428958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25010655|NCT03428958|Growth Substances|growth substances|mesh-ancestor
25010656|NCT03428958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010657|NCT03428958|Growth Inhibitors|growth inhibitors|mesh-ancestor
25010658|NCT03428958|Antidotes|antidotes|mesh-ancestor
25010659|NCT03428958|Protective Agents|protective agents|mesh-ancestor
25010660|NCT03428958|Vitamin B Complex|vitamin b complex|mesh-ancestor
25010661|NCT03428958|Vitamins|vitamins|mesh-ancestor
25010672|NCT03393611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010673|NCT03393611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25010674|NCT03393611|Antimetabolites|antimetabolites|mesh-ancestor
25010675|NCT03393611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698105|NCT01438866|Fluorides, Topical|fluorides, topical|mesh-list
24698106|NCT01438866|Cariostatic Agents|cariostatic agents|mesh-ancestor
24698107|NCT01438866|Protective Agents|protective agents|mesh-ancestor
25850210|NCT00050531|Imatinib Mesylate|imatinib mesylate|mesh-list
25850211|NCT00050531|Molgramostim|molgramostim|mesh-list
25850213|NCT00050531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850214|NCT00050531|Antiviral Agents|antiviral agents|mesh-ancestor
25850215|NCT00050531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25850216|NCT00050531|Immunologic Factors|immunologic factors|mesh-ancestor
25850217|NCT00050531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850218|NCT00050531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25850219|NCT00050531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25010676|NCT03393611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25010677|NCT03393611|Immunologic Factors|immunologic factors|mesh-ancestor
25010678|NCT03393611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010679|NCT03393611|Antiviral Agents|antiviral agents|mesh-ancestor
25010680|NCT03393611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25010681|NCT03393611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25010682|NCT03393611|Alkylating Agents|alkylating agents|mesh-ancestor
25010683|NCT03393611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25010684|NCT03393611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25010685|NCT03393611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24795290|NCT03229538|Hormones|hormones|mesh-ancestor
24698213|NCT01439802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698214|NCT01439984|Clomipramine|clomipramine|mesh-list
25850220|NCT00050531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850221|NCT00050596|Docetaxel|docetaxel|mesh-list
25850222|NCT00050596|Ipilimumab|ipilimumab|mesh-list
25850223|NCT00050596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850224|NCT00050596|Tubulin Modulators|tubulin modulators|mesh-ancestor
25850225|NCT00050596|Antimitotic Agents|antimitotic agents|mesh-ancestor
25850226|NCT00050596|Mitosis Modulators|mitosis modulators|mesh-ancestor
25850227|NCT00050596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850228|NCT00050596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25850229|NCT00050596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25850230|NCT00050609|Tadalafil|tadalafil|mesh-list
25850231|NCT00050609|Vasodilator Agents|vasodilator agents|mesh-ancestor
25850232|NCT00050609|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25850233|NCT00050609|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25850234|NCT00050609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850235|NCT00050609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850236|NCT00050609|Urological Agents|urological agents|mesh-ancestor
25876135|NCT03907488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25876136|NCT03907488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25010688|NCT03382301|Cyclosporine|cyclosporine|mesh-list
25876137|NCT03907488|Alkylating Agents|alkylating agents|mesh-ancestor
25876138|NCT03907488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25876139|NCT03907488|Tubulin Modulators|tubulin modulators|mesh-ancestor
25876140|NCT03907488|Antimitotic Agents|antimitotic agents|mesh-ancestor
25876141|NCT03907488|Mitosis Modulators|mitosis modulators|mesh-ancestor
25876142|NCT03871257|Carboplatin|carboplatin|mesh-list
25010719|NCT03205423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25876143|NCT03871257|Vincristine|vincristine|mesh-list
25876144|NCT03871257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876145|NCT03871257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25876146|NCT03871257|Tubulin Modulators|tubulin modulators|mesh-ancestor
25876147|NCT03871257|Antimitotic Agents|antimitotic agents|mesh-ancestor
25876148|NCT03871257|Mitosis Modulators|mitosis modulators|mesh-ancestor
25876149|NCT03871257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876150|NCT03864406|Darunavir|darunavir|mesh-list
25010756|NCT03086486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876151|NCT03864406|Cobicistat|cobicistat|mesh-list
25876152|NCT03864406|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
25876153|NCT03864406|Rivaroxaban|rivaroxaban|mesh-list
25876154|NCT03864406|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25876155|NCT03864406|Antithrombins|antithrombins|mesh-ancestor
25876156|NCT03864406|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25876157|NCT03864406|Protease Inhibitors|protease inhibitors|mesh-ancestor
25876158|NCT03864406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876159|NCT03864406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876160|NCT03864406|Anticoagulants|anticoagulants|mesh-ancestor
25876161|NCT03864406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25010765|NCT03049449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24571748|NCT00811486|Conivaptan|conivaptan|mesh-list
24585919|NCT00888108|Docetaxel|docetaxel|mesh-list
24585979|NCT00888758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24585980|NCT00888758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24585981|NCT00888758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24585982|NCT00888758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24916693|NCT04238195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25234312|NCT02572375|Codeine|codeine|mesh-list
24585983|NCT00888758|Antifungal Agents|antifungal agents|mesh-ancestor
24585985|NCT00888784|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24585986|NCT00888784|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24700088|NCT01450462|Vitamin D|vitamin d|mesh-list
24825944|NCT02131012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850237|NCT00050635|Octreotide|octreotide|mesh-list
25850238|NCT00050635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25850239|NCT00050635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25850240|NCT00050635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850241|NCT00050648|Cyclosporine|cyclosporine|mesh-list
25850242|NCT00050648|Cyclosporins|cyclosporins|mesh-list
25850243|NCT00050648|Daclizumab|daclizumab|mesh-list
25850244|NCT00050648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850245|NCT00050648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850246|NCT00050648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25850247|NCT00050648|Immunologic Factors|immunologic factors|mesh-ancestor
25850248|NCT00050648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850249|NCT00050648|Antifungal Agents|antifungal agents|mesh-ancestor
25010774|NCT03000569|Dopamine Agents|dopamine agents|mesh-ancestor
25010775|NCT03000569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25850250|NCT00050648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25850251|NCT00050648|Dermatologic Agents|dermatologic agents|mesh-ancestor
25850252|NCT00050648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25850253|NCT00050648|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25850254|NCT00050661|Daclizumab|daclizumab|mesh-list
25850255|NCT00050661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25850256|NCT00050661|Immunologic Factors|immunologic factors|mesh-ancestor
25850257|NCT00050661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850258|NCT00050674|Lenograstim|lenograstim|mesh-list
25850259|NCT00050674|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25850260|NCT00050674|Immunologic Factors|immunologic factors|mesh-ancestor
25850261|NCT00050674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850262|NCT00050713|Sirolimus|sirolimus|mesh-list
25850263|NCT00050713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25850264|NCT00050713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25850265|NCT00050713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25850266|NCT00050713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010799|NCT02942017|Brexanolone|brexanolone|mesh-list
25010816|NCT02939573|Dapsone|dapsone|mesh-list
25850267|NCT00050713|Antifungal Agents|antifungal agents|mesh-ancestor
25850268|NCT00050713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25850269|NCT00050713|Immunologic Factors|immunologic factors|mesh-ancestor
25850270|NCT00050713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850271|NCT00050726|Interleukin-2|interleukin-2|mesh-list
25850272|NCT00050726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850273|NCT00050726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24825945|NCT02131012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24825946|NCT02131012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24825947|NCT02131012|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24825948|NCT02131012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24825949|NCT02131012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825950|NCT02131012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825951|NCT02131220|Tirofiban|tirofiban|mesh-list
24825952|NCT02131220|Saruplase|saruplase|mesh-list
25850274|NCT00050726|Analgesics|analgesics|mesh-ancestor
25850275|NCT00050726|Sensory System Agents|sensory system agents|mesh-ancestor
25850276|NCT00050726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25850277|NCT00050726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850278|NCT00050804|Sertraline|sertraline|mesh-list
25850279|NCT00050804|Antidepressive Agents|antidepressive agents|mesh-ancestor
25850280|NCT00050804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25850281|NCT00050804|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25850282|NCT00050804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25662377|NCT01644474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25662378|NCT01644474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25419922|NCT02663518|Immunologic Factors|immunologic factors|mesh-ancestor
25662379|NCT01644474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25662380|NCT01644474|Antimetabolites|antimetabolites|mesh-ancestor
25662381|NCT01644474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662382|NCT01644474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25662383|NCT01644474|Immunologic Factors|immunologic factors|mesh-ancestor
25662384|NCT01644474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662385|NCT01644500|Glimepiride|glimepiride|mesh-list
25662386|NCT01644500|Dulaglutide|dulaglutide|mesh-list
25850284|NCT00050804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850285|NCT00050804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25010857|NCT02910635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25010858|NCT02910635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25010859|NCT02910635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057395|NCT03505489|Diuretics|diuretics|mesh-ancestor
25010860|NCT02910635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010861|NCT02910635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850286|NCT00050804|Serotonin Agents|serotonin agents|mesh-ancestor
25850287|NCT00050804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850288|NCT00050817|Clopidogrel|clopidogrel|mesh-list
25850289|NCT00050817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25850290|NCT00050817|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25850291|NCT00050817|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25850292|NCT00050817|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25850293|NCT00050817|Purinergic Agents|purinergic agents|mesh-ancestor
25010877|NCT02820857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25850294|NCT00050817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25850295|NCT00050817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443112|NCT00293657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24443113|NCT00293657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443114|NCT00293657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443115|NCT00293670|Goserelin|goserelin|mesh-list
24443116|NCT00293670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24443117|NCT00293670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24443118|NCT00293696|Goserelin|goserelin|mesh-list
25010906|NCT02737306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25010907|NCT02737306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25010908|NCT02737306|Antiviral Agents|antiviral agents|mesh-ancestor
25010909|NCT02737306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25010910|NCT02728648|Oxycodone|oxycodone|mesh-list
25010911|NCT02728648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25010912|NCT02728648|Narcotics|narcotics|mesh-ancestor
25010913|NCT02728648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25010915|NCT02728648|Analgesics|analgesics|mesh-ancestor
24443133|NCT00293735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24443134|NCT00293735|Sympathomimetics|sympathomimetics|mesh-ancestor
24443135|NCT00293735|Autonomic Agents|autonomic agents|mesh-ancestor
24443136|NCT00293735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24443143|NCT00293787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24443144|NCT00293787|Latanoprost|latanoprost|mesh-list
24443145|NCT00293787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24443146|NCT00293787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24443147|NCT00293787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24934995|NCT04056143|Apixaban|apixaban|mesh-list
25850296|NCT00050817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850297|NCT00050830|Canertinib dihydrochloride|canertinib dihydrochloride|mesh-list
25850298|NCT00050830|Anesthetics, Local|anesthetics, local|mesh-ancestor
25850299|NCT00050830|Anesthetics|anesthetics|mesh-ancestor
25850300|NCT00050830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25850301|NCT00050830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850302|NCT00050830|Sensory System Agents|sensory system agents|mesh-ancestor
25850303|NCT00050830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25850304|NCT00050830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850305|NCT00050830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25010971|NCT02477618|Brexanolone|brexanolone|mesh-list
25010972|NCT02477618|Neurosteroids|neurosteroids|mesh-ancestor
25010973|NCT02477618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25010974|NCT02477618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010975|NCT02477618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010976|NCT02477618|GABA Modulators|gaba modulators|mesh-ancestor
25010977|NCT02477618|GABA Agents|gaba agents|mesh-ancestor
24783640|NCT01903070|Linagliptin|linagliptin|mesh-list
24701356|NCT01458600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701357|NCT01458600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25850306|NCT00050830|Protective Agents|protective agents|mesh-ancestor
25850307|NCT00050843|Thalidomide|thalidomide|mesh-list
25850308|NCT00050843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25850309|NCT00050843|Immunologic Factors|immunologic factors|mesh-ancestor
25850310|NCT00050843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850311|NCT00050843|Leprostatic Agents|leprostatic agents|mesh-ancestor
25850312|NCT00050843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25850313|NCT00050843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25409344|NCT03384836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850317|NCT00050843|Growth Inhibitors|growth inhibitors|mesh-ancestor
25850318|NCT00050843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850319|NCT00050856|Enfuvirtide|enfuvirtide|mesh-list
25850320|NCT00050856|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25850321|NCT00050856|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25850322|NCT00050856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850323|NCT00050856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25850324|NCT00050856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24586033|NCT00888862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24633823|NCT01131273|Buprenorphine|buprenorphine|mesh-list
25850325|NCT00050856|Antiviral Agents|antiviral agents|mesh-ancestor
24586034|NCT00888901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24586035|NCT00888901|Methylprednisolone|methylprednisolone|mesh-list
24586048|NCT00888901|Hormones|hormones|mesh-ancestor
24586050|NCT00888901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25850326|NCT00050856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25850327|NCT00050895|Ritonavir|ritonavir|mesh-list
25850328|NCT00050895|Lopinavir|lopinavir|mesh-list
25850329|NCT00050895|Tenofovir|tenofovir|mesh-list
25203456|NCT02714231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25850330|NCT00050895|Lamivudine|lamivudine|mesh-list
25850331|NCT00050895|Zidovudine|zidovudine|mesh-list
25850332|NCT00050895|Stavudine|stavudine|mesh-list
25850333|NCT00050895|Efavirenz|efavirenz|mesh-list
25850334|NCT00050895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25850335|NCT00050895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25850336|NCT00050895|Protease Inhibitors|protease inhibitors|mesh-ancestor
25850337|NCT00050895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850338|NCT00050895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586056|NCT00889044|Clopidogrel|clopidogrel|mesh-list
24586057|NCT00889044|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24586058|NCT00889044|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24586059|NCT00889044|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24586060|NCT00889044|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24902105|NCT04377386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902106|NCT04377386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24902107|NCT04377386|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24902108|NCT04377399|Vitamin D|vitamin d|mesh-list
24902109|NCT04377399|Vitamins|vitamins|mesh-ancestor
24902110|NCT04377399|Micronutrients|micronutrients|mesh-ancestor
24902111|NCT04377399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902112|NCT04377399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24902113|NCT04377321|Colchicine|colchicine|mesh-list
24880310|NCT03872180|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24880311|NCT03872180|Venetoclax|venetoclax|mesh-list
24902114|NCT04377321|Gout Suppressants|gout suppressants|mesh-ancestor
24902115|NCT04377321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24902116|NCT04377321|Tubulin Modulators|tubulin modulators|mesh-ancestor
24902117|NCT04377321|Antimitotic Agents|antimitotic agents|mesh-ancestor
24902118|NCT04377321|Mitosis Modulators|mitosis modulators|mesh-ancestor
24902119|NCT04377321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902120|NCT04377321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24902182|NCT04376528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902183|NCT04376528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24902184|NCT04376528|Immunologic Factors|immunologic factors|mesh-ancestor
24902185|NCT04376528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902186|NCT04376528|Antifungal Agents|antifungal agents|mesh-ancestor
24902187|NCT04376528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902188|NCT04376528|Dermatologic Agents|dermatologic agents|mesh-ancestor
24902189|NCT04376528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24902190|NCT04376528|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24880338|NCT03849469|Pembrolizumab|pembrolizumab|mesh-list
24880339|NCT03849469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24880340|NCT03849469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850339|NCT00050895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24902409|NCT04374071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24902410|NCT04374071|Antiemetics|antiemetics|mesh-ancestor
24902411|NCT04374071|Autonomic Agents|autonomic agents|mesh-ancestor
24902412|NCT04374071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24459264|NCT00344123|Tipranavir|tipranavir|mesh-list
25850340|NCT00050895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25850341|NCT00050895|Antiviral Agents|antiviral agents|mesh-ancestor
25234376|NCT02571712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25234377|NCT02571881|Oxycodone|oxycodone|mesh-list
25234378|NCT02571881|Naloxone|naloxone|mesh-list
25234379|NCT02571881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24956625|NCT03852797|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24956626|NCT03852797|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24956627|NCT03852797|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24956628|NCT03852797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24956629|NCT03852797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902494|NCT04372836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902495|NCT04373044|Hydroxychloroquine|hydroxychloroquine|mesh-list
24902496|NCT04373044|Antimalarials|antimalarials|mesh-ancestor
24902497|NCT04373044|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24902498|NCT04373044|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24902499|NCT04373044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902500|NCT04373044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902501|NCT04373044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902502|NCT04373044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24902503|NCT04373018|Chlorhexidine|chlorhexidine|mesh-list
24902504|NCT04373018|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24902505|NCT04373018|Hydrogen Peroxide|hydrogen peroxide|mesh-list
24902506|NCT04373018|Sodium Hypochlorite|sodium hypochlorite|mesh-list
24902508|NCT04373018|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24902509|NCT04373018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902510|NCT04373018|Disinfectants|disinfectants|mesh-ancestor
24902537|NCT04372264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902538|NCT04372264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25850342|NCT00050895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24786947|NCT01922765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24786948|NCT01922765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24786949|NCT01922765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24786950|NCT01922765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24786951|NCT01922765|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24786952|NCT01922765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24786953|NCT01922765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786954|NCT01922765|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24880510|NCT03608358|Dapagliflozin|dapagliflozin|mesh-list
24880511|NCT03608358|Saxagliptin|saxagliptin|mesh-list
25850343|NCT00050895|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25850344|NCT00050895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24786955|NCT01922765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24786956|NCT01922765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24786957|NCT01922765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24786958|NCT01922765|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24786960|NCT01922804|Micronutrients|micronutrients|mesh-ancestor
24786961|NCT01922804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786962|NCT01922817|Saxagliptin|saxagliptin|mesh-list
24786992|NCT01922999|Protective Agents|protective agents|mesh-ancestor
24786993|NCT01922999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268752|NCT02414581|Disinfectants|disinfectants|mesh-ancestor
24786994|NCT01922999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24786995|NCT01923012|Vitamin K|vitamin k|mesh-list
24786996|NCT01923012|Vitamin K 2|vitamin k 2|mesh-list
24786997|NCT01923012|Vitamins|vitamins|mesh-ancestor
24786998|NCT01923012|Micronutrients|micronutrients|mesh-ancestor
24786999|NCT01923012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787000|NCT01923012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25109005|NCT03128203|Oxytocics|oxytocics|mesh-ancestor
24787001|NCT01923012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24787002|NCT01923012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109006|NCT03128203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25109007|NCT03128203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662387|NCT01644500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25662388|NCT01644500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25662389|NCT01644500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662390|NCT01644500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25662391|NCT01644500|Immunologic Factors|immunologic factors|mesh-ancestor
25662392|NCT01644643|Metronidazole|metronidazole|mesh-list
25662393|NCT01644643|Ceftazidime|ceftazidime|mesh-list
25662394|NCT01644643|Avibactam|avibactam|mesh-list
25662395|NCT01644643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25662396|NCT01644643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24902590|NCT04371965|Povidone-Iodine|povidone-iodine|mesh-list
25662397|NCT01644643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24902591|NCT04371965|Povidone|povidone|mesh-list
24902592|NCT04371965|Plasma Substitutes|plasma substitutes|mesh-ancestor
24902593|NCT04371965|Blood Substitutes|blood substitutes|mesh-ancestor
24902594|NCT04371965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24902595|NCT04371965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902596|NCT04372082|Hydroxychloroquine|hydroxychloroquine|mesh-list
24902597|NCT04372082|Niclosamide|niclosamide|mesh-list
24902598|NCT04372082|Diltiazem|diltiazem|mesh-list
24902599|NCT04372082|Antimalarials|antimalarials|mesh-ancestor
24902600|NCT04372082|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24902601|NCT04372082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24902602|NCT04372082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902603|NCT04372082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902605|NCT04372082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24902608|NCT04372082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24902609|NCT04372082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24818272|NCT02087579|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24703011|NCT01469338|Prednisone|prednisone|mesh-list
24787007|NCT01923064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787008|NCT01923064|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
24787009|NCT01923064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24579315|NCT00854451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25850345|NCT00050895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24818310|NCT02087813|Glucocorticoids|glucocorticoids|mesh-ancestor
24818311|NCT02087813|Hormones|hormones|mesh-ancestor
25268753|NCT02414581|Dermatologic Agents|dermatologic agents|mesh-ancestor
24818312|NCT02087813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24818335|NCT02088060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24902977|NCT04368377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24902978|NCT04368377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24902979|NCT04368377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24902980|NCT04368377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24902981|NCT04368377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24902982|NCT04368377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24902983|NCT04368377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902985|NCT04368377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24902986|NCT04368377|Antithrombins|antithrombins|mesh-ancestor
25202021|NCT02724163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24902987|NCT04368377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24902988|NCT04368377|Protease Inhibitors|protease inhibitors|mesh-ancestor
24902989|NCT04368377|Anticoagulants|anticoagulants|mesh-ancestor
24903096|NCT04366596|Tubulin Modulators|tubulin modulators|mesh-ancestor
24903097|NCT04366596|Antimitotic Agents|antimitotic agents|mesh-ancestor
24903137|NCT04366089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903138|NCT04366089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24903140|NCT04366050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24903141|NCT04366050|Protease Inhibitors|protease inhibitors|mesh-ancestor
24903142|NCT04366050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903143|NCT04366050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903144|NCT04366050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24726145|NCT01602003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24880862|NCT03238196|Fulvestrant|fulvestrant|mesh-list
24880863|NCT03238196|Palbociclib|palbociclib|mesh-list
24880864|NCT03238196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24880865|NCT03238196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880866|NCT03238196|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24880867|NCT03238196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24880868|NCT03238196|Hormone Antagonists|hormone antagonists|mesh-ancestor
24880869|NCT03238196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24880870|NCT03238196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880871|NCT03238196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24880872|NCT03238196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903180|NCT04365582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903182|NCT04365582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24903183|NCT04365582|Antiviral Agents|antiviral agents|mesh-ancestor
24903184|NCT04365582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25268754|NCT02414529|Vitamin D|vitamin d|mesh-list
24903185|NCT04365582|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24903186|NCT04365582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24903187|NCT04365582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24903188|NCT04365582|Antimalarials|antimalarials|mesh-ancestor
24903189|NCT04365582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24903190|NCT04365582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24903191|NCT04365582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24903192|NCT04365270|Chlorhexidine|chlorhexidine|mesh-list
25234406|NCT02571283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25234407|NCT02571283|Respiratory System Agents|respiratory system agents|mesh-ancestor
25234408|NCT02571283|Mydriatics|mydriatics|mesh-ancestor
25234425|NCT02571517|Hormones|hormones|mesh-ancestor
24903193|NCT04365270|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24903194|NCT04365270|Titanium dioxide|titanium dioxide|mesh-list
24903195|NCT04365270|Chitosan|chitosan|mesh-list
24903196|NCT04365270|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24903197|NCT04365270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24880883|NCT03221257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24880884|NCT03221257|Antitubercular Agents|antitubercular agents|mesh-ancestor
24880885|NCT03221257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24880886|NCT03221257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24880887|NCT03221257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202022|NCT02724163|Alkylating Agents|alkylating agents|mesh-ancestor
24790656|NCT01944085|Antipyretics|antipyretics|mesh-ancestor
24450723|NCT00320229|Abciximab|abciximab|mesh-list
24903240|NCT04365231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24903241|NCT04365231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24903242|NCT04365231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903245|NCT04365426|Contraceptive Agents|contraceptive agents|mesh-list
24479601|NCT00427414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24479602|NCT00427414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24479603|NCT00427414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479604|NCT00427427|Trastuzumab|trastuzumab|mesh-list
24479605|NCT00427427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24479606|NCT00427427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479607|NCT00427466|Pemetrexed|pemetrexed|mesh-list
24903278|NCT04365049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24903280|NCT04364945|Remifentanil|remifentanil|mesh-list
24903281|NCT04364945|Sevoflurane|sevoflurane|mesh-list
24903283|NCT04364945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24903284|NCT04364945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903285|NCT04364945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24903319|NCT04365036|Oxaliplatin|oxaliplatin|mesh-list
24903320|NCT04365036|Pegaspargase|pegaspargase|mesh-list
24903321|NCT04365036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24903322|NCT04365036|Antimetabolites|antimetabolites|mesh-ancestor
24903323|NCT04365036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903324|NCT04365036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24903325|NCT04365036|Antiviral Agents|antiviral agents|mesh-ancestor
24903326|NCT04365036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903327|NCT04365036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903328|NCT04365036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24903329|NCT04365036|Immunologic Factors|immunologic factors|mesh-ancestor
24903330|NCT04365036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915115|NCT04674670|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24915116|NCT04674670|Hormone Antagonists|hormone antagonists|mesh-ancestor
24915117|NCT04674670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24915118|NCT04674670|Dopamine Agonists|dopamine agonists|mesh-ancestor
24915119|NCT04669132|Olanzapine|olanzapine|mesh-list
24915120|NCT04669132|Antiemetics|antiemetics|mesh-ancestor
24915121|NCT04669132|Autonomic Agents|autonomic agents|mesh-ancestor
24915122|NCT04669132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24915123|NCT04669132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915124|NCT04669132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24915125|NCT04669132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24915126|NCT04669132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24915127|NCT04669132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24915128|NCT04669132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24880934|NCT03179904|Hormone Antagonists|hormone antagonists|mesh-ancestor
24880935|NCT03179904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24880936|NCT03179904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24880937|NCT03179904|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24880938|NCT03179605|Clobetasol|clobetasol|mesh-list
24880939|NCT03179605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24880940|NCT03179605|Glucocorticoids|glucocorticoids|mesh-ancestor
24880941|NCT03179605|Hormones|hormones|mesh-ancestor
24815926|NCT02072746|Astringents|astringents|mesh-ancestor
25850346|NCT00050895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24818346|NCT02088398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24818348|NCT02088398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662398|NCT01644643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25662399|NCT01644643|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25662400|NCT01644643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903408|NCT04364139|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25850347|NCT00050895|Antimetabolites|antimetabolites|mesh-ancestor
24918455|NCT04219579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918456|NCT04219579|Anticoagulants|anticoagulants|mesh-ancestor
25850348|NCT00050895|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24903453|NCT04364113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24903471|NCT04363866|Antimalarials|antimalarials|mesh-ancestor
24903472|NCT04363866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24903473|NCT04363866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24903474|NCT04363866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903475|NCT04363866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903476|NCT04363866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479741|NCT00428181|Ethanol|ethanol|mesh-list
24903503|NCT04363255|Etoposide|etoposide|mesh-list
24903528|NCT04363060|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24903556|NCT04362384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850349|NCT00050895|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25850350|NCT00050895|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25850351|NCT00050895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25850352|NCT00050895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25202023|NCT02724163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903613|NCT04362332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24903614|NCT04362332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24903615|NCT04362332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903648|NCT04361708|Tubulin Modulators|tubulin modulators|mesh-ancestor
24903649|NCT04361708|Antimitotic Agents|antimitotic agents|mesh-ancestor
24903650|NCT04361708|Mitosis Modulators|mitosis modulators|mesh-ancestor
24903658|NCT04361708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24903659|NCT04361708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903688|NCT04361643|Growth Substances|growth substances|mesh-ancestor
24903689|NCT04361643|Growth Inhibitors|growth inhibitors|mesh-ancestor
24903690|NCT04361643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24903692|NCT04361513|Bupivacaine|bupivacaine|mesh-list
25850353|NCT00050921|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
25850354|NCT00050921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25850355|NCT00050921|Immunologic Factors|immunologic factors|mesh-ancestor
25850356|NCT00050921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903698|NCT04361513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24903699|NCT04361513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24903700|NCT04361513|Glucocorticoids|glucocorticoids|mesh-ancestor
24903702|NCT04361513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24903703|NCT04361175|Letrozole|letrozole|mesh-list
24903704|NCT04361175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903705|NCT04361175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479880|NCT00428727|Antioxidants|antioxidants|mesh-ancestor
24903732|NCT04361422|Isotretinoin|isotretinoin|mesh-list
24903733|NCT04361422|Dermatologic Agents|dermatologic agents|mesh-ancestor
24903734|NCT04361331|Lenvatinib|lenvatinib|mesh-list
24903735|NCT04361331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24903736|NCT04361331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24903737|NCT04361331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903738|NCT04361331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903739|NCT04361214|Leflunomide|leflunomide|mesh-list
24903740|NCT04361214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903741|NCT04361214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903742|NCT04361214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24903743|NCT04361214|Immunologic Factors|immunologic factors|mesh-ancestor
24903744|NCT04361214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903745|NCT04361305|Tadalafil|tadalafil|mesh-list
24903746|NCT04361305|Vasodilator Agents|vasodilator agents|mesh-ancestor
25850357|NCT00050934|Oxcarbazepine|oxcarbazepine|mesh-list
25850358|NCT00050934|Anticonvulsants|anticonvulsants|mesh-ancestor
25850359|NCT00050934|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24579339|NCT00854529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24579340|NCT00854529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24579341|NCT00854529|Growth Substances|growth substances|mesh-ancestor
24579342|NCT00854529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579343|NCT00854529|Growth Inhibitors|growth inhibitors|mesh-ancestor
25268756|NCT02414529|Cholecalciferol|cholecalciferol|mesh-list
24621390|NCT01062087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24621391|NCT01062087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621392|NCT01062139|Cetirizine|cetirizine|mesh-list
25662401|NCT01644643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662402|NCT01644734|Tiotropium Bromide|tiotropium bromide|mesh-list
24621393|NCT01062139|Levocetirizine|levocetirizine|mesh-list
24903818|NCT04360759|Antimalarials|antimalarials|mesh-ancestor
24918978|NCT04214990|Aspirin|aspirin|mesh-list
25850360|NCT00050934|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25850361|NCT00050934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25850362|NCT00050934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850363|NCT00050934|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25850364|NCT00050934|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25850365|NCT00050947|Oxcarbazepine|oxcarbazepine|mesh-list
25850366|NCT00050947|Anticonvulsants|anticonvulsants|mesh-ancestor
25850367|NCT00050947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25850368|NCT00050947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25850369|NCT00050947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25850370|NCT00050947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915390|NCT02980731|Venetoclax|venetoclax|mesh-list
24915391|NCT02980731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915392|NCT02819141|Dexmedetomidine|dexmedetomidine|mesh-list
25850371|NCT00050947|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25850372|NCT00050947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25850373|NCT00050973|Bexarotene|bexarotene|mesh-list
25850374|NCT00050973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850375|NCT00051051|Canertinib dihydrochloride|canertinib dihydrochloride|mesh-list
25850376|NCT00051051|Anesthetics, Local|anesthetics, local|mesh-ancestor
25850377|NCT00051051|Anesthetics|anesthetics|mesh-ancestor
24903883|NCT04359966|Levofloxacin|levofloxacin|mesh-list
24903884|NCT04359966|Ofloxacin|ofloxacin|mesh-list
24903885|NCT04359966|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
24903886|NCT04359966|Esomeprazole|esomeprazole|mesh-list
24903887|NCT04359966|Bismuth|bismuth|mesh-list
24903888|NCT04359966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24903889|NCT04359966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903890|NCT04359966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24903891|NCT04359966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24903896|NCT04359966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903898|NCT04359966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24903899|NCT04359966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24903923|NCT04360031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202024|NCT02724163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881170|NCT02948660|GABA Agonists|gaba agonists|mesh-ancestor
25202025|NCT02724163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25850378|NCT00051051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25850379|NCT00051051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850380|NCT00051051|Sensory System Agents|sensory system agents|mesh-ancestor
25850381|NCT00051051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25850382|NCT00051051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850383|NCT00051051|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25850384|NCT00051051|Protective Agents|protective agents|mesh-ancestor
25850385|NCT00051077|Ribavirin|ribavirin|mesh-list
24903924|NCT04360031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903925|NCT04360031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24903926|NCT04360031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24903927|NCT04360031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24903928|NCT04360031|Antitubercular Agents|antitubercular agents|mesh-ancestor
24903929|NCT04360031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24903930|NCT04360031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903931|NCT04360122|Levamisole|levamisole|mesh-list
24903932|NCT04360122|Inosine Pranobex|inosine pranobex|mesh-list
24903933|NCT04360122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24903934|NCT04360122|Immunologic Factors|immunologic factors|mesh-ancestor
24644553|NCT01191684|Vaccines|vaccines|mesh-list
25268757|NCT02414529|Vitamins|vitamins|mesh-list
24950185|NCT02024230|Warfarin|warfarin|mesh-list
25850386|NCT00051077|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25850387|NCT00051077|Adefovir|adefovir|mesh-list
25850388|NCT00051077|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25850389|NCT00051077|Antimetabolites|antimetabolites|mesh-ancestor
25850390|NCT00051077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850391|NCT00051077|Antiviral Agents|antiviral agents|mesh-ancestor
25850392|NCT00051077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25850393|NCT00051077|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25662403|NCT01644734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25662404|NCT01644734|Autonomic Agents|autonomic agents|mesh-ancestor
25662405|NCT01644734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24600979|NCT00961480|Incretins|incretins|mesh-ancestor
25662406|NCT01644734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662407|NCT01644734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25662408|NCT01644734|Respiratory System Agents|respiratory system agents|mesh-ancestor
25662409|NCT01644734|Parasympatholytics|parasympatholytics|mesh-ancestor
25662410|NCT01644734|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25109415|NCT03124524|Diuretics|diuretics|mesh-ancestor
25202026|NCT02724163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25202027|NCT02724163|Antimetabolites|antimetabolites|mesh-ancestor
25202028|NCT02724163|Antiviral Agents|antiviral agents|mesh-ancestor
25202029|NCT02724163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25202030|NCT02724163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24904298|NCT04356872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904299|NCT04356872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24904300|NCT04356872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24904301|NCT04356872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850394|NCT00051077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24904437|NCT04355806|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24904438|NCT04355806|Immunologic Factors|immunologic factors|mesh-ancestor
24904439|NCT04355806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904440|NCT04355806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904441|NCT04355806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904442|NCT04355598|Lidocaine|lidocaine|mesh-list
24904443|NCT04355598|Nitroglycerin|nitroglycerin|mesh-list
24904444|NCT04355598|Prilocaine|prilocaine|mesh-list
24904445|NCT04355598|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24904476|NCT04355468|Sensory System Agents|sensory system agents|mesh-ancestor
24904477|NCT04355468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24904478|NCT04355416|Curcumin|curcumin|mesh-list
24904479|NCT04355416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24459608|NCT00345306|Hormones|hormones|mesh-ancestor
25850395|NCT00051077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904654|NCT04354350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621394|NCT01062139|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24621395|NCT01062139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24621396|NCT01062139|Histamine Antagonists|histamine antagonists|mesh-ancestor
25850396|NCT00051090|Lamivudine|lamivudine|mesh-list
25109052|NCT03127631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25109053|NCT03127631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25109054|NCT03127631|Antipyretics|antipyretics|mesh-ancestor
25109055|NCT03127631|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25109056|NCT03127631|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25850397|NCT00051090|Efavirenz|efavirenz|mesh-list
25850398|NCT00051090|Abacavir|abacavir|mesh-list
25850399|NCT00051090|Didanosine|didanosine|mesh-list
25850400|NCT00051090|Telbivudine|telbivudine|mesh-list
25850401|NCT00051090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25850402|NCT00051090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25850403|NCT00051090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850404|NCT00051090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850405|NCT00051090|Antiviral Agents|antiviral agents|mesh-ancestor
25850406|NCT00051090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25850407|NCT00051090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25850408|NCT00051090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25202031|NCT02724163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25202032|NCT02724163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24904701|NCT04353986|Antiviral Agents|antiviral agents|mesh-ancestor
24904702|NCT04353986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24904756|NCT04353362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24904757|NCT04353713|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24904759|NCT04353713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24904760|NCT04353336|Hydroxychloroquine|hydroxychloroquine|mesh-list
24904761|NCT04353336|Chloroquine|chloroquine|mesh-list
24904785|NCT04353180|Isotretinoin|isotretinoin|mesh-list
24904786|NCT04353180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904787|NCT04353180|Keratolytic Agents|keratolytic agents|mesh-ancestor
24904788|NCT04353180|Dermatologic Agents|dermatologic agents|mesh-ancestor
24904789|NCT04353024|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
24904790|NCT04353024|Hallucinogens|hallucinogens|mesh-ancestor
24904791|NCT04353024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904792|NCT04353024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25850409|NCT00051090|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25850410|NCT00051090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24623625|NCT01072890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24722453|NCT01580683|Antioxidants|antioxidants|mesh-ancestor
24623626|NCT01072890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24623627|NCT01072890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623628|NCT01072890|Antifungal Agents|antifungal agents|mesh-ancestor
24623629|NCT01072890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24623630|NCT01072890|Immunologic Factors|immunologic factors|mesh-ancestor
24623631|NCT01072890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623632|NCT01072942|Ciprofloxacin|ciprofloxacin|mesh-list
25662411|NCT01644734|Cholinergic Agents|cholinergic agents|mesh-ancestor
25850411|NCT00051090|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25850412|NCT00051090|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24921058|NCT04194905|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24921059|NCT04194905|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24956985|NCT03848780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25850413|NCT00051090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24921061|NCT04194658|Letrozole|letrozole|mesh-list
24623633|NCT01072942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24623634|NCT01072942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24727917|NCT01613469|Vitamins|vitamins|mesh-ancestor
24904946|NCT04352062|Amoxicillin|amoxicillin|mesh-list
24904947|NCT04352062|Levofloxacin|levofloxacin|mesh-list
24904968|NCT04352062|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24904969|NCT04351919|Azithromycin|azithromycin|mesh-list
24904970|NCT04351919|Hydroxychloroquine|hydroxychloroquine|mesh-list
24645638|NCT01199159|Misoprostol|misoprostol|mesh-list
25850414|NCT00051090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25850415|NCT00051090|Antimetabolites|antimetabolites|mesh-ancestor
25850416|NCT00051103|Antineoplastic Agents|antineoplastic agents|mesh-list
25850417|NCT00051116|Lenalidomide|lenalidomide|mesh-list
24520484|NCT01497509|Sympathomimetics|sympathomimetics|mesh-ancestor
24520485|NCT01497509|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24915706|NCT04248998|Tubulin Modulators|tubulin modulators|mesh-ancestor
24915707|NCT04248998|Antimitotic Agents|antimitotic agents|mesh-ancestor
24915708|NCT04248998|Mitosis Modulators|mitosis modulators|mesh-ancestor
24915709|NCT04248998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915710|NCT04248998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24905175|NCT04350671|Protease Inhibitors|protease inhibitors|mesh-ancestor
24905176|NCT04350671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905177|NCT04350671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905178|NCT04350671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24905179|NCT04350671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24905180|NCT04350671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24905181|NCT04350671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25850418|NCT00051116|Immunologic Factors|immunologic factors|mesh-ancestor
25850419|NCT00051116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850420|NCT00051116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25850421|NCT00051116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24905214|NCT04350281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905215|NCT04350281|Antimalarials|antimalarials|mesh-ancestor
24905216|NCT04350281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24905217|NCT04350281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24905219|NCT04350281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905220|NCT04350281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24905221|NCT04350281|Immunologic Factors|immunologic factors|mesh-ancestor
24905222|NCT04350281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850422|NCT00051116|Growth Substances|growth substances|mesh-ancestor
25850423|NCT00051116|Growth Inhibitors|growth inhibitors|mesh-ancestor
25850424|NCT00051116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623648|NCT01073007|Simvastatin|simvastatin|mesh-list
24623649|NCT01073007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24623650|NCT01073007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24623651|NCT01073007|Antimetabolites|antimetabolites|mesh-ancestor
24905568|NCT04346004|Hematinics|hematinics|mesh-ancestor
24905277|NCT04349410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24905278|NCT04349410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24905279|NCT04349410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905280|NCT04349410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905362|NCT04348006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905363|NCT04348006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25850425|NCT00051142|Travoprost|travoprost|mesh-list
25850426|NCT00051142|Latanoprost|latanoprost|mesh-list
24905373|NCT04348006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24905374|NCT04348006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24704099|NCT01476592|Resveratrol|resveratrol|mesh-list
25065518|NCT05321511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24905399|NCT04348045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905400|NCT04347889|Ascorbic Acid|ascorbic acid|mesh-list
24905401|NCT04347889|Hydroxychloroquine|hydroxychloroquine|mesh-list
25662412|NCT01644734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25662413|NCT01644734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662414|NCT01644890|Paclitaxel|paclitaxel|mesh-list
25662415|NCT01644890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25662416|NCT01644890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662417|NCT01644890|Tubulin Modulators|tubulin modulators|mesh-ancestor
25662418|NCT01644890|Antimitotic Agents|antimitotic agents|mesh-ancestor
25662419|NCT01644890|Mitosis Modulators|mitosis modulators|mesh-ancestor
24496779|NCT00506727|Amphetamine|amphetamine|mesh-list
24921518|NCT04190160|Hormones|hormones|mesh-ancestor
25850427|NCT00051142|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25850428|NCT00051142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25850429|NCT00051142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25850430|NCT00051155|Timolol|timolol|mesh-list
25850431|NCT00051155|Travoprost|travoprost|mesh-list
25850432|NCT00051155|Latanoprost|latanoprost|mesh-list
25850433|NCT00051155|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25850434|NCT00051155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25850435|NCT00051155|Adrenergic Agents|adrenergic agents|mesh-ancestor
24905482|NCT04347512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905483|NCT04347512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905484|NCT04347512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24728454|NCT01616225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905486|NCT04347252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24905487|NCT04347252|Hormones|hormones|mesh-ancestor
24481313|NCT00434031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24905519|NCT04346862|Acetylcarnitine|acetylcarnitine|mesh-list
24905520|NCT04346862|Vitamin B Complex|vitamin b complex|mesh-ancestor
24905521|NCT04346862|Vitamins|vitamins|mesh-ancestor
24905522|NCT04346862|Micronutrients|micronutrients|mesh-ancestor
24905523|NCT04346862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818561|NCT02089399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24818562|NCT02089399|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24818563|NCT02089399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881797|NCT01239797|Elotuzumab|elotuzumab|mesh-list
25850436|NCT00051155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25850437|NCT00051155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850438|NCT00051155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905567|NCT04346004|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
24905576|NCT04346329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24905688|NCT04345445|Glucocorticoids|glucocorticoids|mesh-ancestor
25075949|NCT03377101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25075950|NCT03377101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075951|NCT03377101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25075952|NCT03377101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075953|NCT03377101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075954|NCT03376958|Apatinib|apatinib|mesh-list
25075955|NCT03376958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075956|NCT03376958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25075957|NCT03376958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075958|NCT03376958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075959|NCT03376932|Albuterol|albuterol|mesh-list
25075960|NCT03376932|Tiotropium Bromide|tiotropium bromide|mesh-list
25075961|NCT03376932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25075962|NCT03376932|Autonomic Agents|autonomic agents|mesh-ancestor
25075963|NCT03376932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25075964|NCT03376932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075965|NCT03376932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25075966|NCT03376932|Respiratory System Agents|respiratory system agents|mesh-ancestor
25075967|NCT03376932|Parasympatholytics|parasympatholytics|mesh-ancestor
25075968|NCT03376932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25075969|NCT03376932|Cholinergic Agents|cholinergic agents|mesh-ancestor
25075970|NCT03376932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25065574|NCT05320926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25075971|NCT03376932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394189|NCT00132548|Sulfadoxine|sulfadoxine|mesh-list
24881897|NCT00593567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24881898|NCT00593567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24881899|NCT00593567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24881900|NCT00593567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881901|NCT00593567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881902|NCT00593567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881903|NCT00593567|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24881904|NCT00593567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25075984|NCT03376841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075985|NCT03376841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25075987|NCT03376841|Antiviral Agents|antiviral agents|mesh-ancestor
25076026|NCT03376529|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25662420|NCT01644890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662421|NCT01645098|Dexmedetomidine|dexmedetomidine|mesh-list
25662422|NCT01645098|Ketamine|ketamine|mesh-list
25662423|NCT01645098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24922253|NCT04182191|Sensory System Agents|sensory system agents|mesh-ancestor
24922254|NCT04182191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24922255|NCT04182191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922290|NCT04181645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24922291|NCT04181645|Immunologic Factors|immunologic factors|mesh-ancestor
24922292|NCT04181645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922321|NCT04181749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24922323|NCT04181749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24922324|NCT04181749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24922325|NCT04181749|Antimetabolites|antimetabolites|mesh-ancestor
24922326|NCT04181749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25850441|NCT00051155|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25850442|NCT00051155|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25076027|NCT03376529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25076028|NCT03376529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076029|NCT03376464|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25076030|NCT03376464|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25076031|NCT03376464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076032|NCT03376464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076033|NCT03376464|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25076034|NCT03376464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25076035|NCT03376464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076036|NCT03376464|Cholinergic Agents|cholinergic agents|mesh-ancestor
25076037|NCT03376464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25076038|NCT03376438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
25076039|NCT03376243|Emollients|emollients|mesh-list
25076040|NCT03376243|Dermatologic Agents|dermatologic agents|mesh-ancestor
25076041|NCT03376191|Apatinib|apatinib|mesh-list
25076042|NCT03376191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065616|NCT05320094|Antidotes|antidotes|mesh-ancestor
25076043|NCT03376191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25850443|NCT00051181|Travoprost|travoprost|mesh-list
24644703|NCT01192724|Aspirin|aspirin|mesh-list
24626494|NCT01087580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25662424|NCT01645098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25662425|NCT01645098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662426|NCT01645098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25662427|NCT01645098|Analgesics|analgesics|mesh-ancestor
25662428|NCT01645098|Sensory System Agents|sensory system agents|mesh-ancestor
25662429|NCT01645098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25662430|NCT01645098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25662431|NCT01645098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25662432|NCT01645098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25662433|NCT01645098|Adrenergic Agents|adrenergic agents|mesh-ancestor
25662434|NCT01645098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25662435|NCT01645098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662436|NCT01645098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25662437|NCT01645098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25662438|NCT01645098|Anesthetics, General|anesthetics, general|mesh-ancestor
25662439|NCT01645098|Anesthetics|anesthetics|mesh-ancestor
25662440|NCT01645098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25662441|NCT01645098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25662442|NCT01645111|Clevidipine|clevidipine|mesh-list
25662443|NCT01645111|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25850444|NCT00051181|Latanoprost|latanoprost|mesh-list
24626503|NCT01087593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24626505|NCT01087593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24626506|NCT01087593|Contraceptive Agents|contraceptive agents|mesh-ancestor
24626507|NCT01087593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24626508|NCT01087593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24626509|NCT01087632|Folic Acid|folic acid|mesh-list
24626510|NCT01087632|Coenzyme Q10|coenzyme q10|mesh-list
24626511|NCT01087632|Policosanol|policosanol|mesh-list
24626512|NCT01087632|Red yeast rice|red yeast rice|mesh-list
24626513|NCT01087632|Hematinics|hematinics|mesh-ancestor
24626514|NCT01087632|Vitamin B Complex|vitamin b complex|mesh-ancestor
24626515|NCT01087632|Vitamins|vitamins|mesh-ancestor
24626516|NCT01087632|Micronutrients|micronutrients|mesh-ancestor
24626517|NCT01087632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954386|NCT03877120|Autonomic Agents|autonomic agents|mesh-ancestor
24954387|NCT03877120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24954388|NCT03877120|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24954389|NCT03877120|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24954390|NCT03877120|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24954391|NCT03877120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24954392|NCT03877120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24954393|NCT03877120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24954394|NCT03877120|Anesthetics, General|anesthetics, general|mesh-ancestor
24954395|NCT03877120|Anesthetics|anesthetics|mesh-ancestor
24954396|NCT03877120|GABA Modulators|gaba modulators|mesh-ancestor
24954397|NCT03877120|GABA Agents|gaba agents|mesh-ancestor
24954398|NCT03877003|Choline|choline|mesh-list
25850445|NCT00051181|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25850446|NCT00051181|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25850447|NCT00051181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25850448|NCT00051259|Bupropion|bupropion|mesh-list
25850449|NCT00051259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25850450|NCT00051259|Antidepressive Agents|antidepressive agents|mesh-ancestor
25850451|NCT00051259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25850452|NCT00051259|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25662444|NCT01645111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25662445|NCT01645111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076084|NCT03375996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25076085|NCT03375996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076092|NCT03375775|Immunologic Factors|immunologic factors|mesh-list
25202035|NCT02724163|Sensory System Agents|sensory system agents|mesh-ancestor
24454311|NCT04109482|Alkylating Agents|alkylating agents|mesh-ancestor
25076093|NCT03375775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076094|NCT03375671|Midazolam|midazolam|mesh-list
25076095|NCT03375671|Ketamine|ketamine|mesh-list
25076096|NCT03375671|Haloperidol|haloperidol|mesh-list
25076097|NCT03375671|Haloperidol decanoate|haloperidol decanoate|mesh-list
25076098|NCT03375671|Analgesics|analgesics|mesh-ancestor
25076099|NCT03375671|Sensory System Agents|sensory system agents|mesh-ancestor
25076100|NCT03375671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24776231|NCT01857193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776232|NCT01857193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24776233|NCT01857193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24776234|NCT01857193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776235|NCT01857193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776236|NCT01857193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24776237|NCT01857193|Hormone Antagonists|hormone antagonists|mesh-ancestor
24776238|NCT01857193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24776239|NCT01857284|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
24776240|NCT01857284|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24776241|NCT01857284|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24776242|NCT01857284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25076101|NCT03375671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076102|NCT03375671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25076103|NCT03375671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25076104|NCT03375671|Anesthetics, General|anesthetics, general|mesh-ancestor
25076105|NCT03375671|Anesthetics|anesthetics|mesh-ancestor
25076106|NCT03375671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25076107|NCT03375671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25662446|NCT01645111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25076126|NCT03375632|Uricosuric Agents|uricosuric agents|mesh-ancestor
25076127|NCT03375632|Gout Suppressants|gout suppressants|mesh-ancestor
25076128|NCT03375632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25076129|NCT03375632|Renal Agents|renal agents|mesh-ancestor
25076130|NCT03375593|Acetaminophen|acetaminophen|mesh-list
25076131|NCT03375593|Ibuprofen|ibuprofen|mesh-list
25076132|NCT03375593|Oxycodone|oxycodone|mesh-list
25076133|NCT03375593|Hydrocodone|hydrocodone|mesh-list
25076134|NCT03375593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25076135|NCT03375593|Analgesics|analgesics|mesh-ancestor
25076136|NCT03375593|Sensory System Agents|sensory system agents|mesh-ancestor
25076137|NCT03375593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076138|NCT03375593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076139|NCT03375593|Antipyretics|antipyretics|mesh-ancestor
25076140|NCT03375593|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25076141|NCT03375593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25076142|NCT03375593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25076143|NCT03375593|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25076144|NCT03375593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25076154|NCT03375580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076155|NCT03375580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25076156|NCT03375580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25076157|NCT03375580|Antimetabolites|antimetabolites|mesh-ancestor
25076158|NCT03375580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076159|NCT03375580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25076160|NCT03375580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25076161|NCT03375580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25076162|NCT03375515|Hydromorphone|hydromorphone|mesh-list
25076163|NCT03375515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25076164|NCT03375515|Narcotics|narcotics|mesh-ancestor
25076165|NCT03375515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25076166|NCT03375515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076167|NCT03375515|Analgesics|analgesics|mesh-ancestor
25076168|NCT03375515|Sensory System Agents|sensory system agents|mesh-ancestor
25850453|NCT00051259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25850454|NCT00051259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25076188|NCT03375138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076190|NCT03375138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25076192|NCT03375138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076193|NCT03375138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25076194|NCT03375112|Bupivacaine|bupivacaine|mesh-list
25076195|NCT03375112|Anesthetics, Local|anesthetics, local|mesh-ancestor
25076196|NCT03375112|Anesthetics|anesthetics|mesh-ancestor
25076197|NCT03375112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25076198|NCT03375112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076199|NCT03375112|Sensory System Agents|sensory system agents|mesh-ancestor
25076201|NCT03375034|Clonazepam|clonazepam|mesh-list
25076212|NCT03374878|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25076213|NCT03374774|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
25076214|NCT03374774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25076215|NCT03374774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076216|NCT03374722|Analgesics, Opioid|analgesics, opioid|mesh-list
25076217|NCT03374722|Narcotics|narcotics|mesh-ancestor
25076218|NCT03374722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25076219|NCT03374722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076230|NCT03374709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25076231|NCT03374670|Aflibercept|aflibercept|mesh-list
25076232|NCT03374670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25076233|NCT03374670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25076234|NCT03374670|Growth Substances|growth substances|mesh-ancestor
25076235|NCT03374670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076236|NCT03374670|Growth Inhibitors|growth inhibitors|mesh-ancestor
25076237|NCT03374670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25076239|NCT03374540|Rivaroxaban|rivaroxaban|mesh-list
25076240|NCT03374540|Vitamins|vitamins|mesh-ancestor
25076241|NCT03374540|Micronutrients|micronutrients|mesh-ancestor
24623432|NCT01071369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850455|NCT00051259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850456|NCT00051259|Dopamine Agents|dopamine agents|mesh-ancestor
25202036|NCT02724163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202037|NCT02724163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25202038|NCT02723981|Vitamins|vitamins|mesh-list
25202039|NCT02723981|Vitamin K|vitamin k|mesh-list
25202040|NCT02723981|Rivaroxaban|rivaroxaban|mesh-list
25850457|NCT00051259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25076295|NCT03374293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076296|NCT03374280|Cisplatin|cisplatin|mesh-list
25076297|NCT03374280|Pemetrexed|pemetrexed|mesh-list
25076298|NCT03374280|Gefitinib|gefitinib|mesh-list
25076299|NCT03374280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25076300|NCT03374280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25076301|NCT03374280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076302|NCT03374280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25076303|NCT03374280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25076304|NCT03374280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25850458|NCT00051259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850459|NCT00051259|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25850460|NCT00051259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25850461|NCT00051259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850462|NCT00051272|Bupropion|bupropion|mesh-list
25850463|NCT00051272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25850464|NCT00051272|Antidepressive Agents|antidepressive agents|mesh-ancestor
25850465|NCT00051272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25076306|NCT03374228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25076307|NCT03374228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850467|NCT00051272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25850468|NCT00051272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25850469|NCT00051272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850470|NCT00051272|Dopamine Agents|dopamine agents|mesh-ancestor
25850471|NCT00051272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25850472|NCT00051272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850473|NCT00051272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25850474|NCT00051272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25850475|NCT00051272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850476|NCT00051285|Enoximone|enoximone|mesh-list
25850477|NCT00051285|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25850478|NCT00051285|Vasodilator Agents|vasodilator agents|mesh-ancestor
25850479|NCT00051285|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25850480|NCT00051285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25850481|NCT00051285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850482|NCT00051285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850483|NCT00051285|Protective Agents|protective agents|mesh-ancestor
25202041|NCT02723981|Dabigatran|dabigatran|mesh-list
25202042|NCT02723981|Anticoagulants|anticoagulants|mesh-list
25076323|NCT03373955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25076324|NCT03373955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25076325|NCT03373903|Everolimus|everolimus|mesh-list
25076326|NCT03373903|Dactolisib|dactolisib|mesh-list
25076327|NCT03373903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25076328|NCT03373903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25076329|NCT03373903|Immunologic Factors|immunologic factors|mesh-ancestor
25076330|NCT03373903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882252|NCT02345850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24882253|NCT02109081|Dexamethasone|dexamethasone|mesh-list
24882254|NCT02109081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24882255|NCT02109081|Antiemetics|antiemetics|mesh-ancestor
24882256|NCT02109081|Autonomic Agents|autonomic agents|mesh-ancestor
24882257|NCT02109081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25850484|NCT00051285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850485|NCT00051298|Olanzapine|olanzapine|mesh-list
25850486|NCT00051298|Antiemetics|antiemetics|mesh-ancestor
25850487|NCT00051298|Autonomic Agents|autonomic agents|mesh-ancestor
25850488|NCT00051298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25850489|NCT00051298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850490|NCT00051298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25850491|NCT00051298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25850492|NCT00051298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25850493|NCT00051298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25850494|NCT00051298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25850495|NCT00051298|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25850496|NCT00051298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25850497|NCT00051298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25850498|NCT00051298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850499|NCT00051298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25850500|NCT00051298|Serotonin Agents|serotonin agents|mesh-ancestor
25409345|NCT03384836|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25662447|NCT01645111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662448|NCT01645176|Hydroxychloroquine|hydroxychloroquine|mesh-list
25850501|NCT00051389|Fosinopril|fosinopril|mesh-list
24954427|NCT03876938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24954428|NCT03876938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954430|NCT03876938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24954431|NCT03876938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24954432|NCT03876938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24954433|NCT03876938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24954434|NCT03876938|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24954435|NCT03876938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24954436|NCT03876938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24954437|NCT03876938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954438|NCT03876938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24954439|NCT03876938|Serotonin Agents|serotonin agents|mesh-ancestor
24954440|NCT03876938|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24954441|NCT03876886|Paclitaxel|paclitaxel|mesh-list
25076742|NCT03370835|Adrenergic Agents|adrenergic agents|mesh-ancestor
24954442|NCT03876886|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24954443|NCT03876886|Cyclophosphamide|cyclophosphamide|mesh-list
24954444|NCT03876886|Carboplatin|carboplatin|mesh-list
24954445|NCT03876886|Epirubicin|epirubicin|mesh-list
24954446|NCT03876886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24954447|NCT03876886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24954448|NCT03876886|Tubulin Modulators|tubulin modulators|mesh-ancestor
24954449|NCT03876886|Antimitotic Agents|antimitotic agents|mesh-ancestor
24954450|NCT03876886|Mitosis Modulators|mitosis modulators|mesh-ancestor
24954451|NCT03876886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954452|NCT03876886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24954453|NCT03876886|Immunologic Factors|immunologic factors|mesh-ancestor
24954454|NCT03876886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850504|NCT00051389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828421|NCT02145559|Metformin|metformin|mesh-list
25076375|NCT03373708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25076376|NCT03373708|Tubulin Modulators|tubulin modulators|mesh-ancestor
25076377|NCT03373708|Antimitotic Agents|antimitotic agents|mesh-ancestor
25076378|NCT03373708|Mitosis Modulators|mitosis modulators|mesh-ancestor
25076379|NCT03373708|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25076380|NCT03373708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25076381|NCT03373708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25076382|NCT03373708|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25076383|NCT03373708|Hormone Antagonists|hormone antagonists|mesh-ancestor
25076384|NCT03373708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25076385|NCT03373708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25076386|NCT03373708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25076387|NCT03373708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25076388|NCT03373708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25076389|NCT03373708|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25076390|NCT03373708|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25076391|NCT03373708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25076392|NCT03373669|Vaccines|vaccines|mesh-list
25850507|NCT00051441|Benzydamine|benzydamine|mesh-list
25850508|NCT00051441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25850509|NCT00051493|Carboplatin|carboplatin|mesh-list
25850510|NCT00051493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25202043|NCT02723981|Clopidogrel|clopidogrel|mesh-list
25850511|NCT00051506|Cisplatin|cisplatin|mesh-list
25850512|NCT00051506|Carboplatin|carboplatin|mesh-list
25850513|NCT00051506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850514|NCT00051532|Seocalcitol|seocalcitol|mesh-list
25850515|NCT00051532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850516|NCT00051532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25076414|NCT03373305|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25076415|NCT03373305|Lenalidomide|lenalidomide|mesh-list
25076417|NCT03373305|Antibodies|antibodies|mesh-list
25076418|NCT03373305|Immunoglobulins|immunoglobulins|mesh-list
25076419|NCT03373305|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25076420|NCT03373305|Immunoconjugates|immunoconjugates|mesh-list
25076421|NCT03373305|Immunologic Factors|immunologic factors|mesh-ancestor
25076422|NCT03373305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076423|NCT03373305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850517|NCT00051532|Immunologic Factors|immunologic factors|mesh-ancestor
25850518|NCT00051532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850519|NCT00051545|Seocalcitol|seocalcitol|mesh-list
25850520|NCT00051545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25076461|NCT03372837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076462|NCT03372837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25076464|NCT03372785|Metoprolol|metoprolol|mesh-list
25202044|NCT02723981|Micronutrients|micronutrients|mesh-ancestor
24462485|NCT00356460|Antibodies|antibodies|mesh-list
24556135|NCT00745147|Lactulose|lactulose|mesh-list
24556136|NCT00745147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25076465|NCT03372785|Clopidogrel|clopidogrel|mesh-list
25076466|NCT03372785|Ticagrelor|ticagrelor|mesh-list
25076467|NCT03372785|Atorvastatin|atorvastatin|mesh-list
25076468|NCT03372785|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25076469|NCT03372785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25076470|NCT03372785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25076471|NCT03372785|Analgesics|analgesics|mesh-ancestor
25076472|NCT03372785|Sensory System Agents|sensory system agents|mesh-ancestor
25076473|NCT03372785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25850525|NCT00051571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25076504|NCT03372486|Bupivacaine|bupivacaine|mesh-list
25076505|NCT03372486|Naloxone|naloxone|mesh-list
25076506|NCT03372486|Anesthetics, Local|anesthetics, local|mesh-ancestor
25076507|NCT03372486|Anesthetics|anesthetics|mesh-ancestor
25076508|NCT03372486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25076509|NCT03372486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076510|NCT03372486|Sensory System Agents|sensory system agents|mesh-ancestor
25066077|NCT04311073|Tranexamic Acid|tranexamic acid|mesh-list
25076511|NCT03372486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25850526|NCT00051571|Tubulin Modulators|tubulin modulators|mesh-ancestor
25850527|NCT00051571|Antimitotic Agents|antimitotic agents|mesh-ancestor
25850528|NCT00051571|Mitosis Modulators|mitosis modulators|mesh-ancestor
25662449|NCT01645176|Atorvastatin|atorvastatin|mesh-list
25419998|NCT02660138|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25850539|NCT00051584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916609|NCT04238767|Dolutegravir|dolutegravir|mesh-list
24954500|NCT03876574|Antiemetics|antiemetics|mesh-ancestor
24954501|NCT03876574|Autonomic Agents|autonomic agents|mesh-ancestor
24954502|NCT03876574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25850540|NCT00051584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25850541|NCT00051584|Immunologic Factors|immunologic factors|mesh-ancestor
25850542|NCT00051584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850543|NCT00051584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25850544|NCT00051584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25850545|NCT00051584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25850546|NCT00051597|Antibodies|antibodies|mesh-list
25850547|NCT00051597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25066093|NCT04298606|Vaccines|vaccines|mesh-list
25850548|NCT00051597|Immunologic Factors|immunologic factors|mesh-ancestor
24954523|NCT03876041|BB 1101|bb 1101|mesh-list
24954524|NCT03876041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24954525|NCT03876041|Antiemetics|antiemetics|mesh-ancestor
25076613|NCT03371849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076614|NCT03371849|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25076615|NCT03371849|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25076616|NCT03371849|Histamine Antagonists|histamine antagonists|mesh-ancestor
25076617|NCT03371849|Histamine Agents|histamine agents|mesh-ancestor
25076618|NCT03371849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25076619|NCT03371797|Amlodipine|amlodipine|mesh-list
25076620|NCT03371797|Valsartan|valsartan|mesh-list
25076621|NCT03371797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25662450|NCT01645176|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25662451|NCT01645176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25234567|NCT02570789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234568|NCT02570477|Vancomycin|vancomycin|mesh-list
25234569|NCT02570477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25234570|NCT02570477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25234571|NCT02570581|Acetaminophen|acetaminophen|mesh-list
25234572|NCT02570581|Ramipril|ramipril|mesh-list
25234573|NCT02570581|Furosemide|furosemide|mesh-list
25234574|NCT02570581|Memantine|memantine|mesh-list
25850553|NCT00051623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25850554|NCT00051688|Oxaliplatin|oxaliplatin|mesh-list
25850555|NCT00051688|Tezacitabine|tezacitabine|mesh-list
25850556|NCT00051688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850557|NCT00051688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25076656|NCT03371498|Prednisolone acetate|prednisolone acetate|mesh-list
25057922|NCT03500783|Antioxidants|antioxidants|mesh-ancestor
25076657|NCT03371498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25076658|NCT03371498|Prednisolone phosphate|prednisolone phosphate|mesh-list
25076659|NCT03371498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25076660|NCT03371498|Antiemetics|antiemetics|mesh-ancestor
25076661|NCT03371498|Autonomic Agents|autonomic agents|mesh-ancestor
25076662|NCT03371498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076663|NCT03371498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076664|NCT03371498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25076665|NCT03371498|Glucocorticoids|glucocorticoids|mesh-ancestor
25076666|NCT03371498|Hormones|hormones|mesh-ancestor
24816129|NCT02074267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24816130|NCT02074267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25202047|NCT02723981|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25850558|NCT00051688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850559|NCT00051701|Alemtuzumab|alemtuzumab|mesh-list
25850560|NCT00051701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25850561|NCT00051701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850562|NCT00051753|Amoxicillin|amoxicillin|mesh-list
25850563|NCT00051753|Levofloxacin|levofloxacin|mesh-list
25850564|NCT00051753|Ofloxacin|ofloxacin|mesh-list
25850565|NCT00051753|Clavulanic Acid|clavulanic acid|mesh-list
25850566|NCT00051753|Clavulanic Acids|clavulanic acids|mesh-list
25850567|NCT00051753|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25850568|NCT00051753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25850569|NCT00051753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25850570|NCT00051753|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25850571|NCT00051753|Renal Agents|renal agents|mesh-ancestor
25850572|NCT00051753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25850573|NCT00051753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25850574|NCT00051753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850575|NCT00051753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850576|NCT00051753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850577|NCT00051753|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25850578|NCT00051753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25850579|NCT00051753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25850580|NCT00051831|Ritonavir|ritonavir|mesh-list
25850581|NCT00051831|Saquinavir|saquinavir|mesh-list
25268760|NCT02414529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25076667|NCT03371498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25662452|NCT01645176|Antimetabolites|antimetabolites|mesh-ancestor
25662453|NCT01645176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662454|NCT01645176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25662455|NCT01645176|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25662456|NCT01645176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25662457|NCT01645176|Antimalarials|antimalarials|mesh-ancestor
25662458|NCT01645176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25662459|NCT01645176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25662460|NCT01645176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25662461|NCT01645176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25662462|NCT01645280|Methotrexate|methotrexate|mesh-list
25850582|NCT00051831|Tenofovir|tenofovir|mesh-list
25850583|NCT00051831|Emtricitabine|emtricitabine|mesh-list
24929441|NCT04112550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24929442|NCT04112550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929443|NCT04112550|Antipyretics|antipyretics|mesh-ancestor
24929446|NCT04112550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25076668|NCT03371498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25076669|NCT03371498|Protective Agents|protective agents|mesh-ancestor
25076670|NCT03371498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25076671|NCT03371498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25076672|NCT03371342|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25076673|NCT03371342|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25076674|NCT03371342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076675|NCT03371342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882657|NCT05166668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24882658|NCT05166668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882659|NCT05166538|Clopidogrel|clopidogrel|mesh-list
24882661|NCT05166538|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24882662|NCT05166538|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25850584|NCT00051831|Enfuvirtide|enfuvirtide|mesh-list
25850585|NCT00051831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25850586|NCT00051831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25850587|NCT00051831|Protease Inhibitors|protease inhibitors|mesh-ancestor
25850588|NCT00051831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850589|NCT00051831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850590|NCT00051831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25850591|NCT00051831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25850592|NCT00051831|Antiviral Agents|antiviral agents|mesh-ancestor
25850593|NCT00051831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25850594|NCT00051831|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25850595|NCT00051831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25202050|NCT02723981|Purinergic Agents|purinergic agents|mesh-ancestor
25202051|NCT02723981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25202052|NCT02723981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202053|NCT02723981|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25202054|NCT02723981|Antithrombins|antithrombins|mesh-ancestor
25202055|NCT02723981|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25850596|NCT00051831|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25850597|NCT00051831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25850598|NCT00051831|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25850599|NCT00051831|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25850600|NCT00051844|Capravirine|capravirine|mesh-list
25850601|NCT00051844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25850602|NCT00051844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25850603|NCT00051844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850604|NCT00051844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850605|NCT00051844|Antiviral Agents|antiviral agents|mesh-ancestor
25850606|NCT00051844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25850607|NCT00051844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25076692|NCT03371095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25076693|NCT03371095|Alkylating Agents|alkylating agents|mesh-ancestor
25076694|NCT03371095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882679|NCT05148377|Heparin|heparin|mesh-list
24882680|NCT05148377|Anticoagulants|anticoagulants|mesh-ancestor
25202056|NCT02723981|Protease Inhibitors|protease inhibitors|mesh-ancestor
25202057|NCT02723981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202058|NCT02723981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25202059|NCT02723981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25202060|NCT02723981|Hemostatics|hemostatics|mesh-ancestor
25202061|NCT02723981|Coagulants|coagulants|mesh-ancestor
25662463|NCT01645280|Ustekinumab|ustekinumab|mesh-list
25662464|NCT01645280|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25662465|NCT01645280|Abortifacient Agents|abortifacient agents|mesh-ancestor
25662466|NCT01645280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25662467|NCT01645280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662468|NCT01645280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25662469|NCT01645280|Antimetabolites|antimetabolites|mesh-ancestor
25202062|NCT02723903|Fluoxetine|fluoxetine|mesh-list
25202068|NCT02723903|Serotonin Agents|serotonin agents|mesh-ancestor
25202069|NCT02723903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202070|NCT02723903|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25202071|NCT02723903|Antidepressive Agents|antidepressive agents|mesh-ancestor
25202072|NCT02723903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25202073|NCT02723903|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25202074|NCT02723903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25202075|NCT02723903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202076|NCT02723760|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
25076706|NCT03371069|Dopamine Agents|dopamine agents|mesh-ancestor
25076707|NCT03371069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25076709|NCT03371043|Sensory System Agents|sensory system agents|mesh-ancestor
25076710|NCT03371043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076711|NCT03371043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076713|NCT03370848|Psyllium|psyllium|mesh-list
24882684|NCT05144698|Sirolimus|sirolimus|mesh-list
25850608|NCT00051844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25850609|NCT00051896|Vanoxerine|vanoxerine|mesh-list
25850610|NCT00051896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25850611|NCT00051896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25850612|NCT00051896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25850613|NCT00051896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850614|NCT00051896|Dopamine Agents|dopamine agents|mesh-ancestor
25850615|NCT00051896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25850616|NCT00051896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850617|NCT00051974|Bortezomib|bortezomib|mesh-list
25850618|NCT00051974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850619|NCT00051987|Bortezomib|bortezomib|mesh-list
25850620|NCT00051987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25076740|NCT03370835|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25076741|NCT03370835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25850621|NCT00052000|Antibodies|antibodies|mesh-list
25850622|NCT00052000|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25850623|NCT00052000|Immunologic Factors|immunologic factors|mesh-ancestor
25850624|NCT00052000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076743|NCT03370835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25076744|NCT03370835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076746|NCT03370835|Protective Agents|protective agents|mesh-ancestor
25076747|NCT03370835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25076748|NCT03370835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24882729|NCT05051189|Analgesics|analgesics|mesh-ancestor
25850625|NCT00052013|Vatalanib|vatalanib|mesh-list
25850626|NCT00052013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24916565|NCT04239443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24916566|NCT04239443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916567|NCT04239443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491445|NCT00482521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24916592|NCT04239170|Immunologic Factors|immunologic factors|mesh-ancestor
24916593|NCT04239170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916594|NCT04239014|Olaparib|olaparib|mesh-list
24916595|NCT04239014|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24916596|NCT04239014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916597|NCT04239014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916598|NCT04239014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24916599|NCT04238923|Vancomycin|vancomycin|mesh-list
24916600|NCT04238923|Gentamicins|gentamicins|mesh-list
25850627|NCT00052013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850628|NCT00052013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850629|NCT00052026|Carvedilol|carvedilol|mesh-list
25850630|NCT00052026|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25850631|NCT00052026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25850632|NCT00052026|Adrenergic Agents|adrenergic agents|mesh-ancestor
24916602|NCT04238923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24916603|NCT04238923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24916604|NCT04238923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850633|NCT00052026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25850634|NCT00052026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850635|NCT00052026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447969|NCT00309920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447970|NCT00309920|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24447971|NCT00309920|Tubulin Modulators|tubulin modulators|mesh-ancestor
24447972|NCT00309920|Antimitotic Agents|antimitotic agents|mesh-ancestor
24448009|NCT00310011|Immunologic Factors|immunologic factors|mesh-ancestor
24448010|NCT00310011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448011|NCT00310024|Bortezomib|bortezomib|mesh-list
24448012|NCT00310024|Vorinostat|vorinostat|mesh-list
24448013|NCT00310024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448014|NCT00310024|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24448015|NCT00310024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202077|NCT02723760|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24448016|NCT00310024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448017|NCT00310089|Cyclophosphamide|cyclophosphamide|mesh-list
24448018|NCT00310089|Docetaxel|docetaxel|mesh-list
25850636|NCT00052026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25850637|NCT00052026|Antioxidants|antioxidants|mesh-ancestor
25850638|NCT00052026|Protective Agents|protective agents|mesh-ancestor
25850639|NCT00052026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25850640|NCT00052026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25850641|NCT00052026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25850642|NCT00052026|Vasodilator Agents|vasodilator agents|mesh-ancestor
25850643|NCT00052026|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25850644|NCT00052026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24916605|NCT04238923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916606|NCT04238975|Vaccines|vaccines|mesh-list
24916607|NCT04238975|Immunologic Factors|immunologic factors|mesh-ancestor
24916608|NCT04238975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916614|NCT04238767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25076749|NCT03370835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25076750|NCT03370835|Vasodilator Agents|vasodilator agents|mesh-ancestor
25662470|NCT01645280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662471|NCT01645280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662472|NCT01645280|Dermatologic Agents|dermatologic agents|mesh-ancestor
25662473|NCT01645280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25662474|NCT01645280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25662475|NCT01645280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25662476|NCT01645280|Immunologic Factors|immunologic factors|mesh-ancestor
25662477|NCT01645280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25662478|NCT01645280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25662479|NCT01645735|Vancomycin|vancomycin|mesh-list
25662480|NCT01645735|Ceftriaxone|ceftriaxone|mesh-list
25662481|NCT01645735|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
25662482|NCT01645735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25076751|NCT03370835|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25850649|NCT00052039|Antiviral Agents|antiviral agents|mesh-ancestor
25850650|NCT00052039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25850651|NCT00052039|Antimetabolites|antimetabolites|mesh-ancestor
25850652|NCT00052039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850653|NCT00052039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25850654|NCT00052039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25850655|NCT00052039|Immunologic Factors|immunologic factors|mesh-ancestor
25850656|NCT00052039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850657|NCT00052039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25076848|NCT03370380|Growth Inhibitors|growth inhibitors|mesh-ancestor
25850659|NCT00052052|Interferon-gamma|interferon-gamma|mesh-list
25850660|NCT00052052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850661|NCT00052052|Antiviral Agents|antiviral agents|mesh-ancestor
25850662|NCT00052052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25076904|NCT03369847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076905|NCT03369847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25076906|NCT03369847|Respiratory System Agents|respiratory system agents|mesh-ancestor
25076907|NCT03369847|Glucocorticoids|glucocorticoids|mesh-ancestor
25076908|NCT03369847|Hormones|hormones|mesh-ancestor
25076909|NCT03369847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25076910|NCT03369808|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25076911|NCT03369808|Vaccines|vaccines|mesh-list
25076916|NCT03369808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202078|NCT02723760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882915|NCT04769206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24882916|NCT04769206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076978|NCT03369015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076993|NCT03369002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076995|NCT03368989|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25076996|NCT03368989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25076997|NCT03368794|Analgesics, Opioid|analgesics, opioid|mesh-list
25076998|NCT03368794|Narcotics|narcotics|mesh-ancestor
25076999|NCT03368794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25077000|NCT03368794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077001|NCT03368794|Analgesics|analgesics|mesh-ancestor
25077002|NCT03368794|Sensory System Agents|sensory system agents|mesh-ancestor
25077003|NCT03368794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25077004|NCT03368547|Edetic Acid|edetic acid|mesh-list
25077005|NCT03368547|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25077006|NCT03368547|Chelating Agents|chelating agents|mesh-ancestor
25077007|NCT03368547|Sequestering Agents|sequestering agents|mesh-ancestor
25077009|NCT03368547|Anticoagulants|anticoagulants|mesh-ancestor
25077010|NCT03368547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25077011|NCT03368547|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25077013|NCT03368430|Antioxidants|antioxidants|mesh-ancestor
25077014|NCT03368430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077015|NCT03368430|Protective Agents|protective agents|mesh-ancestor
25077016|NCT03368430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916839|NCT04236453|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24916840|NCT04236453|Cobicistat|cobicistat|mesh-list
24916841|NCT04236453|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
24916842|NCT04236453|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
24916843|NCT04236453|Antiviral Agents|antiviral agents|mesh-ancestor
24916844|NCT04236453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24916845|NCT04236453|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24916846|NCT04236453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24916847|NCT04236453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058059|NCT03499743|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25077017|NCT03368430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25077018|NCT03368404|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25077019|NCT03368404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25077020|NCT03368391|Lidocaine|lidocaine|mesh-list
25077021|NCT03368391|Phenylephrine|phenylephrine|mesh-list
25077022|NCT03368391|Epinephrine|epinephrine|mesh-list
25077025|NCT03368391|Tetracaine|tetracaine|mesh-list
25077026|NCT03368391|Mepivacaine|mepivacaine|mesh-list
25077027|NCT03368391|Epinephryl borate|epinephryl borate|mesh-list
25077028|NCT03368391|Anesthetics, Local|anesthetics, local|mesh-ancestor
25077029|NCT03368391|Anesthetics|anesthetics|mesh-ancestor
25077030|NCT03368391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25077031|NCT03368391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662483|NCT01645735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25662484|NCT01645930|Dexamethasone|dexamethasone|mesh-list
25662485|NCT01645930|Lenalidomide|lenalidomide|mesh-list
25662486|NCT01645930|Ixazomib|ixazomib|mesh-list
25662487|NCT01645930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25662488|NCT01645930|Antiemetics|antiemetics|mesh-ancestor
25662489|NCT01645930|Autonomic Agents|autonomic agents|mesh-ancestor
25850666|NCT00052117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850667|NCT00052117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850668|NCT00052117|Antiviral Agents|antiviral agents|mesh-ancestor
25850669|NCT00052117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25850670|NCT00052117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25850671|NCT00052117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25850672|NCT00052169|Docetaxel|docetaxel|mesh-list
25850673|NCT00052169|Gefitinib|gefitinib|mesh-list
25850674|NCT00052169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520542|NCT05337332|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24916924|NCT04235478|Glucocorticoids|glucocorticoids|mesh-ancestor
24916925|NCT04235478|Hormones|hormones|mesh-ancestor
24916926|NCT04235478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25077069|NCT03368131|Trastuzumab|trastuzumab|mesh-list
25077096|NCT03367663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25077097|NCT03367663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25077098|NCT03367585|Vitamin D|vitamin d|mesh-list
25077099|NCT03367585|Cholecalciferol|cholecalciferol|mesh-list
25077100|NCT03367585|Vitamins|vitamins|mesh-ancestor
25077102|NCT03367585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077103|NCT03367585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25077104|NCT03367585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25077106|NCT03367494|Anticonvulsants|anticonvulsants|mesh-ancestor
25077107|NCT03367390|Insulin Lispro|insulin lispro|mesh-list
25077108|NCT03367390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25077109|NCT03367390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077110|NCT03367377|Insulin Glargine|insulin glargine|mesh-list
25876166|NCT03864406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25077168|NCT03366974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24816226|NCT02075242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24816227|NCT02075242|Immunologic Factors|immunologic factors|mesh-ancestor
24816228|NCT02075242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662490|NCT01645930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25662491|NCT01645930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662492|NCT01645930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25662494|NCT01645930|Hormones|hormones|mesh-ancestor
25876167|NCT03864406|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25876168|NCT03864406|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25876169|NCT03847896|Budesonide|budesonide|mesh-list
25876170|NCT03847896|Albuterol|albuterol|mesh-list
25876171|NCT03847896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25876172|NCT03847896|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25876173|NCT03847896|Autonomic Agents|autonomic agents|mesh-ancestor
25850687|NCT00052221|Hematinics|hematinics|mesh-ancestor
25850688|NCT00052273|Capecitabine|capecitabine|mesh-list
25077221|NCT03366584|Carotenoids|carotenoids|mesh-list
25077222|NCT03366584|Picolinic acid|picolinic acid|mesh-list
25077234|NCT03366584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25077236|NCT03366584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25077237|NCT03366584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25077264|NCT03366259|Oxytocics|oxytocics|mesh-ancestor
25077266|NCT03366246|Prilocaine|prilocaine|mesh-list
25077267|NCT03366246|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25077268|NCT03366246|Anesthetics, Local|anesthetics, local|mesh-ancestor
25850689|NCT00052273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24454545|NCT03897868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24454546|NCT03897868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24454547|NCT03897868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24454548|NCT03897868|Vasodilator Agents|vasodilator agents|mesh-ancestor
24454549|NCT03897868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24454550|NCT03897868|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25077275|NCT03366246|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25077276|NCT03366246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25077277|NCT03366246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25077278|NCT03366246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077279|NCT03366246|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25077280|NCT03366064|Pemetrexed|pemetrexed|mesh-list
25077281|NCT03366064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25077282|NCT03366064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25077283|NCT03366064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077284|NCT03366064|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25077285|NCT03366064|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25077286|NCT03366025|Progesterone|progesterone|mesh-list
25077287|NCT03366025|Progestins|progestins|mesh-ancestor
25077288|NCT03366025|Hormones|hormones|mesh-ancestor
25077289|NCT03366025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25077290|NCT03366025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077291|NCT03365999|Tranexamic Acid|tranexamic acid|mesh-list
25077292|NCT03365999|Aminocaproic Acid|aminocaproic acid|mesh-list
25662495|NCT01645930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25154670|NCT05470166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154671|NCT05470166|Sensory System Agents|sensory system agents|mesh-ancestor
24509371|NCT00560079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25077293|NCT03365999|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25077311|NCT03365817|Tramadol|tramadol|mesh-list
25077312|NCT03365817|Methadone|methadone|mesh-list
25850690|NCT00052273|Antimetabolites|antimetabolites|mesh-ancestor
25850691|NCT00052273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850692|NCT00052273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850693|NCT00052286|Modafinil|modafinil|mesh-list
25850694|NCT00052286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25850695|NCT00052286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850696|NCT00052286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25850697|NCT00052286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25850698|NCT00052286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25850699|NCT00052286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077371|NCT03365466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25077372|NCT03365466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25077373|NCT03365466|Antipyretics|antipyretics|mesh-ancestor
24454635|NCT03878524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24454636|NCT03878524|Analgesics|analgesics|mesh-ancestor
24454637|NCT03878524|Sensory System Agents|sensory system agents|mesh-ancestor
25850700|NCT00052299|Cytarabine|cytarabine|mesh-list
25850701|NCT00052299|Etoposide|etoposide|mesh-list
25850702|NCT00052299|Mitoxantrone|mitoxantrone|mesh-list
25850703|NCT00052299|Idarubicin|idarubicin|mesh-list
25077439|NCT03364764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24520587|NCT05336825|Lidocaine|lidocaine|mesh-list
25850704|NCT00052299|Gemtuzumab|gemtuzumab|mesh-list
25850705|NCT00052299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25850706|NCT00052299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850707|NCT00052299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25662496|NCT01645930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25662497|NCT01645930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662498|NCT01645930|Immunologic Factors|immunologic factors|mesh-ancestor
25662499|NCT01645930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25662500|NCT01645930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25662501|NCT01645930|Growth Substances|growth substances|mesh-ancestor
25662502|NCT01645930|Growth Inhibitors|growth inhibitors|mesh-ancestor
25662503|NCT01645930|Protease Inhibitors|protease inhibitors|mesh-ancestor
25662504|NCT01645930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25662505|NCT01645930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662506|NCT01646021|Sirolimus|sirolimus|mesh-list
25850711|NCT00052299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25077455|NCT03364530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077458|NCT03364530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25077459|NCT03364530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25077460|NCT03364530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25850712|NCT00052299|Antimetabolites|antimetabolites|mesh-ancestor
25850713|NCT00052299|Antiviral Agents|antiviral agents|mesh-ancestor
25850714|NCT00052299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25850715|NCT00052299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25850716|NCT00052299|Immunologic Factors|immunologic factors|mesh-ancestor
25850717|NCT00052299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662507|NCT01646021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25662508|NCT01646021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25662509|NCT01646021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25662510|NCT01646021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662511|NCT01646021|Antifungal Agents|antifungal agents|mesh-ancestor
25662512|NCT01646021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25662513|NCT01646021|Immunologic Factors|immunologic factors|mesh-ancestor
25662514|NCT01646021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850721|NCT00052299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25850722|NCT00052299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25850723|NCT00052312|Paclitaxel|paclitaxel|mesh-list
25077570|NCT03363815|Anesthetics, General|anesthetics, general|mesh-ancestor
25077572|NCT03363815|GABA Modulators|gaba modulators|mesh-ancestor
25077573|NCT03363815|GABA Agents|gaba agents|mesh-ancestor
25850724|NCT00052312|Cisplatin|cisplatin|mesh-list
25850725|NCT00052312|Doxorubicin|doxorubicin|mesh-list
25850726|NCT00052312|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25850727|NCT00052312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24917077|NCT04233996|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24917078|NCT04233996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24917079|NCT04233996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25850728|NCT00052312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850729|NCT00052312|Tubulin Modulators|tubulin modulators|mesh-ancestor
25850730|NCT00052312|Antimitotic Agents|antimitotic agents|mesh-ancestor
25850731|NCT00052312|Mitosis Modulators|mitosis modulators|mesh-ancestor
25850732|NCT00052312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850733|NCT00052312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25850734|NCT00052312|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25850735|NCT00052312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25850736|NCT00052312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850737|NCT00052338|Gemcitabine|gemcitabine|mesh-list
25077574|NCT03363815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25850738|NCT00052338|Carboplatin|carboplatin|mesh-list
25850739|NCT00052338|Bortezomib|bortezomib|mesh-list
25850740|NCT00052338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850741|NCT00052338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25850742|NCT00052338|Antimetabolites|antimetabolites|mesh-ancestor
25850743|NCT00052338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859165|NCT02302326|Hematinics|hematinics|mesh-ancestor
25850744|NCT00052338|Antiviral Agents|antiviral agents|mesh-ancestor
25850745|NCT00052338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25850746|NCT00052338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850747|NCT00052338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25850748|NCT00052338|Immunologic Factors|immunologic factors|mesh-ancestor
25850749|NCT00052338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850750|NCT00052351|Metronidazole|metronidazole|mesh-list
25202083|NCT02723578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850751|NCT00052351|Paclitaxel|paclitaxel|mesh-list
25850752|NCT00052351|Cyclophosphamide|cyclophosphamide|mesh-list
25850753|NCT00052351|Doxorubicin|doxorubicin|mesh-list
25850754|NCT00052351|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25850755|NCT00052351|Vaccines|vaccines|mesh-list
25077637|NCT03363295|Moxifloxacin|moxifloxacin|mesh-list
25077638|NCT03363295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25077639|NCT03363295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25077640|NCT03363295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25077641|NCT03363295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25077642|NCT03363295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25077643|NCT03363295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077644|NCT03363295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25077645|NCT03363204|Salicylic Acid|salicylic acid|mesh-list
25850756|NCT00052351|Sargramostim|sargramostim|mesh-list
25850757|NCT00052351|Immunologic Factors|immunologic factors|mesh-ancestor
25850758|NCT00052351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850759|NCT00052351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25850760|NCT00052351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850761|NCT00052351|Tubulin Modulators|tubulin modulators|mesh-ancestor
25850762|NCT00052351|Antimitotic Agents|antimitotic agents|mesh-ancestor
25850763|NCT00052351|Mitosis Modulators|mitosis modulators|mesh-ancestor
25850764|NCT00052351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850765|NCT00052351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25850766|NCT00052351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25850767|NCT00052351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25077669|NCT03363191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077670|NCT03363113|Botulinum Toxins|botulinum toxins|mesh-list
25077671|NCT03363113|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25077672|NCT03363113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25077673|NCT03363113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077674|NCT03363113|Cholinergic Agents|cholinergic agents|mesh-ancestor
25077675|NCT03363113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25077676|NCT03363113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077677|NCT03362905|Lidocaine|lidocaine|mesh-list
25077678|NCT03362905|Anesthetics, Local|anesthetics, local|mesh-ancestor
25077679|NCT03362905|Anesthetics|anesthetics|mesh-ancestor
25077680|NCT03362905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25077681|NCT03362905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850768|NCT00052351|Alkylating Agents|alkylating agents|mesh-ancestor
24448262|NCT00310921|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24448263|NCT00310921|Abortifacient Agents|abortifacient agents|mesh-ancestor
24448264|NCT00310921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25850769|NCT00052351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25850770|NCT00052351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25850771|NCT00052351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25850772|NCT00052351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25850773|NCT00052351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850774|NCT00052351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25850775|NCT00052351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25850776|NCT00052351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25850777|NCT00052351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25077682|NCT03362905|Sensory System Agents|sensory system agents|mesh-ancestor
25077683|NCT03362905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25077684|NCT03362905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25077685|NCT03362905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25077687|NCT03362905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25420074|NCT02655601|Micronutrients|micronutrients|mesh-ancestor
25077694|NCT03362853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25077695|NCT03362853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077696|NCT03362853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850778|NCT00052364|Oxaliplatin|oxaliplatin|mesh-list
25850779|NCT00052364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850780|NCT00052377|Aldesleukin|aldesleukin|mesh-list
25850781|NCT00052377|Interleukin-2|interleukin-2|mesh-list
25850782|NCT00052377|Interleukin-12|interleukin-12|mesh-list
25850783|NCT00052377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850784|NCT00052377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25850785|NCT00052377|Analgesics|analgesics|mesh-ancestor
25850786|NCT00052377|Sensory System Agents|sensory system agents|mesh-ancestor
25850787|NCT00052377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25850788|NCT00052377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448303|NCT00311077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448305|NCT00311116|Vitamins|vitamins|mesh-ancestor
24448306|NCT00311116|Micronutrients|micronutrients|mesh-ancestor
24448307|NCT00311116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448308|NCT00311116|Antioxidants|antioxidants|mesh-ancestor
24448309|NCT00311116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448310|NCT00311116|Protective Agents|protective agents|mesh-ancestor
24448311|NCT00311129|Rituximab|rituximab|mesh-list
24448312|NCT00311129|Fludarabine|fludarabine|mesh-list
25202084|NCT02723578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24859529|NCT02304081|Saxagliptin|saxagliptin|mesh-list
25077740|NCT03362515|Diuretics|diuretics|mesh-ancestor
25077741|NCT03362515|Natriuretic Agents|natriuretic agents|mesh-ancestor
25077742|NCT03362515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077743|NCT03362515|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25077744|NCT03362515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25077745|NCT03362515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077746|NCT03362411|Linrodostat|linrodostat|mesh-list
25077747|NCT03362411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25077748|NCT03362411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883689|NCT05131204|Eculizumab|eculizumab|mesh-list
25077749|NCT03362359|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25077750|NCT03362359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077751|NCT03362359|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25077752|NCT03362281|Amoxicillin|amoxicillin|mesh-list
25077770|NCT03362268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077771|NCT03362216|Diclofenac|diclofenac|mesh-list
25077772|NCT03362216|Salicylates|salicylates|mesh-list
24448313|NCT00311129|Fludarabine phosphate|fludarabine phosphate|mesh-list
25662515|NCT01646073|Adalimumab|adalimumab|mesh-list
25662516|NCT01646073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25662517|NCT01646073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25662518|NCT01646125|Docetaxel|docetaxel|mesh-list
25662519|NCT01646125|Pemetrexed|pemetrexed|mesh-list
25662520|NCT01646125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662521|NCT01646125|Tubulin Modulators|tubulin modulators|mesh-ancestor
25662522|NCT01646125|Antimitotic Agents|antimitotic agents|mesh-ancestor
25662523|NCT01646125|Mitosis Modulators|mitosis modulators|mesh-ancestor
25662524|NCT01646125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662525|NCT01646125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448314|NCT00311129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24448315|NCT00311129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25077773|NCT03362216|Methyl salicylate|methyl salicylate|mesh-list
25077774|NCT03362216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25077775|NCT03362216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25077776|NCT03362216|Analgesics|analgesics|mesh-ancestor
25077777|NCT03362216|Sensory System Agents|sensory system agents|mesh-ancestor
25077778|NCT03362216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25077779|NCT03362216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077780|NCT03362216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25077781|NCT03362216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25077782|NCT03362216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25077783|NCT03362216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25077784|NCT03362216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077795|NCT03362073|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25077798|NCT03362073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077800|NCT03362060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25077801|NCT03362060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917181|NCT04232722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24954618|NCT03874364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25202085|NCT02723578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24954619|NCT03874364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954620|NCT03874364|Sensory System Agents|sensory system agents|mesh-ancestor
24954621|NCT03874364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24954622|NCT03874364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24954623|NCT03874364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25077809|NCT03362008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25077810|NCT03362008|Cholinergic Agents|cholinergic agents|mesh-ancestor
25077811|NCT03362008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25077812|NCT03362008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077813|NCT03362008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077815|NCT03361878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25077816|NCT03361878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077818|NCT03361800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25077819|NCT03361800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25077820|NCT03361800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25077821|NCT03361800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077822|NCT03361774|Fluorides|fluorides|mesh-list
25077823|NCT03361774|Cariostatic Agents|cariostatic agents|mesh-ancestor
24883768|NCT04861584|Antimetabolites|antimetabolites|mesh-ancestor
24883769|NCT04861584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917224|NCT04232085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24917225|NCT04232085|Alkylating Agents|alkylating agents|mesh-ancestor
24917226|NCT04232085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883770|NCT04861584|Antiviral Agents|antiviral agents|mesh-ancestor
24883771|NCT04861584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24883772|NCT04861584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850789|NCT00052377|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25850790|NCT00052377|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25850791|NCT00052377|Antiviral Agents|antiviral agents|mesh-ancestor
25077841|NCT03361709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25077842|NCT03361709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077843|NCT03361709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25077844|NCT03361709|Glucocorticoids|glucocorticoids|mesh-ancestor
25077845|NCT03361709|Hormones|hormones|mesh-ancestor
25662526|NCT01646125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24506257|NCT00544505|Alkylating Agents|alkylating agents|mesh-ancestor
25662527|NCT01646125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25662528|NCT01646151|Bimatoprost|bimatoprost|mesh-list
25662529|NCT01646151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25662530|NCT01646177|Etanercept|etanercept|mesh-list
25662531|NCT01646177|Ixekizumab|ixekizumab|mesh-list
25234819|NCT02568995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25234820|NCT02568995|Respiratory System Agents|respiratory system agents|mesh-ancestor
25234821|NCT02568995|Mydriatics|mydriatics|mesh-ancestor
25234822|NCT02568995|Sympathomimetics|sympathomimetics|mesh-ancestor
25234823|NCT02568995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25234824|NCT02568943|Panobinostat|panobinostat|mesh-list
25234825|NCT02568943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25234826|NCT02568943|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25850792|NCT00052377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25850793|NCT00052377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25850794|NCT00052377|Immunologic Factors|immunologic factors|mesh-ancestor
25850795|NCT00052377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25850796|NCT00052377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25077849|NCT03361618|Zinc Sulfate|zinc sulfate|mesh-list
25077850|NCT03361618|Astringents|astringents|mesh-ancestor
25077851|NCT03361618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077852|NCT03361618|Dermatologic Agents|dermatologic agents|mesh-ancestor
25077853|NCT03361397|Lidocaine|lidocaine|mesh-list
25077854|NCT03361397|Anesthetics, Local|anesthetics, local|mesh-ancestor
25077855|NCT03361397|Anesthetics|anesthetics|mesh-ancestor
25077856|NCT03361397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24883806|NCT04770012|Antipyretics|antipyretics|mesh-ancestor
24883807|NCT04770012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24883808|NCT04770012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24883809|NCT04770012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24883810|NCT04770012|Purinergic Agents|purinergic agents|mesh-ancestor
24883811|NCT04770012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24448409|NCT00311688|Interleukin-2|interleukin-2|mesh-list
25850797|NCT00052377|Growth Substances|growth substances|mesh-ancestor
25850798|NCT00052377|Growth Inhibitors|growth inhibitors|mesh-ancestor
25202086|NCT02723578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25202087|NCT02723838|Gemcitabine|gemcitabine|mesh-list
25202088|NCT02723838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25202089|NCT02723838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25202090|NCT02723838|Antimetabolites|antimetabolites|mesh-ancestor
24572341|NCT00814268|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25850799|NCT00052390|Bevacizumab|bevacizumab|mesh-list
25850800|NCT00052390|Doxorubicin|doxorubicin|mesh-list
25077857|NCT03361397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077858|NCT03361397|Sensory System Agents|sensory system agents|mesh-ancestor
25850801|NCT00052390|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25850802|NCT00052390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25850803|NCT00052390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850804|NCT00052390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25850805|NCT00052390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25850806|NCT00052390|Growth Substances|growth substances|mesh-ancestor
25850807|NCT00052390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850808|NCT00052390|Growth Inhibitors|growth inhibitors|mesh-ancestor
25850809|NCT00052390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25850810|NCT00052390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25850811|NCT00052390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25850812|NCT00052390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850813|NCT00052390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850814|NCT00052403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25850815|NCT00052403|Antibodies|antibodies|mesh-list
25850816|NCT00052403|Immunoglobulins|immunoglobulins|mesh-list
25850817|NCT00052403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25850818|NCT00052403|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
25077890|NCT03361163|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25077892|NCT03361124|Oxytocics|oxytocics|mesh-ancestor
25077893|NCT03361124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25662532|NCT01646177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25662533|NCT01646177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25662534|NCT01646177|Analgesics|analgesics|mesh-ancestor
25662535|NCT01646177|Sensory System Agents|sensory system agents|mesh-ancestor
25662536|NCT01646177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25662537|NCT01646177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662538|NCT01646177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25662539|NCT01646177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25662540|NCT01646177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25662541|NCT01646177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25077900|NCT03361098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850819|NCT00052403|Immunologic Factors|immunologic factors|mesh-list
25850820|NCT00052403|Mitogens|mitogens|mesh-list
25850821|NCT00052403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850822|NCT00052403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850823|NCT00052403|Mitosis Modulators|mitosis modulators|mesh-ancestor
25850824|NCT00052403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850825|NCT00052416|Thalidomide|thalidomide|mesh-list
25850826|NCT00052416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25850827|NCT00052416|Immunologic Factors|immunologic factors|mesh-ancestor
25202091|NCT02723838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202092|NCT02723838|Antiviral Agents|antiviral agents|mesh-ancestor
25202093|NCT02723838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25077904|NCT03361098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25077906|NCT03360981|Hormones|hormones|mesh-ancestor
25077907|NCT03360981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25077908|NCT03360981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077909|NCT03360955|Anesthetics|anesthetics|mesh-list
25077910|NCT03360955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25077911|NCT03360955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077912|NCT03360760|Doxorubicin|doxorubicin|mesh-list
25077913|NCT03360760|Methotrexate|methotrexate|mesh-list
25077914|NCT03360760|Ifosfamide|ifosfamide|mesh-list
25077915|NCT03360760|Isophosphamide mustard|isophosphamide mustard|mesh-list
25077916|NCT03360760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662542|NCT01646177|Immunologic Factors|immunologic factors|mesh-ancestor
25662543|NCT01646177|Dermatologic Agents|dermatologic agents|mesh-ancestor
25662544|NCT01646255|Levodopa|levodopa|mesh-list
25662545|NCT01646255|Rotigotine|rotigotine|mesh-list
25662546|NCT01646255|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25662547|NCT01646255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25662548|NCT01646255|Dopamine Agents|dopamine agents|mesh-ancestor
25662549|NCT01646255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25850830|NCT00052416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25850831|NCT00052416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25850832|NCT00052416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25066623|NCT02262923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25066624|NCT02262923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066625|NCT02262923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25066626|NCT02262923|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25077957|NCT03360682|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25077958|NCT03360682|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25077960|NCT03360279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25850833|NCT00052416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25850834|NCT00052416|Growth Substances|growth substances|mesh-ancestor
25850835|NCT00052416|Growth Inhibitors|growth inhibitors|mesh-ancestor
25850836|NCT00052416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850837|NCT00052455|Vincristine|vincristine|mesh-list
25850838|NCT00052455|Temozolomide|temozolomide|mesh-list
24883929|NCT04435808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883930|NCT04435808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25850839|NCT00052455|Lomustine|lomustine|mesh-list
25850840|NCT00052455|Procarbazine|procarbazine|mesh-list
25850841|NCT00052455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24540415|NCT00667927|Busulfan|busulfan|mesh-list
25662550|NCT01646255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662551|NCT01646255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662552|NCT01646255|Dopamine Agonists|dopamine agonists|mesh-ancestor
25662553|NCT01646268|Rotigotine|rotigotine|mesh-list
25662554|NCT01646268|Dopamine Agonists|dopamine agonists|mesh-ancestor
25662555|NCT01646268|Dopamine Agents|dopamine agents|mesh-ancestor
25662556|NCT01646268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25662557|NCT01646268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662558|NCT01646268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662559|NCT01646320|Metformin|metformin|mesh-list
25662560|NCT01646320|Dapagliflozin|dapagliflozin|mesh-list
25662561|NCT01646320|Saxagliptin|saxagliptin|mesh-list
25078013|NCT03359837|Insulin Glargine|insulin glargine|mesh-list
25078014|NCT03359837|Insulin Aspart|insulin aspart|mesh-list
25078015|NCT03359837|Biphasic Insulins|biphasic insulins|mesh-list
25078016|NCT03359837|Acarbose|acarbose|mesh-list
25078017|NCT03359837|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24816322|NCT02076477|Docetaxel|docetaxel|mesh-list
25078018|NCT03359837|Insulin glulisine|insulin glulisine|mesh-list
25078019|NCT03359837|Repaglinide|repaglinide|mesh-list
25078020|NCT03359837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25078021|NCT03359837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078022|NCT03359837|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24917331|NCT04231279|Secretin|secretin|mesh-list
25078023|NCT03359837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24883961|NCT03994146|Sensory System Agents|sensory system agents|mesh-ancestor
25202100|NCT02723500|Anesthetics, General|anesthetics, general|mesh-ancestor
25202101|NCT02723500|Anesthetics|anesthetics|mesh-ancestor
24883982|NCT03759587|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25850842|NCT00052455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850843|NCT00052455|Tubulin Modulators|tubulin modulators|mesh-ancestor
25850844|NCT00052455|Antimitotic Agents|antimitotic agents|mesh-ancestor
25850845|NCT00052455|Mitosis Modulators|mitosis modulators|mesh-ancestor
25850846|NCT00052455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850847|NCT00052455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25078049|NCT03359681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078050|NCT03359655|Scopolamine|scopolamine|mesh-list
25078052|NCT03359655|Misoprostol|misoprostol|mesh-list
25078053|NCT03359655|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25078054|NCT03359655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25078055|NCT03359655|Abortifacient Agents|abortifacient agents|mesh-ancestor
25078056|NCT03359655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25078057|NCT03359655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078058|NCT03359655|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25078059|NCT03359655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25662562|NCT01646320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25662563|NCT01646320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662564|NCT01646320|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25662565|NCT01646320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662566|NCT01646320|Incretins|incretins|mesh-ancestor
25662567|NCT01646320|Hormones|hormones|mesh-ancestor
25662568|NCT01646320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25662569|NCT01646320|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24670617|NCT02201108|Immunologic Factors|immunologic factors|mesh-ancestor
24456578|NCT00331747|Immunologic Factors|immunologic factors|mesh-ancestor
25234876|NCT02568280|Insulin Aspart|insulin aspart|mesh-list
25234877|NCT02568280|Insulin, Long-Acting|insulin, long-acting|mesh-list
25234878|NCT02568280|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25850850|NCT00052468|Paclitaxel|paclitaxel|mesh-list
24954659|NCT03874156|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24954660|NCT03874156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24954661|NCT03874156|Antimetabolites|antimetabolites|mesh-ancestor
24964229|NCT03784443|Growth Inhibitors|growth inhibitors|mesh-ancestor
25078085|NCT03359291|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24816303|NCT02076230|Phosphoramide Mustards|phosphoramide mustards|mesh-list
24816304|NCT02076230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25850851|NCT00052468|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24816314|NCT02076386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816315|NCT02076386|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24816316|NCT02076386|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24816319|NCT02076451|DS-8273a|ds-8273a|mesh-list
25850852|NCT00052468|Carboplatin|carboplatin|mesh-list
24520771|NCT05326360|Antiemetics|antiemetics|mesh-ancestor
25850853|NCT00052468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25850854|NCT00052468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850855|NCT00052468|Tubulin Modulators|tubulin modulators|mesh-ancestor
25850856|NCT00052468|Antimitotic Agents|antimitotic agents|mesh-ancestor
25850857|NCT00052468|Mitosis Modulators|mitosis modulators|mesh-ancestor
25850858|NCT00052468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850859|NCT00052468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25202105|NCT02723669|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25850860|NCT00052468|Antimetabolites|antimetabolites|mesh-ancestor
25850861|NCT00052468|Antiviral Agents|antiviral agents|mesh-ancestor
25850862|NCT00052468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25850863|NCT00052468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850864|NCT00052468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25850865|NCT00052468|Immunologic Factors|immunologic factors|mesh-ancestor
25850866|NCT00052468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850867|NCT00052494|Cisplatin|cisplatin|mesh-list
24781145|NCT01888263|Lamotrigine|lamotrigine|mesh-list
25662570|NCT01646320|Protease Inhibitors|protease inhibitors|mesh-ancestor
25662571|NCT01646320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25662572|NCT01646385|Etanercept|etanercept|mesh-list
25662573|NCT01646385|Antirheumatic Agents|antirheumatic agents|mesh-list
25662574|NCT01646385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25662575|NCT01646385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25662576|NCT01646385|Analgesics|analgesics|mesh-ancestor
25662577|NCT01646385|Sensory System Agents|sensory system agents|mesh-ancestor
25662578|NCT01646385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25662579|NCT01646385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662580|NCT01646385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25662581|NCT01646385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25662582|NCT01646385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25850870|NCT00052494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850871|NCT00052494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25850872|NCT00052494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25850873|NCT00052494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25066718|NCT02099175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066719|NCT02099175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25066720|NCT02099175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25066721|NCT02099175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25850874|NCT00052494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850875|NCT00052494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25850876|NCT00052507|Bortezomib|bortezomib|mesh-list
25850877|NCT00052507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850878|NCT00052559|Bevacizumab|bevacizumab|mesh-list
25066744|NCT01451736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25850879|NCT00052559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25850880|NCT00052559|Fluorouracil|fluorouracil|mesh-list
25850881|NCT00052559|Antibodies|antibodies|mesh-list
25662583|NCT01646385|Immunologic Factors|immunologic factors|mesh-ancestor
25662584|NCT01646398|Vaccines|vaccines|mesh-list
25662585|NCT01646398|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25662586|NCT01646398|Immunologic Factors|immunologic factors|mesh-ancestor
25662587|NCT01646398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662588|NCT01646671|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25662589|NCT01646671|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25662590|NCT01646671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662591|NCT01646762|Paclitaxel|paclitaxel|mesh-list
25662592|NCT01646762|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25662593|NCT01646762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25662594|NCT01646762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662595|NCT01646762|Tubulin Modulators|tubulin modulators|mesh-ancestor
25662596|NCT01646762|Antimitotic Agents|antimitotic agents|mesh-ancestor
25850882|NCT00052559|Immunoglobulins|immunoglobulins|mesh-list
25850883|NCT00052559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24626775|NCT01088724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626776|NCT01088724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24514261|NCT00589316|Iodine|iodine|mesh-list
24514265|NCT00589316|Fludarabine|fludarabine|mesh-list
25850884|NCT00052559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850885|NCT00052559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25850886|NCT00052559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25850887|NCT00052559|Growth Substances|growth substances|mesh-ancestor
25850888|NCT00052559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066755|NCT01166633|Atorvastatin|atorvastatin|mesh-list
25850889|NCT00052559|Growth Inhibitors|growth inhibitors|mesh-ancestor
25850890|NCT00052559|Immunologic Factors|immunologic factors|mesh-ancestor
25850891|NCT00052559|Antimetabolites|antimetabolites|mesh-ancestor
24860322|NCT02309281|Aflibercept|aflibercept|mesh-list
25850892|NCT00052559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850893|NCT00052559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25850894|NCT00052559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25850895|NCT00052585|Leucovorin|leucovorin|mesh-list
24954746|NCT03872505|Antimitotic Agents|antimitotic agents|mesh-ancestor
24954747|NCT03872505|Mitosis Modulators|mitosis modulators|mesh-ancestor
24954748|NCT03872505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954749|NCT03872505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24954751|NCT03872336|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24954752|NCT03872336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24954753|NCT03872336|Adrenergic Agents|adrenergic agents|mesh-ancestor
24954754|NCT03872336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24954755|NCT03872336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884127|NCT02976337|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24884129|NCT02976337|Sensory System Agents|sensory system agents|mesh-ancestor
24540757|NCT00669591|Bavituximab|bavituximab|mesh-list
24954776|NCT03872232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25662597|NCT01646762|Mitosis Modulators|mitosis modulators|mesh-ancestor
25662598|NCT01646762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674359|NCT01770483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674360|NCT01770483|Immunologic Factors|immunologic factors|mesh-ancestor
25674361|NCT01770483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674362|NCT01770483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25674363|NCT01770652|Deferiprone|deferiprone|mesh-list
25674364|NCT01770652|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25674365|NCT01770652|Chelating Agents|chelating agents|mesh-ancestor
25674366|NCT01770652|Sequestering Agents|sequestering agents|mesh-ancestor
25674367|NCT01770652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674368|NCT01770743|Vaccines|vaccines|mesh-list
25850896|NCT00052585|Fluorouracil|fluorouracil|mesh-list
25850897|NCT00052585|Irinotecan|irinotecan|mesh-list
25066780|NCT00493896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25066781|NCT00493896|Protease Inhibitors|protease inhibitors|mesh-ancestor
25066782|NCT00493896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850899|NCT00052585|Calcium|calcium|mesh-list
25850900|NCT00052585|Levoleucovorin|levoleucovorin|mesh-list
25850901|NCT00052585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25850902|NCT00052585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850903|NCT00052585|Antimetabolites|antimetabolites|mesh-ancestor
24954791|NCT03871972|Antifungal Agents|antifungal agents|mesh-ancestor
24884160|NCT02817789|Analgesics|analgesics|mesh-ancestor
24884161|NCT02817789|Sensory System Agents|sensory system agents|mesh-ancestor
24781146|NCT01888263|Anticonvulsants|anticonvulsants|mesh-ancestor
25850904|NCT00052585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850905|NCT00052585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25850906|NCT00052585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850907|NCT00052585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25850908|NCT00052585|Immunologic Factors|immunologic factors|mesh-ancestor
25850909|NCT00052585|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25850910|NCT00052585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25850911|NCT00052585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850912|NCT00052585|Antidotes|antidotes|mesh-ancestor
25850913|NCT00052585|Protective Agents|protective agents|mesh-ancestor
25850914|NCT00052585|Vitamin B Complex|vitamin b complex|mesh-ancestor
25850915|NCT00052585|Vitamins|vitamins|mesh-ancestor
25850916|NCT00052585|Micronutrients|micronutrients|mesh-ancestor
25850917|NCT00052585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25850918|NCT00052611|Celecoxib|celecoxib|mesh-list
24954888|NCT03871114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24954889|NCT03871114|Immunologic Factors|immunologic factors|mesh-ancestor
24954890|NCT03871114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24954891|NCT03871114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850919|NCT00052611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25850920|NCT00052611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25850921|NCT00052611|Analgesics|analgesics|mesh-ancestor
25850922|NCT00052611|Sensory System Agents|sensory system agents|mesh-ancestor
24954912|NCT03870594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954913|NCT03870594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24954914|NCT03870594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25850931|NCT00052676|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
25850932|NCT00052676|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25850933|NCT00052676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850934|NCT00052689|Gemcitabine|gemcitabine|mesh-list
25850936|NCT00052689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25850937|NCT00052689|Antimetabolites|antimetabolites|mesh-ancestor
25850938|NCT00052689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850939|NCT00052689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850940|NCT00052689|Antiviral Agents|antiviral agents|mesh-ancestor
25850941|NCT00052689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24780841|NCT01886573|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
24780842|NCT01886573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24780843|NCT01886573|Antimetabolites|antimetabolites|mesh-ancestor
24540943|NCT00670254|Hydrocortisone|hydrocortisone|mesh-list
25850942|NCT00052689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850943|NCT00052689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25850944|NCT00052689|Immunologic Factors|immunologic factors|mesh-ancestor
25850945|NCT00052689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850946|NCT00052728|Tamoxifen|tamoxifen|mesh-list
25850947|NCT00052728|Tipifarnib|tipifarnib|mesh-list
24448840|NCT00313235|Alkylating Agents|alkylating agents|mesh-ancestor
24448841|NCT00313235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448842|NCT00313235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850948|NCT00052728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25850949|NCT00052728|Hormone Antagonists|hormone antagonists|mesh-ancestor
25850950|NCT00052728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25850951|NCT00052728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850952|NCT00052728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25850953|NCT00052728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850954|NCT00052728|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25850955|NCT00052728|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25850956|NCT00052728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25850957|NCT00052754|Gefitinib|gefitinib|mesh-list
25850958|NCT00052754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850959|NCT00052754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25850960|NCT00052754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850961|NCT00052754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850962|NCT00052780|Temozolomide|temozolomide|mesh-list
25850963|NCT00052780|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
25850964|NCT00052780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25850965|NCT00052780|Alkylating Agents|alkylating agents|mesh-ancestor
24955063|NCT03868436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24955064|NCT03868436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955065|NCT03868722|Venetoclax|venetoclax|mesh-list
24955066|NCT03868722|Acalabrutinib|acalabrutinib|mesh-list
24955067|NCT03868722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662599|NCT01646827|Aripiprazole|aripiprazole|mesh-list
25850973|NCT00052832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25850975|NCT00052845|Docetaxel|docetaxel|mesh-list
25850976|NCT00052845|Estramustine|estramustine|mesh-list
25850977|NCT00052845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25850978|NCT00052845|Tubulin Modulators|tubulin modulators|mesh-ancestor
24955068|NCT03868306|Chrysarobin|chrysarobin|mesh-list
24955069|NCT03868306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24955070|NCT03868306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24955071|NCT03868306|Analgesics|analgesics|mesh-ancestor
24955072|NCT03868306|Sensory System Agents|sensory system agents|mesh-ancestor
24955073|NCT03868306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955074|NCT03868306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955075|NCT03868306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24955076|NCT03868306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24955077|NCT03868072|Tofacitinib|tofacitinib|mesh-list
24955078|NCT03868072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25850979|NCT00052845|Antimitotic Agents|antimitotic agents|mesh-ancestor
25850980|NCT00052845|Mitosis Modulators|mitosis modulators|mesh-ancestor
25850981|NCT00052845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25850982|NCT00052845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25850983|NCT00052845|Alkylating Agents|alkylating agents|mesh-ancestor
25850984|NCT00052845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24860758|NCT02312440|Hemostatics|hemostatics|mesh-ancestor
25078163|NCT03358888|Analgesics, Opioid|analgesics, opioid|mesh-list
24860777|NCT02312609|Minocycline|minocycline|mesh-list
25850985|NCT00052845|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25850986|NCT00052845|Protective Agents|protective agents|mesh-ancestor
25850987|NCT00052845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25850988|NCT00052845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25202107|NCT02723669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25202108|NCT02723669|Expectorants|expectorants|mesh-ancestor
25850989|NCT00052845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25850990|NCT00052845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25078185|NCT03358719|Laxatives|laxatives|mesh-ancestor
25078186|NCT03358719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25078187|NCT03358719|Antiviral Agents|antiviral agents|mesh-ancestor
25078188|NCT03358719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24955091|NCT03868137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955092|NCT03868137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24955093|NCT03868137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24955094|NCT03868137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24955095|NCT03868137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24955096|NCT03868137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955097|NCT03868111|Sufentanil|sufentanil|mesh-list
25850991|NCT00052845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25850992|NCT00052845|Analgesics|analgesics|mesh-ancestor
25850993|NCT00052845|Sensory System Agents|sensory system agents|mesh-ancestor
25850994|NCT00052845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25850995|NCT00052845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24955105|NCT03868111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25850996|NCT00052845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25851003|NCT00052884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955149|NCT03867994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24955150|NCT03867994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24955151|NCT03867994|Vasodilator Agents|vasodilator agents|mesh-ancestor
24955152|NCT03867994|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24955153|NCT03867994|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24955157|NCT03867695|Ropivacaine|ropivacaine|mesh-list
24955158|NCT03867695|Anesthetics, Local|anesthetics, local|mesh-ancestor
24884524|NCT00409773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851004|NCT00052884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851005|NCT00052884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25851006|NCT00052884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25851007|NCT00052884|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25851008|NCT00052884|Protective Agents|protective agents|mesh-ancestor
25851009|NCT00052923|Cyclophosphamide|cyclophosphamide|mesh-list
25851010|NCT00052923|Carmustine|carmustine|mesh-list
25851011|NCT00052923|Rituximab|rituximab|mesh-list
24955185|NCT03867123|Temozolomide|temozolomide|mesh-list
24955186|NCT03867123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25851012|NCT00052923|Etoposide|etoposide|mesh-list
25851013|NCT00052923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25851014|NCT00052923|Immunologic Factors|immunologic factors|mesh-ancestor
25851015|NCT00052923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851016|NCT00052923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25851017|NCT00052923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25851018|NCT00052923|Alkylating Agents|alkylating agents|mesh-ancestor
25851019|NCT00052923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851020|NCT00052923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851021|NCT00052923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25851022|NCT00052923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24955195|NCT03867240|Anticonvulsants|anticonvulsants|mesh-ancestor
25851023|NCT00052923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25851024|NCT00052923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24449426|NCT00315549|Penicillins|penicillins|mesh-list
25851025|NCT00052923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25851026|NCT00052923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851027|NCT00052936|Prednisone|prednisone|mesh-list
25851028|NCT00052936|Cyclophosphamide|cyclophosphamide|mesh-list
25851029|NCT00052936|Rituximab|rituximab|mesh-list
25851030|NCT00052936|Doxorubicin|doxorubicin|mesh-list
25851031|NCT00052936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25851032|NCT00052936|Vincristine|vincristine|mesh-list
25851033|NCT00052936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25851034|NCT00052936|Immunologic Factors|immunologic factors|mesh-ancestor
25851035|NCT00052936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851036|NCT00052936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25851037|NCT00052936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25851038|NCT00052936|Alkylating Agents|alkylating agents|mesh-ancestor
25851039|NCT00052936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851040|NCT00052936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24455179|NCT02448771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851041|NCT00052936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25078204|NCT03358277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25078205|NCT03358277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851045|NCT00052936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25851046|NCT00052936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851047|NCT00052936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24393201|NCT00129142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851048|NCT00052936|Glucocorticoids|glucocorticoids|mesh-ancestor
25851049|NCT00052936|Hormones|hormones|mesh-ancestor
24393222|NCT00129168|Immunologic Factors|immunologic factors|mesh-ancestor
24393223|NCT00129168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393224|NCT00129168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24393225|NCT00129168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24955389|NCT03865004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24955391|NCT03865004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24955392|NCT03864913|Testosterone|testosterone|mesh-list
24955393|NCT03864913|Androgens|androgens|mesh-ancestor
24955395|NCT03864913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24955396|NCT03864913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393239|NCT00129181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24393261|NCT00129298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393263|NCT00129298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24393264|NCT00129298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662600|NCT01646827|Antidepressive Agents|antidepressive agents|mesh-ancestor
25202109|NCT02723669|Respiratory System Agents|respiratory system agents|mesh-ancestor
25202110|NCT02723669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24918340|NCT04220398|Hormones|hormones|mesh-list
24393360|NCT00129844|Dermatologic Agents|dermatologic agents|mesh-ancestor
24393361|NCT00129857|HU 211|hu 211|mesh-list
24393362|NCT00129857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24393363|NCT00129857|Antiemetics|antiemetics|mesh-ancestor
24393364|NCT00129857|Autonomic Agents|autonomic agents|mesh-ancestor
24393365|NCT00129857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24393366|NCT00129857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393367|NCT00129857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25851050|NCT00052936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24393407|NCT00129922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24393408|NCT00129922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24393409|NCT00129922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24393410|NCT00129922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24393411|NCT00129922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24393412|NCT00129948|Troxacitabine|troxacitabine|mesh-list
24918352|NCT04220632|Prednisolone phosphate|prednisolone phosphate|mesh-list
24918353|NCT04220632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24393413|NCT00129948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393414|NCT00129948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24393415|NCT00129948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25851051|NCT00052936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24955492|NCT03864250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955493|NCT03864250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24955494|NCT03864250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24955496|NCT03864250|Immunologic Factors|immunologic factors|mesh-ancestor
24955497|NCT03864250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24955503|NCT03864523|Pioglitazone|pioglitazone|mesh-list
24955504|NCT03864523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24955505|NCT03864523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955506|NCT03864588|Ropivacaine|ropivacaine|mesh-list
25662601|NCT01646827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25851052|NCT00052936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25851053|NCT00052936|Tubulin Modulators|tubulin modulators|mesh-ancestor
25851054|NCT00052936|Antimitotic Agents|antimitotic agents|mesh-ancestor
25851055|NCT00052936|Mitosis Modulators|mitosis modulators|mesh-ancestor
25851056|NCT00052949|Imatinib Mesylate|imatinib mesylate|mesh-list
24748420|NCT02599324|Paclitaxel|paclitaxel|mesh-list
24955507|NCT03864588|Anesthetics, Local|anesthetics, local|mesh-ancestor
24955508|NCT03864588|Anesthetics|anesthetics|mesh-ancestor
24955523|NCT03864575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955524|NCT03864575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955525|NCT03864575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24918427|NCT04219865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918428|NCT04219982|Scopolamine|scopolamine|mesh-list
24918429|NCT04219982|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24918430|NCT04219982|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24955526|NCT03864575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24955527|NCT03864575|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24393518|NCT00130195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24393519|NCT00130195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24393520|NCT00130195|Tubulin Modulators|tubulin modulators|mesh-ancestor
24393521|NCT00130195|Antimitotic Agents|antimitotic agents|mesh-ancestor
25851057|NCT00052949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25202111|NCT02723669|Antioxidants|antioxidants|mesh-ancestor
25202112|NCT02723669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202113|NCT02723669|Protective Agents|protective agents|mesh-ancestor
25851058|NCT00052949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25851059|NCT00052949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451501|NCT00323973|Sympatholytics|sympatholytics|mesh-ancestor
24955624|NCT03863366|Laxatives|laxatives|mesh-ancestor
24955625|NCT03863366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24955626|NCT03863366|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24955627|NCT03863366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24955628|NCT03863366|Serotonin Agents|serotonin agents|mesh-ancestor
24955629|NCT03863366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24861368|NCT02317341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955647|NCT03862690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955649|NCT03862768|Imatinib Mesylate|imatinib mesylate|mesh-list
25078209|NCT03358277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25078211|NCT03358212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25078212|NCT03358212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078213|NCT03358082|Hydrocortisone|hydrocortisone|mesh-list
25078214|NCT03358082|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25078215|NCT03358082|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25078216|NCT03358082|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25078217|NCT03358082|Tacrolimus|tacrolimus|mesh-list
25078218|NCT03358082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25078219|NCT03358082|Immunologic Factors|immunologic factors|mesh-ancestor
25078220|NCT03358082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078221|NCT03358082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25078222|NCT03358082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078223|NCT03358082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884904|NCT03268811|Teduglutide|teduglutide|mesh-list
24393672|NCT00130676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24393673|NCT00130676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393674|NCT00130676|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24393675|NCT00130676|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24393676|NCT00130676|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24393677|NCT00130676|Contraceptive Agents|contraceptive agents|mesh-ancestor
24393678|NCT00130676|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24393679|NCT00130676|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24393680|NCT00130676|Hormone Antagonists|hormone antagonists|mesh-ancestor
24616916|NCT01039766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24393681|NCT00130676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25202114|NCT02723669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955671|NCT03862586|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25851060|NCT00052949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393730|NCT00130871|Protective Agents|protective agents|mesh-ancestor
25662602|NCT01646827|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25662603|NCT01646827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25662604|NCT01646827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25662605|NCT01646827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851061|NCT00053001|Thalidomide|thalidomide|mesh-list
25851062|NCT00053001|Epoetin Alfa|epoetin alfa|mesh-list
25851063|NCT00053001|Hematinics|hematinics|mesh-ancestor
25851064|NCT00053001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25851065|NCT00053001|Immunologic Factors|immunologic factors|mesh-ancestor
24393736|NCT00130884|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25851066|NCT00053001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861491|NCT02318056|Bacitracin|bacitracin|mesh-list
24393760|NCT00130910|Mitosis Modulators|mitosis modulators|mesh-ancestor
24393762|NCT00130910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393765|NCT00130936|Epirubicin|epirubicin|mesh-list
24393766|NCT00130936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393767|NCT00130936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24393768|NCT00130936|Antimetabolites|antimetabolites|mesh-ancestor
25851067|NCT00053001|Leprostatic Agents|leprostatic agents|mesh-ancestor
24393769|NCT00130936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393770|NCT00130936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24393771|NCT00130936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24393772|NCT00130936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24393773|NCT00130936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851068|NCT00053001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25851069|NCT00053001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24918475|NCT04219280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24918483|NCT04219046|Naloxegol|naloxegol|mesh-list
25851070|NCT00053001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24861567|NCT02318771|Pembrolizumab|pembrolizumab|mesh-list
24781508|NCT01889992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24781509|NCT01889992|Immunologic Factors|immunologic factors|mesh-ancestor
24781510|NCT01889992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781511|NCT01890005|Aspirin|aspirin|mesh-list
24781512|NCT01890005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24781513|NCT01890005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24781514|NCT01890005|Analgesics|analgesics|mesh-ancestor
24507338|NCT00549965|Risedronic Acid|risedronic acid|mesh-list
24781515|NCT01890005|Sensory System Agents|sensory system agents|mesh-ancestor
24781516|NCT01890005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202115|NCT02723669|Antidotes|antidotes|mesh-ancestor
25202116|NCT02723513|Xenon|xenon|mesh-list
25202117|NCT02723513|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24781522|NCT01890005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781523|NCT01890005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24781524|NCT01890005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24781525|NCT01890005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25066890|NCT03449719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25066891|NCT03449719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626556|NCT01087840|Emtricitabine|emtricitabine|mesh-list
24626557|NCT01087840|Raltegravir Potassium|raltegravir potassium|mesh-list
24955728|NCT03862287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24393860|NCT00131053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24393861|NCT00131053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24393884|NCT00131183|Testosterone undecanoate|testosterone undecanoate|mesh-list
24393885|NCT00131183|Androgens|androgens|mesh-ancestor
24393886|NCT00131183|Hormones|hormones|mesh-ancestor
25662606|NCT01646827|Dopamine Agonists|dopamine agonists|mesh-ancestor
25662607|NCT01646827|Dopamine Agents|dopamine agents|mesh-ancestor
25662608|NCT01646827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25674369|NCT01770743|Immunologic Factors|immunologic factors|mesh-ancestor
25851071|NCT00053001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25851072|NCT00053001|Growth Substances|growth substances|mesh-ancestor
25851073|NCT00053001|Growth Inhibitors|growth inhibitors|mesh-ancestor
25851074|NCT00053001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851075|NCT00053027|Rituximab|rituximab|mesh-list
25851076|NCT00053027|Cladribine|cladribine|mesh-list
25851077|NCT00053027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25851078|NCT00053027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851079|NCT00053027|Immunologic Factors|immunologic factors|mesh-ancestor
25851080|NCT00053027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851081|NCT00053027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25851087|NCT00053092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25851088|NCT00053092|Immunologic Factors|immunologic factors|mesh-ancestor
24955876|NCT03860220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24955877|NCT03860220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24955878|NCT03860220|Antimetabolites|antimetabolites|mesh-ancestor
24955879|NCT03860220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955880|NCT03860220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24955881|NCT03860220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24955882|NCT03860220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24955883|NCT03860220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24955884|NCT03860220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25066901|NCT03449654|Liraglutide|liraglutide|mesh-list
24955892|NCT03859934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955893|NCT03859934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24955895|NCT03859908|Chlorhexidine|chlorhexidine|mesh-list
24393997|NCT00131521|Protective Agents|protective agents|mesh-ancestor
24393998|NCT00131521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851089|NCT00053092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394052|NCT00131963|Doxorubicin|doxorubicin|mesh-list
25851093|NCT00053092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885195|NCT01873170|Progestins|progestins|mesh-ancestor
25851094|NCT00053092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851095|NCT00053092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25851096|NCT00053092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25078269|NCT03357822|Interferons|interferons|mesh-list
24955900|NCT03859908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955901|NCT03859908|Disinfectants|disinfectants|mesh-ancestor
24955902|NCT03859908|Dermatologic Agents|dermatologic agents|mesh-ancestor
25420301|NCT02630459|Analgesics|analgesics|mesh-ancestor
25662609|NCT01646827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662610|NCT01646827|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25662611|NCT01646827|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25662612|NCT01646827|Serotonin Agents|serotonin agents|mesh-ancestor
25662613|NCT01646827|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25662614|NCT01646827|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25851097|NCT00053092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25851098|NCT00053092|Antimetabolites|antimetabolites|mesh-ancestor
25851099|NCT00053105|Cytarabine|cytarabine|mesh-list
24955930|NCT03859570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955931|NCT03859570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24955932|NCT03859570|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24955933|NCT03859570|Protective Agents|protective agents|mesh-ancestor
24955934|NCT03859570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955935|NCT03859570|Vasodilator Agents|vasodilator agents|mesh-ancestor
24955936|NCT03859570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24955938|NCT03859362|Ertapenem|ertapenem|mesh-list
24885233|NCT01481272|Protective Agents|protective agents|mesh-ancestor
24885234|NCT01481272|Vitamin B Complex|vitamin b complex|mesh-ancestor
24955964|NCT03859102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24955965|NCT03859102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24955966|NCT03859102|Analgesics|analgesics|mesh-ancestor
24955967|NCT03859102|Sensory System Agents|sensory system agents|mesh-ancestor
24955968|NCT03859102|Antipyretics|antipyretics|mesh-ancestor
24955969|NCT03859102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24955970|NCT03859102|Anticonvulsants|anticonvulsants|mesh-ancestor
25851100|NCT00053105|Methylprednisolone|methylprednisolone|mesh-list
25851101|NCT00053105|Pixantrone|pixantrone|mesh-list
25851102|NCT00053105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851103|NCT00053105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25851104|NCT00053105|Antimetabolites|antimetabolites|mesh-ancestor
24571298|NCT00809068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24571299|NCT00809068|Antimetabolites|antimetabolites|mesh-ancestor
24571300|NCT00809068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571301|NCT00809068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24571320|NCT00809172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24571353|NCT00809237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24394190|NCT00132548|Amodiaquine|amodiaquine|mesh-list
24394191|NCT00132548|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25851105|NCT00053105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851106|NCT00053105|Antiviral Agents|antiviral agents|mesh-ancestor
25851107|NCT00053105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24626574|NCT01087879|Etonogestrel|etonogestrel|mesh-list
24626575|NCT01087879|Desogestrel|desogestrel|mesh-list
24918721|NCT04216758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24394195|NCT00132548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24394196|NCT00132548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24394197|NCT00132548|Antiviral Agents|antiviral agents|mesh-ancestor
24885297|NCT00885963|Sapacitabine|sapacitabine|mesh-list
24452127|NCT00326092|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25202120|NCT02723513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25202121|NCT02723513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202122|NCT02723461|Oxytocin|oxytocin|mesh-list
25202124|NCT02723461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25202125|NCT02723461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662615|NCT01646827|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25662616|NCT01646827|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25662617|NCT01647282|Minocycline|minocycline|mesh-list
25662618|NCT01647282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25662619|NCT01647282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25662620|NCT01647516|Ozanimod|ozanimod|mesh-list
25662621|NCT01647516|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25662622|NCT01647516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202126|NCT02723487|Bupivacaine|bupivacaine|mesh-list
25202127|NCT02723487|Anesthetics, Local|anesthetics, local|mesh-ancestor
25202128|NCT02723487|Anesthetics|anesthetics|mesh-ancestor
25202134|NCT02723448|Aclacinomycins|aclacinomycins|mesh-list
24452128|NCT00326092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202135|NCT02723448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24462880|NCT00357747|Tubulin Modulators|tubulin modulators|mesh-ancestor
25851108|NCT00053105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25851109|NCT00053105|Immunologic Factors|immunologic factors|mesh-ancestor
25851110|NCT00053105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851111|NCT00053105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25851112|NCT00053105|Antiemetics|antiemetics|mesh-ancestor
24862237|NCT02323737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626613|NCT01088009|Antiviral Agents|antiviral agents|mesh-ancestor
24626614|NCT01088009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24626615|NCT01088009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24626616|NCT01088009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24626617|NCT01088022|Dexamethasone|dexamethasone|mesh-list
24626618|NCT01088022|Dexamethasone acetate|dexamethasone acetate|mesh-list
24626619|NCT01088022|Aprepitant|aprepitant|mesh-list
24626620|NCT01088022|Palonosetron|palonosetron|mesh-list
24626621|NCT01088022|BB 1101|bb 1101|mesh-list
25851113|NCT00053105|Autonomic Agents|autonomic agents|mesh-ancestor
25851114|NCT00053105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25851115|NCT00053105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25851116|NCT00053105|Glucocorticoids|glucocorticoids|mesh-ancestor
25851117|NCT00053105|Hormones|hormones|mesh-ancestor
24626626|NCT01088022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626627|NCT01088022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24626628|NCT01088022|Glucocorticoids|glucocorticoids|mesh-ancestor
24626629|NCT01088022|Hormones|hormones|mesh-ancestor
24918791|NCT04216355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626630|NCT01088022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24626631|NCT01088022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24955996|NCT03858582|Pembrolizumab|pembrolizumab|mesh-list
24955997|NCT03858582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24955998|NCT03858582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24955999|NCT03858465|Phenylephrine|phenylephrine|mesh-list
24956000|NCT03858465|Oxymetazoline|oxymetazoline|mesh-list
24956001|NCT03858465|Ephedrine|ephedrine|mesh-list
24956002|NCT03858465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24956003|NCT03858465|Mydriatics|mydriatics|mesh-ancestor
24956004|NCT03858465|Autonomic Agents|autonomic agents|mesh-ancestor
24956005|NCT03858465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24956006|NCT03858465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956008|NCT03858465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24956009|NCT03858465|Nasal Decongestants|nasal decongestants|mesh-ancestor
24956010|NCT03858465|Respiratory System Agents|respiratory system agents|mesh-ancestor
24956011|NCT03858465|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24956028|NCT03858387|Meropenem|meropenem|mesh-list
24956029|NCT03858387|Imipenem|imipenem|mesh-list
24956030|NCT03858387|Cilastatin|cilastatin|mesh-list
25662623|NCT01647516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25662624|NCT01647516|Immunologic Factors|immunologic factors|mesh-ancestor
25662625|NCT01647516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662626|NCT01647581|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25662627|NCT01647581|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
25662628|NCT01647581|beta-Endorphin|beta-endorphin|mesh-list
25662629|NCT01647581|Hormones|hormones|mesh-ancestor
25662630|NCT01647581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25662631|NCT01647581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662632|NCT01647581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25662633|NCT01647581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662634|NCT01647945|Tacrolimus|tacrolimus|mesh-list
24956033|NCT03858387|Protease Inhibitors|protease inhibitors|mesh-ancestor
24956034|NCT03858387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24956035|NCT03858387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956036|NCT03858192|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24956037|NCT03858192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24956038|NCT03858270|Memantine|memantine|mesh-list
24956039|NCT03858270|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24542236|NCT00677755|Mifepristone|mifepristone|mesh-list
24462937|NCT00358020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24462938|NCT00358020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24462939|NCT00358020|Immunologic Factors|immunologic factors|mesh-ancestor
24462940|NCT00358020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462941|NCT00358020|Leprostatic Agents|leprostatic agents|mesh-ancestor
25851119|NCT00053105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25851120|NCT00053105|Protective Agents|protective agents|mesh-ancestor
24462942|NCT00358020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24462943|NCT00358020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24462944|NCT00358020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24462945|NCT00358020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24462946|NCT00358020|Growth Substances|growth substances|mesh-ancestor
24462947|NCT00358020|Growth Inhibitors|growth inhibitors|mesh-ancestor
24462948|NCT00358124|Metformin|metformin|mesh-list
24462949|NCT00358124|Insulin Glargine|insulin glargine|mesh-list
24462950|NCT00358124|Rosiglitazone|rosiglitazone|mesh-list
24462951|NCT00358124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25851121|NCT00053105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24956103|NCT03857581|Autonomic Agents|autonomic agents|mesh-ancestor
24956104|NCT03857581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24956105|NCT03857581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956106|NCT03857581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24956107|NCT03857581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25078272|NCT03357822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24956108|NCT03857581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24956109|NCT03857581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24617434|NCT01043211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24617435|NCT01043211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24617436|NCT01043211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24521099|NCT05112081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24617437|NCT01043211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617438|NCT01043211|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24617439|NCT01043211|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24617698|NCT01045083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25066955|NCT03448835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066956|NCT03448835|Tubulin Modulators|tubulin modulators|mesh-ancestor
24956110|NCT03857581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24956111|NCT03857581|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24956112|NCT03857581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25202139|NCT02723448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202140|NCT02723448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202141|NCT02723448|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24956113|NCT03857581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24956114|NCT03857581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956115|NCT03857581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24885446|NCT05172570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885447|NCT05172570|Antimanic Agents|antimanic agents|mesh-ancestor
24862304|NCT02324296|Ifosfamide|ifosfamide|mesh-list
25851122|NCT00053105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24918967|NCT04214938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662635|NCT01647945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25662636|NCT01647945|Immunologic Factors|immunologic factors|mesh-ancestor
25662637|NCT01647945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662638|NCT01647945|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25662639|NCT01647945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25662640|NCT01647945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918970|NCT04214938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24918971|NCT04214938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24956117|NCT03857581|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24956118|NCT03857581|GABA Antagonists|gaba antagonists|mesh-ancestor
24956119|NCT03857581|GABA Agents|gaba agents|mesh-ancestor
24956120|NCT03857334|Cortivazol|cortivazol|mesh-list
24956121|NCT03857334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24956122|NCT03856853|Pirfenidone|pirfenidone|mesh-list
24956123|NCT03856853|Analgesics|analgesics|mesh-ancestor
24956124|NCT03856853|Sensory System Agents|sensory system agents|mesh-ancestor
24956125|NCT03856853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24956126|NCT03856853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956127|NCT03856853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24956128|NCT03856853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24462971|NCT00358228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24462973|NCT00358280|Bupivacaine|bupivacaine|mesh-list
24462974|NCT00358280|Ropivacaine|ropivacaine|mesh-list
24462975|NCT00358280|Anesthetics, Local|anesthetics, local|mesh-ancestor
24462980|NCT00358280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24462982|NCT00358293|Analgesics|analgesics|mesh-ancestor
24462983|NCT00358293|Sensory System Agents|sensory system agents|mesh-ancestor
25851123|NCT00053105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24956133|NCT03856866|Antimalarials|antimalarials|mesh-ancestor
24956134|NCT03856866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24956135|NCT03856866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24956176|NCT03856697|Gefitinib|gefitinib|mesh-list
24956177|NCT03856697|Maleic acid|maleic acid|mesh-list
24956178|NCT03856697|Abivertinib|abivertinib|mesh-list
24956179|NCT03856697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24956180|NCT03856697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956181|NCT03856697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24956191|NCT03856502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956192|NCT03856502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24956193|NCT03856502|Glucocorticoids|glucocorticoids|mesh-ancestor
24956195|NCT03856502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24956196|NCT03856502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24956197|NCT03856502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24956198|NCT03856502|Protease Inhibitors|protease inhibitors|mesh-ancestor
25078273|NCT03357822|Antiviral Agents|antiviral agents|mesh-ancestor
24956199|NCT03856502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24956200|NCT03856502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956201|NCT03856502|Anesthetics, Local|anesthetics, local|mesh-ancestor
24956202|NCT03856502|Anesthetics|anesthetics|mesh-ancestor
24463060|NCT00358488|Autonomic Agents|autonomic agents|mesh-ancestor
24956203|NCT03856502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24956204|NCT03856502|Sensory System Agents|sensory system agents|mesh-ancestor
24956206|NCT03856242|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24956207|NCT03856242|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24956208|NCT03856242|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24956209|NCT03856242|Adrenergic Agents|adrenergic agents|mesh-ancestor
24956214|NCT03856112|Dexamethasone|dexamethasone|mesh-list
24956215|NCT03856112|Dexamethasone acetate|dexamethasone acetate|mesh-list
24956217|NCT03856112|Ixazomib|ixazomib|mesh-list
24956218|NCT03856112|Ichthammol|ichthammol|mesh-list
24956219|NCT03856112|BB 1101|bb 1101|mesh-list
24956220|NCT03856112|Glycine|glycine|mesh-list
24956221|NCT03856112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24956222|NCT03856112|Antiemetics|antiemetics|mesh-ancestor
24956223|NCT03856112|Autonomic Agents|autonomic agents|mesh-ancestor
24572072|NCT00812864|Capecitabine|capecitabine|mesh-list
24572073|NCT00812864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24956224|NCT03856112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24956225|NCT03856112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956226|NCT03856112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24956227|NCT03856112|Glucocorticoids|glucocorticoids|mesh-ancestor
24956228|NCT03856112|Hormones|hormones|mesh-ancestor
24956229|NCT03856112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24956230|NCT03856112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24956231|NCT03856112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25420378|NCT02628626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25851124|NCT00053118|Carboplatin|carboplatin|mesh-list
25851125|NCT00053118|Etoposide|etoposide|mesh-list
25851126|NCT00053118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24956270|NCT03855501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24956271|NCT03855501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956273|NCT03855579|Milrinone|milrinone|mesh-list
24956274|NCT03855579|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24956275|NCT03855579|Vasodilator Agents|vasodilator agents|mesh-ancestor
24956276|NCT03855579|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24956277|NCT03855579|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24956278|NCT03855579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24956279|NCT03855579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956280|NCT03855579|Protective Agents|protective agents|mesh-ancestor
24956281|NCT03855579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956310|NCT03855384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24956311|NCT03855384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24956312|NCT03855384|Immunologic Factors|immunologic factors|mesh-ancestor
24956313|NCT03855384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956314|NCT03855332|Cilostazol|cilostazol|mesh-list
24956315|NCT03855332|Sildenafil Citrate|sildenafil citrate|mesh-list
25851128|NCT00053118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24956322|NCT03855332|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24956323|NCT03855332|Autonomic Agents|autonomic agents|mesh-ancestor
24956324|NCT03855332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24956346|NCT03855371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956347|NCT03855371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919159|NCT04213898|Epirubicin|epirubicin|mesh-list
24919160|NCT04213898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24708097|NCT01499953|Antithrombins|antithrombins|mesh-ancestor
25851129|NCT00053118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25851130|NCT00053118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25662641|NCT01648101|Ezogabine|ezogabine|mesh-list
25662642|NCT01648101|Anticonvulsants|anticonvulsants|mesh-ancestor
25662643|NCT01648101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25851131|NCT00053118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851132|NCT00053131|Cytarabine|cytarabine|mesh-list
25851133|NCT00053131|Mitoxantrone|mitoxantrone|mesh-list
25851134|NCT00053131|Sargramostim|sargramostim|mesh-list
25851135|NCT00053131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25851136|NCT00053131|Antimetabolites|antimetabolites|mesh-ancestor
25851137|NCT00053131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851138|NCT00053131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24462996|NCT00358293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956427|NCT03854383|Oxytocics|oxytocics|mesh-ancestor
24956428|NCT03854383|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24919189|NCT04213833|Analgesics|analgesics|mesh-ancestor
24919190|NCT04213833|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24919219|NCT04213378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24452175|NCT00326300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452176|NCT00326300|Dopamine Agents|dopamine agents|mesh-ancestor
24452177|NCT00326300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24452178|NCT00326352|Remifentanil|remifentanil|mesh-list
24452179|NCT00326352|Propofol|propofol|mesh-list
24452180|NCT00326352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24452181|NCT00326352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24956458|NCT03854409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24956459|NCT03854344|Lidocaine|lidocaine|mesh-list
24956460|NCT03854344|Bupivacaine|bupivacaine|mesh-list
24464754|NCT00366652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956470|NCT03854344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24956471|NCT03854344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956509|NCT03853993|Immunologic Factors|immunologic factors|mesh-ancestor
24956510|NCT03853993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956511|NCT03853785|Podophyllin|podophyllin|mesh-list
24956512|NCT03853785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24956513|NCT03853785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24956514|NCT03853785|Keratolytic Agents|keratolytic agents|mesh-ancestor
24956565|NCT03853304|Micronutrients|micronutrients|mesh-ancestor
24956566|NCT03853304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956567|NCT03853304|Hematinics|hematinics|mesh-ancestor
24956568|NCT03853304|Vitamin B Complex|vitamin b complex|mesh-ancestor
24956569|NCT03853512|Petrolatum|petrolatum|mesh-list
24956570|NCT03853512|Emollients|emollients|mesh-ancestor
24956571|NCT03853512|Dermatologic Agents|dermatologic agents|mesh-ancestor
24956572|NCT03853369|Nifekalant|nifekalant|mesh-list
24956573|NCT03853369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24494227|NCT00494468|Zolpidem|zolpidem|mesh-list
24885862|NCT04317404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464794|NCT00366834|Serotonin Agents|serotonin agents|mesh-ancestor
24956574|NCT03853200|Chlorhexidine|chlorhexidine|mesh-list
24956575|NCT03853200|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24956576|NCT03853200|Acetic Acid|acetic acid|mesh-list
24956577|NCT03853200|Root Canal Irrigants|root canal irrigants|mesh-list
24956603|NCT03852979|Antimitotic Agents|antimitotic agents|mesh-ancestor
24956604|NCT03852979|Mitosis Modulators|mitosis modulators|mesh-ancestor
24956734|NCT03851835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956735|NCT03851835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24956736|NCT03851835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24956737|NCT03851835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24956738|NCT03851835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24956739|NCT03851835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24956740|NCT03851731|Naltrexone|naltrexone|mesh-list
24956741|NCT03851731|Naloxone|naloxone|mesh-list
24956842|NCT03850587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24956843|NCT03850587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24956844|NCT03850587|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24956845|NCT03850587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25851140|NCT00053131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24956891|NCT03849664|Niacin|niacin|mesh-list
24956892|NCT03849664|Nicotinic Acids|nicotinic acids|mesh-list
25420379|NCT02628626|Adrenergic Agents|adrenergic agents|mesh-ancestor
25851141|NCT00053131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25851142|NCT00053131|Immunologic Factors|immunologic factors|mesh-ancestor
25851143|NCT00053131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851144|NCT00053131|Analgesics|analgesics|mesh-ancestor
25851145|NCT00053131|Sensory System Agents|sensory system agents|mesh-ancestor
25851146|NCT00053131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25851147|NCT00053131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25851148|NCT00053131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25851149|NCT00053131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851150|NCT00053144|Cytarabine|cytarabine|mesh-list
25851151|NCT00053144|Irinotecan|irinotecan|mesh-list
25851152|NCT00053144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25851153|NCT00053144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24956935|NCT03849196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24956936|NCT03849196|Laxatives|laxatives|mesh-ancestor
24956937|NCT03849027|Methoxyflurane|methoxyflurane|mesh-list
24956938|NCT03849027|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24956970|NCT03848182|Gemcitabine|gemcitabine|mesh-list
24956971|NCT03848182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24956973|NCT03848182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956974|NCT03848182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24956975|NCT03848182|Antiviral Agents|antiviral agents|mesh-ancestor
24956976|NCT03848182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24956977|NCT03848182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24956978|NCT03848182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24956979|NCT03848182|Immunologic Factors|immunologic factors|mesh-ancestor
24956980|NCT03848182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956982|NCT03848780|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24956983|NCT03848780|Anesthetics, General|anesthetics, general|mesh-ancestor
24956984|NCT03848780|Anesthetics|anesthetics|mesh-ancestor
25851156|NCT00053144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851157|NCT00053144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25851158|NCT00053144|Antimetabolites|antimetabolites|mesh-ancestor
24957036|NCT03847571|Acetazolamide|acetazolamide|mesh-list
24957037|NCT03847571|Anticonvulsants|anticonvulsants|mesh-ancestor
24957038|NCT03847571|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25851159|NCT00053144|Antiviral Agents|antiviral agents|mesh-ancestor
25851160|NCT00053144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24957043|NCT03847571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957045|NCT03847922|Nitrous Oxide|nitrous oxide|mesh-list
24957046|NCT03847922|Anesthetics, Local|anesthetics, local|mesh-ancestor
24957047|NCT03847922|Anesthetics|anesthetics|mesh-ancestor
24957048|NCT03847922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24957049|NCT03847922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957050|NCT03847922|Sensory System Agents|sensory system agents|mesh-ancestor
24957051|NCT03847922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24957052|NCT03847922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24957053|NCT03847922|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24957054|NCT03847922|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24957055|NCT03847922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24862657|NCT04850222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24521149|NCT05074355|Azacitidine|azacitidine|mesh-list
25851161|NCT00053144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25851162|NCT00053144|Immunologic Factors|immunologic factors|mesh-ancestor
25851163|NCT00053144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851164|NCT00053157|Sargramostim|sargramostim|mesh-list
24827499|NCT02139761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24957092|NCT03847623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957093|NCT03847558|Hormones|hormones|mesh-list
24957094|NCT03847558|Testosterone|testosterone|mesh-list
24957095|NCT03847558|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24463058|NCT00358488|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24463059|NCT00358488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25662644|NCT01648101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662645|NCT01648140|Interferons|interferons|mesh-list
24463062|NCT00358488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463063|NCT00358488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25662646|NCT01648140|Ribavirin|ribavirin|mesh-list
25662647|NCT01648140|Interferon-alpha|interferon-alpha|mesh-list
25662648|NCT01648140|Interferon alpha-2|interferon alpha-2|mesh-list
25662649|NCT01648140|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25851165|NCT00053157|Immunologic Factors|immunologic factors|mesh-ancestor
24463102|NCT00358696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24463103|NCT00358696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24463105|NCT00358696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463106|NCT00358696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24463107|NCT00358696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24412086|NCT00190814|Analgesics|analgesics|mesh-ancestor
24919297|NCT04212793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25851166|NCT00053157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851167|NCT00053196|Mycophenolic Acid|mycophenolic acid|mesh-list
25202145|NCT02723279|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25202146|NCT02723279|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24919325|NCT04212702|Everolimus|everolimus|mesh-list
25851168|NCT00053196|Methotrexate|methotrexate|mesh-list
25851169|NCT00053196|Fludarabine phosphate|fludarabine phosphate|mesh-list
25851170|NCT00053196|Fludarabine|fludarabine|mesh-list
25851171|NCT00053196|Busulfan|busulfan|mesh-list
24452278|NCT00326833|Vitamins|vitamins|mesh-ancestor
24452279|NCT00326833|Micronutrients|micronutrients|mesh-ancestor
24452280|NCT00326833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452281|NCT00326833|Vitamin B Complex|vitamin b complex|mesh-ancestor
24452282|NCT00326833|Hematinics|hematinics|mesh-ancestor
24452283|NCT00326859|Remifentanil|remifentanil|mesh-list
25662650|NCT01648140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662651|NCT01648140|Antiviral Agents|antiviral agents|mesh-ancestor
24452284|NCT00326859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25662652|NCT01648140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25662653|NCT01648140|Antimetabolites|antimetabolites|mesh-ancestor
25662654|NCT01648140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851172|NCT00053196|Allopurinol|allopurinol|mesh-list
25851173|NCT00053196|Tacrolimus|tacrolimus|mesh-list
25851174|NCT00053196|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25851175|NCT00053196|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25851176|NCT00053196|Abortifacient Agents|abortifacient agents|mesh-ancestor
25851177|NCT00053196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25851178|NCT00053196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851179|NCT00053196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25851180|NCT00053196|Antimetabolites|antimetabolites|mesh-ancestor
25851181|NCT00053196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851182|NCT00053196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851183|NCT00053196|Dermatologic Agents|dermatologic agents|mesh-ancestor
24463136|NCT00359112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25202147|NCT02723279|Cholinergic Agents|cholinergic agents|mesh-ancestor
25202148|NCT02723279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25851195|NCT00053196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25851196|NCT00053196|Alkylating Agents|alkylating agents|mesh-ancestor
25851197|NCT00053196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25078336|NCT03357640|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25078337|NCT03357640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24886263|NCT02090998|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25662655|NCT01648140|Immunologic Factors|immunologic factors|mesh-ancestor
25662656|NCT01648140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662657|NCT01648283|Methadone|methadone|mesh-list
25662658|NCT01648283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25662659|NCT01648283|Narcotics|narcotics|mesh-ancestor
25662660|NCT01648283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25662661|NCT01648283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662662|NCT01648283|Analgesics|analgesics|mesh-ancestor
25202151|NCT02723279|Urological Agents|urological agents|mesh-ancestor
25202152|NCT02723266|Tin Fluorides|tin fluorides|mesh-list
25202153|NCT02723266|Cariostatic Agents|cariostatic agents|mesh-ancestor
25202154|NCT02723266|Protective Agents|protective agents|mesh-ancestor
25202155|NCT02723266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202156|NCT02723253|Raltitrexed|raltitrexed|mesh-list
25078359|NCT03357055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25078360|NCT03357055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25078361|NCT03357055|Anesthetics, General|anesthetics, general|mesh-ancestor
25078362|NCT03357055|Anesthetics|anesthetics|mesh-ancestor
25078363|NCT03357055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25078364|NCT03357055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25078365|NCT03357055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24886273|NCT02090998|Adrenergic Agents|adrenergic agents|mesh-ancestor
25851199|NCT00053196|Gout Suppressants|gout suppressants|mesh-ancestor
25078367|NCT03357055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078368|NCT03356964|Hormones|hormones|mesh-list
25078369|NCT03356964|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25078370|NCT03356964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25078371|NCT03356964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078372|NCT03356912|Prednisone|prednisone|mesh-list
25078373|NCT03356912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25078374|NCT03356912|Glucocorticoids|glucocorticoids|mesh-ancestor
25078375|NCT03356912|Hormones|hormones|mesh-ancestor
25078376|NCT03356912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25078377|NCT03356912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078378|NCT03356912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25078379|NCT03356912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25078380|NCT03356899|Bupivacaine|bupivacaine|mesh-list
24463177|NCT00359164|Dermatologic Agents|dermatologic agents|mesh-ancestor
25851200|NCT00053196|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24919452|NCT04212065|Sensory System Agents|sensory system agents|mesh-ancestor
24919453|NCT04212065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24919454|NCT04212065|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24919455|NCT04212000|Ketoconazole|ketoconazole|mesh-list
24919456|NCT04212000|Antifungal Agents|antifungal agents|mesh-ancestor
24919457|NCT04212000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25851201|NCT00053196|Antioxidants|antioxidants|mesh-ancestor
25851202|NCT00053196|Protective Agents|protective agents|mesh-ancestor
25851203|NCT00053209|Gemcitabine|gemcitabine|mesh-list
25851204|NCT00053209|Pemetrexed|pemetrexed|mesh-list
25851205|NCT00053209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25851206|NCT00053209|Antimetabolites|antimetabolites|mesh-ancestor
25851207|NCT00053209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851208|NCT00053209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463181|NCT00359177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24463182|NCT00359177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463183|NCT00359177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24463184|NCT00359177|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24463185|NCT00359177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24463186|NCT00359177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463187|NCT00359190|Lapatinib|lapatinib|mesh-list
24957118|NCT03847155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957120|NCT03847272|Ustekinumab|ustekinumab|mesh-list
24957121|NCT03847272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25851209|NCT00053209|Antiviral Agents|antiviral agents|mesh-ancestor
25851210|NCT00053209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25851211|NCT00053209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851212|NCT00053209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24957136|NCT03847441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24957137|NCT03847441|Dermatologic Agents|dermatologic agents|mesh-ancestor
24957138|NCT03847376|Rilpivirine|rilpivirine|mesh-list
24957139|NCT03847376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24957140|NCT03847376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24957141|NCT03847376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24957142|NCT03847376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957143|NCT03847376|Antiviral Agents|antiviral agents|mesh-ancestor
24957144|NCT03847376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25851213|NCT00053209|Immunologic Factors|immunologic factors|mesh-ancestor
24463194|NCT00359229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24463195|NCT00359229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24463196|NCT00359229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463197|NCT00359229|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24463198|NCT00359229|GABA Agonists|gaba agonists|mesh-ancestor
24463199|NCT00359229|GABA Agents|gaba agents|mesh-ancestor
24463200|NCT00359229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24463201|NCT00359229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851214|NCT00053209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957147|NCT03846739|Oxytocin|oxytocin|mesh-list
24957148|NCT03846739|Oxytocics|oxytocics|mesh-ancestor
24957149|NCT03846739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24957150|NCT03846739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957151|NCT03846973|Tranexamic Acid|tranexamic acid|mesh-list
24957152|NCT03846973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24957153|NCT03846973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24957154|NCT03846973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957155|NCT03846973|Hemostatics|hemostatics|mesh-ancestor
24957156|NCT03846973|Coagulants|coagulants|mesh-ancestor
24957157|NCT03846843|Phenylacetic acid|phenylacetic acid|mesh-list
25851215|NCT00053209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25851216|NCT00053209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24957178|NCT03846765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24957180|NCT03846765|Adrenergic Agents|adrenergic agents|mesh-ancestor
24957184|NCT03846765|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24957247|NCT03846102|Analgesics|analgesics|mesh-ancestor
24957248|NCT03846102|Sensory System Agents|sensory system agents|mesh-ancestor
24957249|NCT03846102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24626678|NCT01088256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626679|NCT01088256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957368|NCT03844984|Anesthetics, General|anesthetics, general|mesh-ancestor
24957369|NCT03844984|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24813656|NCT02059772|Ranibizumab|ranibizumab|mesh-list
24957370|NCT03844984|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24957371|NCT03844984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24957372|NCT03844984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24957373|NCT03844984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24957374|NCT03844984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24957375|NCT03844984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24957376|NCT03844984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24957377|NCT03844984|GABA Modulators|gaba modulators|mesh-ancestor
24957378|NCT03844984|GABA Agents|gaba agents|mesh-ancestor
24957379|NCT03844932|Cyclosporine|cyclosporine|mesh-list
24957380|NCT03844932|Cyclosporins|cyclosporins|mesh-list
24957381|NCT03844932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851221|NCT00053248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851222|NCT00053248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25851223|NCT00053248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851224|NCT00053248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851225|NCT00053287|Thalidomide|thalidomide|mesh-list
25851226|NCT00053287|Carboplatin|carboplatin|mesh-list
25851227|NCT00053287|Fludarabine|fludarabine|mesh-list
25202159|NCT02723253|Antimetabolites|antimetabolites|mesh-ancestor
25851228|NCT00053287|Fludarabine phosphate|fludarabine phosphate|mesh-list
24919566|NCT04210765|Fertility Agents|fertility agents|mesh-ancestor
25851229|NCT00053287|Topotecan|topotecan|mesh-list
25851230|NCT00053287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851231|NCT00053287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24957437|NCT03844451|Respiratory System Agents|respiratory system agents|mesh-ancestor
24957438|NCT03844451|Mydriatics|mydriatics|mesh-ancestor
24957439|NCT03844451|Sympathomimetics|sympathomimetics|mesh-ancestor
24957440|NCT03844451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24957441|NCT03844776|Acetaminophen|acetaminophen|mesh-list
24957442|NCT03844776|Amoxicillin|amoxicillin|mesh-list
24957443|NCT03844776|Metronidazole|metronidazole|mesh-list
24957444|NCT03844776|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24957445|NCT03844776|Chlorhexidine|chlorhexidine|mesh-list
24957446|NCT03844776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24957447|NCT03844776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24886617|NCT04524897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24886619|NCT04524897|Hormones|hormones|mesh-ancestor
25662663|NCT01648283|Sensory System Agents|sensory system agents|mesh-ancestor
25662664|NCT01648283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25662665|NCT01648283|Antitussive Agents|antitussive agents|mesh-ancestor
25662666|NCT01648283|Respiratory System Agents|respiratory system agents|mesh-ancestor
25662667|NCT01648348|Bevacizumab|bevacizumab|mesh-list
25662668|NCT01648348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24463227|NCT00359567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463228|NCT00359567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24463229|NCT00359567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24463230|NCT00359567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24463232|NCT00359567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24394201|NCT00132548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24452340|NCT00327145|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24452341|NCT00327145|Diuretics|diuretics|mesh-ancestor
24661684|NCT01290354|Lapatinib|lapatinib|mesh-list
24957463|NCT03844620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957464|NCT03844620|Antiviral Agents|antiviral agents|mesh-ancestor
24957465|NCT03844620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24957467|NCT03844529|Anesthetics, Local|anesthetics, local|mesh-ancestor
24957481|NCT03844763|Avelumab|avelumab|mesh-list
24957482|NCT03844763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24957483|NCT03844763|Immunologic Factors|immunologic factors|mesh-ancestor
24957484|NCT03844763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957485|NCT03844763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24957486|NCT03844763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24618128|NCT01046864|Vitamins|vitamins|mesh-ancestor
25202160|NCT02723253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202161|NCT02723253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25202162|NCT02723253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24957487|NCT03844763|Alkylating Agents|alkylating agents|mesh-ancestor
24957488|NCT03844763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957489|NCT03844763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25078394|NCT03356873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25078396|NCT03356834|Antiviral Agents|antiviral agents|mesh-ancestor
25078397|NCT03356834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25078398|NCT03356834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25078399|NCT03356834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25078400|NCT03356834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078401|NCT03356834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078402|NCT03356834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25078403|NCT03356834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24463245|NCT00359658|Antifungal Agents|antifungal agents|mesh-ancestor
24463253|NCT00359658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24463254|NCT00359658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24463255|NCT00359658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463256|NCT00359671|Docetaxel|docetaxel|mesh-list
24463257|NCT00359671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463258|NCT00359671|Tubulin Modulators|tubulin modulators|mesh-ancestor
24394205|NCT00132548|Renal Agents|renal agents|mesh-ancestor
24463259|NCT00359671|Antimitotic Agents|antimitotic agents|mesh-ancestor
24463260|NCT00359671|Mitosis Modulators|mitosis modulators|mesh-ancestor
24463261|NCT00359671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957555|NCT03843879|Anesthetics, Local|anesthetics, local|mesh-ancestor
24957556|NCT03843879|Anesthetics|anesthetics|mesh-ancestor
25851233|NCT00053287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851234|NCT00053287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25851235|NCT00053287|Immunologic Factors|immunologic factors|mesh-ancestor
25851236|NCT00053287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851237|NCT00053287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25851238|NCT00053287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25851239|NCT00053287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851240|NCT00053287|Leprostatic Agents|leprostatic agents|mesh-ancestor
25851241|NCT00053287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24957689|NCT03842631|Adrenergic Agents|adrenergic agents|mesh-ancestor
24957690|NCT03842631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25202163|NCT02723383|Baclofen|baclofen|mesh-list
25202164|NCT02723383|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24957696|NCT03842488|Raltegravir Potassium|raltegravir potassium|mesh-list
24957697|NCT03842488|Darunavir|darunavir|mesh-list
24957698|NCT03842488|Cobicistat|cobicistat|mesh-list
24957699|NCT03842488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24957700|NCT03842488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24957701|NCT03842488|Antiviral Agents|antiviral agents|mesh-ancestor
24957702|NCT03842488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24957703|NCT03842488|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24957704|NCT03842488|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24957705|NCT03842488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24957706|NCT03842488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957707|NCT03842488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24957708|NCT03842488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24957709|NCT03842488|Protease Inhibitors|protease inhibitors|mesh-ancestor
24957710|NCT03842488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24957711|NCT03842488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24957712|NCT03842423|Anesthetics|anesthetics|mesh-list
24957753|NCT03841773|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24957754|NCT03841773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957755|NCT03841773|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24957756|NCT03841773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24957757|NCT03841773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24957758|NCT03841773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24957760|NCT03841890|Antifungal Agents|antifungal agents|mesh-ancestor
24957761|NCT03841890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24957762|NCT03841721|Linezolid|linezolid|mesh-list
24957779|NCT03841526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24957780|NCT03841526|Hormones|hormones|mesh-ancestor
24957819|NCT03841474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24475310|NCT00409890|Bromides|bromides|mesh-list
24957876|NCT03839771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24957877|NCT03839771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851242|NCT00053287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24957878|NCT03839771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957879|NCT03839771|Glycine Agents|glycine agents|mesh-ancestor
24452374|NCT00327327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24452375|NCT00327327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851243|NCT00053287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24463287|NCT00359814|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24463288|NCT00359840|Darbepoetin alfa|darbepoetin alfa|mesh-list
24463289|NCT00359840|Hematinics|hematinics|mesh-ancestor
24463290|NCT00359853|Norfloxacin|norfloxacin|mesh-list
24463308|NCT00359892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24957897|NCT03839550|Apatinib|apatinib|mesh-list
24957898|NCT03839550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24957899|NCT03839550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24957900|NCT03839550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25662669|NCT01648348|Endothelial Growth Factors|endothelial growth factors|mesh-list
25662670|NCT01648348|Antibodies|antibodies|mesh-list
25662671|NCT01648348|Immunoglobulins|immunoglobulins|mesh-list
24957901|NCT03839550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662672|NCT01648348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25851244|NCT00053287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25851245|NCT00053287|Growth Substances|growth substances|mesh-ancestor
25851246|NCT00053287|Growth Inhibitors|growth inhibitors|mesh-ancestor
25851247|NCT00053300|Thalidomide|thalidomide|mesh-list
25851248|NCT00053300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25851249|NCT00053300|Immunologic Factors|immunologic factors|mesh-ancestor
25851250|NCT00053300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851251|NCT00053300|Leprostatic Agents|leprostatic agents|mesh-ancestor
24493938|NCT00493116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24493939|NCT00493116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24493940|NCT00493116|Protective Agents|protective agents|mesh-ancestor
24749777|NCT00304070|Doxorubicin|doxorubicin|mesh-list
24957902|NCT03839537|Nitric Oxide|nitric oxide|mesh-list
24957918|NCT03839537|Antimetabolites|antimetabolites|mesh-ancestor
24957919|NCT03839498|Axitinib|axitinib|mesh-list
24957920|NCT03839498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24957921|NCT03839498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24957922|NCT03839498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24957923|NCT03839498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957924|NCT03839485|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24957925|NCT03839485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24957926|NCT03839485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24957927|NCT03839485|Antitubercular Agents|antitubercular agents|mesh-ancestor
24957929|NCT03839251|Antidepressive Agents|antidepressive agents|mesh-ancestor
24957930|NCT03839251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24957931|NCT03839251|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24957932|NCT03839251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24957933|NCT03839251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24957934|NCT03839251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957935|NCT03839251|Dopamine Agonists|dopamine agonists|mesh-ancestor
24957936|NCT03839251|Dopamine Agents|dopamine agents|mesh-ancestor
24957937|NCT03839251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24964616|NCT03781596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078414|NCT03356769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25078415|NCT03356769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25078416|NCT03356769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078417|NCT03356769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25078418|NCT03356769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24626700|NCT01088373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626701|NCT01088451|Insulin|insulin|mesh-list
24626702|NCT01088451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24626703|NCT01088451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626704|NCT01088477|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24626705|NCT01088477|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24626706|NCT01088477|Estradiol|estradiol|mesh-list
24626719|NCT01088516|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24626720|NCT01088516|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24957976|NCT03839134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25202165|NCT02723383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202166|NCT02723383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25851252|NCT00053300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25851253|NCT00053300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25067057|NCT03447691|Narcotics|narcotics|mesh-ancestor
24958007|NCT03838497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958009|NCT03838328|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24958010|NCT03838328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24958011|NCT03838328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958012|NCT03838328|Hemostatics|hemostatics|mesh-ancestor
24958013|NCT03838328|Coagulants|coagulants|mesh-ancestor
24958014|NCT03838575|Chlorhexidine|chlorhexidine|mesh-list
24958015|NCT03838575|Gentamicins|gentamicins|mesh-list
24958016|NCT03838575|Anti-Infective Agents|anti-infective agents|mesh-list
24958017|NCT03838575|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24958018|NCT03838575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24958019|NCT03838575|Disinfectants|disinfectants|mesh-ancestor
24958020|NCT03838575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24958023|NCT03838068|Anesthetics|anesthetics|mesh-list
24958030|NCT03837886|Calcium Carbonate|calcium carbonate|mesh-list
24958032|NCT03837886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25662673|NCT01648348|Immunoglobulin G|immunoglobulin g|mesh-list
25662674|NCT01648348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662675|NCT01648348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25662676|NCT01648348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25662677|NCT01648348|Growth Substances|growth substances|mesh-ancestor
25851254|NCT00053300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25851255|NCT00053300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25851256|NCT00053300|Growth Substances|growth substances|mesh-ancestor
25851257|NCT00053300|Growth Inhibitors|growth inhibitors|mesh-ancestor
25851258|NCT00053300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851259|NCT00053326|Fenretinide|fenretinide|mesh-list
25851260|NCT00053326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851261|NCT00053326|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24496555|NCT00505492|Cisplatin|cisplatin|mesh-list
24496556|NCT00505492|Carboplatin|carboplatin|mesh-list
24496558|NCT00505492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24958033|NCT03837886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958034|NCT03837886|Antacids|antacids|mesh-ancestor
24958035|NCT03837886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958071|NCT03837938|Respiratory System Agents|respiratory system agents|mesh-ancestor
24958072|NCT03837808|Nimotuzumab|nimotuzumab|mesh-list
24958073|NCT03837808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24958074|NCT03837808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24958075|NCT03837470|Furosemide|furosemide|mesh-list
24958076|NCT03837470|Diuretics|diuretics|mesh-ancestor
24958077|NCT03837470|Natriuretic Agents|natriuretic agents|mesh-ancestor
24958078|NCT03837470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958079|NCT03837470|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24958080|NCT03837470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24958081|NCT03837470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958082|NCT03836807|Ketoprofen|ketoprofen|mesh-list
24958083|NCT03836807|Ketoprofen lysine|ketoprofen lysine|mesh-list
24958126|NCT03836781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24958127|NCT03836781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24521424|NCT04769050|Docetaxel|docetaxel|mesh-list
24958128|NCT03836781|Analgesics|analgesics|mesh-ancestor
24958470|NCT03832894|Estrogens|estrogens|mesh-ancestor
24958129|NCT03836781|Sensory System Agents|sensory system agents|mesh-ancestor
24958130|NCT03836781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25851264|NCT00053339|Tamoxifen|tamoxifen|mesh-list
24958141|NCT03836638|Cholinergic Agents|cholinergic agents|mesh-ancestor
24958142|NCT03836638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24958143|NCT03836638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958144|NCT03836599|Allopurinol|allopurinol|mesh-list
24958145|NCT03836599|Verinurad|verinurad|mesh-list
24958146|NCT03836599|Antimetabolites|antimetabolites|mesh-ancestor
24958147|NCT03836599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958148|NCT03836599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24958149|NCT03836599|Gout Suppressants|gout suppressants|mesh-ancestor
24958150|NCT03836599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24958151|NCT03836599|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24958152|NCT03836599|Antioxidants|antioxidants|mesh-ancestor
24958153|NCT03836599|Protective Agents|protective agents|mesh-ancestor
24958154|NCT03836599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958155|NCT03836560|Nicotine|nicotine|mesh-list
24958156|NCT03836560|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25202167|NCT02723383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202168|NCT02723383|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25851265|NCT00053339|Trastuzumab|trastuzumab|mesh-list
25851266|NCT00053339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24958157|NCT03836560|Autonomic Agents|autonomic agents|mesh-ancestor
24958158|NCT03836560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24919804|NCT04208334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958159|NCT03836560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958160|NCT03836560|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24958161|NCT03836560|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24958162|NCT03836560|Cholinergic Agents|cholinergic agents|mesh-ancestor
24958163|NCT03836560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24958165|NCT03836222|Pentoxifylline|pentoxifylline|mesh-list
24958173|NCT03836222|Vasodilator Agents|vasodilator agents|mesh-ancestor
24958174|NCT03836222|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24958175|NCT03836222|Antioxidants|antioxidants|mesh-ancestor
24958176|NCT03836157|Bevacizumab|bevacizumab|mesh-list
24958178|NCT03836157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24958179|NCT03836157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24958180|NCT03836157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25662678|NCT01648348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662679|NCT01648348|Growth Inhibitors|growth inhibitors|mesh-ancestor
25662680|NCT01648348|Immunologic Factors|immunologic factors|mesh-ancestor
25662681|NCT01648582|Metformin|metformin|mesh-list
25662682|NCT01648582|Insulin Glargine|insulin glargine|mesh-list
25662683|NCT01648582|Dulaglutide|dulaglutide|mesh-list
25154735|NCT05469659|Metformin|metformin|mesh-list
25154736|NCT05469659|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
25154737|NCT05469659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24958181|NCT03836157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24958279|NCT03835065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958281|NCT03834610|Testosterone|testosterone|mesh-list
24958319|NCT03834233|Nivolumab|nivolumab|mesh-list
24784337|NCT01907529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24784338|NCT01907529|Alkylating Agents|alkylating agents|mesh-ancestor
25078466|NCT03356080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24958346|NCT03834012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24958347|NCT03834012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958348|NCT03834012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24958349|NCT03834012|Respiratory System Agents|respiratory system agents|mesh-ancestor
24958350|NCT03834129|Dexmedetomidine|dexmedetomidine|mesh-list
24958351|NCT03834129|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24958352|NCT03834129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25067095|NCT03447093|Antithyroid Agents|antithyroid agents|mesh-ancestor
25067096|NCT03447093|Hormone Antagonists|hormone antagonists|mesh-ancestor
24919805|NCT04208516|Dexamethasone|dexamethasone|mesh-list
24919806|NCT04208516|Lidocaine|lidocaine|mesh-list
24958353|NCT03834129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958354|NCT03834129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24958356|NCT03834129|Sensory System Agents|sensory system agents|mesh-ancestor
24958357|NCT03834129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24958408|NCT03833596|Hormones|hormones|mesh-ancestor
24958568|NCT03831984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24958462|NCT03833063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958463|NCT03833063|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24958464|NCT03833063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24958465|NCT03832894|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24958466|NCT03832894|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24958468|NCT03832894|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24958469|NCT03832894|Progesterone|progesterone|mesh-list
24958471|NCT03832894|Hormones|hormones|mesh-ancestor
24958472|NCT03832894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24958473|NCT03832894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958474|NCT03832894|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24958475|NCT03832894|Contraceptive Agents|contraceptive agents|mesh-ancestor
24958476|NCT03832894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24958477|NCT03832894|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24958478|NCT03832894|Progestins|progestins|mesh-ancestor
24958479|NCT03832660|Valsartan|valsartan|mesh-list
24958496|NCT03832816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958497|NCT03832816|Hormones|hormones|mesh-ancestor
24958498|NCT03832816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24958499|NCT03832621|Nivolumab|nivolumab|mesh-list
24958500|NCT03832621|Ipilimumab|ipilimumab|mesh-list
24958501|NCT03832621|Temozolomide|temozolomide|mesh-list
24958502|NCT03832621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24958503|NCT03832621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24958504|NCT03832621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25202169|NCT02723383|GABA Agonists|gaba agonists|mesh-ancestor
25202170|NCT02723383|GABA Agents|gaba agents|mesh-ancestor
25202171|NCT02723383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25202172|NCT02723383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958505|NCT03832621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475800|NCT00411372|Hormones|hormones|mesh-ancestor
24958518|NCT03832465|Ofloxacin|ofloxacin|mesh-list
24958519|NCT03832465|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25078472|NCT03355963|Botulinum Toxins|botulinum toxins|mesh-list
24958520|NCT03832465|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24958522|NCT03832465|Renal Agents|renal agents|mesh-ancestor
24958523|NCT03832465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24958524|NCT03832465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24958526|NCT03832465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24958527|NCT03832465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958538|NCT03832452|Moxifloxacin|moxifloxacin|mesh-list
24958539|NCT03832452|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
25662684|NCT01648582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25662685|NCT01648582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662686|NCT01648699|Hydromorphone|hydromorphone|mesh-list
25662687|NCT01648699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25662688|NCT01648699|Narcotics|narcotics|mesh-ancestor
24958542|NCT03832452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24958543|NCT03832452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24958544|NCT03832452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24958545|NCT03832452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958546|NCT03832452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24958547|NCT03832452|Antiviral Agents|antiviral agents|mesh-ancestor
24958548|NCT03832426|Ritonavir|ritonavir|mesh-list
24958549|NCT03832426|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24958550|NCT03832426|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24958551|NCT03832426|Protease Inhibitors|protease inhibitors|mesh-ancestor
24958552|NCT03832426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24958553|NCT03832426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958554|NCT03832426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24958555|NCT03832426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24958556|NCT03832426|Antiviral Agents|antiviral agents|mesh-ancestor
24958557|NCT03832426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24958558|NCT03832426|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24958559|NCT03832426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24958560|NCT03831984|Bromfenac|bromfenac|mesh-list
24958561|NCT03831984|Hyaluronic Acid|hyaluronic acid|mesh-list
24958562|NCT03831984|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24958563|NCT03831984|Immunologic Factors|immunologic factors|mesh-ancestor
24521483|NCT04745975|Vinorelbine|vinorelbine|mesh-list
24958564|NCT03831984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958565|NCT03831984|Viscosupplements|viscosupplements|mesh-ancestor
24958566|NCT03831984|Protective Agents|protective agents|mesh-ancestor
24958567|NCT03831984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25851267|NCT00053339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851268|NCT00053339|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25851269|NCT00053339|Hormone Antagonists|hormone antagonists|mesh-ancestor
25851270|NCT00053339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25851271|NCT00053339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475833|NCT00411541|Hormones|hormones|mesh-ancestor
24774730|NCT01847521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521484|NCT04745975|Capecitabine|capecitabine|mesh-list
25078495|NCT03355716|Anesthetics, Local|anesthetics, local|mesh-ancestor
24958609|NCT03831126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24958610|NCT03831126|Respiratory System Agents|respiratory system agents|mesh-ancestor
24958616|NCT03830827|Vortioxetine|vortioxetine|mesh-list
24774732|NCT01847599|Lapatinib|lapatinib|mesh-list
24958670|NCT03830398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24958671|NCT03830398|Analgesics|analgesics|mesh-ancestor
24958672|NCT03830398|Sensory System Agents|sensory system agents|mesh-ancestor
24958673|NCT03830398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24958674|NCT03830398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958675|NCT03830398|Antipyretics|antipyretics|mesh-ancestor
24958676|NCT03830164|Vitamins|vitamins|mesh-list
24958677|NCT03830164|Vitamin E|vitamin e|mesh-list
24958678|NCT03830164|Tocopherols|tocopherols|mesh-list
24958679|NCT03830164|Tocotrienols|tocotrienols|mesh-list
24958680|NCT03830164|alpha-Tocopherol|alpha-tocopherol|mesh-list
24958681|NCT03830164|Pentoxifylline|pentoxifylline|mesh-list
24958682|NCT03830164|Atorvastatin|atorvastatin|mesh-list
25662689|NCT01648699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25662690|NCT01648699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662691|NCT01648699|Analgesics|analgesics|mesh-ancestor
25662692|NCT01648699|Sensory System Agents|sensory system agents|mesh-ancestor
24958683|NCT03830164|Micronutrients|micronutrients|mesh-ancestor
24958684|NCT03830164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958685|NCT03830164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24958686|NCT03830164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25662693|NCT01648699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25662694|NCT01648790|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25662695|NCT01648790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24958690|NCT03830164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24958691|NCT03830164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24958692|NCT03830164|Antioxidants|antioxidants|mesh-ancestor
24958693|NCT03830164|Protective Agents|protective agents|mesh-ancestor
24958694|NCT03830164|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24958733|NCT03830086|Analgesics|analgesics|mesh-ancestor
24958734|NCT03830216|Insulin|insulin|mesh-list
24958735|NCT03830216|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24958736|NCT03830216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24958737|NCT03830216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958739|NCT03830034|Ferrous fumarate|ferrous fumarate|mesh-list
24958740|NCT03830034|Iron Chelating Agents|iron chelating agents|mesh-list
24958741|NCT03830034|Trace Elements|trace elements|mesh-ancestor
24958742|NCT03830034|Micronutrients|micronutrients|mesh-ancestor
24958743|NCT03830034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958744|NCT03830034|Chelating Agents|chelating agents|mesh-ancestor
24958745|NCT03830034|Sequestering Agents|sequestering agents|mesh-ancestor
24958766|NCT03829696|Luteolytic Agents|luteolytic agents|mesh-ancestor
24958767|NCT03829696|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24958768|NCT03829696|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24958770|NCT03829839|Oxytocin|oxytocin|mesh-list
24958771|NCT03829839|Oxytocics|oxytocics|mesh-ancestor
24958772|NCT03829839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24958826|NCT03829566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24958843|NCT03829566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24958844|NCT03829566|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24958845|NCT03829566|Protective Agents|protective agents|mesh-ancestor
24958846|NCT03829566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24958847|NCT03829592|Misoprostol|misoprostol|mesh-list
24958848|NCT03829592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24784897|NCT01910870|Alkylating Agents|alkylating agents|mesh-ancestor
24784898|NCT01910870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784899|NCT01910870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466079|NCT00371878|Immunologic Factors|immunologic factors|mesh-ancestor
24463400|NCT00360750|Carboplatin|carboplatin|mesh-list
24784900|NCT01910870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24784901|NCT01910883|Finafloxacin|finafloxacin|mesh-list
24784902|NCT01910883|Fluoroquinolones|fluoroquinolones|mesh-list
24784903|NCT01910883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24919854|NCT04207957|Olorofim|olorofim|mesh-list
24784904|NCT01910883|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24784905|NCT01910883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24784906|NCT01910883|Renal Agents|renal agents|mesh-ancestor
24784907|NCT01910883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24784908|NCT01910883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24784909|NCT01910883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25851272|NCT00053339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25851273|NCT00053339|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25851274|NCT00053339|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25851275|NCT00053339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25851276|NCT00053378|Calcium|calcium|mesh-list
25851277|NCT00053378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24784910|NCT01910883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763864|NCT01777867|Miotics|miotics|mesh-ancestor
25078500|NCT03355716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078501|NCT03355716|Analgesics|analgesics|mesh-ancestor
24784911|NCT01910883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784912|NCT01910883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784913|NCT01910883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24784916|NCT01910987|Bortezomib|bortezomib|mesh-list
24784932|NCT01911195|Isoflurane|isoflurane|mesh-list
24958930|NCT03828929|Thiamine|thiamine|mesh-list
24958931|NCT03828929|Vitamins|vitamins|mesh-ancestor
24958932|NCT03828929|Micronutrients|micronutrients|mesh-ancestor
24958933|NCT03828929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958934|NCT03828929|Antioxidants|antioxidants|mesh-ancestor
24958936|NCT03828929|Protective Agents|protective agents|mesh-ancestor
24958965|NCT03828682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24958966|NCT03828682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25851278|NCT00053378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958969|NCT03828682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24958970|NCT03828682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24958971|NCT03828682|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24958972|NCT03828682|Protective Agents|protective agents|mesh-ancestor
24958973|NCT03828474|Acetazolamide|acetazolamide|mesh-list
24959026|NCT03827876|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24959027|NCT03827876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24959054|NCT03827629|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24521588|NCT04642651|Dexmedetomidine|dexmedetomidine|mesh-list
24959055|NCT03827629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919900|NCT04207450|Disinfectants|disinfectants|mesh-ancestor
24959056|NCT03827629|Sensory System Agents|sensory system agents|mesh-ancestor
24959057|NCT03827629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24959058|NCT03827408|Midazolam|midazolam|mesh-list
24959059|NCT03827408|Dexmedetomidine|dexmedetomidine|mesh-list
24959060|NCT03827408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24959061|NCT03827408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24959062|NCT03827408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959063|NCT03827408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24959064|NCT03827408|Analgesics|analgesics|mesh-ancestor
24959065|NCT03827408|Sensory System Agents|sensory system agents|mesh-ancestor
24959097|NCT03827044|Avelumab|avelumab|mesh-list
24959106|NCT03827278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24959107|NCT03827278|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24610996|NCT01006057|Insulin|insulin|mesh-list
24959108|NCT03827278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24959109|NCT03827278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24959110|NCT03827278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959111|NCT03827278|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24959112|NCT03827278|Hormone Antagonists|hormone antagonists|mesh-ancestor
24774733|NCT01847599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24959165|NCT03826615|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24959166|NCT03826615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24959167|NCT03826615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959170|NCT03826602|Tucatinib|tucatinib|mesh-list
24959171|NCT03826602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24959172|NCT03826602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959173|NCT03826602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851279|NCT00053430|Thalidomide|thalidomide|mesh-list
24959204|NCT03826524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24959205|NCT03826524|Autonomic Agents|autonomic agents|mesh-ancestor
25202173|NCT02723435|Midostaurin|midostaurin|mesh-list
25202174|NCT02723435|Staurosporine|staurosporine|mesh-list
25202175|NCT02723435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25202176|NCT02723435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25202177|NCT02723435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202178|NCT02723435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268761|NCT02414529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25268762|NCT02414490|Immunoglobulins|immunoglobulins|mesh-list
25207724|NCT03462069|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25851280|NCT00053430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24959207|NCT03826524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24959208|NCT03826524|Respiratory System Agents|respiratory system agents|mesh-ancestor
24959213|NCT03826368|Anticonvulsants|anticonvulsants|mesh-ancestor
24959214|NCT03826316|Nalbuphine|nalbuphine|mesh-list
24959215|NCT03826316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24959216|NCT03826316|Narcotics|narcotics|mesh-ancestor
24959217|NCT03826316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24959218|NCT03826316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959219|NCT03826316|Analgesics|analgesics|mesh-ancestor
24959220|NCT03826316|Sensory System Agents|sensory system agents|mesh-ancestor
24959221|NCT03826316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24959222|NCT03825887|Morphine|morphine|mesh-list
24959223|NCT03825887|Nalbuphine|nalbuphine|mesh-list
24959224|NCT03825887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24959225|NCT03825887|Narcotics|narcotics|mesh-ancestor
25078506|NCT03355716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24959226|NCT03825887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24959227|NCT03825887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959228|NCT03825887|Analgesics|analgesics|mesh-ancestor
24959229|NCT03825887|Sensory System Agents|sensory system agents|mesh-ancestor
24959230|NCT03825887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24959231|NCT03826004|Clemastine|clemastine|mesh-list
24959232|NCT03826004|Antipruritics|antipruritics|mesh-ancestor
25851281|NCT00053430|Immunologic Factors|immunologic factors|mesh-ancestor
24499467|NCT00519675|Alitretinoin|alitretinoin|mesh-list
24959267|NCT03825809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24959268|NCT03825809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24959269|NCT03825809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24959270|NCT03825809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24959271|NCT03825809|Antimanic Agents|antimanic agents|mesh-ancestor
24959272|NCT03825809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24959303|NCT03825471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078535|NCT03355612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078537|NCT03355612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25078538|NCT03355612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078539|NCT03355560|Nivolumab|nivolumab|mesh-list
25078540|NCT03355560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25078541|NCT03355560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25078542|NCT03355560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25078545|NCT03355482|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25078546|NCT03355482|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25078548|NCT03355482|Prednisolone acetate|prednisolone acetate|mesh-list
24919986|NCT04205916|Ketorolac|ketorolac|mesh-list
25078551|NCT03355482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25078552|NCT03355482|Antiemetics|antiemetics|mesh-ancestor
25078553|NCT03355482|Autonomic Agents|autonomic agents|mesh-ancestor
25078554|NCT03355482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078555|NCT03355482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059347|NCT03489005|Moxifloxacin|moxifloxacin|mesh-list
25078556|NCT03355482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25078557|NCT03355482|Glucocorticoids|glucocorticoids|mesh-ancestor
25078558|NCT03355482|Hormones|hormones|mesh-ancestor
24785479|NCT01914627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626822|NCT01088763|Glucocorticoids|glucocorticoids|mesh-ancestor
24626823|NCT01088763|Hormones|hormones|mesh-ancestor
24647721|NCT01210339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24647843|NCT01211080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24647992|NCT01211795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24807001|NCT02019290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24959397|NCT03825328|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24959398|NCT03825328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24959399|NCT03825328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24959401|NCT03825328|Antimitotic Agents|antimitotic agents|mesh-ancestor
24959402|NCT03825328|Mitosis Modulators|mitosis modulators|mesh-ancestor
24959403|NCT03825328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959404|NCT03825328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24959405|NCT03825328|Antimetabolites|antimetabolites|mesh-ancestor
24959406|NCT03825328|Antiviral Agents|antiviral agents|mesh-ancestor
24959407|NCT03825328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24959408|NCT03825328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24959409|NCT03825328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24959410|NCT03825328|Immunologic Factors|immunologic factors|mesh-ancestor
25202179|NCT02722954|Pembrolizumab|pembrolizumab|mesh-list
25202180|NCT02722954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24829775|NCT02154360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959441|NCT03825081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24959442|NCT03825081|Adrenergic Agents|adrenergic agents|mesh-ancestor
24959465|NCT03824665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24959466|NCT03824665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24959467|NCT03824665|Anesthetics, General|anesthetics, general|mesh-ancestor
24959468|NCT03824665|Anesthetics|anesthetics|mesh-ancestor
24959470|NCT03825016|Lidocaine|lidocaine|mesh-list
24959471|NCT03825016|Anesthetics, Local|anesthetics, local|mesh-ancestor
24959472|NCT03825016|Anesthetics|anesthetics|mesh-ancestor
24959473|NCT03825016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24959474|NCT03825016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959475|NCT03825016|Sensory System Agents|sensory system agents|mesh-ancestor
24959476|NCT03825016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24959477|NCT03825016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24959478|NCT03825016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24959479|NCT03825016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24959480|NCT03825016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24959481|NCT03825016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959482|NCT03825016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24959483|NCT03825016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24959484|NCT03825016|Analgesics|analgesics|mesh-ancestor
24959485|NCT03825016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24959486|NCT03825016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24959487|NCT03825016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25662696|NCT01649180|Axitinib|axitinib|mesh-list
24500344|NCT00523926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24959488|NCT03825016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24959489|NCT03824717|Ropivacaine|ropivacaine|mesh-list
24959490|NCT03824717|Anesthetics, Local|anesthetics, local|mesh-ancestor
24959491|NCT03824717|Anesthetics|anesthetics|mesh-ancestor
24959492|NCT03824717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24959493|NCT03824717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463443|NCT00360984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24463444|NCT00360984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463445|NCT00361010|Levetiracetam|levetiracetam|mesh-list
24959524|NCT03824171|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24959525|NCT03824314|Fentanyl|fentanyl|mesh-list
24959526|NCT03824314|Midazolam|midazolam|mesh-list
24959639|NCT03823339|Incretins|incretins|mesh-ancestor
24959640|NCT03823339|Hormones|hormones|mesh-ancestor
24959641|NCT03823339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24959642|NCT03823417|Tranexamic Acid|tranexamic acid|mesh-list
24959643|NCT03823417|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24959644|NCT03823417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24959645|NCT03823417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959646|NCT03823417|Hemostatics|hemostatics|mesh-ancestor
24959647|NCT03823417|Coagulants|coagulants|mesh-ancestor
24959648|NCT03823079|Irinotecan|irinotecan|mesh-list
24959649|NCT03823079|Raltitrexed|raltitrexed|mesh-list
24959650|NCT03823079|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24959651|NCT03823079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24959652|NCT03823079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24959653|NCT03823079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959654|NCT03823079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24959657|NCT03823079|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24959659|NCT03823274|Clopidogrel|clopidogrel|mesh-list
24959660|NCT03823274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24959661|NCT03823274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24959662|NCT03823274|Analgesics|analgesics|mesh-ancestor
24959663|NCT03823274|Sensory System Agents|sensory system agents|mesh-ancestor
24785700|NCT01916200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24785701|NCT01916200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785702|NCT01916200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24785703|NCT01916200|Serotonin Agents|serotonin agents|mesh-ancestor
24785704|NCT01916200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785705|NCT01916200|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24785706|NCT01916200|Antidepressive Agents|antidepressive agents|mesh-ancestor
24959664|NCT03823274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24959665|NCT03823274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959666|NCT03823274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24959667|NCT03823274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25202181|NCT02722954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24959668|NCT03823274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24959669|NCT03823274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24959670|NCT03823274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959671|NCT03823274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24959672|NCT03823274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24959673|NCT03823274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24959685|NCT03823482|Sensory System Agents|sensory system agents|mesh-ancestor
24959686|NCT03823482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24959687|NCT03823482|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24959688|NCT03823482|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24959689|NCT03823482|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24959690|NCT03823482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24959695|NCT03823248|Folic Acid|folic acid|mesh-list
24959696|NCT03823248|Vitamin B Complex|vitamin b complex|mesh-list
24495171|NCT00498901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495177|NCT00498953|Docetaxel|docetaxel|mesh-list
24959758|NCT03822845|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
24959759|NCT03822845|Chelating Agents|chelating agents|mesh-ancestor
24959760|NCT03822845|Sequestering Agents|sequestering agents|mesh-ancestor
24959761|NCT03822845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959798|NCT03822091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24959799|NCT03822091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24959800|NCT03822091|Adrenergic Agents|adrenergic agents|mesh-ancestor
24959801|NCT03822091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24959802|NCT03822091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959803|NCT03822091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662697|NCT01649180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24959875|NCT03821714|Glucocorticoids|glucocorticoids|mesh-list
24959876|NCT03821714|Micronutrients|micronutrients|mesh-ancestor
24959916|NCT03821493|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24959918|NCT03821168|Epoetin Alfa|epoetin alfa|mesh-list
24463458|NCT00361075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24463459|NCT00361075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463461|NCT00361088|Bortezomib|bortezomib|mesh-list
25851282|NCT00053430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851283|NCT00053430|Leprostatic Agents|leprostatic agents|mesh-ancestor
25851284|NCT00053430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24463462|NCT00361088|Tipifarnib|tipifarnib|mesh-list
24463463|NCT00361088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463464|NCT00361114|Pyrimethamine|pyrimethamine|mesh-list
24960017|NCT03820180|Fluticasone|fluticasone|mesh-list
24960018|NCT03820180|Xhance|xhance|mesh-list
24960019|NCT03820180|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24960020|NCT03820180|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24960021|NCT03820180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24960022|NCT03820180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24960023|NCT03820180|Autonomic Agents|autonomic agents|mesh-ancestor
24960024|NCT03820180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202182|NCT02723071|Ocrelizumab|ocrelizumab|mesh-list
25851285|NCT00053430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25851286|NCT00053430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24960025|NCT03820180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960026|NCT03820180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24960027|NCT03820180|Respiratory System Agents|respiratory system agents|mesh-ancestor
24960028|NCT03820180|Dermatologic Agents|dermatologic agents|mesh-ancestor
24960029|NCT03820180|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24960030|NCT03820180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24960031|NCT03820180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24960032|NCT03820180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24960033|NCT03820180|Adrenergic Agents|adrenergic agents|mesh-ancestor
24960034|NCT03820180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24960035|NCT03820180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960036|NCT03820180|Glucocorticoids|glucocorticoids|mesh-ancestor
24960037|NCT03820180|Hormones|hormones|mesh-ancestor
25067137|NCT03446872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662698|NCT01649180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25662699|NCT01649180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25662700|NCT01649180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662701|NCT01649271|Trastuzumab|trastuzumab|mesh-list
25662702|NCT01649271|Afatinib|afatinib|mesh-list
25662703|NCT01649271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25662704|NCT01649271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662705|NCT01649271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25851287|NCT00053430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25851288|NCT00053430|Growth Substances|growth substances|mesh-ancestor
25851289|NCT00053430|Growth Inhibitors|growth inhibitors|mesh-ancestor
24960081|NCT03819348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960159|NCT03818945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960160|NCT03818945|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24960161|NCT03818945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24960310|NCT03818295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960312|NCT03818113|Cardioplegic Solutions|cardioplegic solutions|mesh-list
24960313|NCT03818113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24960314|NCT03817931|Solifenacin Succinate|solifenacin succinate|mesh-list
24960315|NCT03817931|Mirabegron|mirabegron|mesh-list
24960316|NCT03817931|Cholinergic Antagonists|cholinergic antagonists|mesh-list
24960317|NCT03817931|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
24960318|NCT03817931|Adrenergic Agents|adrenergic agents|mesh-list
24960319|NCT03817931|Adrenergic Agonists|adrenergic agonists|mesh-list
24960320|NCT03817931|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24960321|NCT03817931|Cholinergic Agents|cholinergic agents|mesh-ancestor
24960322|NCT03817931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24960323|NCT03817931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960324|NCT03817931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786332|NCT01919203|Sensory System Agents|sensory system agents|mesh-ancestor
24477388|NCT00418483|Fibrinolysin|fibrinolysin|mesh-list
24521749|NCT04551547|Vaccines|vaccines|mesh-list
24623913|NCT01073904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24623914|NCT01073995|Triamcinolone|triamcinolone|mesh-list
25202183|NCT02723071|Immunologic Factors|immunologic factors|mesh-ancestor
25202184|NCT02723071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202185|NCT02722902|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25202186|NCT02722902|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25851290|NCT00053430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25078603|NCT03355170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078604|NCT03355170|Antiemetics|antiemetics|mesh-ancestor
25078605|NCT03355170|Autonomic Agents|autonomic agents|mesh-ancestor
25078606|NCT03355170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078607|NCT03355170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078608|NCT03355170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25078609|NCT03355170|Dopamine Agents|dopamine agents|mesh-ancestor
25078610|NCT03355170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25078611|NCT03355053|Dexmedetomidine|dexmedetomidine|mesh-list
25078612|NCT03355053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25078613|NCT03355053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24509272|NCT00559494|Minocycline|minocycline|mesh-list
25078614|NCT03355053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960447|NCT03816592|Analgesics, Opioid|analgesics, opioid|mesh-list
24960491|NCT03816267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960492|NCT03816306|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24960493|NCT03816306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24960531|NCT03816072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24623915|NCT01073995|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24960532|NCT03816072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960533|NCT03816072|Protective Agents|protective agents|mesh-ancestor
24960534|NCT03816046|Botulinum Toxins|botulinum toxins|mesh-list
24960535|NCT03816046|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24960536|NCT03816046|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24960537|NCT03816046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24960538|NCT03816046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24960539|NCT03816046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960540|NCT03816046|Cholinergic Agents|cholinergic agents|mesh-ancestor
25662706|NCT01649271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851291|NCT00053560|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25851292|NCT00053560|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25851293|NCT00053560|Immunologic Factors|immunologic factors|mesh-ancestor
25851294|NCT00053560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851295|NCT00053599|Simvastatin|simvastatin|mesh-list
25851296|NCT00053599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25851297|NCT00053599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25851298|NCT00053599|Antimetabolites|antimetabolites|mesh-ancestor
25851299|NCT00053599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851300|NCT00053599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25851301|NCT00053599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25851302|NCT00053599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851303|NCT00053612|Vitamin A|vitamin a|mesh-list
24960623|NCT03815279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24960624|NCT03815279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960628|NCT03815279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24960630|NCT03815279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24960631|NCT03815279|Immunologic Factors|immunologic factors|mesh-ancestor
24960632|NCT03815279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24960633|NCT03815279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24960634|NCT03815279|Growth Substances|growth substances|mesh-ancestor
24960635|NCT03815279|Growth Inhibitors|growth inhibitors|mesh-ancestor
25851310|NCT00053638|Abacavir|abacavir|mesh-list
24961067|NCT03812354|Cholinergic Agents|cholinergic agents|mesh-ancestor
24463658|NCT00361790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24463659|NCT00361790|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24463660|NCT00361790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24463661|NCT00361790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24463662|NCT00361790|Dopamine Agonists|dopamine agonists|mesh-ancestor
24463663|NCT00361790|Dopamine Agents|dopamine agents|mesh-ancestor
24960669|NCT03814733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24960670|NCT03814733|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25420456|NCT02625480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25851311|NCT00053638|Antiviral Agents|antiviral agents|mesh-ancestor
25851312|NCT00053638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25235473|NCT02564146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235474|NCT02564146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25235475|NCT02564146|Immunologic Factors|immunologic factors|mesh-ancestor
25235476|NCT02564146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235478|NCT02564003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25235479|NCT02564003|Narcotics|narcotics|mesh-ancestor
24960671|NCT03814733|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24960672|NCT03814733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24960673|NCT03814733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960674|NCT03814733|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24960675|NCT03814733|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24509294|NCT00559676|Antimetabolites|antimetabolites|mesh-ancestor
24960676|NCT03814733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24960677|NCT03814733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24960678|NCT03814733|GABA Modulators|gaba modulators|mesh-ancestor
24960679|NCT03814733|GABA Agents|gaba agents|mesh-ancestor
24960681|NCT03814759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24960682|NCT03814577|Antioxidants|antioxidants|mesh-list
24521853|NCT04460248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24960683|NCT03814577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960684|NCT03814577|Protective Agents|protective agents|mesh-ancestor
25202188|NCT02722902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25202189|NCT02722811|Etanercept|etanercept|mesh-list
25851313|NCT00053638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24960685|NCT03814577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960687|NCT03814629|Micronutrients|micronutrients|mesh-ancestor
24960688|NCT03814629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960689|NCT03814707|Hyaluronic Acid|hyaluronic acid|mesh-list
25851314|NCT00053638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24960728|NCT03814642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24960729|NCT03814642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24960730|NCT03814642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24960731|NCT03814291|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
24960732|NCT03814291|Immunologic Factors|immunologic factors|mesh-ancestor
24960733|NCT03814291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960734|NCT03814343|Amphotericin B|amphotericin b|mesh-list
24960735|NCT03814343|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24960736|NCT03814343|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
24960737|NCT03814343|Amebicides|amebicides|mesh-ancestor
24960738|NCT03814343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24960739|NCT03814343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24960740|NCT03814343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24960741|NCT03814343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24960742|NCT03814343|Antifungal Agents|antifungal agents|mesh-ancestor
24960743|NCT03814343|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24960744|NCT03814343|Protective Agents|protective agents|mesh-ancestor
24623510|NCT01072045|Glucocorticoids|glucocorticoids|mesh-ancestor
24463664|NCT00361790|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24521854|NCT04460248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24521855|NCT04460248|Immunologic Factors|immunologic factors|mesh-ancestor
24960791|NCT03813979|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24960793|NCT03813979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24960794|NCT03813979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960795|NCT03813979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24960796|NCT03813979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24960797|NCT03813979|Antiviral Agents|antiviral agents|mesh-ancestor
24960798|NCT03813979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24960799|NCT03814148|Indapamide|indapamide|mesh-list
24477953|NCT00421018|Montelukast|montelukast|mesh-list
25662707|NCT01649271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662708|NCT01649297|Empagliflozin|empagliflozin|mesh-list
25662709|NCT01649297|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25662710|NCT01649297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662711|NCT01649297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25662712|NCT01649297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851315|NCT00053638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851316|NCT00053638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851317|NCT00053638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24960944|NCT03813043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25851318|NCT00053638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25851319|NCT00053638|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25851320|NCT00053638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24960946|NCT03813043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24960947|NCT03813043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24960948|NCT03813043|Anesthetics, General|anesthetics, general|mesh-ancestor
24960949|NCT03813043|Anesthetics|anesthetics|mesh-ancestor
24960951|NCT03813043|GABA Agents|gaba agents|mesh-ancestor
24960952|NCT03813043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24960953|NCT03813043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202190|NCT02722811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24960954|NCT03813069|Permethrin|permethrin|mesh-list
24960955|NCT03813069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851321|NCT00053638|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25851322|NCT00053638|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25851323|NCT00053638|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25851324|NCT00053638|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24829777|NCT02154438|Analgesics|analgesics|mesh-ancestor
25851325|NCT00053716|Alprostadil|alprostadil|mesh-list
24786975|NCT01922921|Pertuzumab|pertuzumab|mesh-list
24961012|NCT03812731|Narcotics|narcotics|mesh-ancestor
24961013|NCT03812731|Analgesics|analgesics|mesh-ancestor
24961014|NCT03812731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24961015|NCT03812731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24961016|NCT03812731|Anesthetics, General|anesthetics, general|mesh-ancestor
24961017|NCT03812523|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24961018|NCT03812523|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24961019|NCT03812523|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24961020|NCT03812523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24961021|NCT03812523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961022|NCT03812523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24961023|NCT03812523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961024|NCT03812523|Analgesics|analgesics|mesh-ancestor
24961025|NCT03812523|Sensory System Agents|sensory system agents|mesh-ancestor
24961026|NCT03812523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816883|NCT02079480|Immunologic Factors|immunologic factors|mesh-ancestor
24961027|NCT03812523|Antidepressive Agents|antidepressive agents|mesh-ancestor
24961028|NCT03812523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24961029|NCT03812523|Dopamine Agents|dopamine agents|mesh-ancestor
24961030|NCT03812562|Nivolumab|nivolumab|mesh-list
24961031|NCT03812562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24961042|NCT03812770|Leucovorin|leucovorin|mesh-list
24961058|NCT03812770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24961059|NCT03812770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24961061|NCT03812354|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24961062|NCT03812354|Autonomic Agents|autonomic agents|mesh-ancestor
24961063|NCT03812354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24920168|NCT04204954|Ciprofloxacin|ciprofloxacin|mesh-list
24961064|NCT03812354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961065|NCT03812354|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24961066|NCT03812354|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24961068|NCT03812354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24961069|NCT03812354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961070|NCT03812315|Propolis|propolis|mesh-list
24961071|NCT03812315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24961072|NCT03812120|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24961073|NCT03812120|Hemostatics|hemostatics|mesh-ancestor
24961074|NCT03812120|Coagulants|coagulants|mesh-ancestor
24961075|NCT03812003|Remifentanil|remifentanil|mesh-list
24961076|NCT03812003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24961077|NCT03812003|Narcotics|narcotics|mesh-ancestor
24961078|NCT03812003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961079|NCT03812003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662713|NCT01649375|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25662714|NCT01649375|Immunologic Factors|immunologic factors|mesh-ancestor
25662715|NCT01649375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662716|NCT01649427|Tacrolimus|tacrolimus|mesh-list
24961080|NCT03812003|Analgesics|analgesics|mesh-ancestor
24961081|NCT03812003|Sensory System Agents|sensory system agents|mesh-ancestor
24961418|NCT03808805|Fosaprepitant|fosaprepitant|mesh-list
25851329|NCT00053768|Prednisone|prednisone|mesh-list
24457704|NCT00334932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24457705|NCT00334932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25235501|NCT02563782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25235502|NCT02563782|Immunologic Factors|immunologic factors|mesh-ancestor
25235504|NCT02563782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24961082|NCT03812003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24463708|NCT00361920|Hormones|hormones|mesh-ancestor
24463709|NCT00361920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24463710|NCT00361920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463711|NCT00361920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24463712|NCT00361920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463713|NCT00361933|Valganciclovir|valganciclovir|mesh-list
24463720|NCT00361959|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25851330|NCT00053768|Cyclophosphamide|cyclophosphamide|mesh-list
25202191|NCT02722811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25202192|NCT02722811|Analgesics|analgesics|mesh-ancestor
25202193|NCT02722811|Sensory System Agents|sensory system agents|mesh-ancestor
25202194|NCT02722811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202195|NCT02722811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202196|NCT02722811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24961167|NCT03810547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961168|NCT03810391|Butorphanol|butorphanol|mesh-list
24961169|NCT03810391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24961170|NCT03810391|Narcotics|narcotics|mesh-ancestor
24961171|NCT03810391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961172|NCT03810391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961173|NCT03810391|Analgesics|analgesics|mesh-ancestor
24961174|NCT03810391|Sensory System Agents|sensory system agents|mesh-ancestor
24961175|NCT03810391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961176|NCT03810391|Antitussive Agents|antitussive agents|mesh-ancestor
24961177|NCT03810391|Respiratory System Agents|respiratory system agents|mesh-ancestor
24961178|NCT03810391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24961179|NCT03810209|Magnesium Sulfate|magnesium sulfate|mesh-list
24961180|NCT03810209|Analgesics|analgesics|mesh-ancestor
24961181|NCT03810209|Sensory System Agents|sensory system agents|mesh-ancestor
24961182|NCT03810209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961183|NCT03810209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961184|NCT03810209|Anesthetics|anesthetics|mesh-ancestor
24961185|NCT03810209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961186|NCT03810209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24961187|NCT03810209|Anticonvulsants|anticonvulsants|mesh-ancestor
24961188|NCT03810209|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24961189|NCT03810209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24961190|NCT03810209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961191|NCT03810209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24961192|NCT03810209|Tocolytic Agents|tocolytic agents|mesh-ancestor
24961193|NCT03810209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24961194|NCT03810066|Osimertinib|osimertinib|mesh-list
24961195|NCT03810066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24961196|NCT03810066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24961197|NCT03810066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24961198|NCT03810066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662717|NCT01649427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25662718|NCT01649427|Immunologic Factors|immunologic factors|mesh-ancestor
25662719|NCT01649427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662720|NCT01649427|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25662721|NCT01649427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25662722|NCT01649427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662723|NCT01649609|Mycophenolic Acid|mycophenolic acid|mesh-list
25662724|NCT01649609|Sirolimus|sirolimus|mesh-list
25851331|NCT00053768|Doxorubicin|doxorubicin|mesh-list
25851332|NCT00053768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25851333|NCT00053768|Etoposide|etoposide|mesh-list
25851334|NCT00053768|Vincristine|vincristine|mesh-list
25851335|NCT00053768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25851336|NCT00053768|Immunologic Factors|immunologic factors|mesh-ancestor
24961213|NCT03809793|Antimetabolites|antimetabolites|mesh-ancestor
24961214|NCT03809793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961215|NCT03809793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24961216|NCT03809702|Pregabalin|pregabalin|mesh-list
24961217|NCT03809702|Analgesics|analgesics|mesh-ancestor
24961218|NCT03809702|Sensory System Agents|sensory system agents|mesh-ancestor
24961263|NCT03809546|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24961264|NCT03809546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24961265|NCT03809546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961266|NCT03809546|Hormones|hormones|mesh-ancestor
24961267|NCT03809546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24961268|NCT03809312|Amoxicillin|amoxicillin|mesh-list
24961269|NCT03809312|Clavulanic Acids|clavulanic acids|mesh-list
24961270|NCT03809312|Clavulanic Acid|clavulanic acid|mesh-list
24961271|NCT03809312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24463805|NCT00362271|Dopamine Agonists|dopamine agonists|mesh-ancestor
25851337|NCT00053768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961336|NCT03809325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24961337|NCT03809325|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24961338|NCT03809325|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24961339|NCT03809325|Serotonin Agents|serotonin agents|mesh-ancestor
24961340|NCT03809325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24961341|NCT03809325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961342|NCT03809325|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24961343|NCT03809325|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24961344|NCT03809325|Dopamine Agents|dopamine agents|mesh-ancestor
24961346|NCT03809260|Vancomycin|vancomycin|mesh-list
24961347|NCT03809260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24961348|NCT03809260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961349|NCT03809260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24961350|NCT03809260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24961351|NCT03809273|Trimetazidine|trimetazidine|mesh-list
24961352|NCT03809273|Vasodilator Agents|vasodilator agents|mesh-ancestor
24961353|NCT03809065|Labetalol|labetalol|mesh-list
25662725|NCT01649609|Tacrolimus|tacrolimus|mesh-list
25662726|NCT01649609|Antimetabolites|antimetabolites|mesh-list
25851338|NCT00053768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25851339|NCT00053768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25851340|NCT00053768|Alkylating Agents|alkylating agents|mesh-ancestor
25851341|NCT00053768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851342|NCT00053768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851343|NCT00053768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24961357|NCT03809065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24961358|NCT03809065|Adrenergic Agents|adrenergic agents|mesh-ancestor
24961365|NCT03809065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961366|NCT03809065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24961367|NCT03809065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24961368|NCT03809143|Buprenorphine|buprenorphine|mesh-list
24961369|NCT03809143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24961370|NCT03809143|Narcotics|narcotics|mesh-ancestor
24961371|NCT03809143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961372|NCT03809143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961374|NCT03809143|Sensory System Agents|sensory system agents|mesh-ancestor
24961375|NCT03809143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961417|NCT03808805|Aprepitant|aprepitant|mesh-list
24961421|NCT03808805|Autonomic Agents|autonomic agents|mesh-ancestor
24961422|NCT03808805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961423|NCT03808805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961424|NCT03808805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24961425|NCT03808805|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24961426|NCT03808805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24478701|NCT00424034|Ambrisentan|ambrisentan|mesh-list
24463860|NCT00362570|Temozolomide|temozolomide|mesh-list
25009900|NCT05058872|Estrogens|estrogens|mesh-ancestor
24463884|NCT00362661|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24463885|NCT00362661|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24463886|NCT00362661|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24961431|NCT03808805|Histamine Antagonists|histamine antagonists|mesh-ancestor
24961432|NCT03808805|Histamine Agents|histamine agents|mesh-ancestor
24961433|NCT03808649|Mannitol|mannitol|mesh-list
24961434|NCT03808649|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24961435|NCT03808649|Diuretics|diuretics|mesh-ancestor
24961436|NCT03808649|Natriuretic Agents|natriuretic agents|mesh-ancestor
24961437|NCT03808649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961438|NCT03808168|Nivolumab|nivolumab|mesh-list
24961439|NCT03808168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24961440|NCT03808168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24961441|NCT03808168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24961442|NCT03808168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961443|NCT03808142|Interferon beta-1b|interferon beta-1b|mesh-list
25078694|NCT03354312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961618|NCT03806582|Norepinephrine|norepinephrine|mesh-list
24961619|NCT03806582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24961620|NCT03806582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25662727|NCT01649609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25662728|NCT01649609|Immunologic Factors|immunologic factors|mesh-ancestor
25662729|NCT01649609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662730|NCT01649609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25662731|NCT01649609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25662732|NCT01649609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662733|NCT01649609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24961621|NCT03806582|Adrenergic Agents|adrenergic agents|mesh-ancestor
24961622|NCT03806582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24961626|NCT03806582|Autonomic Agents|autonomic agents|mesh-ancestor
24961627|NCT03806582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961628|NCT03806582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24463912|NCT00362726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078718|NCT03354117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24807487|NCT02022358|Methotrexate|methotrexate|mesh-list
24787630|NCT01926158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24787631|NCT01926158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787632|NCT01926210|Letrozole|letrozole|mesh-list
24787633|NCT01926210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787634|NCT01926210|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24787635|NCT01926210|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24961684|NCT03805945|Sensory System Agents|sensory system agents|mesh-ancestor
24961685|NCT03805945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961686|NCT03805945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24961687|NCT03805945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24961688|NCT03805945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24961689|NCT03805945|Adrenergic Agents|adrenergic agents|mesh-ancestor
24961732|NCT03806049|Bevacizumab|bevacizumab|mesh-list
24961831|NCT03804931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25202197|NCT02722811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24961832|NCT03804931|Antitubercular Agents|antitubercular agents|mesh-ancestor
24961833|NCT03804931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24961834|NCT03804931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24961835|NCT03805152|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24961836|NCT03805152|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24961844|NCT03805152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961845|NCT03805035|Chlorpheniramine|chlorpheniramine|mesh-list
24961846|NCT03805035|Maleic acid|maleic acid|mesh-list
24961847|NCT03805035|Histamine Antagonists|histamine antagonists|mesh-list
24961848|NCT03805035|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
24961849|NCT03805035|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
24961850|NCT03805035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24961851|NCT03805035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961852|NCT03805035|Histamine Agents|histamine agents|mesh-ancestor
24961853|NCT03805035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24961854|NCT03805035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961855|NCT03805035|Antipruritics|antipruritics|mesh-ancestor
24961856|NCT03805035|Dermatologic Agents|dermatologic agents|mesh-ancestor
24961872|NCT03804840|Sensory System Agents|sensory system agents|mesh-ancestor
24961873|NCT03804840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961874|NCT03804840|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24961875|NCT03804840|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24961876|NCT03804840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24961877|NCT03804840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961878|NCT03804840|Hormones|hormones|mesh-ancestor
24479647|NCT00427596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24961943|NCT03804229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787851|NCT01927913|Sequestering Agents|sequestering agents|mesh-ancestor
24961994|NCT03803839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24961995|NCT03803839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961996|NCT03803371|Acetaminophen|acetaminophen|mesh-list
24961997|NCT03803371|Tramadol|tramadol|mesh-list
24961998|NCT03803371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24961999|NCT03803371|Analgesics|analgesics|mesh-ancestor
25078728|NCT03354117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078729|NCT03354117|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25078730|NCT03354117|Contraceptive Agents|contraceptive agents|mesh-ancestor
25078731|NCT03354117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25078732|NCT03354117|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25078736|NCT03353948|Metformin|metformin|mesh-list
24479727|NCT00428142|Hormones|hormones|mesh-ancestor
24962065|NCT03802747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24962066|NCT03802747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962067|NCT03802747|Immunologic Factors|immunologic factors|mesh-ancestor
25662734|NCT01649609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962068|NCT03802747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962150|NCT03801746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24962151|NCT03801746|Dermatologic Agents|dermatologic agents|mesh-ancestor
24962152|NCT03801746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24962154|NCT03801746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24962155|NCT03801746|Antitubercular Agents|antitubercular agents|mesh-ancestor
24962156|NCT03801746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24962157|NCT03801746|Leprostatic Agents|leprostatic agents|mesh-ancestor
24962158|NCT03801746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24962160|NCT03801746|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24962161|NCT03801746|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24962162|NCT03801746|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24962163|NCT03801746|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24962164|NCT03801746|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24962165|NCT03801746|Uricosuric Agents|uricosuric agents|mesh-ancestor
24962166|NCT03801746|Gout Suppressants|gout suppressants|mesh-ancestor
24962208|NCT03801629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962210|NCT03801629|Sensory System Agents|sensory system agents|mesh-ancestor
24962211|NCT03801629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962213|NCT03801564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24962214|NCT03801564|Immunologic Factors|immunologic factors|mesh-ancestor
24962218|NCT03801590|Riboflavin|riboflavin|mesh-list
24962222|NCT03801590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962223|NCT03801590|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24962224|NCT03801590|Dermatologic Agents|dermatologic agents|mesh-ancestor
24962225|NCT03801759|Adefovir|adefovir|mesh-list
24962226|NCT03801759|Digoxin|digoxin|mesh-list
24962227|NCT03801759|Furosemide|furosemide|mesh-list
24962228|NCT03801759|Diuretics|diuretics|mesh-ancestor
24962229|NCT03801759|Natriuretic Agents|natriuretic agents|mesh-ancestor
24962230|NCT03801759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962231|NCT03801759|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24962232|NCT03801759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24807644|NCT02022930|Glucocorticoids|glucocorticoids|mesh-ancestor
25851344|NCT00053768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25851345|NCT00053768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25851346|NCT00053768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25851347|NCT00053768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851348|NCT00053768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25851349|NCT00053768|Glucocorticoids|glucocorticoids|mesh-ancestor
25851350|NCT00053768|Hormones|hormones|mesh-ancestor
25851351|NCT00053768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24788211|NCT01930318|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24788212|NCT01930318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24788214|NCT01930318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788215|NCT01930318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24788216|NCT01930318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24788217|NCT01930318|Analgesics|analgesics|mesh-ancestor
24788218|NCT01930318|Sensory System Agents|sensory system agents|mesh-ancestor
24788219|NCT01930318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24788223|NCT01930331|Piperaquine|piperaquine|mesh-list
24788224|NCT01930331|Artenimol|artenimol|mesh-list
24788225|NCT01930331|Artemisinins|artemisinins|mesh-list
24788226|NCT01930331|Artemisinin|artemisinin|mesh-list
24788227|NCT01930331|Antimalarials|antimalarials|mesh-ancestor
24788228|NCT01930331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24788229|NCT01930331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24788230|NCT01930331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24962249|NCT03801252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24962250|NCT03801252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24962275|NCT03800953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962276|NCT03800810|Hyaluronic Acid|hyaluronic acid|mesh-list
24962277|NCT03800810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24962278|NCT03800810|Immunologic Factors|immunologic factors|mesh-ancestor
24962279|NCT03800810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962280|NCT03800810|Viscosupplements|viscosupplements|mesh-ancestor
24962281|NCT03800810|Protective Agents|protective agents|mesh-ancestor
24962282|NCT03800667|Ascorbic Acid|ascorbic acid|mesh-list
24962283|NCT03800667|Antioxidants|antioxidants|mesh-ancestor
25202198|NCT02722811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24464057|NCT00363090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24464058|NCT00363090|Tubulin Modulators|tubulin modulators|mesh-ancestor
24464059|NCT00363090|Antimitotic Agents|antimitotic agents|mesh-ancestor
24962449|NCT03798522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962451|NCT03798522|Sensory System Agents|sensory system agents|mesh-ancestor
24962452|NCT03798522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962459|NCT03798392|Anesthetics|anesthetics|mesh-list
24962460|NCT03798392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24962502|NCT03799900|Ketamine|ketamine|mesh-list
24962503|NCT03799900|Analgesics|analgesics|mesh-ancestor
24962504|NCT03799900|Sensory System Agents|sensory system agents|mesh-ancestor
24962505|NCT03799900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962506|NCT03799900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962507|NCT03799900|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24962508|NCT03799900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24962509|NCT03799900|Anesthetics, General|anesthetics, general|mesh-ancestor
24962510|NCT03799900|Anesthetics|anesthetics|mesh-ancestor
24962511|NCT03799900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24962512|NCT03799900|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24962513|NCT03799900|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24962514|NCT03799900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24962515|NCT03799900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962517|NCT03799757|Anesthetics, Local|anesthetics, local|mesh-ancestor
24962518|NCT03799757|Anesthetics|anesthetics|mesh-ancestor
24962519|NCT03799757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24962520|NCT03799757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962521|NCT03799757|Sensory System Agents|sensory system agents|mesh-ancestor
24962522|NCT03799757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962523|NCT03799913|Cyclophosphamide|cyclophosphamide|mesh-list
24962524|NCT03799913|Fludarabine|fludarabine|mesh-list
24962525|NCT03799913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24962526|NCT03799913|Immunologic Factors|immunologic factors|mesh-ancestor
24480518|NCT00431197|Androgens|androgens|mesh-ancestor
24962588|NCT03797079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24962589|NCT03797079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962591|NCT03797079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962592|NCT03797066|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
24962593|NCT03797066|Antiviral Agents|antiviral agents|mesh-ancestor
24962594|NCT03797066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24590058|NCT00910455|SRX246|srx246|mesh-list
24962680|NCT03796377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962714|NCT03795792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962716|NCT03795584|Coagulants|coagulants|mesh-ancestor
24962717|NCT03795571|Gemcitabine|gemcitabine|mesh-list
24962718|NCT03795571|Dexamethasone|dexamethasone|mesh-list
24962719|NCT03795571|Rituximab|rituximab|mesh-list
24962720|NCT03795571|Oxaliplatin|oxaliplatin|mesh-list
24962721|NCT03795571|Lenalidomide|lenalidomide|mesh-list
24962722|NCT03795571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24962723|NCT03795571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962724|NCT03795571|Immunologic Factors|immunologic factors|mesh-ancestor
24962778|NCT03795259|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24962779|NCT03795259|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24962780|NCT03795259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24962781|NCT03795259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962782|NCT03795259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962783|NCT03795272|Rucaparib|rucaparib|mesh-list
24807831|NCT02023853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24962793|NCT03795311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24962794|NCT03795311|Growth Substances|growth substances|mesh-ancestor
24962795|NCT03795311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962796|NCT03795311|Growth Inhibitors|growth inhibitors|mesh-ancestor
24962797|NCT03795207|Durvalumab|durvalumab|mesh-list
24962798|NCT03795207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24962799|NCT03795207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962800|NCT03794765|Metronidazole|metronidazole|mesh-list
24962801|NCT03794765|Ceftriaxone|ceftriaxone|mesh-list
24962802|NCT03794765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24962803|NCT03794765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24962804|NCT03794765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24962805|NCT03794765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24962806|NCT03794843|Nimodipine|nimodipine|mesh-list
24962807|NCT03794843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24962808|NCT03794843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24962809|NCT03794843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24962823|NCT03794505|Anesthetics, Local|anesthetics, local|mesh-ancestor
24962880|NCT03794492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24962881|NCT03794492|Antitubercular Agents|antitubercular agents|mesh-ancestor
24962882|NCT03794492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24962883|NCT03794492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24962902|NCT03794596|Analgesics|analgesics|mesh-ancestor
24962903|NCT03794596|Sensory System Agents|sensory system agents|mesh-ancestor
24962904|NCT03794596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962905|NCT03794596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962930|NCT03794219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24962931|NCT03794219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962950|NCT03794271|Anesthetics|anesthetics|mesh-list
24920508|NCT04201951|Tranexamic Acid|tranexamic acid|mesh-list
24962951|NCT03794271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24962952|NCT03794271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788776|NCT01933698|Amoxicillin|amoxicillin|mesh-list
24962961|NCT03794154|Sensory System Agents|sensory system agents|mesh-ancestor
24962962|NCT03794154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962963|NCT03794154|Antidepressive Agents|antidepressive agents|mesh-ancestor
24962964|NCT03794154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24962965|NCT03794154|Dopamine Agents|dopamine agents|mesh-ancestor
24962966|NCT03794167|Cyclophosphamide|cyclophosphamide|mesh-list
24962968|NCT03794167|Busulfan|busulfan|mesh-list
24962969|NCT03794167|Etoposide|etoposide|mesh-list
24962970|NCT03794167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24962971|NCT03794167|Immunologic Factors|immunologic factors|mesh-ancestor
24963118|NCT03792906|Anesthetics, Local|anesthetics, local|mesh-ancestor
24962972|NCT03794167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962973|NCT03794167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24963003|NCT03793725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963004|NCT03793517|Decitabine|decitabine|mesh-list
24963005|NCT03793517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24963006|NCT03793517|Antimetabolites|antimetabolites|mesh-ancestor
24963007|NCT03793517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963008|NCT03793517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24963009|NCT03793517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24963010|NCT03793309|Vitamin D|vitamin d|mesh-list
24963011|NCT03793309|Ergocalciferols|ergocalciferols|mesh-list
24963012|NCT03793309|Cholecalciferol|cholecalciferol|mesh-list
24963013|NCT03793309|Vitamins|vitamins|mesh-list
24963014|NCT03793309|Micronutrients|micronutrients|mesh-ancestor
24963015|NCT03793309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963016|NCT03793309|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24963045|NCT03793114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963046|NCT03792776|Lidocaine|lidocaine|mesh-list
24963047|NCT03792776|Anesthetics|anesthetics|mesh-list
25078806|NCT03353857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25078807|NCT03353857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25067296|NCT03444636|Fentanyl|fentanyl|mesh-list
24627024|NCT01090128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25078808|NCT03353857|Progestins|progestins|mesh-ancestor
25420535|NCT02619682|Immunologic Factors|immunologic factors|mesh-ancestor
24517007|NCT00605397|Trastuzumab|trastuzumab|mesh-list
24963060|NCT03792828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24963061|NCT03792828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24963062|NCT03792828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202199|NCT02722811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24963063|NCT03792828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24963064|NCT03792828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788929|NCT01934777|Antioxidants|antioxidants|mesh-ancestor
24789003|NCT01935115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24789004|NCT01935115|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24789005|NCT01935115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24789006|NCT01935115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24789007|NCT01935115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24789008|NCT01935115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789009|NCT01935141|Triiodobenzoic Acids|triiodobenzoic acids|mesh-list
24789010|NCT01935141|Plant Growth Regulators|plant growth regulators|mesh-ancestor
24789011|NCT01935141|Growth Substances|growth substances|mesh-ancestor
24789012|NCT01935141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789013|NCT01935193|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
24789014|NCT01935193|Analgesics|analgesics|mesh-ancestor
24789015|NCT01935193|Sensory System Agents|sensory system agents|mesh-ancestor
24789016|NCT01935193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24789017|NCT01935193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851352|NCT00053768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24963090|NCT03792984|Calcium Carbonate|calcium carbonate|mesh-list
24963091|NCT03792984|Calcium|calcium|mesh-list
24963092|NCT03792984|Vitamins|vitamins|mesh-ancestor
24963093|NCT03792984|Micronutrients|micronutrients|mesh-ancestor
24963094|NCT03792984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963095|NCT03792984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24963096|NCT03792984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24963097|NCT03792984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24963098|NCT03792984|Antacids|antacids|mesh-ancestor
24963099|NCT03792984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963100|NCT03792984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24963101|NCT03792815|Etoposide|etoposide|mesh-list
24963102|NCT03792815|Melphalan|melphalan|mesh-list
24963103|NCT03792815|Busulfan|busulfan|mesh-list
24963104|NCT03792815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24963105|NCT03792815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24963106|NCT03792815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24963107|NCT03792815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24963108|NCT03792815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24963109|NCT03792815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963110|NCT03792815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24963111|NCT03792815|Alkylating Agents|alkylating agents|mesh-ancestor
24963112|NCT03792815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24963113|NCT03792815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24963114|NCT03792815|Immunologic Factors|immunologic factors|mesh-ancestor
24963115|NCT03792815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963116|NCT03792906|Norepinephrine|norepinephrine|mesh-list
24963117|NCT03792906|Bupivacaine|bupivacaine|mesh-list
24963153|NCT03792139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24963154|NCT03792139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24963155|NCT03792139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24963156|NCT03792139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963167|NCT03792269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963168|NCT03792269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24963169|NCT03792269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24963170|NCT03792269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24963171|NCT03792269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24963174|NCT03792295|Oxycodone|oxycodone|mesh-list
24464119|NCT00363376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24464120|NCT00363376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24464121|NCT00363376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24464122|NCT00363376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24464123|NCT00363376|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24464124|NCT00363376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24963250|NCT03791905|Fluorouracil|fluorouracil|mesh-list
24963251|NCT03791905|Oxaliplatin|oxaliplatin|mesh-list
24963252|NCT03791905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24963253|NCT03791905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24963254|NCT03791905|Tubulin Modulators|tubulin modulators|mesh-ancestor
24963257|NCT03791905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963258|NCT03791905|Antimetabolites|antimetabolites|mesh-ancestor
24963259|NCT03791905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24963260|NCT03791905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24963261|NCT03791905|Immunologic Factors|immunologic factors|mesh-ancestor
24963262|NCT03791905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963263|NCT03791905|Antidotes|antidotes|mesh-ancestor
24963264|NCT03791905|Protective Agents|protective agents|mesh-ancestor
24963265|NCT03791905|Vitamin B Complex|vitamin b complex|mesh-ancestor
24963266|NCT03791905|Vitamins|vitamins|mesh-ancestor
24963267|NCT03791905|Micronutrients|micronutrients|mesh-ancestor
24963268|NCT03791918|Lenvatinib|lenvatinib|mesh-list
24963269|NCT03791918|Chlorotrianisene|chlorotrianisene|mesh-list
24963270|NCT03791918|Antibodies|antibodies|mesh-list
24963271|NCT03791918|Immunoglobulins|immunoglobulins|mesh-list
24963272|NCT03791918|Immunologic Factors|immunologic factors|mesh-ancestor
24963273|NCT03791918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963274|NCT03791918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24963275|NCT03791918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24963276|NCT03791918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24963277|NCT03791918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963278|NCT03791918|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25078833|NCT03353324|Bevacizumab|bevacizumab|mesh-list
25078834|NCT03353324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25078835|NCT03353324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25078836|NCT03353324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25078837|NCT03353324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25078840|NCT03353324|Growth Inhibitors|growth inhibitors|mesh-ancestor
25078841|NCT03353298|Allopurinol|allopurinol|mesh-list
25078842|NCT03353298|Antimetabolites|antimetabolites|mesh-ancestor
25078843|NCT03353298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078844|NCT03353298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078845|NCT03353298|Gout Suppressants|gout suppressants|mesh-ancestor
25078846|NCT03353298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25078847|NCT03353298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25078848|NCT03353298|Antioxidants|antioxidants|mesh-ancestor
25078849|NCT03353298|Protective Agents|protective agents|mesh-ancestor
25078850|NCT03353298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078852|NCT03353103|Fluorides|fluorides|mesh-list
24464125|NCT00363376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25078853|NCT03353103|Sodium Fluoride|sodium fluoride|mesh-list
25078854|NCT03353103|Cariostatic Agents|cariostatic agents|mesh-ancestor
25662735|NCT01649609|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25662736|NCT01649609|Antitubercular Agents|antitubercular agents|mesh-ancestor
25662737|NCT01649609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25662738|NCT01649609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25662739|NCT01649609|Antifungal Agents|antifungal agents|mesh-ancestor
25662740|NCT01649765|Belimumab|belimumab|mesh-list
25662741|NCT01649765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25078855|NCT03353103|Protective Agents|protective agents|mesh-ancestor
25078856|NCT03353103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662742|NCT01649765|Immunologic Factors|immunologic factors|mesh-ancestor
25078866|NCT03353025|Dopamine Agents|dopamine agents|mesh-ancestor
25078867|NCT03353025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25078868|NCT03353025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078869|NCT03353025|Protective Agents|protective agents|mesh-ancestor
25078870|NCT03353012|Levonorgestrel|levonorgestrel|mesh-list
25078871|NCT03353012|Etonogestrel|etonogestrel|mesh-list
25078872|NCT03353012|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25078873|NCT03353012|Contraceptive Agents|contraceptive agents|mesh-ancestor
25078874|NCT03353012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25078875|NCT03353012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963333|NCT03791827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24963334|NCT03791827|Antifungal Agents|antifungal agents|mesh-ancestor
24963335|NCT03791827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24963336|NCT03791827|Dermatologic Agents|dermatologic agents|mesh-ancestor
24963337|NCT03791827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24963338|NCT03791827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24963339|NCT03791827|Antitubercular Agents|antitubercular agents|mesh-ancestor
24963340|NCT03791827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24963341|NCT03791827|Antimalarials|antimalarials|mesh-ancestor
24963388|NCT03791424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963401|NCT03791099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24963402|NCT03791099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24963403|NCT03791099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24963404|NCT03791099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24963405|NCT03791255|Calcium, Dietary|calcium, dietary|mesh-list
24963406|NCT03791255|Calcium|calcium|mesh-list
24963407|NCT03791255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24963408|NCT03791255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963409|NCT03791255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24963410|NCT03790839|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24481753|NCT00436761|Busulfan|busulfan|mesh-list
24789367|NCT01936545|Hematinics|hematinics|mesh-ancestor
24789368|NCT01936545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24789369|NCT01936636|Fentanyl|fentanyl|mesh-list
24789370|NCT01936636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24789371|NCT01936636|Narcotics|narcotics|mesh-ancestor
24789372|NCT01936636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24789373|NCT01936636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789374|NCT01936636|Analgesics|analgesics|mesh-ancestor
24789375|NCT01936636|Sensory System Agents|sensory system agents|mesh-ancestor
24789376|NCT01936636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24789377|NCT01936636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24789378|NCT01936636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24789379|NCT01936636|Anesthetics, General|anesthetics, general|mesh-ancestor
24789380|NCT01936636|Anesthetics|anesthetics|mesh-ancestor
24789381|NCT01936805|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24789382|NCT01936805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24789383|NCT01936805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24789384|NCT01936805|Antimetabolites|antimetabolites|mesh-ancestor
24963447|NCT03790540|Anesthetics|anesthetics|mesh-ancestor
24963448|NCT03790540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24963449|NCT03790540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963450|NCT03790540|Sensory System Agents|sensory system agents|mesh-ancestor
24963451|NCT03790540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24963453|NCT03790605|Iproplatin|iproplatin|mesh-list
24963454|NCT03790605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24963455|NCT03790605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24963456|NCT03790605|Analgesics|analgesics|mesh-ancestor
24963457|NCT03790605|Sensory System Agents|sensory system agents|mesh-ancestor
24963495|NCT03790566|Sensory System Agents|sensory system agents|mesh-ancestor
24963496|NCT03790566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24963497|NCT03790215|Dydrogesterone|dydrogesterone|mesh-list
24963498|NCT03790215|Progestins|progestins|mesh-ancestor
24579820|NCT00857935|Permethrin|permethrin|mesh-list
24963499|NCT03790215|Hormones|hormones|mesh-ancestor
24963500|NCT03790215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24963501|NCT03790215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819165|NCT02093845|Everolimus|everolimus|mesh-list
24963503|NCT03790228|Pemetrexed|pemetrexed|mesh-list
24963504|NCT03790228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24963505|NCT03790228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24963506|NCT03790228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963507|NCT03790228|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24822151|NCT02109965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24963508|NCT03790228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24963509|NCT03790371|Misoprostol|misoprostol|mesh-list
24963510|NCT03790371|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24963511|NCT03790371|Abortifacient Agents|abortifacient agents|mesh-ancestor
24963512|NCT03790371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24963513|NCT03790371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963514|NCT03790371|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24808053|NCT02024984|Fertility Agents|fertility agents|mesh-ancestor
24963529|NCT03790358|Serotonin Agents|serotonin agents|mesh-ancestor
24963530|NCT03790358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24963531|NCT03790358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963532|NCT03790358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25067376|NCT03443999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25067377|NCT03443999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25067378|NCT03443999|Antifungal Agents|antifungal agents|mesh-ancestor
25067379|NCT03443999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25067382|NCT03443960|Amitriptyline|amitriptyline|mesh-list
25067387|NCT03443960|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25067389|NCT03443960|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24963536|NCT03790384|Mitomycins|mitomycins|mesh-list
24963537|NCT03790384|Mitomycin|mitomycin|mesh-list
24963538|NCT03790384|BCG Vaccine|bcg vaccine|mesh-list
24963539|NCT03790384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25078904|NCT03352843|Antimalarials|antimalarials|mesh-ancestor
24963569|NCT03790072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963570|NCT03790072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24963571|NCT03790072|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24963573|NCT03789890|Antifungal Agents|antifungal agents|mesh-ancestor
24819237|NCT02094287|Dimethindene|dimethindene|mesh-list
24963574|NCT03789890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24963575|NCT03789890|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24963576|NCT03789890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24963578|NCT03789890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963579|NCT03789890|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24963580|NCT03789890|Hormone Antagonists|hormone antagonists|mesh-ancestor
24963581|NCT03789890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24963582|NCT03789890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963586|NCT03790085|Aripiprazole|aripiprazole|mesh-list
24963587|NCT03790085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24963588|NCT03790085|Serotonin Agents|serotonin agents|mesh-ancestor
24963589|NCT03790085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24464134|NCT00363389|Abortifacient Agents|abortifacient agents|mesh-ancestor
24464135|NCT00363389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24464136|NCT00363389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464137|NCT00363389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25851353|NCT00053768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25851354|NCT00053768|Tubulin Modulators|tubulin modulators|mesh-ancestor
24963597|NCT03790085|Dopamine Agents|dopamine agents|mesh-ancestor
24963674|NCT03789539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963676|NCT03789422|Tranexamic Acid|tranexamic acid|mesh-list
24963677|NCT03789422|Levocetirizine|levocetirizine|mesh-list
24963678|NCT03789422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24963679|NCT03789422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24963680|NCT03789422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963681|NCT03789422|Hemostatics|hemostatics|mesh-ancestor
24963682|NCT03789422|Coagulants|coagulants|mesh-ancestor
25202201|NCT02722538|Gemcitabine|gemcitabine|mesh-list
25851355|NCT00053768|Antimitotic Agents|antimitotic agents|mesh-ancestor
25851356|NCT00053768|Mitosis Modulators|mitosis modulators|mesh-ancestor
25851357|NCT00053807|Interferons|interferons|mesh-list
25851358|NCT00053807|Interferon-alpha|interferon-alpha|mesh-list
24963683|NCT03789422|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24963684|NCT03789422|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24963720|NCT03789058|Ibuprofen|ibuprofen|mesh-list
24963721|NCT03789058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24963722|NCT03789058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24963723|NCT03789058|Analgesics|analgesics|mesh-ancestor
24963724|NCT03789058|Sensory System Agents|sensory system agents|mesh-ancestor
24963725|NCT03789058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24963726|NCT03789058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963727|NCT03789058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24963728|NCT03789058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24963729|NCT03789058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24963730|NCT03789058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24963748|NCT03788889|Anticonvulsants|anticonvulsants|mesh-ancestor
24963749|NCT03788889|Antiemetics|antiemetics|mesh-ancestor
24963750|NCT03788889|Autonomic Agents|autonomic agents|mesh-ancestor
24963751|NCT03788889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25040040|NCT03475706|Solabegron|solabegron|mesh-list
24963752|NCT03788889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24963753|NCT03788889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24963754|NCT03788889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24963755|NCT03788889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24963756|NCT03788889|GABA Modulators|gaba modulators|mesh-ancestor
24963757|NCT03788889|GABA Agents|gaba agents|mesh-ancestor
24963758|NCT03788889|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24963759|NCT03788889|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24963761|NCT03788902|Methylphenidate|methylphenidate|mesh-list
24963762|NCT03788902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24963763|NCT03788902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482332|NCT00438737|Growth Inhibitors|growth inhibitors|mesh-ancestor
24963801|NCT03788694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24963802|NCT03788694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963803|NCT03789006|Interleukin-2|interleukin-2|mesh-list
24963804|NCT03789006|Immunoglobulins|immunoglobulins|mesh-list
24963805|NCT03789006|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24963806|NCT03789006|Antibodies|antibodies|mesh-list
24963815|NCT03789006|Sensory System Agents|sensory system agents|mesh-ancestor
24963816|NCT03789006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24963817|NCT03789006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24622814|NCT01068756|Leprostatic Agents|leprostatic agents|mesh-ancestor
25078891|NCT03352895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078892|NCT03352895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25078893|NCT03352895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25078894|NCT03352895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25078895|NCT03352869|Metformin|metformin|mesh-list
25078896|NCT03352869|Exenatide|exenatide|mesh-list
25078897|NCT03352869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25078898|NCT03352869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078899|NCT03352869|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25202202|NCT02722538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25202203|NCT02722538|Antimetabolites|antimetabolites|mesh-ancestor
25202204|NCT02722538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078900|NCT03352869|Incretins|incretins|mesh-ancestor
25078901|NCT03352869|Hormones|hormones|mesh-ancestor
25078902|NCT03352869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24964983|NCT03779282|Dexmedetomidine|dexmedetomidine|mesh-list
25078903|NCT03352843|Primaquine|primaquine|mesh-list
24963829|NCT03788681|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24963830|NCT03788681|Estrogens|estrogens|mesh-ancestor
24963831|NCT03788681|Hormones|hormones|mesh-ancestor
24963832|NCT03788681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25235698|NCT02562950|Anesthetics|anesthetics|mesh-ancestor
25235699|NCT02562950|GABA Modulators|gaba modulators|mesh-ancestor
25235700|NCT02562950|GABA Agents|gaba agents|mesh-ancestor
25235701|NCT02562950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25235702|NCT02562950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963833|NCT03788681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963834|NCT03788681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24963835|NCT03788681|Contraceptive Agents|contraceptive agents|mesh-ancestor
24963836|NCT03788681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24963837|NCT03788681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24963838|NCT03788538|Dexmedetomidine|dexmedetomidine|mesh-list
24789695|NCT01938612|Tremelimumab|tremelimumab|mesh-list
24789696|NCT01938612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24789697|NCT01938612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789698|NCT01938729|Gemcitabine|gemcitabine|mesh-list
24789699|NCT01938729|Dexamethasone|dexamethasone|mesh-list
24789700|NCT01938729|Floxuridine|floxuridine|mesh-list
24789701|NCT01938729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24789702|NCT01938729|Antiemetics|antiemetics|mesh-ancestor
24789703|NCT01938729|Autonomic Agents|autonomic agents|mesh-ancestor
24789704|NCT01938729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24789705|NCT01938729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789706|NCT01938729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24789707|NCT01938729|Glucocorticoids|glucocorticoids|mesh-ancestor
24789708|NCT01938729|Hormones|hormones|mesh-ancestor
24789709|NCT01938729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24789710|NCT01938729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24622828|NCT01068847|Cycloserine|cycloserine|mesh-list
25851359|NCT00053807|Aldesleukin|aldesleukin|mesh-list
25851360|NCT00053807|Fluorouracil|fluorouracil|mesh-list
24963840|NCT03788538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24963841|NCT03788538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963842|NCT03788538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24963843|NCT03788538|Analgesics|analgesics|mesh-ancestor
24963844|NCT03788538|Sensory System Agents|sensory system agents|mesh-ancestor
24963845|NCT03788538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24963846|NCT03788538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24963847|NCT03788538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24963848|NCT03788538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24963849|NCT03788538|Adrenergic Agents|adrenergic agents|mesh-ancestor
24963850|NCT03788538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24963851|NCT03788538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963852|NCT03788395|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24963853|NCT03788395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24963854|NCT03788395|Respiratory System Agents|respiratory system agents|mesh-ancestor
24963855|NCT03788317|Botulinum Toxins|botulinum toxins|mesh-list
24963856|NCT03788317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24963857|NCT03788317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24963858|NCT03788317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24963859|NCT03788317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24963860|NCT03788317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963861|NCT03788317|Cholinergic Agents|cholinergic agents|mesh-ancestor
24963862|NCT03788317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24963863|NCT03788317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662743|NCT01649765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662744|NCT01649791|Lenalidomide|lenalidomide|mesh-list
25662745|NCT01649791|Immunologic Factors|immunologic factors|mesh-ancestor
25662746|NCT01649791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662747|NCT01649791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25662748|NCT01649791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25662749|NCT01649791|Growth Substances|growth substances|mesh-ancestor
25662750|NCT01649791|Growth Inhibitors|growth inhibitors|mesh-ancestor
25851361|NCT00053807|Antimetabolites|antimetabolites|mesh-ancestor
25851362|NCT00053807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851363|NCT00053807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25851364|NCT00053807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851365|NCT00053807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25851366|NCT00053807|Immunologic Factors|immunologic factors|mesh-ancestor
25235711|NCT02562417|Dexamethasone|dexamethasone|mesh-list
25235712|NCT02562417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25235713|NCT02562417|Antiemetics|antiemetics|mesh-ancestor
25235714|NCT02562417|Autonomic Agents|autonomic agents|mesh-ancestor
25235715|NCT02562417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25235716|NCT02562417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235717|NCT02562417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25235718|NCT02562417|Glucocorticoids|glucocorticoids|mesh-ancestor
25235719|NCT02562417|Hormones|hormones|mesh-ancestor
25235720|NCT02562417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25235721|NCT02562417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25235722|NCT02562417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25235723|NCT02562651|Doxycycline|doxycycline|mesh-list
25235724|NCT02562651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25235725|NCT02562651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25235726|NCT02562651|Antimalarials|antimalarials|mesh-ancestor
25235727|NCT02562651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25235728|NCT02562651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25235729|NCT02562625|Pembrolizumab|pembrolizumab|mesh-list
25235731|NCT02562625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24963864|NCT03788317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24963917|NCT03787927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963918|NCT03787927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25010014|NCT04789304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25010015|NCT04789304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010016|NCT04784637|Insulin|insulin|mesh-list
25010017|NCT04784637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25010018|NCT04784637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010021|NCT04780724|Protective Agents|protective agents|mesh-ancestor
24963919|NCT03787927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24963920|NCT03787927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24963921|NCT03787927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24963922|NCT03787927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963923|NCT03787927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24963924|NCT03787927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24963925|NCT03787927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24963926|NCT03787927|Antipyretics|antipyretics|mesh-ancestor
24963927|NCT03787927|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24963928|NCT03787927|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24963929|NCT03787927|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24963930|NCT03787927|Purinergic Agents|purinergic agents|mesh-ancestor
24963931|NCT03787927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24789747|NCT01938911|Oxytocin|oxytocin|mesh-list
24963941|NCT03787641|Heparin Antagonists|heparin antagonists|mesh-ancestor
24963942|NCT03787641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963943|NCT03787641|Coagulants|coagulants|mesh-ancestor
24963944|NCT03787264|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24963945|NCT03787264|Venetoclax|venetoclax|mesh-list
24963946|NCT03787264|Obinutuzumab|obinutuzumab|mesh-list
24963947|NCT03787264|Acalabrutinib|acalabrutinib|mesh-list
24963948|NCT03787264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24963949|NCT03787264|Alkylating Agents|alkylating agents|mesh-ancestor
24963950|NCT03787264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963951|NCT03787264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25421070|NCT02576912|Dronabinol|dronabinol|mesh-list
25662751|NCT01649791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662752|NCT01649856|Rituximab|rituximab|mesh-list
25662753|NCT01649856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25662754|NCT01649856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662755|NCT01649856|Immunologic Factors|immunologic factors|mesh-ancestor
25662756|NCT01649856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662757|NCT01649856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25662758|NCT01649869|Valganciclovir|valganciclovir|mesh-list
25662759|NCT01649869|Antiviral Agents|antiviral agents|mesh-ancestor
25662760|NCT01649869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25662761|NCT01649947|Hydroxychloroquine|hydroxychloroquine|mesh-list
25662762|NCT01649947|Paclitaxel|paclitaxel|mesh-list
25662763|NCT01649947|Bevacizumab|bevacizumab|mesh-list
25662764|NCT01649947|Carboplatin|carboplatin|mesh-list
25662765|NCT01649947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25662766|NCT01649947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662767|NCT01649947|Tubulin Modulators|tubulin modulators|mesh-ancestor
25662768|NCT01649947|Antimitotic Agents|antimitotic agents|mesh-ancestor
25662769|NCT01649947|Mitosis Modulators|mitosis modulators|mesh-ancestor
25662770|NCT01649947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235761|NCT02562326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235763|NCT02562144|Anesthetics, Local|anesthetics, local|mesh-ancestor
24963952|NCT03787264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24963953|NCT03787147|Lidocaine|lidocaine|mesh-list
24963954|NCT03787147|Bupivacaine|bupivacaine|mesh-list
24893017|NCT04455594|Pemetrexed|pemetrexed|mesh-list
24464180|NCT00363701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464181|NCT00363701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464183|NCT00363727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24464184|NCT00363727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25851367|NCT00053807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963955|NCT03787147|Anesthetics, Local|anesthetics, local|mesh-ancestor
24963956|NCT03787147|Anesthetics|anesthetics|mesh-ancestor
24963957|NCT03787147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25078905|NCT03352843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24963958|NCT03787147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963959|NCT03787147|Sensory System Agents|sensory system agents|mesh-ancestor
24963960|NCT03787147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24963961|NCT03787147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24964012|NCT03786562|Nalbuphine|nalbuphine|mesh-list
24964049|NCT03785873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24964050|NCT03785873|Antidotes|antidotes|mesh-ancestor
24964051|NCT03785873|Protective Agents|protective agents|mesh-ancestor
24964052|NCT03785873|Vitamin B Complex|vitamin b complex|mesh-ancestor
24964054|NCT03785873|Micronutrients|micronutrients|mesh-ancestor
24964055|NCT03786237|ON 01910|on 01910|mesh-list
24964056|NCT03786237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24964057|NCT03786237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24964058|NCT03786237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464206|NCT00363753|Antipyretics|antipyretics|mesh-ancestor
25202205|NCT02722538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25202206|NCT02722538|Antiviral Agents|antiviral agents|mesh-ancestor
25202207|NCT02722538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25202208|NCT02722538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202209|NCT02722538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25202210|NCT02722538|Immunologic Factors|immunologic factors|mesh-ancestor
25202211|NCT02722538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202212|NCT02722759|Chrysarobin|chrysarobin|mesh-list
24464207|NCT00363753|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24964066|NCT03786029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964067|NCT03786029|Antipyretics|antipyretics|mesh-ancestor
24964068|NCT03786029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24964069|NCT03786029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24964070|NCT03786029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24964071|NCT03786029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24964072|NCT03786029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24964073|NCT03786029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964074|NCT03785756|Ibuprofen|ibuprofen|mesh-list
25040303|NCT03191864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24964075|NCT03785756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24964076|NCT03785756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24964077|NCT03785756|Analgesics|analgesics|mesh-ancestor
24964078|NCT03785756|Sensory System Agents|sensory system agents|mesh-ancestor
24964079|NCT03785756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24964080|NCT03785756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964081|NCT03785756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24964082|NCT03785756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25662771|NCT01649947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25662772|NCT01649947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25662773|NCT01649947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25662774|NCT01649947|Growth Substances|growth substances|mesh-ancestor
25662775|NCT01649947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662776|NCT01649947|Growth Inhibitors|growth inhibitors|mesh-ancestor
25662777|NCT01649947|Antimalarials|antimalarials|mesh-ancestor
24964083|NCT03785756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25235797|NCT02562183|Fertility Agents, Male|fertility agents, male|mesh-ancestor
25235798|NCT02562183|Fertility Agents|fertility agents|mesh-ancestor
25235799|NCT02562183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25235800|NCT02562183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235801|NCT02562287|Olanzapine|olanzapine|mesh-list
24964084|NCT03785756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24964085|NCT03785756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964086|NCT03785496|Spartalizumab|spartalizumab|mesh-list
24964087|NCT03785496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24964088|NCT03785496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964089|NCT03785496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24964090|NCT03785587|Bromides|bromides|mesh-list
24964091|NCT03785587|Anticonvulsants|anticonvulsants|mesh-ancestor
24482794|NCT00440648|Chelating Agents|chelating agents|mesh-ancestor
24790067|NCT01940601|Immunologic Factors|immunologic factors|mesh-ancestor
24482981|NCT00441246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24626956|NCT01089452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24964156|NCT03785041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24893203|NCT04453189|Famotidine|famotidine|mesh-list
24964161|NCT03785041|Sensory System Agents|sensory system agents|mesh-ancestor
24964162|NCT03785041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24964163|NCT03785041|Anesthetics, Local|anesthetics, local|mesh-ancestor
24964164|NCT03785041|Anesthetics|anesthetics|mesh-ancestor
24964165|NCT03784781|Dimercaprol|dimercaprol|mesh-list
24964166|NCT03784781|Chelating Agents|chelating agents|mesh-ancestor
24964167|NCT03784781|Sequestering Agents|sequestering agents|mesh-ancestor
25268763|NCT02414490|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24964168|NCT03784781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964169|NCT03784794|Thrombin|thrombin|mesh-list
24964170|NCT03784794|Hemostatics|hemostatics|mesh-ancestor
24964171|NCT03784794|Coagulants|coagulants|mesh-ancestor
24964172|NCT03785067|Amlodipine|amlodipine|mesh-list
24964173|NCT03785067|Telmisartan|telmisartan|mesh-list
24964174|NCT03785067|Indapamide|indapamide|mesh-list
24964175|NCT03785067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24964176|NCT03785067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24964177|NCT03785067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24964178|NCT03785067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964179|NCT03785067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24964180|NCT03785067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964181|NCT03785067|Vasodilator Agents|vasodilator agents|mesh-ancestor
24964182|NCT03785067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24964183|NCT03785067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24964184|NCT03785067|Diuretics|diuretics|mesh-ancestor
24964185|NCT03785067|Natriuretic Agents|natriuretic agents|mesh-ancestor
24964186|NCT03785067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24964187|NCT03784495|Melatonin|melatonin|mesh-list
24964188|NCT03784495|Antioxidants|antioxidants|mesh-ancestor
24964189|NCT03784495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964190|NCT03784495|Protective Agents|protective agents|mesh-ancestor
24964191|NCT03784495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964192|NCT03784495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24964193|NCT03784599|Trastuzumab|trastuzumab|mesh-list
25851368|NCT00053807|Antiviral Agents|antiviral agents|mesh-ancestor
24964218|NCT03784677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964220|NCT03784677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24964221|NCT03784677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24964222|NCT03784677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662778|NCT01649947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25662779|NCT01649947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25662780|NCT01649947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25662781|NCT01649947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25662782|NCT01649947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25662783|NCT01650194|Prednisone|prednisone|mesh-list
25662784|NCT01650194|Abiraterone Acetate|abiraterone acetate|mesh-list
25662785|NCT01650194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25851369|NCT00053807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25851370|NCT00053807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25851371|NCT00053807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25851372|NCT00053820|Interferons|interferons|mesh-list
25851373|NCT00053820|Interferon-alpha|interferon-alpha|mesh-list
25235829|NCT02562053|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
24964223|NCT03784443|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
24964224|NCT03784443|Ranibizumab|ranibizumab|mesh-list
24964236|NCT03784378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24964237|NCT03784378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24964238|NCT03784378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637202|NCT01149304|Enoxaparin|enoxaparin|mesh-list
24964239|NCT03784547|Ocrelizumab|ocrelizumab|mesh-list
24964240|NCT03784547|Immunologic Factors|immunologic factors|mesh-ancestor
24964241|NCT03784547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964242|NCT03784391|Nifurtimox|nifurtimox|mesh-list
24964243|NCT03784391|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24964244|NCT03784391|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24964245|NCT03784391|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24964246|NCT03784391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24964247|NCT03784105|Codeine|codeine|mesh-list
24964248|NCT03784105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24964249|NCT03784105|Narcotics|narcotics|mesh-ancestor
24964250|NCT03784105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24964251|NCT03784105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964252|NCT03784105|Analgesics|analgesics|mesh-ancestor
24964308|NCT03783949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24964309|NCT03783949|Immunologic Factors|immunologic factors|mesh-ancestor
24964310|NCT03783949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964311|NCT03783949|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24964312|NCT03783936|Leucovorin|leucovorin|mesh-list
24964313|NCT03783936|Fluorouracil|fluorouracil|mesh-list
24964314|NCT03783936|Oxaliplatin|oxaliplatin|mesh-list
24964331|NCT03784040|Ipilimumab|ipilimumab|mesh-list
24964332|NCT03784040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24964333|NCT03784040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24964351|NCT03783728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24964352|NCT03783728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24790222|NCT01941524|Poractant alfa|poractant alfa|mesh-list
24964368|NCT03783754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964369|NCT03783754|Vasodilator Agents|vasodilator agents|mesh-ancestor
25078910|NCT03352700|Anesthetics|anesthetics|mesh-ancestor
25078911|NCT03352700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24964370|NCT03783754|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24964371|NCT03783754|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24964373|NCT03783754|Natriuretic Agents|natriuretic agents|mesh-ancestor
24964394|NCT03783676|Remifentanil|remifentanil|mesh-list
24964395|NCT03783676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24964396|NCT03783676|Narcotics|narcotics|mesh-ancestor
24964397|NCT03783676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24964398|NCT03783676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202213|NCT02722759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24964400|NCT03783676|Sensory System Agents|sensory system agents|mesh-ancestor
25078936|NCT03352362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25078937|NCT03352362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25078938|NCT03352362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25078939|NCT03352362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078940|NCT03352362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078941|NCT03352362|Antipyretics|antipyretics|mesh-ancestor
25078942|NCT03352349|Terlipressin|terlipressin|mesh-list
24964435|NCT03783429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964436|NCT03783429|Protective Agents|protective agents|mesh-ancestor
24964437|NCT03783429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761021|NCT01760694|Leucovorin|leucovorin|mesh-list
24761166|NCT01761318|Hormones|hormones|mesh-ancestor
24761235|NCT01761877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24964439|NCT03783182|Betamethasone Valerate|betamethasone valerate|mesh-list
24964440|NCT03783182|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24964441|NCT03783182|Betamethasone benzoate|betamethasone benzoate|mesh-list
24964442|NCT03783182|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24964443|NCT03783182|Glucocorticoids|glucocorticoids|mesh-ancestor
24964444|NCT03783182|Hormones|hormones|mesh-ancestor
24483595|NCT00444223|Fluorides|fluorides|mesh-list
24964468|NCT03782987|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24964469|NCT03782987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24964470|NCT03782987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24964471|NCT03782987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964472|NCT03782987|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25662786|NCT01650194|Glucocorticoids|glucocorticoids|mesh-ancestor
24761388|NCT01762514|Amifostine|amifostine|mesh-list
24761524|NCT01762995|Antiviral Agents|antiviral agents|mesh-ancestor
24552426|NCT03164447|UB-421|ub-421|mesh-list
25662787|NCT01650194|Hormones|hormones|mesh-ancestor
24964506|NCT03782805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24964508|NCT03782662|Rifampin|rifampin|mesh-list
24964509|NCT03782662|Verapamil|verapamil|mesh-list
24964510|NCT03782662|Midazolam|midazolam|mesh-list
24964511|NCT03782662|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24964512|NCT03782662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24964513|NCT03782662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24964514|NCT03782662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964515|NCT03782662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24964516|NCT03782662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24964517|NCT03782662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24964518|NCT03782662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24964519|NCT03782662|Anesthetics, General|anesthetics, general|mesh-ancestor
24964520|NCT03782662|Anesthetics|anesthetics|mesh-ancestor
24964521|NCT03782662|GABA Modulators|gaba modulators|mesh-ancestor
24964522|NCT03782662|GABA Agents|gaba agents|mesh-ancestor
24964523|NCT03782662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24964524|NCT03782662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964525|NCT03782662|Antifungal Agents|antifungal agents|mesh-ancestor
24964526|NCT03782662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24964527|NCT03782662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25202214|NCT02722759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24964528|NCT03782662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24808296|NCT02026479|Dexamethasone|dexamethasone|mesh-list
24964558|NCT03782025|Hemostatics|hemostatics|mesh-ancestor
24964559|NCT03782025|Coagulants|coagulants|mesh-ancestor
24964560|NCT03782025|Vitamins|vitamins|mesh-ancestor
24964562|NCT03782025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964563|NCT03781947|Antarelix|antarelix|mesh-list
24964564|NCT03781947|Hormone Antagonists|hormone antagonists|mesh-ancestor
24964565|NCT03781947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24964566|NCT03781947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671275|NCT01324596|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24671276|NCT01324596|Prednisolone phosphate|prednisolone phosphate|mesh-list
24671277|NCT01324596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24671278|NCT01324596|Immunologic Factors|immunologic factors|mesh-ancestor
24671279|NCT01324596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671280|NCT01324596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24671281|NCT01324596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24671282|NCT01324596|Alkylating Agents|alkylating agents|mesh-ancestor
24671283|NCT01324596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671284|NCT01324596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607442|NCT04597697|Insulin|insulin|mesh-list
24762313|NCT01767545|Antiemetics|antiemetics|mesh-ancestor
24964596|NCT03781869|Etoposide phosphate|etoposide phosphate|mesh-list
24964597|NCT03781869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24964598|NCT03781869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24964599|NCT03781869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24964600|NCT03781869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24885454|NCT05172518|Taxane|taxane|mesh-list
24964601|NCT03781869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24964602|NCT03781869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964652|NCT03781544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24964653|NCT03781544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964655|NCT03781544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24964656|NCT03781544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24964657|NCT03781544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24964658|NCT03781544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24964659|NCT03781544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24964660|NCT03781544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964661|NCT03781544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24964662|NCT03781544|Narcotics|narcotics|mesh-ancestor
24964663|NCT03781544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24964664|NCT03781713|Anti-Infective Agents|anti-infective agents|mesh-list
24964665|NCT03781713|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24964671|NCT03781505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964672|NCT03781505|Sensory System Agents|sensory system agents|mesh-ancestor
24964673|NCT03781505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24964674|NCT03781505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24964675|NCT03781505|Analgesics|analgesics|mesh-ancestor
24964676|NCT03781505|Antipyretics|antipyretics|mesh-ancestor
24964677|NCT03781700|Prednisolone|prednisolone|mesh-list
24964678|NCT03781700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24964681|NCT03781700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25078948|NCT03352115|Prednisolone|prednisolone|mesh-list
24583179|NCT00873626|Ciprofloxacin|ciprofloxacin|mesh-list
24626959|NCT01089452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24626960|NCT01089452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24626961|NCT01089452|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24626962|NCT01089452|Protease Inhibitors|protease inhibitors|mesh-ancestor
24626963|NCT01089452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626964|NCT01089465|Dermatologic Agents|dermatologic agents|mesh-list
24763784|NCT01776853|Levan|levan|mesh-list
24626975|NCT01089621|Antidepressive Agents|antidepressive agents|mesh-ancestor
24626976|NCT01089621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24626977|NCT01089621|Dopamine Agents|dopamine agents|mesh-ancestor
25851374|NCT00053820|Aldesleukin|aldesleukin|mesh-list
24626978|NCT01089660|Vaccines|vaccines|mesh-list
24626979|NCT01089660|Immunologic Factors|immunologic factors|mesh-ancestor
24626980|NCT01089660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626981|NCT01089855|Carbamazepine|carbamazepine|mesh-list
24626982|NCT01089855|Anticonvulsants|anticonvulsants|mesh-ancestor
24626983|NCT01089855|Antimanic Agents|antimanic agents|mesh-ancestor
24626984|NCT01089855|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24626985|NCT01089855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25851375|NCT00053820|Fluorouracil|fluorouracil|mesh-list
25851376|NCT00053820|Antimetabolites|antimetabolites|mesh-ancestor
25851377|NCT00053820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626986|NCT01089855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626987|NCT01089855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24626988|NCT01089855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24626989|NCT01089855|Analgesics|analgesics|mesh-ancestor
24626990|NCT01089855|Sensory System Agents|sensory system agents|mesh-ancestor
24626991|NCT01089855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24626992|NCT01089855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24626993|NCT01089855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24626994|NCT01089855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626995|NCT01089855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24626996|NCT01089855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24626997|NCT01089933|Anesthetics|anesthetics|mesh-list
24626998|NCT01089933|Anesthetics, Local|anesthetics, local|mesh-list
24626999|NCT01089933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24627000|NCT01089933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078951|NCT03352115|Hormones|hormones|mesh-ancestor
24964711|NCT03781115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24964712|NCT03781115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964713|NCT03781115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24964714|NCT03781115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24964736|NCT03781011|Choline|choline|mesh-list
24964737|NCT03781011|Lipotropic Agents|lipotropic agents|mesh-ancestor
24964738|NCT03781011|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24964739|NCT03781011|Antimetabolites|antimetabolites|mesh-ancestor
24964752|NCT03780673|Simvastatin|simvastatin|mesh-list
24964753|NCT03780673|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24510928|NCT00566683|Meperidine|meperidine|mesh-list
25044723|NCT01055444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25074940|NCT03385057|Ibuprofen|ibuprofen|mesh-list
24847994|NCT05289323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24847995|NCT05289323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847996|NCT05289323|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24847997|NCT05289323|Autonomic Agents|autonomic agents|mesh-ancestor
24847998|NCT05289323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24485342|NCT00452608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24964754|NCT03780673|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24964755|NCT03780673|Antimetabolites|antimetabolites|mesh-ancestor
24964756|NCT03780673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765087|NCT01785979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24964757|NCT03780673|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24765317|NCT01787669|Antiemetics|antiemetics|mesh-ancestor
24765395|NCT01788332|Olaparib|olaparib|mesh-list
24964758|NCT03780673|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24964759|NCT03780673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24964760|NCT03780673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24964761|NCT03780673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24964762|NCT03780673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24964764|NCT03780686|Norepinephrine|norepinephrine|mesh-list
24964765|NCT03780686|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24964766|NCT03780686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24964767|NCT03780686|Adrenergic Agents|adrenergic agents|mesh-ancestor
24964768|NCT03780686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24964769|NCT03780686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964770|NCT03780686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964771|NCT03780686|Sympathomimetics|sympathomimetics|mesh-ancestor
24964772|NCT03780686|Autonomic Agents|autonomic agents|mesh-ancestor
24964773|NCT03780686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24964774|NCT03780686|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24766480|NCT01795131|Vitamin B Complex|vitamin b complex|mesh-ancestor
24766563|NCT01795430|Etoposide phosphate|etoposide phosphate|mesh-list
24964860|NCT03779776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964861|NCT03780049|Leucovorin|leucovorin|mesh-list
24964862|NCT03780049|Fluorouracil|fluorouracil|mesh-list
24964863|NCT03780049|Oxaliplatin|oxaliplatin|mesh-list
24964864|NCT03780049|Antimetabolites|antimetabolites|mesh-ancestor
24964865|NCT03780049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964866|NCT03780049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24964899|NCT03779789|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24964900|NCT03779789|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24964901|NCT03779789|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24964902|NCT03779789|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24964915|NCT03779516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24964916|NCT03779516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964917|NCT03779516|Sensory System Agents|sensory system agents|mesh-ancestor
24964918|NCT03779516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202215|NCT02722759|Analgesics|analgesics|mesh-ancestor
25202216|NCT02722759|Sensory System Agents|sensory system agents|mesh-ancestor
25202217|NCT02722759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202218|NCT02722759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662788|NCT01650194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25662789|NCT01650194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662790|NCT01650194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25662791|NCT01650194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662792|NCT01650194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25662793|NCT01650194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25662794|NCT01650194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662795|NCT01650194|Hormone Antagonists|hormone antagonists|mesh-ancestor
25662796|NCT01650194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25662797|NCT01650246|Lesinurad|lesinurad|mesh-list
25662798|NCT01650246|Gout Suppressants|gout suppressants|mesh-ancestor
25662799|NCT01650246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25662800|NCT01650246|Uricosuric Agents|uricosuric agents|mesh-ancestor
25662801|NCT01650246|Renal Agents|renal agents|mesh-ancestor
24767296|NCT01799863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24767438|NCT01800708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24964923|NCT03779516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964924|NCT03779451|Progesterone|progesterone|mesh-list
24964925|NCT03779451|Progestins|progestins|mesh-ancestor
24464244|NCT00363909|Antidepressive Agents|antidepressive agents|mesh-ancestor
24464245|NCT00363909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24464246|NCT00363909|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24464247|NCT00363909|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24964937|NCT03779464|Gemcitabine|gemcitabine|mesh-list
24790781|NCT01945099|Insulin|insulin|mesh-list
24790852|NCT01945684|Cholinergic Agents|cholinergic agents|mesh-ancestor
24790853|NCT01945684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24790854|NCT01945684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790855|NCT01945684|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24790856|NCT01945684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24790857|NCT01945736|Methadone|methadone|mesh-list
24790858|NCT01945736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24790859|NCT01945736|Narcotics|narcotics|mesh-ancestor
24790860|NCT01945736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24790861|NCT01945736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790862|NCT01945736|Analgesics|analgesics|mesh-ancestor
24767505|NCT01801228|Diuretics|diuretics|mesh-ancestor
24790863|NCT01945736|Sensory System Agents|sensory system agents|mesh-ancestor
24790864|NCT01945736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24790865|NCT01945736|Antitussive Agents|antitussive agents|mesh-ancestor
24965004|NCT03779360|Clindamycin|clindamycin|mesh-list
24965005|NCT03779360|Clindamycin palmitate|clindamycin palmitate|mesh-list
25078994|NCT03351517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078995|NCT03351517|Analgesics|analgesics|mesh-ancestor
24769204|NCT01813162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24769352|NCT01813812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24965018|NCT03779360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24965019|NCT03779360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24627093|NCT01090661|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24627095|NCT01090661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24627096|NCT01090661|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24627097|NCT01090661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24627098|NCT01090661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627099|NCT01090661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627100|NCT01090661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25202219|NCT02722759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25851378|NCT00053820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24579796|NCT00857831|Calcium|calcium|mesh-list
24627101|NCT01090661|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24627102|NCT01090661|Contraceptive Agents|contraceptive agents|mesh-ancestor
24627103|NCT01090661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24627104|NCT01090661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627105|NCT01090661|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24965080|NCT03779100|Immunoglobulins|immunoglobulins|mesh-list
24965081|NCT03779100|Immunologic Factors|immunologic factors|mesh-ancestor
24965082|NCT03779100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965083|NCT03779100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965084|NCT03779100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24965085|NCT03779100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24965086|NCT03779100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965098|NCT03778723|Fentanyl|fentanyl|mesh-list
24965099|NCT03778723|Anesthetics|anesthetics|mesh-list
24965100|NCT03778723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24965101|NCT03778723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965102|NCT03778723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25662802|NCT01650298|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
25851379|NCT00053820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079023|NCT03351296|Growth Inhibitors|growth inhibitors|mesh-ancestor
25079024|NCT03351296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25079025|NCT03351296|Antimetabolites|antimetabolites|mesh-ancestor
25079026|NCT03351296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079027|NCT03351296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25079028|NCT03351296|Alkylating Agents|alkylating agents|mesh-ancestor
25079029|NCT03351296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25079030|NCT03351205|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25079031|NCT03351205|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24464250|NCT00363909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24452723|NCT05457530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24452725|NCT05457465|Anticonvulsants|anticonvulsants|mesh-ancestor
24452727|NCT05457361|Homoharringtonine|homoharringtonine|mesh-list
25079032|NCT03351205|Estradiol|estradiol|mesh-list
25079033|NCT03351205|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25079034|NCT03351205|Dydrogesterone|dydrogesterone|mesh-list
25079035|NCT03351205|Estrogens|estrogens|mesh-ancestor
25079036|NCT03351205|Hormones|hormones|mesh-ancestor
25079037|NCT03351205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25202220|NCT02722759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25202221|NCT02722746|Epinephrine|epinephrine|mesh-list
25202222|NCT02722746|Ropivacaine|ropivacaine|mesh-list
25202223|NCT02722746|Anesthetics, Local|anesthetics, local|mesh-ancestor
25202224|NCT02722746|Anesthetics|anesthetics|mesh-ancestor
25079038|NCT03351205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965075|NCT03779087|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25079039|NCT03351205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25079040|NCT03351205|Contraceptive Agents|contraceptive agents|mesh-ancestor
25079041|NCT03351205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25079042|NCT03351205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25079043|NCT03351205|Progestins|progestins|mesh-ancestor
25079044|NCT03351062|Tamoxifen|tamoxifen|mesh-list
25079045|NCT03351062|Toremifene|toremifene|mesh-list
25079046|NCT03351062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25079047|NCT03351062|Hormone Antagonists|hormone antagonists|mesh-ancestor
25079050|NCT03351062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25079051|NCT03351062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079052|NCT03351062|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25079053|NCT03351062|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25079054|NCT03351062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24627137|NCT01090713|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
24627138|NCT01090713|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24627139|NCT01090713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650483|NCT01225913|Autonomic Agents|autonomic agents|mesh-ancestor
25851380|NCT00053820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25851381|NCT00053820|Immunologic Factors|immunologic factors|mesh-ancestor
25851382|NCT00053820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627161|NCT01090830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25851383|NCT00053820|Antiviral Agents|antiviral agents|mesh-ancestor
24965205|NCT03778567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24965206|NCT03778567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24965207|NCT03778567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965208|NCT03778567|Antiviral Agents|antiviral agents|mesh-ancestor
24485005|NCT00451100|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24965286|NCT03777956|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24485061|NCT00451373|Daptomycin|daptomycin|mesh-list
24464304|NCT00364143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24464305|NCT00364195|Tesmilifene|tesmilifene|mesh-list
25851384|NCT00053820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25851385|NCT00053820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25851386|NCT00053820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24579975|NCT00859118|Axitinib|axitinib|mesh-list
24965287|NCT03777956|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24965288|NCT03777956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24965289|NCT03777956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965290|NCT03777878|Oxytocin|oxytocin|mesh-list
24965291|NCT03777878|Carbetocin|carbetocin|mesh-list
24965292|NCT03777878|Oxytocics|oxytocics|mesh-ancestor
24965293|NCT03777878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24965294|NCT03777878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464336|NCT00364429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464337|NCT00364429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24464338|NCT00364429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24464339|NCT00364429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24464340|NCT00364429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24464341|NCT00364429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24464342|NCT00364429|Dopamine Agents|dopamine agents|mesh-ancestor
24464343|NCT00364429|Anticonvulsants|anticonvulsants|mesh-ancestor
24464344|NCT00364429|Antiemetics|antiemetics|mesh-ancestor
24464345|NCT00364429|Autonomic Agents|autonomic agents|mesh-ancestor
25851387|NCT00053833|Irinotecan|irinotecan|mesh-list
25851388|NCT00053833|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24965538|NCT03776058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965539|NCT03776058|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24965540|NCT03776058|Hormone Antagonists|hormone antagonists|mesh-ancestor
24965541|NCT03776058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24965542|NCT03776032|Darbepoetin alfa|darbepoetin alfa|mesh-list
24965543|NCT03776032|Hematinics|hematinics|mesh-ancestor
24965544|NCT03775798|Antiviral Agents|antiviral agents|mesh-list
24965681|NCT03775382|Micronutrients|micronutrients|mesh-ancestor
24965682|NCT03775382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662803|NCT01650298|Thrombin|thrombin|mesh-list
25662804|NCT01650298|Hemostatics|hemostatics|mesh-ancestor
25662805|NCT01650298|Coagulants|coagulants|mesh-ancestor
25662806|NCT01650298|Antithrombins|antithrombins|mesh-ancestor
25662807|NCT01650298|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25662808|NCT01650298|Protease Inhibitors|protease inhibitors|mesh-ancestor
25851389|NCT00053833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25851390|NCT00053833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851391|NCT00053833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965683|NCT03775382|Antioxidants|antioxidants|mesh-ancestor
24965684|NCT03775382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965685|NCT03775382|Protective Agents|protective agents|mesh-ancestor
25079055|NCT03350737|Heparin|heparin|mesh-list
25079056|NCT03350737|Anticoagulants|anticoagulants|mesh-ancestor
25851392|NCT00053833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965742|NCT03774953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965743|NCT03774706|Misoprostol|misoprostol|mesh-list
24965744|NCT03774706|Tranexamic Acid|tranexamic acid|mesh-list
24965745|NCT03774706|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24965746|NCT03774706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24965747|NCT03774706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965748|NCT03774706|Hemostatics|hemostatics|mesh-ancestor
24965749|NCT03774706|Coagulants|coagulants|mesh-ancestor
24965750|NCT03774706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24965751|NCT03774706|Abortifacient Agents|abortifacient agents|mesh-ancestor
24965752|NCT03774706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24965753|NCT03774706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965754|NCT03774706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24965755|NCT03774706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24965756|NCT03774706|Oxytocics|oxytocics|mesh-ancestor
24965757|NCT03774771|Cinacalcet|cinacalcet|mesh-list
24791586|NCT03873246|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24965758|NCT03774771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24965759|NCT03774771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965760|NCT03774771|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24965761|NCT03774771|Hormone Antagonists|hormone antagonists|mesh-ancestor
24965769|NCT03774693|Analgesics|analgesics|mesh-ancestor
24965770|NCT03774693|Sensory System Agents|sensory system agents|mesh-ancestor
24965771|NCT03774693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24965777|NCT03774836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24965818|NCT03773991|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24965819|NCT03773991|Vasodilator Agents|vasodilator agents|mesh-ancestor
24965820|NCT03773991|Gasotransmitters|gasotransmitters|mesh-ancestor
24965821|NCT03773991|Protective Agents|protective agents|mesh-ancestor
24965822|NCT03774108|Metformin|metformin|mesh-list
24965823|NCT03774108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24965824|NCT03774108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965825|NCT03774446|Roscovitine|roscovitine|mesh-list
24965826|NCT03774446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965827|NCT03774446|Antiviral Agents|antiviral agents|mesh-ancestor
24965828|NCT03774446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24791725|NCT03333005|Miconazole|miconazole|mesh-list
24791726|NCT03333005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24965846|NCT03773744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24965847|NCT03773744|Alkylating Agents|alkylating agents|mesh-ancestor
24965848|NCT03773744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965849|NCT03773744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965850|NCT03773744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24966005|NCT03772106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608077|NCT02360280|Midazolam|midazolam|mesh-list
24966006|NCT03772106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24966007|NCT03772106|Anesthetics, General|anesthetics, general|mesh-ancestor
25202225|NCT02722746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24581920|NCT00866684|Tacrolimus|tacrolimus|mesh-list
24966008|NCT03772106|Anesthetics|anesthetics|mesh-ancestor
24966009|NCT03772106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24966010|NCT03772106|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24966011|NCT03772054|Propofol|propofol|mesh-list
24966012|NCT03772054|Sevoflurane|sevoflurane|mesh-list
24966013|NCT03772054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24966014|NCT03772054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24966015|NCT03772054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966016|NCT03772054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24966017|NCT03772054|Anesthetics, General|anesthetics, general|mesh-ancestor
24966018|NCT03772054|Anesthetics|anesthetics|mesh-ancestor
24966019|NCT03772054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24966058|NCT03771755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966059|NCT03771755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966060|NCT03771729|Valsartan|valsartan|mesh-list
24966061|NCT03771729|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24966082|NCT03771781|Empagliflozin|empagliflozin|mesh-list
24966083|NCT03771781|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24777627|NCT01865305|Insulin|insulin|mesh-list
24966107|NCT03771638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966109|NCT03771638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24966202|NCT03770637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24966203|NCT03770637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464385|NCT00364559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464386|NCT00364572|Etanercept|etanercept|mesh-list
24464387|NCT00364572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24464388|NCT00364572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24464389|NCT00364572|Analgesics|analgesics|mesh-ancestor
24464390|NCT00364572|Sensory System Agents|sensory system agents|mesh-ancestor
24464391|NCT00364572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202226|NCT02722746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464392|NCT00364572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464393|NCT00364572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24464394|NCT00364572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24464395|NCT00364572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24464396|NCT00364572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24464397|NCT00364572|Immunologic Factors|immunologic factors|mesh-ancestor
24464398|NCT00364702|Methylphenidate|methylphenidate|mesh-list
24966204|NCT03770637|Incretins|incretins|mesh-ancestor
24966205|NCT03770767|Insulin|insulin|mesh-list
24966206|NCT03770767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24966207|NCT03770767|Insulin Aspart|insulin aspart|mesh-list
24966208|NCT03770767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24966209|NCT03770767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966210|NCT03770208|Lidocaine|lidocaine|mesh-list
24966211|NCT03770208|Anesthetics, Local|anesthetics, local|mesh-ancestor
24966212|NCT03770208|Anesthetics|anesthetics|mesh-ancestor
24966213|NCT03770208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24966214|NCT03770208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079058|NCT03350737|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24965106|NCT03778723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25851393|NCT00053872|Cisplatin|cisplatin|mesh-list
25851394|NCT00053872|Vincristine|vincristine|mesh-list
25851395|NCT00053872|Lomustine|lomustine|mesh-list
25662809|NCT01650298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25662810|NCT01650298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662811|NCT01650298|Anticoagulants|anticoagulants|mesh-ancestor
25662812|NCT01650402|Antihypertensive Agents|antihypertensive agents|mesh-list
25662813|NCT01650519|Ibuprofen|ibuprofen|mesh-list
25662814|NCT01650519|Ketorolac|ketorolac|mesh-list
25662815|NCT01650519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25662816|NCT01650519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25662817|NCT01650519|Analgesics|analgesics|mesh-ancestor
25662818|NCT01650519|Sensory System Agents|sensory system agents|mesh-ancestor
25662819|NCT01650519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25851396|NCT00053872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851406|NCT00053885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817246|NCT02082067|Morphine|morphine|mesh-list
25851407|NCT00053885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594040|NCT00931957|Analgesics|analgesics|mesh-ancestor
25079111|NCT03350334|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25079112|NCT03350334|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25079113|NCT03350334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25079114|NCT03350334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25079115|NCT03350334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079116|NCT03350334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25079117|NCT03350334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079118|NCT03350334|Analgesics|analgesics|mesh-ancestor
24853642|NCT02269358|Methotrexate|methotrexate|mesh-list
24966272|NCT03770013|Autonomic Agents|autonomic agents|mesh-ancestor
24966274|NCT03769935|Cisplatin|cisplatin|mesh-list
24966275|NCT03769935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24966276|NCT03769935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24966277|NCT03769935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24966278|NCT03769935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24966279|NCT03769935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966280|NCT03769935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792206|NCT05411718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24944330|NCT03961360|Antipyretics|antipyretics|mesh-ancestor
24792207|NCT05411718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24792208|NCT05411718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24792209|NCT05411718|Antipyretics|antipyretics|mesh-ancestor
24792210|NCT05411718|Gout Suppressants|gout suppressants|mesh-ancestor
24792211|NCT05411679|Olaparib|olaparib|mesh-list
24792212|NCT05411679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24792213|NCT05411679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24792214|NCT05411679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792215|NCT05411679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24792216|NCT05411666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24464536|NCT00365313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24464537|NCT00365313|Analgesics|analgesics|mesh-ancestor
24808948|NCT02029950|Immunologic Factors|immunologic factors|mesh-ancestor
25851408|NCT00053911|Tamoxifen|tamoxifen|mesh-list
24464586|NCT00365339|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24464587|NCT00365339|Histamine Antagonists|histamine antagonists|mesh-ancestor
25202228|NCT02722746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202229|NCT02722746|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25202230|NCT02722746|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25202231|NCT02722746|Adrenergic Agents|adrenergic agents|mesh-ancestor
25202232|NCT02722746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24464592|NCT00365560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24464593|NCT00365560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464594|NCT00365560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24464595|NCT00365560|Respiratory System Agents|respiratory system agents|mesh-ancestor
24464596|NCT00365560|Parasympatholytics|parasympatholytics|mesh-ancestor
24966297|NCT03769818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966298|NCT03769818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24966299|NCT03769818|Glucocorticoids|glucocorticoids|mesh-ancestor
24966300|NCT03769818|Hormones|hormones|mesh-ancestor
24966301|NCT03769818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24966302|NCT03769818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24966303|NCT03769818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24966304|NCT03769818|Protease Inhibitors|protease inhibitors|mesh-ancestor
24966305|NCT03769818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966306|NCT03769818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966307|NCT03769818|Anesthetics, Local|anesthetics, local|mesh-ancestor
24966308|NCT03769818|Anesthetics|anesthetics|mesh-ancestor
24966346|NCT03768908|Lumefantrine|lumefantrine|mesh-list
24966347|NCT03768908|Artemether|artemether|mesh-list
24966348|NCT03768908|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24966349|NCT03768908|Amodiaquine|amodiaquine|mesh-list
24966350|NCT03768908|Antimalarials|antimalarials|mesh-ancestor
24966351|NCT03768908|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24966352|NCT03768908|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24966353|NCT03768908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24966354|NCT03768908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24966355|NCT03768908|Antiviral Agents|antiviral agents|mesh-ancestor
24464597|NCT00365560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24464598|NCT00365560|Cholinergic Agents|cholinergic agents|mesh-ancestor
24464625|NCT00365612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24464626|NCT00365612|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24464627|NCT00365612|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24464628|NCT00365612|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24464629|NCT00365612|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24464631|NCT00365638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24464632|NCT00365638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24464633|NCT00365638|Antimetabolites|antimetabolites|mesh-ancestor
24464634|NCT00365638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464635|NCT00365638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24464636|NCT00365638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24464637|NCT00365638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464638|NCT00365742|Simvastatin|simvastatin|mesh-list
24464639|NCT00365742|Red yeast rice|red yeast rice|mesh-list
24464640|NCT00365742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24464641|NCT00365742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25851409|NCT00053911|Cyclophosphamide|cyclophosphamide|mesh-list
25662820|NCT01650519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662821|NCT01650519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25662822|NCT01650519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25851410|NCT00053911|Docetaxel|docetaxel|mesh-list
25851411|NCT00053911|Fluorouracil|fluorouracil|mesh-list
25851412|NCT00053911|Epirubicin|epirubicin|mesh-list
25851413|NCT00053911|Anastrozole|anastrozole|mesh-list
25851414|NCT00053911|Goserelin|goserelin|mesh-list
25851415|NCT00053911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25851416|NCT00053911|Immunologic Factors|immunologic factors|mesh-ancestor
25851417|NCT00053911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464760|NCT00366652|Antidepressive Agents|antidepressive agents|mesh-ancestor
24464761|NCT00366652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24464762|NCT00366652|Dopamine Agents|dopamine agents|mesh-ancestor
24464763|NCT00366652|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24464764|NCT00366652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966441|NCT03768037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24966442|NCT03768024|Hydromorphone|hydromorphone|mesh-list
24966443|NCT03768024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24966444|NCT03768024|Narcotics|narcotics|mesh-ancestor
24966445|NCT03768024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24966446|NCT03768024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966447|NCT03768024|Analgesics|analgesics|mesh-ancestor
24966448|NCT03768024|Sensory System Agents|sensory system agents|mesh-ancestor
25202233|NCT02722746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202234|NCT02722746|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24966451|NCT03767920|Dexamethasone acetate|dexamethasone acetate|mesh-list
24966452|NCT03767920|Bupivacaine|bupivacaine|mesh-list
24966453|NCT03767920|BB 1101|bb 1101|mesh-list
24966454|NCT03767920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24966457|NCT03767920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24486392|NCT00457678|Growth Substances|growth substances|mesh-ancestor
24966471|NCT03767920|Sensory System Agents|sensory system agents|mesh-ancestor
24966473|NCT03767660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24966474|NCT03767660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24966475|NCT03767660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24966476|NCT03767660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24966477|NCT03767660|Antifungal Agents|antifungal agents|mesh-ancestor
24966478|NCT03767660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24966479|NCT03767660|Immunologic Factors|immunologic factors|mesh-ancestor
24966480|NCT03767660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966482|NCT03767569|Inositol|inositol|mesh-list
24966483|NCT03767569|Hematinics|hematinics|mesh-ancestor
24966484|NCT03767569|Vitamin B Complex|vitamin b complex|mesh-ancestor
24966485|NCT03767569|Vitamins|vitamins|mesh-ancestor
24966486|NCT03767569|Micronutrients|micronutrients|mesh-ancestor
24966487|NCT03767569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966488|NCT03767504|Thymol|thymol|mesh-list
24966489|NCT03767504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24966490|NCT03767504|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24966491|NCT03767504|Antifungal Agents|antifungal agents|mesh-ancestor
24464829|NCT00367081|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24464831|NCT00367081|Antimalarials|antimalarials|mesh-ancestor
24464832|NCT00367081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24464833|NCT00367081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25662823|NCT01650519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25662824|NCT01650519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25662825|NCT01650519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662826|NCT01650545|Cyclosporine|cyclosporine|mesh-list
25662827|NCT01650545|Sirolimus|sirolimus|mesh-list
25662828|NCT01650545|Tacrolimus|tacrolimus|mesh-list
25662829|NCT01650545|Cyclosporins|cyclosporins|mesh-list
25662830|NCT01650545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24966492|NCT03767439|Nivolumab|nivolumab|mesh-list
24966493|NCT03767439|Ipilimumab|ipilimumab|mesh-list
25662831|NCT01650545|Immunologic Factors|immunologic factors|mesh-ancestor
25851434|NCT00053911|Hormone Antagonists|hormone antagonists|mesh-ancestor
25851435|NCT00053911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24966494|NCT03767439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24966495|NCT03767439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24464870|NCT00367185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464871|NCT00367185|Leprostatic Agents|leprostatic agents|mesh-ancestor
24464872|NCT00367185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24464873|NCT00367185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24464874|NCT00367185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24464875|NCT00367185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24464876|NCT00367185|Growth Substances|growth substances|mesh-ancestor
24464885|NCT00367211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464886|NCT00367211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24464887|NCT00367211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25268765|NCT02414490|gamma-Globulins|gamma-globulins|mesh-list
24464928|NCT00367315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24464929|NCT00367315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464930|NCT00367315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464931|NCT00367315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24464932|NCT00367315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24464933|NCT00367315|Analgesics|analgesics|mesh-ancestor
24966566|NCT03766997|Betamethasone|betamethasone|mesh-list
24966567|NCT03766997|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
24453190|NCT05238831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24453191|NCT05238831|Tubulin Modulators|tubulin modulators|mesh-ancestor
24453192|NCT05238831|Antimitotic Agents|antimitotic agents|mesh-ancestor
24453193|NCT05238831|Mitosis Modulators|mitosis modulators|mesh-ancestor
24453194|NCT05238831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24453195|NCT05238831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24453196|NCT05238831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24453197|NCT05238831|Growth Substances|growth substances|mesh-ancestor
24453198|NCT05238831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464964|NCT00367445|Insulin|insulin|mesh-list
24464965|NCT00367445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24464966|NCT00367445|Insulin Glargine|insulin glargine|mesh-list
24464967|NCT00367445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24464968|NCT00367445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464969|NCT00367471|Paclitaxel|paclitaxel|mesh-list
24464970|NCT00367471|Carboplatin|carboplatin|mesh-list
24966568|NCT03766997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24966569|NCT03766997|Glucocorticoids|glucocorticoids|mesh-ancestor
24966571|NCT03766997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25662832|NCT01650545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662833|NCT01650545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25662834|NCT01650545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25662835|NCT01650545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662836|NCT01650545|Antifungal Agents|antifungal agents|mesh-ancestor
25662837|NCT01650545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25662838|NCT01650545|Dermatologic Agents|dermatologic agents|mesh-ancestor
25662839|NCT01650545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24637287|NCT01149629|Droxidopa|droxidopa|mesh-list
24637288|NCT01149629|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24637289|NCT01149629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24637290|NCT01149668|Abexinostat|abexinostat|mesh-list
24637291|NCT01149668|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24637292|NCT01149668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25236232|NCT02558816|Venetoclax|venetoclax|mesh-list
24966572|NCT03766997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966573|NCT03766997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24966574|NCT03766997|Respiratory System Agents|respiratory system agents|mesh-ancestor
24966575|NCT03766997|Dermatologic Agents|dermatologic agents|mesh-ancestor
24966576|NCT03766984|Diclofenac|diclofenac|mesh-list
24966583|NCT03766984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966584|NCT03766984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24966585|NCT03766984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24966586|NCT03766984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24966587|NCT03766984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966588|NCT03766984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966589|NCT03766984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24966590|NCT03766984|Narcotics|narcotics|mesh-ancestor
24966591|NCT03766984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24792440|NCT05167760|Apraclonidine|apraclonidine|mesh-list
25079159|NCT03349866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079160|NCT03349866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25079161|NCT03349866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25079162|NCT03349840|Insulin|insulin|mesh-list
25079163|NCT03349840|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25202235|NCT02722746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25202236|NCT02722746|Autonomic Agents|autonomic agents|mesh-ancestor
25202237|NCT02722746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25202238|NCT02722746|Respiratory System Agents|respiratory system agents|mesh-ancestor
25202239|NCT02722746|Mydriatics|mydriatics|mesh-ancestor
25079165|NCT03349840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25079166|NCT03349840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079168|NCT03349827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079169|NCT03349827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25079170|NCT03349827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25079171|NCT03349827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079172|NCT03349684|Metformin|metformin|mesh-list
25079173|NCT03349684|Acarbose|acarbose|mesh-list
25079174|NCT03349684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25079175|NCT03349684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079176|NCT03349684|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25079177|NCT03349684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25079178|NCT03349684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079179|NCT03349658|Anesthetics|anesthetics|mesh-list
24809069|NCT02031016|Fentanyl|fentanyl|mesh-list
24966598|NCT03766893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24966599|NCT03766893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966600|NCT03766893|Analgesics|analgesics|mesh-ancestor
24966601|NCT03766893|Sensory System Agents|sensory system agents|mesh-ancestor
24609011|NCT00994786|Pregabalin|pregabalin|mesh-list
24966602|NCT03766893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24966603|NCT03766893|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24966604|NCT03766893|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24966605|NCT03766867|Vortioxetine|vortioxetine|mesh-list
24966606|NCT03766867|Antidepressive Agents|antidepressive agents|mesh-ancestor
24966607|NCT03766867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24966608|NCT03766867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24966609|NCT03766867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24966610|NCT03766867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25662840|NCT01650545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25662841|NCT01650545|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25662842|NCT01650545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662843|NCT01650805|Imatinib Mesylate|imatinib mesylate|mesh-list
25662844|NCT01650805|Ponatinib|ponatinib|mesh-list
25662845|NCT01650805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662846|NCT01650805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25662847|NCT01650805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25662848|NCT01650805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966611|NCT03766867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966612|NCT03766867|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25662849|NCT01651000|Calcifediol|calcifediol|mesh-list
24966619|NCT03766867|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24966664|NCT03766594|Urological Agents|urological agents|mesh-ancestor
24966666|NCT03766594|Vitamin B Complex|vitamin b complex|mesh-ancestor
24465036|NCT00367627|Albendazole|albendazole|mesh-list
24465037|NCT00367627|Anthelmintics|anthelmintics|mesh-ancestor
24465038|NCT00367627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24465039|NCT00367627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24465040|NCT00367627|Anticestodal Agents|anticestodal agents|mesh-ancestor
24465041|NCT00367627|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24465042|NCT00367627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24465043|NCT00367627|Tubulin Modulators|tubulin modulators|mesh-ancestor
25851440|NCT00053911|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25851441|NCT00053911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24487554|NCT00463762|Renal Agents|renal agents|mesh-ancestor
24966748|NCT03765697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966750|NCT03765645|Piperacillin|piperacillin|mesh-list
24966751|NCT03765645|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24792654|NCT04887831|Antiviral Agents|antiviral agents|mesh-ancestor
24792655|NCT04887831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24792656|NCT04887831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24792657|NCT04887831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24792658|NCT04887831|Immunologic Factors|immunologic factors|mesh-ancestor
24792659|NCT04887831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792660|NCT04887831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24792661|NCT04854512|Metformin|metformin|mesh-list
24792662|NCT04854512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24783398|NCT01901549|Protective Agents|protective agents|mesh-ancestor
25851442|NCT00053937|Pirfenidone|pirfenidone|mesh-list
24465044|NCT00367627|Antimitotic Agents|antimitotic agents|mesh-ancestor
24465045|NCT00367627|Mitosis Modulators|mitosis modulators|mesh-ancestor
24465046|NCT00367627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465047|NCT00367627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465048|NCT00367653|Azithromycin|azithromycin|mesh-list
24465049|NCT00367653|Chloroquine|chloroquine|mesh-list
24465050|NCT00367653|Mefloquine|mefloquine|mesh-list
24465053|NCT00367653|Amebicides|amebicides|mesh-ancestor
25851443|NCT00053937|Analgesics|analgesics|mesh-ancestor
25662850|NCT01651000|Vitamins|vitamins|mesh-ancestor
25662851|NCT01651000|Micronutrients|micronutrients|mesh-ancestor
25662852|NCT01651000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662853|NCT01651000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25662854|NCT01651039|Dexamethasone|dexamethasone|mesh-list
25662855|NCT01651039|Lenalidomide|lenalidomide|mesh-list
25662856|NCT01651039|Panobinostat|panobinostat|mesh-list
24604298|NCT00978354|Furosemide|furosemide|mesh-list
24511427|NCT00568711|Antimalarials|antimalarials|mesh-ancestor
25662857|NCT01651039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25662858|NCT01651039|Antiemetics|antiemetics|mesh-ancestor
24966838|NCT03764553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966839|NCT03764553|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24784404|NCT01907867|Renal Agents|renal agents|mesh-ancestor
24966879|NCT03764462|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24966880|NCT03764462|Hormone Antagonists|hormone antagonists|mesh-ancestor
24966881|NCT03764462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24966882|NCT03764462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966883|NCT03764462|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24966884|NCT03764462|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24966885|NCT03764462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24966888|NCT03764462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24966889|NCT03764462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24465114|NCT00367913|Leprostatic Agents|leprostatic agents|mesh-ancestor
24465115|NCT00367913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24465116|NCT00367913|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24465117|NCT00367913|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24465118|NCT00367913|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24465119|NCT00367913|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24465120|NCT00367913|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24487808|NCT00465231|Fentanyl|fentanyl|mesh-list
24465227|NCT00368303|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24465228|NCT00368303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24465230|NCT00368329|Carboplatin|carboplatin|mesh-list
24465231|NCT00368329|Fluorouracil|fluorouracil|mesh-list
24465232|NCT00368329|Capecitabine|capecitabine|mesh-list
24465233|NCT00368329|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24966890|NCT03764462|Antiviral Agents|antiviral agents|mesh-ancestor
24966891|NCT03764462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24966892|NCT03764293|Sorafenib|sorafenib|mesh-list
24966893|NCT03764293|Apatinib|apatinib|mesh-list
24966894|NCT03764293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24966895|NCT03764293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24966896|NCT03764293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966897|NCT03764293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966924|NCT03764241|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24966925|NCT03764241|Antithrombins|antithrombins|mesh-ancestor
24966926|NCT03764241|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24966927|NCT03764241|Protease Inhibitors|protease inhibitors|mesh-ancestor
24966928|NCT03764241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966929|NCT03764241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966930|NCT03764241|Anticoagulants|anticoagulants|mesh-ancestor
24966931|NCT03764241|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24966932|NCT03764241|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24966933|NCT03764241|Hemostatics|hemostatics|mesh-ancestor
24966934|NCT03764241|Coagulants|coagulants|mesh-ancestor
24627173|NCT01090882|Sensory System Agents|sensory system agents|mesh-ancestor
24627174|NCT01090882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24627175|NCT01090895|Ascorbic Acid|ascorbic acid|mesh-list
24627176|NCT01090895|Vitamins|vitamins|mesh-ancestor
24627177|NCT01090895|Micronutrients|micronutrients|mesh-ancestor
25079197|NCT03349606|Dopamine Agents|dopamine agents|mesh-ancestor
25079198|NCT03349606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25079199|NCT03349606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079200|NCT03349606|Adrenergic Agents|adrenergic agents|mesh-ancestor
25079201|NCT03349606|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25079202|NCT03349606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25079203|NCT03349606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25079204|NCT03349606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25079205|NCT03349606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25079206|NCT03349489|Insulin|insulin|mesh-list
25079207|NCT03349489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25079211|NCT03349424|Hormones|hormones|mesh-ancestor
25079212|NCT03349424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25079213|NCT03349424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079238|NCT03349190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25079239|NCT03349190|Contraceptive Agents|contraceptive agents|mesh-ancestor
25079240|NCT03349190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25079241|NCT03349190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079242|NCT03349190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25079243|NCT03349177|Cyclophosphamide|cyclophosphamide|mesh-list
25079245|NCT03349177|Fluorouracil|fluorouracil|mesh-list
25079246|NCT03349177|Epirubicin|epirubicin|mesh-list
25079247|NCT03349177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25079248|NCT03349177|Immunologic Factors|immunologic factors|mesh-ancestor
24966984|NCT03763734|Antiemetics|antiemetics|mesh-ancestor
25154807|NCT05469204|Protective Agents|protective agents|mesh-ancestor
24524453|NCT04914741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24524454|NCT04914741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24457819|NCT00335270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24457820|NCT00335270|Antitubercular Agents|antitubercular agents|mesh-ancestor
24397959|NCT00143143|Analgesics|analgesics|mesh-ancestor
24524455|NCT04914741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24966985|NCT03763734|Autonomic Agents|autonomic agents|mesh-ancestor
24465407|NCT00369447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24465409|NCT00369538|Losartan|losartan|mesh-list
24465410|NCT00369538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24465411|NCT00369538|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25851444|NCT00053937|Sensory System Agents|sensory system agents|mesh-ancestor
24627279|NCT01091727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24967162|NCT03762382|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24967163|NCT03762382|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24967164|NCT03762369|Latanoprost|latanoprost|mesh-list
24967165|NCT03762369|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24967166|NCT03762369|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24967168|NCT03762317|Analgesics|analgesics|mesh-ancestor
24967195|NCT03762096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967196|NCT03762096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851445|NCT00053937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25851446|NCT00053937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851447|NCT00053937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25851448|NCT00053937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25851449|NCT00053937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25851450|NCT00053937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25851451|NCT00053937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851452|NCT00053950|NSC 366140|nsc 366140|mesh-list
25851453|NCT00053950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851454|NCT00053963|Romidepsin|romidepsin|mesh-list
25851455|NCT00053963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25851456|NCT00053963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851457|NCT00053976|Methylprednisolone|methylprednisolone|mesh-list
24967197|NCT03762096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24967200|NCT03761511|Nicotinic Acids|nicotinic acids|mesh-list
24967201|NCT03761511|Vitamin B Complex|vitamin b complex|mesh-ancestor
24967202|NCT03761511|Vitamins|vitamins|mesh-ancestor
24967203|NCT03761511|Micronutrients|micronutrients|mesh-ancestor
24967204|NCT03761511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967205|NCT03761511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24967206|NCT03761511|Antimetabolites|antimetabolites|mesh-ancestor
25202240|NCT02722746|Sympathomimetics|sympathomimetics|mesh-ancestor
24967207|NCT03761511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967208|NCT03761511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24967209|NCT03761511|Vasodilator Agents|vasodilator agents|mesh-ancestor
24967231|NCT03761329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967232|NCT03761264|Amoxicillin|amoxicillin|mesh-list
25851458|NCT00053976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25851459|NCT00053976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25851460|NCT00053976|Prednisolone|prednisolone|mesh-list
24465475|NCT00369811|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24465476|NCT00369811|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24967234|NCT03761264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967235|NCT03761264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24967236|NCT03761264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24967238|NCT03761264|Sunscreening Agents|sunscreening agents|mesh-ancestor
24967239|NCT03761264|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24967240|NCT03761264|Protective Agents|protective agents|mesh-ancestor
24967241|NCT03761004|Levodopa|levodopa|mesh-list
24967242|NCT03761004|Carbidopa|carbidopa|mesh-list
24967243|NCT03761004|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24967248|NCT03761004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967249|NCT03761004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662859|NCT01651039|Autonomic Agents|autonomic agents|mesh-ancestor
25662860|NCT01651039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25662861|NCT01651039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662862|NCT01651039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25662863|NCT01651039|Glucocorticoids|glucocorticoids|mesh-ancestor
25662864|NCT01651039|Hormones|hormones|mesh-ancestor
25662865|NCT01651039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25662866|NCT01651039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25236346|NCT02558036|Keratolytic Agents|keratolytic agents|mesh-ancestor
25236347|NCT02558036|Dermatologic Agents|dermatologic agents|mesh-ancestor
25236348|NCT02558023|Nicardipine|nicardipine|mesh-list
25236350|NCT02558023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24967250|NCT03761004|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24967251|NCT03761004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24967252|NCT03761004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24967253|NCT03761004|Immunologic Factors|immunologic factors|mesh-ancestor
24967254|NCT03761004|Dopamine Agonists|dopamine agonists|mesh-ancestor
24793803|NCT02205047|Capecitabine|capecitabine|mesh-list
24793804|NCT02205047|Trastuzumab|trastuzumab|mesh-list
24793806|NCT02205047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793807|NCT02205047|Antimetabolites|antimetabolites|mesh-ancestor
24793808|NCT02205047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793809|NCT02205047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24488784|NCT00470015|Aldesleukin|aldesleukin|mesh-list
25851461|NCT00053976|Prednisolone acetate|prednisolone acetate|mesh-list
25851462|NCT00053976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25851463|NCT00053976|Prednisolone phosphate|prednisolone phosphate|mesh-list
24465581|NCT00370201|Colchicine|colchicine|mesh-list
24465582|NCT00370201|Gout Suppressants|gout suppressants|mesh-ancestor
24465583|NCT00370201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24465584|NCT00370201|Tubulin Modulators|tubulin modulators|mesh-ancestor
24465585|NCT00370201|Antimitotic Agents|antimitotic agents|mesh-ancestor
25851464|NCT00053976|Daclizumab|daclizumab|mesh-list
25851465|NCT00053976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25851466|NCT00053976|Antiemetics|antiemetics|mesh-ancestor
24465586|NCT00370201|Mitosis Modulators|mitosis modulators|mesh-ancestor
24465587|NCT00370201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465588|NCT00370201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465589|NCT00370240|Ropivacaine|ropivacaine|mesh-list
24465590|NCT00370240|Anesthetics, Local|anesthetics, local|mesh-ancestor
24465591|NCT00370240|Anesthetics|anesthetics|mesh-ancestor
24793824|NCT02167477|Dermatologic Agents|dermatologic agents|mesh-ancestor
24627296|NCT01091792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24627297|NCT01091792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24627298|NCT01091792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24627299|NCT01091792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24627301|NCT01091792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627302|NCT01091792|Growth Inhibitors|growth inhibitors|mesh-ancestor
24627303|NCT01091818|Midazolam|midazolam|mesh-list
24627304|NCT01091818|Dexmedetomidine|dexmedetomidine|mesh-list
24627305|NCT01091818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24609740|NCT00997997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202241|NCT02722746|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25202242|NCT02722772|Etanercept|etanercept|mesh-list
25202243|NCT02722772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24627306|NCT01091818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24627308|NCT01091818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24627309|NCT01091818|Analgesics|analgesics|mesh-ancestor
24627310|NCT01091818|Sensory System Agents|sensory system agents|mesh-ancestor
24627311|NCT01091818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24488947|NCT00470678|Ranibizumab|ranibizumab|mesh-list
24465593|NCT00370240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851467|NCT00053976|Autonomic Agents|autonomic agents|mesh-ancestor
25851468|NCT00053976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24627425|NCT01092624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627426|NCT01092624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662867|NCT01651039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662868|NCT01651039|Immunologic Factors|immunologic factors|mesh-ancestor
25662869|NCT01651039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25662870|NCT01651039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25662871|NCT01651039|Growth Substances|growth substances|mesh-ancestor
25662872|NCT01651039|Growth Inhibitors|growth inhibitors|mesh-ancestor
25662873|NCT01651039|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25662874|NCT01651039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627427|NCT01092624|Urological Agents|urological agents|mesh-ancestor
24627428|NCT01092741|Imatinib Mesylate|imatinib mesylate|mesh-list
24627429|NCT01092741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24627430|NCT01092741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24524565|NCT04703075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524566|NCT04703075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24627432|NCT01092741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627434|NCT01092806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24627435|NCT01092806|Immunologic Factors|immunologic factors|mesh-ancestor
24627436|NCT01092806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627437|NCT01092806|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24627438|NCT01092806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795322|NCT03052933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24795323|NCT03052933|Antimetabolites|antimetabolites|mesh-ancestor
24795324|NCT03052933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851469|NCT00053976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851470|NCT00053976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25851471|NCT00053976|Glucocorticoids|glucocorticoids|mesh-ancestor
25851472|NCT00053976|Hormones|hormones|mesh-ancestor
25876174|NCT03847896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24465633|NCT00370370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24465634|NCT00370370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465635|NCT00370370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24795326|NCT03052933|Antiviral Agents|antiviral agents|mesh-ancestor
24795327|NCT03052933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24795328|NCT03052933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795329|NCT03052933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24795330|NCT03052933|Immunologic Factors|immunologic factors|mesh-ancestor
24627453|NCT01092962|Cyclophosphamide|cyclophosphamide|mesh-list
24627454|NCT01092962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24627455|NCT01092962|Immunologic Factors|immunologic factors|mesh-ancestor
24627456|NCT01092962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627457|NCT01092962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24627458|NCT01092962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24627459|NCT01092962|Alkylating Agents|alkylating agents|mesh-ancestor
24627460|NCT01092962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627461|NCT01092962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965228|NCT03778593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24627462|NCT01092962|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24627463|NCT01092962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24627464|NCT01092962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24627466|NCT01092962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24627467|NCT01092962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25202244|NCT02722772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25202245|NCT02722772|Analgesics|analgesics|mesh-ancestor
24627468|NCT01092962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627470|NCT01092975|Oxymetazoline|oxymetazoline|mesh-list
24627471|NCT01092975|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24627472|NCT01092975|Mydriatics|mydriatics|mesh-ancestor
24627473|NCT01092975|Autonomic Agents|autonomic agents|mesh-ancestor
24627474|NCT01092975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24627475|NCT01092975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627476|NCT01092975|Sympathomimetics|sympathomimetics|mesh-ancestor
24465698|NCT00370591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24465699|NCT00370591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24465700|NCT00370591|Autonomic Agents|autonomic agents|mesh-ancestor
24465701|NCT00370591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24465702|NCT00370591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465703|NCT00370591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24465704|NCT00370591|Respiratory System Agents|respiratory system agents|mesh-ancestor
24465705|NCT00370591|Dermatologic Agents|dermatologic agents|mesh-ancestor
24465706|NCT00370591|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24465707|NCT00370591|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24465708|NCT00370591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24465709|NCT00370591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24465710|NCT00370591|Adrenergic Agents|adrenergic agents|mesh-ancestor
24465864|NCT00370851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465865|NCT00370851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25662875|NCT01651039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662876|NCT01651351|Protease Inhibitors|protease inhibitors|mesh-list
25662877|NCT01651351|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25662878|NCT01651351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25662879|NCT01651351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662880|NCT01651351|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25662881|NCT01651351|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25662882|NCT01651442|Zolpidem|zolpidem|mesh-list
24627557|NCT01093365|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24627558|NCT01093365|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24627559|NCT01093365|Cholinergic Agents|cholinergic agents|mesh-ancestor
24627560|NCT01093365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24627561|NCT01093365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627562|NCT01093365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796710|NCT01951599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796711|NCT01951599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796712|NCT01951677|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24796713|NCT01951677|Immunologic Factors|immunologic factors|mesh-ancestor
24796714|NCT01951677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796715|NCT01951677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24796716|NCT01951677|Antacids|antacids|mesh-ancestor
24796717|NCT01951677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851473|NCT00053976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24627564|NCT01093638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24627565|NCT01093638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627566|NCT01093768|Vasopressins|vasopressins|mesh-list
24627567|NCT01093768|Arginine Vasopressin|arginine vasopressin|mesh-list
24627568|NCT01093768|Oxytocin|oxytocin|mesh-list
24627569|NCT01093768|Oxytocics|oxytocics|mesh-ancestor
24627570|NCT01093768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24627571|NCT01093768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465947|NCT00371306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24465948|NCT00371306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465952|NCT00371319|Immunologic Factors|immunologic factors|mesh-ancestor
24465961|NCT00371319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25851474|NCT00053976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25851475|NCT00053976|Protective Agents|protective agents|mesh-ancestor
25851476|NCT00053976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25851477|NCT00053976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851478|NCT00053976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25851479|NCT00053976|Immunologic Factors|immunologic factors|mesh-ancestor
25851480|NCT00054002|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
24465969|NCT00371410|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24465970|NCT00371410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24965249|NCT03778008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24965250|NCT03778008|Antiemetics|antiemetics|mesh-ancestor
24965251|NCT03778008|Autonomic Agents|autonomic agents|mesh-ancestor
24965252|NCT03778008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24965253|NCT03778008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24965254|NCT03778008|Glucocorticoids|glucocorticoids|mesh-ancestor
24965255|NCT03778008|Hormones|hormones|mesh-ancestor
24965256|NCT03778008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25851481|NCT00054002|Trioxsalen|trioxsalen|mesh-list
24610050|NCT00999700|Cetuximab|cetuximab|mesh-list
25851482|NCT00054002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851483|NCT00054002|Dermatologic Agents|dermatologic agents|mesh-ancestor
25851484|NCT00054002|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25851485|NCT00054041|Vaccines|vaccines|mesh-list
25851486|NCT00054041|Immunologic Factors|immunologic factors|mesh-ancestor
24465980|NCT00371488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465981|NCT00371488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24465982|NCT00371488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24465983|NCT00371488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465984|NCT00371501|Aspirin|aspirin|mesh-list
25079261|NCT03349177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25079262|NCT03349177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25079263|NCT03349177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25079264|NCT03349177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771954|NCT01830530|Vasodilator Agents|vasodilator agents|mesh-ancestor
24796922|NCT01953172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796923|NCT01953172|Protective Agents|protective agents|mesh-ancestor
25851491|NCT00054054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797342|NCT01955187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24797343|NCT01955187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24797344|NCT01955187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24797346|NCT01955187|Autonomic Agents|autonomic agents|mesh-ancestor
24797347|NCT01955187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24797348|NCT01955187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24797349|NCT01955187|Glucocorticoids|glucocorticoids|mesh-ancestor
24453509|NCT04960930|Minocycline|minocycline|mesh-list
24466195|NCT00372476|Vinorelbine|vinorelbine|mesh-list
24797350|NCT01955187|Hormones|hormones|mesh-ancestor
24797351|NCT01955187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24797352|NCT01955187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24797628|NCT01956981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24797629|NCT01956981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24797630|NCT01956981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797631|NCT01956981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24797632|NCT01956981|Analgesics|analgesics|mesh-ancestor
24797633|NCT01956981|Sensory System Agents|sensory system agents|mesh-ancestor
24466254|NCT00372736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662883|NCT01651442|Trazodone|trazodone|mesh-list
25662884|NCT01651442|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25662885|NCT01651442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25662886|NCT01651442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25662887|NCT01651442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662888|NCT01651442|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25005232|NCT04368559|Renal Agents|renal agents|mesh-ancestor
24466321|NCT00373061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24466322|NCT00373061|Respiratory System Agents|respiratory system agents|mesh-ancestor
24466323|NCT00373087|Entacapone|entacapone|mesh-list
24466324|NCT00373087|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24466325|NCT00373087|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24466326|NCT00373087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466329|NCT00373126|Nicotine|nicotine|mesh-list
24466337|NCT00373126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24797877|NCT01958944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456576|NCT00331747|(T,G)-A-L|(t,g)-a-l|mesh-list
24797878|NCT01958944|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24797879|NCT01958944|Respiratory System Agents|respiratory system agents|mesh-ancestor
24895926|NCT02819479|Mannitol|mannitol|mesh-list
25851492|NCT00054054|Tubulin Modulators|tubulin modulators|mesh-ancestor
25851493|NCT00054054|Antimitotic Agents|antimitotic agents|mesh-ancestor
25851494|NCT00054054|Mitosis Modulators|mitosis modulators|mesh-ancestor
25851495|NCT00054054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851496|NCT00054054|Antimetabolites|antimetabolites|mesh-ancestor
25851497|NCT00054054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25851498|NCT00054054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25851499|NCT00054054|Immunologic Factors|immunologic factors|mesh-ancestor
25851500|NCT00054054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851501|NCT00054067|Cisplatin|cisplatin|mesh-list
25851502|NCT00054067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466342|NCT00373165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24466343|NCT00373165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24466344|NCT00373165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466345|NCT00373165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466346|NCT00373178|Metformin|metformin|mesh-list
24466347|NCT00373178|Rosiglitazone|rosiglitazone|mesh-list
24466348|NCT00373178|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25876175|NCT03847896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876176|NCT03847896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25876177|NCT03847896|Respiratory System Agents|respiratory system agents|mesh-ancestor
24466363|NCT00373282|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24798140|NCT01960829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591808|NCT00919204|Axitinib|axitinib|mesh-list
24627651|NCT01094249|Antimanic Agents|antimanic agents|mesh-ancestor
24627652|NCT01094275|Omeprazole|omeprazole|mesh-list
24627654|NCT01094275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24895943|NCT02794896|Propofol|propofol|mesh-list
24466364|NCT00373282|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24466365|NCT00373282|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25876178|NCT03847896|Glucocorticoids|glucocorticoids|mesh-ancestor
25876179|NCT03847896|Hormones|hormones|mesh-ancestor
25876180|NCT03847896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25876181|NCT03847896|Tocolytic Agents|tocolytic agents|mesh-ancestor
25876182|NCT03847896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24627776|NCT01094964|Interferons|interferons|mesh-list
24627777|NCT01094964|Interferon-alpha|interferon-alpha|mesh-list
24627778|NCT01094964|Epirubicin|epirubicin|mesh-list
24627779|NCT01094964|Mitomycins|mitomycins|mesh-list
24627780|NCT01094964|Mitomycin|mitomycin|mesh-list
24627781|NCT01094964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24627782|NCT01094964|Antiviral Agents|antiviral agents|mesh-ancestor
24658353|NCT01271283|Growth Substances|growth substances|mesh-ancestor
24627784|NCT01094964|Immunologic Factors|immunologic factors|mesh-ancestor
24627785|NCT01094964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627786|NCT01094964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24627787|NCT01094964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24895959|NCT02783404|Amoxicillin|amoxicillin|mesh-list
24466685|NCT00374621|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24466686|NCT00374621|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
24466687|NCT00374621|Misoprostol|misoprostol|mesh-list
24466688|NCT00374621|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24466689|NCT00374621|Abortifacient Agents|abortifacient agents|mesh-ancestor
24466690|NCT00374621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24466691|NCT00374621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466692|NCT00374621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25662889|NCT01651442|GABA Agonists|gaba agonists|mesh-ancestor
25662890|NCT01651442|GABA Agents|gaba agents|mesh-ancestor
25662891|NCT01651442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25662892|NCT01651442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662893|NCT01651442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25662894|NCT01651442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25662895|NCT01651442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25662896|NCT01651442|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25851508|NCT00054106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851509|NCT00054106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25851510|NCT00054106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851511|NCT00054106|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25851512|NCT00054106|Fertility Agents|fertility agents|mesh-ancestor
25851513|NCT00054106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25851514|NCT00054158|Thalidomide|thalidomide|mesh-list
25851515|NCT00054158|Dexamethasone|dexamethasone|mesh-list
25851516|NCT00054158|Doxorubicin|doxorubicin|mesh-list
24466774|NCT00374881|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24466775|NCT00374881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24466776|NCT00374881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24466777|NCT00374881|Adrenergic Agents|adrenergic agents|mesh-ancestor
24490966|NCT00480649|Xhance|xhance|mesh-list
24627924|NCT01095679|GABA Agonists|gaba agonists|mesh-ancestor
24800274|NCT01974518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24800349|NCT01975142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800421|NCT01975480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24800422|NCT01975480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800423|NCT01975480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24800424|NCT01975480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800425|NCT01975480|Antidepressive Agents|antidepressive agents|mesh-ancestor
24800426|NCT01975480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24800427|NCT01975662|Vancomycin|vancomycin|mesh-list
24800428|NCT01975662|Daptomycin|daptomycin|mesh-list
24800429|NCT01975662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24473025|NCT00401609|Carboplatin|carboplatin|mesh-list
24466855|NCT00375297|Urological Agents|urological agents|mesh-ancestor
24466856|NCT00375310|Gemcitabine|gemcitabine|mesh-list
24466857|NCT00375310|Sorafenib|sorafenib|mesh-list
24466858|NCT00375310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24466859|NCT00375310|Antimetabolites|antimetabolites|mesh-ancestor
24466860|NCT00375310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466861|NCT00375310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466862|NCT00375310|Antiviral Agents|antiviral agents|mesh-ancestor
24466863|NCT00375310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24466864|NCT00375310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466865|NCT00375310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24466866|NCT00375310|Immunologic Factors|immunologic factors|mesh-ancestor
24466867|NCT00375310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466868|NCT00375310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24466869|NCT00375362|Nitroglycerin|nitroglycerin|mesh-list
24466870|NCT00375362|Vasodilator Agents|vasodilator agents|mesh-ancestor
24466871|NCT00375375|Lactulose|lactulose|mesh-list
24800438|NCT01975714|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24800439|NCT01975714|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24800440|NCT01975714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24800441|NCT01975727|Dexamethasone|dexamethasone|mesh-list
24800678|NCT01977378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24800679|NCT01977378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24800680|NCT01977378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800681|NCT01977378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24466943|NCT00375661|Antiviral Agents|antiviral agents|mesh-ancestor
24466944|NCT00375661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24466945|NCT00375661|Antimetabolites|antimetabolites|mesh-ancestor
24466946|NCT00375661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466947|NCT00375661|Immunologic Factors|immunologic factors|mesh-ancestor
25851517|NCT00054158|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25851518|NCT00054158|Vincristine|vincristine|mesh-list
25851519|NCT00054158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25851520|NCT00054158|Antiemetics|antiemetics|mesh-ancestor
25851521|NCT00054158|Autonomic Agents|autonomic agents|mesh-ancestor
25851522|NCT00054158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24800682|NCT01977378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800683|NCT01977378|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24800684|NCT01977378|Antidepressive Agents|antidepressive agents|mesh-ancestor
24800685|NCT01977378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25236533|NCT02557087|Meperidine|meperidine|mesh-list
25236534|NCT02557087|Scopolamine|scopolamine|mesh-list
25236535|NCT02557087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25236536|NCT02557087|Narcotics|narcotics|mesh-ancestor
25236537|NCT02557087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25236538|NCT02557087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236539|NCT02557087|Analgesics|analgesics|mesh-ancestor
25236540|NCT02557087|Sensory System Agents|sensory system agents|mesh-ancestor
25236541|NCT02557087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24800686|NCT01977417|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
24800687|NCT01977417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24800688|NCT01977417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24800689|NCT01977417|Analgesics|analgesics|mesh-ancestor
24800690|NCT01977417|Sensory System Agents|sensory system agents|mesh-ancestor
24800691|NCT01977417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24800692|NCT01977417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800693|NCT01977417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24800694|NCT01977417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24800695|NCT01977430|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24800696|NCT01977430|Furosemide|furosemide|mesh-list
24800697|NCT01977430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24800698|NCT01977430|Diuretics|diuretics|mesh-ancestor
24800699|NCT01977430|Natriuretic Agents|natriuretic agents|mesh-ancestor
24800700|NCT01977430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800701|NCT01977430|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24800702|NCT01977430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24800703|NCT01977430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628008|NCT01096082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24628010|NCT01096095|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
24628011|NCT01096095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637375|NCT01149980|Citalopram|citalopram|mesh-list
24628020|NCT01096199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24628021|NCT01096199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24628022|NCT01096199|Immunologic Factors|immunologic factors|mesh-ancestor
24628023|NCT01096199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628024|NCT01096212|Sevoflurane|sevoflurane|mesh-list
24628025|NCT01096212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24801359|NCT01983124|Vemurafenib|vemurafenib|mesh-list
24801588|NCT01984099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24801589|NCT01984099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24801590|NCT01984099|Hematinics|hematinics|mesh-ancestor
24801591|NCT01984138|Estradiol|estradiol|mesh-list
24801592|NCT01984138|Estrogens|estrogens|mesh-ancestor
24801593|NCT01984138|Hormones|hormones|mesh-ancestor
24801594|NCT01984138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24801595|NCT01984138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467093|NCT00376181|Pioglitazone|pioglitazone|mesh-list
24801603|NCT01984255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24801604|NCT01984255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24801605|NCT01984255|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25079266|NCT03349112|Anesthetics, Local|anesthetics, local|mesh-ancestor
25079267|NCT03349112|Anesthetics|anesthetics|mesh-ancestor
25079268|NCT03349112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24801607|NCT01984372|Insulin|insulin|mesh-list
25079269|NCT03349112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801873|NCT01986049|Sensory System Agents|sensory system agents|mesh-ancestor
24801874|NCT01986049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24801875|NCT01986088|Sumatriptan|sumatriptan|mesh-list
24801876|NCT01986088|Eletriptan|eletriptan|mesh-list
24801877|NCT01986088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24801878|NCT01986088|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24801879|NCT01986088|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24801880|NCT01986088|Serotonin Agents|serotonin agents|mesh-ancestor
24801881|NCT01986088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24801882|NCT01986088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801883|NCT01986088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662897|NCT01651442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25662898|NCT01651442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25662899|NCT01651442|Serotonin Agents|serotonin agents|mesh-ancestor
25662900|NCT01651442|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25662901|NCT01651442|Antidepressive Agents|antidepressive agents|mesh-ancestor
25662902|NCT01651780|Heparin|heparin|mesh-list
25662903|NCT01651780|Calcium heparin|calcium heparin|mesh-list
25662904|NCT01651780|Bivalirudin|bivalirudin|mesh-list
25662905|NCT01651780|Anticoagulants|anticoagulants|mesh-ancestor
24801884|NCT01986127|Adalimumab|adalimumab|mesh-list
24801885|NCT01986127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24628047|NCT01096329|Testosterone enanthate|testosterone enanthate|mesh-list
24628048|NCT01096329|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24628050|NCT01096329|Hormones|hormones|mesh-ancestor
24628051|NCT01096329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24628052|NCT01096329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467094|NCT00376181|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
24467095|NCT00376181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24467096|NCT00376181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534245|NCT00646594|Formoterol Fumarate|formoterol fumarate|mesh-list
24467299|NCT00376987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467300|NCT00377000|Clindamycin|clindamycin|mesh-list
24467301|NCT00377000|Clindamycin palmitate|clindamycin palmitate|mesh-list
24467306|NCT00377000|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24467307|NCT00377000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851523|NCT00054158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851524|NCT00054158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24628104|NCT01096654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24628105|NCT01096654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491898|NCT00484484|Ketamine|ketamine|mesh-list
25851525|NCT00054158|Glucocorticoids|glucocorticoids|mesh-ancestor
25851526|NCT00054158|Hormones|hormones|mesh-ancestor
25851527|NCT00054158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25851528|NCT00054158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25851529|NCT00054158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851530|NCT00054158|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25851531|NCT00054158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25851532|NCT00054158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25851533|NCT00054158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24965269|NCT03778008|Vitamin B Complex|vitamin b complex|mesh-ancestor
24965270|NCT03778008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24965271|NCT03778008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24965272|NCT03778008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25079271|NCT03349112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25079272|NCT03349112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25079273|NCT03349112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25079274|NCT03349112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25079275|NCT03349112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24467350|NCT00377104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467351|NCT00377104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467352|NCT00377143|Warfarin|warfarin|mesh-list
24467353|NCT00377143|Anticoagulants|anticoagulants|mesh-ancestor
24467354|NCT00377273|Fluorouracil|fluorouracil|mesh-list
24467355|NCT00377273|Antimetabolites|antimetabolites|mesh-ancestor
25851534|NCT00054158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851535|NCT00054158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25851536|NCT00054158|Tubulin Modulators|tubulin modulators|mesh-ancestor
25851537|NCT00054158|Antimitotic Agents|antimitotic agents|mesh-ancestor
25851538|NCT00054158|Mitosis Modulators|mitosis modulators|mesh-ancestor
24467432|NCT00377624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25421071|NCT02576912|Hallucinogens|hallucinogens|mesh-ancestor
25662906|NCT01651780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25662907|NCT01651780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25201553|NCT02726867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25662908|NCT01651780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662909|NCT01651780|Antithrombins|antithrombins|mesh-ancestor
25662910|NCT01651780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25662911|NCT01651780|Protease Inhibitors|protease inhibitors|mesh-ancestor
25662912|NCT01651780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25662913|NCT01651793|Caffeine|caffeine|mesh-list
25236606|NCT02556970|Anesthetics|anesthetics|mesh-ancestor
25236607|NCT02556970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25236608|NCT02556879|Liver Extracts|liver extracts|mesh-list
25236609|NCT02556879|Antibodies|antibodies|mesh-list
24492035|NCT00485004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24467438|NCT00377728|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24467439|NCT00377728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24467440|NCT00377728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467441|NCT00377728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467443|NCT00377780|Doxorubicin|doxorubicin|mesh-list
24467444|NCT00377780|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24467445|NCT00377780|Trastuzumab|trastuzumab|mesh-list
25851539|NCT00054158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25851540|NCT00054158|Immunologic Factors|immunologic factors|mesh-ancestor
25851541|NCT00054158|Leprostatic Agents|leprostatic agents|mesh-ancestor
25851542|NCT00054158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24467461|NCT00377793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467464|NCT00377806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24467465|NCT00377806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24467466|NCT00377806|Analgesics|analgesics|mesh-ancestor
24467467|NCT00377806|Sensory System Agents|sensory system agents|mesh-ancestor
24467468|NCT00377806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24467469|NCT00377806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467470|NCT00377806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24467471|NCT00377806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25851543|NCT00054158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25851544|NCT00054158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25851545|NCT00054158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25851546|NCT00054158|Growth Substances|growth substances|mesh-ancestor
25851547|NCT00054158|Growth Inhibitors|growth inhibitors|mesh-ancestor
25851548|NCT00054171|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25079311|NCT03348735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25079312|NCT03348735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079313|NCT03348735|Sensory System Agents|sensory system agents|mesh-ancestor
24965273|NCT03778008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851549|NCT00054171|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24671921|NCT01328457|Neomycin|neomycin|mesh-list
25851550|NCT00054171|Dermatologic Agents|dermatologic agents|mesh-ancestor
24467538|NCT00378027|Fondaparinux|fondaparinux|mesh-list
24467539|NCT00378027|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24467540|NCT00378027|Antithrombins|antithrombins|mesh-ancestor
24467541|NCT00378027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24467542|NCT00378027|Protease Inhibitors|protease inhibitors|mesh-ancestor
24467543|NCT00378027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467544|NCT00378027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467545|NCT00378027|Anticoagulants|anticoagulants|mesh-ancestor
25851551|NCT00054184|Paclitaxel|paclitaxel|mesh-list
25851552|NCT00054184|Docetaxel|docetaxel|mesh-list
25851553|NCT00054184|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
24467548|NCT00378066|Bevacizumab|bevacizumab|mesh-list
24467552|NCT00378066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467553|NCT00378066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24467554|NCT00378066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25662914|NCT01651793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25662915|NCT01651793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662916|NCT01651793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25662917|NCT01651793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25662918|NCT01651793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662919|NCT01651793|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25662920|NCT01651793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25662921|NCT01651793|Purinergic Agents|purinergic agents|mesh-ancestor
25662922|NCT01651793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25236648|NCT02556814|Antioxidants|antioxidants|mesh-ancestor
25079326|NCT03348735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25079327|NCT03348735|Antipruritics|antipruritics|mesh-ancestor
24628149|NCT01096706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24628150|NCT01096745|Gemcitabine|gemcitabine|mesh-list
24628152|NCT01096745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24628153|NCT01096745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24628154|NCT01096745|Antimetabolites|antimetabolites|mesh-ancestor
24628155|NCT01096745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628156|NCT01096745|Antiviral Agents|antiviral agents|mesh-ancestor
24628157|NCT01096745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24628158|NCT01096745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628159|NCT01096745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24803407|NCT01996306|Vitamins|vitamins|mesh-ancestor
24803476|NCT01996488|Olanzapine|olanzapine|mesh-list
24803540|NCT01996930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24467568|NCT00378092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24467569|NCT00378092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24467570|NCT00378092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24467571|NCT00378092|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24467572|NCT00378092|Dopamine Agents|dopamine agents|mesh-ancestor
24467573|NCT00378118|Antibodies|antibodies|mesh-list
24467574|NCT00378118|Immunoglobulins|immunoglobulins|mesh-list
24467575|NCT00378118|HIV Antibodies|hiv antibodies|mesh-list
24467576|NCT00378118|Immunologic Factors|immunologic factors|mesh-ancestor
25851554|NCT00054184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25851555|NCT00054184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851556|NCT00054184|Tubulin Modulators|tubulin modulators|mesh-ancestor
24803541|NCT01996930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24803542|NCT01997099|Diazepam|diazepam|mesh-list
24803543|NCT01997099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24803544|NCT01997099|Anticonvulsants|anticonvulsants|mesh-ancestor
24803545|NCT01997099|Antiemetics|antiemetics|mesh-ancestor
24803546|NCT01997099|Autonomic Agents|autonomic agents|mesh-ancestor
24803547|NCT01997099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803548|NCT01997099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803549|NCT01997099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24803550|NCT01997099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24803551|NCT01997099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24803552|NCT01997099|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24803553|NCT01997099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24804622|NCT02004067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804623|NCT02004067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24804624|NCT02004067|Immunologic Factors|immunologic factors|mesh-ancestor
24804625|NCT02004067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804626|NCT02004067|Antifungal Agents|antifungal agents|mesh-ancestor
24628212|NCT01097278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628213|NCT01097278|Vitamins|vitamins|mesh-ancestor
24805094|NCT02007408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24805095|NCT02007408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805096|NCT02007447|Oxytocin|oxytocin|mesh-list
24805097|NCT02007447|Oxytocics|oxytocics|mesh-ancestor
24853893|NCT02270827|Hydrocortisone|hydrocortisone|mesh-list
24805098|NCT02007447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24805099|NCT02007447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805100|NCT02007603|Amoxicillin|amoxicillin|mesh-list
24805101|NCT02007603|Clavulanic Acids|clavulanic acids|mesh-list
25079328|NCT03348735|Dermatologic Agents|dermatologic agents|mesh-ancestor
24805102|NCT02007603|Clavulanic Acid|clavulanic acid|mesh-list
24805103|NCT02007603|Ampicillin|ampicillin|mesh-list
24805104|NCT02007603|Sulbactam|sulbactam|mesh-list
24805204|NCT02008019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24805431|NCT02009449|Docetaxel|docetaxel|mesh-list
24805432|NCT02009449|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24805433|NCT02009449|Carboplatin|carboplatin|mesh-list
24467586|NCT00378144|Antipyretics|antipyretics|mesh-ancestor
24467587|NCT00378144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24805434|NCT02009449|Pembrolizumab|pembrolizumab|mesh-list
24805435|NCT02009449|Fluorouracil|fluorouracil|mesh-list
24805436|NCT02009449|Capecitabine|capecitabine|mesh-list
24805437|NCT02009449|Oxaliplatin|oxaliplatin|mesh-list
24805438|NCT02009449|Nivolumab|nivolumab|mesh-list
25662923|NCT01651806|Tranexamic Acid|tranexamic acid|mesh-list
25662924|NCT01651806|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25662925|NCT01651806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25662926|NCT01651806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662927|NCT01651806|Hemostatics|hemostatics|mesh-ancestor
25662928|NCT01651806|Coagulants|coagulants|mesh-ancestor
25662929|NCT01651936|Methotrexate|methotrexate|mesh-list
24805442|NCT02009449|Tubulin Modulators|tubulin modulators|mesh-ancestor
24805443|NCT02009449|Antimitotic Agents|antimitotic agents|mesh-ancestor
24805444|NCT02009449|Mitosis Modulators|mitosis modulators|mesh-ancestor
24805445|NCT02009449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805446|NCT02009449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24805447|NCT02009449|Antimetabolites|antimetabolites|mesh-ancestor
24805448|NCT02009449|Antiviral Agents|antiviral agents|mesh-ancestor
24805622|NCT02011191|Vitamin B Complex|vitamin b complex|mesh-ancestor
24805623|NCT02011191|Vitamins|vitamins|mesh-ancestor
24805624|NCT02011191|Micronutrients|micronutrients|mesh-ancestor
24805625|NCT02011191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628214|NCT01097278|Micronutrients|micronutrients|mesh-ancestor
24804574|NCT02003209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24628257|NCT01097551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24853908|NCT02270827|Purinergic Agents|purinergic agents|mesh-ancestor
24628259|NCT01097551|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24628260|NCT01097551|Nasal Decongestants|nasal decongestants|mesh-ancestor
24628261|NCT01097551|Respiratory System Agents|respiratory system agents|mesh-ancestor
24628262|NCT01097551|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24628277|NCT01097811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24628278|NCT01097811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24628279|NCT01097811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24805894|NCT02012569|Coagulants|coagulants|mesh-ancestor
24805896|NCT02012595|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24805897|NCT02012595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896254|NCT01117441|Antimetabolites|antimetabolites|mesh-ancestor
24467618|NCT00378287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24467619|NCT00378287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24467620|NCT00378287|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24805907|NCT02012777|Propranolol|propranolol|mesh-list
24805908|NCT02012777|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24805909|NCT02012777|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24805910|NCT02012777|Adrenergic Agents|adrenergic agents|mesh-ancestor
24805911|NCT02012777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24805912|NCT02012777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25421376|NCT02549833|Antiviral Agents|antiviral agents|mesh-ancestor
25662930|NCT01651936|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25662931|NCT01651936|Abortifacient Agents|abortifacient agents|mesh-ancestor
25662932|NCT01651936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25662933|NCT01651936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662934|NCT01651936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25662935|NCT01651936|Antimetabolites|antimetabolites|mesh-ancestor
25662936|NCT01651936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662937|NCT01651936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662938|NCT01651936|Dermatologic Agents|dermatologic agents|mesh-ancestor
25662939|NCT01651936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25662940|NCT01651936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25662941|NCT01651936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25662942|NCT01651936|Immunologic Factors|immunologic factors|mesh-ancestor
25662943|NCT01651936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25662944|NCT01651936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24805916|NCT02012777|Vasodilator Agents|vasodilator agents|mesh-ancestor
24628280|NCT01097811|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24628281|NCT01097811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628282|NCT01097811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628283|NCT01097902|Ibuprofen|ibuprofen|mesh-list
24628284|NCT01097902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24662648|NCT01295892|Estrogens|estrogens|mesh-list
24628285|NCT01097902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24628286|NCT01097902|Analgesics|analgesics|mesh-ancestor
24628287|NCT01097902|Sensory System Agents|sensory system agents|mesh-ancestor
24628288|NCT01097902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24628289|NCT01097902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628290|NCT01097902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24628292|NCT01097902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24628293|NCT01097902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628294|NCT01097902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628296|NCT01097941|Immunologic Factors|immunologic factors|mesh-ancestor
24628297|NCT01097941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628367|NCT01098383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24628368|NCT01098448|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24628370|NCT01098448|Metronidazole|metronidazole|mesh-list
24628371|NCT01098448|Tetracycline|tetracycline|mesh-list
24628372|NCT01098448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24628373|NCT01098448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24628374|NCT01098448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24628375|NCT01098448|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24628376|NCT01098448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628377|NCT01098448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628378|NCT01098513|Dolutegravir|dolutegravir|mesh-list
24465416|NCT00369538|Diuretics|diuretics|mesh-ancestor
24806796|NCT02018250|Anesthetics, Local|anesthetics, local|mesh-ancestor
24806798|NCT02018250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24806799|NCT02018250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806800|NCT02018250|Sensory System Agents|sensory system agents|mesh-ancestor
24806801|NCT02018250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24806802|NCT02018263|Cocaine|cocaine|mesh-list
24806803|NCT02018263|Nicotine|nicotine|mesh-list
25851563|NCT00054197|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
25851564|NCT00054197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24998392|NCT02960646|Tacrolimus|tacrolimus|mesh-list
25662946|NCT01652040|Testosterone|testosterone|mesh-list
25662947|NCT01652040|Testosterone undecanoate|testosterone undecanoate|mesh-list
25662948|NCT01652040|Testosterone enanthate|testosterone enanthate|mesh-list
25662949|NCT01652040|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25662950|NCT01652040|Androgens|androgens|mesh-ancestor
25662951|NCT01652040|Hormones|hormones|mesh-ancestor
25674370|NCT01770743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467662|NCT00378443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24467663|NCT00378443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25674371|NCT01770912|Triamcinolone|triamcinolone|mesh-list
25674372|NCT01770912|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25674373|NCT01770912|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25674374|NCT01770912|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25674375|NCT01770912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24628396|NCT01098526|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24628397|NCT01098526|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24628398|NCT01098526|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24965334|NCT03777579|Immunoglobulins|immunoglobulins|mesh-list
24965335|NCT03777579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24965336|NCT03777579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965337|NCT03777579|Tubulin Modulators|tubulin modulators|mesh-ancestor
24965338|NCT03777579|Antimitotic Agents|antimitotic agents|mesh-ancestor
24965339|NCT03777579|Mitosis Modulators|mitosis modulators|mesh-ancestor
24965340|NCT03777579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965341|NCT03777579|Immunologic Factors|immunologic factors|mesh-ancestor
24965342|NCT03777579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965343|NCT03777696|Misoprostol|misoprostol|mesh-list
24965344|NCT03777696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25079329|NCT03348696|Dexamethasone|dexamethasone|mesh-list
25079330|NCT03348696|Dexamethasone acetate|dexamethasone acetate|mesh-list
25079331|NCT03348696|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25079332|NCT03348696|BB 1101|bb 1101|mesh-list
25079333|NCT03348696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25079334|NCT03348696|Antiemetics|antiemetics|mesh-ancestor
25079335|NCT03348696|Autonomic Agents|autonomic agents|mesh-ancestor
25079336|NCT03348696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24896342|NCT04437693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24467715|NCT00378547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467716|NCT00378547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24467717|NCT00378547|Analgesics|analgesics|mesh-ancestor
24467718|NCT00378547|Sensory System Agents|sensory system agents|mesh-ancestor
24467719|NCT00378547|Antipyretics|antipyretics|mesh-ancestor
24467720|NCT00378547|Anticonvulsants|anticonvulsants|mesh-ancestor
24467721|NCT00378547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24467722|NCT00378547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25851568|NCT00054197|Mitosis Modulators|mitosis modulators|mesh-ancestor
25202246|NCT02722772|Sensory System Agents|sensory system agents|mesh-ancestor
25202247|NCT02722772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202248|NCT02722772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202249|NCT02722772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25202250|NCT02722772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25202251|NCT02722772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25202252|NCT02722772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25202253|NCT02722772|Immunologic Factors|immunologic factors|mesh-ancestor
24467723|NCT00378547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24467724|NCT00378547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24467725|NCT00378547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25079345|NCT03348696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25079346|NCT03348696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079347|NCT03348527|Hydroxyflutamide|hydroxyflutamide|mesh-list
25079348|NCT03348527|Androgen Antagonists|androgen antagonists|mesh-ancestor
25079349|NCT03348527|Hormone Antagonists|hormone antagonists|mesh-ancestor
25662952|NCT01652040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25662953|NCT01652040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662954|NCT01652040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25662955|NCT01652040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662956|NCT01652040|Anabolic Agents|anabolic agents|mesh-ancestor
25662957|NCT01652495|Methylprednisolone|methylprednisolone|mesh-list
25662958|NCT01652495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25851571|NCT00054197|Antimetabolites|antimetabolites|mesh-ancestor
25851572|NCT00054197|Antiviral Agents|antiviral agents|mesh-ancestor
24526020|NCT02051933|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24526021|NCT02051933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24526022|NCT02051933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079350|NCT03348527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25662959|NCT01652495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25079351|NCT03348527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079352|NCT03348462|Anthralin|anthralin|mesh-list
24672542|NCT01332422|Hormones|hormones|mesh-ancestor
25079353|NCT03348462|Dermatologic Agents|dermatologic agents|mesh-ancestor
25079354|NCT03348423|Fentanyl|fentanyl|mesh-list
25079355|NCT03348423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25079356|NCT03348423|Narcotics|narcotics|mesh-ancestor
24896362|NCT04437004|Serotonin Agents|serotonin agents|mesh-ancestor
24467797|NCT00378768|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24467798|NCT00378768|Immunologic Factors|immunologic factors|mesh-ancestor
24467799|NCT00378768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467800|NCT00378768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24467801|NCT00378781|Minocycline|minocycline|mesh-list
24467802|NCT00378781|Heparin|heparin|mesh-list
25851573|NCT00054197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25851574|NCT00054197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851575|NCT00054197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25851576|NCT00054197|Immunologic Factors|immunologic factors|mesh-ancestor
24467822|NCT00378833|Vitamins|vitamins|mesh-ancestor
24807131|NCT02019875|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24467879|NCT00379015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24467880|NCT00379015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24467881|NCT00379015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851577|NCT00054197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467894|NCT00379028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25851578|NCT00054210|Paclitaxel|paclitaxel|mesh-list
24672673|NCT01333085|Antimitotic Agents|antimitotic agents|mesh-ancestor
25851579|NCT00054210|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25851580|NCT00054210|Carboplatin|carboplatin|mesh-list
24493512|NCT00491166|Bromfenac|bromfenac|mesh-list
24467938|NCT00379067|Urological Agents|urological agents|mesh-ancestor
24467939|NCT00379158|Micronutrients|micronutrients|mesh-list
24467940|NCT00379158|Trace Elements|trace elements|mesh-list
24467941|NCT00379158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467942|NCT00379249|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24467943|NCT00379249|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24467944|NCT00379249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24467945|NCT00379249|Antimetabolites|antimetabolites|mesh-ancestor
24467946|NCT00379249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662960|NCT01652495|Prednisolone|prednisolone|mesh-list
25662961|NCT01652495|Prednisolone acetate|prednisolone acetate|mesh-list
25662962|NCT01652495|Triamcinolone|triamcinolone|mesh-list
25662963|NCT01652495|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25662964|NCT01652495|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25662965|NCT01652495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25662966|NCT01652495|Prednisolone phosphate|prednisolone phosphate|mesh-list
25662967|NCT01652495|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25662968|NCT01652495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25662969|NCT01652495|Antiemetics|antiemetics|mesh-ancestor
25662970|NCT01652495|Autonomic Agents|autonomic agents|mesh-ancestor
25662971|NCT01652495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25674376|NCT01770912|Glucocorticoids|glucocorticoids|mesh-ancestor
24468042|NCT00379509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468044|NCT00379522|Arginine Vasopressin|arginine vasopressin|mesh-list
24468045|NCT00379522|Hemostatics|hemostatics|mesh-ancestor
24468046|NCT00379522|Coagulants|coagulants|mesh-ancestor
24468047|NCT00379522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25851583|NCT00054210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851584|NCT00054210|Tubulin Modulators|tubulin modulators|mesh-ancestor
25851585|NCT00054210|Antimitotic Agents|antimitotic agents|mesh-ancestor
25851586|NCT00054210|Mitosis Modulators|mitosis modulators|mesh-ancestor
25851587|NCT00054210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851588|NCT00054236|Methylprednisolone|methylprednisolone|mesh-list
24468083|NCT00379717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468084|NCT00379730|Prednisolone|prednisolone|mesh-list
24807135|NCT02020005|Autonomic Agents|autonomic agents|mesh-ancestor
24807136|NCT02020005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24807137|NCT02020005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807138|NCT02020005|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24807139|NCT02020005|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24807140|NCT02020005|Cholinergic Agents|cholinergic agents|mesh-ancestor
24807141|NCT02020005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24807142|NCT02020005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468168|NCT00380263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468169|NCT00380263|Vasodilator Agents|vasodilator agents|mesh-ancestor
24468170|NCT00380263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24672958|NCT01334567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24468384|NCT00381251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24468385|NCT00381251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468386|NCT00381264|Nabilone|nabilone|mesh-list
24468388|NCT00381264|Autonomic Agents|autonomic agents|mesh-ancestor
24468389|NCT00381264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24468390|NCT00381264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468391|NCT00381264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24468392|NCT00381264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24468393|NCT00381264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24468394|NCT00381264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24468395|NCT00381264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24468396|NCT00381316|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
24468397|NCT00381316|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24468398|NCT00381316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468399|NCT00381342|Exenatide|exenatide|mesh-list
24468400|NCT00381342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24468401|NCT00381342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468402|NCT00381342|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24468403|NCT00381342|Incretins|incretins|mesh-ancestor
24468404|NCT00381342|Hormones|hormones|mesh-ancestor
24468405|NCT00381342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25202254|NCT02722733|Cytarabine|cytarabine|mesh-list
24468410|NCT00381472|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24468411|NCT00381472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24468412|NCT00381472|Dopamine Agonists|dopamine agonists|mesh-ancestor
24468413|NCT00381472|Dopamine Agents|dopamine agents|mesh-ancestor
24468414|NCT00381472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24468415|NCT00381472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468416|NCT00381472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468417|NCT00381511|Heparin|heparin|mesh-list
24468451|NCT00381589|Anticonvulsants|anticonvulsants|mesh-ancestor
24468452|NCT00381589|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24672959|NCT01334580|Methadone|methadone|mesh-list
25851589|NCT00054236|Cyclophosphamide|cyclophosphamide|mesh-list
25851590|NCT00054236|Fludarabine|fludarabine|mesh-list
24526837|NCT00613457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24526859|NCT00613470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24526863|NCT00613470|Serotonin Agents|serotonin agents|mesh-ancestor
24526864|NCT00613470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526865|NCT00613470|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24526866|NCT00613470|Antidepressive Agents|antidepressive agents|mesh-ancestor
24526867|NCT00613470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24526869|NCT00613496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24526870|NCT00613496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24526871|NCT00613496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24457837|NCT00335348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24457838|NCT00335348|Glucocorticoids|glucocorticoids|mesh-ancestor
24457839|NCT00335348|Hormones|hormones|mesh-ancestor
25236736|NCT02556086|Sofosbuvir|sofosbuvir|mesh-list
25851591|NCT00054236|Fludarabine phosphate|fludarabine phosphate|mesh-list
25851592|NCT00054236|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25851593|NCT00054236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25851594|NCT00054236|Immunologic Factors|immunologic factors|mesh-ancestor
25851595|NCT00054236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468556|NCT00382135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24468557|NCT00382135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468558|NCT00382135|Urological Agents|urological agents|mesh-ancestor
24468560|NCT00382213|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25851596|NCT00054236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25851597|NCT00054236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25851598|NCT00054236|Alkylating Agents|alkylating agents|mesh-ancestor
25851599|NCT00054236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851600|NCT00054236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468580|NCT00382343|Renal Agents|renal agents|mesh-ancestor
24468581|NCT00382343|Antimalarials|antimalarials|mesh-ancestor
24468582|NCT00382343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24468583|NCT00382343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24468584|NCT00382343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24468592|NCT00382356|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24468593|NCT00382356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24493981|NCT00493233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24673057|NCT01335048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24628401|NCT01098526|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24628402|NCT01098526|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24628403|NCT01098526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24628404|NCT01098526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24628406|NCT01098656|Immunologic Factors|immunologic factors|mesh-ancestor
24628407|NCT01098656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807419|NCT02021851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807420|NCT02021851|Antipruritics|antipruritics|mesh-ancestor
24807421|NCT02021851|Dermatologic Agents|dermatologic agents|mesh-ancestor
24807422|NCT02021851|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24807423|NCT02021851|Serotonin Agents|serotonin agents|mesh-ancestor
24807424|NCT02021851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24807425|NCT02021851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24807426|NCT02021851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24807427|NCT02021851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25662972|NCT01652495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25662973|NCT01652495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25662974|NCT01652495|Glucocorticoids|glucocorticoids|mesh-ancestor
25662975|NCT01652495|Hormones|hormones|mesh-ancestor
25662976|NCT01652495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25662977|NCT01652495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25662978|NCT01652495|Protective Agents|protective agents|mesh-ancestor
25662979|NCT01652495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25662980|NCT01652495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25662981|NCT01652495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25662982|NCT01652495|Immunologic Factors|immunologic factors|mesh-ancestor
25662983|NCT01652495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25662984|NCT01652495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25662985|NCT01652573|Calcitonin|calcitonin|mesh-list
25662986|NCT01652573|Salmon calcitonin|salmon calcitonin|mesh-list
25662987|NCT01652573|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
25662988|NCT01652573|Katacalcin|katacalcin|mesh-list
24896410|NCT04436419|Thioctic Acid|thioctic acid|mesh-list
25851601|NCT00054236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24468706|NCT00382889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24468707|NCT00382889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468725|NCT00382980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468726|NCT00382980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24468727|NCT00383032|Mifepristone|mifepristone|mesh-list
24468728|NCT00383032|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24468729|NCT00383032|Abortifacient Agents|abortifacient agents|mesh-ancestor
24468730|NCT00383032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24468731|NCT00383032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468732|NCT00383032|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24468733|NCT00383032|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24468734|NCT00383032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24468735|NCT00383032|Contraceptive Agents|contraceptive agents|mesh-ancestor
24628427|NCT01098994|Micronutrients|micronutrients|mesh-ancestor
24628428|NCT01098994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628429|NCT01098994|Antioxidants|antioxidants|mesh-ancestor
24628430|NCT01098994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628431|NCT01098994|Protective Agents|protective agents|mesh-ancestor
24468750|NCT00383045|Sensory System Agents|sensory system agents|mesh-ancestor
24468751|NCT00383045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24468752|NCT00383045|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24468753|NCT00383045|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24468755|NCT00383136|Abciximab|abciximab|mesh-list
24468756|NCT00383136|Anticoagulants|anticoagulants|mesh-ancestor
24468817|NCT00383487|Micronutrients|micronutrients|mesh-ancestor
24468818|NCT00383487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24468819|NCT00383487|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24468820|NCT00383526|Vaccines|vaccines|mesh-list
24468821|NCT00383526|Immunologic Factors|immunologic factors|mesh-ancestor
24468822|NCT00383526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468825|NCT00383539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468826|NCT00383591|Vaccines|vaccines|mesh-list
24468834|NCT00383682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24468835|NCT00383682|Narcotics|narcotics|mesh-ancestor
24468836|NCT00383682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24468838|NCT00383682|Analgesics|analgesics|mesh-ancestor
25851602|NCT00054236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25851603|NCT00054236|Antimetabolites|antimetabolites|mesh-ancestor
24468845|NCT00383682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468846|NCT00383695|Capecitabine|capecitabine|mesh-list
24468847|NCT00383695|Oxaliplatin|oxaliplatin|mesh-list
24468848|NCT00383695|Cetuximab|cetuximab|mesh-list
24468849|NCT00383695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24468850|NCT00383695|Antimetabolites|antimetabolites|mesh-ancestor
24468851|NCT00383695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468863|NCT00383799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24468864|NCT00383799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24468905|NCT00383877|Isophane insulin, beef|isophane insulin, beef|mesh-list
24468906|NCT00383877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24468907|NCT00383877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468908|NCT00383890|Dexmedetomidine|dexmedetomidine|mesh-list
24468909|NCT00383890|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24468910|NCT00383890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24628436|NCT01099059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24494333|NCT00494897|Cytarabine|cytarabine|mesh-list
24468923|NCT00383916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24468924|NCT00383916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25202255|NCT02722733|Lenograstim|lenograstim|mesh-list
24468958|NCT00384020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25662989|NCT01652573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25662990|NCT01652573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808095|NCT02025140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24469004|NCT00384280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469005|NCT00384280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469006|NCT00384280|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24469007|NCT00384280|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24469008|NCT00384280|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24469036|NCT00384410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24469037|NCT00384410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808917|NCT02029898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24808919|NCT02029898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24808920|NCT02029898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808921|NCT02029898|Analgesics|analgesics|mesh-ancestor
24809177|NCT02031692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24809179|NCT02031692|Micronutrients|micronutrients|mesh-ancestor
24809180|NCT02031692|Antacids|antacids|mesh-ancestor
24809181|NCT02031692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469121|NCT00384605|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24469123|NCT00384605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469124|NCT00384605|Hormones|hormones|mesh-ancestor
24469125|NCT00384605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24469126|NCT00384605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469127|NCT00384618|Vitamin E|vitamin e|mesh-list
24469176|NCT00384800|Growth Inhibitors|growth inhibitors|mesh-ancestor
24469177|NCT00384800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469178|NCT00384800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24469179|NCT00384800|Antimetabolites|antimetabolites|mesh-ancestor
24469180|NCT00384800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851604|NCT00054236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24469182|NCT00384826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24469183|NCT00384826|Carboplatin|carboplatin|mesh-list
24469184|NCT00384826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24469185|NCT00384826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469186|NCT00384826|Tubulin Modulators|tubulin modulators|mesh-ancestor
24469187|NCT00384826|Antimitotic Agents|antimitotic agents|mesh-ancestor
24469188|NCT00384826|Mitosis Modulators|mitosis modulators|mesh-ancestor
24469189|NCT00384826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469190|NCT00384826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24469191|NCT00384826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469192|NCT00384878|Leucovorin|leucovorin|mesh-list
24469193|NCT00384878|Fluorouracil|fluorouracil|mesh-list
25851605|NCT00054236|Antiemetics|antiemetics|mesh-ancestor
25851606|NCT00054236|Autonomic Agents|autonomic agents|mesh-ancestor
25851607|NCT00054236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25851608|NCT00054236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24527526|NCT00617045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24527604|NCT00617656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851609|NCT00054236|Glucocorticoids|glucocorticoids|mesh-ancestor
24628463|NCT01099085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628465|NCT01099085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24628466|NCT01099085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628467|NCT01099137|Vildagliptin|vildagliptin|mesh-list
24628468|NCT01099137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24664085|NCT01304901|Montelukast|montelukast|mesh-list
24664172|NCT01305707|Diazepam|diazepam|mesh-list
24628469|NCT01099137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628470|NCT01099137|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24628471|NCT01099137|Protease Inhibitors|protease inhibitors|mesh-ancestor
24469215|NCT00384917|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24469240|NCT00385021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469241|NCT00385021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24469242|NCT00385021|Immunologic Factors|immunologic factors|mesh-ancestor
24469243|NCT00385021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469244|NCT00385021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24469245|NCT00385021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24469246|NCT00385021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24469247|NCT00385021|Growth Substances|growth substances|mesh-ancestor
24469248|NCT00385021|Growth Inhibitors|growth inhibitors|mesh-ancestor
24469311|NCT00385411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24469312|NCT00385411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24469314|NCT00385437|Antidepressive Agents|antidepressive agents|mesh-ancestor
24469315|NCT00385437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24469316|NCT00385437|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24469317|NCT00385437|Histamine Antagonists|histamine antagonists|mesh-ancestor
24469318|NCT00385437|Histamine Agents|histamine agents|mesh-ancestor
24469319|NCT00385437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24469320|NCT00385437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469321|NCT00385437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469322|NCT00385437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24469323|NCT00385437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24469324|NCT00385437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24469325|NCT00385437|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24673564|NCT01338909|Clopidogrel|clopidogrel|mesh-list
24469326|NCT00385437|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24469327|NCT00385437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24469328|NCT00385437|Adrenergic Agents|adrenergic agents|mesh-ancestor
24469329|NCT00385437|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24469330|NCT00385437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24469331|NCT00385437|Serotonin Agents|serotonin agents|mesh-ancestor
24469353|NCT00385463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469354|NCT00385463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24469356|NCT00385463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24469357|NCT00385463|Glucocorticoids|glucocorticoids|mesh-ancestor
24469359|NCT00385463|Sympathomimetics|sympathomimetics|mesh-ancestor
24469364|NCT00385502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24469365|NCT00385502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469366|NCT00385502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469367|NCT00385502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24469368|NCT00385502|Hormone Antagonists|hormone antagonists|mesh-ancestor
24469369|NCT00385502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24469370|NCT00385502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469371|NCT00385554|UC-781|uc-781|mesh-list
24469372|NCT00385554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24469382|NCT00385606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24469383|NCT00385606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469384|NCT00385606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24469385|NCT00385606|Immunologic Factors|immunologic factors|mesh-ancestor
24469386|NCT00385606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469387|NCT00385606|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24469400|NCT00385645|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
24469401|NCT00385645|Zidovudine|zidovudine|mesh-list
24469402|NCT00385645|Lamivudine|lamivudine|mesh-list
24469403|NCT00385645|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24469404|NCT00385645|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24469405|NCT00385645|Protease Inhibitors|protease inhibitors|mesh-ancestor
25662991|NCT01652573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25662992|NCT01652573|Vasodilator Agents|vasodilator agents|mesh-ancestor
25851610|NCT00054236|Hormones|hormones|mesh-ancestor
25236835|NCT02555761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25236836|NCT02555761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236837|NCT02555761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236838|NCT02555748|Sunitinib|sunitinib|mesh-list
25236839|NCT02555748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24964775|NCT03780686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24964776|NCT03780686|Dopamine Agents|dopamine agents|mesh-ancestor
24964777|NCT03780686|Protective Agents|protective agents|mesh-ancestor
24964778|NCT03780556|Lornoxicam|lornoxicam|mesh-list
24964779|NCT03780556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25236840|NCT02555748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25236841|NCT02555748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24469406|NCT00385645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469408|NCT00385645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25851611|NCT00054236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24469416|NCT00385658|Ezetimibe|ezetimibe|mesh-list
24469417|NCT00385658|Fenofibrate|fenofibrate|mesh-list
24469418|NCT00385658|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24469419|NCT00385658|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24469420|NCT00385658|Antimetabolites|antimetabolites|mesh-ancestor
24469421|NCT00385658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469422|NCT00385658|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24469423|NCT00385658|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24469424|NCT00385658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202257|NCT02722733|Immunologic Factors|immunologic factors|mesh-ancestor
24809736|NCT02036060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809737|NCT02036060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24809739|NCT02036073|Hematinics|hematinics|mesh-ancestor
24809740|NCT02036086|Vemurafenib|vemurafenib|mesh-list
24809741|NCT02036086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809742|NCT02036086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24809743|NCT02036086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809744|NCT02036086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809745|NCT02036125|Methylprednisolone|methylprednisolone|mesh-list
24809748|NCT02036125|Prednisolone|prednisolone|mesh-list
24809932|NCT02036736|Anesthetics, General|anesthetics, general|mesh-ancestor
24809933|NCT02036736|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24809934|NCT02036827|Bromides|bromides|mesh-list
24809935|NCT02036827|Rocuronium|rocuronium|mesh-list
24809936|NCT02036827|Anticonvulsants|anticonvulsants|mesh-ancestor
24809937|NCT02036827|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24817510|NCT02084420|Pantoprazole|pantoprazole|mesh-list
24469429|NCT00385710|GABA Agents|gaba agents|mesh-ancestor
24469430|NCT00385710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24469431|NCT00385710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469432|NCT00385710|Antimanic Agents|antimanic agents|mesh-ancestor
24469433|NCT00385710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24469434|NCT00385710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24469435|NCT00385710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24469436|NCT00385853|Temozolomide|temozolomide|mesh-list
25851612|NCT00054236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25851613|NCT00054236|Protective Agents|protective agents|mesh-ancestor
25662993|NCT01652664|Timolol|timolol|mesh-list
25662994|NCT01652664|Travoprost|travoprost|mesh-list
25662995|NCT01652664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25662996|NCT01652664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25662997|NCT01652664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25662998|NCT01652664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25662999|NCT01652664|Adrenergic Agents|adrenergic agents|mesh-ancestor
25663000|NCT01652664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25663001|NCT01652664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663002|NCT01652664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663003|NCT01652664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25663004|NCT01652664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25663005|NCT01652690|Denosumab|denosumab|mesh-list
25663006|NCT01652690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25663007|NCT01652690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663008|NCT01652703|Evolocumab|evolocumab|mesh-list
24809941|NCT02036827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809942|NCT02036879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24809943|NCT02036879|Norethindrone|norethindrone|mesh-list
24809944|NCT02036879|Norethindrone Acetate|norethindrone acetate|mesh-list
24774735|NCT01847599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810228|NCT02039011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24810229|NCT02039011|Autonomic Agents|autonomic agents|mesh-ancestor
24810230|NCT02039011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24810231|NCT02039011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810232|NCT02039011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24810233|NCT02039011|Respiratory System Agents|respiratory system agents|mesh-ancestor
24469461|NCT00385957|Antiviral Agents|antiviral agents|mesh-ancestor
25851617|NCT00054288|Antimetabolites|antimetabolites|mesh-ancestor
25851618|NCT00054288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469480|NCT00385970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469481|NCT00385970|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24469482|NCT00385970|Immunologic Factors|immunologic factors|mesh-ancestor
24469483|NCT00385970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24469484|NCT00385970|Antiviral Agents|antiviral agents|mesh-ancestor
24469485|NCT00385970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24469486|NCT00385970|Interferon Inducers|interferon inducers|mesh-ancestor
24469487|NCT00385970|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24469489|NCT00386061|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24469490|NCT00386061|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24469491|NCT00386061|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24469492|NCT00386061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24469493|NCT00386061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469494|NCT00386061|Hormones|hormones|mesh-ancestor
24810234|NCT02039011|Parasympatholytics|parasympatholytics|mesh-ancestor
24810235|NCT02039011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24810236|NCT02039011|Cholinergic Agents|cholinergic agents|mesh-ancestor
24810237|NCT02039011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24810238|NCT02039011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810239|NCT02039050|Tiotropium Bromide|tiotropium bromide|mesh-list
24810240|NCT02039050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24810241|NCT02039050|Autonomic Agents|autonomic agents|mesh-ancestor
24810242|NCT02039050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24810243|NCT02039050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810244|NCT02039050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24810245|NCT02039050|Respiratory System Agents|respiratory system agents|mesh-ancestor
24810246|NCT02039050|Parasympatholytics|parasympatholytics|mesh-ancestor
24810247|NCT02039050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24810248|NCT02039050|Cholinergic Agents|cholinergic agents|mesh-ancestor
24810249|NCT02039050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25079375|NCT03348254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24791250|NCT04887389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24469537|NCT00386269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24469563|NCT00386282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24469564|NCT00386282|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24469565|NCT00386373|Imatinib Mesylate|imatinib mesylate|mesh-list
24469566|NCT00386373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469567|NCT00386373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24469568|NCT00386373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851619|NCT00054288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851620|NCT00054288|Antiviral Agents|antiviral agents|mesh-ancestor
25851621|NCT00054288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24469594|NCT00386516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469595|NCT00386516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25851622|NCT00054288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851623|NCT00054288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24791255|NCT04871191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791256|NCT04871191|Immunologic Factors|immunologic factors|mesh-ancestor
24791257|NCT04871191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791258|NCT04871191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24791259|NCT04871191|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24791260|NCT04871191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791261|NCT04871191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24473688|NCT00403806|Autonomic Agents|autonomic agents|mesh-ancestor
24469597|NCT00386516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24469598|NCT00386516|Immunologic Factors|immunologic factors|mesh-ancestor
24469599|NCT00386516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469600|NCT00386529|Aspirin|aspirin|mesh-list
24469601|NCT00386529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24469602|NCT00386529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24469603|NCT00386529|Analgesics|analgesics|mesh-ancestor
25851624|NCT00054288|Immunologic Factors|immunologic factors|mesh-ancestor
24469723|NCT00386841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24469724|NCT00386841|Serotonin Agents|serotonin agents|mesh-ancestor
24469725|NCT00386841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469726|NCT00386841|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25079376|NCT03348254|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25079377|NCT03348254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25079378|NCT03348254|Antitubercular Agents|antitubercular agents|mesh-ancestor
25079379|NCT03348098|Paclitaxel|paclitaxel|mesh-list
24495192|NCT00498953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851625|NCT00054288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851626|NCT00054288|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25851627|NCT00054288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24469768|NCT00387179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469770|NCT00387179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469771|NCT00387179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24469772|NCT00387309|Methylnaltrexone|methylnaltrexone|mesh-list
24469773|NCT00387309|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24469774|NCT00387309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469775|NCT00387309|Sensory System Agents|sensory system agents|mesh-ancestor
24469776|NCT00387309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24469777|NCT00387322|Pemetrexed|pemetrexed|mesh-list
24469778|NCT00387322|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24469780|NCT00387322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851628|NCT00054340|Cyclosporine|cyclosporine|mesh-list
24469793|NCT00387374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079380|NCT03348098|Apatinib|apatinib|mesh-list
25079381|NCT03348098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25663009|NCT01652703|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25663010|NCT01652703|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25663011|NCT01652703|Antimetabolites|antimetabolites|mesh-ancestor
25663012|NCT01652703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663013|NCT01652703|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25663014|NCT01652716|Exenatide|exenatide|mesh-list
25663015|NCT01652716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25663016|NCT01652716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079382|NCT03348098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469866|NCT00387582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469868|NCT00387608|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24469869|NCT00387608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469870|NCT00387608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469871|NCT00387608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469873|NCT00387699|Etoposide|etoposide|mesh-list
24469874|NCT00387699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24674164|NCT01342237|Carboplatin|carboplatin|mesh-list
24469875|NCT00387699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469876|NCT00387699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24469877|NCT00387699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24469878|NCT00387699|Growth Substances|growth substances|mesh-ancestor
24469879|NCT00387699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469880|NCT00387699|Growth Inhibitors|growth inhibitors|mesh-ancestor
24469881|NCT00387699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24469930|NCT00388011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25851629|NCT00054340|Cyclophosphamide|cyclophosphamide|mesh-list
25851630|NCT00054340|Busulfan|busulfan|mesh-list
25851631|NCT00054340|Methotrexate|methotrexate|mesh-list
25851632|NCT00054340|Cyclosporins|cyclosporins|mesh-list
25851633|NCT00054340|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25851634|NCT00054340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25851635|NCT00054340|Immunologic Factors|immunologic factors|mesh-ancestor
24469932|NCT00388011|Analgesics|analgesics|mesh-ancestor
24469938|NCT00388076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24469939|NCT00388076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469940|NCT00388076|Tubulin Modulators|tubulin modulators|mesh-ancestor
24469941|NCT00388076|Antimitotic Agents|antimitotic agents|mesh-ancestor
24469942|NCT00388076|Mitosis Modulators|mitosis modulators|mesh-ancestor
24470002|NCT00388388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470003|NCT00388388|Diuretics|diuretics|mesh-ancestor
24470004|NCT00388388|Natriuretic Agents|natriuretic agents|mesh-ancestor
24470005|NCT00388388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470085|NCT00388739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470086|NCT00388739|Autonomic Agents|autonomic agents|mesh-ancestor
24470087|NCT00388739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24470088|NCT00388739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24470089|NCT00388739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24470090|NCT00388739|Respiratory System Agents|respiratory system agents|mesh-ancestor
24470091|NCT00388739|Tocolytic Agents|tocolytic agents|mesh-ancestor
24470094|NCT00388739|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24470095|NCT00388739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24470096|NCT00388739|Adrenergic Agents|adrenergic agents|mesh-ancestor
25079402|NCT03347968|Anticoagulants|anticoagulants|mesh-ancestor
25202258|NCT02722733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663017|NCT01652716|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25663018|NCT01652716|Incretins|incretins|mesh-ancestor
25202259|NCT02722733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25202260|NCT02722733|Antimetabolites|antimetabolites|mesh-ancestor
25202261|NCT02722733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663019|NCT01652716|Hormones|hormones|mesh-ancestor
25674377|NCT01770912|Hormones|hormones|mesh-ancestor
25236934|NCT02554864|Lidocaine|lidocaine|mesh-list
25202262|NCT02722733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851642|NCT00054340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24470215|NCT00389233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24470218|NCT00389272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24470220|NCT00389272|Sensory System Agents|sensory system agents|mesh-ancestor
24470302|NCT00389584|Irinotecan|irinotecan|mesh-list
24470303|NCT00389584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24470304|NCT00389584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24470337|NCT00389766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24470338|NCT00389766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470339|NCT00389766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470340|NCT00389766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24470341|NCT00389883|Anesthetics|anesthetics|mesh-list
24470342|NCT00389883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24470343|NCT00389883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470345|NCT00389909|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24470369|NCT00389935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470371|NCT00389987|Piperacillin|piperacillin|mesh-list
24470372|NCT00389987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470373|NCT00389987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24470374|NCT00389987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25079408|NCT03347968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079410|NCT03347916|Gabapentin|gabapentin|mesh-list
25079411|NCT03347916|Analgesics|analgesics|mesh-ancestor
25079412|NCT03347916|Sensory System Agents|sensory system agents|mesh-ancestor
25079413|NCT03347916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25079414|NCT03347916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079415|NCT03347916|Anticonvulsants|anticonvulsants|mesh-ancestor
25079416|NCT03347916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24470423|NCT00390130|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24470425|NCT00390130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470426|NCT00390156|Cyclophosphamide|cyclophosphamide|mesh-list
24470427|NCT00390156|Bevacizumab|bevacizumab|mesh-list
24470428|NCT00390156|Imatinib Mesylate|imatinib mesylate|mesh-list
24470429|NCT00390156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24470430|NCT00390156|Immunologic Factors|immunologic factors|mesh-ancestor
24470431|NCT00390156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610522|NCT01002898|Ritonavir|ritonavir|mesh-list
24470432|NCT00390156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24470433|NCT00390156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24470434|NCT00390156|Alkylating Agents|alkylating agents|mesh-ancestor
24470450|NCT00390208|Dexamethasone|dexamethasone|mesh-list
24470486|NCT00390260|Analgesics|analgesics|mesh-ancestor
24470487|NCT00390260|Sensory System Agents|sensory system agents|mesh-ancestor
24470488|NCT00390260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24470489|NCT00390260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470490|NCT00390260|Antipyretics|antipyretics|mesh-ancestor
24470491|NCT00390260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470492|NCT00390260|Respiratory System Agents|respiratory system agents|mesh-ancestor
24470493|NCT00390260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24470494|NCT00390260|Narcotics|narcotics|mesh-ancestor
24470495|NCT00390260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24470496|NCT00390260|Antitussive Agents|antitussive agents|mesh-ancestor
24470497|NCT00390260|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24470498|NCT00390260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25663020|NCT01652716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25663021|NCT01652729|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25663022|NCT01652729|Exenatide|exenatide|mesh-list
25663023|NCT01652729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25663024|NCT01652729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236965|NCT02554695|Denosumab|denosumab|mesh-list
25110207|NCT05464953|Immunologic Factors|immunologic factors|mesh-ancestor
25110208|NCT05464953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25110209|NCT05464953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010918|NCT02614547|Brexanolone|brexanolone|mesh-list
25010919|NCT02614547|Neurosteroids|neurosteroids|mesh-ancestor
25010920|NCT02614547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25010921|NCT02614547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470578|NCT00390728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470580|NCT00390793|Dexamethasone|dexamethasone|mesh-list
24470581|NCT00390793|Prednisone|prednisone|mesh-list
25079421|NCT03347916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25079422|NCT03347916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25079423|NCT03347916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810250|NCT02039050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628490|NCT01099436|Docetaxel|docetaxel|mesh-list
24470636|NCT00390871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24470637|NCT00390871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470659|NCT00390923|Nicotine|nicotine|mesh-list
24470660|NCT00390923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24470661|NCT00390923|Autonomic Agents|autonomic agents|mesh-ancestor
24470662|NCT00390923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24470663|NCT00390923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470664|NCT00390923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24470665|NCT00390923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24470666|NCT00390923|Cholinergic Agents|cholinergic agents|mesh-ancestor
24470667|NCT00390923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25851643|NCT00054340|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25851644|NCT00054340|Abortifacient Agents|abortifacient agents|mesh-ancestor
25851645|NCT00054340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24470823|NCT00392080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470824|NCT00392093|Estrogens|estrogens|mesh-list
24470825|NCT00392093|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24470826|NCT00392093|Hormones|hormones|mesh-ancestor
24470827|NCT00392093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24470828|NCT00392093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470829|NCT00392106|Amiodarone|amiodarone|mesh-list
24470830|NCT00392106|Flecainide|flecainide|mesh-list
24470831|NCT00392106|Propafenone|propafenone|mesh-list
24470832|NCT00392106|Dofetilide|dofetilide|mesh-list
25202263|NCT02722733|Antiviral Agents|antiviral agents|mesh-ancestor
25202264|NCT02722733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25202265|NCT02722733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25202266|NCT02722694|Methotrexate|methotrexate|mesh-list
25202267|NCT02722694|Abatacept|abatacept|mesh-list
25202268|NCT02722694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25202269|NCT02722694|Abortifacient Agents|abortifacient agents|mesh-ancestor
25202270|NCT02722694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25202271|NCT02722694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202272|NCT02722694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25202273|NCT02722694|Antimetabolites|antimetabolites|mesh-ancestor
25202274|NCT02722694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470854|NCT00392262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470903|NCT00392431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24470904|NCT00392431|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24470905|NCT00392431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24470907|NCT00392431|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24470925|NCT00392470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24470926|NCT00392470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24470927|NCT00392470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24470928|NCT00392470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470929|NCT00392470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470930|NCT00392470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24470931|NCT00392522|Nitrous Oxide|nitrous oxide|mesh-list
24470932|NCT00392522|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24470933|NCT00392522|Anesthetics, General|anesthetics, general|mesh-ancestor
24470934|NCT00392522|Anesthetics|anesthetics|mesh-ancestor
24470935|NCT00392522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24470936|NCT00392522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663025|NCT01652729|Incretins|incretins|mesh-ancestor
25663026|NCT01652729|Hormones|hormones|mesh-ancestor
25663027|NCT01652729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25663028|NCT01652729|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24810499|NCT02040597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24810500|NCT02040597|Autonomic Agents|autonomic agents|mesh-ancestor
24810501|NCT02040597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24810502|NCT02040597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810503|NCT02040597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24810504|NCT02040597|Respiratory System Agents|respiratory system agents|mesh-ancestor
24810505|NCT02040597|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24534771|NCT00647972|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25851646|NCT00054340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25851647|NCT00054340|Antimetabolites|antimetabolites|mesh-ancestor
24471031|NCT00392938|Tubulin Modulators|tubulin modulators|mesh-ancestor
24471032|NCT00392938|Antimitotic Agents|antimitotic agents|mesh-ancestor
24471033|NCT00392938|Mitosis Modulators|mitosis modulators|mesh-ancestor
24471034|NCT00392938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471035|NCT00392938|Hormone Antagonists|hormone antagonists|mesh-ancestor
24471036|NCT00392938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24471037|NCT00392938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810526|NCT02040649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471068|NCT00393263|Clobetasol|clobetasol|mesh-list
24471069|NCT00393263|Pimecrolimus|pimecrolimus|mesh-list
24471070|NCT00393263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24628577|NCT01100021|Adrenergic Agents|adrenergic agents|mesh-ancestor
24628509|NCT01099436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24628511|NCT01099462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24628512|NCT01099462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24817536|NCT02084446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817537|NCT02084446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471214|NCT00393770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471215|NCT00393770|Nootropic Agents|nootropic agents|mesh-ancestor
24471216|NCT00393835|Azithromycin|azithromycin|mesh-list
24471217|NCT00393835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24471218|NCT00393835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24471220|NCT00394056|Vestipitant|vestipitant|mesh-list
24810999|NCT02044133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24811001|NCT02044146|Ticagrelor|ticagrelor|mesh-list
24811002|NCT02044146|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24496012|NCT00502970|Hematinics|hematinics|mesh-ancestor
24471222|NCT00394056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24471223|NCT00394056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24471224|NCT00394056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471225|NCT00394056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24471226|NCT00394056|Serotonin Agents|serotonin agents|mesh-ancestor
24471227|NCT00394056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471228|NCT00394056|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24471229|NCT00394056|Antidepressive Agents|antidepressive agents|mesh-ancestor
24471230|NCT00394056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24471290|NCT00394394|Diuretics|diuretics|mesh-ancestor
24471291|NCT00394394|Natriuretic Agents|natriuretic agents|mesh-ancestor
24471292|NCT00394394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471293|NCT00394394|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
25663029|NCT01652729|Protease Inhibitors|protease inhibitors|mesh-ancestor
25663030|NCT01652729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663031|NCT01652729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663032|NCT01652729|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25663033|NCT01652976|Leucovorin|leucovorin|mesh-list
25663034|NCT01652976|Fluorouracil|fluorouracil|mesh-list
25663035|NCT01652976|Oxaliplatin|oxaliplatin|mesh-list
25663036|NCT01652976|Dasatinib|dasatinib|mesh-list
24628521|NCT01099462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628523|NCT01099527|Everolimus|everolimus|mesh-list
24628524|NCT01099527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24628525|NCT01099527|Antimetabolites|antimetabolites|mesh-ancestor
24774736|NCT01847599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24564098|NCT00775086|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24564099|NCT00775086|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24628555|NCT01099748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24628556|NCT01099748|Narcotics|narcotics|mesh-ancestor
24628557|NCT01099748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24628558|NCT01099748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606429|NCT00990418|Narcotics|narcotics|mesh-ancestor
25851648|NCT00054340|Dermatologic Agents|dermatologic agents|mesh-ancestor
25851649|NCT00054340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851650|NCT00054340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25851651|NCT00054340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25851652|NCT00054340|Antifungal Agents|antifungal agents|mesh-ancestor
25851653|NCT00054340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25851654|NCT00054340|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25851655|NCT00054392|Gemcitabine|gemcitabine|mesh-list
24471530|NCT00395759|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24471531|NCT00395759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24471532|NCT00395772|Vitamin K|vitamin k|mesh-list
24471533|NCT00395772|Heparin|heparin|mesh-list
24471534|NCT00395772|Rivaroxaban|rivaroxaban|mesh-list
24471535|NCT00395772|Vitamins|vitamins|mesh-ancestor
24811339|NCT02046447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811995|NCT02049190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24811996|NCT02049203|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
24811999|NCT02049229|Everolimus|everolimus|mesh-list
24812130|NCT02049801|Antiviral Agents|antiviral agents|mesh-ancestor
24812259|NCT02050893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24471585|NCT00396045|Growth Substances|growth substances|mesh-ancestor
25851656|NCT00054392|Paclitaxel|paclitaxel|mesh-list
25851657|NCT00054392|Carboplatin|carboplatin|mesh-list
24471597|NCT00396071|Vildagliptin|vildagliptin|mesh-list
24471598|NCT00396071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24471599|NCT00396071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471630|NCT00396344|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24471631|NCT00396344|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24471632|NCT00396344|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24471646|NCT00396487|Fluorouracil|fluorouracil|mesh-list
24471647|NCT00396487|Capecitabine|capecitabine|mesh-list
24471649|NCT00396487|Antimetabolites|antimetabolites|mesh-ancestor
24471650|NCT00396487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471651|NCT00396487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24471730|NCT00396721|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
24471731|NCT00396721|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24471732|NCT00396721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24471736|NCT00396721|Antifungal Agents|antifungal agents|mesh-ancestor
24471737|NCT00396721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24471738|NCT00396721|Immunologic Factors|immunologic factors|mesh-ancestor
24471756|NCT00396734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471758|NCT00396747|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24496408|NCT00504543|Everolimus|everolimus|mesh-list
24812264|NCT02050893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812266|NCT02050958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24812267|NCT02050958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24812268|NCT02050958|Analgesics|analgesics|mesh-ancestor
24812269|NCT02050958|Sensory System Agents|sensory system agents|mesh-ancestor
24812270|NCT02050958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812271|NCT02050958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812272|NCT02050958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24812273|NCT02050958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24812274|NCT02050958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24812275|NCT02050958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812276|NCT02050958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812277|NCT02051023|Fluorometholone|fluorometholone|mesh-list
25079426|NCT03347890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24812278|NCT02051023|Lubricant Eye Drops|lubricant eye drops|mesh-list
24812279|NCT02051023|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24812280|NCT02051023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24812281|NCT02051023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24772886|NCT01836406|Analgesics|analgesics|mesh-ancestor
24812282|NCT02051023|Glucocorticoids|glucocorticoids|mesh-ancestor
24812283|NCT02051023|Hormones|hormones|mesh-ancestor
24896756|NCT04433156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421489|NCT00219323|Omalizumab|omalizumab|mesh-list
24809925|NCT02036736|Propofol|propofol|mesh-list
24812284|NCT02051023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24812285|NCT02051023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812286|NCT02051023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24628559|NCT01099748|Analgesics|analgesics|mesh-ancestor
25851658|NCT00054392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24628560|NCT01099748|Sensory System Agents|sensory system agents|mesh-ancestor
24628561|NCT01099748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24628562|NCT01099748|Antitussive Agents|antitussive agents|mesh-ancestor
24628566|NCT01099839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24628567|NCT01099839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628569|NCT01099839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628570|NCT01099839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628571|NCT01099839|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24628572|NCT01100021|Doxazosin|doxazosin|mesh-list
24628573|NCT01100021|Tamsulosin|tamsulosin|mesh-list
24628574|NCT01100021|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24628575|NCT01100021|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24812439|NCT02052180|Bupivacaine|bupivacaine|mesh-list
24812784|NCT02054468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812785|NCT02054468|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24812786|NCT02054468|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24812787|NCT02054468|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24628576|NCT01100021|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24628582|NCT01100021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24471935|NCT00397501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25851661|NCT00054392|Antimitotic Agents|antimitotic agents|mesh-ancestor
25851662|NCT00054392|Mitosis Modulators|mitosis modulators|mesh-ancestor
25851663|NCT00054392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851664|NCT00054392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24471937|NCT00397501|Antidotes|antidotes|mesh-ancestor
24628592|NCT01100060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24628593|NCT01100060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24628594|NCT01100060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24628595|NCT01100060|Analgesics|analgesics|mesh-ancestor
24628596|NCT01100060|Sensory System Agents|sensory system agents|mesh-ancestor
24628597|NCT01100060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24628598|NCT01100060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628599|NCT01100060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24628600|NCT01100060|Filaricides|filaricides|mesh-ancestor
24628601|NCT01100060|Antinematodal Agents|antinematodal agents|mesh-ancestor
24628602|NCT01100060|Anthelmintics|anthelmintics|mesh-ancestor
24628603|NCT01100125|Insulin|insulin|mesh-list
24628604|NCT01100125|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24471938|NCT00397501|Protective Agents|protective agents|mesh-ancestor
24471939|NCT00397501|Antioxidants|antioxidants|mesh-ancestor
24471940|NCT00397501|Antitubercular Agents|antitubercular agents|mesh-ancestor
24471941|NCT00397501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25663037|NCT01652976|Antimetabolites|antimetabolites|mesh-ancestor
25663038|NCT01652976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663039|NCT01652976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25663040|NCT01652976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663041|NCT01652976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25663042|NCT01652976|Immunologic Factors|immunologic factors|mesh-ancestor
25663043|NCT01652976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663044|NCT01652976|Antidotes|antidotes|mesh-ancestor
25663045|NCT01652976|Protective Agents|protective agents|mesh-ancestor
25663046|NCT01652976|Vitamin B Complex|vitamin b complex|mesh-ancestor
25663047|NCT01652976|Vitamins|vitamins|mesh-ancestor
25663048|NCT01652976|Micronutrients|micronutrients|mesh-ancestor
25663049|NCT01652976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25663050|NCT01652976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663051|NCT01653158|Docetaxel|docetaxel|mesh-list
25851665|NCT00054392|Antimetabolites|antimetabolites|mesh-ancestor
24472041|NCT00397800|Fludarabine|fludarabine|mesh-list
24628605|NCT01100125|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24628606|NCT01100125|Insulin, Long-Acting|insulin, long-acting|mesh-list
24628607|NCT01100125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24628608|NCT01100125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628609|NCT01100125|Incretins|incretins|mesh-ancestor
24628610|NCT01100125|Hormones|hormones|mesh-ancestor
24628611|NCT01100125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24628612|NCT01100125|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24628613|NCT01100125|Protease Inhibitors|protease inhibitors|mesh-ancestor
24628614|NCT01100125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628615|NCT01100125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628616|NCT01100164|Eszopiclone|eszopiclone|mesh-list
24628617|NCT01100164|Zopiclone|zopiclone|mesh-list
24628618|NCT01100164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24628619|NCT01100164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24496641|NCT00505804|Autonomic Agents|autonomic agents|mesh-ancestor
24472118|NCT00398385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24472119|NCT00398385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24472120|NCT00398385|Immunologic Factors|immunologic factors|mesh-ancestor
24472121|NCT00398385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472123|NCT00398424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472124|NCT00398437|Trastuzumab|trastuzumab|mesh-list
24472125|NCT00398437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24628634|NCT01100203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25079427|NCT03347890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079428|NCT03347890|Incretins|incretins|mesh-ancestor
25079429|NCT03347890|Hormones|hormones|mesh-ancestor
25202277|NCT02722694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202278|NCT02722694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25202279|NCT02722694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24496806|NCT00506935|Vigabatrin|vigabatrin|mesh-list
25079430|NCT03347890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25079431|NCT03347864|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
25079432|NCT03347864|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25079433|NCT03347864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896887|NCT04432428|Sufentanil|sufentanil|mesh-list
25079448|NCT03347760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079450|NCT03347721|Anesthetics, Local|anesthetics, local|mesh-ancestor
25079451|NCT03347721|Anesthetics|anesthetics|mesh-ancestor
24474015|NCT00404781|Aspirin|aspirin|mesh-list
24472293|NCT00398788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24472294|NCT00398788|Narcotics|narcotics|mesh-ancestor
24472295|NCT00398788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24472296|NCT00398788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472297|NCT00398788|Analgesics|analgesics|mesh-ancestor
24472298|NCT00398788|Sensory System Agents|sensory system agents|mesh-ancestor
24472299|NCT00398788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25851669|NCT00054392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24472330|NCT00398892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472331|NCT00398892|Protective Agents|protective agents|mesh-ancestor
24472332|NCT00398892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813010|NCT02055703|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25851670|NCT00054392|Immunologic Factors|immunologic factors|mesh-ancestor
24472349|NCT00398957|Narcotic Antagonists|narcotic antagonists|mesh-list
24472350|NCT00398957|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24472351|NCT00398957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472352|NCT00398957|Sensory System Agents|sensory system agents|mesh-ancestor
24472389|NCT00399061|Dermatologic Agents|dermatologic agents|mesh-ancestor
24472390|NCT00399061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24472391|NCT00399061|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24472392|NCT00399074|Pyrimethamine|pyrimethamine|mesh-list
24472407|NCT00399087|Tubulin Modulators|tubulin modulators|mesh-ancestor
24472408|NCT00399087|Antimitotic Agents|antimitotic agents|mesh-ancestor
24472409|NCT00399087|Mitosis Modulators|mitosis modulators|mesh-ancestor
24472419|NCT00399126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472427|NCT00399152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24472429|NCT00399152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472430|NCT00399152|Growth Inhibitors|growth inhibitors|mesh-ancestor
24472431|NCT00399152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24813011|NCT02055703|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24813012|NCT02055703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24813013|NCT02055703|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24813014|NCT02055703|Protective Agents|protective agents|mesh-ancestor
24813016|NCT02055716|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24813017|NCT02055716|Protective Agents|protective agents|mesh-ancestor
24813018|NCT02055716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813019|NCT02055716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813020|NCT02055911|Ranibizumab|ranibizumab|mesh-list
24813021|NCT02055911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24813022|NCT02055911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24813023|NCT02055911|Growth Substances|growth substances|mesh-ancestor
24813024|NCT02055911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813025|NCT02055911|Growth Inhibitors|growth inhibitors|mesh-ancestor
24813026|NCT02055911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813027|NCT02056041|Liver Extracts|liver extracts|mesh-list
25202281|NCT02722694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24628647|NCT01100216|Cholinergic Agents|cholinergic agents|mesh-ancestor
24628648|NCT01100216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24628649|NCT01100216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675775|NCT01345084|Nimotuzumab|nimotuzumab|mesh-list
24628651|NCT01100294|Immunologic Factors|immunologic factors|mesh-ancestor
24628652|NCT01100294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628653|NCT01100333|Hormones|hormones|mesh-list
24628654|NCT01100333|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24628655|NCT01100333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24628656|NCT01100333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628657|NCT01100346|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24628658|NCT01100346|Hormones|hormones|mesh-ancestor
24628659|NCT01100346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24628660|NCT01100346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813270|NCT02057484|Tacrolimus|tacrolimus|mesh-list
24608964|NCT00994617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608965|NCT00994617|Diuretics|diuretics|mesh-ancestor
24608966|NCT00994617|Natriuretic Agents|natriuretic agents|mesh-ancestor
24628674|NCT01100372|Antimetabolites|antimetabolites|mesh-ancestor
24608969|NCT00994617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24608970|NCT00994695|Vaccines|vaccines|mesh-list
24896940|NCT04432233|Renal Agents|renal agents|mesh-ancestor
24496998|NCT00507793|Sirolimus|sirolimus|mesh-list
24608978|NCT00994708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472488|NCT00399295|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24472489|NCT00399295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472490|NCT00399295|Sensory System Agents|sensory system agents|mesh-ancestor
24472491|NCT00399295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24472492|NCT00399295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24472493|NCT00399295|Narcotics|narcotics|mesh-ancestor
24472494|NCT00399295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24472495|NCT00399295|Analgesics|analgesics|mesh-ancestor
24810146|NCT02038257|Petrolatum|petrolatum|mesh-list
24472563|NCT00399659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472565|NCT00399672|Ribavirin|ribavirin|mesh-list
24813649|NCT02059759|Sensory System Agents|sensory system agents|mesh-ancestor
24813650|NCT02059759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24813651|NCT02059759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813981|NCT02061631|Tubulin Modulators|tubulin modulators|mesh-ancestor
24813982|NCT02061631|Antimitotic Agents|antimitotic agents|mesh-ancestor
24813983|NCT02061631|Mitosis Modulators|mitosis modulators|mesh-ancestor
24813985|NCT02061644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24813986|NCT02061644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851671|NCT00054392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665394|NCT01312077|Morphine|morphine|mesh-list
24628662|NCT01100359|Doxorubicin|doxorubicin|mesh-list
24628663|NCT01100359|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24628664|NCT01100359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24628665|NCT01100359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24628666|NCT01100359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24628667|NCT01100359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24628668|NCT01100359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628669|NCT01100359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628670|NCT01100372|Gemcitabine|gemcitabine|mesh-list
24628671|NCT01100372|Doxorubicin|doxorubicin|mesh-list
24628672|NCT01100372|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24628673|NCT01100372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24628675|NCT01100372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851672|NCT00054405|Aldesleukin|aldesleukin|mesh-list
25851673|NCT00054405|Interleukin-2|interleukin-2|mesh-list
24628676|NCT01100372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24628677|NCT01100372|Antiviral Agents|antiviral agents|mesh-ancestor
24628678|NCT01100372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24814139|NCT02062996|Sympathomimetics|sympathomimetics|mesh-ancestor
24814207|NCT02063269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814208|NCT02063269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24814209|NCT02063269|Protective Agents|protective agents|mesh-ancestor
24814211|NCT02063334|Cholecalciferol|cholecalciferol|mesh-list
24814212|NCT02063334|Vitamins|vitamins|mesh-ancestor
24814213|NCT02063334|Micronutrients|micronutrients|mesh-ancestor
24814215|NCT02063334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24814216|NCT02063334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24814217|NCT02063360|Ritonavir|ritonavir|mesh-list
24814218|NCT02063360|Darunavir|darunavir|mesh-list
24965442|NCT03776851|Epoetin Alfa|epoetin alfa|mesh-list
24814219|NCT02063360|Fostemsavir|fostemsavir|mesh-list
24497443|NCT00510081|Calcium|calcium|mesh-list
24472722|NCT00400374|Celecoxib|celecoxib|mesh-list
24472723|NCT00400374|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24472724|NCT00400374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472725|NCT00400374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24472726|NCT00400374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24814516|NCT02064881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24814517|NCT02064881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814518|NCT02064946|Vitamin D|vitamin d|mesh-list
24814519|NCT02064946|Vitamins|vitamins|mesh-ancestor
24814520|NCT02064946|Micronutrients|micronutrients|mesh-ancestor
24814521|NCT02064946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814522|NCT02064946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24814523|NCT02065063|Palbociclib|palbociclib|mesh-list
25663052|NCT01653158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851674|NCT00054405|Interleukin-12|interleukin-12|mesh-list
24814542|NCT02065219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24814544|NCT02065219|Sensory System Agents|sensory system agents|mesh-ancestor
24814545|NCT02065219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24610244|NCT01000792|Cetirizine|cetirizine|mesh-list
24628679|NCT01100372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628680|NCT01100372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24814710|NCT02066103|Paclitaxel|paclitaxel|mesh-list
24610618|NCT01004068|Clomiphene|clomiphene|mesh-list
24814872|NCT02067078|Protease Inhibitors|protease inhibitors|mesh-ancestor
24814873|NCT02067078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24814874|NCT02067078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814875|NCT02067078|Anesthetics, Local|anesthetics, local|mesh-ancestor
24814876|NCT02067078|Anesthetics|anesthetics|mesh-ancestor
24814877|NCT02067078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24814878|NCT02067078|Sensory System Agents|sensory system agents|mesh-ancestor
24814879|NCT02067078|Analgesics|analgesics|mesh-ancestor
24814880|NCT02067078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24814881|NCT02067078|Sympatholytics|sympatholytics|mesh-ancestor
24814882|NCT02067078|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24965457|NCT03776838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24773245|NCT01838668|Dimethyl Fumarate|dimethyl fumarate|mesh-list
24814896|NCT02067078|Sympathomimetics|sympathomimetics|mesh-ancestor
24814897|NCT02067078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24814898|NCT02067143|Cytarabine|cytarabine|mesh-list
24897021|NCT04430556|Sertraline|sertraline|mesh-list
24472806|NCT00400608|Sympathomimetics|sympathomimetics|mesh-ancestor
24814899|NCT02067143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24814900|NCT02067143|Antimetabolites|antimetabolites|mesh-ancestor
24814901|NCT02067143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814902|NCT02067143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815070|NCT02068170|Contraceptive Agents|contraceptive agents|mesh-ancestor
24610995|NCT01006031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610997|NCT01006057|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24610998|NCT01006057|Insulin, Long-Acting|insulin, long-acting|mesh-list
24610999|NCT01006057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24611000|NCT01006057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611001|NCT01006096|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24611002|NCT01006096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611003|NCT01006096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24611004|NCT01006096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611005|NCT01006096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611006|NCT01006187|Lidocaine|lidocaine|mesh-list
24611007|NCT01006187|Anesthetics, Local|anesthetics, local|mesh-ancestor
24611008|NCT01006187|Anesthetics|anesthetics|mesh-ancestor
24611009|NCT01006187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24611010|NCT01006187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611011|NCT01006187|Sensory System Agents|sensory system agents|mesh-ancestor
24611012|NCT01006187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24815458|NCT02070406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24815459|NCT02070406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24815460|NCT02070406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24815461|NCT02070406|Antiviral Agents|antiviral agents|mesh-ancestor
25202283|NCT02722694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25202284|NCT02722603|Gabapentin|gabapentin|mesh-list
25851684|NCT00054405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25851685|NCT00054405|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24815462|NCT02070406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24815463|NCT02070406|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24815464|NCT02070458|Cytarabine|cytarabine|mesh-list
24815465|NCT02070458|Etoposide|etoposide|mesh-list
24472814|NCT00400647|Mycophenolic Acid|mycophenolic acid|mesh-list
24472815|NCT00400647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24472816|NCT00400647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472817|NCT00400647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24472818|NCT00400647|Antitubercular Agents|antitubercular agents|mesh-ancestor
24472819|NCT00400647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24472820|NCT00400647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24472823|NCT00400725|Clobetasol|clobetasol|mesh-list
24676374|NCT01349777|Clopidogrel|clopidogrel|mesh-list
25079460|NCT03347721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079461|NCT03347708|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25079463|NCT03347708|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25079464|NCT03347708|Immunologic Factors|immunologic factors|mesh-ancestor
25079465|NCT03347708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897052|NCT04430361|Appetite Stimulants|appetite stimulants|mesh-ancestor
24472831|NCT00400738|Saquinavir|saquinavir|mesh-list
25202285|NCT02722603|Tramadol|tramadol|mesh-list
25202286|NCT02722603|Analgesics|analgesics|mesh-ancestor
25202287|NCT02722603|Sensory System Agents|sensory system agents|mesh-ancestor
25202288|NCT02722603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202289|NCT02722603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202290|NCT02722603|Anticonvulsants|anticonvulsants|mesh-ancestor
25202291|NCT02722603|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25202292|NCT02722603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25202293|NCT02722603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25202294|NCT02722603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25202295|NCT02722603|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25202296|NCT02722603|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25202297|NCT02722603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25851686|NCT00054405|Immunologic Factors|immunologic factors|mesh-ancestor
25663053|NCT01653158|Tubulin Modulators|tubulin modulators|mesh-ancestor
25663054|NCT01653158|Antimitotic Agents|antimitotic agents|mesh-ancestor
25663055|NCT01653158|Mitosis Modulators|mitosis modulators|mesh-ancestor
24815479|NCT02070458|Antiviral Agents|antiviral agents|mesh-ancestor
24815480|NCT02070458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24815481|NCT02070458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24815482|NCT02070458|Immunologic Factors|immunologic factors|mesh-ancestor
24815483|NCT02070458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815484|NCT02070458|Analgesics|analgesics|mesh-ancestor
24815485|NCT02070458|Sensory System Agents|sensory system agents|mesh-ancestor
24815486|NCT02070458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24815487|NCT02070458|Protease Inhibitors|protease inhibitors|mesh-ancestor
24815488|NCT02070458|Glycine Agents|glycine agents|mesh-ancestor
24815489|NCT02070458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665775|NCT01314833|Paclitaxel|paclitaxel|mesh-list
24665838|NCT01314989|Cyproheptadine|cyproheptadine|mesh-list
24628681|NCT01100372|Immunologic Factors|immunologic factors|mesh-ancestor
24628682|NCT01100372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628683|NCT01100372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24628684|NCT01100372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24815778|NCT02071966|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24815779|NCT02071966|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24815780|NCT02071966|Purinergic Agents|purinergic agents|mesh-ancestor
24815781|NCT02071966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24815782|NCT02071966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815783|NCT02071966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815784|NCT02072031|Sunitinib|sunitinib|mesh-list
24815785|NCT02072031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815786|NCT02072031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24815787|NCT02072031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24815788|NCT02072031|Growth Substances|growth substances|mesh-ancestor
24815789|NCT02072031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815790|NCT02072031|Growth Inhibitors|growth inhibitors|mesh-ancestor
24460868|NCT00349791|Testosterone|testosterone|mesh-list
24815791|NCT02072031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24815792|NCT02072031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202300|NCT02722603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24472962|NCT00401323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851687|NCT00054405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24472970|NCT00401323|Immunologic Factors|immunologic factors|mesh-ancestor
24472971|NCT00401323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472973|NCT00401362|Methylnaltrexone|methylnaltrexone|mesh-list
24472974|NCT00401362|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24815793|NCT02072031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815795|NCT02072083|Ketamine|ketamine|mesh-list
24815831|NCT02072278|Vortioxetine|vortioxetine|mesh-list
24816051|NCT02073838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24816052|NCT02073838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24816053|NCT02073838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611916|NCT01011205|Antiemetics|antiemetics|mesh-ancestor
24628693|NCT01100736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628694|NCT01100801|Cisplatin|cisplatin|mesh-list
24628695|NCT01100801|Oxaliplatin|oxaliplatin|mesh-list
24628696|NCT01100801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24628697|NCT01100892|Insulin Detemir|insulin detemir|mesh-list
24628698|NCT01100892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24472975|NCT00401362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472976|NCT00401362|Sensory System Agents|sensory system agents|mesh-ancestor
24472977|NCT00401362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24472978|NCT00401362|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24472982|NCT00401427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24676276|NCT01349335|Tolvaptan|tolvaptan|mesh-list
24472983|NCT00401427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24472984|NCT00401427|Tubulin Modulators|tubulin modulators|mesh-ancestor
25421532|NCT02531308|Cyclophosphamide|cyclophosphamide|mesh-list
25663056|NCT01653158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851692|NCT00054418|Risedronic Acid|risedronic acid|mesh-list
25851693|NCT00054418|Calcium Carbonate|calcium carbonate|mesh-list
25851694|NCT00054418|Calcium|calcium|mesh-list
24498047|NCT00513162|Etoposide|etoposide|mesh-list
25202301|NCT02722603|Narcotics|narcotics|mesh-ancestor
25202302|NCT02722447|Rivaroxaban|rivaroxaban|mesh-list
25202303|NCT02722447|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25202304|NCT02722447|Antithrombins|antithrombins|mesh-ancestor
24628708|NCT01101009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24628710|NCT01101009|Vasodilator Agents|vasodilator agents|mesh-ancestor
24628711|NCT01101009|Diuretics|diuretics|mesh-ancestor
24628712|NCT01101009|Natriuretic Agents|natriuretic agents|mesh-ancestor
24628713|NCT01101009|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24628714|NCT01101009|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24628715|NCT01101009|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24628716|NCT01101009|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24676729|NCT01352312|Ofatumumab|ofatumumab|mesh-list
24628717|NCT01101009|Protease Inhibitors|protease inhibitors|mesh-ancestor
24628718|NCT01101009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773346|NCT01839175|Vaccines|vaccines|mesh-list
24628719|NCT01101113|Cinacalcet|cinacalcet|mesh-list
25851695|NCT00054418|Vitamins|vitamins|mesh-ancestor
24472992|NCT00401440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472993|NCT00401440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24444188|NCT00296933|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24444189|NCT00296933|Dopamine Agents|dopamine agents|mesh-ancestor
24444190|NCT00296933|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24628720|NCT01101113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24628721|NCT01101113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628722|NCT01101113|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24628723|NCT01101113|Hormone Antagonists|hormone antagonists|mesh-ancestor
24628724|NCT01101113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24628725|NCT01101152|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24628726|NCT01101152|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24628727|NCT01101152|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24628728|NCT01101152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24628729|NCT01101152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628730|NCT01101152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24628731|NCT01101152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444296|NCT00297375|Tramadol|tramadol|mesh-list
24444297|NCT00297375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24444298|NCT00297375|Analgesics|analgesics|mesh-ancestor
25663057|NCT01653262|Brivaracetam|brivaracetam|mesh-list
25663058|NCT01653262|Anticonvulsants|anticonvulsants|mesh-ancestor
25663059|NCT01653327|Ketamine|ketamine|mesh-list
25663060|NCT01653327|Analgesics|analgesics|mesh-ancestor
25663061|NCT01653327|Sensory System Agents|sensory system agents|mesh-ancestor
25663062|NCT01653327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25663063|NCT01653327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663064|NCT01653327|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24444300|NCT00297375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202305|NCT02722447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24666229|NCT01318096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24666386|NCT01319006|Glycine|glycine|mesh-list
24628744|NCT01101204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24628745|NCT01101204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628746|NCT01101269|Lisinopril|lisinopril|mesh-list
24628747|NCT01101269|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24628748|NCT01101269|Protease Inhibitors|protease inhibitors|mesh-ancestor
24628749|NCT01101269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628750|NCT01101269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628751|NCT01101269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24628752|NCT01101269|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24816055|NCT02073916|Paclitaxel|paclitaxel|mesh-list
24612061|NCT01011751|Antidepressive Agents|antidepressive agents|mesh-ancestor
24816148|NCT02074293|Cholinergic Agents|cholinergic agents|mesh-ancestor
24816291|NCT02075749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24816292|NCT02075749|Immunologic Factors|immunologic factors|mesh-ancestor
24816293|NCT02075749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24897148|NCT04428684|Goserelin|goserelin|mesh-list
24444364|NCT00297661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444365|NCT00297661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24444366|NCT00297661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24444367|NCT00297661|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24444368|NCT00297661|Antifungal Agents|antifungal agents|mesh-ancestor
24444407|NCT00297804|Mitosis Modulators|mitosis modulators|mesh-ancestor
24444415|NCT00297947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24444416|NCT00297947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24444471|NCT00298168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24444472|NCT00298168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851696|NCT00054418|Micronutrients|micronutrients|mesh-ancestor
24473035|NCT00401609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24628766|NCT01101386|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24628768|NCT01101412|Ethanol|ethanol|mesh-list
24628769|NCT01101412|Trimethoprim|trimethoprim|mesh-list
24628770|NCT01101412|Sulfamethoxazole|sulfamethoxazole|mesh-list
24676877|NCT01352663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24628771|NCT01101412|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24628772|NCT01101412|Edetic Acid|edetic acid|mesh-list
24628773|NCT01101412|Calcium|calcium|mesh-list
24628774|NCT01101412|Pentetic Acid|pentetic acid|mesh-list
24473036|NCT00401609|Immunologic Factors|immunologic factors|mesh-ancestor
25851697|NCT00054418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851698|NCT00054418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24444548|NCT00298415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24473106|NCT00401856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24473107|NCT00401869|Epoetin Alfa|epoetin alfa|mesh-list
24473108|NCT00401869|Hematinics|hematinics|mesh-ancestor
24473109|NCT00401921|Minocycline|minocycline|mesh-list
24473110|NCT00401921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24473111|NCT00401921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24473112|NCT00402012|Pioglitazone|pioglitazone|mesh-list
24473113|NCT00402012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24473132|NCT00402077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25202306|NCT02722447|Protease Inhibitors|protease inhibitors|mesh-ancestor
24473141|NCT00402181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24473142|NCT00402181|Antiemetics|antiemetics|mesh-ancestor
24473143|NCT00402181|Autonomic Agents|autonomic agents|mesh-ancestor
24473144|NCT00402181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24473145|NCT00402181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473146|NCT00402181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24473147|NCT00402181|Glucocorticoids|glucocorticoids|mesh-ancestor
24473148|NCT00402181|Hormones|hormones|mesh-ancestor
24473149|NCT00402181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24473150|NCT00402181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24628775|NCT01101412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24628776|NCT01101412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628777|NCT01101412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24628778|NCT01101412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24628779|NCT01101412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24628780|NCT01101412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24473304|NCT00402506|Vitamins|vitamins|mesh-ancestor
24473305|NCT00402506|Micronutrients|micronutrients|mesh-ancestor
24473306|NCT00402506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473307|NCT00402532|Everolimus|everolimus|mesh-list
25005472|NCT03979885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25005473|NCT03979885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005474|NCT03979885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24628810|NCT01101568|Simvastatin|simvastatin|mesh-list
24473561|NCT00403312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24473562|NCT00403312|Autonomic Agents|autonomic agents|mesh-ancestor
24473563|NCT00403312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24473564|NCT00403312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816469|NCT02077257|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24816470|NCT02077257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24816471|NCT02077257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24816472|NCT02077257|Antimetabolites|antimetabolites|mesh-ancestor
24816473|NCT02077257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816474|NCT02077257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25202307|NCT02722447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456881|NCT00332540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24473660|NCT00403728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473662|NCT00403728|Immunologic Factors|immunologic factors|mesh-ancestor
25851699|NCT00054418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24473675|NCT00403780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24473676|NCT00403780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24473686|NCT00403806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24473696|NCT00403806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851700|NCT00054418|Antacids|antacids|mesh-ancestor
24550459|NCT00720590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550461|NCT00720590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24550462|NCT00720590|Antiviral Agents|antiviral agents|mesh-ancestor
24550463|NCT00720590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24550464|NCT00720590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24550465|NCT00720590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24550466|NCT00720603|Plerixafor|plerixafor|mesh-list
24461430|NCT00352339|Aripiprazole|aripiprazole|mesh-list
24445607|NCT00301912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24445608|NCT00301925|Cyclophosphamide|cyclophosphamide|mesh-list
24445609|NCT00301925|Fluorouracil|fluorouracil|mesh-list
24550467|NCT00720603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24550468|NCT00720603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24550469|NCT00720603|Antiviral Agents|antiviral agents|mesh-ancestor
24550470|NCT00720603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24550471|NCT00720616|Insulin|insulin|mesh-list
24550472|NCT00720616|Hormones|hormones|mesh-list
24550473|NCT00720616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24550474|NCT00720616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550475|NCT00720616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24550476|NCT00720772|Sodium thiosulfate|sodium thiosulfate|mesh-list
24550477|NCT00720772|Antidotes|antidotes|mesh-ancestor
24550478|NCT00720772|Protective Agents|protective agents|mesh-ancestor
24550479|NCT00720772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550480|NCT00720772|Antioxidants|antioxidants|mesh-ancestor
24550481|NCT00720772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550482|NCT00720772|Antitubercular Agents|antitubercular agents|mesh-ancestor
24550483|NCT00720772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24550484|NCT00720772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24550485|NCT00720772|Chelating Agents|chelating agents|mesh-ancestor
25079472|NCT03347591|Immunologic Factors|immunologic factors|mesh-ancestor
25079473|NCT03347591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079474|NCT03347591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24473753|NCT00404053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24473754|NCT00404053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24473755|NCT00404053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24897258|NCT04426734|Protective Agents|protective agents|mesh-ancestor
24897266|NCT04426552|Sevoflurane|sevoflurane|mesh-list
24473802|NCT00404222|Respiratory System Agents|respiratory system agents|mesh-ancestor
24473803|NCT00404222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24473804|NCT00404222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25663065|NCT01653327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25663066|NCT01653327|Anesthetics, General|anesthetics, general|mesh-ancestor
25663067|NCT01653327|Anesthetics|anesthetics|mesh-ancestor
25663068|NCT01653327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25663069|NCT01653327|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25663070|NCT01653327|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25663071|NCT01653327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25663072|NCT01653327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663073|NCT01653418|Cytarabine|cytarabine|mesh-list
24530060|NCT00628914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24530062|NCT00628914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24473805|NCT00404222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24473806|NCT00404261|Fluticasone|fluticasone|mesh-list
24473807|NCT00404261|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24473808|NCT00404261|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24473809|NCT00404261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24473810|NCT00404261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25851701|NCT00054418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851702|NCT00054418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24817306|NCT02082418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817308|NCT02082496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24473901|NCT00404404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24817433|NCT02083627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24817434|NCT02083627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817435|NCT02083627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24473934|NCT00404508|Hydralazine|hydralazine|mesh-list
24473936|NCT00404508|Anticonvulsants|anticonvulsants|mesh-ancestor
25851703|NCT00054418|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24473946|NCT00404508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24473947|NCT00404508|Vasodilator Agents|vasodilator agents|mesh-ancestor
24473948|NCT00404534|Amoxicillin|amoxicillin|mesh-list
24473949|NCT00404534|Clarithromycin|clarithromycin|mesh-list
24467245|NCT00376727|Cetuximab|cetuximab|mesh-list
25851704|NCT00054418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24550547|NCT00721201|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24550548|NCT00721201|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24550590|NCT00721331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550591|NCT00721331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550592|NCT00721331|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24550593|NCT00721331|Antidepressive Agents|antidepressive agents|mesh-ancestor
24550594|NCT00721331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24550595|NCT00721331|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24550596|NCT00721331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24550597|NCT00721331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24550598|NCT00721331|Adrenergic Agents|adrenergic agents|mesh-ancestor
24550599|NCT00721344|Moxifloxacin|moxifloxacin|mesh-list
24550600|NCT00721344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24550601|NCT00721344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24550602|NCT00721344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24474045|NCT00404781|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24474046|NCT00404781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24474047|NCT00404794|Mycophenolic Acid|mycophenolic acid|mesh-list
24474048|NCT00404794|Prednisolone|prednisolone|mesh-list
24474049|NCT00404794|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24474050|NCT00404794|Methylprednisolone|methylprednisolone|mesh-list
25851705|NCT00054431|Imatinib Mesylate|imatinib mesylate|mesh-list
24446335|NCT00304473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25851706|NCT00054431|Decitabine|decitabine|mesh-list
24818534|NCT02089295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24614781|NCT01026350|Antibodies|antibodies|mesh-list
24897443|NCT04425707|Hydroxychloroquine|hydroxychloroquine|mesh-list
25851707|NCT00054431|Azacitidine|azacitidine|mesh-list
24897453|NCT04425824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24720256|NCT01567488|Everolimus|everolimus|mesh-list
24550620|NCT00721487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24550621|NCT00721487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550622|NCT00721487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550623|NCT00721487|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24550624|NCT00721487|Hormone Antagonists|hormone antagonists|mesh-ancestor
25079481|NCT03347526|Vigabatrin|vigabatrin|mesh-list
25079482|NCT03347526|Cosyntropin|cosyntropin|mesh-list
25079483|NCT03347526|Anticonvulsants|anticonvulsants|mesh-ancestor
25079484|NCT03347526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25079485|NCT03347526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079486|NCT03347526|GABA Agents|gaba agents|mesh-ancestor
25079487|NCT03347526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24818802|NCT02090920|Vasodilator Agents|vasodilator agents|mesh-ancestor
24818803|NCT02090920|Tocolytic Agents|tocolytic agents|mesh-ancestor
24615232|NCT01028482|Serotonin Agents|serotonin agents|mesh-ancestor
24446412|NCT00304655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663074|NCT01653418|Etoposide|etoposide|mesh-list
24819046|NCT02092766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25663075|NCT01653418|Bortezomib|bortezomib|mesh-list
25663076|NCT01653418|Melphalan|melphalan|mesh-list
25663077|NCT01653418|Carmustine|carmustine|mesh-list
25663078|NCT01653418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25202308|NCT02722447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202309|NCT02722447|Anticoagulants|anticoagulants|mesh-ancestor
25202310|NCT02722421|Efavirenz|efavirenz|mesh-list
25202311|NCT02722421|Levonorgestrel|levonorgestrel|mesh-list
25202312|NCT02722421|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25202313|NCT02722421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25202314|NCT02722421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202315|NCT02722421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202316|NCT02722421|Antiviral Agents|antiviral agents|mesh-ancestor
25202317|NCT02722421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25202318|NCT02722421|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25202319|NCT02722421|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25202320|NCT02722421|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25202321|NCT02722421|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24819943|NCT02097966|Antimetabolites|antimetabolites|mesh-ancestor
24819944|NCT02097966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819945|NCT02097966|Antiviral Agents|antiviral agents|mesh-ancestor
24819946|NCT02097966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24819947|NCT02098148|Xenon|xenon|mesh-list
24819948|NCT02098148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24819949|NCT02098148|Anesthetics, General|anesthetics, general|mesh-ancestor
24819950|NCT02098148|Anesthetics|anesthetics|mesh-ancestor
24819951|NCT02098148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24819952|NCT02098148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819953|NCT02098317|Vitamin D|vitamin d|mesh-list
24819954|NCT02098317|Vitamins|vitamins|mesh-ancestor
24819955|NCT02098317|Micronutrients|micronutrients|mesh-ancestor
24819956|NCT02098317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819957|NCT02098317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24819958|NCT02098330|Methylprednisolone|methylprednisolone|mesh-list
24819959|NCT02098330|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24819960|NCT02098330|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24819961|NCT02098330|Prednisolone|prednisolone|mesh-list
24819962|NCT02098330|Prednisolone acetate|prednisolone acetate|mesh-list
24819963|NCT02098330|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24819964|NCT02098330|Prednisolone phosphate|prednisolone phosphate|mesh-list
24819965|NCT02098330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24819966|NCT02098330|Antiemetics|antiemetics|mesh-ancestor
24819967|NCT02098330|Autonomic Agents|autonomic agents|mesh-ancestor
24819968|NCT02098330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24819969|NCT02098330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819970|NCT02098330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24819971|NCT02098330|Glucocorticoids|glucocorticoids|mesh-ancestor
24819972|NCT02098330|Hormones|hormones|mesh-ancestor
24759666|NCT01753752|Acetylcysteine|acetylcysteine|mesh-list
24759667|NCT01753752|Chitosan|chitosan|mesh-list
24759668|NCT01753752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24759669|NCT01753752|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25851708|NCT00054431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851709|NCT00054431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25851710|NCT00054431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851711|NCT00054431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851712|NCT00054431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24759697|NCT01753882|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24759698|NCT01753882|Antidepressive Agents|antidepressive agents|mesh-ancestor
24759699|NCT01753882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25079510|NCT03347461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759701|NCT01754116|Midazolam|midazolam|mesh-list
25851713|NCT00054431|Antimetabolites|antimetabolites|mesh-ancestor
25851714|NCT00054444|Cisplatin|cisplatin|mesh-list
25851715|NCT00054444|Topotecan|topotecan|mesh-list
24759702|NCT01754116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24759703|NCT01754116|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24759704|NCT01754116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25202322|NCT02722421|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25202323|NCT02722421|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25202324|NCT02722421|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25202325|NCT02722421|Contraceptive Agents|contraceptive agents|mesh-ancestor
24897620|NCT04423627|Clonidine|clonidine|mesh-list
24474221|NCT00405262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25663079|NCT01653418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474222|NCT00405262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474223|NCT00405262|Sensory System Agents|sensory system agents|mesh-ancestor
25663080|NCT01653418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25005496|NCT03947216|Serotonin Agents|serotonin agents|mesh-ancestor
24759735|NCT01754220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759736|NCT01754285|Octreotide|octreotide|mesh-list
24759737|NCT01754285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24759738|NCT01754285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24759739|NCT01754285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759741|NCT01754324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24759743|NCT01754324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24759744|NCT01754324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759745|NCT01754324|Analgesics|analgesics|mesh-ancestor
24759746|NCT01754324|Sensory System Agents|sensory system agents|mesh-ancestor
24759747|NCT01754324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24759748|NCT01754324|Antitussive Agents|antitussive agents|mesh-ancestor
25851716|NCT00054444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759752|NCT01754649|Abortifacient Agents|abortifacient agents|mesh-ancestor
24759753|NCT01754649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25851717|NCT00054444|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25851718|NCT00054444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24759754|NCT01754649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759755|NCT01754649|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24759756|NCT01754649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24759759|NCT01754701|Trace Elements|trace elements|mesh-ancestor
24759760|NCT01754701|Micronutrients|micronutrients|mesh-ancestor
24759761|NCT01754701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759762|NCT01754792|Inositol|inositol|mesh-list
24462168|NCT00355290|Vitamin K|vitamin k|mesh-list
24759763|NCT01754792|Vitamin B Complex|vitamin b complex|mesh-ancestor
24759764|NCT01754792|Vitamins|vitamins|mesh-ancestor
24759765|NCT01754792|Micronutrients|micronutrients|mesh-ancestor
24759766|NCT01754792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759767|NCT01754805|Methotrexate|methotrexate|mesh-list
24759768|NCT01754805|Peficitinib|peficitinib|mesh-list
24759777|NCT01754805|Dermatologic Agents|dermatologic agents|mesh-ancestor
25079511|NCT03347461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24965498|NCT03776409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25079529|NCT03347357|Immunologic Factors|immunologic factors|mesh-ancestor
25079530|NCT03347357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079531|NCT03347357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25079544|NCT03347240|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25079545|NCT03347240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079546|NCT03347240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25079547|NCT03347240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24965515|NCT03776279|Sensory System Agents|sensory system agents|mesh-ancestor
24965516|NCT03776279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24965517|NCT03776279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079548|NCT03347240|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25079550|NCT03347240|GABA Agents|gaba agents|mesh-ancestor
25079551|NCT03347240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25079552|NCT03347240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079553|NCT03346993|Bupivacaine|bupivacaine|mesh-list
25079554|NCT03346993|Anesthetics, Local|anesthetics, local|mesh-ancestor
25079555|NCT03346993|Anesthetics|anesthetics|mesh-ancestor
25079556|NCT03346993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25079557|NCT03346993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774740|NCT01847612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759795|NCT01754870|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24759796|NCT01754870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24759797|NCT01754870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759798|NCT01754870|Immunologic Factors|immunologic factors|mesh-ancestor
24759799|NCT01754870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759800|NCT01754870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24759801|NCT01754870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24759802|NCT01754870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24759803|NCT01754870|Growth Substances|growth substances|mesh-ancestor
24759804|NCT01754870|Growth Inhibitors|growth inhibitors|mesh-ancestor
24759805|NCT01754870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24759806|NCT01754870|Alkylating Agents|alkylating agents|mesh-ancestor
24759807|NCT01754870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759809|NCT01754883|Antidepressive Agents|antidepressive agents|mesh-ancestor
24759810|NCT01754883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24759811|NCT01754883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25421533|NCT02531308|Rituximab|rituximab|mesh-list
25663081|NCT01653418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25663082|NCT01653418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663083|NCT01653418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532046|NCT00637910|Docetaxel|docetaxel|mesh-list
24759812|NCT01754883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759813|NCT01754883|Antimanic Agents|antimanic agents|mesh-ancestor
24759814|NCT01754883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24759815|NCT01754883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24759816|NCT01754883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759817|NCT01754961|Vitamin D|vitamin d|mesh-list
24759818|NCT01754961|Ergocalciferols|ergocalciferols|mesh-list
25851719|NCT00054444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759838|NCT01755078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24759840|NCT01755078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759841|NCT01755078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24759842|NCT01755078|Chelating Agents|chelating agents|mesh-ancestor
24759843|NCT01755078|Sequestering Agents|sequestering agents|mesh-ancestor
24759844|NCT01755117|Ropivacaine|ropivacaine|mesh-list
24759845|NCT01755117|Anesthetics, Local|anesthetics, local|mesh-ancestor
24759846|NCT01755117|Anesthetics|anesthetics|mesh-ancestor
25851720|NCT00054444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202330|NCT02722421|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24759866|NCT01755299|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24759867|NCT01755299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759868|NCT01755299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24759869|NCT01755299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759870|NCT01755299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677903|NCT01359085|Pregabalin|pregabalin|mesh-list
24759871|NCT01755299|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24759872|NCT01755299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24759884|NCT01755338|Autonomic Agents|autonomic agents|mesh-ancestor
24759885|NCT01755338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24759886|NCT01755338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759887|NCT01755338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24759888|NCT01755338|Glucocorticoids|glucocorticoids|mesh-ancestor
24759924|NCT01755494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24759940|NCT01755520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24759941|NCT01755520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759942|NCT01755520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24759943|NCT01755520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24759944|NCT01755520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759945|NCT01755520|Antipyretics|antipyretics|mesh-ancestor
24759946|NCT01755520|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24759947|NCT01755520|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24759948|NCT01755520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24759949|NCT01755520|Purinergic Agents|purinergic agents|mesh-ancestor
24759950|NCT01755520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24759951|NCT01755559|Artesunate|artesunate|mesh-list
24759952|NCT01755559|Lumefantrine|lumefantrine|mesh-list
24759953|NCT01755559|Artemether|artemether|mesh-list
24759954|NCT01755559|Piperaquine|piperaquine|mesh-list
24759955|NCT01755559|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24759957|NCT01755559|Artenimol|artenimol|mesh-list
24500954|NCT00526305|Hormones|hormones|mesh-ancestor
24759962|NCT01755559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759963|NCT01755559|Antiviral Agents|antiviral agents|mesh-ancestor
24759964|NCT01755559|Schistosomicides|schistosomicides|mesh-ancestor
24759965|NCT01755559|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24759966|NCT01755559|Anthelmintics|anthelmintics|mesh-ancestor
24759967|NCT01755572|Liraglutide|liraglutide|mesh-list
24759968|NCT01755572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24759969|NCT01755572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759970|NCT01755572|Incretins|incretins|mesh-ancestor
24759972|NCT01755572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24759973|NCT01755611|Minocycline|minocycline|mesh-list
24759974|NCT01755611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24677948|NCT01359228|Rifaximin|rifaximin|mesh-list
24759975|NCT01755611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24759976|NCT01755663|Metoprolol|metoprolol|mesh-list
24759977|NCT01755663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24759978|NCT01755663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24760005|NCT01755728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24760006|NCT01755728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202331|NCT02722369|Gemcitabine|gemcitabine|mesh-list
25202332|NCT02722369|Hydroxychloroquine|hydroxychloroquine|mesh-list
24760012|NCT01755845|Tubulin Modulators|tubulin modulators|mesh-ancestor
24760013|NCT01755845|Antimitotic Agents|antimitotic agents|mesh-ancestor
24760014|NCT01755845|Mitosis Modulators|mitosis modulators|mesh-ancestor
25663084|NCT01653418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24788522|NCT01931982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24788524|NCT01932151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24788525|NCT01932151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24788527|NCT01932177|Sorafenib|sorafenib|mesh-list
24788528|NCT01932177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24788529|NCT01932177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24788530|NCT01932177|Immunologic Factors|immunologic factors|mesh-ancestor
24788531|NCT01932177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532053|NCT00637910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24457903|NCT00335621|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24457904|NCT00335621|Cholinergic Agents|cholinergic agents|mesh-ancestor
24760015|NCT01755845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760023|NCT01755897|Cisplatin|cisplatin|mesh-list
24760024|NCT01755897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24760025|NCT01755897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760026|NCT01755897|Tubulin Modulators|tubulin modulators|mesh-ancestor
24760027|NCT01755897|Antimitotic Agents|antimitotic agents|mesh-ancestor
24760028|NCT01755897|Mitosis Modulators|mitosis modulators|mesh-ancestor
24760029|NCT01755897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079568|NCT03346837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965554|NCT03775876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24965555|NCT03775876|Anesthetics, General|anesthetics, general|mesh-ancestor
24474959|NCT00408252|Sunitinib|sunitinib|mesh-list
24760098|NCT01756417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24760044|NCT01756105|Insulin, Isophane|insulin, isophane|mesh-list
24760045|NCT01756105|Isophane Insulin, Human|isophane insulin, human|mesh-list
24760046|NCT01756105|Isophane insulin, beef|isophane insulin, beef|mesh-list
24760047|NCT01756105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24516890|NCT00604435|Docetaxel|docetaxel|mesh-list
24551594|NCT05366621|Diphosphonates|diphosphonates|mesh-list
25079571|NCT03346837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25079572|NCT03346837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079573|NCT03346837|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25079574|NCT03346837|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25079575|NCT03346837|Antitubercular Agents|antitubercular agents|mesh-ancestor
25079576|NCT03346837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25079577|NCT03346837|Leprostatic Agents|leprostatic agents|mesh-ancestor
25079578|NCT03346837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25079579|NCT03346837|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24474724|NCT00407186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24474725|NCT00407186|Antimetabolites|antimetabolites|mesh-ancestor
25079580|NCT03346837|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25079581|NCT03346837|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25079582|NCT03346837|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25079583|NCT03346837|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25079584|NCT03346837|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25079586|NCT03346733|Cathartics|cathartics|mesh-ancestor
25079587|NCT03346733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25079588|NCT03346681|Acetylcysteine|acetylcysteine|mesh-list
25079589|NCT03346681|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25079590|NCT03346681|Antiviral Agents|antiviral agents|mesh-ancestor
25079591|NCT03346681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25079592|NCT03346681|Expectorants|expectorants|mesh-ancestor
24550873|NCT00723047|Hemostatics|hemostatics|mesh-ancestor
24760079|NCT01756248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760080|NCT01756248|Growth Inhibitors|growth inhibitors|mesh-ancestor
24760081|NCT01756248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760082|NCT01756261|Aflibercept|aflibercept|mesh-list
24760083|NCT01756261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25421534|NCT02531308|Doxorubicin|doxorubicin|mesh-list
25663085|NCT01653418|Antimetabolites|antimetabolites|mesh-ancestor
25663086|NCT01653418|Antiviral Agents|antiviral agents|mesh-ancestor
25663087|NCT01653418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25663088|NCT01653418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25663089|NCT01653418|Immunologic Factors|immunologic factors|mesh-ancestor
25663090|NCT01653418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663091|NCT01653418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25663092|NCT01653418|Alkylating Agents|alkylating agents|mesh-ancestor
25663093|NCT01653418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25663094|NCT01653509|Acyclovir|acyclovir|mesh-list
25663095|NCT01653509|Antiviral Agents|antiviral agents|mesh-ancestor
25663096|NCT01653509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25663097|NCT01653743|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25237276|NCT02551367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25237277|NCT02551367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237278|NCT02551367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25237279|NCT02551367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24532985|NCT00641927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532986|NCT00641927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760084|NCT01756261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24760085|NCT01756261|Growth Substances|growth substances|mesh-ancestor
24760086|NCT01756261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760087|NCT01756261|Growth Inhibitors|growth inhibitors|mesh-ancestor
24760088|NCT01756261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760089|NCT01756404|Canagliflozin|canagliflozin|mesh-list
24760090|NCT01756404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24760091|NCT01756404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760092|NCT01756404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24760093|NCT01756404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760095|NCT01756417|Canagliflozin|canagliflozin|mesh-list
24760096|NCT01756417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24760097|NCT01756417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760100|NCT01756430|Carvedilol|carvedilol|mesh-list
24760101|NCT01756430|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24760102|NCT01756430|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24760103|NCT01756430|Adrenergic Agents|adrenergic agents|mesh-ancestor
24760104|NCT01756430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24760105|NCT01756430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760106|NCT01756430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851721|NCT00054457|Docetaxel|docetaxel|mesh-list
24760200|NCT01756651|Anesthetics|anesthetics|mesh-ancestor
24760201|NCT01756664|Sunscreening Agents|sunscreening agents|mesh-list
24760202|NCT01756664|Petrolatum|petrolatum|mesh-list
24760203|NCT01756664|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24760204|NCT01756664|Protective Agents|protective agents|mesh-ancestor
24760205|NCT01756664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760206|NCT01756664|Dermatologic Agents|dermatologic agents|mesh-ancestor
24760207|NCT01756664|Emollients|emollients|mesh-ancestor
24760208|NCT01756768|Palbociclib|palbociclib|mesh-list
24760209|NCT01756768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760210|NCT01756768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24760211|NCT01756768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760212|NCT01756768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760213|NCT01756781|Palbociclib|palbociclib|mesh-list
24760214|NCT01756781|Midazolam|midazolam|mesh-list
24501367|NCT00528281|Pemetrexed|pemetrexed|mesh-list
25202333|NCT02722369|Carboplatin|carboplatin|mesh-list
25202334|NCT02722369|Etoposide|etoposide|mesh-list
25202335|NCT02722369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25202336|NCT02722369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25202337|NCT02722369|Antimetabolites|antimetabolites|mesh-ancestor
25202338|NCT02722369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202339|NCT02722369|Antiviral Agents|antiviral agents|mesh-ancestor
25202340|NCT02722369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25202341|NCT02722369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760259|NCT01756989|Growth Substances|growth substances|mesh-ancestor
24760260|NCT01756989|Growth Inhibitors|growth inhibitors|mesh-ancestor
24760262|NCT01757015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24760263|NCT01757015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24760264|NCT01757015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24760265|NCT01757015|Cholinergic Agents|cholinergic agents|mesh-ancestor
24475117|NCT00409019|Tenofovir|tenofovir|mesh-list
24760290|NCT01757236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24760291|NCT01757236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760292|NCT01757236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760293|NCT01757236|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24760294|NCT01757236|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24760295|NCT01757236|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24760296|NCT01757236|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25663098|NCT01653743|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25663099|NCT01653743|Hormones|hormones|mesh-ancestor
25663100|NCT01653743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25663101|NCT01653743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663102|NCT01653743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25663103|NCT01653847|Mycophenolic Acid|mycophenolic acid|mesh-list
25663104|NCT01653847|Everolimus|everolimus|mesh-list
25851722|NCT00054457|Capecitabine|capecitabine|mesh-list
25851723|NCT00054457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851724|NCT00054457|Tubulin Modulators|tubulin modulators|mesh-ancestor
25663105|NCT01653847|Tacrolimus|tacrolimus|mesh-list
25663106|NCT01653847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25663107|NCT01653847|Immunologic Factors|immunologic factors|mesh-ancestor
25851725|NCT00054457|Antimitotic Agents|antimitotic agents|mesh-ancestor
25851726|NCT00054457|Mitosis Modulators|mitosis modulators|mesh-ancestor
25851727|NCT00054457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851728|NCT00054457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25851729|NCT00054457|Antimetabolites|antimetabolites|mesh-ancestor
24531725|NCT00636935|Renal Agents|renal agents|mesh-ancestor
24760297|NCT01757236|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24551131|NCT00724035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24551132|NCT00724035|GABA Modulators|gaba modulators|mesh-ancestor
24551133|NCT00724035|GABA Agents|gaba agents|mesh-ancestor
24551134|NCT00724035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24551135|NCT00724035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551136|NCT00724074|Bupivacaine|bupivacaine|mesh-list
24551137|NCT00724074|Anesthetics, Local|anesthetics, local|mesh-ancestor
24760333|NCT01757366|Ginsenoside Rg3|ginsenoside rg3|mesh-list
24551221|NCT00724581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24760391|NCT01757808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24760392|NCT01757808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24760393|NCT01757808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760394|NCT01757860|Vitamin D|vitamin d|mesh-list
24474775|NCT00407290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760449|NCT01758120|Cyclophosphamide|cyclophosphamide|mesh-list
24760450|NCT01758120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24475246|NCT00409591|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24760451|NCT01758120|Immunologic Factors|immunologic factors|mesh-ancestor
24760452|NCT01758120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760454|NCT01758120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24760455|NCT01758120|Alkylating Agents|alkylating agents|mesh-ancestor
24760456|NCT01758120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760457|NCT01758120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760463|NCT01758120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24760464|NCT01758146|Tamoxifen|tamoxifen|mesh-list
24760465|NCT01758146|Letrozole|letrozole|mesh-list
24760466|NCT01758146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760467|NCT01758146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24760468|NCT01758146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24760469|NCT01758146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760470|NCT01758146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760471|NCT01758146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24760472|NCT01758146|Hormone Antagonists|hormone antagonists|mesh-ancestor
24760473|NCT01758146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24760474|NCT01758146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760475|NCT01758146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24760476|NCT01758146|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24760477|NCT01758146|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24760478|NCT01758146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24760500|NCT01758198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24760501|NCT01758198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24760502|NCT01758198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24760505|NCT01758263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24760506|NCT01758263|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24474879|NCT00407849|Immunologic Factors|immunologic factors|mesh-ancestor
24474915|NCT00408148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24810465|NCT02040415|Eperisone|eperisone|mesh-list
24760530|NCT01758380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24760531|NCT01758380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760532|NCT01758380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24760533|NCT01758380|Protease Inhibitors|protease inhibitors|mesh-ancestor
24760534|NCT01758380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760535|NCT01758380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663108|NCT01653847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663109|NCT01653847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25663110|NCT01653847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663111|NCT01653847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663112|NCT01653847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663113|NCT01653847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25851731|NCT00054470|Tipifarnib|tipifarnib|mesh-list
24760536|NCT01758393|Prednisone|prednisone|mesh-list
24760537|NCT01758393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24760538|NCT01758393|Glucocorticoids|glucocorticoids|mesh-ancestor
24760539|NCT01758393|Hormones|hormones|mesh-ancestor
24760540|NCT01758393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24760541|NCT01758393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760542|NCT01758393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24760543|NCT01758393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760544|NCT01758471|Acarbose|acarbose|mesh-list
24760546|NCT01758471|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24760547|NCT01758471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760548|NCT01758471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760586|NCT01758809|Anesthetics|anesthetics|mesh-ancestor
24760587|NCT01758809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24760588|NCT01758809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760589|NCT01758809|Sensory System Agents|sensory system agents|mesh-ancestor
24760590|NCT01758809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24760610|NCT01758978|Narcotics|narcotics|mesh-ancestor
24760611|NCT01758978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24760612|NCT01758978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760613|NCT01758978|Analgesics|analgesics|mesh-ancestor
24760614|NCT01758978|Sensory System Agents|sensory system agents|mesh-ancestor
24760615|NCT01758978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24760616|NCT01758978|Antitussive Agents|antitussive agents|mesh-ancestor
24760617|NCT01758978|Respiratory System Agents|respiratory system agents|mesh-ancestor
24760618|NCT01759030|Rituximab|rituximab|mesh-list
24760619|NCT01759030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24760620|NCT01759030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760621|NCT01759030|Immunologic Factors|immunologic factors|mesh-ancestor
24760622|NCT01759030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760623|NCT01759030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25014069|NCT05085873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25014070|NCT05085873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25014071|NCT05085873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25014072|NCT05085873|Anesthetics, General|anesthetics, general|mesh-ancestor
25014073|NCT05085873|Anesthetics|anesthetics|mesh-ancestor
25014074|NCT05085873|GABA Modulators|gaba modulators|mesh-ancestor
25014075|NCT05085873|GABA Agents|gaba agents|mesh-ancestor
25014076|NCT05085873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25014077|NCT05085873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502887|NCT04093167|Pembrolizumab|pembrolizumab|mesh-list
24760657|NCT01759524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24760658|NCT01759524|Sympatholytics|sympatholytics|mesh-ancestor
24760659|NCT01759524|Autonomic Agents|autonomic agents|mesh-ancestor
24760660|NCT01759524|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25851732|NCT00054470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25851733|NCT00054470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760713|NCT01759706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24551573|NCT05373004|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24898346|NCT04414995|Antipyretics|antipyretics|mesh-ancestor
24551580|NCT05372887|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24551581|NCT05372887|Antidepressive Agents|antidepressive agents|mesh-ancestor
24551582|NCT05372887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25079668|NCT03346226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24965641|NCT03775928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965642|NCT03775928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24965643|NCT03775928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25079669|NCT03346226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25202342|NCT02722369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25202343|NCT02722369|Immunologic Factors|immunologic factors|mesh-ancestor
25202344|NCT02722369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202345|NCT02722369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25202346|NCT02722369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25202347|NCT02722369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25202348|NCT02722369|Antimalarials|antimalarials|mesh-ancestor
25202349|NCT02722369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25202350|NCT02722369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25202351|NCT02722369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25202352|NCT02722356|Oxytocin|oxytocin|mesh-list
25202353|NCT02722356|Oxytocics|oxytocics|mesh-ancestor
25663114|NCT01653847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25202354|NCT02722356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25421535|NCT02531308|Vincristine|vincristine|mesh-list
25851734|NCT00054483|Bortezomib|bortezomib|mesh-list
25851735|NCT00054483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851736|NCT00054496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25851737|NCT00054496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25202355|NCT02722356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202356|NCT02722343|Tenofovir|tenofovir|mesh-list
25202357|NCT02722343|Emtricitabine|emtricitabine|mesh-list
25202358|NCT02722343|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25010626|NCT03482479|Naltrexone|naltrexone|mesh-list
25014175|NCT04963816|Anesthetics, Local|anesthetics, local|mesh-ancestor
25014179|NCT04933240|Tamoxifen|tamoxifen|mesh-list
25079670|NCT03346226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079671|NCT03346226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25079672|NCT03346226|Anesthetics, General|anesthetics, general|mesh-ancestor
25079674|NCT03346226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25079675|NCT03346226|Analgesics|analgesics|mesh-ancestor
25079692|NCT03346200|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25079693|NCT03346200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25079694|NCT03346187|Atorvastatin|atorvastatin|mesh-list
25079695|NCT03346187|Fenofibrate|fenofibrate|mesh-list
25079696|NCT03346187|Calcium|calcium|mesh-list
25079697|NCT03346187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25079698|NCT03346187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079699|NCT03346187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25079700|NCT03346187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25079701|NCT03346187|Antimetabolites|antimetabolites|mesh-ancestor
25079702|NCT03346187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079703|NCT03346187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25079704|NCT03346187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25079705|NCT03346187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25079706|NCT03346096|Thiotepa|thiotepa|mesh-list
25079707|NCT03346096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25079708|NCT03346096|Alkylating Agents|alkylating agents|mesh-ancestor
25079710|NCT03346096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079711|NCT03346096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25079712|NCT03346096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25079713|NCT03346096|Immunologic Factors|immunologic factors|mesh-ancestor
25079714|NCT03346096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079715|NCT03346083|Betrixaban|betrixaban|mesh-list
25079716|NCT03346083|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25079717|NCT03346083|Antithrombins|antithrombins|mesh-ancestor
25079718|NCT03346083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25079719|NCT03346083|Protease Inhibitors|protease inhibitors|mesh-ancestor
24551586|NCT05372887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24551588|NCT05372887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24551589|NCT05372874|Antiviral Agents|antiviral agents|mesh-list
24551590|NCT05372874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24551593|NCT05366621|Denosumab|denosumab|mesh-list
24760739|NCT01759732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24760741|NCT01759732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760742|NCT01759732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760743|NCT01759732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24760744|NCT01759771|Vitamin D|vitamin d|mesh-list
24760745|NCT01759771|Cholecalciferol|cholecalciferol|mesh-list
24760746|NCT01759771|Vitamins|vitamins|mesh-ancestor
24760747|NCT01759771|Micronutrients|micronutrients|mesh-ancestor
24760748|NCT01759771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760749|NCT01759771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24760750|NCT01759771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24760751|NCT01759810|Vaccines|vaccines|mesh-list
24760752|NCT01759810|Immunologic Factors|immunologic factors|mesh-ancestor
24760753|NCT01759810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760754|NCT01759875|Ritonavir|ritonavir|mesh-list
24760755|NCT01759875|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24760756|NCT01759875|Rabeprazole|rabeprazole|mesh-list
24760757|NCT01759875|Betaine|betaine|mesh-list
24760758|NCT01759875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24760759|NCT01759875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24760760|NCT01759875|Protease Inhibitors|protease inhibitors|mesh-ancestor
24760761|NCT01759875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760762|NCT01759875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202359|NCT02722343|Antiviral Agents|antiviral agents|mesh-ancestor
25663115|NCT01653847|Antitubercular Agents|antitubercular agents|mesh-ancestor
25663116|NCT01653847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25202360|NCT02722343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24760763|NCT01759875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25663117|NCT01653847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24760764|NCT01759875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24760765|NCT01759875|Antiviral Agents|antiviral agents|mesh-ancestor
24760766|NCT01759875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24760767|NCT01759875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24760851|NCT01760226|Doxorubicin|doxorubicin|mesh-list
24760852|NCT01760226|Methotrexate|methotrexate|mesh-list
24760853|NCT01760226|Etoposide|etoposide|mesh-list
24760854|NCT01760226|Vincristine|vincristine|mesh-list
24760855|NCT01760226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24760856|NCT01760226|Immunologic Factors|immunologic factors|mesh-ancestor
24760857|NCT01760226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475575|NCT00410774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24475576|NCT00410774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24475577|NCT00410774|Immunologic Factors|immunologic factors|mesh-ancestor
24475579|NCT00410787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24760878|NCT01760226|Antimetabolites|antimetabolites|mesh-ancestor
24760879|NCT01760226|Dermatologic Agents|dermatologic agents|mesh-ancestor
24760880|NCT01760226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24760881|NCT01760226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24760882|NCT01760226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24760883|NCT01760226|Tubulin Modulators|tubulin modulators|mesh-ancestor
24760928|NCT01760460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24446846|NCT00306254|Antithrombins|antithrombins|mesh-ancestor
24475637|NCT00410982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24475639|NCT00410982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851738|NCT00054496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25851739|NCT00054496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851740|NCT00054496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475704|NCT00411190|Analgesics|analgesics|mesh-ancestor
24475705|NCT00411190|Sensory System Agents|sensory system agents|mesh-ancestor
24761263|NCT01761994|Analgesics|analgesics|mesh-ancestor
24475708|NCT00411190|Antipyretics|antipyretics|mesh-ancestor
24475709|NCT00411190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24475710|NCT00411190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24475711|NCT00411190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25851741|NCT00054522|Calcitriol|calcitriol|mesh-list
24761040|NCT01760746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24761041|NCT01760746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24761043|NCT01760746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761044|NCT01760746|Growth Inhibitors|growth inhibitors|mesh-ancestor
24761045|NCT01760798|Teriparatide|teriparatide|mesh-list
24761071|NCT01760824|Antacids|antacids|mesh-ancestor
24761072|NCT01760863|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24775436|NCT01852318|Analgesics|analgesics|mesh-ancestor
24761076|NCT01760967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24761077|NCT01760967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761078|NCT01760967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24761079|NCT01760967|Analgesics|analgesics|mesh-ancestor
24761080|NCT01760967|Sensory System Agents|sensory system agents|mesh-ancestor
24761081|NCT01760967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24761082|NCT01760967|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24761083|NCT01760967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24761084|NCT01760967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24761085|NCT01760967|Adrenergic Agents|adrenergic agents|mesh-ancestor
24761086|NCT01760967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24761087|NCT01760967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761088|NCT01760980|Exemestane|exemestane|mesh-list
24761089|NCT01760980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761090|NCT01760980|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24761091|NCT01760980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24761092|NCT01760980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761093|NCT01760980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761094|NCT01760980|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25202361|NCT02722343|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24761148|NCT01761214|Moxifloxacin|moxifloxacin|mesh-list
24761149|NCT01761214|Ciprofloxacin|ciprofloxacin|mesh-list
24761150|NCT01761214|Clavulanic Acid|clavulanic acid|mesh-list
24761151|NCT01761214|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24761152|NCT01761214|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
24761197|NCT01761552|Autonomic Agents|autonomic agents|mesh-ancestor
24854311|NCT02273128|Calcitonin|calcitonin|mesh-list
24761198|NCT01761552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24552011|NCT04254627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24552012|NCT04254627|Immunologic Factors|immunologic factors|mesh-ancestor
24552013|NCT04254627|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24552014|NCT04254627|Abortifacient Agents|abortifacient agents|mesh-ancestor
25851743|NCT00054522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25851744|NCT00054522|Antiemetics|antiemetics|mesh-ancestor
25851745|NCT00054522|Autonomic Agents|autonomic agents|mesh-ancestor
24536293|NCT00650637|Nelfinavir|nelfinavir|mesh-list
24761209|NCT01761552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24761210|NCT01761552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761211|NCT01761552|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24761213|NCT01761656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24761214|NCT01761656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24761215|NCT01761656|Antimetabolites|antimetabolites|mesh-ancestor
24761216|NCT01761656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761217|NCT01761656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24761218|NCT01761656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24761219|NCT01761656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761250|NCT01761916|Adrenergic Agents|adrenergic agents|mesh-ancestor
24761251|NCT01761916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24761252|NCT01761916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761253|NCT01761916|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24761254|NCT01761916|Protease Inhibitors|protease inhibitors|mesh-ancestor
24761255|NCT01761916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761256|NCT01761968|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
24761257|NCT01761968|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24761258|NCT01761968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761259|NCT01761968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761260|NCT01761994|Nafamostat|nafamostat|mesh-list
24761261|NCT01761994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24761262|NCT01761994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24761264|NCT01761994|Sensory System Agents|sensory system agents|mesh-ancestor
24552077|NCT04183062|Gemcitabine|gemcitabine|mesh-list
24552078|NCT04183062|Docetaxel|docetaxel|mesh-list
24552079|NCT04183062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24761265|NCT01761994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24552081|NCT04183062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552082|NCT04183062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552189|NCT04098003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24552190|NCT04098003|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25851746|NCT00054522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25851747|NCT00054522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620105|NCT01055418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620107|NCT01055431|Iron|iron|mesh-list
24620110|NCT01055431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620111|NCT01055470|Diclofenac|diclofenac|mesh-list
24620112|NCT01055470|Lornoxicam|lornoxicam|mesh-list
24620113|NCT01055470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24620114|NCT01055470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24620115|NCT01055470|Analgesics|analgesics|mesh-ancestor
24620116|NCT01055470|Sensory System Agents|sensory system agents|mesh-ancestor
24775626|NCT01853813|Growth Inhibitors|growth inhibitors|mesh-ancestor
24761299|NCT01762163|Sensory System Agents|sensory system agents|mesh-ancestor
24761300|NCT01762163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24761301|NCT01762163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761302|NCT01762163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24761303|NCT01762163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24761304|NCT01762163|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24761305|NCT01762163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24761325|NCT01762306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24761328|NCT01762306|Sensory System Agents|sensory system agents|mesh-ancestor
24761329|NCT01762306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24761330|NCT01762306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761331|NCT01762306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24761332|NCT01762306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24965779|NCT03774836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24965780|NCT03774836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965781|NCT03774836|Analgesics|analgesics|mesh-ancestor
24965782|NCT03774836|Sensory System Agents|sensory system agents|mesh-ancestor
24965783|NCT03774836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24965784|NCT03774680|Cetuximab|cetuximab|mesh-list
24965785|NCT03774680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24965786|NCT03774680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663118|NCT01653912|Paclitaxel|paclitaxel|mesh-list
25663119|NCT01653912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25663120|NCT01653912|Carboplatin|carboplatin|mesh-list
24899017|NCT04407312|Cilostazol|cilostazol|mesh-list
25851748|NCT00054522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25851749|NCT00054522|Glucocorticoids|glucocorticoids|mesh-ancestor
25851750|NCT00054522|Hormones|hormones|mesh-ancestor
24476703|NCT00416221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476704|NCT00416221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24476705|NCT00416221|Serotonin Agents|serotonin agents|mesh-ancestor
24965787|NCT03774615|Ferric maltol|ferric maltol|mesh-list
24965788|NCT03774615|Hematinics|hematinics|mesh-ancestor
24965799|NCT03774524|Misoprostol|misoprostol|mesh-list
24965800|NCT03774524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24965801|NCT03774524|Abortifacient Agents|abortifacient agents|mesh-ancestor
24965802|NCT03774524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24965803|NCT03774524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965804|NCT03774524|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24965805|NCT03774524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24965806|NCT03774524|Oxytocics|oxytocics|mesh-ancestor
24965807|NCT03773991|Nitric Oxide|nitric oxide|mesh-list
24965808|NCT03773991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24965809|NCT03773991|Autonomic Agents|autonomic agents|mesh-ancestor
24965810|NCT03773991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24965811|NCT03773991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965812|NCT03773991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24965813|NCT03773991|Respiratory System Agents|respiratory system agents|mesh-ancestor
24775699|NCT01854476|Tranexamic Acid|tranexamic acid|mesh-list
24761333|NCT01762306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24761334|NCT01762306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761335|NCT01762306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761336|NCT01762306|Hematinics|hematinics|mesh-ancestor
25079751|NCT03345797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25079753|NCT03345667|Ranibizumab|ranibizumab|mesh-list
24476777|NCT00416468|Valsartan|valsartan|mesh-list
24476778|NCT00416468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24476779|NCT00416468|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25851751|NCT00054522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25079761|NCT03345628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25079762|NCT03345628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079763|NCT03345498|Entecavir|entecavir|mesh-list
25079764|NCT03345498|Antiviral Agents|antiviral agents|mesh-ancestor
25079765|NCT03345498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25079766|NCT03345303|Bortezomib|bortezomib|mesh-list
25079767|NCT03345303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079768|NCT03345147|Vitamins|vitamins|mesh-list
25079769|NCT03345147|Vitamin A|vitamin a|mesh-list
25079770|NCT03345147|Retinol palmitate|retinol palmitate|mesh-list
25079771|NCT03345147|Micronutrients|micronutrients|mesh-ancestor
25079772|NCT03345147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079773|NCT03345147|Antioxidants|antioxidants|mesh-ancestor
25079774|NCT03345147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079775|NCT03345147|Protective Agents|protective agents|mesh-ancestor
24761355|NCT01762332|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24761375|NCT01762436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24761376|NCT01762436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24761380|NCT01762436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761381|NCT01762475|Sildenafil Citrate|sildenafil citrate|mesh-list
24761382|NCT01762475|Vasodilator Agents|vasodilator agents|mesh-ancestor
24761383|NCT01762475|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24761384|NCT01762475|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24761385|NCT01762475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761386|NCT01762475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761387|NCT01762475|Urological Agents|urological agents|mesh-ancestor
24761389|NCT01762514|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24761390|NCT01762514|Protective Agents|protective agents|mesh-ancestor
24761391|NCT01762514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761392|NCT01762540|Prednisolone|prednisolone|mesh-list
24761393|NCT01762540|Calcium|calcium|mesh-list
24476064|NCT00412698|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24477346|NCT00418353|Betamethasone benzoate|betamethasone benzoate|mesh-list
24477347|NCT00418353|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
24679264|NCT01367600|Methylnaltrexone|methylnaltrexone|mesh-list
24477426|NCT00418548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24477427|NCT00418548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477428|NCT00418548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24477430|NCT00418548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24477431|NCT00418548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24701814|NCT01461174|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24701815|NCT01461174|Dopamine Agents|dopamine agents|mesh-ancestor
24701816|NCT01461174|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24477432|NCT00418548|Immunologic Factors|immunologic factors|mesh-ancestor
24477433|NCT00418587|Vitamin D|vitamin d|mesh-list
24477434|NCT00418587|Ergocalciferols|ergocalciferols|mesh-list
24477435|NCT00418587|Cholecalciferol|cholecalciferol|mesh-list
24477489|NCT00418847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851752|NCT00054522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25851753|NCT00054522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851754|NCT00054522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24477514|NCT00418860|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24477569|NCT00419146|Tocotrienols|tocotrienols|mesh-list
24477570|NCT00419146|alpha-Tocopherol|alpha-tocopherol|mesh-list
25851755|NCT00054522|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25851756|NCT00054522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24761703|NCT01763788|Necitumumab|necitumumab|mesh-list
25851757|NCT00054522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761406|NCT01762644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477813|NCT00420355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25014685|NCT04042077|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24477814|NCT00420355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24477815|NCT00420355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24477816|NCT00420472|Mycophenolic Acid|mycophenolic acid|mesh-list
24679321|NCT01367756|Serotonin Agents|serotonin agents|mesh-ancestor
24477817|NCT00420472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24477818|NCT00420472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477819|NCT00420472|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24477820|NCT00420472|Antitubercular Agents|antitubercular agents|mesh-ancestor
24477821|NCT00420472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24477822|NCT00420472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24477823|NCT00420472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477824|NCT00420472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477825|NCT00420498|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24477826|NCT00420498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24477827|NCT00420498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24477848|NCT00420537|Antifungal Agents|antifungal agents|mesh-ancestor
24477849|NCT00420537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25851758|NCT00054522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25851759|NCT00054522|Vitamins|vitamins|mesh-ancestor
25851760|NCT00054522|Micronutrients|micronutrients|mesh-ancestor
25851761|NCT00054522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25851762|NCT00054535|Aldesleukin|aldesleukin|mesh-list
25851763|NCT00054535|Vaccines|vaccines|mesh-list
24504239|NCT00534625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477877|NCT00420589|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
24477878|NCT00420589|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24477879|NCT00420589|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24761425|NCT01762657|Immunologic Factors|immunologic factors|mesh-ancestor
24761426|NCT01762657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761427|NCT01762657|Antifungal Agents|antifungal agents|mesh-ancestor
24761428|NCT01762657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25663121|NCT01653912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25663122|NCT01653912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663123|NCT01653912|Tubulin Modulators|tubulin modulators|mesh-ancestor
25663124|NCT01653912|Antimitotic Agents|antimitotic agents|mesh-ancestor
25663125|NCT01653912|Mitosis Modulators|mitosis modulators|mesh-ancestor
25663126|NCT01653912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663127|NCT01654107|Nicotine|nicotine|mesh-list
25663128|NCT01654107|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25663129|NCT01654107|Autonomic Agents|autonomic agents|mesh-ancestor
25663130|NCT01654107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25663131|NCT01654107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761429|NCT01762657|Dermatologic Agents|dermatologic agents|mesh-ancestor
24761430|NCT01762657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24478090|NCT00421460|Methyltestosterone|methyltestosterone|mesh-list
24478091|NCT00421460|Testosterone|testosterone|mesh-list
24478092|NCT00421460|Testosterone undecanoate|testosterone undecanoate|mesh-list
24761449|NCT01762787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24761452|NCT01762787|Sensory System Agents|sensory system agents|mesh-ancestor
24761453|NCT01762787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24761454|NCT01762787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899104|NCT04406870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24899105|NCT04406870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24899106|NCT04406870|Adrenergic Agents|adrenergic agents|mesh-ancestor
24899107|NCT04406870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24899108|NCT04406870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476099|NCT00413023|Casopitant|casopitant|mesh-list
24478142|NCT00421551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24478143|NCT00421551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25851764|NCT00054535|Immunologic Factors|immunologic factors|mesh-ancestor
25851765|NCT00054535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851766|NCT00054535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761457|NCT01762787|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24761458|NCT01762787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24761459|NCT01762787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761460|NCT01762787|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24761461|NCT01762787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24761462|NCT01762787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761463|NCT01762787|Antipyretics|antipyretics|mesh-ancestor
24761464|NCT01762787|Glucocorticoids|glucocorticoids|mesh-ancestor
24761465|NCT01762787|Hormones|hormones|mesh-ancestor
25202362|NCT02722343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24762485|NCT01768364|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24761862|NCT01764893|Solifenacin Succinate|solifenacin succinate|mesh-list
25851767|NCT00054535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25851768|NCT00054535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25851769|NCT00054535|Antiviral Agents|antiviral agents|mesh-ancestor
25851770|NCT00054535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25851771|NCT00054548|Paclitaxel|paclitaxel|mesh-list
25851772|NCT00054548|Oblimersen|oblimersen|mesh-list
25851773|NCT00054548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25851774|NCT00054548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851775|NCT00054548|Tubulin Modulators|tubulin modulators|mesh-ancestor
25851776|NCT00054548|Antimitotic Agents|antimitotic agents|mesh-ancestor
25851777|NCT00054548|Mitosis Modulators|mitosis modulators|mesh-ancestor
25851778|NCT00054548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851779|NCT00054561|Vitamin E|vitamin e|mesh-list
24478190|NCT00421824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24478191|NCT00421824|Antimetabolites|antimetabolites|mesh-ancestor
24478192|NCT00421824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478193|NCT00421824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478194|NCT00421863|Amlodipine|amlodipine|mesh-list
24478195|NCT00421863|Telmisartan|telmisartan|mesh-list
24478196|NCT00421863|Clonidine|clonidine|mesh-list
24478197|NCT00421863|Ramipril|ramipril|mesh-list
24478198|NCT00421863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24478199|NCT00421863|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24478200|NCT00421863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24810687|NCT02041481|Antidotes|antidotes|mesh-ancestor
24761480|NCT01762839|Oritavancin|oritavancin|mesh-list
24761481|NCT01762839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24899123|NCT04406883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24478239|NCT00421967|Anesthetics|anesthetics|mesh-ancestor
24478240|NCT00421967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24478241|NCT00421967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478242|NCT00421967|Sensory System Agents|sensory system agents|mesh-ancestor
24478243|NCT00421967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24478244|NCT00421967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24478245|NCT00421967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24504440|NCT00536237|Vitamins|vitamins|mesh-ancestor
24478421|NCT00422682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24478423|NCT00422682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478424|NCT00422682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24478425|NCT00422682|Alkylating Agents|alkylating agents|mesh-ancestor
24478426|NCT00422682|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24478427|NCT00422682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24761482|NCT01762839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24761483|NCT01762839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24761484|NCT01762839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24761485|NCT01762839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761486|NCT01762839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761487|NCT01762839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761488|NCT01762852|Belimumab|belimumab|mesh-list
24761489|NCT01762852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24761540|NCT01763021|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24761541|NCT01763021|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24761542|NCT01763021|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24424706|NCT00230477|Lamivudine|lamivudine|mesh-list
24761543|NCT01763021|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24761544|NCT01763021|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24761545|NCT01763281|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
24761591|NCT01763463|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24552411|NCT03355976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24552412|NCT03355976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552413|NCT03355976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24552414|NCT03355976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202363|NCT02722343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761592|NCT01763463|Bronchodilator Agents|bronchodilator agents|mesh-list
24761593|NCT01763463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24761595|NCT01763463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24761596|NCT01763463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762486|NCT01768377|Lidocaine|lidocaine|mesh-list
24761701|NCT01763749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761702|NCT01763788|Gemcitabine|gemcitabine|mesh-list
24761710|NCT01763788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761711|NCT01763788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24761712|NCT01763788|Immunologic Factors|immunologic factors|mesh-ancestor
24761713|NCT01763788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761714|NCT01763788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24761716|NCT01764087|Tirbanibulin|tirbanibulin|mesh-list
24761717|NCT01764087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24761718|NCT01764087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965817|NCT03773991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24679596|NCT01369290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25079785|NCT03345095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079787|NCT03345004|Ergocalciferols|ergocalciferols|mesh-list
25079788|NCT03345004|Cholecalciferol|cholecalciferol|mesh-list
25079790|NCT03345004|Aluminum sulfate|aluminum sulfate|mesh-list
25079791|NCT03345004|Micronutrients|micronutrients|mesh-ancestor
25079792|NCT03345004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079793|NCT03345004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25079794|NCT03345004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25079795|NCT03345004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25079796|NCT03345004|Immunologic Factors|immunologic factors|mesh-ancestor
25079797|NCT03344952|Botulinum Toxins|botulinum toxins|mesh-list
24899296|NCT04404946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24899297|NCT04404946|Mydriatics|mydriatics|mesh-ancestor
24899298|NCT04404946|Autonomic Agents|autonomic agents|mesh-ancestor
25079804|NCT03344952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25851780|NCT00054561|Interferons|interferons|mesh-list
25079832|NCT03344679|Anesthetics, Local|anesthetics, local|mesh-ancestor
25079833|NCT03344679|Anesthetics|anesthetics|mesh-ancestor
25079834|NCT03344679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25079835|NCT03344679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079836|NCT03344679|Sensory System Agents|sensory system agents|mesh-ancestor
25079837|NCT03344679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25079838|NCT03344679|Analgesics|analgesics|mesh-ancestor
25079839|NCT03344679|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25079840|NCT03344679|Anticonvulsants|anticonvulsants|mesh-ancestor
24606042|NCT00988728|Olanzapine|olanzapine|mesh-list
24761764|NCT01764295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24761808|NCT01764828|Immunologic Factors|immunologic factors|mesh-ancestor
24761809|NCT01764828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761810|NCT01764867|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24761811|NCT01764867|Dexetimide|dexetimide|mesh-list
24761812|NCT01764867|Mirtazapine|mirtazapine|mesh-list
24761813|NCT01764867|Trazodone|trazodone|mesh-list
24761814|NCT01764867|Fluvoxamine|fluvoxamine|mesh-list
24761815|NCT01764867|Citalopram|citalopram|mesh-list
24761816|NCT01764867|Bupropion|bupropion|mesh-list
24761817|NCT01764867|Fluoxetine|fluoxetine|mesh-list
24761818|NCT01764867|Paroxetine|paroxetine|mesh-list
24761819|NCT01764867|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24761820|NCT01764867|Sertraline|sertraline|mesh-list
24761821|NCT01764867|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25421689|NCT02521493|Immunologic Factors|immunologic factors|mesh-ancestor
24761822|NCT01764867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24761823|NCT01764867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24476278|NCT00413790|Darifenacin|darifenacin|mesh-list
24479410|NCT00426647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24479415|NCT00426712|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24761852|NCT01764867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24761853|NCT01764867|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24761855|NCT01764867|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24761856|NCT01764867|Adrenergic Agents|adrenergic agents|mesh-ancestor
24761857|NCT01764867|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24761860|NCT01764867|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24761861|NCT01764867|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24761868|NCT01764893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761870|NCT01765010|Cholecalciferol|cholecalciferol|mesh-list
24761872|NCT01765010|Calcitriol|calcitriol|mesh-list
24761873|NCT01765010|Alfacalcidol|alfacalcidol|mesh-list
24761874|NCT01765010|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
24761875|NCT01765010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24761876|NCT01765010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761877|NCT01765010|Vitamins|vitamins|mesh-ancestor
24761878|NCT01765010|Micronutrients|micronutrients|mesh-ancestor
24761879|NCT01765010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24761880|NCT01765010|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24761881|NCT01765010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24761882|NCT01765010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761883|NCT01765010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24761885|NCT01765023|Atorvastatin|atorvastatin|mesh-list
24761886|NCT01765023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24761887|NCT01765023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761888|NCT01765023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24761889|NCT01765023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24761890|NCT01765023|Antimetabolites|antimetabolites|mesh-ancestor
24761891|NCT01765023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761892|NCT01765023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24761893|NCT01765023|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24761894|NCT01765023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761895|NCT01765088|Temozolomide|temozolomide|mesh-list
24761896|NCT01765088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24899441|NCT04403568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24552779|NCT00727753|Growth Inhibitors|growth inhibitors|mesh-ancestor
24552780|NCT00727766|Clofarabine|clofarabine|mesh-list
24552781|NCT00727766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24552782|NCT00727766|Antimetabolites|antimetabolites|mesh-ancestor
24552783|NCT00727766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552784|NCT00727766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552785|NCT00727831|Leucovorin|leucovorin|mesh-list
24552786|NCT00727831|Methotrexate|methotrexate|mesh-list
24761897|NCT01765088|Alkylating Agents|alkylating agents|mesh-ancestor
25851781|NCT00054561|Interferon-alpha|interferon-alpha|mesh-list
25202364|NCT02722343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202365|NCT02722343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25202366|NCT02722343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25202367|NCT02722083|Chlorpheniramine|chlorpheniramine|mesh-list
25202368|NCT02722083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202369|NCT02722083|Antipruritics|antipruritics|mesh-ancestor
25851782|NCT00054561|Isotretinoin|isotretinoin|mesh-list
25851783|NCT00054561|Vitamins|vitamins|mesh-ancestor
25851784|NCT00054561|Micronutrients|micronutrients|mesh-ancestor
24761946|NCT01765452|Clopidogrel|clopidogrel|mesh-list
24761947|NCT01765452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24761948|NCT01765452|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24761949|NCT01765452|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24761950|NCT01765452|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24761951|NCT01765452|Purinergic Agents|purinergic agents|mesh-ancestor
24761952|NCT01765452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24761953|NCT01765452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761954|NCT01765452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761955|NCT01765556|Ketoconazole|ketoconazole|mesh-list
24761956|NCT01765556|Vemurafenib|vemurafenib|mesh-list
24761957|NCT01765556|Antifungal Agents|antifungal agents|mesh-ancestor
24761958|NCT01765556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24854440|NCT02273583|Antimetabolites|antimetabolites|mesh-ancestor
25421841|NCT02505984|Oxytocics|oxytocics|mesh-ancestor
25851785|NCT00054561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851786|NCT00054561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761969|NCT01765556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24761971|NCT01765608|Anticonvulsants|anticonvulsants|mesh-ancestor
24761972|NCT01765608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24761976|NCT01765608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761978|NCT01765738|Rifampin|rifampin|mesh-list
24761979|NCT01765738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24761980|NCT01765738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24761981|NCT01765738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24761982|NCT01765738|Antitubercular Agents|antitubercular agents|mesh-ancestor
24761983|NCT01765738|Leprostatic Agents|leprostatic agents|mesh-ancestor
24761984|NCT01765738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24761985|NCT01765738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761986|NCT01765738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761987|NCT01765738|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24761988|NCT01765738|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24761989|NCT01765738|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25079881|NCT03344393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079882|NCT03344393|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24761995|NCT01765790|Immunologic Factors|immunologic factors|mesh-ancestor
24762002|NCT01765829|Trifluoperazine|trifluoperazine|mesh-list
24762003|NCT01765829|Risperidone|risperidone|mesh-list
24762031|NCT01765829|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24762032|NCT01765829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24762033|NCT01765829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24762035|NCT01765829|Dopamine Agonists|dopamine agonists|mesh-ancestor
24611084|NCT01006863|Phenylephrine|phenylephrine|mesh-list
24762036|NCT01765829|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24762037|NCT01765829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24762038|NCT01765829|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24762039|NCT01765829|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24762148|NCT01766375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24762149|NCT01766375|Immunologic Factors|immunologic factors|mesh-ancestor
24762150|NCT01766375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24762151|NCT01766375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24762152|NCT01766375|Antifungal Agents|antifungal agents|mesh-ancestor
24762153|NCT01766375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24762154|NCT01766375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24762155|NCT01766375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24762156|NCT01766375|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24762157|NCT01766375|Antitubercular Agents|antitubercular agents|mesh-ancestor
24762158|NCT01766375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24762160|NCT01766414|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
24762161|NCT01766414|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
24762162|NCT01766414|Immunologic Factors|immunologic factors|mesh-ancestor
24762163|NCT01766414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762164|NCT01766414|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24762165|NCT01766414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24762166|NCT01766518|Mycophenolic Acid|mycophenolic acid|mesh-list
24762167|NCT01766518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24762168|NCT01766518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24762169|NCT01766518|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24762170|NCT01766518|Antitubercular Agents|antitubercular agents|mesh-ancestor
24762171|NCT01766518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24762172|NCT01766518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24762173|NCT01766518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899535|NCT04402892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759049|NCT01749111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
24762191|NCT01766609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762193|NCT01766609|Immunologic Factors|immunologic factors|mesh-ancestor
24762194|NCT01766609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762195|NCT01766609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762196|NCT01766830|Immunoglobulin G|immunoglobulin g|mesh-list
24762197|NCT01766830|Immunoglobulin M|immunoglobulin m|mesh-list
24762198|NCT01766830|Immunologic Factors|immunologic factors|mesh-ancestor
24762199|NCT01766830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762200|NCT01766843|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24762262|NCT01767298|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24762263|NCT01767298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24762264|NCT01767363|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
24762265|NCT01767363|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
24754354|NCT01720095|Vitamins|vitamins|mesh-ancestor
24703362|NCT01471262|Liver Extracts|liver extracts|mesh-list
24703363|NCT01471262|Hematinics|hematinics|mesh-ancestor
24703364|NCT01471275|Metformin|metformin|mesh-list
24703365|NCT01471275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24703366|NCT01471275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762273|NCT01767363|Hormone Antagonists|hormone antagonists|mesh-ancestor
24762274|NCT01767363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24762275|NCT01767389|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24762276|NCT01767389|Protease Inhibitors|protease inhibitors|mesh-ancestor
24762277|NCT01767389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762278|NCT01767389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762279|NCT01767389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24762280|NCT01767389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762281|NCT01767402|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24762282|NCT01767402|Immunologic Factors|immunologic factors|mesh-ancestor
24762283|NCT01767402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762284|NCT01767428|Acetaminophen|acetaminophen|mesh-list
24762305|NCT01767545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24762315|NCT01767545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24762316|NCT01767545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24762317|NCT01767545|Glucocorticoids|glucocorticoids|mesh-ancestor
24762318|NCT01767545|Hormones|hormones|mesh-ancestor
24762319|NCT01767545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24762320|NCT01767545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24762321|NCT01767571|Cephalexin|cephalexin|mesh-list
24762322|NCT01767571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24762323|NCT01767571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24762324|NCT01767584|Cephalexin|cephalexin|mesh-list
24679966|NCT01372280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762325|NCT01767584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24762326|NCT01767584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24762327|NCT01767610|Infliximab|infliximab|mesh-list
24762328|NCT01767610|Fenofibrate|fenofibrate|mesh-list
24762329|NCT01767610|Pitavastatin|pitavastatin|mesh-list
24762330|NCT01767610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24762331|NCT01767610|Antimetabolites|antimetabolites|mesh-ancestor
24762332|NCT01767610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762334|NCT01767610|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24762335|NCT01767610|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24762336|NCT01767610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762337|NCT01767610|Dermatologic Agents|dermatologic agents|mesh-ancestor
24762338|NCT01767610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24762339|NCT01767610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24762341|NCT01767623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24762342|NCT01767623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24762343|NCT01767623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762344|NCT01767623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479622|NCT00427570|Fluorouracil|fluorouracil|mesh-list
24479623|NCT00427570|Vincristine|vincristine|mesh-list
24479624|NCT00427570|Semustine|semustine|mesh-list
24479625|NCT00427570|BCG Vaccine|bcg vaccine|mesh-list
24762364|NCT01768078|Betamethasone|betamethasone|mesh-list
24762365|NCT01768078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24762366|NCT01768078|Antitubercular Agents|antitubercular agents|mesh-ancestor
24762367|NCT01768078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25851788|NCT00054561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24479627|NCT00427570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479628|NCT00427570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25851789|NCT00054561|Immunologic Factors|immunologic factors|mesh-ancestor
25851790|NCT00054561|Antioxidants|antioxidants|mesh-ancestor
25851791|NCT00054561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851792|NCT00054561|Protective Agents|protective agents|mesh-ancestor
24479673|NCT00427947|Anesthetics|anesthetics|mesh-ancestor
24479674|NCT00427947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24479675|NCT00427947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479676|NCT00427947|Sensory System Agents|sensory system agents|mesh-ancestor
25663132|NCT01654107|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25663133|NCT01654107|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25663134|NCT01654107|Cholinergic Agents|cholinergic agents|mesh-ancestor
25663135|NCT01654107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25663136|NCT01654107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759358|NCT01750788|Anticoagulants|anticoagulants|mesh-ancestor
24759470|NCT01751828|Sertraline|sertraline|mesh-list
25422371|NCT02460445|Hormone Antagonists|hormone antagonists|mesh-ancestor
24703878|NCT01475227|Astringents|astringents|mesh-ancestor
24762411|NCT01768260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762413|NCT01768260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24762414|NCT01768260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762415|NCT01768260|Antipyretics|antipyretics|mesh-ancestor
24762416|NCT01768273|Midazolam|midazolam|mesh-list
24762417|NCT01768273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24762418|NCT01768273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24762419|NCT01768273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24762420|NCT01768273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762421|NCT01768273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24762422|NCT01768273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24762423|NCT01768273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24762424|NCT01768273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24762425|NCT01768273|Anesthetics, General|anesthetics, general|mesh-ancestor
24762426|NCT01768273|Anesthetics|anesthetics|mesh-ancestor
25079883|NCT03344393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25079884|NCT03344393|Anesthetics, General|anesthetics, general|mesh-ancestor
25079885|NCT03344393|Anesthetics|anesthetics|mesh-ancestor
25079886|NCT03344393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25079887|NCT03344393|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25079888|NCT03344393|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25079889|NCT03344393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24762432|NCT01768299|Mifepristone|mifepristone|mesh-list
24762433|NCT01768299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24762434|NCT01768299|Abortifacient Agents|abortifacient agents|mesh-ancestor
24762435|NCT01768299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24762436|NCT01768299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762458|NCT01768312|Immunologic Factors|immunologic factors|mesh-ancestor
24762459|NCT01768312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762460|NCT01768312|Antifungal Agents|antifungal agents|mesh-ancestor
24762461|NCT01768312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24762462|NCT01768312|Dermatologic Agents|dermatologic agents|mesh-ancestor
24762463|NCT01768312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24762464|NCT01768312|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24762466|NCT01768338|Ofatumumab|ofatumumab|mesh-list
25015628|NCT01304511|Ganirelix|ganirelix|mesh-list
24899742|NCT04400890|Micronutrients|micronutrients|mesh-ancestor
24762472|NCT01768351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24762473|NCT01768351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762474|NCT01768351|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24762475|NCT01768351|Vitamins|vitamins|mesh-ancestor
24762476|NCT01768351|Micronutrients|micronutrients|mesh-ancestor
24762477|NCT01768351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24762478|NCT01768364|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24762479|NCT01768364|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24762480|NCT01768364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24762481|NCT01768364|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24762483|NCT01768364|Antimalarials|antimalarials|mesh-ancestor
24762484|NCT01768364|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24762487|NCT01768377|Fentanyl|fentanyl|mesh-list
24762488|NCT01768377|Midazolam|midazolam|mesh-list
24762489|NCT01768377|Anesthetics, Local|anesthetics, local|mesh-ancestor
24762490|NCT01768377|Anesthetics|anesthetics|mesh-ancestor
24762491|NCT01768377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24762492|NCT01768377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762493|NCT01768377|Sensory System Agents|sensory system agents|mesh-ancestor
24762494|NCT01768377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24553528|NCT00731627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24553529|NCT00731627|Antimetabolites|antimetabolites|mesh-ancestor
24553530|NCT00731627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553531|NCT00731627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24553532|NCT00731627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24553533|NCT00731627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24810832|NCT02042690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24900039|NCT04397653|Antimetabolites|antimetabolites|mesh-ancestor
24762816|NCT01769820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24762820|NCT01769833|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24762821|NCT01769833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24762824|NCT01769833|Immunologic Factors|immunologic factors|mesh-ancestor
24762825|NCT01769833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762827|NCT01769898|Theophylline|theophylline|mesh-list
24762828|NCT01769898|Formoterol Fumarate|formoterol fumarate|mesh-list
24762829|NCT01769898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24762830|NCT01769898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25663137|NCT01654224|Vaccines|vaccines|mesh-list
24762831|NCT01769898|Autonomic Agents|autonomic agents|mesh-ancestor
24762832|NCT01769898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24762833|NCT01769898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762834|NCT01769898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24762835|NCT01769898|Respiratory System Agents|respiratory system agents|mesh-ancestor
24762836|NCT01769898|Glucocorticoids|glucocorticoids|mesh-ancestor
24762837|NCT01769898|Hormones|hormones|mesh-ancestor
25079914|NCT03344042|Sensory System Agents|sensory system agents|mesh-ancestor
25079915|NCT03344042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24763029|NCT01770899|Hormone Antagonists|hormone antagonists|mesh-ancestor
24763030|NCT01770899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24763031|NCT01770899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763032|NCT01770899|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24763033|NCT01770899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24763034|NCT01770899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763036|NCT01770964|Analgesics|analgesics|mesh-ancestor
24763037|NCT01770964|Sensory System Agents|sensory system agents|mesh-ancestor
24763038|NCT01770964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24763039|NCT01770964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763040|NCT01770964|Anticonvulsants|anticonvulsants|mesh-ancestor
24763041|NCT01770964|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24763042|NCT01770964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24763043|NCT01770964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763044|NCT01770964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24763045|NCT01770964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24763046|NCT01770964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24763047|NCT01770964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24763048|NCT01770964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24763049|NCT01771081|Ranibizumab|ranibizumab|mesh-list
24763158|NCT01771822|Sensory System Agents|sensory system agents|mesh-ancestor
25202370|NCT02722083|Dermatologic Agents|dermatologic agents|mesh-ancestor
25851793|NCT00054561|Dermatologic Agents|dermatologic agents|mesh-ancestor
24763159|NCT01771822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24620213|NCT01055847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24620214|NCT01055925|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24620235|NCT01056042|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25079991|NCT03343548|Anticonvulsants|anticonvulsants|mesh-ancestor
25079992|NCT03343548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25079993|NCT03343548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25079994|NCT03343548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079995|NCT03343548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25079996|NCT03343548|Tocolytic Agents|tocolytic agents|mesh-ancestor
25079997|NCT03343548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24620250|NCT01056042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24620251|NCT01056042|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24480524|NCT00431236|Antiemetics|antiemetics|mesh-ancestor
24620252|NCT01056042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24620253|NCT01056042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24620255|NCT01056172|Ribavirin|ribavirin|mesh-list
24620256|NCT01056172|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24620257|NCT01056172|Interferon-alpha|interferon-alpha|mesh-list
24620258|NCT01056172|Antimetabolites|antimetabolites|mesh-ancestor
24620260|NCT01056172|Antiviral Agents|antiviral agents|mesh-ancestor
24763216|NCT01772238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763217|NCT01772251|Insulin|insulin|mesh-list
24763307|NCT01772940|Emtricitabine|emtricitabine|mesh-list
24763308|NCT01772940|Nevirapine|nevirapine|mesh-list
24763309|NCT01772940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24763310|NCT01772940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25851794|NCT00054574|Panitumumab|panitumumab|mesh-list
24480141|NCT00429897|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24480142|NCT00429936|Fenretinide|fenretinide|mesh-list
24480152|NCT00429962|Growth Inhibitors|growth inhibitors|mesh-ancestor
24480153|NCT00429962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480155|NCT00429975|Ofloxacin|ofloxacin|mesh-list
24480156|NCT00429975|Ceftriaxone|ceftriaxone|mesh-list
24480157|NCT00429975|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24480158|NCT00429975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24480159|NCT00429975|Renal Agents|renal agents|mesh-ancestor
24480160|NCT00429975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24480161|NCT00429975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24763329|NCT01772953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24763330|NCT01772979|Trabectedin|trabectedin|mesh-list
24763331|NCT01772979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24704363|NCT01477931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24704390|NCT01478022|Diuretics|diuretics|mesh-ancestor
24763332|NCT01772979|Alkylating Agents|alkylating agents|mesh-ancestor
24462051|NCT00354731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763486|NCT01774370|Anticoagulants|anticoagulants|mesh-ancestor
24763487|NCT01774396|Lidocaine|lidocaine|mesh-list
24763488|NCT01774396|Anesthetics, Local|anesthetics, local|mesh-ancestor
24763489|NCT01774396|Anesthetics|anesthetics|mesh-ancestor
24763490|NCT01774396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24763491|NCT01774396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763492|NCT01774396|Sensory System Agents|sensory system agents|mesh-ancestor
24763493|NCT01774396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24763494|NCT01774396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24763501|NCT01774474|Triamcinolone|triamcinolone|mesh-list
24763526|NCT01774474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763527|NCT01774474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763528|NCT01774474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24763529|NCT01774474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24763530|NCT01774474|Immunologic Factors|immunologic factors|mesh-ancestor
24763531|NCT01774474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24763532|NCT01774474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24763533|NCT01774474|Analgesics|analgesics|mesh-ancestor
24763534|NCT01774474|Sensory System Agents|sensory system agents|mesh-ancestor
24763535|NCT01774474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24763536|NCT01774487|Pentoxifylline|pentoxifylline|mesh-list
24763538|NCT01774487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763539|NCT01774487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763540|NCT01774487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24763541|NCT01774487|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24462293|NCT00355641|Ropinirole|ropinirole|mesh-list
24620281|NCT01056237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25202371|NCT02722083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24620286|NCT01056237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24620288|NCT01056237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24462400|NCT00356005|Artesunate|artesunate|mesh-list
24763582|NCT01775098|Antimetabolites|antimetabolites|mesh-ancestor
24763583|NCT01775098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763584|NCT01775098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763585|NCT01775098|Gout Suppressants|gout suppressants|mesh-ancestor
24763586|NCT01775098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24763587|NCT01775098|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24763684|NCT01775839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763686|NCT01775839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24763687|NCT01775839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763688|NCT01775839|Antipyretics|antipyretics|mesh-ancestor
24763689|NCT01775839|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24462633|NCT00357123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25851795|NCT00054574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24480525|NCT00431236|Autonomic Agents|autonomic agents|mesh-ancestor
24763736|NCT01776515|Acetaminophen|acetaminophen|mesh-list
24763737|NCT01776515|Tramadol|tramadol|mesh-list
24763738|NCT01776515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24763739|NCT01776515|Analgesics|analgesics|mesh-ancestor
24763740|NCT01776515|Sensory System Agents|sensory system agents|mesh-ancestor
24480529|NCT00431236|Glucocorticoids|glucocorticoids|mesh-ancestor
24480530|NCT00431236|Hormones|hormones|mesh-ancestor
24480531|NCT00431236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24480532|NCT00431236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24480533|NCT00431236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480534|NCT00431236|Antipruritics|antipruritics|mesh-ancestor
24629034|NCT01102686|Vitamin B Complex|vitamin b complex|mesh-ancestor
24480746|NCT00432016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25851796|NCT00054574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851797|NCT00054587|Cyclophosphamide|cyclophosphamide|mesh-list
24480752|NCT00432055|Botulinum Toxins|botulinum toxins|mesh-list
24480754|NCT00432055|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24480755|NCT00432055|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24480756|NCT00432055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24480757|NCT00432055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480758|NCT00432055|Cholinergic Agents|cholinergic agents|mesh-ancestor
24620347|NCT01056627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24763964|NCT01778413|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24763965|NCT01778413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25663138|NCT01654224|Immunologic Factors|immunologic factors|mesh-ancestor
25663139|NCT01654224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763994|NCT01778803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24763995|NCT01778803|Tubulin Modulators|tubulin modulators|mesh-ancestor
25080086|NCT03342300|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24763996|NCT01778803|Antimitotic Agents|antimitotic agents|mesh-ancestor
24763997|NCT01778803|Mitosis Modulators|mitosis modulators|mesh-ancestor
24763998|NCT01778803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764000|NCT01778842|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24764001|NCT01778842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24764002|NCT01778842|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24764003|NCT01778842|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24764004|NCT01778842|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24764005|NCT01778842|Purinergic Agents|purinergic agents|mesh-ancestor
24764006|NCT01778842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24629778|NCT01107808|Micronutrients|micronutrients|mesh-ancestor
24481049|NCT00433186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481050|NCT00433186|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24481051|NCT00433186|Antitubercular Agents|antitubercular agents|mesh-ancestor
24481052|NCT00433186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24481053|NCT00433186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24481054|NCT00433186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481055|NCT00433186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481066|NCT00433225|Glucocorticoids|glucocorticoids|mesh-ancestor
24481067|NCT00433225|Hormones|hormones|mesh-ancestor
24481068|NCT00433225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24481069|NCT00433225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481070|NCT00433225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24481071|NCT00433225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481072|NCT00433225|Antiemetics|antiemetics|mesh-ancestor
24481073|NCT00433225|Autonomic Agents|autonomic agents|mesh-ancestor
24629853|NCT01108146|Hydrocortisone|hydrocortisone|mesh-list
24764157|NCT01779687|Antiviral Agents|antiviral agents|mesh-ancestor
24764158|NCT01779687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24764159|NCT01779687|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24764160|NCT01779687|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24764161|NCT01779830|Zolpidem|zolpidem|mesh-list
24764162|NCT01779830|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24764163|NCT01779830|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24764164|NCT01779830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24764165|NCT01779830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764166|NCT01779830|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24764167|NCT01779830|GABA Agonists|gaba agonists|mesh-ancestor
24764168|NCT01779830|GABA Agents|gaba agents|mesh-ancestor
24764201|NCT01779908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24764202|NCT01779921|Thrombin|thrombin|mesh-list
24764203|NCT01779921|Hemostatics|hemostatics|mesh-ancestor
24764204|NCT01779921|Coagulants|coagulants|mesh-ancestor
24764205|NCT01780051|Metformin|metformin|mesh-list
24764206|NCT01780051|Repaglinide|repaglinide|mesh-list
24764207|NCT01780051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24764208|NCT01780051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764209|NCT01780181|Gemcitabine|gemcitabine|mesh-list
24764211|NCT01780181|Vinorelbine|vinorelbine|mesh-list
24764212|NCT01780181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24764213|NCT01780181|Antimetabolites|antimetabolites|mesh-ancestor
24481230|NCT00433784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24764214|NCT01780181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764216|NCT01780181|Antiviral Agents|antiviral agents|mesh-ancestor
24764217|NCT01780181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24630437|NCT01111669|Hemostatics|hemostatics|mesh-ancestor
24431637|NCT00252603|Cholinergic Agents|cholinergic agents|mesh-ancestor
24481305|NCT00434031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24481306|NCT00434031|Immunologic Factors|immunologic factors|mesh-ancestor
24481307|NCT00434031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481308|NCT00434031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24481310|NCT00434031|Alkylating Agents|alkylating agents|mesh-ancestor
24481319|NCT00434031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24481320|NCT00434031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764246|NCT01780233|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24764247|NCT01780233|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24764248|NCT01780259|Triazolam|triazolam|mesh-list
24764249|NCT01780259|Esketamine|esketamine|mesh-list
24764250|NCT01780259|Antidepressive Agents|antidepressive agents|mesh-ancestor
24764251|NCT01780259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24764252|NCT01780259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24764253|NCT01780259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24764254|NCT01780259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25237479|NCT02550262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25154935|NCT05468489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24764255|NCT01780259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24764256|NCT01780259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764286|NCT01780467|Protective Agents|protective agents|mesh-ancestor
24764287|NCT01780519|Lorazepam|lorazepam|mesh-list
24764288|NCT01780519|Anticonvulsants|anticonvulsants|mesh-ancestor
24764289|NCT01780519|Antiemetics|antiemetics|mesh-ancestor
24764290|NCT01780519|Autonomic Agents|autonomic agents|mesh-ancestor
24764291|NCT01780519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24764292|NCT01780519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764293|NCT01780519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24764294|NCT01780519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24764295|NCT01780519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24764296|NCT01780519|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24764297|NCT01780519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24764298|NCT01780519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24764299|NCT01780519|GABA Modulators|gaba modulators|mesh-ancestor
24764301|NCT01780519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24630764|NCT01113489|Hormones|hormones|mesh-ancestor
25080090|NCT03342300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25080091|NCT03342300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25080092|NCT03342300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25080093|NCT03342300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080094|NCT03342261|Antiviral Agents|antiviral agents|mesh-list
25080095|NCT03342261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25080096|NCT03342170|Thrombin|thrombin|mesh-list
25080097|NCT03342170|Hemostatics|hemostatics|mesh-ancestor
25080098|NCT03342170|Coagulants|coagulants|mesh-ancestor
25080099|NCT03342079|Nitrous Oxide|nitrous oxide|mesh-list
25080100|NCT03342079|Anesthetics|anesthetics|mesh-list
25080101|NCT03342079|Anesthetics, Local|anesthetics, local|mesh-list
24630848|NCT01114100|Sertraline|sertraline|mesh-list
24764412|NCT01781377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24764413|NCT01781377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764477|NCT01781988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764478|NCT01781988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24764479|NCT01781988|Immunologic Factors|immunologic factors|mesh-ancestor
24764480|NCT01781988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764483|NCT01782001|Retinol palmitate|retinol palmitate|mesh-list
24764484|NCT01782001|Micronutrients|micronutrients|mesh-ancestor
24764485|NCT01782001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764486|NCT01782001|Antioxidants|antioxidants|mesh-ancestor
24764487|NCT01782001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764488|NCT01782001|Protective Agents|protective agents|mesh-ancestor
24764489|NCT01782001|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24764490|NCT01782001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24764491|NCT01782261|Liraglutide|liraglutide|mesh-list
24764492|NCT01782261|Saxagliptin|saxagliptin|mesh-list
24764569|NCT01782651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24764570|NCT01782651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24764571|NCT01782651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764572|NCT01782781|Epinephrine|epinephrine|mesh-list
24764573|NCT01782781|Ropivacaine|ropivacaine|mesh-list
24764574|NCT01782781|Anesthetics, Local|anesthetics, local|mesh-ancestor
24764575|NCT01782781|Anesthetics|anesthetics|mesh-ancestor
24764576|NCT01782781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24764577|NCT01782781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764578|NCT01782781|Sensory System Agents|sensory system agents|mesh-ancestor
24764579|NCT01782781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24764580|NCT01782781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24764581|NCT01782781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24764582|NCT01782781|Adrenergic Agents|adrenergic agents|mesh-ancestor
24966141|NCT03770936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24966142|NCT03770936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24631269|NCT01116635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24481608|NCT00435851|Hormones|hormones|mesh-list
24481609|NCT00435851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25851798|NCT00054587|Docetaxel|docetaxel|mesh-list
24481686|NCT00436371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25080158|NCT03341429|Liraglutide|liraglutide|mesh-list
25663140|NCT01654276|Febuxostat|febuxostat|mesh-list
25663141|NCT01654276|Gout Suppressants|gout suppressants|mesh-ancestor
25663142|NCT01654276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24779050|NCT01873443|Folic Acid|folic acid|mesh-list
25663143|NCT01654302|Lidocaine|lidocaine|mesh-list
24704858|NCT01480765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24764595|NCT01782846|Narcotics|narcotics|mesh-ancestor
24764596|NCT01782846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24764597|NCT01782846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764598|NCT01782846|Analgesics|analgesics|mesh-ancestor
24854548|NCT02273817|Hormones|hormones|mesh-ancestor
24764599|NCT01782846|Sensory System Agents|sensory system agents|mesh-ancestor
24764600|NCT01782846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24481691|NCT00436423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481692|NCT00436423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481693|NCT00436423|Antiviral Agents|antiviral agents|mesh-ancestor
24481694|NCT00436423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24481695|NCT00436423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481696|NCT00436423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24481697|NCT00436423|Immunologic Factors|immunologic factors|mesh-ancestor
24620370|NCT01056705|Immunologic Factors|immunologic factors|mesh-ancestor
24620371|NCT01056705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620372|NCT01056757|Ribavirin|ribavirin|mesh-list
24620373|NCT01056757|Antimetabolites|antimetabolites|mesh-ancestor
24620377|NCT01056835|Epoprostenol|epoprostenol|mesh-list
24620378|NCT01056835|Tezosentan|tezosentan|mesh-list
24620379|NCT01056835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24764682|NCT01783197|Pemetrexed|pemetrexed|mesh-list
24764683|NCT01783197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24764684|NCT01783197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24764685|NCT01783197|Tubulin Modulators|tubulin modulators|mesh-ancestor
24764686|NCT01783197|Antimitotic Agents|antimitotic agents|mesh-ancestor
24764687|NCT01783197|Mitosis Modulators|mitosis modulators|mesh-ancestor
24631657|NCT01119430|Serotonin Agents|serotonin agents|mesh-ancestor
24764717|NCT01783717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24764718|NCT01783756|Capecitabine|capecitabine|mesh-list
24764719|NCT01783756|Everolimus|everolimus|mesh-list
24764720|NCT01783756|Lapatinib|lapatinib|mesh-list
24764721|NCT01783756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24764722|NCT01783756|Antimetabolites|antimetabolites|mesh-ancestor
24764723|NCT01783756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811235|NCT02045849|Hormone Antagonists|hormone antagonists|mesh-ancestor
24764761|NCT01784107|Belotecan|belotecan|mesh-list
24764762|NCT01784107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24764763|NCT01784107|Alkylating Agents|alkylating agents|mesh-ancestor
24764764|NCT01784107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764765|NCT01784107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24764766|NCT01784107|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24764767|NCT01784107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24764768|NCT01784107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764769|NCT01784120|Doxorubicin|doxorubicin|mesh-list
24764770|NCT01784120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24764771|NCT01784120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24764772|NCT01784120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24764773|NCT01784120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24764776|NCT01784250|Propranolol|propranolol|mesh-list
24764777|NCT01784250|Clonidine|clonidine|mesh-list
25851799|NCT00054587|Fluorouracil|fluorouracil|mesh-list
24764831|NCT01784380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24764832|NCT01784380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764833|NCT01784380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24764834|NCT01784380|Hormone Antagonists|hormone antagonists|mesh-ancestor
24902056|NCT04378283|Sensory System Agents|sensory system agents|mesh-ancestor
25851800|NCT00054587|Trastuzumab|trastuzumab|mesh-list
25851801|NCT00054587|Epirubicin|epirubicin|mesh-list
24482060|NCT00437814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24482061|NCT00437814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482062|NCT00437814|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24482063|NCT00437814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24482116|NCT00437996|Clonidine|clonidine|mesh-list
24482117|NCT00437996|Sufentanil|sufentanil|mesh-list
24482118|NCT00437996|Levobupivacaine|levobupivacaine|mesh-list
24482119|NCT00437996|Analgesics|analgesics|mesh-ancestor
24482120|NCT00437996|Sensory System Agents|sensory system agents|mesh-ancestor
24632112|NCT01122121|Leuprolide|leuprolide|mesh-list
25080167|NCT03341390|Analgesics|analgesics|mesh-ancestor
24764896|NCT01784978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24764897|NCT01784978|Growth Substances|growth substances|mesh-ancestor
24764898|NCT01784978|Growth Inhibitors|growth inhibitors|mesh-ancestor
24764899|NCT01784978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25663144|NCT01654302|Tetracaine|tetracaine|mesh-list
24764900|NCT01784978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409346|NCT03384836|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25663145|NCT01654302|Anesthetics, Local|anesthetics, local|mesh-ancestor
24764901|NCT01784978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764902|NCT01785004|Vitamin D|vitamin d|mesh-list
24764939|NCT01785108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24765182|NCT01786382|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24765183|NCT01786382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24765184|NCT01786395|Isopropyl unoprostone|isopropyl unoprostone|mesh-list
24765185|NCT01786395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24765187|NCT01786538|Fluorouracil|fluorouracil|mesh-list
25851802|NCT00054587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24829778|NCT02154438|Sensory System Agents|sensory system agents|mesh-ancestor
24765188|NCT01786538|Oxaliplatin|oxaliplatin|mesh-list
24765232|NCT01786655|Respiratory System Agents|respiratory system agents|mesh-ancestor
24765234|NCT01786655|Sympathomimetics|sympathomimetics|mesh-ancestor
24765235|NCT01786655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24765236|NCT01786655|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24765237|NCT01786655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24765238|NCT01786759|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24765239|NCT01786759|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24765240|NCT01786759|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24765241|NCT01786759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24765267|NCT01787357|Moxifloxacin|moxifloxacin|mesh-list
24765268|NCT01787357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24765269|NCT01787357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24765270|NCT01787357|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24765271|NCT01787357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24765272|NCT01787357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24765273|NCT01787357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765274|NCT01787357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24765275|NCT01787357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765276|NCT01787357|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24765277|NCT01787357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24765279|NCT01787396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24765280|NCT01787396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765281|NCT01787474|Cytarabine|cytarabine|mesh-list
24765355|NCT01788254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24765356|NCT01788254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24765357|NCT01788254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24765358|NCT01788254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24765359|NCT01788254|Anesthetics, General|anesthetics, general|mesh-ancestor
24765479|NCT01788774|Serotonin Agents|serotonin agents|mesh-ancestor
24765480|NCT01788774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24765519|NCT01789125|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24765520|NCT01789125|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24765521|NCT01789125|Cholinergic Agents|cholinergic agents|mesh-ancestor
24765522|NCT01789125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24765523|NCT01789125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765524|NCT01789216|Ketorolac|ketorolac|mesh-list
24765525|NCT01789216|Meloxicam|meloxicam|mesh-list
24765526|NCT01789216|Pregabalin|pregabalin|mesh-list
24765527|NCT01789216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24765528|NCT01789216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24765530|NCT01789216|Sensory System Agents|sensory system agents|mesh-ancestor
24765531|NCT01789216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24765532|NCT01789216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765533|NCT01789216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24765534|NCT01789216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24765535|NCT01789216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24765537|NCT01789216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765538|NCT01789216|Anticonvulsants|anticonvulsants|mesh-ancestor
24765547|NCT01789242|Dexamethasone|dexamethasone|mesh-list
24765575|NCT01789333|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24765576|NCT01789333|Dermatologic Agents|dermatologic agents|mesh-ancestor
24765577|NCT01789385|Dexmedetomidine|dexmedetomidine|mesh-list
24765578|NCT01789385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24765579|NCT01789385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24765580|NCT01789385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765581|NCT01789385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24765582|NCT01789385|Analgesics|analgesics|mesh-ancestor
24765583|NCT01789385|Sensory System Agents|sensory system agents|mesh-ancestor
24395056|NCT00134992|Hormones|hormones|mesh-ancestor
24765646|NCT01789879|Efavirenz|efavirenz|mesh-list
24765647|NCT01789879|Nevirapine|nevirapine|mesh-list
24765648|NCT01789879|Levonorgestrel|levonorgestrel|mesh-list
24765649|NCT01789879|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24765650|NCT01789879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24765651|NCT01789879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24765652|NCT01789879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765653|NCT01789879|Antiviral Agents|antiviral agents|mesh-ancestor
24765654|NCT01789879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25202372|NCT02722083|Histamine Antagonists|histamine antagonists|mesh-ancestor
25202373|NCT02722083|Histamine Agents|histamine agents|mesh-ancestor
24765655|NCT01789879|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24966255|NCT03770013|Anesthetics, Local|anesthetics, local|mesh-ancestor
24966256|NCT03770013|Anesthetics|anesthetics|mesh-ancestor
24765713|NCT01790022|Prednisolone phosphate|prednisolone phosphate|mesh-list
24765714|NCT01790022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24765765|NCT01790529|Cefuroxime axetil|cefuroxime axetil|mesh-list
24765767|NCT01790529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24765768|NCT01790529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765769|NCT01790529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24765770|NCT01790529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24765771|NCT01790529|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24765772|NCT01790529|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24765774|NCT01790542|Trace Elements|trace elements|mesh-ancestor
24765775|NCT01790542|Micronutrients|micronutrients|mesh-ancestor
24765776|NCT01790542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765777|NCT01790555|Diazepam|diazepam|mesh-list
24765778|NCT01790555|Dronabinol|dronabinol|mesh-list
24765779|NCT01790555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25851803|NCT00054587|Immunologic Factors|immunologic factors|mesh-ancestor
25851804|NCT00054587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765780|NCT01790555|Anticonvulsants|anticonvulsants|mesh-ancestor
24765781|NCT01790555|Antiemetics|antiemetics|mesh-ancestor
24765782|NCT01790555|Autonomic Agents|autonomic agents|mesh-ancestor
24765783|NCT01790555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24765784|NCT01790555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765785|NCT01790555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25851805|NCT00054587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24765815|NCT01790737|Immunologic Factors|immunologic factors|mesh-ancestor
24765816|NCT01790737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765817|NCT01790737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24765818|NCT01790737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24556612|NCT00748371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24765839|NCT01790971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24765852|NCT01790997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765853|NCT01790997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24765854|NCT01790997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24765855|NCT01790997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24765857|NCT01790997|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24765858|NCT01790997|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24765859|NCT01790997|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24765860|NCT01790997|Purinergic Agents|purinergic agents|mesh-ancestor
24765861|NCT01790997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24765862|NCT01791088|Sirolimus|sirolimus|mesh-list
24765863|NCT01791088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24765864|NCT01791088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24765865|NCT01791088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24765866|NCT01791088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24765867|NCT01791088|Antifungal Agents|antifungal agents|mesh-ancestor
24765868|NCT01791088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24765869|NCT01791088|Immunologic Factors|immunologic factors|mesh-ancestor
24765870|NCT01791088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765872|NCT01791114|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24765873|NCT01791114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24765874|NCT01791114|Adrenergic Agents|adrenergic agents|mesh-ancestor
24395692|NCT00136591|Bortezomib|bortezomib|mesh-list
24622769|NCT01068353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24765918|NCT01791374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24765919|NCT01791374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24765920|NCT01791374|Immunologic Factors|immunologic factors|mesh-ancestor
24765921|NCT01791374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765922|NCT01791400|Sumatriptan|sumatriptan|mesh-list
24765923|NCT01791400|Metoclopramide|metoclopramide|mesh-list
24765924|NCT01791400|Antiemetics|antiemetics|mesh-ancestor
24766025|NCT01792037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24766026|NCT01792037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24766027|NCT01792037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24766028|NCT01792037|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24766029|NCT01792037|Anesthetics, General|anesthetics, general|mesh-ancestor
24766030|NCT01792037|Anesthetics|anesthetics|mesh-ancestor
24766031|NCT01792037|GABA Modulators|gaba modulators|mesh-ancestor
24848780|NCT03497156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24848781|NCT03497156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24848782|NCT03497156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24848783|NCT03497156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848784|NCT03497156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24848785|NCT03497156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848786|NCT03497143|Lamotrigine|lamotrigine|mesh-list
24466060|NCT00371735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24848787|NCT03497143|Anticonvulsants|anticonvulsants|mesh-ancestor
24848788|NCT03497143|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24848789|NCT03497143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24848790|NCT03497143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766123|NCT01792713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24766124|NCT01792804|Vancomycin|vancomycin|mesh-list
24766125|NCT01792804|Clindamycin|clindamycin|mesh-list
24766126|NCT01792804|Cefazolin|cefazolin|mesh-list
24766127|NCT01792804|Linezolid|linezolid|mesh-list
24766128|NCT01792804|Daptomycin|daptomycin|mesh-list
24766151|NCT01792934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24766152|NCT01792934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24766153|NCT01792934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24766154|NCT01792934|Growth Substances|growth substances|mesh-ancestor
24766155|NCT01792934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766156|NCT01792934|Growth Inhibitors|growth inhibitors|mesh-ancestor
24766157|NCT01792934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24766158|NCT01792934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24766159|NCT01792934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24766160|NCT01792934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766162|NCT01793038|Enclomiphene|enclomiphene|mesh-list
24766163|NCT01793038|Zuclomiphene|zuclomiphene|mesh-list
24766164|NCT01793038|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24766165|NCT01793038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766250|NCT01793753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24766252|NCT01793753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24766280|NCT01794078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24766281|NCT01794078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766282|NCT01794078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24766284|NCT01794078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24766285|NCT01794078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396022|NCT00137657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24766394|NCT01794507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24766395|NCT01794507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766396|NCT01794507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24766397|NCT01794507|Glucocorticoids|glucocorticoids|mesh-ancestor
24766398|NCT01794507|Hormones|hormones|mesh-ancestor
24766399|NCT01794507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24766400|NCT01794507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24396164|NCT00137995|Hormones|hormones|mesh-ancestor
24766520|NCT01795222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24766521|NCT01795222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24766772|NCT01796613|Estrogens|estrogens|mesh-ancestor
24766798|NCT01796808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24966431|NCT03768258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24766926|NCT01797913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24766927|NCT01797913|Antimetabolites|antimetabolites|mesh-ancestor
24766928|NCT01797913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766929|NCT01797913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24766930|NCT01797913|Antiviral Agents|antiviral agents|mesh-ancestor
24766931|NCT01797913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24766932|NCT01797913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663146|NCT01654302|Anesthetics|anesthetics|mesh-ancestor
25663147|NCT01654302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25663148|NCT01654302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663149|NCT01654302|Sensory System Agents|sensory system agents|mesh-ancestor
25663150|NCT01654302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25663151|NCT01654302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25663152|NCT01654302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25663153|NCT01654302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25663154|NCT01654302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25663155|NCT01654302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663156|NCT01654380|Insulin Glargine|insulin glargine|mesh-list
25663157|NCT01654380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25005704|NCT02913482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25005705|NCT02913482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706001|NCT01488253|Immunologic Factors|immunologic factors|mesh-ancestor
24706002|NCT01488253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706097|NCT01488552|Tubulin Modulators|tubulin modulators|mesh-ancestor
24706098|NCT01488552|Antimitotic Agents|antimitotic agents|mesh-ancestor
24706099|NCT01488552|Mitosis Modulators|mitosis modulators|mesh-ancestor
24706100|NCT01488552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706101|NCT01488552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24766933|NCT01797913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24766934|NCT01797913|Immunologic Factors|immunologic factors|mesh-ancestor
24766935|NCT01797913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766937|NCT01797926|Amlodipine|amlodipine|mesh-list
24557994|NCT00755066|Autonomic Agents|autonomic agents|mesh-ancestor
24557995|NCT00755066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24557996|NCT00755066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557997|NCT00755066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24557998|NCT00755066|Respiratory System Agents|respiratory system agents|mesh-ancestor
24557999|NCT00755066|Dermatologic Agents|dermatologic agents|mesh-ancestor
24558000|NCT00755066|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24620396|NCT01056874|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24620397|NCT01056874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620398|NCT01056874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24766995|NCT01798108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24766996|NCT01798251|Capecitabine|capecitabine|mesh-list
24766997|NCT01798251|Oxaliplatin|oxaliplatin|mesh-list
24482278|NCT00438321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25851806|NCT00054587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25851807|NCT00054587|Alkylating Agents|alkylating agents|mesh-ancestor
25851808|NCT00054587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851809|NCT00054587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851810|NCT00054587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24766998|NCT01798251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24766999|NCT01798251|Antimetabolites|antimetabolites|mesh-ancestor
25202374|NCT02722083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24767000|NCT01798251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767002|NCT01798277|Amiodarone|amiodarone|mesh-list
24767003|NCT01798277|Sotalol|sotalol|mesh-list
24767004|NCT01798277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24767136|NCT01798914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24767137|NCT01798914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767138|NCT01798940|Pioglitazone|pioglitazone|mesh-list
24767139|NCT01798940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24767140|NCT01798940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767173|NCT01799109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24767174|NCT01799109|Respiratory System Agents|respiratory system agents|mesh-ancestor
24767175|NCT01799109|Tocolytic Agents|tocolytic agents|mesh-ancestor
24767176|NCT01799109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24767177|NCT01799109|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24767178|NCT01799109|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24767179|NCT01799109|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24966433|NCT03768258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966434|NCT03768258|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24966435|NCT03768258|Hormone Antagonists|hormone antagonists|mesh-ancestor
24966436|NCT03768037|Pemetrexed|pemetrexed|mesh-list
24966437|NCT03768037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24966438|NCT03768037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456882|NCT00332553|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
24966439|NCT03768037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966440|NCT03768037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24397425|NCT00141544|Androgens|androgens|mesh-ancestor
25409347|NCT03384836|Adrenergic Agents|adrenergic agents|mesh-ancestor
25663158|NCT01654380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663159|NCT01654445|Tenecteplase|tenecteplase|mesh-list
25663160|NCT01654445|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25663161|NCT01654445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25663162|NCT01654445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663163|NCT01654536|Ciclesonide|ciclesonide|mesh-list
25663164|NCT01654536|Glucocorticoids|glucocorticoids|mesh-ancestor
25663165|NCT01654536|Hormones|hormones|mesh-ancestor
25663166|NCT01654536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25663167|NCT01654536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707283|NCT01495104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24707284|NCT01495104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707285|NCT01495104|Antimanic Agents|antimanic agents|mesh-ancestor
24707286|NCT01495104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24767198|NCT01799161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24767199|NCT01799161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24767200|NCT01799161|Respiratory System Agents|respiratory system agents|mesh-ancestor
24767214|NCT01799317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24767215|NCT01799317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24767216|NCT01799356|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24767217|NCT01799356|Moxifloxacin|moxifloxacin|mesh-list
24767218|NCT01799356|Metronidazole|metronidazole|mesh-list
24767219|NCT01799356|Ofloxacin|ofloxacin|mesh-list
24767220|NCT01799356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24767221|NCT01799356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24558418|NCT00757185|Methyltestosterone|methyltestosterone|mesh-list
24558419|NCT00757185|Testosterone|testosterone|mesh-list
24558420|NCT00757185|Testosterone undecanoate|testosterone undecanoate|mesh-list
24558421|NCT00757185|Testosterone enanthate|testosterone enanthate|mesh-list
25851811|NCT00054587|Tubulin Modulators|tubulin modulators|mesh-ancestor
25851812|NCT00054587|Antimitotic Agents|antimitotic agents|mesh-ancestor
24767514|NCT01801410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24767516|NCT01801423|Hydroxyurea|hydroxyurea|mesh-list
24767517|NCT01801423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767518|NCT01801423|Antisickling Agents|antisickling agents|mesh-ancestor
24767615|NCT01802502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24767616|NCT01802593|Methotrexate|methotrexate|mesh-list
24767617|NCT01802593|Mercaptopurine|mercaptopurine|mesh-list
24767621|NCT01802593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24767623|NCT01802593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24767624|NCT01802593|Antimetabolites|antimetabolites|mesh-ancestor
24767625|NCT01802593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767626|NCT01802593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767627|NCT01802593|Dermatologic Agents|dermatologic agents|mesh-ancestor
24767628|NCT01802593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767629|NCT01802593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24767630|NCT01802593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24767631|NCT01802593|Immunologic Factors|immunologic factors|mesh-ancestor
24767632|NCT01802593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24767633|NCT01802593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24767634|NCT01802619|Nitric Oxide|nitric oxide|mesh-list
24767635|NCT01802619|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24767636|NCT01802619|Autonomic Agents|autonomic agents|mesh-ancestor
24767637|NCT01802619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24767638|NCT01802619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767639|NCT01802619|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24767640|NCT01802619|Respiratory System Agents|respiratory system agents|mesh-ancestor
24767641|NCT01802619|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24767642|NCT01802619|Antioxidants|antioxidants|mesh-ancestor
24767643|NCT01802619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767644|NCT01802619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24767645|NCT01802619|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24767646|NCT01802619|Vasodilator Agents|vasodilator agents|mesh-ancestor
24482465|NCT00439062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24620403|NCT01056874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24620405|NCT01056874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620406|NCT01056874|Protective Agents|protective agents|mesh-ancestor
24620407|NCT01056874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620408|NCT01056926|Nicotine|nicotine|mesh-list
24620409|NCT01056926|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24767764|NCT01802970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24767765|NCT01803087|Formoterol Fumarate|formoterol fumarate|mesh-list
24767798|NCT01803191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24482468|NCT00439166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24482469|NCT00439166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24482470|NCT00439166|Antimalarials|antimalarials|mesh-ancestor
24482471|NCT00439166|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24482512|NCT00439361|Etoposide|etoposide|mesh-list
25851813|NCT00054587|Mitosis Modulators|mitosis modulators|mesh-ancestor
25851814|NCT00054587|Antimetabolites|antimetabolites|mesh-ancestor
24767799|NCT01803191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767800|NCT01803191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663168|NCT01654536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25663169|NCT01654601|Clozapine|clozapine|mesh-list
25663170|NCT01654601|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25663171|NCT01654601|Serotonin Agents|serotonin agents|mesh-ancestor
25663172|NCT01654601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24848841|NCT03391466|Fludarabine|fludarabine|mesh-list
24848842|NCT03391466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24767801|NCT01803191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767802|NCT01803191|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24767803|NCT01803191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24767804|NCT01803321|Rilonacept|rilonacept|mesh-list
24767805|NCT01803321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24767806|NCT01803347|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24767807|NCT01803347|Hemostatics|hemostatics|mesh-ancestor
24767808|NCT01803347|Coagulants|coagulants|mesh-ancestor
24767809|NCT01803399|Moxifloxacin|moxifloxacin|mesh-list
24767810|NCT01803399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24767811|NCT01803399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24767812|NCT01803399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24767813|NCT01803399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24767814|NCT01803399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24465611|NCT00370266|Glucocorticoids|glucocorticoids|mesh-ancestor
24767815|NCT01803399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767816|NCT01803399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767817|NCT01803438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
24767818|NCT01803503|Docetaxel|docetaxel|mesh-list
24767819|NCT01803503|Sunitinib|sunitinib|mesh-list
24767820|NCT01803503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767821|NCT01803503|Tubulin Modulators|tubulin modulators|mesh-ancestor
24767822|NCT01803503|Antimitotic Agents|antimitotic agents|mesh-ancestor
24767823|NCT01803503|Mitosis Modulators|mitosis modulators|mesh-ancestor
24767867|NCT01804127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24767868|NCT01804127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767869|NCT01804127|Immunologic Factors|immunologic factors|mesh-ancestor
24767872|NCT01804205|Magnesium Sulfate|magnesium sulfate|mesh-list
24767892|NCT01804218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767893|NCT01804218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767894|NCT01804218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24767895|NCT01804218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24767896|NCT01804218|Sympatholytics|sympatholytics|mesh-ancestor
24767897|NCT01804218|Autonomic Agents|autonomic agents|mesh-ancestor
24767898|NCT01804218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24767900|NCT01804244|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24767901|NCT01804244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24767902|NCT01804244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202375|NCT02722083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398883|NCT00146042|Tubulin Modulators|tubulin modulators|mesh-ancestor
25080527|NCT03337607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25080528|NCT03337607|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25080529|NCT03337607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25080530|NCT03337607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25080531|NCT03337607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080532|NCT03337607|Anticonvulsants|anticonvulsants|mesh-ancestor
25080533|NCT03337607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25080534|NCT03337607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25080559|NCT03337529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768019|NCT01805232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24768020|NCT01805232|Analgesics|analgesics|mesh-ancestor
24768021|NCT01805232|Sensory System Agents|sensory system agents|mesh-ancestor
24768022|NCT01805258|Efavirenz|efavirenz|mesh-list
24768095|NCT01805726|Dexmedetomidine|dexmedetomidine|mesh-list
24768096|NCT01805726|Alfentanil|alfentanil|mesh-list
24399297|NCT00147355|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24768168|NCT01806116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24768169|NCT01806116|Antimetabolites|antimetabolites|mesh-ancestor
24768170|NCT01806116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768171|NCT01806116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768172|NCT01806116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24768173|NCT01806272|Vitamin B 12|vitamin b 12|mesh-list
24768174|NCT01806272|Hydroxocobalamin|hydroxocobalamin|mesh-list
24768175|NCT01806272|Vitamins|vitamins|mesh-ancestor
24768176|NCT01806272|Micronutrients|micronutrients|mesh-ancestor
24768177|NCT01806272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768178|NCT01806272|Vitamin B Complex|vitamin b complex|mesh-ancestor
24768179|NCT01806272|Hematinics|hematinics|mesh-ancestor
24768180|NCT01806311|Amlodipine|amlodipine|mesh-list
24768181|NCT01806311|Candesartan|candesartan|mesh-list
25663173|NCT01654601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663174|NCT01654601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768182|NCT01806311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24768183|NCT01806311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24399609|NCT00148265|Triamcinolone|triamcinolone|mesh-list
24399764|NCT00148564|Dopamine Agents|dopamine agents|mesh-ancestor
25080569|NCT03337503|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25080570|NCT03337503|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25080571|NCT03337503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25080572|NCT03337503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080573|NCT03337503|Hormones|hormones|mesh-ancestor
25080574|NCT03337503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25080575|NCT03337373|Cisatracurium|cisatracurium|mesh-list
25080596|NCT03337126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25080597|NCT03337126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25080598|NCT03337126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25080600|NCT03337035|Oxytocics|oxytocics|mesh-ancestor
25080601|NCT03337035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25080602|NCT03337035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080608|NCT03336970|Calcium|calcium|mesh-list
25080609|NCT03336970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25080610|NCT03336970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080611|NCT03336918|Lithium Carbonate|lithium carbonate|mesh-list
25080612|NCT03336918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080613|NCT03336918|Antidepressive Agents|antidepressive agents|mesh-ancestor
25016730|NCT04661137|Immunologic Factors|immunologic factors|mesh-ancestor
25016731|NCT04661137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25016732|NCT04661137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25016733|NCT04661137|Growth Substances|growth substances|mesh-ancestor
25016734|NCT04661137|Growth Inhibitors|growth inhibitors|mesh-ancestor
25016735|NCT04633889|Deferoxamine|deferoxamine|mesh-list
25016736|NCT04633889|Siderophores|siderophores|mesh-ancestor
25016737|NCT04633889|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25016738|NCT04633889|Chelating Agents|chelating agents|mesh-ancestor
25016757|NCT04509115|Analgesics, Opioid|analgesics, opioid|mesh-list
25080614|NCT03336918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25080615|NCT03336918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25080616|NCT03336918|Antimanic Agents|antimanic agents|mesh-ancestor
25080617|NCT03336918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25080618|NCT03336918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25080619|NCT03336918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768413|NCT01807910|Lipotropic Agents|lipotropic agents|mesh-ancestor
24768414|NCT01807910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24768415|NCT01807910|Antimetabolites|antimetabolites|mesh-ancestor
24768416|NCT01807910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080635|NCT03336840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24782945|NCT01899118|Antimetabolites|antimetabolites|mesh-ancestor
24768417|NCT01807910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24768418|NCT01807910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24768419|NCT01807910|Nootropic Agents|nootropic agents|mesh-ancestor
24768420|NCT01807962|Lidocaine|lidocaine|mesh-list
24768471|NCT01808495|Mitomycin|mitomycin|mesh-list
24768472|NCT01808495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24768473|NCT01808495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768474|NCT01808495|Alkylating Agents|alkylating agents|mesh-ancestor
24400145|NCT00149929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24768502|NCT01808586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24768503|NCT01808586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768504|NCT01808586|Anesthetics, Local|anesthetics, local|mesh-ancestor
24768505|NCT01808586|Anesthetics|anesthetics|mesh-ancestor
24768506|NCT01808586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25851815|NCT00054587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24768540|NCT01808898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24768542|NCT01808911|Rituximab|rituximab|mesh-list
24768543|NCT01808911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24768544|NCT01808911|Immunologic Factors|immunologic factors|mesh-ancestor
24768545|NCT01808911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768546|NCT01808911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24768547|NCT01808911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24768548|NCT01808911|Alkylating Agents|alkylating agents|mesh-ancestor
24400284|NCT00150280|Ibuprofen|ibuprofen|mesh-list
24768682|NCT01809886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24772412|NCT01833676|Sevoflurane|sevoflurane|mesh-list
24768683|NCT01809886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768858|NCT01810926|Immunologic Factors|immunologic factors|mesh-ancestor
25080659|NCT03336632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25080661|NCT03336632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080662|NCT03336632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24894467|NCT04440267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24768884|NCT01811056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237665|NCT02549469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25237666|NCT02549469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25237667|NCT02549469|Gout Suppressants|gout suppressants|mesh-ancestor
24768885|NCT01811056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24768886|NCT01811056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24768887|NCT01811056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24768896|NCT01811160|Melatonin|melatonin|mesh-list
25202376|NCT02722083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25202377|NCT02722096|Lidocaine|lidocaine|mesh-list
25202378|NCT02722096|Ropivacaine|ropivacaine|mesh-list
25202379|NCT02722096|Anesthetics|anesthetics|mesh-list
25202380|NCT02722096|Anesthetics, Local|anesthetics, local|mesh-ancestor
25202381|NCT02722096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25202382|NCT02722096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202383|NCT02722096|Sensory System Agents|sensory system agents|mesh-ancestor
25202384|NCT02722096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202385|NCT02722096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24768905|NCT01811251|Antiemetics|antiemetics|mesh-ancestor
24559892|NCT04128748|Daunorubicin|daunorubicin|mesh-list
24768926|NCT01811277|Oxaliplatin|oxaliplatin|mesh-list
24768927|NCT01811277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768928|NCT01811381|Curcumin|curcumin|mesh-list
24768929|NCT01811381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24768930|NCT01811381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24768931|NCT01811381|Analgesics|analgesics|mesh-ancestor
24768932|NCT01811381|Sensory System Agents|sensory system agents|mesh-ancestor
24768967|NCT01811667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768968|NCT01811667|Antifungal Agents|antifungal agents|mesh-ancestor
24768969|NCT01811667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24768970|NCT01811667|Immunologic Factors|immunologic factors|mesh-ancestor
24768971|NCT01811667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768972|NCT01811810|Androgens|androgens|mesh-list
24768973|NCT01811810|Hormones|hormones|mesh-ancestor
24768974|NCT01811810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24768975|NCT01811810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768977|NCT01811836|Trace Elements|trace elements|mesh-ancestor
24769016|NCT01812122|Protease Inhibitors|protease inhibitors|mesh-ancestor
24769017|NCT01812122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400859|NCT00151515|Minoxidil|minoxidil|mesh-list
24769129|NCT01812720|Antiemetics|antiemetics|mesh-ancestor
24769130|NCT01812720|Autonomic Agents|autonomic agents|mesh-ancestor
24400972|NCT00151801|Interferons|interferons|mesh-list
24769255|NCT01813552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769256|NCT01813552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24769257|NCT01813552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24769258|NCT01813552|Antiviral Agents|antiviral agents|mesh-ancestor
24681735|NCT01381640|Acetaminophen|acetaminophen|mesh-list
25081076|NCT03333083|Raltegravir Potassium|raltegravir potassium|mesh-list
24769259|NCT01813552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24483092|NCT00441740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483093|NCT00441740|Tubulin Modulators|tubulin modulators|mesh-ancestor
24483094|NCT00441740|Antimitotic Agents|antimitotic agents|mesh-ancestor
24483095|NCT00441740|Mitosis Modulators|mitosis modulators|mesh-ancestor
24483096|NCT00441740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24483143|NCT00442026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483144|NCT00442026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24483145|NCT00442026|Antiviral Agents|antiviral agents|mesh-ancestor
24769946|NCT01817153|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24769947|NCT01817153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24769948|NCT01817218|Anti-Infective Agents|anti-infective agents|mesh-list
24769949|NCT01817218|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24770169|NCT01818869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770171|NCT01818908|Cyclophosphamide|cyclophosphamide|mesh-list
24770172|NCT01818908|Doxorubicin|doxorubicin|mesh-list
24770240|NCT01819220|Telmisartan|telmisartan|mesh-list
24770241|NCT01819220|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
24770242|NCT01819220|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
24770244|NCT01819220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24770245|NCT01819220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24770246|NCT01819220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770247|NCT01819220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24770248|NCT01819220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770249|NCT01819220|Vasodilator Agents|vasodilator agents|mesh-ancestor
25663175|NCT01654601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25663176|NCT01654601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25663177|NCT01654601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25005709|NCT02817659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25005710|NCT02817659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708150|NCT01500161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24708151|NCT01500161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24708152|NCT01500161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24708154|NCT01500161|Antiviral Agents|antiviral agents|mesh-ancestor
24708155|NCT01500161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24708156|NCT01500161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25237704|NCT02549105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25237705|NCT02549105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25237706|NCT02549105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237707|NCT02549105|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25237708|NCT02549001|Amorolfine|amorolfine|mesh-list
25237709|NCT02549001|Antifungal Agents|antifungal agents|mesh-ancestor
25237710|NCT02549001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24772413|NCT01833676|Desflurane|desflurane|mesh-list
24770380|NCT01820091|Protective Agents|protective agents|mesh-ancestor
24402172|NCT00155272|Thalidomide|thalidomide|mesh-list
24681807|NCT01382134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24681808|NCT01382134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24681812|NCT01382134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770470|NCT01820767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24483265|NCT00442546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24771261|NCT01825603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24771263|NCT01825603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771264|NCT01825616|Vitamin D|vitamin d|mesh-list
24771265|NCT01825616|Ergocalciferols|ergocalciferols|mesh-list
24771266|NCT01825616|Vitamins|vitamins|mesh-ancestor
24771267|NCT01825616|Micronutrients|micronutrients|mesh-ancestor
24771268|NCT01825616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771269|NCT01825616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24771270|NCT01825616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24771271|NCT01825720|Insulin|insulin|mesh-list
24771272|NCT01825720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24771273|NCT01825720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771274|NCT01825733|Palonosetron|palonosetron|mesh-list
24771275|NCT01825733|Ramosetron|ramosetron|mesh-list
24771312|NCT01825928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24771313|NCT01825928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24771314|NCT01825928|Dopamine Agents|dopamine agents|mesh-ancestor
24771516|NCT01827722|Dexamethasone|dexamethasone|mesh-list
24771517|NCT01827722|Dexamethasone acetate|dexamethasone acetate|mesh-list
24771518|NCT01827722|Ranibizumab|ranibizumab|mesh-list
24771519|NCT01827722|BB 1101|bb 1101|mesh-list
24771664|NCT01828606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771691|NCT01828788|Ropivacaine|ropivacaine|mesh-list
24771692|NCT01828788|Anesthetics, Local|anesthetics, local|mesh-ancestor
24771693|NCT01828788|Anesthetics|anesthetics|mesh-ancestor
24771694|NCT01828788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24771695|NCT01828788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771696|NCT01828788|Sensory System Agents|sensory system agents|mesh-ancestor
24771697|NCT01828788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24771698|NCT01828879|Tacrolimus|tacrolimus|mesh-list
24562970|NCT00769171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24562971|NCT00769171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562972|NCT00769171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562973|NCT00769171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24404102|NCT00162552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771811|NCT01829893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663178|NCT01654601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25663179|NCT01654601|GABA Antagonists|gaba antagonists|mesh-ancestor
25663180|NCT01654601|GABA Agents|gaba agents|mesh-ancestor
25663181|NCT01654861|Ascorbic Acid|ascorbic acid|mesh-list
25663182|NCT01654861|Gemcitabine|gemcitabine|mesh-list
25663183|NCT01654861|Vitamins|vitamins|mesh-ancestor
25663184|NCT01654861|Micronutrients|micronutrients|mesh-ancestor
25663185|NCT01654861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663186|NCT01654861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25663187|NCT01654861|Antimetabolites|antimetabolites|mesh-ancestor
25663188|NCT01654861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663189|NCT01654861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663190|NCT01654861|Antiviral Agents|antiviral agents|mesh-ancestor
25663191|NCT01654861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25663192|NCT01654861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663193|NCT01654861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25663194|NCT01654861|Immunologic Factors|immunologic factors|mesh-ancestor
25663195|NCT01654861|Antioxidants|antioxidants|mesh-ancestor
25237728|NCT02548923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237730|NCT02549118|Meperidine|meperidine|mesh-list
25237731|NCT02549118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25237732|NCT02549118|Narcotics|narcotics|mesh-ancestor
25237733|NCT02549118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25237734|NCT02549118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237735|NCT02549118|Analgesics|analgesics|mesh-ancestor
25237736|NCT02549118|Sensory System Agents|sensory system agents|mesh-ancestor
25237758|NCT02549066|Milrinone|milrinone|mesh-list
24771813|NCT01829893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24771815|NCT01830101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24771816|NCT01830101|Alkylating Agents|alkylating agents|mesh-ancestor
24771817|NCT01830101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080971|NCT03334136|Calcifediol|calcifediol|mesh-list
25080972|NCT03334136|Vitamins|vitamins|mesh-ancestor
24967073|NCT03763045|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24967075|NCT03763045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24967076|NCT03763045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967077|NCT03763045|Urological Agents|urological agents|mesh-ancestor
24793040|NCT04270175|Growth Substances|growth substances|mesh-ancestor
25081008|NCT03333824|Serotonin Agents|serotonin agents|mesh-ancestor
24404191|NCT00162721|Doxorubicin|doxorubicin|mesh-list
24404582|NCT00164112|Azithromycin|azithromycin|mesh-list
24772204|NCT01832350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24772205|NCT01832350|Antimalarials|antimalarials|mesh-ancestor
24772206|NCT01832350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24772207|NCT01832350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24772208|NCT01832350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24772209|NCT01832350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772210|NCT01832350|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24772211|NCT01832350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24772212|NCT01832350|Cholinergic Agents|cholinergic agents|mesh-ancestor
24564195|NCT00775580|Sympatholytics|sympatholytics|mesh-ancestor
24772213|NCT01832350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24772214|NCT01832350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24772215|NCT01832350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24772216|NCT01832350|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24772318|NCT01832948|Micronutrients|micronutrients|mesh-ancestor
24772319|NCT01832948|Hematinics|hematinics|mesh-ancestor
24772320|NCT01832948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24563502|NCT00772122|Immunologic Factors|immunologic factors|mesh-ancestor
24772321|NCT01832948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24772322|NCT01832948|Growth Substances|growth substances|mesh-ancestor
24772323|NCT01832948|Growth Inhibitors|growth inhibitors|mesh-ancestor
24772324|NCT01832987|Trimethoprim|trimethoprim|mesh-list
24772325|NCT01832987|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24772326|NCT01832987|Sulfamethoxazole|sulfamethoxazole|mesh-list
24772327|NCT01832987|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24967103|NCT03762928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25851816|NCT00054587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25851817|NCT00054587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25851818|NCT00054587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25017049|NCT02902757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017050|NCT02902757|Antimetabolites|antimetabolites|mesh-ancestor
25017051|NCT02902757|Antiviral Agents|antiviral agents|mesh-ancestor
25017052|NCT02902757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25017053|NCT02668822|Ibuprofen|ibuprofen|mesh-list
25017054|NCT02668822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25017055|NCT02668822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25017056|NCT02668822|Analgesics|analgesics|mesh-ancestor
25017057|NCT02668822|Sensory System Agents|sensory system agents|mesh-ancestor
24483436|NCT00443508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24483437|NCT00443508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663196|NCT01654861|Protective Agents|protective agents|mesh-ancestor
25663197|NCT01655043|Regadenoson|regadenoson|mesh-list
25663198|NCT01655043|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25663199|NCT01655043|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25663200|NCT01655043|Purinergic Agonists|purinergic agonists|mesh-ancestor
25663201|NCT01655043|Purinergic Agents|purinergic agents|mesh-ancestor
25663202|NCT01655043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25663203|NCT01655043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663204|NCT01655043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422527|NCT02446457|Growth Inhibitors|growth inhibitors|mesh-ancestor
25851819|NCT00054587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24613913|NCT01021579|Antimetabolites|antimetabolites|mesh-ancestor
24613914|NCT01021579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613915|NCT01021579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24613946|NCT01021735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613947|NCT01021735|Immunologic Factors|immunologic factors|mesh-ancestor
24613948|NCT01021735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613949|NCT01021735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24613950|NCT01021735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24613951|NCT01021735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24613952|NCT01021735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24613953|NCT01021735|Analgesics|analgesics|mesh-ancestor
24708260|NCT01500850|Insulin|insulin|mesh-list
24708331|NCT01501123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24708332|NCT01501123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24483438|NCT00443508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483440|NCT00443521|Triamcinolone|triamcinolone|mesh-list
24483468|NCT00443612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24483469|NCT00443690|Rolofylline|rolofylline|mesh-list
24967119|NCT03762785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24967120|NCT03762785|Analgesics|analgesics|mesh-ancestor
24967121|NCT03762785|Sensory System Agents|sensory system agents|mesh-ancestor
24967122|NCT03762785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24787048|NCT01923376|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24772362|NCT01833299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772363|NCT01833299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24772364|NCT01833312|Meperidine|meperidine|mesh-list
24772365|NCT01833312|Buspirone|buspirone|mesh-list
24772366|NCT01833312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24772367|NCT01833312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24772368|NCT01833312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24772369|NCT01833312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772386|NCT01833351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081068|NCT03333278|Micronutrients|micronutrients|mesh-ancestor
25081069|NCT03333278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081070|NCT03333278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25081071|NCT03333278|Antioxidants|antioxidants|mesh-ancestor
25081072|NCT03333278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081073|NCT03333278|Protective Agents|protective agents|mesh-ancestor
25081074|NCT03333278|Vitamin B Complex|vitamin b complex|mesh-ancestor
25081075|NCT03333083|Lamivudine|lamivudine|mesh-list
25081077|NCT03333083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25081078|NCT03333083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25081079|NCT03333083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25081080|NCT03333083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081081|NCT03333083|Antiviral Agents|antiviral agents|mesh-ancestor
25081082|NCT03333083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25081083|NCT03333083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25081084|NCT03333083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25081085|NCT03333083|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25081086|NCT03333083|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24772405|NCT01833663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772406|NCT01833663|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24772407|NCT01833663|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24772408|NCT01833663|Cholinergic Agents|cholinergic agents|mesh-ancestor
24772409|NCT01833663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24772410|NCT01833663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772411|NCT01833663|Urological Agents|urological agents|mesh-ancestor
24772421|NCT01833715|Methadone|methadone|mesh-list
25422528|NCT02445651|Acetylcysteine|acetylcysteine|mesh-list
25663205|NCT01655069|Solifenacin Succinate|solifenacin succinate|mesh-list
25663206|NCT01655069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25663207|NCT01655069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25663208|NCT01655069|Cholinergic Agents|cholinergic agents|mesh-ancestor
25663209|NCT01655069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25663210|NCT01655069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663211|NCT01655069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663212|NCT01655069|Urological Agents|urological agents|mesh-ancestor
25663213|NCT01655563|Tacrolimus|tacrolimus|mesh-list
25663214|NCT01655563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25663215|NCT01655563|Immunologic Factors|immunologic factors|mesh-ancestor
25062259|NCT05038228|Antithrombins|antithrombins|mesh-ancestor
25663216|NCT01655563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663217|NCT01655563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25663218|NCT01655563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202386|NCT02722096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25202387|NCT02722096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25202388|NCT02722096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25202389|NCT02722096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202390|NCT02721940|Zoledronic Acid|zoledronic acid|mesh-list
25202391|NCT02721940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25202392|NCT02721940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202393|NCT02721862|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24772422|NCT01833715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24681958|NCT01383330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25017118|NCT02489942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017119|NCT02489942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24772465|NCT01833793|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24772467|NCT01833819|Dexmedetomidine|dexmedetomidine|mesh-list
24772468|NCT01833819|Remifentanil|remifentanil|mesh-list
24772469|NCT01833819|Anesthetics, Local|anesthetics, local|mesh-ancestor
24772470|NCT01833819|Anesthetics|anesthetics|mesh-ancestor
24772471|NCT01833819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24772472|NCT01833819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772473|NCT01833819|Sensory System Agents|sensory system agents|mesh-ancestor
24772503|NCT01834014|Growth Inhibitors|growth inhibitors|mesh-ancestor
24772504|NCT01834014|Antimetabolites|antimetabolites|mesh-ancestor
24772505|NCT01834014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772515|NCT01834170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24772516|NCT01834170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772517|NCT01834170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24772518|NCT01834170|Immunologic Factors|immunologic factors|mesh-ancestor
24772519|NCT01834170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772520|NCT01834183|Gemcitabine|gemcitabine|mesh-list
24772521|NCT01834183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24772522|NCT01834183|Antimetabolites|antimetabolites|mesh-ancestor
24772523|NCT01834183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772524|NCT01834183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772525|NCT01834183|Antiviral Agents|antiviral agents|mesh-ancestor
24772526|NCT01834183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24772527|NCT01834183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772528|NCT01834183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24772530|NCT01834183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772532|NCT01834209|Prednisolone|prednisolone|mesh-list
24772533|NCT01834209|Abiraterone Acetate|abiraterone acetate|mesh-list
24772534|NCT01834209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24772535|NCT01834209|Glucocorticoids|glucocorticoids|mesh-ancestor
24772536|NCT01834209|Hormones|hormones|mesh-ancestor
24772537|NCT01834209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24772538|NCT01834209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772539|NCT01834209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24772540|NCT01834209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772541|NCT01834209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24772542|NCT01834209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772543|NCT01834209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772612|NCT01834768|Natriuretic Agents|natriuretic agents|mesh-ancestor
25851820|NCT00054587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772651|NCT01834885|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24772692|NCT01834989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851821|NCT00054600|Methoxsalen|methoxsalen|mesh-list
24967127|NCT03762785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24967128|NCT03762785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202398|NCT02721888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202399|NCT02721888|Incretins|incretins|mesh-ancestor
25202400|NCT02721888|Hormones|hormones|mesh-ancestor
25081096|NCT03333018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25081097|NCT03333018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25081098|NCT03333018|Adrenergic Agents|adrenergic agents|mesh-ancestor
25081099|NCT03333018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25081100|NCT03333018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081101|NCT03333018|Anticonvulsants|anticonvulsants|mesh-ancestor
24967151|NCT03762382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24772709|NCT01835184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624648|NCT01077505|rGLP-1 protein|rglp-1 protein|mesh-list
24772711|NCT01835197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24772712|NCT01835197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682219|NCT01384812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24772713|NCT01835197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772715|NCT01835236|Vinorelbine|vinorelbine|mesh-list
24772716|NCT01835236|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24772717|NCT01835236|Trastuzumab|trastuzumab|mesh-list
24772719|NCT01835236|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24772720|NCT01835236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772721|NCT01835236|Tubulin Modulators|tubulin modulators|mesh-ancestor
24772722|NCT01835236|Antimitotic Agents|antimitotic agents|mesh-ancestor
24772723|NCT01835236|Mitosis Modulators|mitosis modulators|mesh-ancestor
24772744|NCT01835418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24772745|NCT01835418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772746|NCT01835418|Vasodilator Agents|vasodilator agents|mesh-ancestor
24772748|NCT01835561|Pomalidomide|pomalidomide|mesh-list
24772749|NCT01835561|Immunologic Factors|immunologic factors|mesh-ancestor
24772750|NCT01835561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772751|NCT01835561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24772752|NCT01835561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24772753|NCT01835561|Growth Substances|growth substances|mesh-ancestor
24772754|NCT01835561|Growth Inhibitors|growth inhibitors|mesh-ancestor
24772755|NCT01835561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772756|NCT01835561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24772757|NCT01835561|Leprostatic Agents|leprostatic agents|mesh-ancestor
24772758|NCT01835561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24772759|NCT01835561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24772760|NCT01835639|Vitamin D|vitamin d|mesh-list
24772761|NCT01835639|Cholecalciferol|cholecalciferol|mesh-list
24772762|NCT01835639|Vitamins|vitamins|mesh-ancestor
24772763|NCT01835639|Micronutrients|micronutrients|mesh-ancestor
24772764|NCT01835639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772765|NCT01835639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24772766|NCT01835639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24772826|NCT01836094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772827|NCT01836094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772829|NCT01836120|Raltitrexed|raltitrexed|mesh-list
24772830|NCT01836120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772831|NCT01836120|Tubulin Modulators|tubulin modulators|mesh-ancestor
24772832|NCT01836120|Antimitotic Agents|antimitotic agents|mesh-ancestor
24772833|NCT01836120|Mitosis Modulators|mitosis modulators|mesh-ancestor
24772834|NCT01836120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772836|NCT01836120|Antimetabolites|antimetabolites|mesh-ancestor
24772837|NCT01836120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24772838|NCT01836120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772839|NCT01836224|Terlipressin|terlipressin|mesh-list
24772840|NCT01836224|Norepinephrine|norepinephrine|mesh-list
25207725|NCT03462069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24772841|NCT01836224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25207726|NCT03462069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207727|NCT03462069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25207728|NCT03462069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207729|NCT03462017|Sildenafil Citrate|sildenafil citrate|mesh-list
25207731|NCT03462017|Vasodilator Agents|vasodilator agents|mesh-ancestor
25207732|NCT03462017|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25207733|NCT03462017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25017303|NCT01670656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24772842|NCT01836224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24772843|NCT01836224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24772844|NCT01836224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24772845|NCT01836224|Adrenergic Agents|adrenergic agents|mesh-ancestor
24772846|NCT01836224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24772847|NCT01836224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772848|NCT01836224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772849|NCT01836224|Sympathomimetics|sympathomimetics|mesh-ancestor
24772850|NCT01836224|Autonomic Agents|autonomic agents|mesh-ancestor
24772851|NCT01836224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24772852|NCT01836289|Cyclophosphamide|cyclophosphamide|mesh-list
24772853|NCT01836289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24772854|NCT01836289|Immunologic Factors|immunologic factors|mesh-ancestor
24772855|NCT01836289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772856|NCT01836289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24772857|NCT01836289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24772858|NCT01836289|Alkylating Agents|alkylating agents|mesh-ancestor
24772860|NCT01836289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24564094|NCT00775086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25237871|NCT02548533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25237875|NCT02548533|Mydriatics|mydriatics|mesh-ancestor
24564096|NCT00775086|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24620700|NCT01058317|Adrenergic Agents|adrenergic agents|mesh-ancestor
24620701|NCT01058317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24620702|NCT01058317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620710|NCT01058382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24620711|NCT01058382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081103|NCT03332953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24772873|NCT01836341|Carboplatin|carboplatin|mesh-list
24772875|NCT01836341|Afatinib|afatinib|mesh-list
24772876|NCT01836341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772877|NCT01836341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772878|NCT01836341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772879|NCT01836341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24772880|NCT01836341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24772881|NCT01836341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24772882|NCT01836406|Ketorolac|ketorolac|mesh-list
24772883|NCT01836406|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24772884|NCT01836406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24772885|NCT01836406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24772887|NCT01836406|Sensory System Agents|sensory system agents|mesh-ancestor
24772888|NCT01836406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24772889|NCT01836406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772890|NCT01836406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24405334|NCT00166491|Insulin|insulin|mesh-list
24772929|NCT01836653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24772930|NCT01836653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772931|NCT01836653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24772932|NCT01836653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24772933|NCT01836653|Growth Substances|growth substances|mesh-ancestor
24772934|NCT01836653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772935|NCT01836653|Growth Inhibitors|growth inhibitors|mesh-ancestor
24484014|NCT00446173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772951|NCT01836822|Dimercaprol|dimercaprol|mesh-list
24772952|NCT01836822|Chelating Agents|chelating agents|mesh-ancestor
24772953|NCT01836822|Sequestering Agents|sequestering agents|mesh-ancestor
24772954|NCT01836822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772956|NCT01836900|Coagulants|coagulants|mesh-ancestor
24772957|NCT01837043|Cyclosporine|cyclosporine|mesh-list
24772958|NCT01837043|Abatacept|abatacept|mesh-list
24772959|NCT01837043|Tacrolimus|tacrolimus|mesh-list
24772961|NCT01837043|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
24772962|NCT01837043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24772963|NCT01837043|Immunologic Factors|immunologic factors|mesh-ancestor
24772964|NCT01837043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772965|NCT01837043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772966|NCT01837043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772967|NCT01837043|Antifungal Agents|antifungal agents|mesh-ancestor
24772968|NCT01837043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24772969|NCT01837043|Dermatologic Agents|dermatologic agents|mesh-ancestor
24772970|NCT01837043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25207734|NCT03462017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772971|NCT01837043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24773022|NCT01837290|GABA Agents|gaba agents|mesh-ancestor
24773023|NCT01837329|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
24773024|NCT01837329|Chelating Agents|chelating agents|mesh-ancestor
24564177|NCT00775489|Beclomethasone|beclomethasone|mesh-list
24773025|NCT01837329|Sequestering Agents|sequestering agents|mesh-ancestor
24773026|NCT01837329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773027|NCT01837329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773028|NCT01837329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24773035|NCT01837394|Morphine|morphine|mesh-list
24773036|NCT01837394|Ondansetron|ondansetron|mesh-list
24773037|NCT01837394|Metoclopramide|metoclopramide|mesh-list
24773038|NCT01837394|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24773039|NCT01837394|Narcotics|narcotics|mesh-ancestor
24773040|NCT01837394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24773041|NCT01837394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773042|NCT01837394|Analgesics|analgesics|mesh-ancestor
24773043|NCT01837394|Sensory System Agents|sensory system agents|mesh-ancestor
24773044|NCT01837394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773079|NCT01837446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25663219|NCT01655563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663220|NCT01655693|Doxorubicin|doxorubicin|mesh-list
25237887|NCT02548403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237888|NCT02548403|Emollients|emollients|mesh-ancestor
25237889|NCT02548403|Dermatologic Agents|dermatologic agents|mesh-ancestor
25237896|NCT02548117|Finasteride|finasteride|mesh-list
25237897|NCT02548117|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25237918|NCT02548286|Amlodipine|amlodipine|mesh-list
24773080|NCT01837446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773081|NCT01837446|Sensory System Agents|sensory system agents|mesh-ancestor
24773082|NCT01837446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773083|NCT01837446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24773084|NCT01837446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24773085|NCT01837446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24773086|NCT01837446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24773087|NCT01837446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773088|NCT01837446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24773089|NCT01837446|Narcotics|narcotics|mesh-ancestor
24773090|NCT01837446|Analgesics|analgesics|mesh-ancestor
24773091|NCT01837446|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24773092|NCT01837446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24773093|NCT01837446|Antiemetics|antiemetics|mesh-ancestor
24773094|NCT01837446|Autonomic Agents|autonomic agents|mesh-ancestor
24773095|NCT01837446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24773096|NCT01837446|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24773097|NCT01837446|Histamine Antagonists|histamine antagonists|mesh-ancestor
24773098|NCT01837446|Histamine Agents|histamine agents|mesh-ancestor
24773099|NCT01837446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24773100|NCT01837446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24484071|NCT00446420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484072|NCT00446433|Lenalidomide|lenalidomide|mesh-list
25851822|NCT00054600|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25851823|NCT00054600|Dermatologic Agents|dermatologic agents|mesh-ancestor
25851824|NCT00054613|Methoxsalen|methoxsalen|mesh-list
25851825|NCT00054613|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24854834|NCT02275897|Methamphetamine|methamphetamine|mesh-list
24484074|NCT00446433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484075|NCT00446433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24484076|NCT00446433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24484077|NCT00446433|Growth Substances|growth substances|mesh-ancestor
24484078|NCT00446433|Growth Inhibitors|growth inhibitors|mesh-ancestor
24484079|NCT00446433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484080|NCT00446472|Becaplermin|becaplermin|mesh-list
24484081|NCT00446472|Anticoagulants|anticoagulants|mesh-ancestor
24484082|NCT00446472|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
25081170|NCT03332602|Cholinergic Agents|cholinergic agents|mesh-ancestor
25081171|NCT03332602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25081172|NCT03332602|Urological Agents|urological agents|mesh-ancestor
25081173|NCT03332576|Cyclophosphamide|cyclophosphamide|mesh-list
25081174|NCT03332576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25081175|NCT03332576|Immunologic Factors|immunologic factors|mesh-ancestor
25081176|NCT03332576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081177|NCT03332576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25081178|NCT03332576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25081179|NCT03332576|Alkylating Agents|alkylating agents|mesh-ancestor
25081180|NCT03332576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081181|NCT03332576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081182|NCT03332576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25081183|NCT03332524|Chlorpheniramine|chlorpheniramine|mesh-list
24773417|NCT01839552|Analgesics|analgesics|mesh-ancestor
24773112|NCT01837498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773113|NCT01837498|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24773114|NCT01837498|Autonomic Agents|autonomic agents|mesh-ancestor
24773115|NCT01837498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773117|NCT01837576|Dermatologic Agents|dermatologic agents|mesh-ancestor
24773118|NCT01837628|Lidocaine|lidocaine|mesh-list
24773119|NCT01837628|Mineral Oil|mineral oil|mesh-list
24773120|NCT01837628|Anesthetics, Local|anesthetics, local|mesh-ancestor
24773121|NCT01837628|Anesthetics|anesthetics|mesh-ancestor
24773122|NCT01837628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24773123|NCT01837628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422529|NCT02445651|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25663221|NCT01655693|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25663222|NCT01655693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25663223|NCT01655693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663224|NCT01655693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25663225|NCT01655693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25851826|NCT00054613|Dermatologic Agents|dermatologic agents|mesh-ancestor
24773124|NCT01837628|Sensory System Agents|sensory system agents|mesh-ancestor
24773160|NCT01837927|Respiratory System Agents|respiratory system agents|mesh-ancestor
24773161|NCT01837927|Parasympatholytics|parasympatholytics|mesh-ancestor
24773162|NCT01837927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24773163|NCT01837927|Cholinergic Agents|cholinergic agents|mesh-ancestor
24773164|NCT01837927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24773165|NCT01837927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773166|NCT01837927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24773167|NCT01837927|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24773168|NCT01837992|Primaquine|primaquine|mesh-list
24773169|NCT01837992|Antimalarials|antimalarials|mesh-ancestor
24773170|NCT01837992|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24773212|NCT01838460|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24773213|NCT01838460|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24773214|NCT01838460|Cholinergic Agents|cholinergic agents|mesh-ancestor
24405515|NCT00167492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773257|NCT01838707|Sensory System Agents|sensory system agents|mesh-ancestor
24773258|NCT01838707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773259|NCT01838707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24773260|NCT01838707|Narcotics|narcotics|mesh-ancestor
24773261|NCT01838707|Analgesics|analgesics|mesh-ancestor
24773300|NCT01838993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773301|NCT01839032|Vinorelbine|vinorelbine|mesh-list
24773302|NCT01839032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24773303|NCT01839032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24773304|NCT01839032|Tubulin Modulators|tubulin modulators|mesh-ancestor
24773305|NCT01839032|Antimitotic Agents|antimitotic agents|mesh-ancestor
24773308|NCT01839084|Isoflurane|isoflurane|mesh-list
24773314|NCT01839097|Prednisone|prednisone|mesh-list
24773315|NCT01839097|Cyclophosphamide|cyclophosphamide|mesh-list
24773316|NCT01839097|Doxorubicin|doxorubicin|mesh-list
24773317|NCT01839097|Vincristine|vincristine|mesh-list
24773318|NCT01839097|Belinostat|belinostat|mesh-list
24773319|NCT01839097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24773320|NCT01839097|Immunologic Factors|immunologic factors|mesh-ancestor
24773321|NCT01839097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773322|NCT01839097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24620720|NCT01058577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24620721|NCT01058577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620722|NCT01058720|Vitamin D|vitamin d|mesh-list
24620723|NCT01058720|Cholecalciferol|cholecalciferol|mesh-list
24620724|NCT01058720|Vitamins|vitamins|mesh-ancestor
24620725|NCT01058720|Micronutrients|micronutrients|mesh-ancestor
24620726|NCT01058720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620727|NCT01058720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24620728|NCT01058720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24773333|NCT01839097|Glucocorticoids|glucocorticoids|mesh-ancestor
24773334|NCT01839097|Hormones|hormones|mesh-ancestor
24773335|NCT01839097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24773336|NCT01839097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24773337|NCT01839097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24773338|NCT01839097|Tubulin Modulators|tubulin modulators|mesh-ancestor
24773339|NCT01839097|Antimitotic Agents|antimitotic agents|mesh-ancestor
24773340|NCT01839097|Mitosis Modulators|mitosis modulators|mesh-ancestor
24773341|NCT01839097|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24773342|NCT01839149|Oxytocin|oxytocin|mesh-list
24773370|NCT01839253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24773371|NCT01839253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24773372|NCT01839253|Sympatholytics|sympatholytics|mesh-ancestor
24773373|NCT01839253|Autonomic Agents|autonomic agents|mesh-ancestor
24773374|NCT01839253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773375|NCT01839253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081186|NCT03332524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24773414|NCT01839552|Narcotics|narcotics|mesh-ancestor
24773415|NCT01839552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24773416|NCT01839552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773418|NCT01839552|Sensory System Agents|sensory system agents|mesh-ancestor
24773419|NCT01839552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773420|NCT01839552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24773421|NCT01839552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24773469|NCT01839851|Glucocorticoids|glucocorticoids|mesh-list
25851827|NCT00054626|Gemcitabine|gemcitabine|mesh-list
24788175|NCT01929941|Antimitotic Agents|antimitotic agents|mesh-ancestor
24773473|NCT01839864|Chrysarobin|chrysarobin|mesh-list
24773474|NCT01839864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24773475|NCT01839864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24773476|NCT01839864|Analgesics|analgesics|mesh-ancestor
25237964|NCT02547792|Immunologic Factors|immunologic factors|mesh-ancestor
25237965|NCT02547792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237967|NCT02547870|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25237968|NCT02547870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25237969|NCT02547870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565553|NCT00781157|Adrenergic Agents|adrenergic agents|mesh-ancestor
24773478|NCT01839864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773479|NCT01839864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773480|NCT01839864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24773483|NCT01839890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24773484|NCT01839890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24773485|NCT01839890|Tubulin Modulators|tubulin modulators|mesh-ancestor
24773486|NCT01839890|Antimitotic Agents|antimitotic agents|mesh-ancestor
24773487|NCT01839890|Mitosis Modulators|mitosis modulators|mesh-ancestor
24773539|NCT01840254|Dexmedetomidine|dexmedetomidine|mesh-list
24773540|NCT01840254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24773541|NCT01840254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25081213|NCT03332316|Dexamethasone|dexamethasone|mesh-list
24773542|NCT01840254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773543|NCT01840254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24773544|NCT01840254|Analgesics|analgesics|mesh-ancestor
24773625|NCT01841099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773626|NCT01841099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24773627|NCT01841099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24773628|NCT01841112|BI 409306|bi 409306|mesh-list
24773629|NCT01841112|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24773630|NCT01841112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773631|NCT01841112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773632|NCT01841125|Citalopram|citalopram|mesh-list
24773633|NCT01841125|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24773634|NCT01841125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24773713|NCT01841424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967288|NCT03760848|GABA Modulators|gaba modulators|mesh-ancestor
24967290|NCT03760848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24967291|NCT03760822|Paclitaxel|paclitaxel|mesh-list
24967292|NCT03760822|Ramucirumab|ramucirumab|mesh-list
24682702|NCT01388049|Immunologic Factors|immunologic factors|mesh-ancestor
24967293|NCT03760822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24967294|NCT03760822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967295|NCT03760822|Tubulin Modulators|tubulin modulators|mesh-ancestor
24967296|NCT03760822|Antimitotic Agents|antimitotic agents|mesh-ancestor
24967297|NCT03760822|Mitosis Modulators|mitosis modulators|mesh-ancestor
24405788|NCT00168415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24773781|NCT01842087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24773782|NCT01842100|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24773783|NCT01842100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24773784|NCT01842113|Rifaximin|rifaximin|mesh-list
24773785|NCT01842113|Lactulose|lactulose|mesh-list
24565110|NCT00778752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24565111|NCT00778752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24565112|NCT00778752|Growth Substances|growth substances|mesh-ancestor
24565113|NCT00778752|Growth Inhibitors|growth inhibitors|mesh-ancestor
24565114|NCT00778752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24620729|NCT01058759|Enoxaparin|enoxaparin|mesh-list
24620730|NCT01058759|Enoxaparin sodium|enoxaparin sodium|mesh-list
24620731|NCT01058759|Anticoagulants|anticoagulants|mesh-ancestor
24620732|NCT01058759|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24620733|NCT01058759|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24620765|NCT01058902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620767|NCT01058902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24620768|NCT01058902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620769|NCT01058902|Antipyretics|antipyretics|mesh-ancestor
24620770|NCT01058915|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24620771|NCT01058915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24620772|NCT01058915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24620773|NCT01058915|Antimetabolites|antimetabolites|mesh-ancestor
25663226|NCT01655693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663227|NCT01655693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663228|NCT01655719|Pioglitazone|pioglitazone|mesh-list
25663229|NCT01655719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25663230|NCT01655719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663231|NCT01655823|Tetrodotoxin|tetrodotoxin|mesh-list
25663232|NCT01655823|Anesthetics, Local|anesthetics, local|mesh-ancestor
25422530|NCT02445651|Antiviral Agents|antiviral agents|mesh-ancestor
24620774|NCT01058915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620775|NCT01058915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24773823|NCT01842230|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24773854|NCT01842269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773877|NCT01842373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773878|NCT01842516|Delpazolid|delpazolid|mesh-list
24773879|NCT01842516|Oxazolidinones|oxazolidinones|mesh-list
24773880|NCT01842516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24773890|NCT01842529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24773891|NCT01842529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773893|NCT01842672|Clofarabine|clofarabine|mesh-list
24773894|NCT01842672|Analgesics|analgesics|mesh-ancestor
24773895|NCT01842672|Sensory System Agents|sensory system agents|mesh-ancestor
24773896|NCT01842672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773897|NCT01842672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773898|NCT01842672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24773899|NCT01842672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24773900|NCT01842672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24773901|NCT01842672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773902|NCT01842672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773903|NCT01842672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24773904|NCT01842672|Antimetabolites|antimetabolites|mesh-ancestor
24773906|NCT01842893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24773907|NCT01842893|Narcotics|narcotics|mesh-ancestor
24773908|NCT01842893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24773909|NCT01842893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773910|NCT01842893|Analgesics|analgesics|mesh-ancestor
25081244|NCT03332069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081245|NCT03332017|Obinutuzumab|obinutuzumab|mesh-list
25081246|NCT03332017|Zanubrutinib|zanubrutinib|mesh-list
25081247|NCT03332017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25081248|NCT03332017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081249|NCT03332017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25081251|NCT03332017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081252|NCT03331913|Botulinum Toxins|botulinum toxins|mesh-list
25081253|NCT03331913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24774062|NCT01843647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24774063|NCT01843647|Tubulin Modulators|tubulin modulators|mesh-ancestor
24774124|NCT01843868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24774125|NCT01843868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202401|NCT02721888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25202402|NCT02721511|Furosemide|furosemide|mesh-list
24774126|NCT01843868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24774129|NCT01843868|Mitosis Modulators|mitosis modulators|mesh-ancestor
24774130|NCT01843868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24774133|NCT01843868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24774134|NCT01843868|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24774135|NCT01843868|Autonomic Agents|autonomic agents|mesh-ancestor
24774136|NCT01843868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24774137|NCT01843868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24774138|NCT01843868|Antipruritics|antipruritics|mesh-ancestor
24774139|NCT01843868|Dermatologic Agents|dermatologic agents|mesh-ancestor
24774140|NCT01843868|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24774141|NCT01843868|Serotonin Agents|serotonin agents|mesh-ancestor
24774142|NCT01843868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24774143|NCT01843868|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24774144|NCT01843868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24774170|NCT01844024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774171|NCT01844024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24774172|NCT01844024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24774173|NCT01844024|Oxytocics|oxytocics|mesh-ancestor
24774174|NCT01844063|Antiviral Agents|antiviral agents|mesh-list
24774175|NCT01844063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24774176|NCT01844141|Ethanol|ethanol|mesh-list
24774177|NCT01844141|Chlorhexidine|chlorhexidine|mesh-list
24774178|NCT01844141|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24565394|NCT00780104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24565395|NCT00780104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774179|NCT01844141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24774180|NCT01844141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25081267|NCT03331770|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24774181|NCT01844141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25238028|NCT02547402|Antimetabolites|antimetabolites|mesh-ancestor
25238029|NCT02547402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238030|NCT02547402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24565465|NCT00780650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565467|NCT00780728|Vasodilator Agents|vasodilator agents|mesh-ancestor
24774234|NCT01844648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774235|NCT01844648|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24774236|NCT01844648|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24774237|NCT01844648|Cholinergic Agents|cholinergic agents|mesh-ancestor
24774238|NCT01844648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24774239|NCT01844648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774240|NCT01844674|Vemurafenib|vemurafenib|mesh-list
24774242|NCT01844674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774243|NCT01844674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24774244|NCT01844674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774245|NCT01844674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774246|NCT01844674|Analgesics|analgesics|mesh-ancestor
24774247|NCT01844674|Sensory System Agents|sensory system agents|mesh-ancestor
24774359|NCT01845194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24774360|NCT01845194|Antimetabolites|antimetabolites|mesh-ancestor
24774361|NCT01845194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24774362|NCT01845194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24565572|NCT00781287|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24774363|NCT01845194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24565573|NCT00781287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774364|NCT01845194|Narcotics|narcotics|mesh-ancestor
24774365|NCT01845194|Analgesics|analgesics|mesh-ancestor
24774366|NCT01845194|Sensory System Agents|sensory system agents|mesh-ancestor
24774368|NCT01845194|Respiratory System Agents|respiratory system agents|mesh-ancestor
24774369|NCT01845194|Diuretics|diuretics|mesh-ancestor
24774370|NCT01845194|Natriuretic Agents|natriuretic agents|mesh-ancestor
25081269|NCT03331692|Anesthetics|anesthetics|mesh-list
24774371|NCT01845194|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24774372|NCT01845194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24774374|NCT01845246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24774408|NCT01845298|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24774409|NCT01845298|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24774410|NCT01845337|Capecitabine|capecitabine|mesh-list
24774411|NCT01845337|Tegafur|tegafur|mesh-list
24774412|NCT01845337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24774413|NCT01845337|Antimetabolites|antimetabolites|mesh-ancestor
24774414|NCT01845337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774415|NCT01845337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25202403|NCT02721511|Diuretics|diuretics|mesh-ancestor
25012760|NCT04496362|Heparin|heparin|mesh-list
24793801|NCT02257346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081270|NCT03331692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25081271|NCT03331692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081272|NCT03331562|Ergocalciferols|ergocalciferols|mesh-list
25081273|NCT03331562|Pembrolizumab|pembrolizumab|mesh-list
25081274|NCT03331562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25081275|NCT03331562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081278|NCT03331562|Vitamins|vitamins|mesh-ancestor
25081280|NCT03331562|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25081281|NCT03331523|Betamethasone|betamethasone|mesh-list
24406325|NCT00169624|Gliclazide|gliclazide|mesh-list
25081323|NCT03331263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25081324|NCT03331263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25081326|NCT03331263|Dermatologic Agents|dermatologic agents|mesh-ancestor
25081327|NCT03331211|Dasatinib|dasatinib|mesh-list
24774533|NCT01846117|Estrogens|estrogens|mesh-ancestor
24774534|NCT01846117|Hormones|hormones|mesh-ancestor
24774535|NCT01846117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24774536|NCT01846143|Poly ICLC|poly iclc|mesh-list
24774537|NCT01846143|Immunologic Factors|immunologic factors|mesh-ancestor
24774538|NCT01846143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774539|NCT01846143|Interferon Inducers|interferon inducers|mesh-ancestor
24774540|NCT01846273|Ranibizumab|ranibizumab|mesh-list
24774541|NCT01846273|Verteporfin|verteporfin|mesh-list
24774542|NCT01846273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24774587|NCT01846559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24406432|NCT00170209|Antimetabolites|antimetabolites|mesh-ancestor
25663233|NCT01655823|Anesthetics|anesthetics|mesh-ancestor
25663234|NCT01655823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25663235|NCT01655823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851828|NCT00054626|Cisplatin|cisplatin|mesh-list
25238068|NCT02547155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25238069|NCT02547155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238070|NCT02547103|Chlorhexidine|chlorhexidine|mesh-list
25238071|NCT02547103|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25238072|NCT02547103|Mupirocin|mupirocin|mesh-list
25238073|NCT02547103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25238074|NCT02547103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25238075|NCT02547103|Disinfectants|disinfectants|mesh-ancestor
25238076|NCT02547103|Dermatologic Agents|dermatologic agents|mesh-ancestor
25238077|NCT02547103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25238078|NCT02547103|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25238079|NCT02547103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238080|NCT02547103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238081|NCT02547116|Rifampin|rifampin|mesh-list
25238082|NCT02547116|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24774670|NCT01847326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562644|NCT00767559|PENTA|penta|mesh-list
24620538|NCT01057407|Sequestering Agents|sequestering agents|mesh-ancestor
24620539|NCT01057407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067432|NCT03443843|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25067433|NCT03443843|Sympathomimetics|sympathomimetics|mesh-ancestor
25067434|NCT03443843|Adrenergic Agents|adrenergic agents|mesh-ancestor
24952438|NCT03894280|Glucocorticoids|glucocorticoids|mesh-ancestor
25067436|NCT03443778|Bupivacaine|bupivacaine|mesh-list
25067437|NCT03443778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25067438|NCT03443778|Antiemetics|antiemetics|mesh-ancestor
25067439|NCT03443778|Autonomic Agents|autonomic agents|mesh-ancestor
24522392|NCT03893175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24920761|NCT04198233|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24920762|NCT04198233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24920763|NCT04198233|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24920764|NCT04198233|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24920765|NCT04198233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24920766|NCT04198233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24920767|NCT04198233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24920768|NCT04198233|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24920769|NCT04198233|Anesthetics, General|anesthetics, general|mesh-ancestor
24920770|NCT04198233|Anesthetics|anesthetics|mesh-ancestor
24920771|NCT04198233|GABA Modulators|gaba modulators|mesh-ancestor
24522399|NCT03893175|Narcotics|narcotics|mesh-ancestor
24522400|NCT03893175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24522401|NCT03862157|Azacitidine|azacitidine|mesh-list
24522402|NCT03862157|Venetoclax|venetoclax|mesh-list
25067465|NCT03443726|Adrenergic Agents|adrenergic agents|mesh-ancestor
25067466|NCT03443726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25067467|NCT03443726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067468|NCT03443726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522474|NCT03760185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522475|NCT03753243|Pembrolizumab|pembrolizumab|mesh-list
24522476|NCT03753243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24920785|NCT04197570|Analgesics, Opioid|analgesics, opioid|mesh-list
24920786|NCT04197570|Analgesics|analgesics|mesh-list
24564639|NCT00777244|Mitotane|mitotane|mesh-list
25851829|NCT00054626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25202404|NCT02721511|Natriuretic Agents|natriuretic agents|mesh-ancestor
25067471|NCT03443726|Autonomic Agents|autonomic agents|mesh-ancestor
25067472|NCT03443726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25067473|NCT03443726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25663236|NCT01655823|Sensory System Agents|sensory system agents|mesh-ancestor
25663237|NCT01655823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25663238|NCT01655823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25663239|NCT01655823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25663240|NCT01655823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663241|NCT01656031|Cytarabine|cytarabine|mesh-list
25663242|NCT01656031|Clofarabine|clofarabine|mesh-list
25663243|NCT01656031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25663244|NCT01656031|Antimetabolites|antimetabolites|mesh-ancestor
25663245|NCT01656031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663246|NCT01656031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663247|NCT01656031|Antiviral Agents|antiviral agents|mesh-ancestor
25663248|NCT01656031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25663249|NCT01656031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25067474|NCT03443726|Respiratory System Agents|respiratory system agents|mesh-ancestor
25067475|NCT03443726|Mydriatics|mydriatics|mesh-ancestor
25067476|NCT03443726|Sympathomimetics|sympathomimetics|mesh-ancestor
25067477|NCT03443726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25238109|NCT02546791|Dasatinib|dasatinib|mesh-list
25067484|NCT03443609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067485|NCT03443570|Rituximab|rituximab|mesh-list
25067486|NCT03443570|Bortezomib|bortezomib|mesh-list
25067487|NCT03443570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25067488|NCT03443570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851830|NCT00054626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24920818|NCT04197349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920826|NCT04197219|Pembrolizumab|pembrolizumab|mesh-list
24920827|NCT04197219|Axitinib|axitinib|mesh-list
24920828|NCT04197219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24920829|NCT04197219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24920830|NCT04197219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24920831|NCT04197219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25067503|NCT03443492|Irinotecan|irinotecan|mesh-list
25067504|NCT03443492|Levoleucovorin|levoleucovorin|mesh-list
25067505|NCT03443492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24406590|NCT00170859|Everolimus|everolimus|mesh-list
24621102|NCT01060683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24621247|NCT01061190|Adrenergic Agents|adrenergic agents|mesh-ancestor
24621248|NCT01061190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24621249|NCT01061190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621250|NCT01061190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621264|NCT01061320|alpha-Tocopherol|alpha-tocopherol|mesh-list
24621265|NCT01061320|Vitamins|vitamins|mesh-ancestor
24621266|NCT01061320|Micronutrients|micronutrients|mesh-ancestor
24623992|NCT01074203|Nitazoxanide|nitazoxanide|mesh-list
24623993|NCT01074203|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24623994|NCT01074203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24623995|NCT01074281|Enalapril|enalapril|mesh-list
24623996|NCT01074281|Enalaprilat|enalaprilat|mesh-list
24623997|NCT01074281|Nitrendipine|nitrendipine|mesh-list
24623998|NCT01074281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623999|NCT01074281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624000|NCT01074281|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24624001|NCT01074281|Protease Inhibitors|protease inhibitors|mesh-ancestor
24624002|NCT01074281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24624003|NCT01074281|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24624004|NCT01074281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24624005|NCT01074281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24624006|NCT01074281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624007|NCT01074281|Vasodilator Agents|vasodilator agents|mesh-ancestor
24624008|NCT01074333|Cetuximab|cetuximab|mesh-list
24624009|NCT01074333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24624010|NCT01074333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624011|NCT01074346|Interferons|interferons|mesh-list
24621569|NCT01063023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24920903|NCT04196309|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24920904|NCT04196309|Tinzaparin|tinzaparin|mesh-list
24920905|NCT04196309|Dalteparin|dalteparin|mesh-list
24920906|NCT04196309|Anticoagulants|anticoagulants|mesh-ancestor
25067521|NCT03443492|Micronutrients|micronutrients|mesh-ancestor
25067522|NCT03443271|Bupivacaine|bupivacaine|mesh-list
25067523|NCT03443271|Anesthetics, Local|anesthetics, local|mesh-ancestor
25067524|NCT03443271|Anesthetics|anesthetics|mesh-ancestor
25067525|NCT03443271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25067526|NCT03443271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067527|NCT03443271|Sensory System Agents|sensory system agents|mesh-ancestor
25067528|NCT03443271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25067529|NCT03443180|Trypsin Inhibitors|trypsin inhibitors|mesh-list
25067530|NCT03443180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25067531|NCT03443180|Protease Inhibitors|protease inhibitors|mesh-ancestor
25067532|NCT03443180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202405|NCT02721511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067533|NCT03443180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067535|NCT03443141|Vitamins|vitamins|mesh-ancestor
24920909|NCT04196309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920910|NCT04196608|Tazobactam|tazobactam|mesh-list
24920911|NCT04196608|Imipenem|imipenem|mesh-list
24920969|NCT04195867|Adrenergic Agents|adrenergic agents|mesh-ancestor
24920970|NCT04195867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25067575|NCT03442673|Tubulin Modulators|tubulin modulators|mesh-ancestor
25067576|NCT03442673|Antimitotic Agents|antimitotic agents|mesh-ancestor
25067577|NCT03442673|Mitosis Modulators|mitosis modulators|mesh-ancestor
25067578|NCT03442621|Cortisone|cortisone|mesh-list
25067579|NCT03442621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25067580|NCT03442491|Hemostatics|hemostatics|mesh-list
25663250|NCT01656031|Immunologic Factors|immunologic factors|mesh-ancestor
24921008|NCT04195321|Autonomic Agents|autonomic agents|mesh-ancestor
24921009|NCT04195321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24921010|NCT04195321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921011|NCT04195321|Sympathomimetics|sympathomimetics|mesh-ancestor
24921012|NCT04195321|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24921013|NCT04195321|Nasal Decongestants|nasal decongestants|mesh-ancestor
24921014|NCT04195321|Respiratory System Agents|respiratory system agents|mesh-ancestor
24921026|NCT04195074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24921027|NCT04195074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24921029|NCT04195074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921030|NCT04195074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24921031|NCT04195074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24921032|NCT04194827|Adalimumab|adalimumab|mesh-list
24921033|NCT04194827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25067618|NCT03441815|Histamine Agonists|histamine agonists|mesh-ancestor
25067619|NCT03441815|Histamine Agents|histamine agents|mesh-ancestor
25067620|NCT03441815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25067621|NCT03441815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067622|NCT03441815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854965|NCT02276495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25067623|NCT03441815|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25067624|NCT03441815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25067625|NCT03441529|Tazobactam|tazobactam|mesh-list
25067626|NCT03441529|Piperacillin|piperacillin|mesh-list
25067627|NCT03441529|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25067628|NCT03441529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25067629|NCT03441529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25067630|NCT03441529|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25067631|NCT03441529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25067632|NCT03441529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067633|NCT03441412|Metoprolol|metoprolol|mesh-list
25067634|NCT03441412|Epinephrine|epinephrine|mesh-list
25067635|NCT03441412|Ticagrelor|ticagrelor|mesh-list
25067636|NCT03441412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25067637|NCT03441412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25067638|NCT03441412|Adrenergic Agents|adrenergic agents|mesh-ancestor
25067639|NCT03441412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24830075|NCT02157207|Protective Agents|protective agents|mesh-ancestor
24921034|NCT04194827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24921035|NCT04194957|Fluorouracil|fluorouracil|mesh-list
24921036|NCT04194957|Capecitabine|capecitabine|mesh-list
24921037|NCT04194957|Antimetabolites|antimetabolites|mesh-ancestor
24921038|NCT04194957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921039|NCT04194957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24921040|NCT04194957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921041|NCT04194957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24921042|NCT04194957|Immunologic Factors|immunologic factors|mesh-ancestor
24921043|NCT04194957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921044|NCT04194905|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24921045|NCT04194905|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24921046|NCT04194905|Levonorgestrel|levonorgestrel|mesh-list
24921047|NCT04194905|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24921048|NCT04194905|Estradiol|estradiol|mesh-list
24921049|NCT04194905|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24921050|NCT04194905|Estrogens|estrogens|mesh-ancestor
24921051|NCT04194905|Hormones|hormones|mesh-ancestor
24774671|NCT01847326|Tubulin Modulators|tubulin modulators|mesh-ancestor
24522593|NCT03628066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921101|NCT04194294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921102|NCT04194125|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
24921103|NCT04194125|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24496424|NCT00504764|Arsenic Trioxide|arsenic trioxide|mesh-list
24496425|NCT00504764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774672|NCT01847326|Antimitotic Agents|antimitotic agents|mesh-ancestor
24774673|NCT01847326|Mitosis Modulators|mitosis modulators|mesh-ancestor
24621579|NCT01063140|Immunologic Factors|immunologic factors|mesh-ancestor
24621936|NCT01064973|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24621938|NCT01064973|GABA Agents|gaba agents|mesh-ancestor
24621939|NCT01064973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25663251|NCT01656031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467728|NCT00378612|Sirolimus|sirolimus|mesh-list
24453934|NCT04646395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851831|NCT00054626|Antimetabolites|antimetabolites|mesh-ancestor
24488560|NCT00469352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24849191|NCT02296229|Androgens|androgens|mesh-list
24849192|NCT02296229|Hormones|hormones|mesh-ancestor
24849193|NCT02296229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24640434|NCT01168011|ON 01910|on 01910|mesh-list
24453973|NCT04635280|Pancrelipase|pancrelipase|mesh-list
24453974|NCT04635280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24453975|NCT04602377|Pembrolizumab|pembrolizumab|mesh-list
25238156|NCT02546349|Fluticasone|fluticasone|mesh-list
25851832|NCT00054626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621964|NCT01064999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621966|NCT01065038|Hydroxyurea|hydroxyurea|mesh-list
24621981|NCT01065129|Plerixafor|plerixafor|mesh-list
24622055|NCT01065376|Dopamine Agents|dopamine agents|mesh-ancestor
24622357|NCT01066728|Autonomic Agents|autonomic agents|mesh-ancestor
24622358|NCT01066728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24622359|NCT01066728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622360|NCT01066728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25067683|NCT03441217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25067684|NCT03441217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067685|NCT03441217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25067686|NCT03441217|Parasympatholytics|parasympatholytics|mesh-ancestor
25067687|NCT03441035|Anesthetics|anesthetics|mesh-list
25067688|NCT03441035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25067689|NCT03441035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067690|NCT03440996|Listerine|listerine|mesh-list
25067691|NCT03440996|Sodium Fluoride|sodium fluoride|mesh-list
25067692|NCT03440996|Cariostatic Agents|cariostatic agents|mesh-ancestor
24622361|NCT01066728|Respiratory System Agents|respiratory system agents|mesh-ancestor
24622362|NCT01066728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24622363|NCT01066728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24744666|NCT04200651|Dexamethasone|dexamethasone|mesh-list
24921171|NCT04193852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24921172|NCT04193852|Contraceptive Agents|contraceptive agents|mesh-ancestor
24921173|NCT04193852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24921174|NCT04193852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24683402|NCT01392014|Antimalarials|antimalarials|mesh-ancestor
24921175|NCT04193852|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24921176|NCT04193852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24407002|NCT00171678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921259|NCT04193059|Alkylating Agents|alkylating agents|mesh-ancestor
24522670|NCT03421756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24522683|NCT03412266|Busulfan|busulfan|mesh-list
24522684|NCT03412266|Semustine|semustine|mesh-list
25067714|NCT03440515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25067715|NCT03440502|Anesthetics|anesthetics|mesh-list
25067716|NCT03440502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25067717|NCT03440502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067718|NCT03440359|Letrozole|letrozole|mesh-list
25067719|NCT03440359|Progesterone|progesterone|mesh-list
25067720|NCT03440359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25067780|NCT03439501|Avelumab|avelumab|mesh-list
25067781|NCT03439501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24622374|NCT01066754|Histamine Antagonists|histamine antagonists|mesh-ancestor
24622375|NCT01066754|Histamine Agents|histamine agents|mesh-ancestor
24622376|NCT01066754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24496819|NCT00506961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24496820|NCT00506961|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24496821|NCT00506961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496822|NCT00506974|Sodium Oxybate|sodium oxybate|mesh-list
24496823|NCT00506974|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24921573|NCT04189211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921574|NCT04189276|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25663252|NCT01656161|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25663253|NCT01656161|Luteolytic Agents|luteolytic agents|mesh-ancestor
25663254|NCT01656161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25663255|NCT01656161|Contraceptive Agents|contraceptive agents|mesh-ancestor
25663256|NCT01656161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25663257|NCT01656161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663258|NCT01656161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25663259|NCT01656161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25663260|NCT01656161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663261|NCT01656187|Memantine|memantine|mesh-list
25663262|NCT01656187|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24921575|NCT04189276|Antiviral Agents|antiviral agents|mesh-ancestor
24921576|NCT04189276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24921578|NCT04189094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921579|NCT04189094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24921580|NCT04189094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24921581|NCT04189094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24921582|NCT04189094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921583|NCT04189094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921584|NCT04189055|Irinotecan|irinotecan|mesh-list
24921585|NCT04189055|Cetuximab|cetuximab|mesh-list
24921586|NCT04189055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25067813|NCT03438890|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25067814|NCT03438890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25067815|NCT03438890|Disinfectants|disinfectants|mesh-ancestor
25067816|NCT03438812|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25067817|NCT03438812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25067818|NCT03438812|Immunologic Factors|immunologic factors|mesh-ancestor
25067819|NCT03438812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067820|NCT03438773|Tacrolimus|tacrolimus|mesh-list
25067821|NCT03438773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25067822|NCT03438773|Immunologic Factors|immunologic factors|mesh-ancestor
24921634|NCT04188431|Antiemetics|antiemetics|mesh-ancestor
24921635|NCT04188431|Autonomic Agents|autonomic agents|mesh-ancestor
24921636|NCT04188431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24921638|NCT04188431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24921640|NCT04188431|Hormones|hormones|mesh-ancestor
24921641|NCT04188431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24921642|NCT04188431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24921643|NCT04188431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24683541|NCT01392807|Naloxegol|naloxegol|mesh-list
24921644|NCT04188561|Hyaluronic Acid|hyaluronic acid|mesh-list
24921645|NCT04188561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24921646|NCT04188561|Immunologic Factors|immunologic factors|mesh-ancestor
24921647|NCT04188561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067851|NCT03438240|Bupivacaine|bupivacaine|mesh-list
25067852|NCT03438240|Anesthetics, Local|anesthetics, local|mesh-list
25067853|NCT03438240|Anesthetics|anesthetics|mesh-list
24921653|NCT04188353|Natriuretic Agents|natriuretic agents|mesh-ancestor
24921654|NCT04188353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921655|NCT04188106|Hydroxyzine|hydroxyzine|mesh-list
24921662|NCT04188106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921663|NCT04188106|Antipruritics|antipruritics|mesh-ancestor
24921664|NCT04188106|Dermatologic Agents|dermatologic agents|mesh-ancestor
25851833|NCT00054626|Antiviral Agents|antiviral agents|mesh-ancestor
24622387|NCT01066767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622388|NCT01066806|Calcium|calcium|mesh-list
24622389|NCT01066806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24921726|NCT04187898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24921727|NCT04187898|Immunologic Factors|immunologic factors|mesh-ancestor
24921728|NCT04187898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921729|NCT04187898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24921730|NCT04187898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24921731|NCT04187898|Alkylating Agents|alkylating agents|mesh-ancestor
24921732|NCT04187898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921733|NCT04187898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921734|NCT04187898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24921735|NCT04187898|Tubulin Modulators|tubulin modulators|mesh-ancestor
24522800|NCT03110822|Prednisolone acetate|prednisolone acetate|mesh-list
24522801|NCT03110822|Lenalidomide|lenalidomide|mesh-list
24953113|NCT03888677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24953114|NCT03888677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24953115|NCT03888664|Interferons|interferons|mesh-list
24953116|NCT03888664|Interferon-gamma|interferon-gamma|mesh-list
24953117|NCT03888664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497185|NCT00508690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24497190|NCT00508859|Sertraline|sertraline|mesh-list
24522804|NCT03110822|Immunologic Factors|immunologic factors|mesh-ancestor
24522805|NCT03110822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522806|NCT03110822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24522807|NCT03110822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24522808|NCT03110822|Growth Substances|growth substances|mesh-ancestor
24921759|NCT04187469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24921760|NCT04187469|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24921761|NCT04187469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24921762|NCT04187469|Antimetabolites|antimetabolites|mesh-ancestor
24921763|NCT04187469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25238215|NCT02545751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25238216|NCT02545751|Immunologic Factors|immunologic factors|mesh-ancestor
25238217|NCT02545751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238219|NCT02545712|Benzyl Alcohol|benzyl alcohol|mesh-list
25238220|NCT02545712|Sorbitol|sorbitol|mesh-list
25238221|NCT02545712|Glycerol|glycerol|mesh-list
25238222|NCT02545712|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25238223|NCT02545712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25238224|NCT02545712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25238225|NCT02545712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238226|NCT02545712|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25238227|NCT02545712|Protective Agents|protective agents|mesh-ancestor
25238228|NCT02545712|Cathartics|cathartics|mesh-ancestor
25238230|NCT02545712|Anesthetics, Local|anesthetics, local|mesh-ancestor
24921771|NCT04187417|Tetracaine|tetracaine|mesh-list
24921772|NCT04187417|Anesthetics, Local|anesthetics, local|mesh-ancestor
24921773|NCT04187417|Anesthetics|anesthetics|mesh-ancestor
24921774|NCT04187417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24921775|NCT04187417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921776|NCT04187417|Sensory System Agents|sensory system agents|mesh-ancestor
24921777|NCT04187417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24921778|NCT04187456|Midazolam|midazolam|mesh-list
24953520|NCT03883841|Hematinics|hematinics|mesh-ancestor
25067883|NCT03437980|Propofol|propofol|mesh-list
25067884|NCT03437980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25067885|NCT03437980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25067886|NCT03437980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067887|NCT03437980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25067888|NCT03437980|Anesthetics, General|anesthetics, general|mesh-ancestor
25067889|NCT03437980|Anesthetics|anesthetics|mesh-ancestor
25067890|NCT03437902|Vitamins|vitamins|mesh-list
25067891|NCT03437902|Ascorbic Acid|ascorbic acid|mesh-list
24921852|NCT04186299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24921853|NCT04186299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25851834|NCT00054626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24921854|NCT04186299|Respiratory System Agents|respiratory system agents|mesh-ancestor
24921855|NCT04186299|Mydriatics|mydriatics|mesh-ancestor
24921856|NCT04186299|Sympathomimetics|sympathomimetics|mesh-ancestor
24921857|NCT04186299|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24921858|NCT04186299|Analgesics|analgesics|mesh-ancestor
24921859|NCT04186299|Sensory System Agents|sensory system agents|mesh-ancestor
24611459|NCT01009593|Sorafenib|sorafenib|mesh-list
25067953|NCT03437707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921889|NCT04185675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24921890|NCT04185675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921891|NCT04185766|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24921892|NCT04185831|Everolimus|everolimus|mesh-list
24921893|NCT04185831|Atezolizumab|atezolizumab|mesh-list
24921894|NCT04185831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921895|NCT04185831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24921896|NCT04185831|Immunologic Factors|immunologic factors|mesh-ancestor
24921897|NCT04185831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067901|NCT03437824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067902|NCT03437824|Vitamin B Complex|vitamin b complex|mesh-ancestor
25067903|NCT03437824|Hematinics|hematinics|mesh-ancestor
25067904|NCT03437785|Ethanol|ethanol|mesh-list
25067905|NCT03437785|Rebamipide|rebamipide|mesh-list
25067906|NCT03437785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25067907|NCT03437785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25067908|NCT03437785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25067909|NCT03437785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067910|NCT03437785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25663263|NCT01656187|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25663264|NCT01656187|Dopamine Agents|dopamine agents|mesh-ancestor
25663265|NCT01656187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25663266|NCT01656187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663267|NCT01656187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663268|NCT01656187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25663269|NCT01656187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25663270|NCT01656252|Cytarabine|cytarabine|mesh-list
25663271|NCT01656252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25663272|NCT01656252|Antimetabolites|antimetabolites|mesh-ancestor
25663273|NCT01656252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663274|NCT01656252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663275|NCT01656252|Antiviral Agents|antiviral agents|mesh-ancestor
25067911|NCT03437785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25067912|NCT03437785|Antioxidants|antioxidants|mesh-ancestor
25067913|NCT03437785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067914|NCT03437785|Protective Agents|protective agents|mesh-ancestor
25067915|NCT03437785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830404|NCT02159131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24623097|NCT01070186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623098|NCT01070186|Growth Inhibitors|growth inhibitors|mesh-ancestor
24623525|NCT01072058|Etanercept|etanercept|mesh-list
24623526|NCT01072058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
24623527|NCT01072058|Infliximab|infliximab|mesh-list
24623528|NCT01072058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24623529|NCT01072058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24623530|NCT01072058|Dermatologic Agents|dermatologic agents|mesh-ancestor
24623531|NCT01072058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24623532|NCT01072058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24623533|NCT01072058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24623536|NCT01072058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24623537|NCT01072058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623538|NCT01072058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24623539|NCT01072058|Immunologic Factors|immunologic factors|mesh-ancestor
24623540|NCT01072071|Furosemide|furosemide|mesh-list
24623541|NCT01072071|Diuretics|diuretics|mesh-ancestor
24623542|NCT01072071|Natriuretic Agents|natriuretic agents|mesh-ancestor
24623543|NCT01072071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921934|NCT04184947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921935|NCT04185077|Heparin|heparin|mesh-list
24921936|NCT04185077|Calcium heparin|calcium heparin|mesh-list
24921937|NCT04185077|Bivalirudin|bivalirudin|mesh-list
24921938|NCT04185077|Antithrombins|antithrombins|mesh-list
24921939|NCT04185077|Thrombin|thrombin|mesh-list
25067943|NCT03437707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25067944|NCT03437707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067945|NCT03437707|Analgesics|analgesics|mesh-ancestor
25067946|NCT03437707|Sensory System Agents|sensory system agents|mesh-ancestor
25202406|NCT02721511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25067947|NCT03437707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25067948|NCT03437707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25067949|NCT03437707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25067950|NCT03437707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25067951|NCT03437707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25067952|NCT03437707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25067954|NCT03437707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067955|NCT03437707|Antipyretics|antipyretics|mesh-ancestor
25067956|NCT03437655|Eugenol|eugenol|mesh-list
25067957|NCT03437655|Zinc Oxide|zinc oxide|mesh-list
25067958|NCT03437655|Dermatologic Agents|dermatologic agents|mesh-ancestor
25067959|NCT03437655|Sunscreening Agents|sunscreening agents|mesh-ancestor
25067960|NCT03437655|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24922014|NCT04184492|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25067961|NCT03437655|Protective Agents|protective agents|mesh-ancestor
25067962|NCT03437655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895839|NCT02960763|Aripiprazole|aripiprazole|mesh-list
25067963|NCT03437655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25067965|NCT03437629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25067966|NCT03437629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067967|NCT03437590|JNJ-55308942|jnj-55308942|mesh-list
24683940|NCT01394770|Amlodipine|amlodipine|mesh-list
25067968|NCT03437590|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
25067969|NCT03437590|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25067970|NCT03437590|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24830467|NCT02159287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922015|NCT04184492|Insulin Aspart|insulin aspart|mesh-list
24922016|NCT04184492|Insulin, Long-Acting|insulin, long-acting|mesh-list
24922017|NCT04184492|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24922018|NCT04184492|Biphasic Insulins|biphasic insulins|mesh-list
24922019|NCT04184492|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24922024|NCT04184505|Azacitidine|azacitidine|mesh-list
24522818|NCT03110822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24522820|NCT03110822|Protective Agents|protective agents|mesh-ancestor
24522821|NCT03110822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24522822|NCT03106987|Olaparib|olaparib|mesh-list
24522823|NCT03106987|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24522824|NCT03106987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24522834|NCT03105843|Respiratory System Agents|respiratory system agents|mesh-ancestor
24522835|NCT03105843|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25238292|NCT02545465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238293|NCT02545426|Dialysis Solutions|dialysis solutions|mesh-list
24522836|NCT03105843|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24522837|NCT03105843|Cholinergic Agents|cholinergic agents|mesh-ancestor
24922055|NCT04184115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24922056|NCT04184115|Mydriatics|mydriatics|mesh-ancestor
24922057|NCT04184115|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24922058|NCT04184115|Cholinergic Agents|cholinergic agents|mesh-ancestor
24922059|NCT04184115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25067971|NCT03437590|Purinergic Agents|purinergic agents|mesh-ancestor
25067972|NCT03437590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25067973|NCT03437590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541682|NCT00674674|Topotecan|topotecan|mesh-list
24922068|NCT04183556|Naproxen|naproxen|mesh-list
24922069|NCT04183556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
24922070|NCT04183556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24922071|NCT04183556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24922072|NCT04183556|Analgesics|analgesics|mesh-ancestor
24922073|NCT04183556|Sensory System Agents|sensory system agents|mesh-ancestor
24922074|NCT04183556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24922075|NCT04183556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922076|NCT04183556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24922077|NCT04183556|Gout Suppressants|gout suppressants|mesh-ancestor
24922078|NCT04183556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24922079|NCT04183556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24922080|NCT04183556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922081|NCT04183725|Oseltamivir|oseltamivir|mesh-list
24522838|NCT03105843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24522839|NCT03105843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522840|NCT03103750|Calcitriol|calcitriol|mesh-list
24522841|NCT03103750|Amphetamine|amphetamine|mesh-list
24522850|NCT03103750|Micronutrients|micronutrients|mesh-ancestor
24522853|NCT03103750|Sympathomimetics|sympathomimetics|mesh-ancestor
25851835|NCT00054626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24522854|NCT03103750|Autonomic Agents|autonomic agents|mesh-ancestor
24922082|NCT04183725|Antiviral Agents|antiviral agents|mesh-ancestor
24922083|NCT04183725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24922084|NCT04183725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24922085|NCT04183725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922087|NCT04183608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24922088|NCT04183608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24922089|NCT04183738|Ritonavir|ritonavir|mesh-list
24922133|NCT04183075|Vitamins|vitamins|mesh-list
24895876|NCT02918084|Letrozole|letrozole|mesh-list
24922134|NCT04183075|Ascorbic Acid|ascorbic acid|mesh-list
24922135|NCT04183075|Micronutrients|micronutrients|mesh-ancestor
24922136|NCT04183075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922137|NCT04183075|Antioxidants|antioxidants|mesh-ancestor
24922138|NCT04183075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922139|NCT04183075|Protective Agents|protective agents|mesh-ancestor
24922140|NCT04183257|Vitamin D|vitamin d|mesh-list
24922141|NCT04183257|Ergocalciferols|ergocalciferols|mesh-list
24922142|NCT04183257|Cholecalciferol|cholecalciferol|mesh-list
24922143|NCT04183257|Vitamins|vitamins|mesh-list
24922144|NCT04183257|Micronutrients|micronutrients|mesh-ancestor
24922145|NCT04183257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922146|NCT04183257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24922147|NCT04183257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24922148|NCT04183296|Propofol|propofol|mesh-list
24922149|NCT04183296|Sevoflurane|sevoflurane|mesh-list
24922150|NCT04183296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24922151|NCT04183296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24522871|NCT03103087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24522873|NCT03103087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24497600|NCT00510640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25033514|NCT03572829|Antipruritics|antipruritics|mesh-ancestor
24922157|NCT04183296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24745724|NCT03643198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25068010|NCT03437187|Analgesics|analgesics|mesh-list
25068011|NCT03437187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068012|NCT03437187|Sensory System Agents|sensory system agents|mesh-ancestor
25068013|NCT03437187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25068014|NCT03437070|Doxorubicin|doxorubicin|mesh-list
25068015|NCT03437070|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25068016|NCT03437070|Trabectedin|trabectedin|mesh-list
25068017|NCT03437070|Olaratumab|olaratumab|mesh-list
25663276|NCT01656252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25663277|NCT01656252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25068018|NCT03437070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25068019|NCT03437070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25068020|NCT03437070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25068021|NCT03437070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25068022|NCT03437070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25068023|NCT03437070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068024|NCT03437070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25068025|NCT03437070|Alkylating Agents|alkylating agents|mesh-ancestor
25068026|NCT03437057|Aspirin|aspirin|mesh-list
25068027|NCT03437057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24522875|NCT03103087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25068037|NCT03437057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068038|NCT03437057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25068040|NCT03437057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623953|NCT01074073|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
24684229|NCT01395953|Buspirone|buspirone|mesh-list
24623954|NCT01074073|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24623957|NCT01074073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623959|NCT01074073|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24623960|NCT01074073|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24922202|NCT04182568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922203|NCT04182568|Tubulin Modulators|tubulin modulators|mesh-ancestor
24922204|NCT04182568|Antimitotic Agents|antimitotic agents|mesh-ancestor
24922205|NCT04182568|Mitosis Modulators|mitosis modulators|mesh-ancestor
24922206|NCT04182568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922207|NCT04182568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24922208|NCT04182568|Immunologic Factors|immunologic factors|mesh-ancestor
25068051|NCT03436836|Bupivacaine|bupivacaine|mesh-list
25068052|NCT03436836|Anesthetics, Local|anesthetics, local|mesh-ancestor
25068053|NCT03436836|Anesthetics|anesthetics|mesh-ancestor
24922209|NCT04182568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922210|NCT04182568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24922226|NCT04182724|Tubulin Modulators|tubulin modulators|mesh-ancestor
24922227|NCT04182724|Antimitotic Agents|antimitotic agents|mesh-ancestor
24922228|NCT04182724|Mitosis Modulators|mitosis modulators|mesh-ancestor
24922229|NCT04182724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922230|NCT04182724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24922231|NCT04182724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24922258|NCT04182191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24922260|NCT04182191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922262|NCT04182399|Anticonvulsants|anticonvulsants|mesh-ancestor
24408491|NCT00178035|Serotonin Agents|serotonin agents|mesh-ancestor
25068060|NCT03436836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25068061|NCT03436836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25068062|NCT03436836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068063|NCT03436836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25068064|NCT03436836|Narcotics|narcotics|mesh-ancestor
25068065|NCT03436836|Analgesics|analgesics|mesh-ancestor
25068066|NCT03436719|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25068067|NCT03436719|Metronidazole|metronidazole|mesh-list
25068068|NCT03436719|Erythromycin|erythromycin|mesh-list
24830574|NCT02160080|Immunologic Factors|immunologic factors|mesh-ancestor
24922275|NCT04181957|Dopamine Agents|dopamine agents|mesh-ancestor
24922276|NCT04181957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24922277|NCT04181645|Gemcitabine|gemcitabine|mesh-list
24922278|NCT04181645|Paclitaxel|paclitaxel|mesh-list
24922279|NCT04181645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24922280|NCT04181645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922281|NCT04181645|Tubulin Modulators|tubulin modulators|mesh-ancestor
24922282|NCT04181645|Antimitotic Agents|antimitotic agents|mesh-ancestor
24922283|NCT04181645|Mitosis Modulators|mitosis modulators|mesh-ancestor
24922284|NCT04181645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922285|NCT04181645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24922286|NCT04181645|Antimetabolites|antimetabolites|mesh-ancestor
24922287|NCT04181645|Antiviral Agents|antiviral agents|mesh-ancestor
24922288|NCT04181645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24922289|NCT04181645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24922294|NCT04181567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24922295|NCT04181567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24922296|NCT04181567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922297|NCT04181736|Guanfacine|guanfacine|mesh-list
24922298|NCT04181736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24922299|NCT04181736|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24922300|NCT04181736|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24709599|NCT01506388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24709600|NCT01506388|Oxytocics|oxytocics|mesh-ancestor
24709601|NCT01506414|Rituximab|rituximab|mesh-list
24709602|NCT01506414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24709603|NCT01506414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24709607|NCT01506505|Aspirin|aspirin|mesh-list
24922301|NCT04181736|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24922302|NCT04181736|Adrenergic Agents|adrenergic agents|mesh-ancestor
25202407|NCT02721511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25851836|NCT00054626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25068074|NCT03436719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25068075|NCT03436719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25068076|NCT03436719|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25068077|NCT03436719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25068078|NCT03436719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068079|NCT03436693|Canagliflozin|canagliflozin|mesh-list
25068080|NCT03436693|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25068081|NCT03436693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068082|NCT03436693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24922360|NCT04181489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24922361|NCT04181489|Alkylating Agents|alkylating agents|mesh-ancestor
24922362|NCT04181489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922363|NCT04181489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922364|NCT04181489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24922365|NCT04181489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24497844|NCT00512070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24497845|NCT00512070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24497846|NCT00512070|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24497847|NCT00512070|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24497848|NCT00512070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24497849|NCT00512070|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24922373|NCT04181489|Mitosis Modulators|mitosis modulators|mesh-ancestor
24922374|NCT04181489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24922375|NCT04181489|Glucocorticoids|glucocorticoids|mesh-ancestor
24922377|NCT04181489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25851837|NCT00054626|Immunologic Factors|immunologic factors|mesh-ancestor
25068083|NCT03436693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068084|NCT03436472|Dexmedetomidine|dexmedetomidine|mesh-list
25068085|NCT03436472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25068086|NCT03436472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25068087|NCT03436472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068088|NCT03436472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25068089|NCT03436472|Analgesics|analgesics|mesh-ancestor
25068090|NCT03436472|Sensory System Agents|sensory system agents|mesh-ancestor
25068091|NCT03436472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25068092|NCT03436472|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25068093|NCT03436472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25068094|NCT03436472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25068095|NCT03436472|Adrenergic Agents|adrenergic agents|mesh-ancestor
25068096|NCT03436472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25068097|NCT03436472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068098|NCT03436303|Dydrogesterone|dydrogesterone|mesh-list
25068099|NCT03436303|Progestins|progestins|mesh-ancestor
24624041|NCT01074593|Antiviral Agents|antiviral agents|mesh-ancestor
24624042|NCT01074593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24624043|NCT01074593|Immunologic Factors|immunologic factors|mesh-ancestor
24624044|NCT01074593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922422|NCT04180384|Mitosis Modulators|mitosis modulators|mesh-ancestor
24922423|NCT04180384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922424|NCT04180072|Bevacizumab|bevacizumab|mesh-list
24922425|NCT04180072|Atezolizumab|atezolizumab|mesh-list
24922426|NCT04180072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24922427|NCT04180072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922428|NCT04180072|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24922429|NCT04180072|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24922430|NCT04180072|Growth Substances|growth substances|mesh-ancestor
24922431|NCT04180072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663278|NCT01656252|Immunologic Factors|immunologic factors|mesh-ancestor
25663279|NCT01656252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663280|NCT01656304|Bevacizumab|bevacizumab|mesh-list
25663281|NCT01656304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25663282|NCT01656304|Antibodies|antibodies|mesh-list
25663283|NCT01656304|Immunoglobulins|immunoglobulins|mesh-list
24709660|NCT01506622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922432|NCT04180072|Growth Inhibitors|growth inhibitors|mesh-ancestor
24922434|NCT04180150|Antiviral Agents|antiviral agents|mesh-ancestor
24922435|NCT04180150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25068101|NCT03436303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25068102|NCT03436303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068103|NCT03436225|Dexamethasone|dexamethasone|mesh-list
25068104|NCT03436225|Dexamethasone acetate|dexamethasone acetate|mesh-list
25068105|NCT03436225|Budesonide|budesonide|mesh-list
25068106|NCT03436225|Albuterol|albuterol|mesh-list
25068107|NCT03436225|BB 1101|bb 1101|mesh-list
25068108|NCT03436225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25068109|NCT03436225|Antiemetics|antiemetics|mesh-ancestor
25068110|NCT03436225|Autonomic Agents|autonomic agents|mesh-ancestor
25202408|NCT02721511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068111|NCT03436225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25068112|NCT03436225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851838|NCT00054626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922458|NCT04179942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24922459|NCT04179942|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24922460|NCT04179942|Vasodilator Agents|vasodilator agents|mesh-ancestor
24922461|NCT04179942|Gasotransmitters|gasotransmitters|mesh-ancestor
24922462|NCT04179942|Protective Agents|protective agents|mesh-ancestor
24624051|NCT01074619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746104|NCT03383380|Antifungal Agents|antifungal agents|mesh-ancestor
24922464|NCT04179604|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24922465|NCT04179604|Vasodilator Agents|vasodilator agents|mesh-ancestor
25851839|NCT00054795|Motexafin gadolinium|motexafin gadolinium|mesh-list
24601725|NCT00965796|Anesthetics|anesthetics|mesh-ancestor
24922490|NCT04179513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922492|NCT04179513|Dermatologic Agents|dermatologic agents|mesh-ancestor
24611536|NCT01009944|Sympatholytics|sympatholytics|mesh-ancestor
24922493|NCT04179513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24922494|NCT04179513|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24922495|NCT04179513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24922496|NCT04179513|Immunologic Factors|immunologic factors|mesh-ancestor
24922497|NCT04179513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24922498|NCT04179513|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24922499|NCT04179617|Nicotine|nicotine|mesh-list
24922500|NCT04179617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24922501|NCT04179617|Autonomic Agents|autonomic agents|mesh-ancestor
24922502|NCT04179617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24922503|NCT04179617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068114|NCT03436225|Glucocorticoids|glucocorticoids|mesh-ancestor
25068115|NCT03436225|Hormones|hormones|mesh-ancestor
24922516|NCT04179071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922517|NCT04179071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922519|NCT04178863|Latanoprost|latanoprost|mesh-list
24922520|NCT04178863|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24922521|NCT04178863|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24922522|NCT04178863|Adrenergic Agents|adrenergic agents|mesh-ancestor
24922523|NCT04178863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24922524|NCT04178863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922525|NCT04178863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922526|NCT04178863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24922527|NCT04178863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24922528|NCT04178863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24922529|NCT04178863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24922530|NCT04179045|Sirolimus|sirolimus|mesh-list
24922531|NCT04179045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24922540|NCT04179006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24922541|NCT04178980|Simvastatin|simvastatin|mesh-list
24922542|NCT04178980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24922543|NCT04178980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24922544|NCT04178980|Antimetabolites|antimetabolites|mesh-ancestor
24498036|NCT00513110|Purinergic Agents|purinergic agents|mesh-ancestor
24498037|NCT00513110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24498038|NCT00513149|Clopidogrel|clopidogrel|mesh-list
24922545|NCT04178980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922546|NCT04178980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24922547|NCT04178980|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24922548|NCT04178980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24922549|NCT04178850|Folic Acid|folic acid|mesh-list
25663284|NCT01656304|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24922550|NCT04178850|Vitamin B Complex|vitamin b complex|mesh-list
24922551|NCT04178850|Infliximab|infliximab|mesh-list
24922553|NCT04178850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24922554|NCT04178850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24922555|NCT04178850|Hematinics|hematinics|mesh-ancestor
24922556|NCT04178850|Vitamins|vitamins|mesh-ancestor
24922557|NCT04178850|Micronutrients|micronutrients|mesh-ancestor
24922558|NCT04178850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922559|NCT04178876|Ethanol|ethanol|mesh-list
25068149|NCT03436121|Sensory System Agents|sensory system agents|mesh-ancestor
25068150|NCT03436121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25068151|NCT03436121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830646|NCT02160301|Glucocorticoids|glucocorticoids|mesh-ancestor
24922567|NCT04178655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498151|NCT00513383|Fluorouracil|fluorouracil|mesh-list
24498152|NCT00513383|Panitumumab|panitumumab|mesh-list
24498153|NCT00513383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24975532|NCT03477539|Lenalidomide|lenalidomide|mesh-list
24817368|NCT02083211|Nimotuzumab|nimotuzumab|mesh-list
24498154|NCT00513383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498155|NCT00513383|Tubulin Modulators|tubulin modulators|mesh-ancestor
25068163|NCT03436121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25068164|NCT03436121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25068165|NCT03436121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24953404|NCT03885219|Antimitotic Agents|antimitotic agents|mesh-ancestor
24953405|NCT03885219|Mitosis Modulators|mitosis modulators|mesh-ancestor
24953406|NCT03885219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953407|NCT03885180|Warfarin|warfarin|mesh-list
24922725|NCT04177173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24922726|NCT04177173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24922727|NCT04177173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24922728|NCT04177186|Botulinum Toxins|botulinum toxins|mesh-list
24603440|NCT00973804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24922729|NCT04177186|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24922730|NCT04177186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24498295|NCT00513955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24498296|NCT00513955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24498297|NCT00513955|Alkylating Agents|alkylating agents|mesh-ancestor
24498298|NCT00513955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498299|NCT00513955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498300|NCT00513955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24498301|NCT00513955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24922731|NCT04177186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922732|NCT04177186|Cholinergic Agents|cholinergic agents|mesh-ancestor
24922733|NCT04177186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24922734|NCT04177186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624118|NCT01074853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624119|NCT01074853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24624120|NCT01074853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25202409|NCT02721420|Piperaquine|piperaquine|mesh-list
24624121|NCT01074853|Vasodilator Agents|vasodilator agents|mesh-ancestor
25019040|NCT03694119|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25019041|NCT03694119|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25019042|NCT03694119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25019043|NCT03694119|Adrenergic Agents|adrenergic agents|mesh-ancestor
25019044|NCT03694119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25019045|NCT03694080|Calcium|calcium|mesh-list
24624123|NCT01074879|Chelating Agents|chelating agents|mesh-ancestor
24624124|NCT01074879|Sequestering Agents|sequestering agents|mesh-ancestor
24624125|NCT01074879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624126|NCT01074892|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24624128|NCT01074892|Medroxyprogesterone|medroxyprogesterone|mesh-list
24624129|NCT01074892|Progestins|progestins|mesh-list
24922789|NCT04177095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24624130|NCT01074892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24624131|NCT01074892|Contraceptive Agents|contraceptive agents|mesh-ancestor
24922798|NCT04177095|Antifungal Agents|antifungal agents|mesh-ancestor
24922799|NCT04176887|Phenytoin|phenytoin|mesh-list
24922800|NCT04176887|Levetiracetam|levetiracetam|mesh-list
24922801|NCT04176887|Anticonvulsants|anticonvulsants|mesh-ancestor
24922802|NCT04176887|Nootropic Agents|nootropic agents|mesh-ancestor
24922803|NCT04176887|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24922804|NCT04176887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24922805|NCT04176887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24922806|NCT04176887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922808|NCT04176887|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24922809|NCT04176978|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24922810|NCT04176978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24922811|NCT04176978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24922812|NCT04176978|Antimetabolites|antimetabolites|mesh-ancestor
24922813|NCT04176978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922851|NCT04175990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24855083|NCT02277171|Antioxidants|antioxidants|mesh-ancestor
24611555|NCT01009970|Immunologic Factors|immunologic factors|mesh-ancestor
24922852|NCT04175990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922853|NCT04176328|Teicoplanin|teicoplanin|mesh-list
24922854|NCT04176328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24408795|NCT00179699|Pemetrexed|pemetrexed|mesh-list
25068185|NCT03435744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24830727|NCT02160704|Clomiphene|clomiphene|mesh-list
24922875|NCT04175496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24922876|NCT04175522|Immunoglobulins|immunoglobulins|mesh-list
24922877|NCT04175522|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24922878|NCT04175522|Antibodies|antibodies|mesh-list
24922879|NCT04175522|Immunoglobulin G|immunoglobulin g|mesh-list
24922880|NCT04175522|Immunologic Factors|immunologic factors|mesh-ancestor
24922881|NCT04175522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922882|NCT04175587|Tretinoin|tretinoin|mesh-list
24922883|NCT04175587|Arsenic Trioxide|arsenic trioxide|mesh-list
24922884|NCT04175587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922885|NCT04175587|Keratolytic Agents|keratolytic agents|mesh-ancestor
24922886|NCT04175587|Dermatologic Agents|dermatologic agents|mesh-ancestor
24922887|NCT04175171|Trastuzumab|trastuzumab|mesh-list
24922888|NCT04175171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24922889|NCT04175171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922890|NCT04175093|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
24922891|NCT04175093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24922892|NCT04175093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922893|NCT04175158|Bevacizumab|bevacizumab|mesh-list
24922894|NCT04175158|Endothelial Growth Factors|endothelial growth factors|mesh-list
24922895|NCT04175158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24922896|NCT04175158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922897|NCT04175158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24922898|NCT04175158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24922899|NCT04175158|Growth Substances|growth substances|mesh-ancestor
25851840|NCT00054795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922925|NCT04174872|Adrenergic Agents|adrenergic agents|mesh-ancestor
24922926|NCT04174872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24922929|NCT04174872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24922930|NCT04174872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25202410|NCT02721420|Artenimol|artenimol|mesh-list
25202411|NCT02721420|Antimalarials|antimalarials|mesh-ancestor
25202412|NCT02721420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25202413|NCT02721420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25202414|NCT02721420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25202415|NCT02721368|Lidocaine|lidocaine|mesh-list
25202416|NCT02721368|Anesthetics, Local|anesthetics, local|mesh-ancestor
25851841|NCT00054795|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25851842|NCT00054795|Dermatologic Agents|dermatologic agents|mesh-ancestor
25851843|NCT00054808|Gallium nitrate|gallium nitrate|mesh-list
25851844|NCT00054808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25851845|NCT00054808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851846|NCT00054808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851847|NCT00054834|Epratuzumab|epratuzumab|mesh-list
25851848|NCT00054834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25851849|NCT00054834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922940|NCT04174339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24922941|NCT04174339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922942|NCT04174378|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24922943|NCT04174378|Luteolytic Agents|luteolytic agents|mesh-ancestor
24922944|NCT04174378|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24922945|NCT04174378|Contraceptive Agents|contraceptive agents|mesh-ancestor
24922946|NCT04174378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24922947|NCT04174378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498549|NCT00515268|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24498550|NCT00515268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24498551|NCT00515268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394641|NCT00133796|Trastuzumab|trastuzumab|mesh-list
24600424|NCT00082706|Antiviral Agents|antiviral agents|mesh-ancestor
24710056|NCT01508195|Canagliflozin|canagliflozin|mesh-list
24600425|NCT00082706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24600426|NCT00082706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851850|NCT00054873|Fluorouracil|fluorouracil|mesh-list
25851851|NCT00054873|Tezacitabine|tezacitabine|mesh-list
25851852|NCT00054873|Antimetabolites|antimetabolites|mesh-ancestor
24600476|NCT00958854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24600477|NCT00958854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24600478|NCT00958854|Growth Substances|growth substances|mesh-ancestor
24600479|NCT00958854|Growth Inhibitors|growth inhibitors|mesh-ancestor
24600481|NCT00958906|Dermatologic Agents|dermatologic agents|mesh-ancestor
24600482|NCT00958906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25202417|NCT02721368|Anesthetics|anesthetics|mesh-ancestor
25202418|NCT02721368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25202419|NCT02721368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202420|NCT02721368|Sensory System Agents|sensory system agents|mesh-ancestor
25202421|NCT02721368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202422|NCT02721368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25202423|NCT02721368|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25202424|NCT02721368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25202425|NCT02721368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25202426|NCT02721368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207735|NCT03462017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207736|NCT03462017|Urological Agents|urological agents|mesh-ancestor
25207737|NCT03462017|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25207738|NCT03462017|Cholinergic Agents|cholinergic agents|mesh-ancestor
25019210|NCT03692754|Calcium|calcium|mesh-list
24600483|NCT00958906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24600484|NCT00959062|Clonidine|clonidine|mesh-list
24600485|NCT00959062|Analgesics|analgesics|mesh-ancestor
24600486|NCT00959062|Sensory System Agents|sensory system agents|mesh-ancestor
24600487|NCT00959062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24600518|NCT00959218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068201|NCT03435666|Capecitabine|capecitabine|mesh-list
25068202|NCT03435666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25068203|NCT03435666|Antimetabolites|antimetabolites|mesh-ancestor
25068204|NCT03435666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068205|NCT03435666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25068206|NCT03435302|Temozolomide|temozolomide|mesh-list
25068207|NCT03435302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25068208|NCT03435302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25068209|NCT03435302|Alkylating Agents|alkylating agents|mesh-ancestor
25068210|NCT03435302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068211|NCT03435289|Gemcitabine|gemcitabine|mesh-list
25068212|NCT03435289|Paclitaxel|paclitaxel|mesh-list
24830743|NCT02160743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24600519|NCT00959218|Hormones|hormones|mesh-ancestor
24600520|NCT00959218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24600521|NCT00959231|Cyclosporine|cyclosporine|mesh-list
24600522|NCT00959231|Mycophenolic Acid|mycophenolic acid|mesh-list
24600523|NCT00959231|Cyclophosphamide|cyclophosphamide|mesh-list
24600556|NCT00959387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600557|NCT00959387|Tubulin Modulators|tubulin modulators|mesh-ancestor
24600558|NCT00959387|Antimitotic Agents|antimitotic agents|mesh-ancestor
24600559|NCT00959387|Mitosis Modulators|mitosis modulators|mesh-ancestor
24600560|NCT00959387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600561|NCT00959400|Fentanyl|fentanyl|mesh-list
24600562|NCT00959400|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24600654|NCT00959725|Infliximab|infliximab|mesh-list
24600655|NCT00959725|Dermatologic Agents|dermatologic agents|mesh-ancestor
24600656|NCT00959725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24600674|NCT00959933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24600675|NCT00959959|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
24600676|NCT00959959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600677|NCT00959959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600678|NCT00959972|Nicotine|nicotine|mesh-list
24600679|NCT00959972|Varenicline|varenicline|mesh-list
24600680|NCT00959972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24600681|NCT00959972|Autonomic Agents|autonomic agents|mesh-ancestor
24600682|NCT00959972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24600683|NCT00959972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600684|NCT00959972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24600685|NCT00959972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25068216|NCT03435289|Tubulin Modulators|tubulin modulators|mesh-ancestor
25851853|NCT00054873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849375|NCT00436254|Sargramostim|sargramostim|mesh-list
25068217|NCT03435289|Antimitotic Agents|antimitotic agents|mesh-ancestor
25068218|NCT03435289|Mitosis Modulators|mitosis modulators|mesh-ancestor
24830756|NCT02161159|Botulinum Toxins|botulinum toxins|mesh-list
24600708|NCT00960245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600709|NCT00960245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600710|NCT00960245|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24600711|NCT00960245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24600712|NCT00960245|Sympatholytics|sympatholytics|mesh-ancestor
24600713|NCT00960245|Autonomic Agents|autonomic agents|mesh-ancestor
24600714|NCT00960245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24600715|NCT00960284|Gemcitabine|gemcitabine|mesh-list
24636404|NCT01145326|Anesthetics|anesthetics|mesh-ancestor
24600799|NCT00960635|Micronutrients|micronutrients|mesh-ancestor
24600800|NCT00960635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600801|NCT00960635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24600802|NCT00960635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24600803|NCT00960635|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24600804|NCT00960635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24600805|NCT00960635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600806|NCT00960635|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24600807|NCT00960713|Rituximab|rituximab|mesh-list
24600835|NCT00960817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24600836|NCT00960817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600837|NCT00960817|Antipyretics|antipyretics|mesh-ancestor
25202427|NCT02721329|Acetaminophen|acetaminophen|mesh-list
25851854|NCT00054873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24600838|NCT00960817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24600839|NCT00960817|Vasodilator Agents|vasodilator agents|mesh-ancestor
24600841|NCT00960830|Antidepressive Agents|antidepressive agents|mesh-ancestor
24408944|NCT00180102|Cytarabine|cytarabine|mesh-list
24601033|NCT00962286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601035|NCT00962299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24601036|NCT00962299|Glucocorticoids|glucocorticoids|mesh-ancestor
24601037|NCT00962299|Hormones|hormones|mesh-ancestor
24601038|NCT00962299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24601039|NCT00962299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851855|NCT00054873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851856|NCT00054873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25851857|NCT00054873|Immunologic Factors|immunologic factors|mesh-ancestor
25851858|NCT00054873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851859|NCT00054873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851860|NCT00054886|Sunitinib|sunitinib|mesh-list
25851861|NCT00054886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851862|NCT00054886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25851863|NCT00054886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25851864|NCT00054886|Growth Substances|growth substances|mesh-ancestor
25068219|NCT03435289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068220|NCT03435289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25068222|NCT03435289|Antiviral Agents|antiviral agents|mesh-ancestor
25851865|NCT00054886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851866|NCT00054886|Growth Inhibitors|growth inhibitors|mesh-ancestor
24636487|NCT01145846|Daunorubicin|daunorubicin|mesh-list
24601094|NCT00962637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601095|NCT00962637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25851867|NCT00054886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24636504|NCT01145859|Antithrombins|antithrombins|mesh-ancestor
24636505|NCT01145859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24636506|NCT01145859|Protease Inhibitors|protease inhibitors|mesh-ancestor
24636507|NCT01145859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851868|NCT00054886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851869|NCT00054886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851870|NCT00054938|Aspirin|aspirin|mesh-list
25851871|NCT00054938|Ramipril|ramipril|mesh-list
25851872|NCT00054938|Pravastatin|pravastatin|mesh-list
24601198|NCT00963443|Autonomic Agents|autonomic agents|mesh-ancestor
24601199|NCT00963443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24601263|NCT00963703|Immunologic Factors|immunologic factors|mesh-ancestor
24601264|NCT00963703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601265|NCT00963703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24601266|NCT00963729|Cyclophosphamide|cyclophosphamide|mesh-list
24601267|NCT00963729|Docetaxel|docetaxel|mesh-list
24601268|NCT00963729|Fluorouracil|fluorouracil|mesh-list
24446966|NCT00306748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25663285|NCT01656304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851873|NCT00054938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469604|NCT00386529|Sensory System Agents|sensory system agents|mesh-ancestor
25155082|NCT05467826|Antiviral Agents|antiviral agents|mesh-ancestor
25155083|NCT05467826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24710162|NCT01508663|Immunologic Factors|immunologic factors|mesh-ancestor
24710163|NCT01508663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710164|NCT01508663|Protease Inhibitors|protease inhibitors|mesh-ancestor
24496270|NCT00504127|Naproxen|naproxen|mesh-list
24710165|NCT01508663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24710166|NCT01508663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710167|NCT01508741|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24710168|NCT01508741|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24710169|NCT01508741|Dermatologic Agents|dermatologic agents|mesh-ancestor
24710170|NCT01508806|Liraglutide|liraglutide|mesh-list
24710196|NCT01508858|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24710198|NCT01508858|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24710200|NCT01508884|Imiquimod|imiquimod|mesh-list
25238451|NCT02544789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24601269|NCT00963729|Letrozole|letrozole|mesh-list
24601270|NCT00963729|Epirubicin|epirubicin|mesh-list
24601271|NCT00963729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24601272|NCT00963729|Immunologic Factors|immunologic factors|mesh-ancestor
24601273|NCT00963729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601274|NCT00963729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24601275|NCT00963729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24601276|NCT00963729|Alkylating Agents|alkylating agents|mesh-ancestor
24601277|NCT00963729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851874|NCT00054938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25851875|NCT00054938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25851876|NCT00054938|Analgesics|analgesics|mesh-ancestor
24601298|NCT00963768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601300|NCT00963833|Interferon-beta|interferon-beta|mesh-list
24601301|NCT00963833|Interferon beta-1b|interferon beta-1b|mesh-list
24601469|NCT00964288|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24636556|NCT01146028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25202428|NCT02721329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25202429|NCT02721329|Analgesics|analgesics|mesh-ancestor
24636561|NCT01146041|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24636562|NCT01146041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636563|NCT01146041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851877|NCT00054938|Sensory System Agents|sensory system agents|mesh-ancestor
24601513|NCT00964561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24601514|NCT00964561|Antitubercular Agents|antitubercular agents|mesh-ancestor
24601661|NCT00965315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601662|NCT00965315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24601663|NCT00965315|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24601720|NCT00965666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24601721|NCT00965666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24601722|NCT00965666|Immunologic Factors|immunologic factors|mesh-ancestor
24601724|NCT00965796|Anesthetics, Local|anesthetics, local|mesh-ancestor
24601726|NCT00965796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24601727|NCT00965796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601728|NCT00965796|Sensory System Agents|sensory system agents|mesh-ancestor
24601823|NCT00966082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068224|NCT03435289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25068225|NCT03435289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25068226|NCT03435289|Immunologic Factors|immunologic factors|mesh-ancestor
24601824|NCT00966082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663286|NCT01656304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25663287|NCT01656304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25663288|NCT01656304|Growth Substances|growth substances|mesh-ancestor
25663289|NCT01656304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663290|NCT01656304|Growth Inhibitors|growth inhibitors|mesh-ancestor
25663291|NCT01656304|Immunologic Factors|immunologic factors|mesh-ancestor
25663292|NCT01656395|Montelukast|montelukast|mesh-list
25663293|NCT01656395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25663294|NCT01656395|Respiratory System Agents|respiratory system agents|mesh-ancestor
25663295|NCT01656395|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25663296|NCT01656395|Hormone Antagonists|hormone antagonists|mesh-ancestor
25663297|NCT01656395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25663298|NCT01656395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663299|NCT01656395|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25663300|NCT01656395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24601826|NCT00966082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24601828|NCT00966121|Propranolol|propranolol|mesh-list
24601829|NCT00966121|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24601830|NCT00966121|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24601831|NCT00966121|Adrenergic Agents|adrenergic agents|mesh-ancestor
25851878|NCT00054938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24601835|NCT00966121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24601836|NCT00966121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24601837|NCT00966121|Vasodilator Agents|vasodilator agents|mesh-ancestor
24601838|NCT00966160|Ritonavir|ritonavir|mesh-list
24601839|NCT00966160|Lopinavir|lopinavir|mesh-list
24601840|NCT00966160|Lamivudine|lamivudine|mesh-list
24601841|NCT00966160|Zidovudine|zidovudine|mesh-list
24601842|NCT00966160|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
24601878|NCT00966316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601879|NCT00966316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24601880|NCT00966316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24601881|NCT00966316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24601882|NCT00966316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24601883|NCT00966316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601884|NCT00966316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24601885|NCT00966316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24601886|NCT00966316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601887|NCT00966316|Antipyretics|antipyretics|mesh-ancestor
24601888|NCT00966329|Maraviroc|maraviroc|mesh-list
24601889|NCT00966329|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24601890|NCT00966329|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24601891|NCT00966329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602388|NCT00968578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25068227|NCT03435289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068229|NCT03435133|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25068230|NCT03435133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24602499|NCT00969085|Sensory System Agents|sensory system agents|mesh-ancestor
24602500|NCT00969085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24602501|NCT00969085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602502|NCT00969085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24602503|NCT00969085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24602504|NCT00969085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602505|NCT00969085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636634|NCT01146483|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24602506|NCT00969085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602508|NCT00969085|Protective Agents|protective agents|mesh-ancestor
24602509|NCT00969137|Nicotine|nicotine|mesh-list
24602510|NCT00969137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24396744|NCT00139854|Alprazolam|alprazolam|mesh-list
24602511|NCT00969137|Autonomic Agents|autonomic agents|mesh-ancestor
24636643|NCT01146535|Interferons|interferons|mesh-list
24602642|NCT00969982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24602643|NCT00969982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602644|NCT00969982|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24602645|NCT00969982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24602646|NCT00969982|Oxytocics|oxytocics|mesh-ancestor
24602647|NCT00969982|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24602648|NCT00969982|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25068231|NCT03435133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25068232|NCT03435133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25068233|NCT03435133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24602688|NCT00970450|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24602689|NCT00970450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24602690|NCT00970450|Serotonin Agents|serotonin agents|mesh-ancestor
24602691|NCT00970450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24602692|NCT00970450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602693|NCT00970528|Acarbose|acarbose|mesh-list
24602694|NCT00970528|Voglibose|voglibose|mesh-list
24602845|NCT00971165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24602846|NCT00971165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24602847|NCT00971165|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24602848|NCT00971165|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24602849|NCT00971165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602850|NCT00971165|Natriuretic Agents|natriuretic agents|mesh-ancestor
24602851|NCT00971165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25422761|NCT02427620|Abortifacient Agents|abortifacient agents|mesh-ancestor
24602954|NCT00971763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24602955|NCT00971763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24602956|NCT00971763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24602957|NCT00971763|Antimetabolites|antimetabolites|mesh-ancestor
24602958|NCT00971763|Antiviral Agents|antiviral agents|mesh-ancestor
24602959|NCT00971763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24602960|NCT00971763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24602961|NCT00971763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24602962|NCT00971763|Tubulin Modulators|tubulin modulators|mesh-ancestor
24603090|NCT00972387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24603091|NCT00972387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24603092|NCT00972387|Alkylating Agents|alkylating agents|mesh-ancestor
24603093|NCT00972387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603094|NCT00972387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603095|NCT00972387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24603096|NCT00972387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24603097|NCT00972387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24603098|NCT00972387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24603099|NCT00972387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603100|NCT00972387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24603101|NCT00972387|Glucocorticoids|glucocorticoids|mesh-ancestor
24603102|NCT00972387|Hormones|hormones|mesh-ancestor
24603103|NCT00972387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24603104|NCT00972387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24603105|NCT00972387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24603106|NCT00972387|Tubulin Modulators|tubulin modulators|mesh-ancestor
24603107|NCT00972387|Antimitotic Agents|antimitotic agents|mesh-ancestor
25851880|NCT00054938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24603108|NCT00972387|Mitosis Modulators|mitosis modulators|mesh-ancestor
24603109|NCT00972426|Timolol|timolol|mesh-list
25068234|NCT03435133|Purinergic Agents|purinergic agents|mesh-ancestor
25068235|NCT03435133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25068236|NCT03435133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068237|NCT03435133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068238|NCT03435107|Durvalumab|durvalumab|mesh-list
24603144|NCT00972660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603145|NCT00972660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24603175|NCT00972829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603176|NCT00972829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24603177|NCT00972829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24603178|NCT00972829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603179|NCT00972842|Lenalidomide|lenalidomide|mesh-list
24603180|NCT00972842|Vorinostat|vorinostat|mesh-list
24603181|NCT00972842|Immunologic Factors|immunologic factors|mesh-ancestor
24603182|NCT00972842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603183|NCT00972842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24603184|NCT00972842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24603185|NCT00972842|Growth Substances|growth substances|mesh-ancestor
24603186|NCT00972842|Growth Inhibitors|growth inhibitors|mesh-ancestor
25663301|NCT01656395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663302|NCT01656629|Vitamin D|vitamin d|mesh-list
25663303|NCT01656629|Alendronate|alendronate|mesh-list
25663304|NCT01656629|Teriparatide|teriparatide|mesh-list
25663305|NCT01656629|Calcium|calcium|mesh-list
25663306|NCT01656629|Vitamins|vitamins|mesh-ancestor
25663307|NCT01656629|Micronutrients|micronutrients|mesh-ancestor
25663308|NCT01656629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851881|NCT00054938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25005781|NCT02586675|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25005782|NCT02586675|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25005783|NCT02586675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25005784|NCT02572843|Durvalumab|durvalumab|mesh-list
25005785|NCT02572843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25005786|NCT02572843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603187|NCT00972842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603188|NCT00972842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24603189|NCT00972842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851882|NCT00054938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24636701|NCT01147016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603477|NCT00973999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24603478|NCT00973999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603479|NCT00973999|Cholinergic Agents|cholinergic agents|mesh-ancestor
24603480|NCT00973999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24603481|NCT00973999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603540|NCT00974324|Growth Substances|growth substances|mesh-ancestor
24603541|NCT00974324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603542|NCT00974324|Growth Inhibitors|growth inhibitors|mesh-ancestor
25068239|NCT03435107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24603652|NCT00974792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24603653|NCT00974792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24603654|NCT00974792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24603655|NCT00974792|Antiviral Agents|antiviral agents|mesh-ancestor
24603656|NCT00974792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24603657|NCT00974792|Antidotes|antidotes|mesh-ancestor
24603660|NCT00974792|Vitamins|vitamins|mesh-ancestor
25851883|NCT00054938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603752|NCT00975351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603753|NCT00975351|Vitamin B Complex|vitamin b complex|mesh-ancestor
24603754|NCT00975351|Vitamins|vitamins|mesh-ancestor
24603755|NCT00975351|Micronutrients|micronutrients|mesh-ancestor
24603756|NCT00975390|Caffeine|caffeine|mesh-list
24603757|NCT00975390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24603781|NCT00975663|Immunologic Factors|immunologic factors|mesh-ancestor
24603782|NCT00975663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671150|NCT01324063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671151|NCT01324063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24671152|NCT01324063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24671153|NCT01324063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24671154|NCT01324063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671155|NCT01324076|Doxorubicin|doxorubicin|mesh-list
24671156|NCT01324076|Sorafenib|sorafenib|mesh-list
24671157|NCT01324076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24671158|NCT01324076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603916|NCT00976105|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25851884|NCT00054938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24603954|NCT00976300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24603955|NCT00976300|Immunologic Factors|immunologic factors|mesh-ancestor
24603956|NCT00976300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202430|NCT02721329|Sensory System Agents|sensory system agents|mesh-ancestor
24603957|NCT00976300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24603958|NCT00976300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24604191|NCT00977444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24604192|NCT00977444|Protective Agents|protective agents|mesh-ancestor
24604193|NCT00977600|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
24604194|NCT00977600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604195|NCT00977756|Ritonavir|ritonavir|mesh-list
24604196|NCT00977756|Lopinavir|lopinavir|mesh-list
24604316|NCT00978471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24604317|NCT00978471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24604318|NCT00978471|Immunologic Factors|immunologic factors|mesh-ancestor
24604319|NCT00978471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604320|NCT00978549|Docetaxel|docetaxel|mesh-list
24604321|NCT00978549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604322|NCT00978549|Tubulin Modulators|tubulin modulators|mesh-ancestor
24604323|NCT00978549|Antimitotic Agents|antimitotic agents|mesh-ancestor
24604324|NCT00978549|Mitosis Modulators|mitosis modulators|mesh-ancestor
25422995|NCT02412670|Antiviral Agents|antiviral agents|mesh-ancestor
25663309|NCT01656629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25663310|NCT01656629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25663311|NCT01656733|Nicotine|nicotine|mesh-list
25663312|NCT01656733|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25663313|NCT01656733|Autonomic Agents|autonomic agents|mesh-ancestor
25663314|NCT01656733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24496418|NCT00504673|Insulin Detemir|insulin detemir|mesh-list
24604325|NCT00978549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604366|NCT00978861|Hydrogen Peroxide|hydrogen peroxide|mesh-list
24604380|NCT00978978|Fentanyl|fentanyl|mesh-list
24604381|NCT00978978|Midazolam|midazolam|mesh-list
24604382|NCT00978978|Propofol|propofol|mesh-list
24604383|NCT00978978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24604384|NCT00978978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24604385|NCT00978978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604386|NCT00978978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24604387|NCT00978978|Anesthetics, General|anesthetics, general|mesh-ancestor
24604388|NCT00978978|Anesthetics|anesthetics|mesh-ancestor
24604389|NCT00978978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24604390|NCT00978978|Narcotics|narcotics|mesh-ancestor
24604391|NCT00978978|Analgesics|analgesics|mesh-ancestor
24604392|NCT00978978|Sensory System Agents|sensory system agents|mesh-ancestor
24604393|NCT00978978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812723|NCT02054299|Analgesics|analgesics|mesh-ancestor
24604394|NCT00978978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24604395|NCT00978978|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24604396|NCT00978978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24604397|NCT00978978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24604400|NCT00978978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24604401|NCT00978978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604403|NCT00979056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24604404|NCT00979056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24604405|NCT00979056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24604407|NCT00979160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604408|NCT00979160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24604409|NCT00979160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604448|NCT00979589|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24604449|NCT00979589|Purinergic Agents|purinergic agents|mesh-ancestor
24604450|NCT00979589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24604451|NCT00979589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604452|NCT00979589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604453|NCT00979589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24604514|NCT00979862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24604515|NCT00979966|Sirolimus|sirolimus|mesh-list
24604516|NCT00979966|Sunitinib|sunitinib|mesh-list
24604517|NCT00979966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851885|NCT00054938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24604529|NCT00979966|Antifungal Agents|antifungal agents|mesh-ancestor
24604530|NCT00979966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24604531|NCT00979966|Immunologic Factors|immunologic factors|mesh-ancestor
24604532|NCT00980031|Eplerenone|eplerenone|mesh-list
24604533|NCT00980031|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24604534|NCT00980031|Hormone Antagonists|hormone antagonists|mesh-ancestor
24604535|NCT00980031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24604536|NCT00980031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604537|NCT00980031|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24604881|NCT00981955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24604882|NCT00981955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604957|NCT00982540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604958|NCT00982540|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24605017|NCT00982891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24605018|NCT00982891|Narcotics|narcotics|mesh-ancestor
24605019|NCT00982891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24605020|NCT00982891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605022|NCT00982891|Sensory System Agents|sensory system agents|mesh-ancestor
24605023|NCT00982891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24605024|NCT00983021|Insulin|insulin|mesh-list
24605025|NCT00983021|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24605026|NCT00983021|Liraglutide|liraglutide|mesh-list
24409267|NCT00181662|Curcumin|curcumin|mesh-list
24605451|NCT00985270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24605453|NCT00985270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24605454|NCT00985270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605455|NCT00985270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605456|NCT00985270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24605457|NCT00985270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24605458|NCT00985270|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24605459|NCT00985270|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24605460|NCT00985270|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24605461|NCT00985270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24605462|NCT00985322|Ramipril|ramipril|mesh-list
24605463|NCT00985322|Antihypertensive Agents|antihypertensive agents|mesh-list
24605464|NCT00985322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24605465|NCT00985322|Protease Inhibitors|protease inhibitors|mesh-ancestor
24605466|NCT00985322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25068260|NCT03434782|Protective Agents|protective agents|mesh-ancestor
25068261|NCT03434782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068262|NCT03434782|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25068263|NCT03434782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25068264|NCT03434704|Antifungal Agents|antifungal agents|mesh-list
24605467|NCT00985322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605469|NCT00985348|Anticonvulsants|anticonvulsants|mesh-ancestor
24605504|NCT00985608|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24605505|NCT00985608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24605506|NCT00985608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24605507|NCT00985608|Antitubercular Agents|antitubercular agents|mesh-ancestor
24605508|NCT00985647|Lamivudine|lamivudine|mesh-list
24605509|NCT00985647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24605605|NCT00986336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24605609|NCT00986336|Dopamine Agents|dopamine agents|mesh-ancestor
24605610|NCT00986336|Anticonvulsants|anticonvulsants|mesh-ancestor
24605611|NCT00986336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24605613|NCT00986466|Ergocalciferols|ergocalciferols|mesh-list
24605614|NCT00986466|Cholecalciferol|cholecalciferol|mesh-list
24605615|NCT00986466|Vitamins|vitamins|mesh-list
24605616|NCT00986466|Micronutrients|micronutrients|mesh-ancestor
24605617|NCT00986466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605618|NCT00986466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24605619|NCT00986466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24605620|NCT00986505|Lidocaine|lidocaine|mesh-list
24409370|NCT00181896|Bupropion|bupropion|mesh-list
25068283|NCT03434704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25068284|NCT03434704|Hormone Antagonists|hormone antagonists|mesh-ancestor
25068285|NCT03434704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25068286|NCT03434704|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25068287|NCT03434704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25068288|NCT03434691|Remifentanil|remifentanil|mesh-list
25068289|NCT03434691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25068290|NCT03434691|Narcotics|narcotics|mesh-ancestor
25068291|NCT03434691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25068292|NCT03434691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068293|NCT03434691|Analgesics|analgesics|mesh-ancestor
24953446|NCT03885141|GABA Agonists|gaba agonists|mesh-ancestor
25068294|NCT03434691|Sensory System Agents|sensory system agents|mesh-ancestor
24605657|NCT00986609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605658|NCT00986609|Interferon Inducers|interferon inducers|mesh-ancestor
24605659|NCT00986609|Laxatives|laxatives|mesh-ancestor
24605660|NCT00986609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24605661|NCT00986609|Antiviral Agents|antiviral agents|mesh-ancestor
24605662|NCT00986609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24605663|NCT00986713|Amphotericin B|amphotericin b|mesh-list
24605664|NCT00986713|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24605665|NCT00986713|Amebicides|amebicides|mesh-ancestor
24605823|NCT00987493|Immunologic Factors|immunologic factors|mesh-ancestor
24605824|NCT00987493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605825|NCT00987493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24605826|NCT00987493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24605827|NCT00987493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24605828|NCT00987493|Growth Substances|growth substances|mesh-ancestor
24605829|NCT00987493|Growth Inhibitors|growth inhibitors|mesh-ancestor
24605830|NCT00987493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24605831|NCT00987493|Alkylating Agents|alkylating agents|mesh-ancestor
24605832|NCT00987493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605833|NCT00987636|Zoledronic Acid|zoledronic acid|mesh-list
24605834|NCT00987636|Diphosphonates|diphosphonates|mesh-list
24605836|NCT00987636|Treosulfan|treosulfan|mesh-list
24605837|NCT00987636|Alkylating Agents|alkylating agents|mesh-ancestor
24605838|NCT00987636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605960|NCT00988195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605961|NCT00988195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605962|NCT00988312|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
24605963|NCT00988312|Immunologic Factors|immunologic factors|mesh-ancestor
24605964|NCT00988312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851886|NCT00054938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851887|NCT00054938|Antipyretics|antipyretics|mesh-ancestor
24710603|NCT01511211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24710604|NCT01511211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25851888|NCT00054938|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25851889|NCT00054938|Protease Inhibitors|protease inhibitors|mesh-ancestor
24606390|NCT00990223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24606392|NCT00990275|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24606393|NCT00990275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24606397|NCT00990301|Moexipril|moexipril|mesh-list
24606468|NCT00990600|Tenofovir|tenofovir|mesh-list
25068316|NCT03434613|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25068317|NCT03434613|Ezetimibe|ezetimibe|mesh-list
25068318|NCT03434613|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24606469|NCT00990600|Emtricitabine|emtricitabine|mesh-list
24606470|NCT00990600|Efavirenz|efavirenz|mesh-list
24606471|NCT00990600|Antiviral Agents|antiviral agents|mesh-ancestor
24606472|NCT00990600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24606579|NCT00990990|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24606581|NCT00990990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606582|NCT00991055|Pioglitazone|pioglitazone|mesh-list
24606583|NCT00991055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25851890|NCT00054938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24606658|NCT00991627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606659|NCT00991627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24606668|NCT00991705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606669|NCT00991705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24606670|NCT00991705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24606671|NCT00991705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606674|NCT00991744|Prednisolone|prednisolone|mesh-list
24606675|NCT00991744|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24606676|NCT00991744|Methylprednisolone|methylprednisolone|mesh-list
24606677|NCT00991744|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24606726|NCT00991822|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25068326|NCT03434340|Dexamethasone|dexamethasone|mesh-list
25068327|NCT03434340|Granisetron|granisetron|mesh-list
25068328|NCT03434340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25068329|NCT03434340|Antiemetics|antiemetics|mesh-ancestor
25068330|NCT03434340|Autonomic Agents|autonomic agents|mesh-ancestor
24830852|NCT02161692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830853|NCT02161692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24830854|NCT02161770|Osimertinib|osimertinib|mesh-list
25851891|NCT00054938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24606832|NCT05408000|Anesthetics, General|anesthetics, general|mesh-ancestor
24606833|NCT05408000|Anesthetics|anesthetics|mesh-ancestor
24606834|NCT05407870|Propofol|propofol|mesh-list
24606835|NCT05407870|Etomidate|etomidate|mesh-list
24606836|NCT05407870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24671259|NCT01324583|Hormones|hormones|mesh-ancestor
24606837|NCT05407870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24606838|NCT05407870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606839|NCT05407870|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24606840|NCT05407870|Anesthetics, General|anesthetics, general|mesh-ancestor
24606841|NCT05407870|Anesthetics|anesthetics|mesh-ancestor
24607180|NCT05072093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24607182|NCT05072093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607183|NCT05072093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24607184|NCT05072093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24607185|NCT05072093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24607186|NCT05072093|Antimalarials|antimalarials|mesh-ancestor
24607187|NCT05072093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24607188|NCT05072093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24607227|NCT04994561|Micronutrients|micronutrients|mesh-ancestor
24607228|NCT04965818|Futibatinib|futibatinib|mesh-list
24607794|NCT03646474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25851892|NCT00054938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25851893|NCT00054938|Antimetabolites|antimetabolites|mesh-ancestor
25851894|NCT00054938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25851895|NCT00054938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25851896|NCT00054977|Fluorouracil|fluorouracil|mesh-list
25851897|NCT00054977|Antimetabolites|antimetabolites|mesh-ancestor
25851898|NCT00054977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607956|NCT03084237|Antimitotic Agents|antimitotic agents|mesh-ancestor
24637102|NCT01148615|Docetaxel|docetaxel|mesh-list
24607957|NCT03084237|Mitosis Modulators|mitosis modulators|mesh-ancestor
24607958|NCT03084237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663315|NCT01656733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663316|NCT01656733|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24710724|NCT01511705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710725|NCT01511705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24710727|NCT01511705|Dermatologic Agents|dermatologic agents|mesh-ancestor
25273818|NCT02382380|Sequestering Agents|sequestering agents|mesh-ancestor
25273819|NCT02382380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273820|NCT02382263|Gemcitabine|gemcitabine|mesh-list
24607959|NCT03084237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24671328|NCT01324960|Aldesleukin|aldesleukin|mesh-list
25020140|NCT03683043|Leuprolide|leuprolide|mesh-list
24608241|NCT01661881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25851899|NCT00054977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24608242|NCT01661881|Alkylating Agents|alkylating agents|mesh-ancestor
24671339|NCT01324960|Antiviral Agents|antiviral agents|mesh-ancestor
24608602|NCT00992706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608603|NCT00992706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24608604|NCT00992706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25068336|NCT03434340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25068337|NCT03434340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25068338|NCT03434340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25068339|NCT03434340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25068340|NCT03434340|Serotonin Agents|serotonin agents|mesh-ancestor
25068341|NCT03434340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25068342|NCT03434340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068344|NCT03434275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25068345|NCT03434275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24830866|NCT02161822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830867|NCT02161939|Sofosbuvir|sofosbuvir|mesh-list
24830868|NCT02161939|Antiviral Agents|antiviral agents|mesh-ancestor
24830869|NCT02161939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24608605|NCT00992706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608606|NCT00992706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608607|NCT00992758|Tositumomab I-131|tositumomab i-131|mesh-list
24608608|NCT00992758|Antibodies|antibodies|mesh-list
24608609|NCT00992758|Immunologic Factors|immunologic factors|mesh-ancestor
24608610|NCT00992758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608611|NCT00992758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608833|NCT00993876|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24671707|NCT01327235|Endostar protein|endostar protein|mesh-list
24608835|NCT00993876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24608836|NCT00993876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608837|NCT00993876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24608838|NCT00993876|Serotonin Agents|serotonin agents|mesh-ancestor
24609139|NCT00995059|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24609140|NCT00995059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609141|NCT00995059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068346|NCT03434275|Analgesics|analgesics|mesh-ancestor
25851900|NCT00054977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609142|NCT00995059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609143|NCT00995059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24609144|NCT00995059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24609184|NCT00995306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24609185|NCT00995306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609243|NCT00995618|Histamine Agents|histamine agents|mesh-ancestor
24609244|NCT00995618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24637234|NCT01149356|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24609245|NCT00995618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24609289|NCT00995917|Vitamin K|vitamin k|mesh-list
24609290|NCT00995917|Vitamins|vitamins|mesh-ancestor
24609291|NCT00995917|Micronutrients|micronutrients|mesh-ancestor
24609292|NCT00995917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609293|NCT00995917|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24609294|NCT00995917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24609295|NCT00995917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609296|NCT00995917|Hemostatics|hemostatics|mesh-ancestor
24609411|NCT00996515|Azacitidine|azacitidine|mesh-list
24609412|NCT00996515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663317|NCT01656733|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25663318|NCT01656733|Cholinergic Agents|cholinergic agents|mesh-ancestor
25663319|NCT01656733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25663320|NCT01656733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663321|NCT01657019|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25663322|NCT01657019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25238640|NCT05225974|Hormones|hormones|mesh-ancestor
24609413|NCT00996515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24609414|NCT00996515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851901|NCT00054977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24609415|NCT00996515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609467|NCT00996866|Cholecalciferol|cholecalciferol|mesh-list
24609468|NCT00996866|Vitamins|vitamins|mesh-ancestor
24609469|NCT00996866|Micronutrients|micronutrients|mesh-ancestor
24609470|NCT00996866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609471|NCT00996866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25202431|NCT02721329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24609472|NCT00996866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24609491|NCT00996983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609492|NCT00996983|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24609512|NCT00997022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24609514|NCT00997022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609515|NCT00997061|Topotecan|topotecan|mesh-list
24609516|NCT00997061|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24609517|NCT00997061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24609518|NCT00997061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609519|NCT00997061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609520|NCT00997061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609521|NCT00997074|Ibuprofen|ibuprofen|mesh-list
24609522|NCT00997074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
24609523|NCT00997074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24609524|NCT00997074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24609525|NCT00997074|Analgesics|analgesics|mesh-ancestor
24637303|NCT01149798|Cisplatin|cisplatin|mesh-list
24609866|NCT00998634|Antidepressive Agents|antidepressive agents|mesh-ancestor
24609867|NCT00998634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24609868|NCT00998634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609869|NCT00998634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609897|NCT00998816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24609899|NCT00998920|Phytoestrogens|phytoestrogens|mesh-ancestor
24609900|NCT00998920|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24609901|NCT00998920|Estrogens|estrogens|mesh-ancestor
24609902|NCT00998920|Hormones|hormones|mesh-ancestor
24609903|NCT00998920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24609964|NCT00999258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24609965|NCT00999258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24609981|NCT00999297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24610024|NCT00999479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24610025|NCT00999479|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24610027|NCT00999479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24610028|NCT00999479|Trace Elements|trace elements|mesh-ancestor
24610029|NCT00999479|Micronutrients|micronutrients|mesh-ancestor
24610031|NCT00999505|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24610040|NCT00999505|Analgesics|analgesics|mesh-ancestor
24610264|NCT01000857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068349|NCT03434275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068350|NCT03434275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25068351|NCT03434275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25068352|NCT03434275|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25068353|NCT03434275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25068354|NCT03434275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25068355|NCT03434275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953512|NCT03884127|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24830878|NCT02161952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24830879|NCT02161952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24830881|NCT02161965|Rivaroxaban|rivaroxaban|mesh-list
25851902|NCT00054977|Immunologic Factors|immunologic factors|mesh-ancestor
25851903|NCT00054977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610265|NCT01000857|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24610367|NCT01001637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24610368|NCT01001637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610369|NCT01001637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24610370|NCT01001637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24610371|NCT01001637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610372|NCT01001637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671449|NCT01325935|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24671451|NCT01325935|Purinergic Agents|purinergic agents|mesh-ancestor
24671452|NCT01325935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25851904|NCT00055042|Vitamin E|vitamin e|mesh-list
25851905|NCT00055042|Vitamins|vitamins|mesh-ancestor
24671481|NCT01326117|Vasodilator Agents|vasodilator agents|mesh-ancestor
24671482|NCT01326117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24671483|NCT01326117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24671484|NCT01326117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202432|NCT02721329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671485|NCT01326117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671531|NCT01326442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24671532|NCT01326468|Sirolimus|sirolimus|mesh-list
24671533|NCT01326468|Cisplatin|cisplatin|mesh-list
24671534|NCT01326468|Cetuximab|cetuximab|mesh-list
24671535|NCT01326468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24671536|NCT01326468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24671537|NCT01326468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24671538|NCT01326468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24671539|NCT01326468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25068357|NCT03434197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25068358|NCT03434197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25068359|NCT03434197|Analgesics|analgesics|mesh-ancestor
25068360|NCT03434197|Sensory System Agents|sensory system agents|mesh-ancestor
25068361|NCT03434197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25068362|NCT03434197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068363|NCT03434197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25068364|NCT03434197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24830882|NCT02161965|Fluindione|fluindione|mesh-list
24671540|NCT01326468|Antifungal Agents|antifungal agents|mesh-ancestor
24671541|NCT01326468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24671542|NCT01326468|Immunologic Factors|immunologic factors|mesh-ancestor
24671655|NCT01327027|Vasopressins|vasopressins|mesh-list
24671656|NCT01327027|Arginine Vasopressin|arginine vasopressin|mesh-list
24671657|NCT01327027|Hemostatics|hemostatics|mesh-ancestor
24671658|NCT01327027|Coagulants|coagulants|mesh-ancestor
24671659|NCT01327027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24671660|NCT01327027|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24671661|NCT01327027|Natriuretic Agents|natriuretic agents|mesh-ancestor
24671662|NCT01327027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671663|NCT01327066|Moxifloxacin|moxifloxacin|mesh-list
24671697|NCT01327144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671698|NCT01327222|Bevacizumab|bevacizumab|mesh-list
24671699|NCT01327222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24671700|NCT01327222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24671701|NCT01327222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24671702|NCT01327222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24671703|NCT01327222|Growth Substances|growth substances|mesh-ancestor
24671704|NCT01327222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671705|NCT01327222|Growth Inhibitors|growth inhibitors|mesh-ancestor
24671708|NCT01327235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24671709|NCT01327235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24671710|NCT01327235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24671711|NCT01327235|Growth Substances|growth substances|mesh-ancestor
24671712|NCT01327235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671713|NCT01327235|Growth Inhibitors|growth inhibitors|mesh-ancestor
24671715|NCT01327261|Benserazide|benserazide|mesh-list
24671716|NCT01327261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24671717|NCT01327261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24671718|NCT01327261|Dopamine Agents|dopamine agents|mesh-ancestor
24671719|NCT01327261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24671720|NCT01327261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671721|NCT01327261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671722|NCT01327261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671723|NCT01327326|Naltrexone|naltrexone|mesh-list
25068365|NCT03434197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25851906|NCT00055042|Micronutrients|micronutrients|mesh-ancestor
25851907|NCT00055042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671855|NCT01328171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671856|NCT01328171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671857|NCT01328171|Hematinics|hematinics|mesh-ancestor
24671859|NCT01328171|Micronutrients|micronutrients|mesh-ancestor
24671860|NCT01328171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24671861|NCT01328223|Sorafenib|sorafenib|mesh-list
24671866|NCT01328236|Dexamethasone|dexamethasone|mesh-list
24671906|NCT01328340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24671907|NCT01328340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671908|NCT01328340|Adrenergic Agents|adrenergic agents|mesh-ancestor
24671909|NCT01328340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25851908|NCT00055042|Antioxidants|antioxidants|mesh-ancestor
25238675|NCT05224492|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25238676|NCT05224492|Protective Agents|protective agents|mesh-ancestor
25238677|NCT05224492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238678|NCT05224492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25238686|NCT05171972|Ofatumumab|ofatumumab|mesh-list
25238687|NCT05171972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24671910|NCT01328340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24671911|NCT01328340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24671912|NCT01328340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24671913|NCT01328392|Dexlansoprazole|dexlansoprazole|mesh-list
24672008|NCT01329250|Moxifloxacin|moxifloxacin|mesh-list
24672009|NCT01329250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24672010|NCT01329250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24672011|NCT01329250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24672012|NCT01329250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24672013|NCT01329250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672014|NCT01329250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672015|NCT01329250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24456048|NCT00329693|Dopamine Agents|dopamine agents|mesh-ancestor
24456049|NCT00329693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24672053|NCT01329406|Sensory System Agents|sensory system agents|mesh-ancestor
24672054|NCT01329406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24672055|NCT01329406|Antidepressive Agents|antidepressive agents|mesh-ancestor
25068370|NCT03434106|Plasma Substitutes|plasma substitutes|mesh-ancestor
25068371|NCT03434106|Blood Substitutes|blood substitutes|mesh-ancestor
25068372|NCT03434054|Losartan|losartan|mesh-list
25068373|NCT03434054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25068374|NCT03434054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25068375|NCT03434054|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25068376|NCT03434054|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25068377|NCT03434054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068378|NCT03433976|Anesthetics|anesthetics|mesh-list
25068379|NCT03433976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25068380|NCT03433976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068381|NCT03433859|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24830891|NCT02161991|Aprepitant|aprepitant|mesh-list
24830892|NCT02161991|Antiemetics|antiemetics|mesh-ancestor
24672056|NCT01329406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24672057|NCT01329588|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24672058|NCT01329588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24672059|NCT01329614|Nicotine|nicotine|mesh-list
24672060|NCT01329614|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24672062|NCT01329614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24672102|NCT01329640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672103|NCT01329640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24672104|NCT01329640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24672105|NCT01329640|Alkylating Agents|alkylating agents|mesh-ancestor
24672106|NCT01329640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24672107|NCT01329640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24672108|NCT01329666|Vitamin D|vitamin d|mesh-list
24672109|NCT01329666|Cholecalciferol|cholecalciferol|mesh-list
24672110|NCT01329666|Vitamins|vitamins|mesh-ancestor
24672111|NCT01329666|Micronutrients|micronutrients|mesh-ancestor
24672112|NCT01329666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672113|NCT01329666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25851909|NCT00055042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851910|NCT00055042|Protective Agents|protective agents|mesh-ancestor
24672197|NCT01330563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24672198|NCT01330563|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24672199|NCT01330563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24672201|NCT01330563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851911|NCT00055107|Nitazoxanide|nitazoxanide|mesh-list
24830895|NCT02161991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851912|NCT00055107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24672339|NCT01331590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672445|NCT01332201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663323|NCT01657019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663324|NCT01657019|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25663325|NCT01657019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25663326|NCT01657019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25663327|NCT01657019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238711|NCT05157412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25238712|NCT05157412|Antiemetics|antiemetics|mesh-ancestor
25238713|NCT05157412|Autonomic Agents|autonomic agents|mesh-ancestor
25238714|NCT05157412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25238715|NCT05157412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25238716|NCT05157412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25238717|NCT05157412|Protective Agents|protective agents|mesh-ancestor
25238718|NCT05157412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25238719|NCT05157412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25238720|NCT05157412|Antimalarials|antimalarials|mesh-ancestor
25238721|NCT05157412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25238722|NCT05157412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25238723|NCT05155436|Amlodipine|amlodipine|mesh-list
25238724|NCT05155436|Telmisartan|telmisartan|mesh-list
25238725|NCT05155436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25238726|NCT05155436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24811661|NCT02047552|Androgens|androgens|mesh-ancestor
24672446|NCT01332201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24672447|NCT01332201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672448|NCT01332201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672450|NCT01332279|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24688278|NCT03191240|Coagulants|coagulants|mesh-ancestor
24672451|NCT01332279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672452|NCT01332279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24672453|NCT01332279|Immunologic Factors|immunologic factors|mesh-ancestor
24672454|NCT01332279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672455|NCT01332279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24672456|NCT01332279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672457|NCT01332279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672458|NCT01332344|Fluticasone|fluticasone|mesh-list
24672459|NCT01332344|Xhance|xhance|mesh-list
24672460|NCT01332344|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24672461|NCT01332344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24672605|NCT01332617|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24672606|NCT01332617|Protective Agents|protective agents|mesh-ancestor
24672607|NCT01332617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24672608|NCT01332617|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24672609|NCT01332617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24672610|NCT01332617|Antimetabolites|antimetabolites|mesh-ancestor
24672611|NCT01332617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672612|NCT01332617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24672614|NCT01332617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672650|NCT01332786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24672651|NCT01332786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672652|NCT01332786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672653|NCT01332929|Bevacizumab|bevacizumab|mesh-list
24672654|NCT01332929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24672655|NCT01332929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672656|NCT01332929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24672808|NCT01333878|Abatacept|abatacept|mesh-list
25068389|NCT03433859|Cholinergic Agents|cholinergic agents|mesh-ancestor
25068390|NCT03433859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25068391|NCT03433807|Idebenone|idebenone|mesh-list
25068392|NCT03433807|Antioxidants|antioxidants|mesh-ancestor
25068393|NCT03433807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068394|NCT03433807|Protective Agents|protective agents|mesh-ancestor
25663328|NCT01657019|Dopamine Agents|dopamine agents|mesh-ancestor
25663329|NCT01657019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25663330|NCT01657162|Alendronate|alendronate|mesh-list
25663331|NCT01657162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25663332|NCT01657162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663333|NCT01657266|Nepafenac|nepafenac|mesh-list
25663334|NCT01657266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25663335|NCT01657266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25663336|NCT01657266|Analgesics|analgesics|mesh-ancestor
25663337|NCT01657266|Sensory System Agents|sensory system agents|mesh-ancestor
25663338|NCT01657266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25663339|NCT01657266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663340|NCT01657266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25663341|NCT01657266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25663342|NCT01657292|Octenidine|octenidine|mesh-list
25663343|NCT01657292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25663344|NCT01657292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24672809|NCT01333878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24672989|NCT01334645|Natriuretic Agents|natriuretic agents|mesh-ancestor
24672990|NCT01334645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672991|NCT01334671|Atorvastatin|atorvastatin|mesh-list
24672992|NCT01334671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24672993|NCT01334671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24672994|NCT01334671|Antimetabolites|antimetabolites|mesh-ancestor
24672995|NCT01334671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672996|NCT01334671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24673221|NCT01336218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25663345|NCT01657461|Plasminogen|plasminogen|mesh-list
25663346|NCT01657461|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25663347|NCT01657461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25663348|NCT01657461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25663349|NCT01657461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663350|NCT01657760|Citalopram|citalopram|mesh-list
25663351|NCT01657760|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25663352|NCT01657760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25663353|NCT01657760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25663354|NCT01657760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663355|NCT01657760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25663356|NCT01657760|Serotonin Agents|serotonin agents|mesh-ancestor
25663357|NCT01657760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663358|NCT01657760|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25663359|NCT01657760|Antidepressive Agents|antidepressive agents|mesh-ancestor
25663360|NCT01657760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25663361|NCT01657799|Veliparib|veliparib|mesh-list
25663362|NCT01657799|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25663363|NCT01657799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663364|NCT01657799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663365|NCT01657799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663366|NCT01657877|Calcium|calcium|mesh-list
25663367|NCT01657877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24673227|NCT01336322|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24673228|NCT01336322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24673229|NCT01336322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673230|NCT01336322|Incretins|incretins|mesh-ancestor
24673249|NCT01336439|Cholinergic Agents|cholinergic agents|mesh-ancestor
24673250|NCT01336439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24673251|NCT01336439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673252|NCT01336439|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24673253|NCT01336439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24673254|NCT01336543|Gemcitabine|gemcitabine|mesh-list
24673274|NCT01336582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673275|NCT01336582|Tubulin Modulators|tubulin modulators|mesh-ancestor
24673276|NCT01336582|Antimitotic Agents|antimitotic agents|mesh-ancestor
24673297|NCT01336751|Insulin Glargine|insulin glargine|mesh-list
24673298|NCT01336751|Insulin Lispro|insulin lispro|mesh-list
24673299|NCT01336751|Protamines|protamines|mesh-list
24673300|NCT01336751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24673301|NCT01336751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673302|NCT01336751|Heparin Antagonists|heparin antagonists|mesh-ancestor
24673303|NCT01336751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673304|NCT01336751|Coagulants|coagulants|mesh-ancestor
24447374|NCT00308334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014456|NCT04517435|Hormones|hormones|mesh-ancestor
24447375|NCT00308334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24673305|NCT01336829|Rilpivirine|rilpivirine|mesh-list
25068403|NCT03433586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25068404|NCT03433586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25068405|NCT03433586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25068406|NCT03433586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25068407|NCT03433586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610487|NCT01002690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610488|NCT01002703|Prednisone|prednisone|mesh-list
24610489|NCT01002703|Lenalidomide|lenalidomide|mesh-list
24610490|NCT01002703|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24610491|NCT01002703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24673491|NCT01338337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673492|NCT01338337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673493|NCT01338389|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
24673494|NCT01338389|Nootropic Agents|nootropic agents|mesh-ancestor
24673495|NCT01338441|Erythromycin|erythromycin|mesh-list
24673496|NCT01338441|Erythromycin Estolate|erythromycin estolate|mesh-list
24673497|NCT01338441|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24673535|NCT01338753|Bevacizumab|bevacizumab|mesh-list
24673536|NCT01338753|Docetaxel|docetaxel|mesh-list
24673537|NCT01338753|Doxorubicin|doxorubicin|mesh-list
24673538|NCT01338753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24673539|NCT01338753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673540|NCT01338753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24673555|NCT01338844|Vitamins|vitamins|mesh-ancestor
25663368|NCT01657877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663369|NCT01657903|Listerine|listerine|mesh-list
25663370|NCT01657903|Fluorides|fluorides|mesh-list
25663371|NCT01657903|Sodium Fluoride|sodium fluoride|mesh-list
25663372|NCT01657903|Cariostatic Agents|cariostatic agents|mesh-ancestor
25663373|NCT01657903|Protective Agents|protective agents|mesh-ancestor
25663374|NCT01657903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663375|NCT01657903|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25663376|NCT01657903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25663377|NCT01658020|Moxifloxacin|moxifloxacin|mesh-list
25663378|NCT01658020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25663379|NCT01658020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25005860|NCT01822652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005861|NCT01822652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005862|NCT01822652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25005863|NCT01822652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25005864|NCT01822652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25005865|NCT01822652|Antimetabolites|antimetabolites|mesh-ancestor
25005866|NCT01821690|Buspirone|buspirone|mesh-list
25876183|NCT03847896|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24673575|NCT01338922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24673576|NCT01338922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673577|NCT01339026|Clopidogrel|clopidogrel|mesh-list
24673578|NCT01339026|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24673579|NCT01339026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24673580|NCT01339026|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24675803|NCT01345370|Temozolomide|temozolomide|mesh-list
24673581|NCT01339026|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24673582|NCT01339026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24673583|NCT01339026|Purinergic Agents|purinergic agents|mesh-ancestor
24673584|NCT01339026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24673585|NCT01339026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688760|NCT02711826|Anesthetics|anesthetics|mesh-ancestor
24673586|NCT01339026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673587|NCT01339039|Plerixafor|plerixafor|mesh-list
24673849|NCT01340820|BCG Vaccine|bcg vaccine|mesh-list
24673850|NCT01340820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24673911|NCT01341080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673912|NCT01341106|Entecavir|entecavir|mesh-list
24673913|NCT01341106|Antiviral Agents|antiviral agents|mesh-ancestor
24673914|NCT01341106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673915|NCT01341158|Interferons|interferons|mesh-list
24673916|NCT01341158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673917|NCT01341158|Antiviral Agents|antiviral agents|mesh-ancestor
24673918|NCT01341158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673919|NCT01341184|Rifampin|rifampin|mesh-list
24673920|NCT01341184|Rifabutin|rifabutin|mesh-list
24673996|NCT01341392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24673997|NCT01341392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673998|NCT01341392|Vasodilator Agents|vasodilator agents|mesh-ancestor
24673999|NCT01341405|Celecoxib|celecoxib|mesh-list
24674000|NCT01341405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24674001|NCT01341405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24674002|NCT01341405|Analgesics|analgesics|mesh-ancestor
24674003|NCT01341405|Sensory System Agents|sensory system agents|mesh-ancestor
24674004|NCT01341405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202433|NCT02721329|Antipyretics|antipyretics|mesh-ancestor
25068419|NCT03433469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25068420|NCT03433469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25068421|NCT03433469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202434|NCT02721433|Denosumab|denosumab|mesh-list
25068423|NCT03433378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25068424|NCT03433378|Keratolytic Agents|keratolytic agents|mesh-ancestor
25068425|NCT03433378|Dermatologic Agents|dermatologic agents|mesh-ancestor
24674005|NCT01341405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674006|NCT01341405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24674007|NCT01341405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24674008|NCT01341405|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24674055|NCT01341743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674057|NCT01341834|Panobinostat|panobinostat|mesh-list
24674058|NCT01341834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24674059|NCT01341834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24674060|NCT01341834|Immunologic Factors|immunologic factors|mesh-ancestor
24674061|NCT01341834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674062|NCT01341834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24674063|NCT01341834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663380|NCT01658020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25663381|NCT01658020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25663382|NCT01658020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663383|NCT01658020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663384|NCT01658020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663385|NCT01658150|Isradipine|isradipine|mesh-list
25663386|NCT01658150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25663387|NCT01658150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25663388|NCT01658150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24674064|NCT01341834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674281|NCT01342835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674282|NCT01342835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24674283|NCT01342835|Anesthetics, General|anesthetics, general|mesh-ancestor
25851918|NCT00055120|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25851919|NCT00055120|Stavudine|stavudine|mesh-list
25851920|NCT00055120|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24674333|NCT05250843|Lenvatinib|lenvatinib|mesh-list
24459271|NCT00344123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24675203|NCT02710097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24675204|NCT02710097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675205|NCT02709954|Ethanol|ethanol|mesh-list
24675206|NCT02709954|Dronabinol|dronabinol|mesh-list
24675207|NCT02709954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24675208|NCT02709954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24675209|NCT02709954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24675210|NCT02709954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675211|NCT02709954|Hallucinogens|hallucinogens|mesh-ancestor
24675212|NCT02709954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24675213|NCT02709954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24689088|NCT02299999|Paclitaxel|paclitaxel|mesh-list
24675214|NCT02709954|Analgesics|analgesics|mesh-ancestor
24675215|NCT02709954|Sensory System Agents|sensory system agents|mesh-ancestor
24675216|NCT02709954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24675217|NCT02709954|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24675218|NCT02709954|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24675219|NCT02709954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24675221|NCT02709954|Hormones|hormones|mesh-ancestor
24675232|NCT02607319|Bemiparin|bemiparin|mesh-list
24675256|NCT02250157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24675258|NCT02225405|Docetaxel|docetaxel|mesh-list
24675259|NCT02225405|Nintedanib|nintedanib|mesh-list
24675260|NCT02225405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24675261|NCT02225405|Tubulin Modulators|tubulin modulators|mesh-ancestor
24675262|NCT02225405|Antimitotic Agents|antimitotic agents|mesh-ancestor
24675263|NCT02225405|Mitosis Modulators|mitosis modulators|mesh-ancestor
25068436|NCT03433326|Antiviral Agents|antiviral agents|mesh-ancestor
25068437|NCT03433326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24675311|NCT00739050|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24675312|NCT00739050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675313|NCT00687531|Mometasone Furoate|mometasone furoate|mesh-list
24675314|NCT00687531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24675315|NCT00687531|Dermatologic Agents|dermatologic agents|mesh-ancestor
24675316|NCT00687531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24675317|NCT00654628|Simvastatin|simvastatin|mesh-list
24675319|NCT00654628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24675320|NCT00654628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24675321|NCT00654628|Antimetabolites|antimetabolites|mesh-ancestor
24675322|NCT00654628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675323|NCT00654628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25851921|NCT00055120|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24675411|NCT00394355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24675412|NCT00394355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675414|NCT00359216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24675415|NCT00359216|Dermatologic Agents|dermatologic agents|mesh-ancestor
24675416|NCT00359216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24675418|NCT00189280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24675419|NCT00189280|Immunologic Factors|immunologic factors|mesh-ancestor
24675420|NCT00189280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675421|NCT00189280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851922|NCT00055120|Protease Inhibitors|protease inhibitors|mesh-ancestor
24675514|NCT01343680|Anticoagulants|anticoagulants|mesh-ancestor
24675515|NCT01343680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24675516|NCT01343680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24675557|NCT01344083|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
24675666|NCT01344395|Anesthetics, Local|anesthetics, local|mesh-ancestor
24675667|NCT01344395|Anesthetics|anesthetics|mesh-ancestor
24675668|NCT01344395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24675669|NCT01344395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675670|NCT01344395|Sensory System Agents|sensory system agents|mesh-ancestor
24675671|NCT01344395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24675672|NCT01344395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24675673|NCT01344395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24675674|NCT01344395|Analgesics|analgesics|mesh-ancestor
24675675|NCT01344395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24675676|NCT01344395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24711317|NCT01514721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25238841|NCT04844918|Tirzepatide|tirzepatide|mesh-list
25238842|NCT04844918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25238843|NCT04844918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238844|NCT04844918|Incretins|incretins|mesh-ancestor
25238845|NCT04844918|Hormones|hormones|mesh-ancestor
24675677|NCT01344395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24675678|NCT01344395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851923|NCT00055120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675739|NCT01344681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675740|NCT01344681|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24675742|NCT01344720|Oxycodone|oxycodone|mesh-list
25068439|NCT03433235|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25068440|NCT03433235|Antithrombins|antithrombins|mesh-ancestor
25068441|NCT03433235|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25068442|NCT03433235|Protease Inhibitors|protease inhibitors|mesh-ancestor
25068443|NCT03433235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25068444|NCT03433235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068445|NCT03433235|Anticoagulants|anticoagulants|mesh-ancestor
25068447|NCT03433222|Keratolytic Agents|keratolytic agents|mesh-ancestor
25068448|NCT03433222|Dermatologic Agents|dermatologic agents|mesh-ancestor
25068449|NCT03433196|Atorvastatin|atorvastatin|mesh-list
24830947|NCT02162134|Analgesics|analgesics|mesh-ancestor
24675743|NCT01344720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24675744|NCT01344720|Narcotics|narcotics|mesh-ancestor
24675745|NCT01344720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24675746|NCT01344720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675798|NCT01345357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24675799|NCT01345357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675800|NCT01345357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24675801|NCT01345357|Immunologic Factors|immunologic factors|mesh-ancestor
24675802|NCT01345357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675804|NCT01345370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24675805|NCT01345370|Alkylating Agents|alkylating agents|mesh-ancestor
24821172|NCT02103725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24610768|NCT01005095|Cholecalciferol|cholecalciferol|mesh-list
24610769|NCT01005095|Vitamins|vitamins|mesh-list
24610770|NCT01005095|Micronutrients|micronutrients|mesh-ancestor
24610771|NCT01005095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610772|NCT01005095|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24610773|NCT01005095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24610774|NCT01005121|Colchicine|colchicine|mesh-list
24610775|NCT01005121|Gout Suppressants|gout suppressants|mesh-ancestor
24610776|NCT01005121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24610777|NCT01005121|Tubulin Modulators|tubulin modulators|mesh-ancestor
24610778|NCT01005121|Antimitotic Agents|antimitotic agents|mesh-ancestor
24676114|NCT01348243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24676115|NCT01348269|Zoledronic Acid|zoledronic acid|mesh-list
24689463|NCT01464268|Riboflavin|riboflavin|mesh-list
24676116|NCT01348269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24676117|NCT01348269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676118|NCT01348282|Rivastigmine|rivastigmine|mesh-list
24676119|NCT01348282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676120|NCT01348282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676121|NCT01348282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676122|NCT01348282|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24676123|NCT01348282|Cholinergic Agents|cholinergic agents|mesh-ancestor
24676124|NCT01348282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24676125|NCT01348282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25068450|NCT03433196|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25068451|NCT03433196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25068452|NCT03433196|Antimetabolites|antimetabolites|mesh-ancestor
25068453|NCT03433196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068454|NCT03433196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25068455|NCT03433196|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24676126|NCT01348282|Protective Agents|protective agents|mesh-ancestor
24676127|NCT01348308|Maraviroc|maraviroc|mesh-list
25663389|NCT01658150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663390|NCT01658150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25663391|NCT01658150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663392|NCT01658150|Vasodilator Agents|vasodilator agents|mesh-ancestor
25663393|NCT01658228|Donepezil|donepezil|mesh-list
24676128|NCT01348308|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24676173|NCT01348880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25238865|NCT04812366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238866|NCT04812366|Hormone Antagonists|hormone antagonists|mesh-ancestor
25238869|NCT04740996|Pembrolizumab|pembrolizumab|mesh-list
24676174|NCT01348880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676175|NCT01348880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676176|NCT01348880|Urological Agents|urological agents|mesh-ancestor
24676177|NCT01348984|Fentanyl|fentanyl|mesh-list
24676178|NCT01348984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24676179|NCT01348984|Narcotics|narcotics|mesh-ancestor
24676256|NCT01349270|Immunoglobulins|immunoglobulins|mesh-list
24676257|NCT01349270|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24676258|NCT01349270|Antibodies|antibodies|mesh-list
24676259|NCT01349270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24676260|NCT01349270|Glucocorticoids|glucocorticoids|mesh-ancestor
24676261|NCT01349270|Hormones|hormones|mesh-ancestor
24676262|NCT01349270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24676263|NCT01349270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676264|NCT01349270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24676272|NCT01349296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676273|NCT01349296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24676274|NCT01349296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676275|NCT01349296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851924|NCT00055120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851925|NCT00055120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24676277|NCT01349335|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24830966|NCT02162251|Cholinergic Agents|cholinergic agents|mesh-ancestor
24676278|NCT01349335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676279|NCT01349335|Natriuretic Agents|natriuretic agents|mesh-ancestor
24676280|NCT01349335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676281|NCT01349348|Tolvaptan|tolvaptan|mesh-list
24676282|NCT01349348|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24676283|NCT01349348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676284|NCT01349348|Natriuretic Agents|natriuretic agents|mesh-ancestor
25851926|NCT00055120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24676396|NCT01350024|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24676397|NCT01350024|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24676398|NCT01350024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24676399|NCT01350024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25068457|NCT03433144|Tranexamic Acid|tranexamic acid|mesh-list
25068458|NCT03433144|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25068459|NCT03433144|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25068460|NCT03433144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676406|NCT01350024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24676407|NCT01350024|Autonomic Agents|autonomic agents|mesh-ancestor
24676408|NCT01350024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24676429|NCT01350050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676430|NCT01350050|Sensory System Agents|sensory system agents|mesh-ancestor
24676431|NCT01350050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24676474|NCT01350596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24676475|NCT01350596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676476|NCT01350596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24676477|NCT01350596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24676478|NCT01350596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24676479|NCT01350596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676480|NCT01350596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676481|NCT01350609|Candesartan|candesartan|mesh-list
24676482|NCT01350609|Candesartan cilexetil|candesartan cilexetil|mesh-list
24676483|NCT01350609|Nifedipine|nifedipine|mesh-list
24676484|NCT01350609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24676485|NCT01350609|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24676486|NCT01350609|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24676487|NCT01350609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676488|NCT01350609|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24676493|NCT01350609|Tocolytic Agents|tocolytic agents|mesh-ancestor
24610803|NCT01005238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24610804|NCT01005238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663394|NCT01658228|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25663395|NCT01658228|Citalopram|citalopram|mesh-list
25663396|NCT01658228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25663397|NCT01658228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238898|NCT04649203|Niacinamide|niacinamide|mesh-list
25238899|NCT04649203|Niacin|niacin|mesh-list
25238900|NCT04649203|Nicotinic Acids|nicotinic acids|mesh-list
25238901|NCT04649203|Vitamin B Complex|vitamin b complex|mesh-ancestor
24610805|NCT01005238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610806|NCT01005238|Antiviral Agents|antiviral agents|mesh-ancestor
24676534|NCT01350882|Citric Acid|citric acid|mesh-list
24676535|NCT01350882|Sodium Citrate|sodium citrate|mesh-list
24676536|NCT01350882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24676537|NCT01350882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24676538|NCT01350882|Immunologic Factors|immunologic factors|mesh-ancestor
24676540|NCT01350882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24676581|NCT01351168|GABA Agents|gaba agents|mesh-ancestor
24676582|NCT01351272|Methylphenidate|methylphenidate|mesh-list
24676583|NCT01351272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24676584|NCT01351272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676585|NCT01351272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24676586|NCT01351272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24676587|NCT01351272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24676588|NCT01351272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676589|NCT01351272|Dopamine Agents|dopamine agents|mesh-ancestor
24676590|NCT01351272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24676591|NCT01351285|Remifentanil|remifentanil|mesh-list
24676592|NCT01351285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24676599|NCT01351298|Lidocaine|lidocaine|mesh-list
24676637|NCT01351493|Gasotransmitters|gasotransmitters|mesh-ancestor
24676638|NCT01351493|Protective Agents|protective agents|mesh-ancestor
24676749|NCT01352338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24676750|NCT01352338|Glucocorticoids|glucocorticoids|mesh-ancestor
25068465|NCT03433092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068466|NCT03433092|Protective Agents|protective agents|mesh-ancestor
25068467|NCT03433092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068481|NCT03433001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24830965|NCT02162251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830967|NCT02162251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24830969|NCT02162251|Nootropic Agents|nootropic agents|mesh-ancestor
24676752|NCT01352338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24676786|NCT01352559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24676787|NCT01352559|Serotonin Agents|serotonin agents|mesh-ancestor
24676788|NCT01352559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676789|NCT01352559|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24637904|NCT01153854|Racecadotril|racecadotril|mesh-list
24676790|NCT01352559|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24676791|NCT01352559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24676792|NCT01352559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676793|NCT01352559|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24676796|NCT01352559|Histamine Agents|histamine agents|mesh-ancestor
24676845|NCT01352572|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24677067|NCT01354262|Cholecalciferol|cholecalciferol|mesh-list
24677069|NCT01354262|Micronutrients|micronutrients|mesh-ancestor
24677070|NCT01354262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677071|NCT01354262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24677072|NCT01354262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24677073|NCT01354275|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24677074|NCT01354275|Hormones|hormones|mesh-ancestor
24677193|NCT01354665|Interferon-beta|interferon-beta|mesh-list
24677194|NCT01354665|Interferon beta-1b|interferon beta-1b|mesh-list
24677195|NCT01354665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24677196|NCT01354665|Antiviral Agents|antiviral agents|mesh-ancestor
24677197|NCT01354665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24677198|NCT01354665|Immunologic Factors|immunologic factors|mesh-ancestor
24677201|NCT01354704|Enoxaparin|enoxaparin|mesh-list
24677243|NCT01355198|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24677244|NCT01355198|Antioxidants|antioxidants|mesh-ancestor
24677245|NCT01355198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677246|NCT01355198|Protective Agents|protective agents|mesh-ancestor
24677247|NCT01355198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068482|NCT03433001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663398|NCT01658228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663399|NCT01658228|Cholinergic Agents|cholinergic agents|mesh-ancestor
25663400|NCT01658228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25663401|NCT01658228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712065|NCT01518413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25238916|NCT04634162|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25238917|NCT04634162|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25238918|NCT04634162|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25238919|NCT04634162|Purinergic Agents|purinergic agents|mesh-ancestor
25238920|NCT04634162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25238921|NCT04634162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238922|NCT04634162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238923|NCT04633148|Cyclophosphamide|cyclophosphamide|mesh-list
25238924|NCT04633148|Fludarabine|fludarabine|mesh-list
25238925|NCT04633148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25238926|NCT04633148|Immunologic Factors|immunologic factors|mesh-ancestor
25238927|NCT04633148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238928|NCT04633148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25238929|NCT04633148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25155117|NCT05461131|Azithromycin|azithromycin|mesh-list
25068483|NCT03433001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25068485|NCT03433001|Hormones|hormones|mesh-ancestor
25068486|NCT03433001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25068487|NCT03433001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25068488|NCT03433001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25068489|NCT03433001|Immunologic Factors|immunologic factors|mesh-ancestor
24677248|NCT01355198|Antidotes|antidotes|mesh-ancestor
24677249|NCT01355198|Glycine Agents|glycine agents|mesh-ancestor
24677250|NCT01355198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24677251|NCT01355263|Vitamin A|vitamin a|mesh-list
24677516|NCT01356680|Alkylating Agents|alkylating agents|mesh-ancestor
24677517|NCT01356680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677518|NCT01356680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24677519|NCT01356680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24677520|NCT01356680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24677521|NCT01356680|Glucocorticoids|glucocorticoids|mesh-ancestor
24677613|NCT01357031|Antidepressive Agents|antidepressive agents|mesh-ancestor
24677614|NCT01357031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24677615|NCT01357031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24677617|NCT01357031|Sensory System Agents|sensory system agents|mesh-ancestor
24677618|NCT01357031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24677619|NCT01357031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24677620|NCT01357031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24677621|NCT01357031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24677622|NCT01357031|Adrenergic Agents|adrenergic agents|mesh-ancestor
24677623|NCT01357031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24677625|NCT01357109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24677626|NCT01357109|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24677627|NCT01357109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677628|NCT01357252|Vildagliptin|vildagliptin|mesh-list
24677629|NCT01357252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24677704|NCT01357902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24677705|NCT01357902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24677706|NCT01357967|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24677912|NCT01359085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24677913|NCT01359085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24677914|NCT01359085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24677915|NCT01359085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24677916|NCT01359085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24677917|NCT01359098|Ciprofloxacin|ciprofloxacin|mesh-list
24677966|NCT01359397|Growth Inhibitors|growth inhibitors|mesh-ancestor
25663402|NCT01658228|Nootropic Agents|nootropic agents|mesh-ancestor
25663403|NCT01658228|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25663404|NCT01658228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25663405|NCT01658228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25663406|NCT01658228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25663407|NCT01658228|Antidepressive Agents|antidepressive agents|mesh-ancestor
25663408|NCT01658228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25663409|NCT01658228|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25663410|NCT01658228|Serotonin Agents|serotonin agents|mesh-ancestor
25663411|NCT01658436|Dactolisib|dactolisib|mesh-list
25663412|NCT01658436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663413|NCT01658579|Insulin|insulin|mesh-list
25663414|NCT01658579|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25663415|NCT01658579|Insulin Glargine|insulin glargine|mesh-list
25663416|NCT01658579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25663417|NCT01658579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663418|NCT01658657|Metoprolol|metoprolol|mesh-list
25238946|NCT04599504|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25238947|NCT04599504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238948|NCT04599504|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25238949|NCT04599504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25238950|NCT04599504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25238951|NCT04599504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238952|NCT04599504|Dopamine Agents|dopamine agents|mesh-ancestor
25238953|NCT04599504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25238954|NCT04589676|Naloxone|naloxone|mesh-list
25238955|NCT04589676|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25238956|NCT04589676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238957|NCT04589676|Sensory System Agents|sensory system agents|mesh-ancestor
25238958|NCT04589676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24677967|NCT01359397|Tubulin Modulators|tubulin modulators|mesh-ancestor
24677968|NCT01359397|Antimitotic Agents|antimitotic agents|mesh-ancestor
24677969|NCT01359397|Mitosis Modulators|mitosis modulators|mesh-ancestor
24821280|NCT02104284|Mannitol|mannitol|mesh-list
24677976|NCT01359423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24677977|NCT01359423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677978|NCT01359423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24677979|NCT01359423|Respiratory System Agents|respiratory system agents|mesh-ancestor
24677980|NCT01359423|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24677981|NCT01359423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24690148|NCT01399645|Incretins|incretins|mesh-ancestor
24677982|NCT01359423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202439|NCT02721238|Plasma-lyte 148|plasma-lyte 148|mesh-list
24677983|NCT01359423|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24677984|NCT01359423|Vasodilator Agents|vasodilator agents|mesh-ancestor
24678017|NCT01359514|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24678018|NCT01359514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24678019|NCT01359514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24678020|NCT01359514|Antidepressive Agents|antidepressive agents|mesh-ancestor
24678021|NCT01359514|Dopamine Agents|dopamine agents|mesh-ancestor
24678022|NCT01359579|Varespladib methyl|varespladib methyl|mesh-list
24678023|NCT01359579|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
24678024|NCT01359579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678098|NCT01359709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24678099|NCT01359709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678101|NCT01359722|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24678102|NCT01359722|Antiviral Agents|antiviral agents|mesh-ancestor
24678103|NCT01359722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25021031|NCT03675555|Antidepressive Agents|antidepressive agents|mesh-ancestor
24584586|NCT00881114|Cetuximab|cetuximab|mesh-list
25021040|NCT03675555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25021041|NCT03675555|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25021042|NCT03675555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25021043|NCT03675555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25021044|NCT03675555|Adrenergic Agents|adrenergic agents|mesh-ancestor
25021045|NCT03675555|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25021046|NCT03675555|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25021047|NCT03675555|Serotonin Agents|serotonin agents|mesh-ancestor
25021048|NCT03675555|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25021049|NCT03675191|Orlistat|orlistat|mesh-list
25021050|NCT03675191|Phentermine|phentermine|mesh-list
25021051|NCT03675191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25021052|NCT03675191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021053|NCT03675191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25021054|NCT03675191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25423069|NCT02403674|Tenofovir|tenofovir|mesh-list
25663419|NCT01658657|Amlodipine|amlodipine|mesh-list
25663420|NCT01658657|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25663421|NCT01658657|Lisinopril|lisinopril|mesh-list
25663422|NCT01658657|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
25663423|NCT01658657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25663424|NCT01658657|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25663425|NCT01658657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25663426|NCT01658657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663427|NCT01658657|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25663428|NCT01658657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663429|NCT01658657|Vasodilator Agents|vasodilator agents|mesh-ancestor
25663430|NCT01658657|Diuretics|diuretics|mesh-ancestor
25663431|NCT01658657|Natriuretic Agents|natriuretic agents|mesh-ancestor
25851927|NCT00055120|Antiviral Agents|antiviral agents|mesh-ancestor
24788826|NCT01934049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24788827|NCT01934049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021056|NCT03675191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678117|NCT01359826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678119|NCT01359826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678120|NCT01359826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24678121|NCT01359826|Analgesics|analgesics|mesh-ancestor
24678122|NCT01359826|Sensory System Agents|sensory system agents|mesh-ancestor
24678123|NCT01359826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24678124|NCT01359826|Antidepressive Agents|antidepressive agents|mesh-ancestor
24678125|NCT01359826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24678128|NCT01359930|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24678298|NCT01360788|Respiratory System Agents|respiratory system agents|mesh-ancestor
24678299|NCT01360788|Tocolytic Agents|tocolytic agents|mesh-ancestor
24678356|NCT01361399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24678357|NCT01361399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24678358|NCT01361399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24678359|NCT01361399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24678360|NCT01361399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24678400|NCT01361789|Dexamethasone|dexamethasone|mesh-list
24678401|NCT01361789|Dexamethasone acetate|dexamethasone acetate|mesh-list
24678402|NCT01361789|Etoricoxib|etoricoxib|mesh-list
24678403|NCT01361789|Parecoxib|parecoxib|mesh-list
24678404|NCT01361789|Valdecoxib|valdecoxib|mesh-list
24678405|NCT01361789|BB 1101|bb 1101|mesh-list
24678406|NCT01361789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24678407|NCT01361789|Antiemetics|antiemetics|mesh-ancestor
24678408|NCT01361789|Autonomic Agents|autonomic agents|mesh-ancestor
24678409|NCT01361789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24678410|NCT01361789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678411|NCT01361789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24678412|NCT01361789|Glucocorticoids|glucocorticoids|mesh-ancestor
24678413|NCT01361789|Hormones|hormones|mesh-ancestor
24678414|NCT01361789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24678415|NCT01361789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24678416|NCT01361789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24678417|NCT01361789|Protease Inhibitors|protease inhibitors|mesh-ancestor
24678418|NCT01361789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678419|NCT01361789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202435|NCT02721433|Zoledronic Acid|zoledronic acid|mesh-list
25202436|NCT02721433|Pamidronate|pamidronate|mesh-list
25202437|NCT02721433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25202438|NCT02721433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202440|NCT02721238|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25202441|NCT02721238|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25202443|NCT02721043|Vaccines|vaccines|mesh-list
25202444|NCT02721043|Poly ICLC|poly iclc|mesh-list
25202445|NCT02721043|Immunologic Factors|immunologic factors|mesh-ancestor
25202446|NCT02721043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202447|NCT02721043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25202448|NCT02721043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25202449|NCT02721043|Growth Substances|growth substances|mesh-ancestor
25202450|NCT02721043|Growth Inhibitors|growth inhibitors|mesh-ancestor
25202451|NCT02721043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25202452|NCT02721043|Interferon Inducers|interferon inducers|mesh-ancestor
25202453|NCT02721290|Ropivacaine|ropivacaine|mesh-list
25202454|NCT02721290|Anesthetics, Local|anesthetics, local|mesh-ancestor
24855262|NCT02278510|Topotecan|topotecan|mesh-list
24678420|NCT01361789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24678421|NCT01361789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24678422|NCT01361789|Analgesics|analgesics|mesh-ancestor
24678423|NCT01361789|Sensory System Agents|sensory system agents|mesh-ancestor
24678424|NCT01361789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24678425|NCT01361789|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24678426|NCT01361789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24678427|NCT01361841|Bimatoprost|bimatoprost|mesh-list
24678428|NCT01361841|Travoprost|travoprost|mesh-list
24678429|NCT01361841|Latanoprost|latanoprost|mesh-list
24678430|NCT01361841|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24678431|NCT01361841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25663432|NCT01658657|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25663433|NCT01658657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24678444|NCT01361984|Adrenergic Agents|adrenergic agents|mesh-ancestor
24678445|NCT01361984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24678446|NCT01361984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678448|NCT01361997|Chlorhexidine|chlorhexidine|mesh-list
24678449|NCT01361997|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24678552|NCT01363063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24678553|NCT01363063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953523|NCT03883880|Antipruritics|antipruritics|mesh-ancestor
24953524|NCT03883880|Dermatologic Agents|dermatologic agents|mesh-ancestor
24953525|NCT03883880|Sensory System Agents|sensory system agents|mesh-ancestor
24953526|NCT03883880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953527|NCT03883880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953528|NCT03883880|Antioxidants|antioxidants|mesh-ancestor
24953529|NCT03883880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678554|NCT01363063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24678555|NCT01363063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24678556|NCT01363063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24678557|NCT01363063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678593|NCT01363115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24678594|NCT01363167|Vitamin D|vitamin d|mesh-list
24678595|NCT01363167|Cholecalciferol|cholecalciferol|mesh-list
24678596|NCT01363167|Vitamins|vitamins|mesh-ancestor
24678597|NCT01363167|Micronutrients|micronutrients|mesh-ancestor
24678598|NCT01363167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678599|NCT01363167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24678600|NCT01363167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24678601|NCT01363193|Heparin|heparin|mesh-list
24678602|NCT01363193|Calcium heparin|calcium heparin|mesh-list
24678603|NCT01363193|Anticoagulants|anticoagulants|mesh-ancestor
24678604|NCT01363193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24678605|NCT01363193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24678606|NCT01363193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678607|NCT01363206|Ipilimumab|ipilimumab|mesh-list
24678608|NCT01363206|Molgramostim|molgramostim|mesh-list
24678609|NCT01363206|Sargramostim|sargramostim|mesh-list
24678610|NCT01363206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24678611|NCT01363206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24678612|NCT01363206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24678614|NCT01363206|Immunologic Factors|immunologic factors|mesh-ancestor
24678637|NCT01363310|Citalopram|citalopram|mesh-list
24610956|NCT01005784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25663434|NCT01658657|Sympatholytics|sympatholytics|mesh-ancestor
25663435|NCT01658657|Autonomic Agents|autonomic agents|mesh-ancestor
25663436|NCT01658657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25663437|NCT01658657|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25663438|NCT01658657|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25663439|NCT01658657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25663440|NCT01658657|Adrenergic Agents|adrenergic agents|mesh-ancestor
25663441|NCT01658657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25663442|NCT01658657|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25663443|NCT01658657|Protease Inhibitors|protease inhibitors|mesh-ancestor
25663444|NCT01658657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663445|NCT01658657|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25663446|NCT01658657|Protective Agents|protective agents|mesh-ancestor
25663447|NCT01658839|Travoprost|travoprost|mesh-list
25663448|NCT01658839|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25663449|NCT01658839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25663450|NCT01658839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25663451|NCT01658904|Melphalan|melphalan|mesh-list
25663452|NCT01658904|Immunologic Factors|immunologic factors|mesh-ancestor
25851928|NCT00055120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25005888|NCT01693783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005889|NCT01502085|Dexamethasone|dexamethasone|mesh-list
24610957|NCT01005797|Sorafenib|sorafenib|mesh-list
24610958|NCT01005797|Panobinostat|panobinostat|mesh-list
24610959|NCT01005797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610960|NCT01005797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24610961|NCT01005797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610962|NCT01005797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678646|NCT01363310|Antidepressive Agents|antidepressive agents|mesh-ancestor
24678647|NCT01363310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24678698|NCT01363557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678699|NCT01363557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678701|NCT01363570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24678702|NCT01363570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24678703|NCT01363570|Growth Substances|growth substances|mesh-ancestor
24678704|NCT01363570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678705|NCT01363570|Growth Inhibitors|growth inhibitors|mesh-ancestor
24678763|NCT01364012|Antimitotic Agents|antimitotic agents|mesh-ancestor
24678764|NCT01364012|Mitosis Modulators|mitosis modulators|mesh-ancestor
24678765|NCT01364012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202455|NCT02721290|Anesthetics|anesthetics|mesh-ancestor
24678766|NCT01364012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24678767|NCT01364012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24678768|NCT01364012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24678769|NCT01364012|Growth Substances|growth substances|mesh-ancestor
24678770|NCT01364012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953530|NCT03883880|Protective Agents|protective agents|mesh-ancestor
24953531|NCT03883880|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24953532|NCT03883880|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24953533|NCT03883880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24953534|NCT03883880|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24953536|NCT03883919|Leucovorin|leucovorin|mesh-list
24953537|NCT03883919|Fluorouracil|fluorouracil|mesh-list
24953538|NCT03883919|Irinotecan|irinotecan|mesh-list
24678771|NCT01364012|Growth Inhibitors|growth inhibitors|mesh-ancestor
24678772|NCT01364181|Udenafil|udenafil|mesh-list
24678773|NCT01364181|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24678774|NCT01364181|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24678775|NCT01364181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678776|NCT01364181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678777|NCT01364194|Bupivacaine|bupivacaine|mesh-list
24678778|NCT01364194|Anesthetics, Local|anesthetics, local|mesh-ancestor
24678779|NCT01364194|Anesthetics|anesthetics|mesh-ancestor
24678817|NCT01364493|Antimetabolites|antimetabolites|mesh-ancestor
24678818|NCT01364493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678819|NCT01364493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24678820|NCT01364493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24678821|NCT01364519|Fluticasone|fluticasone|mesh-list
24678822|NCT01364519|Xhance|xhance|mesh-list
24678823|NCT01364519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24678824|NCT01364519|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24678883|NCT01364857|GTPase-Activating Proteins|gtpase-activating proteins|mesh-list
24678884|NCT01364857|GTP Phosphohydrolase Activators|gtp phosphohydrolase activators|mesh-ancestor
24678886|NCT01364857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678888|NCT01364961|Antioxidants|antioxidants|mesh-ancestor
24678889|NCT01364961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678890|NCT01364961|Protective Agents|protective agents|mesh-ancestor
24678891|NCT01364961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678892|NCT01364961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678893|NCT01364961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24611025|NCT01006499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24611027|NCT01006499|Protective Agents|protective agents|mesh-ancestor
24611028|NCT01006499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611029|NCT01006499|Vasodilator Agents|vasodilator agents|mesh-ancestor
24611030|NCT01006499|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24611031|NCT01006499|Antioxidants|antioxidants|mesh-ancestor
24678979|NCT01365676|Immunologic Factors|immunologic factors|mesh-ancestor
24679981|NCT01372306|Galantamine|galantamine|mesh-list
24678980|NCT01365676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678981|NCT01365741|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24678982|NCT01365741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25663453|NCT01658904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663454|NCT01658904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24678984|NCT01365871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24678985|NCT01365871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678986|NCT01365897|Modafinil|modafinil|mesh-list
24678987|NCT01365897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24678988|NCT01365897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678989|NCT01365897|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24678990|NCT01365897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24638281|NCT01155791|Hormones|hormones|mesh-ancestor
24953540|NCT03883919|Micronutrients|micronutrients|mesh-ancestor
24953541|NCT03883919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953542|NCT03883919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24953543|NCT03883919|Antimetabolites|antimetabolites|mesh-ancestor
24831014|NCT02162485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24678991|NCT01365897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24678992|NCT01365897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678993|NCT01365923|Dexmedetomidine|dexmedetomidine|mesh-list
24678994|NCT01365923|Remifentanil|remifentanil|mesh-list
24855275|NCT02278588|Rasagiline|rasagiline|mesh-list
24678995|NCT01365923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24678996|NCT01365923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24678997|NCT01365923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678998|NCT01365923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24678999|NCT01365923|Analgesics|analgesics|mesh-ancestor
25202456|NCT02721290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25021268|NCT03673501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021269|NCT03673501|Growth Inhibitors|growth inhibitors|mesh-ancestor
25851929|NCT00055120|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24679081|NCT01366313|Sensory System Agents|sensory system agents|mesh-ancestor
24679082|NCT01366313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679083|NCT01366313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24679084|NCT01366313|Antipyretics|antipyretics|mesh-ancestor
24679085|NCT01366326|Bromides|bromides|mesh-list
24679086|NCT01366326|Methylnaltrexone|methylnaltrexone|mesh-list
24679087|NCT01366326|Anticonvulsants|anticonvulsants|mesh-ancestor
24679088|NCT01366326|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24679089|NCT01366326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679092|NCT01366339|Methylnaltrexone|methylnaltrexone|mesh-list
24679131|NCT01366651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24679132|NCT01366651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24679133|NCT01367028|Bevacizumab|bevacizumab|mesh-list
24679134|NCT01367028|Trastuzumab|trastuzumab|mesh-list
24679135|NCT01367028|Docetaxel|docetaxel|mesh-list
24679136|NCT01367028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24679137|NCT01367028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24679138|NCT01367028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24679139|NCT01367028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24679140|NCT01367028|Growth Substances|growth substances|mesh-ancestor
24679218|NCT01367522|Methylnaltrexone|methylnaltrexone|mesh-list
24679219|NCT01367522|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24679223|NCT01367535|Naltrexone|naltrexone|mesh-list
24679231|NCT01367535|Serotonin Agents|serotonin agents|mesh-ancestor
24679232|NCT01367535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679233|NCT01367535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24679234|NCT01367535|Antidepressive Agents|antidepressive agents|mesh-ancestor
24679235|NCT01367535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24679236|NCT01367535|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24679237|NCT01367535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24679238|NCT01367535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24679239|NCT01367535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24679240|NCT01367535|Sensory System Agents|sensory system agents|mesh-ancestor
24679241|NCT01367535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679242|NCT01367535|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24679337|NCT01367912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24679338|NCT01367964|Hormones|hormones|mesh-list
24679339|NCT01367964|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24679340|NCT01367964|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
24679341|NCT01367964|beta-Endorphin|beta-endorphin|mesh-list
24679342|NCT01367964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24679343|NCT01367964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679344|NCT01367964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24679345|NCT01367964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463870|NCT00362583|Analgesics|analgesics|mesh-ancestor
24953544|NCT03883919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953545|NCT03883919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25239065|NCT04183790|Ivacaftor|ivacaftor|mesh-list
24953546|NCT03883919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24953547|NCT03883919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24953548|NCT03883919|Immunologic Factors|immunologic factors|mesh-ancestor
24463871|NCT00362583|Sensory System Agents|sensory system agents|mesh-ancestor
24463872|NCT00362583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24463873|NCT00362583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24463874|NCT00362583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24463875|NCT00362583|Anesthetics, General|anesthetics, general|mesh-ancestor
24463876|NCT00362583|Anesthetics|anesthetics|mesh-ancestor
24463877|NCT00362596|Acyclovir|acyclovir|mesh-list
24463878|NCT00362596|Antiviral Agents|antiviral agents|mesh-ancestor
24679346|NCT01367990|Norepinephrine|norepinephrine|mesh-list
25851930|NCT00055120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24679389|NCT01368068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24679390|NCT01368068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24679391|NCT01368068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24679392|NCT01368068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24679393|NCT01368068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24679394|NCT01368068|Anabolic Agents|anabolic agents|mesh-ancestor
24679396|NCT01368198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24679397|NCT01368198|Lubricant Eye Drops|lubricant eye drops|mesh-list
25202457|NCT02721290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202458|NCT02721290|Sensory System Agents|sensory system agents|mesh-ancestor
24679433|NCT01368445|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24679434|NCT01368445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24679435|NCT01368445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679436|NCT01368445|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24679437|NCT01368445|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24611077|NCT01006720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611078|NCT01006720|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24611079|NCT01006720|Autonomic Agents|autonomic agents|mesh-ancestor
24611080|NCT01006720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679450|NCT01368627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24679451|NCT01368627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24679452|NCT01368627|Antifungal Agents|antifungal agents|mesh-ancestor
24679453|NCT01368627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24679454|NCT01368627|Immunologic Factors|immunologic factors|mesh-ancestor
24679455|NCT01368627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679456|NCT01368757|Lenalidomide|lenalidomide|mesh-list
24679457|NCT01368757|Immunologic Factors|immunologic factors|mesh-ancestor
24679458|NCT01368757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679459|NCT01368757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24679460|NCT01368757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24679461|NCT01368757|Growth Substances|growth substances|mesh-ancestor
24679462|NCT01368757|Growth Inhibitors|growth inhibitors|mesh-ancestor
24679463|NCT01368757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24679464|NCT01368783|Ritonavir|ritonavir|mesh-list
24679465|NCT01368783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24679466|NCT01368783|Tenofovir|tenofovir|mesh-list
24679467|NCT01368783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24679468|NCT01368783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24679469|NCT01368783|Protease Inhibitors|protease inhibitors|mesh-ancestor
24953549|NCT03883919|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24953550|NCT03883919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24953551|NCT03883919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24953552|NCT03883919|Antidotes|antidotes|mesh-ancestor
24831024|NCT02162485|Antidotes|antidotes|mesh-ancestor
24679470|NCT01368783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24679497|NCT01368887|Vitamin B Complex|vitamin b complex|mesh-ancestor
24679499|NCT01368887|Micronutrients|micronutrients|mesh-ancestor
24679500|NCT01368887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679501|NCT01368887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24679502|NCT01368887|Antimetabolites|antimetabolites|mesh-ancestor
24679555|NCT01369212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24679556|NCT01369212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679557|NCT01369212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24679558|NCT01369212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24679559|NCT01369238|Pyranoprofen|pyranoprofen|mesh-list
24679560|NCT01369238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24679561|NCT01369238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24679562|NCT01369238|Analgesics|analgesics|mesh-ancestor
24679563|NCT01369238|Sensory System Agents|sensory system agents|mesh-ancestor
24679618|NCT01369368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24679619|NCT01369368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663455|NCT01658904|Alkylating Agents|alkylating agents|mesh-ancestor
24679620|NCT01369368|Antimanic Agents|antimanic agents|mesh-ancestor
24679621|NCT01369368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24679622|NCT01369368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24679623|NCT01369368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24679624|NCT01369472|Carvedilol|carvedilol|mesh-list
24679625|NCT01369472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24679626|NCT01369472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24679627|NCT01369472|Adrenergic Agents|adrenergic agents|mesh-ancestor
24679628|NCT01369472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24679664|NCT01369693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679665|NCT01369693|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24679666|NCT01369693|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24679667|NCT01369693|Cholinergic Agents|cholinergic agents|mesh-ancestor
24679668|NCT01369693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24679669|NCT01369693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679670|NCT01369693|Respiratory System Agents|respiratory system agents|mesh-ancestor
24679672|NCT01369719|Deferoxamine|deferoxamine|mesh-list
24679673|NCT01369719|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24679674|NCT01369719|Chelating Agents|chelating agents|mesh-ancestor
24679675|NCT01369719|Sequestering Agents|sequestering agents|mesh-ancestor
24679676|NCT01369719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679678|NCT01369979|Imidacloprid|imidacloprid|mesh-list
24679679|NCT01369979|Cholinergic Agents|cholinergic agents|mesh-ancestor
24679680|NCT01369979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24679681|NCT01369979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679682|NCT01369979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679774|NCT01370434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679775|NCT01370434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24679776|NCT01370434|Glucocorticoids|glucocorticoids|mesh-ancestor
24679778|NCT01370434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24679779|NCT01370434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24679780|NCT01370434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24679781|NCT01370434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24953553|NCT03883919|Protective Agents|protective agents|mesh-ancestor
24953554|NCT03883919|Vitamin B Complex|vitamin b complex|mesh-ancestor
24953555|NCT03884036|Vitamin D|vitamin d|mesh-list
24953556|NCT03884036|Vitamins|vitamins|mesh-ancestor
24679782|NCT01370434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679783|NCT01370434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24638537|NCT01156948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24679784|NCT01370434|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24679785|NCT01370434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24679786|NCT01370434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24679787|NCT01370434|Tubulin Modulators|tubulin modulators|mesh-ancestor
24679822|NCT01370915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679823|NCT01370915|Anticonvulsants|anticonvulsants|mesh-ancestor
24679824|NCT01370915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24691488|NCT01407211|Vitamin A|vitamin a|mesh-list
24679825|NCT01370915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24821437|NCT02105311|Travoprost|travoprost|mesh-list
24679890|NCT01371448|Serotonin Agents|serotonin agents|mesh-ancestor
24679891|NCT01371448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679898|NCT01371461|Paroxetine|paroxetine|mesh-list
24679921|NCT01371474|Antidepressive Agents|antidepressive agents|mesh-ancestor
24679922|NCT01371474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24897212|NCT04427618|Hemostatics|hemostatics|mesh-ancestor
24679923|NCT01371474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24679924|NCT01371474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24679925|NCT01371474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24679926|NCT01371487|Trametinib|trametinib|mesh-list
24679927|NCT01371487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24679928|NCT01371487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24679929|NCT01371487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24679930|NCT01371487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679931|NCT01371526|Cosyntropin|cosyntropin|mesh-list
24679932|NCT01371526|Hormones|hormones|mesh-ancestor
24679933|NCT01371526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24679934|NCT01371526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679982|NCT01372306|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24679983|NCT01372306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24679984|NCT01372306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679985|NCT01372306|Cholinergic Agents|cholinergic agents|mesh-ancestor
24679986|NCT01372306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24679987|NCT01372306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679988|NCT01372306|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25663456|NCT01658904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679989|NCT01372306|Autonomic Agents|autonomic agents|mesh-ancestor
24679990|NCT01372306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679991|NCT01372306|Nootropic Agents|nootropic agents|mesh-ancestor
24679993|NCT01372371|Gentamicins|gentamicins|mesh-list
24679994|NCT01372371|Cefuroxime|cefuroxime|mesh-list
24679995|NCT01372371|Cefuroxime axetil|cefuroxime axetil|mesh-list
24679996|NCT01372371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24679997|NCT01372371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24679998|NCT01372371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24679999|NCT01372371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680000|NCT01372371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680040|NCT01372761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680042|NCT01372826|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24680043|NCT01372826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680044|NCT01372826|Sensory System Agents|sensory system agents|mesh-ancestor
24680045|NCT01372826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24680046|NCT01372839|Atorvastatin|atorvastatin|mesh-list
24680047|NCT01372839|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25851931|NCT00055120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25021534|NCT03670901|Rituximab|rituximab|mesh-list
24680048|NCT01372839|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24680049|NCT01372839|Antimetabolites|antimetabolites|mesh-ancestor
24680050|NCT01372839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680051|NCT01372839|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24570994|NCT00807690|Tacrolimus|tacrolimus|mesh-list
24953564|NCT03883776|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
24953565|NCT03883776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24953566|NCT03883776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24953567|NCT03883776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24953568|NCT03883776|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24953569|NCT03883776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953570|NCT03883763|Bupivacaine|bupivacaine|mesh-list
24953571|NCT03883763|Anesthetics, Local|anesthetics, local|mesh-ancestor
24680132|NCT01373138|Pseudoephedrine|pseudoephedrine|mesh-list
24680133|NCT01373138|Ephedrine|ephedrine|mesh-list
24680134|NCT01373138|Desloratadine|desloratadine|mesh-list
24680135|NCT01373138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24680136|NCT01373138|Cholinergic Agents|cholinergic agents|mesh-ancestor
24680199|NCT01373528|Budesonide|budesonide|mesh-list
24680200|NCT01373528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24680201|NCT01373528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24680202|NCT01373528|Autonomic Agents|autonomic agents|mesh-ancestor
24680203|NCT01373528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24680204|NCT01373528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680205|NCT01373528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24680206|NCT01373528|Respiratory System Agents|respiratory system agents|mesh-ancestor
24680207|NCT01373528|Glucocorticoids|glucocorticoids|mesh-ancestor
24680208|NCT01373528|Hormones|hormones|mesh-ancestor
24680209|NCT01373528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24680210|NCT01373541|Palmitic Acid|palmitic acid|mesh-list
24680211|NCT01373541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680221|NCT01373554|Protective Agents|protective agents|mesh-ancestor
24680222|NCT01373554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680223|NCT01373554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680224|NCT01373554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24680225|NCT01373554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24680226|NCT01373554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680227|NCT01373554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680228|NCT01373593|Lidocaine|lidocaine|mesh-list
24680229|NCT01373593|Anesthetics, Local|anesthetics, local|mesh-ancestor
24680230|NCT01373593|Anesthetics|anesthetics|mesh-ancestor
24680231|NCT01373593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24638649|NCT01157455|Antithrombins|antithrombins|mesh-ancestor
24680232|NCT01373593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680339|NCT01374282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680340|NCT01374282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24680341|NCT01374308|Interferons|interferons|mesh-list
24680342|NCT01374308|Interferon-alpha|interferon-alpha|mesh-list
24680343|NCT01374308|Interferon alpha-2|interferon alpha-2|mesh-list
24464952|NCT00367393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464953|NCT00367393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464954|NCT00367419|Erythromycin|erythromycin|mesh-list
24680360|NCT01374581|Lumefantrine|lumefantrine|mesh-list
24680384|NCT01374581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24680385|NCT01374581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24680387|NCT01374581|Sensory System Agents|sensory system agents|mesh-ancestor
24680388|NCT01374620|Paclitaxel|paclitaxel|mesh-list
24680389|NCT01374620|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24680390|NCT01374620|Cyclophosphamide|cyclophosphamide|mesh-list
24680391|NCT01374620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24680392|NCT01374620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680393|NCT01374620|Tubulin Modulators|tubulin modulators|mesh-ancestor
24680394|NCT01374620|Antimitotic Agents|antimitotic agents|mesh-ancestor
24680395|NCT01374620|Mitosis Modulators|mitosis modulators|mesh-ancestor
24680396|NCT01374620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680397|NCT01374620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25202459|NCT02721290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202460|NCT02721082|Nicotine|nicotine|mesh-list
25851932|NCT00055120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24680398|NCT01374620|Immunologic Factors|immunologic factors|mesh-ancestor
24680399|NCT01374620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680400|NCT01374620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24680401|NCT01374620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24680402|NCT01374620|Alkylating Agents|alkylating agents|mesh-ancestor
24680403|NCT01374620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24680404|NCT01374633|Sevoflurane|sevoflurane|mesh-list
24680405|NCT01374633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25851933|NCT00055120|Antimetabolites|antimetabolites|mesh-ancestor
24680490|NCT01374841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680492|NCT01374841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24680499|NCT01375023|Thymoglobulin|thymoglobulin|mesh-list
24680500|NCT01375023|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24680565|NCT01375361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25068507|NCT03432923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068508|NCT03432923|Sensory System Agents|sensory system agents|mesh-ancestor
25068509|NCT03432923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25068511|NCT03432884|Zanubrutinib|zanubrutinib|mesh-list
25068512|NCT03432884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25068513|NCT03432884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24680566|NCT01375361|Autonomic Agents|autonomic agents|mesh-ancestor
24680567|NCT01375361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24680610|NCT01375452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24680611|NCT01375452|Hormone Antagonists|hormone antagonists|mesh-ancestor
25063144|NCT03042143|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24680612|NCT01375452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24680613|NCT01375452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680615|NCT01375556|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25851934|NCT00055133|Paclitaxel|paclitaxel|mesh-list
24680628|NCT01375634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24680629|NCT01375634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24680630|NCT01375634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24680631|NCT01375634|Anesthetics, General|anesthetics, general|mesh-ancestor
24680632|NCT01375634|Anesthetics|anesthetics|mesh-ancestor
24680633|NCT01375634|GABA Modulators|gaba modulators|mesh-ancestor
24680653|NCT01375816|Irinotecan|irinotecan|mesh-list
24611111|NCT01007019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611112|NCT01007084|Propranolol|propranolol|mesh-list
24611113|NCT01007084|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24611114|NCT01007084|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24611115|NCT01007084|Adrenergic Agents|adrenergic agents|mesh-ancestor
24611116|NCT01007084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24611117|NCT01007084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611187|NCT01007695|Antimanic Agents|antimanic agents|mesh-ancestor
24611118|NCT01007084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611119|NCT01007084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24611120|NCT01007084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24611121|NCT01007084|Vasodilator Agents|vasodilator agents|mesh-ancestor
24611122|NCT01007279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24611123|NCT01007279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24611124|NCT01007279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24611125|NCT01007279|Antimetabolites|antimetabolites|mesh-ancestor
24611126|NCT01007279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611127|NCT01007279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24611128|NCT01007279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24611129|NCT01007279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24692381|NCT01413477|Hormones|hormones|mesh-ancestor
24611130|NCT01007500|Dexamethasone|dexamethasone|mesh-list
24611131|NCT01007500|Ondansetron|ondansetron|mesh-list
24680658|NCT01375816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24680659|NCT01375816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24680660|NCT01375816|Growth Substances|growth substances|mesh-ancestor
25851935|NCT00055133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24680661|NCT01375816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680670|NCT01375816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24680671|NCT01375816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680673|NCT01375816|Protective Agents|protective agents|mesh-ancestor
24465281|NCT00368706|Solifenacin Succinate|solifenacin succinate|mesh-list
25202461|NCT02721082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25202462|NCT02721082|Autonomic Agents|autonomic agents|mesh-ancestor
25021685|NCT03669263|Fentanyl|fentanyl|mesh-list
24680674|NCT01375816|Vitamin B Complex|vitamin b complex|mesh-ancestor
24680676|NCT01375816|Micronutrients|micronutrients|mesh-ancestor
24680677|NCT01375842|Atezolizumab|atezolizumab|mesh-list
24680678|NCT01375842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680679|NCT01375881|Ritonavir|ritonavir|mesh-list
24680680|NCT01375881|Darunavir|darunavir|mesh-list
24680743|NCT01376102|Ibandronic Acid|ibandronic acid|mesh-list
24680744|NCT01376102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25068514|NCT03432884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25068515|NCT03432884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25068516|NCT03432884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25068517|NCT03432884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068518|NCT03432884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25068519|NCT03432884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25068520|NCT03432871|Niacinamide|niacinamide|mesh-list
25068522|NCT03432871|Nicotinic Acids|nicotinic acids|mesh-list
25068523|NCT03432871|Vitamin B Complex|vitamin b complex|mesh-ancestor
25068524|NCT03432871|Vitamins|vitamins|mesh-ancestor
25068525|NCT03432871|Micronutrients|micronutrients|mesh-ancestor
25068526|NCT03432871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068527|NCT03432871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25068528|NCT03432871|Antimetabolites|antimetabolites|mesh-ancestor
25068529|NCT03432871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680745|NCT01376102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680746|NCT01376128|Paroxetine|paroxetine|mesh-list
24680747|NCT01376128|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24680801|NCT01376206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24680802|NCT01376206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680803|NCT01376206|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24680804|NCT01376206|Respiratory System Agents|respiratory system agents|mesh-ancestor
24680805|NCT01376206|Dermatologic Agents|dermatologic agents|mesh-ancestor
24680806|NCT01376206|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24680807|NCT01376232|Gemfibrozil|gemfibrozil|mesh-list
24680808|NCT01376232|Glycine|glycine|mesh-list
24680809|NCT01376232|Glycine Agents|glycine agents|mesh-ancestor
24680810|NCT01376232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24680811|NCT01376232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680812|NCT01376232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680813|NCT01376232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24680814|NCT01376232|Antimetabolites|antimetabolites|mesh-ancestor
24680815|NCT01376232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24680816|NCT01376232|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24680817|NCT01376232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24680818|NCT01376232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680819|NCT01376258|Finasteride|finasteride|mesh-list
24680820|NCT01376258|Dutasteride|dutasteride|mesh-list
24680821|NCT01376258|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24680822|NCT01376258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24680823|NCT01376258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680832|NCT01376271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24680833|NCT01376271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680835|NCT01376271|Serotonin Agents|serotonin agents|mesh-ancestor
24680907|NCT01376765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24680908|NCT01376817|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24680909|NCT01376817|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24680910|NCT01376817|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24680911|NCT01376817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24680912|NCT01376882|Caffeine|caffeine|mesh-list
25068530|NCT03432871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25068531|NCT03432871|Vasodilator Agents|vasodilator agents|mesh-ancestor
25068533|NCT03432793|Fluvoxamine|fluvoxamine|mesh-list
25068534|NCT03432793|Caffeine|caffeine|mesh-list
25068535|NCT03432793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25068536|NCT03432793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068537|NCT03432793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25068538|NCT03432793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25068539|NCT03432793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068540|NCT03432793|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25068541|NCT03432793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25068542|NCT03432793|Purinergic Agents|purinergic agents|mesh-ancestor
25068543|NCT03432793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25068544|NCT03432793|Antifungal Agents|antifungal agents|mesh-ancestor
25068545|NCT03432793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25202463|NCT02721082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25068546|NCT03432793|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25068547|NCT03432793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25068548|NCT03432793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25068549|NCT03432793|Hormone Antagonists|hormone antagonists|mesh-ancestor
25068550|NCT03432793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25068551|NCT03432793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25068552|NCT03432793|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25068553|NCT03432793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24831066|NCT02162784|Tocolytic Agents|tocolytic agents|mesh-ancestor
24680913|NCT01376882|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24680914|NCT01376882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680915|NCT01376882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24680916|NCT01376882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680917|NCT01376882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680918|NCT01376882|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24680919|NCT01376882|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24680920|NCT01376882|Purinergic Agents|purinergic agents|mesh-ancestor
24680921|NCT01376882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24680922|NCT01376999|Hormones|hormones|mesh-list
24680923|NCT01376999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24680932|NCT01377051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680933|NCT01377103|Testosterone|testosterone|mesh-list
24680934|NCT01377103|Androgens|androgens|mesh-ancestor
24680935|NCT01377103|Hormones|hormones|mesh-ancestor
24680936|NCT01377103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24680937|NCT01377103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465453|NCT00369694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24680939|NCT01377155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24680940|NCT01377155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680941|NCT01377168|Naltrexone|naltrexone|mesh-list
24680942|NCT01377168|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25068554|NCT03432793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25068555|NCT03432793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25068556|NCT03432793|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24680943|NCT01377168|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24821586|NCT02106650|Vitamin B 12|vitamin b 12|mesh-list
24681032|NCT01377610|Narcotics|narcotics|mesh-ancestor
24681033|NCT01377610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24681034|NCT01377610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681035|NCT01377610|Analgesics|analgesics|mesh-ancestor
24681040|NCT01377961|Lycopene|lycopene|mesh-list
24611179|NCT01007630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611181|NCT01007695|Anticonvulsants|anticonvulsants|mesh-ancestor
24611182|NCT01007695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611183|NCT01007695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611184|NCT01007695|GABA Agents|gaba agents|mesh-ancestor
24611185|NCT01007695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24611186|NCT01007695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611188|NCT01007695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24611189|NCT01007695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24681105|NCT01378286|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24681106|NCT01378286|Anthelmintics|anthelmintics|mesh-ancestor
24681107|NCT01378286|Amebicides|amebicides|mesh-ancestor
24681108|NCT01378286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24681109|NCT01378481|Vorinostat|vorinostat|mesh-list
24681110|NCT01378481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681111|NCT01378481|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24681112|NCT01378481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681113|NCT01378481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681114|NCT01378533|Paclitaxel|paclitaxel|mesh-list
24681235|NCT01379001|Antiemetics|antiemetics|mesh-ancestor
24681236|NCT01379001|Autonomic Agents|autonomic agents|mesh-ancestor
24681237|NCT01379001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24681238|NCT01379001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24681239|NCT01379001|Mydriatics|mydriatics|mesh-ancestor
24681240|NCT01379001|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25423070|NCT02403674|Lamivudine|lamivudine|mesh-list
24681241|NCT01379001|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24681242|NCT01379001|Parasympatholytics|parasympatholytics|mesh-ancestor
24681243|NCT01379079|Aspirin|aspirin|mesh-list
24681244|NCT01379079|Calcium, Dietary|calcium, dietary|mesh-list
24681285|NCT01379326|Piperazine citrate|piperazine citrate|mesh-list
24681286|NCT01379326|DMP 777|dmp 777|mesh-list
24681287|NCT01379326|Antinematodal Agents|antinematodal agents|mesh-ancestor
24681288|NCT01379326|Anthelmintics|anthelmintics|mesh-ancestor
24681289|NCT01379326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24638855|NCT01158755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681290|NCT01379326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24681291|NCT01379326|Tubulin Modulators|tubulin modulators|mesh-ancestor
24681292|NCT01379326|Antimitotic Agents|antimitotic agents|mesh-ancestor
24681293|NCT01379326|Mitosis Modulators|mitosis modulators|mesh-ancestor
24681294|NCT01379326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681350|NCT01379976|Vitamin B Complex|vitamin b complex|mesh-ancestor
24681473|NCT01380548|Dermatologic Agents|dermatologic agents|mesh-ancestor
24681475|NCT01380600|Sargramostim|sargramostim|mesh-list
24681476|NCT01380600|Immunologic Factors|immunologic factors|mesh-ancestor
24681477|NCT01380600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681478|NCT01380600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681479|NCT01380678|Bevacizumab|bevacizumab|mesh-list
24681480|NCT01380678|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
24681481|NCT01380678|Histamine Antagonists|histamine antagonists|mesh-list
24681482|NCT01380678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
24681484|NCT01380678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851936|NCT00055133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851937|NCT00055133|Tubulin Modulators|tubulin modulators|mesh-ancestor
25851938|NCT00055133|Antimitotic Agents|antimitotic agents|mesh-ancestor
24611222|NCT01007851|Luteolytic Agents|luteolytic agents|mesh-ancestor
24897557|NCT04424459|Analgesics, Opioid|analgesics, opioid|mesh-list
24611223|NCT01007851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24611224|NCT01007851|Contraceptive Agents|contraceptive agents|mesh-ancestor
24611225|NCT01007851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24681527|NCT01380912|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24681528|NCT01380912|Protective Agents|protective agents|mesh-ancestor
24681529|NCT01380912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24681530|NCT01380912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681531|NCT01380951|Telbivudine|telbivudine|mesh-list
24681532|NCT01380951|Antiviral Agents|antiviral agents|mesh-ancestor
24681533|NCT01380951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24681534|NCT01380951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24681535|NCT01380951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681536|NCT01380951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681537|NCT01381055|Pentoxifylline|pentoxifylline|mesh-list
24681729|NCT01381627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24681730|NCT01381627|Adrenergic Agents|adrenergic agents|mesh-ancestor
24681731|NCT01381627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24681790|NCT01382017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24681791|NCT01382017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24681792|NCT01382017|Analgesics|analgesics|mesh-ancestor
24681793|NCT01382017|Sensory System Agents|sensory system agents|mesh-ancestor
24681794|NCT01382017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24681795|NCT01382017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24681866|NCT01382407|Cetuximab|cetuximab|mesh-list
24681867|NCT01382407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25068567|NCT03432780|Tubulin Modulators|tubulin modulators|mesh-ancestor
25068568|NCT03432780|Antimitotic Agents|antimitotic agents|mesh-ancestor
25068569|NCT03432780|Mitosis Modulators|mitosis modulators|mesh-ancestor
24681912|NCT01382888|Anticoagulants|anticoagulants|mesh-ancestor
25851939|NCT00055133|Mitosis Modulators|mitosis modulators|mesh-ancestor
24682048|NCT01383655|Analgesics|analgesics|mesh-ancestor
24682049|NCT01383655|Sensory System Agents|sensory system agents|mesh-ancestor
24682050|NCT01383655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24682085|NCT01384214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682086|NCT01384214|Cholinergic Agents|cholinergic agents|mesh-ancestor
24682087|NCT01384214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24682088|NCT01384214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682089|NCT01384214|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25851940|NCT00055133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682090|NCT01384214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24682091|NCT01384227|Proflavine|proflavine|mesh-list
24682170|NCT01384578|alpha-Tocopherol|alpha-tocopherol|mesh-list
24682171|NCT01384578|Pentoxifylline|pentoxifylline|mesh-list
24682172|NCT01384578|Micronutrients|micronutrients|mesh-ancestor
24682173|NCT01384578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682174|NCT01384578|Antioxidants|antioxidants|mesh-ancestor
24682175|NCT01384578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682179|NCT01384578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24682180|NCT01384578|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24682181|NCT01384578|Vasodilator Agents|vasodilator agents|mesh-ancestor
24682182|NCT01384578|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24682184|NCT01384643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25068574|NCT03432767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25068575|NCT03432767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25068577|NCT03432767|Sensory System Agents|sensory system agents|mesh-ancestor
25068579|NCT03432767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068580|NCT03432767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25068581|NCT03432767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25068582|NCT03432728|Anesthetics|anesthetics|mesh-list
25068583|NCT03432728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25068584|NCT03432728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068585|NCT03432689|Cycloserine|cycloserine|mesh-list
25068586|NCT03432689|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25068587|NCT03432689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25068588|NCT03432689|Renal Agents|renal agents|mesh-ancestor
25068589|NCT03432689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24831112|NCT02163174|Antioxidants|antioxidants|mesh-ancestor
24682185|NCT01384643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24682253|NCT01385020|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24682254|NCT01385020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24682255|NCT01385020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682256|NCT01385020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24682258|NCT01385059|Axitinib|axitinib|mesh-list
24682259|NCT01385059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25851941|NCT00055159|Plasminogen|plasminogen|mesh-list
25851942|NCT00055159|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25851943|NCT00055159|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25851944|NCT00055159|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24682260|NCT01385059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24682295|NCT01385631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682296|NCT01385631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24682297|NCT01385683|Clarithromycin|clarithromycin|mesh-list
24682298|NCT01385683|Dabigatran|dabigatran|mesh-list
24682299|NCT01385683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24682300|NCT01385683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24682301|NCT01385683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24682306|NCT01385683|Antithrombins|antithrombins|mesh-ancestor
24682356|NCT01386086|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24682357|NCT01386086|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24682358|NCT01386086|Serotonin Agents|serotonin agents|mesh-ancestor
24639249|NCT01160926|Cediranib|cediranib|mesh-list
25202464|NCT02721082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202465|NCT02721082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24693785|NCT01422291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25068593|NCT03432689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068595|NCT03432676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25068596|NCT03432676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25068597|NCT03432663|Amiodarone|amiodarone|mesh-list
24831127|NCT02163330|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24831128|NCT02163330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24831130|NCT02163330|Diuretics|diuretics|mesh-ancestor
24682575|NCT01386853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682642|NCT01387295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24682643|NCT01387373|Capecitabine|capecitabine|mesh-list
24682644|NCT01387373|Oxaliplatin|oxaliplatin|mesh-list
24682645|NCT01387373|Trastuzumab|trastuzumab|mesh-list
24682646|NCT01387373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24682647|NCT01387373|Antimetabolites|antimetabolites|mesh-ancestor
24682651|NCT01387399|Cisplatin|cisplatin|mesh-list
24682682|NCT01387880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682684|NCT01387906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24682685|NCT01387997|Antibodies|antibodies|mesh-list
24682686|NCT01387997|Immunologic Factors|immunologic factors|mesh-ancestor
24682687|NCT01387997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682688|NCT01388023|Chlorhexidine|chlorhexidine|mesh-list
24682689|NCT01388023|Listerine|listerine|mesh-list
24682690|NCT01388023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24682691|NCT01388023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24682692|NCT01388023|Disinfectants|disinfectants|mesh-ancestor
24682693|NCT01388036|Esmolol|esmolol|mesh-list
24682694|NCT01388036|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24682701|NCT01388049|Antibodies|antibodies|mesh-list
24879274|NCT04920032|Irinotecan|irinotecan|mesh-list
24788953|NCT01934829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788956|NCT01934933|Etanercept|etanercept|mesh-list
24682741|NCT01388114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682742|NCT01388153|Acarbose|acarbose|mesh-list
24682743|NCT01388153|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24682744|NCT01388153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682745|NCT01388153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682746|NCT01388153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24682747|NCT01388153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682748|NCT01388270|Heparin|heparin|mesh-list
24682749|NCT01388270|Calcium heparin|calcium heparin|mesh-list
24467294|NCT00376987|Zinc Oxide|zinc oxide|mesh-list
24682915|NCT01389193|Respiratory System Agents|respiratory system agents|mesh-ancestor
24682916|NCT01389193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24682917|NCT01389193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682958|NCT01389414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682959|NCT01389414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24682960|NCT01389414|Immunologic Factors|immunologic factors|mesh-ancestor
25068598|NCT03432663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25068599|NCT03432663|Vasodilator Agents|vasodilator agents|mesh-ancestor
25068600|NCT03432663|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25068601|NCT03432663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24953719|NCT03882164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25068602|NCT03432663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831140|NCT02163616|Oxytocics|oxytocics|mesh-ancestor
24682961|NCT01389414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682962|NCT01389414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24682964|NCT01389427|Prednisone|prednisone|mesh-list
24682965|NCT01389427|Doxorubicin|doxorubicin|mesh-list
24682966|NCT01389427|Cyclophosphamide|cyclophosphamide|mesh-list
24683010|NCT01389505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24683011|NCT01389505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24683012|NCT01389505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24683013|NCT01389505|Growth Substances|growth substances|mesh-ancestor
24683014|NCT01389505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876184|NCT03847896|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24683191|NCT01390519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683192|NCT01390571|Temozolomide|temozolomide|mesh-list
24683216|NCT01390766|Immunologic Factors|immunologic factors|mesh-ancestor
24683217|NCT01390766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683218|NCT01390766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24683219|NCT01390792|Zanamivir|zanamivir|mesh-list
24683220|NCT01390792|Antiviral Agents|antiviral agents|mesh-ancestor
24683221|NCT01390792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24683222|NCT01390792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683223|NCT01390792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683224|NCT01390805|Valacyclovir|valacyclovir|mesh-list
24683225|NCT01390805|Antiviral Agents|antiviral agents|mesh-ancestor
24683269|NCT01390961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683270|NCT01390961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24683271|NCT01390961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24683327|NCT01391260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24683328|NCT01391260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24683329|NCT01391260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683330|NCT01391260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683332|NCT01391377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24683333|NCT01391377|Antimetabolites|antimetabolites|mesh-ancestor
24683334|NCT01391377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683455|NCT01392430|Itraconazole|itraconazole|mesh-list
24683456|NCT01392430|Fluconazole|fluconazole|mesh-list
24683457|NCT01392430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24683458|NCT01392430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24683459|NCT01392430|Antifungal Agents|antifungal agents|mesh-ancestor
24683460|NCT01392430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24683461|NCT01392430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24683462|NCT01392430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683463|NCT01392430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683464|NCT01392430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24683465|NCT01392430|Hormone Antagonists|hormone antagonists|mesh-ancestor
24683466|NCT01392430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25663457|NCT01658904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663458|NCT01658904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25663459|NCT01658904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25068603|NCT03432663|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25068604|NCT03432663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25068605|NCT03432663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25068606|NCT03432663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683467|NCT01392430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683468|NCT01392430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24683469|NCT01392430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24683470|NCT01392430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24683471|NCT01392430|Antimalarials|antimalarials|mesh-ancestor
24683472|NCT01392430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24683473|NCT01392430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24683474|NCT01392430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24683475|NCT01392430|Leprostatic Agents|leprostatic agents|mesh-ancestor
24683490|NCT01392612|Epoetin Alfa|epoetin alfa|mesh-list
24683491|NCT01392612|Hematinics|hematinics|mesh-ancestor
24683492|NCT01392638|Sildenafil Citrate|sildenafil citrate|mesh-list
24683493|NCT01392638|Vasodilator Agents|vasodilator agents|mesh-ancestor
24683494|NCT01392638|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24683495|NCT01392638|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24683496|NCT01392638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683497|NCT01392638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683557|NCT01392833|Hormones|hormones|mesh-ancestor
24516889|NCT00604409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24683558|NCT01392833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24683559|NCT01392833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542866|NCT00680602|Serotonin Agents|serotonin agents|mesh-ancestor
24683614|NCT01393145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683615|NCT01393145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24611422|NCT01009476|Autonomic Agents|autonomic agents|mesh-ancestor
24611423|NCT01009476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24611424|NCT01009476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24611425|NCT01009476|Protective Agents|protective agents|mesh-ancestor
24639792|NCT01164189|Alkylating Agents|alkylating agents|mesh-ancestor
24611426|NCT01009476|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24611427|NCT01009476|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24611428|NCT01009476|Adrenergic Agents|adrenergic agents|mesh-ancestor
24611429|NCT01009476|Vasodilator Agents|vasodilator agents|mesh-ancestor
24611430|NCT01009502|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
24611431|NCT01009502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24611432|NCT01009502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24611452|NCT01009567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24611453|NCT01009567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24611454|NCT01009567|Dopamine Agonists|dopamine agonists|mesh-ancestor
25068607|NCT03432663|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25068608|NCT03432663|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25068609|NCT03432663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24611456|NCT01009567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24683674|NCT01393548|Brompheniramine|brompheniramine|mesh-list
24683675|NCT01393548|Phenylephrine|phenylephrine|mesh-list
24683676|NCT01393548|Oxymetazoline|oxymetazoline|mesh-list
24683677|NCT01393548|Pseudoephedrine|pseudoephedrine|mesh-list
24683678|NCT01393548|Ephedrine|ephedrine|mesh-list
24683679|NCT01393548|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24683680|NCT01393548|Mydriatics|mydriatics|mesh-ancestor
24683681|NCT01393548|Autonomic Agents|autonomic agents|mesh-ancestor
24683697|NCT01393548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24683698|NCT01393548|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24683699|NCT01393548|Histamine Antagonists|histamine antagonists|mesh-ancestor
24683700|NCT01393548|Histamine Agents|histamine agents|mesh-ancestor
24683701|NCT01393548|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24683702|NCT01393574|Melatonin|melatonin|mesh-list
24683703|NCT01393574|Methylphenidate|methylphenidate|mesh-list
24683704|NCT01393574|Antioxidants|antioxidants|mesh-ancestor
24683705|NCT01393574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683706|NCT01393574|Protective Agents|protective agents|mesh-ancestor
24683716|NCT01393756|Immunologic Factors|immunologic factors|mesh-ancestor
24683732|NCT01393782|Angiotensin II|angiotensin ii|mesh-list
24683733|NCT01393782|Giapreza|giapreza|mesh-list
24683734|NCT01393782|Angiotensinogen|angiotensinogen|mesh-list
24683735|NCT01393782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24683736|NCT01393782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24683737|NCT01393782|Protease Inhibitors|protease inhibitors|mesh-ancestor
24683738|NCT01393782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683739|NCT01393782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683740|NCT01393795|Capsaicin|capsaicin|mesh-list
24683741|NCT01393795|Antipruritics|antipruritics|mesh-ancestor
24683742|NCT01393795|Dermatologic Agents|dermatologic agents|mesh-ancestor
25423148|NCT02397096|Elvitegravir|elvitegravir|mesh-list
25239151|NCT02543697|Respiratory System Agents|respiratory system agents|mesh-ancestor
25239152|NCT02543697|Mydriatics|mydriatics|mesh-ancestor
25239153|NCT02543697|Sympathomimetics|sympathomimetics|mesh-ancestor
25239154|NCT02543697|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24683743|NCT01393795|Sensory System Agents|sensory system agents|mesh-ancestor
24683745|NCT01393795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683746|NCT01393912|Crenolanib|crenolanib|mesh-list
24683762|NCT01394016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24683763|NCT01394016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24683764|NCT01394016|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24683765|NCT01394016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24683766|NCT01394016|Hormone Antagonists|hormone antagonists|mesh-ancestor
24683767|NCT01394016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24683768|NCT01394016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683769|NCT01394029|Deferasirox|deferasirox|mesh-list
24683770|NCT01394029|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24683771|NCT01394029|Chelating Agents|chelating agents|mesh-ancestor
24683772|NCT01394029|Sequestering Agents|sequestering agents|mesh-ancestor
24683822|NCT01394354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24683823|NCT01394354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24683824|NCT01394354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24683854|NCT01394445|Physostigmine|physostigmine|mesh-list
24683855|NCT01394445|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24683856|NCT01394445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698329|NCT01440608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24683857|NCT01394445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683858|NCT01394445|Cholinergic Agents|cholinergic agents|mesh-ancestor
24683859|NCT01394445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24683862|NCT01394445|Autonomic Agents|autonomic agents|mesh-ancestor
24683863|NCT01394445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24683864|NCT01394458|Ethanol|ethanol|mesh-list
24683865|NCT01394458|Heparin|heparin|mesh-list
24683866|NCT01394458|Citric Acid|citric acid|mesh-list
24683867|NCT01394458|Sodium Citrate|sodium citrate|mesh-list
24683868|NCT01394458|Anticoagulants|anticoagulants|mesh-ancestor
24683869|NCT01394458|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24683870|NCT01394458|Chelating Agents|chelating agents|mesh-ancestor
24683871|NCT01394458|Sequestering Agents|sequestering agents|mesh-ancestor
24683872|NCT01394458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683873|NCT01394458|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24683874|NCT01394458|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25851945|NCT00055159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683913|NCT01394731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24683914|NCT01394731|Analgesics|analgesics|mesh-ancestor
24683915|NCT01394731|Sensory System Agents|sensory system agents|mesh-ancestor
24683916|NCT01394731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24683917|NCT01394731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683918|NCT01394731|Antipyretics|antipyretics|mesh-ancestor
24683919|NCT01394731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24683920|NCT01394731|Narcotics|narcotics|mesh-ancestor
24683921|NCT01394731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24683922|NCT01394731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24684018|NCT01395147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684019|NCT01395147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24684020|NCT01395147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24684021|NCT01395147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25068627|NCT03432637|Anesthetics|anesthetics|mesh-list
25068628|NCT03432637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25068629|NCT03432637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068630|NCT03432598|Gemcitabine|gemcitabine|mesh-list
25068632|NCT03432598|Etoposide|etoposide|mesh-list
24684022|NCT01395147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684023|NCT01395147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24684024|NCT01395147|Serotonin Agents|serotonin agents|mesh-ancestor
24684025|NCT01395147|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24684026|NCT01395147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24684027|NCT01395147|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24684028|NCT01395147|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24684030|NCT01395199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24684031|NCT01395199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25663460|NCT01658943|Fluorouracil|fluorouracil|mesh-list
25663461|NCT01658943|Oxaliplatin|oxaliplatin|mesh-list
25663462|NCT01658943|Antimetabolites|antimetabolites|mesh-ancestor
25663463|NCT01658943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468636|NCT00382499|Sensory System Agents|sensory system agents|mesh-ancestor
25045108|NCT00994292|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25663464|NCT01658943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25045109|NCT00994292|Protease Inhibitors|protease inhibitors|mesh-ancestor
25045110|NCT00994292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045111|NCT00994292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715537|NCT01537055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24715538|NCT01537055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24715539|NCT01537055|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24715541|NCT01537055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24715542|NCT01537055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24715543|NCT01537055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715544|NCT01537055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715545|NCT01537055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24788962|NCT01934933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684032|NCT01395199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24684033|NCT01395199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684034|NCT01395199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24684035|NCT01395199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684068|NCT01395420|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24684069|NCT01395420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24684070|NCT01395420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684072|NCT01395433|Citalopram|citalopram|mesh-list
24684073|NCT01395433|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24684074|NCT01395433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25851946|NCT00055185|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
24611503|NCT01009879|Etanercept|etanercept|mesh-list
24611504|NCT01009879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24611505|NCT01009879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24611506|NCT01009879|Analgesics|analgesics|mesh-ancestor
24684084|NCT01395433|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24684085|NCT01395433|Parasympatholytics|parasympatholytics|mesh-ancestor
24684086|NCT01395433|Autonomic Agents|autonomic agents|mesh-ancestor
24684087|NCT01395433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24684088|NCT01395433|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24684089|NCT01395433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24684090|NCT01395433|Cholinergic Agents|cholinergic agents|mesh-ancestor
24684091|NCT01395485|Brodalumab|brodalumab|mesh-list
24684092|NCT01395485|Dermatologic Agents|dermatologic agents|mesh-ancestor
24684093|NCT01395589|Vitamin D|vitamin d|mesh-list
24684094|NCT01395589|Vitamins|vitamins|mesh-ancestor
24684095|NCT01395589|Micronutrients|micronutrients|mesh-ancestor
24684096|NCT01395589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684097|NCT01395589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24684098|NCT01395602|Cabergoline|cabergoline|mesh-list
24684099|NCT01395602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24684100|NCT01395602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24684101|NCT01395602|Dopamine Agonists|dopamine agonists|mesh-ancestor
24684102|NCT01395602|Dopamine Agents|dopamine agents|mesh-ancestor
24684103|NCT01395602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24684104|NCT01395602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684105|NCT01395602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684106|NCT01395654|Rifampin|rifampin|mesh-list
24684107|NCT01395654|Isoniazid|isoniazid|mesh-list
24684108|NCT01395654|Pyrazinamide|pyrazinamide|mesh-list
24684109|NCT01395654|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24684133|NCT01395667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684134|NCT01395667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24684135|NCT01395667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24684136|NCT01395667|Immunologic Factors|immunologic factors|mesh-ancestor
25663465|NCT01658943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663466|NCT01658943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25663467|NCT01658943|Immunologic Factors|immunologic factors|mesh-ancestor
25663468|NCT01658943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663469|NCT01658995|Doxycycline|doxycycline|mesh-list
25663470|NCT01658995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25663471|NCT01658995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25663472|NCT01658995|Antimalarials|antimalarials|mesh-ancestor
25663473|NCT01658995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25663474|NCT01658995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25663475|NCT01659021|Ofatumumab|ofatumumab|mesh-list
25663476|NCT01659021|Idelalisib|idelalisib|mesh-list
25663477|NCT01659021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663478|NCT01659021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663479|NCT01659021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715551|NCT01537094|Vitamins|vitamins|mesh-list
24715552|NCT01537094|Ascorbic Acid|ascorbic acid|mesh-list
24715553|NCT01537094|Micronutrients|micronutrients|mesh-ancestor
24715554|NCT01537094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715555|NCT01537094|Antioxidants|antioxidants|mesh-ancestor
24715556|NCT01537094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715557|NCT01537094|Protective Agents|protective agents|mesh-ancestor
24715587|NCT01537250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25239184|NCT02543710|Taxane|taxane|mesh-list
25239185|NCT02543710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25239186|NCT02543671|Vitamin D|vitamin d|mesh-list
25239187|NCT02543671|Cholecalciferol|cholecalciferol|mesh-list
25239188|NCT02543671|Vitamins|vitamins|mesh-ancestor
25239189|NCT02543671|Micronutrients|micronutrients|mesh-ancestor
25068633|NCT03432598|Carboplatin|carboplatin|mesh-list
25068634|NCT03432598|Pemetrexed|pemetrexed|mesh-list
25068635|NCT03432598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25068636|NCT03432598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25068637|NCT03432598|Tubulin Modulators|tubulin modulators|mesh-ancestor
25068638|NCT03432598|Antimitotic Agents|antimitotic agents|mesh-ancestor
25068639|NCT03432598|Mitosis Modulators|mitosis modulators|mesh-ancestor
25068640|NCT03432598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684155|NCT01395849|Respiratory System Agents|respiratory system agents|mesh-ancestor
24684164|NCT01395849|Glucocorticoids|glucocorticoids|mesh-ancestor
24684181|NCT01395862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24684182|NCT01395862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24684183|NCT01395862|Adrenergic Agents|adrenergic agents|mesh-ancestor
24684184|NCT01395862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24684185|NCT01395862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684186|NCT01395862|Glucocorticoids|glucocorticoids|mesh-ancestor
24684187|NCT01395862|Hormones|hormones|mesh-ancestor
24684188|NCT01395862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24684189|NCT01395862|Sympathomimetics|sympathomimetics|mesh-ancestor
24684190|NCT01395875|Fluticasone|fluticasone|mesh-list
24684192|NCT01395875|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24684193|NCT01395875|Cholinergic Antagonists|cholinergic antagonists|mesh-list
24684194|NCT01395875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24684195|NCT01395875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24684196|NCT01395875|Autonomic Agents|autonomic agents|mesh-ancestor
24699548|NCT01447563|Clopidogrel|clopidogrel|mesh-list
24684197|NCT01395875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24684198|NCT01395875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684199|NCT01395875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25068657|NCT03432572|Micronutrients|micronutrients|mesh-ancestor
25068658|NCT03432572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068659|NCT03432572|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25068660|NCT03432572|Dermatologic Agents|dermatologic agents|mesh-ancestor
25068661|NCT03432468|Valsartan|valsartan|mesh-list
24685301|NCT05274113|Glucocorticoids|glucocorticoids|mesh-ancestor
24684255|NCT01396200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24684256|NCT01396200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684258|NCT01396200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24684259|NCT01396200|Immunologic Factors|immunologic factors|mesh-ancestor
24684260|NCT01396200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684283|NCT01396655|Antimitotic Agents|antimitotic agents|mesh-ancestor
24684284|NCT01396655|Mitosis Modulators|mitosis modulators|mesh-ancestor
24684285|NCT01396655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684327|NCT01396720|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24684328|NCT01396720|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24684329|NCT01396720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25663480|NCT01659320|Minocycline|minocycline|mesh-list
25663481|NCT01659320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25663482|NCT01659320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25663483|NCT01659567|Interferons|interferons|mesh-list
25663484|NCT01659567|Ribavirin|ribavirin|mesh-list
25663485|NCT01659567|Interferon-alpha|interferon-alpha|mesh-list
25663486|NCT01659567|Interferon alpha-2|interferon alpha-2|mesh-list
25663487|NCT01659567|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25663488|NCT01659567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663489|NCT01659567|Antiviral Agents|antiviral agents|mesh-ancestor
25663490|NCT01659567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25663491|NCT01659567|Antimetabolites|antimetabolites|mesh-ancestor
25663492|NCT01659567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684330|NCT01396720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684332|NCT01396720|Serotonin Agents|serotonin agents|mesh-ancestor
25202466|NCT02721082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25423460|NCT02370238|Paclitaxel|paclitaxel|mesh-list
24684333|NCT01396720|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24684334|NCT01396720|Antidepressive Agents|antidepressive agents|mesh-ancestor
24684336|NCT01396720|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24684337|NCT01396720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24684338|NCT01396720|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24684341|NCT01396733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684342|NCT01396733|Protective Agents|protective agents|mesh-ancestor
25851947|NCT00055185|Immunologic Factors|immunologic factors|mesh-ancestor
24684432|NCT05268718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684434|NCT05268718|Hormone Antagonists|hormone antagonists|mesh-ancestor
24611517|NCT01009892|Narcotics|narcotics|mesh-ancestor
24684435|NCT05268718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25068667|NCT03432442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24684452|NCT05268562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24684453|NCT05268562|Anesthetics, General|anesthetics, general|mesh-ancestor
24684455|NCT05268562|Analgesics|analgesics|mesh-ancestor
24684456|NCT05268562|Sensory System Agents|sensory system agents|mesh-ancestor
24684537|NCT05186558|Gemcitabine|gemcitabine|mesh-list
24684538|NCT05186558|Rituximab|rituximab|mesh-list
24684539|NCT05186558|Oxaliplatin|oxaliplatin|mesh-list
24684540|NCT05186558|Lenalidomide|lenalidomide|mesh-list
24684541|NCT05186558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24684542|NCT05186558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684543|NCT05186558|Immunologic Factors|immunologic factors|mesh-ancestor
24684544|NCT05186558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684545|NCT05186558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24684546|NCT05186558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24611518|NCT01009892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24611519|NCT01009892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685113|NCT02112734|Vitamin D|vitamin d|mesh-list
24684613|NCT04971720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24684614|NCT04971720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684616|NCT04965870|Antimetabolites|antimetabolites|mesh-ancestor
24684662|NCT04835129|Hormones|hormones|mesh-ancestor
24684663|NCT04835129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24684664|NCT04835129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24640270|NCT01167127|Oxycodone|oxycodone|mesh-list
24685169|NCT01724606|Sorafenib|sorafenib|mesh-list
24684709|NCT04598815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24684710|NCT04598815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684711|NCT04598815|Antifungal Agents|antifungal agents|mesh-ancestor
24684764|NCT04453449|GABA Modulators|gaba modulators|mesh-ancestor
24684765|NCT04453449|GABA Agents|gaba agents|mesh-ancestor
25068686|NCT03432273|Cholinergic Agents|cholinergic agents|mesh-ancestor
25068687|NCT03432273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25068688|NCT03432273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068689|NCT03432221|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25068690|NCT03432221|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25068691|NCT03432221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25068692|NCT03432221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25068693|NCT03432221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068694|NCT03432221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25068695|NCT03432221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684766|NCT04453449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24684767|NCT04453449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684805|NCT04093596|Alkylating Agents|alkylating agents|mesh-ancestor
24684806|NCT04093596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684807|NCT04093596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684808|NCT04093596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24685049|NCT02607956|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24685050|NCT02607956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24685141|NCT01798004|Melphalan|melphalan|mesh-list
24685142|NCT01798004|Busulfan|busulfan|mesh-list
24685143|NCT01798004|Doxorubicin|doxorubicin|mesh-list
24685144|NCT01798004|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24685145|NCT01798004|Etoposide|etoposide|mesh-list
24685146|NCT01798004|Vincristine|vincristine|mesh-list
24685147|NCT01798004|Etoposide phosphate|etoposide phosphate|mesh-list
24685148|NCT01798004|Topotecan|topotecan|mesh-list
24685150|NCT01798004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24685151|NCT01798004|Immunologic Factors|immunologic factors|mesh-ancestor
24685152|NCT01798004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155192|NCT05444556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25155193|NCT05444556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24685153|NCT01798004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24685154|NCT01798004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24685155|NCT01798004|Alkylating Agents|alkylating agents|mesh-ancestor
24685156|NCT01798004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640479|NCT01168492|Anesthetics, General|anesthetics, general|mesh-ancestor
24685157|NCT01798004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25068704|NCT03432195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068705|NCT03432195|Nootropic Agents|nootropic agents|mesh-ancestor
25068706|NCT03432091|Melatonin|melatonin|mesh-list
25068707|NCT03432091|Antioxidants|antioxidants|mesh-ancestor
25068708|NCT03432091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068709|NCT03432091|Protective Agents|protective agents|mesh-ancestor
25068710|NCT03432091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068711|NCT03432091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25068717|NCT03431974|Aminopterin|aminopterin|mesh-list
25068718|NCT03431974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25068719|NCT03431974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25068720|NCT03431974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068721|NCT03431961|Triamcinolone|triamcinolone|mesh-list
24685299|NCT05274113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685300|NCT05274113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24685449|NCT05272696|Antimitotic Agents|antimitotic agents|mesh-ancestor
24685450|NCT05272696|Mitosis Modulators|mitosis modulators|mesh-ancestor
24685451|NCT05272696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068722|NCT03431961|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25068723|NCT03431961|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25068724|NCT03431961|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25068725|NCT03431961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25068727|NCT03431961|Hormones|hormones|mesh-ancestor
24831252|NCT02164552|Cholecalciferol|cholecalciferol|mesh-list
25851948|NCT00055185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685452|NCT05272696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24685454|NCT05272462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24685455|NCT05272462|Vasodilator Agents|vasodilator agents|mesh-ancestor
24685456|NCT05272371|Dinutuximab|dinutuximab|mesh-list
24685457|NCT05272371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24685501|NCT05271448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24685512|NCT05271370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685513|NCT05271253|Dexmedetomidine|dexmedetomidine|mesh-list
24685514|NCT05271253|Bupivacaine|bupivacaine|mesh-list
24685562|NCT05271058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24685563|NCT05271058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24685564|NCT05271058|Protease Inhibitors|protease inhibitors|mesh-ancestor
24685565|NCT05271058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24685566|NCT05271058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685567|NCT05271058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24685568|NCT05271058|Immunologic Factors|immunologic factors|mesh-ancestor
24685570|NCT05271045|Vitamin A|vitamin a|mesh-list
24685571|NCT05271045|Vitamins|vitamins|mesh-ancestor
24685572|NCT05271045|Micronutrients|micronutrients|mesh-ancestor
24685573|NCT05271045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685574|NCT05271045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25851949|NCT00055198|Daptomycin|daptomycin|mesh-list
24685682|NCT05248724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24685683|NCT05248724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685684|NCT05248724|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24685685|NCT05248724|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24685686|NCT05248724|Adrenergic Agents|adrenergic agents|mesh-ancestor
24685687|NCT05248724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24685688|NCT05248724|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24685689|NCT05248724|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24685690|NCT05248724|Autonomic Agents|autonomic agents|mesh-ancestor
24685691|NCT05248724|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24685692|NCT05248724|Respiratory System Agents|respiratory system agents|mesh-ancestor
24685693|NCT05248724|Mydriatics|mydriatics|mesh-ancestor
24685694|NCT05248724|Sympathomimetics|sympathomimetics|mesh-ancestor
24685695|NCT05248724|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24685699|NCT05245760|Paclitaxel|paclitaxel|mesh-list
24685727|NCT05233982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24685728|NCT05233982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409348|NCT03384836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25663493|NCT01659567|Immunologic Factors|immunologic factors|mesh-ancestor
25663494|NCT01659567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685729|NCT05233982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876185|NCT03847896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24685823|NCT05168735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24640680|NCT01169597|Prednisone|prednisone|mesh-list
24685824|NCT05168735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685825|NCT05168735|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25068728|NCT03431961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25068729|NCT03431961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685830|NCT05168735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24685831|NCT05168735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24685832|NCT05168735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24899001|NCT04407975|Glucocorticoids|glucocorticoids|mesh-ancestor
24685936|NCT05138029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24685937|NCT05138029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24685939|NCT05138029|Protease Inhibitors|protease inhibitors|mesh-ancestor
24685940|NCT05138029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24685941|NCT05138029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685942|NCT05138029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25202467|NCT02721082|Cholinergic Agents|cholinergic agents|mesh-ancestor
24685943|NCT05138029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24685944|NCT05138029|Growth Substances|growth substances|mesh-ancestor
24685945|NCT05138029|Growth Inhibitors|growth inhibitors|mesh-ancestor
24685946|NCT05137119|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24685948|NCT05137119|Clindamycin|clindamycin|mesh-list
24685949|NCT05137119|Cefazolin|cefazolin|mesh-list
24685950|NCT05137119|Daptomycin|daptomycin|mesh-list
24685951|NCT05137119|Penicillins|penicillins|mesh-list
24685952|NCT05137119|Penicillin G|penicillin g|mesh-list
24685953|NCT05137119|Lincomycin|lincomycin|mesh-list
24685954|NCT05137119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24685955|NCT05137119|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24685956|NCT05137119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24685957|NCT05137119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685958|NCT05135039|Canagliflozin|canagliflozin|mesh-list
24685959|NCT05135039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24685969|NCT05129332|Protective Agents|protective agents|mesh-ancestor
24685970|NCT05128591|Rivaroxaban|rivaroxaban|mesh-list
24685971|NCT05128591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24685972|NCT05128591|Antithrombins|antithrombins|mesh-ancestor
24685973|NCT05128591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24685974|NCT05128591|Protease Inhibitors|protease inhibitors|mesh-ancestor
24685975|NCT05128591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24685976|NCT05128591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685977|NCT05128591|Anticoagulants|anticoagulants|mesh-ancestor
24685978|NCT05124977|Anti-Infective Agents|anti-infective agents|mesh-list
24611618|NCT01010100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611620|NCT01010139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24611621|NCT01010139|Narcotics|narcotics|mesh-ancestor
25068733|NCT03431961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686057|NCT05067439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686059|NCT05067439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686060|NCT05067439|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24686061|NCT05067439|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24686062|NCT05067439|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24686063|NCT05067439|Purinergic Agents|purinergic agents|mesh-ancestor
24686064|NCT05067439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24686065|NCT05067439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24686066|NCT05067439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24686067|NCT05067439|Antiviral Agents|antiviral agents|mesh-ancestor
24686068|NCT05067439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24686069|NCT05067439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24686070|NCT05067439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24686071|NCT05067439|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24686072|NCT05067439|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24686073|NCT05067439|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24686220|NCT04990778|Venetoclax|venetoclax|mesh-list
24686221|NCT04990778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611682|NCT01010295|Antimalarials|antimalarials|mesh-ancestor
24611683|NCT01010295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24611684|NCT01010295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24611685|NCT01010295|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24634232|NCT01132586|Cytarabine|cytarabine|mesh-list
24611686|NCT01010295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24686411|NCT04859829|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25239233|NCT02543099|Policosanol|policosanol|mesh-list
25239234|NCT02543099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25239235|NCT02543099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25239236|NCT02543099|Antimetabolites|antimetabolites|mesh-ancestor
25239237|NCT02543099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239238|NCT02543099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25239239|NCT02543099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25239240|NCT02543086|Piperaquine|piperaquine|mesh-list
25239241|NCT02543086|Antimalarials|antimalarials|mesh-ancestor
24636385|NCT01145079|Sirolimus|sirolimus|mesh-list
25006053|NCT05205837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006054|NCT05205837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25006055|NCT05205837|Hormone Antagonists|hormone antagonists|mesh-ancestor
25006057|NCT05205837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686412|NCT04859829|Antibodies|antibodies|mesh-list
24686413|NCT04859829|gamma-Globulins|gamma-globulins|mesh-list
24686414|NCT04859829|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24686415|NCT04859829|Immunologic Factors|immunologic factors|mesh-ancestor
24686416|NCT04859829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686417|NCT04835402|Pembrolizumab|pembrolizumab|mesh-list
24686418|NCT04835402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24686419|NCT04835402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24471361|NCT00394966|Rolapitant|rolapitant|mesh-list
24686420|NCT04820972|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
24686422|NCT04818957|Cholecalciferol|cholecalciferol|mesh-list
24686423|NCT04818957|Vitamins|vitamins|mesh-ancestor
24686424|NCT04818957|Micronutrients|micronutrients|mesh-ancestor
24686425|NCT04818957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686426|NCT04818957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25876186|NCT03847896|Adrenergic Agents|adrenergic agents|mesh-ancestor
24686479|NCT04768829|Carbamide Peroxide|carbamide peroxide|mesh-list
24686480|NCT04768829|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24686481|NCT04768829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24686497|NCT04760912|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24686498|NCT04760912|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24686499|NCT04760912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25068742|NCT03431909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25068743|NCT03431909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068744|NCT03431909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25068745|NCT03431909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25068746|NCT03431909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25068747|NCT03431909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25068748|NCT03431909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068749|NCT03431909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25068750|NCT03431909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25068751|NCT03431909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25068752|NCT03431909|Antipyretics|antipyretics|mesh-ancestor
24831273|NCT02164578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24686502|NCT04760691|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24686503|NCT04760691|Leuprolide|leuprolide|mesh-list
24686504|NCT04760691|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24686505|NCT04760691|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24686506|NCT04760691|Estradiol|estradiol|mesh-list
24634372|NCT01133210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24686507|NCT04760691|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24686508|NCT04760691|Estrogens|estrogens|mesh-list
24686509|NCT04760691|Antiviral Agents|antiviral agents|mesh-ancestor
24686510|NCT04760691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24686511|NCT04760691|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24687152|NCT04301271|Simvastatin|simvastatin|mesh-list
25068757|NCT03431909|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25068758|NCT03431909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25423544|NCT02362503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25663495|NCT01659866|Ciprofloxacin|ciprofloxacin|mesh-list
25663496|NCT01659866|Gentamicins|gentamicins|mesh-list
25663497|NCT01659866|Ceftriaxone|ceftriaxone|mesh-list
25663498|NCT01659866|Imipenem|imipenem|mesh-list
25663499|NCT01659866|Amikacin|amikacin|mesh-list
25663500|NCT01659866|Cefuroxime|cefuroxime|mesh-list
25663501|NCT01659866|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25663502|NCT01659866|Aztreonam|aztreonam|mesh-list
25663503|NCT01659866|Trimethoprim|trimethoprim|mesh-list
25663504|NCT01659866|Sulfamethoxazole|sulfamethoxazole|mesh-list
25663505|NCT01659866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25663506|NCT01659866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25663507|NCT01659866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25663508|NCT01659866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25663509|NCT01659866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851951|NCT00055198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24716387|NCT01541332|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24716388|NCT01541332|Pomalidomide|pomalidomide|mesh-list
24716389|NCT01541332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24716390|NCT01541332|Antiemetics|antiemetics|mesh-ancestor
24716391|NCT01541332|Autonomic Agents|autonomic agents|mesh-ancestor
24716392|NCT01541332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25068759|NCT03431909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24686817|NCT04564612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686818|NCT04564612|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24686819|NCT04564612|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24686820|NCT04564612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24686821|NCT04564612|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24686965|NCT04481412|Vasodilator Agents|vasodilator agents|mesh-ancestor
24687006|NCT04432610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24687007|NCT04432610|Adrenergic Agents|adrenergic agents|mesh-ancestor
24687008|NCT04432610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24687009|NCT04432610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687010|NCT04432610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687011|NCT04432610|Sympatholytics|sympatholytics|mesh-ancestor
24687012|NCT04432610|Autonomic Agents|autonomic agents|mesh-ancestor
24634604|NCT01134341|Vitamins|vitamins|mesh-list
24687013|NCT04432610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24687014|NCT04432610|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24687015|NCT04432610|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24687016|NCT04432610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24687017|NCT04418466|Risperidone|risperidone|mesh-list
24687018|NCT04418466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24687019|NCT04418466|Serotonin Agents|serotonin agents|mesh-ancestor
24687020|NCT04418466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24687021|NCT04418466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687022|NCT04418466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687023|NCT04418466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24687024|NCT04418466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24687025|NCT04418466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24687026|NCT04418466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25068760|NCT03431909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25068761|NCT03431909|Purinergic Agents|purinergic agents|mesh-ancestor
25068762|NCT03431909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25068763|NCT03431909|Coagulants|coagulants|mesh-ancestor
25068764|NCT03431909|Fertility Agents, Male|fertility agents, male|mesh-ancestor
25068765|NCT03431909|Fertility Agents|fertility agents|mesh-ancestor
25068766|NCT03431909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25068767|NCT03431831|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
24687150|NCT04302168|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25851952|NCT00055250|Gemcitabine|gemcitabine|mesh-list
24687194|NCT04245644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24687195|NCT04245644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687196|NCT04245644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24687197|NCT04245644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24687198|NCT04245644|Analgesics|analgesics|mesh-ancestor
24687199|NCT04245644|Sensory System Agents|sensory system agents|mesh-ancestor
24687200|NCT04245644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24687201|NCT04245644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24687202|NCT04245644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24687292|NCT04095104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25409426|NCT03382561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25663510|NCT01659866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663511|NCT01659866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663512|NCT01659866|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25663513|NCT01659866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25663514|NCT01659866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25663515|NCT01659866|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25663516|NCT01659866|Renal Agents|renal agents|mesh-ancestor
25663517|NCT01659866|Antimalarials|antimalarials|mesh-ancestor
24687293|NCT04095104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687296|NCT04074512|Micronutrients|micronutrients|mesh-ancestor
24687297|NCT04074512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611705|NCT01010373|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24611706|NCT01010373|Protective Agents|protective agents|mesh-ancestor
24611707|NCT01010373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24611708|NCT01010373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24611709|NCT01010373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611710|NCT01010373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611711|NCT01010373|Antiviral Agents|antiviral agents|mesh-ancestor
24611712|NCT01010373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24611714|NCT01010425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24611715|NCT01010425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611716|NCT01010451|Anti-Infective Agents|anti-infective agents|mesh-list
24611717|NCT01010451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25851953|NCT00055250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24611749|NCT01010581|Antimetabolites|antimetabolites|mesh-ancestor
24687375|NCT04011150|Fentanyl|fentanyl|mesh-list
24687376|NCT04011150|Ropivacaine|ropivacaine|mesh-list
24687377|NCT04011150|Anesthetics, Local|anesthetics, local|mesh-list
24687378|NCT04011150|Anesthetics|anesthetics|mesh-list
24687379|NCT04011150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24687380|NCT04011150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687381|NCT04011150|Sensory System Agents|sensory system agents|mesh-ancestor
24635137|NCT01137253|Trimethaphan|trimethaphan|mesh-list
24687387|NCT04011150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24687462|NCT03974243|Chiauranib|chiauranib|mesh-list
24687463|NCT03974243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24687464|NCT03974243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24687465|NCT03974243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24687499|NCT03947671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687509|NCT03945643|Sildenafil Citrate|sildenafil citrate|mesh-list
24687510|NCT03945643|Vasodilator Agents|vasodilator agents|mesh-ancestor
24687511|NCT03945643|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24687512|NCT03945643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24687513|NCT03945643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24687514|NCT03945643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687515|NCT03945643|Urological Agents|urological agents|mesh-ancestor
25068783|NCT03431831|Dopamine Agents|dopamine agents|mesh-ancestor
25068784|NCT03431831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24413860|NCT00195468|Antifungal Agents|antifungal agents|mesh-ancestor
24687577|NCT03883412|Hormones|hormones|mesh-ancestor
24687578|NCT03883412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24687579|NCT03867682|Venetoclax|venetoclax|mesh-list
24687580|NCT03867682|Lintuzumab|lintuzumab|mesh-list
24687581|NCT03867682|Spironolactone|spironolactone|mesh-list
24687582|NCT03867682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24687583|NCT03867682|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24687584|NCT03867682|Hormone Antagonists|hormone antagonists|mesh-ancestor
24687585|NCT03867682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24687586|NCT03867682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687587|NCT03867682|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24687588|NCT03867682|Diuretics|diuretics|mesh-ancestor
24687589|NCT03867682|Natriuretic Agents|natriuretic agents|mesh-ancestor
24687590|NCT03867682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24472662|NCT00400088|Antimanic Agents|antimanic agents|mesh-ancestor
24472663|NCT00400088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24472664|NCT00400088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24635903|NCT01141881|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24635905|NCT01141881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25068797|NCT03431766|Disinfectants|disinfectants|mesh-ancestor
25068798|NCT03431714|Artesunate|artesunate|mesh-list
25068799|NCT03431714|Piperaquine|piperaquine|mesh-list
25068800|NCT03431714|Amodiaquine|amodiaquine|mesh-list
25068801|NCT03431714|Artenimol|artenimol|mesh-list
25068802|NCT03431714|Antimalarials|antimalarials|mesh-ancestor
25068803|NCT03431714|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25068804|NCT03431714|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25068805|NCT03431714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25068806|NCT03431714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24687638|NCT03858621|Narcotics|narcotics|mesh-ancestor
24687639|NCT03858621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24687640|NCT03858621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687641|NCT03858621|Analgesics|analgesics|mesh-ancestor
24687642|NCT03858621|Sensory System Agents|sensory system agents|mesh-ancestor
25423698|NCT02346253|Leuprolide|leuprolide|mesh-list
24716752|NCT01543737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716753|NCT01543737|Viscosupplements|viscosupplements|mesh-ancestor
24716754|NCT01543737|Protective Agents|protective agents|mesh-ancestor
24716755|NCT01543750|4-Aminopyridine|4-aminopyridine|mesh-list
24716756|NCT01543750|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24716757|NCT01543750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24716758|NCT01543750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687643|NCT03858621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24687644|NCT03858621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24687645|NCT03858621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24687671|NCT03807921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24687672|NCT03807921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24687673|NCT03807921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687674|NCT03807921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24687675|NCT03807921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24687676|NCT03807921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24687677|NCT03807921|Antipyretics|antipyretics|mesh-ancestor
24687678|NCT03807921|Anticoagulants|anticoagulants|mesh-ancestor
24687679|NCT03794076|Cromolyn Sodium|cromolyn sodium|mesh-list
24687680|NCT03794076|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
24687681|NCT03794076|Immunologic Factors|immunologic factors|mesh-ancestor
24953585|NCT03883347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953586|NCT03883347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24687682|NCT03794076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687683|NCT03794076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24687684|NCT03794076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25851954|NCT00055250|Antimetabolites|antimetabolites|mesh-ancestor
24687685|NCT03794076|Respiratory System Agents|respiratory system agents|mesh-ancestor
24687686|NCT03778944|Dopamine|dopamine|mesh-list
24687687|NCT03778944|Mannitol|mannitol|mesh-list
24687688|NCT03778944|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24687689|NCT03778944|Diuretics|diuretics|mesh-ancestor
24687690|NCT03778944|Natriuretic Agents|natriuretic agents|mesh-ancestor
24687691|NCT03778944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687692|NCT03778944|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24687707|NCT03777462|Mitosis Modulators|mitosis modulators|mesh-ancestor
24543273|NCT00682825|Anesthetics, General|anesthetics, general|mesh-ancestor
24687724|NCT03768440|Ropivacaine|ropivacaine|mesh-list
24687725|NCT03768440|Anesthetics, Local|anesthetics, local|mesh-ancestor
24687726|NCT03768440|Anesthetics|anesthetics|mesh-ancestor
24687727|NCT03768440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24687728|NCT03768440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687729|NCT03768440|Sensory System Agents|sensory system agents|mesh-ancestor
24687730|NCT03768440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24687731|NCT03758170|Dexamethasone|dexamethasone|mesh-list
24687732|NCT03758170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24687733|NCT03758170|Antiemetics|antiemetics|mesh-ancestor
24611772|NCT01010646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611773|NCT01010646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611774|NCT01010672|Sirolimus|sirolimus|mesh-list
24611775|NCT01010672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24611776|NCT01010672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24611777|NCT01010672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24611778|NCT01010672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611779|NCT01010672|Antifungal Agents|antifungal agents|mesh-ancestor
24611780|NCT01010672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24687786|NCT03668951|Dexmedetomidine|dexmedetomidine|mesh-list
24687787|NCT03668951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24687788|NCT03668951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24687789|NCT03668951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636080|NCT01142635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24687790|NCT03668951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24687791|NCT03668951|Analgesics|analgesics|mesh-ancestor
24687792|NCT03668951|Sensory System Agents|sensory system agents|mesh-ancestor
24687793|NCT03668951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24687794|NCT03668951|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24687795|NCT03668951|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25663518|NCT01659866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25663519|NCT01659866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25663520|NCT01659866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25663521|NCT01659866|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25663522|NCT01659866|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25663523|NCT01660022|Piperaquine|piperaquine|mesh-list
25663524|NCT01660022|Artefenomel|artefenomel|mesh-list
24687796|NCT03668951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25663525|NCT01660022|Antimalarials|antimalarials|mesh-ancestor
24716959|NCT01544829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24687797|NCT03668951|Adrenergic Agents|adrenergic agents|mesh-ancestor
24687798|NCT03668951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24687799|NCT03668951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687800|NCT03665207|Insulin|insulin|mesh-list
24687801|NCT03665207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24687802|NCT03665207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687803|NCT03661996|Lidocaine|lidocaine|mesh-list
24687804|NCT03661996|Epinephrine|epinephrine|mesh-list
24687805|NCT03661996|Capsaicin|capsaicin|mesh-list
24687832|NCT03659799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24953587|NCT03883347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24414027|NCT00195845|Galantamine|galantamine|mesh-list
24687840|NCT03638999|Analgesics|analgesics|mesh-ancestor
25063519|NCT03468231|Leucovorin|leucovorin|mesh-list
24687841|NCT03638999|Sensory System Agents|sensory system agents|mesh-ancestor
24687842|NCT03638999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24687843|NCT03638999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687844|NCT03638999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24687845|NCT03638999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24687846|NCT03638999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24687847|NCT03638999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24687849|NCT03635021|Bevacizumab|bevacizumab|mesh-list
24687863|NCT03620942|Mydriatics|mydriatics|mesh-ancestor
24687864|NCT03620942|Autonomic Agents|autonomic agents|mesh-ancestor
24687865|NCT03620942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24687866|NCT03620942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687867|NCT03620942|Sympathomimetics|sympathomimetics|mesh-ancestor
24687868|NCT03620942|Nasal Decongestants|nasal decongestants|mesh-ancestor
24687869|NCT03620942|Respiratory System Agents|respiratory system agents|mesh-ancestor
24636211|NCT01143974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688911|NCT02578368|Vitamins|vitamins|mesh-ancestor
24687870|NCT03620942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24687871|NCT03620942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24687872|NCT03620942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24687873|NCT03620942|Adrenergic Agents|adrenergic agents|mesh-ancestor
24687874|NCT03620942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24687875|NCT03620942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687876|NCT03620942|Protective Agents|protective agents|mesh-ancestor
24687877|NCT03620942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24687878|NCT03620903|Rituximab|rituximab|mesh-list
24687879|NCT03620903|Bortezomib|bortezomib|mesh-list
24687880|NCT03620903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24687881|NCT03620903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24687882|NCT03620903|Immunologic Factors|immunologic factors|mesh-ancestor
24687883|NCT03620903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687884|NCT03620903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24687885|NCT03618550|Gemcitabine|gemcitabine|mesh-list
24687886|NCT03618550|Doxorubicin|doxorubicin|mesh-list
24687887|NCT03618550|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24687888|NCT03618550|Pembrolizumab|pembrolizumab|mesh-list
25851955|NCT00055250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687925|NCT03584516|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24687926|NCT03584516|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24687928|NCT03584516|Prednisolone acetate|prednisolone acetate|mesh-list
24687929|NCT03584516|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24687930|NCT03584516|Prednisolone phosphate|prednisolone phosphate|mesh-list
24687931|NCT03584516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24687932|NCT03584516|Glucocorticoids|glucocorticoids|mesh-ancestor
24687933|NCT03584516|Hormones|hormones|mesh-ancestor
24687934|NCT03584516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24687935|NCT03584516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687936|NCT03584516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24687937|NCT03584516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24687938|NCT03584516|Antiemetics|antiemetics|mesh-ancestor
24687939|NCT03584516|Autonomic Agents|autonomic agents|mesh-ancestor
24687940|NCT03584516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25068821|NCT03431675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25068822|NCT03431675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068823|NCT03431675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25068826|NCT03431649|Sildenafil Citrate|sildenafil citrate|mesh-list
25068857|NCT03431285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25068858|NCT03431285|Narcotics|narcotics|mesh-ancestor
25068859|NCT03431272|Lifitegrast|lifitegrast|mesh-list
25851956|NCT00055250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25068881|NCT03431142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663526|NCT01660022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25068882|NCT03431142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24789143|NCT01935674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789144|NCT01935674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24789145|NCT01935674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24789146|NCT01935674|Antiviral Agents|antiviral agents|mesh-ancestor
24789147|NCT01935674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25068884|NCT03431142|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25068885|NCT03431142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25068886|NCT03431142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068887|NCT03431142|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25068888|NCT03431142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25068889|NCT03431142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25068890|NCT03431142|Antipyretics|antipyretics|mesh-ancestor
25068891|NCT03431142|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25068892|NCT03431142|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25068893|NCT03431142|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24831437|NCT02165332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687990|NCT03555877|Hormone Antagonists|hormone antagonists|mesh-ancestor
24687991|NCT03555877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24687992|NCT03555877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687993|NCT03555877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24687994|NCT03555877|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24688079|NCT03410355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24822282|NCT02110745|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24688110|NCT03360214|Ropivacaine|ropivacaine|mesh-list
24688170|NCT03289325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24688171|NCT03289325|Adrenergic Agents|adrenergic agents|mesh-ancestor
24688172|NCT03289325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25068894|NCT03431142|Purinergic Agents|purinergic agents|mesh-ancestor
25068895|NCT03431142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25068896|NCT03431077|Angiotensin II|angiotensin ii|mesh-list
25068897|NCT03431077|Giapreza|giapreza|mesh-list
25068898|NCT03431077|Angiotensinogen|angiotensinogen|mesh-list
25068909|NCT03430817|Amantadine|amantadine|mesh-list
25068910|NCT03430817|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
25068911|NCT03430817|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25068912|NCT03430817|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25068913|NCT03430817|Antiviral Agents|antiviral agents|mesh-ancestor
25068914|NCT03430817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25068915|NCT03430817|Dopamine Agents|dopamine agents|mesh-ancestor
25068916|NCT03430817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25068917|NCT03430817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068918|NCT03430817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068919|NCT03430817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25068920|NCT03430817|Analgesics|analgesics|mesh-ancestor
25068921|NCT03430817|Sensory System Agents|sensory system agents|mesh-ancestor
25068922|NCT03430817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25068923|NCT03430817|Nootropic Agents|nootropic agents|mesh-ancestor
25068924|NCT03430687|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25068925|NCT03430687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25068926|NCT03430687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25068927|NCT03430661|Clopidogrel|clopidogrel|mesh-list
25068928|NCT03430661|Ticagrelor|ticagrelor|mesh-list
25068929|NCT03430661|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25068932|NCT03430661|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25068933|NCT03430661|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25068934|NCT03430661|Purinergic Agents|purinergic agents|mesh-ancestor
25068935|NCT03430661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25068936|NCT03430661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068937|NCT03430661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953606|NCT03883269|Erythromycin stearate|erythromycin stearate|mesh-list
25068938|NCT03430609|Hormones|hormones|mesh-list
25068939|NCT03430609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25068940|NCT03430609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068941|NCT03430544|Cariprazine|cariprazine|mesh-list
25068942|NCT03430544|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25068957|NCT03430505|Tocolytic Agents|tocolytic agents|mesh-ancestor
25068958|NCT03430505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25068959|NCT03430505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25663527|NCT01660022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25663528|NCT01660022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25663529|NCT01660191|Atorvastatin|atorvastatin|mesh-list
25663530|NCT01660191|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25663531|NCT01660191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25068960|NCT03430505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25068961|NCT03430505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25068972|NCT03430466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25068973|NCT03430466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068975|NCT03430362|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25068976|NCT03430362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25068977|NCT03430362|Antiemetics|antiemetics|mesh-ancestor
25068978|NCT03430362|Autonomic Agents|autonomic agents|mesh-ancestor
25068979|NCT03430362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25068980|NCT03430362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068981|NCT03430362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25068982|NCT03430362|Mydriatics|mydriatics|mesh-ancestor
25068983|NCT03430362|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25068984|NCT03430362|Cholinergic Agents|cholinergic agents|mesh-ancestor
25068985|NCT03430362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25068986|NCT03430362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068987|NCT03430362|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25068988|NCT03430362|Parasympatholytics|parasympatholytics|mesh-ancestor
25068989|NCT03430297|Dacarbazine|dacarbazine|mesh-list
25068990|NCT03430297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25068991|NCT03430297|Alkylating Agents|alkylating agents|mesh-ancestor
25068992|NCT03430297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068993|NCT03430297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25068994|NCT03430180|Naloxone|naloxone|mesh-list
25068995|NCT03430180|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25068996|NCT03430180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068997|NCT03430180|Sensory System Agents|sensory system agents|mesh-ancestor
24953612|NCT03883269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24953614|NCT03883269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953615|NCT03883269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24953616|NCT03883334|Inosine Pranobex|inosine pranobex|mesh-list
24953617|NCT03883334|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24953618|NCT03883334|Immunologic Factors|immunologic factors|mesh-ancestor
24953619|NCT03883334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953620|NCT03883334|Antiviral Agents|antiviral agents|mesh-ancestor
24953621|NCT03883334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24953623|NCT03883022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24953624|NCT03883022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24953625|NCT03883204|Risperidone|risperidone|mesh-list
24953626|NCT03883204|Aripiprazole|aripiprazole|mesh-list
25069011|NCT03429998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069012|NCT03429972|Paclitaxel|paclitaxel|mesh-list
25069013|NCT03429972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25069014|NCT03429972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069015|NCT03429972|Tubulin Modulators|tubulin modulators|mesh-ancestor
25207739|NCT03462017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25069034|NCT03429738|Sensory System Agents|sensory system agents|mesh-ancestor
25069035|NCT03429738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25069036|NCT03429738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069037|NCT03429738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25069038|NCT03429738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25069039|NCT03429738|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24831616|NCT02167321|Vitamins|vitamins|mesh-ancestor
24688173|NCT03289325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688174|NCT03279289|Leucovorin|leucovorin|mesh-list
24688175|NCT03279289|Folic Acid|folic acid|mesh-list
24688176|NCT03279289|Fluorouracil|fluorouracil|mesh-list
24688177|NCT03279289|Irinotecan|irinotecan|mesh-list
24688178|NCT03279289|Aflibercept|aflibercept|mesh-list
24688179|NCT03279289|Levoleucovorin|levoleucovorin|mesh-list
24688180|NCT03279289|Antimetabolites|antimetabolites|mesh-ancestor
24688181|NCT03279289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688182|NCT03279289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24688183|NCT03279289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688184|NCT03279289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24414279|NCT00196690|Nootropic Agents|nootropic agents|mesh-ancestor
25069045|NCT03429738|Respiratory System Agents|respiratory system agents|mesh-ancestor
25069046|NCT03429738|Nasal Decongestants|nasal decongestants|mesh-ancestor
25069047|NCT03429738|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25069048|NCT03429738|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25069049|NCT03429738|Sympathomimetics|sympathomimetics|mesh-ancestor
25069050|NCT03429738|Adrenergic Agents|adrenergic agents|mesh-ancestor
25069051|NCT03429738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25069052|NCT03429621|Simethicone|simethicone|mesh-list
25069053|NCT03429621|Antifoaming Agents|antifoaming agents|mesh-ancestor
25069152|NCT03428568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851957|NCT00055250|Antiviral Agents|antiviral agents|mesh-ancestor
25851958|NCT00055250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25851959|NCT00055250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25851960|NCT00055250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25851961|NCT00055250|Immunologic Factors|immunologic factors|mesh-ancestor
25069054|NCT03429621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069056|NCT03429621|Dermatologic Agents|dermatologic agents|mesh-ancestor
25069057|NCT03429439|Antiviral Agents|antiviral agents|mesh-list
25069058|NCT03429439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25069059|NCT03429400|Morphine|morphine|mesh-list
25069060|NCT03429400|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25069061|NCT03429400|Narcotics|narcotics|mesh-ancestor
24611801|NCT01010789|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24611802|NCT01010789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24611803|NCT01010789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24611804|NCT01010789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611805|NCT01010802|Epoetin Alfa|epoetin alfa|mesh-list
24611806|NCT01010802|Hematinics|hematinics|mesh-ancestor
24611807|NCT01010893|Vaccines|vaccines|mesh-list
24611808|NCT01010893|Immunologic Factors|immunologic factors|mesh-ancestor
24611809|NCT01010893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688271|NCT03203876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24688272|NCT03203876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069069|NCT03429309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25069070|NCT03429309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069071|NCT03429309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25069072|NCT03429309|Anesthetics, General|anesthetics, general|mesh-ancestor
25069073|NCT03429309|Anesthetics|anesthetics|mesh-ancestor
25069074|NCT03429179|Butorphanol|butorphanol|mesh-list
25069077|NCT03429179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25069078|NCT03429179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069079|NCT03429179|Analgesics|analgesics|mesh-ancestor
25069080|NCT03429179|Sensory System Agents|sensory system agents|mesh-ancestor
24831666|NCT02167698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24688314|NCT03141671|Hormones|hormones|mesh-ancestor
24688315|NCT03141671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24688316|NCT03141671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688317|NCT03141671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24688318|NCT03141671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688361|NCT03081052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24688362|NCT03081052|Autonomic Agents|autonomic agents|mesh-ancestor
24688363|NCT03081052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24688364|NCT03081052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688365|NCT03081052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24688366|NCT03081052|Respiratory System Agents|respiratory system agents|mesh-ancestor
24688367|NCT03081052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24688368|NCT03081052|Antioxidants|antioxidants|mesh-ancestor
24688369|NCT03081052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688370|NCT03081052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24688371|NCT03081052|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24688372|NCT03081052|Vasodilator Agents|vasodilator agents|mesh-ancestor
24688373|NCT03081052|Gasotransmitters|gasotransmitters|mesh-ancestor
24688374|NCT03081052|Protective Agents|protective agents|mesh-ancestor
24688375|NCT03080935|Evolocumab|evolocumab|mesh-list
24688376|NCT03080935|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24688417|NCT03071601|Mydriatics|mydriatics|mesh-ancestor
24688418|NCT03071601|Sympathomimetics|sympathomimetics|mesh-ancestor
24688419|NCT03071601|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24688420|NCT03071601|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24688421|NCT03070327|Cyclophosphamide|cyclophosphamide|mesh-list
24688422|NCT03070327|Lenalidomide|lenalidomide|mesh-list
24688423|NCT03070327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25069088|NCT03429101|Trastuzumab|trastuzumab|mesh-list
25069089|NCT03429101|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25069090|NCT03429101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25069091|NCT03429101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069092|NCT03429101|Tubulin Modulators|tubulin modulators|mesh-ancestor
25069093|NCT03429101|Antimitotic Agents|antimitotic agents|mesh-ancestor
25069094|NCT03429101|Mitosis Modulators|mitosis modulators|mesh-ancestor
25069095|NCT03429101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069096|NCT03429075|Citalopram|citalopram|mesh-list
25069097|NCT03429075|Psilocybin|psilocybin|mesh-list
25069098|NCT03429075|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25069099|NCT03429075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25663532|NCT01660191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25663533|NCT01660191|Antimetabolites|antimetabolites|mesh-ancestor
25067072|NCT03447184|Hormones|hormones|mesh-ancestor
25069100|NCT03429075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25069101|NCT03429075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069102|NCT03429075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25069103|NCT03429075|Serotonin Agents|serotonin agents|mesh-ancestor
25069104|NCT03429075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069105|NCT03429075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25069106|NCT03429075|Antidepressive Agents|antidepressive agents|mesh-ancestor
25069107|NCT03429075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25069108|NCT03429075|Hallucinogens|hallucinogens|mesh-ancestor
25069109|NCT03429010|Anesthetics|anesthetics|mesh-list
25069110|NCT03429010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25069111|NCT03429010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688429|NCT03070327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688430|NCT03070327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688431|NCT03070327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24688432|NCT03070327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24688433|NCT03070327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24688434|NCT03070327|Growth Substances|growth substances|mesh-ancestor
24688435|NCT03070327|Growth Inhibitors|growth inhibitors|mesh-ancestor
24688449|NCT03061903|Laxatives|laxatives|mesh-ancestor
25069112|NCT03428906|Oxytocin|oxytocin|mesh-list
25069113|NCT03428906|Oxytocics|oxytocics|mesh-ancestor
25069114|NCT03428906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25069115|NCT03428906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069116|NCT03428880|Morphine|morphine|mesh-list
24954282|NCT03877874|Terbutaline|terbutaline|mesh-list
25069117|NCT03428880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25069118|NCT03428880|Narcotics|narcotics|mesh-ancestor
25069119|NCT03428880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25069120|NCT03428880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069121|NCT03428880|Analgesics|analgesics|mesh-ancestor
25069122|NCT03428880|Sensory System Agents|sensory system agents|mesh-ancestor
25069123|NCT03428880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25069124|NCT03428802|Pembrolizumab|pembrolizumab|mesh-list
25069125|NCT03428802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24688454|NCT03061643|Tubulin Modulators|tubulin modulators|mesh-ancestor
24688455|NCT03061643|Antimitotic Agents|antimitotic agents|mesh-ancestor
24688456|NCT03061643|Mitosis Modulators|mitosis modulators|mesh-ancestor
24688457|NCT03061643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688458|NCT03061643|Hormones|hormones|mesh-ancestor
24641455|NCT01173627|Anesthetics|anesthetics|mesh-ancestor
25851962|NCT00055250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688459|NCT03061643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25851963|NCT00055302|Anastrozole|anastrozole|mesh-list
24688507|NCT03012672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24473587|NCT00403364|Clarithromycin|clarithromycin|mesh-list
24688508|NCT03012672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24688509|NCT03012672|Immunologic Factors|immunologic factors|mesh-ancestor
24688510|NCT03012672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688511|NCT03012672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24688512|NCT03012672|Analgesics|analgesics|mesh-ancestor
24688513|NCT03012672|Sensory System Agents|sensory system agents|mesh-ancestor
24688514|NCT03012672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24688515|NCT03012672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24688516|NCT03012672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24688517|NCT03012672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24688518|NCT03011775|Aspirin|aspirin|mesh-list
24688519|NCT03011775|Pioglitazone|pioglitazone|mesh-list
24688520|NCT03011775|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24688521|NCT03011775|Ramipril|ramipril|mesh-list
24688522|NCT03011775|Bisoprolol|bisoprolol|mesh-list
24688523|NCT03011775|Isosorbide|isosorbide|mesh-list
24688524|NCT03011775|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24688525|NCT03011775|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25069135|NCT03428633|Narcotics|narcotics|mesh-ancestor
25069136|NCT03428633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25069137|NCT03428633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069138|NCT03428633|Analgesics|analgesics|mesh-ancestor
25069139|NCT03428633|Sensory System Agents|sensory system agents|mesh-ancestor
25069140|NCT03428633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25069141|NCT03428633|Anesthetics, Local|anesthetics, local|mesh-ancestor
25069142|NCT03428633|Anesthetics|anesthetics|mesh-ancestor
25069143|NCT03428607|Olaparib|olaparib|mesh-list
25069144|NCT03428607|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25069145|NCT03428607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663534|NCT01660191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717720|NCT01549574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25069146|NCT03428607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069147|NCT03428607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069148|NCT03428568|Clarithromycin|clarithromycin|mesh-list
25069149|NCT03428568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25069150|NCT03428568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25069151|NCT03428568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25069153|NCT03428568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069154|NCT03428568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24688526|NCT03011775|Vasodilator Agents|vasodilator agents|mesh-list
24688527|NCT03011775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
24688528|NCT03011775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24688529|NCT03011775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611812|NCT01010945|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24611813|NCT01010945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24611814|NCT01010945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611815|NCT01010945|Tubulin Modulators|tubulin modulators|mesh-ancestor
24611850|NCT01011010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24611851|NCT01011010|Alkylating Agents|alkylating agents|mesh-ancestor
24611852|NCT01011010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24611853|NCT01011036|Clonazepam|clonazepam|mesh-list
24611854|NCT01011036|Clobazam|clobazam|mesh-list
24611855|NCT01011036|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24611856|NCT01011036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24611857|NCT01011036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24611860|NCT01011036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069158|NCT03428529|Antimetabolites|antimetabolites|mesh-ancestor
25069159|NCT03428529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069160|NCT03428529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25069161|NCT03428529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069162|NCT03428529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25069163|NCT03428529|Immunologic Factors|immunologic factors|mesh-ancestor
25069164|NCT03428529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069165|NCT03428503|Acetaminophen|acetaminophen|mesh-list
25069166|NCT03428503|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
25069167|NCT03428503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25069168|NCT03428503|Analgesics|analgesics|mesh-ancestor
25069169|NCT03428503|Sensory System Agents|sensory system agents|mesh-ancestor
24611861|NCT01011036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611862|NCT01011036|Urological Agents|urological agents|mesh-ancestor
24611863|NCT01011036|Anticonvulsants|anticonvulsants|mesh-ancestor
24611864|NCT01011036|GABA Modulators|gaba modulators|mesh-ancestor
24611865|NCT01011036|GABA Agents|gaba agents|mesh-ancestor
24611866|NCT01011036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24611867|NCT01011036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24611868|NCT01011036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24611869|NCT01011036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24611870|NCT01011036|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24611871|NCT01011036|GABA Agonists|gaba agonists|mesh-ancestor
24611872|NCT01011062|Losartan|losartan|mesh-list
24611873|NCT01011062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24611874|NCT01011062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25851964|NCT00055302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25851965|NCT00055302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688837|NCT02636322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24688838|NCT02636322|Alkylating Agents|alkylating agents|mesh-ancestor
24688840|NCT02636322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822451|NCT02111941|Vaccines|vaccines|mesh-list
25069171|NCT03428503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069173|NCT03428503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25069174|NCT03428503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25069175|NCT03428503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25069176|NCT03428477|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
25069177|NCT03428477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25069178|NCT03428477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25069179|NCT03428425|Paclitaxel|paclitaxel|mesh-list
25069180|NCT03428425|Apatinib|apatinib|mesh-list
25069181|NCT03428425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25069182|NCT03428425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069183|NCT03428425|Tubulin Modulators|tubulin modulators|mesh-ancestor
25069184|NCT03428425|Antimitotic Agents|antimitotic agents|mesh-ancestor
25069185|NCT03428425|Mitosis Modulators|mitosis modulators|mesh-ancestor
25069186|NCT03428425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069187|NCT03428425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25069188|NCT03428425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25069189|NCT03428373|Aspirin|aspirin|mesh-list
24689073|NCT02369653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689074|NCT02369653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689078|NCT02326974|Pertuzumab|pertuzumab|mesh-list
24689079|NCT02326974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24689080|NCT02326974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689113|NCT02299999|Mitosis Modulators|mitosis modulators|mesh-ancestor
24689114|NCT02299999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689115|NCT02299999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24689116|NCT02299999|Immunologic Factors|immunologic factors|mesh-ancestor
24689117|NCT02299999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689118|NCT02299999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24689119|NCT02299999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24689120|NCT02299999|Alkylating Agents|alkylating agents|mesh-ancestor
25069195|NCT03428373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25069196|NCT03428373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069198|NCT03428373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25069199|NCT03428373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25069200|NCT03428373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24953647|NCT03882710|Sympatholytics|sympatholytics|mesh-ancestor
24953648|NCT03882710|Autonomic Agents|autonomic agents|mesh-ancestor
24953649|NCT03882710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953650|NCT03882710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953651|NCT03882710|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24953652|NCT03882710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24953653|NCT03882710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24953654|NCT03882710|Adrenergic Agents|adrenergic agents|mesh-ancestor
24953655|NCT03882710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24953656|NCT03882710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953657|NCT03882814|Meperidine|meperidine|mesh-list
24953658|NCT03882814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24953659|NCT03882814|Narcotics|narcotics|mesh-ancestor
24953660|NCT03882814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24953661|NCT03882814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953662|NCT03882814|Analgesics|analgesics|mesh-ancestor
24953663|NCT03882814|Sensory System Agents|sensory system agents|mesh-ancestor
24953664|NCT03882814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953665|NCT03882814|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24953666|NCT03882775|Heparin|heparin|mesh-list
24953667|NCT03882775|Bivalirudin|bivalirudin|mesh-list
24953668|NCT03882775|Anticoagulants|anticoagulants|mesh-ancestor
24953669|NCT03882775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24953670|NCT03882775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24689121|NCT02299999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24689122|NCT02299999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24689123|NCT02299999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24689124|NCT02299999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24689125|NCT02299999|Growth Substances|growth substances|mesh-ancestor
24689126|NCT02299999|Growth Inhibitors|growth inhibitors|mesh-ancestor
24689127|NCT02299999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24689128|NCT02299999|Antimetabolites|antimetabolites|mesh-ancestor
25851966|NCT00055302|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24689289|NCT01829958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689290|NCT01829958|Immunologic Factors|immunologic factors|mesh-ancestor
24689291|NCT01829958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689292|NCT01829958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24689293|NCT01829958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24689294|NCT01829958|Glucocorticoids|glucocorticoids|mesh-ancestor
24689314|NCT01740297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689315|NCT01740297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24689316|NCT01740297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689317|NCT01729754|Etanercept|etanercept|mesh-list
24689318|NCT01729754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24689319|NCT01729754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24779457|NCT01876290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069201|NCT03428373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069202|NCT03428373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25069203|NCT03428373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25069204|NCT03428373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25069205|NCT03428373|Antipyretics|antipyretics|mesh-ancestor
25069206|NCT03428373|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25069207|NCT03428373|Antithrombins|antithrombins|mesh-ancestor
25069208|NCT03428373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24550607|NCT00721448|Ticagrelor|ticagrelor|mesh-list
25069209|NCT03428373|Protease Inhibitors|protease inhibitors|mesh-ancestor
25069210|NCT03428373|Anticoagulants|anticoagulants|mesh-ancestor
25069211|NCT03428282|Anesthetics|anesthetics|mesh-list
25069212|NCT03428282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25069213|NCT03428282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779458|NCT01876290|Antipruritics|antipruritics|mesh-ancestor
25069215|NCT03428256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24415009|NCT00199017|Antiviral Agents|antiviral agents|mesh-ancestor
25069226|NCT03428191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25069227|NCT03428191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25069228|NCT03428191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25069229|NCT03428191|Adrenergic Agents|adrenergic agents|mesh-ancestor
25069230|NCT03428191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25069231|NCT03428191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069232|NCT03428191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25069233|NCT03428191|Narcotics|narcotics|mesh-ancestor
25069234|NCT03428139|Thioctic Acid|thioctic acid|mesh-list
25069235|NCT03428139|Antioxidants|antioxidants|mesh-ancestor
25069236|NCT03428139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689798|NCT00290251|Ulipristal acetate|ulipristal acetate|mesh-list
25851967|NCT00055302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24689799|NCT00290251|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24689849|NCT01397513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24689850|NCT01397513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24689851|NCT01397513|Analgesics|analgesics|mesh-ancestor
24689852|NCT01397513|Sensory System Agents|sensory system agents|mesh-ancestor
24689853|NCT01397513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24689902|NCT01398046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24689903|NCT01398046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689904|NCT01398046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689905|NCT01398046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24689906|NCT01398046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24689907|NCT01398046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24689908|NCT01398046|Lipotropic Agents|lipotropic agents|mesh-ancestor
24689909|NCT01398046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24689910|NCT01398046|Antimetabolites|antimetabolites|mesh-ancestor
25851968|NCT00055302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689925|NCT01398111|Glycopyrrolate|glycopyrrolate|mesh-list
24689926|NCT01398111|Formoterol Fumarate|formoterol fumarate|mesh-list
24689927|NCT01398111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24689928|NCT01398111|Autonomic Agents|autonomic agents|mesh-ancestor
24689929|NCT01398111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24689930|NCT01398111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689931|NCT01398111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24689932|NCT01398111|Respiratory System Agents|respiratory system agents|mesh-ancestor
24689945|NCT01398189|Serotonin Agents|serotonin agents|mesh-ancestor
24689946|NCT01398189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24689947|NCT01398189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689948|NCT01398189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689949|NCT01398189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24689950|NCT01398189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24689951|NCT01398189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24689952|NCT01398189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24689953|NCT01398189|GABA Antagonists|gaba antagonists|mesh-ancestor
24689954|NCT01398189|GABA Agents|gaba agents|mesh-ancestor
24689955|NCT01398202|Vitamin D|vitamin d|mesh-list
24689962|NCT01398202|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25851969|NCT00055302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689963|NCT01398202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24689964|NCT01398267|Lisinopril|lisinopril|mesh-list
24689965|NCT01398267|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24689966|NCT01398267|Protease Inhibitors|protease inhibitors|mesh-ancestor
24689967|NCT01398267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689968|NCT01398267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689969|NCT01398267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24689970|NCT01398267|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24689971|NCT01398267|Protective Agents|protective agents|mesh-ancestor
24689991|NCT01398293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689992|NCT01398293|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24689993|NCT01398293|Contraceptive Agents|contraceptive agents|mesh-ancestor
24689994|NCT01398293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24689995|NCT01398293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25423699|NCT02346253|Goserelin|goserelin|mesh-list
24718273|NCT01553357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24718274|NCT01553357|Growth Substances|growth substances|mesh-ancestor
24689996|NCT01398293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24689997|NCT01398293|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24689998|NCT01398293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24689999|NCT01398371|Digoxin|digoxin|mesh-list
24690000|NCT01398371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24690001|NCT01398371|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24690002|NCT01398371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690003|NCT01398371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690040|NCT01398618|Antitubercular Agents|antitubercular agents|mesh-ancestor
24690041|NCT01398618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24690042|NCT01398618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24690043|NCT01398618|Leprostatic Agents|leprostatic agents|mesh-ancestor
24415087|NCT00199069|Cytarabine|cytarabine|mesh-list
25069271|NCT03427502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25069272|NCT03427502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25069273|NCT03427502|Adrenergic Agents|adrenergic agents|mesh-ancestor
25069274|NCT03427502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25069275|NCT03427502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069276|NCT03427502|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25069277|NCT03427502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25069278|NCT03427502|Autonomic Agents|autonomic agents|mesh-ancestor
25207740|NCT03462017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069279|NCT03427502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25069280|NCT03427502|Respiratory System Agents|respiratory system agents|mesh-ancestor
25069281|NCT03427502|Mydriatics|mydriatics|mesh-ancestor
25069282|NCT03427502|Sympathomimetics|sympathomimetics|mesh-ancestor
25069283|NCT03427502|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25069284|NCT03427437|Epinephrine|epinephrine|mesh-list
25069285|NCT03427437|Racepinephrine|racepinephrine|mesh-list
24690051|NCT01398618|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24690052|NCT01398618|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24690053|NCT01398618|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24690054|NCT01398618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24690055|NCT01398618|Antimetabolites|antimetabolites|mesh-ancestor
24690056|NCT01398618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24690058|NCT01398657|Hormones|hormones|mesh-ancestor
24690059|NCT01398657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24690060|NCT01398657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690061|NCT01398670|Insulin|insulin|mesh-list
24475200|NCT00409383|Paclitaxel|paclitaxel|mesh-list
24690063|NCT01398670|Insulin Lispro|insulin lispro|mesh-list
24690064|NCT01398670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24690065|NCT01398670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611941|NCT01011374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24611942|NCT01011374|Growth Substances|growth substances|mesh-ancestor
24611943|NCT01011374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611944|NCT01011374|Growth Inhibitors|growth inhibitors|mesh-ancestor
24611945|NCT01011374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611946|NCT01011426|Bisacodyl|bisacodyl|mesh-list
24611947|NCT01011426|Cathartics|cathartics|mesh-ancestor
24611948|NCT01011426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24611949|NCT01011426|Laxatives|laxatives|mesh-ancestor
24611950|NCT01011452|Montelukast|montelukast|mesh-list
24611951|NCT01011452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24611952|NCT01011452|Respiratory System Agents|respiratory system agents|mesh-ancestor
24611953|NCT01011452|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24611954|NCT01011452|Hormone Antagonists|hormone antagonists|mesh-ancestor
24611956|NCT01011452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611959|NCT01011452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611960|NCT01011478|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24611961|NCT01011478|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24611962|NCT01011478|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24611963|NCT01011478|Antimetabolites|antimetabolites|mesh-ancestor
24611964|NCT01011478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611965|NCT01011478|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24611966|NCT01011478|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25069313|NCT03427385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25069314|NCT03427359|Capecitabine|capecitabine|mesh-list
25069315|NCT03427359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069316|NCT03427359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25069317|NCT03427359|Antimetabolites|antimetabolites|mesh-ancestor
25663535|NCT01660191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25663536|NCT01660191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25239428|NCT02541760|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25239429|NCT02541643|Elotuzumab|elotuzumab|mesh-list
25069318|NCT03427359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069319|NCT03427242|Apatinib|apatinib|mesh-list
25069320|NCT03427242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069321|NCT03427242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25069322|NCT03427242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25069323|NCT03427242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069324|NCT03427229|Vancomycin|vancomycin|mesh-list
25069325|NCT03427229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25069326|NCT03427229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25069327|NCT03427216|Diazepam|diazepam|mesh-list
25069328|NCT03427216|Baclofen|baclofen|mesh-list
25069329|NCT03427216|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24690084|NCT01399151|Vitamins|vitamins|mesh-list
24690086|NCT01399151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690087|NCT01399151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24690111|NCT01399450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24690112|NCT01399450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24690113|NCT01399450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415277|NCT00199147|Antiviral Agents|antiviral agents|mesh-ancestor
25069347|NCT03427216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25069348|NCT03427216|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25069349|NCT03427216|Anesthetics, General|anesthetics, general|mesh-ancestor
25069351|NCT03427216|GABA Modulators|gaba modulators|mesh-ancestor
24779459|NCT01876290|Dermatologic Agents|dermatologic agents|mesh-ancestor
25069352|NCT03427086|Biotin|biotin|mesh-list
25207741|NCT03436498|Insulin|insulin|mesh-list
25069355|NCT03427086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069357|NCT03427021|Oxaliplatin|oxaliplatin|mesh-list
25069358|NCT03427021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069360|NCT03426982|Calcium heparin|calcium heparin|mesh-list
25069361|NCT03426982|Anticoagulants|anticoagulants|mesh-ancestor
25069362|NCT03426982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24831994|NCT02170038|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
24690125|NCT01399463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24690126|NCT01399463|Tubulin Modulators|tubulin modulators|mesh-ancestor
24690127|NCT01399463|Antimitotic Agents|antimitotic agents|mesh-ancestor
25069378|NCT03426969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25069379|NCT03426969|Alkylating Agents|alkylating agents|mesh-ancestor
24639345|NCT01161147|Meloxicam|meloxicam|mesh-list
25069380|NCT03426969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069381|NCT03426969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069382|NCT03426969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25069383|NCT03426969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25069385|NCT03426969|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25069386|NCT03426969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832023|NCT02170324|Incretins|incretins|mesh-ancestor
24690161|NCT01400009|Vitamins|vitamins|mesh-ancestor
24690162|NCT01400009|Micronutrients|micronutrients|mesh-ancestor
24690163|NCT01400009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690164|NCT01400009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24690165|NCT01400009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24690166|NCT01400022|Cortisone|cortisone|mesh-list
24690167|NCT01400022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24690168|NCT01400074|Imatinib Mesylate|imatinib mesylate|mesh-list
24690169|NCT01400074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24690170|NCT01400074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24690171|NCT01400074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690172|NCT01400074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690173|NCT01400100|Octreotide|octreotide|mesh-list
24690174|NCT01400100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24690175|NCT01400100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24690176|NCT01400100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24690177|NCT01400100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24690178|NCT01400165|Pindolol|pindolol|mesh-list
24690179|NCT01400165|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24690180|NCT01400165|Trazodone|trazodone|mesh-list
24690181|NCT01400165|Antidepressive Agents|antidepressive agents|mesh-ancestor
24690182|NCT01400165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24690183|NCT01400165|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24690184|NCT01400165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24690185|NCT01400165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24690186|NCT01400165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069387|NCT03426969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24690200|NCT01400165|Vasodilator Agents|vasodilator agents|mesh-ancestor
25663537|NCT01660191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663538|NCT01660256|Rebamipide|rebamipide|mesh-list
24690202|NCT01400191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24690203|NCT01400191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690205|NCT01400217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24690206|NCT01400217|Glucocorticoids|glucocorticoids|mesh-ancestor
24690207|NCT01400217|Hormones|hormones|mesh-ancestor
25851970|NCT00055302|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24641693|NCT01174914|Efavirenz|efavirenz|mesh-list
24690221|NCT01400308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690222|NCT01400308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690223|NCT01400360|Vasodilator Agents|vasodilator agents|mesh-list
24690224|NCT01400464|Prednisone|prednisone|mesh-list
24690225|NCT01400464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24690227|NCT01400464|Hormones|hormones|mesh-ancestor
24690231|NCT01400464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24690233|NCT01400568|Xhance|xhance|mesh-list
24690234|NCT01400568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24690235|NCT01400568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24690236|NCT01400568|Autonomic Agents|autonomic agents|mesh-ancestor
24690237|NCT01400568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24690238|NCT01400568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069413|NCT03426761|Vancomycin|vancomycin|mesh-list
25069414|NCT03426761|Cefazolin|cefazolin|mesh-list
25069415|NCT03426761|Daptomycin|daptomycin|mesh-list
25069416|NCT03426761|Dalbavancin|dalbavancin|mesh-list
25069417|NCT03426761|Nafcillin|nafcillin|mesh-list
25069418|NCT03426761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25024675|NCT03643666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25024676|NCT03643666|Tocolytic Agents|tocolytic agents|mesh-ancestor
25024677|NCT03643666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25024678|NCT03643588|Hyaluronic Acid|hyaluronic acid|mesh-list
25024679|NCT03643588|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25024680|NCT03643588|Immunologic Factors|immunologic factors|mesh-ancestor
25024681|NCT03643588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024682|NCT03643588|Viscosupplements|viscosupplements|mesh-ancestor
25024683|NCT03643588|Protective Agents|protective agents|mesh-ancestor
25069419|NCT03426761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25069420|NCT03426592|Vitamin D|vitamin d|mesh-list
25069421|NCT03426592|Cholecalciferol|cholecalciferol|mesh-list
25069422|NCT03426592|Vitamins|vitamins|mesh-ancestor
25069423|NCT03426592|Micronutrients|micronutrients|mesh-ancestor
24855574|NCT02280070|Immunoglobulins|immunoglobulins|mesh-list
25069424|NCT03426592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069425|NCT03426592|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25069426|NCT03426592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25069427|NCT03426553|Riboflavin|riboflavin|mesh-list
25069428|NCT03426553|Vitamin B Complex|vitamin b complex|mesh-ancestor
25069429|NCT03426553|Vitamins|vitamins|mesh-ancestor
25069430|NCT03426553|Micronutrients|micronutrients|mesh-ancestor
25069431|NCT03426553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069432|NCT03426553|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25069433|NCT03426553|Dermatologic Agents|dermatologic agents|mesh-ancestor
25069434|NCT03426527|Dexmedetomidine|dexmedetomidine|mesh-list
25069435|NCT03426527|Levobupivacaine|levobupivacaine|mesh-list
25069436|NCT03426527|Anesthetics|anesthetics|mesh-ancestor
25069437|NCT03426527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25069438|NCT03426527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069439|NCT03426527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25069440|NCT03426527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25069441|NCT03426527|Analgesics|analgesics|mesh-ancestor
25069442|NCT03426527|Sensory System Agents|sensory system agents|mesh-ancestor
25069443|NCT03426527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25069444|NCT03426527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25069445|NCT03426527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25069446|NCT03426527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25069447|NCT03426527|Adrenergic Agents|adrenergic agents|mesh-ancestor
25069448|NCT03426527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25069449|NCT03426527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069450|NCT03426527|Anesthetics, Local|anesthetics, local|mesh-ancestor
25069451|NCT03426462|Propofol|propofol|mesh-list
25069452|NCT03426462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25069453|NCT03426462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25069454|NCT03426462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069455|NCT03426462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24690282|NCT01400685|Growth Substances|growth substances|mesh-ancestor
24690283|NCT01400685|Growth Inhibitors|growth inhibitors|mesh-ancestor
24690284|NCT01400685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24690285|NCT01400685|Alkylating Agents|alkylating agents|mesh-ancestor
24690286|NCT01400685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690287|NCT01400737|Ibuprofen|ibuprofen|mesh-list
24690288|NCT01400737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24690289|NCT01400737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24690290|NCT01400737|Analgesics|analgesics|mesh-ancestor
24690291|NCT01400737|Sensory System Agents|sensory system agents|mesh-ancestor
24690292|NCT01400737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24690293|NCT01400737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690294|NCT01400737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24690295|NCT01400737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24639837|NCT01164488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24690296|NCT01400737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24690337|NCT01400867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24690338|NCT01400867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24690339|NCT01400867|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25202469|NCT02721082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202470|NCT02721173|Clindamycin|clindamycin|mesh-list
25202471|NCT02721173|Clindamycin palmitate|clindamycin palmitate|mesh-list
25202472|NCT02721173|Clindamycin phosphate|clindamycin phosphate|mesh-list
25202473|NCT02721173|Adapalene|adapalene|mesh-list
25202474|NCT02721173|Tazarotene|tazarotene|mesh-list
25202475|NCT02721173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25202476|NCT02721173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25202477|NCT02721173|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25202478|NCT02721173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024764|NCT03642990|Niacinamide|niacinamide|mesh-list
25024765|NCT03642990|Niacin|niacin|mesh-list
25024766|NCT03642990|Nicotinic Acids|nicotinic acids|mesh-list
24690340|NCT01400867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690341|NCT01400867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690343|NCT01400945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24690344|NCT01400945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24690345|NCT01400945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24690346|NCT01400945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690347|NCT01400945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690348|NCT01401036|Umirolimus|umirolimus|mesh-list
24690349|NCT01401036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24690350|NCT01401036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24690351|NCT01401036|Immunologic Factors|immunologic factors|mesh-ancestor
24690352|NCT01401036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690353|NCT01401075|Viscum album peptide|viscum album peptide|mesh-list
24690354|NCT01401075|Doxifluridine|doxifluridine|mesh-list
24690355|NCT01401075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069459|NCT03426202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25069460|NCT03426202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069461|NCT03426202|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25069462|NCT03426202|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25069463|NCT03426202|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25069464|NCT03426202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069465|NCT03426176|Oxytocin|oxytocin|mesh-list
25069466|NCT03426176|Oxytocics|oxytocics|mesh-ancestor
25069467|NCT03426176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25069468|NCT03426176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690356|NCT01401075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24690357|NCT01401075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24690358|NCT01401075|Antiviral Agents|antiviral agents|mesh-ancestor
24690359|NCT01401075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24690360|NCT01401075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24690361|NCT01401075|Antimetabolites|antimetabolites|mesh-ancestor
24690362|NCT01401075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690581|NCT01402596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24690582|NCT01402596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690585|NCT01402622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24690586|NCT01402622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690587|NCT01402622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24690588|NCT01402622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24611989|NCT01011621|Hormones|hormones|mesh-ancestor
24611997|NCT01011621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24611998|NCT01011621|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24611999|NCT01011621|Protective Agents|protective agents|mesh-ancestor
24612000|NCT01011621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24612001|NCT01011621|Respiratory System Agents|respiratory system agents|mesh-ancestor
24612002|NCT01011660|Amlodipine|amlodipine|mesh-list
24612003|NCT01011660|Telmisartan|telmisartan|mesh-list
24612004|NCT01011660|Amiloride|amiloride|mesh-list
24612005|NCT01011660|Simvastatin|simvastatin|mesh-list
24612006|NCT01011660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25423700|NCT02346253|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24612007|NCT01011660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24612008|NCT01011660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24612009|NCT01011660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069469|NCT03426124|Fibrinolytic Agents|fibrinolytic agents|mesh-list
25069470|NCT03426124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25851971|NCT00055302|Hormone Antagonists|hormone antagonists|mesh-ancestor
25069510|NCT03425929|Oxytocics|oxytocics|mesh-ancestor
25069511|NCT03425929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24415840|NCT00201318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069524|NCT03425734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25069525|NCT03425734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069526|NCT03425734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25069527|NCT03425734|Analgesics|analgesics|mesh-ancestor
24640362|NCT01167738|Immunologic Factors|immunologic factors|mesh-ancestor
25069528|NCT03425734|Sensory System Agents|sensory system agents|mesh-ancestor
24690746|NCT01403662|Minocycline|minocycline|mesh-list
25069529|NCT03425734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25069530|NCT03425734|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25069531|NCT03425734|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25069532|NCT03425734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25069533|NCT03425734|Adrenergic Agents|adrenergic agents|mesh-ancestor
25069534|NCT03425734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25202479|NCT02721173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207742|NCT03436498|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25069535|NCT03425734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069537|NCT03425708|Gout Suppressants|gout suppressants|mesh-ancestor
24612010|NCT01011660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24612011|NCT01011660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612012|NCT01011660|Vasodilator Agents|vasodilator agents|mesh-ancestor
24612013|NCT01011660|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24612014|NCT01011660|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24612015|NCT01011660|Antimetabolites|antimetabolites|mesh-ancestor
24690629|NCT01403103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690630|NCT01403103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24690631|NCT01403103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24690632|NCT01403168|Analgesics|analgesics|mesh-list
25069538|NCT03425708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25069539|NCT03425669|Methylphenidate|methylphenidate|mesh-list
25069540|NCT03425669|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25069541|NCT03425669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069542|NCT03425669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25069543|NCT03425669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25069544|NCT03425669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25069545|NCT03425669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069546|NCT03425669|Dopamine Agents|dopamine agents|mesh-ancestor
25069547|NCT03425669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25069548|NCT03425656|Cyclophosphamide|cyclophosphamide|mesh-list
25069549|NCT03425656|Docetaxel|docetaxel|mesh-list
25069550|NCT03425656|Doxorubicin|doxorubicin|mesh-list
25069551|NCT03425656|Trastuzumab|trastuzumab|mesh-list
24690633|NCT01403168|Sensory System Agents|sensory system agents|mesh-ancestor
24690634|NCT01403168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24690635|NCT01403168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690636|NCT01403181|Ribavirin|ribavirin|mesh-list
24690637|NCT01403181|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24690638|NCT01403181|Antimetabolites|antimetabolites|mesh-ancestor
24690639|NCT01403181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690640|NCT01403181|Antiviral Agents|antiviral agents|mesh-ancestor
24690641|NCT01403181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24690642|NCT01403259|Oxaliplatin|oxaliplatin|mesh-list
24690690|NCT01403415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24690691|NCT01403415|Glucocorticoids|glucocorticoids|mesh-ancestor
24690722|NCT01403506|Acetylcysteine|acetylcysteine|mesh-list
24690723|NCT01403506|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24690724|NCT01403506|Antiviral Agents|antiviral agents|mesh-ancestor
24690725|NCT01403506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24690726|NCT01403506|Expectorants|expectorants|mesh-ancestor
24690727|NCT01403506|Respiratory System Agents|respiratory system agents|mesh-ancestor
24690728|NCT01403506|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24690729|NCT01403506|Antioxidants|antioxidants|mesh-ancestor
24690730|NCT01403506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690731|NCT01403506|Protective Agents|protective agents|mesh-ancestor
24690732|NCT01403506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069552|NCT03425656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24818142|NCT02087111|Ribavirin|ribavirin|mesh-list
25069553|NCT03425656|Immunologic Factors|immunologic factors|mesh-ancestor
25069554|NCT03425656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069555|NCT03425656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25069556|NCT03425656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25069557|NCT03425656|Alkylating Agents|alkylating agents|mesh-ancestor
25069558|NCT03425656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069559|NCT03425656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069560|NCT03425656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25069561|NCT03425656|Tubulin Modulators|tubulin modulators|mesh-ancestor
25069562|NCT03425656|Antimitotic Agents|antimitotic agents|mesh-ancestor
25069563|NCT03425656|Mitosis Modulators|mitosis modulators|mesh-ancestor
25069564|NCT03425656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24690742|NCT01403545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24690743|NCT01403545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24690744|NCT01403545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690745|NCT01403545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690818|NCT01404117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24690819|NCT01404117|Immunologic Factors|immunologic factors|mesh-ancestor
24690820|NCT01404117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690821|NCT01404117|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25069607|NCT03425461|Immunoglobulins|immunoglobulins|mesh-list
25069608|NCT03425461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25069609|NCT03425461|Immunologic Factors|immunologic factors|mesh-ancestor
25069610|NCT03425461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069611|NCT03425461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069612|NCT03425461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25876187|NCT03847896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24690923|NCT01404442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24690924|NCT01404442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24690925|NCT01404442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690926|NCT01404442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24690927|NCT01404442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24690928|NCT01404442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24690929|NCT01404442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24690930|NCT01404442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24690931|NCT01404442|GABA Modulators|gaba modulators|mesh-ancestor
24690933|NCT01404468|Lidocaine|lidocaine|mesh-list
24690952|NCT01404598|Analgesics|analgesics|mesh-ancestor
24690953|NCT01404598|Sensory System Agents|sensory system agents|mesh-ancestor
24612023|NCT01011660|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24612040|NCT01011699|Vasodilator Agents|vasodilator agents|mesh-ancestor
24612041|NCT01011699|Chelating Agents|chelating agents|mesh-ancestor
25069636|NCT03425084|Sensory System Agents|sensory system agents|mesh-ancestor
25069637|NCT03425084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25069638|NCT03424928|Thalidomide|thalidomide|mesh-list
25069639|NCT03424928|Pomalidomide|pomalidomide|mesh-list
25069640|NCT03424928|Immunologic Factors|immunologic factors|mesh-ancestor
25069641|NCT03424928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069642|NCT03424928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25069643|NCT03424928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25069644|NCT03424928|Growth Substances|growth substances|mesh-ancestor
25069645|NCT03424928|Growth Inhibitors|growth inhibitors|mesh-ancestor
24640740|NCT01169805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25069646|NCT03424928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691138|NCT01405157|Protective Agents|protective agents|mesh-ancestor
24691139|NCT01405157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24691140|NCT01405157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691141|NCT01405170|Methylprednisolone|methylprednisolone|mesh-list
24691142|NCT01405170|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24691143|NCT01405170|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24691144|NCT01405170|Prednisolone|prednisolone|mesh-list
24691145|NCT01405170|Prednisolone acetate|prednisolone acetate|mesh-list
24691146|NCT01405170|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24691147|NCT01405170|Prednisolone phosphate|prednisolone phosphate|mesh-list
24691148|NCT01405170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24691149|NCT01405170|Antiemetics|antiemetics|mesh-ancestor
24691150|NCT01405170|Autonomic Agents|autonomic agents|mesh-ancestor
24691151|NCT01405170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25069647|NCT03424928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25069649|NCT03424928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25069650|NCT03424928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25069651|NCT03424889|Xylometazoline|xylometazoline|mesh-list
25069652|NCT03424889|Nasal Decongestants|nasal decongestants|mesh-ancestor
25069653|NCT03424889|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25069666|NCT03424759|Osimertinib|osimertinib|mesh-list
25069667|NCT03424759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069668|NCT03424759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25069669|NCT03424759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25069670|NCT03424759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069671|NCT03424746|Edetic Acid|edetic acid|mesh-list
24691156|NCT01405170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24691158|NCT01405170|Protective Agents|protective agents|mesh-ancestor
24691159|NCT01405170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24691160|NCT01405170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691162|NCT01405235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24691163|NCT01405235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24691164|NCT01405235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691165|NCT01405235|Tubulin Modulators|tubulin modulators|mesh-ancestor
24691166|NCT01405235|Antimitotic Agents|antimitotic agents|mesh-ancestor
25069672|NCT03424746|Pentetic Acid|pentetic acid|mesh-list
25069673|NCT03424746|Anticoagulants|anticoagulants|mesh-ancestor
25069674|NCT03424746|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25069675|NCT03424746|Chelating Agents|chelating agents|mesh-ancestor
25069676|NCT03424746|Sequestering Agents|sequestering agents|mesh-ancestor
25069677|NCT03424746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069678|NCT03424746|Antidotes|antidotes|mesh-ancestor
25069679|NCT03424746|Protective Agents|protective agents|mesh-ancestor
25069680|NCT03424746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069681|NCT03424746|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25069682|NCT03424733|Acetaminophen|acetaminophen|mesh-list
25069683|NCT03424733|Interferons|interferons|mesh-list
25069684|NCT03424733|Interferon-beta|interferon-beta|mesh-list
25069685|NCT03424733|Interferon beta-1a|interferon beta-1a|mesh-list
25069686|NCT03424733|Prednisone|prednisone|mesh-list
25069687|NCT03424733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25069688|NCT03424733|Glucocorticoids|glucocorticoids|mesh-ancestor
25069689|NCT03424733|Hormones|hormones|mesh-ancestor
24832339|NCT02171299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832340|NCT02171299|Sensory System Agents|sensory system agents|mesh-ancestor
24832341|NCT02171299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24832342|NCT02171325|Irinotecan|irinotecan|mesh-list
24832343|NCT02171325|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24691187|NCT01405339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24691208|NCT01405482|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24691209|NCT01405482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24691210|NCT01405482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691211|NCT01405482|Cholinergic Agents|cholinergic agents|mesh-ancestor
24691212|NCT01405482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25069690|NCT03424733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25069691|NCT03424733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069692|NCT03424733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24691213|NCT01405482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691214|NCT01405482|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24691215|NCT01405482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24691217|NCT01405521|Immunologic Factors|immunologic factors|mesh-ancestor
24691218|NCT01405521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691219|NCT01405573|Sorafenib|sorafenib|mesh-list
24691220|NCT01405573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691221|NCT01405573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24691222|NCT01405573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691223|NCT01405573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691224|NCT01405586|Gemcitabine|gemcitabine|mesh-list
24691236|NCT01405612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24691237|NCT01405612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24691238|NCT01405612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24691239|NCT01405612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691240|NCT01405612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24691241|NCT01405612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24416779|NCT00204022|Mycophenolic Acid|mycophenolic acid|mesh-list
24612109|NCT01011998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612110|NCT01011998|Anticonvulsants|anticonvulsants|mesh-ancestor
24612113|NCT01011998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612115|NCT01011998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24612116|NCT01011998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24691253|NCT01405846|Gefitinib|gefitinib|mesh-list
24691254|NCT01405846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691255|NCT01405846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24691256|NCT01405846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691257|NCT01405846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691258|NCT01405872|Interferon beta-1a|interferon beta-1a|mesh-list
24691259|NCT01405872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24691261|NCT01405872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691262|NCT01405872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691263|NCT01405872|Antiviral Agents|antiviral agents|mesh-ancestor
24691264|NCT01405872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24691265|NCT01405989|Ketoconazole|ketoconazole|mesh-list
24691267|NCT01405989|Antifungal Agents|antifungal agents|mesh-ancestor
24691268|NCT01405989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24691269|NCT01405989|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24691270|NCT01405989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25069693|NCT03424733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069694|NCT03424733|Antiviral Agents|antiviral agents|mesh-ancestor
25069695|NCT03424733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25069696|NCT03424733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25069697|NCT03424733|Analgesics|analgesics|mesh-ancestor
24691293|NCT01406002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24691294|NCT01406002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25851972|NCT00055302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24691331|NCT01406158|Urological Agents|urological agents|mesh-ancestor
24691332|NCT01406171|Isavuconazole|isavuconazole|mesh-list
24691333|NCT01406171|Midazolam|midazolam|mesh-list
24691334|NCT01406171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24691335|NCT01406171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24691336|NCT01406171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24691351|NCT01406197|Progestins|progestins|mesh-ancestor
24691352|NCT01406197|Hormones|hormones|mesh-ancestor
24691353|NCT01406197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24691354|NCT01406197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691355|NCT01406262|Moxifloxacin|moxifloxacin|mesh-list
24691356|NCT01406262|rGLP-1 protein|rglp-1 protein|mesh-list
24691357|NCT01406262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24691358|NCT01406262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24691400|NCT01406431|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24691401|NCT01406431|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25069703|NCT03424707|Eperisone|eperisone|mesh-list
25069704|NCT03424707|Anticonvulsants|anticonvulsants|mesh-ancestor
25069705|NCT03424707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25069706|NCT03424707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25069707|NCT03424707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069708|NCT03424707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25069709|NCT03424707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069710|NCT03424707|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25069711|NCT03424707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25069712|NCT03424707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24832368|NCT02171390|Testosterone|testosterone|mesh-list
24691417|NCT01406496|Insulin|insulin|mesh-list
24691418|NCT01406496|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24691419|NCT01406496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24691420|NCT01406496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691421|NCT01406522|Tacrine|tacrine|mesh-list
24691422|NCT01406522|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24691423|NCT01406522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691424|NCT01406522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691425|NCT01406522|Cholinergic Agents|cholinergic agents|mesh-ancestor
24691426|NCT01406522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25207743|NCT03436498|Insulin Aspart|insulin aspart|mesh-list
25851973|NCT00055302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851974|NCT00055341|Ribavirin|ribavirin|mesh-list
25851975|NCT00055341|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25851976|NCT00055341|Antimetabolites|antimetabolites|mesh-ancestor
24641444|NCT01173627|Fentanyl|fentanyl|mesh-list
25851977|NCT00055341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851978|NCT00055341|Antiviral Agents|antiviral agents|mesh-ancestor
25851979|NCT00055341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24691428|NCT01406522|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24691445|NCT01406639|Ranibizumab|ranibizumab|mesh-list
24691446|NCT01406639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24691447|NCT01406639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24691448|NCT01406639|Growth Substances|growth substances|mesh-ancestor
24691449|NCT01406639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691450|NCT01406639|Growth Inhibitors|growth inhibitors|mesh-ancestor
24691451|NCT01406639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691452|NCT01406678|Sufentanil|sufentanil|mesh-list
24691453|NCT01406678|Dsuvia|dsuvia|mesh-list
24691454|NCT01406678|Isoflurane|isoflurane|mesh-list
24691455|NCT01406678|Anesthetics|anesthetics|mesh-ancestor
24691456|NCT01406678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24691457|NCT01406678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691458|NCT01406678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24691459|NCT01406678|Narcotics|narcotics|mesh-ancestor
24691471|NCT01406704|Antioxidants|antioxidants|mesh-ancestor
24691472|NCT01406704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476761|NCT00416429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691473|NCT01406704|Protective Agents|protective agents|mesh-ancestor
24476762|NCT00416429|Antiviral Agents|antiviral agents|mesh-ancestor
24691491|NCT01407211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691501|NCT01407289|Insulin Glargine|insulin glargine|mesh-list
24691502|NCT01407289|Insulin Aspart|insulin aspart|mesh-list
24691503|NCT01407289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24691504|NCT01407289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691505|NCT01407432|Folic Acid|folic acid|mesh-list
24691506|NCT01407432|Vitamin B Complex|vitamin b complex|mesh-list
24691507|NCT01407432|Hematinics|hematinics|mesh-ancestor
24691508|NCT01407432|Vitamins|vitamins|mesh-ancestor
24691509|NCT01407432|Micronutrients|micronutrients|mesh-ancestor
24691510|NCT01407432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691511|NCT01407471|Clobetasol|clobetasol|mesh-list
24691512|NCT01407471|Spironolactone|spironolactone|mesh-list
25069713|NCT03424707|Parasympatholytics|parasympatholytics|mesh-ancestor
25069714|NCT03424707|Autonomic Agents|autonomic agents|mesh-ancestor
25069715|NCT03424707|Vasodilator Agents|vasodilator agents|mesh-ancestor
24458219|NCT00337090|Mirabegron|mirabegron|mesh-list
25069717|NCT03424629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25069718|NCT03424629|Abortifacient Agents|abortifacient agents|mesh-ancestor
25069719|NCT03424629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25069720|NCT03424629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069721|NCT03424629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25069722|NCT03424629|Antimetabolites|antimetabolites|mesh-ancestor
25069723|NCT03424629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069724|NCT03424629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069725|NCT03424629|Dermatologic Agents|dermatologic agents|mesh-ancestor
25069726|NCT03424629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25069727|NCT03424629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25069728|NCT03424629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25069729|NCT03424629|Immunologic Factors|immunologic factors|mesh-ancestor
25069730|NCT03424629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25069731|NCT03424629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25069732|NCT03424473|Tucatinib|tucatinib|mesh-list
25069733|NCT03424473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069734|NCT03424473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25069735|NCT03424473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25069736|NCT03424473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691546|NCT01407822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691547|NCT01407822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24691548|NCT01407822|Antimetabolites|antimetabolites|mesh-ancestor
25202480|NCT02721173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25202481|NCT02721173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25202482|NCT02721173|Analgesics|analgesics|mesh-ancestor
25202483|NCT02721173|Sensory System Agents|sensory system agents|mesh-ancestor
25202484|NCT02721173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202485|NCT02721173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202486|NCT02721173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25202487|NCT02721173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24691549|NCT01407822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691550|NCT01407822|Antiviral Agents|antiviral agents|mesh-ancestor
24691551|NCT01407822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24691552|NCT01407822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691553|NCT01407822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24691554|NCT01407822|Immunologic Factors|immunologic factors|mesh-ancestor
24691555|NCT01407822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691556|NCT01407822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24691557|NCT01407848|Furosemide|furosemide|mesh-list
24691558|NCT01407848|Diuretics|diuretics|mesh-ancestor
24691559|NCT01407848|Natriuretic Agents|natriuretic agents|mesh-ancestor
24641731|NCT01174953|Finasteride|finasteride|mesh-list
24691560|NCT01407848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691561|NCT01407848|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24691562|NCT01407848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25409427|NCT03382561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24720057|NCT01566253|Morphine|morphine|mesh-list
24691563|NCT01407848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691564|NCT01407887|Artesunate|artesunate|mesh-list
24691565|NCT01407887|Amodiaquine|amodiaquine|mesh-list
24691566|NCT01407887|Methylene Blue|methylene blue|mesh-list
24691567|NCT01407887|Antimalarials|antimalarials|mesh-ancestor
24691568|NCT01407887|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24691614|NCT01408160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24691615|NCT01408160|Immunologic Factors|immunologic factors|mesh-ancestor
24691616|NCT01408160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691617|NCT01408173|Caffeine|caffeine|mesh-list
24691618|NCT01408173|Caffeine citrate|caffeine citrate|mesh-list
24691619|NCT01408173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691620|NCT01408173|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24691621|NCT01408173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691622|NCT01408173|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24691623|NCT01408173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691639|NCT01408186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691640|NCT01408199|Lenalidomide|lenalidomide|mesh-list
24691641|NCT01408199|Immunologic Factors|immunologic factors|mesh-ancestor
24691642|NCT01408199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691643|NCT01408199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24691644|NCT01408199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24691645|NCT01408199|Growth Substances|growth substances|mesh-ancestor
24691646|NCT01408199|Growth Inhibitors|growth inhibitors|mesh-ancestor
24691647|NCT01408199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691648|NCT01408342|Rituximab|rituximab|mesh-list
24691649|NCT01408342|Alemtuzumab|alemtuzumab|mesh-list
24691650|NCT01408342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24691651|NCT01408342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691652|NCT01408342|Immunologic Factors|immunologic factors|mesh-ancestor
24691653|NCT01408342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691654|NCT01408342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24691655|NCT01408394|Ecopipam|ecopipam|mesh-list
24691656|NCT01408394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24691657|NCT01408394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24691658|NCT01408394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24691659|NCT01408394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691660|NCT01408394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24691661|NCT01408394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24691662|NCT01408394|Dopamine Agents|dopamine agents|mesh-ancestor
24691663|NCT01408394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24691664|NCT01408394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691665|NCT01408446|Menthol|menthol|mesh-list
24691666|NCT01408446|Antipruritics|antipruritics|mesh-ancestor
24691667|NCT01408446|Dermatologic Agents|dermatologic agents|mesh-ancestor
24691668|NCT01408498|Testosterone|testosterone|mesh-list
24691669|NCT01408498|Androgens|androgens|mesh-ancestor
24691670|NCT01408498|Hormones|hormones|mesh-ancestor
24691671|NCT01408498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24691824|NCT01409174|Sensory System Agents|sensory system agents|mesh-ancestor
24691825|NCT01409174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24691826|NCT01409174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24691827|NCT01409174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24691829|NCT01409187|Interferon-alpha|interferon-alpha|mesh-list
24691830|NCT01409187|Interferon alpha-2|interferon alpha-2|mesh-list
24691831|NCT01409187|Aldesleukin|aldesleukin|mesh-list
24691832|NCT01409187|Ipilimumab|ipilimumab|mesh-list
24691833|NCT01409187|Interleukin-2|interleukin-2|mesh-list
24691834|NCT01409187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691835|NCT01409187|Antiviral Agents|antiviral agents|mesh-ancestor
24691852|NCT01409278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202488|NCT02721173|Dermatologic Agents|dermatologic agents|mesh-ancestor
25025470|NCT03636932|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25025472|NCT03636932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25025473|NCT03636932|Expectorants|expectorants|mesh-ancestor
25025474|NCT03636932|Respiratory System Agents|respiratory system agents|mesh-ancestor
24691853|NCT01409278|Sensory System Agents|sensory system agents|mesh-ancestor
24691854|NCT01409278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24691855|NCT01409369|Charcoal|charcoal|mesh-list
24691856|NCT01409369|Antidotes|antidotes|mesh-ancestor
24691857|NCT01409369|Protective Agents|protective agents|mesh-ancestor
24691858|NCT01409369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691859|NCT01409395|Metformin|metformin|mesh-list
24691860|NCT01409395|Nizatidine|nizatidine|mesh-list
25663539|NCT01660256|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24691861|NCT01409395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24691862|NCT01409395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691902|NCT01409603|Protease Inhibitors|protease inhibitors|mesh-ancestor
24691905|NCT01409616|Salicylic Acid|salicylic acid|mesh-list
24691906|NCT01409616|Salicylates|salicylates|mesh-list
24691907|NCT01409616|Darexaban|darexaban|mesh-list
24691908|NCT01409616|Clopidogrel|clopidogrel|mesh-list
24692563|NCT01415141|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24691911|NCT01409616|Analgesics|analgesics|mesh-ancestor
24691912|NCT01409616|Sensory System Agents|sensory system agents|mesh-ancestor
24691913|NCT01409616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24691914|NCT01409616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691915|NCT01409616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24691916|NCT01409616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24691917|NCT01409616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24691918|NCT01409616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24691919|NCT01409616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691920|NCT01409616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24691921|NCT01409616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24691922|NCT01409616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691923|NCT01409616|Antipyretics|antipyretics|mesh-ancestor
24691924|NCT01409616|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25851980|NCT00055367|Natalizumab|natalizumab|mesh-list
24691942|NCT01409694|Memantine|memantine|mesh-list
24691943|NCT01409694|Micronutrients|micronutrients|mesh-ancestor
24691944|NCT01409694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691945|NCT01409694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24691946|NCT01409694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24691947|NCT01409694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25069743|NCT03424408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069744|NCT03424408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25069745|NCT03424408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25069746|NCT03424408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25069747|NCT03424408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25069748|NCT03424408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069749|NCT03424408|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25069750|NCT03424408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25069751|NCT03424408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25069753|NCT03424356|Fentanyl|fentanyl|mesh-list
25069754|NCT03424356|Narcotics|narcotics|mesh-list
24832407|NCT02171481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691948|NCT01409694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24691978|NCT01410201|Autonomic Agents|autonomic agents|mesh-ancestor
24691979|NCT01410201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24691980|NCT01410201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691981|NCT01410201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24691982|NCT01410201|Glucocorticoids|glucocorticoids|mesh-ancestor
24691983|NCT01410201|Hormones|hormones|mesh-ancestor
24691984|NCT01410201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24691985|NCT01410201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24691986|NCT01410201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691987|NCT01410201|Protease Inhibitors|protease inhibitors|mesh-ancestor
24691988|NCT01410201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202489|NCT02721173|Keratolytic Agents|keratolytic agents|mesh-ancestor
25202490|NCT02721186|Piperaquine|piperaquine|mesh-list
25202491|NCT02721186|Primaquine|primaquine|mesh-list
25202492|NCT02721186|Artenimol|artenimol|mesh-list
25202493|NCT02721186|Antimalarials|antimalarials|mesh-ancestor
25202494|NCT02721186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24691989|NCT01410201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691990|NCT01410214|Cisplatin|cisplatin|mesh-list
24691991|NCT01410214|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24691992|NCT01410214|Vinorelbine|vinorelbine|mesh-list
24691993|NCT01410214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691994|NCT01410214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24692021|NCT01410708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24692022|NCT01410708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642390|NCT01179152|Glucocorticoids|glucocorticoids|mesh-ancestor
24692024|NCT01410747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24692025|NCT01410747|Immunologic Factors|immunologic factors|mesh-ancestor
24692026|NCT01410747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692027|NCT01410747|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24692028|NCT01410747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24692029|NCT01410747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692030|NCT01410916|Eculizumab|eculizumab|mesh-list
24692031|NCT01410916|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24692032|NCT01410916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24692033|NCT01410916|Immunologic Factors|immunologic factors|mesh-ancestor
25851981|NCT00055367|Immunologic Factors|immunologic factors|mesh-ancestor
24721020|NCT01571908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24721021|NCT01571908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721022|NCT01571908|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
24721023|NCT01571921|Tocotrienols|tocotrienols|mesh-list
24721024|NCT01571921|Vitamin E|vitamin e|mesh-list
24692034|NCT01410916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692035|NCT01410968|Poly ICLC|poly iclc|mesh-list
24692036|NCT01410968|Interferon Inducers|interferon inducers|mesh-ancestor
24692037|NCT01410968|Immunologic Factors|immunologic factors|mesh-ancestor
24692038|NCT01410968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692039|NCT01411072|Gemcitabine|gemcitabine|mesh-list
24692040|NCT01411072|Fluorouracil|fluorouracil|mesh-list
24692041|NCT01411072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24692042|NCT01411072|Antimetabolites|antimetabolites|mesh-ancestor
24692043|NCT01411072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692051|NCT01411098|Etoposide|etoposide|mesh-list
24692063|NCT01411111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692064|NCT01411111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24692065|NCT01411111|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24692066|NCT01411111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24692067|NCT01411124|Diphenhydramine|diphenhydramine|mesh-list
24692068|NCT01411124|Promethazine|promethazine|mesh-list
24692069|NCT01411124|Gabapentin|gabapentin|mesh-list
24692070|NCT01411124|Analgesics|analgesics|mesh-ancestor
24692071|NCT01411124|Sensory System Agents|sensory system agents|mesh-ancestor
24692072|NCT01411124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24692073|NCT01411124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692074|NCT01411124|Anticonvulsants|anticonvulsants|mesh-ancestor
24692075|NCT01411124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24692076|NCT01411124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24692077|NCT01411124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24692078|NCT01411124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24692079|NCT01411124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24692080|NCT01411124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24692081|NCT01411124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24692082|NCT01411124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692083|NCT01411124|Antimanic Agents|antimanic agents|mesh-ancestor
24692084|NCT01411124|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24692085|NCT01411124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24692086|NCT01411124|Anesthetics, Local|anesthetics, local|mesh-ancestor
24692123|NCT01411280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692157|NCT01411670|Anticoagulants|anticoagulants|mesh-ancestor
24692158|NCT01411670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24692159|NCT01411670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24692160|NCT01411670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692161|NCT01411670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24692162|NCT01411735|Enalapril|enalapril|mesh-list
25851982|NCT00055367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612122|NCT01012011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851983|NCT00055393|Bupropion|bupropion|mesh-list
24612168|NCT01012284|Antitubercular Agents|antitubercular agents|mesh-ancestor
24692212|NCT01412008|Botulinum Toxins|botulinum toxins|mesh-list
24692213|NCT01412008|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24692214|NCT01412008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24692215|NCT01412008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692216|NCT01412008|Cholinergic Agents|cholinergic agents|mesh-ancestor
24692217|NCT01412008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24692218|NCT01412008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692219|NCT01412073|Misoprostol|misoprostol|mesh-list
24692220|NCT01412073|Oxytocin|oxytocin|mesh-list
24692221|NCT01412073|Oxytocics|oxytocics|mesh-ancestor
24692235|NCT01412294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692236|NCT01412294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24692237|NCT01412294|Antimetabolites|antimetabolites|mesh-ancestor
25069757|NCT03424356|Propofol|propofol|mesh-list
25069758|NCT03424356|Rocuronium|rocuronium|mesh-list
25069759|NCT03424356|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25663540|NCT01660256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25663541|NCT01660256|Antioxidants|antioxidants|mesh-ancestor
25663542|NCT01660256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663543|NCT01660256|Protective Agents|protective agents|mesh-ancestor
25663544|NCT01660256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663545|NCT01660256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25109718|NCT03121963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25069760|NCT03424356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24692238|NCT01412294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692240|NCT01412307|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24692241|NCT01412307|Immunologic Factors|immunologic factors|mesh-ancestor
24692242|NCT01412307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692243|NCT01412307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24692244|NCT01412307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24692245|NCT01412307|Growth Substances|growth substances|mesh-ancestor
24692246|NCT01412307|Growth Inhibitors|growth inhibitors|mesh-ancestor
24692349|NCT01413048|Carvedilol|carvedilol|mesh-list
24692350|NCT01413048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24692374|NCT01413477|Betamethasone Valerate|betamethasone valerate|mesh-list
24692375|NCT01413477|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24692376|NCT01413477|Betamethasone benzoate|betamethasone benzoate|mesh-list
24692377|NCT01413477|Calcipotriene|calcipotriene|mesh-list
24692378|NCT01413477|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24692379|NCT01413477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25069768|NCT03424356|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25069769|NCT03424356|Anticonvulsants|anticonvulsants|mesh-ancestor
25069770|NCT03424356|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24832424|NCT02171507|Antithrombins|antithrombins|mesh-ancestor
24692491|NCT01414608|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24692492|NCT01414608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24692493|NCT01414608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692494|NCT01414608|Tubulin Modulators|tubulin modulators|mesh-ancestor
24692495|NCT01414608|Antimitotic Agents|antimitotic agents|mesh-ancestor
24692496|NCT01414608|Mitosis Modulators|mitosis modulators|mesh-ancestor
24692497|NCT01414608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692499|NCT01414816|Interferon-beta|interferon-beta|mesh-list
24692500|NCT01414816|Interferon beta-1b|interferon beta-1b|mesh-list
24692501|NCT01414816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692502|NCT01414816|Antiviral Agents|antiviral agents|mesh-ancestor
24692503|NCT01414816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24692504|NCT01414816|Immunologic Factors|immunologic factors|mesh-ancestor
24692516|NCT01414868|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24692517|NCT01414868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24692518|NCT01414868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692520|NCT01414881|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24692531|NCT01414998|Autonomic Agents|autonomic agents|mesh-ancestor
24692532|NCT01414998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24692533|NCT01414998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692534|NCT01414998|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24692535|NCT01414998|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24692536|NCT01414998|Cholinergic Agents|cholinergic agents|mesh-ancestor
24692537|NCT01414998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24692538|NCT01414998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692540|NCT01415011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692541|NCT01415011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24692542|NCT01415011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24692543|NCT01415011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069771|NCT03424356|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25069774|NCT03424291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069775|NCT03424291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25069776|NCT03424291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25069777|NCT03424291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202495|NCT02721186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25069778|NCT03424226|Acetazolamide|acetazolamide|mesh-list
25069779|NCT03424226|Anticonvulsants|anticonvulsants|mesh-ancestor
25069780|NCT03424226|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25069781|NCT03424226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25069782|NCT03424226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692559|NCT01415128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24692560|NCT01415128|Adrenergic Agents|adrenergic agents|mesh-ancestor
24692561|NCT01415128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24692579|NCT01415336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24692580|NCT01415336|Alkylating Agents|alkylating agents|mesh-ancestor
24692581|NCT01415336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692582|NCT01415336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692583|NCT01415336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25663546|NCT01660334|Voriconazole|voriconazole|mesh-list
24692584|NCT01415336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25069783|NCT03424226|Diuretics|diuretics|mesh-ancestor
25069784|NCT03424226|Natriuretic Agents|natriuretic agents|mesh-ancestor
25069785|NCT03424226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069786|NCT03424135|Diphenhydramine|diphenhydramine|mesh-list
24692585|NCT01415336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24692586|NCT01415336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24692596|NCT01415505|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24692598|NCT01415505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24692599|NCT01415505|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24692600|NCT01415505|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24692601|NCT01415505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692614|NCT01415557|Trace Elements|trace elements|mesh-list
24692615|NCT01415557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692616|NCT01415596|Albuterol|albuterol|mesh-list
24692617|NCT01415596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24692618|NCT01415596|Autonomic Agents|autonomic agents|mesh-ancestor
24692619|NCT01415596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24692620|NCT01415596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692621|NCT01415596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24692622|NCT01415596|Respiratory System Agents|respiratory system agents|mesh-ancestor
24692623|NCT01415596|Tocolytic Agents|tocolytic agents|mesh-ancestor
24692624|NCT01415596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24692625|NCT01415596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24692626|NCT01415596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24692627|NCT01415596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24692628|NCT01415596|Adrenergic Agents|adrenergic agents|mesh-ancestor
24692629|NCT01415596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24612183|NCT01012349|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24692630|NCT01415596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692631|NCT01415687|Bisacodyl|bisacodyl|mesh-list
24692632|NCT01415687|Magnesium citrate|magnesium citrate|mesh-list
24692633|NCT01415687|Citric Acid|citric acid|mesh-list
24692634|NCT01415687|Sodium Citrate|sodium citrate|mesh-list
24692635|NCT01415687|Anticoagulants|anticoagulants|mesh-ancestor
24692680|NCT01415765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24692681|NCT01415765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24692682|NCT01415765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24692683|NCT01415765|Glucocorticoids|glucocorticoids|mesh-ancestor
24692684|NCT01415765|Hormones|hormones|mesh-ancestor
24692692|NCT01415778|Androgen Antagonists|androgen antagonists|mesh-ancestor
24692693|NCT01415778|Hormone Antagonists|hormone antagonists|mesh-ancestor
24692694|NCT01415778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24692695|NCT01415778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069787|NCT03424135|Promethazine|promethazine|mesh-list
25069788|NCT03424135|Naproxen|naproxen|mesh-list
25069789|NCT03424135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24692696|NCT01415778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692697|NCT01415791|Bicalutamide|bicalutamide|mesh-list
24692698|NCT01415791|Androgen Antagonists|androgen antagonists|mesh-ancestor
24692699|NCT01415791|Hormone Antagonists|hormone antagonists|mesh-ancestor
24692700|NCT01415791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24692701|NCT01415791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692702|NCT01415791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692703|NCT01415895|Clonidine|clonidine|mesh-list
24692704|NCT01415895|Naltrexone|naltrexone|mesh-list
24692705|NCT01415895|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24692742|NCT01416116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24692743|NCT01416116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692744|NCT01416116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24692745|NCT01416116|Narcotics|narcotics|mesh-ancestor
24692746|NCT01416116|Analgesics|analgesics|mesh-ancestor
24692747|NCT01416116|Antipruritics|antipruritics|mesh-ancestor
24692748|NCT01416116|Dermatologic Agents|dermatologic agents|mesh-ancestor
24692749|NCT01416207|Interferons|interferons|mesh-list
24692750|NCT01416207|Interferon beta-1a|interferon beta-1a|mesh-list
24692751|NCT01416207|Interferon-beta|interferon-beta|mesh-list
24692752|NCT01416207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692753|NCT01416207|Antiviral Agents|antiviral agents|mesh-ancestor
24692754|NCT01416207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24692755|NCT01416207|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24692756|NCT01416207|Immunologic Factors|immunologic factors|mesh-ancestor
24692757|NCT01416207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692758|NCT01416220|Lithium Carbonate|lithium carbonate|mesh-list
24692759|NCT01416220|Paroxetine|paroxetine|mesh-list
24692760|NCT01416220|Antidepressive Agents|antidepressive agents|mesh-ancestor
24692761|NCT01416220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25663547|NCT01660334|Antifungal Agents|antifungal agents|mesh-ancestor
25663548|NCT01660334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25663549|NCT01660334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25851984|NCT00055393|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24692762|NCT01416220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855965|NCT02282085|Aripiprazole|aripiprazole|mesh-list
24855966|NCT02282085|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24855967|NCT02282085|Ziprasidone|ziprasidone|mesh-list
24644214|NCT01189773|Sensory System Agents|sensory system agents|mesh-ancestor
24644215|NCT01189773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24644216|NCT01189773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644217|NCT01189773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24692772|NCT01416220|Serotonin Agents|serotonin agents|mesh-ancestor
24692783|NCT01416350|Azithromycin|azithromycin|mesh-list
24692784|NCT01416350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24692785|NCT01416350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24478223|NCT00421915|Analgesics|analgesics|mesh-ancestor
24692786|NCT01416415|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24692787|NCT01416415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24692789|NCT01416480|Dipropizine|dipropizine|mesh-list
24692790|NCT01416480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24692791|NCT01416480|Autonomic Agents|autonomic agents|mesh-ancestor
24692792|NCT01416480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24692793|NCT01416480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692794|NCT01416480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24692795|NCT01416480|Respiratory System Agents|respiratory system agents|mesh-ancestor
24692796|NCT01416480|Vasodilator Agents|vasodilator agents|mesh-ancestor
24692805|NCT01416649|Exenatide|exenatide|mesh-list
24692806|NCT01416649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24692807|NCT01416649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692808|NCT01416649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24692809|NCT01416649|Incretins|incretins|mesh-ancestor
24692810|NCT01416649|Hormones|hormones|mesh-ancestor
24692811|NCT01416649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24692812|NCT01416662|Gemcitabine|gemcitabine|mesh-list
24692813|NCT01416662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24692814|NCT01416662|Antimetabolites|antimetabolites|mesh-ancestor
24692817|NCT01416662|Antiviral Agents|antiviral agents|mesh-ancestor
24692825|NCT01416701|Vitamins|vitamins|mesh-list
24692826|NCT01416701|Micronutrients|micronutrients|mesh-ancestor
24692827|NCT01416701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692828|NCT01416701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24692829|NCT01416701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24692830|NCT01416831|Interleukin-2|interleukin-2|mesh-list
24692831|NCT01416831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692832|NCT01416831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24692833|NCT01416831|Analgesics|analgesics|mesh-ancestor
24692834|NCT01416831|Sensory System Agents|sensory system agents|mesh-ancestor
24692839|NCT01416870|Hormone Antagonists|hormone antagonists|mesh-ancestor
24692840|NCT01416870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24692841|NCT01416870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692842|NCT01416870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692843|NCT01416883|Bicalutamide|bicalutamide|mesh-list
24692844|NCT01416883|Androgen Antagonists|androgen antagonists|mesh-ancestor
24692845|NCT01416883|Hormone Antagonists|hormone antagonists|mesh-ancestor
24692846|NCT01416883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24692856|NCT01416948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24692857|NCT01416948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24692858|NCT01416948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692859|NCT01416948|Dopamine Agents|dopamine agents|mesh-ancestor
24692860|NCT01416948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24417865|NCT00208117|Serotonin Agents|serotonin agents|mesh-ancestor
24692865|NCT01416948|Autonomic Agents|autonomic agents|mesh-ancestor
24692866|NCT01416948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24692867|NCT01416948|Nootropic Agents|nootropic agents|mesh-ancestor
24692868|NCT01416961|Etoposide|etoposide|mesh-list
24692869|NCT01416961|Etoposide phosphate|etoposide phosphate|mesh-list
24692870|NCT01416961|Cisplatin|cisplatin|mesh-list
24692871|NCT01416961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24692872|NCT01416961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069797|NCT03424135|Gout Suppressants|gout suppressants|mesh-ancestor
25069798|NCT03424135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25069799|NCT03424135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25069800|NCT03424135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069801|NCT03424135|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25069802|NCT03424135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25069803|NCT03424135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25069804|NCT03424135|Anesthetics, Local|anesthetics, local|mesh-ancestor
25069805|NCT03424135|Anesthetics|anesthetics|mesh-ancestor
25069806|NCT03424135|Antiemetics|antiemetics|mesh-ancestor
25069807|NCT03424135|Autonomic Agents|autonomic agents|mesh-ancestor
24692873|NCT01416961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24692874|NCT01416961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24692875|NCT01416961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24692876|NCT01416961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692878|NCT01416974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24692879|NCT01416974|Immunologic Factors|immunologic factors|mesh-ancestor
24692880|NCT01416974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692881|NCT01416974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24692882|NCT01416974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24692883|NCT01416974|Alkylating Agents|alkylating agents|mesh-ancestor
24692884|NCT01416974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692885|NCT01416974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692886|NCT01416974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24692899|NCT01417169|Micafungin|micafungin|mesh-list
24692900|NCT01417169|Antifungal Agents|antifungal agents|mesh-ancestor
25207744|NCT03436498|Insulin, Long-Acting|insulin, long-acting|mesh-list
25026013|NCT03632408|Zopiclone|zopiclone|mesh-list
24692901|NCT01417169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24692902|NCT01417273|Vitamin A|vitamin a|mesh-list
24692903|NCT01417273|Vitamins|vitamins|mesh-ancestor
24692904|NCT01417273|Micronutrients|micronutrients|mesh-ancestor
24692905|NCT01417273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692906|NCT01417351|Vitamin D|vitamin d|mesh-list
24692907|NCT01417351|Ergocalciferols|ergocalciferols|mesh-list
24692908|NCT01417351|Cholecalciferol|cholecalciferol|mesh-list
24692909|NCT01417351|Vitamins|vitamins|mesh-list
24692910|NCT01417351|Micronutrients|micronutrients|mesh-ancestor
24692911|NCT01417351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692912|NCT01417351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24692913|NCT01417351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24692914|NCT01417364|Methyltestosterone|methyltestosterone|mesh-list
24692925|NCT01417364|Anabolic Agents|anabolic agents|mesh-ancestor
24692926|NCT01417390|Gemcitabine|gemcitabine|mesh-list
24692928|NCT01417390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692929|NCT01417390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25851985|NCT00055393|Antidepressive Agents|antidepressive agents|mesh-ancestor
24692930|NCT01417390|Antimetabolites|antimetabolites|mesh-ancestor
24692931|NCT01417390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692932|NCT01417390|Antiviral Agents|antiviral agents|mesh-ancestor
24692933|NCT01417390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24692940|NCT01417403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24692941|NCT01417403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24692942|NCT01417403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24692943|NCT01417403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24692944|NCT01417403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692945|NCT01417403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24692947|NCT01417429|Nicotine|nicotine|mesh-list
24692948|NCT01417429|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24692949|NCT01417429|Autonomic Agents|autonomic agents|mesh-ancestor
24612184|NCT01012349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612192|NCT01012349|Sequestering Agents|sequestering agents|mesh-ancestor
24612193|NCT01012479|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24612194|NCT01012479|Candesartan|candesartan|mesh-list
24612195|NCT01012479|Candesartan cilexetil|candesartan cilexetil|mesh-list
24612196|NCT01012479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24612197|NCT01012479|Diuretics|diuretics|mesh-ancestor
24612198|NCT01012479|Natriuretic Agents|natriuretic agents|mesh-ancestor
24612199|NCT01012479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612200|NCT01012479|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24612223|NCT01012700|Poly ICLC|poly iclc|mesh-list
24612224|NCT01012700|Interferon Inducers|interferon inducers|mesh-ancestor
24612225|NCT01012700|Immunologic Factors|immunologic factors|mesh-ancestor
24612226|NCT01012700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612227|NCT01012830|Huperzine A|huperzine a|mesh-list
24612228|NCT01012830|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24612229|NCT01012830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612230|NCT01012830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612231|NCT01012830|Cholinergic Agents|cholinergic agents|mesh-ancestor
24612232|NCT01012830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24612233|NCT01012830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612234|NCT01012830|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24612235|NCT01012830|Protective Agents|protective agents|mesh-ancestor
24612236|NCT01012843|Amoxicillin|amoxicillin|mesh-list
24612237|NCT01012843|Clavulanic Acid|clavulanic acid|mesh-list
24612238|NCT01012843|Clavulanic Acids|clavulanic acids|mesh-list
24612239|NCT01012843|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24612240|NCT01012843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24612241|NCT01012843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24612242|NCT01012843|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24692979|NCT01417494|Vitamin B Complex|vitamin b complex|mesh-ancestor
24692980|NCT01417494|Vitamins|vitamins|mesh-ancestor
24692981|NCT01417494|Micronutrients|micronutrients|mesh-ancestor
24692982|NCT01417572|Lidocaine|lidocaine|mesh-list
24692983|NCT01417572|Anesthetics, Local|anesthetics, local|mesh-ancestor
24692984|NCT01417572|Anesthetics|anesthetics|mesh-ancestor
24692985|NCT01417572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24692986|NCT01417572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693013|NCT01417806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24693014|NCT01417806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24693015|NCT01417806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693016|NCT01417806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693025|NCT01417858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25202496|NCT02721186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24693026|NCT01417858|Adrenergic Agents|adrenergic agents|mesh-ancestor
24693027|NCT01417858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24693028|NCT01417858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693029|NCT01417858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693031|NCT01417897|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24693032|NCT01417897|Insulin Aspart|insulin aspart|mesh-list
24693033|NCT01417897|Insulin glulisine|insulin glulisine|mesh-list
24693034|NCT01417897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24693035|NCT01417897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693037|NCT01417923|Vitamins|vitamins|mesh-ancestor
24693038|NCT01417923|Micronutrients|micronutrients|mesh-ancestor
24693039|NCT01417923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693040|NCT01417923|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24693041|NCT01417949|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24693042|NCT01417949|Antiviral Agents|antiviral agents|mesh-ancestor
24693052|NCT01418118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693075|NCT01418131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693077|NCT01418144|Anesthetics, Local|anesthetics, local|mesh-ancestor
24693078|NCT01418144|Anesthetics|anesthetics|mesh-ancestor
24693079|NCT01418144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24693080|NCT01418144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693081|NCT01418144|Sensory System Agents|sensory system agents|mesh-ancestor
25069827|NCT03423849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25069828|NCT03423849|Antimetabolites|antimetabolites|mesh-ancestor
25069829|NCT03423849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069830|NCT03423849|Antiviral Agents|antiviral agents|mesh-ancestor
25069831|NCT03423849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25069832|NCT03423849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693093|NCT01418183|Anesthetics|anesthetics|mesh-ancestor
24693094|NCT01418183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24693095|NCT01418183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693096|NCT01418183|Sensory System Agents|sensory system agents|mesh-ancestor
24693097|NCT01418183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24693098|NCT01418235|MF59 oil emulsion|mf59 oil emulsion|mesh-list
24693099|NCT01418235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24693100|NCT01418235|Immunologic Factors|immunologic factors|mesh-ancestor
24693101|NCT01418235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693102|NCT01418274|Ritonavir|ritonavir|mesh-list
24693103|NCT01418274|Citalopram|citalopram|mesh-list
24693104|NCT01418274|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24693105|NCT01418274|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24693106|NCT01418274|Protease Inhibitors|protease inhibitors|mesh-ancestor
24693116|NCT01418274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24693117|NCT01418274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24693118|NCT01418274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24693119|NCT01418274|Serotonin Agents|serotonin agents|mesh-ancestor
24693120|NCT01418274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693121|NCT01418274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24693122|NCT01418274|Antidepressive Agents|antidepressive agents|mesh-ancestor
24693123|NCT01418274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24693124|NCT01418417|Pantoprazole|pantoprazole|mesh-list
24693125|NCT01418417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24693126|NCT01418417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25851987|NCT00055393|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24721424|NCT01573975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24721425|NCT01573975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24721426|NCT01573975|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24721427|NCT01573975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24721428|NCT01573975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24721429|NCT01574014|Hydrocortisone|hydrocortisone|mesh-list
24721503|NCT01575158|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24721504|NCT01575236|Chlorhexidine|chlorhexidine|mesh-list
24693127|NCT01418417|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24693128|NCT01418417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693129|NCT01418417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693131|NCT01418430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24693132|NCT01418430|Immunologic Factors|immunologic factors|mesh-ancestor
24693133|NCT01418430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693134|NCT01418443|Pantoprazole|pantoprazole|mesh-list
24693135|NCT01418443|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24693136|NCT01418443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24693137|NCT01418443|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24693156|NCT01418547|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24693157|NCT01418547|Diuretics|diuretics|mesh-ancestor
24693158|NCT01418547|Natriuretic Agents|natriuretic agents|mesh-ancestor
24693159|NCT01418547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693160|NCT01418547|Vasodilator Agents|vasodilator agents|mesh-ancestor
24693161|NCT01418547|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24693162|NCT01418547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069833|NCT03423849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25069834|NCT03423849|Immunologic Factors|immunologic factors|mesh-ancestor
25069835|NCT03423849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069836|NCT03423849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25069837|NCT03423849|Tubulin Modulators|tubulin modulators|mesh-ancestor
25069838|NCT03423849|Antimitotic Agents|antimitotic agents|mesh-ancestor
25069839|NCT03423849|Mitosis Modulators|mitosis modulators|mesh-ancestor
24693164|NCT01418586|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24693165|NCT01418586|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24693167|NCT01418586|Adrenergic Agents|adrenergic agents|mesh-ancestor
24693206|NCT01418651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24693207|NCT01418651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693208|NCT01418651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24693209|NCT01418651|Analgesics|analgesics|mesh-ancestor
24693210|NCT01418651|Sensory System Agents|sensory system agents|mesh-ancestor
24693211|NCT01418651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24693230|NCT01418794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24693231|NCT01418794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24693267|NCT01419340|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24693268|NCT01419340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642640|NCT01180413|Losartan|losartan|mesh-list
24693269|NCT01419340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693270|NCT01419340|Cholinergic Agents|cholinergic agents|mesh-ancestor
24693271|NCT01419340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24693272|NCT01419340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693273|NCT01419340|Nootropic Agents|nootropic agents|mesh-ancestor
24693274|NCT01419353|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24693275|NCT01419353|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24693277|NCT01419353|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24693278|NCT01419353|Estrogens|estrogens|mesh-ancestor
24693279|NCT01419353|Hormones|hormones|mesh-ancestor
24693280|NCT01419353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24693281|NCT01419353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693282|NCT01419353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24693283|NCT01419353|Contraceptive Agents|contraceptive agents|mesh-ancestor
24693284|NCT01419353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25663550|NCT01660334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25663551|NCT01660334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663552|NCT01660334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663553|NCT01660334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25663554|NCT01660334|Hormone Antagonists|hormone antagonists|mesh-ancestor
25663555|NCT01660334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25663556|NCT01660334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663557|NCT01660334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24457973|NCT00335933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25239617|NCT02540785|Autonomic Agents|autonomic agents|mesh-ancestor
25239620|NCT02540785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24693285|NCT01419353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24693286|NCT01419366|Donepezil|donepezil|mesh-list
24693287|NCT01419366|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24693294|NCT01419392|Sildenafil Citrate|sildenafil citrate|mesh-list
24693295|NCT01419392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693296|NCT01419392|Vasodilator Agents|vasodilator agents|mesh-ancestor
24693297|NCT01419392|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24693298|NCT01419392|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24693299|NCT01419392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693300|NCT01419392|Urological Agents|urological agents|mesh-ancestor
24693301|NCT01419405|Pregabalin|pregabalin|mesh-list
24693302|NCT01419405|Remifentanil|remifentanil|mesh-list
24693303|NCT01419405|Analgesics|analgesics|mesh-ancestor
25069840|NCT03423823|Ranibizumab|ranibizumab|mesh-list
25069841|NCT03423823|Aflibercept|aflibercept|mesh-list
25069842|NCT03423823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069843|NCT03423823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25069844|NCT03423823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24693399|NCT01420250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24693401|NCT01420302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24693402|NCT01420302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24693403|NCT01420302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693404|NCT01420328|Simvastatin|simvastatin|mesh-list
24693405|NCT01420328|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
24693406|NCT01420328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24693407|NCT01420328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24693408|NCT01420328|Antimetabolites|antimetabolites|mesh-ancestor
24693409|NCT01420328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693410|NCT01420328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24693411|NCT01420328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24693412|NCT01420328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693413|NCT01420341|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24693414|NCT01420341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24693415|NCT01420341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24693416|NCT01420341|Renal Agents|renal agents|mesh-ancestor
24693417|NCT01420341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25069853|NCT03423667|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25069854|NCT03423667|Antiviral Agents|antiviral agents|mesh-ancestor
25069855|NCT03423667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25069856|NCT03423667|Expectorants|expectorants|mesh-ancestor
24693449|NCT01420523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24693450|NCT01420523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24693451|NCT01420523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642669|NCT01180621|Immunologic Factors|immunologic factors|mesh-ancestor
24693470|NCT01420575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24693472|NCT01420666|Acetaminophen|acetaminophen|mesh-list
24693473|NCT01420666|Ibuprofen|ibuprofen|mesh-list
24693474|NCT01420666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24693477|NCT01420666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24693478|NCT01420666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693479|NCT01420666|Antipyretics|antipyretics|mesh-ancestor
24693480|NCT01420666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24693481|NCT01420666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24693482|NCT01420666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24693483|NCT01420666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24693484|NCT01420666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693485|NCT01420666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693486|NCT01420692|Insulin Detemir|insulin detemir|mesh-list
24693488|NCT01420692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24693489|NCT01420692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693490|NCT01420822|Fluticasone|fluticasone|mesh-list
24693491|NCT01420822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24693492|NCT01420822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24693493|NCT01420822|Autonomic Agents|autonomic agents|mesh-ancestor
24693494|NCT01420822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24693495|NCT01420822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612243|NCT01012843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693520|NCT01420913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24693521|NCT01420913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24693522|NCT01420913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25663558|NCT01660672|Levetiracetam|levetiracetam|mesh-list
25663559|NCT01660672|Anticonvulsants|anticonvulsants|mesh-ancestor
25663560|NCT01660672|Nootropic Agents|nootropic agents|mesh-ancestor
24693523|NCT01420913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24693524|NCT01420913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24693570|NCT01421173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24693571|NCT01421173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24693572|NCT01421173|Antiemetics|antiemetics|mesh-ancestor
24693573|NCT01421173|Autonomic Agents|autonomic agents|mesh-ancestor
25069857|NCT03423667|Respiratory System Agents|respiratory system agents|mesh-ancestor
25069858|NCT03423667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25069859|NCT03423667|Antioxidants|antioxidants|mesh-ancestor
25069860|NCT03423667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069861|NCT03423667|Protective Agents|protective agents|mesh-ancestor
25069862|NCT03423667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069863|NCT03423667|Antidotes|antidotes|mesh-ancestor
25069864|NCT03423537|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24693574|NCT01421173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24693575|NCT01421173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24693576|NCT01421173|Glucocorticoids|glucocorticoids|mesh-ancestor
24693577|NCT01421173|Hormones|hormones|mesh-ancestor
24693578|NCT01421173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24693579|NCT01421173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24693580|NCT01421173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24693581|NCT01421173|Antimetabolites|antimetabolites|mesh-ancestor
24693582|NCT01421173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693583|NCT01421173|Antiviral Agents|antiviral agents|mesh-ancestor
24693584|NCT01421173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24693585|NCT01421173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693643|NCT01421693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24693645|NCT01421693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693646|NCT01421693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693647|NCT01421693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24693648|NCT01421706|Clarithromycin|clarithromycin|mesh-list
24693649|NCT01421706|Sibutramine|sibutramine|mesh-list
25026374|NCT03629262|Dsuvia|dsuvia|mesh-list
25026375|NCT03629262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25026376|NCT03629262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25026377|NCT03629262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026378|NCT03629262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25026379|NCT03629262|Analgesics|analgesics|mesh-ancestor
25026380|NCT03629262|Sensory System Agents|sensory system agents|mesh-ancestor
24591320|NCT00915850|Cisplatin|cisplatin|mesh-list
24693650|NCT01421706|Clopidogrel|clopidogrel|mesh-list
24693651|NCT01421706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24693652|NCT01421706|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24693653|NCT01421706|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24693654|NCT01421706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24693655|NCT01421706|Purinergic Agents|purinergic agents|mesh-ancestor
24693656|NCT01421706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24693657|NCT01421706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693658|NCT01421706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693659|NCT01421706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24693668|NCT01421706|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25069865|NCT03423537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24812961|NCT02055456|Anabolic Agents|anabolic agents|mesh-ancestor
25069866|NCT03423537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069869|NCT03423472|Micronutrients|micronutrients|mesh-ancestor
25069870|NCT03423472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069871|NCT03423342|Niacinamide|niacinamide|mesh-list
25069872|NCT03423342|Niacin|niacin|mesh-list
25069873|NCT03423342|Nicotinic Acids|nicotinic acids|mesh-list
25069874|NCT03423342|Vitamin B Complex|vitamin b complex|mesh-ancestor
24693696|NCT01421901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24693697|NCT01421901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24693698|NCT01421914|Bupivacaine|bupivacaine|mesh-list
24693699|NCT01421914|Anesthetics, Local|anesthetics, local|mesh-ancestor
24693700|NCT01421914|Anesthetics|anesthetics|mesh-ancestor
24693701|NCT01421914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24693702|NCT01421914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693703|NCT01421914|Sensory System Agents|sensory system agents|mesh-ancestor
24693704|NCT01421914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24693705|NCT01421927|Lenalidomide|lenalidomide|mesh-list
24693706|NCT01421927|Immunologic Factors|immunologic factors|mesh-ancestor
24693707|NCT01421927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693708|NCT01421927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24693709|NCT01421927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25202498|NCT02720978|Oxytocics|oxytocics|mesh-ancestor
25202499|NCT02720978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25202500|NCT02720978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202501|NCT02720991|Misoprostol|misoprostol|mesh-list
25202502|NCT02720991|Mifepristone|mifepristone|mesh-list
25202503|NCT02720991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25202504|NCT02720991|Abortifacient Agents|abortifacient agents|mesh-ancestor
25202505|NCT02720991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25202506|NCT02720991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693710|NCT01421927|Growth Substances|growth substances|mesh-ancestor
24693711|NCT01421927|Growth Inhibitors|growth inhibitors|mesh-ancestor
24693712|NCT01421927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24693714|NCT01421940|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24693715|NCT01421940|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24693716|NCT01421940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693717|NCT01421940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693718|NCT01421979|Caffeine|caffeine|mesh-list
24693740|NCT01422018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24693741|NCT01422018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24693742|NCT01422018|Growth Substances|growth substances|mesh-ancestor
24693743|NCT01422018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693744|NCT01422018|Growth Inhibitors|growth inhibitors|mesh-ancestor
24693745|NCT01422096|Leuprolide|leuprolide|mesh-list
25069875|NCT03423342|Vitamins|vitamins|mesh-ancestor
25069876|NCT03423342|Micronutrients|micronutrients|mesh-ancestor
24693753|NCT01422109|Clopidogrel|clopidogrel|mesh-list
24693754|NCT01422109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24693755|NCT01422109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24693756|NCT01422109|Analgesics|analgesics|mesh-ancestor
24693757|NCT01422109|Sensory System Agents|sensory system agents|mesh-ancestor
24693758|NCT01422109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24693759|NCT01422109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693760|NCT01422109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24693761|NCT01422109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24693762|NCT01422109|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24693874|NCT01422616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24693763|NCT01422109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24693787|NCT01422291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24693788|NCT01422291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693789|NCT01422291|Analgesics|analgesics|mesh-ancestor
24693790|NCT01422291|Sensory System Agents|sensory system agents|mesh-ancestor
24693791|NCT01422291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24693792|NCT01422291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24693793|NCT01422291|Antipyretics|antipyretics|mesh-ancestor
24693794|NCT01422291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24693795|NCT01422291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24693796|NCT01422291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24693797|NCT01422317|Tocopherols|tocopherols|mesh-list
24693799|NCT01422317|Tocotrienols|tocotrienols|mesh-list
24693800|NCT01422317|alpha-Tocopherol|alpha-tocopherol|mesh-list
24693801|NCT01422317|Antioxidants|antioxidants|mesh-ancestor
24693802|NCT01422317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693803|NCT01422317|Protective Agents|protective agents|mesh-ancestor
24693804|NCT01422317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693805|NCT01422317|Vitamins|vitamins|mesh-ancestor
24693806|NCT01422317|Micronutrients|micronutrients|mesh-ancestor
24693807|NCT01422330|Etravirine|etravirine|mesh-list
24693808|NCT01422330|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24693809|NCT01422330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24693810|NCT01422330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693811|NCT01422330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693812|NCT01422330|Antiviral Agents|antiviral agents|mesh-ancestor
24693813|NCT01422330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24693814|NCT01422460|Mitogens|mitogens|mesh-list
24693815|NCT01422460|Mitosis Modulators|mitosis modulators|mesh-ancestor
24693816|NCT01422460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693817|NCT01422499|Vorinostat|vorinostat|mesh-list
24693830|NCT01422590|Protease Inhibitors|protease inhibitors|mesh-ancestor
24693831|NCT01422590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693832|NCT01422590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693833|NCT01422603|Clofarabine|clofarabine|mesh-list
24693834|NCT01422603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24693835|NCT01422603|Antimetabolites|antimetabolites|mesh-ancestor
24693836|NCT01422603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693839|NCT01422616|Clonidine|clonidine|mesh-list
24693840|NCT01422616|Labetalol|labetalol|mesh-list
25069889|NCT03423329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069890|NCT03423329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25069891|NCT03423329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25069892|NCT03423329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25069893|NCT03423329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25069894|NCT03423329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069895|NCT03423225|Tacrolimus|tacrolimus|mesh-list
25069896|NCT03423225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25069897|NCT03423225|Immunologic Factors|immunologic factors|mesh-ancestor
25069898|NCT03423225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069899|NCT03423225|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25069900|NCT03423225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25069901|NCT03423225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069902|NCT03423030|Macozinone|macozinone|mesh-list
25069903|NCT03423030|Antitubercular Agents|antitubercular agents|mesh-ancestor
25069904|NCT03423030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25069905|NCT03423030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24653921|NCT01246284|Triamcinolone|triamcinolone|mesh-list
24697413|NCT01434394|Cetuximab|cetuximab|mesh-list
24655619|NCT01257412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655620|NCT01257451|Vildagliptin|vildagliptin|mesh-list
24697455|NCT01434901|Bethanechol|bethanechol|mesh-list
24693847|NCT01422616|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24693848|NCT01422616|Nitroglycerin|nitroglycerin|mesh-list
24693849|NCT01422616|Esmolol|esmolol|mesh-list
24693850|NCT01422616|Glycerol|glycerol|mesh-list
24693851|NCT01422616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24693852|NCT01422616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24693853|NCT01422616|Sympatholytics|sympatholytics|mesh-ancestor
24693854|NCT01422616|Autonomic Agents|autonomic agents|mesh-ancestor
24693855|NCT01422616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24693856|NCT01422616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693857|NCT01422616|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24693873|NCT01422616|Vasodilator Agents|vasodilator agents|mesh-ancestor
24693875|NCT01422616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24693876|NCT01422616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24693877|NCT01422616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24693878|NCT01422616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24693879|NCT01422616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24693880|NCT01422616|Serotonin Agents|serotonin agents|mesh-ancestor
24693881|NCT01422616|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25069913|NCT03422978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25069936|NCT03422887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069937|NCT03422874|Nelfinavir|nelfinavir|mesh-list
25069938|NCT03422874|Ixazomib|ixazomib|mesh-list
24693883|NCT01422616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693884|NCT01422707|Hydrocortisone|hydrocortisone|mesh-list
24693885|NCT01422707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24693886|NCT01422733|Dexamethasone|dexamethasone|mesh-list
24693887|NCT01422733|Hydrocortisone|hydrocortisone|mesh-list
24693888|NCT01422733|Cosyntropin|cosyntropin|mesh-list
24693889|NCT01422733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24693890|NCT01422733|Antiemetics|antiemetics|mesh-ancestor
24693891|NCT01422733|Autonomic Agents|autonomic agents|mesh-ancestor
25069939|NCT03422874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069940|NCT03422874|Protease Inhibitors|protease inhibitors|mesh-ancestor
25069941|NCT03422874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25069942|NCT03422874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069943|NCT03422874|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25069944|NCT03422874|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24832589|NCT02171715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24832590|NCT02171715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832591|NCT02171715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693892|NCT01422733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24693893|NCT01422733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693894|NCT01422733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24693895|NCT01422733|Glucocorticoids|glucocorticoids|mesh-ancestor
24693896|NCT01422733|Hormones|hormones|mesh-ancestor
24693897|NCT01422733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24693898|NCT01422733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24693899|NCT01422733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24693946|NCT01423019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24693947|NCT01423019|Nasal Decongestants|nasal decongestants|mesh-ancestor
24693948|NCT01423019|Respiratory System Agents|respiratory system agents|mesh-ancestor
24693950|NCT01423032|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24693951|NCT01423032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24693952|NCT01423032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779463|NCT01876290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693962|NCT01423123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693963|NCT01423123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24693964|NCT01423175|Clofarabine|clofarabine|mesh-list
24693965|NCT01423175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24693966|NCT01423175|Antimetabolites|antimetabolites|mesh-ancestor
24693967|NCT01423175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693968|NCT01423175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24693969|NCT01423240|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
24693970|NCT01423240|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24693971|NCT01423240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24693982|NCT01423240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24693983|NCT01423240|Serotonin Agents|serotonin agents|mesh-ancestor
24693989|NCT01423292|Anesthetics|anesthetics|mesh-ancestor
24693990|NCT01423292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24693991|NCT01423292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693992|NCT01423292|Sensory System Agents|sensory system agents|mesh-ancestor
24612306|NCT01013454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24612307|NCT01013454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24612308|NCT01013454|Cholinergic Agents|cholinergic agents|mesh-ancestor
24612309|NCT01013454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24694040|NCT01423500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24612322|NCT01013506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24612324|NCT01013506|Goserelin|goserelin|mesh-list
24659559|NCT01278498|Citalopram|citalopram|mesh-list
24612325|NCT01013506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612326|NCT01013506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24612327|NCT01013506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612328|NCT01013506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612329|NCT01013506|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24612330|NCT01013506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24626407|NCT01087229|Nitrous Oxide|nitrous oxide|mesh-list
24626408|NCT01087229|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24612344|NCT01013532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612353|NCT01013532|Antipyretics|antipyretics|mesh-ancestor
24694007|NCT01423305|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24694009|NCT01423305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24694010|NCT01423305|Adrenergic Agents|adrenergic agents|mesh-ancestor
24694011|NCT01423305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24694012|NCT01423305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694014|NCT01423370|Vasodilator Agents|vasodilator agents|mesh-ancestor
24694015|NCT01423370|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24694016|NCT01423370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24694017|NCT01423370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24694018|NCT01423370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694019|NCT01423370|Urological Agents|urological agents|mesh-ancestor
24694020|NCT01423435|Beraprost|beraprost|mesh-list
24694021|NCT01423435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24660867|NCT01286701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24694023|NCT01423487|Metformin|metformin|mesh-list
24694024|NCT01423487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24694025|NCT01423487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694026|NCT01423500|Fludarabine|fludarabine|mesh-list
24626409|NCT01087229|Anesthetics, General|anesthetics, general|mesh-ancestor
24626410|NCT01087229|Anesthetics|anesthetics|mesh-ancestor
24626411|NCT01087229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24626412|NCT01087229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626413|NCT01087229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24626414|NCT01087229|Analgesics|analgesics|mesh-ancestor
24626415|NCT01087229|Sensory System Agents|sensory system agents|mesh-ancestor
24626416|NCT01087229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25069945|NCT03422874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25069946|NCT03422874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25069947|NCT03422874|Antiviral Agents|antiviral agents|mesh-ancestor
25069948|NCT03422874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25069949|NCT03422796|Cilostazol|cilostazol|mesh-list
25663561|NCT01660711|Leucovorin|leucovorin|mesh-list
24760427|NCT01758029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760428|NCT01758029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24760429|NCT01758029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760430|NCT01758029|Anabolic Agents|anabolic agents|mesh-ancestor
24760431|NCT01758094|Testosterone|testosterone|mesh-list
24760432|NCT01758094|Androgens|androgens|mesh-ancestor
25069950|NCT03422796|Sumatriptan|sumatriptan|mesh-list
24694039|NCT01423500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24694041|NCT01423500|Alkylating Agents|alkylating agents|mesh-ancestor
24694046|NCT01423539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24694047|NCT01423539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694048|NCT01423539|Immunologic Factors|immunologic factors|mesh-ancestor
24694049|NCT01423539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694070|NCT01423708|Immunologic Factors|immunologic factors|mesh-ancestor
24694071|NCT01423708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694072|NCT01423747|Fludarabine|fludarabine|mesh-list
24694073|NCT01423747|Etoposide|etoposide|mesh-list
24694082|NCT01423747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24694083|NCT01423747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24694084|NCT01423747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24694085|NCT01423747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24694086|NCT01423747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24694087|NCT01423747|Alkylating Agents|alkylating agents|mesh-ancestor
24694088|NCT01423747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24694089|NCT01423838|Solifenacin Succinate|solifenacin succinate|mesh-list
24694090|NCT01423838|Oxybutynin|oxybutynin|mesh-list
24694091|NCT01423838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24694092|NCT01423838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24694093|NCT01423838|Cholinergic Agents|cholinergic agents|mesh-ancestor
24694094|NCT01423838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24661216|NCT01288495|Cathartics|cathartics|mesh-ancestor
24694095|NCT01423838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694096|NCT01423838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694097|NCT01423838|Urological Agents|urological agents|mesh-ancestor
24694098|NCT01423838|Parasympatholytics|parasympatholytics|mesh-ancestor
25202507|NCT02720991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25069955|NCT03422796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25069956|NCT03422796|Respiratory System Agents|respiratory system agents|mesh-ancestor
25069957|NCT03422796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25069958|NCT03422796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25069959|NCT03422796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069960|NCT03422796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25069961|NCT03422796|Vasodilator Agents|vasodilator agents|mesh-ancestor
25069962|NCT03422796|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25069963|NCT03422796|Protective Agents|protective agents|mesh-ancestor
25069964|NCT03422796|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25069965|NCT03422796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25069966|NCT03422796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25069967|NCT03422796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25069968|NCT03422796|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25069969|NCT03422796|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25069970|NCT03422796|Serotonin Agents|serotonin agents|mesh-ancestor
24832624|NCT02171767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24694099|NCT01423838|Autonomic Agents|autonomic agents|mesh-ancestor
24694100|NCT01423838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24694101|NCT01423864|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24694102|NCT01423864|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24694103|NCT01423864|Methylprednisolone|methylprednisolone|mesh-list
24694105|NCT01423864|Prednisolone acetate|prednisolone acetate|mesh-list
24694254|NCT01424709|Antimetabolites|antimetabolites|mesh-ancestor
24694106|NCT01423864|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24694107|NCT01423864|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24694108|NCT01423864|Prednisolone phosphate|prednisolone phosphate|mesh-list
24694109|NCT01423864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24694110|NCT01423864|Glucocorticoids|glucocorticoids|mesh-ancestor
24694111|NCT01423864|Hormones|hormones|mesh-ancestor
25663562|NCT01660711|Fluorouracil|fluorouracil|mesh-list
25663563|NCT01660711|Oxaliplatin|oxaliplatin|mesh-list
25663564|NCT01660711|Irinotecan|irinotecan|mesh-list
25663565|NCT01660711|Antimetabolites|antimetabolites|mesh-ancestor
25663566|NCT01660711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663567|NCT01660711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25663568|NCT01660711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694112|NCT01423864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24642842|NCT01181765|Infliximab|infliximab|mesh-list
24694114|NCT01423864|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24694155|NCT01424137|Glucocorticoids|glucocorticoids|mesh-ancestor
24694157|NCT01424137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24694158|NCT01424137|Sympathomimetics|sympathomimetics|mesh-ancestor
24694159|NCT01424176|Pramipexole|pramipexole|mesh-list
24694160|NCT01424176|Antioxidants|antioxidants|mesh-ancestor
24694161|NCT01424176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694162|NCT01424176|Protective Agents|protective agents|mesh-ancestor
24694185|NCT01424332|Sensory System Agents|sensory system agents|mesh-ancestor
24694186|NCT01424332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24694187|NCT01424332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694188|NCT01424332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24694189|NCT01424332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24694190|NCT01424332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24694191|NCT01424332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24694192|NCT01424332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694193|NCT01424332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24694194|NCT01424332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24694195|NCT01424332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24694196|NCT01424332|Antipyretics|antipyretics|mesh-ancestor
25851988|NCT00055393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24694210|NCT01424384|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24694211|NCT01424384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24694213|NCT01424384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694214|NCT01424384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24694215|NCT01424384|Serotonin Agents|serotonin agents|mesh-ancestor
24694216|NCT01424384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694217|NCT01424384|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24694218|NCT01424384|Antidepressive Agents|antidepressive agents|mesh-ancestor
24694219|NCT01424384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24694221|NCT01424449|Antidepressive Agents|antidepressive agents|mesh-ancestor
24694222|NCT01424449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24694223|NCT01424449|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24694224|NCT01424449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24694225|NCT01424449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24694226|NCT01424449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851989|NCT00055393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25851990|NCT00055393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694253|NCT01424709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24694255|NCT01424709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694257|NCT01424709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24694258|NCT01424709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24694259|NCT01424709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24694260|NCT01424709|Immunologic Factors|immunologic factors|mesh-ancestor
24694261|NCT01424709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694262|NCT01424709|Tubulin Modulators|tubulin modulators|mesh-ancestor
25851991|NCT00055393|Dopamine Agents|dopamine agents|mesh-ancestor
25851992|NCT00055393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24694263|NCT01424709|Antimitotic Agents|antimitotic agents|mesh-ancestor
24694270|NCT01424761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694271|NCT01424761|Vitamins|vitamins|mesh-ancestor
24694272|NCT01424826|Raltegravir Potassium|raltegravir potassium|mesh-list
24694273|NCT01424826|Rifampin|rifampin|mesh-list
24694274|NCT01424826|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24694275|NCT01424826|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24694276|NCT01424826|Antiviral Agents|antiviral agents|mesh-ancestor
24419512|NCT00212290|Pioglitazone|pioglitazone|mesh-list
25851993|NCT00055393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694283|NCT01424826|Antitubercular Agents|antitubercular agents|mesh-ancestor
24694284|NCT01424826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24694285|NCT01424826|Leprostatic Agents|leprostatic agents|mesh-ancestor
24694286|NCT01424826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24694287|NCT01424826|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24694288|NCT01424826|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25069982|NCT03422640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25069983|NCT03422640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25069984|NCT03422640|Analgesics|analgesics|mesh-ancestor
25069985|NCT03422640|Sensory System Agents|sensory system agents|mesh-ancestor
25069986|NCT03422640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25423701|NCT02346253|Bicalutamide|bicalutamide|mesh-list
25069987|NCT03422640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069988|NCT03422640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25069989|NCT03422640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25069990|NCT03422640|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25069991|NCT03422640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25069992|NCT03422640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25069993|NCT03422640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069994|NCT03422575|Etoricoxib|etoricoxib|mesh-list
24832658|NCT02171910|Respiratory System Agents|respiratory system agents|mesh-ancestor
24694289|NCT01424826|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24694290|NCT01424826|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24694291|NCT01424826|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24694292|NCT01424826|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24694293|NCT01424839|Cisplatin|cisplatin|mesh-list
24694294|NCT01424839|Carboplatin|carboplatin|mesh-list
24694295|NCT01424839|Etoposide|etoposide|mesh-list
24694296|NCT01424839|Etoposide phosphate|etoposide phosphate|mesh-list
24694297|NCT01424839|Ifosfamide|ifosfamide|mesh-list
24694298|NCT01424839|Isophosphamide mustard|isophosphamide mustard|mesh-list
24694299|NCT01424839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694300|NCT01424839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24694301|NCT01424839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24694302|NCT01424839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24694303|NCT01424839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24694304|NCT01424839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694346|NCT01425125|Natriuretic Agents|natriuretic agents|mesh-ancestor
24694347|NCT01425125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694348|NCT01425164|Carvedilol|carvedilol|mesh-list
24694349|NCT01425164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24694350|NCT01425164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24694351|NCT01425164|Adrenergic Agents|adrenergic agents|mesh-ancestor
24694352|NCT01425164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24694353|NCT01425164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694354|NCT01425164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694355|NCT01425164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24694370|NCT01425242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24694371|NCT01425242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24857316|NCT02290717|Xhance|xhance|mesh-list
24694372|NCT01425242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24694373|NCT01425242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694374|NCT01425242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24694375|NCT01425242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694376|NCT01425242|Vasodilator Agents|vasodilator agents|mesh-ancestor
24694380|NCT01425320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24694382|NCT01425320|Sensory System Agents|sensory system agents|mesh-ancestor
24694383|NCT01425320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24694384|NCT01425320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694385|NCT01425320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24612392|NCT01013727|Technetium Tc 99m bicisate|technetium tc 99m bicisate|mesh-list
24612393|NCT01013727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24612394|NCT01013727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612395|NCT01013779|Carboplatin|carboplatin|mesh-list
25851994|NCT00055393|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24612397|NCT01013779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612398|NCT01013779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24612399|NCT01013779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24612407|NCT01013805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612408|NCT01013805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24612410|NCT01013805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24612411|NCT01013805|Immunologic Factors|immunologic factors|mesh-ancestor
24612419|NCT01013831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612420|NCT01013831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24612421|NCT01013831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24694392|NCT01425320|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24694393|NCT01425320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24694394|NCT01425320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25851995|NCT00055393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25851996|NCT00055393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663727|NCT01303536|Antiemetics|antiemetics|mesh-ancestor
24694396|NCT01425320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24694397|NCT01425398|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25070002|NCT03422575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25070003|NCT03422575|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25070004|NCT03422575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25070005|NCT03422575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24694398|NCT01425398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24694399|NCT01425398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24694400|NCT01425398|Antimetabolites|antimetabolites|mesh-ancestor
24694401|NCT01425398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694412|NCT01425424|Cholecalciferol|cholecalciferol|mesh-list
24694414|NCT01425424|Micronutrients|micronutrients|mesh-ancestor
24694415|NCT01425424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694416|NCT01425424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24694417|NCT01425424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24694418|NCT01425476|Vitamin D|vitamin d|mesh-list
24694419|NCT01425476|Cholecalciferol|cholecalciferol|mesh-list
24694420|NCT01425476|Celecoxib|celecoxib|mesh-list
24694421|NCT01425476|Vitamins|vitamins|mesh-ancestor
24694422|NCT01425476|Micronutrients|micronutrients|mesh-ancestor
24694426|NCT01425476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24694429|NCT01425476|Sensory System Agents|sensory system agents|mesh-ancestor
24694430|NCT01425476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24694431|NCT01425476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24694432|NCT01425476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24694433|NCT01425476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24694434|NCT01425476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24694435|NCT01425476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24664258|NCT01305733|Analgesics|analgesics|mesh-ancestor
25070006|NCT03422575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694468|NCT01425658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24694469|NCT01425658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694470|NCT01425658|Analgesics|analgesics|mesh-ancestor
24694471|NCT01425658|Sensory System Agents|sensory system agents|mesh-ancestor
24694472|NCT01425658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24694473|NCT01425658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24694474|NCT01425658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24694475|NCT01425658|Anesthetics, General|anesthetics, general|mesh-ancestor
24694476|NCT01425658|Anesthetics|anesthetics|mesh-ancestor
24694477|NCT01425658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24694478|NCT01425658|Sympatholytics|sympatholytics|mesh-ancestor
24694490|NCT01425697|Disinfectants|disinfectants|mesh-ancestor
24694491|NCT01425697|Dermatologic Agents|dermatologic agents|mesh-ancestor
24694494|NCT01425736|Fluorouracil|fluorouracil|mesh-list
24694495|NCT01425736|Nimotuzumab|nimotuzumab|mesh-list
24694496|NCT01425736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694497|NCT01425736|Tubulin Modulators|tubulin modulators|mesh-ancestor
24694498|NCT01425736|Antimitotic Agents|antimitotic agents|mesh-ancestor
24694499|NCT01425736|Mitosis Modulators|mitosis modulators|mesh-ancestor
24694500|NCT01425736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694501|NCT01425736|Antimetabolites|antimetabolites|mesh-ancestor
24694502|NCT01425736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24694503|NCT01425736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24694504|NCT01425736|Immunologic Factors|immunologic factors|mesh-ancestor
24694505|NCT01425736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694506|NCT01425736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24694536|NCT05386290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24694537|NCT05386290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24694552|NCT05386186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24694553|NCT05386186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694554|NCT05386186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24694555|NCT05386186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25851997|NCT00055419|Cetuximab|cetuximab|mesh-list
24694556|NCT05386186|Immunologic Factors|immunologic factors|mesh-ancestor
24694558|NCT05386160|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24694559|NCT05386160|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24694560|NCT05386160|Growth Substances|growth substances|mesh-ancestor
24694650|NCT05385406|Protective Agents|protective agents|mesh-ancestor
24694651|NCT05385406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694657|NCT05385185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694658|NCT05385185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24694659|NCT05385185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24694660|NCT05385185|Growth Substances|growth substances|mesh-ancestor
24480131|NCT00429897|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24694661|NCT05385185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480132|NCT00429897|Diuretics|diuretics|mesh-ancestor
24480133|NCT00429897|Natriuretic Agents|natriuretic agents|mesh-ancestor
25070024|NCT03422510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25070027|NCT03422445|Temozolomide|temozolomide|mesh-list
25070028|NCT03422445|Apatinib|apatinib|mesh-list
25070029|NCT03422445|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25070030|NCT03422445|Alkylating Agents|alkylating agents|mesh-ancestor
25070031|NCT03422445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070032|NCT03422445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25070033|NCT03422445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25070034|NCT03422445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24694666|NCT05385094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24694667|NCT05385094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694689|NCT05379413|Botulinum Toxins|botulinum toxins|mesh-list
24694690|NCT05379413|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24694693|NCT05379413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24694694|NCT05379413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694695|NCT05379413|Cholinergic Agents|cholinergic agents|mesh-ancestor
24694696|NCT05379413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24694697|NCT05379413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694698|NCT05379413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24694704|NCT05379374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24694705|NCT05379374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25851998|NCT00055419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24694740|NCT05375708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24694741|NCT05375708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694742|NCT05375708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24694743|NCT05375708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24694744|NCT05375708|Growth Substances|growth substances|mesh-ancestor
24694745|NCT05375708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694746|NCT05375708|Growth Inhibitors|growth inhibitors|mesh-ancestor
25851999|NCT00055419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852000|NCT00055432|Gemcitabine|gemcitabine|mesh-list
25852001|NCT00055432|Pemetrexed|pemetrexed|mesh-list
25852002|NCT00055432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24694762|NCT05316428|Ethanol|ethanol|mesh-list
24694763|NCT05316428|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24694764|NCT05316428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24694765|NCT05316428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24694766|NCT05316428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694767|NCT05316220|Mesalamine|mesalamine|mesh-list
25202508|NCT02720991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25202509|NCT02720991|Oxytocics|oxytocics|mesh-ancestor
25202510|NCT02720991|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25202511|NCT02720991|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25202512|NCT02720991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25202513|NCT02720991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25202514|NCT02720991|Contraceptive Agents|contraceptive agents|mesh-ancestor
25202515|NCT02720991|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25852003|NCT00055432|Antimetabolites|antimetabolites|mesh-ancestor
25070044|NCT03422406|Micronutrients|micronutrients|mesh-ancestor
25070045|NCT03422406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070046|NCT03422393|Venetoclax|venetoclax|mesh-list
25070047|NCT03422393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25070048|NCT03422315|Propofol|propofol|mesh-list
25070049|NCT03422315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24694782|NCT05308979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24694783|NCT05308979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694785|NCT05308979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24694786|NCT05308095|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24694787|NCT05308095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852004|NCT00055432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852005|NCT00055432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852006|NCT00055432|Antiviral Agents|antiviral agents|mesh-ancestor
24694833|NCT05176379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24694834|NCT05176379|Hormone Antagonists|hormone antagonists|mesh-ancestor
25663569|NCT01660711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25663570|NCT01660711|Immunologic Factors|immunologic factors|mesh-ancestor
25663571|NCT01660711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070073|NCT03422042|Antitubercular Agents|antitubercular agents|mesh-ancestor
25070074|NCT03422029|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25070075|NCT03422029|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25070076|NCT03422029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612452|NCT01014052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612453|NCT01014052|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24612454|NCT01014052|Protective Agents|protective agents|mesh-ancestor
24612455|NCT01014052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694837|NCT05176379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24694838|NCT05176379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25070078|NCT03421990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25070081|NCT03421860|Epinephrine|epinephrine|mesh-list
25070082|NCT03421860|Oxymetazoline|oxymetazoline|mesh-list
25070083|NCT03421860|Ephedrine|ephedrine|mesh-list
25070084|NCT03421860|Norepinephrine|norepinephrine|mesh-list
25070085|NCT03421860|Ondansetron|ondansetron|mesh-list
25070086|NCT03421860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25070087|NCT03421860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25070088|NCT03421860|Adrenergic Agents|adrenergic agents|mesh-ancestor
25070089|NCT03421860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24832746|NCT02172170|Empagliflozin|empagliflozin|mesh-list
24694984|NCT04838808|Protease Inhibitors|protease inhibitors|mesh-ancestor
24694985|NCT04838808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24695183|NCT04246762|Midazolam|midazolam|mesh-list
24695039|NCT04698525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25852008|NCT00055432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852009|NCT00055432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25852010|NCT00055432|Immunologic Factors|immunologic factors|mesh-ancestor
25852011|NCT00055432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695059|NCT04673162|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24695060|NCT04673162|Prednisolone phosphate|prednisolone phosphate|mesh-list
24695061|NCT04673162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24695062|NCT04673162|Antiemetics|antiemetics|mesh-ancestor
24695063|NCT04673162|Autonomic Agents|autonomic agents|mesh-ancestor
24695064|NCT04673162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24695065|NCT04673162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695066|NCT04673162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24695067|NCT04673162|Glucocorticoids|glucocorticoids|mesh-ancestor
24695068|NCT04673162|Hormones|hormones|mesh-ancestor
25070095|NCT03421860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25070096|NCT03421860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25070097|NCT03421860|Respiratory System Agents|respiratory system agents|mesh-ancestor
25070098|NCT03421860|Mydriatics|mydriatics|mesh-ancestor
25070099|NCT03421860|Sympathomimetics|sympathomimetics|mesh-ancestor
25070100|NCT03421860|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24695069|NCT04673162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24695070|NCT04673162|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24695071|NCT04673162|Protective Agents|protective agents|mesh-ancestor
25852012|NCT00055432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25852013|NCT00055432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25027875|NCT03616236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25027876|NCT03616236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027877|NCT03616236|Analgesics|analgesics|mesh-ancestor
25852014|NCT00055484|Zonisamide|zonisamide|mesh-list
24533660|NCT00644735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533661|NCT00644735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533662|NCT00644748|Gabapentin|gabapentin|mesh-list
25852015|NCT00055484|Anticonvulsants|anticonvulsants|mesh-ancestor
24857381|NCT02291380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852016|NCT00055484|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25852017|NCT00055484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25852018|NCT00055484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027878|NCT03616236|Sensory System Agents|sensory system agents|mesh-ancestor
25027879|NCT03616236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027880|NCT03616236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25027881|NCT03616132|Sirolimus|sirolimus|mesh-list
25027882|NCT03616132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24695188|NCT04246762|Micronutrients|micronutrients|mesh-ancestor
24695196|NCT04246762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24695197|NCT04246762|Anesthetics, General|anesthetics, general|mesh-ancestor
24695198|NCT04246762|Anesthetics|anesthetics|mesh-ancestor
24695199|NCT04246762|GABA Modulators|gaba modulators|mesh-ancestor
24695200|NCT04246762|GABA Agents|gaba agents|mesh-ancestor
24695201|NCT04246762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24695202|NCT04246762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695203|NCT04246762|Anticoagulants|anticoagulants|mesh-ancestor
24695204|NCT04246762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24695205|NCT04246762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24695206|NCT04246762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24695207|NCT04246762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24695208|NCT04246762|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24695215|NCT04246762|Hemostatics|hemostatics|mesh-ancestor
24695216|NCT04246762|Coagulants|coagulants|mesh-ancestor
24695246|NCT04166071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24695247|NCT04072146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24695249|NCT04072146|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24695250|NCT04072146|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25852019|NCT00055484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24695251|NCT04072146|Cholinergic Agents|cholinergic agents|mesh-ancestor
24695252|NCT04072146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24695253|NCT04072146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695254|NCT04072146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421430|NCT00218621|Analgesics|analgesics|mesh-ancestor
25070118|NCT03421821|Anesthetics, Local|anesthetics, local|mesh-ancestor
24832768|NCT02172222|Linagliptin|linagliptin|mesh-list
24832769|NCT02172222|Empagliflozin|empagliflozin|mesh-list
25202516|NCT02720991|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25202517|NCT02720991|Hormone Antagonists|hormone antagonists|mesh-ancestor
25202518|NCT02720991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25202519|NCT02720991|Luteolytic Agents|luteolytic agents|mesh-ancestor
25202520|NCT02720991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25202521|NCT02720991|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25202522|NCT02720822|Morphine|morphine|mesh-list
25202523|NCT02720822|Laxatives|laxatives|mesh-list
24832770|NCT02172222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25852020|NCT00055484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852021|NCT00055523|Adalimumab|adalimumab|mesh-list
25852022|NCT00055523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25852023|NCT00055523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24695279|NCT03996265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24695280|NCT03996265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695281|NCT03996265|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24695282|NCT03996265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24695283|NCT03996265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24695285|NCT03945084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24695286|NCT03945084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24695287|NCT03945084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695288|NCT03945084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24695289|NCT03925194|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24695290|NCT03925194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24695291|NCT03882463|Insulin|insulin|mesh-list
24695292|NCT03882463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24695293|NCT03882463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695294|NCT03861481|Rozanolixizumab|rozanolixizumab|mesh-list
24612496|NCT01014234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612498|NCT01014234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24612499|NCT01014234|Dermatologic Agents|dermatologic agents|mesh-ancestor
24612500|NCT01014234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24612501|NCT01014234|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24612502|NCT01014234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24612503|NCT01014234|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24612504|NCT01014234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612506|NCT01014247|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25070128|NCT03421743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070129|NCT03421717|Chitosan|chitosan|mesh-list
25070130|NCT03421717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25202524|NCT02720822|Cathartics|cathartics|mesh-list
25202525|NCT02720822|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25070131|NCT03421717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24695339|NCT03759028|Oxycodone|oxycodone|mesh-list
24695340|NCT03759028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24695341|NCT03759028|Analgesics|analgesics|mesh-ancestor
24695354|NCT03759028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24695355|NCT03757689|Pembrolizumab|pembrolizumab|mesh-list
24695356|NCT03757689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24695358|NCT03737292|Bupivacaine|bupivacaine|mesh-list
24695359|NCT03737292|Anesthetics, Local|anesthetics, local|mesh-ancestor
24695360|NCT03737292|Anesthetics|anesthetics|mesh-ancestor
24695361|NCT03737292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24695362|NCT03737292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695374|NCT03730974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695375|NCT03713424|Clavulanic Acids|clavulanic acids|mesh-list
24695376|NCT03713424|Clavulanic Acid|clavulanic acid|mesh-list
24695377|NCT03713424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24695378|NCT03713424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25852024|NCT00055536|Natalizumab|natalizumab|mesh-list
25852025|NCT00055536|Immunologic Factors|immunologic factors|mesh-ancestor
25852026|NCT00055536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695426|NCT03596424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695427|NCT03596424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25070132|NCT03421717|Antimetabolites|antimetabolites|mesh-ancestor
25070133|NCT03421717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070134|NCT03421717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24695428|NCT03596424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24695429|NCT03596424|Anesthetics, General|anesthetics, general|mesh-ancestor
24695431|NCT03596424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24695432|NCT03596424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24695437|NCT03563222|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24695438|NCT03563222|SMOFlipid|smoflipid|mesh-list
25202526|NCT02720822|Narcotics|narcotics|mesh-ancestor
24695601|NCT02767882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24695602|NCT02767882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695603|NCT02767882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24695605|NCT02767882|Hormones|hormones|mesh-ancestor
24421812|NCT00220233|Vasodilator Agents|vasodilator agents|mesh-ancestor
24695688|NCT02197221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24695689|NCT02197221|Alkylating Agents|alkylating agents|mesh-ancestor
24695690|NCT02197221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695691|NCT02197221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24695692|NCT02197221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24695693|NCT02197221|Immunologic Factors|immunologic factors|mesh-ancestor
24695694|NCT02197221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695696|NCT02124941|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24695697|NCT02124941|Antiviral Agents|antiviral agents|mesh-ancestor
24695698|NCT02124941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24695699|NCT02124941|Expectorants|expectorants|mesh-ancestor
24695700|NCT02124941|Respiratory System Agents|respiratory system agents|mesh-ancestor
24695701|NCT02124941|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24695702|NCT02124941|Antioxidants|antioxidants|mesh-ancestor
24695720|NCT02094794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25070145|NCT03421496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25070146|NCT03421496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070147|NCT03421483|Folic Acid|folic acid|mesh-list
25070148|NCT03421483|Hematinics|hematinics|mesh-ancestor
24695721|NCT02094794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24695722|NCT02094794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24695724|NCT02010385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24695725|NCT02010385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24695726|NCT02010385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24695728|NCT01949714|Racepinephrine|racepinephrine|mesh-list
24612530|NCT01014338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852027|NCT00055549|Lorazepam|lorazepam|mesh-list
25852028|NCT00055549|Dextromethorphan|dextromethorphan|mesh-list
24612559|NCT01014481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852029|NCT00055549|Antitussive Agents|antitussive agents|mesh-ancestor
24823350|NCT02116842|Fentanyl|fentanyl|mesh-list
25070164|NCT03421366|Hormone Antagonists|hormone antagonists|mesh-ancestor
25070165|NCT03421366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24695840|NCT01425840|Anesthetics|anesthetics|mesh-ancestor
24695841|NCT01425840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24695842|NCT01425840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695843|NCT01425840|Sensory System Agents|sensory system agents|mesh-ancestor
24695844|NCT01425840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24695845|NCT01425840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24695885|NCT01426165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695915|NCT01426334|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24695942|NCT01426633|Trabectedin|trabectedin|mesh-list
25852030|NCT00055549|Respiratory System Agents|respiratory system agents|mesh-ancestor
24695943|NCT01426633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25852032|NCT00055549|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25852033|NCT00055549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25852034|NCT00055549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070178|NCT03421275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25070179|NCT03421275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832815|NCT02172287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24832816|NCT02172287|Cholinergic Agents|cholinergic agents|mesh-ancestor
24696007|NCT01426906|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25852035|NCT00055549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852036|NCT00055549|Anticonvulsants|anticonvulsants|mesh-ancestor
25070180|NCT03421275|Analgesics|analgesics|mesh-ancestor
25070181|NCT03421275|Sensory System Agents|sensory system agents|mesh-ancestor
25070182|NCT03421275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25070183|NCT03421275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25028444|NCT03610893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25028445|NCT03610893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028446|NCT03610880|Yimitasvir|yimitasvir|mesh-list
24696091|NCT01427270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24696093|NCT01427270|Analgesics|analgesics|mesh-ancestor
24696094|NCT01427270|Sensory System Agents|sensory system agents|mesh-ancestor
24696095|NCT01427270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24696096|NCT01427270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24696144|NCT01427582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696145|NCT01427582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24696147|NCT01427686|Dopamine|dopamine|mesh-list
24696148|NCT01427686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24696149|NCT01427686|Sympathomimetics|sympathomimetics|mesh-ancestor
24696150|NCT01427686|Autonomic Agents|autonomic agents|mesh-ancestor
24696151|NCT01427686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24696173|NCT01427946|Immunologic Factors|immunologic factors|mesh-ancestor
24696174|NCT01427946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696175|NCT01427985|Atropine|atropine|mesh-list
24696176|NCT01427985|Fentanyl|fentanyl|mesh-list
24696177|NCT01427985|Mivacurium|mivacurium|mesh-list
24696178|NCT01427985|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24696179|NCT01427985|Narcotics|narcotics|mesh-ancestor
24696180|NCT01427985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24696181|NCT01427985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696182|NCT01427985|Analgesics|analgesics|mesh-ancestor
24696183|NCT01427985|Sensory System Agents|sensory system agents|mesh-ancestor
24696184|NCT01427985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24696185|NCT01427985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24696186|NCT01427985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24696187|NCT01427985|Anesthetics, General|anesthetics, general|mesh-ancestor
24696188|NCT01427985|Anesthetics|anesthetics|mesh-ancestor
25852037|NCT00055549|Antiemetics|antiemetics|mesh-ancestor
25070194|NCT03421119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24696189|NCT01427985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24696190|NCT01427985|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24696191|NCT01427985|Autonomic Agents|autonomic agents|mesh-ancestor
24696192|NCT01427985|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24696245|NCT01428375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24696246|NCT01428375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696247|NCT01428375|Antipyretics|antipyretics|mesh-ancestor
24696248|NCT01428388|Bevacizumab|bevacizumab|mesh-list
24696249|NCT01428388|Ranibizumab|ranibizumab|mesh-list
24696250|NCT01428388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24696251|NCT01428388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24696269|NCT01428414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24696270|NCT01428414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25852038|NCT00055549|Autonomic Agents|autonomic agents|mesh-ancestor
24863066|NCT03601455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25852039|NCT00055549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25852040|NCT00055549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25852041|NCT00055549|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25852042|NCT00055549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25852043|NCT00055549|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24450204|NCT00317967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24696272|NCT01428427|Gemcitabine|gemcitabine|mesh-list
24696273|NCT01428427|Trametinib|trametinib|mesh-list
25202529|NCT02720822|Analgesics|analgesics|mesh-ancestor
25202530|NCT02720822|Sensory System Agents|sensory system agents|mesh-ancestor
25663572|NCT01660711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24723087|NCT01584791|Aspirin|aspirin|mesh-list
24723088|NCT01584791|Clopidogrel|clopidogrel|mesh-list
25239941|NCT02538718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239942|NCT02538627|Trametinib|trametinib|mesh-list
25239943|NCT02538627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25239944|NCT02538627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25239945|NCT02538627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25239946|NCT02538627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239958|NCT02538367|YH12852|yh12852|mesh-list
24696276|NCT01428427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852044|NCT00055549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24696303|NCT01428518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24696304|NCT01428518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696318|NCT01428531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24696319|NCT01428531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696320|NCT01428531|Anticoagulants|anticoagulants|mesh-ancestor
24696321|NCT01428531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24696322|NCT01428531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24696323|NCT01428544|PENTA|penta|mesh-list
24696324|NCT01428544|Fondaparinux|fondaparinux|mesh-list
24696325|NCT01428544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24696326|NCT01428544|Antithrombins|antithrombins|mesh-ancestor
24696327|NCT01428544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24696328|NCT01428544|Protease Inhibitors|protease inhibitors|mesh-ancestor
24696329|NCT01428544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24696330|NCT01428544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696331|NCT01428544|Anticoagulants|anticoagulants|mesh-ancestor
24696332|NCT01428544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24450205|NCT00317980|Meglumine Antimoniate|meglumine antimoniate|mesh-list
25852045|NCT00055549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25852046|NCT00055549|GABA Modulators|gaba modulators|mesh-ancestor
24534002|NCT00645632|Abortifacient Agents|abortifacient agents|mesh-ancestor
24534003|NCT00645632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24534006|NCT00645632|Antimetabolites|antimetabolites|mesh-ancestor
25852047|NCT00055549|GABA Agents|gaba agents|mesh-ancestor
25852048|NCT00055562|Lenalidomide|lenalidomide|mesh-list
25852049|NCT00055562|Immunologic Factors|immunologic factors|mesh-ancestor
25852050|NCT00055562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852051|NCT00055562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24696333|NCT01428544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24696334|NCT01428622|Olodaterol|olodaterol|mesh-list
24696335|NCT01428622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24696336|NCT01428622|Autonomic Agents|autonomic agents|mesh-ancestor
25852052|NCT00055562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24696337|NCT01428622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24696347|NCT01428908|Immunologic Factors|immunologic factors|mesh-ancestor
24696348|NCT01428908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696349|NCT01428986|Maraviroc|maraviroc|mesh-list
24696350|NCT01428986|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24696351|NCT01428986|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24696352|NCT01428986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696353|NCT01428986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24696423|NCT01429415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24696424|NCT01429415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24696425|NCT01429415|Anticonvulsants|anticonvulsants|mesh-ancestor
25202531|NCT02720822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24696432|NCT01429545|Nifedipine|nifedipine|mesh-list
24696433|NCT01429545|Vasotocin|vasotocin|mesh-list
24696434|NCT01429545|Atosiban|atosiban|mesh-list
24696435|NCT01429545|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24696436|NCT01429545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24696437|NCT01429545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696438|NCT01429545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25423777|NCT02338232|Telmisartan|telmisartan|mesh-list
25663573|NCT01660711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25663574|NCT01660711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663575|NCT01660711|Antidotes|antidotes|mesh-ancestor
25663576|NCT01660711|Protective Agents|protective agents|mesh-ancestor
25663577|NCT01660711|Vitamin B Complex|vitamin b complex|mesh-ancestor
25663578|NCT01660711|Vitamins|vitamins|mesh-ancestor
25663579|NCT01660711|Micronutrients|micronutrients|mesh-ancestor
25663580|NCT01660763|Sufentanil|sufentanil|mesh-list
25663581|NCT01660763|Dsuvia|dsuvia|mesh-list
25663582|NCT01660763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25663583|NCT01660763|Narcotics|narcotics|mesh-ancestor
24723178|NCT01585623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24723179|NCT01585623|Sympatholytics|sympatholytics|mesh-ancestor
24723180|NCT01585623|Autonomic Agents|autonomic agents|mesh-ancestor
25239962|NCT02538367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25239963|NCT02538367|Serotonin Agents|serotonin agents|mesh-ancestor
24696439|NCT01429545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696440|NCT01429545|Vasodilator Agents|vasodilator agents|mesh-ancestor
24696441|NCT01429545|Tocolytic Agents|tocolytic agents|mesh-ancestor
24696442|NCT01429545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24696443|NCT01429545|Hormone Antagonists|hormone antagonists|mesh-ancestor
24696444|NCT01429545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24696445|NCT01429545|Oxytocics|oxytocics|mesh-ancestor
24696446|NCT01429545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24696447|NCT01429571|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24696448|NCT01429571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24696449|NCT01429610|Cytarabine|cytarabine|mesh-list
24696450|NCT01429610|Rituximab|rituximab|mesh-list
24696451|NCT01429610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24696452|NCT01429610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24696453|NCT01429610|Immunologic Factors|immunologic factors|mesh-ancestor
24696454|NCT01429610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696455|NCT01429610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24696456|NCT01429610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24696458|NCT01429610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696459|NCT01429610|Antiviral Agents|antiviral agents|mesh-ancestor
24696460|NCT01429610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24696461|NCT01429610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24696462|NCT01429675|Ibandronic Acid|ibandronic acid|mesh-list
24696463|NCT01429675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24696464|NCT01429675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696465|NCT01429701|Gentamicins|gentamicins|mesh-list
24696466|NCT01429701|Polymyxins|polymyxins|mesh-list
24696467|NCT01429701|Polymyxin B|polymyxin b|mesh-list
24696468|NCT01429701|Prednisolone|prednisolone|mesh-list
24696469|NCT01429701|Betamethasone|betamethasone|mesh-list
24696470|NCT01429701|Benzocaine|benzocaine|mesh-list
24696471|NCT01429701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24696472|NCT01429701|Glucocorticoids|glucocorticoids|mesh-ancestor
24696473|NCT01429701|Hormones|hormones|mesh-ancestor
25852053|NCT00055562|Growth Substances|growth substances|mesh-ancestor
24696531|NCT01429844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25852054|NCT00055562|Growth Inhibitors|growth inhibitors|mesh-ancestor
24696552|NCT01429935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24696553|NCT01429935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696555|NCT01429935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24696556|NCT01429935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25019296|NCT03692026|Melatonin|melatonin|mesh-list
24696586|NCT01430078|Niacinamide|niacinamide|mesh-list
24696587|NCT01430078|Peficitinib|peficitinib|mesh-list
25070224|NCT03420937|Atropine|atropine|mesh-list
25070225|NCT03420937|Neostigmine|neostigmine|mesh-list
25070226|NCT03420937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25070227|NCT03420937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24832857|NCT02172339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24832858|NCT02172339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832859|NCT02172352|Tiotropium Bromide|tiotropium bromide|mesh-list
25852055|NCT00055562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852056|NCT00055614|Topotecan|topotecan|mesh-list
24696592|NCT01430078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696593|NCT01430078|Vitamin B Complex|vitamin b complex|mesh-ancestor
25663584|NCT01660763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25663585|NCT01660763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663586|NCT01660763|Analgesics|analgesics|mesh-ancestor
25663587|NCT01660763|Sensory System Agents|sensory system agents|mesh-ancestor
25663588|NCT01660763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25663589|NCT01660763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25663590|NCT01660763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25663591|NCT01660763|Anesthetics, General|anesthetics, general|mesh-ancestor
24696595|NCT01430078|Micronutrients|micronutrients|mesh-ancestor
24696596|NCT01430195|Afamelanotide|afamelanotide|mesh-list
25852057|NCT00055614|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24457974|NCT00335933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25239978|NCT02538224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25239979|NCT02538224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25239980|NCT02538224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25239981|NCT02538224|Analgesics|analgesics|mesh-ancestor
25239982|NCT02538224|Sensory System Agents|sensory system agents|mesh-ancestor
25239983|NCT02538224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239984|NCT02538224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239985|NCT02538224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25239986|NCT02538224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25239987|NCT02538224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25239988|NCT02538224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25239989|NCT02538224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239990|NCT02538211|Vaccines|vaccines|mesh-list
24696597|NCT01430195|Dermatologic Agents|dermatologic agents|mesh-ancestor
24696598|NCT01430234|Pancreatin|pancreatin|mesh-list
24696599|NCT01430234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24696600|NCT01430260|Ciclesonide|ciclesonide|mesh-list
24696601|NCT01430260|Cetirizine|cetirizine|mesh-list
24696602|NCT01430260|Levocetirizine|levocetirizine|mesh-list
24696603|NCT01430260|Glucocorticoids|glucocorticoids|mesh-ancestor
24696604|NCT01430260|Hormones|hormones|mesh-ancestor
24823485|NCT02117583|Analgesics|analgesics|mesh-ancestor
24696649|NCT01430533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24696650|NCT01430533|Dermatologic Agents|dermatologic agents|mesh-ancestor
24696651|NCT01430650|Saw palmetto extract|saw palmetto extract|mesh-list
24837773|NCT02193269|Minocycline|minocycline|mesh-list
24696654|NCT01430689|Immunologic Factors|immunologic factors|mesh-ancestor
24696655|NCT01430689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696656|NCT01430793|Vitamin D|vitamin d|mesh-list
24696657|NCT01430793|Ergocalciferols|ergocalciferols|mesh-list
24696658|NCT01430793|Cholecalciferol|cholecalciferol|mesh-list
24696659|NCT01430793|Vitamins|vitamins|mesh-list
24696660|NCT01430793|Micronutrients|micronutrients|mesh-ancestor
24696672|NCT01430910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696673|NCT01430923|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24696674|NCT01430923|Latanoprost|latanoprost|mesh-list
24696675|NCT01430923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24696676|NCT01431053|Aspirin|aspirin|mesh-list
24696677|NCT01431053|Exemestane|exemestane|mesh-list
24696678|NCT01431053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24696691|NCT01431053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24696692|NCT01431053|Antipyretics|antipyretics|mesh-ancestor
24696693|NCT01431053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25070235|NCT03420937|Parasympatholytics|parasympatholytics|mesh-ancestor
25070236|NCT03420937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24823585|NCT02117986|Polymyxins|polymyxins|mesh-list
24696756|NCT01431326|Autonomic Agents|autonomic agents|mesh-ancestor
24696757|NCT01431326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24696758|NCT01431326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696759|NCT01431326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24696760|NCT01431326|Glucocorticoids|glucocorticoids|mesh-ancestor
24696762|NCT01431326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24696763|NCT01431326|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24696764|NCT01431326|Protective Agents|protective agents|mesh-ancestor
24696765|NCT01431326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24696766|NCT01431326|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24696767|NCT01431326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24696768|NCT01431326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696769|NCT01431326|Hemostatics|hemostatics|mesh-ancestor
24696770|NCT01431326|Coagulants|coagulants|mesh-ancestor
24696771|NCT01431326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24696772|NCT01431326|Narcotics|narcotics|mesh-ancestor
25663592|NCT01660763|Anesthetics|anesthetics|mesh-ancestor
25663593|NCT01660802|Dexamethasone|dexamethasone|mesh-list
25663594|NCT01660802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25663595|NCT01660802|Antiemetics|antiemetics|mesh-ancestor
25663596|NCT01660802|Autonomic Agents|autonomic agents|mesh-ancestor
25663597|NCT01660802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25663598|NCT01660802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663599|NCT01660802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25663600|NCT01660802|Glucocorticoids|glucocorticoids|mesh-ancestor
25663601|NCT01660802|Hormones|hormones|mesh-ancestor
25663602|NCT01660802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25663603|NCT01660802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25663604|NCT01660802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663605|NCT01660893|Phenylephrine|phenylephrine|mesh-list
24696773|NCT01431326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25663606|NCT01660893|Oxymetazoline|oxymetazoline|mesh-list
25240004|NCT02538302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696774|NCT01431326|Analgesics|analgesics|mesh-ancestor
24696775|NCT01431326|Sensory System Agents|sensory system agents|mesh-ancestor
24696776|NCT01431326|Anticoagulants|anticoagulants|mesh-ancestor
24696777|NCT01431326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24696778|NCT01431326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24696779|NCT01431326|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24696780|NCT01431326|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24696781|NCT01431326|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24696782|NCT01431326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24696783|NCT01431326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24696784|NCT01431326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24696785|NCT01431326|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24696786|NCT01431326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24696787|NCT01431326|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24696788|NCT01431326|Hormone Antagonists|hormone antagonists|mesh-ancestor
24696789|NCT01431326|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24696790|NCT01431326|Diuretics|diuretics|mesh-ancestor
24696791|NCT01431326|Natriuretic Agents|natriuretic agents|mesh-ancestor
24696792|NCT01431326|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24696793|NCT01431326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24696794|NCT01431326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24696795|NCT01431326|Vasodilator Agents|vasodilator agents|mesh-ancestor
24696796|NCT01431326|Tocolytic Agents|tocolytic agents|mesh-ancestor
24696797|NCT01431326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24696798|NCT01431326|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25852058|NCT00055614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25852059|NCT00055614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25070248|NCT03420911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25070249|NCT03420911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070250|NCT03420911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25070251|NCT03420911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24696882|NCT01431495|Clopidogrel|clopidogrel|mesh-list
24696883|NCT01431495|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24696884|NCT01431495|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24696885|NCT01431495|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24696886|NCT01431495|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24696887|NCT01431495|Purinergic Agents|purinergic agents|mesh-ancestor
24696888|NCT01431495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24696889|NCT01431495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696910|NCT01431612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24696911|NCT01431612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696912|NCT01431612|Protective Agents|protective agents|mesh-ancestor
24696913|NCT01431612|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24696914|NCT01431612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24696915|NCT01431612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24696916|NCT01431690|Warfarin|warfarin|mesh-list
24696917|NCT01431690|Anticoagulants|anticoagulants|mesh-list
24696918|NCT01431729|Propolis|propolis|mesh-list
24696919|NCT01431729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24696920|NCT01431742|Buprenorphine|buprenorphine|mesh-list
25070252|NCT03420911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25070253|NCT03420911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24696921|NCT01431742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24696922|NCT01431742|Narcotics|narcotics|mesh-ancestor
24696975|NCT01432080|Azithromycin|azithromycin|mesh-list
24696976|NCT01432080|Prednisone|prednisone|mesh-list
24696977|NCT01432080|Budesonide|budesonide|mesh-list
24696978|NCT01432080|Formoterol Fumarate|formoterol fumarate|mesh-list
24696979|NCT01432080|Montelukast|montelukast|mesh-list
24696980|NCT01432080|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24696981|NCT01432080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24696982|NCT01432080|Glucocorticoids|glucocorticoids|mesh-ancestor
24696983|NCT01432080|Hormones|hormones|mesh-ancestor
24696984|NCT01432080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24422721|NCT00223691|Bromides|bromides|mesh-list
24612718|NCT01015209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612720|NCT01015209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612721|NCT01015209|Antidotes|antidotes|mesh-ancestor
24612722|NCT01015209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25663607|NCT01660893|Tetracaine|tetracaine|mesh-list
25663608|NCT01660893|Anesthetics, Local|anesthetics, local|mesh-ancestor
25663609|NCT01660893|Anesthetics|anesthetics|mesh-ancestor
25240016|NCT02538432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25070254|NCT03420911|Anesthetics, General|anesthetics, general|mesh-ancestor
25070256|NCT03420911|GABA Modulators|gaba modulators|mesh-ancestor
25070258|NCT03420911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25070259|NCT03420911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612723|NCT01015209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24612724|NCT01015209|Antimetabolites|antimetabolites|mesh-ancestor
24612725|NCT01015209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24612726|NCT01015209|Chelating Agents|chelating agents|mesh-ancestor
24612727|NCT01015209|Sequestering Agents|sequestering agents|mesh-ancestor
24612728|NCT01015209|Hemostatics|hemostatics|mesh-ancestor
24612729|NCT01015209|Coagulants|coagulants|mesh-ancestor
24612730|NCT01015235|Ketorolac|ketorolac|mesh-list
24612731|NCT01015235|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24612742|NCT01015235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612743|NCT01015248|Rituximab|rituximab|mesh-list
24612744|NCT01015248|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24612745|NCT01015248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24612746|NCT01015248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612747|NCT01015248|Immunologic Factors|immunologic factors|mesh-ancestor
24612748|NCT01015248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612749|NCT01015248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24612750|NCT01015248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24612751|NCT01015248|Alkylating Agents|alkylating agents|mesh-ancestor
24612752|NCT01015248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612753|NCT01015300|Bevacizumab|bevacizumab|mesh-list
24612754|NCT01015300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24612755|NCT01015300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612756|NCT01015300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24612757|NCT01015300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24612758|NCT01015300|Growth Substances|growth substances|mesh-ancestor
24612759|NCT01015300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612760|NCT01015300|Growth Inhibitors|growth inhibitors|mesh-ancestor
24612761|NCT01015339|Paclitaxel|paclitaxel|mesh-list
24697011|NCT01432106|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24697012|NCT01432106|Protease Inhibitors|protease inhibitors|mesh-ancestor
24697013|NCT01432106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24697015|NCT01432119|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24697016|NCT01432119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24697017|NCT01432119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697018|NCT01432119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24697019|NCT01432119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24697020|NCT01432119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697021|NCT01432158|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24697022|NCT01432158|Immunologic Factors|immunologic factors|mesh-ancestor
24697023|NCT01432158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697024|NCT01432223|Paclitaxel|paclitaxel|mesh-list
24697025|NCT01432223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24697026|NCT01432223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697027|NCT01432223|Tubulin Modulators|tubulin modulators|mesh-ancestor
24697028|NCT01432223|Antimitotic Agents|antimitotic agents|mesh-ancestor
24697029|NCT01432223|Mitosis Modulators|mitosis modulators|mesh-ancestor
24643408|NCT01185444|Viscosupplements|viscosupplements|mesh-ancestor
24697030|NCT01432223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070260|NCT03420911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25070261|NCT03420911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25070262|NCT03420911|Analgesics|analgesics|mesh-ancestor
25070263|NCT03420911|Sensory System Agents|sensory system agents|mesh-ancestor
25070264|NCT03420911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24697032|NCT01432249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24697033|NCT01432249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24697034|NCT01432249|Analgesics|analgesics|mesh-ancestor
24697035|NCT01432249|Sensory System Agents|sensory system agents|mesh-ancestor
24697036|NCT01432249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24697037|NCT01432249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697043|NCT01432470|Oxytocin|oxytocin|mesh-list
24697044|NCT01432470|Oxytocics|oxytocics|mesh-ancestor
24697230|NCT01433887|Ribavirin|ribavirin|mesh-list
24697045|NCT01432470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25663610|NCT01660893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25663611|NCT01660893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663612|NCT01660893|Sensory System Agents|sensory system agents|mesh-ancestor
25240028|NCT02538237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25240029|NCT02538237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25240030|NCT02538237|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24761095|NCT01760980|Hormone Antagonists|hormone antagonists|mesh-ancestor
25240031|NCT02538237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240032|NCT02538237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852060|NCT00055614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697046|NCT01432470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697047|NCT01432483|Denileukin diftitox|denileukin diftitox|mesh-list
24697068|NCT01432522|Respiratory System Agents|respiratory system agents|mesh-ancestor
24697070|NCT01432522|Sympathomimetics|sympathomimetics|mesh-ancestor
24697075|NCT01432587|Analgesics|analgesics|mesh-ancestor
24697076|NCT01432587|Sensory System Agents|sensory system agents|mesh-ancestor
24697077|NCT01432587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24697078|NCT01432587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697079|NCT01432587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24823765|NCT02118870|Antipyretics|antipyretics|mesh-ancestor
24697122|NCT01432821|Dopamine Agonists|dopamine agonists|mesh-ancestor
24697123|NCT01432821|Dopamine Agents|dopamine agents|mesh-ancestor
24697124|NCT01432821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24422986|NCT00224354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697130|NCT01432873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697131|NCT01432873|Trace Elements|trace elements|mesh-ancestor
24697132|NCT01432873|Micronutrients|micronutrients|mesh-ancestor
24697134|NCT01432977|Droperidol|droperidol|mesh-list
24697153|NCT01432977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24697155|NCT01432977|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24697156|NCT01432977|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25852061|NCT00055614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697157|NCT01432977|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24697158|NCT01432977|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24697159|NCT01432977|Dopamine Agents|dopamine agents|mesh-ancestor
24697160|NCT01433289|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24697161|NCT01433289|Antioxidants|antioxidants|mesh-ancestor
24697162|NCT01433289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697163|NCT01433289|Protective Agents|protective agents|mesh-ancestor
24697164|NCT01433289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697165|NCT01433289|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24697166|NCT01433289|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24697167|NCT01433289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697168|NCT01433289|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24697169|NCT01433328|Lidocaine|lidocaine|mesh-list
24697170|NCT01433328|Anesthetics, Local|anesthetics, local|mesh-ancestor
24697171|NCT01433328|Anesthetics|anesthetics|mesh-ancestor
24697172|NCT01433328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24697174|NCT01433328|Sensory System Agents|sensory system agents|mesh-ancestor
24697175|NCT01433328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24697176|NCT01433328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24697177|NCT01433328|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24697178|NCT01433328|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24697179|NCT01433328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24697180|NCT01433328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697181|NCT01433445|Panobinostat|panobinostat|mesh-list
24697182|NCT01433445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697183|NCT01433445|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24697184|NCT01433445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24697185|NCT01433445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697186|NCT01433614|Paclitaxel|paclitaxel|mesh-list
24697187|NCT01433614|Capecitabine|capecitabine|mesh-list
24697188|NCT01433614|Epirubicin|epirubicin|mesh-list
24697189|NCT01433614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24697190|NCT01433614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697191|NCT01433614|Tubulin Modulators|tubulin modulators|mesh-ancestor
24697192|NCT01433614|Antimitotic Agents|antimitotic agents|mesh-ancestor
24697193|NCT01433614|Mitosis Modulators|mitosis modulators|mesh-ancestor
24697207|NCT01433627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697208|NCT01433627|Anticoagulants|anticoagulants|mesh-ancestor
24697209|NCT01433627|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25663613|NCT01660893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25663614|NCT01660893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25663615|NCT01660893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25663616|NCT01660893|Adrenergic Agents|adrenergic agents|mesh-ancestor
25663617|NCT01660893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25663618|NCT01660893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240042|NCT02538172|Antiviral Agents|antiviral agents|mesh-ancestor
25852062|NCT00055640|Prednisone|prednisone|mesh-list
25852063|NCT00055640|Cyclophosphamide|cyclophosphamide|mesh-list
25852064|NCT00055640|Rituximab|rituximab|mesh-list
25852065|NCT00055640|Doxorubicin|doxorubicin|mesh-list
25852066|NCT00055640|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25852067|NCT00055640|Vincristine|vincristine|mesh-list
24697210|NCT01433627|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24697211|NCT01433666|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
24840780|NCT02212561|Fludarabine|fludarabine|mesh-list
24423055|NCT00224510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24697221|NCT01433705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24697222|NCT01433705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697223|NCT01433757|Ampicillin|ampicillin|mesh-list
24697224|NCT01433757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24697225|NCT01433757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24697226|NCT01433770|Alefacept|alefacept|mesh-list
24697227|NCT01433770|Dermatologic Agents|dermatologic agents|mesh-ancestor
24697228|NCT01433770|Immunologic Factors|immunologic factors|mesh-ancestor
24697229|NCT01433770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697231|NCT01433887|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24697232|NCT01433887|Antimetabolites|antimetabolites|mesh-ancestor
24697233|NCT01433887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697234|NCT01433887|Antiviral Agents|antiviral agents|mesh-ancestor
24697253|NCT01434017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697254|NCT01434017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24697256|NCT01434017|Hormones|hormones|mesh-ancestor
24697892|NCT01437748|Cholinergic Agents|cholinergic agents|mesh-ancestor
24697259|NCT01434017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697260|NCT01434017|Protease Inhibitors|protease inhibitors|mesh-ancestor
24697261|NCT01434017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24697262|NCT01434017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697263|NCT01434017|Antipruritics|antipruritics|mesh-ancestor
24697270|NCT01434017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24697271|NCT01434017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24697272|NCT01434017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24697273|NCT01434017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24697274|NCT01434017|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24697275|NCT01434017|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24697276|NCT01434017|Dopamine Agents|dopamine agents|mesh-ancestor
24697277|NCT01434069|Leucovorin|leucovorin|mesh-list
24697278|NCT01434069|Fluorouracil|fluorouracil|mesh-list
24697279|NCT01434069|Pasireotide|pasireotide|mesh-list
24697280|NCT01434069|Antimetabolites|antimetabolites|mesh-ancestor
24697281|NCT01434069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697282|NCT01434069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24697283|NCT01434069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697284|NCT01434069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24697285|NCT01434069|Immunologic Factors|immunologic factors|mesh-ancestor
24697298|NCT01434108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697301|NCT01434134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24697302|NCT01434134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24697303|NCT01434134|Sympatholytics|sympatholytics|mesh-ancestor
24697304|NCT01434134|Autonomic Agents|autonomic agents|mesh-ancestor
24697305|NCT01434134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24697306|NCT01434134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697307|NCT01434134|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25070275|NCT03420742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25070276|NCT03420742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070277|NCT03420742|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25070278|NCT03420742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25070279|NCT03420742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25070280|NCT03420742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25070281|NCT03420742|Anesthetics, General|anesthetics, general|mesh-ancestor
25070283|NCT03420742|GABA Modulators|gaba modulators|mesh-ancestor
25070284|NCT03420742|GABA Agents|gaba agents|mesh-ancestor
25070285|NCT03420742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24832895|NCT02172404|Ipratropium|ipratropium|mesh-list
24832896|NCT02172404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24832897|NCT02172404|Autonomic Agents|autonomic agents|mesh-ancestor
24832898|NCT02172404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740560|NCT01689051|Incretins|incretins|mesh-ancestor
25423855|NCT02328105|Paclitaxel|paclitaxel|mesh-list
25663619|NCT01660893|Sympathomimetics|sympathomimetics|mesh-ancestor
25663620|NCT01660893|Autonomic Agents|autonomic agents|mesh-ancestor
25663621|NCT01660893|Nasal Decongestants|nasal decongestants|mesh-ancestor
25663622|NCT01660893|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25663623|NCT01660893|Respiratory System Agents|respiratory system agents|mesh-ancestor
24697313|NCT01434134|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24697316|NCT01434147|Capecitabine|capecitabine|mesh-list
24697317|NCT01434147|Oxaliplatin|oxaliplatin|mesh-list
24697318|NCT01434147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24697319|NCT01434147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697344|NCT01434173|Telithromycin|telithromycin|mesh-list
24697345|NCT01434173|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24697346|NCT01434173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24697347|NCT01434173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25852068|NCT00055640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25070291|NCT03420703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070295|NCT03420638|Epinephrine|epinephrine|mesh-list
25070296|NCT03420638|Bupivacaine|bupivacaine|mesh-list
24832899|NCT02172404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832906|NCT02172417|Ranitidine|ranitidine|mesh-list
24697358|NCT01434173|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24697359|NCT01434173|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24697360|NCT01434173|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24697361|NCT01434173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24697362|NCT01434173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24697363|NCT01434173|Antimalarials|antimalarials|mesh-ancestor
24697364|NCT01434173|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24697365|NCT01434173|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24697366|NCT01434173|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24697368|NCT01434173|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24697369|NCT01434173|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24697370|NCT01434212|Interferons|interferons|mesh-list
24697371|NCT01434212|Ribavirin|ribavirin|mesh-list
24697372|NCT01434212|Interferon-alpha|interferon-alpha|mesh-list
24697373|NCT01434212|Interferon alpha-2|interferon alpha-2|mesh-list
24697374|NCT01434212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697375|NCT01434212|Antiviral Agents|antiviral agents|mesh-ancestor
24697376|NCT01434212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24697377|NCT01434212|Antimetabolites|antimetabolites|mesh-ancestor
24697378|NCT01434212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697379|NCT01434212|Immunologic Factors|immunologic factors|mesh-ancestor
24697380|NCT01434212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697381|NCT01434225|Bumetanide|bumetanide|mesh-list
24697382|NCT01434225|Diuretics|diuretics|mesh-ancestor
24697383|NCT01434225|Natriuretic Agents|natriuretic agents|mesh-ancestor
24482925|NCT00440960|GABA Agents|gaba agents|mesh-ancestor
24697384|NCT01434225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697385|NCT01434225|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24697441|NCT01434862|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24697442|NCT01434862|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
24697443|NCT01434862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697445|NCT01434888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24697446|NCT01434888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25852069|NCT00055640|Immunologic Factors|immunologic factors|mesh-ancestor
24697447|NCT01434888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24697448|NCT01434888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24697449|NCT01434888|Adrenergic Agents|adrenergic agents|mesh-ancestor
24697450|NCT01434888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24697451|NCT01434888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697452|NCT01434888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697453|NCT01434888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24697454|NCT01434888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24697456|NCT01434901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24697457|NCT01434901|Autonomic Agents|autonomic agents|mesh-ancestor
24612786|NCT01015391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612787|NCT01015391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24612788|NCT01015417|Amoxicillin|amoxicillin|mesh-list
24612790|NCT01015417|Clavulanic Acids|clavulanic acids|mesh-list
24612792|NCT01015417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24612793|NCT01015417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24612794|NCT01015417|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24697529|NCT01435343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697530|NCT01435343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25207745|NCT03436498|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24697558|NCT01435486|Caffeine citrate|caffeine citrate|mesh-list
24697559|NCT01435486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697560|NCT01435486|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24697561|NCT01435486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697562|NCT01435486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24697563|NCT01435486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24697567|NCT01435486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24697568|NCT01435499|Cyclophosphamide|cyclophosphamide|mesh-list
24697569|NCT01435499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24697570|NCT01435499|Immunologic Factors|immunologic factors|mesh-ancestor
24697575|NCT01435499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697594|NCT01435837|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24697595|NCT01435837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852070|NCT00055640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852071|NCT00055640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24450379|NCT00318903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852072|NCT00055640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25852073|NCT00055640|Alkylating Agents|alkylating agents|mesh-ancestor
25852074|NCT00055640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852075|NCT00055640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697596|NCT01435837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697597|NCT01435837|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24697598|NCT01435837|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24697625|NCT01435941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24697626|NCT01435941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697627|NCT01435941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24697630|NCT01435954|Finasteride|finasteride|mesh-list
25207746|NCT03436498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24697638|NCT01435954|Adrenergic Agents|adrenergic agents|mesh-ancestor
24697639|NCT01435954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24697640|NCT01435954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852076|NCT00055640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24697641|NCT01435954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697642|NCT01435954|Urological Agents|urological agents|mesh-ancestor
24697643|NCT01435954|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24697644|NCT01435954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24697645|NCT01435954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24697646|NCT01435954|Hormone Antagonists|hormone antagonists|mesh-ancestor
24697647|NCT01435954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24697648|NCT01435954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24697649|NCT01435980|Exenatide|exenatide|mesh-list
24697650|NCT01435980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24697651|NCT01435980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697652|NCT01435980|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24697653|NCT01435980|Incretins|incretins|mesh-ancestor
24697654|NCT01435980|Hormones|hormones|mesh-ancestor
24697655|NCT01435980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24697656|NCT01436123|Everolimus|everolimus|mesh-list
24697657|NCT01436123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697658|NCT01436123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24697659|NCT01436123|Immunologic Factors|immunologic factors|mesh-ancestor
24697660|NCT01436123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697661|NCT01436188|Ibuprofen|ibuprofen|mesh-list
24697662|NCT01436188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24697663|NCT01436188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24697664|NCT01436188|Analgesics|analgesics|mesh-ancestor
24697667|NCT01436188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697668|NCT01436188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24697670|NCT01436188|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24697671|NCT01436188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643482|NCT01185847|Antiviral Agents|antiviral agents|mesh-ancestor
24697672|NCT01436188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697674|NCT01436422|Immunologic Factors|immunologic factors|mesh-ancestor
25070427|NCT03419767|Melatonin|melatonin|mesh-list
25663625|NCT01660893|Mydriatics|mydriatics|mesh-ancestor
25663626|NCT01660893|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25663627|NCT01660893|Protective Agents|protective agents|mesh-ancestor
25663629|NCT01660906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697709|NCT01436578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697711|NCT01436578|Hormone Antagonists|hormone antagonists|mesh-ancestor
24697712|NCT01436578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24697713|NCT01436578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612797|NCT01015456|Mycophenolic Acid|mycophenolic acid|mesh-list
24697714|NCT01436825|Factor VIII|factor viii|mesh-list
24697715|NCT01436825|Coagulants|coagulants|mesh-ancestor
24697716|NCT01436838|Interferons|interferons|mesh-list
24697740|NCT01436994|Propylthiouracil|propylthiouracil|mesh-list
24697741|NCT01436994|Carbimazole|carbimazole|mesh-list
24697742|NCT01436994|Antimetabolites|antimetabolites|mesh-ancestor
24697743|NCT01436994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697744|NCT01436994|Antithyroid Agents|antithyroid agents|mesh-ancestor
24697745|NCT01436994|Hormone Antagonists|hormone antagonists|mesh-ancestor
25852077|NCT00055640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25207748|NCT03435952|Doxycycline|doxycycline|mesh-list
25070357|NCT03420313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25070358|NCT03420313|Narcotics|narcotics|mesh-ancestor
25070359|NCT03420313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24832956|NCT02172456|Autonomic Agents|autonomic agents|mesh-ancestor
24483387|NCT00443170|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24697811|NCT01437371|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24697812|NCT01437371|Protective Agents|protective agents|mesh-ancestor
24697813|NCT01437371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697814|NCT01437462|Propofol|propofol|mesh-list
24697815|NCT01437462|Sevoflurane|sevoflurane|mesh-list
24697816|NCT01437462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24697817|NCT01437462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24697818|NCT01437462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697819|NCT01437462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25070360|NCT03420313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070361|NCT03420313|Analgesics|analgesics|mesh-ancestor
25070362|NCT03420313|Sensory System Agents|sensory system agents|mesh-ancestor
24697850|NCT01437644|Botulinum Toxins|botulinum toxins|mesh-list
24697851|NCT01437644|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24697852|NCT01437644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24697853|NCT01437644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697866|NCT01437696|Ergocalciferols|ergocalciferols|mesh-list
24697867|NCT01437696|Cholecalciferol|cholecalciferol|mesh-list
24697868|NCT01437696|Vitamins|vitamins|mesh-list
24697869|NCT01437696|Micronutrients|micronutrients|mesh-ancestor
24697870|NCT01437696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697871|NCT01437696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24697872|NCT01437696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24832965|NCT02172456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832967|NCT02172469|Tiotropium Bromide|tiotropium bromide|mesh-list
24832968|NCT02172469|Ipratropium|ipratropium|mesh-list
24832969|NCT02172469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24832970|NCT02172469|Autonomic Agents|autonomic agents|mesh-ancestor
24832971|NCT02172469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24832972|NCT02172469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697890|NCT01437748|Parasympatholytics|parasympatholytics|mesh-ancestor
24697891|NCT01437748|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24697893|NCT01437748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24697894|NCT01437748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697895|NCT01437748|Anticonvulsants|anticonvulsants|mesh-ancestor
24697896|NCT01437800|Metformin|metformin|mesh-list
24697897|NCT01437800|Glimepiride|glimepiride|mesh-list
24697898|NCT01437800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24697899|NCT01437800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697900|NCT01437800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24697901|NCT01437800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24697902|NCT01437800|Immunologic Factors|immunologic factors|mesh-ancestor
24697903|NCT01437813|Metformin|metformin|mesh-list
24697915|NCT01437826|Trace Elements|trace elements|mesh-ancestor
24697916|NCT01437826|Micronutrients|micronutrients|mesh-ancestor
25663630|NCT01660906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25663631|NCT01660906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24697917|NCT01437839|Apixaban|apixaban|mesh-list
25663632|NCT01660906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697918|NCT01437839|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24697919|NCT01437839|Antithrombins|antithrombins|mesh-ancestor
24697920|NCT01437839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24697921|NCT01437839|Protease Inhibitors|protease inhibitors|mesh-ancestor
24697929|NCT01437982|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24697930|NCT01437982|Prednisolone acetate|prednisolone acetate|mesh-list
24697931|NCT01437982|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24697932|NCT01437982|Prednisolone phosphate|prednisolone phosphate|mesh-list
24697933|NCT01437982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24697958|NCT01438021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24697973|NCT01438112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697974|NCT01438112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698020|NCT01438515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25070376|NCT03419949|Analgesics|analgesics|mesh-ancestor
25070377|NCT03419949|Sensory System Agents|sensory system agents|mesh-ancestor
25070378|NCT03419949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25070379|NCT03419949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070380|NCT03419949|Anticonvulsants|anticonvulsants|mesh-ancestor
25070381|NCT03419949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25070382|NCT03419949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25852078|NCT00055640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25070383|NCT03419949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070384|NCT03419949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25070385|NCT03419949|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24832982|NCT02172482|Tiotropium Bromide|tiotropium bromide|mesh-list
24423909|NCT00227409|Calcium|calcium|mesh-list
24698042|NCT01438567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24698043|NCT01438567|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24698044|NCT01438580|Aspirin|aspirin|mesh-list
24698045|NCT01438580|Warfarin|warfarin|mesh-list
24698046|NCT01438580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24698047|NCT01438580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24698048|NCT01438580|Analgesics|analgesics|mesh-ancestor
24698049|NCT01438580|Sensory System Agents|sensory system agents|mesh-ancestor
24698050|NCT01438580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25070387|NCT03419949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24698058|NCT01438580|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24545939|NCT00696033|Diazepam|diazepam|mesh-list
25852079|NCT00055640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24698088|NCT01438749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24698089|NCT01438749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24698090|NCT01438749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24698091|NCT01438749|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24698092|NCT01438749|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24698093|NCT01438749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24698094|NCT01438749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24698114|NCT01438944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24698115|NCT01438944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24698116|NCT01438944|Cholinergic Agents|cholinergic agents|mesh-ancestor
25070390|NCT03419949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25070391|NCT03419923|Citric Acid|citric acid|mesh-list
25070392|NCT03419923|Sodium Citrate|sodium citrate|mesh-list
25070393|NCT03419923|Anticoagulants|anticoagulants|mesh-ancestor
25070394|NCT03419923|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25070395|NCT03419923|Chelating Agents|chelating agents|mesh-ancestor
25070396|NCT03419923|Sequestering Agents|sequestering agents|mesh-ancestor
25070397|NCT03419923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070398|NCT03419910|Cyclosporine|cyclosporine|mesh-list
25070399|NCT03419910|BMS-986165|bms-986165|mesh-list
25070400|NCT03419910|Cyclosporins|cyclosporins|mesh-list
24698140|NCT01439178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24698141|NCT01439178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698142|NCT01439178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25852080|NCT00055640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24698143|NCT01439178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24698144|NCT01439178|Growth Substances|growth substances|mesh-ancestor
24698145|NCT01439178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698146|NCT01439178|Growth Inhibitors|growth inhibitors|mesh-ancestor
24698147|NCT01439191|Vinorelbine|vinorelbine|mesh-list
24698148|NCT01439191|Antibodies|antibodies|mesh-list
24698149|NCT01439191|Immunologic Factors|immunologic factors|mesh-ancestor
24698163|NCT01439230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070402|NCT03419910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070403|NCT03419910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25070404|NCT03419910|Immunologic Factors|immunologic factors|mesh-ancestor
24698232|NCT01440062|Ergocalciferols|ergocalciferols|mesh-list
24698233|NCT01440062|Cholecalciferol|cholecalciferol|mesh-list
24698234|NCT01440062|Vitamins|vitamins|mesh-list
24698235|NCT01440062|Micronutrients|micronutrients|mesh-ancestor
24698236|NCT01440062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698237|NCT01440062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24698267|NCT01440270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612804|NCT01015456|Alkylating Agents|alkylating agents|mesh-ancestor
24612805|NCT01015456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612806|NCT01015456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612807|NCT01015456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24612808|NCT01015456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25070408|NCT03419910|Dermatologic Agents|dermatologic agents|mesh-ancestor
25070409|NCT03419910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25070410|NCT03419910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25070411|NCT03419910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25852081|NCT00055640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698274|NCT01440335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24698275|NCT01440335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698276|NCT01440335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24698277|NCT01440335|Respiratory System Agents|respiratory system agents|mesh-ancestor
24698278|NCT01440335|Sympathomimetics|sympathomimetics|mesh-ancestor
24698279|NCT01440335|Tocolytic Agents|tocolytic agents|mesh-ancestor
24698280|NCT01440335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24698281|NCT01440335|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24698282|NCT01440335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24698283|NCT01440335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24698284|NCT01440335|Adrenergic Agents|adrenergic agents|mesh-ancestor
24698285|NCT01440335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24698286|NCT01440335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852082|NCT00055640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25852083|NCT00055640|Glucocorticoids|glucocorticoids|mesh-ancestor
25852084|NCT00055640|Hormones|hormones|mesh-ancestor
25852085|NCT00055640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25852086|NCT00055640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25852087|NCT00055640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24698292|NCT01440400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24698293|NCT01440400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698294|NCT01440439|Insulin|insulin|mesh-list
24698295|NCT01440439|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24698296|NCT01440439|Insulin Glargine|insulin glargine|mesh-list
24698297|NCT01440439|Insulin Detemir|insulin detemir|mesh-list
24698298|NCT01440439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24698299|NCT01440439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698300|NCT01440582|Dexamethasone|dexamethasone|mesh-list
24698341|NCT01440621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25070413|NCT03419858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25070414|NCT03419858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070415|NCT03419858|Sensory System Agents|sensory system agents|mesh-ancestor
25207749|NCT03435952|Pembrolizumab|pembrolizumab|mesh-list
25070416|NCT03419858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24626427|NCT01087398|Fludarabine|fludarabine|mesh-list
24626428|NCT01087398|Cyclosporins|cyclosporins|mesh-list
25070417|NCT03419806|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25070418|NCT03419806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25070419|NCT03419806|Immunologic Factors|immunologic factors|mesh-ancestor
25070420|NCT03419806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070421|NCT03419806|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25070422|NCT03419806|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25070423|NCT03419806|Dopamine Agonists|dopamine agonists|mesh-ancestor
25070424|NCT03419806|Dopamine Agents|dopamine agents|mesh-ancestor
25070425|NCT03419806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25070426|NCT03419806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070430|NCT03419767|Protective Agents|protective agents|mesh-ancestor
25070431|NCT03419767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070432|NCT03419767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25070433|NCT03419715|Bimatoprost|bimatoprost|mesh-list
24483889|NCT00445796|Artesunate|artesunate|mesh-list
24698342|NCT01440621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698353|NCT01440673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24698354|NCT01440673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698381|NCT01440842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24698382|NCT01440842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698384|NCT01440933|Analgesics|analgesics|mesh-ancestor
25070434|NCT03419715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25070435|NCT03419650|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25070436|NCT03419650|Hormones|hormones|mesh-ancestor
25070437|NCT03419650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25070438|NCT03419650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070439|NCT03419624|Metformin|metformin|mesh-list
25070440|NCT03419624|Dapagliflozin|dapagliflozin|mesh-list
25070441|NCT03419624|Exenatide|exenatide|mesh-list
25070442|NCT03419624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25070443|NCT03419624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070444|NCT03419624|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25070445|NCT03419624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070446|NCT03419624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25070447|NCT03419624|Incretins|incretins|mesh-ancestor
25070448|NCT03419624|Hormones|hormones|mesh-ancestor
24833039|NCT02172534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24833040|NCT02172534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833041|NCT02172534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24833042|NCT02172534|Respiratory System Agents|respiratory system agents|mesh-ancestor
24833043|NCT02172534|Parasympatholytics|parasympatholytics|mesh-ancestor
24698385|NCT01440933|Sensory System Agents|sensory system agents|mesh-ancestor
24698386|NCT01440933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24698387|NCT01440933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698388|NCT01440933|Anesthetics|anesthetics|mesh-ancestor
24698389|NCT01440933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24698390|NCT01440933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24698391|NCT01440933|Anticonvulsants|anticonvulsants|mesh-ancestor
24698392|NCT01440933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24698393|NCT01440933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24698394|NCT01440933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698395|NCT01440933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24698396|NCT01440933|Tocolytic Agents|tocolytic agents|mesh-ancestor
24698397|NCT01440933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24698436|NCT01441206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698437|NCT01441206|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24698438|NCT01441206|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24546073|NCT00696579|Immunologic Factors|immunologic factors|mesh-ancestor
24698475|NCT01441388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24698476|NCT01441388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698477|NCT01441388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24698478|NCT01441388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24698479|NCT01441388|Growth Substances|growth substances|mesh-ancestor
25070474|NCT03419429|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25070475|NCT03419429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698613|NCT01442311|Interferons|interferons|mesh-list
24698615|NCT01442311|Interferon-alpha|interferon-alpha|mesh-list
24698616|NCT01442311|Interferon alpha-2|interferon alpha-2|mesh-list
24698617|NCT01442311|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24698618|NCT01442311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698619|NCT01442311|Antiviral Agents|antiviral agents|mesh-ancestor
24698620|NCT01442311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24698621|NCT01442311|Antimetabolites|antimetabolites|mesh-ancestor
24698622|NCT01442311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698623|NCT01442311|Immunologic Factors|immunologic factors|mesh-ancestor
24698624|NCT01442311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698625|NCT01442428|Dexamethasone|dexamethasone|mesh-list
24698626|NCT01442428|Naproxen|naproxen|mesh-list
24698627|NCT01442428|Atorvastatin|atorvastatin|mesh-list
24698628|NCT01442428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24698629|NCT01442428|Antiemetics|antiemetics|mesh-ancestor
25070488|NCT03419130|Pembrolizumab|pembrolizumab|mesh-list
25070489|NCT03419130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24448773|NCT00313105|Autonomic Agents|autonomic agents|mesh-ancestor
24448774|NCT00313105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24448775|NCT00313105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852088|NCT00055640|Tubulin Modulators|tubulin modulators|mesh-ancestor
25852089|NCT00055640|Antimitotic Agents|antimitotic agents|mesh-ancestor
25852090|NCT00055640|Mitosis Modulators|mitosis modulators|mesh-ancestor
25852091|NCT00055653|Cyclosporine|cyclosporine|mesh-list
25852092|NCT00055653|Methylprednisolone|methylprednisolone|mesh-list
25852093|NCT00055653|Cyclophosphamide|cyclophosphamide|mesh-list
25852094|NCT00055653|Melphalan|melphalan|mesh-list
25852095|NCT00055653|Busulfan|busulfan|mesh-list
25663633|NCT01661088|Folfirinox|folfirinox|mesh-list
25663634|NCT01661088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663635|NCT01661114|Gemcitabine|gemcitabine|mesh-list
24448781|NCT00313105|Respiratory System Agents|respiratory system agents|mesh-ancestor
24626555|NCT01087840|Tenofovir|tenofovir|mesh-list
25070490|NCT03419130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25070491|NCT03418974|Atorvastatin|atorvastatin|mesh-list
25070492|NCT03418974|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25070493|NCT03418974|Pitavastatin|pitavastatin|mesh-list
25070494|NCT03418974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25070495|NCT03418974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25070496|NCT03418974|Antimetabolites|antimetabolites|mesh-ancestor
25070497|NCT03418974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070498|NCT03418974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25070499|NCT03418974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25070500|NCT03418974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25070501|NCT03418935|Niacinamide|niacinamide|mesh-list
25070503|NCT03418935|Nicotinic Acids|nicotinic acids|mesh-list
25070504|NCT03418935|Vitamin B Complex|vitamin b complex|mesh-ancestor
25070505|NCT03418935|Vitamins|vitamins|mesh-ancestor
25070506|NCT03418935|Micronutrients|micronutrients|mesh-ancestor
25070507|NCT03418935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070508|NCT03418935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25070509|NCT03418935|Antimetabolites|antimetabolites|mesh-ancestor
25070510|NCT03418935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070511|NCT03418935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25070512|NCT03418935|Vasodilator Agents|vasodilator agents|mesh-ancestor
25070513|NCT03418896|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25070514|NCT03418896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25070515|NCT03418896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698678|NCT01442532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24698679|NCT01442532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698680|NCT01442558|Bupivacaine|bupivacaine|mesh-list
24698681|NCT01442558|Anesthetics, Local|anesthetics, local|mesh-ancestor
24698682|NCT01442558|Anesthetics|anesthetics|mesh-ancestor
24698683|NCT01442558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24698684|NCT01442558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698685|NCT01442558|Sensory System Agents|sensory system agents|mesh-ancestor
24612859|NCT01015547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24612860|NCT01015547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25202534|NCT02720770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25202535|NCT02720770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202536|NCT02720926|Capecitabine|capecitabine|mesh-list
25202537|NCT02720926|Oxaliplatin|oxaliplatin|mesh-list
25202538|NCT02720926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25202539|NCT02720926|Antimetabolites|antimetabolites|mesh-ancestor
25202540|NCT02720926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202541|NCT02720926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25202542|NCT02720965|Anesthetics|anesthetics|mesh-list
25202543|NCT02720965|Anesthetics, Local|anesthetics, local|mesh-list
25202544|NCT02720965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25202545|NCT02720965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202546|NCT02720965|Sensory System Agents|sensory system agents|mesh-ancestor
25202547|NCT02720965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202548|NCT02720783|Econazole|econazole|mesh-list
25202549|NCT02720783|Benzydamine|benzydamine|mesh-list
25202550|NCT02720783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25852096|NCT00055653|Fludarabine|fludarabine|mesh-list
24698854|NCT01443169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24698855|NCT01443169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24698856|NCT01443169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698857|NCT01443169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24698858|NCT01443169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24698859|NCT01443169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25070547|NCT03418506|Autonomic Agents|autonomic agents|mesh-ancestor
25070548|NCT03418506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25070549|NCT03418506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070550|NCT03418506|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25070551|NCT03418506|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25070552|NCT03418506|Cholinergic Agents|cholinergic agents|mesh-ancestor
25070553|NCT03418506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24824295|NCT02122692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25070565|NCT03418246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070567|NCT03418090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25663636|NCT01661114|Cisplatin|cisplatin|mesh-list
24833144|NCT02172807|Tiotropium Bromide|tiotropium bromide|mesh-list
24698860|NCT01443169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24698861|NCT01443169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24698863|NCT01443195|Trace Elements|trace elements|mesh-ancestor
24698864|NCT01443195|Micronutrients|micronutrients|mesh-ancestor
24698865|NCT01443195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698866|NCT01443208|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24698867|NCT01443208|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24698868|NCT01443208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24698869|NCT01443208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24698870|NCT01443208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852097|NCT00055653|Fludarabine phosphate|fludarabine phosphate|mesh-list
24698871|NCT01443208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24699119|NCT01444976|Anesthetics, General|anesthetics, general|mesh-ancestor
24698874|NCT01443208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24698875|NCT01443221|Metformin|metformin|mesh-list
24698876|NCT01443221|Mitiglinide|mitiglinide|mesh-list
24698877|NCT01443221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24698878|NCT01443221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698879|NCT01443247|gamma-Globulins|gamma-globulins|mesh-list
24698880|NCT01443247|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24698895|NCT01443325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698896|NCT01443338|Acitretin|acitretin|mesh-list
24698897|NCT01443338|Keratolytic Agents|keratolytic agents|mesh-ancestor
24698898|NCT01443338|Dermatologic Agents|dermatologic agents|mesh-ancestor
24698899|NCT01443377|Panitumumab|panitumumab|mesh-list
24698900|NCT01443377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25070568|NCT03418090|Anesthetics, General|anesthetics, general|mesh-ancestor
25070569|NCT03418090|Anesthetics|anesthetics|mesh-ancestor
25070570|NCT03418090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25070571|NCT03418090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070572|NCT03417947|Vitamin D|vitamin d|mesh-list
25070573|NCT03417947|Cholecalciferol|cholecalciferol|mesh-list
25070574|NCT03417947|Vitamins|vitamins|mesh-ancestor
25070575|NCT03417947|Micronutrients|micronutrients|mesh-ancestor
25070576|NCT03417947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070577|NCT03417947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25070578|NCT03417947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25070579|NCT03417921|Gemcitabine|gemcitabine|mesh-list
25070580|NCT03417921|Paclitaxel|paclitaxel|mesh-list
25070581|NCT03417921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25070582|NCT03417921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25070583|NCT03417921|Tubulin Modulators|tubulin modulators|mesh-ancestor
25070584|NCT03417921|Antimitotic Agents|antimitotic agents|mesh-ancestor
24833167|NCT02172976|Oxaliplatin|oxaliplatin|mesh-list
24698901|NCT01443377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698902|NCT01443416|Vaccines|vaccines|mesh-list
24698903|NCT01443416|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24698904|NCT01443416|Immunologic Factors|immunologic factors|mesh-ancestor
24698905|NCT01443416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698906|NCT01443429|Beraprost|beraprost|mesh-list
24698907|NCT01443429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24698908|NCT01443429|Vasodilator Agents|vasodilator agents|mesh-ancestor
24698909|NCT01443520|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24953701|NCT03882541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953702|NCT03882541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24953703|NCT03882541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24953704|NCT03882541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24953705|NCT03882541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24953706|NCT03882541|Anesthetics, General|anesthetics, general|mesh-ancestor
24953707|NCT03882541|Anesthetics|anesthetics|mesh-ancestor
24953708|NCT03882541|GABA Modulators|gaba modulators|mesh-ancestor
24953709|NCT03882541|GABA Agents|gaba agents|mesh-ancestor
24833201|NCT02173106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24698910|NCT01443520|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24698911|NCT01443520|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24698936|NCT01443676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698937|NCT01443676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24698938|NCT01443676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24698939|NCT01443676|Growth Substances|growth substances|mesh-ancestor
24698940|NCT01443676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698941|NCT01443676|Growth Inhibitors|growth inhibitors|mesh-ancestor
24698943|NCT01443741|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24698944|NCT01443741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24698945|NCT01443741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698947|NCT01443780|Antioxidants|antioxidants|mesh-ancestor
24698948|NCT01443780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698949|NCT01443780|Protective Agents|protective agents|mesh-ancestor
24698950|NCT01443780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698951|NCT01443780|Trace Elements|trace elements|mesh-ancestor
24698952|NCT01443780|Micronutrients|micronutrients|mesh-ancestor
24698953|NCT01443806|Oseltamivir|oseltamivir|mesh-list
24612897|NCT01015729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612898|NCT01015729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24612899|NCT01015729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24612900|NCT01015729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24612901|NCT01015729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25852098|NCT00055653|Cyclosporins|cyclosporins|mesh-list
24612902|NCT01015729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612903|NCT01015729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24612904|NCT01015729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24953712|NCT03882580|Antineoplastic Agents|antineoplastic agents|mesh-list
24953713|NCT03882099|Vitamin D|vitamin d|mesh-list
24953714|NCT03882099|Vitamins|vitamins|mesh-ancestor
24953715|NCT03882099|Micronutrients|micronutrients|mesh-ancestor
24833211|NCT02173145|Azithromycin|azithromycin|mesh-list
24612930|NCT01015937|Angiotensinogen|angiotensinogen|mesh-list
24612931|NCT01015937|Turmeric extract|turmeric extract|mesh-list
25852099|NCT00055653|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25202551|NCT02720783|Antifungal Agents|antifungal agents|mesh-ancestor
25030169|NCT03597945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030170|NCT03597945|Sensory System Agents|sensory system agents|mesh-ancestor
25030171|NCT03597945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25030172|NCT03597945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25030173|NCT03597945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25030174|NCT03597945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25113285|NCT03112590|Paclitaxel|paclitaxel|mesh-list
24612932|NCT01015937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24612933|NCT01015937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24612934|NCT01015937|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24612935|NCT01015937|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24612936|NCT01015937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612937|NCT01015937|Protease Inhibitors|protease inhibitors|mesh-ancestor
24612938|NCT01015937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612939|NCT01015937|Antioxidants|antioxidants|mesh-ancestor
24612940|NCT01015937|Protective Agents|protective agents|mesh-ancestor
24612941|NCT01015937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612942|NCT01015937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24643669|NCT01186549|Sympathomimetics|sympathomimetics|mesh-ancestor
24612943|NCT01015937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24612945|NCT01016002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612946|NCT01016002|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24612947|NCT01016002|Dermatologic Agents|dermatologic agents|mesh-ancestor
24612948|NCT01016041|Paclitaxel|paclitaxel|mesh-list
24612949|NCT01016041|Everolimus|everolimus|mesh-list
24612950|NCT01016041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24699020|NCT01444352|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24699021|NCT01444352|Immunologic Factors|immunologic factors|mesh-ancestor
24953716|NCT03882099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699026|NCT01444521|Irinotecan|irinotecan|mesh-list
24699027|NCT01444521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24699028|NCT01444521|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24699029|NCT01444521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24699030|NCT01444521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699031|NCT01444521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699032|NCT01444547|Paclitaxel|paclitaxel|mesh-list
24699068|NCT01444677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24699069|NCT01444677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699070|NCT01444677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699071|NCT01444677|Antiviral Agents|antiviral agents|mesh-ancestor
24699072|NCT01444703|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24699073|NCT01444807|Sorafenib|sorafenib|mesh-list
24699116|NCT01444976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24699117|NCT01444976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24699118|NCT01444976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24699120|NCT01444976|GABA Modulators|gaba modulators|mesh-ancestor
24699121|NCT01444976|GABA Agents|gaba agents|mesh-ancestor
24699122|NCT01444976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24699123|NCT01444976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699124|NCT01445106|Nelfinavir|nelfinavir|mesh-list
24699126|NCT01445106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24699127|NCT01445106|Protease Inhibitors|protease inhibitors|mesh-ancestor
25202552|NCT02720783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25202553|NCT02720783|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25202554|NCT02720783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25202555|NCT02720783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202556|NCT02720783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202557|NCT02720783|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25202558|NCT02720783|Hormone Antagonists|hormone antagonists|mesh-ancestor
24699128|NCT01445106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25207750|NCT03435952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24699129|NCT01445106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699173|NCT01445236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699174|NCT01445236|Antifungal Agents|antifungal agents|mesh-ancestor
24699175|NCT01445236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24699176|NCT01445236|Dermatologic Agents|dermatologic agents|mesh-ancestor
24699177|NCT01445236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24699179|NCT01445262|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24699180|NCT01445262|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24953733|NCT03882255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24953734|NCT03882255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953735|NCT03882255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833214|NCT02173262|Ciprofloxacin|ciprofloxacin|mesh-list
24833215|NCT02173262|Lenograstim|lenograstim|mesh-list
24833216|NCT02173262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24699193|NCT01445379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699194|NCT01445392|Pemetrexed|pemetrexed|mesh-list
24699195|NCT01445392|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24699204|NCT01445405|Bortezomib|bortezomib|mesh-list
24699205|NCT01445405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24699220|NCT01445522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699222|NCT01445522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24699223|NCT01445522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24699224|NCT01445522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699225|NCT01445561|Interleukin-2|interleukin-2|mesh-list
24699226|NCT01445561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24699227|NCT01445561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24953743|NCT03882008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25070595|NCT03417700|Vitamin D|vitamin d|mesh-list
25070596|NCT03417700|Vitamins|vitamins|mesh-ancestor
25070597|NCT03417700|Micronutrients|micronutrients|mesh-ancestor
25070598|NCT03417700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070599|NCT03417700|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25070600|NCT03417648|Vitamin E|vitamin e|mesh-list
25070601|NCT03417648|Vitamins|vitamins|mesh-ancestor
25070602|NCT03417648|Micronutrients|micronutrients|mesh-ancestor
25070603|NCT03417648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070604|NCT03417648|Antioxidants|antioxidants|mesh-ancestor
25070605|NCT03417648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070606|NCT03417648|Protective Agents|protective agents|mesh-ancestor
25070607|NCT03417518|Propofol|propofol|mesh-list
25070608|NCT03417518|Desflurane|desflurane|mesh-list
25070609|NCT03417518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25070610|NCT03417518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25070611|NCT03417518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070612|NCT03417518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25070613|NCT03417518|Anesthetics, General|anesthetics, general|mesh-ancestor
25070614|NCT03417518|Anesthetics|anesthetics|mesh-ancestor
25070615|NCT03417518|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25070616|NCT03417453|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25070617|NCT03417453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25070618|NCT03417427|Cytarabine|cytarabine|mesh-list
24699239|NCT01445639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24699240|NCT01445639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070619|NCT03417427|Decitabine|decitabine|mesh-list
25070620|NCT03417427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25070621|NCT03417427|Antimetabolites|antimetabolites|mesh-ancestor
25070622|NCT03417427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699241|NCT01445639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24699242|NCT01445639|Analgesics|analgesics|mesh-ancestor
24699246|NCT01445639|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24699247|NCT01445639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24699282|NCT01445964|Atenolol|atenolol|mesh-list
24699283|NCT01445964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24699284|NCT01445964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24699285|NCT01445964|Sympatholytics|sympatholytics|mesh-ancestor
24699286|NCT01445964|Autonomic Agents|autonomic agents|mesh-ancestor
24699287|NCT01445964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24699288|NCT01445964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699289|NCT01445964|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24699290|NCT01445964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24699291|NCT01445964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24699292|NCT01445964|Adrenergic Agents|adrenergic agents|mesh-ancestor
24699293|NCT01445964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24699294|NCT01445964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699295|NCT01446094|Regadenoson|regadenoson|mesh-list
24699296|NCT01446094|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
24699297|NCT01446094|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24699298|NCT01446094|Purinergic Agonists|purinergic agonists|mesh-ancestor
24699299|NCT01446094|Purinergic Agents|purinergic agents|mesh-ancestor
24699300|NCT01446094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24699301|NCT01446094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699302|NCT01446094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699303|NCT01446107|Fluorides|fluorides|mesh-list
24699304|NCT01446107|Fluorides, Topical|fluorides, topical|mesh-list
24699319|NCT01446211|Glucocorticoids|glucocorticoids|mesh-list
24699320|NCT01446211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24699321|NCT01446211|Immunologic Factors|immunologic factors|mesh-ancestor
24699322|NCT01446211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699323|NCT01446211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24699324|NCT01446211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24699325|NCT01446211|Alkylating Agents|alkylating agents|mesh-ancestor
24699326|NCT01446211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699327|NCT01446211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24699328|NCT01446211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24699329|NCT01446211|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24699330|NCT01446211|Abortifacient Agents|abortifacient agents|mesh-ancestor
24699331|NCT01446211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24699332|NCT01446211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25070624|NCT03417427|Antiviral Agents|antiviral agents|mesh-ancestor
25070625|NCT03417427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25070626|NCT03417427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25070627|NCT03417427|Immunologic Factors|immunologic factors|mesh-ancestor
25070628|NCT03417427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070629|NCT03417427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699362|NCT01446328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24699363|NCT01446328|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24699364|NCT01446328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24699703|NCT01448642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24699366|NCT01446328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699367|NCT01446328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24699368|NCT01446328|Serotonin Agents|serotonin agents|mesh-ancestor
24699369|NCT01446328|Antidepressive Agents|antidepressive agents|mesh-ancestor
24699370|NCT01446328|Dopamine Agonists|dopamine agonists|mesh-ancestor
24699371|NCT01446328|Dopamine Agents|dopamine agents|mesh-ancestor
24699372|NCT01446328|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24699373|NCT01446328|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24699374|NCT01446328|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24699375|NCT01446328|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24699376|NCT01446328|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24699377|NCT01446328|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24699378|NCT01446328|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24699379|NCT01446445|Valganciclovir|valganciclovir|mesh-list
24699380|NCT01446445|Ganciclovir|ganciclovir|mesh-list
24699381|NCT01446445|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
24699383|NCT01446445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24699416|NCT01446497|Adrenergic Agents|adrenergic agents|mesh-ancestor
24699417|NCT01446497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24699418|NCT01446497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699419|NCT01446497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699420|NCT01446497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24699421|NCT01446497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24699422|NCT01446497|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24699423|NCT01446497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25207751|NCT03435952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24829805|NCT02154594|Dermatologic Agents|dermatologic agents|mesh-ancestor
25070635|NCT03417388|Losartan|losartan|mesh-list
25070636|NCT03417388|Lisinopril|lisinopril|mesh-list
25070637|NCT03417388|Atorvastatin|atorvastatin|mesh-list
25070638|NCT03417388|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25070639|NCT03417388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25070640|NCT03417388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25070641|NCT03417388|Analgesics|analgesics|mesh-ancestor
25070642|NCT03417388|Sensory System Agents|sensory system agents|mesh-ancestor
25070643|NCT03417388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25070644|NCT03417388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070645|NCT03417388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25070646|NCT03417388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25070647|NCT03417388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25070648|NCT03417388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25070649|NCT03417388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070650|NCT03417388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25070651|NCT03417388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25070652|NCT03417388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25070653|NCT03417388|Antipyretics|antipyretics|mesh-ancestor
25070654|NCT03417388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25070655|NCT03417388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25070656|NCT03417388|Antimetabolites|antimetabolites|mesh-ancestor
24699424|NCT01446497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24699425|NCT01446523|Lactulose|lactulose|mesh-list
24699426|NCT01446523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24699427|NCT01446562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24699428|NCT01446562|Immunologic Factors|immunologic factors|mesh-ancestor
24699429|NCT01446562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699430|NCT01446679|Atorvastatin|atorvastatin|mesh-list
24699431|NCT01446679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24699432|NCT01446679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24699433|NCT01446679|Antimetabolites|antimetabolites|mesh-ancestor
24699435|NCT01446679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24699458|NCT01446926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699460|NCT01446952|Tocopherols|tocopherols|mesh-list
24699461|NCT01446952|Tocotrienols|tocotrienols|mesh-list
24699462|NCT01446952|Vitamins|vitamins|mesh-ancestor
25070682|NCT03417206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070683|NCT03417206|Analgesics|analgesics|mesh-ancestor
25070684|NCT03417206|Sensory System Agents|sensory system agents|mesh-ancestor
25070685|NCT03417206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25070686|NCT03417076|Bexagliflozin|bexagliflozin|mesh-list
25070687|NCT03417076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25070688|NCT03417076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070689|NCT03417037|Nivolumab|nivolumab|mesh-list
25070690|NCT03417037|Linrodostat|linrodostat|mesh-list
25070691|NCT03417037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25070692|NCT03417037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25070693|NCT03417037|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24699537|NCT01447394|Immunologic Factors|immunologic factors|mesh-ancestor
24699538|NCT01447394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699539|NCT01447485|Valsartan|valsartan|mesh-list
24699540|NCT01447485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24699544|NCT01447550|Bosentan|bosentan|mesh-list
24699551|NCT01447563|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24699552|NCT01447563|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24612986|NCT01016184|Vitamin D|vitamin d|mesh-list
24699553|NCT01447563|Purinergic Agents|purinergic agents|mesh-ancestor
24699554|NCT01447563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24626576|NCT01087879|NuvaRing|nuvaring|mesh-list
25070699|NCT03416777|alpha-Tocopherol|alpha-tocopherol|mesh-list
25070700|NCT03416777|Antioxidants|antioxidants|mesh-ancestor
25070701|NCT03416777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070702|NCT03416777|Protective Agents|protective agents|mesh-ancestor
25070703|NCT03416777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070704|NCT03416777|Vitamins|vitamins|mesh-ancestor
25070705|NCT03416777|Micronutrients|micronutrients|mesh-ancestor
25070706|NCT03416569|Prazosin|prazosin|mesh-list
25070707|NCT03416569|Nicotine|nicotine|mesh-list
25070708|NCT03416569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25070709|NCT03416569|Autonomic Agents|autonomic agents|mesh-ancestor
24699555|NCT01447563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699556|NCT01447563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699558|NCT01447589|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24699559|NCT01447589|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25207752|NCT03435952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24699560|NCT01447589|Protease Inhibitors|protease inhibitors|mesh-ancestor
24699561|NCT01447589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699562|NCT01447589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699600|NCT01448018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24699602|NCT01448018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699603|NCT01448018|Growth Inhibitors|growth inhibitors|mesh-ancestor
24425825|NCT00234429|Gefitinib|gefitinib|mesh-list
24699622|NCT01448109|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24699623|NCT01448109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24699624|NCT01448174|Atorvastatin|atorvastatin|mesh-list
24699625|NCT01448174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24699626|NCT01448174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24699627|NCT01448174|Antimetabolites|antimetabolites|mesh-ancestor
24699631|NCT01448174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699644|NCT01448291|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24699645|NCT01448291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24699646|NCT01448291|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24699647|NCT01448291|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24699648|NCT01448291|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24699649|NCT01448317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24699650|NCT01448317|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24699651|NCT01448317|Immunologic Factors|immunologic factors|mesh-ancestor
24699652|NCT01448317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699654|NCT01448330|Clopidogrel|clopidogrel|mesh-list
24699655|NCT01448330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24699656|NCT01448330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24699657|NCT01448330|Analgesics|analgesics|mesh-ancestor
24699658|NCT01448330|Sensory System Agents|sensory system agents|mesh-ancestor
24699659|NCT01448330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24699660|NCT01448330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699661|NCT01448330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24699662|NCT01448330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25070710|NCT03416569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25070711|NCT03416569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070712|NCT03416569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25070713|NCT03416569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25070714|NCT03416569|Cholinergic Agents|cholinergic agents|mesh-ancestor
25070715|NCT03416569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25070716|NCT03416569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070717|NCT03416569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25070718|NCT03416569|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25070719|NCT03416569|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25070720|NCT03416569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25070721|NCT03416569|Adrenergic Agents|adrenergic agents|mesh-ancestor
25070722|NCT03416517|Irinotecan|irinotecan|mesh-list
24699701|NCT01448642|Atorvastatin|atorvastatin|mesh-list
24699702|NCT01448642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24699704|NCT01448642|Antimetabolites|antimetabolites|mesh-ancestor
24699705|NCT01448642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699706|NCT01448642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24699707|NCT01448642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24699708|NCT01448642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699732|NCT01448733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699733|NCT01448733|Dermatologic Agents|dermatologic agents|mesh-ancestor
24699734|NCT01448733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24699735|NCT01448733|Keratolytic Agents|keratolytic agents|mesh-ancestor
24699736|NCT01448746|Heparin|heparin|mesh-list
24699737|NCT01448746|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24699738|NCT01448746|Tinzaparin|tinzaparin|mesh-list
24699739|NCT01448746|Dalteparin|dalteparin|mesh-list
24699740|NCT01448746|Anticoagulants|anticoagulants|mesh-ancestor
24612987|NCT01016184|Vitamins|vitamins|mesh-ancestor
24612988|NCT01016184|Micronutrients|micronutrients|mesh-ancestor
24612989|NCT01016184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612990|NCT01016184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24612992|NCT01016223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24612993|NCT01016223|Glucocorticoids|glucocorticoids|mesh-ancestor
24612994|NCT01016223|Hormones|hormones|mesh-ancestor
24612995|NCT01016223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24612996|NCT01016223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070724|NCT03416517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25070725|NCT03416517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699816|NCT01449188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24699819|NCT01449188|Dermatologic Agents|dermatologic agents|mesh-ancestor
24699820|NCT01449188|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24699821|NCT01449188|Serotonin Agents|serotonin agents|mesh-ancestor
24699822|NCT01449188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24699823|NCT01449188|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24699824|NCT01449188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24699825|NCT01449188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24699826|NCT01449188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24699827|NCT01449188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24699829|NCT01449253|Sildenafil Citrate|sildenafil citrate|mesh-list
24699986|NCT01450046|Micronutrients|micronutrients|mesh-ancestor
24699987|NCT01450046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699989|NCT01450046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699990|NCT01450046|Protective Agents|protective agents|mesh-ancestor
24699991|NCT01450111|Lacosamide|lacosamide|mesh-list
24699992|NCT01450111|Anticonvulsants|anticonvulsants|mesh-ancestor
24699993|NCT01450111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24699994|NCT01450111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24699995|NCT01450111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24699996|NCT01450111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699997|NCT01450124|Boswellic acid|boswellic acid|mesh-list
24699998|NCT01450124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24699999|NCT01450124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24700000|NCT01450124|Analgesics|analgesics|mesh-ancestor
24700005|NCT01450124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24700034|NCT01450176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24700035|NCT01450176|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24700036|NCT01450176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24700037|NCT01450176|Histamine Antagonists|histamine antagonists|mesh-ancestor
24700038|NCT01450176|Histamine Agents|histamine agents|mesh-ancestor
24700039|NCT01450176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24700040|NCT01450176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700041|NCT01450215|Lenalidomide|lenalidomide|mesh-list
24700063|NCT01450345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24700064|NCT01450345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24700065|NCT01450345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24700066|NCT01450358|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24700067|NCT01450358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24700069|NCT01450384|Sorafenib|sorafenib|mesh-list
24700070|NCT01450384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24700071|NCT01450384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700072|NCT01450384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700073|NCT01450384|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24700074|NCT01450384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24700075|NCT01450384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24700076|NCT01450410|Nicotinic Acids|nicotinic acids|mesh-list
24700078|NCT01450410|Niacinamide|niacinamide|mesh-list
24700079|NCT01450410|Vitamin B Complex|vitamin b complex|mesh-ancestor
24700080|NCT01450410|Vitamins|vitamins|mesh-ancestor
24700081|NCT01450410|Micronutrients|micronutrients|mesh-ancestor
24613037|NCT01016665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24613038|NCT01016665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613070|NCT01016860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24613071|NCT01016860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613072|NCT01016860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613073|NCT01016860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549040|NCT00713011|Tocolytic Agents|tocolytic agents|mesh-ancestor
24613074|NCT01016886|Bisoprolol|bisoprolol|mesh-list
25070761|NCT03416348|Ethanol|ethanol|mesh-list
25070762|NCT03416348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25070763|NCT03416348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25070764|NCT03416348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25070770|NCT03416270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070771|NCT03416231|Docetaxel|docetaxel|mesh-list
25070772|NCT03416231|Apatinib|apatinib|mesh-list
25070773|NCT03416231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25070774|NCT03416231|Tubulin Modulators|tubulin modulators|mesh-ancestor
24953744|NCT03882008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070775|NCT03416231|Antimitotic Agents|antimitotic agents|mesh-ancestor
25070776|NCT03416231|Mitosis Modulators|mitosis modulators|mesh-ancestor
25070777|NCT03416231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070778|NCT03416231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25070779|NCT03416231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25070780|NCT03416062|Niacinamide|niacinamide|mesh-list
25070781|NCT03416062|Vitamin B Complex|vitamin b complex|mesh-ancestor
25070782|NCT03416062|Vitamins|vitamins|mesh-ancestor
25070783|NCT03416062|Micronutrients|micronutrients|mesh-ancestor
24700111|NCT01450566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24700112|NCT01450566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24700113|NCT01450566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24700114|NCT01450566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24700115|NCT01450566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24700116|NCT01450566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070815|NCT03415802|Paclitaxel|paclitaxel|mesh-list
25070816|NCT03415802|Tegafur|tegafur|mesh-list
25070817|NCT03415802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25070818|NCT03415802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25070821|NCT03415802|Mitosis Modulators|mitosis modulators|mesh-ancestor
25070822|NCT03415802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070823|NCT03415802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25070824|NCT03415802|Antimetabolites|antimetabolites|mesh-ancestor
25070825|NCT03415763|Leucovorin|leucovorin|mesh-list
25070826|NCT03415763|Capecitabine|capecitabine|mesh-list
25070827|NCT03415763|Oxaliplatin|oxaliplatin|mesh-list
25070871|NCT03415594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25070872|NCT03415594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25070874|NCT03415594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25070875|NCT03415594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070876|NCT03415594|Incretins|incretins|mesh-ancestor
25070877|NCT03415555|Acetaminophen|acetaminophen|mesh-list
25070878|NCT03415555|Oxycodone|oxycodone|mesh-list
25070879|NCT03415555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25070880|NCT03415555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070881|NCT03415555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25070882|NCT03415555|Analgesics|analgesics|mesh-ancestor
25070883|NCT03415555|Sensory System Agents|sensory system agents|mesh-ancestor
25070884|NCT03415555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25070885|NCT03415555|Antipyretics|antipyretics|mesh-ancestor
25070886|NCT03415555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25070887|NCT03415555|Narcotics|narcotics|mesh-ancestor
25070888|NCT03415477|Denosumab|denosumab|mesh-list
25070889|NCT03415477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25070890|NCT03415477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070891|NCT03415386|Anticoagulants|anticoagulants|mesh-list
25070892|NCT03415386|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25070893|NCT03415269|Ambroxol|ambroxol|mesh-list
25070894|NCT03415269|Expectorants|expectorants|mesh-ancestor
25070895|NCT03415269|Respiratory System Agents|respiratory system agents|mesh-ancestor
25070896|NCT03415191|Ketamine|ketamine|mesh-list
25070897|NCT03415191|Analgesics|analgesics|mesh-ancestor
25070898|NCT03415191|Sensory System Agents|sensory system agents|mesh-ancestor
25070899|NCT03415191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25070900|NCT03415191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070901|NCT03415191|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25070902|NCT03415191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25070936|NCT03414918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24953784|NCT03881904|Estrogens|estrogens|mesh-ancestor
25070937|NCT03414918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25070938|NCT03414918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25070939|NCT03414918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25070940|NCT03414918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070941|NCT03414918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25070942|NCT03414918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25070944|NCT03414892|Enzyme Activators|enzyme activators|mesh-ancestor
25070945|NCT03414892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070946|NCT03414879|Lidocaine|lidocaine|mesh-list
25070950|NCT03414879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25070951|NCT03414879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070952|NCT03414879|Sensory System Agents|sensory system agents|mesh-ancestor
25070953|NCT03414879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25070954|NCT03414879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25070955|NCT03414879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25070956|NCT03414879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25070957|NCT03414879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25070958|NCT03414879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070959|NCT03414879|Analgesics|analgesics|mesh-ancestor
25070960|NCT03414879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25070961|NCT03414879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24700125|NCT01450774|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25070992|NCT03413891|Tranexamic Acid|tranexamic acid|mesh-list
25070993|NCT03413891|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25070994|NCT03413891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25070995|NCT03413891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070996|NCT03413891|Hemostatics|hemostatics|mesh-ancestor
25070997|NCT03413891|Coagulants|coagulants|mesh-ancestor
24833613|NCT02174666|Phytoestrogens|phytoestrogens|mesh-ancestor
24700126|NCT01450774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24700127|NCT01450774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24700128|NCT01450774|Adrenergic Agents|adrenergic agents|mesh-ancestor
24700129|NCT01450774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24700157|NCT01450995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24700158|NCT01450995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700159|NCT01450995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700160|NCT01451060|Ephedrine|ephedrine|mesh-list
24700161|NCT01451060|Metaraminol|metaraminol|mesh-list
25071022|NCT03413722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25071023|NCT03413722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071024|NCT03413722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071025|NCT03413579|Nimotuzumab|nimotuzumab|mesh-list
25071026|NCT03413579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25071027|NCT03413579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071028|NCT03413436|Cisplatin|cisplatin|mesh-list
25071029|NCT03413436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24953746|NCT03882008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24953747|NCT03882008|Immunologic Factors|immunologic factors|mesh-ancestor
24953748|NCT03882008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953749|NCT03882008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24953750|NCT03881995|Insulin Glargine|insulin glargine|mesh-list
24953751|NCT03881995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24953752|NCT03881995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953753|NCT03881943|Aspirin|aspirin|mesh-list
24953754|NCT03881943|Ticagrelor|ticagrelor|mesh-list
24953755|NCT03881943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24953756|NCT03881943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24953757|NCT03881943|Analgesics|analgesics|mesh-ancestor
24953758|NCT03881943|Sensory System Agents|sensory system agents|mesh-ancestor
24953759|NCT03881943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953760|NCT03881943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953761|NCT03881943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24953762|NCT03881943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24953763|NCT03881943|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24953764|NCT03881943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24953765|NCT03881943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953777|NCT03881904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24953778|NCT03881904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24953779|NCT03881904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24953780|NCT03881904|Contraceptive Agents|contraceptive agents|mesh-ancestor
24953781|NCT03881904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24953782|NCT03881904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953783|NCT03881904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24953786|NCT03881904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24953787|NCT03881904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24953788|NCT03881904|Progestins|progestins|mesh-ancestor
24953789|NCT03881644|Sumatriptan|sumatriptan|mesh-list
24953790|NCT03881644|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
24953791|NCT03881644|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24833709|NCT02175381|Gemcitabine|gemcitabine|mesh-list
24700185|NCT01451229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24700186|NCT01451229|Analgesics|analgesics|mesh-ancestor
24700187|NCT01451229|Sensory System Agents|sensory system agents|mesh-ancestor
24700188|NCT01451229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24700189|NCT01451229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24700197|NCT01451268|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24700198|NCT01451268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700199|NCT01451268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700200|NCT01451294|Phenylephrine|phenylephrine|mesh-list
24700201|NCT01451294|Oxymetazoline|oxymetazoline|mesh-list
24700202|NCT01451294|Ephedrine|ephedrine|mesh-list
24700203|NCT01451294|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24700204|NCT01451294|Mydriatics|mydriatics|mesh-ancestor
24700205|NCT01451294|Autonomic Agents|autonomic agents|mesh-ancestor
24700206|NCT01451294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24700207|NCT01451294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700208|NCT01451294|Sympathomimetics|sympathomimetics|mesh-ancestor
24700209|NCT01451294|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24700210|NCT01451294|Nasal Decongestants|nasal decongestants|mesh-ancestor
24700211|NCT01451294|Respiratory System Agents|respiratory system agents|mesh-ancestor
24700212|NCT01451294|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24700213|NCT01451294|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24700214|NCT01451294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24726455|NCT01603251|Ivermectin|ivermectin|mesh-list
24700215|NCT01451294|Adrenergic Agents|adrenergic agents|mesh-ancestor
24953792|NCT03881644|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24953793|NCT03881644|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24953805|NCT03881787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25071083|NCT03413059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25071084|NCT03413059|Narcotics|narcotics|mesh-ancestor
25071085|NCT03413059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25071086|NCT03413059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071087|NCT03413059|Analgesics|analgesics|mesh-ancestor
25071088|NCT03413059|Sensory System Agents|sensory system agents|mesh-ancestor
25071089|NCT03413059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25071090|NCT03413059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25071091|NCT03413059|Glucocorticoids|glucocorticoids|mesh-ancestor
25071092|NCT03413059|Hormones|hormones|mesh-ancestor
25071093|NCT03413059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25071094|NCT03413059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25071095|NCT03413059|Immunologic Factors|immunologic factors|mesh-ancestor
25071098|NCT03413020|Amoxicillin|amoxicillin|mesh-list
25071118|NCT03413020|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25071119|NCT03413020|Renal Agents|renal agents|mesh-ancestor
25071120|NCT03413020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25071121|NCT03413020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25071122|NCT03413020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071123|NCT03413020|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25071124|NCT03413020|Antacids|antacids|mesh-ancestor
25071125|NCT03413020|Diuretics|diuretics|mesh-ancestor
25071126|NCT03413020|Natriuretic Agents|natriuretic agents|mesh-ancestor
25071127|NCT03413020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071128|NCT03413020|Expectorants|expectorants|mesh-ancestor
25071129|NCT03413020|Respiratory System Agents|respiratory system agents|mesh-ancestor
25071130|NCT03413007|Antigen-Antibody Complex|antigen-antibody complex|mesh-list
25071131|NCT03413007|Immunologic Factors|immunologic factors|mesh-ancestor
25071132|NCT03413007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071133|NCT03412994|Apatinib|apatinib|mesh-list
25071134|NCT03412994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071150|NCT03412682|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25071151|NCT03412682|Autonomic Agents|autonomic agents|mesh-ancestor
25071152|NCT03412682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25071153|NCT03412682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071154|NCT03412682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25071155|NCT03412682|Respiratory System Agents|respiratory system agents|mesh-ancestor
25071156|NCT03412682|Glucocorticoids|glucocorticoids|mesh-ancestor
25071158|NCT03412682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25071159|NCT03412682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25071160|NCT03412682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24700317|NCT01451853|Sensory System Agents|sensory system agents|mesh-ancestor
24700318|NCT01451853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24700319|NCT01451853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700320|NCT01451853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24700321|NCT01451853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24700322|NCT01451853|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24700323|NCT01451853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24700324|NCT01451853|Antioxidants|antioxidants|mesh-ancestor
24700325|NCT01451853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700326|NCT01451853|Protective Agents|protective agents|mesh-ancestor
24700327|NCT01451853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24700328|NCT01451853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700329|NCT01451853|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25071166|NCT03412552|Sensory System Agents|sensory system agents|mesh-ancestor
25071167|NCT03412552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25071168|NCT03412552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071169|NCT03412552|Anesthetics|anesthetics|mesh-ancestor
25071170|NCT03412552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25071193|NCT03412474|Acetaminophen|acetaminophen|mesh-list
25071213|NCT03412409|Cyclophosphamide|cyclophosphamide|mesh-list
25071214|NCT03412409|Busulfan|busulfan|mesh-list
25071215|NCT03412409|Semustine|semustine|mesh-list
25071216|NCT03412409|Fludarabine|fludarabine|mesh-list
25071217|NCT03412409|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25071218|NCT03412409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25071219|NCT03412409|Immunologic Factors|immunologic factors|mesh-ancestor
25071220|NCT03412409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071221|NCT03412409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25423856|NCT02328105|Carboplatin|carboplatin|mesh-list
25663637|NCT01661114|Fluorouracil|fluorouracil|mesh-list
25852100|NCT00055653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25852101|NCT00055653|Immunologic Factors|immunologic factors|mesh-ancestor
25663638|NCT01661114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663639|NCT01661114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25663640|NCT01661114|Antimetabolites|antimetabolites|mesh-ancestor
25852102|NCT00055653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240406|NCT02536014|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24444617|NCT00298636|Purinergic Agonists|purinergic agonists|mesh-ancestor
24444618|NCT00298636|Purinergic Agents|purinergic agents|mesh-ancestor
24444619|NCT00298636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25071222|NCT03412409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25071223|NCT03412409|Alkylating Agents|alkylating agents|mesh-ancestor
25071224|NCT03412409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071225|NCT03412409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071226|NCT03412409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25071227|NCT03412409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25071228|NCT03412409|Antimetabolites|antimetabolites|mesh-ancestor
25071229|NCT03412409|Antiviral Agents|antiviral agents|mesh-ancestor
25071230|NCT03412409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25071231|NCT03412305|Amoxicillin|amoxicillin|mesh-list
24956544|NCT03853642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956545|NCT03853642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24956546|NCT03853642|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24956547|NCT03853642|Vasodilator Agents|vasodilator agents|mesh-ancestor
24956548|NCT03853642|Gasotransmitters|gasotransmitters|mesh-ancestor
24956549|NCT03853642|Protective Agents|protective agents|mesh-ancestor
24956550|NCT03853538|Petrolatum|petrolatum|mesh-list
24953825|NCT03881293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24953826|NCT03881293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24953827|NCT03881293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24427008|NCT00237159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953864|NCT03880981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24953865|NCT03880981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24953866|NCT03880981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24953867|NCT03880981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24953868|NCT03880981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24953869|NCT03880981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953870|NCT03880903|Albuterol|albuterol|mesh-list
25071232|NCT03412305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25071233|NCT03412305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25071234|NCT03412071|Metronidazole|metronidazole|mesh-list
24700330|NCT01451879|Miglustat|miglustat|mesh-list
24700331|NCT01451879|Rituximab|rituximab|mesh-list
24700332|NCT01451879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24700333|NCT01451879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24700334|NCT01451879|Immunologic Factors|immunologic factors|mesh-ancestor
25071235|NCT03412071|Clindamycin|clindamycin|mesh-list
25071236|NCT03412071|Clindamycin palmitate|clindamycin palmitate|mesh-list
25071237|NCT03412071|Clindamycin phosphate|clindamycin phosphate|mesh-list
25071238|NCT03412071|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25071239|NCT03412071|Tinidazole|tinidazole|mesh-list
25071240|NCT03412071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25071241|NCT03412071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24700355|NCT01451918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071270|NCT03411850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24875563|NCT04043806|Elexacaftor|elexacaftor|mesh-list
25071271|NCT03411850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071272|NCT03411850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071309|NCT03411473|Pembrolizumab|pembrolizumab|mesh-list
25071310|NCT03411473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25071311|NCT03411473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071312|NCT03411434|Methylphenidate|methylphenidate|mesh-list
25071313|NCT03411434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25071314|NCT03411434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071315|NCT03411434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24427161|NCT00237575|Gemcitabine|gemcitabine|mesh-list
25071338|NCT03411252|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25071339|NCT03411252|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25663641|NCT01661114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663642|NCT01661114|Antiviral Agents|antiviral agents|mesh-ancestor
25663643|NCT01661114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25663644|NCT01661114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663645|NCT01661114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25663646|NCT01661114|Immunologic Factors|immunologic factors|mesh-ancestor
25663647|NCT01661114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071340|NCT03411252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25071342|NCT03411252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25071343|NCT03411252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071344|NCT03411252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071345|NCT03411252|Urological Agents|urological agents|mesh-ancestor
25071346|NCT03411161|Paclitaxel|paclitaxel|mesh-list
25852103|NCT00055653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25852104|NCT00055653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25071347|NCT03411161|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25071348|NCT03411161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25071349|NCT03411161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071350|NCT03411161|Tubulin Modulators|tubulin modulators|mesh-ancestor
25071351|NCT03411161|Antimitotic Agents|antimitotic agents|mesh-ancestor
25071352|NCT03411161|Mitosis Modulators|mitosis modulators|mesh-ancestor
25071353|NCT03411161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071354|NCT03411109|Hydromorphone|hydromorphone|mesh-list
25071355|NCT03411109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25071356|NCT03411109|Narcotics|narcotics|mesh-ancestor
25071357|NCT03411109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25071358|NCT03411109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071359|NCT03411109|Analgesics|analgesics|mesh-ancestor
25071360|NCT03411109|Sensory System Agents|sensory system agents|mesh-ancestor
25071361|NCT03411109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25071362|NCT03411096|Ropivacaine|ropivacaine|mesh-list
25071363|NCT03411096|Anesthetics, Local|anesthetics, local|mesh-ancestor
25071364|NCT03411096|Anesthetics|anesthetics|mesh-ancestor
25071365|NCT03411096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25071366|NCT03411096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071387|NCT03410784|Antimitotic Agents|antimitotic agents|mesh-ancestor
25071388|NCT03410784|Mitosis Modulators|mitosis modulators|mesh-ancestor
25071389|NCT03410784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071390|NCT03410784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25071391|NCT03410771|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25071392|NCT03410771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25071394|NCT03410524|Antifoaming Agents|antifoaming agents|mesh-ancestor
25071395|NCT03410524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071396|NCT03410524|Emollients|emollients|mesh-ancestor
25071397|NCT03410524|Dermatologic Agents|dermatologic agents|mesh-ancestor
25071398|NCT03410511|Nicotine|nicotine|mesh-list
25071399|NCT03410511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25071400|NCT03410511|Autonomic Agents|autonomic agents|mesh-ancestor
25071401|NCT03410511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25071402|NCT03410511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071403|NCT03410511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25071404|NCT03410511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25071405|NCT03410511|Cholinergic Agents|cholinergic agents|mesh-ancestor
25071406|NCT03410511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25071407|NCT03410511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071408|NCT03410212|Ketorolac|ketorolac|mesh-list
25071409|NCT03410212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25071410|NCT03410212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25071415|NCT03410212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071416|NCT03410212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25071417|NCT03410212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25071418|NCT03410212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25071419|NCT03410212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427282|NCT00237900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071459|NCT03409432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25071460|NCT03409432|Immunoconjugates|immunoconjugates|mesh-list
25071486|NCT03408847|Beclomethasone|beclomethasone|mesh-list
25071487|NCT03408847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25071488|NCT03408847|Glucocorticoids|glucocorticoids|mesh-ancestor
25071525|NCT03408145|Viscosupplements|viscosupplements|mesh-ancestor
25071580|NCT03407521|Natriuretic Agents|natriuretic agents|mesh-ancestor
25071596|NCT03407404|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25071597|NCT03407404|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25071598|NCT03407404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25071599|NCT03407404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071600|NCT03407404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25071601|NCT03407404|Narcotics|narcotics|mesh-ancestor
25071602|NCT03407404|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25071603|NCT03407404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25071604|NCT03407404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25071605|NCT03407404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25071606|NCT03407404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25071608|NCT03407404|GABA Agents|gaba agents|mesh-ancestor
25071609|NCT03407300|Docetaxel|docetaxel|mesh-list
25071610|NCT03407300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071611|NCT03407300|Tubulin Modulators|tubulin modulators|mesh-ancestor
25071612|NCT03407300|Antimitotic Agents|antimitotic agents|mesh-ancestor
25071613|NCT03407300|Mitosis Modulators|mitosis modulators|mesh-ancestor
25071614|NCT03407300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071615|NCT03407209|Anesthetics|anesthetics|mesh-list
25071616|NCT03407209|Anesthetics, Local|anesthetics, local|mesh-list
25071617|NCT03407209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25071618|NCT03407209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071619|NCT03407209|Sensory System Agents|sensory system agents|mesh-ancestor
25071620|NCT03407209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25071621|NCT03407196|Dapagliflozin|dapagliflozin|mesh-list
25071622|NCT03407196|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25071623|NCT03407196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071624|NCT03407196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25071688|NCT03406832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25071689|NCT03406832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25071691|NCT03406819|Tirofiban|tirofiban|mesh-list
25071692|NCT03406819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24427579|NCT00238368|Antiemetics|antiemetics|mesh-ancestor
25071713|NCT03406689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071714|NCT03406689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25071715|NCT03406689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25071716|NCT03406676|Methylene Blue|methylene blue|mesh-list
25071717|NCT03406676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25071718|NCT03406676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071722|NCT03406546|Dexmedetomidine|dexmedetomidine|mesh-list
25071723|NCT03406546|Remifentanil|remifentanil|mesh-list
25071724|NCT03406546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25071725|NCT03406546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25071726|NCT03406546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071727|NCT03406546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25071728|NCT03406546|Analgesics|analgesics|mesh-ancestor
25071729|NCT03406546|Sensory System Agents|sensory system agents|mesh-ancestor
25071730|NCT03406546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25071731|NCT03406546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25071732|NCT03406546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25071733|NCT03406546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25071734|NCT03406546|Adrenergic Agents|adrenergic agents|mesh-ancestor
25071735|NCT03406546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25071736|NCT03406546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071737|NCT03406546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25071738|NCT03406546|Narcotics|narcotics|mesh-ancestor
25071739|NCT03406533|Fentanyl|fentanyl|mesh-list
25071746|NCT03406533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071747|NCT03406533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25207753|NCT03435952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25071749|NCT03406533|Anesthetics|anesthetics|mesh-ancestor
25071750|NCT03406533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25071751|NCT03406533|Analgesics|analgesics|mesh-ancestor
25071752|NCT03406533|Sensory System Agents|sensory system agents|mesh-ancestor
25071753|NCT03406533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25071754|NCT03406533|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25071755|NCT03406533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25071756|NCT03406533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25071784|NCT03406299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25071785|NCT03406299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25071786|NCT03406299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25071787|NCT03406299|Immunologic Factors|immunologic factors|mesh-ancestor
25071788|NCT03406299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071790|NCT03406299|Protective Agents|protective agents|mesh-ancestor
25071791|NCT03406299|Vitamin B Complex|vitamin b complex|mesh-ancestor
25071793|NCT03406299|Micronutrients|micronutrients|mesh-ancestor
25071794|NCT03406169|Sildenafil Citrate|sildenafil citrate|mesh-list
25071795|NCT03406169|Pentoxifylline|pentoxifylline|mesh-list
25071796|NCT03406169|Vasodilator Agents|vasodilator agents|mesh-ancestor
25071797|NCT03406169|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25071798|NCT03406169|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25071799|NCT03406169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25071800|NCT03406169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071801|NCT03406169|Urological Agents|urological agents|mesh-ancestor
25423931|NCT02316171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25071802|NCT03406169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25071803|NCT03406169|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25071804|NCT03406169|Protective Agents|protective agents|mesh-ancestor
24427686|NCT00238732|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24953899|NCT03880916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24953900|NCT03880916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24953901|NCT03880916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953902|NCT03880916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24953903|NCT03880916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953904|NCT03880916|Analgesics|analgesics|mesh-ancestor
24953905|NCT03880916|Sensory System Agents|sensory system agents|mesh-ancestor
24953906|NCT03880916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953907|NCT03880916|Antidepressive Agents|antidepressive agents|mesh-ancestor
24953908|NCT03880916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24953909|NCT03880916|Dopamine Agents|dopamine agents|mesh-ancestor
25071838|NCT03405805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071839|NCT03405584|Amoxicillin|amoxicillin|mesh-list
25071840|NCT03405584|Potassium Citrate|potassium citrate|mesh-list
25071841|NCT03405584|Esomeprazole|esomeprazole|mesh-list
25071843|NCT03405584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071844|NCT03405584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25071845|NCT03405584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25071846|NCT03405584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25071847|NCT03405584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25071848|NCT03405584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25071849|NCT03405584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25071873|NCT03405207|Cholecalciferol|cholecalciferol|mesh-list
25071874|NCT03405207|Vitamins|vitamins|mesh-ancestor
25071875|NCT03405207|Micronutrients|micronutrients|mesh-ancestor
25071876|NCT03405207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071877|NCT03405207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25071878|NCT03405207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25071879|NCT03405194|Efavirenz|efavirenz|mesh-list
25071880|NCT03405194|Cobicistat|cobicistat|mesh-list
25071881|NCT03405194|Elvitegravir|elvitegravir|mesh-list
25071882|NCT03405194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25071883|NCT03405194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25071884|NCT03405194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25071885|NCT03405194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071886|NCT03405194|Antiviral Agents|antiviral agents|mesh-ancestor
24834630|NCT02180087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24834631|NCT02180087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24834632|NCT02180087|Analgesics|analgesics|mesh-ancestor
24700384|NCT01452243|Vitamin D|vitamin d|mesh-list
24700385|NCT01452243|Calcium|calcium|mesh-list
24700386|NCT01452243|Vitamins|vitamins|mesh-ancestor
25071894|NCT03405194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25071899|NCT03405168|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25071900|NCT03405168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25071901|NCT03405168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25071902|NCT03405168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25071903|NCT03405168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25071904|NCT03405168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25071905|NCT03405168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071906|NCT03405168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071907|NCT03405168|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25071908|NCT03405168|Contraceptive Agents|contraceptive agents|mesh-ancestor
25071909|NCT03405168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25071910|NCT03405168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071911|NCT03405168|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25071912|NCT03405168|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25071913|NCT03405168|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25071914|NCT03405155|Nivolumab|nivolumab|mesh-list
25071915|NCT03405155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25071916|NCT03405155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071917|NCT03405155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25071918|NCT03405155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071919|NCT03405142|Panitumumab|panitumumab|mesh-list
25071920|NCT03405142|Diethylenetriamine|diethylenetriamine|mesh-list
24427796|NCT00239031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25072003|NCT03404479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072005|NCT03404479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25072006|NCT03404479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25072007|NCT03404479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25072008|NCT03404479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25072009|NCT03404479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072011|NCT03404414|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25072012|NCT03404414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072014|NCT03404310|Astringents|astringents|mesh-ancestor
25072015|NCT03404310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072016|NCT03404310|Dermatologic Agents|dermatologic agents|mesh-ancestor
25072017|NCT03404037|Endostatins|endostatins|mesh-list
25072018|NCT03404037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25072019|NCT03404037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25072020|NCT03404037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25072021|NCT03404037|Growth Substances|growth substances|mesh-ancestor
25072022|NCT03404037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072023|NCT03404037|Growth Inhibitors|growth inhibitors|mesh-ancestor
25072024|NCT03404024|Mitogens|mitogens|mesh-list
25072025|NCT03404024|Mitosis Modulators|mitosis modulators|mesh-ancestor
25072026|NCT03404024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072027|NCT03404011|Glycerol|glycerol|mesh-list
25072028|NCT03404011|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25072029|NCT03404011|Protective Agents|protective agents|mesh-ancestor
24700430|NCT01452568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25072032|NCT03403985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25072033|NCT03403985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072034|NCT03403972|Vancomycin|vancomycin|mesh-list
25072035|NCT03403972|Simvastatin|simvastatin|mesh-list
25072036|NCT03403972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25072037|NCT03403972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25072038|NCT03403972|Antimetabolites|antimetabolites|mesh-ancestor
25072039|NCT03403972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072040|NCT03403972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25072041|NCT03403972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25072042|NCT03403972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25072043|NCT03403972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25072044|NCT03403972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25072045|NCT03403946|Pyrithione zinc|pyrithione zinc|mesh-list
25072046|NCT03403946|Keratolytic Agents|keratolytic agents|mesh-ancestor
25072047|NCT03403946|Dermatologic Agents|dermatologic agents|mesh-ancestor
25072096|NCT03403439|Antifungal Agents|antifungal agents|mesh-ancestor
25072097|NCT03403439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25072098|NCT03403439|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25072099|NCT03403439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25072100|NCT03403439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427966|NCT00239382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25072122|NCT03403101|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25072123|NCT03403101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25072124|NCT03403101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25072125|NCT03403101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072126|NCT03403049|Gemcitabine|gemcitabine|mesh-list
25072127|NCT03403049|Capecitabine|capecitabine|mesh-list
25072128|NCT03403049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25072129|NCT03403049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25072130|NCT03403049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25072131|NCT03403049|Antimetabolites|antimetabolites|mesh-ancestor
24874317|NCT04822350|Avelumab|avelumab|mesh-list
25072132|NCT03403049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072133|NCT03403049|Antiviral Agents|antiviral agents|mesh-ancestor
25072136|NCT03403049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25072137|NCT03403049|Immunologic Factors|immunologic factors|mesh-ancestor
25072138|NCT03403049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072139|NCT03403049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25072140|NCT03403023|Cyclosporine|cyclosporine|mesh-list
25072141|NCT03403023|Cyclosporins|cyclosporins|mesh-list
25072142|NCT03403023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25072143|NCT03403023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072144|NCT03403023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25072145|NCT03403023|Immunologic Factors|immunologic factors|mesh-ancestor
25072146|NCT03403023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072147|NCT03403023|Antifungal Agents|antifungal agents|mesh-ancestor
25072148|NCT03403023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25072149|NCT03403023|Dermatologic Agents|dermatologic agents|mesh-ancestor
24953938|NCT03880487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25072172|NCT03402815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25072174|NCT03402815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25006561|NCT04892420|Sensory System Agents|sensory system agents|mesh-ancestor
25072175|NCT03402815|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25072176|NCT03402698|Cholecalciferol|cholecalciferol|mesh-list
24613125|NCT01017159|Immunologic Factors|immunologic factors|mesh-ancestor
24613126|NCT01017159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613127|NCT01017198|Antacids|antacids|mesh-list
24613128|NCT01017198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700503|NCT01452724|Lansoprazole|lansoprazole|mesh-list
24700504|NCT01452724|Dexlansoprazole|dexlansoprazole|mesh-list
24700505|NCT01452724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25072177|NCT03402698|Vitamin D|vitamin d|mesh-list
25852105|NCT00055653|Alkylating Agents|alkylating agents|mesh-ancestor
25852106|NCT00055653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072178|NCT03402698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25072179|NCT03402698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072180|NCT03402698|Vitamins|vitamins|mesh-ancestor
25072181|NCT03402698|Micronutrients|micronutrients|mesh-ancestor
25072182|NCT03402698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24428148|NCT00239746|Ibuprofen|ibuprofen|mesh-list
24700533|NCT01452828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24643782|NCT01187264|Antimetabolites|antimetabolites|mesh-ancestor
24700537|NCT01452867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24700538|NCT01452867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24700539|NCT01452867|Disinfectants|disinfectants|mesh-ancestor
24700540|NCT01452880|Remifentanil|remifentanil|mesh-list
24700541|NCT01452880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24700542|NCT01452880|Narcotics|narcotics|mesh-ancestor
24700543|NCT01452880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24700544|NCT01452880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700545|NCT01452880|Analgesics|analgesics|mesh-ancestor
24700546|NCT01452880|Sensory System Agents|sensory system agents|mesh-ancestor
24700547|NCT01452880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24700548|NCT01452906|Omeprazole|omeprazole|mesh-list
24700549|NCT01452906|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24700550|NCT01452906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24700551|NCT01452906|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24700552|NCT01452906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700553|NCT01452906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072197|NCT03402321|Hemostatics|hemostatics|mesh-ancestor
25072198|NCT03402321|Coagulants|coagulants|mesh-ancestor
25072199|NCT03402295|Thalidomide|thalidomide|mesh-list
25072200|NCT03402295|Dexamethasone|dexamethasone|mesh-list
25072201|NCT03402295|Cyclophosphamide|cyclophosphamide|mesh-list
25072227|NCT03402295|Growth Inhibitors|growth inhibitors|mesh-ancestor
25072228|NCT03402204|Ubenimex|ubenimex|mesh-list
25072229|NCT03402204|Simvastatin|simvastatin|mesh-list
25072230|NCT03402204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25072231|NCT03402204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25072232|NCT03402204|Antimetabolites|antimetabolites|mesh-ancestor
25072233|NCT03402204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24876103|NCT03724084|Cytarabine|cytarabine|mesh-list
25072234|NCT03402204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25072235|NCT03402204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25072236|NCT03402204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25072237|NCT03402204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25072238|NCT03402204|Immunologic Factors|immunologic factors|mesh-ancestor
25072239|NCT03402204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072240|NCT03402204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25072241|NCT03402204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25072242|NCT03402204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25072243|NCT03402204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24835023|NCT02182076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24700636|NCT01453881|Adrenergic Agents|adrenergic agents|mesh-ancestor
24700696|NCT01454180|Vitamin B Complex|vitamin b complex|mesh-ancestor
24643836|NCT01187615|Cisplatin|cisplatin|mesh-list
24700698|NCT01454180|Micronutrients|micronutrients|mesh-ancestor
24700699|NCT01454440|Eptifibatide|eptifibatide|mesh-list
24700700|NCT01454440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24700701|NCT01454479|Lapatinib|lapatinib|mesh-list
24700702|NCT01454479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486280|NCT00457054|Lithium Carbonate|lithium carbonate|mesh-list
24700703|NCT01454479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25663648|NCT01661140|Methotrexate|methotrexate|mesh-list
25663649|NCT01661140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24700704|NCT01454479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700705|NCT01454479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852107|NCT00055653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727509|NCT01610869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727510|NCT01610921|Adenosine|adenosine|mesh-list
24727513|NCT01610921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24727514|NCT01610921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852108|NCT00055653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24727545|NCT01610947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24727546|NCT01610947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727548|NCT01610947|Immunologic Factors|immunologic factors|mesh-ancestor
24700707|NCT01454518|Anesthetics, Local|anesthetics, local|mesh-list
24700739|NCT01454635|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24700740|NCT01454635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24700741|NCT01454635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24700742|NCT01454635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700743|NCT01454635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24700745|NCT01454635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700746|NCT01454700|Insulin|insulin|mesh-list
24700747|NCT01454700|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24700781|NCT01455129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700782|NCT01455129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24700783|NCT01455129|Respiratory System Agents|respiratory system agents|mesh-ancestor
24700784|NCT01455129|Parasympatholytics|parasympatholytics|mesh-ancestor
24700828|NCT01455337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700829|NCT01455337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700830|NCT01455337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24700831|NCT01455337|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24700833|NCT01455337|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24700834|NCT01455337|Antioxidants|antioxidants|mesh-ancestor
24700835|NCT01455350|Lidocaine|lidocaine|mesh-list
24700836|NCT01455350|Anesthetics, Local|anesthetics, local|mesh-ancestor
24700837|NCT01455350|Anesthetics|anesthetics|mesh-ancestor
24700838|NCT01455350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24700839|NCT01455350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700840|NCT01455350|Sensory System Agents|sensory system agents|mesh-ancestor
24700841|NCT01455350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24700842|NCT01455350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24700881|NCT01455532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700882|NCT01455532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25072280|NCT03402113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25072281|NCT03402113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25072282|NCT03402113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428383|NCT00240396|Narcotics|narcotics|mesh-list
24700901|NCT01455649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700902|NCT01455649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700903|NCT01455649|Antifungal Agents|antifungal agents|mesh-ancestor
24700904|NCT01455649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24700905|NCT01455649|Dermatologic Agents|dermatologic agents|mesh-ancestor
24700912|NCT01455831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24700913|NCT01455831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24613184|NCT01017640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24613185|NCT01017640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613186|NCT01017640|Alkylating Agents|alkylating agents|mesh-ancestor
24613189|NCT01017640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613190|NCT01017640|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24613191|NCT01017666|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
24700987|NCT01456247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24700988|NCT01456247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700989|NCT01456247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701024|NCT01456364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24701025|NCT01456364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701026|NCT01456364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701027|NCT01456468|Tretinoin|tretinoin|mesh-list
25072310|NCT03402087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663650|NCT01661140|Abortifacient Agents|abortifacient agents|mesh-ancestor
25663651|NCT01661140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25663652|NCT01661140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663653|NCT01661140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25663654|NCT01661140|Antimetabolites|antimetabolites|mesh-ancestor
25663655|NCT01661140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663656|NCT01661140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616472|NCT01037491|Sensory System Agents|sensory system agents|mesh-ancestor
24616473|NCT01037491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24616474|NCT01037491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616475|NCT01037491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24616479|NCT01037491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727794|NCT01612832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25072311|NCT03402087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25072313|NCT03402087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072314|NCT03402087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25072315|NCT03402087|Dermatologic Agents|dermatologic agents|mesh-ancestor
25072316|NCT03402087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25072317|NCT03402087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25072318|NCT03402087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25072319|NCT03402087|Immunologic Factors|immunologic factors|mesh-ancestor
25072320|NCT03402087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25072321|NCT03402087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25072322|NCT03402087|Antidotes|antidotes|mesh-ancestor
25072323|NCT03402087|Protective Agents|protective agents|mesh-ancestor
24701126|NCT01457040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24549740|NCT00717379|Antiemetics|antiemetics|mesh-ancestor
24549741|NCT00717379|Autonomic Agents|autonomic agents|mesh-ancestor
24701127|NCT01457040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701128|NCT01457040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24701129|NCT01457040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24701130|NCT01457040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701131|NCT01457040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701146|NCT01457261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24701147|NCT01457261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701148|NCT01457261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24701149|NCT01457261|Respiratory System Agents|respiratory system agents|mesh-ancestor
24701150|NCT01457261|Tocolytic Agents|tocolytic agents|mesh-ancestor
24701151|NCT01457261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24701152|NCT01457261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24701153|NCT01457261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24701154|NCT01457261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24701155|NCT01457261|Adrenergic Agents|adrenergic agents|mesh-ancestor
24701156|NCT01457261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24701157|NCT01457261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701158|NCT01457469|Nicotine|nicotine|mesh-list
25072326|NCT03402087|Micronutrients|micronutrients|mesh-ancestor
25207754|NCT03435952|Antimalarials|antimalarials|mesh-ancestor
25207755|NCT03435952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25207756|NCT03435952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25072336|NCT03402048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701214|NCT01457716|Formoterol Fumarate|formoterol fumarate|mesh-list
24701215|NCT01457716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24701216|NCT01457716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24701217|NCT01457716|Autonomic Agents|autonomic agents|mesh-ancestor
24701256|NCT01457937|Interferons|interferons|mesh-list
24701258|NCT01457937|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24701259|NCT01457937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701260|NCT01457937|Antiviral Agents|antiviral agents|mesh-ancestor
24701293|NCT01458054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24701294|NCT01458054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24701295|NCT01458054|Antiviral Agents|antiviral agents|mesh-ancestor
24428617|NCT00240812|Analgesics|analgesics|mesh-ancestor
24953969|NCT03880409|Anesthetics, Local|anesthetics, local|mesh-ancestor
24953970|NCT03880409|Anesthetics|anesthetics|mesh-ancestor
24953971|NCT03880409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24953972|NCT03880409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953973|NCT03880409|Sensory System Agents|sensory system agents|mesh-ancestor
24953974|NCT03880409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835151|NCT02182336|Coagulants|coagulants|mesh-ancestor
24613246|NCT01017822|Capecitabine|capecitabine|mesh-list
24613247|NCT01017822|Conatumumab|conatumumab|mesh-list
24613248|NCT01017822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25663657|NCT01661140|Dermatologic Agents|dermatologic agents|mesh-ancestor
25663658|NCT01661140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663659|NCT01661140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25663660|NCT01661140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25663661|NCT01661140|Immunologic Factors|immunologic factors|mesh-ancestor
25663662|NCT01661140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25663663|NCT01661140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25663664|NCT01661270|Aflibercept|aflibercept|mesh-list
25240538|NCT05298761|Lidocaine|lidocaine|mesh-list
25240539|NCT05298761|Nalbuphine|nalbuphine|mesh-list
25240540|NCT05298761|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24613249|NCT01017822|Antimetabolites|antimetabolites|mesh-ancestor
24613250|NCT01017822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613251|NCT01017822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613252|NCT01017822|Antiviral Agents|antiviral agents|mesh-ancestor
24613253|NCT01017822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25852109|NCT00055653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24613254|NCT01017822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613255|NCT01017822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24613256|NCT01017822|Immunologic Factors|immunologic factors|mesh-ancestor
24613257|NCT01017822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613258|NCT01017822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24613259|NCT01017926|Triazolam|triazolam|mesh-list
24613260|NCT01017926|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24613261|NCT01017926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24613262|NCT01017926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24613263|NCT01017926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24613264|NCT01017926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701318|NCT01458301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24953975|NCT03880409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25072361|NCT03401827|Antimetabolites|antimetabolites|mesh-ancestor
25072362|NCT03401827|Antiviral Agents|antiviral agents|mesh-ancestor
25072363|NCT03401827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24701319|NCT01458301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701320|NCT01458301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24701321|NCT01458301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701323|NCT01458301|Hormone Antagonists|hormone antagonists|mesh-ancestor
24701352|NCT01458600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24701353|NCT01458600|Analgesics|analgesics|mesh-ancestor
24701354|NCT01458600|Sensory System Agents|sensory system agents|mesh-ancestor
24701355|NCT01458600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24701380|NCT01458626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701381|NCT01458626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24701382|NCT01458626|Serotonin Agents|serotonin agents|mesh-ancestor
25852110|NCT00055653|Antimetabolites|antimetabolites|mesh-ancestor
25072365|NCT03401827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25072366|NCT03401827|Immunologic Factors|immunologic factors|mesh-ancestor
25072367|NCT03401827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072368|NCT03401736|Midazolam|midazolam|mesh-list
25072369|NCT03401736|Dexmedetomidine|dexmedetomidine|mesh-list
24428674|NCT00240864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25072404|NCT03401606|Dexmedetomidine|dexmedetomidine|mesh-list
25072405|NCT03401606|Remifentanil|remifentanil|mesh-list
25072406|NCT03401606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25072407|NCT03401606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25072408|NCT03401606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072409|NCT03401606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25072410|NCT03401606|Analgesics|analgesics|mesh-ancestor
25072411|NCT03401606|Sensory System Agents|sensory system agents|mesh-ancestor
25072412|NCT03401606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25072413|NCT03401606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24835223|NCT02182505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24835225|NCT02182505|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24701393|NCT01458626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24701394|NCT01458626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24701395|NCT01458626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24701396|NCT01458626|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24701397|NCT01458626|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24701398|NCT01458626|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24701399|NCT01458626|Adrenergic Agents|adrenergic agents|mesh-ancestor
25852111|NCT00055653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701400|NCT01458626|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24701401|NCT01458626|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24701402|NCT01458626|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24701403|NCT01458743|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
24701404|NCT01458743|Cephalosporins|cephalosporins|mesh-list
24701405|NCT01458743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24701406|NCT01458743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24701407|NCT01458769|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24701408|NCT01458769|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25663665|NCT01661270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25663666|NCT01661270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24701409|NCT01458769|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24701410|NCT01458769|Protease Inhibitors|protease inhibitors|mesh-ancestor
24701411|NCT01458769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25072434|NCT03401593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25072435|NCT03401593|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25072436|NCT03401593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25072437|NCT03401593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25072438|NCT03401593|GABA Modulators|gaba modulators|mesh-ancestor
25072439|NCT03401593|GABA Agents|gaba agents|mesh-ancestor
25072440|NCT03401593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25072441|NCT03401593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072442|NCT03401541|Vitamin D|vitamin d|mesh-list
25072443|NCT03401541|Calcifediol|calcifediol|mesh-list
25072444|NCT03401541|Ergocalciferols|ergocalciferols|mesh-list
25072445|NCT03401541|Vitamins|vitamins|mesh-ancestor
25072446|NCT03401541|Micronutrients|micronutrients|mesh-ancestor
25072447|NCT03401541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072457|NCT03401515|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25072458|NCT03401515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25072459|NCT03401515|Vasodilator Agents|vasodilator agents|mesh-ancestor
25072460|NCT03401502|Ranolazine|ranolazine|mesh-list
25072461|NCT03401502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25207757|NCT03421652|Nivolumab|nivolumab|mesh-list
25072526|NCT03401177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25072527|NCT03401177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072528|NCT03401073|Immunoglobulins|immunoglobulins|mesh-list
25072529|NCT03401073|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25072530|NCT03401073|Antibodies|antibodies|mesh-list
25072531|NCT03401073|gamma-Globulins|gamma-globulins|mesh-list
25072532|NCT03401073|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24701430|NCT01458977|Antiviral Agents|antiviral agents|mesh-ancestor
24701431|NCT01458977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24701450|NCT01459146|Praziquantel|praziquantel|mesh-list
24701451|NCT01459146|Antimalarials|antimalarials|mesh-ancestor
24701452|NCT01459146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24701453|NCT01459146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25072553|NCT03400735|Cefdinir|cefdinir|mesh-list
25072554|NCT03400735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25072555|NCT03400735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25072556|NCT03400722|Clomiphene|clomiphene|mesh-list
25072557|NCT03400722|Hormones|hormones|mesh-list
25072558|NCT03400722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25072559|NCT03400722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072560|NCT03400722|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25072561|NCT03400722|Hormone Antagonists|hormone antagonists|mesh-ancestor
25072562|NCT03400722|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25072563|NCT03400722|Fertility Agents|fertility agents|mesh-ancestor
25072564|NCT03400722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25072565|NCT03400722|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25072566|NCT03400722|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25072567|NCT03400709|Acetylcysteine|acetylcysteine|mesh-list
25072568|NCT03400709|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25072569|NCT03400709|Antiviral Agents|antiviral agents|mesh-ancestor
25072570|NCT03400709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25072578|NCT03400709|Antidotes|antidotes|mesh-ancestor
25072579|NCT03400683|Letrozole|letrozole|mesh-list
25072580|NCT03400683|Misoprostol|misoprostol|mesh-list
25072581|NCT03400683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25202559|NCT02720783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25072582|NCT03400683|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25072583|NCT03400683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25072584|NCT03400683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25072585|NCT03400683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072586|NCT03400683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25072587|NCT03400683|Hormone Antagonists|hormone antagonists|mesh-ancestor
25072588|NCT03400683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25072589|NCT03400683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072590|NCT03400683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25072591|NCT03400683|Abortifacient Agents|abortifacient agents|mesh-ancestor
25072592|NCT03400683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25072593|NCT03400683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25852112|NCT00055653|Antifungal Agents|antifungal agents|mesh-ancestor
25852113|NCT00055653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25852114|NCT00055653|Dermatologic Agents|dermatologic agents|mesh-ancestor
25852115|NCT00055653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25852116|NCT00055653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25852117|NCT00055653|Antiemetics|antiemetics|mesh-ancestor
25852118|NCT00055653|Autonomic Agents|autonomic agents|mesh-ancestor
25240576|NCT05298683|Immunologic Factors|immunologic factors|mesh-ancestor
25240577|NCT05298683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25240579|NCT05298683|Growth Substances|growth substances|mesh-ancestor
25852119|NCT00055653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25852120|NCT00055653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25072594|NCT03400683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25072595|NCT03400683|Oxytocics|oxytocics|mesh-ancestor
25072596|NCT03400592|Irinotecan|irinotecan|mesh-list
25072597|NCT03400592|Nimotuzumab|nimotuzumab|mesh-list
25072598|NCT03400592|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25072599|NCT03400592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25072600|NCT03400592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25072601|NCT03400592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428963|NCT00241982|Hormones|hormones|mesh-ancestor
25072610|NCT03400423|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25072612|NCT03400423|Purinergic Agents|purinergic agents|mesh-ancestor
25072613|NCT03400423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25072614|NCT03400267|Acetaminophen|acetaminophen|mesh-list
25072615|NCT03400267|Fentanyl|fentanyl|mesh-list
25072616|NCT03400267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25072617|NCT03400267|Narcotics|narcotics|mesh-ancestor
25072618|NCT03400267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25072619|NCT03400267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072620|NCT03400267|Analgesics|analgesics|mesh-ancestor
25072621|NCT03400267|Sensory System Agents|sensory system agents|mesh-ancestor
25072622|NCT03400267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25072623|NCT03400267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25072624|NCT03400267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25072625|NCT03400267|Anesthetics, General|anesthetics, general|mesh-ancestor
25072626|NCT03400267|Anesthetics|anesthetics|mesh-ancestor
25072627|NCT03400267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25072629|NCT03400254|Hydroxychloroquine|hydroxychloroquine|mesh-list
25072630|NCT03400254|Gedatolisib|gedatolisib|mesh-list
25072631|NCT03400254|Antimalarials|antimalarials|mesh-ancestor
25072632|NCT03400254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25072633|NCT03400254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24701508|NCT01459380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24701509|NCT01459380|Veliparib|veliparib|mesh-list
24701510|NCT01459380|Endothelial Growth Factors|endothelial growth factors|mesh-list
24701511|NCT01459380|Antibodies|antibodies|mesh-list
24701512|NCT01459380|Immunoglobulins|immunoglobulins|mesh-list
24701513|NCT01459380|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24701514|NCT01459380|Immunoglobulin G|immunoglobulin g|mesh-list
24701515|NCT01459380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549838|NCT00717704|Dasatinib|dasatinib|mesh-list
24701516|NCT01459380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24701517|NCT01459380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24701518|NCT01459380|Growth Substances|growth substances|mesh-ancestor
24701519|NCT01459380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701520|NCT01459380|Growth Inhibitors|growth inhibitors|mesh-ancestor
24701521|NCT01459380|Immunologic Factors|immunologic factors|mesh-ancestor
24701522|NCT01459380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24701523|NCT01459380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25072646|NCT03400241|Respiratory System Agents|respiratory system agents|mesh-ancestor
25072647|NCT03400241|Parasympatholytics|parasympatholytics|mesh-ancestor
25072648|NCT03400241|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25072649|NCT03400241|Cholinergic Agents|cholinergic agents|mesh-ancestor
25072650|NCT03400241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25072651|NCT03400241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072652|NCT03400241|Anticonvulsants|anticonvulsants|mesh-ancestor
25072654|NCT03400189|Anticonvulsants|anticonvulsants|mesh-ancestor
25072655|NCT03400111|Acetaminophen|acetaminophen|mesh-list
25072656|NCT03400111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25072660|NCT03400111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072661|NCT03400111|Antipyretics|antipyretics|mesh-ancestor
25072662|NCT03400020|Ascorbic Acid|ascorbic acid|mesh-list
25072663|NCT03400020|Vitamins|vitamins|mesh-ancestor
25072664|NCT03400020|Micronutrients|micronutrients|mesh-ancestor
25072665|NCT03400020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072666|NCT03400020|Antioxidants|antioxidants|mesh-ancestor
25072667|NCT03400020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072668|NCT03400020|Protective Agents|protective agents|mesh-ancestor
25072669|NCT03399955|Amphotericin B|amphotericin b|mesh-list
25072676|NCT03399955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25072677|NCT03399955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25072678|NCT03399955|Antifungal Agents|antifungal agents|mesh-ancestor
25663667|NCT01661270|Growth Substances|growth substances|mesh-ancestor
25663668|NCT01661270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663669|NCT01661270|Growth Inhibitors|growth inhibitors|mesh-ancestor
24954003|NCT03879889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24954004|NCT03879889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954005|NCT03879889|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24954006|NCT03879889|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24954007|NCT03879889|Cholinergic Agents|cholinergic agents|mesh-ancestor
24954008|NCT03879889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24954009|NCT03879889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633865|NCT01131468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24633867|NCT01131468|Respiratory System Agents|respiratory system agents|mesh-ancestor
24633868|NCT01131468|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24633870|NCT01131468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633934|NCT01131728|Autonomic Agents|autonomic agents|mesh-ancestor
24633935|NCT01131728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24633936|NCT01131728|Respiratory System Agents|respiratory system agents|mesh-ancestor
24633937|NCT01131728|Nasal Decongestants|nasal decongestants|mesh-ancestor
24633938|NCT01131728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24633939|NCT01131728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24633940|NCT01131728|Sympathomimetics|sympathomimetics|mesh-ancestor
24633941|NCT01131728|Adrenergic Agents|adrenergic agents|mesh-ancestor
25072683|NCT03399903|Analgesics|analgesics|mesh-ancestor
25072684|NCT03399903|Sensory System Agents|sensory system agents|mesh-ancestor
25202560|NCT02720783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072685|NCT03399903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25072686|NCT03399903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072687|NCT03399903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25072688|NCT03399903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25072721|NCT03399708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24890529|NCT04482764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25072722|NCT03399708|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25072723|NCT03399708|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25072724|NCT03399708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25072725|NCT03399708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072727|NCT03399669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25072728|NCT03399669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25072729|NCT03399669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25072730|NCT03399669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072731|NCT03399643|Atezolizumab|atezolizumab|mesh-list
25072732|NCT03399643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25072733|NCT03399604|Treprostinil|treprostinil|mesh-list
25072734|NCT03399604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25072735|NCT03399526|Calcitriol|calcitriol|mesh-list
25072736|NCT03399526|Betamethasone|betamethasone|mesh-list
25072737|NCT03399526|Betamethasone Valerate|betamethasone valerate|mesh-list
25072738|NCT03399526|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24835584|NCT02183116|Meloxicam|meloxicam|mesh-list
24633942|NCT01131728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24633943|NCT01131741|Epinephrine|epinephrine|mesh-list
24633944|NCT01131741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24633945|NCT01131741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24633946|NCT01131741|Adrenergic Agents|adrenergic agents|mesh-ancestor
24633947|NCT01131741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24633948|NCT01131741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633952|NCT01131741|Autonomic Agents|autonomic agents|mesh-ancestor
24633985|NCT01131767|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24634040|NCT01131897|Nootropic Agents|nootropic agents|mesh-ancestor
24634041|NCT01131910|Vaccines|vaccines|mesh-list
25072740|NCT03399526|Clobetasol|clobetasol|mesh-list
25072741|NCT03399526|Prednicarbate|prednicarbate|mesh-list
25072742|NCT03399526|Calcipotriene|calcipotriene|mesh-list
25663670|NCT01661270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663671|NCT01661283|Bevacizumab|bevacizumab|mesh-list
25663672|NCT01661283|Everolimus|everolimus|mesh-list
25072743|NCT03399526|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25852122|NCT00055653|Hormones|hormones|mesh-ancestor
25072744|NCT03399526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25072745|NCT03399526|Glucocorticoids|glucocorticoids|mesh-ancestor
25072746|NCT03399526|Hormones|hormones|mesh-ancestor
25072747|NCT03399526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25072748|NCT03399526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072749|NCT03399526|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25072750|NCT03399526|Respiratory System Agents|respiratory system agents|mesh-ancestor
25072751|NCT03399526|Dermatologic Agents|dermatologic agents|mesh-ancestor
25072752|NCT03399526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25072753|NCT03399526|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25072754|NCT03399526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25072755|NCT03399526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072756|NCT03399526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25072757|NCT03399526|Vitamins|vitamins|mesh-ancestor
25072784|NCT03399474|Adrenergic Agents|adrenergic agents|mesh-ancestor
25072785|NCT03399474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25072786|NCT03399448|Cyclophosphamide|cyclophosphamide|mesh-list
25072787|NCT03399448|Fludarabine|fludarabine|mesh-list
25072788|NCT03399448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25072789|NCT03399448|Immunologic Factors|immunologic factors|mesh-ancestor
25072790|NCT03399448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072791|NCT03399448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25072792|NCT03399448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25072793|NCT03399448|Alkylating Agents|alkylating agents|mesh-ancestor
25072794|NCT03399448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072795|NCT03399448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25072796|NCT03399448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25072797|NCT03399435|Epinephrine|epinephrine|mesh-list
25072798|NCT03399435|Racepinephrine|racepinephrine|mesh-list
25072799|NCT03399435|Bupivacaine|bupivacaine|mesh-list
25072800|NCT03399435|Epinephryl borate|epinephryl borate|mesh-list
25072801|NCT03399435|Neosaxitoxin|neosaxitoxin|mesh-list
25072802|NCT03399435|Anesthetics, Local|anesthetics, local|mesh-ancestor
25072804|NCT03399435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25072805|NCT03399435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072806|NCT03399435|Sensory System Agents|sensory system agents|mesh-ancestor
25072837|NCT03399032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072839|NCT03399019|Dexmedetomidine|dexmedetomidine|mesh-list
25072840|NCT03399019|Propofol|propofol|mesh-list
25072841|NCT03399019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25072842|NCT03399019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25072843|NCT03399019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550328|NCT00720291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24550329|NCT00720304|Docetaxel|docetaxel|mesh-list
25072844|NCT03399019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25072845|NCT03399019|Anesthetics, General|anesthetics, general|mesh-ancestor
25072860|NCT03399019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25072861|NCT03399019|GABA Modulators|gaba modulators|mesh-ancestor
25072862|NCT03399019|GABA Agents|gaba agents|mesh-ancestor
25072863|NCT03398993|Clomiphene|clomiphene|mesh-list
25072864|NCT03398993|Enclomiphene|enclomiphene|mesh-list
25072865|NCT03398993|Zuclomiphene|zuclomiphene|mesh-list
25072867|NCT03398993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25072868|NCT03398993|Hormone Antagonists|hormone antagonists|mesh-ancestor
25072869|NCT03398993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25072870|NCT03398993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072871|NCT03398993|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25072872|NCT03398993|Fertility Agents|fertility agents|mesh-ancestor
25072873|NCT03398993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25072874|NCT03398993|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25072875|NCT03398993|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25072876|NCT03398941|Octreotide|octreotide|mesh-list
25072877|NCT03398941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24824944|NCT02126332|Analgesics|analgesics|mesh-ancestor
24634241|NCT01132586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24634242|NCT01132586|Immunologic Factors|immunologic factors|mesh-ancestor
24634243|NCT01132586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634244|NCT01132586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24634245|NCT01132586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24634246|NCT01132586|Growth Substances|growth substances|mesh-ancestor
24634247|NCT01132586|Growth Inhibitors|growth inhibitors|mesh-ancestor
24634248|NCT01132586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25072884|NCT03398876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072885|NCT03398876|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25072886|NCT03398876|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25072887|NCT03398876|Cholinergic Agents|cholinergic agents|mesh-ancestor
25072888|NCT03398876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25072889|NCT03398876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072891|NCT03398837|Lenabasum|lenabasum|mesh-list
25072892|NCT03398837|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25072893|NCT03398837|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25072894|NCT03398837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24429482|NCT00244153|Autonomic Agents|autonomic agents|mesh-ancestor
24634249|NCT01132586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24634250|NCT01132586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24550330|NCT00720304|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24634251|NCT01132586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634252|NCT01132599|Choline|choline|mesh-list
24634262|NCT01132638|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25072917|NCT03398811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25072918|NCT03398811|Contraceptive Agents|contraceptive agents|mesh-ancestor
25072919|NCT03398811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25072920|NCT03398811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25072921|NCT03398811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25072922|NCT03398811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25072923|NCT03398811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25072924|NCT03398811|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25072925|NCT03398811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25072926|NCT03398811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25072927|NCT03398785|Epinephrine|epinephrine|mesh-list
25072928|NCT03398785|Racepinephrine|racepinephrine|mesh-list
25072929|NCT03398785|Epinephryl borate|epinephryl borate|mesh-list
25072930|NCT03398785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24835773|NCT02183376|Linagliptin|linagliptin|mesh-list
25852123|NCT00055653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24429546|NCT00244309|Urological Agents|urological agents|mesh-ancestor
24634287|NCT01132677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24634288|NCT01132677|Viscosupplements|viscosupplements|mesh-ancestor
24634289|NCT01132703|Glyburide|glyburide|mesh-list
24634290|NCT01132703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24634291|NCT01132703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634292|NCT01132716|Valacyclovir|valacyclovir|mesh-list
24634293|NCT01132716|Antiviral Agents|antiviral agents|mesh-ancestor
24634294|NCT01132716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24634295|NCT01132729|Valacyclovir|valacyclovir|mesh-list
24634296|NCT01132729|Antiviral Agents|antiviral agents|mesh-ancestor
24634297|NCT01132729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24634298|NCT01132768|Atenolol|atenolol|mesh-list
24634299|NCT01132768|Olmesartan|olmesartan|mesh-list
25072931|NCT03398785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25072932|NCT03398785|Adrenergic Agents|adrenergic agents|mesh-ancestor
25072933|NCT03398785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25072934|NCT03398785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072935|NCT03398785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072936|NCT03398785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25072937|NCT03398785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25072938|NCT03398785|Autonomic Agents|autonomic agents|mesh-ancestor
25072939|NCT03398785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24429599|NCT00244504|Moxonidine|moxonidine|mesh-list
24634399|NCT01133366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24634401|NCT01133366|Antimetabolites|antimetabolites|mesh-ancestor
24634402|NCT01133366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852124|NCT00055653|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24634414|NCT01133444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634415|NCT01133444|Hormone Antagonists|hormone antagonists|mesh-ancestor
25072956|NCT03398577|Dapagliflozin|dapagliflozin|mesh-list
25072957|NCT03398577|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25072958|NCT03398577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072959|NCT03398577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25072960|NCT03398577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429671|NCT00244738|Castor Oil|castor oil|mesh-list
24634428|NCT01133470|Fexofenadine|fexofenadine|mesh-list
24634429|NCT01133470|Pseudoephedrine|pseudoephedrine|mesh-list
24634431|NCT01133470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24634536|NCT01133873|Respiratory System Agents|respiratory system agents|mesh-ancestor
24634537|NCT01133886|Decitabine|decitabine|mesh-list
24634538|NCT01133886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24634539|NCT01133886|Antimetabolites|antimetabolites|mesh-ancestor
25852125|NCT00055653|Protective Agents|protective agents|mesh-ancestor
25852126|NCT00055666|Beclomethasone|beclomethasone|mesh-list
25852127|NCT00055666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24634540|NCT01133886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634542|NCT01133886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634543|NCT01133912|Gemcitabine|gemcitabine|mesh-list
24634544|NCT01133912|Paclitaxel|paclitaxel|mesh-list
24634545|NCT01133912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24634546|NCT01133912|Lapatinib|lapatinib|mesh-list
24634547|NCT01133912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24634548|NCT01133912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24634549|NCT01133912|Tubulin Modulators|tubulin modulators|mesh-ancestor
24634550|NCT01133912|Antimitotic Agents|antimitotic agents|mesh-ancestor
24634585|NCT01134185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634647|NCT01134484|Dexamethasone|dexamethasone|mesh-list
24634648|NCT01134484|Bortezomib|bortezomib|mesh-list
24634649|NCT01134484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24634650|NCT01134484|Antiemetics|antiemetics|mesh-ancestor
24634651|NCT01134484|Autonomic Agents|autonomic agents|mesh-ancestor
24634652|NCT01134484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24634653|NCT01134484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634654|NCT01134484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24634655|NCT01134484|Glucocorticoids|glucocorticoids|mesh-ancestor
24634656|NCT01134484|Hormones|hormones|mesh-ancestor
24429932|NCT00245505|Mesalamine|mesalamine|mesh-list
25073036|NCT03397888|Anticoagulants|anticoagulants|mesh-ancestor
25073037|NCT03397875|Zinc Oxide|zinc oxide|mesh-list
25073038|NCT03397875|Dermatologic Agents|dermatologic agents|mesh-ancestor
25073039|NCT03397875|Sunscreening Agents|sunscreening agents|mesh-ancestor
25073040|NCT03397875|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25073041|NCT03397875|Protective Agents|protective agents|mesh-ancestor
25073042|NCT03397875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073043|NCT03397862|Donepezil|donepezil|mesh-list
24469867|NCT00387608|Veliparib|veliparib|mesh-list
25073044|NCT03397862|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25073045|NCT03397862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073046|NCT03397862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073047|NCT03397862|Cholinergic Agents|cholinergic agents|mesh-ancestor
25073048|NCT03397862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24825001|NCT02126917|Ethanol|ethanol|mesh-list
25073084|NCT03397446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25073085|NCT03397264|Aflibercept|aflibercept|mesh-list
25073086|NCT03397264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25073087|NCT03397264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24634703|NCT01134692|Adrenergic Agents|adrenergic agents|mesh-ancestor
24634704|NCT01134692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24634705|NCT01134692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634706|NCT01134692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634707|NCT01134692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24634708|NCT01134692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24634709|NCT01134692|Vasodilator Agents|vasodilator agents|mesh-ancestor
24634710|NCT01134692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24634722|NCT01134718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073102|NCT03397173|Ascorbic Acid|ascorbic acid|mesh-list
25073103|NCT03397173|Azacitidine|azacitidine|mesh-list
25073104|NCT03397173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25073105|NCT03397173|Antimetabolites|antimetabolites|mesh-ancestor
25073106|NCT03397173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073107|NCT03397173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073108|NCT03397173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073109|NCT03397173|Antioxidants|antioxidants|mesh-ancestor
25073110|NCT03397173|Protective Agents|protective agents|mesh-ancestor
25073111|NCT03397173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073113|NCT03397173|Micronutrients|micronutrients|mesh-ancestor
25073114|NCT03397082|Lidocaine|lidocaine|mesh-list
25073115|NCT03397082|Anesthetics, Local|anesthetics, local|mesh-ancestor
25073116|NCT03397082|Anesthetics|anesthetics|mesh-ancestor
24954020|NCT03879837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835941|NCT02183610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835943|NCT02183623|Linagliptin|linagliptin|mesh-list
24634726|NCT01134848|Neostigmine|neostigmine|mesh-list
24634727|NCT01134848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24634728|NCT01134848|Narcotics|narcotics|mesh-ancestor
24634729|NCT01134848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25852128|NCT00055666|Glucocorticoids|glucocorticoids|mesh-ancestor
24634730|NCT01134848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634731|NCT01134848|Analgesics|analgesics|mesh-ancestor
24634732|NCT01134848|Sensory System Agents|sensory system agents|mesh-ancestor
24634733|NCT01134848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24634734|NCT01134848|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25852129|NCT00055666|Hormones|hormones|mesh-ancestor
25073117|NCT03397082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24954021|NCT03879837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954022|NCT03879837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25073122|NCT03397082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25073123|NCT03397082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24634743|NCT01134848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24634744|NCT01134861|Cisplatin|cisplatin|mesh-list
25202561|NCT02720692|Meloxicam|meloxicam|mesh-list
24634749|NCT01134861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24634750|NCT01134861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24634751|NCT01134861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634752|NCT01134861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634753|NCT01134861|Tubulin Modulators|tubulin modulators|mesh-ancestor
24634754|NCT01134861|Antimitotic Agents|antimitotic agents|mesh-ancestor
24634915|NCT01135771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24634916|NCT01135771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634918|NCT01135927|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24634919|NCT01135927|Insulin Detemir|insulin detemir|mesh-list
24634920|NCT01135927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24634921|NCT01135927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634922|NCT01135953|Cycloserine|cycloserine|mesh-list
25073147|NCT03396861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073148|NCT03396601|Ketamine|ketamine|mesh-list
25073149|NCT03396601|Analgesics|analgesics|mesh-ancestor
24634931|NCT01136005|Provitamins|provitamins|mesh-list
24634932|NCT01136005|Vitamins|vitamins|mesh-ancestor
24634933|NCT01136005|Micronutrients|micronutrients|mesh-ancestor
24634934|NCT01136005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634935|NCT01136031|Paclitaxel|paclitaxel|mesh-list
24634936|NCT01136031|Irinotecan|irinotecan|mesh-list
24634938|NCT01136031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24634939|NCT01136031|Tubulin Modulators|tubulin modulators|mesh-ancestor
24634940|NCT01136031|Antimitotic Agents|antimitotic agents|mesh-ancestor
25073204|NCT03396393|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25073205|NCT03396393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25073206|NCT03396380|Calcium, Dietary|calcium, dietary|mesh-list
25073208|NCT03396380|Citric Acid|citric acid|mesh-list
25073209|NCT03396380|Sodium Citrate|sodium citrate|mesh-list
25073210|NCT03396380|Clomiphene|clomiphene|mesh-list
25073211|NCT03396380|Enclomiphene|enclomiphene|mesh-list
25073212|NCT03396380|Zuclomiphene|zuclomiphene|mesh-list
25073213|NCT03396380|Calcium|calcium|mesh-list
25073214|NCT03396380|Vitamins|vitamins|mesh-ancestor
25073215|NCT03396380|Micronutrients|micronutrients|mesh-ancestor
25073216|NCT03396380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073217|NCT03396380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25073218|NCT03396380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25073219|NCT03396380|Anticoagulants|anticoagulants|mesh-ancestor
25073220|NCT03396380|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25073221|NCT03396380|Chelating Agents|chelating agents|mesh-ancestor
24634954|NCT01136213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24634955|NCT01136213|Antidepressive Agents|antidepressive agents|mesh-ancestor
24634956|NCT01136213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24634957|NCT01136213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24634958|NCT01136213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24634959|NCT01136213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634961|NCT01136252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24634977|NCT01136278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634978|NCT01136278|Hallucinogens|hallucinogens|mesh-ancestor
24634979|NCT01136278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24634980|NCT01136278|Serotonin Agents|serotonin agents|mesh-ancestor
24634981|NCT01136278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24634982|NCT01136278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24635024|NCT01136499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635025|NCT01136499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635026|NCT01136525|Valacyclovir|valacyclovir|mesh-list
24635027|NCT01136525|Antiviral Agents|antiviral agents|mesh-ancestor
24430314|NCT00247078|Antivenins|antivenins|mesh-list
25073231|NCT03396380|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25073232|NCT03396315|Zoledronic Acid|zoledronic acid|mesh-list
25202562|NCT02720692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25073233|NCT03396315|Alendronate|alendronate|mesh-list
25073234|NCT03396315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25073235|NCT03396315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073236|NCT03396250|Diphenhydramine|diphenhydramine|mesh-list
25073237|NCT03396250|Promethazine|promethazine|mesh-list
24635071|NCT01136850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24635072|NCT01136850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24635073|NCT01136850|Amebicides|amebicides|mesh-ancestor
24635074|NCT01136850|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24635075|NCT01136850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25852130|NCT00055666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24635113|NCT01137019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073239|NCT03396250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25073240|NCT03396250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25073241|NCT03396250|Analgesics|analgesics|mesh-ancestor
25073242|NCT03396250|Sensory System Agents|sensory system agents|mesh-ancestor
25073243|NCT03396250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25073244|NCT03396250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073245|NCT03396250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25073246|NCT03396250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24836114|NCT02184117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836115|NCT02184247|Theophylline|theophylline|mesh-list
24635169|NCT01137591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635170|NCT01137591|Antipyretics|antipyretics|mesh-ancestor
24635171|NCT01137591|Antiviral Agents|antiviral agents|mesh-ancestor
24635172|NCT01137591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24635173|NCT01137591|Expectorants|expectorants|mesh-ancestor
24635174|NCT01137591|Respiratory System Agents|respiratory system agents|mesh-ancestor
24635175|NCT01137591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24635176|NCT01137591|Antioxidants|antioxidants|mesh-ancestor
24635177|NCT01137591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635179|NCT01137656|Acetylcholine|acetylcholine|mesh-list
24635180|NCT01137656|Vasodilator Agents|vasodilator agents|mesh-ancestor
24635182|NCT01137656|Cholinergic Agents|cholinergic agents|mesh-ancestor
24635183|NCT01137656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24635255|NCT01137955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24635256|NCT01137955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24635257|NCT01137955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24635259|NCT01137994|Vinorelbine|vinorelbine|mesh-list
24635260|NCT01137994|Docetaxel|docetaxel|mesh-list
25852131|NCT00055666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852132|NCT00055666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24635262|NCT01137994|Lapatinib|lapatinib|mesh-list
24635263|NCT01137994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24635264|NCT01137994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24635265|NCT01137994|Tubulin Modulators|tubulin modulators|mesh-ancestor
24635266|NCT01137994|Antimitotic Agents|antimitotic agents|mesh-ancestor
24635267|NCT01137994|Mitosis Modulators|mitosis modulators|mesh-ancestor
24635268|NCT01137994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635269|NCT01137994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25073247|NCT03396250|Gout Suppressants|gout suppressants|mesh-ancestor
25073248|NCT03396250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25073249|NCT03396250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073250|NCT03396250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073251|NCT03396250|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24958808|NCT03829917|Antifungal Agents|antifungal agents|mesh-ancestor
25073252|NCT03396250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25073253|NCT03396250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25073255|NCT03396250|Anesthetics|anesthetics|mesh-ancestor
24635285|NCT01138085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635286|NCT01138085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635287|NCT01138137|Acetylcysteine|acetylcysteine|mesh-list
24635288|NCT01138137|Paclitaxel|paclitaxel|mesh-list
24635289|NCT01138137|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24635290|NCT01138137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24635291|NCT01138137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24635292|NCT01138137|Tubulin Modulators|tubulin modulators|mesh-ancestor
24635293|NCT01138137|Antimitotic Agents|antimitotic agents|mesh-ancestor
24635294|NCT01138137|Mitosis Modulators|mitosis modulators|mesh-ancestor
24635295|NCT01138137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635296|NCT01138137|Antiviral Agents|antiviral agents|mesh-ancestor
24635297|NCT01138137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24635298|NCT01138137|Expectorants|expectorants|mesh-ancestor
24635321|NCT01138423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635324|NCT01138449|Micronutrients|micronutrients|mesh-ancestor
24635391|NCT01138852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852133|NCT00055666|Respiratory System Agents|respiratory system agents|mesh-ancestor
24635392|NCT01138904|Oxaliplatin|oxaliplatin|mesh-list
24635398|NCT01138904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635400|NCT01138956|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24635401|NCT01138956|Antiviral Agents|antiviral agents|mesh-ancestor
24635402|NCT01138956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24635403|NCT01138956|Expectorants|expectorants|mesh-ancestor
24635404|NCT01138956|Respiratory System Agents|respiratory system agents|mesh-ancestor
24635405|NCT01138956|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24635409|NCT01138956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073266|NCT03396107|Dexamethasone|dexamethasone|mesh-list
25073267|NCT03396107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25073268|NCT03396107|Antiemetics|antiemetics|mesh-ancestor
25073269|NCT03396107|Autonomic Agents|autonomic agents|mesh-ancestor
25073270|NCT03396107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25073271|NCT03396107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893970|NCT04445636|Dexmedetomidine|dexmedetomidine|mesh-list
25073272|NCT03396107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25073273|NCT03396107|Glucocorticoids|glucocorticoids|mesh-ancestor
25073275|NCT03396107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25073276|NCT03396107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25073277|NCT03396107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24430717|NCT00249132|Dopamine Agents|dopamine agents|mesh-ancestor
24635437|NCT01139203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24635439|NCT01139203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635440|NCT01139203|Antiviral Agents|antiviral agents|mesh-ancestor
24635441|NCT01139203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24635442|NCT01139203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24635487|NCT01139723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24635488|NCT01139723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24635489|NCT01139723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24635490|NCT01139723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24635491|NCT01139723|Growth Substances|growth substances|mesh-ancestor
24635492|NCT01139723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635493|NCT01139723|Growth Inhibitors|growth inhibitors|mesh-ancestor
24635494|NCT01139749|Salicylic Acid|salicylic acid|mesh-list
24635495|NCT01139749|Ciclopirox|ciclopirox|mesh-list
24635496|NCT01139749|Salicylates|salicylates|mesh-list
24635497|NCT01139749|Isotretinoin|isotretinoin|mesh-list
24635498|NCT01139749|Dermatologic Agents|dermatologic agents|mesh-ancestor
24635499|NCT01139749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24635500|NCT01139749|Antifungal Agents|antifungal agents|mesh-ancestor
25073299|NCT03395977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25073300|NCT03395951|Diuretics|diuretics|mesh-list
25073301|NCT03395951|Natriuretic Agents|natriuretic agents|mesh-ancestor
25073302|NCT03395951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635501|NCT01139749|Keratolytic Agents|keratolytic agents|mesh-ancestor
24635502|NCT01139749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24635504|NCT01139749|Analgesics|analgesics|mesh-ancestor
24635505|NCT01139749|Sensory System Agents|sensory system agents|mesh-ancestor
24635506|NCT01139749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24635507|NCT01139749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073320|NCT03395873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25073321|NCT03395873|Antimetabolites|antimetabolites|mesh-ancestor
25073322|NCT03395873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663673|NCT01661283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25663674|NCT01661283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663675|NCT01661283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25073323|NCT03395873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073324|NCT03395873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073325|NCT03395873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24954050|NCT03879746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25073326|NCT03395847|Pembrolizumab|pembrolizumab|mesh-list
25073327|NCT03395847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25073328|NCT03395847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073329|NCT03395756|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25073330|NCT03395756|Medroxyprogesterone|medroxyprogesterone|mesh-list
25073331|NCT03395756|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25073332|NCT03395756|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25073333|NCT03395756|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25073334|NCT03395756|Contraceptive Agents|contraceptive agents|mesh-ancestor
25073335|NCT03395756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25073336|NCT03395756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073337|NCT03395756|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25073338|NCT03395756|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25852134|NCT00055679|Cyclophosphamide|cyclophosphamide|mesh-list
25852135|NCT00055679|Fluorouracil|fluorouracil|mesh-list
25073339|NCT03395756|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25073340|NCT03395756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25073341|NCT03395756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073343|NCT03395730|Oxytocics|oxytocics|mesh-ancestor
25073344|NCT03395730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25073345|NCT03395730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073346|NCT03395665|Estradiol|estradiol|mesh-list
24836211|NCT02184351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24836212|NCT02184364|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24836213|NCT02184364|Estrogens|estrogens|mesh-ancestor
25852136|NCT00055679|Epirubicin|epirubicin|mesh-list
25852137|NCT00055679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25852138|NCT00055679|Immunologic Factors|immunologic factors|mesh-ancestor
25852139|NCT00055679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852140|NCT00055679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25852141|NCT00055679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24635545|NCT01140100|Propofol|propofol|mesh-list
24635546|NCT01140100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24635547|NCT01140100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24635548|NCT01140100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635551|NCT01140100|Anesthetics|anesthetics|mesh-ancestor
24635552|NCT01140100|Anticonvulsants|anticonvulsants|mesh-ancestor
24635553|NCT01140100|GABA Modulators|gaba modulators|mesh-ancestor
24635554|NCT01140100|GABA Agents|gaba agents|mesh-ancestor
24635555|NCT01140100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665928|NCT01315938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24635556|NCT01140100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635558|NCT01140126|Antibodies|antibodies|mesh-list
24635559|NCT01140126|Immunologic Factors|immunologic factors|mesh-ancestor
24635601|NCT01140425|Moxifloxacin|moxifloxacin|mesh-list
24635602|NCT01140425|PF 232798|pf 232798|mesh-list
24635603|NCT01140425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24635604|NCT01140425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25073348|NCT03395665|Estrogens|estrogens|mesh-ancestor
25073349|NCT03395665|Hormones|hormones|mesh-ancestor
25073350|NCT03395665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25073351|NCT03395665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073352|NCT03395665|Progestins|progestins|mesh-ancestor
25073353|NCT03395587|Temozolomide|temozolomide|mesh-list
25073354|NCT03395587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25073355|NCT03395587|Alkylating Agents|alkylating agents|mesh-ancestor
25073356|NCT03395587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073357|NCT03395587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073358|NCT03395574|Terlipressin|terlipressin|mesh-list
25073359|NCT03395574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25073360|NCT03395574|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25073361|NCT03395470|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25073362|NCT03395470|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25073363|NCT03395470|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25073364|NCT03395470|Antimetabolites|antimetabolites|mesh-ancestor
25073365|NCT03395470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073366|NCT03395470|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25073367|NCT03395470|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25073368|NCT03395470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073369|NCT03395405|Nitazoxanide|nitazoxanide|mesh-list
25073370|NCT03395405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25852142|NCT00055679|Alkylating Agents|alkylating agents|mesh-ancestor
24789621|NCT01938183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24789622|NCT01938183|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24789623|NCT01938183|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24789625|NCT01938235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24789626|NCT01938235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663676|NCT01661283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25663677|NCT01661283|Growth Substances|growth substances|mesh-ancestor
25663678|NCT01661283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789627|NCT01938235|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24789628|NCT01938235|Incretins|incretins|mesh-ancestor
24789629|NCT01938235|Hormones|hormones|mesh-ancestor
24789630|NCT01938235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25073371|NCT03395405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25073372|NCT03395262|Caffeine|caffeine|mesh-list
24786777|NCT01921790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25852143|NCT00055679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852144|NCT00055679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24635605|NCT01140425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24635606|NCT01140425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24635608|NCT01140425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635609|NCT01140425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24635610|NCT01140425|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24635651|NCT01140529|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24431250|NCT00250978|Bevacizumab|bevacizumab|mesh-list
24954055|NCT03879746|Adrenergic Agents|adrenergic agents|mesh-ancestor
24954056|NCT03879746|Urological Agents|urological agents|mesh-ancestor
24954058|NCT03879590|Doxofylline|doxofylline|mesh-list
24635688|NCT01140828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635689|NCT01140893|Exenatide|exenatide|mesh-list
24635690|NCT01140893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24635691|NCT01140893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635692|NCT01140893|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24635693|NCT01140893|Incretins|incretins|mesh-ancestor
24635694|NCT01140893|Hormones|hormones|mesh-ancestor
24635722|NCT01140971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24635723|NCT01140971|Oxytocics|oxytocics|mesh-ancestor
25852145|NCT00055679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25852146|NCT00055679|Antimetabolites|antimetabolites|mesh-ancestor
25852147|NCT00055679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25852148|NCT00055679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25852149|NCT00055679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24954059|NCT03879590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24954060|NCT03879590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24954061|NCT03879590|Autonomic Agents|autonomic agents|mesh-ancestor
24954062|NCT03879590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24954063|NCT03879590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954064|NCT03879590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24954065|NCT03879590|Respiratory System Agents|respiratory system agents|mesh-ancestor
24954067|NCT03879590|Hormones|hormones|mesh-ancestor
24635806|NCT01141244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635862|NCT01141465|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24635864|NCT01141465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24635866|NCT01141465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25852150|NCT00055679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25852151|NCT00055679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852152|NCT00055718|Silymarin|silymarin|mesh-list
24635867|NCT01141465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635868|NCT01141465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24666077|NCT01317017|Interferon-gamma|interferon-gamma|mesh-list
24635869|NCT01141465|Respiratory System Agents|respiratory system agents|mesh-ancestor
24635870|NCT01141465|Dermatologic Agents|dermatologic agents|mesh-ancestor
24635871|NCT01141465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24635872|NCT01141465|Glucocorticoids|glucocorticoids|mesh-ancestor
24635873|NCT01141465|Hormones|hormones|mesh-ancestor
25663679|NCT01661283|Growth Inhibitors|growth inhibitors|mesh-ancestor
25663680|NCT01661283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25663681|NCT01661283|Immunologic Factors|immunologic factors|mesh-ancestor
25663682|NCT01661595|Sildenafil Citrate|sildenafil citrate|mesh-list
25663683|NCT01661595|Tadalafil|tadalafil|mesh-list
25663684|NCT01661595|Vasodilator Agents|vasodilator agents|mesh-ancestor
25663685|NCT01661595|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25663686|NCT01661595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25663687|NCT01661595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663688|NCT01661595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852153|NCT00055718|Antioxidants|antioxidants|mesh-ancestor
25006675|NCT04785625|Bupivacaine|bupivacaine|mesh-list
25006676|NCT04785625|Anesthetics, Local|anesthetics, local|mesh-ancestor
24825137|NCT02127593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636012|NCT01142414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636013|NCT01142414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24636014|NCT01142414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24636049|NCT01142505|Natriuretic Agents|natriuretic agents|mesh-ancestor
24636051|NCT01142518|Interferon-beta|interferon-beta|mesh-list
24636052|NCT01142518|Interferon beta-1a|interferon beta-1a|mesh-list
24636053|NCT01142518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24636054|NCT01142518|Antiviral Agents|antiviral agents|mesh-ancestor
24636055|NCT01142518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25073415|NCT03395093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25073416|NCT03395093|Narcotics|narcotics|mesh-ancestor
25073417|NCT03395093|Analgesics|analgesics|mesh-ancestor
25073418|NCT03395093|Sensory System Agents|sensory system agents|mesh-ancestor
25073419|NCT03395093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25073420|NCT03395093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25073421|NCT03395093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25073422|NCT03395093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25073423|NCT03395093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25073424|NCT03395093|GABA Modulators|gaba modulators|mesh-ancestor
25073425|NCT03395093|GABA Agents|gaba agents|mesh-ancestor
24836306|NCT02185196|Cholecalciferol|cholecalciferol|mesh-list
24836307|NCT02185196|Vitamins|vitamins|mesh-ancestor
24836308|NCT02185196|Micronutrients|micronutrients|mesh-ancestor
25852154|NCT00055718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836309|NCT02185196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836310|NCT02185196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24636056|NCT01142518|Immunologic Factors|immunologic factors|mesh-ancestor
24636057|NCT01142518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636059|NCT01142557|Interferons|interferons|mesh-list
24636060|NCT01142557|Interferon-beta|interferon-beta|mesh-list
24636061|NCT01142557|Interferon beta-1a|interferon beta-1a|mesh-list
24636062|NCT01142557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24636063|NCT01142557|Antiviral Agents|antiviral agents|mesh-ancestor
24636064|NCT01142557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24636065|NCT01142557|Immunologic Factors|immunologic factors|mesh-ancestor
24636102|NCT01142700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24636104|NCT01142778|Trastuzumab|trastuzumab|mesh-list
24636105|NCT01142778|Docetaxel|docetaxel|mesh-list
24636106|NCT01142778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25073427|NCT03395093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073428|NCT03395028|Lenograstim|lenograstim|mesh-list
25073429|NCT03395028|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25073430|NCT03395028|Immunologic Factors|immunologic factors|mesh-ancestor
25073431|NCT03395028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073432|NCT03395002|Fluticasone|fluticasone|mesh-list
25073433|NCT03395002|Xhance|xhance|mesh-list
25073434|NCT03395002|Tiotropium Bromide|tiotropium bromide|mesh-list
25073435|NCT03395002|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24636282|NCT01144390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24636284|NCT01144390|Respiratory System Agents|respiratory system agents|mesh-ancestor
24636285|NCT01144533|Hyaluronic Acid|hyaluronic acid|mesh-list
24636286|NCT01144533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24636304|NCT01144676|Antiviral Agents|antiviral agents|mesh-ancestor
24636305|NCT01144676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24636306|NCT01144702|Artesunate|artesunate|mesh-list
24636307|NCT01144702|Mefloquine|mefloquine|mesh-list
24636308|NCT01144702|Antimalarials|antimalarials|mesh-ancestor
24636309|NCT01144702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24636310|NCT01144702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24636313|NCT01144702|Antiviral Agents|antiviral agents|mesh-ancestor
24636341|NCT01144910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073446|NCT03395002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25073447|NCT03395002|Cholinergic Agents|cholinergic agents|mesh-ancestor
25073448|NCT03395002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24825146|NCT02127684|Growth Inhibitors|growth inhibitors|mesh-ancestor
24636464|NCT01145612|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24636465|NCT01145612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24636466|NCT01145612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25663689|NCT01661595|Urological Agents|urological agents|mesh-ancestor
25663690|NCT01661621|Doxazosin|doxazosin|mesh-list
24636468|NCT01145612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24636469|NCT01145677|Topiramate|topiramate|mesh-list
25852155|NCT00055718|Protective Agents|protective agents|mesh-ancestor
25852156|NCT00055718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852157|NCT00055757|Gemcitabine|gemcitabine|mesh-list
25852158|NCT00055757|Cisplatin|cisplatin|mesh-list
25423932|NCT02316106|Daratumumab|daratumumab|mesh-list
24816138|NCT02074280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24636472|NCT01145677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636473|NCT01145703|Vitamin D|vitamin d|mesh-list
24636474|NCT01145703|Ergocalciferols|ergocalciferols|mesh-list
25852159|NCT00055757|Tipifarnib|tipifarnib|mesh-list
25852160|NCT00055757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852161|NCT00055757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25852162|NCT00055757|Antimetabolites|antimetabolites|mesh-ancestor
25852163|NCT00055757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852164|NCT00055757|Antiviral Agents|antiviral agents|mesh-ancestor
25852165|NCT00055757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25852166|NCT00055757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852167|NCT00055757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25852168|NCT00055757|Immunologic Factors|immunologic factors|mesh-ancestor
24721485|NCT01574742|Minocycline|minocycline|mesh-list
25202563|NCT02720692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25202564|NCT02720692|Analgesics|analgesics|mesh-ancestor
25852169|NCT00055757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852170|NCT00055770|Docetaxel|docetaxel|mesh-list
25073471|NCT03394989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25073472|NCT03394989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073473|NCT03394989|Glucocorticoids|glucocorticoids|mesh-ancestor
25073474|NCT03394989|Hormones|hormones|mesh-ancestor
25073475|NCT03394989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25073476|NCT03394989|Sympathomimetics|sympathomimetics|mesh-ancestor
24836362|NCT02185456|Miconazole|miconazole|mesh-list
24636534|NCT01145976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24636536|NCT01146002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24636537|NCT01146002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24636538|NCT01146002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25852171|NCT00055770|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25852172|NCT00055770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852173|NCT00055770|Tubulin Modulators|tubulin modulators|mesh-ancestor
25852174|NCT00055770|Antimitotic Agents|antimitotic agents|mesh-ancestor
25852175|NCT00055770|Mitosis Modulators|mitosis modulators|mesh-ancestor
25852176|NCT00055770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852177|NCT00055770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24636601|NCT01146145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24636602|NCT01146145|Anesthetics, General|anesthetics, general|mesh-ancestor
24636603|NCT01146145|Anesthetics|anesthetics|mesh-ancestor
24636604|NCT01146145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24636605|NCT01146145|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24636606|NCT01146145|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24636607|NCT01146145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24636608|NCT01146145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636609|NCT01146145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24636610|NCT01146145|Narcotics|narcotics|mesh-ancestor
24636611|NCT01146301|Clopidogrel|clopidogrel|mesh-list
25852178|NCT00055770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636612|NCT01146301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24636613|NCT01146301|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24636614|NCT01146301|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24636615|NCT01146301|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25073477|NCT03394950|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25073478|NCT03394950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25073479|NCT03394950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24636616|NCT01146301|Purinergic Agents|purinergic agents|mesh-ancestor
24636617|NCT01146301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25852179|NCT00055809|Interferons|interferons|mesh-list
24636618|NCT01146301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636619|NCT01146301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636650|NCT01146535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636651|NCT01146535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636719|NCT01147029|Growth Substances|growth substances|mesh-ancestor
24636720|NCT01147029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636721|NCT01147029|Growth Inhibitors|growth inhibitors|mesh-ancestor
24636722|NCT01147029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852180|NCT00055809|Interferon-alpha|interferon-alpha|mesh-list
24636724|NCT01147133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24636725|NCT01147133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24636726|NCT01147133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24636727|NCT01147133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24636728|NCT01147133|Purinergic Agents|purinergic agents|mesh-ancestor
25663691|NCT01661621|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24636732|NCT01147146|Fentanyl|fentanyl|mesh-list
24730763|NCT01630226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730764|NCT01630278|Ibuprofen|ibuprofen|mesh-list
24730765|NCT01630278|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24789665|NCT01938300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24636750|NCT01147146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24636751|NCT01147146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24636752|NCT01147146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24636754|NCT01147146|GABA Agents|gaba agents|mesh-ancestor
24636755|NCT01147146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24636756|NCT01147146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636757|NCT01147146|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24636758|NCT01147146|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25073501|NCT03394807|Sensory System Agents|sensory system agents|mesh-ancestor
25073502|NCT03394807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25073503|NCT03394729|Propolis|propolis|mesh-list
25073504|NCT03394729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25073505|NCT03394586|Golimumab|golimumab|mesh-list
25073506|NCT03394586|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24636810|NCT01147510|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24636811|NCT01147510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24636812|NCT01147510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636814|NCT01147523|Spironolactone|spironolactone|mesh-list
24636815|NCT01147523|Vitamins|vitamins|mesh-ancestor
24636816|NCT01147523|Micronutrients|micronutrients|mesh-ancestor
24636817|NCT01147523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636818|NCT01147523|Antioxidants|antioxidants|mesh-ancestor
25852181|NCT00055809|Interferon alpha-2|interferon alpha-2|mesh-list
24636819|NCT01147523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636820|NCT01147523|Protective Agents|protective agents|mesh-ancestor
24636821|NCT01147523|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24636822|NCT01147523|Hormone Antagonists|hormone antagonists|mesh-ancestor
24636823|NCT01147523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24636824|NCT01147523|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24636825|NCT01147523|Diuretics|diuretics|mesh-ancestor
24636826|NCT01147523|Natriuretic Agents|natriuretic agents|mesh-ancestor
24636827|NCT01147588|Esomeprazole|esomeprazole|mesh-list
24636828|NCT01147588|Omeprazole|omeprazole|mesh-list
24636829|NCT01147588|Lansoprazole|lansoprazole|mesh-list
24636830|NCT01147588|Dexlansoprazole|dexlansoprazole|mesh-list
24636831|NCT01147588|Clopidogrel|clopidogrel|mesh-list
24636832|NCT01147588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25852182|NCT00055809|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24636834|NCT01147588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24636836|NCT01147588|Purinergic Agents|purinergic agents|mesh-ancestor
24636837|NCT01147588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24636838|NCT01147588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636839|NCT01147588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636840|NCT01147588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24636841|NCT01147588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24636842|NCT01147588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24666411|NCT01319214|Propranolol|propranolol|mesh-list
24636849|NCT01147692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636851|NCT01147692|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24636892|NCT01147757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24636894|NCT01147770|Progestins|progestins|mesh-ancestor
24636895|NCT01147770|Hormones|hormones|mesh-ancestor
24636896|NCT01147770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24636897|NCT01147770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636898|NCT01148004|Ritonavir|ritonavir|mesh-list
24636899|NCT01148004|Lopinavir|lopinavir|mesh-list
24836400|NCT02185690|Carboplatin|carboplatin|mesh-list
24636905|NCT01148004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636906|NCT01148004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24636907|NCT01148004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24636924|NCT01148043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24636974|NCT01148277|Fentanyl|fentanyl|mesh-list
24636975|NCT01148277|Midazolam|midazolam|mesh-list
24636976|NCT01148277|Propofol|propofol|mesh-list
24636977|NCT01148277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25663692|NCT01661621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25663693|NCT01661621|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25663694|NCT01661621|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25663695|NCT01661621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24636978|NCT01148277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24731110|NCT01632436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731111|NCT01632514|Cholecalciferol|cholecalciferol|mesh-list
24731113|NCT01632514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24731115|NCT01632514|Vitamins|vitamins|mesh-ancestor
24636979|NCT01148277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636980|NCT01148277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24636981|NCT01148277|Anesthetics, General|anesthetics, general|mesh-ancestor
24636982|NCT01148277|Anesthetics|anesthetics|mesh-ancestor
24636983|NCT01148277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24636984|NCT01148277|Narcotics|narcotics|mesh-ancestor
24637029|NCT01148342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637030|NCT01148342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24637031|NCT01148342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25073549|NCT03394222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25073550|NCT03394222|Autonomic Agents|autonomic agents|mesh-ancestor
25073551|NCT03394222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25073552|NCT03394222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836434|NCT02185859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24637106|NCT01148615|Antimitotic Agents|antimitotic agents|mesh-ancestor
24666469|NCT01319357|Hormones|hormones|mesh-ancestor
24637107|NCT01148615|Mitosis Modulators|mitosis modulators|mesh-ancestor
24637108|NCT01148615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637109|NCT01148615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24637110|NCT01148615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24637111|NCT01148615|Growth Substances|growth substances|mesh-ancestor
24637112|NCT01148615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637113|NCT01148615|Growth Inhibitors|growth inhibitors|mesh-ancestor
24637115|NCT01148628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637141|NCT01148992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637143|NCT01149005|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24637144|NCT01149005|Insulin Lispro|insulin lispro|mesh-list
24637145|NCT01149005|Insulin Aspart|insulin aspart|mesh-list
24637146|NCT01149005|Insulin, Short-Acting|insulin, short-acting|mesh-list
24637147|NCT01149005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24637148|NCT01149005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637150|NCT01149018|Hallucinogens|hallucinogens|mesh-ancestor
24637151|NCT01149018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637152|NCT01149018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24637153|NCT01149018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24637154|NCT01149018|Analgesics|analgesics|mesh-ancestor
24637155|NCT01149018|Sensory System Agents|sensory system agents|mesh-ancestor
24637156|NCT01149018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24637157|NCT01149018|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24637201|NCT01149278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24637204|NCT01149304|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24637205|NCT01149304|Anticoagulants|anticoagulants|mesh-ancestor
24637263|NCT01149564|Sensory System Agents|sensory system agents|mesh-ancestor
24637264|NCT01149564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24637265|NCT01149564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637266|NCT01149564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24637267|NCT01149564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24637268|NCT01149564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24637269|NCT01149564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24452059|NCT00325910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24637317|NCT01149902|Docetaxel|docetaxel|mesh-list
24637318|NCT01149902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24637319|NCT01149902|Immunologic Factors|immunologic factors|mesh-ancestor
24637320|NCT01149902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637321|NCT01149902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24637322|NCT01149902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24637323|NCT01149902|Alkylating Agents|alkylating agents|mesh-ancestor
24637330|NCT01149941|Ibuprofen|ibuprofen|mesh-list
25073553|NCT03394222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25073554|NCT03394222|Respiratory System Agents|respiratory system agents|mesh-ancestor
25073555|NCT03394222|Glucocorticoids|glucocorticoids|mesh-ancestor
25073556|NCT03394222|Hormones|hormones|mesh-ancestor
25073557|NCT03394222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25073558|NCT03394209|Oseltamivir|oseltamivir|mesh-list
25073559|NCT03394209|Favipiravir|favipiravir|mesh-list
25073560|NCT03394209|Antiviral Agents|antiviral agents|mesh-ancestor
25663696|NCT01661621|Adrenergic Agents|adrenergic agents|mesh-ancestor
25663697|NCT01661621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25663698|NCT01661621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073561|NCT03394209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25663699|NCT01661621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073562|NCT03394209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836441|NCT02185859|Anticonvulsants|anticonvulsants|mesh-ancestor
24836442|NCT02185859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24836443|NCT02185859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24836444|NCT02185859|Tocolytic Agents|tocolytic agents|mesh-ancestor
24637331|NCT01149941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24637332|NCT01149941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24637333|NCT01149941|Analgesics|analgesics|mesh-ancestor
25852183|NCT00055809|Bevacizumab|bevacizumab|mesh-list
25852184|NCT00055809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25852185|NCT00055809|Antibodies|antibodies|mesh-list
25852186|NCT00055809|Immunoglobulins|immunoglobulins|mesh-list
25852187|NCT00055809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25852188|NCT00055809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637342|NCT01149954|Ibuprofen|ibuprofen|mesh-list
24637381|NCT01149980|Serotonin Agents|serotonin agents|mesh-ancestor
24666531|NCT01319734|Antioxidants|antioxidants|mesh-ancestor
24637385|NCT01149980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24637551|NCT01151306|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24637554|NCT01151384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637555|NCT01151384|Tubulin Modulators|tubulin modulators|mesh-ancestor
24637557|NCT01151384|Mitosis Modulators|mitosis modulators|mesh-ancestor
24637558|NCT01151384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637559|NCT01151397|Vitamin D|vitamin d|mesh-list
25073563|NCT03394209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073564|NCT03394196|Ritonavir|ritonavir|mesh-list
25073565|NCT03394196|Lopinavir|lopinavir|mesh-list
25073566|NCT03394196|Darunavir|darunavir|mesh-list
25073567|NCT03394196|Tenofovir|tenofovir|mesh-list
25073568|NCT03394196|Lamivudine|lamivudine|mesh-list
25073569|NCT03394196|Zidovudine|zidovudine|mesh-list
25073570|NCT03394196|Emtricitabine|emtricitabine|mesh-list
25073571|NCT03394196|Raltegravir Potassium|raltegravir potassium|mesh-list
25073572|NCT03394196|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25073573|NCT03394196|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25073574|NCT03394196|Protease Inhibitors|protease inhibitors|mesh-ancestor
25073575|NCT03394196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432445|NCT00254800|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24637562|NCT01151397|Micronutrients|micronutrients|mesh-ancestor
25852189|NCT00055809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24637563|NCT01151397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637564|NCT01151397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24637566|NCT01151397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852190|NCT00055809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24637567|NCT01151397|Antiviral Agents|antiviral agents|mesh-ancestor
24637577|NCT01151670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637579|NCT01151696|Antipruritics|antipruritics|mesh-ancestor
24637580|NCT01151696|Dermatologic Agents|dermatologic agents|mesh-ancestor
24637581|NCT01151696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24637582|NCT01151696|Histamine Antagonists|histamine antagonists|mesh-ancestor
24637627|NCT01151865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25073592|NCT03394131|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25073593|NCT03394131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25073594|NCT03394131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073595|NCT03394118|Osimertinib|osimertinib|mesh-list
25073596|NCT03394118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073597|NCT03394118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25073598|NCT03394118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663700|NCT01661621|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25663701|NCT01661621|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25663702|NCT01661621|Cholinergic Agents|cholinergic agents|mesh-ancestor
25663703|NCT01661621|Urological Agents|urological agents|mesh-ancestor
25663704|NCT01661790|Bevacizumab|bevacizumab|mesh-list
25073676|NCT03393819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25073600|NCT03394105|Docetaxel|docetaxel|mesh-list
25663705|NCT01661790|Cisplatin|cisplatin|mesh-list
25852191|NCT00055809|Growth Substances|growth substances|mesh-ancestor
24763638|NCT01775540|Hormones|hormones|mesh-ancestor
24637628|NCT01151865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637629|NCT01151865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24637631|NCT01151865|Sensory System Agents|sensory system agents|mesh-ancestor
24637632|NCT01151865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24637633|NCT01151865|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24637634|NCT01151865|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24637635|NCT01151865|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24637636|NCT01151865|Adrenergic Agents|adrenergic agents|mesh-ancestor
24637637|NCT01151865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25852192|NCT00055809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050623|NCT00481325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25050642|NCT00480831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24637638|NCT01151865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637697|NCT01152710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637699|NCT01152723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24637701|NCT01152723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25852193|NCT00055809|Growth Inhibitors|growth inhibitors|mesh-ancestor
24637734|NCT01152827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637735|NCT01152827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24637736|NCT01152827|Immunologic Factors|immunologic factors|mesh-ancestor
24637737|NCT01152827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637738|NCT01152840|Everolimus|everolimus|mesh-list
25852194|NCT00055809|Immunologic Factors|immunologic factors|mesh-ancestor
24637739|NCT01152840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637740|NCT01152840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24637741|NCT01152840|Immunologic Factors|immunologic factors|mesh-ancestor
24637742|NCT01152840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637850|NCT01153373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24637851|NCT01153373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24637852|NCT01153373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073601|NCT03394105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073602|NCT03394105|Tubulin Modulators|tubulin modulators|mesh-ancestor
24432650|NCT00255593|Rituximab|rituximab|mesh-list
24637870|NCT01153659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24637872|NCT01153659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637902|NCT01153828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637903|NCT01153828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637905|NCT01153854|Antidiarrheals|antidiarrheals|mesh-ancestor
24637906|NCT01153854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24637907|NCT01153854|Protease Inhibitors|protease inhibitors|mesh-ancestor
24637908|NCT01153854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637909|NCT01153854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637910|NCT01153880|Mupirocin|mupirocin|mesh-list
24637911|NCT01153880|Retapamulin|retapamulin|mesh-list
24637912|NCT01153880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24637932|NCT01154114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637936|NCT01154361|Cortisone|cortisone|mesh-list
24637944|NCT01154361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637945|NCT01154361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24637946|NCT01154361|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
25852195|NCT00055809|Antiviral Agents|antiviral agents|mesh-ancestor
24637948|NCT01154361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637949|NCT01154361|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24637950|NCT01154361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24637951|NCT01154361|Immunologic Factors|immunologic factors|mesh-ancestor
24637954|NCT01154387|Thymoglobulin|thymoglobulin|mesh-list
24637955|NCT01154387|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25050647|NCT00479817|Trebananib|trebananib|mesh-list
25050677|NCT00478595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050678|NCT00478595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050679|NCT00478595|Hormones|hormones|mesh-ancestor
24701771|NCT01460797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701773|NCT01460836|Aztreonam|aztreonam|mesh-list
24701774|NCT01460836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24701775|NCT01460836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24701776|NCT01460888|Olaparib|olaparib|mesh-list
24701777|NCT01460888|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24701778|NCT01460888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637956|NCT01154387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24637957|NCT01154387|Immunologic Factors|immunologic factors|mesh-ancestor
24637969|NCT01154400|Chelating Agents|chelating agents|mesh-ancestor
25663706|NCT01661790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24637970|NCT01154400|Sequestering Agents|sequestering agents|mesh-ancestor
24637971|NCT01154400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637973|NCT01154426|Veliparib|veliparib|mesh-list
24638357|NCT01155986|Anesthetics|anesthetics|mesh-ancestor
24637974|NCT01154426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24638007|NCT01154439|Sensory System Agents|sensory system agents|mesh-ancestor
24638008|NCT01154439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24638009|NCT01154439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24638010|NCT01154439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24638011|NCT01154439|Alkylating Agents|alkylating agents|mesh-ancestor
24638012|NCT01154465|Povidone-Iodine|povidone-iodine|mesh-list
25852196|NCT00055809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24638033|NCT01154569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24638034|NCT01154569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24638035|NCT01154647|Citalopram|citalopram|mesh-list
24638036|NCT01154647|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24638037|NCT01154647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24638038|NCT01154647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24638039|NCT01154647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638040|NCT01154647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24432773|NCT00256009|Oxytocics|oxytocics|mesh-ancestor
24638089|NCT01154829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24638090|NCT01154829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24638091|NCT01154829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24666743|NCT01320878|Iloprost|iloprost|mesh-list
24638092|NCT01154829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24638093|NCT01154829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638094|NCT01154829|Dopamine Agonists|dopamine agonists|mesh-ancestor
24638145|NCT01154959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24638147|NCT01155037|Immunologic Factors|immunologic factors|mesh-ancestor
24638148|NCT01155037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638149|NCT01155089|Anastrozole|anastrozole|mesh-list
25073623|NCT03394001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24701834|NCT01461577|Insulin Glargine|insulin glargine|mesh-list
24701842|NCT01461616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701843|NCT01461746|Docetaxel|docetaxel|mesh-list
24701844|NCT01461746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701845|NCT01461746|Tubulin Modulators|tubulin modulators|mesh-ancestor
24701846|NCT01461746|Antimitotic Agents|antimitotic agents|mesh-ancestor
24701847|NCT01461746|Mitosis Modulators|mitosis modulators|mesh-ancestor
24701848|NCT01461746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701849|NCT01461759|Cisplatin|cisplatin|mesh-list
24701850|NCT01461759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073624|NCT03394001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25073625|NCT03394001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25073626|NCT03394001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073627|NCT03393988|Fentanyl|fentanyl|mesh-list
25073635|NCT03393988|Sensory System Agents|sensory system agents|mesh-ancestor
25073636|NCT03393988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25073637|NCT03393988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25073638|NCT03393988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25073639|NCT03393988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25073640|NCT03393988|Adrenergic Agents|adrenergic agents|mesh-ancestor
25073641|NCT03393988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25073642|NCT03393988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073643|NCT03393988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25073644|NCT03393988|Narcotics|narcotics|mesh-ancestor
25073645|NCT03393988|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25073646|NCT03393988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25073647|NCT03393988|Anesthetics, General|anesthetics, general|mesh-ancestor
25073649|NCT03393988|Autonomic Agents|autonomic agents|mesh-ancestor
25073650|NCT03393949|Methylprednisolone|methylprednisolone|mesh-list
25073651|NCT03393949|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25073664|NCT03393949|Hormones|hormones|mesh-ancestor
25073671|NCT03393858|Immunologic Factors|immunologic factors|mesh-ancestor
25073672|NCT03393858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073673|NCT03393819|Ethanol|ethanol|mesh-list
25073674|NCT03393819|Chlorhexidine|chlorhexidine|mesh-list
25073675|NCT03393819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25073677|NCT03393819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25073678|NCT03393819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073679|NCT03393819|Disinfectants|disinfectants|mesh-ancestor
25073680|NCT03393780|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25073681|NCT03393780|Hormones|hormones|mesh-ancestor
25073682|NCT03393780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25073684|NCT03393767|Ranibizumab|ranibizumab|mesh-list
25073685|NCT03393767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25073690|NCT03393767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073692|NCT03393728|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24836573|NCT02186457|Polymyxins|polymyxins|mesh-list
24701851|NCT01461772|Carboplatin|carboplatin|mesh-list
24853817|NCT02270437|Analgesics|analgesics|mesh-ancestor
24638288|NCT01155895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24638289|NCT01155895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24638290|NCT01155895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638291|NCT01155895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24638292|NCT01155895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638293|NCT01155895|Vasodilator Agents|vasodilator agents|mesh-ancestor
24638294|NCT01155895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24638295|NCT01155895|Protease Inhibitors|protease inhibitors|mesh-ancestor
24638296|NCT01155895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24638297|NCT01155908|Amlodipine|amlodipine|mesh-list
24638298|NCT01155908|Benazepril|benazepril|mesh-list
24638299|NCT01155908|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24638300|NCT01155908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24638301|NCT01155908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25852197|NCT00055822|Leucovorin|leucovorin|mesh-list
24638314|NCT01155921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638315|NCT01155921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24638316|NCT01155921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24638317|NCT01155921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24638318|NCT01155921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25033156|NCT03576053|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25113752|NCT02278315|Hormones|hormones|mesh-ancestor
24638319|NCT01155921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24638320|NCT01155921|Dopamine Agents|dopamine agents|mesh-ancestor
25852198|NCT00055822|Fluorouracil|fluorouracil|mesh-list
24638322|NCT01155934|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24638323|NCT01155934|Serotonin Agents|serotonin agents|mesh-ancestor
25852199|NCT00055822|Oxaliplatin|oxaliplatin|mesh-list
24638324|NCT01155934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24638325|NCT01155934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638326|NCT01155934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852200|NCT00055822|Oblimersen|oblimersen|mesh-list
24638327|NCT01155934|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24638328|NCT01155934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24638329|NCT01155934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24638330|NCT01155934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24638331|NCT01155934|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24638336|NCT01155947|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24638337|NCT01155947|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25073701|NCT03393715|Perindopril|perindopril|mesh-list
25073702|NCT03393715|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25073703|NCT03393715|Protease Inhibitors|protease inhibitors|mesh-ancestor
25073704|NCT03393715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073705|NCT03393715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073706|NCT03393715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25073708|NCT03393702|Analgesics|analgesics|mesh-ancestor
25073709|NCT03393702|Sensory System Agents|sensory system agents|mesh-ancestor
25073710|NCT03393702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25073711|NCT03393702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073712|NCT03393702|Anticonvulsants|anticonvulsants|mesh-ancestor
25073713|NCT03393702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25073714|NCT03393702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25073715|NCT03393702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25073716|NCT03393702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25073717|NCT03393702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25073718|NCT03393702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25073719|NCT03393702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24638350|NCT01155960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638351|NCT01155960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24638352|NCT01155960|Hormone Antagonists|hormone antagonists|mesh-ancestor
24666800|NCT01321021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24638353|NCT01155960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24638354|NCT01155960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638355|NCT01155986|Lidocaine|lidocaine|mesh-list
25852201|NCT00055822|Calcium|calcium|mesh-list
25852202|NCT00055822|Levoleucovorin|levoleucovorin|mesh-list
25273960|NCT02381717|Morphine|morphine|mesh-list
24638356|NCT01155986|Anesthetics, Local|anesthetics, local|mesh-ancestor
24638363|NCT01155986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24638364|NCT01155986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24638365|NCT01155986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24638380|NCT01156246|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24638381|NCT01156246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638382|NCT01156350|Fludarabine|fludarabine|mesh-list
24638383|NCT01156350|Busulfan|busulfan|mesh-list
24638384|NCT01156350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638385|NCT01156350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638386|NCT01156350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24638387|NCT01156350|Immunologic Factors|immunologic factors|mesh-ancestor
25852203|NCT00055822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24638388|NCT01156350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638451|NCT01156779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24638452|NCT01156779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638453|NCT01156779|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24638455|NCT01156779|Hormones|hormones|mesh-ancestor
25852204|NCT00055822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702039|NCT01463735|Protective Agents|protective agents|mesh-ancestor
24638456|NCT01156779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24638457|NCT01156857|Ulipristal acetate|ulipristal acetate|mesh-list
24638458|NCT01156857|Progestins|progestins|mesh-list
24954087|NCT03879564|Anesthetics|anesthetics|mesh-ancestor
24954088|NCT03879564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24954089|NCT03879564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24954090|NCT03879564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24954091|NCT03879564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25202565|NCT02720692|Sensory System Agents|sensory system agents|mesh-ancestor
25202566|NCT02720692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25033221|NCT03575234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25033222|NCT03575234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25033227|NCT03575130|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25033229|NCT03575078|Olaparib|olaparib|mesh-list
24954092|NCT03879564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954093|NCT03879486|Povidone-Iodine|povidone-iodine|mesh-list
24954094|NCT03879486|Formaldehyde|formaldehyde|mesh-list
24954095|NCT03879486|Povidone|povidone|mesh-list
24954096|NCT03879486|Plasma Substitutes|plasma substitutes|mesh-ancestor
24954097|NCT03879486|Blood Substitutes|blood substitutes|mesh-ancestor
24954098|NCT03879486|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24954099|NCT03879486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24954100|NCT03879486|Disinfectants|disinfectants|mesh-ancestor
24954101|NCT03879356|Acetylcysteine|acetylcysteine|mesh-list
24954102|NCT03879356|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24954103|NCT03879356|Antiviral Agents|antiviral agents|mesh-ancestor
24954104|NCT03879356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24954105|NCT03879356|Expectorants|expectorants|mesh-ancestor
24954106|NCT03879356|Respiratory System Agents|respiratory system agents|mesh-ancestor
24954107|NCT03879356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24954108|NCT03879356|Antioxidants|antioxidants|mesh-ancestor
24954109|NCT03879356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954110|NCT03879356|Protective Agents|protective agents|mesh-ancestor
24954111|NCT03879356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638459|NCT01156857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24666854|NCT01321255|Aspirin|aspirin|mesh-list
24638460|NCT01156857|Contraceptive Agents|contraceptive agents|mesh-ancestor
24638461|NCT01156857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24638462|NCT01156857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638463|NCT01156857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24638464|NCT01156857|Hormones|hormones|mesh-ancestor
24638465|NCT01156857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24638500|NCT01156883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24638501|NCT01156883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24638502|NCT01156883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24638503|NCT01156883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24638504|NCT01156883|Abortifacient Agents|abortifacient agents|mesh-ancestor
25073721|NCT03393702|Antimanic Agents|antimanic agents|mesh-ancestor
25073722|NCT03393572|Magnesium Sulfate|magnesium sulfate|mesh-list
25073723|NCT03393572|Nalbuphine|nalbuphine|mesh-list
25073724|NCT03393572|Bupivacaine|bupivacaine|mesh-list
25073725|NCT03393572|Anesthetics, Local|anesthetics, local|mesh-ancestor
25073726|NCT03393572|Anesthetics|anesthetics|mesh-ancestor
25663707|NCT01661790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25240714|NCT05297123|Dermatologic Agents|dermatologic agents|mesh-ancestor
25240718|NCT05276102|Emollients|emollients|mesh-list
25240719|NCT05276102|Dermatologic Agents|dermatologic agents|mesh-ancestor
25240720|NCT05264168|Rivaroxaban|rivaroxaban|mesh-list
25240721|NCT05264168|Apixaban|apixaban|mesh-list
25073727|NCT03393572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24638540|NCT01156961|Bevacizumab|bevacizumab|mesh-list
25073766|NCT03393403|Adrenergic Agents|adrenergic agents|mesh-ancestor
24638542|NCT01156961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638543|NCT01156961|Tubulin Modulators|tubulin modulators|mesh-ancestor
24638544|NCT01156961|Antimitotic Agents|antimitotic agents|mesh-ancestor
24638545|NCT01156961|Mitosis Modulators|mitosis modulators|mesh-ancestor
24638546|NCT01156961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638547|NCT01156961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24638548|NCT01156961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24638549|NCT01156961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24638550|NCT01156961|Growth Substances|growth substances|mesh-ancestor
24638551|NCT01156961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638552|NCT01156961|Growth Inhibitors|growth inhibitors|mesh-ancestor
24638554|NCT01157000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24638555|NCT01157000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638556|NCT01157000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24638557|NCT01157000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638558|NCT01157013|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24638559|NCT01157013|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24638560|NCT01157013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638561|NCT01157026|Tamoxifen|tamoxifen|mesh-list
24638562|NCT01157026|Tocotrienols|tocotrienols|mesh-list
24638563|NCT01157026|Vitamin E|vitamin e|mesh-list
24638564|NCT01157026|Tocopherols|tocopherols|mesh-list
24638565|NCT01157026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24638566|NCT01157026|Hormone Antagonists|hormone antagonists|mesh-ancestor
25202567|NCT02720692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202568|NCT02720692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25202569|NCT02720692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24702242|NCT01464671|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24702243|NCT01464671|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24702244|NCT01464671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702245|NCT01464671|Antithrombins|antithrombins|mesh-ancestor
24702246|NCT01464671|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24702247|NCT01464671|Protease Inhibitors|protease inhibitors|mesh-ancestor
25202570|NCT02720692|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25852205|NCT00055822|Antimetabolites|antimetabolites|mesh-ancestor
25033300|NCT03574649|Antimetabolites|antimetabolites|mesh-ancestor
25033301|NCT03574649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25033302|NCT03574649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25033304|NCT03574402|Carboplatin|carboplatin|mesh-list
25033305|NCT03574402|Pemetrexed|pemetrexed|mesh-list
25033306|NCT03574402|Afatinib|afatinib|mesh-list
25033307|NCT03574402|Crizotinib|crizotinib|mesh-list
25033308|NCT03574402|Nimotuzumab|nimotuzumab|mesh-list
25033309|NCT03574402|Ensartinib|ensartinib|mesh-list
24638567|NCT01157026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24638568|NCT01157026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638569|NCT01157026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24638570|NCT01157026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852206|NCT00055822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638584|NCT01157052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24638585|NCT01157052|Antimetabolites|antimetabolites|mesh-ancestor
24638586|NCT01157052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638587|NCT01157052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638588|NCT01157247|Fentanyl|fentanyl|mesh-list
24638589|NCT01157247|Anesthetics|anesthetics|mesh-list
24638590|NCT01157247|Anesthetics, Local|anesthetics, local|mesh-list
24638591|NCT01157247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24638592|NCT01157247|Narcotics|narcotics|mesh-ancestor
25073732|NCT03393572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25073734|NCT03393572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25073735|NCT03393572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25073736|NCT03393572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073737|NCT03393572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25663708|NCT01661790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25663709|NCT01661790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25663710|NCT01661790|Growth Substances|growth substances|mesh-ancestor
25073738|NCT03393572|Tocolytic Agents|tocolytic agents|mesh-ancestor
24732534|NCT01640002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25073739|NCT03393572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25073740|NCT03393572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25073741|NCT03393572|Narcotics|narcotics|mesh-ancestor
25073742|NCT03393507|Apatinib|apatinib|mesh-list
25073746|NCT03393507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073747|NCT03393481|Enoxaparin|enoxaparin|mesh-list
24638618|NCT01157312|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24638619|NCT01157312|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24638620|NCT01157455|Aspirin|aspirin|mesh-list
24638621|NCT01157455|Everolimus|everolimus|mesh-list
24638622|NCT01157455|Heparin|heparin|mesh-list
24638623|NCT01157455|Bivalirudin|bivalirudin|mesh-list
24638624|NCT01157455|Clopidogrel|clopidogrel|mesh-list
24638625|NCT01157455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24638626|NCT01157455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24638627|NCT01157455|Analgesics|analgesics|mesh-ancestor
24666894|NCT01321268|Provitamins|provitamins|mesh-ancestor
24638628|NCT01157455|Sensory System Agents|sensory system agents|mesh-ancestor
24638629|NCT01157455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24638678|NCT01157546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24638679|NCT01157546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24638680|NCT01157546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25852207|NCT00055822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24638681|NCT01157546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24638682|NCT01157546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638683|NCT01157559|Ziprasidone|ziprasidone|mesh-list
24433396|NCT00258271|Cytarabine|cytarabine|mesh-list
25073754|NCT03393416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073755|NCT03393403|Dexmedetomidine|dexmedetomidine|mesh-list
24836677|NCT02186899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202571|NCT02720692|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25202572|NCT02720692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202573|NCT02720692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202574|NCT02720705|Dexmedetomidine|dexmedetomidine|mesh-list
25202575|NCT02720705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25202576|NCT02720705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25202577|NCT02720705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202578|NCT02720705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25202579|NCT02720705|Analgesics|analgesics|mesh-ancestor
25852208|NCT00055822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638699|NCT01157572|Autonomic Agents|autonomic agents|mesh-ancestor
24638700|NCT01157572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24638701|NCT01157572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638702|NCT01157572|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24638703|NCT01157572|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24638704|NCT01157572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24638705|NCT01157572|Adrenergic Agents|adrenergic agents|mesh-ancestor
24638706|NCT01157572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24638707|NCT01157572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638708|NCT01157585|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24638709|NCT01157585|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24638710|NCT01157585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24940371|NCT04002024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24638711|NCT01157585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24638712|NCT01157585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638713|NCT01157585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24638738|NCT01157819|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24638739|NCT01157819|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24638740|NCT01157858|Everolimus|everolimus|mesh-list
24638741|NCT01157858|Octreotide|octreotide|mesh-list
24638742|NCT01157858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638743|NCT01157858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24638763|NCT01157975|Prednisone|prednisone|mesh-list
24638775|NCT01158105|Bortezomib|bortezomib|mesh-list
24638776|NCT01158105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638777|NCT01158144|Paclitaxel|paclitaxel|mesh-list
24638778|NCT01158144|Carboplatin|carboplatin|mesh-list
24638779|NCT01158144|Endostar protein|endostar protein|mesh-list
24638780|NCT01158144|Endostatins|endostatins|mesh-list
24638781|NCT01158144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24638782|NCT01158144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663711|NCT01661790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663712|NCT01661790|Growth Inhibitors|growth inhibitors|mesh-ancestor
24732665|NCT01640743|Tacrolimus|tacrolimus|mesh-list
24732666|NCT01640743|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24732667|NCT01640743|Prednisolone phosphate|prednisolone phosphate|mesh-list
24545412|NCT00693381|Mycophenolic Acid|mycophenolic acid|mesh-list
24732668|NCT01640743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24732669|NCT01640743|Immunologic Factors|immunologic factors|mesh-ancestor
24732670|NCT01640743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732749|NCT01641289|Acetaminophen|acetaminophen|mesh-list
24638783|NCT01158144|Tubulin Modulators|tubulin modulators|mesh-ancestor
24638784|NCT01158144|Antimitotic Agents|antimitotic agents|mesh-ancestor
24638785|NCT01158144|Mitosis Modulators|mitosis modulators|mesh-ancestor
24638786|NCT01158144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073763|NCT03393403|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25073764|NCT03393403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25073765|NCT03393403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25073767|NCT03393403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25073768|NCT03393403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073769|NCT03393377|Valsartan|valsartan|mesh-list
24638885|NCT01158859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24638886|NCT01158859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24666935|NCT01321671|Pregabalin|pregabalin|mesh-list
24638887|NCT01158859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24638888|NCT01158859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24638890|NCT01158937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24638891|NCT01158937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24638892|NCT01159080|Mycophenolic Acid|mycophenolic acid|mesh-list
24638936|NCT01159236|Antimitotic Agents|antimitotic agents|mesh-ancestor
24638937|NCT01159236|Mitosis Modulators|mitosis modulators|mesh-ancestor
24638938|NCT01159236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638939|NCT01159236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24638940|NCT01159236|Immunologic Factors|immunologic factors|mesh-ancestor
24638941|NCT01159236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639062|NCT01159847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639087|NCT01160185|Antimitotic Agents|antimitotic agents|mesh-ancestor
24940376|NCT04001712|Caffeine|caffeine|mesh-list
24639088|NCT01160185|Mitosis Modulators|mitosis modulators|mesh-ancestor
24639089|NCT01160185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073770|NCT03393377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25073771|NCT03393377|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25073772|NCT03393377|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25073773|NCT03393377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073774|NCT03393364|Ketorolac|ketorolac|mesh-list
25073775|NCT03393364|Oxycodone|oxycodone|mesh-list
25073776|NCT03393364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25073777|NCT03393364|Narcotics|narcotics|mesh-ancestor
25073778|NCT03393364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25073779|NCT03393364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202580|NCT02720705|Sensory System Agents|sensory system agents|mesh-ancestor
25073780|NCT03393364|Analgesics|analgesics|mesh-ancestor
25073781|NCT03393364|Sensory System Agents|sensory system agents|mesh-ancestor
25073782|NCT03393364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25073783|NCT03393364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25073784|NCT03393364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25073785|NCT03393364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24639146|NCT01160328|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24639147|NCT01160328|Fertility Agents|fertility agents|mesh-ancestor
24639148|NCT01160328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24639149|NCT01160341|Methyltestosterone|methyltestosterone|mesh-list
24639151|NCT01160341|Testosterone undecanoate|testosterone undecanoate|mesh-list
24639152|NCT01160341|Testosterone enanthate|testosterone enanthate|mesh-list
24639153|NCT01160341|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24639154|NCT01160341|Androgens|androgens|mesh-ancestor
24639155|NCT01160341|Hormones|hormones|mesh-ancestor
25852209|NCT00055822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24639156|NCT01160341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24639157|NCT01160341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639158|NCT01160341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24639159|NCT01160341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639188|NCT01160432|Antitussive Agents|antitussive agents|mesh-ancestor
25663713|NCT01661946|Bevacizumab|bevacizumab|mesh-list
25663714|NCT01661946|Ranibizumab|ranibizumab|mesh-list
25663715|NCT01661946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25663716|NCT01661946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663717|NCT01661946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25663718|NCT01661946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24617219|NCT01041690|Growth Substances|growth substances|mesh-ancestor
24617220|NCT01041690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617222|NCT01041729|Atorvastatin|atorvastatin|mesh-list
24639189|NCT01160432|Respiratory System Agents|respiratory system agents|mesh-ancestor
25852210|NCT00055822|Immunologic Factors|immunologic factors|mesh-ancestor
25852211|NCT00055822|Antidotes|antidotes|mesh-ancestor
25852212|NCT00055822|Protective Agents|protective agents|mesh-ancestor
25073787|NCT03393364|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24702495|NCT01466114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25073788|NCT03393364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073789|NCT03393364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073790|NCT03393325|Tadalafil|tadalafil|mesh-list
25073791|NCT03393325|Vasodilator Agents|vasodilator agents|mesh-ancestor
25073792|NCT03393325|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25073793|NCT03393325|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25073794|NCT03393325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073815|NCT03393117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25073795|NCT03393325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073797|NCT03393273|Elotuzumab|elotuzumab|mesh-list
25073798|NCT03393273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073799|NCT03393247|Azathioprine|azathioprine|mesh-list
24639196|NCT01160588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639197|NCT01160588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24639200|NCT01160627|Acetylcysteine|acetylcysteine|mesh-list
24639225|NCT01160718|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24639226|NCT01160718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24639227|NCT01160718|Hormone Antagonists|hormone antagonists|mesh-ancestor
24639228|NCT01160718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24639229|NCT01160718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639231|NCT01160731|Panobinostat|panobinostat|mesh-list
24639232|NCT01160731|Etoposide phosphate|etoposide phosphate|mesh-list
24639241|NCT01160900|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24639242|NCT01160900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24639243|NCT01160900|Antithrombins|antithrombins|mesh-ancestor
24639244|NCT01160900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24639245|NCT01160900|Protease Inhibitors|protease inhibitors|mesh-ancestor
24639246|NCT01160900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852213|NCT00055822|Vitamin B Complex|vitamin b complex|mesh-ancestor
24639273|NCT01160965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24639274|NCT01160978|Simvastatin|simvastatin|mesh-list
24639275|NCT01160978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24639276|NCT01160978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24639277|NCT01160978|Antimetabolites|antimetabolites|mesh-ancestor
24639278|NCT01160978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639279|NCT01160978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24639280|NCT01160978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24639281|NCT01160978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639282|NCT01160991|Olanzapine|olanzapine|mesh-list
24639283|NCT01160991|Amisulpride|amisulpride|mesh-list
24639284|NCT01160991|Antiemetics|antiemetics|mesh-ancestor
24639285|NCT01160991|Autonomic Agents|autonomic agents|mesh-ancestor
24639286|NCT01160991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25073800|NCT03393247|Infliximab|infliximab|mesh-list
25073801|NCT03393247|Dermatologic Agents|dermatologic agents|mesh-ancestor
25073802|NCT03393247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25073805|NCT03393247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073806|NCT03393247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25073807|NCT03393247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073808|NCT03393247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25073809|NCT03393247|Immunologic Factors|immunologic factors|mesh-ancestor
25073810|NCT03393247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073811|NCT03393117|Narcotics|narcotics|mesh-list
25073812|NCT03393117|Bupivacaine|bupivacaine|mesh-list
25073813|NCT03393117|Anesthetics, Local|anesthetics, local|mesh-ancestor
24639296|NCT01160991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639297|NCT01160991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24639298|NCT01160991|Serotonin Agents|serotonin agents|mesh-ancestor
24639299|NCT01160991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24639300|NCT01160991|Dopamine Agents|dopamine agents|mesh-ancestor
24639301|NCT01160991|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25663719|NCT01661946|Growth Substances|growth substances|mesh-ancestor
25663720|NCT01661946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639302|NCT01160991|Antidepressive Agents|antidepressive agents|mesh-ancestor
25663721|NCT01661946|Growth Inhibitors|growth inhibitors|mesh-ancestor
25852214|NCT00055822|Vitamins|vitamins|mesh-ancestor
24639311|NCT01161017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24639312|NCT01161017|Analgesics|analgesics|mesh-ancestor
24639313|NCT01161017|Sensory System Agents|sensory system agents|mesh-ancestor
24639314|NCT01161017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24639315|NCT01161017|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24639316|NCT01161017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24639317|NCT01161017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24639318|NCT01161017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639319|NCT01161017|Adrenergic Agents|adrenergic agents|mesh-ancestor
24639320|NCT01161017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24462841|NCT00357682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24667055|NCT01321957|Immunologic Factors|immunologic factors|mesh-ancestor
24639321|NCT01161069|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1h)-one|mesh-list
24639423|NCT01161459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24639424|NCT01161459|Immunologic Factors|immunologic factors|mesh-ancestor
24639425|NCT01161459|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24639426|NCT01161459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073820|NCT03393026|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25073821|NCT03393026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25073822|NCT03393026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25073823|NCT03393026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25073824|NCT03393026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073825|NCT03393026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25073826|NCT03393026|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25073827|NCT03393026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25073828|NCT03393026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24434042|NCT00261300|Pantoprazole|pantoprazole|mesh-list
24639472|NCT01161888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639473|NCT01161888|Interferon Inducers|interferon inducers|mesh-ancestor
24639474|NCT01161927|Nizatidine|nizatidine|mesh-list
24639475|NCT01161927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24639476|NCT01161927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24639477|NCT01161927|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24639478|NCT01161927|Histamine Antagonists|histamine antagonists|mesh-ancestor
24639479|NCT01161927|Histamine Agents|histamine agents|mesh-ancestor
24639480|NCT01161927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24639481|NCT01161927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639482|NCT01161927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639483|NCT01161940|Nizatidine|nizatidine|mesh-list
24639484|NCT01161940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24639485|NCT01161940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24639486|NCT01161940|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24639487|NCT01161940|Histamine Antagonists|histamine antagonists|mesh-ancestor
24639488|NCT01161940|Histamine Agents|histamine agents|mesh-ancestor
25202581|NCT02720705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24639498|NCT01161966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639500|NCT01161979|Anticonvulsants|anticonvulsants|mesh-ancestor
24639501|NCT01161979|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25852215|NCT00055822|Micronutrients|micronutrients|mesh-ancestor
25852216|NCT00055835|Gemcitabine|gemcitabine|mesh-list
25852217|NCT00055835|Paclitaxel|paclitaxel|mesh-list
25852218|NCT00055835|Cisplatin|cisplatin|mesh-list
25852219|NCT00055835|Carboplatin|carboplatin|mesh-list
25852220|NCT00055835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24702779|NCT01467596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702780|NCT01467648|Doripenem|doripenem|mesh-list
24702781|NCT01467648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24702782|NCT01467648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25852221|NCT00055835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073831|NCT03393026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073832|NCT03393026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25073833|NCT03393026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25073834|NCT03393026|Serotonin Agents|serotonin agents|mesh-ancestor
25073835|NCT03393026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24813133|NCT02056717|Antiemetics|antiemetics|mesh-ancestor
25073836|NCT03393026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25073837|NCT03393026|Dopamine Agents|dopamine agents|mesh-ancestor
25073838|NCT03392961|Insulin|insulin|mesh-list
25073839|NCT03392961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25073840|NCT03392961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073841|NCT03392909|Gentamicins|gentamicins|mesh-list
25073842|NCT03392909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25073843|NCT03392909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25073844|NCT03392909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25852222|NCT00055835|Tubulin Modulators|tubulin modulators|mesh-ancestor
25073845|NCT03392909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073846|NCT03392909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639513|NCT01162460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639514|NCT01162603|Latanoprost|latanoprost|mesh-list
24639515|NCT01162603|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24639516|NCT01162603|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24639517|NCT01162720|Oxymetazoline|oxymetazoline|mesh-list
24639518|NCT01162720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24639519|NCT01162720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24639520|NCT01162720|Adrenergic Agents|adrenergic agents|mesh-ancestor
24639521|NCT01162720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24639522|NCT01162720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639523|NCT01162720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639524|NCT01162720|Sympathomimetics|sympathomimetics|mesh-ancestor
24639525|NCT01162720|Autonomic Agents|autonomic agents|mesh-ancestor
24639526|NCT01162720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24639550|NCT01162824|Sensory System Agents|sensory system agents|mesh-ancestor
24639551|NCT01162824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24639552|NCT01162824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639553|NCT01162824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24639554|NCT01162824|Vasodilator Agents|vasodilator agents|mesh-ancestor
25073850|NCT03392792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25073851|NCT03392792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073853|NCT03392740|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25073854|NCT03392740|Protease Inhibitors|protease inhibitors|mesh-ancestor
25073855|NCT03392740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073856|NCT03392740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073857|NCT03392740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25073858|NCT03392740|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25073859|NCT03392740|Protective Agents|protective agents|mesh-ancestor
25073860|NCT03392740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073861|NCT03392623|Niacinamide|niacinamide|mesh-list
25073863|NCT03392623|Nicotinic Acids|nicotinic acids|mesh-list
25073865|NCT03392623|Sunscreening Agents|sunscreening agents|mesh-list
25073866|NCT03392623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073867|NCT03392623|Keratolytic Agents|keratolytic agents|mesh-ancestor
25073868|NCT03392623|Dermatologic Agents|dermatologic agents|mesh-ancestor
25073869|NCT03392623|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24549622|NCT00716248|Antioxidants|antioxidants|mesh-ancestor
24639602|NCT01162967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639603|NCT01162967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462843|NCT00357682|Analgesics|analgesics|mesh-ancestor
24639604|NCT01162967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24639605|NCT01162967|Hormone Antagonists|hormone antagonists|mesh-ancestor
24639639|NCT01163396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24639640|NCT01163396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639641|NCT01163396|Antidotes|antidotes|mesh-ancestor
25073871|NCT03392623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073872|NCT03392623|Vitamin B Complex|vitamin b complex|mesh-ancestor
25073873|NCT03392623|Vitamins|vitamins|mesh-ancestor
25073874|NCT03392623|Micronutrients|micronutrients|mesh-ancestor
25073875|NCT03392623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25073876|NCT03392623|Antimetabolites|antimetabolites|mesh-ancestor
25073877|NCT03392623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073878|NCT03392623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25073879|NCT03392623|Vasodilator Agents|vasodilator agents|mesh-ancestor
25073880|NCT03392571|Gemcitabine|gemcitabine|mesh-list
25073881|NCT03392571|Paclitaxel|paclitaxel|mesh-list
25073882|NCT03392571|Cisplatin|cisplatin|mesh-list
25073883|NCT03392571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25073884|NCT03392571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639645|NCT01163396|Micronutrients|micronutrients|mesh-ancestor
24639646|NCT01163435|Clarithromycin|clarithromycin|mesh-list
24639647|NCT01163435|Levofloxacin|levofloxacin|mesh-list
24639648|NCT01163435|Ofloxacin|ofloxacin|mesh-list
24639649|NCT01163435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24639680|NCT01163799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639681|NCT01163825|Mitogens|mitogens|mesh-list
24639682|NCT01163825|Mitosis Modulators|mitosis modulators|mesh-ancestor
24639683|NCT01163825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639684|NCT01163903|Doxorubicin|doxorubicin|mesh-list
24639685|NCT01163903|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24639686|NCT01163903|Pantoprazole|pantoprazole|mesh-list
24702947|NCT01468688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24702948|NCT01468688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24639687|NCT01163903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24639688|NCT01163903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639689|NCT01163903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25852223|NCT00055835|Antimitotic Agents|antimitotic agents|mesh-ancestor
24639690|NCT01163903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24639691|NCT01163903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639692|NCT01163903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639693|NCT01163903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24639694|NCT01163903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24639695|NCT01163903|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24639697|NCT01163929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24639698|NCT01163929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639699|NCT01163929|Tubulin Modulators|tubulin modulators|mesh-ancestor
24639700|NCT01163929|Antimitotic Agents|antimitotic agents|mesh-ancestor
24639701|NCT01163929|Mitosis Modulators|mitosis modulators|mesh-ancestor
24639736|NCT01164059|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24639737|NCT01164059|Haloperidol decanoate|haloperidol decanoate|mesh-list
25073892|NCT03392571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25073893|NCT03392571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073894|NCT03392571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25073895|NCT03392571|Immunologic Factors|immunologic factors|mesh-ancestor
25073896|NCT03392571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073897|NCT03392545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
25073898|NCT03392545|Immunologic Factors|immunologic factors|mesh-ancestor
25073899|NCT03392545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073900|NCT03392311|Calcipotriene|calcipotriene|mesh-list
25073901|NCT03392311|Dermatologic Agents|dermatologic agents|mesh-ancestor
25073902|NCT03392272|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25073903|NCT03392272|Hemostatics|hemostatics|mesh-ancestor
25073904|NCT03392272|Coagulants|coagulants|mesh-ancestor
25073905|NCT03392103|Raltitrexed|raltitrexed|mesh-list
24639738|NCT01164059|Flupenthixol|flupenthixol|mesh-list
24639739|NCT01164059|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
24639741|NCT01164059|Autonomic Agents|autonomic agents|mesh-ancestor
24639742|NCT01164059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24639743|NCT01164059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639744|NCT01164059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24639745|NCT01164059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24639746|NCT01164059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24639747|NCT01164059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25852224|NCT00055835|Mitosis Modulators|mitosis modulators|mesh-ancestor
24639748|NCT01164059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24639749|NCT01164059|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24639773|NCT01164085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24639774|NCT01164085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24639775|NCT01164085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639787|NCT01164189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24639788|NCT01164189|Growth Substances|growth substances|mesh-ancestor
24639789|NCT01164189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639790|NCT01164189|Growth Inhibitors|growth inhibitors|mesh-ancestor
24639791|NCT01164189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24639803|NCT01164215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24639806|NCT01164215|Protective Agents|protective agents|mesh-ancestor
24639807|NCT01164215|Vitamin B Complex|vitamin b complex|mesh-ancestor
24639809|NCT01164215|Micronutrients|micronutrients|mesh-ancestor
24639810|NCT01164267|Everolimus|everolimus|mesh-list
25073906|NCT03392103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25073907|NCT03392103|Antimetabolites|antimetabolites|mesh-ancestor
25073908|NCT03392103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073909|NCT03392103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073910|NCT03392103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25073911|NCT03392103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073912|NCT03392051|Clopidogrel|clopidogrel|mesh-list
25073913|NCT03392051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25073914|NCT03392051|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25073915|NCT03392051|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25073916|NCT03392051|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25073917|NCT03392051|Purinergic Agents|purinergic agents|mesh-ancestor
25073918|NCT03392051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25073919|NCT03392051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073938|NCT03391934|Vitamin B Complex|vitamin b complex|mesh-ancestor
24825315|NCT02128178|Enoxaparin|enoxaparin|mesh-list
24639918|NCT01164826|Analgesics|analgesics|mesh-ancestor
24639919|NCT01164826|Sensory System Agents|sensory system agents|mesh-ancestor
24639920|NCT01164826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24639921|NCT01164826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617363|NCT01042704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24617364|NCT01042704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639922|NCT01164826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24639923|NCT01164826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24639928|NCT01164917|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24639929|NCT01164917|Immunologic Factors|immunologic factors|mesh-ancestor
24639930|NCT01164917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639931|NCT01164943|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24940446|NCT04001231|Incretins|incretins|mesh-ancestor
24639969|NCT01165255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639970|NCT01165255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24639971|NCT01165255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24639973|NCT01165268|Dapagliflozin|dapagliflozin|mesh-list
24639974|NCT01165268|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24639975|NCT01165268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639977|NCT01165268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639978|NCT01165294|Ketamine|ketamine|mesh-list
24639979|NCT01165294|Analgesics|analgesics|mesh-ancestor
24639980|NCT01165294|Sensory System Agents|sensory system agents|mesh-ancestor
24639981|NCT01165294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25852225|NCT00055835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639982|NCT01165294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639983|NCT01165294|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24639984|NCT01165294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24639985|NCT01165294|Anesthetics, General|anesthetics, general|mesh-ancestor
24639986|NCT01165294|Anesthetics|anesthetics|mesh-ancestor
24639987|NCT01165294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24640023|NCT01165645|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24640024|NCT01165645|Protease Inhibitors|protease inhibitors|mesh-ancestor
24640025|NCT01165645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640026|NCT01165645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640027|NCT01165645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24640028|NCT01165645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24640029|NCT01165645|Antiviral Agents|antiviral agents|mesh-ancestor
24640030|NCT01165645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25073947|NCT03391856|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25073948|NCT03391856|Antioxidants|antioxidants|mesh-ancestor
24640041|NCT01165814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24640042|NCT01165814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24640043|NCT01165814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24640068|NCT01165866|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24640069|NCT01165866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24640070|NCT01165866|Dopamine Agents|dopamine agents|mesh-ancestor
24640071|NCT01165905|Gemcitabine|gemcitabine|mesh-list
24640072|NCT01165905|ON 01910|on 01910|mesh-list
24640076|NCT01165905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640078|NCT01165905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24640079|NCT01165905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640091|NCT01165970|Laxatives|laxatives|mesh-ancestor
24640092|NCT01165970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24640093|NCT01166035|Lenalidomide|lenalidomide|mesh-list
24640094|NCT01166035|Cetuximab|cetuximab|mesh-list
24640115|NCT01166048|Dopamine Agents|dopamine agents|mesh-ancestor
24640116|NCT01166087|Fluoxetine|fluoxetine|mesh-list
24640117|NCT01166087|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24640118|NCT01166087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25073974|NCT03391700|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25073975|NCT03391700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25073976|NCT03391700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640127|NCT01166087|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24640128|NCT01166087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24640129|NCT01166087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640130|NCT01166100|Fluoxetine|fluoxetine|mesh-list
24640131|NCT01166100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24640132|NCT01166100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24640133|NCT01166100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24640134|NCT01166100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640135|NCT01166100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24640136|NCT01166100|Serotonin Agents|serotonin agents|mesh-ancestor
24640145|NCT01166165|Vitamin D|vitamin d|mesh-list
24640163|NCT01166451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640165|NCT01166477|Lopinavir|lopinavir|mesh-list
24640166|NCT01166477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25663722|NCT01661972|Capecitabine|capecitabine|mesh-list
25663723|NCT01661972|Aflibercept|aflibercept|mesh-list
25852226|NCT00055835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25852227|NCT00055835|Antimetabolites|antimetabolites|mesh-ancestor
25852228|NCT00055835|Antiviral Agents|antiviral agents|mesh-ancestor
25852229|NCT00055835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25852230|NCT00055835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852231|NCT00055835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24640167|NCT01166477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24640168|NCT01166477|Protease Inhibitors|protease inhibitors|mesh-ancestor
24640169|NCT01166477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640170|NCT01166477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640171|NCT01166477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24640172|NCT01166477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24640173|NCT01166477|Antiviral Agents|antiviral agents|mesh-ancestor
24640174|NCT01166477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24640175|NCT01166477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25073991|NCT03391570|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
25073992|NCT03391570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25073993|NCT03391570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073994|NCT03391570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073996|NCT03391570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24954115|NCT03879382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24954116|NCT03879382|Immunologic Factors|immunologic factors|mesh-ancestor
24640282|NCT01167231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434791|NCT00263484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24954125|NCT03879174|Pembrolizumab|pembrolizumab|mesh-list
24954126|NCT03879174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24954127|NCT03879174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24954128|NCT03879174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24954129|NCT03879174|Hormone Antagonists|hormone antagonists|mesh-ancestor
24954130|NCT03879174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24954131|NCT03879174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954132|NCT03879174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25073998|NCT03391570|Sensory System Agents|sensory system agents|mesh-ancestor
25073999|NCT03391570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25074000|NCT03391570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074001|NCT03391570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25074006|NCT03391427|Anesthetics|anesthetics|mesh-ancestor
25074007|NCT03391427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25074008|NCT03391427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074009|NCT03391427|Sensory System Agents|sensory system agents|mesh-ancestor
25074010|NCT03391427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25074011|NCT03391427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25074012|NCT03391427|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25074013|NCT03391427|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25074014|NCT03391427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25074015|NCT03391427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074016|NCT03391427|Analgesics|analgesics|mesh-ancestor
25074017|NCT03391427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25074035|NCT03391219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25074036|NCT03391219|Growth Substances|growth substances|mesh-ancestor
25074037|NCT03391219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074038|NCT03391219|Growth Inhibitors|growth inhibitors|mesh-ancestor
25074039|NCT03391219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25074040|NCT03391219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25074041|NCT03391219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074042|NCT03391219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25074043|NCT03391219|Vasodilator Agents|vasodilator agents|mesh-ancestor
25074044|NCT03391219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25074045|NCT03391219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25074046|NCT03391050|Dabrafenib|dabrafenib|mesh-list
25074047|NCT03391050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25074048|NCT03391050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25074049|NCT03391050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836962|NCT02188277|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24640510|NCT01168531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24640543|NCT01168804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24640544|NCT01168804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663724|NCT01661972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25663725|NCT01661972|Antimetabolites|antimetabolites|mesh-ancestor
25663726|NCT01661972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663727|NCT01661972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006741|NCT04671810|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25006742|NCT04671810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25006743|NCT04671810|Immunologic Factors|immunologic factors|mesh-ancestor
25006744|NCT04671810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006746|NCT04671615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006747|NCT04671615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25006748|NCT04671615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25006749|NCT04671615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109769|NCT03122041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640545|NCT01168804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24640546|NCT01168804|Glucocorticoids|glucocorticoids|mesh-ancestor
24640547|NCT01168804|Hormones|hormones|mesh-ancestor
24640548|NCT01168804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24640549|NCT01168804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24640550|NCT01168804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640551|NCT01168804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24640552|NCT01168804|Alkylating Agents|alkylating agents|mesh-ancestor
24640553|NCT01168804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640554|NCT01168817|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24640555|NCT01168817|Vasodilator Agents|vasodilator agents|mesh-ancestor
24640556|NCT01168817|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24640557|NCT01168817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24640558|NCT01168817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640559|NCT01168817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640560|NCT01168817|Urological Agents|urological agents|mesh-ancestor
24640561|NCT01168895|Ciprofloxacin|ciprofloxacin|mesh-list
25852232|NCT00055835|Immunologic Factors|immunologic factors|mesh-ancestor
25074050|NCT03391050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074052|NCT03390972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24940533|NCT04000932|Glucocorticoids|glucocorticoids|mesh-ancestor
24640623|NCT01169389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25852233|NCT00055835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940498|NCT04001348|GABA Modulators|gaba modulators|mesh-ancestor
24940499|NCT04001348|GABA Agents|gaba agents|mesh-ancestor
24940500|NCT04001348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24940501|NCT04001348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940502|NCT04000919|Carbidopa|carbidopa|mesh-list
24940503|NCT04000919|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24940504|NCT04000919|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24940505|NCT04000919|Dopamine Agents|dopamine agents|mesh-ancestor
24640629|NCT01169402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24640630|NCT01169402|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24640631|NCT01169402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24640632|NCT01169402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640633|NCT01169402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640634|NCT01169402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24640635|NCT01169402|Hormone Antagonists|hormone antagonists|mesh-ancestor
25202582|NCT02720705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24640636|NCT01169402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24667636|NCT05352815|Insulin|insulin|mesh-list
24640637|NCT01169402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640638|NCT01169402|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24640639|NCT01169402|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24640641|NCT01169415|Dexamethasone acetate|dexamethasone acetate|mesh-list
24640642|NCT01169415|BB 1101|bb 1101|mesh-list
24640643|NCT01169415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24640644|NCT01169415|Antiemetics|antiemetics|mesh-ancestor
25663728|NCT01661972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25663729|NCT01661972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25663730|NCT01661972|Growth Substances|growth substances|mesh-ancestor
25663731|NCT01661972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663732|NCT01661972|Growth Inhibitors|growth inhibitors|mesh-ancestor
25663733|NCT01662115|Nicotine|nicotine|mesh-list
25663734|NCT01662115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25663735|NCT01662115|Autonomic Agents|autonomic agents|mesh-ancestor
25663736|NCT01662115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25663737|NCT01662115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663738|NCT01662115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25663739|NCT01662115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24640645|NCT01169415|Autonomic Agents|autonomic agents|mesh-ancestor
24640662|NCT01169571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24640663|NCT01169571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24640664|NCT01169571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640665|NCT01169571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24640666|NCT01169571|Analgesics|analgesics|mesh-ancestor
24640667|NCT01169571|Sensory System Agents|sensory system agents|mesh-ancestor
24640668|NCT01169571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24640670|NCT01169571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24640704|NCT01169688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24462845|NCT00357682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24640705|NCT01169688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074063|NCT03390972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25074064|NCT03390972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940506|NCT04000919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24703454|NCT01471847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24703455|NCT01471847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703456|NCT01471886|Ketorolac|ketorolac|mesh-list
24703457|NCT01471886|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24703458|NCT01471886|Naproxen|naproxen|mesh-list
24440220|NCT00281983|Alkylating Agents|alkylating agents|mesh-ancestor
24703479|NCT01471899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703480|NCT01471899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24703481|NCT01471899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24703482|NCT01471899|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24644269|NCT01190137|Vitamin D|vitamin d|mesh-list
24640717|NCT01169792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24640718|NCT01169792|Hormone Antagonists|hormone antagonists|mesh-ancestor
24640766|NCT01169909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640767|NCT01169909|Growth Inhibitors|growth inhibitors|mesh-ancestor
24640768|NCT01169909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640770|NCT01169922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24640771|NCT01169922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24640772|NCT01169922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24640773|NCT01169922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640775|NCT01169935|Anticoagulants|anticoagulants|mesh-ancestor
24640776|NCT01169935|Plasma Substitutes|plasma substitutes|mesh-ancestor
24640777|NCT01169935|Blood Substitutes|blood substitutes|mesh-ancestor
25852234|NCT00055861|Bevacizumab|bevacizumab|mesh-list
24640779|NCT01170052|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24640780|NCT01170052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24640781|NCT01170052|Alkylating Agents|alkylating agents|mesh-ancestor
24640782|NCT01170052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640783|NCT01170052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640784|NCT01170052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24640785|NCT01170052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24640786|NCT01170052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24640792|NCT01170078|Hematinics|hematinics|mesh-ancestor
24640794|NCT01170104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640795|NCT01170104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24640796|NCT01170104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640797|NCT01170104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640799|NCT01170130|Anesthetics, Local|anesthetics, local|mesh-ancestor
24640800|NCT01170130|Anesthetics|anesthetics|mesh-ancestor
24640801|NCT01170130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24640802|NCT01170130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613431|NCT01019083|Micronutrients|micronutrients|mesh-ancestor
25074079|NCT03390790|Lidocaine|lidocaine|mesh-list
25074080|NCT03390790|Anesthetics, Local|anesthetics, local|mesh-ancestor
25074083|NCT03390790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074084|NCT03390790|Sensory System Agents|sensory system agents|mesh-ancestor
25074085|NCT03390790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25074086|NCT03390790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24640983|NCT01171170|Paclitaxel|paclitaxel|mesh-list
24640984|NCT01171170|Bevacizumab|bevacizumab|mesh-list
24640985|NCT01171170|Carboplatin|carboplatin|mesh-list
24640986|NCT01171170|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24640987|NCT01171170|Nitroglycerin|nitroglycerin|mesh-list
24640988|NCT01171170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24640989|NCT01171170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640990|NCT01171170|Tubulin Modulators|tubulin modulators|mesh-ancestor
24640991|NCT01171170|Antimitotic Agents|antimitotic agents|mesh-ancestor
24640992|NCT01171170|Mitosis Modulators|mitosis modulators|mesh-ancestor
24640993|NCT01171170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25423933|NCT02316106|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24640994|NCT01171170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24640995|NCT01171170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24640996|NCT01171170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24641041|NCT01171482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641042|NCT01171482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24641043|NCT01171482|Immunologic Factors|immunologic factors|mesh-ancestor
24641044|NCT01171482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641045|NCT01171482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24641046|NCT01171482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641047|NCT01171482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24641048|NCT01171482|Alkylating Agents|alkylating agents|mesh-ancestor
24641049|NCT01171482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24641050|NCT01171547|Daptomycin|daptomycin|mesh-list
24641051|NCT01171547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25074104|NCT03390712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25074105|NCT03390712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25074106|NCT03390712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25074107|NCT03390712|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25074108|NCT03390712|Dopamine Agents|dopamine agents|mesh-ancestor
25074110|NCT03390712|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25074111|NCT03390673|Bevacizumab|bevacizumab|mesh-list
25074112|NCT03390673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25074113|NCT03390673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25074114|NCT03390673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25074115|NCT03390673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25074116|NCT03390673|Growth Substances|growth substances|mesh-ancestor
25074117|NCT03390673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852235|NCT00055861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25852236|NCT00055861|Docetaxel|docetaxel|mesh-list
25852237|NCT00055861|Antibodies|antibodies|mesh-list
25852238|NCT00055861|Immunoglobulins|immunoglobulins|mesh-list
25852239|NCT00055861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25852240|NCT00055861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852241|NCT00055861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25852242|NCT00055861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25852243|NCT00055861|Growth Substances|growth substances|mesh-ancestor
25852244|NCT00055861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852245|NCT00055861|Growth Inhibitors|growth inhibitors|mesh-ancestor
25852246|NCT00055861|Immunologic Factors|immunologic factors|mesh-ancestor
25074118|NCT03390673|Growth Inhibitors|growth inhibitors|mesh-ancestor
25074119|NCT03390608|Trastuzumab|trastuzumab|mesh-list
24641145|NCT01172041|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24641146|NCT01172041|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24641147|NCT01172041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641148|NCT01172171|Melatonin|melatonin|mesh-list
24641149|NCT01172171|Antioxidants|antioxidants|mesh-ancestor
24641212|NCT01172444|Sensory System Agents|sensory system agents|mesh-ancestor
24641275|NCT01172691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24641276|NCT01172691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641277|NCT01172691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24641278|NCT01172691|Respiratory System Agents|respiratory system agents|mesh-ancestor
24641279|NCT01172691|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25852247|NCT00055861|Tubulin Modulators|tubulin modulators|mesh-ancestor
24641281|NCT01172691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641282|NCT01172691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24641283|NCT01172691|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24641308|NCT01172782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24641309|NCT01172782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641310|NCT01172782|Analgesics|analgesics|mesh-ancestor
24641311|NCT01172782|Sensory System Agents|sensory system agents|mesh-ancestor
24940537|NCT04000633|Lidocaine|lidocaine|mesh-list
24703672|NCT01473251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703673|NCT01473251|Growth Inhibitors|growth inhibitors|mesh-ancestor
24703674|NCT01473277|Triamcinolone|triamcinolone|mesh-list
24940542|NCT04000633|Sensory System Agents|sensory system agents|mesh-ancestor
24940543|NCT04000633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24940544|NCT04000633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24703688|NCT01473277|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24703689|NCT01473277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24703690|NCT01473277|Cholinergic Agents|cholinergic agents|mesh-ancestor
24703691|NCT01473277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24703693|NCT01473303|Fluorouracil|fluorouracil|mesh-list
24703694|NCT01473303|Oxaliplatin|oxaliplatin|mesh-list
25852248|NCT00055861|Antimitotic Agents|antimitotic agents|mesh-ancestor
24617538|NCT01043666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617539|NCT01043666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617540|NCT01043666|Urological Agents|urological agents|mesh-ancestor
24617541|NCT01043666|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24735077|NCT01655524|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24735078|NCT01655524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24735079|NCT01655524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735081|NCT01655524|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24703695|NCT01473303|Irinotecan|irinotecan|mesh-list
24703696|NCT01473303|Calcium|calcium|mesh-list
24703724|NCT01473316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641312|NCT01172782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24641313|NCT01172912|Dexamethasone|dexamethasone|mesh-list
24641314|NCT01172912|Carboplatin|carboplatin|mesh-list
24641316|NCT01172912|Ifosfamide|ifosfamide|mesh-list
24641317|NCT01172912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641318|NCT01172912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24641351|NCT01172964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641353|NCT01173003|Mifepristone|mifepristone|mesh-list
24641354|NCT01173003|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24641355|NCT01173003|Abortifacient Agents|abortifacient agents|mesh-ancestor
24641356|NCT01173003|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24641357|NCT01173003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641358|NCT01173003|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24641359|NCT01173003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24641361|NCT01173003|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24641362|NCT01173003|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24641363|NCT01173003|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24641364|NCT01173003|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24641365|NCT01173003|Contraceptive Agents|contraceptive agents|mesh-ancestor
24641366|NCT01173003|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25074150|NCT03390465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074151|NCT03390465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25074152|NCT03390465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074153|NCT03390465|Vasodilator Agents|vasodilator agents|mesh-ancestor
25074154|NCT03390465|Diuretics|diuretics|mesh-ancestor
25074155|NCT03390465|Natriuretic Agents|natriuretic agents|mesh-ancestor
25074156|NCT03390465|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25074157|NCT03390387|Dexamethasone|dexamethasone|mesh-list
25074158|NCT03390387|Dexamethasone acetate|dexamethasone acetate|mesh-list
25074159|NCT03390387|Methylprednisolone|methylprednisolone|mesh-list
25074160|NCT03390387|Bortezomib|bortezomib|mesh-list
25074161|NCT03390387|Daunorubicin|daunorubicin|mesh-list
25074162|NCT03390387|Idarubicin|idarubicin|mesh-list
25074163|NCT03390387|BB 1101|bb 1101|mesh-list
25074164|NCT03390387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25074165|NCT03390387|Antiemetics|antiemetics|mesh-ancestor
24959816|NCT03822312|Tobramycin|tobramycin|mesh-list
25074166|NCT03390387|Autonomic Agents|autonomic agents|mesh-ancestor
24837094|NCT02188810|Immunologic Factors|immunologic factors|mesh-ancestor
24641367|NCT01173003|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24703731|NCT01473472|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24641368|NCT01173003|Hormone Antagonists|hormone antagonists|mesh-ancestor
24641370|NCT01173003|Luteolytic Agents|luteolytic agents|mesh-ancestor
24641398|NCT01173263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24641399|NCT01173263|Anesthetics, General|anesthetics, general|mesh-ancestor
24641400|NCT01173263|Anesthetics|anesthetics|mesh-ancestor
24641402|NCT01173315|Micronutrients|micronutrients|mesh-ancestor
24641403|NCT01173315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852249|NCT00055861|Mitosis Modulators|mitosis modulators|mesh-ancestor
24641404|NCT01173510|Raltegravir Potassium|raltegravir potassium|mesh-list
24462846|NCT00357682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663740|NCT01662115|Cholinergic Agents|cholinergic agents|mesh-ancestor
25663741|NCT01662115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25663742|NCT01662115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663743|NCT01662297|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25663744|NCT01662297|Trazodone|trazodone|mesh-list
25663745|NCT01662297|Antidepressive Agents|antidepressive agents|mesh-ancestor
25663746|NCT01662297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25663747|NCT01662297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24641405|NCT01173510|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24641406|NCT01173510|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25663748|NCT01662297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24735548|NCT01657487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24735577|NCT01657747|Cholinergic Agents|cholinergic agents|mesh-ancestor
25006751|NCT04668365|Cyclophosphamide|cyclophosphamide|mesh-list
25006752|NCT04668365|Rituximab|rituximab|mesh-list
24735578|NCT01657747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24883266|NCT04167761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24735633|NCT01657864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735641|NCT01657890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24735643|NCT01657929|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24735644|NCT01657929|Immunologic Factors|immunologic factors|mesh-ancestor
24641407|NCT01173510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24641408|NCT01173510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24641409|NCT01173510|Antiviral Agents|antiviral agents|mesh-ancestor
24641410|NCT01173510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24641589|NCT01174394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24641590|NCT01174394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641591|NCT01174394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25034380|NCT03564964|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
25034381|NCT03564964|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25034383|NCT03564964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24641593|NCT01174394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641594|NCT01174394|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24641595|NCT01174394|Antidepressive Agents|antidepressive agents|mesh-ancestor
24641596|NCT01174394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25074168|NCT03390387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074169|NCT03390387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25074170|NCT03390387|Glucocorticoids|glucocorticoids|mesh-ancestor
25074172|NCT03390387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25074173|NCT03390387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25074174|NCT03390387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25074175|NCT03390387|Protease Inhibitors|protease inhibitors|mesh-ancestor
25074176|NCT03390387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25074177|NCT03390387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074178|NCT03390387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25074179|NCT03390387|Protective Agents|protective agents|mesh-ancestor
25074180|NCT03390387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24837110|NCT02188953|Antacids|antacids|mesh-ancestor
24837112|NCT02188953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24641597|NCT01174394|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24641638|NCT01174563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641922|NCT01176747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641639|NCT01174563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641683|NCT01174888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24641684|NCT01174888|Keratolytic Agents|keratolytic agents|mesh-ancestor
24641685|NCT01174888|Dermatologic Agents|dermatologic agents|mesh-ancestor
24641686|NCT01174888|Tubulin Modulators|tubulin modulators|mesh-ancestor
24641694|NCT01174914|Lopinavir|lopinavir|mesh-list
24641695|NCT01174914|Nevirapine|nevirapine|mesh-list
24641696|NCT01174914|Stavudine|stavudine|mesh-list
24641697|NCT01174914|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
24641698|NCT01174914|Naltrexone|naltrexone|mesh-list
24641699|NCT01174914|Antiviral Agents|antiviral agents|mesh-ancestor
24641700|NCT01174914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24641701|NCT01174914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24641702|NCT01174914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24641703|NCT01174914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641704|NCT01174914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641705|NCT01174914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24641748|NCT01175109|Imatinib Mesylate|imatinib mesylate|mesh-list
24641749|NCT01175109|Panobinostat|panobinostat|mesh-list
25074181|NCT03390387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25074182|NCT03390387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25663749|NCT01662297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25663750|NCT01662297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663751|NCT01662297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25663752|NCT01662297|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25663753|NCT01662297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25663754|NCT01662297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25663755|NCT01662297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663756|NCT01662297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25663757|NCT01662297|Serotonin Agents|serotonin agents|mesh-ancestor
24735826|NCT01658891|Respiratory System Agents|respiratory system agents|mesh-ancestor
24617656|NCT01044719|Meropenem|meropenem|mesh-list
24617657|NCT01044719|Tobramycin|tobramycin|mesh-list
24617658|NCT01044719|Ceftazidime|ceftazidime|mesh-list
25074184|NCT03390374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25074185|NCT03390374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25074186|NCT03390374|Antifungal Agents|antifungal agents|mesh-ancestor
25074187|NCT03390374|Ionophores|ionophores|mesh-ancestor
25074188|NCT03390374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25074189|NCT03390374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837125|NCT02189304|Hormones|hormones|mesh-ancestor
24837127|NCT02189304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24641750|NCT01175109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852250|NCT00055861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852251|NCT00055874|Interferons|interferons|mesh-list
25202583|NCT02720705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25202584|NCT02720705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25202585|NCT02720705|Adrenergic Agents|adrenergic agents|mesh-ancestor
25202586|NCT02720705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25202587|NCT02720705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202588|NCT02720471|Anesthetics|anesthetics|mesh-list
25202589|NCT02720471|Anesthetics, Local|anesthetics, local|mesh-list
25852252|NCT00055874|Cytarabine|cytarabine|mesh-list
24703943|NCT01475578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852253|NCT00055874|Interferon-alpha|interferon-alpha|mesh-list
24641762|NCT01175200|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24641763|NCT01175200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24447840|NCT00309686|Dopamine Agents|dopamine agents|mesh-ancestor
24641764|NCT01175200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24641765|NCT01175200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24641766|NCT01175200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24641767|NCT01175200|Purinergic Agents|purinergic agents|mesh-ancestor
24641768|NCT01175200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24641769|NCT01175200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641770|NCT01175200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641771|NCT01175200|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24641772|NCT01175200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24641773|NCT01175200|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24641774|NCT01175200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641820|NCT01175525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24641821|NCT01175525|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24641822|NCT01175525|Respiratory System Agents|respiratory system agents|mesh-ancestor
24641823|NCT01175538|Lactulose|lactulose|mesh-list
24641824|NCT01175538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24641825|NCT01175577|Carotenoids|carotenoids|mesh-list
24641897|NCT01176409|Antiviral Agents|antiviral agents|mesh-ancestor
24641899|NCT01176552|Interferon-alpha|interferon-alpha|mesh-list
25852254|NCT00055874|Imatinib Mesylate|imatinib mesylate|mesh-list
24641921|NCT01176747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24641923|NCT01176747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24641924|NCT01176747|Respiratory System Agents|respiratory system agents|mesh-ancestor
24641925|NCT01176747|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24641926|NCT01176747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24641927|NCT01176747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25074190|NCT03390062|Apatinib|apatinib|mesh-list
25074191|NCT03390062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25074193|NCT03390062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25074194|NCT03390062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641928|NCT01176747|Adrenergic Agents|adrenergic agents|mesh-ancestor
24641929|NCT01176747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24641930|NCT01176747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641931|NCT01176760|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24641932|NCT01176760|Protease Inhibitors|protease inhibitors|mesh-ancestor
24641933|NCT01176760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641934|NCT01176760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641935|NCT01176760|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24641936|NCT01176760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641937|NCT01176799|Cyclophosphamide|cyclophosphamide|mesh-list
24641979|NCT01176903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704061|NCT01476410|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24704062|NCT01476410|Dacarbazine|dacarbazine|mesh-list
25663758|NCT01662297|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25663759|NCT01662310|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25663760|NCT01662310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24736052|NCT01659892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24736053|NCT01659892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736054|NCT01659892|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24736055|NCT01659892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24736056|NCT01659892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736058|NCT01659905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24789797|NCT01939171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789798|NCT01939171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24789799|NCT01939327|Rituximab|rituximab|mesh-list
24704063|NCT01476410|Vinblastine|vinblastine|mesh-list
25852255|NCT00055874|Hydroxyurea|hydroxyurea|mesh-list
25852256|NCT00055874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852257|NCT00055874|Antiviral Agents|antiviral agents|mesh-ancestor
24641981|NCT01176903|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24641982|NCT01177176|Bupropion|bupropion|mesh-list
24641983|NCT01177176|Nicotine|nicotine|mesh-list
24641984|NCT01177176|Varenicline|varenicline|mesh-list
24641985|NCT01177176|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24641986|NCT01177176|Autonomic Agents|autonomic agents|mesh-ancestor
24641987|NCT01177176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24642004|NCT01177306|Guanfacine|guanfacine|mesh-list
24642013|NCT01177358|Botulinum Toxins|botulinum toxins|mesh-list
24642014|NCT01177358|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24642015|NCT01177358|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24642016|NCT01177358|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24642017|NCT01177358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24642018|NCT01177358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642019|NCT01177358|Cholinergic Agents|cholinergic agents|mesh-ancestor
24642020|NCT01177358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24642077|NCT01177514|Gabapentin|gabapentin|mesh-list
24642078|NCT01177514|Analgesics|analgesics|mesh-ancestor
24642079|NCT01177514|Sensory System Agents|sensory system agents|mesh-ancestor
24642196|NCT01178112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642198|NCT01178151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25202590|NCT02720471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24642199|NCT01178151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24642200|NCT01178151|Immunologic Factors|immunologic factors|mesh-ancestor
24642230|NCT01178320|Vasodilator Agents|vasodilator agents|mesh-ancestor
24642231|NCT01178320|Vitamin B Complex|vitamin b complex|mesh-ancestor
24642232|NCT01178320|Vitamins|vitamins|mesh-ancestor
24642233|NCT01178320|Micronutrients|micronutrients|mesh-ancestor
24642234|NCT01178320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642235|NCT01178372|Lactulose|lactulose|mesh-list
24642236|NCT01178372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25074196|NCT03390036|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25074197|NCT03390036|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25074198|NCT03390036|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25074199|NCT03390036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25074200|NCT03390036|Glucocorticoids|glucocorticoids|mesh-ancestor
25074201|NCT03390036|Hormones|hormones|mesh-ancestor
25074202|NCT03390036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24642237|NCT01178450|Cinacalcet|cinacalcet|mesh-list
24642238|NCT01178450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24642239|NCT01178450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642240|NCT01178450|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24642241|NCT01178450|Hormone Antagonists|hormone antagonists|mesh-ancestor
24642242|NCT01178450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24642243|NCT01178645|Cytarabine|cytarabine|mesh-list
24642244|NCT01178645|Etoposide|etoposide|mesh-list
24642245|NCT01178645|Melphalan|melphalan|mesh-list
24642358|NCT01179009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24642359|NCT01179009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24642360|NCT01179009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24642362|NCT01179009|GABA Agents|gaba agents|mesh-ancestor
24642363|NCT01179009|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25663761|NCT01662310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25663762|NCT01662310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25663763|NCT01662310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663764|NCT01662310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25663765|NCT01662310|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25663766|NCT01662310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25663767|NCT01662310|Serotonin Agents|serotonin agents|mesh-ancestor
25663768|NCT01662310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25663769|NCT01662310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663770|NCT01662310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24642364|NCT01179009|Mydriatics|mydriatics|mesh-ancestor
24642365|NCT01179009|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24642366|NCT01179009|Cholinergic Agents|cholinergic agents|mesh-ancestor
24642401|NCT01179230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642402|NCT01179230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642403|NCT01179230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24642404|NCT01179230|Vasodilator Agents|vasodilator agents|mesh-ancestor
24642405|NCT01179256|Curcumin|curcumin|mesh-list
24642406|NCT01179256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24642407|NCT01179256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24642408|NCT01179256|Analgesics|analgesics|mesh-ancestor
24642409|NCT01179256|Sensory System Agents|sensory system agents|mesh-ancestor
24642410|NCT01179256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24642411|NCT01179256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642412|NCT01179256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24642413|NCT01179256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24642414|NCT01179256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642415|NCT01179256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642459|NCT01179464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642460|NCT01179503|Calcium, Dietary|calcium, dietary|mesh-list
24642462|NCT01179503|Calcium|calcium|mesh-list
24642463|NCT01179503|Vitamins|vitamins|mesh-ancestor
24642464|NCT01179503|Micronutrients|micronutrients|mesh-ancestor
24642465|NCT01179503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642466|NCT01179503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25074203|NCT03390036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074204|NCT03390036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25074205|NCT03390036|Immunologic Factors|immunologic factors|mesh-ancestor
25074206|NCT03390036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613484|NCT01019382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25074207|NCT03390036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550026|NCT00718757|Antiemetics|antiemetics|mesh-ancestor
25074226|NCT03389763|Remifentanil|remifentanil|mesh-list
25074227|NCT03389763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25074228|NCT03389763|Narcotics|narcotics|mesh-ancestor
25074229|NCT03389763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24837149|NCT02189343|Glucocorticoids|glucocorticoids|mesh-ancestor
24642467|NCT01179503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24642469|NCT01179529|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24642470|NCT01179529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25034772|NCT03562533|Carboplatin|carboplatin|mesh-list
25034773|NCT03562533|Doxorubicin|doxorubicin|mesh-list
25034774|NCT03562533|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25034775|NCT03562533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25034776|NCT03562533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25034841|NCT03562169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25034843|NCT03562143|Trace Elements|trace elements|mesh-ancestor
25034844|NCT03562143|Micronutrients|micronutrients|mesh-ancestor
24642471|NCT01179529|Respiratory System Agents|respiratory system agents|mesh-ancestor
24642472|NCT01179594|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24642473|NCT01179594|Interferon-alpha|interferon-alpha|mesh-list
24642474|NCT01179594|Entecavir|entecavir|mesh-list
24642475|NCT01179594|Antiviral Agents|antiviral agents|mesh-ancestor
24642476|NCT01179594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24642477|NCT01179594|Immunologic Factors|immunologic factors|mesh-ancestor
24642478|NCT01179594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642479|NCT01179620|Certoparin|certoparin|mesh-list
24642480|NCT01179620|Anticoagulants|anticoagulants|mesh-ancestor
24642481|NCT01179646|Pantoprazole|pantoprazole|mesh-list
24642502|NCT01179828|Oxycodone|oxycodone|mesh-list
24642517|NCT01179828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642518|NCT01179828|Urological Agents|urological agents|mesh-ancestor
24642519|NCT01179828|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24642520|NCT01179828|Antidepressive Agents|antidepressive agents|mesh-ancestor
24642521|NCT01179828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24837279|NCT02190760|Dexamethasone|dexamethasone|mesh-list
25074230|NCT03389763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074231|NCT03389763|Analgesics|analgesics|mesh-ancestor
25074232|NCT03389763|Sensory System Agents|sensory system agents|mesh-ancestor
25074233|NCT03389763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25074235|NCT03389724|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24959879|NCT03821714|Hormones|hormones|mesh-ancestor
25074236|NCT03389724|Protease Inhibitors|protease inhibitors|mesh-ancestor
25074237|NCT03389724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613542|NCT01019603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074238|NCT03389724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954133|NCT03879174|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24954134|NCT03879174|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25075046|NCT03383744|Vitamin A|vitamin a|mesh-list
24954135|NCT03879174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24954136|NCT03879122|Docetaxel|docetaxel|mesh-list
24954137|NCT03879122|Nivolumab|nivolumab|mesh-list
24954138|NCT03879122|Ipilimumab|ipilimumab|mesh-list
24954139|NCT03879122|Androgens|androgens|mesh-list
24642522|NCT01179828|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24642523|NCT01179828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24642524|NCT01179828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24642525|NCT01179828|Adrenergic Agents|adrenergic agents|mesh-ancestor
24642526|NCT01179828|Anticonvulsants|anticonvulsants|mesh-ancestor
24436054|NCT00268788|Antibodies|antibodies|mesh-list
24642694|NCT01180946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24642697|NCT01180959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25852258|NCT00055874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25852259|NCT00055874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24448056|NCT00310128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24448057|NCT00310128|Antimetabolites|antimetabolites|mesh-ancestor
24448058|NCT00310128|Antiviral Agents|antiviral agents|mesh-ancestor
24642748|NCT01181193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642871|NCT01181934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642874|NCT01181960|Antipsychotic Agents|antipsychotic agents|mesh-list
24642875|NCT01181960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24642876|NCT01181960|Serotonin Agents|serotonin agents|mesh-ancestor
24642877|NCT01181960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24462849|NCT00357682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24642878|NCT01181960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642879|NCT01181960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642880|NCT01181960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25852260|NCT00055874|Antimetabolites|antimetabolites|mesh-ancestor
25202591|NCT02720471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202592|NCT02720471|Sensory System Agents|sensory system agents|mesh-ancestor
25202593|NCT02720471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202594|NCT02720601|Capecitabine|capecitabine|mesh-list
25202595|NCT02720601|Irinotecan|irinotecan|mesh-list
25202596|NCT02720601|Camptothecin|camptothecin|mesh-list
25202597|NCT02720601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25202598|NCT02720601|Antimetabolites|antimetabolites|mesh-ancestor
24642881|NCT01181960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24642882|NCT01181960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24642883|NCT01181960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24642884|NCT01181960|Dopamine Agents|dopamine agents|mesh-ancestor
24642885|NCT01181960|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24954140|NCT03879122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24954142|NCT03879122|Antimitotic Agents|antimitotic agents|mesh-ancestor
24954143|NCT03879122|Mitosis Modulators|mitosis modulators|mesh-ancestor
24954144|NCT03879122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954145|NCT03879122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24954146|NCT03879122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24954147|NCT03879122|Hormones|hormones|mesh-ancestor
24545727|NCT00694694|Azithromycin|azithromycin|mesh-list
24779915|NCT01879748|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24779916|NCT01879748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24779917|NCT01879748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779918|NCT01879748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24779919|NCT01879748|Protective Agents|protective agents|mesh-ancestor
24779920|NCT01879748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779921|NCT01879917|Liraglutide|liraglutide|mesh-list
24779922|NCT01879917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24779923|NCT01879917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779924|NCT01879917|Incretins|incretins|mesh-ancestor
24779925|NCT01879917|Hormones|hormones|mesh-ancestor
24642886|NCT01181960|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24642887|NCT01181999|Rituximab|rituximab|mesh-list
24642888|NCT01181999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24642925|NCT01182142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642926|NCT01182142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642927|NCT01182168|Gemcitabine|gemcitabine|mesh-list
24642928|NCT01182168|Everolimus|everolimus|mesh-list
24642929|NCT01182168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626440|NCT01087398|Abortifacient Agents|abortifacient agents|mesh-ancestor
24626441|NCT01087398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25663771|NCT01662310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24737133|NCT01667094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24737134|NCT01667094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24737167|NCT01667315|Bupivacaine|bupivacaine|mesh-list
24737168|NCT01667315|Anesthetics, Local|anesthetics, local|mesh-ancestor
24737169|NCT01667315|Anesthetics|anesthetics|mesh-ancestor
24737170|NCT01667315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24737171|NCT01667315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737172|NCT01667315|Sensory System Agents|sensory system agents|mesh-ancestor
24765028|NCT01785693|Analgesics|analgesics|mesh-ancestor
24626442|NCT01087398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24626443|NCT01087398|Antimetabolites|antimetabolites|mesh-ancestor
24626444|NCT01087398|Dermatologic Agents|dermatologic agents|mesh-ancestor
24626445|NCT01087398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626446|NCT01087398|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24626447|NCT01087398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24626448|NCT01087398|Antifungal Agents|antifungal agents|mesh-ancestor
24626449|NCT01087398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24704159|NCT01476813|Glycopyrrolate|glycopyrrolate|mesh-list
24837208|NCT02190058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837209|NCT02190149|Factor VIII|factor viii|mesh-list
24837210|NCT02190149|Coagulants|coagulants|mesh-ancestor
24643019|NCT01183247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24643020|NCT01183247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24643021|NCT01183247|Immunologic Factors|immunologic factors|mesh-ancestor
24643022|NCT01183247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24643023|NCT01183247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24643024|NCT01183247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24643025|NCT01183247|Antifungal Agents|antifungal agents|mesh-ancestor
24643027|NCT01183364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24643028|NCT01183364|Tubulin Modulators|tubulin modulators|mesh-ancestor
24643029|NCT01183364|Antimitotic Agents|antimitotic agents|mesh-ancestor
25852261|NCT00055874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852262|NCT00055874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25852263|NCT00055874|Immunologic Factors|immunologic factors|mesh-ancestor
25852264|NCT00055874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852265|NCT00055874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25852266|NCT00055874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852267|NCT00055874|Antisickling Agents|antisickling agents|mesh-ancestor
24626450|NCT01087398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24626452|NCT01087437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24626453|NCT01087437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626454|NCT01087476|Doxycycline|doxycycline|mesh-list
24626455|NCT01087476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24954148|NCT03879122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24954149|NCT03879122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954150|NCT03879278|Immunoglobulins|immunoglobulins|mesh-list
24954151|NCT03879278|Immunoglobulin G|immunoglobulin g|mesh-list
24954152|NCT03879278|Immunologic Factors|immunologic factors|mesh-ancestor
24954153|NCT03879278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954154|NCT03879057|Antibodies|antibodies|mesh-list
24954155|NCT03879057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25023679|NCT03652480|Hormones|hormones|mesh-ancestor
24954156|NCT03879057|Immunologic Factors|immunologic factors|mesh-ancestor
24954157|NCT03879057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954158|NCT03878888|Bupivacaine|bupivacaine|mesh-list
24954159|NCT03878888|Anesthetics, Local|anesthetics, local|mesh-ancestor
24954160|NCT03878888|Anesthetics|anesthetics|mesh-ancestor
25074239|NCT03389724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25074240|NCT03389672|Anesthetics|anesthetics|mesh-list
24959954|NCT03820245|Antioxidants|antioxidants|mesh-ancestor
25074241|NCT03389672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25074242|NCT03389672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074243|NCT03389659|Vitamin D|vitamin d|mesh-list
25074244|NCT03389659|Cholecalciferol|cholecalciferol|mesh-list
25074245|NCT03389659|Vitamins|vitamins|mesh-ancestor
25074246|NCT03389659|Micronutrients|micronutrients|mesh-ancestor
25663772|NCT01662310|Dopamine Agents|dopamine agents|mesh-ancestor
25663773|NCT01662336|Ritonavir|ritonavir|mesh-list
25663774|NCT01662336|Lopinavir|lopinavir|mesh-list
25663775|NCT01662336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25663776|NCT01662336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25663777|NCT01662336|Protease Inhibitors|protease inhibitors|mesh-ancestor
25663778|NCT01662336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663779|NCT01662336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663780|NCT01662336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25663781|NCT01662336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24765058|NCT01785862|Ibuprofen|ibuprofen|mesh-list
24737585|NCT01669824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737586|NCT01669824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24737620|NCT01669967|Dermatologic Agents|dermatologic agents|mesh-ancestor
24737622|NCT01670071|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24737623|NCT01670071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24737624|NCT01670071|Serotonin Agents|serotonin agents|mesh-ancestor
24737625|NCT01670071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25852268|NCT00055874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25852269|NCT00055887|Gemcitabine|gemcitabine|mesh-list
25852270|NCT00055887|Paclitaxel|paclitaxel|mesh-list
25852271|NCT00055887|Vinorelbine|vinorelbine|mesh-list
25852272|NCT00055887|Cisplatin|cisplatin|mesh-list
25852273|NCT00055887|Carboplatin|carboplatin|mesh-list
25852274|NCT00055887|Efaproxiral|efaproxiral|mesh-list
25852275|NCT00055887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25074247|NCT03389659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074248|NCT03389659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25074282|NCT03389321|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25074283|NCT03389321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837275|NCT02190708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837276|NCT02190708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24837277|NCT02190708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24837278|NCT02190708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837280|NCT02190760|Bupivacaine|bupivacaine|mesh-list
24837281|NCT02190760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24837282|NCT02190760|Antiemetics|antiemetics|mesh-ancestor
24837283|NCT02190760|Autonomic Agents|autonomic agents|mesh-ancestor
24837284|NCT02190760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24837285|NCT02190760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837288|NCT02190760|Hormones|hormones|mesh-ancestor
24643049|NCT01183494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24643050|NCT01183494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643051|NCT01183494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643052|NCT01183494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24643053|NCT01183494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24643054|NCT01183494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24643055|NCT01183494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24643056|NCT01183494|Growth Substances|growth substances|mesh-ancestor
24704308|NCT01477632|Norethindrone Acetate|norethindrone acetate|mesh-list
24704384|NCT01478022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24704385|NCT01478022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24643057|NCT01183494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643058|NCT01183494|Growth Inhibitors|growth inhibitors|mesh-ancestor
25074284|NCT03389321|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25074285|NCT03389321|Enzyme Activators|enzyme activators|mesh-ancestor
25074286|NCT03389295|Cisplatin|cisplatin|mesh-list
25074287|NCT03389295|Docetaxel|docetaxel|mesh-list
25074288|NCT03389295|Fluorouracil|fluorouracil|mesh-list
25074289|NCT03389295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25074290|NCT03389295|Tubulin Modulators|tubulin modulators|mesh-ancestor
25074291|NCT03389295|Antimitotic Agents|antimitotic agents|mesh-ancestor
25074292|NCT03389295|Mitosis Modulators|mitosis modulators|mesh-ancestor
25074293|NCT03389295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074333|NCT03388970|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25074334|NCT03388970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25074335|NCT03388970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074337|NCT03388970|Coagulants|coagulants|mesh-ancestor
25074338|NCT03388957|Propranolol|propranolol|mesh-list
25074339|NCT03388957|Midazolam|midazolam|mesh-list
25074340|NCT03388957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25663782|NCT01662336|Antiviral Agents|antiviral agents|mesh-ancestor
25663783|NCT01662336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25663784|NCT01662336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25663785|NCT01662336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25663786|NCT01662492|Botulinum Toxins|botulinum toxins|mesh-list
25663787|NCT01662492|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25663788|NCT01662492|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25663789|NCT01662492|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25663790|NCT01662492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25663791|NCT01662492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663792|NCT01662492|Cholinergic Agents|cholinergic agents|mesh-ancestor
25663793|NCT01662492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25074341|NCT03388957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25424314|NCT02272790|Tubulin Modulators|tubulin modulators|mesh-ancestor
25240915|NCT04498832|Immunologic Factors|immunologic factors|mesh-ancestor
25852276|NCT00055887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25074342|NCT03388957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25074343|NCT03388957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074344|NCT03388957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25074345|NCT03388957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25074346|NCT03388957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25074347|NCT03388957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25074348|NCT03388957|Anesthetics, General|anesthetics, general|mesh-ancestor
25074349|NCT03388957|Anesthetics|anesthetics|mesh-ancestor
25074350|NCT03388957|GABA Modulators|gaba modulators|mesh-ancestor
25074351|NCT03388957|GABA Agents|gaba agents|mesh-ancestor
24436412|NCT00269854|Dermatologic Agents|dermatologic agents|mesh-ancestor
25074379|NCT03388853|Protective Agents|protective agents|mesh-ancestor
25207758|NCT03421652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25074380|NCT03388853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074381|NCT03388853|Antidotes|antidotes|mesh-ancestor
25074382|NCT03388853|Antitussive Agents|antitussive agents|mesh-ancestor
25023732|NCT03652142|Nivolumab|nivolumab|mesh-list
25074383|NCT03388853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25074384|NCT03388853|Autonomic Agents|autonomic agents|mesh-ancestor
25074385|NCT03388853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25074386|NCT03388853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25074387|NCT03388853|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25074388|NCT03388853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25074389|NCT03388827|Misoprostol|misoprostol|mesh-list
24940621|NCT03999099|Suvorexant|suvorexant|mesh-list
24704478|NCT01478490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25074390|NCT03388827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24954161|NCT03878888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25074391|NCT03388827|Abortifacient Agents|abortifacient agents|mesh-ancestor
25074392|NCT03388827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25074393|NCT03388827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074394|NCT03388827|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25074395|NCT03388827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25074397|NCT03388814|Bupivacaine|bupivacaine|mesh-list
25074398|NCT03388814|Anesthetics, Local|anesthetics, local|mesh-ancestor
25074399|NCT03388814|Anesthetics|anesthetics|mesh-ancestor
25074400|NCT03388814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25074403|NCT03388814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24643060|NCT01183572|Folic Acid|folic acid|mesh-list
24643061|NCT01183572|Vitamin B Complex|vitamin b complex|mesh-list
25074405|NCT03388697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25074406|NCT03388697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074407|NCT03388671|Bupivacaine|bupivacaine|mesh-list
25074448|NCT03388346|Sequestering Agents|sequestering agents|mesh-ancestor
25074449|NCT03388346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074450|NCT03388346|Anticoagulants|anticoagulants|mesh-ancestor
25074451|NCT03388346|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25074452|NCT03388346|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25074453|NCT03388151|Midazolam|midazolam|mesh-list
25074454|NCT03388151|Propofol|propofol|mesh-list
25074455|NCT03388151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25074456|NCT03388151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24954169|NCT03878771|Benzocaine|benzocaine|mesh-list
24954170|NCT03878771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24954171|NCT03878771|Glucocorticoids|glucocorticoids|mesh-ancestor
24954223|NCT03878082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24954224|NCT03878082|Antipyretics|antipyretics|mesh-ancestor
25074504|NCT03387904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25074505|NCT03387826|Ticagrelor|ticagrelor|mesh-list
25074506|NCT03387826|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25074507|NCT03387826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25074508|NCT03387826|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25074509|NCT03387826|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25074510|NCT03387826|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25074511|NCT03387826|Purinergic Agents|purinergic agents|mesh-ancestor
25074512|NCT03387826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25074513|NCT03387826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074514|NCT03387826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663794|NCT01662492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663795|NCT01662492|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25074515|NCT03387787|Insulin|insulin|mesh-list
25074516|NCT03387787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25074547|NCT03387592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663796|NCT01662492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25074548|NCT03387592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25074549|NCT03387592|Immunologic Factors|immunologic factors|mesh-ancestor
25074559|NCT03387566|Endothelial Growth Factors|endothelial growth factors|mesh-list
25074560|NCT03387566|Immunologic Factors|immunologic factors|mesh-ancestor
24643099|NCT01183663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24643100|NCT01183663|Immunologic Factors|immunologic factors|mesh-ancestor
24643101|NCT01183663|Antidotes|antidotes|mesh-ancestor
25074561|NCT03387566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074562|NCT03387566|Growth Substances|growth substances|mesh-ancestor
25074566|NCT03387241|Fluticasone|fluticasone|mesh-list
25074567|NCT03387241|Xhance|xhance|mesh-list
25074568|NCT03387241|Formoterol Fumarate|formoterol fumarate|mesh-list
25074569|NCT03387241|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25074570|NCT03387241|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25202599|NCT02720601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074571|NCT03387241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25074572|NCT03387241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25074573|NCT03387241|Autonomic Agents|autonomic agents|mesh-ancestor
25074574|NCT03387241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25074575|NCT03387241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074576|NCT03387241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25074577|NCT03387241|Respiratory System Agents|respiratory system agents|mesh-ancestor
25074578|NCT03387241|Dermatologic Agents|dermatologic agents|mesh-ancestor
25074579|NCT03387241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25074580|NCT03387241|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25074581|NCT03387241|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25074582|NCT03387241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25074583|NCT03387241|Adrenergic Agents|adrenergic agents|mesh-ancestor
25074584|NCT03387241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25074585|NCT03387241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074586|NCT03387241|Glucocorticoids|glucocorticoids|mesh-ancestor
25074587|NCT03387241|Hormones|hormones|mesh-ancestor
25074588|NCT03387241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25074589|NCT03387241|Sympathomimetics|sympathomimetics|mesh-ancestor
25074590|NCT03387163|Valsartan|valsartan|mesh-list
25074596|NCT03387111|Leucovorin|leucovorin|mesh-list
25074605|NCT03387111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25074606|NCT03387111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25074607|NCT03387111|Tubulin Modulators|tubulin modulators|mesh-ancestor
25074608|NCT03387111|Antimitotic Agents|antimitotic agents|mesh-ancestor
25074609|NCT03387111|Mitosis Modulators|mitosis modulators|mesh-ancestor
25074610|NCT03387111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074611|NCT03387111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25074612|NCT03387111|Immunologic Factors|immunologic factors|mesh-ancestor
25074613|NCT03387111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074614|NCT03387111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25074615|NCT03387111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25074616|NCT03387111|Alkylating Agents|alkylating agents|mesh-ancestor
25074617|NCT03387111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25074618|NCT03387111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25074619|NCT03387111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25074620|NCT03387111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24960339|NCT03818334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24960340|NCT03818334|Immunologic Factors|immunologic factors|mesh-ancestor
25074683|NCT03386838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25074684|NCT03386838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25074685|NCT03386838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25074686|NCT03386656|Tranexamic Acid|tranexamic acid|mesh-list
25074687|NCT03386656|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25074688|NCT03386656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25074689|NCT03386656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074690|NCT03386656|Hemostatics|hemostatics|mesh-ancestor
25074691|NCT03386656|Coagulants|coagulants|mesh-ancestor
25074692|NCT03386643|Clobetasol|clobetasol|mesh-list
25074693|NCT03386643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25074694|NCT03386643|Glucocorticoids|glucocorticoids|mesh-ancestor
25074695|NCT03386643|Hormones|hormones|mesh-ancestor
25074696|NCT03386643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25074697|NCT03386643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074698|NCT03386630|Sufentanil|sufentanil|mesh-list
25074699|NCT03386630|Morphine|morphine|mesh-list
24954234|NCT03877718|Sumatriptan|sumatriptan|mesh-list
24954235|NCT03877718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24954236|NCT03877718|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24954237|NCT03877718|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24954245|NCT03877718|Histamine Antagonists|histamine antagonists|mesh-ancestor
24954246|NCT03877718|Histamine Agents|histamine agents|mesh-ancestor
24954247|NCT03877718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24954248|NCT03877718|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24954249|NCT03877718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24954250|NCT03877718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24954251|NCT03877718|Anesthetics, Local|anesthetics, local|mesh-ancestor
24954253|NCT03877718|Sensory System Agents|sensory system agents|mesh-ancestor
24954254|NCT03877718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24954255|NCT03877718|Antiemetics|antiemetics|mesh-ancestor
24954256|NCT03877718|Autonomic Agents|autonomic agents|mesh-ancestor
24954257|NCT03877718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24954258|NCT03877965|Digoxin|digoxin|mesh-list
24954259|NCT03877965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24954260|NCT03877965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24954261|NCT03877965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24954262|NCT03877965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954263|NCT03877965|Protective Agents|protective agents|mesh-ancestor
24954264|NCT03877965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954265|NCT03877536|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24954266|NCT03877536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24954267|NCT03877536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24954268|NCT03877536|Antiviral Agents|antiviral agents|mesh-ancestor
24954269|NCT03877536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24954270|NCT03877549|Dexamethasone|dexamethasone|mesh-list
25074701|NCT03386630|Bupivacaine|bupivacaine|mesh-list
25074702|NCT03386630|Anesthetics, Local|anesthetics, local|mesh-ancestor
25074703|NCT03386630|Anesthetics|anesthetics|mesh-ancestor
25074704|NCT03386630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24837779|NCT02193308|Amlodipine|amlodipine|mesh-list
24643155|NCT01184144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074724|NCT03386565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074725|NCT03386565|Sensory System Agents|sensory system agents|mesh-ancestor
25074726|NCT03386565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25074727|NCT03386565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25074728|NCT03386565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25074729|NCT03386565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25852277|NCT00055887|Tubulin Modulators|tubulin modulators|mesh-ancestor
25852278|NCT00055887|Antimitotic Agents|antimitotic agents|mesh-ancestor
24442576|NCT00291720|Hormone Antagonists|hormone antagonists|mesh-ancestor
24704777|NCT01480323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24704778|NCT01480323|Analgesics|analgesics|mesh-ancestor
24704779|NCT01480323|Sensory System Agents|sensory system agents|mesh-ancestor
24704780|NCT01480323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25074730|NCT03386565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24845366|NCT02237729|Adalimumab|adalimumab|mesh-list
25074731|NCT03386565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074747|NCT03386318|Oxycodone|oxycodone|mesh-list
25074748|NCT03386318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25074749|NCT03386318|Narcotics|narcotics|mesh-ancestor
25074750|NCT03386318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25074751|NCT03386318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074752|NCT03386318|Analgesics|analgesics|mesh-ancestor
25074753|NCT03386318|Sensory System Agents|sensory system agents|mesh-ancestor
25074754|NCT03386318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25074798|NCT03385967|Sensory System Agents|sensory system agents|mesh-ancestor
25074799|NCT03385967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25074800|NCT03385967|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25074801|NCT03385967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25074802|NCT03385967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25074803|NCT03385967|Adrenergic Agents|adrenergic agents|mesh-ancestor
25074804|NCT03385967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25074805|NCT03385967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074806|NCT03385967|Anesthetics, Local|anesthetics, local|mesh-ancestor
25074832|NCT03385538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25074833|NCT03385538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074834|NCT03385538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074835|NCT03385525|Valproic Acid|valproic acid|mesh-list
25074837|NCT03385525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25074838|NCT03385525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074839|NCT03385525|GABA Agents|gaba agents|mesh-ancestor
25074840|NCT03385525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25074841|NCT03385525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074862|NCT03385382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25074864|NCT03385382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24704781|NCT01480323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074865|NCT03385382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25074866|NCT03385382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25074867|NCT03385382|Growth Substances|growth substances|mesh-ancestor
25074868|NCT03385382|Growth Inhibitors|growth inhibitors|mesh-ancestor
25074869|NCT03385356|Vitamin D|vitamin d|mesh-list
25074870|NCT03385356|Vitamins|vitamins|mesh-ancestor
25074895|NCT03385174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25074896|NCT03385174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074898|NCT03385161|Botulinum Toxins|botulinum toxins|mesh-list
25074899|NCT03385161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25074900|NCT03385161|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25074901|NCT03385161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25074902|NCT03385161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24643227|NCT01184560|Appetite Depressants|appetite depressants|mesh-ancestor
24643228|NCT01184638|Propofol|propofol|mesh-list
24643285|NCT01185015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24643286|NCT01185015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24643287|NCT01185015|Vasodilator Agents|vasodilator agents|mesh-ancestor
24643288|NCT01185015|Vitamin B Complex|vitamin b complex|mesh-ancestor
24643291|NCT01185015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643292|NCT01185067|Grape Seed Extract|grape seed extract|mesh-list
25074926|NCT03385096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25074927|NCT03385096|Immunologic Factors|immunologic factors|mesh-ancestor
25074928|NCT03385096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074929|NCT03385096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25074930|NCT03385096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25074931|NCT03385096|Alkylating Agents|alkylating agents|mesh-ancestor
24960686|NCT03814629|Vitamins|vitamins|mesh-list
25074932|NCT03385096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074933|NCT03385096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25074934|NCT03385096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25852279|NCT00055887|Mitosis Modulators|mitosis modulators|mesh-ancestor
25074952|NCT03385057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074954|NCT03384862|Vitamin B 12|vitamin b 12|mesh-list
25074955|NCT03384862|Hydroxocobalamin|hydroxocobalamin|mesh-list
25074956|NCT03384862|Vitamins|vitamins|mesh-ancestor
25074972|NCT03384524|Autonomic Agents|autonomic agents|mesh-ancestor
25074973|NCT03384524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25074974|NCT03384524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074975|NCT03384524|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25074976|NCT03384524|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25852280|NCT00055887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074977|NCT03384524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25074978|NCT03384524|Adrenergic Agents|adrenergic agents|mesh-ancestor
25074979|NCT03384524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25074980|NCT03384524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074981|NCT03384524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25074982|NCT03384524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25074983|NCT03384524|Urological Agents|urological agents|mesh-ancestor
25074984|NCT03384524|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25074985|NCT03384524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25074986|NCT03384524|Hormone Antagonists|hormone antagonists|mesh-ancestor
25074987|NCT03384524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25074988|NCT03384524|Dopamine Agonists|dopamine agonists|mesh-ancestor
25074989|NCT03384524|Dopamine Agents|dopamine agents|mesh-ancestor
25074990|NCT03384511|Apatinib|apatinib|mesh-list
25074991|NCT03384511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25074992|NCT03384511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25074993|NCT03384511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704898|NCT01480986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25074994|NCT03384511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786677|NCT01921361|Dexmedetomidine|dexmedetomidine|mesh-list
25074995|NCT03384277|Cyclophosphamide|cyclophosphamide|mesh-list
25074996|NCT03384277|Rituximab|rituximab|mesh-list
25074997|NCT03384277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25074998|NCT03384277|Immunologic Factors|immunologic factors|mesh-ancestor
24643293|NCT01185067|Resveratrol|resveratrol|mesh-list
24643294|NCT01185067|Antioxidants|antioxidants|mesh-list
24643296|NCT01185067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643297|NCT01185067|Protective Agents|protective agents|mesh-ancestor
24643298|NCT01185067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643299|NCT01185067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643300|NCT01185067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24438586|NCT00276289|Diuretics|diuretics|mesh-ancestor
25075003|NCT03384277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075004|NCT03384277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075005|NCT03384277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25075006|NCT03384277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25075007|NCT03384238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25075008|NCT03384238|Panitumumab|panitumumab|mesh-list
25075009|NCT03384238|Antibodies|antibodies|mesh-list
25075010|NCT03384238|Immunoglobulins|immunoglobulins|mesh-list
25075011|NCT03384238|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25075012|NCT03384238|Immunologic Factors|immunologic factors|mesh-ancestor
25075013|NCT03384238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075014|NCT03384238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075015|NCT03384121|Rifampin|rifampin|mesh-list
25075016|NCT03384121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25075017|NCT03384121|Antitubercular Agents|antitubercular agents|mesh-ancestor
25075018|NCT03384121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25075019|NCT03384121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25075020|NCT03384121|Leprostatic Agents|leprostatic agents|mesh-ancestor
25075021|NCT03384121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25075022|NCT03384121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075023|NCT03384121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075024|NCT03384121|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25075025|NCT03384121|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25075026|NCT03384121|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25075027|NCT03384121|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25075028|NCT03384121|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25075029|NCT03384121|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25075030|NCT03384095|Hyaluronic Acid|hyaluronic acid|mesh-list
25075031|NCT03384095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25075032|NCT03384095|Immunologic Factors|immunologic factors|mesh-ancestor
24838102|NCT02195336|Paclitaxel|paclitaxel|mesh-list
25852281|NCT00055887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25075033|NCT03384095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075034|NCT03384095|Viscosupplements|viscosupplements|mesh-ancestor
25075035|NCT03384095|Protective Agents|protective agents|mesh-ancestor
25075036|NCT03383939|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25075037|NCT03383939|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25075038|NCT03383939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25075039|NCT03383939|Protease Inhibitors|protease inhibitors|mesh-ancestor
25075040|NCT03383939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202600|NCT02720601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852282|NCT00055887|Antimetabolites|antimetabolites|mesh-ancestor
25075041|NCT03383939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075042|NCT03383822|Insulin|insulin|mesh-list
25075043|NCT03383822|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25075044|NCT03383822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25075045|NCT03383822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075047|NCT03383744|Vitamins|vitamins|mesh-ancestor
25075048|NCT03383744|Micronutrients|micronutrients|mesh-ancestor
25075049|NCT03383744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075050|NCT03383406|Cytarabine|cytarabine|mesh-list
25075051|NCT03383406|Methotrexate|methotrexate|mesh-list
25075052|NCT03383406|Etoposide|etoposide|mesh-list
25075053|NCT03383406|Ifosfamide|ifosfamide|mesh-list
25075054|NCT03383406|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24954284|NCT03877874|Autonomic Agents|autonomic agents|mesh-ancestor
24954285|NCT03877874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24954286|NCT03877874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954287|NCT03877874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24954288|NCT03877874|Respiratory System Agents|respiratory system agents|mesh-ancestor
24954289|NCT03877874|Sympathomimetics|sympathomimetics|mesh-ancestor
24954290|NCT03877874|Tocolytic Agents|tocolytic agents|mesh-ancestor
24954291|NCT03877874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24954292|NCT03877874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24954293|NCT03877874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24954294|NCT03877874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24705084|NCT01482052|Vaccines|vaccines|mesh-list
24954295|NCT03877874|Adrenergic Agents|adrenergic agents|mesh-ancestor
24954296|NCT03877874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24954297|NCT03877874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954298|NCT03877692|Labetalol|labetalol|mesh-list
24954299|NCT03877692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25852283|NCT00055887|Antiviral Agents|antiviral agents|mesh-ancestor
24740386|NCT01688154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740387|NCT01688154|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24740388|NCT01688154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24740430|NCT01688518|Lidocaine|lidocaine|mesh-list
24954300|NCT03877692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24954301|NCT03877692|Adrenergic Agents|adrenergic agents|mesh-ancestor
24954302|NCT03877692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24954303|NCT03877692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954304|NCT03877692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954305|NCT03877692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24954317|NCT03877679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954318|NCT03877679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24954319|NCT03877679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954320|NCT03877679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24954321|NCT03877679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25075095|NCT03383328|Prednisolone|prednisolone|mesh-list
25075096|NCT03383328|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25075097|NCT03383328|Methylprednisolone|methylprednisolone|mesh-list
25075098|NCT03383328|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25075099|NCT03383328|Prednisolone acetate|prednisolone acetate|mesh-list
25075100|NCT03383328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25075101|NCT03383328|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25075102|NCT03383328|Prednisolone phosphate|prednisolone phosphate|mesh-list
25075103|NCT03383328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25075104|NCT03383328|Glucocorticoids|glucocorticoids|mesh-ancestor
25075105|NCT03383328|Hormones|hormones|mesh-ancestor
25075106|NCT03383328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25075107|NCT03383328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075108|NCT03383328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25075109|NCT03383328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075110|NCT03383328|Antiemetics|antiemetics|mesh-ancestor
25075111|NCT03383328|Autonomic Agents|autonomic agents|mesh-ancestor
25075146|NCT03383237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25075147|NCT03383237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229653|NCT02601287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25075148|NCT03383237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075149|NCT03383185|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25075150|NCT03383185|Contraceptive Agents|contraceptive agents|mesh-list
25075151|NCT03383185|Medroxyprogesterone|medroxyprogesterone|mesh-list
24786823|NCT01921972|Memantine|memantine|mesh-list
24705258|NCT01483365|Progestins|progestins|mesh-ancestor
24705259|NCT01483365|Hormones|hormones|mesh-ancestor
24705260|NCT01483365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24705261|NCT01483365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705262|NCT01483508|Proanthocyanidin|proanthocyanidin|mesh-list
24705263|NCT01483508|Procyanidin|procyanidin|mesh-list
24705264|NCT01483508|Antioxidants|antioxidants|mesh-ancestor
25852284|NCT00055887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25852285|NCT00055887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852286|NCT00055887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24940639|NCT03999203|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24940640|NCT03999203|Autonomic Agents|autonomic agents|mesh-ancestor
25852287|NCT00055887|Immunologic Factors|immunologic factors|mesh-ancestor
25075153|NCT03383185|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25075154|NCT03383185|Progestins|progestins|mesh-list
25075156|NCT03383185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075157|NCT03383185|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25202601|NCT02720601|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25202602|NCT02720601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25075159|NCT03383185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25075161|NCT03383185|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25075162|NCT03383185|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25075163|NCT03383185|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25075164|NCT03383185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25075165|NCT03383185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075166|NCT03383120|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25075167|NCT03383120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25075168|NCT03383094|Pembrolizumab|pembrolizumab|mesh-list
25663797|NCT01662648|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25663798|NCT01662648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25663799|NCT01662648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25663800|NCT01662648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25663801|NCT01662648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852288|NCT00055887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663802|NCT01662648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24741348|NCT01693445|Irinotecan|irinotecan|mesh-list
24741349|NCT01693445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24741350|NCT01693445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24741351|NCT01693445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24741352|NCT01693445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24741353|NCT01693445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741354|NCT01693601|Panobinostat|panobinostat|mesh-list
25075169|NCT03383094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075173|NCT03383068|Acarbose|acarbose|mesh-list
25075174|NCT03383068|Orlistat|orlistat|mesh-list
25075175|NCT03383068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25075176|NCT03383068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075177|NCT03383068|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25075178|NCT03383068|Incretins|incretins|mesh-ancestor
25075179|NCT03383068|Hormones|hormones|mesh-ancestor
25075180|NCT03383068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24643307|NCT01185119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24643308|NCT01185119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643309|NCT01185119|Incretins|incretins|mesh-ancestor
24643310|NCT01185158|Gefitinib|gefitinib|mesh-list
24643311|NCT01185158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24643312|NCT01185158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24643313|NCT01185158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075218|NCT03382886|Bevacizumab|bevacizumab|mesh-list
25075219|NCT03382886|Nivolumab|nivolumab|mesh-list
25075220|NCT03382886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25075221|NCT03382886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075222|NCT03382886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25075223|NCT03382886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24960983|NCT03813030|Anesthetics, Local|anesthetics, local|mesh-ancestor
25075224|NCT03382886|Growth Substances|growth substances|mesh-ancestor
25075225|NCT03382886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643335|NCT01185223|Valganciclovir|valganciclovir|mesh-list
24643336|NCT01185223|Ganciclovir|ganciclovir|mesh-list
24643337|NCT01185223|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25075243|NCT03382743|Anesthetics, Local|anesthetics, local|mesh-ancestor
25075244|NCT03382743|Anesthetics|anesthetics|mesh-ancestor
25075245|NCT03382743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25075246|NCT03382743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075247|NCT03382743|Sensory System Agents|sensory system agents|mesh-ancestor
25075248|NCT03382743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25075249|NCT03382743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25075250|NCT03382743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25075251|NCT03382743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25075252|NCT03382743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25075253|NCT03382743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075254|NCT03382717|Amorolfine|amorolfine|mesh-list
25075255|NCT03382717|Antifungal Agents|antifungal agents|mesh-ancestor
25075256|NCT03382717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25075257|NCT03382600|Pembrolizumab|pembrolizumab|mesh-list
25075258|NCT03382600|Oxaliplatin|oxaliplatin|mesh-list
25075259|NCT03382600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075260|NCT03382600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25075261|NCT03382587|Aflibercept|aflibercept|mesh-list
25075262|NCT03382587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25075263|NCT03382587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25075264|NCT03382587|Growth Substances|growth substances|mesh-ancestor
25075265|NCT03382587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075266|NCT03382587|Growth Inhibitors|growth inhibitors|mesh-ancestor
25075267|NCT03382587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075268|NCT03382470|Anti-Infective Agents|anti-infective agents|mesh-list
25075269|NCT03382470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25424315|NCT02272790|Antimitotic Agents|antimitotic agents|mesh-ancestor
25663803|NCT01662648|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25663804|NCT01662648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25663805|NCT01662648|Serotonin Agents|serotonin agents|mesh-ancestor
25663806|NCT01662648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25663807|NCT01662648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663808|NCT01662648|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25663809|NCT01662648|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25663810|NCT01662648|Dopamine Agents|dopamine agents|mesh-ancestor
25663811|NCT01662791|Rifaximin|rifaximin|mesh-list
24742079|NCT05293704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24742080|NCT05293704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766032|NCT01792037|GABA Agents|gaba agents|mesh-ancestor
25852289|NCT00055887|Antisickling Agents|antisickling agents|mesh-ancestor
24742081|NCT05293704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24742082|NCT05293704|Immunologic Factors|immunologic factors|mesh-ancestor
25852290|NCT00055913|Bevacizumab|bevacizumab|mesh-list
24618340|NCT01047956|Respiratory System Agents|respiratory system agents|mesh-ancestor
25075282|NCT03382314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25075283|NCT03382314|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24705423|NCT01485146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25075285|NCT03382314|Hormone Antagonists|hormone antagonists|mesh-ancestor
25075286|NCT03382314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25075287|NCT03382275|Iron|iron|mesh-list
25075288|NCT03382275|Ferric maltol|ferric maltol|mesh-list
25075289|NCT03382275|Trace Elements|trace elements|mesh-ancestor
25075290|NCT03382275|Micronutrients|micronutrients|mesh-ancestor
25075291|NCT03382275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075292|NCT03382275|Hematinics|hematinics|mesh-ancestor
24940647|NCT03999203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075326|NCT03381755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075327|NCT03381755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075329|NCT03381703|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
25075330|NCT03381703|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25075331|NCT03381703|Serotonin Agents|serotonin agents|mesh-ancestor
25075332|NCT03381703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25075333|NCT03381703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075334|NCT03381703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075335|NCT03381664|Quinidine|quinidine|mesh-list
25075336|NCT03381664|Dextromethorphan|dextromethorphan|mesh-list
25075337|NCT03381664|Antitussive Agents|antitussive agents|mesh-ancestor
25075338|NCT03381664|Respiratory System Agents|respiratory system agents|mesh-ancestor
25075339|NCT03381664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25075340|NCT03381664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25075341|NCT03381664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25075342|NCT03381664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075343|NCT03381664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075344|NCT03381664|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25075345|NCT03381664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25075346|NCT03381664|Adrenergic Agents|adrenergic agents|mesh-ancestor
25075347|NCT03381664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25075348|NCT03381664|Antimalarials|antimalarials|mesh-ancestor
25075349|NCT03381664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24439521|NCT00279162|Hormones|hormones|mesh-ancestor
25075376|NCT03381495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25075377|NCT03381495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25075378|NCT03381495|Anesthetics, General|anesthetics, general|mesh-ancestor
25075379|NCT03381482|Anesthetics|anesthetics|mesh-list
25075380|NCT03381482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25075381|NCT03381482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075382|NCT03381430|Gefitinib|gefitinib|mesh-list
25075383|NCT03381430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075384|NCT03381430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25075385|NCT03381430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075386|NCT03381430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075387|NCT03381352|Capecitabine|capecitabine|mesh-list
25075388|NCT03381352|Mitomycins|mitomycins|mesh-list
25075389|NCT03381352|Mitomycin|mitomycin|mesh-list
25075390|NCT03381352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25075391|NCT03381352|Antimetabolites|antimetabolites|mesh-ancestor
25075406|NCT03381261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075407|NCT03381261|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25075408|NCT03381261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25075409|NCT03381118|Cytarabine|cytarabine|mesh-list
25075410|NCT03381118|Nivolumab|nivolumab|mesh-list
24613612|NCT01019941|Docetaxel|docetaxel|mesh-list
24705361|NCT01484600|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24705362|NCT01484600|Immunologic Factors|immunologic factors|mesh-ancestor
25663812|NCT01662791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25663813|NCT01662791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25663814|NCT01662791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25663815|NCT01662856|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25663816|NCT01662856|Hemostatics|hemostatics|mesh-ancestor
25663817|NCT01662856|Coagulants|coagulants|mesh-ancestor
25663818|NCT01662895|Deferoxamine|deferoxamine|mesh-list
25663819|NCT01662895|Siderophores|siderophores|mesh-ancestor
24742437|NCT05267431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24742438|NCT05267431|Immunologic Factors|immunologic factors|mesh-ancestor
24742439|NCT05267431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25240996|NCT04240626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25240997|NCT04240626|Narcotics|narcotics|mesh-ancestor
25240998|NCT04240626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25240999|NCT04240626|Anticonvulsants|anticonvulsants|mesh-ancestor
25241000|NCT04240626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25241001|NCT04240626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24742443|NCT05267431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25852291|NCT00055913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24705363|NCT01484600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705364|NCT01484613|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25075411|NCT03381118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25075412|NCT03381118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075413|NCT03381118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24961204|NCT03809949|Narcotics|narcotics|mesh-ancestor
25075414|NCT03381118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075415|NCT03381118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25075417|NCT03381118|Antiviral Agents|antiviral agents|mesh-ancestor
25075439|NCT03381053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075440|NCT03381053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075441|NCT03381040|Hyaluronic Acid|hyaluronic acid|mesh-list
25075442|NCT03381040|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25075443|NCT03381040|Immunologic Factors|immunologic factors|mesh-ancestor
25075444|NCT03381040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075445|NCT03381040|Viscosupplements|viscosupplements|mesh-ancestor
25075446|NCT03381040|Protective Agents|protective agents|mesh-ancestor
25075447|NCT03380975|Montelukast|montelukast|mesh-list
25075448|NCT03380975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25202603|NCT02720601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075594|NCT03379974|Hemostatics|hemostatics|mesh-ancestor
25075449|NCT03380975|Respiratory System Agents|respiratory system agents|mesh-ancestor
25075450|NCT03380975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25075451|NCT03380975|Hormone Antagonists|hormone antagonists|mesh-ancestor
25852292|NCT00055913|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25852293|NCT00055913|Antibodies|antibodies|mesh-list
25852294|NCT00055913|Immunoglobulins|immunoglobulins|mesh-list
25075452|NCT03380975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25075453|NCT03380975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075454|NCT03380975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25075455|NCT03380975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25075456|NCT03380975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075458|NCT03380949|Analgesics, Opioid|analgesics, opioid|mesh-list
25075459|NCT03380949|Narcotics|narcotics|mesh-ancestor
25075460|NCT03380949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25075461|NCT03380949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075462|NCT03380949|Analgesics|analgesics|mesh-ancestor
25075463|NCT03380949|Sensory System Agents|sensory system agents|mesh-ancestor
25075464|NCT03380949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24705384|NCT01484756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705385|NCT01484964|Peficitinib|peficitinib|mesh-list
25075466|NCT03380936|Immunoglobulins|immunoglobulins|mesh-list
25075467|NCT03380936|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25075468|NCT03380936|Antibodies|antibodies|mesh-list
25075469|NCT03380936|gamma-Globulins|gamma-globulins|mesh-list
25075470|NCT03380936|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25852295|NCT00055913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25075484|NCT03380871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075485|NCT03380871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25075486|NCT03380871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24961273|NCT03809312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075487|NCT03380871|Interferon Inducers|interferon inducers|mesh-ancestor
25663820|NCT01662895|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25663821|NCT01662895|Chelating Agents|chelating agents|mesh-ancestor
25663822|NCT01662895|Sequestering Agents|sequestering agents|mesh-ancestor
25663823|NCT01662895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663824|NCT01662908|Heparin|heparin|mesh-list
25663825|NCT01662908|Enoxaparin|enoxaparin|mesh-list
25663826|NCT01662908|Calcium heparin|calcium heparin|mesh-list
25663827|NCT01662908|Warfarin|warfarin|mesh-list
25663828|NCT01662908|Edoxaban|edoxaban|mesh-list
25663829|NCT01662908|Anticoagulants|anticoagulants|mesh-ancestor
25663830|NCT01662908|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25663831|NCT01662908|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25241004|NCT04240626|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25241005|NCT04240626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24742860|NCT05146778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742862|NCT05146778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24742864|NCT05146778|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24766343|NCT01794247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24742865|NCT05146778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24742866|NCT05146778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24742867|NCT05146778|Adrenergic Agents|adrenergic agents|mesh-ancestor
24742868|NCT05146778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25075488|NCT03380871|Immunologic Factors|immunologic factors|mesh-ancestor
25075489|NCT03380871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954344|NCT03877601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24954345|NCT03877601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25229722|NCT02600988|Vitamin D|vitamin d|mesh-list
24954346|NCT03877601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24954347|NCT03877601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24954348|NCT03877601|Growth Substances|growth substances|mesh-ancestor
24954349|NCT03877601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954350|NCT03877601|Growth Inhibitors|growth inhibitors|mesh-ancestor
24954351|NCT03877315|Cimetidine|cimetidine|mesh-list
24954352|NCT03877315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24954353|NCT03877315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24954354|NCT03877315|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24954355|NCT03877315|Histamine Antagonists|histamine antagonists|mesh-ancestor
24954356|NCT03877315|Histamine Agents|histamine agents|mesh-ancestor
24954357|NCT03877315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24954359|NCT03877315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954368|NCT03877120|Diazepam|diazepam|mesh-list
24954369|NCT03877120|Dexmedetomidine|dexmedetomidine|mesh-list
24954370|NCT03877120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24954371|NCT03877120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24954372|NCT03877120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954373|NCT03877120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24954374|NCT03877120|Analgesics|analgesics|mesh-ancestor
24954375|NCT03877120|Sensory System Agents|sensory system agents|mesh-ancestor
24626458|NCT01087476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25075490|NCT03380728|Ibogaine|ibogaine|mesh-list
25075491|NCT03380728|Hallucinogens|hallucinogens|mesh-ancestor
25075492|NCT03380728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075493|NCT03380728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25075494|NCT03380728|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24705386|NCT01484964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705422|NCT01485146|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
24940657|NCT03999190|Raclopride|raclopride|mesh-list
24940658|NCT03999190|Dextroamphetamine|dextroamphetamine|mesh-list
24940659|NCT03999190|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25852296|NCT00055913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852297|NCT00055913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25852298|NCT00055913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25075501|NCT03380689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852299|NCT00055913|Growth Substances|growth substances|mesh-ancestor
25852300|NCT00055913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075502|NCT03380689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25075503|NCT03380689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25202604|NCT02720601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25202605|NCT02720458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25202606|NCT02720458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25075504|NCT03380689|Growth Substances|growth substances|mesh-ancestor
25075505|NCT03380689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075506|NCT03380689|Growth Inhibitors|growth inhibitors|mesh-ancestor
25075507|NCT03380689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25075508|NCT03380689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25075509|NCT03380689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663832|NCT01662908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663833|NCT01662908|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25663834|NCT01662908|Antithrombins|antithrombins|mesh-ancestor
25663835|NCT01662908|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25663836|NCT01662908|Protease Inhibitors|protease inhibitors|mesh-ancestor
25663837|NCT01662908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663838|NCT01662986|Bromides|bromides|mesh-list
25663839|NCT01662986|Tiotropium Bromide|tiotropium bromide|mesh-list
25663840|NCT01662986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25663841|NCT01662986|Autonomic Agents|autonomic agents|mesh-ancestor
25663842|NCT01662986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24743167|NCT04975802|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24743168|NCT04975802|Purinergic Agents|purinergic agents|mesh-ancestor
24743169|NCT04975802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24743171|NCT04973930|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24743172|NCT04973930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24743173|NCT04973930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24407779|NCT00175396|Hormones|hormones|mesh-ancestor
25075510|NCT03380689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626459|NCT01087476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25075520|NCT03380533|Buprenorphine|buprenorphine|mesh-list
25075521|NCT03380533|Tramadol|tramadol|mesh-list
25075522|NCT03380533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25075523|NCT03380533|Narcotics|narcotics|mesh-ancestor
25075524|NCT03380533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25075525|NCT03380533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075526|NCT03380533|Analgesics|analgesics|mesh-ancestor
25075527|NCT03380533|Sensory System Agents|sensory system agents|mesh-ancestor
25075528|NCT03380533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25075529|NCT03380533|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25075530|NCT03380468|Pemetrexed|pemetrexed|mesh-list
25075554|NCT03380403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25075555|NCT03380403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25075556|NCT03380403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25075557|NCT03380403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25075558|NCT03380403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075559|NCT03380403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075560|NCT03380403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075561|NCT03380403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25075562|NCT03380403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25075564|NCT03380325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25075565|NCT03380325|Vasodilator Agents|vasodilator agents|mesh-ancestor
25075566|NCT03380130|Nivolumab|nivolumab|mesh-list
25075567|NCT03380130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25075568|NCT03380130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075569|NCT03380130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25075571|NCT03380039|Cyclophosphamide|cyclophosphamide|mesh-list
25075580|NCT03380039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075581|NCT03380039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25075582|NCT03379987|Morphine|morphine|mesh-list
25075583|NCT03379987|Bupivacaine|bupivacaine|mesh-list
25075584|NCT03379987|Anesthetics, Local|anesthetics, local|mesh-ancestor
25075585|NCT03379987|Anesthetics|anesthetics|mesh-ancestor
25075586|NCT03379987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25075587|NCT03379987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075588|NCT03379987|Sensory System Agents|sensory system agents|mesh-ancestor
25075589|NCT03379987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25075590|NCT03379987|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25075591|NCT03379987|Narcotics|narcotics|mesh-ancestor
25075592|NCT03379987|Analgesics|analgesics|mesh-ancestor
25075593|NCT03379974|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25075595|NCT03379974|Coagulants|coagulants|mesh-ancestor
24440260|NCT00282100|Gefitinib|gefitinib|mesh-list
24626462|NCT01087554|Vorinostat|vorinostat|mesh-list
24626463|NCT01087554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626464|NCT01087554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24626465|NCT01087554|Immunologic Factors|immunologic factors|mesh-ancestor
24626466|NCT01087554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626467|NCT01087554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24626468|NCT01087554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24626469|NCT01087554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24644418|NCT01190748|Galantamine|galantamine|mesh-list
24626471|NCT01087554|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24626472|NCT01087554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075815|NCT03377907|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24626473|NCT01087554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626475|NCT01087567|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24626476|NCT01087567|Metformin|metformin|mesh-list
24626477|NCT01087567|Pioglitazone|pioglitazone|mesh-list
25663843|NCT01662986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663844|NCT01662986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25663845|NCT01662986|Respiratory System Agents|respiratory system agents|mesh-ancestor
25663846|NCT01662986|Parasympatholytics|parasympatholytics|mesh-ancestor
25663847|NCT01662986|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25663848|NCT01662986|Cholinergic Agents|cholinergic agents|mesh-ancestor
25663849|NCT01662986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24743470|NCT04777539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743472|NCT04774315|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24743473|NCT04774315|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24743474|NCT04774315|Respiratory System Agents|respiratory system agents|mesh-ancestor
24743475|NCT04767503|Propofol|propofol|mesh-list
24743476|NCT04767503|Desflurane|desflurane|mesh-list
24743477|NCT04767503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24743478|NCT04767503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24743479|NCT04767503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075631|NCT03379012|Methyltestosterone|methyltestosterone|mesh-list
25075632|NCT03379012|Sunitinib|sunitinib|mesh-list
25075633|NCT03379012|Testosterone|testosterone|mesh-list
25075634|NCT03379012|Testosterone undecanoate|testosterone undecanoate|mesh-list
25075652|NCT03378960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25075653|NCT03378960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25075654|NCT03378960|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25075669|NCT03378934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075671|NCT03378934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25075672|NCT03378934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075673|NCT03378934|Antipyretics|antipyretics|mesh-ancestor
25075674|NCT03378934|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25075675|NCT03378934|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25075676|NCT03378934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25075677|NCT03378934|Purinergic Agents|purinergic agents|mesh-ancestor
25075678|NCT03378934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25075679|NCT03378791|Ferrous fumarate|ferrous fumarate|mesh-list
25075680|NCT03378791|Trace Elements|trace elements|mesh-ancestor
25075681|NCT03378791|Micronutrients|micronutrients|mesh-ancestor
25075682|NCT03378791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075683|NCT03378726|Micronutrients|micronutrients|mesh-list
25075684|NCT03378726|Trace Elements|trace elements|mesh-list
25075686|NCT03378713|Methyltestosterone|methyltestosterone|mesh-list
25075689|NCT03378713|Testosterone enanthate|testosterone enanthate|mesh-list
25075690|NCT03378713|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25075692|NCT03378713|Hormones|hormones|mesh-ancestor
25075693|NCT03378713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25075694|NCT03378713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075695|NCT03378713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25075696|NCT03378713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075697|NCT03378713|Anabolic Agents|anabolic agents|mesh-ancestor
25075698|NCT03378674|Remifentanil|remifentanil|mesh-list
25075699|NCT03378674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25075700|NCT03378674|Narcotics|narcotics|mesh-ancestor
25075701|NCT03378674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25075702|NCT03378674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075703|NCT03378674|Analgesics|analgesics|mesh-ancestor
25075704|NCT03378674|Sensory System Agents|sensory system agents|mesh-ancestor
25075705|NCT03378674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25075706|NCT03378661|Benzonidazole|benzonidazole|mesh-list
25075707|NCT03378661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25075708|NCT03378661|Immunologic Factors|immunologic factors|mesh-ancestor
25075709|NCT03378661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075710|NCT03378661|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25075711|NCT03378661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25075712|NCT03378661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25075713|NCT03378661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25075714|NCT03378648|Bromides|bromides|mesh-list
25075715|NCT03378648|Anticonvulsants|anticonvulsants|mesh-ancestor
25075716|NCT03378427|Doxycycline|doxycycline|mesh-list
25075730|NCT03378427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25075731|NCT03378427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25075732|NCT03378427|Antimalarials|antimalarials|mesh-ancestor
25075733|NCT03378427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25075734|NCT03378427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25075735|NCT03378427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25075736|NCT03378427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25075737|NCT03378427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663850|NCT01662986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663851|NCT01662986|Anticonvulsants|anticonvulsants|mesh-ancestor
25663852|NCT01662999|Dapagliflozin|dapagliflozin|mesh-list
25663853|NCT01662999|Saxagliptin|saxagliptin|mesh-list
25663854|NCT01662999|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25663855|NCT01662999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663856|NCT01662999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25663857|NCT01662999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940662|NCT03999190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24743633|NCT04704518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24743634|NCT04704518|Immunologic Factors|immunologic factors|mesh-ancestor
24743635|NCT04704518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743636|NCT04704518|Viscosupplements|viscosupplements|mesh-ancestor
24408486|NCT00178035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24744009|NCT04540133|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25241038|NCT04126824|Triamcinolone|triamcinolone|mesh-list
25241039|NCT04126824|Bupivacaine|bupivacaine|mesh-list
25241040|NCT04126824|Anesthetics, Local|anesthetics, local|mesh-ancestor
25241041|NCT04126824|Anesthetics|anesthetics|mesh-ancestor
25241042|NCT04126824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25075886|NCT03377465|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
25075742|NCT03378427|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25075743|NCT03378427|Renal Agents|renal agents|mesh-ancestor
25075781|NCT03378297|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25075782|NCT03378297|Hormone Antagonists|hormone antagonists|mesh-ancestor
25075783|NCT03378297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25075784|NCT03378297|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25075785|NCT03378297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25075811|NCT03377907|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25075812|NCT03377907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25075813|NCT03377907|Anesthetics, General|anesthetics, general|mesh-ancestor
25075814|NCT03377907|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25075820|NCT03377842|Oxaliplatin|oxaliplatin|mesh-list
25075821|NCT03377842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075822|NCT03377842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25075823|NCT03377842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075824|NCT03377842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075825|NCT03377842|Antimetabolites|antimetabolites|mesh-ancestor
25075826|NCT03377842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24839031|NCT02201667|Clopidogrel|clopidogrel|mesh-list
24839032|NCT02201667|Ticagrelor|ticagrelor|mesh-list
24643388|NCT01185418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24643390|NCT01185418|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24643391|NCT01185418|Dopamine Agents|dopamine agents|mesh-ancestor
25852301|NCT00055913|Growth Inhibitors|growth inhibitors|mesh-ancestor
24643402|NCT01185418|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25075827|NCT03377842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25075828|NCT03377842|Immunologic Factors|immunologic factors|mesh-ancestor
25075829|NCT03377842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075830|NCT03377842|Antidotes|antidotes|mesh-ancestor
25075831|NCT03377842|Protective Agents|protective agents|mesh-ancestor
25075832|NCT03377842|Vitamin B Complex|vitamin b complex|mesh-ancestor
25075833|NCT03377842|Vitamins|vitamins|mesh-ancestor
24626480|NCT01087567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075834|NCT03377842|Micronutrients|micronutrients|mesh-ancestor
25075835|NCT03377725|Decitabine|decitabine|mesh-list
25075836|NCT03377725|Arsenic Trioxide|arsenic trioxide|mesh-list
25075837|NCT03377725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25075838|NCT03377725|Antimetabolites|antimetabolites|mesh-ancestor
24643409|NCT01185444|Protective Agents|protective agents|mesh-ancestor
24643411|NCT01185470|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24643412|NCT01185470|Narcotics|narcotics|mesh-ancestor
24643413|NCT01185470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24643465|NCT01185769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075857|NCT03377608|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25075858|NCT03377608|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25075859|NCT03377608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25075860|NCT03377608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075861|NCT03377608|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25075862|NCT03377608|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25075863|NCT03377608|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24643467|NCT01185769|Micronutrients|micronutrients|mesh-ancestor
24643483|NCT01185847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25663858|NCT01662999|Incretins|incretins|mesh-ancestor
25663859|NCT01662999|Hormones|hormones|mesh-ancestor
25663860|NCT01662999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25663861|NCT01662999|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25663862|NCT01662999|Protease Inhibitors|protease inhibitors|mesh-ancestor
25663863|NCT01662999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663864|NCT01663012|Etirinotecan pegol|etirinotecan pegol|mesh-list
25663865|NCT01663012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663866|NCT01663012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25663867|NCT01663012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24643484|NCT01185847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24744366|NCT04321993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24744367|NCT04321993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24744369|NCT04310150|Coagulants|coagulants|mesh-ancestor
24744404|NCT04292873|Vitamins|vitamins|mesh-ancestor
24744405|NCT04292873|Micronutrients|micronutrients|mesh-ancestor
24744406|NCT04292873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744407|NCT04292873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24643485|NCT01185847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24643486|NCT01185847|Immunologic Factors|immunologic factors|mesh-ancestor
24643487|NCT01185847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643489|NCT01185847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24643490|NCT01185860|Ritonavir|ritonavir|mesh-list
24643491|NCT01185860|Ribavirin|ribavirin|mesh-list
24643492|NCT01185860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25075885|NCT03377465|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25075895|NCT03377400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25075896|NCT03377348|Triamcinolone|triamcinolone|mesh-list
25075897|NCT03377348|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25075898|NCT03377348|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24829807|NCT02154646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24829808|NCT02154646|Antimetabolites|antimetabolites|mesh-ancestor
24829809|NCT02154646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829810|NCT02154646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075899|NCT03377348|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25075900|NCT03377348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25075901|NCT03377348|Glucocorticoids|glucocorticoids|mesh-ancestor
25075903|NCT03377348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24998430|NCT02787369|Idelalisib|idelalisib|mesh-list
24998431|NCT02787369|Ricolinostat|ricolinostat|mesh-list
24998432|NCT02787369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998433|NCT02787369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998434|NCT02787369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998435|NCT02787369|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24998436|NCT02761694|Paclitaxel|paclitaxel|mesh-list
24998437|NCT02761694|Fulvestrant|fulvestrant|mesh-list
24998438|NCT02761694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24998439|NCT02761694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998440|NCT02761694|Tubulin Modulators|tubulin modulators|mesh-ancestor
24998442|NCT02761694|Mitosis Modulators|mitosis modulators|mesh-ancestor
25048602|NCT00682981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25048603|NCT00682981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048604|NCT00682981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048605|NCT00680784|Ketoprofen|ketoprofen|mesh-list
25048606|NCT00680784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25048607|NCT00680784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25048608|NCT00680784|Analgesics|analgesics|mesh-ancestor
24705763|NCT01486706|Gabapentin|gabapentin|mesh-list
24613654|NCT01020214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24613655|NCT01020214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613661|NCT01020253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24613662|NCT01020253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613664|NCT01020253|Micronutrients|micronutrients|mesh-ancestor
24705791|NCT01486875|Insulin Aspart|insulin aspart|mesh-list
24705792|NCT01486875|Biphasic Insulins|biphasic insulins|mesh-list
24705793|NCT01486875|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24705794|NCT01486875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24705795|NCT01486875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705796|NCT01486888|Insulin|insulin|mesh-list
25663869|NCT01663012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663870|NCT01663103|Rilonacept|rilonacept|mesh-list
25663871|NCT01663103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25663872|NCT01663233|Amlodipine|amlodipine|mesh-list
25663873|NCT01663233|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25663874|NCT01663233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25663875|NCT01663233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25663876|NCT01663233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25852302|NCT00055913|Immunologic Factors|immunologic factors|mesh-ancestor
24850969|NCT02254668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24850970|NCT02254668|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24744826|NCT04124497|Dexamethasone|dexamethasone|mesh-list
24744827|NCT04124497|Daratumumab|daratumumab|mesh-list
24744853|NCT04115059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744855|NCT04114890|Antiviral Agents|antiviral agents|mesh-ancestor
24744856|NCT04114890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24744857|NCT04114890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24744858|NCT04114890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24744859|NCT04114890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048609|NCT00680784|Sensory System Agents|sensory system agents|mesh-ancestor
25048610|NCT00680784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25048611|NCT00680784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048612|NCT00680784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25048613|NCT00680784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25048614|NCT00680784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25048615|NCT00680784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048616|NCT00680784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048618|NCT00680472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24998443|NCT02761694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936305|NCT04042051|Trastuzumab|trastuzumab|mesh-list
24998464|NCT02691793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998465|NCT02691793|Growth Inhibitors|growth inhibitors|mesh-ancestor
24998466|NCT02691793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24998498|NCT02611960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998499|NCT02611960|Tubulin Modulators|tubulin modulators|mesh-ancestor
25202607|NCT02720458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202609|NCT02720575|Vitamins|vitamins|mesh-ancestor
25202610|NCT02720575|Micronutrients|micronutrients|mesh-ancestor
25202611|NCT02720575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998500|NCT02611960|Antimitotic Agents|antimitotic agents|mesh-ancestor
24998501|NCT02611960|Mitosis Modulators|mitosis modulators|mesh-ancestor
24998502|NCT02611960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24998503|NCT02588781|Pemetrexed|pemetrexed|mesh-list
24998504|NCT02588781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998505|NCT02588781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705804|NCT01486901|Isophane insulin, beef|isophane insulin, beef|mesh-list
24998506|NCT02588781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998507|NCT02588781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24998508|NCT02588781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24998509|NCT02574455|Gemcitabine|gemcitabine|mesh-list
24998532|NCT02566304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24998533|NCT02566304|Immunologic Factors|immunologic factors|mesh-ancestor
24998534|NCT02566304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998535|NCT02566304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24998536|NCT02566304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24998537|NCT02566304|Alkylating Agents|alkylating agents|mesh-ancestor
24998538|NCT02566304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998539|NCT02566304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998540|NCT02566304|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24998541|NCT02566304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24998542|NCT02566304|Antimetabolites|antimetabolites|mesh-ancestor
24998543|NCT02566304|Antiviral Agents|antiviral agents|mesh-ancestor
24998544|NCT02566304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24998545|NCT02566304|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24998546|NCT02566304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998547|NCT02566304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24998548|NCT02566304|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24998549|NCT02566304|Antitubercular Agents|antitubercular agents|mesh-ancestor
24998550|NCT02566304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24936650|NCT04038125|Glucocorticoids|glucocorticoids|mesh-ancestor
24936439|NCT04040452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25663877|NCT01663233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663878|NCT01663233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25663879|NCT01663233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663880|NCT01663233|Vasodilator Agents|vasodilator agents|mesh-ancestor
25663881|NCT01663233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25663882|NCT01663259|Cetuximab|cetuximab|mesh-list
25663883|NCT01663259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25663884|NCT01663259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663885|NCT01663272|Gemcitabine|gemcitabine|mesh-list
25663886|NCT01663272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24745265|NCT03846570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745339|NCT03816397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24745405|NCT03785106|Antimetabolites|antimetabolites|mesh-ancestor
24745406|NCT03785106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745407|NCT03785106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24745408|NCT03785106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24745409|NCT03785106|Leprostatic Agents|leprostatic agents|mesh-ancestor
24745410|NCT03785106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25229842|NCT02600247|Acetaminophen|acetaminophen|mesh-list
24705805|NCT01486901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24936440|NCT04040452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936441|NCT04040452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24936442|NCT04040452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24936443|NCT04040452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24936444|NCT04040452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24936445|NCT04040452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936446|NCT04040309|Lidocaine|lidocaine|mesh-list
24936447|NCT04040309|Anesthetics, Local|anesthetics, local|mesh-ancestor
24936448|NCT04040309|Anesthetics|anesthetics|mesh-ancestor
24998577|NCT02518594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24998578|NCT02518594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998580|NCT02467608|Antitubercular Agents|antitubercular agents|mesh-ancestor
24998581|NCT02467608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24998582|NCT02467608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24998583|NCT02467608|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24998584|NCT02467608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24998585|NCT02467608|Antimetabolites|antimetabolites|mesh-ancestor
24998586|NCT02467608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998587|NCT02467608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24998588|NCT02461849|Imatinib Mesylate|imatinib mesylate|mesh-list
24998589|NCT02461849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998590|NCT02461849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24998591|NCT02461849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998592|NCT02461849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998593|NCT02450123|Sunitinib|sunitinib|mesh-list
24998594|NCT02450123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852303|NCT00055913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24998595|NCT02450123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24998596|NCT02450123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24998597|NCT02450123|Growth Substances|growth substances|mesh-ancestor
24998598|NCT02450123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998599|NCT02450123|Growth Inhibitors|growth inhibitors|mesh-ancestor
24998600|NCT02450123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24998601|NCT02450123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998602|NCT02450123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998603|NCT02448329|Paclitaxel|paclitaxel|mesh-list
24998604|NCT02448329|Adavosertib|adavosertib|mesh-list
24998606|NCT02448329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998620|NCT02447406|Antimitotic Agents|antimitotic agents|mesh-ancestor
24998621|NCT02447406|Mitosis Modulators|mitosis modulators|mesh-ancestor
24705871|NCT01487278|Abortifacient Agents|abortifacient agents|mesh-ancestor
24998622|NCT02447406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998623|NCT02426281|Gemcitabine|gemcitabine|mesh-list
24998624|NCT02426281|Paclitaxel|paclitaxel|mesh-list
24998625|NCT02426281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24998626|NCT02426281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998627|NCT02426281|Tubulin Modulators|tubulin modulators|mesh-ancestor
24998628|NCT02426281|Antimitotic Agents|antimitotic agents|mesh-ancestor
24998647|NCT02397083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24998648|NCT02397083|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24998649|NCT02397083|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24998650|NCT02397083|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24998651|NCT02232087|Fluticasone|fluticasone|mesh-list
24998663|NCT02232087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24998664|NCT02232087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25663887|NCT01663272|Antimetabolites|antimetabolites|mesh-ancestor
25663888|NCT01663272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663889|NCT01663272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663890|NCT01663272|Antiviral Agents|antiviral agents|mesh-ancestor
25663891|NCT01663272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25663892|NCT01663272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663893|NCT01663272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25663894|NCT01663272|Immunologic Factors|immunologic factors|mesh-ancestor
25663895|NCT01663272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745484|NCT03760835|Autonomic Agents|autonomic agents|mesh-ancestor
24745485|NCT03760835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24745486|NCT03760835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745487|NCT03760835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24745488|NCT03760835|Hormones|hormones|mesh-ancestor
24745489|NCT03760835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24745490|NCT03760835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24745491|NCT03760835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998665|NCT02232087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24998666|NCT02232087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24998667|NCT02232087|Adrenergic Agents|adrenergic agents|mesh-ancestor
24998668|NCT02232087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24936518|NCT04039126|Iodine|iodine|mesh-list
24936638|NCT04037878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24936639|NCT04037878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936640|NCT04037878|Analgesics|analgesics|mesh-ancestor
24936641|NCT04037878|Sensory System Agents|sensory system agents|mesh-ancestor
24936642|NCT04037878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24936643|NCT04038125|Dexamethasone|dexamethasone|mesh-list
24936644|NCT04038125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24936645|NCT04038125|Antiemetics|antiemetics|mesh-ancestor
24936646|NCT04038125|Autonomic Agents|autonomic agents|mesh-ancestor
24936647|NCT04038125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24936648|NCT04038125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936649|NCT04038125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24936652|NCT04038125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24936653|NCT04038125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24936654|NCT04038125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24936655|NCT04038073|Antibodies|antibodies|mesh-list
24936656|NCT04038073|Antistreptolysin|antistreptolysin|mesh-list
24936657|NCT04038073|Immunologic Factors|immunologic factors|mesh-ancestor
25048625|NCT00680472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25048626|NCT00680472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25048627|NCT00680472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706022|NCT01488266|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25048628|NCT00680472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048629|NCT00680342|Silymarin|silymarin|mesh-list
25048630|NCT00680342|Antioxidants|antioxidants|mesh-ancestor
24441865|NCT00288561|Growth Substances|growth substances|mesh-ancestor
25048639|NCT00679731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25048641|NCT00679731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048642|NCT00679731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048643|NCT00679731|Dermatologic Agents|dermatologic agents|mesh-ancestor
25048644|NCT00679731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048645|NCT00679731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25048646|NCT00679731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25048647|NCT00679731|Immunologic Factors|immunologic factors|mesh-ancestor
25048648|NCT00679731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25048649|NCT00679731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25048650|NCT00679588|Enoxaparin|enoxaparin|mesh-list
25048651|NCT00679588|Semuloparin|semuloparin|mesh-list
25048652|NCT00679588|Enoxaparin sodium|enoxaparin sodium|mesh-list
25048653|NCT00679588|Anticoagulants|anticoagulants|mesh-ancestor
25202612|NCT02720575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25202613|NCT02720406|Ketamine|ketamine|mesh-list
25048654|NCT00679588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25048655|NCT00679588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25048656|NCT00679588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048657|NCT00678119|Sunitinib|sunitinib|mesh-list
25048658|NCT00678119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24643494|NCT01185860|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24643495|NCT01185860|Protease Inhibitors|protease inhibitors|mesh-ancestor
24643496|NCT01185860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643497|NCT01185860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643498|NCT01185860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25048659|NCT00678119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25663896|NCT01663532|Aripiprazole|aripiprazole|mesh-list
25663897|NCT01663532|Antidepressive Agents|antidepressive agents|mesh-ancestor
25663898|NCT01663532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25663899|NCT01663532|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25663900|NCT01663532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25663901|NCT01663532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25663902|NCT01663532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663903|NCT01663532|Dopamine Agonists|dopamine agonists|mesh-ancestor
25663904|NCT01663532|Dopamine Agents|dopamine agents|mesh-ancestor
24746142|NCT03325439|Brivaracetam|brivaracetam|mesh-list
24746385|NCT05437432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24746386|NCT05437432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24746387|NCT05437432|Antimanic Agents|antimanic agents|mesh-ancestor
24746388|NCT05437432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24746389|NCT05437432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24746390|NCT05437224|Ambrisentan|ambrisentan|mesh-list
24746391|NCT05437224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24746392|NCT05436990|Pembrolizumab|pembrolizumab|mesh-list
24746393|NCT05436990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24746418|NCT05436678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25048660|NCT00678119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25048661|NCT00678119|Growth Substances|growth substances|mesh-ancestor
25048662|NCT00678119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048663|NCT00678119|Growth Inhibitors|growth inhibitors|mesh-ancestor
25048664|NCT00678119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25048665|NCT00678119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24936672|NCT04037774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798280|NCT01962181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798281|NCT01962181|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24998696|NCT01720563|Leucovorin|leucovorin|mesh-list
24998697|NCT01720563|Tegafur|tegafur|mesh-list
24998698|NCT01720563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998699|NCT01720563|Antidotes|antidotes|mesh-ancestor
24998700|NCT01720563|Protective Agents|protective agents|mesh-ancestor
24998701|NCT01720563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998702|NCT01720563|Vitamin B Complex|vitamin b complex|mesh-ancestor
24998703|NCT01720563|Vitamins|vitamins|mesh-ancestor
24998704|NCT01720563|Micronutrients|micronutrients|mesh-ancestor
24998705|NCT01720563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24998706|NCT01720563|Antimetabolites|antimetabolites|mesh-ancestor
24998707|NCT01720563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998708|NCT01560585|Isotretinoin|isotretinoin|mesh-list
24998709|NCT01560585|Dermatologic Agents|dermatologic agents|mesh-ancestor
24998710|NCT01539226|Dapivirine|dapivirine|mesh-list
24998711|NCT01539226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24998712|NCT01539226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24998713|NCT01539226|Antiviral Agents|antiviral agents|mesh-ancestor
24998714|NCT01539226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24998715|NCT01376427|Dexamethasone|dexamethasone|mesh-list
24998716|NCT01376427|Methotrexate|methotrexate|mesh-list
24998717|NCT01376427|Vincristine|vincristine|mesh-list
25852304|NCT00055913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998747|NCT01096966|Anesthetics, Local|anesthetics, local|mesh-ancestor
24998748|NCT01096966|Anesthetics|anesthetics|mesh-ancestor
24998749|NCT01096966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24998750|NCT01096966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998751|NCT01096966|Sensory System Agents|sensory system agents|mesh-ancestor
24998752|NCT01096966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24998754|NCT00979212|Carboplatin|carboplatin|mesh-list
24998769|NCT00777491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998770|NCT00777491|Antiviral Agents|antiviral agents|mesh-ancestor
24998771|NCT00777491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24998772|NCT00777491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998773|NCT00777491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24998774|NCT00777491|Immunologic Factors|immunologic factors|mesh-ancestor
24998775|NCT00777491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998777|NCT00759655|Coagulants|coagulants|mesh-ancestor
24998779|NCT00145795|Lopinavir|lopinavir|mesh-list
24998780|NCT00145795|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24998781|NCT00145795|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24998782|NCT00145795|Protease Inhibitors|protease inhibitors|mesh-ancestor
24998783|NCT00145795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998784|NCT00145795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663905|NCT01663532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25663906|NCT01663532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663907|NCT01663532|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25663908|NCT01663532|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25663909|NCT01663532|Serotonin Agents|serotonin agents|mesh-ancestor
25663910|NCT01663532|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25663911|NCT01663532|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25663912|NCT01663532|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25663913|NCT01663532|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25663914|NCT01663623|Azathioprine|azathioprine|mesh-list
24998785|NCT00145795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24998786|NCT00145795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24703871|NCT01475032|Hormones|hormones|mesh-ancestor
24746662|NCT04590586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24746663|NCT04590586|Growth Substances|growth substances|mesh-ancestor
24746664|NCT04590586|Growth Inhibitors|growth inhibitors|mesh-ancestor
24746680|NCT04485949|Temozolomide|temozolomide|mesh-list
24746681|NCT04485949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24746682|NCT04485949|Alkylating Agents|alkylating agents|mesh-ancestor
24746683|NCT04485949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643531|NCT01185938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998803|NCT00002874|Hormone Antagonists|hormone antagonists|mesh-ancestor
24706083|NCT01488526|Antiviral Agents|antiviral agents|mesh-ancestor
24940743|NCT03998670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940744|NCT03998670|Adrenergic Agents|adrenergic agents|mesh-ancestor
24940745|NCT03998670|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24940746|NCT03998670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24940747|NCT03998670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24998804|NCT00002874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24998805|NCT00002874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998806|NCT00002874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998808|NCT05422716|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24998809|NCT05422716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998810|NCT05422716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24998811|NCT05422716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24998812|NCT05422716|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24998813|NCT05422716|GABA Agonists|gaba agonists|mesh-ancestor
24998814|NCT05422716|GABA Agents|gaba agents|mesh-ancestor
24998815|NCT05422716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24998816|NCT05422716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998821|NCT05422534|Ubiquinone|ubiquinone|mesh-list
24998822|NCT05422534|Micronutrients|micronutrients|mesh-ancestor
24998823|NCT05422534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998832|NCT05422183|Lenvatinib|lenvatinib|mesh-list
24998833|NCT05422183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998834|NCT05422183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24998835|NCT05422183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442630|NCT00291811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25048667|NCT00677079|Iniparib|iniparib|mesh-list
24839667|NCT02205775|Atorvastatin|atorvastatin|mesh-list
24462850|NCT00357682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24643539|NCT01185977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643540|NCT01185977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24643541|NCT01185977|Serotonin Agents|serotonin agents|mesh-ancestor
25048668|NCT00677079|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25048669|NCT00677079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048670|NCT00677079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048671|NCT00677079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048672|NCT00677053|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1h)-one|mesh-list
25048677|NCT00677053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048678|NCT00677053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048679|NCT00677053|Anticoagulants|anticoagulants|mesh-ancestor
25048680|NCT00676832|Prednisolone|prednisolone|mesh-list
24998903|NCT05422001|Analgesics|analgesics|mesh-ancestor
24998904|NCT05422001|Sensory System Agents|sensory system agents|mesh-ancestor
24998905|NCT05422001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24998906|NCT05422001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442814|NCT00292747|Autonomic Agents|autonomic agents|mesh-ancestor
24936785|NCT04036201|Anesthetics, Local|anesthetics, local|mesh-ancestor
24936786|NCT04036201|Anesthetics|anesthetics|mesh-ancestor
24936787|NCT04036201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24936789|NCT04036201|Sensory System Agents|sensory system agents|mesh-ancestor
24998916|NCT05421936|Osimertinib|osimertinib|mesh-list
24998917|NCT05421936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998918|NCT05421936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25663915|NCT01663623|Belimumab|belimumab|mesh-list
25663916|NCT01663623|Antimetabolites|antimetabolites|mesh-ancestor
25663917|NCT01663623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663918|NCT01663623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25663919|NCT01663623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663920|NCT01663623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25663921|NCT01663623|Immunologic Factors|immunologic factors|mesh-ancestor
25663922|NCT01663623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241139|NCT04033263|Cariostatic Agents|cariostatic agents|mesh-ancestor
24537396|NCT00654524|Vitamin D|vitamin d|mesh-list
24747774|NCT03096834|Sensory System Agents|sensory system agents|mesh-ancestor
24747775|NCT03096834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24431810|NCT00252954|Nootropic Agents|nootropic agents|mesh-ancestor
24431811|NCT00253058|Cetirizine|cetirizine|mesh-list
24747813|NCT03085485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24747814|NCT03083197|Azithromycin|azithromycin|mesh-list
24998919|NCT05421936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998920|NCT05421936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998921|NCT05421897|Cyclophosphamide|cyclophosphamide|mesh-list
24706198|NCT01489176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24706199|NCT01489176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706200|NCT01489176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998922|NCT05421897|Temozolomide|temozolomide|mesh-list
24998923|NCT05421897|Irinotecan|irinotecan|mesh-list
24998924|NCT05421897|Topotecan|topotecan|mesh-list
24998925|NCT05421897|Dinutuximab|dinutuximab|mesh-list
24998926|NCT05421897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24998927|NCT05421897|Immunologic Factors|immunologic factors|mesh-ancestor
24998928|NCT05421897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998929|NCT05421897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24998930|NCT05421897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24998931|NCT05421897|Alkylating Agents|alkylating agents|mesh-ancestor
24998932|NCT05421897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998933|NCT05421897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998934|NCT05421897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24998962|NCT05421741|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24998963|NCT05421741|Vancomycin|vancomycin|mesh-list
24998964|NCT05421741|Gentamicins|gentamicins|mesh-list
24998965|NCT05421741|Tobramycin|tobramycin|mesh-list
24998966|NCT05421741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24998967|NCT05421741|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24998968|NCT05421741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998974|NCT05421416|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24998976|NCT05421416|Histamine Antagonists|histamine antagonists|mesh-ancestor
24998977|NCT05421416|Histamine Agents|histamine agents|mesh-ancestor
24998978|NCT05421416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24998979|NCT05421416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998988|NCT05418504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24998989|NCT05418504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999004|NCT05388006|Venetoclax|venetoclax|mesh-list
24999005|NCT05388006|Acalabrutinib|acalabrutinib|mesh-list
24999006|NCT05388006|Immunoglobulins|immunoglobulins|mesh-list
24999007|NCT05388006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24999008|NCT05388006|Immunoglobulin G|immunoglobulin g|mesh-list
24999009|NCT05388006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24999010|NCT05388006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999011|NCT05388006|Immunologic Factors|immunologic factors|mesh-ancestor
24999013|NCT05345249|Ropivacaine|ropivacaine|mesh-list
24999027|NCT05322902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24999028|NCT05322902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999029|NCT05322902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24706225|NCT01489319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706226|NCT01489319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24999030|NCT05322902|Anesthetics, General|anesthetics, general|mesh-ancestor
24999031|NCT05322902|Anesthetics|anesthetics|mesh-ancestor
24999038|NCT05320627|Edoxaban|edoxaban|mesh-list
24999039|NCT05320627|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24999040|NCT05320627|Antithrombins|antithrombins|mesh-ancestor
25202614|NCT02720406|Analgesics|analgesics|mesh-ancestor
24999041|NCT05320627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24999042|NCT05320627|Protease Inhibitors|protease inhibitors|mesh-ancestor
24999043|NCT05320627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24999044|NCT05320627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999045|NCT05320627|Anticoagulants|anticoagulants|mesh-ancestor
25663923|NCT01663623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25663924|NCT01663714|Tositumomab I-131|tositumomab i-131|mesh-list
25663925|NCT01663714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663926|NCT01663727|Paclitaxel|paclitaxel|mesh-list
25663927|NCT01663727|Bevacizumab|bevacizumab|mesh-list
25663928|NCT01663727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25663929|NCT01663727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663930|NCT01663727|Tubulin Modulators|tubulin modulators|mesh-ancestor
24999046|NCT05317468|Contraceptive Agents|contraceptive agents|mesh-list
24999047|NCT05317468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25424316|NCT02272790|Mitosis Modulators|mitosis modulators|mesh-ancestor
24999049|NCT05313282|Apatinib|apatinib|mesh-list
24999050|NCT05313282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999051|NCT05313282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24839866|NCT02206477|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
24643542|NCT01185977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643543|NCT01185977|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24643571|NCT01186120|Immunologic Factors|immunologic factors|mesh-ancestor
24643572|NCT01186120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643590|NCT01186146|Antipyretics|antipyretics|mesh-ancestor
24643591|NCT01186146|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24643592|NCT01186146|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24643593|NCT01186146|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24643594|NCT01186146|Purinergic Agents|purinergic agents|mesh-ancestor
24643595|NCT01186146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24643597|NCT01186159|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24643598|NCT01186159|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24643599|NCT01186159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643600|NCT01186159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706227|NCT01489319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24706276|NCT01489566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24706277|NCT01489566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706278|NCT01489592|Turmeric extract|turmeric extract|mesh-list
24706279|NCT01489592|Antioxidants|antioxidants|mesh-ancestor
24706280|NCT01489592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706281|NCT01489592|Protective Agents|protective agents|mesh-ancestor
24706282|NCT01489592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706285|NCT01489631|Bupivacaine|bupivacaine|mesh-list
24956794|NCT03851393|Anticoagulants|anticoagulants|mesh-ancestor
24956795|NCT03851393|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25852305|NCT00055913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643601|NCT01186159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24643602|NCT01186159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24643603|NCT01186159|Analgesics|analgesics|mesh-ancestor
24643604|NCT01186159|Sensory System Agents|sensory system agents|mesh-ancestor
24999052|NCT05313282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24999053|NCT05313282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999054|NCT05312762|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24999055|NCT05312762|Chitosan|chitosan|mesh-list
24999056|NCT05312762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24936976|NCT04034225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24936977|NCT04034199|Zoledronic Acid|zoledronic acid|mesh-list
24798286|NCT01962181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24798287|NCT01962285|Propofol|propofol|mesh-list
24798288|NCT01962285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24798289|NCT01962285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24798290|NCT01962285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798291|NCT01962285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24798292|NCT01962285|Anesthetics, General|anesthetics, general|mesh-ancestor
24798293|NCT01962285|Anesthetics|anesthetics|mesh-ancestor
24798294|NCT01962363|Tocotrienols|tocotrienols|mesh-list
24798295|NCT01962363|Tocotrienol, alpha|tocotrienol, alpha|mesh-list
24839892|NCT02206503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24643605|NCT01186159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24643606|NCT01186159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643607|NCT01186159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25048681|NCT00676832|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25048682|NCT00676832|Methylprednisolone|methylprednisolone|mesh-list
25048683|NCT00676832|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25048684|NCT00676832|Prednisolone acetate|prednisolone acetate|mesh-list
25048685|NCT00676832|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25663931|NCT01663727|Antimitotic Agents|antimitotic agents|mesh-ancestor
25663932|NCT01663727|Mitosis Modulators|mitosis modulators|mesh-ancestor
25663933|NCT01663727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748619|NCT02325466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748620|NCT02325466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24748621|NCT02325466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24748622|NCT02325466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24748692|NCT02215980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24748693|NCT02215980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748694|NCT02215980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24748695|NCT02215980|Glucocorticoids|glucocorticoids|mesh-ancestor
24748704|NCT02215980|Growth Inhibitors|growth inhibitors|mesh-ancestor
24748705|NCT02212015|Paclitaxel|paclitaxel|mesh-list
25048686|NCT00676832|Prednisolone phosphate|prednisolone phosphate|mesh-list
25048687|NCT00676832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25048688|NCT00676832|Glucocorticoids|glucocorticoids|mesh-ancestor
25048689|NCT00676832|Hormones|hormones|mesh-ancestor
25048690|NCT00676832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25048691|NCT00676832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048692|NCT00676832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24956796|NCT03851393|Chelating Agents|chelating agents|mesh-ancestor
24956797|NCT03851393|Sequestering Agents|sequestering agents|mesh-ancestor
24706303|NCT01489631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24706317|NCT01489683|Sensory System Agents|sensory system agents|mesh-ancestor
24706318|NCT01489683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24706319|NCT01489683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24706320|NCT01489683|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24706321|NCT01489683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24706322|NCT01489683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25048693|NCT00676832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048694|NCT00676832|Antiemetics|antiemetics|mesh-ancestor
25048695|NCT00676832|Autonomic Agents|autonomic agents|mesh-ancestor
25048773|NCT00672386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25048696|NCT00676832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25048697|NCT00676832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25048698|NCT00676832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25048699|NCT00676832|Protective Agents|protective agents|mesh-ancestor
25048700|NCT00675844|Dexelvucitabine|dexelvucitabine|mesh-list
25048701|NCT00675844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25048702|NCT00675844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25048703|NCT00675844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852306|NCT00055939|Exatecan|exatecan|mesh-list
24643636|NCT01186445|Sensory System Agents|sensory system agents|mesh-ancestor
24643637|NCT01186445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24643639|NCT01186471|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24643640|NCT01186471|Autonomic Agents|autonomic agents|mesh-ancestor
24798317|NCT01962454|Testosterone undecanoate|testosterone undecanoate|mesh-list
24798318|NCT01962454|Testosterone enanthate|testosterone enanthate|mesh-list
24798319|NCT01962454|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24798320|NCT01962454|Androgens|androgens|mesh-ancestor
24798321|NCT01962454|Hormones|hormones|mesh-ancestor
24798322|NCT01962454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24999175|NCT05071014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24999176|NCT05071014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999183|NCT05060432|Pembrolizumab|pembrolizumab|mesh-list
24999184|NCT05060432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24999185|NCT05060432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999186|NCT05037162|Fibrin fragment D|fibrin fragment d|mesh-list
24999187|NCT05037162|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24999188|NCT05037162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24999189|NCT05037162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999190|NCT05037162|Hemostatics|hemostatics|mesh-ancestor
24999191|NCT05037162|Coagulants|coagulants|mesh-ancestor
24999192|NCT05012189|Oseltamivir|oseltamivir|mesh-list
24999193|NCT05012189|Baloxavir|baloxavir|mesh-list
24999194|NCT05012189|Antiviral Agents|antiviral agents|mesh-ancestor
24999195|NCT05012189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24999196|NCT05012189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663934|NCT01663727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25663935|NCT01663727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25663936|NCT01663727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25663937|NCT01663727|Growth Substances|growth substances|mesh-ancestor
25663938|NCT01663727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663939|NCT01663727|Growth Inhibitors|growth inhibitors|mesh-ancestor
25663940|NCT01663740|Valganciclovir|valganciclovir|mesh-list
25663941|NCT01663740|Antiviral Agents|antiviral agents|mesh-ancestor
25663942|NCT01663740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25663943|NCT01663857|Gemcitabine|gemcitabine|mesh-list
25663944|NCT01663857|Carboplatin|carboplatin|mesh-list
25007028|NCT04349371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25007029|NCT04349371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25007030|NCT04349371|Antimalarials|antimalarials|mesh-ancestor
25007031|NCT04349371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25109784|NCT03122314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24749017|NCT01863186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24999197|NCT05012189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829811|NCT02154646|Antiviral Agents|antiviral agents|mesh-ancestor
24643700|NCT01186653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24643701|NCT01186653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24643702|NCT01186653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24643703|NCT01186653|Adrenergic Agents|adrenergic agents|mesh-ancestor
24643704|NCT01186653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24643705|NCT01186653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643706|NCT01186653|Sympathomimetics|sympathomimetics|mesh-ancestor
24643707|NCT01186731|Docetaxel|docetaxel|mesh-list
25852307|NCT00055939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24643708|NCT01186731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24643709|NCT01186731|Tubulin Modulators|tubulin modulators|mesh-ancestor
24643710|NCT01186731|Antimitotic Agents|antimitotic agents|mesh-ancestor
24643711|NCT01186731|Mitosis Modulators|mitosis modulators|mesh-ancestor
24999228|NCT04895748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643712|NCT01186731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643713|NCT01186835|Botulinum Toxins|botulinum toxins|mesh-list
24643714|NCT01186835|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24643715|NCT01186835|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24643716|NCT01186835|Hyaluronic Acid|hyaluronic acid|mesh-list
24643717|NCT01186835|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25852308|NCT00055939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24643718|NCT01186835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24643719|NCT01186835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643720|NCT01186835|Cholinergic Agents|cholinergic agents|mesh-ancestor
24643721|NCT01186835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24643722|NCT01186835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999260|NCT04839328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999261|NCT04795869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24999262|NCT04795869|Pembrolizumab|pembrolizumab|mesh-list
24999263|NCT04795869|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24999264|NCT04795869|Antibodies|antibodies|mesh-list
24999265|NCT04795869|Immunoglobulins|immunoglobulins|mesh-list
24999266|NCT04795869|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24937244|NCT04031703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24937245|NCT04031703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24937246|NCT04031703|Tubulin Modulators|tubulin modulators|mesh-ancestor
24937247|NCT04031703|Antimitotic Agents|antimitotic agents|mesh-ancestor
24937248|NCT04031703|Mitosis Modulators|mitosis modulators|mesh-ancestor
25202615|NCT02720406|Sensory System Agents|sensory system agents|mesh-ancestor
25852309|NCT00055939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24937250|NCT04031703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24937251|NCT04031703|Immunologic Factors|immunologic factors|mesh-ancestor
24937252|NCT04031703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937253|NCT04031703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24937254|NCT04031703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24937255|NCT04031703|Alkylating Agents|alkylating agents|mesh-ancestor
24937256|NCT04031703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24937257|NCT04031703|Antimetabolites|antimetabolites|mesh-ancestor
24937258|NCT04031703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24643723|NCT01186835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24643724|NCT01186835|Immunologic Factors|immunologic factors|mesh-ancestor
24643732|NCT01186887|Analgesics|analgesics|mesh-ancestor
24643733|NCT01186887|Sensory System Agents|sensory system agents|mesh-ancestor
24643734|NCT01186887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24643735|NCT01186887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643736|NCT01186887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24798363|NCT01963221|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25424468|NCT02252172|Growth Substances|growth substances|mesh-ancestor
25663945|NCT01663857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663946|NCT01663857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25663947|NCT01663857|Antimetabolites|antimetabolites|mesh-ancestor
25663948|NCT01663857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663949|NCT01663857|Antiviral Agents|antiviral agents|mesh-ancestor
25663950|NCT01663857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24798364|NCT01963221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798365|NCT01963299|Clonidine|clonidine|mesh-list
24798376|NCT01963299|Autonomic Agents|autonomic agents|mesh-ancestor
24798377|NCT01963299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24999283|NCT04721613|Melatonin|melatonin|mesh-list
24999284|NCT04721613|Antioxidants|antioxidants|mesh-ancestor
24999285|NCT04721613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999286|NCT04721613|Protective Agents|protective agents|mesh-ancestor
24999287|NCT04721613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999288|NCT04721613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24999294|NCT04644289|Durvalumab|durvalumab|mesh-list
24999295|NCT04644289|Olaparib|olaparib|mesh-list
24999296|NCT04644289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24999297|NCT04644289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999298|NCT04644289|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24999299|NCT04644289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840245|NCT02208778|Analgesics|analgesics|mesh-ancestor
24643737|NCT01186887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24643738|NCT01186887|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24643739|NCT01186887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24999300|NCT04644289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999303|NCT04591275|Denosumab|denosumab|mesh-list
24999304|NCT04591275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24999305|NCT04591275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999314|NCT04571645|Heparin|heparin|mesh-list
24999315|NCT04571645|Anticoagulants|anticoagulants|mesh-ancestor
24999316|NCT04571645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24999317|NCT04571645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24999318|NCT04571645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999319|NCT04565847|Albuterol|albuterol|mesh-list
24999320|NCT04565847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24999321|NCT04565847|Autonomic Agents|autonomic agents|mesh-ancestor
25202616|NCT02720406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202617|NCT02720406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999322|NCT04565847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25048744|NCT00673062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25048745|NCT00673062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048746|NCT00672997|Timolol|timolol|mesh-list
25048747|NCT00672997|Travoprost|travoprost|mesh-list
25048748|NCT00672997|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25048749|NCT00672997|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25048750|NCT00672997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25048751|NCT00672997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25048763|NCT00672412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048764|NCT00672412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048766|NCT00672412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25048767|NCT00672412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25048768|NCT00672412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25048769|NCT00672412|Antimetabolites|antimetabolites|mesh-ancestor
25048770|NCT00672412|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25048771|NCT00672412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25048772|NCT00672386|Metformin|metformin|mesh-list
25048774|NCT00672386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048775|NCT00670033|Travoprost|travoprost|mesh-list
25048776|NCT00670033|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25048786|NCT00668772|Respiratory System Agents|respiratory system agents|mesh-ancestor
25048787|NCT00668772|Parasympatholytics|parasympatholytics|mesh-ancestor
24999329|NCT04565847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24999330|NCT04565847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24999331|NCT04565847|Adrenergic Agents|adrenergic agents|mesh-ancestor
24999332|NCT04565847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24999333|NCT04565847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999335|NCT04554732|Mitosis Modulators|mitosis modulators|mesh-ancestor
24999336|NCT04554732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999337|NCT04504045|Metformin|metformin|mesh-list
24999338|NCT04504045|Efavirenz|efavirenz|mesh-list
24999339|NCT04504045|Losartan|losartan|mesh-list
24999340|NCT04504045|Metoprolol|metoprolol|mesh-list
24999341|NCT04504045|Midazolam|midazolam|mesh-list
24999342|NCT04504045|Caffeine|caffeine|mesh-list
24999343|NCT04504045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24999344|NCT04504045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999345|NCT04504045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24999346|NCT04504045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24999347|NCT04504045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24999348|NCT04504045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24750522|NCT01699204|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24750523|NCT01699204|Antiviral Agents|antiviral agents|mesh-ancestor
24750524|NCT01699204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24750525|NCT01699204|Expectorants|expectorants|mesh-ancestor
24750526|NCT01699204|Respiratory System Agents|respiratory system agents|mesh-ancestor
24750527|NCT01699204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24750528|NCT01699204|Antioxidants|antioxidants|mesh-ancestor
24750529|NCT01699204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750530|NCT01699204|Protective Agents|protective agents|mesh-ancestor
24750531|NCT01699204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750532|NCT01699204|Antidotes|antidotes|mesh-ancestor
24750533|NCT01699282|Antivitamins K|antivitamins k|mesh-list
24750534|NCT01699282|Anticoagulants|anticoagulants|mesh-ancestor
24750535|NCT01699347|Picibanil|picibanil|mesh-list
24943954|NCT03965637|Ascorbic Acid|ascorbic acid|mesh-list
24999349|NCT04504045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24999350|NCT04504045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24999351|NCT04504045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24999352|NCT04504045|Anesthetics, General|anesthetics, general|mesh-ancestor
24999353|NCT04504045|Anesthetics|anesthetics|mesh-ancestor
24999354|NCT04504045|GABA Modulators|gaba modulators|mesh-ancestor
24999355|NCT04504045|GABA Agents|gaba agents|mesh-ancestor
24999356|NCT04504045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24999357|NCT04504045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999358|NCT04504045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24999359|NCT04504045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24999360|NCT04504045|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24999361|NCT04504045|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24999362|NCT04504045|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24999363|NCT04504045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24999364|NCT04504045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24999365|NCT04504045|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24999366|NCT04504045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24999367|NCT04504045|Purinergic Agents|purinergic agents|mesh-ancestor
25852310|NCT00055939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999368|NCT04504045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25852311|NCT00055939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999369|NCT04504045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24999370|NCT04504045|Antiviral Agents|antiviral agents|mesh-ancestor
24999371|NCT04504045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24999372|NCT04504045|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24999373|NCT04504045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24999374|NCT04504045|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24999375|NCT04504045|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24999376|NCT04504045|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24999377|NCT04504045|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24999378|NCT04504045|Sympatholytics|sympatholytics|mesh-ancestor
24999379|NCT04504045|Autonomic Agents|autonomic agents|mesh-ancestor
25852312|NCT00055952|Exatecan|exatecan|mesh-list
24706630|NCT01491009|Midazolam|midazolam|mesh-list
24798382|NCT01963299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798384|NCT01963325|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24798385|NCT01963325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24798386|NCT01963325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24798387|NCT01963325|Tubulin Modulators|tubulin modulators|mesh-ancestor
24798388|NCT01963325|Antimitotic Agents|antimitotic agents|mesh-ancestor
24798389|NCT01963325|Mitosis Modulators|mitosis modulators|mesh-ancestor
24798390|NCT01963325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798391|NCT01963390|Testosterone|testosterone|mesh-list
24798392|NCT01963390|Androgens|androgens|mesh-ancestor
24798393|NCT01963390|Hormones|hormones|mesh-ancestor
25663951|NCT01663857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663952|NCT01663857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25663953|NCT01663857|Immunologic Factors|immunologic factors|mesh-ancestor
25663954|NCT01663857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663955|NCT01663935|Levodopa|levodopa|mesh-list
25663956|NCT01663935|Carbidopa|carbidopa|mesh-list
25663957|NCT01663935|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25663958|NCT01663935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25663959|NCT01663935|Dopamine Agents|dopamine agents|mesh-ancestor
25663960|NCT01663935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25663961|NCT01663935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663962|NCT01663935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663963|NCT01663935|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24750917|NCT01701076|Alkylating Agents|alkylating agents|mesh-ancestor
24750919|NCT01701089|Antidepressive Agents|antidepressive agents|mesh-ancestor
24750920|NCT01701089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24750921|NCT01701089|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24750922|NCT01701089|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24750923|NCT01701089|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24750924|NCT01701089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750925|NCT01701089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750954|NCT01701323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24750955|NCT01701323|Antimetabolites|antimetabolites|mesh-ancestor
24750956|NCT01701323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750957|NCT01701323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24750958|NCT01701323|Immunologic Factors|immunologic factors|mesh-ancestor
24750959|NCT01701323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750960|NCT01701323|Antiviral Agents|antiviral agents|mesh-ancestor
24750961|NCT01701323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24750963|NCT01701336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24798394|NCT01963390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24798395|NCT01963390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798396|NCT01963416|Micronutrients|micronutrients|mesh-list
24798402|NCT01963442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24798403|NCT01963442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24798404|NCT01963442|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24798405|NCT01963442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24798407|NCT01963546|Dexmedetomidine|dexmedetomidine|mesh-list
25048802|NCT00667953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25048803|NCT00667953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048804|NCT00666497|Azacitidine|azacitidine|mesh-list
25048805|NCT00666497|Mocetinostat|mocetinostat|mesh-list
25048806|NCT00666497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25048807|NCT00666497|Antimetabolites|antimetabolites|mesh-ancestor
25048808|NCT00666497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048809|NCT00666497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048810|NCT00666497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048811|NCT00666497|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24798411|NCT01963546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24798412|NCT01963546|Analgesics|analgesics|mesh-ancestor
24798413|NCT01963546|Sensory System Agents|sensory system agents|mesh-ancestor
24798414|NCT01963546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202618|NCT02720406|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24798415|NCT01963546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24798416|NCT01963546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24798417|NCT01963546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24798418|NCT01963546|Adrenergic Agents|adrenergic agents|mesh-ancestor
24592150|NCT00920413|Antioxidants|antioxidants|mesh-ancestor
24798419|NCT01963546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24798420|NCT01963546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798422|NCT01963559|Prilocaine|prilocaine|mesh-list
24798423|NCT01963559|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24798424|NCT01963559|Anesthetics, Local|anesthetics, local|mesh-ancestor
24798425|NCT01963559|Anesthetics|anesthetics|mesh-ancestor
24798426|NCT01963559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24798427|NCT01963559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798428|NCT01963559|Sensory System Agents|sensory system agents|mesh-ancestor
24798429|NCT01963559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25663964|NCT01663935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663965|NCT01663987|Bromides|bromides|mesh-list
25663966|NCT01663987|Tiotropium Bromide|tiotropium bromide|mesh-list
25663967|NCT01663987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25663968|NCT01663987|Autonomic Agents|autonomic agents|mesh-ancestor
25663969|NCT01663987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25663970|NCT01663987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25663971|NCT01663987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25663972|NCT01663987|Respiratory System Agents|respiratory system agents|mesh-ancestor
25663973|NCT01663987|Parasympatholytics|parasympatholytics|mesh-ancestor
25663974|NCT01663987|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25663975|NCT01663987|Cholinergic Agents|cholinergic agents|mesh-ancestor
25663976|NCT01663987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25663977|NCT01663987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663978|NCT01663987|Anticonvulsants|anticonvulsants|mesh-ancestor
25663979|NCT01664039|Bimatoprost|bimatoprost|mesh-list
25663980|NCT01664039|Travoprost|travoprost|mesh-list
25663981|NCT01664039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25663982|NCT01664039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24798430|NCT01963559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24999454|NCT04332341|Antimetabolites|antimetabolites|mesh-ancestor
24944115|NCT03963193|Cisplatin|cisplatin|mesh-list
24706762|NCT01491711|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
24706763|NCT01491711|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24706764|NCT01491711|Dermatologic Agents|dermatologic agents|mesh-ancestor
24706765|NCT01491867|Travoprost|travoprost|mesh-list
24706766|NCT01491867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24492637|NCT00487123|Valsartan|valsartan|mesh-list
24999486|NCT04209855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24999487|NCT04209855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24999488|NCT04209855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24999489|NCT04209855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24999511|NCT04108234|Ketamine|ketamine|mesh-list
24999512|NCT04108234|Analgesics|analgesics|mesh-ancestor
24999513|NCT04108234|Sensory System Agents|sensory system agents|mesh-ancestor
24999514|NCT04108234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24999515|NCT04108234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999516|NCT04108234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24999517|NCT04108234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24999518|NCT04108234|Anesthetics, General|anesthetics, general|mesh-ancestor
24999519|NCT04108234|Anesthetics|anesthetics|mesh-ancestor
24999520|NCT04108234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24999521|NCT04108234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24999522|NCT04108234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24999523|NCT04108234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24999524|NCT04108234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999525|NCT04093219|Acetaminophen|acetaminophen|mesh-list
24999526|NCT04093219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24999527|NCT04093219|Analgesics|analgesics|mesh-ancestor
24999528|NCT04093219|Sensory System Agents|sensory system agents|mesh-ancestor
24999529|NCT04093219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24999530|NCT04093219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999531|NCT04093219|Antipyretics|antipyretics|mesh-ancestor
24999571|NCT03981614|Antimetabolites|antimetabolites|mesh-ancestor
24999572|NCT03981614|Antiviral Agents|antiviral agents|mesh-ancestor
24999573|NCT03981614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24706827|NCT01492608|Sensory System Agents|sensory system agents|mesh-ancestor
24706828|NCT01492608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24999579|NCT03949894|Tolvaptan|tolvaptan|mesh-list
24999580|NCT03949894|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24999581|NCT03949894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999582|NCT03949894|Natriuretic Agents|natriuretic agents|mesh-ancestor
24999583|NCT03949894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999584|NCT03912220|Niacinamide|niacinamide|mesh-list
24999586|NCT03912220|Nicotinic Acids|nicotinic acids|mesh-list
24999593|NCT03912220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999622|NCT03781960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999624|NCT03762850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24999625|NCT03762850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24999626|NCT03762850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24999627|NCT03762850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937542|NCT04027829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937543|NCT04027829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24937587|NCT04027530|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24937588|NCT04027530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937589|NCT04027530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24937590|NCT04027530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798432|NCT01963559|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25048812|NCT00663767|Celecoxib|celecoxib|mesh-list
25048813|NCT00663767|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
25048814|NCT00663767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25048815|NCT00663767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25048816|NCT00663767|Analgesics|analgesics|mesh-ancestor
25048817|NCT00663767|Sensory System Agents|sensory system agents|mesh-ancestor
25048818|NCT00663767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25048819|NCT00663767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048820|NCT00663767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25048821|NCT00663767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25048824|NCT00663767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048825|NCT00662740|Tiotropium Bromide|tiotropium bromide|mesh-list
25048826|NCT00662740|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25409428|NCT03382561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24751682|NCT01705392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24706881|NCT01492894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706882|NCT01492894|Antifungal Agents|antifungal agents|mesh-ancestor
24706883|NCT01492894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24798433|NCT01963559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24798434|NCT01963559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798435|NCT01963559|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24798437|NCT01963663|Pioglitazone|pioglitazone|mesh-list
24798438|NCT01963663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24798439|NCT01963663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798440|NCT01963702|Capecitabine|capecitabine|mesh-list
24798441|NCT01963702|Oxaliplatin|oxaliplatin|mesh-list
24798442|NCT01963702|Docetaxel|docetaxel|mesh-list
24798443|NCT01963702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24798444|NCT01963702|Antimetabolites|antimetabolites|mesh-ancestor
24798445|NCT01963702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798446|NCT01963702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24798447|NCT01963702|Tubulin Modulators|tubulin modulators|mesh-ancestor
24944306|NCT03961698|Antimitotic Agents|antimitotic agents|mesh-ancestor
24999635|NCT03671811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24999637|NCT03671811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24999638|NCT03671811|Contraceptive Agents|contraceptive agents|mesh-ancestor
24999639|NCT03671811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24999640|NCT03671811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999641|NCT03671811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24999642|NCT03671811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24999643|NCT03671811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24999644|NCT03671811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999645|NCT03671811|Appetite Stimulants|appetite stimulants|mesh-ancestor
24999646|NCT03671811|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25852313|NCT00055952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25852314|NCT00055952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24999663|NCT03602066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24999696|NCT03502577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999697|NCT03502577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999698|NCT03502577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24999699|NCT03501966|Acetazolamide|acetazolamide|mesh-list
24999700|NCT03501966|Diuretics|diuretics|mesh-list
25852315|NCT00055952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643757|NCT01187108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643759|NCT01187108|Natriuretic Agents|natriuretic agents|mesh-ancestor
24643760|NCT01187186|Ipragliflozin|ipragliflozin|mesh-list
24643761|NCT01187186|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24643762|NCT01187186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643764|NCT01187186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643765|NCT01187212|Cisplatin|cisplatin|mesh-list
24999701|NCT03501966|Natriuretic Agents|natriuretic agents|mesh-ancestor
24999702|NCT03501966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999703|NCT03501966|Anticonvulsants|anticonvulsants|mesh-ancestor
24999704|NCT03501966|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24999705|NCT03501966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24999706|NCT03501966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999707|NCT03501368|Trametinib|trametinib|mesh-list
24999708|NCT03501368|Ceritinib|ceritinib|mesh-list
24643828|NCT01187589|Tocolytic Agents|tocolytic agents|mesh-ancestor
24643829|NCT01187589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24643830|NCT01187589|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24643831|NCT01187589|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24643832|NCT01187589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24643833|NCT01187589|Adrenergic Agents|adrenergic agents|mesh-ancestor
24643834|NCT01187589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24643835|NCT01187589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643838|NCT01187615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24643839|NCT01187615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643840|NCT01187615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999728|NCT03492671|Antiviral Agents|antiviral agents|mesh-ancestor
24999729|NCT03492671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24999730|NCT03492671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24999731|NCT03492671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24999732|NCT03492671|Immunologic Factors|immunologic factors|mesh-ancestor
25663983|NCT01664039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25663984|NCT01664247|Liraglutide|liraglutide|mesh-list
25663985|NCT01664247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24999733|NCT03492671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999734|NCT03477630|Hyaluronic Acid|hyaluronic acid|mesh-list
24999735|NCT03477630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24999736|NCT03477630|Immunologic Factors|immunologic factors|mesh-ancestor
24643850|NCT01187719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24643852|NCT01187849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24800618|NCT01976936|Dihydromevinolin|dihydromevinolin|mesh-list
24643853|NCT01187849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643855|NCT01187862|Losartan|losartan|mesh-list
24643856|NCT01187862|Metoprolol|metoprolol|mesh-list
24643857|NCT01187862|Midazolam|midazolam|mesh-list
24999806|NCT03121014|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24999807|NCT03121014|Abortifacient Agents|abortifacient agents|mesh-ancestor
24999808|NCT03121014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24999809|NCT03121014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999810|NCT03121014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24999811|NCT03121014|Antimetabolites|antimetabolites|mesh-ancestor
24999812|NCT03121014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999813|NCT03121014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999814|NCT03121014|Dermatologic Agents|dermatologic agents|mesh-ancestor
24999815|NCT03121014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24999816|NCT03121014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24937821|NCT04025203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24937822|NCT04025203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24937823|NCT04025203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937824|NCT04025203|Anticonvulsants|anticonvulsants|mesh-ancestor
24937825|NCT04025203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24707160|NCT01494363|Vitamins|vitamins|mesh-ancestor
24999882|NCT02918201|Tranexamic Acid|tranexamic acid|mesh-list
24999883|NCT02918201|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24999884|NCT02918201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24999885|NCT02918201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999886|NCT02918201|Hemostatics|hemostatics|mesh-ancestor
24999887|NCT02918201|Coagulants|coagulants|mesh-ancestor
24999888|NCT02906007|Bedaquiline|bedaquiline|mesh-list
24999889|NCT02906007|Antitubercular Agents|antitubercular agents|mesh-ancestor
24999890|NCT02906007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24999891|NCT02906007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24999893|NCT02884219|Indomethacin|indomethacin|mesh-list
24999894|NCT02884219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
24999895|NCT02884219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24999930|NCT02727803|Alkylating Agents|alkylating agents|mesh-ancestor
24999931|NCT02727803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999932|NCT02727803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999933|NCT02727803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24999934|NCT02727803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24999935|NCT02727803|Antimetabolites|antimetabolites|mesh-ancestor
24999937|NCT02696993|Ipilimumab|ipilimumab|mesh-list
25075921|NCT03377257|Zolmitriptan|zolmitriptan|mesh-list
24643862|NCT01187862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24999938|NCT02696993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24999939|NCT02696993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999940|NCT02696993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24999941|NCT02696993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999942|NCT02647827|Metformin|metformin|mesh-list
24707248|NCT01494805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24999943|NCT02647827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24999944|NCT02647827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999945|NCT02625961|Pembrolizumab|pembrolizumab|mesh-list
24999946|NCT02625961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24999947|NCT02625961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999955|NCT02532660|Dexetimide|dexetimide|mesh-list
24643940|NCT01188005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643946|NCT01188031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643948|NCT01188031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24643949|NCT01188031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24643950|NCT01188031|GABA Modulators|gaba modulators|mesh-ancestor
24643951|NCT01188031|GABA Agents|gaba agents|mesh-ancestor
24999959|NCT02532660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24999960|NCT02532660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999961|NCT02532660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24999962|NCT02532660|Serotonin Agents|serotonin agents|mesh-ancestor
24999963|NCT02532660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999964|NCT02532660|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24999965|NCT02532660|Antidepressive Agents|antidepressive agents|mesh-ancestor
24752243|NCT01709370|Hormone Antagonists|hormone antagonists|mesh-ancestor
24752384|NCT01710072|Antipyretics|antipyretics|mesh-ancestor
24999966|NCT02532660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24999967|NCT02532660|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24999968|NCT02532660|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24999969|NCT02532660|Parasympatholytics|parasympatholytics|mesh-ancestor
24999970|NCT02532660|Autonomic Agents|autonomic agents|mesh-ancestor
24999971|NCT02532660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24999972|NCT02532660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24999973|NCT02532660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24999974|NCT02532660|Cholinergic Agents|cholinergic agents|mesh-ancestor
24999977|NCT02434354|Pembrolizumab|pembrolizumab|mesh-list
24999978|NCT02434354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24999989|NCT02342275|Adrenergic Agents|adrenergic agents|mesh-ancestor
24841165|NCT02214563|Cholecalciferol|cholecalciferol|mesh-list
24841166|NCT02214563|Vitamins|vitamins|mesh-list
24841167|NCT02214563|Micronutrients|micronutrients|mesh-ancestor
24841171|NCT02214602|Doxorubicin|doxorubicin|mesh-list
24643952|NCT01188031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24643953|NCT01188031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643955|NCT01188057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24643956|NCT01188057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24999990|NCT02342275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24707253|NCT01494857|Adalimumab|adalimumab|mesh-list
24707324|NCT01495195|Antidepressive Agents|antidepressive agents|mesh-ancestor
24707325|NCT01495195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24999999|NCT02342275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25000001|NCT02199236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25000002|NCT02199236|Antimetabolites|antimetabolites|mesh-ancestor
25000003|NCT02199236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000004|NCT02199236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25000010|NCT02183870|Crizotinib|crizotinib|mesh-list
25000011|NCT02183870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25000012|NCT02183870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25000013|NCT02183870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25000014|NCT02183870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000015|NCT02162849|Nicotine|nicotine|mesh-list
25000016|NCT02162849|Varenicline|varenicline|mesh-list
25000017|NCT02162849|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25000018|NCT02162849|Autonomic Agents|autonomic agents|mesh-ancestor
25000019|NCT02162849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25000020|NCT02162849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000021|NCT02162849|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25000022|NCT02162849|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25000023|NCT02162849|Cholinergic Agents|cholinergic agents|mesh-ancestor
25000024|NCT02162849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25000502|NCT04374019|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25000031|NCT01970722|Gemcitabine|gemcitabine|mesh-list
25000032|NCT01970722|Paclitaxel|paclitaxel|mesh-list
25000033|NCT01970722|Cisplatin|cisplatin|mesh-list
25000034|NCT01970722|Carboplatin|carboplatin|mesh-list
25000035|NCT01970722|Doxorubicin|doxorubicin|mesh-list
25000036|NCT01970722|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25000037|NCT01970722|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25000038|NCT01970722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24676101|NCT01348243|Clodronic Acid|clodronic acid|mesh-list
25852316|NCT00055952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613831|NCT01021163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613833|NCT01021163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613834|NCT01021163|Antidotes|antidotes|mesh-ancestor
24613835|NCT01021176|Diltiazem|diltiazem|mesh-list
24613836|NCT01021176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24613837|NCT01021176|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24613838|NCT01021176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24613839|NCT01021176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613840|NCT01021176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25000084|NCT01827553|Folfirinox|folfirinox|mesh-list
25000202|NCT04166487|Carboplatin|carboplatin|mesh-list
24938042|NCT04022811|Autonomic Agents|autonomic agents|mesh-ancestor
24938043|NCT04022811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24938044|NCT04022811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938045|NCT04022811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24938046|NCT04022811|Glucocorticoids|glucocorticoids|mesh-ancestor
25663986|NCT01664247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774674|NCT01847326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25663987|NCT01664247|Incretins|incretins|mesh-ancestor
25048882|NCT00658762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25048883|NCT00658762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25048884|NCT00658762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048885|NCT00658762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25048886|NCT00658762|Serotonin Agents|serotonin agents|mesh-ancestor
25048887|NCT00658762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613845|NCT01021358|Ketoconazole|ketoconazole|mesh-list
24613853|NCT01021358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24613854|NCT01021358|Hormone Antagonists|hormone antagonists|mesh-ancestor
24613855|NCT01021358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24613856|NCT01021358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613857|NCT01021358|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24613859|NCT01021436|Amikacin|amikacin|mesh-list
25048888|NCT00658762|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25048889|NCT00658762|Antidepressive Agents|antidepressive agents|mesh-ancestor
25048890|NCT00658762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25048891|NCT00658762|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25048892|NCT00658762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25048893|NCT00658762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048894|NCT00658372|Paroxetine|paroxetine|mesh-list
25000171|NCT03639948|Carboplatin|carboplatin|mesh-list
25000172|NCT03639948|Docetaxel|docetaxel|mesh-list
25000173|NCT03639948|Pembrolizumab|pembrolizumab|mesh-list
25000174|NCT03639948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841456|NCT02216045|Antimetabolites|antimetabolites|mesh-ancestor
24643957|NCT01188057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643958|NCT01188057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25000196|NCT03968406|Talazoparib|talazoparib|mesh-list
25000197|NCT03968406|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25000198|NCT03968406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25000199|NCT03968406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000200|NCT03968406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25000201|NCT04166487|Paclitaxel|paclitaxel|mesh-list
25000211|NCT04166487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25000212|NCT04166487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202619|NCT02720406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25202620|NCT02720406|Anesthetics, General|anesthetics, general|mesh-ancestor
25202621|NCT02720406|Anesthetics|anesthetics|mesh-ancestor
25000213|NCT04166487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25000214|NCT04166487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25000215|NCT04237649|Spartalizumab|spartalizumab|mesh-list
25000216|NCT04237649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25000217|NCT04237649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000218|NCT04237649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25000225|NCT04294576|Pembrolizumab|pembrolizumab|mesh-list
25000226|NCT04294576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24643959|NCT01188057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24643960|NCT01188057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24643961|NCT01188057|GABA Modulators|gaba modulators|mesh-ancestor
24643962|NCT01188057|GABA Agents|gaba agents|mesh-ancestor
24643963|NCT01188057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24643964|NCT01188057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643965|NCT01188148|Memantine|memantine|mesh-list
25000283|NCT04897880|Panobinostat|panobinostat|mesh-list
25000284|NCT04897880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25000285|NCT04897880|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25000286|NCT04897880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613873|NCT01021488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24940791|NCT03997864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707418|NCT01495624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25000287|NCT04897880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048905|NCT00658372|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24643991|NCT01188265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643993|NCT01188265|Antimanic Agents|antimanic agents|mesh-ancestor
24643994|NCT01188265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24643995|NCT01188265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24643996|NCT01188265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24643997|NCT01188278|Imatinib Mesylate|imatinib mesylate|mesh-list
24644000|NCT01188278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24644001|NCT01188278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644002|NCT01188278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644003|NCT01188304|Aspirin|aspirin|mesh-list
25007107|NCT04161248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25007108|NCT04161248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25007109|NCT04161248|Glucocorticoids|glucocorticoids|mesh-ancestor
25007110|NCT04161248|Hormones|hormones|mesh-ancestor
25007111|NCT04161248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25007112|NCT04161248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24644004|NCT01188304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24644005|NCT01188304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24644006|NCT01188304|Analgesics|analgesics|mesh-ancestor
24644007|NCT01188304|Sensory System Agents|sensory system agents|mesh-ancestor
24644008|NCT01188304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24644009|NCT01188304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644010|NCT01188304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24644011|NCT01188304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24644012|NCT01188304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24644013|NCT01188304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24644014|NCT01188304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644015|NCT01188304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24644025|NCT01188317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644026|NCT01188317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25852317|NCT00055952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644030|NCT01188317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644032|NCT01188408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644033|NCT01188408|Tubulin Modulators|tubulin modulators|mesh-ancestor
24644034|NCT01188408|Antimitotic Agents|antimitotic agents|mesh-ancestor
24644035|NCT01188408|Mitosis Modulators|mitosis modulators|mesh-ancestor
25852318|NCT00055965|Gemcitabine|gemcitabine|mesh-list
25048906|NCT00658372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25048907|NCT00658372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048908|NCT00658047|Methotrexate|methotrexate|mesh-list
25048909|NCT00658047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25048910|NCT00658047|Abortifacient Agents|abortifacient agents|mesh-ancestor
25048911|NCT00658047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25048912|NCT00658047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048913|NCT00658047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25048914|NCT00658047|Antimetabolites|antimetabolites|mesh-ancestor
25048915|NCT00658047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048916|NCT00658047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048917|NCT00658047|Dermatologic Agents|dermatologic agents|mesh-ancestor
25048918|NCT00658047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048919|NCT00658047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25048920|NCT00658047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25048921|NCT00658047|Immunologic Factors|immunologic factors|mesh-ancestor
25048922|NCT00658047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24938210|NCT04021017|Contraceptive Agents|contraceptive agents|mesh-ancestor
24938211|NCT04021017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24938212|NCT04021017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24938214|NCT04021173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24938215|NCT04021173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24938216|NCT04021173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938217|NCT04020666|Kallikreins|kallikreins|mesh-list
24938218|NCT04020666|Coagulants|coagulants|mesh-ancestor
24938219|NCT04020666|Fertility Agents, Male|fertility agents, male|mesh-ancestor
24938220|NCT04020666|Fertility Agents|fertility agents|mesh-ancestor
24938221|NCT04020666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25000425|NCT05404919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000427|NCT05404919|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25000428|NCT05404919|Immunologic Factors|immunologic factors|mesh-ancestor
25000429|NCT05404919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000430|NCT04450654|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25000431|NCT04450654|Immunologic Factors|immunologic factors|mesh-ancestor
25000432|NCT04450654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000433|NCT04437485|Norepinephrine|norepinephrine|mesh-list
25000434|NCT04437485|Bupropion|bupropion|mesh-list
25000435|NCT04437485|Antidepressive Agents|antidepressive agents|mesh-list
25000436|NCT04437485|Serotonin|serotonin|mesh-list
25000437|NCT04437485|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25663988|NCT01664247|Hormones|hormones|mesh-ancestor
25663989|NCT01664247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25663990|NCT01664494|Capecitabine|capecitabine|mesh-list
25663991|NCT01664494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25663992|NCT01664494|Antimetabolites|antimetabolites|mesh-ancestor
25663993|NCT01664494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754876|NCT01723527|Methadone|methadone|mesh-list
25000438|NCT04437485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25000439|NCT04437485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25000440|NCT04437485|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25000441|NCT04437485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25000442|NCT04437485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25000443|NCT04437485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000444|NCT04437485|Dopamine Agents|dopamine agents|mesh-ancestor
25000445|NCT04437485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25000446|NCT04437485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000447|NCT04437485|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24644080|NCT01188863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000453|NCT04437485|Sympathomimetics|sympathomimetics|mesh-ancestor
25000454|NCT04437485|Autonomic Agents|autonomic agents|mesh-ancestor
25000582|NCT04175509|Analgesics|analgesics|mesh-ancestor
25000455|NCT04437485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25000456|NCT04437485|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25000457|NCT04437485|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25000458|NCT04437485|Serotonin Agents|serotonin agents|mesh-ancestor
25000459|NCT04436224|Fentanyl|fentanyl|mesh-list
25000460|NCT04436224|Hydromorphone|hydromorphone|mesh-list
25000461|NCT04436224|Butorphanol|butorphanol|mesh-list
25000462|NCT04436224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25000463|NCT04436224|Narcotics|narcotics|mesh-ancestor
25000464|NCT04436224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25000465|NCT04436224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000466|NCT04436224|Analgesics|analgesics|mesh-ancestor
25000467|NCT04436224|Sensory System Agents|sensory system agents|mesh-ancestor
25000468|NCT04436224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25000469|NCT04436224|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25000470|NCT04436224|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25000471|NCT04436224|Anesthetics, General|anesthetics, general|mesh-ancestor
25000472|NCT04436224|Anesthetics|anesthetics|mesh-ancestor
25000473|NCT04436224|Antitussive Agents|antitussive agents|mesh-ancestor
25000474|NCT04436224|Respiratory System Agents|respiratory system agents|mesh-ancestor
25000475|NCT04436224|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25000476|NCT04433988|Pentoxifylline|pentoxifylline|mesh-list
25000477|NCT04433988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25000478|NCT04433988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25000479|NCT04433988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000480|NCT04433988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25000481|NCT04433988|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25000482|NCT04433988|Protective Agents|protective agents|mesh-ancestor
25000483|NCT04433988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644081|NCT01188863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24644082|NCT01188863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644083|NCT01188889|Imatinib Mesylate|imatinib mesylate|mesh-list
24644084|NCT01188889|Everolimus|everolimus|mesh-list
24644085|NCT01188889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25000494|NCT04374019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25000495|NCT04374019|Antiviral Agents|antiviral agents|mesh-ancestor
25000496|NCT04374019|Schistosomicides|schistosomicides|mesh-ancestor
25000497|NCT04374019|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25000498|NCT04374019|Anthelmintics|anthelmintics|mesh-ancestor
25000499|NCT04374019|Protease Inhibitors|protease inhibitors|mesh-ancestor
25000500|NCT04374019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25000501|NCT04374019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000503|NCT04374019|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25000504|NCT04357730|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25000505|NCT04357730|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25000506|NCT04357730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25000507|NCT04357730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000508|NCT04344678|Sildenafil Citrate|sildenafil citrate|mesh-list
25000509|NCT04344678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202622|NCT02720406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25202623|NCT02720406|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25202624|NCT02720406|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25202625|NCT02720406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25202626|NCT02720406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202627|NCT02720367|Gemcitabine|gemcitabine|mesh-list
25202628|NCT02720367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25202629|NCT02720367|Antimetabolites|antimetabolites|mesh-ancestor
25409429|NCT03382561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852319|NCT00055965|Cisplatin|cisplatin|mesh-list
25202630|NCT02720367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202632|NCT02720367|Antiviral Agents|antiviral agents|mesh-ancestor
25000510|NCT04344678|Vasodilator Agents|vasodilator agents|mesh-ancestor
25000530|NCT04311463|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24940820|NCT03997279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25000531|NCT04311463|Antidepressive Agents|antidepressive agents|mesh-ancestor
25000532|NCT04311463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25000533|NCT04311463|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25000534|NCT04311463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25000535|NCT04311463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25000536|NCT04295005|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25000537|NCT04295005|Empagliflozin|empagliflozin|mesh-list
25000538|NCT04295005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25000539|NCT04295005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000540|NCT04295005|Incretins|incretins|mesh-ancestor
25000541|NCT04295005|Hormones|hormones|mesh-ancestor
25000542|NCT04295005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25000543|NCT04295005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25000544|NCT04295005|Protease Inhibitors|protease inhibitors|mesh-ancestor
25000545|NCT04295005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048923|NCT00658047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25048924|NCT00658008|Paroxetine|paroxetine|mesh-list
25048925|NCT00658008|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25048926|NCT00658008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25048927|NCT00658008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24644091|NCT01188889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048928|NCT00658008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048929|NCT00658008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25048930|NCT00658008|Serotonin Agents|serotonin agents|mesh-ancestor
25048931|NCT00658008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048932|NCT00658008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25048933|NCT00658008|Antidepressive Agents|antidepressive agents|mesh-ancestor
25048934|NCT00658008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24938403|NCT04019106|Budesonide|budesonide|mesh-list
24938404|NCT04019106|Pulmonary Surfactants|pulmonary surfactants|mesh-list
24938405|NCT04019106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24938407|NCT04019106|Autonomic Agents|autonomic agents|mesh-ancestor
24707985|NCT01499121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24707986|NCT01499121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24707987|NCT01499121|Growth Substances|growth substances|mesh-ancestor
25000546|NCT04295005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000547|NCT04295005|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25000549|NCT04225988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25000550|NCT04225988|Immunologic Factors|immunologic factors|mesh-ancestor
25000551|NCT04225988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000552|NCT04225988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25000578|NCT04179890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25000580|NCT04175509|Acetaminophen|acetaminophen|mesh-list
25000581|NCT04175509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25025868|NCT03633552|Temozolomide|temozolomide|mesh-list
25000584|NCT04175509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25000585|NCT04175509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000586|NCT04175509|Antipyretics|antipyretics|mesh-ancestor
25000587|NCT04148105|Cilostazol|cilostazol|mesh-list
25000588|NCT04148105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25000589|NCT04148105|Autonomic Agents|autonomic agents|mesh-ancestor
25000590|NCT04148105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25000591|NCT04148105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000592|NCT04148105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25000593|NCT04148105|Respiratory System Agents|respiratory system agents|mesh-ancestor
25000594|NCT04148105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25000595|NCT04148105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25000596|NCT04148105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000597|NCT04148105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25000598|NCT04148105|Vasodilator Agents|vasodilator agents|mesh-ancestor
25000611|NCT04147351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000614|NCT04140396|Anesthetics, Local|anesthetics, local|mesh-ancestor
25000615|NCT04140396|Anesthetics|anesthetics|mesh-ancestor
25000616|NCT04140396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25000617|NCT04140396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000618|NCT04140396|Sensory System Agents|sensory system agents|mesh-ancestor
25000621|NCT04140396|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25000622|NCT04140396|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25000623|NCT04140396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25000624|NCT04140396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000625|NCT04059003|Taxane|taxane|mesh-list
25000626|NCT04059003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25000627|NCT04050410|Moxonidine|moxonidine|mesh-list
25000628|NCT04050410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25000629|NCT04044209|Nivolumab|nivolumab|mesh-list
25000630|NCT04044209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25000631|NCT04044209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25000632|NCT04044209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25000633|NCT04044209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000634|NCT03990363|Allopurinol|allopurinol|mesh-list
25000635|NCT03990363|Verinurad|verinurad|mesh-list
25000636|NCT03990363|Antimetabolites|antimetabolites|mesh-ancestor
25000637|NCT03990363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000638|NCT03990363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25000639|NCT03990363|Gout Suppressants|gout suppressants|mesh-ancestor
25000640|NCT03990363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25000641|NCT03990363|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25000642|NCT03990363|Antioxidants|antioxidants|mesh-ancestor
25000643|NCT03990363|Protective Agents|protective agents|mesh-ancestor
25000657|NCT03930186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000658|NCT03911973|Talazoparib|talazoparib|mesh-list
25000659|NCT03911973|Gedatolisib|gedatolisib|mesh-list
25000660|NCT03911973|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25000661|NCT03911973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25000662|NCT03911973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000663|NCT03911973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25000664|NCT03911973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24644092|NCT01188954|Doxycycline|doxycycline|mesh-list
24644093|NCT01188954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24644094|NCT01188954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24644095|NCT01188954|Antimalarials|antimalarials|mesh-ancestor
24644096|NCT01188954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24708036|NCT01499589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24708037|NCT01499589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940824|NCT03997279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644153|NCT01189448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25000695|NCT03787849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25000696|NCT03787849|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25000698|NCT03781440|Anesthetics, Local|anesthetics, local|mesh-ancestor
25000700|NCT03781440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25000701|NCT03781440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000702|NCT03781440|Sensory System Agents|sensory system agents|mesh-ancestor
24644191|NCT01189695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644192|NCT01189695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644193|NCT01189695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24644194|NCT01189695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24644195|NCT01189695|Antiviral Agents|antiviral agents|mesh-ancestor
24644196|NCT01189695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24644197|NCT01189695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25000703|NCT03781440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25000704|NCT03781440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25000705|NCT03781440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25000706|NCT03781440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25000707|NCT03781440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25000708|NCT03781440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000710|NCT03777319|Spironolactone|spironolactone|mesh-list
25230039|NCT02598778|Disinfectants|disinfectants|mesh-ancestor
25000711|NCT03777319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25000712|NCT03777319|Glucocorticoids|glucocorticoids|mesh-ancestor
25000713|NCT03777319|Hormones|hormones|mesh-ancestor
25000714|NCT03777319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25000715|NCT03777319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000716|NCT03777319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25852320|NCT00055965|Carboplatin|carboplatin|mesh-list
25000765|NCT03490513|Anastrozole|anastrozole|mesh-list
25000766|NCT03490513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24938667|NCT04017455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24938668|NCT04017455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24938669|NCT04017455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24938670|NCT04017455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24938671|NCT04017455|Growth Substances|growth substances|mesh-ancestor
24938672|NCT04017455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938673|NCT04017455|Growth Inhibitors|growth inhibitors|mesh-ancestor
24938674|NCT04017338|Ezetimibe|ezetimibe|mesh-list
24938675|NCT04017338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24938676|NCT04017338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24938677|NCT04017338|Antimetabolites|antimetabolites|mesh-ancestor
24938678|NCT04017338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938679|NCT04017338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24938680|NCT04017221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24938681|NCT04017221|Protease Inhibitors|protease inhibitors|mesh-ancestor
24938682|NCT04017221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24938684|NCT04017221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25000776|NCT03471728|Linaclotide|linaclotide|mesh-list
25000777|NCT03471728|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25000778|NCT03471728|Enzyme Activators|enzyme activators|mesh-ancestor
24613927|NCT01021696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613928|NCT01021696|Analgesics|analgesics|mesh-ancestor
25000779|NCT03471728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000780|NCT03471728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25000781|NCT03463057|Atezolizumab|atezolizumab|mesh-list
25000782|NCT03463057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25000783|NCT03456635|Anti-Infective Agents|anti-infective agents|mesh-list
25000784|NCT03456635|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25048941|NCT00657501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25048942|NCT00657501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048943|NCT00657189|Sifalimumab|sifalimumab|mesh-list
25048944|NCT00657189|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25048945|NCT00657189|Immunologic Factors|immunologic factors|mesh-ancestor
25048946|NCT00657189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048947|NCT00656539|Azithromycin|azithromycin|mesh-list
25048948|NCT00656539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25048949|NCT00656539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25048951|NCT00656357|Anesthetics, Local|anesthetics, local|mesh-ancestor
24644333|NCT01190371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24644334|NCT01190371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24644335|NCT01190371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25048972|NCT00654706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25048973|NCT00654706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048974|NCT00650949|Carboplatin|carboplatin|mesh-list
25048975|NCT00650949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048976|NCT00650832|Darunavir|darunavir|mesh-list
25000791|NCT03342027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25000792|NCT03342027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000793|NCT03342027|Dopamine Agents|dopamine agents|mesh-ancestor
25000794|NCT03342027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25000795|NCT03342027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000796|NCT03342027|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25000797|NCT03342027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25000798|NCT03342027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25000816|NCT03081858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000827|NCT03053362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000828|NCT03053362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25000829|NCT03053362|Serotonin Agents|serotonin agents|mesh-ancestor
25000830|NCT03053362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25000831|NCT03053362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25000885|NCT05462938|Anesthetics, General|anesthetics, general|mesh-ancestor
25000886|NCT05462938|Anesthetics|anesthetics|mesh-ancestor
25000887|NCT05462938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25000888|NCT05462938|Analgesics|analgesics|mesh-ancestor
25000889|NCT05462938|Sensory System Agents|sensory system agents|mesh-ancestor
25000890|NCT05462938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25000891|NCT05462938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25000892|NCT05462938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25000893|NCT05462938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24842238|NCT02220296|Insulin|insulin|mesh-list
24756670|NCT01735058|Immunologic Factors|immunologic factors|mesh-ancestor
24756671|NCT01735058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644346|NCT01190384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24644347|NCT01190384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644348|NCT01190462|Cetuximab|cetuximab|mesh-list
24644349|NCT01190462|Simvastatin|simvastatin|mesh-list
24644350|NCT01190462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24644351|NCT01190462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644352|NCT01190462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24644353|NCT01190462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24644354|NCT01190462|Antimetabolites|antimetabolites|mesh-ancestor
24644373|NCT01190670|Peficitinib|peficitinib|mesh-list
24644374|NCT01190670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25000894|NCT05462938|Adrenergic Agents|adrenergic agents|mesh-ancestor
25000895|NCT05462938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25000964|NCT05462535|Diuretics|diuretics|mesh-ancestor
25000965|NCT05462535|Natriuretic Agents|natriuretic agents|mesh-ancestor
25000966|NCT05462535|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25000967|NCT05462496|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25000968|NCT05462496|Metronidazole|metronidazole|mesh-list
25000969|NCT05462496|Ciprofloxacin|ciprofloxacin|mesh-list
24842307|NCT02220530|Anesthetics, General|anesthetics, general|mesh-ancestor
24644375|NCT01190670|Immunologic Factors|immunologic factors|mesh-ancestor
25852321|NCT00055965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644378|NCT01190670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25000970|NCT05462496|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25000971|NCT05462496|Pembrolizumab|pembrolizumab|mesh-list
25000973|NCT05462496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25000974|NCT05462496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25000975|NCT05462496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25000976|NCT05462496|Antitubercular Agents|antitubercular agents|mesh-ancestor
25000977|NCT05462496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24708452|NCT01501370|Growth Inhibitors|growth inhibitors|mesh-ancestor
24708453|NCT01501370|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24708565|NCT01501708|Voriconazole|voriconazole|mesh-list
24708566|NCT01501708|Amphotericin B|amphotericin b|mesh-list
25000978|NCT05462496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25000979|NCT05462496|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25000980|NCT05462496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25000981|NCT05462496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25000982|NCT05462496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000983|NCT05462496|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25000984|NCT05462496|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25000987|NCT05462236|Pembrolizumab|pembrolizumab|mesh-list
25048977|NCT00650832|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25048978|NCT00650832|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25048979|NCT00650832|Protease Inhibitors|protease inhibitors|mesh-ancestor
25000989|NCT05462236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25000990|NCT05462236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25000991|NCT05462236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25000992|NCT05462236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25000993|NCT05462236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25000994|NCT05462236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000995|NCT05462093|Liver Extracts|liver extracts|mesh-list
25000996|NCT05462093|Hematinics|hematinics|mesh-ancestor
24938899|NCT04015375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24938900|NCT04015375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24938901|NCT04015375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24938902|NCT04015375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24938903|NCT04015375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938904|NCT04015375|Leprostatic Agents|leprostatic agents|mesh-ancestor
24938905|NCT04015375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24644612|NCT01191957|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24644613|NCT01191983|Epoetin Alfa|epoetin alfa|mesh-list
24644614|NCT01191983|Hematinics|hematinics|mesh-ancestor
24644616|NCT01192087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24644617|NCT01192087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644618|NCT01192113|Vitamin B 12|vitamin b 12|mesh-list
24644619|NCT01192113|Vitamin B Complex|vitamin b complex|mesh-ancestor
24644620|NCT01192113|Vitamins|vitamins|mesh-ancestor
24644621|NCT01192113|Micronutrients|micronutrients|mesh-ancestor
25663994|NCT01664494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25663995|NCT01664533|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25663996|NCT01664533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644622|NCT01192113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768940|NCT01811459|Haloperidol|haloperidol|mesh-list
25001053|NCT05461508|Amoxicillin|amoxicillin|mesh-list
25001054|NCT05461508|Fucoidan|fucoidan|mesh-list
25001055|NCT05461508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25001056|NCT05461508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25001057|NCT05461508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25001058|NCT05461508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25001059|NCT05461508|Anticoagulants|anticoagulants|mesh-ancestor
25001060|NCT05461508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25001070|NCT05461404|Emollients|emollients|mesh-list
25202637|NCT02720367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708631|NCT01501799|Adapalene|adapalene|mesh-list
25001071|NCT05461404|Dermatologic Agents|dermatologic agents|mesh-ancestor
25001072|NCT05461365|Insulin|insulin|mesh-list
25001073|NCT05461365|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25001074|NCT05461365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25001075|NCT05461365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25001086|NCT05461261|Prednisolone|prednisolone|mesh-list
25001087|NCT05461261|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25048986|NCT00650702|Latanoprost|latanoprost|mesh-list
25049025|NCT00645177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049026|NCT00643383|Acetaminophen|acetaminophen|mesh-list
25001113|NCT05461235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25001114|NCT05461235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25001115|NCT05461235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25001116|NCT05461235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25001118|NCT05457647|Vitamin B Complex|vitamin b complex|mesh-ancestor
25001119|NCT05457647|Vitamins|vitamins|mesh-ancestor
25001120|NCT05457647|Micronutrients|micronutrients|mesh-ancestor
25001121|NCT05457647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25001122|NCT05457647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25001123|NCT05457647|Dermatologic Agents|dermatologic agents|mesh-ancestor
25001124|NCT05456230|Midazolam|midazolam|mesh-list
25001125|NCT05456230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25001126|NCT05456230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25001127|NCT05456230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25001128|NCT05456230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25001129|NCT05456230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25001130|NCT05456230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25001131|NCT05456230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25001132|NCT05456230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25001133|NCT05456230|Anesthetics, General|anesthetics, general|mesh-ancestor
25001134|NCT05456230|Anesthetics|anesthetics|mesh-ancestor
25001135|NCT05456230|GABA Modulators|gaba modulators|mesh-ancestor
25001136|NCT05456230|GABA Agents|gaba agents|mesh-ancestor
25001137|NCT05456230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25001138|NCT05456230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945802|NCT03946514|Losartan|losartan|mesh-list
25001152|NCT05443971|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25001153|NCT05443971|Immunoglobulin G|immunoglobulin g|mesh-list
25001154|NCT05443971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24644623|NCT01192165|Paclitaxel|paclitaxel|mesh-list
24644624|NCT01192165|Docetaxel|docetaxel|mesh-list
24644625|NCT01192165|Carboplatin|carboplatin|mesh-list
24644626|NCT01192165|Pemetrexed|pemetrexed|mesh-list
24644627|NCT01192165|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25049027|NCT00643383|Tramadol|tramadol|mesh-list
25001238|NCT05404048|Atezolizumab|atezolizumab|mesh-list
25001239|NCT05404048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774675|NCT01847326|Antimetabolites|antimetabolites|mesh-ancestor
25202638|NCT02720120|Ocrelizumab|ocrelizumab|mesh-list
25001389|NCT05342584|Daunorubicin|daunorubicin|mesh-list
25001390|NCT05342584|Venetoclax|venetoclax|mesh-list
25001391|NCT05342584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25001392|NCT05342584|Antimetabolites|antimetabolites|mesh-ancestor
25001403|NCT05342584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25001404|NCT05340309|Atezolizumab|atezolizumab|mesh-list
25001405|NCT05340309|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25001406|NCT05340309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25001407|NCT05340309|Immunologic Factors|immunologic factors|mesh-ancestor
25001408|NCT05340309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25001409|NCT05340257|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25001410|NCT05340257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25001411|NCT05340257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25001412|NCT05340257|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25663997|NCT01664533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25001413|NCT05340257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25663998|NCT01664533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25001414|NCT05340257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25001416|NCT05335356|Dermatologic Agents|dermatologic agents|mesh-ancestor
25001434|NCT05302271|Prednisone|prednisone|mesh-list
25001435|NCT05302271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25001436|NCT05302271|Glucocorticoids|glucocorticoids|mesh-ancestor
25001437|NCT05302271|Hormones|hormones|mesh-ancestor
25001438|NCT05302271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25001439|NCT05302271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25001460|NCT05296603|Lenvatinib|lenvatinib|mesh-list
25001461|NCT05296603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25001462|NCT05296603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25001463|NCT05296603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842729|NCT02223026|Protease Inhibitors|protease inhibitors|mesh-ancestor
24644638|NCT01192165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24644640|NCT01192230|Endostatins|endostatins|mesh-list
25852322|NCT00055965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24449256|NCT00314756|Imiquimod|imiquimod|mesh-list
24644647|NCT01192230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24644648|NCT01192230|Growth Substances|growth substances|mesh-ancestor
24644649|NCT01192230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644650|NCT01192230|Growth Inhibitors|growth inhibitors|mesh-ancestor
24644651|NCT01192243|Carboplatin|carboplatin|mesh-list
24644652|NCT01192243|Pemetrexed|pemetrexed|mesh-list
24644653|NCT01192243|Gefitinib|gefitinib|mesh-list
24644654|NCT01192243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644656|NCT01192243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25001493|NCT05294263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25001494|NCT05294263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202639|NCT02720120|Immunologic Factors|immunologic factors|mesh-ancestor
24644657|NCT01192243|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24644658|NCT01192243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24644659|NCT01192243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24644660|NCT01192308|Tamoxifen|tamoxifen|mesh-list
24644661|NCT01192308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25852323|NCT00055965|Antimetabolites|antimetabolites|mesh-ancestor
24644688|NCT01192503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644689|NCT01192529|Phentermine|phentermine|mesh-list
24644690|NCT01192529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24644691|NCT01192529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852324|NCT00055965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852325|NCT00055965|Antiviral Agents|antiviral agents|mesh-ancestor
25852326|NCT00055965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25852327|NCT00055965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852328|NCT00055965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25852329|NCT00055965|Immunologic Factors|immunologic factors|mesh-ancestor
25852330|NCT00055965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852331|NCT00055978|Celecoxib|celecoxib|mesh-list
25852332|NCT00055978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25852333|NCT00055978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24798499|NCT01963962|Levonorgestrel|levonorgestrel|mesh-list
24798500|NCT01963962|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24798501|NCT01963962|Contraceptive Agents|contraceptive agents|mesh-ancestor
24798502|NCT01963962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24798503|NCT01963962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798504|NCT01963962|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24798505|NCT01963962|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24798506|NCT01963962|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24798507|NCT01963962|Trace Elements|trace elements|mesh-ancestor
24798508|NCT01963962|Micronutrients|micronutrients|mesh-ancestor
24798510|NCT01964001|Coenzyme Q10|coenzyme q10|mesh-list
24798511|NCT01964001|Vitamin B 6|vitamin b 6|mesh-list
24798512|NCT01964001|Pyridoxal|pyridoxal|mesh-list
24798513|NCT01964001|Pyridoxine|pyridoxine|mesh-list
24798514|NCT01964001|Vitamin B Complex|vitamin b complex|mesh-list
24798515|NCT01964001|Ubiquinone|ubiquinone|mesh-list
24798516|NCT01964001|Micronutrients|micronutrients|mesh-ancestor
24798517|NCT01964001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798518|NCT01964027|Irinotecan|irinotecan|mesh-list
24798523|NCT01964027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039488|NCT03818828|Cadexomer iodine|cadexomer iodine|mesh-list
25039489|NCT03818828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25039490|NCT03818828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24798536|NCT01964040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24798537|NCT01964040|Analgesics|analgesics|mesh-ancestor
24798538|NCT01964040|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24798539|NCT01964040|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25241472|NCT01751126|Antifungal Agents|antifungal agents|mesh-ancestor
25241473|NCT01751126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25241474|NCT01751126|Dermatologic Agents|dermatologic agents|mesh-ancestor
25241475|NCT01751126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25274005|NCT02381184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24709214|NCT01504516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24842972|NCT02224768|Ipilimumab|ipilimumab|mesh-list
25852334|NCT00055978|Analgesics|analgesics|mesh-ancestor
25852335|NCT00055978|Sensory System Agents|sensory system agents|mesh-ancestor
25852336|NCT00055978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25852337|NCT00055978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202640|NCT02720120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852338|NCT00055978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25852339|NCT00055978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25852340|NCT00055978|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25852341|NCT00055978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25001659|NCT05227833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25001660|NCT05227833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25001661|NCT05227833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25001662|NCT05227833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25001663|NCT05227833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709332|NCT01505127|Amoxicillin|amoxicillin|mesh-list
25049097|NCT00635505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25001692|NCT05159778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25001693|NCT05159778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644704|NCT01192724|Cilostazol|cilostazol|mesh-list
24644705|NCT01192724|Clopidogrel|clopidogrel|mesh-list
24939564|NCT04008888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24939565|NCT04008888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24939566|NCT04008888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939567|NCT04008888|Protease Inhibitors|protease inhibitors|mesh-ancestor
25049099|NCT00635505|Adrenergic Agents|adrenergic agents|mesh-ancestor
25049100|NCT00635505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25049101|NCT00635505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049102|NCT00635193|Doxorubicin|doxorubicin|mesh-list
25049103|NCT00635193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25049104|NCT00635193|Volociximab|volociximab|mesh-list
25039669|NCT03721965|Autonomic Agents|autonomic agents|mesh-ancestor
25039670|NCT03721965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039671|NCT03721965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25039672|NCT03721965|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25039673|NCT03721965|Protective Agents|protective agents|mesh-ancestor
25039674|NCT03720613|Naloxegol|naloxegol|mesh-list
25039675|NCT03720613|Lubiprostone|lubiprostone|mesh-list
25049105|NCT00635193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25049106|NCT00635193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25049119|NCT00634829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25049120|NCT00634829|Autonomic Agents|autonomic agents|mesh-ancestor
25049121|NCT00634829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25049122|NCT00634829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049123|NCT00634829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25049124|NCT00634829|Respiratory System Agents|respiratory system agents|mesh-ancestor
25049125|NCT00634829|Tocolytic Agents|tocolytic agents|mesh-ancestor
25049126|NCT00634829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25049127|NCT00634829|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25049128|NCT00634829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25049129|NCT00634829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25049130|NCT00634829|Adrenergic Agents|adrenergic agents|mesh-ancestor
25663999|NCT01664533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664000|NCT01664559|Ketorolac|ketorolac|mesh-list
25664001|NCT01664559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25664002|NCT01664559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25664003|NCT01664559|Analgesics|analgesics|mesh-ancestor
25049131|NCT00634829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25664004|NCT01664559|Sensory System Agents|sensory system agents|mesh-ancestor
25664005|NCT01664559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25664006|NCT01664559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664007|NCT01664559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25664008|NCT01664559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25664009|NCT01664559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25664010|NCT01664559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664011|NCT01664559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664012|NCT01664624|Exenatide|exenatide|mesh-list
25664013|NCT01664624|Alogliptin|alogliptin|mesh-list
25664014|NCT01664624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25241532|NCT05301530|Docetaxel|docetaxel|mesh-list
25241533|NCT05301530|Trastuzumab|trastuzumab|mesh-list
25241534|NCT05301530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25241535|NCT05301530|Tubulin Modulators|tubulin modulators|mesh-ancestor
25241536|NCT05301530|Antimitotic Agents|antimitotic agents|mesh-ancestor
25241537|NCT05301530|Mitosis Modulators|mitosis modulators|mesh-ancestor
25049132|NCT00634829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049133|NCT00634517|Albuterol|albuterol|mesh-list
25049134|NCT00634517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25049135|NCT00634517|Autonomic Agents|autonomic agents|mesh-ancestor
25049136|NCT00634517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24843148|NCT02225834|Atorvastatin|atorvastatin|mesh-list
24644706|NCT01192724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24644707|NCT01192724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24644708|NCT01192724|Analgesics|analgesics|mesh-ancestor
24644709|NCT01192724|Sensory System Agents|sensory system agents|mesh-ancestor
24644710|NCT01192724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24644711|NCT01192724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644712|NCT01192724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24644718|NCT01192724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24644756|NCT01192854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24644757|NCT01192854|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24644758|NCT01192854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24644759|NCT01192854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644760|NCT01192854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644761|NCT01192971|Apatinib|apatinib|mesh-list
24644762|NCT01192971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644763|NCT01192971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24644764|NCT01192971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644765|NCT01192971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644766|NCT01192984|Mogamulizumab|mogamulizumab|mesh-list
24644767|NCT01192984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644769|NCT01193166|Risperidone|risperidone|mesh-list
24644770|NCT01193166|Aripiprazole|aripiprazole|mesh-list
24644771|NCT01193166|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24644772|NCT01193166|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24644773|NCT01193166|Perphenazine|perphenazine|mesh-list
24644774|NCT01193166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24644775|NCT01193166|Serotonin Agents|serotonin agents|mesh-ancestor
24644776|NCT01193166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25049137|NCT00634517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049138|NCT00634517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25049139|NCT00634517|Respiratory System Agents|respiratory system agents|mesh-ancestor
25049140|NCT00634517|Tocolytic Agents|tocolytic agents|mesh-ancestor
25049141|NCT00634517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25049142|NCT00634517|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25049143|NCT00634517|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25049144|NCT00634517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25049145|NCT00634517|Adrenergic Agents|adrenergic agents|mesh-ancestor
25049146|NCT00634517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25202650|NCT02720341|Armin|armin|mesh-list
25202651|NCT02720341|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25202652|NCT02720341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202653|NCT02720341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202654|NCT02720341|Cholinergic Agents|cholinergic agents|mesh-ancestor
25202655|NCT02720341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25049147|NCT00634517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039753|NCT03684278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25039754|NCT03682770|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25039755|NCT03682770|Immunologic Factors|immunologic factors|mesh-ancestor
25039756|NCT03682770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039758|NCT03676751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25049148|NCT00633997|Vildagliptin|vildagliptin|mesh-list
25049149|NCT00633997|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25049150|NCT00633997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049151|NCT00633997|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25049152|NCT00633997|Protease Inhibitors|protease inhibitors|mesh-ancestor
25049153|NCT00633997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664015|NCT01664624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664016|NCT01664624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25664017|NCT01664624|Incretins|incretins|mesh-ancestor
25664018|NCT01664624|Hormones|hormones|mesh-ancestor
25664019|NCT01664624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25049154|NCT00633997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049155|NCT00631111|Aspirin|aspirin|mesh-list
25664020|NCT01664624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25852343|NCT00055978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241565|NCT05301023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25241566|NCT05301023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25241567|NCT05301023|Antitubercular Agents|antitubercular agents|mesh-ancestor
24483146|NCT00442026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24483147|NCT00442026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483148|NCT00442026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24483149|NCT00442026|Immunologic Factors|immunologic factors|mesh-ancestor
25852344|NCT00055991|Bexarotene|bexarotene|mesh-list
25852345|NCT00055991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25241568|NCT05301010|Docetaxel|docetaxel|mesh-list
25241569|NCT05301010|Trastuzumab|trastuzumab|mesh-list
25049156|NCT00631111|Ascorbic Acid|ascorbic acid|mesh-list
25049157|NCT00631111|Ibuprofen|ibuprofen|mesh-list
25049158|NCT00631111|Vitamins|vitamins|mesh-ancestor
25049159|NCT00631111|Micronutrients|micronutrients|mesh-ancestor
24603060|NCT00972218|Adalimumab|adalimumab|mesh-list
24644954|NCT01194232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644778|NCT01193166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644779|NCT01193166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24644780|NCT01193166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24644781|NCT01193166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24644782|NCT01193166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24644783|NCT01193166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24644784|NCT01193166|Dopamine Agents|dopamine agents|mesh-ancestor
24644790|NCT01193166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24644791|NCT01193166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24644792|NCT01193166|Antidepressive Agents|antidepressive agents|mesh-ancestor
24644793|NCT01193166|Dopamine Agonists|dopamine agonists|mesh-ancestor
24644794|NCT01193166|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25852346|NCT00056004|Zileuton|zileuton|mesh-list
25852347|NCT00056004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25049172|NCT00631111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25049173|NCT00631111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049175|NCT00631111|Antioxidants|antioxidants|mesh-ancestor
25049176|NCT00631111|Protective Agents|protective agents|mesh-ancestor
25049178|NCT00630799|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25049179|NCT00630799|Fertility Agents|fertility agents|mesh-ancestor
25049180|NCT00630799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25049181|NCT00630799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049182|NCT00630799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25049183|NCT00630799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25049184|NCT00630656|Talactoferrin alfa|talactoferrin alfa|mesh-list
25049185|NCT00630656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25049186|NCT00630552|Conatumumab|conatumumab|mesh-list
25049187|NCT00630552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25049188|NCT00630552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25049189|NCT00630201|Buprenorphine|buprenorphine|mesh-list
25049190|NCT00630201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25049191|NCT00630201|Narcotics|narcotics|mesh-ancestor
24644828|NCT01193400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644829|NCT01193400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25049192|NCT00630201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25049193|NCT00630201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644855|NCT01193478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24644856|NCT01193491|Geldanamycin|geldanamycin|mesh-list
24644857|NCT01193491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24644858|NCT01193491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644859|NCT01193491|Antiviral Agents|antiviral agents|mesh-ancestor
24644860|NCT01193491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24644861|NCT01193491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664021|NCT01664624|Protease Inhibitors|protease inhibitors|mesh-ancestor
25664022|NCT01664624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664023|NCT01664624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664024|NCT01664741|Nicotine|nicotine|mesh-list
25664025|NCT01664741|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25664026|NCT01664741|Autonomic Agents|autonomic agents|mesh-ancestor
25664027|NCT01664741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25664028|NCT01664741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664029|NCT01664741|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24644862|NCT01193491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644863|NCT01193491|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
24644864|NCT01193491|Protease Inhibitors|protease inhibitors|mesh-ancestor
24757853|NCT01742689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422536|NCT00222833|Aripiprazole|aripiprazole|mesh-list
24757920|NCT01742988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24757921|NCT01742988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24757922|NCT01742988|Immunologic Factors|immunologic factors|mesh-ancestor
24757923|NCT01742988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644865|NCT01193504|Loteprednol Etabonate|loteprednol etabonate|mesh-list
24644866|NCT01193504|Prednisolone acetate|prednisolone acetate|mesh-list
24644867|NCT01193504|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24644868|NCT01193504|Methylprednisolone|methylprednisolone|mesh-list
24644869|NCT01193504|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24644870|NCT01193504|Prednisolone|prednisolone|mesh-list
24644871|NCT01193504|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24644872|NCT01193504|Prednisolone phosphate|prednisolone phosphate|mesh-list
24644873|NCT01193504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24644874|NCT01193504|Antiemetics|antiemetics|mesh-ancestor
24644875|NCT01193504|Autonomic Agents|autonomic agents|mesh-ancestor
24644876|NCT01193504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25852348|NCT00056004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24644942|NCT01194037|Immunologic Factors|immunologic factors|mesh-ancestor
24644943|NCT01194037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644946|NCT01194115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24644947|NCT01194115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24644948|NCT01194115|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24644949|NCT01194115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24644950|NCT01194232|Sildenafil Citrate|sildenafil citrate|mesh-list
24644951|NCT01194232|Vasodilator Agents|vasodilator agents|mesh-ancestor
24644952|NCT01194232|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24644953|NCT01194232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25049214|NCT00629551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049215|NCT00629551|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25049216|NCT00629551|Antidepressive Agents|antidepressive agents|mesh-ancestor
25049217|NCT00629551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25049218|NCT00629551|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25049222|NCT00626704|Conatumumab|conatumumab|mesh-list
25049223|NCT00626704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25049224|NCT00626704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644972|NCT01194336|Autonomic Agents|autonomic agents|mesh-ancestor
24644994|NCT01194778|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24644995|NCT01194778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852349|NCT00056004|Analgesics|analgesics|mesh-ancestor
24644998|NCT01194791|Dexamethasone|dexamethasone|mesh-list
24644999|NCT01194791|Cyclophosphamide|cyclophosphamide|mesh-list
24645000|NCT01194791|Lenalidomide|lenalidomide|mesh-list
24645001|NCT01194791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24645002|NCT01194791|Immunologic Factors|immunologic factors|mesh-ancestor
24645003|NCT01194791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645004|NCT01194791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24645005|NCT01194791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24645006|NCT01194791|Alkylating Agents|alkylating agents|mesh-ancestor
24645007|NCT01194791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645008|NCT01194791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939871|NCT04006054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24710184|NCT01508858|Liraglutide|liraglutide|mesh-list
24710332|NCT01509560|Immunologic Factors|immunologic factors|mesh-ancestor
24710343|NCT01509755|Glimepiride|glimepiride|mesh-list
24710344|NCT01509755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25050746|NCT00468442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25050747|NCT00468442|Antifungal Agents|antifungal agents|mesh-ancestor
24939872|NCT04006054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24939873|NCT04006054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24939874|NCT04006054|Anesthetics, General|anesthetics, general|mesh-ancestor
24939875|NCT04006054|Anesthetics|anesthetics|mesh-ancestor
24939876|NCT04006054|GABA Modulators|gaba modulators|mesh-ancestor
24939877|NCT04006054|GABA Agents|gaba agents|mesh-ancestor
24939879|NCT04005872|Fluorides|fluorides|mesh-list
24939880|NCT04005872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25664030|NCT01664741|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25664031|NCT01664741|Cholinergic Agents|cholinergic agents|mesh-ancestor
25664032|NCT01664741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25664033|NCT01664741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664034|NCT01664858|Calcium|calcium|mesh-list
25664035|NCT01664858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25852350|NCT00056004|Sensory System Agents|sensory system agents|mesh-ancestor
24939882|NCT04005872|Cariostatic Agents|cariostatic agents|mesh-ancestor
24939883|NCT04005872|Protective Agents|protective agents|mesh-ancestor
24798560|NCT01964157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798561|NCT01964170|Goserelin|goserelin|mesh-list
24798562|NCT01964170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24798563|NCT01964170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24798564|NCT01964183|Mirabegron|mirabegron|mesh-list
24798565|NCT01964183|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24592296|NCT00921167|Growth Inhibitors|growth inhibitors|mesh-ancestor
24798566|NCT01964183|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24798567|NCT01964183|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24798568|NCT01964183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24798569|NCT01964183|Adrenergic Agents|adrenergic agents|mesh-ancestor
24798570|NCT01964183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24798571|NCT01964183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843546|NCT02228083|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24843547|NCT02228083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24843548|NCT02228083|Autonomic Agents|autonomic agents|mesh-ancestor
24843549|NCT02228083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24843550|NCT02228083|Respiratory System Agents|respiratory system agents|mesh-ancestor
24645017|NCT01194791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24645018|NCT01194791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24798572|NCT01964183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798584|NCT01964248|Sensory System Agents|sensory system agents|mesh-ancestor
24798585|NCT01964248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24798586|NCT01964248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24798587|NCT01964248|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24798588|NCT01964248|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24798589|NCT01964248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24798590|NCT01964248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798591|NCT01964248|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25050748|NCT00468442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24798594|NCT01964287|Paclitaxel|paclitaxel|mesh-list
24798595|NCT01964287|Oxaliplatin|oxaliplatin|mesh-list
24843572|NCT02228239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24645077|NCT01195428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24645078|NCT01195428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24645079|NCT01195454|Insulin|insulin|mesh-list
24645080|NCT01195454|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24645081|NCT01195454|Insulin Glargine|insulin glargine|mesh-list
24645082|NCT01195454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24645083|NCT01195454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645084|NCT01195493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24645085|NCT01195571|Vaccines|vaccines|mesh-list
24645086|NCT01195571|Immunologic Factors|immunologic factors|mesh-ancestor
24645087|NCT01195571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645088|NCT01195649|Sorafenib|sorafenib|mesh-list
24645089|NCT01195649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852351|NCT00056004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25002170|NCT04852224|Goserelin|goserelin|mesh-list
25002171|NCT04852224|Androgens|androgens|mesh-list
25002172|NCT04852224|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25002173|NCT04852224|Fertility Agents|fertility agents|mesh-ancestor
25002174|NCT04852224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25002175|NCT04852224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25002176|NCT04852224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24710384|NCT01510093|Insulin Aspart|insulin aspart|mesh-list
25002177|NCT04852224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25002178|NCT04852224|Hormones|hormones|mesh-ancestor
25002179|NCT04852224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24843583|NCT02228239|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24645121|NCT01195974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645123|NCT01196013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24645124|NCT01196013|Antimetabolites|antimetabolites|mesh-ancestor
24645125|NCT01196013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449515|NCT00315887|Buprenorphine|buprenorphine|mesh-list
24645126|NCT01196013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852352|NCT00056004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852353|NCT00056004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25852354|NCT00056004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25202675|NCT02719834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202676|NCT02719834|Antipyretics|antipyretics|mesh-ancestor
25202677|NCT02719808|Tenofovir|tenofovir|mesh-list
25202678|NCT02719808|Antiviral Agents|antiviral agents|mesh-ancestor
25202679|NCT02719808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25002293|NCT04747314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25002295|NCT04747314|Serotonin Agents|serotonin agents|mesh-ancestor
25002296|NCT04747314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25002297|NCT04747314|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25002298|NCT04747314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24843715|NCT02228928|Capsaicin|capsaicin|mesh-list
24645149|NCT01196234|Tubulin Modulators|tubulin modulators|mesh-ancestor
24645150|NCT01196234|Antimitotic Agents|antimitotic agents|mesh-ancestor
24645151|NCT01196234|Mitosis Modulators|mitosis modulators|mesh-ancestor
24645152|NCT01196234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645153|NCT01196234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24645154|NCT01196234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24645155|NCT01196260|Capecitabine|capecitabine|mesh-list
24645156|NCT01196260|Oxaliplatin|oxaliplatin|mesh-list
24645157|NCT01196260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24645158|NCT01196260|Antimetabolites|antimetabolites|mesh-ancestor
24645190|NCT01196507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24645192|NCT01196507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24645193|NCT01196507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645194|NCT01196507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645195|NCT01196507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24645196|NCT01196507|Antioxidants|antioxidants|mesh-ancestor
25202680|NCT02719808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24710471|NCT01510626|Omalizumab|omalizumab|mesh-list
24710559|NCT01511146|Alkylating Agents|alkylating agents|mesh-ancestor
24710560|NCT01511146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24710562|NCT01511159|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24710563|NCT01511159|Liraglutide|liraglutide|mesh-list
24710564|NCT01511159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24589201|NCT00906113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589202|NCT00906113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589203|NCT00906113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24589204|NCT00906113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24589205|NCT00906113|Immunologic Factors|immunologic factors|mesh-ancestor
24589206|NCT00906113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589208|NCT00906126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25040359|NCT03148860|Ustekinumab|ustekinumab|mesh-list
25040360|NCT03148860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25040361|NCT03148860|Abortifacient Agents|abortifacient agents|mesh-ancestor
25040362|NCT03148860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24645203|NCT01196507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24645205|NCT01196546|Vildagliptin|vildagliptin|mesh-list
24645238|NCT01196767|Anesthetics, Local|anesthetics, local|mesh-ancestor
24645247|NCT01197001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24645248|NCT01197001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24645249|NCT01197001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645250|NCT01197001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24645251|NCT01197001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852355|NCT00056004|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25002321|NCT04747314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25002322|NCT04747314|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25002323|NCT04747314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25002324|NCT04747314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25002325|NCT04747314|Adrenergic Agents|adrenergic agents|mesh-ancestor
25002326|NCT04747314|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25002335|NCT04724759|Lidocaine|lidocaine|mesh-list
25002336|NCT04724759|Dexmedetomidine|dexmedetomidine|mesh-list
25002337|NCT04724759|Ketamine|ketamine|mesh-list
25002338|NCT04724759|Anesthetics, Local|anesthetics, local|mesh-ancestor
25002339|NCT04724759|Anesthetics|anesthetics|mesh-ancestor
25049226|NCT00626704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25049227|NCT00626704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049228|NCT00626704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049229|NCT00626704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25852356|NCT00056004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049245|NCT00625833|Reboxetine|reboxetine|mesh-list
25049250|NCT00625833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25049251|NCT00625833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049252|NCT00625833|Adrenergic Agents|adrenergic agents|mesh-ancestor
25049253|NCT00625833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25049254|NCT00625833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049255|NCT00625664|Gemcitabine|gemcitabine|mesh-list
25202681|NCT02719808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25202682|NCT02719808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202683|NCT02719808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202684|NCT02719808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25202685|NCT02719808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25207759|NCT03421652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207760|NCT03421652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25207761|NCT03421652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829813|NCT02154646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829814|NCT02154646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24829815|NCT02154646|Immunologic Factors|immunologic factors|mesh-ancestor
24829816|NCT02154646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829817|NCT02154737|Gemcitabine|gemcitabine|mesh-list
24829818|NCT02154737|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24829819|NCT02154737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24829820|NCT02154737|Antimetabolites|antimetabolites|mesh-ancestor
24829821|NCT02154737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829822|NCT02154737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24829823|NCT02154737|Antiviral Agents|antiviral agents|mesh-ancestor
24829824|NCT02154737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24829825|NCT02154737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829826|NCT02154737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24829827|NCT02154737|Immunologic Factors|immunologic factors|mesh-ancestor
24710687|NCT01511562|Cytarabine|cytarabine|mesh-list
25049261|NCT00625664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25049262|NCT00625664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049263|NCT00625664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25049264|NCT00625664|Immunologic Factors|immunologic factors|mesh-ancestor
25049265|NCT00625664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049266|NCT00625651|Bevacizumab|bevacizumab|mesh-list
25002340|NCT04724759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25002341|NCT04724759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25002342|NCT04724759|Sensory System Agents|sensory system agents|mesh-ancestor
25002343|NCT04724759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25002344|NCT04724759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25002345|NCT04724759|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25002346|NCT04724759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25002347|NCT04724759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25002348|NCT04724759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645277|NCT01197040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24645320|NCT01197261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25002349|NCT04724759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25002350|NCT04724759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25002351|NCT04724759|Analgesics|analgesics|mesh-ancestor
25002352|NCT04724759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25002353|NCT04724759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25002354|NCT04724759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25002355|NCT04724759|Adrenergic Agents|adrenergic agents|mesh-ancestor
25002356|NCT04724759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25002357|NCT04724759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25002358|NCT04724759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25002359|NCT04724759|Anesthetics, General|anesthetics, general|mesh-ancestor
25002360|NCT04724759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25002361|NCT04724759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24843836|NCT02229773|Pravastatin|pravastatin|mesh-list
24645322|NCT01197261|Sensory System Agents|sensory system agents|mesh-ancestor
25202686|NCT02719574|Cytarabine|cytarabine|mesh-list
25202687|NCT02719574|Azacitidine|azacitidine|mesh-list
25202688|NCT02719574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25202689|NCT02719574|Antimetabolites|antimetabolites|mesh-ancestor
25202690|NCT02719574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202691|NCT02719574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25202692|NCT02719574|Antiviral Agents|antiviral agents|mesh-ancestor
25202693|NCT02719574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25202694|NCT02719574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25852357|NCT00056004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852358|NCT00056004|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24758738|NCT01747616|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24758739|NCT01747616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24758740|NCT01747616|Antiviral Agents|antiviral agents|mesh-ancestor
24758741|NCT01747616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24758742|NCT01747616|Expectorants|expectorants|mesh-ancestor
24758743|NCT01747616|Respiratory System Agents|respiratory system agents|mesh-ancestor
25852359|NCT00056004|Hormone Antagonists|hormone antagonists|mesh-ancestor
25852360|NCT00056004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24758744|NCT01747616|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24758745|NCT01747616|Antioxidants|antioxidants|mesh-ancestor
24758747|NCT01747616|Protective Agents|protective agents|mesh-ancestor
25202695|NCT02719574|Immunologic Factors|immunologic factors|mesh-ancestor
25202696|NCT02719574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202697|NCT02719574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202699|NCT02719405|Chelating Agents|chelating agents|mesh-ancestor
25202700|NCT02719405|Sequestering Agents|sequestering agents|mesh-ancestor
24645323|NCT01197261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24645324|NCT01197261|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24645325|NCT01197469|Tadalafil|tadalafil|mesh-list
24645326|NCT01197469|Vasodilator Agents|vasodilator agents|mesh-ancestor
24645327|NCT01197469|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24645328|NCT01197469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24645329|NCT01197469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24645330|NCT01197469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645331|NCT01197469|Urological Agents|urological agents|mesh-ancestor
24645332|NCT01197664|Fluorouracil|fluorouracil|mesh-list
24645333|NCT01197664|Antimetabolites|antimetabolites|mesh-ancestor
24645334|NCT01197664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645335|NCT01197664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24645336|NCT01197664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24645337|NCT01197664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24645338|NCT01197664|Immunologic Factors|immunologic factors|mesh-ancestor
24946994|NCT03933605|Antiemetics|antiemetics|mesh-ancestor
24645402|NCT01198210|Antiemetics|antiemetics|mesh-ancestor
24645403|NCT01198210|Autonomic Agents|autonomic agents|mesh-ancestor
24645404|NCT01198210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25852361|NCT00056030|Leucovorin|leucovorin|mesh-list
25852362|NCT00056030|Fluorouracil|fluorouracil|mesh-list
25852363|NCT00056030|Oxaliplatin|oxaliplatin|mesh-list
25852364|NCT00056030|Cetuximab|cetuximab|mesh-list
25852365|NCT00056030|Calcium|calcium|mesh-list
25852366|NCT00056030|Levoleucovorin|levoleucovorin|mesh-list
25852367|NCT00056030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25852368|NCT00056030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852369|NCT00056030|Antimetabolites|antimetabolites|mesh-ancestor
25852370|NCT00056030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645405|NCT01198210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645406|NCT01198210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24645407|NCT01198210|Glucocorticoids|glucocorticoids|mesh-ancestor
24645408|NCT01198210|Hormones|hormones|mesh-ancestor
24645409|NCT01198210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24645410|NCT01198210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24645424|NCT01198210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24645425|NCT01198223|Nystatin|nystatin|mesh-list
24645426|NCT01198223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24645427|NCT01198223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24645428|NCT01198223|Antifungal Agents|antifungal agents|mesh-ancestor
24645429|NCT01198223|Ionophores|ionophores|mesh-ancestor
24645430|NCT01198223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24645431|NCT01198223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645433|NCT01198236|Antifungal Agents|antifungal agents|mesh-ancestor
24645434|NCT01198236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25409430|NCT03382561|Keratolytic Agents|keratolytic agents|mesh-ancestor
25664036|NCT01664858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664037|NCT01664897|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25664038|NCT01664897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664039|NCT01664897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25664040|NCT01664897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664041|NCT01664897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664042|NCT01664923|Bicalutamide|bicalutamide|mesh-list
25664043|NCT01664923|Androgen Antagonists|androgen antagonists|mesh-ancestor
25664044|NCT01664923|Hormone Antagonists|hormone antagonists|mesh-ancestor
25852371|NCT00056030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25852372|NCT00056030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852373|NCT00056030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25852374|NCT00056030|Immunologic Factors|immunologic factors|mesh-ancestor
25852375|NCT00056030|Antidotes|antidotes|mesh-ancestor
25852376|NCT00056030|Protective Agents|protective agents|mesh-ancestor
25852377|NCT00056030|Vitamin B Complex|vitamin b complex|mesh-ancestor
25852378|NCT00056030|Vitamins|vitamins|mesh-ancestor
25852379|NCT00056030|Micronutrients|micronutrients|mesh-ancestor
25852380|NCT00056030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25852381|NCT00056056|Bexarotene|bexarotene|mesh-list
25852382|NCT00056056|Methoxsalen|methoxsalen|mesh-list
25852383|NCT00056056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852384|NCT00056056|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25852385|NCT00056056|Dermatologic Agents|dermatologic agents|mesh-ancestor
25852386|NCT00056082|Celecoxib|celecoxib|mesh-list
25852387|NCT00056082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24645435|NCT01198236|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24829828|NCT02154737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940060|NCT04004117|Anesthetics|anesthetics|mesh-ancestor
24645534|NCT01198496|Natriuretic Agents|natriuretic agents|mesh-ancestor
24645535|NCT01198535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24645536|NCT01198535|Cetuximab|cetuximab|mesh-list
24645537|NCT01198535|Antibodies|antibodies|mesh-list
24645538|NCT01198535|Immunoglobulins|immunoglobulins|mesh-list
24645539|NCT01198535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24645540|NCT01198535|R04929097|r04929097|mesh-list
24645541|NCT01198535|Immunologic Factors|immunologic factors|mesh-ancestor
24645542|NCT01198535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645543|NCT01198535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24645544|NCT01198535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24645545|NCT01198535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645546|NCT01198639|Remifentanil|remifentanil|mesh-list
24645582|NCT01198782|Lubricant Eye Drops|lubricant eye drops|mesh-list
24645583|NCT01198782|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24645584|NCT01198821|Gemcitabine|gemcitabine|mesh-list
24645585|NCT01198821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24645586|NCT01198821|Antimetabolites|antimetabolites|mesh-ancestor
24645587|NCT01198821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645588|NCT01198821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25002497|NCT04604782|Regadenoson|regadenoson|mesh-list
25002498|NCT04604782|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25002499|NCT04604782|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25002500|NCT04604782|Purinergic Agonists|purinergic agonists|mesh-ancestor
25002501|NCT04604782|Purinergic Agents|purinergic agents|mesh-ancestor
25002502|NCT04604782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25002503|NCT04604782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764881|NCT01784900|Catumaxomab|catumaxomab|mesh-list
25202701|NCT02719405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027145|NCT03622450|Meropenem|meropenem|mesh-list
25002524|NCT04573946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25002525|NCT04573946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25002526|NCT04573946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25002566|NCT04518462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25002567|NCT04518462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25002568|NCT04518462|Sensory System Agents|sensory system agents|mesh-ancestor
25002569|NCT04518462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25002570|NCT04505254|Obinutuzumab|obinutuzumab|mesh-list
25002571|NCT04505254|Acalabrutinib|acalabrutinib|mesh-list
25002572|NCT04505254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25002573|NCT04505254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24645613|NCT01198912|Antimalarials|antimalarials|mesh-ancestor
24645614|NCT01198912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24645615|NCT01198912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24645616|NCT01198925|Piperacillin|piperacillin|mesh-list
24645617|NCT01198925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25664045|NCT01664923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25664046|NCT01664923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664047|NCT01664923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664048|NCT01664949|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25664049|NCT01664949|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25664050|NCT01664949|Lubricant Eye Drops|lubricant eye drops|mesh-list
25664051|NCT01664949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25664052|NCT01664949|Laxatives|laxatives|mesh-ancestor
25664053|NCT01664949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25664054|NCT01665508|Nebivolol|nebivolol|mesh-list
25852388|NCT00056082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25852389|NCT00056082|Analgesics|analgesics|mesh-ancestor
25852390|NCT00056082|Sensory System Agents|sensory system agents|mesh-ancestor
25852391|NCT00056082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25852392|NCT00056082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645618|NCT01198925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24645620|NCT01198938|Antioxidants|antioxidants|mesh-ancestor
25002601|NCT04490057|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25002602|NCT04490057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25002603|NCT04490057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25002605|NCT04490057|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25002606|NCT04490057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25002607|NCT04490057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25002611|NCT04471233|Pregabalin|pregabalin|mesh-list
25002612|NCT04471233|Analgesics|analgesics|mesh-ancestor
25002613|NCT04471233|Sensory System Agents|sensory system agents|mesh-ancestor
24645284|NCT01197144|Adalimumab|adalimumab|mesh-list
25002614|NCT04471233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25002615|NCT04471233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25002616|NCT04471233|Anticonvulsants|anticonvulsants|mesh-ancestor
25002617|NCT04471233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25002621|NCT04471233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25002622|NCT04471233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25002623|NCT04471233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25002624|NCT04471233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25202702|NCT02719418|Tinzaparin|tinzaparin|mesh-list
24589407|NCT00907270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24645639|NCT01199159|Vitamins|vitamins|mesh-ancestor
24645640|NCT01199159|Micronutrients|micronutrients|mesh-ancestor
24645641|NCT01199159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645642|NCT01199159|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24645643|NCT01199159|Abortifacient Agents|abortifacient agents|mesh-ancestor
24645644|NCT01199159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24645645|NCT01199159|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24645688|NCT01199367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24645689|NCT01199367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645690|NCT01199367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24645691|NCT01199367|Hormone Antagonists|hormone antagonists|mesh-ancestor
24645692|NCT01199367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24645693|NCT01199367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645695|NCT01199406|Levobupivacaine|levobupivacaine|mesh-list
24645696|NCT01199406|Anesthetics, Local|anesthetics, local|mesh-ancestor
24645697|NCT01199406|Anesthetics|anesthetics|mesh-ancestor
24646205|NCT01202474|Insulin Glargine|insulin glargine|mesh-list
24645733|NCT01199458|Anesthetics, General|anesthetics, general|mesh-ancestor
24645735|NCT01199510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24645736|NCT01199510|Lubricant Eye Drops|lubricant eye drops|mesh-list
24645737|NCT01199510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24645738|NCT01199523|Moxifloxacin|moxifloxacin|mesh-list
25002643|NCT04447781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844118|NCT02231320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24645739|NCT01199523|Mirabegron|mirabegron|mesh-list
24645740|NCT01199523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24645741|NCT01199523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24645742|NCT01199523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24645743|NCT01199523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25002668|NCT04416568|Nivolumab|nivolumab|mesh-list
25002669|NCT04416568|Ipilimumab|ipilimumab|mesh-list
25002670|NCT04416568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25002671|NCT04416568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25002672|NCT04416568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25002673|NCT04416568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25002674|NCT04412096|Timolol|timolol|mesh-list
25002675|NCT04412096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25002676|NCT04412096|Latanoprost|latanoprost|mesh-list
25002677|NCT04412096|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24844126|NCT02231333|Protective Agents|protective agents|mesh-ancestor
25664055|NCT01665508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25664056|NCT01665508|Vasodilator Agents|vasodilator agents|mesh-ancestor
25664057|NCT01665508|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25664058|NCT01665508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24645878|NCT01200537|Contraceptives, Oral|contraceptives, oral|mesh-list
24645879|NCT01200537|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
24645880|NCT01200537|Estradiol|estradiol|mesh-list
24645881|NCT01200537|Estrogens|estrogens|mesh-ancestor
25852393|NCT00056082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25852395|NCT00056082|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25852396|NCT00056082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25852397|NCT00056082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852398|NCT00056082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852399|NCT00056095|Cyclosporine|cyclosporine|mesh-list
24620519|NCT01057329|Sensory System Agents|sensory system agents|mesh-ancestor
24645882|NCT01200537|Hormones|hormones|mesh-ancestor
24645924|NCT01200706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24956959|NCT03848806|Vitamins|vitamins|mesh-ancestor
24711653|NCT01516554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24711654|NCT01516554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24711655|NCT01516554|Anabolic Agents|anabolic agents|mesh-ancestor
24711656|NCT01516567|Cyclophosphamide|cyclophosphamide|mesh-list
24645925|NCT01200706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24645927|NCT01200732|Vasodilator Agents|vasodilator agents|mesh-ancestor
24645928|NCT01200732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24645929|NCT01200732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24645930|NCT01200732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24645931|NCT01200732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645932|NCT01200732|Urological Agents|urological agents|mesh-ancestor
24607762|NCT03735979|Antithrombins|antithrombins|mesh-ancestor
25049279|NCT00624858|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25049280|NCT00624858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25049281|NCT00624858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049282|NCT00624858|Sensory System Agents|sensory system agents|mesh-ancestor
24645999|NCT01201161|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24646000|NCT01201161|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24646001|NCT01201161|Growth Substances|growth substances|mesh-ancestor
24646002|NCT01201161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646003|NCT01201161|Growth Inhibitors|growth inhibitors|mesh-ancestor
24646004|NCT01201161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25002791|NCT04313959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24844208|NCT02231788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24844209|NCT02231788|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24844214|NCT02231788|Vasodilator Agents|vasodilator agents|mesh-ancestor
24646044|NCT01201551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646045|NCT01201551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646046|NCT01201577|Azithromycin|azithromycin|mesh-list
24711754|NCT01516814|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24711755|NCT01516814|Antithrombins|antithrombins|mesh-ancestor
24711756|NCT01516814|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24711757|NCT01516814|Protease Inhibitors|protease inhibitors|mesh-ancestor
24646047|NCT01201577|Sulfalene|sulfalene|mesh-list
24826446|NCT02134366|GABA Agonists|gaba agonists|mesh-ancestor
25002849|NCT04257500|Estradiol|estradiol|mesh-list
25002850|NCT04257500|Estrogens|estrogens|mesh-ancestor
25002851|NCT04257500|Hormones|hormones|mesh-ancestor
25002852|NCT04257500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24940426|NCT04001608|Sofosbuvir|sofosbuvir|mesh-list
24940427|NCT04001608|Antiviral Agents|antiviral agents|mesh-ancestor
24940428|NCT04001608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24940429|NCT04001465|Methacholine Chloride|methacholine chloride|mesh-list
24940430|NCT04001465|Miotics|miotics|mesh-ancestor
24940431|NCT04001465|Autonomic Agents|autonomic agents|mesh-ancestor
24940432|NCT04001465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24940433|NCT04001465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940434|NCT04001465|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24940435|NCT04001465|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
24646108|NCT01202084|Respiratory System Agents|respiratory system agents|mesh-ancestor
24646109|NCT01202084|Dermatologic Agents|dermatologic agents|mesh-ancestor
24646110|NCT01202084|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24646111|NCT01202084|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24646112|NCT01202084|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24646113|NCT01202084|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24646114|NCT01202084|Adrenergic Agents|adrenergic agents|mesh-ancestor
24646115|NCT01202084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25664059|NCT01665508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25664060|NCT01665508|Adrenergic Agents|adrenergic agents|mesh-ancestor
25664061|NCT01665508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25664062|NCT01665508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664063|NCT01665508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664064|NCT01665599|Testosterone|testosterone|mesh-list
25409431|NCT03382561|Dermatologic Agents|dermatologic agents|mesh-ancestor
24646116|NCT01202084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646118|NCT01202097|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24646119|NCT01202097|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24646120|NCT01202097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24646121|NCT01202097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25202703|NCT02719418|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24646123|NCT01202097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24646125|NCT01202097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24646126|NCT01202097|Respiratory System Agents|respiratory system agents|mesh-ancestor
24646127|NCT01202097|Dermatologic Agents|dermatologic agents|mesh-ancestor
24646135|NCT01202097|Glucocorticoids|glucocorticoids|mesh-ancestor
24646138|NCT01202097|Sympathomimetics|sympathomimetics|mesh-ancestor
24646139|NCT01202149|Pimecrolimus|pimecrolimus|mesh-list
24646193|NCT01202435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646195|NCT01202435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24646196|NCT01202435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24646197|NCT01202435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646198|NCT01202435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24646199|NCT01202435|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24646200|NCT01202435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24646201|NCT01202435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24646202|NCT01202435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24646203|NCT01202474|Insulin|insulin|mesh-list
24646204|NCT01202474|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24646286|NCT01203020|Vidarabine|vidarabine|mesh-list
24646287|NCT01203020|Fludarabine|fludarabine|mesh-list
24646337|NCT01203254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646385|NCT01203384|Sensory System Agents|sensory system agents|mesh-ancestor
24646386|NCT01203384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24646387|NCT01203384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646388|NCT01203384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24646434|NCT01203709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646453|NCT01203982|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24646454|NCT01203982|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24646455|NCT01203982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24646456|NCT01203982|Antimetabolites|antimetabolites|mesh-ancestor
24646457|NCT01203982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646458|NCT01203982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24646459|NCT01203982|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24646460|NCT01203982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646461|NCT01204086|Fluoxetine|fluoxetine|mesh-list
24646462|NCT01204086|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25202704|NCT02719418|Dalteparin|dalteparin|mesh-list
25202705|NCT02719418|Anticoagulants|anticoagulants|mesh-ancestor
24853580|NCT02269072|Testosterone|testosterone|mesh-list
24646463|NCT01204086|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24646464|NCT01204086|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25002932|NCT04191616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24646501|NCT01204125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646502|NCT01204125|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24646503|NCT01204125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646505|NCT01204138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24646506|NCT01204138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24646562|NCT01204307|Tubulin Modulators|tubulin modulators|mesh-ancestor
24646563|NCT01204307|Antimitotic Agents|antimitotic agents|mesh-ancestor
24646564|NCT01204307|Mitosis Modulators|mitosis modulators|mesh-ancestor
24646619|NCT01204437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646620|NCT01204437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24646621|NCT01204437|Immunologic Factors|immunologic factors|mesh-ancestor
24646622|NCT01204437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646623|NCT01204437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24646624|NCT01204437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24646625|NCT01204437|Alkylating Agents|alkylating agents|mesh-ancestor
24646626|NCT01204437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24646627|NCT01204437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24646628|NCT01204437|Antimetabolites|antimetabolites|mesh-ancestor
24646629|NCT01204437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24646630|NCT01204437|Abortifacient Agents|abortifacient agents|mesh-ancestor
24646631|NCT01204437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24646632|NCT01204437|Dermatologic Agents|dermatologic agents|mesh-ancestor
24646633|NCT01204437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852400|NCT00056095|Cyclophosphamide|cyclophosphamide|mesh-list
24646634|NCT01204437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24646635|NCT01204437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24646636|NCT01204437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24646637|NCT01204437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24646654|NCT01204450|Antimanic Agents|antimanic agents|mesh-ancestor
24646655|NCT01204450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24646656|NCT01204450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24646657|NCT01204450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25002950|NCT04166942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25002951|NCT04166942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25002952|NCT04145674|Methadone|methadone|mesh-list
25002953|NCT04145674|D-methadone|d-methadone|mesh-list
25002954|NCT04145674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25002955|NCT04145674|Narcotics|narcotics|mesh-ancestor
25002956|NCT04145674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24464380|NCT00364559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24712105|NCT01518608|Alfentanil|alfentanil|mesh-list
24712106|NCT01518608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24712118|NCT01518621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24647026|NCT01205997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25049304|NCT00622063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202706|NCT02719418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24798613|NCT01964287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24645361|NCT01198054|Growth Inhibitors|growth inhibitors|mesh-ancestor
24798614|NCT01964287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24798615|NCT01964287|Antidotes|antidotes|mesh-ancestor
24798616|NCT01964287|Protective Agents|protective agents|mesh-ancestor
24798617|NCT01964287|Vitamin B Complex|vitamin b complex|mesh-ancestor
24798618|NCT01964287|Vitamins|vitamins|mesh-ancestor
24798619|NCT01964287|Micronutrients|micronutrients|mesh-ancestor
24798620|NCT01964365|Fenofibric acid|fenofibric acid|mesh-list
24798621|NCT01964365|Fenofibrate|fenofibrate|mesh-list
24798622|NCT01964365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24798623|NCT01964365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24592369|NCT00921505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24592370|NCT00921505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592371|NCT00921505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844428|NCT02232685|Choline|choline|mesh-list
24646665|NCT01204476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24646666|NCT01204476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24646667|NCT01204580|Metformin|metformin|mesh-list
24646668|NCT01204580|Glimepiride|glimepiride|mesh-list
24646669|NCT01204580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24646670|NCT01204580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646671|NCT01204580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24646672|NCT01204580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24592372|NCT00921531|Thalidomide|thalidomide|mesh-list
24592373|NCT00921531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24592374|NCT00921531|Immunologic Factors|immunologic factors|mesh-ancestor
24592375|NCT00921531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592376|NCT00921531|Leprostatic Agents|leprostatic agents|mesh-ancestor
24592377|NCT00921531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24592384|NCT00921570|Amlodipine|amlodipine|mesh-list
24798624|NCT01964365|Antimetabolites|antimetabolites|mesh-ancestor
25003006|NCT04124614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25003007|NCT04124614|Serotonin Agents|serotonin agents|mesh-ancestor
25003008|NCT04124614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25003009|NCT04124614|Dopamine Agonists|dopamine agonists|mesh-ancestor
25003010|NCT04124614|Dopamine Agents|dopamine agents|mesh-ancestor
24614465|NCT01024322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24646676|NCT01204593|Insulin Glargine|insulin glargine|mesh-list
24646677|NCT01204593|Insulin glulisine|insulin glulisine|mesh-list
24646695|NCT01204801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24646696|NCT01204801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646697|NCT01204801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646698|NCT01204840|Hormones|hormones|mesh-list
24646699|NCT01204840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24646869|NCT01205321|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
24646871|NCT01205321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24646872|NCT01205321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646873|NCT01205321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25003092|NCT04032665|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25003094|NCT04032665|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25664065|NCT01665599|Androgens|androgens|mesh-ancestor
25003095|NCT04032665|Protease Inhibitors|protease inhibitors|mesh-ancestor
25664066|NCT01665599|Hormones|hormones|mesh-ancestor
25852401|NCT00056095|Fludarabine|fludarabine|mesh-list
25852402|NCT00056095|Fludarabine phosphate|fludarabine phosphate|mesh-list
25003096|NCT04032665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25003097|NCT04032665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25003098|NCT04032665|Anticoagulants|anticoagulants|mesh-ancestor
24646995|NCT01205984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24646996|NCT01205984|Prednisolone|prednisolone|mesh-list
24646997|NCT01205984|Prednisolone acetate|prednisolone acetate|mesh-list
24646998|NCT01205984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24646999|NCT01205984|Prednisolone phosphate|prednisolone phosphate|mesh-list
25003176|NCT03959085|Antiviral Agents|antiviral agents|mesh-ancestor
25003177|NCT03959085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25003183|NCT03959085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25003185|NCT03959085|Antimitotic Agents|antimitotic agents|mesh-ancestor
25003186|NCT03959085|Mitosis Modulators|mitosis modulators|mesh-ancestor
25003187|NCT03959085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24647000|NCT01205984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24647001|NCT01205984|Antiemetics|antiemetics|mesh-ancestor
24647002|NCT01205984|Autonomic Agents|autonomic agents|mesh-ancestor
24647003|NCT01205984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24647004|NCT01205984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647005|NCT01205984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24647489|NCT01209065|Dolutegravir|dolutegravir|mesh-list
24647027|NCT01205997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24647028|NCT01205997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24647029|NCT01205997|Anesthetics, General|anesthetics, general|mesh-ancestor
24647031|NCT01205997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24647032|NCT01205997|Anticonvulsants|anticonvulsants|mesh-ancestor
24647033|NCT01205997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24647034|NCT01205997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24647035|NCT01205997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647036|NCT01205997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24647037|NCT01205997|Tocolytic Agents|tocolytic agents|mesh-ancestor
24647038|NCT01205997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24647039|NCT01206010|Varenicline|varenicline|mesh-list
24647040|NCT01206010|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24647041|NCT01206010|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24647042|NCT01206010|Cholinergic Agents|cholinergic agents|mesh-ancestor
24647043|NCT01206010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24647044|NCT01206010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647092|NCT01206205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24647097|NCT01206270|Methyltestosterone|methyltestosterone|mesh-list
24647098|NCT01206270|Castor Oil|castor oil|mesh-list
24647099|NCT01206270|Testosterone|testosterone|mesh-list
24647100|NCT01206270|Testosterone undecanoate|testosterone undecanoate|mesh-list
24647101|NCT01206270|Testosterone enanthate|testosterone enanthate|mesh-list
24647102|NCT01206270|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25049328|NCT00616811|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25049330|NCT00616811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049331|NCT00616811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049332|NCT00616798|Antipsychotic Agents|antipsychotic agents|mesh-list
25049333|NCT00616798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25003338|NCT03794778|Carboplatin|carboplatin|mesh-list
25003339|NCT03794778|Doxorubicin|doxorubicin|mesh-list
25003340|NCT03794778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25003341|NCT03794778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25003342|NCT03794778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25003343|NCT03794778|Tubulin Modulators|tubulin modulators|mesh-ancestor
25003344|NCT03794778|Antimitotic Agents|antimitotic agents|mesh-ancestor
25003345|NCT03794778|Mitosis Modulators|mitosis modulators|mesh-ancestor
25003346|NCT03794778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25003347|NCT03794778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25003348|NCT03794778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25003349|NCT03794778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25003350|NCT03794778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25003366|NCT03785340|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24844754|NCT02234193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24647176|NCT01206881|Cyclophosphamide|cyclophosphamide|mesh-list
24647177|NCT01206881|Docetaxel|docetaxel|mesh-list
24647178|NCT01206881|Doxorubicin|doxorubicin|mesh-list
24647179|NCT01206881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24647180|NCT01206881|Trastuzumab|trastuzumab|mesh-list
24647181|NCT01206881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24647182|NCT01206881|Immunologic Factors|immunologic factors|mesh-ancestor
24647183|NCT01206881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664067|NCT01665599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24647234|NCT01207128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24647235|NCT01207128|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24647236|NCT01207128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24647237|NCT01207128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25003367|NCT03785340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25003368|NCT03785340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25003369|NCT03785340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25003370|NCT03785340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25003371|NCT03785340|Adrenergic Agents|adrenergic agents|mesh-ancestor
25003372|NCT03785340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25003373|NCT03785340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25003374|NCT03785340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25003376|NCT03774810|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25003377|NCT03774810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25003378|NCT03774810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25003379|NCT03774810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25003380|NCT03774810|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25003381|NCT03774810|GABA Agonists|gaba agonists|mesh-ancestor
25003382|NCT03774810|GABA Agents|gaba agents|mesh-ancestor
25003383|NCT03774810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25003384|NCT03774810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25003388|NCT03739931|Durvalumab|durvalumab|mesh-list
24648291|NCT01213407|Temozolomide|temozolomide|mesh-list
25003389|NCT03739931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25852403|NCT00056095|Cyclosporins|cyclosporins|mesh-list
25003428|NCT03703271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25003429|NCT03703271|Antimetabolites|antimetabolites|mesh-ancestor
25003430|NCT03703271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25003431|NCT03703271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25003432|NCT03703271|Dermatologic Agents|dermatologic agents|mesh-ancestor
25003433|NCT03703271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25003434|NCT03703271|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25003435|NCT03703271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24647238|NCT01207128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647240|NCT01207128|Hormone Antagonists|hormone antagonists|mesh-ancestor
24647241|NCT01207128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24647242|NCT01207128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647243|NCT01207128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24647244|NCT01207206|Ketamine|ketamine|mesh-list
24647245|NCT01207206|Analgesics|analgesics|mesh-ancestor
24647246|NCT01207206|Sensory System Agents|sensory system agents|mesh-ancestor
24647247|NCT01207206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24647248|NCT01207206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647249|NCT01207206|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24647250|NCT01207206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24647251|NCT01207206|Anesthetics, General|anesthetics, general|mesh-ancestor
24647252|NCT01207206|Anesthetics|anesthetics|mesh-ancestor
24647253|NCT01207206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24647254|NCT01207206|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24647255|NCT01207206|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24647256|NCT01207206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25852404|NCT00056095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24647259|NCT01207245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24647260|NCT01207245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24647261|NCT01207297|Cyclophosphamide|cyclophosphamide|mesh-list
24647262|NCT01207297|Tacrolimus|tacrolimus|mesh-list
24647263|NCT01207297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24647264|NCT01207297|Immunologic Factors|immunologic factors|mesh-ancestor
24647265|NCT01207297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647266|NCT01207297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24647267|NCT01207297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24647318|NCT01207947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25003438|NCT03703271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25049349|NCT00615251|Progesterone|progesterone|mesh-list
25049350|NCT00615251|Progestins|progestins|mesh-ancestor
25003457|NCT03657264|Moxifloxacin|moxifloxacin|mesh-list
25003458|NCT03657264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25003500|NCT03601806|Growth Substances|growth substances|mesh-ancestor
24941030|NCT03995485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24941031|NCT03995563|Dexamethasone|dexamethasone|mesh-list
24941032|NCT03995563|Ropivacaine|ropivacaine|mesh-list
24941033|NCT03995563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24941034|NCT03995563|Antiemetics|antiemetics|mesh-ancestor
24941035|NCT03995563|Autonomic Agents|autonomic agents|mesh-ancestor
24941038|NCT03995563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24941039|NCT03995563|Glucocorticoids|glucocorticoids|mesh-ancestor
24941040|NCT03995563|Hormones|hormones|mesh-ancestor
24941041|NCT03995563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24941042|NCT03995563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24941043|NCT03995563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941044|NCT03995563|Anesthetics, Local|anesthetics, local|mesh-ancestor
24829831|NCT02154776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941045|NCT03995563|Anesthetics|anesthetics|mesh-ancestor
24941046|NCT03995563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24941047|NCT03995563|Sensory System Agents|sensory system agents|mesh-ancestor
24941048|NCT03995251|Testosterone|testosterone|mesh-list
24941049|NCT03995251|Androgens|androgens|mesh-ancestor
24941050|NCT03995251|Hormones|hormones|mesh-ancestor
24941051|NCT03995251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24941052|NCT03995251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765950|NCT01791608|Zinc|zinc|mesh-list
24647319|NCT01207947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647320|NCT01207947|Urological Agents|urological agents|mesh-ancestor
24798673|NCT01964534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24798675|NCT01964534|Immunologic Factors|immunologic factors|mesh-ancestor
24798676|NCT01964534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798678|NCT01964573|Dopamine Agonists|dopamine agonists|mesh-ancestor
24798679|NCT01964573|Dopamine Agents|dopamine agents|mesh-ancestor
24798680|NCT01964573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24844930|NCT02235324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647325|NCT01208012|Hormones|hormones|mesh-ancestor
24647326|NCT01208012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24647327|NCT01208090|Ponesimod|ponesimod|mesh-list
24647350|NCT01208441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647352|NCT01208441|Hormone Antagonists|hormone antagonists|mesh-ancestor
24647353|NCT01208441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24647354|NCT01208441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647355|NCT01208454|Vitamin A|vitamin a|mesh-list
24647356|NCT01208454|Vorinostat|vorinostat|mesh-list
24647357|NCT01208454|Tretinoin|tretinoin|mesh-list
24647358|NCT01208454|Isotretinoin|isotretinoin|mesh-list
24647359|NCT01208454|Vitamins|vitamins|mesh-ancestor
24647360|NCT01208454|Micronutrients|micronutrients|mesh-ancestor
24647415|NCT01208766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647417|NCT01208766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24647418|NCT01208766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24647419|NCT01208766|Growth Substances|growth substances|mesh-ancestor
24647420|NCT01208766|Growth Inhibitors|growth inhibitors|mesh-ancestor
25852405|NCT00056095|Immunologic Factors|immunologic factors|mesh-ancestor
24647421|NCT01208766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24647422|NCT01208766|Alkylating Agents|alkylating agents|mesh-ancestor
24647423|NCT01208766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798691|NCT01964586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798692|NCT01964586|Sensory System Agents|sensory system agents|mesh-ancestor
24798693|NCT01964586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25003501|NCT03601806|Growth Inhibitors|growth inhibitors|mesh-ancestor
25003502|NCT03601806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852406|NCT00056095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852407|NCT00056095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25852408|NCT00056095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25852409|NCT00056095|Alkylating Agents|alkylating agents|mesh-ancestor
25852410|NCT00056095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852411|NCT00056095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852412|NCT00056095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25202707|NCT02719418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25202708|NCT02719418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852413|NCT00056095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25852414|NCT00056095|Antimetabolites|antimetabolites|mesh-ancestor
25852415|NCT00056095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852416|NCT00056095|Antifungal Agents|antifungal agents|mesh-ancestor
25852417|NCT00056095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25852418|NCT00056095|Dermatologic Agents|dermatologic agents|mesh-ancestor
25852419|NCT00056095|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25852420|NCT00056225|Vitamins|vitamins|mesh-list
25852421|NCT00056225|Vitamin B 12|vitamin b 12|mesh-list
25852422|NCT00056225|Hydroxocobalamin|hydroxocobalamin|mesh-list
25852423|NCT00056225|Vitamin B 6|vitamin b 6|mesh-list
25852424|NCT00056225|Pyridoxal|pyridoxal|mesh-list
25852425|NCT00056225|Pyridoxine|pyridoxine|mesh-list
25852426|NCT00056225|Vitamin B Complex|vitamin b complex|mesh-list
25852427|NCT00056225|Micronutrients|micronutrients|mesh-ancestor
25852428|NCT00056225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852429|NCT00056225|Hematinics|hematinics|mesh-ancestor
25202709|NCT02719431|Warfarin|warfarin|mesh-list
25202710|NCT02719431|Anticoagulants|anticoagulants|mesh-ancestor
24845048|NCT02235909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845050|NCT02235948|Hematinics|hematinics|mesh-ancestor
24647481|NCT01209026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24647482|NCT01209026|Contraceptive Agents|contraceptive agents|mesh-ancestor
24647483|NCT01209026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24647484|NCT01209026|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24647485|NCT01209026|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24647486|NCT01209026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24647487|NCT01209065|Ritonavir|ritonavir|mesh-list
24647488|NCT01209065|Fosamprenavir|fosamprenavir|mesh-list
24647490|NCT01209065|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24647491|NCT01209065|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24647492|NCT01209065|Protease Inhibitors|protease inhibitors|mesh-ancestor
24647493|NCT01209065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24647494|NCT01209065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647522|NCT01209208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24647523|NCT01209208|Analgesics|analgesics|mesh-ancestor
24647524|NCT01209208|Sensory System Agents|sensory system agents|mesh-ancestor
24647525|NCT01209208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24647570|NCT01209455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24647571|NCT01209455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852430|NCT00056264|Infliximab|infliximab|mesh-list
25049379|NCT00612742|Androgens|androgens|mesh-ancestor
25049380|NCT00612742|Hormones|hormones|mesh-ancestor
25049381|NCT00612742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25049382|NCT00612742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049383|NCT00612170|Reboxetine|reboxetine|mesh-list
25049384|NCT00612170|Antidepressive Agents|antidepressive agents|mesh-ancestor
25049385|NCT00612170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24647585|NCT01209533|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24647613|NCT01209715|Sympathomimetics|sympathomimetics|mesh-ancestor
24647614|NCT01209728|Ethanol|ethanol|mesh-list
25049410|NCT00612118|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25049411|NCT00612118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25049413|NCT00609323|Tetracaine|tetracaine|mesh-list
25003636|NCT03197064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25003642|NCT03173560|Everolimus|everolimus|mesh-list
25003643|NCT03173560|Lenvatinib|lenvatinib|mesh-list
25003644|NCT03173560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25003645|NCT03173560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25003646|NCT03173560|Immunologic Factors|immunologic factors|mesh-ancestor
25003647|NCT03173560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25003648|NCT03173560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24647622|NCT01209806|Magnesium Hydroxide|magnesium hydroxide|mesh-list
24647623|NCT01209806|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
24647624|NCT01209806|TEMPO|tempo|mesh-list
24647625|NCT01209806|Antifoaming Agents|antifoaming agents|mesh-ancestor
24647626|NCT01209806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647627|NCT01209806|Emollients|emollients|mesh-ancestor
25027801|NCT03616639|Morphine|morphine|mesh-list
24647628|NCT01209806|Dermatologic Agents|dermatologic agents|mesh-ancestor
24647634|NCT01209806|Antioxidants|antioxidants|mesh-ancestor
24647657|NCT01209858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24647658|NCT01209858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24647659|NCT01209858|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24647660|NCT01209858|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24647661|NCT01209858|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
24647662|NCT01209858|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24647663|NCT01209858|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24647719|NCT01210339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647720|NCT01210339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25852431|NCT00056264|Dermatologic Agents|dermatologic agents|mesh-ancestor
24941223|NCT03993626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941224|NCT03993366|Pramlintide|pramlintide|mesh-list
24941225|NCT03993366|Insulin Aspart|insulin aspart|mesh-list
25852432|NCT00056264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24941226|NCT03993366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24941227|NCT03993366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941258|NCT03992937|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24766142|NCT01792804|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25003827|NCT03003546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25003828|NCT03003546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24829833|NCT02154776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25003911|NCT02924038|Interferon Inducers|interferon inducers|mesh-ancestor
25003912|NCT02924038|Immunologic Factors|immunologic factors|mesh-ancestor
25003913|NCT02924038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049415|NCT00609323|Anesthetics|anesthetics|mesh-ancestor
25049416|NCT00609323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25049417|NCT00609323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049419|NCT00609323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25049420|NCT00609323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25049421|NCT00609323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25049422|NCT00609323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25049423|NCT00609323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25049424|NCT00609323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049426|NCT00607256|Antidepressive Agents|antidepressive agents|mesh-ancestor
25049427|NCT00607256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24619957|NCT01054781|Rituximab|rituximab|mesh-list
24647799|NCT01210755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24647800|NCT01210755|Protease Inhibitors|protease inhibitors|mesh-ancestor
24647801|NCT01210755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24647802|NCT01210755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647803|NCT01210755|Anticoagulants|anticoagulants|mesh-ancestor
24647804|NCT01210911|Metformin|metformin|mesh-list
24647805|NCT01210911|Gemcitabine|gemcitabine|mesh-list
24647806|NCT01210911|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24647807|NCT01210911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24647808|NCT01210911|Antimetabolites|antimetabolites|mesh-ancestor
25852433|NCT00056264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24647815|NCT01210911|Immunologic Factors|immunologic factors|mesh-ancestor
24647817|NCT01210911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24647818|NCT01210911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24647819|NCT01210976|Simendan|simendan|mesh-list
25852434|NCT00056277|Lamotrigine|lamotrigine|mesh-list
24647820|NCT01210976|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24647821|NCT01210976|Vasodilator Agents|vasodilator agents|mesh-ancestor
24647822|NCT01210976|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24647823|NCT01210976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24647824|NCT01210976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852435|NCT00056277|Anticonvulsants|anticonvulsants|mesh-ancestor
24647825|NCT01210976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647827|NCT01210976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647828|NCT01211002|Endostatins|endostatins|mesh-list
24647829|NCT01211002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647830|NCT01211002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25049444|NCT00606697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25049445|NCT00603616|Rifaximin|rifaximin|mesh-list
25049446|NCT00603616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25049447|NCT00603616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25049448|NCT00603616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25049449|NCT00603577|Xaliproden|xaliproden|mesh-list
25049450|NCT00603577|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25049451|NCT00603577|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25049452|NCT00603577|Serotonin Agents|serotonin agents|mesh-ancestor
25049453|NCT00603577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24829834|NCT02154776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25027890|NCT03615950|Vitamin D|vitamin d|mesh-list
25049454|NCT00603577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049455|NCT00603577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049456|NCT00602745|Fluorouracil|fluorouracil|mesh-list
25049457|NCT00602745|Antimetabolites|antimetabolites|mesh-ancestor
25075925|NCT03377257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24647871|NCT01211210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647872|NCT01211210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24647873|NCT01211210|Immunologic Factors|immunologic factors|mesh-ancestor
24647874|NCT01211210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647875|NCT01211223|Amoxicillin|amoxicillin|mesh-list
24647876|NCT01211223|Metronidazole|metronidazole|mesh-list
24647877|NCT01211223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24798700|NCT01964586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24798701|NCT01964586|Analgesics|analgesics|mesh-ancestor
24798702|NCT01964586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24831317|NCT02164812|Efavirenz|efavirenz|mesh-list
24798703|NCT01964586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24798704|NCT01964586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24798705|NCT01964586|Adrenergic Agents|adrenergic agents|mesh-ancestor
24592435|NCT00921726|Zanamivir|zanamivir|mesh-list
24798715|NCT01964651|JNJ-42165279|jnj-42165279|mesh-list
24798716|NCT01964651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24798717|NCT01964651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647912|NCT01211327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24647914|NCT01211327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647915|NCT01211327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24647916|NCT01211327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647917|NCT01211327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24798730|NCT01964781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24798731|NCT01964781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798732|NCT01964781|Hemostatics|hemostatics|mesh-ancestor
24798733|NCT01964781|Coagulants|coagulants|mesh-ancestor
24798734|NCT01964781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24798735|NCT01964781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24798736|NCT01964781|Adrenergic Agents|adrenergic agents|mesh-ancestor
24798737|NCT01964781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24798738|NCT01964781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24798739|NCT01964781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24798740|NCT01964781|Autonomic Agents|autonomic agents|mesh-ancestor
24798741|NCT01964781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24798742|NCT01964781|Respiratory System Agents|respiratory system agents|mesh-ancestor
24798743|NCT01964781|Mydriatics|mydriatics|mesh-ancestor
24798744|NCT01964781|Sympathomimetics|sympathomimetics|mesh-ancestor
24798745|NCT01964781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24798746|NCT01964846|Curcumin|curcumin|mesh-list
24798747|NCT01964846|Resveratrol|resveratrol|mesh-list
24798748|NCT01964846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24798749|NCT01964846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24798750|NCT01964846|Analgesics|analgesics|mesh-ancestor
24798751|NCT01964846|Sensory System Agents|sensory system agents|mesh-ancestor
25049490|NCT00602329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25049503|NCT00602329|Protective Agents|protective agents|mesh-ancestor
25049504|NCT00602329|Vitamin B Complex|vitamin b complex|mesh-ancestor
25049505|NCT00602329|Vitamins|vitamins|mesh-ancestor
25049506|NCT00602329|Micronutrients|micronutrients|mesh-ancestor
25049507|NCT00600288|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25049508|NCT00600288|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25049509|NCT00598312|Leuprolide|leuprolide|mesh-list
24648037|NCT01211860|Nootropic Agents|nootropic agents|mesh-ancestor
24648038|NCT01211860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24648039|NCT01211860|Vasodilator Agents|vasodilator agents|mesh-ancestor
24648040|NCT01211912|Acetaminophen|acetaminophen|mesh-list
24648041|NCT01211912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24648042|NCT01211912|Analgesics|analgesics|mesh-ancestor
24648043|NCT01211912|Sensory System Agents|sensory system agents|mesh-ancestor
24648044|NCT01211912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24648045|NCT01211912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648046|NCT01211912|Antipyretics|antipyretics|mesh-ancestor
24648047|NCT01211925|Aspirin|aspirin|mesh-list
25202711|NCT02719379|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24648048|NCT01211925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24648049|NCT01211925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24648050|NCT01211925|Analgesics|analgesics|mesh-ancestor
25852436|NCT00056277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25852437|NCT00056277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24648077|NCT01212250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648078|NCT01212250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648079|NCT01212250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24648080|NCT01212250|Antioxidants|antioxidants|mesh-ancestor
24648081|NCT01212250|Protective Agents|protective agents|mesh-ancestor
24648082|NCT01212250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25852438|NCT00056277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648083|NCT01212250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24648084|NCT01212250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24648085|NCT01212250|Vasodilator Agents|vasodilator agents|mesh-ancestor
24648086|NCT01212250|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24648087|NCT01212250|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24648088|NCT01212315|Triclosan|triclosan|mesh-list
24648089|NCT01212315|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24648090|NCT01212315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25409432|NCT03382561|Tubulin Modulators|tubulin modulators|mesh-ancestor
25852439|NCT00056277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25852440|NCT00056277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852441|NCT00056277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24648091|NCT01212315|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25049513|NCT00598312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049514|NCT00598312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25049515|NCT00598312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25049517|NCT00595699|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25049518|NCT00595699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25049519|NCT00595699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25049520|NCT00595699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049521|NCT00595699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24798752|NCT01964846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24798753|NCT01964846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798754|NCT01964846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24798755|NCT01964846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24798756|NCT01964846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648286|NCT01213394|Antitubercular Agents|antitubercular agents|mesh-ancestor
24648287|NCT01213394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24648288|NCT01213394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24648289|NCT01213394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648290|NCT01213394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648292|NCT01213407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24648293|NCT01213407|Alkylating Agents|alkylating agents|mesh-ancestor
24648294|NCT01213407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648295|NCT01213407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648297|NCT01213433|Amodiaquine|amodiaquine|mesh-list
24648298|NCT01213433|Antimalarials|antimalarials|mesh-ancestor
24648299|NCT01213433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24648300|NCT01213433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24648301|NCT01213433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24648302|NCT01213433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648303|NCT01213433|Antiviral Agents|antiviral agents|mesh-ancestor
24648304|NCT01213433|Schistosomicides|schistosomicides|mesh-ancestor
24648305|NCT01213433|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24648306|NCT01213433|Anthelmintics|anthelmintics|mesh-ancestor
24648307|NCT01213498|Atorvastatin|atorvastatin|mesh-list
24648308|NCT01213498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24648309|NCT01213498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24648310|NCT01213498|Antimetabolites|antimetabolites|mesh-ancestor
24614658|NCT01025765|Metformin|metformin|mesh-list
25004060|NCT02764541|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25004061|NCT02764541|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25004062|NCT02764541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25004063|NCT02764541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25004065|NCT02763579|Etoposide|etoposide|mesh-list
25004066|NCT02763579|Atezolizumab|atezolizumab|mesh-list
25004067|NCT02763579|Antibodies|antibodies|mesh-list
25004068|NCT02763579|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25004069|NCT02763579|Immunologic Factors|immunologic factors|mesh-ancestor
25004070|NCT02763579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004071|NCT02763579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609919|NCT00998972|Protective Agents|protective agents|mesh-ancestor
25004072|NCT02763579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25004073|NCT02763579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25004074|NCT02763579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25004075|NCT02763579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648346|NCT01213693|Dermatologic Agents|dermatologic agents|mesh-ancestor
24648347|NCT01213693|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24648348|NCT01213693|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24648349|NCT01213693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24648350|NCT01213693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24648351|NCT01213693|Adrenergic Agents|adrenergic agents|mesh-ancestor
24648352|NCT01213693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24549790|NCT00717561|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24648353|NCT01213693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648355|NCT01213719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24648356|NCT01213719|Lipotropic Agents|lipotropic agents|mesh-ancestor
24648357|NCT01213719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24648358|NCT01213719|Antimetabolites|antimetabolites|mesh-ancestor
24648472|NCT01214941|Antifungal Agents|antifungal agents|mesh-ancestor
25664068|NCT01665599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664069|NCT01665768|Rituximab|rituximab|mesh-list
25664070|NCT01665768|Everolimus|everolimus|mesh-list
25004152|NCT02591953|Sensory System Agents|sensory system agents|mesh-ancestor
25004153|NCT02591953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25004154|NCT02591953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25004155|NCT02591953|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25004156|NCT02591953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25004157|NCT02591953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25004158|NCT02591953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004159|NCT02591953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25004160|NCT02591953|Antiemetics|antiemetics|mesh-ancestor
25004161|NCT02591953|Autonomic Agents|autonomic agents|mesh-ancestor
25004162|NCT02591953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25004163|NCT02591953|Glucocorticoids|glucocorticoids|mesh-ancestor
25004164|NCT02591953|Hormones|hormones|mesh-ancestor
25075926|NCT03377257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648473|NCT01214941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24648474|NCT01214941|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25004195|NCT02503722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004196|NCT02503722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845777|NCT02238860|Tenofovir|tenofovir|mesh-list
24648480|NCT01214941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24648481|NCT01214941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648482|NCT01214941|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24648483|NCT01214941|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24648484|NCT01214941|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24648485|NCT01214941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24648486|NCT01214941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25202712|NCT02719379|Immunologic Factors|immunologic factors|mesh-ancestor
24648487|NCT01214941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24648488|NCT01214941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24648489|NCT01214941|Purinergic Agents|purinergic agents|mesh-ancestor
24648490|NCT01214941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24648491|NCT01214941|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24648492|NCT01214993|Dolutegravir|dolutegravir|mesh-list
24648493|NCT01214993|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24648494|NCT01214993|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25852442|NCT00056277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25852443|NCT00056277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25852444|NCT00056277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25004240|NCT02201381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24941639|NCT03989271|Protective Agents|protective agents|mesh-ancestor
24941640|NCT03989271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798773|NCT01965041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798774|NCT01965041|Growth Inhibitors|growth inhibitors|mesh-ancestor
24798775|NCT01965041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24798776|NCT01965080|Exemestane|exemestane|mesh-list
24798777|NCT01965080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648510|NCT01215136|Paclitaxel|paclitaxel|mesh-list
24648574|NCT01215578|Growth Substances|growth substances|mesh-ancestor
24648575|NCT01215578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648576|NCT01215578|Growth Inhibitors|growth inhibitors|mesh-ancestor
24648577|NCT01215578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24648578|NCT01215578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625733|NCT01083264|Progestins|progestins|mesh-ancestor
24648609|NCT01216007|Sevoflurane|sevoflurane|mesh-list
24648610|NCT01216007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24648611|NCT01216007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24648612|NCT01216007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852445|NCT00056277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24648613|NCT01216007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24648614|NCT01216007|Anesthetics, General|anesthetics, general|mesh-ancestor
24648615|NCT01216007|Anesthetics|anesthetics|mesh-ancestor
24648616|NCT01216007|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24648617|NCT01216007|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24648624|NCT01216046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24648625|NCT01216046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648626|NCT01216085|Imatinib Mesylate|imatinib mesylate|mesh-list
25004416|NCT01773395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25004417|NCT01773395|Immunologic Factors|immunologic factors|mesh-ancestor
25004418|NCT01773395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25852446|NCT00056329|Vitamin E|vitamin e|mesh-list
25004435|NCT01704859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25004436|NCT01704859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24846005|NCT02240537|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
24846006|NCT02240537|Immunologic Factors|immunologic factors|mesh-ancestor
25004463|NCT01142284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25004464|NCT01142284|Autonomic Agents|autonomic agents|mesh-ancestor
25004465|NCT01142284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25004466|NCT01142284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004467|NCT01142284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25004468|NCT01142284|Respiratory System Agents|respiratory system agents|mesh-ancestor
25004469|NCT01142284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25004470|NCT01142284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25004471|NCT01142284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004472|NCT01142284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25004473|NCT01142284|Vasodilator Agents|vasodilator agents|mesh-ancestor
25004474|NCT01142284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25004475|NCT01142284|Protective Agents|protective agents|mesh-ancestor
25004476|NCT01142284|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25202713|NCT02719379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004477|NCT01142284|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24610205|NCT01000597|Xhance|xhance|mesh-list
25004478|NCT01142284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004479|NCT01142284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25004480|NCT01142284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25004481|NCT01142284|Antimetabolites|antimetabolites|mesh-ancestor
25004482|NCT01142284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24941863|NCT03986905|Autonomic Agents|autonomic agents|mesh-ancestor
24941864|NCT03986905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24941865|NCT03986905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941866|NCT03986905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24941867|NCT03986905|Mydriatics|mydriatics|mesh-ancestor
24941871|NCT03986905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941873|NCT03986905|Parasympatholytics|parasympatholytics|mesh-ancestor
24766936|NCT01797926|Losartan|losartan|mesh-list
24798779|NCT01965080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24798780|NCT01965080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24798781|NCT01965080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798782|NCT01965080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24798783|NCT01965080|Hormone Antagonists|hormone antagonists|mesh-ancestor
24798784|NCT01965080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24713998|NCT01528618|Immunologic Factors|immunologic factors|mesh-ancestor
24798785|NCT01965080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798786|NCT01965275|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24798787|NCT01965275|Gefitinib|gefitinib|mesh-list
24798788|NCT01965275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24592585|NCT00923000|Morphine|morphine|mesh-list
24592657|NCT00923637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592658|NCT00923637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24592665|NCT00923663|Growth Substances|growth substances|mesh-ancestor
24592666|NCT00923663|Growth Inhibitors|growth inhibitors|mesh-ancestor
24592667|NCT00923663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622140|NCT01065727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622141|NCT01065727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622143|NCT01065805|Antiviral Agents|antiviral agents|mesh-ancestor
24622144|NCT01065805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24622145|NCT01065857|Picosulfate sodium|picosulfate sodium|mesh-list
24622146|NCT01065857|Sodium sulfate|sodium sulfate|mesh-list
24622147|NCT01065857|Magnesium Oxide|magnesium oxide|mesh-list
25049582|NCT00583674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25202714|NCT02719327|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
25049583|NCT00583674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24453346|NCT05126836|Cilostazol|cilostazol|mesh-list
25049584|NCT00583674|Growth Substances|growth substances|mesh-ancestor
24549888|NCT00717925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24829835|NCT02154776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049585|NCT00583674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049586|NCT00583674|Growth Inhibitors|growth inhibitors|mesh-ancestor
25049587|NCT00583609|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25049588|NCT00583609|Laxatives|laxatives|mesh-ancestor
25049590|NCT00581477|Droxidopa|droxidopa|mesh-list
24826755|NCT02135887|Fluorouracil|fluorouracil|mesh-list
24648804|NCT01216904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25268963|NCT02412930|Analgesics|analgesics|mesh-ancestor
25268964|NCT02413021|Cytarabine|cytarabine|mesh-list
24648805|NCT01216904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648807|NCT01216904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24648808|NCT01216904|Cholinergic Agents|cholinergic agents|mesh-ancestor
24648809|NCT01216904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24648810|NCT01216904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648813|NCT01216956|Niacinamide|niacinamide|mesh-list
24648814|NCT01216956|Vitamin B Complex|vitamin b complex|mesh-ancestor
24648815|NCT01216956|Vitamins|vitamins|mesh-ancestor
24648816|NCT01216956|Micronutrients|micronutrients|mesh-ancestor
24648817|NCT01216956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648818|NCT01216956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25852447|NCT00056329|Tocopherols|tocopherols|mesh-list
24648903|NCT01217294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24648904|NCT01217294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648905|NCT01217294|Analgesics|analgesics|mesh-ancestor
24648906|NCT01217294|Sensory System Agents|sensory system agents|mesh-ancestor
24648907|NCT01217294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24648908|NCT01217359|Interferons|interferons|mesh-list
24648909|NCT01217359|Interferon-alpha|interferon-alpha|mesh-list
24648935|NCT01217450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648937|NCT01217580|Anesthetics, Local|anesthetics, local|mesh-ancestor
24648938|NCT01217580|Anesthetics|anesthetics|mesh-ancestor
24649073|NCT01218581|Letrozole|letrozole|mesh-list
24649074|NCT01218581|Goserelin|goserelin|mesh-list
25852448|NCT00056329|Vitamins|vitamins|mesh-ancestor
24649075|NCT01218581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649076|NCT01218581|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24649077|NCT01218581|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24649078|NCT01218581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24649079|NCT01218581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649080|NCT01218581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24649081|NCT01218581|Hormone Antagonists|hormone antagonists|mesh-ancestor
24942043|NCT03984656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942044|NCT03984760|Sevelamer|sevelamer|mesh-list
24942045|NCT03984760|Chelating Agents|chelating agents|mesh-ancestor
24942046|NCT03984760|Sequestering Agents|sequestering agents|mesh-ancestor
24942047|NCT03984760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767102|NCT01798680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24714201|NCT01529294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24714202|NCT01529320|Methylprednisolone|methylprednisolone|mesh-list
24767103|NCT01798680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24767104|NCT01798771|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24942048|NCT03984591|Eplerenone|eplerenone|mesh-list
24942271|NCT03982537|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24942272|NCT03982537|Antiviral Agents|antiviral agents|mesh-ancestor
24942273|NCT03982537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24942274|NCT03982537|Expectorants|expectorants|mesh-ancestor
24942275|NCT03982537|Respiratory System Agents|respiratory system agents|mesh-ancestor
24942276|NCT03982537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24942277|NCT03982537|Antioxidants|antioxidants|mesh-ancestor
24942278|NCT03982537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942279|NCT03982537|Protective Agents|protective agents|mesh-ancestor
24942280|NCT03982537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942281|NCT03982537|Antidotes|antidotes|mesh-ancestor
24942283|NCT03982784|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24942774|NCT03978286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24942775|NCT03978286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24942776|NCT03978286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942777|NCT03978286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24942779|NCT03978286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942780|NCT03978286|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24942781|NCT03978286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24942782|NCT03978286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24942783|NCT03978286|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24550019|NCT00718705|Josamycin|josamycin|mesh-list
24942784|NCT03978286|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24942785|NCT03978286|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25202715|NCT02719327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24942786|NCT03978286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24846294|NCT02242292|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24846295|NCT02242292|Antiemetics|antiemetics|mesh-ancestor
24649082|NCT01218581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25409433|NCT03382561|Antimitotic Agents|antimitotic agents|mesh-ancestor
25664071|NCT01665768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24649083|NCT01218581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649084|NCT01218581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24649113|NCT01218620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24649114|NCT01218620|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24649115|NCT01218620|Antitubercular Agents|antitubercular agents|mesh-ancestor
24649116|NCT01218620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24649117|NCT01218620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24649118|NCT01218620|Leprostatic Agents|leprostatic agents|mesh-ancestor
24649119|NCT01218620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24622170|NCT01065870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622171|NCT01065870|Tubulin Modulators|tubulin modulators|mesh-ancestor
24622172|NCT01065870|Antimitotic Agents|antimitotic agents|mesh-ancestor
24622173|NCT01065870|Mitosis Modulators|mitosis modulators|mesh-ancestor
24622174|NCT01065961|Dexamethasone|dexamethasone|mesh-list
24622175|NCT01065961|Dexamethasone acetate|dexamethasone acetate|mesh-list
24714203|NCT01529320|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24622177|NCT01065961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24622178|NCT01065961|Antiemetics|antiemetics|mesh-ancestor
24622179|NCT01065961|Autonomic Agents|autonomic agents|mesh-ancestor
24622180|NCT01065961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24649127|NCT01218620|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24649128|NCT01218620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24649129|NCT01218620|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24649130|NCT01218620|Hormone Antagonists|hormone antagonists|mesh-ancestor
24649131|NCT01218620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24649132|NCT01218620|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24649133|NCT01218620|Antitussive Agents|antitussive agents|mesh-ancestor
24649134|NCT01218620|Respiratory System Agents|respiratory system agents|mesh-ancestor
24649135|NCT01218620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24649136|NCT01218620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24649137|NCT01218620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24649150|NCT01218711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649152|NCT01218711|Natriuretic Agents|natriuretic agents|mesh-ancestor
24649153|NCT01218711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649154|NCT01218711|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24649155|NCT01218711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24649157|NCT01218724|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24649158|NCT01218724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24649159|NCT01218724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24622192|NCT01065987|Analgesics|analgesics|mesh-ancestor
24622193|NCT01065987|Sensory System Agents|sensory system agents|mesh-ancestor
24942935|NCT03976544|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24942936|NCT03976544|Contraceptive Agents|contraceptive agents|mesh-ancestor
24942937|NCT03976544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24942938|NCT03976544|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24649160|NCT01218724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24649161|NCT01218724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24649172|NCT01218737|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24649173|NCT01218737|Prednisolone acetate|prednisolone acetate|mesh-list
24443883|NCT00296062|Irinotecan|irinotecan|mesh-list
24649192|NCT01218737|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24649193|NCT01218737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24649194|NCT01218737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24649195|NCT01218737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24649196|NCT01218737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649198|NCT01218750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24649199|NCT01218750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649200|NCT01218750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24649201|NCT01218750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24649202|NCT01218750|Growth Substances|growth substances|mesh-ancestor
24649203|NCT01218750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649204|NCT01218750|Growth Inhibitors|growth inhibitors|mesh-ancestor
24649205|NCT01218893|Chloroquine|chloroquine|mesh-list
25852449|NCT00056329|Micronutrients|micronutrients|mesh-ancestor
25202716|NCT02719327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24649235|NCT01219036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24649236|NCT01219062|Morphine|morphine|mesh-list
24649238|NCT01219062|Anesthetics, Local|anesthetics, local|mesh-ancestor
24649239|NCT01219062|Anesthetics|anesthetics|mesh-ancestor
25852450|NCT00056329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649240|NCT01219062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24649242|NCT01219062|Sensory System Agents|sensory system agents|mesh-ancestor
24649243|NCT01219062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24649244|NCT01219062|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25852451|NCT00056329|Antioxidants|antioxidants|mesh-ancestor
24798801|NCT01965301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24798802|NCT01965301|Antiemetics|antiemetics|mesh-ancestor
24798803|NCT01965301|Autonomic Agents|autonomic agents|mesh-ancestor
24798804|NCT01965301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24798805|NCT01965301|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24798806|NCT01965301|Histamine Antagonists|histamine antagonists|mesh-ancestor
24798807|NCT01965301|Histamine Agents|histamine agents|mesh-ancestor
24798808|NCT01965301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24798809|NCT01965301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798810|NCT01965301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24798811|NCT01965301|Antipruritics|antipruritics|mesh-ancestor
24798812|NCT01965301|Dermatologic Agents|dermatologic agents|mesh-ancestor
24798813|NCT01965353|Dexamethasone|dexamethasone|mesh-list
24649326|NCT01219400|Protease Inhibitors|protease inhibitors|mesh-ancestor
25050802|NCT00467025|Trebananib|trebananib|mesh-list
25852452|NCT00056329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649344|NCT01219556|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24649345|NCT01219556|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24649346|NCT01219569|Propofol|propofol|mesh-list
24649375|NCT01219686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24649376|NCT01219686|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24649377|NCT01219686|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24649378|NCT01219686|Parasympatholytics|parasympatholytics|mesh-ancestor
24649379|NCT01219686|Autonomic Agents|autonomic agents|mesh-ancestor
24649380|NCT01219686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24798815|NCT01965353|Bortezomib|bortezomib|mesh-list
24798816|NCT01965353|Panobinostat|panobinostat|mesh-list
24798817|NCT01965353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25852453|NCT00056329|Protective Agents|protective agents|mesh-ancestor
24649486|NCT01220154|Paclitaxel|paclitaxel|mesh-list
24649487|NCT01220154|Bevacizumab|bevacizumab|mesh-list
24649488|NCT01220154|Carboplatin|carboplatin|mesh-list
24649489|NCT01220154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24649490|NCT01220154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649491|NCT01220154|Tubulin Modulators|tubulin modulators|mesh-ancestor
24649492|NCT01220154|Antimitotic Agents|antimitotic agents|mesh-ancestor
24649493|NCT01220154|Mitosis Modulators|mitosis modulators|mesh-ancestor
24649494|NCT01220154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649495|NCT01220154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24649496|NCT01220154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24798820|NCT01965353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24798821|NCT01965353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798823|NCT01965353|Glucocorticoids|glucocorticoids|mesh-ancestor
24798824|NCT01965353|Hormones|hormones|mesh-ancestor
24798825|NCT01965353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24798826|NCT01965353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24798827|NCT01965353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649527|NCT01220245|Heparin|heparin|mesh-list
24649528|NCT01220245|Anticoagulants|anticoagulants|mesh-ancestor
24649529|NCT01220245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24649530|NCT01220245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24649536|NCT01220258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24649537|NCT01220284|Vinorelbine|vinorelbine|mesh-list
24649538|NCT01220284|Satraplatin|satraplatin|mesh-list
24649539|NCT01220284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24649540|NCT01220284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649541|NCT01220284|Tubulin Modulators|tubulin modulators|mesh-ancestor
24649542|NCT01220284|Antimitotic Agents|antimitotic agents|mesh-ancestor
24649543|NCT01220284|Mitosis Modulators|mitosis modulators|mesh-ancestor
24649544|NCT01220284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649546|NCT01220362|Bupivacaine|bupivacaine|mesh-list
24649547|NCT01220362|Anesthetics, Local|anesthetics, local|mesh-ancestor
24649548|NCT01220362|Anesthetics|anesthetics|mesh-ancestor
24649549|NCT01220362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24649550|NCT01220362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649551|NCT01220362|Sensory System Agents|sensory system agents|mesh-ancestor
24649552|NCT01220362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24649553|NCT01220362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24649555|NCT01220362|Analgesics|analgesics|mesh-ancestor
24649556|NCT01220362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25852454|NCT00056368|Fluconazole|fluconazole|mesh-list
24831779|NCT02168907|Thioctic Acid|thioctic acid|mesh-list
25268990|NCT02412683|Oxaliplatin|oxaliplatin|mesh-list
24649797|NCT01221896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24649798|NCT01221896|Nootropic Agents|nootropic agents|mesh-ancestor
24649799|NCT01221909|Tranexamic Acid|tranexamic acid|mesh-list
24649800|NCT01221909|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24649801|NCT01221909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24649802|NCT01221909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649803|NCT01221909|Hemostatics|hemostatics|mesh-ancestor
24649804|NCT01221909|Coagulants|coagulants|mesh-ancestor
24649806|NCT01221935|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
24649807|NCT01221935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24649808|NCT01221935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25852455|NCT00056368|Anidulafungin|anidulafungin|mesh-list
24649809|NCT01221935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649810|NCT01221935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24649811|NCT01221935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649812|NCT01221935|Antidepressive Agents|antidepressive agents|mesh-ancestor
24649813|NCT01221935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24649814|NCT01222013|Imatinib Mesylate|imatinib mesylate|mesh-list
24649815|NCT01222013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649816|NCT01222013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24649817|NCT01222013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852456|NCT00056368|Antifungal Agents|antifungal agents|mesh-ancestor
24798832|NCT01965353|Growth Inhibitors|growth inhibitors|mesh-ancestor
24798833|NCT01965353|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24798834|NCT01965353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24798835|NCT01965353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798837|NCT01965405|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24798840|NCT01965405|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24798841|NCT01965405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24798842|NCT01965405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24798843|NCT01965405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798844|NCT01965405|Dopamine Agents|dopamine agents|mesh-ancestor
24798845|NCT01965405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24798846|NCT01965405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846386|NCT02242474|Sensory System Agents|sensory system agents|mesh-ancestor
24714556|NCT01531244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24714557|NCT01531244|Immunologic Factors|immunologic factors|mesh-ancestor
24846387|NCT02242474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24649935|NCT01222676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649936|NCT01222676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24649937|NCT01222676|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24649938|NCT01222780|Vincristine|vincristine|mesh-list
24669790|NCT03613181|Abortifacient Agents|abortifacient agents|mesh-ancestor
24649939|NCT01222780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24672222|NCT01330654|Metoprolol|metoprolol|mesh-list
24649940|NCT01222780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649941|NCT01222780|Tubulin Modulators|tubulin modulators|mesh-ancestor
24649942|NCT01222780|Antimitotic Agents|antimitotic agents|mesh-ancestor
24649943|NCT01222780|Mitosis Modulators|mitosis modulators|mesh-ancestor
24649944|NCT01222780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649945|NCT01222819|Lenograstim|lenograstim|mesh-list
24649946|NCT01222819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24649947|NCT01222819|Immunologic Factors|immunologic factors|mesh-ancestor
24649948|NCT01222819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649965|NCT01222923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24650109|NCT01224028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650112|NCT01224041|Immunologic Factors|immunologic factors|mesh-ancestor
24650143|NCT01224353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650144|NCT01224353|Protective Agents|protective agents|mesh-ancestor
24650145|NCT01224353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650146|NCT01224353|Vitamin B Complex|vitamin b complex|mesh-ancestor
24650147|NCT01224353|Vitamins|vitamins|mesh-ancestor
24650148|NCT01224353|Micronutrients|micronutrients|mesh-ancestor
24650149|NCT01224366|Vildagliptin|vildagliptin|mesh-list
24650150|NCT01224366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24650151|NCT01224366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650152|NCT01224366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24650153|NCT01224366|Protease Inhibitors|protease inhibitors|mesh-ancestor
24650154|NCT01224366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409434|NCT03382561|Mitosis Modulators|mitosis modulators|mesh-ancestor
25664072|NCT01665768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650155|NCT01224366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650157|NCT01224392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24650158|NCT01224392|Antimetabolites|antimetabolites|mesh-ancestor
24650159|NCT01224392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650160|NCT01224392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650161|NCT01224405|Docetaxel|docetaxel|mesh-list
24650162|NCT01224405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650163|NCT01224405|Tubulin Modulators|tubulin modulators|mesh-ancestor
24714558|NCT01531244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943104|NCT03974685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943357|NCT03972358|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24943358|NCT03972358|Hormone Antagonists|hormone antagonists|mesh-ancestor
24846407|NCT02242591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24846409|NCT02242591|Sensory System Agents|sensory system agents|mesh-ancestor
24650164|NCT01224405|Antimitotic Agents|antimitotic agents|mesh-ancestor
24650165|NCT01224405|Mitosis Modulators|mitosis modulators|mesh-ancestor
24650176|NCT01224457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24650177|NCT01224457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24650178|NCT01224457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650179|NCT01224457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24650180|NCT01224457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24650181|NCT01224457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24650182|NCT01224457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650184|NCT01224457|GABA Agents|gaba agents|mesh-ancestor
24650185|NCT01224457|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24650186|NCT01224457|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24650189|NCT01224470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24650190|NCT01224470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24650191|NCT01224470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650192|NCT01224470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24650193|NCT01224470|Analgesics|analgesics|mesh-ancestor
24650194|NCT01224470|Sensory System Agents|sensory system agents|mesh-ancestor
24650195|NCT01224470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24650196|NCT01224470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24650197|NCT01224470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24650198|NCT01224470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24650199|NCT01224470|Adrenergic Agents|adrenergic agents|mesh-ancestor
24650200|NCT01224470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24650218|NCT01224535|Micronutrients|micronutrients|mesh-list
24650219|NCT01224535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650220|NCT01224613|Vaccines|vaccines|mesh-list
24650221|NCT01224613|Immunologic Factors|immunologic factors|mesh-ancestor
25202717|NCT02719210|Mannitol|mannitol|mesh-list
24943359|NCT03972358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24943360|NCT03972358|Luteolytic Agents|luteolytic agents|mesh-ancestor
24943361|NCT03972358|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24943362|NCT03972358|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24650290|NCT01224951|Respiratory System Agents|respiratory system agents|mesh-ancestor
24650311|NCT01225094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24650312|NCT01225094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24650314|NCT01225094|Sensory System Agents|sensory system agents|mesh-ancestor
24650315|NCT01225094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24650316|NCT01225094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650317|NCT01225094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24650318|NCT01225094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24650319|NCT01225094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650320|NCT01225094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24650321|NCT01225094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650369|NCT01225419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24650370|NCT01225419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24650371|NCT01225419|Antiviral Agents|antiviral agents|mesh-ancestor
25230407|NCT02596100|Betrixaban|betrixaban|mesh-list
24650372|NCT01225419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24943363|NCT03972462|Sirolimus|sirolimus|mesh-list
24943364|NCT03972462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24943365|NCT03972462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24943366|NCT03972462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24943367|NCT03972462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943368|NCT03972462|Antifungal Agents|antifungal agents|mesh-ancestor
24943369|NCT03972462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24943370|NCT03972462|Immunologic Factors|immunologic factors|mesh-ancestor
24943371|NCT03972462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943372|NCT03972046|Trametinib|trametinib|mesh-list
24943373|NCT03972046|Dabrafenib|dabrafenib|mesh-list
24943374|NCT03972046|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
24943375|NCT03972046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650373|NCT01225445|Ramipril|ramipril|mesh-list
24650374|NCT01225445|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24650375|NCT01225445|Protease Inhibitors|protease inhibitors|mesh-ancestor
24650376|NCT01225445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24650377|NCT01225445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650378|NCT01225445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24650379|NCT01225484|Ropivacaine|ropivacaine|mesh-list
24650380|NCT01225484|Anesthetics, Local|anesthetics, local|mesh-ancestor
24650381|NCT01225484|Anesthetics|anesthetics|mesh-ancestor
24650382|NCT01225484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24650383|NCT01225484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650384|NCT01225484|Sensory System Agents|sensory system agents|mesh-ancestor
24714651|NCT01531764|Antimitotic Agents|antimitotic agents|mesh-ancestor
24650385|NCT01225484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24650386|NCT01225523|Paclitaxel|paclitaxel|mesh-list
24650387|NCT01225523|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24650388|NCT01225523|Cisplatin|cisplatin|mesh-list
24650389|NCT01225523|Fluorouracil|fluorouracil|mesh-list
24650390|NCT01225523|Capecitabine|capecitabine|mesh-list
24650391|NCT01225523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24650392|NCT01225523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650393|NCT01225523|Tubulin Modulators|tubulin modulators|mesh-ancestor
24650394|NCT01225523|Antimitotic Agents|antimitotic agents|mesh-ancestor
24650396|NCT01225523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650398|NCT01225523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24650399|NCT01225523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24650461|NCT01225874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24650462|NCT01225874|Immunologic Factors|immunologic factors|mesh-ancestor
24650463|NCT01225874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24650485|NCT01225913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852457|NCT00056368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25202718|NCT02719210|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25852458|NCT00056368|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25852459|NCT00056368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25852460|NCT00056368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852461|NCT00056368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852462|NCT00056368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25852463|NCT00056368|Hormone Antagonists|hormone antagonists|mesh-ancestor
25852464|NCT00056368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25852465|NCT00056368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852466|NCT00056368|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25852467|NCT00056368|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25852468|NCT00056381|Anidulafungin|anidulafungin|mesh-list
24650534|NCT01226186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24650535|NCT01226186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650536|NCT01226186|Analgesics|analgesics|mesh-ancestor
24650537|NCT01226186|Sensory System Agents|sensory system agents|mesh-ancestor
24650539|NCT01226212|Sulfalene|sulfalene|mesh-list
24650540|NCT01226212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714824|NCT01532960|Poly ICLC|poly iclc|mesh-list
24650541|NCT01226212|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24650542|NCT01226212|Renal Agents|renal agents|mesh-ancestor
24650543|NCT01226212|Antimalarials|antimalarials|mesh-ancestor
24650544|NCT01226212|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24650567|NCT01226602|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25852469|NCT00056381|Antifungal Agents|antifungal agents|mesh-ancestor
24798856|NCT01965522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798857|NCT01965522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24798858|NCT01965522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24798859|NCT01965522|Antioxidants|antioxidants|mesh-ancestor
24798860|NCT01965522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798861|NCT01965522|Protective Agents|protective agents|mesh-ancestor
24798862|NCT01965522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24798863|NCT01965587|Levonorgestrel|levonorgestrel|mesh-list
25852470|NCT00056381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25852471|NCT00056433|Hydroxyurea|hydroxyurea|mesh-list
25852472|NCT00056433|Sildenafil Citrate|sildenafil citrate|mesh-list
25852473|NCT00056433|Vasodilator Agents|vasodilator agents|mesh-ancestor
25852474|NCT00056433|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25852475|NCT00056433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24650780|NCT01227915|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
24650782|NCT01227915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24650783|NCT01227915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24650784|NCT01227915|Glucocorticoids|glucocorticoids|mesh-ancestor
24650785|NCT01227915|Hormones|hormones|mesh-ancestor
24650786|NCT01227915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24650787|NCT01227915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650788|NCT01227915|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24650789|NCT01227915|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24650790|NCT01227941|Doxorubicin|doxorubicin|mesh-list
24650791|NCT01227941|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24650792|NCT01227941|Niraparib|niraparib|mesh-list
24650793|NCT01227941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24650794|NCT01227941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650795|NCT01227941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24650796|NCT01227941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24650797|NCT01227941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24650798|NCT01227941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650799|NCT01227941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24650814|NCT01228214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24650816|NCT01228214|Analgesics|analgesics|mesh-ancestor
24650817|NCT01228214|Sensory System Agents|sensory system agents|mesh-ancestor
24650818|NCT01228214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202719|NCT02719210|Diuretics|diuretics|mesh-ancestor
25202720|NCT02719210|Natriuretic Agents|natriuretic agents|mesh-ancestor
25852476|NCT00056433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852477|NCT00056433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852478|NCT00056433|Urological Agents|urological agents|mesh-ancestor
25852479|NCT00056433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650830|NCT01228214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24650831|NCT01228214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24650832|NCT01228214|Purinergic Agents|purinergic agents|mesh-ancestor
24650833|NCT01228214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24650834|NCT01228214|Diuretics|diuretics|mesh-ancestor
24650835|NCT01228214|Natriuretic Agents|natriuretic agents|mesh-ancestor
25852480|NCT00056433|Antisickling Agents|antisickling agents|mesh-ancestor
25852481|NCT00056433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24650836|NCT01228214|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24650837|NCT01228214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24650849|NCT01228227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24650851|NCT01228240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24650852|NCT01228240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650853|NCT01228279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24650854|NCT01228279|Icodextrin|icodextrin|mesh-list
24650855|NCT01228279|Dialysis Solutions|dialysis solutions|mesh-ancestor
24650856|NCT01228292|Heparin|heparin|mesh-list
24650857|NCT01228292|Calcium heparin|calcium heparin|mesh-list
24650858|NCT01228292|Anticoagulants|anticoagulants|mesh-ancestor
24650859|NCT01228292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25852482|NCT00056446|Vatalanib|vatalanib|mesh-list
25852483|NCT00056446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24846474|NCT02242812|Sympatholytics|sympatholytics|mesh-ancestor
24650871|NCT01228344|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24650872|NCT01228344|Antimalarials|antimalarials|mesh-ancestor
24650873|NCT01228344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24650874|NCT01228344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25852484|NCT00056446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24650875|NCT01228344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24650877|NCT01228357|Mirtazapine|mirtazapine|mesh-list
24650878|NCT01228357|Sertraline|sertraline|mesh-list
24650879|NCT01228357|Fluoxetine|fluoxetine|mesh-list
24650880|NCT01228357|Paroxetine|paroxetine|mesh-list
24650881|NCT01228357|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24650882|NCT01228357|Nortriptyline|nortriptyline|mesh-list
24715017|NCT01533740|Hematinics|hematinics|mesh-ancestor
24650883|NCT01228357|Antidepressive Agents|antidepressive agents|mesh-ancestor
24650884|NCT01228357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24650885|NCT01228357|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25852485|NCT00056446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650886|NCT01228357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24650887|NCT01228357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24650888|NCT01228357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852486|NCT00056459|Vatalanib|vatalanib|mesh-list
25852487|NCT00056459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25852488|NCT00056459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24943493|NCT03970577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24943495|NCT03970668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24589962|NCT00910013|Anesthetics|anesthetics|mesh-ancestor
24943496|NCT03970668|Linagliptin|linagliptin|mesh-list
24943497|NCT03970668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24943498|NCT03970668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943499|NCT03970668|Incretins|incretins|mesh-ancestor
25852489|NCT00056459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852490|NCT00056576|Zonisamide|zonisamide|mesh-list
24650937|NCT01228552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24650938|NCT01228552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24650939|NCT01228552|Analgesics|analgesics|mesh-ancestor
24650940|NCT01228552|Sensory System Agents|sensory system agents|mesh-ancestor
24650941|NCT01228552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24650942|NCT01228552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650943|NCT01228552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24650944|NCT01228552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24650945|NCT01228552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24651003|NCT01228656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24651004|NCT01228656|Antifungal Agents|antifungal agents|mesh-ancestor
24651005|NCT01228656|Keratolytic Agents|keratolytic agents|mesh-ancestor
25202721|NCT02719210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852491|NCT00056576|Anticonvulsants|anticonvulsants|mesh-ancestor
24651006|NCT01228656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24651007|NCT01228656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24651008|NCT01228656|Analgesics|analgesics|mesh-ancestor
24651009|NCT01228656|Sensory System Agents|sensory system agents|mesh-ancestor
24651010|NCT01228656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24651011|NCT01228656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651012|NCT01228656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24651013|NCT01228656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24651014|NCT01228656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651015|NCT01228656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651017|NCT01228682|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24651018|NCT01228682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651019|NCT01228682|Natriuretic Agents|natriuretic agents|mesh-ancestor
24651020|NCT01228682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651021|NCT01228994|Baclofen|baclofen|mesh-list
24651022|NCT01228994|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24715041|NCT01534026|Aspirin|aspirin|mesh-list
25852492|NCT00056576|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25852493|NCT00056576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25852494|NCT00056576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852495|NCT00056576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25852496|NCT00056576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852497|NCT00056641|Ritonavir|ritonavir|mesh-list
25852498|NCT00056641|Lopinavir|lopinavir|mesh-list
25852499|NCT00056641|Saquinavir|saquinavir|mesh-list
25852500|NCT00056641|Amprenavir|amprenavir|mesh-list
25852501|NCT00056641|Tipranavir|tipranavir|mesh-list
25852502|NCT00056641|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25852503|NCT00056641|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25852504|NCT00056641|Protease Inhibitors|protease inhibitors|mesh-ancestor
24943500|NCT03970668|Hormones|hormones|mesh-ancestor
24943501|NCT03970668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24943694|NCT03967665|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24943695|NCT03967665|Antiviral Agents|antiviral agents|mesh-ancestor
24943696|NCT03967665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25230438|NCT02595658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230439|NCT02595918|Nivolumab|nivolumab|mesh-list
24943697|NCT03967665|Expectorants|expectorants|mesh-ancestor
24943698|NCT03967665|Respiratory System Agents|respiratory system agents|mesh-ancestor
24943699|NCT03967665|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24846485|NCT02242825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24651055|NCT01229085|Sensory System Agents|sensory system agents|mesh-ancestor
24651056|NCT01229085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25852505|NCT00056641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852506|NCT00056641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852507|NCT00056641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25852508|NCT00056641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25852509|NCT00056641|Antiviral Agents|antiviral agents|mesh-ancestor
25852510|NCT00056641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24651057|NCT01229085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651058|NCT01229085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24651059|NCT01229085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25409435|NCT03382106|Sildenafil Citrate|sildenafil citrate|mesh-list
25852511|NCT00056641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25852512|NCT00056641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25664073|NCT01665768|Immunologic Factors|immunologic factors|mesh-ancestor
24771903|NCT01830478|Immunologic Factors|immunologic factors|mesh-ancestor
24651060|NCT01229085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24651061|NCT01229085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651062|NCT01229085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651069|NCT01229202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24651070|NCT01229202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651071|NCT01229202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24651072|NCT01229202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24651074|NCT01229202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852513|NCT00056641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24651075|NCT01229202|Growth Inhibitors|growth inhibitors|mesh-ancestor
24651076|NCT01229241|Anesthetics|anesthetics|mesh-list
24651077|NCT01229241|Anesthetics, Local|anesthetics, local|mesh-list
24651083|NCT01229280|Muscarinic Antagonists|muscarinic antagonists|mesh-list
24651084|NCT01229280|Cholinergic Agents|cholinergic agents|mesh-list
24651085|NCT01229280|Cholinergic Antagonists|cholinergic antagonists|mesh-list
24651086|NCT01229280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24651087|NCT01229280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651088|NCT01229280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651097|NCT01229332|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24651098|NCT01229332|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24651099|NCT01229332|Dopamine Agents|dopamine agents|mesh-ancestor
24669994|NCT03395080|Paclitaxel|paclitaxel|mesh-list
24651100|NCT01229332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24651101|NCT01229332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651102|NCT01229332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651103|NCT01229332|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24651104|NCT01229332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651106|NCT01229579|Astringents|astringents|mesh-ancestor
24651107|NCT01229579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651108|NCT01229579|Dermatologic Agents|dermatologic agents|mesh-ancestor
24651110|NCT01229592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24651112|NCT01229592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24651113|NCT01229592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651114|NCT01229605|Cyclophosphamide|cyclophosphamide|mesh-list
24651115|NCT01229605|Docetaxel|docetaxel|mesh-list
24651116|NCT01229605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24798887|NCT01965626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798889|NCT01965730|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25049617|NCT00580125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24651140|NCT01229761|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24651141|NCT01229761|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24651142|NCT01229761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24651143|NCT01229761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24651145|NCT01229774|Etoricoxib|etoricoxib|mesh-list
24651146|NCT01229774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24651147|NCT01229774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24651148|NCT01229774|Analgesics|analgesics|mesh-ancestor
24651149|NCT01229774|Sensory System Agents|sensory system agents|mesh-ancestor
24651150|NCT01229774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24651151|NCT01229774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651152|NCT01229774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24651153|NCT01229774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24651154|NCT01229774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24651155|NCT01229774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651156|NCT01229774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651157|NCT01229774|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24651158|NCT01229813|Bevacizumab|bevacizumab|mesh-list
24651159|NCT01229813|Capecitabine|capecitabine|mesh-list
24651160|NCT01229813|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24651161|NCT01229813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24651168|NCT01229813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24651170|NCT01229813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651171|NCT01229813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24651172|NCT01229813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651173|NCT01229839|Ethiodized Oil|ethiodized oil|mesh-list
24651174|NCT01229839|Antineoplastic Agents|antineoplastic agents|mesh-list
24651197|NCT01230359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798890|NCT01965730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25664074|NCT01665768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772003|NCT01830907|Vitamins|vitamins|mesh-list
25049618|NCT00580125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049619|NCT00580125|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24651212|NCT01230463|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24651213|NCT01230463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24651214|NCT01230463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24651215|NCT01230463|Analgesics|analgesics|mesh-ancestor
24651216|NCT01230463|Sensory System Agents|sensory system agents|mesh-ancestor
24651217|NCT01230463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24651218|NCT01230463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715209|NCT01535092|Silybin|silybin|mesh-list
24651219|NCT01230463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24651222|NCT01230463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651223|NCT01230463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651224|NCT01230476|Cetuximab|cetuximab|mesh-list
24651225|NCT01230476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24651226|NCT01230476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651227|NCT01230541|Udenafil|udenafil|mesh-list
24651228|NCT01230541|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24651229|NCT01230541|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24651301|NCT01230983|Dermatologic Agents|dermatologic agents|mesh-ancestor
24651302|NCT01230983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24651303|NCT01230983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24651304|NCT01230983|Immunologic Factors|immunologic factors|mesh-ancestor
24651305|NCT01230983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24651418|NCT01231529|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24651309|NCT01230983|Antidotes|antidotes|mesh-ancestor
24651310|NCT01230983|Protective Agents|protective agents|mesh-ancestor
24651311|NCT01230983|Vitamin B Complex|vitamin b complex|mesh-ancestor
24651324|NCT01231113|Artesunate|artesunate|mesh-list
24651325|NCT01231113|Piperaquine|piperaquine|mesh-list
24651326|NCT01231113|Amodiaquine|amodiaquine|mesh-list
24651327|NCT01231113|Artenimol|artenimol|mesh-list
24651328|NCT01231113|Antimalarials|antimalarials|mesh-ancestor
24651329|NCT01231113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24651370|NCT01231165|Antipyretics|antipyretics|mesh-ancestor
24651371|NCT01231165|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24651372|NCT01231165|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24651373|NCT01231165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25049622|NCT00580125|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25049623|NCT00580125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25049624|NCT00580125|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25049625|NCT00580125|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25049626|NCT00579189|Moxifloxacin|moxifloxacin|mesh-list
25049627|NCT00579189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25049628|NCT00579189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25049629|NCT00579189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25049630|NCT00579189|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25049631|NCT00579189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24651376|NCT01231165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24651377|NCT01231165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24651378|NCT01231165|Antimetabolites|antimetabolites|mesh-ancestor
24651379|NCT01231165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24651380|NCT01231165|Diuretics|diuretics|mesh-ancestor
24651381|NCT01231165|Natriuretic Agents|natriuretic agents|mesh-ancestor
24651382|NCT01231165|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24651383|NCT01231165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25852514|NCT00056641|Antitubercular Agents|antitubercular agents|mesh-ancestor
25852515|NCT00056641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25852516|NCT00056654|Leuprolide|leuprolide|mesh-list
25852517|NCT00056654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25852518|NCT00056654|Fertility Agents|fertility agents|mesh-ancestor
24651394|NCT01231243|Hydrogen Peroxide|hydrogen peroxide|mesh-list
24651395|NCT01231243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24651396|NCT01231243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24651397|NCT01231438|Alfacalcidol|alfacalcidol|mesh-list
24651398|NCT01231438|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24651399|NCT01231438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651400|NCT01231490|Naproxen|naproxen|mesh-list
24651401|NCT01231490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24651403|NCT01231490|Analgesics|analgesics|mesh-ancestor
24651404|NCT01231490|Sensory System Agents|sensory system agents|mesh-ancestor
25664075|NCT01665768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25664076|NCT01665768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25664077|NCT01665911|Listerine|listerine|mesh-list
25664078|NCT01665911|Fluorides|fluorides|mesh-list
25664079|NCT01665911|Sodium Fluoride|sodium fluoride|mesh-list
25664080|NCT01665911|Cariostatic Agents|cariostatic agents|mesh-ancestor
24832199|NCT02170896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832200|NCT02170896|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832201|NCT02170896|Anticoagulants|anticoagulants|mesh-ancestor
24651405|NCT01231490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24651406|NCT01231490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651407|NCT01231490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24651410|NCT01231490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24651411|NCT01231490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049637|NCT00579020|Dexamethasone acetate|dexamethasone acetate|mesh-list
25049638|NCT00579020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25049639|NCT00579020|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25049640|NCT00579020|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25049641|NCT00579020|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24846517|NCT02242877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24846518|NCT02242877|Diuretics|diuretics|mesh-ancestor
24846519|NCT02242877|Natriuretic Agents|natriuretic agents|mesh-ancestor
24846520|NCT02242877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651412|NCT01231490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651413|NCT01231529|Dolutegravir|dolutegravir|mesh-list
24651414|NCT01231529|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24651415|NCT01231529|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24651416|NCT01231529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651417|NCT01231529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852519|NCT00056654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25852520|NCT00056654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852521|NCT00056654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24651441|NCT01231542|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24651442|NCT01231542|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24651443|NCT01231542|Antiviral Agents|antiviral agents|mesh-ancestor
24651444|NCT01231594|Trametinib|trametinib|mesh-list
24651445|NCT01231594|Dabrafenib|dabrafenib|mesh-list
24651446|NCT01231594|Antineoplastic Agents|antineoplastic agents|mesh-list
24651447|NCT01231594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24651448|NCT01231594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651449|NCT01231594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651450|NCT01231685|Ritonavir|ritonavir|mesh-list
24651451|NCT01231685|Lopinavir|lopinavir|mesh-list
24651452|NCT01231685|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24651453|NCT01231685|Darunavir|darunavir|mesh-list
24651454|NCT01231685|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
25049642|NCT00579020|BB 1101|bb 1101|mesh-list
25049643|NCT00579020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25049644|NCT00579020|Antiemetics|antiemetics|mesh-ancestor
25049645|NCT00579020|Autonomic Agents|autonomic agents|mesh-ancestor
25049646|NCT00579020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25049647|NCT00579020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049648|NCT00579020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25049649|NCT00579020|Glucocorticoids|glucocorticoids|mesh-ancestor
25049650|NCT00579020|Hormones|hormones|mesh-ancestor
25049651|NCT00579020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24846522|NCT02242877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24846523|NCT02242877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846524|NCT02242877|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24846526|NCT02242929|Imiquimod|imiquimod|mesh-list
24651455|NCT01231685|Raltegravir Potassium|raltegravir potassium|mesh-list
24651456|NCT01231685|Protease Inhibitors|protease inhibitors|mesh-list
24651457|NCT01231685|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24651458|NCT01231685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651459|NCT01231685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651460|NCT01231685|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24651461|NCT01231685|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24651462|NCT01231685|Antiviral Agents|antiviral agents|mesh-ancestor
24651463|NCT01231685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24651472|NCT01231698|Adrenergic Agents|adrenergic agents|mesh-ancestor
24651473|NCT01231698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24827002|NCT02137161|Tobramycin|tobramycin|mesh-list
25664081|NCT01665911|Protective Agents|protective agents|mesh-ancestor
25664082|NCT01665911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664083|NCT01665911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25664084|NCT01665911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25664085|NCT01665950|Simvastatin|simvastatin|mesh-list
25664086|NCT01665950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25664087|NCT01665950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25664088|NCT01665950|Antimetabolites|antimetabolites|mesh-ancestor
25664089|NCT01665950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651491|NCT01231802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651492|NCT01231802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24651493|NCT01231802|Immunologic Factors|immunologic factors|mesh-ancestor
24651494|NCT01231802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651495|NCT01231802|Antidotes|antidotes|mesh-ancestor
24651496|NCT01231802|Protective Agents|protective agents|mesh-ancestor
24651497|NCT01231802|Vitamin B Complex|vitamin b complex|mesh-ancestor
24651498|NCT01231802|Vitamins|vitamins|mesh-ancestor
24651500|NCT01231802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651501|NCT01231828|Lactulose|lactulose|mesh-list
25852522|NCT00056654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852523|NCT00056693|Sunitinib|sunitinib|mesh-list
25852524|NCT00056693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852525|NCT00056693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25852526|NCT00056693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25852527|NCT00056693|Growth Substances|growth substances|mesh-ancestor
25049652|NCT00579020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25049653|NCT00579020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25049654|NCT00579020|Protease Inhibitors|protease inhibitors|mesh-ancestor
24798891|NCT01965730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798892|NCT01965730|Hemostatics|hemostatics|mesh-ancestor
24798893|NCT01965730|Coagulants|coagulants|mesh-ancestor
24798895|NCT01965925|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24798896|NCT01965925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798897|NCT01965925|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24798898|NCT01965925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24798899|NCT01965925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24798900|NCT01965925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715479|NCT01536652|Insulin Aspart|insulin aspart|mesh-list
24798901|NCT01965977|Bortezomib|bortezomib|mesh-list
24798902|NCT01965977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24798903|NCT01966055|Solithromycin|solithromycin|mesh-list
24798904|NCT01966055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24798905|NCT01966055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24798906|NCT01966133|Doxorubicin|doxorubicin|mesh-list
24798907|NCT01966133|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24846531|NCT02242929|Interferon Inducers|interferon inducers|mesh-ancestor
24846532|NCT02242955|Diazepam|diazepam|mesh-list
24846533|NCT02242955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24846534|NCT02242955|Anticonvulsants|anticonvulsants|mesh-ancestor
24846535|NCT02242955|Antiemetics|antiemetics|mesh-ancestor
24846536|NCT02242955|Autonomic Agents|autonomic agents|mesh-ancestor
24846549|NCT02242955|Anesthetics|anesthetics|mesh-ancestor
25852528|NCT00056693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651589|NCT01232257|Antioxidants|antioxidants|mesh-ancestor
24651590|NCT01232257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651591|NCT01232257|Protective Agents|protective agents|mesh-ancestor
24798909|NCT01966133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24798910|NCT01966133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24798911|NCT01966133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24798912|NCT01966133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24798913|NCT01966133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24798914|NCT01966133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798915|NCT01966172|Acetaminophen|acetaminophen|mesh-list
24798917|NCT01966172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24798918|NCT01966172|Morphine|morphine|mesh-list
24798919|NCT01966172|Gabapentin|gabapentin|mesh-list
24798920|NCT01966172|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24798921|NCT01966172|Narcotics|narcotics|mesh-ancestor
24798922|NCT01966172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24798923|NCT01966172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846551|NCT02242955|GABA Agents|gaba agents|mesh-ancestor
24846552|NCT02242955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24846553|NCT02242955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651592|NCT01232257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651593|NCT01232257|Antidotes|antidotes|mesh-ancestor
24651594|NCT01232270|Propofol|propofol|mesh-list
24651595|NCT01232270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24651596|NCT01232270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24651597|NCT01232270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651598|NCT01232270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24651599|NCT01232270|Anesthetics, General|anesthetics, general|mesh-ancestor
24651602|NCT01232374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651603|NCT01232374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24651604|NCT01232400|Esmolol|esmolol|mesh-list
24651605|NCT01232400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25409436|NCT03382106|Vasodilator Agents|vasodilator agents|mesh-ancestor
25852530|NCT00056693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25852531|NCT00056693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651606|NCT01232400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24651607|NCT01232400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24651717|NCT01233505|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24651718|NCT01233505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651720|NCT01233570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24651721|NCT01233570|Immunologic Factors|immunologic factors|mesh-ancestor
24651722|NCT01233570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651723|NCT01233570|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24651724|NCT01233570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651725|NCT01233570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651726|NCT01233583|Adalimumab|adalimumab|mesh-list
24651727|NCT01233583|Etanercept|etanercept|mesh-list
24651728|NCT01233583|Infliximab|infliximab|mesh-list
24651729|NCT01233583|Acitretin|acitretin|mesh-list
24651730|NCT01233583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24651751|NCT01233635|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24651752|NCT01233635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24651753|NCT01233635|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24651773|NCT01233791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24651783|NCT01233791|GABA Agents|gaba agents|mesh-ancestor
24651784|NCT01233791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24651785|NCT01233791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651787|NCT01233843|Fluorouracil|fluorouracil|mesh-list
24651788|NCT01233843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651789|NCT01233843|Antimetabolites|antimetabolites|mesh-ancestor
24651790|NCT01233843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651791|NCT01233843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24651792|NCT01233843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24651793|NCT01233843|Immunologic Factors|immunologic factors|mesh-ancestor
24651813|NCT01233947|Hormone Antagonists|hormone antagonists|mesh-ancestor
24651814|NCT01233947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24651815|NCT01233947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651816|NCT01234051|Docetaxel|docetaxel|mesh-list
24651817|NCT01234051|Oxaliplatin|oxaliplatin|mesh-list
24651818|NCT01234051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651819|NCT01234051|Tubulin Modulators|tubulin modulators|mesh-ancestor
24651820|NCT01234051|Antimitotic Agents|antimitotic agents|mesh-ancestor
24651821|NCT01234051|Mitosis Modulators|mitosis modulators|mesh-ancestor
24943952|NCT03965442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943953|NCT03965442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943955|NCT03965637|Vitamins|vitamins|mesh-ancestor
24943956|NCT03965637|Micronutrients|micronutrients|mesh-ancestor
24943957|NCT03965637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943958|NCT03965637|Antioxidants|antioxidants|mesh-ancestor
24943959|NCT03965637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943960|NCT03965637|Protective Agents|protective agents|mesh-ancestor
24769132|NCT01812720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651877|NCT01234298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24651878|NCT01234324|Cisplatin|cisplatin|mesh-list
24651890|NCT01234324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24651892|NCT01234454|Risperidone|risperidone|mesh-list
24651893|NCT01234454|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24651894|NCT01234454|Serotonin Agents|serotonin agents|mesh-ancestor
24651909|NCT01234454|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24651910|NCT01234454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24651912|NCT01234506|Secoisolariciresinol|secoisolariciresinol|mesh-list
24651913|NCT01234506|Vitamins|vitamins|mesh-ancestor
24651915|NCT01234506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651916|NCT01234506|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24651918|NCT01234506|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24769146|NCT01812928|Sensory System Agents|sensory system agents|mesh-ancestor
24798925|NCT01966172|Sensory System Agents|sensory system agents|mesh-ancestor
24651978|NCT01234896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24651979|NCT01234896|Cholinergic Agents|cholinergic agents|mesh-ancestor
24651980|NCT01234896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24651981|NCT01234896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651982|NCT01234935|Gemcitabine|gemcitabine|mesh-list
25664090|NCT01665950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25664091|NCT01665950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25664092|NCT01665950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651983|NCT01234935|Dasatinib|dasatinib|mesh-list
24651984|NCT01234935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24651985|NCT01234935|Antimetabolites|antimetabolites|mesh-ancestor
24651986|NCT01234935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651987|NCT01234935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651988|NCT01234935|Antiviral Agents|antiviral agents|mesh-ancestor
25852532|NCT00056693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652000|NCT01234974|Immunologic Factors|immunologic factors|mesh-ancestor
24652001|NCT01234974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652002|NCT01234974|Hormones|hormones|mesh-ancestor
24652003|NCT01234974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24652004|NCT01235013|Maraviroc|maraviroc|mesh-list
24652005|NCT01235013|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24652006|NCT01235013|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24652007|NCT01235013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652008|NCT01235013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24652009|NCT01235013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24652010|NCT01235013|Antiviral Agents|antiviral agents|mesh-ancestor
24652011|NCT01235013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24652012|NCT01235013|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24652013|NCT01235117|Azacitidine|azacitidine|mesh-list
24652014|NCT01235117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24652015|NCT01235117|Antimetabolites|antimetabolites|mesh-ancestor
24652016|NCT01235117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715698|NCT01538225|Analgesics|analgesics|mesh-ancestor
24652017|NCT01235117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652018|NCT01235117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652033|NCT01235260|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
24652034|NCT01235260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24652035|NCT01235260|Growth Substances|growth substances|mesh-ancestor
24652036|NCT01235260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652037|NCT01235273|Hormones|hormones|mesh-list
25852533|NCT00056797|Interleukin-2|interleukin-2|mesh-list
25202722|NCT02719132|Metformin|metformin|mesh-list
25202723|NCT02719132|Dapagliflozin|dapagliflozin|mesh-list
24652040|NCT01235325|Vitamin K|vitamin k|mesh-list
24652041|NCT01235325|Vitamin K 1|vitamin k 1|mesh-list
24652042|NCT01235325|Vitamins|vitamins|mesh-ancestor
24652043|NCT01235325|Micronutrients|micronutrients|mesh-ancestor
24652044|NCT01235325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652045|NCT01235325|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24652046|NCT01235325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24652047|NCT01235325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652048|NCT01235325|Hemostatics|hemostatics|mesh-ancestor
24652049|NCT01235325|Coagulants|coagulants|mesh-ancestor
24652050|NCT01235416|Motesanib diphosphate|motesanib diphosphate|mesh-list
24652052|NCT01235416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652053|NCT01235416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652106|NCT01236495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24652107|NCT01236495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652108|NCT01236495|Analgesics|analgesics|mesh-ancestor
24652109|NCT01236495|Sensory System Agents|sensory system agents|mesh-ancestor
24944122|NCT03963193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944123|NCT03963193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24944124|NCT03963193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24944126|NCT03963115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24944127|NCT03963115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24944128|NCT03963115|Adrenergic Agents|adrenergic agents|mesh-ancestor
24944129|NCT03963115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24846613|NCT02243254|Ibuprofen|ibuprofen|mesh-list
25852534|NCT00056797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852535|NCT00056797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25852536|NCT00056797|Analgesics|analgesics|mesh-ancestor
25852537|NCT00056797|Sensory System Agents|sensory system agents|mesh-ancestor
24715730|NCT01538381|Afatinib|afatinib|mesh-list
24652115|NCT01236586|R04929097|r04929097|mesh-list
24652116|NCT01236586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24652117|NCT01236586|Antiemetics|antiemetics|mesh-ancestor
24652118|NCT01236586|Autonomic Agents|autonomic agents|mesh-ancestor
24652119|NCT01236586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24652120|NCT01236586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652121|NCT01236586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24652122|NCT01236586|Glucocorticoids|glucocorticoids|mesh-ancestor
24652123|NCT01236586|Hormones|hormones|mesh-ancestor
24652124|NCT01236586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25424469|NCT02252172|Growth Inhibitors|growth inhibitors|mesh-ancestor
25852538|NCT00056797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24466595|NCT00374101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25852539|NCT00056797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852540|NCT00056810|4-Aminopyridine|4-aminopyridine|mesh-list
24652125|NCT01236586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24652126|NCT01236586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652127|NCT01236586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24944144|NCT03963024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652128|NCT01236586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652129|NCT01236612|Chloroquine|chloroquine|mesh-list
24652130|NCT01236612|Proguanil|proguanil|mesh-list
24652131|NCT01236612|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
24652133|NCT01236612|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24652134|NCT01236612|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24652135|NCT01236612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24652136|NCT01236612|Antimalarials|antimalarials|mesh-ancestor
25202724|NCT02719132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24652142|NCT01236651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24652144|NCT01236651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24652145|NCT01236651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652146|NCT01236651|Analgesics|analgesics|mesh-ancestor
24652147|NCT01236651|Sensory System Agents|sensory system agents|mesh-ancestor
24652148|NCT01236651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24652149|NCT01236651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24652150|NCT01236651|Parasympatholytics|parasympatholytics|mesh-ancestor
24652151|NCT01236651|Autonomic Agents|autonomic agents|mesh-ancestor
24652152|NCT01236651|Vasodilator Agents|vasodilator agents|mesh-ancestor
24652153|NCT01236716|Gemcitabine|gemcitabine|mesh-list
24652154|NCT01236716|Paclitaxel|paclitaxel|mesh-list
24652155|NCT01236716|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24652156|NCT01236716|Carboplatin|carboplatin|mesh-list
24652157|NCT01236716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24652158|NCT01236716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652159|NCT01236716|Tubulin Modulators|tubulin modulators|mesh-ancestor
24652160|NCT01236716|Antimitotic Agents|antimitotic agents|mesh-ancestor
24652161|NCT01236716|Mitosis Modulators|mitosis modulators|mesh-ancestor
24652162|NCT01236716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652163|NCT01236716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24652165|NCT01236716|Antiviral Agents|antiviral agents|mesh-ancestor
24652166|NCT01236716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24652167|NCT01236716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652168|NCT01236716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24944145|NCT03963024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24944146|NCT03963128|Vitamin D|vitamin d|mesh-list
24846642|NCT02243436|Etoposide|etoposide|mesh-list
24652169|NCT01236716|Immunologic Factors|immunologic factors|mesh-ancestor
24652170|NCT01236716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652171|NCT01236859|Gabapentin|gabapentin|mesh-list
24652172|NCT01236859|Analgesics|analgesics|mesh-ancestor
24652173|NCT01236859|Sensory System Agents|sensory system agents|mesh-ancestor
24652174|NCT01236859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24652176|NCT01236859|Anticonvulsants|anticonvulsants|mesh-ancestor
24652184|NCT01236859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652185|NCT01236859|Antimanic Agents|antimanic agents|mesh-ancestor
24652203|NCT01237028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24652204|NCT01237028|Vitamins|vitamins|mesh-ancestor
24652205|NCT01237028|Micronutrients|micronutrients|mesh-ancestor
24652206|NCT01237028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24652207|NCT01237067|Carboplatin|carboplatin|mesh-list
24652208|NCT01237067|Olaparib|olaparib|mesh-list
24652234|NCT01237249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652235|NCT01237249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24652236|NCT01237249|Alkylating Agents|alkylating agents|mesh-ancestor
24652237|NCT01237249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652238|NCT01237249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24652239|NCT01237249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24652240|NCT01237249|Immunologic Factors|immunologic factors|mesh-ancestor
24652241|NCT01237249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24652242|NCT01237249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24652243|NCT01237249|Growth Substances|growth substances|mesh-ancestor
25664093|NCT01666119|Buprenorphine|buprenorphine|mesh-list
25664094|NCT01666119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24652244|NCT01237249|Growth Inhibitors|growth inhibitors|mesh-ancestor
24652247|NCT01237262|Infliximab|infliximab|mesh-list
24652248|NCT01237262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24652249|NCT01237262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25664095|NCT01666119|Narcotics|narcotics|mesh-ancestor
24449243|NCT00314743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652250|NCT01237262|Dermatologic Agents|dermatologic agents|mesh-ancestor
24652251|NCT01237262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24652252|NCT01237262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24652253|NCT01237262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24652254|NCT01237262|Analgesics|analgesics|mesh-ancestor
24652255|NCT01237262|Sensory System Agents|sensory system agents|mesh-ancestor
24652256|NCT01237262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24652257|NCT01237262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652258|NCT01237262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24652259|NCT01237262|Immunologic Factors|immunologic factors|mesh-ancestor
24652260|NCT01237275|Sertraline|sertraline|mesh-list
24652261|NCT01237275|Fluoxetine|fluoxetine|mesh-list
24652262|NCT01237275|Paroxetine|paroxetine|mesh-list
24652263|NCT01237275|Antidepressive Agents|antidepressive agents|mesh-ancestor
24652264|NCT01237275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25202725|NCT02719132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652265|NCT01237275|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24944315|NCT03961360|Aspirin|aspirin|mesh-list
24944316|NCT03961360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24652330|NCT01237808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652331|NCT01237808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24652332|NCT01237808|Antimetabolites|antimetabolites|mesh-ancestor
24652333|NCT01237808|Antiviral Agents|antiviral agents|mesh-ancestor
24652334|NCT01237808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24652335|NCT01237808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24652336|NCT01237808|Immunologic Factors|immunologic factors|mesh-ancestor
24652337|NCT01237808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652338|NCT01237808|Keratolytic Agents|keratolytic agents|mesh-ancestor
24652339|NCT01237808|Dermatologic Agents|dermatologic agents|mesh-ancestor
24652340|NCT01237925|Chlorpheniramine|chlorpheniramine|mesh-list
24652341|NCT01237925|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
24652342|NCT01237925|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24652343|NCT01237925|Histamine Antagonists|histamine antagonists|mesh-ancestor
24652344|NCT01237925|Histamine Agents|histamine agents|mesh-ancestor
24652345|NCT01237925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24652584|NCT01239004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24652346|NCT01237925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652347|NCT01237925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652348|NCT01237925|Antipruritics|antipruritics|mesh-ancestor
24652349|NCT01237925|Dermatologic Agents|dermatologic agents|mesh-ancestor
24652350|NCT01237925|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24652351|NCT01237977|Botulinum Toxins|botulinum toxins|mesh-list
24652352|NCT01237977|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24652368|NCT01238029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652369|NCT01238029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24652370|NCT01238029|Tubulin Modulators|tubulin modulators|mesh-ancestor
24652371|NCT01238029|Antimitotic Agents|antimitotic agents|mesh-ancestor
24944864|NCT03956823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652406|NCT01238133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652407|NCT01238133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652408|NCT01238146|Rituximab|rituximab|mesh-list
24652409|NCT01238146|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24652410|NCT01238146|Obatoclax|obatoclax|mesh-list
24652411|NCT01238146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24652412|NCT01238146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652413|NCT01238146|Immunologic Factors|immunologic factors|mesh-ancestor
24652414|NCT01238146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652415|NCT01238146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24652416|NCT01238146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24652417|NCT01238146|Alkylating Agents|alkylating agents|mesh-ancestor
24652420|NCT01238185|Aspirin|aspirin|mesh-list
24652463|NCT01238406|Pancrelipase|pancrelipase|mesh-list
24652464|NCT01238406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24652465|NCT01238523|Calpastatin|calpastatin|mesh-list
24652466|NCT01238523|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
24652467|NCT01238523|Protease Inhibitors|protease inhibitors|mesh-ancestor
24652468|NCT01238523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652469|NCT01238523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652471|NCT01238562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24652472|NCT01238562|Immunologic Factors|immunologic factors|mesh-ancestor
24652473|NCT01238562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652475|NCT01238627|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24652524|NCT01238718|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25664096|NCT01666119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24652536|NCT01238770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24652538|NCT01238796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24652539|NCT01238796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24652540|NCT01238926|Vitamins|vitamins|mesh-list
24652559|NCT01238965|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
24652560|NCT01238965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24652561|NCT01238965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652562|NCT01238965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24652563|NCT01238965|Antimetabolites|antimetabolites|mesh-ancestor
24652564|NCT01238965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652565|NCT01238965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24652566|NCT01238965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652567|NCT01238965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24652568|NCT01238965|Immunologic Factors|immunologic factors|mesh-ancestor
24944865|NCT03956823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24944866|NCT03956823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944867|NCT03956823|Vasodilator Agents|vasodilator agents|mesh-ancestor
24944868|NCT03956823|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24944869|NCT03956823|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24798948|NCT01966263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24798949|NCT01966263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592816|NCT00925457|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24592817|NCT00925457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24846657|NCT02243436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24652569|NCT01238965|Antidotes|antidotes|mesh-ancestor
24652570|NCT01238965|Protective Agents|protective agents|mesh-ancestor
24652571|NCT01238965|Vitamin B Complex|vitamin b complex|mesh-ancestor
24652572|NCT01238965|Vitamins|vitamins|mesh-ancestor
24652573|NCT01238965|Micronutrients|micronutrients|mesh-ancestor
24652574|NCT01238965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652575|NCT01238978|Vildagliptin|vildagliptin|mesh-list
24652576|NCT01238978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24652577|NCT01238978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652578|NCT01238978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24652585|NCT01239004|Antimetabolites|antimetabolites|mesh-ancestor
25852541|NCT00056810|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24716087|NCT01539733|Olanzapine|olanzapine|mesh-list
25230657|NCT02594241|Hormones|hormones|mesh-ancestor
24652586|NCT01239004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652587|NCT01239004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24652589|NCT01239017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24652590|NCT01239017|Analgesics|analgesics|mesh-ancestor
24652591|NCT01239017|Sensory System Agents|sensory system agents|mesh-ancestor
24652592|NCT01239017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24652593|NCT01239017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652605|NCT01239173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24652606|NCT01239173|Adrenergic Agents|adrenergic agents|mesh-ancestor
24652607|NCT01239173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24774677|NCT01847326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24652629|NCT01239459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652630|NCT01239459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24652631|NCT01239459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24652632|NCT01239459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24652633|NCT01239459|Immunologic Factors|immunologic factors|mesh-ancestor
24592818|NCT00925457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592820|NCT00925457|Autonomic Agents|autonomic agents|mesh-ancestor
24592821|NCT00925457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24592822|NCT00925457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592823|NCT00925457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24592824|NCT00925457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24592825|NCT00925457|Dopamine Agents|dopamine agents|mesh-ancestor
24592826|NCT00925457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24592828|NCT00925730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24592829|NCT00925730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24592830|NCT00925730|Analgesics|analgesics|mesh-ancestor
24652634|NCT01239459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24652635|NCT01239459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24652636|NCT01239459|Antimetabolites|antimetabolites|mesh-ancestor
24652638|NCT01239459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24652666|NCT01239498|Autonomic Agents|autonomic agents|mesh-ancestor
24652667|NCT01239498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24652668|NCT01239498|Respiratory System Agents|respiratory system agents|mesh-ancestor
24652669|NCT01239498|Mydriatics|mydriatics|mesh-ancestor
24716130|NCT01540084|Propofol|propofol|mesh-list
24652718|NCT01239849|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24652719|NCT01239849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652721|NCT01239875|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24652722|NCT01239875|Immunologic Factors|immunologic factors|mesh-ancestor
24652723|NCT01239875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592832|NCT00925730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24652783|NCT01240109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24652784|NCT01240109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652785|NCT01240109|Analgesics|analgesics|mesh-ancestor
24652786|NCT01240109|Sensory System Agents|sensory system agents|mesh-ancestor
24652787|NCT01240109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24652788|NCT01240148|Lidocaine|lidocaine|mesh-list
24652789|NCT01240148|Anesthetics, Local|anesthetics, local|mesh-ancestor
24652790|NCT01240148|Anesthetics|anesthetics|mesh-ancestor
24652791|NCT01240148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24652792|NCT01240148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852542|NCT00056810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24652815|NCT01240226|Hormone Antagonists|hormone antagonists|mesh-ancestor
24592835|NCT00925730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24592836|NCT00925730|Dermatologic Agents|dermatologic agents|mesh-ancestor
24592837|NCT00925730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24592838|NCT00925730|Immunologic Factors|immunologic factors|mesh-ancestor
24592839|NCT00925730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24592840|NCT00925730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24846685|NCT02243553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24652816|NCT01240226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24652817|NCT01240226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652818|NCT01240226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24652820|NCT01240252|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24652821|NCT01240252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24652822|NCT01240252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652824|NCT01240265|Ergocalciferols|ergocalciferols|mesh-list
24652825|NCT01240265|Cholecalciferol|cholecalciferol|mesh-list
24652827|NCT01240265|Micronutrients|micronutrients|mesh-ancestor
24652828|NCT01240265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652829|NCT01240265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24652830|NCT01240265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24652831|NCT01240408|Lenvatinib|lenvatinib|mesh-list
24652882|NCT01240850|Glucocorticoids|glucocorticoids|mesh-ancestor
24652883|NCT01240850|Hormones|hormones|mesh-ancestor
24652884|NCT01240850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24716195|NCT01540526|Axitinib|axitinib|mesh-list
24652885|NCT01240850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652886|NCT01240850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24652887|NCT01240850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652888|NCT01240850|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24652889|NCT01240850|Abortifacient Agents|abortifacient agents|mesh-ancestor
24652890|NCT01240850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24652891|NCT01240850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24652892|NCT01240850|Antimetabolites|antimetabolites|mesh-ancestor
24652893|NCT01240850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652894|NCT01240850|Dermatologic Agents|dermatologic agents|mesh-ancestor
24652895|NCT01240850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652896|NCT01240850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24652936|NCT01241006|Prednisone|prednisone|mesh-list
24652937|NCT01241006|Glucocorticoids|glucocorticoids|mesh-list
24652938|NCT01241006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24652939|NCT01241006|Antiemetics|antiemetics|mesh-ancestor
24652940|NCT01241006|Autonomic Agents|autonomic agents|mesh-ancestor
24652941|NCT01241006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24652942|NCT01241006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592841|NCT00925730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852543|NCT00056810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622194|NCT01065987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24622195|NCT01065987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622196|NCT01065987|Anticonvulsants|anticonvulsants|mesh-ancestor
24622197|NCT01065987|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25852544|NCT00056823|Ranibizumab|ranibizumab|mesh-list
25852545|NCT00056823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25852546|NCT00056823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25852547|NCT00056823|Growth Substances|growth substances|mesh-ancestor
25852548|NCT00056823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652964|NCT01241097|Ezetimibe|ezetimibe|mesh-list
24652965|NCT01241097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24652966|NCT01241097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24652967|NCT01241097|Antimetabolites|antimetabolites|mesh-ancestor
24652968|NCT01241097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652969|NCT01241097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24652970|NCT01241097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24652971|NCT01241097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652972|NCT01241110|Ofloxacin|ofloxacin|mesh-list
24652973|NCT01241110|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24652974|NCT01241110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24652975|NCT01241110|Renal Agents|renal agents|mesh-ancestor
24610650|NCT01004315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610651|NCT01004315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610652|NCT01004315|Urological Agents|urological agents|mesh-ancestor
24610653|NCT01004380|Carboplatin|carboplatin|mesh-list
24854074|NCT02271555|Analgesics|analgesics|mesh-ancestor
24854075|NCT02271555|Sensory System Agents|sensory system agents|mesh-ancestor
24854076|NCT02271555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24854077|NCT02271646|Bupivacaine|bupivacaine|mesh-list
24854078|NCT02271646|Anesthetics, Local|anesthetics, local|mesh-ancestor
24854079|NCT02271646|Anesthetics|anesthetics|mesh-ancestor
24652976|NCT01241110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24652977|NCT01241110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24652978|NCT01241110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24652979|NCT01241110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774678|NCT01847326|Immunologic Factors|immunologic factors|mesh-ancestor
24622206|NCT01065987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622208|NCT01066013|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24622209|NCT01066091|Palmitic Acid|palmitic acid|mesh-list
24622210|NCT01066091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622211|NCT01066091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622212|NCT01066169|Lactitol|lactitol|mesh-list
24653011|NCT01241409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24653012|NCT01241409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24653013|NCT01241409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653014|NCT01241409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653015|NCT01241422|Montelukast|montelukast|mesh-list
24653016|NCT01241422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24653017|NCT01241422|Respiratory System Agents|respiratory system agents|mesh-ancestor
24653018|NCT01241422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24653019|NCT01241422|Hormone Antagonists|hormone antagonists|mesh-ancestor
24653020|NCT01241422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24653042|NCT01241682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24653043|NCT01241682|Immunologic Factors|immunologic factors|mesh-ancestor
24653044|NCT01241682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653045|NCT01241682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24653046|NCT01241682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24653047|NCT01241682|Alkylating Agents|alkylating agents|mesh-ancestor
24653094|NCT01242046|Caffeine|caffeine|mesh-list
24653095|NCT01242046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24653096|NCT01242046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653098|NCT01242046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653099|NCT01242046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653100|NCT01242046|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24653101|NCT01242046|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24653102|NCT01242046|Purinergic Agents|purinergic agents|mesh-ancestor
24653116|NCT01242098|Autonomic Agents|autonomic agents|mesh-ancestor
24653117|NCT01242098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25852549|NCT00056823|Growth Inhibitors|growth inhibitors|mesh-ancestor
25852550|NCT00056823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653132|NCT01242202|Acarbose|acarbose|mesh-list
24653133|NCT01242202|Voglibose|voglibose|mesh-list
24622213|NCT01066169|Cathartics|cathartics|mesh-ancestor
24798950|NCT01966263|Sensory System Agents|sensory system agents|mesh-ancestor
24798951|NCT01966263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24798952|NCT01966263|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24798953|NCT01966263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24798954|NCT01966263|Adrenergic Agents|adrenergic agents|mesh-ancestor
24944870|NCT03957083|Oxytocin|oxytocin|mesh-list
24944997|NCT03955458|Ropivacaine|ropivacaine|mesh-list
24944998|NCT03955458|Anesthetics, Local|anesthetics, local|mesh-ancestor
25202726|NCT02719132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25202727|NCT02719132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202728|NCT02718820|Docetaxel|docetaxel|mesh-list
25852551|NCT00056836|Ranibizumab|ranibizumab|mesh-list
25202729|NCT02718820|Pembrolizumab|pembrolizumab|mesh-list
25202730|NCT02718820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25202731|NCT02718820|Tubulin Modulators|tubulin modulators|mesh-ancestor
25202732|NCT02718820|Antimitotic Agents|antimitotic agents|mesh-ancestor
25202733|NCT02718820|Mitosis Modulators|mitosis modulators|mesh-ancestor
25202734|NCT02718820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202735|NCT02718820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25202736|NCT02718950|Liraglutide|liraglutide|mesh-list
24944999|NCT03955458|Anesthetics|anesthetics|mesh-ancestor
24945000|NCT03955458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24945001|NCT03955458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945002|NCT03955458|Sensory System Agents|sensory system agents|mesh-ancestor
24945003|NCT03955458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24945004|NCT03955497|Hyaluronic Acid|hyaluronic acid|mesh-list
24945005|NCT03955497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24653134|NCT01242202|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
24653135|NCT01242202|Miglitol|miglitol|mesh-list
24653136|NCT01242202|Ipragliflozin|ipragliflozin|mesh-list
24653137|NCT01242202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653138|NCT01242202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653139|NCT01242202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24653140|NCT01242202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653141|NCT01242202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24653142|NCT01242215|Glimepiride|glimepiride|mesh-list
24653143|NCT01242215|Gliclazide|gliclazide|mesh-list
24653144|NCT01242215|Glyburide|glyburide|mesh-list
24653145|NCT01242215|Ipragliflozin|ipragliflozin|mesh-list
24653146|NCT01242215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24653147|NCT01242215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24653148|NCT01242215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653149|NCT01242215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24653153|NCT01242228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24653159|NCT01242228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24653160|NCT01242228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653161|NCT01242228|Incretins|incretins|mesh-ancestor
24653162|NCT01242228|Hormones|hormones|mesh-ancestor
24653163|NCT01242228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24653164|NCT01242228|Protease Inhibitors|protease inhibitors|mesh-ancestor
24653165|NCT01242228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653166|NCT01242228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653167|NCT01242228|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24945009|NCT03955497|Protective Agents|protective agents|mesh-ancestor
24945010|NCT03954990|Metronidazole|metronidazole|mesh-list
24945011|NCT03954990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24945012|NCT03954990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24945013|NCT03954990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24945014|NCT03954990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24945015|NCT03954964|Analgesics, Opioid|analgesics, opioid|mesh-list
24945016|NCT03954964|Narcotics|narcotics|mesh-ancestor
24945017|NCT03954964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24653221|NCT01242449|Antimitotic Agents|antimitotic agents|mesh-ancestor
24653222|NCT01242449|Mitosis Modulators|mitosis modulators|mesh-ancestor
24653223|NCT01242449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653224|NCT01242566|Temozolomide|temozolomide|mesh-list
24653225|NCT01242566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24653226|NCT01242566|Alkylating Agents|alkylating agents|mesh-ancestor
24670347|NCT02936622|Tubulin Modulators|tubulin modulators|mesh-ancestor
24653227|NCT01242566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653228|NCT01242566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653231|NCT01242579|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24653232|NCT01242579|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24653250|NCT01242605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24653251|NCT01242605|Immunologic Factors|immunologic factors|mesh-ancestor
24653252|NCT01242605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653257|NCT01242631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653258|NCT01242774|Panobinostat|panobinostat|mesh-list
24653259|NCT01242774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653260|NCT01242774|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24653261|NCT01242774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653262|NCT01242774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653264|NCT01242787|Antiviral Agents|antiviral agents|mesh-ancestor
24653265|NCT01242787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24653302|NCT01243203|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24653303|NCT01243203|Cholinergic Agents|cholinergic agents|mesh-ancestor
25424470|NCT02252042|Docetaxel|docetaxel|mesh-list
25269305|NCT02410694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24945018|NCT03954964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945020|NCT03954964|Sensory System Agents|sensory system agents|mesh-ancestor
24945021|NCT03954964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25029550|NCT03602118|Phenobarbital|phenobarbital|mesh-list
24945022|NCT03954860|Tranexamic Acid|tranexamic acid|mesh-list
24945023|NCT03954860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24945024|NCT03954860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24945025|NCT03954860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945026|NCT03954860|Hemostatics|hemostatics|mesh-ancestor
24945214|NCT03952715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24945215|NCT03952715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24945216|NCT03952715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24945217|NCT03952715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945218|NCT03953118|Azithromycin|azithromycin|mesh-list
24945219|NCT03953118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24945220|NCT03953118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24945221|NCT03952832|Leflunomide|leflunomide|mesh-list
24846723|NCT02243553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24846724|NCT02243566|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24846725|NCT02243566|Telmisartan|telmisartan|mesh-list
24846726|NCT02243566|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
24846727|NCT02243566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24846728|NCT02243566|Diuretics|diuretics|mesh-ancestor
24846729|NCT02243566|Natriuretic Agents|natriuretic agents|mesh-ancestor
24846730|NCT02243566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653460|NCT01243970|Mydriatics|mydriatics|mesh-ancestor
24846731|NCT02243566|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24846734|NCT02243566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24945224|NCT03952832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24945225|NCT03952832|Immunologic Factors|immunologic factors|mesh-ancestor
24945226|NCT03952832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945227|NCT03952572|Prednisone|prednisone|mesh-list
24653344|NCT01243476|Growth Substances|growth substances|mesh-ancestor
24653345|NCT01243476|Growth Inhibitors|growth inhibitors|mesh-ancestor
24653346|NCT01243476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653347|NCT01243528|Vitamin D|vitamin d|mesh-list
24653348|NCT01243528|Vitamins|vitamins|mesh-ancestor
24653349|NCT01243528|Micronutrients|micronutrients|mesh-ancestor
24653350|NCT01243528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653351|NCT01243528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24653352|NCT01243632|Gemcitabine|gemcitabine|mesh-list
24653353|NCT01243632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24653354|NCT01243632|Antimetabolites|antimetabolites|mesh-ancestor
24653355|NCT01243632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653356|NCT01243632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653370|NCT01243697|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24653371|NCT01243697|Contraceptive Agents|contraceptive agents|mesh-ancestor
24653372|NCT01243697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24653373|NCT01243697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653374|NCT01243697|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24653375|NCT01243697|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24653376|NCT01243697|Progestins|progestins|mesh-ancestor
24653377|NCT01243697|Hormones|hormones|mesh-ancestor
24653378|NCT01243697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24653379|NCT01243710|Taurolidine|taurolidine|mesh-list
24653380|NCT01243710|Heparin|heparin|mesh-list
24653381|NCT01243710|Anticoagulants|anticoagulants|mesh-ancestor
24653382|NCT01243710|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24653384|NCT01243710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653385|NCT01243710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24653386|NCT01243710|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24653387|NCT01243710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653417|NCT01243788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24653418|NCT01243788|Adrenergic Agents|adrenergic agents|mesh-ancestor
24653419|NCT01243788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24945474|NCT03950544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24945475|NCT03950544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24945476|NCT03950544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945478|NCT03950141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24945479|NCT03950141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25202737|NCT02718950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24945480|NCT03950141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25424471|NCT02252042|Pembrolizumab|pembrolizumab|mesh-list
25664097|NCT01666119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269327|NCT02410746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24966948|NCT03764163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25852552|NCT00056836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25852553|NCT00056836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25852554|NCT00056836|Growth Substances|growth substances|mesh-ancestor
25852555|NCT00056836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852556|NCT00056836|Growth Inhibitors|growth inhibitors|mesh-ancestor
25852557|NCT00056836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852559|NCT00056875|Mitosis Modulators|mitosis modulators|mesh-ancestor
25852560|NCT00056875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852561|NCT00056966|Fludarabine|fludarabine|mesh-list
25852562|NCT00056966|Alemtuzumab|alemtuzumab|mesh-list
24945481|NCT03950141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852563|NCT00056966|Tacrolimus|tacrolimus|mesh-list
25852564|NCT00056966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852565|NCT00056966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852566|NCT00056966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25852567|NCT00056966|Immunologic Factors|immunologic factors|mesh-ancestor
25852568|NCT00056966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852569|NCT00056966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25852570|NCT00056966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24945482|NCT03950362|Avelumab|avelumab|mesh-list
24945483|NCT03950362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24653420|NCT01243788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653421|NCT01243801|Ketamine|ketamine|mesh-list
24653422|NCT01243801|Analgesics|analgesics|mesh-ancestor
24653423|NCT01243801|Sensory System Agents|sensory system agents|mesh-ancestor
24653424|NCT01243801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24653425|NCT01243801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653426|NCT01243801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24653427|NCT01243801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24653428|NCT01243801|Anesthetics, General|anesthetics, general|mesh-ancestor
24653429|NCT01243801|Anesthetics|anesthetics|mesh-ancestor
24653430|NCT01243801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24653431|NCT01243801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24653455|NCT01243827|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24653456|NCT01243970|Phenylephrine|phenylephrine|mesh-list
24653457|NCT01243970|Oxymetazoline|oxymetazoline|mesh-list
24653458|NCT01243970|Ephedrine|ephedrine|mesh-list
24653459|NCT01243970|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24653461|NCT01243970|Autonomic Agents|autonomic agents|mesh-ancestor
24941405|NCT03991312|Itraconazole|itraconazole|mesh-list
24653462|NCT01243970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24945484|NCT03950362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24945485|NCT03950154|Bevacizumab|bevacizumab|mesh-list
24945486|NCT03950154|Capecitabine|capecitabine|mesh-list
24945487|NCT03950154|Oxaliplatin|oxaliplatin|mesh-list
24945488|NCT03950154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24945489|NCT03950154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24945490|NCT03950154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24945491|NCT03950154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24653463|NCT01243970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653464|NCT01243970|Sympathomimetics|sympathomimetics|mesh-ancestor
24653465|NCT01243970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24653478|NCT01243996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25664098|NCT01666119|Analgesics|analgesics|mesh-ancestor
25664099|NCT01666119|Sensory System Agents|sensory system agents|mesh-ancestor
25664100|NCT01666119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25664101|NCT01666119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25664102|NCT01666197|Diclofenac|diclofenac|mesh-list
25664103|NCT01666197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25664104|NCT01666197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25664105|NCT01666197|Analgesics|analgesics|mesh-ancestor
25664106|NCT01666197|Sensory System Agents|sensory system agents|mesh-ancestor
25664107|NCT01666197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25664108|NCT01666197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664109|NCT01666197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25664110|NCT01666197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25664111|NCT01666197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24653480|NCT01243996|Sensory System Agents|sensory system agents|mesh-ancestor
25275476|NCT02372357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24653481|NCT01243996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24653482|NCT01243996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653483|NCT01243996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24653484|NCT01243996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24653485|NCT01243996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24653486|NCT01243996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653487|NCT01243996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653488|NCT01244009|Niraparib|niraparib|mesh-list
24653489|NCT01244009|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24653490|NCT01244009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653491|NCT01244009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653642|NCT01244789|Carboplatin|carboplatin|mesh-list
24653492|NCT01244009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653493|NCT01244100|Aspirin|aspirin|mesh-list
24653494|NCT01244100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24653497|NCT01244100|Sensory System Agents|sensory system agents|mesh-ancestor
24653498|NCT01244100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24653499|NCT01244100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653500|NCT01244100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24653502|NCT01244100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24653503|NCT01244100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24653504|NCT01244100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653505|NCT01244100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24653506|NCT01244100|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24653507|NCT01244100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653509|NCT01244113|Propofol|propofol|mesh-list
24653510|NCT01244113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24653511|NCT01244113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24653512|NCT01244113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653513|NCT01244113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24653514|NCT01244113|Anesthetics, General|anesthetics, general|mesh-ancestor
24653515|NCT01244113|Anesthetics|anesthetics|mesh-ancestor
24653516|NCT01244178|Insulin|insulin|mesh-list
24653517|NCT01244178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24653518|NCT01244178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24653519|NCT01244178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653520|NCT01244204|Vitamin D|vitamin d|mesh-list
24945492|NCT03950154|Growth Substances|growth substances|mesh-ancestor
24653521|NCT01244204|Vitamins|vitamins|mesh-ancestor
24653522|NCT01244204|Micronutrients|micronutrients|mesh-ancestor
24653523|NCT01244204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653524|NCT01244204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24653525|NCT01244217|Fexofenadine|fexofenadine|mesh-list
24653526|NCT01244217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24653527|NCT01244217|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24653539|NCT01244230|Histamine Agents|histamine agents|mesh-ancestor
24653555|NCT01244256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24653556|NCT01244256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653557|NCT01244256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24653558|NCT01244256|Respiratory System Agents|respiratory system agents|mesh-ancestor
24653559|NCT01244256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24653560|NCT01244256|Antifungal Agents|antifungal agents|mesh-ancestor
24653561|NCT01244256|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24653562|NCT01244256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24653563|NCT01244256|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24653564|NCT01244256|Hormone Antagonists|hormone antagonists|mesh-ancestor
24653565|NCT01244256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24653590|NCT01244334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653592|NCT01244334|Autonomic Agents|autonomic agents|mesh-ancestor
24653593|NCT01244334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24653594|NCT01244334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24716561|NCT01542424|Biphasic Insulins|biphasic insulins|mesh-list
24653595|NCT01244334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24653596|NCT01244334|Protective Agents|protective agents|mesh-ancestor
24653597|NCT01244347|Folic Acid|folic acid|mesh-list
24653598|NCT01244347|Vitamin B Complex|vitamin b complex|mesh-list
24653599|NCT01244347|Hematinics|hematinics|mesh-ancestor
24653600|NCT01244347|Vitamins|vitamins|mesh-ancestor
24653601|NCT01244347|Micronutrients|micronutrients|mesh-ancestor
24653602|NCT01244347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653603|NCT01244360|Resveratrol|resveratrol|mesh-list
25664112|NCT01666197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653604|NCT01244360|Antioxidants|antioxidants|mesh-ancestor
25409437|NCT03382106|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25852571|NCT00056966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25852572|NCT00056979|Fludarabine|fludarabine|mesh-list
25269337|NCT02410590|Atropine|atropine|mesh-list
25269338|NCT02410590|Rocuronium|rocuronium|mesh-list
25269339|NCT02410590|Cisatracurium|cisatracurium|mesh-list
25852573|NCT00056979|Alemtuzumab|alemtuzumab|mesh-list
25852574|NCT00056979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852575|NCT00056979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25852576|NCT00057005|Cyclophosphamide|cyclophosphamide|mesh-list
25852577|NCT00057005|Alemtuzumab|alemtuzumab|mesh-list
25852578|NCT00057005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25852579|NCT00057005|Immunologic Factors|immunologic factors|mesh-ancestor
25852580|NCT00057005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852581|NCT00057005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24449322|NCT00314990|Vitamins|vitamins|mesh-ancestor
24653605|NCT01244360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653606|NCT01244360|Protective Agents|protective agents|mesh-ancestor
24653607|NCT01244360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653629|NCT01244659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653630|NCT01244659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653631|NCT01244698|Clindamycin|clindamycin|mesh-list
24653632|NCT01244698|Clindamycin palmitate|clindamycin palmitate|mesh-list
25852582|NCT00057005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25852583|NCT00057005|Alkylating Agents|alkylating agents|mesh-ancestor
25852584|NCT00057005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852585|NCT00057005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852586|NCT00057005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24653633|NCT01244698|Clindamycin phosphate|clindamycin phosphate|mesh-list
24653634|NCT01244698|Cefazolin|cefazolin|mesh-list
24653635|NCT01244698|Cefadroxil|cefadroxil|mesh-list
24653636|NCT01244698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24653637|NCT01244698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24653638|NCT01244698|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24653639|NCT01244698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653640|NCT01244698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653641|NCT01244789|Paclitaxel|paclitaxel|mesh-list
24653643|NCT01244789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24653680|NCT01244971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24653681|NCT01244971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653722|NCT01245452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653723|NCT01245452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24812605|NCT02053766|Anesthetics|anesthetics|mesh-ancestor
24653724|NCT01245452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24653725|NCT01245452|Immunologic Factors|immunologic factors|mesh-ancestor
24653726|NCT01245452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24615074|NCT01027689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24653727|NCT01245452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24653728|NCT01245530|Donepezil|donepezil|mesh-list
24653729|NCT01245530|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24653730|NCT01245530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653731|NCT01245530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653732|NCT01245530|Cholinergic Agents|cholinergic agents|mesh-ancestor
24653733|NCT01245530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24653734|NCT01245530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653735|NCT01245530|Nootropic Agents|nootropic agents|mesh-ancestor
24653736|NCT01245543|Docetaxel|docetaxel|mesh-list
24653737|NCT01245543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653738|NCT01245543|Tubulin Modulators|tubulin modulators|mesh-ancestor
24653739|NCT01245543|Antimitotic Agents|antimitotic agents|mesh-ancestor
24653740|NCT01245543|Mitosis Modulators|mitosis modulators|mesh-ancestor
24653741|NCT01245543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653742|NCT01245556|Ipilimumab|ipilimumab|mesh-list
25664113|NCT01666197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664114|NCT01666210|Dexamethasone|dexamethasone|mesh-list
25664115|NCT01666210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25664116|NCT01666210|Antiemetics|antiemetics|mesh-ancestor
25664117|NCT01666210|Autonomic Agents|autonomic agents|mesh-ancestor
25664118|NCT01666210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25664119|NCT01666210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664120|NCT01666210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25664121|NCT01666210|Glucocorticoids|glucocorticoids|mesh-ancestor
25664122|NCT01666210|Hormones|hormones|mesh-ancestor
25664123|NCT01666210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25664124|NCT01666210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25664125|NCT01666210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852587|NCT00057005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24653743|NCT01245556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25852588|NCT00057031|Calcitriol|calcitriol|mesh-list
24653744|NCT01245556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653745|NCT01245556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24827180|NCT02137733|Bisoprolol|bisoprolol|mesh-list
24945505|NCT03950271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24561867|NCT00763347|Incretins|incretins|mesh-ancestor
24798955|NCT01966263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24653789|NCT01245816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24653790|NCT01245816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24653791|NCT01245816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24653792|NCT01245816|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
24653793|NCT01245816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653794|NCT01245816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653795|NCT01245816|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24653796|NCT01245816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24653797|NCT01245816|Analgesics|analgesics|mesh-ancestor
24653798|NCT01245816|Sensory System Agents|sensory system agents|mesh-ancestor
24653799|NCT01245816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24653800|NCT01245816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653801|NCT01245816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24941450|NCT03990922|Morphine|morphine|mesh-list
24653802|NCT01245816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24653803|NCT01245816|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24774679|NCT01847326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653814|NCT01245868|Sensory System Agents|sensory system agents|mesh-ancestor
24653815|NCT01245868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24653816|NCT01245868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24653817|NCT01245868|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24653818|NCT01245868|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24653819|NCT01245868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24653820|NCT01245868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653821|NCT01245881|Sunscreening Agents|sunscreening agents|mesh-list
24653822|NCT01245881|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24653823|NCT01245881|Protective Agents|protective agents|mesh-ancestor
24653824|NCT01245881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653825|NCT01245881|Dermatologic Agents|dermatologic agents|mesh-ancestor
24653826|NCT01245894|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24653827|NCT01245894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24653828|NCT01245894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24653829|NCT01245894|Antimetabolites|antimetabolites|mesh-ancestor
24798958|NCT01966263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24798960|NCT01966263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24653832|NCT01245894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24653833|NCT01245894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653836|NCT01245946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24653860|NCT01245959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24653861|NCT01245959|Immunologic Factors|immunologic factors|mesh-ancestor
25202738|NCT02718950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653862|NCT01245959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653863|NCT01245998|Dalteparin|dalteparin|mesh-list
24653864|NCT01245998|Tinzaparin|tinzaparin|mesh-list
24653865|NCT01245998|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24653866|NCT01245998|Anticoagulants|anticoagulants|mesh-ancestor
24653900|NCT01246180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653901|NCT01246180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653903|NCT01246180|Natriuretic Agents|natriuretic agents|mesh-ancestor
24653904|NCT01246180|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24653905|NCT01246180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24653906|NCT01246180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24653907|NCT01246180|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24653908|NCT01246180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24653909|NCT01246232|Amisulpride|amisulpride|mesh-list
24653910|NCT01246232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24653911|NCT01246232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24653912|NCT01246232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24653913|NCT01246232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653914|NCT01246232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24653945|NCT01246323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24653946|NCT01246323|Anesthetics, General|anesthetics, general|mesh-ancestor
24653949|NCT01246362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25664126|NCT01666314|Prednisone|prednisone|mesh-list
24653954|NCT01246362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24653955|NCT01246362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24653956|NCT01246362|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24653957|NCT01246362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25852589|NCT00057031|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25852590|NCT00057031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852591|NCT00057031|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25852592|NCT00057031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25852593|NCT00057031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852594|NCT00057031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25852595|NCT00057031|Vitamins|vitamins|mesh-ancestor
25852596|NCT00057031|Micronutrients|micronutrients|mesh-ancestor
25852597|NCT00057031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25852598|NCT00057122|Rifampin|rifampin|mesh-list
25852599|NCT00057122|Rifapentine|rifapentine|mesh-list
25852600|NCT00057122|Isoniazid|isoniazid|mesh-list
25852601|NCT00057122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25852602|NCT00057122|Antitubercular Agents|antitubercular agents|mesh-ancestor
25852603|NCT00057122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25852604|NCT00057122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25852605|NCT00057122|Leprostatic Agents|leprostatic agents|mesh-ancestor
25852606|NCT00057122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24653965|NCT01246453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653967|NCT01246557|Lenalidomide|lenalidomide|mesh-list
24653968|NCT01246557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24653969|NCT01246557|Antiemetics|antiemetics|mesh-ancestor
24653970|NCT01246557|Autonomic Agents|autonomic agents|mesh-ancestor
24653971|NCT01246557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24653972|NCT01246557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852607|NCT00057122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653973|NCT01246557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24653974|NCT01246557|Glucocorticoids|glucocorticoids|mesh-ancestor
24653975|NCT01246557|Hormones|hormones|mesh-ancestor
24653976|NCT01246557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24576482|NCT00838838|Androgens|androgens|mesh-ancestor
24653977|NCT01246557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24653978|NCT01246557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653979|NCT01246557|Immunologic Factors|immunologic factors|mesh-ancestor
24653980|NCT01246557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24653981|NCT01246557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24653982|NCT01246557|Growth Substances|growth substances|mesh-ancestor
24654002|NCT01246752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654003|NCT01246752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654004|NCT01246752|Antiviral Agents|antiviral agents|mesh-ancestor
24654005|NCT01246752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24654006|NCT01246752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24654007|NCT01246752|Immunologic Factors|immunologic factors|mesh-ancestor
24654008|NCT01246752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654009|NCT01246804|Raltegravir Potassium|raltegravir potassium|mesh-list
24654010|NCT01246804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24654011|NCT01246804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24654012|NCT01246804|Antiviral Agents|antiviral agents|mesh-ancestor
24654013|NCT01246804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24654014|NCT01246804|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24654015|NCT01246804|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25852608|NCT00057122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852609|NCT00057122|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25852610|NCT00057122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24654023|NCT01246817|Antifungal Agents|antifungal agents|mesh-ancestor
24654024|NCT01246817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24654025|NCT01246817|Immunologic Factors|immunologic factors|mesh-ancestor
24654026|NCT01246817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654083|NCT01247558|Vitamin B 12|vitamin b 12|mesh-list
24654084|NCT01247558|Vitamin B Complex|vitamin b complex|mesh-ancestor
24654086|NCT01247558|Micronutrients|micronutrients|mesh-ancestor
24654087|NCT01247558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654088|NCT01247688|Fludarabine|fludarabine|mesh-list
24654089|NCT01247688|Cyclophosphamide|cyclophosphamide|mesh-list
24654090|NCT01247688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654091|NCT01247688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945809|NCT03946514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24945810|NCT03946514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945811|NCT03946514|Vasodilator Agents|vasodilator agents|mesh-ancestor
24945812|NCT03946514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24945813|NCT03946514|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24945814|NCT03946514|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24945815|NCT03946514|Diuretics|diuretics|mesh-ancestor
24945816|NCT03946514|Natriuretic Agents|natriuretic agents|mesh-ancestor
25852611|NCT00057122|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24654121|NCT01247714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654123|NCT01247805|Citric Acid|citric acid|mesh-list
24654124|NCT01247805|Sodium Citrate|sodium citrate|mesh-list
24654125|NCT01247805|Anticoagulants|anticoagulants|mesh-ancestor
24654126|NCT01247805|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24654127|NCT01247805|Chelating Agents|chelating agents|mesh-ancestor
24654128|NCT01247805|Sequestering Agents|sequestering agents|mesh-ancestor
24654129|NCT01247805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654130|NCT01247805|Vasodilator Agents|vasodilator agents|mesh-ancestor
24654131|NCT01247805|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24654132|NCT01247805|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24654133|NCT01247805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654134|NCT01247805|Urological Agents|urological agents|mesh-ancestor
24654135|NCT01247857|Ropivacaine|ropivacaine|mesh-list
24654136|NCT01247857|Anesthetics, Local|anesthetics, local|mesh-ancestor
24654137|NCT01247857|Anesthetics|anesthetics|mesh-ancestor
24654138|NCT01247857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24654139|NCT01247857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654140|NCT01247857|Sensory System Agents|sensory system agents|mesh-ancestor
24654141|NCT01247857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24654143|NCT01247870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24654144|NCT01247870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654145|NCT01247909|Gentamicins|gentamicins|mesh-list
24654146|NCT01247909|Ceftriaxone|ceftriaxone|mesh-list
24654202|NCT01248195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24945817|NCT03946514|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24798962|NCT01966263|Mydriatics|mydriatics|mesh-ancestor
24798963|NCT01966263|Sympathomimetics|sympathomimetics|mesh-ancestor
24846796|NCT02244086|Bupivacaine|bupivacaine|mesh-list
24846797|NCT02244086|Anesthetics, Local|anesthetics, local|mesh-ancestor
24846798|NCT02244086|Anesthetics|anesthetics|mesh-ancestor
24846799|NCT02244086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24846800|NCT02244086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846801|NCT02244086|Sensory System Agents|sensory system agents|mesh-ancestor
24654218|NCT01248234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24654219|NCT01248234|Anesthetics, General|anesthetics, general|mesh-ancestor
24654220|NCT01248234|Anesthetics|anesthetics|mesh-ancestor
24654221|NCT01248260|Folic Acid|folic acid|mesh-list
24654222|NCT01248260|Hematinics|hematinics|mesh-ancestor
25852612|NCT00057122|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25852613|NCT00057122|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24798964|NCT01966263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24798965|NCT01966276|Methylphenidate|methylphenidate|mesh-list
24798966|NCT01966276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24798967|NCT01966276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798968|NCT01966276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24798969|NCT01966276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24798970|NCT01966276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24798971|NCT01966276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798972|NCT01966276|Dopamine Agents|dopamine agents|mesh-ancestor
24798973|NCT01966276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24798974|NCT01966289|Cyclophosphamide|cyclophosphamide|mesh-list
24654223|NCT01248260|Vitamin B Complex|vitamin b complex|mesh-ancestor
24654224|NCT01248260|Vitamins|vitamins|mesh-ancestor
24654225|NCT01248260|Micronutrients|micronutrients|mesh-ancestor
24654226|NCT01248260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654227|NCT01248273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
24654240|NCT01248299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24654241|NCT01248299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24654242|NCT01248299|Immunologic Factors|immunologic factors|mesh-ancestor
24654243|NCT01248299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654244|NCT01248325|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24654246|NCT01248338|Nebivolol|nebivolol|mesh-list
24654247|NCT01248338|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25424472|NCT02252042|Methotrexate|methotrexate|mesh-list
24654248|NCT01248338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24654249|NCT01248338|Sympatholytics|sympatholytics|mesh-ancestor
24654250|NCT01248338|Autonomic Agents|autonomic agents|mesh-ancestor
24654251|NCT01248338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24654252|NCT01248338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654253|NCT01248338|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24654254|NCT01248338|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24654255|NCT01248338|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24654256|NCT01248338|Adrenergic Agents|adrenergic agents|mesh-ancestor
24654263|NCT01248403|Paclitaxel|paclitaxel|mesh-list
24654266|NCT01248403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654267|NCT01248403|Tubulin Modulators|tubulin modulators|mesh-ancestor
24654268|NCT01248403|Antimitotic Agents|antimitotic agents|mesh-ancestor
24654269|NCT01248403|Mitosis Modulators|mitosis modulators|mesh-ancestor
24654272|NCT01248403|Immunologic Factors|immunologic factors|mesh-ancestor
24799005|NCT01966575|Medroxyprogesterone|medroxyprogesterone|mesh-list
24799006|NCT01966575|Progestins|progestins|mesh-list
24799007|NCT01966575|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24799008|NCT01966575|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24945899|NCT03944980|Antimitotic Agents|antimitotic agents|mesh-ancestor
24945960|NCT03944291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24945961|NCT03944291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945962|NCT03944291|Sensory System Agents|sensory system agents|mesh-ancestor
24945963|NCT03944291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24945964|NCT03944304|Paclitaxel|paclitaxel|mesh-list
24945965|NCT03944304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24945966|NCT03944304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654273|NCT01248403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654274|NCT01248442|Cholecalciferol|cholecalciferol|mesh-list
24654276|NCT01248442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24654277|NCT01248442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654278|NCT01248442|Vitamins|vitamins|mesh-ancestor
24654279|NCT01248442|Micronutrients|micronutrients|mesh-ancestor
24654280|NCT01248442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24654281|NCT01248481|Acarbose|acarbose|mesh-list
24654282|NCT01248481|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24654283|NCT01248481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654284|NCT01248481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654285|NCT01248481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24654286|NCT01248481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654287|NCT01248494|Letrozole|letrozole|mesh-list
24654325|NCT01248871|Propofol|propofol|mesh-list
24654326|NCT01248871|Sevoflurane|sevoflurane|mesh-list
24654327|NCT01248871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24654328|NCT01248871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24654329|NCT01248871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654330|NCT01248871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24654331|NCT01248871|Anesthetics, General|anesthetics, general|mesh-ancestor
24654332|NCT01248871|Anesthetics|anesthetics|mesh-ancestor
24945967|NCT03944304|Tubulin Modulators|tubulin modulators|mesh-ancestor
24945968|NCT03944304|Antimitotic Agents|antimitotic agents|mesh-ancestor
24945969|NCT03944304|Mitosis Modulators|mitosis modulators|mesh-ancestor
24945970|NCT03944304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945971|NCT03944252|Cetuximab|cetuximab|mesh-list
24945972|NCT03944252|Avelumab|avelumab|mesh-list
24945973|NCT03944252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24945974|NCT03944252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24945975|NCT03944070|Ranibizumab|ranibizumab|mesh-list
24945976|NCT03944070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24945977|NCT03944070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24945978|NCT03944070|Growth Substances|growth substances|mesh-ancestor
24945979|NCT03944070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945980|NCT03944070|Growth Inhibitors|growth inhibitors|mesh-ancestor
24654333|NCT01248871|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24654334|NCT01248871|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24654335|NCT01248871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24827415|NCT02138812|Paclitaxel|paclitaxel|mesh-list
24654351|NCT01248923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24654352|NCT01248923|Glucocorticoids|glucocorticoids|mesh-ancestor
24654353|NCT01248923|Hormones|hormones|mesh-ancestor
24654354|NCT01248923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24654355|NCT01248923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25852614|NCT00057122|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25852615|NCT00057122|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25852616|NCT00057122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25852617|NCT00057122|Antimetabolites|antimetabolites|mesh-ancestor
24654364|NCT01249001|Aprepitant|aprepitant|mesh-list
24654365|NCT01249001|Fosaprepitant|fosaprepitant|mesh-list
24654366|NCT01249001|Antiemetics|antiemetics|mesh-ancestor
24654367|NCT01249001|Autonomic Agents|autonomic agents|mesh-ancestor
24654368|NCT01249001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24654369|NCT01249001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654370|NCT01249001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24654371|NCT01249001|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24654372|NCT01249001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24654373|NCT01249001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654374|NCT01249339|Lobeline|lobeline|mesh-list
24654375|NCT01249339|Nicotine|nicotine|mesh-list
24654376|NCT01249339|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24654377|NCT01249339|Autonomic Agents|autonomic agents|mesh-ancestor
24654378|NCT01249339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24654379|NCT01249339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654380|NCT01249339|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24654381|NCT01249339|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24654382|NCT01249339|Cholinergic Agents|cholinergic agents|mesh-ancestor
24945981|NCT03944070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771353|NCT01826396|Irinotecan|irinotecan|mesh-list
24946117|NCT03942991|Mepivacaine|mepivacaine|mesh-list
24946262|NCT03942068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946263|NCT03942068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24946264|NCT03942068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654383|NCT01249339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25852618|NCT00057122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25852619|NCT00057265|Lamivudine|lamivudine|mesh-list
24654386|NCT01249352|Fluorouracil|fluorouracil|mesh-list
24654399|NCT01249430|Azacitidine|azacitidine|mesh-list
24654400|NCT01249430|Etoposide phosphate|etoposide phosphate|mesh-list
24654401|NCT01249430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24654402|NCT01249430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654403|NCT01249430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24654404|NCT01249430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24654405|NCT01249430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654406|NCT01249430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654443|NCT01249638|Capecitabine|capecitabine|mesh-list
24654444|NCT01249638|Irinotecan|irinotecan|mesh-list
24654445|NCT01249638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24654446|NCT01249638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654447|NCT01249638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24654448|NCT01249638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24654450|NCT01249638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654451|NCT01249638|Growth Inhibitors|growth inhibitors|mesh-ancestor
24654452|NCT01249638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24654453|NCT01249638|Antimetabolites|antimetabolites|mesh-ancestor
24654454|NCT01249638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654455|NCT01249638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24654456|NCT01249638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24654457|NCT01249638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654458|NCT01249677|Insulin Glargine|insulin glargine|mesh-list
24654459|NCT01249677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24654460|NCT01249677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654461|NCT01249690|Thalidomide|thalidomide|mesh-list
24654462|NCT01249690|Dexamethasone|dexamethasone|mesh-list
24654463|NCT01249690|Dexamethasone acetate|dexamethasone acetate|mesh-list
24654464|NCT01249690|Bortezomib|bortezomib|mesh-list
24654465|NCT01249690|Pirarubicin|pirarubicin|mesh-list
24654466|NCT01249690|Doxorubicin|doxorubicin|mesh-list
24654467|NCT01249690|BB 1101|bb 1101|mesh-list
24654468|NCT01249690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24654469|NCT01249690|Antiemetics|antiemetics|mesh-ancestor
24654470|NCT01249690|Autonomic Agents|autonomic agents|mesh-ancestor
24654471|NCT01249690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202739|NCT02718950|Incretins|incretins|mesh-ancestor
24829839|NCT02154776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654472|NCT01249690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654474|NCT01249690|Glucocorticoids|glucocorticoids|mesh-ancestor
24654475|NCT01249690|Hormones|hormones|mesh-ancestor
24654476|NCT01249690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24946265|NCT03942458|Clopidogrel|clopidogrel|mesh-list
24946266|NCT03942458|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24946267|NCT03942458|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24946268|NCT03942458|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24654496|NCT01249820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24654498|NCT01249846|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24654499|NCT01249846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24654500|NCT01249846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24654501|NCT01249846|Disinfectants|disinfectants|mesh-ancestor
24654503|NCT01249937|Triamcinolone|triamcinolone|mesh-list
24654504|NCT01249937|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24654505|NCT01249937|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24654506|NCT01249937|Ranibizumab|ranibizumab|mesh-list
24654507|NCT01249937|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24654532|NCT01250249|BCG Vaccine|bcg vaccine|mesh-list
24654533|NCT01250249|Immunologic Factors|immunologic factors|mesh-ancestor
24654534|NCT01250249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654535|NCT01250249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24654536|NCT01250340|Aspirin|aspirin|mesh-list
24654537|NCT01250340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24654538|NCT01250340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24654539|NCT01250340|Analgesics|analgesics|mesh-ancestor
24654540|NCT01250340|Sensory System Agents|sensory system agents|mesh-ancestor
24654541|NCT01250340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24654542|NCT01250340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654543|NCT01250340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24654544|NCT01250340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24654545|NCT01250340|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24654546|NCT01250340|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24654547|NCT01250340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654548|NCT01250340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25852620|NCT00057265|Telbivudine|telbivudine|mesh-list
25852621|NCT00057265|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25852622|NCT00057265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25852623|NCT00057265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852624|NCT00057265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852625|NCT00057265|Antiviral Agents|antiviral agents|mesh-ancestor
25852626|NCT00057265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25852627|NCT00057265|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25852628|NCT00057265|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24827431|NCT02139098|Amitriptyline|amitriptyline|mesh-list
24654550|NCT01250340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654552|NCT01250366|Ribavirin|ribavirin|mesh-list
24654553|NCT01250366|Antimetabolites|antimetabolites|mesh-ancestor
24654554|NCT01250366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654556|NCT01250366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24654557|NCT01250405|Cinacalcet|cinacalcet|mesh-list
24654558|NCT01250405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24654559|NCT01250405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654560|NCT01250405|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25202740|NCT02718950|Hormones|hormones|mesh-ancestor
24654561|NCT01250405|Hormone Antagonists|hormone antagonists|mesh-ancestor
24654562|NCT01250405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24654564|NCT01250457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24654565|NCT01250457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24654566|NCT01250457|Adrenergic Agents|adrenergic agents|mesh-ancestor
24654567|NCT01250457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24654568|NCT01250457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654580|NCT01250496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24654581|NCT01250496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654582|NCT01250496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24654583|NCT01250496|Respiratory System Agents|respiratory system agents|mesh-ancestor
24654584|NCT01250496|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24654585|NCT01250496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24654586|NCT01250496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664128|NCT01666314|Glucocorticoids|glucocorticoids|mesh-ancestor
25424473|NCT02252042|Cetuximab|cetuximab|mesh-list
25664129|NCT01666314|Hormones|hormones|mesh-ancestor
24654588|NCT01250496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24654590|NCT01250496|Purinergic Agents|purinergic agents|mesh-ancestor
24654591|NCT01250496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24654592|NCT01250496|Protective Agents|protective agents|mesh-ancestor
24654594|NCT01250535|Lovastatin|lovastatin|mesh-list
24654595|NCT01250535|L 647318|l 647318|mesh-list
24654596|NCT01250535|Dihydromevinolin|dihydromevinolin|mesh-list
24654597|NCT01250535|Anticoagulants|anticoagulants|mesh-ancestor
24654603|NCT01250535|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24654605|NCT01250548|Apremilast|apremilast|mesh-list
24654606|NCT01250548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24654607|NCT01250548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24654608|NCT01250548|Analgesics|analgesics|mesh-ancestor
24654609|NCT01250548|Sensory System Agents|sensory system agents|mesh-ancestor
24654610|NCT01250548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24774680|NCT01847326|Antisickling Agents|antisickling agents|mesh-ancestor
24799011|NCT01966575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24799012|NCT01966575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799013|NCT01966575|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24799014|NCT01966575|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24799015|NCT01966575|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24799016|NCT01966575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24799017|NCT01966575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799018|NCT01966575|Hormones|hormones|mesh-ancestor
24799019|NCT01966575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24592851|NCT00925873|Vidarabine|vidarabine|mesh-list
24799020|NCT01966627|Liver Extracts|liver extracts|mesh-list
24799021|NCT01966627|Hematinics|hematinics|mesh-ancestor
25852629|NCT00057278|Gabapentin|gabapentin|mesh-list
24654615|NCT01250548|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24654616|NCT01250548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654617|NCT01250548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654618|NCT01250561|Valacyclovir|valacyclovir|mesh-list
24654620|NCT01250561|Analgesics|analgesics|mesh-ancestor
24654621|NCT01250561|Sensory System Agents|sensory system agents|mesh-ancestor
24654622|NCT01250561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24654623|NCT01250561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654624|NCT01250561|Anticonvulsants|anticonvulsants|mesh-ancestor
24654625|NCT01250561|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24654626|NCT01250561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24654627|NCT01250561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24654628|NCT01250561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24654629|NCT01250561|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24654630|NCT01250561|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24654631|NCT01250561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24654632|NCT01250561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654633|NCT01250561|Antimanic Agents|antimanic agents|mesh-ancestor
24654634|NCT01250561|Antiviral Agents|antiviral agents|mesh-ancestor
24654635|NCT01250561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24654636|NCT01250652|Cetirizine|cetirizine|mesh-list
24654637|NCT01250652|Hydroxyzine|hydroxyzine|mesh-list
24654638|NCT01250652|Levocetirizine|levocetirizine|mesh-list
25852630|NCT00057278|Analgesics|analgesics|mesh-ancestor
25852631|NCT00057278|Sensory System Agents|sensory system agents|mesh-ancestor
25852632|NCT00057278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25852633|NCT00057278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852634|NCT00057278|Anticonvulsants|anticonvulsants|mesh-ancestor
25852635|NCT00057278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24799023|NCT01966653|Nitrofurantoin|nitrofurantoin|mesh-list
24799024|NCT01966653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24799025|NCT01966653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24799026|NCT01966653|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24645958|NCT01200914|Heparin|heparin|mesh-list
25852636|NCT00057278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25852637|NCT00057278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25852638|NCT00057278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25852639|NCT00057278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25852640|NCT00057278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25852641|NCT00057278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24654639|NCT01250652|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24654640|NCT01250652|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24467972|NCT00379418|Abciximab|abciximab|mesh-list
24654641|NCT01250652|Histamine Antagonists|histamine antagonists|mesh-ancestor
24654643|NCT01250652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24654644|NCT01250652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654645|NCT01250652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654646|NCT01250652|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24654647|NCT01250652|Antipruritics|antipruritics|mesh-ancestor
25852642|NCT00057278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852643|NCT00057278|Antimanic Agents|antimanic agents|mesh-ancestor
25852644|NCT00057304|Insulin|insulin|mesh-list
25852645|NCT00057304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24654667|NCT01250808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24654668|NCT01250808|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24654669|NCT01250808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654670|NCT01250808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24654671|NCT01250808|Alkylating Agents|alkylating agents|mesh-ancestor
24799035|NCT01966692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24799036|NCT01966692|Respiratory System Agents|respiratory system agents|mesh-ancestor
24799037|NCT01966692|Dermatologic Agents|dermatologic agents|mesh-ancestor
24799038|NCT01966692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24799039|NCT01966783|Budesonide|budesonide|mesh-list
24799040|NCT01966783|Mesalamine|mesalamine|mesh-list
24799041|NCT01966783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24799042|NCT01966783|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24799043|NCT01966783|Autonomic Agents|autonomic agents|mesh-ancestor
24799044|NCT01966783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24799045|NCT01966783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677009|NCT01353742|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
24846885|NCT02244242|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24654672|NCT01250808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654673|NCT01250808|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24654674|NCT01250808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24654675|NCT01250808|Immunologic Factors|immunologic factors|mesh-ancestor
24654676|NCT01250821|Menotropins|menotropins|mesh-list
24654677|NCT01250821|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24654678|NCT01250821|Fertility Agents|fertility agents|mesh-ancestor
24654679|NCT01250821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24654680|NCT01250821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654681|NCT01250847|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24654682|NCT01250847|Antidepressive Agents|antidepressive agents|mesh-ancestor
24654683|NCT01250847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24654684|NCT01250847|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24654685|NCT01250847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24654686|NCT01250847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24654687|NCT01250847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654688|NCT01250886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24654699|NCT01251029|Respiratory System Agents|respiratory system agents|mesh-ancestor
24654700|NCT01251029|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24654702|NCT01251029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654703|NCT01251029|Protective Agents|protective agents|mesh-ancestor
25230979|NCT02592720|Bivalirudin|bivalirudin|mesh-list
24654704|NCT01251029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654705|NCT01251029|Antidotes|antidotes|mesh-ancestor
24654707|NCT01251107|Cyclophosphamide|cyclophosphamide|mesh-list
24654708|NCT01251107|Dacarbazine|dacarbazine|mesh-list
24654709|NCT01251107|Doxorubicin|doxorubicin|mesh-list
24654710|NCT01251107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24654711|NCT01251107|Etoposide|etoposide|mesh-list
24654712|NCT01251107|Etoposide phosphate|etoposide phosphate|mesh-list
24799051|NCT01966783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24799052|NCT01966783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24799054|NCT01966783|Sensory System Agents|sensory system agents|mesh-ancestor
24799055|NCT01966783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24799056|NCT01966822|Ritonavir|ritonavir|mesh-list
24799057|NCT01966822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
25674596|NCT01774305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674597|NCT01774591|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25674598|NCT01774591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25674599|NCT01774591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25674600|NCT01774591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674601|NCT01774604|Indomethacin|indomethacin|mesh-list
25674602|NCT01774604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25674603|NCT01774604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25674604|NCT01774604|Analgesics|analgesics|mesh-ancestor
25674605|NCT01774604|Sensory System Agents|sensory system agents|mesh-ancestor
25852646|NCT00057304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852648|NCT00057343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25852649|NCT00057343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799060|NCT01966822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24799061|NCT01966822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24799062|NCT01966822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799063|NCT01966822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24799064|NCT01966822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24799065|NCT01966822|Antiviral Agents|antiviral agents|mesh-ancestor
24799066|NCT01966822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24799067|NCT01966822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24799068|NCT01966822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24799069|NCT01966822|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24799070|NCT01966822|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24799071|NCT01966913|Bevacizumab|bevacizumab|mesh-list
24799072|NCT01966913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24799073|NCT01966913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799074|NCT01966913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24799075|NCT01966913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24654720|NCT01251107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24654721|NCT01251107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24654722|NCT01251107|Alkylating Agents|alkylating agents|mesh-ancestor
24654723|NCT01251107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654724|NCT01251107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654725|NCT01251107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24654726|NCT01251107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24654727|NCT01251107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24654728|NCT01251107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24654729|NCT01251107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654730|NCT01251107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24654731|NCT01251107|Glucocorticoids|glucocorticoids|mesh-ancestor
24799080|NCT01967017|Anesthetics, Local|anesthetics, local|mesh-ancestor
24799081|NCT01967017|Anesthetics|anesthetics|mesh-ancestor
24799082|NCT01967017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24799083|NCT01967017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799084|NCT01967017|Sensory System Agents|sensory system agents|mesh-ancestor
24799085|NCT01967017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24799086|NCT01967017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24846922|NCT02244294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24846923|NCT02244294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25852650|NCT00057343|Immunologic Factors|immunologic factors|mesh-ancestor
24654732|NCT01251107|Hormones|hormones|mesh-ancestor
24654733|NCT01251107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24654740|NCT01251133|Immunologic Factors|immunologic factors|mesh-ancestor
24654741|NCT01251133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654743|NCT01251172|Mechlorethamine|mechlorethamine|mesh-list
24654744|NCT01251172|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
24654745|NCT01251172|R04929097|r04929097|mesh-list
24654746|NCT01251172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24654747|NCT01251172|Alkylating Agents|alkylating agents|mesh-ancestor
24654748|NCT01251172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654749|NCT01251172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654750|NCT01251172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24654751|NCT01251172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24654752|NCT01251172|Immunologic Factors|immunologic factors|mesh-ancestor
24654753|NCT01251172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654754|NCT01251172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654755|NCT01251211|Botulinum Toxins|botulinum toxins|mesh-list
24654756|NCT01251211|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24654757|NCT01251211|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24654758|NCT01251211|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24654759|NCT01251211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24654772|NCT01251263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24654773|NCT01251263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654774|NCT01251263|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24654775|NCT01251263|Contraceptive Agents|contraceptive agents|mesh-ancestor
25664130|NCT01666314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25664131|NCT01666314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654776|NCT01251263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25664132|NCT01666314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24654797|NCT01251471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654798|NCT01251471|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24654799|NCT01251471|Antidepressive Agents|antidepressive agents|mesh-ancestor
24654800|NCT01251471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24654801|NCT01251484|Nintedanib|nintedanib|mesh-list
24654802|NCT01251484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654803|NCT01251484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24654804|NCT01251484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654805|NCT01251484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654806|NCT01251627|Decitabine|decitabine|mesh-list
24654808|NCT01251627|Antimetabolites|antimetabolites|mesh-ancestor
24654809|NCT01251627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654810|NCT01251627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654811|NCT01251627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654812|NCT01251640|Gemcitabine|gemcitabine|mesh-list
24654813|NCT01251640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24654814|NCT01251640|Antimetabolites|antimetabolites|mesh-ancestor
24654830|NCT01251718|Nootropic Agents|nootropic agents|mesh-ancestor
24654831|NCT01251796|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24654832|NCT01251796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654834|NCT01251796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654835|NCT01251796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654836|NCT01251809|Pegaspargase|pegaspargase|mesh-list
24654837|NCT01251809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654838|NCT01251822|Prucalopride|prucalopride|mesh-list
24654839|NCT01251822|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24654840|NCT01251822|Laxatives|laxatives|mesh-ancestor
24654847|NCT01251822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654848|NCT01251835|Rifampin|rifampin|mesh-list
24654849|NCT01251835|Sitaxsentan|sitaxsentan|mesh-list
24654850|NCT01251835|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24654851|NCT01251835|Antitubercular Agents|antitubercular agents|mesh-ancestor
24654852|NCT01251835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24654853|NCT01251835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24654854|NCT01251835|Leprostatic Agents|leprostatic agents|mesh-ancestor
24654855|NCT01251835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24654869|NCT01251848|Protease Inhibitors|protease inhibitors|mesh-ancestor
24654870|NCT01251848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654871|NCT01251848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654887|NCT01251874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24654889|NCT01251926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24799089|NCT01967017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24799090|NCT01967017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799091|NCT01967095|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24799092|NCT01967095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799093|NCT01967095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24799094|NCT01967095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24799095|NCT01967095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799096|NCT01967199|Paclitaxel|paclitaxel|mesh-list
24799097|NCT01967199|Everolimus|everolimus|mesh-list
24799098|NCT01967199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24799099|NCT01967199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950019|NCT02938923|Testosterone|testosterone|mesh-list
25049656|NCT00579020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799100|NCT01967199|Tubulin Modulators|tubulin modulators|mesh-ancestor
24654890|NCT01251926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654892|NCT01251926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24654893|NCT01251926|Growth Substances|growth substances|mesh-ancestor
24654894|NCT01251926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654895|NCT01251926|Growth Inhibitors|growth inhibitors|mesh-ancestor
24654897|NCT01251991|Calcium polycarbophil|calcium polycarbophil|mesh-list
25852651|NCT00057343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654899|NCT01251991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24654915|NCT01252056|Protective Agents|protective agents|mesh-ancestor
24654916|NCT01252056|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25852652|NCT00057343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24654917|NCT01252056|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24654918|NCT01252056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654919|NCT01252056|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25852653|NCT00057356|Conivaptan|conivaptan|mesh-list
24799101|NCT01967199|Antimitotic Agents|antimitotic agents|mesh-ancestor
24946461|NCT03939624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25049657|NCT00579020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25049658|NCT00579020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25049659|NCT00579020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25049660|NCT00579020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25049661|NCT00579020|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25049662|NCT00579020|Contraceptive Agents|contraceptive agents|mesh-ancestor
25049663|NCT00579020|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24654932|NCT01252069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24654933|NCT01252121|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24654934|NCT01252121|Lubricant Eye Drops|lubricant eye drops|mesh-list
24654935|NCT01252121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24654936|NCT01252160|Capsaicin|capsaicin|mesh-list
24654937|NCT01252160|Antipruritics|antipruritics|mesh-ancestor
24654938|NCT01252160|Dermatologic Agents|dermatologic agents|mesh-ancestor
24654939|NCT01252160|Sensory System Agents|sensory system agents|mesh-ancestor
24654940|NCT01252160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24654941|NCT01252160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654942|NCT01252225|Lidocaine|lidocaine|mesh-list
24654943|NCT01252225|Anesthetics, Local|anesthetics, local|mesh-ancestor
24654944|NCT01252225|Anesthetics|anesthetics|mesh-ancestor
24654945|NCT01252225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24654946|NCT01252225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654947|NCT01252225|Sensory System Agents|sensory system agents|mesh-ancestor
24654989|NCT01252758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24654990|NCT01252758|Adrenergic Agents|adrenergic agents|mesh-ancestor
24654991|NCT01252758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24654992|NCT01252758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654993|NCT01253252|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24654994|NCT01253252|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24654995|NCT01253252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654996|NCT01253382|Ecallantide|ecallantide|mesh-list
24654997|NCT01253382|Analgesics|analgesics|mesh-ancestor
24654998|NCT01253382|Sensory System Agents|sensory system agents|mesh-ancestor
24654999|NCT01253382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24655000|NCT01253382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655001|NCT01253382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24655002|NCT01253382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24655003|NCT01253382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24655004|NCT01253382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24655005|NCT01253473|Budesonide|budesonide|mesh-list
24655006|NCT01253473|Albuterol|albuterol|mesh-list
24655007|NCT01253473|Formoterol Fumarate|formoterol fumarate|mesh-list
24655008|NCT01253473|Ipratropium|ipratropium|mesh-list
25049665|NCT00579020|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25049666|NCT00579020|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25049667|NCT00578955|Azithromycin|azithromycin|mesh-list
25049669|NCT00578955|Dexamethasone acetate|dexamethasone acetate|mesh-list
25049670|NCT00578955|BB 1101|bb 1101|mesh-list
25049671|NCT00578955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25049672|NCT00578955|Antiemetics|antiemetics|mesh-ancestor
25049673|NCT00578955|Autonomic Agents|autonomic agents|mesh-ancestor
25049674|NCT00578955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25664133|NCT01666314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24846956|NCT02244437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674606|NCT01774604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25674607|NCT01774604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674608|NCT01774604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25674609|NCT01774604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25674610|NCT01774604|Gout Suppressants|gout suppressants|mesh-ancestor
25674611|NCT01774604|Tocolytic Agents|tocolytic agents|mesh-ancestor
25674612|NCT01774604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25674613|NCT01774604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25674614|NCT01774604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852654|NCT00057356|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25852655|NCT00057356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852656|NCT00057356|Natriuretic Agents|natriuretic agents|mesh-ancestor
25852657|NCT00057356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852658|NCT00057369|Dalbavancin|dalbavancin|mesh-list
25852659|NCT00057369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24655012|NCT01253473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24655013|NCT01253473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655035|NCT01253681|Antimitotic Agents|antimitotic agents|mesh-ancestor
24655036|NCT01253681|Mitosis Modulators|mitosis modulators|mesh-ancestor
24655037|NCT01253681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655038|NCT01253681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24655039|NCT01253681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24655040|NCT01253681|Growth Substances|growth substances|mesh-ancestor
24655041|NCT01253681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655042|NCT01253681|Growth Inhibitors|growth inhibitors|mesh-ancestor
24655044|NCT01253694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24655045|NCT01253694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24655046|NCT01253694|Growth Substances|growth substances|mesh-ancestor
24655047|NCT01253694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655048|NCT01253694|Growth Inhibitors|growth inhibitors|mesh-ancestor
24655049|NCT01253694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655051|NCT01253928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24655052|NCT01253928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655055|NCT01254006|Micronutrients|micronutrients|mesh-ancestor
24655056|NCT01254006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655057|NCT01254006|Vitamin B Complex|vitamin b complex|mesh-ancestor
24655058|NCT01254071|Tamsulosin|tamsulosin|mesh-list
25049675|NCT00578955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049676|NCT00578955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25049677|NCT00578955|Glucocorticoids|glucocorticoids|mesh-ancestor
24946539|NCT03938259|Sensory System Agents|sensory system agents|mesh-ancestor
24946540|NCT03938259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24655060|NCT01254071|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24655061|NCT01254071|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24655089|NCT01254383|Urological Agents|urological agents|mesh-ancestor
24655090|NCT01254461|Pravastatin|pravastatin|mesh-list
24655091|NCT01254461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24655092|NCT01254461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24655093|NCT01254461|Antimetabolites|antimetabolites|mesh-ancestor
24655094|NCT01254461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655095|NCT01254461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24655128|NCT01254526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655129|NCT01254526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24655131|NCT01254526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24655132|NCT01254526|Growth Substances|growth substances|mesh-ancestor
24655133|NCT01254526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655134|NCT01254526|Growth Inhibitors|growth inhibitors|mesh-ancestor
24655135|NCT01254578|Lenalidomide|lenalidomide|mesh-list
24655136|NCT01254578|Immunologic Factors|immunologic factors|mesh-ancestor
24655137|NCT01254578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655138|NCT01254578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24655139|NCT01254578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24655140|NCT01254578|Growth Substances|growth substances|mesh-ancestor
24655141|NCT01254578|Growth Inhibitors|growth inhibitors|mesh-ancestor
24655142|NCT01254578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655143|NCT01254591|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24655144|NCT01254591|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24655145|NCT01254591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655146|NCT01254617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24655150|NCT01254617|Immunoglobulins|immunoglobulins|mesh-list
24655172|NCT00660673|Dopamine Agonists|dopamine agonists|mesh-ancestor
24655173|NCT01254708|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24655175|NCT01254708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24655176|NCT01254708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24655177|NCT01254708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24655179|NCT01254799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24655180|NCT01254799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24655181|NCT01254799|Antimalarials|antimalarials|mesh-ancestor
24655182|NCT01254799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24655183|NCT01254799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24655185|NCT01254825|Anesthetics, Local|anesthetics, local|mesh-ancestor
24655186|NCT01254825|Anesthetics|anesthetics|mesh-ancestor
24655187|NCT01254825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24655188|NCT01254825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655215|NCT01255046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24946541|NCT03938259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24946542|NCT03938259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24655230|NCT01255215|Vasodilator Agents|vasodilator agents|mesh-ancestor
24655232|NCT01255215|Protective Agents|protective agents|mesh-ancestor
24655234|NCT01255358|Dexamethasone acetate|dexamethasone acetate|mesh-list
24655235|NCT01255358|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24718092|NCT01551836|Acetaminophen|acetaminophen|mesh-list
24655237|NCT01255358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24655238|NCT01255358|Antiemetics|antiemetics|mesh-ancestor
24655239|NCT01255358|Autonomic Agents|autonomic agents|mesh-ancestor
24655240|NCT01255358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24655241|NCT01255358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655242|NCT01255358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24655263|NCT01255371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24655265|NCT01255410|Immunologic Factors|immunologic factors|mesh-ancestor
24655266|NCT01255410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655267|NCT01255475|Amlodipine|amlodipine|mesh-list
24655268|NCT01255475|Hydralazine|hydralazine|mesh-list
24655269|NCT01255475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24655270|NCT01255475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24655271|NCT01255475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25852660|NCT00057369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24655272|NCT01255475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655273|NCT01255475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24655275|NCT01255475|Vasodilator Agents|vasodilator agents|mesh-ancestor
24655276|NCT01255527|Bortezomib|bortezomib|mesh-list
24655277|NCT01255527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655278|NCT01255579|Fluticasone|fluticasone|mesh-list
24655279|NCT01255579|Beclomethasone|beclomethasone|mesh-list
24655280|NCT01255579|Formoterol Fumarate|formoterol fumarate|mesh-list
24655281|NCT01255579|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24655282|NCT01255579|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24655291|NCT01255579|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24655292|NCT01255579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24655295|NCT01255579|Adrenergic Agents|adrenergic agents|mesh-ancestor
24655296|NCT01255579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24655297|NCT01255579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655298|NCT01255579|Glucocorticoids|glucocorticoids|mesh-ancestor
24655300|NCT01255579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24655301|NCT01255579|Sympathomimetics|sympathomimetics|mesh-ancestor
24655302|NCT01255644|Valganciclovir|valganciclovir|mesh-list
24655303|NCT01255644|Antiviral Agents|antiviral agents|mesh-ancestor
24655310|NCT01255774|Growth Inhibitors|growth inhibitors|mesh-ancestor
24946550|NCT03937518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24946551|NCT03937518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946552|NCT03937687|Caffeine|caffeine|mesh-list
24946553|NCT03937687|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24718140|NCT01552148|Morphine|morphine|mesh-list
24946554|NCT03937687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946555|NCT03937687|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24946556|NCT03937687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24946557|NCT03937687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946559|NCT03937687|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24946560|NCT03937687|Purinergic Agents|purinergic agents|mesh-ancestor
24946561|NCT03937687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24946562|NCT03937609|Infliximab|infliximab|mesh-list
24946563|NCT03937609|Dermatologic Agents|dermatologic agents|mesh-ancestor
24846975|NCT02244515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24846976|NCT02244515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24846978|NCT02244515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24846979|NCT02244515|Analgesics|analgesics|mesh-ancestor
24655311|NCT01255774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655312|NCT01255800|Cetuximab|cetuximab|mesh-list
24655313|NCT01255800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24655314|NCT01255800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655315|NCT01255852|Atorvastatin|atorvastatin|mesh-list
24655316|NCT01255852|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24655317|NCT01255852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24655319|NCT01255852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655320|NCT01255852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24670746|NCT01998971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24655321|NCT01255852|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24655322|NCT01255852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24655325|NCT01255878|Sensory System Agents|sensory system agents|mesh-ancestor
24655326|NCT01255878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24655327|NCT01255878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655328|NCT01255878|Anticonvulsants|anticonvulsants|mesh-ancestor
24655329|NCT01255878|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24655330|NCT01255878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24655331|NCT01255878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24655332|NCT01255878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24655333|NCT01255878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24655334|NCT01255878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24655335|NCT01255878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24655336|NCT01255878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655337|NCT01255878|Antimanic Agents|antimanic agents|mesh-ancestor
24655339|NCT01255891|Hormones|hormones|mesh-ancestor
24655438|NCT01256632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655439|NCT01256775|Aspirin|aspirin|mesh-list
24655440|NCT01256775|Nitroaspirin|nitroaspirin|mesh-list
24655441|NCT01256775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24655442|NCT01256775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24655443|NCT01256775|Analgesics|analgesics|mesh-ancestor
25852662|NCT00057382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25852663|NCT00057382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852664|NCT00057382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24655444|NCT01256775|Sensory System Agents|sensory system agents|mesh-ancestor
24655445|NCT01256775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24655446|NCT01256775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655447|NCT01256775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24655448|NCT01256775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24655449|NCT01256775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24655450|NCT01256775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24655451|NCT01256775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655452|NCT01256775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25852665|NCT00057382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24655488|NCT01256866|GABA Agents|gaba agents|mesh-ancestor
24655489|NCT01256905|Modafinil|modafinil|mesh-list
24655490|NCT01256905|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24655491|NCT01256905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655492|NCT01256905|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24946735|NCT03935984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946736|NCT03935984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24946738|NCT03935555|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
24946739|NCT03935555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24946740|NCT03935646|Adderall|adderall|mesh-list
24946741|NCT03935646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24946742|NCT03935646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655545|NCT01257139|Antimitotic Agents|antimitotic agents|mesh-ancestor
24655566|NCT01257243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655567|NCT01257243|Appetite Depressants|appetite depressants|mesh-ancestor
24655568|NCT01257243|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24655569|NCT01257243|Sympathomimetics|sympathomimetics|mesh-ancestor
25030598|NCT03594513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24655570|NCT01257243|Autonomic Agents|autonomic agents|mesh-ancestor
24655571|NCT01257243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24655572|NCT01257243|Nasal Decongestants|nasal decongestants|mesh-ancestor
24655573|NCT01257243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24655574|NCT01257243|Antifungal Agents|antifungal agents|mesh-ancestor
24655575|NCT01257243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24655577|NCT01257334|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24655578|NCT01257334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655579|NCT01257334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24655580|NCT01257334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655581|NCT01257360|Panitumumab|panitumumab|mesh-list
24718352|NCT01554124|Meropenem|meropenem|mesh-list
24655602|NCT01257386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24655603|NCT01257386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655604|NCT01257386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24655605|NCT01257386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24655640|NCT01257490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24655641|NCT01257490|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24655642|NCT01257490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24655643|NCT01257490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24655644|NCT01257490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655645|NCT01257490|Dopamine Agents|dopamine agents|mesh-ancestor
24655646|NCT01257490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24655647|NCT01257490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655648|NCT01257490|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24655649|NCT01257490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24655650|NCT01257490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24655651|NCT01257516|Pregabalin|pregabalin|mesh-list
24655652|NCT01257516|Analgesics|analgesics|mesh-ancestor
24655653|NCT01257516|Sensory System Agents|sensory system agents|mesh-ancestor
24655654|NCT01257516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24946995|NCT03933605|Autonomic Agents|autonomic agents|mesh-ancestor
24946996|NCT03933605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24946997|NCT03933605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24946998|NCT03933605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24946999|NCT03933605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24947000|NCT03933605|Serotonin Agents|serotonin agents|mesh-ancestor
24947001|NCT03933293|Ezetimibe|ezetimibe|mesh-list
24947002|NCT03933293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24847012|NCT02244632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24847014|NCT02244632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24847015|NCT02244632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24847016|NCT02244632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24847017|NCT02244671|Botulinum Toxins|botulinum toxins|mesh-list
24847018|NCT02244671|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24847019|NCT02244671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24655655|NCT01257516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655670|NCT01257529|Anticonvulsants|anticonvulsants|mesh-ancestor
24655671|NCT01257529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24655672|NCT01257529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24655703|NCT01257672|Dopamine Agents|dopamine agents|mesh-ancestor
24655704|NCT00077285|Cyclophosphamide|cyclophosphamide|mesh-list
24655706|NCT00077285|Carboplatin|carboplatin|mesh-list
24655707|NCT00077285|Doxorubicin|doxorubicin|mesh-list
24655708|NCT00077285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24655709|NCT00077285|Irinotecan|irinotecan|mesh-list
24655710|NCT00077285|Etoposide|etoposide|mesh-list
24655711|NCT00077285|Vincristine|vincristine|mesh-list
24655712|NCT00077285|Dexrazoxane|dexrazoxane|mesh-list
24655713|NCT00077285|Razoxane|razoxane|mesh-list
24655714|NCT00077285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24655715|NCT00077285|Immunologic Factors|immunologic factors|mesh-ancestor
24655716|NCT00077285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655717|NCT00077285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24678046|NCT01359657|Dexamethasone|dexamethasone|mesh-list
24655718|NCT00077285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24655719|NCT00077285|Alkylating Agents|alkylating agents|mesh-ancestor
24655720|NCT00077285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655721|NCT00077285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655722|NCT00077285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24655723|NCT00077285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24655724|NCT00077285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24655725|NCT00077285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24655726|NCT00077285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24655727|NCT00077285|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24655728|NCT00077285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24655729|NCT00077285|Tubulin Modulators|tubulin modulators|mesh-ancestor
24655749|NCT01257828|Protective Agents|protective agents|mesh-ancestor
24655750|NCT01257867|Lithium Carbonate|lithium carbonate|mesh-list
24947003|NCT03933293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24947004|NCT03933293|Antimetabolites|antimetabolites|mesh-ancestor
24947005|NCT03933293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947006|NCT03933293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24947008|NCT03933345|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24655751|NCT01257867|Antidepressive Agents|antidepressive agents|mesh-ancestor
24655752|NCT01257867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24655753|NCT01257867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24655754|NCT01257867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655756|NCT01257867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24655757|NCT01257867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24655758|NCT01257867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655759|NCT01257893|Aspirin|aspirin|mesh-list
24655760|NCT01257893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24655761|NCT01257893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24655762|NCT01257893|Analgesics|analgesics|mesh-ancestor
24655763|NCT01257893|Sensory System Agents|sensory system agents|mesh-ancestor
24655764|NCT01257893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24655765|NCT01257893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655766|NCT01257893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24655767|NCT01257893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24655768|NCT01257893|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24655792|NCT01258010|Coagulants|coagulants|mesh-ancestor
24655793|NCT01258036|Hormones|hormones|mesh-list
24655794|NCT01258036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24655795|NCT01258036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655807|NCT01258296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24655808|NCT01258296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655809|NCT01258296|Analgesics|analgesics|mesh-ancestor
24655810|NCT01258296|Sensory System Agents|sensory system agents|mesh-ancestor
24655811|NCT01258296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24655812|NCT01258296|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24655814|NCT01258296|Anesthetics, General|anesthetics, general|mesh-ancestor
24655815|NCT01258296|Anesthetics|anesthetics|mesh-ancestor
24655816|NCT01258309|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
24655818|NCT01258309|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24655819|NCT01258309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24655820|NCT01258309|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24655821|NCT01258309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24655822|NCT01258309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24655823|NCT01258309|Analgesics|analgesics|mesh-ancestor
24718449|NCT01554930|Diuretics|diuretics|mesh-ancestor
24718503|NCT01555190|Micronutrients|micronutrients|mesh-ancestor
24718504|NCT01555190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718505|NCT01555216|Ropivacaine|ropivacaine|mesh-list
24718506|NCT01555216|Anesthetics, Local|anesthetics, local|mesh-ancestor
24718507|NCT01555216|Anesthetics|anesthetics|mesh-ancestor
24655824|NCT01258309|Sensory System Agents|sensory system agents|mesh-ancestor
24655825|NCT01258309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24655826|NCT01258309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655827|NCT01258309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24655828|NCT01258309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24655829|NCT01258309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24655830|NCT01258309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24655831|NCT01258309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655832|NCT01258309|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24655833|NCT01258309|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24655834|NCT01258309|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24947009|NCT03933345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947010|NCT03933345|Sensory System Agents|sensory system agents|mesh-ancestor
24947011|NCT03933345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24947012|NCT03933358|Hormones|hormones|mesh-list
24947013|NCT03933358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24947014|NCT03933358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947015|NCT03933319|Doxorubicin|doxorubicin|mesh-list
24947016|NCT03933319|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24947017|NCT03933319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24947018|NCT03933319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24947019|NCT03933319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24947020|NCT03933319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24947021|NCT03933319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24947022|NCT03933319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799102|NCT01967199|Mitosis Modulators|mitosis modulators|mesh-ancestor
24799103|NCT01967199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799104|NCT01967199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24655857|NCT01258439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24655858|NCT01258439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24799111|NCT01967251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799112|NCT01967264|Udenafil|udenafil|mesh-list
24832839|NCT02172326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799113|NCT01967264|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24947099|NCT03932526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24947144|NCT03931915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24947145|NCT03932071|Zoledronic Acid|zoledronic acid|mesh-list
24947146|NCT03932071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24718508|NCT01555216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24947147|NCT03932071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947148|NCT03931668|Maleic acid|maleic acid|mesh-list
24947149|NCT03931668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24947151|NCT03931863|Ondansetron|ondansetron|mesh-list
24947360|NCT03929744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947361|NCT03929744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24655913|NCT01258712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24655914|NCT01258712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655915|NCT01258712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24655916|NCT01258712|Antimetabolites|antimetabolites|mesh-ancestor
24655917|NCT01258712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655918|NCT01258712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655919|NCT01258712|Dermatologic Agents|dermatologic agents|mesh-ancestor
24655920|NCT01258712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24655921|NCT01258712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24655922|NCT01258712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24655923|NCT01258712|Immunologic Factors|immunologic factors|mesh-ancestor
24655924|NCT01258712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24655933|NCT01258764|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24655934|NCT01258764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24655935|NCT01258764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655936|NCT01258764|Protease Inhibitors|protease inhibitors|mesh-ancestor
24655937|NCT01258764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24655948|NCT01258868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24655950|NCT01258868|Analgesics|analgesics|mesh-ancestor
24655951|NCT01258868|Sensory System Agents|sensory system agents|mesh-ancestor
24655952|NCT01258868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24655953|NCT01258868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655954|NCT01258868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24655955|NCT01258868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24655956|NCT01258868|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24655957|NCT01258868|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24655958|NCT01258868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24655959|NCT01258868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655960|NCT01258920|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24655961|NCT01258920|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24655962|NCT01258920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24655963|NCT01258920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24655964|NCT01258920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655965|NCT01258920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24655992|NCT01259141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655993|NCT01259141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655994|NCT01259193|Zoledronic Acid|zoledronic acid|mesh-list
24655996|NCT01259193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656059|NCT01259557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24656061|NCT01259817|Interferons|interferons|mesh-list
24656062|NCT01259817|Interferon-alpha|interferon-alpha|mesh-list
24656063|NCT01259817|Interferon alpha-2|interferon alpha-2|mesh-list
24656064|NCT01259817|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24656065|NCT01259817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656066|NCT01259817|Antiviral Agents|antiviral agents|mesh-ancestor
24656067|NCT01259817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24656068|NCT01259817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24656069|NCT01259817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24947627|NCT03927313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24947628|NCT03927313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24947633|NCT03927313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24947634|NCT03927313|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24947635|NCT03927313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24947636|NCT03927313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947637|NCT03927313|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24947638|NCT03927313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24947639|NCT03927313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664134|NCT01666444|Doxorubicin|doxorubicin|mesh-list
25664135|NCT01666444|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24656203|NCT01260558|Sirolimus|sirolimus|mesh-list
24656204|NCT01260558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25852666|NCT00057382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852667|NCT00057382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656238|NCT01260675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656239|NCT01260675|Analgesics|analgesics|mesh-ancestor
24656240|NCT01260675|Sensory System Agents|sensory system agents|mesh-ancestor
24656241|NCT01260675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24947646|NCT03927313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24947647|NCT03927313|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24947648|NCT03927313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25876188|NCT03847896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656268|NCT01260753|Fluticasone|fluticasone|mesh-list
24656269|NCT01260753|Xhance|xhance|mesh-list
24656270|NCT01260753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24656271|NCT01260753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24656272|NCT01260753|Autonomic Agents|autonomic agents|mesh-ancestor
24656273|NCT01260753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24656274|NCT01260753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656275|NCT01260753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24656276|NCT01260753|Respiratory System Agents|respiratory system agents|mesh-ancestor
24656277|NCT01260753|Dermatologic Agents|dermatologic agents|mesh-ancestor
24656278|NCT01260753|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24656279|NCT01260818|Tranexamic Acid|tranexamic acid|mesh-list
24656280|NCT01260818|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24656281|NCT01260818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24656282|NCT01260818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656283|NCT01260818|Hemostatics|hemostatics|mesh-ancestor
24947653|NCT03927313|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24772955|NCT01836900|Hemostatics|hemostatics|mesh-list
24799114|NCT01967264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24799115|NCT01967264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24799116|NCT01967264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799118|NCT01967368|Immunologic Factors|immunologic factors|mesh-ancestor
24847093|NCT02245165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847094|NCT02245191|Phenylephrine|phenylephrine|mesh-list
24847095|NCT02245191|Oxymetazoline|oxymetazoline|mesh-list
24847096|NCT02245191|Ephedrine|ephedrine|mesh-list
24847097|NCT02245191|Metaraminol|metaraminol|mesh-list
25876189|NCT03811002|Cisplatin|cisplatin|mesh-list
25876190|NCT03811002|Carboplatin|carboplatin|mesh-list
24656310|NCT01261065|Protective Agents|protective agents|mesh-ancestor
25876191|NCT03811002|Etoposide|etoposide|mesh-list
25876192|NCT03811002|Etoposide phosphate|etoposide phosphate|mesh-list
25876193|NCT03811002|Atezolizumab|atezolizumab|mesh-list
25876194|NCT03811002|Podophyllotoxin|podophyllotoxin|mesh-list
25876195|NCT03811002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25876196|NCT03811002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876197|NCT03811002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25876198|NCT03811002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25876199|NCT03811002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25876200|NCT03811002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656343|NCT01261117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24656344|NCT01261117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24656345|NCT01261117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656346|NCT01261117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656347|NCT01261130|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24656348|NCT01261130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24656349|NCT01261130|Immunologic Factors|immunologic factors|mesh-ancestor
24656350|NCT01261130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656351|NCT01261130|Antacids|antacids|mesh-ancestor
24656352|NCT01261130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656353|NCT01261130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24656354|NCT01261156|Diltiazem|diltiazem|mesh-list
24656355|NCT01261156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24656356|NCT01261156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25852670|NCT00057408|Olanzapine|olanzapine|mesh-list
24656357|NCT01261156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24656358|NCT01261156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656359|NCT01261156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24656360|NCT01261156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656361|NCT01261156|Vasodilator Agents|vasodilator agents|mesh-ancestor
24656362|NCT01261169|Mycophenolic Acid|mycophenolic acid|mesh-list
24656363|NCT01261169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24656365|NCT01261169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25852671|NCT00057408|Antipsychotic Agents|antipsychotic agents|mesh-list
25852672|NCT00057408|Antiemetics|antiemetics|mesh-ancestor
25852673|NCT00057408|Autonomic Agents|autonomic agents|mesh-ancestor
24947897|NCT03925233|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24947898|NCT03925233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24947899|NCT03925233|Anticoagulants|anticoagulants|mesh-ancestor
24947900|NCT03925233|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24947901|NCT03925233|Chelating Agents|chelating agents|mesh-ancestor
24947902|NCT03925233|Sequestering Agents|sequestering agents|mesh-ancestor
24947903|NCT03925233|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24947904|NCT03925233|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24947905|NCT03925233|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24947906|NCT03925233|Hormone Antagonists|hormone antagonists|mesh-ancestor
24947907|NCT03925233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24656408|NCT01261546|Antiemetics|antiemetics|mesh-ancestor
24656409|NCT01261546|Autonomic Agents|autonomic agents|mesh-ancestor
24656422|NCT01261637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656423|NCT01261637|Sensory System Agents|sensory system agents|mesh-ancestor
24656424|NCT01261637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24656427|NCT01261689|Ropivacaine|ropivacaine|mesh-list
24656428|NCT01261689|Anesthetics, Local|anesthetics, local|mesh-ancestor
24656437|NCT01261689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24656438|NCT01261689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24656439|NCT01261689|Anesthetics, General|anesthetics, general|mesh-ancestor
24656440|NCT01261702|Magnesium Sulfate|magnesium sulfate|mesh-list
24656441|NCT01261702|Analgesics|analgesics|mesh-ancestor
24656442|NCT01261702|Sensory System Agents|sensory system agents|mesh-ancestor
24656443|NCT01261702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24656444|NCT01261702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656445|NCT01261702|Anesthetics|anesthetics|mesh-ancestor
24656446|NCT01261702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24656447|NCT01261702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24656448|NCT01261702|Anticonvulsants|anticonvulsants|mesh-ancestor
24656449|NCT01261702|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24947908|NCT03925233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24947909|NCT03925233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25852674|NCT00057408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25852675|NCT00057408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948080|NCT03923075|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24656450|NCT01261702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24656451|NCT01261702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656452|NCT01261702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24656453|NCT01261702|Tocolytic Agents|tocolytic agents|mesh-ancestor
24656454|NCT01261702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24656463|NCT01261741|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24656464|NCT01261832|Cilostazol|cilostazol|mesh-list
24656465|NCT01261832|Clopidogrel|clopidogrel|mesh-list
24656466|NCT01261832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24656467|NCT01261832|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24656468|NCT01261832|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24656469|NCT01261832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24656470|NCT01261832|Purinergic Agents|purinergic agents|mesh-ancestor
24656471|NCT01261832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24656472|NCT01261832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656473|NCT01261832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656474|NCT01261832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24656475|NCT01261832|Autonomic Agents|autonomic agents|mesh-ancestor
24656476|NCT01261832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24656477|NCT01261832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24656478|NCT01261832|Respiratory System Agents|respiratory system agents|mesh-ancestor
24656479|NCT01261832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24656480|NCT01261832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24656481|NCT01261832|Vasodilator Agents|vasodilator agents|mesh-ancestor
24656482|NCT01261832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24948139|NCT03923036|Cetuximab|cetuximab|mesh-list
24847127|NCT02245256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24656483|NCT01261832|Protective Agents|protective agents|mesh-ancestor
24656484|NCT01261832|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24656485|NCT01261832|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24656486|NCT01261832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656487|NCT01261897|Ropivacaine|ropivacaine|mesh-list
24656488|NCT01261897|Anesthetics, Local|anesthetics, local|mesh-ancestor
24656489|NCT01261897|Anesthetics|anesthetics|mesh-ancestor
24656490|NCT01261897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24656491|NCT01261897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656492|NCT01261897|Sensory System Agents|sensory system agents|mesh-ancestor
24656493|NCT01261897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24656494|NCT01261923|Alitretinoin|alitretinoin|mesh-list
24656495|NCT01261923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656496|NCT01261923|Dermatologic Agents|dermatologic agents|mesh-ancestor
24656497|NCT01262183|Panitumumab|panitumumab|mesh-list
24656498|NCT01262183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24656499|NCT01262183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656548|NCT01262482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24656549|NCT01262482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656550|NCT01262482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656551|NCT01262586|Glimepiride|glimepiride|mesh-list
24656552|NCT01262586|Vildagliptin|vildagliptin|mesh-list
24656553|NCT01262586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24718930|NCT01558011|Docetaxel|docetaxel|mesh-list
24656554|NCT01262586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24656555|NCT01262586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656556|NCT01262586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24656557|NCT01262586|Immunologic Factors|immunologic factors|mesh-ancestor
24656558|NCT01262586|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24656592|NCT01262963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656593|NCT01262963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656595|NCT01263002|Clevudine|clevudine|mesh-list
24565469|NCT00780728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24656596|NCT01263002|Antiviral Agents|antiviral agents|mesh-ancestor
24656597|NCT01263002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24656598|NCT01263002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24656599|NCT01263002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24678924|NCT01365104|Siderophores|siderophores|mesh-ancestor
24656600|NCT01263002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656608|NCT01263080|Hematinics|hematinics|mesh-ancestor
24656609|NCT01263080|Antidepressive Agents|antidepressive agents|mesh-ancestor
24656610|NCT01263080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24656611|NCT01263080|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25852676|NCT00057408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24656612|NCT01263080|Histamine Antagonists|histamine antagonists|mesh-ancestor
24656613|NCT01263080|Histamine Agents|histamine agents|mesh-ancestor
24656614|NCT01263080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24656615|NCT01263080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656616|NCT01263080|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24656617|NCT01263080|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24656618|NCT01263080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24656619|NCT01263080|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24656620|NCT01263080|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24656621|NCT01263080|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24656622|NCT01263080|Adrenergic Agents|adrenergic agents|mesh-ancestor
24656623|NCT01263080|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24656624|NCT01263080|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24656625|NCT01263080|Serotonin Agents|serotonin agents|mesh-ancestor
24656626|NCT01263080|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24656627|NCT01263145|Paclitaxel|paclitaxel|mesh-list
25852677|NCT00057408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24656628|NCT01263145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24656629|NCT01263145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656630|NCT01263145|Tubulin Modulators|tubulin modulators|mesh-ancestor
24656631|NCT01263145|Antimitotic Agents|antimitotic agents|mesh-ancestor
24656632|NCT01263145|Mitosis Modulators|mitosis modulators|mesh-ancestor
24656633|NCT01263145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656635|NCT01263158|Oxytocics|oxytocics|mesh-ancestor
24656642|NCT01263171|Levoleucovorin|levoleucovorin|mesh-list
24656658|NCT01263210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719117|NCT01559285|Anesthetics|anesthetics|mesh-ancestor
24719212|NCT01560013|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24719213|NCT01560013|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24719214|NCT01560013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719215|NCT01560013|Sensory System Agents|sensory system agents|mesh-ancestor
24719216|NCT01560013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24719217|NCT01560052|Methylprednisolone|methylprednisolone|mesh-list
24719218|NCT01560052|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24719219|NCT01560052|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24719220|NCT01560052|Prednisolone|prednisolone|mesh-list
25852678|NCT00057408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25852679|NCT00057408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24941732|NCT03988452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24941733|NCT03988452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24941734|NCT03988452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24941735|NCT03988452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24719241|NCT01560065|Vitamins|vitamins|mesh-ancestor
24656659|NCT01263288|Cholecalciferol|cholecalciferol|mesh-list
24656660|NCT01263288|Vitamin D|vitamin d|mesh-list
24656661|NCT01263288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24656662|NCT01263288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656663|NCT01263288|Vitamins|vitamins|mesh-ancestor
24773676|NCT01841307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799121|NCT01967381|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24799122|NCT01967381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799123|NCT01967381|Sympathomimetics|sympathomimetics|mesh-ancestor
24799124|NCT01967381|Autonomic Agents|autonomic agents|mesh-ancestor
24799125|NCT01967381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24799126|NCT01967381|Dopamine Agents|dopamine agents|mesh-ancestor
24799127|NCT01967381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24799128|NCT01967381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664136|NCT01666444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24656664|NCT01263288|Micronutrients|micronutrients|mesh-ancestor
24656665|NCT01263288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25852680|NCT00057408|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25664137|NCT01666444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656666|NCT01263353|Everolimus|everolimus|mesh-list
24656667|NCT01263353|Pasireotide|pasireotide|mesh-list
24656668|NCT01263353|Somatostatin|somatostatin|mesh-list
24656669|NCT01263353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656670|NCT01263353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24656671|NCT01263353|Immunologic Factors|immunologic factors|mesh-ancestor
24656672|NCT01263353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656674|NCT01263353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24656675|NCT01263366|Norepinephrine|norepinephrine|mesh-list
24656676|NCT01263366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24656677|NCT01263366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24656678|NCT01263366|Adrenergic Agents|adrenergic agents|mesh-ancestor
24656679|NCT01263366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24656680|NCT01263366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656681|NCT01263366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656682|NCT01263366|Sympathomimetics|sympathomimetics|mesh-ancestor
24656683|NCT01263366|Autonomic Agents|autonomic agents|mesh-ancestor
24656684|NCT01263366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24656685|NCT01263366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24656686|NCT01263418|Ofatumumab|ofatumumab|mesh-list
24657487|NCT01267604|Melatonin|melatonin|mesh-list
24656689|NCT01263548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24656690|NCT01263548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656759|NCT01263860|Interferon-alpha|interferon-alpha|mesh-list
24656760|NCT01263860|Antimetabolites|antimetabolites|mesh-ancestor
25852682|NCT00057408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24656761|NCT01263860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656771|NCT01263951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656772|NCT01263951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24656773|NCT01263951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656774|NCT01263951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656775|NCT01264094|Clevudine|clevudine|mesh-list
24656776|NCT01264094|Antiviral Agents|antiviral agents|mesh-ancestor
24656777|NCT01264094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24656778|NCT01264133|Adefovir|adefovir|mesh-list
24656779|NCT01264133|Clevudine|clevudine|mesh-list
24656780|NCT01264133|Antiviral Agents|antiviral agents|mesh-ancestor
24656781|NCT01264133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24656852|NCT01264354|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
24656853|NCT01264354|Clevudine|clevudine|mesh-list
24656854|NCT01264354|Antiviral Agents|antiviral agents|mesh-ancestor
24656855|NCT01264354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24656856|NCT01264354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24656857|NCT01264354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24656858|NCT01264354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656859|NCT01264354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656860|NCT01264367|Interferons|interferons|mesh-list
24656861|NCT01264367|Clevudine|clevudine|mesh-list
24656862|NCT01264367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656863|NCT01264367|Antiviral Agents|antiviral agents|mesh-ancestor
24656864|NCT01264367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24656865|NCT01264432|Veliparib|veliparib|mesh-list
24656866|NCT01264432|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24656867|NCT01264432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656868|NCT01264432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656879|NCT01264497|Growth Substances|growth substances|mesh-ancestor
24719254|NCT01560117|Rituximab|rituximab|mesh-list
24656880|NCT01264497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656881|NCT01264536|Lactoferrin|lactoferrin|mesh-list
24799144|NCT01967472|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24799146|NCT01967472|Antimalarials|antimalarials|mesh-ancestor
24774685|NCT01847339|Anesthetics|anesthetics|mesh-ancestor
24657046|NCT01265199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24657047|NCT01265199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657048|NCT01265342|Beclomethasone|beclomethasone|mesh-list
24657049|NCT01265342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25664138|NCT01666444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24657050|NCT01265342|Glucocorticoids|glucocorticoids|mesh-ancestor
24657051|NCT01265342|Hormones|hormones|mesh-ancestor
24657052|NCT01265342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24657053|NCT01265342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664139|NCT01666444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25664140|NCT01666444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657099|NCT01265641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657100|NCT01265641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799177|NCT01967524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799178|NCT01967524|Cholinergic Agents|cholinergic agents|mesh-ancestor
24799179|NCT01967524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24799180|NCT01967524|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24799181|NCT01967758|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24657206|NCT01266187|Immunologic Factors|immunologic factors|mesh-ancestor
24657207|NCT01266187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657209|NCT01266187|Protective Agents|protective agents|mesh-ancestor
24719376|NCT01561014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719377|NCT01561014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24719378|NCT01561014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719379|NCT01561014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24719380|NCT01561014|Immunologic Factors|immunologic factors|mesh-ancestor
24719381|NCT01561014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719383|NCT01561014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852687|NCT00057421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24657327|NCT01266759|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24657329|NCT01266772|Montelukast|montelukast|mesh-list
24657330|NCT01266772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24657331|NCT01266772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24657333|NCT01266772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24657334|NCT01266772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657335|NCT01266772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24657336|NCT01266772|Respiratory System Agents|respiratory system agents|mesh-ancestor
25852688|NCT00057421|Glucocorticoids|glucocorticoids|mesh-ancestor
25852689|NCT00057421|Hormones|hormones|mesh-ancestor
25876201|NCT03811002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657337|NCT01266772|Glucocorticoids|glucocorticoids|mesh-ancestor
24657338|NCT01266772|Hormones|hormones|mesh-ancestor
24657359|NCT01266811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24657361|NCT01266811|Hormones|hormones|mesh-ancestor
24657362|NCT01266811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24657363|NCT01266811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24657364|NCT01266811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657365|NCT01266811|Protease Inhibitors|protease inhibitors|mesh-ancestor
24657366|NCT01266811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657367|NCT01266811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657368|NCT01266837|Everolimus|everolimus|mesh-list
24657369|NCT01266837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657374|NCT01266928|Vitamins|vitamins|mesh-ancestor
24657403|NCT01267084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24657404|NCT01267084|Hormone Antagonists|hormone antagonists|mesh-ancestor
24657405|NCT01267084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24657406|NCT01267084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24657407|NCT01267084|Alkylating Agents|alkylating agents|mesh-ancestor
25664141|NCT01666444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664142|NCT01666652|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25664143|NCT01666652|Aluminum sulfate|aluminum sulfate|mesh-list
25664144|NCT01666652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25664145|NCT01666652|Immunologic Factors|immunologic factors|mesh-ancestor
25664146|NCT01666652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664147|NCT01666652|Antacids|antacids|mesh-ancestor
24657473|NCT01267448|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24657475|NCT01267448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657476|NCT01267448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657477|NCT01267487|Heparin|heparin|mesh-list
24657478|NCT01267487|Calcium heparin|calcium heparin|mesh-list
24657479|NCT01267487|Protamines|protamines|mesh-list
24657480|NCT01267487|Anticoagulants|anticoagulants|mesh-ancestor
24657481|NCT01267487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25852691|NCT00057421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657482|NCT01267487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24657483|NCT01267487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657485|NCT01267487|Coagulants|coagulants|mesh-ancestor
24657494|NCT01267604|Vitamins|vitamins|mesh-ancestor
24657495|NCT01267604|Micronutrients|micronutrients|mesh-ancestor
24657496|NCT01267643|Alefacept|alefacept|mesh-list
24657497|NCT01267643|Dermatologic Agents|dermatologic agents|mesh-ancestor
24657498|NCT01267643|Immunologic Factors|immunologic factors|mesh-ancestor
24657499|NCT01267643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657500|NCT01267669|Somatostatin|somatostatin|mesh-list
24657501|NCT01267669|Hormones|hormones|mesh-ancestor
25852692|NCT00057421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24657636|NCT01268709|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24657637|NCT01268709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24657638|NCT01268709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24657639|NCT01268709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657640|NCT01268709|Adrenergic Agents|adrenergic agents|mesh-ancestor
24657641|NCT01268709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24657642|NCT01268709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657661|NCT01268839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24657662|NCT01268839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657663|NCT01268839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657664|NCT01268839|Antiviral Agents|antiviral agents|mesh-ancestor
24657665|NCT01268839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24657666|NCT01268839|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24657667|NCT01268839|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24657668|NCT01268839|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25852693|NCT00057421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852694|NCT00057447|Interferons|interferons|mesh-list
25852695|NCT00057447|Interferon-gamma|interferon-gamma|mesh-list
25852696|NCT00057447|Rituximab|rituximab|mesh-list
24657680|NCT01268904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657681|NCT01268904|Antimanic Agents|antimanic agents|mesh-ancestor
24657682|NCT01268904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24657683|NCT01268904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24657684|NCT01268904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24657685|NCT01268917|Aspirin|aspirin|mesh-list
24657686|NCT01268917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24657687|NCT01268917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24657688|NCT01268917|Analgesics|analgesics|mesh-ancestor
24657689|NCT01268917|Sensory System Agents|sensory system agents|mesh-ancestor
24774700|NCT01847404|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24657696|NCT01268917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657697|NCT01268917|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24657698|NCT01268917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24657699|NCT01268917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657701|NCT01268930|Hemostatics|hemostatics|mesh-list
24657702|NCT01268930|Coagulants|coagulants|mesh-ancestor
24657703|NCT01268995|Cyclosporine|cyclosporine|mesh-list
24657704|NCT01268995|Tacrolimus|tacrolimus|mesh-list
24657705|NCT01268995|Cyclosporins|cyclosporins|mesh-list
24657706|NCT01268995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24657707|NCT01268995|Immunologic Factors|immunologic factors|mesh-ancestor
24657708|NCT01268995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657709|NCT01268995|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25852697|NCT00057447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24657725|NCT01269021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24657726|NCT01269021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24657727|NCT01269021|Antitubercular Agents|antitubercular agents|mesh-ancestor
24657733|NCT01269099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24657734|NCT01269099|Narcotics|narcotics|mesh-ancestor
24657735|NCT01269099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25852698|NCT00057447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657772|NCT01269203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657818|NCT01269294|Antiviral Agents|antiviral agents|mesh-ancestor
24774182|NCT01844141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774183|NCT01844141|Disinfectants|disinfectants|mesh-ancestor
24774184|NCT01844141|Dermatologic Agents|dermatologic agents|mesh-ancestor
24774185|NCT01844323|Palbociclib|palbociclib|mesh-list
24565466|NCT00780728|Sildenafil Citrate|sildenafil citrate|mesh-list
24799245|NCT01967979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24799246|NCT01967979|Antidepressive Agents|antidepressive agents|mesh-ancestor
24657933|NCT01269541|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24657934|NCT01269541|Antitubercular Agents|antitubercular agents|mesh-ancestor
24657935|NCT01269541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24657936|NCT01269541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24657937|NCT01269541|Leprostatic Agents|leprostatic agents|mesh-ancestor
24657938|NCT01269541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25852699|NCT00057447|Immunologic Factors|immunologic factors|mesh-ancestor
25852700|NCT00057447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852701|NCT00057447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24799261|NCT01968005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948854|NCT05401370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24847298|NCT02246049|Fluorouracil|fluorouracil|mesh-list
25852702|NCT00057447|Antiviral Agents|antiviral agents|mesh-ancestor
25852703|NCT00057447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25852704|NCT00057512|Masoprocol|masoprocol|mesh-list
25852705|NCT00057512|Antioxidants|antioxidants|mesh-ancestor
25852706|NCT00057512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852707|NCT00057512|Protective Agents|protective agents|mesh-ancestor
25852708|NCT00057512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852709|NCT00057512|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25852710|NCT00057512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657942|NCT01269541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24657943|NCT01269541|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24657944|NCT01269541|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24657945|NCT01269541|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24657946|NCT01269541|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24657947|NCT01269541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24657950|NCT01269606|Insulin Aspart|insulin aspart|mesh-list
24657951|NCT01269606|Insulin, Long-Acting|insulin, long-acting|mesh-list
24657952|NCT01269606|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24657953|NCT01269606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24657954|NCT01269606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657955|NCT01269671|Peppermint oil|peppermint oil|mesh-list
24657957|NCT01269671|Simethicone|simethicone|mesh-list
24657958|NCT01269671|Antioxidants|antioxidants|mesh-ancestor
24657959|NCT01269671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657960|NCT01269671|Protective Agents|protective agents|mesh-ancestor
24657961|NCT01269671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657962|NCT01269671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24657963|NCT01269671|Antifoaming Agents|antifoaming agents|mesh-ancestor
24657964|NCT01269671|Emollients|emollients|mesh-ancestor
24657965|NCT01269671|Dermatologic Agents|dermatologic agents|mesh-ancestor
24657966|NCT01269671|Antiemetics|antiemetics|mesh-ancestor
24657967|NCT01269671|Autonomic Agents|autonomic agents|mesh-ancestor
24657968|NCT01269671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24657969|NCT01269671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24657970|NCT01269671|Parasympatholytics|parasympatholytics|mesh-ancestor
24657971|NCT01269684|Everolimus|everolimus|mesh-list
24657972|NCT01269684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25202742|NCT02719015|Pembrolizumab|pembrolizumab|mesh-list
24657973|NCT01269684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24657998|NCT01269827|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24657999|NCT01269827|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24658000|NCT01269827|Protective Agents|protective agents|mesh-ancestor
24658001|NCT01269827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658005|NCT01269853|Bevacizumab|bevacizumab|mesh-list
25852711|NCT00057512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25852712|NCT00057512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25852713|NCT00057512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25852714|NCT00057512|Analgesics|analgesics|mesh-ancestor
25852715|NCT00057512|Sensory System Agents|sensory system agents|mesh-ancestor
25852716|NCT00057512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25852717|NCT00057512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25852718|NCT00057512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24941759|NCT03988010|Sensory System Agents|sensory system agents|mesh-ancestor
25852719|NCT00057564|Thalidomide|thalidomide|mesh-list
25852720|NCT00057564|Dexamethasone|dexamethasone|mesh-list
25852721|NCT00057564|Dexamethasone acetate|dexamethasone acetate|mesh-list
25852722|NCT00057564|BB 1101|bb 1101|mesh-list
24658014|NCT01269866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24658015|NCT01269866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24658016|NCT01269866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24658017|NCT01269866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658018|NCT01269866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24658019|NCT01269866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658020|NCT01269866|Analgesics|analgesics|mesh-ancestor
24658021|NCT01269866|Sensory System Agents|sensory system agents|mesh-ancestor
24658022|NCT01269866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658023|NCT01269866|Antidepressive Agents|antidepressive agents|mesh-ancestor
24658024|NCT01269866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24658025|NCT01269866|Dopamine Agents|dopamine agents|mesh-ancestor
24658026|NCT01269970|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24658027|NCT01269970|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24658028|NCT01269970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658029|NCT01269996|Metformin|metformin|mesh-list
24658030|NCT01269996|Gliclazide|gliclazide|mesh-list
24658031|NCT01269996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24658032|NCT01269996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658033|NCT01270035|Adalimumab|adalimumab|mesh-list
24658034|NCT01270035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24658035|NCT01270035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24658036|NCT01270074|Azithromycin|azithromycin|mesh-list
24658047|NCT01270152|Vitamins|vitamins|mesh-ancestor
25852723|NCT00057564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24658163|NCT01270724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24658164|NCT01270724|Immunologic Factors|immunologic factors|mesh-ancestor
24658165|NCT01270724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658167|NCT01270737|Phytoestrogens|phytoestrogens|mesh-ancestor
24658169|NCT01270737|Estrogens|estrogens|mesh-ancestor
24658180|NCT01270776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25852724|NCT00057564|Antiemetics|antiemetics|mesh-ancestor
24658515|NCT01272258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658516|NCT01272258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24658517|NCT01272258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24658518|NCT01272258|Antiviral Agents|antiviral agents|mesh-ancestor
24658519|NCT01272258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24658520|NCT01272310|Interferons|interferons|mesh-list
24658521|NCT01272310|Ribavirin|ribavirin|mesh-list
24658522|NCT01272310|Interferon-alpha|interferon-alpha|mesh-list
24658523|NCT01272310|Interferon alpha-2|interferon alpha-2|mesh-list
24658524|NCT01272310|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24658525|NCT01272310|Hydroxychloroquine|hydroxychloroquine|mesh-list
24658526|NCT01272310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24658527|NCT01272310|Antiviral Agents|antiviral agents|mesh-ancestor
24658528|NCT01272310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24658669|NCT01273493|Hormones|hormones|mesh-ancestor
24658670|NCT01273493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24658671|NCT01273493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24658747|NCT01273779|Talactoferrin alfa|talactoferrin alfa|mesh-list
24659016|NCT01275274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659031|NCT01275352|Natriuretic Agents|natriuretic agents|mesh-ancestor
25852725|NCT00057564|Autonomic Agents|autonomic agents|mesh-ancestor
24659274|NCT01276613|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25208323|NCT02666430|Insulin Glargine|insulin glargine|mesh-list
24854420|NCT02273570|Vitamins|vitamins|mesh-ancestor
24457017|NCT00332969|Octreotide|octreotide|mesh-list
24659276|NCT01276691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24659278|NCT01276691|Analgesics|analgesics|mesh-ancestor
25852726|NCT00057564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24659280|NCT01276691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24659316|NCT01276769|Tubulin Modulators|tubulin modulators|mesh-ancestor
24659317|NCT01276769|Antimitotic Agents|antimitotic agents|mesh-ancestor
24659333|NCT01276912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799294|NCT01968161|Asenapine|asenapine|mesh-list
24799295|NCT01968161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24799296|NCT01968161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24799297|NCT01968161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24799298|NCT01968161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799299|NCT01968161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24799300|NCT01968200|Enalapril|enalapril|mesh-list
24799301|NCT01968200|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24593211|NCT00927498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593212|NCT00927511|Fulvestrant|fulvestrant|mesh-list
24593213|NCT00927511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24593214|NCT00927511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24593215|NCT00927511|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24593216|NCT00927511|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24847426|NCT02246920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24659550|NCT01278446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659552|NCT01278459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24659553|NCT01278459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24659554|NCT01278459|Antimetabolites|antimetabolites|mesh-ancestor
24659555|NCT01278459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659557|NCT01278459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24659565|NCT01278498|Serotonin Agents|serotonin agents|mesh-ancestor
24659566|NCT01278498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659567|NCT01278498|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24659568|NCT01278498|Antidepressive Agents|antidepressive agents|mesh-ancestor
24659569|NCT01278498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24659570|NCT01278576|Botulinum Toxins|botulinum toxins|mesh-list
24659571|NCT01278576|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24659572|NCT01278576|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24659573|NCT01278576|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24659574|NCT01278576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24659575|NCT01278576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659576|NCT01278576|Cholinergic Agents|cholinergic agents|mesh-ancestor
24659577|NCT01278576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25876202|NCT03811002|Immunologic Factors|immunologic factors|mesh-ancestor
24455569|NCT00327808|Autonomic Agents|autonomic agents|mesh-ancestor
24659578|NCT01278576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659609|NCT01278784|Sequestering Agents|sequestering agents|mesh-ancestor
24659610|NCT01278784|Hemostatics|hemostatics|mesh-ancestor
24659611|NCT01278784|Coagulants|coagulants|mesh-ancestor
24593217|NCT00927511|Hormone Antagonists|hormone antagonists|mesh-ancestor
24593218|NCT00927511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24827936|NCT02142335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24659617|NCT01279083|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24659618|NCT01279083|Adrenergic Agents|adrenergic agents|mesh-ancestor
24659619|NCT01279083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24659620|NCT01279083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659621|NCT01279083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659622|NCT01279083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24659623|NCT01279083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24659624|NCT01279096|Dexamethasone|dexamethasone|mesh-list
24659625|NCT01279096|Etoposide|etoposide|mesh-list
24659626|NCT01279096|Asparaginase|asparaginase|mesh-list
24659627|NCT01279096|Mitoxantrone|mitoxantrone|mesh-list
24659628|NCT01279096|Clofarabine|clofarabine|mesh-list
24659629|NCT01279096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25202743|NCT02719015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24659630|NCT01279096|Antiemetics|antiemetics|mesh-ancestor
24659648|NCT01279096|Antimetabolites|antimetabolites|mesh-ancestor
24659669|NCT01279252|Lansoprazole|lansoprazole|mesh-list
24659670|NCT01279252|Dexlansoprazole|dexlansoprazole|mesh-list
24659671|NCT01279252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24659672|NCT01279252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24828019|NCT02142790|Paclitaxel|paclitaxel|mesh-list
24950102|NCT02633059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25876203|NCT03811002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876204|NCT03811002|Keratolytic Agents|keratolytic agents|mesh-ancestor
24950110|NCT02633059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950371|NCT00393783|Trastuzumab|trastuzumab|mesh-list
24950494|NCT03915561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24950496|NCT03915340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24950497|NCT03915340|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24950498|NCT03915340|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24659690|NCT01279291|Doxorubicin|doxorubicin|mesh-list
24659691|NCT01279291|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24659692|NCT01279291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24659693|NCT01279291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659694|NCT01279291|Tubulin Modulators|tubulin modulators|mesh-ancestor
24659695|NCT01279291|Antimitotic Agents|antimitotic agents|mesh-ancestor
24659696|NCT01279291|Mitosis Modulators|mitosis modulators|mesh-ancestor
24659697|NCT01279291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659698|NCT01279291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24659699|NCT01279291|Antimetabolites|antimetabolites|mesh-ancestor
24659706|NCT01279291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24659707|NCT01279291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24659708|NCT01279291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24659736|NCT01279512|Acarbose|acarbose|mesh-list
24659737|NCT01279512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24659738|NCT01279512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659751|NCT01279551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24659752|NCT01279551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24659753|NCT01279551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24659754|NCT01279551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659756|NCT01279629|Tazarotene|tazarotene|mesh-list
24659757|NCT01279629|Calcipotriene|calcipotriene|mesh-list
24659788|NCT01279707|Antibodies|antibodies|mesh-list
24659789|NCT01279707|Immunoglobulins|immunoglobulins|mesh-list
24659790|NCT01279707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24659791|NCT01279707|Immunologic Factors|immunologic factors|mesh-ancestor
24950499|NCT03915340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24950500|NCT03915340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799340|NCT01968564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24799341|NCT01968564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24799342|NCT01968564|Analgesics|analgesics|mesh-ancestor
24799370|NCT01968759|Sevelamer|sevelamer|mesh-list
24828135|NCT02143531|Antipruritics|antipruritics|mesh-ancestor
24659919|NCT01280682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24659921|NCT01280734|Antioxidants|antioxidants|mesh-ancestor
24659922|NCT01280734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659923|NCT01280734|Protective Agents|protective agents|mesh-ancestor
24659949|NCT01281111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24659950|NCT01281111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24659951|NCT01281111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659952|NCT01281111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24659953|NCT01281111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24659954|NCT01281111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24659955|NCT01281111|Antipyretics|antipyretics|mesh-ancestor
24659956|NCT01281111|Dermatologic Agents|dermatologic agents|mesh-ancestor
24659957|NCT01281111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24659958|NCT01281111|Immunologic Factors|immunologic factors|mesh-ancestor
24659965|NCT01281150|Tubulin Modulators|tubulin modulators|mesh-ancestor
24950673|NCT03912974|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24950674|NCT03912974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25664148|NCT01666652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660001|NCT01281527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24660002|NCT01281527|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24660003|NCT01281527|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24660004|NCT01281527|Serotonin Agents|serotonin agents|mesh-ancestor
24660005|NCT01281527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25852731|NCT00057564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25852732|NCT00057564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24660063|NCT01281696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24660064|NCT01281696|Antimetabolites|antimetabolites|mesh-ancestor
24660065|NCT01281696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660066|NCT01281696|Dermatologic Agents|dermatologic agents|mesh-ancestor
24660067|NCT01281696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852733|NCT00057564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852734|NCT00057564|Protease Inhibitors|protease inhibitors|mesh-ancestor
25202744|NCT02719015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25202745|NCT02718911|Durvalumab|durvalumab|mesh-list
25852735|NCT00057564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660093|NCT01281748|Protective Agents|protective agents|mesh-ancestor
24660094|NCT01281748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24660095|NCT01281748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660096|NCT01281761|Irinotecan|irinotecan|mesh-list
24660097|NCT01281761|Cetuximab|cetuximab|mesh-list
24660098|NCT01281761|Simvastatin|simvastatin|mesh-list
24660099|NCT01281761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24660129|NCT01281800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660131|NCT01281800|Antiviral Agents|antiviral agents|mesh-ancestor
24660132|NCT01281800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24660133|NCT01281800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660134|NCT01281800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24660135|NCT01281800|Immunologic Factors|immunologic factors|mesh-ancestor
24660136|NCT01281800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660137|NCT01281813|Ritonavir|ritonavir|mesh-list
24660138|NCT01281813|Darunavir|darunavir|mesh-list
24660139|NCT01281813|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24660140|NCT01281813|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24660141|NCT01281813|Protease Inhibitors|protease inhibitors|mesh-ancestor
24720034|NCT01565798|Trace Elements|trace elements|mesh-ancestor
24660142|NCT01281813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24799448|NCT01969032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25664149|NCT01666652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25664150|NCT01666730|Leucovorin|leucovorin|mesh-list
25664151|NCT01666730|Metformin|metformin|mesh-list
25664152|NCT01666730|Fluorouracil|fluorouracil|mesh-list
25664153|NCT01666730|Oxaliplatin|oxaliplatin|mesh-list
25664154|NCT01666730|Calcium|calcium|mesh-list
25664155|NCT01666730|Levoleucovorin|levoleucovorin|mesh-list
25664156|NCT01666730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25664157|NCT01666730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664158|NCT01666730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25664159|NCT01666730|Antimetabolites|antimetabolites|mesh-ancestor
25664160|NCT01666730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664161|NCT01666730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25664162|NCT01666730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799452|NCT01969032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24799455|NCT01969032|Immunologic Factors|immunologic factors|mesh-ancestor
24799456|NCT01969032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660149|NCT01281813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24660150|NCT01281852|Paclitaxel|paclitaxel|mesh-list
24660151|NCT01281852|Cisplatin|cisplatin|mesh-list
24660152|NCT01281852|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24660153|NCT01281852|Veliparib|veliparib|mesh-list
24660154|NCT01281852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24660155|NCT01281852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660156|NCT01281852|Tubulin Modulators|tubulin modulators|mesh-ancestor
24660157|NCT01281852|Antimitotic Agents|antimitotic agents|mesh-ancestor
24660158|NCT01281852|Mitosis Modulators|mitosis modulators|mesh-ancestor
24660159|NCT01281852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660160|NCT01281852|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24660161|NCT01281852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660162|NCT01281878|Vitamin B 6|vitamin b 6|mesh-list
24660163|NCT01281878|Pyridoxal|pyridoxal|mesh-list
24660164|NCT01281878|Pyridoxine|pyridoxine|mesh-list
24660165|NCT01281878|Vitamins|vitamins|mesh-ancestor
24660166|NCT01281878|Micronutrients|micronutrients|mesh-ancestor
24660167|NCT01281878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660168|NCT01281878|Vitamin B Complex|vitamin b complex|mesh-ancestor
24660169|NCT01281891|Morphine|morphine|mesh-list
24660170|NCT01281891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24660171|NCT01281891|Narcotics|narcotics|mesh-ancestor
24799463|NCT01969071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24799464|NCT01969071|Vasodilator Agents|vasodilator agents|mesh-ancestor
24799465|NCT01969071|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24799466|NCT01969071|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24799467|NCT01969071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828471|NCT02145715|Dexamethasone|dexamethasone|mesh-list
24799543|NCT01969617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24799544|NCT01969617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799545|NCT01969617|Sensory System Agents|sensory system agents|mesh-ancestor
24799546|NCT01969617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24799547|NCT01969617|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24799548|NCT01969656|Calcitriol|calcitriol|mesh-list
24799549|NCT01969656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24799550|NCT01969656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202746|NCT02718911|Tremelimumab|tremelimumab|mesh-list
24799551|NCT01969656|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24799552|NCT01969656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24847739|NCT02248493|Acetaminophen|acetaminophen|mesh-list
24799553|NCT01969656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799554|NCT01969656|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24799556|NCT01969656|Micronutrients|micronutrients|mesh-ancestor
24799557|NCT01969656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24799558|NCT01969669|Ketoconazole|ketoconazole|mesh-list
24799559|NCT01969669|Venetoclax|venetoclax|mesh-list
24593410|NCT00928837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24799560|NCT01969669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799561|NCT01969669|Antifungal Agents|antifungal agents|mesh-ancestor
24593481|NCT00929591|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24593482|NCT00929630|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24593483|NCT00929630|Hemostatics|hemostatics|mesh-ancestor
24593484|NCT00929630|Coagulants|coagulants|mesh-ancestor
24593485|NCT00929799|Hormones|hormones|mesh-list
24799562|NCT01969669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24799563|NCT01969669|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24660232|NCT01282333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24660233|NCT01282333|Antimetabolites|antimetabolites|mesh-ancestor
24660234|NCT01282333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660235|NCT01282333|Antiviral Agents|antiviral agents|mesh-ancestor
24660236|NCT01282333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24660237|NCT01282333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660238|NCT01282333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25876205|NCT03811002|Dermatologic Agents|dermatologic agents|mesh-ancestor
24660239|NCT01282333|Immunologic Factors|immunologic factors|mesh-ancestor
24660240|NCT01282333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664163|NCT01666730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25664164|NCT01666730|Immunologic Factors|immunologic factors|mesh-ancestor
24660241|NCT01282333|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24660243|NCT01282385|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24660244|NCT01282385|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24660245|NCT01282385|Antimetabolites|antimetabolites|mesh-ancestor
25049822|NCT00562497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950851|NCT03910647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950852|NCT03910634|Carboplatin|carboplatin|mesh-list
24950853|NCT03910634|Fluorouracil|fluorouracil|mesh-list
24950854|NCT03910634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950855|NCT03910634|Antimetabolites|antimetabolites|mesh-ancestor
24950856|NCT03910634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950857|NCT03910634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24950858|NCT03910634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24847807|NCT05353673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660246|NCT01282385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660261|NCT01282502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660262|NCT01282502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660264|NCT01282515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24660265|NCT01282515|Glucocorticoids|glucocorticoids|mesh-ancestor
24660266|NCT01282515|Hormones|hormones|mesh-ancestor
24660267|NCT01282515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24660268|NCT01282515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660269|NCT01282528|Infliximab|infliximab|mesh-list
24660270|NCT01282528|Dermatologic Agents|dermatologic agents|mesh-ancestor
25852736|NCT00057564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660272|NCT01282528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24660273|NCT01282541|Botulinum Toxins|botulinum toxins|mesh-list
24660274|NCT01282541|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24660275|NCT01282541|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24660295|NCT01282632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24660297|NCT01282632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24660310|NCT01282632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24660311|NCT01282632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24660312|NCT01282632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25852737|NCT00057564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24660340|NCT01282879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24660341|NCT01282879|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24660342|NCT01282879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24660344|NCT01282879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660345|NCT01282879|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24660346|NCT01282879|Hormone Antagonists|hormone antagonists|mesh-ancestor
24660347|NCT01282879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25208324|NCT02666430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24660363|NCT01283061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24660364|NCT01283061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799580|NCT01969682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24799581|NCT01969682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660449|NCT01283724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24660450|NCT01283724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24799587|NCT01969682|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24799588|NCT01969682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24799590|NCT01969695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799591|NCT01969773|Botulinum Toxins|botulinum toxins|mesh-list
24799592|NCT01969773|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24799593|NCT01969773|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24799594|NCT01969773|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24799595|NCT01969773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24799596|NCT01969773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799597|NCT01969773|Cholinergic Agents|cholinergic agents|mesh-ancestor
24720277|NCT01567540|Incretins|incretins|mesh-ancestor
24799598|NCT01969773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24799599|NCT01969773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799600|NCT01969773|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24799601|NCT01969773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24799602|NCT01969877|Cetuximab|cetuximab|mesh-list
24799603|NCT01969877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25049894|NCT00557401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24799606|NCT01969903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24660530|NCT01284166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24799613|NCT01969903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24799614|NCT01969903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24799615|NCT01969903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24799616|NCT01969903|Adrenergic Agents|adrenergic agents|mesh-ancestor
24799617|NCT01969903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24799618|NCT01969903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799619|NCT01969942|Melphalan|melphalan|mesh-list
24799620|NCT01969942|Busulfan|busulfan|mesh-list
24799621|NCT01969942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24799622|NCT01969942|Alkylating Agents|alkylating agents|mesh-ancestor
24799623|NCT01969942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799624|NCT01969942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799625|NCT01969942|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24799626|NCT01969942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24799627|NCT01969942|Immunologic Factors|immunologic factors|mesh-ancestor
24799628|NCT01969942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799629|NCT01969955|Paclitaxel|paclitaxel|mesh-list
24799630|NCT01969955|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24828628|NCT02146638|Anesthetics|anesthetics|mesh-ancestor
25852738|NCT00057564|Immunologic Factors|immunologic factors|mesh-ancestor
24660549|NCT01284413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660562|NCT01284439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660565|NCT01284452|Hydrocortisone|hydrocortisone|mesh-list
24660566|NCT01284452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24660567|NCT01284478|Dexamethasone|dexamethasone|mesh-list
24660568|NCT01284478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24660569|NCT01284478|Antiemetics|antiemetics|mesh-ancestor
24660570|NCT01284478|Autonomic Agents|autonomic agents|mesh-ancestor
24720284|NCT01567605|Lidocaine|lidocaine|mesh-list
24660571|NCT01284478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24660572|NCT01284478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660573|NCT01284478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24660574|NCT01284478|Glucocorticoids|glucocorticoids|mesh-ancestor
24660575|NCT01284478|Hormones|hormones|mesh-ancestor
24660576|NCT01284478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24660577|NCT01284478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24660578|NCT01284478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660579|NCT01284556|Phenobarbital|phenobarbital|mesh-list
24660580|NCT01284556|Anticonvulsants|anticonvulsants|mesh-ancestor
24799636|NCT01969955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799638|NCT01970046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24799639|NCT01970046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799640|NCT01970059|Metoprolol|metoprolol|mesh-list
24799641|NCT01970059|Carvedilol|carvedilol|mesh-list
24799642|NCT01970059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24799643|NCT01970059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24799645|NCT01970059|Autonomic Agents|autonomic agents|mesh-ancestor
24799646|NCT01970059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24799648|NCT01970059|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24799649|NCT01970059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24799650|NCT01970059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24799651|NCT01970059|Adrenergic Agents|adrenergic agents|mesh-ancestor
24799652|NCT01970059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24799653|NCT01970059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799654|NCT01970059|Antioxidants|antioxidants|mesh-ancestor
24799655|NCT01970059|Protective Agents|protective agents|mesh-ancestor
24799656|NCT01970059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24799657|NCT01970059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24799658|NCT01970059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24799659|NCT01970059|Vasodilator Agents|vasodilator agents|mesh-ancestor
24847885|NCT05353101|Tobramycin|tobramycin|mesh-list
24660581|NCT01284556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24660582|NCT01284556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24660583|NCT01284556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660584|NCT01284556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24660585|NCT01284556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24660586|NCT01284556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24828652|NCT02146911|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24799708|NCT01970553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799710|NCT01970553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24799711|NCT01970553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660879|NCT01286857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720425|NCT01568307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720426|NCT01568307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24660881|NCT01286896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660882|NCT01286896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24660883|NCT01286896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24799712|NCT01970553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24799713|NCT01970553|Immunologic Factors|immunologic factors|mesh-ancestor
24662362|NCT01294215|Vasodilator Agents|vasodilator agents|mesh-ancestor
24799714|NCT01970553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661055|NCT01287715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24799767|NCT01971242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661118|NCT01287962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24661183|NCT01288339|Vitamin B Complex|vitamin b complex|mesh-ancestor
24661185|NCT01288339|Micronutrients|micronutrients|mesh-ancestor
24661186|NCT01288339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24661187|NCT01288378|Caspofungin|caspofungin|mesh-list
24661188|NCT01288378|Antifungal Agents|antifungal agents|mesh-ancestor
24661189|NCT01288378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24661190|NCT01288378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661191|NCT01288378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661192|NCT01288404|Fluorometholone|fluorometholone|mesh-list
24661193|NCT01288404|Bevacizumab|bevacizumab|mesh-list
24661194|NCT01288404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24661195|NCT01288404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661196|NCT01288404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24661197|NCT01288404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24661198|NCT01288404|Growth Substances|growth substances|mesh-ancestor
24799769|NCT01971242|Incretins|incretins|mesh-ancestor
24661201|NCT01288404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24661204|NCT01288404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24661205|NCT01288404|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24661206|NCT01288417|Raltegravir Potassium|raltegravir potassium|mesh-list
24661207|NCT01288417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24661208|NCT01288417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24661209|NCT01288417|Antiviral Agents|antiviral agents|mesh-ancestor
24661210|NCT01288417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24661211|NCT01288417|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24661212|NCT01288417|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24661213|NCT01288417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661214|NCT01288417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661215|NCT01288495|Psyllium|psyllium|mesh-list
24661310|NCT01288872|Praziquantel|praziquantel|mesh-list
24661311|NCT01288872|Anthelmintics|anthelmintics|mesh-ancestor
24661312|NCT01288872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24661313|NCT01288872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24661314|NCT01288885|Ipragliflozin|ipragliflozin|mesh-list
24661315|NCT01288885|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24799793|NCT01971281|Antimetabolites|antimetabolites|mesh-ancestor
24661359|NCT01289132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24661360|NCT01289132|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24661378|NCT01289236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661379|NCT01289236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24661381|NCT01289236|Sensory System Agents|sensory system agents|mesh-ancestor
24661382|NCT01289236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24661383|NCT01289236|Antidepressive Agents|antidepressive agents|mesh-ancestor
24661384|NCT01289236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24661385|NCT01289301|Cyclosporine|cyclosporine|mesh-list
24661386|NCT01289301|Sirolimus|sirolimus|mesh-list
24661387|NCT01289301|Everolimus|everolimus|mesh-list
24661388|NCT01289301|Tacrolimus|tacrolimus|mesh-list
24661389|NCT01289301|Cyclosporins|cyclosporins|mesh-list
24661390|NCT01289301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
24661391|NCT01289301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24661392|NCT01289301|Immunologic Factors|immunologic factors|mesh-ancestor
24661393|NCT01289301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661394|NCT01289301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852739|NCT00057564|Leprostatic Agents|leprostatic agents|mesh-ancestor
24661443|NCT01289496|Immunologic Factors|immunologic factors|mesh-ancestor
24661444|NCT01289496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852740|NCT00057564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25852741|NCT00057564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25852742|NCT00057564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25852743|NCT00057564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25852744|NCT00057564|Growth Substances|growth substances|mesh-ancestor
25852745|NCT00057564|Growth Inhibitors|growth inhibitors|mesh-ancestor
25852746|NCT00057616|Lenalidomide|lenalidomide|mesh-list
25852747|NCT00057616|Immunologic Factors|immunologic factors|mesh-ancestor
25852748|NCT00057616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852750|NCT00057616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25852751|NCT00057616|Growth Substances|growth substances|mesh-ancestor
25852752|NCT00057616|Growth Inhibitors|growth inhibitors|mesh-ancestor
24661502|NCT01289756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661503|NCT01289756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24661504|NCT01289756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24661505|NCT01289756|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24720476|NCT01568645|Vasodilator Agents|vasodilator agents|mesh-ancestor
24661632|NCT01290198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24661633|NCT01290198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661634|NCT01290198|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24661635|NCT01290198|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24661637|NCT01290211|Fosamprenavir|fosamprenavir|mesh-list
24661638|NCT01290211|Maraviroc|maraviroc|mesh-list
24661639|NCT01290211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24661640|NCT01290211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24661682|NCT01290328|Epoetin Alfa|epoetin alfa|mesh-list
24661685|NCT01290354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852753|NCT00057616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661790|NCT01291069|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24661791|NCT01291069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24661792|NCT01291069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661793|NCT01291069|Urological Agents|urological agents|mesh-ancestor
25852754|NCT00057642|Sertraline|sertraline|mesh-list
24661819|NCT01291186|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24661820|NCT01291186|Autonomic Agents|autonomic agents|mesh-ancestor
24661821|NCT01291186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24661822|NCT01291186|Respiratory System Agents|respiratory system agents|mesh-ancestor
24661823|NCT01291186|Mydriatics|mydriatics|mesh-ancestor
24661840|NCT01291212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24661841|NCT01291212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661842|NCT01291212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24661843|NCT01291212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661844|NCT01291212|Anabolic Agents|anabolic agents|mesh-ancestor
24661845|NCT01291316|Clonazepam|clonazepam|mesh-list
24661846|NCT01291316|Clobazam|clobazam|mesh-list
24661847|NCT01291316|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24799826|NCT01971489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24799827|NCT01971489|Immunologic Factors|immunologic factors|mesh-ancestor
24799828|NCT01971489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799829|NCT01971515|Tamoxifen|tamoxifen|mesh-list
24799830|NCT01971515|Trastuzumab|trastuzumab|mesh-list
24799831|NCT01971515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24799832|NCT01971515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799833|NCT01971515|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24799834|NCT01971515|Hormone Antagonists|hormone antagonists|mesh-ancestor
24720529|NCT01569048|Anesthetics|anesthetics|mesh-ancestor
24799835|NCT01971515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24828914|NCT02148120|Hormones|hormones|mesh-ancestor
24661891|NCT01291459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661892|NCT01291459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661893|NCT01291459|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24661894|NCT01291459|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24661895|NCT01291459|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24661897|NCT01291459|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24661898|NCT01291459|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24661899|NCT01291459|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24661900|NCT01291472|Ketorolac|ketorolac|mesh-list
24661901|NCT01291472|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24661902|NCT01291472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24799855|NCT01971632|Analgesics|analgesics|mesh-ancestor
24661911|NCT01291472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661912|NCT01291472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661913|NCT01291511|Iloperidone|iloperidone|mesh-list
24661914|NCT01291511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24661928|NCT01291524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24661929|NCT01291524|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24661930|NCT01291524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24661931|NCT01291524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25852755|NCT00057642|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25852756|NCT00057642|Antidepressive Agents|antidepressive agents|mesh-ancestor
25852757|NCT00057642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25852759|NCT00057642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24452228|NCT00326456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24452229|NCT00326456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24452230|NCT00326456|Tubulin Modulators|tubulin modulators|mesh-ancestor
24452231|NCT00326456|Antimitotic Agents|antimitotic agents|mesh-ancestor
24661932|NCT01291524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24661933|NCT01291537|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24661934|NCT01291537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25852760|NCT00057642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24661946|NCT01291563|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24661947|NCT01291563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24661948|NCT01291563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24661949|NCT01291563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24661950|NCT01291563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24661951|NCT01291563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661952|NCT01291563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661953|NCT01291563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661954|NCT01291563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24661955|NCT01291563|Contraceptive Agents|contraceptive agents|mesh-ancestor
24799879|NCT01971658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24799881|NCT01971658|Leprostatic Agents|leprostatic agents|mesh-ancestor
24662048|NCT01292083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24662049|NCT01292109|Picosulfate sodium|picosulfate sodium|mesh-list
24662050|NCT01292109|Cathartics|cathartics|mesh-ancestor
24662051|NCT01292109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24662052|NCT01292161|Silymarin|silymarin|mesh-list
24662053|NCT01292161|Antioxidants|antioxidants|mesh-ancestor
24662054|NCT01292161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662055|NCT01292161|Protective Agents|protective agents|mesh-ancestor
25202747|NCT02718911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24662056|NCT01292161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662058|NCT01292174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24662059|NCT01292174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24662060|NCT01292174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24662061|NCT01292174|Antiviral Agents|antiviral agents|mesh-ancestor
24662062|NCT01292174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24829009|NCT02149212|Aminaftone|aminaftone|mesh-list
24662171|NCT01293136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24662172|NCT01293149|Clonidine|clonidine|mesh-list
24662173|NCT01293149|Ropivacaine|ropivacaine|mesh-list
24662238|NCT01293643|Clindamycin palmitate|clindamycin palmitate|mesh-list
24662239|NCT01293643|Clindamycin phosphate|clindamycin phosphate|mesh-list
24662240|NCT01293643|Amphotericin B|amphotericin b|mesh-list
24662241|NCT01293643|Tetracycline|tetracycline|mesh-list
24662242|NCT01293643|Ketoconazole|ketoconazole|mesh-list
24662243|NCT01293643|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24662244|NCT01293643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24662324|NCT01294059|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24662343|NCT01294072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24662344|NCT01294072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24662345|NCT01294072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662346|NCT01294072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24662347|NCT01294072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662348|NCT01294176|Thioctic Acid|thioctic acid|mesh-list
24662349|NCT01294176|Antioxidants|antioxidants|mesh-ancestor
24662350|NCT01294176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662351|NCT01294176|Protective Agents|protective agents|mesh-ancestor
24662352|NCT01294176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662353|NCT01294176|Vitamin B Complex|vitamin b complex|mesh-ancestor
24662354|NCT01294176|Vitamins|vitamins|mesh-ancestor
25664165|NCT01666730|Antidotes|antidotes|mesh-ancestor
25664166|NCT01666730|Protective Agents|protective agents|mesh-ancestor
25664167|NCT01666730|Vitamin B Complex|vitamin b complex|mesh-ancestor
25664168|NCT01666730|Vitamins|vitamins|mesh-ancestor
25664169|NCT01666730|Micronutrients|micronutrients|mesh-ancestor
25664170|NCT01666782|Vaccines|vaccines|mesh-list
24662355|NCT01294176|Micronutrients|micronutrients|mesh-ancestor
24662356|NCT01294215|Nifedipine|nifedipine|mesh-list
24662357|NCT01294215|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25664171|NCT01666782|Immunologic Factors|immunologic factors|mesh-ancestor
25664172|NCT01666782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664173|NCT01666912|Contraceptive Agents|contraceptive agents|mesh-list
25664174|NCT01666912|Etonogestrel|etonogestrel|mesh-list
24662358|NCT01294215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24662359|NCT01294215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662360|NCT01294215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24662361|NCT01294215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799919|NCT01971918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593813|NCT00931073|Antifungal Agents|antifungal agents|mesh-ancestor
24799922|NCT01972113|Vitamin K 2|vitamin k 2|mesh-list
24799923|NCT01972113|Vitamin MK 7|vitamin mk 7|mesh-list
24799924|NCT01972113|Micronutrients|micronutrients|mesh-ancestor
24593961|NCT00931736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593962|NCT00931736|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24593963|NCT00931736|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24593964|NCT00931736|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24593965|NCT00931736|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24593966|NCT00931736|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24593967|NCT00931736|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24593968|NCT00931736|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24593969|NCT00931736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24593970|NCT00931736|Antimetabolites|antimetabolites|mesh-ancestor
24593971|NCT00931736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24622235|NCT01066247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24622236|NCT01066247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24622237|NCT01066247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24622238|NCT01066247|Anesthetics, General|anesthetics, general|mesh-ancestor
24622239|NCT01066247|Anesthetics|anesthetics|mesh-ancestor
24622240|NCT01066247|GABA Modulators|gaba modulators|mesh-ancestor
24622241|NCT01066247|GABA Agents|gaba agents|mesh-ancestor
24622242|NCT01066247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24622243|NCT01066247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622244|NCT01066299|Oxytocin|oxytocin|mesh-list
25049853|NCT00560183|Morphine|morphine|mesh-list
25049854|NCT00560183|Oxycodone|oxycodone|mesh-list
25049855|NCT00560183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25049856|NCT00560183|Narcotics|narcotics|mesh-ancestor
25049857|NCT00560183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24662365|NCT01294293|Paclitaxel|paclitaxel|mesh-list
24662366|NCT01294293|Doxorubicin|doxorubicin|mesh-list
24662367|NCT01294293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24662368|NCT01294293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24662369|NCT01294293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662370|NCT01294293|Tubulin Modulators|tubulin modulators|mesh-ancestor
24662371|NCT01294293|Antimitotic Agents|antimitotic agents|mesh-ancestor
24662372|NCT01294293|Mitosis Modulators|mitosis modulators|mesh-ancestor
24662373|NCT01294293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662374|NCT01294293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24662375|NCT01294293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24662376|NCT01294293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25049874|NCT00558207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25049875|NCT00558207|Immunologic Factors|immunologic factors|mesh-ancestor
25049876|NCT00558207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049877|NCT00558038|Lactulose|lactulose|mesh-list
25049878|NCT00558038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24829164|NCT02150122|Vitamins|vitamins|mesh-ancestor
24662575|NCT01295372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25049882|NCT00557973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049883|NCT00557973|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25049884|NCT00557973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25049885|NCT00557973|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25049886|NCT00557973|GABA Agonists|gaba agonists|mesh-ancestor
25049887|NCT00557973|GABA Agents|gaba agents|mesh-ancestor
25049888|NCT00557973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25049889|NCT00557973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049890|NCT00557401|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
25049891|NCT00557401|Baclofen|baclofen|mesh-list
25049892|NCT00557401|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25049893|NCT00557401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049896|NCT00557401|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25049897|NCT00557401|GABA Agonists|gaba agonists|mesh-ancestor
24662577|NCT01295372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24662578|NCT01295372|Dopamine Agents|dopamine agents|mesh-ancestor
24662579|NCT01295450|Vitamins|vitamins|mesh-list
24662580|NCT01295450|Micronutrients|micronutrients|mesh-ancestor
24662581|NCT01295450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662584|NCT01295502|Carboplatin|carboplatin|mesh-list
24662639|NCT01295866|Respiratory System Agents|respiratory system agents|mesh-ancestor
25852762|NCT00057642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25852763|NCT00057642|Serotonin Agents|serotonin agents|mesh-ancestor
25852764|NCT00057642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848172|NCT05000736|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25049898|NCT00557401|GABA Agents|gaba agents|mesh-ancestor
25049899|NCT00557401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25049900|NCT00557401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049901|NCT00557128|Lisinopril|lisinopril|mesh-list
25049902|NCT00557128|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25049903|NCT00557128|Protease Inhibitors|protease inhibitors|mesh-ancestor
25049904|NCT00557128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049905|NCT00557128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049906|NCT00557128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25049907|NCT00557128|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25049908|NCT00557128|Protective Agents|protective agents|mesh-ancestor
25049909|NCT00557128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951252|NCT03906669|Progesterone|progesterone|mesh-list
24951253|NCT03906669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622254|NCT01066377|Antimalarials|antimalarials|mesh-ancestor
24720843|NCT01570985|Hormones|hormones|mesh-ancestor
24622255|NCT01066377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24622256|NCT01066377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24622257|NCT01066403|Pergolide|pergolide|mesh-list
24622258|NCT01066403|Dopamine Agonists|dopamine agonists|mesh-ancestor
24622259|NCT01066403|Dopamine Agents|dopamine agents|mesh-ancestor
24622260|NCT01066403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24829851|NCT02154932|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24829206|NCT02150317|Estrogens|estrogens|mesh-ancestor
24662826|NCT01297023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662827|NCT01297023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24662828|NCT01297023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24662829|NCT01297036|Donepezil|donepezil|mesh-list
24662830|NCT01297036|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24662831|NCT01297036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24662832|NCT01297036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662833|NCT01297036|Cholinergic Agents|cholinergic agents|mesh-ancestor
24662834|NCT01297036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24662835|NCT01297036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662836|NCT01297036|Nootropic Agents|nootropic agents|mesh-ancestor
24799977|NCT01972490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799978|NCT01972490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24799979|NCT01972490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24799980|NCT01972490|Growth Substances|growth substances|mesh-ancestor
24799981|NCT01972490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799982|NCT01972490|Growth Inhibitors|growth inhibitors|mesh-ancestor
24799983|NCT01972503|Oxaliplatin|oxaliplatin|mesh-list
24799984|NCT01972503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799985|NCT01972620|Bupivacaine|bupivacaine|mesh-list
24799986|NCT01972620|Anesthetics, Local|anesthetics, local|mesh-ancestor
24799987|NCT01972620|Anesthetics|anesthetics|mesh-ancestor
24799988|NCT01972620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24799989|NCT01972620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799990|NCT01972620|Sensory System Agents|sensory system agents|mesh-ancestor
24799991|NCT01972620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24799992|NCT01972711|Amisulpride|amisulpride|mesh-list
24799993|NCT01972711|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24799994|NCT01972711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24799995|NCT01972711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24848242|NCT04849715|Rituximab|rituximab|mesh-list
24662866|NCT01297179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24662867|NCT01297179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24662868|NCT01297179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24799996|NCT01972711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799997|NCT01972711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24799998|NCT01972711|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24800000|NCT01972711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25664175|NCT01666912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25664176|NCT01666912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664177|NCT01666912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25664178|NCT01666912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24662872|NCT01297179|Adrenergic Agents|adrenergic agents|mesh-ancestor
24662873|NCT01297179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24662874|NCT01297179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662875|NCT01297179|Urological Agents|urological agents|mesh-ancestor
24662876|NCT01297192|Solifenacin Succinate|solifenacin succinate|mesh-list
25852765|NCT00057642|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25852766|NCT00057642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25852767|NCT00057707|Modafinil|modafinil|mesh-list
25852768|NCT00057707|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25852769|NCT00057707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852770|NCT00057707|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24662886|NCT01297192|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24662887|NCT01297192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24662888|NCT01297192|Adrenergic Agents|adrenergic agents|mesh-ancestor
24662890|NCT01297452|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25202748|NCT02718911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662892|NCT01297452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24662893|NCT01297452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662894|NCT01297452|Tubulin Modulators|tubulin modulators|mesh-ancestor
24662895|NCT01297452|Antimitotic Agents|antimitotic agents|mesh-ancestor
24800015|NCT01972880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24800016|NCT01972880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662896|NCT01297452|Mitosis Modulators|mitosis modulators|mesh-ancestor
24662897|NCT01297452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662898|NCT01297569|Ranibizumab|ranibizumab|mesh-list
24662899|NCT01297569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24662900|NCT01297569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24662901|NCT01297569|Growth Substances|growth substances|mesh-ancestor
24662902|NCT01297569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662903|NCT01297569|Growth Inhibitors|growth inhibitors|mesh-ancestor
24662904|NCT01297569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662923|NCT01297686|Glucocorticoids|glucocorticoids|mesh-ancestor
24829278|NCT02150993|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24662978|NCT01297829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24662979|NCT01297829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24662980|NCT01297829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662982|NCT01297842|Imipenem|imipenem|mesh-list
24662983|NCT01297842|Ertapenem|ertapenem|mesh-list
24662984|NCT01297842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24662985|NCT01297842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24662986|NCT01297855|Rifampin|rifampin|mesh-list
24662987|NCT01297855|Colistin|colistin|mesh-list
24662988|NCT01297855|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24662989|NCT01297855|Antitubercular Agents|antitubercular agents|mesh-ancestor
24662990|NCT01297855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24662991|NCT01297855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24662992|NCT01297855|Leprostatic Agents|leprostatic agents|mesh-ancestor
24662993|NCT01297855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24662994|NCT01297855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663738|NCT01303536|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24662995|NCT01297855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662996|NCT01297855|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24662997|NCT01297855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25424549|NCT02248597|Mycophenolic Acid|mycophenolic acid|mesh-list
24662998|NCT01297855|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24662999|NCT01297855|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24663000|NCT01297855|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24663001|NCT01297855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24663005|NCT01297894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24663021|NCT01297946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24663022|NCT01297998|Gemcitabine|gemcitabine|mesh-list
24829328|NCT02151604|Xenon|xenon|mesh-list
24663078|NCT01298271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594057|NCT00932100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24594058|NCT00932100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594060|NCT00932217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24594061|NCT00932217|Immunologic Factors|immunologic factors|mesh-ancestor
24594062|NCT00932217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594063|NCT00932386|Dexmedetomidine|dexmedetomidine|mesh-list
24594064|NCT00932386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24594065|NCT00932386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24594066|NCT00932386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594067|NCT00932386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24594068|NCT00932386|Analgesics|analgesics|mesh-ancestor
24594069|NCT00932386|Sensory System Agents|sensory system agents|mesh-ancestor
24663094|NCT01298297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24663095|NCT01298297|Narcotics|narcotics|mesh-ancestor
24663096|NCT01298297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24663097|NCT01298297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663098|NCT01298297|Analgesics|analgesics|mesh-ancestor
24663099|NCT01298297|Sensory System Agents|sensory system agents|mesh-ancestor
24663100|NCT01298297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663101|NCT01298297|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24663102|NCT01298310|Lidocaine|lidocaine|mesh-list
24663103|NCT01298310|Anesthetics, Local|anesthetics, local|mesh-ancestor
24663104|NCT01298310|Anesthetics|anesthetics|mesh-ancestor
24663106|NCT01298310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663107|NCT01298310|Sensory System Agents|sensory system agents|mesh-ancestor
24663108|NCT01298310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663109|NCT01298310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24663110|NCT01298310|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24663111|NCT01298310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24663112|NCT01298310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24663113|NCT01298310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663115|NCT01298336|Clarithromycin|clarithromycin|mesh-list
24663116|NCT01298336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24663117|NCT01298336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24663118|NCT01298336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24663119|NCT01298336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24663120|NCT01298336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663121|NCT01298336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663122|NCT01298336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663123|NCT01298336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24663124|NCT01298336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24663125|NCT01298336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24663127|NCT01298401|Capecitabine|capecitabine|mesh-list
24663128|NCT01298401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24594070|NCT00932386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24594071|NCT00932386|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24594072|NCT00932386|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24594073|NCT00932386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24594074|NCT00932386|Adrenergic Agents|adrenergic agents|mesh-ancestor
24594075|NCT00932386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24594076|NCT00932386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622266|NCT01066429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24848320|NCT04574713|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25424550|NCT02248597|Cyclophosphamide|cyclophosphamide|mesh-list
25664179|NCT01666951|Tacrolimus|tacrolimus|mesh-list
25664180|NCT01666951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25664181|NCT01666951|Immunologic Factors|immunologic factors|mesh-ancestor
25664182|NCT01666951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834122|NCT02177305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834125|NCT02177318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24848321|NCT04574713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663167|NCT01298713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663169|NCT01298713|Hormone Antagonists|hormone antagonists|mesh-ancestor
24451569|NCT00324298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24663170|NCT01298713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24663171|NCT01298713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24663189|NCT01299012|Hormones|hormones|mesh-ancestor
24663190|NCT01299012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24663198|NCT01299181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663200|NCT01299194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24663201|NCT01299194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24663202|NCT01299194|Antimetabolites|antimetabolites|mesh-ancestor
24663203|NCT01299194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663234|NCT01299597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663235|NCT01299597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24663236|NCT01299597|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24663237|NCT01299597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663239|NCT01299662|Interferon Inducers|interferon inducers|mesh-ancestor
24663240|NCT01299662|Immunologic Factors|immunologic factors|mesh-ancestor
24663241|NCT01299662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663242|NCT01299701|Vadimezan|vadimezan|mesh-list
24663243|NCT01299701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663244|NCT01299779|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24663245|NCT01299779|Laxatives|laxatives|mesh-ancestor
24663246|NCT01299779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24663247|NCT01299831|Hormones|hormones|mesh-list
24663248|NCT01299831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24663249|NCT01299831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663250|NCT01299857|Rituximab|rituximab|mesh-list
24663251|NCT01299857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24663252|NCT01299857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800025|NCT01972906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800026|NCT01972906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24800027|NCT01972906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24663284|NCT01300026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663285|NCT01300156|Oxaliplatin|oxaliplatin|mesh-list
24663286|NCT01300156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663287|NCT01300312|Diclofenac|diclofenac|mesh-list
24663288|NCT01300312|Eperisone|eperisone|mesh-list
24663289|NCT01300312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24663290|NCT01300312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24663291|NCT01300312|Analgesics|analgesics|mesh-ancestor
24663292|NCT01300312|Sensory System Agents|sensory system agents|mesh-ancestor
24663293|NCT01300312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663294|NCT01300312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663295|NCT01300312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24663303|NCT01300312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24663304|NCT01300312|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24663305|NCT01300312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24663306|NCT01300312|Parasympatholytics|parasympatholytics|mesh-ancestor
24663307|NCT01300312|Autonomic Agents|autonomic agents|mesh-ancestor
24663308|NCT01300312|Vasodilator Agents|vasodilator agents|mesh-ancestor
24663309|NCT01300364|Citalopram|citalopram|mesh-list
24663310|NCT01300364|Reboxetine|reboxetine|mesh-list
24663332|NCT01300377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24663334|NCT01300377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24663335|NCT01300377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663358|NCT01300754|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24663359|NCT01300754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24663360|NCT01300754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663361|NCT01300780|Etoricoxib|etoricoxib|mesh-list
24800028|NCT01972906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24800029|NCT01972906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800030|NCT01972906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664183|NCT01666951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25664184|NCT01666951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664185|NCT01666951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834207|NCT02177422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24834208|NCT02177422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834209|NCT02177422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24800031|NCT01972984|Anastrozole|anastrozole|mesh-list
24800032|NCT01972984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24800033|NCT01972984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800034|NCT01972984|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24800035|NCT01972984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24800036|NCT01972984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800037|NCT01972984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800038|NCT01972984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24800039|NCT01972984|Hormone Antagonists|hormone antagonists|mesh-ancestor
24663362|NCT01300780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24663363|NCT01300780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24663364|NCT01300780|Analgesics|analgesics|mesh-ancestor
24663365|NCT01300780|Sensory System Agents|sensory system agents|mesh-ancestor
24663366|NCT01300780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663367|NCT01300780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663368|NCT01300780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24663369|NCT01300780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25852771|NCT00057707|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25876206|NCT03811002|Tubulin Modulators|tubulin modulators|mesh-ancestor
24663405|NCT01300988|Autonomic Agents|autonomic agents|mesh-ancestor
24663406|NCT01300988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663407|NCT01300988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663408|NCT01300988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24663409|NCT01300988|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24663410|NCT01300988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24800040|NCT01972984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24800041|NCT01972984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800042|NCT01973010|Ibuprofen|ibuprofen|mesh-list
24663436|NCT01301222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24663437|NCT01301222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24663525|NCT01302093|Thiorphan|thiorphan|mesh-list
24663526|NCT01302093|Antidiarrheals|antidiarrheals|mesh-ancestor
24663527|NCT01302093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24663528|NCT01302093|Protease Inhibitors|protease inhibitors|mesh-ancestor
24663529|NCT01302093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663530|NCT01302093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663531|NCT01302106|Clofarabine|clofarabine|mesh-list
25202749|NCT02718755|Vidarabine|vidarabine|mesh-list
24721172|NCT01572363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663532|NCT01302106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24663533|NCT01302106|Antimetabolites|antimetabolites|mesh-ancestor
24800070|NCT01973140|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24800071|NCT01973140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800072|NCT01973140|Natriuretic Agents|natriuretic agents|mesh-ancestor
24800073|NCT01973140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800074|NCT01973309|Paclitaxel|paclitaxel|mesh-list
24663551|NCT01302158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663552|NCT01302158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24663553|NCT01302158|Immunologic Factors|immunologic factors|mesh-ancestor
24663554|NCT01302158|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24663555|NCT01302158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663556|NCT01302171|Lenograstim|lenograstim|mesh-list
24663557|NCT01302171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24663558|NCT01302171|Immunologic Factors|immunologic factors|mesh-ancestor
24663559|NCT01302171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663560|NCT01302210|Mupirocin|mupirocin|mesh-list
24663561|NCT01302210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24663562|NCT01302210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24663563|NCT01302210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24663564|NCT01302210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663565|NCT01302210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663566|NCT01302236|Eplerenone|eplerenone|mesh-list
24663567|NCT01302236|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25664186|NCT01667029|Sulfasalazine|sulfasalazine|mesh-list
25664187|NCT01667029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25664188|NCT01667029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25664189|NCT01667029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25664190|NCT01667029|Analgesics|analgesics|mesh-ancestor
24663590|NCT01302340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663591|NCT01302340|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24663592|NCT01302340|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24663594|NCT01302340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852772|NCT00057707|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24663617|NCT01302587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24663618|NCT01302587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24663620|NCT01302587|Adrenergic Agents|adrenergic agents|mesh-ancestor
24663624|NCT01302613|Capecitabine|capecitabine|mesh-list
24663625|NCT01302613|Oxaliplatin|oxaliplatin|mesh-list
24663626|NCT01302613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24663627|NCT01302613|Antimetabolites|antimetabolites|mesh-ancestor
24663638|NCT01302756|Vitamin B Complex|vitamin b complex|mesh-ancestor
24663639|NCT01302756|Vitamins|vitamins|mesh-ancestor
24663640|NCT01302756|Micronutrients|micronutrients|mesh-ancestor
24663642|NCT01302821|Tryptophan|tryptophan|mesh-list
24663643|NCT01302821|Vaccines|vaccines|mesh-list
24663644|NCT01302821|Immunologic Factors|immunologic factors|mesh-ancestor
24663645|NCT01302821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663646|NCT01302821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24663647|NCT01302821|Antidepressive Agents|antidepressive agents|mesh-ancestor
24663648|NCT01302821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24663649|NCT01302951|Moxifloxacin|moxifloxacin|mesh-list
24663650|NCT01302951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24663651|NCT01302951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24663652|NCT01302951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24663667|NCT01303029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24663668|NCT01303029|Immunologic Factors|immunologic factors|mesh-ancestor
24663669|NCT01303029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663670|NCT01303029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24663671|NCT01303042|Insulin Lispro|insulin lispro|mesh-list
25202750|NCT02718755|Cytarabine|cytarabine|mesh-list
24663672|NCT01303042|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
24663673|NCT01303042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24663674|NCT01303042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663675|NCT01303055|Metformin|metformin|mesh-list
24663676|NCT01303055|Alogliptin|alogliptin|mesh-list
24663677|NCT01303055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24663686|NCT01303094|Trabectedin|trabectedin|mesh-list
24663687|NCT01303094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24663688|NCT01303094|Alkylating Agents|alkylating agents|mesh-ancestor
24663689|NCT01303094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663690|NCT01303094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663691|NCT01303107|Bupivacaine|bupivacaine|mesh-list
24663692|NCT01303107|Anesthetics, Local|anesthetics, local|mesh-ancestor
24663693|NCT01303107|Anesthetics|anesthetics|mesh-ancestor
24663694|NCT01303107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24663695|NCT01303107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663696|NCT01303107|Sensory System Agents|sensory system agents|mesh-ancestor
24663697|NCT01303107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663698|NCT01303237|Cetuximab|cetuximab|mesh-list
24663699|NCT01303237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24663700|NCT01303237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663710|NCT01303471|Sensory System Agents|sensory system agents|mesh-ancestor
24663711|NCT01303471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663712|NCT01303497|Paclitaxel|paclitaxel|mesh-list
24663713|NCT01303497|Bevacizumab|bevacizumab|mesh-list
24663729|NCT01303536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663730|NCT01303536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951436|NCT03904563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951437|NCT03904563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24951438|NCT03904563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24951439|NCT03904563|Growth Substances|growth substances|mesh-ancestor
24951440|NCT03904563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951441|NCT03904563|Growth Inhibitors|growth inhibitors|mesh-ancestor
24951443|NCT03904732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24951444|NCT03904732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25852773|NCT00057707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852774|NCT00057720|Doxorubicin|doxorubicin|mesh-list
24951452|NCT03904732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24951453|NCT03904732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951454|NCT03904732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24951455|NCT03904732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24663731|NCT01303536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24663732|NCT01303536|Antipruritics|antipruritics|mesh-ancestor
24663733|NCT01303536|Dermatologic Agents|dermatologic agents|mesh-ancestor
24663734|NCT01303536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24663735|NCT01303536|Serotonin Agents|serotonin agents|mesh-ancestor
24663736|NCT01303536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24663737|NCT01303536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663739|NCT01303536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24663740|NCT01303536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24663741|NCT01303536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24663742|NCT01303536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24663744|NCT01303549|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24663787|NCT01303640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663789|NCT01303679|Bevacizumab|bevacizumab|mesh-list
24663790|NCT01303679|Exemestane|exemestane|mesh-list
24663791|NCT01303679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24663792|NCT01303679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663793|NCT01303679|Tubulin Modulators|tubulin modulators|mesh-ancestor
24951457|NCT03904732|Antipyretics|antipyretics|mesh-ancestor
24951458|NCT03904537|Antibodies|antibodies|mesh-list
24951459|NCT03904537|Immunologic Factors|immunologic factors|mesh-ancestor
24951460|NCT03904537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800093|NCT01973400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800094|NCT01973400|Vitamins|vitamins|mesh-ancestor
24800095|NCT01973400|Micronutrients|micronutrients|mesh-ancestor
24800096|NCT01973504|Chrysarobin|chrysarobin|mesh-list
24800097|NCT01973504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24800098|NCT01973504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24800099|NCT01973504|Analgesics|analgesics|mesh-ancestor
24800100|NCT01973504|Sensory System Agents|sensory system agents|mesh-ancestor
24663794|NCT01303679|Antimitotic Agents|antimitotic agents|mesh-ancestor
24663795|NCT01303679|Mitosis Modulators|mitosis modulators|mesh-ancestor
24663796|NCT01303679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663797|NCT01303679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24663798|NCT01303679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24663799|NCT01303679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24663800|NCT01303679|Growth Substances|growth substances|mesh-ancestor
24663801|NCT01303679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663802|NCT01303679|Growth Inhibitors|growth inhibitors|mesh-ancestor
24663803|NCT01303679|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24663804|NCT01303679|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24663805|NCT01303679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852775|NCT00057720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25852776|NCT00057720|Topotecan|topotecan|mesh-list
24663806|NCT01303679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24663807|NCT01303679|Hormone Antagonists|hormone antagonists|mesh-ancestor
24663808|NCT01303679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24663809|NCT01303705|Cyclophosphamide|cyclophosphamide|mesh-list
24663810|NCT01303705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24663811|NCT01303705|Immunologic Factors|immunologic factors|mesh-ancestor
24663812|NCT01303705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664191|NCT01667029|Sensory System Agents|sensory system agents|mesh-ancestor
25664192|NCT01667029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25664193|NCT01667029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834582|NCT02179814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24496824|NCT00506974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24834583|NCT02179814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24834584|NCT02179814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834585|NCT02179814|Anesthetics, Local|anesthetics, local|mesh-ancestor
24834596|NCT02179814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834597|NCT02179814|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24663813|NCT01303705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24663814|NCT01303705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25852777|NCT00057720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24800110|NCT01973660|Paclitaxel|paclitaxel|mesh-list
24800111|NCT01973660|Trastuzumab|trastuzumab|mesh-list
24800112|NCT01973660|Letrozole|letrozole|mesh-list
24800113|NCT01973660|Lapatinib|lapatinib|mesh-list
24800114|NCT01973660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24800115|NCT01973660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800116|NCT01973660|Tubulin Modulators|tubulin modulators|mesh-ancestor
24848487|NCT04042727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24848488|NCT04042727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24848489|NCT04042727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24848490|NCT04042727|Adrenergic Agents|adrenergic agents|mesh-ancestor
24848491|NCT04042727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24848492|NCT04042727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848493|NCT04042155|Rivaroxaban|rivaroxaban|mesh-list
24663834|NCT01303874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24663835|NCT01303874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24663836|NCT01303874|Analgesics|analgesics|mesh-ancestor
24663837|NCT01303874|Sensory System Agents|sensory system agents|mesh-ancestor
24663838|NCT01303874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663839|NCT01303874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663840|NCT01303874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25852778|NCT00057720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852779|NCT00057720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24663860|NCT01303887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24800117|NCT01973660|Antimitotic Agents|antimitotic agents|mesh-ancestor
24800118|NCT01973660|Mitosis Modulators|mitosis modulators|mesh-ancestor
24800119|NCT01973660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800120|NCT01973660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24800121|NCT01973660|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24800122|NCT01973660|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24800123|NCT01973660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800124|NCT01973660|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24800125|NCT01973660|Hormone Antagonists|hormone antagonists|mesh-ancestor
24800126|NCT01973660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25202751|NCT02718755|Fludarabine|fludarabine|mesh-list
24829852|NCT02154932|Abortifacient Agents|abortifacient agents|mesh-ancestor
24800127|NCT01973660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800128|NCT01973660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24848502|NCT04042155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848503|NCT04042155|Anticoagulants|anticoagulants|mesh-ancestor
24663861|NCT01303887|Tubulin Modulators|tubulin modulators|mesh-ancestor
24663862|NCT01303887|Antimitotic Agents|antimitotic agents|mesh-ancestor
24663863|NCT01303887|Mitosis Modulators|mitosis modulators|mesh-ancestor
24663864|NCT01303887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24663865|NCT01303887|Glucocorticoids|glucocorticoids|mesh-ancestor
24663867|NCT01303887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24663868|NCT01303887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25852780|NCT00057720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25852781|NCT00057720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663873|NCT01303926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24721585|NCT01575678|Melatonin|melatonin|mesh-list
24721649|NCT01576094|Simendan|simendan|mesh-list
24663874|NCT01303926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664194|NCT01667029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25664195|NCT01667029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25664196|NCT01667029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25664197|NCT01667107|Posaconazole|posaconazole|mesh-list
25664198|NCT01667107|Antifungal Agents|antifungal agents|mesh-ancestor
25664199|NCT01667107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25664200|NCT01667107|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25664201|NCT01667107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25664202|NCT01667107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25664203|NCT01667107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24834662|NCT02180334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24663876|NCT01303926|Antimitotic Agents|antimitotic agents|mesh-ancestor
24663877|NCT01303926|Mitosis Modulators|mitosis modulators|mesh-ancestor
24663878|NCT01303926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663879|NCT01303926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24663880|NCT01303926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24663952|NCT01304212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24663953|NCT01304212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663955|NCT01304264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800129|NCT01973660|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24800130|NCT01973660|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24800131|NCT01973660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24800132|NCT01973660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24800133|NCT01973751|Budesonide|budesonide|mesh-list
24800134|NCT01973751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24800135|NCT01973751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24663956|NCT01304264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663957|NCT01304316|Phenylephrine|phenylephrine|mesh-list
24663958|NCT01304316|Oxymetazoline|oxymetazoline|mesh-list
24663959|NCT01304316|Tetracaine|tetracaine|mesh-list
24663960|NCT01304316|Anesthetics, Local|anesthetics, local|mesh-ancestor
24663962|NCT01304316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24663963|NCT01304316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663964|NCT01304316|Sensory System Agents|sensory system agents|mesh-ancestor
24663965|NCT01304316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663966|NCT01304316|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24663967|NCT01304316|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24663968|NCT01304316|Adrenergic Agents|adrenergic agents|mesh-ancestor
24663969|NCT01304316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24663970|NCT01304316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663971|NCT01304316|Sympathomimetics|sympathomimetics|mesh-ancestor
24663974|NCT01304316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24663975|NCT01304316|Respiratory System Agents|respiratory system agents|mesh-ancestor
24663976|NCT01304316|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24663978|NCT01304316|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24663979|NCT01304316|Protective Agents|protective agents|mesh-ancestor
24663981|NCT01304342|Remifentanil|remifentanil|mesh-list
24663992|NCT01304342|Anesthetics|anesthetics|mesh-ancestor
24663993|NCT01304472|Clopidogrel|clopidogrel|mesh-list
24663994|NCT01304472|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24663995|NCT01304472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24664015|NCT01304602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24664016|NCT01304602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24664017|NCT01304602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664018|NCT01304602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24664020|NCT01304784|Docetaxel|docetaxel|mesh-list
24664021|NCT01304784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24664022|NCT01304784|Capecitabine|capecitabine|mesh-list
24664023|NCT01304784|Trastuzumab|trastuzumab|mesh-list
24664024|NCT01304784|Lapatinib|lapatinib|mesh-list
25202752|NCT02718755|Fludarabine phosphate|fludarabine phosphate|mesh-list
24664025|NCT01304784|Antibodies, Bispecific|antibodies, bispecific|mesh-list
24664026|NCT01304784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24664027|NCT01304784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24664028|NCT01304784|Tubulin Modulators|tubulin modulators|mesh-ancestor
24664029|NCT01304784|Antimitotic Agents|antimitotic agents|mesh-ancestor
24664030|NCT01304784|Mitosis Modulators|mitosis modulators|mesh-ancestor
24664031|NCT01304784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664032|NCT01304784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24664033|NCT01304784|Antimetabolites|antimetabolites|mesh-ancestor
24664034|NCT01304784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24664035|NCT01304784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24664036|NCT01304784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800137|NCT01973751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24800138|NCT01973751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800139|NCT01973751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24800140|NCT01973751|Respiratory System Agents|respiratory system agents|mesh-ancestor
24800141|NCT01973751|Glucocorticoids|glucocorticoids|mesh-ancestor
24800142|NCT01973751|Hormones|hormones|mesh-ancestor
24800143|NCT01973751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24800144|NCT01973790|Z 338|z 338|mesh-list
24800145|NCT01973790|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25664204|NCT01667107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24848513|NCT04014387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24848514|NCT04014387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848515|NCT04014387|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
24664037|NCT01304784|Immunologic Factors|immunologic factors|mesh-ancestor
24664038|NCT01304784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664039|NCT01304797|Cyclophosphamide|cyclophosphamide|mesh-list
24664040|NCT01304797|Trastuzumab|trastuzumab|mesh-list
24664041|NCT01304797|Doxorubicin|doxorubicin|mesh-list
24664042|NCT01304797|Immunoconjugates|immunoconjugates|mesh-list
24664043|NCT01304797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24664044|NCT01304797|Immunologic Factors|immunologic factors|mesh-ancestor
24664045|NCT01304797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664046|NCT01304797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24664047|NCT01304797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24664048|NCT01304797|Alkylating Agents|alkylating agents|mesh-ancestor
24664049|NCT01304797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852782|NCT00057720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852783|NCT00057720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24664050|NCT01304797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800149|NCT01973790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24800150|NCT01973790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800151|NCT01973790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24800152|NCT01973816|Cyproterone Acetate|cyproterone acetate|mesh-list
24848526|NCT03993912|Hormones|hormones|mesh-ancestor
24664097|NCT01304927|Calcium|calcium|mesh-list
24664098|NCT01304927|Vitamins|vitamins|mesh-ancestor
24664099|NCT01304927|Micronutrients|micronutrients|mesh-ancestor
24664100|NCT01304927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664101|NCT01304927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24664102|NCT01304927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24664103|NCT01305057|Pyridoxine|pyridoxine|mesh-list
24664104|NCT01305057|Vitamin B Complex|vitamin b complex|mesh-ancestor
24664106|NCT01305057|Micronutrients|micronutrients|mesh-ancestor
24664107|NCT01305057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664115|NCT01305135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24664120|NCT01305135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24664121|NCT01305135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24664122|NCT01305135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24664124|NCT01305148|Anticoagulants|anticoagulants|mesh-ancestor
24664125|NCT01305187|Hyaluronic Acid|hyaluronic acid|mesh-list
24664126|NCT01305187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24664127|NCT01305187|Immunologic Factors|immunologic factors|mesh-ancestor
24664128|NCT01305187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664129|NCT01305187|Viscosupplements|viscosupplements|mesh-ancestor
24664130|NCT01305187|Protective Agents|protective agents|mesh-ancestor
24664131|NCT01305226|Streptokinase|streptokinase|mesh-list
24664133|NCT01305226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24664134|NCT01305226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664136|NCT01305317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24664137|NCT01305317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24664138|NCT01305317|Antimetabolites|antimetabolites|mesh-ancestor
24829426|NCT02152332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24664189|NCT01305707|Nortriptyline|nortriptyline|mesh-list
24664197|NCT01305707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664198|NCT01305707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664199|NCT01305707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24664200|NCT01305707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24664201|NCT01305707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24664202|NCT01305707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24664203|NCT01305707|Dopamine Agents|dopamine agents|mesh-ancestor
24664204|NCT01305707|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24664205|NCT01305707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24664206|NCT01305707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24664207|NCT01305707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24664208|NCT01305707|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24664209|NCT01305707|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24664210|NCT01305707|Parasympatholytics|parasympatholytics|mesh-ancestor
24664211|NCT01305707|Autonomic Agents|autonomic agents|mesh-ancestor
24664212|NCT01305707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24664213|NCT01305707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24800162|NCT01973816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664214|NCT01305707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24664215|NCT01305707|Cholinergic Agents|cholinergic agents|mesh-ancestor
24664216|NCT01305707|Antiemetics|antiemetics|mesh-ancestor
24664217|NCT01305707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24721799|NCT01577121|Indomethacin|indomethacin|mesh-list
24664218|NCT01305707|Dopamine Agonists|dopamine agonists|mesh-ancestor
24664219|NCT01305707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24664220|NCT01305707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24664221|NCT01305707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24664222|NCT01305707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25852784|NCT00057759|Sildenafil Citrate|sildenafil citrate|mesh-list
25852785|NCT00057759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852786|NCT00057759|Vasodilator Agents|vasodilator agents|mesh-ancestor
24664223|NCT01305707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24664225|NCT01305707|Sensory System Agents|sensory system agents|mesh-ancestor
24664226|NCT01305707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24664227|NCT01305707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24664228|NCT01305707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24664229|NCT01305707|Antimanic Agents|antimanic agents|mesh-ancestor
24664230|NCT01305707|Anticonvulsants|anticonvulsants|mesh-ancestor
24664231|NCT01305707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24664232|NCT01305707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24664233|NCT01305707|GABA Modulators|gaba modulators|mesh-ancestor
24664234|NCT01305707|GABA Agents|gaba agents|mesh-ancestor
24664235|NCT01305707|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24664236|NCT01305707|Histamine Antagonists|histamine antagonists|mesh-ancestor
24664237|NCT01305707|Histamine Agents|histamine agents|mesh-ancestor
24664238|NCT01305707|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24664239|NCT01305707|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24721801|NCT01577121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24664299|NCT01305837|Protective Agents|protective agents|mesh-ancestor
24664300|NCT01305837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24664301|NCT01305837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24664304|NCT01305850|Enalaprilat|enalaprilat|mesh-list
24664305|NCT01305850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24664306|NCT01305850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24664307|NCT01305850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24664308|NCT01305850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24800163|NCT01973816|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24800164|NCT01973816|Contraceptive Agents|contraceptive agents|mesh-ancestor
24800165|NCT01973816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24800166|NCT01973816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24777168|NCT01862523|Capsaicin|capsaicin|mesh-list
24800167|NCT01973816|Androgen Antagonists|androgen antagonists|mesh-ancestor
24800168|NCT01973816|Hormone Antagonists|hormone antagonists|mesh-ancestor
24800169|NCT01973816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800170|NCT01973816|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24800171|NCT01973816|Luteolytic Agents|luteolytic agents|mesh-ancestor
24800172|NCT01973816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24800173|NCT01973842|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24800174|NCT01973842|Luteolytic Agents|luteolytic agents|mesh-ancestor
24800175|NCT01973842|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24800176|NCT01973842|Contraceptive Agents|contraceptive agents|mesh-ancestor
24800177|NCT01973842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24800178|NCT01973842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800179|NCT01973842|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24664320|NCT01306097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852787|NCT00057759|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25852788|NCT00057759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25852789|NCT00057759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852790|NCT00057759|Urological Agents|urological agents|mesh-ancestor
25852791|NCT00057798|Gemcitabine|gemcitabine|mesh-list
25852792|NCT00057798|Vinorelbine|vinorelbine|mesh-list
25852793|NCT00057798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25852794|NCT00057798|Antimetabolites|antimetabolites|mesh-ancestor
25876207|NCT03811002|Antimitotic Agents|antimitotic agents|mesh-ancestor
24664324|NCT01306123|Hydroxocobalamin|hydroxocobalamin|mesh-list
24664325|NCT01306123|Vitamins|vitamins|mesh-ancestor
24664326|NCT01306123|Micronutrients|micronutrients|mesh-ancestor
24664327|NCT01306123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800186|NCT01973855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24800188|NCT01973868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24800189|NCT01973868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800190|NCT01973920|Insulin|insulin|mesh-list
24800191|NCT01973920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24800192|NCT01973920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800193|NCT01973933|Metformin|metformin|mesh-list
24800194|NCT01973933|Pyrimethamine|pyrimethamine|mesh-list
24800195|NCT01973933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24664328|NCT01306123|Vitamin B Complex|vitamin b complex|mesh-ancestor
24664329|NCT01306123|Hematinics|hematinics|mesh-ancestor
24664330|NCT01306240|Pulmonary Surfactants|pulmonary surfactants|mesh-list
24664331|NCT01306240|Respiratory System Agents|respiratory system agents|mesh-ancestor
24664332|NCT01306266|Rizatriptan|rizatriptan|mesh-list
24664333|NCT01306266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24451654|NCT00324467|Antipyretics|antipyretics|mesh-ancestor
24664334|NCT01306266|Serotonin Agents|serotonin agents|mesh-ancestor
24455902|NCT00329368|Folic Acid|folic acid|mesh-list
24664335|NCT01306266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24664336|NCT01306266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664337|NCT01306266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664338|NCT01306318|Diclofenac|diclofenac|mesh-list
24664339|NCT01306318|Eperisone|eperisone|mesh-list
24664340|NCT01306318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24664341|NCT01306318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24664342|NCT01306318|Analgesics|analgesics|mesh-ancestor
24664748|NCT01308528|Anticoagulants|anticoagulants|mesh-ancestor
24664392|NCT01306591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24664393|NCT01306591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24455903|NCT00329368|Vitamin B Complex|vitamin b complex|mesh-list
24664394|NCT01306591|Growth Substances|growth substances|mesh-ancestor
24664395|NCT01306591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664396|NCT01306591|Growth Inhibitors|growth inhibitors|mesh-ancestor
24664409|NCT01306708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24664423|NCT01306721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25202753|NCT02718755|Asparaginase|asparaginase|mesh-list
24664424|NCT01306721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941912|NCT03985891|Antibodies|antibodies|mesh-list
24664426|NCT01306721|Respiratory System Agents|respiratory system agents|mesh-ancestor
24664428|NCT01306721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24664429|NCT01306721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24664430|NCT01306721|Sympathomimetics|sympathomimetics|mesh-ancestor
24664431|NCT01306721|Adrenergic Agents|adrenergic agents|mesh-ancestor
24664432|NCT01306721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24664433|NCT01306721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664434|NCT01306721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24453457|NCT05008224|Hormones|hormones|mesh-ancestor
24800196|NCT01973933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800197|NCT01973933|Antimalarials|antimalarials|mesh-ancestor
24800198|NCT01973933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24800199|NCT01973933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24800204|NCT01974024|Methylprednisolone|methylprednisolone|mesh-list
24800205|NCT01974024|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24800206|NCT01974024|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24800207|NCT01974024|Prednisolone|prednisolone|mesh-list
24800208|NCT01974024|Prednisolone acetate|prednisolone acetate|mesh-list
24800209|NCT01974024|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24800210|NCT01974024|Prednisolone phosphate|prednisolone phosphate|mesh-list
25852795|NCT00057798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852796|NCT00057798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852797|NCT00057798|Antiviral Agents|antiviral agents|mesh-ancestor
25852798|NCT00057798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25852799|NCT00057798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852800|NCT00057798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25852801|NCT00057798|Immunologic Factors|immunologic factors|mesh-ancestor
25852802|NCT00057798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664435|NCT01306721|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24664436|NCT01306721|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24664437|NCT01306721|Histamine Antagonists|histamine antagonists|mesh-ancestor
24664438|NCT01306721|Histamine Agents|histamine agents|mesh-ancestor
24664439|NCT01306760|Ketamine|ketamine|mesh-list
24664440|NCT01306760|Propofol|propofol|mesh-list
24664441|NCT01306760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24664442|NCT01306760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24664443|NCT01306760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664444|NCT01306760|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24584057|NCT00878345|Analgesics|analgesics|mesh-ancestor
24664445|NCT01306760|Anesthetics, General|anesthetics, general|mesh-ancestor
24664446|NCT01306760|Anesthetics|anesthetics|mesh-ancestor
24664447|NCT01306760|Analgesics|analgesics|mesh-ancestor
24664489|NCT01307202|Anticonvulsants|anticonvulsants|mesh-ancestor
24800222|NCT01974024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24800225|NCT01974037|Antipruritics|antipruritics|mesh-ancestor
24800226|NCT01974037|Dermatologic Agents|dermatologic agents|mesh-ancestor
24800227|NCT01974037|Sensory System Agents|sensory system agents|mesh-ancestor
24800229|NCT01974037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800231|NCT01974167|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
24800232|NCT01974167|Eldecalcitol|eldecalcitol|mesh-list
24800233|NCT01974167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24800234|NCT01974167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800235|NCT01974167|Vitamins|vitamins|mesh-ancestor
24800236|NCT01974167|Micronutrients|micronutrients|mesh-ancestor
24664449|NCT01306760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24664450|NCT01306760|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24664451|NCT01306760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24664931|NCT01309425|Adrenergic Agents|adrenergic agents|mesh-ancestor
24664452|NCT01306760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24800252|NCT01974336|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24800253|NCT01974336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25202754|NCT02718755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800255|NCT01974375|Micafungin|micafungin|mesh-list
24800256|NCT01974375|Antifungal Agents|antifungal agents|mesh-ancestor
24800257|NCT01974375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24800258|NCT01974375|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24800259|NCT01974375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24800261|NCT01974375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800262|NCT01974375|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24800263|NCT01974375|Hormone Antagonists|hormone antagonists|mesh-ancestor
24800264|NCT01974375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24800265|NCT01974375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800266|NCT01974375|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24800267|NCT01974375|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24594299|NCT00933387|Antimitotic Agents|antimitotic agents|mesh-ancestor
24594300|NCT00933387|Mitosis Modulators|mitosis modulators|mesh-ancestor
24594301|NCT00933387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594302|NCT00933387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24800268|NCT01974401|Chlorhexidine|chlorhexidine|mesh-list
24800269|NCT01974401|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24800270|NCT01974401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24800271|NCT01974401|Disinfectants|disinfectants|mesh-ancestor
24800272|NCT01974518|Cyclophosphamide|cyclophosphamide|mesh-list
24800273|NCT01974518|Rituximab|rituximab|mesh-list
24664453|NCT01306760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24664454|NCT01306760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664455|NCT01306773|Oseltamivir|oseltamivir|mesh-list
24664456|NCT01306773|Antiviral Agents|antiviral agents|mesh-ancestor
24664457|NCT01306773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24664458|NCT01306773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800285|NCT01974622|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24848653|NCT03803202|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24848654|NCT03803202|Immunologic Factors|immunologic factors|mesh-ancestor
24848655|NCT03803202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848656|NCT03796650|Vancomycin|vancomycin|mesh-list
24848657|NCT03796650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24848658|NCT03796650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24639266|NCT01160965|Ropivacaine|ropivacaine|mesh-list
24664482|NCT01307189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24664483|NCT01307189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664484|NCT01307202|Gabapentin|gabapentin|mesh-list
24664485|NCT01307202|Analgesics|analgesics|mesh-ancestor
24664486|NCT01307202|Sensory System Agents|sensory system agents|mesh-ancestor
24664487|NCT01307202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24664488|NCT01307202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664490|NCT01307202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24664491|NCT01307202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24664492|NCT01307202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24664493|NCT01307202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24664494|NCT01307202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24664495|NCT01307202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24664496|NCT01307202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24664497|NCT01307202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664498|NCT01307202|Antimanic Agents|antimanic agents|mesh-ancestor
24664512|NCT01307475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24664513|NCT01307475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664515|NCT01307475|Vasodilator Agents|vasodilator agents|mesh-ancestor
24664516|NCT01307475|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24664517|NCT01307475|Purinergic Agonists|purinergic agonists|mesh-ancestor
24664518|NCT01307475|Purinergic Agents|purinergic agents|mesh-ancestor
24664519|NCT01307475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24800313|NCT01974934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24800314|NCT01974934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800315|NCT01974934|Antidepressive Agents|antidepressive agents|mesh-ancestor
25049955|NCT00553306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049956|NCT00553306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25049957|NCT00553306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25049961|NCT00553306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25049962|NCT00553306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25049964|NCT00553306|Sensory System Agents|sensory system agents|mesh-ancestor
25049965|NCT00553306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25049966|NCT00553306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25049967|NCT00553306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25049968|NCT00553306|Antiviral Agents|antiviral agents|mesh-ancestor
25049969|NCT00553306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25049970|NCT00552708|Lisinopril|lisinopril|mesh-list
25049971|NCT00552708|Carvedilol|carvedilol|mesh-list
25049972|NCT00552708|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25049973|NCT00552708|Protease Inhibitors|protease inhibitors|mesh-ancestor
25049974|NCT00552708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049975|NCT00552708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049976|NCT00552708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25049977|NCT00552708|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24941929|NCT03985969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25049978|NCT00552708|Protective Agents|protective agents|mesh-ancestor
25049979|NCT00552708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049980|NCT00552708|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25049981|NCT00552708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25852803|NCT00057798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24951623|NCT03902782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852804|NCT00057798|Tubulin Modulators|tubulin modulators|mesh-ancestor
24664548|NCT01307592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24664549|NCT01307592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24664550|NCT01307592|Immunologic Factors|immunologic factors|mesh-ancestor
24664551|NCT01307592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664552|NCT01307592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24664553|NCT01307592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24664554|NCT01307592|Antimetabolites|antimetabolites|mesh-ancestor
24664555|NCT01307592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664556|NCT01307592|Antiviral Agents|antiviral agents|mesh-ancestor
24664557|NCT01307592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24664558|NCT01307592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24664559|NCT01307592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24664560|NCT01307592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24664561|NCT01307592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24664562|NCT01307592|Growth Substances|growth substances|mesh-ancestor
24664563|NCT01307592|Growth Inhibitors|growth inhibitors|mesh-ancestor
25852805|NCT00057798|Antimitotic Agents|antimitotic agents|mesh-ancestor
25852806|NCT00057798|Mitosis Modulators|mitosis modulators|mesh-ancestor
25852807|NCT00057850|Cisplatin|cisplatin|mesh-list
24664688|NCT01308255|Antimetabolites|antimetabolites|mesh-ancestor
25852808|NCT00057850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852809|NCT00057889|Ipilimumab|ipilimumab|mesh-list
25852810|NCT00057889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24664576|NCT01307839|Anesthetics, Local|anesthetics, local|mesh-ancestor
24664577|NCT01307839|Anesthetics|anesthetics|mesh-ancestor
24664578|NCT01307839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24664579|NCT01307839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664580|NCT01307839|Sensory System Agents|sensory system agents|mesh-ancestor
24664581|NCT01307839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24664582|NCT01307839|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25664205|NCT01667107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664206|NCT01667107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664207|NCT01667107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25664208|NCT01667107|Hormone Antagonists|hormone antagonists|mesh-ancestor
25664209|NCT01667107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24664583|NCT01307839|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24664584|NCT01307839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24664612|NCT01307969|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24664613|NCT01307969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24664614|NCT01307969|Autonomic Agents|autonomic agents|mesh-ancestor
24664615|NCT01307969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24664616|NCT01307969|Respiratory System Agents|respiratory system agents|mesh-ancestor
24664617|NCT01307969|Mydriatics|mydriatics|mesh-ancestor
24664618|NCT01307969|Sympathomimetics|sympathomimetics|mesh-ancestor
24664619|NCT01307969|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24664620|NCT01308047|Bupivacaine|bupivacaine|mesh-list
24664621|NCT01308047|Anesthetics, Local|anesthetics, local|mesh-ancestor
24664622|NCT01308047|Anesthetics|anesthetics|mesh-ancestor
24664623|NCT01308047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24664624|NCT01308047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664625|NCT01308047|Sensory System Agents|sensory system agents|mesh-ancestor
24664626|NCT01308047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24664628|NCT01308086|Fluorouracil|fluorouracil|mesh-list
24664629|NCT01308086|Capecitabine|capecitabine|mesh-list
24664630|NCT01308086|Oxaliplatin|oxaliplatin|mesh-list
24664631|NCT01308086|Levoleucovorin|levoleucovorin|mesh-list
24664632|NCT01308086|Antimetabolites|antimetabolites|mesh-ancestor
24664633|NCT01308086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664634|NCT01308086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24664635|NCT01308086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24664636|NCT01308086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24664637|NCT01308086|Immunologic Factors|immunologic factors|mesh-ancestor
24800344|NCT01975129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24800345|NCT01975129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800346|NCT01975142|Trastuzumab|trastuzumab|mesh-list
24800347|NCT01975142|Maytansine|maytansine|mesh-list
24800348|NCT01975142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24800350|NCT01975142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24800351|NCT01975142|Tubulin Modulators|tubulin modulators|mesh-ancestor
24800352|NCT01975142|Antimitotic Agents|antimitotic agents|mesh-ancestor
24800353|NCT01975142|Mitosis Modulators|mitosis modulators|mesh-ancestor
24800354|NCT01975142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800355|NCT01975194|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24800356|NCT01975194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24800357|NCT01975194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24800358|NCT01975194|Antimetabolites|antimetabolites|mesh-ancestor
24800359|NCT01975194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664658|NCT01308203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664659|NCT01308203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24664660|NCT01308203|Vasodilator Agents|vasodilator agents|mesh-ancestor
24664661|NCT01308203|Vitamin B Complex|vitamin b complex|mesh-ancestor
24664662|NCT01308203|Vitamins|vitamins|mesh-ancestor
24664663|NCT01308203|Micronutrients|micronutrients|mesh-ancestor
24664664|NCT01308203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664665|NCT01308229|Paclitaxel|paclitaxel|mesh-list
24664679|NCT01308255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24664681|NCT01308255|Infliximab|infliximab|mesh-list
24664685|NCT01308255|Abortifacient Agents|abortifacient agents|mesh-ancestor
24664686|NCT01308255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24664687|NCT01308255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25852811|NCT00057889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852812|NCT00057889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25852813|NCT00057889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664689|NCT01308255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664690|NCT01308255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24664691|NCT01308255|Dermatologic Agents|dermatologic agents|mesh-ancestor
24664692|NCT01308255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24664693|NCT01308255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24664694|NCT01308255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24664695|NCT01308255|Immunologic Factors|immunologic factors|mesh-ancestor
24664696|NCT01308255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24664697|NCT01308255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24664698|NCT01308255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24625479|NCT01082263|Serotonin Agents|serotonin agents|mesh-ancestor
24664703|NCT01308255|Glucocorticoids|glucocorticoids|mesh-ancestor
24664704|NCT01308255|Hormones|hormones|mesh-ancestor
24664705|NCT01308255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24664706|NCT01308255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24664707|NCT01308255|Protective Agents|protective agents|mesh-ancestor
24664708|NCT01308255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24664710|NCT01308255|Vitamin B Complex|vitamin b complex|mesh-ancestor
24664711|NCT01308268|Ivermectin|ivermectin|mesh-list
24935279|NCT04052659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24935281|NCT04052659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935282|NCT04052659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935283|NCT04052659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935284|NCT04052269|Sildenafil Citrate|sildenafil citrate|mesh-list
24664719|NCT01308268|Tubulin Modulators|tubulin modulators|mesh-ancestor
24664740|NCT01308346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664741|NCT01308437|Insulin|insulin|mesh-list
24664742|NCT01308437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24664743|NCT01308437|Isophane Insulin, Human|isophane insulin, human|mesh-list
24664744|NCT01308437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24664745|NCT01308437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664747|NCT01308528|Enoxaparin sodium|enoxaparin sodium|mesh-list
24664757|NCT01308541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24664758|NCT01308541|Anesthetics, General|anesthetics, general|mesh-ancestor
24664759|NCT01308541|Anesthetics|anesthetics|mesh-ancestor
24664760|NCT01308554|Bupivacaine|bupivacaine|mesh-list
25852814|NCT00057928|Gemcitabine|gemcitabine|mesh-list
24664761|NCT01308554|Anesthetics, Local|anesthetics, local|mesh-ancestor
24664762|NCT01308554|Anesthetics|anesthetics|mesh-ancestor
24664763|NCT01308554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24664764|NCT01308554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664765|NCT01308554|Sensory System Agents|sensory system agents|mesh-ancestor
24664766|NCT01308554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24664767|NCT01308606|Simeprevir|simeprevir|mesh-list
24935286|NCT04052269|Vasodilator Agents|vasodilator agents|mesh-ancestor
24935287|NCT04052269|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24935288|NCT04052269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24829549|NCT02153060|BB 1101|bb 1101|mesh-list
24935317|NCT04051853|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24935318|NCT04051853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24935319|NCT04051853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24935320|NCT04051853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848941|NCT03249714|Immunologic Factors|immunologic factors|mesh-ancestor
24848942|NCT03249714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664783|NCT01308658|Protease Inhibitors|protease inhibitors|mesh-ancestor
24664784|NCT01308658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24664785|NCT01308658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664786|NCT01308658|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24664787|NCT01308658|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24664788|NCT01308658|Antiviral Agents|antiviral agents|mesh-ancestor
24664789|NCT01308658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24664790|NCT01308658|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24664791|NCT01308658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24664792|NCT01308671|Varenicline|varenicline|mesh-list
24664793|NCT01308671|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24664794|NCT01308671|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24664795|NCT01308671|Cholinergic Agents|cholinergic agents|mesh-ancestor
24664796|NCT01308671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25852815|NCT00057928|Paclitaxel|paclitaxel|mesh-list
24664813|NCT01308723|Immunologic Factors|immunologic factors|mesh-ancestor
24664820|NCT01308944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664869|NCT01309074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24664870|NCT01309074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24664871|NCT01309074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24408489|NCT00178035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951846|NCT03900637|Leuprolide|leuprolide|mesh-list
24951847|NCT03900637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951848|NCT03900637|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24951849|NCT03900637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24951850|NCT03900637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951851|NCT03900637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664897|NCT01309178|Antidepressive Agents|antidepressive agents|mesh-ancestor
24664899|NCT01309178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24664900|NCT01309178|Analgesics|analgesics|mesh-ancestor
24664901|NCT01309178|Sensory System Agents|sensory system agents|mesh-ancestor
24664902|NCT01309178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24664903|NCT01309178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664904|NCT01309178|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24664905|NCT01309178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24664906|NCT01309178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24664917|NCT01309412|Siltuximab|siltuximab|mesh-list
24664918|NCT01309412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24664919|NCT01309425|Tapentadol|tapentadol|mesh-list
24664921|NCT01309425|Narcotics|narcotics|mesh-ancestor
24664922|NCT01309425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24664923|NCT01309425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664924|NCT01309425|Analgesics|analgesics|mesh-ancestor
24664925|NCT01309425|Sensory System Agents|sensory system agents|mesh-ancestor
24664926|NCT01309425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24664927|NCT01309425|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25852816|NCT00057928|Cisplatin|cisplatin|mesh-list
24664928|NCT01309425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24664929|NCT01309425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24664930|NCT01309425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664946|NCT01309438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24664947|NCT01309438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24664948|NCT01309438|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24664949|NCT01309477|Tacrolimus|tacrolimus|mesh-list
24664950|NCT01309477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25852817|NCT00057928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25852818|NCT00057928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852819|NCT00057928|Tubulin Modulators|tubulin modulators|mesh-ancestor
24664951|NCT01309477|Immunologic Factors|immunologic factors|mesh-ancestor
24665002|NCT01309633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24665003|NCT01309633|Immunologic Factors|immunologic factors|mesh-ancestor
24665004|NCT01309633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24665005|NCT01309685|Varenicline|varenicline|mesh-list
24665006|NCT01309685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24665007|NCT01309685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24665008|NCT01309685|Cholinergic Agents|cholinergic agents|mesh-ancestor
24665009|NCT01309685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665010|NCT01309685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935393|NCT04051099|Anesthetics, Local|anesthetics, local|mesh-ancestor
24935394|NCT04051099|Anesthetics|anesthetics|mesh-ancestor
24935395|NCT04051099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24935396|NCT04051099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935397|NCT04051099|Sensory System Agents|sensory system agents|mesh-ancestor
25202755|NCT02718755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24935398|NCT04051099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24935399|NCT04051099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24759907|NCT01755403|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24759908|NCT01755403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24759909|NCT01755403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24759910|NCT01755403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24759912|NCT01755468|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24759913|NCT01755468|Metformin|metformin|mesh-list
24759914|NCT01755468|Insulin Glargine|insulin glargine|mesh-list
24759915|NCT01755468|Insulin Lispro|insulin lispro|mesh-list
24759916|NCT01755468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24759917|NCT01755468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665028|NCT01309776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24665029|NCT01309776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24665030|NCT01309776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665031|NCT01309776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665045|NCT01309789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24665046|NCT01309789|Immunologic Factors|immunologic factors|mesh-ancestor
24665047|NCT01309789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665048|NCT01309789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24665049|NCT01309789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24665050|NCT01309789|Alkylating Agents|alkylating agents|mesh-ancestor
24665051|NCT01309789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665052|NCT01309789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665053|NCT01309789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24665054|NCT01309789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24935413|NCT04050592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24935415|NCT04050670|Tirzepatide|tirzepatide|mesh-list
24935416|NCT04050670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24935417|NCT04050670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935418|NCT04050670|Incretins|incretins|mesh-ancestor
24935419|NCT04050670|Hormones|hormones|mesh-ancestor
24935420|NCT04050670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24935423|NCT04050826|Anesthetics, Local|anesthetics, local|mesh-ancestor
24935424|NCT04050826|Anesthetics|anesthetics|mesh-ancestor
24935425|NCT04050826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24935426|NCT04050826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935427|NCT04050826|Sensory System Agents|sensory system agents|mesh-ancestor
24935428|NCT04050826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24935429|NCT04050826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24935430|NCT04050826|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24935431|NCT04050826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24935437|NCT04050488|Dermatologic Agents|dermatologic agents|mesh-ancestor
24935438|NCT04050761|Nivolumab|nivolumab|mesh-list
24935439|NCT04050761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24935440|NCT04050761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935441|NCT04050761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24935442|NCT04050761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935443|NCT04050735|Ethanol|ethanol|mesh-list
24935444|NCT04050735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24935445|NCT04050735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24935446|NCT04050735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24935447|NCT04050735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935448|NCT04050215|Edetic Acid|edetic acid|mesh-list
24935449|NCT04050215|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
24935450|NCT04050215|Chelating Agents|chelating agents|mesh-ancestor
24935451|NCT04050215|Sequestering Agents|sequestering agents|mesh-ancestor
24935452|NCT04050215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935453|NCT04050215|Anticoagulants|anticoagulants|mesh-ancestor
24935454|NCT04050215|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24935455|NCT04050215|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24935456|NCT04050267|Nitrous Oxide|nitrous oxide|mesh-list
24935457|NCT04050267|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24935458|NCT04050267|Anesthetics, General|anesthetics, general|mesh-ancestor
24935459|NCT04050267|Anesthetics|anesthetics|mesh-ancestor
24935460|NCT04050267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24935461|NCT04050267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935462|NCT04050267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24935463|NCT04050267|Analgesics|analgesics|mesh-ancestor
24941948|NCT03985865|Quinine|quinine|mesh-list
24935464|NCT04050267|Sensory System Agents|sensory system agents|mesh-ancestor
25202756|NCT02718755|Antimetabolites|antimetabolites|mesh-ancestor
24665170|NCT01310647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24665171|NCT01310647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665172|NCT01310647|Androgens|androgens|mesh-ancestor
24665198|NCT01310738|Deoxycholic Acid|deoxycholic acid|mesh-list
24665199|NCT01310738|Amebicides|amebicides|mesh-ancestor
24665200|NCT01310738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24665201|NCT01310738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24665202|NCT01310738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24665203|NCT01310738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24665204|NCT01310738|Antifungal Agents|antifungal agents|mesh-ancestor
24665205|NCT01310738|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24665206|NCT01310738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24665207|NCT01310751|Iloprost|iloprost|mesh-list
24665208|NCT01310751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24665209|NCT01310751|Vasodilator Agents|vasodilator agents|mesh-ancestor
24665210|NCT01310842|Nicotine|nicotine|mesh-list
24665211|NCT01310842|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24665212|NCT01310842|Autonomic Agents|autonomic agents|mesh-ancestor
24665213|NCT01310842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24665214|NCT01310842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609687|NCT00997828|Everolimus|everolimus|mesh-list
24665222|NCT01310985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24665223|NCT01310985|Antimetabolites|antimetabolites|mesh-ancestor
24665224|NCT01310985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665225|NCT01310985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665226|NCT01310985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24665227|NCT01311037|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24665228|NCT01311037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24665229|NCT01311037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24665230|NCT01311037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665231|NCT01311037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24665232|NCT01311037|Hormone Antagonists|hormone antagonists|mesh-ancestor
24665233|NCT01311037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24835431|NCT02182791|Nevirapine|nevirapine|mesh-list
24835432|NCT02182791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24835433|NCT02182791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24835434|NCT02182791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24665234|NCT01311037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665235|NCT01311050|Bevacizumab|bevacizumab|mesh-list
24665236|NCT01311050|Capecitabine|capecitabine|mesh-list
24665237|NCT01311050|Oxaliplatin|oxaliplatin|mesh-list
24665238|NCT01311050|Irinotecan|irinotecan|mesh-list
24665239|NCT01311050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24665240|NCT01311050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665241|NCT01311050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24665242|NCT01311050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24665243|NCT01311050|Growth Substances|growth substances|mesh-ancestor
24665244|NCT01311050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665245|NCT01311050|Growth Inhibitors|growth inhibitors|mesh-ancestor
24665246|NCT01311050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24665247|NCT01311050|Antimetabolites|antimetabolites|mesh-ancestor
24665248|NCT01311050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665249|NCT01311050|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24665250|NCT01311050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24665265|NCT01311167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665266|NCT01311167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24665267|NCT01311167|Glucocorticoids|glucocorticoids|mesh-ancestor
24665269|NCT01311167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24665270|NCT01311167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24665271|NCT01311167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665272|NCT01311336|Loratadine|loratadine|mesh-list
24665273|NCT01311336|Antipruritics|antipruritics|mesh-ancestor
24665274|NCT01311336|Dermatologic Agents|dermatologic agents|mesh-ancestor
24665275|NCT01311336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24665276|NCT01311336|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24665277|NCT01311336|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24665278|NCT01311336|Histamine Antagonists|histamine antagonists|mesh-ancestor
24665279|NCT01311336|Histamine Agents|histamine agents|mesh-ancestor
24665280|NCT01311336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665281|NCT01311336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665282|NCT01311336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665283|NCT01311414|Urapidil|urapidil|mesh-list
24665284|NCT01311414|Cafedrine|cafedrine|mesh-list
24665285|NCT01311414|Theodrenaline|theodrenaline|mesh-list
24665286|NCT01311414|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24665291|NCT01311414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665292|NCT01311414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665293|NCT01311414|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24665294|NCT01311414|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24665295|NCT01311414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24665296|NCT01311414|Adrenergic Agents|adrenergic agents|mesh-ancestor
24665297|NCT01311570|Buprenorphine|buprenorphine|mesh-list
24665298|NCT01311570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24665299|NCT01311570|Narcotics|narcotics|mesh-ancestor
24665300|NCT01311570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24665301|NCT01311570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665302|NCT01311570|Analgesics|analgesics|mesh-ancestor
24665303|NCT01311570|Sensory System Agents|sensory system agents|mesh-ancestor
24935521|NCT04049539|Antiviral Agents|antiviral agents|mesh-ancestor
24935522|NCT04049539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24935523|NCT04049539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24935524|NCT04049539|Immunologic Factors|immunologic factors|mesh-ancestor
24935525|NCT04049539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935526|NCT04049539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25664210|NCT01667107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664211|NCT01667419|Vemurafenib|vemurafenib|mesh-list
25664212|NCT01667419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664213|NCT01667419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25664214|NCT01667419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664215|NCT01667419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664216|NCT01667432|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24935528|NCT04049539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24935529|NCT04049539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24665339|NCT01311778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24665340|NCT01311778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24665341|NCT01311778|Anesthetics, General|anesthetics, general|mesh-ancestor
24665342|NCT01311778|Anesthetics|anesthetics|mesh-ancestor
24665343|NCT01311778|Anticonvulsants|anticonvulsants|mesh-ancestor
24665344|NCT01311804|Parecoxib|parecoxib|mesh-list
24665345|NCT01311804|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24665346|NCT01311804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24665347|NCT01311804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24665348|NCT01311804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665349|NCT01311804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24665350|NCT01311804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24665352|NCT01311804|Sensory System Agents|sensory system agents|mesh-ancestor
24665353|NCT01311804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24665354|NCT01311804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665355|NCT01311804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24665356|NCT01311804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24665357|NCT01311882|Zopiclone|zopiclone|mesh-list
24665389|NCT01312064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24665390|NCT01312064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24935546|NCT04049344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935547|NCT04049344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24665411|NCT01312298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665412|NCT01312298|Sensory System Agents|sensory system agents|mesh-ancestor
24665413|NCT01312298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24665414|NCT01312298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24665415|NCT01312298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24665416|NCT01312298|Anesthetics, General|anesthetics, general|mesh-ancestor
25050062|NCT00544115|Alkylating Agents|alkylating agents|mesh-ancestor
25050063|NCT00544115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050064|NCT00544115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050065|NCT00544115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25050066|NCT00544115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25050067|NCT00544115|Abortifacient Agents|abortifacient agents|mesh-ancestor
25050068|NCT00544115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25050069|NCT00544115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25050070|NCT00544115|Antimetabolites|antimetabolites|mesh-ancestor
25050078|NCT00544115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25050079|NCT00544115|Antifungal Agents|antifungal agents|mesh-ancestor
24453997|NCT04575233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25852820|NCT00057928|Antimitotic Agents|antimitotic agents|mesh-ancestor
24665636|NCT01313819|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24665637|NCT01313819|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25050086|NCT00543582|Mocetinostat|mocetinostat|mesh-list
25050087|NCT00543582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25050088|NCT00543582|Antimetabolites|antimetabolites|mesh-ancestor
25050089|NCT00543582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050090|NCT00543582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050091|NCT00543582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050092|NCT00543582|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25050093|NCT00543374|Remestemcel-l|remestemcel-l|mesh-list
25050094|NCT00543374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25050095|NCT00543374|Antiviral Agents|antiviral agents|mesh-ancestor
25050096|NCT00543374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25050108|NCT00540358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935627|NCT04048707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24722881|NCT01583114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24935628|NCT04048707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935629|NCT04048707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24935630|NCT04048707|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24935631|NCT04048707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24935632|NCT04048707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24935633|NCT04048707|Adrenergic Agents|adrenergic agents|mesh-ancestor
24935635|NCT04048707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935636|NCT04048707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24935637|NCT04048707|Protease Inhibitors|protease inhibitors|mesh-ancestor
24935638|NCT04048707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935639|NCT04048317|Doxorubicin|doxorubicin|mesh-list
24935640|NCT04048317|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25664217|NCT01667432|Antiviral Agents|antiviral agents|mesh-ancestor
24935641|NCT04048317|Ethiodized Oil|ethiodized oil|mesh-list
25852821|NCT00057928|Mitosis Modulators|mitosis modulators|mesh-ancestor
25852822|NCT00057928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852823|NCT00057928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24665646|NCT01313819|Sensory System Agents|sensory system agents|mesh-ancestor
24665647|NCT01313819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24665700|NCT01314209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665701|NCT01314209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665703|NCT01314274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24665704|NCT01314274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665705|NCT01314274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24665706|NCT01314274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24665734|NCT01314352|Cholinergic Agents|cholinergic agents|mesh-ancestor
24665735|NCT01314352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665736|NCT01314352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666215|NCT01318044|GABA Modulators|gaba modulators|mesh-ancestor
25852824|NCT00057928|Antimetabolites|antimetabolites|mesh-ancestor
24935661|NCT04048226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24935662|NCT04048226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665784|NCT01314833|Mitosis Modulators|mitosis modulators|mesh-ancestor
24665785|NCT01314833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665786|NCT01314833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24665787|NCT01314833|Immunologic Factors|immunologic factors|mesh-ancestor
24665832|NCT01314937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24665834|NCT01314976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24665835|NCT01314976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24665855|NCT01315093|Dalteparin|dalteparin|mesh-list
24665861|NCT01315262|Vasodilator Agents|vasodilator agents|mesh-ancestor
24665862|NCT01315262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24665968|NCT01316133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24665969|NCT01316133|Immunologic Factors|immunologic factors|mesh-ancestor
25852825|NCT00057928|Antiviral Agents|antiviral agents|mesh-ancestor
24666062|NCT01316952|Vasodilator Agents|vasodilator agents|mesh-ancestor
24666063|NCT01316952|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24666064|NCT01316952|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24935772|NCT04047875|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24935773|NCT04047745|Bupivacaine|bupivacaine|mesh-list
24935774|NCT04047745|Ropivacaine|ropivacaine|mesh-list
24935775|NCT04047745|Anesthetics, Local|anesthetics, local|mesh-ancestor
24935776|NCT04047745|Anesthetics|anesthetics|mesh-ancestor
24935777|NCT04047745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25852826|NCT00057928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24666071|NCT01316978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666072|NCT01316978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24666073|NCT01316978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24666074|NCT01316978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24666075|NCT01316978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666076|NCT01316978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666078|NCT01317017|Antiviral Agents|antiviral agents|mesh-ancestor
24666079|NCT01317017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24666080|NCT01317069|Fluorouracil|fluorouracil|mesh-list
24666081|NCT01317069|Antimetabolites|antimetabolites|mesh-ancestor
24666122|NCT01317511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666124|NCT01317563|Selenium|selenium|mesh-list
24666125|NCT01317563|Vitamins|vitamins|mesh-ancestor
24666126|NCT01317563|Micronutrients|micronutrients|mesh-ancestor
24666127|NCT01317563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666128|NCT01317563|Antioxidants|antioxidants|mesh-ancestor
24666129|NCT01317563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666130|NCT01317563|Protective Agents|protective agents|mesh-ancestor
24666131|NCT01317563|Trace Elements|trace elements|mesh-ancestor
24666132|NCT01317589|Fentanyl|fentanyl|mesh-list
24666133|NCT01317589|Methadone|methadone|mesh-list
24666134|NCT01317589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24666135|NCT01317589|Narcotics|narcotics|mesh-ancestor
24723077|NCT01584726|Anticonvulsants|anticonvulsants|mesh-ancestor
24723196|NCT01585792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24666136|NCT01317589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24666137|NCT01317589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666139|NCT01317589|Sensory System Agents|sensory system agents|mesh-ancestor
24666140|NCT01317589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24666141|NCT01317589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24666203|NCT01318005|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24456074|NCT00329810|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24666208|NCT01318044|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24666209|NCT01318044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24666210|NCT01318044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666211|NCT01318044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24666212|NCT01318044|Anesthetics, General|anesthetics, general|mesh-ancestor
24935813|NCT04047576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24935814|NCT04047576|Immunologic Factors|immunologic factors|mesh-ancestor
24935816|NCT04047797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24935818|NCT04047797|Antibodies|antibodies|mesh-list
24666213|NCT01318044|Anesthetics|anesthetics|mesh-ancestor
24666214|NCT01318044|Anticonvulsants|anticonvulsants|mesh-ancestor
24666226|NCT01318096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24666237|NCT01318096|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24666238|NCT01318096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24666239|NCT01318148|Caspofungin|caspofungin|mesh-list
24666240|NCT01318148|Antifungal Agents|antifungal agents|mesh-ancestor
24666241|NCT01318148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24666242|NCT01318148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666243|NCT01318148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666244|NCT01318161|Morphine|morphine|mesh-list
24666245|NCT01318161|Ropivacaine|ropivacaine|mesh-list
24666246|NCT01318161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24666247|NCT01318161|Narcotics|narcotics|mesh-ancestor
24666248|NCT01318161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24666249|NCT01318161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666250|NCT01318161|Analgesics|analgesics|mesh-ancestor
24666251|NCT01318161|Sensory System Agents|sensory system agents|mesh-ancestor
24666252|NCT01318161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24935819|NCT04047797|Immunoglobulins|immunoglobulins|mesh-list
24935820|NCT04047797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24935821|NCT04047797|Glycine|glycine|mesh-list
24935822|NCT04047797|Immunologic Factors|immunologic factors|mesh-ancestor
24935823|NCT04047797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666277|NCT01318265|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24666278|NCT01318369|Diazepam|diazepam|mesh-list
24666279|NCT01318369|Dronabinol|dronabinol|mesh-list
24666280|NCT01318369|Hallucinogens|hallucinogens|mesh-ancestor
24666281|NCT01318369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666282|NCT01318369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24666283|NCT01318369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24666284|NCT01318369|Analgesics|analgesics|mesh-ancestor
24666285|NCT01318369|Sensory System Agents|sensory system agents|mesh-ancestor
24666286|NCT01318369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24666287|NCT01318369|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24666288|NCT01318369|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24666289|NCT01318369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24666290|NCT01318369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666291|NCT01318369|Hormones|hormones|mesh-ancestor
24666292|NCT01318369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24666293|NCT01318369|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24666294|NCT01318369|Anticonvulsants|anticonvulsants|mesh-ancestor
24666295|NCT01318369|Antiemetics|antiemetics|mesh-ancestor
24666296|NCT01318369|Autonomic Agents|autonomic agents|mesh-ancestor
24666297|NCT01318369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24666299|NCT01318369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24666316|NCT01318460|Protective Agents|protective agents|mesh-ancestor
24666317|NCT01318460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852827|NCT00057928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852828|NCT00057928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25852829|NCT00057928|Immunologic Factors|immunologic factors|mesh-ancestor
25852830|NCT00057928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852831|NCT00057967|Alemtuzumab|alemtuzumab|mesh-list
25050123|NCT00539721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25050124|NCT00539721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050125|NCT00539721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25050126|NCT00539721|Antipruritics|antipruritics|mesh-ancestor
25050127|NCT00539721|Dermatologic Agents|dermatologic agents|mesh-ancestor
25852832|NCT00057967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24849560|NCT02249039|Sympatholytics|sympatholytics|mesh-ancestor
24666325|NCT01318590|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24666326|NCT01318590|Anesthetics, Local|anesthetics, local|mesh-ancestor
24666328|NCT01318590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24666329|NCT01318590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666330|NCT01318590|Sensory System Agents|sensory system agents|mesh-ancestor
24666331|NCT01318590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24666332|NCT01318590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24666333|NCT01318590|Glucocorticoids|glucocorticoids|mesh-ancestor
24666418|NCT01319214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24666419|NCT01319214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24666420|NCT01319214|Vasodilator Agents|vasodilator agents|mesh-ancestor
24666422|NCT01319240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25208325|NCT02666430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208326|NCT02643420|Cyclophosphamide|cyclophosphamide|mesh-list
25208327|NCT02643420|Docetaxel|docetaxel|mesh-list
25208328|NCT02643420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24829854|NCT02154932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666423|NCT01319240|Liraglutide|liraglutide|mesh-list
24666424|NCT01319240|Insulin, Long-Acting|insulin, long-acting|mesh-list
24666425|NCT01319240|Xultophy|xultophy|mesh-list
24666426|NCT01319240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24935892|NCT04047004|Doxorubicin|doxorubicin|mesh-list
25050148|NCT00537043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24829928|NCT02155504|Antifungal Agents|antifungal agents|mesh-ancestor
24666456|NCT01319331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666457|NCT01319331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666458|NCT01319344|Eplerenone|eplerenone|mesh-list
24666459|NCT01319344|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24666460|NCT01319344|Hormone Antagonists|hormone antagonists|mesh-ancestor
24666461|NCT01319344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24666462|NCT01319344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666463|NCT01319344|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24666464|NCT01319344|Diuretics|diuretics|mesh-ancestor
24666465|NCT01319344|Natriuretic Agents|natriuretic agents|mesh-ancestor
24666466|NCT01319344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24666467|NCT01319357|Saxagliptin|saxagliptin|mesh-list
24666468|NCT01319357|Incretins|incretins|mesh-ancestor
24666470|NCT01319357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24666471|NCT01319357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666483|NCT01319448|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24666484|NCT01319448|Amodiaquine|amodiaquine|mesh-list
24666485|NCT01319448|Mefloquine|mefloquine|mesh-list
24666486|NCT01319448|Proguanil|proguanil|mesh-list
24666487|NCT01319448|Antimalarials|antimalarials|mesh-ancestor
24666488|NCT01319448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24666489|NCT01319448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24666490|NCT01319448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24666491|NCT01319448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24666492|NCT01319448|Antiviral Agents|antiviral agents|mesh-ancestor
24666493|NCT01319448|Schistosomicides|schistosomicides|mesh-ancestor
24666494|NCT01319448|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24666495|NCT01319448|Anthelmintics|anthelmintics|mesh-ancestor
24666496|NCT01319448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24666497|NCT01319448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935973|NCT04045769|Moxifloxacin|moxifloxacin|mesh-list
25852833|NCT00057967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935865|NCT04047017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25202757|NCT02718755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935867|NCT04047017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935868|NCT04047017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935869|NCT04046874|Analgesics|analgesics|mesh-list
24935891|NCT04047186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935898|NCT04047004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935899|NCT04046861|Ascorbic Acid|ascorbic acid|mesh-list
24935900|NCT04046861|Vitamins|vitamins|mesh-ancestor
24849660|NCT02249546|Expectorants|expectorants|mesh-ancestor
25852834|NCT00058006|Celecoxib|celecoxib|mesh-list
25852835|NCT00058006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24666646|NCT01320254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24935901|NCT04046861|Micronutrients|micronutrients|mesh-ancestor
24935902|NCT04046861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852836|NCT00058006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25852837|NCT00058006|Analgesics|analgesics|mesh-ancestor
25876208|NCT03811002|Mitosis Modulators|mitosis modulators|mesh-ancestor
24935909|NCT04046822|Incretins|incretins|mesh-ancestor
24935910|NCT04046822|Hormones|hormones|mesh-ancestor
24935911|NCT04046822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24935912|NCT04046510|Oxytocin|oxytocin|mesh-list
24935913|NCT04046510|Oxytocics|oxytocics|mesh-ancestor
24935914|NCT04046510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24935915|NCT04046510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935916|NCT04046653|Sulforaphane|sulforaphane|mesh-list
24935917|NCT04046653|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24935918|NCT04046653|Protective Agents|protective agents|mesh-ancestor
24935919|NCT04046653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935920|NCT04046653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760379|NCT01757769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24666755|NCT01320982|Aspirin|aspirin|mesh-list
24666756|NCT01320982|Minocycline|minocycline|mesh-list
24666757|NCT01320982|Pramipexole|pramipexole|mesh-list
24666758|NCT01320982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24666759|NCT01320982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24666760|NCT01320982|Analgesics|analgesics|mesh-ancestor
24666761|NCT01320982|Sensory System Agents|sensory system agents|mesh-ancestor
24666762|NCT01320982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24666763|NCT01320982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666764|NCT01320982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24666765|NCT01320982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24666766|NCT01320982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24666767|NCT01320982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24448813|NCT00313157|Autonomic Agents|autonomic agents|mesh-ancestor
24666804|NCT01321021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24666805|NCT01321021|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24666807|NCT01321021|Dermatologic Agents|dermatologic agents|mesh-ancestor
24666809|NCT01321034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24666861|NCT01321255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24666862|NCT01321255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666863|NCT01321255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24666864|NCT01321255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24666865|NCT01321255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24666866|NCT01321255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24666867|NCT01321255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849710|NCT02249780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849711|NCT02249871|Omeprazole|omeprazole|mesh-list
24849712|NCT02249871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24849713|NCT02249871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24642219|NCT01178320|Niacin|niacin|mesh-list
24666876|NCT01321255|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24666877|NCT01321255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24666970|NCT01321775|Growth Inhibitors|growth inhibitors|mesh-ancestor
24666971|NCT01321788|Tinzaparin|tinzaparin|mesh-list
24666972|NCT01321788|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24666973|NCT01321788|Dalteparin|dalteparin|mesh-list
24666974|NCT01321788|Anticoagulants|anticoagulants|mesh-ancestor
24666975|NCT01321788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24666976|NCT01321788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24666977|NCT01321788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666978|NCT01321801|Pregabalin|pregabalin|mesh-list
24615794|NCT01031927|Glycine|glycine|mesh-list
24666997|NCT01321827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24666998|NCT01321827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666999|NCT01321827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24667000|NCT01321827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24667059|NCT01322061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667060|NCT01322061|Antioxidants|antioxidants|mesh-ancestor
24667061|NCT01322061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24667099|NCT01322191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24667100|NCT01322191|Narcotics|narcotics|mesh-ancestor
24667101|NCT01322191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24667102|NCT01322191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667104|NCT01322191|Sensory System Agents|sensory system agents|mesh-ancestor
24667105|NCT01322191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24667106|NCT01322204|Codeine|codeine|mesh-list
24667107|NCT01322204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24667123|NCT01322282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24667124|NCT01322282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667126|NCT01322308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24667127|NCT01322308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667129|NCT01322438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24667130|NCT01322438|Antitubercular Agents|antitubercular agents|mesh-ancestor
25852838|NCT00058006|Sensory System Agents|sensory system agents|mesh-ancestor
25202758|NCT02718755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24936044|NCT04044976|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24936045|NCT04044976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936046|NCT04044976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24936047|NCT04044976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24936048|NCT04044976|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24936049|NCT04044976|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24936050|NCT04044976|Purinergic Agents|purinergic agents|mesh-ancestor
24936051|NCT04044976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24936052|NCT04045015|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
24936053|NCT04045015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24936054|NCT04044651|Nivolumab|nivolumab|mesh-list
25050153|NCT00537043|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25050154|NCT00535366|Fluticasone|fluticasone|mesh-list
25050155|NCT00535366|Ciclesonide|ciclesonide|mesh-list
25050156|NCT00535366|Tiotropium Bromide|tiotropium bromide|mesh-list
25050157|NCT00535366|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25050158|NCT00535366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25050159|NCT00535366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24830257|NCT02158052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050161|NCT00535366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25050162|NCT00535366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852839|NCT00058006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25050163|NCT00535366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25050164|NCT00535366|Respiratory System Agents|respiratory system agents|mesh-ancestor
25050165|NCT00535366|Dermatologic Agents|dermatologic agents|mesh-ancestor
25050166|NCT00535366|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24952503|NCT03893864|Antioxidants|antioxidants|mesh-list
24952504|NCT03893864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952505|NCT03893864|Protective Agents|protective agents|mesh-ancestor
24952506|NCT03893864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952507|NCT03893864|Micronutrients|micronutrients|mesh-ancestor
24667685|NCT05327296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24952509|NCT03893630|Aspirin|aspirin|mesh-list
24952510|NCT03893630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24952511|NCT03893630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24952512|NCT03893630|Analgesics|analgesics|mesh-ancestor
24952513|NCT03893630|Sensory System Agents|sensory system agents|mesh-ancestor
24952516|NCT03893630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24625496|NCT01082276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24625497|NCT01082276|Serotonin Agents|serotonin agents|mesh-ancestor
24812008|NCT02049255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24667686|NCT05327296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24667690|NCT05327296|Anesthetics|anesthetics|mesh-ancestor
24830319|NCT02158689|Menotropins|menotropins|mesh-list
24667875|NCT05261516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24667876|NCT05261516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24667877|NCT05261516|Tocolytic Agents|tocolytic agents|mesh-ancestor
24667878|NCT05261516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24667882|NCT05257408|Paclitaxel|paclitaxel|mesh-list
24667883|NCT05257408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24667884|NCT05257408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24667885|NCT05257408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24667886|NCT05257408|Tubulin Modulators|tubulin modulators|mesh-ancestor
24667887|NCT05257408|Antimitotic Agents|antimitotic agents|mesh-ancestor
24667888|NCT05257408|Mitosis Modulators|mitosis modulators|mesh-ancestor
24667889|NCT05257408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625498|NCT01082276|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24667988|NCT05197049|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25202759|NCT02718755|Immunologic Factors|immunologic factors|mesh-ancestor
25208329|NCT02643420|Immunologic Factors|immunologic factors|mesh-ancestor
24667989|NCT05197049|Immunologic Factors|immunologic factors|mesh-ancestor
24936074|NCT04044430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936077|NCT04044417|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24668358|NCT04936763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24668360|NCT04936763|Protective Agents|protective agents|mesh-ancestor
24615808|NCT01031992|Coagulants|coagulants|mesh-ancestor
24668434|NCT04918147|Acetaminophen|acetaminophen|mesh-list
24668435|NCT04918147|Diphenhydramine|diphenhydramine|mesh-list
24668436|NCT04918147|Promethazine|promethazine|mesh-list
24668437|NCT04918147|Prednisone|prednisone|mesh-list
24668438|NCT04918147|Methylprednisolone|methylprednisolone|mesh-list
24668439|NCT04918147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24936119|NCT04043858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24936120|NCT04043858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24668455|NCT04918147|Autonomic Agents|autonomic agents|mesh-ancestor
24668456|NCT04918147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25852841|NCT00058006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25852842|NCT00058006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25852843|NCT00058006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25852844|NCT00058006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25852845|NCT00058006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852846|NCT00058006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852847|NCT00058045|Aldesleukin|aldesleukin|mesh-list
25202760|NCT02718755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852848|NCT00058045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852849|NCT00058045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25852850|NCT00058045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25852851|NCT00058045|Antiviral Agents|antiviral agents|mesh-ancestor
25852852|NCT00058045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25852853|NCT00058071|Amifostine|amifostine|mesh-list
25852854|NCT00058071|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25852855|NCT00058071|Protective Agents|protective agents|mesh-ancestor
25852856|NCT00058071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852857|NCT00058084|Prednisone|prednisone|mesh-list
25852858|NCT00058084|Mitoxantrone|mitoxantrone|mesh-list
25852859|NCT00058084|Epothilone B|epothilone b|mesh-list
25852860|NCT00058084|Epothilones|epothilones|mesh-list
25852861|NCT00058084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25852862|NCT00058084|Glucocorticoids|glucocorticoids|mesh-ancestor
25852863|NCT00058084|Hormones|hormones|mesh-ancestor
25852864|NCT00058084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24533496|NCT00644137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24533497|NCT00644137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24533498|NCT00644137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25852865|NCT00058084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852866|NCT00058084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25852867|NCT00058084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852868|NCT00058084|Analgesics|analgesics|mesh-ancestor
25852869|NCT00058084|Sensory System Agents|sensory system agents|mesh-ancestor
25852870|NCT00058084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25852871|NCT00058084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25852872|NCT00058084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25852873|NCT00058084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852874|NCT00058084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852875|NCT00058084|Tubulin Modulators|tubulin modulators|mesh-ancestor
25852876|NCT00058084|Antimitotic Agents|antimitotic agents|mesh-ancestor
25852877|NCT00058084|Mitosis Modulators|mitosis modulators|mesh-ancestor
25852878|NCT00058097|Tipifarnib|tipifarnib|mesh-list
25852879|NCT00058097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852880|NCT00058149|Gemcitabine|gemcitabine|mesh-list
25852881|NCT00058149|Oxaliplatin|oxaliplatin|mesh-list
24774702|NCT01847404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936136|NCT04044079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936137|NCT04044079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24936138|NCT04044079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24936139|NCT04044079|Oxytocics|oxytocics|mesh-ancestor
24849888|NCT02251041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849889|NCT02251041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24849890|NCT02251041|Dermatologic Agents|dermatologic agents|mesh-ancestor
24849891|NCT02251041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25852882|NCT00058149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25852883|NCT00058149|Antimetabolites|antimetabolites|mesh-ancestor
25876209|NCT03809429|Cetrorelix|cetrorelix|mesh-list
24533500|NCT00644176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24533501|NCT00644176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25202761|NCT02718755|Antiviral Agents|antiviral agents|mesh-ancestor
24533504|NCT00644215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24936154|NCT04043676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24936155|NCT04043676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24936156|NCT04043676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075930|NCT03377257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849903|NCT02251041|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24849904|NCT02251041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25852884|NCT00058149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852885|NCT00058149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852886|NCT00058149|Antiviral Agents|antiviral agents|mesh-ancestor
25852887|NCT00058149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25852888|NCT00058149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852889|NCT00058149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25852890|NCT00058149|Immunologic Factors|immunologic factors|mesh-ancestor
25852891|NCT00058149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852892|NCT00058201|Leucovorin|leucovorin|mesh-list
25852893|NCT00058201|Gemcitabine|gemcitabine|mesh-list
25852894|NCT00058201|Fluorouracil|fluorouracil|mesh-list
25852895|NCT00058201|Calcium|calcium|mesh-list
25852896|NCT00058201|Levoleucovorin|levoleucovorin|mesh-list
25852897|NCT00058201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25852898|NCT00058201|Antimetabolites|antimetabolites|mesh-ancestor
24936157|NCT04043676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936160|NCT04043520|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24724229|NCT01591980|Pregabalin|pregabalin|mesh-list
24936162|NCT04043520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24936163|NCT04043520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936164|NCT04043702|Topiramate|topiramate|mesh-list
24936165|NCT04043702|Anticonvulsants|anticonvulsants|mesh-ancestor
24936166|NCT04043702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24936167|NCT04043702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936168|NCT04043624|Lidocaine|lidocaine|mesh-list
24936169|NCT04043624|Anesthetics, Local|anesthetics, local|mesh-ancestor
24936170|NCT04043624|Anesthetics|anesthetics|mesh-ancestor
24936171|NCT04043624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24936172|NCT04043624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936173|NCT04043624|Sensory System Agents|sensory system agents|mesh-ancestor
25852899|NCT00058201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852900|NCT00058201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852901|NCT00058201|Antiviral Agents|antiviral agents|mesh-ancestor
25852902|NCT00058201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25852903|NCT00058201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852904|NCT00058201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25852905|NCT00058201|Immunologic Factors|immunologic factors|mesh-ancestor
25852906|NCT00058201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852907|NCT00058201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25852908|NCT00058201|Antidotes|antidotes|mesh-ancestor
25852909|NCT00058201|Protective Agents|protective agents|mesh-ancestor
25852910|NCT00058201|Vitamin B Complex|vitamin b complex|mesh-ancestor
24936178|NCT04043624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24936179|NCT04043624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936180|NCT04043494|Cytarabine|cytarabine|mesh-list
24936181|NCT04043494|Dexamethasone|dexamethasone|mesh-list
24936182|NCT04043494|Prednisone|prednisone|mesh-list
24936183|NCT04043494|Prednisolone|prednisolone|mesh-list
24936184|NCT04043494|Cyclophosphamide|cyclophosphamide|mesh-list
24936185|NCT04043494|Ifosfamide|ifosfamide|mesh-list
24936186|NCT04043494|Doxorubicin|doxorubicin|mesh-list
24936187|NCT04043494|Methotrexate|methotrexate|mesh-list
24936188|NCT04043494|Vincristine|vincristine|mesh-list
24936189|NCT04043494|Daunorubicin|daunorubicin|mesh-list
24936190|NCT04043494|Asparaginase|asparaginase|mesh-list
24533535|NCT00644306|Growth Inhibitors|growth inhibitors|mesh-ancestor
24533536|NCT00644319|Ibuprofen|ibuprofen|mesh-list
24533537|NCT00644319|Morphine|morphine|mesh-list
24533538|NCT00644319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25852911|NCT00058201|Vitamins|vitamins|mesh-ancestor
25852912|NCT00058201|Micronutrients|micronutrients|mesh-ancestor
25852913|NCT00058227|Rituximab|rituximab|mesh-list
25852914|NCT00058227|Fludarabine|fludarabine|mesh-list
25852915|NCT00058227|Fludarabine phosphate|fludarabine phosphate|mesh-list
25852916|NCT00058227|Alvocidib|alvocidib|mesh-list
24830540|NCT02159820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852917|NCT00058227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25852918|NCT00058227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24836217|NCT02184429|PF-06669571|pf-06669571|mesh-list
24849948|NCT02251145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849949|NCT02251145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24849950|NCT02251145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24849951|NCT02251145|Antiviral Agents|antiviral agents|mesh-ancestor
25852919|NCT00058227|Immunologic Factors|immunologic factors|mesh-ancestor
25852920|NCT00058227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852921|NCT00058227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25852922|NCT00058227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25852923|NCT00058227|Antimetabolites|antimetabolites|mesh-ancestor
25852924|NCT00058227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852925|NCT00058227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25852926|NCT00058227|Growth Inhibitors|growth inhibitors|mesh-ancestor
25852927|NCT00058227|Growth Substances|growth substances|mesh-ancestor
25852928|NCT00058227|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25852929|NCT00058227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852930|NCT00058253|Docetaxel|docetaxel|mesh-list
25852931|NCT00058253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852932|NCT00058253|Tubulin Modulators|tubulin modulators|mesh-ancestor
25852933|NCT00058253|Antimitotic Agents|antimitotic agents|mesh-ancestor
25852934|NCT00058253|Mitosis Modulators|mitosis modulators|mesh-ancestor
25852935|NCT00058253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936223|NCT04043494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24936224|NCT04043494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24936226|NCT04043494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24936227|NCT04043494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24936228|NCT04043494|Tubulin Modulators|tubulin modulators|mesh-ancestor
25852936|NCT00058279|Aldesleukin|aldesleukin|mesh-list
25852937|NCT00058279|Ipilimumab|ipilimumab|mesh-list
25852938|NCT00058279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25852939|NCT00058279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852940|NCT00058279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25852941|NCT00058279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852942|NCT00058279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25852943|NCT00058279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25852944|NCT00058279|Antiviral Agents|antiviral agents|mesh-ancestor
25852945|NCT00058279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24936252|NCT04042974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24936260|NCT04042805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936262|NCT04042506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25852946|NCT00058292|Cytarabine|cytarabine|mesh-list
25852947|NCT00058292|Rituximab|rituximab|mesh-list
25852948|NCT00058292|Etoposide|etoposide|mesh-list
25852949|NCT00058292|Etoposide phosphate|etoposide phosphate|mesh-list
25202762|NCT02718755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24936312|NCT04042051|Antimitotic Agents|antimitotic agents|mesh-ancestor
24936313|NCT04042051|Mitosis Modulators|mitosis modulators|mesh-ancestor
24936314|NCT04042051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936315|NCT04042220|Glucocorticoids|glucocorticoids|mesh-list
24936316|NCT04042220|Hormones|hormones|mesh-ancestor
24936317|NCT04042220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24936318|NCT04042220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936319|NCT04041856|Povidone-Iodine|povidone-iodine|mesh-list
25852950|NCT00058292|Melphalan|melphalan|mesh-list
25852951|NCT00058292|Carmustine|carmustine|mesh-list
25852952|NCT00058292|Lenograstim|lenograstim|mesh-list
25852953|NCT00058292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24533760|NCT00645073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24533761|NCT00645073|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24936350|NCT04041791|Penicillins|penicillins|mesh-list
24724473|NCT01593163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24724512|NCT01593371|Metformin|metformin|mesh-list
24936352|NCT04041791|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24936353|NCT04041791|Penicillin G|penicillin g|mesh-list
24936354|NCT04041791|Penicillin G Benzathine|penicillin g benzathine|mesh-list
24936355|NCT04041791|Penicillin G Procaine|penicillin g procaine|mesh-list
25664218|NCT01667432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25664219|NCT01667562|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25664220|NCT01667562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664221|NCT01667562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25664222|NCT01667562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664223|NCT01667562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664224|NCT01667679|Sumatriptan|sumatriptan|mesh-list
24836242|NCT02184637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24836243|NCT02184637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24836244|NCT02184637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24836252|NCT02184819|Dermatologic Agents|dermatologic agents|mesh-ancestor
24836253|NCT02184819|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24836260|NCT02184832|Metformin|metformin|mesh-list
24936356|NCT04041791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24936357|NCT04041791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24846671|NCT02243553|Digoxin|digoxin|mesh-list
24936358|NCT04041791|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24936359|NCT04041791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202763|NCT02718976|Lidocaine|lidocaine|mesh-list
25202764|NCT02718976|Epinephrine|epinephrine|mesh-list
25852954|NCT00058292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852955|NCT00058292|Immunologic Factors|immunologic factors|mesh-ancestor
25852956|NCT00058292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852957|NCT00058292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25852958|NCT00058292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25852959|NCT00058292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25852960|NCT00058292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25852961|NCT00058292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852962|NCT00058292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852963|NCT00058292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24936415|NCT04040322|Iloprost|iloprost|mesh-list
24936416|NCT04040322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24671759|NCT01327521|Mitomycins|mitomycins|mesh-list
24936417|NCT04040322|Vasodilator Agents|vasodilator agents|mesh-ancestor
24936419|NCT04040465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24936420|NCT04040465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25852964|NCT00058292|Antimetabolites|antimetabolites|mesh-ancestor
24936451|NCT04040309|Sensory System Agents|sensory system agents|mesh-ancestor
24936452|NCT04040309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25852965|NCT00058292|Antiviral Agents|antiviral agents|mesh-ancestor
24850176|NCT02251977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850177|NCT02251977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24850178|NCT02251977|Immunologic Factors|immunologic factors|mesh-ancestor
24850179|NCT02251977|Antidotes|antidotes|mesh-ancestor
24850180|NCT02251977|Protective Agents|protective agents|mesh-ancestor
24850181|NCT02251977|Vitamin B Complex|vitamin b complex|mesh-ancestor
24850182|NCT02251977|Vitamins|vitamins|mesh-ancestor
24724548|NCT01593488|Cytarabine|cytarabine|mesh-list
24850183|NCT02251977|Micronutrients|micronutrients|mesh-ancestor
24850184|NCT02252107|Decitabine|decitabine|mesh-list
25852966|NCT00058292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25852967|NCT00058292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24936476|NCT04039828|Trace Elements|trace elements|mesh-ancestor
24936477|NCT04039828|Micronutrients|micronutrients|mesh-ancestor
24936478|NCT04039828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936479|NCT04039828|Astringents|astringents|mesh-ancestor
24936480|NCT04039828|Dermatologic Agents|dermatologic agents|mesh-ancestor
24936482|NCT04039880|Antifungal Agents|antifungal agents|mesh-ancestor
25050200|NCT00532038|Sensory System Agents|sensory system agents|mesh-ancestor
25050201|NCT00532038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25050202|NCT00532038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050203|NCT00532038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25050205|NCT00532038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25050206|NCT00532038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050207|NCT00532038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850216|NCT02252341|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25202765|NCT02718976|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
24850217|NCT02252341|Antiviral Agents|antiviral agents|mesh-ancestor
25202766|NCT02718976|Anesthetics, Local|anesthetics, local|mesh-ancestor
25202767|NCT02718976|Anesthetics|anesthetics|mesh-ancestor
25202768|NCT02718976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24724610|NCT01593826|Charcoal|charcoal|mesh-list
25202769|NCT02718976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936601|NCT04038320|Sofosbuvir|sofosbuvir|mesh-list
25664225|NCT01667679|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25664226|NCT01667679|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25664227|NCT01667679|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25664228|NCT01667679|Serotonin Agents|serotonin agents|mesh-ancestor
25664229|NCT01667679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25664230|NCT01667679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664231|NCT01667679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25852974|NCT00058305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25852975|NCT00058305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852976|NCT00058305|Tubulin Modulators|tubulin modulators|mesh-ancestor
25852977|NCT00058305|Antimitotic Agents|antimitotic agents|mesh-ancestor
25852978|NCT00058305|Mitosis Modulators|mitosis modulators|mesh-ancestor
25852979|NCT00058305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852980|NCT00058305|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25231907|NCT02586142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25050209|NCT00531622|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25050210|NCT00531622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25050211|NCT00531622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25050212|NCT00531622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050213|NCT00531622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050214|NCT00531622|Serotonin Agents|serotonin agents|mesh-ancestor
25852981|NCT00058305|Immunologic Factors|immunologic factors|mesh-ancestor
24936541|NCT04039152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24936542|NCT04039152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24936543|NCT04038970|Methotrexate|methotrexate|mesh-list
24936544|NCT04038970|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24936545|NCT04038970|Abortifacient Agents|abortifacient agents|mesh-ancestor
25852982|NCT00058305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936572|NCT04038749|Cabergoline|cabergoline|mesh-list
24936573|NCT04038749|Bromocriptine|bromocriptine|mesh-list
24936574|NCT04038749|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24936575|NCT04038749|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24936576|NCT04038749|Dopamine Agonists|dopamine agonists|mesh-ancestor
24936577|NCT04038749|Dopamine Agents|dopamine agents|mesh-ancestor
24936578|NCT04038749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24936579|NCT04038749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936580|NCT04038749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936581|NCT04038749|Hormone Antagonists|hormone antagonists|mesh-ancestor
24936582|NCT04038749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24936583|NCT04038411|Etoposide|etoposide|mesh-list
24812090|NCT02049606|Sensory System Agents|sensory system agents|mesh-ancestor
24812091|NCT02049606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812092|NCT02049606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812093|NCT02049606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25852983|NCT00058318|Gemcitabine|gemcitabine|mesh-list
24724738|NCT01594489|Aminophylline|aminophylline|mesh-list
24812094|NCT02049606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24812095|NCT02049606|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24812096|NCT02049606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24812097|NCT02049606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852984|NCT00058318|Capecitabine|capecitabine|mesh-list
25852985|NCT00058318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25852986|NCT00058318|Antimetabolites|antimetabolites|mesh-ancestor
25852987|NCT00058318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25852988|NCT00058318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25852989|NCT00058318|Antiviral Agents|antiviral agents|mesh-ancestor
25852990|NCT00058318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25852991|NCT00058318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25852992|NCT00058318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25852993|NCT00058318|Immunologic Factors|immunologic factors|mesh-ancestor
25202771|NCT02718976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25852994|NCT00058318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936592|NCT04038411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24936593|NCT04038411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936594|NCT04038411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25664232|NCT01667731|Sofosbuvir|sofosbuvir|mesh-list
25664233|NCT01667731|Antiviral Agents|antiviral agents|mesh-ancestor
25664234|NCT01667731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25664235|NCT01667796|Vitamin D|vitamin d|mesh-list
25664236|NCT01667796|Cholecalciferol|cholecalciferol|mesh-list
25852995|NCT00058331|Epoetin Alfa|epoetin alfa|mesh-list
25853000|NCT00058357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25853001|NCT00058357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853002|NCT00058357|Sensory System Agents|sensory system agents|mesh-ancestor
25269933|NCT02407782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24936595|NCT04038411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24936596|NCT04038411|Growth Substances|growth substances|mesh-ancestor
24936597|NCT04038411|Growth Inhibitors|growth inhibitors|mesh-ancestor
24936599|NCT04038619|Antidiarrheals|antidiarrheals|mesh-list
24936600|NCT04038619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24936621|NCT04038008|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24936622|NCT04038008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24936623|NCT04038008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24936624|NCT04038008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050240|NCT00529178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050241|NCT00529178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24850333|NCT02252770|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24850334|NCT02252770|Autonomic Agents|autonomic agents|mesh-ancestor
24850335|NCT02252770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24850336|NCT02252770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850337|NCT02252770|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24850338|NCT02252770|Respiratory System Agents|respiratory system agents|mesh-ancestor
24850339|NCT02252770|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24850340|NCT02252770|Antioxidants|antioxidants|mesh-ancestor
24850341|NCT02252770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850342|NCT02252770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24646031|NCT01201499|Analgesics|analgesics|mesh-ancestor
24444739|NCT00299013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25853003|NCT00058357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24444740|NCT00299013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24444741|NCT00299013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24444742|NCT00299013|Protective Agents|protective agents|mesh-ancestor
24444744|NCT00299026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24444745|NCT00299026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24444746|NCT00299026|Tubulin Modulators|tubulin modulators|mesh-ancestor
24444747|NCT00299026|Antimitotic Agents|antimitotic agents|mesh-ancestor
24444748|NCT00299026|Mitosis Modulators|mitosis modulators|mesh-ancestor
24444749|NCT00299026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050242|NCT00529178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25050243|NCT00529178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050244|NCT00529152|Deferiprone|deferiprone|mesh-list
25050245|NCT00529152|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25050246|NCT00529152|Chelating Agents|chelating agents|mesh-ancestor
25050271|NCT00526227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25050272|NCT00526227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24444790|NCT00299091|Antiviral Agents|antiviral agents|mesh-ancestor
24761272|NCT01761994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761273|NCT01761994|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24761274|NCT01761994|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24761275|NCT01761994|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24761276|NCT01761994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24761277|NCT01761994|Immunologic Factors|immunologic factors|mesh-ancestor
24761286|NCT01762150|Antimetabolites|antimetabolites|mesh-ancestor
25664237|NCT01667796|Vitamins|vitamins|mesh-ancestor
25664238|NCT01667796|Micronutrients|micronutrients|mesh-ancestor
25664239|NCT01667796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664240|NCT01667796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25664241|NCT01667796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25664242|NCT01667900|Dulaglutide|dulaglutide|mesh-list
25664243|NCT01667900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25664244|NCT01667900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664245|NCT01667926|Ketamine|ketamine|mesh-list
25664246|NCT01667926|Analgesics|analgesics|mesh-ancestor
25664247|NCT01667926|Sensory System Agents|sensory system agents|mesh-ancestor
25664248|NCT01667926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25853004|NCT00058357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24761287|NCT01762150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761288|NCT01762150|Antiviral Agents|antiviral agents|mesh-ancestor
24761289|NCT01762150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24761290|NCT01762150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761291|NCT01762150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24761292|NCT01762150|Immunologic Factors|immunologic factors|mesh-ancestor
24761293|NCT01762150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761294|NCT01762150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24625524|NCT01082341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936748|NCT04036487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25853005|NCT00058357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24936758|NCT04036500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936759|NCT04036448|Lenalidomide|lenalidomide|mesh-list
24936760|NCT04036448|Immunologic Factors|immunologic factors|mesh-ancestor
24936761|NCT04036448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936762|NCT04036448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24936763|NCT04036448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24936764|NCT04036448|Growth Substances|growth substances|mesh-ancestor
24936765|NCT04036448|Growth Inhibitors|growth inhibitors|mesh-ancestor
24622445|NCT01067053|Oxaliplatin|oxaliplatin|mesh-list
24850457|NCT02253095|Albendazole|albendazole|mesh-list
24850458|NCT02253095|Anthelmintics|anthelmintics|mesh-ancestor
24850459|NCT02253095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24850460|NCT02253095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24850461|NCT02253095|Anticestodal Agents|anticestodal agents|mesh-ancestor
24850462|NCT02253095|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24850463|NCT02253095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24936805|NCT04035850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24936806|NCT04035850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24936807|NCT04035850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936808|NCT04035850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24936809|NCT04035850|Serotonin Agents|serotonin agents|mesh-ancestor
24936810|NCT04035850|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24936811|NCT04035850|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24936812|NCT04035850|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24936813|NCT04035850|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24936814|NCT04035876|Apatinib|apatinib|mesh-list
24936815|NCT04035876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24936816|NCT04035876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24936817|NCT04035876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24936818|NCT04035876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936819|NCT04035889|Melatonin|melatonin|mesh-list
24936820|NCT04035889|Antioxidants|antioxidants|mesh-ancestor
24936821|NCT04035889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936822|NCT04035889|Protective Agents|protective agents|mesh-ancestor
24936823|NCT04035889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202772|NCT02718976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24936830|NCT04035798|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24936831|NCT04035798|Dopamine Agents|dopamine agents|mesh-ancestor
24936832|NCT04035798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24936833|NCT04035798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936834|NCT04035798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936835|NCT04035798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24936836|NCT04035798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24936837|NCT04035707|Rocuronium|rocuronium|mesh-list
24936838|NCT04035707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936839|NCT04035707|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24936840|NCT04035707|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24936841|NCT04035707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24936842|NCT04035707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24936843|NCT04035603|Cycloserine|cycloserine|mesh-list
24936844|NCT04035603|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24936845|NCT04035603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24936846|NCT04035603|Renal Agents|renal agents|mesh-ancestor
24936847|NCT04035603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24936848|NCT04035603|Antitubercular Agents|antitubercular agents|mesh-ancestor
24850503|NCT02253121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850504|NCT02253420|Itraconazole|itraconazole|mesh-list
24850505|NCT02253420|Rifampin|rifampin|mesh-list
24850506|NCT02253420|Antifungal Agents|antifungal agents|mesh-ancestor
24850507|NCT02253420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24850508|NCT02253420|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24850509|NCT02253420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25664250|NCT01667926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25664251|NCT01667926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25664252|NCT01667926|Anesthetics, General|anesthetics, general|mesh-ancestor
25664253|NCT01667926|Anesthetics|anesthetics|mesh-ancestor
24600480|NCT00958906|Infliximab|infliximab|mesh-list
24850510|NCT02253420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850511|NCT02253420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936849|NCT04035603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24936850|NCT04035603|Antimetabolites|antimetabolites|mesh-ancestor
24936851|NCT04035603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936852|NCT04035525|Coenzyme Q10|coenzyme q10|mesh-list
24936853|NCT04035525|Ubiquinone|ubiquinone|mesh-list
24936854|NCT04035525|Vitamins|vitamins|mesh-ancestor
24936855|NCT04035525|Micronutrients|micronutrients|mesh-ancestor
24936856|NCT04035525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936857|NCT04035135|Immunoglobulins|immunoglobulins|mesh-list
24936858|NCT04035135|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24936859|NCT04035135|Antibodies|antibodies|mesh-list
24936860|NCT04035135|gamma-Globulins|gamma-globulins|mesh-list
24850555|NCT02253524|Antiemetics|antiemetics|mesh-ancestor
25044348|NCT01111955|Metformin|metformin|mesh-list
24850556|NCT02253524|Autonomic Agents|autonomic agents|mesh-ancestor
25853006|NCT00058357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25853007|NCT00058357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25853008|NCT00058357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853009|NCT00058435|Abagovomab|abagovomab|mesh-list
25853010|NCT00058435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24936898|NCT04035070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075934|NCT03377218|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24850557|NCT02253524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24850558|NCT02253524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850559|NCT02253524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24850560|NCT02253524|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24850561|NCT02253524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24850562|NCT02253524|Dopamine Agents|dopamine agents|mesh-ancestor
24850585|NCT02253758|Anesthetics|anesthetics|mesh-ancestor
24936919|NCT04034836|Sensory System Agents|sensory system agents|mesh-ancestor
24936920|NCT04034836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24936921|NCT04034836|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24936939|NCT04034589|Fulvestrant|fulvestrant|mesh-list
24936940|NCT04034589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24936941|NCT04034589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24936942|NCT04034589|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24725030|NCT01596075|Cannabidiol|cannabidiol|mesh-list
24936943|NCT04034589|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24936944|NCT04034589|Hormone Antagonists|hormone antagonists|mesh-ancestor
24936945|NCT04034589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24936946|NCT04034589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936947|NCT04034368|Tenofovir|tenofovir|mesh-list
24936948|NCT04034368|Antiviral Agents|antiviral agents|mesh-ancestor
24936949|NCT04034368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24936950|NCT04034368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24936951|NCT04034368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24936952|NCT04034368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24936957|NCT04034173|Folic Acid|folic acid|mesh-list
24936958|NCT04034173|Irinotecan|irinotecan|mesh-list
24936959|NCT04034173|Panitumumab|panitumumab|mesh-list
24953316|NCT03886441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24936960|NCT04034173|Levoleucovorin|levoleucovorin|mesh-list
24936961|NCT04034173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24936962|NCT04034173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24936963|NCT04034173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24936964|NCT04034173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936965|NCT04034173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24936966|NCT04034173|Antidotes|antidotes|mesh-ancestor
24936967|NCT04034173|Protective Agents|protective agents|mesh-ancestor
24936968|NCT04034173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936969|NCT04034173|Vitamin B Complex|vitamin b complex|mesh-ancestor
24936970|NCT04034173|Vitamins|vitamins|mesh-ancestor
24936971|NCT04034173|Micronutrients|micronutrients|mesh-ancestor
24936972|NCT04034173|Hematinics|hematinics|mesh-ancestor
24936973|NCT04034173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25664254|NCT01667926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25664255|NCT01667926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24850617|NCT02253810|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25269967|NCT02407392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269968|NCT02407392|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24850618|NCT02253810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24850619|NCT02253810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850620|NCT02253810|Hemostatics|hemostatics|mesh-ancestor
24850621|NCT02253810|Coagulants|coagulants|mesh-ancestor
24850622|NCT02253836|Ritonavir|ritonavir|mesh-list
24850623|NCT02253836|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24850624|NCT02253836|Tipranavir|tipranavir|mesh-list
24850625|NCT02253836|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25853011|NCT00058435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24725086|NCT01596400|Antiemetics|antiemetics|mesh-ancestor
24937001|NCT04033562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24937002|NCT04033562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937004|NCT04033562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937005|NCT04033562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24937006|NCT04033562|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24937007|NCT04033562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24937008|NCT04033562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24937009|NCT04033562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937010|NCT04033471|Midazolam|midazolam|mesh-list
24937011|NCT04033471|Morphine|morphine|mesh-list
24937012|NCT04033471|Bupivacaine|bupivacaine|mesh-list
24937013|NCT04033471|Anesthetics, Local|anesthetics, local|mesh-ancestor
24937014|NCT04033471|Anesthetics|anesthetics|mesh-ancestor
24937015|NCT04033471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24937016|NCT04033471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850636|NCT02253849|Ritonavir|ritonavir|mesh-list
24533898|NCT00645398|Sensory System Agents|sensory system agents|mesh-ancestor
24533899|NCT00645398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24533900|NCT00645398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774703|NCT01847404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24937023|NCT04033471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24937024|NCT04033471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24937025|NCT04033471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24937026|NCT04033471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24937027|NCT04033471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24937030|NCT04033471|GABA Agents|gaba agents|mesh-ancestor
24937031|NCT04033471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24937032|NCT04033471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937034|NCT04033250|Picosulfate sodium|picosulfate sodium|mesh-list
24937035|NCT04033250|Magnesium Oxide|magnesium oxide|mesh-list
24937036|NCT04033250|Sodium Citrate|sodium citrate|mesh-list
24937037|NCT04033250|Citric Acid|citric acid|mesh-list
24937038|NCT04033250|Cathartics|cathartics|mesh-ancestor
24937039|NCT04033250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24850665|NCT02253862|Tipranavir|tipranavir|mesh-list
24850666|NCT02253862|Tadalafil|tadalafil|mesh-list
24850667|NCT02253862|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24850668|NCT02253862|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24850669|NCT02253862|Protease Inhibitors|protease inhibitors|mesh-ancestor
24850670|NCT02253862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850671|NCT02253862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687084|NCT04391608|Antiviral Agents|antiviral agents|mesh-ancestor
24687085|NCT04391608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24687086|NCT04391608|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24855127|NCT02277600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24855129|NCT02277600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855130|NCT02277600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855131|NCT02277600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24855132|NCT02277600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24850672|NCT02253862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24850673|NCT02253862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24850674|NCT02253862|Antiviral Agents|antiviral agents|mesh-ancestor
24672254|NCT01330810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24850683|NCT02253875|Tipranavir|tipranavir|mesh-list
25853012|NCT00058448|Docetaxel|docetaxel|mesh-list
25853013|NCT00058448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853014|NCT00058448|Tubulin Modulators|tubulin modulators|mesh-ancestor
25853015|NCT00058448|Antimitotic Agents|antimitotic agents|mesh-ancestor
25853016|NCT00058448|Mitosis Modulators|mitosis modulators|mesh-ancestor
25853017|NCT00058448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853018|NCT00058461|Cytarabine|cytarabine|mesh-list
25664256|NCT01667926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25664257|NCT01667926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24937040|NCT04033250|Laxatives|laxatives|mesh-ancestor
24937041|NCT04033250|Anticoagulants|anticoagulants|mesh-ancestor
25853019|NCT00058461|Rituximab|rituximab|mesh-list
24937042|NCT04033250|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25050282|NCT00526227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24937043|NCT04033250|Chelating Agents|chelating agents|mesh-ancestor
24937044|NCT04033250|Sequestering Agents|sequestering agents|mesh-ancestor
24937045|NCT04033250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937046|NCT04033250|Antacids|antacids|mesh-ancestor
24937047|NCT04033172|Fulvestrant|fulvestrant|mesh-list
24937065|NCT04033029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761669|NCT01763658|Immunologic Factors|immunologic factors|mesh-ancestor
24761670|NCT01763671|Paclitaxel|paclitaxel|mesh-list
24761671|NCT01763671|Docetaxel|docetaxel|mesh-list
24761672|NCT01763671|Bevacizumab|bevacizumab|mesh-list
24761673|NCT01763671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24725216|NCT01596777|Loperamide|loperamide|mesh-list
24761674|NCT01763671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761675|NCT01763671|Tubulin Modulators|tubulin modulators|mesh-ancestor
24761676|NCT01763671|Antimitotic Agents|antimitotic agents|mesh-ancestor
24761677|NCT01763671|Mitosis Modulators|mitosis modulators|mesh-ancestor
24761678|NCT01763671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850723|NCT02253901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24850724|NCT02253901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24761687|NCT01763710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24761688|NCT01763710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761689|NCT01763710|Tubulin Modulators|tubulin modulators|mesh-ancestor
24761690|NCT01763710|Antimitotic Agents|antimitotic agents|mesh-ancestor
24761691|NCT01763710|Mitosis Modulators|mitosis modulators|mesh-ancestor
24761692|NCT01763710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625551|NCT01082445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625552|NCT01082445|Protective Agents|protective agents|mesh-ancestor
24625553|NCT01082445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625554|NCT01082445|Antidotes|antidotes|mesh-ancestor
24625555|NCT01082458|Lidocaine|lidocaine|mesh-list
24625563|NCT01082458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24625564|NCT01082458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24625565|NCT01082458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24937070|NCT04033055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24937109|NCT04032860|Antiviral Agents|antiviral agents|mesh-ancestor
24937110|NCT04032860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24937111|NCT04032860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24937112|NCT04032860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24937113|NCT04032860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850795|NCT02253966|Autonomic Agents|autonomic agents|mesh-ancestor
24850797|NCT02253966|Glucocorticoids|glucocorticoids|mesh-ancestor
24937114|NCT04032860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937115|NCT04032860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24937116|NCT04032860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24937126|NCT04032847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24937127|NCT04032847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050299|NCT00524277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937129|NCT04032834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24937156|NCT04032366|Autonomic Agents|autonomic agents|mesh-ancestor
24937157|NCT04032366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937158|NCT04032366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937159|NCT04032366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24937160|NCT04032366|Respiratory System Agents|respiratory system agents|mesh-ancestor
24937171|NCT04032132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24937173|NCT04032132|Sensory System Agents|sensory system agents|mesh-ancestor
24937174|NCT04032132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24725299|NCT01596998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24937175|NCT04032132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937176|NCT04032132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24937177|NCT04032132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24937178|NCT04032132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24937179|NCT04032132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24937190|NCT04032184|Dermatologic Agents|dermatologic agents|mesh-ancestor
24850836|NCT02254044|Antimitotic Agents|antimitotic agents|mesh-ancestor
24850837|NCT02254044|Mitosis Modulators|mitosis modulators|mesh-ancestor
24850838|NCT02254044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647938|NCT01211496|Sympathomimetics|sympathomimetics|mesh-ancestor
25853020|NCT00058461|Carboplatin|carboplatin|mesh-list
25853021|NCT00058461|Methotrexate|methotrexate|mesh-list
25853022|NCT00058461|Etoposide|etoposide|mesh-list
25853023|NCT00058461|Ifosfamide|ifosfamide|mesh-list
25853025|NCT00058461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853027|NCT00058461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853028|NCT00058461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25853029|NCT00058461|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25853030|NCT00058461|Abortifacient Agents|abortifacient agents|mesh-ancestor
25853031|NCT00058461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25853032|NCT00058461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25853033|NCT00058461|Antimetabolites|antimetabolites|mesh-ancestor
25853034|NCT00058461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853035|NCT00058461|Dermatologic Agents|dermatologic agents|mesh-ancestor
25853036|NCT00058461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853037|NCT00058461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24937213|NCT04032210|Micronutrients|micronutrients|mesh-ancestor
24937215|NCT04031859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24850853|NCT02254148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24850854|NCT02254148|Anesthetics, General|anesthetics, general|mesh-ancestor
24850855|NCT02254148|Anesthetics|anesthetics|mesh-ancestor
24850856|NCT02254148|GABA Modulators|gaba modulators|mesh-ancestor
24850857|NCT02254148|GABA Agents|gaba agents|mesh-ancestor
24850858|NCT02254148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24850859|NCT02254148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850860|NCT02254148|Anticoagulants|anticoagulants|mesh-ancestor
24850861|NCT02254148|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24850862|NCT02254148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24850863|NCT02254148|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24937239|NCT04031703|Docetaxel|docetaxel|mesh-list
24761780|NCT01764581|Tacrolimus|tacrolimus|mesh-list
24761904|NCT01765257|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24761905|NCT01765257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761914|NCT01765296|Sensory System Agents|sensory system agents|mesh-ancestor
24761915|NCT01765296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24761916|NCT01765296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761917|NCT01765296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24761919|NCT01765296|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24761920|NCT01765296|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24761921|NCT01765296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761922|NCT01765296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761923|NCT01765309|Botulinum Toxins|botulinum toxins|mesh-list
24761924|NCT01765309|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24761925|NCT01765309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24761926|NCT01765309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761927|NCT01765309|Cholinergic Agents|cholinergic agents|mesh-ancestor
24761928|NCT01765309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050300|NCT00524277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050301|NCT00523250|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24850892|NCT02254174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24850914|NCT02254226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24850915|NCT02254226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850916|NCT02254226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24850917|NCT02254226|Respiratory System Agents|respiratory system agents|mesh-ancestor
24850918|NCT02254226|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24850920|NCT02254226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25853038|NCT00058461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24850928|NCT02254239|Immunoglobulins|immunoglobulins|mesh-list
24850929|NCT02254239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24850930|NCT02254239|Immunoconjugates|immunoconjugates|mesh-list
24937302|NCT04030715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24937303|NCT04030741|Metronidazole|metronidazole|mesh-list
24937304|NCT04030741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24937305|NCT04030741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24937306|NCT04030741|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25664259|NCT01667978|Ritonavir|ritonavir|mesh-list
25664260|NCT01667978|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25664261|NCT01667978|Norethindrone|norethindrone|mesh-list
25664262|NCT01667978|Norethindrone Acetate|norethindrone acetate|mesh-list
25664263|NCT01667978|Protease Inhibitors|protease inhibitors|mesh-list
25664264|NCT01667978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25664265|NCT01667978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24850934|NCT02254239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24850936|NCT02254447|Candesartan cilexetil|candesartan cilexetil|mesh-list
24533947|NCT00645515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24533948|NCT00645515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533964|NCT00645554|Autonomic Agents|autonomic agents|mesh-ancestor
24533965|NCT00645554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24533966|NCT00645554|Nootropic Agents|nootropic agents|mesh-ancestor
24533968|NCT00645580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24533969|NCT00645580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24533970|NCT00645580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24533971|NCT00645580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533972|NCT00645580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24533973|NCT00645580|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24533974|NCT00645580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25853039|NCT00058461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24533995|NCT00645632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24533996|NCT00645632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24830986|NCT02162381|Methylphenidate|methylphenidate|mesh-list
24534018|NCT00645658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24534019|NCT00645658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534020|NCT00645723|Colistin|colistin|mesh-list
24937331|NCT04030572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24937332|NCT04030572|Adrenergic Agents|adrenergic agents|mesh-ancestor
24937333|NCT04030572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24937334|NCT04030572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937335|NCT04030481|Anesthetics|anesthetics|mesh-list
24937336|NCT04030481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24937337|NCT04030481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937338|NCT04030260|Nivolumab|nivolumab|mesh-list
24937339|NCT04030260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24937340|NCT04030260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24937341|NCT04030260|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24850951|NCT02254525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850952|NCT02254525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850953|NCT02254577|Progesterone|progesterone|mesh-list
24850954|NCT02254577|Progestins|progestins|mesh-ancestor
24534021|NCT00645723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25853040|NCT00058461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25853041|NCT00058461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25853042|NCT00058461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25853043|NCT00058461|Antiviral Agents|antiviral agents|mesh-ancestor
24534114|NCT00646087|Sensory System Agents|sensory system agents|mesh-ancestor
24937342|NCT04030260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937343|NCT04030039|Interferons|interferons|mesh-list
24937344|NCT04030039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24937345|NCT04030039|Antiviral Agents|antiviral agents|mesh-ancestor
24937346|NCT04030039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24937347|NCT04030091|Insulin|insulin|mesh-list
24937348|NCT04030091|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24937349|NCT04030091|Insulin, Isophane|insulin, isophane|mesh-list
24937350|NCT04030091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24937351|NCT04030091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937352|NCT04029831|Ketamine|ketamine|mesh-list
24937353|NCT04029831|Propofol|propofol|mesh-list
24937395|NCT04029467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24937396|NCT04029467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937397|NCT04029467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24937398|NCT04029467|Analgesics|analgesics|mesh-ancestor
24937399|NCT04029467|Sensory System Agents|sensory system agents|mesh-ancestor
25664266|NCT01667978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664267|NCT01667978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664268|NCT01667978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25664269|NCT01667978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25664270|NCT01667978|Antiviral Agents|antiviral agents|mesh-ancestor
24836624|NCT02186600|Antacids|antacids|mesh-ancestor
24937400|NCT04029467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25853044|NCT00058461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25853045|NCT00058461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24937410|NCT04029090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937411|NCT04029090|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24937412|NCT04029090|Protective Agents|protective agents|mesh-ancestor
24937413|NCT04029090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937415|NCT04029272|Exenatide|exenatide|mesh-list
24937416|NCT04029272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24937417|NCT04029272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937418|NCT04029272|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24851002|NCT02254889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937419|NCT04029272|Incretins|incretins|mesh-ancestor
24937421|NCT04029272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24937422|NCT04028778|Gefitinib|gefitinib|mesh-list
24937423|NCT04028778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24937424|NCT04028778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24937425|NCT04028778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851025|NCT02254980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851026|NCT02254980|Protective Agents|protective agents|mesh-ancestor
24851027|NCT02255006|Glyburide|glyburide|mesh-list
24851028|NCT02255006|Celecoxib|celecoxib|mesh-list
25853046|NCT00058461|Alkylating Agents|alkylating agents|mesh-ancestor
25853047|NCT00058474|Fluorouracil|fluorouracil|mesh-list
24937465|NCT04028869|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
24937466|NCT04028869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24937478|NCT04028622|Anesthetics|anesthetics|mesh-list
24937479|NCT04028622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24937480|NCT04028622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937481|NCT04028596|Acetaminophen|acetaminophen|mesh-list
24937482|NCT04028596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24937483|NCT04028596|Analgesics|analgesics|mesh-ancestor
24937484|NCT04028596|Sensory System Agents|sensory system agents|mesh-ancestor
24937485|NCT04028596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851036|NCT02255006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24851037|NCT02255006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24851038|NCT02255006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24851039|NCT02255006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851040|NCT02255006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851041|NCT02255006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24851042|NCT02255045|Diclofenac|diclofenac|mesh-list
24851043|NCT02255045|Meloxicam|meloxicam|mesh-list
25202782|NCT02718976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25853048|NCT00058474|Capecitabine|capecitabine|mesh-list
25853049|NCT00058474|Oxaliplatin|oxaliplatin|mesh-list
25853050|NCT00058474|Antimetabolites|antimetabolites|mesh-ancestor
25853051|NCT00058474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853052|NCT00058474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25853053|NCT00058474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853054|NCT00058474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25853055|NCT00058474|Immunologic Factors|immunologic factors|mesh-ancestor
25853056|NCT00058474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853057|NCT00058487|Thalidomide|thalidomide|mesh-list
24937486|NCT04028596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937487|NCT04028596|Antipyretics|antipyretics|mesh-ancestor
24937488|NCT04028505|Terlipressin|terlipressin|mesh-list
24937489|NCT04028505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24937490|NCT04028505|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24937491|NCT04028518|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24937492|NCT04028518|Plasminogen|plasminogen|mesh-list
24937493|NCT04028518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24937494|NCT04028518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24851045|NCT02255045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25853058|NCT00058487|Epirubicin|epirubicin|mesh-list
25853059|NCT00058487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25853060|NCT00058487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853061|NCT00058487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24534184|NCT00646321|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25853062|NCT00058487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25853063|NCT00058487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853064|NCT00058487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853065|NCT00058487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25853066|NCT00058487|Immunologic Factors|immunologic factors|mesh-ancestor
24937495|NCT04028518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937497|NCT04028323|Terlipressin|terlipressin|mesh-list
25853067|NCT00058487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937498|NCT04028323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24937499|NCT04028323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24937500|NCT04028323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24937501|NCT04028323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24937502|NCT04028323|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24937503|NCT04028466|Omeprazole|omeprazole|mesh-list
24937504|NCT04028466|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24937505|NCT04028466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24937506|NCT04028466|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24937507|NCT04028466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24937508|NCT04028466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937509|NCT04028141|Ketamine|ketamine|mesh-list
24851049|NCT02255045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851050|NCT02255045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24851051|NCT02255045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24851052|NCT02255045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24851053|NCT02255045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851054|NCT02255045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851055|NCT02255045|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24851056|NCT02255084|Menthol|menthol|mesh-list
24851069|NCT02255162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851070|NCT02255162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25853068|NCT00058487|Leprostatic Agents|leprostatic agents|mesh-ancestor
25853069|NCT00058487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25853070|NCT00058487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25853071|NCT00058487|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25853072|NCT00058487|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25853073|NCT00058487|Growth Substances|growth substances|mesh-ancestor
25853074|NCT00058487|Growth Inhibitors|growth inhibitors|mesh-ancestor
25853075|NCT00058578|Cyclophosphamide|cyclophosphamide|mesh-list
25853076|NCT00058578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25853077|NCT00058578|Immunologic Factors|immunologic factors|mesh-ancestor
25853078|NCT00058578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853079|NCT00058578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25853080|NCT00058578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25853081|NCT00058578|Alkylating Agents|alkylating agents|mesh-ancestor
25853082|NCT00058578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853083|NCT00058578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853084|NCT00058578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25853085|NCT00058682|Anidulafungin|anidulafungin|mesh-list
25853086|NCT00058682|Antifungal Agents|antifungal agents|mesh-ancestor
24648072|NCT01212250|Carvedilol|carvedilol|mesh-list
25853087|NCT00058682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25853088|NCT00058747|Imatinib Mesylate|imatinib mesylate|mesh-list
25853089|NCT00058747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853090|NCT00058747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25853091|NCT00058747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24937559|NCT04027764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937560|NCT04027751|Tropisetron|tropisetron|mesh-list
24937561|NCT04027751|Antiemetics|antiemetics|mesh-ancestor
24937562|NCT04027751|Autonomic Agents|autonomic agents|mesh-ancestor
25853092|NCT00058747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853093|NCT00058890|Gabapentin|gabapentin|mesh-list
25853094|NCT00058890|Analgesics|analgesics|mesh-ancestor
25853095|NCT00058890|Sensory System Agents|sensory system agents|mesh-ancestor
25853096|NCT00058890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25853097|NCT00058890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853098|NCT00058890|Anticonvulsants|anticonvulsants|mesh-ancestor
25853099|NCT00058890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25853100|NCT00058890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25853101|NCT00058890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25853102|NCT00058890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25853103|NCT00058890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25853104|NCT00058890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25853105|NCT00058890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25853106|NCT00058890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853107|NCT00058890|Antimanic Agents|antimanic agents|mesh-ancestor
25853108|NCT00058903|Sertraline|sertraline|mesh-list
25853109|NCT00058903|Antidepressive Agents|antidepressive agents|mesh-ancestor
25853110|NCT00058903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25853111|NCT00058903|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25853112|NCT00058903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25202783|NCT02718976|Autonomic Agents|autonomic agents|mesh-ancestor
25664271|NCT01667978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25853113|NCT00058903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25853114|NCT00058903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853115|NCT00058903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24937576|NCT04028024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050308|NCT00522834|Paclitaxel|paclitaxel|mesh-list
25050309|NCT00522834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25050310|NCT00522834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050311|NCT00522834|Tubulin Modulators|tubulin modulators|mesh-ancestor
25050312|NCT00522834|Antimitotic Agents|antimitotic agents|mesh-ancestor
25050313|NCT00522834|Mitosis Modulators|mitosis modulators|mesh-ancestor
25050314|NCT00522834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050315|NCT00520923|Olanzapine|olanzapine|mesh-list
25050316|NCT00520923|Antiemetics|antiemetics|mesh-ancestor
25050317|NCT00520923|Autonomic Agents|autonomic agents|mesh-ancestor
25050318|NCT00520923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937577|NCT04027959|Vitamin B 12|vitamin b 12|mesh-list
24937578|NCT04027959|Hydroxocobalamin|hydroxocobalamin|mesh-list
24937579|NCT04027959|Vitamins|vitamins|mesh-ancestor
24937580|NCT04027959|Micronutrients|micronutrients|mesh-ancestor
24937581|NCT04027959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851131|NCT02255591|Anesthetics, Local|anesthetics, local|mesh-ancestor
24851132|NCT02255591|Anesthetics|anesthetics|mesh-ancestor
24851133|NCT02255591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25853116|NCT00058903|Serotonin Agents|serotonin agents|mesh-ancestor
24937592|NCT04027192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24937593|NCT04027192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24937594|NCT04027192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24937595|NCT04027192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937596|NCT04027192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24937597|NCT04027192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24937598|NCT04027192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24937599|NCT04027192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24937600|NCT04027192|Anesthetics, General|anesthetics, general|mesh-ancestor
24937601|NCT04027192|Anesthetics|anesthetics|mesh-ancestor
24937602|NCT04027192|GABA Modulators|gaba modulators|mesh-ancestor
24937603|NCT04027192|GABA Agents|gaba agents|mesh-ancestor
24937604|NCT04027192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24937605|NCT04027192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851148|NCT02255591|Autonomic Agents|autonomic agents|mesh-ancestor
24851149|NCT02255591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24851150|NCT02255591|Respiratory System Agents|respiratory system agents|mesh-ancestor
24851151|NCT02255591|Mydriatics|mydriatics|mesh-ancestor
25853117|NCT00058903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853118|NCT00058929|Treprostinil|treprostinil|mesh-list
24725995|NCT01601093|Sulbactam|sulbactam|mesh-list
25853119|NCT00058929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25853120|NCT00058955|Sodium Oxybate|sodium oxybate|mesh-list
25853121|NCT00058955|Triazolam|triazolam|mesh-list
25853122|NCT00058955|Pentobarbital|pentobarbital|mesh-list
25853123|NCT00058955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25853124|NCT00058955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25853125|NCT00058955|Anesthetics, General|anesthetics, general|mesh-ancestor
25853126|NCT00058955|Anesthetics|anesthetics|mesh-ancestor
25853127|NCT00058955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25853128|NCT00058955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937612|NCT04027166|Methadone|methadone|mesh-list
24937613|NCT04027166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24937614|NCT04027166|Narcotics|narcotics|mesh-ancestor
24937615|NCT04027166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24937616|NCT04027166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937617|NCT04027166|Analgesics|analgesics|mesh-ancestor
24937618|NCT04027166|Sensory System Agents|sensory system agents|mesh-ancestor
24937619|NCT04027166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937620|NCT04027166|Antitussive Agents|antitussive agents|mesh-ancestor
24937621|NCT04027166|Respiratory System Agents|respiratory system agents|mesh-ancestor
24534225|NCT00646529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24534226|NCT00646529|Autonomic Agents|autonomic agents|mesh-ancestor
24534227|NCT00646529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24534228|NCT00646529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534229|NCT00646529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24534230|NCT00646529|Respiratory System Agents|respiratory system agents|mesh-ancestor
25853129|NCT00058955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25853130|NCT00058955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25853131|NCT00058955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25853132|NCT00058955|GABA Modulators|gaba modulators|mesh-ancestor
25853133|NCT00058955|GABA Agents|gaba agents|mesh-ancestor
25424551|NCT02248597|Busulfan|busulfan|mesh-list
25853134|NCT00058955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24851185|NCT02255812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851187|NCT02255942|Iron|iron|mesh-list
24851188|NCT02255942|Zinc Sulfate|zinc sulfate|mesh-list
24851189|NCT02255942|Zinc Oxide|zinc oxide|mesh-list
24851190|NCT02255942|Trace Elements|trace elements|mesh-ancestor
24851191|NCT02255942|Micronutrients|micronutrients|mesh-ancestor
24851192|NCT02255942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851193|NCT02255942|Astringents|astringents|mesh-ancestor
24851194|NCT02255942|Dermatologic Agents|dermatologic agents|mesh-ancestor
24851195|NCT02255942|Sunscreening Agents|sunscreening agents|mesh-ancestor
24851196|NCT02255942|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24851197|NCT02255942|Protective Agents|protective agents|mesh-ancestor
24851198|NCT02255955|Acetaminophen|acetaminophen|mesh-list
24851199|NCT02255955|Naproxen|naproxen|mesh-list
25853135|NCT00058955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853136|NCT00058955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24851204|NCT02255955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851205|NCT02255955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851206|NCT02255955|Antipyretics|antipyretics|mesh-ancestor
24851207|NCT02255955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25853137|NCT00058968|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25853138|NCT00058968|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25853139|NCT00058968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24937655|NCT04026685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937657|NCT04026451|Propofol|propofol|mesh-list
24937658|NCT04026451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24937659|NCT04026451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24937660|NCT04026451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937661|NCT04026451|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24937662|NCT04026451|Anesthetics, General|anesthetics, general|mesh-ancestor
24851208|NCT02255955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24851209|NCT02255955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24851210|NCT02255955|Gout Suppressants|gout suppressants|mesh-ancestor
24851211|NCT02255955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24851212|NCT02255955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851214|NCT02255955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24812201|NCT02050178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853140|NCT00058968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25853141|NCT00058968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853142|NCT00058968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24937681|NCT04026074|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24937682|NCT04026074|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24937683|NCT04026074|Narcotics|narcotics|mesh-ancestor
24937684|NCT04026074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24937687|NCT04026074|Sensory System Agents|sensory system agents|mesh-ancestor
24812203|NCT02050360|Vasodilator Agents|vasodilator agents|mesh-ancestor
24812204|NCT02050360|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24812205|NCT02050360|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24726114|NCT01601912|Dexetimide|dexetimide|mesh-list
24812206|NCT02050360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812207|NCT02050360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812208|NCT02050360|Urological Agents|urological agents|mesh-ancestor
24456933|NCT00332761|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24851219|NCT02256033|Istradefylline|istradefylline|mesh-list
24851220|NCT02256033|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
24851221|NCT02256033|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24851222|NCT02256033|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24851223|NCT02256033|Purinergic Agents|purinergic agents|mesh-ancestor
24851224|NCT02256033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24937696|NCT04026074|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24937697|NCT04026074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24937698|NCT04026074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24937699|NCT04026074|Adrenergic Agents|adrenergic agents|mesh-ancestor
24937700|NCT04026074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24937701|NCT04026074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937702|NCT04026074|Anesthetics, Local|anesthetics, local|mesh-ancestor
24937703|NCT04026074|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24937704|NCT04026022|Fentanyl|fentanyl|mesh-list
24937705|NCT04026022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24937706|NCT04026022|Narcotics|narcotics|mesh-ancestor
24937707|NCT04026022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24937708|NCT04026022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937709|NCT04026022|Analgesics|analgesics|mesh-ancestor
24937710|NCT04026022|Sensory System Agents|sensory system agents|mesh-ancestor
24836753|NCT02187276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24937711|NCT04026022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937712|NCT04026022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24937713|NCT04026022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24937714|NCT04026022|Anesthetics, General|anesthetics, general|mesh-ancestor
25853143|NCT00058968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853144|NCT00058968|Analgesics|analgesics|mesh-ancestor
25853145|NCT00058968|Sensory System Agents|sensory system agents|mesh-ancestor
25853146|NCT00058968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25853147|NCT00058968|Antidepressive Agents|antidepressive agents|mesh-ancestor
25853148|NCT00058968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25853149|NCT00058968|Dopamine Agents|dopamine agents|mesh-ancestor
24851254|NCT02256150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851256|NCT02256150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24851257|NCT02256150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24851258|NCT02256150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24851259|NCT02256150|Antimalarials|antimalarials|mesh-ancestor
24851260|NCT02256150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24650238|NCT01224756|Tinoridine|tinoridine|mesh-list
25853150|NCT00058994|Anecortave|anecortave|mesh-list
25853151|NCT00058994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25853152|NCT00058994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25853153|NCT00058994|Growth Substances|growth substances|mesh-ancestor
25853154|NCT00058994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853155|NCT00058994|Growth Inhibitors|growth inhibitors|mesh-ancestor
25853156|NCT00058994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853157|NCT00059254|Palmitic Acid|palmitic acid|mesh-list
25853158|NCT00059254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853159|NCT00059254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853160|NCT00059267|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25853161|NCT00059267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25853162|NCT00059267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25232087|NCT02584751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25853163|NCT00059267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853164|NCT00059267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853165|NCT00059267|Antiviral Agents|antiviral agents|mesh-ancestor
25853166|NCT00059267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25853167|NCT00059306|Aspirin|aspirin|mesh-list
25853168|NCT00059306|Clopidogrel|clopidogrel|mesh-list
25853169|NCT00059306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24726235|NCT01602406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853170|NCT00059306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25853171|NCT00059306|Analgesics|analgesics|mesh-ancestor
25853172|NCT00059306|Sensory System Agents|sensory system agents|mesh-ancestor
24937745|NCT04025840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937746|NCT04025840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24534291|NCT00646620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24937797|NCT04025593|Hormones|hormones|mesh-ancestor
24937798|NCT04025593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24937799|NCT04025593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24937800|NCT04025593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24937801|NCT04025593|Tubulin Modulators|tubulin modulators|mesh-ancestor
24937802|NCT04025593|Antimitotic Agents|antimitotic agents|mesh-ancestor
25853173|NCT00059306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25853174|NCT00059306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853175|NCT00059306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24937803|NCT04025593|Mitosis Modulators|mitosis modulators|mesh-ancestor
24937804|NCT04025593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24937805|NCT04025593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24937806|NCT04025593|Growth Substances|growth substances|mesh-ancestor
24937807|NCT04025593|Growth Inhibitors|growth inhibitors|mesh-ancestor
24937808|NCT04025593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24937809|NCT04025593|Antimetabolites|antimetabolites|mesh-ancestor
24937811|NCT04025203|Ibuprofen arginine|ibuprofen arginine|mesh-list
24937812|NCT04025203|Gabapentin|gabapentin|mesh-list
24851338|NCT02256683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24851339|NCT02256683|Protease Inhibitors|protease inhibitors|mesh-ancestor
24851340|NCT02256683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851341|NCT02256683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853176|NCT00059306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25853177|NCT00059306|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25853178|NCT00059306|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25853179|NCT00059306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853180|NCT00059306|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25853183|NCT00059306|Antipyretics|antipyretics|mesh-ancestor
25853184|NCT00059306|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24937814|NCT04025203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24937815|NCT04025203|Analgesics|analgesics|mesh-ancestor
24937816|NCT04025203|Sensory System Agents|sensory system agents|mesh-ancestor
24937817|NCT04025203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24762612|NCT01768884|Vasodilator Agents|vasodilator agents|mesh-ancestor
24762613|NCT01768884|Gasotransmitters|gasotransmitters|mesh-ancestor
25853185|NCT00059306|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25853186|NCT00059306|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25853187|NCT00059306|Purinergic Agents|purinergic agents|mesh-ancestor
25853188|NCT00059306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25853189|NCT00059358|Interferons|interferons|mesh-list
25853191|NCT00059358|Interferon-alpha|interferon-alpha|mesh-list
25853192|NCT00059358|Interferon alpha-2|interferon alpha-2|mesh-list
25853193|NCT00059358|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25853194|NCT00059358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853195|NCT00059358|Antiviral Agents|antiviral agents|mesh-ancestor
25853196|NCT00059358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25853197|NCT00059358|Antimetabolites|antimetabolites|mesh-ancestor
25853198|NCT00059358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853199|NCT00059358|Immunologic Factors|immunologic factors|mesh-ancestor
25853200|NCT00059358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232095|NCT02584751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25232096|NCT02584751|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25232097|NCT02584751|Vasodilator Agents|vasodilator agents|mesh-ancestor
25232098|NCT02584751|Gasotransmitters|gasotransmitters|mesh-ancestor
25876210|NCT03809429|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25876211|NCT03809429|Hormones|hormones|mesh-ancestor
25876212|NCT03809429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25876213|NCT03809429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534331|NCT00646711|GABA Agents|gaba agents|mesh-ancestor
24534332|NCT00646711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24534333|NCT00646711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534334|NCT00646711|Antimanic Agents|antimanic agents|mesh-ancestor
24534335|NCT00646711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24625567|NCT01082458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625568|NCT01082458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24625569|NCT01082458|Narcotics|narcotics|mesh-ancestor
24625570|NCT01082458|Analgesics|analgesics|mesh-ancestor
24625571|NCT01082471|Morphine|morphine|mesh-list
24625572|NCT01082471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24625573|NCT01082471|Narcotics|narcotics|mesh-ancestor
24625574|NCT01082471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24851373|NCT02256735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24534336|NCT00646711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24534337|NCT00646711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24726342|NCT01602900|Antidepressive Agents|antidepressive agents|mesh-ancestor
25876214|NCT03809429|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25876215|NCT03809429|Fertility Agents|fertility agents|mesh-ancestor
25876216|NCT03809429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25876217|NCT03809429|Hormone Antagonists|hormone antagonists|mesh-ancestor
25876218|NCT03808610|Cytarabine|cytarabine|mesh-list
25876219|NCT03808610|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
25876220|NCT03808610|Dexamethasone|dexamethasone|mesh-list
25876221|NCT03808610|Dexamethasone acetate|dexamethasone acetate|mesh-list
25876222|NCT03808610|Prednisone|prednisone|mesh-list
25876223|NCT03808610|Cortisone|cortisone|mesh-list
24625575|NCT01082471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625576|NCT01082471|Analgesics|analgesics|mesh-ancestor
24625577|NCT01082471|Sensory System Agents|sensory system agents|mesh-ancestor
24637499|NCT01150786|Selenium|selenium|mesh-list
24625578|NCT01082471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24625579|NCT01082484|Treprostinil|treprostinil|mesh-list
24625580|NCT01082484|Iloprost|iloprost|mesh-list
24625581|NCT01082484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24625582|NCT01082484|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24625583|NCT01082484|Vasodilator Agents|vasodilator agents|mesh-ancestor
24625584|NCT01082510|Tegafur|tegafur|mesh-list
24625585|NCT01082510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24625586|NCT01082510|Antimetabolites|antimetabolites|mesh-ancestor
25876224|NCT03808610|Cyclophosphamide|cyclophosphamide|mesh-list
25876225|NCT03808610|Rituximab|rituximab|mesh-list
25664272|NCT01667978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25876226|NCT03808610|Methotrexate|methotrexate|mesh-list
24625587|NCT01082510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876227|NCT03808610|Vincristine|vincristine|mesh-list
24836857|NCT02187614|Antipyretics|antipyretics|mesh-ancestor
24625588|NCT01082510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24625590|NCT01082627|Hormones|hormones|mesh-ancestor
24937853|NCT04024683|Ropivacaine|ropivacaine|mesh-list
24937854|NCT04024683|Anesthetics, Local|anesthetics, local|mesh-ancestor
24937855|NCT04024683|Anesthetics|anesthetics|mesh-ancestor
24937856|NCT04024683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24937857|NCT04024683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851390|NCT02256748|Midazolam|midazolam|mesh-list
25853201|NCT00059462|Interleukin-2|interleukin-2|mesh-list
25853202|NCT00059462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853203|NCT00059462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25853204|NCT00059462|Analgesics|analgesics|mesh-ancestor
25853205|NCT00059462|Sensory System Agents|sensory system agents|mesh-ancestor
25853206|NCT00059462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25853207|NCT00059462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853208|NCT00059592|Valacyclovir|valacyclovir|mesh-list
24937858|NCT04024683|Sensory System Agents|sensory system agents|mesh-ancestor
25050319|NCT00520923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937859|NCT04024683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25853209|NCT00059592|Antiviral Agents|antiviral agents|mesh-ancestor
24534397|NCT00646854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24534398|NCT00646854|Tubulin Modulators|tubulin modulators|mesh-ancestor
24534399|NCT00646854|Antimitotic Agents|antimitotic agents|mesh-ancestor
24534400|NCT00646854|Mitosis Modulators|mitosis modulators|mesh-ancestor
24534401|NCT00646880|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24534403|NCT00646880|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24534404|NCT00646880|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25853210|NCT00059592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25853211|NCT00059618|Carboplatin|carboplatin|mesh-list
25853212|NCT00059618|Bortezomib|bortezomib|mesh-list
25853213|NCT00059618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853214|NCT00059631|Bortezomib|bortezomib|mesh-list
25853215|NCT00059631|Mitoxantrone|mitoxantrone|mesh-list
25853216|NCT00059631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853217|NCT00059631|Analgesics|analgesics|mesh-ancestor
25853218|NCT00059631|Sensory System Agents|sensory system agents|mesh-ancestor
24534411|NCT00646880|Autonomic Agents|autonomic agents|mesh-ancestor
24534412|NCT00646880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24534413|NCT00646932|Ergocalciferols|ergocalciferols|mesh-list
25853219|NCT00059631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24534417|NCT00646932|Micronutrients|micronutrients|mesh-ancestor
24534418|NCT00646932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24534420|NCT00646945|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24450965|NCT00321178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450966|NCT00321178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450967|NCT00321178|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24450968|NCT00321178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24450969|NCT00321191|Nitrous Oxide|nitrous oxide|mesh-list
24450970|NCT00321191|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24450971|NCT00321191|Anesthetics, General|anesthetics, general|mesh-ancestor
24450972|NCT00321191|Anesthetics|anesthetics|mesh-ancestor
24726431|NCT01603186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24450973|NCT00321191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24450974|NCT00321191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450975|NCT00321191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24450976|NCT00321191|Analgesics|analgesics|mesh-ancestor
24450977|NCT00321191|Sensory System Agents|sensory system agents|mesh-ancestor
24450978|NCT00321191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24451019|NCT00321490|Antidepressive Agents|antidepressive agents|mesh-ancestor
24451020|NCT00321490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24937860|NCT04024800|Pembrolizumab|pembrolizumab|mesh-list
24937861|NCT04024800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24937862|NCT04024800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779907|NCT01879527|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24779908|NCT01879527|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24534464|NCT00647127|Buprenorphine|buprenorphine|mesh-list
24534465|NCT00647127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24534467|NCT00647127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24534468|NCT00647127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534469|NCT00647127|Analgesics|analgesics|mesh-ancestor
24534470|NCT00647127|Sensory System Agents|sensory system agents|mesh-ancestor
24534471|NCT00647127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24534472|NCT00647127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25853220|NCT00059631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876228|NCT03808610|Asparaginase|asparaginase|mesh-list
25664273|NCT01667978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25853223|NCT00059631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853224|NCT00059631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853225|NCT00059722|Gefitinib|gefitinib|mesh-list
25853226|NCT00059722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853227|NCT00059722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24534614|NCT00647686|Sensory System Agents|sensory system agents|mesh-ancestor
24534615|NCT00647686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24534616|NCT00647686|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25853228|NCT00059722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853229|NCT00059722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853230|NCT00059735|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
25853231|NCT00059735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853232|NCT00059735|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25853233|NCT00059735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853234|NCT00059735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853235|NCT00059761|Cisplatin|cisplatin|mesh-list
25853236|NCT00059761|Irinotecan|irinotecan|mesh-list
24726529|NCT01603758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25853237|NCT00059761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853238|NCT00059761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25853239|NCT00059761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25853240|NCT00059761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853241|NCT00059761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853242|NCT00059800|Boron|boron|mesh-list
25853243|NCT00059800|Trace Elements|trace elements|mesh-ancestor
24553522|NCT00731601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24553523|NCT00731601|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24937909|NCT04024241|Antimetabolites|antimetabolites|mesh-ancestor
24937910|NCT04024241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937911|NCT04024241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24553524|NCT00731601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24937912|NCT04024241|Antiviral Agents|antiviral agents|mesh-ancestor
25853244|NCT00059800|Micronutrients|micronutrients|mesh-ancestor
25853245|NCT00059800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853246|NCT00059813|Interferons|interferons|mesh-list
25853247|NCT00059813|Interferon-alpha|interferon-alpha|mesh-list
25853248|NCT00059813|Interferon alpha-2|interferon alpha-2|mesh-list
25853249|NCT00059813|Oblimersen|oblimersen|mesh-list
25853250|NCT00059813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24534751|NCT00647946|Antiviral Agents|antiviral agents|mesh-ancestor
24937922|NCT04024241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24937923|NCT04024163|Benzonidazole|benzonidazole|mesh-list
25853251|NCT00059813|Antiviral Agents|antiviral agents|mesh-ancestor
25853252|NCT00059813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25853253|NCT00059813|Immunologic Factors|immunologic factors|mesh-ancestor
25853254|NCT00059813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853255|NCT00059826|Interferons|interferons|mesh-list
25853256|NCT00059826|Interferon-alpha|interferon-alpha|mesh-list
24937948|NCT04023565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937949|NCT04023565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24451062|NCT00321633|Mitosis Modulators|mitosis modulators|mesh-ancestor
24451063|NCT00321633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853257|NCT00059826|Interferon alpha-2|interferon alpha-2|mesh-list
25853258|NCT00059826|Cisplatin|cisplatin|mesh-list
25853259|NCT00059826|Fluorouracil|fluorouracil|mesh-list
25853260|NCT00059826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24534787|NCT00647985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24534788|NCT00647985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534789|NCT00647985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534791|NCT00648011|Quinapril|quinapril|mesh-list
24534792|NCT00648011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24534793|NCT00648011|Diuretics|diuretics|mesh-ancestor
24534794|NCT00648011|Natriuretic Agents|natriuretic agents|mesh-ancestor
24534795|NCT00648011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534796|NCT00648011|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24534797|NCT00648011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25664274|NCT01667978|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25664275|NCT01667978|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25853261|NCT00059826|Antimetabolites|antimetabolites|mesh-ancestor
25853262|NCT00059826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876229|NCT03808610|Venetoclax|venetoclax|mesh-list
25853263|NCT00059826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25853264|NCT00059826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25853265|NCT00059826|Immunologic Factors|immunologic factors|mesh-ancestor
25853266|NCT00059826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853267|NCT00059826|Antiviral Agents|antiviral agents|mesh-ancestor
25853268|NCT00059826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25853269|NCT00059852|Gemcitabine|gemcitabine|mesh-list
25853270|NCT00059852|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25853271|NCT00059852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25853272|NCT00059852|Antimetabolites|antimetabolites|mesh-ancestor
25853273|NCT00059852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853274|NCT00059852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853275|NCT00059852|Antiviral Agents|antiviral agents|mesh-ancestor
25853276|NCT00059852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25853277|NCT00059852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853278|NCT00059852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25853279|NCT00059852|Immunologic Factors|immunologic factors|mesh-ancestor
25853280|NCT00059852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853281|NCT00059852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25853282|NCT00059865|Gemcitabine|gemcitabine|mesh-list
24534809|NCT00648050|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24534810|NCT00648050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24534811|NCT00648050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534812|NCT00648050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24534813|NCT00648050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534814|NCT00648050|Vasodilator Agents|vasodilator agents|mesh-ancestor
24937951|NCT04023617|Nivolumab|nivolumab|mesh-list
24937952|NCT04023617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24937953|NCT04023617|Tubulin Modulators|tubulin modulators|mesh-ancestor
24937954|NCT04023617|Antimitotic Agents|antimitotic agents|mesh-ancestor
24937955|NCT04023617|Mitosis Modulators|mitosis modulators|mesh-ancestor
24937958|NCT04023617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24937960|NCT04023630|Clopidogrel|clopidogrel|mesh-list
24937961|NCT04023630|Ticagrelor|ticagrelor|mesh-list
25853283|NCT00059865|Pemetrexed|pemetrexed|mesh-list
25853284|NCT00059865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25853285|NCT00059865|Antimetabolites|antimetabolites|mesh-ancestor
25853286|NCT00059865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853287|NCT00059865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853288|NCT00059865|Antiviral Agents|antiviral agents|mesh-ancestor
25853289|NCT00059865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25853290|NCT00059865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24726690|NCT01605279|Dobutamine|dobutamine|mesh-list
25853291|NCT00059865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25853292|NCT00059865|Immunologic Factors|immunologic factors|mesh-ancestor
25853293|NCT00059865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853294|NCT00059865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25853295|NCT00059865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25853296|NCT00059878|Interferons|interferons|mesh-list
25853297|NCT00059878|Interferon-gamma|interferon-gamma|mesh-list
25853298|NCT00059878|Voriconazole|voriconazole|mesh-list
25853299|NCT00059878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853300|NCT00059878|Antiviral Agents|antiviral agents|mesh-ancestor
25853301|NCT00059878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25853302|NCT00059878|Antifungal Agents|antifungal agents|mesh-ancestor
25853303|NCT00059878|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25853304|NCT00059878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24937965|NCT04023630|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24937966|NCT04023630|Purinergic Agents|purinergic agents|mesh-ancestor
24937967|NCT04023630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25853305|NCT00059878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853306|NCT00059878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853307|NCT00059878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25853308|NCT00059878|Hormone Antagonists|hormone antagonists|mesh-ancestor
25853309|NCT00059878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25853310|NCT00059878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853311|NCT00059878|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25853312|NCT00059904|Aldesleukin|aldesleukin|mesh-list
25853313|NCT00059904|Rituximab|rituximab|mesh-list
25853314|NCT00059904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25853315|NCT00059904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853316|NCT00059904|Immunologic Factors|immunologic factors|mesh-ancestor
24534823|NCT00648063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25853317|NCT00059904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534826|NCT00648076|Anticonvulsants|anticonvulsants|mesh-ancestor
24534827|NCT00648076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534828|NCT00648076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534830|NCT00648076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25853318|NCT00059904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25853319|NCT00059904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25853320|NCT00059904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25853321|NCT00059904|Antiviral Agents|antiviral agents|mesh-ancestor
25853322|NCT00059904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24726732|NCT01605344|Micronutrients|micronutrients|mesh-ancestor
25853323|NCT00059917|Camptothecin|camptothecin|mesh-list
25853324|NCT00059917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25853325|NCT00059917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853326|NCT00059917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24444301|NCT00297375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853327|NCT00059917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25853328|NCT00059917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853329|NCT00059917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853330|NCT00059943|Docetaxel|docetaxel|mesh-list
25853331|NCT00059943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853332|NCT00059943|Tubulin Modulators|tubulin modulators|mesh-ancestor
25853333|NCT00059943|Antimitotic Agents|antimitotic agents|mesh-ancestor
25853334|NCT00059943|Mitosis Modulators|mitosis modulators|mesh-ancestor
25853335|NCT00059943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853336|NCT00060112|Gemcitabine|gemcitabine|mesh-list
25853337|NCT00060112|Oblimersen|oblimersen|mesh-list
25853338|NCT00060112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25853339|NCT00060112|Antimetabolites|antimetabolites|mesh-ancestor
25853340|NCT00060112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853341|NCT00060112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24534835|NCT00648076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24534836|NCT00648128|Clarithromycin|clarithromycin|mesh-list
24534837|NCT00648128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24534838|NCT00648128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24534839|NCT00648128|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24534840|NCT00648128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534841|NCT00648128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812241|NCT02050802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25853342|NCT00060112|Antiviral Agents|antiviral agents|mesh-ancestor
24534856|NCT00648141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853343|NCT00060112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25853344|NCT00060112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853345|NCT00060112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25853346|NCT00060112|Immunologic Factors|immunologic factors|mesh-ancestor
25202784|NCT02718976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25202785|NCT02718976|Respiratory System Agents|respiratory system agents|mesh-ancestor
25853347|NCT00060112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853348|NCT00060125|Tipifarnib|tipifarnib|mesh-list
25853349|NCT00060125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853350|NCT00060138|Zoledronic Acid|zoledronic acid|mesh-list
25853351|NCT00060138|Antibodies|antibodies|mesh-list
25853352|NCT00060138|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25853353|NCT00060138|Immunologic Factors|immunologic factors|mesh-ancestor
25853354|NCT00060138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853355|NCT00060138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25853356|NCT00060242|Fosbretabulin|fosbretabulin|mesh-list
25853357|NCT00060242|Combretastatin|combretastatin|mesh-list
25853358|NCT00060242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25853359|NCT00060242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853360|NCT00060242|Tubulin Modulators|tubulin modulators|mesh-ancestor
25853361|NCT00060242|Antimitotic Agents|antimitotic agents|mesh-ancestor
25853362|NCT00060242|Mitosis Modulators|mitosis modulators|mesh-ancestor
25853363|NCT00060242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853364|NCT00060255|Cyclophosphamide|cyclophosphamide|mesh-list
25853365|NCT00060255|Melphalan|melphalan|mesh-list
25853366|NCT00060255|Busulfan|busulfan|mesh-list
25853367|NCT00060255|Thiotepa|thiotepa|mesh-list
25853368|NCT00060255|Carmustine|carmustine|mesh-list
25853369|NCT00060255|Carboplatin|carboplatin|mesh-list
25664276|NCT01667978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25664277|NCT01667978|Contraceptive Agents|contraceptive agents|mesh-ancestor
25424552|NCT02248597|Fludarabine|fludarabine|mesh-list
25664278|NCT01667978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25853370|NCT00060255|Etoposide|etoposide|mesh-list
25853371|NCT00060255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25853372|NCT00060255|Immunologic Factors|immunologic factors|mesh-ancestor
24938011|NCT04023292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938013|NCT04023292|Hormone Antagonists|hormone antagonists|mesh-ancestor
24938014|NCT04023292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24938015|NCT04023292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938016|NCT04023292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24938017|NCT04023292|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24938018|NCT04023292|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24938019|NCT04023292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24938020|NCT04023305|Sevoflurane|sevoflurane|mesh-list
24938021|NCT04023305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24938022|NCT04023305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24938023|NCT04023305|Anesthetics, General|anesthetics, general|mesh-ancestor
24938024|NCT04023305|Anesthetics|anesthetics|mesh-ancestor
24938025|NCT04023305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24938062|NCT04022941|Sodium Benzoate|sodium benzoate|mesh-list
24938063|NCT04022941|Antifungal Agents|antifungal agents|mesh-ancestor
24451102|NCT00322036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24451103|NCT00322036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24451104|NCT00322036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24451105|NCT00322036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24451106|NCT00322036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24451107|NCT00322036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25062349|NCT04923659|Analgesics|analgesics|mesh-ancestor
24451108|NCT00322036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451110|NCT00322062|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24451111|NCT00322062|Antioxidants|antioxidants|mesh-ancestor
24451112|NCT00322062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451113|NCT00322062|Protective Agents|protective agents|mesh-ancestor
24451114|NCT00322062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853373|NCT00060255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534943|NCT00648310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24534945|NCT00648310|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24534946|NCT00648310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24534947|NCT00648310|Cholinergic Agents|cholinergic agents|mesh-ancestor
24534948|NCT00648310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25853374|NCT00060255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25853375|NCT00060255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25853376|NCT00060255|Alkylating Agents|alkylating agents|mesh-ancestor
25853377|NCT00060255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853378|NCT00060255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853379|NCT00060255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25853380|NCT00060255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25853381|NCT00060255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25853382|NCT00060255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25853383|NCT00060255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853384|NCT00060294|Rituximab|rituximab|mesh-list
25853385|NCT00060294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25853386|NCT00060294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853387|NCT00060294|Immunologic Factors|immunologic factors|mesh-ancestor
25853388|NCT00060294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853389|NCT00060294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25853390|NCT00060307|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25853391|NCT00060307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853392|NCT00060307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25853393|NCT00060307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853394|NCT00060307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853395|NCT00060359|Paclitaxel|paclitaxel|mesh-list
25853396|NCT00060359|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25853397|NCT00060359|Carboplatin|carboplatin|mesh-list
25853398|NCT00060359|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
25853399|NCT00060359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25853400|NCT00060359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853401|NCT00060359|Tubulin Modulators|tubulin modulators|mesh-ancestor
25853402|NCT00060359|Antimitotic Agents|antimitotic agents|mesh-ancestor
25853403|NCT00060359|Mitosis Modulators|mitosis modulators|mesh-ancestor
25853404|NCT00060359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853405|NCT00060372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25853406|NCT00060372|Ipilimumab|ipilimumab|mesh-list
25853407|NCT00060372|Antibodies|antibodies|mesh-list
25853408|NCT00060372|Immunoglobulins|immunoglobulins|mesh-list
25853409|NCT00060372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25853410|NCT00060372|Immunologic Factors|immunologic factors|mesh-ancestor
25853411|NCT00060372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853412|NCT00060372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853413|NCT00060372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25853414|NCT00060372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853416|NCT00060385|Cyclophosphamide|cyclophosphamide|mesh-list
25853417|NCT00060385|Doxorubicin|doxorubicin|mesh-list
25853418|NCT00060385|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25853419|NCT00060385|Etoposide|etoposide|mesh-list
25853420|NCT00060385|Vincristine|vincristine|mesh-list
25853421|NCT00060385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25853422|NCT00060385|Immunologic Factors|immunologic factors|mesh-ancestor
24534989|NCT00648388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24534990|NCT00648388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24534991|NCT00648388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534992|NCT00648388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24534993|NCT00648388|Vasodilator Agents|vasodilator agents|mesh-ancestor
25853423|NCT00060385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853424|NCT00060385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25853425|NCT00060385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25853426|NCT00060385|Alkylating Agents|alkylating agents|mesh-ancestor
25853427|NCT00060385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853428|NCT00060385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853429|NCT00060385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25853430|NCT00060385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25853431|NCT00060385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25853432|NCT00060385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25853433|NCT00060385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853434|NCT00060385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25853435|NCT00060385|Glucocorticoids|glucocorticoids|mesh-ancestor
25853436|NCT00060385|Hormones|hormones|mesh-ancestor
25853437|NCT00060385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25853438|NCT00060385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25853439|NCT00060385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25853440|NCT00060385|Tubulin Modulators|tubulin modulators|mesh-ancestor
25853441|NCT00060385|Antimitotic Agents|antimitotic agents|mesh-ancestor
25853442|NCT00060385|Mitosis Modulators|mitosis modulators|mesh-ancestor
25853443|NCT00060398|Dexamethasone|dexamethasone|mesh-list
25853444|NCT00060398|Epoetin Alfa|epoetin alfa|mesh-list
25853445|NCT00060398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25853446|NCT00060398|Antiemetics|antiemetics|mesh-ancestor
25853447|NCT00060398|Autonomic Agents|autonomic agents|mesh-ancestor
25853448|NCT00060398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25853449|NCT00060398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853450|NCT00060398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25853451|NCT00060398|Glucocorticoids|glucocorticoids|mesh-ancestor
25853452|NCT00060398|Hormones|hormones|mesh-ancestor
24938099|NCT04022161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24938100|NCT04022161|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24938101|NCT04022161|Vasodilator Agents|vasodilator agents|mesh-ancestor
24727031|NCT01607762|Olanzapine|olanzapine|mesh-list
24938102|NCT04022161|Gasotransmitters|gasotransmitters|mesh-ancestor
24938103|NCT04022161|Protective Agents|protective agents|mesh-ancestor
24938104|NCT04022421|Hydroxychloroquine|hydroxychloroquine|mesh-list
24938105|NCT04022421|Antimalarials|antimalarials|mesh-ancestor
24954312|NCT03877679|Curcumin|curcumin|mesh-list
24938106|NCT04022421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24938107|NCT04022421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24938108|NCT04022421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24938109|NCT04022421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24938110|NCT04022421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938111|NCT04022421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24938112|NCT04022096|Lansoprazole|lansoprazole|mesh-list
24938113|NCT04022096|Dexlansoprazole|dexlansoprazole|mesh-list
24938114|NCT04022096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24938115|NCT04022096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24938116|NCT04022096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24938117|NCT04022096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24938118|NCT04022096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938120|NCT04022291|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24851534|NCT02257008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851535|NCT02257008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853453|NCT00060398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25853454|NCT00060398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25853455|NCT00060398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853456|NCT00060398|Hematinics|hematinics|mesh-ancestor
24831488|NCT02165917|Protective Agents|protective agents|mesh-ancestor
24938142|NCT04021992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25853457|NCT00060411|Leucovorin|leucovorin|mesh-list
25853458|NCT00060411|Bevacizumab|bevacizumab|mesh-list
25853459|NCT00060411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25853460|NCT00060411|Fluorouracil|fluorouracil|mesh-list
25853461|NCT00060411|Oxaliplatin|oxaliplatin|mesh-list
24727101|NCT01607996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24727102|NCT01607996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853462|NCT00060411|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25853463|NCT00060411|Antibodies|antibodies|mesh-list
25853464|NCT00060411|Immunoglobulins|immunoglobulins|mesh-list
25853465|NCT00060411|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25853466|NCT00060411|Levoleucovorin|levoleucovorin|mesh-list
25853467|NCT00060411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853468|NCT00060411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25853469|NCT00060411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25853470|NCT00060411|Growth Substances|growth substances|mesh-ancestor
25853471|NCT00060411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853472|NCT00060411|Growth Inhibitors|growth inhibitors|mesh-ancestor
25853473|NCT00060411|Immunologic Factors|immunologic factors|mesh-ancestor
25853474|NCT00060411|Antimetabolites|antimetabolites|mesh-ancestor
25853475|NCT00060411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853476|NCT00060411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25853477|NCT00060411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24938146|NCT04021992|Antiviral Agents|antiviral agents|mesh-ancestor
25853478|NCT00060411|Antidotes|antidotes|mesh-ancestor
24938147|NCT04021992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24938148|NCT04021992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24938149|NCT04021992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24938150|NCT04021992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24938151|NCT04021992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24938152|NCT04021992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24938153|NCT04021992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24938154|NCT04021992|Tubulin Modulators|tubulin modulators|mesh-ancestor
24938155|NCT04021992|Antimitotic Agents|antimitotic agents|mesh-ancestor
25853479|NCT00060411|Protective Agents|protective agents|mesh-ancestor
25853480|NCT00060411|Vitamin B Complex|vitamin b complex|mesh-ancestor
25853481|NCT00060411|Vitamins|vitamins|mesh-ancestor
24535086|NCT00648544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535087|NCT00648544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24535088|NCT00648544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24535089|NCT00648544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535090|NCT00648570|Dexetimide|dexetimide|mesh-list
24535092|NCT00648570|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25853482|NCT00060411|Micronutrients|micronutrients|mesh-ancestor
25853483|NCT00060411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25853484|NCT00060411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853485|NCT00060450|Nitric Oxide|nitric oxide|mesh-list
25853486|NCT00060450|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24535114|NCT00648583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535115|NCT00648583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24535116|NCT00648583|Antipruritics|antipruritics|mesh-ancestor
25853487|NCT00060450|Autonomic Agents|autonomic agents|mesh-ancestor
25853488|NCT00060450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25853489|NCT00060450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938156|NCT04021992|Mitosis Modulators|mitosis modulators|mesh-ancestor
24938157|NCT04022005|Gemcitabine|gemcitabine|mesh-list
24938158|NCT04022005|Rituximab|rituximab|mesh-list
25853490|NCT00060450|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25853491|NCT00060450|Respiratory System Agents|respiratory system agents|mesh-ancestor
25853492|NCT00060450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25853493|NCT00060450|Antioxidants|antioxidants|mesh-ancestor
25853494|NCT00060450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853495|NCT00060450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25853496|NCT00060450|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25853497|NCT00060450|Vasodilator Agents|vasodilator agents|mesh-ancestor
25853498|NCT00060450|Gasotransmitters|gasotransmitters|mesh-ancestor
24727214|NCT01608464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24727215|NCT01608464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24727216|NCT01608464|Immunologic Factors|immunologic factors|mesh-ancestor
24727217|NCT01608464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727218|NCT01608464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24727220|NCT01608464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853499|NCT00060450|Protective Agents|protective agents|mesh-ancestor
25853500|NCT00060463|Contraceptive Agents|contraceptive agents|mesh-list
25853501|NCT00060463|Contraceptives, Postcoital|contraceptives, postcoital|mesh-list
25853502|NCT00060463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25853503|NCT00060463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938176|NCT04021498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938178|NCT04021498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25050327|NCT00520923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24938179|NCT04021498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24938181|NCT04021433|Analgesics|analgesics|mesh-ancestor
24938182|NCT04021433|Sensory System Agents|sensory system agents|mesh-ancestor
24938183|NCT04021433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24938184|NCT04021433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938185|NCT04021433|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24938186|NCT04021433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24938187|NCT04021433|Anesthetics, General|anesthetics, general|mesh-ancestor
24938188|NCT04021433|Anesthetics|anesthetics|mesh-ancestor
24938189|NCT04021433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24938190|NCT04021433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24938191|NCT04021433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24938208|NCT04021017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535198|NCT00648778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24535199|NCT00648778|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24535200|NCT00648778|Dopamine Agents|dopamine agents|mesh-ancestor
24535202|NCT00648778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535204|NCT00648791|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24535205|NCT00648791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24535206|NCT00648791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535207|NCT00648791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535208|NCT00648791|Hormone Antagonists|hormone antagonists|mesh-ancestor
24535211|NCT00648791|Urological Agents|urological agents|mesh-ancestor
24535212|NCT00648804|Ondansetron|ondansetron|mesh-list
24535213|NCT00648804|Antiemetics|antiemetics|mesh-ancestor
24535214|NCT00648804|Autonomic Agents|autonomic agents|mesh-ancestor
24535215|NCT00648804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24535216|NCT00648804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535217|NCT00648804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24535218|NCT00648804|Antipruritics|antipruritics|mesh-ancestor
24535219|NCT00648804|Dermatologic Agents|dermatologic agents|mesh-ancestor
24535220|NCT00648804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24535223|NCT00648804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535226|NCT00648804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24535227|NCT00648804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24535228|NCT00648804|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24535230|NCT00648817|Antiviral Agents|antiviral agents|mesh-ancestor
24535240|NCT00648830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24535241|NCT00648830|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24535242|NCT00648830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24831757|NCT02168634|Cholinergic Agents|cholinergic agents|mesh-ancestor
25853504|NCT00060463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24851647|NCT02257697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851649|NCT02257697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24851650|NCT02257697|Alkylating Agents|alkylating agents|mesh-ancestor
24851651|NCT02257697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851656|NCT02257697|Analgesics|analgesics|mesh-ancestor
25853506|NCT00060476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25202786|NCT02718976|Mydriatics|mydriatics|mesh-ancestor
25853507|NCT00060476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25853508|NCT00060476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24938266|NCT04020588|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24938267|NCT04020588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24938268|NCT04020588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853509|NCT00060476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853510|NCT00060476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24616378|NCT01036841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727292|NCT01608984|Analgesics|analgesics|mesh-ancestor
24727293|NCT01608984|Sensory System Agents|sensory system agents|mesh-ancestor
24727294|NCT01608984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24727295|NCT01608984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24727296|NCT01608984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25853511|NCT00060476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25853513|NCT00060476|Sensory System Agents|sensory system agents|mesh-ancestor
24535288|NCT00648934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24535289|NCT00648934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535290|NCT00648947|Clopidogrel|clopidogrel|mesh-list
24535291|NCT00648947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24535292|NCT00648947|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24535293|NCT00648947|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24535294|NCT00648947|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24535295|NCT00648947|Purinergic Agents|purinergic agents|mesh-ancestor
25853514|NCT00060476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25853515|NCT00060476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853516|NCT00060476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25853517|NCT00060476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25853518|NCT00060489|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25853519|NCT00060489|Antidepressive Agents|antidepressive agents|mesh-ancestor
25853520|NCT00060489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25853521|NCT00060489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25853522|NCT00060489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25853523|NCT00060489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25853524|NCT00060489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853525|NCT00060502|Gemcitabine|gemcitabine|mesh-list
24535304|NCT00648960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535305|NCT00648960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24535306|NCT00648960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24535309|NCT00648973|Pseudoephedrine|pseudoephedrine|mesh-list
24535310|NCT00648973|Ephedrine|ephedrine|mesh-list
25853526|NCT00060502|Infliximab|infliximab|mesh-list
25853527|NCT00060502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25853528|NCT00060502|Antimetabolites|antimetabolites|mesh-ancestor
25853529|NCT00060502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853530|NCT00060502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853531|NCT00060502|Antiviral Agents|antiviral agents|mesh-ancestor
25853532|NCT00060502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24938308|NCT04020094|Atezolizumab|atezolizumab|mesh-list
24938309|NCT04020094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24938310|NCT04020016|Nalbuphine|nalbuphine|mesh-list
24938311|NCT04020016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24851697|NCT02258204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24851698|NCT02258204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24851699|NCT02258204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851700|NCT02258282|Etanercept|etanercept|mesh-list
24851701|NCT02258282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24851702|NCT02258282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24851703|NCT02258282|Analgesics|analgesics|mesh-ancestor
25853533|NCT00060502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698366|NCT01440790|Vitamins|vitamins|mesh-list
24851704|NCT02258282|Sensory System Agents|sensory system agents|mesh-ancestor
24938312|NCT04020016|Narcotics|narcotics|mesh-ancestor
24938313|NCT04020016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24938314|NCT04020016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938315|NCT04020016|Analgesics|analgesics|mesh-ancestor
24763014|NCT01770795|Gemcitabine|gemcitabine|mesh-list
24938316|NCT04020016|Sensory System Agents|sensory system agents|mesh-ancestor
24938317|NCT04020016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24938318|NCT04020003|Simendan|simendan|mesh-list
24938319|NCT04020003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24938320|NCT04020003|Vasodilator Agents|vasodilator agents|mesh-ancestor
24938321|NCT04020003|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24938322|NCT04020003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24938323|NCT04020003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24938324|NCT04020003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938325|NCT04020003|Protective Agents|protective agents|mesh-ancestor
24938326|NCT04020003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938327|NCT04020133|Epinephrine|epinephrine|mesh-list
24851710|NCT02258282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24851711|NCT02258282|Immunologic Factors|immunologic factors|mesh-ancestor
24851712|NCT02258542|Benralizumab|benralizumab|mesh-list
24851713|NCT02258542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24851714|NCT02258542|Respiratory System Agents|respiratory system agents|mesh-ancestor
24851715|NCT02258581|Tenofovir|tenofovir|mesh-list
24851718|NCT02258581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24851719|NCT02258581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24851720|NCT02258581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24851721|NCT02258581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851722|NCT02258581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851723|NCT02258581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24851724|NCT02258581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24851725|NCT02258607|Trametinib|trametinib|mesh-list
25853534|NCT00060502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24535334|NCT00648973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24535335|NCT00648973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24535336|NCT00648973|Sympathomimetics|sympathomimetics|mesh-ancestor
24535337|NCT00648973|Adrenergic Agents|adrenergic agents|mesh-ancestor
24535338|NCT00648986|Tazarotene|tazarotene|mesh-list
24938339|NCT04020133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938340|NCT04020133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24938342|NCT04020133|Autonomic Agents|autonomic agents|mesh-ancestor
24938343|NCT04020133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24938344|NCT04020133|Respiratory System Agents|respiratory system agents|mesh-ancestor
24938345|NCT04020133|Mydriatics|mydriatics|mesh-ancestor
24938346|NCT04020133|Sympathomimetics|sympathomimetics|mesh-ancestor
24938347|NCT04020133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24851730|NCT02258607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851732|NCT02258620|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24851733|NCT02258620|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
24851734|NCT02258620|Nitroglycerin|nitroglycerin|mesh-list
24851735|NCT02258620|Vasodilator Agents|vasodilator agents|mesh-ancestor
24851736|NCT02258620|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24851737|NCT02258620|Diuretics|diuretics|mesh-ancestor
24851738|NCT02258620|Natriuretic Agents|natriuretic agents|mesh-ancestor
24812288|NCT02051153|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24812289|NCT02051153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812290|NCT02051153|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25853535|NCT00060502|Immunologic Factors|immunologic factors|mesh-ancestor
25853536|NCT00060502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812291|NCT02051153|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24812292|NCT02051153|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24727398|NCT01609517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24812293|NCT02051153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535355|NCT00649012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24535356|NCT00649012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535357|NCT00649038|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24535358|NCT00649038|Benazepril|benazepril|mesh-list
24535359|NCT00649038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24535360|NCT00649038|Diuretics|diuretics|mesh-ancestor
25202787|NCT02718976|Sympathomimetics|sympathomimetics|mesh-ancestor
25202788|NCT02718976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25050352|NCT00517049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853537|NCT00060502|Dermatologic Agents|dermatologic agents|mesh-ancestor
25853538|NCT00060502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25853539|NCT00060502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25853540|NCT00060554|Heparin|heparin|mesh-list
25853541|NCT00060554|PENTA|penta|mesh-list
25853542|NCT00060554|Fondaparinux|fondaparinux|mesh-list
25050364|NCT00514267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050365|NCT00514267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25050366|NCT00514267|Glucocorticoids|glucocorticoids|mesh-ancestor
25050368|NCT00514267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25853543|NCT00060554|Anticoagulants|anticoagulants|mesh-ancestor
24535398|NCT00649077|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24535399|NCT00649077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24535400|NCT00649077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535401|NCT00649077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535403|NCT00649090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24535404|NCT00649090|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24535405|NCT00649090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24535406|NCT00649090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535407|NCT00649090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535461|NCT00649168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535463|NCT00649181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24535465|NCT00649181|Natriuretic Agents|natriuretic agents|mesh-ancestor
25853544|NCT00060554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25853545|NCT00060554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25853546|NCT00060554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853547|NCT00060554|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25853548|NCT00060554|Antithrombins|antithrombins|mesh-ancestor
25853549|NCT00060554|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25664279|NCT01667978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664280|NCT01667978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25853550|NCT00060554|Protease Inhibitors|protease inhibitors|mesh-ancestor
25853551|NCT00060554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853552|NCT00060567|Irinotecan|irinotecan|mesh-list
25853553|NCT00060567|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
25853554|NCT00060567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25853555|NCT00060567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24535471|NCT00649194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25853556|NCT00060567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853557|NCT00060567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853558|NCT00060567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853559|NCT00060567|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25202789|NCT02718976|Chelating Agents|chelating agents|mesh-ancestor
25202790|NCT02718976|Sequestering Agents|sequestering agents|mesh-ancestor
24938359|NCT04019496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24938360|NCT04019496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24938361|NCT04019496|Vasodilator Agents|vasodilator agents|mesh-ancestor
24938363|NCT04019548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24938364|NCT04019600|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24938365|NCT04019600|Natriuretic Agents|natriuretic agents|mesh-ancestor
24938366|NCT04019600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938367|NCT04019574|Moxifloxacin|moxifloxacin|mesh-list
24938368|NCT04019574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24938369|NCT04019574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25853560|NCT00060632|Sirolimus|sirolimus|mesh-list
24535478|NCT00649207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535479|NCT00649207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535480|NCT00649207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853561|NCT00060632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25853562|NCT00060632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25853563|NCT00060632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25853564|NCT00060632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853565|NCT00060632|Antifungal Agents|antifungal agents|mesh-ancestor
25853566|NCT00060632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25853567|NCT00060632|Immunologic Factors|immunologic factors|mesh-ancestor
25853568|NCT00060632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853569|NCT00060645|Sirolimus|sirolimus|mesh-list
25853570|NCT00060645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25853571|NCT00060645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25853572|NCT00060645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25853573|NCT00060645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853574|NCT00060645|Antifungal Agents|antifungal agents|mesh-ancestor
25853575|NCT00060645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25853576|NCT00060645|Immunologic Factors|immunologic factors|mesh-ancestor
24535496|NCT00649233|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24535498|NCT00649233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535499|NCT00649259|Oxybutynin|oxybutynin|mesh-list
24535500|NCT00649259|Parasympatholytics|parasympatholytics|mesh-ancestor
24535501|NCT00649259|Autonomic Agents|autonomic agents|mesh-ancestor
24535502|NCT00649259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24938390|NCT04019652|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24763087|NCT01771328|Cortisone|cortisone|mesh-list
24938406|NCT04019106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24832184|NCT02170844|Anticoagulants|anticoagulants|mesh-ancestor
25853577|NCT00060645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853578|NCT00060671|Rituximab|rituximab|mesh-list
25853579|NCT00060671|Pixantrone|pixantrone|mesh-list
25853580|NCT00060671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25853581|NCT00060671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853582|NCT00060671|Immunologic Factors|immunologic factors|mesh-ancestor
25853583|NCT00060671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853584|NCT00060671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25853585|NCT00060671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25853586|NCT00060671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25853587|NCT00060671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853588|NCT00060671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727621|NCT01611480|Imiquimod|imiquimod|mesh-list
24727629|NCT01611506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853589|NCT00060684|Dexamethasone|dexamethasone|mesh-list
25853590|NCT00060684|Rituximab|rituximab|mesh-list
25853591|NCT00060684|Fludarabine|fludarabine|mesh-list
24938409|NCT04019106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938410|NCT04019106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24938411|NCT04019106|Respiratory System Agents|respiratory system agents|mesh-ancestor
24938412|NCT04019106|Glucocorticoids|glucocorticoids|mesh-ancestor
24838068|NCT02195115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838069|NCT02195115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838074|NCT02195115|Adrenergic Agents|adrenergic agents|mesh-ancestor
24938414|NCT04019106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24938415|NCT04018833|Ranibizumab|ranibizumab|mesh-list
24938416|NCT04018833|Aflibercept|aflibercept|mesh-list
24938417|NCT04018833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24832215|NCT02170922|Anticoagulants|anticoagulants|mesh-ancestor
24451166|NCT00322543|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24451167|NCT00322543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451168|NCT00322543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451169|NCT00322569|Pimecrolimus|pimecrolimus|mesh-list
25853592|NCT00060684|Pixantrone|pixantrone|mesh-list
24451170|NCT00322569|Paclitaxel|paclitaxel|mesh-list
25853593|NCT00060684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24451171|NCT00322569|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24451172|NCT00322569|Tacrolimus|tacrolimus|mesh-list
25853594|NCT00060684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853595|NCT00060684|Immunologic Factors|immunologic factors|mesh-ancestor
24763173|NCT01771874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25853596|NCT00060684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853597|NCT00060684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25853598|NCT00060684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25853599|NCT00060684|Antiemetics|antiemetics|mesh-ancestor
25853600|NCT00060684|Autonomic Agents|autonomic agents|mesh-ancestor
25853601|NCT00060684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25853602|NCT00060684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25853603|NCT00060684|Glucocorticoids|glucocorticoids|mesh-ancestor
25853604|NCT00060684|Hormones|hormones|mesh-ancestor
25853605|NCT00060684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25853606|NCT00060684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25853607|NCT00060684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853608|NCT00060684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25853609|NCT00060684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25853610|NCT00060684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853611|NCT00060866|Propranolol|propranolol|mesh-list
25853612|NCT00060866|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25853613|NCT00060866|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25853614|NCT00060866|Adrenergic Agents|adrenergic agents|mesh-ancestor
25853615|NCT00060866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25853616|NCT00060866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853617|NCT00060866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853618|NCT00060866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25853619|NCT00060866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25853620|NCT00060866|Vasodilator Agents|vasodilator agents|mesh-ancestor
25853621|NCT00060905|Valproic Acid|valproic acid|mesh-list
25853622|NCT00060905|Anticonvulsants|anticonvulsants|mesh-ancestor
25853623|NCT00060905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853624|NCT00060905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853625|NCT00060905|GABA Agents|gaba agents|mesh-ancestor
25853626|NCT00060905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535638|NCT00649493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535639|NCT00649506|Nitrofurantoin|nitrofurantoin|mesh-list
24535640|NCT00649506|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24535641|NCT00649506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24535642|NCT00649506|Renal Agents|renal agents|mesh-ancestor
24535643|NCT00649506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24938434|NCT04018703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938435|NCT04018703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24535644|NCT00649519|Amlodipine|amlodipine|mesh-list
24535645|NCT00649519|Benazepril|benazepril|mesh-list
24535646|NCT00649519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24535647|NCT00649519|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24535648|NCT00649519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24535655|NCT00649519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535656|NCT00649532|Ondansetron|ondansetron|mesh-list
24535657|NCT00649532|Antiemetics|antiemetics|mesh-ancestor
24535658|NCT00649532|Autonomic Agents|autonomic agents|mesh-ancestor
24535659|NCT00649532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24535660|NCT00649532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664281|NCT01667978|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25664282|NCT01668004|Golimumab|golimumab|mesh-list
24535661|NCT00649532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25664283|NCT01668004|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24535662|NCT00649532|Antipruritics|antipruritics|mesh-ancestor
25853627|NCT00060905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535699|NCT00649597|Benazepril|benazepril|mesh-list
24535700|NCT00649597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24535701|NCT00649597|Diuretics|diuretics|mesh-ancestor
24535702|NCT00649597|Natriuretic Agents|natriuretic agents|mesh-ancestor
24535703|NCT00649597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535704|NCT00649597|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24535705|NCT00649597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24535706|NCT00649597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535707|NCT00649597|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24535708|NCT00649597|Protease Inhibitors|protease inhibitors|mesh-ancestor
25202791|NCT02718677|Factor VIII|factor viii|mesh-list
25202792|NCT02718677|Coagulants|coagulants|mesh-ancestor
25853628|NCT00060905|Antimanic Agents|antimanic agents|mesh-ancestor
25853629|NCT00060905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25853630|NCT00060905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25853631|NCT00060905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25853632|NCT00060918|Metoprolol|metoprolol|mesh-list
25853633|NCT00060918|Carvedilol|carvedilol|mesh-list
25853634|NCT00060918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25853635|NCT00060918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25853636|NCT00060918|Sympatholytics|sympatholytics|mesh-ancestor
25853637|NCT00060918|Autonomic Agents|autonomic agents|mesh-ancestor
24938441|NCT04018703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24938442|NCT04018703|Adrenergic Agents|adrenergic agents|mesh-ancestor
24938443|NCT04018703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24938444|NCT04018703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938445|NCT04018703|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24938446|NCT04018703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24727724|NCT01612273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24727725|NCT01612273|Antipyretics|antipyretics|mesh-ancestor
24938447|NCT04018703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24938448|NCT04018703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25853638|NCT00060918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25853639|NCT00060918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853640|NCT00060918|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25853641|NCT00060918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25853642|NCT00060918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24832330|NCT02171221|DFP-11207|dfp-11207|mesh-list
25853643|NCT00060918|Adrenergic Agents|adrenergic agents|mesh-ancestor
25853644|NCT00060918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25853645|NCT00060918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853646|NCT00060918|Antioxidants|antioxidants|mesh-ancestor
25853647|NCT00060918|Protective Agents|protective agents|mesh-ancestor
25853648|NCT00060918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25853649|NCT00060918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25853650|NCT00060918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25853651|NCT00060918|Vasodilator Agents|vasodilator agents|mesh-ancestor
25853652|NCT00060918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25853653|NCT00060918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25853654|NCT00060931|Metoprolol|metoprolol|mesh-list
25853655|NCT00060931|Carvedilol|carvedilol|mesh-list
25853656|NCT00060931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25853657|NCT00060931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25853658|NCT00060931|Sympatholytics|sympatholytics|mesh-ancestor
25853659|NCT00060931|Autonomic Agents|autonomic agents|mesh-ancestor
25853660|NCT00060931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25853661|NCT00060931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853662|NCT00060931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25853663|NCT00060931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25853664|NCT00060931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25853665|NCT00060931|Adrenergic Agents|adrenergic agents|mesh-ancestor
25853666|NCT00060931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24938457|NCT04018690|Anesthetics|anesthetics|mesh-ancestor
25853667|NCT00060931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853668|NCT00060931|Antioxidants|antioxidants|mesh-ancestor
24535862|NCT00649844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535863|NCT00649844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24535864|NCT00649844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24535865|NCT00649844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24535866|NCT00649844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24535867|NCT00649844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25853669|NCT00060931|Protective Agents|protective agents|mesh-ancestor
25853670|NCT00060931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24535869|NCT00649844|GABA Antagonists|gaba antagonists|mesh-ancestor
24535870|NCT00649844|GABA Agents|gaba agents|mesh-ancestor
24535871|NCT00649857|Cetirizine|cetirizine|mesh-list
24535872|NCT00649857|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24535873|NCT00649857|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24535874|NCT00649857|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24535875|NCT00649857|Histamine Antagonists|histamine antagonists|mesh-ancestor
24535876|NCT00649857|Histamine Agents|histamine agents|mesh-ancestor
24727781|NCT01612832|Pregabalin|pregabalin|mesh-list
24727782|NCT01612832|Analgesics|analgesics|mesh-ancestor
24535877|NCT00649857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535878|NCT00649857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535879|NCT00649857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535880|NCT00649870|Valacyclovir|valacyclovir|mesh-list
24535881|NCT00649870|Antiviral Agents|antiviral agents|mesh-ancestor
24535882|NCT00649870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24535883|NCT00649883|Vaccines|vaccines|mesh-list
24535884|NCT00649883|Immunologic Factors|immunologic factors|mesh-ancestor
24535885|NCT00649883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853671|NCT00060931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24802166|NCT01988298|Antipyretics|antipyretics|mesh-ancestor
25853672|NCT00060931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25853673|NCT00060931|Vasodilator Agents|vasodilator agents|mesh-ancestor
25853674|NCT00060931|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25853675|NCT00060931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24938469|NCT04018417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24938470|NCT04018417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24938471|NCT04018417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24938472|NCT04018417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24938473|NCT04018417|Antifungal Agents|antifungal agents|mesh-ancestor
24938474|NCT04018365|Empagliflozin|empagliflozin|mesh-list
24938475|NCT04018365|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24938476|NCT04018365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938477|NCT04018365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25853676|NCT00060957|Botulinum Toxins|botulinum toxins|mesh-list
25853677|NCT00060957|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25853678|NCT00060957|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25853679|NCT00060957|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25853680|NCT00060957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24535962|NCT00650065|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24535963|NCT00650065|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24535964|NCT00650065|Histamine Antagonists|histamine antagonists|mesh-ancestor
24535965|NCT00650065|Histamine Agents|histamine agents|mesh-ancestor
24535966|NCT00650065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535967|NCT00650065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535968|NCT00650065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536042|NCT00650221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24536043|NCT00650221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24536050|NCT00650234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24536051|NCT00650234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536052|NCT00650247|Sumatriptan|sumatriptan|mesh-list
24536053|NCT00650247|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24536054|NCT00650247|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25853681|NCT00060957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853682|NCT00060957|Cholinergic Agents|cholinergic agents|mesh-ancestor
25853683|NCT00060957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25853684|NCT00060957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853685|NCT00060957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25853686|NCT00060957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25853687|NCT00060996|Treprostinil|treprostinil|mesh-list
25853688|NCT00060996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25853689|NCT00061022|Disufenton sodium|disufenton sodium|mesh-list
25853690|NCT00061022|Antioxidants|antioxidants|mesh-ancestor
25853691|NCT00061022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853692|NCT00061022|Protective Agents|protective agents|mesh-ancestor
25853693|NCT00061022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853694|NCT00061074|Nicotine|nicotine|mesh-list
25853695|NCT00061074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25853696|NCT00061074|Autonomic Agents|autonomic agents|mesh-ancestor
25853697|NCT00061074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24536071|NCT00650299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24536072|NCT00650299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24536073|NCT00650299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536074|NCT00650299|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24536075|NCT00650299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24536076|NCT00650299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24536077|NCT00650299|GABA Modulators|gaba modulators|mesh-ancestor
24536078|NCT00650299|GABA Agents|gaba agents|mesh-ancestor
25853698|NCT00061074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853699|NCT00061074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25853700|NCT00061074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25853701|NCT00061074|Cholinergic Agents|cholinergic agents|mesh-ancestor
25853702|NCT00061074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25202793|NCT02718716|Rozanolixizumab|rozanolixizumab|mesh-list
24536111|NCT00650364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536112|NCT00650364|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25853703|NCT00061074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536113|NCT00650364|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24536114|NCT00650364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24536115|NCT00650364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24536116|NCT00650364|Adrenergic Agents|adrenergic agents|mesh-ancestor
24536117|NCT00650364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24536118|NCT00650364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536119|NCT00650377|Finasteride|finasteride|mesh-list
24727937|NCT01613664|Coagulants|coagulants|mesh-ancestor
24536151|NCT00650416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536152|NCT00650416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24536153|NCT00650416|Antioxidants|antioxidants|mesh-ancestor
24536154|NCT00650416|Protective Agents|protective agents|mesh-ancestor
24536173|NCT00650442|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24536174|NCT00650442|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24536176|NCT00650442|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24536177|NCT00650442|Estrogens|estrogens|mesh-ancestor
24536178|NCT00650442|Hormones|hormones|mesh-ancestor
25853704|NCT00061087|Methylphenidate|methylphenidate|mesh-list
25853705|NCT00061087|Bupropion|bupropion|mesh-list
25853706|NCT00061087|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25853707|NCT00061087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938528|NCT04018313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24938529|NCT04018313|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24938530|NCT04018313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24938531|NCT04018313|Respiratory System Agents|respiratory system agents|mesh-ancestor
24938532|NCT04018313|Immunologic Factors|immunologic factors|mesh-ancestor
24938533|NCT04018313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938534|NCT04018274|Levonorgestrel|levonorgestrel|mesh-list
24938535|NCT04018274|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24938536|NCT04018274|Contraceptive Agents|contraceptive agents|mesh-list
24938537|NCT04018274|Contraceptives, Oral|contraceptives, oral|mesh-list
25853708|NCT00061087|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25853709|NCT00061087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25853710|NCT00061087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25853711|NCT00061087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853712|NCT00061087|Dopamine Agents|dopamine agents|mesh-ancestor
25853713|NCT00061087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25853714|NCT00061087|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25853715|NCT00061087|Antidepressive Agents|antidepressive agents|mesh-ancestor
25853716|NCT00061087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25853717|NCT00061087|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25853718|NCT00061087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25853719|NCT00061087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853720|NCT00061113|Fluoxetine|fluoxetine|mesh-list
25853721|NCT00061113|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25853722|NCT00061113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25853723|NCT00061113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25853724|NCT00061113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853725|NCT00061113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25853726|NCT00061113|Serotonin Agents|serotonin agents|mesh-ancestor
25853727|NCT00061113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853728|NCT00061113|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25853729|NCT00061113|Antidepressive Agents|antidepressive agents|mesh-ancestor
25853730|NCT00061113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25853731|NCT00061113|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25853732|NCT00061113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25853733|NCT00061113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876230|NCT03808610|Pegaspargase|pegaspargase|mesh-list
25876231|NCT03808610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25876232|NCT03808610|Antibodies|antibodies|mesh-list
25876233|NCT03808610|Immunoglobulins|immunoglobulins|mesh-list
25876234|NCT03808610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25876235|NCT03808610|BB 1101|bb 1101|mesh-list
24839049|NCT02201667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25853734|NCT00061152|Capsaicin|capsaicin|mesh-list
25853735|NCT00061152|Antipruritics|antipruritics|mesh-ancestor
25853736|NCT00061152|Dermatologic Agents|dermatologic agents|mesh-ancestor
25853737|NCT00061152|Sensory System Agents|sensory system agents|mesh-ancestor
25853738|NCT00061152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25853739|NCT00061152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853740|NCT00061178|Bevacizumab|bevacizumab|mesh-list
25853741|NCT00061178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25853742|NCT00061178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853743|NCT00061178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25853744|NCT00061178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24728073|NCT01614132|Antimitotic Agents|antimitotic agents|mesh-ancestor
25853745|NCT00061178|Growth Substances|growth substances|mesh-ancestor
25853746|NCT00061178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853747|NCT00061178|Growth Inhibitors|growth inhibitors|mesh-ancestor
25853748|NCT00061243|Vaccines|vaccines|mesh-list
25853749|NCT00061243|Immunologic Factors|immunologic factors|mesh-ancestor
25853750|NCT00061243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853751|NCT00061256|Vitamin D|vitamin d|mesh-list
24938567|NCT04017741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24536413|NCT00651235|Atenolol|atenolol|mesh-list
24536238|NCT00650520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24536239|NCT00650520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536240|NCT00650520|Dopamine Agonists|dopamine agonists|mesh-ancestor
24536241|NCT00650520|Dopamine Agents|dopamine agents|mesh-ancestor
24536242|NCT00650520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24728122|NCT01614236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24728123|NCT01614236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24728124|NCT01614236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728125|NCT01614236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24536243|NCT00650520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536244|NCT00650533|Glimepiride|glimepiride|mesh-list
24536245|NCT00650533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24536246|NCT00650533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25853752|NCT00061256|Alendronate|alendronate|mesh-list
25853753|NCT00061256|Calcium Carbonate|calcium carbonate|mesh-list
25853754|NCT00061256|Calcium|calcium|mesh-list
25853755|NCT00061256|Vitamins|vitamins|mesh-ancestor
25853756|NCT00061256|Micronutrients|micronutrients|mesh-ancestor
25853757|NCT00061256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853758|NCT00061256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24536248|NCT00650533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24536249|NCT00650533|Immunologic Factors|immunologic factors|mesh-ancestor
24536250|NCT00650598|Diclofenac|diclofenac|mesh-list
24536251|NCT00650598|Valdecoxib|valdecoxib|mesh-list
24536252|NCT00650598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24536253|NCT00650598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24536254|NCT00650598|Analgesics|analgesics|mesh-ancestor
24536255|NCT00650598|Sensory System Agents|sensory system agents|mesh-ancestor
24536256|NCT00650598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24536257|NCT00650598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853759|NCT00061256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25853760|NCT00061256|Antacids|antacids|mesh-ancestor
25853761|NCT00061256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536280|NCT00650624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536281|NCT00650624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24616483|NCT01037491|Antipyretics|antipyretics|mesh-ancestor
24536282|NCT00650624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24536283|NCT00650624|Analgesics|analgesics|mesh-ancestor
24536284|NCT00650624|Sensory System Agents|sensory system agents|mesh-ancestor
24536330|NCT00650793|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24938576|NCT04017741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24938577|NCT04017741|Antiemetics|antiemetics|mesh-ancestor
25853762|NCT00061256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25853763|NCT00061282|Clotrimazole|clotrimazole|mesh-list
25853764|NCT00061282|Miconazole|miconazole|mesh-list
25853765|NCT00061282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25853766|NCT00061282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25232299|NCT02583633|Nifedipine|nifedipine|mesh-list
25853767|NCT00061282|Antifungal Agents|antifungal agents|mesh-ancestor
25853768|NCT00061282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25664284|NCT01668004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25853769|NCT00061282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25853770|NCT00061282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876236|NCT03808610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25270127|NCT02406300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25270128|NCT02406300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853771|NCT00061282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853772|NCT00061282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25853773|NCT00061282|Hormone Antagonists|hormone antagonists|mesh-ancestor
25853774|NCT00061282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25853775|NCT00061282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853776|NCT00061282|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25853777|NCT00061282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25853778|NCT00061308|Gemcitabine|gemcitabine|mesh-list
24536582|NCT00651690|Cholinergic Agents|cholinergic agents|mesh-ancestor
24536416|NCT00651235|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24536417|NCT00651235|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24536418|NCT00651235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853779|NCT00061308|Topotecan|topotecan|mesh-list
24938616|NCT04017845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24938617|NCT04017845|Vasodilator Agents|vasodilator agents|mesh-ancestor
24938618|NCT04017845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24938620|NCT04017845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24938621|NCT04017845|Laxatives|laxatives|mesh-ancestor
24938622|NCT04017845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24938623|NCT04017845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24938624|NCT04017845|Analgesics|analgesics|mesh-ancestor
24938625|NCT04017845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24938626|NCT04017845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24938627|NCT04017988|Ethanol|ethanol|mesh-list
24938628|NCT04017988|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24938629|NCT04017988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24938630|NCT04017988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24938631|NCT04017988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938643|NCT04017624|Nicotine|nicotine|mesh-list
24938644|NCT04017624|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24938645|NCT04017624|Autonomic Agents|autonomic agents|mesh-ancestor
24938646|NCT04017624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24938647|NCT04017624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938648|NCT04017624|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25050371|NCT00512317|Ganaxolone|ganaxolone|mesh-list
24938649|NCT04017624|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25853780|NCT00061308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24536509|NCT00651547|Respiratory System Agents|respiratory system agents|mesh-ancestor
24536510|NCT00651547|Glucocorticoids|glucocorticoids|mesh-ancestor
24536512|NCT00651547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24536513|NCT00651547|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24536514|NCT00651547|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24536538|NCT00651599|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24536539|NCT00651599|Hormone Antagonists|hormone antagonists|mesh-ancestor
24536540|NCT00651599|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25853781|NCT00061308|Antimetabolites|antimetabolites|mesh-ancestor
25853782|NCT00061308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853783|NCT00061308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24728206|NCT01614938|Cisplatin|cisplatin|mesh-list
25853784|NCT00061308|Antiviral Agents|antiviral agents|mesh-ancestor
25853785|NCT00061308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24763291|NCT01772797|Ceritinib|ceritinib|mesh-list
24938683|NCT04017221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853786|NCT00061308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853787|NCT00061308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25853788|NCT00061308|Immunologic Factors|immunologic factors|mesh-ancestor
25853789|NCT00061308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853790|NCT00061308|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25853791|NCT00061308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25853792|NCT00061321|Nevirapine|nevirapine|mesh-list
25853793|NCT00061321|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24536541|NCT00651599|Diuretics|diuretics|mesh-ancestor
24536547|NCT00651612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24536548|NCT00651612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24536550|NCT00651612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24536551|NCT00651612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536552|NCT00651612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536553|NCT00651612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25664285|NCT01668004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25664286|NCT01668004|Immunologic Factors|immunologic factors|mesh-ancestor
24839885|NCT02206490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839886|NCT02206503|Dexamethasone|dexamethasone|mesh-list
24839887|NCT02206503|Cyclophosphamide|cyclophosphamide|mesh-list
24839888|NCT02206503|Lenalidomide|lenalidomide|mesh-list
24839889|NCT02206503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24839890|NCT02206503|Immunologic Factors|immunologic factors|mesh-ancestor
24728267|NCT01615211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24536554|NCT00651612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24536555|NCT00651612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24536584|NCT00651690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536585|NCT00651690|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24536586|NCT00651690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24536610|NCT00651768|Autonomic Agents|autonomic agents|mesh-ancestor
24536611|NCT00651768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24536612|NCT00651768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536613|NCT00651768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24536614|NCT00651768|Respiratory System Agents|respiratory system agents|mesh-ancestor
24763450|NCT01773681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24763451|NCT01773681|Immunologic Factors|immunologic factors|mesh-ancestor
24763452|NCT01773681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763453|NCT01773681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24763454|NCT01773772|Progesterone|progesterone|mesh-list
24763455|NCT01773772|Progestins|progestins|mesh-ancestor
24763457|NCT01773772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24763458|NCT01773772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763459|NCT01773798|Insulin|insulin|mesh-list
24763460|NCT01773798|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24763461|NCT01773798|Insulin Aspart|insulin aspart|mesh-list
24763462|NCT01773798|Insulin, Long-Acting|insulin, long-acting|mesh-list
24763463|NCT01773798|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24763464|NCT01773798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24763465|NCT01773798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763466|NCT01773824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24763467|NCT01773824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24763468|NCT01773837|Methylphenidate|methylphenidate|mesh-list
24763469|NCT01773837|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24763470|NCT01773837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938701|NCT04016740|Ketamine|ketamine|mesh-list
24938702|NCT04016740|Remifentanil|remifentanil|mesh-list
24938703|NCT04016740|Propofol|propofol|mesh-list
24938704|NCT04016740|Ropivacaine|ropivacaine|mesh-list
24938705|NCT04016740|Sevoflurane|sevoflurane|mesh-list
24938706|NCT04016740|Rocuronium|rocuronium|mesh-list
24938707|NCT04016740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24938708|NCT04016740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24938709|NCT04016740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938710|NCT04016740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24938711|NCT04016740|Anesthetics, General|anesthetics, general|mesh-ancestor
24938712|NCT04016740|Anesthetics|anesthetics|mesh-ancestor
24938713|NCT04016740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24536615|NCT00651768|Glucocorticoids|glucocorticoids|mesh-ancestor
25050384|NCT00511459|Antimitotic Agents|antimitotic agents|mesh-ancestor
25050385|NCT00511459|Mitosis Modulators|mitosis modulators|mesh-ancestor
25050386|NCT00511459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852067|NCT02260206|Colchicine|colchicine|mesh-list
25853794|NCT00061321|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25853795|NCT00061321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853796|NCT00061321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853797|NCT00061321|Antiviral Agents|antiviral agents|mesh-ancestor
25853798|NCT00061321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25232311|NCT02583568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232312|NCT02583568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25853799|NCT00061321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25853800|NCT00061321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25853801|NCT00061321|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24728395|NCT01615978|Incretins|incretins|mesh-ancestor
25853802|NCT00061321|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24635968|NCT01142258|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25853803|NCT00061360|Cyclosporine|cyclosporine|mesh-list
25664287|NCT01668004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664288|NCT01668017|Niacinamide|niacinamide|mesh-list
25664289|NCT01668017|Vitamin B Complex|vitamin b complex|mesh-ancestor
25664290|NCT01668017|Vitamins|vitamins|mesh-ancestor
25664291|NCT01668017|Micronutrients|micronutrients|mesh-ancestor
25664292|NCT01668017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050388|NCT00511459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25050389|NCT00511459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25664293|NCT01668030|Bacitracin|bacitracin|mesh-list
25050390|NCT00511459|Growth Substances|growth substances|mesh-ancestor
25050391|NCT00511459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050392|NCT00511459|Growth Inhibitors|growth inhibitors|mesh-ancestor
25050394|NCT00511043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25050395|NCT00511043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050396|NCT00511043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050398|NCT00508989|Acetylcholine|acetylcholine|mesh-list
25050399|NCT00508989|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25050400|NCT00508989|Antimetabolites|antimetabolites|mesh-ancestor
25050401|NCT00508989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050402|NCT00508989|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25050403|NCT00508989|Vasodilator Agents|vasodilator agents|mesh-ancestor
25050404|NCT00508989|Vitamin B Complex|vitamin b complex|mesh-ancestor
25050407|NCT00508989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728412|NCT01616069|Adrenergic Agents|adrenergic agents|mesh-ancestor
24728413|NCT01616069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24728414|NCT01616069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728416|NCT01616069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25050409|NCT00508989|Cholinergic Agents|cholinergic agents|mesh-ancestor
24852089|NCT02260414|Tinzaparin|tinzaparin|mesh-list
24536669|NCT00652002|Hormones|hormones|mesh-ancestor
24536670|NCT00652002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25853804|NCT00061360|Sirolimus|sirolimus|mesh-list
25853805|NCT00061360|Cyclosporins|cyclosporins|mesh-list
25853806|NCT00061360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853807|NCT00061360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853808|NCT00061360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25853809|NCT00061360|Immunologic Factors|immunologic factors|mesh-ancestor
25853810|NCT00061360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853811|NCT00061360|Antifungal Agents|antifungal agents|mesh-ancestor
25853812|NCT00061360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25853813|NCT00061360|Dermatologic Agents|dermatologic agents|mesh-ancestor
25853814|NCT00061360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25853815|NCT00061360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25853816|NCT00061360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25853817|NCT00061360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25853818|NCT00061360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853819|NCT00061425|Epratuzumab|epratuzumab|mesh-list
25853820|NCT00061425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25853821|NCT00061425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853822|NCT00061438|Meropenem|meropenem|mesh-list
25853823|NCT00061438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25853824|NCT00061438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25853825|NCT00061451|Gemcitabine|gemcitabine|mesh-list
25853826|NCT00061451|Pemetrexed|pemetrexed|mesh-list
24449357|NCT00315185|Cetuximab|cetuximab|mesh-list
24728452|NCT01616225|Hormones|hormones|mesh-list
24728506|NCT01616680|Antibodies|antibodies|mesh-list
24536694|NCT00652106|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24536695|NCT00652106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24536696|NCT00652106|Adrenergic Agents|adrenergic agents|mesh-ancestor
24536697|NCT00652106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25853827|NCT00061451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25853828|NCT00061451|Antimetabolites|antimetabolites|mesh-ancestor
25853829|NCT00061451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954804|NCT03872011|Protective Agents|protective agents|mesh-ancestor
24954805|NCT03872011|Vitamin B Complex|vitamin b complex|mesh-ancestor
24780539|NCT01884857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25853830|NCT00061451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853831|NCT00061451|Antiviral Agents|antiviral agents|mesh-ancestor
24536710|NCT00652119|Tubulin Modulators|tubulin modulators|mesh-ancestor
24536711|NCT00652119|Antimitotic Agents|antimitotic agents|mesh-ancestor
24536712|NCT00652119|Mitosis Modulators|mitosis modulators|mesh-ancestor
24536713|NCT00652119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536714|NCT00652119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24536715|NCT00652119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24536716|NCT00652119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24536717|NCT00652119|Growth Substances|growth substances|mesh-ancestor
25202794|NCT02718716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24728507|NCT01616680|Immunoglobulins|immunoglobulins|mesh-list
25853832|NCT00061451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25853833|NCT00061451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24938738|NCT04016246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24938740|NCT04016246|Anesthetics|anesthetics|mesh-ancestor
24938741|NCT04016233|Tenofovir|tenofovir|mesh-list
24536736|NCT00652171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25853834|NCT00061451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24536737|NCT00652171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536738|NCT00652171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24536739|NCT00652171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24536740|NCT00652171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24536741|NCT00652171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24536742|NCT00652171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24536743|NCT00652184|Valacyclovir|valacyclovir|mesh-list
24536744|NCT00652184|Sorivudine|sorivudine|mesh-list
24536745|NCT00652184|Antiviral Agents|antiviral agents|mesh-ancestor
25853835|NCT00061451|Immunologic Factors|immunologic factors|mesh-ancestor
25853836|NCT00061451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853837|NCT00061451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25853838|NCT00061451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25853839|NCT00061464|Gemcitabine|gemcitabine|mesh-list
24616508|NCT01037608|Nabiximols|nabiximols|mesh-list
25853840|NCT00061464|Pemetrexed|pemetrexed|mesh-list
25853841|NCT00061464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25853842|NCT00061464|Antimetabolites|antimetabolites|mesh-ancestor
25853843|NCT00061464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853844|NCT00061464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853845|NCT00061464|Antiviral Agents|antiviral agents|mesh-ancestor
25853846|NCT00061464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25853847|NCT00061464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853848|NCT00061464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25853849|NCT00061464|Immunologic Factors|immunologic factors|mesh-ancestor
25853850|NCT00061464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853851|NCT00061464|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24938743|NCT04016233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24938744|NCT04016233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24938745|NCT04016233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24938746|NCT04016233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24938747|NCT04016233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938748|NCT04016233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24938749|NCT04016233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24938750|NCT04016051|Clarithromycin|clarithromycin|mesh-list
24938751|NCT04016051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24938752|NCT04016051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24536780|NCT00652392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24536781|NCT00652392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536782|NCT00652392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24536783|NCT00652392|Respiratory System Agents|respiratory system agents|mesh-ancestor
24536785|NCT00652392|Hormones|hormones|mesh-ancestor
25853852|NCT00061464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25853853|NCT00061477|Gemcitabine|gemcitabine|mesh-list
25853854|NCT00061477|Pemetrexed|pemetrexed|mesh-list
25853855|NCT00061477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25853856|NCT00061477|Antimetabolites|antimetabolites|mesh-ancestor
25853857|NCT00061477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853858|NCT00061477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853859|NCT00061477|Antiviral Agents|antiviral agents|mesh-ancestor
25853860|NCT00061477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25853861|NCT00061477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24393593|NCT00130455|Citalopram|citalopram|mesh-list
25853862|NCT00061477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25853863|NCT00061477|Immunologic Factors|immunologic factors|mesh-ancestor
25853864|NCT00061477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853865|NCT00061477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24536797|NCT00652483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24536798|NCT00652483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24536800|NCT00652483|Adrenergic Agents|adrenergic agents|mesh-ancestor
24536801|NCT00652483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24536802|NCT00652483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536803|NCT00652483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536804|NCT00652496|Bimatoprost|bimatoprost|mesh-list
24536805|NCT00652496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24536806|NCT00652496|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25202795|NCT02718716|Immunologic Factors|immunologic factors|mesh-ancestor
24536807|NCT00652496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24536808|NCT00652600|Propranolol|propranolol|mesh-list
24536809|NCT00652600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24536810|NCT00652600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24536811|NCT00652600|Adrenergic Agents|adrenergic agents|mesh-ancestor
24938753|NCT04016051|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24938754|NCT04016051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24938755|NCT04016051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270164|NCT02406170|Tubulin Modulators|tubulin modulators|mesh-ancestor
24938756|NCT04016051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24938757|NCT04016051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24938759|NCT04016116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25853866|NCT00061477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25853867|NCT00061503|Travoprost|travoprost|mesh-list
25853868|NCT00061503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25853869|NCT00061516|Brinzolamide|brinzolamide|mesh-list
25853870|NCT00061516|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24536821|NCT00652639|GABA Agents|gaba agents|mesh-ancestor
24536822|NCT00652639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24536823|NCT00652639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536824|NCT00652639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536825|NCT00652652|Furosemide|furosemide|mesh-list
24536826|NCT00652652|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24536827|NCT00652652|Diuretics|diuretics|mesh-ancestor
24536828|NCT00652652|Natriuretic Agents|natriuretic agents|mesh-ancestor
24536829|NCT00652652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536830|NCT00652652|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24536831|NCT00652652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24536832|NCT00652652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536833|NCT00652665|Leflunomide|leflunomide|mesh-list
24536834|NCT00652665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536835|NCT00652665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536836|NCT00652665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24536837|NCT00652665|Immunologic Factors|immunologic factors|mesh-ancestor
24536838|NCT00652665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536839|NCT00652691|Cyclophosphamide|cyclophosphamide|mesh-list
24536841|NCT00652691|Topotecan|topotecan|mesh-list
24536842|NCT00652691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24536843|NCT00652691|Immunologic Factors|immunologic factors|mesh-ancestor
24938786|NCT04015908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938788|NCT04015908|Anticonvulsants|anticonvulsants|mesh-ancestor
24938789|NCT04015908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24938790|NCT04015908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24852173|NCT02261025|Antipyretics|antipyretics|mesh-ancestor
24536844|NCT00652691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536845|NCT00652691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24536846|NCT00652691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24536847|NCT00652691|Alkylating Agents|alkylating agents|mesh-ancestor
24536848|NCT00652691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536849|NCT00652691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24536866|NCT00652730|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25853871|NCT00061516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853872|NCT00061516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853873|NCT00061529|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25853874|NCT00061529|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25853875|NCT00061529|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25853876|NCT00061529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25853877|NCT00061529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25853878|NCT00061529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25853879|NCT00061529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24938792|NCT04015908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24938794|NCT04015908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25853880|NCT00061529|Adrenergic Agents|adrenergic agents|mesh-ancestor
25853881|NCT00061529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25853882|NCT00061529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853883|NCT00061529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853884|NCT00061542|Timolol|timolol|mesh-list
25853885|NCT00061542|Betaxolol|betaxolol|mesh-list
25853886|NCT00061542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25853887|NCT00061542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25853888|NCT00061542|Adrenergic Agents|adrenergic agents|mesh-ancestor
25853889|NCT00061542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25853890|NCT00061542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853891|NCT00061542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853892|NCT00061542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25853893|NCT00061542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25853894|NCT00061542|Sympatholytics|sympatholytics|mesh-ancestor
25853895|NCT00061542|Autonomic Agents|autonomic agents|mesh-ancestor
25664294|NCT01668030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24840805|NCT02212613|Dopamine Agents|dopamine agents|mesh-ancestor
24536898|NCT00652821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24536899|NCT00652821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536901|NCT00652821|Sensory System Agents|sensory system agents|mesh-ancestor
24536902|NCT00652821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25853896|NCT00061542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24938836|NCT04015414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852237|NCT02261207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24852238|NCT02261207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852239|NCT02261207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852240|NCT02261220|Durvalumab|durvalumab|mesh-list
24852241|NCT02261220|Tremelimumab|tremelimumab|mesh-list
24852242|NCT02261220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24852243|NCT02261220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853897|NCT00061542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25853898|NCT00061594|Ranibizumab|ranibizumab|mesh-list
24536913|NCT00652860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24536914|NCT00652860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536915|NCT00652860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536916|NCT00652860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24536917|NCT00652860|Alkylating Agents|alkylating agents|mesh-ancestor
24536918|NCT00652860|Immunologic Factors|immunologic factors|mesh-ancestor
25853899|NCT00061594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25853900|NCT00061594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25853901|NCT00061594|Growth Substances|growth substances|mesh-ancestor
25853902|NCT00061594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853903|NCT00061594|Growth Inhibitors|growth inhibitors|mesh-ancestor
25853904|NCT00061594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24536920|NCT00652860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24536921|NCT00652873|Cabergoline|cabergoline|mesh-list
24536922|NCT00652873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24536923|NCT00652873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25853905|NCT00061620|Tezacitabine|tezacitabine|mesh-list
24938864|NCT04015492|Coagulants|coagulants|mesh-ancestor
24938865|NCT04015687|Lamotrigine|lamotrigine|mesh-list
24938866|NCT04015687|Anticonvulsants|anticonvulsants|mesh-ancestor
24938867|NCT04015687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24938868|NCT04015687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24852250|NCT02261376|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24536924|NCT00652873|Dopamine Agonists|dopamine agonists|mesh-ancestor
24536925|NCT00652873|Dopamine Agents|dopamine agents|mesh-ancestor
24536926|NCT00652873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24536927|NCT00652873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536928|NCT00652873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394240|NCT00132639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853906|NCT00061620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853907|NCT00061620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853908|NCT00061620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853909|NCT00061646|Carboplatin|carboplatin|mesh-list
25853910|NCT00061646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853911|NCT00061711|Hormones|hormones|mesh-list
25853912|NCT00061711|Phytoestrogens|phytoestrogens|mesh-list
25853913|NCT00061711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24938869|NCT04015687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938870|NCT04015687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24938871|NCT04015687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938872|NCT04015687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24938873|NCT04015687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25853914|NCT00061711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853915|NCT00061711|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25853916|NCT00061711|Estrogens|estrogens|mesh-ancestor
24637610|NCT01151787|Analgesics|analgesics|mesh-ancestor
25853917|NCT00061750|Deferasirox|deferasirox|mesh-list
24536932|NCT00652886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25853918|NCT00061750|Deferoxamine|deferoxamine|mesh-list
25853919|NCT00061750|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25853920|NCT00061750|Chelating Agents|chelating agents|mesh-ancestor
25853921|NCT00061750|Sequestering Agents|sequestering agents|mesh-ancestor
25853922|NCT00061750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853923|NCT00061750|Siderophores|siderophores|mesh-ancestor
25853924|NCT00061763|Deferasirox|deferasirox|mesh-list
25853925|NCT00061763|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25853926|NCT00061763|Chelating Agents|chelating agents|mesh-ancestor
25270178|NCT02406014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476864|NCT00416767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24476865|NCT00416767|Immunologic Factors|immunologic factors|mesh-ancestor
24942191|NCT03983460|Glucocorticoids|glucocorticoids|mesh-ancestor
24942192|NCT03983460|Hormones|hormones|mesh-ancestor
25853927|NCT00061763|Sequestering Agents|sequestering agents|mesh-ancestor
25853928|NCT00061763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536949|NCT00652925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536950|NCT00652925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24536951|NCT00652925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24536952|NCT00652925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24536953|NCT00652925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24536954|NCT00652925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536955|NCT00652925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536956|NCT00652925|Gout Suppressants|gout suppressants|mesh-ancestor
24536957|NCT00653003|Leflunomide|leflunomide|mesh-list
24536958|NCT00653003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536959|NCT00653003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536960|NCT00653003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24536961|NCT00653003|Immunologic Factors|immunologic factors|mesh-ancestor
24536962|NCT00653003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536963|NCT00653016|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24536964|NCT00653016|Norelgestromin|norelgestromin|mesh-list
24536965|NCT00653016|Estradiol|estradiol|mesh-list
24536966|NCT00653016|Estrogens|estrogens|mesh-ancestor
24536967|NCT00653016|Hormones|hormones|mesh-ancestor
24536968|NCT00653016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25853929|NCT00061776|Capsaicin|capsaicin|mesh-list
25853930|NCT00061776|Antipruritics|antipruritics|mesh-ancestor
25853931|NCT00061776|Dermatologic Agents|dermatologic agents|mesh-ancestor
24938876|NCT04015687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24938878|NCT04015778|Carboplatin|carboplatin|mesh-list
24938879|NCT04015778|Nivolumab|nivolumab|mesh-list
24938880|NCT04015778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25853932|NCT00061776|Sensory System Agents|sensory system agents|mesh-ancestor
25853933|NCT00061776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25853934|NCT00061776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853935|NCT00061789|Acetylcholine|acetylcholine|mesh-list
25232361|NCT02583516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24846789|NCT02244021|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24846790|NCT02244021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24846792|NCT02244073|Insulin|insulin|mesh-list
25853936|NCT00061789|Vasodilator Agents|vasodilator agents|mesh-ancestor
25853937|NCT00061789|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25853938|NCT00061789|Cholinergic Agents|cholinergic agents|mesh-ancestor
25853939|NCT00061789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25853940|NCT00061789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728886|NCT01618799|Lamotrigine|lamotrigine|mesh-list
25853941|NCT00061789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853942|NCT00061802|Risperidone|risperidone|mesh-list
25853943|NCT00061802|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25853944|NCT00061802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25853945|NCT00061802|Serotonin Agents|serotonin agents|mesh-ancestor
25853946|NCT00061802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25853947|NCT00061802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853948|NCT00061802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853949|NCT00061802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25853950|NCT00061802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25853951|NCT00061802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25853952|NCT00061802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25853953|NCT00061802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25853954|NCT00061802|Dopamine Agents|dopamine agents|mesh-ancestor
25853955|NCT00061802|Antidepressive Agents|antidepressive agents|mesh-ancestor
25853956|NCT00061815|Leucovorin|leucovorin|mesh-list
25853957|NCT00061815|Fluorouracil|fluorouracil|mesh-list
25853958|NCT00061815|Oxaliplatin|oxaliplatin|mesh-list
24536981|NCT00653055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24536982|NCT00653055|Dopamine Agonists|dopamine agonists|mesh-ancestor
24536983|NCT00653055|Dopamine Agents|dopamine agents|mesh-ancestor
24536984|NCT00653055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24536986|NCT00653055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536988|NCT00653120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25202796|NCT02718716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853959|NCT00061815|Cetuximab|cetuximab|mesh-list
25853960|NCT00061815|Antimetabolites|antimetabolites|mesh-ancestor
25664295|NCT01668030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25664296|NCT01668030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25664297|NCT01668654|Ezogabine|ezogabine|mesh-list
25853961|NCT00061815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853962|NCT00061815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25853963|NCT00061815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476867|NCT00416767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24841184|NCT02214680|Adrenergic Agents|adrenergic agents|mesh-ancestor
24841185|NCT02214680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24841187|NCT02214680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853964|NCT00061815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25853965|NCT00061815|Immunologic Factors|immunologic factors|mesh-ancestor
25853966|NCT00061815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399917|NCT00148902|Docetaxel|docetaxel|mesh-list
25853967|NCT00061815|Antidotes|antidotes|mesh-ancestor
25853968|NCT00061815|Protective Agents|protective agents|mesh-ancestor
25853969|NCT00061815|Vitamin B Complex|vitamin b complex|mesh-ancestor
25853970|NCT00061815|Vitamins|vitamins|mesh-ancestor
25853971|NCT00061815|Micronutrients|micronutrients|mesh-ancestor
25853972|NCT00061815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25853973|NCT00061854|Soblidotin|soblidotin|mesh-list
24954957|NCT03870022|Carbon Monoxide|carbon monoxide|mesh-list
24954958|NCT03870022|Antimetabolites|antimetabolites|mesh-ancestor
24954959|NCT03870022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954960|NCT03870022|Gasotransmitters|gasotransmitters|mesh-ancestor
25853974|NCT00061854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853975|NCT00061867|Doxorubicin|doxorubicin|mesh-list
25853976|NCT00061867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25853977|NCT00061867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25853978|NCT00061867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25853979|NCT00061867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25853980|NCT00061867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25853981|NCT00061867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853982|NCT00061867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853983|NCT00061906|Celecoxib|celecoxib|mesh-list
25853984|NCT00061906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25853985|NCT00061906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25853986|NCT00061906|Analgesics|analgesics|mesh-ancestor
25853987|NCT00061906|Sensory System Agents|sensory system agents|mesh-ancestor
25853988|NCT00061906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25853989|NCT00061906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25853990|NCT00061906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25853991|NCT00061906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25853992|NCT00061906|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25853993|NCT00061906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25853994|NCT00061906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25853995|NCT00061906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25853996|NCT00061919|Thalidomide|thalidomide|mesh-list
25853997|NCT00061919|Carboplatin|carboplatin|mesh-list
25853998|NCT00061919|Etoposide|etoposide|mesh-list
25853999|NCT00061919|Etoposide phosphate|etoposide phosphate|mesh-list
25854000|NCT00061919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854001|NCT00061919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25854002|NCT00061919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25854003|NCT00061919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25854004|NCT00061919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536990|NCT00653120|Adrenergic Agents|adrenergic agents|mesh-ancestor
24536992|NCT00653120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536993|NCT00653120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536994|NCT00653120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24536995|NCT00653120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24536996|NCT00653120|Vasodilator Agents|vasodilator agents|mesh-ancestor
24536997|NCT00653172|Streptogramin A|streptogramin a|mesh-list
24536998|NCT00653172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24536999|NCT00653172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24537000|NCT00653237|Chlorhexidine|chlorhexidine|mesh-list
25854005|NCT00061919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854006|NCT00061919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25854007|NCT00061919|Immunologic Factors|immunologic factors|mesh-ancestor
25854008|NCT00061919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854009|NCT00061919|Leprostatic Agents|leprostatic agents|mesh-ancestor
25854010|NCT00061919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25854011|NCT00061919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25854012|NCT00061919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25664298|NCT01668654|Anticonvulsants|anticonvulsants|mesh-ancestor
25664299|NCT01668654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25664300|NCT01668654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664301|NCT01668667|Gabapentin|gabapentin|mesh-list
25664302|NCT01668667|Analgesics|analgesics|mesh-ancestor
25664303|NCT01668667|Sensory System Agents|sensory system agents|mesh-ancestor
25664304|NCT01668667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24841471|NCT02216149|Capecitabine|capecitabine|mesh-list
24537002|NCT00653237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24537003|NCT00653237|Disinfectants|disinfectants|mesh-ancestor
24537005|NCT00653250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24537006|NCT00653250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24537007|NCT00653250|Analgesics|analgesics|mesh-ancestor
24537008|NCT00653250|Sensory System Agents|sensory system agents|mesh-ancestor
24537009|NCT00653250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24537010|NCT00653250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854013|NCT00061919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24852316|NCT02261922|Ticagrelor|ticagrelor|mesh-list
24852317|NCT02261922|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24852318|NCT02261922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24852319|NCT02261922|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25854014|NCT00061919|Growth Substances|growth substances|mesh-ancestor
24537051|NCT00653380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24537052|NCT00653380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24537053|NCT00653380|Antimalarials|antimalarials|mesh-ancestor
25854015|NCT00061919|Growth Inhibitors|growth inhibitors|mesh-ancestor
25854016|NCT00061958|Arsenic Trioxide|arsenic trioxide|mesh-list
25854017|NCT00061958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854018|NCT00061984|Doxorubicin|doxorubicin|mesh-list
25854019|NCT00061984|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25854020|NCT00061984|Ifosfamide|ifosfamide|mesh-list
25854021|NCT00061984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25854022|NCT00061984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854023|NCT00061984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25854024|NCT00061984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25854025|NCT00061984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854026|NCT00061984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854027|NCT00061984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25854028|NCT00061984|Alkylating Agents|alkylating agents|mesh-ancestor
25854029|NCT00061997|Inositol|inositol|mesh-list
25854030|NCT00061997|Vitamin B Complex|vitamin b complex|mesh-ancestor
25854031|NCT00061997|Vitamins|vitamins|mesh-ancestor
25854032|NCT00061997|Micronutrients|micronutrients|mesh-ancestor
25854033|NCT00061997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854034|NCT00062023|Aspirin|aspirin|mesh-list
24938917|NCT04014634|Antiemetics|antiemetics|mesh-ancestor
24938918|NCT04014634|Autonomic Agents|autonomic agents|mesh-ancestor
25854035|NCT00062023|Sulindac|sulindac|mesh-list
25854036|NCT00062023|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25854037|NCT00062023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25854038|NCT00062023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25854039|NCT00062023|Analgesics|analgesics|mesh-ancestor
25854040|NCT00062023|Sensory System Agents|sensory system agents|mesh-ancestor
25854041|NCT00062023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25854042|NCT00062023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854043|NCT00062023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25854044|NCT00062023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25854045|NCT00062023|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25854046|NCT00062023|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25854047|NCT00062023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938921|NCT04014634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24938922|NCT04014634|Glucocorticoids|glucocorticoids|mesh-ancestor
24938923|NCT04014634|Hormones|hormones|mesh-ancestor
24938924|NCT04014634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24938925|NCT04014634|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24938926|NCT04014634|Protective Agents|protective agents|mesh-ancestor
24938927|NCT04014634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24938928|NCT04014634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24938929|NCT04014855|Lactoferrin|lactoferrin|mesh-list
25202797|NCT02718547|Timolol|timolol|mesh-list
24938930|NCT04014855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24938931|NCT04014556|Aflibercept|aflibercept|mesh-list
24938932|NCT04014556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25202798|NCT02718547|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24537065|NCT00653393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537067|NCT00653406|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24537068|NCT00653406|Serotonin Agents|serotonin agents|mesh-ancestor
24537069|NCT00653406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24537070|NCT00653406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854048|NCT00062023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25854049|NCT00062023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25854050|NCT00062023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854051|NCT00062023|Antipyretics|antipyretics|mesh-ancestor
25876237|NCT03808610|Immunologic Factors|immunologic factors|mesh-ancestor
24841704|NCT02217631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841705|NCT02217631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24841706|NCT02217631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841707|NCT02217631|Antiemetics|antiemetics|mesh-ancestor
24841708|NCT02217631|Autonomic Agents|autonomic agents|mesh-ancestor
24841710|NCT02217631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25854052|NCT00062023|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25854053|NCT00062023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25854054|NCT00062023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854055|NCT00062036|Aldesleukin|aldesleukin|mesh-list
25854056|NCT00062036|Cyclophosphamide|cyclophosphamide|mesh-list
25854057|NCT00062036|Fludarabine|fludarabine|mesh-list
25854058|NCT00062036|Fludarabine phosphate|fludarabine phosphate|mesh-list
25854059|NCT00062036|Interleukin-2|interleukin-2|mesh-list
25854060|NCT00062036|Freund's Adjuvant|freund's adjuvant|mesh-list
25854061|NCT00062036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25854062|NCT00062036|Immunologic Factors|immunologic factors|mesh-ancestor
25854063|NCT00062036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854064|NCT00062036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25854065|NCT00062036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24938933|NCT04014556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24938934|NCT04014556|Growth Substances|growth substances|mesh-ancestor
24938935|NCT04014556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938936|NCT04014556|Growth Inhibitors|growth inhibitors|mesh-ancestor
24938937|NCT04014556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24763642|NCT01775540|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24763643|NCT01775540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24763644|NCT01775579|Metformin|metformin|mesh-list
24729214|NCT01620450|Insulin|insulin|mesh-list
24763645|NCT01775579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25854066|NCT00062036|Alkylating Agents|alkylating agents|mesh-ancestor
25854067|NCT00062036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854068|NCT00062036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854069|NCT00062036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25854070|NCT00062036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24452224|NCT00326456|Paclitaxel|paclitaxel|mesh-list
25854071|NCT00062036|Antimetabolites|antimetabolites|mesh-ancestor
25854072|NCT00062036|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25854073|NCT00062036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25854074|NCT00062036|Analgesics|analgesics|mesh-ancestor
25854075|NCT00062036|Sensory System Agents|sensory system agents|mesh-ancestor
25854076|NCT00062036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25854077|NCT00062036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25854078|NCT00062036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25854079|NCT00062036|Antiviral Agents|antiviral agents|mesh-ancestor
25854080|NCT00062036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25854081|NCT00062062|Paclitaxel|paclitaxel|mesh-list
25854082|NCT00062062|Carboplatin|carboplatin|mesh-list
25854083|NCT00062062|Gefitinib|gefitinib|mesh-list
25854084|NCT00062062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25854085|NCT00062062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854086|NCT00062062|Tubulin Modulators|tubulin modulators|mesh-ancestor
25854087|NCT00062062|Antimitotic Agents|antimitotic agents|mesh-ancestor
24537084|NCT00653419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24537085|NCT00653419|Serotonin Agents|serotonin agents|mesh-ancestor
24537086|NCT00653419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24537087|NCT00653419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537088|NCT00653445|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24537089|NCT00653445|Ezetimibe|ezetimibe|mesh-list
24537090|NCT00653445|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24537091|NCT00653445|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24537092|NCT00653445|Antimetabolites|antimetabolites|mesh-ancestor
24537093|NCT00653445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537095|NCT00653445|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24537096|NCT00653445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537097|NCT00653458|Ondansetron|ondansetron|mesh-list
24537098|NCT00653458|Antiemetics|antiemetics|mesh-ancestor
24537099|NCT00653458|Autonomic Agents|autonomic agents|mesh-ancestor
24537112|NCT00653458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24537113|NCT00653458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24537115|NCT00653510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25664305|NCT01668667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664306|NCT01668667|Anticonvulsants|anticonvulsants|mesh-ancestor
25664307|NCT01668667|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25664308|NCT01668667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25664309|NCT01668667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25664310|NCT01668667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25664311|NCT01668667|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24729278|NCT01620944|Protease Inhibitors|protease inhibitors|mesh-ancestor
24537117|NCT00653510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537118|NCT00653549|Torsemide|torsemide|mesh-list
24537119|NCT00653549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24537120|NCT00653549|Diuretics|diuretics|mesh-ancestor
24763646|NCT01775579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24763647|NCT01775579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763648|NCT01775579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24763649|NCT01775579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24763650|NCT01775579|Antimetabolites|antimetabolites|mesh-ancestor
24763651|NCT01775579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763652|NCT01775579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24763653|NCT01775579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24763654|NCT01775579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763655|NCT01775618|Factor VIII|factor viii|mesh-list
24763656|NCT01775618|Coagulants|coagulants|mesh-ancestor
24763657|NCT01775631|Rituximab|rituximab|mesh-list
24763658|NCT01775631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24537121|NCT00653549|Natriuretic Agents|natriuretic agents|mesh-ancestor
24537122|NCT00653549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537123|NCT00653549|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24537124|NCT00653549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24537125|NCT00653549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537126|NCT00653562|Zolpidem|zolpidem|mesh-list
24537127|NCT00653562|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24537128|NCT00653562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25854088|NCT00062062|Mitosis Modulators|mitosis modulators|mesh-ancestor
25854089|NCT00062062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451244|NCT00322803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25854090|NCT00062062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25854091|NCT00062062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854092|NCT00062075|Romidepsin|romidepsin|mesh-list
25854093|NCT00062075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25854094|NCT00062075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854095|NCT00062101|Celecoxib|celecoxib|mesh-list
25854096|NCT00062101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25854097|NCT00062101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854098|NCT00062101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25854099|NCT00062101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854100|NCT00062101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854101|NCT00062101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25854102|NCT00062101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25854103|NCT00062101|Analgesics|analgesics|mesh-ancestor
25854104|NCT00062101|Sensory System Agents|sensory system agents|mesh-ancestor
25854105|NCT00062101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25854106|NCT00062101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854107|NCT00062101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25854108|NCT00062101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25854109|NCT00062101|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25854110|NCT00062101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25854111|NCT00062114|Rituximab|rituximab|mesh-list
25854112|NCT00062114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25854113|NCT00062114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854114|NCT00062114|Immunologic Factors|immunologic factors|mesh-ancestor
25854115|NCT00062114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854116|NCT00062114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25854117|NCT00062127|Thalidomide|thalidomide|mesh-list
25854118|NCT00062127|Irinotecan|irinotecan|mesh-list
25854119|NCT00062127|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25202799|NCT02718547|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25854120|NCT00062127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24537177|NCT00653848|Antimitotic Agents|antimitotic agents|mesh-ancestor
24537178|NCT00653848|Mitosis Modulators|mitosis modulators|mesh-ancestor
24537179|NCT00653848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537180|NCT00653874|Bilirubin|bilirubin|mesh-list
24537181|NCT00653874|Antioxidants|antioxidants|mesh-ancestor
24537182|NCT00653874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445576|NCT00301886|Zoledronic Acid|zoledronic acid|mesh-list
24537183|NCT00653874|Protective Agents|protective agents|mesh-ancestor
24537184|NCT00653874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537185|NCT00653926|Epinephrine|epinephrine|mesh-list
24537186|NCT00653926|Ropivacaine|ropivacaine|mesh-list
24537187|NCT00653926|Anesthetics, Local|anesthetics, local|mesh-ancestor
24625614|NCT01082705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24625615|NCT01082718|Artesunate|artesunate|mesh-list
24842010|NCT02219412|Ticagrelor|ticagrelor|mesh-list
25854121|NCT00062127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842024|NCT02219412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842026|NCT02219412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24754419|NCT01720485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24679142|NCT01367028|Growth Inhibitors|growth inhibitors|mesh-ancestor
25854122|NCT00062127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625616|NCT01082718|Mefloquine|mefloquine|mesh-list
24625617|NCT01082718|Antimalarials|antimalarials|mesh-ancestor
24625618|NCT01082718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24625619|NCT01082718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24625620|NCT01082718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24625621|NCT01082718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854123|NCT00062127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854124|NCT00062127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25854125|NCT00062127|Immunologic Factors|immunologic factors|mesh-ancestor
25854126|NCT00062127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854127|NCT00062127|Leprostatic Agents|leprostatic agents|mesh-ancestor
25854128|NCT00062127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25854129|NCT00062127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25854130|NCT00062127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25854131|NCT00062127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25854132|NCT00062127|Growth Substances|growth substances|mesh-ancestor
25854133|NCT00062127|Growth Inhibitors|growth inhibitors|mesh-ancestor
25854134|NCT00062140|Cyclophosphamide|cyclophosphamide|mesh-list
25854135|NCT00062140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24537194|NCT00653926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24537195|NCT00653926|Adrenergic Agents|adrenergic agents|mesh-ancestor
24537196|NCT00653926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24625622|NCT01082718|Antiviral Agents|antiviral agents|mesh-ancestor
24938938|NCT04014192|Dapagliflozin|dapagliflozin|mesh-list
24938939|NCT04014192|Empagliflozin|empagliflozin|mesh-list
24938940|NCT04014192|Canagliflozin|canagliflozin|mesh-list
25854136|NCT00062140|Immunologic Factors|immunologic factors|mesh-ancestor
24616649|NCT01038505|Sirolimus|sirolimus|mesh-list
24537226|NCT00654017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537227|NCT00654017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537233|NCT00654043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664312|NCT01668667|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25664313|NCT01668667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25664314|NCT01668667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664315|NCT01668667|Antimanic Agents|antimanic agents|mesh-ancestor
25664316|NCT01668797|Brexpiprazole|brexpiprazole|mesh-list
25664317|NCT01668797|Serotonin Agents|serotonin agents|mesh-ancestor
25664318|NCT01668797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25664319|NCT01668797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664320|NCT01668797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664321|NCT01668797|Dopamine Agonists|dopamine agonists|mesh-ancestor
25664322|NCT01668797|Dopamine Agents|dopamine agents|mesh-ancestor
25664323|NCT01668836|Resveratrol|resveratrol|mesh-list
25664324|NCT01668836|Antioxidants|antioxidants|mesh-ancestor
25664325|NCT01668836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664326|NCT01668836|Protective Agents|protective agents|mesh-ancestor
25664327|NCT01668836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664328|NCT01668836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664329|NCT01668836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25664330|NCT01669122|Nicotine|nicotine|mesh-list
25664331|NCT01669122|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25664332|NCT01669122|Autonomic Agents|autonomic agents|mesh-ancestor
24537234|NCT00654043|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24842037|NCT02219646|Vasodilator Agents|vasodilator agents|mesh-ancestor
24842038|NCT02219646|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24537235|NCT00654043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25854137|NCT00062140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854138|NCT00062140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25854139|NCT00062140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25854140|NCT00062140|Alkylating Agents|alkylating agents|mesh-ancestor
25854141|NCT00062140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854142|NCT00062140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854143|NCT00062140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25854144|NCT00062179|Celecoxib|celecoxib|mesh-list
25854145|NCT00062179|Paclitaxel|paclitaxel|mesh-list
25854146|NCT00062179|Carboplatin|carboplatin|mesh-list
25854147|NCT00062179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24938944|NCT04014192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938946|NCT04014101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24938947|NCT04014101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24938948|NCT04014101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24938949|NCT04014101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852421|NCT02262533|Adrenergic Agents|adrenergic agents|mesh-ancestor
24537276|NCT00654160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537277|NCT00654160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24537278|NCT00654160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24537279|NCT00654160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24537280|NCT00654160|Immunologic Factors|immunologic factors|mesh-ancestor
24537281|NCT00654160|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24537282|NCT00654160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24537283|NCT00654160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537284|NCT00654160|Antidotes|antidotes|mesh-ancestor
24537285|NCT00654160|Protective Agents|protective agents|mesh-ancestor
24537286|NCT00654160|Vitamin B Complex|vitamin b complex|mesh-ancestor
24537288|NCT00654160|Micronutrients|micronutrients|mesh-ancestor
24537289|NCT00654173|Atorvastatin|atorvastatin|mesh-list
25854148|NCT00062179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854149|NCT00062179|Tubulin Modulators|tubulin modulators|mesh-ancestor
25854150|NCT00062179|Antimitotic Agents|antimitotic agents|mesh-ancestor
24537299|NCT00654225|Atorvastatin|atorvastatin|mesh-list
24537300|NCT00654225|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24537301|NCT00654225|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24537302|NCT00654225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24537303|NCT00654225|Antimetabolites|antimetabolites|mesh-ancestor
25854151|NCT00062179|Mitosis Modulators|mitosis modulators|mesh-ancestor
25854152|NCT00062179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854153|NCT00062179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25854154|NCT00062179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25854155|NCT00062179|Analgesics|analgesics|mesh-ancestor
25854156|NCT00062179|Sensory System Agents|sensory system agents|mesh-ancestor
25854157|NCT00062179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25854158|NCT00062179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854159|NCT00062179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25854160|NCT00062179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25854161|NCT00062179|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25854162|NCT00062179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25854163|NCT00062179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537313|NCT00654277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24537314|NCT00654277|Antipruritics|antipruritics|mesh-ancestor
24537315|NCT00654277|Dermatologic Agents|dermatologic agents|mesh-ancestor
24537316|NCT00654277|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24537317|NCT00654277|Serotonin Agents|serotonin agents|mesh-ancestor
24537318|NCT00654277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24537319|NCT00654277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537320|NCT00654277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24537321|NCT00654277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24537322|NCT00654277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25854164|NCT00062205|Imatinib Mesylate|imatinib mesylate|mesh-list
25854165|NCT00062205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854166|NCT00062205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25854167|NCT00062205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854168|NCT00062205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854169|NCT00062231|Amoxicillin|amoxicillin|mesh-list
25854170|NCT00062231|Moxifloxacin|moxifloxacin|mesh-list
25854171|NCT00062231|Ciprofloxacin|ciprofloxacin|mesh-list
25664333|NCT01669122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25664334|NCT01669122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842212|NCT02220088|Immunologic Factors|immunologic factors|mesh-ancestor
24842213|NCT02220088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842214|NCT02220088|Antidotes|antidotes|mesh-ancestor
24842215|NCT02220088|Protective Agents|protective agents|mesh-ancestor
24842216|NCT02220088|Vitamin B Complex|vitamin b complex|mesh-ancestor
24842217|NCT02220088|Vitamins|vitamins|mesh-ancestor
24842218|NCT02220088|Micronutrients|micronutrients|mesh-ancestor
24842219|NCT02220088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25854172|NCT00062231|Clavulanic Acid|clavulanic acid|mesh-list
25854173|NCT00062231|Clavulanic Acids|clavulanic acids|mesh-list
25854174|NCT00062231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24729579|NCT01622439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24729580|NCT01622439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24729581|NCT01622439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729582|NCT01622439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24729583|NCT01622439|Glucocorticoids|glucocorticoids|mesh-ancestor
24729585|NCT01622439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24729586|NCT01622439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25854175|NCT00062231|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25854176|NCT00062231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25854177|NCT00062231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25854178|NCT00062231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25854179|NCT00062231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25854180|NCT00062231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854181|NCT00062231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854182|NCT00062231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882917|NCT04769206|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25854183|NCT00062231|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25854184|NCT00062231|Contraceptive Agents|contraceptive agents|mesh-ancestor
25854185|NCT00062231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24537323|NCT00654277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24537324|NCT00654277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24537338|NCT00654290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24537343|NCT00654290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24537386|NCT00654459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24537387|NCT00654485|Atorvastatin|atorvastatin|mesh-list
24537388|NCT00654485|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24537389|NCT00654485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25075940|NCT03377218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537390|NCT00654485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24537391|NCT00654485|Antimetabolites|antimetabolites|mesh-ancestor
24537392|NCT00654485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537393|NCT00654485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24537394|NCT00654485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24537395|NCT00654485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537423|NCT00654576|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24537424|NCT00654576|Serotonin Agents|serotonin agents|mesh-ancestor
24537425|NCT00654576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24729609|NCT01622556|Immunologic Factors|immunologic factors|mesh-ancestor
24537426|NCT00654576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537427|NCT00654576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537428|NCT00654576|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25854186|NCT00062231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854187|NCT00062231|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25854188|NCT00062231|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25854189|NCT00062231|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25854190|NCT00062231|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25854191|NCT00062231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24537522|NCT00655109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24537535|NCT00655109|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24537537|NCT00655109|Histamine Antagonists|histamine antagonists|mesh-ancestor
24537538|NCT00655109|Histamine Agents|histamine agents|mesh-ancestor
24537539|NCT00655109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24537540|NCT00655109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537541|NCT00655122|Dalteparin|dalteparin|mesh-list
24537542|NCT00655122|Tinzaparin|tinzaparin|mesh-list
25664335|NCT01669122|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25664336|NCT01669122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25664337|NCT01669122|Cholinergic Agents|cholinergic agents|mesh-ancestor
25664338|NCT01669122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25664339|NCT01669122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664340|NCT01669343|Letrozole|letrozole|mesh-list
25664341|NCT01669343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24842495|NCT02221492|Antiviral Agents|antiviral agents|mesh-ancestor
24537543|NCT00655122|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24537545|NCT00655122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24537546|NCT00655122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24537547|NCT00655122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729668|NCT01623102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24729669|NCT01623102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24729708|NCT01623375|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24537548|NCT00655135|Vedolizumab|vedolizumab|mesh-list
24938957|NCT04014244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24938958|NCT04014244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938959|NCT04014244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25854192|NCT00062231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25854193|NCT00062244|Oblimersen|oblimersen|mesh-list
25854194|NCT00062244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854195|NCT00062257|Irofulven|irofulven|mesh-list
25854196|NCT00062257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25854197|NCT00062257|Alkylating Agents|alkylating agents|mesh-ancestor
25854198|NCT00062257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854199|NCT00062257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854200|NCT00062270|Gemcitabine|gemcitabine|mesh-list
25854201|NCT00062270|Cisplatin|cisplatin|mesh-list
25854202|NCT00062270|Docetaxel|docetaxel|mesh-list
25854203|NCT00062270|Gefitinib|gefitinib|mesh-list
25854204|NCT00062270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854205|NCT00062270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25854206|NCT00062270|Antimetabolites|antimetabolites|mesh-ancestor
24537615|NCT00655512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24537616|NCT00655512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24537617|NCT00655512|Analgesics|analgesics|mesh-ancestor
25854207|NCT00062270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854208|NCT00062270|Antiviral Agents|antiviral agents|mesh-ancestor
25854209|NCT00062270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25854210|NCT00062270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854211|NCT00062270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25854212|NCT00062270|Immunologic Factors|immunologic factors|mesh-ancestor
25854213|NCT00062270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854214|NCT00062270|Tubulin Modulators|tubulin modulators|mesh-ancestor
25854215|NCT00062270|Antimitotic Agents|antimitotic agents|mesh-ancestor
24729709|NCT01623375|Insulin, Long-Acting|insulin, long-acting|mesh-list
25854216|NCT00062270|Mitosis Modulators|mitosis modulators|mesh-ancestor
25854217|NCT00062270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25854218|NCT00062283|Alanosine|alanosine|mesh-list
25854219|NCT00062283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25854220|NCT00062283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854221|NCT00062283|Chelating Agents|chelating agents|mesh-ancestor
25854222|NCT00062283|Sequestering Agents|sequestering agents|mesh-ancestor
25854223|NCT00062283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854224|NCT00062296|Rituximab|rituximab|mesh-list
25854225|NCT00062296|Epirubicin|epirubicin|mesh-list
25854226|NCT00062296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25854227|NCT00062296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854228|NCT00062296|Immunologic Factors|immunologic factors|mesh-ancestor
25854229|NCT00062296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854230|NCT00062296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25854231|NCT00062296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25854232|NCT00062296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25854233|NCT00062296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25854234|NCT00062296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854235|NCT00062296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854236|NCT00062322|Cisplatin|cisplatin|mesh-list
25854237|NCT00062322|Irinotecan|irinotecan|mesh-list
24537620|NCT00655512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24537621|NCT00655512|Dermatologic Agents|dermatologic agents|mesh-ancestor
24537622|NCT00655512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24537623|NCT00655512|Immunologic Factors|immunologic factors|mesh-ancestor
24537624|NCT00655512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25664342|NCT01669343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24537625|NCT00655512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664343|NCT01669343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25664344|NCT01669343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664345|NCT01669343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664346|NCT01669343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25664347|NCT01669343|Hormone Antagonists|hormone antagonists|mesh-ancestor
25664348|NCT01669343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24842699|NCT02222727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24842700|NCT02222727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537626|NCT00655512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537627|NCT00655590|Sildenafil Citrate|sildenafil citrate|mesh-list
24537628|NCT00655590|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24537629|NCT00655590|Vasodilator Agents|vasodilator agents|mesh-ancestor
24537630|NCT00655590|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24537631|NCT00655590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24537632|NCT00655590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537633|NCT00655590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537634|NCT00655590|Urological Agents|urological agents|mesh-ancestor
24537637|NCT00655603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24537638|NCT00655603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537639|NCT00655603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24537640|NCT00655616|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24537666|NCT00655655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24938974|NCT04014361|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24938976|NCT04014283|Antioxidants|antioxidants|mesh-ancestor
24938977|NCT04014283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938978|NCT04014283|Protective Agents|protective agents|mesh-ancestor
24938979|NCT04014283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938980|NCT04014283|Trace Elements|trace elements|mesh-ancestor
24938981|NCT04014283|Micronutrients|micronutrients|mesh-ancestor
24938982|NCT04013815|Ropivacaine|ropivacaine|mesh-list
24938983|NCT04013815|Anesthetics, Local|anesthetics, local|mesh-ancestor
24938984|NCT04013815|Anesthetics|anesthetics|mesh-ancestor
24938985|NCT04013815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24938986|NCT04013815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938987|NCT04013815|Sensory System Agents|sensory system agents|mesh-ancestor
25854238|NCT00062322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854239|NCT00062322|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25854240|NCT00062322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25854241|NCT00062322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854242|NCT00062322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854243|NCT00062426|Leucovorin|leucovorin|mesh-list
25854244|NCT00062426|Bevacizumab|bevacizumab|mesh-list
25854245|NCT00062426|Fluorouracil|fluorouracil|mesh-list
25854246|NCT00062426|Capecitabine|capecitabine|mesh-list
25854247|NCT00062426|Oxaliplatin|oxaliplatin|mesh-list
25854248|NCT00062426|Calcium|calcium|mesh-list
24537690|NCT00655824|Ofatumumab|ofatumumab|mesh-list
24537691|NCT00655824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24537692|NCT00655837|Gemcitabine|gemcitabine|mesh-list
24537693|NCT00655837|Rituximab|rituximab|mesh-list
24537694|NCT00655837|Dacetuzumab|dacetuzumab|mesh-list
25854249|NCT00062426|Levoleucovorin|levoleucovorin|mesh-list
25854250|NCT00062426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25854251|NCT00062426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24537704|NCT00655837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24537705|NCT00655837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537706|NCT00655837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24537709|NCT00655915|Anesthetics, Local|anesthetics, local|mesh-ancestor
24938989|NCT04013581|Empagliflozin|empagliflozin|mesh-list
24938990|NCT04013581|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24938991|NCT04013581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938992|NCT04013581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24938993|NCT04013581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938994|NCT04013919|Insulin|insulin|mesh-list
24938995|NCT04013919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24938996|NCT04013919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24938997|NCT04013919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938998|NCT04013646|Epoetin Alfa|epoetin alfa|mesh-list
24938999|NCT04013646|Hematinics|hematinics|mesh-ancestor
24939000|NCT04013659|Hydrogen Peroxide|hydrogen peroxide|mesh-list
24939001|NCT04013659|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24939002|NCT04013659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24939003|NCT04013620|Abatacept|abatacept|mesh-list
24939004|NCT04013620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25075941|NCT03377218|Protective Agents|protective agents|mesh-ancestor
25854252|NCT00062426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25854253|NCT00062426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25854254|NCT00062426|Growth Substances|growth substances|mesh-ancestor
25664349|NCT01669343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664350|NCT01669421|Protease Inhibitors|protease inhibitors|mesh-list
25854255|NCT00062426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854257|NCT00062426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25854258|NCT00062426|Antimetabolites|antimetabolites|mesh-ancestor
25854259|NCT00062426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854260|NCT00062426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25854261|NCT00062426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25854262|NCT00062426|Immunologic Factors|immunologic factors|mesh-ancestor
25854263|NCT00062426|Antidotes|antidotes|mesh-ancestor
25854264|NCT00062426|Protective Agents|protective agents|mesh-ancestor
25854265|NCT00062426|Vitamin B Complex|vitamin b complex|mesh-ancestor
25854266|NCT00062426|Vitamins|vitamins|mesh-ancestor
25854267|NCT00062426|Micronutrients|micronutrients|mesh-ancestor
25854268|NCT00062478|Camptothecin|camptothecin|mesh-list
25854269|NCT00062478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25854270|NCT00062478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24636945|NCT01148160|Hormone Antagonists|hormone antagonists|mesh-ancestor
25854271|NCT00062478|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25854272|NCT00062478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25854273|NCT00062478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939007|NCT04013620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25854274|NCT00062478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854275|NCT00062556|Niacin|niacin|mesh-list
25854276|NCT00062556|Lovastatin|lovastatin|mesh-list
24537789|NCT00656188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537790|NCT00656188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537791|NCT00656188|Urological Agents|urological agents|mesh-ancestor
24537793|NCT00656214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24537794|NCT00656214|Antioxidants|antioxidants|mesh-ancestor
25854277|NCT00062556|L 647318|l 647318|mesh-list
25854278|NCT00062556|Dihydromevinolin|dihydromevinolin|mesh-list
25854279|NCT00062556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25854280|NCT00062556|Antimetabolites|antimetabolites|mesh-ancestor
25854281|NCT00062556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854282|NCT00062556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25854283|NCT00062556|Vasodilator Agents|vasodilator agents|mesh-ancestor
25854284|NCT00062556|Vitamin B Complex|vitamin b complex|mesh-ancestor
25854285|NCT00062556|Vitamins|vitamins|mesh-ancestor
25854286|NCT00062556|Micronutrients|micronutrients|mesh-ancestor
25854287|NCT00062556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854288|NCT00062556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25854289|NCT00062556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25854290|NCT00062556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854291|NCT00062595|Vitamin K 1|vitamin k 1|mesh-list
25854292|NCT00062595|Vitamin K|vitamin k|mesh-list
25854293|NCT00062595|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25854294|NCT00062595|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25854295|NCT00062595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854296|NCT00062595|Hemostatics|hemostatics|mesh-ancestor
25854297|NCT00062595|Coagulants|coagulants|mesh-ancestor
25854298|NCT00062595|Vitamins|vitamins|mesh-ancestor
25854299|NCT00062595|Micronutrients|micronutrients|mesh-ancestor
25854300|NCT00062595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854301|NCT00062660|Tipranavir|tipranavir|mesh-list
25854302|NCT00062660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25854303|NCT00062660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25854304|NCT00062660|Antiviral Agents|antiviral agents|mesh-ancestor
25854305|NCT00062660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25854306|NCT00062673|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25854307|NCT00062673|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25854308|NCT00062673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25854309|NCT00062673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25854310|NCT00062673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854311|NCT00062673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25854312|NCT00062673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854313|NCT00062673|Analgesics|analgesics|mesh-ancestor
24537816|NCT00656318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537817|NCT00656318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24537872|NCT00656591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537874|NCT00656591|Dermatologic Agents|dermatologic agents|mesh-ancestor
24537875|NCT00656591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537876|NCT00656591|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24537877|NCT00656591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24537878|NCT00656591|Immunologic Factors|immunologic factors|mesh-ancestor
25854314|NCT00062673|Sensory System Agents|sensory system agents|mesh-ancestor
25854315|NCT00062673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25664351|NCT01669421|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25664352|NCT01669421|Protein C Inhibitor|protein c inhibitor|mesh-list
25854316|NCT00062673|Antidepressive Agents|antidepressive agents|mesh-ancestor
25854317|NCT00062673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25854318|NCT00062673|Dopamine Agents|dopamine agents|mesh-ancestor
25854319|NCT00062686|Lapatinib|lapatinib|mesh-list
25854320|NCT00062686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854321|NCT00062686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25854322|NCT00062686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854323|NCT00062686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854324|NCT00062699|Calcitriol|calcitriol|mesh-list
25854325|NCT00062699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24729958|NCT01624805|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25854326|NCT00062699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854327|NCT00062699|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25854328|NCT00062699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25854329|NCT00062699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939013|NCT04013958|Sensory System Agents|sensory system agents|mesh-ancestor
24939014|NCT04013958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24939015|NCT04013958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939016|NCT04013958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24939017|NCT04013958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24939018|NCT04013958|Anesthetics, General|anesthetics, general|mesh-ancestor
24939019|NCT04013958|Anesthetics|anesthetics|mesh-ancestor
24939020|NCT04013958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24939021|NCT04013958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25050461|NCT00498212|Immunologic Factors|immunologic factors|mesh-ancestor
25854330|NCT00062699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24537915|NCT00656747|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24537916|NCT00656747|Contraceptive Agents|contraceptive agents|mesh-ancestor
24537917|NCT00656747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24537918|NCT00656747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537919|NCT00656747|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24537922|NCT00656747|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24537924|NCT00656773|Morphine|morphine|mesh-list
24537925|NCT00656773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24537926|NCT00656773|Narcotics|narcotics|mesh-ancestor
24537927|NCT00656773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24537928|NCT00656773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537929|NCT00656773|Analgesics|analgesics|mesh-ancestor
24537930|NCT00656773|Sensory System Agents|sensory system agents|mesh-ancestor
24537931|NCT00656773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25854331|NCT00062699|Vitamins|vitamins|mesh-ancestor
25854332|NCT00062699|Micronutrients|micronutrients|mesh-ancestor
25854333|NCT00062699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25876238|NCT03808610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876239|NCT03808610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25876240|NCT03808610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25876241|NCT03808610|Alkylating Agents|alkylating agents|mesh-ancestor
25876242|NCT03808610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876243|NCT03808610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876244|NCT03808610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25876245|NCT03808610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25876246|NCT03808610|Antiemetics|antiemetics|mesh-ancestor
24537932|NCT00656773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24537933|NCT00656773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24537934|NCT00656773|Anesthetics, General|anesthetics, general|mesh-ancestor
24537935|NCT00656773|Anesthetics|anesthetics|mesh-ancestor
24537936|NCT00656786|Vitamin K 3|vitamin k 3|mesh-list
24537937|NCT00656786|Vitamin K|vitamin k|mesh-list
24537938|NCT00656786|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24537939|NCT00656786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24537940|NCT00656786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537941|NCT00656786|Hemostatics|hemostatics|mesh-ancestor
24537942|NCT00656786|Coagulants|coagulants|mesh-ancestor
24955121|NCT03868046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24955122|NCT03868046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955123|NCT03868046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24955124|NCT03867929|Vitamin D|vitamin d|mesh-list
24955125|NCT03867929|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
24955126|NCT03867929|Calcifediol|calcifediol|mesh-list
24955127|NCT03867929|Vitamins|vitamins|mesh-ancestor
25664353|NCT01669421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24955128|NCT03867929|Micronutrients|micronutrients|mesh-ancestor
24843287|NCT02226783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24955129|NCT03867929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955130|NCT03867929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24955132|NCT03867994|Atorvastatin|atorvastatin|mesh-list
25854334|NCT00062712|Sirolimus|sirolimus|mesh-list
25854335|NCT00062712|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25854336|NCT00062712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25854337|NCT00062712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25854338|NCT00062712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25854339|NCT00062712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854340|NCT00062712|Antifungal Agents|antifungal agents|mesh-ancestor
24463579|NCT00361452|Sympathomimetics|sympathomimetics|mesh-ancestor
24463580|NCT00361452|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24463581|NCT00361452|Tocolytic Agents|tocolytic agents|mesh-ancestor
25854341|NCT00062712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25854342|NCT00062712|Immunologic Factors|immunologic factors|mesh-ancestor
25854343|NCT00062712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854344|NCT00062790|Dutasteride|dutasteride|mesh-list
25854345|NCT00062790|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25854346|NCT00062790|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25854347|NCT00062790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854348|NCT00062790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854349|NCT00062790|Hormone Antagonists|hormone antagonists|mesh-ancestor
25854350|NCT00062790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25854351|NCT00062790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854352|NCT00062803|Heparin|heparin|mesh-list
25854353|NCT00062803|Warfarin|warfarin|mesh-list
24852503|NCT02262637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25854354|NCT00062803|Acenocoumarol|acenocoumarol|mesh-list
25854355|NCT00062803|Anticoagulants|anticoagulants|mesh-ancestor
24537980|NCT00657059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24537981|NCT00657059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537982|NCT00657059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24537983|NCT00657059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24537984|NCT00657059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24537985|NCT00657059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24537986|NCT00657059|Antitubercular Agents|antitubercular agents|mesh-ancestor
25854356|NCT00062803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25854357|NCT00062803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25854358|NCT00062803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854359|NCT00062816|Ribavirin|ribavirin|mesh-list
25854360|NCT00062816|Antimetabolites|antimetabolites|mesh-ancestor
25854361|NCT00062816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854362|NCT00062816|Antiviral Agents|antiviral agents|mesh-ancestor
25854363|NCT00062816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25208330|NCT02643420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854364|NCT00062842|Irinotecan|irinotecan|mesh-list
25854365|NCT00062842|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25854366|NCT00062842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25854367|NCT00062842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854368|NCT00062842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854369|NCT00062842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854370|NCT00062881|Mafosfamide|mafosfamide|mesh-list
25854371|NCT00062881|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24537995|NCT00657059|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24537996|NCT00657059|Protective Agents|protective agents|mesh-ancestor
24537997|NCT00657059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24537998|NCT00657059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24537999|NCT00657059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24538000|NCT00657137|Capecitabine|capecitabine|mesh-list
24538001|NCT00657137|Lapatinib|lapatinib|mesh-list
24538002|NCT00657137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24538003|NCT00657137|Antimetabolites|antimetabolites|mesh-ancestor
24538004|NCT00657137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538009|NCT00657163|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24538010|NCT00657163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25854372|NCT00062881|Immunologic Factors|immunologic factors|mesh-ancestor
25854373|NCT00062881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854374|NCT00062881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854375|NCT00062894|Tositumomab I-131|tositumomab i-131|mesh-list
25854376|NCT00062894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854377|NCT00062946|Fallypride|fallypride|mesh-list
25854378|NCT00062946|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25664354|NCT01669421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664355|NCT01669421|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25854379|NCT00062946|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25854380|NCT00062946|Dopamine Agents|dopamine agents|mesh-ancestor
25854381|NCT00062946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25854382|NCT00062946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854383|NCT00062946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854384|NCT00062972|Donepezil|donepezil|mesh-list
25854385|NCT00062972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25854386|NCT00062972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854387|NCT00062972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854388|NCT00062972|Cholinergic Agents|cholinergic agents|mesh-ancestor
25854389|NCT00062972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25854390|NCT00062972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854391|NCT00062972|Nootropic Agents|nootropic agents|mesh-ancestor
25854392|NCT00063011|Calcium|calcium|mesh-list
24538011|NCT00657163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24538012|NCT00657163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538013|NCT00657163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24538014|NCT00657163|Serotonin Agents|serotonin agents|mesh-ancestor
24538015|NCT00657163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538016|NCT00657163|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24538017|NCT00657163|Antidepressive Agents|antidepressive agents|mesh-ancestor
24538018|NCT00657163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24538019|NCT00657163|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24538023|NCT00657202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24538024|NCT00657202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24538025|NCT00657202|Growth Substances|growth substances|mesh-ancestor
24538026|NCT00657202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538027|NCT00657202|Growth Inhibitors|growth inhibitors|mesh-ancestor
24538028|NCT00657202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538029|NCT00657228|Heparin|heparin|mesh-list
24538030|NCT00657228|Anticoagulants|anticoagulants|mesh-ancestor
24538031|NCT00657228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24538032|NCT00657228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24538033|NCT00657228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538034|NCT00657254|Sorafenib|sorafenib|mesh-list
24616752|NCT01039090|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24538035|NCT00657254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538036|NCT00657254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24538037|NCT00657254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538038|NCT00657254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538039|NCT00657306|Hydrocortisone|hydrocortisone|mesh-list
24538040|NCT00657306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25854393|NCT00063011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25854394|NCT00063011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854395|NCT00063024|Calcium|calcium|mesh-list
24827539|NCT02140073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050472|NCT00495131|Interferon alpha-2|interferon alpha-2|mesh-list
25050473|NCT00495131|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25050474|NCT00495131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050475|NCT00495131|Antiviral Agents|antiviral agents|mesh-ancestor
25050476|NCT00495131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25050477|NCT00495131|Antimetabolites|antimetabolites|mesh-ancestor
25050478|NCT00495131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050479|NCT00495131|Immunologic Factors|immunologic factors|mesh-ancestor
25050480|NCT00495131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050481|NCT00491738|Bevacizumab|bevacizumab|mesh-list
24538107|NCT00657475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538108|NCT00657488|Thalidomide|thalidomide|mesh-list
24538109|NCT00657488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24538110|NCT00657488|Immunologic Factors|immunologic factors|mesh-ancestor
24538111|NCT00657488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538112|NCT00657488|Leprostatic Agents|leprostatic agents|mesh-ancestor
24538113|NCT00657488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24538139|NCT00657644|Vasodilator Agents|vasodilator agents|mesh-ancestor
24538140|NCT00657644|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24538142|NCT00657644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538143|NCT00657644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538144|NCT00657644|Urological Agents|urological agents|mesh-ancestor
24538145|NCT00657748|Triacetin|triacetin|mesh-list
24538146|NCT00657748|Lithium Carbonate|lithium carbonate|mesh-list
24538147|NCT00657748|Antidepressive Agents|antidepressive agents|mesh-ancestor
24538148|NCT00657748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24538169|NCT00657774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24843655|NCT02228616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24843656|NCT02228616|Serotonin Agents|serotonin agents|mesh-ancestor
24843657|NCT02228616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24843658|NCT02228616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538170|NCT00657774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538171|NCT00657774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24538172|NCT00657774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538173|NCT00657839|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24538175|NCT00657839|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25050483|NCT00491738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25050484|NCT00491738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050485|NCT00491738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24852532|NCT02262676|Anticoagulants|anticoagulants|mesh-ancestor
24538176|NCT00657839|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24538177|NCT00657839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854396|NCT00063024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24538178|NCT00657839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538179|NCT00657839|Urological Agents|urological agents|mesh-ancestor
24538180|NCT00657852|Pamidronate|pamidronate|mesh-list
24538181|NCT00657852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25854397|NCT00063024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854398|NCT00063076|Bexarotene|bexarotene|mesh-list
25854399|NCT00063076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854400|NCT00063089|Immunoglobulins|immunoglobulins|mesh-list
25854401|NCT00063089|Antibodies|antibodies|mesh-list
24538193|NCT00657878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24538194|NCT00657878|Topotecan|topotecan|mesh-list
24538195|NCT00657878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24538196|NCT00657878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538197|NCT00657878|Tubulin Modulators|tubulin modulators|mesh-ancestor
24538198|NCT00657878|Antimitotic Agents|antimitotic agents|mesh-ancestor
24538199|NCT00657878|Mitosis Modulators|mitosis modulators|mesh-ancestor
24538200|NCT00657878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538201|NCT00657878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24538202|NCT00657878|Antimetabolites|antimetabolites|mesh-ancestor
24538203|NCT00657878|Antiviral Agents|antiviral agents|mesh-ancestor
24538204|NCT00657878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24730190|NCT01627041|Daunorubicin|daunorubicin|mesh-list
24538205|NCT00657878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538206|NCT00657878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24538207|NCT00657878|Immunologic Factors|immunologic factors|mesh-ancestor
24538232|NCT00657943|Insulin Detemir|insulin detemir|mesh-list
24538233|NCT00657943|Protamines|protamines|mesh-list
24538234|NCT00657943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24538235|NCT00657943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538236|NCT00657943|Heparin Antagonists|heparin antagonists|mesh-ancestor
24538263|NCT00658255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24538264|NCT00658255|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24538294|NCT00658580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25202800|NCT02718547|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
24538296|NCT00658580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24538297|NCT00658580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24538298|NCT00658580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538299|NCT00658580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854402|NCT00063089|gamma-Globulins|gamma-globulins|mesh-list
25854403|NCT00063089|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25854404|NCT00063089|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25854405|NCT00063089|Immunologic Factors|immunologic factors|mesh-ancestor
25854406|NCT00063089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939022|NCT04013958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24939023|NCT04013958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24939024|NCT04013958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591313|NCT00915837|Hormones|hormones|mesh-ancestor
25854407|NCT00063128|Insulin|insulin|mesh-list
25854408|NCT00063128|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25854409|NCT00063128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25854410|NCT00063128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854411|NCT00063141|Irinotecan|irinotecan|mesh-list
25854412|NCT00063141|Cetuximab|cetuximab|mesh-list
25664356|NCT01669421|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25664357|NCT01669434|Ramipril|ramipril|mesh-list
25664358|NCT01669434|Enalapril|enalapril|mesh-list
25664359|NCT01669434|Enalaprilat|enalaprilat|mesh-list
25664360|NCT01669434|Lisinopril|lisinopril|mesh-list
25664361|NCT01669434|Perindopril|perindopril|mesh-list
25854413|NCT00063141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24843753|NCT02229201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25854414|NCT00063141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25854415|NCT00063141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854416|NCT00063141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854417|NCT00063141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854418|NCT00063141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25854419|NCT00063193|Minocycline|minocycline|mesh-list
25854420|NCT00063193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25854421|NCT00063193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25854422|NCT00063310|Leuprolide|leuprolide|mesh-list
25854423|NCT00063310|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25854424|NCT00063310|Fertility Agents|fertility agents|mesh-ancestor
25854425|NCT00063310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25854426|NCT00063310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854427|NCT00063310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25854428|NCT00063310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538401|NCT00659100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24538402|NCT00659100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24538416|NCT00659178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24538417|NCT00659178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854429|NCT00063323|Bupropion|bupropion|mesh-list
25854430|NCT00063323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25854431|NCT00063323|Antidepressive Agents|antidepressive agents|mesh-ancestor
25854432|NCT00063323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24538503|NCT00659568|Antifungal Agents|antifungal agents|mesh-ancestor
24538504|NCT00659568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24538505|NCT00659568|Immunologic Factors|immunologic factors|mesh-ancestor
24538506|NCT00659594|Ciclesonide|ciclesonide|mesh-list
24538507|NCT00659594|Glucocorticoids|glucocorticoids|mesh-ancestor
24538508|NCT00659594|Hormones|hormones|mesh-ancestor
24538509|NCT00659594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24538510|NCT00659594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538511|NCT00659594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24538512|NCT00659659|Benralizumab|benralizumab|mesh-list
24538513|NCT00659659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24538514|NCT00659659|Respiratory System Agents|respiratory system agents|mesh-ancestor
24538515|NCT00659685|Ondansetron|ondansetron|mesh-list
24538516|NCT00659685|Antiemetics|antiemetics|mesh-ancestor
24642493|NCT01179724|Pantoprazole|pantoprazole|mesh-list
24538517|NCT00659685|Autonomic Agents|autonomic agents|mesh-ancestor
24538518|NCT00659685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24538547|NCT00659841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24538548|NCT00659841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538549|NCT00659841|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24538550|NCT00659919|Trazodone|trazodone|mesh-list
24538551|NCT00659919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24538552|NCT00659919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24538553|NCT00659919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24538554|NCT00659919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538555|NCT00659919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24538556|NCT00659919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24538557|NCT00659919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24538558|NCT00659919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24538559|NCT00659919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538561|NCT00659919|Serotonin Agents|serotonin agents|mesh-ancestor
24538563|NCT00659919|Antidepressive Agents|antidepressive agents|mesh-ancestor
24538565|NCT00659958|Anticonvulsants|anticonvulsants|mesh-ancestor
24538566|NCT00659958|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24538572|NCT00659997|Levamisole|levamisole|mesh-list
24538573|NCT00659997|Anthelmintics|anthelmintics|mesh-ancestor
24538574|NCT00659997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24538575|NCT00659997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24538576|NCT00659997|Anticestodal Agents|anticestodal agents|mesh-ancestor
24538577|NCT00659997|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24538578|NCT00659997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24538579|NCT00659997|Tubulin Modulators|tubulin modulators|mesh-ancestor
24538580|NCT00659997|Antimitotic Agents|antimitotic agents|mesh-ancestor
24538661|NCT00660244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538662|NCT00660257|Vaccines|vaccines|mesh-list
24538663|NCT00660257|Immunologic Factors|immunologic factors|mesh-ancestor
25664362|NCT01669434|Benazepril|benazepril|mesh-list
25664363|NCT01669434|Captopril|captopril|mesh-list
25664364|NCT01669434|Quinapril|quinapril|mesh-list
25664365|NCT01669434|Trandolapril|trandolapril|mesh-list
25854433|NCT00063323|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25854434|NCT00063323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25854435|NCT00063323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25854436|NCT00063323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854437|NCT00063323|Dopamine Agents|dopamine agents|mesh-ancestor
25854438|NCT00063323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25854439|NCT00063323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854440|NCT00063323|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25854441|NCT00063323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24451269|NCT00322920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451270|NCT00322920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451271|NCT00322972|Azithromycin|azithromycin|mesh-list
24451272|NCT00322972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24538720|NCT00660582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538721|NCT00660582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24538722|NCT00660582|Antidotes|antidotes|mesh-ancestor
24538723|NCT00660582|Protective Agents|protective agents|mesh-ancestor
24538724|NCT00660582|Vitamin B Complex|vitamin b complex|mesh-ancestor
24538725|NCT00660582|Vitamins|vitamins|mesh-ancestor
24538726|NCT00660582|Micronutrients|micronutrients|mesh-ancestor
24538727|NCT00660582|Hematinics|hematinics|mesh-ancestor
24538728|NCT00660621|Bevacizumab|bevacizumab|mesh-list
24451353|NCT00323323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451354|NCT00323323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451355|NCT00323323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24451356|NCT00323323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25854442|NCT00063323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451357|NCT00323323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25854443|NCT00063388|Cetuximab|cetuximab|mesh-list
24939063|NCT04013386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939064|NCT04013386|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24939065|NCT04013386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24939066|NCT04013386|Antidepressive Agents|antidepressive agents|mesh-ancestor
24939067|NCT04013386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24939068|NCT04013386|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24939069|NCT04013386|Histamine Antagonists|histamine antagonists|mesh-ancestor
24939070|NCT04013386|Histamine Agents|histamine agents|mesh-ancestor
24939071|NCT04013386|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24939072|NCT04013386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25202801|NCT02718547|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24800380|NCT01975324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24939085|NCT04013438|Estradiol|estradiol|mesh-list
24939114|NCT04013243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24939115|NCT04013243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538767|NCT00660751|Dopamine Agents|dopamine agents|mesh-ancestor
24538768|NCT00660764|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24538769|NCT00660764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25854444|NCT00063388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25854445|NCT00063388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854446|NCT00063401|Paclitaxel|paclitaxel|mesh-list
25854447|NCT00063401|Carboplatin|carboplatin|mesh-list
25854448|NCT00063401|Cetuximab|cetuximab|mesh-list
25854449|NCT00063401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25854450|NCT00063401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538830|NCT00660894|Antimetabolites|antimetabolites|mesh-ancestor
25854451|NCT00063401|Tubulin Modulators|tubulin modulators|mesh-ancestor
25854452|NCT00063401|Antimitotic Agents|antimitotic agents|mesh-ancestor
25854453|NCT00063401|Mitosis Modulators|mitosis modulators|mesh-ancestor
25854454|NCT00063401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854455|NCT00063401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24538798|NCT00660855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538800|NCT00660855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24538802|NCT00660855|Sensory System Agents|sensory system agents|mesh-ancestor
25854456|NCT00063414|Alicaforsen|alicaforsen|mesh-list
25854457|NCT00063414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25854458|NCT00063414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25854459|NCT00063414|Immunologic Factors|immunologic factors|mesh-ancestor
25854460|NCT00063414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854461|NCT00063453|Vitamins|vitamins|mesh-list
25854462|NCT00063453|Vitamin E|vitamin e|mesh-list
25854463|NCT00063453|Tocopherols|tocopherols|mesh-list
25854464|NCT00063453|Tocotrienols|tocotrienols|mesh-list
25854465|NCT00063453|alpha-Tocopherol|alpha-tocopherol|mesh-list
24939124|NCT04013464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24730543|NCT01628770|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
24730545|NCT01628783|Citalopram|citalopram|mesh-list
24939125|NCT04013464|Serotonin Agents|serotonin agents|mesh-ancestor
24939126|NCT04013464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939127|NCT04013464|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24939128|NCT04013464|Antidepressive Agents|antidepressive agents|mesh-ancestor
24939129|NCT04013464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24763806|NCT01777100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25854466|NCT00063453|Selenium|selenium|mesh-list
25854467|NCT00063453|Micronutrients|micronutrients|mesh-ancestor
25854468|NCT00063453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451373|NCT00323375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24451374|NCT00323375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24451375|NCT00323375|Antimalarials|antimalarials|mesh-ancestor
24451376|NCT00323375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24451377|NCT00323505|Interferons|interferons|mesh-list
24451378|NCT00323505|Interferon-alpha|interferon-alpha|mesh-list
25854469|NCT00063453|Antioxidants|antioxidants|mesh-ancestor
24451414|NCT00323583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24451415|NCT00323583|Immunologic Factors|immunologic factors|mesh-ancestor
24451416|NCT00323583|Antidotes|antidotes|mesh-ancestor
25854470|NCT00063453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854471|NCT00063453|Protective Agents|protective agents|mesh-ancestor
25854472|NCT00063453|Trace Elements|trace elements|mesh-ancestor
25854473|NCT00063479|Zoledronic Acid|zoledronic acid|mesh-list
25854474|NCT00063479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25854475|NCT00063479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854476|NCT00063583|Pirfenidone|pirfenidone|mesh-list
25854477|NCT00063583|Analgesics|analgesics|mesh-ancestor
25854478|NCT00063583|Sensory System Agents|sensory system agents|mesh-ancestor
25854479|NCT00063583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25854480|NCT00063583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854481|NCT00063583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25854482|NCT00063583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24458344|NCT00337506|Hormones|hormones|mesh-ancestor
25854483|NCT00063583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24451430|NCT00323687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24763821|NCT01777477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24763823|NCT01777477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24763824|NCT01777477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763825|NCT01777477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24763826|NCT01777477|Immunologic Factors|immunologic factors|mesh-ancestor
24763827|NCT01777477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763828|NCT01777477|Amebicides|amebicides|mesh-ancestor
24763829|NCT01777477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24763830|NCT01777477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24763831|NCT01777477|Antimalarials|antimalarials|mesh-ancestor
24939130|NCT04012918|Capecitabine|capecitabine|mesh-list
25854484|NCT00063583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25854485|NCT00063583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854486|NCT00063596|Vitamin A|vitamin a|mesh-list
25854487|NCT00063596|Vitamins|vitamins|mesh-ancestor
25854488|NCT00063596|Micronutrients|micronutrients|mesh-ancestor
25854489|NCT00063596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854490|NCT00063609|Zoledronic Acid|zoledronic acid|mesh-list
25854491|NCT00063609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25854492|NCT00063609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854493|NCT00063687|Oxypurinol|oxypurinol|mesh-list
25854494|NCT00063687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854495|NCT00063687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854496|NCT00063713|Bortezomib|bortezomib|mesh-list
24538832|NCT00660894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538833|NCT00660920|Ponatinib|ponatinib|mesh-list
24538834|NCT00660920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538836|NCT00660920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538837|NCT00660920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538838|NCT00660933|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24538839|NCT00660933|Hematinics|hematinics|mesh-ancestor
25854497|NCT00063713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939145|NCT04012619|Pemetrexed|pemetrexed|mesh-list
24939146|NCT04012619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939147|NCT04012619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939148|NCT04012619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939149|NCT04012619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24939150|NCT04012619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24939151|NCT04012775|Insulin|insulin|mesh-list
25854498|NCT00063726|Bortezomib|bortezomib|mesh-list
25854499|NCT00063726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939153|NCT04012775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24939154|NCT04012775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939155|NCT04012606|Carboplatin|carboplatin|mesh-list
25854501|NCT00063791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854502|NCT00063804|Ritonavir|ritonavir|mesh-list
25854503|NCT00063804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25854504|NCT00063804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25854505|NCT00063804|Protease Inhibitors|protease inhibitors|mesh-ancestor
25854506|NCT00063804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854507|NCT00063804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854508|NCT00063804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25854509|NCT00063804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25854510|NCT00063804|Antiviral Agents|antiviral agents|mesh-ancestor
25854511|NCT00063804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25854512|NCT00063804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25208331|NCT02643420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24538851|NCT00660972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24538852|NCT00660972|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24540087|NCT00666575|Anticonvulsants|anticonvulsants|mesh-ancestor
25854513|NCT00063804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25854514|NCT00063830|Alicaforsen|alicaforsen|mesh-list
25854515|NCT00063830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25854516|NCT00063830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25854517|NCT00063830|Immunologic Factors|immunologic factors|mesh-ancestor
25854518|NCT00063830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854519|NCT00063869|Etanercept|etanercept|mesh-list
25854520|NCT00063869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25854521|NCT00063869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25854522|NCT00063869|Analgesics|analgesics|mesh-ancestor
25854523|NCT00063869|Sensory System Agents|sensory system agents|mesh-ancestor
25854524|NCT00063869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25854525|NCT00063869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854526|NCT00063869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24538866|NCT00661063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538867|NCT00661063|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24538868|NCT00661063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24538869|NCT00661063|Anesthetics, General|anesthetics, general|mesh-ancestor
24538870|NCT00661063|Anesthetics|anesthetics|mesh-ancestor
24538871|NCT00661063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24538872|NCT00661063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24538873|NCT00661063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24538874|NCT00661063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24538875|NCT00661063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538876|NCT00661063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24538877|NCT00661063|Sympatholytics|sympatholytics|mesh-ancestor
24538878|NCT00661063|Autonomic Agents|autonomic agents|mesh-ancestor
24538879|NCT00661063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24538880|NCT00661063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24538881|NCT00661063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24538882|NCT00661063|Adrenergic Agents|adrenergic agents|mesh-ancestor
25854527|NCT00063869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25854528|NCT00063869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25854529|NCT00063869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25854530|NCT00063869|Immunologic Factors|immunologic factors|mesh-ancestor
25854531|NCT00063895|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25854532|NCT00063895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854533|NCT00063895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25854534|NCT00063895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854535|NCT00063895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854536|NCT00063947|Gemcitabine|gemcitabine|mesh-list
25854537|NCT00063947|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25854538|NCT00063947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25854539|NCT00063947|Antimetabolites|antimetabolites|mesh-ancestor
25854540|NCT00063947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854541|NCT00063947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538884|NCT00661076|Adefovir|adefovir|mesh-list
24538885|NCT00661076|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
24538886|NCT00661076|Antiviral Agents|antiviral agents|mesh-ancestor
25854542|NCT00063947|Antiviral Agents|antiviral agents|mesh-ancestor
25854543|NCT00063947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25854544|NCT00063947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854545|NCT00063947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25854548|NCT00063947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25854549|NCT00063960|Irinotecan|irinotecan|mesh-list
25854550|NCT00063960|Floxuridine|floxuridine|mesh-list
25854551|NCT00063960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25854552|NCT00063960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25854553|NCT00063960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854554|NCT00063960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854555|NCT00063960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854556|NCT00063960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25854557|NCT00063960|Antimetabolites|antimetabolites|mesh-ancestor
25854558|NCT00064012|Docetaxel|docetaxel|mesh-list
25854559|NCT00064012|Bortezomib|bortezomib|mesh-list
25854560|NCT00064012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854561|NCT00064012|Tubulin Modulators|tubulin modulators|mesh-ancestor
25854562|NCT00064012|Antimitotic Agents|antimitotic agents|mesh-ancestor
24939159|NCT04012606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24939161|NCT04012606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939162|NCT04012606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939163|NCT04012450|Anesthetics|anesthetics|mesh-list
24939164|NCT04012450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24939165|NCT04012450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939166|NCT04012424|Curcumin|curcumin|mesh-list
24939167|NCT04012424|Analgesics|analgesics|mesh-list
25075944|NCT03377101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24812418|NCT02052128|Hormone Antagonists|hormone antagonists|mesh-ancestor
25854563|NCT00064012|Mitosis Modulators|mitosis modulators|mesh-ancestor
25854564|NCT00064012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854565|NCT00064051|Gemcitabine|gemcitabine|mesh-list
25854566|NCT00064051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25854567|NCT00064051|Antimetabolites|antimetabolites|mesh-ancestor
25854568|NCT00064051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854569|NCT00064051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854570|NCT00064051|Antiviral Agents|antiviral agents|mesh-ancestor
25854571|NCT00064051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25854572|NCT00064051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854573|NCT00064051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25854574|NCT00064051|Immunologic Factors|immunologic factors|mesh-ancestor
25854575|NCT00064051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854576|NCT00064064|Gemcitabine|gemcitabine|mesh-list
25854577|NCT00064064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25854578|NCT00064064|Antimetabolites|antimetabolites|mesh-ancestor
25854579|NCT00064064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854580|NCT00064064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854581|NCT00064064|Antiviral Agents|antiviral agents|mesh-ancestor
25854582|NCT00064064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25854583|NCT00064064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854584|NCT00064064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25854585|NCT00064064|Immunologic Factors|immunologic factors|mesh-ancestor
25854586|NCT00064064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854587|NCT00064090|Cytarabine|cytarabine|mesh-list
24939168|NCT04012424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24939169|NCT04012424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24939170|NCT04012424|Sensory System Agents|sensory system agents|mesh-ancestor
24939171|NCT04012424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24939172|NCT04012424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939173|NCT04012424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24939174|NCT04012424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24939175|NCT04012424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939176|NCT04012424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854588|NCT00064090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25854589|NCT00064090|Antimetabolites|antimetabolites|mesh-ancestor
25854590|NCT00064090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854591|NCT00064090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854592|NCT00064090|Antiviral Agents|antiviral agents|mesh-ancestor
25854593|NCT00064090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25854594|NCT00064090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25854595|NCT00064090|Immunologic Factors|immunologic factors|mesh-ancestor
25854596|NCT00064090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854597|NCT00064116|Rituximab|rituximab|mesh-list
25854598|NCT00064116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25854599|NCT00064116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854601|NCT00064116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854602|NCT00064116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25854603|NCT00064129|Ipilimumab|ipilimumab|mesh-list
25854604|NCT00064129|Sargramostim|sargramostim|mesh-list
25854605|NCT00064129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25854606|NCT00064129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854607|NCT00064129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25854608|NCT00064129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854609|NCT00064129|Immunologic Factors|immunologic factors|mesh-ancestor
25854610|NCT00064129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854611|NCT00064142|Halofuginone|halofuginone|mesh-list
25854612|NCT00064142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854613|NCT00064142|Coccidiostats|coccidiostats|mesh-ancestor
24939191|NCT04012268|Analgesics|analgesics|mesh-ancestor
24852653|NCT02263495|Gemcitabine|gemcitabine|mesh-list
25854614|NCT00064142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25854615|NCT00064142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25854616|NCT00064142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25854617|NCT00064142|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25854618|NCT00064142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854619|NCT00064142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854620|NCT00064142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25854621|NCT00064142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25854622|NCT00064142|Growth Substances|growth substances|mesh-ancestor
25854623|NCT00064142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854624|NCT00064142|Growth Inhibitors|growth inhibitors|mesh-ancestor
25854625|NCT00064181|Leucovorin|leucovorin|mesh-list
25854626|NCT00064181|Celecoxib|celecoxib|mesh-list
25854627|NCT00064181|Fluorouracil|fluorouracil|mesh-list
25854628|NCT00064181|Capecitabine|capecitabine|mesh-list
25854629|NCT00064181|Irinotecan|irinotecan|mesh-list
25854630|NCT00064181|Calcium|calcium|mesh-list
25854631|NCT00064181|Levoleucovorin|levoleucovorin|mesh-list
25854632|NCT00064181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25854633|NCT00064181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854634|NCT00064181|Antimetabolites|antimetabolites|mesh-ancestor
25854635|NCT00064181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854636|NCT00064181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25854637|NCT00064181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538938|NCT00661297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25854638|NCT00064181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25854639|NCT00064181|Immunologic Factors|immunologic factors|mesh-ancestor
25854640|NCT00064181|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25854641|NCT00064181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25854642|NCT00064181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854643|NCT00064181|Antidotes|antidotes|mesh-ancestor
25854644|NCT00064181|Protective Agents|protective agents|mesh-ancestor
25854645|NCT00064181|Vitamin B Complex|vitamin b complex|mesh-ancestor
24451459|NCT00323817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451460|NCT00323817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538939|NCT00661297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854646|NCT00064181|Vitamins|vitamins|mesh-ancestor
25854647|NCT00064181|Micronutrients|micronutrients|mesh-ancestor
25854648|NCT00064181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25854649|NCT00064181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25854650|NCT00064181|Analgesics|analgesics|mesh-ancestor
25854651|NCT00064181|Sensory System Agents|sensory system agents|mesh-ancestor
25854652|NCT00064181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25854653|NCT00064181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25854654|NCT00064181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25854655|NCT00064181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25854656|NCT00064181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25854657|NCT00064194|Vitamin E|vitamin e|mesh-list
25854658|NCT00064194|Selenium|selenium|mesh-list
25664366|NCT01669434|Fosinopril|fosinopril|mesh-list
25664367|NCT01669434|Moexipril|moexipril|mesh-list
25664368|NCT01669434|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25664369|NCT01669434|Protease Inhibitors|protease inhibitors|mesh-ancestor
25664370|NCT01669434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664371|NCT01669434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664372|NCT01669434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25664373|NCT01669434|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25664374|NCT01669434|Protective Agents|protective agents|mesh-ancestor
25854660|NCT00064194|Micronutrients|micronutrients|mesh-ancestor
25854661|NCT00064194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854663|NCT00064194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854664|NCT00064194|Protective Agents|protective agents|mesh-ancestor
25854665|NCT00064194|Trace Elements|trace elements|mesh-ancestor
25854666|NCT00064207|Gemcitabine|gemcitabine|mesh-list
25854667|NCT00064207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25854668|NCT00064207|Antimetabolites|antimetabolites|mesh-ancestor
25854669|NCT00064207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854670|NCT00064207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854671|NCT00064207|Antiviral Agents|antiviral agents|mesh-ancestor
25854672|NCT00064207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25854673|NCT00064207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854674|NCT00064207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25050494|NCT00489203|Methotrexate|methotrexate|mesh-list
25050495|NCT00489203|Tacrolimus|tacrolimus|mesh-list
25050496|NCT00489203|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25050497|NCT00489203|Abortifacient Agents|abortifacient agents|mesh-ancestor
25050498|NCT00489203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25854675|NCT00064207|Immunologic Factors|immunologic factors|mesh-ancestor
25854676|NCT00064207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050499|NCT00489203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050500|NCT00489203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25050501|NCT00489203|Antimetabolites|antimetabolites|mesh-ancestor
25050502|NCT00489203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050503|NCT00489203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939218|NCT04012294|Gout Suppressants|gout suppressants|mesh-ancestor
24939219|NCT04012294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24939220|NCT04012294|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24939221|NCT04012294|Antioxidants|antioxidants|mesh-ancestor
24939222|NCT04012294|Protective Agents|protective agents|mesh-ancestor
24852697|NCT02263924|Vitamin E|vitamin e|mesh-list
25854677|NCT00064220|Soblidotin|soblidotin|mesh-list
25854678|NCT00064220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854679|NCT00064233|Dasatinib|dasatinib|mesh-list
25854680|NCT00064233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854681|NCT00064233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24539018|NCT00661765|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24539019|NCT00661765|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24539020|NCT00661765|Cholinergic Agents|cholinergic agents|mesh-ancestor
24539021|NCT00661765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25854682|NCT00064233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854683|NCT00064233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854684|NCT00064246|Rituximab|rituximab|mesh-list
25854685|NCT00064246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25854686|NCT00064246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25854687|NCT00064246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854688|NCT00064246|Immunologic Factors|immunologic factors|mesh-ancestor
25854689|NCT00064246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854690|NCT00064246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25854691|NCT00064285|Imatinib Mesylate|imatinib mesylate|mesh-list
25854692|NCT00064285|Alvocidib|alvocidib|mesh-list
25854693|NCT00064285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854694|NCT00064285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25854695|NCT00064285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854696|NCT00064285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854697|NCT00064285|Growth Inhibitors|growth inhibitors|mesh-ancestor
25854698|NCT00064285|Growth Substances|growth substances|mesh-ancestor
25854699|NCT00064285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854700|NCT00064389|Albuterol|albuterol|mesh-list
25854701|NCT00064389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25854702|NCT00064389|Autonomic Agents|autonomic agents|mesh-ancestor
24939223|NCT04012294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939225|NCT04011930|Cholecalciferol|cholecalciferol|mesh-list
24939227|NCT04011930|Vitamins|vitamins|mesh-ancestor
24939228|NCT04011930|Micronutrients|micronutrients|mesh-ancestor
24939229|NCT04011930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939242|NCT04011670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24852710|NCT02263976|Bromides|bromides|mesh-list
24852711|NCT02263976|Tiotropium Bromide|tiotropium bromide|mesh-list
24852712|NCT02263976|Methacholine Chloride|methacholine chloride|mesh-list
25854703|NCT00064389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25854704|NCT00064389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854705|NCT00064389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25854706|NCT00064389|Respiratory System Agents|respiratory system agents|mesh-ancestor
25854707|NCT00064389|Tocolytic Agents|tocolytic agents|mesh-ancestor
25854708|NCT00064389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25854709|NCT00064389|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25854710|NCT00064389|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25854711|NCT00064389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25854712|NCT00064389|Adrenergic Agents|adrenergic agents|mesh-ancestor
25854713|NCT00064389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25854714|NCT00064389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539039|NCT00661973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24539040|NCT00661973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24539041|NCT00661973|Autonomic Agents|autonomic agents|mesh-ancestor
24539042|NCT00661973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24539043|NCT00661973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539044|NCT00661973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24539045|NCT00661973|Respiratory System Agents|respiratory system agents|mesh-ancestor
24539049|NCT00662077|Ibandronic Acid|ibandronic acid|mesh-list
24539050|NCT00662077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24939243|NCT04011670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939244|NCT04011670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24939245|NCT04011670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939246|NCT04011670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939247|NCT04011670|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24939248|NCT04011670|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24939249|NCT04011670|Purinergic Agents|purinergic agents|mesh-ancestor
24939250|NCT04011670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25854715|NCT00064402|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25854716|NCT00064402|Formoterol Fumarate|formoterol fumarate|mesh-list
25854717|NCT00064402|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25854718|NCT00064402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25854719|NCT00064402|Autonomic Agents|autonomic agents|mesh-ancestor
25854720|NCT00064402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25854721|NCT00064402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854722|NCT00064402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24939301|NCT04011410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24939302|NCT04011410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24939303|NCT04011410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939304|NCT04011410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939305|NCT04011410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24939306|NCT04011241|Itraconazole|itraconazole|mesh-list
24939307|NCT04011241|Antifungal Agents|antifungal agents|mesh-ancestor
24939308|NCT04011241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24939309|NCT04011241|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24939310|NCT04011241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24955435|NCT03865147|Sympathomimetics|sympathomimetics|mesh-ancestor
24939311|NCT04011241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24659310|NCT01276769|Paclitaxel|paclitaxel|mesh-list
25854723|NCT00064402|Respiratory System Agents|respiratory system agents|mesh-ancestor
25854724|NCT00064402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25854725|NCT00064402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25854726|NCT00064402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25854727|NCT00064402|Adrenergic Agents|adrenergic agents|mesh-ancestor
25854728|NCT00064402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25854729|NCT00064402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854730|NCT00064415|Formoterol Fumarate|formoterol fumarate|mesh-list
25854731|NCT00064415|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24939313|NCT04011241|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25854732|NCT00064415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25854733|NCT00064415|Autonomic Agents|autonomic agents|mesh-ancestor
24466641|NCT00374426|Sertraline|sertraline|mesh-list
24539150|NCT00662467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539152|NCT00662467|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24539153|NCT00662467|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24443685|NCT00295789|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24443686|NCT00295789|Carboplatin|carboplatin|mesh-list
24443687|NCT00295789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24939314|NCT04011241|Hormone Antagonists|hormone antagonists|mesh-ancestor
24939315|NCT04011241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24939316|NCT04011241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540088|NCT00666575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25854734|NCT00064415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25424553|NCT02248597|Fludarabine phosphate|fludarabine phosphate|mesh-list
25854735|NCT00064415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854736|NCT00064415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25854737|NCT00064415|Respiratory System Agents|respiratory system agents|mesh-ancestor
25854738|NCT00064415|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25854739|NCT00064415|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25854740|NCT00064415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25854741|NCT00064415|Adrenergic Agents|adrenergic agents|mesh-ancestor
24774704|NCT01847404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25854742|NCT00064415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25854743|NCT00064415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854744|NCT00064428|PENTA|penta|mesh-list
25854745|NCT00064428|Fondaparinux|fondaparinux|mesh-list
25854746|NCT00064428|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25854747|NCT00064428|Antithrombins|antithrombins|mesh-ancestor
25854748|NCT00064428|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25854749|NCT00064428|Protease Inhibitors|protease inhibitors|mesh-ancestor
25854750|NCT00064428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854751|NCT00064428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854752|NCT00064428|Anticoagulants|anticoagulants|mesh-ancestor
25854753|NCT00064428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25854754|NCT00064428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24539165|NCT00662610|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
24539166|NCT00662610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24539167|NCT00662610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24539168|NCT00662610|Analgesics|analgesics|mesh-ancestor
24539169|NCT00662610|Sensory System Agents|sensory system agents|mesh-ancestor
24539170|NCT00662610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25876247|NCT03808610|Autonomic Agents|autonomic agents|mesh-ancestor
25876248|NCT03808610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25876249|NCT03808610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25876250|NCT03808610|Glucocorticoids|glucocorticoids|mesh-ancestor
25876251|NCT03808610|Hormones|hormones|mesh-ancestor
25876252|NCT03808610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25876253|NCT03808610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25876254|NCT03808610|Protease Inhibitors|protease inhibitors|mesh-ancestor
25876255|NCT03808610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876256|NCT03808610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25876257|NCT03808610|Abortifacient Agents|abortifacient agents|mesh-ancestor
25876258|NCT03808610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25876259|NCT03808610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24774705|NCT01847404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876260|NCT03808610|Antimetabolites|antimetabolites|mesh-ancestor
25876261|NCT03808610|Dermatologic Agents|dermatologic agents|mesh-ancestor
25876262|NCT03808610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25876263|NCT03808610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25876264|NCT03808610|Antiviral Agents|antiviral agents|mesh-ancestor
25876265|NCT03808610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25876266|NCT03808610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25876267|NCT03808610|Tubulin Modulators|tubulin modulators|mesh-ancestor
25876268|NCT03808610|Antimitotic Agents|antimitotic agents|mesh-ancestor
25876269|NCT03808610|Mitosis Modulators|mitosis modulators|mesh-ancestor
25876270|NCT03798626|Leucovorin|leucovorin|mesh-list
25876271|NCT03798626|Paclitaxel|paclitaxel|mesh-list
25876272|NCT03798626|Bevacizumab|bevacizumab|mesh-list
25876273|NCT03798626|Fluorouracil|fluorouracil|mesh-list
25876274|NCT03798626|Oxaliplatin|oxaliplatin|mesh-list
25876275|NCT03798626|Irinotecan|irinotecan|mesh-list
25876276|NCT03798626|Ramucirumab|ramucirumab|mesh-list
25876277|NCT03798626|Levoleucovorin|levoleucovorin|mesh-list
25876278|NCT03798626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25876279|NCT03798626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876280|NCT03798626|Tubulin Modulators|tubulin modulators|mesh-ancestor
25876281|NCT03798626|Antimitotic Agents|antimitotic agents|mesh-ancestor
25876282|NCT03798626|Mitosis Modulators|mitosis modulators|mesh-ancestor
25876283|NCT03798626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876284|NCT03798626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25876285|NCT03798626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25876286|NCT03798626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25876287|NCT03798626|Growth Substances|growth substances|mesh-ancestor
24939329|NCT04011098|Anesthetics|anesthetics|mesh-ancestor
25876288|NCT03798626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876289|NCT03798626|Growth Inhibitors|growth inhibitors|mesh-ancestor
25876290|NCT03798626|Antimetabolites|antimetabolites|mesh-ancestor
25876291|NCT03798626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25876292|NCT03798626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25876293|NCT03798626|Immunologic Factors|immunologic factors|mesh-ancestor
25854756|NCT00064467|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25854757|NCT00064467|Antidepressive Agents|antidepressive agents|mesh-ancestor
25854758|NCT00064467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25854759|NCT00064467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25854760|NCT00064467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25854761|NCT00064467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25854762|NCT00064467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854763|NCT00064467|Dopamine Agents|dopamine agents|mesh-ancestor
25854764|NCT00064467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25854765|NCT00064467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854766|NCT00064467|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25854767|NCT00064467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25854768|NCT00064467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854769|NCT00064610|Bortezomib|bortezomib|mesh-list
25854770|NCT00064610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854771|NCT00064623|Capsaicin|capsaicin|mesh-list
25854772|NCT00064623|Antipruritics|antipruritics|mesh-ancestor
25854773|NCT00064623|Dermatologic Agents|dermatologic agents|mesh-ancestor
24465003|NCT00367497|Autonomic Agents|autonomic agents|mesh-ancestor
24813648|NCT02059759|Analgesics|analgesics|mesh-ancestor
25854774|NCT00064623|Sensory System Agents|sensory system agents|mesh-ancestor
25854775|NCT00064623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25854776|NCT00064623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539295|NCT00663195|Furosemide|furosemide|mesh-list
24539296|NCT00663195|Spironolactone|spironolactone|mesh-list
24539297|NCT00663195|Diuretics|diuretics|mesh-ancestor
24539298|NCT00663195|Natriuretic Agents|natriuretic agents|mesh-ancestor
24539299|NCT00663195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539300|NCT00663195|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25854777|NCT00064636|Bortezomib|bortezomib|mesh-list
25854778|NCT00064636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854779|NCT00064649|Finasteride|finasteride|mesh-list
25854780|NCT00064649|Alfuzosin|alfuzosin|mesh-list
25854781|NCT00064649|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25854782|NCT00064649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25854783|NCT00064649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854784|NCT00064649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854785|NCT00064649|Hormone Antagonists|hormone antagonists|mesh-ancestor
25854786|NCT00064649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25854787|NCT00064649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854788|NCT00064649|Urological Agents|urological agents|mesh-ancestor
25854789|NCT00064649|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25854790|NCT00064649|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25854791|NCT00064649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25854792|NCT00064649|Adrenergic Agents|adrenergic agents|mesh-ancestor
24443723|NCT00295893|Immunologic Factors|immunologic factors|mesh-ancestor
24443724|NCT00295893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443725|NCT00295893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24443744|NCT00295919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24443748|NCT00295919|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24443749|NCT00295919|Protective Agents|protective agents|mesh-ancestor
24443750|NCT00295945|Fentanyl|fentanyl|mesh-list
24443751|NCT00295945|Hydromorphone|hydromorphone|mesh-list
24443752|NCT00295945|Ropivacaine|ropivacaine|mesh-list
24939340|NCT04011033|Cyclophosphamide|cyclophosphamide|mesh-list
24939341|NCT04011033|Interleukin-2|interleukin-2|mesh-list
24939342|NCT04011033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25202802|NCT02718547|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25202803|NCT02718547|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25202804|NCT02718547|Adrenergic Agents|adrenergic agents|mesh-ancestor
25202805|NCT02718547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25202806|NCT02718547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939343|NCT04011033|Immunologic Factors|immunologic factors|mesh-ancestor
24443753|NCT00295945|Anesthetics, Local|anesthetics, local|mesh-ancestor
25854793|NCT00064649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25854794|NCT00064727|Rosiglitazone|rosiglitazone|mesh-list
25854795|NCT00064727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25854796|NCT00064727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443754|NCT00295945|Anesthetics|anesthetics|mesh-ancestor
25854797|NCT00064766|Doxycycline|doxycycline|mesh-list
25854798|NCT00064766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25854799|NCT00064766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25854800|NCT00064766|Antimalarials|antimalarials|mesh-ancestor
25854801|NCT00064766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25854802|NCT00064766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25854803|NCT00064857|Pycnogenols|pycnogenols|mesh-list
25854804|NCT00064857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25854805|NCT00064857|Immunologic Factors|immunologic factors|mesh-ancestor
25854806|NCT00064857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854807|NCT00064857|Antioxidants|antioxidants|mesh-ancestor
24539362|NCT00663455|Immunologic Factors|immunologic factors|mesh-ancestor
25854808|NCT00064857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854809|NCT00064857|Protective Agents|protective agents|mesh-ancestor
25854810|NCT00064857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24443755|NCT00295945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25854811|NCT00064974|Lenalidomide|lenalidomide|mesh-list
24539379|NCT00663559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24539380|NCT00663559|Growth Substances|growth substances|mesh-ancestor
24539381|NCT00663559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539382|NCT00663559|Growth Inhibitors|growth inhibitors|mesh-ancestor
24539383|NCT00663559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24539384|NCT00663559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854812|NCT00064974|Immunologic Factors|immunologic factors|mesh-ancestor
25854813|NCT00064974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854814|NCT00064974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25854815|NCT00064974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25854816|NCT00064974|Growth Substances|growth substances|mesh-ancestor
25854817|NCT00064974|Growth Inhibitors|growth inhibitors|mesh-ancestor
25854818|NCT00064974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854819|NCT00065117|Leucovorin|leucovorin|mesh-list
25854820|NCT00065117|Fluorouracil|fluorouracil|mesh-list
25854821|NCT00065117|Oxaliplatin|oxaliplatin|mesh-list
25854822|NCT00065117|Antimetabolites|antimetabolites|mesh-ancestor
25854823|NCT00065117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854824|NCT00065117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24539393|NCT00663624|Insulin Aspart|insulin aspart|mesh-list
24539394|NCT00663624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24539395|NCT00663624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539396|NCT00663689|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24539397|NCT00663689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854825|NCT00065117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24539405|NCT00663728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539406|NCT00663728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539407|NCT00663728|Urological Agents|urological agents|mesh-ancestor
24539409|NCT00663741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24539410|NCT00663741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24539411|NCT00663741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539412|NCT00663741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539413|NCT00663806|Ciprofloxacin|ciprofloxacin|mesh-list
25854826|NCT00065117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25854827|NCT00065117|Immunologic Factors|immunologic factors|mesh-ancestor
25854828|NCT00065117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731632|NCT01635829|Anticonvulsants|anticonvulsants|mesh-ancestor
25854829|NCT00065117|Antidotes|antidotes|mesh-ancestor
25854830|NCT00065117|Protective Agents|protective agents|mesh-ancestor
25854831|NCT00065117|Vitamin B Complex|vitamin b complex|mesh-ancestor
25854832|NCT00065117|Vitamins|vitamins|mesh-ancestor
25854833|NCT00065117|Micronutrients|micronutrients|mesh-ancestor
25854834|NCT00065130|Insulin|insulin|mesh-list
25854835|NCT00065130|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25854836|NCT00065130|Insulin Aspart|insulin aspart|mesh-list
24539512|NCT00664196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539513|NCT00664222|Furosemide|furosemide|mesh-list
24939354|NCT04011033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24939356|NCT04010929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939357|NCT04010929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539514|NCT00664222|Spironolactone|spironolactone|mesh-list
24539515|NCT00664222|Diuretics|diuretics|mesh-ancestor
25854837|NCT00065130|Isophane Insulin, Human|isophane insulin, human|mesh-list
25854838|NCT00065130|Insulin, Isophane|insulin, isophane|mesh-list
25854839|NCT00065130|Isophane insulin, beef|isophane insulin, beef|mesh-list
25854840|NCT00065130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24539521|NCT00664222|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24539522|NCT00664222|Hormone Antagonists|hormone antagonists|mesh-ancestor
25854841|NCT00065130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854842|NCT00065143|Clofarabine|clofarabine|mesh-list
24774706|NCT01847404|Antipyretics|antipyretics|mesh-ancestor
25854843|NCT00065143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25854844|NCT00065143|Antimetabolites|antimetabolites|mesh-ancestor
25854845|NCT00065143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854846|NCT00065143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854847|NCT00065169|Celecoxib|celecoxib|mesh-list
25876294|NCT03798626|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25854848|NCT00065169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25854849|NCT00065169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25854850|NCT00065169|Analgesics|analgesics|mesh-ancestor
25854851|NCT00065169|Sensory System Agents|sensory system agents|mesh-ancestor
25854852|NCT00065169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25854853|NCT00065169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854854|NCT00065169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25051012|NCT00450970|Satraplatin|satraplatin|mesh-list
25854855|NCT00065169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25854856|NCT00065169|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25854857|NCT00065169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24539730|NCT00665327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24539731|NCT00665327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539732|NCT00665327|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24539733|NCT00665327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24539734|NCT00665327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25854858|NCT00065169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854859|NCT00065169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854861|NCT00065273|Risperidone|risperidone|mesh-list
25854862|NCT00065273|Clozapine|clozapine|mesh-list
24539793|NCT00665639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539794|NCT00665678|Paroxetine|paroxetine|mesh-list
24539799|NCT00665678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24539801|NCT00665678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539802|NCT00665678|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24539803|NCT00665678|Antidepressive Agents|antidepressive agents|mesh-ancestor
24539804|NCT00665678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24539805|NCT00665678|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24939366|NCT04010942|Hormone Antagonists|hormone antagonists|mesh-ancestor
24939367|NCT04010942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24939368|NCT04010942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24939369|NCT04010942|Fertility Agents|fertility agents|mesh-ancestor
24939370|NCT04010942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24939376|NCT04010669|Somatostatin|somatostatin|mesh-list
24764092|NCT01779401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24764093|NCT01779401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764094|NCT01779401|Antipyretics|antipyretics|mesh-ancestor
24764095|NCT01779401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24764096|NCT01779401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24764097|NCT01779401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24539835|NCT00665743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539837|NCT00665756|Mitomycin|mitomycin|mesh-list
25854863|NCT00065273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25854864|NCT00065273|Serotonin Agents|serotonin agents|mesh-ancestor
25854865|NCT00065273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25854866|NCT00065273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854867|NCT00065273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854868|NCT00065273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25854869|NCT00065273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25854870|NCT00065273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25854871|NCT00065273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24539927|NCT00666042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24539928|NCT00666042|Contraceptive Agents|contraceptive agents|mesh-ancestor
24539929|NCT00666042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24764102|NCT01779401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25050504|NCT00489203|Dermatologic Agents|dermatologic agents|mesh-ancestor
24731776|NCT01636557|Vitamin K|vitamin k|mesh-list
24539970|NCT00666068|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24539971|NCT00666068|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
24539972|NCT00666068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24539998|NCT00666185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24539999|NCT00666185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540000|NCT00666185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540001|NCT00666185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25854872|NCT00065273|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25854873|NCT00065273|Dopamine Agents|dopamine agents|mesh-ancestor
25854874|NCT00065273|Antiemetics|antiemetics|mesh-ancestor
25854875|NCT00065273|Autonomic Agents|autonomic agents|mesh-ancestor
25854876|NCT00065273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25854877|NCT00065273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25854878|NCT00065273|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25270310|NCT02405689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25270311|NCT02405689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25270312|NCT02405689|Adrenergic Agents|adrenergic agents|mesh-ancestor
25270313|NCT02405689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25854879|NCT00065273|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25854880|NCT00065273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24540086|NCT00666575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854881|NCT00065273|GABA Antagonists|gaba antagonists|mesh-ancestor
25854882|NCT00065273|GABA Agents|gaba agents|mesh-ancestor
25854883|NCT00065325|Fulvestrant|fulvestrant|mesh-list
25854884|NCT00065325|Exemestane|exemestane|mesh-list
24540091|NCT00666575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24540092|NCT00666575|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24540093|NCT00666575|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24540094|NCT00666575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25854885|NCT00065325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25854886|NCT00065325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24540110|NCT00666653|Antioxidants|antioxidants|mesh-ancestor
24540111|NCT00666653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540112|NCT00666653|Protective Agents|protective agents|mesh-ancestor
24540113|NCT00666653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540114|NCT00666653|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24540115|NCT00666653|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24662806|NCT01297010|Antiemetics|antiemetics|mesh-ancestor
24540116|NCT00666653|Dopamine Agonists|dopamine agonists|mesh-ancestor
24540117|NCT00666653|Dopamine Agents|dopamine agents|mesh-ancestor
24540118|NCT00666653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24444988|NCT00299923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24444989|NCT00299923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24444990|NCT00299923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24444992|NCT00299923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24540199|NCT00666939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24540200|NCT00666939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24540201|NCT00666939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24540202|NCT00666939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24540203|NCT00666939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24540204|NCT00666939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24540205|NCT00666939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540206|NCT00666939|Antimanic Agents|antimanic agents|mesh-ancestor
24443769|NCT00295958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443770|NCT00295971|Fludarabine|fludarabine|mesh-list
24540226|NCT00667043|Analgesics|analgesics|mesh-ancestor
24540227|NCT00667043|Sensory System Agents|sensory system agents|mesh-ancestor
25854887|NCT00065325|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25854888|NCT00065325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25854889|NCT00065325|Hormone Antagonists|hormone antagonists|mesh-ancestor
25854890|NCT00065325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24764111|NCT01779466|Coagulants|coagulants|mesh-ancestor
24764112|NCT01779466|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24764113|NCT01779466|Natriuretic Agents|natriuretic agents|mesh-ancestor
24764114|NCT01779466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854891|NCT00065325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540238|NCT00667056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24540239|NCT00667056|Immunologic Factors|immunologic factors|mesh-ancestor
25854892|NCT00065325|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25854893|NCT00065325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25854894|NCT00065325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854895|NCT00065325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854896|NCT00065351|Lenalidomide|lenalidomide|mesh-list
25854897|NCT00065351|Immunologic Factors|immunologic factors|mesh-ancestor
25854898|NCT00065351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854899|NCT00065351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25854900|NCT00065351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24731948|NCT01637233|Antimetabolites|antimetabolites|mesh-ancestor
25854901|NCT00065351|Growth Substances|growth substances|mesh-ancestor
25854902|NCT00065351|Growth Inhibitors|growth inhibitors|mesh-ancestor
25854903|NCT00065351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854904|NCT00065390|Pyrimethamine|pyrimethamine|mesh-list
25664375|NCT01669434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664376|NCT01669538|Galantamine|galantamine|mesh-list
25664377|NCT01669538|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25664378|NCT01669538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854905|NCT00065390|Antimalarials|antimalarials|mesh-ancestor
25854906|NCT00065390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25664379|NCT01669538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540285|NCT00667160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24540286|NCT00667160|Immunologic Factors|immunologic factors|mesh-ancestor
24540287|NCT00667160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202807|NCT02718547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854907|NCT00065390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25854908|NCT00065390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25854909|NCT00065390|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25854910|NCT00065390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854911|NCT00065390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854912|NCT00065455|Vitamin A|vitamin a|mesh-list
25854913|NCT00065455|Vitamins|vitamins|mesh-ancestor
25854914|NCT00065455|Micronutrients|micronutrients|mesh-ancestor
25854915|NCT00065455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854916|NCT00065533|Pemetrexed|pemetrexed|mesh-list
25232597|NCT02582190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854917|NCT00065533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25854918|NCT00065533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854919|NCT00065533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854920|NCT00065533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25854921|NCT00065533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25854922|NCT00065546|Choline|choline|mesh-list
25854923|NCT00065546|Estrogens|estrogens|mesh-list
25854924|NCT00065546|Hormones|hormones|mesh-ancestor
25854925|NCT00065546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25854926|NCT00065546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854927|NCT00065546|Lipotropic Agents|lipotropic agents|mesh-ancestor
25854928|NCT00065546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25854929|NCT00065546|Antimetabolites|antimetabolites|mesh-ancestor
25854930|NCT00065546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854931|NCT00065546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25854932|NCT00065546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24764120|NCT01779479|Mitosis Modulators|mitosis modulators|mesh-ancestor
24764121|NCT01779479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764122|NCT01779492|Oxycodone|oxycodone|mesh-list
24764123|NCT01779492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24764124|NCT01779492|Narcotics|narcotics|mesh-ancestor
24764125|NCT01779492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24540340|NCT00667433|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24540341|NCT00667472|Ranibizumab|ranibizumab|mesh-list
24540342|NCT00667472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25854933|NCT00065546|Nootropic Agents|nootropic agents|mesh-ancestor
25854934|NCT00065559|Celecoxib|celecoxib|mesh-list
25854935|NCT00065559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25854936|NCT00065559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25854937|NCT00065559|Analgesics|analgesics|mesh-ancestor
24443788|NCT00295984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443790|NCT00295984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24443791|NCT00295984|Cholinergic Agents|cholinergic agents|mesh-ancestor
24443792|NCT00295984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24443793|NCT00295984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443794|NCT00295997|Mycophenolic Acid|mycophenolic acid|mesh-list
24540364|NCT00667498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24540365|NCT00667498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540366|NCT00667537|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
24540396|NCT00667797|Respiratory System Agents|respiratory system agents|mesh-ancestor
24939385|NCT04010578|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25202808|NCT02718547|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24540398|NCT00667797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24540399|NCT00667797|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24540401|NCT00667797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24540402|NCT00667797|Adrenergic Agents|adrenergic agents|mesh-ancestor
24774707|NCT01847404|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24444092|NCT00296712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24444093|NCT00296712|Serotonin Agents|serotonin agents|mesh-ancestor
24444094|NCT00296712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444095|NCT00296712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24444096|NCT00296712|Antidepressive Agents|antidepressive agents|mesh-ancestor
24540424|NCT00667927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24939417|NCT04009759|Anesthetics, General|anesthetics, general|mesh-ancestor
24540452|NCT00668018|Urological Agents|urological agents|mesh-ancestor
24540455|NCT00668031|Coagulants|coagulants|mesh-ancestor
24540456|NCT00668031|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24540457|NCT00668031|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24540458|NCT00668031|Protease Inhibitors|protease inhibitors|mesh-ancestor
24540459|NCT00668031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854938|NCT00065559|Sensory System Agents|sensory system agents|mesh-ancestor
25854939|NCT00065559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25854940|NCT00065559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854941|NCT00065559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25854942|NCT00065559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25854943|NCT00065559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24540473|NCT00668057|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24540474|NCT00668057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24540475|NCT00668057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540476|NCT00668057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540477|NCT00668057|Urological Agents|urological agents|mesh-ancestor
24540478|NCT00668096|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24540479|NCT00668096|Vasodilator Agents|vasodilator agents|mesh-ancestor
25854944|NCT00065559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24540499|NCT00668122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854945|NCT00065559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854946|NCT00065559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854947|NCT00065624|Thioctic Acid|thioctic acid|mesh-list
25854948|NCT00065624|Antioxidants|antioxidants|mesh-ancestor
25854949|NCT00065624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540535|NCT00668330|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
24540536|NCT00668330|Calcium|calcium|mesh-list
25854950|NCT00065624|Protective Agents|protective agents|mesh-ancestor
25854951|NCT00065624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939420|NCT04009759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24939421|NCT04009759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24939422|NCT04009759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24939423|NCT04009759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540559|NCT00668356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24540560|NCT00668499|Pemetrexed|pemetrexed|mesh-list
24540561|NCT00668499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24540562|NCT00668499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540563|NCT00668499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540572|NCT00668538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540573|NCT00668538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540574|NCT00668538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24540575|NCT00668538|Hormone Antagonists|hormone antagonists|mesh-ancestor
24540576|NCT00668538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25854952|NCT00065624|Vitamin B Complex|vitamin b complex|mesh-ancestor
25854953|NCT00065624|Vitamins|vitamins|mesh-ancestor
24732138|NCT01638026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25854954|NCT00065624|Micronutrients|micronutrients|mesh-ancestor
25854955|NCT00065637|Teriparatide|teriparatide|mesh-list
25854956|NCT00065637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25854957|NCT00065637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540598|NCT00668616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24540599|NCT00668616|Tubulin Modulators|tubulin modulators|mesh-ancestor
24540600|NCT00668616|Antimitotic Agents|antimitotic agents|mesh-ancestor
24540601|NCT00668616|Mitosis Modulators|mitosis modulators|mesh-ancestor
24540602|NCT00668616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939430|NCT04009772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24939431|NCT04009772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24939432|NCT04009772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24939433|NCT04009772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24939434|NCT04009889|Silicon|silicon|mesh-list
24540628|NCT00668759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24540629|NCT00668759|Vasodilator Agents|vasodilator agents|mesh-ancestor
24540630|NCT00668759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24540631|NCT00668759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24540632|NCT00668759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540633|NCT00668759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24540634|NCT00668759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24540635|NCT00668759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24540636|NCT00668759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540637|NCT00668759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25854958|NCT00065637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25854959|NCT00065741|Silymarin|silymarin|mesh-list
25854960|NCT00065741|Antioxidants|antioxidants|mesh-ancestor
25854961|NCT00065741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854962|NCT00065741|Protective Agents|protective agents|mesh-ancestor
25854964|NCT00065767|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25854965|NCT00065767|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25854966|NCT00065767|Hormone Antagonists|hormone antagonists|mesh-ancestor
25854967|NCT00065767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25854968|NCT00065767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854969|NCT00065767|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25854970|NCT00065767|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25854971|NCT00065767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24452245|NCT00326586|Androgen Antagonists|androgen antagonists|mesh-ancestor
25854972|NCT00065871|Contraceptive Agents|contraceptive agents|mesh-list
24939445|NCT04009603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24939446|NCT04009603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939447|NCT04009525|Cyclosporine|cyclosporine|mesh-list
24939448|NCT04009525|Mycophenolic Acid|mycophenolic acid|mesh-list
24939449|NCT04009525|Cyclophosphamide|cyclophosphamide|mesh-list
24939450|NCT04009525|Busulfan|busulfan|mesh-list
24939451|NCT04009525|Methotrexate|methotrexate|mesh-list
24939452|NCT04009525|Fludarabine|fludarabine|mesh-list
24939453|NCT04009525|Tacrolimus|tacrolimus|mesh-list
24939454|NCT04009525|Cyclosporins|cyclosporins|mesh-list
24939455|NCT04009525|Thymoglobulin|thymoglobulin|mesh-list
24939456|NCT04009525|Basiliximab|basiliximab|mesh-list
24939457|NCT04009525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24939458|NCT04009525|Immunologic Factors|immunologic factors|mesh-ancestor
24939465|NCT04009525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24939466|NCT04009525|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24939468|NCT04009525|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25050505|NCT00489203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24833353|NCT02173756|Analgesics|analgesics|mesh-ancestor
25854973|NCT00065871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25854974|NCT00065871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854975|NCT00065884|Valproic Acid|valproic acid|mesh-list
25854976|NCT00065884|Anticonvulsants|anticonvulsants|mesh-ancestor
25854977|NCT00065884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25854978|NCT00065884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25854979|NCT00065884|GABA Agents|gaba agents|mesh-ancestor
25854980|NCT00065884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24540705|NCT00669344|Rivastigmine|rivastigmine|mesh-list
24540706|NCT00669344|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24540707|NCT00669344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540708|NCT00669344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540709|NCT00669344|Cholinergic Agents|cholinergic agents|mesh-ancestor
25854981|NCT00065884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854982|NCT00065884|Antimanic Agents|antimanic agents|mesh-ancestor
25854983|NCT00065884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25854984|NCT00065884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25854985|NCT00065884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25854986|NCT00065923|Topiramate|topiramate|mesh-list
25854987|NCT00065923|Anticonvulsants|anticonvulsants|mesh-ancestor
25854988|NCT00065923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25202809|NCT02718547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25050516|NCT00489203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25050517|NCT00489203|Respiratory System Agents|respiratory system agents|mesh-ancestor
24939470|NCT04009525|Antimetabolites|antimetabolites|mesh-ancestor
24939471|NCT04009525|Dermatologic Agents|dermatologic agents|mesh-ancestor
24939472|NCT04009525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939473|NCT04009525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25854989|NCT00065923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25854990|NCT00065936|Naltrexone|naltrexone|mesh-list
25854991|NCT00065936|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25854992|NCT00065936|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25854993|NCT00065936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833450|NCT02173964|Pinaverium|pinaverium|mesh-list
25854994|NCT00065936|Sensory System Agents|sensory system agents|mesh-ancestor
25854995|NCT00065936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25854996|NCT00065949|Magnesium Sulfate|magnesium sulfate|mesh-list
25854997|NCT00065949|Analgesics|analgesics|mesh-ancestor
25854998|NCT00065949|Sensory System Agents|sensory system agents|mesh-ancestor
25854999|NCT00065949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24939478|NCT04009525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24939479|NCT04009525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24732289|NCT01638715|Rituximab|rituximab|mesh-list
25855000|NCT00065949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540842|NCT00669786|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24540843|NCT00669786|Fertility Agents|fertility agents|mesh-ancestor
25424554|NCT02248597|Tacrolimus|tacrolimus|mesh-list
24540844|NCT00669786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24540846|NCT00669812|Prednisolone|prednisolone|mesh-list
24540847|NCT00669812|Cyclophosphamide|cyclophosphamide|mesh-list
24540848|NCT00669812|Melphalan|melphalan|mesh-list
24540849|NCT00669812|Ifosfamide|ifosfamide|mesh-list
24540850|NCT00669812|Carmustine|carmustine|mesh-list
24540851|NCT00669812|Doxorubicin|doxorubicin|mesh-list
24540852|NCT00669812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24540853|NCT00669812|Methotrexate|methotrexate|mesh-list
24540854|NCT00669812|Etoposide|etoposide|mesh-list
25855001|NCT00065949|Anesthetics|anesthetics|mesh-ancestor
24540879|NCT00669812|Antiviral Agents|antiviral agents|mesh-ancestor
24540880|NCT00669812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24833616|NCT02174666|Hormones|hormones|mesh-ancestor
25855002|NCT00065949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24732374|NCT01638988|Fertility Agents|fertility agents|mesh-ancestor
24939492|NCT04008979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24939493|NCT04008979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802926|NCT01993290|Ropivacaine|ropivacaine|mesh-list
24939494|NCT04008979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24939495|NCT04008979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24939496|NCT04008979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24597279|NCT00948168|Exenatide|exenatide|mesh-list
25855003|NCT00065949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25855004|NCT00065949|Anticonvulsants|anticonvulsants|mesh-ancestor
25855005|NCT00065949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25855006|NCT00065949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24408490|NCT00178035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25855007|NCT00065949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855008|NCT00065949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25855009|NCT00065949|Tocolytic Agents|tocolytic agents|mesh-ancestor
24767401|NCT01800630|Gemcitabine|gemcitabine|mesh-list
24942362|NCT03981887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855010|NCT00065949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24942363|NCT03981887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732427|NCT01639326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24617108|NCT01041066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25855011|NCT00065962|Secretin|secretin|mesh-list
25855012|NCT00065962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25855013|NCT00065962|Hormones|hormones|mesh-ancestor
25855014|NCT00065962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25855015|NCT00065962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540904|NCT00669890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24540905|NCT00669890|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24540906|NCT00669890|Abortifacient Agents|abortifacient agents|mesh-ancestor
24939497|NCT04008979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24939498|NCT04008979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939499|NCT04008979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24939500|NCT04008979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24597379|NCT00949026|Sirolimus|sirolimus|mesh-list
24540907|NCT00669890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24540908|NCT00669890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24540909|NCT00669890|Antimetabolites|antimetabolites|mesh-ancestor
24540910|NCT00669890|Dermatologic Agents|dermatologic agents|mesh-ancestor
25855016|NCT00066001|Metronidazole|metronidazole|mesh-list
25855017|NCT00066001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25855018|NCT00066001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25855019|NCT00066001|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25855020|NCT00066001|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25855021|NCT00066027|Doxycycline|doxycycline|mesh-list
24540925|NCT00669994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24540926|NCT00669994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540927|NCT00669994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540928|NCT00669994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24540929|NCT00669994|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24540930|NCT00669994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24540931|NCT00670150|Arsenic Trioxide|arsenic trioxide|mesh-list
24540932|NCT00670150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24540933|NCT00670215|Ciprofloxacin|ciprofloxacin|mesh-list
24540934|NCT00670215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24540935|NCT00670215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24540936|NCT00670215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25855022|NCT00066027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25855023|NCT00066027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25855024|NCT00066027|Antimalarials|antimalarials|mesh-ancestor
25855025|NCT00066027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25424630|NCT02230189|Miotics|miotics|mesh-ancestor
25855026|NCT00066027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25270382|NCT02405078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270383|NCT02405078|Antimetabolites|antimetabolites|mesh-ancestor
25270384|NCT02405078|Antiviral Agents|antiviral agents|mesh-ancestor
25855028|NCT00066040|Chlorhexidine, thymol drug combination|chlorhexidine, thymol drug combination|mesh-list
24541087|NCT00670761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24541088|NCT00670761|Oxytocics|oxytocics|mesh-ancestor
25855029|NCT00066040|Fluorides|fluorides|mesh-list
24732553|NCT01640275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24732554|NCT01640275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25855030|NCT00066040|Fluorides, Topical|fluorides, topical|mesh-list
25855031|NCT00066040|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
25855032|NCT00066040|Cariostatic Agents|cariostatic agents|mesh-ancestor
25855033|NCT00066040|Protective Agents|protective agents|mesh-ancestor
25855034|NCT00066040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855035|NCT00066040|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25855036|NCT00066040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24541099|NCT00670787|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24541100|NCT00670787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24541102|NCT00670813|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25202810|NCT02718547|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25202811|NCT02718547|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25202812|NCT02718547|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25202813|NCT02718742|Paclitaxel|paclitaxel|mesh-list
25202814|NCT02718742|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25202815|NCT02718742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25202816|NCT02718742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939513|NCT04009044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939514|NCT04009044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24541206|NCT00671424|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24541208|NCT00671476|Doxorubicin|doxorubicin|mesh-list
24833929|NCT02176200|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24732605|NCT01640574|Artenimol|artenimol|mesh-list
25855037|NCT00066040|Disinfectants|disinfectants|mesh-ancestor
25876295|NCT03798626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25876296|NCT03798626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876297|NCT03798626|Antidotes|antidotes|mesh-ancestor
25876298|NCT03798626|Protective Agents|protective agents|mesh-ancestor
25876299|NCT03798626|Vitamin B Complex|vitamin b complex|mesh-ancestor
25876300|NCT03798626|Vitamins|vitamins|mesh-ancestor
25876301|NCT03798626|Micronutrients|micronutrients|mesh-ancestor
25876302|NCT03793179|Carboplatin|carboplatin|mesh-list
25876303|NCT03793179|Pembrolizumab|pembrolizumab|mesh-list
25876304|NCT03793179|Pemetrexed|pemetrexed|mesh-list
25876305|NCT03793179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876306|NCT03793179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24541392|NCT00672464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24541393|NCT00672464|Serotonin Agents|serotonin agents|mesh-ancestor
24541395|NCT00672568|Antipruritics|antipruritics|mesh-ancestor
24541396|NCT00672568|Dermatologic Agents|dermatologic agents|mesh-ancestor
24541397|NCT00672568|Sensory System Agents|sensory system agents|mesh-ancestor
24541398|NCT00672568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24541406|NCT00672659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541407|NCT00672659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25876307|NCT03793179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939530|NCT04008784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939531|NCT04008784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939532|NCT04008966|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24939533|NCT04008966|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24939534|NCT04008966|Cetrorelix|cetrorelix|mesh-list
24939535|NCT04008966|Progesterone|progesterone|mesh-list
24939536|NCT04008966|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24939538|NCT04008966|Hormones|hormones|mesh-ancestor
24939539|NCT04008966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24939540|NCT04008966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834267|NCT02177500|Telmisartan|telmisartan|mesh-list
25876308|NCT03793179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664380|NCT01669538|Cholinergic Agents|cholinergic agents|mesh-ancestor
25664381|NCT01669538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25664382|NCT01669538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664383|NCT01669538|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25664384|NCT01669538|Autonomic Agents|autonomic agents|mesh-ancestor
25664385|NCT01669538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25664386|NCT01669538|Nootropic Agents|nootropic agents|mesh-ancestor
25664387|NCT01669642|Ketamine|ketamine|mesh-list
24462511|NCT00356616|Tenofovir|tenofovir|mesh-list
25855038|NCT00066092|Lenograstim|lenograstim|mesh-list
25855039|NCT00066092|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25855040|NCT00066092|Immunologic Factors|immunologic factors|mesh-ancestor
25855041|NCT00066092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855042|NCT00066157|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25855043|NCT00066157|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25855044|NCT00066157|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25855045|NCT00066157|Medroxyprogesterone|medroxyprogesterone|mesh-list
25855046|NCT00066157|Estradiol|estradiol|mesh-list
25855047|NCT00066157|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24541871|NCT00675714|Testosterone enanthate|testosterone enanthate|mesh-list
24541872|NCT00675714|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24541873|NCT00675714|Oxandrolone|oxandrolone|mesh-list
25855048|NCT00066157|Estrogens|estrogens|mesh-list
25855049|NCT00066157|Progesterone|progesterone|mesh-list
24732690|NCT01640782|Levoleucovorin|levoleucovorin|mesh-list
25855050|NCT00066157|Hormones|hormones|mesh-ancestor
25855051|NCT00066157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25855052|NCT00066157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939611|NCT04008186|Midazolam|midazolam|mesh-list
24939612|NCT04008186|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24939613|NCT04008186|Gemfibrozil|gemfibrozil|mesh-list
24939614|NCT04008186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24834595|NCT02179814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25855053|NCT00066157|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25855054|NCT00066157|Contraceptive Agents|contraceptive agents|mesh-ancestor
25855055|NCT00066157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25855056|NCT00066157|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25855057|NCT00066157|Progestins|progestins|mesh-ancestor
25855058|NCT00066157|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25855059|NCT00066157|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25855060|NCT00066157|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25855061|NCT00066157|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25855062|NCT00066157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25855063|NCT00066157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855064|NCT00066196|Dacarbazine|dacarbazine|mesh-list
25855065|NCT00066196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25855066|NCT00066196|Alkylating Agents|alkylating agents|mesh-ancestor
25855067|NCT00066196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764355|NCT01780883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855068|NCT00066196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24834745|NCT02180880|Pregabalin|pregabalin|mesh-list
24542410|NCT00678522|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24542412|NCT00678613|Norfloxacin|norfloxacin|mesh-list
25855069|NCT00066248|Cyproheptadine|cyproheptadine|mesh-list
25855070|NCT00066248|Megestrol|megestrol|mesh-list
25855071|NCT00066248|Megestrol Acetate|megestrol acetate|mesh-list
25855072|NCT00066248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25855073|NCT00066248|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25855074|NCT00066248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25855075|NCT00066248|Contraceptive Agents|contraceptive agents|mesh-ancestor
25855076|NCT00066248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25855077|NCT00066248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855078|NCT00066248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24617183|NCT01041508|Cyclosporins|cyclosporins|mesh-list
25855079|NCT00066248|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25855080|NCT00066248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24542470|NCT00678782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25855081|NCT00066248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855082|NCT00066248|Appetite Stimulants|appetite stimulants|mesh-ancestor
25664388|NCT01669642|Analgesics|analgesics|mesh-ancestor
25664389|NCT01669642|Sensory System Agents|sensory system agents|mesh-ancestor
25664390|NCT01669642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25664391|NCT01669642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664392|NCT01669642|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25664393|NCT01669642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25664394|NCT01669642|Anesthetics, General|anesthetics, general|mesh-ancestor
24764358|NCT01780883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25664395|NCT01669642|Anesthetics|anesthetics|mesh-ancestor
24764364|NCT01780909|Antiemetics|antiemetics|mesh-ancestor
24598930|NCT05351606|Nicotine|nicotine|mesh-list
25855085|NCT00066248|Dermatologic Agents|dermatologic agents|mesh-ancestor
25855086|NCT00066248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24542639|NCT00679653|Sibutramine|sibutramine|mesh-list
24542660|NCT00679653|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24542661|NCT00679653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24542702|NCT00679744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542703|NCT00679744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542763|NCT00680329|Travoprost|travoprost|mesh-list
24542764|NCT00680329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25855087|NCT00066248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25855088|NCT00066248|Histamine Antagonists|histamine antagonists|mesh-ancestor
24542837|NCT00680498|Growth Inhibitors|growth inhibitors|mesh-ancestor
24542838|NCT00680498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855089|NCT00066248|Histamine Agents|histamine agents|mesh-ancestor
25855090|NCT00066248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24446967|NCT00306774|Vitamin D|vitamin d|mesh-list
24542933|NCT00681005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542934|NCT00681005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542935|NCT00681135|Olaflur|olaflur|mesh-list
24542936|NCT00681135|Cariostatic Agents|cariostatic agents|mesh-ancestor
24542937|NCT00681135|Protective Agents|protective agents|mesh-ancestor
25855091|NCT00066248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855092|NCT00066248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25855093|NCT00066248|Serotonin Agents|serotonin agents|mesh-ancestor
25855094|NCT00066248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25855095|NCT00066274|Leucovorin|leucovorin|mesh-list
24542942|NCT00681148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542943|NCT00681148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24542944|NCT00681148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24542945|NCT00681148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542946|NCT00681148|Cholinergic Agents|cholinergic agents|mesh-ancestor
24542947|NCT00681148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24542948|NCT00681174|Acetaminophen|acetaminophen|mesh-list
24542950|NCT00681174|Remifentanil|remifentanil|mesh-list
24542951|NCT00681174|Oxycodone|oxycodone|mesh-list
24542952|NCT00681174|Propofol|propofol|mesh-list
24542953|NCT00681174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25161701|NCT02581007|Cyclophosphamide|cyclophosphamide|mesh-list
24542990|NCT00681343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25855096|NCT00066274|Fluorouracil|fluorouracil|mesh-list
24542991|NCT00681343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24542992|NCT00681343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542994|NCT00681395|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25855097|NCT00066274|Oxaliplatin|oxaliplatin|mesh-list
24939627|NCT04008186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24939628|NCT04008186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939629|NCT04008186|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24939630|NCT04008186|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24939631|NCT04008186|Antimetabolites|antimetabolites|mesh-ancestor
24939632|NCT04008186|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25664396|NCT01669642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25664397|NCT01669642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25664398|NCT01669642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25664399|NCT01669642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25664400|NCT01669642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664401|NCT01669720|Aflibercept|aflibercept|mesh-list
25664402|NCT01669720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25664403|NCT01669720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24939633|NCT04008186|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24852997|NCT02265289|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24852998|NCT02265289|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24852999|NCT02265289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25855099|NCT00066274|Calcium|calcium|mesh-list
25855100|NCT00066274|Levoleucovorin|levoleucovorin|mesh-list
25855101|NCT00066274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25855102|NCT00066274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855103|NCT00066274|Antimetabolites|antimetabolites|mesh-ancestor
25855104|NCT00066274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855105|NCT00066274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25855106|NCT00066274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855107|NCT00066274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25855108|NCT00066274|Immunologic Factors|immunologic factors|mesh-ancestor
24834936|NCT02181920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24543036|NCT00681733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543037|NCT00681733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24543038|NCT00681733|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24543040|NCT00681733|Vasodilator Agents|vasodilator agents|mesh-ancestor
24543041|NCT00681733|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24543042|NCT00681733|Antioxidants|antioxidants|mesh-ancestor
24939637|NCT04008186|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24955737|NCT03862079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24955738|NCT03862079|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24955739|NCT03862079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24955740|NCT03862079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955741|NCT03862079|Antifungal Agents|antifungal agents|mesh-ancestor
24955743|NCT03862079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24853002|NCT02265289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853003|NCT02265289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853004|NCT02265328|Prednisolone|prednisolone|mesh-list
24543044|NCT00681746|Antidotes|antidotes|mesh-ancestor
24543045|NCT00681746|Protective Agents|protective agents|mesh-ancestor
24543046|NCT00681746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543047|NCT00681746|GABA Modulators|gaba modulators|mesh-ancestor
24543048|NCT00681746|GABA Agents|gaba agents|mesh-ancestor
25855109|NCT00066274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25855110|NCT00066274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25855111|NCT00066274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855112|NCT00066274|Antidotes|antidotes|mesh-ancestor
25855113|NCT00066274|Protective Agents|protective agents|mesh-ancestor
24543184|NCT00682279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543186|NCT00682279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24543188|NCT00682292|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24543189|NCT00682292|Daclizumab|daclizumab|mesh-list
24835012|NCT02182050|Nintedanib|nintedanib|mesh-list
24543266|NCT00682760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543267|NCT00682760|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24543268|NCT00682760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24543269|NCT00682825|Anesthetics|anesthetics|mesh-list
24955752|NCT03862144|Serotonin Agents|serotonin agents|mesh-ancestor
24939638|NCT04008186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24543349|NCT00683202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543417|NCT00683670|Immunologic Factors|immunologic factors|mesh-ancestor
24543418|NCT00683670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543428|NCT00683735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664404|NCT01669720|Growth Substances|growth substances|mesh-ancestor
25664405|NCT01669720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664406|NCT01669720|Growth Inhibitors|growth inhibitors|mesh-ancestor
25664407|NCT01669720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664408|NCT01669785|Listerine|listerine|mesh-list
25664409|NCT01669785|Fluorides|fluorides|mesh-list
25664410|NCT01669785|Sodium Fluoride|sodium fluoride|mesh-list
25664411|NCT01669785|Cariostatic Agents|cariostatic agents|mesh-ancestor
25664414|NCT01669785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25664415|NCT01669785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25664416|NCT01669798|Nintedanib|nintedanib|mesh-list
25664417|NCT01669798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664418|NCT01669798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25664419|NCT01669798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664420|NCT01669798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543432|NCT00683735|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24543433|NCT00683735|Protease Inhibitors|protease inhibitors|mesh-ancestor
24543434|NCT00683735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543435|NCT00683735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543436|NCT00683865|Moxifloxacin|moxifloxacin|mesh-list
24543437|NCT00683865|Ofloxacin|ofloxacin|mesh-list
25855114|NCT00066274|Vitamin B Complex|vitamin b complex|mesh-ancestor
25855115|NCT00066274|Vitamins|vitamins|mesh-ancestor
25855116|NCT00066274|Micronutrients|micronutrients|mesh-ancestor
25855117|NCT00066326|Imatinib Mesylate|imatinib mesylate|mesh-list
25855118|NCT00066326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855119|NCT00066326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24543507|NCT00683995|Anesthetics, General|anesthetics, general|mesh-ancestor
24543509|NCT00684099|Docetaxel|docetaxel|mesh-list
24543510|NCT00684099|Pemetrexed|pemetrexed|mesh-list
25855120|NCT00066326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543518|NCT00684099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25855121|NCT00066326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855122|NCT00066339|Gefitinib|gefitinib|mesh-list
25855123|NCT00066339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855124|NCT00066339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25855125|NCT00066339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855126|NCT00066339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855127|NCT00066352|Bortezomib|bortezomib|mesh-list
25855128|NCT00066352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855129|NCT00066378|Gefitinib|gefitinib|mesh-list
25855130|NCT00066378|Anastrozole|anastrozole|mesh-list
24939649|NCT04008186|Vasodilator Agents|vasodilator agents|mesh-ancestor
24939651|NCT04008433|Lidocaine|lidocaine|mesh-list
24939652|NCT04008433|Anesthetics, Local|anesthetics, local|mesh-ancestor
24939653|NCT04008433|Anesthetics|anesthetics|mesh-ancestor
24939654|NCT04008433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24939655|NCT04008433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939656|NCT04008433|Sensory System Agents|sensory system agents|mesh-ancestor
24939657|NCT04008433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25855131|NCT00066378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543692|NCT00685022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24543693|NCT00685022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543694|NCT00685022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24543695|NCT00685022|Respiratory System Agents|respiratory system agents|mesh-ancestor
24543696|NCT00685022|Tocolytic Agents|tocolytic agents|mesh-ancestor
24543697|NCT00685022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24543698|NCT00685022|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24543699|NCT00685022|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24543700|NCT00685022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24543736|NCT00685191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24543737|NCT00685191|Antiviral Agents|antiviral agents|mesh-ancestor
24543738|NCT00685191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24543739|NCT00685191|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24543740|NCT00685191|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24543741|NCT00685191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543742|NCT00685191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543743|NCT00685230|Antivenins|antivenins|mesh-list
24543744|NCT00685230|Immunologic Factors|immunologic factors|mesh-ancestor
24543745|NCT00685230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543746|NCT00685269|Eszopiclone|eszopiclone|mesh-list
24543747|NCT00685269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25855132|NCT00066378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25855133|NCT00066378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855134|NCT00066378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664421|NCT01669811|Esomeprazole|esomeprazole|mesh-list
25664422|NCT01669811|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25664423|NCT01669811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25855135|NCT00066378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25855136|NCT00066378|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25855143|NCT00066391|Irinotecan|irinotecan|mesh-list
25855144|NCT00066391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855145|NCT00066391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25855146|NCT00066391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25855147|NCT00066391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855148|NCT00066391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855149|NCT00066417|Cyclosporine|cyclosporine|mesh-list
25855150|NCT00066417|Methylprednisolone|methylprednisolone|mesh-list
25855151|NCT00066417|Cyclophosphamide|cyclophosphamide|mesh-list
25855152|NCT00066417|Thiotepa|thiotepa|mesh-list
24543831|NCT00685607|Emollients|emollients|mesh-ancestor
24543832|NCT00685607|Dermatologic Agents|dermatologic agents|mesh-ancestor
24543833|NCT00685633|Bicalutamide|bicalutamide|mesh-list
25855153|NCT00066417|Fludarabine|fludarabine|mesh-list
25855154|NCT00066417|Fludarabine phosphate|fludarabine phosphate|mesh-list
25855155|NCT00066417|Cyclosporins|cyclosporins|mesh-list
25855156|NCT00066417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25855157|NCT00066417|Immunologic Factors|immunologic factors|mesh-ancestor
25855158|NCT00066417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855159|NCT00066417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25855160|NCT00066417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25855161|NCT00066417|Alkylating Agents|alkylating agents|mesh-ancestor
25855162|NCT00066417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855163|NCT00066417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543867|NCT00685776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543869|NCT00685828|Imatinib Mesylate|imatinib mesylate|mesh-list
24543870|NCT00685828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543871|NCT00685828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24543872|NCT00685828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855164|NCT00066417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25855165|NCT00066417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25855166|NCT00066417|Antimetabolites|antimetabolites|mesh-ancestor
25855167|NCT00066417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855168|NCT00066417|Antifungal Agents|antifungal agents|mesh-ancestor
25855169|NCT00066417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25855170|NCT00066417|Dermatologic Agents|dermatologic agents|mesh-ancestor
25855171|NCT00066417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25161702|NCT02581007|Melphalan|melphalan|mesh-list
25855172|NCT00066417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25855173|NCT00066417|Antiemetics|antiemetics|mesh-ancestor
25855174|NCT00066417|Autonomic Agents|autonomic agents|mesh-ancestor
25855175|NCT00066417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25855176|NCT00066417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25855177|NCT00066417|Glucocorticoids|glucocorticoids|mesh-ancestor
24447028|NCT00307203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24447029|NCT00307203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803216|NCT01995058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24803217|NCT01995058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447030|NCT00307203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24447031|NCT00307203|Antidepressive Agents|antidepressive agents|mesh-ancestor
24447032|NCT00307203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24447033|NCT00307203|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24447034|NCT00307203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24447035|NCT00307203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25664424|NCT01669811|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25664425|NCT01669811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664426|NCT01669811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664427|NCT01669928|Antihypertensive Agents|antihypertensive agents|mesh-list
25664428|NCT01669928|Calcium Channel Blockers|calcium channel blockers|mesh-list
25664429|NCT01669928|Angiotensin II|angiotensin ii|mesh-list
25664430|NCT01669928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25855178|NCT00066417|Hormones|hormones|mesh-ancestor
25855179|NCT00066417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24447036|NCT00307203|Dopamine Agents|dopamine agents|mesh-ancestor
24447037|NCT00307203|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24939674|NCT04008043|Hydrocodone|hydrocodone|mesh-list
24939675|NCT04008043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24939676|NCT04008043|Antiemetics|antiemetics|mesh-ancestor
24939677|NCT04008043|Autonomic Agents|autonomic agents|mesh-ancestor
24853057|NCT02265770|Valproic Acid|valproic acid|mesh-list
24853058|NCT02265770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24853059|NCT02265770|Immunologic Factors|immunologic factors|mesh-ancestor
25855180|NCT00066417|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25855181|NCT00066417|Protective Agents|protective agents|mesh-ancestor
25855182|NCT00066443|Docetaxel|docetaxel|mesh-list
25855183|NCT00066443|Epirubicin|epirubicin|mesh-list
25855184|NCT00066443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855185|NCT00066443|Tubulin Modulators|tubulin modulators|mesh-ancestor
25855186|NCT00066443|Antimitotic Agents|antimitotic agents|mesh-ancestor
25855187|NCT00066443|Mitosis Modulators|mitosis modulators|mesh-ancestor
25855188|NCT00066443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939678|NCT04008043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24939679|NCT04008043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939680|NCT04008043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24939681|NCT04008043|Glucocorticoids|glucocorticoids|mesh-ancestor
24544122|NCT00687388|Terazosin|terazosin|mesh-list
24544123|NCT00687388|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
24544124|NCT00687388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24544125|NCT00687388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24544126|NCT00687388|Analgesics|analgesics|mesh-ancestor
25855189|NCT00066443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25855190|NCT00066443|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25855191|NCT00066443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25855192|NCT00066443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855193|NCT00066456|Docetaxel|docetaxel|mesh-list
25855194|NCT00066456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855195|NCT00066456|Tubulin Modulators|tubulin modulators|mesh-ancestor
25855196|NCT00066456|Antimitotic Agents|antimitotic agents|mesh-ancestor
25855197|NCT00066456|Mitosis Modulators|mitosis modulators|mesh-ancestor
25855198|NCT00066456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855199|NCT00066482|Cyclophosphamide|cyclophosphamide|mesh-list
25855200|NCT00066482|Cisplatin|cisplatin|mesh-list
24544158|NCT00687648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24544159|NCT00687648|Immunologic Factors|immunologic factors|mesh-ancestor
24544160|NCT00687648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855201|NCT00066482|Etoposide|etoposide|mesh-list
25855202|NCT00066482|Bleomycin|bleomycin|mesh-list
25855203|NCT00066482|Lenograstim|lenograstim|mesh-list
24835240|NCT02182518|Adrenergic Agents|adrenergic agents|mesh-ancestor
24544170|NCT00687648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25161703|NCT02581007|Fludarabine|fludarabine|mesh-list
24544207|NCT00687817|Carboplatin|carboplatin|mesh-list
24544208|NCT00687817|Bavituximab|bavituximab|mesh-list
24544209|NCT00687817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24544210|NCT00687817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544211|NCT00687817|Tubulin Modulators|tubulin modulators|mesh-ancestor
24544212|NCT00687817|Antimitotic Agents|antimitotic agents|mesh-ancestor
24544213|NCT00687817|Mitosis Modulators|mitosis modulators|mesh-ancestor
25855205|NCT00066482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25855206|NCT00066482|Immunologic Factors|immunologic factors|mesh-ancestor
25855207|NCT00066482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855208|NCT00066482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25855209|NCT00066482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24544225|NCT00687843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24544226|NCT00687843|Antiviral Agents|antiviral agents|mesh-ancestor
24544227|NCT00687843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24544228|NCT00687843|Interferon Inducers|interferon inducers|mesh-ancestor
24544229|NCT00687843|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24544230|NCT00687843|Protective Agents|protective agents|mesh-ancestor
25855210|NCT00066482|Alkylating Agents|alkylating agents|mesh-ancestor
25855211|NCT00066482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855212|NCT00066482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855213|NCT00066482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25855214|NCT00066482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25855215|NCT00066482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25855216|NCT00066482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25855217|NCT00066482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855218|NCT00066482|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24846739|NCT02243618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25855219|NCT00066482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25855221|NCT00066508|Bortezomib|bortezomib|mesh-list
25855222|NCT00066508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855223|NCT00066547|Antibodies|antibodies|mesh-list
25855224|NCT00066547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25855225|NCT00066547|Immunologic Factors|immunologic factors|mesh-ancestor
25855226|NCT00066547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733408|NCT01645787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855227|NCT00066586|Exemestane|exemestane|mesh-list
25855228|NCT00066586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855229|NCT00066586|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25855230|NCT00066586|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25855231|NCT00066586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855232|NCT00066586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447133|NCT00307606|Prednisolone|prednisolone|mesh-list
24447153|NCT00307619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835376|NCT02182739|Meloxicam|meloxicam|mesh-list
24544434|NCT00688961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24544487|NCT00689169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24544543|NCT00689494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24544544|NCT00689494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855233|NCT00066586|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25855234|NCT00066586|Hormone Antagonists|hormone antagonists|mesh-ancestor
25855235|NCT00066586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25855236|NCT00066586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855237|NCT00066599|Voriconazole|voriconazole|mesh-list
24544545|NCT00689494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24544546|NCT00689494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24939731|NCT04007328|Prednisolone phosphate|prednisolone phosphate|mesh-list
24939732|NCT04007328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24939733|NCT04007328|Antiemetics|antiemetics|mesh-ancestor
24544581|NCT00689585|Ethosuximide|ethosuximide|mesh-list
24544582|NCT00689585|Anticonvulsants|anticonvulsants|mesh-ancestor
24544583|NCT00689598|Spironolactone|spironolactone|mesh-list
24544584|NCT00689598|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24544585|NCT00689598|Hormone Antagonists|hormone antagonists|mesh-ancestor
24544586|NCT00689598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24544587|NCT00689598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855238|NCT00066599|Antifungal Agents|antifungal agents|mesh-ancestor
25855239|NCT00066599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25855240|NCT00066599|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25855241|NCT00066599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25855242|NCT00066599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855243|NCT00066599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855244|NCT00066599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25855245|NCT00066599|Hormone Antagonists|hormone antagonists|mesh-ancestor
25855246|NCT00066599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25855247|NCT00066599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855248|NCT00066599|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24544596|NCT00689624|Antimetabolites|antimetabolites|mesh-ancestor
24544597|NCT00689624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664431|NCT01669928|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
25664432|NCT01669928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25664433|NCT01669928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664434|NCT01669928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664435|NCT01669928|Protease Inhibitors|protease inhibitors|mesh-ancestor
25664436|NCT01669928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664437|NCT01669928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25664438|NCT01669928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25664439|NCT01670019|Asenapine|asenapine|mesh-list
24544598|NCT00689624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25855250|NCT00066612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25855251|NCT00066612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25855252|NCT00066612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855253|NCT00066612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855254|NCT00066612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855255|NCT00066625|Oxaliplatin|oxaliplatin|mesh-list
25855256|NCT00066625|Bortezomib|bortezomib|mesh-list
25855257|NCT00066625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855258|NCT00066638|Romidepsin|romidepsin|mesh-list
25855259|NCT00066638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24544671|NCT00689832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25161704|NCT02581007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24447181|NCT00307645|Glucocorticoids|glucocorticoids|mesh-ancestor
25855260|NCT00066638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855261|NCT00066651|Immunotoxins|immunotoxins|mesh-list
25855262|NCT00066651|Immunologic Factors|immunologic factors|mesh-ancestor
25855263|NCT00066651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855264|NCT00066716|Celecoxib|celecoxib|mesh-list
25855265|NCT00066716|Paclitaxel|paclitaxel|mesh-list
25855266|NCT00066716|Carboplatin|carboplatin|mesh-list
25855267|NCT00066716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25855268|NCT00066716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855269|NCT00066716|Tubulin Modulators|tubulin modulators|mesh-ancestor
25855270|NCT00066716|Antimitotic Agents|antimitotic agents|mesh-ancestor
25855271|NCT00066716|Mitosis Modulators|mitosis modulators|mesh-ancestor
25855272|NCT00066716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544739|NCT00689949|Folic Acid|folic acid|mesh-list
24544740|NCT00689949|Hematinics|hematinics|mesh-ancestor
24544741|NCT00689949|Vitamin B Complex|vitamin b complex|mesh-ancestor
24544742|NCT00689949|Vitamins|vitamins|mesh-ancestor
25855273|NCT00066716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25855274|NCT00066716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25855275|NCT00066716|Analgesics|analgesics|mesh-ancestor
25855276|NCT00066716|Sensory System Agents|sensory system agents|mesh-ancestor
25855277|NCT00066716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25855278|NCT00066716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544831|NCT00690521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544833|NCT00690534|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24544834|NCT00690534|Nitroprusside|nitroprusside|mesh-list
24544835|NCT00690534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24544836|NCT00690534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835545|NCT02183077|Meloxicam|meloxicam|mesh-list
25855279|NCT00066716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25855280|NCT00066716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25855281|NCT00066716|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25855282|NCT00066716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25855283|NCT00066716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855284|NCT00066768|Gemcitabine|gemcitabine|mesh-list
25855285|NCT00066768|Suramin|suramin|mesh-list
25855286|NCT00066768|Docetaxel|docetaxel|mesh-list
24853139|NCT02266030|Antipyretics|antipyretics|mesh-ancestor
25855287|NCT00066768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25855288|NCT00066768|Antimetabolites|antimetabolites|mesh-ancestor
25855289|NCT00066768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544884|NCT00690781|Chelating Agents|chelating agents|mesh-ancestor
24544885|NCT00690781|Sequestering Agents|sequestering agents|mesh-ancestor
25855290|NCT00066768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544886|NCT00690781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544887|NCT00690846|Adalimumab|adalimumab|mesh-list
24544888|NCT00690846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24544889|NCT00690846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24544890|NCT00690872|Gemcitabine|gemcitabine|mesh-list
24544891|NCT00690872|Carboplatin|carboplatin|mesh-list
24544892|NCT00690872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24835554|NCT02183077|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25161705|NCT02581007|Immunologic Factors|immunologic factors|mesh-ancestor
25855291|NCT00066768|Antiviral Agents|antiviral agents|mesh-ancestor
25855292|NCT00066768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24544918|NCT00690937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544919|NCT00690937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24544920|NCT00690937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24544921|NCT00690937|Antimetabolites|antimetabolites|mesh-ancestor
24544922|NCT00690937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24544923|NCT00690950|Dutasteride|dutasteride|mesh-list
25855293|NCT00066768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855294|NCT00066768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24544935|NCT00691067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855296|NCT00066768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855297|NCT00066768|Tubulin Modulators|tubulin modulators|mesh-ancestor
25855298|NCT00066768|Antimitotic Agents|antimitotic agents|mesh-ancestor
25855299|NCT00066768|Mitosis Modulators|mitosis modulators|mesh-ancestor
25855300|NCT00066768|Antinematodal Agents|antinematodal agents|mesh-ancestor
25855301|NCT00066768|Anthelmintics|anthelmintics|mesh-ancestor
25855302|NCT00066768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25855303|NCT00066768|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25855304|NCT00066768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25855305|NCT00066794|Cytarabine|cytarabine|mesh-list
25855306|NCT00066794|Cyclosporine|cyclosporine|mesh-list
25855307|NCT00066794|Daunorubicin|daunorubicin|mesh-list
25855308|NCT00066794|Cyclosporins|cyclosporins|mesh-list
25855309|NCT00066794|Sargramostim|sargramostim|mesh-list
25855310|NCT00066794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24545002|NCT00691379|Bevacizumab|bevacizumab|mesh-list
24545003|NCT00691379|Carboplatin|carboplatin|mesh-list
24939773|NCT04007003|Insulin|insulin|mesh-list
24939774|NCT04007003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24545004|NCT00691379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24545005|NCT00691379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24545006|NCT00691379|Tubulin Modulators|tubulin modulators|mesh-ancestor
24545007|NCT00691379|Antimitotic Agents|antimitotic agents|mesh-ancestor
24545008|NCT00691379|Mitosis Modulators|mitosis modulators|mesh-ancestor
24545009|NCT00691379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855311|NCT00066794|Antimetabolites|antimetabolites|mesh-ancestor
25855312|NCT00066794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855313|NCT00066794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855314|NCT00066794|Antiviral Agents|antiviral agents|mesh-ancestor
25855315|NCT00066794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25855316|NCT00066794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25855317|NCT00066794|Immunologic Factors|immunologic factors|mesh-ancestor
25855318|NCT00066794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855319|NCT00066794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855320|NCT00066794|Antifungal Agents|antifungal agents|mesh-ancestor
25855321|NCT00066794|Dermatologic Agents|dermatologic agents|mesh-ancestor
25855322|NCT00066794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25855323|NCT00066794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25855324|NCT00066794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25855325|NCT00066794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25855326|NCT00066794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24835699|NCT02183272|Analgesics|analgesics|mesh-ancestor
25855327|NCT00066846|Leucovorin|leucovorin|mesh-list
25855328|NCT00066846|Bevacizumab|bevacizumab|mesh-list
25855329|NCT00066846|Fluorouracil|fluorouracil|mesh-list
25855330|NCT00066846|Calcium|calcium|mesh-list
25855331|NCT00066846|Levoleucovorin|levoleucovorin|mesh-list
24446615|NCT00305474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446616|NCT00305474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446617|NCT00305474|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24446618|NCT00305474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24446619|NCT00305474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24939782|NCT04006847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24939783|NCT04006847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617368|NCT01042704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24617369|NCT01042704|Growth Substances|growth substances|mesh-ancestor
24617370|NCT01042704|Growth Inhibitors|growth inhibitors|mesh-ancestor
24617371|NCT01042704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24617372|NCT01042704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24733590|NCT01647256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939784|NCT04006847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939786|NCT04006821|Antibodies|antibodies|mesh-list
24939787|NCT04006821|Immunologic Factors|immunologic factors|mesh-ancestor
24939788|NCT04006821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664440|NCT01670019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25664441|NCT01670019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25664442|NCT01670019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25664443|NCT01670019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664444|NCT01670019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25664445|NCT01670097|Dexamethasone|dexamethasone|mesh-list
25664446|NCT01670097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24457006|NCT00332904|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24457007|NCT00332904|Hormone Antagonists|hormone antagonists|mesh-ancestor
25050991|NCT00455156|Contraceptive Agents|contraceptive agents|mesh-ancestor
24939789|NCT04006821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446625|NCT00305487|Hormones|hormones|mesh-ancestor
24545089|NCT00691912|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24545090|NCT00691912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24545091|NCT00691912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24545092|NCT00691912|Tubulin Modulators|tubulin modulators|mesh-ancestor
25855332|NCT00066846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25855333|NCT00066846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855334|NCT00066846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25855335|NCT00066846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25855336|NCT00066846|Growth Substances|growth substances|mesh-ancestor
25855337|NCT00066846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855338|NCT00066846|Growth Inhibitors|growth inhibitors|mesh-ancestor
25855339|NCT00066846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24939796|NCT04006470|Protective Agents|protective agents|mesh-ancestor
24939797|NCT04006470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939798|NCT04006639|Analgesics|analgesics|mesh-list
24939799|NCT04006639|Sensory System Agents|sensory system agents|mesh-ancestor
24939800|NCT04006639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24939801|NCT04006639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939802|NCT04006483|Fluorides|fluorides|mesh-list
24939803|NCT04006483|Tin Fluorides|tin fluorides|mesh-list
24939804|NCT04006483|Cariostatic Agents|cariostatic agents|mesh-ancestor
24939805|NCT04006483|Protective Agents|protective agents|mesh-ancestor
24939806|NCT04006483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939807|NCT04006262|Nivolumab|nivolumab|mesh-list
24939808|NCT04006262|Ipilimumab|ipilimumab|mesh-list
24812502|NCT02052713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24545106|NCT00691951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545107|NCT00691951|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24545108|NCT00691951|Respiratory System Agents|respiratory system agents|mesh-ancestor
24545109|NCT00691951|Glucocorticoids|glucocorticoids|mesh-ancestor
24545110|NCT00691951|Hormones|hormones|mesh-ancestor
24545111|NCT00691951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25855340|NCT00066846|Antimetabolites|antimetabolites|mesh-ancestor
25855341|NCT00066846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855342|NCT00066846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25855343|NCT00066846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24446646|NCT00305513|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24545147|NCT00692120|Vitamins|vitamins|mesh-list
25855344|NCT00066846|Immunologic Factors|immunologic factors|mesh-ancestor
25855345|NCT00066846|Antidotes|antidotes|mesh-ancestor
25855346|NCT00066846|Protective Agents|protective agents|mesh-ancestor
25855347|NCT00066846|Vitamin B Complex|vitamin b complex|mesh-ancestor
25855348|NCT00066846|Vitamins|vitamins|mesh-ancestor
25855349|NCT00066846|Micronutrients|micronutrients|mesh-ancestor
25855350|NCT00066859|Sertraline|sertraline|mesh-list
25855351|NCT00066859|Antidepressive Agents|antidepressive agents|mesh-ancestor
24545170|NCT00692263|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24545171|NCT00692263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24545172|NCT00692263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25855352|NCT00066859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24545185|NCT00692263|Sensory System Agents|sensory system agents|mesh-ancestor
24545186|NCT00692315|Vitamin B 12|vitamin b 12|mesh-list
24545187|NCT00692315|Vitamins|vitamins|mesh-ancestor
25855353|NCT00066859|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25855354|NCT00066859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25161706|NCT02581007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855355|NCT00066859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25855356|NCT00066859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855357|NCT00066859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25855358|NCT00066859|Serotonin Agents|serotonin agents|mesh-ancestor
25855359|NCT00066859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855360|NCT00066872|Imiquimod|imiquimod|mesh-list
24545191|NCT00692328|Levodopa|levodopa|mesh-list
24545192|NCT00692328|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25855361|NCT00066872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24733639|NCT01647685|Methylprednisolone|methylprednisolone|mesh-list
25664447|NCT01670097|Antiemetics|antiemetics|mesh-ancestor
25664448|NCT01670097|Autonomic Agents|autonomic agents|mesh-ancestor
25664449|NCT01670097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25664450|NCT01670097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855362|NCT00066872|Immunologic Factors|immunologic factors|mesh-ancestor
24939818|NCT04006691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939819|NCT04006691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25855363|NCT00066872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855364|NCT00066872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855365|NCT00066872|Interferon Inducers|interferon inducers|mesh-ancestor
24545209|NCT00692510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24545210|NCT00692510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855366|NCT00066885|Calcitriol|calcitriol|mesh-list
25855367|NCT00066885|Docetaxel|docetaxel|mesh-list
25855368|NCT00066885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855369|NCT00066885|Tubulin Modulators|tubulin modulators|mesh-ancestor
25855370|NCT00066885|Antimitotic Agents|antimitotic agents|mesh-ancestor
25855371|NCT00066885|Mitosis Modulators|mitosis modulators|mesh-ancestor
25855372|NCT00066885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855373|NCT00066885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25855374|NCT00066885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545226|NCT00692510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24545227|NCT00692510|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24545228|NCT00692510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24545229|NCT00692510|Purinergic Agents|purinergic agents|mesh-ancestor
24545273|NCT00692731|Purinergic Agents|purinergic agents|mesh-ancestor
24545274|NCT00692731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25855375|NCT00066885|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25855376|NCT00066885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25855377|NCT00066885|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25855378|NCT00066885|Vitamins|vitamins|mesh-ancestor
24545282|NCT00692900|Antimitotic Agents|antimitotic agents|mesh-ancestor
24545283|NCT00692900|Mitosis Modulators|mitosis modulators|mesh-ancestor
24835852|NCT02183467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25855379|NCT00066885|Micronutrients|micronutrients|mesh-ancestor
25855380|NCT00066885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25855381|NCT00066989|Immunoglobulins|immunoglobulins|mesh-list
25855382|NCT00066989|Antibodies|antibodies|mesh-list
25855383|NCT00066989|gamma-Globulins|gamma-globulins|mesh-list
25855384|NCT00066989|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25855385|NCT00066989|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24545330|NCT00693043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545332|NCT00693056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24545333|NCT00693056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24545334|NCT00693069|Clopidogrel|clopidogrel|mesh-list
24939826|NCT04006093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24939827|NCT04006093|Protease Inhibitors|protease inhibitors|mesh-ancestor
24939828|NCT04006093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939829|NCT04006093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939830|NCT04006093|Anticoagulants|anticoagulants|mesh-ancestor
24939831|NCT04006041|Paclitaxel|paclitaxel|mesh-list
24939832|NCT04006041|Cisplatin|cisplatin|mesh-list
24939833|NCT04006041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25855386|NCT00066989|Immunologic Factors|immunologic factors|mesh-ancestor
25855387|NCT00066989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855388|NCT00067015|Goserelin|goserelin|mesh-list
25855389|NCT00067015|Bicalutamide|bicalutamide|mesh-list
25855390|NCT00067015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24545469|NCT00693446|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24545470|NCT00693446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24545471|NCT00693446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545472|NCT00693446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25855391|NCT00067015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855392|NCT00067015|Androgen Antagonists|androgen antagonists|mesh-ancestor
25855393|NCT00067015|Hormone Antagonists|hormone antagonists|mesh-ancestor
24835989|NCT02183701|Losartan|losartan|mesh-list
25855394|NCT00067015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24545502|NCT00693576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545503|NCT00693576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24545504|NCT00693576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24545505|NCT00693576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24955950|NCT03859102|Anesthetics|anesthetics|mesh-list
24955951|NCT03859102|Anesthetics, Local|anesthetics, local|mesh-list
24955952|NCT03859102|Lansoprazole|lansoprazole|mesh-list
24955953|NCT03859102|Dexlansoprazole|dexlansoprazole|mesh-list
24955954|NCT03859102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24955955|NCT03859102|Antiemetics|antiemetics|mesh-ancestor
24545507|NCT00693589|Vitamin B 12|vitamin b 12|mesh-list
24545508|NCT00693589|Hydroxocobalamin|hydroxocobalamin|mesh-list
24545509|NCT00693589|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25855395|NCT00067015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855396|NCT00067041|Treprostinil|treprostinil|mesh-list
25855397|NCT00067041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25855398|NCT00067080|Deferasirox|deferasirox|mesh-list
25855399|NCT00067080|Deferoxamine|deferoxamine|mesh-list
25855400|NCT00067080|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25855401|NCT00067080|Chelating Agents|chelating agents|mesh-ancestor
25855402|NCT00067080|Sequestering Agents|sequestering agents|mesh-ancestor
25855403|NCT00067080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855404|NCT00067080|Siderophores|siderophores|mesh-ancestor
25855405|NCT00067093|Vitamin K|vitamin k|mesh-list
25855406|NCT00067093|Heparin|heparin|mesh-list
25855407|NCT00067093|Calcium heparin|calcium heparin|mesh-list
25855408|NCT00067093|Idraparinux|idraparinux|mesh-list
24545538|NCT00693732|Citalopram|citalopram|mesh-list
25855409|NCT00067093|Vitamins|vitamins|mesh-ancestor
24545542|NCT00693732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545544|NCT00693732|Serotonin Agents|serotonin agents|mesh-ancestor
24545545|NCT00693732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545546|NCT00693732|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25855410|NCT00067093|Micronutrients|micronutrients|mesh-ancestor
25855411|NCT00067093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855412|NCT00067093|Anticoagulants|anticoagulants|mesh-ancestor
25855413|NCT00067093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25855414|NCT00067093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25855415|NCT00067093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161707|NCT02581007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25855416|NCT00067093|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25855417|NCT00067093|Hemostatics|hemostatics|mesh-ancestor
25855418|NCT00067093|Coagulants|coagulants|mesh-ancestor
25855419|NCT00067093|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25855420|NCT00067093|Antithrombins|antithrombins|mesh-ancestor
25855421|NCT00067093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25855422|NCT00067093|Protease Inhibitors|protease inhibitors|mesh-ancestor
25855423|NCT00067093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855424|NCT00067119|Aspirin|aspirin|mesh-list
25855425|NCT00067119|Dipyridamole|dipyridamole|mesh-list
25855426|NCT00067119|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
25855427|NCT00067119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25855428|NCT00067119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25855429|NCT00067119|Analgesics|analgesics|mesh-ancestor
25855430|NCT00067119|Sensory System Agents|sensory system agents|mesh-ancestor
25855431|NCT00067119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25855432|NCT00067119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855433|NCT00067119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25855434|NCT00067119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25855435|NCT00067119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25855436|NCT00067119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25855437|NCT00067119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855438|NCT00067119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25855439|NCT00067119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25855440|NCT00067119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855441|NCT00067119|Antipyretics|antipyretics|mesh-ancestor
25855442|NCT00067119|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25855443|NCT00067119|Vasodilator Agents|vasodilator agents|mesh-ancestor
24545821|NCT00695071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855444|NCT00067158|Nicotine|nicotine|mesh-list
25855445|NCT00067158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25855446|NCT00067158|Autonomic Agents|autonomic agents|mesh-ancestor
25855447|NCT00067158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25855448|NCT00067158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855449|NCT00067158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25855450|NCT00067158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25855451|NCT00067158|Cholinergic Agents|cholinergic agents|mesh-ancestor
25855452|NCT00067158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25855453|NCT00067158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855454|NCT00067262|Valproic Acid|valproic acid|mesh-list
25855455|NCT00067262|Anticonvulsants|anticonvulsants|mesh-ancestor
24545872|NCT00695604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24545874|NCT00695604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24466257|NCT00372762|Diuretics|diuretics|mesh-ancestor
24545875|NCT00695604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855456|NCT00067262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855457|NCT00067262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545878|NCT00695604|Dermatologic Agents|dermatologic agents|mesh-ancestor
24545879|NCT00695604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24545881|NCT00695630|Antidotes|antidotes|mesh-ancestor
24545882|NCT00695630|Protective Agents|protective agents|mesh-ancestor
24545883|NCT00695630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545884|NCT00695630|GABA Modulators|gaba modulators|mesh-ancestor
24939851|NCT04006353|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24939852|NCT04006353|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24939853|NCT04006353|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24545907|NCT00695929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25161708|NCT02581007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25161709|NCT02581007|Alkylating Agents|alkylating agents|mesh-ancestor
24545908|NCT00695929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545909|NCT00695929|Protective Agents|protective agents|mesh-ancestor
24545910|NCT00695929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545911|NCT00695929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24545912|NCT00695994|Gemcitabine|gemcitabine|mesh-list
24545913|NCT00695994|Carboplatin|carboplatin|mesh-list
25855459|NCT00067262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25855460|NCT00067262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545982|NCT00696111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855461|NCT00067262|Antimanic Agents|antimanic agents|mesh-ancestor
25855462|NCT00067262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24545994|NCT00696202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24545995|NCT00696202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24545996|NCT00696215|Rasagiline|rasagiline|mesh-list
24545997|NCT00696215|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24545998|NCT00696215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24545999|NCT00696215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546000|NCT00696215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24546001|NCT00696215|Protective Agents|protective agents|mesh-ancestor
24546002|NCT00696215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546003|NCT00696475|Diazoxide|diazoxide|mesh-list
25855463|NCT00067262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24836198|NCT02184351|Miconazole|miconazole|mesh-list
24546046|NCT00696566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24546047|NCT00696566|Purinergic Agents|purinergic agents|mesh-ancestor
24546048|NCT00696566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24546049|NCT00696566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546050|NCT00696566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546051|NCT00696566|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25855464|NCT00067262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25855465|NCT00067301|Citalopram|citalopram|mesh-list
25855466|NCT00067301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25855467|NCT00067301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25855468|NCT00067301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25855469|NCT00067301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855470|NCT00067301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25855471|NCT00067301|Serotonin Agents|serotonin agents|mesh-ancestor
25855472|NCT00067301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546154|NCT00696982|Hormones|hormones|mesh-ancestor
25855473|NCT00067301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25855474|NCT00067301|Antidepressive Agents|antidepressive agents|mesh-ancestor
24546177|NCT00697021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546238|NCT00697164|Epoetin Alfa|epoetin alfa|mesh-list
24546239|NCT00697164|Hematinics|hematinics|mesh-ancestor
24546240|NCT00697281|Indoleacetic Acids|indoleacetic acids|mesh-list
24546241|NCT00697281|Plant Growth Regulators|plant growth regulators|mesh-ancestor
24546242|NCT00697281|Growth Substances|growth substances|mesh-ancestor
24546245|NCT00697372|Everolimus|everolimus|mesh-list
24546246|NCT00697372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24546247|NCT00697372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25664451|NCT01670097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25664452|NCT01670097|Glucocorticoids|glucocorticoids|mesh-ancestor
24546248|NCT00697372|Immunologic Factors|immunologic factors|mesh-ancestor
24546249|NCT00697372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664453|NCT01670097|Hormones|hormones|mesh-ancestor
25664454|NCT01670097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24546251|NCT00697372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24546252|NCT00697372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24546253|NCT00697372|Antifungal Agents|antifungal agents|mesh-ancestor
24625638|NCT01082731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24733998|NCT01650129|Insulin|insulin|mesh-list
24733999|NCT01650129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24734000|NCT01650129|Insulin Aspart|insulin aspart|mesh-list
24625639|NCT01082731|Anthelmintics|anthelmintics|mesh-ancestor
24625640|NCT01082744|Sufentanil|sufentanil|mesh-list
24625641|NCT01082744|Ropivacaine|ropivacaine|mesh-list
24625642|NCT01082744|Anesthetics, Local|anesthetics, local|mesh-ancestor
24625643|NCT01082744|Anesthetics|anesthetics|mesh-ancestor
25855475|NCT00067301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25855476|NCT00067340|Chlorhexidine|chlorhexidine|mesh-list
25855477|NCT00067340|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25855478|NCT00067340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25855479|NCT00067340|Disinfectants|disinfectants|mesh-ancestor
24447454|NCT00308503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447455|NCT00308529|Bevacizumab|bevacizumab|mesh-list
25855480|NCT00067353|Fluorides|fluorides|mesh-list
25855481|NCT00067353|Fluorides, Topical|fluorides, topical|mesh-list
25855482|NCT00067353|Cariostatic Agents|cariostatic agents|mesh-ancestor
25855483|NCT00067353|Protective Agents|protective agents|mesh-ancestor
24447482|NCT00308594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24546346|NCT00697814|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25855484|NCT00067353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836315|NCT02185222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855485|NCT00067405|Micronutrients|micronutrients|mesh-list
25855486|NCT00067405|Trace Elements|trace elements|mesh-list
25855487|NCT00067405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855488|NCT00067431|Valproic Acid|valproic acid|mesh-list
25855489|NCT00067431|Anticonvulsants|anticonvulsants|mesh-ancestor
25855490|NCT00067431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855491|NCT00067431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855492|NCT00067431|GABA Agents|gaba agents|mesh-ancestor
25855493|NCT00067431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25855494|NCT00067431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855495|NCT00067431|Antimanic Agents|antimanic agents|mesh-ancestor
25855496|NCT00067431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24942523|NCT03980002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942524|NCT03980002|Leprostatic Agents|leprostatic agents|mesh-ancestor
24942525|NCT03980002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24734041|NCT01650428|Irinotecan|irinotecan|mesh-list
25855497|NCT00067431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24546374|NCT00697892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24939889|NCT04005781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939890|NCT04005781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939891|NCT04005781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24939892|NCT04005768|Hydroxychloroquine|hydroxychloroquine|mesh-list
24939893|NCT04005768|Antimalarials|antimalarials|mesh-ancestor
24939894|NCT04005768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24853320|NCT02267408|Anticoagulants|anticoagulants|mesh-ancestor
24546416|NCT00698269|Insulin Aspart|insulin aspart|mesh-list
24546417|NCT00698269|Insulin, Long-Acting|insulin, long-acting|mesh-list
24939896|NCT04005768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24939897|NCT04005768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939898|NCT04005768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939899|NCT04005768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24939900|NCT04005612|Vitamin D|vitamin d|mesh-list
24939901|NCT04005612|Ergocalciferols|ergocalciferols|mesh-list
24546472|NCT00698724|Methylprednisolone|methylprednisolone|mesh-list
24546473|NCT00698724|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24546474|NCT00698724|Prednisolone|prednisolone|mesh-list
24546475|NCT00698724|Bromfenac|bromfenac|mesh-list
24546476|NCT00698724|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24546477|NCT00698724|Prednisolone phosphate|prednisolone phosphate|mesh-list
24546478|NCT00698724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25664455|NCT01670097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25664456|NCT01670097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664457|NCT01670110|Pasireotide|pasireotide|mesh-list
25664458|NCT01670110|Hormones|hormones|mesh-ancestor
25664459|NCT01670110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25664460|NCT01670110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664461|NCT01670279|Brexpiprazole|brexpiprazole|mesh-list
24546479|NCT00698724|Antiemetics|antiemetics|mesh-ancestor
24546480|NCT00698724|Autonomic Agents|autonomic agents|mesh-ancestor
24546481|NCT00698724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24546485|NCT00698724|Hormones|hormones|mesh-ancestor
24546499|NCT00698763|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24546500|NCT00698763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24546501|NCT00698763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24546502|NCT00698763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546503|NCT00698763|Protective Agents|protective agents|mesh-ancestor
24546504|NCT00698763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546505|NCT00698776|Lenalidomide|lenalidomide|mesh-list
24546506|NCT00698776|KRN 7000|krn 7000|mesh-list
24546507|NCT00698776|Immunologic Factors|immunologic factors|mesh-ancestor
24546508|NCT00698776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546509|NCT00698776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24546510|NCT00698776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24546511|NCT00698776|Growth Substances|growth substances|mesh-ancestor
24546512|NCT00698776|Growth Inhibitors|growth inhibitors|mesh-ancestor
24546513|NCT00698776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24546514|NCT00698776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24546515|NCT00698802|Insulin|insulin|mesh-list
24546516|NCT00698802|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24546517|NCT00698802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24546518|NCT00698802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546519|NCT00698945|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24617470|NCT01043419|Xenon|xenon|mesh-list
24939902|NCT04005612|Cholecalciferol|cholecalciferol|mesh-list
24956007|NCT03858465|Sympathomimetics|sympathomimetics|mesh-ancestor
24939903|NCT04005612|Vitamins|vitamins|mesh-list
24939904|NCT04005612|Micronutrients|micronutrients|mesh-ancestor
24939905|NCT04005612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546607|NCT00699322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24546608|NCT00699322|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24546609|NCT00699322|Protease Inhibitors|protease inhibitors|mesh-ancestor
24546610|NCT00699322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202817|NCT02718742|Tubulin Modulators|tubulin modulators|mesh-ancestor
25855498|NCT00067431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25855499|NCT00067444|Paroxetine|paroxetine|mesh-list
25855500|NCT00067444|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25855501|NCT00067444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25855502|NCT00067444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25855503|NCT00067444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855504|NCT00067444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25855505|NCT00067444|Serotonin Agents|serotonin agents|mesh-ancestor
25855506|NCT00067444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855507|NCT00067444|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25855508|NCT00067444|Antidepressive Agents|antidepressive agents|mesh-ancestor
25855509|NCT00067444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25855510|NCT00067444|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25855511|NCT00067444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25855512|NCT00067444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855513|NCT00067457|Alosetron|alosetron|mesh-list
24829861|NCT02155023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546611|NCT00699322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546612|NCT00699322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24546647|NCT00699478|Vitamin B Complex|vitamin b complex|mesh-ancestor
24546649|NCT00699478|Micronutrients|micronutrients|mesh-ancestor
24546650|NCT00699478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546651|NCT00699504|Moxifloxacin|moxifloxacin|mesh-list
24546652|NCT00699504|Cangrelor|cangrelor|mesh-list
24546653|NCT00699504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24546654|NCT00699504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24546655|NCT00699504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25855514|NCT00067457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24546707|NCT00699894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24546708|NCT00699894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546722|NCT00699920|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24546723|NCT00699920|Antimalarials|antimalarials|mesh-ancestor
24546724|NCT00699920|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24546725|NCT00699920|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24546726|NCT00699920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24546728|NCT00699946|Antiemetics|antiemetics|mesh-ancestor
25409438|NCT03382106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25664462|NCT01670279|Serotonin Agents|serotonin agents|mesh-ancestor
24546741|NCT00699946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24546742|NCT00699946|Serotonin Agents|serotonin agents|mesh-ancestor
24546743|NCT00700024|Methyltestosterone|methyltestosterone|mesh-list
25161710|NCT02581007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161711|NCT02581007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161712|NCT02581007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25161714|NCT02540330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25161715|NCT02540330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161716|NCT02540330|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25161717|NCT02540330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25161718|NCT02540330|Hormone Antagonists|hormone antagonists|mesh-ancestor
25161719|NCT02540330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25161720|NCT02540330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161721|NCT02483260|Ribavirin|ribavirin|mesh-list
25161722|NCT02483260|Antimetabolites|antimetabolites|mesh-ancestor
25161723|NCT02483260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161724|NCT02483260|Antiviral Agents|antiviral agents|mesh-ancestor
25161725|NCT02483260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25161726|NCT02483247|Paclitaxel|paclitaxel|mesh-list
25161727|NCT02483247|Doxorubicin|doxorubicin|mesh-list
25161728|NCT02483247|Pembrolizumab|pembrolizumab|mesh-list
24734216|NCT01651312|Mirabegron|mirabegron|mesh-list
25161729|NCT02483247|Capecitabine|capecitabine|mesh-list
25161730|NCT02483247|Nivolumab|nivolumab|mesh-list
25161731|NCT02483247|Sunitinib|sunitinib|mesh-list
25161732|NCT02483247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25161733|NCT02483247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161734|NCT02483247|Tubulin Modulators|tubulin modulators|mesh-ancestor
24546764|NCT00700128|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24546766|NCT00700128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24546767|NCT00700128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546768|NCT00700128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546769|NCT00700154|Insulin|insulin|mesh-list
24546783|NCT00700297|Gout Suppressants|gout suppressants|mesh-ancestor
24546784|NCT00700297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24546785|NCT00700297|Tubulin Modulators|tubulin modulators|mesh-ancestor
24546794|NCT00700466|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24546795|NCT00700466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24546796|NCT00700466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24546797|NCT00700466|Sympatholytics|sympatholytics|mesh-ancestor
24546798|NCT00700466|Autonomic Agents|autonomic agents|mesh-ancestor
24547241|NCT00703170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855515|NCT00067457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25855516|NCT00067457|Serotonin Agents|serotonin agents|mesh-ancestor
24547260|NCT00703235|Growth Substances|growth substances|mesh-ancestor
24547261|NCT00703235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547262|NCT00703235|Growth Inhibitors|growth inhibitors|mesh-ancestor
24734240|NCT01651364|Dopamine Agents|dopamine agents|mesh-ancestor
24939963|NCT04005222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24939965|NCT04005222|Micronutrients|micronutrients|mesh-ancestor
25855517|NCT00067457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25855518|NCT00067457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446760|NCT00305825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24547285|NCT00703313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24547286|NCT00703313|Contraceptive Agents|contraceptive agents|mesh-ancestor
24547287|NCT00703313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24547288|NCT00703313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547289|NCT00703313|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24547290|NCT00703313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24547291|NCT00703313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24547292|NCT00703313|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24547293|NCT00703313|Renal Agents|renal agents|mesh-ancestor
24547294|NCT00703313|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24547295|NCT00703313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24547297|NCT00703352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25161735|NCT02483247|Antimitotic Agents|antimitotic agents|mesh-ancestor
25664463|NCT01670279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25664464|NCT01670279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547360|NCT00703625|Tubulin Modulators|tubulin modulators|mesh-ancestor
25664465|NCT01670279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855519|NCT00067457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855521|NCT00067496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25855522|NCT00067496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855523|NCT00067496|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25855524|NCT00067496|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25855525|NCT00067496|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24939976|NCT04004754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24939985|NCT04004871|Paclitaxel|paclitaxel|mesh-list
24939986|NCT04004871|Cisplatin|cisplatin|mesh-list
25855526|NCT00067496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855527|NCT00067509|Progesterone|progesterone|mesh-list
24547396|NCT00703742|Citalopram|citalopram|mesh-list
24547397|NCT00703742|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25855528|NCT00067509|Estrogens|estrogens|mesh-list
25855529|NCT00067509|Progestins|progestins|mesh-ancestor
24547398|NCT00703742|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24547399|NCT00703742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24547400|NCT00703742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547401|NCT00703742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24547402|NCT00703742|Serotonin Agents|serotonin agents|mesh-ancestor
24547403|NCT00703742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547404|NCT00703742|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25855530|NCT00067509|Hormones|hormones|mesh-ancestor
25855531|NCT00067509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25855532|NCT00067509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939996|NCT04004871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24939997|NCT04004871|Immunologic Factors|immunologic factors|mesh-ancestor
24939998|NCT04004871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939999|NCT04004884|Ulipristal acetate|ulipristal acetate|mesh-list
24853401|NCT02268006|Capecitabine|capecitabine|mesh-list
25855533|NCT00067535|Cocaine|cocaine|mesh-list
24836496|NCT02186119|Ranibizumab|ranibizumab|mesh-list
25855534|NCT00067535|Anesthetics, Local|anesthetics, local|mesh-ancestor
25855535|NCT00067535|Anesthetics|anesthetics|mesh-ancestor
25855536|NCT00067535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24547580|NCT00704704|Leprostatic Agents|leprostatic agents|mesh-ancestor
24547581|NCT00704704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24547582|NCT00704704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24547583|NCT00704704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24547584|NCT00704704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24547585|NCT00704704|Growth Substances|growth substances|mesh-ancestor
24547586|NCT00704704|Growth Inhibitors|growth inhibitors|mesh-ancestor
24547587|NCT00704704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547589|NCT00704743|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
24547590|NCT00704743|Protease Inhibitors|protease inhibitors|mesh-ancestor
24547591|NCT00704743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547592|NCT00704743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547593|NCT00704756|Ribavirin|ribavirin|mesh-list
25855537|NCT00067535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547594|NCT00704756|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25855538|NCT00067535|Sensory System Agents|sensory system agents|mesh-ancestor
25855539|NCT00067535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25855540|NCT00067535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25855541|NCT00067535|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25855542|NCT00067535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25855543|NCT00067535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25876309|NCT03793179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24940004|NCT04004884|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24940005|NCT04004988|Tirzepatide|tirzepatide|mesh-list
24940006|NCT04004988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24940007|NCT04004988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547602|NCT00704821|Docetaxel|docetaxel|mesh-list
24547610|NCT00704899|Amitriptyline|amitriptyline|mesh-list
24547611|NCT00704899|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24547612|NCT00704899|Antidepressive Agents|antidepressive agents|mesh-ancestor
24547613|NCT00704899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24547614|NCT00704899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25664466|NCT01670279|Dopamine Agonists|dopamine agonists|mesh-ancestor
25664467|NCT01670279|Dopamine Agents|dopamine agents|mesh-ancestor
25664468|NCT01670526|Rivastigmine|rivastigmine|mesh-list
25664469|NCT01670526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
25664470|NCT01670526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664471|NCT01670526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202819|NCT02718742|Mitosis Modulators|mitosis modulators|mesh-ancestor
25202820|NCT02718742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202821|NCT02718469|Vaccines|vaccines|mesh-list
25202822|NCT02718469|Immunologic Factors|immunologic factors|mesh-ancestor
25267415|NCT02422823|Adrenergic Agents|adrenergic agents|mesh-ancestor
24617510|NCT01043575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617511|NCT01043575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547645|NCT00704951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547647|NCT00704990|Ascorbic Acid|ascorbic acid|mesh-list
24547648|NCT00704990|Vitamin B 6|vitamin b 6|mesh-list
24547649|NCT00704990|Pyridoxal|pyridoxal|mesh-list
24547650|NCT00704990|Pyridoxine|pyridoxine|mesh-list
24547651|NCT00704990|Zinc|zinc|mesh-list
25855545|NCT00067535|Dopamine Agents|dopamine agents|mesh-ancestor
25855546|NCT00067535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25855547|NCT00067548|EKB 569|ekb 569|mesh-list
24547661|NCT00705042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24547662|NCT00705042|Analgesics|analgesics|mesh-ancestor
24547663|NCT00705042|Sensory System Agents|sensory system agents|mesh-ancestor
24547664|NCT00705042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24547665|NCT00705042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855548|NCT00067548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855549|NCT00067548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24547666|NCT00705042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24547667|NCT00705042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24547668|NCT00705042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24547669|NCT00705042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24547670|NCT00705042|Immunologic Factors|immunologic factors|mesh-ancestor
24547671|NCT00705120|Cyclosporine|cyclosporine|mesh-list
24547672|NCT00705120|Cyclophosphamide|cyclophosphamide|mesh-list
24547673|NCT00705120|Busulfan|busulfan|mesh-list
24547674|NCT00705120|Cyclosporins|cyclosporins|mesh-list
24547675|NCT00705120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24547676|NCT00705120|Immunologic Factors|immunologic factors|mesh-ancestor
24547677|NCT00705120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547678|NCT00705120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24547679|NCT00705120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24547680|NCT00705120|Alkylating Agents|alkylating agents|mesh-ancestor
24547681|NCT00705120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547682|NCT00705120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547683|NCT00705120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24547684|NCT00705120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547685|NCT00705120|Antifungal Agents|antifungal agents|mesh-ancestor
25855550|NCT00067548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855551|NCT00067548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940012|NCT04004702|Anticonvulsants|anticonvulsants|mesh-ancestor
24940013|NCT04004702|Nootropic Agents|nootropic agents|mesh-ancestor
24940014|NCT04004507|Phentolamine|phentolamine|mesh-list
24940015|NCT04004507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24547726|NCT00705419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24547727|NCT00705445|Zinc|zinc|mesh-list
24547728|NCT00705445|Trace Elements|trace elements|mesh-list
24547729|NCT00705445|Micronutrients|micronutrients|mesh-list
24547730|NCT00705445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547731|NCT00705471|Infliximab|infliximab|mesh-list
24547732|NCT00705471|Dermatologic Agents|dermatologic agents|mesh-ancestor
24547735|NCT00705510|Cyclosporine|cyclosporine|mesh-list
25855552|NCT00067561|Alosetron|alosetron|mesh-list
25855553|NCT00067561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25855554|NCT00067561|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25855555|NCT00067561|Serotonin Agents|serotonin agents|mesh-ancestor
25855556|NCT00067561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25855557|NCT00067561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547759|NCT00705549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664472|NCT01670526|Cholinergic Agents|cholinergic agents|mesh-ancestor
24940035|NCT04004234|Tubulin Modulators|tubulin modulators|mesh-ancestor
25664473|NCT01670526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25664474|NCT01670526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664475|NCT01670526|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25664476|NCT01670526|Protective Agents|protective agents|mesh-ancestor
25664477|NCT01670721|Leucovorin|leucovorin|mesh-list
25664478|NCT01670721|Fluorouracil|fluorouracil|mesh-list
25664479|NCT01670721|Irinotecan|irinotecan|mesh-list
25664480|NCT01670721|Aflibercept|aflibercept|mesh-list
25664481|NCT01670721|Antimetabolites|antimetabolites|mesh-ancestor
24940036|NCT04004234|Antimitotic Agents|antimitotic agents|mesh-ancestor
24940041|NCT04004234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24940042|NCT04004234|Antimetabolites|antimetabolites|mesh-ancestor
24940043|NCT04004234|Antiviral Agents|antiviral agents|mesh-ancestor
24940044|NCT04004234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24547876|NCT00706225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24547900|NCT00706576|Mitosis Modulators|mitosis modulators|mesh-ancestor
25855558|NCT00067561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855559|NCT00067600|Calcium|calcium|mesh-list
25855560|NCT00067600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25855561|NCT00067600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855562|NCT00067626|Chromium|chromium|mesh-list
25855563|NCT00067626|Trace Elements|trace elements|mesh-ancestor
25855564|NCT00067626|Micronutrients|micronutrients|mesh-ancestor
25855565|NCT00067626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855566|NCT00067730|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
25855567|NCT00067730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25855568|NCT00067743|Lenalidomide|lenalidomide|mesh-list
25855569|NCT00067743|Immunologic Factors|immunologic factors|mesh-ancestor
25855570|NCT00067743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855571|NCT00067743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24548040|NCT00707369|Amoxicillin|amoxicillin|mesh-list
24548041|NCT00707369|Metronidazole|metronidazole|mesh-list
24548042|NCT00707369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24548043|NCT00707369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24548044|NCT00707369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24548045|NCT00707369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24548046|NCT00707408|Imatinib Mesylate|imatinib mesylate|mesh-list
24548047|NCT00707408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24548048|NCT00707408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24548132|NCT00707824|Nalbuphine|nalbuphine|mesh-list
24548133|NCT00707824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24548134|NCT00707824|Narcotics|narcotics|mesh-ancestor
24548135|NCT00707824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24548136|NCT00707824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855572|NCT00067743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25855573|NCT00067743|Growth Substances|growth substances|mesh-ancestor
24444024|NCT00296530|Hormone Antagonists|hormone antagonists|mesh-ancestor
24444025|NCT00296530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24447057|NCT00307307|Niacin|niacin|mesh-list
25855574|NCT00067743|Growth Inhibitors|growth inhibitors|mesh-ancestor
25855575|NCT00067743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24678309|NCT01360827|Cisplatin|cisplatin|mesh-list
24826985|NCT02136992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827001|NCT02137109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827022|NCT02137161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24827023|NCT02137161|Analgesics|analgesics|mesh-ancestor
24827024|NCT02137161|Sensory System Agents|sensory system agents|mesh-ancestor
24827025|NCT02137161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24827026|NCT02137213|Naloxone|naloxone|mesh-list
24827027|NCT02137213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24712613|NCT01521793|Protective Agents|protective agents|mesh-ancestor
25855576|NCT00067756|Butyric Acid|butyric acid|mesh-list
24444075|NCT00296699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25267471|NCT02423018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24444076|NCT00296699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444077|NCT00296699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24444078|NCT00296699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444079|NCT00296699|Analgesics|analgesics|mesh-ancestor
24444080|NCT00296699|Sensory System Agents|sensory system agents|mesh-ancestor
24444081|NCT00296699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24444082|NCT00296699|Antidepressive Agents|antidepressive agents|mesh-ancestor
24444083|NCT00296699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25267410|NCT02422888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267411|NCT02422823|Epinephrine|epinephrine|mesh-list
25267412|NCT02422823|Carticaine|carticaine|mesh-list
25267413|NCT02422823|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25267414|NCT02422823|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25855577|NCT00067756|Histamine Antagonists|histamine antagonists|mesh-ancestor
25855578|NCT00067756|Histamine Agents|histamine agents|mesh-ancestor
25855579|NCT00067756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25855580|NCT00067756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855581|NCT00067756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876310|NCT03793179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25876311|NCT03793166|Nivolumab|nivolumab|mesh-list
25876312|NCT03793166|Ipilimumab|ipilimumab|mesh-list
25855583|NCT00067860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25855584|NCT00067860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855585|NCT00067899|Vitamins|vitamins|mesh-list
25855586|NCT00067899|Ascorbic Acid|ascorbic acid|mesh-list
25855587|NCT00067899|Vitamin E|vitamin e|mesh-list
25855588|NCT00067899|Micronutrients|micronutrients|mesh-ancestor
25855589|NCT00067899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855590|NCT00067899|Antioxidants|antioxidants|mesh-ancestor
25855591|NCT00067899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855592|NCT00067899|Protective Agents|protective agents|mesh-ancestor
25267430|NCT02422823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25267431|NCT02422823|Sensory System Agents|sensory system agents|mesh-ancestor
25267432|NCT02423096|Haloperidol|haloperidol|mesh-list
25267433|NCT02423096|Olanzapine|olanzapine|mesh-list
25267434|NCT02423096|Risperidone|risperidone|mesh-list
25267435|NCT02423096|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25267436|NCT02423096|Sulpiride|sulpiride|mesh-list
25267437|NCT02423096|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25267438|NCT02423096|Serotonin Agents|serotonin agents|mesh-ancestor
25267439|NCT02423096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25267440|NCT02423096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267441|NCT02423096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855593|NCT00067912|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25855594|NCT00067912|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25855595|NCT00067912|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25855596|NCT00067912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25855597|NCT00067912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25855598|NCT00067912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679206|NCT01367496|Naltrexone|naltrexone|mesh-list
25855599|NCT00067912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25855600|NCT00067912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855601|NCT00067912|Analgesics|analgesics|mesh-ancestor
24827120|NCT02137525|Narcotics|narcotics|mesh-ancestor
24942588|NCT03979469|Fentanyl|fentanyl|mesh-list
25855602|NCT00067912|Sensory System Agents|sensory system agents|mesh-ancestor
25855603|NCT00067912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267442|NCT02423096|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25267443|NCT02423096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25267444|NCT02423096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25267445|NCT02423096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25267446|NCT02423096|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25267447|NCT02423096|Dopamine Agents|dopamine agents|mesh-ancestor
25267448|NCT02423096|Antiemetics|antiemetics|mesh-ancestor
25267449|NCT02423096|Autonomic Agents|autonomic agents|mesh-ancestor
25267450|NCT02423096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267451|NCT02423096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25267452|NCT02423096|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25855604|NCT00067912|Antidepressive Agents|antidepressive agents|mesh-ancestor
24456820|NCT00332319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24456821|NCT00332319|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24456822|NCT00332319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24456823|NCT00332319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456824|NCT00332345|Timolol|timolol|mesh-list
24456825|NCT00332345|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24456826|NCT00332345|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24625697|NCT01083017|Chlorthalidone|chlorthalidone|mesh-list
25855605|NCT00067912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25855606|NCT00067912|Dopamine Agents|dopamine agents|mesh-ancestor
24734895|NCT01654575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855607|NCT00067912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25855608|NCT00067925|Calcium|calcium|mesh-list
25855609|NCT00067925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25855610|NCT00067925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855611|NCT00067938|Lamotrigine|lamotrigine|mesh-list
25855612|NCT00067938|Anticonvulsants|anticonvulsants|mesh-ancestor
25855613|NCT00067938|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24827121|NCT02137525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24827122|NCT02137525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827123|NCT02137525|Analgesics|analgesics|mesh-ancestor
24827124|NCT02137525|Sensory System Agents|sensory system agents|mesh-ancestor
24500011|NCT00522158|Simvastatin|simvastatin|mesh-list
25855614|NCT00067938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25267461|NCT02423018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25855616|NCT00067938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24827126|NCT02137525|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24827127|NCT02137525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24827128|NCT02137525|Anesthetics, General|anesthetics, general|mesh-ancestor
24827131|NCT02137616|Risperidone|risperidone|mesh-list
24827132|NCT02137616|Aripiprazole|aripiprazole|mesh-list
24827133|NCT02137616|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24827134|NCT02137616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24827135|NCT02137616|Serotonin Agents|serotonin agents|mesh-ancestor
24827136|NCT02137616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24827137|NCT02137616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827138|NCT02137616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827139|NCT02137616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25855617|NCT00067938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855618|NCT00067938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25855619|NCT00067938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25267462|NCT02423018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267463|NCT02423018|Anticonvulsants|anticonvulsants|mesh-ancestor
25267464|NCT02423018|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25267465|NCT02423018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25267466|NCT02423018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267467|NCT02423018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25267468|NCT02423018|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25267469|NCT02423018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25267470|NCT02423018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25267472|NCT02423083|Guanabenz|guanabenz|mesh-list
25267473|NCT02423083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25267474|NCT02423083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25267475|NCT02423083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25267476|NCT02423083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25267477|NCT02423083|Adrenergic Agents|adrenergic agents|mesh-ancestor
25267478|NCT02423083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25267479|NCT02423083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456833|NCT00332345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24456834|NCT00332345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24940115|NCT04003688|Tocolytic Agents|tocolytic agents|mesh-ancestor
24735042|NCT01655303|Metoprolol|metoprolol|mesh-list
24827148|NCT02137616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24827149|NCT02137616|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24827150|NCT02137616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24827151|NCT02137616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24713907|NCT01527968|Hemostatics|hemostatics|mesh-ancestor
25855620|NCT00067938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24735102|NCT01655641|Hemostatics|hemostatics|mesh-ancestor
25267480|NCT02423083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267481|NCT02422563|Paclitaxel|paclitaxel|mesh-list
25267482|NCT02422563|Carboplatin|carboplatin|mesh-list
25267483|NCT02422563|Ifosfamide|ifosfamide|mesh-list
25267484|NCT02422563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25267492|NCT02422706|Metronidazole|metronidazole|mesh-list
25267493|NCT02422706|Clarithromycin|clarithromycin|mesh-list
25267494|NCT02422706|Levofloxacin|levofloxacin|mesh-list
25267495|NCT02422706|Ofloxacin|ofloxacin|mesh-list
24680001|NCT01372423|Lubiprostone|lubiprostone|mesh-list
25855621|NCT00067938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25855622|NCT00067938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25855623|NCT00067951|Metformin|metformin|mesh-list
25855624|NCT00067951|Rosiglitazone|rosiglitazone|mesh-list
25855625|NCT00067951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25855626|NCT00067951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855627|NCT00068029|Octreotide|octreotide|mesh-list
25855628|NCT00068029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25855629|NCT00068029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25855630|NCT00068029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855631|NCT00068042|Octreotide|octreotide|mesh-list
25855632|NCT00068042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25855633|NCT00068042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25267496|NCT02422706|Nitazoxanide|nitazoxanide|mesh-list
25267497|NCT02422706|Doxycycline|doxycycline|mesh-list
25267498|NCT02422706|Omeprazole|omeprazole|mesh-list
25267499|NCT02422706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25267500|NCT02422706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25267501|NCT02422706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25267502|NCT02422706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25267503|NCT02422706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25267504|NCT02422706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25267505|NCT02422706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25855634|NCT00068042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855635|NCT00068055|gamma-Globulins|gamma-globulins|mesh-list
25855636|NCT00068055|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25855637|NCT00068055|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25855638|NCT00068055|Immunologic Factors|immunologic factors|mesh-ancestor
25855639|NCT00068055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855640|NCT00068068|Talaporfin|talaporfin|mesh-list
25855641|NCT00068068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855642|NCT00068068|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25855643|NCT00068068|Dermatologic Agents|dermatologic agents|mesh-ancestor
25855644|NCT00068081|Capsaicin|capsaicin|mesh-list
25855645|NCT00068081|Antipruritics|antipruritics|mesh-ancestor
25855646|NCT00068081|Dermatologic Agents|dermatologic agents|mesh-ancestor
25855647|NCT00068081|Sensory System Agents|sensory system agents|mesh-ancestor
25855648|NCT00068081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25855649|NCT00068081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855650|NCT00068276|Cholecalciferol|cholecalciferol|mesh-list
25855651|NCT00068276|Vitamin D|vitamin d|mesh-list
25855652|NCT00068276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25855653|NCT00068276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855654|NCT00068276|Vitamins|vitamins|mesh-ancestor
25855655|NCT00068276|Micronutrients|micronutrients|mesh-ancestor
25855656|NCT00068276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25855657|NCT00068289|Bortezomib|bortezomib|mesh-list
25855658|NCT00068289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855659|NCT00068302|Sirolimus|sirolimus|mesh-list
25855660|NCT00068302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25855661|NCT00068302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25855662|NCT00068302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25855663|NCT00068302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855664|NCT00068302|Antifungal Agents|antifungal agents|mesh-ancestor
25855665|NCT00068302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25855666|NCT00068302|Immunologic Factors|immunologic factors|mesh-ancestor
25855667|NCT00068302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855668|NCT00068315|Rituximab|rituximab|mesh-list
25855669|NCT00068315|Fludarabine|fludarabine|mesh-list
25855670|NCT00068315|Fludarabine phosphate|fludarabine phosphate|mesh-list
25855672|NCT00068315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25855674|NCT00068315|Immunologic Factors|immunologic factors|mesh-ancestor
25855675|NCT00068315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855676|NCT00068315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25855677|NCT00068315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25855678|NCT00068315|Antimetabolites|antimetabolites|mesh-ancestor
25855679|NCT00068315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267506|NCT02422706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25267507|NCT02422706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267508|NCT02422706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25267509|NCT02422706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25267510|NCT02422706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25267511|NCT02422706|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25267512|NCT02422706|Renal Agents|renal agents|mesh-ancestor
25267513|NCT02422706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25267514|NCT02422706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25267515|NCT02422706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267516|NCT02422706|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25267517|NCT02422706|Antimalarials|antimalarials|mesh-ancestor
25267518|NCT02422485|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
25855680|NCT00068315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25855681|NCT00068432|Gemcitabine|gemcitabine|mesh-list
25855682|NCT00068432|Celecoxib|celecoxib|mesh-list
25855683|NCT00068432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25855684|NCT00068432|Antimetabolites|antimetabolites|mesh-ancestor
25855685|NCT00068432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855686|NCT00068432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855687|NCT00068432|Antiviral Agents|antiviral agents|mesh-ancestor
25855688|NCT00068432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25855689|NCT00068432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24827400|NCT02138799|Rifampin|rifampin|mesh-list
25855690|NCT00068432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25855691|NCT00068432|Immunologic Factors|immunologic factors|mesh-ancestor
25855692|NCT00068432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855693|NCT00068432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25855694|NCT00068432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25855695|NCT00068432|Analgesics|analgesics|mesh-ancestor
25855696|NCT00068432|Sensory System Agents|sensory system agents|mesh-ancestor
25855697|NCT00068432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25855698|NCT00068432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25855699|NCT00068432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25855700|NCT00068432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25855701|NCT00068432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25855702|NCT00068458|Calcium, Dietary|calcium, dietary|mesh-list
24446970|NCT00306774|Micronutrients|micronutrients|mesh-ancestor
25855703|NCT00068458|Calcium|calcium|mesh-list
25855704|NCT00068458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25855705|NCT00068458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855706|NCT00068458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25855707|NCT00068471|Anidulafungin|anidulafungin|mesh-list
25855708|NCT00068471|Antifungal Agents|antifungal agents|mesh-ancestor
25855709|NCT00068471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25855710|NCT00068484|Bortezomib|bortezomib|mesh-list
25267519|NCT02422485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25267520|NCT02422485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25267521|NCT02422485|Analgesics|analgesics|mesh-ancestor
25267522|NCT02422485|Sensory System Agents|sensory system agents|mesh-ancestor
25267523|NCT02422485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267524|NCT02422485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267525|NCT02422485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25267526|NCT02422485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25267527|NCT02422589|Ceritinib|ceritinib|mesh-list
25267528|NCT02422589|Midazolam|midazolam|mesh-list
25267529|NCT02422589|Warfarin|warfarin|mesh-list
25855711|NCT00068484|Topotecan|topotecan|mesh-list
25855712|NCT00068484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855713|NCT00068484|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25855714|NCT00068484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25855715|NCT00068484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855716|NCT00068484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855717|NCT00068497|Gefitinib|gefitinib|mesh-list
25855718|NCT00068497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855719|NCT00068497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25855720|NCT00068497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855721|NCT00068497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855722|NCT00068523|Cyclosporine|cyclosporine|mesh-list
25855723|NCT00068523|Methylprednisolone|methylprednisolone|mesh-list
25855724|NCT00068523|Cyclophosphamide|cyclophosphamide|mesh-list
25855725|NCT00068523|Fludarabine|fludarabine|mesh-list
24942651|NCT03978988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24942652|NCT03978988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25855726|NCT00068523|Fludarabine phosphate|fludarabine phosphate|mesh-list
25855727|NCT00068523|Cyclosporins|cyclosporins|mesh-list
25855728|NCT00068523|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25855729|NCT00068523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25855730|NCT00068523|Immunologic Factors|immunologic factors|mesh-ancestor
25855731|NCT00068523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855732|NCT00068523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25855733|NCT00068523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25855734|NCT00068523|Alkylating Agents|alkylating agents|mesh-ancestor
25855735|NCT00068523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855736|NCT00068523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855737|NCT00068523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25855738|NCT00068523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25855739|NCT00068523|Antimetabolites|antimetabolites|mesh-ancestor
25855740|NCT00068523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855741|NCT00068523|Antifungal Agents|antifungal agents|mesh-ancestor
25855742|NCT00068523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25855743|NCT00068523|Dermatologic Agents|dermatologic agents|mesh-ancestor
25855744|NCT00068523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25855745|NCT00068523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25855746|NCT00068523|Antiemetics|antiemetics|mesh-ancestor
25855747|NCT00068523|Autonomic Agents|autonomic agents|mesh-ancestor
25855748|NCT00068523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267530|NCT02422589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25267531|NCT02422589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25267532|NCT02422589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25267533|NCT02422589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267534|NCT02422589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25267535|NCT02422589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25267536|NCT02422589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25267537|NCT02422589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25267538|NCT02422589|Anesthetics, General|anesthetics, general|mesh-ancestor
25267539|NCT02422589|Anesthetics|anesthetics|mesh-ancestor
25267540|NCT02422589|GABA Modulators|gaba modulators|mesh-ancestor
25267541|NCT02422589|GABA Agents|gaba agents|mesh-ancestor
25267542|NCT02422589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25855749|NCT00068523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25855750|NCT00068523|Glucocorticoids|glucocorticoids|mesh-ancestor
25855751|NCT00068523|Hormones|hormones|mesh-ancestor
25855752|NCT00068523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25855753|NCT00068523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25855754|NCT00068523|Protective Agents|protective agents|mesh-ancestor
25855755|NCT00068549|Gemcitabine|gemcitabine|mesh-list
25855756|NCT00068549|Cisplatin|cisplatin|mesh-list
25855757|NCT00068549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855758|NCT00068549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25855759|NCT00068549|Antimetabolites|antimetabolites|mesh-ancestor
25855760|NCT00068549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855761|NCT00068549|Antiviral Agents|antiviral agents|mesh-ancestor
25855762|NCT00068549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25855763|NCT00068549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855764|NCT00068549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25855765|NCT00068549|Immunologic Factors|immunologic factors|mesh-ancestor
25855766|NCT00068549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855767|NCT00068653|Celecoxib|celecoxib|mesh-list
25855768|NCT00068653|Gefitinib|gefitinib|mesh-list
25855769|NCT00068653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25855770|NCT00068653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25855771|NCT00068653|Analgesics|analgesics|mesh-ancestor
25855772|NCT00068653|Sensory System Agents|sensory system agents|mesh-ancestor
25855773|NCT00068653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25855774|NCT00068653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855775|NCT00068653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25855776|NCT00068653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25855777|NCT00068653|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25855778|NCT00068653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25855781|NCT00068653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855782|NCT00068653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25855783|NCT00068666|Temozolomide|temozolomide|mesh-list
25855784|NCT00068666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25855785|NCT00068666|Alkylating Agents|alkylating agents|mesh-ancestor
25855786|NCT00068666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855787|NCT00068666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855788|NCT00068731|Lycopene|lycopene|mesh-list
25855789|NCT00068731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25855790|NCT00068731|Antioxidants|antioxidants|mesh-ancestor
25855791|NCT00068731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855792|NCT00068731|Protective Agents|protective agents|mesh-ancestor
25855793|NCT00068731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855794|NCT00068731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25855795|NCT00068731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25855796|NCT00068731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855797|NCT00068744|Cisplatin|cisplatin|mesh-list
25855798|NCT00068744|Fluorouracil|fluorouracil|mesh-list
25855799|NCT00068744|Mitomycins|mitomycins|mesh-list
25267546|NCT02422589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25267547|NCT02422589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25267548|NCT02422602|Rivaroxaban|rivaroxaban|mesh-list
25267549|NCT02422602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25267550|NCT02422602|Antithrombins|antithrombins|mesh-ancestor
25267551|NCT02422602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25267552|NCT02422602|Protease Inhibitors|protease inhibitors|mesh-ancestor
25267553|NCT02422602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25267554|NCT02422602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267555|NCT02422602|Anticoagulants|anticoagulants|mesh-ancestor
25267556|NCT02422654|Eliglustat|eliglustat|mesh-list
25267557|NCT02422654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855800|NCT00068744|Mitomycin|mitomycin|mesh-list
25855801|NCT00068744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855802|NCT00068744|Antimetabolites|antimetabolites|mesh-ancestor
25855803|NCT00068744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855804|NCT00068744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25855805|NCT00068744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25855806|NCT00068744|Immunologic Factors|immunologic factors|mesh-ancestor
25855807|NCT00068744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855808|NCT00068744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25855809|NCT00068744|Alkylating Agents|alkylating agents|mesh-ancestor
25855810|NCT00068744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25855811|NCT00068744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855812|NCT00068757|Paclitaxel|paclitaxel|mesh-list
25855813|NCT00068757|Trastuzumab|trastuzumab|mesh-list
25855814|NCT00068757|Lonafarnib|lonafarnib|mesh-list
25855815|NCT00068757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25855816|NCT00068757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855817|NCT00068757|Tubulin Modulators|tubulin modulators|mesh-ancestor
25855818|NCT00068757|Antimitotic Agents|antimitotic agents|mesh-ancestor
25855819|NCT00068757|Mitosis Modulators|mitosis modulators|mesh-ancestor
25855820|NCT00068757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855821|NCT00068757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25855822|NCT00068757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855823|NCT00068783|Imatinib Mesylate|imatinib mesylate|mesh-list
24680955|NCT01377246|Octreotide|octreotide|mesh-list
25855824|NCT00068783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855825|NCT00068783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25855826|NCT00068783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855827|NCT00068783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855828|NCT00068809|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25267558|NCT02422654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267559|NCT02422056|Tranexamic Acid|tranexamic acid|mesh-list
25267560|NCT02422056|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25267561|NCT02422056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25267562|NCT02422056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267563|NCT02422056|Hemostatics|hemostatics|mesh-ancestor
25267564|NCT02422056|Coagulants|coagulants|mesh-ancestor
25267565|NCT02422199|Capecitabine|capecitabine|mesh-list
25855829|NCT00068809|Antiviral Agents|antiviral agents|mesh-ancestor
25855834|NCT00068848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447055|NCT00307255|Immunologic Factors|immunologic factors|mesh-ancestor
24447056|NCT00307255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447059|NCT00307307|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24447060|NCT00307307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24447061|NCT00307307|Antimetabolites|antimetabolites|mesh-ancestor
24447062|NCT00307307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447063|NCT00307307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24447065|NCT00307307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855835|NCT00068848|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25855836|NCT00068861|Metformin|metformin|mesh-list
25855837|NCT00068861|Clomiphene|clomiphene|mesh-list
25855838|NCT00068861|Enclomiphene|enclomiphene|mesh-list
25855839|NCT00068861|Zuclomiphene|zuclomiphene|mesh-list
24681117|NCT01378533|Epirubicin|epirubicin|mesh-list
24447072|NCT00307411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24447073|NCT00307411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855840|NCT00068861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25855841|NCT00068861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855842|NCT00068861|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25855843|NCT00068861|Hormone Antagonists|hormone antagonists|mesh-ancestor
25855844|NCT00068861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25855845|NCT00068861|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25855846|NCT00068861|Fertility Agents|fertility agents|mesh-ancestor
25855847|NCT00068861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25855848|NCT00068861|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25855849|NCT00068861|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25855850|NCT00068952|Temozolomide|temozolomide|mesh-list
25855851|NCT00068952|Carmustine|carmustine|mesh-list
25855852|NCT00068952|Lomustine|lomustine|mesh-list
25855853|NCT00068952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25855854|NCT00068952|Alkylating Agents|alkylating agents|mesh-ancestor
25855855|NCT00068952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855856|NCT00068952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855857|NCT00069251|Bupropion|bupropion|mesh-list
25855858|NCT00069251|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24447113|NCT00307515|Coagulants|coagulants|mesh-ancestor
25855859|NCT00069251|Antidepressive Agents|antidepressive agents|mesh-ancestor
25855860|NCT00069251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25267566|NCT02422199|Lapatinib|lapatinib|mesh-list
25267567|NCT02422199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25267568|NCT02422199|Antimetabolites|antimetabolites|mesh-ancestor
25267569|NCT02422199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267570|NCT02422199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267571|NCT02422199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25267572|NCT02422199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25267573|NCT02422017|Timolol|timolol|mesh-list
25267574|NCT02422017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25267575|NCT02422017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25855861|NCT00069251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25855862|NCT00069251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25855863|NCT00069251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25855864|NCT00069251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855865|NCT00069251|Dopamine Agents|dopamine agents|mesh-ancestor
25855866|NCT00069251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25855867|NCT00069251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467310|NCT00377052|Gemcitabine|gemcitabine|mesh-list
25855868|NCT00069251|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25855869|NCT00069251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25855870|NCT00069251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449852|NCT00317330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24449854|NCT00317330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449855|NCT00317330|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25855871|NCT00069355|Propranolol|propranolol|mesh-list
25855872|NCT00069355|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25855873|NCT00069355|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25855874|NCT00069355|Adrenergic Agents|adrenergic agents|mesh-ancestor
25855875|NCT00069355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25855876|NCT00069355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855877|NCT00069355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855878|NCT00069355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25855879|NCT00069355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25855880|NCT00069355|Vasodilator Agents|vasodilator agents|mesh-ancestor
25855882|NCT00069459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25855883|NCT00069459|Antidepressive Agents|antidepressive agents|mesh-ancestor
25855884|NCT00069459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25855885|NCT00069459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25855886|NCT00069459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25855887|NCT00069459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25855888|NCT00069459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855889|NCT00069459|Dopamine Agents|dopamine agents|mesh-ancestor
25855890|NCT00069459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25855891|NCT00069459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855892|NCT00069459|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25855893|NCT00069459|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25855894|NCT00069459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735836|NCT01658891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24735837|NCT01659008|Estradiol|estradiol|mesh-list
24735838|NCT01659008|Estrogens|estrogens|mesh-ancestor
25855895|NCT00069498|Aminosalicylic Acid|aminosalicylic acid|mesh-list
25855896|NCT00069498|Mesalamine|mesalamine|mesh-list
25855897|NCT00069498|Antitubercular Agents|antitubercular agents|mesh-ancestor
25855898|NCT00069498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25855899|NCT00069498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25855900|NCT00069498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25855901|NCT00069498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25855902|NCT00069498|Analgesics|analgesics|mesh-ancestor
25855903|NCT00069498|Sensory System Agents|sensory system agents|mesh-ancestor
25855904|NCT00069498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25855905|NCT00069498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855906|NCT00069498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25855907|NCT00069498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25855908|NCT00069550|Dextromethorphan|dextromethorphan|mesh-list
25855909|NCT00069550|Donepezil|donepezil|mesh-list
25267576|NCT02422017|Adrenergic Agents|adrenergic agents|mesh-ancestor
25267577|NCT02422017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25267578|NCT02422017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267579|NCT02422017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267580|NCT02422017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25267581|NCT02422017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25267582|NCT02422030|Atorvastatin|atorvastatin|mesh-list
25267583|NCT02422030|Fenofibric acid|fenofibric acid|mesh-list
25267584|NCT02422030|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25267585|NCT02422030|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25267586|NCT02422030|Antimetabolites|antimetabolites|mesh-ancestor
25267587|NCT02422030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267588|NCT02422030|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25267589|NCT02422030|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25267590|NCT02422030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25267591|NCT02422108|Denosumab|denosumab|mesh-list
25267592|NCT02422108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24449859|NCT00317330|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24940228|NCT04002635|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25855910|NCT00069550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24827585|NCT02140268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24827586|NCT02140268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24735854|NCT01659099|Obinutuzumab|obinutuzumab|mesh-list
25855911|NCT00069550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467410|NCT00377546|Analgesics|analgesics|mesh-ancestor
25855912|NCT00069550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855913|NCT00069550|Cholinergic Agents|cholinergic agents|mesh-ancestor
25855914|NCT00069550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25855915|NCT00069550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447232|NCT00307671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24447233|NCT00307671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24447234|NCT00307671|Abortifacient Agents|abortifacient agents|mesh-ancestor
24447249|NCT00307671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25855920|NCT00069550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25855921|NCT00069706|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25855922|NCT00069706|Latanoprost|latanoprost|mesh-list
25855923|NCT00069706|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25876313|NCT03793166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25876314|NCT03793166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876315|NCT03793166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25876316|NCT03793166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876317|NCT03779334|Risdiplam|risdiplam|mesh-list
25876318|NCT03779334|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25876319|NCT03779334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25876320|NCT03779334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876321|NCT03769467|Pembrolizumab|pembrolizumab|mesh-list
25876322|NCT03769467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25876323|NCT03769467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876324|NCT03739411|Temozolomide|temozolomide|mesh-list
25876325|NCT03739411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25876326|NCT03739411|Alkylating Agents|alkylating agents|mesh-ancestor
25876327|NCT03739411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876328|NCT03739411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876329|NCT03733067|Abatacept|abatacept|mesh-list
25876330|NCT03733067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25876331|NCT03733067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876332|NCT03733067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827588|NCT02140268|Anesthetics|anesthetics|mesh-ancestor
25876333|NCT03733067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25876334|NCT03733067|Immunologic Factors|immunologic factors|mesh-ancestor
25876335|NCT03733067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876336|NCT03733067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25876337|NCT03725202|Upadacitinib|upadacitinib|mesh-list
25876338|NCT03725202|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25876339|NCT03725202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25876340|NCT03725202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876341|NCT03725202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876342|NCT03725202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25876343|NCT03712826|Ustekinumab|ustekinumab|mesh-list
25876344|NCT03712826|Dermatologic Agents|dermatologic agents|mesh-ancestor
25876345|NCT03705507|Dexamethasone|dexamethasone|mesh-list
25267593|NCT02422108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267594|NCT02421913|Ketamine|ketamine|mesh-list
25267595|NCT02421913|Analgesics|analgesics|mesh-ancestor
25267596|NCT02421913|Sensory System Agents|sensory system agents|mesh-ancestor
25267597|NCT02421913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267598|NCT02421913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449860|NCT00317330|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24449875|NCT00317408|Leucovorin|leucovorin|mesh-list
24449876|NCT00317408|Cytarabine|cytarabine|mesh-list
25876346|NCT03705507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25876347|NCT03705507|Antiemetics|antiemetics|mesh-ancestor
25876348|NCT03705507|Autonomic Agents|autonomic agents|mesh-ancestor
25876349|NCT03705507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25876350|NCT03705507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876351|NCT03705507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25876352|NCT03705507|Glucocorticoids|glucocorticoids|mesh-ancestor
25876353|NCT03705507|Hormones|hormones|mesh-ancestor
25876354|NCT03705507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25876355|NCT03705507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25876356|NCT03705507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876357|NCT03660826|Durvalumab|durvalumab|mesh-list
25876358|NCT03660826|Olaparib|olaparib|mesh-list
25876359|NCT03660826|Cediranib|cediranib|mesh-list
25876360|NCT03660826|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25876361|NCT03660826|Immunoglobulins|immunoglobulins|mesh-list
25876362|NCT03660826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25876363|NCT03660826|Immunoglobulin G|immunoglobulin g|mesh-list
25876364|NCT03660826|Maleic acid|maleic acid|mesh-list
25876365|NCT03660826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25876366|NCT03660826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855930|NCT00069875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827599|NCT02140333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855931|NCT00069875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24827603|NCT02140437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24827605|NCT02140437|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24827606|NCT02140437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24827607|NCT02140437|Hormone Antagonists|hormone antagonists|mesh-ancestor
25855932|NCT00069875|Antimetabolites|antimetabolites|mesh-ancestor
25855933|NCT00069875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855934|NCT00069875|Antiviral Agents|antiviral agents|mesh-ancestor
25855935|NCT00069875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25855936|NCT00069875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25855937|NCT00069875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24682576|NCT01386866|Motesanib diphosphate|motesanib diphosphate|mesh-list
25855938|NCT00069875|Immunologic Factors|immunologic factors|mesh-ancestor
25855939|NCT00069875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855940|NCT00069888|Docetaxel|docetaxel|mesh-list
25855941|NCT00069888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855942|NCT00069888|Tubulin Modulators|tubulin modulators|mesh-ancestor
25855943|NCT00069888|Antimitotic Agents|antimitotic agents|mesh-ancestor
25855944|NCT00069888|Mitosis Modulators|mitosis modulators|mesh-ancestor
25855945|NCT00069888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855946|NCT00069901|Paclitaxel|paclitaxel|mesh-list
25855947|NCT00069901|Carboplatin|carboplatin|mesh-list
25855948|NCT00069901|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
25855949|NCT00069901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25855950|NCT00069901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855951|NCT00069901|Tubulin Modulators|tubulin modulators|mesh-ancestor
25855952|NCT00069901|Antimitotic Agents|antimitotic agents|mesh-ancestor
25855953|NCT00069901|Mitosis Modulators|mitosis modulators|mesh-ancestor
25855954|NCT00069901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855955|NCT00069927|Methylphenidate|methylphenidate|mesh-list
25855956|NCT00069927|Amphetamine|amphetamine|mesh-list
25855957|NCT00069927|Adderall|adderall|mesh-list
25855958|NCT00069927|Dextroamphetamine|dextroamphetamine|mesh-list
25267599|NCT02421913|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25267600|NCT02421913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25267601|NCT02421913|Anesthetics, General|anesthetics, general|mesh-ancestor
25267602|NCT02421913|Anesthetics|anesthetics|mesh-ancestor
25267603|NCT02421913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25267604|NCT02421913|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25267605|NCT02421913|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24449895|NCT00317408|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24449896|NCT00317408|Levoleucovorin|levoleucovorin|mesh-list
24449897|NCT00317408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24449898|NCT00317408|Antiemetics|antiemetics|mesh-ancestor
24449899|NCT00317408|Autonomic Agents|autonomic agents|mesh-ancestor
24449900|NCT00317408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24449901|NCT00317408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827628|NCT02140450|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24827629|NCT02140450|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24827630|NCT02140450|Diuretics|diuretics|mesh-ancestor
24827631|NCT02140450|Natriuretic Agents|natriuretic agents|mesh-ancestor
25855959|NCT00069927|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25855960|NCT00069927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855961|NCT00069927|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25855962|NCT00069927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25855963|NCT00069927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25855964|NCT00069927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855965|NCT00069927|Dopamine Agents|dopamine agents|mesh-ancestor
25855966|NCT00069927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25855967|NCT00069927|Sympathomimetics|sympathomimetics|mesh-ancestor
25855968|NCT00069927|Autonomic Agents|autonomic agents|mesh-ancestor
25855969|NCT00069927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24683016|NCT01389544|Ritonavir|ritonavir|mesh-list
25855970|NCT00069927|Adrenergic Agents|adrenergic agents|mesh-ancestor
25855977|NCT00069966|Rituximab|rituximab|mesh-list
25855978|NCT00069966|Pixantrone|pixantrone|mesh-list
25855979|NCT00069966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25855980|NCT00069966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25855981|NCT00069966|Immunologic Factors|immunologic factors|mesh-ancestor
25855982|NCT00069966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855983|NCT00069966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25855984|NCT00069966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25855985|NCT00069966|Antimetabolites|antimetabolites|mesh-ancestor
25855986|NCT00069966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25855987|NCT00069966|Antiviral Agents|antiviral agents|mesh-ancestor
25855988|NCT00069966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25855989|NCT00069966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25855990|NCT00069966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25855991|NCT00069966|Antiemetics|antiemetics|mesh-ancestor
25855992|NCT00069966|Autonomic Agents|autonomic agents|mesh-ancestor
25855993|NCT00069966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25855994|NCT00069966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25855995|NCT00069966|Glucocorticoids|glucocorticoids|mesh-ancestor
25855996|NCT00069966|Hormones|hormones|mesh-ancestor
25855997|NCT00069966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25267606|NCT02421913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25267607|NCT02421913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275428|NCT02372110|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25275429|NCT02372110|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25275430|NCT02372110|Purinergic Agents|purinergic agents|mesh-ancestor
25275431|NCT02372110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25275432|NCT02372240|Dexamethasone|dexamethasone|mesh-list
25275433|NCT02372240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25275434|NCT02372240|Antiemetics|antiemetics|mesh-ancestor
25275435|NCT02372240|Autonomic Agents|autonomic agents|mesh-ancestor
25275436|NCT02372240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275437|NCT02372240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275438|NCT02372240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25275439|NCT02372240|Glucocorticoids|glucocorticoids|mesh-ancestor
25275440|NCT02372240|Hormones|hormones|mesh-ancestor
24942700|NCT03978845|Anesthetics, Local|anesthetics, local|mesh-list
24942701|NCT03978845|Anesthetics|anesthetics|mesh-list
24942702|NCT03978845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24942703|NCT03978845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25855998|NCT00069966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25855999|NCT00069966|Protective Agents|protective agents|mesh-ancestor
25856000|NCT00069966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25856001|NCT00069966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25856002|NCT00069966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856003|NCT00069992|Fludarabine|fludarabine|mesh-list
25856004|NCT00069992|Alemtuzumab|alemtuzumab|mesh-list
25856005|NCT00069992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856006|NCT00069992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25856007|NCT00070057|Celecoxib|celecoxib|mesh-list
25856008|NCT00070057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25856009|NCT00070057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25664482|NCT01670721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664483|NCT01670721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25664484|NCT01670721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664485|NCT01670721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25664486|NCT01670721|Immunologic Factors|immunologic factors|mesh-ancestor
25664487|NCT01670721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664488|NCT01670721|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25856014|NCT00070057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25856015|NCT00070057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25856016|NCT00070057|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25856017|NCT00070057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25856018|NCT00070057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856019|NCT00070057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856020|NCT00070083|Prednisone|prednisone|mesh-list
25856021|NCT00070083|Cyclophosphamide|cyclophosphamide|mesh-list
25856022|NCT00070083|Rituximab|rituximab|mesh-list
25856023|NCT00070083|Doxorubicin|doxorubicin|mesh-list
25856024|NCT00070083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25856025|NCT00070083|Vincristine|vincristine|mesh-list
25856026|NCT00070083|Oblimersen|oblimersen|mesh-list
25856027|NCT00070083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25856028|NCT00070083|Immunologic Factors|immunologic factors|mesh-ancestor
24599846|NCT03549715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856029|NCT00070083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856030|NCT00070083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25856031|NCT00070083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25856032|NCT00070083|Alkylating Agents|alkylating agents|mesh-ancestor
25856033|NCT00070083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856034|NCT00070083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856035|NCT00070083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25856036|NCT00070083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25856037|NCT00070083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25856038|NCT00070083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25856039|NCT00070083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25856040|NCT00070083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856041|NCT00070083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25856042|NCT00070083|Glucocorticoids|glucocorticoids|mesh-ancestor
25267608|NCT02421926|Imatinib Mesylate|imatinib mesylate|mesh-list
25267609|NCT02421926|Dasatinib|dasatinib|mesh-list
25267610|NCT02421926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267611|NCT02421926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25267612|NCT02421926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25267613|NCT02421926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267614|NCT02421575|Hydroxychloroquine|hydroxychloroquine|mesh-list
25267615|NCT02421575|Antimalarials|antimalarials|mesh-ancestor
25267616|NCT02421575|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25267617|NCT02421575|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25267618|NCT02421575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25267619|NCT02421575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856043|NCT00070083|Hormones|hormones|mesh-ancestor
25856044|NCT00070083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25856045|NCT00070083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25856046|NCT00070083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25856047|NCT00070083|Tubulin Modulators|tubulin modulators|mesh-ancestor
25856048|NCT00070083|Antimitotic Agents|antimitotic agents|mesh-ancestor
25856049|NCT00070083|Mitosis Modulators|mitosis modulators|mesh-ancestor
25856050|NCT00070122|Leucovorin|leucovorin|mesh-list
25856051|NCT00070122|Bevacizumab|bevacizumab|mesh-list
25856052|NCT00070122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25856053|NCT00070122|Fluorouracil|fluorouracil|mesh-list
25856054|NCT00070122|Capecitabine|capecitabine|mesh-list
25856055|NCT00070122|Oxaliplatin|oxaliplatin|mesh-list
25856056|NCT00070122|Antibodies|antibodies|mesh-list
25856057|NCT00070122|Immunoglobulins|immunoglobulins|mesh-list
25856058|NCT00070122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25856059|NCT00070122|Levoleucovorin|levoleucovorin|mesh-list
25856060|NCT00070122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856061|NCT00070122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25856062|NCT00070122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25856063|NCT00070122|Growth Substances|growth substances|mesh-ancestor
25856064|NCT00070122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856065|NCT00070122|Growth Inhibitors|growth inhibitors|mesh-ancestor
25409439|NCT03382106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856066|NCT00070122|Immunologic Factors|immunologic factors|mesh-ancestor
25856067|NCT00070122|Antimetabolites|antimetabolites|mesh-ancestor
25856068|NCT00070122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856069|NCT00070122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25856079|NCT00070148|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24827639|NCT02140489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827640|NCT02140489|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24719756|NCT01563835|Chelating Agents|chelating agents|mesh-ancestor
25856080|NCT00070148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25856081|NCT00070148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25856082|NCT00070148|Contraceptive Agents|contraceptive agents|mesh-ancestor
25856083|NCT00070148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25856084|NCT00070148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856085|NCT00070148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25856086|NCT00070148|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25856087|NCT00070148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25856088|NCT00070148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856089|NCT00070148|Appetite Stimulants|appetite stimulants|mesh-ancestor
25856090|NCT00070148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25267620|NCT02421575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267621|NCT02421575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25267622|NCT02421640|Cisplatin|cisplatin|mesh-list
25267623|NCT02421640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267624|NCT02422277|Sildenafil Citrate|sildenafil citrate|mesh-list
25267625|NCT02422277|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
25267626|NCT02422277|Vasodilator Agents|vasodilator agents|mesh-ancestor
24456836|NCT00332345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25856091|NCT00070148|Androgens|androgens|mesh-ancestor
25856092|NCT00070148|Hormones|hormones|mesh-ancestor
25856093|NCT00070148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25856094|NCT00070148|Anabolic Agents|anabolic agents|mesh-ancestor
25856095|NCT00070161|Donepezil|donepezil|mesh-list
25856096|NCT00070161|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25856097|NCT00070161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856098|NCT00070161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856099|NCT00070161|Cholinergic Agents|cholinergic agents|mesh-ancestor
25856100|NCT00070161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25856101|NCT00070161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856102|NCT00070161|Nootropic Agents|nootropic agents|mesh-ancestor
25856103|NCT00070174|Cytarabine|cytarabine|mesh-list
25856104|NCT00070174|Cyclosporine|cyclosporine|mesh-list
25856105|NCT00070174|Cyclophosphamide|cyclophosphamide|mesh-list
24827641|NCT02140489|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24827642|NCT02140489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24827643|NCT02140515|Hormones|hormones|mesh-list
25856106|NCT00070174|Busulfan|busulfan|mesh-list
25856107|NCT00070174|Methotrexate|methotrexate|mesh-list
25856108|NCT00070174|Etoposide|etoposide|mesh-list
25856109|NCT00070174|Daunorubicin|daunorubicin|mesh-list
25856110|NCT00070174|Asparaginase|asparaginase|mesh-list
25856111|NCT00070174|Mitoxantrone|mitoxantrone|mesh-list
25856112|NCT00070174|Gemtuzumab|gemtuzumab|mesh-list
25856113|NCT00070174|Cyclosporins|cyclosporins|mesh-list
25664489|NCT01670721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25664490|NCT01670721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664491|NCT01670721|Antidotes|antidotes|mesh-ancestor
25664492|NCT01670721|Protective Agents|protective agents|mesh-ancestor
25664493|NCT01670721|Vitamin B Complex|vitamin b complex|mesh-ancestor
25664494|NCT01670721|Vitamins|vitamins|mesh-ancestor
25664495|NCT01670721|Micronutrients|micronutrients|mesh-ancestor
25664496|NCT01670721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25856114|NCT00070174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25856115|NCT00070174|Immunologic Factors|immunologic factors|mesh-ancestor
25856116|NCT00070174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856117|NCT00070174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25856124|NCT00070174|Abortifacient Agents|abortifacient agents|mesh-ancestor
25856125|NCT00070174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25856126|NCT00070174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25856127|NCT00070174|Antimetabolites|antimetabolites|mesh-ancestor
25856128|NCT00070174|Dermatologic Agents|dermatologic agents|mesh-ancestor
25856129|NCT00070174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856130|NCT00070174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25856131|NCT00070174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25856132|NCT00070174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25856133|NCT00070174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25856134|NCT00070174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25856135|NCT00070174|Antiviral Agents|antiviral agents|mesh-ancestor
25856136|NCT00070174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25856137|NCT00070174|Antifungal Agents|antifungal agents|mesh-ancestor
25856138|NCT00070174|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25856139|NCT00070174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25267627|NCT02422277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25267628|NCT02422277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25267629|NCT02422277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267630|NCT02422277|Urological Agents|urological agents|mesh-ancestor
25856140|NCT00070174|Analgesics|analgesics|mesh-ancestor
24827644|NCT02140515|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24827645|NCT02140515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24719901|NCT01564823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25856141|NCT00070174|Sensory System Agents|sensory system agents|mesh-ancestor
25856142|NCT00070174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25856143|NCT00070174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25856144|NCT00070187|Interferons|interferons|mesh-list
25856145|NCT00070187|Cytarabine|cytarabine|mesh-list
25856146|NCT00070187|Aldesleukin|aldesleukin|mesh-list
25856147|NCT00070187|Interferon-gamma|interferon-gamma|mesh-list
25856148|NCT00070187|Cyclosporine|cyclosporine|mesh-list
25856149|NCT00070187|Etoposide|etoposide|mesh-list
25856150|NCT00070187|Melphalan|melphalan|mesh-list
25856151|NCT00070187|Interleukin-2|interleukin-2|mesh-list
25856152|NCT00070187|Carmustine|carmustine|mesh-list
25856153|NCT00070187|Cyclosporins|cyclosporins|mesh-list
25856154|NCT00070187|Lenograstim|lenograstim|mesh-list
25856155|NCT00070187|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25856156|NCT00070187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856157|NCT00070187|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25856158|NCT00070187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25856159|NCT00070187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856160|NCT00070187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856161|NCT00070187|Antiviral Agents|antiviral agents|mesh-ancestor
25856162|NCT00070187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25856163|NCT00070187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25856164|NCT00070187|Antimetabolites|antimetabolites|mesh-ancestor
25856165|NCT00070187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25856166|NCT00070187|Immunologic Factors|immunologic factors|mesh-ancestor
25856167|NCT00070187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856168|NCT00070187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25856169|NCT00070187|Antifungal Agents|antifungal agents|mesh-ancestor
24625791|NCT01083537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24625808|NCT01083784|Anticonvulsants|anticonvulsants|mesh-list
24625809|NCT01083784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856170|NCT00070187|Dermatologic Agents|dermatologic agents|mesh-ancestor
25856171|NCT00070187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25856172|NCT00070187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25856173|NCT00070187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25856174|NCT00070187|Alkylating Agents|alkylating agents|mesh-ancestor
24847217|NCT02245464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25856175|NCT00070187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25856176|NCT00070187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25856177|NCT00070187|Analgesics|analgesics|mesh-ancestor
25856178|NCT00070187|Sensory System Agents|sensory system agents|mesh-ancestor
25856179|NCT00070187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25856180|NCT00070187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25856181|NCT00070187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25856182|NCT00070200|Cyclophosphamide|cyclophosphamide|mesh-list
25856183|NCT00070200|Melphalan|melphalan|mesh-list
25856184|NCT00070200|Cisplatin|cisplatin|mesh-list
25856185|NCT00070200|Doxorubicin|doxorubicin|mesh-list
25856186|NCT00070200|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25856187|NCT00070200|Etoposide|etoposide|mesh-list
25856188|NCT00070200|Vincristine|vincristine|mesh-list
25856189|NCT00070200|Topotecan|topotecan|mesh-list
25856190|NCT00070200|Isotretinoin|isotretinoin|mesh-list
25856191|NCT00070200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25856192|NCT00070200|Immunologic Factors|immunologic factors|mesh-ancestor
25856193|NCT00070200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267632|NCT02422121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25267633|NCT02422121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25267634|NCT02422121|Analgesics|analgesics|mesh-ancestor
25267635|NCT02422121|Sensory System Agents|sensory system agents|mesh-ancestor
25267636|NCT02422121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267637|NCT02422121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267638|NCT02422121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25267639|NCT02422121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24516821|NCT00603824|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24516822|NCT00603824|Antithrombins|antithrombins|mesh-ancestor
24516823|NCT00603824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24516824|NCT00603824|Protease Inhibitors|protease inhibitors|mesh-ancestor
25856194|NCT00070200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24940282|NCT04002349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25856195|NCT00070200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25856196|NCT00070200|Alkylating Agents|alkylating agents|mesh-ancestor
25856197|NCT00070200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856198|NCT00070200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856199|NCT00070200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25856200|NCT00070200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24827646|NCT02140515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827647|NCT02140580|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25856201|NCT00070200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25856202|NCT00070200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25856203|NCT00070200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856204|NCT00070200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25856205|NCT00070200|Tubulin Modulators|tubulin modulators|mesh-ancestor
25856206|NCT00070200|Antimitotic Agents|antimitotic agents|mesh-ancestor
25856207|NCT00070200|Mitosis Modulators|mitosis modulators|mesh-ancestor
25856208|NCT00070200|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25856209|NCT00070200|Dermatologic Agents|dermatologic agents|mesh-ancestor
25856210|NCT00070213|Leucovorin|leucovorin|mesh-list
25856211|NCT00070213|Fluorouracil|fluorouracil|mesh-list
25856212|NCT00070213|Capecitabine|capecitabine|mesh-list
25856213|NCT00070213|Oxaliplatin|oxaliplatin|mesh-list
25856214|NCT00070213|Calcium|calcium|mesh-list
25856215|NCT00070213|Levoleucovorin|levoleucovorin|mesh-list
25856216|NCT00070213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25856217|NCT00070213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856218|NCT00070213|Antimetabolites|antimetabolites|mesh-ancestor
25856219|NCT00070213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856220|NCT00070213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25856221|NCT00070213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856222|NCT00070213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25856223|NCT00070213|Immunologic Factors|immunologic factors|mesh-ancestor
25856224|NCT00070213|Antidotes|antidotes|mesh-ancestor
25856225|NCT00070213|Protective Agents|protective agents|mesh-ancestor
25856226|NCT00070213|Vitamin B Complex|vitamin b complex|mesh-ancestor
24827648|NCT02140580|Respiratory System Agents|respiratory system agents|mesh-ancestor
24827650|NCT02140632|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24827651|NCT02140632|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25856227|NCT00070213|Vitamins|vitamins|mesh-ancestor
25664497|NCT01670721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25664498|NCT01670721|Growth Substances|growth substances|mesh-ancestor
25664499|NCT01670721|Growth Inhibitors|growth inhibitors|mesh-ancestor
25664500|NCT01671280|Azithromycin|azithromycin|mesh-list
25664501|NCT01671280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25664502|NCT01671280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25856228|NCT00070213|Micronutrients|micronutrients|mesh-ancestor
25856229|NCT00070239|Alvocidib|alvocidib|mesh-list
25856230|NCT00070239|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25267641|NCT02421289|Efavirenz|efavirenz|mesh-list
25267642|NCT02421289|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25267643|NCT02421289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25267644|NCT02421289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856231|NCT00070239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25856232|NCT00070239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856233|NCT00070239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856234|NCT00070239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856235|NCT00070239|Growth Inhibitors|growth inhibitors|mesh-ancestor
25856236|NCT00070239|Growth Substances|growth substances|mesh-ancestor
25856237|NCT00070239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25856238|NCT00070239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856239|NCT00070252|Docetaxel|docetaxel|mesh-list
25856240|NCT00070252|Capecitabine|capecitabine|mesh-list
25856241|NCT00070252|Tipifarnib|tipifarnib|mesh-list
25856242|NCT00070252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856243|NCT00070252|Tubulin Modulators|tubulin modulators|mesh-ancestor
25856244|NCT00070252|Antimitotic Agents|antimitotic agents|mesh-ancestor
25856245|NCT00070252|Mitosis Modulators|mitosis modulators|mesh-ancestor
24684142|NCT01395732|Bosentan|bosentan|mesh-list
25856246|NCT00070252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856247|NCT00070252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25856248|NCT00070252|Antimetabolites|antimetabolites|mesh-ancestor
25856249|NCT00070265|Capecitabine|capecitabine|mesh-list
25856250|NCT00070265|Oxaliplatin|oxaliplatin|mesh-list
25856251|NCT00070265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25856252|NCT00070265|Antimetabolites|antimetabolites|mesh-ancestor
25856253|NCT00070265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856254|NCT00070265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856255|NCT00070278|Gemcitabine|gemcitabine|mesh-list
25856256|NCT00070278|Paclitaxel|paclitaxel|mesh-list
25856257|NCT00070278|Cyclophosphamide|cyclophosphamide|mesh-list
25856258|NCT00070278|Epirubicin|epirubicin|mesh-list
25856259|NCT00070278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25856260|NCT00070278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856261|NCT00070278|Tubulin Modulators|tubulin modulators|mesh-ancestor
25856262|NCT00070278|Antimitotic Agents|antimitotic agents|mesh-ancestor
25856263|NCT00070278|Mitosis Modulators|mitosis modulators|mesh-ancestor
25856264|NCT00070278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856265|NCT00070278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25856266|NCT00070278|Immunologic Factors|immunologic factors|mesh-ancestor
25856267|NCT00070278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856268|NCT00070278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25856269|NCT00070278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25856270|NCT00070278|Alkylating Agents|alkylating agents|mesh-ancestor
25856271|NCT00070278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25856272|NCT00070278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25856273|NCT00070278|Antimetabolites|antimetabolites|mesh-ancestor
25856274|NCT00070278|Antiviral Agents|antiviral agents|mesh-ancestor
25856275|NCT00070278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25856276|NCT00070278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856277|NCT00070278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25856278|NCT00070278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25856279|NCT00070278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25856280|NCT00070304|Gemcitabine|gemcitabine|mesh-list
25856281|NCT00070304|Vinorelbine|vinorelbine|mesh-list
25856282|NCT00070304|Lenograstim|lenograstim|mesh-list
25856283|NCT00070304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25856284|NCT00070304|Antimetabolites|antimetabolites|mesh-ancestor
25856285|NCT00070304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684344|NCT01396733|Vitamin B Complex|vitamin b complex|mesh-ancestor
25856286|NCT00070304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856287|NCT00070304|Antiviral Agents|antiviral agents|mesh-ancestor
25856288|NCT00070304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25856289|NCT00070304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856290|NCT00070304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25856291|NCT00070304|Immunologic Factors|immunologic factors|mesh-ancestor
25856292|NCT00070304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856293|NCT00070304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25856294|NCT00070304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25856295|NCT00070304|Tubulin Modulators|tubulin modulators|mesh-ancestor
25856296|NCT00070304|Antimitotic Agents|antimitotic agents|mesh-ancestor
25267645|NCT02421289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267646|NCT02421289|Antiviral Agents|antiviral agents|mesh-ancestor
25267648|NCT02421289|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25856297|NCT00070304|Mitosis Modulators|mitosis modulators|mesh-ancestor
25856298|NCT00070343|Dacarbazine|dacarbazine|mesh-list
25856299|NCT00070343|Oblimersen|oblimersen|mesh-list
25856300|NCT00070343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25856301|NCT00070343|Alkylating Agents|alkylating agents|mesh-ancestor
25856302|NCT00070343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856303|NCT00070343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856304|NCT00070382|Epoetin Alfa|epoetin alfa|mesh-list
25856305|NCT00070382|Darbepoetin alfa|darbepoetin alfa|mesh-list
25856306|NCT00070382|Hematinics|hematinics|mesh-ancestor
25856307|NCT00070434|Leucovorin|leucovorin|mesh-list
25856308|NCT00070434|Pyridoxine|pyridoxine|mesh-list
25856309|NCT00070434|Fluorouracil|fluorouracil|mesh-list
25856310|NCT00070434|Capecitabine|capecitabine|mesh-list
25856311|NCT00070434|Oxaliplatin|oxaliplatin|mesh-list
25856312|NCT00070434|Irinotecan|irinotecan|mesh-list
25856313|NCT00070434|Levoleucovorin|levoleucovorin|mesh-list
25856314|NCT00070434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856315|NCT00070434|Antimetabolites|antimetabolites|mesh-ancestor
25856316|NCT00070434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856317|NCT00070434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25856318|NCT00070434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856319|NCT00070434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25856320|NCT00070434|Immunologic Factors|immunologic factors|mesh-ancestor
25856321|NCT00070434|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25856322|NCT00070434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25856323|NCT00070434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856324|NCT00070434|Antidotes|antidotes|mesh-ancestor
24736398|NCT01661855|Protective Agents|protective agents|mesh-ancestor
25856325|NCT00070434|Protective Agents|protective agents|mesh-ancestor
25856326|NCT00070434|Vitamin B Complex|vitamin b complex|mesh-ancestor
25856327|NCT00070434|Vitamins|vitamins|mesh-ancestor
25856328|NCT00070434|Micronutrients|micronutrients|mesh-ancestor
25856329|NCT00070447|Prednisone|prednisone|mesh-list
25856330|NCT00070447|Cyclophosphamide|cyclophosphamide|mesh-list
25856331|NCT00070447|Rituximab|rituximab|mesh-list
25856332|NCT00070447|Doxorubicin|doxorubicin|mesh-list
25856333|NCT00070447|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25856334|NCT00070447|Vincristine|vincristine|mesh-list
25856335|NCT00070447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25856336|NCT00070447|Immunologic Factors|immunologic factors|mesh-ancestor
25856337|NCT00070447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856338|NCT00070447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25856339|NCT00070447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25856340|NCT00070447|Alkylating Agents|alkylating agents|mesh-ancestor
25856341|NCT00070447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856342|NCT00070447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856343|NCT00070447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25856344|NCT00070447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25856345|NCT00070447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25856346|NCT00070447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25856347|NCT00070447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25856348|NCT00070447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856349|NCT00070447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25856350|NCT00070447|Glucocorticoids|glucocorticoids|mesh-ancestor
25856351|NCT00070447|Hormones|hormones|mesh-ancestor
25856352|NCT00070447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25856353|NCT00070447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25856354|NCT00070447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25856355|NCT00070447|Tubulin Modulators|tubulin modulators|mesh-ancestor
25267649|NCT02421289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25267650|NCT02421289|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25267651|NCT02421289|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25267652|NCT02421289|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25267653|NCT02421289|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25267654|NCT02420938|Rituximab|rituximab|mesh-list
25664503|NCT01671319|Cyclophosphamide|cyclophosphamide|mesh-list
25664504|NCT01671319|Docetaxel|docetaxel|mesh-list
25664505|NCT01671319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25664506|NCT01671319|Immunologic Factors|immunologic factors|mesh-ancestor
25664507|NCT01671319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664508|NCT01671319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25664509|NCT01671319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25664510|NCT01671319|Alkylating Agents|alkylating agents|mesh-ancestor
24827666|NCT02140632|Protective Agents|protective agents|mesh-ancestor
24827667|NCT02140632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24827668|NCT02140632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827669|NCT02140736|Epoetin Alfa|epoetin alfa|mesh-list
24827670|NCT02140736|Hematinics|hematinics|mesh-ancestor
24827671|NCT02140801|Clopidogrel|clopidogrel|mesh-list
24827672|NCT02140801|Ticagrelor|ticagrelor|mesh-list
24827673|NCT02140801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24684606|NCT04975269|Diuretics|diuretics|mesh-ancestor
25856361|NCT00070473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856362|NCT00070473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25856363|NCT00070473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25856364|NCT00070486|Gemcitabine|gemcitabine|mesh-list
25856365|NCT00070486|Celecoxib|celecoxib|mesh-list
24942901|NCT03977012|Buprenorphine|buprenorphine|mesh-list
25856366|NCT00070486|Zileuton|zileuton|mesh-list
25856367|NCT00070486|Carboplatin|carboplatin|mesh-list
25856368|NCT00070486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856369|NCT00070486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25856370|NCT00070486|Antimetabolites|antimetabolites|mesh-ancestor
25856371|NCT00070486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856372|NCT00070486|Antiviral Agents|antiviral agents|mesh-ancestor
25856373|NCT00070486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25856374|NCT00070486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856375|NCT00070486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25856376|NCT00070486|Immunologic Factors|immunologic factors|mesh-ancestor
25856377|NCT00070486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856378|NCT00070486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25856379|NCT00070486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25856380|NCT00070486|Analgesics|analgesics|mesh-ancestor
25856381|NCT00070486|Sensory System Agents|sensory system agents|mesh-ancestor
25856382|NCT00070486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25856383|NCT00070486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25856384|NCT00070486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25856385|NCT00070486|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25267658|NCT02420938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267659|NCT02420938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25267660|NCT02421042|Lenvatinib|lenvatinib|mesh-list
25267661|NCT02421042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267662|NCT02421042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25267663|NCT02421042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25267664|NCT02421042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267665|NCT02420899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25267666|NCT02420899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25267667|NCT02420899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25267668|NCT02420899|Antimetabolites|antimetabolites|mesh-ancestor
25267669|NCT02420899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267670|NCT02420899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25856386|NCT00070486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25856387|NCT00070486|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25856388|NCT00070486|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25856389|NCT00070486|Hormone Antagonists|hormone antagonists|mesh-ancestor
25664511|NCT01671319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664512|NCT01671319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664513|NCT01671319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25664514|NCT01671319|Tubulin Modulators|tubulin modulators|mesh-ancestor
25856392|NCT00070525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856393|NCT00070538|Cytarabine|cytarabine|mesh-list
25856394|NCT00070538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25856395|NCT00070538|Antimetabolites|antimetabolites|mesh-ancestor
25856396|NCT00070538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856397|NCT00070538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856398|NCT00070538|Antiviral Agents|antiviral agents|mesh-ancestor
25856399|NCT00070538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25856400|NCT00070538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25856401|NCT00070538|Immunologic Factors|immunologic factors|mesh-ancestor
25856402|NCT00070538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856403|NCT00070551|Cytarabine|cytarabine|mesh-list
25856404|NCT00070551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25856405|NCT00070551|Antimetabolites|antimetabolites|mesh-ancestor
25856406|NCT00070551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856407|NCT00070551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856408|NCT00070551|Antiviral Agents|antiviral agents|mesh-ancestor
25856409|NCT00070551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25051163|NCT00434850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25051164|NCT00434850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25051165|NCT00434850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25051166|NCT00434850|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25051167|NCT00434850|Protective Agents|protective agents|mesh-ancestor
25051168|NCT00434811|Sirolimus|sirolimus|mesh-list
25051169|NCT00434811|Etanercept|etanercept|mesh-list
25856410|NCT00070551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25856411|NCT00070551|Immunologic Factors|immunologic factors|mesh-ancestor
25856412|NCT00070551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856413|NCT00070629|Paclitaxel|paclitaxel|mesh-list
25856414|NCT00070629|Docetaxel|docetaxel|mesh-list
25856415|NCT00070629|Cisplatin|cisplatin|mesh-list
25856416|NCT00070629|Carboplatin|carboplatin|mesh-list
25856417|NCT00070629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24827686|NCT02140814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827687|NCT02140814|Vitamin B Complex|vitamin b complex|mesh-ancestor
24827688|NCT02140814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24827689|NCT02140814|Antimetabolites|antimetabolites|mesh-ancestor
25856418|NCT00070629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856419|NCT00070629|Tubulin Modulators|tubulin modulators|mesh-ancestor
25856420|NCT00070629|Antimitotic Agents|antimitotic agents|mesh-ancestor
25856421|NCT00070629|Mitosis Modulators|mitosis modulators|mesh-ancestor
25856422|NCT00070629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856423|NCT00070642|Dacarbazine|dacarbazine|mesh-list
25856424|NCT00070642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25856425|NCT00070642|Alkylating Agents|alkylating agents|mesh-ancestor
25856426|NCT00070642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856427|NCT00070642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827706|NCT02141009|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24827707|NCT02141009|Immunologic Factors|immunologic factors|mesh-ancestor
24827708|NCT02141009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827709|NCT02141035|Acetylcarnitine|acetylcarnitine|mesh-list
24827710|NCT02141035|Vitamin B Complex|vitamin b complex|mesh-ancestor
24827711|NCT02141035|Vitamins|vitamins|mesh-ancestor
24827712|NCT02141035|Micronutrients|micronutrients|mesh-ancestor
24827713|NCT02141035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827714|NCT02141035|Nootropic Agents|nootropic agents|mesh-ancestor
24827715|NCT02141087|Pirfenidone|pirfenidone|mesh-list
25267671|NCT02420899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25267672|NCT02420899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25267673|NCT02421029|Calcium, Dietary|calcium, dietary|mesh-list
25267674|NCT02421029|Edetic Acid|edetic acid|mesh-list
25267675|NCT02421029|Calcium|calcium|mesh-list
25664515|NCT01671319|Antimitotic Agents|antimitotic agents|mesh-ancestor
25664516|NCT01671319|Mitosis Modulators|mitosis modulators|mesh-ancestor
25664517|NCT01671332|Suramin|suramin|mesh-list
25664518|NCT01671332|Docetaxel|docetaxel|mesh-list
25664519|NCT01671332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664520|NCT01671332|Tubulin Modulators|tubulin modulators|mesh-ancestor
25664521|NCT01671332|Antimitotic Agents|antimitotic agents|mesh-ancestor
24469468|NCT00385970|Calcium|calcium|mesh-list
25267677|NCT02421029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25856428|NCT00070655|Vitamin K|vitamin k|mesh-list
24853721|NCT02269696|Metoprolol|metoprolol|mesh-list
25856429|NCT00070655|Warfarin|warfarin|mesh-list
25856430|NCT00070655|Acenocoumarol|acenocoumarol|mesh-list
25856431|NCT00070655|Idraparinux|idraparinux|mesh-list
25856432|NCT00070655|Vitamins|vitamins|mesh-ancestor
25856433|NCT00070655|Micronutrients|micronutrients|mesh-ancestor
25856434|NCT00070655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856435|NCT00070655|Anticoagulants|anticoagulants|mesh-ancestor
25856436|NCT00070655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25856437|NCT00070655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25856438|NCT00070655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856439|NCT00070655|Hemostatics|hemostatics|mesh-ancestor
25856440|NCT00070655|Coagulants|coagulants|mesh-ancestor
25856441|NCT00070655|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25856442|NCT00070655|Antithrombins|antithrombins|mesh-ancestor
25856443|NCT00070655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25856444|NCT00070655|Protease Inhibitors|protease inhibitors|mesh-ancestor
25856445|NCT00070655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856446|NCT00070733|Methyltestosterone|methyltestosterone|mesh-list
25856447|NCT00070733|Testosterone|testosterone|mesh-list
25856448|NCT00070733|Testosterone undecanoate|testosterone undecanoate|mesh-list
25856449|NCT00070733|Testosterone enanthate|testosterone enanthate|mesh-list
25856450|NCT00070733|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25856451|NCT00070733|Androgens|androgens|mesh-ancestor
25856452|NCT00070733|Hormones|hormones|mesh-ancestor
25856453|NCT00070733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25856454|NCT00070733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856455|NCT00070733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25856456|NCT00070733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856457|NCT00070733|Anabolic Agents|anabolic agents|mesh-ancestor
25856458|NCT00070759|Daclizumab|daclizumab|mesh-list
25856459|NCT00070759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25856460|NCT00070759|Immunologic Factors|immunologic factors|mesh-ancestor
25856461|NCT00070759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856462|NCT00070837|Antibodies|antibodies|mesh-list
25856463|NCT00070837|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25856464|NCT00070837|Immunologic Factors|immunologic factors|mesh-ancestor
25856465|NCT00070837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736576|NCT01663038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24958929|NCT03828929|Ascorbic Acid|ascorbic acid|mesh-list
25856466|NCT00071071|Zanolimumab|zanolimumab|mesh-list
25856467|NCT00071071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25856468|NCT00071071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856469|NCT00071084|Zanolimumab|zanolimumab|mesh-list
25856470|NCT00071084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25856471|NCT00071084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856472|NCT00071097|Darunavir|darunavir|mesh-list
25856473|NCT00071097|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25856474|NCT00071097|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25856475|NCT00071097|Protease Inhibitors|protease inhibitors|mesh-ancestor
25856476|NCT00071097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856477|NCT00071097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856478|NCT00071097|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25856479|NCT00071097|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25856480|NCT00071097|Antiviral Agents|antiviral agents|mesh-ancestor
25856481|NCT00071097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25856482|NCT00071136|Gemcitabine|gemcitabine|mesh-list
25856483|NCT00071136|Pemetrexed|pemetrexed|mesh-list
25856484|NCT00071136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25856485|NCT00071136|Antimetabolites|antimetabolites|mesh-ancestor
25856486|NCT00071136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856487|NCT00071136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856488|NCT00071136|Antiviral Agents|antiviral agents|mesh-ancestor
25856489|NCT00071136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25856490|NCT00071136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469714|NCT00386828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24469715|NCT00386828|Growth Substances|growth substances|mesh-ancestor
24469718|NCT00386841|Citalopram|citalopram|mesh-list
25856491|NCT00071136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25856492|NCT00071136|Immunologic Factors|immunologic factors|mesh-ancestor
25856493|NCT00071136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856494|NCT00071136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25856495|NCT00071136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25856496|NCT00071188|Paclitaxel|paclitaxel|mesh-list
25856497|NCT00071188|Carboplatin|carboplatin|mesh-list
25856498|NCT00071188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25856499|NCT00071188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856500|NCT00071188|Tubulin Modulators|tubulin modulators|mesh-ancestor
25270846|NCT02402621|Fentanyl|fentanyl|mesh-list
25856501|NCT00071188|Antimitotic Agents|antimitotic agents|mesh-ancestor
25856502|NCT00071188|Mitosis Modulators|mitosis modulators|mesh-ancestor
25267678|NCT02421029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856503|NCT00071188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943025|NCT03975166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25856504|NCT00071201|Adefovir|adefovir|mesh-list
25856505|NCT00071201|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25856506|NCT00071201|Antiviral Agents|antiviral agents|mesh-ancestor
25856507|NCT00071201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25856508|NCT00071201|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25856509|NCT00071201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25856510|NCT00071201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856511|NCT00071201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856512|NCT00071227|Triamcinolone|triamcinolone|mesh-list
25856513|NCT00071227|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25856514|NCT00071227|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25856515|NCT00071227|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25856516|NCT00071227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25856517|NCT00071227|Glucocorticoids|glucocorticoids|mesh-ancestor
25856518|NCT00071227|Hormones|hormones|mesh-ancestor
25856519|NCT00071227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25856520|NCT00071227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856521|NCT00071227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25856522|NCT00071227|Immunologic Factors|immunologic factors|mesh-ancestor
25856523|NCT00071227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856524|NCT00071227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856525|NCT00071240|Hormones|hormones|mesh-list
24827722|NCT02141087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24827723|NCT02141087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24827724|NCT02141087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827725|NCT02141100|Thioguanine|thioguanine|mesh-list
24827726|NCT02141100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24827727|NCT02141100|Antimetabolites|antimetabolites|mesh-ancestor
24827728|NCT02141100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827729|NCT02141100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827730|NCT02141113|Guanfacine|guanfacine|mesh-list
24827731|NCT02141113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24943061|NCT03974984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943062|NCT03974789|Dexamethasone|dexamethasone|mesh-list
24943064|NCT03974789|Antiemetics|antiemetics|mesh-ancestor
24827732|NCT02141113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24827733|NCT02141113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24827734|NCT02141113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24827735|NCT02141113|Adrenergic Agents|adrenergic agents|mesh-ancestor
24827736|NCT02141113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25856526|NCT00071240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25856527|NCT00071240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856528|NCT00071253|Valproic Acid|valproic acid|mesh-list
25856529|NCT00071253|Olanzapine|olanzapine|mesh-list
25856530|NCT00071253|Antiemetics|antiemetics|mesh-ancestor
25856531|NCT00071253|Autonomic Agents|autonomic agents|mesh-ancestor
25856532|NCT00071253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267679|NCT02421029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25267680|NCT02421029|Anticoagulants|anticoagulants|mesh-ancestor
25267681|NCT02421029|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25267682|NCT02421029|Chelating Agents|chelating agents|mesh-ancestor
25267683|NCT02421029|Sequestering Agents|sequestering agents|mesh-ancestor
25267684|NCT02421029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267685|NCT02421029|Antidotes|antidotes|mesh-ancestor
25267686|NCT02421029|Protective Agents|protective agents|mesh-ancestor
25267687|NCT02421029|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25267688|NCT02420834|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25267689|NCT02420834|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25267690|NCT02420834|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25267691|NCT02420834|Laxatives|laxatives|mesh-ancestor
25267692|NCT02420834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25267693|NCT02420665|Acetic Acid|acetic acid|mesh-list
25267694|NCT02420665|Proflavine|proflavine|mesh-list
25856533|NCT00071253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856534|NCT00071253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25856535|NCT00071253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25856536|NCT00071253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25856537|NCT00071253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25856538|NCT00071253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24685575|NCT05270967|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25856540|NCT00071253|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25856541|NCT00071253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25856542|NCT00071253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856543|NCT00071253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25856544|NCT00071253|Serotonin Agents|serotonin agents|mesh-ancestor
25856545|NCT00071253|Anticonvulsants|anticonvulsants|mesh-ancestor
25856546|NCT00071253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856547|NCT00071253|GABA Agents|gaba agents|mesh-ancestor
25856548|NCT00071253|Antimanic Agents|antimanic agents|mesh-ancestor
24736632|NCT01663961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736633|NCT01663961|Protective Agents|protective agents|mesh-ancestor
24736634|NCT01663961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943085|NCT03974932|Analgesics|analgesics|mesh-ancestor
25856549|NCT00071266|Niacin|niacin|mesh-list
25856550|NCT00071266|Lovastatin|lovastatin|mesh-list
25856551|NCT00071266|L 647318|l 647318|mesh-list
25856552|NCT00071266|Dihydromevinolin|dihydromevinolin|mesh-list
25856553|NCT00071266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25856554|NCT00071266|Antimetabolites|antimetabolites|mesh-ancestor
25856555|NCT00071266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856556|NCT00071266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25856557|NCT00071266|Vasodilator Agents|vasodilator agents|mesh-ancestor
25856558|NCT00071266|Vitamin B Complex|vitamin b complex|mesh-ancestor
25856559|NCT00071266|Vitamins|vitamins|mesh-ancestor
25856560|NCT00071266|Micronutrients|micronutrients|mesh-ancestor
25856561|NCT00071266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856562|NCT00071266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25856563|NCT00071266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25856564|NCT00071266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856565|NCT00071279|Idraparinux|idraparinux|mesh-list
25856566|NCT00071279|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25856567|NCT00071279|Antithrombins|antithrombins|mesh-ancestor
25856568|NCT00071279|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25856569|NCT00071279|Protease Inhibitors|protease inhibitors|mesh-ancestor
25856570|NCT00071279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856571|NCT00071279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856572|NCT00071279|Anticoagulants|anticoagulants|mesh-ancestor
24827747|NCT02141139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24827749|NCT02141139|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24827750|NCT02141139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24827751|NCT02141139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736641|NCT01664013|Botulinum Toxins|botulinum toxins|mesh-list
24736643|NCT01664013|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24827752|NCT02141178|Bupivacaine|bupivacaine|mesh-list
24827753|NCT02141178|Anesthetics, Local|anesthetics, local|mesh-ancestor
25856573|NCT00071331|Tolvaptan|tolvaptan|mesh-list
25856574|NCT00071331|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25856575|NCT00071331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856576|NCT00071331|Natriuretic Agents|natriuretic agents|mesh-ancestor
25856577|NCT00071331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856578|NCT00071448|Insulin|insulin|mesh-list
25856579|NCT00071448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25267695|NCT02420665|Retinol acetate|retinol acetate|mesh-list
25267696|NCT02420665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25267697|NCT02420665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24853740|NCT02269748|Analgesics|analgesics|mesh-list
25856580|NCT00071448|Insulin Aspart|insulin aspart|mesh-list
25856581|NCT00071448|Insulin Lispro|insulin lispro|mesh-list
25856582|NCT00071448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25856583|NCT00071448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856584|NCT00071539|Immunotoxins|immunotoxins|mesh-list
25856585|NCT00071539|Immunologic Factors|immunologic factors|mesh-ancestor
25856586|NCT00071539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876367|NCT03660826|Immunologic Factors|immunologic factors|mesh-ancestor
25876368|NCT03660826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876369|NCT03660826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876370|NCT03660826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470075|NCT00388700|Micronutrients|micronutrients|mesh-ancestor
25876371|NCT03660826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25876372|NCT03637660|Penicillins|penicillins|mesh-list
25876373|NCT03637660|Penicillin G Benzathine|penicillin g benzathine|mesh-list
25876374|NCT03637660|Penicillin G|penicillin g|mesh-list
25664522|NCT01671332|Mitosis Modulators|mitosis modulators|mesh-ancestor
25664523|NCT01671332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856590|NCT00071643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25856591|NCT00071643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856592|NCT00071643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25856593|NCT00071643|Serotonin Agents|serotonin agents|mesh-ancestor
25856594|NCT00071643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856595|NCT00071643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25856596|NCT00071643|Antidepressive Agents|antidepressive agents|mesh-ancestor
25856597|NCT00071643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25856598|NCT00071695|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25856599|NCT00071695|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25856600|NCT00071695|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25856601|NCT00071695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25856602|NCT00071695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25856603|NCT00071695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856604|NCT00071695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25856605|NCT00071695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856607|NCT00071695|Sensory System Agents|sensory system agents|mesh-ancestor
25856608|NCT00071695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25856609|NCT00071695|Antidepressive Agents|antidepressive agents|mesh-ancestor
25856610|NCT00071695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25856611|NCT00071695|Dopamine Agents|dopamine agents|mesh-ancestor
25856612|NCT00071695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25856613|NCT00071747|Lamotrigine|lamotrigine|mesh-list
25856614|NCT00071747|Anticonvulsants|anticonvulsants|mesh-ancestor
25856615|NCT00071747|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25856616|NCT00071747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25856617|NCT00071747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856618|NCT00071747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25856619|NCT00071747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856620|NCT00071747|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25856621|NCT00071747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25856622|NCT00071747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24736703|NCT01664676|Hormones|hormones|mesh-ancestor
24736704|NCT01664676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24736705|NCT01664728|Abiraterone Acetate|abiraterone acetate|mesh-list
24736706|NCT01664728|Glucocorticoids|glucocorticoids|mesh-list
24736707|NCT01664728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943150|NCT03973840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25856623|NCT00071747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25856624|NCT00071747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25856625|NCT00071838|Daclizumab|daclizumab|mesh-list
25856626|NCT00071838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25856627|NCT00071838|Immunologic Factors|immunologic factors|mesh-ancestor
25856628|NCT00071838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856629|NCT00071929|Oxaliplatin|oxaliplatin|mesh-list
24827761|NCT02141321|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24827762|NCT02141321|Abortifacient Agents|abortifacient agents|mesh-ancestor
24827763|NCT02141321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25267698|NCT02420665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25267699|NCT02420665|Immunologic Factors|immunologic factors|mesh-ancestor
24827764|NCT02141321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827765|NCT02141321|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24827766|NCT02141321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24827767|NCT02141321|Oxytocics|oxytocics|mesh-ancestor
24827768|NCT02141321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24827769|NCT02141321|Vasodilator Agents|vasodilator agents|mesh-ancestor
24827770|NCT02141321|Urological Agents|urological agents|mesh-ancestor
24827771|NCT02141347|Durvalumab|durvalumab|mesh-list
24827772|NCT02141347|Tremelimumab|tremelimumab|mesh-list
24827791|NCT02141425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720837|NCT01570985|Triamcinolone|triamcinolone|mesh-list
25856630|NCT00071929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856631|NCT00071942|Metronidazole|metronidazole|mesh-list
25856632|NCT00071942|Vaccines|vaccines|mesh-list
25856633|NCT00071942|Immunologic Factors|immunologic factors|mesh-ancestor
25856634|NCT00071942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856635|NCT00071942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25856636|NCT00071942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25856637|NCT00071942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24827792|NCT02141425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24827793|NCT02141425|Immunologic Factors|immunologic factors|mesh-ancestor
24827794|NCT02141425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827795|NCT02141477|Decitabine|decitabine|mesh-list
24827796|NCT02141477|Homoharringtonine|homoharringtonine|mesh-list
24827797|NCT02141477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24827798|NCT02141477|Antimetabolites|antimetabolites|mesh-ancestor
24827799|NCT02141477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827800|NCT02141477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827801|NCT02141477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856638|NCT00071942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24686283|NCT04918823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25856639|NCT00071955|Immunoglobulins|immunoglobulins|mesh-list
25856640|NCT00071955|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25856641|NCT00071955|Antibodies|antibodies|mesh-list
25856642|NCT00071955|Sargramostim|sargramostim|mesh-list
25856643|NCT00071955|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
25856644|NCT00071955|Immunologic Factors|immunologic factors|mesh-ancestor
25856645|NCT00071955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856646|NCT00071968|Sirolimus|sirolimus|mesh-list
25856647|NCT00071968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25856648|NCT00071968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25856649|NCT00071968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25856650|NCT00071968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856651|NCT00071968|Antifungal Agents|antifungal agents|mesh-ancestor
25856652|NCT00071968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25856653|NCT00071968|Immunologic Factors|immunologic factors|mesh-ancestor
25856654|NCT00071968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856655|NCT00071994|Gefitinib|gefitinib|mesh-list
25856656|NCT00071994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856657|NCT00071994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25856658|NCT00071994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856659|NCT00071994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856660|NCT00072007|Prednisone|prednisone|mesh-list
25856661|NCT00072007|Cyclophosphamide|cyclophosphamide|mesh-list
25856662|NCT00072007|Rituximab|rituximab|mesh-list
25856663|NCT00072007|Doxorubicin|doxorubicin|mesh-list
25856664|NCT00072007|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25856665|NCT00072007|Vincristine|vincristine|mesh-list
25267700|NCT02420665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267701|NCT02420665|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25267702|NCT02420665|Protective Agents|protective agents|mesh-ancestor
25267703|NCT02420665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267704|NCT02420665|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25267705|NCT02420782|Itraconazole|itraconazole|mesh-list
24856507|NCT02284984|Rituximab|rituximab|mesh-list
25856666|NCT00072007|Cladribine|cladribine|mesh-list
25856667|NCT00072007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25856668|NCT00072007|Immunologic Factors|immunologic factors|mesh-ancestor
25856669|NCT00072007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856670|NCT00072007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25876375|NCT03637660|Penicillin G Procaine|penicillin g procaine|mesh-list
25876376|NCT03637660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25876377|NCT03637660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25876378|NCT03622775|Daratumumab|daratumumab|mesh-list
25876379|NCT03622775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664524|NCT01671332|Antinematodal Agents|antinematodal agents|mesh-ancestor
25664525|NCT01671332|Anthelmintics|anthelmintics|mesh-ancestor
25664526|NCT01671332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25664527|NCT01671332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25664528|NCT01671332|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25664529|NCT01671332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25664530|NCT01671423|Prednisone|prednisone|mesh-list
25664531|NCT01671423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25664532|NCT01671423|Glucocorticoids|glucocorticoids|mesh-ancestor
25664533|NCT01671423|Hormones|hormones|mesh-ancestor
25664534|NCT01671423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25664535|NCT01671423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664536|NCT01671423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25664537|NCT01671423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664538|NCT01671488|Mitomycins|mitomycins|mesh-list
25664539|NCT01671488|Mitomycin|mitomycin|mesh-list
25856677|NCT00072007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25856678|NCT00072007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25856679|NCT00072007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25856680|NCT00072007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856681|NCT00072007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25856682|NCT00072007|Glucocorticoids|glucocorticoids|mesh-ancestor
25856683|NCT00072007|Hormones|hormones|mesh-ancestor
25856684|NCT00072007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24827802|NCT02141477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24827803|NCT02141477|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24827804|NCT02141698|Esomeprazole|esomeprazole|mesh-list
24827805|NCT02141698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24827806|NCT02141698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24827807|NCT02141698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24827808|NCT02141698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24827809|NCT02141698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827810|NCT02141737|Lidocaine|lidocaine|mesh-list
24827811|NCT02141737|Fentanyl|fentanyl|mesh-list
24736859|NCT01665404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24827812|NCT02141737|Midazolam|midazolam|mesh-list
24827813|NCT02141737|Etomidate|etomidate|mesh-list
25856685|NCT00072007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25856686|NCT00072007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25856687|NCT00072007|Tubulin Modulators|tubulin modulators|mesh-ancestor
25856688|NCT00072007|Antimitotic Agents|antimitotic agents|mesh-ancestor
25856689|NCT00072007|Mitosis Modulators|mitosis modulators|mesh-ancestor
25856690|NCT00072020|Zoledronic Acid|zoledronic acid|mesh-list
25856691|NCT00072020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25856692|NCT00072020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856693|NCT00072033|Cisplatin|cisplatin|mesh-list
25856694|NCT00072033|Docetaxel|docetaxel|mesh-list
25856695|NCT00072033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856696|NCT00072033|Tubulin Modulators|tubulin modulators|mesh-ancestor
25856697|NCT00072033|Antimitotic Agents|antimitotic agents|mesh-ancestor
25267706|NCT02420782|Midazolam|midazolam|mesh-list
25267707|NCT02420782|Pilocarpine|pilocarpine|mesh-list
25267708|NCT02420782|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25267709|NCT02420782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25267710|NCT02420782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25267711|NCT02420782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267712|NCT02420782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25267713|NCT02420782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25856698|NCT00072033|Mitosis Modulators|mitosis modulators|mesh-ancestor
25856699|NCT00072033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856700|NCT00072046|Interferons|interferons|mesh-list
25856701|NCT00072046|Interferon-alpha|interferon-alpha|mesh-list
25856702|NCT00072046|Bevacizumab|bevacizumab|mesh-list
25856703|NCT00072046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25856704|NCT00072046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856705|NCT00072046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25856706|NCT00072046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25051190|NCT00434811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25051191|NCT00434811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25051192|NCT00434226|Paclitaxel|paclitaxel|mesh-list
25051193|NCT00434226|Bevacizumab|bevacizumab|mesh-list
25856707|NCT00072046|Growth Substances|growth substances|mesh-ancestor
25856708|NCT00072046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856709|NCT00072046|Growth Inhibitors|growth inhibitors|mesh-ancestor
25856710|NCT00072046|Antiviral Agents|antiviral agents|mesh-ancestor
25856711|NCT00072046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25856712|NCT00072046|Immunologic Factors|immunologic factors|mesh-ancestor
25856713|NCT00072059|Epoetin Alfa|epoetin alfa|mesh-list
25856714|NCT00072059|Hematinics|hematinics|mesh-ancestor
25856715|NCT00072072|Celecoxib|celecoxib|mesh-list
25856727|NCT00072072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25856728|NCT00072072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24827844|NCT02141958|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24827845|NCT02141958|Protective Agents|protective agents|mesh-ancestor
24720939|NCT01571570|Simeprevir|simeprevir|mesh-list
25856729|NCT00072072|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25856730|NCT00072072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25856731|NCT00072085|Aldesleukin|aldesleukin|mesh-list
25856732|NCT00072085|Freund's Adjuvant|freund's adjuvant|mesh-list
25856733|NCT00072085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856734|NCT00072085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25856735|NCT00072085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25856736|NCT00072085|Antiviral Agents|antiviral agents|mesh-ancestor
25856737|NCT00072085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25856738|NCT00072085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25051194|NCT00434226|Carboplatin|carboplatin|mesh-list
25856739|NCT00072085|Immunologic Factors|immunologic factors|mesh-ancestor
25856740|NCT00072085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856741|NCT00072098|Interleukin-12|interleukin-12|mesh-list
25856742|NCT00072098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25856743|NCT00072098|Immunologic Factors|immunologic factors|mesh-ancestor
25856744|NCT00072098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856745|NCT00072098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25267714|NCT02420782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25267715|NCT02420782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25267716|NCT02420782|Anesthetics, General|anesthetics, general|mesh-ancestor
25267717|NCT02420782|Anesthetics|anesthetics|mesh-ancestor
25267718|NCT02420782|GABA Modulators|gaba modulators|mesh-ancestor
25267719|NCT02420782|GABA Agents|gaba agents|mesh-ancestor
25267720|NCT02420782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25267721|NCT02420782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267722|NCT02420782|Antifungal Agents|antifungal agents|mesh-ancestor
25267723|NCT02420782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25267724|NCT02420782|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25664540|NCT01671488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25664541|NCT01671488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664542|NCT01671488|Alkylating Agents|alkylating agents|mesh-ancestor
25664543|NCT01671488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664544|NCT01671488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25664545|NCT01671488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664546|NCT01672710|Niacin|niacin|mesh-list
25664547|NCT01672710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25664548|NCT01672710|Antimetabolites|antimetabolites|mesh-ancestor
24827864|NCT02142036|Vemurafenib|vemurafenib|mesh-list
24827865|NCT02142036|Dabrafenib|dabrafenib|mesh-list
24827866|NCT02142036|Crizotinib|crizotinib|mesh-list
24827867|NCT02142036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25856749|NCT00072098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856750|NCT00072111|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25267727|NCT02420782|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25267728|NCT02420782|Hormone Antagonists|hormone antagonists|mesh-ancestor
25267729|NCT02420782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25267730|NCT02420782|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25267732|NCT02420782|Autonomic Agents|autonomic agents|mesh-ancestor
24943212|NCT03973138|Ranibizumab|ranibizumab|mesh-list
25267733|NCT02420782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267734|NCT02420782|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25267735|NCT02420782|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25267736|NCT02420782|Cholinergic Agents|cholinergic agents|mesh-ancestor
25267737|NCT02420652|Aspirin|aspirin|mesh-list
25267738|NCT02420652|Metformin|metformin|mesh-list
25267739|NCT02420652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25267740|NCT02420652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267741|NCT02420652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25267742|NCT02420652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25267743|NCT02420652|Analgesics|analgesics|mesh-ancestor
25267744|NCT02420652|Sensory System Agents|sensory system agents|mesh-ancestor
25267745|NCT02420652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267746|NCT02420652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25267747|NCT02420652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25267748|NCT02420652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25856751|NCT00072111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24456838|NCT00332384|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24736986|NCT01666223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736987|NCT01666223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24736988|NCT01666223|Cathartics|cathartics|mesh-ancestor
24736989|NCT01666223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24736990|NCT01666236|Triamcinolone|triamcinolone|mesh-list
24736991|NCT01666236|Ranibizumab|ranibizumab|mesh-list
24736992|NCT01666236|Verteporfin|verteporfin|mesh-list
24736993|NCT01666236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25050646|NCT00479817|Paclitaxel|paclitaxel|mesh-list
25664549|NCT01672710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664550|NCT01672710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25856752|NCT00072124|Cisplatin|cisplatin|mesh-list
25856753|NCT00072124|Dacarbazine|dacarbazine|mesh-list
25856755|NCT00072124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25856756|NCT00072124|Alkylating Agents|alkylating agents|mesh-ancestor
25856757|NCT00072124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856758|NCT00072137|Metronidazole|metronidazole|mesh-list
25856759|NCT00072137|Molgramostim|molgramostim|mesh-list
25856760|NCT00072137|Vaccines|vaccines|mesh-list
25856761|NCT00072137|Sargramostim|sargramostim|mesh-list
25267749|NCT02420652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25267750|NCT02420652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827899|NCT02142192|Natalizumab|natalizumab|mesh-list
25267751|NCT02420652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25267752|NCT02420652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25267753|NCT02420652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25267754|NCT02420652|Antipyretics|antipyretics|mesh-ancestor
25267755|NCT02420509|Leucovorin|leucovorin|mesh-list
25267756|NCT02420509|Capecitabine|capecitabine|mesh-list
25267757|NCT02420509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267758|NCT02420509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267759|NCT02420509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25267760|NCT02420509|Antimetabolites|antimetabolites|mesh-ancestor
25267761|NCT02420509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267762|NCT02420509|Antidotes|antidotes|mesh-ancestor
25267763|NCT02420509|Protective Agents|protective agents|mesh-ancestor
25267764|NCT02420509|Vitamin B Complex|vitamin b complex|mesh-ancestor
25267765|NCT02420509|Vitamins|vitamins|mesh-ancestor
25267766|NCT02420509|Micronutrients|micronutrients|mesh-ancestor
25267767|NCT02420496|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25267768|NCT02420496|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25267769|NCT02420496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25267770|NCT02420392|Dapagliflozin|dapagliflozin|mesh-list
25267771|NCT02420392|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25267772|NCT02420392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267773|NCT02420392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25267774|NCT02420392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267775|NCT02420444|BCG Vaccine|bcg vaccine|mesh-list
25267776|NCT02420444|Immunologic Factors|immunologic factors|mesh-ancestor
25267777|NCT02420444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267778|NCT02420444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25267779|NCT02420418|Acetylcysteine|acetylcysteine|mesh-list
25267780|NCT02420418|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25856762|NCT00072137|Immunologic Factors|immunologic factors|mesh-ancestor
25856763|NCT00072137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856764|NCT00072137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856765|NCT00072137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25856766|NCT00072137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25856767|NCT00072137|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25856768|NCT00072137|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25856769|NCT00072150|Bortezomib|bortezomib|mesh-list
25856770|NCT00072150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856771|NCT00072163|Thalidomide|thalidomide|mesh-list
25856772|NCT00072163|Temozolomide|temozolomide|mesh-list
25856773|NCT00072163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25856774|NCT00072163|Alkylating Agents|alkylating agents|mesh-ancestor
25856775|NCT00072163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856776|NCT00072163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856777|NCT00072163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25856778|NCT00072163|Immunologic Factors|immunologic factors|mesh-ancestor
25856779|NCT00072163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856780|NCT00072163|Leprostatic Agents|leprostatic agents|mesh-ancestor
25856781|NCT00072163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25856782|NCT00072163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25856783|NCT00072163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25856784|NCT00072163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25856785|NCT00072163|Growth Substances|growth substances|mesh-ancestor
25856786|NCT00072163|Growth Inhibitors|growth inhibitors|mesh-ancestor
25856787|NCT00072215|Paclitaxel|paclitaxel|mesh-list
25856788|NCT00072215|Vinblastine|vinblastine|mesh-list
25856789|NCT00072215|Cisplatin|cisplatin|mesh-list
24827868|NCT02142036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827869|NCT02142036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24827870|NCT02142036|Immunologic Factors|immunologic factors|mesh-ancestor
24827871|NCT02142036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827894|NCT02142140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25856790|NCT00072215|Ifosfamide|ifosfamide|mesh-list
25856791|NCT00072215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25856793|NCT00072215|Tubulin Modulators|tubulin modulators|mesh-ancestor
25856794|NCT00072215|Antimitotic Agents|antimitotic agents|mesh-ancestor
25856795|NCT00072215|Mitosis Modulators|mitosis modulators|mesh-ancestor
25856796|NCT00072215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856797|NCT00072215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25856798|NCT00072215|Alkylating Agents|alkylating agents|mesh-ancestor
25856799|NCT00072228|Gemcitabine|gemcitabine|mesh-list
24827909|NCT02142218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827910|NCT02142296|Aflibercept|aflibercept|mesh-list
24827911|NCT02142296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25267781|NCT02420418|Antiviral Agents|antiviral agents|mesh-ancestor
25267782|NCT02420418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25267783|NCT02420418|Expectorants|expectorants|mesh-ancestor
25267784|NCT02420418|Respiratory System Agents|respiratory system agents|mesh-ancestor
25267785|NCT02420418|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25267786|NCT02420418|Antioxidants|antioxidants|mesh-ancestor
25267787|NCT02420418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267788|NCT02420418|Protective Agents|protective agents|mesh-ancestor
24827912|NCT02142296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24827913|NCT02142296|Growth Substances|growth substances|mesh-ancestor
24827914|NCT02142296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827915|NCT02142296|Growth Inhibitors|growth inhibitors|mesh-ancestor
24827916|NCT02142296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827917|NCT02142309|Pioglitazone|pioglitazone|mesh-list
24827918|NCT02142309|Glimepiride|glimepiride|mesh-list
24827919|NCT02142309|Vildagliptin|vildagliptin|mesh-list
25856800|NCT00072228|Soblidotin|soblidotin|mesh-list
25856801|NCT00072228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25856802|NCT00072228|Antimetabolites|antimetabolites|mesh-ancestor
25856803|NCT00072228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856804|NCT00072228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856805|NCT00072228|Antiviral Agents|antiviral agents|mesh-ancestor
25856806|NCT00072228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25856807|NCT00072228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856808|NCT00072228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25856809|NCT00072228|Immunologic Factors|immunologic factors|mesh-ancestor
25856810|NCT00072228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856811|NCT00072267|Topotecan|topotecan|mesh-list
25856812|NCT00072267|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
25856813|NCT00072267|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25856814|NCT00072267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25856815|NCT00072267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856816|NCT00072267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856817|NCT00072267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827920|NCT02142309|Canagliflozin|canagliflozin|mesh-list
24827921|NCT02142309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24827922|NCT02142309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827949|NCT02142556|Antidepressive Agents|antidepressive agents|mesh-ancestor
24827950|NCT02142556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24827961|NCT02142569|Protective Agents|protective agents|mesh-ancestor
24827962|NCT02142569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827963|NCT02142569|Vitamins|vitamins|mesh-ancestor
24827964|NCT02142569|Micronutrients|micronutrients|mesh-ancestor
24856646|NCT02285972|Tenoxicam|tenoxicam|mesh-list
24827965|NCT02142569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24827966|NCT02142569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25664551|NCT01672710|Vasodilator Agents|vasodilator agents|mesh-ancestor
25664552|NCT01672710|Vitamin B Complex|vitamin b complex|mesh-ancestor
25664553|NCT01672710|Vitamins|vitamins|mesh-ancestor
25664554|NCT01672710|Micronutrients|micronutrients|mesh-ancestor
25664555|NCT01672710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664556|NCT01672723|Naltrexone|naltrexone|mesh-list
25664557|NCT01672723|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25664558|NCT01672723|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25664559|NCT01672723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664560|NCT01672723|Sensory System Agents|sensory system agents|mesh-ancestor
25856827|NCT00072319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856828|NCT00072319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25856829|NCT00072319|Immunologic Factors|immunologic factors|mesh-ancestor
25856830|NCT00072319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856831|NCT00072319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24827985|NCT02142595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827986|NCT02142595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24827987|NCT02142595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24827988|NCT02142595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24827989|NCT02142595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24827990|NCT02142595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24827991|NCT02142595|Anesthetics, General|anesthetics, general|mesh-ancestor
24827992|NCT02142595|Anesthetics|anesthetics|mesh-ancestor
24827993|NCT02142595|GABA Modulators|gaba modulators|mesh-ancestor
24827995|NCT02142634|Budesonide|budesonide|mesh-list
24827996|NCT02142634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24827997|NCT02142634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24827998|NCT02142634|Autonomic Agents|autonomic agents|mesh-ancestor
24827999|NCT02142634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24687243|NCT04186663|Fluorides|fluorides|mesh-list
24828046|NCT02142920|Gedatolisib|gedatolisib|mesh-list
25856832|NCT00072319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25856833|NCT00072319|Alkylating Agents|alkylating agents|mesh-ancestor
25267789|NCT02420418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267790|NCT02420418|Antidotes|antidotes|mesh-ancestor
25267791|NCT02420171|Insulin|insulin|mesh-list
25856834|NCT00072319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25856835|NCT00072319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25856836|NCT00072319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25856837|NCT00072319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25856838|NCT00072319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856839|NCT00072332|Cisplatin|cisplatin|mesh-list
25856840|NCT00072332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447556|NCT00308945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24447557|NCT00308945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24447559|NCT00308971|Tocopherols|tocopherols|mesh-list
24447560|NCT00308971|Tocotrienols|tocotrienols|mesh-list
24447561|NCT00308971|alpha-Tocopherol|alpha-tocopherol|mesh-list
24447562|NCT00308971|Thioctic Acid|thioctic acid|mesh-list
24828114|NCT02143479|Immunologic Factors|immunologic factors|mesh-ancestor
24828115|NCT02143479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828116|NCT02143479|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24828131|NCT02143531|Autonomic Agents|autonomic agents|mesh-ancestor
24828132|NCT02143531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24828133|NCT02143531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828134|NCT02143531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24455058|NCT02955602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455059|NCT02955602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25664561|NCT01672723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25664562|NCT01672736|Dexamethasone|dexamethasone|mesh-list
25664563|NCT01672736|Dexamethasone acetate|dexamethasone acetate|mesh-list
25664564|NCT01672736|Bortezomib|bortezomib|mesh-list
25664565|NCT01672736|BB 1101|bb 1101|mesh-list
25664566|NCT01672736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25664567|NCT01672736|Antiemetics|antiemetics|mesh-ancestor
25664568|NCT01672736|Autonomic Agents|autonomic agents|mesh-ancestor
25664569|NCT01672736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25664570|NCT01672736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664571|NCT01672736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25664572|NCT01672736|Glucocorticoids|glucocorticoids|mesh-ancestor
25664573|NCT01672736|Hormones|hormones|mesh-ancestor
25856841|NCT00072345|Thalidomide|thalidomide|mesh-list
25856842|NCT00072345|Temozolomide|temozolomide|mesh-list
24828136|NCT02143531|Dermatologic Agents|dermatologic agents|mesh-ancestor
24828137|NCT02143531|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24828138|NCT02143531|Serotonin Agents|serotonin agents|mesh-ancestor
24828139|NCT02143531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24828140|NCT02143531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828141|NCT02143531|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24828142|NCT02143531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24828143|NCT02143531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24737104|NCT01666691|CKD732|ckd732|mesh-list
24828144|NCT02143531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24828145|NCT02143531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24828146|NCT02143531|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24828147|NCT02143531|Dopamine Agents|dopamine agents|mesh-ancestor
24828148|NCT02143531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24828174|NCT02143804|Molgramostim|molgramostim|mesh-list
24828175|NCT02143804|Sargramostim|sargramostim|mesh-list
24828176|NCT02143804|Immunologic Factors|immunologic factors|mesh-ancestor
24828177|NCT02143804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856843|NCT00072345|Lomustine|lomustine|mesh-list
25856844|NCT00072345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24828178|NCT02143804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828180|NCT02143934|Lumefantrine|lumefantrine|mesh-list
24828181|NCT02143934|Artemether|artemether|mesh-list
24828183|NCT02143934|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24828184|NCT02143934|Amebicides|amebicides|mesh-ancestor
24828185|NCT02143934|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25267792|NCT02420171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25267793|NCT02420171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267794|NCT02420132|Ranibizumab|ranibizumab|mesh-list
25267795|NCT02420132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25267796|NCT02420132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25267797|NCT02420132|Growth Substances|growth substances|mesh-ancestor
25267798|NCT02420132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267799|NCT02420132|Growth Inhibitors|growth inhibitors|mesh-ancestor
24828187|NCT02143934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24828188|NCT02143934|Antimalarials|antimalarials|mesh-ancestor
24828189|NCT02143934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24828190|NCT02144025|Cyclosporine|cyclosporine|mesh-list
24828191|NCT02144025|Cyclosporins|cyclosporins|mesh-list
24828192|NCT02144025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828193|NCT02144025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828194|NCT02144025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24828195|NCT02144025|Immunologic Factors|immunologic factors|mesh-ancestor
24828196|NCT02144025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828197|NCT02144025|Antifungal Agents|antifungal agents|mesh-ancestor
24828198|NCT02144025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24828199|NCT02144025|Dermatologic Agents|dermatologic agents|mesh-ancestor
24828200|NCT02144025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24828208|NCT02144142|Anti-Infective Agents|anti-infective agents|mesh-list
24456561|NCT00331708|Antimalarials|antimalarials|mesh-ancestor
24828209|NCT02144142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25856845|NCT00072345|Alkylating Agents|alkylating agents|mesh-ancestor
25856846|NCT00072345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856847|NCT00072345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856848|NCT00072345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25856849|NCT00072345|Immunologic Factors|immunologic factors|mesh-ancestor
25856850|NCT00072345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856851|NCT00072345|Leprostatic Agents|leprostatic agents|mesh-ancestor
25856852|NCT00072345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25856853|NCT00072345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25856854|NCT00072345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24828214|NCT02144194|Antimitotic Agents|antimitotic agents|mesh-ancestor
24828215|NCT02144194|Mitosis Modulators|mitosis modulators|mesh-ancestor
24828216|NCT02144194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828217|NCT02144194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24828218|NCT02144246|Moxifloxacin|moxifloxacin|mesh-list
24828219|NCT02144246|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24828220|NCT02144246|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24828221|NCT02144246|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24828222|NCT02144246|Norgestimate|norgestimate|mesh-list
24828223|NCT02144246|Norgestrel|norgestrel|mesh-list
24828224|NCT02144246|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24828225|NCT02144246|Estradiol|estradiol|mesh-list
24828226|NCT02144246|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25856855|NCT00072345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24828227|NCT02144246|Estrogens|estrogens|mesh-ancestor
24828229|NCT02144246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24828230|NCT02144246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828231|NCT02144246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24828232|NCT02144246|Contraceptive Agents|contraceptive agents|mesh-ancestor
24828233|NCT02144246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24828234|NCT02144246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24585372|NCT00885300|Cloxacillin|cloxacillin|mesh-list
24828235|NCT02144246|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24828236|NCT02144246|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25856856|NCT00072345|Growth Substances|growth substances|mesh-ancestor
25856857|NCT00072345|Growth Inhibitors|growth inhibitors|mesh-ancestor
25856858|NCT00072436|Gemcitabine|gemcitabine|mesh-list
25856859|NCT00072436|Alvocidib|alvocidib|mesh-list
25856860|NCT00072436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25856861|NCT00072436|Antimetabolites|antimetabolites|mesh-ancestor
25856862|NCT00072436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856863|NCT00072436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856864|NCT00072436|Antiviral Agents|antiviral agents|mesh-ancestor
25856865|NCT00072436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25856866|NCT00072436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25267800|NCT02420132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267801|NCT02420080|Brincidofovir|brincidofovir|mesh-list
25267802|NCT02420080|Antiviral Agents|antiviral agents|mesh-ancestor
25267803|NCT02420080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24456840|NCT00332384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24421456|NCT00219219|Zoledronic Acid|zoledronic acid|mesh-list
25856867|NCT00072436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25856868|NCT00072436|Immunologic Factors|immunologic factors|mesh-ancestor
24448689|NCT00312598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24828237|NCT02144246|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24828238|NCT02144246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24687551|NCT03897439|Bupropion|bupropion|mesh-list
24828250|NCT02144389|Anthelmintics|anthelmintics|mesh-ancestor
24828251|NCT02144389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24828252|NCT02144389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24828253|NCT02144415|Amphetamine|amphetamine|mesh-list
24828254|NCT02144415|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
24828255|NCT02144415|Dextroamphetamine|dextroamphetamine|mesh-list
24828282|NCT02144623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24828283|NCT02144662|Ranibizumab|ranibizumab|mesh-list
24828284|NCT02144662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24828285|NCT02144662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24828286|NCT02144662|Growth Substances|growth substances|mesh-ancestor
24828287|NCT02144662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828288|NCT02144662|Growth Inhibitors|growth inhibitors|mesh-ancestor
24828289|NCT02144662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828290|NCT02144688|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24828291|NCT02144688|Antiviral Agents|antiviral agents|mesh-ancestor
24828292|NCT02144688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24828293|NCT02144753|Psyllium|psyllium|mesh-list
24828294|NCT02144753|Calcium polycarbophil|calcium polycarbophil|mesh-list
24828295|NCT02144753|Cathartics|cathartics|mesh-ancestor
24828296|NCT02144753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24828297|NCT02144753|Antidiarrheals|antidiarrheals|mesh-ancestor
24828298|NCT02144766|Ropivacaine|ropivacaine|mesh-list
24828299|NCT02144766|Anesthetics, Local|anesthetics, local|mesh-ancestor
24828300|NCT02144766|Anesthetics|anesthetics|mesh-ancestor
24721551|NCT01575483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25664574|NCT01672736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25664575|NCT01672736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25664576|NCT01672736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664577|NCT01672736|Protease Inhibitors|protease inhibitors|mesh-ancestor
25664578|NCT01672736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664579|NCT01672736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664580|NCT01672788|Metformin|metformin|mesh-list
25664581|NCT01672788|Empagliflozin|empagliflozin|mesh-list
25664582|NCT01672788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25664583|NCT01672788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856873|NCT00072462|Tamoxifen|tamoxifen|mesh-list
25856874|NCT00072462|Anastrozole|anastrozole|mesh-list
25856875|NCT00072462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856876|NCT00072462|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25856877|NCT00072462|Hormone Antagonists|hormone antagonists|mesh-ancestor
25856878|NCT00072462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24456571|NCT00331708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856879|NCT00072462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856880|NCT00072462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25856881|NCT00072462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856882|NCT00072462|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25856883|NCT00072462|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25856884|NCT00072462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25856885|NCT00072462|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25856886|NCT00072462|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25856887|NCT00072462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828301|NCT02144766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24828302|NCT02144766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828303|NCT02144766|Sensory System Agents|sensory system agents|mesh-ancestor
24828354|NCT02145104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24828355|NCT02145104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24828356|NCT02145104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267804|NCT02419742|Paclitaxel|paclitaxel|mesh-list
25267805|NCT02419742|Docetaxel|docetaxel|mesh-list
25267806|NCT02419742|Cyclophosphamide|cyclophosphamide|mesh-list
25267807|NCT02419742|Carboplatin|carboplatin|mesh-list
25267808|NCT02419742|Doxorubicin|doxorubicin|mesh-list
25267809|NCT02419742|Trastuzumab|trastuzumab|mesh-list
25267810|NCT02419742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25267811|NCT02419742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267812|NCT02419742|Tubulin Modulators|tubulin modulators|mesh-ancestor
25856888|NCT00072527|Cisplatin|cisplatin|mesh-list
25856889|NCT00072527|Carboplatin|carboplatin|mesh-list
25856890|NCT00072527|Irinotecan|irinotecan|mesh-list
25856891|NCT00072527|Etoposide|etoposide|mesh-list
25856892|NCT00072527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856893|NCT00072527|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25856894|NCT00072527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25856895|NCT00072527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856896|NCT00072527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828358|NCT02145195|Cholecalciferol|cholecalciferol|mesh-list
24828359|NCT02145195|Vitamins|vitamins|mesh-ancestor
24828360|NCT02145195|Micronutrients|micronutrients|mesh-ancestor
24828361|NCT02145195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828362|NCT02145195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24828363|NCT02145195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24828364|NCT02145260|Dialysis Solutions|dialysis solutions|mesh-list
24828365|NCT02145260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24828366|NCT02145338|Trimethoprim|trimethoprim|mesh-list
24828367|NCT02145338|Nitrofurantoin|nitrofurantoin|mesh-list
24828368|NCT02145338|Cephalexin|cephalexin|mesh-list
24828371|NCT02145338|Renal Agents|renal agents|mesh-ancestor
24828376|NCT02145338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828377|NCT02145338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828378|NCT02145338|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24828379|NCT02145338|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24828380|NCT02145338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24828381|NCT02145338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24828382|NCT02145520|Magnesium Sulfate|magnesium sulfate|mesh-list
24828383|NCT02145520|Analgesics|analgesics|mesh-ancestor
25856897|NCT00072527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25856898|NCT00072527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25664584|NCT01672788|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25664585|NCT01672788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664586|NCT01672801|Nimodipine|nimodipine|mesh-list
25664587|NCT01672801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25664588|NCT01672801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24848061|NCT05223582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24637003|NCT01148303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24656197|NCT01260519|Heparin|heparin|mesh-list
25856899|NCT00072540|Celecoxib|celecoxib|mesh-list
25856900|NCT00072540|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25856901|NCT00072540|Mitogens|mitogens|mesh-list
25856902|NCT00072540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25856903|NCT00072540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24828384|NCT02145520|Sensory System Agents|sensory system agents|mesh-ancestor
24828385|NCT02145520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24828386|NCT02145520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828398|NCT02145546|Sotalol|sotalol|mesh-list
24828399|NCT02145546|Propafenone|propafenone|mesh-list
24828400|NCT02145546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24828401|NCT02145546|Vasodilator Agents|vasodilator agents|mesh-ancestor
24828402|NCT02145546|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24828403|NCT02145546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24828404|NCT02145546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828405|NCT02145546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24828408|NCT02145546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828411|NCT02145546|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24828412|NCT02145546|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24828413|NCT02145546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24828414|NCT02145546|Adrenergic Agents|adrenergic agents|mesh-ancestor
24828415|NCT02145546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24828416|NCT02145546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828417|NCT02145546|Sympatholytics|sympatholytics|mesh-ancestor
24828418|NCT02145546|Autonomic Agents|autonomic agents|mesh-ancestor
25856904|NCT00072540|Analgesics|analgesics|mesh-ancestor
25856905|NCT00072540|Sensory System Agents|sensory system agents|mesh-ancestor
25856906|NCT00072540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25856907|NCT00072540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856908|NCT00072540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25856909|NCT00072540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24828419|NCT02145546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267813|NCT02419742|Antimitotic Agents|antimitotic agents|mesh-ancestor
25267814|NCT02419742|Mitosis Modulators|mitosis modulators|mesh-ancestor
25267815|NCT02419742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267816|NCT02419742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25267817|NCT02419742|Immunologic Factors|immunologic factors|mesh-ancestor
25267818|NCT02419742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267819|NCT02419742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25267820|NCT02419742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25856910|NCT00072540|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24770019|NCT01817400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24770020|NCT01817400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24770021|NCT01817400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24770022|NCT01817400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24940387|NCT04001855|Acetic Acid|acetic acid|mesh-list
24828420|NCT02145546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25664589|NCT01672801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25664590|NCT01672801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664591|NCT01672801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25664592|NCT01672801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664593|NCT01672801|Vasodilator Agents|vasodilator agents|mesh-ancestor
25664594|NCT01672827|Flutemetamol|flutemetamol|mesh-list
25664595|NCT01672827|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25664596|NCT01672827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664597|NCT01672957|Mycophenolic Acid|mycophenolic acid|mesh-list
25856911|NCT00072540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24828423|NCT02145559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24828426|NCT02145559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24828427|NCT02145559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24828428|NCT02145559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828429|NCT02145559|Antifungal Agents|antifungal agents|mesh-ancestor
24828430|NCT02145559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24828431|NCT02145559|Immunologic Factors|immunologic factors|mesh-ancestor
25856912|NCT00072540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856913|NCT00072540|Mitosis Modulators|mitosis modulators|mesh-ancestor
25856914|NCT00072553|Leucovorin|leucovorin|mesh-list
25856915|NCT00072553|Celecoxib|celecoxib|mesh-list
25856916|NCT00072553|Fluorouracil|fluorouracil|mesh-list
25856917|NCT00072553|Oxaliplatin|oxaliplatin|mesh-list
25856918|NCT00072553|Calcium|calcium|mesh-list
25856919|NCT00072553|Levoleucovorin|levoleucovorin|mesh-list
25856920|NCT00072553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25856921|NCT00072553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856922|NCT00072553|Antimetabolites|antimetabolites|mesh-ancestor
25856923|NCT00072553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472873|NCT00400855|Xhance|xhance|mesh-list
25856924|NCT00072553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25856925|NCT00072553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856926|NCT00072553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25856927|NCT00072553|Immunologic Factors|immunologic factors|mesh-ancestor
25856928|NCT00072553|Antidotes|antidotes|mesh-ancestor
25856929|NCT00072553|Protective Agents|protective agents|mesh-ancestor
25856930|NCT00072553|Vitamin B Complex|vitamin b complex|mesh-ancestor
25856931|NCT00072553|Vitamins|vitamins|mesh-ancestor
25856932|NCT00072553|Micronutrients|micronutrients|mesh-ancestor
25856933|NCT00072553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25856934|NCT00072553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25856935|NCT00072553|Analgesics|analgesics|mesh-ancestor
25856936|NCT00072553|Sensory System Agents|sensory system agents|mesh-ancestor
25856937|NCT00072553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25856938|NCT00072553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25856939|NCT00072553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25856940|NCT00072553|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25856941|NCT00072553|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25856942|NCT00072553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856943|NCT00072579|Sargramostim|sargramostim|mesh-list
25856944|NCT00072579|Immunologic Factors|immunologic factors|mesh-ancestor
25856945|NCT00072579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856946|NCT00072592|Rituximab|rituximab|mesh-list
25856947|NCT00072592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25856948|NCT00072592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856949|NCT00072592|Immunologic Factors|immunologic factors|mesh-ancestor
25856950|NCT00072592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856951|NCT00072592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25267821|NCT02419742|Alkylating Agents|alkylating agents|mesh-ancestor
25267822|NCT02419742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25267823|NCT02419742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25267824|NCT02419742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25267825|NCT02419742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25267826|NCT02419742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25267827|NCT02419742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25664598|NCT01672957|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25664599|NCT01672957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25664600|NCT01672957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664601|NCT01672957|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25664602|NCT01672957|Antitubercular Agents|antitubercular agents|mesh-ancestor
25664603|NCT01672957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25664604|NCT01672957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25664605|NCT01672957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25267828|NCT02420002|Nitrous Oxide|nitrous oxide|mesh-list
25267829|NCT02420002|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25267830|NCT02420002|Anesthetics, General|anesthetics, general|mesh-ancestor
25856952|NCT00072618|Sulindac sulfone|sulindac sulfone|mesh-list
25856955|NCT00072618|Protective Agents|protective agents|mesh-ancestor
25856956|NCT00072618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856957|NCT00072618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25664606|NCT01672957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856958|NCT00072618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856959|NCT00072618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856960|NCT00072618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25856961|NCT00072618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25856962|NCT00072618|Analgesics|analgesics|mesh-ancestor
25856963|NCT00072618|Sensory System Agents|sensory system agents|mesh-ancestor
25856964|NCT00072618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25856965|NCT00072618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25856966|NCT00072618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25856967|NCT00072631|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25856968|NCT00072631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856969|NCT00072631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25856970|NCT00072631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856971|NCT00072631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856972|NCT00072670|Trabectedin|trabectedin|mesh-list
25856973|NCT00072670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25856974|NCT00072670|Alkylating Agents|alkylating agents|mesh-ancestor
24828464|NCT02145689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828465|NCT02145689|Cholinergic Agents|cholinergic agents|mesh-ancestor
24828466|NCT02145689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24828467|NCT02145689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828468|NCT02145689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24828469|NCT02145689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24828472|NCT02145715|Bortezomib|bortezomib|mesh-list
24828473|NCT02145715|Panobinostat|panobinostat|mesh-list
24828474|NCT02145715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24828475|NCT02145715|Antiemetics|antiemetics|mesh-ancestor
24828476|NCT02145715|Autonomic Agents|autonomic agents|mesh-ancestor
25856975|NCT00072670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828477|NCT02145715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24828478|NCT02145715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828479|NCT02145715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24828480|NCT02145715|Glucocorticoids|glucocorticoids|mesh-ancestor
24828481|NCT02145715|Hormones|hormones|mesh-ancestor
24828482|NCT02145715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24828483|NCT02145715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25856976|NCT00072670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856977|NCT00072683|Tolvaptan|tolvaptan|mesh-list
25876380|NCT03576547|Dexamethasone|dexamethasone|mesh-list
24448705|NCT00312650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24448706|NCT00312650|Immunologic Factors|immunologic factors|mesh-ancestor
24448707|NCT00312650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447595|NCT00309192|Glucocorticoids|glucocorticoids|mesh-ancestor
24447597|NCT00309192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24447598|NCT00309192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447599|NCT00309192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24447600|NCT00309192|Immunologic Factors|immunologic factors|mesh-ancestor
24447601|NCT00309192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24447603|NCT00309205|Dapivirine|dapivirine|mesh-list
24447604|NCT00309205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24447605|NCT00309205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24447606|NCT00309205|Antiviral Agents|antiviral agents|mesh-ancestor
24447607|NCT00309205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24687972|NCT03563690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24828485|NCT02145715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24828486|NCT02145715|Immunologic Factors|immunologic factors|mesh-ancestor
25267832|NCT02420002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25267833|NCT02420002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267834|NCT02420002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25664607|NCT01672957|Immunologic Factors|immunologic factors|mesh-ancestor
25664608|NCT01672957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664609|NCT01672983|Ritonavir|ritonavir|mesh-list
25664610|NCT01672983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25664611|NCT01672983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25664612|NCT01672983|Protease Inhibitors|protease inhibitors|mesh-ancestor
25267838|NCT02419729|Estrogens|estrogens|mesh-list
25267839|NCT02419729|Hormones|hormones|mesh-ancestor
25267840|NCT02419729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25267841|NCT02419729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267842|NCT02419651|Diclofenac|diclofenac|mesh-list
25267843|NCT02419651|Tramadol|tramadol|mesh-list
25856978|NCT00072683|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25856979|NCT00072683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25856980|NCT00072683|Natriuretic Agents|natriuretic agents|mesh-ancestor
25856981|NCT00072683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856982|NCT00072722|Pomalidomide|pomalidomide|mesh-list
25856983|NCT00072722|Immunologic Factors|immunologic factors|mesh-ancestor
25856984|NCT00072722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25856985|NCT00072722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25856986|NCT00072722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25856987|NCT00072722|Growth Substances|growth substances|mesh-ancestor
25856988|NCT00072722|Growth Inhibitors|growth inhibitors|mesh-ancestor
25856989|NCT00072722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856990|NCT00072748|EKB 569|ekb 569|mesh-list
24940406|NCT04001725|Hormones|hormones|mesh-ancestor
24828487|NCT02145715|Leprostatic Agents|leprostatic agents|mesh-ancestor
24828488|NCT02145715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24828489|NCT02145715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24828490|NCT02145715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24828491|NCT02145715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24828492|NCT02145715|Growth Substances|growth substances|mesh-ancestor
24828493|NCT02145715|Growth Inhibitors|growth inhibitors|mesh-ancestor
24828494|NCT02145715|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24828495|NCT02145715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828496|NCT02145715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828498|NCT02145767|Progestins|progestins|mesh-ancestor
24828499|NCT02145767|Hormones|hormones|mesh-ancestor
25856991|NCT00072748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828504|NCT02145832|Antifungal Agents|antifungal agents|mesh-list
24828505|NCT02145832|Clotrimazole|clotrimazole|mesh-list
24828506|NCT02145832|Miconazole|miconazole|mesh-list
24828507|NCT02145832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24828508|NCT02145832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24828509|NCT02145832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24828510|NCT02145832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828511|NCT02145832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828512|NCT02145832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24828513|NCT02145832|Hormone Antagonists|hormone antagonists|mesh-ancestor
24721872|NCT01577693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267844|NCT02419651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25267845|NCT02419651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25267846|NCT02419651|Analgesics|analgesics|mesh-ancestor
25267847|NCT02419651|Sensory System Agents|sensory system agents|mesh-ancestor
25267848|NCT02419651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25664613|NCT01672983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664614|NCT01672983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267849|NCT02419651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267850|NCT02419651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25267851|NCT02419651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25267852|NCT02419651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25267853|NCT02419651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664615|NCT01672983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25664616|NCT01672983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25664617|NCT01672983|Antiviral Agents|antiviral agents|mesh-ancestor
25664618|NCT01672983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25664619|NCT01672983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25664620|NCT01672983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25664621|NCT01673009|Imatinib Mesylate|imatinib mesylate|mesh-list
25664622|NCT01673009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664623|NCT01673009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25664624|NCT01673009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275441|NCT02372240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25275442|NCT02372240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25856992|NCT00072748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25856993|NCT00072748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25856994|NCT00072748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765196|NCT01786538|Antidotes|antidotes|mesh-ancestor
25856996|NCT00072787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25856997|NCT00072826|Acetylcholine|acetylcholine|mesh-list
25856998|NCT00072826|Oxypurinol|oxypurinol|mesh-list
25856999|NCT00072826|Vasodilator Agents|vasodilator agents|mesh-ancestor
25857000|NCT00072826|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24943592|NCT03968263|Analgesics|analgesics|mesh-ancestor
25857001|NCT00072826|Cholinergic Agents|cholinergic agents|mesh-ancestor
24688112|NCT03360214|Anesthetics|anesthetics|mesh-ancestor
24828524|NCT02145884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24828525|NCT02145884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828526|NCT02145884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828527|NCT02145884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24828528|NCT02145884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24828529|NCT02145910|Vemurafenib|vemurafenib|mesh-list
24828530|NCT02145910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828531|NCT02145910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24828532|NCT02145910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828533|NCT02145910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828534|NCT02145949|Tryptophan|tryptophan|mesh-list
24828535|NCT02145949|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24828536|NCT02145949|Antidepressive Agents|antidepressive agents|mesh-ancestor
24828537|NCT02145949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24828538|NCT02145975|Fentanyl|fentanyl|mesh-list
24828539|NCT02145975|Morphine|morphine|mesh-list
24828540|NCT02145975|Analgesics, Opioid|analgesics, opioid|mesh-list
24828541|NCT02145975|Narcotics|narcotics|mesh-ancestor
24828542|NCT02145975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24585824|NCT00887211|Antifungal Agents|antifungal agents|mesh-ancestor
24828563|NCT02146209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24828564|NCT02146209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24828565|NCT02146222|Docetaxel|docetaxel|mesh-list
24828566|NCT02146222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828567|NCT02146222|Tubulin Modulators|tubulin modulators|mesh-ancestor
24943603|NCT03968146|Fentanyl|fentanyl|mesh-list
24828568|NCT02146222|Antimitotic Agents|antimitotic agents|mesh-ancestor
24828569|NCT02146222|Mitosis Modulators|mitosis modulators|mesh-ancestor
24828585|NCT02146391|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24828586|NCT02146391|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24828587|NCT02146456|Tranexamic Acid|tranexamic acid|mesh-list
24828588|NCT02146456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24828589|NCT02146456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25857002|NCT00072826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25857003|NCT00072826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857004|NCT00072826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857005|NCT00072826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857006|NCT00072839|Teduglutide|teduglutide|mesh-list
25857007|NCT00072839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25857008|NCT00072839|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25664625|NCT01673009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674378|NCT01770912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25674379|NCT01770912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674380|NCT01770912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25674381|NCT01770912|Immunologic Factors|immunologic factors|mesh-ancestor
25674382|NCT01770912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857009|NCT00072839|Protective Agents|protective agents|mesh-ancestor
25857010|NCT00072839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857017|NCT00072865|Carboplatin|carboplatin|mesh-list
25857018|NCT00072865|Pemetrexed|pemetrexed|mesh-list
25857019|NCT00072865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857020|NCT00072865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25267858|NCT02419820|Aspirin|aspirin|mesh-list
25267859|NCT02419820|Clopidogrel|clopidogrel|mesh-list
25267861|NCT02419820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25267862|NCT02419820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25267863|NCT02419820|Analgesics|analgesics|mesh-ancestor
25267864|NCT02419820|Sensory System Agents|sensory system agents|mesh-ancestor
25267865|NCT02419820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267866|NCT02419820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702967|NCT01468740|Etoposide|etoposide|mesh-list
25857021|NCT00072865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857022|NCT00072865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25857023|NCT00072865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25857024|NCT00072904|Repaglinide|repaglinide|mesh-list
25857025|NCT00072904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25857026|NCT00072904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857027|NCT00072930|Zoledronic Acid|zoledronic acid|mesh-list
25857028|NCT00072930|Prednisone|prednisone|mesh-list
25857029|NCT00072930|Docetaxel|docetaxel|mesh-list
24688262|NCT03215940|Hormones|hormones|mesh-ancestor
25857030|NCT00072930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857031|NCT00072930|Tubulin Modulators|tubulin modulators|mesh-ancestor
24447650|NCT00309322|Adrenergic Agents|adrenergic agents|mesh-ancestor
24447651|NCT00309322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24828590|NCT02146456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828591|NCT02146456|Hemostatics|hemostatics|mesh-ancestor
24828592|NCT02146456|Coagulants|coagulants|mesh-ancestor
24828593|NCT02146534|4-Aminopyridine|4-aminopyridine|mesh-list
24828594|NCT02146534|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24828595|NCT02146534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24828596|NCT02146534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828597|NCT02146547|Aripiprazole|aripiprazole|mesh-list
24828598|NCT02146547|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24828599|NCT02146547|Antidepressive Agents|antidepressive agents|mesh-ancestor
24828600|NCT02146547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25857032|NCT00072930|Antimitotic Agents|antimitotic agents|mesh-ancestor
25857033|NCT00072930|Mitosis Modulators|mitosis modulators|mesh-ancestor
25857034|NCT00072930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857035|NCT00072930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25857036|NCT00072930|Glucocorticoids|glucocorticoids|mesh-ancestor
25857037|NCT00072930|Hormones|hormones|mesh-ancestor
25857038|NCT00072930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25857039|NCT00072930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857040|NCT00072930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25857041|NCT00072930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25857042|NCT00072943|Interferons|interferons|mesh-list
25857043|NCT00072943|Interferon-gamma|interferon-gamma|mesh-list
25857044|NCT00072943|Antibodies|antibodies|mesh-list
25857045|NCT00072943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25857046|NCT00072943|Immunologic Factors|immunologic factors|mesh-ancestor
25857047|NCT00072943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857048|NCT00072943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857049|NCT00072943|Antiviral Agents|antiviral agents|mesh-ancestor
25857050|NCT00072943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25857051|NCT00072969|Daclizumab|daclizumab|mesh-list
25857052|NCT00072969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25857053|NCT00072969|Immunologic Factors|immunologic factors|mesh-ancestor
25857054|NCT00072969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857055|NCT00072982|Borage oil|borage oil|mesh-list
25857056|NCT00072982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25857057|NCT00073047|Daclizumab|daclizumab|mesh-list
25857058|NCT00073047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25664626|NCT01673191|Dexamethasone|dexamethasone|mesh-list
25857059|NCT00073047|Immunologic Factors|immunologic factors|mesh-ancestor
25857060|NCT00073047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857061|NCT00073164|Valproic Acid|valproic acid|mesh-list
24447655|NCT00309335|Phentolamine|phentolamine|mesh-list
25267867|NCT02419820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25267868|NCT02419820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25267869|NCT02419820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25267870|NCT02419820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25267871|NCT02419820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267872|NCT02419820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25267873|NCT02419820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25267874|NCT02419820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25267875|NCT02419820|Antipyretics|antipyretics|mesh-ancestor
24940445|NCT04001231|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25857063|NCT00073164|Risperidone|risperidone|mesh-list
24828760|NCT02147548|Etifoxine|etifoxine|mesh-list
25857064|NCT00073164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25857065|NCT00073164|Serotonin Agents|serotonin agents|mesh-ancestor
25857066|NCT00073164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25857067|NCT00073164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857068|NCT00073164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857069|NCT00073164|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25857070|NCT00073164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24828605|NCT02146547|Dopamine Agonists|dopamine agonists|mesh-ancestor
24828606|NCT02146547|Dopamine Agents|dopamine agents|mesh-ancestor
24828607|NCT02146547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24828608|NCT02146547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828609|NCT02146547|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24828610|NCT02146547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24828611|NCT02146547|Serotonin Agents|serotonin agents|mesh-ancestor
24447680|NCT00309413|Cannabidiol|cannabidiol|mesh-list
24447681|NCT00309413|Anticonvulsants|anticonvulsants|mesh-ancestor
24447683|NCT00309478|Cyclophosphamide|cyclophosphamide|mesh-list
25857071|NCT00073164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25857072|NCT00073164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25857073|NCT00073164|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25857074|NCT00073164|Dopamine Agents|dopamine agents|mesh-ancestor
24688651|NCT02810457|Bevacizumab|bevacizumab|mesh-list
25857075|NCT00073164|Antiemetics|antiemetics|mesh-ancestor
25857076|NCT00073164|Autonomic Agents|autonomic agents|mesh-ancestor
25857077|NCT00073164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25857078|NCT00073164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25857079|NCT00073164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25857080|NCT00073164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25857081|NCT00073164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25857082|NCT00073164|Anticonvulsants|anticonvulsants|mesh-ancestor
25857083|NCT00073164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857084|NCT00073164|GABA Agents|gaba agents|mesh-ancestor
25857085|NCT00073164|Antimanic Agents|antimanic agents|mesh-ancestor
25857086|NCT00073203|Paroxetine|paroxetine|mesh-list
25857087|NCT00073203|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25857088|NCT00073203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25857089|NCT00073203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25857090|NCT00073203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857091|NCT00073203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25857092|NCT00073203|Serotonin Agents|serotonin agents|mesh-ancestor
24959429|NCT03824925|Zinc|zinc|mesh-list
25857093|NCT00073203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857094|NCT00073203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25857095|NCT00073203|Antidepressive Agents|antidepressive agents|mesh-ancestor
25857096|NCT00073203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25876381|NCT03576547|Dexamethasone acetate|dexamethasone acetate|mesh-list
25876382|NCT03576547|Rituximab|rituximab|mesh-list
25876383|NCT03576547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25267876|NCT02419820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25267877|NCT02419820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25664627|NCT01673191|Prednisolone acetate|prednisolone acetate|mesh-list
25876384|NCT03576547|Venetoclax|venetoclax|mesh-list
25876385|NCT03576547|Ponatinib|ponatinib|mesh-list
25876386|NCT03576547|Antibodies|antibodies|mesh-list
25876387|NCT03576547|Immunoglobulins|immunoglobulins|mesh-list
25876388|NCT03576547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25876389|NCT03576547|BB 1101|bb 1101|mesh-list
25876390|NCT03576547|Immunologic Factors|immunologic factors|mesh-ancestor
25876391|NCT03576547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876393|NCT03576547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25876394|NCT03576547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25876395|NCT03576547|Antiemetics|antiemetics|mesh-ancestor
25876396|NCT03576547|Autonomic Agents|autonomic agents|mesh-ancestor
25267878|NCT02419820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25267879|NCT02419820|Purinergic Agents|purinergic agents|mesh-ancestor
25267880|NCT02419820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25267881|NCT02419820|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25267882|NCT02419820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25267883|NCT02419820|Serotonin Agents|serotonin agents|mesh-ancestor
25267884|NCT02419534|Diltiazem|diltiazem|mesh-list
25267885|NCT02419534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25267886|NCT02419534|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25267887|NCT02419534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25857097|NCT00073203|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25857098|NCT00073203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25857099|NCT00073203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857100|NCT00073320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24828756|NCT02147535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828757|NCT02147535|Dopamine Agents|dopamine agents|mesh-ancestor
24828758|NCT02147535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24828759|NCT02147548|Lorazepam|lorazepam|mesh-list
24828762|NCT02147548|Antiemetics|antiemetics|mesh-ancestor
24828763|NCT02147548|Autonomic Agents|autonomic agents|mesh-ancestor
24828764|NCT02147548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24828765|NCT02147548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828766|NCT02147548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24828767|NCT02147548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24828768|NCT02147548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24828769|NCT02147548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24828770|NCT02147548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25857101|NCT00073320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25857102|NCT00073320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25857103|NCT00073320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25857104|NCT00073320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857105|NCT00073320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25857106|NCT00073320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25857107|NCT00073320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24828850|NCT02147964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25857108|NCT00073320|Serotonin Agents|serotonin agents|mesh-ancestor
25857109|NCT00073320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25857110|NCT00073320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857111|NCT00073320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25857112|NCT00073320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25857113|NCT00073320|Dopamine Agents|dopamine agents|mesh-ancestor
25857114|NCT00073372|Abciximab|abciximab|mesh-list
25857115|NCT00073372|Anticoagulants|anticoagulants|mesh-ancestor
25857116|NCT00073372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25876397|NCT03576547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25876398|NCT03576547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25876399|NCT03576547|Glucocorticoids|glucocorticoids|mesh-ancestor
25876400|NCT03576547|Hormones|hormones|mesh-ancestor
25876401|NCT03576547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24828851|NCT02147964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828852|NCT02147964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25267888|NCT02419534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267889|NCT02419534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25267890|NCT02419534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267891|NCT02419534|Vasodilator Agents|vasodilator agents|mesh-ancestor
25267892|NCT02419638|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25267893|NCT02419638|Dermatologic Agents|dermatologic agents|mesh-ancestor
25267894|NCT02419638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25664628|NCT01673191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25664629|NCT01673191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25664630|NCT01673191|Antiemetics|antiemetics|mesh-ancestor
25664631|NCT01673191|Autonomic Agents|autonomic agents|mesh-ancestor
25664632|NCT01673191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25664633|NCT01673191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664634|NCT01673191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25664635|NCT01673191|Glucocorticoids|glucocorticoids|mesh-ancestor
25876402|NCT03576547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25857120|NCT00073385|Antimitotic Agents|antimitotic agents|mesh-ancestor
25857121|NCT00073385|Mitosis Modulators|mitosis modulators|mesh-ancestor
25857122|NCT00073385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857123|NCT00073411|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25857124|NCT00073411|Citalopram|citalopram|mesh-list
25857125|NCT00073411|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25857126|NCT00073411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24828853|NCT02147964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828856|NCT02147964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24828857|NCT02147964|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24828858|NCT02147964|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24828859|NCT02147964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828860|NCT02147964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828861|NCT02147964|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24828862|NCT02147964|Hormone Antagonists|hormone antagonists|mesh-ancestor
24447758|NCT00309543|Protective Agents|protective agents|mesh-ancestor
24447759|NCT00309543|Vitamin B Complex|vitamin b complex|mesh-ancestor
24447760|NCT00309543|Vitamins|vitamins|mesh-ancestor
24447761|NCT00309543|Micronutrients|micronutrients|mesh-ancestor
24447762|NCT00309556|Docetaxel|docetaxel|mesh-list
24447763|NCT00309556|Capecitabine|capecitabine|mesh-list
24447764|NCT00309556|Trastuzumab|trastuzumab|mesh-list
24447765|NCT00309556|Epirubicin|epirubicin|mesh-list
24447766|NCT00309556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857127|NCT00073411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25857128|NCT00073411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857129|NCT00073411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25857130|NCT00073411|Serotonin Agents|serotonin agents|mesh-ancestor
25857131|NCT00073411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857132|NCT00073411|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25857133|NCT00073411|Antidepressive Agents|antidepressive agents|mesh-ancestor
24828887|NCT02148094|Tenofovir|tenofovir|mesh-list
24828892|NCT02148094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24828893|NCT02148094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24829019|NCT02149225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829020|NCT02149225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24829048|NCT02149459|Biguanides|biguanides|mesh-list
25267901|NCT02419443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267902|NCT02419443|Anticonvulsants|anticonvulsants|mesh-ancestor
25267903|NCT02419443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25267904|NCT02419443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25267905|NCT02419443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25267906|NCT02419443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25267907|NCT02419443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25267908|NCT02419443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25267909|NCT02419443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25267910|NCT02419443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267911|NCT02419443|Antimanic Agents|antimanic agents|mesh-ancestor
25267912|NCT02419859|Insulin|insulin|mesh-list
25267913|NCT02419859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25267914|NCT02419859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25267915|NCT02419859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267916|NCT02419352|Atropine|atropine|mesh-list
25267917|NCT02419352|Neostigmine|neostigmine|mesh-list
25857134|NCT00073411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25664636|NCT01673191|Hormones|hormones|mesh-ancestor
25664637|NCT01673191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25857135|NCT00073411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24829054|NCT02149628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24829055|NCT02149628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829056|NCT02149628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24829057|NCT02149628|Anesthetics, General|anesthetics, general|mesh-ancestor
24829058|NCT02149628|Anesthetics|anesthetics|mesh-ancestor
24829059|NCT02149628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24829060|NCT02149706|Freund's Adjuvant|freund's adjuvant|mesh-list
24829061|NCT02149706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24829062|NCT02149706|Immunologic Factors|immunologic factors|mesh-ancestor
24829064|NCT02149758|Etoricoxib|etoricoxib|mesh-list
25267918|NCT02419352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25267919|NCT02419352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25267927|NCT02419352|Parasympatholytics|parasympatholytics|mesh-ancestor
25267928|NCT02419352|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25267929|NCT02419352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25267930|NCT02419352|Cholinergic Agents|cholinergic agents|mesh-ancestor
25267931|NCT02419352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25267932|NCT02419352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267933|NCT02419352|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25267934|NCT02419352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25267935|NCT02419352|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25267936|NCT02419261|Analgesics|analgesics|mesh-list
25267937|NCT02419261|Ropivacaine|ropivacaine|mesh-list
25267938|NCT02419261|Anesthetics, Local|anesthetics, local|mesh-ancestor
25267939|NCT02419261|Anesthetics|anesthetics|mesh-ancestor
25267940|NCT02419261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25267941|NCT02419261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267942|NCT02419261|Sensory System Agents|sensory system agents|mesh-ancestor
25267943|NCT02419261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267944|NCT02419118|Dexamethasone|dexamethasone|mesh-list
25267945|NCT02419118|Lenalidomide|lenalidomide|mesh-list
25267946|NCT02419118|Daratumumab|daratumumab|mesh-list
25267947|NCT02419118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25267948|NCT02419118|Antiemetics|antiemetics|mesh-ancestor
24829086|NCT02149888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25857138|NCT00073411|Sensory System Agents|sensory system agents|mesh-ancestor
25857139|NCT00073411|Dopamine Agents|dopamine agents|mesh-ancestor
25857140|NCT00073437|Infliximab|infliximab|mesh-list
25857141|NCT00073437|Dermatologic Agents|dermatologic agents|mesh-ancestor
25857142|NCT00073437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25857143|NCT00073437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25857144|NCT00073580|Hirudins|hirudins|mesh-list
25857145|NCT00073580|Anticoagulants|anticoagulants|mesh-list
25857146|NCT00073580|Bivalirudin|bivalirudin|mesh-list
25857147|NCT00073580|Antithrombins|antithrombins|mesh-ancestor
25857148|NCT00073580|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25857149|NCT00073580|Protease Inhibitors|protease inhibitors|mesh-ancestor
25857150|NCT00073580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857151|NCT00073580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857152|NCT00073580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25857153|NCT00073580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25857154|NCT00073593|Heparin|heparin|mesh-list
25857155|NCT00073593|Bivalirudin|bivalirudin|mesh-list
25857156|NCT00073593|Protamines|protamines|mesh-list
25857157|NCT00073593|Anticoagulants|anticoagulants|mesh-ancestor
25857158|NCT00073593|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25857159|NCT00073593|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24829090|NCT02149888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24829091|NCT02149901|Pseudoephedrine|pseudoephedrine|mesh-list
24829092|NCT02149901|Ephedrine|ephedrine|mesh-list
24829093|NCT02149901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24829094|NCT02149901|Autonomic Agents|autonomic agents|mesh-ancestor
25857160|NCT00073593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857161|NCT00073593|Antithrombins|antithrombins|mesh-ancestor
24829098|NCT02149901|Respiratory System Agents|respiratory system agents|mesh-ancestor
24829099|NCT02149901|Nasal Decongestants|nasal decongestants|mesh-ancestor
24829100|NCT02149901|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25857162|NCT00073593|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25857163|NCT00073593|Protease Inhibitors|protease inhibitors|mesh-ancestor
25857164|NCT00073593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857165|NCT00073593|Heparin Antagonists|heparin antagonists|mesh-ancestor
25857166|NCT00073593|Coagulants|coagulants|mesh-ancestor
25857167|NCT00073658|Risperidone|risperidone|mesh-list
25857168|NCT00073658|Citalopram|citalopram|mesh-list
25267950|NCT02419118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267951|NCT02419118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267952|NCT02419118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25267953|NCT02419118|Glucocorticoids|glucocorticoids|mesh-ancestor
25267954|NCT02419118|Hormones|hormones|mesh-ancestor
25267955|NCT02419118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25267956|NCT02419118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24940532|NCT04000932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25857169|NCT00073658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25857170|NCT00073658|Serotonin Agents|serotonin agents|mesh-ancestor
25857171|NCT00073658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25857172|NCT00073658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857173|NCT00073658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857174|NCT00073658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25857175|NCT00073658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25857176|NCT00073658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24737866|NCT01670955|Vitamins|vitamins|mesh-ancestor
25857177|NCT00073658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25857178|NCT00073658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25857179|NCT00073658|Dopamine Agents|dopamine agents|mesh-ancestor
25857180|NCT00073658|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25857181|NCT00073658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25857182|NCT00073658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25857183|NCT00073658|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25857184|NCT00073658|Antidepressive Agents|antidepressive agents|mesh-ancestor
25857185|NCT00073697|Dexetimide|dexetimide|mesh-list
25857186|NCT00073697|Citalopram|citalopram|mesh-list
25857187|NCT00073697|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25857188|NCT00073697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25857189|NCT00073697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25857190|NCT00073697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857191|NCT00073697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25857192|NCT00073697|Serotonin Agents|serotonin agents|mesh-ancestor
25857193|NCT00073697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857194|NCT00073697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25857195|NCT00073697|Antidepressive Agents|antidepressive agents|mesh-ancestor
25857196|NCT00073697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25857197|NCT00073697|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25857198|NCT00073697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25857199|NCT00073697|Parasympatholytics|parasympatholytics|mesh-ancestor
25857200|NCT00073697|Autonomic Agents|autonomic agents|mesh-ancestor
25857201|NCT00073697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25857202|NCT00073697|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25857203|NCT00073697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25857204|NCT00073697|Cholinergic Agents|cholinergic agents|mesh-ancestor
24829166|NCT02150122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829175|NCT02150161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857205|NCT00073710|Calcitriol|calcitriol|mesh-list
25876403|NCT03576547|Protease Inhibitors|protease inhibitors|mesh-ancestor
25664638|NCT01673191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25876404|NCT03576547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876405|NCT03576547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876406|NCT03576547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25876407|NCT03560752|Vaccines|vaccines|mesh-list
25876408|NCT03560752|Immunologic Factors|immunologic factors|mesh-ancestor
25876409|NCT03560752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857206|NCT00073710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25857207|NCT00073710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857208|NCT00073710|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25857209|NCT00073710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25857210|NCT00073710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857211|NCT00073710|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25857213|NCT00073710|Micronutrients|micronutrients|mesh-ancestor
25267957|NCT02419118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267959|NCT02419118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25267960|NCT02419118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25267961|NCT02419118|Growth Substances|growth substances|mesh-ancestor
25267962|NCT02419118|Growth Inhibitors|growth inhibitors|mesh-ancestor
25267963|NCT02419105|Vitamin D|vitamin d|mesh-list
25267964|NCT02419105|Cholecalciferol|cholecalciferol|mesh-list
25267965|NCT02419105|Testosterone|testosterone|mesh-list
25267966|NCT02419105|Vitamins|vitamins|mesh-ancestor
25267967|NCT02419105|Micronutrients|micronutrients|mesh-ancestor
25267968|NCT02419105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943756|NCT03967496|Adrenergic Agents|adrenergic agents|mesh-ancestor
25267969|NCT02419105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25857214|NCT00073710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25857215|NCT00073723|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25857216|NCT00073723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857217|NCT00073736|Cytarabine|cytarabine|mesh-list
25857218|NCT00073736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25857219|NCT00073736|Antimetabolites|antimetabolites|mesh-ancestor
25857220|NCT00073736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857221|NCT00073736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857222|NCT00073736|Antiviral Agents|antiviral agents|mesh-ancestor
25857223|NCT00073736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24829176|NCT02150161|Sensory System Agents|sensory system agents|mesh-ancestor
24829177|NCT02150161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24829178|NCT02150161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24829179|NCT02150161|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24829180|NCT02150161|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24829181|NCT02150161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24829183|NCT02150161|Analgesics|analgesics|mesh-ancestor
24829205|NCT02150317|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25857224|NCT00073736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25857225|NCT00073736|Immunologic Factors|immunologic factors|mesh-ancestor
25857226|NCT00073736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857227|NCT00073814|Albuterol|albuterol|mesh-list
25857228|NCT00073814|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25857229|NCT00073814|Autonomic Agents|autonomic agents|mesh-ancestor
25857230|NCT00073814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25857231|NCT00073814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857232|NCT00073814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25857233|NCT00073814|Respiratory System Agents|respiratory system agents|mesh-ancestor
25857234|NCT00073814|Tocolytic Agents|tocolytic agents|mesh-ancestor
25857235|NCT00073814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24829207|NCT02150317|Hormones|hormones|mesh-ancestor
24829208|NCT02150317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24829209|NCT02150317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829210|NCT02150317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24829211|NCT02150330|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24829212|NCT02150330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24829213|NCT02150330|Immunologic Factors|immunologic factors|mesh-ancestor
24737948|NCT01671891|Capecitabine|capecitabine|mesh-list
24829214|NCT02150330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829215|NCT02150447|Lansoprazole|lansoprazole|mesh-list
24829216|NCT02150447|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24829217|NCT02150447|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24611934|NCT01011348|Ubiquinone|ubiquinone|mesh-list
24447835|NCT00309686|Serotonin Agents|serotonin agents|mesh-ancestor
24447836|NCT00309686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24447837|NCT00309686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447838|NCT00309686|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24447839|NCT00309686|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24447841|NCT00309699|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24447842|NCT00309699|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25268009|NCT02418702|Anesthetics, General|anesthetics, general|mesh-ancestor
24447843|NCT00309699|Antidepressive Agents|antidepressive agents|mesh-ancestor
24447844|NCT00309699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24447845|NCT00309699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24848527|NCT03993912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25271076|NCT02401269|Antipyretics|antipyretics|mesh-ancestor
25271077|NCT02401295|Itraconazole|itraconazole|mesh-list
25271078|NCT02401295|Celecoxib|celecoxib|mesh-list
25271079|NCT02401295|Tretinoin|tretinoin|mesh-list
25271080|NCT02401295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25271081|NCT02401295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24447846|NCT00309699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25857236|NCT00073814|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25857237|NCT00073814|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25857238|NCT00073814|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25857239|NCT00073814|Adrenergic Agents|adrenergic agents|mesh-ancestor
25857240|NCT00073814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25857241|NCT00073814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829287|NCT02151084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25857242|NCT00073827|Albuterol|albuterol|mesh-list
25267970|NCT02419105|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25267971|NCT02419105|Androgens|androgens|mesh-ancestor
25267972|NCT02419105|Hormones|hormones|mesh-ancestor
25857243|NCT00073827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25857244|NCT00073827|Autonomic Agents|autonomic agents|mesh-ancestor
25857245|NCT00073827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25857246|NCT00073827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829224|NCT02150616|Sevoflurane|sevoflurane|mesh-list
24829225|NCT02150616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24829226|NCT02150616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25857247|NCT00073827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25857248|NCT00073827|Respiratory System Agents|respiratory system agents|mesh-ancestor
25857249|NCT00073827|Tocolytic Agents|tocolytic agents|mesh-ancestor
25857250|NCT00073827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25857251|NCT00073827|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25857252|NCT00073827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25857253|NCT00073827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24829227|NCT02150616|Anesthetics, General|anesthetics, general|mesh-ancestor
24829228|NCT02150616|Anesthetics|anesthetics|mesh-ancestor
24829229|NCT02150616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24829230|NCT02150616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829231|NCT02150707|Liraglutide|liraglutide|mesh-list
24829232|NCT02150707|Exenatide|exenatide|mesh-list
24829233|NCT02150707|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24829234|NCT02150707|Glucagon|glucagon|mesh-list
24829235|NCT02150707|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24829236|NCT02150707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24829237|NCT02150707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829238|NCT02150707|Incretins|incretins|mesh-ancestor
24829239|NCT02150707|Hormones|hormones|mesh-ancestor
24829254|NCT02150928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24829255|NCT02150993|Ritonavir|ritonavir|mesh-list
24829256|NCT02150993|Lopinavir|lopinavir|mesh-list
24829257|NCT02150993|Tenofovir|tenofovir|mesh-list
24829258|NCT02150993|Lamivudine|lamivudine|mesh-list
24829259|NCT02150993|Zidovudine|zidovudine|mesh-list
24829260|NCT02150993|Emtricitabine|emtricitabine|mesh-list
24829268|NCT02150993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24829269|NCT02150993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24829270|NCT02150993|Antiviral Agents|antiviral agents|mesh-ancestor
24829271|NCT02150993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24829272|NCT02150993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24829273|NCT02150993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24829274|NCT02150993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24829275|NCT02150993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24829276|NCT02150993|Antimetabolites|antimetabolites|mesh-ancestor
24829277|NCT02150993|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25664639|NCT01673191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664640|NCT01673191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25664641|NCT01673282|Lacosamide|lacosamide|mesh-list
25664642|NCT01673282|Anticonvulsants|anticonvulsants|mesh-ancestor
25664643|NCT01673282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25664644|NCT01673282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25664645|NCT01673282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25664646|NCT01673282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664647|NCT01673386|Sunitinib|sunitinib|mesh-list
25857254|NCT00073827|Adrenergic Agents|adrenergic agents|mesh-ancestor
25857255|NCT00073827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25857256|NCT00073827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271113|NCT02401243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271115|NCT02401139|Analgesics|analgesics|mesh-ancestor
25271116|NCT02401139|Sensory System Agents|sensory system agents|mesh-ancestor
25271117|NCT02401139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25271118|NCT02401139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271119|NCT02401139|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25271120|NCT02401139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25271121|NCT02401139|Anesthetics, General|anesthetics, general|mesh-ancestor
25271122|NCT02401139|Anesthetics|anesthetics|mesh-ancestor
25271123|NCT02401139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25271124|NCT02401139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25271125|NCT02401139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25857257|NCT00073840|Albuterol|albuterol|mesh-list
25857258|NCT00073840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25857259|NCT00073840|Autonomic Agents|autonomic agents|mesh-ancestor
25857260|NCT00073840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25857261|NCT00073840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857262|NCT00073840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25857263|NCT00073840|Respiratory System Agents|respiratory system agents|mesh-ancestor
25268010|NCT02418702|Anesthetics|anesthetics|mesh-ancestor
25857264|NCT00073840|Tocolytic Agents|tocolytic agents|mesh-ancestor
24829279|NCT02151084|Gemcitabine|gemcitabine|mesh-list
24829280|NCT02151084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24829281|NCT02151084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24829282|NCT02151084|Antimetabolites|antimetabolites|mesh-ancestor
24829283|NCT02151084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829284|NCT02151084|Antiviral Agents|antiviral agents|mesh-ancestor
24829285|NCT02151084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24829286|NCT02151084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829309|NCT02151305|Remifentanil|remifentanil|mesh-list
24829310|NCT02151305|Propofol|propofol|mesh-list
25267973|NCT02419105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25267974|NCT02419170|Cyclophosphamide|cyclophosphamide|mesh-list
25267975|NCT02419170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25267976|NCT02419170|Immunologic Factors|immunologic factors|mesh-ancestor
24940549|NCT04000386|Zinc Oxide|zinc oxide|mesh-list
24829311|NCT02151305|Sevoflurane|sevoflurane|mesh-list
24829312|NCT02151305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24829313|NCT02151305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24829314|NCT02151305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829315|NCT02151305|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25857265|NCT00073840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25857266|NCT00073840|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25857267|NCT00073840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25857268|NCT00073840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25857269|NCT00073840|Adrenergic Agents|adrenergic agents|mesh-ancestor
25857270|NCT00073840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25857271|NCT00073840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109639|NCT03122665|Analgesics|analgesics|mesh-ancestor
25857272|NCT00073879|Cyclophosphamide|cyclophosphamide|mesh-list
25857273|NCT00073879|Fludarabine|fludarabine|mesh-list
25857274|NCT00073879|Fludarabine phosphate|fludarabine phosphate|mesh-list
25857275|NCT00073879|Alemtuzumab|alemtuzumab|mesh-list
25857276|NCT00073879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25857277|NCT00073879|Immunologic Factors|immunologic factors|mesh-ancestor
25857278|NCT00073879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857279|NCT00073879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25857280|NCT00073879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25857281|NCT00073879|Alkylating Agents|alkylating agents|mesh-ancestor
25664648|NCT01673386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664649|NCT01673386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25664650|NCT01673386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25664651|NCT01673386|Growth Substances|growth substances|mesh-ancestor
25664652|NCT01673386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664653|NCT01673386|Growth Inhibitors|growth inhibitors|mesh-ancestor
25664654|NCT01673386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25664655|NCT01673386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664656|NCT01673386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664657|NCT01673490|Tamsulosin|tamsulosin|mesh-list
25664658|NCT01673490|Dutasteride|dutasteride|mesh-list
25664659|NCT01673490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25664660|NCT01673490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25857282|NCT00073879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857290|NCT00073905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25857291|NCT00073905|Antimetabolites|antimetabolites|mesh-ancestor
25857292|NCT00073905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857293|NCT00073905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857294|NCT00073905|Antiviral Agents|antiviral agents|mesh-ancestor
25857295|NCT00073905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25857296|NCT00073905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857297|NCT00073905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25857298|NCT00073905|Immunologic Factors|immunologic factors|mesh-ancestor
25857299|NCT00073905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857300|NCT00073931|Tositumomab I-131|tositumomab i-131|mesh-list
25857301|NCT00073931|Sargramostim|sargramostim|mesh-list
25857302|NCT00073931|Immunologic Factors|immunologic factors|mesh-ancestor
25857303|NCT00073931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857304|NCT00073931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857305|NCT00073970|Celecoxib|celecoxib|mesh-list
25857306|NCT00073970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25857307|NCT00073970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25857308|NCT00073970|Analgesics|analgesics|mesh-ancestor
25857309|NCT00073970|Sensory System Agents|sensory system agents|mesh-ancestor
25857310|NCT00073970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25857311|NCT00073970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857312|NCT00073970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25857313|NCT00073970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25857314|NCT00073970|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25857315|NCT00073970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25857316|NCT00073970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24738091|NCT01673087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25267977|NCT02419170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267978|NCT02419170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25267979|NCT02419170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25267980|NCT02419170|Alkylating Agents|alkylating agents|mesh-ancestor
25267981|NCT02419170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857317|NCT00073970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857318|NCT00074009|Bortezomib|bortezomib|mesh-list
25857319|NCT00074009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517141|NCT00606203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25857320|NCT00074022|Docetaxel|docetaxel|mesh-list
24517142|NCT00606203|Analgesics|analgesics|mesh-ancestor
24517143|NCT00606203|Sensory System Agents|sensory system agents|mesh-ancestor
25664662|NCT01673490|Adrenergic Agents|adrenergic agents|mesh-ancestor
25664663|NCT01673490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25664664|NCT01673490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664665|NCT01673490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664666|NCT01673490|Urological Agents|urological agents|mesh-ancestor
25664667|NCT01673490|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25857321|NCT00074022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857322|NCT00074022|Tubulin Modulators|tubulin modulators|mesh-ancestor
25857323|NCT00074022|Antimitotic Agents|antimitotic agents|mesh-ancestor
25857324|NCT00074022|Mitosis Modulators|mitosis modulators|mesh-ancestor
25857325|NCT00074022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857326|NCT00074074|Infliximab|infliximab|mesh-list
25857327|NCT00074074|Dermatologic Agents|dermatologic agents|mesh-ancestor
25857328|NCT00074074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25267982|NCT02419170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267983|NCT02419170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25267984|NCT02419235|Ethanol|ethanol|mesh-list
25267985|NCT02419235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25267986|NCT02419235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25267987|NCT02419235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25267988|NCT02419235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267989|NCT02418988|Chlorotrianisene|chlorotrianisene|mesh-list
25267990|NCT02418988|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25267991|NCT02418988|Estrogens|estrogens|mesh-ancestor
25267992|NCT02418988|Hormones|hormones|mesh-ancestor
25267993|NCT02418988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25267994|NCT02418988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267995|NCT02418988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25267996|NCT02418988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267997|NCT02418572|Testosterone|testosterone|mesh-list
25267998|NCT02418572|Androgens|androgens|mesh-ancestor
25267999|NCT02418572|Hormones|hormones|mesh-ancestor
25268000|NCT02418572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25268001|NCT02418572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268002|NCT02418702|Ketamine|ketamine|mesh-list
25268003|NCT02418702|Analgesics|analgesics|mesh-ancestor
25268004|NCT02418702|Sensory System Agents|sensory system agents|mesh-ancestor
25268005|NCT02418702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25268006|NCT02418702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268007|NCT02418702|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25268008|NCT02418702|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25268011|NCT02418702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25268012|NCT02418702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25268013|NCT02418702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25268014|NCT02418702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25268015|NCT02418702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268016|NCT02418884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25268017|NCT02418884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25857329|NCT00074074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25857330|NCT00074087|Doxorubicin|doxorubicin|mesh-list
24765450|NCT01788605|Antiemetics|antiemetics|mesh-ancestor
25857331|NCT00074087|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25857332|NCT00074087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25857333|NCT00074087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857334|NCT00074087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25857335|NCT00074087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25857336|NCT00074087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857337|NCT00074087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857338|NCT00074100|Amonafide|amonafide|mesh-list
25857339|NCT00074100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857340|NCT00074100|Antiviral Agents|antiviral agents|mesh-ancestor
25857341|NCT00074100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25857342|NCT00074100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857343|NCT00074100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857344|NCT00074139|Cyclophosphamide|cyclophosphamide|mesh-list
25857345|NCT00074139|Docetaxel|docetaxel|mesh-list
25857346|NCT00074139|Doxorubicin|doxorubicin|mesh-list
25857347|NCT00074139|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24829341|NCT02151630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25857348|NCT00074139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25857349|NCT00074139|Immunologic Factors|immunologic factors|mesh-ancestor
25857350|NCT00074139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857351|NCT00074139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25857352|NCT00074139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25857353|NCT00074139|Alkylating Agents|alkylating agents|mesh-ancestor
25857354|NCT00074139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857355|NCT00074139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857356|NCT00074139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25857357|NCT00074139|Tubulin Modulators|tubulin modulators|mesh-ancestor
25857358|NCT00074139|Antimitotic Agents|antimitotic agents|mesh-ancestor
25857359|NCT00074139|Mitosis Modulators|mitosis modulators|mesh-ancestor
25857360|NCT00074139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25857361|NCT00074139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25857362|NCT00074139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25857363|NCT00074139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857364|NCT00074178|Cytarabine|cytarabine|mesh-list
25857365|NCT00074178|Dexamethasone|dexamethasone|mesh-list
25857366|NCT00074178|Cyclophosphamide|cyclophosphamide|mesh-list
25857367|NCT00074178|Methotrexate|methotrexate|mesh-list
25857368|NCT00074178|Etoposide|etoposide|mesh-list
25857369|NCT00074178|Etoposide phosphate|etoposide phosphate|mesh-list
25857370|NCT00074178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25857371|NCT00074178|Immunologic Factors|immunologic factors|mesh-ancestor
25857372|NCT00074178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857373|NCT00074178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25857374|NCT00074178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25857375|NCT00074178|Alkylating Agents|alkylating agents|mesh-ancestor
24447977|NCT00309920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24447978|NCT00309920|Antimetabolites|antimetabolites|mesh-ancestor
24447979|NCT00309920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24447980|NCT00309920|Hematinics|hematinics|mesh-ancestor
24447981|NCT00309998|Bevacizumab|bevacizumab|mesh-list
24447982|NCT00309998|Vinorelbine|vinorelbine|mesh-list
24447983|NCT00309998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24447984|NCT00309998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447985|NCT00309998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24447986|NCT00309998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24447987|NCT00309998|Growth Substances|growth substances|mesh-ancestor
25857376|NCT00074178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857377|NCT00074178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857378|NCT00074178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24829343|NCT02151630|Sensory System Agents|sensory system agents|mesh-ancestor
24829344|NCT02151630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25857379|NCT00074178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25857380|NCT00074178|Antiemetics|antiemetics|mesh-ancestor
25857381|NCT00074178|Autonomic Agents|autonomic agents|mesh-ancestor
25268018|NCT02418884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25268019|NCT02418884|Antimetabolites|antimetabolites|mesh-ancestor
25275443|NCT02372240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857382|NCT00074178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25857383|NCT00074178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25857384|NCT00074178|Glucocorticoids|glucocorticoids|mesh-ancestor
25857385|NCT00074178|Hormones|hormones|mesh-ancestor
25857386|NCT00074178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25857387|NCT00074178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25857388|NCT00074178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25857389|NCT00074178|Abortifacient Agents|abortifacient agents|mesh-ancestor
25857390|NCT00074178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24738336|NCT01674868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25857391|NCT00074178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25857392|NCT00074178|Antimetabolites|antimetabolites|mesh-ancestor
25857393|NCT00074178|Dermatologic Agents|dermatologic agents|mesh-ancestor
25857394|NCT00074178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857395|NCT00074178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25857396|NCT00074178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25857397|NCT00074178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25857398|NCT00074178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25857399|NCT00074178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25857400|NCT00074178|Antiviral Agents|antiviral agents|mesh-ancestor
25857401|NCT00074178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25857402|NCT00074191|Cytarabine|cytarabine|mesh-list
25857403|NCT00074191|Dexamethasone|dexamethasone|mesh-list
25857404|NCT00074191|Methotrexate|methotrexate|mesh-list
25857405|NCT00074191|Lomustine|lomustine|mesh-list
25857406|NCT00074191|Procarbazine|procarbazine|mesh-list
25857407|NCT00074191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25857408|NCT00074191|Antiemetics|antiemetics|mesh-ancestor
25857409|NCT00074191|Autonomic Agents|autonomic agents|mesh-ancestor
24690718|NCT01403415|Analgesics|analgesics|mesh-ancestor
25857410|NCT00074191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25857411|NCT00074191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857412|NCT00074191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25857413|NCT00074191|Glucocorticoids|glucocorticoids|mesh-ancestor
25857414|NCT00074191|Hormones|hormones|mesh-ancestor
25857415|NCT00074191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25857416|NCT00074191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25857417|NCT00074191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857418|NCT00074191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25857419|NCT00074191|Abortifacient Agents|abortifacient agents|mesh-ancestor
25857420|NCT00074191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25857421|NCT00074191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25857422|NCT00074191|Antimetabolites|antimetabolites|mesh-ancestor
25857423|NCT00074191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455148|NCT02645149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857424|NCT00074191|Dermatologic Agents|dermatologic agents|mesh-ancestor
25857425|NCT00074191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857426|NCT00074191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25857427|NCT00074191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25857428|NCT00074191|Immunologic Factors|immunologic factors|mesh-ancestor
25857429|NCT00074191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24617939|NCT01046162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25857430|NCT00074191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25857431|NCT00074191|Antiviral Agents|antiviral agents|mesh-ancestor
25857432|NCT00074191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25857433|NCT00074191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25857434|NCT00074191|Alkylating Agents|alkylating agents|mesh-ancestor
25857435|NCT00074204|Gemcitabine|gemcitabine|mesh-list
25268020|NCT02418884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268021|NCT02418884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25268022|NCT02418884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25268023|NCT02418884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25268024|NCT02418624|Carboplatin|carboplatin|mesh-list
25268025|NCT02418624|Olaparib|olaparib|mesh-list
25268027|NCT02418624|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25857436|NCT00074204|Carboplatin|carboplatin|mesh-list
24517159|NCT00606268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24517160|NCT00606333|Sirolimus|sirolimus|mesh-list
24517161|NCT00606333|Paclitaxel|paclitaxel|mesh-list
25857437|NCT00074204|Docetaxel|docetaxel|mesh-list
25857438|NCT00074204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857439|NCT00074204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25857440|NCT00074204|Antimetabolites|antimetabolites|mesh-ancestor
25857441|NCT00074204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857442|NCT00074204|Antiviral Agents|antiviral agents|mesh-ancestor
25857443|NCT00074204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24829349|NCT02151630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829350|NCT02151630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829351|NCT02151695|Aflibercept|aflibercept|mesh-list
24829352|NCT02151695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24829353|NCT02151695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24829354|NCT02151695|Growth Substances|growth substances|mesh-ancestor
24829355|NCT02151695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829356|NCT02151695|Growth Inhibitors|growth inhibitors|mesh-ancestor
24829357|NCT02151695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24829358|NCT02151721|Gefitinib|gefitinib|mesh-list
24829359|NCT02151721|Vorinostat|vorinostat|mesh-list
24829360|NCT02151721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24829364|NCT02151721|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24829366|NCT02151812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24829367|NCT02151812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24829368|NCT02151812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857444|NCT00074204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857445|NCT00074204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25857446|NCT00074204|Immunologic Factors|immunologic factors|mesh-ancestor
25857447|NCT00074204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857448|NCT00074204|Tubulin Modulators|tubulin modulators|mesh-ancestor
25857449|NCT00074204|Antimitotic Agents|antimitotic agents|mesh-ancestor
25857450|NCT00074204|Mitosis Modulators|mitosis modulators|mesh-ancestor
25857451|NCT00074230|BIRC5 protein, human|birc5 protein, human|mesh-list
25857452|NCT00074230|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25857453|NCT00074230|Protease Inhibitors|protease inhibitors|mesh-ancestor
25857454|NCT00074230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857455|NCT00074230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448021|NCT00310089|Cediranib|cediranib|mesh-list
24448022|NCT00310089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24448023|NCT00310089|Immunologic Factors|immunologic factors|mesh-ancestor
24448024|NCT00310089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448025|NCT00310089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24448026|NCT00310089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24448027|NCT00310089|Alkylating Agents|alkylating agents|mesh-ancestor
24448028|NCT00310089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857456|NCT00074321|Capecitabine|capecitabine|mesh-list
25424631|NCT02230189|Autonomic Agents|autonomic agents|mesh-ancestor
25857457|NCT00074321|Oxaliplatin|oxaliplatin|mesh-list
25857458|NCT00074321|Irinotecan|irinotecan|mesh-list
25857459|NCT00074321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25857460|NCT00074321|Antimetabolites|antimetabolites|mesh-ancestor
24829379|NCT02151929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24829383|NCT02151968|Anesthetics|anesthetics|mesh-list
25857461|NCT00074321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857462|NCT00074321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738501|NCT01675895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25857463|NCT00074321|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25857464|NCT00074321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25857465|NCT00074321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857466|NCT00074334|Immunotoxins|immunotoxins|mesh-list
25268028|NCT02418624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25268029|NCT02418624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268030|NCT02418533|Menotropins|menotropins|mesh-list
25268031|NCT02418533|Hormones|hormones|mesh-list
25268032|NCT02418533|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25268033|NCT02418533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25857467|NCT00074334|Immunologic Factors|immunologic factors|mesh-ancestor
25857468|NCT00074334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857469|NCT00074399|Nevirapine|nevirapine|mesh-list
25857470|NCT00074399|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25857471|NCT00074399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25857472|NCT00074399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857473|NCT00074399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857474|NCT00074399|Antiviral Agents|antiviral agents|mesh-ancestor
25857475|NCT00074399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25857476|NCT00074399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25857477|NCT00074399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25857478|NCT00074399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25857479|NCT00074399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25857480|NCT00074438|Rituximab|rituximab|mesh-list
25857481|NCT00074438|Methotrexate|methotrexate|mesh-list
25857482|NCT00074438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25857483|NCT00074438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857484|NCT00074438|Immunologic Factors|immunologic factors|mesh-ancestor
25857485|NCT00074438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857486|NCT00074438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25857487|NCT00074438|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25857488|NCT00074438|Abortifacient Agents|abortifacient agents|mesh-ancestor
25857489|NCT00074438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25857490|NCT00074438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25857491|NCT00074438|Antimetabolites|antimetabolites|mesh-ancestor
25857492|NCT00074438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738639|NCT01676506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738654|NCT01676571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24738655|NCT01676571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24738656|NCT01676571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738657|NCT01676571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24738658|NCT01676571|Serotonin Agents|serotonin agents|mesh-ancestor
24738659|NCT01676571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24738660|NCT01676571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24738661|NCT01676571|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25857493|NCT00074438|Dermatologic Agents|dermatologic agents|mesh-ancestor
25857494|NCT00074438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829396|NCT02152176|Narcotics|narcotics|mesh-ancestor
24829397|NCT02152176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24829398|NCT02152176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612028|NCT01011699|Niacin|niacin|mesh-list
25268034|NCT02418533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268035|NCT02418533|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25268036|NCT02418533|Fertility Agents|fertility agents|mesh-ancestor
25268037|NCT02418533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25268038|NCT02418273|Denosumab|denosumab|mesh-list
25268039|NCT02418273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25268040|NCT02418273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268041|NCT02418130|Inositol|inositol|mesh-list
25268042|NCT02418130|Thiamine|thiamine|mesh-list
25268043|NCT02418130|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25268044|NCT02418130|Vitamin B Complex|vitamin b complex|mesh-ancestor
25268045|NCT02418130|Vitamins|vitamins|mesh-ancestor
25857495|NCT00074438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25857496|NCT00074438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25424708|NCT02224391|Nicotine|nicotine|mesh-list
24848569|NCT03954379|Analgesics|analgesics|mesh-list
25857497|NCT00074438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25857498|NCT00074607|Gemcitabine|gemcitabine|mesh-list
25857499|NCT00074607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25857500|NCT00074607|Antimetabolites|antimetabolites|mesh-ancestor
25857501|NCT00074607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857502|NCT00074607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857503|NCT00074607|Antiviral Agents|antiviral agents|mesh-ancestor
24829429|NCT02152332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829430|NCT02152332|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24829431|NCT02152332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24829432|NCT02152332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24738692|NCT01676844|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24738693|NCT01676844|Potassium phosphate|potassium phosphate|mesh-list
24738694|NCT01676844|Cariostatic Agents|cariostatic agents|mesh-ancestor
24829436|NCT02152358|Antiviral Agents|antiviral agents|mesh-ancestor
24724702|NCT01594229|Rituximab|rituximab|mesh-list
25857504|NCT00074607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25857505|NCT00074607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857506|NCT00074607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25857507|NCT00074607|Immunologic Factors|immunologic factors|mesh-ancestor
25857508|NCT00074607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857509|NCT00074620|Hirudins|hirudins|mesh-list
25857510|NCT00074620|Antithrombins|antithrombins|mesh-ancestor
24448167|NCT00310583|Pregabalin|pregabalin|mesh-list
24448179|NCT00310583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24448180|NCT00310583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25268046|NCT02418130|Micronutrients|micronutrients|mesh-ancestor
25268047|NCT02418130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268048|NCT02418130|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25268049|NCT02418130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25268050|NCT02417883|Furosemide|furosemide|mesh-list
25268051|NCT02417883|Diuretics|diuretics|mesh-ancestor
25268052|NCT02417883|Natriuretic Agents|natriuretic agents|mesh-ancestor
25268053|NCT02417883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268054|NCT02417883|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25268055|NCT02417883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25268056|NCT02417883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268057|NCT02417896|Spironolactone|spironolactone|mesh-list
25857511|NCT00074620|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24738718|NCT01677039|Ethanol|ethanol|mesh-list
24691154|NCT01405170|Glucocorticoids|glucocorticoids|mesh-ancestor
24448222|NCT00310778|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24448223|NCT00310778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448224|NCT00310778|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24448225|NCT00310778|Protease Inhibitors|protease inhibitors|mesh-ancestor
24448226|NCT00310778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857512|NCT00074620|Protease Inhibitors|protease inhibitors|mesh-ancestor
25857513|NCT00074620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857514|NCT00074620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857515|NCT00074620|Anticoagulants|anticoagulants|mesh-ancestor
25857516|NCT00074620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25233443|NCT02576600|Anesthetics|anesthetics|mesh-ancestor
25233444|NCT02576600|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25233445|NCT02576600|Narcotics|narcotics|mesh-ancestor
25063361|NCT01968590|Micronutrients|micronutrients|mesh-ancestor
25857517|NCT00074620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24445622|NCT00301925|Antimetabolites|antimetabolites|mesh-ancestor
24448284|NCT00311038|Adrenergic Agents|adrenergic agents|mesh-ancestor
24448285|NCT00311038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24448286|NCT00311038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448287|NCT00311038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857518|NCT00074737|Cytarabine|cytarabine|mesh-list
25857519|NCT00074737|Idarubicin|idarubicin|mesh-list
25857520|NCT00074737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25857521|NCT00074737|Antimetabolites|antimetabolites|mesh-ancestor
25857522|NCT00074737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857523|NCT00074737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857524|NCT00074737|Antiviral Agents|antiviral agents|mesh-ancestor
25857525|NCT00074737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24738834|NCT01677650|Respiratory System Agents|respiratory system agents|mesh-ancestor
25857526|NCT00074737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25857527|NCT00074737|Immunologic Factors|immunologic factors|mesh-ancestor
24691188|NCT01405352|Vitamin A|vitamin a|mesh-list
25857528|NCT00074737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857529|NCT00074737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25857530|NCT00074737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25857531|NCT00074737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25857532|NCT00074737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857533|NCT00074750|Molgramostim|molgramostim|mesh-list
24848593|NCT03910387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24848594|NCT03910387|Tubulin Modulators|tubulin modulators|mesh-ancestor
24848595|NCT03910387|Antimitotic Agents|antimitotic agents|mesh-ancestor
24848596|NCT03910387|Mitosis Modulators|mitosis modulators|mesh-ancestor
24848597|NCT03910387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848598|NCT03910387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24848618|NCT03843463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848619|NCT03843463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24848620|NCT03843463|Serotonin Agents|serotonin agents|mesh-ancestor
24848621|NCT03843463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857534|NCT00074750|Sargramostim|sargramostim|mesh-list
25857535|NCT00074750|Immunologic Factors|immunologic factors|mesh-ancestor
25857536|NCT00074750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857537|NCT00074750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857538|NCT00074776|Lamotrigine|lamotrigine|mesh-list
24829465|NCT02152475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829467|NCT02152514|Morphine|morphine|mesh-list
24724915|NCT01595724|Dienogest|dienogest|mesh-list
25857539|NCT00074776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25857540|NCT00074776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857541|NCT00074776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25857542|NCT00074776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25857543|NCT00074776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857544|NCT00074776|Anticonvulsants|anticonvulsants|mesh-ancestor
25857545|NCT00074776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24556303|NCT00746837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25857546|NCT00074776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25857547|NCT00074776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25857548|NCT00074776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25857549|NCT00074776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25857550|NCT00074828|Enoxaparin|enoxaparin|mesh-list
25857551|NCT00074828|Anticoagulants|anticoagulants|mesh-ancestor
24829469|NCT02152514|Narcotics|narcotics|mesh-ancestor
24829470|NCT02152514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24829471|NCT02152514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829472|NCT02152514|Analgesics|analgesics|mesh-ancestor
24829473|NCT02152514|Sensory System Agents|sensory system agents|mesh-ancestor
24829474|NCT02152514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24829475|NCT02152514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24448351|NCT00311467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448352|NCT00311467|Antiviral Agents|antiviral agents|mesh-ancestor
24473795|NCT00404222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25233446|NCT02576600|Analgesics|analgesics|mesh-ancestor
24448353|NCT00311467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25233449|NCT02576457|BMS-936559|bms-936559|mesh-list
24448355|NCT00311545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448356|NCT00311558|Interferons|interferons|mesh-list
24448357|NCT00311558|Interferon-alpha|interferon-alpha|mesh-list
24448358|NCT00311558|Interferon alpha-2|interferon alpha-2|mesh-list
24448359|NCT00311558|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
24448360|NCT00311558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448361|NCT00311558|Antiviral Agents|antiviral agents|mesh-ancestor
24448362|NCT00311558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24448363|NCT00311558|Immunologic Factors|immunologic factors|mesh-ancestor
24448365|NCT00311558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25857552|NCT00074828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24448404|NCT00311636|Luteolytic Agents|luteolytic agents|mesh-ancestor
24612053|NCT01011751|Cyproterone|cyproterone|mesh-list
25857553|NCT00074828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25857554|NCT00074828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857555|NCT00074841|Azithromycin|azithromycin|mesh-list
25857556|NCT00074841|Chloroquine|chloroquine|mesh-list
25857557|NCT00074841|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
25857558|NCT00074841|Pyrimethamine|pyrimethamine|mesh-list
25857559|NCT00074841|Sulfadoxine|sulfadoxine|mesh-list
25857560|NCT00074841|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24829486|NCT02152579|Diuretics|diuretics|mesh-ancestor
25664668|NCT01673490|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25664669|NCT01673490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664670|NCT01673490|Hormone Antagonists|hormone antagonists|mesh-ancestor
25664671|NCT01673490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25664672|NCT01673594|Naltrexone|naltrexone|mesh-list
25664673|NCT01673594|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25664674|NCT01673594|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25664675|NCT01673594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664676|NCT01673594|Sensory System Agents|sensory system agents|mesh-ancestor
25664677|NCT01673594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25664678|NCT01673646|Pasireotide|pasireotide|mesh-list
25857561|NCT00074841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25271326|NCT02399566|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24612507|NCT01014247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25271327|NCT02399566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25271328|NCT02399566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25271329|NCT02399592|Bevacizumab|bevacizumab|mesh-list
25271330|NCT02399592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25271331|NCT02399592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25271332|NCT02399592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25271333|NCT02399592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25271334|NCT02399592|Growth Substances|growth substances|mesh-ancestor
25271335|NCT02399592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271336|NCT02399592|Growth Inhibitors|growth inhibitors|mesh-ancestor
25271337|NCT02399657|Dexamethasone|dexamethasone|mesh-list
25271338|NCT02399657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25271339|NCT02399657|Antiemetics|antiemetics|mesh-ancestor
25271340|NCT02399657|Autonomic Agents|autonomic agents|mesh-ancestor
25271341|NCT02399657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25271342|NCT02399657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271343|NCT02399657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25271344|NCT02399657|Glucocorticoids|glucocorticoids|mesh-ancestor
25271345|NCT02399657|Hormones|hormones|mesh-ancestor
25271346|NCT02399657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25271347|NCT02399657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25857562|NCT00074841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24829491|NCT02152579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829492|NCT02152709|Vaccines|vaccines|mesh-list
25857563|NCT00074841|Amebicides|amebicides|mesh-ancestor
25857564|NCT00074841|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25857565|NCT00074841|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25857566|NCT00074841|Antimalarials|antimalarials|mesh-ancestor
25857567|NCT00074841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25857568|NCT00074841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25268060|NCT02417896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25268061|NCT02417896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268062|NCT02417896|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24445967|NCT00303381|Interferons|interferons|mesh-list
24445991|NCT00303433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25268063|NCT02417896|Diuretics|diuretics|mesh-ancestor
25268064|NCT02417896|Natriuretic Agents|natriuretic agents|mesh-ancestor
25268065|NCT02418065|Testosterone|testosterone|mesh-list
25268066|NCT02418065|Androgens|androgens|mesh-ancestor
25268067|NCT02418065|Hormones|hormones|mesh-ancestor
25857569|NCT00074841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25268068|NCT02418065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24829499|NCT02152787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24829500|NCT02152787|Anesthetics, General|anesthetics, general|mesh-ancestor
24829502|NCT02152800|Valacyclovir|valacyclovir|mesh-list
24829503|NCT02152800|Antiviral Agents|antiviral agents|mesh-ancestor
24829504|NCT02152800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24829505|NCT02152865|Lupeol|lupeol|mesh-list
24617991|NCT01046461|Aprepitant|aprepitant|mesh-list
25857570|NCT00074841|Analgesics|analgesics|mesh-ancestor
25857571|NCT00074841|Sensory System Agents|sensory system agents|mesh-ancestor
25664679|NCT01673646|Hormones|hormones|mesh-ancestor
25664680|NCT01673646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25664681|NCT01673646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664682|NCT01673828|Pregnanolone|pregnanolone|mesh-list
25664683|NCT01673828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25664684|NCT01673828|Anesthetics|anesthetics|mesh-ancestor
25664685|NCT01673828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25664686|NCT01673828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664687|NCT01673854|Ipilimumab|ipilimumab|mesh-list
25664688|NCT01673854|Vemurafenib|vemurafenib|mesh-list
25664689|NCT01673854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25664690|NCT01673854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664691|NCT01673854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25664692|NCT01673854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664693|NCT01673854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25664694|NCT01673854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664695|NCT01673984|Goserelin|goserelin|mesh-list
25664696|NCT01673984|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25664697|NCT01673984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25664698|NCT01673984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664699|NCT01673984|Luteolytic Agents|luteolytic agents|mesh-ancestor
25664700|NCT01673984|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25664701|NCT01673984|Contraceptive Agents|contraceptive agents|mesh-ancestor
25876410|NCT03549000|Spartalizumab|spartalizumab|mesh-list
25271358|NCT02399462|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
25271359|NCT02399462|beta-Endorphin|beta-endorphin|mesh-list
25857572|NCT00074841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24448410|NCT00311688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448411|NCT00311688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24448412|NCT00311688|Analgesics|analgesics|mesh-ancestor
24448413|NCT00311688|Sensory System Agents|sensory system agents|mesh-ancestor
24448414|NCT00311688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24448415|NCT00311688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448416|NCT00311740|Valsartan|valsartan|mesh-list
24448417|NCT00311740|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24448419|NCT00311740|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24448420|NCT00311740|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24449419|NCT00315536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24449420|NCT00315536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24449421|NCT00315536|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24449422|NCT00315536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24449423|NCT00315536|Cholinergic Agents|cholinergic agents|mesh-ancestor
24449424|NCT00315536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24449425|NCT00315536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857573|NCT00074841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857574|NCT00074841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25857575|NCT00074841|Filaricides|filaricides|mesh-ancestor
25857576|NCT00074841|Antinematodal Agents|antinematodal agents|mesh-ancestor
25857577|NCT00074841|Anthelmintics|anthelmintics|mesh-ancestor
24691361|NCT01406262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857578|NCT00074841|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25857579|NCT00074841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857580|NCT00074841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857581|NCT00074841|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25857582|NCT00074841|Renal Agents|renal agents|mesh-ancestor
25857583|NCT00075010|Decitabine|decitabine|mesh-list
25857584|NCT00075010|Valproic Acid|valproic acid|mesh-list
25857585|NCT00075010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25857586|NCT00075010|Antimetabolites|antimetabolites|mesh-ancestor
25857587|NCT00075010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857588|NCT00075010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857589|NCT00075010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857590|NCT00075010|Anticonvulsants|anticonvulsants|mesh-ancestor
25857591|NCT00075010|GABA Agents|gaba agents|mesh-ancestor
25857592|NCT00075010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25857593|NCT00075010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857594|NCT00075010|Antimanic Agents|antimanic agents|mesh-ancestor
25857595|NCT00075010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25857596|NCT00075010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25857597|NCT00075010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25857598|NCT00075075|Infliximab|infliximab|mesh-list
25857599|NCT00075075|Dermatologic Agents|dermatologic agents|mesh-ancestor
25857600|NCT00075075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25857601|NCT00075075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25857602|NCT00075101|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
25857603|NCT00075101|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25857604|NCT00075101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857605|NCT00075101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857606|NCT00075101|Cholinergic Agents|cholinergic agents|mesh-ancestor
25857607|NCT00075101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25857608|NCT00075101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857609|NCT00075179|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25857610|NCT00075179|Natriuretic Agents|natriuretic agents|mesh-ancestor
25857611|NCT00075179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857612|NCT00075192|Leuprolide|leuprolide|mesh-list
25268069|NCT02418065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857613|NCT00075192|Bicalutamide|bicalutamide|mesh-list
25857614|NCT00075192|Tremelimumab|tremelimumab|mesh-list
25857615|NCT00075192|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25857616|NCT00075192|Fertility Agents|fertility agents|mesh-ancestor
25857617|NCT00075192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25857618|NCT00075192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857619|NCT00075192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25857620|NCT00075192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857621|NCT00075192|Androgen Antagonists|androgen antagonists|mesh-ancestor
25857622|NCT00075192|Hormone Antagonists|hormone antagonists|mesh-ancestor
24829525|NCT02152943|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25664702|NCT01673984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25664703|NCT01673984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271391|NCT02399397|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25271392|NCT02399397|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25271393|NCT02399397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25271394|NCT02399410|Bevacizumab|bevacizumab|mesh-list
25271395|NCT02399410|Oxaliplatin|oxaliplatin|mesh-list
25271396|NCT02399410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25857623|NCT00075192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25857624|NCT00075205|Rimonabant|rimonabant|mesh-list
25857625|NCT00075205|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25857626|NCT00075205|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
25857627|NCT00075205|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25857628|NCT00075205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25857629|NCT00075205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857630|NCT00075205|Hormones|hormones|mesh-ancestor
25857631|NCT00075205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25857632|NCT00075205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857633|NCT00075231|Ritonavir|ritonavir|mesh-list
25857634|NCT00075231|Lopinavir|lopinavir|mesh-list
25857635|NCT00075231|Lamivudine|lamivudine|mesh-list
25857636|NCT00075231|Zidovudine|zidovudine|mesh-list
25857637|NCT00075231|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25857638|NCT00075231|Efavirenz|efavirenz|mesh-list
25857639|NCT00075231|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25857640|NCT00075231|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25857641|NCT00075231|Protease Inhibitors|protease inhibitors|mesh-ancestor
25857642|NCT00075231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857643|NCT00075231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857644|NCT00075231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25857645|NCT00075231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25857646|NCT00075231|Antiviral Agents|antiviral agents|mesh-ancestor
25857647|NCT00075231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25857648|NCT00075231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25857649|NCT00075231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25857650|NCT00075231|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25857651|NCT00075231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25857652|NCT00075231|Antimetabolites|antimetabolites|mesh-ancestor
25857653|NCT00075231|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25857654|NCT00075231|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25857655|NCT00075231|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25857656|NCT00075231|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25857657|NCT00075231|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25876411|NCT03549000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25268070|NCT02418078|Anesthetics|anesthetics|mesh-list
25268071|NCT02418078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25268072|NCT02418078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268073|NCT02417610|Hyaluronic Acid|hyaluronic acid|mesh-list
25268074|NCT02417610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25268075|NCT02417610|Immunologic Factors|immunologic factors|mesh-ancestor
25268076|NCT02417610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268077|NCT02417610|Viscosupplements|viscosupplements|mesh-ancestor
25268078|NCT02417610|Protective Agents|protective agents|mesh-ancestor
25268079|NCT02417506|Ibuprofen|ibuprofen|mesh-list
25268080|NCT02417506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25268081|NCT02417506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24739047|NCT01678937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24739049|NCT01678963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24739050|NCT01678963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24739051|NCT01678963|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24739052|NCT01678963|Protective Agents|protective agents|mesh-ancestor
24739053|NCT01678963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739054|NCT01678963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25424991|NCT02188121|Antimetabolites|antimetabolites|mesh-ancestor
25664704|NCT01673984|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25664705|NCT01674010|Inositol|inositol|mesh-list
25664706|NCT01674010|Lamotrigine|lamotrigine|mesh-list
25664707|NCT01674010|Valproic Acid|valproic acid|mesh-list
25664708|NCT01674010|Anticonvulsants|anticonvulsants|mesh-ancestor
25664709|NCT01674010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25664710|NCT01674010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25664711|NCT01674010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739056|NCT01678963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25857658|NCT00075374|Docetaxel|docetaxel|mesh-list
24829527|NCT02152943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829528|NCT02152943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829529|NCT02152943|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24829530|NCT02152943|Hormone Antagonists|hormone antagonists|mesh-ancestor
24829531|NCT02152943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24829533|NCT02152969|Telmisartan|telmisartan|mesh-list
24829534|NCT02152969|Chlorthalidone|chlorthalidone|mesh-list
25857659|NCT00075374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857660|NCT00075374|Tubulin Modulators|tubulin modulators|mesh-ancestor
25857661|NCT00075374|Antimitotic Agents|antimitotic agents|mesh-ancestor
25857662|NCT00075374|Mitosis Modulators|mitosis modulators|mesh-ancestor
25857663|NCT00075374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857664|NCT00075413|Arsenic Trioxide|arsenic trioxide|mesh-list
25857665|NCT00075413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857666|NCT00075426|Arsenic Trioxide|arsenic trioxide|mesh-list
25857667|NCT00075426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857668|NCT00075439|Gefitinib|gefitinib|mesh-list
25857669|NCT00075439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857670|NCT00075439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25857671|NCT00075439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857672|NCT00075439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857673|NCT00075452|Gemcitabine|gemcitabine|mesh-list
25857674|NCT00075452|Oxaliplatin|oxaliplatin|mesh-list
25857675|NCT00075452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25857676|NCT00075452|Antimetabolites|antimetabolites|mesh-ancestor
25857677|NCT00075452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739063|NCT01679041|Immunologic Factors|immunologic factors|mesh-ancestor
25857678|NCT00075452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857679|NCT00075452|Antiviral Agents|antiviral agents|mesh-ancestor
25857680|NCT00075452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25857681|NCT00075452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857682|NCT00075452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25857683|NCT00075452|Immunologic Factors|immunologic factors|mesh-ancestor
25857684|NCT00075452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857685|NCT00075465|Docetaxel|docetaxel|mesh-list
25857686|NCT00075465|Epirubicin|epirubicin|mesh-list
25857687|NCT00075465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857688|NCT00075465|Tubulin Modulators|tubulin modulators|mesh-ancestor
25857689|NCT00075465|Antimitotic Agents|antimitotic agents|mesh-ancestor
25857690|NCT00075465|Mitosis Modulators|mitosis modulators|mesh-ancestor
25857691|NCT00075465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857692|NCT00075465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25268082|NCT02417506|Analgesics|analgesics|mesh-ancestor
25268083|NCT02417506|Sensory System Agents|sensory system agents|mesh-ancestor
25268084|NCT02417506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25268085|NCT02417506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268086|NCT02417506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25268087|NCT02417506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25268088|NCT02417506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25268089|NCT02417506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857693|NCT00075465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25857694|NCT00075465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24739087|NCT01679093|Hormones|hormones|mesh-ancestor
24652019|NCT01235143|Sevoflurane|sevoflurane|mesh-list
25857695|NCT00075465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857696|NCT00075491|Fenretinide|fenretinide|mesh-list
25857697|NCT00075491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857698|NCT00075491|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24829582|NCT02153177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24829583|NCT02153177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829585|NCT02153177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24829586|NCT02153177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24829587|NCT02153177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25857699|NCT00075491|Protective Agents|protective agents|mesh-ancestor
25857700|NCT00075491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857701|NCT00075517|Gemcitabine|gemcitabine|mesh-list
25857702|NCT00075517|Docetaxel|docetaxel|mesh-list
25857703|NCT00075517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25857704|NCT00075517|Antimetabolites|antimetabolites|mesh-ancestor
25857705|NCT00075517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857707|NCT00075517|Antiviral Agents|antiviral agents|mesh-ancestor
25857708|NCT00075517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24403720|NCT00161330|Amoxicillin|amoxicillin|mesh-list
25857709|NCT00075517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857710|NCT00075517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25857711|NCT00075517|Immunologic Factors|immunologic factors|mesh-ancestor
25857712|NCT00075517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857713|NCT00075517|Tubulin Modulators|tubulin modulators|mesh-ancestor
25857714|NCT00075517|Antimitotic Agents|antimitotic agents|mesh-ancestor
25857715|NCT00075517|Mitosis Modulators|mitosis modulators|mesh-ancestor
24448516|NCT00312039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25857717|NCT00075543|Oxaliplatin|oxaliplatin|mesh-list
24448558|NCT00312182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24448559|NCT00312260|Gabapentin|gabapentin|mesh-list
24448560|NCT00312260|Amitriptyline|amitriptyline|mesh-list
24448561|NCT00312260|Analgesics|analgesics|mesh-ancestor
25857718|NCT00075543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857719|NCT00075543|Tubulin Modulators|tubulin modulators|mesh-ancestor
25233500|NCT02576301|Immunologic Factors|immunologic factors|mesh-ancestor
25857720|NCT00075543|Antimitotic Agents|antimitotic agents|mesh-ancestor
24829588|NCT02153177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24829589|NCT02153177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857721|NCT00075543|Mitosis Modulators|mitosis modulators|mesh-ancestor
25268090|NCT02417506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268091|NCT02417493|Epinephrine|epinephrine|mesh-list
25268092|NCT02417493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25268093|NCT02417493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25268094|NCT02417493|Adrenergic Agents|adrenergic agents|mesh-ancestor
25268095|NCT02417493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25268096|NCT02417493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517169|NCT00606333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25857722|NCT00075543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857723|NCT00075556|Capecitabine|capecitabine|mesh-list
25857724|NCT00075556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25857725|NCT00075556|Antimetabolites|antimetabolites|mesh-ancestor
25857726|NCT00075556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857727|NCT00075556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857728|NCT00075595|Leucovorin|leucovorin|mesh-list
25857729|NCT00075595|Fluorouracil|fluorouracil|mesh-list
25857730|NCT00075595|Irinotecan|irinotecan|mesh-list
25857731|NCT00075595|Calcium|calcium|mesh-list
25857732|NCT00075595|Levoleucovorin|levoleucovorin|mesh-list
25857733|NCT00075595|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25857734|NCT00075595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857735|NCT00075595|Antimetabolites|antimetabolites|mesh-ancestor
25857736|NCT00075595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857737|NCT00075595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25857738|NCT00075595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857739|NCT00075595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25857740|NCT00075595|Immunologic Factors|immunologic factors|mesh-ancestor
25857741|NCT00075595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25857742|NCT00075595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25857743|NCT00075595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857744|NCT00075595|Antidotes|antidotes|mesh-ancestor
25857745|NCT00075595|Protective Agents|protective agents|mesh-ancestor
25857746|NCT00075595|Vitamin B Complex|vitamin b complex|mesh-ancestor
25857747|NCT00075595|Vitamins|vitamins|mesh-ancestor
25857748|NCT00075595|Micronutrients|micronutrients|mesh-ancestor
25857749|NCT00075621|Melphalan|melphalan|mesh-list
25857750|NCT00075621|Immunologic Factors|immunologic factors|mesh-ancestor
25857751|NCT00075621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857752|NCT00075621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25857753|NCT00075621|Alkylating Agents|alkylating agents|mesh-ancestor
25268097|NCT02417493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268098|NCT02417493|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25268099|NCT02417493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25268100|NCT02417493|Autonomic Agents|autonomic agents|mesh-ancestor
25268101|NCT02417493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25268102|NCT02417493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25857754|NCT00075621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857755|NCT00075621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857756|NCT00075621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25857757|NCT00075621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24448623|NCT00312481|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24448624|NCT00312481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448625|NCT00312481|Antioxidants|antioxidants|mesh-ancestor
24448626|NCT00312481|Protective Agents|protective agents|mesh-ancestor
24829603|NCT02153281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829604|NCT02153281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829605|NCT02153424|Apixaban|apixaban|mesh-list
24829606|NCT02153424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24829607|NCT02153424|Antithrombins|antithrombins|mesh-ancestor
24725920|NCT01600573|Topotecan|topotecan|mesh-list
25857760|NCT00075634|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25857761|NCT00075634|Decitabine|decitabine|mesh-list
25857762|NCT00075634|Azacitidine|azacitidine|mesh-list
25857763|NCT00075634|Lenograstim|lenograstim|mesh-list
24474069|NCT00404794|Glucocorticoids|glucocorticoids|mesh-ancestor
25857764|NCT00075634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25857765|NCT00075634|Immunologic Factors|immunologic factors|mesh-ancestor
25857766|NCT00075634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857767|NCT00075634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25857768|NCT00075634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25857769|NCT00075634|Alkylating Agents|alkylating agents|mesh-ancestor
25857770|NCT00075634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857771|NCT00075634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857772|NCT00075634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25857773|NCT00075634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25857774|NCT00075634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25857775|NCT00075634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25857776|NCT00075634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857777|NCT00075634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25857778|NCT00075634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24618037|NCT01046539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24618038|NCT01046539|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25857779|NCT00075634|Antimetabolites|antimetabolites|mesh-ancestor
24448657|NCT00312533|Protective Agents|protective agents|mesh-ancestor
24448658|NCT00312533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448659|NCT00312546|Enfuvirtide|enfuvirtide|mesh-list
24448660|NCT00312546|Valproic Acid|valproic acid|mesh-list
25857780|NCT00075647|Sirolimus|sirolimus|mesh-list
24612160|NCT01012232|Ropivacaine|ropivacaine|mesh-list
25857781|NCT00075647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25857782|NCT00075647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25857783|NCT00075647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25857784|NCT00075647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857785|NCT00075647|Antifungal Agents|antifungal agents|mesh-ancestor
25857786|NCT00075647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25857787|NCT00075647|Immunologic Factors|immunologic factors|mesh-ancestor
25857788|NCT00075647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268105|NCT02417493|Sympathomimetics|sympathomimetics|mesh-ancestor
25268106|NCT02417493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25268107|NCT02417649|Broncho-Vaxom|broncho-vaxom|mesh-list
25268108|NCT02417649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25268109|NCT02417649|Immunologic Factors|immunologic factors|mesh-ancestor
25268110|NCT02417649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268111|NCT02417467|Nicotine|nicotine|mesh-list
25268112|NCT02417467|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25268113|NCT02417467|Autonomic Agents|autonomic agents|mesh-ancestor
25857789|NCT00075673|Celecoxib|celecoxib|mesh-list
25857790|NCT00075673|Vinorelbine|vinorelbine|mesh-list
25857791|NCT00075673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25857792|NCT00075673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25271527|NCT02398552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25271528|NCT02398552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271529|NCT02398552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271530|NCT02398357|Nadroparin|nadroparin|mesh-list
25857793|NCT00075673|Analgesics|analgesics|mesh-ancestor
25857794|NCT00075673|Sensory System Agents|sensory system agents|mesh-ancestor
25857795|NCT00075673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25857796|NCT00075673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857797|NCT00075673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25857798|NCT00075673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25857799|NCT00075673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25857800|NCT00075673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25857801|NCT00075673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448665|NCT00312546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24739404|NCT01681134|Immunologic Factors|immunologic factors|mesh-ancestor
24448666|NCT00312546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448667|NCT00312546|Antimanic Agents|antimanic agents|mesh-ancestor
24448675|NCT00312546|Antiviral Agents|antiviral agents|mesh-ancestor
24448676|NCT00312546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24448677|NCT00312598|Aripiprazole|aripiprazole|mesh-list
24448678|NCT00312598|Antidepressive Agents|antidepressive agents|mesh-ancestor
25857802|NCT00075673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857803|NCT00075673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25857804|NCT00075673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857805|NCT00075673|Tubulin Modulators|tubulin modulators|mesh-ancestor
25857806|NCT00075673|Antimitotic Agents|antimitotic agents|mesh-ancestor
25857807|NCT00075673|Mitosis Modulators|mitosis modulators|mesh-ancestor
25857808|NCT00075686|Gemcitabine|gemcitabine|mesh-list
25857809|NCT00075686|Cetuximab|cetuximab|mesh-list
25857810|NCT00075686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25857811|NCT00075686|Antimetabolites|antimetabolites|mesh-ancestor
25857812|NCT00075686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857813|NCT00075686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24829614|NCT02153437|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24726137|NCT01601938|Selenium|selenium|mesh-list
25857814|NCT00075686|Antiviral Agents|antiviral agents|mesh-ancestor
25857815|NCT00075686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25857816|NCT00075686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857817|NCT00075686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25857818|NCT00075686|Immunologic Factors|immunologic factors|mesh-ancestor
25857819|NCT00075686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857820|NCT00075686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25857821|NCT00075699|Cisplatin|cisplatin|mesh-list
25857822|NCT00075699|Vincristine|vincristine|mesh-list
25857823|NCT00075699|Vinorelbine|vinorelbine|mesh-list
25857824|NCT00075699|Mitomycins|mitomycins|mesh-list
25857825|NCT00075699|Mitomycin|mitomycin|mesh-list
25857826|NCT00075699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857827|NCT00075699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25857828|NCT00075699|Tubulin Modulators|tubulin modulators|mesh-ancestor
25857829|NCT00075699|Antimitotic Agents|antimitotic agents|mesh-ancestor
25857830|NCT00075699|Mitosis Modulators|mitosis modulators|mesh-ancestor
25857831|NCT00075699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857832|NCT00075699|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25857833|NCT00075699|Alkylating Agents|alkylating agents|mesh-ancestor
25857834|NCT00075699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25857835|NCT00075699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857836|NCT00075712|Paclitaxel|paclitaxel|mesh-list
25857837|NCT00075712|Carboplatin|carboplatin|mesh-list
25857838|NCT00075712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25857839|NCT00075712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857840|NCT00075712|Tubulin Modulators|tubulin modulators|mesh-ancestor
25857841|NCT00075712|Antimitotic Agents|antimitotic agents|mesh-ancestor
24829615|NCT02153437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25857842|NCT00075712|Mitosis Modulators|mitosis modulators|mesh-ancestor
25857843|NCT00075712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857844|NCT00075738|Leucovorin|leucovorin|mesh-list
25425067|NCT02177071|Mercaptopurine|mercaptopurine|mesh-list
25664712|NCT01674010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25664713|NCT01674010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664714|NCT01674010|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25664715|NCT01674010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25664716|NCT01674010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25664717|NCT01674010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25664718|NCT01674010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25664719|NCT01674010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25268115|NCT02417467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268116|NCT02417467|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25268118|NCT02417467|Cholinergic Agents|cholinergic agents|mesh-ancestor
25857845|NCT00075738|Cisplatin|cisplatin|mesh-list
25857846|NCT00075738|Fluorouracil|fluorouracil|mesh-list
25857847|NCT00075738|Irinotecan|irinotecan|mesh-list
25857848|NCT00075738|Calcium|calcium|mesh-list
25857849|NCT00075738|Levoleucovorin|levoleucovorin|mesh-list
25857850|NCT00075738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857851|NCT00075738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25857852|NCT00075738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857853|NCT00075738|Antimetabolites|antimetabolites|mesh-ancestor
24651241|NCT01230697|Sorafenib|sorafenib|mesh-list
25857854|NCT00075738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857855|NCT00075738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25857856|NCT00075738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25857857|NCT00075738|Immunologic Factors|immunologic factors|mesh-ancestor
25857858|NCT00075738|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25857859|NCT00075738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25857860|NCT00075738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857861|NCT00075738|Antidotes|antidotes|mesh-ancestor
25857862|NCT00075738|Protective Agents|protective agents|mesh-ancestor
25857863|NCT00075738|Vitamin B Complex|vitamin b complex|mesh-ancestor
25857864|NCT00075738|Vitamins|vitamins|mesh-ancestor
25857865|NCT00075738|Micronutrients|micronutrients|mesh-ancestor
25857866|NCT00075751|Gemcitabine|gemcitabine|mesh-list
25857867|NCT00075751|Carboplatin|carboplatin|mesh-list
25857868|NCT00075751|Bortezomib|bortezomib|mesh-list
25857869|NCT00075751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857870|NCT00075751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25857871|NCT00075751|Antimetabolites|antimetabolites|mesh-ancestor
25857872|NCT00075751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857873|NCT00075751|Antiviral Agents|antiviral agents|mesh-ancestor
25857874|NCT00075751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25857875|NCT00075751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857876|NCT00075751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25857877|NCT00075751|Immunologic Factors|immunologic factors|mesh-ancestor
25857878|NCT00075751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857879|NCT00075777|Valproic Acid|valproic acid|mesh-list
25857880|NCT00075777|Anticonvulsants|anticonvulsants|mesh-ancestor
25857881|NCT00075777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857882|NCT00075777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857883|NCT00075777|GABA Agents|gaba agents|mesh-ancestor
25857884|NCT00075777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24739705|NCT01683552|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24739706|NCT01683552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24739707|NCT01683552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857885|NCT00075777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829617|NCT02153437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24829618|NCT02153437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829619|NCT02153437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829620|NCT02153437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24829621|NCT02153437|Sympatholytics|sympatholytics|mesh-ancestor
24829622|NCT02153437|Autonomic Agents|autonomic agents|mesh-ancestor
24829623|NCT02153437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24829624|NCT02153450|Metformin|metformin|mesh-list
24829625|NCT02153450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24829626|NCT02153450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857886|NCT00075777|Antimanic Agents|antimanic agents|mesh-ancestor
25857887|NCT00075777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25857888|NCT00075777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25857889|NCT00075777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25857890|NCT00075855|Testosterone|testosterone|mesh-list
24739709|NCT01683552|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24739710|NCT01683552|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24739711|NCT01683552|Histamine Antagonists|histamine antagonists|mesh-ancestor
24739712|NCT01683552|Histamine Agents|histamine agents|mesh-ancestor
24739714|NCT01683656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24739715|NCT01683656|Antimetabolites|antimetabolites|mesh-ancestor
24496380|NCT00504413|Narcotics|narcotics|mesh-ancestor
25857891|NCT00075855|Androgens|androgens|mesh-ancestor
25857892|NCT00075855|Hormones|hormones|mesh-ancestor
25857893|NCT00075855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25857894|NCT00075855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857895|NCT00075868|Octreotide|octreotide|mesh-list
25857905|NCT00075907|Ritonavir|ritonavir|mesh-list
25857906|NCT00075907|Lopinavir|lopinavir|mesh-list
25857907|NCT00075907|Efavirenz|efavirenz|mesh-list
25857908|NCT00075907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25857909|NCT00075907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25857910|NCT00075907|Protease Inhibitors|protease inhibitors|mesh-ancestor
25857911|NCT00075907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25268121|NCT02417389|Alendronate|alendronate|mesh-list
25268122|NCT02417389|Cinacalcet|cinacalcet|mesh-list
25268123|NCT02417389|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25268124|NCT02417389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268125|NCT02417389|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25268126|NCT02417389|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25268127|NCT02417389|Hormone Antagonists|hormone antagonists|mesh-ancestor
25268128|NCT02417389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25268129|NCT02417090|Metformin|metformin|mesh-list
25268130|NCT02417090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25268131|NCT02417090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268132|NCT02417077|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25268133|NCT02417077|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25268134|NCT02417077|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25268135|NCT02417077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25268136|NCT02417077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268137|NCT02417077|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25268138|NCT02417077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25268139|NCT02417077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268140|NCT02417077|Cholinergic Agents|cholinergic agents|mesh-ancestor
24618098|NCT01046786|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24943932|NCT03966066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24943933|NCT03966066|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25664720|NCT01674010|GABA Agents|gaba agents|mesh-ancestor
25664721|NCT01674010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25664722|NCT01674010|Antimanic Agents|antimanic agents|mesh-ancestor
25664723|NCT01674010|Vitamin B Complex|vitamin b complex|mesh-ancestor
25664724|NCT01674010|Vitamins|vitamins|mesh-ancestor
25664725|NCT01674010|Micronutrients|micronutrients|mesh-ancestor
25664726|NCT01674062|Trastuzumab|trastuzumab|mesh-list
25664727|NCT01674062|Pertuzumab|pertuzumab|mesh-list
25664728|NCT01674062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25664729|NCT01674062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664730|NCT01674569|Ranibizumab|ranibizumab|mesh-list
25857914|NCT00075907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24393259|NCT00129298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24393260|NCT00129298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25857915|NCT00075907|Antiviral Agents|antiviral agents|mesh-ancestor
25857916|NCT00075907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25857917|NCT00075907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25857918|NCT00075907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25857919|NCT00075907|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25857920|NCT00075907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25857921|NCT00075907|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24829632|NCT02153541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24829633|NCT02153541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829634|NCT02153541|Sensory System Agents|sensory system agents|mesh-ancestor
25857922|NCT00075907|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25857923|NCT00075907|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25857924|NCT00075907|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25857925|NCT00075907|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25857926|NCT00075933|Beta-lapachone|beta-lapachone|mesh-list
25857927|NCT00075933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25857928|NCT00075933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25857929|NCT00075933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25857930|NCT00075933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25857931|NCT00075933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857932|NCT00075933|Antiviral Agents|antiviral agents|mesh-ancestor
25857933|NCT00075959|Disufenton sodium|disufenton sodium|mesh-list
25857934|NCT00075959|Antioxidants|antioxidants|mesh-ancestor
25857935|NCT00075959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857936|NCT00075959|Protective Agents|protective agents|mesh-ancestor
25857937|NCT00075959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857938|NCT00075972|Nicotine|nicotine|mesh-list
25857939|NCT00075972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25857940|NCT00075972|Autonomic Agents|autonomic agents|mesh-ancestor
25857941|NCT00075972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25857942|NCT00075972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857943|NCT00075972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25268141|NCT02417077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25268142|NCT02417116|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25268143|NCT02417116|Hyaluronic Acid|hyaluronic acid|mesh-list
25268144|NCT02417116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25268145|NCT02417116|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25268146|NCT02417116|Immunologic Factors|immunologic factors|mesh-ancestor
25268147|NCT02417116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268148|NCT02417116|Viscosupplements|viscosupplements|mesh-ancestor
25268149|NCT02417116|Protective Agents|protective agents|mesh-ancestor
25268150|NCT02417298|Ketamine|ketamine|mesh-list
25268151|NCT02417298|Analgesics|analgesics|mesh-ancestor
25268152|NCT02417298|Sensory System Agents|sensory system agents|mesh-ancestor
25857944|NCT00075972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25857945|NCT00075972|Cholinergic Agents|cholinergic agents|mesh-ancestor
25857946|NCT00075972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25857947|NCT00075972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857948|NCT00075998|Interferons|interferons|mesh-list
25857949|NCT00075998|Interferon-gamma|interferon-gamma|mesh-list
25857950|NCT00075998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857951|NCT00075998|Antiviral Agents|antiviral agents|mesh-ancestor
25857952|NCT00075998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25857953|NCT00076115|Risperidone|risperidone|mesh-list
25857954|NCT00076115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25857955|NCT00076115|Serotonin Agents|serotonin agents|mesh-ancestor
24448727|NCT00312819|Disulfiram|disulfiram|mesh-list
24448728|NCT00312819|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24448729|NCT00312819|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25271608|NCT02397772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25271609|NCT02397772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25271610|NCT02397772|Anticestodal Agents|anticestodal agents|mesh-ancestor
25271611|NCT02397772|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25857956|NCT00076115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25857957|NCT00076115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857958|NCT00076115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857959|NCT00076115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25857960|NCT00076115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25857961|NCT00076115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25857962|NCT00076115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25857963|NCT00076115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25857964|NCT00076115|Dopamine Agents|dopamine agents|mesh-ancestor
25857965|NCT00076206|Sirolimus|sirolimus|mesh-list
25857966|NCT00076206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25857967|NCT00076206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25857968|NCT00076206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24692688|NCT01415765|Tubulin Modulators|tubulin modulators|mesh-ancestor
25857969|NCT00076206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857970|NCT00076206|Antifungal Agents|antifungal agents|mesh-ancestor
25857971|NCT00076206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25857972|NCT00076206|Immunologic Factors|immunologic factors|mesh-ancestor
25857973|NCT00076206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25857974|NCT00076232|Acyclovir|acyclovir|mesh-list
25857975|NCT00076232|Antiviral Agents|antiviral agents|mesh-ancestor
25857976|NCT00076232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25857977|NCT00076284|Aplaviroc|aplaviroc|mesh-list
25857978|NCT00076284|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25857979|NCT00076284|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25857980|NCT00076284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25857981|NCT00076284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25857982|NCT00076284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25857983|NCT00076284|Antiviral Agents|antiviral agents|mesh-ancestor
25857984|NCT00076284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25857985|NCT00076323|Primaquine|primaquine|mesh-list
25857986|NCT00076323|Antimalarials|antimalarials|mesh-ancestor
25857987|NCT00076323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25857988|NCT00076323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25857989|NCT00076323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24829646|NCT02153567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24829647|NCT02153567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829648|NCT02153567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24829649|NCT02153567|Serotonin Agents|serotonin agents|mesh-ancestor
24829650|NCT02153567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829651|NCT02153567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24829652|NCT02153567|Antidepressive Agents|antidepressive agents|mesh-ancestor
24829653|NCT02153567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24829654|NCT02153593|Tranexamic Acid|tranexamic acid|mesh-list
25857990|NCT00076349|Rituximab|rituximab|mesh-list
25857991|NCT00076349|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25857992|NCT00076349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25857993|NCT00076349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25857994|NCT00076349|Immunologic Factors|immunologic factors|mesh-ancestor
25857995|NCT00076349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268153|NCT02417298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24456853|NCT00332397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24456854|NCT00332397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664731|NCT01674569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25664732|NCT01674569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25664733|NCT01674569|Growth Substances|growth substances|mesh-ancestor
25664734|NCT01674569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664735|NCT01674569|Growth Inhibitors|growth inhibitors|mesh-ancestor
25664736|NCT01674569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664737|NCT01674621|Abaloparatide|abaloparatide|mesh-list
25664738|NCT01674621|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
25664739|NCT01674621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25271630|NCT02397382|Caffeine|caffeine|mesh-list
25271631|NCT02397382|Omeprazole|omeprazole|mesh-list
25271632|NCT02397382|Warfarin|warfarin|mesh-list
25857996|NCT00076349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25857997|NCT00076349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25857998|NCT00076349|Alkylating Agents|alkylating agents|mesh-ancestor
25857999|NCT00076349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740274|NCT01687439|Antimitotic Agents|antimitotic agents|mesh-ancestor
24740275|NCT01687439|Mitosis Modulators|mitosis modulators|mesh-ancestor
25858000|NCT00076362|Octreotide|octreotide|mesh-list
25858001|NCT00076362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25858002|NCT00076362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25858003|NCT00076362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393353|NCT00129818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25858004|NCT00076388|Docetaxel|docetaxel|mesh-list
25858005|NCT00076388|Gefitinib|gefitinib|mesh-list
25858006|NCT00076388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858007|NCT00076388|Tubulin Modulators|tubulin modulators|mesh-ancestor
25858008|NCT00076388|Antimitotic Agents|antimitotic agents|mesh-ancestor
25858009|NCT00076388|Mitosis Modulators|mitosis modulators|mesh-ancestor
25858010|NCT00076388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858011|NCT00076388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25858012|NCT00076388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858013|NCT00076401|Motexafin gadolinium|motexafin gadolinium|mesh-list
25858014|NCT00076401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858015|NCT00076401|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25858016|NCT00076401|Dermatologic Agents|dermatologic agents|mesh-ancestor
24829662|NCT02153606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24829663|NCT02153606|Protective Agents|protective agents|mesh-ancestor
24829664|NCT02153606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829665|NCT02153658|Chlorhexidine|chlorhexidine|mesh-list
24829666|NCT02153658|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25858017|NCT00076414|Acetylcholine|acetylcholine|mesh-list
25858018|NCT00076414|Vasodilator Agents|vasodilator agents|mesh-ancestor
25858019|NCT00076414|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25858020|NCT00076414|Cholinergic Agents|cholinergic agents|mesh-ancestor
25858021|NCT00076414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24740313|NCT01687751|Sensory System Agents|sensory system agents|mesh-ancestor
24740314|NCT01687751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740315|NCT01687751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24740316|NCT01687751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24740317|NCT01687751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25858022|NCT00076414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858023|NCT00076414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858024|NCT00076440|Leuprolide|leuprolide|mesh-list
25858025|NCT00076440|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25858026|NCT00076440|Fertility Agents|fertility agents|mesh-ancestor
25858027|NCT00076440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25858028|NCT00076440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858029|NCT00076440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25858030|NCT00076440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25268154|NCT02417298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268155|NCT02417298|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25268156|NCT02417298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25268157|NCT02417298|Anesthetics, General|anesthetics, general|mesh-ancestor
25268158|NCT02417298|Anesthetics|anesthetics|mesh-ancestor
25268159|NCT02417298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25268160|NCT02417298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25268161|NCT02417298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25664740|NCT01674621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664741|NCT01674621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25664742|NCT01674647|Vitamin K|vitamin k|mesh-list
25664743|NCT01674647|Rivaroxaban|rivaroxaban|mesh-list
25664744|NCT01674647|Vitamins|vitamins|mesh-ancestor
25664745|NCT01674647|Micronutrients|micronutrients|mesh-ancestor
25664746|NCT01674647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858031|NCT00076492|Coenzyme Q10|coenzyme q10|mesh-list
25858032|NCT00076492|Vitamins|vitamins|mesh-ancestor
25858033|NCT00076492|Micronutrients|micronutrients|mesh-ancestor
24454789|NCT03690544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858034|NCT00076492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858035|NCT00076518|Fenofibrate|fenofibrate|mesh-list
25858036|NCT00076518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25858037|NCT00076518|Antimetabolites|antimetabolites|mesh-ancestor
25858038|NCT00076518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858039|NCT00076518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25858040|NCT00076531|Leuprolide|leuprolide|mesh-list
25858041|NCT00076531|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25858042|NCT00076531|Fertility Agents|fertility agents|mesh-ancestor
25858043|NCT00076531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25858044|NCT00076531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858045|NCT00076531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25858046|NCT00076531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858047|NCT00076544|Ziconotide|ziconotide|mesh-list
25858048|NCT00076544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25858049|NCT00076544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25858050|NCT00076544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858051|NCT00076544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24829668|NCT02153658|Disinfectants|disinfectants|mesh-ancestor
24829670|NCT02153762|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24829671|NCT02153762|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24829672|NCT02153762|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24829673|NCT02153762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24829674|NCT02153866|Vaccines|vaccines|mesh-list
24829675|NCT02153866|Immunologic Factors|immunologic factors|mesh-ancestor
24829676|NCT02153866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829677|NCT02153879|Niacin|niacin|mesh-list
24740331|NCT01687868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24740437|NCT01688518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740438|NCT01688518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24740439|NCT01688518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24740452|NCT01688570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740453|NCT01688570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24740454|NCT01688570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740455|NCT01688570|Analgesics|analgesics|mesh-ancestor
24740456|NCT01688570|Sensory System Agents|sensory system agents|mesh-ancestor
24740457|NCT01688570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740458|NCT01688570|Antidepressive Agents|antidepressive agents|mesh-ancestor
24829678|NCT02153879|Fenofibrate|fenofibrate|mesh-list
24829679|NCT02153879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24829680|NCT02153879|Antimetabolites|antimetabolites|mesh-ancestor
24829681|NCT02153879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829682|NCT02153879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24829683|NCT02153879|Vasodilator Agents|vasodilator agents|mesh-ancestor
24829684|NCT02153879|Vitamin B Complex|vitamin b complex|mesh-ancestor
24829685|NCT02153879|Vitamins|vitamins|mesh-ancestor
24829686|NCT02153879|Micronutrients|micronutrients|mesh-ancestor
25858052|NCT00076544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858053|NCT00076544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25268165|NCT02417207|Antiviral Agents|antiviral agents|mesh-ancestor
25268166|NCT02417207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25268167|NCT02416999|Bevacizumab|bevacizumab|mesh-list
25268168|NCT02416999|Temozolomide|temozolomide|mesh-list
24482617|NCT00440102|Ketamine|ketamine|mesh-list
24482618|NCT00440102|Etomidate|etomidate|mesh-list
25858055|NCT00076544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25268169|NCT02416999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25268170|NCT02416999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25268171|NCT02416999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25268172|NCT02416999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25268173|NCT02416999|Growth Substances|growth substances|mesh-ancestor
25268174|NCT02416999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268175|NCT02416999|Growth Inhibitors|growth inhibitors|mesh-ancestor
25268176|NCT02416999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25268177|NCT02416999|Alkylating Agents|alkylating agents|mesh-ancestor
25268178|NCT02416999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268179|NCT02417337|Acetaminophen|acetaminophen|mesh-list
25268180|NCT02417337|Ibuprofen|ibuprofen|mesh-list
25268181|NCT02417337|Diclofenac|diclofenac|mesh-list
25858056|NCT00076544|Analgesics|analgesics|mesh-ancestor
25858057|NCT00076544|Sensory System Agents|sensory system agents|mesh-ancestor
25858058|NCT00076544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25858059|NCT00076609|Capecitabine|capecitabine|mesh-list
25858060|NCT00076609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25858061|NCT00076609|Antimetabolites|antimetabolites|mesh-ancestor
25858062|NCT00076609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858063|NCT00076609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858064|NCT00076635|Interferons|interferons|mesh-list
25858065|NCT00076635|Interferon-gamma|interferon-gamma|mesh-list
25858066|NCT00076635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858067|NCT00076635|Antiviral Agents|antiviral agents|mesh-ancestor
25858068|NCT00076635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25858069|NCT00076674|Levodopa|levodopa|mesh-list
25858070|NCT00076674|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25858071|NCT00076674|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25858072|NCT00076674|Dopamine Agents|dopamine agents|mesh-ancestor
25858073|NCT00076674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25858074|NCT00076674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858075|NCT00076674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858076|NCT00076726|Infliximab|infliximab|mesh-list
25858077|NCT00076726|Dermatologic Agents|dermatologic agents|mesh-ancestor
25858078|NCT00076726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25858079|NCT00076726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25858080|NCT00076791|Tenofovir|tenofovir|mesh-list
25858081|NCT00076791|Emtricitabine|emtricitabine|mesh-list
25858082|NCT00076791|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25858083|NCT00076791|Antiviral Agents|antiviral agents|mesh-ancestor
25858084|NCT00076791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25858085|NCT00076791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25858086|NCT00076791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25858087|NCT00076791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858088|NCT00076791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858089|NCT00076791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25858090|NCT00076791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25858091|NCT00076856|Temozolomide|temozolomide|mesh-list
25858092|NCT00076856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25858093|NCT00076856|Alkylating Agents|alkylating agents|mesh-ancestor
25858094|NCT00076856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664747|NCT01674647|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25664748|NCT01674647|Antithrombins|antithrombins|mesh-ancestor
25664749|NCT01674647|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25664750|NCT01674647|Protease Inhibitors|protease inhibitors|mesh-ancestor
25664751|NCT01674647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664752|NCT01674647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664753|NCT01674647|Anticoagulants|anticoagulants|mesh-ancestor
25664754|NCT01674647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25664755|NCT01674647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25664756|NCT01674647|Hemostatics|hemostatics|mesh-ancestor
25664757|NCT01674647|Coagulants|coagulants|mesh-ancestor
25664758|NCT01674712|Simvastatin|simvastatin|mesh-list
25664759|NCT01674712|Fenofibrate|fenofibrate|mesh-list
25664760|NCT01674712|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25664761|NCT01674712|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25664762|NCT01674712|Antimetabolites|antimetabolites|mesh-ancestor
25268183|NCT02417337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25268184|NCT02417337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25268185|NCT02417337|Analgesics|analgesics|mesh-ancestor
25268186|NCT02417337|Sensory System Agents|sensory system agents|mesh-ancestor
25268187|NCT02417337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25858095|NCT00076856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858096|NCT00076869|Amphotericin B|amphotericin b|mesh-list
25858097|NCT00076869|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25858098|NCT00076869|Caspofungin|caspofungin|mesh-list
25858099|NCT00076869|Amebicides|amebicides|mesh-ancestor
25858100|NCT00076869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25858101|NCT00076869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25858102|NCT00076869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25858103|NCT00076869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25858104|NCT00076869|Antifungal Agents|antifungal agents|mesh-ancestor
25858105|NCT00076869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858106|NCT00076869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858107|NCT00076960|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
25858108|NCT00076960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858109|NCT00076960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448756|NCT00313001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24448757|NCT00313053|Vincristine|vincristine|mesh-list
24741128|NCT01692158|Heparin|heparin|mesh-list
24448761|NCT00313053|Antimitotic Agents|antimitotic agents|mesh-ancestor
25858110|NCT00076986|Carmustine|carmustine|mesh-list
25858111|NCT00076986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25858112|NCT00076986|Alkylating Agents|alkylating agents|mesh-ancestor
25858113|NCT00076986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858114|NCT00076986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858115|NCT00077025|Gefitinib|gefitinib|mesh-list
25858116|NCT00077025|Anastrozole|anastrozole|mesh-list
24829695|NCT02153944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829696|NCT02153944|Dopamine Agents|dopamine agents|mesh-ancestor
24829697|NCT02153944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24829698|NCT02153944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24829699|NCT02153944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24829700|NCT02153944|Adrenergic Agents|adrenergic agents|mesh-ancestor
24829701|NCT02153944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24829702|NCT02153944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24829703|NCT02153944|Vasodilator Agents|vasodilator agents|mesh-ancestor
24829704|NCT02154074|Dexmedetomidine|dexmedetomidine|mesh-list
24829705|NCT02154074|Isoflurane|isoflurane|mesh-list
24829706|NCT02154074|Anesthetics|anesthetics|mesh-ancestor
25268188|NCT02417337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268189|NCT02417337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25268190|NCT02417337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25268191|NCT02417337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25268192|NCT02417337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25268193|NCT02417337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268194|NCT02417337|Antipyretics|antipyretics|mesh-ancestor
25268195|NCT02416817|Thrombin|thrombin|mesh-list
25268196|NCT02416817|Hemostatics|hemostatics|mesh-ancestor
25268197|NCT02416817|Coagulants|coagulants|mesh-ancestor
25268198|NCT02416674|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25664763|NCT01674712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664764|NCT01674712|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25268199|NCT02416674|Immunologic Factors|immunologic factors|mesh-ancestor
25425068|NCT02177071|Azathioprine|azathioprine|mesh-list
25858117|NCT00077025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858118|NCT00077025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24482820|NCT00440713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24482821|NCT00440713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24482822|NCT00440713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482823|NCT00440713|Dopamine Agonists|dopamine agonists|mesh-ancestor
24482824|NCT00440713|Dopamine Agents|dopamine agents|mesh-ancestor
25858119|NCT00077025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858120|NCT00077025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268200|NCT02416674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268206|NCT02416752|Analgesics|analgesics|mesh-ancestor
25268207|NCT02416752|Sensory System Agents|sensory system agents|mesh-ancestor
25268208|NCT02416752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25268209|NCT02416765|Glucagon|glucagon|mesh-list
25268210|NCT02416765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858121|NCT00077025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25858122|NCT00077025|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24829707|NCT02154074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24829708|NCT02154074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829709|NCT02154074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24829710|NCT02154074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24829711|NCT02154074|Analgesics|analgesics|mesh-ancestor
24829712|NCT02154074|Sensory System Agents|sensory system agents|mesh-ancestor
24829713|NCT02154074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24829714|NCT02154074|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24829715|NCT02154074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24829716|NCT02154074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24829717|NCT02154074|Adrenergic Agents|adrenergic agents|mesh-ancestor
24829755|NCT02154334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829756|NCT02154334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829757|NCT02154334|Sympathomimetics|sympathomimetics|mesh-ancestor
24829758|NCT02154334|Autonomic Agents|autonomic agents|mesh-ancestor
24829759|NCT02154334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24829760|NCT02154334|Nasal Decongestants|nasal decongestants|mesh-ancestor
25858123|NCT00077025|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25858124|NCT00077025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25858125|NCT00077025|Hormone Antagonists|hormone antagonists|mesh-ancestor
25858126|NCT00077025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25858127|NCT00077025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858128|NCT00077051|Cisplatin|cisplatin|mesh-list
25858129|NCT00077051|Tetrahydrouridine|tetrahydrouridine|mesh-list
25858130|NCT00077051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858131|NCT00077051|Antimetabolites|antimetabolites|mesh-ancestor
25858132|NCT00077051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858133|NCT00077077|Capecitabine|capecitabine|mesh-list
25858134|NCT00077077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25858135|NCT00077077|Antimetabolites|antimetabolites|mesh-ancestor
25858136|NCT00077077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858137|NCT00077077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858138|NCT00077103|Cisplatin|cisplatin|mesh-list
25858139|NCT00077103|Doxorubicin|doxorubicin|mesh-list
25858140|NCT00077103|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25858141|NCT00077103|Fosbretabulin|fosbretabulin|mesh-list
25858142|NCT00077103|Combretastatin|combretastatin|mesh-list
25858143|NCT00077103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858144|NCT00077103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25858145|NCT00077103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25858146|NCT00077103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25858147|NCT00077103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858148|NCT00077103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858149|NCT00077103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25858150|NCT00077103|Tubulin Modulators|tubulin modulators|mesh-ancestor
25858151|NCT00077103|Antimitotic Agents|antimitotic agents|mesh-ancestor
25858152|NCT00077103|Mitosis Modulators|mitosis modulators|mesh-ancestor
25858153|NCT00077116|Cytarabine|cytarabine|mesh-list
25858154|NCT00077116|Cyclophosphamide|cyclophosphamide|mesh-list
25664765|NCT01674712|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25664766|NCT01674712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664767|NCT01674725|Ribavirin|ribavirin|mesh-list
25664768|NCT01674725|Antimetabolites|antimetabolites|mesh-ancestor
25664769|NCT01674725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664770|NCT01674725|Antiviral Agents|antiviral agents|mesh-ancestor
25664771|NCT01674725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25664772|NCT01675050|Cyproheptadine|cyproheptadine|mesh-list
25858158|NCT00077116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25858159|NCT00077116|Immunologic Factors|immunologic factors|mesh-ancestor
25858160|NCT00077116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858161|NCT00077116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25858162|NCT00077116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25268211|NCT02416765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25275445|NCT02372188|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24740756|NCT01690104|Leprostatic Agents|leprostatic agents|mesh-ancestor
25858163|NCT00077116|Alkylating Agents|alkylating agents|mesh-ancestor
25858164|NCT00077116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740803|NCT01690325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24740804|NCT01690325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24740805|NCT01690325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24740806|NCT01690325|Growth Substances|growth substances|mesh-ancestor
24740807|NCT01690325|Growth Inhibitors|growth inhibitors|mesh-ancestor
24740808|NCT01690325|Tubulin Modulators|tubulin modulators|mesh-ancestor
24740809|NCT01690325|Antimitotic Agents|antimitotic agents|mesh-ancestor
24740810|NCT01690325|Mitosis Modulators|mitosis modulators|mesh-ancestor
24740811|NCT01690325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24740814|NCT01690325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858165|NCT00077116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858166|NCT00077116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25858167|NCT00077116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24829766|NCT02154334|Protective Agents|protective agents|mesh-ancestor
24829767|NCT02154360|Aprepitant|aprepitant|mesh-list
25858168|NCT00077116|Antimetabolites|antimetabolites|mesh-ancestor
25858169|NCT00077116|Antiviral Agents|antiviral agents|mesh-ancestor
25858170|NCT00077116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25858171|NCT00077116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25858172|NCT00077116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25858173|NCT00077116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25858174|NCT00077116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858175|NCT00077116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25858176|NCT00077129|Paclitaxel|paclitaxel|mesh-list
25858177|NCT00077129|Carboplatin|carboplatin|mesh-list
25858178|NCT00077129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25858179|NCT00077129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858180|NCT00077129|Tubulin Modulators|tubulin modulators|mesh-ancestor
25858181|NCT00077129|Antimitotic Agents|antimitotic agents|mesh-ancestor
25858182|NCT00077129|Mitosis Modulators|mitosis modulators|mesh-ancestor
25858183|NCT00077129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858184|NCT00077168|Tamoxifen|tamoxifen|mesh-list
25858185|NCT00077168|Anastrozole|anastrozole|mesh-list
25858186|NCT00077168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858187|NCT00077168|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24740829|NCT01690338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740831|NCT01690364|Cisatracurium|cisatracurium|mesh-list
24740832|NCT01690364|Vecuronium Bromide|vecuronium bromide|mesh-list
24740833|NCT01690364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24740834|NCT01690364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858188|NCT00077168|Hormone Antagonists|hormone antagonists|mesh-ancestor
25858189|NCT00077168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25858190|NCT00077168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858191|NCT00077168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25858192|NCT00077168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858193|NCT00077168|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25858194|NCT00077168|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25858195|NCT00077168|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25858196|NCT00077168|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25858197|NCT00077168|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25858198|NCT00077168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876412|NCT03549000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876413|NCT03549000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876414|NCT03546686|Nivolumab|nivolumab|mesh-list
25876415|NCT03546686|Ipilimumab|ipilimumab|mesh-list
25876416|NCT03546686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25876417|NCT03546686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25425069|NCT02177071|Infliximab|infliximab|mesh-list
25858199|NCT00077181|Cytarabine|cytarabine|mesh-list
25858200|NCT00077181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25858201|NCT00077181|Antimetabolites|antimetabolites|mesh-ancestor
25858202|NCT00077181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858203|NCT00077181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858204|NCT00077181|Antiviral Agents|antiviral agents|mesh-ancestor
25271773|NCT02396979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25271774|NCT02396979|Narcotics|narcotics|mesh-ancestor
25271775|NCT02396979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25271776|NCT02396979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271777|NCT02396979|Analgesics|analgesics|mesh-ancestor
25271778|NCT02396979|Sensory System Agents|sensory system agents|mesh-ancestor
25271779|NCT02396979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25271780|NCT02396979|Antitussive Agents|antitussive agents|mesh-ancestor
25271781|NCT02396979|Respiratory System Agents|respiratory system agents|mesh-ancestor
25271782|NCT02397070|Salicylic Acid|salicylic acid|mesh-list
25271783|NCT02397070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25858205|NCT00077181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25858206|NCT00077181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25268213|NCT02416765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25268214|NCT02416804|Buprenorphine|buprenorphine|mesh-list
25268215|NCT02416804|Tramadol|tramadol|mesh-list
25268216|NCT02416804|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25268217|NCT02416804|Narcotics|narcotics|mesh-ancestor
25268218|NCT02416804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25268219|NCT02416804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268220|NCT02416804|Analgesics|analgesics|mesh-ancestor
25268221|NCT02416804|Sensory System Agents|sensory system agents|mesh-ancestor
25268222|NCT02416804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25268223|NCT02416804|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24517290|NCT00607074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25858207|NCT00077181|Immunologic Factors|immunologic factors|mesh-ancestor
25858208|NCT00077181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858209|NCT00077194|Romidepsin|romidepsin|mesh-list
25858210|NCT00077194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25858211|NCT00077194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24829787|NCT02154438|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24829788|NCT02154438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25858212|NCT00077220|Paclitaxel|paclitaxel|mesh-list
25858213|NCT00077220|Carboplatin|carboplatin|mesh-list
24740909|NCT01690598|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24740910|NCT01690598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24740912|NCT01690598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740913|NCT01690598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24740914|NCT01690598|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24740915|NCT01690637|Oseltamivir|oseltamivir|mesh-list
24740916|NCT01690637|Antiviral Agents|antiviral agents|mesh-ancestor
24740917|NCT01690637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24740918|NCT01690637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829789|NCT02154438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829790|NCT02154464|Acetaminophen|acetaminophen|mesh-list
24693259|NCT01419262|Ergocalciferols|ergocalciferols|mesh-list
24448766|NCT00313079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448767|NCT00313079|Tubulin Modulators|tubulin modulators|mesh-ancestor
24448768|NCT00313079|Antimitotic Agents|antimitotic agents|mesh-ancestor
24448769|NCT00313079|Mitosis Modulators|mitosis modulators|mesh-ancestor
24448770|NCT00313079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448772|NCT00313105|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25858214|NCT00077220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25664774|NCT01675050|Dermatologic Agents|dermatologic agents|mesh-ancestor
25664775|NCT01675050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25664776|NCT01675050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25664777|NCT01675050|Histamine Antagonists|histamine antagonists|mesh-ancestor
25664778|NCT01675050|Histamine Agents|histamine agents|mesh-ancestor
25664779|NCT01675050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25664780|NCT01675050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664781|NCT01675050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664782|NCT01675050|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25664783|NCT01675050|Serotonin Agents|serotonin agents|mesh-ancestor
25664784|NCT01675050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25664785|NCT01675128|Irinotecan|irinotecan|mesh-list
25664786|NCT01675128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25664787|NCT01675128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25858221|NCT00077233|Fluorouracil|fluorouracil|mesh-list
25858222|NCT00077233|Oxaliplatin|oxaliplatin|mesh-list
24448776|NCT00313105|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24448777|NCT00313105|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24448778|NCT00313105|Cholinergic Agents|cholinergic agents|mesh-ancestor
24448779|NCT00313105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24448780|NCT00313105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451957|NCT00325429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24741011|NCT01691001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24451958|NCT00325429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451960|NCT00325455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24405666|NCT00167882|Mesalamine|mesalamine|mesh-list
24740951|NCT01690767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24740952|NCT01690767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740953|NCT01690780|Ibuprofen|ibuprofen|mesh-list
24740954|NCT01690780|Morphine|morphine|mesh-list
24740955|NCT01690780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24740956|NCT01690780|Narcotics|narcotics|mesh-ancestor
24740957|NCT01690780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24740958|NCT01690780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451961|NCT00325455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24829845|NCT02154854|Immunologic Factors|immunologic factors|mesh-ancestor
24829846|NCT02154854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829847|NCT02154854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24829879|NCT02155088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829881|NCT02155166|Lidocaine|lidocaine|mesh-list
24829882|NCT02155166|Anesthetics, Local|anesthetics, local|mesh-ancestor
24829883|NCT02155166|Anesthetics|anesthetics|mesh-ancestor
24829884|NCT02155166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24829885|NCT02155166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451973|NCT00325546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858223|NCT00077233|Irinotecan|irinotecan|mesh-list
25858224|NCT00077233|Cetuximab|cetuximab|mesh-list
25858225|NCT00077233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858226|NCT00077233|Antimetabolites|antimetabolites|mesh-ancestor
25268224|NCT02416687|Etonogestrel|etonogestrel|mesh-list
25268225|NCT02416687|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25268226|NCT02416687|Contraceptive Agents|contraceptive agents|mesh-ancestor
25268227|NCT02416687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25268228|NCT02416687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268229|NCT02416687|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25858227|NCT00077233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858228|NCT00077233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25858229|NCT00077233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858230|NCT00077233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24829890|NCT02155166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24829891|NCT02155166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24829892|NCT02155166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829893|NCT02155166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24829894|NCT02155166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24829896|NCT02155166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24829897|NCT02155166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24829898|NCT02155166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25858231|NCT00077233|Immunologic Factors|immunologic factors|mesh-ancestor
25858232|NCT00077233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25858233|NCT00077233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25858234|NCT00077233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858235|NCT00077233|Antidotes|antidotes|mesh-ancestor
25858236|NCT00077233|Protective Agents|protective agents|mesh-ancestor
25858237|NCT00077233|Vitamin B Complex|vitamin b complex|mesh-ancestor
25858238|NCT00077233|Vitamins|vitamins|mesh-ancestor
25858239|NCT00077233|Micronutrients|micronutrients|mesh-ancestor
25858240|NCT00077233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25858243|NCT00077246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25664789|NCT01675128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664790|NCT01675128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858244|NCT00077246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858245|NCT00077246|Tubulin Modulators|tubulin modulators|mesh-ancestor
25858246|NCT00077246|Antimitotic Agents|antimitotic agents|mesh-ancestor
25858247|NCT00077246|Mitosis Modulators|mitosis modulators|mesh-ancestor
25858248|NCT00077246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740959|NCT01690780|Analgesics|analgesics|mesh-ancestor
24740982|NCT01690884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740983|NCT01690884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740984|NCT01690884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24740985|NCT01690884|Vasodilator Agents|vasodilator agents|mesh-ancestor
24740986|NCT01690884|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24740987|NCT01690884|Purinergic Agonists|purinergic agonists|mesh-ancestor
24740988|NCT01690884|Purinergic Agents|purinergic agents|mesh-ancestor
24741008|NCT01691001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24741009|NCT01691001|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24741010|NCT01691001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24741013|NCT01691001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24741014|NCT01691001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741015|NCT01691053|Spironolactone|spironolactone|mesh-list
25858249|NCT00077259|Epothilones|epothilones|mesh-list
25858250|NCT00077259|Desoxyepothilone B|desoxyepothilone b|mesh-list
25858251|NCT00077259|Tubulin Modulators|tubulin modulators|mesh-ancestor
25858252|NCT00077259|Antimitotic Agents|antimitotic agents|mesh-ancestor
24829914|NCT02155439|Triamcinolone|triamcinolone|mesh-list
24829915|NCT02155439|Fluorouracil|fluorouracil|mesh-list
24829916|NCT02155439|Antimetabolites|antimetabolites|mesh-ancestor
24829917|NCT02155439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829918|NCT02155439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24829919|NCT02155439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24829920|NCT02155439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24829921|NCT02155439|Immunologic Factors|immunologic factors|mesh-ancestor
24829922|NCT02155439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829923|NCT02155439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25858253|NCT00077259|Mitosis Modulators|mitosis modulators|mesh-ancestor
25858254|NCT00077259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858255|NCT00077259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858256|NCT00077298|Bevacizumab|bevacizumab|mesh-list
24612269|NCT01013012|Hormones|hormones|mesh-ancestor
24829936|NCT02155504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24829937|NCT02155504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829938|NCT02155504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24829940|NCT02155517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25268230|NCT02416869|Dexamethasone|dexamethasone|mesh-list
25268231|NCT02416869|Dexamethasone acetate|dexamethasone acetate|mesh-list
25268232|NCT02416869|BB 1101|bb 1101|mesh-list
25268233|NCT02416869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25268234|NCT02416869|Antiemetics|antiemetics|mesh-ancestor
25268235|NCT02416869|Autonomic Agents|autonomic agents|mesh-ancestor
25268236|NCT02416869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25268237|NCT02416869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268238|NCT02416869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25268239|NCT02416869|Glucocorticoids|glucocorticoids|mesh-ancestor
25268240|NCT02416869|Hormones|hormones|mesh-ancestor
25268241|NCT02416869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24727171|NCT01608360|Lidocaine|lidocaine|mesh-list
25858257|NCT00077298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25858258|NCT00077298|Cetuximab|cetuximab|mesh-list
25858259|NCT00077298|Irinotecan|irinotecan|mesh-list
25858260|NCT00077298|Antibodies|antibodies|mesh-list
25858261|NCT00077298|Immunoglobulins|immunoglobulins|mesh-list
25858262|NCT00077298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25858263|NCT00077298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858264|NCT00077298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25664791|NCT01675141|Lenalidomide|lenalidomide|mesh-list
25664792|NCT01675141|Immunologic Factors|immunologic factors|mesh-ancestor
25664793|NCT01675141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664794|NCT01675141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24849241|NCT01767129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24849242|NCT01767129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24849243|NCT01767129|Adrenergic Agents|adrenergic agents|mesh-ancestor
24849244|NCT01767129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24849245|NCT01767129|Antimalarials|antimalarials|mesh-ancestor
24849246|NCT01767129|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25271854|NCT02396030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24829941|NCT02155517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24829942|NCT02155517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829943|NCT02155517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24829944|NCT02155517|Anesthetics, General|anesthetics, general|mesh-ancestor
24587474|NCT00895089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24829945|NCT02155517|Anesthetics|anesthetics|mesh-ancestor
24829946|NCT02155530|Atorvastatin|atorvastatin|mesh-list
24829947|NCT02155530|Pravastatin|pravastatin|mesh-list
24829948|NCT02155530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24829949|NCT02155530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24829950|NCT02155530|Antimetabolites|antimetabolites|mesh-ancestor
24829951|NCT02155530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829952|NCT02155530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24829954|NCT02155530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829965|NCT02155777|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24829966|NCT02155777|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25858265|NCT00077298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25858266|NCT00077298|Growth Substances|growth substances|mesh-ancestor
25858267|NCT00077298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741021|NCT01691053|Diuretics|diuretics|mesh-ancestor
24741072|NCT01691651|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24741073|NCT01691651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24741074|NCT01691651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741075|NCT01691651|Cholinergic Agents|cholinergic agents|mesh-ancestor
24741076|NCT01691651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25858268|NCT00077298|Growth Inhibitors|growth inhibitors|mesh-ancestor
25858269|NCT00077298|Immunologic Factors|immunologic factors|mesh-ancestor
25858270|NCT00077298|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25858271|NCT00077298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25858272|NCT00077298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405771|NCT00168402|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24405772|NCT00168402|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24741078|NCT01691651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25858273|NCT00077298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858274|NCT00077311|Cisplatin|cisplatin|mesh-list
25858275|NCT00077311|Docetaxel|docetaxel|mesh-list
25858276|NCT00077311|Darbepoetin alfa|darbepoetin alfa|mesh-list
25858277|NCT00077311|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
25858278|NCT00077311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858279|NCT00077311|Tubulin Modulators|tubulin modulators|mesh-ancestor
25858280|NCT00077311|Antimitotic Agents|antimitotic agents|mesh-ancestor
25858281|NCT00077311|Mitosis Modulators|mitosis modulators|mesh-ancestor
25858282|NCT00077311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858283|NCT00077311|Hematinics|hematinics|mesh-ancestor
25858284|NCT00077311|Protective Agents|protective agents|mesh-ancestor
25858285|NCT00077311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858286|NCT00077337|Romidepsin|romidepsin|mesh-list
25858287|NCT00077337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25858288|NCT00077337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858289|NCT00077350|Gemcitabine|gemcitabine|mesh-list
25858290|NCT00077350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25858291|NCT00077350|Antimetabolites|antimetabolites|mesh-ancestor
25858292|NCT00077350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858293|NCT00077350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858294|NCT00077350|Antiviral Agents|antiviral agents|mesh-ancestor
25858295|NCT00077350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25858296|NCT00077350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858297|NCT00077350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25664795|NCT01675141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25664796|NCT01675141|Growth Substances|growth substances|mesh-ancestor
25664797|NCT01675141|Growth Inhibitors|growth inhibitors|mesh-ancestor
25664798|NCT01675141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664799|NCT01675154|Orlistat|orlistat|mesh-list
25664800|NCT01675154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664801|NCT01675154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664802|NCT01675154|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25858298|NCT00077350|Immunologic Factors|immunologic factors|mesh-ancestor
25233763|NCT02575248|Fertility Agents|fertility agents|mesh-ancestor
25271880|NCT02396043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271881|NCT02396043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25271882|NCT02396043|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25271883|NCT02396043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25858299|NCT00077350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858300|NCT00077363|Capecitabine|capecitabine|mesh-list
25858301|NCT00077363|Tipifarnib|tipifarnib|mesh-list
25858302|NCT00077363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25858303|NCT00077363|Antimetabolites|antimetabolites|mesh-ancestor
25858304|NCT00077363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858305|NCT00077363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858306|NCT00077389|Cisplatin|cisplatin|mesh-list
24456855|NCT00332397|Antifungal Agents|antifungal agents|mesh-ancestor
24456856|NCT00332397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24741126|NCT01692132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741127|NCT01692132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618231|NCT01047215|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24618232|NCT01047215|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24943971|NCT03965117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618233|NCT01047215|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25858307|NCT00077389|Carboplatin|carboplatin|mesh-list
25858308|NCT00077389|Doxorubicin|doxorubicin|mesh-list
25858309|NCT00077389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25858310|NCT00077389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858311|NCT00077389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25858312|NCT00077389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25858313|NCT00077389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25858314|NCT00077389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830062|NCT02157181|Cladribine|cladribine|mesh-list
25858315|NCT00077389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858316|NCT00077402|Fenretinide|fenretinide|mesh-list
25858317|NCT00077402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858318|NCT00077402|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24829987|NCT02156570|Sofosbuvir|sofosbuvir|mesh-list
24829988|NCT02156570|Antimetabolites|antimetabolites|mesh-ancestor
24829989|NCT02156570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829990|NCT02156570|Antiviral Agents|antiviral agents|mesh-ancestor
24829991|NCT02156570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25858319|NCT00077402|Protective Agents|protective agents|mesh-ancestor
25858320|NCT00077402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858321|NCT00077415|Gemcitabine|gemcitabine|mesh-list
24830007|NCT02156596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830009|NCT02156661|Oxytocics|oxytocics|mesh-ancestor
25858322|NCT00077415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24830010|NCT02156661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24830011|NCT02156661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830012|NCT02156726|Cyclophosphamide|cyclophosphamide|mesh-list
24830013|NCT02156726|Fludarabine|fludarabine|mesh-list
24830014|NCT02156726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24830015|NCT02156726|Immunologic Factors|immunologic factors|mesh-ancestor
25858323|NCT00077415|Antimetabolites|antimetabolites|mesh-ancestor
25858324|NCT00077415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858325|NCT00077415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858326|NCT00077415|Antiviral Agents|antiviral agents|mesh-ancestor
25858327|NCT00077415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25858328|NCT00077415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664803|NCT01675154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25664804|NCT01675167|Buprenorphine|buprenorphine|mesh-list
25664805|NCT01675167|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25664806|NCT01675167|Narcotics|narcotics|mesh-ancestor
25664807|NCT01675167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25664808|NCT01675167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664809|NCT01675167|Analgesics|analgesics|mesh-ancestor
25664810|NCT01675167|Sensory System Agents|sensory system agents|mesh-ancestor
25664811|NCT01675167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25858329|NCT00077415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25858331|NCT00077415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858332|NCT00077428|Doxorubicin|doxorubicin|mesh-list
25858333|NCT00077428|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25858334|NCT00077428|Bortezomib|bortezomib|mesh-list
25858335|NCT00077428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25858336|NCT00077428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858337|NCT00077428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25858338|NCT00077428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25273612|NCT02384746|Ixazomib|ixazomib|mesh-list
25858339|NCT00077428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858340|NCT00077428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858341|NCT00077441|Bortezomib|bortezomib|mesh-list
25858342|NCT00077441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858343|NCT00077454|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24448809|NCT00313157|Diltiazem|diltiazem|mesh-list
25858344|NCT00077454|Temozolomide|temozolomide|mesh-list
25858345|NCT00077454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858346|NCT00077454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24448810|NCT00313157|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24448811|NCT00313157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24448812|NCT00313157|Sympatholytics|sympatholytics|mesh-ancestor
24393717|NCT00130858|Topotecan|topotecan|mesh-list
24830018|NCT02156726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24830019|NCT02156726|Alkylating Agents|alkylating agents|mesh-ancestor
24830020|NCT02156726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830021|NCT02156726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24830022|NCT02156726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25268246|NCT02416869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268247|NCT02416739|Niacinamide|niacinamide|mesh-list
25268248|NCT02416739|Niacin|niacin|mesh-list
25268249|NCT02416739|Nicotinic Acids|nicotinic acids|mesh-list
25268250|NCT02416739|Vitamin B Complex|vitamin b complex|mesh-ancestor
25268251|NCT02416739|Vitamins|vitamins|mesh-ancestor
25268252|NCT02416739|Micronutrients|micronutrients|mesh-ancestor
25268253|NCT02416739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741178|NCT01692652|Loteprednol Etabonate|loteprednol etabonate|mesh-list
24741179|NCT01692652|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24741181|NCT01692678|Trabectedin|trabectedin|mesh-list
24741182|NCT01692678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24741183|NCT01692678|Alkylating Agents|alkylating agents|mesh-ancestor
24741184|NCT01692678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741185|NCT01692678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24741186|NCT01692704|Gemcitabine|gemcitabine|mesh-list
24741187|NCT01692704|Floxuridine|floxuridine|mesh-list
24830034|NCT02156843|Pyridoxamine|pyridoxamine|mesh-list
24830035|NCT02156843|Vitamin B Complex|vitamin b complex|mesh-ancestor
24830036|NCT02156843|Vitamins|vitamins|mesh-ancestor
24830037|NCT02156843|Micronutrients|micronutrients|mesh-ancestor
24830038|NCT02156843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830039|NCT02156960|Denosumab|denosumab|mesh-list
24830040|NCT02156960|Teriparatide|teriparatide|mesh-list
24830041|NCT02156960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24727412|NCT01609673|Everolimus|everolimus|mesh-list
24448816|NCT00313157|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24448817|NCT00313157|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25858347|NCT00077454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858348|NCT00077454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858349|NCT00077454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25858350|NCT00077454|Alkylating Agents|alkylating agents|mesh-ancestor
25858351|NCT00077467|Bortezomib|bortezomib|mesh-list
24830042|NCT02156960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830043|NCT02156960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24830044|NCT02156999|Vitamin D|vitamin d|mesh-list
24830045|NCT02156999|Ibandronic Acid|ibandronic acid|mesh-list
24830046|NCT02156999|Vitamins|vitamins|mesh-ancestor
24830047|NCT02156999|Micronutrients|micronutrients|mesh-ancestor
24830048|NCT02156999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830049|NCT02156999|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24830050|NCT02157012|Tofacitinib|tofacitinib|mesh-list
25664812|NCT01675167|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24830051|NCT02157012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24830052|NCT02157012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664813|NCT01675297|Cholecalciferol|cholecalciferol|mesh-list
25664814|NCT01675297|Vitamin D|vitamin d|mesh-list
25664815|NCT01675297|Risedronic Acid|risedronic acid|mesh-list
24405877|NCT00168688|Trace Elements|trace elements|mesh-list
24741199|NCT01692717|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24741200|NCT01692717|Atorvastatin|atorvastatin|mesh-list
24741201|NCT01692717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24741202|NCT01692717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24741203|NCT01692717|Antimetabolites|antimetabolites|mesh-ancestor
24741204|NCT01692717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741205|NCT01692717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24741206|NCT01692717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24830054|NCT02157077|Aflibercept|aflibercept|mesh-list
24830055|NCT02157077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24830058|NCT02157077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830059|NCT02157077|Growth Inhibitors|growth inhibitors|mesh-ancestor
24830060|NCT02157077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24830061|NCT02157181|Rituximab|rituximab|mesh-list
24830063|NCT02157181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25858352|NCT00077467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858353|NCT00077493|Antibodies|antibodies|mesh-list
25858354|NCT00077493|Immunoglobulins|immunoglobulins|mesh-list
25858355|NCT00077493|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25858356|NCT00077493|Immunoconjugates|immunoconjugates|mesh-list
25858357|NCT00077493|Immunotoxins|immunotoxins|mesh-list
25858358|NCT00077493|Immunologic Factors|immunologic factors|mesh-ancestor
25268254|NCT02416739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25268255|NCT02416739|Antimetabolites|antimetabolites|mesh-ancestor
25268256|NCT02416739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268257|NCT02416739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25268258|NCT02416739|Vasodilator Agents|vasodilator agents|mesh-ancestor
25268259|NCT02416583|Oxytocin|oxytocin|mesh-list
25268260|NCT02416583|Dinoprostone|dinoprostone|mesh-list
25268261|NCT02416583|Oxytocics|oxytocics|mesh-ancestor
25268262|NCT02416583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24830074|NCT02157207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741207|NCT01692717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858359|NCT00077493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830076|NCT02157272|Rivaroxaban|rivaroxaban|mesh-list
24830077|NCT02157272|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24830078|NCT02157272|Antithrombins|antithrombins|mesh-ancestor
24830079|NCT02157272|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24830080|NCT02157272|Protease Inhibitors|protease inhibitors|mesh-ancestor
24830081|NCT02157272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830082|NCT02157272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830083|NCT02157272|Anticoagulants|anticoagulants|mesh-ancestor
24830085|NCT02157311|Lamivudine|lamivudine|mesh-list
24830086|NCT02157311|Emtricitabine|emtricitabine|mesh-list
24830087|NCT02157311|Efavirenz|efavirenz|mesh-list
24830088|NCT02157311|Lopinavir|lopinavir|mesh-list
24830089|NCT02157311|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24830090|NCT02157311|Darunavir|darunavir|mesh-list
24830091|NCT02157311|Abacavir|abacavir|mesh-list
24830092|NCT02157311|Rilpivirine|rilpivirine|mesh-list
24830093|NCT02157311|Etravirine|etravirine|mesh-list
24830094|NCT02157311|Antiviral Agents|antiviral agents|mesh-ancestor
24830095|NCT02157311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24830096|NCT02157311|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24830097|NCT02157311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24830098|NCT02157311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858360|NCT00077519|Tipifarnib|tipifarnib|mesh-list
25858361|NCT00077519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858362|NCT00077532|Ipilimumab|ipilimumab|mesh-list
25858363|NCT00077532|Freund's Adjuvant|freund's adjuvant|mesh-list
25858364|NCT00077532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25858365|NCT00077532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858366|NCT00077532|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25858367|NCT00077532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858368|NCT00077532|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25858369|NCT00077532|Immunologic Factors|immunologic factors|mesh-ancestor
25858370|NCT00077532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858371|NCT00077545|Cisplatin|cisplatin|mesh-list
25425147|NCT02166463|Vincristine|vincristine|mesh-list
25858372|NCT00077545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858373|NCT00077558|Fludarabine|fludarabine|mesh-list
24830102|NCT02157311|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24830103|NCT02157311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24830104|NCT02157311|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24830105|NCT02157311|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25858385|NCT00077584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858386|NCT00077597|Epoetin Alfa|epoetin alfa|mesh-list
25858387|NCT00077597|Hematinics|hematinics|mesh-ancestor
25858388|NCT00077688|Paclitaxel|paclitaxel|mesh-list
25858389|NCT00077688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25858390|NCT00077688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858391|NCT00077688|Tubulin Modulators|tubulin modulators|mesh-ancestor
25858392|NCT00077688|Antimitotic Agents|antimitotic agents|mesh-ancestor
25858393|NCT00077688|Mitosis Modulators|mitosis modulators|mesh-ancestor
25858394|NCT00077688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858395|NCT00077714|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25858396|NCT00077714|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25858397|NCT00077714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25268263|NCT02416583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268264|NCT02416427|Atorvastatin|atorvastatin|mesh-list
25268265|NCT02416427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25268266|NCT02416427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25268267|NCT02416427|Antimetabolites|antimetabolites|mesh-ancestor
25858398|NCT00077714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24454866|NCT03412591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24454867|NCT03412591|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
24454868|NCT03412591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25858399|NCT00077714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858400|NCT00077714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25858401|NCT00077714|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25858402|NCT00077714|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25858403|NCT00077714|Serotonin Agents|serotonin agents|mesh-ancestor
25858404|NCT00077714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25858405|NCT00077714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664816|NCT01675297|Etidronic Acid|etidronic acid|mesh-list
25664817|NCT01675297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25664818|NCT01675297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664819|NCT01675297|Vitamins|vitamins|mesh-ancestor
25664820|NCT01675297|Micronutrients|micronutrients|mesh-ancestor
25664821|NCT01675297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24830118|NCT02157337|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24830119|NCT02157337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830120|NCT02157415|Polihexanide|polihexanide|mesh-list
24830121|NCT02157415|Disinfectants|disinfectants|mesh-ancestor
24830122|NCT02157415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24830123|NCT02157428|Flumazenil|flumazenil|mesh-list
24830124|NCT02157428|Antidotes|antidotes|mesh-ancestor
24830125|NCT02157428|Protective Agents|protective agents|mesh-ancestor
24830126|NCT02157428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830127|NCT02157428|GABA Modulators|gaba modulators|mesh-ancestor
24830128|NCT02157428|GABA Agents|gaba agents|mesh-ancestor
24587734|NCT00896558|GABA Modulators|gaba modulators|mesh-ancestor
25858411|NCT00077727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858412|NCT00077727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858413|NCT00077727|Cholinergic Agents|cholinergic agents|mesh-ancestor
25858414|NCT00077727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25858415|NCT00077727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858416|NCT00077727|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25858417|NCT00077727|Autonomic Agents|autonomic agents|mesh-ancestor
25268272|NCT02416388|Cytarabine|cytarabine|mesh-list
25268273|NCT02416388|Cyclosporine|cyclosporine|mesh-list
25268274|NCT02416388|Mycophenolic Acid|mycophenolic acid|mesh-list
25268275|NCT02416388|Dexamethasone|dexamethasone|mesh-list
25268276|NCT02416388|Methotrexate|methotrexate|mesh-list
25268277|NCT02416388|Daunorubicin|daunorubicin|mesh-list
25268278|NCT02416388|Venetoclax|venetoclax|mesh-list
25268279|NCT02416388|Idarubicin|idarubicin|mesh-list
25268280|NCT02416388|Cyclosporins|cyclosporins|mesh-list
25268281|NCT02416388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25268282|NCT02416388|Antiemetics|antiemetics|mesh-ancestor
25268283|NCT02416388|Autonomic Agents|autonomic agents|mesh-ancestor
25268284|NCT02416388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25268285|NCT02416388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268286|NCT02416388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25268287|NCT02416388|Glucocorticoids|glucocorticoids|mesh-ancestor
25268288|NCT02416388|Hormones|hormones|mesh-ancestor
25858418|NCT00077727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25858419|NCT00077727|Nootropic Agents|nootropic agents|mesh-ancestor
25858420|NCT00077753|Enoxaparin|enoxaparin|mesh-list
25858421|NCT00077753|Enoxaparin sodium|enoxaparin sodium|mesh-list
24741312|NCT01693328|Anesthetics|anesthetics|mesh-ancestor
24943980|NCT03965247|Lithium Carbonate|lithium carbonate|mesh-list
25858422|NCT00077753|Anticoagulants|anticoagulants|mesh-ancestor
25858423|NCT00077753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25858424|NCT00077753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25858425|NCT00077753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858426|NCT00077779|Adalimumab|adalimumab|mesh-list
25858427|NCT00077779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25858428|NCT00077779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25858429|NCT00077792|Enoxaparin|enoxaparin|mesh-list
25858430|NCT00077792|Enoxaparin sodium|enoxaparin sodium|mesh-list
25858431|NCT00077792|Anticoagulants|anticoagulants|mesh-ancestor
25858432|NCT00077792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25664822|NCT01675297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25664823|NCT01675297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25664824|NCT01675297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664825|NCT01675531|Oxycodone|oxycodone|mesh-list
25664826|NCT01675531|Naloxone|naloxone|mesh-list
25664827|NCT01675531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25664828|NCT01675531|Narcotics|narcotics|mesh-ancestor
24830130|NCT02157428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830133|NCT02157467|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24830134|NCT02157467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25664829|NCT01675531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25858433|NCT00077792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24830135|NCT02157467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24830136|NCT02157467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24830137|NCT02157467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24830138|NCT02157467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830139|NCT02157467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830140|NCT02157467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24830141|NCT02157467|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25858434|NCT00077792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858435|NCT00077805|Enoxaparin|enoxaparin|mesh-list
25858436|NCT00077805|Enoxaparin sodium|enoxaparin sodium|mesh-list
25858437|NCT00077805|Anticoagulants|anticoagulants|mesh-ancestor
25858438|NCT00077805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25858439|NCT00077805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25858440|NCT00077805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858441|NCT00077818|Enoxaparin|enoxaparin|mesh-list
25858442|NCT00077818|Enoxaparin sodium|enoxaparin sodium|mesh-list
25858443|NCT00077818|Anticoagulants|anticoagulants|mesh-ancestor
25858444|NCT00077818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25858445|NCT00077818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25858446|NCT00077818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858447|NCT00077844|Enoxaparin|enoxaparin|mesh-list
25858448|NCT00077844|Enoxaparin sodium|enoxaparin sodium|mesh-list
25858449|NCT00077844|Anticoagulants|anticoagulants|mesh-ancestor
25858450|NCT00077844|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25858451|NCT00077844|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25858452|NCT00077844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858453|NCT00077870|Ocrelizumab|ocrelizumab|mesh-list
25858454|NCT00077870|Immunologic Factors|immunologic factors|mesh-ancestor
25858455|NCT00077870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858456|NCT00077883|Cisplatin|cisplatin|mesh-list
25858457|NCT00077883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24830143|NCT02157467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25858458|NCT00077948|Metoprolol|metoprolol|mesh-list
24448880|NCT00313482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24448881|NCT00313482|Immunologic Factors|immunologic factors|mesh-ancestor
24448882|NCT00313508|Vidarabine|vidarabine|mesh-list
25858459|NCT00077948|Enoximone|enoximone|mesh-list
25858460|NCT00077948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25858461|NCT00077948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25858462|NCT00077948|Sympatholytics|sympatholytics|mesh-ancestor
25858463|NCT00077948|Autonomic Agents|autonomic agents|mesh-ancestor
25858464|NCT00077948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25858465|NCT00077948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268290|NCT02416388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25268291|NCT02416388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858466|NCT00077948|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25858467|NCT00077948|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25858468|NCT00077948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25858469|NCT00077948|Adrenergic Agents|adrenergic agents|mesh-ancestor
25858470|NCT00077948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25858471|NCT00077948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858472|NCT00077948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25858473|NCT00077948|Vasodilator Agents|vasodilator agents|mesh-ancestor
25858474|NCT00077948|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25858475|NCT00077948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25664830|NCT01675531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664831|NCT01675531|Analgesics|analgesics|mesh-ancestor
25664832|NCT01675531|Sensory System Agents|sensory system agents|mesh-ancestor
25664833|NCT01675531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25664834|NCT01675531|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25664835|NCT01675622|Morphine|morphine|mesh-list
25664836|NCT01675622|Oxycodone|oxycodone|mesh-list
25664837|NCT01675622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25664838|NCT01675622|Narcotics|narcotics|mesh-ancestor
25664839|NCT01675622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25858476|NCT00077948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858477|NCT00077948|Protective Agents|protective agents|mesh-ancestor
25858478|NCT00077961|Alemtuzumab|alemtuzumab|mesh-list
25858479|NCT00077961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25858480|NCT00077961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858481|NCT00077987|Sunitinib|sunitinib|mesh-list
25858482|NCT00077987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858483|NCT00077987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25858484|NCT00077987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25858485|NCT00077987|Growth Substances|growth substances|mesh-ancestor
24741679|NCT05290493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858486|NCT00077987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858487|NCT00077987|Growth Inhibitors|growth inhibitors|mesh-ancestor
25858488|NCT00077987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25858489|NCT00077987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858490|NCT00077987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830152|NCT02157558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24830153|NCT02157558|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24830154|NCT02157558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24830155|NCT02157558|Histamine Antagonists|histamine antagonists|mesh-ancestor
24830156|NCT02157558|Histamine Agents|histamine agents|mesh-ancestor
24830157|NCT02157558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24830158|NCT02157558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830159|NCT02157558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830160|NCT02157571|Levofloxacin|levofloxacin|mesh-list
24830161|NCT02157571|Ofloxacin|ofloxacin|mesh-list
24830162|NCT02157571|Prulifloxacin|prulifloxacin|mesh-list
24830163|NCT02157571|Fluoroquinolones|fluoroquinolones|mesh-list
25858491|NCT00078000|Sunitinib|sunitinib|mesh-list
25858492|NCT00078000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858493|NCT00078000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25858494|NCT00078000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25858495|NCT00078000|Growth Substances|growth substances|mesh-ancestor
25858496|NCT00078000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858497|NCT00078000|Growth Inhibitors|growth inhibitors|mesh-ancestor
25858498|NCT00078000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25858499|NCT00078000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858500|NCT00078000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612336|NCT01013532|Aspirin|aspirin|mesh-list
25858501|NCT00078039|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24741680|NCT05290493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741681|NCT05290337|Zanubrutinib|zanubrutinib|mesh-list
24741682|NCT05290337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24741683|NCT05290337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24741685|NCT05290337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741686|NCT05290324|Midazolam|midazolam|mesh-list
25858502|NCT00078039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25858503|NCT00078039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25858504|NCT00078039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25858505|NCT00078039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858506|NCT00078039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25858507|NCT00078039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25858508|NCT00078039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25858509|NCT00078039|Serotonin Agents|serotonin agents|mesh-ancestor
25858510|NCT00078039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25858511|NCT00078039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858512|NCT00078039|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25858513|NCT00078039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25858514|NCT00078039|Dopamine Agents|dopamine agents|mesh-ancestor
25858515|NCT00078117|Buprenorphine|buprenorphine|mesh-list
25858516|NCT00078117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25858517|NCT00078117|Narcotics|narcotics|mesh-ancestor
25858518|NCT00078117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25858519|NCT00078117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830164|NCT02157571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24830165|NCT02157571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24830166|NCT02157571|Renal Agents|renal agents|mesh-ancestor
25268292|NCT02416388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25268293|NCT02416388|Abortifacient Agents|abortifacient agents|mesh-ancestor
25268294|NCT02416388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25268295|NCT02416388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24906655|NCT04338373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24830171|NCT02157571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858520|NCT00078117|Analgesics|analgesics|mesh-ancestor
25409516|NCT03373851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25858521|NCT00078117|Sensory System Agents|sensory system agents|mesh-ancestor
25858522|NCT00078117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25858524|NCT00078130|Buprenorphine|buprenorphine|mesh-list
24483646|NCT00444379|Antiviral Agents|antiviral agents|mesh-ancestor
24483647|NCT00444379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24943573|NCT03968588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24454026|NCT04520217|Imipramine|imipramine|mesh-list
25664840|NCT01675622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858525|NCT00078130|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25858526|NCT00078130|Naloxone|naloxone|mesh-list
25858527|NCT00078130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25858528|NCT00078130|Narcotics|narcotics|mesh-ancestor
25858529|NCT00078130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25858530|NCT00078130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858531|NCT00078130|Analgesics|analgesics|mesh-ancestor
25858532|NCT00078130|Sensory System Agents|sensory system agents|mesh-ancestor
25858533|NCT00078130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25858534|NCT00078130|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25858535|NCT00078182|Tenofovir|tenofovir|mesh-list
25858536|NCT00078182|Antiviral Agents|antiviral agents|mesh-ancestor
25858537|NCT00078182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25858538|NCT00078182|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25858539|NCT00078182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25858540|NCT00078182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858541|NCT00078182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858542|NCT00078182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25858543|NCT00078182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25858544|NCT00078195|Omalizumab|omalizumab|mesh-list
25858545|NCT00078195|Immunoglobulins|immunoglobulins|mesh-list
25858546|NCT00078195|Immunologic Factors|immunologic factors|mesh-list
25858547|NCT00078195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25858548|NCT00078195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858549|NCT00078195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25858550|NCT00078195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25858551|NCT00078195|Respiratory System Agents|respiratory system agents|mesh-ancestor
25858552|NCT00078234|Rituximab|rituximab|mesh-list
25858553|NCT00078234|Fludarabine|fludarabine|mesh-list
25858554|NCT00078234|Oblimersen|oblimersen|mesh-list
25858555|NCT00078234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25858556|NCT00078234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858557|NCT00078234|Immunologic Factors|immunologic factors|mesh-ancestor
25858558|NCT00078234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858559|NCT00078234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25858560|NCT00078247|Lamivudine|lamivudine|mesh-list
25858561|NCT00078247|Zidovudine|zidovudine|mesh-list
25858562|NCT00078247|Abacavir|abacavir|mesh-list
25858563|NCT00078247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25858564|NCT00078247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25858565|NCT00078247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858566|NCT00078247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858567|NCT00078247|Antiviral Agents|antiviral agents|mesh-ancestor
25858568|NCT00078247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24741829|NCT05292586|Hormones|hormones|mesh-ancestor
25858569|NCT00078247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25858570|NCT00078247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25858571|NCT00078247|Antimetabolites|antimetabolites|mesh-ancestor
25858572|NCT00078260|Pemetrexed|pemetrexed|mesh-list
25858573|NCT00078260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25268296|NCT02416388|Antimetabolites|antimetabolites|mesh-ancestor
25268297|NCT02416388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268298|NCT02416388|Dermatologic Agents|dermatologic agents|mesh-ancestor
25268299|NCT02416388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25268300|NCT02416388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25268301|NCT02416388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25268302|NCT02416388|Immunologic Factors|immunologic factors|mesh-ancestor
25268303|NCT02416388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25858574|NCT00078260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858575|NCT00078260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858576|NCT00078260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25664841|NCT01675622|Analgesics|analgesics|mesh-ancestor
25664842|NCT01675622|Sensory System Agents|sensory system agents|mesh-ancestor
25664843|NCT01675622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25664844|NCT01675635|Morphine|morphine|mesh-list
25664845|NCT01675635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25664846|NCT01675635|Narcotics|narcotics|mesh-ancestor
25664847|NCT01675635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25858577|NCT00078260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25858579|NCT00078351|Viscosupplements|viscosupplements|mesh-ancestor
25858580|NCT00078351|Protective Agents|protective agents|mesh-ancestor
25858581|NCT00078351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858582|NCT00078390|S 3304|s 3304|mesh-list
25858583|NCT00078390|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
25858584|NCT00078390|Protease Inhibitors|protease inhibitors|mesh-ancestor
25858585|NCT00078390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858586|NCT00078390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830173|NCT02157571|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24830174|NCT02157571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24830175|NCT02157571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24830176|NCT02157649|Phenylpropanolamine|phenylpropanolamine|mesh-list
24830177|NCT02157649|Codeine|codeine|mesh-list
24830178|NCT02157649|Guaifenesin|guaifenesin|mesh-list
24830179|NCT02157649|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
24830180|NCT02157649|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24830181|NCT02157649|Narcotics|narcotics|mesh-ancestor
24830182|NCT02157649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24830183|NCT02157649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830184|NCT02157649|Analgesics|analgesics|mesh-ancestor
24618263|NCT01047566|Digoxin|digoxin|mesh-list
24830185|NCT02157649|Sensory System Agents|sensory system agents|mesh-ancestor
24830186|NCT02157649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24830187|NCT02157649|Antitussive Agents|antitussive agents|mesh-ancestor
24830188|NCT02157649|Respiratory System Agents|respiratory system agents|mesh-ancestor
24830189|NCT02157649|Expectorants|expectorants|mesh-ancestor
24830190|NCT02157649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25858587|NCT00078442|Interferons|interferons|mesh-list
25858588|NCT00078442|Interferon-alpha|interferon-alpha|mesh-list
25858589|NCT00078442|Interferon alpha-2|interferon alpha-2|mesh-list
25858590|NCT00078442|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25858591|NCT00078442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858592|NCT00078442|Antiviral Agents|antiviral agents|mesh-ancestor
25858593|NCT00078442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25858594|NCT00078442|Immunologic Factors|immunologic factors|mesh-ancestor
24830191|NCT02157649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24830192|NCT02157649|Adrenergic Agents|adrenergic agents|mesh-ancestor
24830193|NCT02157649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24830194|NCT02157649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830195|NCT02157649|Appetite Depressants|appetite depressants|mesh-ancestor
24830196|NCT02157649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24830197|NCT02157649|Sympathomimetics|sympathomimetics|mesh-ancestor
24830198|NCT02157649|Autonomic Agents|autonomic agents|mesh-ancestor
25858595|NCT00078442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858596|NCT00078481|Idebenone|idebenone|mesh-list
25858597|NCT00078481|Antioxidants|antioxidants|mesh-ancestor
25858598|NCT00078481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858599|NCT00078481|Protective Agents|protective agents|mesh-ancestor
25858600|NCT00078481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858601|NCT00078546|Antibodies|antibodies|mesh-list
25858602|NCT00078546|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25858603|NCT00078546|Immunologic Factors|immunologic factors|mesh-ancestor
25858604|NCT00078546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858605|NCT00078572|Capecitabine|capecitabine|mesh-list
25858606|NCT00078572|Lapatinib|lapatinib|mesh-list
25858607|NCT00078572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25858608|NCT00078572|Antimetabolites|antimetabolites|mesh-ancestor
25858609|NCT00078572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858610|NCT00078572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24741881|NCT05291793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25858611|NCT00078572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25858612|NCT00078572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858613|NCT00078598|Rituximab|rituximab|mesh-list
25858614|NCT00078598|Tositumomab I-131|tositumomab i-131|mesh-list
25858615|NCT00078598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25858616|NCT00078598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858617|NCT00078598|Immunologic Factors|immunologic factors|mesh-ancestor
25858618|NCT00078598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858619|NCT00078598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25858620|NCT00078611|Natalizumab|natalizumab|mesh-list
25858621|NCT00078611|Immunologic Factors|immunologic factors|mesh-ancestor
25858622|NCT00078611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858623|NCT00078689|Daclizumab|daclizumab|mesh-list
25858624|NCT00078689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25858625|NCT00078689|Immunologic Factors|immunologic factors|mesh-ancestor
24830218|NCT02157792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24830222|NCT02157818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24694248|NCT01424709|Gemcitabine|gemcitabine|mesh-list
24830234|NCT02157818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24830235|NCT02157818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24830236|NCT02157818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24830237|NCT02157818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24830238|NCT02157818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25858626|NCT00078689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858627|NCT00078793|Etanercept|etanercept|mesh-list
25858628|NCT00078793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25858629|NCT00078793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25858630|NCT00078793|Analgesics|analgesics|mesh-ancestor
25858631|NCT00078793|Sensory System Agents|sensory system agents|mesh-ancestor
25858632|NCT00078793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25858633|NCT00078793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830239|NCT02157818|Anesthetics, General|anesthetics, general|mesh-ancestor
24830240|NCT02157818|Anesthetics|anesthetics|mesh-ancestor
24830241|NCT02157818|GABA Modulators|gaba modulators|mesh-ancestor
24830242|NCT02157818|GABA Agents|gaba agents|mesh-ancestor
24830243|NCT02158013|Diltiazem|diltiazem|mesh-list
24830244|NCT02158013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24830245|NCT02158013|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24830246|NCT02158013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24830247|NCT02158013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830248|NCT02158013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24830249|NCT02158013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830250|NCT02158013|Vasodilator Agents|vasodilator agents|mesh-ancestor
24830251|NCT02158052|Tacrolimus|tacrolimus|mesh-list
24830252|NCT02158052|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24830253|NCT02158052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24830254|NCT02158052|Immunologic Factors|immunologic factors|mesh-ancestor
24830255|NCT02158052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830256|NCT02158052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25858634|NCT00078793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25858635|NCT00078793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25858636|NCT00078793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25858637|NCT00078793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25268311|NCT02416388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25268312|NCT02416388|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25268313|NCT02416388|Antitubercular Agents|antitubercular agents|mesh-ancestor
25268314|NCT02416388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25268316|NCT02416232|Dabrafenib|dabrafenib|mesh-list
25268317|NCT02416232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24741908|NCT05294887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24741964|NCT05294640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741965|NCT05294640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24943997|NCT03965208|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24943998|NCT03965208|Protease Inhibitors|protease inhibitors|mesh-ancestor
24741966|NCT05294640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24741967|NCT05294640|Adrenergic Agents|adrenergic agents|mesh-ancestor
24741968|NCT05294640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25858638|NCT00078793|Immunologic Factors|immunologic factors|mesh-ancestor
25858639|NCT00078806|Etanercept|etanercept|mesh-list
25858640|NCT00078806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25858641|NCT00078806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25858642|NCT00078806|Analgesics|analgesics|mesh-ancestor
25858643|NCT00078806|Sensory System Agents|sensory system agents|mesh-ancestor
25858644|NCT00078806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25858645|NCT00078806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858646|NCT00078806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25858647|NCT00078806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24448890|NCT00313508|Immunologic Factors|immunologic factors|mesh-ancestor
24448891|NCT00313508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448892|NCT00313508|Antiviral Agents|antiviral agents|mesh-ancestor
24448893|NCT00313508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24448895|NCT00313521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24448896|NCT00313521|Alkylating Agents|alkylating agents|mesh-ancestor
24448897|NCT00313521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448898|NCT00313521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448899|NCT00313521|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24448900|NCT00313521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24448901|NCT00313521|Immunologic Factors|immunologic factors|mesh-ancestor
24448902|NCT00313521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448903|NCT00313534|Masoprocol|masoprocol|mesh-list
24483906|NCT00445861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448904|NCT00313534|Antioxidants|antioxidants|mesh-ancestor
24448905|NCT00313534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858648|NCT00078806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25858649|NCT00078806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25858650|NCT00078806|Immunologic Factors|immunologic factors|mesh-ancestor
25858651|NCT00078832|Anastrozole|anastrozole|mesh-list
25858652|NCT00078832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25858653|NCT00078832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858654|NCT00078832|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25858655|NCT00078832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25858656|NCT00078832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858657|NCT00078832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858658|NCT00078832|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25858659|NCT00078832|Hormone Antagonists|hormone antagonists|mesh-ancestor
24830258|NCT02158052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830259|NCT02158078|Insulin|insulin|mesh-list
24830260|NCT02158078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24830261|NCT02158078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830262|NCT02158117|Naloxone|naloxone|mesh-list
24830263|NCT02158117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24830264|NCT02158117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830265|NCT02158117|Sensory System Agents|sensory system agents|mesh-ancestor
24694336|NCT01425099|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25858660|NCT00078832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25858661|NCT00078832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858662|NCT00078845|Amifostine|amifostine|mesh-list
25858663|NCT00078845|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25858664|NCT00078845|Protective Agents|protective agents|mesh-ancestor
25268318|NCT02416232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25268319|NCT02416232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25268320|NCT02416232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268321|NCT02416271|Vitamin D|vitamin d|mesh-list
25268322|NCT02416271|Alendronate|alendronate|mesh-list
25268323|NCT02416271|Teriparatide|teriparatide|mesh-list
25858665|NCT00078845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858666|NCT00078858|Cyclosporine|cyclosporine|mesh-list
25858667|NCT00078858|Mycophenolic Acid|mycophenolic acid|mesh-list
25858668|NCT00078858|Fludarabine|fludarabine|mesh-list
25858669|NCT00078858|Fludarabine phosphate|fludarabine phosphate|mesh-list
25858670|NCT00078858|Cyclosporins|cyclosporins|mesh-list
25858671|NCT00078858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24830273|NCT02158143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24830274|NCT02158182|Rifaximin|rifaximin|mesh-list
24830275|NCT02158182|Lactulose|lactulose|mesh-list
24830276|NCT02158182|N-Methylaspartate|n-methylaspartate|mesh-list
24830277|NCT02158182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24830278|NCT02158182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24830279|NCT02158182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24830280|NCT02158182|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
24830281|NCT02158182|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24830282|NCT02158182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24830283|NCT02158182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830284|NCT02158182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830285|NCT02158221|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
24830286|NCT02158221|Growth Substances|growth substances|mesh-ancestor
25858672|NCT00078858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25858673|NCT00078858|Antimetabolites|antimetabolites|mesh-ancestor
25858674|NCT00078858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393954|NCT00131391|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25664849|NCT01675635|Analgesics|analgesics|mesh-ancestor
25664850|NCT01675635|Sensory System Agents|sensory system agents|mesh-ancestor
25664851|NCT01675635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25664852|NCT01675661|Acetylcysteine|acetylcysteine|mesh-list
24907727|NCT04328480|Colchicine|colchicine|mesh-list
25664853|NCT01675661|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25664854|NCT01675661|Antiviral Agents|antiviral agents|mesh-ancestor
25664855|NCT01675661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25664856|NCT01675661|Expectorants|expectorants|mesh-ancestor
25858675|NCT00078858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25858676|NCT00078858|Immunologic Factors|immunologic factors|mesh-ancestor
25858677|NCT00078858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858678|NCT00078858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858679|NCT00078858|Antifungal Agents|antifungal agents|mesh-ancestor
25858680|NCT00078858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25858681|NCT00078858|Dermatologic Agents|dermatologic agents|mesh-ancestor
25858682|NCT00078858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25858683|NCT00078858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25858684|NCT00078858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25858685|NCT00078858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25858686|NCT00078858|Antitubercular Agents|antitubercular agents|mesh-ancestor
25858687|NCT00078858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25858688|NCT00078910|Sulindac sulfone|sulindac sulfone|mesh-list
25858689|NCT00078910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24830287|NCT02158221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830288|NCT02158221|Vasodilator Agents|vasodilator agents|mesh-ancestor
24830290|NCT02158221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858690|NCT00078910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25858691|NCT00078910|Protective Agents|protective agents|mesh-ancestor
25858692|NCT00078910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830292|NCT02158286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24830293|NCT02158286|Analgesics|analgesics|mesh-ancestor
24830294|NCT02158286|Sensory System Agents|sensory system agents|mesh-ancestor
24830295|NCT02158286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25268326|NCT02416271|Micronutrients|micronutrients|mesh-ancestor
25268327|NCT02416271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268328|NCT02416271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25268329|NCT02416271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24454928|NCT03161353|Tamoxifen|tamoxifen|mesh-list
24830299|NCT02158481|Antioxidants|antioxidants|mesh-ancestor
24830300|NCT02158481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830301|NCT02158481|Protective Agents|protective agents|mesh-ancestor
24830302|NCT02158481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830303|NCT02158598|Vitamin D|vitamin d|mesh-list
24830304|NCT02158598|Ergocalciferols|ergocalciferols|mesh-list
24830305|NCT02158598|Cholecalciferol|cholecalciferol|mesh-list
24830306|NCT02158598|Vitamins|vitamins|mesh-list
24830307|NCT02158598|Micronutrients|micronutrients|mesh-ancestor
24830308|NCT02158598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830309|NCT02158598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24830310|NCT02158598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24830311|NCT02158624|Ranibizumab|ranibizumab|mesh-list
24830312|NCT02158624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24616489|NCT01037491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25858693|NCT00078910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25858694|NCT00078910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858695|NCT00078910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858696|NCT00078910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24830320|NCT02158689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24830321|NCT02158689|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24830322|NCT02158689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24830323|NCT02158689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830324|NCT02158689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830325|NCT02158689|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24830326|NCT02158689|Hormone Antagonists|hormone antagonists|mesh-ancestor
24830327|NCT02158689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24742356|NCT05273996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24742357|NCT05273996|Serotonin Agents|serotonin agents|mesh-ancestor
24742358|NCT05273996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24742359|NCT05273242|Artesunate|artesunate|mesh-list
24742363|NCT05273242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24742364|NCT05273242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24830328|NCT02158689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830329|NCT02158689|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24830330|NCT02158689|Fertility Agents|fertility agents|mesh-ancestor
24830331|NCT02158689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24830332|NCT02158702|Dexamethasone|dexamethasone|mesh-list
24830333|NCT02158702|Pomalidomide|pomalidomide|mesh-list
24830334|NCT02158702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24830335|NCT02158702|Antiemetics|antiemetics|mesh-ancestor
24830336|NCT02158702|Autonomic Agents|autonomic agents|mesh-ancestor
25858697|NCT00078910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24849604|NCT02249364|Propofol|propofol|mesh-list
25858698|NCT00078910|Analgesics|analgesics|mesh-ancestor
25858699|NCT00078910|Sensory System Agents|sensory system agents|mesh-ancestor
25858700|NCT00078910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25858701|NCT00078910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25858702|NCT00078910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25858703|NCT00078962|Gemcitabine|gemcitabine|mesh-list
25858704|NCT00078962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25858705|NCT00078962|Antimetabolites|antimetabolites|mesh-ancestor
25858706|NCT00078962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858707|NCT00078962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858708|NCT00078962|Antiviral Agents|antiviral agents|mesh-ancestor
25858709|NCT00078962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25858710|NCT00078962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858711|NCT00078962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25858712|NCT00078962|Immunologic Factors|immunologic factors|mesh-ancestor
25858713|NCT00078962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858714|NCT00078975|Gemcitabine|gemcitabine|mesh-list
25858715|NCT00078975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25858716|NCT00078975|Antimetabolites|antimetabolites|mesh-ancestor
25858717|NCT00078975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830351|NCT02158845|Levonorgestrel|levonorgestrel|mesh-list
24830352|NCT02158845|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24830353|NCT02158845|Fertility Agents|fertility agents|mesh-ancestor
25858718|NCT00078975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24742483|NCT05262686|Aldesleukin|aldesleukin|mesh-list
24742484|NCT05262686|Interleukin-2|interleukin-2|mesh-list
24742485|NCT05262686|Belimumab|belimumab|mesh-list
24742486|NCT05262686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24742487|NCT05262686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24830354|NCT02158845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24830355|NCT02158845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268330|NCT02416531|Clobetasol|clobetasol|mesh-list
25268331|NCT02416531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25268332|NCT02416531|Glucocorticoids|glucocorticoids|mesh-ancestor
25268333|NCT02416531|Hormones|hormones|mesh-ancestor
24454930|NCT03161353|Docetaxel|docetaxel|mesh-list
24454931|NCT03161353|Trastuzumab|trastuzumab|mesh-list
24454932|NCT03161353|Letrozole|letrozole|mesh-list
24830356|NCT02158845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24830357|NCT02158845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24830358|NCT02158845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24830359|NCT02158845|Contraceptive Agents|contraceptive agents|mesh-ancestor
24830360|NCT02158845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24830361|NCT02158845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24830362|NCT02158845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24830363|NCT02158910|Donepezil|donepezil|mesh-list
24830364|NCT02158910|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24830365|NCT02158910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830366|NCT02158910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830367|NCT02158910|Cholinergic Agents|cholinergic agents|mesh-ancestor
24830368|NCT02158910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24830369|NCT02158910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858719|NCT00078975|Antiviral Agents|antiviral agents|mesh-ancestor
25858720|NCT00078975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24830378|NCT02159027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24830379|NCT02159027|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24830380|NCT02159066|Infigratinib|infigratinib|mesh-list
24830381|NCT02159066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24830382|NCT02159105|Chrysarobin|chrysarobin|mesh-list
24830383|NCT02159105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24830384|NCT02159105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24830385|NCT02159105|Analgesics|analgesics|mesh-ancestor
24830386|NCT02159105|Sensory System Agents|sensory system agents|mesh-ancestor
24742488|NCT05262686|Analgesics|analgesics|mesh-ancestor
25664857|NCT01675661|Respiratory System Agents|respiratory system agents|mesh-ancestor
25664858|NCT01675661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25664859|NCT01675661|Antioxidants|antioxidants|mesh-ancestor
25664860|NCT01675661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664861|NCT01675661|Protective Agents|protective agents|mesh-ancestor
25664862|NCT01675661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664863|NCT01675661|Antidotes|antidotes|mesh-ancestor
25664864|NCT01675765|Cyclophosphamide|cyclophosphamide|mesh-list
24454107|NCT04432012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24454108|NCT04432012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24454109|NCT04432012|Glucocorticoids|glucocorticoids|mesh-ancestor
24454110|NCT04432012|Hormones|hormones|mesh-ancestor
24454111|NCT04432012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24454112|NCT04432012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24454113|NCT04432012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24454114|NCT04432012|Protease Inhibitors|protease inhibitors|mesh-ancestor
25858721|NCT00078975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858722|NCT00078975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25858723|NCT00078975|Immunologic Factors|immunologic factors|mesh-ancestor
25858724|NCT00078975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858725|NCT00078988|Carboplatin|carboplatin|mesh-list
25858726|NCT00078988|Etoposide|etoposide|mesh-list
25858727|NCT00078988|Thiotepa|thiotepa|mesh-list
25858728|NCT00078988|Isotretinoin|isotretinoin|mesh-list
25858729|NCT00078988|Lenograstim|lenograstim|mesh-list
25858730|NCT00078988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858731|NCT00078988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25858732|NCT00078988|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25858733|NCT00078988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25858734|NCT00078988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858735|NCT00078988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858736|NCT00078988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25858737|NCT00078988|Immunologic Factors|immunologic factors|mesh-ancestor
25858738|NCT00078988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858739|NCT00078988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25858740|NCT00078988|Alkylating Agents|alkylating agents|mesh-ancestor
25858741|NCT00078988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25858742|NCT00078988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25858743|NCT00078988|Dermatologic Agents|dermatologic agents|mesh-ancestor
25858744|NCT00079014|Doxorubicin|doxorubicin|mesh-list
25858745|NCT00079014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25858746|NCT00079014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25858747|NCT00079014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25268334|NCT02416531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25268336|NCT02416258|Betamethasone|betamethasone|mesh-list
25268337|NCT02416258|Betamethasone Valerate|betamethasone valerate|mesh-list
25268338|NCT02416258|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25268339|NCT02416258|Betamethasone benzoate|betamethasone benzoate|mesh-list
25268340|NCT02416258|Calcipotriene|calcipotriene|mesh-list
25858748|NCT00079014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25858749|NCT00079014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25858750|NCT00079014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858751|NCT00079014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858752|NCT00079027|Doxorubicin|doxorubicin|mesh-list
24742598|NCT05219799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25858753|NCT00079027|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25858754|NCT00079027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25858755|NCT00079027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858756|NCT00079027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25858757|NCT00079027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25858758|NCT00079027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858759|NCT00079027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876418|NCT03546686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25876419|NCT03546686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876420|NCT03513952|Atezolizumab|atezolizumab|mesh-list
25876421|NCT03513952|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24830387|NCT02159105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24830388|NCT02159105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830389|NCT02159105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24830390|NCT02159105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24830391|NCT02159131|Cabotegravir|cabotegravir|mesh-list
24830392|NCT02159131|Levonorgestrel|levonorgestrel|mesh-list
24830393|NCT02159131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24830394|NCT02159131|Contraceptive Agents|contraceptive agents|mesh-ancestor
25425148|NCT02166463|Etoposide phosphate|etoposide phosphate|mesh-list
25664865|NCT01675765|Cisplatin|cisplatin|mesh-list
25664866|NCT01675765|Pemetrexed|pemetrexed|mesh-list
25664867|NCT01675765|Immunologic Factors|immunologic factors|mesh-list
25664868|NCT01675765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25664869|NCT01675765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664870|NCT01675765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25664871|NCT01675765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25664872|NCT01675765|Alkylating Agents|alkylating agents|mesh-ancestor
25858761|NCT00079053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858762|NCT00079053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25858763|NCT00079053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858764|NCT00079053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858765|NCT00079066|Cetuximab|cetuximab|mesh-list
25858766|NCT00079066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25858767|NCT00079066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858768|NCT00079079|Gemcitabine|gemcitabine|mesh-list
25858769|NCT00079079|Cisplatin|cisplatin|mesh-list
25858770|NCT00079079|Carboplatin|carboplatin|mesh-list
25858771|NCT00079079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858772|NCT00079079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25858773|NCT00079079|Antimetabolites|antimetabolites|mesh-ancestor
25858774|NCT00079079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858775|NCT00079079|Antiviral Agents|antiviral agents|mesh-ancestor
25858776|NCT00079079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25858777|NCT00079079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858778|NCT00079079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25858779|NCT00079079|Immunologic Factors|immunologic factors|mesh-ancestor
25858780|NCT00079079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858781|NCT00079092|Thalidomide|thalidomide|mesh-list
25858782|NCT00079092|Procarbazine|procarbazine|mesh-list
25858783|NCT00079092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25858784|NCT00079092|Immunologic Factors|immunologic factors|mesh-ancestor
25858785|NCT00079092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858786|NCT00079092|Leprostatic Agents|leprostatic agents|mesh-ancestor
25858787|NCT00079092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25858788|NCT00079092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25858789|NCT00079092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25858790|NCT00079092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25858791|NCT00079092|Growth Substances|growth substances|mesh-ancestor
25858792|NCT00079092|Growth Inhibitors|growth inhibitors|mesh-ancestor
25858793|NCT00079092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24830400|NCT02159131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25268341|NCT02416258|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24940814|NCT03997279|Amoxicillin|amoxicillin|mesh-list
24830401|NCT02159131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24830406|NCT02159131|Antiviral Agents|antiviral agents|mesh-ancestor
24830407|NCT02159131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24830408|NCT02159196|Acetylcysteine|acetylcysteine|mesh-list
24830409|NCT02159196|Albuterol|albuterol|mesh-list
24830410|NCT02159196|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24830411|NCT02159196|Antiviral Agents|antiviral agents|mesh-ancestor
24830412|NCT02159196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24830413|NCT02159196|Expectorants|expectorants|mesh-ancestor
24830414|NCT02159196|Respiratory System Agents|respiratory system agents|mesh-ancestor
24830415|NCT02159196|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24830416|NCT02159196|Antioxidants|antioxidants|mesh-ancestor
24830417|NCT02159196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830418|NCT02159196|Protective Agents|protective agents|mesh-ancestor
24830419|NCT02159196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830420|NCT02159196|Antidotes|antidotes|mesh-ancestor
24830421|NCT02159196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24830422|NCT02159196|Autonomic Agents|autonomic agents|mesh-ancestor
24830423|NCT02159196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24830424|NCT02159196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24830425|NCT02159196|Tocolytic Agents|tocolytic agents|mesh-ancestor
24830426|NCT02159196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25858794|NCT00079105|Prednisolone|prednisolone|mesh-list
25858795|NCT00079105|Cyclophosphamide|cyclophosphamide|mesh-list
24830452|NCT02159248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24830453|NCT02159248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24830454|NCT02159248|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
25858796|NCT00079105|Etoposide|etoposide|mesh-list
24830461|NCT02159287|Calcium heparin|calcium heparin|mesh-list
24830462|NCT02159287|Enoxaparin|enoxaparin|mesh-list
24830463|NCT02159287|Enoxaparin sodium|enoxaparin sodium|mesh-list
24830464|NCT02159287|Anticoagulants|anticoagulants|mesh-ancestor
24830465|NCT02159287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24830466|NCT02159287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25858797|NCT00079105|Vincristine|vincristine|mesh-list
25858798|NCT00079105|Mitoxantrone|mitoxantrone|mesh-list
25858799|NCT00079105|Bleomycin|bleomycin|mesh-list
25858800|NCT00079105|Vinblastine|vinblastine|mesh-list
25858801|NCT00079105|Procarbazine|procarbazine|mesh-list
24694592|NCT05385900|Oxaliplatin|oxaliplatin|mesh-list
25858802|NCT00079105|Prednisolone phosphate|prednisolone phosphate|mesh-list
25858803|NCT00079105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25858804|NCT00079105|Immunologic Factors|immunologic factors|mesh-ancestor
24830476|NCT02159326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24830477|NCT02159326|Contraceptive Agents|contraceptive agents|mesh-ancestor
24830478|NCT02159326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24830479|NCT02159326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830480|NCT02159326|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24830481|NCT02159326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24830482|NCT02159326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25268344|NCT02416258|Hormones|hormones|mesh-ancestor
25268345|NCT02416258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25268346|NCT02416258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268347|NCT02416258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25268348|NCT02416258|Respiratory System Agents|respiratory system agents|mesh-ancestor
25268349|NCT02416258|Dermatologic Agents|dermatologic agents|mesh-ancestor
25268350|NCT02416245|Micronutrients|micronutrients|mesh-list
25268351|NCT02416245|Trace Elements|trace elements|mesh-list
25268352|NCT02416245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830483|NCT02159326|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24830484|NCT02159326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24830485|NCT02159326|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
24830486|NCT02159326|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24830487|NCT02159326|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24830489|NCT02159573|Natalizumab|natalizumab|mesh-list
24830490|NCT02159573|Immunologic Factors|immunologic factors|mesh-ancestor
24830491|NCT02159573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830492|NCT02159573|Dermatologic Agents|dermatologic agents|mesh-ancestor
24830493|NCT02159573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24830495|NCT02159599|Darunavir|darunavir|mesh-list
24830496|NCT02159599|Tenofovir|tenofovir|mesh-list
24830497|NCT02159599|Lamivudine|lamivudine|mesh-list
24830498|NCT02159599|Emtricitabine|emtricitabine|mesh-list
25858805|NCT00079105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858806|NCT00079105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25858807|NCT00079105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25858808|NCT00079105|Alkylating Agents|alkylating agents|mesh-ancestor
25858809|NCT00079105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858810|NCT00079105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858811|NCT00079105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25858812|NCT00079105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24830499|NCT02159599|Abacavir|abacavir|mesh-list
24830500|NCT02159599|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24830501|NCT02159599|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24830502|NCT02159599|Protease Inhibitors|protease inhibitors|mesh-ancestor
24830503|NCT02159599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664873|NCT01675765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664874|NCT01675765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664875|NCT01675765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25664876|NCT01675765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664877|NCT01675765|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25858814|NCT00079105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25858815|NCT00079105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858816|NCT00079105|Tubulin Modulators|tubulin modulators|mesh-ancestor
25858817|NCT00079105|Antimitotic Agents|antimitotic agents|mesh-ancestor
24522768|NCT03145766|Immunologic Factors|immunologic factors|mesh-ancestor
24743264|NCT04921527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24743265|NCT04921527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24743266|NCT04921527|Tubulin Modulators|tubulin modulators|mesh-ancestor
24743267|NCT04921527|Antimitotic Agents|antimitotic agents|mesh-ancestor
25858818|NCT00079105|Mitosis Modulators|mitosis modulators|mesh-ancestor
25858819|NCT00079105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25858820|NCT00079105|Glucocorticoids|glucocorticoids|mesh-ancestor
25858821|NCT00079105|Hormones|hormones|mesh-ancestor
25858822|NCT00079105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25858823|NCT00079105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25858824|NCT00079105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25858825|NCT00079105|Analgesics|analgesics|mesh-ancestor
25858826|NCT00079105|Sensory System Agents|sensory system agents|mesh-ancestor
25858827|NCT00079105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25858828|NCT00079118|Docetaxel|docetaxel|mesh-list
25858829|NCT00079118|Irinotecan|irinotecan|mesh-list
25858830|NCT00079118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858831|NCT00079118|Tubulin Modulators|tubulin modulators|mesh-ancestor
25858832|NCT00079118|Antimitotic Agents|antimitotic agents|mesh-ancestor
25858833|NCT00079118|Mitosis Modulators|mitosis modulators|mesh-ancestor
25858834|NCT00079118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858835|NCT00079118|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24830519|NCT02159651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448967|NCT00313690|Tubulin Modulators|tubulin modulators|mesh-ancestor
24448968|NCT00313690|Antimitotic Agents|antimitotic agents|mesh-ancestor
24448969|NCT00313690|Mitosis Modulators|mitosis modulators|mesh-ancestor
24448970|NCT00313690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448971|NCT00313742|Insulin|insulin|mesh-list
24448972|NCT00313742|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24448973|NCT00313742|Insulin Glargine|insulin glargine|mesh-list
24448974|NCT00313742|Insulin Detemir|insulin detemir|mesh-list
25268353|NCT02416570|Clarithromycin|clarithromycin|mesh-list
25268354|NCT02416570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25268355|NCT02416570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25858836|NCT00079118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25858837|NCT00079118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858838|NCT00079131|Oblimersen|oblimersen|mesh-list
25858839|NCT00079131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858840|NCT00079144|Aldesleukin|aldesleukin|mesh-list
25858841|NCT00079144|Cyclophosphamide|cyclophosphamide|mesh-list
25858842|NCT00079144|Fludarabine|fludarabine|mesh-list
25858843|NCT00079144|Fludarabine phosphate|fludarabine phosphate|mesh-list
25858844|NCT00079144|Freund's Adjuvant|freund's adjuvant|mesh-list
25858845|NCT00079144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25858846|NCT00079144|Immunologic Factors|immunologic factors|mesh-ancestor
24448978|NCT00313742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24448979|NCT00313742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448980|NCT00313833|Buprenorphine|buprenorphine|mesh-list
24448981|NCT00313833|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24448982|NCT00313833|Narcotics|narcotics|mesh-ancestor
24448983|NCT00313833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24448984|NCT00313833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448985|NCT00313833|Analgesics|analgesics|mesh-ancestor
24448986|NCT00313833|Sensory System Agents|sensory system agents|mesh-ancestor
24448987|NCT00313833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24448988|NCT00313833|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24448989|NCT00313859|Simvastatin|simvastatin|mesh-list
24407969|NCT00176020|Nicotinic Acids|nicotinic acids|mesh-list
25268356|NCT02416570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25268357|NCT02416570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25268358|NCT02416570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268359|NCT02416570|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25268360|NCT02416570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25268361|NCT02416141|Tramadol|tramadol|mesh-list
25268362|NCT02416141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25268363|NCT02416141|Narcotics|narcotics|mesh-ancestor
25858847|NCT00079144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268372|NCT02416167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25268373|NCT02416167|Renal Agents|renal agents|mesh-ancestor
25275446|NCT02372188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275447|NCT02372188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25275448|NCT02372188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275449|NCT02372188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275450|NCT02372188|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25275451|NCT02372188|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25275452|NCT02372188|Purinergic Agents|purinergic agents|mesh-ancestor
25275453|NCT02372188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25275454|NCT02372292|Furosemide|furosemide|mesh-list
25275455|NCT02372292|Diuretics|diuretics|mesh-ancestor
25275456|NCT02372292|Natriuretic Agents|natriuretic agents|mesh-ancestor
25275457|NCT02372292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858848|NCT00079144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24708093|NCT01499953|PENTA|penta|mesh-list
24448990|NCT00313859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24830561|NCT02160054|Immunologic Factors|immunologic factors|mesh-ancestor
24830562|NCT02160054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618446|NCT01048307|Disinfectants|disinfectants|mesh-ancestor
25858849|NCT00079144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25858850|NCT00079144|Alkylating Agents|alkylating agents|mesh-ancestor
25858851|NCT00079144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858852|NCT00079144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858853|NCT00079144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25858854|NCT00079144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25858855|NCT00079144|Antimetabolites|antimetabolites|mesh-ancestor
25858856|NCT00079144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24830572|NCT02160080|Antimetabolites|antimetabolites|mesh-ancestor
24830573|NCT02160080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448991|NCT00313859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25858857|NCT00079144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25858858|NCT00079144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25858859|NCT00079144|Antiviral Agents|antiviral agents|mesh-ancestor
25858860|NCT00079144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25858861|NCT00079157|Sargramostim|sargramostim|mesh-list
25858862|NCT00079157|Freund's Adjuvant|freund's adjuvant|mesh-list
25858863|NCT00079157|Immunologic Factors|immunologic factors|mesh-ancestor
25858864|NCT00079157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858865|NCT00079157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25858866|NCT00079170|Docetaxel|docetaxel|mesh-list
25858867|NCT00079170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858868|NCT00079170|Tubulin Modulators|tubulin modulators|mesh-ancestor
25858869|NCT00079170|Antimitotic Agents|antimitotic agents|mesh-ancestor
25858870|NCT00079170|Mitosis Modulators|mitosis modulators|mesh-ancestor
25858871|NCT00079170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858872|NCT00079222|Itraconazole|itraconazole|mesh-list
25858873|NCT00079222|Voriconazole|voriconazole|mesh-list
25858874|NCT00079222|Antifungal Agents|antifungal agents|mesh-ancestor
25268377|NCT02416115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25268378|NCT02416115|Narcotics|narcotics|mesh-ancestor
25268379|NCT02416115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25858876|NCT00079222|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25858877|NCT00079222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25858878|NCT00079222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24743686|NCT04659382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24743757|NCT04635098|Analgesics|analgesics|mesh-ancestor
25858879|NCT00079222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858880|NCT00079222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25858881|NCT00079222|Hormone Antagonists|hormone antagonists|mesh-ancestor
25858882|NCT00079222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25858883|NCT00079222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858884|NCT00079222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25858885|NCT00079235|Sirolimus|sirolimus|mesh-list
25858886|NCT00079235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25858887|NCT00079235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25858888|NCT00079235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25858889|NCT00079235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858890|NCT00079235|Antifungal Agents|antifungal agents|mesh-ancestor
25858891|NCT00079235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25858892|NCT00079235|Immunologic Factors|immunologic factors|mesh-ancestor
25858893|NCT00079235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858894|NCT00079248|Progesterone|progesterone|mesh-list
25858895|NCT00079248|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25858896|NCT00079248|Estrogens|estrogens|mesh-list
25858897|NCT00079248|Progestins|progestins|mesh-ancestor
25858898|NCT00079248|Hormones|hormones|mesh-ancestor
25858899|NCT00079248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25858900|NCT00079248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858901|NCT00079261|Gemcitabine|gemcitabine|mesh-list
25858902|NCT00079261|Prednisone|prednisone|mesh-list
25858903|NCT00079261|Cyclophosphamide|cyclophosphamide|mesh-list
25858904|NCT00079261|Doxorubicin|doxorubicin|mesh-list
25858905|NCT00079261|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24830575|NCT02160080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830576|NCT02160132|Methylprednisolone|methylprednisolone|mesh-list
24830577|NCT02160132|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24830578|NCT02160132|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24830580|NCT02160132|Prednisolone acetate|prednisolone acetate|mesh-list
24830581|NCT02160132|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24830582|NCT02160132|Prednisolone phosphate|prednisolone phosphate|mesh-list
24830583|NCT02160132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24830584|NCT02160132|Antiemetics|antiemetics|mesh-ancestor
24830585|NCT02160132|Autonomic Agents|autonomic agents|mesh-ancestor
24830586|NCT02160132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24830588|NCT02160132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25858906|NCT00079261|Vincristine|vincristine|mesh-list
25858907|NCT00079261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25858908|NCT00079261|Immunologic Factors|immunologic factors|mesh-ancestor
25858909|NCT00079261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858910|NCT00079261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25858911|NCT00079261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25858912|NCT00079261|Alkylating Agents|alkylating agents|mesh-ancestor
25858913|NCT00079261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268380|NCT02416115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268381|NCT02416115|Analgesics|analgesics|mesh-ancestor
25268382|NCT02416115|Sensory System Agents|sensory system agents|mesh-ancestor
25268383|NCT02416115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25268384|NCT02416115|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25858914|NCT00079261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858915|NCT00079261|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25858916|NCT00079261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25858917|NCT00079261|Antimetabolites|antimetabolites|mesh-ancestor
25858918|NCT00079261|Antiviral Agents|antiviral agents|mesh-ancestor
25858919|NCT00079261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25858920|NCT00079261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858921|NCT00079261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25858922|NCT00079261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25858926|NCT00079261|Hormones|hormones|mesh-ancestor
25858927|NCT00079261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25858928|NCT00079261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25858929|NCT00079261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25858930|NCT00079261|Tubulin Modulators|tubulin modulators|mesh-ancestor
25858931|NCT00079261|Antimitotic Agents|antimitotic agents|mesh-ancestor
25858932|NCT00079261|Mitosis Modulators|mitosis modulators|mesh-ancestor
24830589|NCT02160132|Glucocorticoids|glucocorticoids|mesh-ancestor
24830590|NCT02160132|Hormones|hormones|mesh-ancestor
24830591|NCT02160132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24830592|NCT02160132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24830593|NCT02160132|Protective Agents|protective agents|mesh-ancestor
24830594|NCT02160132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24830595|NCT02160132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24830596|NCT02160158|Fesoterodine|fesoterodine|mesh-list
24830601|NCT02160158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830602|NCT02160158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858933|NCT00079287|Gemcitabine|gemcitabine|mesh-list
25858934|NCT00079287|Paclitaxel|paclitaxel|mesh-list
25858935|NCT00079287|Vinorelbine|vinorelbine|mesh-list
24743892|NCT04570436|Sensory System Agents|sensory system agents|mesh-ancestor
24743893|NCT04570436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25858936|NCT00079287|Docetaxel|docetaxel|mesh-list
25858937|NCT00079287|Carboplatin|carboplatin|mesh-list
25858938|NCT00079287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25858939|NCT00079287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858940|NCT00079287|Tubulin Modulators|tubulin modulators|mesh-ancestor
25858941|NCT00079287|Antimitotic Agents|antimitotic agents|mesh-ancestor
25268385|NCT02416115|Antiemetics|antiemetics|mesh-ancestor
25268386|NCT02416115|Autonomic Agents|autonomic agents|mesh-ancestor
25268387|NCT02416115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25268388|NCT02416115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25268389|NCT02416115|Serotonin Agents|serotonin agents|mesh-ancestor
25268390|NCT02416115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25268391|NCT02416115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268392|NCT02416063|Dexmedetomidine|dexmedetomidine|mesh-list
25268393|NCT02416063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25858942|NCT00079287|Mitosis Modulators|mitosis modulators|mesh-ancestor
25858943|NCT00079287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858944|NCT00079287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25858945|NCT00079287|Antimetabolites|antimetabolites|mesh-ancestor
25858946|NCT00079287|Antiviral Agents|antiviral agents|mesh-ancestor
25858947|NCT00079287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25858948|NCT00079287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858949|NCT00079287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25858950|NCT00079287|Immunologic Factors|immunologic factors|mesh-ancestor
25858951|NCT00079287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858952|NCT00079300|Imiquimod|imiquimod|mesh-list
25858953|NCT00079300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25858954|NCT00079300|Immunologic Factors|immunologic factors|mesh-ancestor
25858955|NCT00079300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858956|NCT00079300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858957|NCT00079300|Interferon Inducers|interferon inducers|mesh-ancestor
25858958|NCT00079313|Imatinib Mesylate|imatinib mesylate|mesh-list
25858959|NCT00079313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858960|NCT00079313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25858961|NCT00079313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858962|NCT00079313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858963|NCT00079352|Gemcitabine|gemcitabine|mesh-list
25858964|NCT00079352|Irinotecan|irinotecan|mesh-list
25858965|NCT00079352|Alvocidib|alvocidib|mesh-list
25858966|NCT00079352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25858967|NCT00079352|Antimetabolites|antimetabolites|mesh-ancestor
25858968|NCT00079352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858969|NCT00079352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858970|NCT00079352|Antiviral Agents|antiviral agents|mesh-ancestor
25858971|NCT00079352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25858972|NCT00079352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858973|NCT00079352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25858974|NCT00079352|Immunologic Factors|immunologic factors|mesh-ancestor
25858975|NCT00079352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858976|NCT00079352|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25858977|NCT00079352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25858978|NCT00079352|Growth Inhibitors|growth inhibitors|mesh-ancestor
25858979|NCT00079352|Growth Substances|growth substances|mesh-ancestor
25858980|NCT00079352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24830603|NCT02160158|Urological Agents|urological agents|mesh-ancestor
24830605|NCT02160184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24830606|NCT02160223|Neostigmine|neostigmine|mesh-list
24830607|NCT02160223|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24830608|NCT02160223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830609|NCT02160223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858981|NCT00079365|Gemcitabine|gemcitabine|mesh-list
25858982|NCT00079365|Fluorouracil|fluorouracil|mesh-list
25268394|NCT02416063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25268395|NCT02416063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268396|NCT02416063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25268397|NCT02416063|Analgesics|analgesics|mesh-ancestor
25268398|NCT02416063|Sensory System Agents|sensory system agents|mesh-ancestor
25268399|NCT02416063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24830656|NCT02160301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25268401|NCT02416063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25858983|NCT00079365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25858984|NCT00079365|Antimetabolites|antimetabolites|mesh-ancestor
25858985|NCT00079365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858986|NCT00079365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25858987|NCT00079365|Antiviral Agents|antiviral agents|mesh-ancestor
25858988|NCT00079365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25858989|NCT00079365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25858990|NCT00079365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24830610|NCT02160223|Cholinergic Agents|cholinergic agents|mesh-ancestor
24830611|NCT02160223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24394194|NCT00132548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24830612|NCT02160223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830613|NCT02160223|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24830614|NCT02160223|Autonomic Agents|autonomic agents|mesh-ancestor
24830615|NCT02160223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24830616|NCT02160236|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
25858991|NCT00079365|Immunologic Factors|immunologic factors|mesh-ancestor
25858992|NCT00079365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25858993|NCT00079378|Decitabine|decitabine|mesh-list
25858994|NCT00079378|Azacitidine|azacitidine|mesh-list
25858995|NCT00079378|Valproic Acid|valproic acid|mesh-list
25858996|NCT00079378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25858997|NCT00079378|Antimetabolites|antimetabolites|mesh-ancestor
24830621|NCT02160236|Sensory System Agents|sensory system agents|mesh-ancestor
24830622|NCT02160236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24830623|NCT02160236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830624|NCT02160236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24830625|NCT02160236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24830626|NCT02160236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24830627|NCT02160236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24944029|NCT03964779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944030|NCT03964493|Vancomycin|vancomycin|mesh-list
24744075|NCT04520776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24744076|NCT04520776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24744077|NCT04520776|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24744078|NCT04520776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24744079|NCT04520776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234065|NCT02573610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24744080|NCT04520776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744081|NCT04516317|Artesunate|artesunate|mesh-list
24830628|NCT02160236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830630|NCT02160275|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24830631|NCT02160275|Pancrelipase|pancrelipase|mesh-list
24830632|NCT02160275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24729079|NCT01619683|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25858998|NCT00079378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25858999|NCT00079378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859000|NCT00079378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859001|NCT00079378|Anticonvulsants|anticonvulsants|mesh-ancestor
25859002|NCT00079378|GABA Agents|gaba agents|mesh-ancestor
25859003|NCT00079378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25859004|NCT00079378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859005|NCT00079378|Antimanic Agents|antimanic agents|mesh-ancestor
24612864|NCT01015547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24612866|NCT01015547|Sensory System Agents|sensory system agents|mesh-ancestor
24612867|NCT01015547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24612868|NCT01015547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24612887|NCT01015664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25070524|NCT03418610|Azelaic acid|azelaic acid|mesh-list
25859006|NCT00079378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25859007|NCT00079378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25268402|NCT02416063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25268403|NCT02416063|Adrenergic Agents|adrenergic agents|mesh-ancestor
25268404|NCT02416063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25268405|NCT02416063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268406|NCT02416128|Prednisolone|prednisolone|mesh-list
25268407|NCT02416128|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25268408|NCT02416128|Methylprednisolone|methylprednisolone|mesh-list
25268409|NCT02416128|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24940868|NCT03997058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25859008|NCT00079378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25859009|NCT00079430|Paclitaxel|paclitaxel|mesh-list
25859010|NCT00079430|Bevacizumab|bevacizumab|mesh-list
24744159|NCT04489732|Interferons|interferons|mesh-list
25859011|NCT00079430|Carboplatin|carboplatin|mesh-list
24944031|NCT03964493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24944032|NCT03964493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24944033|NCT03964350|Ethanol|ethanol|mesh-list
24944034|NCT03964350|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24944036|NCT03964350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24944037|NCT03964350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944038|NCT03964324|Nitric Oxide|nitric oxide|mesh-list
24944039|NCT03964324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25859012|NCT00079430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25859013|NCT00079430|Antibodies|antibodies|mesh-list
24525467|NCT03326791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25859014|NCT00079430|Immunoglobulins|immunoglobulins|mesh-list
25859015|NCT00079430|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25859016|NCT00079430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25859017|NCT00079430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859018|NCT00079430|Tubulin Modulators|tubulin modulators|mesh-ancestor
25859019|NCT00079430|Antimitotic Agents|antimitotic agents|mesh-ancestor
25859020|NCT00079430|Mitosis Modulators|mitosis modulators|mesh-ancestor
25859021|NCT00079430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859022|NCT00079430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25859023|NCT00079430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25859024|NCT00079430|Growth Substances|growth substances|mesh-ancestor
25859025|NCT00079430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859026|NCT00079430|Growth Inhibitors|growth inhibitors|mesh-ancestor
25859027|NCT00079430|Immunologic Factors|immunologic factors|mesh-ancestor
25859028|NCT00079443|Rituximab|rituximab|mesh-list
25859029|NCT00079443|Fludarabine|fludarabine|mesh-list
25664878|NCT01675765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25664879|NCT01675778|Hydromorphone|hydromorphone|mesh-list
25664880|NCT01675778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25664881|NCT01675778|Narcotics|narcotics|mesh-ancestor
25664882|NCT01675778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25664883|NCT01675778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664884|NCT01675778|Analgesics|analgesics|mesh-ancestor
25664885|NCT01675778|Sensory System Agents|sensory system agents|mesh-ancestor
25664886|NCT01675778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25664887|NCT01676116|Liraglutide|liraglutide|mesh-list
25664888|NCT01676116|Exenatide|exenatide|mesh-list
25664889|NCT01676116|Xultophy|xultophy|mesh-list
25664890|NCT01676116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25859030|NCT00079443|Fludarabine phosphate|fludarabine phosphate|mesh-list
25859031|NCT00079443|Romidepsin|romidepsin|mesh-list
24830638|NCT02160301|Oxycodone|oxycodone|mesh-list
24830639|NCT02160301|Gabapentin|gabapentin|mesh-list
24448993|NCT00313859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859035|NCT00079443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859036|NCT00079443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25859037|NCT00079443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25859038|NCT00079443|Antimetabolites|antimetabolites|mesh-ancestor
24744160|NCT04489732|Interferon-gamma|interferon-gamma|mesh-list
24744161|NCT04489732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652901|NCT01240889|Fluticasone|fluticasone|mesh-list
24744162|NCT04489732|Antiviral Agents|antiviral agents|mesh-ancestor
24744163|NCT04489732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24744164|NCT04486716|Ofatumumab|ofatumumab|mesh-list
24744165|NCT04486716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24744166|NCT04484350|Enalapril|enalapril|mesh-list
24744167|NCT04484350|Labetalol|labetalol|mesh-list
24744168|NCT04484350|Hydralazine|hydralazine|mesh-list
25859039|NCT00079443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859040|NCT00079443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25859041|NCT00079443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25859042|NCT00079456|Sirolimus|sirolimus|mesh-list
25859043|NCT00079456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25859044|NCT00079456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25859045|NCT00079456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25859046|NCT00079456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859047|NCT00079456|Antifungal Agents|antifungal agents|mesh-ancestor
25859048|NCT00079456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25859049|NCT00079456|Immunologic Factors|immunologic factors|mesh-ancestor
25859050|NCT00079456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859051|NCT00079469|Bupropion|bupropion|mesh-list
25859052|NCT00079469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25859053|NCT00079469|Antidepressive Agents|antidepressive agents|mesh-ancestor
25859054|NCT00079469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25859055|NCT00079469|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25859056|NCT00079469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25859057|NCT00079469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25268410|NCT02416128|Prednisolone acetate|prednisolone acetate|mesh-list
25268411|NCT02416128|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25268412|NCT02416128|Prednisolone phosphate|prednisolone phosphate|mesh-list
25268413|NCT02416128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25268414|NCT02416128|Glucocorticoids|glucocorticoids|mesh-ancestor
25268416|NCT02416128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25268417|NCT02416128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744169|NCT04484350|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24744170|NCT04484350|Protease Inhibitors|protease inhibitors|mesh-ancestor
24744171|NCT04484350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24744181|NCT04484350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24744182|NCT04484350|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24744183|NCT04484350|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24744184|NCT04484350|Vasodilator Agents|vasodilator agents|mesh-ancestor
24744186|NCT04464577|Fluconazole|fluconazole|mesh-list
24744187|NCT04464577|Bupropion|bupropion|mesh-list
24744188|NCT04464577|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24944040|NCT03964324|Autonomic Agents|autonomic agents|mesh-ancestor
24944041|NCT03964324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24744189|NCT04464577|Antidepressive Agents|antidepressive agents|mesh-ancestor
24744190|NCT04464577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25859058|NCT00079469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859059|NCT00079469|Dopamine Agents|dopamine agents|mesh-ancestor
25859060|NCT00079469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25859064|NCT00079469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859065|NCT00079508|Bivalirudin|bivalirudin|mesh-list
25859066|NCT00079508|Antithrombins|antithrombins|mesh-ancestor
25859067|NCT00079508|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25859068|NCT00079508|Protease Inhibitors|protease inhibitors|mesh-ancestor
24940878|NCT03996772|Edoxaban|edoxaban|mesh-list
25859069|NCT00079508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859070|NCT00079508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859071|NCT00079508|Anticoagulants|anticoagulants|mesh-ancestor
25859072|NCT00079560|Dronabinol|dronabinol|mesh-list
25859073|NCT00079560|Hallucinogens|hallucinogens|mesh-ancestor
25234115|NCT02573558|Dexmedetomidine|dexmedetomidine|mesh-list
25859074|NCT00079560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859075|NCT00079560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25859076|NCT00079560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24830644|NCT02160301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830645|NCT02160301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24830648|NCT02160301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24830649|NCT02160301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24830650|NCT02160301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24830651|NCT02160301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24830652|NCT02160301|Analgesics|analgesics|mesh-ancestor
24830653|NCT02160301|Sensory System Agents|sensory system agents|mesh-ancestor
24830654|NCT02160301|Antipyretics|antipyretics|mesh-ancestor
24830655|NCT02160301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24830657|NCT02160301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24830658|NCT02160301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25859077|NCT00079560|Analgesics|analgesics|mesh-ancestor
25859078|NCT00079560|Sensory System Agents|sensory system agents|mesh-ancestor
24830659|NCT02160301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830660|NCT02160301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268418|NCT02416128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25268419|NCT02416128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25268420|NCT02416128|Antiemetics|antiemetics|mesh-ancestor
25268421|NCT02416128|Autonomic Agents|autonomic agents|mesh-ancestor
25268422|NCT02416128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25268423|NCT02416128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25268424|NCT02416128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25268425|NCT02416128|Protective Agents|protective agents|mesh-ancestor
25268426|NCT02415985|Lopinavir|lopinavir|mesh-list
25268427|NCT02415985|Rifabutin|rifabutin|mesh-list
25268428|NCT02415985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25268429|NCT02415985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25268430|NCT02415985|Protease Inhibitors|protease inhibitors|mesh-ancestor
25268431|NCT02415985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25268432|NCT02415985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268433|NCT02415985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25268434|NCT02415985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25268435|NCT02415985|Antiviral Agents|antiviral agents|mesh-ancestor
25268436|NCT02415985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25268437|NCT02415985|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25268438|NCT02415985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25268439|NCT02415985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25859079|NCT00079560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25859080|NCT00079560|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25859081|NCT00079560|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25859082|NCT00079560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24830661|NCT02160301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24830662|NCT02160301|Narcotics|narcotics|mesh-ancestor
24830663|NCT02160301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24830664|NCT02160301|Anticonvulsants|anticonvulsants|mesh-ancestor
24830665|NCT02160301|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24830666|NCT02160301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24830667|NCT02160301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24830668|NCT02160301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24830669|NCT02160301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24830670|NCT02160301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24830671|NCT02160301|Antimanic Agents|antimanic agents|mesh-ancestor
24830672|NCT02160353|Prednisolone|prednisolone|mesh-list
24830673|NCT02160353|Abiraterone Acetate|abiraterone acetate|mesh-list
25859083|NCT00079560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859084|NCT00079560|Hormones|hormones|mesh-ancestor
25859085|NCT00079560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24744210|NCT04460924|Integrase Inhibitors|integrase inhibitors|mesh-list
24944046|NCT03964324|Antioxidants|antioxidants|mesh-ancestor
24944047|NCT03964324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944048|NCT03964324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24944050|NCT03964324|Vasodilator Agents|vasodilator agents|mesh-ancestor
25859086|NCT00079586|Heparin|heparin|mesh-list
25859087|NCT00079586|Bivalirudin|bivalirudin|mesh-list
25859088|NCT00079586|Anticoagulants|anticoagulants|mesh-ancestor
25859089|NCT00079586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25859090|NCT00079586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25859091|NCT00079586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859092|NCT00079586|Antithrombins|antithrombins|mesh-ancestor
25859093|NCT00079586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25859094|NCT00079586|Protease Inhibitors|protease inhibitors|mesh-ancestor
25859095|NCT00079586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859096|NCT00079612|Sorafenib|sorafenib|mesh-list
25859097|NCT00079612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859098|NCT00079612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25859099|NCT00079612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859100|NCT00079612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859101|NCT00079638|Niacin|niacin|mesh-list
25859102|NCT00079638|Atorvastatin|atorvastatin|mesh-list
25859103|NCT00079638|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25859104|NCT00079638|Simvastatin|simvastatin|mesh-list
24830674|NCT02160353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24830675|NCT02160353|Glucocorticoids|glucocorticoids|mesh-ancestor
24830676|NCT02160353|Hormones|hormones|mesh-ancestor
24830677|NCT02160353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24830678|NCT02160353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830679|NCT02160353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24830680|NCT02160353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24830681|NCT02160353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24830682|NCT02160353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729231|NCT01620684|Antimetabolites|antimetabolites|mesh-ancestor
25859105|NCT00079638|Ezetimibe|ezetimibe|mesh-list
25859106|NCT00079638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25859107|NCT00079638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25859108|NCT00079638|Antimetabolites|antimetabolites|mesh-ancestor
25859109|NCT00079638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859110|NCT00079638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25859111|NCT00079638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25268440|NCT02415985|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25268441|NCT02415985|Antitubercular Agents|antitubercular agents|mesh-ancestor
25268442|NCT02415920|Oxytocin|oxytocin|mesh-list
25268443|NCT02415920|Oxytocics|oxytocics|mesh-ancestor
25268444|NCT02415920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25268445|NCT02415920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268446|NCT02415829|Capecitabine|capecitabine|mesh-list
25268447|NCT02415829|Oxaliplatin|oxaliplatin|mesh-list
25859112|NCT00079638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859113|NCT00079638|Vasodilator Agents|vasodilator agents|mesh-ancestor
25859114|NCT00079638|Vitamin B Complex|vitamin b complex|mesh-ancestor
25859115|NCT00079638|Vitamins|vitamins|mesh-ancestor
25859116|NCT00079638|Micronutrients|micronutrients|mesh-ancestor
25859117|NCT00079638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859118|NCT00079716|Dacetuzumab|dacetuzumab|mesh-list
25859119|NCT00079716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25859120|NCT00079716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859121|NCT00079755|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25859122|NCT00079755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25859123|NCT00079755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859124|NCT00079768|Alemtuzumab|alemtuzumab|mesh-list
25859125|NCT00079768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25859126|NCT00079768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859127|NCT00079807|Thioctic Acid|thioctic acid|mesh-list
25859128|NCT00079807|Antioxidants|antioxidants|mesh-ancestor
25859129|NCT00079807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859130|NCT00079807|Protective Agents|protective agents|mesh-ancestor
25859131|NCT00079807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859132|NCT00079807|Vitamin B Complex|vitamin b complex|mesh-ancestor
25859133|NCT00079807|Vitamins|vitamins|mesh-ancestor
25859134|NCT00079807|Micronutrients|micronutrients|mesh-ancestor
25859135|NCT00079820|Vaccines|vaccines|mesh-list
25859136|NCT00079820|Immunologic Factors|immunologic factors|mesh-ancestor
25859137|NCT00079820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859138|NCT00079833|Esomeprazole|esomeprazole|mesh-list
25859139|NCT00079833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25859140|NCT00079833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25859141|NCT00079833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25859142|NCT00079833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859143|NCT00079833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859144|NCT00079872|Pemetrexed|pemetrexed|mesh-list
25859145|NCT00079872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859146|NCT00079872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859147|NCT00079872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859148|NCT00079872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25859149|NCT00079872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25268448|NCT02415829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25268449|NCT02415829|Antimetabolites|antimetabolites|mesh-ancestor
25268450|NCT02415829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268451|NCT02415829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25268452|NCT02415881|Panitumumab|panitumumab|mesh-list
25268453|NCT02415881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25268454|NCT02415881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25268455|NCT02415803|Clopidogrel|clopidogrel|mesh-list
25268456|NCT02415803|Ticagrelor|ticagrelor|mesh-list
25859150|NCT00079885|Tigecycline|tigecycline|mesh-list
25859151|NCT00079885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25859152|NCT00079885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25859153|NCT00079885|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25859154|NCT00079885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859155|NCT00079885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859156|NCT00079911|Valacyclovir|valacyclovir|mesh-list
25859157|NCT00079911|Antiviral Agents|antiviral agents|mesh-ancestor
25859158|NCT00079911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25859159|NCT00079924|Teriparatide|teriparatide|mesh-list
25859160|NCT00079924|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25859161|NCT00079924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25859162|NCT00079924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859163|NCT00079924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25859164|NCT00079924|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25859165|NCT00079924|Hormone Antagonists|hormone antagonists|mesh-ancestor
25859166|NCT00079924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25859167|NCT00079924|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25859168|NCT00079924|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25859169|NCT00079963|Vitamins|vitamins|mesh-list
25859170|NCT00079963|Ascorbic Acid|ascorbic acid|mesh-list
25859171|NCT00079963|Vitamin E|vitamin e|mesh-list
25859172|NCT00079963|Micronutrients|micronutrients|mesh-ancestor
25859173|NCT00079963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859174|NCT00079963|Antioxidants|antioxidants|mesh-ancestor
25859175|NCT00079963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859176|NCT00079963|Protective Agents|protective agents|mesh-ancestor
25859177|NCT00079976|Tigecycline|tigecycline|mesh-list
24944057|NCT03963752|Megestrol|megestrol|mesh-list
24944058|NCT03963752|Megestrol Acetate|megestrol acetate|mesh-list
24944059|NCT03963752|Leuprolide|leuprolide|mesh-list
24944060|NCT03963752|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25859178|NCT00079976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25859179|NCT00079976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25859180|NCT00079976|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25859181|NCT00079976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729424|NCT01621451|Antipyretics|antipyretics|mesh-ancestor
25859182|NCT00079976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859183|NCT00079989|Tigecycline|tigecycline|mesh-list
25859184|NCT00079989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25859185|NCT00079989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25859186|NCT00079989|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25859187|NCT00079989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859188|NCT00079989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859189|NCT00080028|Motexafin gadolinium|motexafin gadolinium|mesh-list
25859190|NCT00080028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859191|NCT00080028|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25859192|NCT00080028|Dermatologic Agents|dermatologic agents|mesh-ancestor
25859193|NCT00080041|Motexafin gadolinium|motexafin gadolinium|mesh-list
25859194|NCT00080041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859195|NCT00080041|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25859196|NCT00080041|Dermatologic Agents|dermatologic agents|mesh-ancestor
25859197|NCT00080054|Motexafin gadolinium|motexafin gadolinium|mesh-list
25859198|NCT00080054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859199|NCT00080054|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25859200|NCT00080054|Dermatologic Agents|dermatologic agents|mesh-ancestor
25859201|NCT00080080|Docetaxel|docetaxel|mesh-list
25859202|NCT00080080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859203|NCT00080080|Tubulin Modulators|tubulin modulators|mesh-ancestor
25859204|NCT00080080|Antimitotic Agents|antimitotic agents|mesh-ancestor
25859205|NCT00080080|Mitosis Modulators|mitosis modulators|mesh-ancestor
25268457|NCT02415803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25859206|NCT00080080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859207|NCT00080145|Risperidone|risperidone|mesh-list
25859208|NCT00080145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25859209|NCT00080145|Serotonin Agents|serotonin agents|mesh-ancestor
25859210|NCT00080145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25859211|NCT00080145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859212|NCT00080145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859213|NCT00080145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25859214|NCT00080145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25859215|NCT00080145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25859216|NCT00080145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25859217|NCT00080145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25859218|NCT00080145|Dopamine Agents|dopamine agents|mesh-ancestor
24694993|NCT04765371|Dexamethasone|dexamethasone|mesh-list
25859219|NCT00080158|Mirtazapine|mirtazapine|mesh-list
25859220|NCT00080158|Citalopram|citalopram|mesh-list
25859221|NCT00080158|Bupropion|bupropion|mesh-list
25859222|NCT00080158|Fluoxetine|fluoxetine|mesh-list
25859223|NCT00080158|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25859224|NCT00080158|Sertraline|sertraline|mesh-list
25859225|NCT00080158|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25859226|NCT00080158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25859227|NCT00080158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25859228|NCT00080158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859229|NCT00080158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25859230|NCT00080158|Serotonin Agents|serotonin agents|mesh-ancestor
25859231|NCT00080158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859232|NCT00080158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25859233|NCT00080158|Antidepressive Agents|antidepressive agents|mesh-ancestor
25859234|NCT00080158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25859235|NCT00080158|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25859236|NCT00080158|Dopamine Agents|dopamine agents|mesh-ancestor
25859237|NCT00080158|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25859238|NCT00080158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25268462|NCT02415803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25268463|NCT02415803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268464|NCT02415803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268465|NCT02415777|Riboflavin|riboflavin|mesh-list
25268466|NCT02415777|Thiamine|thiamine|mesh-list
25268467|NCT02415777|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25268468|NCT02415777|Vitamin B Complex|vitamin b complex|mesh-ancestor
25268469|NCT02415777|Vitamins|vitamins|mesh-ancestor
25268470|NCT02415777|Micronutrients|micronutrients|mesh-ancestor
25268471|NCT02415777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268472|NCT02415777|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25268473|NCT02415777|Dermatologic Agents|dermatologic agents|mesh-ancestor
25268474|NCT02415777|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25268475|NCT02415777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25268476|NCT02415569|Bisacodyl|bisacodyl|mesh-list
25268477|NCT02415569|Cathartics|cathartics|mesh-ancestor
25268478|NCT02415569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25268479|NCT02415569|Laxatives|laxatives|mesh-ancestor
25859239|NCT00080158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859240|NCT00080158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25859241|NCT00080158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25859242|NCT00080158|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25859243|NCT00080158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25859244|NCT00080158|Histamine Antagonists|histamine antagonists|mesh-ancestor
25859245|NCT00080158|Histamine Agents|histamine agents|mesh-ancestor
25859246|NCT00080158|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25268492|NCT02415699|Vitamin B Complex|vitamin b complex|mesh-ancestor
25859247|NCT00080158|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25859248|NCT00080158|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25859249|NCT00080158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25859250|NCT00080158|Adrenergic Agents|adrenergic agents|mesh-ancestor
25859251|NCT00080158|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25859252|NCT00080158|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25859253|NCT00080158|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25859254|NCT00080197|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
25859255|NCT00080197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859256|NCT00080197|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25859257|NCT00080197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448994|NCT00313859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24448995|NCT00313859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24448996|NCT00313859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448997|NCT00313885|SR 46349B|sr 46349b|mesh-list
24448998|NCT00313885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24449030|NCT00313963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25859258|NCT00080197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859259|NCT00080275|Niacin|niacin|mesh-list
25859260|NCT00080275|Simvastatin|simvastatin|mesh-list
25859261|NCT00080275|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25859262|NCT00080275|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25859263|NCT00080275|Antimetabolites|antimetabolites|mesh-ancestor
25859264|NCT00080275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859265|NCT00080275|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25859266|NCT00080275|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25859267|NCT00080275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830730|NCT02160704|Hormone Antagonists|hormone antagonists|mesh-ancestor
24830731|NCT02160704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25859268|NCT00080275|Vasodilator Agents|vasodilator agents|mesh-ancestor
25859269|NCT00080275|Vitamin B Complex|vitamin b complex|mesh-ancestor
25859270|NCT00080275|Vitamins|vitamins|mesh-ancestor
24744606|NCT04224558|Hormones|hormones|mesh-ancestor
24944062|NCT03963752|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24663583|NCT01302340|Dronabinol|dronabinol|mesh-list
24744637|NCT04219774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744638|NCT04219774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24744639|NCT04219774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24744640|NCT04219774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24744641|NCT04219774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24744642|NCT04219774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859271|NCT00080275|Micronutrients|micronutrients|mesh-ancestor
25859272|NCT00080275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859273|NCT00080314|Aripiprazole|aripiprazole|mesh-list
25268480|NCT02415699|Leucovorin|leucovorin|mesh-list
25268481|NCT02415699|Fluorouracil|fluorouracil|mesh-list
25268482|NCT02415699|Oxaliplatin|oxaliplatin|mesh-list
25268483|NCT02415699|Antimetabolites|antimetabolites|mesh-ancestor
25268484|NCT02415699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268485|NCT02415699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25268486|NCT02415699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25268487|NCT02415699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25268488|NCT02415699|Immunologic Factors|immunologic factors|mesh-ancestor
25859274|NCT00080314|Antidepressive Agents|antidepressive agents|mesh-ancestor
24677799|NCT01358344|Pantoprazole|pantoprazole|mesh-list
25859275|NCT00080314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25859276|NCT00080314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25859277|NCT00080314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25859278|NCT00080314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25859279|NCT00080314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859280|NCT00080314|Dopamine Agonists|dopamine agonists|mesh-ancestor
25859281|NCT00080314|Dopamine Agents|dopamine agents|mesh-ancestor
25859282|NCT00080314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25859283|NCT00080314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859284|NCT00080314|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25859285|NCT00080314|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25859286|NCT00080314|Serotonin Agents|serotonin agents|mesh-ancestor
25859287|NCT00080314|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25859288|NCT00080314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25859289|NCT00080314|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25859290|NCT00080314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25859291|NCT00080327|Aripiprazole|aripiprazole|mesh-list
25859292|NCT00080327|Antidepressive Agents|antidepressive agents|mesh-ancestor
25859293|NCT00080327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25859294|NCT00080327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25859295|NCT00080327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25859296|NCT00080327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25859297|NCT00080327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859298|NCT00080327|Dopamine Agonists|dopamine agonists|mesh-ancestor
24830745|NCT02160743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830747|NCT02160743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24830748|NCT02160743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830749|NCT02160925|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
24830750|NCT02160925|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25859304|NCT00080327|Serotonin Agents|serotonin agents|mesh-ancestor
25859305|NCT00080327|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25859306|NCT00080327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25859307|NCT00080327|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24462976|NCT00358280|Anesthetics|anesthetics|mesh-ancestor
24462977|NCT00358280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24462978|NCT00358280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462979|NCT00358280|Sensory System Agents|sensory system agents|mesh-ancestor
25859308|NCT00080327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25859309|NCT00080340|Gefitinib|gefitinib|mesh-list
24744687|NCT04198428|Analgesics, Opioid|analgesics, opioid|mesh-list
24744688|NCT04198428|Narcotics|narcotics|mesh-ancestor
24944063|NCT03963752|Contraceptive Agents|contraceptive agents|mesh-ancestor
24944064|NCT03963752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24944065|NCT03963752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744689|NCT04198428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25859310|NCT00080340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859311|NCT00080340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25859312|NCT00080340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25268489|NCT02415699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268490|NCT02415699|Antidotes|antidotes|mesh-ancestor
25268491|NCT02415699|Protective Agents|protective agents|mesh-ancestor
25268493|NCT02415699|Vitamins|vitamins|mesh-ancestor
25268494|NCT02415699|Micronutrients|micronutrients|mesh-ancestor
25859313|NCT00080340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859314|NCT00080353|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25859315|NCT00080353|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25859316|NCT00080353|Immunologic Factors|immunologic factors|mesh-ancestor
25859317|NCT00080353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859318|NCT00080405|Bortezomib|bortezomib|mesh-list
25859319|NCT00080405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859320|NCT00080418|Paclitaxel|paclitaxel|mesh-list
25859321|NCT00080418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25859322|NCT00080418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859323|NCT00080418|Tubulin Modulators|tubulin modulators|mesh-ancestor
25859324|NCT00080418|Antimitotic Agents|antimitotic agents|mesh-ancestor
25859325|NCT00080418|Mitosis Modulators|mitosis modulators|mesh-ancestor
24695124|NCT04425902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24830755|NCT02161055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830758|NCT02161159|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24729681|NCT01623102|Immunologic Factors|immunologic factors|mesh-ancestor
25859326|NCT00080418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859327|NCT00080431|Daclizumab|daclizumab|mesh-list
25859328|NCT00080431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25859329|NCT00080431|Immunologic Factors|immunologic factors|mesh-ancestor
25859330|NCT00080431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859331|NCT00080444|Dexamethasone|dexamethasone|mesh-list
25859332|NCT00080444|Dexamethasone acetate|dexamethasone acetate|mesh-list
25859333|NCT00080444|Ondansetron|ondansetron|mesh-list
24744691|NCT04198428|Analgesics|analgesics|mesh-ancestor
25859334|NCT00080444|Aprepitant|aprepitant|mesh-list
25859335|NCT00080444|Fosaprepitant|fosaprepitant|mesh-list
25859336|NCT00080444|BB 1101|bb 1101|mesh-list
25859337|NCT00080444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25859338|NCT00080444|Antiemetics|antiemetics|mesh-ancestor
24695151|NCT04425902|Sympatholytics|sympatholytics|mesh-ancestor
25268501|NCT02415192|Amlodipine|amlodipine|mesh-list
25268502|NCT02415192|Valsartan|valsartan|mesh-list
25268503|NCT02415192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25268504|NCT02415192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25268505|NCT02415192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25268506|NCT02415192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268507|NCT02415192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25268508|NCT02415192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268509|NCT02415192|Vasodilator Agents|vasodilator agents|mesh-ancestor
25268510|NCT02415192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25859341|NCT00080444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859342|NCT00080444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25859343|NCT00080444|Glucocorticoids|glucocorticoids|mesh-ancestor
25859344|NCT00080444|Hormones|hormones|mesh-ancestor
25859345|NCT00080444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25859346|NCT00080444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25859347|NCT00080444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859348|NCT00080444|Protease Inhibitors|protease inhibitors|mesh-ancestor
25859349|NCT00080444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859350|NCT00080444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859351|NCT00080444|Antipruritics|antipruritics|mesh-ancestor
25859352|NCT00080444|Dermatologic Agents|dermatologic agents|mesh-ancestor
25859353|NCT00080444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25859354|NCT00080444|Serotonin Agents|serotonin agents|mesh-ancestor
24744732|NCT04169438|Dermatologic Agents|dermatologic agents|mesh-ancestor
24744733|NCT04160494|Atezolizumab|atezolizumab|mesh-list
24744734|NCT04160494|Immunoconjugates|immunoconjugates|mesh-list
24744735|NCT04160494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24744736|NCT04160494|Immunologic Factors|immunologic factors|mesh-ancestor
25859355|NCT00080444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24463094|NCT00358683|Certolizumab Pegol|certolizumab pegol|mesh-list
25859356|NCT00080444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25859357|NCT00080444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25859358|NCT00080444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24830761|NCT02161159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859359|NCT00080444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25859360|NCT00080444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25859361|NCT00080444|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25859362|NCT00080457|Sitaxsentan|sitaxsentan|mesh-list
25859363|NCT00080457|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25859364|NCT00080457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859365|NCT00080496|Imipenem|imipenem|mesh-list
25859366|NCT00080496|Tigecycline|tigecycline|mesh-list
25859367|NCT00080496|Cilastatin|cilastatin|mesh-list
25859368|NCT00080496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25859369|NCT00080496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25268511|NCT02415192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25268513|NCT02415335|Dexamethasone acetate|dexamethasone acetate|mesh-list
25268514|NCT02415335|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25268515|NCT02415335|BB 1101|bb 1101|mesh-list
25268516|NCT02415335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25268517|NCT02415335|Antiemetics|antiemetics|mesh-ancestor
25268518|NCT02415335|Autonomic Agents|autonomic agents|mesh-ancestor
25268519|NCT02415335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25859370|NCT00080496|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25859371|NCT00080496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859372|NCT00080496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744808|NCT04133922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25859373|NCT00080496|Protease Inhibitors|protease inhibitors|mesh-ancestor
25859374|NCT00080509|Desoxyepothilone B|desoxyepothilone b|mesh-list
25859375|NCT00080509|Tubulin Modulators|tubulin modulators|mesh-ancestor
25859376|NCT00080509|Antimitotic Agents|antimitotic agents|mesh-ancestor
25859377|NCT00080509|Mitosis Modulators|mitosis modulators|mesh-ancestor
25859378|NCT00080509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859379|NCT00080509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859380|NCT00080522|Ritonavir|ritonavir|mesh-list
25859381|NCT00080522|Lopinavir|lopinavir|mesh-list
25859382|NCT00080522|Lamivudine|lamivudine|mesh-list
25859383|NCT00080522|Zidovudine|zidovudine|mesh-list
25859384|NCT00080522|Stavudine|stavudine|mesh-list
25859385|NCT00080522|Didanosine|didanosine|mesh-list
25859386|NCT00080522|Efavirenz|efavirenz|mesh-list
25272425|NCT02392702|Ivacaftor|ivacaftor|mesh-list
25859387|NCT00080522|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25859388|NCT00080522|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25859389|NCT00080522|Protease Inhibitors|protease inhibitors|mesh-ancestor
25859390|NCT00080522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859391|NCT00080522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859392|NCT00080522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25859393|NCT00080522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25859394|NCT00080522|Antiviral Agents|antiviral agents|mesh-ancestor
25859395|NCT00080522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25859396|NCT00080522|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25859397|NCT00080522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25859398|NCT00080522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25859399|NCT00080522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25859400|NCT00080522|Antimetabolites|antimetabolites|mesh-ancestor
25859401|NCT00080522|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25859402|NCT00080522|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25859403|NCT00080522|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25859404|NCT00080522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25859405|NCT00080522|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25859406|NCT00080613|Exemestane|exemestane|mesh-list
25859407|NCT00080613|Hormones|hormones|mesh-list
25859408|NCT00080613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25268520|NCT02415335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268521|NCT02415335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25268522|NCT02415335|Glucocorticoids|glucocorticoids|mesh-ancestor
25268523|NCT02415335|Hormones|hormones|mesh-ancestor
25268524|NCT02415335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25268525|NCT02415335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25268526|NCT02415335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25268527|NCT02415335|Protease Inhibitors|protease inhibitors|mesh-ancestor
25268528|NCT02415335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859409|NCT00080613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859410|NCT00080613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859411|NCT00080613|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25859412|NCT00080613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25859413|NCT00080613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859414|NCT00080613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830769|NCT02161237|Immunologic Factors|immunologic factors|mesh-ancestor
24830770|NCT02161237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830771|NCT02161237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24744983|NCT04055818|Niacinamide|niacinamide|mesh-list
24744985|NCT04055818|Nicotinic Acids|nicotinic acids|mesh-list
24730015|NCT01625351|Sirolimus|sirolimus|mesh-list
25859415|NCT00080613|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25859416|NCT00080613|Hormone Antagonists|hormone antagonists|mesh-ancestor
25859417|NCT00080626|Docetaxel|docetaxel|mesh-list
25859418|NCT00080626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859419|NCT00080626|Tubulin Modulators|tubulin modulators|mesh-ancestor
24744986|NCT04055818|Decitabine|decitabine|mesh-list
24744987|NCT04055818|Tetrahydrouridine|tetrahydrouridine|mesh-list
24744988|NCT04055818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24744989|NCT04055818|Antimetabolites|antimetabolites|mesh-ancestor
24744990|NCT04055818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448830|NCT00313183|Pramlintide|pramlintide|mesh-list
25859420|NCT00080626|Antimitotic Agents|antimitotic agents|mesh-ancestor
25859421|NCT00080626|Mitosis Modulators|mitosis modulators|mesh-ancestor
25859422|NCT00080626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745022|NCT04038502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745023|NCT04022200|Paclitaxel|paclitaxel|mesh-list
24745024|NCT04022200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24745025|NCT04022200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876422|NCT03513952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876423|NCT03513952|Immunologic Factors|immunologic factors|mesh-ancestor
25876424|NCT03513952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876425|NCT03501498|Loperamide|loperamide|mesh-list
24830776|NCT02161354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25876426|NCT03501498|Antidiarrheals|antidiarrheals|mesh-list
25876427|NCT03501498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25876428|NCT03497676|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25876429|NCT03497676|Rilpivirine|rilpivirine|mesh-list
25876430|NCT03497676|Cabotegravir|cabotegravir|mesh-list
25876431|NCT03497676|Antiviral Agents|antiviral agents|mesh-ancestor
25876432|NCT03497676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25876433|NCT03497676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25859423|NCT00080665|Docetaxel|docetaxel|mesh-list
25859424|NCT00080665|Imatinib Mesylate|imatinib mesylate|mesh-list
24463045|NCT00358384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25859425|NCT00080665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859426|NCT00080665|Tubulin Modulators|tubulin modulators|mesh-ancestor
25859427|NCT00080665|Antimitotic Agents|antimitotic agents|mesh-ancestor
25859428|NCT00080665|Mitosis Modulators|mitosis modulators|mesh-ancestor
25859429|NCT00080665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859430|NCT00080665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25859431|NCT00080665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859432|NCT00080678|Docetaxel|docetaxel|mesh-list
25859433|NCT00080678|Imatinib Mesylate|imatinib mesylate|mesh-list
25859434|NCT00080678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859435|NCT00080678|Tubulin Modulators|tubulin modulators|mesh-ancestor
25859436|NCT00080678|Antimitotic Agents|antimitotic agents|mesh-ancestor
25859437|NCT00080678|Mitosis Modulators|mitosis modulators|mesh-ancestor
25859438|NCT00080678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859439|NCT00080678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24745040|NCT04012177|Choline|choline|mesh-list
25859440|NCT00080678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859441|NCT00080743|Tamoxifen|tamoxifen|mesh-list
25859442|NCT00080743|Gefitinib|gefitinib|mesh-list
25859443|NCT00080743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859444|NCT00080743|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25859445|NCT00080743|Hormone Antagonists|hormone antagonists|mesh-ancestor
25859446|NCT00080743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25859447|NCT00080743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859448|NCT00080743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25859449|NCT00080743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859450|NCT00080743|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25859451|NCT00080743|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25859452|NCT00080743|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25859453|NCT00080743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25859454|NCT00080743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859455|NCT00080782|Celecoxib|celecoxib|mesh-list
25859456|NCT00080782|Doxorubicin|doxorubicin|mesh-list
25859457|NCT00080782|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25859458|NCT00080782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25859459|NCT00080782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859460|NCT00080782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25859461|NCT00080782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25859462|NCT00080782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859463|NCT00080782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859464|NCT00080782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25859465|NCT00080782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25859466|NCT00080782|Analgesics|analgesics|mesh-ancestor
25859467|NCT00080782|Sensory System Agents|sensory system agents|mesh-ancestor
24745100|NCT04000529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24745101|NCT04000529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745102|NCT04000529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745106|NCT03993249|Nivolumab|nivolumab|mesh-list
24745108|NCT03993249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745111|NCT03990883|Lidocaine|lidocaine|mesh-list
25859468|NCT00080782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25268554|NCT02415270|Menthol|menthol|mesh-list
25268555|NCT02415270|Nicotine|nicotine|mesh-list
25268556|NCT02415270|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25268557|NCT02415270|Autonomic Agents|autonomic agents|mesh-ancestor
25268558|NCT02415270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25268559|NCT02415270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859469|NCT00080782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859470|NCT00080782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25859471|NCT00080782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25859472|NCT00080782|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25859473|NCT00080782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25859474|NCT00080795|Gemcitabine|gemcitabine|mesh-list
25859475|NCT00080795|Cisplatin|cisplatin|mesh-list
25859476|NCT00080795|Doxorubicin|doxorubicin|mesh-list
24830795|NCT02161614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25859477|NCT00080795|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25859478|NCT00080795|Ifosfamide|ifosfamide|mesh-list
25859479|NCT00080795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859480|NCT00080795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25859481|NCT00080795|Antimetabolites|antimetabolites|mesh-ancestor
25859482|NCT00080795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859483|NCT00080795|Antiviral Agents|antiviral agents|mesh-ancestor
25859484|NCT00080795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25859485|NCT00080795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859486|NCT00080795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25859487|NCT00080795|Immunologic Factors|immunologic factors|mesh-ancestor
25859488|NCT00080795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859489|NCT00080795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25859490|NCT00080795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25859491|NCT00080795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25859492|NCT00080795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25859493|NCT00080795|Alkylating Agents|alkylating agents|mesh-ancestor
25859494|NCT00080808|Phentolamine|phentolamine|mesh-list
25859495|NCT00080808|Sildenafil Citrate|sildenafil citrate|mesh-list
25859496|NCT00080808|Alprostadil|alprostadil|mesh-list
25859497|NCT00080808|Papaverine|papaverine|mesh-list
25859498|NCT00080808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859499|NCT00080808|Vasodilator Agents|vasodilator agents|mesh-ancestor
24830799|NCT02161614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24830800|NCT02161614|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24830801|NCT02161653|Pyridoxine|pyridoxine|mesh-list
24830802|NCT02161653|Prednisone|prednisone|mesh-list
24535091|NCT00648570|Citalopram|citalopram|mesh-list
24409777|NCT00183040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859500|NCT00080808|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24745300|NCT03837925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24745301|NCT03837925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859501|NCT00080808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24830822|NCT02161653|Vitamin B Complex|vitamin b complex|mesh-ancestor
25859502|NCT00080808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859503|NCT00080808|Urological Agents|urological agents|mesh-ancestor
25859504|NCT00080808|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25859505|NCT00080808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25859506|NCT00080808|Adrenergic Agents|adrenergic agents|mesh-ancestor
25859507|NCT00080808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25859508|NCT00080808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859509|NCT00080808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25859510|NCT00080808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25859511|NCT00080847|Prednisone|prednisone|mesh-list
24695547|NCT03142035|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25859512|NCT00080847|Cyclophosphamide|cyclophosphamide|mesh-list
25859513|NCT00080847|Rituximab|rituximab|mesh-list
25859514|NCT00080847|Doxorubicin|doxorubicin|mesh-list
25859515|NCT00080847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25859516|NCT00080847|Vincristine|vincristine|mesh-list
25859517|NCT00080847|Oblimersen|oblimersen|mesh-list
25859518|NCT00080847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25859519|NCT00080847|Immunologic Factors|immunologic factors|mesh-ancestor
25859520|NCT00080847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830842|NCT02161692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830843|NCT02161692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24830844|NCT02161692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24830845|NCT02161692|Alkylating Agents|alkylating agents|mesh-ancestor
24830846|NCT02161692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830847|NCT02161692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859521|NCT00080847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25859522|NCT00080847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25859523|NCT00080847|Alkylating Agents|alkylating agents|mesh-ancestor
25859524|NCT00080847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859525|NCT00080847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859526|NCT00080847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25859527|NCT00080847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25859528|NCT00080847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25859529|NCT00080847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25859530|NCT00080847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25859531|NCT00080847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859532|NCT00080847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24745357|NCT03809923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24745359|NCT03809923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24745360|NCT03809923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24745361|NCT03809923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24745362|NCT03809923|Adrenergic Agents|adrenergic agents|mesh-ancestor
24745363|NCT03809923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24745364|NCT03808961|Vitamins|vitamins|mesh-list
24745365|NCT03808961|Niacin|niacin|mesh-list
24745366|NCT03808961|Niacinamide|niacinamide|mesh-list
24745367|NCT03808961|Nicotinic Acids|nicotinic acids|mesh-list
24745368|NCT03808961|Vitamin B Complex|vitamin b complex|mesh-list
25859533|NCT00080847|Glucocorticoids|glucocorticoids|mesh-ancestor
25859534|NCT00080847|Hormones|hormones|mesh-ancestor
25859535|NCT00080847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24463160|NCT00359151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463161|NCT00359151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24463162|NCT00359151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24830848|NCT02161692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24830849|NCT02161692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24830850|NCT02161692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24830851|NCT02161692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24616826|NCT01039363|Antiviral Agents|antiviral agents|mesh-ancestor
25859536|NCT00080847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25268560|NCT02415270|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25268561|NCT02415270|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25268562|NCT02415270|Cholinergic Agents|cholinergic agents|mesh-ancestor
25268563|NCT02415270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25268564|NCT02415270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268565|NCT02415270|Antipruritics|antipruritics|mesh-ancestor
25268569|NCT02415257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25859537|NCT00080847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25859538|NCT00080847|Tubulin Modulators|tubulin modulators|mesh-ancestor
25859539|NCT00080847|Antimitotic Agents|antimitotic agents|mesh-ancestor
25859540|NCT00080847|Mitosis Modulators|mitosis modulators|mesh-ancestor
25859541|NCT00080860|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
24745369|NCT03808961|Micronutrients|micronutrients|mesh-ancestor
24745370|NCT03808961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745378|NCT03806452|Antisickling Agents|antisickling agents|mesh-ancestor
25859542|NCT00080860|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25859543|NCT00080860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859544|NCT00080886|Cytarabine|cytarabine|mesh-list
25859545|NCT00080886|Rituximab|rituximab|mesh-list
25859546|NCT00080886|Etoposide|etoposide|mesh-list
25859547|NCT00080886|Melphalan|melphalan|mesh-list
25859548|NCT00080886|Carmustine|carmustine|mesh-list
25859549|NCT00080886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25859550|NCT00080886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859551|NCT00080886|Immunologic Factors|immunologic factors|mesh-ancestor
25859552|NCT00080886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859553|NCT00080886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25859554|NCT00080886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25859555|NCT00080886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25859556|NCT00080886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25859557|NCT00080886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859558|NCT00080886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859559|NCT00080886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25859560|NCT00080886|Antimetabolites|antimetabolites|mesh-ancestor
25859561|NCT00080886|Antiviral Agents|antiviral agents|mesh-ancestor
25859562|NCT00080886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25859563|NCT00080886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25859564|NCT00080886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25859565|NCT00080886|Alkylating Agents|alkylating agents|mesh-ancestor
25859566|NCT00080886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25859567|NCT00080925|Cytarabine|cytarabine|mesh-list
25859568|NCT00080925|Cyclosporine|cyclosporine|mesh-list
25859569|NCT00080925|Prednisone|prednisone|mesh-list
25859570|NCT00080925|Cyclophosphamide|cyclophosphamide|mesh-list
25859571|NCT00080925|Rituximab|rituximab|mesh-list
25859572|NCT00080925|Doxorubicin|doxorubicin|mesh-list
25859573|NCT00080925|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25859574|NCT00080925|Fludarabine|fludarabine|mesh-list
25859575|NCT00080925|Fludarabine phosphate|fludarabine phosphate|mesh-list
25859576|NCT00080925|Etoposide|etoposide|mesh-list
24653649|NCT01244880|Ketamine|ketamine|mesh-list
24618550|NCT01048983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618551|NCT01048983|Dopamine Agents|dopamine agents|mesh-ancestor
24618552|NCT01048983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24618553|NCT01048983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618554|NCT01048983|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24618555|NCT01048983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25859577|NCT00080925|Vincristine|vincristine|mesh-list
25859578|NCT00080925|Cyclosporins|cyclosporins|mesh-list
25859579|NCT00080925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25859580|NCT00080925|Immunologic Factors|immunologic factors|mesh-ancestor
25859581|NCT00080925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695676|NCT02246257|Antimetabolites|antimetabolites|mesh-ancestor
25859582|NCT00080925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24851233|NCT02256124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859583|NCT00080925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25859584|NCT00080925|Alkylating Agents|alkylating agents|mesh-ancestor
25859585|NCT00080925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859586|NCT00080925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859587|NCT00080925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25859588|NCT00080925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25268570|NCT02415257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25268571|NCT02415257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25268572|NCT02415257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268573|NCT02415179|Fluticasone|fluticasone|mesh-list
25268574|NCT02415179|Mometasone Furoate|mometasone furoate|mesh-list
25859589|NCT00080925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25859590|NCT00080925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25859591|NCT00080925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25859592|NCT00080925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859593|NCT00080925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25859594|NCT00080925|Glucocorticoids|glucocorticoids|mesh-ancestor
25859595|NCT00080925|Hormones|hormones|mesh-ancestor
25859596|NCT00080925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25859597|NCT00080925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25859598|NCT00080925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25859599|NCT00080925|Antimetabolites|antimetabolites|mesh-ancestor
25859600|NCT00080925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25859601|NCT00080925|Antiviral Agents|antiviral agents|mesh-ancestor
25859602|NCT00080925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25859603|NCT00080925|Tubulin Modulators|tubulin modulators|mesh-ancestor
25859604|NCT00080925|Antimitotic Agents|antimitotic agents|mesh-ancestor
25859605|NCT00080925|Mitosis Modulators|mitosis modulators|mesh-ancestor
25859606|NCT00080925|Antifungal Agents|antifungal agents|mesh-ancestor
25859607|NCT00080925|Dermatologic Agents|dermatologic agents|mesh-ancestor
25859608|NCT00080925|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25859609|NCT00080951|Leucovorin|leucovorin|mesh-list
25859610|NCT00080951|Fluorouracil|fluorouracil|mesh-list
25859611|NCT00080951|Oxaliplatin|oxaliplatin|mesh-list
25859612|NCT00080951|Irinotecan|irinotecan|mesh-list
25859613|NCT00080951|Calcium|calcium|mesh-list
25859614|NCT00080951|Levoleucovorin|levoleucovorin|mesh-list
25859615|NCT00080951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25859616|NCT00080951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859617|NCT00080951|Antimetabolites|antimetabolites|mesh-ancestor
25859618|NCT00080951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859619|NCT00080951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25859620|NCT00080951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859621|NCT00080951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25859622|NCT00080951|Immunologic Factors|immunologic factors|mesh-ancestor
25859623|NCT00080951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25859624|NCT00080951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25859625|NCT00080951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859626|NCT00080951|Antidotes|antidotes|mesh-ancestor
25859627|NCT00080951|Protective Agents|protective agents|mesh-ancestor
25859628|NCT00080951|Vitamin B Complex|vitamin b complex|mesh-ancestor
25859629|NCT00080951|Vitamins|vitamins|mesh-ancestor
25859630|NCT00080951|Micronutrients|micronutrients|mesh-ancestor
25859631|NCT00080977|Aldesleukin|aldesleukin|mesh-list
25859632|NCT00080977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859633|NCT00080977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25859634|NCT00080977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25268577|NCT02415179|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25268578|NCT02415179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25268579|NCT02415179|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25268580|NCT02415179|Autonomic Agents|autonomic agents|mesh-ancestor
25425149|NCT02166463|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25664891|NCT01676116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664892|NCT01676116|Incretins|incretins|mesh-ancestor
25664893|NCT01676116|Hormones|hormones|mesh-ancestor
25664894|NCT01676116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25664895|NCT01676116|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25664896|NCT01676220|Insulin|insulin|mesh-list
25664897|NCT01676220|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25664898|NCT01676220|Insulin Glargine|insulin glargine|mesh-list
25664899|NCT01676220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24650727|NCT01227603|Vasodilator Agents|vasodilator agents|mesh-ancestor
25268581|NCT02415179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25268582|NCT02415179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268583|NCT02415179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25268584|NCT02415179|Respiratory System Agents|respiratory system agents|mesh-ancestor
25268585|NCT02415179|Dermatologic Agents|dermatologic agents|mesh-ancestor
25268586|NCT02415179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25268587|NCT02415179|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25268588|NCT02415179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25268589|NCT02415179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25268590|NCT02415179|Adrenergic Agents|adrenergic agents|mesh-ancestor
25268591|NCT02415179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25268592|NCT02415179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268594|NCT02415179|Hormones|hormones|mesh-ancestor
25268595|NCT02415179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25268596|NCT02415179|Sympathomimetics|sympathomimetics|mesh-ancestor
25268600|NCT02415114|Protective Agents|protective agents|mesh-ancestor
25268601|NCT02415114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268602|NCT02415114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25268603|NCT02415114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25859635|NCT00080977|Antiviral Agents|antiviral agents|mesh-ancestor
25859636|NCT00080977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25859637|NCT00080990|Leucovorin|leucovorin|mesh-list
25859638|NCT00080990|Fluorouracil|fluorouracil|mesh-list
25859639|NCT00080990|Oxaliplatin|oxaliplatin|mesh-list
25859640|NCT00080990|Alvocidib|alvocidib|mesh-list
25859641|NCT00080990|Calcium|calcium|mesh-list
25859642|NCT00080990|Levoleucovorin|levoleucovorin|mesh-list
25859643|NCT00080990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25859644|NCT00080990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859645|NCT00080990|Antimetabolites|antimetabolites|mesh-ancestor
25859646|NCT00080990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859647|NCT00080990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25859648|NCT00080990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859649|NCT00080990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25859650|NCT00080990|Immunologic Factors|immunologic factors|mesh-ancestor
24745672|NCT03651102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24745673|NCT03651102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24745674|NCT03651102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24745675|NCT03651102|Growth Substances|growth substances|mesh-ancestor
24410190|NCT00184847|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24410191|NCT00184847|Purinergic Agents|purinergic agents|mesh-ancestor
24410192|NCT00184847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24529741|NCT00627692|Prucalopride|prucalopride|mesh-list
25859651|NCT00080990|Antidotes|antidotes|mesh-ancestor
25859652|NCT00080990|Protective Agents|protective agents|mesh-ancestor
25859653|NCT00080990|Vitamin B Complex|vitamin b complex|mesh-ancestor
25859654|NCT00080990|Vitamins|vitamins|mesh-ancestor
25859655|NCT00080990|Micronutrients|micronutrients|mesh-ancestor
25859656|NCT00080990|Growth Inhibitors|growth inhibitors|mesh-ancestor
25859657|NCT00080990|Growth Substances|growth substances|mesh-ancestor
25859658|NCT00080990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25859659|NCT00080990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859660|NCT00081042|Paclitaxel|paclitaxel|mesh-list
25859661|NCT00081042|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25859662|NCT00081042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25859663|NCT00081042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859664|NCT00081042|Tubulin Modulators|tubulin modulators|mesh-ancestor
25268605|NCT02414919|Etonogestrel|etonogestrel|mesh-list
25268606|NCT02414919|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25268607|NCT02414919|Contraceptive Agents|contraceptive agents|mesh-ancestor
25268608|NCT02414919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25268609|NCT02414919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268610|NCT02414919|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25268611|NCT02414919|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25268614|NCT02415023|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25268615|NCT02415023|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25268616|NCT02415023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25268617|NCT02415023|Tubulin Modulators|tubulin modulators|mesh-ancestor
25268618|NCT02415023|Antimitotic Agents|antimitotic agents|mesh-ancestor
25268619|NCT02415023|Mitosis Modulators|mitosis modulators|mesh-ancestor
24830907|NCT02162121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25664900|NCT01676220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859665|NCT00081042|Antimitotic Agents|antimitotic agents|mesh-ancestor
25859666|NCT00081042|Mitosis Modulators|mitosis modulators|mesh-ancestor
25876434|NCT03497676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25664901|NCT01676311|Huperzine A|huperzine a|mesh-list
25664902|NCT01676311|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25859667|NCT00081042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859668|NCT00081055|Cyclosporine|cyclosporine|mesh-list
25859669|NCT00081055|Cyclophosphamide|cyclophosphamide|mesh-list
25859670|NCT00081055|Busulfan|busulfan|mesh-list
25859671|NCT00081055|Methotrexate|methotrexate|mesh-list
25859672|NCT00081055|Cyclosporins|cyclosporins|mesh-list
25859673|NCT00081055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25859674|NCT00081055|Immunologic Factors|immunologic factors|mesh-ancestor
25859675|NCT00081055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859676|NCT00081055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24830908|NCT02162121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830909|NCT02162121|Sensory System Agents|sensory system agents|mesh-ancestor
25859677|NCT00081055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25005430|NCT04107727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005431|NCT04107727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005432|NCT04107727|Antiviral Agents|antiviral agents|mesh-ancestor
25005433|NCT04107727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24944097|NCT03963466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944098|NCT03963466|Hemostatics|hemostatics|mesh-ancestor
25859678|NCT00081055|Alkylating Agents|alkylating agents|mesh-ancestor
24944099|NCT03963466|Coagulants|coagulants|mesh-ancestor
24944100|NCT03963479|Vitamin B 6|vitamin b 6|mesh-list
25859679|NCT00081055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859680|NCT00081055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859681|NCT00081055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25859682|NCT00081055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25859683|NCT00081055|Abortifacient Agents|abortifacient agents|mesh-ancestor
25859684|NCT00081055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25859685|NCT00081055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24449080|NCT00314171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24449089|NCT00314184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24449090|NCT00314184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449092|NCT00314210|Antidepressive Agents|antidepressive agents|mesh-ancestor
24449093|NCT00314210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24449094|NCT00314210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24449095|NCT00314210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24449096|NCT00314210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24695977|NCT01426880|Paclitaxel|paclitaxel|mesh-list
25859686|NCT00081055|Antimetabolites|antimetabolites|mesh-ancestor
25859687|NCT00081055|Dermatologic Agents|dermatologic agents|mesh-ancestor
25859688|NCT00081055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859689|NCT00081055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25859690|NCT00081055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25859691|NCT00081055|Antifungal Agents|antifungal agents|mesh-ancestor
25859692|NCT00081055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25859693|NCT00081055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25859694|NCT00081068|Alemtuzumab|alemtuzumab|mesh-list
25859695|NCT00081068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25859696|NCT00081068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859697|NCT00081094|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25859698|NCT00081094|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25005462|NCT03997097|Sildenafil Citrate|sildenafil citrate|mesh-list
24410226|NCT00184899|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24410227|NCT00184899|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24745710|NCT03649802|Cholecalciferol|cholecalciferol|mesh-list
24745711|NCT03649802|Vitamins|vitamins|mesh-list
24745712|NCT03649802|Micronutrients|micronutrients|mesh-ancestor
24745713|NCT03649802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859699|NCT00081094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859700|NCT00081107|Epothilones|epothilones|mesh-list
25859701|NCT00081107|Desoxyepothilone B|desoxyepothilone b|mesh-list
25859702|NCT00081107|Tubulin Modulators|tubulin modulators|mesh-ancestor
25859703|NCT00081107|Antimitotic Agents|antimitotic agents|mesh-ancestor
25859704|NCT00081107|Mitosis Modulators|mitosis modulators|mesh-ancestor
25859705|NCT00081107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859706|NCT00081107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859707|NCT00081133|Imatinib Mesylate|imatinib mesylate|mesh-list
25664903|NCT01676311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664904|NCT01676311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664905|NCT01676311|Cholinergic Agents|cholinergic agents|mesh-ancestor
25664906|NCT01676311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25664907|NCT01676311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664908|NCT01676311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25859708|NCT00081133|Arsenic Trioxide|arsenic trioxide|mesh-list
25859709|NCT00081133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859710|NCT00081133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25859711|NCT00081133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859712|NCT00081133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859714|NCT00081172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25664909|NCT01676311|Protective Agents|protective agents|mesh-ancestor
25859715|NCT00081172|Immunologic Factors|immunologic factors|mesh-ancestor
25272493|NCT02391883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272494|NCT02391805|Tenofovir|tenofovir|mesh-list
25272495|NCT02391805|Entecavir|entecavir|mesh-list
25859716|NCT00081172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268623|NCT02414880|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25268624|NCT02414880|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25268625|NCT02414880|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24696012|NCT01426971|Ibuprofen|ibuprofen|mesh-list
25859717|NCT00081224|Celecoxib|celecoxib|mesh-list
25859718|NCT00081224|Capecitabine|capecitabine|mesh-list
25859719|NCT00081224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25859720|NCT00081224|Antimetabolites|antimetabolites|mesh-ancestor
24745714|NCT03649802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24745729|NCT03620578|Nivolumab|nivolumab|mesh-list
24745730|NCT03620578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24745731|NCT03620578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859721|NCT00081224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859722|NCT00081224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859723|NCT00081224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25859724|NCT00081224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24830944|NCT02162134|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24830945|NCT02162134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24830946|NCT02162134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24830948|NCT02162134|Sensory System Agents|sensory system agents|mesh-ancestor
24830949|NCT02162134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24830950|NCT02162134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25859725|NCT00081224|Analgesics|analgesics|mesh-ancestor
25859726|NCT00081224|Sensory System Agents|sensory system agents|mesh-ancestor
25859727|NCT00081224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25859728|NCT00081224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859729|NCT00081224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25859730|NCT00081224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25859731|NCT00081224|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25859732|NCT00081224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25859733|NCT00081224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859734|NCT00081237|Oxaliplatin|oxaliplatin|mesh-list
25859735|NCT00081237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859736|NCT00081276|Cisplatin|cisplatin|mesh-list
25859737|NCT00081276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859738|NCT00081302|Paclitaxel|paclitaxel|mesh-list
25859739|NCT00081302|Carboplatin|carboplatin|mesh-list
25859740|NCT00081302|Cetuximab|cetuximab|mesh-list
24830960|NCT02162134|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24830961|NCT02162134|Cholinergic Agents|cholinergic agents|mesh-ancestor
24830962|NCT02162251|Donepezil|donepezil|mesh-list
25859741|NCT00081302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25859742|NCT00081302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859743|NCT00081302|Tubulin Modulators|tubulin modulators|mesh-ancestor
25859744|NCT00081302|Antimitotic Agents|antimitotic agents|mesh-ancestor
25859745|NCT00081302|Mitosis Modulators|mitosis modulators|mesh-ancestor
25859746|NCT00081302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859747|NCT00081302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25859748|NCT00081315|Amifostine|amifostine|mesh-list
25859749|NCT00081315|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25859750|NCT00081315|Protective Agents|protective agents|mesh-ancestor
25859751|NCT00081315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859752|NCT00081380|Valproic Acid|valproic acid|mesh-list
25859753|NCT00081380|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25859754|NCT00081380|Antipsychotic Agents|antipsychotic agents|mesh-list
25859755|NCT00081380|Antidepressive Agents|antidepressive agents|mesh-ancestor
25664910|NCT01676415|Mometasone Furoate|mometasone furoate|mesh-list
25664911|NCT01676415|Prednisone|prednisone|mesh-list
25664912|NCT01676415|Glucocorticoids|glucocorticoids|mesh-list
25664913|NCT01676415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25664914|NCT01676415|Hormones|hormones|mesh-ancestor
25664915|NCT01676415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25664916|NCT01676415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859756|NCT00081380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25859757|NCT00081380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25859758|NCT00081380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25859759|NCT00081380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859760|NCT00081380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859761|NCT00081380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859762|NCT00081380|Antimanic Agents|antimanic agents|mesh-ancestor
25859763|NCT00081380|Anticonvulsants|anticonvulsants|mesh-ancestor
25859764|NCT00081380|GABA Agents|gaba agents|mesh-ancestor
25268626|NCT02414880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25268685|NCT02414802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25268627|NCT02414880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268628|NCT02414880|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25268629|NCT02414880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25268630|NCT02414880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268631|NCT02414880|Cholinergic Agents|cholinergic agents|mesh-ancestor
25268632|NCT02414880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25859765|NCT00081380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25859766|NCT00081471|Darbepoetin alfa|darbepoetin alfa|mesh-list
25859767|NCT00081471|Hematinics|hematinics|mesh-ancestor
24481653|NCT00436241|Capecitabine|capecitabine|mesh-list
25859768|NCT00081484|Epoetin Alfa|epoetin alfa|mesh-list
25859769|NCT00081484|Hematinics|hematinics|mesh-ancestor
25859770|NCT00081536|Capecitabine|capecitabine|mesh-list
25268633|NCT02414880|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25268634|NCT02414880|Autonomic Agents|autonomic agents|mesh-ancestor
25268635|NCT02414984|Golimumab|golimumab|mesh-list
25268636|NCT02414984|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25268637|NCT02414984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25268638|NCT02414984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25268639|NCT02414984|Immunologic Factors|immunologic factors|mesh-ancestor
25268640|NCT02414984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268641|NCT02414945|Cyclophosphamide|cyclophosphamide|mesh-list
25859771|NCT00081536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25859772|NCT00081536|Antimetabolites|antimetabolites|mesh-ancestor
24831004|NCT02162485|Charcoal|charcoal|mesh-list
24831005|NCT02162485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25859773|NCT00081536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859774|NCT00081536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859775|NCT00081549|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
25859776|NCT00081549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859777|NCT00081575|Levofloxacin|levofloxacin|mesh-list
25859778|NCT00081575|Ofloxacin|ofloxacin|mesh-list
24831007|NCT02162485|Autonomic Agents|autonomic agents|mesh-ancestor
24831008|NCT02162485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24831009|NCT02162485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831010|NCT02162485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24831011|NCT02162485|Respiratory System Agents|respiratory system agents|mesh-ancestor
24831012|NCT02162485|Dermatologic Agents|dermatologic agents|mesh-ancestor
24831013|NCT02162485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24617006|NCT01040286|Analgesics|analgesics|mesh-ancestor
25859779|NCT00081575|Tigecycline|tigecycline|mesh-list
25859780|NCT00081575|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25859781|NCT00081575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25859782|NCT00081575|Renal Agents|renal agents|mesh-ancestor
25859783|NCT00081575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24745907|NCT03523520|Anticonvulsants|anticonvulsants|mesh-ancestor
24745908|NCT03523520|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24745909|NCT03523520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859784|NCT00081575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25859785|NCT00081575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25859786|NCT00081575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859787|NCT00081575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859788|NCT00081575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664917|NCT01676415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25664918|NCT01676415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664919|NCT01676415|Dermatologic Agents|dermatologic agents|mesh-ancestor
25664920|NCT01676415|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25272507|NCT02391662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24487666|NCT00464373|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24487667|NCT00464373|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24446796|NCT00306020|Morphine|morphine|mesh-list
25859790|NCT00081575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25859791|NCT00081575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25859792|NCT00081588|Darunavir|darunavir|mesh-list
25859793|NCT00081588|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25859794|NCT00081588|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25859795|NCT00081588|Protease Inhibitors|protease inhibitors|mesh-ancestor
25859796|NCT00081588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25268643|NCT02414945|Interleukin-2|interleukin-2|mesh-list
25268644|NCT02414945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25268645|NCT02414945|Immunologic Factors|immunologic factors|mesh-ancestor
25268646|NCT02414945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268647|NCT02414945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25268648|NCT02414945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25268649|NCT02414945|Alkylating Agents|alkylating agents|mesh-ancestor
25268650|NCT02414945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449920|NCT00317408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24449921|NCT00317408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24777745|NCT01866267|Antiviral Agents|antiviral agents|mesh-ancestor
24449922|NCT00317408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24449923|NCT00317408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24449924|NCT00317408|Antiviral Agents|antiviral agents|mesh-ancestor
24449925|NCT00317408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24449926|NCT00317408|Antidotes|antidotes|mesh-ancestor
25859797|NCT00081588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859798|NCT00081588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25859799|NCT00081588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25859800|NCT00081588|Antiviral Agents|antiviral agents|mesh-ancestor
25859801|NCT00081588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24456870|NCT00332436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24456871|NCT00332436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24456873|NCT00332540|Bimatoprost|bimatoprost|mesh-list
24456874|NCT00332540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24456875|NCT00332540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24456876|NCT00332540|Adrenergic Agents|adrenergic agents|mesh-ancestor
25859802|NCT00081614|Bevacizumab|bevacizumab|mesh-list
24456877|NCT00332540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24422433|NCT00222495|Serotonin Agents|serotonin agents|mesh-ancestor
24422434|NCT00222495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25859803|NCT00081614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25859804|NCT00081614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24449108|NCT00314405|Methylene Blue|methylene blue|mesh-list
24449109|NCT00314405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449110|NCT00314405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449118|NCT00314509|Ciclesonide|ciclesonide|mesh-list
24449119|NCT00314509|Formoterol Fumarate|formoterol fumarate|mesh-list
25268651|NCT02414945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25268652|NCT02414945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25268653|NCT02414945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25268654|NCT02414945|Analgesics|analgesics|mesh-ancestor
25268655|NCT02414945|Sensory System Agents|sensory system agents|mesh-ancestor
25268656|NCT02414945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25268657|NCT02415062|Donepezil|donepezil|mesh-list
25268658|NCT02415062|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25268659|NCT02415062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25268660|NCT02415062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268661|NCT02415062|Cholinergic Agents|cholinergic agents|mesh-ancestor
25268662|NCT02415062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25268663|NCT02415062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268664|NCT02415062|Nootropic Agents|nootropic agents|mesh-ancestor
25268665|NCT02415036|Melphalan|melphalan|mesh-list
25268666|NCT02415036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25268667|NCT02415036|Alkylating Agents|alkylating agents|mesh-ancestor
25664921|NCT01677195|Calcium Carbonate|calcium carbonate|mesh-list
25664922|NCT01677195|Antacids|antacids|mesh-ancestor
25664923|NCT01677195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664924|NCT01677195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25664925|NCT01677286|Doxycycline|doxycycline|mesh-list
25268668|NCT02415036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268669|NCT02415036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859805|NCT00081614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859806|NCT00081614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25272515|NCT02391662|Antiviral Agents|antiviral agents|mesh-ancestor
25859807|NCT00081614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25859808|NCT00081614|Growth Substances|growth substances|mesh-ancestor
25268670|NCT02415036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25268671|NCT02415036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25268672|NCT02415036|Immunologic Factors|immunologic factors|mesh-ancestor
25268673|NCT02415036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268674|NCT02414802|Calcium, Dietary|calcium, dietary|mesh-list
25268675|NCT02414802|Heparin|heparin|mesh-list
25268676|NCT02414802|Calcium heparin|calcium heparin|mesh-list
25268677|NCT02414802|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25268678|NCT02414802|Tinzaparin|tinzaparin|mesh-list
25268679|NCT02414802|Dalteparin|dalteparin|mesh-list
25268680|NCT02414802|Calcium|calcium|mesh-list
25268681|NCT02414802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25859809|NCT00081614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940982|NCT03996655|Neostigmine|neostigmine|mesh-list
25859810|NCT00081614|Growth Inhibitors|growth inhibitors|mesh-ancestor
25859811|NCT00081614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25859812|NCT00081614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859813|NCT00081614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859814|NCT00081744|Tigecycline|tigecycline|mesh-list
25859815|NCT00081744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25859816|NCT00081744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25859817|NCT00081744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25859818|NCT00081744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859819|NCT00081744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859820|NCT00081757|Thalidomide|thalidomide|mesh-list
25859821|NCT00081757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25268682|NCT02414802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268683|NCT02414802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25268684|NCT02414802|Anticoagulants|anticoagulants|mesh-ancestor
25268686|NCT02414802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25268687|NCT02414802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268688|NCT02414750|Vemurafenib|vemurafenib|mesh-list
25268689|NCT02414750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25268690|NCT02414750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25268691|NCT02414750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25268692|NCT02414750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268693|NCT02414503|Oxytocin|oxytocin|mesh-list
25268694|NCT02414503|Oxytocics|oxytocics|mesh-ancestor
25268695|NCT02414503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25268696|NCT02414503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268697|NCT02414555|Phenylephrine|phenylephrine|mesh-list
25268698|NCT02414555|Norepinephrine|norepinephrine|mesh-list
25268699|NCT02414555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25268700|NCT02414555|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25268701|NCT02414555|Mydriatics|mydriatics|mesh-ancestor
25268702|NCT02414555|Autonomic Agents|autonomic agents|mesh-ancestor
25859822|NCT00081757|Immunologic Factors|immunologic factors|mesh-ancestor
25859823|NCT00081757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941001|NCT03996252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24746024|NCT03456700|Auranofin|auranofin|mesh-list
24746054|NCT03435185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24746055|NCT03435185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24746056|NCT03435185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24746057|NCT03435185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831019|NCT02162485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831020|NCT02162485|Glucocorticoids|glucocorticoids|mesh-ancestor
24831021|NCT02162485|Hormones|hormones|mesh-ancestor
24831022|NCT02162485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24831023|NCT02162485|Sympathomimetics|sympathomimetics|mesh-ancestor
25859824|NCT00081757|Leprostatic Agents|leprostatic agents|mesh-ancestor
25859825|NCT00081757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25859826|NCT00081757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25859827|NCT00081757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25859828|NCT00081757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25859829|NCT00081757|Growth Substances|growth substances|mesh-ancestor
25859830|NCT00081757|Growth Inhibitors|growth inhibitors|mesh-ancestor
25859831|NCT00081757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859832|NCT00081796|Capecitabine|capecitabine|mesh-list
25664926|NCT01677286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25664927|NCT01677286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25664928|NCT01677286|Antimalarials|antimalarials|mesh-ancestor
25664929|NCT01677286|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25859833|NCT00081796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25859834|NCT00081796|Antimetabolites|antimetabolites|mesh-ancestor
25859835|NCT00081796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859836|NCT00081796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24831028|NCT02162537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24831029|NCT02162537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25268703|NCT02414555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25268704|NCT02414555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746074|NCT03408574|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25859837|NCT00081822|Cytarabine|cytarabine|mesh-list
25859838|NCT00081822|Clofarabine|clofarabine|mesh-list
25859839|NCT00081822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25859840|NCT00081822|Antimetabolites|antimetabolites|mesh-ancestor
24746075|NCT03408574|Autonomic Agents|autonomic agents|mesh-ancestor
24746076|NCT03408574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24746077|NCT03408574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746078|NCT03408574|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24746079|NCT03408574|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24746080|NCT03408574|Cholinergic Agents|cholinergic agents|mesh-ancestor
24746081|NCT03408574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25268705|NCT02414555|Sympathomimetics|sympathomimetics|mesh-ancestor
25268706|NCT02414555|Nasal Decongestants|nasal decongestants|mesh-ancestor
25268707|NCT02414555|Respiratory System Agents|respiratory system agents|mesh-ancestor
25268708|NCT02414555|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25268709|NCT02414555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25268710|NCT02414555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25268711|NCT02414555|Adrenergic Agents|adrenergic agents|mesh-ancestor
25268712|NCT02414555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25268713|NCT02414555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268714|NCT02414555|Protective Agents|protective agents|mesh-ancestor
25268715|NCT02414568|Prednisone|prednisone|mesh-list
25268716|NCT02414568|Doxorubicin|doxorubicin|mesh-list
25268717|NCT02414568|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25268718|NCT02414568|Vinblastine|vinblastine|mesh-list
24831032|NCT02162537|Growth Substances|growth substances|mesh-ancestor
24831033|NCT02162537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831034|NCT02162537|Growth Inhibitors|growth inhibitors|mesh-ancestor
24831035|NCT02162537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24831036|NCT02162537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859841|NCT00081822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859842|NCT00081822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859843|NCT00081822|Antiviral Agents|antiviral agents|mesh-ancestor
25859844|NCT00081822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25859845|NCT00081822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25859846|NCT00081822|Immunologic Factors|immunologic factors|mesh-ancestor
25859847|NCT00081822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859848|NCT00081835|Immunoglobulins|immunoglobulins|mesh-list
25859849|NCT00081835|Antibodies|antibodies|mesh-list
25859850|NCT00081835|gamma-Globulins|gamma-globulins|mesh-list
25859851|NCT00081835|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25859852|NCT00081835|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25859853|NCT00081835|Immunologic Factors|immunologic factors|mesh-ancestor
25859854|NCT00081835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859855|NCT00081848|Metronidazole|metronidazole|mesh-list
25859856|NCT00081848|Celecoxib|celecoxib|mesh-list
25859857|NCT00081848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25859858|NCT00081848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25859859|NCT00081848|Analgesics|analgesics|mesh-ancestor
25859860|NCT00081848|Sensory System Agents|sensory system agents|mesh-ancestor
25859861|NCT00081848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25859862|NCT00081848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859863|NCT00081848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25859864|NCT00081848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25859865|NCT00081848|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25859866|NCT00081848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25859867|NCT00081848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859868|NCT00081848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859869|NCT00081848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25859870|NCT00081848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24746082|NCT03408574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859871|NCT00081848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25859872|NCT00081848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25859873|NCT00081874|Everolimus|everolimus|mesh-list
25859874|NCT00081874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859877|NCT00081874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859878|NCT00081887|Clofarabine|clofarabine|mesh-list
25859879|NCT00081887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25859880|NCT00081887|Antimetabolites|antimetabolites|mesh-ancestor
25859881|NCT00081887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859882|NCT00081887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859883|NCT00081900|N(1),N(11)-diethylnorspermine|n(1),n(11)-diethylnorspermine|mesh-list
25859884|NCT00081900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25859885|NCT00081900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859886|NCT00081926|Imatinib Mesylate|imatinib mesylate|mesh-list
25859887|NCT00081926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25268719|NCT02414568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25268720|NCT02414568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25268721|NCT02414568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25268722|NCT02414568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25268723|NCT02414568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25268724|NCT02414568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268725|NCT02414568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25859888|NCT00081926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25859889|NCT00081926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859890|NCT00081926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859891|NCT00081978|Etravirine|etravirine|mesh-list
25859892|NCT00081978|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25859893|NCT00081978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25859894|NCT00081978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859895|NCT00081978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169610|NCT01795911|Antimetabolites|antimetabolites|mesh-ancestor
24618584|NCT01049022|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24618591|NCT01049048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618592|NCT01049048|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24618593|NCT01049048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24618594|NCT01049061|Farletuzumab|farletuzumab|mesh-list
24410597|NCT00186420|Docetaxel|docetaxel|mesh-list
24618595|NCT01049061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618596|NCT01049178|Silymarin|silymarin|mesh-list
24618597|NCT01049178|Antioxidants|antioxidants|mesh-ancestor
24618598|NCT01049178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618599|NCT01049178|Protective Agents|protective agents|mesh-ancestor
25859896|NCT00081978|Antiviral Agents|antiviral agents|mesh-ancestor
25859897|NCT00081978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25859898|NCT00082043|Dutasteride|dutasteride|mesh-list
25859899|NCT00082043|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24456880|NCT00332540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25859900|NCT00082043|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25859901|NCT00082043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859902|NCT00082043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859903|NCT00082043|Hormone Antagonists|hormone antagonists|mesh-ancestor
25859904|NCT00082043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25859905|NCT00082043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859906|NCT00082082|Thymalfasin|thymalfasin|mesh-list
25859907|NCT00082082|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25859908|NCT00082082|Immunologic Factors|immunologic factors|mesh-ancestor
24831062|NCT02162784|Respiratory System Agents|respiratory system agents|mesh-ancestor
24696560|NCT01430013|Endostatins|endostatins|mesh-list
24831073|NCT02162784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831076|NCT02162797|Trace Elements|trace elements|mesh-ancestor
24831077|NCT02162797|Micronutrients|micronutrients|mesh-ancestor
24831078|NCT02162797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831079|NCT02162875|Praziquantel|praziquantel|mesh-list
24831080|NCT02162875|Anthelmintics|anthelmintics|mesh-ancestor
24831081|NCT02162875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24831082|NCT02162875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24831083|NCT02162888|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24831084|NCT02162888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24831085|NCT02162888|Alkylating Agents|alkylating agents|mesh-ancestor
24831086|NCT02162888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831087|NCT02162888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24831088|NCT02162966|Colistin|colistin|mesh-list
25876435|NCT03497676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859909|NCT00082082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268727|NCT02414568|Hormones|hormones|mesh-ancestor
25268728|NCT02414568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25268729|NCT02414568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268730|NCT02414568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25268731|NCT02414568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25268732|NCT02414568|Alkylating Agents|alkylating agents|mesh-ancestor
25268733|NCT02414568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25268734|NCT02414568|Tubulin Modulators|tubulin modulators|mesh-ancestor
25268735|NCT02414568|Antimitotic Agents|antimitotic agents|mesh-ancestor
25268736|NCT02414568|Mitosis Modulators|mitosis modulators|mesh-ancestor
25268737|NCT02414776|Hydroxychloroquine|hydroxychloroquine|mesh-list
25268738|NCT02414776|Antimalarials|antimalarials|mesh-ancestor
25268739|NCT02414776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25268740|NCT02414776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25268741|NCT02414776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25268742|NCT02414776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25268743|NCT02414776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859910|NCT00082095|Doxorubicin|doxorubicin|mesh-list
25859911|NCT00082095|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25859912|NCT00082095|Capecitabine|capecitabine|mesh-list
24618611|NCT01049347|Paroxetine|paroxetine|mesh-list
24746116|NCT03358030|Riboflavin|riboflavin|mesh-list
24746117|NCT03358030|Vitamin B Complex|vitamin b complex|mesh-ancestor
24746118|NCT03358030|Vitamins|vitamins|mesh-ancestor
24746119|NCT03358030|Micronutrients|micronutrients|mesh-ancestor
24746120|NCT03358030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859913|NCT00082095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25859914|NCT00082095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859915|NCT00082095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25859916|NCT00082095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25859917|NCT00082095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859918|NCT00082095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859919|NCT00082095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25859920|NCT00082095|Antimetabolites|antimetabolites|mesh-ancestor
25859921|NCT00082186|Bosentan|bosentan|mesh-list
25859922|NCT00082186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25859923|NCT00082186|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25859924|NCT00082186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859925|NCT00082199|Aripiprazole|aripiprazole|mesh-list
25859926|NCT00082199|Antidepressive Agents|antidepressive agents|mesh-ancestor
25859927|NCT00082199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24831089|NCT02162966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24831090|NCT02162966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24831091|NCT02163070|Vitamins|vitamins|mesh-list
24831092|NCT02163070|Vitamin E|vitamin e|mesh-list
24612684|NCT01015066|Buprenorphine|buprenorphine|mesh-list
25859928|NCT00082199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25859929|NCT00082199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24746162|NCT03260504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746163|NCT03260504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24746164|NCT03260504|Analgesics|analgesics|mesh-ancestor
24746165|NCT03260504|Sensory System Agents|sensory system agents|mesh-ancestor
24746166|NCT03260504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24746197|NCT03242772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24746198|NCT03242772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24746199|NCT03242772|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25169565|NCT01811576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25169566|NCT01811576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169567|NCT01811498|Bevacizumab|bevacizumab|mesh-list
25169568|NCT01811498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25169569|NCT01811498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169570|NCT01811498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25169571|NCT01811498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25169572|NCT01811498|Growth Substances|growth substances|mesh-ancestor
25169573|NCT01811498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169574|NCT01811498|Growth Inhibitors|growth inhibitors|mesh-ancestor
25169575|NCT01810575|Alprostadil|alprostadil|mesh-list
25169576|NCT01810575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25169577|NCT01810575|Vasodilator Agents|vasodilator agents|mesh-ancestor
25169578|NCT01810575|Urological Agents|urological agents|mesh-ancestor
25169579|NCT01807546|ON 01910|on 01910|mesh-list
25169580|NCT01807546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169581|NCT01807546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25272558|NCT02391688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25272559|NCT02391688|Antitussive Agents|antitussive agents|mesh-ancestor
25272560|NCT02391688|Respiratory System Agents|respiratory system agents|mesh-ancestor
25169582|NCT01807546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169583|NCT01807546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169584|NCT01804829|Immunoglobulins|immunoglobulins|mesh-list
25169586|NCT01804829|gamma-Globulins|gamma-globulins|mesh-list
25169587|NCT01804829|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25169588|NCT01804829|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25859930|NCT00082199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25859931|NCT00082199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536182|NCT00650442|Contraceptive Agents|contraceptive agents|mesh-ancestor
25859932|NCT00082199|Dopamine Agonists|dopamine agonists|mesh-ancestor
25859933|NCT00082199|Dopamine Agents|dopamine agents|mesh-ancestor
25859934|NCT00082199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25859935|NCT00082199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859936|NCT00082199|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25859937|NCT00082199|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25859938|NCT00082199|Serotonin Agents|serotonin agents|mesh-ancestor
25859939|NCT00082199|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25859940|NCT00082199|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25859941|NCT00082199|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25859942|NCT00082199|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25859943|NCT00082212|Cetuximab|cetuximab|mesh-list
24777386|NCT01863706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24777387|NCT01863706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24777388|NCT01863719|Colistin|colistin|mesh-list
24778043|NCT01868802|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24778045|NCT01868802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778046|NCT01868880|Bisoprolol|bisoprolol|mesh-list
24778047|NCT01868880|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24778048|NCT01868880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24778049|NCT01868880|Adrenergic Agents|adrenergic agents|mesh-ancestor
24778083|NCT01869010|Antiviral Agents|antiviral agents|mesh-ancestor
24778084|NCT01869010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24778085|NCT01869010|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24778086|NCT01869010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24778087|NCT01869010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24785611|NCT01915459|Cholinergic Agents|cholinergic agents|mesh-ancestor
24778160|NCT01869569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785662|NCT01915901|Immunologic Factors|immunologic factors|mesh-ancestor
24778403|NCT01870635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24778404|NCT01870635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25859944|NCT00082212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25859945|NCT00082212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859946|NCT00082225|Antibodies|antibodies|mesh-list
25859947|NCT00082225|Immunologic Factors|immunologic factors|mesh-ancestor
25859948|NCT00082225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859949|NCT00082251|Niacin|niacin|mesh-list
25859950|NCT00082251|Simvastatin|simvastatin|mesh-list
25859951|NCT00082251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25859952|NCT00082251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24746248|NCT03190369|Hylan|hylan|mesh-list
24778407|NCT01870648|Autonomic Agents|autonomic agents|mesh-ancestor
24778408|NCT01870648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24778409|NCT01870648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778410|NCT01870648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24778411|NCT01870648|Antipruritics|antipruritics|mesh-ancestor
24778412|NCT01870648|Dermatologic Agents|dermatologic agents|mesh-ancestor
24778413|NCT01870648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24778414|NCT01870648|Serotonin Agents|serotonin agents|mesh-ancestor
24778415|NCT01870648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24778416|NCT01870648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778417|NCT01870648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24778418|NCT01870648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24570223|NCT00803868|Cholinergic Agents|cholinergic agents|mesh-ancestor
24570224|NCT00803868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24570225|NCT00803868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570226|NCT00803868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570227|NCT00803907|Imiquimod|imiquimod|mesh-list
25664930|NCT01677286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25664931|NCT01677299|Metformin|metformin|mesh-list
25664932|NCT01677299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25664933|NCT01677299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859953|NCT00082251|Antimetabolites|antimetabolites|mesh-ancestor
25664934|NCT01677377|Risperidone|risperidone|mesh-list
25664935|NCT01677377|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25169589|NCT01804829|Immunoglobulin G|immunoglobulin g|mesh-list
25169590|NCT01804829|Immunologic Factors|immunologic factors|mesh-ancestor
25169591|NCT01804829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169592|NCT01802723|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25169593|NCT01802723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25169594|NCT01802723|Autonomic Agents|autonomic agents|mesh-ancestor
25169595|NCT01802723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25169596|NCT01802723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169597|NCT01802723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25169598|NCT01802723|Respiratory System Agents|respiratory system agents|mesh-ancestor
25169599|NCT01802723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25169600|NCT01802723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25169601|NCT01802723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25169602|NCT01802723|Adrenergic Agents|adrenergic agents|mesh-ancestor
25169603|NCT01802723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25169604|NCT01802723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169605|NCT01795911|Interferons|interferons|mesh-list
25169607|NCT01795911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169608|NCT01795911|Antiviral Agents|antiviral agents|mesh-ancestor
25169609|NCT01795911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25169611|NCT01795911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169614|NCT01792050|Tryptophan|tryptophan|mesh-list
25169615|NCT01792050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25169616|NCT01792050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169617|NCT01792050|Tubulin Modulators|tubulin modulators|mesh-ancestor
25169618|NCT01792050|Antimitotic Agents|antimitotic agents|mesh-ancestor
25169619|NCT01792050|Mitosis Modulators|mitosis modulators|mesh-ancestor
25169620|NCT01792050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169621|NCT01792050|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25169622|NCT01792050|Antidepressive Agents|antidepressive agents|mesh-ancestor
25169623|NCT01792050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25169624|NCT01790282|Estradiol|estradiol|mesh-list
25169625|NCT01790282|Progesterone|progesterone|mesh-list
25169626|NCT01790282|Estrogens|estrogens|mesh-ancestor
25169627|NCT01790282|Hormones|hormones|mesh-ancestor
25169628|NCT01790282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25169629|NCT01790282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169630|NCT01790282|Progestins|progestins|mesh-ancestor
25169631|NCT01790100|Ribavirin|ribavirin|mesh-list
24746255|NCT05438316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24746256|NCT05438316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169632|NCT01790100|Antimetabolites|antimetabolites|mesh-ancestor
25169633|NCT01790100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169634|NCT01790100|Antiviral Agents|antiviral agents|mesh-ancestor
25169635|NCT01790100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25169636|NCT01789736|Travoprost|travoprost|mesh-list
25169637|NCT01789736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25169638|NCT01789736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25169639|NCT01789736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25169640|NCT01785771|Exenatide|exenatide|mesh-list
25169641|NCT01785771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25169642|NCT01785771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169643|NCT01785771|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25169644|NCT01785771|Incretins|incretins|mesh-ancestor
25169645|NCT01785771|Hormones|hormones|mesh-ancestor
25169646|NCT01785771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25169647|NCT01785433|Tiotropium Bromide|tiotropium bromide|mesh-list
25169648|NCT01785433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25169649|NCT01785433|Autonomic Agents|autonomic agents|mesh-ancestor
25169650|NCT01785433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25169651|NCT01785433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169652|NCT01785433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25169653|NCT01785433|Respiratory System Agents|respiratory system agents|mesh-ancestor
25169654|NCT01785433|Parasympatholytics|parasympatholytics|mesh-ancestor
25169655|NCT01785433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25169656|NCT01785433|Cholinergic Agents|cholinergic agents|mesh-ancestor
25169657|NCT01785433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25169658|NCT01785433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169659|NCT01784874|Vaccines|vaccines|mesh-list
25169660|NCT01784874|Immunologic Factors|immunologic factors|mesh-ancestor
25169661|NCT01784874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664936|NCT01677377|Serotonin Agents|serotonin agents|mesh-ancestor
25169662|NCT01782729|Tacrolimus|tacrolimus|mesh-list
25169663|NCT01782729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25169664|NCT01782729|Immunologic Factors|immunologic factors|mesh-ancestor
25169665|NCT01782729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169666|NCT01782729|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25169667|NCT01782729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169668|NCT01782729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169669|NCT01780844|Mycophenolic Acid|mycophenolic acid|mesh-list
25169670|NCT01780844|Prednisone|prednisone|mesh-list
25169671|NCT01780844|Tacrolimus|tacrolimus|mesh-list
25169672|NCT01780844|Basiliximab|basiliximab|mesh-list
25169673|NCT01780844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25169674|NCT01780844|Glucocorticoids|glucocorticoids|mesh-ancestor
25169675|NCT01780844|Hormones|hormones|mesh-ancestor
25169676|NCT01780844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25169677|NCT01780844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169678|NCT01780844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25859954|NCT00082251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169679|NCT01780844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169680|NCT01780844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25169681|NCT01780844|Immunologic Factors|immunologic factors|mesh-ancestor
25169682|NCT01780844|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25169684|NCT01780844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169686|NCT01780844|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25169687|NCT01780844|Antitubercular Agents|antitubercular agents|mesh-ancestor
25169688|NCT01780844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25169689|NCT01780844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24746336|NCT05437575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746337|NCT05437575|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24746338|NCT05437575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24746339|NCT05437575|Anesthetics, General|anesthetics, general|mesh-ancestor
24746340|NCT05437575|Anesthetics|anesthetics|mesh-ancestor
24536276|NCT00650624|Valdecoxib|valdecoxib|mesh-list
24746341|NCT05437575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24944174|NCT03962829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25169691|NCT01780428|Promethazine|promethazine|mesh-list
25169692|NCT01780428|Diphenhydramine|diphenhydramine|mesh-list
25169693|NCT01780428|Hydrocodone|hydrocodone|mesh-list
25169694|NCT01780428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25169695|NCT01780428|Analgesics|analgesics|mesh-ancestor
25169696|NCT01780428|Sensory System Agents|sensory system agents|mesh-ancestor
25169697|NCT01780428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25169698|NCT01780428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169699|NCT01780428|Antipyretics|antipyretics|mesh-ancestor
25169700|NCT01780428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25169701|NCT01780428|Narcotics|narcotics|mesh-ancestor
25169702|NCT01780428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25169703|NCT01780428|Antitussive Agents|antitussive agents|mesh-ancestor
25169704|NCT01780428|Respiratory System Agents|respiratory system agents|mesh-ancestor
25169705|NCT01780428|Antipruritics|antipruritics|mesh-ancestor
25169706|NCT01780428|Dermatologic Agents|dermatologic agents|mesh-ancestor
25169707|NCT01780428|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25169708|NCT01780428|Histamine Antagonists|histamine antagonists|mesh-ancestor
25169709|NCT01780428|Histamine Agents|histamine agents|mesh-ancestor
25169710|NCT01780428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25169711|NCT01780428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169712|NCT01780428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25169713|NCT01780428|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25169714|NCT01780428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25169715|NCT01780428|Anesthetics, Local|anesthetics, local|mesh-ancestor
25169716|NCT01780428|Anesthetics|anesthetics|mesh-ancestor
25169717|NCT01780428|Antiemetics|antiemetics|mesh-ancestor
25169718|NCT01780428|Autonomic Agents|autonomic agents|mesh-ancestor
25169719|NCT01780428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25169721|NCT01779947|Estrogens|estrogens|mesh-ancestor
25169722|NCT01779947|Hormones|hormones|mesh-ancestor
24746377|NCT05437432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24746378|NCT05437432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746379|NCT05437432|Adrenergic Agents|adrenergic agents|mesh-ancestor
24746447|NCT05436522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24746448|NCT05436522|Anesthetics, General|anesthetics, general|mesh-ancestor
24746449|NCT05436522|Anesthetics|anesthetics|mesh-ancestor
24746450|NCT05432518|Everolimus|everolimus|mesh-list
24746451|NCT05432518|Dasatinib|dasatinib|mesh-list
24746452|NCT05432518|Olaparib|olaparib|mesh-list
25859955|NCT00082251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25169723|NCT01779947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24590065|NCT00910533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24590066|NCT00910598|Glatiramer Acetate|glatiramer acetate|mesh-list
24590067|NCT00910598|(T,G)-A-L|(t,g)-a-l|mesh-list
25169724|NCT01779947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169725|NCT01779453|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
25169726|NCT01779453|Atorvastatin|atorvastatin|mesh-list
25169727|NCT01779453|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25169728|NCT01779453|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25169729|NCT01779453|Antimetabolites|antimetabolites|mesh-ancestor
25169730|NCT01779453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169731|NCT01779453|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25169732|NCT01779453|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25169733|NCT01779453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169734|NCT01779453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25169735|NCT01779453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169736|NCT01777555|Levodopa|levodopa|mesh-list
25169737|NCT01777555|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25169738|NCT01777555|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25169739|NCT01777555|Dopamine Agents|dopamine agents|mesh-ancestor
25169740|NCT01777555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25169745|NCT01776606|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25169746|NCT01776606|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25169747|NCT01776606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25169748|NCT01776606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169749|NCT01776606|Cholinergic Agents|cholinergic agents|mesh-ancestor
25169750|NCT01776606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25859956|NCT00082251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25169751|NCT01776606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169752|NCT01776606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25169753|NCT01776606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25169755|NCT01774578|Docetaxel|docetaxel|mesh-list
25169756|NCT01774578|Pemetrexed|pemetrexed|mesh-list
25169757|NCT01774578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25169758|NCT01774578|Antimetabolites|antimetabolites|mesh-ancestor
25169759|NCT01774578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169760|NCT01774578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169761|NCT01774578|Antiviral Agents|antiviral agents|mesh-ancestor
25169762|NCT01774578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25169763|NCT01774578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169764|NCT01774578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25169765|NCT01774578|Immunologic Factors|immunologic factors|mesh-ancestor
25169766|NCT01774578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169767|NCT01774578|Tubulin Modulators|tubulin modulators|mesh-ancestor
25169768|NCT01774578|Antimitotic Agents|antimitotic agents|mesh-ancestor
25169769|NCT01774578|Mitosis Modulators|mitosis modulators|mesh-ancestor
25169770|NCT01774578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25169771|NCT01774578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25169772|NCT01773928|Vaccines|vaccines|mesh-list
25169773|NCT01773928|Immunologic Factors|immunologic factors|mesh-ancestor
25169774|NCT01773928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169775|NCT01773785|Docetaxel|docetaxel|mesh-list
25169776|NCT01773785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169777|NCT01773785|Tubulin Modulators|tubulin modulators|mesh-ancestor
25169778|NCT01773785|Antimitotic Agents|antimitotic agents|mesh-ancestor
25169779|NCT01773785|Mitosis Modulators|mitosis modulators|mesh-ancestor
25169780|NCT01773785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169781|NCT01768975|Dapansutrile|dapansutrile|mesh-list
25169782|NCT01768975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25169783|NCT01758458|Interferons|interferons|mesh-list
25169784|NCT01758458|Aldesleukin|aldesleukin|mesh-list
25169785|NCT01758458|Interferon-beta|interferon-beta|mesh-list
25169786|NCT01758458|Interleukin-2|interleukin-2|mesh-list
25169787|NCT01758458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169789|NCT01758458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25169790|NCT01758458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25169791|NCT01758458|Analgesics|analgesics|mesh-ancestor
25169792|NCT01758458|Sensory System Agents|sensory system agents|mesh-ancestor
25169793|NCT01758458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25169794|NCT01758458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169795|NCT01758458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25169796|NCT01758458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25169797|NCT01758458|Immunologic Factors|immunologic factors|mesh-ancestor
25664937|NCT01677377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25664938|NCT01677377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169798|NCT01756924|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25169799|NCT01756924|Vancomycin|vancomycin|mesh-list
25169800|NCT01756924|Ciprofloxacin|ciprofloxacin|mesh-list
25169801|NCT01756924|Levofloxacin|levofloxacin|mesh-list
25169802|NCT01756924|Rifampin|rifampin|mesh-list
25169803|NCT01756924|Cefazolin|cefazolin|mesh-list
25169804|NCT01756924|Ceftriaxone|ceftriaxone|mesh-list
25169805|NCT01756924|Linezolid|linezolid|mesh-list
25169806|NCT01756924|Daptomycin|daptomycin|mesh-list
25169807|NCT01756924|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25169808|NCT01756924|Oxacillin|oxacillin|mesh-list
25169809|NCT01756924|Nafcillin|nafcillin|mesh-list
25169815|NCT01756924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25169816|NCT01756924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169817|NCT01756924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169818|NCT01756924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169819|NCT01756924|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25169820|NCT01756924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25169821|NCT01756924|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25169822|NCT01756924|Renal Agents|renal agents|mesh-ancestor
25169823|NCT01756924|Leprostatic Agents|leprostatic agents|mesh-ancestor
25169824|NCT01756924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25169825|NCT01756924|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25169826|NCT01756924|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25169827|NCT01756924|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24570230|NCT00803907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778905|NCT01872884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24778906|NCT01872884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24778908|NCT01872884|Anesthetics, General|anesthetics, general|mesh-ancestor
24778961|NCT01873027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24778962|NCT01873027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24778963|NCT01873027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24778964|NCT01873027|Antifungal Agents|antifungal agents|mesh-ancestor
24778965|NCT01873079|Esomeprazole|esomeprazole|mesh-list
24570682|NCT00805649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24570683|NCT00805649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24570684|NCT00805649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24570685|NCT00805649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24570686|NCT00805649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24570687|NCT00805649|GABA Modulators|gaba modulators|mesh-ancestor
24778999|NCT01873222|Sirolimus|sirolimus|mesh-list
24779000|NCT01873222|Umirolimus|umirolimus|mesh-list
24779034|NCT01873339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24779035|NCT01873378|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24779036|NCT01873378|Luteolytic Agents|luteolytic agents|mesh-ancestor
24779037|NCT01873378|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24779038|NCT01873378|Contraceptive Agents|contraceptive agents|mesh-ancestor
24779039|NCT01873378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25081780|NCT03327272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627624|NCT01094028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24627625|NCT01094028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081818|NCT03327116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081819|NCT03327116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081820|NCT03327116|Dermatologic Agents|dermatologic agents|mesh-ancestor
25081821|NCT03327116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25081822|NCT03327116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25081823|NCT03327116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25081824|NCT03327116|Immunologic Factors|immunologic factors|mesh-ancestor
24779122|NCT01873833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779123|NCT01873833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24779124|NCT01873833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24779125|NCT01873833|Antimetabolites|antimetabolites|mesh-ancestor
24779126|NCT01873833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24779127|NCT01873833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24779128|NCT01873833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24779129|NCT01873885|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
24779130|NCT01873885|Vasodilator Agents|vasodilator agents|mesh-ancestor
24779132|NCT01874002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24779133|NCT01874002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24779134|NCT01874002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24779135|NCT01874002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779136|NCT01874002|Antifungal Agents|antifungal agents|mesh-ancestor
24779137|NCT01874002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24746608|NCT04765514|Temozolomide|temozolomide|mesh-list
24746609|NCT04765514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24746610|NCT04765514|Alkylating Agents|alkylating agents|mesh-ancestor
25169828|NCT01756924|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25169829|NCT01756924|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25169830|NCT01756924|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25169831|NCT01756924|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25169832|NCT01756924|Antimalarials|antimalarials|mesh-ancestor
25169833|NCT01756924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25169834|NCT01756924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25169835|NCT01756339|Moxifloxacin|moxifloxacin|mesh-list
25169836|NCT01756339|Solithromycin|solithromycin|mesh-list
25169837|NCT01756339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25169838|NCT01756339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25169839|NCT01756339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25169840|NCT01756339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25169841|NCT01756339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169842|NCT01756339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169843|NCT01756339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169844|NCT01749969|Dexamethasone|dexamethasone|mesh-list
25169845|NCT01749969|Lenalidomide|lenalidomide|mesh-list
25169846|NCT01749969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25169847|NCT01749969|Antiemetics|antiemetics|mesh-ancestor
25169848|NCT01749969|Autonomic Agents|autonomic agents|mesh-ancestor
25169849|NCT01749969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25169850|NCT01749969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169851|NCT01749969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25169852|NCT01749969|Glucocorticoids|glucocorticoids|mesh-ancestor
25169853|NCT01749969|Hormones|hormones|mesh-ancestor
25169854|NCT01749969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25169855|NCT01749969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25169856|NCT01749969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169857|NCT01749969|Immunologic Factors|immunologic factors|mesh-ancestor
24746671|NCT04561557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24746672|NCT04561557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24746673|NCT04561557|Alkylating Agents|alkylating agents|mesh-ancestor
25169858|NCT01749969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25169859|NCT01749969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25169860|NCT01749969|Growth Substances|growth substances|mesh-ancestor
25169861|NCT01749969|Growth Inhibitors|growth inhibitors|mesh-ancestor
25169862|NCT01746836|Ponatinib|ponatinib|mesh-list
25169863|NCT01746836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169864|NCT01746836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25169865|NCT01746836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169866|NCT01746836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169867|NCT01741155|Docetaxel|docetaxel|mesh-list
25169868|NCT01741155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169869|NCT01741155|Tubulin Modulators|tubulin modulators|mesh-ancestor
25169870|NCT01741155|Antimitotic Agents|antimitotic agents|mesh-ancestor
25169871|NCT01741155|Mitosis Modulators|mitosis modulators|mesh-ancestor
25169872|NCT01741155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169873|NCT01737905|Epinephrine|epinephrine|mesh-list
25169874|NCT01737905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25169875|NCT01737905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25169876|NCT01737905|Adrenergic Agents|adrenergic agents|mesh-ancestor
25169877|NCT01737905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25169878|NCT01737905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169879|NCT01737905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169880|NCT01737905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25169881|NCT01737905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25169882|NCT01737905|Autonomic Agents|autonomic agents|mesh-ancestor
25169883|NCT01737905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25169884|NCT01737905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25169885|NCT01737905|Respiratory System Agents|respiratory system agents|mesh-ancestor
25169886|NCT01737905|Mydriatics|mydriatics|mesh-ancestor
25169887|NCT01737905|Sympathomimetics|sympathomimetics|mesh-ancestor
25169888|NCT01737905|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25203636|NCT02713074|Plasma Substitutes|plasma substitutes|mesh-ancestor
25203637|NCT02713074|Blood Substitutes|blood substitutes|mesh-ancestor
24746674|NCT04561557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746675|NCT04561557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746676|NCT04561557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24654555|NCT01250366|Antiviral Agents|antiviral agents|mesh-ancestor
24746710|NCT04191382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746711|NCT04191382|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24746712|NCT04191382|Hormone Antagonists|hormone antagonists|mesh-ancestor
24746713|NCT04191382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24746714|NCT04191382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591435|NCT00916630|Pemetrexed|pemetrexed|mesh-list
24746715|NCT04148534|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-list
24746716|NCT04148534|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24857378|NCT02291380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746717|NCT04148534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24746718|NCT04148534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24746719|NCT04148534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746720|NCT04100096|Brexpiprazole|brexpiprazole|mesh-list
25203638|NCT02713074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25203639|NCT02713074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25203640|NCT02713087|Phenylephrine|phenylephrine|mesh-list
25203641|NCT02713087|Oxymetazoline|oxymetazoline|mesh-list
25203642|NCT02713087|Ephedrine|ephedrine|mesh-list
25203643|NCT02713087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25203644|NCT02713087|Mydriatics|mydriatics|mesh-ancestor
25203645|NCT02713087|Autonomic Agents|autonomic agents|mesh-ancestor
25203646|NCT02713087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25203647|NCT02713087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203648|NCT02713087|Sympathomimetics|sympathomimetics|mesh-ancestor
25203649|NCT02713087|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25203650|NCT02713087|Nasal Decongestants|nasal decongestants|mesh-ancestor
25203651|NCT02713087|Respiratory System Agents|respiratory system agents|mesh-ancestor
25203652|NCT02713087|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25203653|NCT02713087|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25203654|NCT02713087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25203655|NCT02713087|Adrenergic Agents|adrenergic agents|mesh-ancestor
25203656|NCT02713087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25203657|NCT02713087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203658|NCT02713087|Protective Agents|protective agents|mesh-ancestor
25169889|NCT01737892|Epinephrine|epinephrine|mesh-list
25169890|NCT01737892|Racepinephrine|racepinephrine|mesh-list
25169891|NCT01737892|Epinephryl borate|epinephryl borate|mesh-list
25169892|NCT01737892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25169893|NCT01737892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25169894|NCT01737892|Adrenergic Agents|adrenergic agents|mesh-ancestor
25169895|NCT01737892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25169896|NCT01737892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169897|NCT01737892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169898|NCT01737892|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25169899|NCT01737892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25169900|NCT01737892|Autonomic Agents|autonomic agents|mesh-ancestor
25169901|NCT01737892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25169902|NCT01737892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25169903|NCT01737892|Respiratory System Agents|respiratory system agents|mesh-ancestor
25169904|NCT01737892|Mydriatics|mydriatics|mesh-ancestor
25169905|NCT01737892|Sympathomimetics|sympathomimetics|mesh-ancestor
25169906|NCT01737892|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25169907|NCT01730027|Montelukast|montelukast|mesh-list
25169908|NCT01730027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25169909|NCT01730027|Respiratory System Agents|respiratory system agents|mesh-ancestor
25169910|NCT01730027|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25169911|NCT01730027|Hormone Antagonists|hormone antagonists|mesh-ancestor
25169912|NCT01730027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25169913|NCT01730027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169914|NCT01730027|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25169915|NCT01730027|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25169916|NCT01730027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169917|NCT01729403|Metformin|metformin|mesh-list
25169918|NCT01729403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25169919|NCT01729403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169920|NCT01728753|Favipiravir|favipiravir|mesh-list
25169921|NCT01728753|Antiviral Agents|antiviral agents|mesh-ancestor
25169922|NCT01728753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25169923|NCT01728064|Ubiquinone|ubiquinone|mesh-list
25169924|NCT01728064|Micronutrients|micronutrients|mesh-ancestor
25169925|NCT01728064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169927|NCT01726946|Antimetabolites|antimetabolites|mesh-ancestor
25169928|NCT01726946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169929|NCT01726946|Antiviral Agents|antiviral agents|mesh-ancestor
25169930|NCT01726946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25169931|NCT01725152|Ganaxolone|ganaxolone|mesh-list
25169932|NCT01725152|Neurosteroids|neurosteroids|mesh-ancestor
25169933|NCT01725152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25169934|NCT01725152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664939|NCT01677377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591891|NCT00919451|Cyclosporine|cyclosporine|mesh-list
25169935|NCT01725152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169936|NCT01725152|GABA Modulators|gaba modulators|mesh-ancestor
25169937|NCT01725152|GABA Agents|gaba agents|mesh-ancestor
25169938|NCT01721733|Ubiquinone|ubiquinone|mesh-list
25169939|NCT01721733|Micronutrients|micronutrients|mesh-ancestor
25169940|NCT01721733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169941|NCT01719016|Adenosine|adenosine|mesh-list
25169942|NCT01719016|Analgesics|analgesics|mesh-ancestor
25169943|NCT01719016|Sensory System Agents|sensory system agents|mesh-ancestor
25169944|NCT01719016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25169945|NCT01719016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169946|NCT01719016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25169947|NCT01719016|Vasodilator Agents|vasodilator agents|mesh-ancestor
25169948|NCT01719016|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25169949|NCT01719016|Purinergic Agonists|purinergic agonists|mesh-ancestor
25169950|NCT01719016|Purinergic Agents|purinergic agents|mesh-ancestor
25169951|NCT01719016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25169952|NCT01719016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169953|NCT01718158|Ribavirin|ribavirin|mesh-list
25169954|NCT01718158|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25169955|NCT01718158|Antimetabolites|antimetabolites|mesh-ancestor
25169956|NCT01718158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169957|NCT01718158|Antiviral Agents|antiviral agents|mesh-ancestor
25169958|NCT01718158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25169959|NCT01718145|Ribavirin|ribavirin|mesh-list
25169960|NCT01718145|Asunaprevir|asunaprevir|mesh-list
25169961|NCT01718145|Antimetabolites|antimetabolites|mesh-ancestor
25169962|NCT01718145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169963|NCT01718145|Antiviral Agents|antiviral agents|mesh-ancestor
25169964|NCT01718145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25169965|NCT01718145|Protease Inhibitors|protease inhibitors|mesh-ancestor
25169966|NCT01718145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169967|NCT01714739|Nivolumab|nivolumab|mesh-list
25169968|NCT01714739|Ipilimumab|ipilimumab|mesh-list
25169969|NCT01714739|Immunoglobulins|immunoglobulins|mesh-list
25169970|NCT01714739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25169971|NCT01714739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169972|NCT01714739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25169973|NCT01714739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169974|NCT01714739|Immunologic Factors|immunologic factors|mesh-ancestor
25169975|NCT01714739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169976|NCT01712451|Fluticasone|fluticasone|mesh-list
25169978|NCT01712451|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25169979|NCT01712451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25169980|NCT01712451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25169981|NCT01712451|Autonomic Agents|autonomic agents|mesh-ancestor
25169982|NCT01712451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25169983|NCT01712451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25169984|NCT01712451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24746923|NCT02679144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25169985|NCT01712451|Respiratory System Agents|respiratory system agents|mesh-ancestor
25169986|NCT01712451|Dermatologic Agents|dermatologic agents|mesh-ancestor
25169987|NCT01712451|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25169988|NCT01712451|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25169989|NCT01712451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25169990|NCT01712451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25169991|NCT01712451|Adrenergic Agents|adrenergic agents|mesh-ancestor
25169992|NCT01712451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25169993|NCT01712451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169994|NCT01712217|Crizotinib|crizotinib|mesh-list
25169995|NCT01712217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25169996|NCT01712217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25169997|NCT01712217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25169998|NCT01712217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25169999|NCT01709214|Oxycodone|oxycodone|mesh-list
25170000|NCT01709214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25170001|NCT01709214|Narcotics|narcotics|mesh-ancestor
25170002|NCT01709214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25170003|NCT01709214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170004|NCT01709214|Analgesics|analgesics|mesh-ancestor
25170005|NCT01709214|Sensory System Agents|sensory system agents|mesh-ancestor
25170006|NCT01709214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25170007|NCT01704365|Vaccines|vaccines|mesh-list
25170008|NCT01704365|Immunologic Factors|immunologic factors|mesh-ancestor
25170009|NCT01704365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664940|NCT01677377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24592243|NCT00921063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24592252|NCT00921063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170010|NCT01699737|Glimepiride|glimepiride|mesh-list
25170011|NCT01699737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25170012|NCT01699737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25170013|NCT01699737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170014|NCT01699737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25170015|NCT01699737|Immunologic Factors|immunologic factors|mesh-ancestor
25170016|NCT01699464|Timolol|timolol|mesh-list
24746924|NCT02679144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24746925|NCT02679144|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
24746926|NCT02679144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170017|NCT01699464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25170018|NCT01699464|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25170019|NCT01699464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25170020|NCT01699464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25170021|NCT01699464|Adrenergic Agents|adrenergic agents|mesh-ancestor
25170022|NCT01699464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25170023|NCT01699464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170024|NCT01699464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170025|NCT01699464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25170026|NCT01699464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25170027|NCT01698281|Dexamethasone|dexamethasone|mesh-list
25170028|NCT01698281|Doxorubicin|doxorubicin|mesh-list
25170029|NCT01698281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25170030|NCT01698281|Antiemetics|antiemetics|mesh-ancestor
25170031|NCT01698281|Autonomic Agents|autonomic agents|mesh-ancestor
25170032|NCT01698281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25170033|NCT01698281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644190|NCT01189695|Protease Inhibitors|protease inhibitors|mesh-ancestor
25170034|NCT01698281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25170035|NCT01698281|Glucocorticoids|glucocorticoids|mesh-ancestor
25170036|NCT01698281|Hormones|hormones|mesh-ancestor
25203659|NCT02713087|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24450431|NCT00319033|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24450432|NCT00319033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450433|NCT00319059|Annexin A5|annexin a5|mesh-list
24450434|NCT00319059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450435|NCT00319059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450436|NCT00319072|Hormones|hormones|mesh-list
25859957|NCT00082251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859958|NCT00082251|Vasodilator Agents|vasodilator agents|mesh-ancestor
25859959|NCT00082251|Vitamin B Complex|vitamin b complex|mesh-ancestor
25859960|NCT00082251|Vitamins|vitamins|mesh-ancestor
25859961|NCT00082251|Micronutrients|micronutrients|mesh-ancestor
25859962|NCT00082251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944191|NCT03962725|Rocuronium|rocuronium|mesh-list
24747017|NCT02277106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24747018|NCT02277106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24747019|NCT02277106|GABA Modulators|gaba modulators|mesh-ancestor
24747020|NCT02277106|GABA Agents|gaba agents|mesh-ancestor
24747021|NCT02203773|Posaconazole|posaconazole|mesh-list
24747022|NCT02203773|Azacitidine|azacitidine|mesh-list
25859963|NCT00082277|Risedronic Acid|risedronic acid|mesh-list
25859964|NCT00082277|Anastrozole|anastrozole|mesh-list
25859965|NCT00082277|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25859966|NCT00082277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25859967|NCT00082277|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25859968|NCT00082277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25859969|NCT00082277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859970|NCT00082277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859971|NCT00082277|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25859972|NCT00082277|Hormone Antagonists|hormone antagonists|mesh-ancestor
25170159|NCT01677754|Autonomic Agents|autonomic agents|mesh-ancestor
25859973|NCT00082277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25859974|NCT00082277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859975|NCT00082277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25859976|NCT00082277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25859977|NCT00082277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25859978|NCT00082277|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25664941|NCT01677377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25664942|NCT01677377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25664943|NCT01677377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25859979|NCT00082316|Capsaicin|capsaicin|mesh-list
24592354|NCT00921414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24592355|NCT00921414|Immunologic Factors|immunologic factors|mesh-ancestor
24501511|NCT00529022|Azacitidine|azacitidine|mesh-list
25859980|NCT00082316|Antipruritics|antipruritics|mesh-ancestor
25859981|NCT00082316|Dermatologic Agents|dermatologic agents|mesh-ancestor
25859982|NCT00082316|Sensory System Agents|sensory system agents|mesh-ancestor
25859983|NCT00082316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25170037|NCT01698281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25170038|NCT01698281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25170039|NCT01698281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170040|NCT01698281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25170041|NCT01698281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25170042|NCT01698281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25170043|NCT01698281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170044|NCT01698281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170046|NCT01697072|Capecitabine|capecitabine|mesh-list
25170047|NCT01697072|Epirubicin|epirubicin|mesh-list
25170048|NCT01697072|Rilotumumab|rilotumumab|mesh-list
25170049|NCT01697072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24747024|NCT02203773|Venetoclax|venetoclax|mesh-list
24747026|NCT02203773|Antimetabolites|antimetabolites|mesh-ancestor
24944192|NCT03962725|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
25170050|NCT01697072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25170051|NCT01697072|Antimetabolites|antimetabolites|mesh-ancestor
25170052|NCT01697072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170053|NCT01697072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25170054|NCT01697072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25170055|NCT01697072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25170056|NCT01697072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170057|NCT01697072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25170058|NCT01696435|Vitamin D|vitamin d|mesh-list
25170059|NCT01696435|Ergocalciferols|ergocalciferols|mesh-list
25170060|NCT01696435|Cholecalciferol|cholecalciferol|mesh-list
25170061|NCT01696435|Vitamins|vitamins|mesh-list
25170062|NCT01696435|Micronutrients|micronutrients|mesh-ancestor
25170063|NCT01696435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170064|NCT01696435|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25170065|NCT01696435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25170066|NCT01694277|Sunitinib|sunitinib|mesh-list
25170067|NCT01694277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170068|NCT01694277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25170069|NCT01694277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25170070|NCT01694277|Growth Substances|growth substances|mesh-ancestor
25170071|NCT01694277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170072|NCT01694277|Growth Inhibitors|growth inhibitors|mesh-ancestor
25170073|NCT01694277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25170074|NCT01694277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203660|NCT02712957|Naproxen|naproxen|mesh-list
25170075|NCT01694277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170076|NCT01691846|Metformin|metformin|mesh-list
25170077|NCT01691846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25170078|NCT01691846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170079|NCT01689246|Methylene Blue|methylene blue|mesh-list
25170080|NCT01689246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170081|NCT01689246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170082|NCT01687985|Laxatives|laxatives|mesh-list
25170083|NCT01687985|Cathartics|cathartics|mesh-list
25170084|NCT01687985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25170085|NCT01686620|Insulin Lispro|insulin lispro|mesh-list
25170086|NCT01686620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25170087|NCT01686620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170088|NCT01685268|Prednisone|prednisone|mesh-list
24747139|NCT01746173|Cyclophosphamide|cyclophosphamide|mesh-list
24747140|NCT01746173|Melphalan|melphalan|mesh-list
24747141|NCT01746173|Busulfan|busulfan|mesh-list
24747142|NCT01746173|Doxorubicin|doxorubicin|mesh-list
24747143|NCT01746173|Etoposide|etoposide|mesh-list
24654701|NCT01251029|Antioxidants|antioxidants|mesh-ancestor
25170089|NCT01685268|Prednisolone|prednisolone|mesh-list
25170090|NCT01685268|Abiraterone Acetate|abiraterone acetate|mesh-list
25170091|NCT01685268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25170092|NCT01685268|Glucocorticoids|glucocorticoids|mesh-ancestor
25664944|NCT01677377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25664945|NCT01677377|Dopamine Agents|dopamine agents|mesh-ancestor
25664946|NCT01677507|Timolol|timolol|mesh-list
25170093|NCT01685268|Hormones|hormones|mesh-ancestor
25170094|NCT01685268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25170095|NCT01685268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592498|NCT00922129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25071851|NCT03405584|Diuretics|diuretics|mesh-ancestor
24700387|NCT01452243|Micronutrients|micronutrients|mesh-ancestor
24592499|NCT00922129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170096|NCT01685268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25170097|NCT01685268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170098|NCT01685268|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25170099|NCT01685268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170100|NCT01685268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170101|NCT01685268|Hormone Antagonists|hormone antagonists|mesh-ancestor
25170102|NCT01685268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25170103|NCT01685255|Tamoxifen|tamoxifen|mesh-list
25170104|NCT01685255|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25170105|NCT01685255|Hormone Antagonists|hormone antagonists|mesh-ancestor
25170106|NCT01685255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25170107|NCT01685255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170108|NCT01685255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25170109|NCT01685255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170110|NCT01685255|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25170111|NCT01685255|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25170112|NCT01685255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25170113|NCT01684722|Vitamin D|vitamin d|mesh-list
25170114|NCT01684722|Ergocalciferols|ergocalciferols|mesh-list
25170115|NCT01684722|Cholecalciferol|cholecalciferol|mesh-list
25170116|NCT01684722|Vitamins|vitamins|mesh-list
25170117|NCT01684722|Micronutrients|micronutrients|mesh-ancestor
25170118|NCT01684722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170119|NCT01684722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25170120|NCT01684722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25170121|NCT01683084|Telmisartan|telmisartan|mesh-list
24927663|NCT04131231|Antiviral Agents|antiviral agents|mesh-ancestor
25170122|NCT01683084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25170123|NCT01683084|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25170124|NCT01683084|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25170125|NCT01683084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859984|NCT00082316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25859985|NCT00082394|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24747150|NCT01746173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24747151|NCT01746173|Alkylating Agents|alkylating agents|mesh-ancestor
24747152|NCT01746173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24747153|NCT01746173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24747154|NCT01746173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25170126|NCT01679951|Methotrexate|methotrexate|mesh-list
25170127|NCT01679951|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25170128|NCT01679951|Abortifacient Agents|abortifacient agents|mesh-ancestor
25170129|NCT01679951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25170130|NCT01679951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170131|NCT01679951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25170132|NCT01679951|Antimetabolites|antimetabolites|mesh-ancestor
25170133|NCT01679951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170134|NCT01679951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170135|NCT01679951|Dermatologic Agents|dermatologic agents|mesh-ancestor
25170136|NCT01679951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170137|NCT01679951|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25170138|NCT01679951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25170139|NCT01679951|Immunologic Factors|immunologic factors|mesh-ancestor
25170140|NCT01679951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25170141|NCT01679951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25170142|NCT01677754|Memantine|memantine|mesh-list
25170143|NCT01677754|Rivastigmine|rivastigmine|mesh-list
25170144|NCT01677754|Donepezil|donepezil|mesh-list
25170145|NCT01677754|Galantamine|galantamine|mesh-list
25170146|NCT01677754|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25170147|NCT01677754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170148|NCT01677754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170149|NCT01677754|Cholinergic Agents|cholinergic agents|mesh-ancestor
25170150|NCT01677754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25170151|NCT01677754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170152|NCT01677754|Nootropic Agents|nootropic agents|mesh-ancestor
25170153|NCT01677754|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25664947|NCT01677507|Latanoprost|latanoprost|mesh-list
25664948|NCT01677507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25664949|NCT01677507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25664950|NCT01677507|Adrenergic Agents|adrenergic agents|mesh-ancestor
24592678|NCT00923741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170154|NCT01677754|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25170155|NCT01677754|Dopamine Agents|dopamine agents|mesh-ancestor
25170156|NCT01677754|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25170157|NCT01677754|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25170158|NCT01677754|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25170161|NCT01677754|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25170162|NCT01677754|Protective Agents|protective agents|mesh-ancestor
24747196|NCT01555541|Cytarabine|cytarabine|mesh-list
24747197|NCT01555541|Etoposide|etoposide|mesh-list
24747198|NCT01555541|Ofatumumab|ofatumumab|mesh-list
24747199|NCT01555541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24747200|NCT01555541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24747201|NCT01555541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24747202|NCT01555541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24747203|NCT01555541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24747204|NCT01555541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24747205|NCT01555541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24747206|NCT01555541|Antimetabolites|antimetabolites|mesh-ancestor
24747207|NCT01555541|Antiviral Agents|antiviral agents|mesh-ancestor
24747208|NCT01555541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25170163|NCT01677338|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
25170164|NCT01677338|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25170165|NCT01677338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170166|NCT01675609|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25170167|NCT01675609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25170168|NCT01675609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25170169|NCT01675609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24505618|NCT00541710|Genistein|genistein|mesh-list
25170170|NCT01675609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25170171|NCT01675609|Adrenergic Agents|adrenergic agents|mesh-ancestor
25170172|NCT01675609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25170173|NCT01675609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170174|NCT01675609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170175|NCT01673659|Mometasone Furoate|mometasone furoate|mesh-list
25170176|NCT01673659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25170177|NCT01673659|Dermatologic Agents|dermatologic agents|mesh-ancestor
25170178|NCT01673659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25170179|NCT01669980|Vancomycin|vancomycin|mesh-list
25170180|NCT01669980|Ceftriaxone|ceftriaxone|mesh-list
25170181|NCT01669980|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
25170182|NCT01669980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25170183|NCT01669980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25170184|NCT01666977|Carboplatin|carboplatin|mesh-list
25170185|NCT01666977|Pemetrexed|pemetrexed|mesh-list
25170186|NCT01666977|Trebananib|trebananib|mesh-list
25170187|NCT01666977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170188|NCT01666977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170189|NCT01666977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170190|NCT01666977|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25170191|NCT01666977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25170192|NCT01666977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25170193|NCT01666977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25170194|NCT01666977|Growth Substances|growth substances|mesh-ancestor
25170195|NCT01666977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24747209|NCT01555541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24747210|NCT01555541|Immunologic Factors|immunologic factors|mesh-ancestor
24944200|NCT03962725|Sensory System Agents|sensory system agents|mesh-ancestor
24944201|NCT03962725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24944202|NCT03962725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24747217|NCT01398852|Riboflavin|riboflavin|mesh-list
24747218|NCT01398852|Vitamin B Complex|vitamin b complex|mesh-ancestor
24747219|NCT01398852|Vitamins|vitamins|mesh-ancestor
24747220|NCT01398852|Micronutrients|micronutrients|mesh-ancestor
24747221|NCT01398852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24747222|NCT01398852|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24747223|NCT01398852|Dermatologic Agents|dermatologic agents|mesh-ancestor
24747224|NCT01398839|Riboflavin|riboflavin|mesh-list
24747225|NCT01398839|Vitamin B Complex|vitamin b complex|mesh-ancestor
24747226|NCT01398839|Vitamins|vitamins|mesh-ancestor
25664951|NCT01677507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24747227|NCT01398839|Micronutrients|micronutrients|mesh-ancestor
24747228|NCT01398839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24747229|NCT01398839|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25664952|NCT01677507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24747230|NCT01398839|Dermatologic Agents|dermatologic agents|mesh-ancestor
25170196|NCT01666977|Growth Inhibitors|growth inhibitors|mesh-ancestor
25170197|NCT01665391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25170198|NCT01665391|Immunologic Factors|immunologic factors|mesh-ancestor
25170199|NCT01665391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170200|NCT01661634|Ularitide|ularitide|mesh-list
25170201|NCT01661634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25170202|NCT01661634|Autonomic Agents|autonomic agents|mesh-ancestor
25170210|NCT01661166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25170211|NCT01661166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25170212|NCT01661166|Cholinergic Agents|cholinergic agents|mesh-ancestor
25170213|NCT01661166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25170214|NCT01661166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170215|NCT01661166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170216|NCT01661166|Urological Agents|urological agents|mesh-ancestor
25170218|NCT01660633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25170219|NCT01660633|Alkylating Agents|alkylating agents|mesh-ancestor
25170220|NCT01660633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859986|NCT00082394|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25859987|NCT00082394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25859988|NCT00082394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25859989|NCT00082394|Protease Inhibitors|protease inhibitors|mesh-ancestor
25859990|NCT00082394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25859991|NCT00082394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25859992|NCT00082394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25859993|NCT00082394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25859994|NCT00082394|Antiviral Agents|antiviral agents|mesh-ancestor
25859995|NCT00082394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25859996|NCT00082394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24645069|NCT01195376|Dactolisib|dactolisib|mesh-list
25859997|NCT00082394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25859998|NCT00082446|Vaccines|vaccines|mesh-list
25859999|NCT00082446|Immunologic Factors|immunologic factors|mesh-ancestor
25860000|NCT00082446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860001|NCT00082472|Cisplatin|cisplatin|mesh-list
25860002|NCT00082472|Docetaxel|docetaxel|mesh-list
25860003|NCT00082472|Doxorubicin|doxorubicin|mesh-list
25860004|NCT00082472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25860005|NCT00082472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170221|NCT01660633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170222|NCT01660633|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25170223|NCT01660633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25170224|NCT01660633|Immunologic Factors|immunologic factors|mesh-ancestor
25170225|NCT01660633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170226|NCT01658826|Valacyclovir|valacyclovir|mesh-list
25170227|NCT01658826|Pritelivir|pritelivir|mesh-list
25170228|NCT01658826|Antiviral Agents|antiviral agents|mesh-ancestor
25170229|NCT01658826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25170230|NCT01658826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170231|NCT01658826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170232|NCT01658501|Metformin|metformin|mesh-list
25170233|NCT01658501|Liraglutide|liraglutide|mesh-list
25170234|NCT01658501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25170235|NCT01658501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170236|NCT01658501|Incretins|incretins|mesh-ancestor
25170237|NCT01658501|Hormones|hormones|mesh-ancestor
25170238|NCT01658501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25170239|NCT01652482|Leucovorin|leucovorin|mesh-list
25170240|NCT01652482|Fluorouracil|fluorouracil|mesh-list
24747236|NCT01349959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24747237|NCT01349959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24747238|NCT01349959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24944206|NCT03962725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24944207|NCT03962725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170241|NCT01652482|Irinotecan|irinotecan|mesh-list
25170242|NCT01652482|Cetuximab|cetuximab|mesh-list
25170243|NCT01652482|Antimetabolites|antimetabolites|mesh-ancestor
25203666|NCT02712957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170244|NCT01652482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170245|NCT01652482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25170246|NCT01652482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170247|NCT01652482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25170248|NCT01652482|Immunologic Factors|immunologic factors|mesh-ancestor
25170249|NCT01652482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170250|NCT01652482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25425150|NCT02166463|Bleomycin|bleomycin|mesh-list
25170251|NCT01652482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25170252|NCT01652482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170253|NCT01652482|Antidotes|antidotes|mesh-ancestor
25170254|NCT01652482|Protective Agents|protective agents|mesh-ancestor
25170255|NCT01652482|Vitamin B Complex|vitamin b complex|mesh-ancestor
25170256|NCT01652482|Vitamins|vitamins|mesh-ancestor
25170257|NCT01652482|Micronutrients|micronutrients|mesh-ancestor
25170258|NCT01652482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25170259|NCT01651871|Cetirizine|cetirizine|mesh-list
25170260|NCT01651871|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25170261|NCT01651871|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25170262|NCT01651871|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25170263|NCT01651871|Histamine Antagonists|histamine antagonists|mesh-ancestor
25170264|NCT01651871|Histamine Agents|histamine agents|mesh-ancestor
25170265|NCT01651871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25170266|NCT01651871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170267|NCT01651871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170268|NCT01649999|Peficitinib|peficitinib|mesh-list
25170269|NCT01649999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170270|NCT01649999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170271|NCT01649999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25170272|NCT01649999|Immunologic Factors|immunologic factors|mesh-ancestor
25170273|NCT01649999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170274|NCT01643226|Riboflavin|riboflavin|mesh-list
25170275|NCT01643226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25170277|NCT01643226|Vitamins|vitamins|mesh-ancestor
25170278|NCT01643226|Micronutrients|micronutrients|mesh-ancestor
25170279|NCT01643226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170280|NCT01643226|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25170281|NCT01643226|Dermatologic Agents|dermatologic agents|mesh-ancestor
25170282|NCT01640080|Esketamine|esketamine|mesh-list
25170283|NCT01640080|Antidepressive Agents|antidepressive agents|mesh-ancestor
25170284|NCT01640080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25170285|NCT01632228|Bevacizumab|bevacizumab|mesh-list
25170286|NCT01632228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25170287|NCT01632228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170288|NCT01632228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25170289|NCT01632228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25170290|NCT01632228|Growth Substances|growth substances|mesh-ancestor
25170291|NCT01632228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170292|NCT01632228|Growth Inhibitors|growth inhibitors|mesh-ancestor
25170293|NCT01632137|Rebamipide|rebamipide|mesh-list
25170294|NCT01632137|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25170295|NCT01632137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25170296|NCT01632137|Antioxidants|antioxidants|mesh-ancestor
25170297|NCT01632137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170298|NCT01632137|Protective Agents|protective agents|mesh-ancestor
25170299|NCT01632137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170300|NCT01632137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170301|NCT01628094|Ritonavir|ritonavir|mesh-list
25170302|NCT01628094|Ribavirin|ribavirin|mesh-list
25170303|NCT01628094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25170304|NCT01628094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25170305|NCT01628094|Protease Inhibitors|protease inhibitors|mesh-ancestor
25170306|NCT01628094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170307|NCT01628094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170308|NCT01628094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25170309|NCT01628094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25170310|NCT01628094|Antiviral Agents|antiviral agents|mesh-ancestor
25170311|NCT01628094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25170312|NCT01628094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25170313|NCT01628094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25170314|NCT01628094|Antimetabolites|antimetabolites|mesh-ancestor
25203661|NCT02712957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25203662|NCT02712957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25203663|NCT02712957|Analgesics|analgesics|mesh-ancestor
25203664|NCT02712957|Sensory System Agents|sensory system agents|mesh-ancestor
25203665|NCT02712957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24747537|NCT00644228|Immunologic Factors|immunologic factors|mesh-ancestor
25203676|NCT02712944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25203677|NCT02712944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203679|NCT02712866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25203680|NCT02712619|Metformin|metformin|mesh-list
25203681|NCT02712619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25203682|NCT02712619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203683|NCT02712671|Interferons|interferons|mesh-list
25203684|NCT02712671|Interferon-gamma|interferon-gamma|mesh-list
25203685|NCT02712671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25203686|NCT02712671|Antiviral Agents|antiviral agents|mesh-ancestor
25203687|NCT02712671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25203688|NCT02712697|Prednisone|prednisone|mesh-list
25203689|NCT02712697|Hormones|hormones|mesh-list
25203690|NCT02712697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25203691|NCT02712697|Glucocorticoids|glucocorticoids|mesh-ancestor
24747517|NCT00644228|Dexamethasone|dexamethasone|mesh-list
24747518|NCT00644228|Dexamethasone acetate|dexamethasone acetate|mesh-list
24747519|NCT00644228|Lenalidomide|lenalidomide|mesh-list
24747520|NCT00644228|Bortezomib|bortezomib|mesh-list
24747521|NCT00644228|Ichthammol|ichthammol|mesh-list
24747522|NCT00644228|BB 1101|bb 1101|mesh-list
24747523|NCT00644228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24747525|NCT00644228|Autonomic Agents|autonomic agents|mesh-ancestor
24747526|NCT00644228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25860006|NCT00082472|Tubulin Modulators|tubulin modulators|mesh-ancestor
25860007|NCT00082472|Antimitotic Agents|antimitotic agents|mesh-ancestor
25860008|NCT00082472|Mitosis Modulators|mitosis modulators|mesh-ancestor
25203692|NCT02712697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25203693|NCT02712697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203694|NCT02712697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25203695|NCT02712697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170315|NCT01566240|Paclitaxel|paclitaxel|mesh-list
25170316|NCT01566240|Carboplatin|carboplatin|mesh-list
25170317|NCT01566240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25170318|NCT01566240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170319|NCT01566240|Tubulin Modulators|tubulin modulators|mesh-ancestor
25170320|NCT01566240|Antimitotic Agents|antimitotic agents|mesh-ancestor
25170321|NCT01566240|Mitosis Modulators|mitosis modulators|mesh-ancestor
25170322|NCT01566240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170323|NCT01563731|Antihypertensive Agents|antihypertensive agents|mesh-list
25170324|NCT01563731|Calcium Channel Blockers|calcium channel blockers|mesh-list
25170325|NCT01563731|Atorvastatin|atorvastatin|mesh-list
25170326|NCT01563731|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25170327|NCT01563731|Simvastatin|simvastatin|mesh-list
25170328|NCT01563731|Pravastatin|pravastatin|mesh-list
25170329|NCT01563731|Enzyme Inhibitors|enzyme inhibitors|mesh-list
24747527|NCT00644228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24747528|NCT00644228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24747529|NCT00644228|Glucocorticoids|glucocorticoids|mesh-ancestor
24747530|NCT00644228|Hormones|hormones|mesh-ancestor
24747531|NCT00644228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24747532|NCT00644228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24747533|NCT00644228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24747534|NCT00644228|Protease Inhibitors|protease inhibitors|mesh-ancestor
24747535|NCT00644228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24747536|NCT00644228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24747541|NCT00644228|Growth Inhibitors|growth inhibitors|mesh-ancestor
24747542|NCT00644228|Dermatologic Agents|dermatologic agents|mesh-ancestor
25860009|NCT00082472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170330|NCT01563731|Diuretics|diuretics|mesh-list
25170331|NCT01563731|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25170332|NCT01563731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
25170333|NCT01563731|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
25170334|NCT01563731|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
25170335|NCT01563731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25170336|NCT01563731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170337|NCT01563731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25170338|NCT01563731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25170339|NCT01563731|Antimetabolites|antimetabolites|mesh-ancestor
25170340|NCT01563731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170341|NCT01563731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25170342|NCT01563731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25170343|NCT01563731|Natriuretic Agents|natriuretic agents|mesh-ancestor
25170344|NCT01563731|Protease Inhibitors|protease inhibitors|mesh-ancestor
25170345|NCT01563731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25170346|NCT01563731|Hormone Antagonists|hormone antagonists|mesh-ancestor
25170347|NCT01563731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25170348|NCT01563731|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25170349|NCT01516346|Hydralazine|hydralazine|mesh-list
25170350|NCT01516346|Isosorbide|isosorbide|mesh-list
25170351|NCT01516346|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25170352|NCT01516346|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25170353|NCT01516346|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25170354|NCT01516346|Diuretics|diuretics|mesh-ancestor
25170355|NCT01516346|Natriuretic Agents|natriuretic agents|mesh-ancestor
25170356|NCT01516346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170357|NCT01516346|Vasodilator Agents|vasodilator agents|mesh-ancestor
25170358|NCT01516346|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25170359|NCT01516346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170360|NCT01516346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25170361|NCT01445067|Calcitonin|calcitonin|mesh-list
25170362|NCT01445067|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
25170363|NCT01445067|Katacalcin|katacalcin|mesh-list
25170364|NCT01445067|Vasodilator Agents|vasodilator agents|mesh-ancestor
25170365|NCT01445067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25170366|NCT01445067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170367|NCT01445067|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25170368|NCT01399372|Cytarabine|cytarabine|mesh-list
25170369|NCT01399372|Rituximab|rituximab|mesh-list
25170370|NCT01399372|Methotrexate|methotrexate|mesh-list
25170371|NCT01399372|Vincristine|vincristine|mesh-list
25170372|NCT01399372|Procarbazine|procarbazine|mesh-list
25170373|NCT01399372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25170374|NCT01399372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170375|NCT01399372|Immunologic Factors|immunologic factors|mesh-ancestor
25170376|NCT01399372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170377|NCT01399372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25170378|NCT01399372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25170379|NCT01399372|Abortifacient Agents|abortifacient agents|mesh-ancestor
25170380|NCT01399372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25170381|NCT01399372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25170382|NCT01399372|Antimetabolites|antimetabolites|mesh-ancestor
25170383|NCT01399372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170384|NCT01399372|Dermatologic Agents|dermatologic agents|mesh-ancestor
25170385|NCT01399372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170386|NCT01399372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25170387|NCT01399372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25170388|NCT01399372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25170389|NCT01399372|Antiviral Agents|antiviral agents|mesh-ancestor
25170390|NCT01399372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25170391|NCT01399372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25170392|NCT01399372|Tubulin Modulators|tubulin modulators|mesh-ancestor
25170393|NCT01399372|Antimitotic Agents|antimitotic agents|mesh-ancestor
25170394|NCT01399372|Mitosis Modulators|mitosis modulators|mesh-ancestor
25170395|NCT01371630|Cytarabine|cytarabine|mesh-list
25170396|NCT01371630|Dexamethasone|dexamethasone|mesh-list
24747655|NCT00316888|Antimetabolites|antimetabolites|mesh-ancestor
24747656|NCT00316888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24747657|NCT00316888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24747658|NCT00316888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24747659|NCT00316888|Immunologic Factors|immunologic factors|mesh-ancestor
24747660|NCT00316888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24747661|NCT00316888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24747663|NCT00095784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24747664|NCT00095784|Antimetabolites|antimetabolites|mesh-ancestor
24747665|NCT00095784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24747666|NCT00095784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24747667|NCT00095784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170399|NCT01371630|Rituximab|rituximab|mesh-list
25170400|NCT01371630|Methotrexate|methotrexate|mesh-list
25170401|NCT01371630|Vincristine|vincristine|mesh-list
25170402|NCT01371630|Mercaptopurine|mercaptopurine|mesh-list
25170403|NCT01371630|Blinatumomab|blinatumomab|mesh-list
25170404|NCT01371630|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25170405|NCT01371630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25170406|NCT01371630|Immunologic Factors|immunologic factors|mesh-ancestor
25170407|NCT01371630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170408|NCT01371630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25170409|NCT01371630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25170410|NCT01371630|Alkylating Agents|alkylating agents|mesh-ancestor
25170411|NCT01371630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170412|NCT01371630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170413|NCT01371630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25170414|NCT01371630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25170415|NCT01371630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25170416|NCT01371630|Antiemetics|antiemetics|mesh-ancestor
25170417|NCT01371630|Autonomic Agents|autonomic agents|mesh-ancestor
25425151|NCT02166463|Podophyllotoxin|podophyllotoxin|mesh-list
25170418|NCT01371630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25170419|NCT01371630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25170420|NCT01371630|Glucocorticoids|glucocorticoids|mesh-ancestor
25170421|NCT01371630|Hormones|hormones|mesh-ancestor
25170422|NCT01371630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25170423|NCT01371630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25170424|NCT01371630|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25170425|NCT01371630|Abortifacient Agents|abortifacient agents|mesh-ancestor
25170426|NCT01371630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25170427|NCT01371630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25170428|NCT01371630|Antimetabolites|antimetabolites|mesh-ancestor
25170429|NCT01371630|Dermatologic Agents|dermatologic agents|mesh-ancestor
25170430|NCT01371630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170431|NCT01371630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25170432|NCT01371630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25170433|NCT01371630|Antiviral Agents|antiviral agents|mesh-ancestor
25170434|NCT01371630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25170435|NCT01371630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25170436|NCT01371630|Tubulin Modulators|tubulin modulators|mesh-ancestor
25170437|NCT01371630|Antimitotic Agents|antimitotic agents|mesh-ancestor
25170438|NCT01371630|Mitosis Modulators|mitosis modulators|mesh-ancestor
25170439|NCT01371630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25170440|NCT01303796|Decitabine|decitabine|mesh-list
25170441|NCT01303796|Sapacitabine|sapacitabine|mesh-list
25170442|NCT01303796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25170443|NCT01303796|Antimetabolites|antimetabolites|mesh-ancestor
25170444|NCT01303796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170445|NCT01303796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170446|NCT01303796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170447|NCT01235923|Epoetin Alfa|epoetin alfa|mesh-list
25170448|NCT01235923|Hematinics|hematinics|mesh-ancestor
25170449|NCT00976911|Paclitaxel|paclitaxel|mesh-list
25170450|NCT00976911|Bevacizumab|bevacizumab|mesh-list
25170451|NCT00976911|Doxorubicin|doxorubicin|mesh-list
25170452|NCT00976911|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25170453|NCT00976911|Topotecan|topotecan|mesh-list
25170454|NCT00976911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25170455|NCT00976911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170456|NCT00976911|Tubulin Modulators|tubulin modulators|mesh-ancestor
25170457|NCT00976911|Antimitotic Agents|antimitotic agents|mesh-ancestor
25170458|NCT00976911|Mitosis Modulators|mitosis modulators|mesh-ancestor
25170459|NCT00976911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170460|NCT00976911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25170461|NCT00976911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25170462|NCT00976911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25170463|NCT00976911|Growth Substances|growth substances|mesh-ancestor
25170464|NCT00976911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170466|NCT00976911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25170467|NCT00976911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25170468|NCT00976911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25170469|NCT00976911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170470|NCT00976911|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25170471|NCT00896493|Cyclosporine|cyclosporine|mesh-list
25170472|NCT00896493|Cyclosporins|cyclosporins|mesh-list
25170473|NCT00896493|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25170474|NCT00896493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170475|NCT00896493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170476|NCT00896493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25170477|NCT00896493|Immunologic Factors|immunologic factors|mesh-ancestor
25170478|NCT00896493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170479|NCT00896493|Antifungal Agents|antifungal agents|mesh-ancestor
25170480|NCT00896493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25170481|NCT00896493|Dermatologic Agents|dermatologic agents|mesh-ancestor
25170482|NCT00896493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25170483|NCT00896493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25170484|NCT00848328|Rituximab|rituximab|mesh-list
25170485|NCT00848328|Lenalidomide|lenalidomide|mesh-list
25170486|NCT00848328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25170487|NCT00848328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170488|NCT00848328|Immunologic Factors|immunologic factors|mesh-ancestor
25170489|NCT00848328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170490|NCT00848328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25170491|NCT00848328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25170492|NCT00848328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25170493|NCT00848328|Growth Substances|growth substances|mesh-ancestor
25170494|NCT00848328|Growth Inhibitors|growth inhibitors|mesh-ancestor
25170495|NCT00712582|Cyclophosphamide|cyclophosphamide|mesh-list
25170496|NCT00712582|Ifosfamide|ifosfamide|mesh-list
25170497|NCT00712582|Isophosphamide mustard|isophosphamide mustard|mesh-list
25170498|NCT00712582|Carmustine|carmustine|mesh-list
25170499|NCT00712582|Rituximab|rituximab|mesh-list
25170500|NCT00712582|Carboplatin|carboplatin|mesh-list
25170501|NCT00712582|Etoposide|etoposide|mesh-list
25170502|NCT00712582|Etoposide phosphate|etoposide phosphate|mesh-list
25170503|NCT00712582|Mitoxantrone|mitoxantrone|mesh-list
25170504|NCT00712582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25170505|NCT00712582|Immunologic Factors|immunologic factors|mesh-ancestor
25170506|NCT00712582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170507|NCT00712582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25170508|NCT00712582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25170510|NCT00712582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170512|NCT00712582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25170513|NCT00712582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25170514|NCT00712582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25170515|NCT00712582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25170516|NCT00712582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25170517|NCT00712582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170518|NCT00712582|Analgesics|analgesics|mesh-ancestor
25170519|NCT00712582|Sensory System Agents|sensory system agents|mesh-ancestor
25170520|NCT00712582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25170521|NCT00700258|Sirolimus|sirolimus|mesh-list
25170522|NCT00700258|Sunitinib|sunitinib|mesh-list
25170523|NCT00700258|Axitinib|axitinib|mesh-list
25170524|NCT00700258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170525|NCT00700258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25170526|NCT00700258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25170527|NCT00700258|Growth Substances|growth substances|mesh-ancestor
25170528|NCT00700258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170529|NCT00700258|Growth Inhibitors|growth inhibitors|mesh-ancestor
25860010|NCT00082472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25860011|NCT00082472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25860012|NCT00082472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25860013|NCT00082472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412196|NCT00190931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412197|NCT00190944|Teriparatide|teriparatide|mesh-list
24412198|NCT00190944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24412199|NCT00190944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412200|NCT00190944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24412201|NCT00190957|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24412202|NCT00190957|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24747750|NCT03126812|Mitosis Modulators|mitosis modulators|mesh-ancestor
24747751|NCT03126812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444123|NCT00296751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25860014|NCT00082485|Baclofen|baclofen|mesh-list
25170530|NCT00700258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25170531|NCT00700258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170532|NCT00700258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170533|NCT00700258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25170534|NCT00700258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25170535|NCT00700258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25170536|NCT00700258|Antifungal Agents|antifungal agents|mesh-ancestor
25170537|NCT00700258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25170538|NCT00700258|Immunologic Factors|immunologic factors|mesh-ancestor
25860015|NCT00082485|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25860016|NCT00082485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860017|NCT00082485|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25860018|NCT00082485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25860019|NCT00082485|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24779212|NCT01874717|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24779213|NCT01874717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24779214|NCT01874717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779215|NCT01874717|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24780231|NCT01882556|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24780232|NCT01882556|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24780233|NCT01882556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24780234|NCT01882556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24780441|NCT01884428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24780442|NCT01884428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24780443|NCT01884428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24780444|NCT01884428|Tubulin Modulators|tubulin modulators|mesh-ancestor
24780445|NCT01884428|Antimitotic Agents|antimitotic agents|mesh-ancestor
24780446|NCT01884428|Mitosis Modulators|mitosis modulators|mesh-ancestor
24780447|NCT01884428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24780448|NCT01884428|Alkylating Agents|alkylating agents|mesh-ancestor
24780449|NCT01884428|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24780580|NCT01885013|Cyclophosphamide|cyclophosphamide|mesh-list
24780582|NCT01885013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24780614|NCT01885338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24747753|NCT03110432|Nicotinic Acids|nicotinic acids|mesh-list
24780615|NCT01885338|Expectorants|expectorants|mesh-ancestor
24780616|NCT01885338|Respiratory System Agents|respiratory system agents|mesh-ancestor
24780617|NCT01885338|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24780618|NCT01885338|Antioxidants|antioxidants|mesh-ancestor
24786479|NCT01920204|Midostaurin|midostaurin|mesh-list
24781049|NCT01887704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24781050|NCT01887704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24781051|NCT01887704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24781052|NCT01887704|Purinergic Agents|purinergic agents|mesh-ancestor
24781053|NCT01887704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24781054|NCT01887704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24781055|NCT01887704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24781056|NCT01887704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24781057|NCT01887704|Antifungal Agents|antifungal agents|mesh-ancestor
24781058|NCT01887743|Pantoprazole|pantoprazole|mesh-list
24781059|NCT01887743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24781060|NCT01887743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24781061|NCT01887743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24781062|NCT01887743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781063|NCT01887743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781064|NCT01887795|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24781065|NCT01887795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170660|NCT00364637|Anesthetics, General|anesthetics, general|mesh-ancestor
25170548|NCT00585507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25170549|NCT00585507|Hormone Antagonists|hormone antagonists|mesh-ancestor
25170550|NCT00585507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25170551|NCT00585507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170552|NCT00573131|Paclitaxel|paclitaxel|mesh-list
25170553|NCT00573131|Cisplatin|cisplatin|mesh-list
25170554|NCT00573131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25170555|NCT00573131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170556|NCT00573131|Tubulin Modulators|tubulin modulators|mesh-ancestor
25170557|NCT00573131|Antimitotic Agents|antimitotic agents|mesh-ancestor
25170558|NCT00573131|Mitosis Modulators|mitosis modulators|mesh-ancestor
25170559|NCT00573131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170560|NCT00533949|Paclitaxel|paclitaxel|mesh-list
25170561|NCT00533949|Carboplatin|carboplatin|mesh-list
25170562|NCT00533949|Cetuximab|cetuximab|mesh-list
25170563|NCT00533949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25170564|NCT00533949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170565|NCT00533949|Tubulin Modulators|tubulin modulators|mesh-ancestor
25170566|NCT00533949|Antimitotic Agents|antimitotic agents|mesh-ancestor
25170567|NCT00533949|Mitosis Modulators|mitosis modulators|mesh-ancestor
25170568|NCT00533949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170569|NCT00533949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25170570|NCT00529763|Dasatinib|dasatinib|mesh-list
25170571|NCT00529763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170572|NCT00529763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25170573|NCT00529763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170574|NCT00529763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24747914|NCT03015792|Ichthammol|ichthammol|mesh-list
24747915|NCT03015792|BB 1101|bb 1101|mesh-list
25170656|NCT00364637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25170657|NCT00364637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170658|NCT00364637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25170659|NCT00364637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25170670|NCT00288080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25170671|NCT00288080|Glucocorticoids|glucocorticoids|mesh-ancestor
25170672|NCT00288080|Hormones|hormones|mesh-ancestor
25170673|NCT00288080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25170674|NCT00288080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25170675|NCT00288080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170676|NCT00288080|Tubulin Modulators|tubulin modulators|mesh-ancestor
25170677|NCT00288080|Antimitotic Agents|antimitotic agents|mesh-ancestor
25170678|NCT00288080|Mitosis Modulators|mitosis modulators|mesh-ancestor
25170679|NCT00288080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852720|NCT02263976|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25170680|NCT00288080|Hormone Antagonists|hormone antagonists|mesh-ancestor
25170681|NCT00194714|Vaccines|vaccines|mesh-list
25170682|NCT00194714|Immunologic Factors|immunologic factors|mesh-ancestor
25170683|NCT00194714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394368|NCT00133185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25170692|NCT02894138|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25170693|NCT02894138|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25170694|NCT02894138|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25170766|NCT02893826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25170695|NCT02894138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170696|NCT02894307|Rivaroxaban|rivaroxaban|mesh-list
25170697|NCT02894307|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25170698|NCT02894307|Antithrombins|antithrombins|mesh-ancestor
25170699|NCT02894307|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25170700|NCT02894307|Protease Inhibitors|protease inhibitors|mesh-ancestor
25170701|NCT02894307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170702|NCT02894307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170703|NCT02894307|Anticoagulants|anticoagulants|mesh-ancestor
25170704|NCT02894151|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24748060|NCT02975934|Rucaparib|rucaparib|mesh-list
24748130|NCT02901067|Antimetabolites|antimetabolites|mesh-ancestor
25170705|NCT02894151|Medroxyprogesterone|medroxyprogesterone|mesh-list
25170706|NCT02894151|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25170707|NCT02894151|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25170708|NCT02894151|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25170709|NCT02894151|Contraceptive Agents|contraceptive agents|mesh-ancestor
25170710|NCT02894151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25170711|NCT02894151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170712|NCT02894151|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25170713|NCT02894151|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25170714|NCT02894151|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25170715|NCT02894151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25170716|NCT02894151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170717|NCT02893995|Treprostinil|treprostinil|mesh-list
25170718|NCT02893995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25170719|NCT02894268|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25170720|NCT02894268|Doxycycline|doxycycline|mesh-list
25170721|NCT02894268|Furazolidone|furazolidone|mesh-list
25170722|NCT02894268|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
25170723|NCT02894268|Esomeprazole|esomeprazole|mesh-list
25170724|NCT02894268|Bismuth|bismuth|mesh-list
25170725|NCT02894268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25170726|NCT02894268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25170727|NCT02894268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25170728|NCT02894268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25170729|NCT02894268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170730|NCT02894268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170731|NCT02894268|Antimalarials|antimalarials|mesh-ancestor
25170732|NCT02894268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25170733|NCT02894268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25170735|NCT02894268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25170736|NCT02894268|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25170737|NCT02894268|Renal Agents|renal agents|mesh-ancestor
25170738|NCT02894268|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25170739|NCT02894268|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25170741|NCT02893618|Choline|choline|mesh-list
25170742|NCT02893618|Lipotropic Agents|lipotropic agents|mesh-ancestor
25170743|NCT02893618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25170744|NCT02893618|Antimetabolites|antimetabolites|mesh-ancestor
25170745|NCT02893618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170746|NCT02893618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25170747|NCT02893618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25170748|NCT02893618|Nootropic Agents|nootropic agents|mesh-ancestor
25170749|NCT02893618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25170750|NCT02893618|Vasodilator Agents|vasodilator agents|mesh-ancestor
25170751|NCT02893722|Oxytocin|oxytocin|mesh-list
25170752|NCT02893722|Atosiban|atosiban|mesh-list
25170753|NCT02893722|Oxytocics|oxytocics|mesh-ancestor
25170754|NCT02893722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25170755|NCT02893722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170756|NCT02893722|Hormone Antagonists|hormone antagonists|mesh-ancestor
25170757|NCT02893722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25170758|NCT02893722|Tocolytic Agents|tocolytic agents|mesh-ancestor
25170759|NCT02893709|Omeprazole|omeprazole|mesh-list
25664953|NCT01677507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170760|NCT02893709|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25860021|NCT00082485|GABA Agents|gaba agents|mesh-ancestor
25860022|NCT00082485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25664954|NCT01677507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25664955|NCT01677507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25664956|NCT01677507|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24593900|NCT00931450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25170761|NCT02893709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25170762|NCT02893709|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25170763|NCT02893709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170764|NCT02893709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203697|NCT02712775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25203698|NCT02712775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25203699|NCT02712658|Terbutaline|terbutaline|mesh-list
24748133|NCT02886286|Fentanyl|fentanyl|mesh-list
25203700|NCT02712658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25170765|NCT02893826|Nimodipine|nimodipine|mesh-list
25170767|NCT02893826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25170768|NCT02893826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25170769|NCT02893826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170770|NCT02893826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25170771|NCT02893826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170772|NCT02893826|Vasodilator Agents|vasodilator agents|mesh-ancestor
25170773|NCT02893332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25170774|NCT02893332|Gefitinib|gefitinib|mesh-list
25170775|NCT02893332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170776|NCT02893332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25170777|NCT02893332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170778|NCT02893332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170779|NCT02893280|Aspirin|aspirin|mesh-list
25170780|NCT02893280|Enoxaparin|enoxaparin|mesh-list
25170781|NCT02893280|Streptokinase|streptokinase|mesh-list
25170782|NCT02893280|Clopidogrel|clopidogrel|mesh-list
25170783|NCT02893280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25170784|NCT02893280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25170785|NCT02893280|Analgesics|analgesics|mesh-ancestor
25170786|NCT02893280|Sensory System Agents|sensory system agents|mesh-ancestor
25170787|NCT02893280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25170788|NCT02893280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170789|NCT02893280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25170790|NCT02893280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25170791|NCT02893280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25170792|NCT02893280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25170793|NCT02893280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170794|NCT02893280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24944245|NCT03962283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24944246|NCT03962283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24944247|NCT03962283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25170795|NCT02893280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25170796|NCT02893280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170797|NCT02893280|Antipyretics|antipyretics|mesh-ancestor
25170798|NCT02893280|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25170799|NCT02893280|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25170800|NCT02893280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25170801|NCT02893280|Purinergic Agents|purinergic agents|mesh-ancestor
25170802|NCT02893280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25170804|NCT02893553|Midodrine|midodrine|mesh-list
25170805|NCT02893553|Bromides|bromides|mesh-list
25170806|NCT02893553|Mirabegron|mirabegron|mesh-list
25170807|NCT02893553|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
25170808|NCT02893553|Anticonvulsants|anticonvulsants|mesh-ancestor
25170809|NCT02893553|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25170810|NCT02893553|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25170811|NCT02893553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25170812|NCT02893553|Adrenergic Agents|adrenergic agents|mesh-ancestor
25170813|NCT02893553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25664957|NCT01677507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25664958|NCT01677741|Dabrafenib|dabrafenib|mesh-list
25664959|NCT01677741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25664960|NCT01677741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25664961|NCT01677741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664962|NCT01677741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170814|NCT02893553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170815|NCT02893553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664963|NCT01677988|Folfirinox|folfirinox|mesh-list
25170816|NCT02893553|Urological Agents|urological agents|mesh-ancestor
25170817|NCT02893553|Sympathomimetics|sympathomimetics|mesh-ancestor
25170818|NCT02893553|Autonomic Agents|autonomic agents|mesh-ancestor
25170819|NCT02893553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25170820|NCT02893553|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25170821|NCT02893553|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25170822|NCT02893553|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25170823|NCT02893553|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25170824|NCT02893553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170825|NCT02893553|Cholinergic Agents|cholinergic agents|mesh-ancestor
25170826|NCT02893540|Capecitabine|capecitabine|mesh-list
25170827|NCT02893540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25170828|NCT02893540|Antimetabolites|antimetabolites|mesh-ancestor
25170829|NCT02893540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170830|NCT02893540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170831|NCT02893371|Lamotrigine|lamotrigine|mesh-list
25170832|NCT02893371|Carbamazepine|carbamazepine|mesh-list
25170833|NCT02893371|Oxcarbazepine|oxcarbazepine|mesh-list
25170834|NCT02893371|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25170835|NCT02893371|Valproic Acid|valproic acid|mesh-list
25170836|NCT02893371|Haloperidol|haloperidol|mesh-list
25170837|NCT02893371|Olanzapine|olanzapine|mesh-list
25170838|NCT02893371|Risperidone|risperidone|mesh-list
25170839|NCT02893371|Aripiprazole|aripiprazole|mesh-list
25860023|NCT00082485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748217|NCT02787551|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25860024|NCT00082511|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25860025|NCT00082511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25860026|NCT00082511|Immunologic Factors|immunologic factors|mesh-ancestor
25860027|NCT00082511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860028|NCT00082524|Caspofungin|caspofungin|mesh-list
25860029|NCT00082524|Antifungal Agents|antifungal agents|mesh-ancestor
25860030|NCT00082524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25860031|NCT00082524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860032|NCT00082524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860033|NCT00082537|Caspofungin|caspofungin|mesh-list
25860034|NCT00082537|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25860035|NCT00082537|Antifungal Agents|antifungal agents|mesh-ancestor
25860036|NCT00082537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25124981|NCT03072199|Rituximab|rituximab|mesh-list
24784009|NCT01905215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784010|NCT01905371|Amphetamine|amphetamine|mesh-list
24784011|NCT01905371|Dextroamphetamine|dextroamphetamine|mesh-list
24787253|NCT01924104|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24784182|NCT01906788|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24784183|NCT01906788|Antimalarials|antimalarials|mesh-ancestor
24784184|NCT01906788|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24784185|NCT01906788|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24784312|NCT01907308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784313|NCT01907308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24784314|NCT01907308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24784315|NCT01907308|Growth Substances|growth substances|mesh-ancestor
24784316|NCT01907308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784317|NCT01907308|Growth Inhibitors|growth inhibitors|mesh-ancestor
24784511|NCT01908335|Antiviral Agents|antiviral agents|mesh-ancestor
24784512|NCT01908335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24784513|NCT01908335|Immunologic Factors|immunologic factors|mesh-ancestor
24784514|NCT01908335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784517|NCT01908387|Azacitidine|azacitidine|mesh-list
24784518|NCT01908387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24784519|NCT01908387|Antimetabolites|antimetabolites|mesh-ancestor
24784520|NCT01908387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784521|NCT01908387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412661|NCT00191737|Adrenergic Agents|adrenergic agents|mesh-ancestor
24748314|NCT02713867|Nivolumab|nivolumab|mesh-list
24785395|NCT01914042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785872|NCT01917019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24841600|NCT02216799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24785905|NCT01917058|Immunologic Factors|immunologic factors|mesh-ancestor
24785906|NCT01917058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785907|NCT01917058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24785908|NCT01917097|Dexmedetomidine|dexmedetomidine|mesh-list
24785909|NCT01917097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24785910|NCT01917097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24785911|NCT01917097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622384|NCT01066767|Histamine Agents|histamine agents|mesh-ancestor
24785944|NCT01917279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24785945|NCT01917279|Tubulin Modulators|tubulin modulators|mesh-ancestor
24785946|NCT01917279|Antimitotic Agents|antimitotic agents|mesh-ancestor
24785947|NCT01917279|Mitosis Modulators|mitosis modulators|mesh-ancestor
24785948|NCT01917279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785949|NCT01917279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24785950|NCT01917279|Antimetabolites|antimetabolites|mesh-ancestor
24785951|NCT01917318|Iloperidone|iloperidone|mesh-list
25170840|NCT02893371|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25170841|NCT02893371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25170842|NCT02893371|Ziprasidone|ziprasidone|mesh-list
25170843|NCT02893371|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25170844|NCT02893371|Clozapine|clozapine|mesh-list
25170845|NCT02893371|Asenapine|asenapine|mesh-list
25170846|NCT02893371|Perphenazine|perphenazine|mesh-list
25170847|NCT02893371|Lithium Carbonate|lithium carbonate|mesh-list
25170848|NCT02893371|Mirtazapine|mirtazapine|mesh-list
25170849|NCT02893371|Fluvoxamine|fluvoxamine|mesh-list
25170850|NCT02893371|Doxepin|doxepin|mesh-list
25170851|NCT02893371|Citalopram|citalopram|mesh-list
25170852|NCT02893371|Bupropion|bupropion|mesh-list
25170853|NCT02893371|Sertraline|sertraline|mesh-list
25170854|NCT02893371|Fluoxetine|fluoxetine|mesh-list
25170855|NCT02893371|Paroxetine|paroxetine|mesh-list
25170857|NCT02893371|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25170858|NCT02893371|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
25170859|NCT02893371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25170861|NCT02893371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25170862|NCT02893371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170863|NCT02893371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170864|NCT02893371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25170865|NCT02893371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25170866|NCT02893371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25170867|NCT02893371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25170868|NCT02893371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25170869|NCT02893371|Dopamine Agents|dopamine agents|mesh-ancestor
25170870|NCT02893371|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25170871|NCT02893371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25170872|NCT02893371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25170873|NCT02893371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25170874|NCT02893371|Antidepressive Agents|antidepressive agents|mesh-ancestor
25170875|NCT02893371|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25170876|NCT02893371|Autonomic Agents|autonomic agents|mesh-ancestor
24748317|NCT02713867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24748318|NCT02713867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748319|NCT02692651|Vancomycin|vancomycin|mesh-list
24748320|NCT02692651|Fidaxomicin|fidaxomicin|mesh-list
24748321|NCT02692651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24748322|NCT02692651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24748323|NCT02688712|Fluorouracil|fluorouracil|mesh-list
24748324|NCT02688712|Capecitabine|capecitabine|mesh-list
24748325|NCT02688712|Antimetabolites|antimetabolites|mesh-ancestor
25170877|NCT02893371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25170878|NCT02893371|Antiemetics|antiemetics|mesh-ancestor
25170879|NCT02893371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25170880|NCT02893371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25170881|NCT02893371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25170891|NCT02893371|Sensory System Agents|sensory system agents|mesh-ancestor
25170892|NCT02893371|Antimanic Agents|antimanic agents|mesh-ancestor
25170893|NCT02893371|Anticonvulsants|anticonvulsants|mesh-ancestor
25170894|NCT02893371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25170895|NCT02893371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25170896|NCT02893371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25170897|NCT02893371|GABA Agents|gaba agents|mesh-ancestor
25170898|NCT02893371|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25170899|NCT02893371|Histamine Antagonists|histamine antagonists|mesh-ancestor
25170900|NCT02893371|Histamine Agents|histamine agents|mesh-ancestor
25170901|NCT02893371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25170902|NCT02893371|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25170903|NCT02893371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25170904|NCT02893371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25170905|NCT02893371|Adrenergic Agents|adrenergic agents|mesh-ancestor
25170906|NCT02893371|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25170907|NCT02893371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25170908|NCT02893371|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24748380|NCT02654314|Melatonin|melatonin|mesh-list
25170909|NCT02893371|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25170910|NCT02893371|GABA Antagonists|gaba antagonists|mesh-ancestor
25170911|NCT02893371|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25170912|NCT02893371|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25170913|NCT02893371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25170914|NCT02893371|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25170915|NCT02893371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25170916|NCT02893371|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25170928|NCT02893176|Macitentan|macitentan|mesh-list
25170929|NCT02893176|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25170930|NCT02893176|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25170931|NCT02893176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170932|NCT02893176|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25170933|NCT02893384|Anesthetics|anesthetics|mesh-list
25170934|NCT02893384|Anesthetics, Local|anesthetics, local|mesh-list
25170935|NCT02893384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25170936|NCT02893384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170937|NCT02893384|Sensory System Agents|sensory system agents|mesh-ancestor
25170938|NCT02893384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25170939|NCT02893228|Levobupivacaine|levobupivacaine|mesh-list
25170940|NCT02893228|Anesthetics, Local|anesthetics, local|mesh-ancestor
25170941|NCT02893228|Anesthetics|anesthetics|mesh-ancestor
25170942|NCT02893228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25170943|NCT02893228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170944|NCT02893228|Sensory System Agents|sensory system agents|mesh-ancestor
25170945|NCT02893228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25170946|NCT02893488|Lamivudine|lamivudine|mesh-list
25170947|NCT02893488|Dolutegravir|dolutegravir|mesh-list
25170948|NCT02893488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25170949|NCT02893488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25170950|NCT02893488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170951|NCT02893488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170952|NCT02893488|Antiviral Agents|antiviral agents|mesh-ancestor
25170953|NCT02893488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25170954|NCT02893488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25170955|NCT02893488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25170956|NCT02893488|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25170957|NCT02893488|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25170958|NCT02893254|Adalimumab|adalimumab|mesh-list
25170959|NCT02893254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25170960|NCT02893254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25170961|NCT02893111|Bortezomib|bortezomib|mesh-list
25170962|NCT02893111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25170963|NCT02893124|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25170964|NCT02893124|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25170965|NCT02893124|Antiviral Agents|antiviral agents|mesh-ancestor
25170966|NCT02893124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25170967|NCT02892916|Ketamine|ketamine|mesh-list
25170968|NCT02892916|Analgesics|analgesics|mesh-ancestor
25170969|NCT02892916|Sensory System Agents|sensory system agents|mesh-ancestor
25170970|NCT02892916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25170971|NCT02892916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170972|NCT02892916|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25170973|NCT02892916|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25170974|NCT02892916|Anesthetics, General|anesthetics, general|mesh-ancestor
25170975|NCT02892916|Anesthetics|anesthetics|mesh-ancestor
25170976|NCT02892916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25170977|NCT02892916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25170978|NCT02892916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25170979|NCT02892916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25170980|NCT02892916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25170981|NCT02892942|Cetrorelix|cetrorelix|mesh-list
25170982|NCT02892942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25170983|NCT02892942|Fertility Agents|fertility agents|mesh-ancestor
25170984|NCT02892942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25170985|NCT02892942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170986|NCT02892942|Hormone Antagonists|hormone antagonists|mesh-ancestor
25170987|NCT02892942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25170988|NCT02892812|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25170989|NCT02892812|Immunologic Factors|immunologic factors|mesh-ancestor
25170990|NCT02892812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170991|NCT02892591|Oxycodone|oxycodone|mesh-list
25170992|NCT02892591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25170993|NCT02892591|Narcotics|narcotics|mesh-ancestor
25170994|NCT02892591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25425538|NCT02135042|Immunologic Factors|immunologic factors|mesh-ancestor
25170995|NCT02892591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25170996|NCT02892591|Analgesics|analgesics|mesh-ancestor
24748446|NCT02587520|Vaccines|vaccines|mesh-list
25170997|NCT02892591|Sensory System Agents|sensory system agents|mesh-ancestor
25170998|NCT02892591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25860037|NCT00082537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25170999|NCT02892357|Omeprazole|omeprazole|mesh-list
25171000|NCT02892357|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25171001|NCT02892357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25171003|NCT02892357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25171004|NCT02892357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171006|NCT02892318|Guadecitabine|guadecitabine|mesh-list
25171007|NCT02892318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171008|NCT02891967|Z 350|z 350|mesh-list
25171009|NCT02891967|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25171010|NCT02891967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25171011|NCT02891967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25171012|NCT02891967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171013|NCT02891967|Hormone Antagonists|hormone antagonists|mesh-ancestor
25171063|NCT02891083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25171014|NCT02891967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25203701|NCT02712658|Autonomic Agents|autonomic agents|mesh-ancestor
25203702|NCT02712658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25203703|NCT02712658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203704|NCT02712658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25203705|NCT02712658|Respiratory System Agents|respiratory system agents|mesh-ancestor
25203706|NCT02712658|Sympathomimetics|sympathomimetics|mesh-ancestor
25203707|NCT02712658|Tocolytic Agents|tocolytic agents|mesh-ancestor
25860038|NCT00082537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860039|NCT00082537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25860040|NCT00082537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25876436|NCT03497676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876437|NCT03497676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25876438|NCT03497676|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25876439|NCT03497676|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25876440|NCT03463460|Pembrolizumab|pembrolizumab|mesh-list
25876441|NCT03463460|Sunitinib|sunitinib|mesh-list
25876442|NCT03463460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25876443|NCT03463460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876444|NCT03463460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25876445|NCT03463460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25876446|NCT03463460|Growth Substances|growth substances|mesh-ancestor
25876447|NCT03463460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171016|NCT02891980|Vaccines|vaccines|mesh-list
25171017|NCT02891980|Immunologic Factors|immunologic factors|mesh-ancestor
25171018|NCT02891980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171019|NCT02891785|Antipain|antipain|mesh-list
25171020|NCT02891785|Protease Inhibitors|protease inhibitors|mesh-ancestor
25171021|NCT02891785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25171022|NCT02891785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171023|NCT02891616|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25171024|NCT02891616|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25171025|NCT02891616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171026|NCT02891395|Imatinib Mesylate|imatinib mesylate|mesh-list
25171027|NCT02891395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171028|NCT02891395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25171029|NCT02891395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25171030|NCT02891395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171031|NCT02891161|Durvalumab|durvalumab|mesh-list
25171032|NCT02891161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25171033|NCT02891161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171034|NCT02891278|Cytarabine|cytarabine|mesh-list
25171035|NCT02891278|Sertraline|sertraline|mesh-list
25171036|NCT02891278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25171037|NCT02891278|Antimetabolites|antimetabolites|mesh-ancestor
24748587|NCT02363998|Lofexidine|lofexidine|mesh-list
25171038|NCT02891278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171039|NCT02891278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171040|NCT02891278|Antiviral Agents|antiviral agents|mesh-ancestor
25171041|NCT02891278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24707649|NCT01497093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171042|NCT02891278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25171043|NCT02891278|Immunologic Factors|immunologic factors|mesh-ancestor
25171044|NCT02891278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171045|NCT02891278|Antidepressive Agents|antidepressive agents|mesh-ancestor
25171046|NCT02891278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25171047|NCT02891278|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25171048|NCT02891278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25171049|NCT02891278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25171050|NCT02891278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25171051|NCT02891278|Serotonin Agents|serotonin agents|mesh-ancestor
25171053|NCT02891018|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25171054|NCT02891018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25171055|NCT02891018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171056|NCT02891018|Tubulin Modulators|tubulin modulators|mesh-ancestor
25171057|NCT02891018|Antimitotic Agents|antimitotic agents|mesh-ancestor
25171058|NCT02891018|Mitosis Modulators|mitosis modulators|mesh-ancestor
25171059|NCT02891018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171060|NCT02891083|Paclitaxel|paclitaxel|mesh-list
25171061|NCT02891083|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25171062|NCT02891083|Cisplatin|cisplatin|mesh-list
25860041|NCT00082563|Azithromycin|azithromycin|mesh-list
25171064|NCT02891083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171065|NCT02891083|Tubulin Modulators|tubulin modulators|mesh-ancestor
25171066|NCT02891083|Antimitotic Agents|antimitotic agents|mesh-ancestor
25171067|NCT02891083|Mitosis Modulators|mitosis modulators|mesh-ancestor
25171068|NCT02891083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171069|NCT02891005|Paclitaxel|paclitaxel|mesh-list
25171070|NCT02891005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25171071|NCT02891005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171072|NCT02891005|Tubulin Modulators|tubulin modulators|mesh-ancestor
25171073|NCT02891005|Antimitotic Agents|antimitotic agents|mesh-ancestor
25171074|NCT02891005|Mitosis Modulators|mitosis modulators|mesh-ancestor
25171075|NCT02891005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171076|NCT02890875|Ethanol|ethanol|mesh-list
25171077|NCT02890875|Heparin|heparin|mesh-list
25171078|NCT02890875|Anticoagulants|anticoagulants|mesh-ancestor
25171079|NCT02890875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25171080|NCT02890875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25171081|NCT02890875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171082|NCT02890875|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25171083|NCT02890875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25171084|NCT02890875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25171085|NCT02890875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171086|NCT02890719|Ribavirin|ribavirin|mesh-list
25171087|NCT02890719|Grazoprevir|grazoprevir|mesh-list
25171088|NCT02890719|Antimetabolites|antimetabolites|mesh-ancestor
25171089|NCT02890719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171090|NCT02890719|Antiviral Agents|antiviral agents|mesh-ancestor
25171091|NCT02890719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25171092|NCT02890745|Empagliflozin|empagliflozin|mesh-list
25171093|NCT02890745|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25171094|NCT02890745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171095|NCT02890745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25171096|NCT02890745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171097|NCT02890771|Turmeric extract|turmeric extract|mesh-list
25171098|NCT02890771|Antioxidants|antioxidants|mesh-ancestor
25171099|NCT02890771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171100|NCT02890771|Protective Agents|protective agents|mesh-ancestor
25171101|NCT02890771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171102|NCT02890823|Cholecalciferol|cholecalciferol|mesh-list
25171103|NCT02890823|Vitamin D|vitamin d|mesh-list
25171104|NCT02890823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25171105|NCT02890823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171106|NCT02890823|Vitamins|vitamins|mesh-ancestor
25171107|NCT02890823|Micronutrients|micronutrients|mesh-ancestor
25171108|NCT02890823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25171109|NCT02890602|Prednisolone|prednisolone|mesh-list
25171110|NCT02890602|Cyclophosphamide|cyclophosphamide|mesh-list
25171111|NCT02890602|Vincristine|vincristine|mesh-list
25171112|NCT02890602|Darbepoetin alfa|darbepoetin alfa|mesh-list
25171113|NCT02890602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25171114|NCT02890602|Immunologic Factors|immunologic factors|mesh-ancestor
25171115|NCT02890602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171116|NCT02890602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25171117|NCT02890602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25171118|NCT02890602|Alkylating Agents|alkylating agents|mesh-ancestor
25171119|NCT02890602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171120|NCT02890602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171121|NCT02890602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25171122|NCT02890602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25171123|NCT02890602|Tubulin Modulators|tubulin modulators|mesh-ancestor
25171124|NCT02890602|Antimitotic Agents|antimitotic agents|mesh-ancestor
25171125|NCT02890602|Mitosis Modulators|mitosis modulators|mesh-ancestor
25171126|NCT02890602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25171127|NCT02890602|Glucocorticoids|glucocorticoids|mesh-ancestor
25171128|NCT02890602|Hormones|hormones|mesh-ancestor
25171129|NCT02890602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25171130|NCT02890602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25171131|NCT02890602|Hematinics|hematinics|mesh-ancestor
25171132|NCT02890589|Chromium|chromium|mesh-list
25171133|NCT02890589|Everolimus|everolimus|mesh-list
25171134|NCT02890589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171135|NCT02890589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25171136|NCT02890589|Immunologic Factors|immunologic factors|mesh-ancestor
25171137|NCT02890589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171138|NCT02890589|Trace Elements|trace elements|mesh-ancestor
25171139|NCT02890589|Micronutrients|micronutrients|mesh-ancestor
25171141|NCT02890173|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25171142|NCT02890173|Hormone Antagonists|hormone antagonists|mesh-ancestor
25171143|NCT02890173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25171144|NCT02890173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171145|NCT02890173|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25171146|NCT02890173|Diuretics|diuretics|mesh-ancestor
25171147|NCT02890173|Natriuretic Agents|natriuretic agents|mesh-ancestor
25171148|NCT02890173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25171149|NCT02890238|Sildenafil Citrate|sildenafil citrate|mesh-list
25171150|NCT02890238|Citric Acid|citric acid|mesh-list
25171151|NCT02890238|Sodium Citrate|sodium citrate|mesh-list
25171152|NCT02890238|Clomiphene|clomiphene|mesh-list
25171153|NCT02890238|Enclomiphene|enclomiphene|mesh-list
25171154|NCT02890238|Zuclomiphene|zuclomiphene|mesh-list
25171155|NCT02890238|Anticoagulants|anticoagulants|mesh-ancestor
25171156|NCT02890238|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25171157|NCT02890238|Chelating Agents|chelating agents|mesh-ancestor
25171158|NCT02890238|Sequestering Agents|sequestering agents|mesh-ancestor
25171159|NCT02890238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171160|NCT02890238|Vasodilator Agents|vasodilator agents|mesh-ancestor
24748770|NCT02168829|Protease Inhibitors|protease inhibitors|mesh-ancestor
24748830|NCT02106195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748831|NCT02102243|Insulin|insulin|mesh-list
25171161|NCT02890238|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25171162|NCT02890238|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25171163|NCT02890238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25171164|NCT02890238|Urological Agents|urological agents|mesh-ancestor
25171165|NCT02890238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25171166|NCT02890238|Hormone Antagonists|hormone antagonists|mesh-ancestor
25171167|NCT02890238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25171168|NCT02890238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171169|NCT02890238|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25171170|NCT02890238|Fertility Agents|fertility agents|mesh-ancestor
25171171|NCT02890238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25171172|NCT02890238|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25171173|NCT02890238|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25171174|NCT02890511|Paclitaxel|paclitaxel|mesh-list
25171175|NCT02890511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25171176|NCT02890511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171177|NCT02890511|Tubulin Modulators|tubulin modulators|mesh-ancestor
25171178|NCT02890511|Antimitotic Agents|antimitotic agents|mesh-ancestor
25171179|NCT02890511|Mitosis Modulators|mitosis modulators|mesh-ancestor
25171180|NCT02890511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171181|NCT02890277|Anti-Infective Agents|anti-infective agents|mesh-list
25171182|NCT02890277|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25171183|NCT02890277|Chitosan|chitosan|mesh-list
25171184|NCT02890277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25171185|NCT02890277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25171186|NCT02890277|Antimetabolites|antimetabolites|mesh-ancestor
25171187|NCT02890277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171188|NCT02890277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25171189|NCT02890277|Chelating Agents|chelating agents|mesh-ancestor
25171190|NCT02890277|Sequestering Agents|sequestering agents|mesh-ancestor
25171191|NCT02890277|Hemostatics|hemostatics|mesh-ancestor
25171192|NCT02890277|Coagulants|coagulants|mesh-ancestor
25425616|NCT02123758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203759|NCT02712528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25203760|NCT02712528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25203761|NCT02712528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25203762|NCT02712502|Amoxicillin|amoxicillin|mesh-list
24944342|NCT03961334|Analgesics|analgesics|mesh-ancestor
24944343|NCT03961334|Sensory System Agents|sensory system agents|mesh-ancestor
25203763|NCT02712502|Levofloxacin|levofloxacin|mesh-list
25203765|NCT02712502|Clavulanic Acid|clavulanic acid|mesh-list
25203766|NCT02712502|Clavulanic Acids|clavulanic acids|mesh-list
25203767|NCT02712502|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25203768|NCT02712502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25203769|NCT02712502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25203770|NCT02712502|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25203771|NCT02712502|Renal Agents|renal agents|mesh-ancestor
25203772|NCT02712502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25203773|NCT02712502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25203774|NCT02712502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203775|NCT02712502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203776|NCT02712502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25203777|NCT02712502|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25203778|NCT02712502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25171193|NCT02890186|Remifentanil|remifentanil|mesh-list
25171194|NCT02890186|Propofol|propofol|mesh-list
25171195|NCT02890186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25171196|NCT02890186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25171197|NCT02890186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171198|NCT02890186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25171199|NCT02890186|Anesthetics, General|anesthetics, general|mesh-ancestor
25171200|NCT02890186|Anesthetics|anesthetics|mesh-ancestor
25171201|NCT02890186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25171202|NCT02890186|Narcotics|narcotics|mesh-ancestor
25171203|NCT02890186|Analgesics|analgesics|mesh-ancestor
25171204|NCT02890186|Sensory System Agents|sensory system agents|mesh-ancestor
25171205|NCT02890186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25171206|NCT02890199|Lidocaine|lidocaine|mesh-list
25171207|NCT02890199|Bupivacaine|bupivacaine|mesh-list
25171208|NCT02890199|Anesthetics, Local|anesthetics, local|mesh-ancestor
25171209|NCT02890199|Anesthetics|anesthetics|mesh-ancestor
25171210|NCT02890199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25171211|NCT02890199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171212|NCT02890199|Sensory System Agents|sensory system agents|mesh-ancestor
25171213|NCT02890199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25171214|NCT02890199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25171215|NCT02890199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25171216|NCT02890199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25171217|NCT02890199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25171218|NCT02890199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171219|NCT02890082|Tamoxifen|tamoxifen|mesh-list
25171220|NCT02890082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25171221|NCT02890082|Hormone Antagonists|hormone antagonists|mesh-ancestor
25171222|NCT02890082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25171235|NCT02890368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25171236|NCT02890368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25171237|NCT02890368|Immunologic Factors|immunologic factors|mesh-ancestor
25171238|NCT02890368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171239|NCT02890368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171240|NCT02889835|Chlorhexidine|chlorhexidine|mesh-list
25171241|NCT02889835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25171242|NCT02889835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25171243|NCT02889835|Disinfectants|disinfectants|mesh-ancestor
25171244|NCT02889692|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25171245|NCT02889692|Gefitinib|gefitinib|mesh-list
25171246|NCT02889692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171247|NCT02889692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25171248|NCT02889692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25171249|NCT02889692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171250|NCT02889822|Alprostadil|alprostadil|mesh-list
25171251|NCT02889822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25171252|NCT02889822|Vasodilator Agents|vasodilator agents|mesh-ancestor
25171253|NCT02889822|Urological Agents|urological agents|mesh-ancestor
25171254|NCT02889653|Anticoagulants|anticoagulants|mesh-list
25860042|NCT00082563|Chloroquine|chloroquine|mesh-list
25860043|NCT00082563|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
25860044|NCT00082563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24595103|NCT00936793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595104|NCT00936793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24595105|NCT00936793|Respiratory System Agents|respiratory system agents|mesh-ancestor
24595107|NCT00936819|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24595108|NCT00936819|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25860045|NCT00082563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25860046|NCT00082563|Amebicides|amebicides|mesh-ancestor
25860047|NCT00082563|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24595147|NCT00936988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24595148|NCT00936988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595149|NCT00936988|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24595150|NCT00936988|Hormone Antagonists|hormone antagonists|mesh-ancestor
24595185|NCT00937144|Vasodilator Agents|vasodilator agents|mesh-ancestor
24595186|NCT00937144|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24595187|NCT00937144|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24595188|NCT00937144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595189|NCT00937144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860048|NCT00082563|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25664964|NCT01677988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860049|NCT00082563|Antimalarials|antimalarials|mesh-ancestor
25860050|NCT00082563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25860051|NCT00082563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25860052|NCT00082563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25860053|NCT00082563|Analgesics|analgesics|mesh-ancestor
25860054|NCT00082563|Sensory System Agents|sensory system agents|mesh-ancestor
25860055|NCT00082563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25860056|NCT00082563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860057|NCT00082563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24748965|NCT01913730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24748966|NCT01913730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24748967|NCT01913730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748968|NCT01904123|Tyrphostins|tyrphostins|mesh-list
24748969|NCT01904123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748970|NCT01904123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24748971|NCT01904123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860058|NCT00082563|Filaricides|filaricides|mesh-ancestor
25860059|NCT00082563|Antinematodal Agents|antinematodal agents|mesh-ancestor
25860060|NCT00082563|Anthelmintics|anthelmintics|mesh-ancestor
25860061|NCT00082576|Azithromycin|azithromycin|mesh-list
24748982|NCT01898117|Mitosis Modulators|mitosis modulators|mesh-ancestor
24748983|NCT01898117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748984|NCT01898117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24748985|NCT01898117|Immunologic Factors|immunologic factors|mesh-ancestor
24748986|NCT01898117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171287|NCT02889549|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25171288|NCT02889549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25171289|NCT02889549|Purinergic Agents|purinergic agents|mesh-ancestor
25171290|NCT02889549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25171291|NCT02889549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171292|NCT02889549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171293|NCT02889432|Melatonin|melatonin|mesh-list
25171294|NCT02889432|Antioxidants|antioxidants|mesh-ancestor
25171295|NCT02889432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171296|NCT02889432|Protective Agents|protective agents|mesh-ancestor
25664965|NCT01678209|Methylphenidate|methylphenidate|mesh-list
25664966|NCT01678209|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25664967|NCT01678209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25664968|NCT01678209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25664969|NCT01678209|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25664970|NCT01678209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25664971|NCT01678209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25664972|NCT01678209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664973|NCT01678209|Dopamine Agents|dopamine agents|mesh-ancestor
25664974|NCT01678209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25664975|NCT01678209|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25664976|NCT01678209|Adrenergic Agents|adrenergic agents|mesh-ancestor
25664977|NCT01678313|Celecoxib|celecoxib|mesh-list
25664978|NCT01678313|Doxazosin|doxazosin|mesh-list
25664979|NCT01678313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25664980|NCT01678313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25664981|NCT01678313|Analgesics|analgesics|mesh-ancestor
25664982|NCT01678313|Sensory System Agents|sensory system agents|mesh-ancestor
24595286|NCT00937807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24595287|NCT00937807|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25171297|NCT02889432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171298|NCT02889432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25171299|NCT02889497|Vaccines|vaccines|mesh-list
25171300|NCT02889497|Immunologic Factors|immunologic factors|mesh-ancestor
25171301|NCT02889497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171302|NCT02889367|Odalasvir|odalasvir|mesh-list
25171303|NCT02889367|Antiviral Agents|antiviral agents|mesh-ancestor
25171304|NCT02889367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25171305|NCT02889081|Vitamin D|vitamin d|mesh-list
25171306|NCT02889081|Vitamins|vitamins|mesh-ancestor
25171307|NCT02889081|Micronutrients|micronutrients|mesh-ancestor
25171308|NCT02889081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171309|NCT02889081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25171310|NCT02889224|Hydrocortisone|hydrocortisone|mesh-list
25171311|NCT02889224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25171312|NCT02888990|Dasatinib|dasatinib|mesh-list
25171313|NCT02888990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171314|NCT02888990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25171315|NCT02888990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25171316|NCT02888990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171317|NCT02888899|Loperamide|loperamide|mesh-list
25171318|NCT02888899|Antidiarrheals|antidiarrheals|mesh-list
25171319|NCT02888899|Calcium polycarbophil|calcium polycarbophil|mesh-list
25171320|NCT02888899|Psyllium|psyllium|mesh-list
25171321|NCT02888899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25171323|NCT02889003|Pioglitazone|pioglitazone|mesh-list
25171324|NCT02889003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25171325|NCT02889003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171326|NCT02888730|Tobramycin|tobramycin|mesh-list
24749058|NCT01828840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24749059|NCT01828840|Narcotics|narcotics|mesh-ancestor
24749060|NCT01828840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24749061|NCT01828840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171327|NCT02888730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25171328|NCT02888730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25203779|NCT02712502|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25203780|NCT02712346|Ambrisentan|ambrisentan|mesh-list
25203781|NCT02712346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25203783|NCT02712476|Mannitol|mannitol|mesh-list
25203784|NCT02712476|Diuretics|diuretics|mesh-ancestor
25203785|NCT02712476|Natriuretic Agents|natriuretic agents|mesh-ancestor
25203786|NCT02712476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203787|NCT02712476|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25203788|NCT02712476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25203789|NCT02712476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203790|NCT02712476|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25203791|NCT02712125|Isosorbide|isosorbide|mesh-list
25203792|NCT02712125|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25203793|NCT02712125|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25203794|NCT02712125|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25203795|NCT02712125|Diuretics|diuretics|mesh-ancestor
25203796|NCT02712125|Natriuretic Agents|natriuretic agents|mesh-ancestor
25203797|NCT02712125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203798|NCT02712125|Vasodilator Agents|vasodilator agents|mesh-ancestor
25203799|NCT02712125|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25203800|NCT02712125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203801|NCT02712177|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25203802|NCT02712177|Immunologic Factors|immunologic factors|mesh-ancestor
25203803|NCT02712177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203804|NCT02712203|Vaccines|vaccines|mesh-list
25203805|NCT02712203|Immunologic Factors|immunologic factors|mesh-ancestor
25203806|NCT02712203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203807|NCT02712307|Penicillins|penicillins|mesh-list
25203808|NCT02712307|Penicillin V|penicillin v|mesh-list
25203809|NCT02712307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25203810|NCT02712307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25203811|NCT02712151|Ropivacaine|ropivacaine|mesh-list
25203812|NCT02712151|Anesthetics, Local|anesthetics, local|mesh-ancestor
25203813|NCT02712151|Anesthetics|anesthetics|mesh-ancestor
25203814|NCT02712151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25203815|NCT02712151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203816|NCT02712151|Sensory System Agents|sensory system agents|mesh-ancestor
25664983|NCT01678313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25664984|NCT01678313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203817|NCT02712151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25203818|NCT02711865|Antibodies|antibodies|mesh-list
25203819|NCT02711865|Immunologic Factors|immunologic factors|mesh-ancestor
25203820|NCT02711865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203821|NCT02711904|Remifentanil|remifentanil|mesh-list
25203822|NCT02711904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25203823|NCT02711904|Narcotics|narcotics|mesh-ancestor
25203824|NCT02711904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25203825|NCT02711904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203826|NCT02711904|Analgesics|analgesics|mesh-ancestor
25203827|NCT02711904|Sensory System Agents|sensory system agents|mesh-ancestor
25203828|NCT02711904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25203829|NCT02711943|Levofloxacin|levofloxacin|mesh-list
25203830|NCT02711943|Ofloxacin|ofloxacin|mesh-list
25203831|NCT02711943|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25203832|NCT02711943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25203833|NCT02711943|Renal Agents|renal agents|mesh-ancestor
25203834|NCT02711943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25203835|NCT02711943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25203836|NCT02711943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24455519|NCT00327678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24455520|NCT00327678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24455521|NCT00327678|Immunologic Factors|immunologic factors|mesh-ancestor
24455523|NCT00327678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25203837|NCT02711943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203838|NCT02711943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749121|NCT01646034|Doxorubicin|doxorubicin|mesh-list
24749122|NCT01646034|Thiotepa|thiotepa|mesh-list
24749123|NCT01646034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24749124|NCT01646034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749125|NCT01646034|Tubulin Modulators|tubulin modulators|mesh-ancestor
24749126|NCT01646034|Antimitotic Agents|antimitotic agents|mesh-ancestor
24749127|NCT01646034|Mitosis Modulators|mitosis modulators|mesh-ancestor
24749128|NCT01646034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749129|NCT01646034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25203839|NCT02711943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25203840|NCT02711943|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25203841|NCT02711943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25203842|NCT02711982|Methylprednisolone|methylprednisolone|mesh-list
25203843|NCT02711982|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25203844|NCT02711982|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25203845|NCT02711982|Prednisolone|prednisolone|mesh-list
25203846|NCT02711982|Prednisolone acetate|prednisolone acetate|mesh-list
25171329|NCT02888652|Clopidogrel|clopidogrel|mesh-list
25171330|NCT02888652|Ticagrelor|ticagrelor|mesh-list
25171331|NCT02888652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25171332|NCT02888652|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25171333|NCT02888652|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25171334|NCT02888652|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25171335|NCT02888652|Purinergic Agents|purinergic agents|mesh-ancestor
25171336|NCT02888652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25171337|NCT02888652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171338|NCT02888652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171339|NCT02888574|Oxytocin|oxytocin|mesh-list
25171340|NCT02888574|Oxytocics|oxytocics|mesh-ancestor
25171341|NCT02888574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25171342|NCT02888574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171343|NCT02888301|Clofarabine|clofarabine|mesh-list
25171344|NCT02888301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25171345|NCT02888301|Antimetabolites|antimetabolites|mesh-ancestor
25171346|NCT02888301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171347|NCT02888301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171348|NCT02888548|Botulinum Toxins|botulinum toxins|mesh-list
25171349|NCT02888548|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25171350|NCT02888548|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25171351|NCT02888548|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25171352|NCT02888548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25005737|NCT02787044|Vaccines|vaccines|mesh-list
25171354|NCT02888548|Cholinergic Agents|cholinergic agents|mesh-ancestor
25171355|NCT02888548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25171356|NCT02888548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171357|NCT02888548|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25171358|NCT02888548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25171359|NCT02888327|Oseltamivir|oseltamivir|mesh-list
25171361|NCT02888327|Midazolam|midazolam|mesh-list
25171362|NCT02888327|Pitavastatin|pitavastatin|mesh-list
25171363|NCT02888327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25171364|NCT02888327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25171365|NCT02888327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25171366|NCT02888327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171367|NCT02888327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24595614|NCT00939835|Antidepressive Agents|antidepressive agents|mesh-ancestor
24595615|NCT00939835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24595616|NCT00939835|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25171368|NCT02888327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25171369|NCT02888327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25171370|NCT02888327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25171371|NCT02888327|Anesthetics, General|anesthetics, general|mesh-ancestor
25171372|NCT02888327|Anesthetics|anesthetics|mesh-ancestor
25171373|NCT02888327|GABA Modulators|gaba modulators|mesh-ancestor
25171374|NCT02888327|GABA Agents|gaba agents|mesh-ancestor
25171375|NCT02888327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25171376|NCT02888327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171377|NCT02888327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25171378|NCT02888327|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25171379|NCT02888327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25171380|NCT02888327|Protective Agents|protective agents|mesh-ancestor
25171381|NCT02888327|Antiviral Agents|antiviral agents|mesh-ancestor
25171382|NCT02888327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25171383|NCT02888327|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25171384|NCT02888327|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25171385|NCT02888327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25171386|NCT02888327|Antimetabolites|antimetabolites|mesh-ancestor
25171387|NCT02888327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25171388|NCT02888275|Dexmedetomidine|dexmedetomidine|mesh-list
25171389|NCT02888275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25171390|NCT02888275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25171391|NCT02888275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171392|NCT02888275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25171393|NCT02888275|Analgesics|analgesics|mesh-ancestor
25171394|NCT02888275|Sensory System Agents|sensory system agents|mesh-ancestor
25171395|NCT02888275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25171396|NCT02888275|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25171397|NCT02888275|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25171398|NCT02888275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25171399|NCT02888275|Adrenergic Agents|adrenergic agents|mesh-ancestor
25171400|NCT02888275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25860062|NCT00082576|Chloroquine|chloroquine|mesh-list
25203847|NCT02711982|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25171401|NCT02888275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171402|NCT02888561|Dobutamine|dobutamine|mesh-list
25171403|NCT02888561|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25171404|NCT02888561|Sympathomimetics|sympathomimetics|mesh-ancestor
25171405|NCT02888561|Autonomic Agents|autonomic agents|mesh-ancestor
25171406|NCT02888561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25171407|NCT02888561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171408|NCT02888561|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25171409|NCT02888561|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25171410|NCT02888561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25171411|NCT02888561|Adrenergic Agents|adrenergic agents|mesh-ancestor
25171412|NCT02888561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25171413|NCT02888561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171414|NCT02888561|Protective Agents|protective agents|mesh-ancestor
25171415|NCT02888444|Varenicline|varenicline|mesh-list
25171416|NCT02888444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25171417|NCT02888444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25171418|NCT02888444|Cholinergic Agents|cholinergic agents|mesh-ancestor
25171419|NCT02888444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24618813|NCT01049815|Sevelamer|sevelamer|mesh-list
25860063|NCT00082576|Mefloquine|mefloquine|mesh-list
24618842|NCT01049854|Alkylating Agents|alkylating agents|mesh-ancestor
24618843|NCT01049854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005738|NCT02787044|Immunologic Factors|immunologic factors|mesh-ancestor
24618845|NCT01049854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24618846|NCT01049854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24618847|NCT01049854|Antimetabolites|antimetabolites|mesh-ancestor
25171420|NCT02888444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171421|NCT02888444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171422|NCT02888054|Allopurinol|allopurinol|mesh-list
25171423|NCT02888054|Lesinurad|lesinurad|mesh-list
25171424|NCT02888054|Antimetabolites|antimetabolites|mesh-ancestor
25171425|NCT02888054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171426|NCT02888054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664985|NCT01678313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25664986|NCT01678313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25664987|NCT01678313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25876448|NCT03463460|Growth Inhibitors|growth inhibitors|mesh-ancestor
25171427|NCT02888054|Gout Suppressants|gout suppressants|mesh-ancestor
25171428|NCT02888054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25171429|NCT02888054|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25171430|NCT02888054|Antioxidants|antioxidants|mesh-ancestor
25171431|NCT02888054|Protective Agents|protective agents|mesh-ancestor
25171432|NCT02888054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171433|NCT02888054|Uricosuric Agents|uricosuric agents|mesh-ancestor
25171434|NCT02888054|Renal Agents|renal agents|mesh-ancestor
25171435|NCT02888392|Psyllium|psyllium|mesh-list
25171436|NCT02888392|Cathartics|cathartics|mesh-ancestor
25171437|NCT02888392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25171438|NCT02888223|Factor VIII|factor viii|mesh-list
25171439|NCT02888223|Coagulants|coagulants|mesh-ancestor
25171440|NCT02887976|Methylprednisolone|methylprednisolone|mesh-list
25171441|NCT02887976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25171442|NCT02887976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25171443|NCT02887976|Prednisolone|prednisolone|mesh-list
25171444|NCT02887976|Prednisolone acetate|prednisolone acetate|mesh-list
25171445|NCT02887976|Abiraterone Acetate|abiraterone acetate|mesh-list
25171446|NCT02887976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25171447|NCT02887976|Prednisolone phosphate|prednisolone phosphate|mesh-list
25171448|NCT02887976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25171449|NCT02887976|Antiemetics|antiemetics|mesh-ancestor
25171450|NCT02887976|Autonomic Agents|autonomic agents|mesh-ancestor
25171451|NCT02887976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25171452|NCT02887976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171453|NCT02887976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25171454|NCT02887976|Glucocorticoids|glucocorticoids|mesh-ancestor
25171455|NCT02887976|Hormones|hormones|mesh-ancestor
25171456|NCT02887976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25171457|NCT02887976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25171458|NCT02887976|Protective Agents|protective agents|mesh-ancestor
25171459|NCT02887976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25171460|NCT02887976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171461|NCT02887976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25171462|NCT02887976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25171463|NCT02887976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171464|NCT02887976|Hormone Antagonists|hormone antagonists|mesh-ancestor
25171465|NCT02887976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25171466|NCT02887807|Cyclosporine|cyclosporine|mesh-list
25171467|NCT02887807|Cyclosporins|cyclosporins|mesh-list
25171468|NCT02887807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25171469|NCT02887807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171470|NCT02887807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25171471|NCT02887807|Immunologic Factors|immunologic factors|mesh-ancestor
25171472|NCT02887807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171473|NCT02887807|Antifungal Agents|antifungal agents|mesh-ancestor
25171474|NCT02887807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25171475|NCT02887807|Dermatologic Agents|dermatologic agents|mesh-ancestor
25171476|NCT02887807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25171479|NCT02887677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25171480|NCT02887677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171481|NCT02887677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25171482|NCT02887677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171483|NCT02887573|Mosapride|mosapride|mesh-list
25171484|NCT02887573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171485|NCT02887573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25171486|NCT02887573|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25171487|NCT02887573|Serotonin Agents|serotonin agents|mesh-ancestor
25171488|NCT02887573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25171489|NCT02887573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171490|NCT02887534|Tizanidine|tizanidine|mesh-list
25171491|NCT02887534|Analgesics|analgesics|mesh-ancestor
25171492|NCT02887534|Sensory System Agents|sensory system agents|mesh-ancestor
25171493|NCT02887534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25171494|NCT02887534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171495|NCT02887534|Anticonvulsants|anticonvulsants|mesh-ancestor
25171496|NCT02887534|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25171497|NCT02887534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25171498|NCT02887534|Parasympatholytics|parasympatholytics|mesh-ancestor
25171499|NCT02887534|Autonomic Agents|autonomic agents|mesh-ancestor
25171500|NCT02887534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25171501|NCT02887534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24749285|NCT01346787|Antiemetics|antiemetics|mesh-ancestor
25234994|NCT02567929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24749351|NCT01166113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25425766|NCT02105766|Immunologic Factors|immunologic factors|mesh-ancestor
24749353|NCT01166113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24749360|NCT01160107|Glucocorticoids|glucocorticoids|mesh-ancestor
24749361|NCT01160107|Hormones|hormones|mesh-ancestor
24749362|NCT01160107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24749363|NCT01160107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749364|NCT01160107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25171502|NCT02887534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25171503|NCT02887534|Adrenergic Agents|adrenergic agents|mesh-ancestor
25171504|NCT02887534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25171505|NCT02887534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171506|NCT02887443|Midazolam|midazolam|mesh-list
25171507|NCT02887443|Idebenone|idebenone|mesh-list
25171508|NCT02887443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25171509|NCT02887443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25171510|NCT02887443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25171511|NCT02887443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171512|NCT02887443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25171513|NCT02887443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25171514|NCT02887443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25171515|NCT02887443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25171516|NCT02887443|Anesthetics, General|anesthetics, general|mesh-ancestor
25171517|NCT02887443|Anesthetics|anesthetics|mesh-ancestor
25171518|NCT02887443|GABA Modulators|gaba modulators|mesh-ancestor
25171519|NCT02887443|GABA Agents|gaba agents|mesh-ancestor
25171520|NCT02887443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25171521|NCT02887443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171522|NCT02887443|Antioxidants|antioxidants|mesh-ancestor
25171523|NCT02887443|Protective Agents|protective agents|mesh-ancestor
25171524|NCT02887365|Tegafur|tegafur|mesh-list
25171525|NCT02887365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25171526|NCT02887365|Antimetabolites|antimetabolites|mesh-ancestor
25171527|NCT02887365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171528|NCT02887365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171529|NCT02887625|Insulin|insulin|mesh-list
25171530|NCT02887625|Insulin Glargine|insulin glargine|mesh-list
25171531|NCT02887625|Pioglitazone|pioglitazone|mesh-list
25171532|NCT02887625|Insulin Aspart|insulin aspart|mesh-list
25171533|NCT02887625|Exenatide|exenatide|mesh-list
25171534|NCT02887625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25171535|NCT02887625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171536|NCT02887625|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25171537|NCT02887625|Incretins|incretins|mesh-ancestor
25171538|NCT02887625|Hormones|hormones|mesh-ancestor
25171539|NCT02887625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25171540|NCT02887222|Bupivacaine|bupivacaine|mesh-list
25005733|NCT02796261|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25005734|NCT02796261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25005735|NCT02796261|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
25171541|NCT02887222|Anesthetics, Local|anesthetics, local|mesh-ancestor
25171542|NCT02887222|Anesthetics|anesthetics|mesh-ancestor
25171543|NCT02887222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25171544|NCT02887222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171545|NCT02887222|Sensory System Agents|sensory system agents|mesh-ancestor
25171546|NCT02887222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25171547|NCT02887313|Leucovorin|leucovorin|mesh-list
25171548|NCT02887313|Fluorouracil|fluorouracil|mesh-list
25171549|NCT02887313|Oxaliplatin|oxaliplatin|mesh-list
25171550|NCT02887313|Antimetabolites|antimetabolites|mesh-ancestor
25171551|NCT02887313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171552|NCT02887313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25171553|NCT02887313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171554|NCT02887313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25005736|NCT02796261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25005739|NCT02787044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625911|NCT01084291|Immunologic Factors|immunologic factors|mesh-ancestor
24625912|NCT01084291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625913|NCT01084369|Methyltestosterone|methyltestosterone|mesh-list
24625914|NCT01084369|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24413774|NCT00195195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749383|NCT01150045|Antidotes|antidotes|mesh-ancestor
25171555|NCT02887313|Immunologic Factors|immunologic factors|mesh-ancestor
25171556|NCT02887313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171557|NCT02887313|Antidotes|antidotes|mesh-ancestor
25171558|NCT02887313|Protective Agents|protective agents|mesh-ancestor
25171559|NCT02887313|Vitamin B Complex|vitamin b complex|mesh-ancestor
25171560|NCT02887313|Vitamins|vitamins|mesh-ancestor
25171561|NCT02887313|Micronutrients|micronutrients|mesh-ancestor
25171562|NCT02886988|Botulinum Toxins|botulinum toxins|mesh-list
25171563|NCT02886988|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25171564|NCT02886988|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25171565|NCT02886988|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25171566|NCT02886988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25171567|NCT02886988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171568|NCT02886988|Cholinergic Agents|cholinergic agents|mesh-ancestor
25171569|NCT02886988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25171570|NCT02886988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171571|NCT02886988|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25171572|NCT02886988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25171573|NCT02886897|Antibodies|antibodies|mesh-list
25171574|NCT02886897|Immunologic Factors|immunologic factors|mesh-ancestor
25171575|NCT02886897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203848|NCT02711982|Prednisolone phosphate|prednisolone phosphate|mesh-list
25203849|NCT02711982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25203850|NCT02711982|Antiemetics|antiemetics|mesh-ancestor
25203851|NCT02711982|Autonomic Agents|autonomic agents|mesh-ancestor
25203852|NCT02711982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25203853|NCT02711982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203854|NCT02711982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25203855|NCT02711982|Glucocorticoids|glucocorticoids|mesh-ancestor
25203856|NCT02711982|Hormones|hormones|mesh-ancestor
25203857|NCT02711982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25203858|NCT02711982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25203859|NCT02711982|Protective Agents|protective agents|mesh-ancestor
25203860|NCT02711982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25203861|NCT02711982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25203862|NCT02711891|Loperamide|loperamide|mesh-list
25203863|NCT02711891|Antidiarrheals|antidiarrheals|mesh-list
25203864|NCT02711891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25203865|NCT02711917|Propofol|propofol|mesh-list
25203866|NCT02711917|Etomidate|etomidate|mesh-list
25203867|NCT02711917|Rocuronium|rocuronium|mesh-list
25203868|NCT02711917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25203869|NCT02711917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25203870|NCT02711917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203871|NCT02711917|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25203880|NCT02711449|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25203881|NCT02711449|Prednisolone|prednisolone|mesh-list
25203882|NCT02711449|Prednisolone acetate|prednisolone acetate|mesh-list
25203883|NCT02711449|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25203884|NCT02711449|Prednisolone phosphate|prednisolone phosphate|mesh-list
25203885|NCT02711449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25203886|NCT02711449|Antiemetics|antiemetics|mesh-ancestor
25203887|NCT02711449|Autonomic Agents|autonomic agents|mesh-ancestor
25203888|NCT02711449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25203889|NCT02711449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203890|NCT02711449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25203891|NCT02711449|Glucocorticoids|glucocorticoids|mesh-ancestor
25203892|NCT02711449|Hormones|hormones|mesh-ancestor
25203893|NCT02711449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25203894|NCT02711449|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25203895|NCT02711449|Protective Agents|protective agents|mesh-ancestor
25203896|NCT02711449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25203897|NCT02711449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25203898|NCT02711592|Analgesics|analgesics|mesh-list
25171585|NCT02886585|Pembrolizumab|pembrolizumab|mesh-list
25171586|NCT02886585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25171587|NCT02886585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171588|NCT02886429|Dexmedetomidine|dexmedetomidine|mesh-list
25171589|NCT02886429|Bupivacaine|bupivacaine|mesh-list
25171590|NCT02886429|Anesthetics, Local|anesthetics, local|mesh-ancestor
25171591|NCT02886429|Anesthetics|anesthetics|mesh-ancestor
25171592|NCT02886429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25171593|NCT02886429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171595|NCT02886429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25171596|NCT02886429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25171597|NCT02886429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25171598|NCT02886429|Analgesics|analgesics|mesh-ancestor
25171599|NCT02886429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25171600|NCT02886429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25171601|NCT02886429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24596562|NCT00944333|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25171602|NCT02886429|Adrenergic Agents|adrenergic agents|mesh-ancestor
25171603|NCT02886429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25171604|NCT02886429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171605|NCT02886377|Antibodies|antibodies|mesh-list
25171606|NCT02886377|Immunologic Factors|immunologic factors|mesh-ancestor
25171607|NCT02886377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171608|NCT02886351|Nitrous Oxide|nitrous oxide|mesh-list
25171609|NCT02886351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25171610|NCT02886351|Anesthetics, General|anesthetics, general|mesh-ancestor
25171611|NCT02886351|Anesthetics|anesthetics|mesh-ancestor
25171612|NCT02886351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25171613|NCT02886351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171614|NCT02886351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25171615|NCT02886351|Analgesics|analgesics|mesh-ancestor
25171616|NCT02886351|Sensory System Agents|sensory system agents|mesh-ancestor
25171617|NCT02886351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25171618|NCT02886195|Pemetrexed|pemetrexed|mesh-list
25171619|NCT02886195|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25171620|NCT02886195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171621|NCT02886195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25171622|NCT02886195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171623|NCT02886195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25171624|NCT02886195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25171628|NCT02886299|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24749473|NCT01050855|Busulfan|busulfan|mesh-list
24749536|NCT00887146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749537|NCT00887146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24749538|NCT00887146|Alkylating Agents|alkylating agents|mesh-ancestor
24749539|NCT00880893|Vaccines|vaccines|mesh-list
24749540|NCT00880893|Immunologic Factors|immunologic factors|mesh-ancestor
24749541|NCT00880893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413912|NCT00195598|Paroxetine|paroxetine|mesh-list
25171629|NCT02886299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25171630|NCT02886299|Antimetabolites|antimetabolites|mesh-ancestor
25171631|NCT02886299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171632|NCT02886299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25171633|NCT02886299|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25171634|NCT02886299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25171635|NCT02886065|Lenalidomide|lenalidomide|mesh-list
25171636|NCT02886065|Poly ICLC|poly iclc|mesh-list
25171637|NCT02886065|Citarinostat|citarinostat|mesh-list
25171638|NCT02886065|Immunologic Factors|immunologic factors|mesh-ancestor
25171639|NCT02886065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171640|NCT02886065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25171641|NCT02886065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25171642|NCT02886065|Growth Substances|growth substances|mesh-ancestor
25171643|NCT02886065|Growth Inhibitors|growth inhibitors|mesh-ancestor
25171644|NCT02886065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171645|NCT02886065|Interferon Inducers|interferon inducers|mesh-ancestor
25171646|NCT02886065|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25171647|NCT02886065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25171648|NCT02886065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860064|NCT00082576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25860065|NCT00082576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25860066|NCT00082576|Amebicides|amebicides|mesh-ancestor
25860067|NCT00082576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25860068|NCT00082576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25860069|NCT00082576|Antimalarials|antimalarials|mesh-ancestor
25860070|NCT00082576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25860071|NCT00082589|Eplerenone|eplerenone|mesh-list
25860072|NCT00082589|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25860073|NCT00082589|Hormone Antagonists|hormone antagonists|mesh-ancestor
25860074|NCT00082589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25860075|NCT00082589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860076|NCT00082589|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25860077|NCT00082589|Diuretics|diuretics|mesh-ancestor
25860078|NCT00082589|Natriuretic Agents|natriuretic agents|mesh-ancestor
25860079|NCT00082589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25860080|NCT00082602|Galantamine|galantamine|mesh-list
25860081|NCT00082602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25860082|NCT00082602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860083|NCT00082602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538975|NCT00661375|Sorafenib|sorafenib|mesh-list
25664988|NCT01678313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24596740|NCT00945022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24596741|NCT00945022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596746|NCT00945178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25860084|NCT00082602|Cholinergic Agents|cholinergic agents|mesh-ancestor
24749726|NCT00476606|Stavudine|stavudine|mesh-list
25171687|NCT02885740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171688|NCT02885740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25171689|NCT02885740|Vasodilator Agents|vasodilator agents|mesh-ancestor
25171690|NCT02885740|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25171691|NCT02885740|Purinergic Agonists|purinergic agonists|mesh-ancestor
25171692|NCT02885740|Purinergic Agents|purinergic agents|mesh-ancestor
25171693|NCT02885740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25171694|NCT02885740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171696|NCT02885948|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25171697|NCT02885948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171698|NCT02885948|Sensory System Agents|sensory system agents|mesh-ancestor
25171699|NCT02885948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25171700|NCT02885922|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25171701|NCT02885922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171702|NCT02885441|Ketorolac|ketorolac|mesh-list
25171703|NCT02885441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25171704|NCT02885441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25171705|NCT02885441|Analgesics|analgesics|mesh-ancestor
25171706|NCT02885441|Sensory System Agents|sensory system agents|mesh-ancestor
25171707|NCT02885441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25171708|NCT02885441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171709|NCT02885441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25171710|NCT02885441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25171711|NCT02885441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25171712|NCT02885441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25171713|NCT02885441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171714|NCT02885688|Insulin|insulin|mesh-list
25171715|NCT02885688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25171716|NCT02885688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171717|NCT02885597|Methotrexate|methotrexate|mesh-list
25171718|NCT02885597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25171719|NCT02885597|Abortifacient Agents|abortifacient agents|mesh-ancestor
25171720|NCT02885597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25171721|NCT02885597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171722|NCT02885597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25171723|NCT02885597|Antimetabolites|antimetabolites|mesh-ancestor
25171724|NCT02885597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171726|NCT02885597|Dermatologic Agents|dermatologic agents|mesh-ancestor
25171727|NCT02885597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25171728|NCT02885597|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25171729|NCT02885597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25171730|NCT02885597|Immunologic Factors|immunologic factors|mesh-ancestor
25171731|NCT02885597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25171732|NCT02885597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25171733|NCT02885558|Efonidipine|efonidipine|mesh-list
25171734|NCT02885558|Nifedipine|nifedipine|mesh-list
25171735|NCT02885558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25171736|NCT02885558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25171737|NCT02885558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171738|NCT02885558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25171739|NCT02885558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171740|NCT02885558|Vasodilator Agents|vasodilator agents|mesh-ancestor
25171741|NCT02885558|Tocolytic Agents|tocolytic agents|mesh-ancestor
25171742|NCT02885558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25171743|NCT02885558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25171744|NCT02885558|Diuretics|diuretics|mesh-ancestor
25171745|NCT02885558|Natriuretic Agents|natriuretic agents|mesh-ancestor
25171746|NCT02885545|Anticoagulants|anticoagulants|mesh-list
25171747|NCT02885454|Simeprevir|simeprevir|mesh-list
25171748|NCT02885454|Odalasvir|odalasvir|mesh-list
25171749|NCT02885454|Drospirenone|drospirenone|mesh-list
25171750|NCT02885454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25171751|NCT02885454|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
25664989|NCT01678313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25664990|NCT01678313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25664991|NCT01678313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25664992|NCT01678313|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24852875|NCT02264587|Autonomic Agents|autonomic agents|mesh-ancestor
24596809|NCT00945620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24596810|NCT00945620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171752|NCT02885454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25171753|NCT02885454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25171754|NCT02885454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25171755|NCT02885454|Contraceptive Agents|contraceptive agents|mesh-ancestor
25171756|NCT02885454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25171757|NCT02885454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171758|NCT02885454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25171759|NCT02885454|Estrogens|estrogens|mesh-ancestor
25171760|NCT02885454|Hormones|hormones|mesh-ancestor
25171761|NCT02885454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25171762|NCT02885454|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25171763|NCT02885454|Hormone Antagonists|hormone antagonists|mesh-ancestor
25171764|NCT02885454|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25171765|NCT02885454|Diuretics|diuretics|mesh-ancestor
25171766|NCT02885454|Natriuretic Agents|natriuretic agents|mesh-ancestor
25171767|NCT02885454|Antiviral Agents|antiviral agents|mesh-ancestor
25171768|NCT02885454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25171769|NCT02885454|Protease Inhibitors|protease inhibitors|mesh-ancestor
25171770|NCT02885454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25171771|NCT02885454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203899|NCT02711592|Sensory System Agents|sensory system agents|mesh-ancestor
25203900|NCT02711592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25203901|NCT02711592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203902|NCT02711410|Clopidogrel|clopidogrel|mesh-list
25203903|NCT02711410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25203904|NCT02711410|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25203905|NCT02711410|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25203906|NCT02711410|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25203907|NCT02711410|Purinergic Agents|purinergic agents|mesh-ancestor
25203908|NCT02711410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25203909|NCT02711410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203910|NCT02711410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203911|NCT02711670|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25203912|NCT02711670|Chlorthalidone|chlorthalidone|mesh-list
25203913|NCT02711670|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25203914|NCT02711670|Diuretics|diuretics|mesh-ancestor
25203915|NCT02711670|Natriuretic Agents|natriuretic agents|mesh-ancestor
24618910|NCT01050270|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24618911|NCT01050270|Serotonin Agents|serotonin agents|mesh-ancestor
25203916|NCT02711670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203917|NCT02711670|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25203918|NCT02711670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25203919|NCT02711670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203920|NCT02711579|Celecoxib|celecoxib|mesh-list
25203921|NCT02711579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25203923|NCT02711579|Analgesics|analgesics|mesh-ancestor
25203924|NCT02711579|Sensory System Agents|sensory system agents|mesh-ancestor
25203925|NCT02711579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25203926|NCT02711579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203927|NCT02711579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25203928|NCT02711579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25203929|NCT02711579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25203930|NCT02711579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25203931|NCT02711579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203932|NCT02711579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203933|NCT02711683|3-n-butylphthalide|3-n-butylphthalide|mesh-list
25203934|NCT02711683|Donepezil|donepezil|mesh-list
25203935|NCT02711683|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25203936|NCT02711683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203937|NCT02711683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25203938|NCT02711683|Cholinergic Agents|cholinergic agents|mesh-ancestor
25203939|NCT02711683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25203940|NCT02711683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203941|NCT02711683|Nootropic Agents|nootropic agents|mesh-ancestor
25664993|NCT01678313|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25664994|NCT01678313|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25664995|NCT01678313|Adrenergic Agents|adrenergic agents|mesh-ancestor
25664996|NCT01678313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25203942|NCT02711683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25203943|NCT02711683|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25203944|NCT02711683|Protective Agents|protective agents|mesh-ancestor
25203945|NCT02711176|Amoxicillin|amoxicillin|mesh-list
25203946|NCT02711176|Clarithromycin|clarithromycin|mesh-list
25203947|NCT02711176|Tinidazole|tinidazole|mesh-list
25203948|NCT02711176|Esomeprazole|esomeprazole|mesh-list
25203949|NCT02711176|Lansoprazole|lansoprazole|mesh-list
25203950|NCT02711176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25203951|NCT02711176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25203952|NCT02711176|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25203953|NCT02711176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25203954|NCT02711176|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25203955|NCT02711176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203956|NCT02711176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618914|NCT01050270|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25203957|NCT02711176|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25203958|NCT02711176|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25203959|NCT02711176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25203960|NCT02711176|Alkylating Agents|alkylating agents|mesh-ancestor
25203961|NCT02711176|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25203962|NCT02711176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25203963|NCT02711176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25203964|NCT02711189|Oxytocin|oxytocin|mesh-list
25203965|NCT02711189|Oxytocics|oxytocics|mesh-ancestor
25171772|NCT02885168|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
25171773|NCT02885168|Phenylephrine|phenylephrine|mesh-list
25171774|NCT02885168|Protein C|protein c|mesh-list
25171775|NCT02885168|Oxymetazoline|oxymetazoline|mesh-list
25171776|NCT02885168|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25171777|NCT02885168|Mydriatics|mydriatics|mesh-ancestor
25171778|NCT02885168|Autonomic Agents|autonomic agents|mesh-ancestor
25171779|NCT02885168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25171780|NCT02885168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171781|NCT02885168|Sympathomimetics|sympathomimetics|mesh-ancestor
25171782|NCT02885168|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25171783|NCT02885168|Nasal Decongestants|nasal decongestants|mesh-ancestor
25171784|NCT02885168|Respiratory System Agents|respiratory system agents|mesh-ancestor
25171785|NCT02885168|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25171786|NCT02885168|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25171787|NCT02885168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25171788|NCT02885168|Adrenergic Agents|adrenergic agents|mesh-ancestor
25171789|NCT02885168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25171790|NCT02885168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171791|NCT02885168|Protective Agents|protective agents|mesh-ancestor
25171792|NCT02885168|Anticoagulants|anticoagulants|mesh-ancestor
25171793|NCT02885168|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25171794|NCT02885168|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25171795|NCT02885168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25171796|NCT02885311|Naltrexone|naltrexone|mesh-list
25171797|NCT02885311|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25171798|NCT02885311|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25171799|NCT02885311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171800|NCT02885311|Sensory System Agents|sensory system agents|mesh-ancestor
25171801|NCT02885311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24749725|NCT00476606|Nevirapine|nevirapine|mesh-list
24749727|NCT00476606|Didanosine|didanosine|mesh-list
24749728|NCT00476606|Efavirenz|efavirenz|mesh-list
24749729|NCT00476606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24625946|NCT01084473|Analgesics|analgesics|mesh-ancestor
24625947|NCT01084473|Sensory System Agents|sensory system agents|mesh-ancestor
24749730|NCT00476606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24749731|NCT00476606|Protease Inhibitors|protease inhibitors|mesh-ancestor
24749732|NCT00476606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24655521|NCT01257048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24749733|NCT00476606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171802|NCT02884986|Etoricoxib|etoricoxib|mesh-list
25171803|NCT02884986|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25171804|NCT02884986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25171805|NCT02884986|Analgesics|analgesics|mesh-ancestor
25171806|NCT02884986|Sensory System Agents|sensory system agents|mesh-ancestor
25171807|NCT02884986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25171808|NCT02884986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171809|NCT02884986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25664997|NCT01678443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25171810|NCT02884986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24597180|NCT00947453|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25171811|NCT02884986|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25171812|NCT02884986|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25171813|NCT02884986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25171814|NCT02884986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171815|NCT02884921|Acetaminophen|acetaminophen|mesh-list
25171816|NCT02884921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25171817|NCT02884921|Analgesics|analgesics|mesh-ancestor
25171818|NCT02884921|Sensory System Agents|sensory system agents|mesh-ancestor
25171819|NCT02884921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25171820|NCT02884921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171821|NCT02884921|Antipyretics|antipyretics|mesh-ancestor
25171823|NCT02884596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25171824|NCT02884596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25171825|NCT02884596|Serotonin Agents|serotonin agents|mesh-ancestor
25171826|NCT02884596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25171827|NCT02884596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171828|NCT02884596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171829|NCT02884596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25171830|NCT02884596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25171831|NCT02884817|Listerine|listerine|mesh-list
25171832|NCT02884817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25171833|NCT02884817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25171834|NCT02884713|Doxycycline|doxycycline|mesh-list
25171835|NCT02884713|Levofloxacin|levofloxacin|mesh-list
25171836|NCT02884713|Ofloxacin|ofloxacin|mesh-list
25171837|NCT02884713|Esomeprazole|esomeprazole|mesh-list
25171838|NCT02884713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25171839|NCT02884713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25171840|NCT02884713|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25171841|NCT02884713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25171842|NCT02884713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171843|NCT02884713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25171844|NCT02884713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24749752|NCT00379340|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25171845|NCT02884713|Antimalarials|antimalarials|mesh-ancestor
25171846|NCT02884713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25171847|NCT02884713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25171848|NCT02884713|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25171849|NCT02884713|Renal Agents|renal agents|mesh-ancestor
25171850|NCT02884713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25171851|NCT02884713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25171852|NCT02884713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171853|NCT02884713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25171854|NCT02884713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25171855|NCT02884388|Anesthetics|anesthetics|mesh-list
25171856|NCT02884388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25171857|NCT02884388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171858|NCT02884440|Ropivacaine|ropivacaine|mesh-list
25171859|NCT02884440|Anesthetics|anesthetics|mesh-ancestor
25171860|NCT02884440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25171861|NCT02884440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171862|NCT02884440|Anesthetics, Local|anesthetics, local|mesh-ancestor
25171863|NCT02884440|Sensory System Agents|sensory system agents|mesh-ancestor
25171864|NCT02884440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25171865|NCT02884635|Methotrexate|methotrexate|mesh-list
25171866|NCT02884635|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25171867|NCT02884635|Abortifacient Agents|abortifacient agents|mesh-ancestor
24749753|NCT00379340|Etoposide|etoposide|mesh-list
24749754|NCT00379340|Vincristine|vincristine|mesh-list
24749782|NCT00304070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749783|NCT00304070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24749784|NCT00304070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24749785|NCT00304070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25171868|NCT02884635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25171869|NCT02884635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171870|NCT02884635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25171871|NCT02884635|Antimetabolites|antimetabolites|mesh-ancestor
25171872|NCT02884635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171873|NCT02884635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171874|NCT02884635|Dermatologic Agents|dermatologic agents|mesh-ancestor
25171875|NCT02884635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25171876|NCT02884635|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25171877|NCT02884635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25664998|NCT01678443|Antibodies|antibodies|mesh-list
24597378|NCT00948987|Antipyretics|antipyretics|mesh-ancestor
25171878|NCT02884635|Immunologic Factors|immunologic factors|mesh-ancestor
25171879|NCT02884635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25171880|NCT02884635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25171881|NCT02884479|Docetaxel|docetaxel|mesh-list
25171882|NCT02884479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171883|NCT02884479|Tubulin Modulators|tubulin modulators|mesh-ancestor
25171884|NCT02884479|Antimitotic Agents|antimitotic agents|mesh-ancestor
25171885|NCT02884479|Mitosis Modulators|mitosis modulators|mesh-ancestor
25171886|NCT02884479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171887|NCT02884310|Remifentanil|remifentanil|mesh-list
25171888|NCT02884310|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25171889|NCT02884310|Narcotics|narcotics|mesh-ancestor
25171890|NCT02884310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25171891|NCT02884310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171892|NCT02884310|Analgesics|analgesics|mesh-ancestor
25171893|NCT02884310|Sensory System Agents|sensory system agents|mesh-ancestor
25171894|NCT02884310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25171895|NCT02884050|Topiramate|topiramate|mesh-list
25171896|NCT02884050|Anticonvulsants|anticonvulsants|mesh-ancestor
25171897|NCT02884050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25171898|NCT02884050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171899|NCT02884115|Penicillins|penicillins|mesh-list
25171900|NCT02884115|Penicillin G Benzathine|penicillin g benzathine|mesh-list
25171901|NCT02884115|Penicillin G|penicillin g|mesh-list
25171902|NCT02884115|Penicillin G Procaine|penicillin g procaine|mesh-list
24749790|NCT00066950|Chlorhexidine|chlorhexidine|mesh-list
24749809|NCT00001322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24749810|NCT00001322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749811|NCT00001322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24618917|NCT01050270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25171903|NCT02884115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25171904|NCT02884115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25171905|NCT02884128|Leucovorin|leucovorin|mesh-list
25171906|NCT02884128|Fluorouracil|fluorouracil|mesh-list
25171907|NCT02884128|Irinotecan|irinotecan|mesh-list
25171908|NCT02884128|Antimetabolites|antimetabolites|mesh-ancestor
25171909|NCT02884128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171910|NCT02884128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25171911|NCT02884128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171912|NCT02884128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25171913|NCT02884128|Immunologic Factors|immunologic factors|mesh-ancestor
25171914|NCT02884128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171915|NCT02884128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25171916|NCT02884128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25171917|NCT02884128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25171918|NCT02884128|Antidotes|antidotes|mesh-ancestor
25171919|NCT02884128|Protective Agents|protective agents|mesh-ancestor
25171920|NCT02884128|Vitamin B Complex|vitamin b complex|mesh-ancestor
25171921|NCT02884128|Vitamins|vitamins|mesh-ancestor
25171922|NCT02884128|Micronutrients|micronutrients|mesh-ancestor
25171923|NCT02884037|Rifaximin|rifaximin|mesh-list
24650991|NCT01228630|Respiratory System Agents|respiratory system agents|mesh-ancestor
24650993|NCT01228630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25860085|NCT00082602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25860086|NCT00082602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860087|NCT00082602|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25860088|NCT00082602|Autonomic Agents|autonomic agents|mesh-ancestor
25860089|NCT00082602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25860090|NCT00082602|Nootropic Agents|nootropic agents|mesh-ancestor
25860091|NCT00082667|Gefitinib|gefitinib|mesh-list
24450804|NCT00320632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450805|NCT00320632|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24450806|NCT00320632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24749812|NCT00001322|Progestins|progestins|mesh-ancestor
24749813|NCT00001322|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24749814|NCT00001322|Fertility Agents|fertility agents|mesh-ancestor
25860092|NCT00082667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860093|NCT00082667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25860094|NCT00082667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860095|NCT00082667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859076|NCT02301676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24859077|NCT02301676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24859078|NCT02301676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859079|NCT02301676|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24859080|NCT02301676|Anesthetics, General|anesthetics, general|mesh-ancestor
25664999|NCT01678443|Immunoglobulins|immunoglobulins|mesh-list
24597677|NCT00950794|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24859082|NCT02301676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24749835|NCT01694134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749836|NCT01694134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24749838|NCT01694134|Autonomic Agents|autonomic agents|mesh-ancestor
24655557|NCT01257243|Guaifenesin|guaifenesin|mesh-list
24749848|NCT01694212|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24749849|NCT01694212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24749850|NCT01694212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24749851|NCT01694212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24749852|NCT01694212|Analgesics|analgesics|mesh-ancestor
25860096|NCT00082719|Interferons|interferons|mesh-list
25860097|NCT00082719|Interferon-alpha|interferon-alpha|mesh-list
25860098|NCT00082719|Interferon alpha-2|interferon alpha-2|mesh-list
24749853|NCT01694212|Sensory System Agents|sensory system agents|mesh-ancestor
24749854|NCT01694212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24749855|NCT01694212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749856|NCT01694212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24749857|NCT01694212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24749858|NCT01694212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24749859|NCT01694212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24749860|NCT01694212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625952|NCT01084473|Adrenergic Agents|adrenergic agents|mesh-ancestor
24749861|NCT01694264|Entecavir|entecavir|mesh-list
24859083|NCT02301676|Analgesics|analgesics|mesh-ancestor
24859084|NCT02301676|Sensory System Agents|sensory system agents|mesh-ancestor
24859085|NCT02301676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24859086|NCT02301676|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24859087|NCT02301676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24859088|NCT02301676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24859089|NCT02301676|Adrenergic Agents|adrenergic agents|mesh-ancestor
24859090|NCT02301676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24859104|NCT02301780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859106|NCT02301780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24859107|NCT02301780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24859108|NCT02301780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24859109|NCT02301780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171924|NCT02884037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25171925|NCT02884037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25171926|NCT02884037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25171927|NCT02884180|Dexamethasone|dexamethasone|mesh-list
25171928|NCT02884180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25171929|NCT02884180|Antiemetics|antiemetics|mesh-ancestor
25171930|NCT02884180|Autonomic Agents|autonomic agents|mesh-ancestor
25171931|NCT02884180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25171932|NCT02884180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171933|NCT02884180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25171934|NCT02884180|Glucocorticoids|glucocorticoids|mesh-ancestor
25171935|NCT02884180|Hormones|hormones|mesh-ancestor
25171936|NCT02884180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25171937|NCT02884180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25171938|NCT02884180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171939|NCT02883647|Tenofovir|tenofovir|mesh-list
25171940|NCT02883647|Entecavir|entecavir|mesh-list
25171941|NCT02883647|Antiviral Agents|antiviral agents|mesh-ancestor
25171942|NCT02883647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25171943|NCT02883647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25171944|NCT02883647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25171945|NCT02883647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750001|NCT01695356|Protective Agents|protective agents|mesh-ancestor
25171946|NCT02883647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171947|NCT02883647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25171948|NCT02883647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24749879|NCT01694407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24749880|NCT01694407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24749881|NCT01694407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749882|NCT01694407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24749883|NCT01694407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24749884|NCT01694459|Heparin|heparin|mesh-list
24749885|NCT01694459|Calcium heparin|calcium heparin|mesh-list
24749886|NCT01694459|Anticoagulants|anticoagulants|mesh-ancestor
24414280|NCT00196703|Memantine|memantine|mesh-list
24749887|NCT01694459|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25665000|NCT01678443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24749888|NCT01694459|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25860099|NCT00082719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597883|NCT00952432|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24749889|NCT01694459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749890|NCT01694498|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24749891|NCT01694498|Hemostatics|hemostatics|mesh-ancestor
25203966|NCT02711189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25203967|NCT02711189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203968|NCT02711202|Sirolimus|sirolimus|mesh-list
25203969|NCT02711202|Alemtuzumab|alemtuzumab|mesh-list
25203970|NCT02711202|Infliximab|infliximab|mesh-list
25203971|NCT02711202|Tacrolimus|tacrolimus|mesh-list
25203972|NCT02711202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25203973|NCT02711202|Immunologic Factors|immunologic factors|mesh-ancestor
25203974|NCT02711202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203975|NCT02711202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25203976|NCT02711202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25203977|NCT02711202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171949|NCT02883595|Thymalfasin|thymalfasin|mesh-list
25171950|NCT02883595|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25171951|NCT02883595|Immunologic Factors|immunologic factors|mesh-ancestor
25171952|NCT02883595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171953|NCT02883556|Pembrolizumab|pembrolizumab|mesh-list
25171954|NCT02883556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25171955|NCT02883556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25171956|NCT02883569|Ibuprofen|ibuprofen|mesh-list
25171957|NCT02883569|Aceclofenac|aceclofenac|mesh-list
25171958|NCT02883569|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
25171959|NCT02883569|Tramadol|tramadol|mesh-list
25171960|NCT02883569|Codeine|codeine|mesh-list
25171961|NCT02883569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25171962|NCT02883569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25171963|NCT02883569|Analgesics|analgesics|mesh-ancestor
25171964|NCT02883569|Sensory System Agents|sensory system agents|mesh-ancestor
25171965|NCT02883569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25171966|NCT02883569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171967|NCT02883569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25171968|NCT02883569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25171969|NCT02883569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25171970|NCT02883569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25171971|NCT02883569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171972|NCT02883569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25171973|NCT02883569|Narcotics|narcotics|mesh-ancestor
25171974|NCT02883569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25171975|NCT02883569|Antitussive Agents|antitussive agents|mesh-ancestor
25171976|NCT02883569|Respiratory System Agents|respiratory system agents|mesh-ancestor
25171977|NCT02883478|Riboflavin|riboflavin|mesh-list
25171978|NCT02883478|Vitamin B Complex|vitamin b complex|mesh-ancestor
25171979|NCT02883478|Vitamins|vitamins|mesh-ancestor
25171980|NCT02883478|Micronutrients|micronutrients|mesh-ancestor
25171981|NCT02883478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171982|NCT02883478|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25171983|NCT02883478|Dermatologic Agents|dermatologic agents|mesh-ancestor
25171984|NCT02883179|Lidocaine|lidocaine|mesh-list
25171985|NCT02883179|Prilocaine|prilocaine|mesh-list
25171986|NCT02883179|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25171987|NCT02883179|Anesthetics, Local|anesthetics, local|mesh-ancestor
25171988|NCT02883179|Anesthetics|anesthetics|mesh-ancestor
25171989|NCT02883179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25171990|NCT02883179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25171991|NCT02883179|Sensory System Agents|sensory system agents|mesh-ancestor
25171992|NCT02883179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25171993|NCT02883179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25171994|NCT02883179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25171995|NCT02883179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25082502|NCT03322098|Atropine|atropine|mesh-list
25171996|NCT02883179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25171997|NCT02883179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25171998|NCT02883179|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25171999|NCT02883192|Ondansetron|ondansetron|mesh-list
25172000|NCT02883192|Antiemetics|antiemetics|mesh-ancestor
25172001|NCT02883192|Autonomic Agents|autonomic agents|mesh-ancestor
25172002|NCT02883192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25172003|NCT02883192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172004|NCT02883192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25172005|NCT02883192|Antipruritics|antipruritics|mesh-ancestor
25172006|NCT02883192|Dermatologic Agents|dermatologic agents|mesh-ancestor
25665001|NCT01678443|Immunologic Factors|immunologic factors|mesh-ancestor
25860100|NCT00082719|Antiviral Agents|antiviral agents|mesh-ancestor
24852941|NCT02264834|Analgesics|analgesics|mesh-ancestor
25172007|NCT02883192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25172008|NCT02883192|Serotonin Agents|serotonin agents|mesh-ancestor
25172009|NCT02883192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25172010|NCT02883192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172011|NCT02883192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25172012|NCT02883192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25172013|NCT02883192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25172014|NCT02883192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25172015|NCT02883192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25172016|NCT02883439|Fluticasone|fluticasone|mesh-list
25172018|NCT02883439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25172019|NCT02883439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25172020|NCT02883439|Autonomic Agents|autonomic agents|mesh-ancestor
25172021|NCT02883439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24859113|NCT02301780|Antipyretics|antipyretics|mesh-ancestor
25172022|NCT02883439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172023|NCT02883439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25172024|NCT02883439|Respiratory System Agents|respiratory system agents|mesh-ancestor
25172025|NCT02883439|Dermatologic Agents|dermatologic agents|mesh-ancestor
25172026|NCT02883439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25172027|NCT02883426|Vaccines|vaccines|mesh-list
25172028|NCT02883426|Immunologic Factors|immunologic factors|mesh-ancestor
25172029|NCT02883426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172030|NCT02883114|Itraconazole|itraconazole|mesh-list
25172031|NCT02883114|Antifungal Agents|antifungal agents|mesh-ancestor
25172032|NCT02883114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25172033|NCT02883114|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25172034|NCT02883114|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25172035|NCT02883114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25172036|NCT02883114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749900|NCT01694576|Tubulin Modulators|tubulin modulators|mesh-ancestor
25172037|NCT02883114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25172038|NCT02883114|Hormone Antagonists|hormone antagonists|mesh-ancestor
25172039|NCT02883114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25172040|NCT02883114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172041|NCT02883114|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25172042|NCT02883023|Bleomycin|bleomycin|mesh-list
25172043|NCT02883023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25172044|NCT02883023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172045|NCT02882893|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25172046|NCT02882893|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25172047|NCT02882893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25172048|NCT02882893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25172049|NCT02882893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172050|NCT02882893|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25172051|NCT02882893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25172052|NCT02882893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172053|NCT02882893|Cholinergic Agents|cholinergic agents|mesh-ancestor
25172054|NCT02882893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25172055|NCT02882828|Tacrolimus|tacrolimus|mesh-list
25172056|NCT02882828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25172057|NCT02882828|Immunologic Factors|immunologic factors|mesh-ancestor
25172058|NCT02882828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172059|NCT02882828|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25172060|NCT02882828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25172061|NCT02882828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172062|NCT02882984|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25172063|NCT02882984|Gefitinib|gefitinib|mesh-list
24749998|NCT01695356|Terephthalylidene dicamphor sulfonic acid|terephthalylidene dicamphor sulfonic acid|mesh-list
24749999|NCT01695356|Benzophenone|benzophenone|mesh-list
24414420|NCT00197548|Hematinics|hematinics|mesh-ancestor
24750000|NCT01695356|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24750002|NCT01695356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750003|NCT01695356|Dermatologic Agents|dermatologic agents|mesh-ancestor
25172064|NCT02882984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172065|NCT02882984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25172066|NCT02882984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25172067|NCT02882984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172068|NCT02882789|Delpazolid|delpazolid|mesh-list
25172069|NCT02882789|Oxazolidinones|oxazolidinones|mesh-list
25172070|NCT02882789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25172071|NCT02882789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25665002|NCT01678443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172072|NCT02882789|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25172073|NCT02882789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25172148|NCT02882269|Antimetabolites|antimetabolites|mesh-ancestor
25172074|NCT02882789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172075|NCT02882737|Glucagon|glucagon|mesh-list
25172076|NCT02882737|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25172077|NCT02882737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25172078|NCT02882737|Hormones|hormones|mesh-ancestor
25172079|NCT02882737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25172080|NCT02882737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172081|NCT02882737|Incretins|incretins|mesh-ancestor
25172082|NCT02882555|Capsaicin|capsaicin|mesh-list
25172083|NCT02882555|Antipruritics|antipruritics|mesh-ancestor
25172084|NCT02882555|Dermatologic Agents|dermatologic agents|mesh-ancestor
25172085|NCT02882555|Sensory System Agents|sensory system agents|mesh-ancestor
25172086|NCT02882555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25172087|NCT02882555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172088|NCT02882932|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25172089|NCT02882308|Durvalumab|durvalumab|mesh-list
25172090|NCT02882308|Olaparib|olaparib|mesh-list
25172091|NCT02882308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172092|NCT02882308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25172093|NCT02882308|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25172094|NCT02882308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859256|NCT02302547|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25172095|NCT02882308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172096|NCT02882581|Metformin|metformin|mesh-list
25172097|NCT02882581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25172098|NCT02882581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750019|NCT01695798|Vaccines|vaccines|mesh-list
25172099|NCT02882347|Somatostatin|somatostatin|mesh-list
25172100|NCT02882347|Hormones|hormones|mesh-ancestor
25172101|NCT02882347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25172102|NCT02882347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172103|NCT02882477|Metformin|metformin|mesh-list
25172104|NCT02882477|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25172105|NCT02882477|Acetylcysteine|acetylcysteine|mesh-list
25172106|NCT02882477|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25172107|NCT02882477|Deferiprone|deferiprone|mesh-list
25172108|NCT02882477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25172109|NCT02882477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172110|NCT02882477|Incretins|incretins|mesh-ancestor
25172111|NCT02882477|Hormones|hormones|mesh-ancestor
25172112|NCT02882477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25172113|NCT02882477|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25172114|NCT02882477|Protease Inhibitors|protease inhibitors|mesh-ancestor
25172115|NCT02882477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25172116|NCT02882477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172117|NCT02882477|Antiviral Agents|antiviral agents|mesh-ancestor
25172118|NCT02882477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25172119|NCT02882477|Expectorants|expectorants|mesh-ancestor
25172120|NCT02882477|Respiratory System Agents|respiratory system agents|mesh-ancestor
25172121|NCT02882477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25172122|NCT02882477|Antioxidants|antioxidants|mesh-ancestor
25172123|NCT02882477|Protective Agents|protective agents|mesh-ancestor
25172124|NCT02882477|Antidotes|antidotes|mesh-ancestor
25172125|NCT02882477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25172126|NCT02882477|Chelating Agents|chelating agents|mesh-ancestor
25172127|NCT02882477|Sequestering Agents|sequestering agents|mesh-ancestor
25172128|NCT02882425|Selexipag|selexipag|mesh-list
25172129|NCT02882425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25172130|NCT02882451|Ascorbic Acid|ascorbic acid|mesh-list
25172131|NCT02882451|Pinaverium|pinaverium|mesh-list
25172132|NCT02882451|Bromides|bromides|mesh-list
25172133|NCT02882451|Vitamins|vitamins|mesh-ancestor
25172134|NCT02882451|Micronutrients|micronutrients|mesh-ancestor
25172135|NCT02882451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172136|NCT02882451|Antioxidants|antioxidants|mesh-ancestor
25082503|NCT03322098|Glycopyrrolate|glycopyrrolate|mesh-list
25172137|NCT02882451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172138|NCT02882451|Protective Agents|protective agents|mesh-ancestor
25172139|NCT02882451|Anticonvulsants|anticonvulsants|mesh-ancestor
24750043|NCT01696110|Antithrombins|antithrombins|mesh-ancestor
25172140|NCT02882451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25172141|NCT02882451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25172142|NCT02882451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25172143|NCT02882451|Parasympatholytics|parasympatholytics|mesh-ancestor
25172144|NCT02882451|Autonomic Agents|autonomic agents|mesh-ancestor
24598818|NCT00958321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598820|NCT00958386|Panitumumab|panitumumab|mesh-list
24598821|NCT00958386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24598822|NCT00958386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24598823|NCT00958386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598824|NCT00958386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598825|NCT00958386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598826|NCT00958386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24598827|NCT00958425|Hyaluronic Acid|hyaluronic acid|mesh-list
24598828|NCT00958425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24598829|NCT00958425|Immunologic Factors|immunologic factors|mesh-ancestor
25172145|NCT02882451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25172146|NCT02882269|Capecitabine|capecitabine|mesh-list
25172147|NCT02882269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25172149|NCT02882269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172150|NCT02882269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25203978|NCT02711202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25203979|NCT02711202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25203980|NCT02711202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25203981|NCT02711202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25203982|NCT02711202|Antifungal Agents|antifungal agents|mesh-ancestor
25203983|NCT02711202|Dermatologic Agents|dermatologic agents|mesh-ancestor
24750089|NCT01696474|Bortezomib|bortezomib|mesh-list
24750090|NCT01696474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24750091|NCT01696500|Immunoglobulins|immunoglobulins|mesh-list
24750092|NCT01696500|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24750093|NCT01696500|Antibodies|antibodies|mesh-list
24750128|NCT01696617|Serotonin Agents|serotonin agents|mesh-ancestor
24750129|NCT01696617|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24750130|NCT01696617|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25203984|NCT02711202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25203985|NCT02711202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25203986|NCT02711202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25203987|NCT02711228|Immunoglobulins|immunoglobulins|mesh-list
25203988|NCT02711228|Antibodies|antibodies|mesh-list
25203989|NCT02711228|gamma-Globulins|gamma-globulins|mesh-list
25203990|NCT02711228|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25203991|NCT02711228|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25203992|NCT02711228|Immunologic Factors|immunologic factors|mesh-ancestor
25203993|NCT02711228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25203994|NCT02711215|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25203995|NCT02711215|Mirtazapine|mirtazapine|mesh-list
25203996|NCT02711215|Citalopram|citalopram|mesh-list
25203997|NCT02711215|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25203998|NCT02711215|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25860101|NCT00082719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25860102|NCT00082719|Immunologic Factors|immunologic factors|mesh-ancestor
25126549|NCT03061604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24785952|NCT01917318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24787467|NCT01925378|Nelfinavir|nelfinavir|mesh-list
24627926|NCT01095679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24921806|NCT04186936|Emollients|emollients|mesh-ancestor
24921813|NCT04187014|Hemostatics|hemostatics|mesh-ancestor
24786248|NCT01918813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786250|NCT01918852|Capecitabine|capecitabine|mesh-list
24786251|NCT01918852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24786252|NCT01918852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24786253|NCT01918852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24786254|NCT01918852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24786255|NCT01918852|Growth Substances|growth substances|mesh-ancestor
24801111|NCT01980849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24787646|NCT01926236|Levoleucovorin|levoleucovorin|mesh-list
24787286|NCT01924286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25665003|NCT01678443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665004|NCT01678794|Candesartan|candesartan|mesh-list
25665005|NCT01678794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25665006|NCT01678794|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25665007|NCT01678794|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25665008|NCT01678794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665009|NCT01678820|Metformin|metformin|mesh-list
25665010|NCT01678820|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25665011|NCT01678820|Glimepiride|glimepiride|mesh-list
25665012|NCT01678820|Simvastatin|simvastatin|mesh-list
25665013|NCT01678820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25665014|NCT01678820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599340|NCT04720547|GABA Agents|gaba agents|mesh-ancestor
24599341|NCT04720547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24599342|NCT04720547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599343|NCT04718285|Favipiravir|favipiravir|mesh-list
24599344|NCT04718285|Montelukast|montelukast|mesh-list
24599345|NCT04718285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24599346|NCT04718285|Respiratory System Agents|respiratory system agents|mesh-ancestor
24599347|NCT04718285|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24787288|NCT01924286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24787289|NCT01924286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787290|NCT01924325|Aspirin|aspirin|mesh-list
24787291|NCT01924325|Apixaban|apixaban|mesh-list
24787292|NCT01924325|Clopidogrel|clopidogrel|mesh-list
24787293|NCT01924325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24787294|NCT01924325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24787295|NCT01924325|Analgesics|analgesics|mesh-ancestor
25082284|NCT03323671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082285|NCT03323671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082296|NCT03323593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25082297|NCT03323593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082298|NCT03323593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24787876|NCT01928056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788315|NCT01930773|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25082350|NCT03323385|Analgesics|analgesics|mesh-ancestor
25082387|NCT03323047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25082388|NCT03323047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789252|NCT01936025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24789253|NCT01936064|Cyclophosphamide|cyclophosphamide|mesh-list
24789254|NCT01936064|Epirubicin|epirubicin|mesh-list
24789272|NCT01936090|Alkylating Agents|alkylating agents|mesh-ancestor
24628040|NCT01096277|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24628042|NCT01096277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25082308|NCT03323567|Lidocaine|lidocaine|mesh-list
24621673|NCT01063426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24621674|NCT01063426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24621675|NCT01063439|Cytarabine|cytarabine|mesh-list
24621676|NCT01063439|Etoposide|etoposide|mesh-list
24789924|NCT01939691|Autonomic Agents|autonomic agents|mesh-ancestor
24789925|NCT01939691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24787958|NCT01928563|Udenafil|udenafil|mesh-list
24790031|NCT01940250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24790032|NCT01940250|Anticonvulsants|anticonvulsants|mesh-ancestor
24790033|NCT01940250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24790034|NCT01940250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24790542|NCT01943487|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24790543|NCT01943487|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24790544|NCT01943487|Adrenergic Agents|adrenergic agents|mesh-ancestor
24790545|NCT01943487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24790546|NCT01943487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790582|NCT01943760|Sensory System Agents|sensory system agents|mesh-ancestor
24790583|NCT01943760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24621778|NCT01063920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24788149|NCT01929746|Daclizumab|daclizumab|mesh-list
25082494|NCT03322150|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25082495|NCT03322150|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25082496|NCT03322150|Cholinergic Agents|cholinergic agents|mesh-ancestor
25082497|NCT03322150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25082498|NCT03322150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082499|NCT03322124|Octenidine|octenidine|mesh-list
25172151|NCT02882594|Anesthetics|anesthetics|mesh-list
24750170|NCT01696825|Anesthetics|anesthetics|mesh-ancestor
24618919|NCT01050270|Antiviral Agents|antiviral agents|mesh-ancestor
24618920|NCT01050270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24618921|NCT01050270|Expectorants|expectorants|mesh-ancestor
24618922|NCT01050270|Respiratory System Agents|respiratory system agents|mesh-ancestor
24944383|NCT03960905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24944384|NCT03961087|Ubiquinone|ubiquinone|mesh-list
25665015|NCT01678820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25665016|NCT01678820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25665017|NCT01678820|Antimetabolites|antimetabolites|mesh-ancestor
25665018|NCT01678820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665019|NCT01678820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25665020|NCT01678820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25665021|NCT01678820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24944385|NCT03961087|Coenzyme Q10|coenzyme q10|mesh-list
24944386|NCT03961087|Meclofenoxate|meclofenoxate|mesh-list
25425941|NCT02076009|Growth Inhibitors|growth inhibitors|mesh-ancestor
25172152|NCT02882594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25172153|NCT02882594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172154|NCT02882100|Vaccines|vaccines|mesh-list
25172155|NCT02882100|Immunologic Factors|immunologic factors|mesh-ancestor
25172156|NCT02882100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172157|NCT02882113|Tacrolimus|tacrolimus|mesh-list
25172158|NCT02882113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25172159|NCT02882113|Immunologic Factors|immunologic factors|mesh-ancestor
25172160|NCT02882113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172161|NCT02882113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25172162|NCT02882113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25172163|NCT02882113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172164|NCT02882217|Histamine|histamine|mesh-list
25172165|NCT02882217|Glutarimide|glutarimide|mesh-list
25172166|NCT02882217|Histamine Agonists|histamine agonists|mesh-ancestor
25172167|NCT02882217|Histamine Agents|histamine agents|mesh-ancestor
25172168|NCT02882217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25172169|NCT02882217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172170|NCT02882217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172171|NCT02882217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25172172|NCT02882217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25172173|NCT02881866|Furosemide|furosemide|mesh-list
25172174|NCT02881866|Diuretics|diuretics|mesh-ancestor
25172175|NCT02881866|Natriuretic Agents|natriuretic agents|mesh-ancestor
25172176|NCT02881866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172177|NCT02881866|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25172178|NCT02881866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25172398|NCT02879669|Cyclophosphamide|cyclophosphamide|mesh-list
25172179|NCT02881866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172180|NCT02881892|Dialysis Solutions|dialysis solutions|mesh-list
25172181|NCT02881892|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25172183|NCT02882191|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25172184|NCT02882191|Contraceptive Agents|contraceptive agents|mesh-ancestor
25172185|NCT02882191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25172186|NCT02882191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172187|NCT02882191|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25172188|NCT02882191|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25172189|NCT02882191|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25172190|NCT02882126|Treprostinil|treprostinil|mesh-list
25172191|NCT02882126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25172192|NCT02882230|Dolutegravir|dolutegravir|mesh-list
25172193|NCT02882230|Rilpivirine|rilpivirine|mesh-list
25172194|NCT02882230|Elvitegravir|elvitegravir|mesh-list
25172195|NCT02882230|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25172196|NCT02882230|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25172197|NCT02882230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24944387|NCT03961087|Micronutrients|micronutrients|mesh-ancestor
24944388|NCT03961087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172198|NCT02882230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172199|NCT02882230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25172200|NCT02882230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25172201|NCT02882230|Antiviral Agents|antiviral agents|mesh-ancestor
25172202|NCT02882230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25172203|NCT02882230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25172204|NCT02882230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25172205|NCT02881749|Mechlorethamine|mechlorethamine|mesh-list
25172206|NCT02881749|Alkylating Agents|alkylating agents|mesh-ancestor
25172207|NCT02881749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172208|NCT02881749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25172209|NCT02881749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172210|NCT02881762|Maraviroc|maraviroc|mesh-list
25172211|NCT02881762|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25172212|NCT02881762|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25172213|NCT02881762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172214|NCT02881762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25172215|NCT02881762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25172216|NCT02881762|Antiviral Agents|antiviral agents|mesh-ancestor
25172217|NCT02881762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25172218|NCT02881762|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25172219|NCT02882087|Methotrexate|methotrexate|mesh-list
25172220|NCT02882087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25172221|NCT02882087|Abortifacient Agents|abortifacient agents|mesh-ancestor
25172222|NCT02882087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25172223|NCT02882087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599928|NCT03040778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599929|NCT03040778|Protective Agents|protective agents|mesh-ancestor
24599930|NCT03040778|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24599931|NCT03040778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24599932|NCT03040778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24599936|NCT03032328|Vitamin D|vitamin d|mesh-list
25172224|NCT02882087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25172225|NCT02882087|Antimetabolites|antimetabolites|mesh-ancestor
25172226|NCT02882087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813265|NCT02057367|Anesthetics|anesthetics|mesh-ancestor
25172227|NCT02882087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172228|NCT02882087|Dermatologic Agents|dermatologic agents|mesh-ancestor
25172229|NCT02882087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25172230|NCT02882087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25172231|NCT02882087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24750217|NCT01697098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24750218|NCT01697098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24750219|NCT01697098|Protease Inhibitors|protease inhibitors|mesh-ancestor
25172232|NCT02882087|Immunologic Factors|immunologic factors|mesh-ancestor
25172233|NCT02882087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25172234|NCT02882087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25172235|NCT02881346|Betamethasone|betamethasone|mesh-list
25172236|NCT02881346|Betamethasone Valerate|betamethasone valerate|mesh-list
25172237|NCT02881346|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25172238|NCT02881346|Betamethasone benzoate|betamethasone benzoate|mesh-list
25172239|NCT02881346|Calcipotriene|calcipotriene|mesh-list
25172240|NCT02881346|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25172241|NCT02881346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25172242|NCT02881346|Glucocorticoids|glucocorticoids|mesh-ancestor
25172243|NCT02881346|Hormones|hormones|mesh-ancestor
25172244|NCT02881346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25172245|NCT02881346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172246|NCT02881346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25172247|NCT02881346|Respiratory System Agents|respiratory system agents|mesh-ancestor
25172248|NCT02881346|Dermatologic Agents|dermatologic agents|mesh-ancestor
25172249|NCT02881528|Metformin|metformin|mesh-list
25172250|NCT02881528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25172251|NCT02881528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172252|NCT02881619|Etodolac|etodolac|mesh-list
25172253|NCT02881619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25172254|NCT02881619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25172255|NCT02881619|Analgesics|analgesics|mesh-ancestor
25172256|NCT02881619|Sensory System Agents|sensory system agents|mesh-ancestor
25172257|NCT02881619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25172258|NCT02881619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172259|NCT02881619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25172260|NCT02881619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25172261|NCT02881619|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25172262|NCT02881619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25172263|NCT02881619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25172264|NCT02881619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172266|NCT02880995|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25172267|NCT02880995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24750220|NCT01697098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25172268|NCT02880995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25172269|NCT02880995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172270|NCT02880995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25172271|NCT02880995|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25172272|NCT02880995|Dopamine Agents|dopamine agents|mesh-ancestor
25172273|NCT02880995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25172274|NCT02880995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172275|NCT02880995|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25172276|NCT02880995|Antidepressive Agents|antidepressive agents|mesh-ancestor
25172277|NCT02880943|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25172278|NCT02880943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172279|NCT02881177|Oxytocin|oxytocin|mesh-list
25172280|NCT02881177|Oxytocics|oxytocics|mesh-ancestor
25172281|NCT02881177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25665022|NCT01678820|Incretins|incretins|mesh-ancestor
25665023|NCT01678820|Hormones|hormones|mesh-ancestor
25665024|NCT01678820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25665025|NCT01678820|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25665026|NCT01678820|Protease Inhibitors|protease inhibitors|mesh-ancestor
25665027|NCT01678820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24853069|NCT02265770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24853070|NCT02265770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24853072|NCT02265770|Dermatologic Agents|dermatologic agents|mesh-ancestor
24853073|NCT02265770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24853074|NCT02265770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24853075|NCT02265770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24853076|NCT02265770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24853077|NCT02265770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24853078|NCT02265770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24853079|NCT02265770|Tubulin Modulators|tubulin modulators|mesh-ancestor
24853080|NCT02265770|Antimitotic Agents|antimitotic agents|mesh-ancestor
24664080|NCT01304836|Hormones|hormones|mesh-ancestor
24600045|NCT02748707|Celecoxib|celecoxib|mesh-list
24853082|NCT02265770|Anticonvulsants|anticonvulsants|mesh-ancestor
24853083|NCT02265770|GABA Agents|gaba agents|mesh-ancestor
24853084|NCT02265770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24853085|NCT02265770|Antimanic Agents|antimanic agents|mesh-ancestor
25172282|NCT02881177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172283|NCT02881125|Paclitaxel|paclitaxel|mesh-list
25172284|NCT02881125|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25172285|NCT02881125|Nortriptyline|nortriptyline|mesh-list
25172286|NCT02881125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25172287|NCT02881125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172288|NCT02881125|Tubulin Modulators|tubulin modulators|mesh-ancestor
25172289|NCT02881125|Antimitotic Agents|antimitotic agents|mesh-ancestor
25172290|NCT02881125|Mitosis Modulators|mitosis modulators|mesh-ancestor
25172291|NCT02881125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172292|NCT02881125|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25172293|NCT02881125|Antidepressive Agents|antidepressive agents|mesh-ancestor
25172294|NCT02881125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25172295|NCT02881125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25172296|NCT02881125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25172297|NCT02881125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25172298|NCT02881125|Adrenergic Agents|adrenergic agents|mesh-ancestor
24859688|NCT02305173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172299|NCT02881125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25172300|NCT02881125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172301|NCT02880787|Rocuronium|rocuronium|mesh-list
25172302|NCT02880787|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25172303|NCT02880787|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25172304|NCT02880787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25172305|NCT02880787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25172306|NCT02880787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172307|NCT02880800|Morphine|morphine|mesh-list
25172308|NCT02880800|Hydromorphone|hydromorphone|mesh-list
25172309|NCT02880800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25172310|NCT02880800|Narcotics|narcotics|mesh-ancestor
25172311|NCT02880800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25172312|NCT02880800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172313|NCT02880800|Analgesics|analgesics|mesh-ancestor
25172314|NCT02880800|Sensory System Agents|sensory system agents|mesh-ancestor
25172315|NCT02880800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25203999|NCT02711215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25204000|NCT02711215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25204001|NCT02711215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204002|NCT02711215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25204003|NCT02711215|Serotonin Agents|serotonin agents|mesh-ancestor
25426094|NCT02057133|Pertuzumab|pertuzumab|mesh-list
25665028|NCT01678820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25665029|NCT01678820|Immunologic Factors|immunologic factors|mesh-ancestor
25665030|NCT01678911|Gabapentin|gabapentin|mesh-list
25665031|NCT01678911|Analgesics|analgesics|mesh-ancestor
25665032|NCT01678911|Sensory System Agents|sensory system agents|mesh-ancestor
25665033|NCT01678911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25665034|NCT01678911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665035|NCT01678911|Anticonvulsants|anticonvulsants|mesh-ancestor
25665036|NCT01678911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25665037|NCT01678911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25665038|NCT01678911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25665039|NCT01678911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25665040|NCT01678911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25665041|NCT01678911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25665042|NCT01678911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25665043|NCT01678911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204005|NCT02711215|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25204006|NCT02711215|Antidepressive Agents|antidepressive agents|mesh-ancestor
25204007|NCT02711215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25204008|NCT02711215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204009|NCT02711215|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25204010|NCT02711215|Analgesics|analgesics|mesh-ancestor
25204011|NCT02711215|Sensory System Agents|sensory system agents|mesh-ancestor
25204012|NCT02711215|Dopamine Agents|dopamine agents|mesh-ancestor
25204013|NCT02711215|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25204014|NCT02711215|Histamine Antagonists|histamine antagonists|mesh-ancestor
25204015|NCT02711215|Histamine Agents|histamine agents|mesh-ancestor
25204016|NCT02711215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25204017|NCT02711215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24750311|NCT01697631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25204018|NCT02711215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25204019|NCT02711215|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25204020|NCT02711215|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25204021|NCT02711215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25204022|NCT02711215|Adrenergic Agents|adrenergic agents|mesh-ancestor
25204023|NCT02711215|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25204024|NCT02711215|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25204025|NCT02711215|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25204026|NCT02711358|Indomethacin|indomethacin|mesh-list
25204027|NCT02711358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25204028|NCT02711358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25204029|NCT02711358|Analgesics|analgesics|mesh-ancestor
25204030|NCT02711358|Sensory System Agents|sensory system agents|mesh-ancestor
25204031|NCT02711358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204032|NCT02711358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204033|NCT02711358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25204034|NCT02711358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25204035|NCT02711358|Gout Suppressants|gout suppressants|mesh-ancestor
25204036|NCT02711358|Tocolytic Agents|tocolytic agents|mesh-ancestor
24750375|NCT01697826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24750376|NCT01698138|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24944400|NCT03960775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24944401|NCT03960775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24750402|NCT01698177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204037|NCT02711358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25204038|NCT02711358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25204039|NCT02711358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25204040|NCT02711358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204042|NCT02711267|Antiviral Agents|antiviral agents|mesh-ancestor
25204043|NCT02711267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25204044|NCT02711280|Propofol|propofol|mesh-list
25204045|NCT02711280|Sevoflurane|sevoflurane|mesh-list
25204046|NCT02711280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25204047|NCT02711280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25204048|NCT02711280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204049|NCT02711280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25204050|NCT02711280|Anesthetics, General|anesthetics, general|mesh-ancestor
25204051|NCT02711280|Anesthetics|anesthetics|mesh-ancestor
25204052|NCT02711280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25204053|NCT02711280|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25204054|NCT02711241|Dipyrone|dipyrone|mesh-list
25860103|NCT00082719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860104|NCT00082784|Bortezomib|bortezomib|mesh-list
25860105|NCT00082784|Alvocidib|alvocidib|mesh-list
25860106|NCT00082784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860107|NCT00082784|Growth Inhibitors|growth inhibitors|mesh-ancestor
25860108|NCT00082784|Growth Substances|growth substances|mesh-ancestor
25860109|NCT00082784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126782|NCT03059719|Hormones|hormones|mesh-ancestor
24750403|NCT01698203|Ropivacaine|ropivacaine|mesh-list
24449101|NCT00314379|Vitamin E|vitamin e|mesh-list
24750422|NCT01698541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750423|NCT01698541|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24750424|NCT01698541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750426|NCT01698567|Antithrombins|antithrombins|mesh-list
25082500|NCT03322124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25082501|NCT03322124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25665044|NCT01678911|Antimanic Agents|antimanic agents|mesh-ancestor
25860110|NCT00082784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24790774|NCT01945047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24790775|NCT01945047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24790776|NCT01945047|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24790777|NCT01945047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24790778|NCT01945047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24627978|NCT01095926|Doxorubicin|doxorubicin|mesh-list
24791014|NCT05406895|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24628110|NCT01096654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082321|NCT03323541|Lenograstim|lenograstim|mesh-list
24893516|NCT04448587|Protease Inhibitors|protease inhibitors|mesh-ancestor
24791899|NCT02553460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24791901|NCT02553460|Hormones|hormones|mesh-ancestor
24791902|NCT02553460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24791903|NCT02553460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24788417|NCT01931293|Vitamin B Complex|vitamin b complex|mesh-list
24792261|NCT05396781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24792781|NCT04714619|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24792782|NCT04714619|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24792783|NCT04714619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24792784|NCT04714619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792785|NCT04714619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24792786|NCT04714619|Hormone Antagonists|hormone antagonists|mesh-ancestor
24792787|NCT04714619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24793503|NCT03328884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24793504|NCT03328884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793505|NCT03328884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793508|NCT03299309|Vaccines|vaccines|mesh-list
24788748|NCT01933412|Vaccines|vaccines|mesh-list
24750474|NCT01698749|Dexamethasone|dexamethasone|mesh-list
24750475|NCT01698749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24750476|NCT01698749|Antiemetics|antiemetics|mesh-ancestor
24793726|NCT02625610|Protective Agents|protective agents|mesh-ancestor
24967717|NCT03757260|Anti-Infective Agents|anti-infective agents|mesh-list
24967718|NCT03757260|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24967719|NCT03757221|Daratumumab|daratumumab|mesh-list
24967720|NCT03757221|Ixazomib|ixazomib|mesh-list
24967721|NCT03757221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967722|NCT03757221|Protease Inhibitors|protease inhibitors|mesh-ancestor
24967723|NCT03757221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788794|NCT01933906|Interferon-alpha|interferon-alpha|mesh-list
24967994|NCT03755427|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24967995|NCT03755427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24926539|NCT04140461|Flucytosine|flucytosine|mesh-list
24926656|NCT04139772|Hormone Antagonists|hormone antagonists|mesh-ancestor
24968671|NCT03749590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24968672|NCT03749590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24968673|NCT03749590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082899|NCT03319121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25082900|NCT03319121|Respiratory System Agents|respiratory system agents|mesh-ancestor
25082901|NCT03319121|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25082902|NCT03319121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24806429|NCT02015728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24806573|NCT02016495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806574|NCT02016495|Protective Agents|protective agents|mesh-ancestor
25172316|NCT02880462|Sulforaphane|sulforaphane|mesh-list
25172317|NCT02880462|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25172318|NCT02880462|Protective Agents|protective agents|mesh-ancestor
25172319|NCT02880462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172320|NCT02880462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172321|NCT02880410|Temozolomide|temozolomide|mesh-list
25172322|NCT02880410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25172323|NCT02880410|Alkylating Agents|alkylating agents|mesh-ancestor
25172324|NCT02880410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172325|NCT02880410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172327|NCT02880345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25172328|NCT02880345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172329|NCT02880280|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25172330|NCT02880280|Menotropins|menotropins|mesh-list
25172331|NCT02880280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25172332|NCT02880280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172333|NCT02880280|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24750477|NCT01698749|Autonomic Agents|autonomic agents|mesh-ancestor
25172334|NCT02880280|Fertility Agents|fertility agents|mesh-ancestor
25172335|NCT02879955|Acarbose|acarbose|mesh-list
25172336|NCT02879955|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25172337|NCT02879955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601050|NCT00962442|Acetylcysteine|acetylcysteine|mesh-list
24601062|NCT00962507|Everolimus|everolimus|mesh-list
25172338|NCT02879955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172339|NCT02879955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25172340|NCT02879955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172341|NCT02880033|Deferiprone|deferiprone|mesh-list
25172342|NCT02880033|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25172343|NCT02880033|Chelating Agents|chelating agents|mesh-ancestor
25172344|NCT02880033|Sequestering Agents|sequestering agents|mesh-ancestor
25172345|NCT02880033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172346|NCT02879981|Trimethoprim|trimethoprim|mesh-list
25172347|NCT02879981|Sulfamethoxazole|sulfamethoxazole|mesh-list
25172348|NCT02879981|Phenylpropanolamine|phenylpropanolamine|mesh-list
25172349|NCT02879981|Guaifenesin|guaifenesin|mesh-list
25172350|NCT02879981|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
25172351|NCT02879981|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25172352|NCT02879981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25172353|NCT02879981|Renal Agents|renal agents|mesh-ancestor
25172354|NCT02879981|Antimalarials|antimalarials|mesh-ancestor
25172355|NCT02879981|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25172356|NCT02879981|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25172357|NCT02879981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25172358|NCT02879981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25172359|NCT02879981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172360|NCT02879981|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25172361|NCT02879981|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24750547|NCT01699360|Antifungal Agents|antifungal agents|mesh-ancestor
24750548|NCT01699360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24750549|NCT01699360|Dermatologic Agents|dermatologic agents|mesh-ancestor
24750550|NCT01699360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24750577|NCT01699490|Fluoxetine|fluoxetine|mesh-list
24750578|NCT01699490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24750579|NCT01699490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25172362|NCT02879981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25172363|NCT02879981|Expectorants|expectorants|mesh-ancestor
25172364|NCT02879981|Respiratory System Agents|respiratory system agents|mesh-ancestor
25172365|NCT02879981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25172366|NCT02879981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25172367|NCT02879981|Adrenergic Agents|adrenergic agents|mesh-ancestor
25172368|NCT02879981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25172369|NCT02879981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172370|NCT02879981|Appetite Depressants|appetite depressants|mesh-ancestor
25172371|NCT02879981|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25172372|NCT02879981|Sympathomimetics|sympathomimetics|mesh-ancestor
25172373|NCT02879981|Autonomic Agents|autonomic agents|mesh-ancestor
25172374|NCT02879981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25172375|NCT02879981|Nasal Decongestants|nasal decongestants|mesh-ancestor
25172376|NCT02879981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25172377|NCT02880007|Cisplatin|cisplatin|mesh-list
25172378|NCT02880007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172379|NCT02880085|Lidocaine|lidocaine|mesh-list
25172380|NCT02880085|Anesthetics, Local|anesthetics, local|mesh-list
25172381|NCT02880085|Anesthetics|anesthetics|mesh-list
25172382|NCT02880085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25172383|NCT02880085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172384|NCT02880085|Sensory System Agents|sensory system agents|mesh-ancestor
25172385|NCT02880085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25172386|NCT02880085|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25172387|NCT02880085|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25172388|NCT02880085|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25172389|NCT02880085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25172390|NCT02880085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172391|NCT02879916|Levobupivacaine|levobupivacaine|mesh-list
25172392|NCT02879916|Anesthetics, Local|anesthetics, local|mesh-ancestor
25172393|NCT02879916|Anesthetics|anesthetics|mesh-ancestor
25172394|NCT02879916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25172395|NCT02879916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750580|NCT01699490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24750620|NCT01699724|Sertraline|sertraline|mesh-list
25172396|NCT02879916|Sensory System Agents|sensory system agents|mesh-ancestor
25172397|NCT02879916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25172399|NCT02879669|Carboplatin|carboplatin|mesh-list
25172401|NCT02879669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25172402|NCT02879669|Immunologic Factors|immunologic factors|mesh-ancestor
25665045|NCT01678976|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25665046|NCT01678976|Oxcarbazepine|oxcarbazepine|mesh-list
25172403|NCT02879669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172404|NCT02879669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25172405|NCT02879669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25172406|NCT02879669|Alkylating Agents|alkylating agents|mesh-ancestor
25172407|NCT02879669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172408|NCT02879669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172409|NCT02879669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25172410|NCT02879669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25172411|NCT02879669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25172412|NCT02879669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25172413|NCT02879435|Bupivacaine|bupivacaine|mesh-list
25172414|NCT02879435|Anesthetics, Local|anesthetics, local|mesh-ancestor
25172415|NCT02879435|Anesthetics|anesthetics|mesh-ancestor
25172416|NCT02879435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25172417|NCT02879435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172418|NCT02879435|Sensory System Agents|sensory system agents|mesh-ancestor
25172419|NCT02879435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25172420|NCT02879760|Pembrolizumab|pembrolizumab|mesh-list
25172421|NCT02879760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25172422|NCT02879760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172423|NCT02879513|Paclitaxel|paclitaxel|mesh-list
25172424|NCT02879513|Cyclophosphamide|cyclophosphamide|mesh-list
25172425|NCT02879513|Epirubicin|epirubicin|mesh-list
25172426|NCT02879513|Fluorouracil|fluorouracil|mesh-list
25172427|NCT02879513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25172428|NCT02879513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172429|NCT02879513|Tubulin Modulators|tubulin modulators|mesh-ancestor
25172430|NCT02879513|Antimitotic Agents|antimitotic agents|mesh-ancestor
25172431|NCT02879513|Mitosis Modulators|mitosis modulators|mesh-ancestor
25172432|NCT02879513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172433|NCT02879513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25172434|NCT02879513|Immunologic Factors|immunologic factors|mesh-ancestor
25172435|NCT02879513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172436|NCT02879513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25172437|NCT02879513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25172438|NCT02879513|Alkylating Agents|alkylating agents|mesh-ancestor
25172439|NCT02879513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25172440|NCT02879513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25172441|NCT02879513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25172442|NCT02879513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25172443|NCT02879513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25172444|NCT02879513|Antimetabolites|antimetabolites|mesh-ancestor
25172445|NCT02879513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25172446|NCT02879643|Vincristine|vincristine|mesh-list
25172447|NCT02879643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25860111|NCT00082784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860112|NCT00082784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860113|NCT00082797|Leucovorin|leucovorin|mesh-list
25860114|NCT00082797|Methotrexate|methotrexate|mesh-list
25860115|NCT00082797|Calcium|calcium|mesh-list
24750678|NCT01699997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750680|NCT01700010|Lapatinib|lapatinib|mesh-list
24750681|NCT01700010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24750682|NCT01700010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24750683|NCT01700010|Tubulin Modulators|tubulin modulators|mesh-ancestor
24750684|NCT01700010|Antimitotic Agents|antimitotic agents|mesh-ancestor
25172448|NCT02879643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172449|NCT02879643|Tubulin Modulators|tubulin modulators|mesh-ancestor
25172450|NCT02879643|Antimitotic Agents|antimitotic agents|mesh-ancestor
25172451|NCT02879643|Mitosis Modulators|mitosis modulators|mesh-ancestor
25172452|NCT02879643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172453|NCT02879721|Candesartan|candesartan|mesh-list
25172454|NCT02879721|Enalapril|enalapril|mesh-list
25172455|NCT02879721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25172456|NCT02879721|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25172457|NCT02879721|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25172458|NCT02879721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172459|NCT02879721|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25172460|NCT02879721|Protease Inhibitors|protease inhibitors|mesh-ancestor
25172461|NCT02879721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25172462|NCT02879292|Anesthetics|anesthetics|mesh-list
25172463|NCT02879292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25172464|NCT02879292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172465|NCT02879227|Cisplatin|cisplatin|mesh-list
25860116|NCT00082797|Levoleucovorin|levoleucovorin|mesh-list
25172466|NCT02879227|Oxaliplatin|oxaliplatin|mesh-list
25172467|NCT02879227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172468|NCT02879110|Sulforaphane|sulforaphane|mesh-list
25172469|NCT02879110|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25172470|NCT02879110|Protective Agents|protective agents|mesh-ancestor
25172471|NCT02879110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172472|NCT02879110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172473|NCT02879097|Paclitaxel|paclitaxel|mesh-list
25172474|NCT02879097|Carboplatin|carboplatin|mesh-list
25172475|NCT02879097|Bevacizumab|bevacizumab|mesh-list
25172476|NCT02879097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25172477|NCT02879097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172478|NCT02879097|Tubulin Modulators|tubulin modulators|mesh-ancestor
24750685|NCT01700010|Mitosis Modulators|mitosis modulators|mesh-ancestor
24750686|NCT01700010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750687|NCT01700010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24750688|NCT01700010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750689|NCT01700270|Fluvoxamine|fluvoxamine|mesh-list
25172632|NCT02878161|Etanercept|etanercept|mesh-list
24750699|NCT01700270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25172479|NCT02879097|Antimitotic Agents|antimitotic agents|mesh-ancestor
25172480|NCT02879097|Mitosis Modulators|mitosis modulators|mesh-ancestor
25172481|NCT02879097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172482|NCT02879097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25172483|NCT02879097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25172484|NCT02879097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25172485|NCT02879097|Growth Substances|growth substances|mesh-ancestor
25172486|NCT02879097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172487|NCT02879097|Growth Inhibitors|growth inhibitors|mesh-ancestor
25172488|NCT02879006|Omalizumab|omalizumab|mesh-list
25172489|NCT02879006|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25172490|NCT02879006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25172491|NCT02879006|Respiratory System Agents|respiratory system agents|mesh-ancestor
25172492|NCT02878837|Midazolam|midazolam|mesh-list
25172493|NCT02878837|Dexmedetomidine|dexmedetomidine|mesh-list
25172494|NCT02878837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25172495|NCT02878837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25172496|NCT02878837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172497|NCT02878837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25172498|NCT02878837|Analgesics|analgesics|mesh-ancestor
25172499|NCT02878837|Sensory System Agents|sensory system agents|mesh-ancestor
25172500|NCT02878837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25172501|NCT02878837|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25172502|NCT02878837|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25172503|NCT02878837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25172504|NCT02878837|Adrenergic Agents|adrenergic agents|mesh-ancestor
25172505|NCT02878837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25172506|NCT02878837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172507|NCT02878837|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25172508|NCT02878837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25172509|NCT02878837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25172510|NCT02878837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25172511|NCT02878837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25172512|NCT02878837|Anesthetics, General|anesthetics, general|mesh-ancestor
25172513|NCT02878837|Anesthetics|anesthetics|mesh-ancestor
25172514|NCT02878837|GABA Modulators|gaba modulators|mesh-ancestor
25172515|NCT02878837|GABA Agents|gaba agents|mesh-ancestor
25172516|NCT02878785|Decitabine|decitabine|mesh-list
25172517|NCT02878785|Talazoparib|talazoparib|mesh-list
25051249|NCT00429923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25051250|NCT00429923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051252|NCT00427856|Rituximab|rituximab|mesh-list
25172518|NCT02878785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25172519|NCT02878785|Antimetabolites|antimetabolites|mesh-ancestor
25172520|NCT02878785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172521|NCT02878785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172522|NCT02878785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25172523|NCT02878785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25172524|NCT02878863|Peoniflorin|peoniflorin|mesh-list
25172525|NCT02878863|Silymarin|silymarin|mesh-list
25172526|NCT02878863|Antioxidants|antioxidants|mesh-ancestor
25172527|NCT02878863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172528|NCT02878863|Protective Agents|protective agents|mesh-ancestor
25172529|NCT02878863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172530|NCT02878863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25172531|NCT02878863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25172532|NCT02878863|Analgesics|analgesics|mesh-ancestor
25172533|NCT02878863|Sensory System Agents|sensory system agents|mesh-ancestor
25172534|NCT02878863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25172535|NCT02878863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25172536|NCT02878863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25204055|NCT02711241|Papaverine|papaverine|mesh-list
25204056|NCT02711241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25204057|NCT02711241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25204058|NCT02711241|Analgesics|analgesics|mesh-ancestor
25204059|NCT02711241|Sensory System Agents|sensory system agents|mesh-ancestor
25204060|NCT02711241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204061|NCT02711241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204062|NCT02711241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24860147|NCT02307695|Incretins|incretins|mesh-ancestor
25172538|NCT02878772|Vinpocetine|vinpocetine|mesh-list
25172539|NCT02878772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25172540|NCT02878772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25172541|NCT02878772|Analgesics|analgesics|mesh-ancestor
25172542|NCT02878772|Sensory System Agents|sensory system agents|mesh-ancestor
25172543|NCT02878772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25860117|NCT00082797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25860118|NCT00082797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172544|NCT02878772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172545|NCT02878772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25172546|NCT02878772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25172547|NCT02878772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25172548|NCT02878772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25172549|NCT02878772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172550|NCT02878772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25172551|NCT02878772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25172552|NCT02878772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25172553|NCT02878772|Antipyretics|antipyretics|mesh-ancestor
25172554|NCT02878772|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25172555|NCT02878772|Vasodilator Agents|vasodilator agents|mesh-ancestor
25172556|NCT02878772|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25172557|NCT02878772|Protective Agents|protective agents|mesh-ancestor
25172558|NCT02878772|Nootropic Agents|nootropic agents|mesh-ancestor
25172559|NCT02878564|Praziquantel|praziquantel|mesh-list
25172560|NCT02878564|Anthelmintics|anthelmintics|mesh-ancestor
25172561|NCT02878564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25172562|NCT02878564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25172563|NCT02878512|Anesthetics|anesthetics|mesh-list
25172564|NCT02878512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25172565|NCT02878512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172566|NCT02878707|Dexmedetomidine|dexmedetomidine|mesh-list
25172567|NCT02878707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25172568|NCT02878707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25172569|NCT02878707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172570|NCT02878707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25172571|NCT02878707|Analgesics|analgesics|mesh-ancestor
25172572|NCT02878707|Sensory System Agents|sensory system agents|mesh-ancestor
25172573|NCT02878707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25172574|NCT02878707|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25172575|NCT02878707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25172576|NCT02878707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25172577|NCT02878707|Adrenergic Agents|adrenergic agents|mesh-ancestor
25172578|NCT02878707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25172579|NCT02878707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172580|NCT02878681|Ranibizumab|ranibizumab|mesh-list
25172581|NCT02878681|Aflibercept|aflibercept|mesh-list
25172582|NCT02878681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25172583|NCT02878681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25172584|NCT02878681|Growth Substances|growth substances|mesh-ancestor
25172585|NCT02878681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172586|NCT02878681|Growth Inhibitors|growth inhibitors|mesh-ancestor
25172587|NCT02878681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172588|NCT02878421|Nicotine|nicotine|mesh-list
25172589|NCT02878421|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25172590|NCT02878421|Autonomic Agents|autonomic agents|mesh-ancestor
25172591|NCT02878421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25172592|NCT02878421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172593|NCT02878421|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25172594|NCT02878421|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25172595|NCT02878421|Cholinergic Agents|cholinergic agents|mesh-ancestor
25172596|NCT02878421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24602614|NCT00969813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25172597|NCT02878421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172598|NCT02878538|Deferiprone|deferiprone|mesh-list
25172599|NCT02878538|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25172600|NCT02878538|Chelating Agents|chelating agents|mesh-ancestor
25172601|NCT02878538|Sequestering Agents|sequestering agents|mesh-ancestor
25172602|NCT02878538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172603|NCT02878200|Piperaquine|piperaquine|mesh-list
25172604|NCT02878200|Artenimol|artenimol|mesh-list
25172605|NCT02878200|Antimalarials|antimalarials|mesh-ancestor
25172606|NCT02878200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25172607|NCT02878200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25172608|NCT02878200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25172609|NCT02878291|Vaccines|vaccines|mesh-list
25172610|NCT02878291|Immunologic Factors|immunologic factors|mesh-ancestor
25860119|NCT00082797|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25860120|NCT00082797|Abortifacient Agents|abortifacient agents|mesh-ancestor
25860121|NCT00082797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25860122|NCT00082797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25860123|NCT00082797|Antimetabolites|antimetabolites|mesh-ancestor
25172920|NCT02876250|Cyclosporine|cyclosporine|mesh-list
24860281|NCT02308930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860282|NCT02308930|Protective Agents|protective agents|mesh-ancestor
24860283|NCT02308930|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24860284|NCT02308930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24540731|NCT00669435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540732|NCT00669435|Vasodilator Agents|vasodilator agents|mesh-ancestor
24540733|NCT00669435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24540734|NCT00669435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24540735|NCT00669435|Antimetabolites|antimetabolites|mesh-ancestor
24540736|NCT00669435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25876449|NCT03463460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24806575|NCT02016495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806576|NCT02016495|Vitamin B Complex|vitamin b complex|mesh-ancestor
24806577|NCT02016495|Vitamins|vitamins|mesh-ancestor
24806578|NCT02016495|Micronutrients|micronutrients|mesh-ancestor
24806579|NCT02016547|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24806580|NCT02016547|Abciximab|abciximab|mesh-list
24806581|NCT02016547|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24789287|NCT01936129|(T,G)-A-L|(t,g)-a-l|mesh-list
24970733|NCT03731169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24970734|NCT03731117|Furosemide|furosemide|mesh-list
24970735|NCT03731117|Diuretics|diuretics|mesh-ancestor
24794151|NCT05413863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794152|NCT05413772|Temocillin|temocillin|mesh-list
24794153|NCT05413772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25083188|NCT03317574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25083189|NCT03317574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083190|NCT03317574|Cholinergic Agents|cholinergic agents|mesh-ancestor
24970786|NCT03730857|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24970787|NCT03730766|Amoxicillin|amoxicillin|mesh-list
25083223|NCT03317236|Antidepressive Agents|antidepressive agents|mesh-ancestor
24807527|NCT02022488|Anesthetics|anesthetics|mesh-ancestor
24970788|NCT03730766|Metronidazole|metronidazole|mesh-list
24970807|NCT03730740|Lenalidomide|lenalidomide|mesh-list
24970808|NCT03730740|Immunologic Factors|immunologic factors|mesh-ancestor
24970809|NCT03730740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970810|NCT03730740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24970811|NCT03730740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24970812|NCT03730740|Growth Substances|growth substances|mesh-ancestor
24789434|NCT01937182|Citalopram|citalopram|mesh-list
24970867|NCT03730363|Pentamidine|pentamidine|mesh-list
24970868|NCT03730363|Antifungal Agents|antifungal agents|mesh-ancestor
24789539|NCT01937754|Antioxidants|antioxidants|mesh-ancestor
24970905|NCT03730064|Antidotes|antidotes|mesh-ancestor
24970906|NCT03730038|Pitavastatin|pitavastatin|mesh-list
24970907|NCT03730038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24970908|NCT03730038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24970944|NCT03729804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25083225|NCT03317236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24808102|NCT02025166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970979|NCT03729505|Sensory System Agents|sensory system agents|mesh-ancestor
24970980|NCT03729505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25665047|NCT01678976|Anticonvulsants|anticonvulsants|mesh-ancestor
24970981|NCT03729505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24970982|NCT03729505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24970983|NCT03729505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25426095|NCT02057133|Everolimus|everolimus|mesh-list
24602839|NCT00971152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24602862|NCT00971399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25073518|NCT03394430|Midazolam|midazolam|mesh-list
24970984|NCT03729505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25172611|NCT02878291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172612|NCT02878083|Adalimumab|adalimumab|mesh-list
25172613|NCT02878083|Vedolizumab|vedolizumab|mesh-list
25172614|NCT02878083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25172615|NCT02878083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25172616|NCT02878083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25172617|NCT02878265|Vitamins|vitamins|mesh-list
25172618|NCT02878265|Vitamin A|vitamin a|mesh-list
25172619|NCT02878265|Zinc|zinc|mesh-list
25172620|NCT02878265|Retinol palmitate|retinol palmitate|mesh-list
25172621|NCT02878265|Micronutrients|micronutrients|mesh-ancestor
25172622|NCT02878265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172623|NCT02878265|Trace Elements|trace elements|mesh-ancestor
25172624|NCT02878265|Antioxidants|antioxidants|mesh-ancestor
25172625|NCT02878265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172626|NCT02878265|Protective Agents|protective agents|mesh-ancestor
25172627|NCT02878265|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25860124|NCT00082797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172628|NCT02878265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172629|NCT02878161|Prednisone|prednisone|mesh-list
25172630|NCT02878161|Methylprednisolone|methylprednisolone|mesh-list
25172631|NCT02878161|Adalimumab|adalimumab|mesh-list
25172633|NCT02878161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25172634|NCT02878161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25172636|NCT02878161|Infliximab|infliximab|mesh-list
25172637|NCT02878161|Glucocorticoids|glucocorticoids|mesh-list
25172638|NCT02878161|Leflunomide|leflunomide|mesh-list
25172639|NCT02878161|Hormones|hormones|mesh-ancestor
25860125|NCT00082797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172640|NCT02878161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25172641|NCT02878161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172642|NCT02878161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25172643|NCT02878161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172644|NCT02878161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25172645|NCT02878161|Abortifacient Agents|abortifacient agents|mesh-ancestor
25172646|NCT02878161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25172647|NCT02878161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25172648|NCT02878161|Antimetabolites|antimetabolites|mesh-ancestor
25172649|NCT02878161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172650|NCT02878161|Dermatologic Agents|dermatologic agents|mesh-ancestor
25172651|NCT02878161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25172652|NCT02878161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25172653|NCT02878161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25172654|NCT02878161|Immunologic Factors|immunologic factors|mesh-ancestor
25172655|NCT02878161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25172656|NCT02878161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25172657|NCT02878161|Antiemetics|antiemetics|mesh-ancestor
25172658|NCT02878161|Autonomic Agents|autonomic agents|mesh-ancestor
25172659|NCT02878161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25172660|NCT02878161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25172661|NCT02878161|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25172662|NCT02878161|Protective Agents|protective agents|mesh-ancestor
25172663|NCT02878161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25172664|NCT02878161|Analgesics|analgesics|mesh-ancestor
25172665|NCT02878161|Sensory System Agents|sensory system agents|mesh-ancestor
25172666|NCT02878018|Hormones|hormones|mesh-list
25172667|NCT02878018|Adrenergic Agents|adrenergic agents|mesh-list
25172668|NCT02878018|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25172669|NCT02878018|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25172670|NCT02878018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25172671|NCT02878018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172672|NCT02878018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25172673|NCT02878018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172674|NCT02878018|Immunologic Factors|immunologic factors|mesh-ancestor
25172675|NCT02878018|Protease Inhibitors|protease inhibitors|mesh-ancestor
25051277|NCT00425100|Fesoterodine|fesoterodine|mesh-list
25172676|NCT02878018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25172677|NCT02878031|Amoxicillin|amoxicillin|mesh-list
25172678|NCT02878031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25172679|NCT02878031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25665048|NCT01678976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25665049|NCT01678976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24603170|NCT00972829|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24603171|NCT00972829|Ezetimibe|ezetimibe|mesh-list
24603172|NCT00972829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25172680|NCT02878122|Carboplatin|carboplatin|mesh-list
25172681|NCT02878122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172682|NCT02877901|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25172683|NCT02877901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25172684|NCT02877901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25172685|NCT02877901|Cholinergic Agents|cholinergic agents|mesh-ancestor
25172686|NCT02877901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25172687|NCT02877901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172688|NCT02877901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172689|NCT02877901|Urological Agents|urological agents|mesh-ancestor
25172690|NCT02877888|Fluorides|fluorides|mesh-list
25172691|NCT02877888|Fluorides, Topical|fluorides, topical|mesh-list
25172692|NCT02877888|Cariostatic Agents|cariostatic agents|mesh-ancestor
25172693|NCT02877888|Protective Agents|protective agents|mesh-ancestor
25172694|NCT02877888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172696|NCT02877615|GABA-A Receptor Antagonists|gaba-a receptor antagonists|mesh-ancestor
25172697|NCT02877615|GABA Antagonists|gaba antagonists|mesh-ancestor
25172698|NCT02877615|GABA Agents|gaba agents|mesh-ancestor
25172699|NCT02877615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25172700|NCT02877615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172701|NCT02877615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172702|NCT02877771|Insulin|insulin|mesh-list
25172703|NCT02877771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25172704|NCT02877771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172705|NCT02877537|Albuterol|albuterol|mesh-list
25172706|NCT02877537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25172707|NCT02877537|Autonomic Agents|autonomic agents|mesh-ancestor
25172708|NCT02877537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25172709|NCT02877537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172710|NCT02877537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25172711|NCT02877537|Respiratory System Agents|respiratory system agents|mesh-ancestor
25172712|NCT02877537|Tocolytic Agents|tocolytic agents|mesh-ancestor
25172713|NCT02877537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25172714|NCT02877537|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25172715|NCT02877537|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25172716|NCT02877537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25172717|NCT02877537|Adrenergic Agents|adrenergic agents|mesh-ancestor
25172718|NCT02877537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25172719|NCT02877537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172720|NCT02877511|Sunscreening Agents|sunscreening agents|mesh-list
25172721|NCT02877511|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25172722|NCT02877511|Protective Agents|protective agents|mesh-ancestor
25172723|NCT02877511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172724|NCT02877511|Dermatologic Agents|dermatologic agents|mesh-ancestor
25172725|NCT02877641|Vitamin D|vitamin d|mesh-list
25172726|NCT02877641|Cholecalciferol|cholecalciferol|mesh-list
25172727|NCT02877641|Vitamins|vitamins|mesh-list
25172728|NCT02877641|Micronutrients|micronutrients|mesh-ancestor
25172729|NCT02877641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172730|NCT02877641|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25172731|NCT02877641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25172732|NCT02877238|Sevoflurane|sevoflurane|mesh-list
25172733|NCT02877238|Anesthetics|anesthetics|mesh-ancestor
25172734|NCT02877238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25172735|NCT02877238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172736|NCT02877238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25172737|NCT02877238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25172738|NCT02877238|Anesthetics, General|anesthetics, general|mesh-ancestor
25172739|NCT02877173|Alprostadil|alprostadil|mesh-list
25172740|NCT02877173|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25172741|NCT02877173|Vasodilator Agents|vasodilator agents|mesh-ancestor
25172742|NCT02877173|Urological Agents|urological agents|mesh-ancestor
25172743|NCT02877277|Ascorbic Acid|ascorbic acid|mesh-list
25172744|NCT02877277|Vitamins|vitamins|mesh-ancestor
25172745|NCT02877277|Micronutrients|micronutrients|mesh-ancestor
25172746|NCT02877277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172747|NCT02877277|Antioxidants|antioxidants|mesh-ancestor
25172748|NCT02877277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665050|NCT01678976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25665051|NCT01678976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172749|NCT02877277|Protective Agents|protective agents|mesh-ancestor
25172750|NCT02877303|Cytarabine|cytarabine|mesh-list
25172751|NCT02877303|Dexamethasone|dexamethasone|mesh-list
25172752|NCT02877303|Dexamethasone acetate|dexamethasone acetate|mesh-list
25172753|NCT02877303|Prednisone|prednisone|mesh-list
25172754|NCT02877303|Cortisone|cortisone|mesh-list
25172755|NCT02877303|Cyclophosphamide|cyclophosphamide|mesh-list
25172756|NCT02877303|Rituximab|rituximab|mesh-list
25172757|NCT02877303|Doxorubicin|doxorubicin|mesh-list
25172758|NCT02877303|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25172759|NCT02877303|Methotrexate|methotrexate|mesh-list
25172760|NCT02877303|Vincristine|vincristine|mesh-list
25172761|NCT02877303|Mercaptopurine|mercaptopurine|mesh-list
25172762|NCT02877303|Ofatumumab|ofatumumab|mesh-list
25172763|NCT02877303|Blinatumomab|blinatumomab|mesh-list
25172764|NCT02877303|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25172765|NCT02877303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25172766|NCT02877303|Muromonab-CD3|muromonab-cd3|mesh-list
25172767|NCT02877303|Antibodies|antibodies|mesh-list
25172768|NCT02877303|Immunoglobulins|immunoglobulins|mesh-list
25172769|NCT02877303|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25172770|NCT02877303|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25172771|NCT02877303|BB 1101|bb 1101|mesh-list
25172772|NCT02877303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25172773|NCT02877303|Immunologic Factors|immunologic factors|mesh-ancestor
25172774|NCT02877303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172775|NCT02877303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25172776|NCT02877303|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25172777|NCT02877303|Alkylating Agents|alkylating agents|mesh-ancestor
25172778|NCT02877303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172779|NCT02877303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172780|NCT02877303|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25172781|NCT02877303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25172782|NCT02877303|Antiemetics|antiemetics|mesh-ancestor
25172783|NCT02877303|Autonomic Agents|autonomic agents|mesh-ancestor
25172784|NCT02877303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25172785|NCT02877303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25172786|NCT02877303|Glucocorticoids|glucocorticoids|mesh-ancestor
25172787|NCT02877303|Hormones|hormones|mesh-ancestor
25172788|NCT02877303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25172789|NCT02877303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25172790|NCT02877303|Protease Inhibitors|protease inhibitors|mesh-ancestor
25172791|NCT02877303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25172792|NCT02877303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25172793|NCT02877303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25172794|NCT02877303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25172795|NCT02877303|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25172796|NCT02877303|Abortifacient Agents|abortifacient agents|mesh-ancestor
24751034|NCT01701778|Analgesics|analgesics|mesh-ancestor
25172797|NCT02877303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25172798|NCT02877303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25172799|NCT02877303|Antimetabolites|antimetabolites|mesh-ancestor
25172800|NCT02877303|Dermatologic Agents|dermatologic agents|mesh-ancestor
25172801|NCT02877303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25172802|NCT02877303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25172803|NCT02877303|Antiviral Agents|antiviral agents|mesh-ancestor
25172804|NCT02877303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25172805|NCT02877303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25172806|NCT02877303|Tubulin Modulators|tubulin modulators|mesh-ancestor
25172807|NCT02877303|Antimitotic Agents|antimitotic agents|mesh-ancestor
25172808|NCT02877303|Mitosis Modulators|mitosis modulators|mesh-ancestor
25204063|NCT02711241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25204064|NCT02711241|Antipyretics|antipyretics|mesh-ancestor
25204065|NCT02711241|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25204066|NCT02711241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25204067|NCT02711241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204068|NCT02711241|Vasodilator Agents|vasodilator agents|mesh-ancestor
25204069|NCT02711241|Urological Agents|urological agents|mesh-ancestor
25204070|NCT02711059|Parathyroid Hormone|parathyroid hormone|mesh-list
25204071|NCT02711059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25204072|NCT02711059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207789|NCT03387657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207790|NCT03387657|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25207791|NCT03387657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25207792|NCT03332303|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25207793|NCT03332303|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25207794|NCT03332303|Estradiol|estradiol|mesh-list
25207795|NCT03332303|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25207796|NCT03332303|Estrogens|estrogens|mesh-ancestor
25207797|NCT03332303|Hormones|hormones|mesh-ancestor
25207798|NCT03332303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25207799|NCT03332303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207800|NCT03332303|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25207801|NCT03332303|Contraceptive Agents|contraceptive agents|mesh-ancestor
25207802|NCT03332303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25207803|NCT03332303|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25207804|NCT03312907|Rituximab|rituximab|mesh-list
25207805|NCT03312907|Belimumab|belimumab|mesh-list
25207806|NCT03312907|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25207807|NCT03312907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25207808|NCT03312907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207812|NCT03148756|Dalbavancin|dalbavancin|mesh-list
25207813|NCT03148756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25207814|NCT03148756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25207815|NCT03079102|Nitric Oxide|nitric oxide|mesh-list
25207816|NCT03079102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25207817|NCT03079102|Autonomic Agents|autonomic agents|mesh-ancestor
25207818|NCT03079102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25207819|NCT03079102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207820|NCT03079102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25207821|NCT03079102|Respiratory System Agents|respiratory system agents|mesh-ancestor
25207822|NCT03079102|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24654698|NCT01251029|Expectorants|expectorants|mesh-ancestor
25207823|NCT03079102|Antioxidants|antioxidants|mesh-ancestor
24541078|NCT00670722|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24541079|NCT00670722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24541080|NCT00670722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541081|NCT00670761|Misoprostol|misoprostol|mesh-list
24541082|NCT00670761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24541083|NCT00670761|Abortifacient Agents|abortifacient agents|mesh-ancestor
24541084|NCT00670761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25860126|NCT00082797|Dermatologic Agents|dermatologic agents|mesh-ancestor
25860127|NCT00082797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860128|NCT00082797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25860129|NCT00082797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25860130|NCT00082797|Immunologic Factors|immunologic factors|mesh-ancestor
25860131|NCT00082797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25860132|NCT00082797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25860133|NCT00082797|Antidotes|antidotes|mesh-ancestor
25860134|NCT00082797|Protective Agents|protective agents|mesh-ancestor
25860135|NCT00082797|Vitamin B Complex|vitamin b complex|mesh-ancestor
25860136|NCT00082797|Vitamins|vitamins|mesh-ancestor
24794291|NCT05304533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24794292|NCT05304533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24794293|NCT05304533|Vasodilator Agents|vasodilator agents|mesh-ancestor
24971050|NCT03728946|Anesthetics|anesthetics|mesh-ancestor
24971051|NCT03728946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24971052|NCT03728946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971053|NCT03728946|Sensory System Agents|sensory system agents|mesh-ancestor
24971054|NCT03728946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24971091|NCT03728777|Resveratrol|resveratrol|mesh-list
24971092|NCT03728777|Antioxidants|antioxidants|mesh-ancestor
25082424|NCT03322878|Tocolytic Agents|tocolytic agents|mesh-ancestor
24971171|NCT03727763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24971303|NCT03726749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24971305|NCT03726736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24971306|NCT03726736|Tubulin Modulators|tubulin modulators|mesh-ancestor
24971307|NCT03726736|Antimitotic Agents|antimitotic agents|mesh-ancestor
24971308|NCT03726736|Mitosis Modulators|mitosis modulators|mesh-ancestor
24971309|NCT03726736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971310|NCT03726593|Artesunate|artesunate|mesh-list
24808118|NCT02025218|Gefitinib|gefitinib|mesh-list
24808119|NCT02025218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808120|NCT02025218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24808121|NCT02025218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808122|NCT02025218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628443|NCT01099059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24628444|NCT01099059|Antiviral Agents|antiviral agents|mesh-ancestor
24628445|NCT01099059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24603191|NCT00972855|Bicalutamide|bicalutamide|mesh-list
24808365|NCT02026778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24808366|NCT02026778|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24808367|NCT02026778|Vasodilator Agents|vasodilator agents|mesh-ancestor
24808368|NCT02026778|Histamine Agonists|histamine agonists|mesh-ancestor
24808369|NCT02026778|Histamine Agents|histamine agents|mesh-ancestor
25860137|NCT00082797|Micronutrients|micronutrients|mesh-ancestor
25172809|NCT02876991|Listerine|listerine|mesh-list
25172810|NCT02876991|Fluorides|fluorides|mesh-list
25172811|NCT02876991|Sodium Fluoride|sodium fluoride|mesh-list
25172812|NCT02876991|Cariostatic Agents|cariostatic agents|mesh-ancestor
25172813|NCT02876991|Protective Agents|protective agents|mesh-ancestor
25172814|NCT02876991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172815|NCT02876991|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25172816|NCT02876991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25172818|NCT02876770|Antioxidants|antioxidants|mesh-ancestor
25172819|NCT02876770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172820|NCT02876770|Protective Agents|protective agents|mesh-ancestor
25172821|NCT02876770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172822|NCT02876770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25172823|NCT02876822|Vitamin D|vitamin d|mesh-list
25172824|NCT02876822|Cholecalciferol|cholecalciferol|mesh-list
25172825|NCT02876822|Vitamins|vitamins|mesh-ancestor
25172826|NCT02876822|Micronutrients|micronutrients|mesh-ancestor
25172827|NCT02876822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172828|NCT02876822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25204073|NCT02711007|Apatinib|apatinib|mesh-list
24655171|NCT00660673|Immunologic Factors|immunologic factors|mesh-ancestor
25172829|NCT02876822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25172830|NCT02876718|Rivaroxaban|rivaroxaban|mesh-list
25172831|NCT02876718|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25172832|NCT02876718|Antithrombins|antithrombins|mesh-ancestor
25172833|NCT02876718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25172834|NCT02876718|Protease Inhibitors|protease inhibitors|mesh-ancestor
25172835|NCT02876718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25172836|NCT02876718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172837|NCT02876718|Anticoagulants|anticoagulants|mesh-ancestor
25172838|NCT02876978|Cyclophosphamide|cyclophosphamide|mesh-list
25172839|NCT02876978|Fludarabine|fludarabine|mesh-list
25172840|NCT02876978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25172841|NCT02876978|Immunologic Factors|immunologic factors|mesh-ancestor
25172842|NCT02876978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172843|NCT02876978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25172844|NCT02876978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25172845|NCT02876978|Alkylating Agents|alkylating agents|mesh-ancestor
25172846|NCT02876978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172847|NCT02876978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172848|NCT02876978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25172849|NCT02876679|Cyclosporine|cyclosporine|mesh-list
25172850|NCT02876679|Mycophenolic Acid|mycophenolic acid|mesh-list
25172851|NCT02876679|Cyclophosphamide|cyclophosphamide|mesh-list
25172852|NCT02876679|Cyclosporins|cyclosporins|mesh-list
25172853|NCT02876679|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25172854|NCT02876679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25172855|NCT02876679|Immunologic Factors|immunologic factors|mesh-ancestor
25172856|NCT02876679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172857|NCT02876679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25172858|NCT02876679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25172859|NCT02876679|Alkylating Agents|alkylating agents|mesh-ancestor
25172860|NCT02876679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172861|NCT02876679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172862|NCT02876679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25172863|NCT02876679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25172864|NCT02876679|Antifungal Agents|antifungal agents|mesh-ancestor
25172865|NCT02876679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25172866|NCT02876679|Dermatologic Agents|dermatologic agents|mesh-ancestor
25172867|NCT02876679|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25172868|NCT02876679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25172869|NCT02876679|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25172870|NCT02876679|Antitubercular Agents|antitubercular agents|mesh-ancestor
25172871|NCT02876679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25172872|NCT02876796|Firsocostat|firsocostat|mesh-list
25172873|NCT02876796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25172874|NCT02876796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172875|NCT02876549|Chloroquine|chloroquine|mesh-list
25172877|NCT02876549|Amebicides|amebicides|mesh-ancestor
25172878|NCT02876549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25172879|NCT02876549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25172880|NCT02876549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25172881|NCT02876549|Antimalarials|antimalarials|mesh-ancestor
25172882|NCT02876549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25172884|NCT02876432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25172885|NCT02876432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25172886|NCT02876432|Analgesics|analgesics|mesh-ancestor
25172887|NCT02876432|Sensory System Agents|sensory system agents|mesh-ancestor
25172888|NCT02876432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25172889|NCT02876432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172893|NCT02876432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25172894|NCT02876432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172895|NCT02876276|Hyaluronic Acid|hyaluronic acid|mesh-list
25172896|NCT02876276|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25172897|NCT02876276|Immunologic Factors|immunologic factors|mesh-ancestor
25172898|NCT02876276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172899|NCT02876276|Viscosupplements|viscosupplements|mesh-ancestor
25172900|NCT02876276|Protective Agents|protective agents|mesh-ancestor
25172901|NCT02876354|Vitamin K|vitamin k|mesh-list
25172902|NCT02876354|Vitamin K 2|vitamin k 2|mesh-list
25172903|NCT02876354|Vitamins|vitamins|mesh-ancestor
25172904|NCT02876354|Micronutrients|micronutrients|mesh-ancestor
25172905|NCT02876354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172906|NCT02876354|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25172907|NCT02876354|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25172908|NCT02876354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172909|NCT02876354|Hemostatics|hemostatics|mesh-ancestor
25172910|NCT02876354|Coagulants|coagulants|mesh-ancestor
25172911|NCT02876224|Bevacizumab|bevacizumab|mesh-list
25172912|NCT02876224|Atezolizumab|atezolizumab|mesh-list
25172913|NCT02876224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25172914|NCT02876224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172915|NCT02876224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25172916|NCT02876224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25172917|NCT02876224|Growth Substances|growth substances|mesh-ancestor
25172918|NCT02876224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172919|NCT02876224|Growth Inhibitors|growth inhibitors|mesh-ancestor
24751318|NCT01703390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751320|NCT01703455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751321|NCT01703455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24751322|NCT01703455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24751323|NCT01703455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751324|NCT01703468|Oxcarbazepine|oxcarbazepine|mesh-list
24751325|NCT01703468|Anticonvulsants|anticonvulsants|mesh-ancestor
24751326|NCT01703468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24751327|NCT01703468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25172921|NCT02876250|Cyclosporins|cyclosporins|mesh-list
25172922|NCT02876250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25172923|NCT02876250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172924|NCT02876250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25172925|NCT02876250|Immunologic Factors|immunologic factors|mesh-ancestor
25172926|NCT02876250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172927|NCT02876250|Antifungal Agents|antifungal agents|mesh-ancestor
25172928|NCT02876250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25172929|NCT02876250|Dermatologic Agents|dermatologic agents|mesh-ancestor
25172930|NCT02876250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25172931|NCT02876250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25172932|NCT02876484|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
25172933|NCT02876484|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
25172934|NCT02876484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25172935|NCT02876484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25172936|NCT02876484|Antimetabolites|antimetabolites|mesh-ancestor
25172937|NCT02876484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172938|NCT02876484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25172939|NCT02876484|Cathartics|cathartics|mesh-ancestor
25172940|NCT02876484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25172946|NCT02876094|Celecoxib|celecoxib|mesh-list
25172947|NCT02876094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25172948|NCT02876094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25172949|NCT02876094|Analgesics|analgesics|mesh-ancestor
25172950|NCT02876094|Sensory System Agents|sensory system agents|mesh-ancestor
25172951|NCT02876094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25172952|NCT02876094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172953|NCT02876094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25172954|NCT02876094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25172955|NCT02876094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25172956|NCT02876094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25172957|NCT02876094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25172958|NCT02876094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172959|NCT02876081|Afatinib|afatinib|mesh-list
25172960|NCT02876081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25172961|NCT02876081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25172962|NCT02876081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25172963|NCT02876081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172964|NCT02876146|Albendazole|albendazole|mesh-list
25172965|NCT02876146|Benzimidazole|benzimidazole|mesh-list
25172966|NCT02876146|Anthelmintics|anthelmintics|mesh-ancestor
25172967|NCT02876146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25172968|NCT02876146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25172969|NCT02876146|Anticestodal Agents|anticestodal agents|mesh-ancestor
25172970|NCT02876146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24751410|NCT01703910|Immunologic Factors|immunologic factors|mesh-ancestor
25172971|NCT02876146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25172972|NCT02876146|Tubulin Modulators|tubulin modulators|mesh-ancestor
25172973|NCT02876146|Antimitotic Agents|antimitotic agents|mesh-ancestor
25172974|NCT02876146|Mitosis Modulators|mitosis modulators|mesh-ancestor
25172975|NCT02876146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172976|NCT02876146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655584|NCT01257373|Cobalt|cobalt|mesh-list
25172977|NCT02875756|Ivermectin|ivermectin|mesh-list
25172978|NCT02875756|Selamectin|selamectin|mesh-list
25172979|NCT02875756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25172980|NCT02875756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25172981|NCT02875743|Posaconazole|posaconazole|mesh-list
25172982|NCT02875743|Antifungal Agents|antifungal agents|mesh-ancestor
25172983|NCT02875743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25172984|NCT02875743|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25172985|NCT02875743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25172986|NCT02875743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25172987|NCT02875743|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25172988|NCT02875743|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25172989|NCT02875743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25172990|NCT02875743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25172991|NCT02875743|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25172992|NCT02875743|Hormone Antagonists|hormone antagonists|mesh-ancestor
25172993|NCT02875743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25172994|NCT02875743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25172995|NCT02875821|Metformin|metformin|mesh-list
25172996|NCT02875821|Pioglitazone|pioglitazone|mesh-list
25172997|NCT02875821|Ipragliflozin|ipragliflozin|mesh-list
25172998|NCT02875821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25172999|NCT02875821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173000|NCT02875821|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25173001|NCT02875821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173002|NCT02875886|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25173003|NCT02875886|Amiloride|amiloride|mesh-list
25173004|NCT02875886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25173005|NCT02875886|Diuretics|diuretics|mesh-ancestor
25173006|NCT02875886|Natriuretic Agents|natriuretic agents|mesh-ancestor
25173007|NCT02875886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173008|NCT02875886|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25173009|NCT02875886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25173010|NCT02875886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173011|NCT02875886|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
25173012|NCT02875886|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25173013|NCT02875886|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
25173014|NCT02875886|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25173015|NCT02875873|Methamphetamine|methamphetamine|mesh-list
25173016|NCT02875873|Plasma-lyte 148|plasma-lyte 148|mesh-list
25173017|NCT02875873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25173018|NCT02875873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173019|NCT02875873|Sympathomimetics|sympathomimetics|mesh-ancestor
25173020|NCT02875873|Autonomic Agents|autonomic agents|mesh-ancestor
25173021|NCT02875873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25173022|NCT02875873|Dopamine Agents|dopamine agents|mesh-ancestor
25173023|NCT02875873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25173024|NCT02875873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173025|NCT02875873|Adrenergic Agents|adrenergic agents|mesh-ancestor
25173026|NCT02875873|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25173027|NCT02875873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25173028|NCT02875873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24751459|NCT01704469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751460|NCT01704469|Sensory System Agents|sensory system agents|mesh-ancestor
24751465|NCT01704482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24751466|NCT01704482|Expectorants|expectorants|mesh-ancestor
24751467|NCT01704482|Respiratory System Agents|respiratory system agents|mesh-ancestor
24604718|NCT00981318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24751468|NCT01704482|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24751469|NCT01704482|Antioxidants|antioxidants|mesh-ancestor
24751470|NCT01704482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751471|NCT01704482|Protective Agents|protective agents|mesh-ancestor
24751472|NCT01704482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751473|NCT01704482|Antidotes|antidotes|mesh-ancestor
24751474|NCT01704508|Lumefantrine|lumefantrine|mesh-list
24751476|NCT01704508|Piperaquine|piperaquine|mesh-list
24751487|NCT01704612|Anesthetics|anesthetics|mesh-ancestor
25173029|NCT02875873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25173030|NCT02875873|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25173031|NCT02875873|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25173032|NCT02875457|Cisplatin|cisplatin|mesh-list
25173033|NCT02875457|Etoposide|etoposide|mesh-list
25173034|NCT02875457|Etoposide phosphate|etoposide phosphate|mesh-list
25173035|NCT02875457|Apatinib|apatinib|mesh-list
25173036|NCT02875457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25173037|NCT02875457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25173038|NCT02875457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25173039|NCT02875457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25173040|NCT02875457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25173041|NCT02875457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173042|NCT02875457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25173043|NCT02875587|Cabergoline|cabergoline|mesh-list
25173044|NCT02875587|Calcium|calcium|mesh-list
25173045|NCT02875587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25173046|NCT02875587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173047|NCT02875587|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25173048|NCT02875587|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25173049|NCT02875587|Dopamine Agonists|dopamine agonists|mesh-ancestor
24808373|NCT02026817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808374|NCT02026817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24808375|NCT02026817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24808376|NCT02026817|Antimetabolites|antimetabolites|mesh-ancestor
24808377|NCT02026817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808378|NCT02026817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24808379|NCT02026817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24808380|NCT02026817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808381|NCT02026856|Selenious Acid|selenious acid|mesh-list
24808382|NCT02026856|Sodium Selenite|sodium selenite|mesh-list
24808383|NCT02026856|Trace Elements|trace elements|mesh-ancestor
24808384|NCT02026856|Micronutrients|micronutrients|mesh-ancestor
24808385|NCT02026856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971402|NCT03726177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971403|NCT03726177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24971484|NCT03725891|Sensory System Agents|sensory system agents|mesh-ancestor
24971485|NCT03725891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24808505|NCT02027493|Interferons|interferons|mesh-list
24971647|NCT03723395|GABA Agents|gaba agents|mesh-ancestor
24971648|NCT03723395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24789778|NCT01939093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24971744|NCT03723031|Oxytocics|oxytocics|mesh-ancestor
24971745|NCT03722940|Magnesium Sulfate|magnesium sulfate|mesh-list
24971746|NCT03722940|Analgesics|analgesics|mesh-ancestor
24971747|NCT03722940|Sensory System Agents|sensory system agents|mesh-ancestor
24930486|NCT04101370|Bosentan|bosentan|mesh-list
24971780|NCT03722498|Leucovorin|leucovorin|mesh-list
24971781|NCT03722498|Fluorouracil|fluorouracil|mesh-list
24971782|NCT03722498|Oxaliplatin|oxaliplatin|mesh-list
24971783|NCT03722498|Sorafenib|sorafenib|mesh-list
24971784|NCT03722498|Antimetabolites|antimetabolites|mesh-ancestor
25173116|NCT02874989|Quercetin|quercetin|mesh-list
24971785|NCT03722498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971786|NCT03722498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24971787|NCT03722498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789841|NCT01939444|Naloxone|naloxone|mesh-list
24930647|NCT04099238|Rivaroxaban|rivaroxaban|mesh-list
24972005|NCT03720873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24972006|NCT03720873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24794421|NCT05233709|Urological Agents|urological agents|mesh-ancestor
24794422|NCT05216952|Misoprostol|misoprostol|mesh-list
24794423|NCT05216952|Ulipristal acetate|ulipristal acetate|mesh-list
24794424|NCT05216952|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24794425|NCT05216952|Abortifacient Agents|abortifacient agents|mesh-ancestor
25665052|NCT01678976|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24628063|NCT01096472|Octenidine|octenidine|mesh-list
24972544|NCT03716804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604850|NCT00981929|Omeprazole|omeprazole|mesh-list
24972545|NCT03716804|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24972546|NCT03716804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24972547|NCT03716804|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24972548|NCT03716804|Renal Agents|renal agents|mesh-ancestor
24972549|NCT03716791|Dimethyl sulfone|dimethyl sulfone|mesh-list
24972550|NCT03716791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24972551|NCT03716765|Vitamin D|vitamin d|mesh-list
24972552|NCT03716765|Vitamins|vitamins|mesh-ancestor
24972553|NCT03716765|Micronutrients|micronutrients|mesh-ancestor
25173050|NCT02875587|Dopamine Agents|dopamine agents|mesh-ancestor
25173051|NCT02875587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25173052|NCT02875587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173053|NCT02875717|Aspirin|aspirin|mesh-list
25173054|NCT02875717|Heparin|heparin|mesh-list
25173055|NCT02875717|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25173056|NCT02875717|Tinzaparin|tinzaparin|mesh-list
25173057|NCT02875717|Dalteparin|dalteparin|mesh-list
25173058|NCT02875717|Anticoagulants|anticoagulants|mesh-ancestor
25173059|NCT02875717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25173060|NCT02875717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25173061|NCT02875717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173062|NCT02875717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25173063|NCT02875717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25173064|NCT02875717|Analgesics|analgesics|mesh-ancestor
25173065|NCT02875717|Sensory System Agents|sensory system agents|mesh-ancestor
25173066|NCT02875717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25173067|NCT02875717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173068|NCT02875717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25173069|NCT02875717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24751610|NCT01705158|Doxorubicin|doxorubicin|mesh-list
25173070|NCT02875717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25173071|NCT02875717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25173072|NCT02875717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25173073|NCT02875717|Antipyretics|antipyretics|mesh-ancestor
25204074|NCT02711007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25204075|NCT02711007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25204076|NCT02711007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25204077|NCT02711007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204078|NCT02710877|Sufentanil|sufentanil|mesh-list
25204079|NCT02710877|Dsuvia|dsuvia|mesh-list
25204080|NCT02710877|Levobupivacaine|levobupivacaine|mesh-list
25204081|NCT02710877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25204082|NCT02710877|Narcotics|narcotics|mesh-ancestor
25204083|NCT02710877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25204084|NCT02710877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204085|NCT02710877|Analgesics|analgesics|mesh-ancestor
25204086|NCT02710877|Sensory System Agents|sensory system agents|mesh-ancestor
25204087|NCT02710877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204088|NCT02710877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25204089|NCT02710877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25204090|NCT02710877|Anesthetics, General|anesthetics, general|mesh-ancestor
25204091|NCT02710877|Anesthetics|anesthetics|mesh-ancestor
25204092|NCT02710877|Anesthetics, Local|anesthetics, local|mesh-ancestor
25204093|NCT02710656|Paclitaxel|paclitaxel|mesh-list
25204094|NCT02710656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25204095|NCT02710656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25204096|NCT02710656|Tubulin Modulators|tubulin modulators|mesh-ancestor
25204097|NCT02710656|Antimitotic Agents|antimitotic agents|mesh-ancestor
25204098|NCT02710656|Mitosis Modulators|mitosis modulators|mesh-ancestor
25204099|NCT02710656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204100|NCT02710539|Amlodipine|amlodipine|mesh-list
25204101|NCT02710539|Perindopril|perindopril|mesh-list
25204102|NCT02710539|Indapamide|indapamide|mesh-list
25204103|NCT02710539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25204104|NCT02710539|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25204105|NCT02710539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25204106|NCT02710539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204107|NCT02710539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25204108|NCT02710539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204109|NCT02710539|Vasodilator Agents|vasodilator agents|mesh-ancestor
25204110|NCT02710539|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25665053|NCT01678976|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25204111|NCT02710539|Protease Inhibitors|protease inhibitors|mesh-ancestor
25204112|NCT02710539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25204113|NCT02710539|Diuretics|diuretics|mesh-ancestor
25204114|NCT02710539|Natriuretic Agents|natriuretic agents|mesh-ancestor
25204115|NCT02710539|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25204116|NCT02710604|Tenofovir|tenofovir|mesh-list
25204117|NCT02710604|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
25204118|NCT02710604|Antiviral Agents|antiviral agents|mesh-ancestor
25204119|NCT02710604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25204120|NCT02710604|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25204121|NCT02710604|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25204122|NCT02710604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25204123|NCT02710604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204124|NCT02710604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25204125|NCT02710604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25204126|NCT02710552|Amlodipine|amlodipine|mesh-list
25204127|NCT02710552|Antihypertensive Agents|antihypertensive agents|mesh-list
25204128|NCT02710552|Perindopril|perindopril|mesh-list
25204129|NCT02710552|Indapamide|indapamide|mesh-list
25204130|NCT02710552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25204131|NCT02710552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25204132|NCT02710552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204133|NCT02710552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25860138|NCT00082823|Aflibercept|aflibercept|mesh-list
25173074|NCT02875262|Deferoxamine|deferoxamine|mesh-list
25173075|NCT02875262|Siderophores|siderophores|mesh-ancestor
25173076|NCT02875262|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25173077|NCT02875262|Chelating Agents|chelating agents|mesh-ancestor
25173078|NCT02875262|Sequestering Agents|sequestering agents|mesh-ancestor
25173079|NCT02875262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173080|NCT02875093|Cytarabine|cytarabine|mesh-list
25173081|NCT02875093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25173082|NCT02875093|Antimetabolites|antimetabolites|mesh-ancestor
25173083|NCT02875093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173084|NCT02875093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25173085|NCT02875093|Antiviral Agents|antiviral agents|mesh-ancestor
25173086|NCT02875093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25173087|NCT02875093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25173088|NCT02875093|Immunologic Factors|immunologic factors|mesh-ancestor
25173089|NCT02875093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173090|NCT02875288|Bupivacaine|bupivacaine|mesh-list
25173091|NCT02875288|Anesthetics, Local|anesthetics, local|mesh-ancestor
25173092|NCT02875288|Anesthetics|anesthetics|mesh-ancestor
25173093|NCT02875288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25173094|NCT02875288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173095|NCT02875288|Sensory System Agents|sensory system agents|mesh-ancestor
25173096|NCT02875288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25173097|NCT02875015|Lidocaine|lidocaine|mesh-list
25173098|NCT02875015|Bupivacaine|bupivacaine|mesh-list
25173099|NCT02875015|Anesthetics, Local|anesthetics, local|mesh-ancestor
25173100|NCT02875015|Anesthetics|anesthetics|mesh-ancestor
25173101|NCT02875015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25173102|NCT02875015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173103|NCT02875015|Sensory System Agents|sensory system agents|mesh-ancestor
25173104|NCT02875015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25173105|NCT02875015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25173106|NCT02875015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25173107|NCT02875015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25173108|NCT02875015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25173109|NCT02875015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173110|NCT02875002|Belinostat|belinostat|mesh-list
25173111|NCT02875002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25173112|NCT02875002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25173113|NCT02875002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25173114|NCT02875002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173115|NCT02874989|Dasatinib|dasatinib|mesh-list
25173117|NCT02874989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25173118|NCT02874989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25173119|NCT02874989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25173120|NCT02874989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173121|NCT02874989|Antioxidants|antioxidants|mesh-ancestor
25173122|NCT02874989|Protective Agents|protective agents|mesh-ancestor
25173123|NCT02874989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173124|NCT02874963|Ethanol|ethanol|mesh-list
25173125|NCT02874963|Listerine|listerine|mesh-list
25173126|NCT02874963|Thymol|thymol|mesh-list
25173127|NCT02874963|Eucalyptol|eucalyptol|mesh-list
25173128|NCT02874963|Salicylates|salicylates|mesh-list
24605224|NCT00983944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24605225|NCT00983944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25173129|NCT02874963|Methyl salicylate|methyl salicylate|mesh-list
25173130|NCT02874963|Menthol|menthol|mesh-list
25173131|NCT02874963|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25173132|NCT02874963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25173133|NCT02874963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25173134|NCT02874963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173135|NCT02874963|Antipruritics|antipruritics|mesh-ancestor
25173136|NCT02874963|Dermatologic Agents|dermatologic agents|mesh-ancestor
25173137|NCT02874963|Protective Agents|protective agents|mesh-ancestor
25173138|NCT02874963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25173139|NCT02874963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25173140|NCT02874963|Analgesics|analgesics|mesh-ancestor
25173141|NCT02874963|Sensory System Agents|sensory system agents|mesh-ancestor
25173142|NCT02874963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25173143|NCT02874963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25173144|NCT02874963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25173145|NCT02874963|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25173146|NCT02874963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25173147|NCT02874963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173148|NCT02874963|Antifungal Agents|antifungal agents|mesh-ancestor
25173149|NCT02874963|Antitussive Agents|antitussive agents|mesh-ancestor
25173150|NCT02874963|Respiratory System Agents|respiratory system agents|mesh-ancestor
25173151|NCT02874963|Insect Repellents|insect repellents|mesh-ancestor
25173152|NCT02874768|Dexmedetomidine|dexmedetomidine|mesh-list
25173153|NCT02874768|Propofol|propofol|mesh-list
25173154|NCT02874768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25173155|NCT02874768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25173156|NCT02874768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173157|NCT02874768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25173158|NCT02874768|Anesthetics, General|anesthetics, general|mesh-ancestor
25173159|NCT02874768|Anesthetics|anesthetics|mesh-ancestor
25173160|NCT02874768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25173161|NCT02874768|Analgesics|analgesics|mesh-ancestor
25173162|NCT02874768|Sensory System Agents|sensory system agents|mesh-ancestor
25173163|NCT02874768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25173164|NCT02874768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25173165|NCT02874768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25173166|NCT02874768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25173167|NCT02874768|Adrenergic Agents|adrenergic agents|mesh-ancestor
25173168|NCT02874768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25173169|NCT02874768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173170|NCT02874586|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25173171|NCT02874586|Immunologic Factors|immunologic factors|mesh-ancestor
25173172|NCT02874586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173173|NCT02874690|Methylphenidate|methylphenidate|mesh-list
25173174|NCT02874690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25173175|NCT02874690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173176|NCT02874690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25173177|NCT02874690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25173178|NCT02874690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25173179|NCT02874690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173180|NCT02874690|Dopamine Agents|dopamine agents|mesh-ancestor
25173181|NCT02874690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25173182|NCT02874807|Empagliflozin|empagliflozin|mesh-list
24751867|NCT01706887|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24751868|NCT01706887|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25173183|NCT02874807|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25173184|NCT02874807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173185|NCT02874807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25173186|NCT02874807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173187|NCT02874729|Dimercaprol|dimercaprol|mesh-list
25173188|NCT02874729|Chelating Agents|chelating agents|mesh-ancestor
25173189|NCT02874729|Sequestering Agents|sequestering agents|mesh-ancestor
25173190|NCT02874729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173191|NCT02874820|Idazoxan|idazoxan|mesh-list
25173192|NCT02874820|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25173193|NCT02874820|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25665054|NCT01679002|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25665055|NCT01679002|Oxcarbazepine|oxcarbazepine|mesh-list
25665056|NCT01679002|Anticonvulsants|anticonvulsants|mesh-ancestor
25173199|NCT02874378|Dexmedetomidine|dexmedetomidine|mesh-list
25173200|NCT02874378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25173201|NCT02874378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25173202|NCT02874378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173203|NCT02874378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25173204|NCT02874378|Analgesics|analgesics|mesh-ancestor
25173205|NCT02874378|Sensory System Agents|sensory system agents|mesh-ancestor
25173206|NCT02874378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25173207|NCT02874378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25173208|NCT02874378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25173209|NCT02874378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25173210|NCT02874378|Adrenergic Agents|adrenergic agents|mesh-ancestor
25173211|NCT02874378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25173212|NCT02874378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173213|NCT02874326|Octreotide|octreotide|mesh-list
25173214|NCT02874326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25173215|NCT02874326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25173216|NCT02874326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25173217|NCT02874287|Hydroxychloroquine|hydroxychloroquine|mesh-list
25173218|NCT02874287|Antimalarials|antimalarials|mesh-ancestor
25173219|NCT02874287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25173220|NCT02874287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25173221|NCT02874287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25173222|NCT02874287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25173223|NCT02874287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173224|NCT02874287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25173225|NCT02874248|Drospirenone|drospirenone|mesh-list
25173226|NCT02874248|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25173227|NCT02874248|Hormone Antagonists|hormone antagonists|mesh-ancestor
25173228|NCT02874248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25173229|NCT02874248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173230|NCT02874248|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25173231|NCT02874248|Diuretics|diuretics|mesh-ancestor
25173232|NCT02874248|Natriuretic Agents|natriuretic agents|mesh-ancestor
25173233|NCT02873598|Gemcitabine|gemcitabine|mesh-list
25173234|NCT02873598|Paclitaxel|paclitaxel|mesh-list
25173235|NCT02873598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25173236|NCT02873598|Folfirinox|folfirinox|mesh-list
25173237|NCT02873598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25173238|NCT02873598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25173239|NCT02873598|Tubulin Modulators|tubulin modulators|mesh-ancestor
25173240|NCT02873598|Antimitotic Agents|antimitotic agents|mesh-ancestor
25173241|NCT02873598|Mitosis Modulators|mitosis modulators|mesh-ancestor
25173242|NCT02873598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173243|NCT02873598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25173244|NCT02873598|Antimetabolites|antimetabolites|mesh-ancestor
25665060|NCT01679002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665061|NCT01679002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25665062|NCT01679002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25665063|NCT01679405|Gemcitabine|gemcitabine|mesh-list
24605482|NCT00985374|Everolimus|everolimus|mesh-list
25173245|NCT02873598|Antiviral Agents|antiviral agents|mesh-ancestor
25173246|NCT02873598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25173247|NCT02873598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25173248|NCT02873598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25173249|NCT02873598|Immunologic Factors|immunologic factors|mesh-ancestor
25173250|NCT02873598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204141|NCT02710552|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25173273|NCT02873559|Testosterone|testosterone|mesh-list
25173274|NCT02873559|Androgens|androgens|mesh-ancestor
25173275|NCT02873559|Hormones|hormones|mesh-ancestor
25173276|NCT02873559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25173277|NCT02873559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173278|NCT02874313|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25173279|NCT02874313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173280|NCT02873871|Hemostatics|hemostatics|mesh-list
25173281|NCT02873871|Coagulants|coagulants|mesh-ancestor
25173282|NCT02873273|Dexamethasone|dexamethasone|mesh-list
25173283|NCT02873273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25173284|NCT02873273|Antiemetics|antiemetics|mesh-ancestor
25173285|NCT02873273|Autonomic Agents|autonomic agents|mesh-ancestor
25173286|NCT02873273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25173287|NCT02873273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173288|NCT02873273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25173289|NCT02873273|Glucocorticoids|glucocorticoids|mesh-ancestor
25173290|NCT02873273|Hormones|hormones|mesh-ancestor
25173291|NCT02873273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25173292|NCT02873273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25173293|NCT02873273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25173294|NCT02873325|Antiviral Agents|antiviral agents|mesh-list
25173295|NCT02873325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25173296|NCT02873234|Antidepressive Agents|antidepressive agents|mesh-list
25173297|NCT02873234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25173298|NCT02873364|Vitamin D|vitamin d|mesh-list
25173299|NCT02873364|Ergocalciferols|ergocalciferols|mesh-list
24752016|NCT01707823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25173300|NCT02873364|Cholecalciferol|cholecalciferol|mesh-list
25173301|NCT02873364|Vitamins|vitamins|mesh-list
25173302|NCT02873364|Micronutrients|micronutrients|mesh-ancestor
25173303|NCT02873364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173304|NCT02873364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25173305|NCT02873364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25173306|NCT02873351|Levodopa|levodopa|mesh-list
25173307|NCT02873351|Carbidopa|carbidopa|mesh-list
25173311|NCT02873351|Dopamine Agents|dopamine agents|mesh-ancestor
25173312|NCT02873351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25173313|NCT02873351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173314|NCT02873351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173315|NCT02873351|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25173316|NCT02873351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25173317|NCT02873351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25173318|NCT02873351|Immunologic Factors|immunologic factors|mesh-ancestor
25173319|NCT02873351|Dopamine Agonists|dopamine agonists|mesh-ancestor
25173320|NCT02873091|Sufentanil|sufentanil|mesh-list
25173321|NCT02873091|Ropivacaine|ropivacaine|mesh-list
25173322|NCT02873091|Anesthetics, Local|anesthetics, local|mesh-ancestor
25173323|NCT02873091|Anesthetics|anesthetics|mesh-ancestor
25173324|NCT02873091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25173325|NCT02873091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752062|NCT01708005|Vitamins|vitamins|mesh-ancestor
24752063|NCT01708005|Micronutrients|micronutrients|mesh-ancestor
24752064|NCT01708005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752065|NCT01708005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25173326|NCT02873091|Sensory System Agents|sensory system agents|mesh-ancestor
25173327|NCT02873091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25173328|NCT02873091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25173329|NCT02873091|Narcotics|narcotics|mesh-ancestor
25173330|NCT02873091|Analgesics|analgesics|mesh-ancestor
25173331|NCT02873091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25173332|NCT02873091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25173333|NCT02873091|Anesthetics, General|anesthetics, general|mesh-ancestor
25173334|NCT02873065|Amoxicillin|amoxicillin|mesh-list
25173335|NCT02873065|Clarithromycin|clarithromycin|mesh-list
25173336|NCT02873065|Potassium Citrate|potassium citrate|mesh-list
25173337|NCT02873065|Bismuth|bismuth|mesh-list
25173338|NCT02873065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173339|NCT02873065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25665064|NCT01679405|Cisplatin|cisplatin|mesh-list
24605800|NCT00987376|Nootropic Agents|nootropic agents|mesh-ancestor
24605801|NCT00987441|Sufentanil|sufentanil|mesh-list
25173340|NCT02873065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25173341|NCT02873065|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25173342|NCT02873065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25173343|NCT02873065|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25173344|NCT02873065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25173345|NCT02873065|Antacids|antacids|mesh-ancestor
25173346|NCT02873065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25173347|NCT02873065|Diuretics|diuretics|mesh-ancestor
25173348|NCT02873065|Natriuretic Agents|natriuretic agents|mesh-ancestor
25204143|NCT02710448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25173349|NCT02873065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173350|NCT02873065|Expectorants|expectorants|mesh-ancestor
25173351|NCT02873065|Respiratory System Agents|respiratory system agents|mesh-ancestor
25173352|NCT02872818|Metformin|metformin|mesh-list
25173353|NCT02872818|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25173354|NCT02872818|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25173355|NCT02872818|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25173356|NCT02872818|Medroxyprogesterone|medroxyprogesterone|mesh-list
25173357|NCT02872818|Estradiol|estradiol|mesh-list
25173358|NCT02872818|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25173359|NCT02872818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25173360|NCT02872818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173361|NCT02872818|Estrogens|estrogens|mesh-ancestor
25173362|NCT02872818|Hormones|hormones|mesh-ancestor
25173363|NCT02872818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24752066|NCT01708005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25173364|NCT02872818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25173365|NCT02872818|Contraceptive Agents|contraceptive agents|mesh-ancestor
25173366|NCT02872818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25173367|NCT02872818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25173368|NCT02872818|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25173369|NCT02872818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25173370|NCT02872818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25173371|NCT02872818|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25173372|NCT02872818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25173373|NCT02872818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25173374|NCT02873026|Triamcinolone|triamcinolone|mesh-list
25173375|NCT02873026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25173376|NCT02873026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25173377|NCT02873026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25173378|NCT02873026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25173379|NCT02873026|Glucocorticoids|glucocorticoids|mesh-ancestor
25173380|NCT02873026|Hormones|hormones|mesh-ancestor
25173381|NCT02873026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25173382|NCT02873026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173383|NCT02873026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25173384|NCT02873026|Immunologic Factors|immunologic factors|mesh-ancestor
25173385|NCT02873026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25173386|NCT02873026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173387|NCT02872584|Prednisone|prednisone|mesh-list
25173388|NCT02872584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25173389|NCT02872584|Glucocorticoids|glucocorticoids|mesh-ancestor
25173390|NCT02872584|Hormones|hormones|mesh-ancestor
25173391|NCT02872584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24752095|NCT01708369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24752096|NCT01708369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752098|NCT01708369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24752099|NCT01708369|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24752100|NCT01708369|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24752101|NCT01708369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752102|NCT01708369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25173392|NCT02872584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173393|NCT02872584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25173394|NCT02872584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25173395|NCT02872597|Dexamethasone|dexamethasone|mesh-list
25173396|NCT02872597|Prednisone|prednisone|mesh-list
25173397|NCT02872597|Methylprednisolone|methylprednisolone|mesh-list
25173398|NCT02872597|Prednisolone|prednisolone|mesh-list
25173399|NCT02872597|Albuterol|albuterol|mesh-list
25665065|NCT01679405|Afatinib|afatinib|mesh-list
25665066|NCT01679405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25173400|NCT02872597|Ipratropium|ipratropium|mesh-list
24605887|NCT00987792|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25208700|NCT01408641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208702|NCT01246310|Vitamin B Complex|vitamin b complex|mesh-ancestor
25208703|NCT01246310|Vitamins|vitamins|mesh-ancestor
25208704|NCT01246310|Micronutrients|micronutrients|mesh-ancestor
25173401|NCT02872597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25173402|NCT02872597|Antiemetics|antiemetics|mesh-ancestor
25173403|NCT02872597|Autonomic Agents|autonomic agents|mesh-ancestor
25173404|NCT02872597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25173405|NCT02872597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173406|NCT02872597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25173407|NCT02872597|Glucocorticoids|glucocorticoids|mesh-ancestor
25173408|NCT02872597|Hormones|hormones|mesh-ancestor
25173409|NCT02872597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25173410|NCT02872597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25173411|NCT02872597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25173412|NCT02872597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173413|NCT02872597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25173414|NCT02872597|Protective Agents|protective agents|mesh-ancestor
25173415|NCT02872597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25173416|NCT02872597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25173417|NCT02872597|Respiratory System Agents|respiratory system agents|mesh-ancestor
25173418|NCT02872597|Tocolytic Agents|tocolytic agents|mesh-ancestor
25173419|NCT02872597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25173420|NCT02872597|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25173421|NCT02872597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25173422|NCT02872597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25173423|NCT02872597|Adrenergic Agents|adrenergic agents|mesh-ancestor
25173424|NCT02872597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25173425|NCT02872597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25173426|NCT02872597|Cholinergic Agents|cholinergic agents|mesh-ancestor
25173427|NCT02872649|Warfarin|warfarin|mesh-list
25173428|NCT02872649|Dabigatran|dabigatran|mesh-list
25173429|NCT02872649|Phenprocoumon|phenprocoumon|mesh-list
25173430|NCT02872649|Anticoagulants|anticoagulants|mesh-ancestor
25173431|NCT02872649|Antithrombins|antithrombins|mesh-ancestor
25173432|NCT02872649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25173433|NCT02872649|Protease Inhibitors|protease inhibitors|mesh-ancestor
25173434|NCT02872649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25173435|NCT02872649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173436|NCT02872389|Sevoflurane|sevoflurane|mesh-list
25173437|NCT02872389|Desflurane|desflurane|mesh-list
25173438|NCT02872389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25173439|NCT02872389|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25173440|NCT02872389|Anesthetics, General|anesthetics, general|mesh-ancestor
25173441|NCT02872389|Anesthetics|anesthetics|mesh-ancestor
25173442|NCT02872389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25173443|NCT02872389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173444|NCT02872272|Amikacin|amikacin|mesh-list
25173445|NCT02872272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25173446|NCT02872272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25173447|NCT02872428|Valproic Acid|valproic acid|mesh-list
25173448|NCT02872428|Anticonvulsants|anticonvulsants|mesh-ancestor
25173449|NCT02872428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24659230|NCT01276431|Buprenorphine|buprenorphine|mesh-list
25173450|NCT02872428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173451|NCT02872428|GABA Agents|gaba agents|mesh-ancestor
25173452|NCT02872428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25173453|NCT02872428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173454|NCT02872428|Antimanic Agents|antimanic agents|mesh-ancestor
25173455|NCT02872428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24752152|NCT01708707|Morphine|morphine|mesh-list
25173456|NCT02872428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25173457|NCT02872428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25173458|NCT02871882|Bile Acids and Salts|bile acids and salts|mesh-list
25173459|NCT02871882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25173460|NCT02871869|Buformin|buformin|mesh-list
25173461|NCT02871869|Prednisone|prednisone|mesh-list
25665067|NCT01679405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25665068|NCT01679405|Antimetabolites|antimetabolites|mesh-ancestor
25665069|NCT01679405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665070|NCT01679405|Antiviral Agents|antiviral agents|mesh-ancestor
25665071|NCT01679405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25665072|NCT01679405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25173462|NCT02871869|Cyclophosphamide|cyclophosphamide|mesh-list
25173463|NCT02871869|Rituximab|rituximab|mesh-list
25173466|NCT02871869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25173467|NCT02871869|Immunologic Factors|immunologic factors|mesh-ancestor
25173468|NCT02871869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173469|NCT02871869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25173470|NCT02871869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25173471|NCT02871869|Alkylating Agents|alkylating agents|mesh-ancestor
25173472|NCT02871869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173473|NCT02871869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25173474|NCT02871869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25173475|NCT02871869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25173476|NCT02871869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25173477|NCT02871869|Glucocorticoids|glucocorticoids|mesh-ancestor
25173478|NCT02871869|Hormones|hormones|mesh-ancestor
25173479|NCT02871869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25173480|NCT02871869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25173481|NCT02871869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25173482|NCT02871869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25173483|NCT02871869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25173484|NCT02871869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25173485|NCT02871869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25173486|NCT02871869|Tubulin Modulators|tubulin modulators|mesh-ancestor
25173487|NCT02871869|Antimitotic Agents|antimitotic agents|mesh-ancestor
25173488|NCT02871869|Mitosis Modulators|mitosis modulators|mesh-ancestor
25173489|NCT02871869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25173490|NCT02872090|Glycopyrrolate|glycopyrrolate|mesh-list
25173491|NCT02872090|Tiotropium Bromide|tiotropium bromide|mesh-list
25173492|NCT02872090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25173493|NCT02872090|Autonomic Agents|autonomic agents|mesh-ancestor
25173494|NCT02872090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25173495|NCT02872090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173496|NCT02872090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25173497|NCT02872090|Respiratory System Agents|respiratory system agents|mesh-ancestor
25173498|NCT02872090|Parasympatholytics|parasympatholytics|mesh-ancestor
25173499|NCT02872090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24542069|NCT00676702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542070|NCT00676702|Hemostatics|hemostatics|mesh-ancestor
24542071|NCT00676702|Coagulants|coagulants|mesh-ancestor
24542072|NCT00676702|Vitamins|vitamins|mesh-ancestor
24542073|NCT00676702|Micronutrients|micronutrients|mesh-ancestor
24542074|NCT00676702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542075|NCT00676741|Insulin|insulin|mesh-list
24542076|NCT00676741|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24542077|NCT00676741|Insulin Aspart|insulin aspart|mesh-list
24451603|NCT00324389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451605|NCT00324454|Anticonvulsants|anticonvulsants|mesh-ancestor
24451606|NCT00324454|Nootropic Agents|nootropic agents|mesh-ancestor
24451607|NCT00324467|Acetaminophen|acetaminophen|mesh-list
24451608|NCT00324467|Diphenhydramine|diphenhydramine|mesh-list
25860140|NCT00082823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24451618|NCT00324467|Etoposide|etoposide|mesh-list
24862223|NCT02323607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25204157|NCT02710396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204158|NCT02710396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25204159|NCT02710396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25204160|NCT02710396|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25204161|NCT02710396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25204163|NCT02710266|Anticoagulants|anticoagulants|mesh-ancestor
25204164|NCT02710266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25204165|NCT02710266|Protease Inhibitors|protease inhibitors|mesh-ancestor
25204166|NCT02710266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25204167|NCT02710266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173523|NCT02871661|Amitriptyline|amitriptyline|mesh-list
25173524|NCT02871661|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25173525|NCT02871661|Antidepressive Agents|antidepressive agents|mesh-ancestor
25173526|NCT02871661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25173527|NCT02871661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25173528|NCT02871661|Analgesics|analgesics|mesh-ancestor
25173529|NCT02871661|Sensory System Agents|sensory system agents|mesh-ancestor
25173530|NCT02871661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25173531|NCT02871661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173532|NCT02871661|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25860141|NCT00082823|Growth Substances|growth substances|mesh-ancestor
25208725|NCT01203722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25208726|NCT01203722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25208727|NCT01203722|Antifungal Agents|antifungal agents|mesh-ancestor
25173533|NCT02871661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25173534|NCT02871661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25173535|NCT02871661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752344|NCT01709994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24752345|NCT01709994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173536|NCT02871661|Adrenergic Agents|adrenergic agents|mesh-ancestor
25173537|NCT02871661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25173538|NCT02871986|Estrogens|estrogens|mesh-list
25173539|NCT02871986|Hormones|hormones|mesh-ancestor
25173540|NCT02871986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25173541|NCT02871986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173542|NCT02871713|Morphine|morphine|mesh-list
25173543|NCT02871713|Ropivacaine|ropivacaine|mesh-list
25173544|NCT02871713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25173545|NCT02871713|Narcotics|narcotics|mesh-ancestor
25173546|NCT02871713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25173547|NCT02871713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173548|NCT02871713|Analgesics|analgesics|mesh-ancestor
25173550|NCT02871713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25173551|NCT02871713|Anesthetics, Local|anesthetics, local|mesh-ancestor
25173552|NCT02871713|Anesthetics|anesthetics|mesh-ancestor
25173553|NCT02871765|Warfarin|warfarin|mesh-list
25173554|NCT02871765|Anticoagulants|anticoagulants|mesh-ancestor
24752346|NCT01709994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24752347|NCT01709994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24752348|NCT01709994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24752349|NCT01709994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25173564|NCT02872038|Cefazolin|cefazolin|mesh-list
25173565|NCT02872038|Ceftazidime|ceftazidime|mesh-list
25173566|NCT02872038|Cefepime|cefepime|mesh-list
25173567|NCT02872038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25173568|NCT02872038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25173569|NCT02871648|Fludrocortisone|fludrocortisone|mesh-list
25173570|NCT02871648|Eplerenone|eplerenone|mesh-list
25173571|NCT02871648|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25173572|NCT02871648|Hormone Antagonists|hormone antagonists|mesh-ancestor
25173573|NCT02871648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25173574|NCT02871648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752373|NCT01710072|Sensory System Agents|sensory system agents|mesh-ancestor
24752374|NCT01710072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24752375|NCT01710072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752393|NCT01710163|Dopamine Agents|dopamine agents|mesh-ancestor
24752394|NCT01710163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24752395|NCT01710163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752396|NCT01710163|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24752397|NCT01710163|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24752398|NCT01710163|Serotonin Agents|serotonin agents|mesh-ancestor
24752399|NCT01710163|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25860142|NCT00082823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860143|NCT00082823|Growth Inhibitors|growth inhibitors|mesh-ancestor
25860144|NCT00082823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25173575|NCT02871648|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25173576|NCT02871648|Diuretics|diuretics|mesh-ancestor
25173577|NCT02871648|Natriuretic Agents|natriuretic agents|mesh-ancestor
25173578|NCT02871648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25173579|NCT02871648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25173580|NCT02871323|Durvalumab|durvalumab|mesh-list
25173581|NCT02871323|Immunoglobulins|immunoglobulins|mesh-list
25173582|NCT02871323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25173583|NCT02871323|Immunoglobulin G|immunoglobulin g|mesh-list
25173584|NCT02871323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25173585|NCT02871323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25173586|NCT02871323|Immunologic Factors|immunologic factors|mesh-ancestor
25173587|NCT02871323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173588|NCT02871518|Cisplatin|cisplatin|mesh-list
25173589|NCT02871518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25173590|NCT02871505|Penicillins|penicillins|mesh-list
25173591|NCT02871505|Penicillin G|penicillin g|mesh-list
25173592|NCT02871505|Penicillin G Benzathine|penicillin g benzathine|mesh-list
25665073|NCT01679405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25665074|NCT01679405|Immunologic Factors|immunologic factors|mesh-ancestor
25665075|NCT01679405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665076|NCT01679405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24606194|NCT00989352|Alkylating Agents|alkylating agents|mesh-ancestor
25173593|NCT02871505|Penicillin G Procaine|penicillin g procaine|mesh-list
25173594|NCT02871505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25173595|NCT02871505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25173596|NCT02871349|Propranolol|propranolol|mesh-list
25173597|NCT02871349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25173598|NCT02871349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25173599|NCT02871349|Adrenergic Agents|adrenergic agents|mesh-ancestor
25173600|NCT02871349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25173601|NCT02871349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173602|NCT02871349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173603|NCT02871349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25173604|NCT02871349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25173605|NCT02871349|Vasodilator Agents|vasodilator agents|mesh-ancestor
25173606|NCT02871193|Dexamethasone|dexamethasone|mesh-list
25173607|NCT02871193|Ropivacaine|ropivacaine|mesh-list
25173608|NCT02871193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25173609|NCT02871193|Antiemetics|antiemetics|mesh-ancestor
25173610|NCT02871193|Autonomic Agents|autonomic agents|mesh-ancestor
25173611|NCT02871193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25173612|NCT02871193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173613|NCT02871193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25173614|NCT02871193|Glucocorticoids|glucocorticoids|mesh-ancestor
25173615|NCT02871193|Hormones|hormones|mesh-ancestor
25173616|NCT02871193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25173617|NCT02871193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25173618|NCT02871193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25173619|NCT02871193|Anesthetics, Local|anesthetics, local|mesh-ancestor
24752453|NCT01710488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24752454|NCT01710488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25173620|NCT02871193|Anesthetics|anesthetics|mesh-ancestor
25173621|NCT02871193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25173622|NCT02871193|Sensory System Agents|sensory system agents|mesh-ancestor
25173623|NCT02871141|Antidepressive Agents|antidepressive agents|mesh-list
25173624|NCT02871141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25173625|NCT02870907|Cyclophosphamide|cyclophosphamide|mesh-list
25173626|NCT02870907|Thiotepa|thiotepa|mesh-list
25173627|NCT02870907|Carboplatin|carboplatin|mesh-list
25173628|NCT02870907|Etoposide|etoposide|mesh-list
25173629|NCT02870907|Etoposide phosphate|etoposide phosphate|mesh-list
25173630|NCT02870907|Vincristine|vincristine|mesh-list
25173631|NCT02870907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25173632|NCT02870907|Immunologic Factors|immunologic factors|mesh-ancestor
25173633|NCT02870907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173634|NCT02870907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25173635|NCT02870907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25173636|NCT02870907|Alkylating Agents|alkylating agents|mesh-ancestor
25173637|NCT02870907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173638|NCT02870907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25173639|NCT02870907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25173640|NCT02870907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25173641|NCT02870907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25173642|NCT02870907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25173643|NCT02870907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25173644|NCT02870907|Tubulin Modulators|tubulin modulators|mesh-ancestor
25173645|NCT02870907|Antimitotic Agents|antimitotic agents|mesh-ancestor
25173646|NCT02870907|Mitosis Modulators|mitosis modulators|mesh-ancestor
25173648|NCT02870634|Trace Elements|trace elements|mesh-ancestor
25173649|NCT02870634|Micronutrients|micronutrients|mesh-ancestor
25173650|NCT02870634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173651|NCT02870478|Atropine|atropine|mesh-list
25173652|NCT02870478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25173653|NCT02870478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25173654|NCT02870478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25173655|NCT02870478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25173656|NCT02870478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25173657|NCT02870478|Autonomic Agents|autonomic agents|mesh-ancestor
25173658|NCT02870478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25173659|NCT02870478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173660|NCT02870478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25173661|NCT02870478|Respiratory System Agents|respiratory system agents|mesh-ancestor
25173662|NCT02870478|Mydriatics|mydriatics|mesh-ancestor
25173663|NCT02870478|Parasympatholytics|parasympatholytics|mesh-ancestor
25173664|NCT02870478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25173665|NCT02870478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25665077|NCT01679613|Ketoconazole|ketoconazole|mesh-list
25173676|NCT02870673|Hormones|hormones|mesh-ancestor
24451629|NCT00324467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451630|NCT00324467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451631|NCT00324467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24451632|NCT00324467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24451633|NCT00324467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24972554|NCT03716765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972555|NCT03716765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24931194|NCT04092101|Nicotine|nicotine|mesh-list
24972580|NCT03716622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931238|NCT04091204|Olaparib|olaparib|mesh-list
24972743|NCT03715478|Antiemetics|antiemetics|mesh-ancestor
24972744|NCT03715478|Autonomic Agents|autonomic agents|mesh-ancestor
24972745|NCT03715478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24972746|NCT03715478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972920|NCT03713918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972921|NCT03713918|Antimanic Agents|antimanic agents|mesh-ancestor
24972922|NCT03713918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24628454|NCT01099072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24972923|NCT03713918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24972977|NCT03713658|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24972978|NCT03713372|Antibodies|antibodies|mesh-list
24972979|NCT03713372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24972980|NCT03713372|Immunologic Factors|immunologic factors|mesh-ancestor
24972981|NCT03713372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972982|NCT03713346|Caseins|caseins|mesh-list
24972983|NCT03713346|Chelating Agents|chelating agents|mesh-ancestor
24972994|NCT03713190|Empagliflozin|empagliflozin|mesh-list
24972995|NCT03713190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24972996|NCT03713190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972997|NCT03713190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24972998|NCT03713190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972999|NCT03712956|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24973000|NCT03712956|Doxorubicin|doxorubicin|mesh-list
24973001|NCT03712956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24973002|NCT03712956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973003|NCT03712956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25083323|NCT03316599|Paclitaxel|paclitaxel|mesh-list
25083324|NCT03316599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24973004|NCT03712956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24625081|NCT01080469|Tacrolimus|tacrolimus|mesh-list
24973214|NCT03710902|Antihypertensive Agents|antihypertensive agents|mesh-list
24973216|NCT03710863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24973217|NCT03710863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25173677|NCT02870673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25173678|NCT02870673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173679|NCT02870673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25173680|NCT02870673|Immunologic Factors|immunologic factors|mesh-ancestor
25173681|NCT02870673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25173682|NCT02870673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173683|NCT02870673|Anesthetics, Local|anesthetics, local|mesh-ancestor
25173684|NCT02870673|Anesthetics|anesthetics|mesh-ancestor
25173685|NCT02870673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25173686|NCT02870673|Sensory System Agents|sensory system agents|mesh-ancestor
25173687|NCT02870673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25173688|NCT02870673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25173689|NCT02870673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25173690|NCT02870673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25173691|NCT02870673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25173693|NCT02870361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25173694|NCT02870361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173695|NCT02870790|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25173696|NCT02870790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24752578|NCT01711086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24417168|NCT00205738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25173697|NCT02870790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25173698|NCT02870790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25173699|NCT02870790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173700|NCT02870790|Antiviral Agents|antiviral agents|mesh-ancestor
25173701|NCT02870790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25173702|NCT02870790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25173703|NCT02870790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25173704|NCT02870231|Liraglutide|liraglutide|mesh-list
25173705|NCT02870231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25173706|NCT02870231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173707|NCT02870231|Incretins|incretins|mesh-ancestor
25173708|NCT02870231|Hormones|hormones|mesh-ancestor
25173709|NCT02870231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25204168|NCT02710305|Lidocaine|lidocaine|mesh-list
25204169|NCT02710305|Scopolamine|scopolamine|mesh-list
25204170|NCT02710305|Bromides|bromides|mesh-list
25204171|NCT02710305|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25204172|NCT02710305|Anesthetics, Local|anesthetics, local|mesh-ancestor
25204173|NCT02710305|Anesthetics|anesthetics|mesh-ancestor
25204174|NCT02710305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25204175|NCT02710305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204181|NCT02710305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25204182|NCT02710305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204183|NCT02710305|Anticonvulsants|anticonvulsants|mesh-ancestor
25204184|NCT02710305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25204185|NCT02710305|Antiemetics|antiemetics|mesh-ancestor
25204186|NCT02710305|Autonomic Agents|autonomic agents|mesh-ancestor
25204187|NCT02710305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25204188|NCT02710305|Mydriatics|mydriatics|mesh-ancestor
25204189|NCT02710305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25204190|NCT02710305|Cholinergic Agents|cholinergic agents|mesh-ancestor
25204191|NCT02710305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25204192|NCT02710305|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25204193|NCT02710305|Parasympatholytics|parasympatholytics|mesh-ancestor
25204195|NCT02710110|Antipruritics|antipruritics|mesh-ancestor
25204196|NCT02710110|Dermatologic Agents|dermatologic agents|mesh-ancestor
25204197|NCT02710110|Sensory System Agents|sensory system agents|mesh-ancestor
25204198|NCT02710110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204199|NCT02710110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204200|NCT02710162|Capsaicin|capsaicin|mesh-list
25204201|NCT02710162|Antipruritics|antipruritics|mesh-ancestor
25204202|NCT02710162|Dermatologic Agents|dermatologic agents|mesh-ancestor
25204203|NCT02710162|Sensory System Agents|sensory system agents|mesh-ancestor
25204204|NCT02710162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204205|NCT02710162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204206|NCT02709863|Propofol|propofol|mesh-list
25204207|NCT02709863|Sevoflurane|sevoflurane|mesh-list
25204208|NCT02709863|Desflurane|desflurane|mesh-list
25204209|NCT02709863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25204210|NCT02709863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25204211|NCT02709863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204212|NCT02709863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25204213|NCT02709863|Anesthetics, General|anesthetics, general|mesh-ancestor
25204214|NCT02709863|Anesthetics|anesthetics|mesh-ancestor
25204215|NCT02709863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25204216|NCT02709863|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25204217|NCT02709902|Adapalene|adapalene|mesh-list
25204218|NCT02709902|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
25204219|NCT02709902|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25204220|NCT02709902|Dermatologic Agents|dermatologic agents|mesh-ancestor
25204221|NCT02709902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25204222|NCT02709902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25204223|NCT02709902|Analgesics|analgesics|mesh-ancestor
24491278|NCT00481819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24491280|NCT00481884|Emollients|emollients|mesh-ancestor
24491281|NCT00481884|Dermatologic Agents|dermatologic agents|mesh-ancestor
24491282|NCT00481923|Rimonabant|rimonabant|mesh-list
25860146|NCT00082836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24491315|NCT00482066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606614|NCT00991211|Tubulin Modulators|tubulin modulators|mesh-ancestor
24606615|NCT00991211|Antimitotic Agents|antimitotic agents|mesh-ancestor
24606616|NCT00991211|Mitosis Modulators|mitosis modulators|mesh-ancestor
24606617|NCT00991250|Temozolomide|temozolomide|mesh-list
25204224|NCT02709902|Sensory System Agents|sensory system agents|mesh-ancestor
25204225|NCT02709902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25173711|NCT02869984|Antiemetics|antiemetics|mesh-ancestor
25173712|NCT02869984|Autonomic Agents|autonomic agents|mesh-ancestor
25173713|NCT02869984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25173714|NCT02869984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173715|NCT02869984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25173716|NCT02869984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25173717|NCT02869984|Serotonin Agents|serotonin agents|mesh-ancestor
25173718|NCT02869984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25173719|NCT02869984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173720|NCT02870153|Oxaliplatin|oxaliplatin|mesh-list
25173721|NCT02870153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25173722|NCT02869841|Levobupivacaine|levobupivacaine|mesh-list
25173723|NCT02869841|Anesthetics, Local|anesthetics, local|mesh-ancestor
25173724|NCT02869841|Anesthetics|anesthetics|mesh-ancestor
24944544|NCT03959540|Levodopa|levodopa|mesh-list
24752696|NCT01711567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24752697|NCT01711567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24417263|NCT00206128|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25173978|NCT02867904|Prednisolone|prednisolone|mesh-list
24944554|NCT03959501|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24944556|NCT03959501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24944557|NCT03959501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173725|NCT02869841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25173726|NCT02869841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173727|NCT02869841|Sensory System Agents|sensory system agents|mesh-ancestor
25173728|NCT02869841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25173729|NCT02870036|Leucovorin|leucovorin|mesh-list
25173730|NCT02870036|Thalidomide|thalidomide|mesh-list
25173731|NCT02870036|Fluorouracil|fluorouracil|mesh-list
25173732|NCT02870036|Calcium|calcium|mesh-list
25173733|NCT02870036|Levoleucovorin|levoleucovorin|mesh-list
25173734|NCT02870036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25173735|NCT02870036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173736|NCT02870036|Antimetabolites|antimetabolites|mesh-ancestor
25173737|NCT02870036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173738|NCT02870036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25173739|NCT02870036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25173740|NCT02870036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25173741|NCT02870036|Immunologic Factors|immunologic factors|mesh-ancestor
25173742|NCT02870036|Antidotes|antidotes|mesh-ancestor
25173743|NCT02870036|Protective Agents|protective agents|mesh-ancestor
25173744|NCT02870036|Vitamin B Complex|vitamin b complex|mesh-ancestor
25173745|NCT02870036|Vitamins|vitamins|mesh-ancestor
25173746|NCT02870036|Micronutrients|micronutrients|mesh-ancestor
25173747|NCT02870036|Leprostatic Agents|leprostatic agents|mesh-ancestor
25173748|NCT02870036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25173749|NCT02870036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25173750|NCT02870036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25173751|NCT02870036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25173752|NCT02870036|Growth Substances|growth substances|mesh-ancestor
25665078|NCT01679613|Nintedanib|nintedanib|mesh-list
25665079|NCT01679613|Antifungal Agents|antifungal agents|mesh-ancestor
25665080|NCT01679613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25665081|NCT01679613|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25665082|NCT01679613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25665083|NCT01679613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665084|NCT01679613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665085|NCT01679613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25665086|NCT01679613|Hormone Antagonists|hormone antagonists|mesh-ancestor
25173753|NCT02870036|Growth Inhibitors|growth inhibitors|mesh-ancestor
25173754|NCT02869815|Methylene Blue|methylene blue|mesh-list
25173755|NCT02869815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860155|NCT00082862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860156|NCT00082862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25860157|NCT00082862|Antimetabolites|antimetabolites|mesh-ancestor
25173756|NCT02869815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173757|NCT02869763|Ethanol|ethanol|mesh-list
25173758|NCT02869763|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25173759|NCT02869763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25173760|NCT02869763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25173761|NCT02869763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173762|NCT02869672|Vaccines|vaccines|mesh-list
25665087|NCT01679613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25860158|NCT00082862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173763|NCT02869672|Immunologic Factors|immunologic factors|mesh-ancestor
24857715|NCT02293668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619213|NCT01051401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24619214|NCT01051401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25173764|NCT02869672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173765|NCT02869347|Complement C1s|complement c1s|mesh-list
25173766|NCT02869347|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25173767|NCT02869347|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
25173768|NCT02869347|Immunologic Factors|immunologic factors|mesh-ancestor
25173769|NCT02869347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173770|NCT02869347|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25173771|NCT02869347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25173772|NCT02870062|Chlorhexidine|chlorhexidine|mesh-list
25173773|NCT02870062|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25173774|NCT02870062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25173775|NCT02870062|Disinfectants|disinfectants|mesh-ancestor
25173776|NCT02869204|Ascorbic Acid|ascorbic acid|mesh-list
25173777|NCT02869204|Vitamins|vitamins|mesh-ancestor
25173778|NCT02869204|Micronutrients|micronutrients|mesh-ancestor
25173779|NCT02869204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173780|NCT02869204|Antioxidants|antioxidants|mesh-ancestor
25173781|NCT02869204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173782|NCT02869204|Protective Agents|protective agents|mesh-ancestor
25173783|NCT02869321|Fentanyl|fentanyl|mesh-list
25173784|NCT02869321|Morphine|morphine|mesh-list
25173785|NCT02869321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25173787|NCT02869321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25173788|NCT02869321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862431|NCT02325180|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24862432|NCT02325180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24862433|NCT02325206|Dapagliflozin|dapagliflozin|mesh-list
24862434|NCT02325206|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24862435|NCT02325206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542230|NCT00677729|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24542231|NCT00677729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25665088|NCT01679613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665089|NCT01679613|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25665090|NCT01679613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665091|NCT01679613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25674383|NCT01770912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674384|NCT01771250|Insulin|insulin|mesh-list
25674385|NCT01771250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25674386|NCT01771250|Insulin Glargine|insulin glargine|mesh-list
25674387|NCT01771250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24542232|NCT00677729|Adrenergic Agents|adrenergic agents|mesh-ancestor
24542233|NCT00677729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24542234|NCT00677729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173789|NCT02869321|Analgesics|analgesics|mesh-ancestor
25173790|NCT02869321|Sensory System Agents|sensory system agents|mesh-ancestor
25173791|NCT02869321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25173792|NCT02869321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25173793|NCT02869321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24944564|NCT03959501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944565|NCT03959501|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25173794|NCT02869321|Anesthetics, General|anesthetics, general|mesh-ancestor
25173795|NCT02869321|Anesthetics|anesthetics|mesh-ancestor
25173796|NCT02869165|Estrogens|estrogens|mesh-list
25173797|NCT02869165|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25173798|NCT02869165|Hormones|hormones|mesh-ancestor
25173799|NCT02869165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25173800|NCT02869165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173801|NCT02869126|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
25173802|NCT02869126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25173803|NCT02869126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173804|NCT02869100|Listerine|listerine|mesh-list
25173805|NCT02869100|Fluorides|fluorides|mesh-list
25173806|NCT02869100|Sodium Fluoride|sodium fluoride|mesh-list
25173807|NCT02869100|Cariostatic Agents|cariostatic agents|mesh-ancestor
25173808|NCT02869100|Protective Agents|protective agents|mesh-ancestor
25173809|NCT02869100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173810|NCT02869100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25173811|NCT02869100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25173812|NCT02868944|Sufentanil|sufentanil|mesh-list
25173813|NCT02868944|Morphine|morphine|mesh-list
25173814|NCT02868944|Levobupivacaine|levobupivacaine|mesh-list
25173815|NCT02868944|Anesthetics|anesthetics|mesh-list
25173816|NCT02868944|Anesthetics, Local|anesthetics, local|mesh-list
25173817|NCT02868944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25173818|NCT02868944|Narcotics|narcotics|mesh-ancestor
25173819|NCT02868944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25173820|NCT02868944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173821|NCT02868944|Analgesics|analgesics|mesh-ancestor
25173822|NCT02868944|Sensory System Agents|sensory system agents|mesh-ancestor
25173823|NCT02868944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25173824|NCT02868944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25173825|NCT02868944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25173826|NCT02868944|Anesthetics, General|anesthetics, general|mesh-ancestor
25173827|NCT02868931|Insulin|insulin|mesh-list
25173828|NCT02868931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25173829|NCT02868931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173830|NCT02868749|Hyaluronic Acid|hyaluronic acid|mesh-list
25173831|NCT02868749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25173832|NCT02868749|Immunologic Factors|immunologic factors|mesh-ancestor
25173833|NCT02868749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173834|NCT02868749|Viscosupplements|viscosupplements|mesh-ancestor
25173835|NCT02868749|Protective Agents|protective agents|mesh-ancestor
25173836|NCT02869035|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25173837|NCT02869035|Citalopram|citalopram|mesh-list
25173838|NCT02869035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25173839|NCT02869035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25173840|NCT02869035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25173841|NCT02869035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173842|NCT02869035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25173843|NCT02869035|Serotonin Agents|serotonin agents|mesh-ancestor
25173844|NCT02869035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173845|NCT02869035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25173846|NCT02869035|Antidepressive Agents|antidepressive agents|mesh-ancestor
25173847|NCT02869035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25173848|NCT02869035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25173849|NCT02869035|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25173851|NCT02869035|Sensory System Agents|sensory system agents|mesh-ancestor
25173852|NCT02869035|Dopamine Agents|dopamine agents|mesh-ancestor
25173853|NCT02868996|Kallikreins|kallikreins|mesh-list
25173854|NCT02868996|Coagulants|coagulants|mesh-ancestor
25173855|NCT02868996|Fertility Agents, Male|fertility agents, male|mesh-ancestor
25173856|NCT02868996|Fertility Agents|fertility agents|mesh-ancestor
25173857|NCT02868996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25173858|NCT02868996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173859|NCT02868814|Pregabalin|pregabalin|mesh-list
25173860|NCT02868814|Analgesics|analgesics|mesh-ancestor
25173861|NCT02868814|Sensory System Agents|sensory system agents|mesh-ancestor
25173862|NCT02868814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25173863|NCT02868814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173864|NCT02868814|Anticonvulsants|anticonvulsants|mesh-ancestor
25173865|NCT02868814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25173866|NCT02868814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25173867|NCT02868814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173868|NCT02868814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25173869|NCT02868814|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25173870|NCT02868814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25173871|NCT02868814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25173872|NCT02868814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25173873|NCT02868801|Pregabalin|pregabalin|mesh-list
25173874|NCT02868801|Analgesics|analgesics|mesh-ancestor
25173875|NCT02868801|Sensory System Agents|sensory system agents|mesh-ancestor
25173876|NCT02868801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25173877|NCT02868801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173878|NCT02868801|Anticonvulsants|anticonvulsants|mesh-ancestor
24752757|NCT01711827|Glucocorticoids|glucocorticoids|mesh-ancestor
24752758|NCT01711827|Hormones|hormones|mesh-ancestor
24752759|NCT01711827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24752760|NCT01711827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173879|NCT02868801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25173880|NCT02868801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25173881|NCT02868801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173882|NCT02868801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25173883|NCT02868801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25173884|NCT02868801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25173885|NCT02868801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25173886|NCT02868801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25173887|NCT02868580|Lamivudine|lamivudine|mesh-list
25173888|NCT02868580|Abacavir|abacavir|mesh-list
25173889|NCT02868580|Dolutegravir|dolutegravir|mesh-list
25173890|NCT02868580|Triumeq|triumeq|mesh-list
25173891|NCT02868580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25173892|NCT02868580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25173893|NCT02868580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25173894|NCT02868580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173895|NCT02868580|Antiviral Agents|antiviral agents|mesh-ancestor
25173896|NCT02868580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25173897|NCT02868580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25173898|NCT02868580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25173899|NCT02868580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25173900|NCT02868580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25173901|NCT02868827|Vitamin D|vitamin d|mesh-list
25173902|NCT02868827|Cholecalciferol|cholecalciferol|mesh-list
25173903|NCT02868827|Vitamins|vitamins|mesh-ancestor
25173904|NCT02868827|Micronutrients|micronutrients|mesh-ancestor
24752776|NCT01711931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173905|NCT02868827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173906|NCT02868827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25173907|NCT02868827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25173979|NCT02867904|Prednisolone acetate|prednisolone acetate|mesh-list
25173908|NCT02868606|Insulin|insulin|mesh-list
25173909|NCT02868606|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25173910|NCT02868606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25173911|NCT02868606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173912|NCT02868385|Praziquantel|praziquantel|mesh-list
25173913|NCT02868385|Anthelmintics|anthelmintics|mesh-ancestor
25173914|NCT02868385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25173915|NCT02868385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25173916|NCT02868632|Durvalumab|durvalumab|mesh-list
25173917|NCT02868632|Tremelimumab|tremelimumab|mesh-list
25173918|NCT02868632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25173919|NCT02868632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25173920|NCT02868372|Povidone-Iodine|povidone-iodine|mesh-list
25173921|NCT02868372|Povidone|povidone|mesh-list
25173922|NCT02868372|Plasma Substitutes|plasma substitutes|mesh-ancestor
25173923|NCT02868372|Blood Substitutes|blood substitutes|mesh-ancestor
25173924|NCT02868372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25173925|NCT02868372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25173926|NCT02868437|Hyaluronic Acid|hyaluronic acid|mesh-list
25173927|NCT02868437|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25173928|NCT02868437|Immunologic Factors|immunologic factors|mesh-ancestor
25426096|NCT02057133|Letrozole|letrozole|mesh-list
25173936|NCT02868151|Antioxidants|antioxidants|mesh-ancestor
25173937|NCT02868151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173938|NCT02868151|Protective Agents|protective agents|mesh-ancestor
25173939|NCT02868073|Vaccines|vaccines|mesh-list
25173940|NCT02868073|Immunologic Factors|immunologic factors|mesh-ancestor
25173941|NCT02868073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173942|NCT02867982|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25173943|NCT02867982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25173944|NCT02867956|Etoposide|etoposide|mesh-list
25173945|NCT02867956|Apatinib|apatinib|mesh-list
25173946|NCT02867956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25173947|NCT02867956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25173948|NCT02867956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25173949|NCT02867956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25173950|NCT02867956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25173990|NCT02867904|Hormones|hormones|mesh-ancestor
25173955|NCT02867930|Propofol|propofol|mesh-list
25173956|NCT02867930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25173957|NCT02867930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25173958|NCT02867930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173959|NCT02867930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25173960|NCT02867930|Anesthetics, General|anesthetics, general|mesh-ancestor
25173961|NCT02867930|Anesthetics|anesthetics|mesh-ancestor
25173962|NCT02867930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25173963|NCT02867930|Analgesics|analgesics|mesh-ancestor
25173964|NCT02867930|Sensory System Agents|sensory system agents|mesh-ancestor
25173965|NCT02867930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25173966|NCT02867930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25173967|NCT02867930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25173968|NCT02867930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25173969|NCT02867930|Adrenergic Agents|adrenergic agents|mesh-ancestor
25173970|NCT02867930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25173971|NCT02867930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25173972|NCT02867930|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25173973|NCT02867930|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25173974|NCT02867930|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25173975|NCT02867904|Methylprednisolone|methylprednisolone|mesh-list
25173976|NCT02867904|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25173977|NCT02867904|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25173981|NCT02867904|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25173982|NCT02867904|Prednisolone phosphate|prednisolone phosphate|mesh-list
25173983|NCT02867904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25173984|NCT02867904|Antiemetics|antiemetics|mesh-ancestor
24542494|NCT00678977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24542495|NCT00678977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542496|NCT00678977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24542497|NCT00678977|Immunologic Factors|immunologic factors|mesh-ancestor
24862731|NCT04674241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24862732|NCT04674241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24862733|NCT04674241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24862734|NCT04674241|Adrenergic Agents|adrenergic agents|mesh-ancestor
24862735|NCT04674241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24862736|NCT04674241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862737|NCT04650204|Anticonvulsants|anticonvulsants|mesh-list
24862781|NCT04382924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862782|NCT04382924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862783|NCT04382924|Vasodilator Agents|vasodilator agents|mesh-ancestor
24862784|NCT04382924|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24660734|NCT01285505|Alprazolam|alprazolam|mesh-list
25426097|NCT02057133|Fulvestrant|fulvestrant|mesh-list
25665092|NCT01680172|Ketamine|ketamine|mesh-list
24973218|NCT03710863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973386|NCT03709927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24973387|NCT03709927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24794593|NCT04910386|Immunologic Factors|immunologic factors|mesh-ancestor
24794594|NCT04910386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794595|NCT04905979|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24794596|NCT04905979|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24794597|NCT04905979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25173985|NCT02867904|Autonomic Agents|autonomic agents|mesh-ancestor
25173986|NCT02867904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25173987|NCT02867904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25173988|NCT02867904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25173989|NCT02867904|Glucocorticoids|glucocorticoids|mesh-ancestor
25173991|NCT02867904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25173992|NCT02867904|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25173993|NCT02867904|Protective Agents|protective agents|mesh-ancestor
25173994|NCT02867904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25173995|NCT02867904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25173996|NCT02867904|Anesthetics, Local|anesthetics, local|mesh-ancestor
25173997|NCT02867904|Anesthetics|anesthetics|mesh-ancestor
25173998|NCT02867904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25173999|NCT02867904|Sensory System Agents|sensory system agents|mesh-ancestor
25174000|NCT02867878|Adenosine|adenosine|mesh-list
25174001|NCT02867878|Analgesics|analgesics|mesh-ancestor
25174002|NCT02867878|Sensory System Agents|sensory system agents|mesh-ancestor
25174003|NCT02867878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25174004|NCT02867878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174005|NCT02867878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25174006|NCT02867878|Vasodilator Agents|vasodilator agents|mesh-ancestor
25174007|NCT02867878|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25174008|NCT02867878|Purinergic Agonists|purinergic agonists|mesh-ancestor
25174009|NCT02867878|Purinergic Agents|purinergic agents|mesh-ancestor
25174010|NCT02867878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25174011|NCT02867878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174012|NCT02867917|Psyllium|psyllium|mesh-list
25174013|NCT02867917|Cathartics|cathartics|mesh-ancestor
25174014|NCT02867917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25174015|NCT02867566|Rituximab|rituximab|mesh-list
25174016|NCT02867566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25174017|NCT02867566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174018|NCT02867566|Immunologic Factors|immunologic factors|mesh-ancestor
25174019|NCT02867566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174020|NCT02867566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25174021|NCT02867852|Abiraterone Acetate|abiraterone acetate|mesh-list
25174022|NCT02867852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174023|NCT02867852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25174025|NCT02867852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174026|NCT02867852|Hormone Antagonists|hormone antagonists|mesh-ancestor
25174027|NCT02867852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25174028|NCT02867852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174029|NCT02867852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25174030|NCT02867722|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25174031|NCT02867722|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25174032|NCT02867722|Dermatologic Agents|dermatologic agents|mesh-ancestor
25174033|NCT02867553|Rituximab|rituximab|mesh-list
25174034|NCT02867553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25174035|NCT02867553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174036|NCT02867553|Immunologic Factors|immunologic factors|mesh-ancestor
25174037|NCT02867553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174038|NCT02867553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25174039|NCT02867800|Acetaminophen|acetaminophen|mesh-list
25174040|NCT02867800|Diphenhydramine|diphenhydramine|mesh-list
25174041|NCT02867800|Promethazine|promethazine|mesh-list
25174042|NCT02867800|Cyclosporine|cyclosporine|mesh-list
25174043|NCT02867800|Sirolimus|sirolimus|mesh-list
25174044|NCT02867800|Mycophenolic Acid|mycophenolic acid|mesh-list
25174045|NCT02867800|Methylprednisolone|methylprednisolone|mesh-list
25174046|NCT02867800|Methotrexate|methotrexate|mesh-list
25174047|NCT02867800|Fludarabine|fludarabine|mesh-list
25174048|NCT02867800|Melphalan|melphalan|mesh-list
25174049|NCT02867800|Alemtuzumab|alemtuzumab|mesh-list
25174050|NCT02867800|Abatacept|abatacept|mesh-list
25174051|NCT02867800|Thiotepa|thiotepa|mesh-list
25174052|NCT02867800|Meperidine|meperidine|mesh-list
25174053|NCT02867800|Tacrolimus|tacrolimus|mesh-list
24752916|NCT01712828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24752917|NCT01712828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24752918|NCT01712828|Histamine Antagonists|histamine antagonists|mesh-ancestor
24543132|NCT00681993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25860159|NCT00082862|Antiviral Agents|antiviral agents|mesh-ancestor
25174054|NCT02867800|Cyclosporins|cyclosporins|mesh-list
25174055|NCT02867800|Thymoglobulin|thymoglobulin|mesh-list
25174056|NCT02867800|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25174057|NCT02867800|Abortifacient Agents|abortifacient agents|mesh-ancestor
25174058|NCT02867800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25174059|NCT02867800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174060|NCT02867800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25174061|NCT02867800|Antimetabolites|antimetabolites|mesh-ancestor
25174062|NCT02867800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174063|NCT02867800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174064|NCT02867800|Dermatologic Agents|dermatologic agents|mesh-ancestor
25174065|NCT02867800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25174066|NCT02867800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25174067|NCT02867800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25174068|NCT02867800|Immunologic Factors|immunologic factors|mesh-ancestor
25174069|NCT02867800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25174070|NCT02867800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25174071|NCT02867800|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25174072|NCT02867800|Antifungal Agents|antifungal agents|mesh-ancestor
25174073|NCT02867800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25174074|NCT02867800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25174075|NCT02867800|Analgesics|analgesics|mesh-ancestor
25174076|NCT02867800|Sensory System Agents|sensory system agents|mesh-ancestor
25174077|NCT02867800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25174078|NCT02867800|Antipyretics|antipyretics|mesh-ancestor
25174079|NCT02867800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25174080|NCT02867800|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25174081|NCT02867800|Antitubercular Agents|antitubercular agents|mesh-ancestor
25174082|NCT02867800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25174083|NCT02867800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25174084|NCT02867800|Antiemetics|antiemetics|mesh-ancestor
25174085|NCT02867800|Autonomic Agents|autonomic agents|mesh-ancestor
25174086|NCT02867800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25174087|NCT02867800|Glucocorticoids|glucocorticoids|mesh-ancestor
25174088|NCT02867800|Hormones|hormones|mesh-ancestor
25860160|NCT00082862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24752958|NCT01712997|Iloprost|iloprost|mesh-list
25174089|NCT02867800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25174090|NCT02867800|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25174091|NCT02867800|Protective Agents|protective agents|mesh-ancestor
25174288|NCT02866214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25174092|NCT02867800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25174093|NCT02867800|Alkylating Agents|alkylating agents|mesh-ancestor
25174094|NCT02867800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25174095|NCT02867800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25174096|NCT02867800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25174097|NCT02867800|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25174098|NCT02867800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25174099|NCT02867800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25174100|NCT02867800|Anesthetics, Local|anesthetics, local|mesh-ancestor
25174101|NCT02867800|Anesthetics|anesthetics|mesh-ancestor
25174102|NCT02867800|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25174103|NCT02867800|Histamine Antagonists|histamine antagonists|mesh-ancestor
25174104|NCT02867800|Histamine Agents|histamine agents|mesh-ancestor
25174105|NCT02867800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25174106|NCT02867800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25174107|NCT02867800|Antipruritics|antipruritics|mesh-ancestor
25174108|NCT02867800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25174109|NCT02867800|Narcotics|narcotics|mesh-ancestor
25174110|NCT02867800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25174111|NCT02867839|Oxaliplatin|oxaliplatin|mesh-list
25174112|NCT02867839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174113|NCT02867176|Ketorolac|ketorolac|mesh-list
25174114|NCT02867176|Gabapentin|gabapentin|mesh-list
25174115|NCT02867176|Analgesics|analgesics|mesh-ancestor
25174116|NCT02867176|Sensory System Agents|sensory system agents|mesh-ancestor
25174117|NCT02867176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25174118|NCT02867176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174119|NCT02867176|Anticonvulsants|anticonvulsants|mesh-ancestor
25174120|NCT02867176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25174121|NCT02867176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25174122|NCT02867176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25174123|NCT02867176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25426098|NCT02057133|Anastrozole|anastrozole|mesh-list
25174124|NCT02867176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25174125|NCT02867176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25174126|NCT02867176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25174127|NCT02867176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174128|NCT02867176|Antimanic Agents|antimanic agents|mesh-ancestor
25174129|NCT02867176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25174130|NCT02867176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25174131|NCT02867176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25174132|NCT02867176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25174133|NCT02867176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25174134|NCT02867176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25174135|NCT02867293|Anesthetics|anesthetics|mesh-list
25174136|NCT02867293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25174137|NCT02867293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174138|NCT02867306|Methotrexate|methotrexate|mesh-list
25174139|NCT02867306|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25174140|NCT02867306|Abortifacient Agents|abortifacient agents|mesh-ancestor
25174141|NCT02867306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25174142|NCT02867306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174143|NCT02867306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25174144|NCT02867306|Antimetabolites|antimetabolites|mesh-ancestor
25174145|NCT02867306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174146|NCT02867306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174147|NCT02867306|Dermatologic Agents|dermatologic agents|mesh-ancestor
25174148|NCT02867306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25174149|NCT02867306|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25174150|NCT02867306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25174151|NCT02867306|Immunologic Factors|immunologic factors|mesh-ancestor
25174152|NCT02867306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25174153|NCT02867306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25174154|NCT02867397|Oxaliplatin|oxaliplatin|mesh-list
25174155|NCT02867397|Epirubicin|epirubicin|mesh-list
25174156|NCT02867397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174157|NCT02867397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25174158|NCT02867397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25174159|NCT02867397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25174160|NCT02867397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25174161|NCT02867397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174162|NCT02867280|Sorafenib|sorafenib|mesh-list
25174163|NCT02867280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174164|NCT02867280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25174165|NCT02867280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25174166|NCT02867280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174167|NCT02867124|Naltrexone|naltrexone|mesh-list
25174168|NCT02867124|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24752990|NCT01713153|Misoprostol|misoprostol|mesh-list
24944598|NCT03959176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24753029|NCT01713361|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24753030|NCT01713361|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25174169|NCT02867124|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25174170|NCT02867124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174171|NCT02867124|Sensory System Agents|sensory system agents|mesh-ancestor
25174172|NCT02867124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25174173|NCT02867332|Cyclophosphamide|cyclophosphamide|mesh-list
25174174|NCT02867332|Interleukin-2|interleukin-2|mesh-list
25174175|NCT02867332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25174176|NCT02867332|Immunologic Factors|immunologic factors|mesh-ancestor
25174177|NCT02867332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174178|NCT02867332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25174179|NCT02867332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25174180|NCT02867332|Alkylating Agents|alkylating agents|mesh-ancestor
25174181|NCT02867332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174182|NCT02867332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174183|NCT02867332|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25174184|NCT02867332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25174185|NCT02867332|Analgesics|analgesics|mesh-ancestor
25174186|NCT02867332|Sensory System Agents|sensory system agents|mesh-ancestor
25174187|NCT02867332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25174188|NCT02867345|Cyclophosphamide|cyclophosphamide|mesh-list
25174189|NCT02867345|Interleukin-2|interleukin-2|mesh-list
25174190|NCT02867345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24718295|NCT01553773|Estradiol|estradiol|mesh-list
25174191|NCT02867345|Immunologic Factors|immunologic factors|mesh-ancestor
25174192|NCT02867345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174194|NCT02867345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25174195|NCT02867345|Alkylating Agents|alkylating agents|mesh-ancestor
25174196|NCT02867345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174197|NCT02867345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174198|NCT02867345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25174199|NCT02867345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25174200|NCT02867345|Analgesics|analgesics|mesh-ancestor
25174201|NCT02867345|Sensory System Agents|sensory system agents|mesh-ancestor
25174202|NCT02867345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204231|NCT02709824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25204232|NCT02709824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25204233|NCT02709824|Disinfectants|disinfectants|mesh-ancestor
25204234|NCT02709824|Dermatologic Agents|dermatologic agents|mesh-ancestor
25204235|NCT02709720|Cisplatin|cisplatin|mesh-list
25204236|NCT02709720|Vinorelbine|vinorelbine|mesh-list
25204237|NCT02709720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25204238|NCT02709720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25204239|NCT02709720|Tubulin Modulators|tubulin modulators|mesh-ancestor
25204240|NCT02709720|Antimitotic Agents|antimitotic agents|mesh-ancestor
25204241|NCT02709720|Mitosis Modulators|mitosis modulators|mesh-ancestor
25204242|NCT02709720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753040|NCT01713387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25204243|NCT02709668|Vitamin B Complex|vitamin b complex|mesh-list
25204244|NCT02709668|Vitamins|vitamins|mesh-ancestor
25204245|NCT02709668|Micronutrients|micronutrients|mesh-ancestor
25204246|NCT02709668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204247|NCT02709590|Diclofenac|diclofenac|mesh-list
25204248|NCT02709590|Lidocaine|lidocaine|mesh-list
25204249|NCT02709590|Anesthetics, Local|anesthetics, local|mesh-ancestor
25204250|NCT02709590|Anesthetics|anesthetics|mesh-ancestor
25204251|NCT02709590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25204252|NCT02709590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204253|NCT02709590|Sensory System Agents|sensory system agents|mesh-ancestor
25204254|NCT02709590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204255|NCT02709590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25204256|NCT02709590|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25204257|NCT02709590|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25204258|NCT02709590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25204259|NCT02709590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204260|NCT02709590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25204261|NCT02709590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25204263|NCT02709590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25204264|NCT02709590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25204265|NCT02709590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25204266|NCT02709590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25204267|NCT02709603|Scopolamine|scopolamine|mesh-list
25204268|NCT02709603|Bromides|bromides|mesh-list
25204269|NCT02709603|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25204270|NCT02709603|Anticonvulsants|anticonvulsants|mesh-ancestor
25204271|NCT02709603|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25174204|NCT02866903|Oxaliplatin|oxaliplatin|mesh-list
25174205|NCT02866903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25174206|NCT02866903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174207|NCT02866903|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25174208|NCT02866903|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25174209|NCT02866903|Growth Substances|growth substances|mesh-ancestor
25174210|NCT02866903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174211|NCT02866903|Growth Inhibitors|growth inhibitors|mesh-ancestor
25174212|NCT02867046|Dexamethasone|dexamethasone|mesh-list
25174213|NCT02867046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25174214|NCT02867046|Antiemetics|antiemetics|mesh-ancestor
25174215|NCT02867046|Autonomic Agents|autonomic agents|mesh-ancestor
25174216|NCT02867046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25174217|NCT02867046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174218|NCT02867046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25174219|NCT02867046|Glucocorticoids|glucocorticoids|mesh-ancestor
25174220|NCT02867046|Hormones|hormones|mesh-ancestor
25174221|NCT02867046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25174222|NCT02867046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25174223|NCT02867046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174224|NCT02867020|Prednisone|prednisone|mesh-list
25665093|NCT01680172|Analgesics|analgesics|mesh-ancestor
25174225|NCT02867020|Goserelin|goserelin|mesh-list
25174226|NCT02867020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25174227|NCT02867020|Glucocorticoids|glucocorticoids|mesh-ancestor
25174228|NCT02867020|Hormones|hormones|mesh-ancestor
25174229|NCT02867020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25174230|NCT02867020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174231|NCT02867020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25174232|NCT02867020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174233|NCT02867007|Mogamulizumab|mogamulizumab|mesh-list
25174234|NCT02867007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174235|NCT02866955|Tamoxifen|tamoxifen|mesh-list
25174243|NCT02866955|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25174244|NCT02866955|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25174245|NCT02866955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25174246|NCT02866955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25174247|NCT02866955|Alkylating Agents|alkylating agents|mesh-ancestor
25174248|NCT02866955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174250|NCT02866786|Cyproterone Acetate|cyproterone acetate|mesh-list
25174251|NCT02866786|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25174252|NCT02866786|Estradiol|estradiol|mesh-list
25174253|NCT02866786|Cyproterone|cyproterone|mesh-list
24619282|NCT01051765|Irinotecan|irinotecan|mesh-list
24753055|NCT01713426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25174254|NCT02866786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25174255|NCT02866786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174256|NCT02866786|Estrogens|estrogens|mesh-ancestor
25174257|NCT02866786|Hormones|hormones|mesh-ancestor
25174258|NCT02866786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25174259|NCT02866786|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25174260|NCT02866786|Contraceptive Agents|contraceptive agents|mesh-ancestor
25174261|NCT02866786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25174262|NCT02866786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25174263|NCT02866786|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25174264|NCT02866786|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25174265|NCT02866786|Androgen Antagonists|androgen antagonists|mesh-ancestor
25174266|NCT02866786|Hormone Antagonists|hormone antagonists|mesh-ancestor
25174267|NCT02866786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174268|NCT02866786|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25174269|NCT02866409|Dexmedetomidine|dexmedetomidine|mesh-list
25174270|NCT02866409|Bupivacaine|bupivacaine|mesh-list
25174271|NCT02866409|Anesthetics, Local|anesthetics, local|mesh-ancestor
25174272|NCT02866409|Anesthetics|anesthetics|mesh-ancestor
25174273|NCT02866409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25174274|NCT02866409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174275|NCT02866409|Sensory System Agents|sensory system agents|mesh-ancestor
24862949|NCT03914885|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24862950|NCT03914885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24862951|NCT03914885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862952|NCT03914885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24862953|NCT03914885|Alkylating Agents|alkylating agents|mesh-ancestor
24794598|NCT04905979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24973818|NCT03706703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24973819|NCT03706703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24973820|NCT03706703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24974050|NCT05175625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974052|NCT05175547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24974053|NCT05175547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24753057|NCT01713426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24974054|NCT05175547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974055|NCT05175547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24974056|NCT05175547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974058|NCT05175508|Tretinoin|tretinoin|mesh-list
24974059|NCT05175508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24974060|NCT05175508|Antimetabolites|antimetabolites|mesh-ancestor
24974061|NCT05175508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974152|NCT05156684|Pentoxifylline|pentoxifylline|mesh-list
24974153|NCT05156684|Zinc Sulfate|zinc sulfate|mesh-list
24974155|NCT05156684|Micronutrients|micronutrients|mesh-ancestor
24974156|NCT05156684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974157|NCT05156684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24974158|NCT05156684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24974159|NCT05156684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974160|NCT05156684|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24974161|NCT05156684|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24974162|NCT05156684|Protective Agents|protective agents|mesh-ancestor
24974163|NCT05156684|Vasodilator Agents|vasodilator agents|mesh-ancestor
24974164|NCT05156684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24974166|NCT05156684|Astringents|astringents|mesh-ancestor
24974167|NCT05156684|Dermatologic Agents|dermatologic agents|mesh-ancestor
24974216|NCT05122559|Antidotes|antidotes|mesh-ancestor
24974377|NCT04763928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24974378|NCT04763928|Antimetabolites|antimetabolites|mesh-ancestor
24974379|NCT04763928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974380|NCT04763928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24974574|NCT04394481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974576|NCT04394481|Glucocorticoids|glucocorticoids|mesh-ancestor
24974577|NCT04394481|Hormones|hormones|mesh-ancestor
24974578|NCT04394481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24974579|NCT04394481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24974580|NCT04394481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24933149|NCT04074265|Mydriatics|mydriatics|mesh-ancestor
24588117|NCT00901069|Rituximab|rituximab|mesh-list
24588118|NCT00901069|Vincristine|vincristine|mesh-list
24753136|NCT01714011|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24588124|NCT00901069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24588126|NCT00901069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588127|NCT00901069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588128|NCT00901069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24588129|NCT00901069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24974697|NCT05309070|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24974698|NCT05309070|Antiviral Agents|antiviral agents|mesh-ancestor
25174276|NCT02866409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25174277|NCT02866409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25174278|NCT02866409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25174279|NCT02866409|Analgesics|analgesics|mesh-ancestor
25174280|NCT02866409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25174281|NCT02866409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25174282|NCT02866409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25174283|NCT02866409|Adrenergic Agents|adrenergic agents|mesh-ancestor
25174284|NCT02866409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25174285|NCT02866409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174286|NCT02866214|Febuxostat|febuxostat|mesh-list
25174287|NCT02866214|Gout Suppressants|gout suppressants|mesh-ancestor
25174289|NCT02866448|Aspirin|aspirin|mesh-list
25174290|NCT02866448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25174291|NCT02866448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25174292|NCT02866448|Analgesics|analgesics|mesh-ancestor
25174293|NCT02866448|Sensory System Agents|sensory system agents|mesh-ancestor
25174294|NCT02866448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25174295|NCT02866448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174296|NCT02866448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25174297|NCT02866448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25174298|NCT02866448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25174299|NCT02866448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25174300|NCT02866448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174301|NCT02866448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25174302|NCT02866448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25174303|NCT02866448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25174304|NCT02866448|Antipyretics|antipyretics|mesh-ancestor
25174305|NCT02866435|Potassium phosphate|potassium phosphate|mesh-list
25174306|NCT02866435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174307|NCT02866435|Cariostatic Agents|cariostatic agents|mesh-ancestor
25174308|NCT02866435|Protective Agents|protective agents|mesh-ancestor
25174309|NCT02866370|Paclitaxel|paclitaxel|mesh-list
25174310|NCT02866370|Carboplatin|carboplatin|mesh-list
25174311|NCT02866370|Doxorubicin|doxorubicin|mesh-list
25174312|NCT02866370|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25174313|NCT02866370|Topotecan|topotecan|mesh-list
25174314|NCT02866370|Nintedanib|nintedanib|mesh-list
25174315|NCT02866370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25174316|NCT02866370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174317|NCT02866370|Tubulin Modulators|tubulin modulators|mesh-ancestor
25174318|NCT02866370|Antimitotic Agents|antimitotic agents|mesh-ancestor
25174319|NCT02866370|Mitosis Modulators|mitosis modulators|mesh-ancestor
25174320|NCT02866370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174321|NCT02866370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25174322|NCT02866370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24641577|NCT01174303|Insulin|insulin|mesh-list
25174323|NCT02866370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25174324|NCT02866370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25174325|NCT02866370|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25174326|NCT02866370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25174327|NCT02866253|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25174328|NCT02866253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25174329|NCT02866253|Immunologic Factors|immunologic factors|mesh-ancestor
25174330|NCT02866253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174331|NCT02866396|Pregabalin|pregabalin|mesh-list
25174332|NCT02866396|Analgesics|analgesics|mesh-ancestor
25174333|NCT02866396|Sensory System Agents|sensory system agents|mesh-ancestor
25174334|NCT02866396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25174335|NCT02866396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174336|NCT02866396|Anticonvulsants|anticonvulsants|mesh-ancestor
25174337|NCT02866396|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25174338|NCT02866396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25174339|NCT02866396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174340|NCT02866396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25174341|NCT02866396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25174342|NCT02866396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25174343|NCT02866396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25174344|NCT02866396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25174345|NCT02866136|Carboplatin|carboplatin|mesh-list
25174346|NCT02866136|Etoposide|etoposide|mesh-list
25174347|NCT02866136|Etoposide phosphate|etoposide phosphate|mesh-list
25174348|NCT02866136|Melphalan|melphalan|mesh-list
25174349|NCT02866136|Vincristine|vincristine|mesh-list
25174350|NCT02866136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174351|NCT02866136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25174352|NCT02866136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25174353|NCT02866136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25174354|NCT02866136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25174355|NCT02866136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204272|NCT02709603|Antiemetics|antiemetics|mesh-ancestor
25174356|NCT02866136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25174358|NCT02866136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25174359|NCT02866136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25174360|NCT02866136|Immunologic Factors|immunologic factors|mesh-ancestor
25174361|NCT02866136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174362|NCT02866136|Tubulin Modulators|tubulin modulators|mesh-ancestor
25174363|NCT02866136|Antimitotic Agents|antimitotic agents|mesh-ancestor
25174364|NCT02866136|Mitosis Modulators|mitosis modulators|mesh-ancestor
24753248|NCT01714401|Albuterol|albuterol|mesh-list
24753249|NCT01714401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24753250|NCT01714401|Autonomic Agents|autonomic agents|mesh-ancestor
25174365|NCT02865824|Aspirin|aspirin|mesh-list
25174366|NCT02865824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25174367|NCT02865824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25174368|NCT02865824|Analgesics|analgesics|mesh-ancestor
25174369|NCT02865824|Sensory System Agents|sensory system agents|mesh-ancestor
25174370|NCT02865824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25174371|NCT02865824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174372|NCT02865824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25174373|NCT02865824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25174374|NCT02865824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25174375|NCT02865824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25174376|NCT02865824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174377|NCT02865824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25174378|NCT02865824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25174379|NCT02865824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25174380|NCT02865824|Antipyretics|antipyretics|mesh-ancestor
25174381|NCT02865980|Povidone-Iodine|povidone-iodine|mesh-list
25174382|NCT02865980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25174383|NCT02865980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25174384|NCT02865785|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25174385|NCT02865785|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25174461|NCT02865668|Canagliflozin|canagliflozin|mesh-list
25174397|NCT02865993|Povidone-Iodine|povidone-iodine|mesh-list
25174398|NCT02865993|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25174399|NCT02865993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25665094|NCT01680172|Sensory System Agents|sensory system agents|mesh-ancestor
25174400|NCT02866071|Ketamine|ketamine|mesh-list
25174401|NCT02866071|Analgesics|analgesics|mesh-ancestor
25174402|NCT02866071|Sensory System Agents|sensory system agents|mesh-ancestor
25174403|NCT02866071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25174404|NCT02866071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174405|NCT02866071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25174406|NCT02866071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25174407|NCT02866071|Anesthetics, General|anesthetics, general|mesh-ancestor
25174408|NCT02866071|Anesthetics|anesthetics|mesh-ancestor
25174409|NCT02866071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25174410|NCT02866071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25174411|NCT02866071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25174412|NCT02866071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25174413|NCT02866071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174414|NCT02865733|Treprostinil|treprostinil|mesh-list
25174415|NCT02865733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25174416|NCT02865629|Acetylcysteine|acetylcysteine|mesh-list
25174417|NCT02865629|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25174418|NCT02865629|Antiviral Agents|antiviral agents|mesh-ancestor
25174419|NCT02865629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25174420|NCT02865629|Expectorants|expectorants|mesh-ancestor
25174421|NCT02865629|Respiratory System Agents|respiratory system agents|mesh-ancestor
25174422|NCT02865629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25174423|NCT02865629|Antioxidants|antioxidants|mesh-ancestor
25174424|NCT02865629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174425|NCT02865629|Protective Agents|protective agents|mesh-ancestor
25174426|NCT02865629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174427|NCT02865629|Antidotes|antidotes|mesh-ancestor
25174428|NCT02865681|Letrozole|letrozole|mesh-list
25174429|NCT02865681|Clomiphene|clomiphene|mesh-list
25174430|NCT02865681|Enclomiphene|enclomiphene|mesh-list
25174432|NCT02865681|Menotropins|menotropins|mesh-list
25174433|NCT02865681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174434|NCT02865681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174435|NCT02865681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25174436|NCT02865681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25174437|NCT02865681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25174438|NCT02865681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25174439|NCT02865681|Hormone Antagonists|hormone antagonists|mesh-ancestor
25174440|NCT02865681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25174441|NCT02865681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174442|NCT02865681|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25174443|NCT02865681|Fertility Agents|fertility agents|mesh-ancestor
25174444|NCT02865681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25174445|NCT02865681|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25174446|NCT02865681|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25174447|NCT02865642|Citalopram|citalopram|mesh-list
25174448|NCT02865642|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25174450|NCT02865642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25174451|NCT02865642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25174452|NCT02865642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174453|NCT02865642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25174454|NCT02865642|Serotonin Agents|serotonin agents|mesh-ancestor
25174455|NCT02865642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174456|NCT02865642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25174457|NCT02865642|Antidepressive Agents|antidepressive agents|mesh-ancestor
25174458|NCT02865642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25174459|NCT02865642|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25174460|NCT02865668|Metformin|metformin|mesh-list
25174462|NCT02865668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25174463|NCT02865668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174464|NCT02865668|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25174465|NCT02865668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174466|NCT02865564|Gentamicins|gentamicins|mesh-list
25174467|NCT02865564|Ampicillin|ampicillin|mesh-list
25174468|NCT02865564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25174469|NCT02865564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25174470|NCT02865564|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25174471|NCT02865564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25174472|NCT02865564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174473|NCT02865616|Vancomycin|vancomycin|mesh-list
25174474|NCT02865616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25174475|NCT02865616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25174476|NCT02865460|Coenzyme Q10|coenzyme q10|mesh-list
25174477|NCT02865460|Micronutrients|micronutrients|mesh-ancestor
25174478|NCT02865460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174479|NCT02865460|Vitamins|vitamins|mesh-ancestor
25174480|NCT02865369|Asunaprevir|asunaprevir|mesh-list
25174481|NCT02865369|Protease Inhibitors|protease inhibitors|mesh-ancestor
25174482|NCT02865369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25174483|NCT02865369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174484|NCT02865356|Cyclosporine|cyclosporine|mesh-list
25174485|NCT02865356|Cyclosporins|cyclosporins|mesh-list
25174486|NCT02865356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25174487|NCT02865356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174488|NCT02865356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25174489|NCT02865356|Immunologic Factors|immunologic factors|mesh-ancestor
25174490|NCT02865356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174491|NCT02865356|Antifungal Agents|antifungal agents|mesh-ancestor
25174492|NCT02865356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25174493|NCT02865356|Dermatologic Agents|dermatologic agents|mesh-ancestor
25174494|NCT02865356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25174495|NCT02865356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25204273|NCT02709603|Autonomic Agents|autonomic agents|mesh-ancestor
25204274|NCT02709603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204275|NCT02709603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204276|NCT02709603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24753382|NCT01715090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24753383|NCT01715090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753384|NCT01715142|Gemcitabine|gemcitabine|mesh-list
24753385|NCT01715142|Paclitaxel|paclitaxel|mesh-list
24753386|NCT01715142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24753387|NCT01715142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24753388|NCT01715142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25204277|NCT02709603|Mydriatics|mydriatics|mesh-ancestor
25204278|NCT02709603|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25204279|NCT02709603|Cholinergic Agents|cholinergic agents|mesh-ancestor
25204280|NCT02709603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24584155|NCT00878865|Alprazolam|alprazolam|mesh-list
25174496|NCT02865304|Endostar protein|endostar protein|mesh-list
25174497|NCT02865304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25174498|NCT02865304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25174499|NCT02865304|Growth Substances|growth substances|mesh-ancestor
25174500|NCT02865304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174501|NCT02865304|Growth Inhibitors|growth inhibitors|mesh-ancestor
25174502|NCT02865304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174503|NCT02865174|Heparin|heparin|mesh-list
25174504|NCT02865174|Enoxaparin|enoxaparin|mesh-list
25174505|NCT02865174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25174506|NCT02865174|Tinzaparin|tinzaparin|mesh-list
25174507|NCT02865174|Dalteparin|dalteparin|mesh-list
25174508|NCT02865174|Tranylcypromine|tranylcypromine|mesh-list
25174509|NCT02865174|Tranexamic Acid|tranexamic acid|mesh-list
25174510|NCT02865174|Thrombin|thrombin|mesh-list
25174514|NCT02865174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174515|NCT02865174|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25174516|NCT02865174|Hemostatics|hemostatics|mesh-ancestor
25174517|NCT02865174|Coagulants|coagulants|mesh-ancestor
25174518|NCT02865174|Antidepressive Agents|antidepressive agents|mesh-ancestor
25174519|NCT02865174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25174520|NCT02865174|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25174521|NCT02865174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25174522|NCT02865174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25174523|NCT02865174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25174524|NCT02865174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25174525|NCT02865174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174526|NCT02865005|Dapsone|dapsone|mesh-list
25174527|NCT02865005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25174528|NCT02865005|Antimalarials|antimalarials|mesh-ancestor
25174529|NCT02865005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25174530|NCT02865005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25174531|NCT02865005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25174532|NCT02865005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25174533|NCT02865005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174534|NCT02865005|Leprostatic Agents|leprostatic agents|mesh-ancestor
25174535|NCT02865005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25174536|NCT02864927|Vaccines|vaccines|mesh-list
25174537|NCT02864927|Immunologic Factors|immunologic factors|mesh-ancestor
25174538|NCT02864927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174539|NCT02864849|Capecitabine|capecitabine|mesh-list
25174540|NCT02864849|Oxaliplatin|oxaliplatin|mesh-list
25174541|NCT02864849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25174542|NCT02864849|Antimetabolites|antimetabolites|mesh-ancestor
25174543|NCT02864849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174544|NCT02864849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174546|NCT02865018|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25174547|NCT02865018|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25174548|NCT02865018|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25174549|NCT02865018|Histamine Antagonists|histamine antagonists|mesh-ancestor
25174550|NCT02865018|Histamine Agents|histamine agents|mesh-ancestor
25174551|NCT02865018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25174552|NCT02865018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418034|NCT00208442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25174553|NCT02865018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174554|NCT02864758|Vitamin K|vitamin k|mesh-list
25174555|NCT02864758|Rivaroxaban|rivaroxaban|mesh-list
25174556|NCT02864758|Dabigatran|dabigatran|mesh-list
25174557|NCT02864758|Vitamins|vitamins|mesh-ancestor
25174558|NCT02864758|Micronutrients|micronutrients|mesh-ancestor
25174559|NCT02864758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174560|NCT02864758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25174561|NCT02864758|Antithrombins|antithrombins|mesh-ancestor
25174562|NCT02864758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25174563|NCT02864758|Protease Inhibitors|protease inhibitors|mesh-ancestor
25174564|NCT02864758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25174565|NCT02864758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584423|NCT00880321|Anesthetics|anesthetics|mesh-ancestor
25174566|NCT02864758|Anticoagulants|anticoagulants|mesh-ancestor
25174567|NCT02864758|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25174568|NCT02864758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25174569|NCT02864758|Hemostatics|hemostatics|mesh-ancestor
25174570|NCT02864758|Coagulants|coagulants|mesh-ancestor
25174571|NCT02864784|Calcium Carbonate|calcium carbonate|mesh-list
25174572|NCT02864784|Calcium|calcium|mesh-list
25174573|NCT02864784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25174574|NCT02864784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174575|NCT02864784|Antacids|antacids|mesh-ancestor
25174576|NCT02864784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174577|NCT02864784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25174578|NCT02864602|Dexamethasone|dexamethasone|mesh-list
25174579|NCT02864602|Dexamethasone acetate|dexamethasone acetate|mesh-list
25174580|NCT02864602|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25174581|NCT02864602|BB 1101|bb 1101|mesh-list
25174582|NCT02864602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25174583|NCT02864602|Antiemetics|antiemetics|mesh-ancestor
25174591|NCT02864602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25174593|NCT02864602|Protease Inhibitors|protease inhibitors|mesh-ancestor
25174594|NCT02864602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25174595|NCT02864602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174601|NCT02864472|Growth Inhibitors|growth inhibitors|mesh-ancestor
25174602|NCT02864472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174603|NCT02864550|Doxycycline|doxycycline|mesh-list
25174604|NCT02864550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25174605|NCT02864550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25174606|NCT02864550|Antimalarials|antimalarials|mesh-ancestor
25174607|NCT02864550|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25174608|NCT02864550|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25174609|NCT02864264|Interferons|interferons|mesh-list
25174610|NCT02864264|Interferon-gamma|interferon-gamma|mesh-list
25174611|NCT02864264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174612|NCT02864264|Antiviral Agents|antiviral agents|mesh-ancestor
25174613|NCT02864264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25174614|NCT02864199|Ribavirin|ribavirin|mesh-list
25174615|NCT02864199|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25174616|NCT02864199|Antimetabolites|antimetabolites|mesh-ancestor
25174617|NCT02864199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174618|NCT02864199|Antiviral Agents|antiviral agents|mesh-ancestor
25174619|NCT02864199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25174620|NCT02863861|Dexmedetomidine|dexmedetomidine|mesh-list
25174621|NCT02863861|Ketamine|ketamine|mesh-list
25174622|NCT02863861|Propofol|propofol|mesh-list
25174623|NCT02863861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25174624|NCT02863861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25174625|NCT02863861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174626|NCT02863861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25174627|NCT02863861|Anesthetics, General|anesthetics, general|mesh-ancestor
25174628|NCT02863861|Anesthetics|anesthetics|mesh-ancestor
25174629|NCT02863861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25174630|NCT02863861|Analgesics|analgesics|mesh-ancestor
25174631|NCT02863861|Sensory System Agents|sensory system agents|mesh-ancestor
25174632|NCT02863861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24753450|NCT01715441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24753451|NCT01715441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24753452|NCT01715493|Muramidase|muramidase|mesh-list
24753453|NCT01715493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25174633|NCT02863861|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25174634|NCT02863861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25174635|NCT02863861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25174636|NCT02863861|Adrenergic Agents|adrenergic agents|mesh-ancestor
25174637|NCT02863861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25174638|NCT02863861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174639|NCT02863861|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25174640|NCT02863861|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25174641|NCT02863861|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25174648|NCT02864095|Epinephrine|epinephrine|mesh-list
25174649|NCT02864095|Tranexamic Acid|tranexamic acid|mesh-list
25174650|NCT02864095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25174651|NCT02864095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25174652|NCT02864095|Adrenergic Agents|adrenergic agents|mesh-ancestor
25174653|NCT02864095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25174654|NCT02864095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174655|NCT02864095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174656|NCT02864095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25174657|NCT02864095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25174658|NCT02864095|Autonomic Agents|autonomic agents|mesh-ancestor
24753565|NCT01715987|Antiviral Agents|antiviral agents|mesh-ancestor
25174661|NCT02864095|Respiratory System Agents|respiratory system agents|mesh-ancestor
25174662|NCT02864095|Mydriatics|mydriatics|mesh-ancestor
25174663|NCT02864095|Sympathomimetics|sympathomimetics|mesh-ancestor
25174664|NCT02864095|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25174665|NCT02864095|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25174666|NCT02864095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25174667|NCT02864095|Hemostatics|hemostatics|mesh-ancestor
25174668|NCT02864095|Coagulants|coagulants|mesh-ancestor
25174669|NCT02863835|Albuterol|albuterol|mesh-list
25174670|NCT02863835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25174671|NCT02863835|Autonomic Agents|autonomic agents|mesh-ancestor
25174672|NCT02863835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25174673|NCT02863835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174674|NCT02863835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24753454|NCT01715519|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
24753455|NCT01715519|Antidepressive Agents|antidepressive agents|mesh-ancestor
24944620|NCT03958942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24944621|NCT03959124|Memantine|memantine|mesh-list
25174675|NCT02863835|Respiratory System Agents|respiratory system agents|mesh-ancestor
25174676|NCT02863835|Tocolytic Agents|tocolytic agents|mesh-ancestor
25174677|NCT02863835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25174678|NCT02863835|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25174679|NCT02863835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25174680|NCT02863835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25174681|NCT02863835|Adrenergic Agents|adrenergic agents|mesh-ancestor
25174682|NCT02863835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25174683|NCT02863835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174684|NCT02863913|Cyclophosphamide|cyclophosphamide|mesh-list
25174685|NCT02863913|Interleukin-2|interleukin-2|mesh-list
25174686|NCT02863913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25174687|NCT02863913|Immunologic Factors|immunologic factors|mesh-ancestor
25174688|NCT02863913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174689|NCT02863913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25174690|NCT02863913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25174691|NCT02863913|Alkylating Agents|alkylating agents|mesh-ancestor
25174692|NCT02863913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174693|NCT02863913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174694|NCT02863913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25174695|NCT02863913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25174696|NCT02863913|Analgesics|analgesics|mesh-ancestor
25174697|NCT02863913|Sensory System Agents|sensory system agents|mesh-ancestor
25174698|NCT02863913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25174699|NCT02863614|Ibuprofen|ibuprofen|mesh-list
25174700|NCT02863614|Lorazepam|lorazepam|mesh-list
25174701|NCT02863614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25174702|NCT02863614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24944622|NCT03959124|Rivastigmine|rivastigmine|mesh-list
24944623|NCT03959124|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24753501|NCT01715636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24753502|NCT01715636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753503|NCT01715636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450126|NCT00317811|Melphalan|melphalan|mesh-list
24753505|NCT01715636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25174703|NCT02863614|Analgesics|analgesics|mesh-ancestor
25174704|NCT02863614|Sensory System Agents|sensory system agents|mesh-ancestor
25174705|NCT02863614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25174706|NCT02863614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174707|NCT02863614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25174708|NCT02863614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25174709|NCT02863614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25174710|NCT02863614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25174711|NCT02863614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174712|NCT02863614|Anticonvulsants|anticonvulsants|mesh-ancestor
25174713|NCT02863614|Antiemetics|antiemetics|mesh-ancestor
25174714|NCT02863614|Autonomic Agents|autonomic agents|mesh-ancestor
25174715|NCT02863614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25174716|NCT02863614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25174717|NCT02863614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25174718|NCT02863614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25174719|NCT02863614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25174720|NCT02863614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25174721|NCT02863614|GABA Modulators|gaba modulators|mesh-ancestor
25174722|NCT02863614|GABA Agents|gaba agents|mesh-ancestor
25174723|NCT02863614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25174724|NCT02863809|Riboflavin|riboflavin|mesh-list
25174725|NCT02863809|Dextrans|dextrans|mesh-list
25174726|NCT02863809|Vitamins|vitamins|mesh-ancestor
25174727|NCT02863809|Micronutrients|micronutrients|mesh-ancestor
25174728|NCT02863809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174729|NCT02863809|Vitamin B Complex|vitamin b complex|mesh-ancestor
25174730|NCT02863809|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25174731|NCT02863809|Dermatologic Agents|dermatologic agents|mesh-ancestor
25174732|NCT02863809|Anticoagulants|anticoagulants|mesh-ancestor
25174733|NCT02863809|Plasma Substitutes|plasma substitutes|mesh-ancestor
25174734|NCT02863809|Blood Substitutes|blood substitutes|mesh-ancestor
25174735|NCT02863406|Dimercaprol|dimercaprol|mesh-list
25174736|NCT02863406|Chelating Agents|chelating agents|mesh-ancestor
25174737|NCT02863406|Sequestering Agents|sequestering agents|mesh-ancestor
25174738|NCT02863406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204281|NCT02709603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204282|NCT02709603|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25204283|NCT02709603|Parasympatholytics|parasympatholytics|mesh-ancestor
24543750|NCT00685347|Albuterol|albuterol|mesh-list
24944637|NCT03958708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24944638|NCT03958708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24944639|NCT03958708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24944640|NCT03958513|Bupivacaine|bupivacaine|mesh-list
24753523|NCT01715701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753534|NCT01715909|Oseltamivir|oseltamivir|mesh-list
25204284|NCT02709564|Misoprostol|misoprostol|mesh-list
25204285|NCT02709564|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25204286|NCT02709564|Abortifacient Agents|abortifacient agents|mesh-ancestor
25204287|NCT02709564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25204288|NCT02709564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204289|NCT02709564|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25204290|NCT02709564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25204291|NCT02709564|Oxytocics|oxytocics|mesh-ancestor
25204292|NCT02709265|Amikacin|amikacin|mesh-list
25204293|NCT02709265|Fosfomycin|fosfomycin|mesh-list
25204294|NCT02709265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25204295|NCT02709265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25204296|NCT02709304|Lidocaine|lidocaine|mesh-list
25204297|NCT02709304|Anesthetics, Local|anesthetics, local|mesh-ancestor
25204298|NCT02709304|Anesthetics|anesthetics|mesh-ancestor
25204299|NCT02709304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25204300|NCT02709304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204301|NCT02709304|Sensory System Agents|sensory system agents|mesh-ancestor
25204302|NCT02709304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204303|NCT02709304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25665095|NCT01680172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25665096|NCT01680172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204304|NCT02709304|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25204305|NCT02709304|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25204306|NCT02709304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25204307|NCT02709304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204308|NCT02709473|Remifentanil|remifentanil|mesh-list
25204309|NCT02709473|Propofol|propofol|mesh-list
25860162|NCT00082862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25860163|NCT00082862|Immunologic Factors|immunologic factors|mesh-ancestor
25860164|NCT00082862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665097|NCT01680172|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25204310|NCT02709473|Rocuronium|rocuronium|mesh-list
25204311|NCT02709473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25204312|NCT02709473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25204313|NCT02709473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204314|NCT02709473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25204315|NCT02709473|Anesthetics, General|anesthetics, general|mesh-ancestor
25204316|NCT02709473|Anesthetics|anesthetics|mesh-ancestor
25204317|NCT02709473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25204318|NCT02709473|Narcotics|narcotics|mesh-ancestor
25204319|NCT02709473|Analgesics|analgesics|mesh-ancestor
25204320|NCT02709473|Sensory System Agents|sensory system agents|mesh-ancestor
25204321|NCT02709473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204322|NCT02709473|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25204323|NCT02709473|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25204324|NCT02709473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25204325|NCT02709187|Candesartan|candesartan|mesh-list
25204326|NCT02709187|Candesartan cilexetil|candesartan cilexetil|mesh-list
24753535|NCT01715909|Antiviral Agents|antiviral agents|mesh-ancestor
24944642|NCT03958513|Anesthetics|anesthetics|mesh-ancestor
24944643|NCT03958513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24944644|NCT03958513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944645|NCT03958513|Sensory System Agents|sensory system agents|mesh-ancestor
24944646|NCT03958513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24944647|NCT03958461|Anti-Infective Agents|anti-infective agents|mesh-list
24944648|NCT03958344|Prednisolone|prednisolone|mesh-list
24944649|NCT03958344|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25204327|NCT02709187|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25204328|NCT02709187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25204330|NCT02709187|Antimetabolites|antimetabolites|mesh-ancestor
25204331|NCT02709187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204332|NCT02709187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25204333|NCT02709187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25204334|NCT02709187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25204335|NCT02709187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25204336|NCT02709187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25204337|NCT02709187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25204338|NCT02709200|Dexmedetomidine|dexmedetomidine|mesh-list
25204339|NCT02709200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25204340|NCT02709200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24806403|NCT02015650|Mitomycins|mitomycins|mesh-list
24806404|NCT02015650|Mitomycin|mitomycin|mesh-list
24806405|NCT02015650|Antimetabolites|antimetabolites|mesh-ancestor
24601245|NCT00963664|Dihydromevinolin|dihydromevinolin|mesh-list
24601246|NCT00963664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24601247|NCT00963664|Antiviral Agents|antiviral agents|mesh-ancestor
24601248|NCT00963664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24601249|NCT00963664|Immunologic Factors|immunologic factors|mesh-ancestor
24601250|NCT00963664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174739|NCT02863367|Gemcitabine|gemcitabine|mesh-list
25174740|NCT02863367|Apatinib|apatinib|mesh-list
25174741|NCT02863367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25174742|NCT02863367|Antimetabolites|antimetabolites|mesh-ancestor
25174743|NCT02863367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174744|NCT02863367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174745|NCT02863367|Antiviral Agents|antiviral agents|mesh-ancestor
25174746|NCT02863367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25174747|NCT02863367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25174748|NCT02863367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25174749|NCT02863367|Immunologic Factors|immunologic factors|mesh-ancestor
25174750|NCT02863367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174751|NCT02863367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25174752|NCT02863679|Tetracaine|tetracaine|mesh-list
25174753|NCT02863679|Anesthetics, Local|anesthetics, local|mesh-ancestor
25174754|NCT02863679|Anesthetics|anesthetics|mesh-ancestor
25174755|NCT02863679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25174756|NCT02863679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174757|NCT02863679|Sensory System Agents|sensory system agents|mesh-ancestor
25665098|NCT01680172|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25665099|NCT01680172|Anesthetics, General|anesthetics, general|mesh-ancestor
25665100|NCT01680172|Anesthetics|anesthetics|mesh-ancestor
25174758|NCT02863679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25174759|NCT02863705|Timolol|timolol|mesh-list
25174760|NCT02863705|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25174761|NCT02863705|Bimatoprost|bimatoprost|mesh-list
25174762|NCT02863705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25174763|NCT02863705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25174764|NCT02863705|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25174765|NCT02863705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25174766|NCT02863705|Adrenergic Agents|adrenergic agents|mesh-ancestor
25174767|NCT02863705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25174768|NCT02863705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174769|NCT02863705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174770|NCT02863705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25174771|NCT02863705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25174772|NCT02863705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25174773|NCT02863705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25174774|NCT02863705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25174775|NCT02863471|Gemcitabine|gemcitabine|mesh-list
25174776|NCT02863471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25174777|NCT02863471|Antimetabolites|antimetabolites|mesh-ancestor
25174778|NCT02863471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174779|NCT02863471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174780|NCT02863471|Antiviral Agents|antiviral agents|mesh-ancestor
25174781|NCT02863471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25174782|NCT02863471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25174783|NCT02863471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25174784|NCT02863471|Immunologic Factors|immunologic factors|mesh-ancestor
25174785|NCT02863471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174786|NCT02863276|Insulin|insulin|mesh-list
25174787|NCT02863276|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24601251|NCT00963664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25174788|NCT02863276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25174861|NCT02862873|Serotonin Agents|serotonin agents|mesh-ancestor
25174789|NCT02863276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174790|NCT02862977|Ketoprofen|ketoprofen|mesh-list
25174794|NCT02862977|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25174795|NCT02862977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174796|NCT02862977|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25174797|NCT02862977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25174798|NCT02862977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174799|NCT02862977|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25174800|NCT02862977|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25174801|NCT02862977|Purinergic Agents|purinergic agents|mesh-ancestor
25174802|NCT02862977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25174803|NCT02862977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24806719|NCT02017704|Vitamins|vitamins|mesh-ancestor
25174804|NCT02862977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25174805|NCT02862977|Analgesics|analgesics|mesh-ancestor
25174806|NCT02862977|Sensory System Agents|sensory system agents|mesh-ancestor
25174807|NCT02862977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25174808|NCT02862977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25174809|NCT02862977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25174810|NCT02862977|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25174811|NCT02862977|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25174812|NCT02862977|Antidepressive Agents|antidepressive agents|mesh-ancestor
25174813|NCT02862977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25174814|NCT02862977|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25174815|NCT02862977|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25174816|NCT02862977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25174817|NCT02862977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25174818|NCT02862977|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25174819|NCT02862977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25174820|NCT02862977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25174821|NCT02862977|Adrenergic Agents|adrenergic agents|mesh-ancestor
25174822|NCT02863120|Bupivacaine|bupivacaine|mesh-list
25174823|NCT02863120|Ropivacaine|ropivacaine|mesh-list
25174824|NCT02863120|Anesthetics, Local|anesthetics, local|mesh-ancestor
25174825|NCT02863120|Anesthetics|anesthetics|mesh-ancestor
25174826|NCT02863120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25174827|NCT02863120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174828|NCT02863120|Sensory System Agents|sensory system agents|mesh-ancestor
25174829|NCT02863120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25174830|NCT02863185|Atorvastatin|atorvastatin|mesh-list
25174831|NCT02863185|Pitavastatin|pitavastatin|mesh-list
25174832|NCT02863185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25174833|NCT02863185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25174834|NCT02863185|Antimetabolites|antimetabolites|mesh-ancestor
25174835|NCT02863185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174836|NCT02863185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25174837|NCT02863185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25174838|NCT02863185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25174839|NCT02862665|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25174840|NCT02862665|Hematinics|hematinics|mesh-ancestor
25174841|NCT02862782|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25174842|NCT02862782|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25174843|NCT02862782|Luteolytic Agents|luteolytic agents|mesh-ancestor
25174844|NCT02862782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25174845|NCT02862782|Contraceptive Agents|contraceptive agents|mesh-ancestor
25174846|NCT02862782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25174847|NCT02862782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174848|NCT02862782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25174849|NCT02862782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25174850|NCT02862782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174851|NCT02862873|Ondansetron|ondansetron|mesh-list
25174852|NCT02862873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25174853|NCT02862873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174854|NCT02862873|Antiemetics|antiemetics|mesh-ancestor
25174855|NCT02862873|Autonomic Agents|autonomic agents|mesh-ancestor
25174856|NCT02862873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25174857|NCT02862873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25174858|NCT02862873|Antipruritics|antipruritics|mesh-ancestor
25174859|NCT02862873|Dermatologic Agents|dermatologic agents|mesh-ancestor
25174860|NCT02862873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25174862|NCT02862873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25174937|NCT02862327|Ropivacaine|ropivacaine|mesh-list
25174863|NCT02862873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174864|NCT02862873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25174865|NCT02862873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25174866|NCT02862873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25174867|NCT02862873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25174868|NCT02862691|Acetaminophen|acetaminophen|mesh-list
25174869|NCT02862691|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25174872|NCT02862691|Bupivacaine|bupivacaine|mesh-list
25174873|NCT02862691|Anesthetics, Local|anesthetics, local|mesh-list
25174874|NCT02862691|Anesthetics|anesthetics|mesh-list
24753625|NCT01716624|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25174875|NCT02862691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25174876|NCT02862691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174877|NCT02862691|Sensory System Agents|sensory system agents|mesh-ancestor
25174878|NCT02862691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25174879|NCT02862691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25174881|NCT02862691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25174882|NCT02862691|Narcotics|narcotics|mesh-ancestor
25174883|NCT02862691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25174884|NCT02862691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25174885|NCT02862691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25174886|NCT02862769|Lidocaine|lidocaine|mesh-list
25174887|NCT02862769|Anesthetics, Local|anesthetics, local|mesh-ancestor
25174888|NCT02862769|Anesthetics|anesthetics|mesh-ancestor
25174889|NCT02862769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25174890|NCT02862769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174891|NCT02862769|Sensory System Agents|sensory system agents|mesh-ancestor
25174892|NCT02862769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25174893|NCT02862769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25174894|NCT02862769|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25174895|NCT02862769|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25174896|NCT02862769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25174897|NCT02862769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174898|NCT02862483|Tadalafil|tadalafil|mesh-list
25174899|NCT02862483|Tamsulosin|tamsulosin|mesh-list
25174900|NCT02862483|Vasodilator Agents|vasodilator agents|mesh-ancestor
25174901|NCT02862483|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25174902|NCT02862483|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25174903|NCT02862483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25174904|NCT02862483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174905|NCT02862483|Urological Agents|urological agents|mesh-ancestor
25174906|NCT02862483|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25174907|NCT02862483|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25174908|NCT02862483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25174909|NCT02862483|Adrenergic Agents|adrenergic agents|mesh-ancestor
25174910|NCT02862483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25174911|NCT02862483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174912|NCT02862509|Budesonide|budesonide|mesh-list
25174913|NCT02862509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25174914|NCT02862509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25174915|NCT02862509|Autonomic Agents|autonomic agents|mesh-ancestor
25174916|NCT02862509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25174917|NCT02862509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174918|NCT02862509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25174919|NCT02862509|Respiratory System Agents|respiratory system agents|mesh-ancestor
25174920|NCT02862509|Glucocorticoids|glucocorticoids|mesh-ancestor
25174921|NCT02862509|Hormones|hormones|mesh-ancestor
24753667|NCT01716689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174922|NCT02862509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25174923|NCT02862145|Dexamethasone|dexamethasone|mesh-list
25174924|NCT02862145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25174925|NCT02862145|Antiemetics|antiemetics|mesh-ancestor
25174926|NCT02862145|Autonomic Agents|autonomic agents|mesh-ancestor
25174927|NCT02862145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25174928|NCT02862145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174929|NCT02862145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25174930|NCT02862145|Glucocorticoids|glucocorticoids|mesh-ancestor
25174931|NCT02862145|Hormones|hormones|mesh-ancestor
25174932|NCT02862145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25174933|NCT02862145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25174934|NCT02862145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174935|NCT02862327|Dexamethasone|dexamethasone|mesh-list
25174936|NCT02862327|Dexamethasone acetate|dexamethasone acetate|mesh-list
24753729|NCT01717235|Ropinirole|ropinirole|mesh-list
25174942|NCT02862327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25174943|NCT02862327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174944|NCT02862327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25174945|NCT02862327|Glucocorticoids|glucocorticoids|mesh-ancestor
25174946|NCT02862327|Hormones|hormones|mesh-ancestor
25174947|NCT02862327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25174948|NCT02862327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25174949|NCT02862327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174950|NCT02862327|Protease Inhibitors|protease inhibitors|mesh-ancestor
25174951|NCT02862327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24807057|NCT02019459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807058|NCT02019485|Tapentadol|tapentadol|mesh-list
24807059|NCT02019485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24807060|NCT02019485|Narcotics|narcotics|mesh-ancestor
24476288|NCT00413829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24476289|NCT00413829|Growth Substances|growth substances|mesh-ancestor
24476290|NCT00413829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476291|NCT00413829|Growth Inhibitors|growth inhibitors|mesh-ancestor
24476292|NCT00413829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476293|NCT00413946|Epoetin Alfa|epoetin alfa|mesh-list
24476294|NCT00413946|Hematinics|hematinics|mesh-ancestor
24426232|NCT00235261|Analgesics|analgesics|mesh-ancestor
24476295|NCT00414024|Tegaserod|tegaserod|mesh-list
24476296|NCT00414024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24476297|NCT00414024|Serotonin Agents|serotonin agents|mesh-ancestor
24476298|NCT00414024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24476322|NCT00414128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24476323|NCT00414128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24476324|NCT00414128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476325|NCT00414180|Bupropion|bupropion|mesh-list
24476326|NCT00414180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24476327|NCT00414180|Antidepressive Agents|antidepressive agents|mesh-ancestor
24476328|NCT00414180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24476329|NCT00414180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25174952|NCT02862327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174953|NCT02862327|Anesthetics, Local|anesthetics, local|mesh-ancestor
25174954|NCT02862327|Anesthetics|anesthetics|mesh-ancestor
25174955|NCT02862327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25174956|NCT02862327|Sensory System Agents|sensory system agents|mesh-ancestor
25174957|NCT02862210|Lithium Carbonate|lithium carbonate|mesh-list
25174958|NCT02862210|Antidepressive Agents|antidepressive agents|mesh-ancestor
25174959|NCT02862210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24753756|NCT01717599|Analgesics|analgesics|mesh-ancestor
24753757|NCT01717599|Sensory System Agents|sensory system agents|mesh-ancestor
24753765|NCT01717612|Thrombin|thrombin|mesh-list
24753766|NCT01717612|Hemostatics|hemostatics|mesh-ancestor
24753767|NCT01717612|Coagulants|coagulants|mesh-ancestor
24753768|NCT01717625|Montelukast|montelukast|mesh-list
25860165|NCT00082914|Denileukin diftitox|denileukin diftitox|mesh-list
25174960|NCT02862210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25174961|NCT02862210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174963|NCT02862210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25174964|NCT02862210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25174965|NCT02862210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174966|NCT02861950|Bupivacaine|bupivacaine|mesh-list
25174967|NCT02861950|Ropivacaine|ropivacaine|mesh-list
25174968|NCT02861950|Anesthetics, Local|anesthetics, local|mesh-ancestor
25174969|NCT02861950|Anesthetics|anesthetics|mesh-ancestor
25174970|NCT02861950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25174971|NCT02861950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174972|NCT02861950|Sensory System Agents|sensory system agents|mesh-ancestor
25174973|NCT02861950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25174974|NCT02862015|Gemcitabine|gemcitabine|mesh-list
25174975|NCT02862015|Folfirinox|folfirinox|mesh-list
25174976|NCT02862015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25174977|NCT02862015|Antimetabolites|antimetabolites|mesh-ancestor
25207843|NCT02932618|Factor VIII|factor viii|mesh-list
25174978|NCT02862015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25174979|NCT02862015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25174982|NCT02862015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25174983|NCT02862015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25174984|NCT02862015|Immunologic Factors|immunologic factors|mesh-ancestor
25174985|NCT02862015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174986|NCT02861976|Analgesics, Opioid|analgesics, opioid|mesh-list
25174987|NCT02861976|Narcotics|narcotics|mesh-ancestor
25174988|NCT02861976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25174989|NCT02861976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174991|NCT02861976|Sensory System Agents|sensory system agents|mesh-ancestor
25174992|NCT02861976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25174993|NCT02861859|Olanzapine|olanzapine|mesh-list
25174994|NCT02861859|Antiemetics|antiemetics|mesh-ancestor
25174995|NCT02861859|Autonomic Agents|autonomic agents|mesh-ancestor
25174996|NCT02861859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25174997|NCT02861859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25174998|NCT02861859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25174999|NCT02861859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25175000|NCT02861859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25175001|NCT02861859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25175002|NCT02861859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25175003|NCT02861859|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25175004|NCT02861859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25175005|NCT02861859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25175006|NCT02861859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175007|NCT02861859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25175008|NCT02861859|Serotonin Agents|serotonin agents|mesh-ancestor
25204341|NCT02709200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204342|NCT02709200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25204343|NCT02709200|Analgesics|analgesics|mesh-ancestor
25204344|NCT02709200|Sensory System Agents|sensory system agents|mesh-ancestor
25204345|NCT02709200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204346|NCT02709200|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25204347|NCT02709200|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25204348|NCT02709200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25204349|NCT02709200|Adrenergic Agents|adrenergic agents|mesh-ancestor
25204350|NCT02709200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25204351|NCT02709200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204352|NCT02709382|Tazobactam|tazobactam|mesh-list
25204353|NCT02709382|Cefepime|cefepime|mesh-list
25204354|NCT02709382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25204355|NCT02709382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25204356|NCT02709382|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25204357|NCT02709382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24944671|NCT03958201|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24944672|NCT03958201|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24944673|NCT03958201|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24944674|NCT03958201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204358|NCT02709382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207824|NCT03079102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207825|NCT03079102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25426099|NCT02057133|Exemestane|exemestane|mesh-list
25207826|NCT03079102|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25207827|NCT03079102|Vasodilator Agents|vasodilator agents|mesh-ancestor
25207829|NCT03079102|Protective Agents|protective agents|mesh-ancestor
25207830|NCT02964013|Carboplatin|carboplatin|mesh-list
25207831|NCT02964013|Pembrolizumab|pembrolizumab|mesh-list
25207832|NCT02964013|Etoposide|etoposide|mesh-list
25207833|NCT02964013|Pemetrexed|pemetrexed|mesh-list
25207834|NCT02964013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207835|NCT02964013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25207836|NCT02964013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25207837|NCT02964013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25207838|NCT02964013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25207839|NCT02964013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25207840|NCT02964013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207841|NCT02964013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25207842|NCT02964013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25207844|NCT02932618|Coagulants|coagulants|mesh-ancestor
25207845|NCT02916316|Doxorubicin|doxorubicin|mesh-list
25207846|NCT02916316|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25207847|NCT02916316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25207848|NCT02916316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207849|NCT02916316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25207850|NCT02916316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25207851|NCT02916316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25207852|NCT02916316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207853|NCT02699840|Vaccines|vaccines|mesh-list
25207854|NCT02699840|Immunologic Factors|immunologic factors|mesh-ancestor
25207855|NCT02699840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207856|NCT02584426|Cefazolin|cefazolin|mesh-list
25207857|NCT02584426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25207858|NCT02584426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25207859|NCT02545842|Insulin Glargine|insulin glargine|mesh-list
25207860|NCT02545842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24477238|NCT00417898|Antipyretics|antipyretics|mesh-ancestor
25175009|NCT02861482|Oxytocin|oxytocin|mesh-list
24857809|NCT02294110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175010|NCT02861482|Carboprost tromethamine|carboprost tromethamine|mesh-list
25175011|NCT02861482|Oxytocics|oxytocics|mesh-ancestor
25175012|NCT02861482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25175013|NCT02861482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175014|NCT02861716|Fentanyl|fentanyl|mesh-list
25175015|NCT02861716|Dexmedetomidine|dexmedetomidine|mesh-list
25175016|NCT02861716|Bupivacaine|bupivacaine|mesh-list
25175017|NCT02861716|Anesthetics, Local|anesthetics, local|mesh-ancestor
25175018|NCT02861716|Anesthetics|anesthetics|mesh-ancestor
25175019|NCT02861716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25175020|NCT02861716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175021|NCT02861716|Sensory System Agents|sensory system agents|mesh-ancestor
25175022|NCT02861716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25175023|NCT02861716|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25175024|NCT02861716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25175025|NCT02861716|Analgesics|analgesics|mesh-ancestor
25175026|NCT02861716|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25175027|NCT02861716|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25175028|NCT02861716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25175029|NCT02861716|Adrenergic Agents|adrenergic agents|mesh-ancestor
25175030|NCT02861716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25175031|NCT02861716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175032|NCT02861716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25175033|NCT02861716|Narcotics|narcotics|mesh-ancestor
25175034|NCT02861716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25175035|NCT02861716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25175036|NCT02861716|Anesthetics, General|anesthetics, general|mesh-ancestor
25175037|NCT02861690|Paclitaxel|paclitaxel|mesh-list
25175038|NCT02861690|Nedaplatin|nedaplatin|mesh-list
25175039|NCT02861690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25175040|NCT02861690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175041|NCT02861690|Tubulin Modulators|tubulin modulators|mesh-ancestor
25175042|NCT02861690|Antimitotic Agents|antimitotic agents|mesh-ancestor
25175043|NCT02861690|Mitosis Modulators|mitosis modulators|mesh-ancestor
25175044|NCT02861690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175045|NCT02861261|Promethazine|promethazine|mesh-list
25175046|NCT02861261|Diphenhydramine|diphenhydramine|mesh-list
25175047|NCT02861261|Antipruritics|antipruritics|mesh-ancestor
25175048|NCT02861261|Dermatologic Agents|dermatologic agents|mesh-ancestor
25175049|NCT02861261|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25175050|NCT02861261|Histamine Antagonists|histamine antagonists|mesh-ancestor
25175051|NCT02861261|Histamine Agents|histamine agents|mesh-ancestor
25175052|NCT02861261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25175053|NCT02861261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175054|NCT02861261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175055|NCT02861261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25175056|NCT02861261|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25175057|NCT02861261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25175058|NCT02861261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25175059|NCT02861261|Anesthetics, Local|anesthetics, local|mesh-ancestor
25175060|NCT02861261|Anesthetics|anesthetics|mesh-ancestor
25175061|NCT02861261|Sensory System Agents|sensory system agents|mesh-ancestor
25175062|NCT02861261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25175063|NCT02861261|Antiemetics|antiemetics|mesh-ancestor
25175064|NCT02861261|Autonomic Agents|autonomic agents|mesh-ancestor
25175065|NCT02861261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25175066|NCT02861222|Doxorubicin|doxorubicin|mesh-list
25204369|NCT02709031|Cicletanine|cicletanine|mesh-list
25175068|NCT02861222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175069|NCT02861222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25175071|NCT02861222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25175072|NCT02861222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175073|NCT02861378|Phentolamine|phentolamine|mesh-list
25175074|NCT02861378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25175075|NCT02861378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25175076|NCT02861378|Adrenergic Agents|adrenergic agents|mesh-ancestor
25175077|NCT02861378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24753858|NCT01718236|Succinylcholine|succinylcholine|mesh-list
24753859|NCT01718236|Neostigmine|neostigmine|mesh-list
25175078|NCT02861378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175079|NCT02861378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175080|NCT02861378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25175081|NCT02861105|Enoxaparin|enoxaparin|mesh-list
25175082|NCT02861105|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25175083|NCT02861105|Anticoagulants|anticoagulants|mesh-ancestor
25175084|NCT02861105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25175085|NCT02861105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25175086|NCT02861105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175087|NCT02860936|Lenvatinib|lenvatinib|mesh-list
25175088|NCT02860936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175089|NCT02860936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25175090|NCT02860936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25175091|NCT02860936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175092|NCT02860949|Ketorolac|ketorolac|mesh-list
25175093|NCT02860949|Epinephrine|epinephrine|mesh-list
25175094|NCT02860949|Morphine|morphine|mesh-list
25175095|NCT02860949|Bupivacaine|bupivacaine|mesh-list
25175096|NCT02860949|Anesthetics, Local|anesthetics, local|mesh-ancestor
25175097|NCT02860949|Anesthetics|anesthetics|mesh-ancestor
25175098|NCT02860949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25175099|NCT02860949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175100|NCT02860949|Sensory System Agents|sensory system agents|mesh-ancestor
25175101|NCT02860949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24753911|NCT01718314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24753912|NCT01718314|Abortifacient Agents|abortifacient agents|mesh-ancestor
25175102|NCT02860949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25175103|NCT02860949|Narcotics|narcotics|mesh-ancestor
25175104|NCT02860949|Analgesics|analgesics|mesh-ancestor
25175105|NCT02860949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25175106|NCT02860949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25175107|NCT02860949|Adrenergic Agents|adrenergic agents|mesh-ancestor
25175108|NCT02860949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25175109|NCT02860949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175110|NCT02860949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25175111|NCT02860949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25175112|NCT02860949|Autonomic Agents|autonomic agents|mesh-ancestor
25175113|NCT02860949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25175114|NCT02860949|Respiratory System Agents|respiratory system agents|mesh-ancestor
25175115|NCT02860949|Mydriatics|mydriatics|mesh-ancestor
25175116|NCT02860949|Sympathomimetics|sympathomimetics|mesh-ancestor
25175117|NCT02860949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25175118|NCT02860949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25175119|NCT02860949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25175120|NCT02860949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25175121|NCT02860949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25175122|NCT02860949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25860166|NCT00082914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860167|NCT00082927|Ibandronic Acid|ibandronic acid|mesh-list
24533778|NCT00645125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25208933|NCT00003042|Hormone Antagonists|hormone antagonists|mesh-ancestor
25208934|NCT00003042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25208935|NCT00003042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25208936|NCT00003042|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25208937|NCT00003042|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25208938|NCT00003042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24457554|NCT00334672|Abortifacient Agents|abortifacient agents|mesh-ancestor
24837713|NCT02192827|BB 1101|bb 1101|mesh-list
24457555|NCT00334672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25175123|NCT02860949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25175124|NCT02860923|Exenatide|exenatide|mesh-list
25175125|NCT02860923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25175126|NCT02860923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175127|NCT02860923|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25175128|NCT02860923|Incretins|incretins|mesh-ancestor
25175129|NCT02860923|Hormones|hormones|mesh-ancestor
25175130|NCT02860923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25175131|NCT02861040|Vincristine|vincristine|mesh-list
25175132|NCT02861040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25175133|NCT02861040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175134|NCT02861040|Tubulin Modulators|tubulin modulators|mesh-ancestor
25175135|NCT02861040|Antimitotic Agents|antimitotic agents|mesh-ancestor
25175136|NCT02861040|Mitosis Modulators|mitosis modulators|mesh-ancestor
25175137|NCT02861040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175138|NCT02860962|Dextromethorphan|dextromethorphan|mesh-list
25175139|NCT02860962|Antitussive Agents|antitussive agents|mesh-ancestor
25175140|NCT02860962|Respiratory System Agents|respiratory system agents|mesh-ancestor
25175141|NCT02860962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25175142|NCT02860962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25175143|NCT02860962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25175144|NCT02860962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175145|NCT02860962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175146|NCT02860858|Aflibercept|aflibercept|mesh-list
25175147|NCT02860858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25175148|NCT02860858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25175149|NCT02860858|Growth Substances|growth substances|mesh-ancestor
25175150|NCT02860858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175151|NCT02860858|Growth Inhibitors|growth inhibitors|mesh-ancestor
25175152|NCT02860858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175153|NCT02860897|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25175154|NCT02860897|Estrogens|estrogens|mesh-ancestor
25175155|NCT02860897|Hormones|hormones|mesh-ancestor
25175156|NCT02860897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25175157|NCT02860897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175158|NCT02860819|Gemcitabine|gemcitabine|mesh-list
25175159|NCT02860819|Carboplatin|carboplatin|mesh-list
25175160|NCT02860819|Veliparib|veliparib|mesh-list
25175161|NCT02860819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175162|NCT02860819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25175163|NCT02860819|Antimetabolites|antimetabolites|mesh-ancestor
25175164|NCT02860819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175165|NCT02860819|Antiviral Agents|antiviral agents|mesh-ancestor
25175166|NCT02860819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25175167|NCT02860819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25175168|NCT02860819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25175169|NCT02860819|Immunologic Factors|immunologic factors|mesh-ancestor
25175170|NCT02860819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426100|NCT02057133|Loperamide|loperamide|mesh-list
25665101|NCT01680172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25665102|NCT01680172|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25665103|NCT01680172|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25665104|NCT01680172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25665105|NCT01680172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665106|NCT01680341|Insulin|insulin|mesh-list
25665107|NCT01680341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25665108|NCT01680341|Insulin Aspart|insulin aspart|mesh-list
25665109|NCT01680341|Insulin, Long-Acting|insulin, long-acting|mesh-list
25665110|NCT01680341|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25665111|NCT01680341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25665112|NCT01680341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860168|NCT00082927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25860169|NCT00082927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860170|NCT00082940|Denileukin diftitox|denileukin diftitox|mesh-list
25860171|NCT00082940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175171|NCT02860819|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25175172|NCT02860663|Vitamin D|vitamin d|mesh-list
25175173|NCT02860663|Ergocalciferols|ergocalciferols|mesh-list
25175174|NCT02860663|Cholecalciferol|cholecalciferol|mesh-list
25175175|NCT02860663|Vitamins|vitamins|mesh-list
25175176|NCT02860663|Micronutrients|micronutrients|mesh-ancestor
25175177|NCT02860663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175178|NCT02860663|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25175179|NCT02860663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25175180|NCT02860624|Esomeprazole|esomeprazole|mesh-list
25175181|NCT02860624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25175182|NCT02860624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25175183|NCT02860624|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25175184|NCT02860624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25175185|NCT02860624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175186|NCT02860494|Everolimus|everolimus|mesh-list
25175187|NCT02860494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175188|NCT02860494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25175189|NCT02860494|Immunologic Factors|immunologic factors|mesh-ancestor
25175190|NCT02860494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175191|NCT02860234|Capecitabine|capecitabine|mesh-list
25175192|NCT02860234|Oxaliplatin|oxaliplatin|mesh-list
25175193|NCT02860234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25175194|NCT02860234|Antimetabolites|antimetabolites|mesh-ancestor
25175195|NCT02860234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175196|NCT02860234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175197|NCT02860299|Heparin|heparin|mesh-list
25175198|NCT02860299|Calcium heparin|calcium heparin|mesh-list
25175199|NCT02860299|Anticoagulants|anticoagulants|mesh-ancestor
25175200|NCT02860299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175201|NCT02860299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25175202|NCT02860299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25204359|NCT02709525|Hyaluronic Acid|hyaluronic acid|mesh-list
25204360|NCT02709525|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25204361|NCT02709525|Immunologic Factors|immunologic factors|mesh-ancestor
25204362|NCT02709525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204363|NCT02709525|Viscosupplements|viscosupplements|mesh-ancestor
25204364|NCT02709525|Protective Agents|protective agents|mesh-ancestor
25204365|NCT02708992|Azithromycin|azithromycin|mesh-list
25204366|NCT02708992|Cefixime|cefixime|mesh-list
25204367|NCT02708992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25204368|NCT02708992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25204371|NCT02709031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25204372|NCT02709031|Diuretics|diuretics|mesh-ancestor
24754003|NCT01718652|Dermatologic Agents|dermatologic agents|mesh-ancestor
24754004|NCT01718652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24754014|NCT01718717|Morphine|morphine|mesh-list
24754015|NCT01718717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24754016|NCT01718717|Narcotics|narcotics|mesh-ancestor
25204373|NCT02709031|Natriuretic Agents|natriuretic agents|mesh-ancestor
25204374|NCT02709031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204375|NCT02708628|Heparin|heparin|mesh-list
25204376|NCT02708628|Allantoin|allantoin|mesh-list
25204377|NCT02708628|Anticoagulants|anticoagulants|mesh-ancestor
25204378|NCT02708628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25204379|NCT02708628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25204380|NCT02708628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204381|NCT02708628|Dermatologic Agents|dermatologic agents|mesh-ancestor
25204382|NCT02708693|Triamcinolone|triamcinolone|mesh-list
25204383|NCT02708693|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25204384|NCT02708693|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25204385|NCT02708693|Lidocaine|lidocaine|mesh-list
25204386|NCT02708693|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25204387|NCT02708693|Anesthetics, Local|anesthetics, local|mesh-ancestor
25204388|NCT02708693|Anesthetics|anesthetics|mesh-ancestor
25204389|NCT02708693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25204390|NCT02708693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665113|NCT01680458|Fluconazole|fluconazole|mesh-list
25665114|NCT01680458|Antifungal Agents|antifungal agents|mesh-ancestor
25665115|NCT01680458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24665145|NCT01310452|Insulin|insulin|mesh-list
25665116|NCT01680458|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25665117|NCT01680458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25665118|NCT01680458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860172|NCT00082966|Bortezomib|bortezomib|mesh-list
25860173|NCT00082966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860174|NCT00083005|Thalidomide|thalidomide|mesh-list
24807217|NCT02020330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24807218|NCT02020499|Lanreotide|lanreotide|mesh-list
24807219|NCT02020499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807220|NCT02020551|Lidocaine|lidocaine|mesh-list
24807221|NCT02020551|Anesthetics, Local|anesthetics, local|mesh-ancestor
24807222|NCT02020551|Anesthetics|anesthetics|mesh-ancestor
24754045|NCT01718873|Growth Inhibitors|growth inhibitors|mesh-ancestor
24754046|NCT01718873|Antimetabolites|antimetabolites|mesh-ancestor
24754047|NCT01718873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807223|NCT02020551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24807224|NCT02020551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807225|NCT02020551|Sensory System Agents|sensory system agents|mesh-ancestor
24478097|NCT00421460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24478098|NCT00421460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478099|NCT00421460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24478101|NCT00421460|Anabolic Agents|anabolic agents|mesh-ancestor
24478102|NCT00421473|Atovaquone|atovaquone|mesh-list
24478103|NCT00421473|Proguanil|proguanil|mesh-list
24478104|NCT00421473|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
24807228|NCT02020551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24974699|NCT05309070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24974700|NCT05309070|Expectorants|expectorants|mesh-ancestor
24974701|NCT05309070|Respiratory System Agents|respiratory system agents|mesh-ancestor
24974702|NCT05309070|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24974703|NCT05309070|Antioxidants|antioxidants|mesh-ancestor
24974704|NCT05309070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974705|NCT05309070|Protective Agents|protective agents|mesh-ancestor
24974706|NCT05309070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974707|NCT05309070|Antidotes|antidotes|mesh-ancestor
24974708|NCT05308888|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24974709|NCT05308888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24974710|NCT05308888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974711|NCT05308849|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24754074|NCT01718912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754075|NCT01718951|Pamidronate|pamidronate|mesh-list
24754118|NCT01719159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544347|NCT00688493|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24974712|NCT05308849|beta-Lactams|beta-lactams|mesh-list
24974713|NCT05308849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24974714|NCT05308628|Complement C3|complement c3|mesh-list
24974715|NCT05308628|Immunologic Factors|immunologic factors|mesh-ancestor
24974716|NCT05308628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175208|NCT02860117|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25175209|NCT02860117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25175210|NCT02860117|Anesthetics, General|anesthetics, general|mesh-ancestor
25175211|NCT02860117|Anesthetics|anesthetics|mesh-ancestor
25175212|NCT02860117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25175500|NCT02857842|Prednisolone|prednisolone|mesh-list
25175213|NCT02860117|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25175214|NCT02860117|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25175215|NCT02860117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25175216|NCT02860117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175217|NCT02860221|Epinephrine|epinephrine|mesh-list
25175218|NCT02860221|Tranexamic Acid|tranexamic acid|mesh-list
25175219|NCT02860221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25175220|NCT02860221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25175221|NCT02860221|Adrenergic Agents|adrenergic agents|mesh-ancestor
25175222|NCT02860221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25175223|NCT02860221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175224|NCT02860221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175225|NCT02860221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25175226|NCT02860221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25175227|NCT02860221|Autonomic Agents|autonomic agents|mesh-ancestor
24754119|NCT01719159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24944694|NCT03958123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25175228|NCT02860221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25175229|NCT02860221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25175230|NCT02860221|Respiratory System Agents|respiratory system agents|mesh-ancestor
25175232|NCT02860221|Sympathomimetics|sympathomimetics|mesh-ancestor
25175233|NCT02860221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25175234|NCT02860221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25860175|NCT00083005|Docetaxel|docetaxel|mesh-list
25175235|NCT02860221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25175236|NCT02860221|Hemostatics|hemostatics|mesh-ancestor
25175237|NCT02860221|Coagulants|coagulants|mesh-ancestor
25175238|NCT02859792|Riluzole|riluzole|mesh-list
25175239|NCT02859792|Anticonvulsants|anticonvulsants|mesh-ancestor
25175240|NCT02859792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25175241|NCT02859792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25175242|NCT02859792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25175243|NCT02859792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175244|NCT02859792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175245|NCT02859792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25175246|NCT02859792|Protective Agents|protective agents|mesh-ancestor
25175247|NCT02859909|Immunoglobulins|immunoglobulins|mesh-list
25175248|NCT02859909|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25175249|NCT02859909|Immunologic Factors|immunologic factors|mesh-ancestor
25175250|NCT02859909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175251|NCT02859480|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25175252|NCT02859480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25175253|NCT02859480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25175254|NCT02859480|Antimetabolites|antimetabolites|mesh-ancestor
25175255|NCT02859480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175256|NCT02859480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25175257|NCT02859480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25175258|NCT02859480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25175269|NCT02859584|Hydrocortisone|hydrocortisone|mesh-list
25175270|NCT02859584|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25175271|NCT02859584|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25175272|NCT02859584|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25175273|NCT02859584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25175274|NCT02859571|Oxytocin|oxytocin|mesh-list
25175275|NCT02859571|Oxytocics|oxytocics|mesh-ancestor
25175276|NCT02859571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24754175|NCT01719588|Adrenergic Agents|adrenergic agents|mesh-ancestor
25175277|NCT02859571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175278|NCT02859285|Estradiol|estradiol|mesh-list
25175279|NCT02859285|Estrogens|estrogens|mesh-ancestor
25175280|NCT02859285|Hormones|hormones|mesh-ancestor
25175281|NCT02859285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25175282|NCT02859285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175283|NCT02859129|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
25175284|NCT02859129|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25175285|NCT02859129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25175286|NCT02859129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25175287|NCT02859129|Antimetabolites|antimetabolites|mesh-ancestor
25175288|NCT02859129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175289|NCT02859129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25175290|NCT02859129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25175291|NCT02859129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25175292|NCT02859129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25175293|NCT02859103|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25175946|NCT02855346|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25175294|NCT02859103|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25175295|NCT02859103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25175296|NCT02859103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25175297|NCT02859103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175298|NCT02859103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25175299|NCT02859103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175300|NCT02859103|Antidepressive Agents|antidepressive agents|mesh-ancestor
25175301|NCT02859103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25175303|NCT02859259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25175304|NCT02859259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25175305|NCT02859259|Antiviral Agents|antiviral agents|mesh-ancestor
25175306|NCT02859259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25175307|NCT02859259|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25175308|NCT02859259|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24754232|NCT01719705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25175309|NCT02859259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175310|NCT02859077|Gemcitabine|gemcitabine|mesh-list
25175311|NCT02859077|Carboplatin|carboplatin|mesh-list
25175312|NCT02859077|Pemetrexed|pemetrexed|mesh-list
25175313|NCT02859077|Gefitinib|gefitinib|mesh-list
25175314|NCT02859077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175315|NCT02859077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25175316|NCT02859077|Antimetabolites|antimetabolites|mesh-ancestor
25860176|NCT00083005|Estramustine|estramustine|mesh-list
25860177|NCT00083005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175317|NCT02859077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175318|NCT02859077|Antiviral Agents|antiviral agents|mesh-ancestor
25175319|NCT02859077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25175320|NCT02859077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25175321|NCT02859077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25175322|NCT02859077|Immunologic Factors|immunologic factors|mesh-ancestor
25175323|NCT02859077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175324|NCT02859077|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25175325|NCT02859077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25175326|NCT02859077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25175327|NCT02858843|Ivacaftor|ivacaftor|mesh-list
25175328|NCT02858843|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25175329|NCT02858843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25175330|NCT02858843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175331|NCT02858817|Atovaquone|atovaquone|mesh-list
25175332|NCT02858817|Proguanil|proguanil|mesh-list
25175333|NCT02858817|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
25175334|NCT02858817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25175335|NCT02858817|Antimalarials|antimalarials|mesh-ancestor
25175336|NCT02858817|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24540442|NCT00668005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24540443|NCT00668005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24754257|NCT01719835|Antimetabolites|antimetabolites|mesh-ancestor
24754258|NCT01719835|Antiviral Agents|antiviral agents|mesh-ancestor
24754259|NCT01719835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25175464|NCT02857959|Penicillin G Procaine|penicillin g procaine|mesh-list
24944709|NCT03958396|Sensory System Agents|sensory system agents|mesh-ancestor
24944710|NCT03958396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24944711|NCT03958097|Antibodies|antibodies|mesh-list
24857837|NCT02294266|Sympathomimetics|sympathomimetics|mesh-ancestor
25175337|NCT02858817|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25175338|NCT02858817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25175339|NCT02858817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175340|NCT02858817|Antimetabolites|antimetabolites|mesh-ancestor
25175341|NCT02858856|Juzentaihoto|juzentaihoto|mesh-list
25175342|NCT02858856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175343|NCT02858856|Mitogens|mitogens|mesh-ancestor
25175344|NCT02858856|Mitosis Modulators|mitosis modulators|mesh-ancestor
25175345|NCT02858856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175346|NCT02858622|Fentanyl|fentanyl|mesh-list
25175347|NCT02858622|Meperidine|meperidine|mesh-list
25175348|NCT02858622|Bupivacaine|bupivacaine|mesh-list
25175349|NCT02858622|Anesthetics, Local|anesthetics, local|mesh-ancestor
25175350|NCT02858622|Anesthetics|anesthetics|mesh-ancestor
25175351|NCT02858622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25175352|NCT02858622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175353|NCT02858622|Sensory System Agents|sensory system agents|mesh-ancestor
25175354|NCT02858622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25175355|NCT02858622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25175356|NCT02858622|Narcotics|narcotics|mesh-ancestor
25175357|NCT02858622|Analgesics|analgesics|mesh-ancestor
25175359|NCT02858622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25175360|NCT02858622|Anesthetics, General|anesthetics, general|mesh-ancestor
25175362|NCT02858804|Thalidomide|thalidomide|mesh-list
25175363|NCT02858804|Dexamethasone|dexamethasone|mesh-list
25175364|NCT02858804|Prednisone|prednisone|mesh-list
25175365|NCT02858804|Cyclophosphamide|cyclophosphamide|mesh-list
25175366|NCT02858804|Rituximab|rituximab|mesh-list
25175367|NCT02858804|Doxorubicin|doxorubicin|mesh-list
25175368|NCT02858804|Etoposide|etoposide|mesh-list
25175369|NCT02858804|Vincristine|vincristine|mesh-list
25175370|NCT02858804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25175371|NCT02858804|Immunologic Factors|immunologic factors|mesh-ancestor
25175372|NCT02858804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175373|NCT02858804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25175374|NCT02858804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25175375|NCT02858804|Alkylating Agents|alkylating agents|mesh-ancestor
25175376|NCT02858804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175377|NCT02858804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175378|NCT02858804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25175379|NCT02858804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25175380|NCT02858804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25175381|NCT02858804|Antiemetics|antiemetics|mesh-ancestor
25175382|NCT02858804|Autonomic Agents|autonomic agents|mesh-ancestor
25175383|NCT02858804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25426175|NCT02048813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25175384|NCT02858804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25175385|NCT02858804|Glucocorticoids|glucocorticoids|mesh-ancestor
25175387|NCT02858804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25175388|NCT02858804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25175389|NCT02858804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25175390|NCT02858804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25175391|NCT02858804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25175392|NCT02858804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25175393|NCT02858804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25175394|NCT02858804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25175395|NCT02858804|Antimetabolites|antimetabolites|mesh-ancestor
25175396|NCT02858804|Antiviral Agents|antiviral agents|mesh-ancestor
25175397|NCT02858804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25175398|NCT02858804|Tubulin Modulators|tubulin modulators|mesh-ancestor
25175399|NCT02858804|Antimitotic Agents|antimitotic agents|mesh-ancestor
25175400|NCT02858804|Mitosis Modulators|mitosis modulators|mesh-ancestor
25175401|NCT02858804|Leprostatic Agents|leprostatic agents|mesh-ancestor
25175402|NCT02858804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25175403|NCT02858804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25175404|NCT02858804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25175405|NCT02858804|Growth Substances|growth substances|mesh-ancestor
25175406|NCT02858804|Growth Inhibitors|growth inhibitors|mesh-ancestor
25204391|NCT02708693|Sensory System Agents|sensory system agents|mesh-ancestor
25204392|NCT02708693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204393|NCT02708693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25083447|NCT03315533|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25204399|NCT02708693|Glucocorticoids|glucocorticoids|mesh-ancestor
25204400|NCT02708693|Hormones|hormones|mesh-ancestor
25204401|NCT02708693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25204402|NCT02708693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25204403|NCT02708693|Immunologic Factors|immunologic factors|mesh-ancestor
25204404|NCT02708693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25204405|NCT02708511|Copper|copper|mesh-list
25204406|NCT02708511|Trace Elements|trace elements|mesh-ancestor
25204407|NCT02708511|Micronutrients|micronutrients|mesh-ancestor
25204408|NCT02708511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204409|NCT02708160|Fluorides|fluorides|mesh-list
25204410|NCT02708160|Cariostatic Agents|cariostatic agents|mesh-ancestor
25204411|NCT02708160|Protective Agents|protective agents|mesh-ancestor
25204412|NCT02708160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204413|NCT02708446|Misoprostol|misoprostol|mesh-list
25204414|NCT02708446|Mifepristone|mifepristone|mesh-list
25204415|NCT02708446|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25204416|NCT02708446|Abortifacient Agents|abortifacient agents|mesh-ancestor
25204417|NCT02708446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25204418|NCT02708446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204419|NCT02708446|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25204420|NCT02708446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25204421|NCT02708446|Oxytocics|oxytocics|mesh-ancestor
25204422|NCT02708446|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25204423|NCT02708446|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25204424|NCT02708446|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25204425|NCT02708446|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25204426|NCT02708446|Contraceptive Agents|contraceptive agents|mesh-ancestor
25204427|NCT02708446|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25204428|NCT02708446|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25204429|NCT02708446|Hormone Antagonists|hormone antagonists|mesh-ancestor
25204430|NCT02708446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25204431|NCT02708446|Luteolytic Agents|luteolytic agents|mesh-ancestor
25204432|NCT02708446|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25204433|NCT02708446|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25204435|NCT02708251|Nitroglycerin|nitroglycerin|mesh-list
24807431|NCT02021864|Vitamin D|vitamin d|mesh-list
24479007|NCT00425217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24479041|NCT00425360|Antiviral Agents|antiviral agents|mesh-ancestor
24974768|NCT05291650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24975016|NCT04844268|Immunologic Factors|immunologic factors|mesh-ancestor
25860178|NCT00083005|Tubulin Modulators|tubulin modulators|mesh-ancestor
24975017|NCT04844268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975019|NCT04818216|Niacin|niacin|mesh-list
24975020|NCT04818216|Nicotinic Acids|nicotinic acids|mesh-list
25083362|NCT03316482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25083364|NCT03316469|Clomiphene|clomiphene|mesh-list
25083365|NCT03316469|Enclomiphene|enclomiphene|mesh-list
25083366|NCT03316469|Zuclomiphene|zuclomiphene|mesh-list
25083367|NCT03316469|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25860179|NCT00083005|Antimitotic Agents|antimitotic agents|mesh-ancestor
25860180|NCT00083005|Mitosis Modulators|mitosis modulators|mesh-ancestor
25860181|NCT00083005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860182|NCT00083005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25083368|NCT03316469|Hormone Antagonists|hormone antagonists|mesh-ancestor
25083369|NCT03316469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25083370|NCT03316469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083371|NCT03316469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25083372|NCT03316469|Fertility Agents|fertility agents|mesh-ancestor
24933687|NCT04068506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25083407|NCT03316326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083443|NCT03315676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25083444|NCT03315676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25083445|NCT03315676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25083446|NCT03315676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083448|NCT03315533|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25083449|NCT03315533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25083450|NCT03315533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25083451|NCT03315533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083452|NCT03315533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25083453|NCT03315533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175407|NCT02858505|Iron|iron|mesh-list
25175408|NCT02858505|Trace Elements|trace elements|mesh-ancestor
25175409|NCT02858505|Micronutrients|micronutrients|mesh-ancestor
25175410|NCT02858505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175411|NCT02858258|Rituximab|rituximab|mesh-list
25175412|NCT02858258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25175413|NCT02858258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175414|NCT02858258|Immunologic Factors|immunologic factors|mesh-ancestor
25175415|NCT02858258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175416|NCT02858258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25175417|NCT02858219|Botulinum Toxins|botulinum toxins|mesh-list
25175418|NCT02858219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25175419|NCT02858219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25175420|NCT02858219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24527208|NCT00615524|Exemestane|exemestane|mesh-list
25175421|NCT02858219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25175422|NCT02858219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175423|NCT02858219|Cholinergic Agents|cholinergic agents|mesh-ancestor
25175424|NCT02858219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25175425|NCT02858219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175426|NCT02858219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25175427|NCT02858219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25175428|NCT02858297|Triamcinolone|triamcinolone|mesh-list
25175429|NCT02858297|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25175430|NCT02858297|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25175431|NCT02858297|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25175432|NCT02858297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25175433|NCT02858297|Glucocorticoids|glucocorticoids|mesh-ancestor
25175434|NCT02858297|Hormones|hormones|mesh-ancestor
25175435|NCT02858297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25175436|NCT02858297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175437|NCT02858297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25175438|NCT02858297|Immunologic Factors|immunologic factors|mesh-ancestor
25175439|NCT02858297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25175440|NCT02858297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175441|NCT02858193|Carbocysteine|carbocysteine|mesh-list
25175442|NCT02858193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25175443|NCT02858193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25175444|NCT02858193|Expectorants|expectorants|mesh-ancestor
25175445|NCT02858193|Respiratory System Agents|respiratory system agents|mesh-ancestor
25175446|NCT02858024|Dapivirine|dapivirine|mesh-list
25175447|NCT02858024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25175448|NCT02858024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25175449|NCT02858024|Antiviral Agents|antiviral agents|mesh-ancestor
25175450|NCT02858024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25175451|NCT02858206|Paclitaxel|paclitaxel|mesh-list
25175452|NCT02858206|Nimotuzumab|nimotuzumab|mesh-list
24754371|NCT01720212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665119|NCT01680458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665120|NCT01680458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25665121|NCT01680458|Hormone Antagonists|hormone antagonists|mesh-ancestor
25674388|NCT01771250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922984|NCT04173832|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24922985|NCT04173832|Antiviral Agents|antiviral agents|mesh-ancestor
24922986|NCT04173832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24754372|NCT01720212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754373|NCT01720212|Urological Agents|urological agents|mesh-ancestor
24754374|NCT01720238|Lamivudine|lamivudine|mesh-list
24754375|NCT01720238|Adefovir|adefovir|mesh-list
24754376|NCT01720238|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
24754377|NCT01720238|Entecavir|entecavir|mesh-list
24754378|NCT01720238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24754380|NCT01720238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24944725|NCT03957902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944726|NCT03957902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24944727|NCT03957902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25175453|NCT02858206|Nedaplatin|nedaplatin|mesh-list
25175454|NCT02858206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25175455|NCT02858206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175456|NCT02858206|Tubulin Modulators|tubulin modulators|mesh-ancestor
25175457|NCT02858206|Antimitotic Agents|antimitotic agents|mesh-ancestor
25175458|NCT02858206|Mitosis Modulators|mitosis modulators|mesh-ancestor
25175459|NCT02858206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175460|NCT02858206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25175461|NCT02857959|Penicillins|penicillins|mesh-list
25175462|NCT02857959|Penicillin G|penicillin g|mesh-list
25175463|NCT02857959|Penicillin G Benzathine|penicillin g benzathine|mesh-list
25175465|NCT02857959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25175466|NCT02857959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25175467|NCT02857946|Linagliptin|linagliptin|mesh-list
25175468|NCT02857946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25175469|NCT02857946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175470|NCT02857946|Incretins|incretins|mesh-ancestor
25175471|NCT02857946|Hormones|hormones|mesh-ancestor
25175472|NCT02857946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25175473|NCT02857946|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25175474|NCT02857946|Protease Inhibitors|protease inhibitors|mesh-ancestor
25175475|NCT02857946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25175476|NCT02857946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175477|NCT02857712|Axitinib|axitinib|mesh-list
25175478|NCT02857712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175479|NCT02857712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25175480|NCT02857712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25175481|NCT02857712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175482|NCT02857920|Bevacizumab|bevacizumab|mesh-list
25175483|NCT02857920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25175484|NCT02857920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175485|NCT02857920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25175486|NCT02857920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25175487|NCT02857920|Growth Substances|growth substances|mesh-ancestor
25175488|NCT02857920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175489|NCT02857920|Growth Inhibitors|growth inhibitors|mesh-ancestor
25175490|NCT02857829|Caffeine|caffeine|mesh-list
25175491|NCT02857829|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25175492|NCT02857829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175493|NCT02857829|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25175494|NCT02857829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25175495|NCT02857829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175496|NCT02857829|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25175497|NCT02857829|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25175498|NCT02857829|Purinergic Agents|purinergic agents|mesh-ancestor
25175499|NCT02857829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25175501|NCT02857842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25175502|NCT02857842|Glucocorticoids|glucocorticoids|mesh-ancestor
25175504|NCT02857842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25175505|NCT02857842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175506|NCT02857842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25175507|NCT02857842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175508|NCT02857777|Esketamine|esketamine|mesh-list
25175509|NCT02857777|Antidepressive Agents|antidepressive agents|mesh-ancestor
25175510|NCT02857777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25175511|NCT02857686|Anesthetics|anesthetics|mesh-list
25665122|NCT01680458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25665123|NCT01680458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498745|NCT00516152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498746|NCT00516152|Dermatologic Agents|dermatologic agents|mesh-ancestor
24498747|NCT00516152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498748|NCT00516152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24498749|NCT00516152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24923143|NCT04172311|Nootropic Agents|nootropic agents|mesh-ancestor
24923144|NCT04172220|Midazolam|midazolam|mesh-list
24923145|NCT04172220|Anesthetics|anesthetics|mesh-list
24923146|NCT04172220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25175512|NCT02857686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25175513|NCT02857686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175514|NCT02857582|Metronidazole|metronidazole|mesh-list
25175515|NCT02857582|Vancomycin|vancomycin|mesh-list
25175516|NCT02857582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25175517|NCT02857582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25175518|NCT02857582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25175519|NCT02857582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25175520|NCT02857569|Nivolumab|nivolumab|mesh-list
25175521|NCT02857569|Ipilimumab|ipilimumab|mesh-list
25175522|NCT02857569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25175523|NCT02857569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175524|NCT02857569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25175525|NCT02857569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175526|NCT02857491|Ranibizumab|ranibizumab|mesh-list
25175527|NCT02857491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25175528|NCT02857491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25175529|NCT02857491|Growth Substances|growth substances|mesh-ancestor
25175530|NCT02857491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175531|NCT02857491|Growth Inhibitors|growth inhibitors|mesh-ancestor
25175532|NCT02857491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175533|NCT02857309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
25175534|NCT02857309|Mineralocorticoids|mineralocorticoids|mesh-list
25175535|NCT02857309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
25236862|NCT02555488|Methylene Blue|methylene blue|mesh-list
25175536|NCT02857309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175537|NCT02857309|Hormones|hormones|mesh-ancestor
25175538|NCT02857309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25175541|NCT02857309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25175543|NCT02857309|Natriuretic Agents|natriuretic agents|mesh-ancestor
25175544|NCT02857465|Dexamethasone|dexamethasone|mesh-list
25175545|NCT02857465|Dexamethasone acetate|dexamethasone acetate|mesh-list
25175546|NCT02857465|Sufentanil|sufentanil|mesh-list
25175547|NCT02857465|Dsuvia|dsuvia|mesh-list
25175548|NCT02857465|Ropivacaine|ropivacaine|mesh-list
25175549|NCT02857465|BB 1101|bb 1101|mesh-list
25175550|NCT02857465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25175551|NCT02857465|Antiemetics|antiemetics|mesh-ancestor
25175552|NCT02857465|Autonomic Agents|autonomic agents|mesh-ancestor
25175553|NCT02857465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25175554|NCT02857465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175555|NCT02857465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25175556|NCT02857465|Glucocorticoids|glucocorticoids|mesh-ancestor
25175557|NCT02857465|Hormones|hormones|mesh-ancestor
25175558|NCT02857465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25175559|NCT02857465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25175560|NCT02857465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175561|NCT02857465|Protease Inhibitors|protease inhibitors|mesh-ancestor
25175562|NCT02857465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25175563|NCT02857465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175564|NCT02857465|Anesthetics, Local|anesthetics, local|mesh-ancestor
25175565|NCT02857465|Anesthetics|anesthetics|mesh-ancestor
25175566|NCT02857465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25175567|NCT02857465|Sensory System Agents|sensory system agents|mesh-ancestor
25175568|NCT02857465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25175569|NCT02857465|Narcotics|narcotics|mesh-ancestor
25175570|NCT02857465|Analgesics|analgesics|mesh-ancestor
25175571|NCT02857465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25665124|NCT01680458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25665125|NCT01680458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25665126|NCT01680497|Hyaluronic Acid|hyaluronic acid|mesh-list
25665127|NCT01680497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25665128|NCT01680497|Immunologic Factors|immunologic factors|mesh-ancestor
25665129|NCT01680497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665130|NCT01680497|Viscosupplements|viscosupplements|mesh-ancestor
25665131|NCT01680497|Protective Agents|protective agents|mesh-ancestor
25175572|NCT02857465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25175573|NCT02857465|Anesthetics, General|anesthetics, general|mesh-ancestor
24923286|NCT04171466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24923287|NCT04171466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24923288|NCT04171466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24923289|NCT04171466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923290|NCT04171466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923293|NCT04171180|Budesonide|budesonide|mesh-list
24498951|NCT00516945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24498952|NCT00516945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498953|NCT00516945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498954|NCT00516945|Antiviral Agents|antiviral agents|mesh-ancestor
24498955|NCT00516945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24923332|NCT04171349|Analgesics|analgesics|mesh-ancestor
24923333|NCT04171349|Sensory System Agents|sensory system agents|mesh-ancestor
24923334|NCT04171349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25175574|NCT02857218|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25175575|NCT02857218|Hematinics|hematinics|mesh-ancestor
25175576|NCT02857218|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25175577|NCT02857218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25175582|NCT02857244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25175583|NCT02857244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25175947|NCT02855346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25175587|NCT02857244|Analgesics|analgesics|mesh-ancestor
25175588|NCT02857244|Sensory System Agents|sensory system agents|mesh-ancestor
25175589|NCT02857244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25175590|NCT02857244|Antidepressive Agents|antidepressive agents|mesh-ancestor
25175591|NCT02857244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25175592|NCT02857244|Dopamine Agents|dopamine agents|mesh-ancestor
25175593|NCT02857244|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25175594|NCT02857244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25175595|NCT02857244|Cholinergic Agents|cholinergic agents|mesh-ancestor
25175596|NCT02857244|Nootropic Agents|nootropic agents|mesh-ancestor
25175597|NCT02857244|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25175598|NCT02857244|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25175599|NCT02857244|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25175600|NCT02857244|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25175601|NCT02857361|Ketamine|ketamine|mesh-list
25175602|NCT02857361|Analgesics|analgesics|mesh-ancestor
25175603|NCT02857361|Sensory System Agents|sensory system agents|mesh-ancestor
25175604|NCT02857361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25175605|NCT02857361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175606|NCT02857361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25175607|NCT02857361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25175608|NCT02857361|Anesthetics, General|anesthetics, general|mesh-ancestor
25175609|NCT02857361|Anesthetics|anesthetics|mesh-ancestor
25175610|NCT02857361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25175611|NCT02857361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25175612|NCT02857361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25175613|NCT02857361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25175614|NCT02857361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175919|NCT02855788|Mitosis Modulators|mitosis modulators|mesh-ancestor
25175670|NCT02856854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24460344|NCT00348244|Prednisolone acetate|prednisolone acetate|mesh-list
24944751|NCT03957668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25175671|NCT02856854|Antimetabolites|antimetabolites|mesh-ancestor
25175672|NCT02856854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25175673|NCT02856854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25175674|NCT02856854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25175675|NCT02856854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25175676|NCT02856854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25175677|NCT02856854|GABA Modulators|gaba modulators|mesh-ancestor
25665132|NCT01680549|Gabapentin|gabapentin|mesh-list
25665133|NCT01680549|Analgesics|analgesics|mesh-ancestor
25665134|NCT01680549|Sensory System Agents|sensory system agents|mesh-ancestor
25665135|NCT01680549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25665136|NCT01680549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665137|NCT01680549|Anticonvulsants|anticonvulsants|mesh-ancestor
25665138|NCT01680549|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25665139|NCT01680549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25665140|NCT01680549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25665141|NCT01680549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25665142|NCT01680549|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25665143|NCT01680549|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25665144|NCT01680549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25665145|NCT01680549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923663|NCT04168138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24923666|NCT04168099|Gemifloxacin|gemifloxacin|mesh-list
25175678|NCT02856854|GABA Agents|gaba agents|mesh-ancestor
25175679|NCT02857062|Emollients|emollients|mesh-list
25175680|NCT02857062|Dermatologic Agents|dermatologic agents|mesh-ancestor
25175687|NCT02857166|Antibodies|antibodies|mesh-list
25175688|NCT02857166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25175689|NCT02857166|Immunologic Factors|immunologic factors|mesh-ancestor
25175690|NCT02857166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175691|NCT02856932|Methamphetamine|methamphetamine|mesh-list
25204534|NCT02707484|Growth Substances|growth substances|mesh-ancestor
25175692|NCT02856932|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25175693|NCT02856932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175694|NCT02856932|Sympathomimetics|sympathomimetics|mesh-ancestor
25175695|NCT02856932|Autonomic Agents|autonomic agents|mesh-ancestor
25175696|NCT02856932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25175697|NCT02856932|Dopamine Agents|dopamine agents|mesh-ancestor
25175698|NCT02856932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25175699|NCT02856932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175700|NCT02856932|Adrenergic Agents|adrenergic agents|mesh-ancestor
25175701|NCT02856932|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25175702|NCT02856932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25175703|NCT02856932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25175704|NCT02856932|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25175705|NCT02856867|Leucovorin|leucovorin|mesh-list
25175706|NCT02856867|Fluorouracil|fluorouracil|mesh-list
25175707|NCT02856867|Oxaliplatin|oxaliplatin|mesh-list
25175708|NCT02856867|Nintedanib|nintedanib|mesh-list
25175709|NCT02856867|Antimetabolites|antimetabolites|mesh-ancestor
25175710|NCT02856867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175711|NCT02856867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25175712|NCT02856867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175718|NCT02856867|Vitamin B Complex|vitamin b complex|mesh-ancestor
25175719|NCT02856867|Vitamins|vitamins|mesh-ancestor
25860183|NCT00083005|Immunologic Factors|immunologic factors|mesh-ancestor
25175721|NCT02856867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25175722|NCT02856867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25204436|NCT02708251|Anesthetics, Local|anesthetics, local|mesh-ancestor
25204437|NCT02708251|Anesthetics|anesthetics|mesh-ancestor
25204438|NCT02708251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25204439|NCT02708251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204440|NCT02708251|Sensory System Agents|sensory system agents|mesh-ancestor
25204441|NCT02708251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204442|NCT02708251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25204443|NCT02708251|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25204444|NCT02708251|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25204445|NCT02708251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25204446|NCT02708251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204447|NCT02708251|Vasodilator Agents|vasodilator agents|mesh-ancestor
25204448|NCT02708459|Morphine|morphine|mesh-list
25204449|NCT02708459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25204450|NCT02708459|Narcotics|narcotics|mesh-ancestor
25204451|NCT02708459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25204452|NCT02708459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204453|NCT02708459|Analgesics|analgesics|mesh-ancestor
25204454|NCT02708459|Sensory System Agents|sensory system agents|mesh-ancestor
25204455|NCT02708459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204456|NCT02708173|Vaccines|vaccines|mesh-list
25204457|NCT02708173|Immunologic Factors|immunologic factors|mesh-ancestor
25204458|NCT02708173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204459|NCT02707809|Dexmedetomidine|dexmedetomidine|mesh-list
24754520|NCT01721135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24754521|NCT01721135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24754522|NCT01721135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860184|NCT00083005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204460|NCT02707809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25204461|NCT02707809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25204462|NCT02707809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204463|NCT02707809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25204464|NCT02707809|Analgesics|analgesics|mesh-ancestor
25204465|NCT02707809|Sensory System Agents|sensory system agents|mesh-ancestor
25204466|NCT02707809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25665146|NCT01680549|Antimanic Agents|antimanic agents|mesh-ancestor
25665147|NCT01680653|Glucagon|glucagon|mesh-list
25665148|NCT01680653|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24624170|NCT01074970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24624180|NCT01075022|Vitamin D|vitamin d|mesh-list
24624181|NCT01075022|Cholecalciferol|cholecalciferol|mesh-list
24624182|NCT01075022|Vitamins|vitamins|mesh-ancestor
24626076|NCT01085552|Epoetin Alfa|epoetin alfa|mesh-list
24624188|NCT01075113|Vorinostat|vorinostat|mesh-list
24624189|NCT01075113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624190|NCT01075113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24624191|NCT01075113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24624192|NCT01075113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924092|NCT04163471|Hemostatics|hemostatics|mesh-list
25204535|NCT02707484|Growth Inhibitors|growth inhibitors|mesh-ancestor
25204467|NCT02707809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25204468|NCT02707809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25204469|NCT02707809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25204470|NCT02707809|Adrenergic Agents|adrenergic agents|mesh-ancestor
25204471|NCT02707809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25204472|NCT02707809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204473|NCT02707900|Vorinostat|vorinostat|mesh-list
25204474|NCT02707900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25204475|NCT02707900|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25204476|NCT02707900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25204477|NCT02707900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204478|NCT02707874|Ropivacaine|ropivacaine|mesh-list
25204479|NCT02707874|Anesthetics, Local|anesthetics, local|mesh-ancestor
25204480|NCT02707874|Anesthetics|anesthetics|mesh-ancestor
25204481|NCT02707874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25204482|NCT02707874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204483|NCT02707874|Sensory System Agents|sensory system agents|mesh-ancestor
25204484|NCT02707874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204485|NCT02707926|Anti-HIV Agents|anti-hiv agents|mesh-list
25204486|NCT02707926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25204487|NCT02707926|Antiviral Agents|antiviral agents|mesh-ancestor
25204488|NCT02707926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25204489|NCT02707913|Amlodipine|amlodipine|mesh-list
25204490|NCT02707913|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25204493|NCT02707913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204494|NCT02707913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25204495|NCT02707913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204496|NCT02707913|Vasodilator Agents|vasodilator agents|mesh-ancestor
24944769|NCT03957499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24857859|NCT02294292|Adrenergic Agents|adrenergic agents|mesh-ancestor
25204497|NCT02707666|Pembrolizumab|pembrolizumab|mesh-list
25204498|NCT02707666|Pemetrexed|pemetrexed|mesh-list
25204499|NCT02707666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25204500|NCT02707666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25204501|NCT02707666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25204502|NCT02707666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204503|NCT02707666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24807914|NCT02024295|Nootropic Agents|nootropic agents|mesh-ancestor
25175723|NCT02856906|Salicylic Acid|salicylic acid|mesh-list
25175724|NCT02856906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25175725|NCT02856906|Antifungal Agents|antifungal agents|mesh-ancestor
25175726|NCT02856906|Keratolytic Agents|keratolytic agents|mesh-ancestor
25175727|NCT02856906|Dermatologic Agents|dermatologic agents|mesh-ancestor
25175728|NCT02857153|Urapidil|urapidil|mesh-list
25175729|NCT02857153|Phenylephrine|phenylephrine|mesh-list
25175730|NCT02857153|Oxymetazoline|oxymetazoline|mesh-list
25175731|NCT02857153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25175732|NCT02857153|Mydriatics|mydriatics|mesh-ancestor
25175733|NCT02857153|Autonomic Agents|autonomic agents|mesh-ancestor
25175734|NCT02857153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25175735|NCT02857153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665149|NCT01680653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25665150|NCT01680653|Hormones|hormones|mesh-ancestor
25665151|NCT01680653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25665152|NCT01680653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665153|NCT01680653|Incretins|incretins|mesh-ancestor
25665154|NCT01680861|Mycophenolic Acid|mycophenolic acid|mesh-list
25665155|NCT01680861|Methylprednisolone|methylprednisolone|mesh-list
25665156|NCT01680861|Everolimus|everolimus|mesh-list
25665157|NCT01680861|Tacrolimus|tacrolimus|mesh-list
25665158|NCT01680861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25175736|NCT02857153|Sympathomimetics|sympathomimetics|mesh-ancestor
25175737|NCT02857153|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25175738|NCT02857153|Nasal Decongestants|nasal decongestants|mesh-ancestor
25665159|NCT01680861|Immunologic Factors|immunologic factors|mesh-ancestor
25175739|NCT02857153|Respiratory System Agents|respiratory system agents|mesh-ancestor
25175740|NCT02857153|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25175741|NCT02857153|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25175742|NCT02857153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25175743|NCT02857153|Adrenergic Agents|adrenergic agents|mesh-ancestor
25175744|NCT02857153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25175745|NCT02857153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175746|NCT02857153|Protective Agents|protective agents|mesh-ancestor
25175747|NCT02857153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25175748|NCT02857153|Vasodilator Agents|vasodilator agents|mesh-ancestor
25175749|NCT02857153|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25175750|NCT02857153|Serotonin Agents|serotonin agents|mesh-ancestor
25175751|NCT02857153|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25175752|NCT02857153|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25175753|NCT02857153|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25175754|NCT02856789|Hemostatics|hemostatics|mesh-list
25175755|NCT02856789|Coagulants|coagulants|mesh-ancestor
25175756|NCT02856724|Dinoprostone|dinoprostone|mesh-list
25175757|NCT02856724|Oxytocics|oxytocics|mesh-ancestor
25175758|NCT02856724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25175759|NCT02856724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175761|NCT02856776|Cholecalciferol|cholecalciferol|mesh-list
25175762|NCT02856776|Vitamins|vitamins|mesh-ancestor
25175763|NCT02856776|Micronutrients|micronutrients|mesh-ancestor
25175764|NCT02856776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175765|NCT02856776|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25175766|NCT02856776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25175767|NCT02856750|Gabapentin|gabapentin|mesh-list
25175768|NCT02856750|Analgesics|analgesics|mesh-ancestor
24857861|NCT02294292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175769|NCT02856750|Sensory System Agents|sensory system agents|mesh-ancestor
25175770|NCT02856750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25175771|NCT02856750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175772|NCT02856750|Anticonvulsants|anticonvulsants|mesh-ancestor
25175773|NCT02856750|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25175774|NCT02856750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25175775|NCT02856750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25175776|NCT02856750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25175777|NCT02856750|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25175778|NCT02856750|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25175779|NCT02856750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25175781|NCT02856750|Antimanic Agents|antimanic agents|mesh-ancestor
25175782|NCT02856685|Mitoxantrone|mitoxantrone|mesh-list
25175783|NCT02856685|Analgesics|analgesics|mesh-ancestor
25175784|NCT02856685|Sensory System Agents|sensory system agents|mesh-ancestor
25175785|NCT02856685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25175786|NCT02856685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175787|NCT02856685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175788|NCT02856685|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25175789|NCT02856685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25175790|NCT02856685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25175791|NCT02856685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175792|NCT02856568|Gemcitabine|gemcitabine|mesh-list
25175793|NCT02856568|Cisplatin|cisplatin|mesh-list
25175794|NCT02856568|Ricolinostat|ricolinostat|mesh-list
25175795|NCT02856568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175796|NCT02856568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25175797|NCT02856568|Antimetabolites|antimetabolites|mesh-ancestor
25175798|NCT02856568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481645|NCT00436072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481646|NCT00436072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481647|NCT00436072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24481648|NCT00436124|Oseltamivir|oseltamivir|mesh-list
24481649|NCT00436124|Antiviral Agents|antiviral agents|mesh-ancestor
24481650|NCT00436124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24808010|NCT02024659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808011|NCT02024659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24808012|NCT02024659|Respiratory System Agents|respiratory system agents|mesh-ancestor
24808013|NCT02024659|Glucocorticoids|glucocorticoids|mesh-ancestor
24808014|NCT02024659|Hormones|hormones|mesh-ancestor
25130730|NCT03031184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25083574|NCT03314792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25083575|NCT03314792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25083576|NCT03314792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083577|NCT03314792|Adrenergic Agents|adrenergic agents|mesh-ancestor
25860185|NCT00083005|Leprostatic Agents|leprostatic agents|mesh-ancestor
25083578|NCT03314792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25083579|NCT03314740|Paclitaxel|paclitaxel|mesh-list
25083580|NCT03314740|Olaparib|olaparib|mesh-list
25083610|NCT03314493|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25083611|NCT03314493|Hormone Antagonists|hormone antagonists|mesh-ancestor
25083612|NCT03314493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25083613|NCT03314493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083614|NCT03314493|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25083615|NCT03314493|Diuretics|diuretics|mesh-ancestor
25083616|NCT03314493|Natriuretic Agents|natriuretic agents|mesh-ancestor
25083617|NCT03314298|Methyltestosterone|methyltestosterone|mesh-list
25083618|NCT03314298|Anastrozole|anastrozole|mesh-list
25083619|NCT03314298|Testosterone|testosterone|mesh-list
25083620|NCT03314298|Testosterone undecanoate|testosterone undecanoate|mesh-list
25083621|NCT03314298|Testosterone enanthate|testosterone enanthate|mesh-list
25083622|NCT03314298|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25083623|NCT03314298|Androgens|androgens|mesh-ancestor
24933904|NCT04066231|Erythromycin|erythromycin|mesh-list
25083743|NCT03313401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25083744|NCT03313401|Growth Substances|growth substances|mesh-ancestor
25083745|NCT03313401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083746|NCT03313401|Growth Inhibitors|growth inhibitors|mesh-ancestor
25083747|NCT03313401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083748|NCT03313336|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25083749|NCT03313336|Anesthetics, Local|anesthetics, local|mesh-ancestor
25083750|NCT03313336|Anesthetics|anesthetics|mesh-ancestor
25083751|NCT03313336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25083752|NCT03313336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083753|NCT03313336|Sensory System Agents|sensory system agents|mesh-ancestor
24934046|NCT04064632|Darunavir|darunavir|mesh-list
25083789|NCT03312426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083790|NCT03312413|Dexmedetomidine|dexmedetomidine|mesh-list
25083791|NCT03312413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25083792|NCT03312413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25083819|NCT03312257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25083820|NCT03312257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25083821|NCT03312257|Autonomic Agents|autonomic agents|mesh-ancestor
25083822|NCT03312257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25083823|NCT03312257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083824|NCT03312257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25083825|NCT03312257|Respiratory System Agents|respiratory system agents|mesh-ancestor
25083827|NCT03312257|Parasympatholytics|parasympatholytics|mesh-ancestor
25083983|NCT03311321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25083984|NCT03311321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083986|NCT03311321|Coagulants|coagulants|mesh-ancestor
25084017|NCT03310736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25175799|NCT02856568|Antiviral Agents|antiviral agents|mesh-ancestor
25175800|NCT02856568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25175801|NCT02856568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25175802|NCT02856568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25175803|NCT02856568|Immunologic Factors|immunologic factors|mesh-ancestor
25175804|NCT02856568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175805|NCT02856568|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25175806|NCT02856295|Enoxaparin|enoxaparin|mesh-list
25175807|NCT02856295|Anticoagulants|anticoagulants|mesh-ancestor
25175808|NCT02856295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25175809|NCT02856295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25175810|NCT02856295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175811|NCT02856243|Antiviral Agents|antiviral agents|mesh-list
25175812|NCT02856243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25175813|NCT02856503|Vitamin D|vitamin d|mesh-list
25175814|NCT02856503|Cholecalciferol|cholecalciferol|mesh-list
25175815|NCT02856503|Vitamins|vitamins|mesh-ancestor
25175816|NCT02856503|Micronutrients|micronutrients|mesh-ancestor
25175817|NCT02856503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175818|NCT02856503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25175819|NCT02856503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25175820|NCT02856178|Caspofungin|caspofungin|mesh-list
25175821|NCT02856178|Olorofim|olorofim|mesh-list
25175822|NCT02856178|Antifungal Agents|antifungal agents|mesh-ancestor
25175823|NCT02856178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25175824|NCT02856178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25175825|NCT02856178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175826|NCT02856542|Betamethasone|betamethasone|mesh-list
25175827|NCT02856542|Betamethasone Valerate|betamethasone valerate|mesh-list
25175828|NCT02856542|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25175829|NCT02856542|Betamethasone benzoate|betamethasone benzoate|mesh-list
25175830|NCT02856542|Calcipotriene|calcipotriene|mesh-list
25175831|NCT02856542|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25175832|NCT02856542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25175833|NCT02856542|Glucocorticoids|glucocorticoids|mesh-ancestor
25175834|NCT02856542|Hormones|hormones|mesh-ancestor
25175835|NCT02856542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25175836|NCT02856542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175837|NCT02856542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25175838|NCT02856542|Respiratory System Agents|respiratory system agents|mesh-ancestor
25175839|NCT02856542|Dermatologic Agents|dermatologic agents|mesh-ancestor
25175840|NCT02856425|Pembrolizumab|pembrolizumab|mesh-list
25175841|NCT02856425|Nintedanib|nintedanib|mesh-list
25175842|NCT02856425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25175843|NCT02856425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175844|NCT02856425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25175845|NCT02856425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25175846|NCT02856425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175847|NCT02856100|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
25175848|NCT02856100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175849|NCT02856048|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25175850|NCT02856048|Luteolytic Agents|luteolytic agents|mesh-ancestor
25175851|NCT02856048|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25175852|NCT02856048|Contraceptive Agents|contraceptive agents|mesh-ancestor
25175853|NCT02856048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25175854|NCT02856048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175855|NCT02856048|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25175856|NCT02856048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25175857|NCT02856048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175858|NCT02856230|Paclitaxel|paclitaxel|mesh-list
25175859|NCT02856230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25175860|NCT02856230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175861|NCT02856230|Tubulin Modulators|tubulin modulators|mesh-ancestor
25175862|NCT02856230|Antimitotic Agents|antimitotic agents|mesh-ancestor
25175863|NCT02856230|Mitosis Modulators|mitosis modulators|mesh-ancestor
25175948|NCT02855346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25175864|NCT02856230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175865|NCT02856087|Remifentanil|remifentanil|mesh-list
25175866|NCT02856087|Naloxone|naloxone|mesh-list
25175867|NCT02856087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25175868|NCT02856087|Narcotics|narcotics|mesh-ancestor
25175869|NCT02856087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25175870|NCT02856087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175871|NCT02856087|Analgesics|analgesics|mesh-ancestor
25175872|NCT02856087|Sensory System Agents|sensory system agents|mesh-ancestor
25175873|NCT02856087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25175874|NCT02856087|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25175875|NCT02855632|Hormones|hormones|mesh-list
25175876|NCT02855632|Progesterone|progesterone|mesh-list
25175877|NCT02855632|Lenograstim|lenograstim|mesh-list
25175878|NCT02855632|Estrogens|estrogens|mesh-list
25175879|NCT02855632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25175880|NCT02855632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175881|NCT02855632|Progestins|progestins|mesh-ancestor
25175882|NCT02855632|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25175883|NCT02855632|Immunologic Factors|immunologic factors|mesh-ancestor
25175884|NCT02855684|Insulin|insulin|mesh-list
25175885|NCT02855684|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25175886|NCT02855684|Insulin Glargine|insulin glargine|mesh-list
25175887|NCT02855684|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25175888|NCT02855684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175889|NCT02855866|Acetaminophen|acetaminophen|mesh-list
25175890|NCT02855866|Dexamethasone|dexamethasone|mesh-list
25175891|NCT02855866|Cortisone|cortisone|mesh-list
25175892|NCT02855866|Dexamethasone acetate|dexamethasone acetate|mesh-list
25175893|NCT02855866|BB 1101|bb 1101|mesh-list
25175894|NCT02855866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25175895|NCT02855866|Antiemetics|antiemetics|mesh-ancestor
25175896|NCT02855866|Autonomic Agents|autonomic agents|mesh-ancestor
25175897|NCT02855866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25175898|NCT02855866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175899|NCT02855866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25175900|NCT02855866|Glucocorticoids|glucocorticoids|mesh-ancestor
25175901|NCT02855866|Hormones|hormones|mesh-ancestor
25175902|NCT02855866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25175903|NCT02855866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25175904|NCT02855866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175905|NCT02855866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25175906|NCT02855866|Analgesics|analgesics|mesh-ancestor
25175907|NCT02855866|Sensory System Agents|sensory system agents|mesh-ancestor
25175908|NCT02855866|Antipyretics|antipyretics|mesh-ancestor
25175909|NCT02855866|Protease Inhibitors|protease inhibitors|mesh-ancestor
25175910|NCT02855866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25175911|NCT02855866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175912|NCT02855788|Leucovorin|leucovorin|mesh-list
25175913|NCT02855788|Paclitaxel|paclitaxel|mesh-list
25175914|NCT02855788|Oxaliplatin|oxaliplatin|mesh-list
25175915|NCT02855788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25175916|NCT02855788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175917|NCT02855788|Tubulin Modulators|tubulin modulators|mesh-ancestor
25175918|NCT02855788|Antimitotic Agents|antimitotic agents|mesh-ancestor
25175923|NCT02855788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175924|NCT02855788|Vitamin B Complex|vitamin b complex|mesh-ancestor
25175925|NCT02855788|Vitamins|vitamins|mesh-ancestor
25175926|NCT02855788|Micronutrients|micronutrients|mesh-ancestor
25175927|NCT02855502|Prednisolone|prednisolone|mesh-list
25175928|NCT02855502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25175929|NCT02855502|Glucocorticoids|glucocorticoids|mesh-ancestor
25175930|NCT02855502|Hormones|hormones|mesh-ancestor
25175931|NCT02855502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25175932|NCT02855502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175933|NCT02855502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25175934|NCT02855502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175935|NCT02855515|Anesthetics|anesthetics|mesh-list
25175936|NCT02855515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25175937|NCT02855515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175938|NCT02855346|Dapivirine|dapivirine|mesh-list
25175939|NCT02855346|Levonorgestrel|levonorgestrel|mesh-list
25175940|NCT02855346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25175941|NCT02855346|Contraceptive Agents|contraceptive agents|mesh-ancestor
25175942|NCT02855346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25175943|NCT02855346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175944|NCT02855346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25175945|NCT02855346|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25175949|NCT02855346|Antiviral Agents|antiviral agents|mesh-ancestor
25175950|NCT02855346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25175951|NCT02855307|Insulin|insulin|mesh-list
25175952|NCT02855307|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25175953|NCT02855307|Hormones|hormones|mesh-list
25175954|NCT02855307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25175955|NCT02855307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175956|NCT02855307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25175957|NCT02855294|Drospirenone|drospirenone|mesh-list
25175958|NCT02855294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25175959|NCT02855294|Hormone Antagonists|hormone antagonists|mesh-ancestor
25175960|NCT02855294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25175961|NCT02855294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808061|NCT02025010|Hormones|hormones|mesh-ancestor
25175962|NCT02855294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25175964|NCT02855294|Natriuretic Agents|natriuretic agents|mesh-ancestor
25204504|NCT02707666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25204505|NCT02707653|Misoprostol|misoprostol|mesh-list
25204506|NCT02707653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25204507|NCT02707653|Abortifacient Agents|abortifacient agents|mesh-ancestor
25204508|NCT02707653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25204509|NCT02707653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204510|NCT02707653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25204511|NCT02707653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25204512|NCT02707653|Oxytocics|oxytocics|mesh-ancestor
25204516|NCT02707458|Probucol|probucol|mesh-list
25204517|NCT02707458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25204518|NCT02707458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25204519|NCT02707458|Antimetabolites|antimetabolites|mesh-ancestor
25204520|NCT02707458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204521|NCT02707458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25204522|NCT02707458|Antioxidants|antioxidants|mesh-ancestor
25204523|NCT02707458|Protective Agents|protective agents|mesh-ancestor
25204524|NCT02707458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204525|NCT02707484|Thalidomide|thalidomide|mesh-list
25204526|NCT02707484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25204527|NCT02707484|Immunologic Factors|immunologic factors|mesh-ancestor
24500396|NCT00524095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500397|NCT00524095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24500398|NCT00524095|Respiratory System Agents|respiratory system agents|mesh-ancestor
24500399|NCT00524095|Dermatologic Agents|dermatologic agents|mesh-ancestor
25665160|NCT01680861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500400|NCT00524095|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24500401|NCT00524095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24500402|NCT00524095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25204528|NCT02707484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204529|NCT02707484|Leprostatic Agents|leprostatic agents|mesh-ancestor
25204530|NCT02707484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25204531|NCT02707484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25204532|NCT02707484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25204533|NCT02707484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25204544|NCT02707445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204545|NCT02707445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204546|NCT02707393|Cyclosporine|cyclosporine|mesh-list
25204547|NCT02707393|Mycophenolic Acid|mycophenolic acid|mesh-list
25204548|NCT02707393|Fludarabine|fludarabine|mesh-list
25204549|NCT02707393|Melphalan|melphalan|mesh-list
25204550|NCT02707393|Thiotepa|thiotepa|mesh-list
25204551|NCT02707393|Cyclosporins|cyclosporins|mesh-list
25204552|NCT02707393|Thymoglobulin|thymoglobulin|mesh-list
25204553|NCT02707393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25204554|NCT02707393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204555|NCT02707393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25204556|NCT02707393|Immunologic Factors|immunologic factors|mesh-ancestor
25204557|NCT02707393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204558|NCT02707393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25204559|NCT02707393|Antifungal Agents|antifungal agents|mesh-ancestor
25204560|NCT02707393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25204561|NCT02707393|Dermatologic Agents|dermatologic agents|mesh-ancestor
25204562|NCT02707393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25204563|NCT02707393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25204564|NCT02707393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25204565|NCT02707393|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25204566|NCT02707393|Antitubercular Agents|antitubercular agents|mesh-ancestor
25204567|NCT02707393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25204568|NCT02707393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25204569|NCT02707393|Alkylating Agents|alkylating agents|mesh-ancestor
25204570|NCT02707393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24808085|NCT02025023|Hormones|hormones|mesh-ancestor
24482485|NCT00439192|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24482486|NCT00439192|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24482487|NCT00439192|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24482510|NCT00439283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24482511|NCT00439361|Carboplatin|carboplatin|mesh-list
24482513|NCT00439361|Bortezomib|bortezomib|mesh-list
24482514|NCT00439361|Ifosfamide|ifosfamide|mesh-list
24482515|NCT00439361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24482526|NCT00439400|Antimalarials|antimalarials|mesh-ancestor
24482527|NCT00439400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24482528|NCT00439400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24482529|NCT00439426|Capecitabine|capecitabine|mesh-list
24622835|NCT01068847|Sensory System Agents|sensory system agents|mesh-ancestor
24622836|NCT01068847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24622837|NCT01068847|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24622838|NCT01068847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24622839|NCT01068847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622840|NCT01068847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24622841|NCT01068847|Vasodilator Agents|vasodilator agents|mesh-ancestor
24622842|NCT01068847|Tocolytic Agents|tocolytic agents|mesh-ancestor
24628767|NCT01101412|Calcium, Dietary|calcium, dietary|mesh-list
24622843|NCT01068847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24622844|NCT01068847|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25665161|NCT01680861|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25665162|NCT01680861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665163|NCT01680861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665164|NCT01680861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665165|NCT01680861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25665166|NCT01680861|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25665167|NCT01680861|Antitubercular Agents|antitubercular agents|mesh-ancestor
25665168|NCT01680861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24622845|NCT01068847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24523144|NCT02512497|Romidepsin|romidepsin|mesh-list
24808141|NCT02025361|Sensory System Agents|sensory system agents|mesh-ancestor
24591260|NCT00915733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24482530|NCT00439426|Oxaliplatin|oxaliplatin|mesh-list
24482531|NCT00439426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24754675|NCT01722305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419438|NCT00212095|Docetaxel|docetaxel|mesh-list
24482532|NCT00439426|Antimetabolites|antimetabolites|mesh-ancestor
24808145|NCT02025361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24808146|NCT02025361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24808147|NCT02025361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084019|NCT03310606|Lactams|lactams|mesh-list
25084020|NCT03310606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25175965|NCT02855203|Pembrolizumab|pembrolizumab|mesh-list
25175966|NCT02855203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25175967|NCT02855203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25175968|NCT02855138|Isotretinoin|isotretinoin|mesh-list
25175969|NCT02855138|Dermatologic Agents|dermatologic agents|mesh-ancestor
25175970|NCT02855073|Hyaluronic Acid|hyaluronic acid|mesh-list
25175971|NCT02855073|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25175972|NCT02855073|Immunologic Factors|immunologic factors|mesh-ancestor
25175973|NCT02855073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175974|NCT02855073|Viscosupplements|viscosupplements|mesh-ancestor
25175975|NCT02855073|Protective Agents|protective agents|mesh-ancestor
25175976|NCT02854995|Triamcinolone|triamcinolone|mesh-list
25175977|NCT02854995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25175978|NCT02854995|Glucocorticoids|glucocorticoids|mesh-ancestor
25175979|NCT02854995|Hormones|hormones|mesh-ancestor
25175980|NCT02854995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25175981|NCT02854995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175982|NCT02854904|Dexmedetomidine|dexmedetomidine|mesh-list
25175983|NCT02854904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25175984|NCT02854904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25175985|NCT02854904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25175986|NCT02854904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25175987|NCT02854904|Analgesics|analgesics|mesh-ancestor
25175988|NCT02854904|Sensory System Agents|sensory system agents|mesh-ancestor
25175989|NCT02854904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25175990|NCT02854904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25175991|NCT02854904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25175992|NCT02854904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25175993|NCT02854904|Adrenergic Agents|adrenergic agents|mesh-ancestor
25175994|NCT02854904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25175995|NCT02854904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25175996|NCT02854670|Capsaicin|capsaicin|mesh-list
25175997|NCT02854670|Antipruritics|antipruritics|mesh-ancestor
25175998|NCT02854670|Dermatologic Agents|dermatologic agents|mesh-ancestor
25175999|NCT02854670|Sensory System Agents|sensory system agents|mesh-ancestor
25176000|NCT02854670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25176001|NCT02854670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176002|NCT02854761|Vitamin D|vitamin d|mesh-list
25176003|NCT02854761|Vitamins|vitamins|mesh-ancestor
25176004|NCT02854761|Micronutrients|micronutrients|mesh-ancestor
25176005|NCT02854761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176006|NCT02854761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25176007|NCT02854748|Empagliflozin|empagliflozin|mesh-list
25176008|NCT02854748|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25176082|NCT02854072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25176009|NCT02854748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176010|NCT02854748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25176011|NCT02854748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176012|NCT02854592|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25176013|NCT02854592|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25176014|NCT02854592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25176015|NCT02854592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176016|NCT02854722|Calcium, Dietary|calcium, dietary|mesh-list
25176017|NCT02854722|Vitamin D|vitamin d|mesh-list
25176018|NCT02854722|Ergocalciferols|ergocalciferols|mesh-list
25176019|NCT02854722|Cholecalciferol|cholecalciferol|mesh-list
25176020|NCT02854722|Vitamins|vitamins|mesh-list
25176021|NCT02854722|Calcium|calcium|mesh-list
25176022|NCT02854722|Deferasirox|deferasirox|mesh-list
25176023|NCT02854722|Micronutrients|micronutrients|mesh-ancestor
25176024|NCT02854722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176025|NCT02854722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25665169|NCT01680861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25176026|NCT02854722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25176027|NCT02854722|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25176028|NCT02854722|Chelating Agents|chelating agents|mesh-ancestor
25176029|NCT02854722|Sequestering Agents|sequestering agents|mesh-ancestor
25176030|NCT02854722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176031|NCT02854787|Phenylephrine|phenylephrine|mesh-list
25176032|NCT02854787|Oxymetazoline|oxymetazoline|mesh-list
25176033|NCT02854787|Norepinephrine|norepinephrine|mesh-list
25176034|NCT02854787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25176037|NCT02854787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25176038|NCT02854787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176039|NCT02854787|Sympathomimetics|sympathomimetics|mesh-ancestor
25176040|NCT02854787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25176041|NCT02854787|Nasal Decongestants|nasal decongestants|mesh-ancestor
25176042|NCT02854787|Respiratory System Agents|respiratory system agents|mesh-ancestor
25176043|NCT02854787|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25176044|NCT02854787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25176045|NCT02854787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25176046|NCT02854787|Adrenergic Agents|adrenergic agents|mesh-ancestor
25176047|NCT02854787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25176048|NCT02854787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176049|NCT02854787|Protective Agents|protective agents|mesh-ancestor
25176050|NCT02854241|Liver Extracts|liver extracts|mesh-list
25176051|NCT02854241|Hematinics|hematinics|mesh-ancestor
25176052|NCT02854345|Parathyroid Hormone|parathyroid hormone|mesh-list
25176053|NCT02854345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25176054|NCT02854345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176055|NCT02853864|Dexmedetomidine|dexmedetomidine|mesh-list
25176057|NCT02853864|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25176058|NCT02853864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25176059|NCT02853864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176060|NCT02853864|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25176061|NCT02853864|Anesthetics, General|anesthetics, general|mesh-ancestor
25176062|NCT02853864|Anesthetics|anesthetics|mesh-ancestor
25176063|NCT02853864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25176064|NCT02853864|Analgesics|analgesics|mesh-ancestor
25176065|NCT02853864|Sensory System Agents|sensory system agents|mesh-ancestor
25176066|NCT02853864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25176067|NCT02853864|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25176068|NCT02853864|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25176069|NCT02853864|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24754691|NCT01722396|Vitamin D|vitamin d|mesh-list
24944882|NCT03956888|Respiratory System Agents|respiratory system agents|mesh-ancestor
24944883|NCT03956888|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24944884|NCT03956888|Antioxidants|antioxidants|mesh-ancestor
24857902|NCT02294357|Methylprednisolone|methylprednisolone|mesh-list
25176070|NCT02853864|Adrenergic Agents|adrenergic agents|mesh-ancestor
25176071|NCT02853864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25176072|NCT02853864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176073|NCT02854072|Gemcitabine|gemcitabine|mesh-list
24808148|NCT02025374|Bupivacaine|bupivacaine|mesh-list
25176074|NCT02854072|Capecitabine|capecitabine|mesh-list
25176075|NCT02854072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25176076|NCT02854072|Antimetabolites|antimetabolites|mesh-ancestor
25176077|NCT02854072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176078|NCT02854072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176079|NCT02854072|Antiviral Agents|antiviral agents|mesh-ancestor
25176080|NCT02854072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25176081|NCT02854072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25176084|NCT02854072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176086|NCT02853799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25176087|NCT02853799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176088|NCT02853630|Metformin|metformin|mesh-list
25176089|NCT02853630|Vildagliptin|vildagliptin|mesh-list
25176090|NCT02853630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25176091|NCT02853630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176092|NCT02853630|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25176093|NCT02853630|Protease Inhibitors|protease inhibitors|mesh-ancestor
25176094|NCT02853630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25176095|NCT02853630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204579|NCT02707575|Ranibizumab|ranibizumab|mesh-list
25204580|NCT02707575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25204581|NCT02707575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25204582|NCT02707575|Growth Substances|growth substances|mesh-ancestor
25204583|NCT02707575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523300|NCT02178709|Protective Agents|protective agents|mesh-ancestor
24925056|NCT04154735|Tacrolimus|tacrolimus|mesh-list
24925057|NCT04154735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25204584|NCT02707575|Growth Inhibitors|growth inhibitors|mesh-ancestor
25204585|NCT02707575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25204587|NCT02707328|Paclitaxel|paclitaxel|mesh-list
25204588|NCT02707328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25204589|NCT02707328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25204590|NCT02707328|Tubulin Modulators|tubulin modulators|mesh-ancestor
25204591|NCT02707328|Antimitotic Agents|antimitotic agents|mesh-ancestor
25204592|NCT02707328|Mitosis Modulators|mitosis modulators|mesh-ancestor
25204593|NCT02707328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204594|NCT02707328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25204595|NCT02707328|Antimetabolites|antimetabolites|mesh-ancestor
25204596|NCT02707328|Antiviral Agents|antiviral agents|mesh-ancestor
25204597|NCT02707328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25204598|NCT02707328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857903|NCT02294357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25860186|NCT00083005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25204599|NCT02707328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25204600|NCT02707328|Immunologic Factors|immunologic factors|mesh-ancestor
25204601|NCT02707328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207861|NCT02545842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207862|NCT02480803|Levodopa|levodopa|mesh-list
25207863|NCT02480803|Carbidopa|carbidopa|mesh-list
25207864|NCT02480803|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25207865|NCT02480803|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25207866|NCT02480803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25207867|NCT02480803|Dopamine Agents|dopamine agents|mesh-ancestor
25207868|NCT02480803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25207869|NCT02480803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207870|NCT02480803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207871|NCT02480803|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25207872|NCT02480803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25207873|NCT02480803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25207874|NCT02480803|Immunologic Factors|immunologic factors|mesh-ancestor
25207875|NCT02480803|Dopamine Agonists|dopamine agonists|mesh-ancestor
25207876|NCT02415153|Pomalidomide|pomalidomide|mesh-list
25207877|NCT02415153|Immunologic Factors|immunologic factors|mesh-ancestor
25207878|NCT02415153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207879|NCT02415153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25207880|NCT02415153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25207881|NCT02415153|Growth Substances|growth substances|mesh-ancestor
25207882|NCT02415153|Growth Inhibitors|growth inhibitors|mesh-ancestor
25207883|NCT02415153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207884|NCT02399371|Pembrolizumab|pembrolizumab|mesh-list
25207885|NCT02399371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25207886|NCT02399371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207887|NCT02330926|Ibuprofen|ibuprofen|mesh-list
25207888|NCT02330926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25207889|NCT02330926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25207890|NCT02330926|Analgesics|analgesics|mesh-ancestor
24483417|NCT00443339|Hematinics|hematinics|mesh-ancestor
24483432|NCT00443508|Tacrolimus|tacrolimus|mesh-list
24483433|NCT00443508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24483434|NCT00443508|Immunologic Factors|immunologic factors|mesh-ancestor
24483435|NCT00443508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483439|NCT00443508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24483441|NCT00443521|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24483443|NCT00443521|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24483444|NCT00443521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24483446|NCT00443521|Hormones|hormones|mesh-ancestor
24483447|NCT00443521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24483448|NCT00443521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483449|NCT00443521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24483450|NCT00443521|Immunologic Factors|immunologic factors|mesh-ancestor
24483451|NCT00443521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483452|NCT00443521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483453|NCT00443573|Protein C|protein c|mesh-list
25176096|NCT02853539|Denosumab|denosumab|mesh-list
25176097|NCT02853539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25176098|NCT02853539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176099|NCT02853526|Propranolol|propranolol|mesh-list
25665170|NCT01680861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25665171|NCT01680861|Antiemetics|antiemetics|mesh-ancestor
25665172|NCT01680861|Autonomic Agents|autonomic agents|mesh-ancestor
25665173|NCT01680861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25665174|NCT01680861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24523470|NCT00467142|Vitamin B Complex|vitamin b complex|mesh-ancestor
25176100|NCT02853526|Warfarin|warfarin|mesh-list
25176101|NCT02853526|Anticoagulants|anticoagulants|mesh-ancestor
25176102|NCT02853526|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25176103|NCT02853526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25176104|NCT02853526|Adrenergic Agents|adrenergic agents|mesh-ancestor
25176105|NCT02853526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25176106|NCT02853526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176107|NCT02853526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176108|NCT02853526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25176109|NCT02853526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25176110|NCT02853526|Vasodilator Agents|vasodilator agents|mesh-ancestor
25176111|NCT02853552|Misoprostol|misoprostol|mesh-list
25176112|NCT02853552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25176113|NCT02853552|Abortifacient Agents|abortifacient agents|mesh-ancestor
25176114|NCT02853552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25176115|NCT02853552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176116|NCT02853552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25176117|NCT02853552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25176118|NCT02853552|Oxytocics|oxytocics|mesh-ancestor
25176119|NCT02853253|SMOFlipid|smoflipid|mesh-list
25176120|NCT02853253|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25176121|NCT02853253|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25176122|NCT02853253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25176123|NCT02853370|Rituximab|rituximab|mesh-list
25176124|NCT02853370|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25176125|NCT02853370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25176126|NCT02853370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176127|NCT02853370|Immunologic Factors|immunologic factors|mesh-ancestor
25176128|NCT02853370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176129|NCT02853370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25176130|NCT02853370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25176131|NCT02853370|Alkylating Agents|alkylating agents|mesh-ancestor
25176132|NCT02853370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176133|NCT02853578|Budesonide|budesonide|mesh-list
25176134|NCT02853578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25176135|NCT02853578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25176136|NCT02853578|Autonomic Agents|autonomic agents|mesh-ancestor
25176137|NCT02853578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25176138|NCT02853578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176139|NCT02853578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25176140|NCT02853578|Respiratory System Agents|respiratory system agents|mesh-ancestor
25176141|NCT02853578|Glucocorticoids|glucocorticoids|mesh-ancestor
25176142|NCT02853578|Hormones|hormones|mesh-ancestor
25176143|NCT02853578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25176144|NCT02853136|Fluvoxamine|fluvoxamine|mesh-list
25176145|NCT02853136|BI 409306|bi 409306|mesh-list
25176146|NCT02853136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25176147|NCT02853136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25176148|NCT02853136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25176149|NCT02853136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176150|NCT02853136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25176151|NCT02853136|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25176152|NCT02853136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25176153|NCT02853136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25176154|NCT02853136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176155|NCT02853136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25176156|NCT02853136|Serotonin Agents|serotonin agents|mesh-ancestor
25176157|NCT02853136|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25176158|NCT02853136|Antidepressive Agents|antidepressive agents|mesh-ancestor
25176159|NCT02853136|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25176160|NCT02853136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25176161|NCT02853136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25176162|NCT02853136|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25176163|NCT02853136|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25176164|NCT02853071|Estramustine|estramustine|mesh-list
25665175|NCT01680861|Glucocorticoids|glucocorticoids|mesh-ancestor
25665176|NCT01680861|Hormones|hormones|mesh-ancestor
25674389|NCT01771627|Nicotine|nicotine|mesh-list
25674390|NCT01771627|Varenicline|varenicline|mesh-list
25674391|NCT01771627|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24925239|NCT04152356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24925240|NCT04152356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25176165|NCT02853071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25176166|NCT02853071|Alkylating Agents|alkylating agents|mesh-ancestor
25176167|NCT02853071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176168|NCT02853071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176169|NCT02853071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25176171|NCT02852837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176173|NCT02852798|Apatinib|apatinib|mesh-list
25176174|NCT02852798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176175|NCT02852798|Tubulin Modulators|tubulin modulators|mesh-ancestor
25176176|NCT02852798|Antimitotic Agents|antimitotic agents|mesh-ancestor
25176177|NCT02852798|Mitosis Modulators|mitosis modulators|mesh-ancestor
25176178|NCT02852798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176179|NCT02852798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25176180|NCT02852798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25176181|NCT02852681|Drospirenone|drospirenone|mesh-list
25176182|NCT02852681|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25176183|NCT02852681|Hormone Antagonists|hormone antagonists|mesh-ancestor
25176184|NCT02852681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25176185|NCT02852681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176186|NCT02852681|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25176187|NCT02852681|Diuretics|diuretics|mesh-ancestor
25176188|NCT02852681|Natriuretic Agents|natriuretic agents|mesh-ancestor
25176189|NCT02852694|Adalimumab|adalimumab|mesh-list
25176190|NCT02852694|Methotrexate|methotrexate|mesh-list
25176191|NCT02852694|Mercaptopurine|mercaptopurine|mesh-list
25176192|NCT02852694|Azathioprine|azathioprine|mesh-list
25176193|NCT02852694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25176194|NCT02852694|Abortifacient Agents|abortifacient agents|mesh-ancestor
25176195|NCT02852694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25176196|NCT02852694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176197|NCT02852694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25176198|NCT02852694|Antimetabolites|antimetabolites|mesh-ancestor
25176199|NCT02852694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176200|NCT02852694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176201|NCT02852694|Dermatologic Agents|dermatologic agents|mesh-ancestor
25176202|NCT02852694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25176203|NCT02852694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25176204|NCT02852694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25176205|NCT02852694|Immunologic Factors|immunologic factors|mesh-ancestor
25176206|NCT02852694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25176207|NCT02852694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25176208|NCT02852694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25176209|NCT02852720|Anesthetics|anesthetics|mesh-list
25176210|NCT02852720|Levobupivacaine|levobupivacaine|mesh-list
25176211|NCT02852720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25176212|NCT02852720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176213|NCT02852720|Anesthetics, Local|anesthetics, local|mesh-ancestor
25176214|NCT02852720|Sensory System Agents|sensory system agents|mesh-ancestor
25176215|NCT02852720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25176216|NCT02852564|Ethacrynic Acid|ethacrynic acid|mesh-list
24808250|NCT02025998|Ibudilast|ibudilast|mesh-list
25176217|NCT02852564|Diuretics|diuretics|mesh-ancestor
25176218|NCT02852564|Natriuretic Agents|natriuretic agents|mesh-ancestor
25176219|NCT02852564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176220|NCT02852564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25176221|NCT02852564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176222|NCT02852577|Clonazepam|clonazepam|mesh-list
25176223|NCT02852577|Paroxetine|paroxetine|mesh-list
25176224|NCT02852577|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25176225|NCT02852577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25176226|NCT02852577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25176227|NCT02852577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176228|NCT02852577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25176229|NCT02852577|Serotonin Agents|serotonin agents|mesh-ancestor
25176230|NCT02852577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176231|NCT02852577|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25176232|NCT02852577|Antidepressive Agents|antidepressive agents|mesh-ancestor
25176233|NCT02852577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25665177|NCT01680861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25674392|NCT01771627|Autonomic Agents|autonomic agents|mesh-ancestor
25176234|NCT02852577|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25176235|NCT02852577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25176236|NCT02852577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25176237|NCT02852577|Anticonvulsants|anticonvulsants|mesh-ancestor
25176238|NCT02852577|GABA Modulators|gaba modulators|mesh-ancestor
25176239|NCT02852577|GABA Agents|gaba agents|mesh-ancestor
25176240|NCT02852486|Pioglitazone|pioglitazone|mesh-list
25176241|NCT02852486|Imatinib Mesylate|imatinib mesylate|mesh-list
25176242|NCT02852486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25176243|NCT02852486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176244|NCT02852486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176245|NCT02852486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25176246|NCT02852486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25176247|NCT02852486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176248|NCT02852083|Pioglitazone|pioglitazone|mesh-list
25176249|NCT02852083|Clarithromycin|clarithromycin|mesh-list
25176250|NCT02852083|Nivolumab|nivolumab|mesh-list
25176251|NCT02852083|Treosulfan|treosulfan|mesh-list
25176252|NCT02852083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25176253|NCT02852083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176254|NCT02852083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25176255|NCT02852083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176256|NCT02852083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25176257|NCT02852083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176258|NCT02852083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25176259|NCT02852083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25176260|NCT02852083|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25176261|NCT02852083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25176262|NCT02852083|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25176263|NCT02852083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25176264|NCT02852083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25176265|NCT02852083|Alkylating Agents|alkylating agents|mesh-ancestor
25176266|NCT02852239|Dabrafenib|dabrafenib|mesh-list
25176267|NCT02852239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176268|NCT02852239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25176269|NCT02852239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25176270|NCT02852239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176271|NCT02852122|Choline|choline|mesh-list
25176272|NCT02852122|Lipotropic Agents|lipotropic agents|mesh-ancestor
25176273|NCT02852122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25176274|NCT02852122|Antimetabolites|antimetabolites|mesh-ancestor
25176275|NCT02852122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176276|NCT02852122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25176277|NCT02852122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24754837|NCT01723150|Sulfamethoxazole|sulfamethoxazole|mesh-list
24754838|NCT01723150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24754839|NCT01723150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24754840|NCT01723150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24754841|NCT01723150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25176278|NCT02852122|Nootropic Agents|nootropic agents|mesh-ancestor
25176279|NCT02852382|Morphine|morphine|mesh-list
25176280|NCT02852382|Bupivacaine|bupivacaine|mesh-list
25176281|NCT02852382|Anesthetics, Local|anesthetics, local|mesh-ancestor
25176282|NCT02852382|Anesthetics|anesthetics|mesh-ancestor
25176283|NCT02852382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25176284|NCT02852382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176285|NCT02852382|Sensory System Agents|sensory system agents|mesh-ancestor
25176286|NCT02852382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25176287|NCT02852382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25176288|NCT02852382|Narcotics|narcotics|mesh-ancestor
24483924|NCT00445900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25176289|NCT02852382|Analgesics|analgesics|mesh-ancestor
25204602|NCT02707315|Gemcitabine|gemcitabine|mesh-list
24808358|NCT02026778|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24808359|NCT02026778|Serotonin Agents|serotonin agents|mesh-ancestor
24808360|NCT02026778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24808361|NCT02026778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808362|NCT02026778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25860187|NCT00083005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24484316|NCT00447759|Diclofenac|diclofenac|mesh-list
24484317|NCT00447759|Naproxen|naproxen|mesh-list
24484318|NCT00447759|Meloxicam|meloxicam|mesh-list
25860188|NCT00083005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24484319|NCT00447759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24484320|NCT00447759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24484321|NCT00447759|Analgesics|analgesics|mesh-ancestor
24484322|NCT00447759|Sensory System Agents|sensory system agents|mesh-ancestor
25860189|NCT00083005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25860190|NCT00083005|Growth Substances|growth substances|mesh-ancestor
24523713|NCT05340803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25860191|NCT00083005|Growth Inhibitors|growth inhibitors|mesh-ancestor
25860192|NCT00083005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24484323|NCT00447759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24484324|NCT00447759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484325|NCT00447759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25860193|NCT00083005|Alkylating Agents|alkylating agents|mesh-ancestor
25860194|NCT00083005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24754842|NCT01723150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24754843|NCT01723150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944920|NCT03955939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24944921|NCT03955939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944930|NCT03955809|Anesthetics|anesthetics|mesh-ancestor
24754844|NCT01723150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24754845|NCT01723150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25860195|NCT00083031|Cyclophosphamide|cyclophosphamide|mesh-list
25860196|NCT00083031|Bevacizumab|bevacizumab|mesh-list
24808397|NCT02026947|Antifungal Agents|antifungal agents|mesh-ancestor
24808398|NCT02026947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24808399|NCT02026973|Fulvestrant|fulvestrant|mesh-list
24808400|NCT02026973|Anastrozole|anastrozole|mesh-list
24808401|NCT02026973|Somatostatin|somatostatin|mesh-list
24808402|NCT02026973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24808403|NCT02026973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176290|NCT02851888|Ropivacaine|ropivacaine|mesh-list
25176291|NCT02851888|Anesthetics|anesthetics|mesh-ancestor
25176292|NCT02851888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25176293|NCT02851888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176294|NCT02851888|Anesthetics, Local|anesthetics, local|mesh-ancestor
25176295|NCT02851888|Sensory System Agents|sensory system agents|mesh-ancestor
25176296|NCT02851888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25176297|NCT02851914|Antidepressive Agents|antidepressive agents|mesh-list
25176298|NCT02851914|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
25176299|NCT02851914|Serotonin|serotonin|mesh-list
25176300|NCT02851914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25176301|NCT02851914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25176302|NCT02851914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25176303|NCT02851914|Serotonin Agents|serotonin agents|mesh-ancestor
25176304|NCT02851914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25176305|NCT02851914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176306|NCT02851914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176307|NCT02851914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25176308|NCT02851914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25176309|NCT02852070|Dimercaprol|dimercaprol|mesh-list
25176310|NCT02852070|Chelating Agents|chelating agents|mesh-ancestor
25176311|NCT02852070|Sequestering Agents|sequestering agents|mesh-ancestor
25176312|NCT02852070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176313|NCT02851745|Linagliptin|linagliptin|mesh-list
25176314|NCT02851745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25176315|NCT02851745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176316|NCT02851745|Incretins|incretins|mesh-ancestor
25176317|NCT02851745|Hormones|hormones|mesh-ancestor
25176318|NCT02851745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25176319|NCT02851745|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25176320|NCT02851745|Protease Inhibitors|protease inhibitors|mesh-ancestor
25176321|NCT02851745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25176322|NCT02851745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176323|NCT02851472|Nitric Oxide|nitric oxide|mesh-list
25176324|NCT02851472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25176325|NCT02851472|Autonomic Agents|autonomic agents|mesh-ancestor
25176326|NCT02851472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25176327|NCT02851472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176328|NCT02851472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25176329|NCT02851472|Respiratory System Agents|respiratory system agents|mesh-ancestor
25176330|NCT02851472|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25176331|NCT02851472|Antioxidants|antioxidants|mesh-ancestor
25176332|NCT02851472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176333|NCT02851472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25665178|NCT01680861|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25665179|NCT01680861|Protective Agents|protective agents|mesh-ancestor
25665180|NCT01680887|Varenicline|varenicline|mesh-list
25665181|NCT01680887|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24925533|NCT04149262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523929|NCT05338489|Rifampin|rifampin|mesh-list
24523930|NCT05338489|Antifungal Agents|antifungal agents|mesh-ancestor
24523931|NCT05338489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24523932|NCT05338489|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24523933|NCT05338489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24523934|NCT05338489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24523935|NCT05338489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925555|NCT04149327|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24925556|NCT04149067|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24925557|NCT04149067|Dapagliflozin|dapagliflozin|mesh-list
24523943|NCT05338489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24523944|NCT05338489|Leprostatic Agents|leprostatic agents|mesh-ancestor
24523945|NCT05338489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24523946|NCT05338489|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24998792|NCT00005044|Flutamide|flutamide|mesh-list
24523947|NCT05338489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24484336|NCT00447863|Hormones|hormones|mesh-ancestor
25176334|NCT02851472|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25176335|NCT02851472|Vasodilator Agents|vasodilator agents|mesh-ancestor
25176336|NCT02851472|Gasotransmitters|gasotransmitters|mesh-ancestor
25176337|NCT02851472|Protective Agents|protective agents|mesh-ancestor
25176338|NCT02851459|Vaccines|vaccines|mesh-list
25176339|NCT02851459|Immunologic Factors|immunologic factors|mesh-ancestor
25176340|NCT02851459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176341|NCT02851433|Anesthetics|anesthetics|mesh-list
25176342|NCT02851433|Propofol|propofol|mesh-list
25176343|NCT02851433|Sevoflurane|sevoflurane|mesh-list
25176344|NCT02851433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25176345|NCT02851433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176346|NCT02851433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25176347|NCT02851433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25176348|NCT02851433|Anesthetics, General|anesthetics, general|mesh-ancestor
25176349|NCT02851433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25176350|NCT02851433|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25176351|NCT02851095|Metformin|metformin|mesh-list
25176353|NCT02851095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25176354|NCT02851095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176355|NCT02851095|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25176356|NCT02851095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176357|NCT02851394|Tramadol|tramadol|mesh-list
25176358|NCT02851394|Levobupivacaine|levobupivacaine|mesh-list
25176359|NCT02851394|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25176360|NCT02851394|Narcotics|narcotics|mesh-ancestor
25176361|NCT02851394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25176362|NCT02851394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176363|NCT02851394|Analgesics|analgesics|mesh-ancestor
25176364|NCT02851394|Sensory System Agents|sensory system agents|mesh-ancestor
25176365|NCT02851394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25176366|NCT02851394|Anesthetics, Local|anesthetics, local|mesh-ancestor
25176367|NCT02851394|Anesthetics|anesthetics|mesh-ancestor
25176368|NCT02851303|Morphine|morphine|mesh-list
25176369|NCT02851303|Methadone|methadone|mesh-list
24944936|NCT03956134|Tapentadol|tapentadol|mesh-list
25176370|NCT02851303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25176371|NCT02851303|Narcotics|narcotics|mesh-ancestor
25176372|NCT02851303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25176373|NCT02851303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665182|NCT01680887|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25665183|NCT01680887|Cholinergic Agents|cholinergic agents|mesh-ancestor
25665184|NCT01680887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25665185|NCT01680887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665186|NCT01680887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665187|NCT01680900|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
25665188|NCT01680900|Antidepressive Agents|antidepressive agents|mesh-ancestor
25665189|NCT01680900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25665190|NCT01680900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25665191|NCT01680900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25665192|NCT01680900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25665193|NCT01680900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665194|NCT01680900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25665195|NCT01680900|Serotonin Agents|serotonin agents|mesh-ancestor
25665196|NCT01680900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665197|NCT01680900|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25176374|NCT02851303|Analgesics|analgesics|mesh-ancestor
24925661|NCT04148820|Protease Inhibitors|protease inhibitors|mesh-ancestor
24925674|NCT04148599|Lidocaine|lidocaine|mesh-list
24925675|NCT04148599|Dexmedetomidine|dexmedetomidine|mesh-list
24925676|NCT04148599|Anesthetics, Local|anesthetics, local|mesh-ancestor
25176375|NCT02851303|Sensory System Agents|sensory system agents|mesh-ancestor
25176376|NCT02851303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25176377|NCT02851303|Antitussive Agents|antitussive agents|mesh-ancestor
25176378|NCT02851303|Respiratory System Agents|respiratory system agents|mesh-ancestor
25176379|NCT02851212|Metformin|metformin|mesh-list
25176380|NCT02851212|Canagliflozin|canagliflozin|mesh-list
25176381|NCT02851212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25176382|NCT02851212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176383|NCT02851212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24530380|NCT00630045|Capecitabine|capecitabine|mesh-list
25176384|NCT02851212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176385|NCT02851004|Pembrolizumab|pembrolizumab|mesh-list
25176386|NCT02851004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25176387|NCT02851004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176388|NCT02850718|Sildenafil Citrate|sildenafil citrate|mesh-list
25176389|NCT02850718|Vasodilator Agents|vasodilator agents|mesh-ancestor
25176390|NCT02850718|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25176391|NCT02850718|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25176392|NCT02850718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25176393|NCT02850718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176394|NCT02850718|Urological Agents|urological agents|mesh-ancestor
25176395|NCT02850744|Temozolomide|temozolomide|mesh-list
25176396|NCT02850744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25176397|NCT02850744|Alkylating Agents|alkylating agents|mesh-ancestor
25176398|NCT02850744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176399|NCT02850744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176400|NCT02850887|Anesthetics|anesthetics|mesh-list
25176401|NCT02850887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25176402|NCT02850887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176403|NCT02850913|Doxycycline|doxycycline|mesh-list
25176404|NCT02850913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25176405|NCT02850913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25176406|NCT02850913|Antimalarials|antimalarials|mesh-ancestor
25176407|NCT02850913|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25176408|NCT02850913|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25176409|NCT02850848|Entecavir|entecavir|mesh-list
25176410|NCT02850848|Antiviral Agents|antiviral agents|mesh-ancestor
25176411|NCT02850848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25176412|NCT05383131|Pirfenidone|pirfenidone|mesh-list
25176413|NCT05383131|Nintedanib|nintedanib|mesh-list
25176414|NCT05383131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176415|NCT05383131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25176416|NCT05383131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25176417|NCT05383131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176418|NCT05383131|Analgesics|analgesics|mesh-ancestor
25176419|NCT05383131|Sensory System Agents|sensory system agents|mesh-ancestor
25176420|NCT05383131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25176421|NCT05383131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176422|NCT05383131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25176423|NCT05383131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25176424|NCT05383131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25176425|NCT05383131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25204610|NCT02707315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25204611|NCT02707315|Immunologic Factors|immunologic factors|mesh-ancestor
25204612|NCT02707315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204613|NCT02706977|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25204614|NCT02706977|Carbidopa|carbidopa|mesh-list
25204615|NCT02706977|Levodopa|levodopa|mesh-list
25204616|NCT02706977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25204617|NCT02706977|Immunologic Factors|immunologic factors|mesh-ancestor
25204618|NCT02706977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204619|NCT02706977|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25204620|NCT02706977|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25204621|NCT02706977|Dopamine Agonists|dopamine agonists|mesh-ancestor
25204622|NCT02706977|Dopamine Agents|dopamine agents|mesh-ancestor
25204623|NCT02706977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25665198|NCT01680900|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25665199|NCT01680991|Obinutuzumab|obinutuzumab|mesh-list
25665200|NCT01680991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25665201|NCT01680991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25204624|NCT02706977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204625|NCT02706977|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24925819|NCT04147845|Immunologic Factors|immunologic factors|mesh-ancestor
25665202|NCT01681030|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25665203|NCT01681030|Hemostatics|hemostatics|mesh-ancestor
25204626|NCT02706977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25204627|NCT02707120|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25204628|NCT02707120|Lubricant Eye Drops|lubricant eye drops|mesh-list
25204629|NCT02707120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25204630|NCT02707081|Lidocaine|lidocaine|mesh-list
25204631|NCT02707081|Anesthetics, Local|anesthetics, local|mesh-ancestor
25204632|NCT02707081|Anesthetics|anesthetics|mesh-ancestor
25204633|NCT02707081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25204634|NCT02707081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530289|NCT00629720|Alfuzosin|alfuzosin|mesh-list
25204635|NCT02707081|Sensory System Agents|sensory system agents|mesh-ancestor
25204636|NCT02707081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204637|NCT02707081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25204638|NCT02707081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25204639|NCT02707081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25204640|NCT02707081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25204641|NCT02707081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204642|NCT02707263|Heparin|heparin|mesh-list
25204643|NCT02707263|Calcium heparin|calcium heparin|mesh-list
25204644|NCT02707263|Anticoagulants|anticoagulants|mesh-ancestor
25204645|NCT02707263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25204646|NCT02707263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25204647|NCT02707263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204648|NCT02707224|Candesartan|candesartan|mesh-list
25204649|NCT02707224|Candesartan cilexetil|candesartan cilexetil|mesh-list
25204650|NCT02707224|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25204651|NCT02707224|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25204652|NCT02707224|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25204653|NCT02707224|Antimetabolites|antimetabolites|mesh-ancestor
25204654|NCT02707224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484443|NCT00448383|Adalimumab|adalimumab|mesh-list
25176430|NCT05382923|Melatonin|melatonin|mesh-list
25176431|NCT05382923|Antioxidants|antioxidants|mesh-ancestor
25176432|NCT05382923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176433|NCT05382923|Protective Agents|protective agents|mesh-ancestor
25176434|NCT05382923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176435|NCT05382923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25176436|NCT05382741|Durvalumab|durvalumab|mesh-list
25176437|NCT05382741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25176438|NCT05382741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176439|NCT05382728|Osimertinib|osimertinib|mesh-list
25176440|NCT05382728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176441|NCT05382728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25176442|NCT05382728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25176443|NCT05382728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176492|NCT05382390|Antimetabolites|antimetabolites|mesh-ancestor
25176493|NCT05382390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176494|NCT05382390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176495|NCT05382390|Antiviral Agents|antiviral agents|mesh-ancestor
25176496|NCT05382390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25176497|NCT05382390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25176498|NCT05382390|Immunologic Factors|immunologic factors|mesh-ancestor
25176499|NCT05382390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176500|NCT05382390|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25176501|NCT05382390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25176502|NCT05382390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25176503|NCT05382390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25176504|NCT05382390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25176505|NCT05382351|Tenofovir|tenofovir|mesh-list
25176506|NCT05382351|Entecavir|entecavir|mesh-list
25176507|NCT05382351|Antiviral Agents|antiviral agents|mesh-ancestor
25176508|NCT05382351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25176509|NCT05382351|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25176510|NCT05382351|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25176511|NCT05382351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25176512|NCT05382351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176513|NCT05382351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25176514|NCT05382351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25665204|NCT01681030|Coagulants|coagulants|mesh-ancestor
25665205|NCT01681095|Tryptophan|tryptophan|mesh-list
25665206|NCT01681095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25665207|NCT01681095|Antidepressive Agents|antidepressive agents|mesh-ancestor
25084025|NCT03310567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25084026|NCT03310372|Temozolomide|temozolomide|mesh-list
25084027|NCT03310372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25084028|NCT03310372|Alkylating Agents|alkylating agents|mesh-ancestor
25084096|NCT03309592|Ambrisentan|ambrisentan|mesh-list
25084098|NCT03309592|Vasodilator Agents|vasodilator agents|mesh-ancestor
25084099|NCT03309592|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25084100|NCT03309592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25084101|NCT03309592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24934368|NCT04061798|Heparin|heparin|mesh-list
25084266|NCT03308331|Cholinergic Agents|cholinergic agents|mesh-ancestor
25084267|NCT03308331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25084268|NCT03308331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084269|NCT03308253|Vancomycin|vancomycin|mesh-list
25084270|NCT03308253|Tobramycin|tobramycin|mesh-list
25176632|NCT05381363|Antiviral Agents|antiviral agents|mesh-ancestor
25084922|NCT03302351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25084923|NCT03302351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628113|NCT01096654|Mydriatics|mydriatics|mesh-ancestor
25085353|NCT03298906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085739|NCT03295786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085851|NCT03294525|Antidepressive Agents|antidepressive agents|mesh-list
25085852|NCT03294525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25085853|NCT03294525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25176590|NCT05381623|Hemostatics|hemostatics|mesh-list
25176591|NCT05381623|Coagulants|coagulants|mesh-ancestor
25176602|NCT05381558|Triamcinolone|triamcinolone|mesh-list
25176603|NCT05381558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25176604|NCT05381558|Glucocorticoids|glucocorticoids|mesh-ancestor
25176605|NCT05381558|Hormones|hormones|mesh-ancestor
25176606|NCT05381558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25176607|NCT05381558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176608|NCT05381428|Indomethacin|indomethacin|mesh-list
25176609|NCT05381428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25176610|NCT05381428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25176611|NCT05381428|Analgesics|analgesics|mesh-ancestor
25176612|NCT05381428|Sensory System Agents|sensory system agents|mesh-ancestor
25176613|NCT05381428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25176614|NCT05381428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176615|NCT05381428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25176616|NCT05381428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25176617|NCT05381428|Gout Suppressants|gout suppressants|mesh-ancestor
25176618|NCT05381428|Tocolytic Agents|tocolytic agents|mesh-ancestor
25176619|NCT05381428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25176620|NCT05381428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25176621|NCT05381428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25176622|NCT05381428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176623|NCT05381389|Bupivacaine|bupivacaine|mesh-list
25176624|NCT05381389|Anesthetics, Local|anesthetics, local|mesh-ancestor
25176625|NCT05381389|Anesthetics|anesthetics|mesh-ancestor
25176689|NCT05380934|Abortifacient Agents|abortifacient agents|mesh-ancestor
25176626|NCT05381389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25176627|NCT05381389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176628|NCT05381389|Sensory System Agents|sensory system agents|mesh-ancestor
25176629|NCT05381389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25176630|NCT05381363|Interferons|interferons|mesh-list
25176631|NCT05381363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176633|NCT05381363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25176634|NCT05381207|Fluticasone|fluticasone|mesh-list
25176635|NCT05381207|Xhance|xhance|mesh-list
25176636|NCT05381207|Montelukast|montelukast|mesh-list
25176637|NCT05381207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25176638|NCT05381207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25176639|NCT05381207|Autonomic Agents|autonomic agents|mesh-ancestor
25176640|NCT05381207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25176641|NCT05381207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176642|NCT05381207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25176643|NCT05381207|Respiratory System Agents|respiratory system agents|mesh-ancestor
25176644|NCT05381207|Dermatologic Agents|dermatologic agents|mesh-ancestor
25176645|NCT05381207|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25176646|NCT05381207|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25176647|NCT05381207|Hormone Antagonists|hormone antagonists|mesh-ancestor
25176648|NCT05381207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25176649|NCT05381207|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25176650|NCT05381207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24926331|NCT04142762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24926332|NCT04142762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24926333|NCT04142762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944996|NCT03955458|Bupivacaine|bupivacaine|mesh-list
25176651|NCT05381207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176652|NCT05381168|Calcium, Dietary|calcium, dietary|mesh-list
25176653|NCT05381168|Calcium Carbonate|calcium carbonate|mesh-list
25176654|NCT05381168|Calcium|calcium|mesh-list
25176655|NCT05381168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25176656|NCT05381168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176657|NCT05381168|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25176658|NCT05381168|Antacids|antacids|mesh-ancestor
25176659|NCT05381168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176660|NCT05381168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25204655|NCT02707224|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25204656|NCT02707224|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25204657|NCT02707224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25204658|NCT02707224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25204659|NCT02707224|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25204660|NCT02707224|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25204661|NCT02707159|Gemcitabine|gemcitabine|mesh-list
25204662|NCT02707159|Paclitaxel|paclitaxel|mesh-list
25204663|NCT02707159|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25204664|NCT02707159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25176661|NCT05381038|Paclitaxel|paclitaxel|mesh-list
25176662|NCT05381038|Docetaxel|docetaxel|mesh-list
25176663|NCT05381038|Irinotecan|irinotecan|mesh-list
25176664|NCT05381038|Azacitidine|azacitidine|mesh-list
25176665|NCT05381038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25176666|NCT05381038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176667|NCT05381038|Tubulin Modulators|tubulin modulators|mesh-ancestor
25176668|NCT05381038|Antimitotic Agents|antimitotic agents|mesh-ancestor
25176669|NCT05381038|Mitosis Modulators|mitosis modulators|mesh-ancestor
25176670|NCT05381038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176671|NCT05381038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25176672|NCT05381038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25176673|NCT05381038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25176674|NCT05381038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25176675|NCT05381038|Antimetabolites|antimetabolites|mesh-ancestor
25176676|NCT05380986|Apatinib|apatinib|mesh-list
25176677|NCT05380986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176678|NCT05380986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25176679|NCT05380986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25176680|NCT05380986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176681|NCT05380960|Fibrin fragment D|fibrin fragment d|mesh-list
25176682|NCT05380960|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24755301|NCT01725620|Immunologic Factors|immunologic factors|mesh-ancestor
24755302|NCT01725672|Metformin|metformin|mesh-list
25176683|NCT05380960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25176684|NCT05380960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176685|NCT05380960|Hemostatics|hemostatics|mesh-ancestor
25176686|NCT05380960|Coagulants|coagulants|mesh-ancestor
25176687|NCT05380934|Methotrexate|methotrexate|mesh-list
25176688|NCT05380934|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25176690|NCT05380934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25176691|NCT05380934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176692|NCT05380934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25176693|NCT05380934|Antimetabolites|antimetabolites|mesh-ancestor
25176694|NCT05380934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176695|NCT05380934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176696|NCT05380934|Dermatologic Agents|dermatologic agents|mesh-ancestor
25176697|NCT05380934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25176698|NCT05380934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25176699|NCT05380934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25176700|NCT05380934|Immunologic Factors|immunologic factors|mesh-ancestor
25176701|NCT05380934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25176702|NCT05380934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25665208|NCT01681095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25665209|NCT01681186|Lansoprazole|lansoprazole|mesh-list
25665210|NCT01681186|Dexlansoprazole|dexlansoprazole|mesh-list
25665211|NCT01681186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25665212|NCT01681186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25665213|NCT01681186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24624460|NCT01076478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24624461|NCT01076478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624462|NCT01076478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24926575|NCT04140006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926576|NCT04139928|Magnesium citrate|magnesium citrate|mesh-list
24926577|NCT04139928|Magnesium Oxide|magnesium oxide|mesh-list
24643648|NCT01186497|Rabeprazole|rabeprazole|mesh-list
24926578|NCT04139928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926585|NCT04139941|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
24926586|NCT04139941|Immunologic Factors|immunologic factors|mesh-ancestor
24926587|NCT04139941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926588|NCT04140058|Ondansetron|ondansetron|mesh-list
24926589|NCT04140058|Antiemetics|antiemetics|mesh-ancestor
25176703|NCT05380856|Neurotransmitter Agents|neurotransmitter agents|mesh-list
25176704|NCT05380856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176705|NCT05380856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176706|NCT05380778|Anesthetics|anesthetics|mesh-list
25176707|NCT05380778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25176708|NCT05380778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176709|NCT05380713|Cyclophosphamide|cyclophosphamide|mesh-list
25176710|NCT05380713|Durvalumab|durvalumab|mesh-list
25176711|NCT05380713|Tremelimumab|tremelimumab|mesh-list
25176712|NCT05380713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25176713|NCT05380713|Immunologic Factors|immunologic factors|mesh-ancestor
25176714|NCT05380713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176715|NCT05380713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25176716|NCT05380713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25176717|NCT05380713|Alkylating Agents|alkylating agents|mesh-ancestor
25176718|NCT05380713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176719|NCT05380713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176720|NCT05380713|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25176721|NCT05380713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25176722|NCT05380479|Megestrol|megestrol|mesh-list
25176723|NCT05380479|Megestrol Acetate|megestrol acetate|mesh-list
25176724|NCT05380479|Mirtazapine|mirtazapine|mesh-list
25176725|NCT05380479|Antidepressive Agents|antidepressive agents|mesh-ancestor
25176726|NCT05380479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25176727|NCT05380479|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25176728|NCT05380479|Histamine Antagonists|histamine antagonists|mesh-ancestor
25176729|NCT05380479|Histamine Agents|histamine agents|mesh-ancestor
25176730|NCT05380479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25176731|NCT05380479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176732|NCT05380479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485803|NCT00455117|Parecoxib|parecoxib|mesh-list
25176733|NCT05380479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24622898|NCT01069055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24622899|NCT01069055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24622900|NCT01069055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24622901|NCT01069055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24755303|NCT01725672|Glimepiride|glimepiride|mesh-list
24755304|NCT01725672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24857960|NCT02294552|Alkylating Agents|alkylating agents|mesh-ancestor
24857961|NCT02294552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622902|NCT01069055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622904|NCT01069081|Docetaxel|docetaxel|mesh-list
24622905|NCT01069081|Esomeprazole|esomeprazole|mesh-list
24622906|NCT01069081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622907|NCT01069081|Tubulin Modulators|tubulin modulators|mesh-ancestor
25176734|NCT05380479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25176735|NCT05380479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25176736|NCT05380479|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25665214|NCT01681186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665215|NCT01681186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665216|NCT01681212|Ipilimumab|ipilimumab|mesh-list
25665217|NCT01681212|Dacarbazine|dacarbazine|mesh-list
25665218|NCT01681212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25665219|NCT01681212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665220|NCT01681212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25665221|NCT01681212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665222|NCT01681212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25665223|NCT01681212|Alkylating Agents|alkylating agents|mesh-ancestor
25665224|NCT01681472|Leucovorin|leucovorin|mesh-list
25665225|NCT01681472|Tetrahydrofolates|tetrahydrofolates|mesh-list
25665226|NCT01681472|Levoleucovorin|levoleucovorin|mesh-list
24524708|NCT04512911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
24524709|NCT04504734|Bucillamine|bucillamine|mesh-list
24524710|NCT04504734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24926965|NCT04137029|Formoterol Fumarate|formoterol fumarate|mesh-list
24926966|NCT04137029|Tiotropium Bromide|tiotropium bromide|mesh-list
25176737|NCT05380479|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25176738|NCT05380479|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25176739|NCT05380479|Adrenergic Agents|adrenergic agents|mesh-ancestor
25176740|NCT05380479|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25176741|NCT05380479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25176742|NCT05380479|Serotonin Agents|serotonin agents|mesh-ancestor
25176743|NCT05380479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25176744|NCT05380479|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25176745|NCT05380479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25176746|NCT05380479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25176747|NCT05380479|Contraceptive Agents|contraceptive agents|mesh-ancestor
25176748|NCT05380479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25204700|NCT02707016|Anesthetics|anesthetics|mesh-ancestor
25176749|NCT05380479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25176750|NCT05380479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25176751|NCT05380479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25176752|NCT05380479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176753|NCT05380479|Appetite Stimulants|appetite stimulants|mesh-ancestor
25176754|NCT05380479|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25176760|NCT05380388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176762|NCT05380245|Clarithromycin|clarithromycin|mesh-list
25176763|NCT05380245|Voriconazole|voriconazole|mesh-list
25176764|NCT05380245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25176765|NCT05380245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25176766|NCT05380245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25176767|NCT05380245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25176768|NCT05380245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176769|NCT05380245|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25176770|NCT05380245|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25176771|NCT05380245|Antifungal Agents|antifungal agents|mesh-ancestor
24543392|NCT00683345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24543393|NCT00683358|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
24543394|NCT00683358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24619564|NCT01052987|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25176772|NCT05380245|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25176773|NCT05380245|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25176774|NCT05380245|Hormone Antagonists|hormone antagonists|mesh-ancestor
25176775|NCT05380245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25176776|NCT05380245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622908|NCT01069081|Antimitotic Agents|antimitotic agents|mesh-ancestor
24622915|NCT01069094|Leuprolide|leuprolide|mesh-list
25176777|NCT05379972|Pembrolizumab|pembrolizumab|mesh-list
25176778|NCT05379972|Olaparib|olaparib|mesh-list
25176779|NCT05379972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25176780|NCT05379972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176781|NCT05379972|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25176782|NCT05379972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25176783|NCT05379972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176784|NCT05379959|Methamphetamine|methamphetamine|mesh-list
25176785|NCT05379959|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25176786|NCT05379959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176787|NCT05379959|Sympathomimetics|sympathomimetics|mesh-ancestor
25176788|NCT05379959|Autonomic Agents|autonomic agents|mesh-ancestor
25176789|NCT05379959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25176790|NCT05379959|Dopamine Agents|dopamine agents|mesh-ancestor
25176791|NCT05379959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25176792|NCT05379959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176793|NCT05379959|Adrenergic Agents|adrenergic agents|mesh-ancestor
25176794|NCT05379959|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25176795|NCT05379959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25176796|NCT05379959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25176797|NCT05379959|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25665227|NCT01681472|Antidotes|antidotes|mesh-ancestor
25665228|NCT01681472|Protective Agents|protective agents|mesh-ancestor
25665229|NCT01681472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665230|NCT01681472|Vitamin B Complex|vitamin b complex|mesh-ancestor
25665231|NCT01681472|Vitamins|vitamins|mesh-ancestor
25665232|NCT01681472|Micronutrients|micronutrients|mesh-ancestor
24524964|NCT04171258|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24524965|NCT04171258|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24524966|NCT04171258|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24524967|NCT04171258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25176803|NCT05379647|Cyclophosphamide|cyclophosphamide|mesh-list
25176804|NCT05379647|Rituximab|rituximab|mesh-list
25176805|NCT05379647|Fludarabine|fludarabine|mesh-list
25176806|NCT05379647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24755365|NCT01726205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25176807|NCT05379647|Immunologic Factors|immunologic factors|mesh-ancestor
25176808|NCT05379647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176809|NCT05379647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25176810|NCT05379647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25176811|NCT05379647|Alkylating Agents|alkylating agents|mesh-ancestor
25176812|NCT05379647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176813|NCT05379647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176814|NCT05379647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25176815|NCT05379647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25176816|NCT05379569|Cyclophosphamide|cyclophosphamide|mesh-list
25176817|NCT05379569|Fludarabine|fludarabine|mesh-list
25176818|NCT05379569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25176819|NCT05379569|Immunologic Factors|immunologic factors|mesh-ancestor
25176820|NCT05379569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176821|NCT05379569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25176822|NCT05379569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25176823|NCT05379569|Alkylating Agents|alkylating agents|mesh-ancestor
25176824|NCT05379569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176825|NCT05379569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176826|NCT05379569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25176827|NCT05379530|Anesthetics|anesthetics|mesh-list
25176828|NCT05379530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25176829|NCT05379530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176830|NCT05379478|Antibodies|antibodies|mesh-list
25176831|NCT05379478|Immunologic Factors|immunologic factors|mesh-ancestor
25176832|NCT05379478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176833|NCT05379322|Adalimumab|adalimumab|mesh-list
25176834|NCT05379322|Etanercept|etanercept|mesh-list
25176835|NCT05379322|Golimumab|golimumab|mesh-list
25176836|NCT05379322|Upadacitinib|upadacitinib|mesh-list
25176837|NCT05379322|Tofacitinib|tofacitinib|mesh-list
25176838|NCT05379322|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
25176839|NCT05379322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25176840|NCT05379322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25176841|NCT05379322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25176842|NCT05379322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25176843|NCT05379322|Analgesics|analgesics|mesh-ancestor
25176844|NCT05379322|Sensory System Agents|sensory system agents|mesh-ancestor
25176845|NCT05379322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25176846|NCT05379322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176847|NCT05379322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25176848|NCT05379322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25176849|NCT05379322|Immunologic Factors|immunologic factors|mesh-ancestor
25176850|NCT05379322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25176851|NCT05379322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25176852|NCT05379322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176853|NCT05379322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25176854|NCT05379283|Lidocaine|lidocaine|mesh-list
25176855|NCT05379283|Anesthetics, Local|anesthetics, local|mesh-ancestor
25176856|NCT05379283|Anesthetics|anesthetics|mesh-ancestor
25176857|NCT05379283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25176858|NCT05379283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176859|NCT05379283|Sensory System Agents|sensory system agents|mesh-ancestor
25176860|NCT05379283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25176861|NCT05379283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25176862|NCT05379283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25176863|NCT05379283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25176864|NCT05379283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25176865|NCT05379283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665233|NCT01681576|Valsartan|valsartan|mesh-list
25665234|NCT01681576|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25665235|NCT01681576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25665236|NCT01681576|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24525402|NCT03521102|Antipyretics|antipyretics|mesh-ancestor
24808886|NCT02029599|Antipyretics|antipyretics|mesh-ancestor
25176866|NCT05379257|Furosemide|furosemide|mesh-list
25176868|NCT05379257|Natriuretic Agents|natriuretic agents|mesh-ancestor
25176869|NCT05379257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176870|NCT05379257|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25176871|NCT05379257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25176872|NCT05379257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204665|NCT02707159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25204666|NCT02707159|Tubulin Modulators|tubulin modulators|mesh-ancestor
25204667|NCT02707159|Antimitotic Agents|antimitotic agents|mesh-ancestor
25204668|NCT02707159|Mitosis Modulators|mitosis modulators|mesh-ancestor
25204669|NCT02707159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204670|NCT02707159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25204671|NCT02707159|Antimetabolites|antimetabolites|mesh-ancestor
25204672|NCT02707159|Antiviral Agents|antiviral agents|mesh-ancestor
25204673|NCT02707159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25204674|NCT02707159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25204675|NCT02707159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25204676|NCT02707159|Immunologic Factors|immunologic factors|mesh-ancestor
25204677|NCT02707159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204678|NCT02707211|Antibodies|antibodies|mesh-list
25204679|NCT02707211|Immunoglobulin M|immunoglobulin m|mesh-list
25204680|NCT02707211|Immunologic Factors|immunologic factors|mesh-ancestor
25204681|NCT02707211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204682|NCT02707250|Meperidine|meperidine|mesh-list
25204683|NCT02707250|Bupivacaine|bupivacaine|mesh-list
25204684|NCT02707250|Anesthetics, Local|anesthetics, local|mesh-ancestor
25204685|NCT02707250|Anesthetics|anesthetics|mesh-ancestor
25204686|NCT02707250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25204687|NCT02707250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204695|NCT02707094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204697|NCT02707016|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25204698|NCT02707016|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25204699|NCT02707016|Anesthetics, General|anesthetics, general|mesh-ancestor
25204701|NCT02707016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25204702|NCT02707016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204703|NCT02706704|Adalimumab|adalimumab|mesh-list
25204704|NCT02706704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25204705|NCT02706704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25204706|NCT02706769|Acetaminophen|acetaminophen|mesh-list
25204707|NCT02706769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25204708|NCT02706769|Analgesics|analgesics|mesh-ancestor
25204709|NCT02706769|Sensory System Agents|sensory system agents|mesh-ancestor
25204710|NCT02706769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204711|NCT02706769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204712|NCT02706769|Antipyretics|antipyretics|mesh-ancestor
25204720|NCT02706860|Atorvastatin|atorvastatin|mesh-list
25204721|NCT02706860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25204722|NCT02706860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25204723|NCT02706860|Antimetabolites|antimetabolites|mesh-ancestor
25204724|NCT02706860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204725|NCT02706860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25204726|NCT02706860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25204727|NCT02706860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25204728|NCT02706470|Cyclosporine|cyclosporine|mesh-list
25204729|NCT02706470|Cyclosporins|cyclosporins|mesh-list
25204730|NCT02706470|Dydrogesterone|dydrogesterone|mesh-list
25204731|NCT02706470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25204732|NCT02706470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204733|NCT02706470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25176873|NCT05379049|Adalimumab|adalimumab|mesh-list
25176874|NCT05379049|Etanercept|etanercept|mesh-list
25176875|NCT05379049|Infliximab|infliximab|mesh-list
25176876|NCT05379049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25176877|NCT05379049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25176878|NCT05379049|Dermatologic Agents|dermatologic agents|mesh-ancestor
25176879|NCT05379049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25176880|NCT05379049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25176881|NCT05379049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25176882|NCT05379049|Analgesics|analgesics|mesh-ancestor
25176883|NCT05379049|Sensory System Agents|sensory system agents|mesh-ancestor
25176884|NCT05379049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25176885|NCT05379049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176886|NCT05379049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25665237|NCT01681576|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24525750|NCT02799134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24525751|NCT02799134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525752|NCT02799134|Antioxidants|antioxidants|mesh-ancestor
24525753|NCT02799134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176887|NCT05379049|Immunologic Factors|immunologic factors|mesh-ancestor
25176888|NCT05378932|Melatonin|melatonin|mesh-list
25176889|NCT05378932|Antioxidants|antioxidants|mesh-ancestor
25176890|NCT05378932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176891|NCT05378932|Protective Agents|protective agents|mesh-ancestor
25176892|NCT05378932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176893|NCT05378932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25176894|NCT05378919|Folic Acid|folic acid|mesh-list
25176895|NCT05378919|Leucovorin|leucovorin|mesh-list
25176896|NCT05378919|Fluorouracil|fluorouracil|mesh-list
25176897|NCT05378919|Oxaliplatin|oxaliplatin|mesh-list
25176898|NCT05378919|Levoleucovorin|levoleucovorin|mesh-list
25176899|NCT05378919|Antimetabolites|antimetabolites|mesh-ancestor
25176900|NCT05378919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176901|NCT05378919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25176902|NCT05378919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176903|NCT05378919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25176911|NCT05378919|Protective Agents|protective agents|mesh-ancestor
25176913|NCT05378867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25176914|NCT05378867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176915|NCT05378867|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25176916|NCT05378867|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25176917|NCT05378867|Growth Substances|growth substances|mesh-ancestor
25176918|NCT05378867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176919|NCT05378867|Growth Inhibitors|growth inhibitors|mesh-ancestor
25176926|NCT05378711|Fluoxetine|fluoxetine|mesh-list
25176927|NCT05378711|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25176928|NCT05378711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25176929|NCT05378711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25176930|NCT05378711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176931|NCT05378711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24945067|NCT03953989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945069|NCT03953950|Spironolactone|spironolactone|mesh-list
24945070|NCT03953950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24857975|NCT02294591|Antiviral Agents|antiviral agents|mesh-ancestor
25176932|NCT05378711|Serotonin Agents|serotonin agents|mesh-ancestor
25176933|NCT05378711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176934|NCT05378711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25176935|NCT05378711|Antidepressive Agents|antidepressive agents|mesh-ancestor
25176936|NCT05378711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25176937|NCT05378711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25176938|NCT05378711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25176939|NCT05378711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25176940|NCT05378646|Interferons|interferons|mesh-list
25176941|NCT05378646|Interferon-gamma|interferon-gamma|mesh-list
25176942|NCT05378646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176943|NCT05378646|Antiviral Agents|antiviral agents|mesh-ancestor
25176944|NCT05378646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25176945|NCT05378555|Ketamine|ketamine|mesh-list
25176946|NCT05378555|Analgesics|analgesics|mesh-ancestor
25176947|NCT05378555|Sensory System Agents|sensory system agents|mesh-ancestor
25176948|NCT05378555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25176949|NCT05378555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486895|NCT00460473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24486896|NCT00460473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486898|NCT00460486|Disinfectants|disinfectants|mesh-ancestor
24486940|NCT00460707|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24486941|NCT00460707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24486942|NCT00460707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486943|NCT00460707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486944|NCT00460707|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24486945|NCT00460707|Hormone Antagonists|hormone antagonists|mesh-ancestor
24486946|NCT00460707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24486947|NCT00460707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665238|NCT01681576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665239|NCT01681849|Paroxetine|paroxetine|mesh-list
25665240|NCT01681849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25665241|NCT01681849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24486948|NCT00460707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24486949|NCT00460707|Antiemetics|antiemetics|mesh-ancestor
24486950|NCT00460707|Autonomic Agents|autonomic agents|mesh-ancestor
24486951|NCT00460707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24486952|NCT00460707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25860198|NCT00083031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25860199|NCT00083031|Immunologic Factors|immunologic factors|mesh-ancestor
25860200|NCT00083031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487105|NCT00461643|Enclomiphene|enclomiphene|mesh-list
24487106|NCT00461643|Zuclomiphene|zuclomiphene|mesh-list
24809021|NCT02030717|Sympatholytics|sympatholytics|mesh-ancestor
24809022|NCT02030717|Autonomic Agents|autonomic agents|mesh-ancestor
24809023|NCT02030717|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25176951|NCT05378555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25176952|NCT05378555|Anesthetics, General|anesthetics, general|mesh-ancestor
25176953|NCT05378555|Anesthetics|anesthetics|mesh-ancestor
25176954|NCT05378555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25176955|NCT05378555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25176956|NCT05378555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25176957|NCT05378555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25176958|NCT05378555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176959|NCT05378503|Topiramate|topiramate|mesh-list
25176960|NCT05378503|Phentermine|phentermine|mesh-list
25176961|NCT05378503|Anticonvulsants|anticonvulsants|mesh-ancestor
25176962|NCT05378503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25176963|NCT05378503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176964|NCT05378503|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25176965|NCT05378503|Appetite Depressants|appetite depressants|mesh-ancestor
25176966|NCT05378503|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25176967|NCT05378503|Sympathomimetics|sympathomimetics|mesh-ancestor
25176968|NCT05378503|Autonomic Agents|autonomic agents|mesh-ancestor
24755544|NCT01727271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25176969|NCT05378503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25176970|NCT05378503|Adrenergic Agents|adrenergic agents|mesh-ancestor
25176971|NCT05378503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25176972|NCT05378503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176973|NCT05378425|Pembrolizumab|pembrolizumab|mesh-list
25176974|NCT05378425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25176975|NCT05378425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176976|NCT05378269|Tamoxifen|tamoxifen|mesh-list
25176977|NCT05378269|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25176978|NCT05378269|Hormone Antagonists|hormone antagonists|mesh-ancestor
25176979|NCT05378269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25176980|NCT05378269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25176981|NCT05378269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25176982|NCT05378269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25176995|NCT05372380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25176996|NCT05372380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25176997|NCT05372380|Antimetabolites|antimetabolites|mesh-ancestor
25176998|NCT05372380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25176999|NCT05372380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25177000|NCT05372380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25177001|NCT05372380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25177002|NCT05370898|Calcium Carbonate|calcium carbonate|mesh-list
25177003|NCT05370898|Antacids|antacids|mesh-ancestor
25177004|NCT05370898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177005|NCT05370898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24755673|NCT01728272|Metoprolol|metoprolol|mesh-list
24755674|NCT01728272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24755675|NCT01728272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24755676|NCT01728272|Sympatholytics|sympatholytics|mesh-ancestor
24755677|NCT01728272|Autonomic Agents|autonomic agents|mesh-ancestor
25177041|NCT05358691|Durvalumab|durvalumab|mesh-list
25177042|NCT05358691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25177043|NCT05358691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25177044|NCT05345717|Abatacept|abatacept|mesh-list
25177045|NCT05345717|Proteasome Inhibitors|proteasome inhibitors|mesh-list
25177046|NCT05345717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25177047|NCT05345717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177048|NCT05345717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25177049|NCT05345717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25177050|NCT05345717|Immunologic Factors|immunologic factors|mesh-ancestor
25177051|NCT05345717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177052|NCT05345717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25177053|NCT05345717|Protease Inhibitors|protease inhibitors|mesh-ancestor
24624553|NCT01076673|Viscosupplements|viscosupplements|mesh-ancestor
25177054|NCT05345717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25204734|NCT02706470|Immunologic Factors|immunologic factors|mesh-ancestor
25204735|NCT02706470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204736|NCT02706470|Antifungal Agents|antifungal agents|mesh-ancestor
25204737|NCT02706470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25204738|NCT02706470|Dermatologic Agents|dermatologic agents|mesh-ancestor
25204739|NCT02706470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25177055|NCT05336968|Triamcinolone|triamcinolone|mesh-list
25177056|NCT05336968|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25177057|NCT05336968|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25177058|NCT05336968|Ketorolac|ketorolac|mesh-list
24755678|NCT01728272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25177059|NCT05336968|Ropivacaine|ropivacaine|mesh-list
25177060|NCT05336968|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25177061|NCT05336968|Anesthetics, Local|anesthetics, local|mesh-ancestor
25177062|NCT05336968|Anesthetics|anesthetics|mesh-ancestor
25177063|NCT05336968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25177064|NCT05336968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177065|NCT05336968|Sensory System Agents|sensory system agents|mesh-ancestor
25177066|NCT05336968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25177067|NCT05336968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25177068|NCT05336968|Glucocorticoids|glucocorticoids|mesh-ancestor
25177069|NCT05336968|Hormones|hormones|mesh-ancestor
25177070|NCT05336968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25177071|NCT05336968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25177072|NCT05336968|Immunologic Factors|immunologic factors|mesh-ancestor
25177073|NCT05336968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25177074|NCT05336968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177075|NCT05336968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25177076|NCT05336968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25177077|NCT05336968|Analgesics|analgesics|mesh-ancestor
25177078|NCT05336968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25177079|NCT05336968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25177080|NCT05332444|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25177081|NCT05332444|Amoxicillin|amoxicillin|mesh-list
25177082|NCT05332444|Metronidazole|metronidazole|mesh-list
25177083|NCT05332444|Clarithromycin|clarithromycin|mesh-list
25177084|NCT05332444|Levofloxacin|levofloxacin|mesh-list
25177085|NCT05332444|Tetracycline|tetracycline|mesh-list
25177086|NCT05332444|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25177087|NCT05332444|Rabeprazole|rabeprazole|mesh-list
25177088|NCT05332444|Bismuth|bismuth|mesh-list
25177089|NCT05332444|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25177090|NCT05332444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25177091|NCT05332444|Antitubercular Agents|antitubercular agents|mesh-ancestor
25177092|NCT05332444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25177093|NCT05332444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25177094|NCT05332444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25177095|NCT05332444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860201|NCT00083031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25177096|NCT05332444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177097|NCT05332444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25177098|NCT05332444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25177099|NCT05332444|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25177100|NCT05332444|Renal Agents|renal agents|mesh-ancestor
25177101|NCT05332444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25177102|NCT05332444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25177103|NCT05332444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25177104|NCT05332444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25177105|NCT05332444|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25177106|NCT05332444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25177107|NCT05332444|Antacids|antacids|mesh-ancestor
25177108|NCT05329532|Pembrolizumab|pembrolizumab|mesh-list
25177109|NCT05329532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25177110|NCT05329532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25177111|NCT05317182|Salicylic Acid|salicylic acid|mesh-list
25177112|NCT05317182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25177113|NCT05317182|Antifungal Agents|antifungal agents|mesh-ancestor
25177114|NCT05317182|Keratolytic Agents|keratolytic agents|mesh-ancestor
25177115|NCT05317182|Dermatologic Agents|dermatologic agents|mesh-ancestor
25177116|NCT05303909|Gentamicins|gentamicins|mesh-list
25177117|NCT05303909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25177118|NCT05303909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25177119|NCT05303909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25177120|NCT05303909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665242|NCT01681849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25177162|NCT05291598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25177163|NCT05291598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25177164|NCT05291598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25177165|NCT05291598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177166|NCT05291598|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25177167|NCT05289804|Lidocaine|lidocaine|mesh-list
25177168|NCT05289804|Anesthetics, Local|anesthetics, local|mesh-list
25177169|NCT05289804|Prilocaine|prilocaine|mesh-list
25177170|NCT05289804|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25177171|NCT05289804|Anesthetics|anesthetics|mesh-list
25177172|NCT05289804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25177173|NCT05289804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177174|NCT05289804|Sensory System Agents|sensory system agents|mesh-ancestor
25177175|NCT05289804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25177176|NCT05289804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25177177|NCT05289804|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25177178|NCT05289804|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25177179|NCT05289804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25177180|NCT05289804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177181|NCT05289804|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25177182|NCT05277922|Nitroprusside|nitroprusside|mesh-list
25177183|NCT05277922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25177184|NCT05277922|Vasodilator Agents|vasodilator agents|mesh-ancestor
25177185|NCT05277922|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25177186|NCT05277922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177187|NCT05265806|Oxytocin|oxytocin|mesh-list
25177188|NCT05265806|Oxytocics|oxytocics|mesh-ancestor
25665243|NCT01681849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665244|NCT01681849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25177189|NCT05265806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25177190|NCT05265806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177191|NCT05263908|Ritonavir|ritonavir|mesh-list
24755886|NCT01729806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755887|NCT01729806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25860202|NCT00083031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24755899|NCT01729897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24945077|NCT03953950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24945078|NCT03953950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177192|NCT05263908|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25177193|NCT05263908|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25177194|NCT05263908|Protease Inhibitors|protease inhibitors|mesh-ancestor
25177195|NCT05263908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25177196|NCT05263908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177197|NCT05263908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25177198|NCT05263908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25177199|NCT05263908|Antiviral Agents|antiviral agents|mesh-ancestor
25177200|NCT05263908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25177201|NCT05263908|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25177202|NCT05263908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24488631|NCT00469586|Glimepiride|glimepiride|mesh-list
24488632|NCT00469586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24488633|NCT00469586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488634|NCT00469586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24488635|NCT00469586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24488636|NCT00469586|Immunologic Factors|immunologic factors|mesh-ancestor
24488637|NCT00469599|Alfacalcidol|alfacalcidol|mesh-list
24488638|NCT00469599|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
24488641|NCT00469599|Vitamins|vitamins|mesh-ancestor
24488662|NCT00469690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488663|NCT00469690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24488664|NCT00469690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24488665|NCT00469690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24488666|NCT00469690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25132401|NCT03018821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25132402|NCT03018821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25132403|NCT03018821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132404|NCT03018821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25132405|NCT03018821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25086219|NCT03290963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086220|NCT03290859|Propofol|propofol|mesh-list
25086221|NCT03290859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25086222|NCT03290859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25086310|NCT03290417|Vitamins|vitamins|mesh-list
25086311|NCT03290417|Curcumin|curcumin|mesh-list
25086312|NCT03290417|Turmeric extract|turmeric extract|mesh-list
25086313|NCT03290417|Micronutrients|micronutrients|mesh-ancestor
25086493|NCT03289026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25086494|NCT03289026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25086560|NCT03288428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25086864|NCT03285165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25086865|NCT03285165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25087027|NCT03283202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25087028|NCT03283202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25087029|NCT03283202|Tubulin Modulators|tubulin modulators|mesh-ancestor
25087030|NCT03283202|Antimitotic Agents|antimitotic agents|mesh-ancestor
25087031|NCT03283202|Mitosis Modulators|mitosis modulators|mesh-ancestor
25087032|NCT03283176|Folic Acid|folic acid|mesh-list
25087339|NCT03279978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087340|NCT03279978|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25087341|NCT03279978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25087342|NCT03279978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25087343|NCT03279978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25087344|NCT03279978|Anesthetics, General|anesthetics, general|mesh-ancestor
25087345|NCT03279978|Anesthetics|anesthetics|mesh-ancestor
24670397|NCT02663622|Methotrexate|methotrexate|mesh-list
25087403|NCT03279757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25087404|NCT03279757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25087455|NCT03279341|Serotonin Agents|serotonin agents|mesh-ancestor
25087456|NCT03279341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25087521|NCT03278938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25177203|NCT05261594|Caffeine|caffeine|mesh-list
25177204|NCT05261594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25177205|NCT05261594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177206|NCT05261594|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25177207|NCT05261594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24624597|NCT01076868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24624598|NCT01076868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24624599|NCT01076868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24624600|NCT01076894|Anesthetics|anesthetics|mesh-list
24624601|NCT01076894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24624602|NCT01076894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209242|NCT02704780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25209243|NCT02704780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209244|NCT02704780|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25209245|NCT02704780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25209246|NCT02704780|Oxytocics|oxytocics|mesh-ancestor
25209247|NCT02704546|Methylphenidate|methylphenidate|mesh-list
25209248|NCT02704546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25209249|NCT02704546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177208|NCT05261594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177209|NCT05261594|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25177210|NCT05261594|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25177211|NCT05261594|Purinergic Agents|purinergic agents|mesh-ancestor
25177212|NCT05261594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25177213|NCT05253417|Cannabidiol|cannabidiol|mesh-list
25177214|NCT05253417|Anticonvulsants|anticonvulsants|mesh-ancestor
25204740|NCT02706470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25204741|NCT02706470|Progestins|progestins|mesh-ancestor
25204742|NCT02706470|Hormones|hormones|mesh-ancestor
25204743|NCT02706470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25204744|NCT02706535|Itraconazole|itraconazole|mesh-list
25204745|NCT02706535|Rifampin|rifampin|mesh-list
25204746|NCT02706535|Antifungal Agents|antifungal agents|mesh-ancestor
25177216|NCT05220020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25177217|NCT05220020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25177218|NCT05220020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25177219|NCT05220020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177220|NCT05215431|Antioxidants|antioxidants|mesh-list
25177221|NCT05215431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177222|NCT05215431|Protective Agents|protective agents|mesh-ancestor
25177223|NCT05215431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177224|NCT05199038|Octreotide|octreotide|mesh-list
25177225|NCT05199038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25177226|NCT05199038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25177227|NCT05199038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25177233|NCT05191862|Cilostazol|cilostazol|mesh-list
25177245|NCT05191862|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25177246|NCT05191862|Protective Agents|protective agents|mesh-ancestor
25177247|NCT05191862|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25177248|NCT05191862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25177249|NCT05191862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25177250|NCT05190432|Taxifolin|taxifolin|mesh-list
25177251|NCT05190432|Ergothioneine|ergothioneine|mesh-list
25177252|NCT05190432|Antioxidants|antioxidants|mesh-ancestor
25177253|NCT05190432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177254|NCT05190432|Protective Agents|protective agents|mesh-ancestor
25177255|NCT05190432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177256|NCT05190432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25177257|NCT05190432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25177258|NCT05190432|Analgesics|analgesics|mesh-ancestor
25177259|NCT05190432|Sensory System Agents|sensory system agents|mesh-ancestor
25177260|NCT05190432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25177261|NCT05190432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25177262|NCT05190432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25177263|NCT05187429|Nivolumab|nivolumab|mesh-list
25426408|NCT02003222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25665245|NCT01681849|Serotonin Agents|serotonin agents|mesh-ancestor
25665246|NCT01681849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665247|NCT01681849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25665248|NCT01681849|Antidepressive Agents|antidepressive agents|mesh-ancestor
25665249|NCT01681849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25665250|NCT01681849|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25665251|NCT01681849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25665252|NCT01681849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665253|NCT01681992|Vaccines|vaccines|mesh-list
25665254|NCT01681992|Immunologic Factors|immunologic factors|mesh-ancestor
25665255|NCT01681992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665256|NCT01682031|Selenium|selenium|mesh-list
25665257|NCT01682031|Cisplatin|cisplatin|mesh-list
25665258|NCT01682031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25177264|NCT05187429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25177265|NCT05187429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25177266|NCT05187429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25177267|NCT05187429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177268|NCT05180968|Dronabinol|dronabinol|mesh-list
25177269|NCT05180968|Nabilone|nabilone|mesh-list
25177270|NCT05180968|Antiemetics|antiemetics|mesh-ancestor
25177271|NCT05180968|Autonomic Agents|autonomic agents|mesh-ancestor
25177272|NCT05180968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25177273|NCT05180968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177274|NCT05180968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25177275|NCT05180968|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25177276|NCT05180968|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25177277|NCT05180968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25177278|NCT05180968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25177279|NCT05180968|Hallucinogens|hallucinogens|mesh-ancestor
25177280|NCT05180968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25177281|NCT05180968|Analgesics|analgesics|mesh-ancestor
25177282|NCT05180968|Sensory System Agents|sensory system agents|mesh-ancestor
25177283|NCT05180968|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25177284|NCT05180968|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25177285|NCT05180968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25177286|NCT05180968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177287|NCT05180968|Hormones|hormones|mesh-ancestor
25177288|NCT05180968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25177304|NCT05176158|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
25204753|NCT02706535|Hormone Antagonists|hormone antagonists|mesh-ancestor
25177310|NCT05176158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177311|NCT05176158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25177312|NCT05176158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24420789|NCT00216788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24420790|NCT00216788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25177318|NCT05169060|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
25177319|NCT05169060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25177320|NCT05169060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25177321|NCT05169060|Analgesics|analgesics|mesh-ancestor
25177322|NCT05169060|Sensory System Agents|sensory system agents|mesh-ancestor
25177323|NCT05169060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25177324|NCT05169060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177325|NCT05169060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25177326|NCT05169060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25177327|NCT05165771|Tofacitinib|tofacitinib|mesh-list
25177328|NCT05165771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25177329|NCT05165771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25177330|NCT05165771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177332|NCT05158374|Metformin|metformin|mesh-list
25177333|NCT05158374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25177334|NCT05158374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177335|NCT05158374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25177336|NCT05158374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25177337|NCT05158374|Analgesics|analgesics|mesh-ancestor
25177338|NCT05158374|Sensory System Agents|sensory system agents|mesh-ancestor
25177339|NCT05158374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24945100|NCT03953677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857995|NCT02294643|Aspirin|aspirin|mesh-list
24756064|NCT01731067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24756065|NCT01731067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24756066|NCT01731067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24756067|NCT01731067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25177340|NCT05158374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25177341|NCT05158374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25177342|NCT05158374|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25177343|NCT05158374|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25177344|NCT05158374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177345|NCT05158374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25177346|NCT05158374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25177347|NCT05158374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25177348|NCT05158374|Antipyretics|antipyretics|mesh-ancestor
25177349|NCT05156606|Testosterone|testosterone|mesh-list
25177350|NCT05156606|Androgens|androgens|mesh-ancestor
25177351|NCT05156606|Hormones|hormones|mesh-ancestor
25177352|NCT05156606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25177353|NCT05156606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177354|NCT05153174|Sulforaphane|sulforaphane|mesh-list
24928190|NCT04124913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24928191|NCT04124913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209253|NCT02704546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209254|NCT02704546|Dopamine Agents|dopamine agents|mesh-ancestor
25209255|NCT02704546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25209256|NCT02704481|Misoprostol|misoprostol|mesh-list
25209257|NCT02704481|Mifepristone|mifepristone|mesh-list
25209258|NCT02704481|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24499051|NCT00517504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25177355|NCT05153174|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25177356|NCT05153174|Protective Agents|protective agents|mesh-ancestor
25177357|NCT05153174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177358|NCT05153174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25177359|NCT05151328|Plecanatide|plecanatide|mesh-list
25177360|NCT05151328|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25177361|NCT05151328|Enzyme Activators|enzyme activators|mesh-ancestor
25177362|NCT05151328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177363|NCT05151328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25177364|NCT05148702|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25177365|NCT05148702|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25177366|NCT05148702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25177367|NCT05148702|Antitubercular Agents|antitubercular agents|mesh-ancestor
25177368|NCT05147272|Gemcitabine|gemcitabine|mesh-list
25177369|NCT05147272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25177370|NCT05147272|Antimetabolites|antimetabolites|mesh-ancestor
25177371|NCT05147272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177372|NCT05147272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25177373|NCT05147272|Antiviral Agents|antiviral agents|mesh-ancestor
25177374|NCT05147272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25177375|NCT05147272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25177376|NCT05147272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25177377|NCT05147272|Immunologic Factors|immunologic factors|mesh-ancestor
25177378|NCT05147272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177379|NCT05146154|Imipenem|imipenem|mesh-list
25177380|NCT05146154|Relebactam|relebactam|mesh-list
25177381|NCT05146154|Cilastatin|cilastatin|mesh-list
25177382|NCT05146154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25177383|NCT05146154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25177384|NCT05146154|Protease Inhibitors|protease inhibitors|mesh-ancestor
25177385|NCT05146154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25177386|NCT05146154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177387|NCT05146154|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25177388|NCT05132920|Dexamethasone|dexamethasone|mesh-list
25177389|NCT05132920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25177390|NCT05132920|Antiemetics|antiemetics|mesh-ancestor
25177391|NCT05132920|Autonomic Agents|autonomic agents|mesh-ancestor
25177392|NCT05132920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25177393|NCT05132920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177394|NCT05132920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25177395|NCT05132920|Glucocorticoids|glucocorticoids|mesh-ancestor
25177396|NCT05132920|Hormones|hormones|mesh-ancestor
25177397|NCT05132920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25177398|NCT05132920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24756191|NCT01731574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25177399|NCT05132920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25177400|NCT05122481|Ascorbic Acid|ascorbic acid|mesh-list
25177401|NCT05122481|Vitamins|vitamins|mesh-ancestor
25177402|NCT05122481|Micronutrients|micronutrients|mesh-ancestor
25177403|NCT05122481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177404|NCT05122481|Antioxidants|antioxidants|mesh-ancestor
25177405|NCT05122481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177406|NCT05122481|Protective Agents|protective agents|mesh-ancestor
25177407|NCT05121909|Listerine|listerine|mesh-list
25177408|NCT05121909|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
25177409|NCT05121909|Sodium Fluoride|sodium fluoride|mesh-list
25665259|NCT01682031|Antioxidants|antioxidants|mesh-ancestor
25665260|NCT01682031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665261|NCT01682031|Protective Agents|protective agents|mesh-ancestor
25665262|NCT01682031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665263|NCT01682031|Trace Elements|trace elements|mesh-ancestor
25665264|NCT01682031|Micronutrients|micronutrients|mesh-ancestor
25665265|NCT01682044|Rituximab|rituximab|mesh-list
25665266|NCT01682044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25665267|NCT01682044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665268|NCT01682044|Immunologic Factors|immunologic factors|mesh-ancestor
25209273|NCT02704481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25209274|NCT02704481|Luteolytic Agents|luteolytic agents|mesh-ancestor
25209275|NCT02704481|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25177410|NCT05121909|Cariostatic Agents|cariostatic agents|mesh-ancestor
25177411|NCT05121909|Protective Agents|protective agents|mesh-ancestor
25177412|NCT05121909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177413|NCT05121909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25177414|NCT05115136|Diphenhydramine|diphenhydramine|mesh-list
25177415|NCT05115136|Promethazine|promethazine|mesh-list
25177416|NCT05115136|Doxepin|doxepin|mesh-list
25177417|NCT05115136|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25177418|NCT05115136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25177419|NCT05115136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25177420|NCT05115136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177421|NCT05115136|Anesthetics, Local|anesthetics, local|mesh-ancestor
25177422|NCT05115136|Anesthetics|anesthetics|mesh-ancestor
25177423|NCT05115136|Sensory System Agents|sensory system agents|mesh-ancestor
25177424|NCT05115136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25177425|NCT05115136|Antiemetics|antiemetics|mesh-ancestor
25177426|NCT05115136|Autonomic Agents|autonomic agents|mesh-ancestor
25177427|NCT05115136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25177428|NCT05115136|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25177429|NCT05115136|Histamine Antagonists|histamine antagonists|mesh-ancestor
25177430|NCT05115136|Histamine Agents|histamine agents|mesh-ancestor
25177431|NCT05115136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25177432|NCT05115136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177433|NCT05115136|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25177434|NCT05115136|Antipruritics|antipruritics|mesh-ancestor
25177435|NCT05115136|Dermatologic Agents|dermatologic agents|mesh-ancestor
25177436|NCT05115136|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25177437|NCT05115136|Antidepressive Agents|antidepressive agents|mesh-ancestor
25860203|NCT00083031|Alkylating Agents|alkylating agents|mesh-ancestor
25177438|NCT05115136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25204747|NCT02706535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25204748|NCT02706535|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25204749|NCT02706535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25204750|NCT02706535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25204751|NCT02706535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204752|NCT02706535|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25204757|NCT02706535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25204758|NCT02706535|Antitubercular Agents|antitubercular agents|mesh-ancestor
25860204|NCT00083031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945106|NCT03953677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25204759|NCT02706535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25204760|NCT02706535|Leprostatic Agents|leprostatic agents|mesh-ancestor
25204761|NCT02706535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25204762|NCT02706535|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25204763|NCT02706535|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25204764|NCT02706535|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25204765|NCT02706535|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25204766|NCT02706535|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25204767|NCT02706535|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25204768|NCT02706509|Tramadol|tramadol|mesh-list
25204769|NCT02706509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25204770|NCT02706509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204771|NCT02706509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25204772|NCT02706509|Narcotics|narcotics|mesh-ancestor
25204773|NCT02706509|Analgesics|analgesics|mesh-ancestor
25204774|NCT02706509|Sensory System Agents|sensory system agents|mesh-ancestor
25204775|NCT02706509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204776|NCT02706236|Pancrelipase|pancrelipase|mesh-list
25204777|NCT02706236|Pancreatin|pancreatin|mesh-list
25204778|NCT02706236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25204779|NCT05265676|Enoxaparin|enoxaparin|mesh-list
25204780|NCT05265676|Enoxaparin sodium|enoxaparin sodium|mesh-list
25204781|NCT05265676|Anticoagulants|anticoagulants|mesh-ancestor
25204782|NCT05265676|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25204783|NCT05265676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25204784|NCT05265676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204789|NCT05265442|Methadone|methadone|mesh-list
25665269|NCT01682044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665270|NCT01682044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25665271|NCT01682135|Ramucirumab|ramucirumab|mesh-list
25665272|NCT01682135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25204791|NCT05265442|Narcotics|narcotics|mesh-ancestor
25204792|NCT05265442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25204793|NCT05265442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204794|NCT05265442|Analgesics|analgesics|mesh-ancestor
25204795|NCT05265442|Sensory System Agents|sensory system agents|mesh-ancestor
25204796|NCT05265442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204797|NCT05265442|Antitussive Agents|antitussive agents|mesh-ancestor
25204798|NCT05265442|Respiratory System Agents|respiratory system agents|mesh-ancestor
25204799|NCT05265299|Aspirin|aspirin|mesh-list
25204800|NCT05265299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25204801|NCT05265299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25204802|NCT05265299|Analgesics|analgesics|mesh-ancestor
25204803|NCT05265299|Sensory System Agents|sensory system agents|mesh-ancestor
25204804|NCT05265299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204805|NCT05265299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204806|NCT05265299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25204807|NCT05265299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25204808|NCT05265299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25204809|NCT05265299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25204810|NCT05265299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204811|NCT05265299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25204812|NCT05265299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25204813|NCT05265299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25204814|NCT05265299|Antipyretics|antipyretics|mesh-ancestor
25204815|NCT05264922|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25204816|NCT05264922|Hemostatics|hemostatics|mesh-ancestor
24489899|NCT00475813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25204817|NCT05264922|Coagulants|coagulants|mesh-ancestor
25204818|NCT05264883|Azacitidine|azacitidine|mesh-list
25204819|NCT05264883|Decitabine|decitabine|mesh-list
25177439|NCT05101629|Pembrolizumab|pembrolizumab|mesh-list
25177440|NCT05101629|Lenvatinib|lenvatinib|mesh-list
25177441|NCT05101629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25177442|NCT05101629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25177443|NCT05101629|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25177444|NCT05101629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25177455|NCT05073315|Adalimumab|adalimumab|mesh-list
25177456|NCT05073315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25177457|NCT05073315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25177458|NCT05065736|Clofarabine|clofarabine|mesh-list
24756368|NCT01732744|Disinfectants|disinfectants|mesh-ancestor
24756369|NCT01732744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25177459|NCT05065736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25177460|NCT05065736|Antimetabolites|antimetabolites|mesh-ancestor
25177461|NCT05065736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177462|NCT05065736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25177473|NCT05052541|Dronabinol|dronabinol|mesh-list
25177474|NCT05052541|Hallucinogens|hallucinogens|mesh-ancestor
25177475|NCT05052541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177476|NCT05052541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25177477|NCT05052541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25177478|NCT05052541|Analgesics|analgesics|mesh-ancestor
25177479|NCT05052541|Sensory System Agents|sensory system agents|mesh-ancestor
25177480|NCT05052541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25177481|NCT05052541|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25177482|NCT05052541|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25177483|NCT05052541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25177484|NCT05052541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177485|NCT05052541|Hormones|hormones|mesh-ancestor
25177486|NCT05052541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25177487|NCT05052151|Dialysis Solutions|dialysis solutions|mesh-list
25177488|NCT05052151|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25177489|NCT05049863|Mycophenolic Acid|mycophenolic acid|mesh-list
25177490|NCT05049863|Irinotecan|irinotecan|mesh-list
25177491|NCT05049863|Allopurinol|allopurinol|mesh-list
25177492|NCT05049863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25177493|NCT05049863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25177494|NCT05049863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756380|NCT01733017|Lycopene|lycopene|mesh-list
25177495|NCT05049863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177496|NCT05049863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25177497|NCT05049863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25177498|NCT05049863|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25177499|NCT05049863|Antitubercular Agents|antitubercular agents|mesh-ancestor
25177500|NCT05049863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25177502|NCT05049863|Antimetabolites|antimetabolites|mesh-ancestor
25177503|NCT05049863|Gout Suppressants|gout suppressants|mesh-ancestor
25177504|NCT05049863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25177505|NCT05049863|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25177506|NCT05049863|Antioxidants|antioxidants|mesh-ancestor
25177507|NCT05049863|Protective Agents|protective agents|mesh-ancestor
25177508|NCT05049863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177511|NCT05026203|Midazolam|midazolam|mesh-list
25177512|NCT05026203|Ketamine|ketamine|mesh-list
25177513|NCT05026203|Analgesics|analgesics|mesh-ancestor
25177521|NCT05026203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24490557|NCT00478907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490558|NCT00478907|Anticonvulsants|anticonvulsants|mesh-ancestor
24490559|NCT00478907|GABA Modulators|gaba modulators|mesh-ancestor
24490560|NCT00478907|GABA Agents|gaba agents|mesh-ancestor
24490561|NCT00478946|Leucovorin|leucovorin|mesh-list
24490562|NCT00478946|Antidotes|antidotes|mesh-ancestor
24490563|NCT00478946|Protective Agents|protective agents|mesh-ancestor
24490564|NCT00478946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490565|NCT00478946|Vitamin B Complex|vitamin b complex|mesh-ancestor
24490566|NCT00478946|Vitamins|vitamins|mesh-ancestor
24490567|NCT00478946|Micronutrients|micronutrients|mesh-ancestor
25087522|NCT03278938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25087523|NCT03278938|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25087524|NCT03278938|Serotonin Agents|serotonin agents|mesh-ancestor
25087525|NCT03278860|Oxytocin|oxytocin|mesh-list
25087526|NCT03278860|Oxytocics|oxytocics|mesh-ancestor
25087527|NCT03278860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25087528|NCT03278860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087529|NCT03278808|Azithromycin|azithromycin|mesh-list
25087530|NCT03278808|Chloroquine|chloroquine|mesh-list
25087531|NCT03278808|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
25087532|NCT03278808|Atovaquone|atovaquone|mesh-list
25087533|NCT03278808|Proguanil|proguanil|mesh-list
25087534|NCT03278808|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
25087535|NCT03278808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25087607|NCT03278431|Anthelmintics|anthelmintics|mesh-ancestor
25087608|NCT03278431|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25087609|NCT03278431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25087610|NCT03278431|Anticestodal Agents|anticestodal agents|mesh-ancestor
25087611|NCT03278431|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25087612|NCT03278431|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25087613|NCT03278431|Tubulin Modulators|tubulin modulators|mesh-ancestor
25087614|NCT03278431|Antimitotic Agents|antimitotic agents|mesh-ancestor
25087615|NCT03278431|Mitosis Modulators|mitosis modulators|mesh-ancestor
25087616|NCT03278431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087617|NCT03278431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25087618|NCT03278431|Antinematodal Agents|antinematodal agents|mesh-ancestor
25087619|NCT03278431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25087620|NCT03278431|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
25087621|NCT03278431|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25087622|NCT03278431|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25087623|NCT03278431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25087688|NCT03277430|Immunologic Factors|immunologic factors|mesh-ancestor
25087689|NCT03277430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087690|NCT03277430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25087719|NCT03277339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25087720|NCT03277339|Serotonin Agents|serotonin agents|mesh-ancestor
25087721|NCT03277339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087722|NCT03277339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25087723|NCT03277339|Antidepressive Agents|antidepressive agents|mesh-ancestor
24945110|NCT03953677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945111|NCT03953729|Ibuprofen|ibuprofen|mesh-list
24756451|NCT01733459|Metformin|metformin|mesh-list
25087724|NCT03277339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25087725|NCT03277339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25087726|NCT03277339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25087888|NCT03275558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087889|NCT03275519|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25087890|NCT03275519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25665273|NCT01682213|Dabrafenib|dabrafenib|mesh-list
25087891|NCT03275519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25087892|NCT03275519|Antitubercular Agents|antitubercular agents|mesh-ancestor
25087893|NCT03275506|Bevacizumab|bevacizumab|mesh-list
25087894|NCT03275506|Pembrolizumab|pembrolizumab|mesh-list
25087895|NCT03275506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25087896|NCT03275506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25087897|NCT03275506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25087898|NCT03275506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25087899|NCT03275506|Growth Substances|growth substances|mesh-ancestor
25087900|NCT03275506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177514|NCT05026203|Sensory System Agents|sensory system agents|mesh-ancestor
25177515|NCT05026203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25177516|NCT05026203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177517|NCT05026203|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25177518|NCT05026203|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25177519|NCT05026203|Anesthetics, General|anesthetics, general|mesh-ancestor
25177520|NCT05026203|Anesthetics|anesthetics|mesh-ancestor
25177522|NCT05026203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24490568|NCT00478959|Lenalidomide|lenalidomide|mesh-list
25177523|NCT05026203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25177524|NCT05026203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25177525|NCT05026203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177526|NCT05026203|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25177527|NCT05026203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25177528|NCT05026203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25177529|NCT05026203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25177530|NCT05026203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25177531|NCT05026203|GABA Modulators|gaba modulators|mesh-ancestor
25177532|NCT05026203|GABA Agents|gaba agents|mesh-ancestor
25177533|NCT05019534|Cetuximab|cetuximab|mesh-list
25177534|NCT05019534|Vemurafenib|vemurafenib|mesh-list
25177535|NCT05019534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25177536|NCT05019534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25177537|NCT05019534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25177538|NCT05019534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25177539|NCT05019534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177540|NCT05013463|Hydroxychloroquine|hydroxychloroquine|mesh-list
25177541|NCT05013463|Indapamide|indapamide|mesh-list
25177542|NCT05013463|Antimalarials|antimalarials|mesh-ancestor
25177543|NCT05013463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25860205|NCT00083031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860206|NCT00083031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25860207|NCT00083031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25177544|NCT05013463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25177545|NCT05013463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25177546|NCT05013463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25177547|NCT05013463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177548|NCT05013463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25177549|NCT05013463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25177550|NCT05013463|Diuretics|diuretics|mesh-ancestor
25177551|NCT05013463|Natriuretic Agents|natriuretic agents|mesh-ancestor
25177552|NCT05013463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177553|NCT05013463|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25177554|NCT05013463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25177555|NCT05001152|Ozanimod|ozanimod|mesh-list
25177556|NCT05001152|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25177557|NCT05001152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177558|NCT05001152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25177559|NCT05001152|Immunologic Factors|immunologic factors|mesh-ancestor
25177560|NCT05001152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177561|NCT04996667|Nitric Oxide|nitric oxide|mesh-list
25177562|NCT04996667|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25177563|NCT04996667|Autonomic Agents|autonomic agents|mesh-ancestor
25177564|NCT04996667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25177565|NCT04996667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177566|NCT04996667|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25177567|NCT04996667|Respiratory System Agents|respiratory system agents|mesh-ancestor
25177568|NCT04996667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25177569|NCT04996667|Antioxidants|antioxidants|mesh-ancestor
25177570|NCT04996667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177571|NCT04996667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25177572|NCT04996667|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25177573|NCT04996667|Vasodilator Agents|vasodilator agents|mesh-ancestor
25177574|NCT04996667|Gasotransmitters|gasotransmitters|mesh-ancestor
25177575|NCT04996667|Protective Agents|protective agents|mesh-ancestor
25177576|NCT04992156|Palbociclib|palbociclib|mesh-list
25177577|NCT04992156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25426409|NCT02003222|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25177578|NCT04992156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25177579|NCT04992156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25177580|NCT04992156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177581|NCT04982614|Vaccines|vaccines|mesh-list
25177582|NCT04982614|Immunologic Factors|immunologic factors|mesh-ancestor
25177583|NCT04982614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204820|NCT05264883|Venetoclax|venetoclax|mesh-list
25204821|NCT05264883|Aclarubicin|aclarubicin|mesh-list
25204822|NCT05264883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25204823|NCT05264883|Antimetabolites|antimetabolites|mesh-ancestor
25204824|NCT05264883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204825|NCT05264883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25204826|NCT05264883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25204827|NCT05264883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25204828|NCT05264883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25204829|NCT05264883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25204830|NCT05264805|Bupivacaine|bupivacaine|mesh-list
25204831|NCT05264805|Anesthetics, Local|anesthetics, local|mesh-ancestor
25204832|NCT05264805|Anesthetics|anesthetics|mesh-ancestor
24491004|NCT00480675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25177584|NCT04979780|Heparin|heparin|mesh-list
25177585|NCT04979780|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25177586|NCT04979780|Tinzaparin|tinzaparin|mesh-list
25177587|NCT04979780|Dalteparin|dalteparin|mesh-list
25177588|NCT04979780|Rivaroxaban|rivaroxaban|mesh-list
25177589|NCT04979780|Anticoagulants|anticoagulants|mesh-list
25177590|NCT04979780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25177591|NCT04979780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25177592|NCT04979780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177593|NCT04979780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25177594|NCT04979780|Antithrombins|antithrombins|mesh-ancestor
25177595|NCT04979780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25177596|NCT04979780|Protease Inhibitors|protease inhibitors|mesh-ancestor
25177597|NCT04979780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25177598|NCT04975152|Cemiplimab|cemiplimab|mesh-list
25177599|NCT04975152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25177600|NCT04975152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25177601|NCT04974385|Bupivacaine|bupivacaine|mesh-list
25177602|NCT04974385|Anesthetics, Local|anesthetics, local|mesh-ancestor
25177603|NCT04974385|Anesthetics|anesthetics|mesh-ancestor
25177604|NCT04974385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25177605|NCT04974385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177606|NCT04974385|Sensory System Agents|sensory system agents|mesh-ancestor
25177607|NCT04974385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25177608|NCT04965311|Botulinum Toxins|botulinum toxins|mesh-list
25177609|NCT04965311|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25177610|NCT04965311|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25177611|NCT04965311|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25177612|NCT04965311|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25177613|NCT04965311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25177614|NCT04965311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177615|NCT04965311|Cholinergic Agents|cholinergic agents|mesh-ancestor
25177616|NCT04965311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25177617|NCT04965311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177618|NCT04965311|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25177619|NCT04965311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25177620|NCT04964843|Acetylcysteine|acetylcysteine|mesh-list
25177621|NCT04964843|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25177622|NCT04964843|Antiviral Agents|antiviral agents|mesh-ancestor
25177623|NCT04964843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25177624|NCT04964843|Expectorants|expectorants|mesh-ancestor
25177625|NCT04964843|Respiratory System Agents|respiratory system agents|mesh-ancestor
25177626|NCT04964843|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25177627|NCT04964843|Antioxidants|antioxidants|mesh-ancestor
25177628|NCT04964843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177629|NCT04964843|Protective Agents|protective agents|mesh-ancestor
25177630|NCT04964843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177631|NCT04964843|Antidotes|antidotes|mesh-ancestor
25177632|NCT04956705|Vitamin D|vitamin d|mesh-list
25177633|NCT04956705|Calcium|calcium|mesh-list
25177634|NCT04956705|Vitamins|vitamins|mesh-ancestor
25177635|NCT04956705|Micronutrients|micronutrients|mesh-ancestor
25177636|NCT04956705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177637|NCT04956705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25177638|NCT04956705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25177639|NCT04951323|Vaccines|vaccines|mesh-list
25177641|NCT04951323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177642|NCT04945720|Durvalumab|durvalumab|mesh-list
25177643|NCT04945720|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25177644|NCT04945720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25177645|NCT04945720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25177646|NCT04945720|Immunologic Factors|immunologic factors|mesh-ancestor
25177647|NCT04945720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177648|NCT04939935|Metformin|metformin|mesh-list
25177649|NCT04939935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25177650|NCT04939935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177651|NCT04937881|Tenofovir|tenofovir|mesh-list
25177652|NCT04937881|Antiviral Agents|antiviral agents|mesh-ancestor
25177653|NCT04937881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25177654|NCT04937881|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25177655|NCT04937881|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25177657|NCT04937881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177667|NCT04932980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25177668|NCT04932980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25177669|NCT04932980|Growth Substances|growth substances|mesh-ancestor
25177670|NCT04932980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177671|NCT04932980|Growth Inhibitors|growth inhibitors|mesh-ancestor
25177672|NCT04932980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25177682|NCT04925284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25177683|NCT04925284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25177684|NCT04925284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25177685|NCT04925284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177686|NCT04923542|Hormones|hormones|mesh-list
25177687|NCT04923542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25860208|NCT00083031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24619709|NCT01053403|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24547075|NCT00702182|Tubulin Modulators|tubulin modulators|mesh-ancestor
24756595|NCT01734473|Caseins|caseins|mesh-list
24756596|NCT01734473|Chelating Agents|chelating agents|mesh-ancestor
24756597|NCT01734473|Sequestering Agents|sequestering agents|mesh-ancestor
25177688|NCT04923542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177689|NCT04920682|Iodine|iodine|mesh-list
25177690|NCT04920682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25177691|NCT04920682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25177692|NCT04920682|Trace Elements|trace elements|mesh-ancestor
25177693|NCT04920682|Micronutrients|micronutrients|mesh-ancestor
25177694|NCT04920682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177695|NCT04907721|Glucagon|glucagon|mesh-list
25177696|NCT04907721|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25177697|NCT04907721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25177698|NCT04907721|Hormones|hormones|mesh-ancestor
25177699|NCT04907721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25177700|NCT04907721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177701|NCT04907721|Incretins|incretins|mesh-ancestor
25177702|NCT04907019|Rifampin|rifampin|mesh-list
25177703|NCT04907019|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25177704|NCT04907019|Antitubercular Agents|antitubercular agents|mesh-ancestor
25177705|NCT04907019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25177706|NCT04907019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24756617|NCT01734694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756618|NCT01734798|Gemcitabine|gemcitabine|mesh-list
24756619|NCT01734798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24756620|NCT01734798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24756621|NCT01734798|Antimetabolites|antimetabolites|mesh-ancestor
24756622|NCT01734798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756623|NCT01734798|Antiviral Agents|antiviral agents|mesh-ancestor
24756624|NCT01734798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24756625|NCT01734798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756626|NCT01734798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24756627|NCT01734798|Immunologic Factors|immunologic factors|mesh-ancestor
25177707|NCT04907019|Leprostatic Agents|leprostatic agents|mesh-ancestor
25177708|NCT04907019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25177709|NCT04907019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25177710|NCT04907019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177711|NCT04907019|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25177712|NCT04907019|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25177728|NCT04883255|Hallucinogens|hallucinogens|mesh-ancestor
25177729|NCT04883255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931133|NCT04092621|Amiodarone|amiodarone|mesh-list
25177730|NCT04883255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25177731|NCT04883255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25177732|NCT04883255|Analgesics|analgesics|mesh-ancestor
25177733|NCT04883255|Sensory System Agents|sensory system agents|mesh-ancestor
25860209|NCT00083031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24492026|NCT00484991|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24492027|NCT00484991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24492028|NCT00484991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492029|NCT00484991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24492030|NCT00484991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492031|NCT00484991|Vasodilator Agents|vasodilator agents|mesh-ancestor
24492032|NCT00485004|Sirolimus|sirolimus|mesh-list
24492033|NCT00485004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24492034|NCT00485004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25860210|NCT00083031|Growth Substances|growth substances|mesh-ancestor
25860211|NCT00083031|Growth Inhibitors|growth inhibitors|mesh-ancestor
25860212|NCT00083031|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24492074|NCT00485108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24492075|NCT00485121|Ezetimibe|ezetimibe|mesh-list
24492076|NCT00485121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24492077|NCT00485121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24492078|NCT00485121|Antimetabolites|antimetabolites|mesh-ancestor
24492079|NCT00485121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492080|NCT00485121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24492081|NCT00485160|Ibuprofen|ibuprofen|mesh-list
24492082|NCT00485160|Indomethacin|indomethacin|mesh-list
24492083|NCT00485160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24492084|NCT00485160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24492085|NCT00485160|Analgesics|analgesics|mesh-ancestor
24492086|NCT00485160|Sensory System Agents|sensory system agents|mesh-ancestor
24492087|NCT00485160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24492088|NCT00485160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492089|NCT00485160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24492090|NCT00485160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24492091|NCT00485160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24492092|NCT00485160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492093|NCT00485160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492094|NCT00485160|Gout Suppressants|gout suppressants|mesh-ancestor
24972816|NCT03715023|PC-786|pc-786|mesh-list
25087901|NCT03275506|Growth Inhibitors|growth inhibitors|mesh-ancestor
25087902|NCT03275415|Budesonide|budesonide|mesh-list
25087903|NCT03275415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25177734|NCT04883255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24421504|NCT00219388|Vasodilator Agents|vasodilator agents|mesh-ancestor
24756776|NCT01735669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24756777|NCT01735669|Narcotics|narcotics|mesh-ancestor
24756778|NCT01735669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24756779|NCT01735669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756780|NCT01735669|Analgesics|analgesics|mesh-ancestor
24756781|NCT01735669|Sensory System Agents|sensory system agents|mesh-ancestor
25177735|NCT04883255|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25177736|NCT04883255|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25177737|NCT04883255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25177738|NCT04883255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177739|NCT04883255|Hormones|hormones|mesh-ancestor
25177740|NCT04883255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25177741|NCT04879134|Apomorphine|apomorphine|mesh-list
25177742|NCT04879134|Emetics|emetics|mesh-ancestor
25177743|NCT04879134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177744|NCT04879134|Autonomic Agents|autonomic agents|mesh-ancestor
25177745|NCT04879134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25177746|NCT04879134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25177747|NCT04879134|Dopamine Agonists|dopamine agonists|mesh-ancestor
25177748|NCT04879134|Dopamine Agents|dopamine agents|mesh-ancestor
25177749|NCT04879134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25177750|NCT04879134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177751|NCT04873557|Copper|copper|mesh-list
25177752|NCT04873557|Trace Elements|trace elements|mesh-ancestor
25177753|NCT04873557|Micronutrients|micronutrients|mesh-ancestor
25177754|NCT04873557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177755|NCT04859660|Tamsulosin|tamsulosin|mesh-list
25177756|NCT04859660|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25665274|NCT01682213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24499693|NCT00520585|Atorvastatin|atorvastatin|mesh-list
24499694|NCT00520585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24499695|NCT00520585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24499696|NCT00520585|Antimetabolites|antimetabolites|mesh-ancestor
24625066|NCT01080443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24625067|NCT01080443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24625068|NCT01080443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25177757|NCT04859660|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25177758|NCT04859660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25177759|NCT04859660|Adrenergic Agents|adrenergic agents|mesh-ancestor
25177760|NCT04859660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25177761|NCT04859660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177762|NCT04859660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177763|NCT04859660|Urological Agents|urological agents|mesh-ancestor
25177764|NCT04851613|Fulvestrant|fulvestrant|mesh-list
24756782|NCT01735669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24561445|NCT00760448|Insulin Detemir|insulin detemir|mesh-list
24625964|NCT01084720|Emollients|emollients|mesh-ancestor
25177765|NCT04851613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25177766|NCT04851613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25177767|NCT04851613|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25177768|NCT04851613|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25177769|NCT04851613|Hormone Antagonists|hormone antagonists|mesh-ancestor
25177770|NCT04851613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25177771|NCT04851613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177772|NCT04847440|Tenofovir|tenofovir|mesh-list
25177773|NCT04847440|Antiviral Agents|antiviral agents|mesh-ancestor
25177774|NCT04847440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25177775|NCT04847440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25177776|NCT04847440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25177777|NCT04847440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25177778|NCT04847440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177779|NCT04847440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25177780|NCT04847440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25204833|NCT05264805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25204834|NCT05264805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204835|NCT05264805|Sensory System Agents|sensory system agents|mesh-ancestor
25204836|NCT05264805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204837|NCT05264558|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25204838|NCT05264558|Antiviral Agents|antiviral agents|mesh-ancestor
25204839|NCT05264558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25207891|NCT02330926|Sensory System Agents|sensory system agents|mesh-ancestor
25207892|NCT02330926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25207893|NCT02330926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756795|NCT01735747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207894|NCT02330926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25207895|NCT02330926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25207896|NCT02330926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25207897|NCT02330926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25207898|NCT02330926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207899|NCT02274285|Vaccines|vaccines|mesh-list
25207900|NCT02274285|Immunologic Factors|immunologic factors|mesh-ancestor
25207901|NCT02274285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207902|NCT02145507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25207903|NCT02078427|BAX 855|bax 855|mesh-list
25207904|NCT02078427|Coagulants|coagulants|mesh-ancestor
25207905|NCT02046434|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25207906|NCT02046434|Glycerol|glycerol|mesh-list
25207907|NCT02046434|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25207908|NCT02046434|Protective Agents|protective agents|mesh-ancestor
25207909|NCT02046434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207910|NCT02046434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207911|NCT01743651|Baclofen|baclofen|mesh-list
25207912|NCT01743651|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25207913|NCT01743651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207914|NCT01743651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24462861|NCT00357708|Vorinostat|vorinostat|mesh-list
25665275|NCT01682213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25665276|NCT01682213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665277|NCT01682213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665278|NCT01682460|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25665279|NCT01682460|Lubricant Eye Drops|lubricant eye drops|mesh-list
25665280|NCT01682460|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25665281|NCT01682512|Rituximab|rituximab|mesh-list
24529668|NCT00627432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25860213|NCT00083031|Abortifacient Agents|abortifacient agents|mesh-ancestor
24529669|NCT00627432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529670|NCT00627432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24529671|NCT00627432|Immunologic Factors|immunologic factors|mesh-ancestor
24529672|NCT00627432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529674|NCT00627471|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24529675|NCT00627471|Insulin Glargine|insulin glargine|mesh-list
24529676|NCT00627471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24529709|NCT00627666|Leucovorin|leucovorin|mesh-list
25207931|NCT00981656|Antimetabolites|antimetabolites|mesh-ancestor
25207932|NCT00981656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207933|NCT00981656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25207934|NCT00981656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25207935|NCT00981656|Immunologic Factors|immunologic factors|mesh-ancestor
25207936|NCT00981656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207937|NCT00981656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25207938|NCT00981656|Alkylating Agents|alkylating agents|mesh-ancestor
25207939|NCT00981656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25207940|NCT00981656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25207942|NCT00848731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25207943|NCT00848731|Autonomic Agents|autonomic agents|mesh-ancestor
25207944|NCT00848731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25177782|NCT04846829|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25177783|NCT04846829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25177784|NCT04846829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25177785|NCT04846829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177786|NCT04846829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25177787|NCT04846829|Serotonin Agents|serotonin agents|mesh-ancestor
25177788|NCT04846829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177789|NCT04846829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25177790|NCT04846829|Antidepressive Agents|antidepressive agents|mesh-ancestor
25177791|NCT04846829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25177809|NCT04831151|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
25177810|NCT04831151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177811|NCT04831151|Androgen Antagonists|androgen antagonists|mesh-ancestor
25177812|NCT04831151|Hormone Antagonists|hormone antagonists|mesh-ancestor
25177813|NCT04831151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25177814|NCT04831086|Tocolytic Agents|tocolytic agents|mesh-list
25177815|NCT04831086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25177816|NCT04831086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177817|NCT04831047|Phenylephrine|phenylephrine|mesh-list
25177818|NCT04831047|Oxymetazoline|oxymetazoline|mesh-list
25177819|NCT04831047|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25177820|NCT04831047|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25177821|NCT04831047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25177822|NCT04831047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25177823|NCT04831047|Adrenergic Agents|adrenergic agents|mesh-ancestor
25177824|NCT04831047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25177832|NCT04831047|Respiratory System Agents|respiratory system agents|mesh-ancestor
25177833|NCT04831047|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25177834|NCT04831047|Mydriatics|mydriatics|mesh-ancestor
25177835|NCT04831047|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25177836|NCT04831047|Protective Agents|protective agents|mesh-ancestor
25177844|NCT04825496|Cyclophosphamide|cyclophosphamide|mesh-list
25177845|NCT04825496|Fludarabine|fludarabine|mesh-list
25177846|NCT04825496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25177847|NCT04825496|Immunologic Factors|immunologic factors|mesh-ancestor
25177848|NCT04825496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177849|NCT04825496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25177850|NCT04825496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25177851|NCT04825496|Alkylating Agents|alkylating agents|mesh-ancestor
25177852|NCT04825496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25426410|NCT02003222|BB 1101|bb 1101|mesh-list
25665282|NCT01682512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25665283|NCT01682512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665284|NCT01682512|Immunologic Factors|immunologic factors|mesh-ancestor
25665285|NCT01682512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665286|NCT01682512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25665287|NCT01682538|Nitisinone|nitisinone|mesh-list
25665288|NCT01682538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665289|NCT01682538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665290|NCT01682603|Botulinum Toxins|botulinum toxins|mesh-list
24499722|NCT00520754|Histamine Antagonists|histamine antagonists|mesh-ancestor
24499724|NCT00520754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24499725|NCT00520754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499726|NCT00520754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499727|NCT00520806|Methocarbamol|methocarbamol|mesh-list
24499728|NCT00520806|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24499729|NCT00520806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499730|NCT00520806|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24625214|NCT01080963|Daptomycin|daptomycin|mesh-list
24625215|NCT01080963|Cefuroxime|cefuroxime|mesh-list
24625216|NCT01080963|Cefuroxime axetil|cefuroxime axetil|mesh-list
24625217|NCT01080963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24625218|NCT01080963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24625219|NCT01081002|Lidocaine|lidocaine|mesh-list
24625220|NCT01081002|Anesthetics, Local|anesthetics, local|mesh-ancestor
24625221|NCT01081002|Anesthetics|anesthetics|mesh-ancestor
25087904|NCT03275415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25087905|NCT03275415|Autonomic Agents|autonomic agents|mesh-ancestor
25087915|NCT03275376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25087916|NCT03275376|Antimetabolites|antimetabolites|mesh-ancestor
25087917|NCT03275376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087918|NCT03275376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25087919|NCT03275376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25088411|NCT04630002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25088412|NCT04630002|Antiviral Agents|antiviral agents|mesh-ancestor
25088413|NCT04630002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25088414|NCT04630002|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25088415|NCT04630002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25088416|NCT04630002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25088417|NCT04630002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25088430|NCT04431466|Ivermectin|ivermectin|mesh-list
25088431|NCT04431466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25088432|NCT04431466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25088545|NCT03849651|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25088618|NCT03475134|Cyclophosphamide|cyclophosphamide|mesh-list
25088619|NCT03475134|Nivolumab|nivolumab|mesh-list
25088620|NCT03475134|Fludarabine|fludarabine|mesh-list
25088621|NCT03475134|Interleukin-2|interleukin-2|mesh-list
25088622|NCT03475134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25088623|NCT03475134|Immunologic Factors|immunologic factors|mesh-ancestor
25088695|NCT03272425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088697|NCT03272425|Gout Suppressants|gout suppressants|mesh-ancestor
25088793|NCT03271918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25091454|NCT03248765|Analgesics|analgesics|mesh-ancestor
25091455|NCT03248765|Sensory System Agents|sensory system agents|mesh-ancestor
25091456|NCT03248765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25091457|NCT03248817|Phenylephrine|phenylephrine|mesh-list
25092736|NCT03239327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24625974|NCT01084863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24945114|NCT03953729|Analgesics|analgesics|mesh-ancestor
25092737|NCT03239327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25092738|NCT03239327|Oxytocics|oxytocics|mesh-ancestor
25092739|NCT03239327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25092809|NCT03238703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092811|NCT03238703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25092812|NCT03238703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25092813|NCT03238703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092814|NCT03238703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25665291|NCT01682603|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25665292|NCT01682603|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25665293|NCT01682603|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25665294|NCT01682603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25665295|NCT01682603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665296|NCT01682603|Cholinergic Agents|cholinergic agents|mesh-ancestor
25665297|NCT01682603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25665298|NCT01682603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665299|NCT01682603|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25665300|NCT01682603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25665301|NCT01682642|Goserelin|goserelin|mesh-list
25665302|NCT01682642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25665303|NCT01682642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665304|NCT01682681|Topiramate|topiramate|mesh-list
25665305|NCT01682681|Anticonvulsants|anticonvulsants|mesh-ancestor
25665306|NCT01682681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24499743|NCT00520897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092815|NCT03238703|Hormone Antagonists|hormone antagonists|mesh-ancestor
25177853|NCT04825496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25177854|NCT04825496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25177855|NCT04820361|Parasympatholytics|parasympatholytics|mesh-list
25177856|NCT04820361|Autonomic Agents|autonomic agents|mesh-ancestor
24494672|NCT00496301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25177865|NCT04811014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177866|NCT04811014|Analgesics|analgesics|mesh-ancestor
25177867|NCT04811014|Sensory System Agents|sensory system agents|mesh-ancestor
25177868|NCT04811014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25177869|NCT04811014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25177870|NCT04806178|BCG Vaccine|bcg vaccine|mesh-list
25177871|NCT04806178|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25177872|NCT04806178|Immunologic Factors|immunologic factors|mesh-ancestor
25177873|NCT04806178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177874|NCT04801368|Anesthetics|anesthetics|mesh-list
25177875|NCT04801368|Anesthetics, Local|anesthetics, local|mesh-list
25177876|NCT04801368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25177877|NCT04801368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177878|NCT04801368|Sensory System Agents|sensory system agents|mesh-ancestor
25177879|NCT04801368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25177880|NCT04798638|Osimertinib|osimertinib|mesh-list
25177881|NCT04798638|Complement Factor H|complement factor h|mesh-list
25177882|NCT04798638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25177883|NCT04798638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25177884|NCT04798638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25177885|NCT04798638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177886|NCT04798638|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25177887|NCT04798638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25177888|NCT04798638|Immunologic Factors|immunologic factors|mesh-ancestor
24757252|NCT01738815|Anticonvulsants|anticonvulsants|mesh-ancestor
25177889|NCT04798638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177890|NCT04796220|Gemcitabine|gemcitabine|mesh-list
25177891|NCT04796220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25177892|NCT04796220|Antimetabolites|antimetabolites|mesh-ancestor
25177893|NCT04796220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177894|NCT04796220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25177895|NCT04796220|Antiviral Agents|antiviral agents|mesh-ancestor
25177896|NCT04796220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25177897|NCT04796220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25177898|NCT04796220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25177899|NCT04796220|Immunologic Factors|immunologic factors|mesh-ancestor
25177900|NCT04796220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177901|NCT04790188|Nootropic Agents|nootropic agents|mesh-list
25177902|NCT04782037|Calcium|calcium|mesh-list
25177903|NCT04782037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25177904|NCT04782037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177905|NCT04781192|Durvalumab|durvalumab|mesh-list
25177992|NCT04747912|Abortifacient Agents|abortifacient agents|mesh-ancestor
25177931|NCT04768504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25177932|NCT04768504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177933|NCT04767698|Belimumab|belimumab|mesh-list
25177934|NCT04767698|Ocrelizumab|ocrelizumab|mesh-list
25177935|NCT04767698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25177936|NCT04767698|Immunologic Factors|immunologic factors|mesh-ancestor
25177937|NCT04767698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177938|NCT04762082|Tadalafil|tadalafil|mesh-list
25177939|NCT04762082|Vasodilator Agents|vasodilator agents|mesh-ancestor
25177940|NCT04762082|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25177941|NCT04762082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25177942|NCT04762082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25177943|NCT04762082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177944|NCT04762082|Urological Agents|urological agents|mesh-ancestor
25204840|NCT05264506|Estradiol|estradiol|mesh-list
25204841|NCT05264506|Estrogens|estrogens|mesh-ancestor
25204842|NCT05264506|Hormones|hormones|mesh-ancestor
25204843|NCT05264506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25204845|NCT05264493|Naloxone|naloxone|mesh-list
25665307|NCT01682681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665308|NCT01682720|Sofosbuvir|sofosbuvir|mesh-list
25665309|NCT01682720|Antiviral Agents|antiviral agents|mesh-ancestor
25204846|NCT05264493|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25860214|NCT00083031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24499748|NCT00520949|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
24499831|NCT00521222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24499833|NCT00521248|Morphine|morphine|mesh-list
25665310|NCT01682720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25204847|NCT05264493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204848|NCT05264493|Sensory System Agents|sensory system agents|mesh-ancestor
25204849|NCT05264493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204850|NCT05264142|Voriconazole|voriconazole|mesh-list
25204851|NCT05264142|Fluvoxamine|fluvoxamine|mesh-list
25204852|NCT05264142|Omeprazole|omeprazole|mesh-list
25204853|NCT05264142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25204854|NCT05264142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25204855|NCT05264142|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25204856|NCT05264142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25204857|NCT05264142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204858|NCT05264142|Antifungal Agents|antifungal agents|mesh-ancestor
25204859|NCT05264142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25204860|NCT05264142|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25204861|NCT05264142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25204862|NCT05264142|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25204863|NCT05264142|Hormone Antagonists|hormone antagonists|mesh-ancestor
25204864|NCT05264142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25204865|NCT05264142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204866|NCT05264142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25204867|NCT05264142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25204868|NCT05264142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25204869|NCT05264142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25204870|NCT05264142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25204871|NCT05264142|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25204872|NCT05264142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25204880|NCT05264077|Midazolam|midazolam|mesh-list
25204881|NCT05264077|Dexmedetomidine|dexmedetomidine|mesh-list
25204882|NCT05264077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25204883|NCT05264077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25204884|NCT05264077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204885|NCT05264077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25204886|NCT05264077|Analgesics|analgesics|mesh-ancestor
25204887|NCT05264077|Sensory System Agents|sensory system agents|mesh-ancestor
25204888|NCT05264077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204889|NCT05264077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25204890|NCT05264077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25204891|NCT05264077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25204892|NCT05264077|Adrenergic Agents|adrenergic agents|mesh-ancestor
25204893|NCT05264077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25204894|NCT05264077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204895|NCT05264077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25204896|NCT05264077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25204897|NCT05264077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25204898|NCT05264077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25204899|NCT05264077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24493475|NCT00491049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25177956|NCT04748991|Amiodarone|amiodarone|mesh-list
25177957|NCT04748991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25177958|NCT04748991|Vasodilator Agents|vasodilator agents|mesh-ancestor
25177959|NCT04748991|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25177960|NCT04748991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25177961|NCT04748991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177962|NCT04748991|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25177963|NCT04748991|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25177964|NCT04748991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25177965|NCT04748991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25177966|NCT04748991|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25177967|NCT04748991|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25177968|NCT04748991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25177969|NCT04747912|Dexamethasone|dexamethasone|mesh-list
25177970|NCT04747912|Dexamethasone acetate|dexamethasone acetate|mesh-list
25177971|NCT04747912|Methotrexate|methotrexate|mesh-list
25177972|NCT04747912|Vincristine|vincristine|mesh-list
25665311|NCT01682759|Metformin|metformin|mesh-list
25665312|NCT01682759|Insulin Glargine|insulin glargine|mesh-list
25665313|NCT01682759|Glimepiride|glimepiride|mesh-list
25665314|NCT01682759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25177973|NCT04747912|Dasatinib|dasatinib|mesh-list
25177974|NCT04747912|Ponatinib|ponatinib|mesh-list
25177975|NCT04747912|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25177976|NCT04747912|BB 1101|bb 1101|mesh-list
25177977|NCT04747912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25177978|NCT04747912|Antiemetics|antiemetics|mesh-ancestor
25177979|NCT04747912|Autonomic Agents|autonomic agents|mesh-ancestor
25177980|NCT04747912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25177981|NCT04747912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25177982|NCT04747912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25177983|NCT04747912|Glucocorticoids|glucocorticoids|mesh-ancestor
25177985|NCT04747912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25177986|NCT04747912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25177987|NCT04747912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25177988|NCT04747912|Protease Inhibitors|protease inhibitors|mesh-ancestor
25177989|NCT04747912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25177990|NCT04747912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25177991|NCT04747912|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25178001|NCT04747912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25178002|NCT04747912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25178003|NCT04747912|Tubulin Modulators|tubulin modulators|mesh-ancestor
25178004|NCT04747912|Antimitotic Agents|antimitotic agents|mesh-ancestor
25178005|NCT04747912|Mitosis Modulators|mitosis modulators|mesh-ancestor
25178006|NCT04747912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24757380|NCT01739556|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24757381|NCT01739556|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25178007|NCT04747912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25178008|NCT04747912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25178010|NCT04746547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25178011|NCT04746547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25178012|NCT04746547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25178013|NCT04746547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178014|NCT04746547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25178015|NCT04746547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25178016|NCT04746547|Antiviral Agents|antiviral agents|mesh-ancestor
25178017|NCT04746547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25178018|NCT04742634|Decitabine|decitabine|mesh-list
25178019|NCT04742634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25178020|NCT04742634|Antimetabolites|antimetabolites|mesh-ancestor
25204900|NCT05264077|Anesthetics, General|anesthetics, general|mesh-ancestor
25178021|NCT04742634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178022|NCT04742634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178023|NCT04742634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25178024|NCT04738695|Antibodies|antibodies|mesh-list
25178025|NCT04738695|Immunologic Factors|immunologic factors|mesh-ancestor
25178026|NCT04738695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178031|NCT04725656|Nicotine|nicotine|mesh-list
25178032|NCT04725656|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25178033|NCT04725656|Autonomic Agents|autonomic agents|mesh-ancestor
25178034|NCT04725656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25178035|NCT04725656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178036|NCT04725656|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25178037|NCT04725656|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25178038|NCT04725656|Cholinergic Agents|cholinergic agents|mesh-ancestor
25178039|NCT04725656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25178040|NCT04725656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178041|NCT04713969|Pantoprazole|pantoprazole|mesh-list
25178042|NCT04713969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25178043|NCT04713969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25178044|NCT04713969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25178045|NCT04713969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25178046|NCT04713969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178047|NCT04706130|Artesunate|artesunate|mesh-list
25178048|NCT04706130|Primaquine|primaquine|mesh-list
25178049|NCT04706130|Antimalarials|antimalarials|mesh-ancestor
25178050|NCT04706130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25178051|NCT04706130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25178052|NCT04706130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25178053|NCT04706130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178054|NCT04706130|Antiviral Agents|antiviral agents|mesh-ancestor
25178055|NCT04706130|Schistosomicides|schistosomicides|mesh-ancestor
25178056|NCT04706130|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25178057|NCT04706130|Anthelmintics|anthelmintics|mesh-ancestor
25178058|NCT04701580|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25178059|NCT04701580|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25426486|NCT01996293|Lamotrigine|lamotrigine|mesh-list
24933282|NCT04072068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933283|NCT04072068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933284|NCT04072068|Anticoagulants|anticoagulants|mesh-ancestor
24933285|NCT04072198|Leucovorin|leucovorin|mesh-list
24933286|NCT04072198|Bevacizumab|bevacizumab|mesh-list
25178060|NCT04701580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178086|NCT04669782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178087|NCT04669782|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25178088|NCT04669782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25178089|NCT04669782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178090|NCT04669782|Hemostatics|hemostatics|mesh-ancestor
24493719|NCT00492141|Camptothecin|camptothecin|mesh-list
25178091|NCT04669782|Coagulants|coagulants|mesh-ancestor
25178092|NCT04669782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25178093|NCT04669782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25178094|NCT04669041|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25178095|NCT04669041|Ezetimibe|ezetimibe|mesh-list
24493977|NCT00493233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493978|NCT00493233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092816|NCT03238703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25092841|NCT03238625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25092842|NCT03238625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25092843|NCT03238625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25092844|NCT03238625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092845|NCT03238430|Morphine|morphine|mesh-list
25092846|NCT03238430|Ropivacaine|ropivacaine|mesh-list
25092847|NCT03238430|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25092989|NCT03237533|Antiemetics|antiemetics|mesh-ancestor
25092990|NCT03237533|Autonomic Agents|autonomic agents|mesh-ancestor
25092991|NCT03237533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25092992|NCT03237533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092993|NCT03237533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24769441|NCT01814189|Anesthetics, Local|anesthetics, local|mesh-ancestor
25092994|NCT03237533|Glucocorticoids|glucocorticoids|mesh-ancestor
25093232|NCT03236987|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25093233|NCT03236493|PF-06700841|pf-06700841|mesh-list
25093234|NCT03236493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25093235|NCT03236493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25093264|NCT03236324|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25093265|NCT03236324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25093867|NCT03230786|Metformin|metformin|mesh-list
25093868|NCT03230786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25093869|NCT03230786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093870|NCT03230825|Contraceptive Agents|contraceptive agents|mesh-list
25093871|NCT03230825|Contraceptives, Oral|contraceptives, oral|mesh-list
25093872|NCT03230825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25093899|NCT03230630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25093900|NCT03230734|Docetaxel|docetaxel|mesh-list
25093901|NCT03230734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25093902|NCT03230734|Tubulin Modulators|tubulin modulators|mesh-ancestor
24793083|NCT04232683|Tamsulosin|tamsulosin|mesh-list
25094382|NCT03226821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094383|NCT03226626|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25094384|NCT03226626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25094516|NCT03226145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25094517|NCT03226145|Cholinergic Agents|cholinergic agents|mesh-ancestor
25094518|NCT03226145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25094519|NCT03226145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094552|NCT03225352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25094553|NCT03225352|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24757487|NCT01740336|Tubulin Modulators|tubulin modulators|mesh-ancestor
25096468|NCT03211728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096470|NCT03211728|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25096471|NCT03211728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25096472|NCT03211728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096473|NCT03211728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25096474|NCT03211728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25096619|NCT03210246|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
25665315|NCT01682759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665316|NCT01682759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25665317|NCT01682759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25665318|NCT01682759|Immunologic Factors|immunologic factors|mesh-ancestor
25665319|NCT01682811|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24933369|NCT04071574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933370|NCT04071574|Luteolytic Agents|luteolytic agents|mesh-ancestor
24933371|NCT04071574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24933372|NCT04071574|Contraceptive Agents|contraceptive agents|mesh-ancestor
24933376|NCT04071574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25096620|NCT03210246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25096621|NCT03210246|Contraceptive Agents|contraceptive agents|mesh-ancestor
25096622|NCT03210246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25096623|NCT03210246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096655|NCT03210480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25096656|NCT03210480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178096|NCT04669041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25178097|NCT04669041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25178098|NCT04669041|Antimetabolites|antimetabolites|mesh-ancestor
25178099|NCT04669041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178100|NCT04669041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25178530|NCT04276298|Metronidazole|metronidazole|mesh-list
25178101|NCT04669041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24945148|NCT03953235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178102|NCT04669041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25178103|NCT04666948|Vancomycin|vancomycin|mesh-list
25178104|NCT04666948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25178105|NCT04666948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25178106|NCT04666649|Venetoclax|venetoclax|mesh-list
25178107|NCT04666649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178122|NCT04648046|Cyclophosphamide|cyclophosphamide|mesh-list
25178123|NCT04648046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25178124|NCT04648046|Immunologic Factors|immunologic factors|mesh-ancestor
25178125|NCT04648046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178126|NCT04648046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25178127|NCT04648046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25178128|NCT04648046|Alkylating Agents|alkylating agents|mesh-ancestor
25178129|NCT04648046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178130|NCT04648046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178131|NCT04648046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25178132|NCT04646187|Adalimumab|adalimumab|mesh-list
25178133|NCT04646187|Infliximab|infliximab|mesh-list
25178134|NCT04646187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25178135|NCT04646187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25178136|NCT04646187|Dermatologic Agents|dermatologic agents|mesh-ancestor
25178137|NCT04646187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25178149|NCT04642807|Protease Inhibitors|protease inhibitors|mesh-ancestor
25178150|NCT04642807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25178151|NCT04642807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204901|NCT05264077|Anesthetics|anesthetics|mesh-ancestor
25204902|NCT05264077|GABA Modulators|gaba modulators|mesh-ancestor
25204903|NCT05264077|GABA Agents|gaba agents|mesh-ancestor
25204913|NCT05263947|Bevacizumab|bevacizumab|mesh-list
25204914|NCT05263947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25204915|NCT05263947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25204916|NCT05263947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25204917|NCT05263947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25204918|NCT05263947|Growth Substances|growth substances|mesh-ancestor
25204919|NCT05263947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204920|NCT05263947|Growth Inhibitors|growth inhibitors|mesh-ancestor
25204921|NCT05263882|Gemcitabine|gemcitabine|mesh-list
24757537|NCT01740921|Incretins|incretins|mesh-ancestor
25178153|NCT04636255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25178154|NCT04636255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178155|NCT04636086|Cholecalciferol|cholecalciferol|mesh-list
25178156|NCT04636086|Vitamin D|vitamin d|mesh-list
25178157|NCT04636086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25178158|NCT04636086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178159|NCT04636086|Vitamins|vitamins|mesh-ancestor
25178160|NCT04636086|Micronutrients|micronutrients|mesh-ancestor
25178161|NCT04636086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25178175|NCT04619316|Trametinib|trametinib|mesh-list
25178176|NCT04619316|Dabrafenib|dabrafenib|mesh-list
25178177|NCT04619316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178178|NCT04619316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25178179|NCT04619316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665320|NCT01682811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25665321|NCT01682811|Dermatologic Agents|dermatologic agents|mesh-ancestor
25665322|NCT01682837|Potassium Citrate|potassium citrate|mesh-list
25665323|NCT01682837|Magnesium citrate|magnesium citrate|mesh-list
25665324|NCT01682837|Citric Acid|citric acid|mesh-list
25665325|NCT01682837|Sodium Citrate|sodium citrate|mesh-list
24428650|NCT00240838|Acetaminophen|acetaminophen|mesh-list
24502003|NCT00531973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24502143|NCT05319301|Melatonin|melatonin|mesh-list
24502144|NCT05319301|Antioxidants|antioxidants|mesh-ancestor
24502145|NCT05319301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502146|NCT05319301|Protective Agents|protective agents|mesh-ancestor
24933488|NCT04070079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24933489|NCT04070001|Ibuprofen|ibuprofen|mesh-list
24933490|NCT04070001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24933491|NCT04070001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24933492|NCT04070001|Analgesics|analgesics|mesh-ancestor
24933493|NCT04070001|Sensory System Agents|sensory system agents|mesh-ancestor
24933496|NCT04070001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25178180|NCT04619316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178181|NCT04619095|Psyllium|psyllium|mesh-list
25178182|NCT04619095|Cathartics|cathartics|mesh-ancestor
25178183|NCT04619095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25178184|NCT04612920|Acetaminophen|acetaminophen|mesh-list
25178185|NCT04612920|Ibuprofen|ibuprofen|mesh-list
25178186|NCT04612920|Oxycodone|oxycodone|mesh-list
25178187|NCT04612920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25178188|NCT04612920|Analgesics|analgesics|mesh-ancestor
25178189|NCT04612920|Sensory System Agents|sensory system agents|mesh-ancestor
25178190|NCT04612920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25178191|NCT04612920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178192|NCT04612920|Antipyretics|antipyretics|mesh-ancestor
25178267|NCT04520451|Glucocorticoids|glucocorticoids|mesh-list
25178205|NCT04610658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178206|NCT04610658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25178207|NCT04610658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178208|NCT04597099|Flutamide|flutamide|mesh-list
25178209|NCT04597099|Estradiol|estradiol|mesh-list
25178210|NCT04597099|Progesterone|progesterone|mesh-list
25178211|NCT04597099|Estrogens|estrogens|mesh-ancestor
25178212|NCT04597099|Hormones|hormones|mesh-ancestor
25178213|NCT04597099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25178217|NCT04597099|Hormone Antagonists|hormone antagonists|mesh-ancestor
25178218|NCT04597099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25178219|NCT04597099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178220|NCT04577716|Listerine|listerine|mesh-list
25178221|NCT04577716|Fluorides|fluorides|mesh-list
25178222|NCT04577716|Sodium Fluoride|sodium fluoride|mesh-list
25178223|NCT04577716|Cariostatic Agents|cariostatic agents|mesh-ancestor
25178224|NCT04577716|Protective Agents|protective agents|mesh-ancestor
25178225|NCT04577716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178226|NCT04577716|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25178227|NCT04577716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25860215|NCT00083031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25178240|NCT04559100|Carbon Monoxide|carbon monoxide|mesh-list
25178241|NCT04559100|Antimetabolites|antimetabolites|mesh-ancestor
25178242|NCT04559100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178243|NCT04559100|Gasotransmitters|gasotransmitters|mesh-ancestor
25178244|NCT04559100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25178245|NCT04559100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178246|NCT04547439|Melatonin|melatonin|mesh-list
25178247|NCT04547439|Antioxidants|antioxidants|mesh-ancestor
25178248|NCT04547439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178249|NCT04547439|Protective Agents|protective agents|mesh-ancestor
25178250|NCT04547439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178251|NCT04547439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25178252|NCT04543942|Ethanol|ethanol|mesh-list
25178253|NCT04543942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25178254|NCT04543942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25178255|NCT04543942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25426487|NCT01996293|Anticonvulsants|anticonvulsants|mesh-ancestor
25665326|NCT01682837|Anticoagulants|anticoagulants|mesh-ancestor
25665327|NCT01682837|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25665328|NCT01682837|Chelating Agents|chelating agents|mesh-ancestor
25665329|NCT01682837|Sequestering Agents|sequestering agents|mesh-ancestor
25665330|NCT01682837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665331|NCT01682837|Diuretics|diuretics|mesh-ancestor
25665332|NCT01682837|Natriuretic Agents|natriuretic agents|mesh-ancestor
25665333|NCT01682837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665334|NCT01682837|Expectorants|expectorants|mesh-ancestor
25665335|NCT01682837|Respiratory System Agents|respiratory system agents|mesh-ancestor
25665336|NCT01682837|Cathartics|cathartics|mesh-ancestor
25665337|NCT01682837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25665338|NCT01682863|Glycopyrrolate|glycopyrrolate|mesh-list
25860217|NCT00083031|Dermatologic Agents|dermatologic agents|mesh-ancestor
25860218|NCT00083031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933619|NCT04068766|Bupivacaine|bupivacaine|mesh-list
24933620|NCT04068766|Anesthetics, Local|anesthetics, local|mesh-ancestor
24933621|NCT04068766|Anesthetics|anesthetics|mesh-ancestor
24933622|NCT04068766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24933623|NCT04068766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933624|NCT04068766|Sensory System Agents|sensory system agents|mesh-ancestor
25178256|NCT04543942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178258|NCT04535037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25178259|NCT04535037|Immunologic Factors|immunologic factors|mesh-ancestor
25178260|NCT04535037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178261|NCT04522544|Durvalumab|durvalumab|mesh-list
25178262|NCT04522544|Tremelimumab|tremelimumab|mesh-list
25178263|NCT04522544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25178264|NCT04522544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178265|NCT04520451|Prednisone|prednisone|mesh-list
25178266|NCT04520451|Prednisolone|prednisolone|mesh-list
25178278|NCT04515134|Ubiquinone|ubiquinone|mesh-list
25178279|NCT04515134|Coenzyme Q10|coenzyme q10|mesh-list
25178280|NCT04515134|Micronutrients|micronutrients|mesh-ancestor
25178281|NCT04515134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178282|NCT04515134|Vitamins|vitamins|mesh-ancestor
25204922|NCT05263882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25204923|NCT05263882|Antimetabolites|antimetabolites|mesh-ancestor
25204924|NCT05263882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204925|NCT05263882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25204926|NCT05263882|Antiviral Agents|antiviral agents|mesh-ancestor
25204927|NCT05263882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25204928|NCT05263882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25204929|NCT05263882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25204930|NCT05263882|Immunologic Factors|immunologic factors|mesh-ancestor
25204931|NCT05263882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204932|NCT05263778|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
25204933|NCT05263778|Ezetimibe|ezetimibe|mesh-list
25204934|NCT05263778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25204935|NCT05263778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25204936|NCT05263778|Antimetabolites|antimetabolites|mesh-ancestor
25204937|NCT05263778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204938|NCT05263778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25237820|NCT02548468|Tacrolimus|tacrolimus|mesh-list
25204939|NCT05263778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757693|NCT01741831|Darunavir|darunavir|mesh-list
24809546|NCT02034331|Acetylcholine|acetylcholine|mesh-list
24809547|NCT02034331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809548|NCT02034331|Vasodilator Agents|vasodilator agents|mesh-ancestor
24809549|NCT02034331|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24809550|NCT02034331|Cholinergic Agents|cholinergic agents|mesh-ancestor
24809551|NCT02034331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24809552|NCT02034331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494638|NCT00496223|Growth Substances|growth substances|mesh-ancestor
24494673|NCT00496301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24494674|NCT00496301|Immunologic Factors|immunologic factors|mesh-ancestor
24494675|NCT00496301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494676|NCT00496301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24494677|NCT00496392|Fentanyl|fentanyl|mesh-list
24494678|NCT00496392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24494679|NCT00496392|Narcotics|narcotics|mesh-ancestor
24494680|NCT00496392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24494681|NCT00496392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494682|NCT00496392|Analgesics|analgesics|mesh-ancestor
24494683|NCT00496392|Sensory System Agents|sensory system agents|mesh-ancestor
24494692|NCT00496405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24494693|NCT00496405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24494694|NCT00496405|Growth Substances|growth substances|mesh-ancestor
24494695|NCT00496405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494710|NCT00496444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25178283|NCT04496063|Ustekinumab|ustekinumab|mesh-list
25665339|NCT01682863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25665340|NCT01682863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25665341|NCT01682863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25665342|NCT01682863|Cholinergic Agents|cholinergic agents|mesh-ancestor
25665343|NCT01682863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25665344|NCT01682863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665345|NCT01682863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860227|NCT00083057|Mitosis Modulators|mitosis modulators|mesh-ancestor
24502159|NCT05318794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24502160|NCT05318794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502306|NCT05302388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24502307|NCT05302388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24502308|NCT05302388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25178284|NCT04496063|Dermatologic Agents|dermatologic agents|mesh-ancestor
25178343|NCT04449536|Protective Agents|protective agents|mesh-ancestor
25178344|NCT04449536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178345|NCT04435015|Camostat|camostat|mesh-list
25178346|NCT04435015|Protease Inhibitors|protease inhibitors|mesh-ancestor
25178347|NCT04435015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25178348|NCT04435015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178349|NCT04435015|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25178350|NCT04435015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25178351|NCT04427072|Docetaxel|docetaxel|mesh-list
25178352|NCT04427072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178353|NCT04427072|Tubulin Modulators|tubulin modulators|mesh-ancestor
25178354|NCT04427072|Antimitotic Agents|antimitotic agents|mesh-ancestor
25178355|NCT04427072|Mitosis Modulators|mitosis modulators|mesh-ancestor
25178356|NCT04427072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178357|NCT04414228|Anesthetics|anesthetics|mesh-list
25178358|NCT04414228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25178359|NCT04414228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178360|NCT04413201|Afatinib|afatinib|mesh-list
25178361|NCT04413201|Osimertinib|osimertinib|mesh-list
25178362|NCT04413201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178363|NCT04413201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25178364|NCT04413201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25178365|NCT04413201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178392|NCT04400539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178393|NCT04400539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25178394|NCT04400539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178395|NCT04395248|Anesthetics|anesthetics|mesh-list
25178396|NCT04395248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25178397|NCT04395248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178398|NCT04387617|Cannabidiol|cannabidiol|mesh-list
24945184|NCT03953287|Sensory System Agents|sensory system agents|mesh-ancestor
24945185|NCT03953287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858060|NCT02294955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757773|NCT01742390|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24757775|NCT01742429|Metronidazole|metronidazole|mesh-list
24757776|NCT01742429|Levofloxacin|levofloxacin|mesh-list
25178399|NCT04387617|Anticonvulsants|anticonvulsants|mesh-ancestor
25178400|NCT04384562|Methylphenidate|methylphenidate|mesh-list
25665346|NCT01683058|Aripiprazole|aripiprazole|mesh-list
25665347|NCT01683058|Antidepressive Agents|antidepressive agents|mesh-ancestor
25665348|NCT01683058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25665349|NCT01683058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25665350|NCT01683058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25665351|NCT01683058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25665352|NCT01683058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665353|NCT01683058|Dopamine Agonists|dopamine agonists|mesh-ancestor
25665354|NCT01683058|Dopamine Agents|dopamine agents|mesh-ancestor
25665355|NCT01683058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25665356|NCT01683058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665357|NCT01683058|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25665358|NCT01683058|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25665359|NCT01683058|Serotonin Agents|serotonin agents|mesh-ancestor
24502763|NCT04447716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24502764|NCT04447716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24502765|NCT04447716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24502766|NCT04447716|Growth Substances|growth substances|mesh-ancestor
24502767|NCT04447716|Growth Inhibitors|growth inhibitors|mesh-ancestor
24502768|NCT04447716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502769|NCT04447716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24502770|NCT04447716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24503583|NCT00532285|Antiviral Agents|antiviral agents|mesh-ancestor
25178401|NCT04384562|Reboxetine|reboxetine|mesh-list
25178402|NCT04384562|Nicotine|nicotine|mesh-list
25178403|NCT04384562|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24494782|NCT00497016|Atorvastatin|atorvastatin|mesh-list
25178404|NCT04384562|Autonomic Agents|autonomic agents|mesh-ancestor
25178405|NCT04384562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25178406|NCT04384562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178407|NCT04384562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25178408|NCT04384562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25178409|NCT04384562|Cholinergic Agents|cholinergic agents|mesh-ancestor
24494995|NCT00497900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25178410|NCT04384562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25178531|NCT04276298|Lidocaine|lidocaine|mesh-list
25178411|NCT04384562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178412|NCT04384562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25178413|NCT04384562|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25178414|NCT04384562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25178415|NCT04384562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25178416|NCT04384562|Dopamine Agents|dopamine agents|mesh-ancestor
25178417|NCT04384562|Antidepressive Agents|antidepressive agents|mesh-ancestor
25178418|NCT04384562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25178419|NCT04384562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25178420|NCT04384562|Adrenergic Agents|adrenergic agents|mesh-ancestor
24757778|NCT01742429|Tetracycline|tetracycline|mesh-list
24757779|NCT01742429|Bismuth|bismuth|mesh-list
24422487|NCT00222573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178429|NCT04338165|Evolocumab|evolocumab|mesh-list
25178430|NCT04338165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25178431|NCT04338165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25178432|NCT04338165|Antimetabolites|antimetabolites|mesh-ancestor
25178433|NCT04338165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178434|NCT04338165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25178435|NCT04329949|Paclitaxel|paclitaxel|mesh-list
25178436|NCT04329949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25204940|NCT05263778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25204941|NCT05263778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204942|NCT05263700|FAPI-46|fapi-46|mesh-list
25204943|NCT05263700|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24757787|NCT01742429|Renal Agents|renal agents|mesh-ancestor
25204944|NCT05263700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204945|NCT05260684|Trametinib|trametinib|mesh-list
25204946|NCT05260684|Vemurafenib|vemurafenib|mesh-list
25204947|NCT05260684|Dabrafenib|dabrafenib|mesh-list
25204948|NCT05260684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25204949|NCT05260684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25204950|NCT05260684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25204951|NCT05260684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204952|NCT05260619|Lenalidomide|lenalidomide|mesh-list
25204953|NCT05260619|Immunologic Factors|immunologic factors|mesh-ancestor
25204954|NCT05260619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204955|NCT05260619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25204956|NCT05260619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25204957|NCT05260619|Growth Substances|growth substances|mesh-ancestor
25204958|NCT05260619|Growth Inhibitors|growth inhibitors|mesh-ancestor
25204959|NCT05260619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25204960|NCT05260554|Fosfomycin|fosfomycin|mesh-list
25204961|NCT05260554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25204962|NCT05260554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25665360|NCT01683058|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25665361|NCT01683058|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25665362|NCT01683058|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25665363|NCT01683058|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25665364|NCT01683071|Bupivacaine|bupivacaine|mesh-list
25665365|NCT01683071|Anesthetics, Local|anesthetics, local|mesh-ancestor
25665366|NCT01683071|Anesthetics|anesthetics|mesh-ancestor
25665367|NCT01683071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25665368|NCT01683071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503595|NCT00532324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24503596|NCT00532324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503597|NCT00532324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503598|NCT00532350|Tiotropium Bromide|tiotropium bromide|mesh-list
25204963|NCT05260255|Vitamin D|vitamin d|mesh-list
25204964|NCT05260255|Ergocalciferols|ergocalciferols|mesh-list
25204965|NCT05260255|Vitamins|vitamins|mesh-ancestor
25204966|NCT05260255|Micronutrients|micronutrients|mesh-ancestor
25204967|NCT05260255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757821|NCT01742637|Analgesics|analgesics|mesh-ancestor
24757822|NCT01742637|Sensory System Agents|sensory system agents|mesh-ancestor
24757823|NCT01742637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24757824|NCT01742637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757825|NCT01742637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24757841|NCT01742676|Immunologic Factors|immunologic factors|mesh-ancestor
24757842|NCT01742676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757867|NCT01742702|Bisoprolol|bisoprolol|mesh-list
25860228|NCT00083057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178511|NCT04285580|Bimatoprost|bimatoprost|mesh-list
25178512|NCT04285580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25178513|NCT04280692|Lumefantrine|lumefantrine|mesh-list
25178514|NCT04280692|Artemether|artemether|mesh-list
25178515|NCT04280692|Pyrimethamine|pyrimethamine|mesh-list
25178516|NCT04280692|Piperaquine|piperaquine|mesh-list
25178517|NCT04280692|Primaquine|primaquine|mesh-list
25178518|NCT04280692|Sulfadoxine|sulfadoxine|mesh-list
25178519|NCT04280692|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25178520|NCT04280692|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25178521|NCT04280692|Antimalarials|antimalarials|mesh-ancestor
25178522|NCT04280692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25178523|NCT04280692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25178524|NCT04280692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25178525|NCT04280692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25178526|NCT04280692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25178527|NCT04280692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178528|NCT04280692|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25178529|NCT04280692|Renal Agents|renal agents|mesh-ancestor
25178532|NCT04276298|Diltiazem|diltiazem|mesh-list
25178533|NCT04276298|Anesthetics, Local|anesthetics, local|mesh-ancestor
25178534|NCT04276298|Anesthetics|anesthetics|mesh-ancestor
25178535|NCT04276298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25178536|NCT04276298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860229|NCT00083057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25860230|NCT00083057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860231|NCT00083070|Temozolomide|temozolomide|mesh-list
25860232|NCT00083070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25860233|NCT00083070|Alkylating Agents|alkylating agents|mesh-ancestor
25860234|NCT00083070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860235|NCT00083070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860236|NCT00083083|Paclitaxel|paclitaxel|mesh-list
25860237|NCT00083083|Etoposide|etoposide|mesh-list
25860238|NCT00083083|Vinorelbine|vinorelbine|mesh-list
25860239|NCT00083083|Vinblastine|vinblastine|mesh-list
25860240|NCT00083083|Docetaxel|docetaxel|mesh-list
25860241|NCT00083083|Cisplatin|cisplatin|mesh-list
25860242|NCT00083083|Carboplatin|carboplatin|mesh-list
25860243|NCT00083083|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25860244|NCT00083083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25860245|NCT00083083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860246|NCT00083083|Tubulin Modulators|tubulin modulators|mesh-ancestor
24495224|NCT00498992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24495225|NCT00498992|Sensory System Agents|sensory system agents|mesh-ancestor
24495226|NCT00498992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24495227|NCT00498992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24495228|NCT00498992|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24495229|NCT00498992|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25860247|NCT00083083|Antimitotic Agents|antimitotic agents|mesh-ancestor
25665369|NCT01683071|Sensory System Agents|sensory system agents|mesh-ancestor
25665370|NCT01683071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25665371|NCT01683266|Insulin|insulin|mesh-list
25665372|NCT01683266|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24757941|NCT01743066|Micronutrients|micronutrients|mesh-ancestor
24757942|NCT01743066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757943|NCT01743066|Antioxidants|antioxidants|mesh-ancestor
25426561|NCT01989780|Fertility Agents|fertility agents|mesh-ancestor
25665373|NCT01683266|Insulin Glargine|insulin glargine|mesh-list
25665374|NCT01683266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24933961|NCT04065919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24933962|NCT04065919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24757944|NCT01743066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757945|NCT01743066|Protective Agents|protective agents|mesh-ancestor
24757946|NCT01743079|Lamivudine|lamivudine|mesh-list
24757947|NCT01743079|Telbivudine|telbivudine|mesh-list
24757948|NCT01743079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24757950|NCT01743079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860248|NCT00083083|Mitosis Modulators|mitosis modulators|mesh-ancestor
25860249|NCT00083083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495279|NCT00499135|Alovudine|alovudine|mesh-list
24495280|NCT00499135|Sunitinib|sunitinib|mesh-list
24495281|NCT00499135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495282|NCT00499135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25096657|NCT03210493|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25096658|NCT03210493|Antiviral Agents|antiviral agents|mesh-ancestor
25096659|NCT03210493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24773409|NCT01839500|Trastuzumab|trastuzumab|mesh-list
25096694|NCT03210038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096695|NCT03209908|Tenofovir|tenofovir|mesh-list
25096727|NCT03209466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25096728|NCT03209466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25096729|NCT03209466|Disinfectants|disinfectants|mesh-ancestor
25096730|NCT03209466|Dermatologic Agents|dermatologic agents|mesh-ancestor
24773481|NCT01839864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25178537|NCT04276298|Sensory System Agents|sensory system agents|mesh-ancestor
25178538|NCT04276298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25178539|NCT04276298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25178540|NCT04276298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25178541|NCT04276298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25178542|NCT04276298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25178543|NCT04276298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178544|NCT04276298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25178545|NCT04276298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24757993|NCT01743235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24757995|NCT01743235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25178546|NCT04276298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25178547|NCT04276298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25178548|NCT04276298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25178549|NCT04276298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25178550|NCT04276298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25178551|NCT04276298|Vasodilator Agents|vasodilator agents|mesh-ancestor
25178552|NCT04273880|Ascorbic Acid|ascorbic acid|mesh-list
25178559|NCT04273880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25178560|NCT04273880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25178561|NCT04273880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178562|NCT04273880|Dopamine Agents|dopamine agents|mesh-ancestor
25178563|NCT04273880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25178564|NCT04273880|Antioxidants|antioxidants|mesh-ancestor
25178565|NCT04273880|Protective Agents|protective agents|mesh-ancestor
25178566|NCT04260464|PF-06700841|pf-06700841|mesh-list
25178567|NCT04260464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25178568|NCT04260464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25178569|NCT04260464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178570|NCT04260412|Psyllium|psyllium|mesh-list
25178571|NCT04260412|Cathartics|cathartics|mesh-ancestor
25178572|NCT04260412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25178573|NCT04257448|Gemcitabine|gemcitabine|mesh-list
25178574|NCT04257448|Paclitaxel|paclitaxel|mesh-list
25178575|NCT04257448|Lenalidomide|lenalidomide|mesh-list
25178576|NCT04257448|Azacitidine|azacitidine|mesh-list
25178597|NCT04257448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25178598|NCT04257448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25178599|NCT04247867|Psyllium|psyllium|mesh-list
25178600|NCT04247867|Cathartics|cathartics|mesh-ancestor
25178601|NCT04247867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25178602|NCT04238390|Meropenem|meropenem|mesh-list
25178603|NCT04238390|Tazobactam|tazobactam|mesh-list
25178604|NCT04238390|Ceftolozane|ceftolozane|mesh-list
25178605|NCT04238390|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
25178606|NCT04238390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25665375|NCT01683266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665376|NCT01683331|Insulin|insulin|mesh-list
25665377|NCT01683331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25178607|NCT04238390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24457648|NCT00334854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457649|NCT00334854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860250|NCT00083083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25860251|NCT00083083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25860252|NCT00083083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860253|NCT00083083|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24944763|NCT03957499|Hormones|hormones|mesh-ancestor
24510630|NCT00565214|Vitamins|vitamins|mesh-list
24934217|NCT04062656|Folic Acid|folic acid|mesh-list
25178608|NCT04238390|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25178609|NCT04238390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25178610|NCT04238390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178611|NCT04238390|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25178612|NCT04238390|Renal Agents|renal agents|mesh-ancestor
25178613|NCT04236830|Fluorides|fluorides|mesh-list
25178614|NCT04236830|Cariostatic Agents|cariostatic agents|mesh-ancestor
25178615|NCT04236830|Protective Agents|protective agents|mesh-ancestor
25178616|NCT04236830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178617|NCT04232969|Exenatide|exenatide|mesh-list
25178618|NCT04232969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25178619|NCT04232969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178620|NCT04232969|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25178621|NCT04232969|Incretins|incretins|mesh-ancestor
25178622|NCT04232969|Hormones|hormones|mesh-ancestor
25178623|NCT04232969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25178624|NCT04219722|Hyaluronic Acid|hyaluronic acid|mesh-list
25178625|NCT04219722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25178626|NCT04219722|Immunologic Factors|immunologic factors|mesh-ancestor
25178627|NCT04219722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178628|NCT04219722|Viscosupplements|viscosupplements|mesh-ancestor
25178629|NCT04219722|Protective Agents|protective agents|mesh-ancestor
25178652|NCT04210505|Povidone-Iodine|povidone-iodine|mesh-list
25178653|NCT04210505|Povidone|povidone|mesh-list
25204970|NCT05259995|Oxymetazoline|oxymetazoline|mesh-list
25204971|NCT05259995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25204972|NCT05259995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25204973|NCT05259995|Adrenergic Agents|adrenergic agents|mesh-ancestor
25204974|NCT05259995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25204975|NCT05259995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25204976|NCT05259995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204977|NCT05259995|Sympathomimetics|sympathomimetics|mesh-ancestor
25204978|NCT05259995|Autonomic Agents|autonomic agents|mesh-ancestor
25204979|NCT05259995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204980|NCT05259995|Nasal Decongestants|nasal decongestants|mesh-ancestor
25204981|NCT05259995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25204982|NCT05259995|Respiratory System Agents|respiratory system agents|mesh-ancestor
25207946|NCT00848731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25207947|NCT00848731|Respiratory System Agents|respiratory system agents|mesh-ancestor
25207948|NCT00848731|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25207950|NCT00848731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207951|NCT00848731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25207952|NCT00848731|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25207953|NCT00848731|Vasodilator Agents|vasodilator agents|mesh-ancestor
25207954|NCT00848731|Gasotransmitters|gasotransmitters|mesh-ancestor
25207955|NCT00848731|Protective Agents|protective agents|mesh-ancestor
25207956|NCT00838526|Rabeprazole|rabeprazole|mesh-list
25207957|NCT00838526|Ranitidine|ranitidine|mesh-list
25207958|NCT00838526|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
25207959|NCT00838526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24758129|NCT01744106|Pseudoephedrine|pseudoephedrine|mesh-list
25207960|NCT00838526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25207961|NCT00838526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25207962|NCT00838526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25207963|NCT00838526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207964|NCT00838526|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25207965|NCT00838526|Histamine Antagonists|histamine antagonists|mesh-ancestor
25665378|NCT01683331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665379|NCT01683422|Gemcitabine|gemcitabine|mesh-list
25665380|NCT01683422|Capecitabine|capecitabine|mesh-list
25665381|NCT01683422|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25665382|NCT01683422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25665383|NCT01683422|Antimetabolites|antimetabolites|mesh-ancestor
25665384|NCT01683422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665385|NCT01683422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207966|NCT00838526|Histamine Agents|histamine agents|mesh-ancestor
25207967|NCT00838526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24505526|NCT00541320|Protease Inhibitors|protease inhibitors|mesh-ancestor
24505527|NCT00541320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505528|NCT00541320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505529|NCT00541320|Anticoagulants|anticoagulants|mesh-ancestor
24505530|NCT00541333|Glatiramer Acetate|glatiramer acetate|mesh-list
24505537|NCT00541359|Topotecan|topotecan|mesh-list
25207968|NCT00838526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207969|NCT00627250|Amantadine|amantadine|mesh-list
25207970|NCT00627250|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25207971|NCT00627250|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25207972|NCT00627250|Antiviral Agents|antiviral agents|mesh-ancestor
25207973|NCT00627250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25207974|NCT00627250|Dopamine Agents|dopamine agents|mesh-ancestor
25207975|NCT00627250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25207976|NCT00627250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207977|NCT00627250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207978|NCT00627250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25178664|NCT04166877|Magnesium Sulfate|magnesium sulfate|mesh-list
25178665|NCT04166877|Analgesics|analgesics|mesh-ancestor
25178666|NCT04166877|Sensory System Agents|sensory system agents|mesh-ancestor
25178667|NCT04166877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25178668|NCT04166877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178669|NCT04166877|Anesthetics|anesthetics|mesh-ancestor
25178670|NCT04166877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25178678|NCT04166877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25178679|NCT04166292|Lidocaine|lidocaine|mesh-list
24758192|NCT01744288|Ticagrelor|ticagrelor|mesh-list
25178680|NCT04166292|Anesthetics, Local|anesthetics, local|mesh-ancestor
25178681|NCT04166292|Anesthetics|anesthetics|mesh-ancestor
25178682|NCT04166292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25178683|NCT04166292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178684|NCT04166292|Sensory System Agents|sensory system agents|mesh-ancestor
25178685|NCT04166292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25178686|NCT04166292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25178687|NCT04166292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25178688|NCT04166292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25178689|NCT04166292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25178690|NCT04166292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178699|NCT04156087|Gemcitabine|gemcitabine|mesh-list
25178700|NCT04156087|Durvalumab|durvalumab|mesh-list
25178701|NCT04156087|Tremelimumab|tremelimumab|mesh-list
25178702|NCT04156087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25178703|NCT04156087|Antimetabolites|antimetabolites|mesh-ancestor
25178704|NCT04156087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178705|NCT04156087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178706|NCT04156087|Antiviral Agents|antiviral agents|mesh-ancestor
24758253|NCT01744470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758254|NCT01744587|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
25178707|NCT04156087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25178708|NCT04156087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25178709|NCT04156087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25178710|NCT04156087|Immunologic Factors|immunologic factors|mesh-ancestor
25178711|NCT04156087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178712|NCT04156087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25178713|NCT04156074|Vitamin D|vitamin d|mesh-list
25178714|NCT04156074|Ergocalciferols|ergocalciferols|mesh-list
25178715|NCT04156074|Cholecalciferol|cholecalciferol|mesh-list
25178716|NCT04156074|Vitamins|vitamins|mesh-list
25178717|NCT04156074|Micronutrients|micronutrients|mesh-ancestor
25178718|NCT04156074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178719|NCT04156074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25178720|NCT04156074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25178721|NCT04151277|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25178722|NCT04151277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178725|NCT04127981|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25178726|NCT04127981|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25178727|NCT04127981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178728|NCT04117763|Empagliflozin|empagliflozin|mesh-list
25178729|NCT04117763|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25665386|NCT01683422|Antiviral Agents|antiviral agents|mesh-ancestor
25665387|NCT01683422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25665388|NCT01683422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665389|NCT01683422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25665390|NCT01683422|Immunologic Factors|immunologic factors|mesh-ancestor
25665391|NCT01683422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505826|NCT00542711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25178730|NCT04117763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178731|NCT04117763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25178732|NCT04117763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178733|NCT04117451|Propolis|propolis|mesh-list
25178734|NCT04117451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25178735|NCT04109924|Trifluridine|trifluridine|mesh-list
25178736|NCT04109924|Bevacizumab|bevacizumab|mesh-list
25178737|NCT04109924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24495862|NCT00502229|Fertility Agents|fertility agents|mesh-ancestor
24809704|NCT02035943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809706|NCT02035956|Immunologic Factors|immunologic factors|mesh-ancestor
24809707|NCT02035956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600416|NCT00082706|Leucovorin|leucovorin|mesh-list
24495863|NCT00502229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24495864|NCT00502229|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24495865|NCT00502229|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24495866|NCT00502268|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
24495867|NCT00502268|Ergocalciferols|ergocalciferols|mesh-list
24495868|NCT00502268|Vitamins|vitamins|mesh-ancestor
24443154|NCT00293800|Timolol|timolol|mesh-list
24495869|NCT00502268|Micronutrients|micronutrients|mesh-ancestor
24495870|NCT00502268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495871|NCT00502268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24495872|NCT00502268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24495873|NCT00502294|Visilizumab|visilizumab|mesh-list
24495874|NCT00502294|Immunologic Factors|immunologic factors|mesh-ancestor
24495893|NCT00502437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495894|NCT00502437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24773549|NCT01840254|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25178738|NCT04109924|Irinotecan|irinotecan|mesh-list
25178739|NCT04109924|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
25178740|NCT04109924|Antibodies|antibodies|mesh-list
25178741|NCT04109924|Immunoglobulins|immunoglobulins|mesh-list
25178742|NCT04109924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25178743|NCT04109924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178744|NCT04109924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25178745|NCT04109924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25178746|NCT04109924|Growth Substances|growth substances|mesh-ancestor
25178747|NCT04109924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178748|NCT04109924|Growth Inhibitors|growth inhibitors|mesh-ancestor
25178749|NCT04109924|Immunologic Factors|immunologic factors|mesh-ancestor
25178750|NCT04109924|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25178751|NCT04109924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25178752|NCT04109924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25178753|NCT04109924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178754|NCT04109924|Antimetabolites|antimetabolites|mesh-ancestor
25178755|NCT04109924|Antiviral Agents|antiviral agents|mesh-ancestor
25178756|NCT04109924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25178757|NCT04109924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25178758|NCT04096391|Analgesics|analgesics|mesh-list
25178759|NCT04096391|Sensory System Agents|sensory system agents|mesh-ancestor
25178760|NCT04096391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25178761|NCT04096391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619944|NCT01054651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25178774|NCT04084106|Amoxicillin|amoxicillin|mesh-list
25178775|NCT04084106|Clavulanic Acids|clavulanic acids|mesh-list
25178776|NCT04084106|Clavulanic Acid|clavulanic acid|mesh-list
25178777|NCT04084106|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25178778|NCT04084106|Penicillin V|penicillin v|mesh-list
25178779|NCT04084106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25178780|NCT04084106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25178781|NCT04084106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25178782|NCT04084106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178784|NCT04083157|Imiquimod|imiquimod|mesh-list
24758423|NCT01745666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25860254|NCT00083096|Temozolomide|temozolomide|mesh-list
25178800|NCT04072952|Palbociclib|palbociclib|mesh-list
25178801|NCT04072952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178802|NCT04072952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25178803|NCT04072952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25178804|NCT04072952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178805|NCT04072341|Propolis|propolis|mesh-list
25178806|NCT04072341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25178807|NCT04071821|Cetirizine|cetirizine|mesh-list
25178808|NCT04071821|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25860255|NCT00083096|Lonafarnib|lonafarnib|mesh-list
25178809|NCT04071821|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25178810|NCT04071821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25178811|NCT04071821|Histamine Antagonists|histamine antagonists|mesh-ancestor
25178812|NCT04071821|Histamine Agents|histamine agents|mesh-ancestor
25178813|NCT04071821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24449123|NCT00314509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051330|NCT00417118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25178814|NCT04071821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178815|NCT04071821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178816|NCT04064840|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25178817|NCT04064840|Luteolytic Agents|luteolytic agents|mesh-ancestor
25178818|NCT04064840|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25178819|NCT04064840|Contraceptive Agents|contraceptive agents|mesh-ancestor
25178820|NCT04064840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25178821|NCT04064840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178822|NCT04064840|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25178823|NCT04064840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25178824|NCT04064840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178825|NCT04063579|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25178826|NCT04063579|Natriuretic Agents|natriuretic agents|mesh-ancestor
25178827|NCT04063579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178847|NCT04047641|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
25178848|NCT04047641|Idarubicin|idarubicin|mesh-list
25178849|NCT04047641|Cladribine|cladribine|mesh-list
25178850|NCT04047641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25178851|NCT04047641|Antimetabolites|antimetabolites|mesh-ancestor
25178872|NCT04042753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25178873|NCT04042753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178874|NCT04042753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25178875|NCT04042753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178877|NCT04027348|Dexamethasone|dexamethasone|mesh-list
25178878|NCT04027348|Octreotide|octreotide|mesh-list
25178879|NCT04027348|Metoclopramide|metoclopramide|mesh-list
25178880|NCT04027348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25178881|NCT04027348|Antiemetics|antiemetics|mesh-ancestor
25178882|NCT04027348|Autonomic Agents|autonomic agents|mesh-ancestor
25178883|NCT04027348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25178884|NCT04027348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178885|NCT04027348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25178886|NCT04027348|Glucocorticoids|glucocorticoids|mesh-ancestor
25178887|NCT04027348|Hormones|hormones|mesh-ancestor
25178888|NCT04027348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25178889|NCT04027348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25178890|NCT04027348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178891|NCT04027348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25178892|NCT04027348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25178893|NCT04027348|Dopamine Agents|dopamine agents|mesh-ancestor
25178894|NCT04027348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25178895|NCT04027348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178896|NCT03998176|Tenofovir|tenofovir|mesh-list
25178897|NCT03998176|Emtricitabine|emtricitabine|mesh-list
25178898|NCT03998176|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25178899|NCT03998176|Antiviral Agents|antiviral agents|mesh-ancestor
25178900|NCT03998176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25178901|NCT03998176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25178902|NCT03998176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25178903|NCT03998176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25178974|NCT03923725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25178905|NCT03998176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25178906|NCT03998176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25204991|NCT05244031|Analgesics, Opioid|analgesics, opioid|mesh-list
25204992|NCT05244031|Narcotics|narcotics|mesh-ancestor
25204993|NCT05244031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25204994|NCT05244031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25204995|NCT05244031|Analgesics|analgesics|mesh-ancestor
25204996|NCT05244031|Sensory System Agents|sensory system agents|mesh-ancestor
25204997|NCT05244031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25204998|NCT05241340|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25204999|NCT05241340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205000|NCT05241340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496073|NCT00503386|Serotonin Agents|serotonin agents|mesh-ancestor
24758557|NCT01746771|Trastuzumab|trastuzumab|mesh-list
24758558|NCT01746771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25178907|NCT03982212|Glatiramer Acetate|glatiramer acetate|mesh-list
25178908|NCT03982212|(T,G)-A-L|(t,g)-a-l|mesh-list
25178909|NCT03982212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25178910|NCT03982212|Immunologic Factors|immunologic factors|mesh-ancestor
25178911|NCT03982212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178912|NCT03982212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25178913|NCT03982212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25178919|NCT03956680|Nivolumab|nivolumab|mesh-list
25178920|NCT03956680|Ipilimumab|ipilimumab|mesh-list
25178921|NCT03956680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25178922|NCT03956680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178923|NCT03956680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25178924|NCT03956680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178925|NCT03954366|Rucaparib|rucaparib|mesh-list
25178926|NCT03954366|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25178927|NCT03954366|Contraceptive Agents|contraceptive agents|mesh-list
25178928|NCT03954366|Contraceptives, Oral|contraceptives, oral|mesh-list
25178929|NCT03954366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25178930|NCT03954366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25178931|NCT03954366|Antimetabolites|antimetabolites|mesh-ancestor
25178932|NCT03954366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178933|NCT03954366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25178934|NCT03954366|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25178935|NCT03954366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25178936|NCT03954366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25178937|NCT03954366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178938|NCT03954366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25178939|NCT03954366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25178940|NCT03954366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178944|NCT03943667|Gemcitabine|gemcitabine|mesh-list
25178945|NCT03943667|Paclitaxel|paclitaxel|mesh-list
25178946|NCT03943667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25178947|NCT03943667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178948|NCT03943667|Tubulin Modulators|tubulin modulators|mesh-ancestor
25178949|NCT03943667|Antimitotic Agents|antimitotic agents|mesh-ancestor
25178950|NCT03943667|Mitosis Modulators|mitosis modulators|mesh-ancestor
25178951|NCT03943667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25178952|NCT03943667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25178953|NCT03943667|Antimetabolites|antimetabolites|mesh-ancestor
25178954|NCT03943667|Antiviral Agents|antiviral agents|mesh-ancestor
25178955|NCT03943667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25178956|NCT03943667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25178957|NCT03943667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25178958|NCT03943667|Immunologic Factors|immunologic factors|mesh-ancestor
25178959|NCT03943667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178960|NCT03933202|Cladribine|cladribine|mesh-list
25178961|NCT03933202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25178962|NCT03933202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25178963|NCT03933202|Immunologic Factors|immunologic factors|mesh-ancestor
25178964|NCT03933202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178965|NCT03923725|Artesunate|artesunate|mesh-list
25178966|NCT03923725|Lumefantrine|lumefantrine|mesh-list
25178967|NCT03923725|Artemether|artemether|mesh-list
25178968|NCT03923725|Piperaquine|piperaquine|mesh-list
25178969|NCT03923725|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25178970|NCT03923725|Amodiaquine|amodiaquine|mesh-list
25178971|NCT03923725|Mefloquine|mefloquine|mesh-list
25178972|NCT03923725|Antimalarials|antimalarials|mesh-ancestor
25178973|NCT03923725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25178988|NCT03876288|Immunoglobulins|immunoglobulins|mesh-list
25178989|NCT03876288|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25178990|NCT03876288|gamma-Globulins|gamma-globulins|mesh-list
25178991|NCT03876288|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25178992|NCT03876288|Immunologic Factors|immunologic factors|mesh-ancestor
25178993|NCT03876288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178994|NCT03865290|Ondansetron|ondansetron|mesh-list
25178995|NCT03865290|Antiemetics|antiemetics|mesh-ancestor
25178996|NCT03865290|Autonomic Agents|autonomic agents|mesh-ancestor
25178997|NCT03865290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25178998|NCT03865290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25178999|NCT03865290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25179000|NCT03865290|Antipruritics|antipruritics|mesh-ancestor
25179001|NCT03865290|Dermatologic Agents|dermatologic agents|mesh-ancestor
25179002|NCT03865290|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25179003|NCT03865290|Serotonin Agents|serotonin agents|mesh-ancestor
25179004|NCT03865290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25179005|NCT03865290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179006|NCT03865290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25179007|NCT03865290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25179008|NCT03865290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25179009|NCT03865290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25179010|NCT03865290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25179011|NCT03848845|Pembrolizumab|pembrolizumab|mesh-list
25179012|NCT03848845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25179013|NCT03848845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179014|NCT03844815|Decitabine|decitabine|mesh-list
25179015|NCT03844815|Venetoclax|venetoclax|mesh-list
25179016|NCT03844815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25179017|NCT03844815|Antimetabolites|antimetabolites|mesh-ancestor
25179018|NCT03844815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179019|NCT03844815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179020|NCT03844815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25179021|NCT03839914|Vancomycin|vancomycin|mesh-list
25179022|NCT03839914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25179023|NCT03839914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25179024|NCT03832972|Estrogens|estrogens|mesh-list
25179025|NCT03832972|Hormones|hormones|mesh-ancestor
25179026|NCT03832972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25179027|NCT03832972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179028|NCT03829488|Plasma-lyte 148|plasma-lyte 148|mesh-list
25179029|NCT03829488|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25179030|NCT03829488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25179037|NCT03798691|Vaccines|vaccines|mesh-list
25179038|NCT03798691|Immunologic Factors|immunologic factors|mesh-ancestor
25179039|NCT03798691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179046|NCT03775525|Capecitabine|capecitabine|mesh-list
25179047|NCT03775525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25179048|NCT03775525|Antimetabolites|antimetabolites|mesh-ancestor
25179055|NCT03767933|Acetaminophen|acetaminophen|mesh-list
24809961|NCT02036983|Anesthetics, Local|anesthetics, local|mesh-list
25179056|NCT03767933|Ibuprofen|ibuprofen|mesh-list
24810058|NCT02037633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24810059|NCT02037633|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24496623|NCT00505791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496624|NCT00505804|Dexmedetomidine|dexmedetomidine|mesh-list
24496625|NCT00505804|Haloperidol|haloperidol|mesh-list
24496626|NCT00505804|Haloperidol decanoate|haloperidol decanoate|mesh-list
24496627|NCT00505804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24496628|NCT00505804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24496629|NCT00505804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496630|NCT00505804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24496631|NCT00505804|Analgesics|analgesics|mesh-ancestor
24496632|NCT00505804|Sensory System Agents|sensory system agents|mesh-ancestor
24496633|NCT00505804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25179057|NCT03767933|Hydromorphone|hydromorphone|mesh-list
25179058|NCT03767933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25179059|NCT03767933|Analgesics|analgesics|mesh-ancestor
25179060|NCT03767933|Sensory System Agents|sensory system agents|mesh-ancestor
25179061|NCT03767933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25179062|NCT03767933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179063|NCT03767933|Antipyretics|antipyretics|mesh-ancestor
25179064|NCT03767933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25179065|NCT03767933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25179066|NCT03767933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25179067|NCT03767933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25179068|NCT03767933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25179339|NCT03516812|Testosterone enanthate|testosterone enanthate|mesh-list
25179069|NCT03767933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179070|NCT03767933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25179071|NCT03767933|Narcotics|narcotics|mesh-ancestor
25179072|NCT03767933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25205009|NCT05233696|Paclitaxel|paclitaxel|mesh-list
25205010|NCT05233696|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25205011|NCT05233696|Pembrolizumab|pembrolizumab|mesh-list
25205012|NCT05233696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25205013|NCT05233696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25205014|NCT05233696|Tubulin Modulators|tubulin modulators|mesh-ancestor
25205015|NCT05233696|Antimitotic Agents|antimitotic agents|mesh-ancestor
25205016|NCT05233696|Mitosis Modulators|mitosis modulators|mesh-ancestor
25205017|NCT05233696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945209|NCT03952715|Analgesics|analgesics|mesh-ancestor
24506708|NCT00546546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506745|NCT00546832|Celecoxib|celecoxib|mesh-list
25205018|NCT05233696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25205019|NCT05227313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25205021|NCT05225545|Trace Elements|trace elements|mesh-ancestor
25205022|NCT05225545|Micronutrients|micronutrients|mesh-ancestor
25205023|NCT05225545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496654|NCT00505817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496657|NCT00505817|Hormone Antagonists|hormone antagonists|mesh-ancestor
25205024|NCT05222971|Durvalumab|durvalumab|mesh-list
25205025|NCT05222971|Olaparib|olaparib|mesh-list
25205026|NCT05222971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25205027|NCT05222971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25205028|NCT05222971|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25205029|NCT05222971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205030|NCT05222971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205031|NCT05219487|Risdiplam|risdiplam|mesh-list
25205032|NCT05219487|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25205033|NCT05219487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25205034|NCT05219487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179090|NCT03741517|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25179091|NCT03741517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179092|NCT03739853|Sulfasalazine|sulfasalazine|mesh-list
25179093|NCT03739853|Adalimumab|adalimumab|mesh-list
25179094|NCT03739853|Methotrexate|methotrexate|mesh-list
25179095|NCT03739853|Leflunomide|leflunomide|mesh-list
25179096|NCT03739853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25179097|NCT03739853|Abortifacient Agents|abortifacient agents|mesh-ancestor
25179098|NCT03739853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25179099|NCT03739853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179100|NCT03739853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25179101|NCT03739853|Antimetabolites|antimetabolites|mesh-ancestor
25179102|NCT03739853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179103|NCT03739853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179104|NCT03739853|Dermatologic Agents|dermatologic agents|mesh-ancestor
25179105|NCT03739853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25179106|NCT03739853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25179107|NCT03739853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25179108|NCT03739853|Immunologic Factors|immunologic factors|mesh-ancestor
25179109|NCT03739853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25179110|NCT03739853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25179111|NCT03739853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25179112|NCT03739853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25179113|NCT03739853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25179114|NCT03739853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25179115|NCT03739853|Analgesics|analgesics|mesh-ancestor
25179116|NCT03739853|Sensory System Agents|sensory system agents|mesh-ancestor
25179117|NCT03739853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25179118|NCT03739853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25179119|NCT03734770|Progesterone|progesterone|mesh-list
25179120|NCT03734770|Progestins|progestins|mesh-ancestor
25179121|NCT03734770|Hormones|hormones|mesh-ancestor
25179122|NCT03734770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25179123|NCT03734770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179124|NCT03730194|Melatonin|melatonin|mesh-list
25179125|NCT03730194|Antioxidants|antioxidants|mesh-ancestor
25179126|NCT03730194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179127|NCT03730194|Protective Agents|protective agents|mesh-ancestor
25179128|NCT03730194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179129|NCT03730194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25179130|NCT03718130|Vaccines|vaccines|mesh-list
25179131|NCT03718130|Immunologic Factors|immunologic factors|mesh-ancestor
25179587|NCT03326310|Azacitidine|azacitidine|mesh-list
25179132|NCT03718130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179133|NCT03672500|Epinephrine|epinephrine|mesh-list
25179134|NCT03672500|Bupivacaine|bupivacaine|mesh-list
25179135|NCT03672500|Anesthetics, Local|anesthetics, local|mesh-ancestor
25179136|NCT03672500|Anesthetics|anesthetics|mesh-ancestor
25179137|NCT03672500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25179138|NCT03672500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179139|NCT03672500|Sensory System Agents|sensory system agents|mesh-ancestor
25179140|NCT03672500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25179147|NCT03672500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25665392|NCT01683422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25665393|NCT01683838|4-Aminopyridine|4-aminopyridine|mesh-list
24774804|NCT01848119|Anticonvulsants|anticonvulsants|mesh-ancestor
24457687|NCT00334880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457690|NCT00334906|Memantine|memantine|mesh-list
25209707|NCT02701595|Amoxicillin|amoxicillin|mesh-list
25209708|NCT02701595|Vancomycin|vancomycin|mesh-list
25209709|NCT02701595|Gentamicins|gentamicins|mesh-list
25209710|NCT02701595|Ceftriaxone|ceftriaxone|mesh-list
25209711|NCT02701595|Penicillins|penicillins|mesh-list
25209712|NCT02701595|Penicillin G|penicillin g|mesh-list
25209713|NCT02701595|Penicillin G Benzathine|penicillin g benzathine|mesh-list
25209715|NCT02701595|Netilmicin|netilmicin|mesh-list
25179148|NCT03672500|Autonomic Agents|autonomic agents|mesh-ancestor
25179149|NCT03672500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25179150|NCT03672500|Respiratory System Agents|respiratory system agents|mesh-ancestor
25179152|NCT03672500|Sympathomimetics|sympathomimetics|mesh-ancestor
25179153|NCT03672500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25179154|NCT03667820|Osimertinib|osimertinib|mesh-list
25179155|NCT03667820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179156|NCT03667820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25179157|NCT03667820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25179158|NCT03667820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179159|NCT03667651|Decanoic acid|decanoic acid|mesh-list
25179160|NCT03667651|Antifungal Agents|antifungal agents|mesh-ancestor
25179161|NCT03667651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25179162|NCT03654989|Treprostinil|treprostinil|mesh-list
25179163|NCT03654989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25179164|NCT03606694|Metformin|metformin|mesh-list
25179165|NCT03606694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25179166|NCT03606694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179167|NCT03597776|Lidocaine|lidocaine|mesh-list
25179168|NCT03597776|Anesthetics, Local|anesthetics, local|mesh-ancestor
25179169|NCT03597776|Anesthetics|anesthetics|mesh-ancestor
25179170|NCT03597776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25179171|NCT03597776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758861|NCT01748318|Renal Agents|renal agents|mesh-ancestor
25179172|NCT03597776|Sensory System Agents|sensory system agents|mesh-ancestor
25179173|NCT03597776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25179174|NCT03597776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25179175|NCT03597776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25179176|NCT03597776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25179177|NCT03597776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25179178|NCT03597776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179179|NCT03560882|Atorvastatin|atorvastatin|mesh-list
25179180|NCT03560882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25179181|NCT03560882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25179182|NCT03560882|Antimetabolites|antimetabolites|mesh-ancestor
25179183|NCT03560882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179184|NCT03560882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25179185|NCT03560882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25179186|NCT03560882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25179189|NCT03556202|Mirikizumab|mirikizumab|mesh-list
25179190|NCT03556202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25179191|NCT03556202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25179192|NCT03556202|Analgesics|analgesics|mesh-ancestor
25179193|NCT03556202|Sensory System Agents|sensory system agents|mesh-ancestor
25179194|NCT03556202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25179195|NCT03556202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179196|NCT03556202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25179197|NCT03556202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25179198|NCT03556202|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25179199|NCT03556202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25179206|NCT03553004|Niraparib|niraparib|mesh-list
25179207|NCT03553004|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25179208|NCT03553004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25179209|NCT03553004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179210|NCT03553004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665394|NCT01683838|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25665395|NCT01683838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25665396|NCT01683838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665397|NCT01683994|Prednisone|prednisone|mesh-list
25665398|NCT01683994|Docetaxel|docetaxel|mesh-list
25665399|NCT01683994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665400|NCT01683994|Tubulin Modulators|tubulin modulators|mesh-ancestor
25665401|NCT01683994|Antimitotic Agents|antimitotic agents|mesh-ancestor
25665402|NCT01683994|Mitosis Modulators|mitosis modulators|mesh-ancestor
25179211|NCT03542266|Azacitidine|azacitidine|mesh-list
24507294|NCT00549666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507295|NCT00549666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25179212|NCT03542266|Cc-486|cc-486|mesh-list
25179213|NCT03542266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25179230|NCT03534284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25179231|NCT03534284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25179232|NCT03534284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179233|NCT03534284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25179234|NCT03534284|Serotonin Agents|serotonin agents|mesh-ancestor
25179235|NCT03534284|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25179236|NCT03534284|Antidepressive Agents|antidepressive agents|mesh-ancestor
25179237|NCT03531073|Methotrexate|methotrexate|mesh-list
25179238|NCT03531073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25179239|NCT03531073|Abortifacient Agents|abortifacient agents|mesh-ancestor
25179240|NCT03531073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25179241|NCT03531073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179242|NCT03531073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25179243|NCT03531073|Antimetabolites|antimetabolites|mesh-ancestor
25179244|NCT03531073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179245|NCT03531073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179246|NCT03531073|Dermatologic Agents|dermatologic agents|mesh-ancestor
25179247|NCT03531073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25179248|NCT03531073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25179249|NCT03531073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25179250|NCT03531073|Immunologic Factors|immunologic factors|mesh-ancestor
25179251|NCT03531073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25179252|NCT03531073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25179279|NCT03525795|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
25179280|NCT03525795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25179281|NCT03525795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179282|NCT03525795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25179283|NCT03525795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179284|NCT03525795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25179291|NCT03523975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179292|NCT03523975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25179293|NCT03523975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25179294|NCT03523975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25179295|NCT03523975|Growth Substances|growth substances|mesh-ancestor
25179296|NCT03523975|Growth Inhibitors|growth inhibitors|mesh-ancestor
25179297|NCT03523000|Fentanyl|fentanyl|mesh-list
25179298|NCT03523000|Bupivacaine|bupivacaine|mesh-list
25179299|NCT03523000|Anesthetics, Local|anesthetics, local|mesh-ancestor
25179300|NCT03523000|Anesthetics|anesthetics|mesh-ancestor
25179301|NCT03523000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25179302|NCT03523000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179303|NCT03523000|Sensory System Agents|sensory system agents|mesh-ancestor
25179304|NCT03523000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25179305|NCT03523000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25179306|NCT03523000|Narcotics|narcotics|mesh-ancestor
25179307|NCT03523000|Analgesics|analgesics|mesh-ancestor
25179308|NCT03523000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25179309|NCT03523000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25179310|NCT03523000|Anesthetics, General|anesthetics, general|mesh-ancestor
25179311|NCT03522831|Albuterol|albuterol|mesh-list
25179312|NCT03522831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25179313|NCT03522831|Autonomic Agents|autonomic agents|mesh-ancestor
25179314|NCT03522831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25179315|NCT03522831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179316|NCT03522831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25179317|NCT03522831|Respiratory System Agents|respiratory system agents|mesh-ancestor
25179318|NCT03522831|Tocolytic Agents|tocolytic agents|mesh-ancestor
25179319|NCT03522831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25179320|NCT03522831|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25179321|NCT03522831|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25179322|NCT03522831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25179323|NCT03522831|Adrenergic Agents|adrenergic agents|mesh-ancestor
25179324|NCT03522831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25179325|NCT03522831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179326|NCT03522259|Rivaroxaban|rivaroxaban|mesh-list
25665403|NCT01683994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665404|NCT01683994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24934575|NCT04060719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620034|NCT01055301|Bortezomib|bortezomib|mesh-list
24510999|NCT00566904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25209789|NCT02701309|Iron|iron|mesh-list
25179327|NCT03522259|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25179328|NCT03522259|Antithrombins|antithrombins|mesh-ancestor
24945352|NCT03951402|Narcotics|narcotics|mesh-ancestor
25179329|NCT03522259|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25179330|NCT03522259|Protease Inhibitors|protease inhibitors|mesh-ancestor
25179331|NCT03522259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25179332|NCT03522259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179333|NCT03522259|Anticoagulants|anticoagulants|mesh-ancestor
25179334|NCT03516812|Methyltestosterone|methyltestosterone|mesh-list
25179335|NCT03516812|Olaparib|olaparib|mesh-list
25179336|NCT03516812|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25179337|NCT03516812|Testosterone|testosterone|mesh-list
25179338|NCT03516812|Testosterone undecanoate|testosterone undecanoate|mesh-list
25179340|NCT03516812|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25179341|NCT03516812|Androgens|androgens|mesh-ancestor
25179342|NCT03516812|Hormones|hormones|mesh-ancestor
25179343|NCT03516812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25179344|NCT03516812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179345|NCT03516812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25179346|NCT03516812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179347|NCT03516812|Anabolic Agents|anabolic agents|mesh-ancestor
25179348|NCT03516812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25179349|NCT03516812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179371|NCT03504501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25179372|NCT03504501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25179373|NCT03504501|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25179374|NCT03504501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25179375|NCT03504501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25179377|NCT03504501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25179378|NCT03504501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25179379|NCT03504501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25179380|NCT03494322|Cetuximab|cetuximab|mesh-list
25179381|NCT03494322|Avelumab|avelumab|mesh-list
25179382|NCT03494322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25179383|NCT03494322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25205072|NCT05207358|Mycophenolic Acid|mycophenolic acid|mesh-list
25205073|NCT05207358|Cyclophosphamide|cyclophosphamide|mesh-list
25205074|NCT05207358|Rituximab|rituximab|mesh-list
25205075|NCT05207358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25205076|NCT05207358|Immunologic Factors|immunologic factors|mesh-ancestor
25205077|NCT05207358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205078|NCT05207358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25205079|NCT05207358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25205080|NCT05207358|Alkylating Agents|alkylating agents|mesh-ancestor
25205081|NCT05207358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205082|NCT05207358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25205083|NCT05207358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25205084|NCT05207358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25205085|NCT05207358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25205086|NCT05207358|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25205087|NCT05207358|Antitubercular Agents|antitubercular agents|mesh-ancestor
25205088|NCT05207358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25205089|NCT05207358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25205090|NCT05207358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25179389|NCT03485274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25179390|NCT03485274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25179391|NCT03485274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25179392|NCT03485274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25179393|NCT03485274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179394|NCT03485274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25179395|NCT03485274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25179396|NCT03485274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25179397|NCT03485274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179398|NCT03485274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25179399|NCT03485274|Serotonin Agents|serotonin agents|mesh-ancestor
25860256|NCT00083096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25426868|NCT01950520|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25665405|NCT01683994|Glucocorticoids|glucocorticoids|mesh-ancestor
25665406|NCT01683994|Hormones|hormones|mesh-ancestor
25665407|NCT01683994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25179400|NCT03485274|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25179401|NCT03485274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25179402|NCT03485274|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25179403|NCT03485274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25179404|NCT03477396|Estrogens|estrogens|mesh-list
25179405|NCT03477396|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25179406|NCT03477396|Hormones|hormones|mesh-ancestor
25179407|NCT03477396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25179408|NCT03477396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179409|NCT03477396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25179410|NCT03477396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25179411|NCT03477396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179412|NCT03477396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25179413|NCT03477396|Hormone Antagonists|hormone antagonists|mesh-ancestor
25179414|NCT03464461|Ketorolac|ketorolac|mesh-list
25179415|NCT03464461|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25179416|NCT03464461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25179417|NCT03464461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25179418|NCT03464461|Analgesics|analgesics|mesh-ancestor
25179419|NCT03464461|Sensory System Agents|sensory system agents|mesh-ancestor
25179425|NCT03464461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25179426|NCT03464461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179428|NCT03448159|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25179429|NCT03448159|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25179430|NCT03448159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25179431|NCT03448159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179432|NCT03448159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25179433|NCT03448159|Serotonin Agents|serotonin agents|mesh-ancestor
24770586|NCT01821235|Antimanic Agents|antimanic agents|mesh-ancestor
25179434|NCT03448159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179435|NCT03448159|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25179436|NCT03448159|Antidepressive Agents|antidepressive agents|mesh-ancestor
25179437|NCT03448159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25179438|NCT03448159|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25179439|NCT03448159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25179440|NCT03448159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25179447|NCT03409848|Nivolumab|nivolumab|mesh-list
25179448|NCT03409848|Ipilimumab|ipilimumab|mesh-list
25179449|NCT03409848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25179450|NCT03409848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179451|NCT03409848|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25179452|NCT03409848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179453|NCT03401047|Estradiol|estradiol|mesh-list
25179454|NCT03401047|Estrogens|estrogens|mesh-ancestor
25179455|NCT03401047|Hormones|hormones|mesh-ancestor
24497679|NCT00511277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497680|NCT00511303|Imatinib Mesylate|imatinib mesylate|mesh-list
24497681|NCT00511303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497682|NCT00511303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24497683|NCT00511303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497684|NCT00511303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497685|NCT00511316|Montelukast|montelukast|mesh-list
24497686|NCT00511316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24497687|NCT00511316|Respiratory System Agents|respiratory system agents|mesh-ancestor
24497688|NCT00511316|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24497689|NCT00511316|Hormone Antagonists|hormone antagonists|mesh-ancestor
24497690|NCT00511316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24497691|NCT00511316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497692|NCT00511316|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24497693|NCT00511316|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24497694|NCT00511316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497726|NCT00511628|Serotonin Agents|serotonin agents|mesh-ancestor
24497727|NCT00511628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24770587|NCT01821248|Gemcitabine|gemcitabine|mesh-list
24497728|NCT00511628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497729|NCT00511628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497730|NCT00511628|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24497731|NCT00511628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24497732|NCT00511628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24497733|NCT00511628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24497742|NCT00511654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24497743|NCT00511654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24497744|NCT00511654|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24497745|NCT00511654|Anesthetics, General|anesthetics, general|mesh-ancestor
24497747|NCT00511654|GABA Modulators|gaba modulators|mesh-ancestor
24773550|NCT01840254|Adrenergic Agents|adrenergic agents|mesh-ancestor
24773551|NCT01840254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24773552|NCT01840254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457367|NCT00334152|Casopitant|casopitant|mesh-list
25097245|NCT03205228|Flupenthixol|flupenthixol|mesh-list
25097077|NCT03206957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25097078|NCT03206957|Growth Substances|growth substances|mesh-ancestor
25097079|NCT03206957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179456|NCT03401047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25179457|NCT03401047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179459|NCT03400332|Ipilimumab|ipilimumab|mesh-list
25179460|NCT03400332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25179461|NCT03400332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179462|NCT03400332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25179463|NCT03400332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179464|NCT03399773|Cyclophosphamide|cyclophosphamide|mesh-list
25179465|NCT03399773|Thiotepa|thiotepa|mesh-list
25179466|NCT03399773|Fludarabine|fludarabine|mesh-list
25179467|NCT03399773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25179468|NCT03399773|Immunologic Factors|immunologic factors|mesh-ancestor
25179469|NCT03399773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179470|NCT03399773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25179471|NCT03399773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25179472|NCT03399773|Alkylating Agents|alkylating agents|mesh-ancestor
25179473|NCT03399773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179474|NCT03399773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179475|NCT03399773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25179476|NCT03396926|Bevacizumab|bevacizumab|mesh-list
25179544|NCT03367572|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25179477|NCT03396926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25179478|NCT03396926|Pembrolizumab|pembrolizumab|mesh-list
25179479|NCT03396926|Capecitabine|capecitabine|mesh-list
25179480|NCT03396926|Endothelial Growth Factors|endothelial growth factors|mesh-list
25179481|NCT03396926|Antibodies|antibodies|mesh-list
25179482|NCT03396926|Immunoglobulins|immunoglobulins|mesh-list
25179483|NCT03396926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25179484|NCT03396926|Immunoglobulin G|immunoglobulin g|mesh-list
25179485|NCT03396926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179486|NCT03396926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25205104|NCT05201846|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25179487|NCT03396926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25179488|NCT03396926|Growth Substances|growth substances|mesh-ancestor
25179489|NCT03396926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179490|NCT03396926|Growth Inhibitors|growth inhibitors|mesh-ancestor
25179491|NCT03396926|Immunologic Factors|immunologic factors|mesh-ancestor
25179492|NCT03396926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25179493|NCT03396926|Antimetabolites|antimetabolites|mesh-ancestor
25179494|NCT03396926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179495|NCT03396276|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25179496|NCT03396276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25179497|NCT03396276|Narcotics|narcotics|mesh-ancestor
25179498|NCT03396276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25179499|NCT03396276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179500|NCT03396276|Analgesics|analgesics|mesh-ancestor
25179501|NCT03396276|Sensory System Agents|sensory system agents|mesh-ancestor
25179502|NCT03396276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25179503|NCT03396276|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25179504|NCT03384589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25179505|NCT03384589|Immunologic Factors|immunologic factors|mesh-ancestor
25179506|NCT03384589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179507|NCT03379428|Trastuzumab|trastuzumab|mesh-list
25179508|NCT03379428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25179509|NCT03379428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179510|NCT03373760|Durvalumab|durvalumab|mesh-list
25179511|NCT03373760|Ipilimumab|ipilimumab|mesh-list
25179512|NCT03373760|Tremelimumab|tremelimumab|mesh-list
25179513|NCT03373760|Immunoglobulins|immunoglobulins|mesh-list
25179514|NCT03373760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25179515|NCT03373760|Immunoglobulin G|immunoglobulin g|mesh-list
25179516|NCT03373760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25179517|NCT03373760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179518|NCT03373760|Immunologic Factors|immunologic factors|mesh-ancestor
25179519|NCT03373760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179520|NCT03373760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25179521|NCT03373760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179522|NCT03367572|Dexamethasone|dexamethasone|mesh-list
25179523|NCT03367572|Dexamethasone acetate|dexamethasone acetate|mesh-list
25179524|NCT03367572|Olanzapine|olanzapine|mesh-list
25860257|NCT00083096|Alkylating Agents|alkylating agents|mesh-ancestor
25860258|NCT00083096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860259|NCT00083096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860260|NCT00083096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25179525|NCT03367572|Palonosetron|palonosetron|mesh-list
25179526|NCT03367572|Prochlorperazine|prochlorperazine|mesh-list
25179527|NCT03367572|Ichthammol|ichthammol|mesh-list
25179528|NCT03367572|BB 1101|bb 1101|mesh-list
25179529|NCT03367572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25179530|NCT03367572|Antiemetics|antiemetics|mesh-ancestor
25179531|NCT03367572|Autonomic Agents|autonomic agents|mesh-ancestor
25179532|NCT03367572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25179533|NCT03367572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179534|NCT03367572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25179535|NCT03367572|Glucocorticoids|glucocorticoids|mesh-ancestor
25179536|NCT03367572|Hormones|hormones|mesh-ancestor
25179537|NCT03367572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25179538|NCT03367572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25179539|NCT03367572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179540|NCT03367572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25179541|NCT03367572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25179542|NCT03367572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25179543|NCT03367572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25179545|NCT03367572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25179546|NCT03367572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25179547|NCT03367572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179548|NCT03367572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25179549|NCT03367572|Serotonin Agents|serotonin agents|mesh-ancestor
25179550|NCT03367572|Protease Inhibitors|protease inhibitors|mesh-ancestor
25179551|NCT03367572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25179552|NCT03367572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25179553|NCT03367572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25179554|NCT03367572|Dermatologic Agents|dermatologic agents|mesh-ancestor
25179555|NCT03367572|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25179556|NCT03367572|Dopamine Agents|dopamine agents|mesh-ancestor
25179557|NCT03354039|Tamoxifen|tamoxifen|mesh-list
25179558|NCT03354039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25179559|NCT03354039|Hormone Antagonists|hormone antagonists|mesh-ancestor
25179560|NCT03354039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25205105|NCT05201846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25179561|NCT03354039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179562|NCT03354039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24945406|NCT03950700|Epinephrine|epinephrine|mesh-list
25179563|NCT03354039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179564|NCT03354039|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25179565|NCT03354039|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25179566|NCT03354039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25179567|NCT03345810|Gemcitabine|gemcitabine|mesh-list
25179568|NCT03345810|Paclitaxel|paclitaxel|mesh-list
25179569|NCT03345810|Vinorelbine|vinorelbine|mesh-list
25179570|NCT03345810|Carboplatin|carboplatin|mesh-list
25179571|NCT03345810|Durvalumab|durvalumab|mesh-list
25179572|NCT03345810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25179573|NCT03345810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179574|NCT03345810|Tubulin Modulators|tubulin modulators|mesh-ancestor
25179575|NCT03345810|Antimitotic Agents|antimitotic agents|mesh-ancestor
25179576|NCT03345810|Mitosis Modulators|mitosis modulators|mesh-ancestor
25179577|NCT03345810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179578|NCT03345810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25179579|NCT03345810|Antimetabolites|antimetabolites|mesh-ancestor
25179580|NCT03345810|Antiviral Agents|antiviral agents|mesh-ancestor
25179581|NCT03345810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25179582|NCT03345810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25179583|NCT03345810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25179584|NCT03345810|Immunologic Factors|immunologic factors|mesh-ancestor
25179585|NCT03345810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179586|NCT03345810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25179588|NCT03326310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25179589|NCT03326310|Antimetabolites|antimetabolites|mesh-ancestor
25179590|NCT03326310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179591|NCT03326310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179592|NCT03326310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25179593|NCT03314363|Trace Elements|trace elements|mesh-list
25179594|NCT03314363|Micronutrients|micronutrients|mesh-list
25179595|NCT03314363|Citric Acid|citric acid|mesh-list
25179596|NCT03314363|Sodium Citrate|sodium citrate|mesh-list
25179597|NCT03314363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179598|NCT03314363|Anticoagulants|anticoagulants|mesh-ancestor
25179599|NCT03314363|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25179600|NCT03314363|Chelating Agents|chelating agents|mesh-ancestor
25179601|NCT03314363|Sequestering Agents|sequestering agents|mesh-ancestor
25179602|NCT03314363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179603|NCT03302728|Lenalidomide|lenalidomide|mesh-list
25179604|NCT03302728|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25179605|NCT03302728|Immunologic Factors|immunologic factors|mesh-ancestor
25179606|NCT03302728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179607|NCT03302728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25179608|NCT03302728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25179609|NCT03302728|Growth Substances|growth substances|mesh-ancestor
25179610|NCT03302728|Growth Inhibitors|growth inhibitors|mesh-ancestor
25179611|NCT03302728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179612|NCT03302728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25179613|NCT03299660|Fluorouracil|fluorouracil|mesh-list
25179614|NCT03299660|Capecitabine|capecitabine|mesh-list
25179615|NCT03299660|Avelumab|avelumab|mesh-list
25179616|NCT03299660|Antimetabolites|antimetabolites|mesh-ancestor
25179617|NCT03299660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179618|NCT03299660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25179623|NCT03299660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25179624|NCT03248570|Pembrolizumab|pembrolizumab|mesh-list
25179625|NCT03248570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25179626|NCT03248570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179627|NCT03248167|Cannabidiol|cannabidiol|mesh-list
25179628|NCT03248167|Anticonvulsants|anticonvulsants|mesh-ancestor
25179632|NCT03245840|Budesonide|budesonide|mesh-list
25179633|NCT03245840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25179634|NCT03245840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24498019|NCT00513058|Lapatinib|lapatinib|mesh-list
25179635|NCT03245840|Autonomic Agents|autonomic agents|mesh-ancestor
25207979|NCT00627250|Analgesics|analgesics|mesh-ancestor
24810218|NCT02038816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810219|NCT02038816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810220|NCT02038816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605394|NCT00984893|Diphosphonates|diphosphonates|mesh-list
24443246|NCT00294190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498107|NCT00513188|Tubulin Modulators|tubulin modulators|mesh-ancestor
24498108|NCT00513188|Antimitotic Agents|antimitotic agents|mesh-ancestor
24498109|NCT00513188|Mitosis Modulators|mitosis modulators|mesh-ancestor
24498110|NCT00513201|Insulin|insulin|mesh-list
24498111|NCT00513201|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24498112|NCT00513201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25097080|NCT03206957|Growth Inhibitors|growth inhibitors|mesh-ancestor
25097082|NCT03206944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25097083|NCT03206944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25097084|NCT03206944|Analgesics|analgesics|mesh-ancestor
25097085|NCT03206944|Sensory System Agents|sensory system agents|mesh-ancestor
25097205|NCT03206320|Lidocaine|lidocaine|mesh-list
25097228|NCT03206008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097229|NCT03206008|Anesthetics|anesthetics|mesh-ancestor
25097230|NCT03206008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25097231|NCT03206008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25097232|NCT03206008|Anticonvulsants|anticonvulsants|mesh-ancestor
25097233|NCT03206008|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25097234|NCT03206008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25097235|NCT03206008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097236|NCT03206008|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25097237|NCT03206008|Tocolytic Agents|tocolytic agents|mesh-ancestor
25097238|NCT03206008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25097239|NCT03205891|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25097240|NCT03205891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25097241|NCT03205891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097242|NCT03205696|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25097243|NCT03205696|Antiviral Agents|antiviral agents|mesh-ancestor
25097244|NCT03205696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25097246|NCT03205228|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
24509402|NCT00560170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25209938|NCT02700217|Anesthetics|anesthetics|mesh-ancestor
25097248|NCT03205228|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25097249|NCT03205228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25097250|NCT03205228|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25097251|NCT03205228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25097252|NCT03205228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097290|NCT03204734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097291|NCT03204734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097356|NCT03204578|GABA Agents|gaba agents|mesh-ancestor
25097357|NCT03204578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25097358|NCT03204578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097359|NCT03204474|Lacosamide|lacosamide|mesh-list
25097360|NCT03204474|Anticonvulsants|anticonvulsants|mesh-ancestor
25097361|NCT03204474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25097362|NCT03204474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25097363|NCT03204474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25097430|NCT03204032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25097431|NCT03204032|Growth Substances|growth substances|mesh-ancestor
25097432|NCT03204032|Growth Inhibitors|growth inhibitors|mesh-ancestor
25179640|NCT03245840|Glucocorticoids|glucocorticoids|mesh-ancestor
25179641|NCT03245840|Hormones|hormones|mesh-ancestor
25179642|NCT03245840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25179643|NCT03230604|Z 350|z 350|mesh-list
25179644|NCT03230604|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25179645|NCT03230604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25179646|NCT03230604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25179647|NCT03230604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179648|NCT03230604|Hormone Antagonists|hormone antagonists|mesh-ancestor
25179649|NCT03230604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25179650|NCT03230604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179651|NCT03221036|Vedolizumab|vedolizumab|mesh-list
25179652|NCT03221036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25179660|NCT03217669|Sirolimus|sirolimus|mesh-list
25179661|NCT03217669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25179662|NCT03217669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25179663|NCT03217669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25179664|NCT03217669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179665|NCT03217669|Antifungal Agents|antifungal agents|mesh-ancestor
25179666|NCT03217669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25179667|NCT03217669|Immunologic Factors|immunologic factors|mesh-ancestor
25179668|NCT03217669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179673|NCT03203525|Leucovorin|leucovorin|mesh-list
25179674|NCT03203525|Sirolimus|sirolimus|mesh-list
25179675|NCT03203525|Bevacizumab|bevacizumab|mesh-list
25179676|NCT03203525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25179677|NCT03203525|Doxorubicin|doxorubicin|mesh-list
25179678|NCT03203525|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25179679|NCT03203525|Fluorouracil|fluorouracil|mesh-list
25179680|NCT03203525|Oxaliplatin|oxaliplatin|mesh-list
25179681|NCT03203525|Endothelial Growth Factors|endothelial growth factors|mesh-list
25179682|NCT03203525|Antibodies|antibodies|mesh-list
25179683|NCT03203525|Immunoglobulins|immunoglobulins|mesh-list
25179684|NCT03203525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25179685|NCT03203525|Immunoglobulin G|immunoglobulin g|mesh-list
25179686|NCT03203525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179687|NCT03203525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25179688|NCT03203525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25179689|NCT03203525|Growth Substances|growth substances|mesh-ancestor
25179690|NCT03203525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179691|NCT03203525|Growth Inhibitors|growth inhibitors|mesh-ancestor
25179692|NCT03203525|Immunologic Factors|immunologic factors|mesh-ancestor
25860261|NCT00083109|Suramin|suramin|mesh-list
25860262|NCT00083109|Fluorouracil|fluorouracil|mesh-list
25860263|NCT00083109|Antimetabolites|antimetabolites|mesh-ancestor
24945541|NCT03949842|Autonomic Agents|autonomic agents|mesh-ancestor
25179693|NCT03203525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25179694|NCT03203525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25179695|NCT03203525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25665408|NCT01683994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665409|NCT01683994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25665410|NCT01684020|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25179696|NCT03203525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24934733|NCT04059523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934734|NCT04059523|Keratolytic Agents|keratolytic agents|mesh-ancestor
24934735|NCT04059523|Dermatologic Agents|dermatologic agents|mesh-ancestor
25179697|NCT03203525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179698|NCT03203525|Antimetabolites|antimetabolites|mesh-ancestor
25179699|NCT03203525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25179700|NCT03203525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25179701|NCT03203525|Antidotes|antidotes|mesh-ancestor
25179731|NCT03168555|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
25860264|NCT00083109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179732|NCT03168555|Cathartics|cathartics|mesh-ancestor
25179733|NCT03168555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25179735|NCT03153527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25179736|NCT03153527|Glucocorticoids|glucocorticoids|mesh-ancestor
25179737|NCT03153527|Hormones|hormones|mesh-ancestor
25179738|NCT03153527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25179739|NCT03153527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179740|NCT03153527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25179741|NCT03153527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179742|NCT03141203|Romidepsin|romidepsin|mesh-list
25179743|NCT03141203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25179744|NCT03141203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24394324|NCT00132925|Hormones|hormones|mesh-ancestor
25179810|NCT03082755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25179811|NCT03082755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179813|NCT03068910|Spironolactone|spironolactone|mesh-list
25179814|NCT03068910|Progesterone|progesterone|mesh-list
25179815|NCT03068910|Progestins|progestins|mesh-ancestor
25179816|NCT03068910|Hormones|hormones|mesh-ancestor
25179817|NCT03068910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25179818|NCT03068910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179819|NCT03068910|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25179820|NCT03068910|Hormone Antagonists|hormone antagonists|mesh-ancestor
25179821|NCT03068910|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25179822|NCT03068910|Diuretics|diuretics|mesh-ancestor
25179823|NCT03068910|Natriuretic Agents|natriuretic agents|mesh-ancestor
25179824|NCT03059147|Nivolumab|nivolumab|mesh-list
25179825|NCT03059147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25179826|NCT03059147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179827|NCT03059147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25179828|NCT03059147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179829|NCT03043729|Leucovorin|leucovorin|mesh-list
25179830|NCT03043729|Oxaliplatin|oxaliplatin|mesh-list
25179831|NCT03043729|Aflibercept|aflibercept|mesh-list
25179832|NCT03043729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179833|NCT03043729|Antidotes|antidotes|mesh-ancestor
25179834|NCT03043729|Protective Agents|protective agents|mesh-ancestor
25179835|NCT03043729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179836|NCT03043729|Vitamin B Complex|vitamin b complex|mesh-ancestor
25179837|NCT03043729|Vitamins|vitamins|mesh-ancestor
25179838|NCT03043729|Micronutrients|micronutrients|mesh-ancestor
25179839|NCT03043729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25179840|NCT03043729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25179841|NCT03043729|Growth Substances|growth substances|mesh-ancestor
25179842|NCT03043729|Growth Inhibitors|growth inhibitors|mesh-ancestor
25179843|NCT03043547|Leucovorin|leucovorin|mesh-list
25179844|NCT03043547|Antidotes|antidotes|mesh-ancestor
24498899|NCT00516750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24498900|NCT00516750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24498901|NCT00516750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24498902|NCT00516750|Tubulin Modulators|tubulin modulators|mesh-ancestor
24498903|NCT00516750|Antimitotic Agents|antimitotic agents|mesh-ancestor
24498904|NCT00516750|Mitosis Modulators|mitosis modulators|mesh-ancestor
24498905|NCT00516802|Olaparib|olaparib|mesh-list
24498906|NCT00516802|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
24498907|NCT00516802|Dacarbazine|dacarbazine|mesh-list
24498908|NCT00516802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499017|NCT00517283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24499020|NCT00517309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499022|NCT00517322|Irbesartan|irbesartan|mesh-list
24499023|NCT00517322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25665411|NCT01684020|Hemostatics|hemostatics|mesh-ancestor
25665412|NCT01684020|Coagulants|coagulants|mesh-ancestor
25665413|NCT01684202|Tolvaptan|tolvaptan|mesh-list
25665414|NCT01684202|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24934741|NCT04059224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179878|NCT02992964|Nivolumab|nivolumab|mesh-list
25179879|NCT02992964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25179880|NCT02992964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179881|NCT02992964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24945582|NCT03949478|Ibuprofen|ibuprofen|mesh-list
25179882|NCT02992964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179883|NCT02981472|Vitamin K|vitamin k|mesh-list
25179884|NCT02981472|Heparin|heparin|mesh-list
25179885|NCT02981472|Enoxaparin|enoxaparin|mesh-list
25179962|NCT02823028|Autonomic Agents|autonomic agents|mesh-ancestor
25179900|NCT02981472|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25179901|NCT02981472|Protease Inhibitors|protease inhibitors|mesh-ancestor
25179902|NCT02981472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25179903|NCT02981472|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25179905|NCT02981472|Coagulants|coagulants|mesh-ancestor
25179906|NCT02962063|Paclitaxel|paclitaxel|mesh-list
25179907|NCT02962063|Carboplatin|carboplatin|mesh-list
25179908|NCT02962063|Durvalumab|durvalumab|mesh-list
25179909|NCT02962063|Tremelimumab|tremelimumab|mesh-list
25179910|NCT02962063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25179911|NCT02962063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179912|NCT02962063|Tubulin Modulators|tubulin modulators|mesh-ancestor
25179913|NCT02962063|Antimitotic Agents|antimitotic agents|mesh-ancestor
25179914|NCT02962063|Mitosis Modulators|mitosis modulators|mesh-ancestor
25179915|NCT02962063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179916|NCT02962063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24858450|NCT02297568|Micronutrients|micronutrients|mesh-ancestor
25179924|NCT02918955|Cisplatin|cisplatin|mesh-list
25179925|NCT02918955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179926|NCT02911792|Metformin|metformin|mesh-list
25179927|NCT02911792|Dapagliflozin|dapagliflozin|mesh-list
25179928|NCT02911792|Glipizide|glipizide|mesh-list
25179929|NCT02911792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25179930|NCT02911792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179931|NCT02911792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25179932|NCT02911792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179933|NCT02890212|Selenium|selenium|mesh-list
25179934|NCT02890212|Antioxidants|antioxidants|mesh-ancestor
25179935|NCT02890212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179936|NCT02890212|Protective Agents|protective agents|mesh-ancestor
25179937|NCT02890212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179938|NCT02890212|Trace Elements|trace elements|mesh-ancestor
25179939|NCT02890212|Micronutrients|micronutrients|mesh-ancestor
25179940|NCT02873962|Bevacizumab|bevacizumab|mesh-list
25179941|NCT02873962|Nivolumab|nivolumab|mesh-list
25179942|NCT02873962|Rucaparib|rucaparib|mesh-list
25179943|NCT02873962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25179944|NCT02873962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179945|NCT02873962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25179946|NCT02873962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25179947|NCT02873962|Growth Substances|growth substances|mesh-ancestor
25179948|NCT02873962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179949|NCT02873962|Growth Inhibitors|growth inhibitors|mesh-ancestor
25179950|NCT02873962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25179951|NCT02873962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179952|NCT02873962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25179953|NCT02873962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449125|NCT00314509|Respiratory System Agents|respiratory system agents|mesh-ancestor
25179960|NCT02823028|Nicotine|nicotine|mesh-list
25179961|NCT02823028|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25179963|NCT02823028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25179964|NCT02823028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179965|NCT02823028|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25179966|NCT02823028|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25179967|NCT02823028|Cholinergic Agents|cholinergic agents|mesh-ancestor
25179968|NCT02823028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25179969|NCT02823028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179970|NCT02821923|Erythritol|erythritol|mesh-list
25179971|NCT02821923|Vasodilator Agents|vasodilator agents|mesh-ancestor
25179972|NCT02794402|Exenatide|exenatide|mesh-list
25179973|NCT02794402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25665415|NCT01684202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179974|NCT02794402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25179975|NCT02794402|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25179976|NCT02794402|Incretins|incretins|mesh-ancestor
25179977|NCT02794402|Hormones|hormones|mesh-ancestor
24934810|NCT04057755|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25179978|NCT02794402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25179980|NCT02789657|Carboplatin|carboplatin|mesh-list
25179981|NCT02789657|Trastuzumab|trastuzumab|mesh-list
25179982|NCT02789657|Pertuzumab|pertuzumab|mesh-list
25179983|NCT02789657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25179984|NCT02789657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179985|NCT02789657|Tubulin Modulators|tubulin modulators|mesh-ancestor
25179986|NCT02789657|Antimitotic Agents|antimitotic agents|mesh-ancestor
25179987|NCT02789657|Mitosis Modulators|mitosis modulators|mesh-ancestor
25205115|NCT05194189|Micronutrients|micronutrients|mesh-ancestor
24499036|NCT00517387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810301|NCT02039479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179988|NCT02789657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179989|NCT02789657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25179991|NCT02783092|Anticonvulsants|anticonvulsants|mesh-ancestor
25179993|NCT02776917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25179994|NCT02776917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25179995|NCT02776917|Tubulin Modulators|tubulin modulators|mesh-ancestor
24945612|NCT03949101|Mydriatics|mydriatics|mesh-ancestor
25179996|NCT02776917|Antimitotic Agents|antimitotic agents|mesh-ancestor
25179997|NCT02776917|Mitosis Modulators|mitosis modulators|mesh-ancestor
25179998|NCT02776917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25179999|NCT02768948|Losartan|losartan|mesh-list
25180000|NCT02768948|Telmisartan|telmisartan|mesh-list
25180001|NCT02768948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25180002|NCT02768948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25180003|NCT02768948|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25180004|NCT02768948|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25180005|NCT02768948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180006|NCT02754063|3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol|3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol|mesh-list
25180007|NCT02754063|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25180008|NCT02754063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25180009|NCT02754063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25180010|NCT02754063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180011|NCT02754063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25180012|NCT02754063|Dopamine Agonists|dopamine agonists|mesh-ancestor
25180013|NCT02754063|Dopamine Agents|dopamine agents|mesh-ancestor
25180014|NCT02754063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25180015|NCT02754063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180016|NCT02715466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25180017|NCT02685605|Temozolomide|temozolomide|mesh-list
25180018|NCT02685605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25180019|NCT02685605|Alkylating Agents|alkylating agents|mesh-ancestor
25180020|NCT02685605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180021|NCT02685605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180022|NCT02677805|Botulinum Toxins|botulinum toxins|mesh-list
25180023|NCT02677805|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25180024|NCT02677805|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25180025|NCT02677805|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25180026|NCT02677805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25180027|NCT02677805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180028|NCT02677805|Cholinergic Agents|cholinergic agents|mesh-ancestor
25180029|NCT02677805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25180030|NCT02677805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180031|NCT02677805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25180032|NCT02677805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24395012|NCT00134914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25180033|NCT02640222|Vitamin K|vitamin k|mesh-list
25180034|NCT02640222|Rivaroxaban|rivaroxaban|mesh-list
25180035|NCT02640222|Apixaban|apixaban|mesh-list
25180036|NCT02640222|Dabigatran|dabigatran|mesh-list
25180037|NCT02640222|Vitamins|vitamins|mesh-ancestor
25180038|NCT02640222|Micronutrients|micronutrients|mesh-ancestor
25180039|NCT02640222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180040|NCT02640222|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25180041|NCT02640222|Antithrombins|antithrombins|mesh-ancestor
25180042|NCT02640222|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25180043|NCT02640222|Protease Inhibitors|protease inhibitors|mesh-ancestor
25180044|NCT02640222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180045|NCT02640222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665416|NCT01684202|Natriuretic Agents|natriuretic agents|mesh-ancestor
24934836|NCT04057989|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25180046|NCT02640222|Anticoagulants|anticoagulants|mesh-ancestor
25180047|NCT02640222|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25180048|NCT02640222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25180049|NCT02640222|Hemostatics|hemostatics|mesh-ancestor
25180050|NCT02640222|Coagulants|coagulants|mesh-ancestor
25205116|NCT05194189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205117|NCT05194189|Antioxidants|antioxidants|mesh-ancestor
25205118|NCT05194189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205119|NCT05194189|Protective Agents|protective agents|mesh-ancestor
25205120|NCT05181462|Gemcitabine|gemcitabine|mesh-list
25205121|NCT05181462|Carboplatin|carboplatin|mesh-list
25205122|NCT05181462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25205123|NCT05181462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25205124|NCT05181462|Antimetabolites|antimetabolites|mesh-ancestor
24499635|NCT00520325|Immunologic Factors|immunologic factors|mesh-ancestor
24499636|NCT00520325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499637|NCT00520325|Coagulants|coagulants|mesh-ancestor
25860265|NCT00083109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25860266|NCT00083109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24499797|NCT00521157|Sensory System Agents|sensory system agents|mesh-ancestor
24499798|NCT00521157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24499799|NCT00521170|Levocetirizine|levocetirizine|mesh-list
24499800|NCT00521170|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24499801|NCT00521170|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24499802|NCT00521170|Histamine Antagonists|histamine antagonists|mesh-ancestor
24499803|NCT00521170|Histamine Agents|histamine agents|mesh-ancestor
24499804|NCT00521170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24499805|NCT00521170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098219|NCT03198403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25098283|NCT03197961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25098284|NCT03197961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25098411|NCT03197584|Growth Inhibitors|growth inhibitors|mesh-ancestor
25098412|NCT03197584|Antimetabolites|antimetabolites|mesh-ancestor
25098413|NCT03197584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25098414|NCT03197584|Antidotes|antidotes|mesh-ancestor
25098803|NCT03195413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25098804|NCT03195413|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25098805|NCT03195413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25098806|NCT03195413|Autonomic Agents|autonomic agents|mesh-ancestor
25098807|NCT03195413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25098808|NCT03195413|Respiratory System Agents|respiratory system agents|mesh-ancestor
25098809|NCT03195413|Mydriatics|mydriatics|mesh-ancestor
25098810|NCT03195413|Sympathomimetics|sympathomimetics|mesh-ancestor
25098811|NCT03195413|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25098813|NCT03195205|Immunologic Factors|immunologic factors|mesh-ancestor
25098839|NCT03195153|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25098840|NCT03195153|Antioxidants|antioxidants|mesh-ancestor
25098841|NCT03195153|Protective Agents|protective agents|mesh-ancestor
25098842|NCT03195153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098843|NCT03195270|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25098844|NCT03195270|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24967959|NCT03755609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25099140|NCT03193359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099142|NCT03193359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25099143|NCT03193359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099144|NCT03193359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25099145|NCT03193359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25099147|NCT03193346|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25099148|NCT03193346|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25099149|NCT03193346|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25099150|NCT03193346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25180112|NCT02586038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25099151|NCT03193346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099152|NCT03193346|Cholinergic Agents|cholinergic agents|mesh-ancestor
25099153|NCT03193346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25099154|NCT03193346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099177|NCT03193463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25099178|NCT03193463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25099179|NCT03193463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099180|NCT03193463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099181|NCT03193281|Imatinib Mesylate|imatinib mesylate|mesh-list
25099457|NCT03191162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25665417|NCT01684202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180051|NCT02630628|Mycophenolic Acid|mycophenolic acid|mesh-list
25180053|NCT02630628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25180054|NCT02630628|Immunologic Factors|immunologic factors|mesh-ancestor
25180055|NCT02630628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180056|NCT02630628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25180057|NCT02630628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180058|NCT02630628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180059|NCT02630628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25180060|NCT02630628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180061|NCT02630628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25180062|NCT02630628|Antitubercular Agents|antitubercular agents|mesh-ancestor
25180063|NCT02630628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25180064|NCT02630628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25180065|NCT02616666|Dapagliflozin|dapagliflozin|mesh-list
24499806|NCT00521170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180066|NCT02616666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25180067|NCT02616666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180068|NCT02616666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25180069|NCT02616666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180070|NCT02603848|Ibuprofen|ibuprofen|mesh-list
25180071|NCT02603848|Morphine|morphine|mesh-list
25180072|NCT02603848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25180073|NCT02603848|Narcotics|narcotics|mesh-ancestor
25180074|NCT02603848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25180075|NCT02603848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180076|NCT02603848|Analgesics|analgesics|mesh-ancestor
25180077|NCT02603848|Sensory System Agents|sensory system agents|mesh-ancestor
25180078|NCT02603848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25180079|NCT02603848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25180080|NCT02603848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25180081|NCT02603848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25180082|NCT02603848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25180083|NCT02603848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25180084|NCT02603848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180085|NCT02603848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180086|NCT02600117|Tenofovir|tenofovir|mesh-list
25180087|NCT02600117|Antiviral Agents|antiviral agents|mesh-ancestor
25180088|NCT02600117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25180089|NCT02600117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25180090|NCT02600117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25180091|NCT02600117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180092|NCT02600117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180093|NCT02600117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25180094|NCT02600117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25180095|NCT02586038|Thalidomide|thalidomide|mesh-list
25180096|NCT02586038|Dexamethasone|dexamethasone|mesh-list
25180097|NCT02586038|Cyclophosphamide|cyclophosphamide|mesh-list
25180098|NCT02586038|Ixazomib|ixazomib|mesh-list
25180099|NCT02586038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25180100|NCT02586038|Immunologic Factors|immunologic factors|mesh-ancestor
25180101|NCT02586038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180102|NCT02586038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25180103|NCT02586038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25180104|NCT02586038|Alkylating Agents|alkylating agents|mesh-ancestor
25180105|NCT02586038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180106|NCT02586038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180107|NCT02586038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25180108|NCT02586038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25180109|NCT02586038|Antiemetics|antiemetics|mesh-ancestor
25180110|NCT02586038|Autonomic Agents|autonomic agents|mesh-ancestor
25180111|NCT02586038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25180135|NCT02555839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25180136|NCT02555839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180137|NCT02555839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25180139|NCT02555839|Hormones|hormones|mesh-ancestor
25180140|NCT02555839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25180141|NCT02555839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25180142|NCT02555839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180143|NCT02555839|Protease Inhibitors|protease inhibitors|mesh-ancestor
25180144|NCT02555839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051420|NCT00406588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180145|NCT02555839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935182|NCT04054063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24935187|NCT04053959|Insulin|insulin|mesh-list
24935188|NCT04053959|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24935189|NCT04053959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25180146|NCT02555839|Immunologic Factors|immunologic factors|mesh-ancestor
25180147|NCT02555839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25180148|NCT02555839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25180149|NCT02555839|Growth Substances|growth substances|mesh-ancestor
25180150|NCT02555839|Growth Inhibitors|growth inhibitors|mesh-ancestor
25180151|NCT02555839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25180152|NCT02555839|Leprostatic Agents|leprostatic agents|mesh-ancestor
25180153|NCT02555839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25180154|NCT02555839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25180155|NCT02535936|Anesthetics|anesthetics|mesh-list
25180156|NCT02535936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25180157|NCT02535936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180165|NCT02526368|Carbamide Peroxide|carbamide peroxide|mesh-list
25180166|NCT02526368|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25180167|NCT02526368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25180168|NCT02513667|Ceritinib|ceritinib|mesh-list
25180169|NCT02513667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180170|NCT02513667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25180171|NCT02513667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180172|NCT02513667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180200|NCT02395601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180202|NCT02389374|Lumefantrine|lumefantrine|mesh-list
25180203|NCT02389374|Artemether|artemether|mesh-list
25180204|NCT02389374|Primaquine|primaquine|mesh-list
25180205|NCT02389374|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25180206|NCT02389374|Amebicides|amebicides|mesh-ancestor
25180207|NCT02389374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25180208|NCT02389374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25180209|NCT02389374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25180210|NCT02389374|Antimalarials|antimalarials|mesh-ancestor
25180211|NCT02389374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25180212|NCT02386839|Mecasermin|mecasermin|mesh-list
24500236|NCT00523393|Insulin|insulin|mesh-list
25180213|NCT02386839|Growth Substances|growth substances|mesh-ancestor
25180214|NCT02386839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180215|NCT02376699|Gemcitabine|gemcitabine|mesh-list
25180216|NCT02376699|Paclitaxel|paclitaxel|mesh-list
25180217|NCT02376699|Pembrolizumab|pembrolizumab|mesh-list
25180218|NCT02376699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25180219|NCT02376699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180220|NCT02376699|Tubulin Modulators|tubulin modulators|mesh-ancestor
25180221|NCT02376699|Antimitotic Agents|antimitotic agents|mesh-ancestor
25180222|NCT02376699|Mitosis Modulators|mitosis modulators|mesh-ancestor
25180223|NCT02376699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180224|NCT02376699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25180225|NCT02376699|Antimetabolites|antimetabolites|mesh-ancestor
25180226|NCT02376699|Antiviral Agents|antiviral agents|mesh-ancestor
25180227|NCT02376699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25180228|NCT02376699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180229|NCT02376699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25180230|NCT02376699|Immunologic Factors|immunologic factors|mesh-ancestor
25180231|NCT02376699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180232|NCT02376699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25180241|NCT02339532|Carboplatin|carboplatin|mesh-list
25180242|NCT02339532|Docetaxel|docetaxel|mesh-list
25180243|NCT02339532|Trastuzumab|trastuzumab|mesh-list
25180244|NCT02339532|Pertuzumab|pertuzumab|mesh-list
25180245|NCT02339532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180246|NCT02339532|Tubulin Modulators|tubulin modulators|mesh-ancestor
25180247|NCT02339532|Antimitotic Agents|antimitotic agents|mesh-ancestor
25180248|NCT02339532|Mitosis Modulators|mitosis modulators|mesh-ancestor
25180249|NCT02339532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180250|NCT02339532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25180251|NCT02312258|Ixazomib|ixazomib|mesh-list
25180252|NCT02312258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180253|NCT02312258|Protease Inhibitors|protease inhibitors|mesh-ancestor
25665418|NCT01684215|Letrozole|letrozole|mesh-list
25665419|NCT01684215|Palbociclib|palbociclib|mesh-list
25665420|NCT01684215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665421|NCT01684215|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25180254|NCT02312258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180255|NCT02312258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180256|NCT02304809|Vemurafenib|vemurafenib|mesh-list
25180257|NCT02304809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531184|NCT00634413|Autonomic Agents|autonomic agents|mesh-ancestor
24531185|NCT00634413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24445818|NCT00302666|Hormone Antagonists|hormone antagonists|mesh-ancestor
24531186|NCT00634413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531187|NCT00634413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24531188|NCT00634413|Respiratory System Agents|respiratory system agents|mesh-ancestor
24531189|NCT00634413|Glucocorticoids|glucocorticoids|mesh-ancestor
24531190|NCT00634413|Hormones|hormones|mesh-ancestor
24531191|NCT00634413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24531192|NCT00634413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24531193|NCT00634413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24668568|NCT04837716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24668569|NCT04837716|Immunoglobulin G|immunoglobulin g|mesh-list
25180258|NCT02304809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25180271|NCT02219581|Antiemetics|antiemetics|mesh-ancestor
25180272|NCT02219581|Autonomic Agents|autonomic agents|mesh-ancestor
25180273|NCT02219581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25180274|NCT02219581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180275|NCT02219581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25180276|NCT02219581|Glucocorticoids|glucocorticoids|mesh-ancestor
25180277|NCT02219581|Hormones|hormones|mesh-ancestor
25180278|NCT02219581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25180279|NCT02219581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25180280|NCT02219581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180281|NCT02219581|Protease Inhibitors|protease inhibitors|mesh-ancestor
25180282|NCT02219581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180283|NCT02219581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180284|NCT02213380|Anesthetics|anesthetics|mesh-list
25180285|NCT02213380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24396330|NCT00138593|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25180286|NCT02213380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180287|NCT02187991|Paclitaxel|paclitaxel|mesh-list
24500749|NCT00525642|Alkylating Agents|alkylating agents|mesh-ancestor
25180288|NCT02187991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25180289|NCT02187991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180290|NCT02187991|Tubulin Modulators|tubulin modulators|mesh-ancestor
25180291|NCT02187991|Antimitotic Agents|antimitotic agents|mesh-ancestor
25180292|NCT02187991|Mitosis Modulators|mitosis modulators|mesh-ancestor
25180293|NCT02187991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180299|NCT02179086|Temozolomide|temozolomide|mesh-list
25180300|NCT02179086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25180301|NCT02179086|Alkylating Agents|alkylating agents|mesh-ancestor
25180302|NCT02179086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180303|NCT02179086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180304|NCT02131753|Cladribine|cladribine|mesh-list
25180305|NCT02131753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180306|NCT02131753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25180307|NCT02131753|Immunologic Factors|immunologic factors|mesh-ancestor
25180308|NCT02131753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180309|NCT02122185|Metformin|metformin|mesh-list
25180310|NCT02122185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25180311|NCT02122185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180318|NCT02087865|Donepezil|donepezil|mesh-list
25180319|NCT02087865|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25180320|NCT02087865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180321|NCT02087865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180322|NCT02087865|Cholinergic Agents|cholinergic agents|mesh-ancestor
25426869|NCT01950520|Urological Agents|urological agents|mesh-ancestor
25665422|NCT01684215|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25665423|NCT01684215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665424|NCT01684215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665425|NCT01684215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25665426|NCT01684215|Hormone Antagonists|hormone antagonists|mesh-ancestor
25665427|NCT01684215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25665428|NCT01684215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665429|NCT01684215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25665430|NCT01684410|Protease Inhibitors|protease inhibitors|mesh-list
25665431|NCT01684410|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25665432|NCT01684410|Protein C Inhibitor|protein c inhibitor|mesh-list
25665433|NCT01684410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674393|NCT01771627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24668650|NCT04681677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24668651|NCT04681677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24668652|NCT04681677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24668653|NCT04681677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24668669|NCT04650542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24668670|NCT04650542|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24668671|NCT04650542|Antidepressive Agents|antidepressive agents|mesh-ancestor
24668672|NCT04650542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24668673|NCT04650542|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25180323|NCT02087865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25180324|NCT02087865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180325|NCT02087865|Nootropic Agents|nootropic agents|mesh-ancestor
24945685|NCT03948243|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25180334|NCT02007512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25180335|NCT02007512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180336|NCT02007512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180337|NCT02007512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25180338|NCT02007512|Hormone Antagonists|hormone antagonists|mesh-ancestor
25180339|NCT02007512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25180340|NCT02007512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180341|NCT02004834|Levobupivacaine|levobupivacaine|mesh-list
25180342|NCT02004834|Anesthetics, Local|anesthetics, local|mesh-ancestor
25180343|NCT02004834|Anesthetics|anesthetics|mesh-ancestor
25180344|NCT02004834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25180345|NCT02004834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180346|NCT02004834|Sensory System Agents|sensory system agents|mesh-ancestor
25180347|NCT02004834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25180349|NCT01999179|Enoxaparin|enoxaparin|mesh-list
25180350|NCT01999179|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25180351|NCT01999179|Tinzaparin|tinzaparin|mesh-list
25180352|NCT01999179|Dalteparin|dalteparin|mesh-list
25180353|NCT01999179|Rivaroxaban|rivaroxaban|mesh-list
25180354|NCT01999179|Dabigatran|dabigatran|mesh-list
25180355|NCT01999179|Apixaban|apixaban|mesh-list
25180356|NCT01999179|Edoxaban|edoxaban|mesh-list
25180357|NCT01999179|Anticoagulants|anticoagulants|mesh-list
24500751|NCT00525642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24945686|NCT03948243|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25180358|NCT01999179|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25180359|NCT01999179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25180360|NCT01999179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180361|NCT01999179|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25180362|NCT01999179|Antithrombins|antithrombins|mesh-ancestor
25180363|NCT01999179|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25180364|NCT01999179|Protease Inhibitors|protease inhibitors|mesh-ancestor
25180365|NCT01999179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180366|NCT01889199|Flutamide|flutamide|mesh-list
25180367|NCT01889199|Androgen Antagonists|androgen antagonists|mesh-ancestor
25180368|NCT01889199|Hormone Antagonists|hormone antagonists|mesh-ancestor
25180369|NCT01889199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25180370|NCT01889199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180371|NCT01889199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25180372|NCT01889199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180373|NCT01868269|Dexamethasone|dexamethasone|mesh-list
25180374|NCT01868269|Dexamethasone acetate|dexamethasone acetate|mesh-list
25180375|NCT01868269|Cyclophosphamide|cyclophosphamide|mesh-list
25180376|NCT01868269|Rituximab|rituximab|mesh-list
25180377|NCT01868269|BB 1101|bb 1101|mesh-list
25180378|NCT01868269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25180379|NCT01868269|Immunologic Factors|immunologic factors|mesh-ancestor
25665434|NCT01684410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665435|NCT01684410|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25665436|NCT01684410|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25665437|NCT01684423|Rivaroxaban|rivaroxaban|mesh-list
25665438|NCT01684423|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25665439|NCT01684423|Antithrombins|antithrombins|mesh-ancestor
25665440|NCT01684423|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25665441|NCT01684423|Protease Inhibitors|protease inhibitors|mesh-ancestor
25665442|NCT01684423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665443|NCT01684423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665444|NCT01684423|Anticoagulants|anticoagulants|mesh-ancestor
25180380|NCT01868269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456341|NCT00330941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25180381|NCT01868269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25180388|NCT01868269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25180390|NCT01868269|Autonomic Agents|autonomic agents|mesh-ancestor
25180391|NCT01868269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25180392|NCT01868269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25180393|NCT01868269|Glucocorticoids|glucocorticoids|mesh-ancestor
25180394|NCT01868269|Hormones|hormones|mesh-ancestor
25180395|NCT01868269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25180396|NCT01868269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25180397|NCT01868269|Protease Inhibitors|protease inhibitors|mesh-ancestor
25180398|NCT01868269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180399|NCT01796197|Paclitaxel|paclitaxel|mesh-list
25180400|NCT01796197|Cyclophosphamide|cyclophosphamide|mesh-list
25180401|NCT01796197|Doxorubicin|doxorubicin|mesh-list
25180402|NCT01796197|Trastuzumab|trastuzumab|mesh-list
25180403|NCT01796197|Pertuzumab|pertuzumab|mesh-list
25180409|NCT01796197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180410|NCT01796197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25180411|NCT01796197|Immunologic Factors|immunologic factors|mesh-ancestor
25180412|NCT01796197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180413|NCT01796197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25180414|NCT01796197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25180415|NCT01796197|Alkylating Agents|alkylating agents|mesh-ancestor
25180416|NCT01796197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25180417|NCT01796197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25180418|NCT01796197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25180419|NCT01796197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25180420|NCT01796197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180421|NCT01796197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25205125|NCT05181462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205127|NCT05181462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25205128|NCT05181462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205129|NCT05181462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25205130|NCT05181462|Immunologic Factors|immunologic factors|mesh-ancestor
25205131|NCT05181462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500903|NCT00526175|Dermatologic Agents|dermatologic agents|mesh-ancestor
24535612|NCT00649441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24623049|NCT01069874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24604961|NCT00982566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501065|NCT00526513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501066|NCT00526617|Temozolomide|temozolomide|mesh-list
24501067|NCT00526617|Veliparib|veliparib|mesh-list
24501068|NCT00526617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24501069|NCT00526617|Alkylating Agents|alkylating agents|mesh-ancestor
24501070|NCT00526617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945696|NCT03948243|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25180422|NCT01748448|Vitamin D|vitamin d|mesh-list
25180423|NCT01748448|Cholecalciferol|cholecalciferol|mesh-list
25180424|NCT01748448|Vitamins|vitamins|mesh-ancestor
25180425|NCT01748448|Micronutrients|micronutrients|mesh-ancestor
25180426|NCT01748448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180427|NCT01748448|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25180428|NCT01748448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25180429|NCT01730313|Pyridoxine|pyridoxine|mesh-list
25180430|NCT01730313|Vitamin B 6|vitamin b 6|mesh-list
25180431|NCT01730313|Phenytoin|phenytoin|mesh-list
25180432|NCT01730313|Valproic Acid|valproic acid|mesh-list
25180433|NCT01730313|Vitamins|vitamins|mesh-ancestor
25180434|NCT01730313|Micronutrients|micronutrients|mesh-ancestor
25180435|NCT01730313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180436|NCT01730313|Vitamin B Complex|vitamin b complex|mesh-ancestor
25180437|NCT01730313|Anticonvulsants|anticonvulsants|mesh-ancestor
25180438|NCT01730313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180439|NCT01730313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180440|NCT01730313|GABA Agents|gaba agents|mesh-ancestor
25180441|NCT01730313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25180442|NCT01730313|Antimanic Agents|antimanic agents|mesh-ancestor
25180443|NCT01730313|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25180444|NCT01730313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25180445|NCT01730313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24501071|NCT00526617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665445|NCT01684748|Olmesartan|olmesartan|mesh-list
25180446|NCT01730313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25180447|NCT01730313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25180448|NCT01730313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25180449|NCT01730313|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25180450|NCT01730313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25180452|NCT01679119|Prednisolone|prednisolone|mesh-list
25180453|NCT01679119|Cyclophosphamide|cyclophosphamide|mesh-list
25180454|NCT01679119|Rituximab|rituximab|mesh-list
25180455|NCT01679119|Vincristine|vincristine|mesh-list
25180456|NCT01679119|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25180457|NCT01679119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25180458|NCT01679119|Immunologic Factors|immunologic factors|mesh-ancestor
25180459|NCT01679119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180460|NCT01679119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25180461|NCT01679119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25180462|NCT01679119|Alkylating Agents|alkylating agents|mesh-ancestor
25180463|NCT01679119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180464|NCT01679119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180465|NCT01679119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25180466|NCT01679119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25180467|NCT01679119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25180468|NCT01679119|Antimetabolites|antimetabolites|mesh-ancestor
25180469|NCT01679119|Antiviral Agents|antiviral agents|mesh-ancestor
25180470|NCT01679119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25180471|NCT01679119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180472|NCT01679119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25180473|NCT01679119|Tubulin Modulators|tubulin modulators|mesh-ancestor
25180474|NCT01679119|Antimitotic Agents|antimitotic agents|mesh-ancestor
25180475|NCT01679119|Mitosis Modulators|mitosis modulators|mesh-ancestor
25180476|NCT01679119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25180477|NCT01679119|Glucocorticoids|glucocorticoids|mesh-ancestor
25180478|NCT01679119|Hormones|hormones|mesh-ancestor
25180479|NCT01679119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25180480|NCT01679119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25180481|NCT01679119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25180482|NCT01617096|Dapivirine|dapivirine|mesh-list
25180483|NCT01617096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25180484|NCT01617096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25180485|NCT01617096|Antiviral Agents|antiviral agents|mesh-ancestor
25180486|NCT01617096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25180487|NCT01478698|Plasminogen|plasminogen|mesh-list
25180488|NCT01478698|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25180489|NCT01478698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25180490|NCT01478698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25180491|NCT01478698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180492|NCT01428089|Progesterone|progesterone|mesh-list
25180493|NCT01428089|Progestins|progestins|mesh-ancestor
25180494|NCT01428089|Hormones|hormones|mesh-ancestor
25180495|NCT01428089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25180496|NCT01428089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180497|NCT01372254|Nicotine|nicotine|mesh-list
25180498|NCT01372254|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25180499|NCT01372254|Autonomic Agents|autonomic agents|mesh-ancestor
25180500|NCT01372254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25180501|NCT01372254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180502|NCT01372254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25180503|NCT01372254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25180504|NCT01372254|Cholinergic Agents|cholinergic agents|mesh-ancestor
25180505|NCT01372254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25180506|NCT01372254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180507|NCT01351766|Nicotine|nicotine|mesh-list
25180508|NCT01351766|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25180509|NCT01351766|Autonomic Agents|autonomic agents|mesh-ancestor
25180510|NCT01351766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25180511|NCT01351766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849513|NCT02248883|Moxifloxacin|moxifloxacin|mesh-list
25180512|NCT01351766|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25180513|NCT01351766|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25180514|NCT01351766|Cholinergic Agents|cholinergic agents|mesh-ancestor
25180515|NCT01351766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25180516|NCT01351766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180517|NCT01340430|Trastuzumab|trastuzumab|mesh-list
25180518|NCT01340430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25180519|NCT01340430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180520|NCT01199380|Nicotine|nicotine|mesh-list
25180521|NCT01199380|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25180522|NCT01199380|Autonomic Agents|autonomic agents|mesh-ancestor
25180536|NCT01064635|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25180537|NCT01064635|Hormone Antagonists|hormone antagonists|mesh-ancestor
24531622|NCT00636831|Cefazolin|cefazolin|mesh-list
25180538|NCT01064635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25180539|NCT01064635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180540|NCT00930228|Flutamide|flutamide|mesh-list
25180541|NCT00930228|Androgen Antagonists|androgen antagonists|mesh-ancestor
25180542|NCT00930228|Hormone Antagonists|hormone antagonists|mesh-ancestor
25180543|NCT00930228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25180544|NCT00930228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180545|NCT00930228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25180546|NCT00930228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180547|NCT00929006|Progesterone|progesterone|mesh-list
25180548|NCT00929006|Progestins|progestins|mesh-ancestor
25180549|NCT00929006|Hormones|hormones|mesh-ancestor
25180550|NCT00929006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25180551|NCT00929006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180556|NCT00877214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25180557|NCT00877214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180558|NCT00877214|Immunologic Factors|immunologic factors|mesh-ancestor
25180559|NCT00877214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180560|NCT00877214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25180561|NCT00810017|Trastuzumab|trastuzumab|mesh-list
25180562|NCT00810017|Etoposide|etoposide|mesh-list
25180563|NCT00810017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25180564|NCT00810017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180565|NCT00810017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25180566|NCT00810017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25180567|NCT00810017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25180568|NCT00810017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180569|NCT00810017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180570|NCT00669669|Plerixafor|plerixafor|mesh-list
25180571|NCT00669669|Temozolomide|temozolomide|mesh-list
25180572|NCT00669669|Carmustine|carmustine|mesh-list
25180573|NCT00669669|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
25180574|NCT00669669|Lenograstim|lenograstim|mesh-list
25180575|NCT00669669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25180576|NCT00669669|Immunologic Factors|immunologic factors|mesh-ancestor
25180577|NCT00669669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180578|NCT00669669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25180579|NCT00669669|Alkylating Agents|alkylating agents|mesh-ancestor
25180580|NCT00669669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180581|NCT00669669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180582|NCT00669669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25180583|NCT00669669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25180584|NCT00669669|Antiviral Agents|antiviral agents|mesh-ancestor
25180585|NCT00669669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25180586|NCT00669669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180679|NCT00002981|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25180680|NCT00002981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180681|NCT02850250|Cefuroxime|cefuroxime|mesh-list
25180682|NCT02850250|Cefuroxime axetil|cefuroxime axetil|mesh-list
25180683|NCT02850250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25180684|NCT02850250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25180685|NCT02850445|Olanzapine|olanzapine|mesh-list
25180686|NCT02850445|Antiemetics|antiemetics|mesh-ancestor
25180687|NCT02850445|Autonomic Agents|autonomic agents|mesh-ancestor
25180688|NCT02850445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25180689|NCT02850445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180690|NCT02850445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25180691|NCT02850445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25180692|NCT02850445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25180693|NCT02850445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25180694|NCT02850445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25180695|NCT02850445|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25180696|NCT02850445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25180844|NCT02849171|Lipotropic Agents|lipotropic agents|mesh-ancestor
25180705|NCT02850211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25180706|NCT02850211|Analgesics|analgesics|mesh-ancestor
25180707|NCT02850211|Sensory System Agents|sensory system agents|mesh-ancestor
25180708|NCT02850211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25180709|NCT02850211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180710|NCT02850211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25180711|NCT02850211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25180712|NCT02850211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25180713|NCT02850211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665446|NCT01684748|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25180714|NCT02850211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180715|NCT02850211|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25180716|NCT02850211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25180717|NCT02850211|Narcotics|narcotics|mesh-ancestor
25180718|NCT02850211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25180719|NCT02850289|Interferons|interferons|mesh-list
25180721|NCT02850289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180722|NCT02850289|Antiviral Agents|antiviral agents|mesh-ancestor
25180723|NCT02850289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25180724|NCT02850289|Antimetabolites|antimetabolites|mesh-ancestor
25180725|NCT02850289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180726|NCT02850484|Budesonide|budesonide|mesh-list
25180727|NCT02850484|Formoterol Fumarate|formoterol fumarate|mesh-list
25180728|NCT02850484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25180729|NCT02850484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25180730|NCT02850484|Autonomic Agents|autonomic agents|mesh-ancestor
25180731|NCT02850484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25180732|NCT02850484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180733|NCT02850484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25180734|NCT02850484|Respiratory System Agents|respiratory system agents|mesh-ancestor
25180735|NCT02850484|Glucocorticoids|glucocorticoids|mesh-ancestor
25180736|NCT02850484|Hormones|hormones|mesh-ancestor
25180737|NCT02850484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25180738|NCT02850484|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25180739|NCT02850484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25180740|NCT02850484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25180741|NCT02850484|Adrenergic Agents|adrenergic agents|mesh-ancestor
25180742|NCT02850484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25180743|NCT02850484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205151|NCT05174598|Micronutrients|micronutrients|mesh-ancestor
25205152|NCT05174598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25205153|NCT05151848|Adalimumab|adalimumab|mesh-list
25205154|NCT05151848|Tofacitinib|tofacitinib|mesh-list
25205155|NCT05151848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25205156|NCT05151848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25205157|NCT05151848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25205158|NCT05151848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205159|NCT05151848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205160|NCT05134688|Magnesium Sulfate|magnesium sulfate|mesh-list
25205161|NCT05134688|Analgesics|analgesics|mesh-ancestor
25205162|NCT05134688|Sensory System Agents|sensory system agents|mesh-ancestor
25205163|NCT05134688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25205164|NCT05134688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205165|NCT05134688|Anesthetics|anesthetics|mesh-ancestor
25180744|NCT02850081|Atorvastatin|atorvastatin|mesh-list
25180745|NCT02850081|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
25180746|NCT02850081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25180747|NCT02850081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25180748|NCT02850081|Antimetabolites|antimetabolites|mesh-ancestor
25180749|NCT02850081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180750|NCT02850081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25180751|NCT02850081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180752|NCT02849873|Tazarotene|tazarotene|mesh-list
25180753|NCT02849873|Dermatologic Agents|dermatologic agents|mesh-ancestor
25180754|NCT02849873|Keratolytic Agents|keratolytic agents|mesh-ancestor
25180755|NCT02849782|4-Aminopyridine|4-aminopyridine|mesh-list
25180756|NCT02849782|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25180757|NCT02849782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25180758|NCT02849782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180766|NCT02849743|Oxytocin|oxytocin|mesh-list
25180767|NCT02849743|Oxytocics|oxytocics|mesh-ancestor
25180768|NCT02849743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25180769|NCT02849743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180770|NCT02849483|Ramosetron|ramosetron|mesh-list
25180771|NCT02849483|Antiemetics|antiemetics|mesh-ancestor
25180772|NCT02849483|Autonomic Agents|autonomic agents|mesh-ancestor
25180773|NCT02849483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25180774|NCT02849483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180775|NCT02849483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25180776|NCT02849483|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25180777|NCT02849483|Serotonin Agents|serotonin agents|mesh-ancestor
25180778|NCT02849483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25180779|NCT02849483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180780|NCT02849730|Fentanyl|fentanyl|mesh-list
25210191|NCT02698969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210192|NCT02698969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25210193|NCT02698969|Anesthetics, General|anesthetics, general|mesh-ancestor
25210195|NCT02698969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25210196|NCT02698969|Narcotics|narcotics|mesh-ancestor
25210197|NCT02698969|Analgesics|analgesics|mesh-ancestor
25210198|NCT02698969|Sensory System Agents|sensory system agents|mesh-ancestor
25210199|NCT02698969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25210200|NCT02698969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25210201|NCT02698969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25210202|NCT02698969|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25180781|NCT02849730|Analgesics|analgesics|mesh-list
25180782|NCT02849730|Ropivacaine|ropivacaine|mesh-list
25180783|NCT02849730|Anesthetics, Local|anesthetics, local|mesh-ancestor
25180784|NCT02849730|Anesthetics|anesthetics|mesh-ancestor
25180785|NCT02849730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25180786|NCT02849730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180787|NCT02849730|Sensory System Agents|sensory system agents|mesh-ancestor
25180788|NCT02849730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25180789|NCT02849730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25180790|NCT02849730|Narcotics|narcotics|mesh-ancestor
25180803|NCT02849548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180804|NCT02849548|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25180805|NCT02849548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25180806|NCT02849548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180807|NCT02849236|Ropivacaine|ropivacaine|mesh-list
25180808|NCT02849236|Anesthetics, Local|anesthetics, local|mesh-ancestor
25180809|NCT02849236|Anesthetics|anesthetics|mesh-ancestor
25180810|NCT02849236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25180811|NCT02849236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180812|NCT02849236|Sensory System Agents|sensory system agents|mesh-ancestor
25180813|NCT02849236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25180814|NCT02848963|Ketamine|ketamine|mesh-list
25180815|NCT02848963|Propofol|propofol|mesh-list
25180816|NCT02848963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25180817|NCT02848963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25180818|NCT02848963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180819|NCT02848963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25180820|NCT02848963|Anesthetics, General|anesthetics, general|mesh-ancestor
25180821|NCT02848963|Anesthetics|anesthetics|mesh-ancestor
25180822|NCT02848963|Analgesics|analgesics|mesh-ancestor
25180823|NCT02848963|Sensory System Agents|sensory system agents|mesh-ancestor
25180824|NCT02848963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25180825|NCT02848963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25180826|NCT02848963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25180827|NCT02848963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25180828|NCT02848963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25180829|NCT02848963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180830|NCT02848937|Citric Acid|citric acid|mesh-list
25180831|NCT02848937|Sodium Citrate|sodium citrate|mesh-list
25180832|NCT02848937|Anticoagulants|anticoagulants|mesh-ancestor
25180833|NCT02848937|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25180834|NCT02848937|Chelating Agents|chelating agents|mesh-ancestor
25180835|NCT02848937|Sequestering Agents|sequestering agents|mesh-ancestor
25180836|NCT02848937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180837|NCT02848950|Metformin|metformin|mesh-list
25180838|NCT02848950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25180839|NCT02848950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180840|NCT02849132|Entecavir|entecavir|mesh-list
25180841|NCT02849132|Antiviral Agents|antiviral agents|mesh-ancestor
25180842|NCT02849132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25665447|NCT01684748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25665448|NCT01684748|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25665449|NCT01684748|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25665450|NCT01684748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665451|NCT01684878|Gemcitabine|gemcitabine|mesh-list
25665452|NCT01684878|Paclitaxel|paclitaxel|mesh-list
25665453|NCT01684878|Topotecan|topotecan|mesh-list
25665454|NCT01684878|Pertuzumab|pertuzumab|mesh-list
25665455|NCT01684878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25665456|NCT01684878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665457|NCT01684878|Tubulin Modulators|tubulin modulators|mesh-ancestor
25180843|NCT02849171|Choline|choline|mesh-list
25180845|NCT02849171|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25180846|NCT02849171|Antimetabolites|antimetabolites|mesh-ancestor
25665458|NCT01684878|Antimitotic Agents|antimitotic agents|mesh-ancestor
24531968|NCT00637715|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24531969|NCT00637715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24531970|NCT00637715|Adrenergic Agents|adrenergic agents|mesh-ancestor
24669376|NCT04058717|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24669377|NCT04058717|Cholinergic Agents|cholinergic agents|mesh-ancestor
25210223|NCT02698930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25210224|NCT02698930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210225|NCT02698930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25210226|NCT02698930|Analgesics|analgesics|mesh-ancestor
25210227|NCT02698930|Sensory System Agents|sensory system agents|mesh-ancestor
25210228|NCT02698930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25210229|NCT02698930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25210230|NCT02698930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25210231|NCT02698930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25210232|NCT02698930|Adrenergic Agents|adrenergic agents|mesh-ancestor
24394214|NCT00132561|Antiviral Agents|antiviral agents|mesh-ancestor
25180847|NCT02849171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180848|NCT02849171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25180849|NCT02849171|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25180850|NCT02849171|Nootropic Agents|nootropic agents|mesh-ancestor
25180851|NCT02848612|Heparin|heparin|mesh-list
25180852|NCT02848612|Calcium heparin|calcium heparin|mesh-list
25180853|NCT02848612|Anticoagulants|anticoagulants|mesh-ancestor
25180854|NCT02848612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25180855|NCT02848612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25180856|NCT02848612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180857|NCT02848794|Irinotecan|irinotecan|mesh-list
25180858|NCT02848794|Apatinib|apatinib|mesh-list
25180859|NCT02848794|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25180860|NCT02848794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25180861|NCT02848794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180862|NCT02848794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180863|NCT02848794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180864|NCT02848794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25180891|NCT02848768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180892|NCT02848508|Metformin|metformin|mesh-list
25180893|NCT02848508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24503524|NCT00532168|Protease Inhibitors|protease inhibitors|mesh-ancestor
24503935|NCT00533468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24503936|NCT00533468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503937|NCT00533468|Sensory System Agents|sensory system agents|mesh-ancestor
24503986|NCT00533611|Vitamins|vitamins|mesh-ancestor
24503987|NCT00533611|Micronutrients|micronutrients|mesh-ancestor
24503988|NCT00533624|Mycophenolic Acid|mycophenolic acid|mesh-list
24503989|NCT00533624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24503990|NCT00533624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810616|NCT02040987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810617|NCT02040987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810618|NCT02041117|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24503991|NCT00533624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24503997|NCT00533637|Cetirizine|cetirizine|mesh-list
25180894|NCT02848508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205166|NCT05134688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25205167|NCT05134688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25205168|NCT05134688|Anticonvulsants|anticonvulsants|mesh-ancestor
25205169|NCT05134688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25205170|NCT05134688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25665459|NCT01684878|Mitosis Modulators|mitosis modulators|mesh-ancestor
25665460|NCT01684878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665461|NCT01684878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25665462|NCT01684878|Antimetabolites|antimetabolites|mesh-ancestor
25665463|NCT01684878|Antiviral Agents|antiviral agents|mesh-ancestor
25665464|NCT01684878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25665465|NCT01684878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665466|NCT01684878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25665467|NCT01684878|Immunologic Factors|immunologic factors|mesh-ancestor
25665468|NCT01684878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665469|NCT01684878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25665470|NCT01684878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25665471|NCT01684878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25665472|NCT01684943|Insulin|insulin|mesh-list
25665473|NCT01684943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25665474|NCT01684943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205171|NCT05134688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205172|NCT05134688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25205173|NCT05134688|Tocolytic Agents|tocolytic agents|mesh-ancestor
25205174|NCT05134688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25205178|NCT05087589|Tofacitinib|tofacitinib|mesh-list
25205179|NCT05087589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25205180|NCT05087589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205181|NCT05087589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205182|NCT05079061|Misoprostol|misoprostol|mesh-list
25205183|NCT05079061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25205184|NCT05079061|Abortifacient Agents|abortifacient agents|mesh-ancestor
25205185|NCT05079061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25205186|NCT05079061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205187|NCT05079061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25205188|NCT05079061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25205189|NCT05079061|Oxytocics|oxytocics|mesh-ancestor
25205190|NCT05069545|Insulin|insulin|mesh-list
25205191|NCT05069545|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25205192|NCT05069545|Insulin Aspart|insulin aspart|mesh-list
25205193|NCT05069545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25205194|NCT05069545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207980|NCT00627250|Sensory System Agents|sensory system agents|mesh-ancestor
25207981|NCT00627250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25207982|NCT00454285|Amoxicillin|amoxicillin|mesh-list
25207983|NCT00454285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25207984|NCT00454285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25207985|NCT00405613|Aspirin|aspirin|mesh-list
25207986|NCT00405613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25207987|NCT00405613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25207988|NCT00405613|Analgesics|analgesics|mesh-ancestor
25207989|NCT00405613|Sensory System Agents|sensory system agents|mesh-ancestor
25207990|NCT00405613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25207991|NCT00405613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399736|NCT00148551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24399737|NCT00148551|Glucocorticoids|glucocorticoids|mesh-ancestor
25207992|NCT00405613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25207993|NCT00405613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25207994|NCT00405613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25207995|NCT00405613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25207996|NCT00405613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207997|NCT00405613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25207998|NCT00405613|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25207999|NCT00405613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208000|NCT00405613|Antipyretics|antipyretics|mesh-ancestor
25208001|NCT00126672|Sirolimus|sirolimus|mesh-list
25208002|NCT00126672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25208003|NCT00126672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25208004|NCT00126672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25208005|NCT00126672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208006|NCT00126672|Antifungal Agents|antifungal agents|mesh-ancestor
25208007|NCT00126672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25208008|NCT00126672|Immunologic Factors|immunologic factors|mesh-ancestor
25208009|NCT00126672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208010|NCT03172780|Diclofenac|diclofenac|mesh-list
24504167|NCT00534391|Neomycin|neomycin|mesh-list
25180895|NCT02848443|Trifluridine|trifluridine|mesh-list
25180896|NCT02848443|Bevacizumab|bevacizumab|mesh-list
25180897|NCT02848443|Nivolumab|nivolumab|mesh-list
25180898|NCT02848443|Oxaliplatin|oxaliplatin|mesh-list
25180899|NCT02848443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25180900|NCT02848443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180901|NCT02848443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25180902|NCT02848443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25180903|NCT02848443|Growth Substances|growth substances|mesh-ancestor
25180904|NCT02848443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180905|NCT02848443|Growth Inhibitors|growth inhibitors|mesh-ancestor
25180906|NCT02848443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25180907|NCT02848443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180908|NCT02848443|Antimetabolites|antimetabolites|mesh-ancestor
25180909|NCT02848443|Antiviral Agents|antiviral agents|mesh-ancestor
25180910|NCT02848443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25180911|NCT02848183|Cytarabine|cytarabine|mesh-list
25180912|NCT02848183|Etoposide|etoposide|mesh-list
25180913|NCT02848183|Mitoxantrone|mitoxantrone|mesh-list
25180914|NCT02848183|Idarubicin|idarubicin|mesh-list
25180915|NCT02848183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25180916|NCT02848183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24532352|NCT00639522|Paclitaxel|paclitaxel|mesh-list
24532353|NCT00639522|Capecitabine|capecitabine|mesh-list
24532354|NCT00639522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25180917|NCT02848183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25180918|NCT02848183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25180919|NCT02848183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180920|NCT02848183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180921|NCT02848183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25180922|NCT02848183|Antimetabolites|antimetabolites|mesh-ancestor
25180923|NCT02848183|Antiviral Agents|antiviral agents|mesh-ancestor
25180924|NCT02848183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25180925|NCT02848183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25180926|NCT02848183|Immunologic Factors|immunologic factors|mesh-ancestor
25180927|NCT02848183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180928|NCT02848183|Analgesics|analgesics|mesh-ancestor
25180929|NCT02848183|Sensory System Agents|sensory system agents|mesh-ancestor
25180930|NCT02848183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25180931|NCT02848183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25180932|NCT02848417|Curcumin|curcumin|mesh-list
25180933|NCT02848417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25180934|NCT02848417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25180935|NCT02848417|Analgesics|analgesics|mesh-ancestor
25180936|NCT02848417|Sensory System Agents|sensory system agents|mesh-ancestor
25180937|NCT02848417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25180938|NCT02848417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180939|NCT02848417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25180940|NCT02848417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25180941|NCT02848417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25180942|NCT02848417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180943|NCT02848417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180944|NCT02848209|Phenol|phenol|mesh-list
25180945|NCT02848209|Croton Oil|croton oil|mesh-list
25180946|NCT02848209|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25180947|NCT02848209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25180948|NCT02848209|Disinfectants|disinfectants|mesh-ancestor
25180949|NCT02848209|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25180950|NCT02848209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25180951|NCT02848209|Dermatologic Agents|dermatologic agents|mesh-ancestor
25180952|NCT02848300|Bimatoprost|bimatoprost|mesh-list
25180953|NCT02848300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25180954|NCT02848170|Olmesartan|olmesartan|mesh-list
25180955|NCT02848170|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25180956|NCT02848170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25180957|NCT02848170|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25180958|NCT02848170|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25180959|NCT02848170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180960|NCT02848339|Aspirin|aspirin|mesh-list
25180961|NCT02848339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25180962|NCT02848339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25180963|NCT02848339|Analgesics|analgesics|mesh-ancestor
25180964|NCT02848339|Sensory System Agents|sensory system agents|mesh-ancestor
25180965|NCT02848339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25180966|NCT02848339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180967|NCT02848339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25180968|NCT02848339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25180969|NCT02848339|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25180970|NCT02848339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25180971|NCT02848339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180972|NCT02848339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25180973|NCT02848339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25180974|NCT02848339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180975|NCT02848339|Antipyretics|antipyretics|mesh-ancestor
25180976|NCT02848157|Dexmedetomidine|dexmedetomidine|mesh-list
25180977|NCT02848157|Ropivacaine|ropivacaine|mesh-list
25180978|NCT02848157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25180979|NCT02848157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25180980|NCT02848157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180981|NCT02848157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25180982|NCT02848157|Analgesics|analgesics|mesh-ancestor
25180983|NCT02848157|Sensory System Agents|sensory system agents|mesh-ancestor
25180984|NCT02848157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25180985|NCT02848157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25665475|NCT01685060|Ceritinib|ceritinib|mesh-list
25665476|NCT01685060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665477|NCT01685060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25210276|NCT02698553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25210277|NCT02698553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25210278|NCT02698553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210279|NCT02698553|Dopamine Agents|dopamine agents|mesh-ancestor
25210280|NCT02698553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25210285|NCT02698514|Sevoflurane|sevoflurane|mesh-list
25180986|NCT02848157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25180987|NCT02848157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25180988|NCT02848157|Adrenergic Agents|adrenergic agents|mesh-ancestor
25180989|NCT02848157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25180990|NCT02848157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25180991|NCT02848157|Anesthetics, Local|anesthetics, local|mesh-ancestor
25180992|NCT02848157|Anesthetics|anesthetics|mesh-ancestor
25180993|NCT02848287|Ropivacaine|ropivacaine|mesh-list
25180994|NCT02848287|Anesthetics, Local|anesthetics, local|mesh-ancestor
25180995|NCT02848287|Anesthetics|anesthetics|mesh-ancestor
25180996|NCT02848287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25180997|NCT02848287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25180998|NCT02848287|Sensory System Agents|sensory system agents|mesh-ancestor
24400129|NCT00149903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25180999|NCT02848287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25181000|NCT02847884|Infliximab|infliximab|mesh-list
25181001|NCT02847884|Dermatologic Agents|dermatologic agents|mesh-ancestor
25181002|NCT02847884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25181003|NCT02847884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25181004|NCT02848040|Bile Acids and Salts|bile acids and salts|mesh-list
25181005|NCT02848040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25181006|NCT02847806|Insulin|insulin|mesh-list
25181007|NCT02847806|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25181008|NCT02847806|Estradiol|estradiol|mesh-list
25181009|NCT02847806|Testosterone|testosterone|mesh-list
25181010|NCT02847806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25181011|NCT02847806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181012|NCT02847806|Estrogens|estrogens|mesh-ancestor
25181013|NCT02847806|Hormones|hormones|mesh-ancestor
25181014|NCT02847806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25181015|NCT02847806|Androgens|androgens|mesh-ancestor
25181016|NCT02847702|Naproxen|naproxen|mesh-list
25181017|NCT02847702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25181018|NCT02847702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25181019|NCT02847702|Analgesics|analgesics|mesh-ancestor
25181020|NCT02847702|Sensory System Agents|sensory system agents|mesh-ancestor
25181021|NCT02847702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25181022|NCT02847702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181023|NCT02847702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25181024|NCT02847702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25181025|NCT02847702|Gout Suppressants|gout suppressants|mesh-ancestor
25181026|NCT02847702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25181027|NCT02847702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25181028|NCT02847702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181029|NCT02847442|Levodopa|levodopa|mesh-list
25181030|NCT02847442|Opicapone|opicapone|mesh-list
25181031|NCT02847442|Dopa Decarboxylase|dopa decarboxylase|mesh-list
25181032|NCT02847442|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-list
25181033|NCT02847442|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25181034|NCT02847442|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25181035|NCT02847442|Dopamine Agents|dopamine agents|mesh-ancestor
25181036|NCT02847442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25181037|NCT02847442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181038|NCT02847442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181039|NCT02847442|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25181040|NCT02847442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25181041|NCT02847455|Rabeprazole|rabeprazole|mesh-list
25181042|NCT02847455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25181043|NCT02847455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25665478|NCT01685060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665479|NCT01685060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665480|NCT01685073|Zolpidem|zolpidem|mesh-list
25665481|NCT01685073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25665482|NCT01685073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25665483|NCT01685073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25665484|NCT01685073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665485|NCT01685073|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24669804|NCT03611010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24669805|NCT03611010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25181044|NCT02847455|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24810656|NCT02041455|Melatonin|melatonin|mesh-list
25181045|NCT02847455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25181046|NCT02847455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181047|NCT02847429|Crenolanib|crenolanib|mesh-list
25181048|NCT02847429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181049|NCT02847403|Exenatide|exenatide|mesh-list
25181050|NCT02847403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25181051|NCT02847403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181052|NCT02847403|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25181053|NCT02847403|Incretins|incretins|mesh-ancestor
25181054|NCT02847403|Hormones|hormones|mesh-ancestor
25181055|NCT02847403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25181056|NCT02847481|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25181057|NCT02847481|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25181058|NCT02847481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25181059|NCT02847481|Antitubercular Agents|antitubercular agents|mesh-ancestor
25181060|NCT02847338|Amlodipine|amlodipine|mesh-list
25181061|NCT02847338|Lisinopril|lisinopril|mesh-list
25181062|NCT02847338|Chlorthalidone|chlorthalidone|mesh-list
25181063|NCT02847338|Amiloride|amiloride|mesh-list
25181064|NCT02847338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25181065|NCT02847338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25181066|NCT02847338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25181067|NCT02847338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181068|NCT02847338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25181069|NCT02847338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181070|NCT02847338|Vasodilator Agents|vasodilator agents|mesh-ancestor
25181071|NCT02847338|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25181072|NCT02847338|Protease Inhibitors|protease inhibitors|mesh-ancestor
25181073|NCT02847338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25181074|NCT02847338|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25181075|NCT02847338|Protective Agents|protective agents|mesh-ancestor
25181076|NCT02847338|Diuretics|diuretics|mesh-ancestor
25181077|NCT02847338|Natriuretic Agents|natriuretic agents|mesh-ancestor
25181078|NCT02847338|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25181079|NCT02847338|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24946000|NCT03943888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400447|NCT00150579|Sympathomimetics|sympathomimetics|mesh-ancestor
25181080|NCT02847338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25181081|NCT02847338|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
25181082|NCT02847338|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25181083|NCT02847104|Insulin|insulin|mesh-list
25181084|NCT02847104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25181085|NCT02847104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25181086|NCT02847104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181087|NCT02847013|Bupivacaine|bupivacaine|mesh-list
25181088|NCT02847013|Anesthetics, Local|anesthetics, local|mesh-ancestor
25181089|NCT02847013|Anesthetics|anesthetics|mesh-ancestor
25181097|NCT02847091|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25181098|NCT02847091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181099|NCT02846909|Progesterone|progesterone|mesh-list
25181100|NCT02846909|Progestins|progestins|mesh-ancestor
25181101|NCT02846909|Hormones|hormones|mesh-ancestor
25181102|NCT02846909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25181103|NCT02846909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181104|NCT02846935|Decitabine|decitabine|mesh-list
25665486|NCT01685073|GABA Agonists|gaba agonists|mesh-ancestor
25665487|NCT01685073|GABA Agents|gaba agents|mesh-ancestor
25665488|NCT01685073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25665489|NCT01685073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665490|NCT01685138|Ceritinib|ceritinib|mesh-list
25665491|NCT01685138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665492|NCT01685138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25665493|NCT01685138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25181105|NCT02846935|Tetrahydrouridine|tetrahydrouridine|mesh-list
25181106|NCT02846935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24456496|NCT00331435|Dermatologic Agents|dermatologic agents|mesh-ancestor
24456498|NCT00331487|Rosiglitazone|rosiglitazone|mesh-list
24532981|NCT00641927|Lithium Carbonate|lithium carbonate|mesh-list
25860267|NCT00083109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25860268|NCT00083109|Immunologic Factors|immunologic factors|mesh-ancestor
25860269|NCT00083109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860270|NCT00083109|Antinematodal Agents|antinematodal agents|mesh-ancestor
25860271|NCT00083109|Anthelmintics|anthelmintics|mesh-ancestor
25860272|NCT00083109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25860273|NCT00083109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25860274|NCT00083109|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25860275|NCT00083109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25860276|NCT00083135|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
25210312|NCT02698748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25210313|NCT02698748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25210314|NCT02698748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25210315|NCT02698748|Analgesics|analgesics|mesh-ancestor
25210316|NCT02698748|Sensory System Agents|sensory system agents|mesh-ancestor
25210317|NCT02698748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25210318|NCT02698748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210319|NCT02698748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25210320|NCT02698748|Filaricides|filaricides|mesh-ancestor
25210321|NCT02698748|Antinematodal Agents|antinematodal agents|mesh-ancestor
25181107|NCT02846935|Antimetabolites|antimetabolites|mesh-ancestor
25181108|NCT02846935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181109|NCT02846935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181110|NCT02846935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25181111|NCT02847286|Dapivirine|dapivirine|mesh-list
25181112|NCT02847286|Clotrimazole|clotrimazole|mesh-list
25181113|NCT02847286|Miconazole|miconazole|mesh-list
25181114|NCT02847286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25181115|NCT02847286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25181116|NCT02847286|Antiviral Agents|antiviral agents|mesh-ancestor
25181117|NCT02847286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25181118|NCT02847286|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25181119|NCT02847286|Antifungal Agents|antifungal agents|mesh-ancestor
25181120|NCT02847286|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25181121|NCT02847286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25181122|NCT02847286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25181123|NCT02847286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181124|NCT02847286|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25181125|NCT02847286|Hormone Antagonists|hormone antagonists|mesh-ancestor
25181126|NCT02847286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25181127|NCT02847286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181128|NCT02847286|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25181129|NCT02847286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25181131|NCT02847000|Tetrahydrouridine|tetrahydrouridine|mesh-list
25181132|NCT02847000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25181133|NCT02847000|Antimetabolites|antimetabolites|mesh-ancestor
25181134|NCT02847000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181135|NCT02847000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181136|NCT02847000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25181137|NCT02847143|Oxytocin|oxytocin|mesh-list
25665494|NCT01685138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665495|NCT01685203|Ribavirin|ribavirin|mesh-list
25665496|NCT01685203|Antimetabolites|antimetabolites|mesh-ancestor
25665497|NCT01685203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665498|NCT01685203|Antiviral Agents|antiviral agents|mesh-ancestor
25665499|NCT01685203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25665500|NCT01685242|Cetirizine|cetirizine|mesh-list
25665501|NCT01685242|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25665502|NCT01685242|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25665503|NCT01685242|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25665504|NCT01685242|Histamine Antagonists|histamine antagonists|mesh-ancestor
25665505|NCT01685242|Histamine Agents|histamine agents|mesh-ancestor
25665506|NCT01685242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25665507|NCT01685242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665508|NCT01685242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665509|NCT01685372|Vaccines|vaccines|mesh-list
25665510|NCT01685372|Immunologic Factors|immunologic factors|mesh-ancestor
25665511|NCT01685372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665512|NCT01685411|Mycophenolic Acid|mycophenolic acid|mesh-list
25665513|NCT01685411|Cyclophosphamide|cyclophosphamide|mesh-list
25665514|NCT01685411|Busulfan|busulfan|mesh-list
25665515|NCT01685411|Allopurinol|allopurinol|mesh-list
25860280|NCT00083135|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25860281|NCT00083148|Capecitabine|capecitabine|mesh-list
25860282|NCT00083148|Irinotecan|irinotecan|mesh-list
25860283|NCT00083148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25210323|NCT02698267|Itraconazole|itraconazole|mesh-list
25210324|NCT02698267|Antifungal Agents|antifungal agents|mesh-ancestor
25860284|NCT00083148|Antimetabolites|antimetabolites|mesh-ancestor
25860285|NCT00083148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860286|NCT00083148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755602|NCT01727453|Warfarin|warfarin|mesh-list
25181138|NCT02847143|Oxytocics|oxytocics|mesh-ancestor
25181139|NCT02847143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25181140|NCT02847143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181141|NCT02846857|Insulin|insulin|mesh-list
25181142|NCT02846857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25181143|NCT02846857|Glucagon|glucagon|mesh-list
25181144|NCT02846857|Hormones|hormones|mesh-list
25181145|NCT02846857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25181146|NCT02846857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181147|NCT02846857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25181148|NCT02846857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25205225|NCT05029466|Psilocybin|psilocybin|mesh-list
25205226|NCT05029466|Hallucinogens|hallucinogens|mesh-ancestor
25205227|NCT05029466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205228|NCT05029466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25205229|NCT05024006|Interferons|interferons|mesh-list
25860287|NCT00083148|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25205230|NCT05024006|Ritonavir|ritonavir|mesh-list
25205231|NCT05024006|Lopinavir|lopinavir|mesh-list
25860288|NCT00083148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25860289|NCT00083148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860290|NCT00083161|Cyclophosphamide|cyclophosphamide|mesh-list
25860291|NCT00083161|Cisplatin|cisplatin|mesh-list
25860292|NCT00083161|Etoposide|etoposide|mesh-list
25860293|NCT00083161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25860294|NCT00083161|Immunologic Factors|immunologic factors|mesh-ancestor
25860295|NCT00083161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860296|NCT00083161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25860297|NCT00083161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25860298|NCT00083161|Alkylating Agents|alkylating agents|mesh-ancestor
25181157|NCT02846701|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25181158|NCT02846701|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25181159|NCT02846701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25181160|NCT02846701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25181161|NCT02846701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181162|NCT02846701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25181163|NCT02846701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181165|NCT02846701|Sensory System Agents|sensory system agents|mesh-ancestor
25181166|NCT02846701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25181167|NCT02846701|Antidepressive Agents|antidepressive agents|mesh-ancestor
25181168|NCT02846701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25181169|NCT02846701|Dopamine Agents|dopamine agents|mesh-ancestor
25181170|NCT02846831|Insulin|insulin|mesh-list
25181171|NCT02846831|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25181172|NCT02846831|Hormones|hormones|mesh-list
25181173|NCT02846831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25181174|NCT02846831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665516|NCT01685411|Levetiracetam|levetiracetam|mesh-list
25665517|NCT01685411|Tacrolimus|tacrolimus|mesh-list
25665518|NCT01685411|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25665519|NCT01685411|Lenograstim|lenograstim|mesh-list
25665520|NCT01685411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25665521|NCT01685411|Immunologic Factors|immunologic factors|mesh-ancestor
25665522|NCT01685411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665523|NCT01685411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25665524|NCT01685411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25665525|NCT01685411|Alkylating Agents|alkylating agents|mesh-ancestor
25665526|NCT01685411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409517|NCT03373851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665527|NCT01685411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24670120|NCT03251326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24670121|NCT03251326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24670123|NCT03251326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24670124|NCT03251326|Vasodilator Agents|vasodilator agents|mesh-ancestor
24670125|NCT03251326|Antiemetics|antiemetics|mesh-ancestor
24670126|NCT03251326|Autonomic Agents|autonomic agents|mesh-ancestor
24670127|NCT03251326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24670128|NCT03251326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24453037|NCT05354258|Anthelmintics|anthelmintics|mesh-ancestor
25181175|NCT02846831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25181176|NCT02846766|Lenvatinib|lenvatinib|mesh-list
25181177|NCT02846766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181178|NCT02846766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25181179|NCT02846766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25181180|NCT02846766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181181|NCT02846493|Dexamethasone|dexamethasone|mesh-list
25181182|NCT02846493|Bromocriptine|bromocriptine|mesh-list
25181183|NCT02846493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25181184|NCT02846493|Antiemetics|antiemetics|mesh-ancestor
25181185|NCT02846493|Autonomic Agents|autonomic agents|mesh-ancestor
25181186|NCT02846493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25181187|NCT02846493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181194|NCT02846493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25181195|NCT02846493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25181196|NCT02846493|Hormone Antagonists|hormone antagonists|mesh-ancestor
25181197|NCT02846493|Dopamine Agonists|dopamine agonists|mesh-ancestor
25181198|NCT02846493|Dopamine Agents|dopamine agents|mesh-ancestor
25181199|NCT02846493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25181200|NCT02846493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181201|NCT02846519|Rifampin|rifampin|mesh-list
25181202|NCT02846519|Esketamine|esketamine|mesh-list
25181203|NCT02846519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25181204|NCT02846519|Antitubercular Agents|antitubercular agents|mesh-ancestor
25181205|NCT02846519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25181206|NCT02846519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25181207|NCT02846519|Leprostatic Agents|leprostatic agents|mesh-ancestor
25181208|NCT02846519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25181209|NCT02846519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25181210|NCT02846519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181211|NCT02846519|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25181212|NCT02846519|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25181213|NCT02846519|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25181214|NCT02846519|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25181215|NCT02846519|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25181216|NCT02846519|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25181217|NCT02846519|Antidepressive Agents|antidepressive agents|mesh-ancestor
25181218|NCT02846519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25181219|NCT02846506|Metformin|metformin|mesh-list
25181220|NCT02846506|Canagliflozin|canagliflozin|mesh-list
25181221|NCT02846506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25181222|NCT02846506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181223|NCT02846506|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25181224|NCT02846506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181225|NCT02846428|Cyclophosphamide|cyclophosphamide|mesh-list
25181226|NCT02846428|Docetaxel|docetaxel|mesh-list
25181227|NCT02846428|Fluorouracil|fluorouracil|mesh-list
25181228|NCT02846428|Capecitabine|capecitabine|mesh-list
25181229|NCT02846428|Epirubicin|epirubicin|mesh-list
25181230|NCT02846428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25181231|NCT02846428|Immunologic Factors|immunologic factors|mesh-ancestor
25181232|NCT02846428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181233|NCT02846428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25181234|NCT02846428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25181235|NCT02846428|Alkylating Agents|alkylating agents|mesh-ancestor
25181236|NCT02846428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665528|NCT01685411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24472632|NCT00399867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25665529|NCT01685411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25665530|NCT01685411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665531|NCT01685411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25665532|NCT01685411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25665533|NCT01685411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25665534|NCT01685411|Antitubercular Agents|antitubercular agents|mesh-ancestor
25665535|NCT01685411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25665536|NCT01685411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24647103|NCT01206270|Androgens|androgens|mesh-ancestor
24647104|NCT01206270|Hormones|hormones|mesh-ancestor
24647105|NCT01206270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24647108|NCT01206270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25210330|NCT02698267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25210331|NCT02698267|Hormone Antagonists|hormone antagonists|mesh-ancestor
25210332|NCT02698267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24514318|NCT00589862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429755|NCT00244998|Fulvestrant|fulvestrant|mesh-list
24457759|NCT00335166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24457760|NCT00335166|Dopamine Agonists|dopamine agonists|mesh-ancestor
24514688|NCT00592241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24456548|NCT00331643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181237|NCT02846428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181238|NCT02846428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25181239|NCT02846428|Tubulin Modulators|tubulin modulators|mesh-ancestor
24401357|NCT00152750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25181240|NCT02846428|Antimitotic Agents|antimitotic agents|mesh-ancestor
25181241|NCT02846428|Mitosis Modulators|mitosis modulators|mesh-ancestor
25181242|NCT02846428|Antimetabolites|antimetabolites|mesh-ancestor
25181243|NCT02846428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25181244|NCT02846428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25181245|NCT02846428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25181246|NCT02846428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25181247|NCT02846428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25181254|NCT02846155|Simethicone|simethicone|mesh-list
25181255|NCT02846155|Antifoaming Agents|antifoaming agents|mesh-ancestor
25181256|NCT02846155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181257|NCT02846155|Emollients|emollients|mesh-ancestor
25181258|NCT02846155|Dermatologic Agents|dermatologic agents|mesh-ancestor
25181259|NCT02846090|Dexmedetomidine|dexmedetomidine|mesh-list
25181260|NCT02846090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25181261|NCT02846090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25181262|NCT02846090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181263|NCT02846090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25181265|NCT02846090|Sensory System Agents|sensory system agents|mesh-ancestor
25181266|NCT02846090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25181267|NCT02846090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25181268|NCT02846090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25181269|NCT02846090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25181270|NCT02846090|Adrenergic Agents|adrenergic agents|mesh-ancestor
25181271|NCT02846090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25181272|NCT02846090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181273|NCT02846142|Levonorgestrel|levonorgestrel|mesh-list
25181274|NCT02846142|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25181275|NCT02846142|Estradiol|estradiol|mesh-list
25181276|NCT02846142|Estrogens|estrogens|mesh-ancestor
25181277|NCT02846142|Hormones|hormones|mesh-ancestor
25181278|NCT02846142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25181279|NCT02846142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181280|NCT02846142|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25181281|NCT02846142|Contraceptive Agents|contraceptive agents|mesh-ancestor
25181282|NCT02846142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25181283|NCT02846142|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25665537|NCT01685411|Anticonvulsants|anticonvulsants|mesh-ancestor
25665538|NCT01685411|Nootropic Agents|nootropic agents|mesh-ancestor
25665539|NCT01685411|Antimetabolites|antimetabolites|mesh-ancestor
25665540|NCT01685411|Gout Suppressants|gout suppressants|mesh-ancestor
25665541|NCT01685411|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25665542|NCT01685411|Antioxidants|antioxidants|mesh-ancestor
25665543|NCT01685411|Protective Agents|protective agents|mesh-ancestor
25665544|NCT01685684|Oxycodone|oxycodone|mesh-list
25665545|NCT01685684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25665546|NCT01685684|Narcotics|narcotics|mesh-ancestor
25665547|NCT01685684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25665548|NCT01685684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665549|NCT01685684|Analgesics|analgesics|mesh-ancestor
25665550|NCT01685684|Sensory System Agents|sensory system agents|mesh-ancestor
25665551|NCT01685684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25674394|NCT01771627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674395|NCT01771627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25674396|NCT01771627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25860300|NCT00083161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181284|NCT02846142|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25181285|NCT02846142|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25181286|NCT02846142|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25181287|NCT02846025|Folic Acid|folic acid|mesh-list
24504806|NCT00538239|Sirolimus|sirolimus|mesh-list
25181288|NCT02846025|Vitamin B Complex|vitamin b complex|mesh-list
25181289|NCT02846025|Antioxidants|antioxidants|mesh-list
25181290|NCT02846025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181291|NCT02846025|Protective Agents|protective agents|mesh-ancestor
25181292|NCT02846025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181293|NCT02846025|Hematinics|hematinics|mesh-ancestor
25181294|NCT02846025|Vitamins|vitamins|mesh-ancestor
25181295|NCT02846025|Micronutrients|micronutrients|mesh-ancestor
25181296|NCT02845804|Everolimus|everolimus|mesh-list
25181297|NCT02845804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181298|NCT02845804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25181299|NCT02845804|Immunologic Factors|immunologic factors|mesh-ancestor
25181300|NCT02845804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181301|NCT02845856|Cetuximab|cetuximab|mesh-list
25181302|NCT02845856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25181303|NCT02845856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181304|NCT02845843|Interferons|interferons|mesh-list
25181305|NCT02845843|Ritonavir|ritonavir|mesh-list
25181306|NCT02845843|Lopinavir|lopinavir|mesh-list
25181307|NCT02845843|Interferon-beta|interferon-beta|mesh-list
25181308|NCT02845843|Interferon beta-1b|interferon beta-1b|mesh-list
25181309|NCT02845843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181310|NCT02845843|Antiviral Agents|antiviral agents|mesh-ancestor
25181311|NCT02845843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25181312|NCT02845843|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25181313|NCT02845843|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25181314|NCT02845843|Protease Inhibitors|protease inhibitors|mesh-ancestor
25181315|NCT02845843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25181316|NCT02845843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181317|NCT02845843|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25181318|NCT02845843|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25181319|NCT02845843|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25181320|NCT02845843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25181321|NCT02845843|Immunologic Factors|immunologic factors|mesh-ancestor
25181322|NCT02845843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181323|NCT02845843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25181324|NCT02845661|Dexmedetomidine|dexmedetomidine|mesh-list
25181325|NCT02845661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25181326|NCT02845661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25181327|NCT02845661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181328|NCT02845661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25181329|NCT02845661|Analgesics|analgesics|mesh-ancestor
25181330|NCT02845661|Sensory System Agents|sensory system agents|mesh-ancestor
25181331|NCT02845661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25181332|NCT02845661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25181333|NCT02845661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24401558|NCT00153244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181334|NCT02845661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25181335|NCT02845661|Adrenergic Agents|adrenergic agents|mesh-ancestor
25181336|NCT02845661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25181337|NCT02845661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181338|NCT02845908|Leucovorin|leucovorin|mesh-list
25181339|NCT02845908|Fluorouracil|fluorouracil|mesh-list
25181340|NCT02845908|Oxaliplatin|oxaliplatin|mesh-list
25181341|NCT02845908|Antimetabolites|antimetabolites|mesh-ancestor
25181342|NCT02845908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181343|NCT02845908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25181344|NCT02845908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181345|NCT02845908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25181346|NCT02845908|Immunologic Factors|immunologic factors|mesh-ancestor
25181347|NCT02845908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181348|NCT02845908|Antidotes|antidotes|mesh-ancestor
25181349|NCT02845908|Protective Agents|protective agents|mesh-ancestor
25181350|NCT02845908|Vitamin B Complex|vitamin b complex|mesh-ancestor
25181351|NCT02845908|Vitamins|vitamins|mesh-ancestor
25181352|NCT02845908|Micronutrients|micronutrients|mesh-ancestor
25181353|NCT02845999|Cyclophosphamide|cyclophosphamide|mesh-list
25181354|NCT02845999|Fludarabine|fludarabine|mesh-list
25181355|NCT02845999|Cetuximab|cetuximab|mesh-list
25181356|NCT02845999|Interleukin-2|interleukin-2|mesh-list
25181357|NCT02845999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25665552|NCT01685801|Ivacaftor|ivacaftor|mesh-list
24670444|NCT02567825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24670445|NCT02567825|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24670446|NCT02567825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24670447|NCT02567825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24670448|NCT02567825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24670449|NCT02567825|Renal Agents|renal agents|mesh-ancestor
24670450|NCT02567825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24670451|NCT02567825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24670453|NCT02567825|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24670454|NCT02567825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25210338|NCT02698280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181358|NCT02845999|Immunologic Factors|immunologic factors|mesh-ancestor
25181359|NCT02845999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181360|NCT02845999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25181361|NCT02845999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25181362|NCT02845999|Alkylating Agents|alkylating agents|mesh-ancestor
24504967|NCT00538811|Ribavirin|ribavirin|mesh-list
25181363|NCT02845999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181364|NCT02845999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181365|NCT02845999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25181366|NCT02845999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25181367|NCT02845999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25181368|NCT02845999|Analgesics|analgesics|mesh-ancestor
25181369|NCT02845999|Sensory System Agents|sensory system agents|mesh-ancestor
25181370|NCT02845999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25181371|NCT02845648|Cholinergic Antagonists|cholinergic antagonists|mesh-list
25181372|NCT02845648|Cholinergic Agents|cholinergic agents|mesh-ancestor
25181373|NCT02845648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25181374|NCT02845648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181375|NCT02845648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181376|NCT02845986|Oxaliplatin|oxaliplatin|mesh-list
25181377|NCT02845986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181378|NCT02845778|Melatonin|melatonin|mesh-list
25181379|NCT02845778|Antioxidants|antioxidants|mesh-ancestor
25181380|NCT02845778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181381|NCT02845778|Protective Agents|protective agents|mesh-ancestor
25181382|NCT02845778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181383|NCT02845778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25181384|NCT02845713|Ivermectin|ivermectin|mesh-list
25181385|NCT02845713|Albendazole|albendazole|mesh-list
25181386|NCT02845713|Diethylcarbamazine|diethylcarbamazine|mesh-list
25181387|NCT02845713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25181388|NCT02845713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402273|NCT00156299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181389|NCT02845713|Anthelmintics|anthelmintics|mesh-ancestor
25181390|NCT02845713|Anticestodal Agents|anticestodal agents|mesh-ancestor
25181391|NCT02845713|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25181392|NCT02845713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25181393|NCT02845713|Tubulin Modulators|tubulin modulators|mesh-ancestor
25181394|NCT02845713|Antimitotic Agents|antimitotic agents|mesh-ancestor
25181395|NCT02845713|Mitosis Modulators|mitosis modulators|mesh-ancestor
25181396|NCT02845713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181397|NCT02845713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181398|NCT02845713|Filaricides|filaricides|mesh-ancestor
25181399|NCT02845713|Antinematodal Agents|antinematodal agents|mesh-ancestor
25181400|NCT02845713|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25181401|NCT02845713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25181402|NCT02845765|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
25181403|NCT02845765|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25181404|NCT02845765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25181405|NCT02845765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665553|NCT01685801|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25665554|NCT01685801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25665555|NCT01685801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665556|NCT01685983|Prednisolone|prednisolone|mesh-list
25665557|NCT01685983|Abiraterone Acetate|abiraterone acetate|mesh-list
25665558|NCT01685983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25665559|NCT01685983|Glucocorticoids|glucocorticoids|mesh-ancestor
25665560|NCT01685983|Hormones|hormones|mesh-ancestor
25665561|NCT01685983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25665562|NCT01685983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665563|NCT01685983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24670726|NCT01998971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24670727|NCT01998971|Antiemetics|antiemetics|mesh-ancestor
24670728|NCT01998971|Autonomic Agents|autonomic agents|mesh-ancestor
24670759|NCT01998971|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24670760|NCT01998971|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24670761|NCT01998971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24670762|NCT01998971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25210348|NCT02698124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181406|NCT02845570|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25181407|NCT02845570|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25181408|NCT02845570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181409|NCT02845388|Sildenafil Citrate|sildenafil citrate|mesh-list
25181410|NCT02845388|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25181411|NCT02845388|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25181412|NCT02845388|Estradiol|estradiol|mesh-list
25181413|NCT02845388|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25181414|NCT02845388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181415|NCT02845388|Estrogens|estrogens|mesh-ancestor
25181416|NCT02845388|Hormones|hormones|mesh-ancestor
25181417|NCT02845388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25181418|NCT02845388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181419|NCT02845388|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25181420|NCT02845388|Contraceptive Agents|contraceptive agents|mesh-ancestor
25181421|NCT02845388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25181422|NCT02845388|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25181423|NCT02845388|Vasodilator Agents|vasodilator agents|mesh-ancestor
25181424|NCT02845388|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25181425|NCT02845388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25181426|NCT02845388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25181427|NCT02845388|Urological Agents|urological agents|mesh-ancestor
25181428|NCT02845466|Becaplermin|becaplermin|mesh-list
25181429|NCT02845466|Anticoagulants|anticoagulants|mesh-ancestor
24402558|NCT00157859|Pyrimethamine|pyrimethamine|mesh-list
25181430|NCT02845466|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
25181431|NCT02845466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25181432|NCT02845466|Growth Substances|growth substances|mesh-ancestor
25181433|NCT02845466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759279|NCT01750437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181434|NCT02845349|Vortioxetine|vortioxetine|mesh-list
25181435|NCT02845349|Antidepressive Agents|antidepressive agents|mesh-ancestor
25181436|NCT02845349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25181437|NCT02845349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25181438|NCT02845349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25181439|NCT02845349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25181440|NCT02845349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181441|NCT02845349|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25181442|NCT02845349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25181443|NCT02845349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25181444|NCT02845349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181445|NCT02845349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25181446|NCT02845349|Serotonin Agents|serotonin agents|mesh-ancestor
25181447|NCT02845349|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25181448|NCT02845349|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25181449|NCT02845349|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25181450|NCT02845349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25181451|NCT02845219|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25181452|NCT02845219|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
25181453|NCT02845219|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25181454|NCT02845219|Contraceptive Agents|contraceptive agents|mesh-ancestor
25181455|NCT02845219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25181456|NCT02845219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181457|NCT02845219|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25665564|NCT01685983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665565|NCT01685983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25665566|NCT01685983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665567|NCT01685983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665568|NCT01685983|Hormone Antagonists|hormone antagonists|mesh-ancestor
25665569|NCT01685983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25665570|NCT01685996|Zonisamide|zonisamide|mesh-list
25665571|NCT01685996|Anticonvulsants|anticonvulsants|mesh-ancestor
25181458|NCT02845219|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25181459|NCT02845219|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25181460|NCT02845219|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25181461|NCT02845219|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25181462|NCT02845219|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
25181463|NCT02845219|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25181464|NCT02845219|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25181465|NCT02845024|Doxycycline|doxycycline|mesh-list
25181466|NCT02845024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25181467|NCT02845024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25181468|NCT02845024|Antimalarials|antimalarials|mesh-ancestor
25181469|NCT02845024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25181470|NCT02845024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25205232|NCT05024006|Interferon-beta|interferon-beta|mesh-list
25205233|NCT05024006|Interferon beta-1a|interferon beta-1a|mesh-list
25205234|NCT05024006|Remdesivir|remdesivir|mesh-list
25205235|NCT05024006|Hydroxychloroquine|hydroxychloroquine|mesh-list
25205236|NCT05024006|Acalabrutinib|acalabrutinib|mesh-list
25205237|NCT05024006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402756|NCT00158405|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25205244|NCT05024006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205246|NCT05024006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25205247|NCT05024006|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25205248|NCT05024006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25205249|NCT05024006|Antimalarials|antimalarials|mesh-ancestor
25205250|NCT05024006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25205251|NCT05024006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25205252|NCT05024006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25205253|NCT05024006|Immunologic Factors|immunologic factors|mesh-ancestor
25205254|NCT05024006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205255|NCT05024006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25205256|NCT05024006|Antimetabolites|antimetabolites|mesh-ancestor
25205262|NCT04993027|Vancomycin|vancomycin|mesh-list
25205263|NCT04993027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25205264|NCT04993027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24461507|NCT00352482|Urological Agents|urological agents|mesh-ancestor
24461508|NCT00352495|Carboplatin|carboplatin|mesh-list
24461509|NCT00352495|Vinblastine|vinblastine|mesh-list
24461510|NCT00352495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461511|NCT00352495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24461512|NCT00352495|Tubulin Modulators|tubulin modulators|mesh-ancestor
24461537|NCT00352599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24461540|NCT00352625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24461541|NCT00352625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24461542|NCT00352625|Analgesics|analgesics|mesh-ancestor
24461543|NCT00352625|Sensory System Agents|sensory system agents|mesh-ancestor
24461544|NCT00352625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24403048|NCT00159133|Antiemetics|antiemetics|mesh-ancestor
24403049|NCT00159133|Autonomic Agents|autonomic agents|mesh-ancestor
24461545|NCT00352625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461546|NCT00352625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24461547|NCT00352625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24461548|NCT00352625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24461569|NCT00352742|Bortezomib|bortezomib|mesh-list
24461570|NCT00352742|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
25099544|NCT03190239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25099545|NCT03190239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099546|NCT03190239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25099547|NCT03190239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25099548|NCT03190239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25099549|NCT03189914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25099607|NCT03188978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25099608|NCT03188978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25099609|NCT03188978|Antimetabolites|antimetabolites|mesh-ancestor
25100035|NCT03186001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25100036|NCT03186001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100037|NCT03185871|Celecoxib|celecoxib|mesh-list
25100038|NCT03185871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25100039|NCT03185871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25100040|NCT03185871|Analgesics|analgesics|mesh-ancestor
25100159|NCT03185143|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25100160|NCT03185143|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25100161|NCT03185143|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25665572|NCT01685996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25210366|NCT02698306|Sensory System Agents|sensory system agents|mesh-ancestor
24514791|NCT00592930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24396362|NCT00138736|Lectins|lectins|mesh-list
24396592|NCT00139360|Bevacizumab|bevacizumab|mesh-list
24397689|NCT00142337|Antiviral Agents|antiviral agents|mesh-ancestor
24397770|NCT00142493|GABA Modulators|gaba modulators|mesh-ancestor
24968512|NCT03750721|Leprostatic Agents|leprostatic agents|mesh-ancestor
25100477|NCT03182634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100478|NCT03182595|Acetaminophen|acetaminophen|mesh-list
25100479|NCT03182595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25100480|NCT03182595|Analgesics|analgesics|mesh-ancestor
24507366|NCT00550121|Ascorbic Acid|ascorbic acid|mesh-list
25100510|NCT03182296|Incretins|incretins|mesh-ancestor
25100511|NCT03182296|Hormones|hormones|mesh-ancestor
25100512|NCT03182296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25100648|NCT03180957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25100649|NCT03180957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25100650|NCT03180970|Lugol's solution|lugol's solution|mesh-list
25100651|NCT03180970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25100652|NCT03180970|Hemostatics|hemostatics|mesh-ancestor
25100653|NCT03180970|Coagulants|coagulants|mesh-ancestor
25100654|NCT03180879|Ibuprofen|ibuprofen|mesh-list
25100655|NCT03180879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25100656|NCT03180879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25100657|NCT03180879|Analgesics|analgesics|mesh-ancestor
25100658|NCT03180879|Sensory System Agents|sensory system agents|mesh-ancestor
25100659|NCT03180879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25181471|NCT02844894|Dexmedetomidine|dexmedetomidine|mesh-list
25181472|NCT02844894|Esmolol|esmolol|mesh-list
24403052|NCT00159133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25181473|NCT02844894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25181474|NCT02844894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25181475|NCT02844894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181476|NCT02844894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25181477|NCT02844894|Analgesics|analgesics|mesh-ancestor
25181478|NCT02844894|Sensory System Agents|sensory system agents|mesh-ancestor
25181479|NCT02844894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25181480|NCT02844894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25181481|NCT02844894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25181482|NCT02844894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25181483|NCT02844894|Adrenergic Agents|adrenergic agents|mesh-ancestor
25181484|NCT02844894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25181485|NCT02844894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181486|NCT02844894|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25181487|NCT02844894|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25181488|NCT02844894|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25181489|NCT02844790|Insulin|insulin|mesh-list
25181490|NCT02844790|Insulin Aspart|insulin aspart|mesh-list
25181491|NCT02844790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25181492|NCT02844790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181493|NCT02844933|Cannabidiol|cannabidiol|mesh-list
25181494|NCT02844933|Anticonvulsants|anticonvulsants|mesh-ancestor
25181495|NCT02844881|Apatinib|apatinib|mesh-list
25181496|NCT02844881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181497|NCT02844881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25181498|NCT02844881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24946186|NCT03942354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24946187|NCT03942354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181499|NCT02844881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181500|NCT02844712|beta-Lactams|beta-lactams|mesh-list
25181501|NCT02844712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25181502|NCT02844712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25181503|NCT02845050|Cisplatin|cisplatin|mesh-list
25181504|NCT02845050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181505|NCT02844621|Omeprazole|omeprazole|mesh-list
25181506|NCT02844621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25181507|NCT02844621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25181508|NCT02844621|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25181509|NCT02844621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665573|NCT01685996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25665574|NCT01685996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665575|NCT01685996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25665576|NCT01685996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665577|NCT01686152|Imiquimod|imiquimod|mesh-list
25665578|NCT01686152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25272645|NCT02390739|Fludarabine|fludarabine|mesh-list
25181510|NCT02844621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181511|NCT02844673|Hydroxyurea|hydroxyurea|mesh-list
25181512|NCT02844673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181513|NCT02844673|Antisickling Agents|antisickling agents|mesh-ancestor
25181514|NCT02844673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25181515|NCT02844673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181516|NCT02844673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25181517|NCT02844803|Metformin|metformin|mesh-list
25181518|NCT02844803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25181519|NCT02844803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181520|NCT02844530|Epratuzumab|epratuzumab|mesh-list
25181521|NCT02844530|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
25181522|NCT02844530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25181525|NCT02844530|Sequestering Agents|sequestering agents|mesh-ancestor
25181526|NCT02844530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181527|NCT02844517|Pancrelipase|pancrelipase|mesh-list
25181528|NCT02844517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25181529|NCT02844634|Tenofovir|tenofovir|mesh-list
25181530|NCT02844634|Emtricitabine|emtricitabine|mesh-list
25181531|NCT02844634|Doxycycline|doxycycline|mesh-list
25181532|NCT02844634|Antiviral Agents|antiviral agents|mesh-ancestor
25181533|NCT02844634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25181534|NCT02844634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25181535|NCT02844634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25181536|NCT02844634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25181537|NCT02844634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181538|NCT02844634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25181539|NCT02844634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25181540|NCT02844634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25181541|NCT02844634|Antimalarials|antimalarials|mesh-ancestor
25181542|NCT02844634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25181543|NCT02844634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25181544|NCT02844153|Metformin|metformin|mesh-list
25181545|NCT02844153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25181546|NCT02844153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946233|NCT03941899|Anesthetics|anesthetics|mesh-ancestor
25181547|NCT02844387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25181548|NCT02844322|Rituximab|rituximab|mesh-list
25181549|NCT02844322|Bortezomib|bortezomib|mesh-list
25181550|NCT02844322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25181551|NCT02844322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181552|NCT02844322|Immunologic Factors|immunologic factors|mesh-ancestor
25181553|NCT02844322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181554|NCT02844322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25181555|NCT02844075|Pembrolizumab|pembrolizumab|mesh-list
25181556|NCT02844075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25181557|NCT02844075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181558|NCT02844309|Thalidomide|thalidomide|mesh-list
25181559|NCT02844309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25181560|NCT02844309|Immunologic Factors|immunologic factors|mesh-ancestor
25181561|NCT02844309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181562|NCT02844309|Leprostatic Agents|leprostatic agents|mesh-ancestor
25181563|NCT02844309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25181564|NCT02844309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25181565|NCT02844309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25181566|NCT02844309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25181567|NCT02844309|Growth Substances|growth substances|mesh-ancestor
25181568|NCT02844309|Growth Inhibitors|growth inhibitors|mesh-ancestor
25181569|NCT02844309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181570|NCT05242926|Docetaxel|docetaxel|mesh-list
25181571|NCT05242926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181572|NCT05242926|Tubulin Modulators|tubulin modulators|mesh-ancestor
25181573|NCT05242926|Antimitotic Agents|antimitotic agents|mesh-ancestor
24404201|NCT00162734|Interferons|interferons|mesh-list
25181574|NCT05242926|Mitosis Modulators|mitosis modulators|mesh-ancestor
25181575|NCT05242926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181576|NCT05242783|Terlipressin|terlipressin|mesh-list
25181577|NCT05242783|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25181578|NCT05242783|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25181579|NCT05242718|Palmidrol|palmidrol|mesh-list
25181580|NCT05242718|Acetylcysteine|acetylcysteine|mesh-list
25181581|NCT05242718|Curcumin|curcumin|mesh-list
25665579|NCT01686152|Immunologic Factors|immunologic factors|mesh-ancestor
25181582|NCT05242718|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25181583|NCT05242718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25181584|NCT05242718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24455930|NCT00329394|Sensory System Agents|sensory system agents|mesh-ancestor
24455941|NCT00329394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181585|NCT05242718|Analgesics|analgesics|mesh-ancestor
25181586|NCT05242718|Sensory System Agents|sensory system agents|mesh-ancestor
25181587|NCT05242718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25181588|NCT05242718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181589|NCT05242718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25181590|NCT05242718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25181591|NCT05242718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181592|NCT05242718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25181593|NCT05242718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181594|NCT05242718|Antiviral Agents|antiviral agents|mesh-ancestor
25181595|NCT05242718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25181596|NCT05242718|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25181605|NCT05242718|Protective Agents|protective agents|mesh-ancestor
25181606|NCT05242718|Antidotes|antidotes|mesh-ancestor
25181607|NCT05242419|Huperzine A|huperzine a|mesh-list
25181608|NCT05242419|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25181609|NCT05242419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449126|NCT00314509|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24404845|NCT00165048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25181610|NCT05242419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181611|NCT05242419|Cholinergic Agents|cholinergic agents|mesh-ancestor
25181612|NCT05242419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25181613|NCT05242419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181614|NCT05242419|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25181615|NCT05242419|Protective Agents|protective agents|mesh-ancestor
25181616|NCT05242133|Interferons|interferons|mesh-list
25181617|NCT05242133|Interferon-beta|interferon-beta|mesh-list
25181618|NCT05242133|Interferon beta-1a|interferon beta-1a|mesh-list
25181619|NCT05242133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181620|NCT05242133|Antiviral Agents|antiviral agents|mesh-ancestor
25181621|NCT05242133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25181622|NCT05242133|Immunologic Factors|immunologic factors|mesh-ancestor
25181623|NCT05242133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181624|NCT05242133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25181625|NCT05242120|Anesthetics|anesthetics|mesh-list
25181626|NCT05242120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25181627|NCT05242120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205279|NCT04956146|Carboplatin|carboplatin|mesh-list
25205280|NCT04956146|Pemetrexed|pemetrexed|mesh-list
25205281|NCT04956146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25205282|NCT04956146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205283|NCT04956146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181628|NCT05241938|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25181629|NCT05241938|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25181631|NCT05241912|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25181632|NCT05241912|Sympathomimetics|sympathomimetics|mesh-ancestor
25181633|NCT05241912|Autonomic Agents|autonomic agents|mesh-ancestor
25181634|NCT05241912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25181635|NCT05241912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181636|NCT05241912|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25181637|NCT05241912|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25181638|NCT05241912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25181639|NCT05241912|Adrenergic Agents|adrenergic agents|mesh-ancestor
25181640|NCT05241912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25181641|NCT05241912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181642|NCT05241912|Protective Agents|protective agents|mesh-ancestor
25181643|NCT05241821|Fibrinolytic Agents|fibrinolytic agents|mesh-list
25181644|NCT05241821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25181645|NCT05241821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181646|NCT05239182|Gemcitabine|gemcitabine|mesh-list
25181647|NCT05239182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25181648|NCT05239182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25181649|NCT05239182|Antimetabolites|antimetabolites|mesh-ancestor
25181650|NCT05239182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181651|NCT05239182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181652|NCT05239182|Antiviral Agents|antiviral agents|mesh-ancestor
25181653|NCT05239182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25665580|NCT01686152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665581|NCT01686152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665582|NCT01686152|Interferon Inducers|interferon inducers|mesh-ancestor
25665583|NCT01686165|Rituximab|rituximab|mesh-list
25181654|NCT05239182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25181655|NCT05239182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25181659|NCT05217654|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25181660|NCT05217654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629814|NCT01108042|Docetaxel|docetaxel|mesh-list
25181661|NCT05217654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25181662|NCT05217654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181666|NCT05168462|Norepinephrine|norepinephrine|mesh-list
25181667|NCT05168462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25181668|NCT05168462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25181669|NCT05168462|Adrenergic Agents|adrenergic agents|mesh-ancestor
25181670|NCT05168462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25181671|NCT05168462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181672|NCT05168462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181673|NCT05168462|Sympathomimetics|sympathomimetics|mesh-ancestor
25181674|NCT05168462|Autonomic Agents|autonomic agents|mesh-ancestor
25181675|NCT05168462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25181676|NCT05168462|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25181677|NCT05135104|Palbociclib|palbociclib|mesh-list
25181678|NCT05135104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181679|NCT05135104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25181680|NCT05135104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25181681|NCT05135104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181682|NCT05104047|Lobeline|lobeline|mesh-list
25181683|NCT05104047|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25181684|NCT05104047|Autonomic Agents|autonomic agents|mesh-ancestor
25181685|NCT05104047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25181686|NCT05104047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181687|NCT05104047|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25181688|NCT05104047|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25181689|NCT05104047|Cholinergic Agents|cholinergic agents|mesh-ancestor
25181690|NCT05104047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25182100|NCT04135937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25181691|NCT05104047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181692|NCT05104047|Respiratory System Agents|respiratory system agents|mesh-ancestor
25181694|NCT05078502|Cholecalciferol|cholecalciferol|mesh-list
25181695|NCT05078502|Vitamins|vitamins|mesh-ancestor
25181696|NCT05078502|Micronutrients|micronutrients|mesh-ancestor
25181697|NCT05078502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181698|NCT05078502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25181699|NCT05078502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25181700|NCT05040880|Telmisartan|telmisartan|mesh-list
24630829|NCT01114048|Autonomic Agents|autonomic agents|mesh-ancestor
24630830|NCT01114048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24630831|NCT01114048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24630832|NCT01114048|Glucocorticoids|glucocorticoids|mesh-ancestor
24630834|NCT01114048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24630835|NCT01114048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24630836|NCT01114048|Leprostatic Agents|leprostatic agents|mesh-ancestor
24630837|NCT01114048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24630838|NCT01114048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24630839|NCT01114048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24630840|NCT01114048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24630841|NCT01114048|Growth Substances|growth substances|mesh-ancestor
24630842|NCT01114048|Growth Inhibitors|growth inhibitors|mesh-ancestor
24630899|NCT01114568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630900|NCT01114750|Dextrans|dextrans|mesh-list
24630901|NCT01114750|Anticoagulants|anticoagulants|mesh-ancestor
24630902|NCT01114750|Plasma Substitutes|plasma substitutes|mesh-ancestor
24630903|NCT01114750|Blood Substitutes|blood substitutes|mesh-ancestor
24630904|NCT01114841|Tazarotene|tazarotene|mesh-list
24630905|NCT01114841|Dermatologic Agents|dermatologic agents|mesh-ancestor
24630906|NCT01114841|Keratolytic Agents|keratolytic agents|mesh-ancestor
24630907|NCT01114854|Topiramate|topiramate|mesh-list
24630908|NCT01114854|Anticonvulsants|anticonvulsants|mesh-ancestor
25181701|NCT05040880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24701612|NCT01459887|Prednisone|prednisone|mesh-list
25181702|NCT05040880|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25181703|NCT05040880|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25181704|NCT05040880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181705|NCT05007509|Vaccines|vaccines|mesh-list
24630909|NCT01114854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25181724|NCT04967573|Protease Inhibitors|protease inhibitors|mesh-ancestor
25181725|NCT04967573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25181726|NCT04967573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181727|NCT04967573|Anticoagulants|anticoagulants|mesh-ancestor
25181728|NCT04954365|Amisulpride|amisulpride|mesh-list
25181729|NCT04954365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25181730|NCT04954365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25181731|NCT04954365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25181732|NCT04954365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181733|NCT04954365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25181734|NCT04954365|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25181735|NCT04954365|Dopamine Agents|dopamine agents|mesh-ancestor
25181736|NCT04954365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25181737|NCT04954365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181738|NCT04954365|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25181739|NCT04954365|Antidepressive Agents|antidepressive agents|mesh-ancestor
25181740|NCT04931979|Pembrolizumab|pembrolizumab|mesh-list
25181741|NCT04931979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25181742|NCT04931979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181743|NCT04918810|Docetaxel|docetaxel|mesh-list
25181744|NCT04918810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181745|NCT04918810|Tubulin Modulators|tubulin modulators|mesh-ancestor
25181746|NCT04918810|Antimitotic Agents|antimitotic agents|mesh-ancestor
25181747|NCT04918810|Mitosis Modulators|mitosis modulators|mesh-ancestor
25181748|NCT04918810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631265|NCT01116635|Doxorubicin|doxorubicin|mesh-list
25181761|NCT04887402|Clomiphene|clomiphene|mesh-list
25181762|NCT04887402|Enclomiphene|enclomiphene|mesh-list
25181763|NCT04887402|Zuclomiphene|zuclomiphene|mesh-list
25181764|NCT04887402|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25181765|NCT04887402|Hormone Antagonists|hormone antagonists|mesh-ancestor
25181766|NCT04887402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25181767|NCT04887402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181768|NCT04887402|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25181769|NCT04887402|Fertility Agents|fertility agents|mesh-ancestor
25181770|NCT04887402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25181771|NCT04887402|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25181772|NCT04887402|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25205284|NCT04956146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25205285|NCT04956146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25205286|NCT04951817|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25205287|NCT04951817|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25205288|NCT04951817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205289|NCT04942067|Dexamethasone|dexamethasone|mesh-list
25205290|NCT04942067|Dexamethasone acetate|dexamethasone acetate|mesh-list
25205291|NCT04942067|Lenalidomide|lenalidomide|mesh-list
25205292|NCT04942067|Daratumumab|daratumumab|mesh-list
25205293|NCT04942067|Pomalidomide|pomalidomide|mesh-list
25205295|NCT04942067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25205296|NCT04942067|Antiemetics|antiemetics|mesh-ancestor
25205297|NCT04942067|Autonomic Agents|autonomic agents|mesh-ancestor
25205298|NCT04942067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25205299|NCT04942067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205300|NCT04942067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25205301|NCT04942067|Glucocorticoids|glucocorticoids|mesh-ancestor
25205303|NCT04942067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25205304|NCT04942067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25205305|NCT04942067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25205306|NCT04942067|Protease Inhibitors|protease inhibitors|mesh-ancestor
25205307|NCT04942067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205308|NCT04942067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205309|NCT04942067|Immunologic Factors|immunologic factors|mesh-ancestor
25205310|NCT04942067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25205311|NCT04942067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25205312|NCT04942067|Growth Substances|growth substances|mesh-ancestor
25205313|NCT04942067|Growth Inhibitors|growth inhibitors|mesh-ancestor
25205314|NCT04931368|Rituximab|rituximab|mesh-list
25205315|NCT04931368|Methotrexate|methotrexate|mesh-list
25205316|NCT04931368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25181789|NCT04782700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25181790|NCT04782700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181791|NCT04782700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25181792|NCT04782700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181793|NCT04750005|Listerine|listerine|mesh-list
25181794|NCT04750005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25181795|NCT04750005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25181796|NCT04748783|Listerine|listerine|mesh-list
25181797|NCT04748783|Chlorhexidine|chlorhexidine|mesh-list
25181798|NCT04748783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25181799|NCT04748783|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25181800|NCT04748783|Sodium Fluoride|sodium fluoride|mesh-list
25181801|NCT04748783|Cariostatic Agents|cariostatic agents|mesh-ancestor
25181802|NCT04748783|Protective Agents|protective agents|mesh-ancestor
25181803|NCT04748783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181804|NCT04748783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25181849|NCT04646356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25181850|NCT04646356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181853|NCT04635241|Anticoagulants|anticoagulants|mesh-ancestor
25181854|NCT04635241|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25181855|NCT04635241|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25181856|NCT04635241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181857|NCT04628663|Dexmedetomidine|dexmedetomidine|mesh-list
24407873|NCT00175812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407874|NCT00175812|Keratolytic Agents|keratolytic agents|mesh-ancestor
24407875|NCT00175812|Dermatologic Agents|dermatologic agents|mesh-ancestor
25181858|NCT04628663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25181859|NCT04628663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25181860|NCT04628663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181861|NCT04628663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25181862|NCT04628663|Analgesics|analgesics|mesh-ancestor
25181863|NCT04628663|Sensory System Agents|sensory system agents|mesh-ancestor
25181864|NCT04628663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25181865|NCT04628663|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25181866|NCT04628663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25181867|NCT04628663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25181868|NCT04628663|Adrenergic Agents|adrenergic agents|mesh-ancestor
25181869|NCT04628663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25181870|NCT04628663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181891|NCT04570176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25181892|NCT04570176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25665584|NCT01686165|Belinostat|belinostat|mesh-list
25665585|NCT01686165|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25181893|NCT04570176|Autonomic Agents|autonomic agents|mesh-ancestor
25181894|NCT04570176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25181895|NCT04570176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25181896|NCT04570176|Respiratory System Agents|respiratory system agents|mesh-ancestor
25860302|NCT00083161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25860303|NCT00083161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25181898|NCT04570176|Sympathomimetics|sympathomimetics|mesh-ancestor
25181899|NCT04570176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24407876|NCT00175812|Anticonvulsants|anticonvulsants|mesh-ancestor
25181905|NCT04545541|Heparin|heparin|mesh-list
25181906|NCT04545541|Calcium heparin|calcium heparin|mesh-list
25181907|NCT04545541|Anticoagulants|anticoagulants|mesh-ancestor
25181908|NCT04545541|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25181909|NCT04545541|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25181910|NCT04545541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181911|NCT04481308|Fentanyl|fentanyl|mesh-list
25181912|NCT04481308|Propofol|propofol|mesh-list
25181913|NCT04481308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25181914|NCT04481308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25181915|NCT04481308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181916|NCT04481308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25181917|NCT04481308|Anesthetics, General|anesthetics, general|mesh-ancestor
25181918|NCT04481308|Anesthetics|anesthetics|mesh-ancestor
25181919|NCT04481308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25181920|NCT04481308|Narcotics|narcotics|mesh-ancestor
25181921|NCT04481308|Analgesics|analgesics|mesh-ancestor
25181922|NCT04481308|Sensory System Agents|sensory system agents|mesh-ancestor
25181923|NCT04481308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25181924|NCT04481308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25181925|NCT04475848|Midazolam|midazolam|mesh-list
25181926|NCT04475848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25181927|NCT04475848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25181928|NCT04475848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25181929|NCT04475848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181930|NCT04475848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25181931|NCT04475848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25181932|NCT04475848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25181933|NCT04475848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25181934|NCT04475848|Anesthetics, General|anesthetics, general|mesh-ancestor
25181935|NCT04475848|Anesthetics|anesthetics|mesh-ancestor
25181936|NCT04475848|GABA Modulators|gaba modulators|mesh-ancestor
25181937|NCT04475848|GABA Agents|gaba agents|mesh-ancestor
25181938|NCT04475848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25181939|NCT04475848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25181941|NCT04469699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25181942|NCT04469699|Dermatologic Agents|dermatologic agents|mesh-ancestor
25181943|NCT04452565|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25181944|NCT04452565|Dexamethasone|dexamethasone|mesh-list
25181945|NCT04452565|Dexamethasone acetate|dexamethasone acetate|mesh-list
25181946|NCT04452565|BB 1101|bb 1101|mesh-list
25181947|NCT04452565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25181948|NCT04452565|Antiemetics|antiemetics|mesh-ancestor
25181949|NCT04452565|Autonomic Agents|autonomic agents|mesh-ancestor
25181950|NCT04452565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25181951|NCT04452565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181952|NCT04452565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25181953|NCT04452565|Glucocorticoids|glucocorticoids|mesh-ancestor
25181954|NCT04452565|Hormones|hormones|mesh-ancestor
25181964|NCT04452565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25181966|NCT04452565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25181967|NCT04410328|Aspirin|aspirin|mesh-list
25181968|NCT04410328|Dipyridamole|dipyridamole|mesh-list
25181969|NCT04410328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25181970|NCT04410328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25181971|NCT04410328|Analgesics|analgesics|mesh-ancestor
25181972|NCT04410328|Sensory System Agents|sensory system agents|mesh-ancestor
25181973|NCT04410328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25181974|NCT04410328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25181975|NCT04410328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25181976|NCT04410328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25181977|NCT04410328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25181978|NCT04410328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25181979|NCT04410328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665586|NCT01686165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25665587|NCT01686165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25181980|NCT04410328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25181981|NCT04410328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25181982|NCT04410328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25181983|NCT04410328|Antipyretics|antipyretics|mesh-ancestor
25181984|NCT04410328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25181985|NCT04410328|Vasodilator Agents|vasodilator agents|mesh-ancestor
25181986|NCT04400474|Atezolizumab|atezolizumab|mesh-list
24456259|NCT00330785|Atorvastatin|atorvastatin|mesh-list
25181987|NCT04400474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860304|NCT00083161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24395710|NCT00136734|Methylphenidate|methylphenidate|mesh-list
24397202|NCT00141063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24397203|NCT00141063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24811328|NCT02046421|Luteolytic Agents|luteolytic agents|mesh-ancestor
24811329|NCT02046421|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24811330|NCT02046421|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24397339|NCT00141375|Anticonvulsants|anticonvulsants|mesh-ancestor
24397340|NCT00141375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24397368|NCT00141401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24397369|NCT00141401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24397370|NCT00141401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397371|NCT00141401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24397372|NCT00141401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25181998|NCT04385589|Dapagliflozin|dapagliflozin|mesh-list
25181999|NCT04385589|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25182000|NCT04385589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25182001|NCT04385589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182002|NCT04385589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182003|NCT04375787|Atorvastatin|atorvastatin|mesh-list
25182004|NCT04375787|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25182005|NCT04375787|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25182006|NCT04375787|Antimetabolites|antimetabolites|mesh-ancestor
25182007|NCT04375787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182008|NCT04375787|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25182009|NCT04375787|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25182010|NCT04375787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25182011|NCT04355143|Colchicine|colchicine|mesh-list
25182031|NCT04345796|Protective Agents|protective agents|mesh-ancestor
25182032|NCT04345796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25182033|NCT04345796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25182034|NCT04345796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25182035|NCT04345796|Vasodilator Agents|vasodilator agents|mesh-ancestor
25182036|NCT04345796|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25182037|NCT04345796|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25182038|NCT04327063|Ropivacaine|ropivacaine|mesh-list
25182039|NCT04327063|Anesthetics, Local|anesthetics, local|mesh-ancestor
25182040|NCT04327063|Anesthetics|anesthetics|mesh-ancestor
25182041|NCT04327063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25182042|NCT04327063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182043|NCT04327063|Sensory System Agents|sensory system agents|mesh-ancestor
25182044|NCT04327063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25182045|NCT04280601|Vitamin D|vitamin d|mesh-list
25182046|NCT04280601|Vitamins|vitamins|mesh-ancestor
25182047|NCT04280601|Micronutrients|micronutrients|mesh-ancestor
25182048|NCT04280601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182049|NCT04280601|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24409074|NCT00180843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25182062|NCT04224584|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25182063|NCT04224584|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25182064|NCT04224584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25182065|NCT04224584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25182066|NCT04224584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182067|NCT04224584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25182068|NCT04224584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182069|NCT04224584|Analgesics|analgesics|mesh-ancestor
25182070|NCT04224584|Sensory System Agents|sensory system agents|mesh-ancestor
25182071|NCT04224584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25182072|NCT04224584|Antidepressive Agents|antidepressive agents|mesh-ancestor
25182073|NCT04224584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25182074|NCT04224584|Dopamine Agents|dopamine agents|mesh-ancestor
25205337|NCT04899791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205338|NCT04899791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25205360|NCT04882293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25205369|NCT04863248|Docetaxel|docetaxel|mesh-list
25205370|NCT04863248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25205371|NCT04863248|Tubulin Modulators|tubulin modulators|mesh-ancestor
25205372|NCT04863248|Antimitotic Agents|antimitotic agents|mesh-ancestor
25205373|NCT04863248|Mitosis Modulators|mitosis modulators|mesh-ancestor
25665588|NCT01686165|Immunologic Factors|immunologic factors|mesh-ancestor
25205374|NCT04863248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205375|NCT04862962|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25205376|NCT04862962|Ezetimibe|ezetimibe|mesh-list
25205377|NCT04862962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25205378|NCT04862962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25205379|NCT04862962|Antimetabolites|antimetabolites|mesh-ancestor
25205380|NCT04862962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205381|NCT04862962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25205382|NCT04862962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25205383|NCT04862962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205384|NCT04848714|Antivenins|antivenins|mesh-list
25205385|NCT04848714|Immunologic Factors|immunologic factors|mesh-ancestor
25205386|NCT04848714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398868|NCT00146016|Dopamine Agents|dopamine agents|mesh-ancestor
25182075|NCT04191421|Spartalizumab|spartalizumab|mesh-list
25182076|NCT04191421|Siltuximab|siltuximab|mesh-list
25182077|NCT04191421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25182078|NCT04191421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182079|NCT04191421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25182080|NCT04139434|Azacitidine|azacitidine|mesh-list
25182081|NCT04139434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25182082|NCT04139434|Antimetabolites|antimetabolites|mesh-ancestor
25182083|NCT04139434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182084|NCT04139434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25182085|NCT04139434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25182086|NCT04135937|Bupropion|bupropion|mesh-list
25182087|NCT04135937|Nicotine|nicotine|mesh-list
25182088|NCT04135937|Varenicline|varenicline|mesh-list
25182089|NCT04135937|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25182090|NCT04135937|Autonomic Agents|autonomic agents|mesh-ancestor
25182091|NCT04135937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25182092|NCT04135937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182093|NCT04135937|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25182094|NCT04135937|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25182095|NCT04135937|Cholinergic Agents|cholinergic agents|mesh-ancestor
25182096|NCT04135937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25182097|NCT04135937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182098|NCT04135937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25182099|NCT04135937|Antidepressive Agents|antidepressive agents|mesh-ancestor
25182101|NCT04135937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25182102|NCT04135937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25182103|NCT04135937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25182104|NCT04135937|Dopamine Agents|dopamine agents|mesh-ancestor
25182105|NCT04135937|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25182106|NCT04135937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25182107|NCT04135937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25182108|NCT04135495|Ivacaftor|ivacaftor|mesh-list
25182109|NCT04135495|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25182110|NCT04135495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25182111|NCT04135495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182112|NCT04129437|Ibuprofen|ibuprofen|mesh-list
25182113|NCT04129437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25182114|NCT04129437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25182115|NCT04129437|Analgesics|analgesics|mesh-ancestor
25182116|NCT04129437|Sensory System Agents|sensory system agents|mesh-ancestor
25182117|NCT04129437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25182118|NCT04129437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182119|NCT04129437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25182120|NCT04129437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25182121|NCT04129437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25182122|NCT04129437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25182123|NCT04129437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182124|NCT04073290|Rifaximin|rifaximin|mesh-list
25182125|NCT04073290|Lactulose|lactulose|mesh-list
25182126|NCT04073290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25182127|NCT04073290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25182128|NCT04073290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25182129|NCT03998488|Psyllium|psyllium|mesh-list
25182130|NCT03998488|Calcium polycarbophil|calcium polycarbophil|mesh-list
25182131|NCT03998488|Cathartics|cathartics|mesh-ancestor
25182132|NCT03998488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25182133|NCT03998488|Antidiarrheals|antidiarrheals|mesh-ancestor
25182134|NCT03987685|Topotecan|topotecan|mesh-list
25182135|NCT03987685|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25182136|NCT03987685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25860305|NCT00083161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449584|NCT00316095|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24449586|NCT00316160|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24537444|NCT00654576|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24446392|NCT00304629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446393|NCT00304629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446394|NCT00304629|Cholinergic Agents|cholinergic agents|mesh-ancestor
25182137|NCT03987685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25182138|NCT03987685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182139|NCT03987685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25182140|NCT03967223|Cyclophosphamide|cyclophosphamide|mesh-list
25182141|NCT03967223|Fludarabine|fludarabine|mesh-list
25182142|NCT03967223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25182143|NCT03967223|Immunologic Factors|immunologic factors|mesh-ancestor
25182144|NCT03967223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398869|NCT00146016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25182145|NCT03967223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25182146|NCT03967223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25182147|NCT03967223|Alkylating Agents|alkylating agents|mesh-ancestor
25182148|NCT03967223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182149|NCT03967223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25182150|NCT03967223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25182152|NCT03936790|Ropivacaine|ropivacaine|mesh-list
25182153|NCT03936790|Anesthetics, Local|anesthetics, local|mesh-ancestor
25182154|NCT03936790|Anesthetics|anesthetics|mesh-ancestor
25182155|NCT03936790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25182156|NCT03936790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182157|NCT03936790|Sensory System Agents|sensory system agents|mesh-ancestor
25182158|NCT03936790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25182159|NCT03936790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25182160|NCT03936790|Narcotics|narcotics|mesh-ancestor
25182161|NCT03936790|Analgesics|analgesics|mesh-ancestor
25182162|NCT03936790|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25182163|NCT03936790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25182164|NCT03936790|Anesthetics, General|anesthetics, general|mesh-ancestor
25182165|NCT03931057|Midazolam|midazolam|mesh-list
25182166|NCT03931057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25182167|NCT03931057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25182168|NCT03931057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25182169|NCT03931057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182170|NCT03931057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25182171|NCT03931057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25182172|NCT03931057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25182173|NCT03931057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25182174|NCT03931057|Anesthetics, General|anesthetics, general|mesh-ancestor
25182175|NCT03931057|Anesthetics|anesthetics|mesh-ancestor
25182176|NCT03931057|GABA Modulators|gaba modulators|mesh-ancestor
25182177|NCT03931057|GABA Agents|gaba agents|mesh-ancestor
25182178|NCT03931057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25182179|NCT03931057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182200|NCT03896880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182201|NCT03896880|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25182202|NCT03896880|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25182203|NCT03866668|Esomeprazole|esomeprazole|mesh-list
25182204|NCT03866668|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25182205|NCT03866668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25182206|NCT03866668|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25182207|NCT03866668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25182208|NCT03866668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182217|NCT03845582|Retinol acetate|retinol acetate|mesh-list
25182218|NCT03845582|Vitamins|vitamins|mesh-ancestor
25182219|NCT03845582|Micronutrients|micronutrients|mesh-ancestor
25182220|NCT03845582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399807|NCT00148681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24400327|NCT00150332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665589|NCT01686165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665590|NCT01686165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25665591|NCT01686165|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25665592|NCT01686165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665593|NCT01686165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665594|NCT01686451|Simvastatin|simvastatin|mesh-list
25665595|NCT01686451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24400328|NCT00150358|Sildenafil Citrate|sildenafil citrate|mesh-list
24410060|NCT00184106|Antidepressive Agents|antidepressive agents|mesh-ancestor
25860307|NCT00083187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860308|NCT00083187|Antisickling Agents|antisickling agents|mesh-ancestor
25860309|NCT00083187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860310|NCT00083187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860311|NCT00083187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24410061|NCT00184106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24400483|NCT00150657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24400731|NCT00151203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400801|NCT00151346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182221|NCT03845582|Protective Agents|protective agents|mesh-ancestor
25182222|NCT03845582|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25182223|NCT03845582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25182224|NCT03845582|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25182225|NCT03845582|Immunologic Factors|immunologic factors|mesh-ancestor
25182226|NCT03721406|Ropivacaine|ropivacaine|mesh-list
25182227|NCT03721406|Anesthetics, Local|anesthetics, local|mesh-ancestor
25182228|NCT03721406|Anesthetics|anesthetics|mesh-ancestor
25182229|NCT03721406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25182230|NCT03721406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182231|NCT03721406|Sensory System Agents|sensory system agents|mesh-ancestor
25182232|NCT03721406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25182233|NCT03708549|Metformin|metformin|mesh-list
25182234|NCT03708549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25182235|NCT03708549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182236|NCT03673124|Letrozole|letrozole|mesh-list
25182237|NCT03673124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25182238|NCT03673124|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25182239|NCT03673124|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25182240|NCT03673124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25182241|NCT03673124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182242|NCT03673124|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25182243|NCT03673124|Hormone Antagonists|hormone antagonists|mesh-ancestor
25182244|NCT03673124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25182249|NCT03635489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25182251|NCT03635489|Tubulin Modulators|tubulin modulators|mesh-ancestor
25182252|NCT03635489|Antimitotic Agents|antimitotic agents|mesh-ancestor
25182253|NCT03635489|Mitosis Modulators|mitosis modulators|mesh-ancestor
25182254|NCT03635489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182255|NCT03635489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25182256|NCT03635489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25182257|NCT03635489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25182258|NCT03635489|Growth Substances|growth substances|mesh-ancestor
25182259|NCT03635489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182260|NCT03635489|Growth Inhibitors|growth inhibitors|mesh-ancestor
25182261|NCT03610061|Durvalumab|durvalumab|mesh-list
25182262|NCT03610061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25182263|NCT03610061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25182264|NCT03582293|Tranexamic Acid|tranexamic acid|mesh-list
25182265|NCT03582293|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25182266|NCT03582293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25182267|NCT03582293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182268|NCT03582293|Hemostatics|hemostatics|mesh-ancestor
25182269|NCT03582293|Coagulants|coagulants|mesh-ancestor
25182270|NCT03574337|Neostigmine|neostigmine|mesh-list
25182271|NCT03574337|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25182272|NCT03574337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25182273|NCT03574337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182274|NCT03574337|Cholinergic Agents|cholinergic agents|mesh-ancestor
25182275|NCT03574337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25182276|NCT03574337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182277|NCT03574337|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25182278|NCT03574337|Autonomic Agents|autonomic agents|mesh-ancestor
25182279|NCT03574337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25182282|NCT03530696|Palbociclib|palbociclib|mesh-list
25182283|NCT03530696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25182284|NCT03530696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25665596|NCT01686451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25665597|NCT01686451|Antimetabolites|antimetabolites|mesh-ancestor
25665598|NCT01686451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665599|NCT01686451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25665600|NCT01686451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24537893|NCT00656695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25182285|NCT03530696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25182286|NCT03530696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182287|NCT03213457|Norethindrone|norethindrone|mesh-list
25182288|NCT03213457|Norethindrone Acetate|norethindrone acetate|mesh-list
25182290|NCT03213457|Estrogens|estrogens|mesh-ancestor
25182292|NCT03213457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25182293|NCT03213457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182294|NCT03213457|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25182295|NCT03213457|Contraceptive Agents|contraceptive agents|mesh-ancestor
25182296|NCT03213457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25182297|NCT03213457|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25182298|NCT03213457|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25182299|NCT03213457|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25182300|NCT03213457|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25182301|NCT03126110|Nivolumab|nivolumab|mesh-list
25182302|NCT03126110|Ipilimumab|ipilimumab|mesh-list
25182303|NCT03126110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24550454|NCT00720590|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25182304|NCT03126110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25182305|NCT03126110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25182306|NCT03126110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182307|NCT02982720|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25182308|NCT02982720|Pembrolizumab|pembrolizumab|mesh-list
25182309|NCT02982720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25182310|NCT02982720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25182311|NCT02982720|Antiviral Agents|antiviral agents|mesh-ancestor
25182312|NCT02982720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25208011|NCT03172780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25208012|NCT03172780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25208013|NCT03172780|Analgesics|analgesics|mesh-ancestor
25208014|NCT03172780|Sensory System Agents|sensory system agents|mesh-ancestor
25208015|NCT03172780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25182315|NCT02721342|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25182316|NCT02721342|Protease Inhibitors|protease inhibitors|mesh-ancestor
25182317|NCT02721342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25182318|NCT02721342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182319|NCT02721342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25182320|NCT02721342|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25182321|NCT02721342|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25182342|NCT02375672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25182343|NCT02375672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25182399|NCT02153632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25182400|NCT02065362|Cyclophosphamide|cyclophosphamide|mesh-list
25182401|NCT02065362|Fludarabine|fludarabine|mesh-list
25182402|NCT02065362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25182403|NCT02065362|Immunologic Factors|immunologic factors|mesh-ancestor
25182404|NCT02065362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182405|NCT02065362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25182406|NCT02065362|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25182407|NCT02065362|Alkylating Agents|alkylating agents|mesh-ancestor
25182408|NCT02065362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182409|NCT02065362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25182410|NCT02065362|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25182411|NCT02013141|Telavancin|telavancin|mesh-list
25182412|NCT02013141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25182413|NCT02013141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25182414|NCT01934452|Sunitinib|sunitinib|mesh-list
25182415|NCT01934452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25182416|NCT01934452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25182417|NCT01934452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25182418|NCT01934452|Growth Substances|growth substances|mesh-ancestor
25182419|NCT01934452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182420|NCT01934452|Growth Inhibitors|growth inhibitors|mesh-ancestor
25182421|NCT01934452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25182422|NCT01934452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25182423|NCT01934452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182425|NCT01818167|Dermatologic Agents|dermatologic agents|mesh-ancestor
25182426|NCT01773083|Heparin|heparin|mesh-list
25182427|NCT01773083|Calcium heparin|calcium heparin|mesh-list
25182428|NCT01773083|Anticoagulants|anticoagulants|mesh-ancestor
25182429|NCT01773083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25665601|NCT01686451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25182430|NCT01773083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25182431|NCT01773083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182432|NCT01723579|Estradiol|estradiol|mesh-list
25182433|NCT01723579|Estrogens|estrogens|mesh-ancestor
25182434|NCT01723579|Hormones|hormones|mesh-ancestor
25182435|NCT01723579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25182436|NCT01723579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182437|NCT01689909|Zolpidem|zolpidem|mesh-list
25182438|NCT01689909|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25182439|NCT01689909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25182440|NCT01689909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25182441|NCT01689909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182442|NCT01689909|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25182443|NCT01689909|GABA Agonists|gaba agonists|mesh-ancestor
25182444|NCT01689909|GABA Agents|gaba agents|mesh-ancestor
25182445|NCT01689909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25182446|NCT01689909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182447|NCT01615874|Prednisone|prednisone|mesh-list
25182448|NCT01615874|Prednisolone|prednisolone|mesh-list
25182449|NCT01615874|Montelukast|montelukast|mesh-list
25182450|NCT01615874|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
25182451|NCT01615874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25182452|NCT01615874|Glucocorticoids|glucocorticoids|mesh-ancestor
25182453|NCT01615874|Hormones|hormones|mesh-ancestor
25182454|NCT01615874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25182455|NCT01615874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182456|NCT01615874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25182457|NCT01615874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25182458|NCT01615874|Autonomic Agents|autonomic agents|mesh-ancestor
25182459|NCT01615874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25182460|NCT01615874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25182461|NCT01615874|Respiratory System Agents|respiratory system agents|mesh-ancestor
24405180|NCT00165737|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24405181|NCT00165737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540547|NCT00668343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24405202|NCT00165763|Nootropic Agents|nootropic agents|mesh-ancestor
24811620|NCT02047474|Calcium|calcium|mesh-list
24811621|NCT02047474|Levoleucovorin|levoleucovorin|mesh-list
24811622|NCT02047474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24811623|NCT02047474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811624|NCT02047474|Antimetabolites|antimetabolites|mesh-ancestor
25860312|NCT00083213|Aflibercept|aflibercept|mesh-list
24811625|NCT02047474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100660|NCT03180879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860313|NCT00083213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25100686|NCT03180723|Antifungal Agents|antifungal agents|mesh-ancestor
25100687|NCT03180723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25100688|NCT03180723|Dermatologic Agents|dermatologic agents|mesh-ancestor
25100689|NCT03180723|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25100690|NCT03180710|Insulin Lispro|insulin lispro|mesh-list
25100691|NCT03180710|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25100692|NCT03180710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100693|NCT03180476|Apatinib|apatinib|mesh-list
25100694|NCT03180476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25100695|NCT03180476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25100696|NCT03180476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100697|NCT03180476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100698|NCT03180632|Lorazepam|lorazepam|mesh-list
25100699|NCT03180632|Anticonvulsants|anticonvulsants|mesh-ancestor
25100700|NCT03180632|Antiemetics|antiemetics|mesh-ancestor
25100701|NCT03180632|Autonomic Agents|autonomic agents|mesh-ancestor
25100702|NCT03180632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100703|NCT03180632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100704|NCT03180632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25100705|NCT03180632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25100706|NCT03180632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25100707|NCT03180632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25100708|NCT03180632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24968640|NCT03749642|Gabapentin|gabapentin|mesh-list
25100956|NCT03178292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100957|NCT03178292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25100958|NCT03178292|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25100959|NCT03178292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25101011|NCT03178526|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25860315|NCT00083213|Growth Substances|growth substances|mesh-ancestor
25860316|NCT00083213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101012|NCT03178526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25101013|NCT03178123|Interferons|interferons|mesh-list
25101015|NCT03178123|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25101016|NCT03178123|Immunologic Factors|immunologic factors|mesh-ancestor
25101306|NCT03175679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101307|NCT03175666|Leucovorin|leucovorin|mesh-list
25101308|NCT03175666|Paclitaxel|paclitaxel|mesh-list
24968939|NCT03746782|Hemostatics|hemostatics|mesh-ancestor
25101634|NCT03173365|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25101635|NCT03173365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25101636|NCT03173365|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25101637|NCT03173365|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25101696|NCT03172988|BB 1101|bb 1101|mesh-list
24449127|NCT00314509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25101846|NCT03171974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25101847|NCT03171974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25101848|NCT03171974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779395|NCT01876004|Methotrexate|methotrexate|mesh-list
25101866|NCT03171987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25101867|NCT03171987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25101868|NCT03171987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25101869|NCT03172052|Streptokinase|streptokinase|mesh-list
25101870|NCT03172052|Mesna|mesna|mesh-list
25101871|NCT03172052|Protective Agents|protective agents|mesh-ancestor
25102612|NCT03167268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182462|NCT01615874|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25182463|NCT01615874|Hormone Antagonists|hormone antagonists|mesh-ancestor
25182464|NCT01615874|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25182465|NCT01615874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25182466|NCT01615874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182467|NCT01615874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25182468|NCT01566149|Mometasone Furoate|mometasone furoate|mesh-list
25182469|NCT01566149|Formoterol Fumarate|formoterol fumarate|mesh-list
25182470|NCT01566149|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
24811626|NCT02047474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25182471|NCT01566149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25182472|NCT01566149|Autonomic Agents|autonomic agents|mesh-ancestor
25182473|NCT01566149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25182474|NCT01566149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182475|NCT01566149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25182476|NCT01566149|Respiratory System Agents|respiratory system agents|mesh-ancestor
25182477|NCT01566149|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25182478|NCT01566149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25182479|NCT01566149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24946668|NCT03936153|Abexinostat|abexinostat|mesh-list
25182480|NCT01566149|Adrenergic Agents|adrenergic agents|mesh-ancestor
25182481|NCT01566149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25182482|NCT01566149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182483|NCT01566149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25182484|NCT01566149|Dermatologic Agents|dermatologic agents|mesh-ancestor
25182485|NCT01566149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25182486|NCT01386125|Mometasone Furoate|mometasone furoate|mesh-list
25182487|NCT01386125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25182488|NCT01386125|Dermatologic Agents|dermatologic agents|mesh-ancestor
25182489|NCT01386125|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25182490|NCT01316250|Imatinib Mesylate|imatinib mesylate|mesh-list
25182491|NCT01316250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25182492|NCT01316250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25182493|NCT01316250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25182494|NCT01316250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182495|NCT01236430|Atorvastatin|atorvastatin|mesh-list
25182496|NCT01236430|Ezetimibe|ezetimibe|mesh-list
25182497|NCT01236430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25182498|NCT01236430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25182499|NCT01236430|Antimetabolites|antimetabolites|mesh-ancestor
25182500|NCT01236430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665602|NCT01686581|Botulinum Toxins|botulinum toxins|mesh-list
25665603|NCT01686581|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25665604|NCT01686581|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25665605|NCT01686581|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25860317|NCT00083213|Growth Inhibitors|growth inhibitors|mesh-ancestor
25860318|NCT00083213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860320|NCT00083252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860321|NCT00083278|Ipilimumab|ipilimumab|mesh-list
25860322|NCT00083278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25860323|NCT00083278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860324|NCT00083278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25860325|NCT00083278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860326|NCT00083304|Efaproxiral|efaproxiral|mesh-list
25860327|NCT00083304|Antisickling Agents|antisickling agents|mesh-ancestor
25860328|NCT00083343|Caspofungin|caspofungin|mesh-list
25182501|NCT01236430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25182502|NCT01236430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25182503|NCT01236430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717049|NCT01545284|Acitretin|acitretin|mesh-list
25182504|NCT01165424|Mometasone Furoate|mometasone furoate|mesh-list
25182505|NCT01165424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25182506|NCT01165424|Dermatologic Agents|dermatologic agents|mesh-ancestor
25182507|NCT01165424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25182508|NCT01135134|Mometasone Furoate|mometasone furoate|mesh-list
25182509|NCT01135134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25182510|NCT01135134|Dermatologic Agents|dermatologic agents|mesh-ancestor
25182511|NCT01135134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25182512|NCT01026870|Mometasone Furoate|mometasone furoate|mesh-list
25182513|NCT01026870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25182514|NCT01026870|Dermatologic Agents|dermatologic agents|mesh-ancestor
25182515|NCT01026870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25182516|NCT00903721|Mometasone Furoate|mometasone furoate|mesh-list
25182517|NCT00903721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25182518|NCT00903721|Dermatologic Agents|dermatologic agents|mesh-ancestor
25182519|NCT00903721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25182520|NCT00867165|Ezetimibe|ezetimibe|mesh-list
24411785|NCT00189995|GABA Agents|gaba agents|mesh-ancestor
24428317|NCT00240123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24428318|NCT00240123|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24428319|NCT00240123|Histamine Antagonists|histamine antagonists|mesh-ancestor
25182521|NCT00867165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25182522|NCT00867165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25182523|NCT00867165|Antimetabolites|antimetabolites|mesh-ancestor
25182524|NCT00867165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182525|NCT00867165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25182526|NCT00817076|Desloratadine|desloratadine|mesh-list
25182527|NCT00817076|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25182528|NCT00817076|Cholinergic Agents|cholinergic agents|mesh-ancestor
25182529|NCT00817076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25182530|NCT00817076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182531|NCT00817076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182532|NCT00817076|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25182533|NCT00817076|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25182534|NCT00817076|Histamine Antagonists|histamine antagonists|mesh-ancestor
25182535|NCT00817076|Histamine Agents|histamine agents|mesh-ancestor
25182536|NCT00817050|Fluticasone|fluticasone|mesh-list
25182537|NCT00817050|Mometasone Furoate|mometasone furoate|mesh-list
25182538|NCT00817050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25182539|NCT00817050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25182540|NCT00817050|Autonomic Agents|autonomic agents|mesh-ancestor
25182541|NCT00817050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25182542|NCT00817050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182543|NCT00817050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25182544|NCT00817050|Respiratory System Agents|respiratory system agents|mesh-ancestor
25182545|NCT00817050|Dermatologic Agents|dermatologic agents|mesh-ancestor
25182546|NCT00817050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25182547|NCT00816972|Loratadine|loratadine|mesh-list
25182548|NCT00816972|Mandelic Acids|mandelic acids|mesh-list
25182549|NCT00816972|Oxybutynin|oxybutynin|mesh-list
25182550|NCT00816972|Desloratadine|desloratadine|mesh-list
25182551|NCT00816972|Parasympatholytics|parasympatholytics|mesh-ancestor
25182552|NCT00816972|Autonomic Agents|autonomic agents|mesh-ancestor
25665606|NCT01686581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25665607|NCT01686581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665608|NCT01686581|Cholinergic Agents|cholinergic agents|mesh-ancestor
25665609|NCT01686581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25665610|NCT01686581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665611|NCT01686581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25665612|NCT01686581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25665613|NCT01686633|Fluticasone|fluticasone|mesh-list
25665614|NCT01686633|Xhance|xhance|mesh-list
25860329|NCT00083343|Antifungal Agents|antifungal agents|mesh-ancestor
25860330|NCT00083343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25860331|NCT00083343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665615|NCT01686633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25860332|NCT00083343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860333|NCT00083408|Pamidronate|pamidronate|mesh-list
25860334|NCT00083408|Thalidomide|thalidomide|mesh-list
25860335|NCT00083408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25860336|NCT00083408|Immunologic Factors|immunologic factors|mesh-ancestor
24539772|NCT00665600|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25182553|NCT00816972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25182554|NCT00816972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182555|NCT00816972|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25182556|NCT00816972|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25182557|NCT00816972|Cholinergic Agents|cholinergic agents|mesh-ancestor
25182558|NCT00816972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25182559|NCT00816972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182560|NCT00816972|Urological Agents|urological agents|mesh-ancestor
25182561|NCT00816972|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25182562|NCT00816972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25182563|NCT00816972|Renal Agents|renal agents|mesh-ancestor
25182564|NCT00816972|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25182565|NCT00816972|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25182566|NCT00816972|Histamine Antagonists|histamine antagonists|mesh-ancestor
25182567|NCT00816972|Histamine Agents|histamine agents|mesh-ancestor
25182568|NCT00816972|Antipruritics|antipruritics|mesh-ancestor
25182569|NCT00816972|Dermatologic Agents|dermatologic agents|mesh-ancestor
25182570|NCT00816972|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25182571|NCT00805324|Desloratadine|desloratadine|mesh-list
25182572|NCT00805324|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25182573|NCT00805324|Cholinergic Agents|cholinergic agents|mesh-ancestor
25182574|NCT00805324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25182575|NCT00805324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182576|NCT00805324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182577|NCT00805324|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25182578|NCT00805324|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25182579|NCT00805324|Histamine Antagonists|histamine antagonists|mesh-ancestor
25182580|NCT00805324|Histamine Agents|histamine agents|mesh-ancestor
25182581|NCT00794794|Cetirizine|cetirizine|mesh-list
25182582|NCT00794794|Desloratadine|desloratadine|mesh-list
25182583|NCT00794794|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25182584|NCT00794794|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25182585|NCT00794794|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25182586|NCT00794794|Histamine Antagonists|histamine antagonists|mesh-ancestor
25182587|NCT00794794|Histamine Agents|histamine agents|mesh-ancestor
25182588|NCT00794794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25182589|NCT00794794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182590|NCT00794794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182591|NCT00794794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25182592|NCT00794794|Cholinergic Agents|cholinergic agents|mesh-ancestor
25182593|NCT00794378|Cetirizine|cetirizine|mesh-list
25182594|NCT00794378|Desloratadine|desloratadine|mesh-list
25182595|NCT00794378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25182596|NCT00794378|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25182597|NCT00794378|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25182598|NCT00794378|Histamine Antagonists|histamine antagonists|mesh-ancestor
25182599|NCT00794378|Histamine Agents|histamine agents|mesh-ancestor
24459954|NCT00346918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25182600|NCT00794378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25182601|NCT00794378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182602|NCT00794378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182603|NCT00794378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25182604|NCT00794378|Cholinergic Agents|cholinergic agents|mesh-ancestor
25182605|NCT00789152|Levocetirizine|levocetirizine|mesh-list
25182606|NCT00789152|Desloratadine|desloratadine|mesh-list
25182607|NCT00789152|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25665616|NCT01686633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25665617|NCT01686633|Autonomic Agents|autonomic agents|mesh-ancestor
25665618|NCT01686633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25665619|NCT01686633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665620|NCT01686633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25665621|NCT01686633|Respiratory System Agents|respiratory system agents|mesh-ancestor
25665622|NCT01686633|Dermatologic Agents|dermatologic agents|mesh-ancestor
25665623|NCT01686633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25860338|NCT00083408|Leprostatic Agents|leprostatic agents|mesh-ancestor
25860339|NCT00083408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25860340|NCT00083408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25049540|NCT00589823|Fentanyl|fentanyl|mesh-list
25182608|NCT00789152|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25182609|NCT00789152|Histamine Antagonists|histamine antagonists|mesh-ancestor
25182610|NCT00789152|Histamine Agents|histamine agents|mesh-ancestor
25182611|NCT00789152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25182612|NCT00789152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182613|NCT00789152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182614|NCT00789152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25182615|NCT00789152|Cholinergic Agents|cholinergic agents|mesh-ancestor
25182616|NCT00783458|Fluticasone|fluticasone|mesh-list
25182617|NCT00783458|Mometasone Furoate|mometasone furoate|mesh-list
25182618|NCT00783458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25182619|NCT00783458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24540596|NCT00668616|Epirubicin|epirubicin|mesh-list
25182620|NCT00783458|Autonomic Agents|autonomic agents|mesh-ancestor
25182621|NCT00783458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25182622|NCT00783458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182623|NCT00783458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25182624|NCT00783458|Respiratory System Agents|respiratory system agents|mesh-ancestor
25182625|NCT00783458|Dermatologic Agents|dermatologic agents|mesh-ancestor
25182626|NCT00783458|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25182627|NCT00783211|Fexofenadine|fexofenadine|mesh-list
25182628|NCT00783211|Desloratadine|desloratadine|mesh-list
25182629|NCT00783211|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25182630|NCT00783211|Cholinergic Agents|cholinergic agents|mesh-ancestor
25182631|NCT00783211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25182632|NCT00783211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182633|NCT00783211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182634|NCT00783211|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25182635|NCT00783211|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25182636|NCT00783211|Histamine Antagonists|histamine antagonists|mesh-ancestor
25182637|NCT00783211|Histamine Agents|histamine agents|mesh-ancestor
25182638|NCT00783211|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25182639|NCT00783146|Fexofenadine|fexofenadine|mesh-list
25182640|NCT00783146|Desloratadine|desloratadine|mesh-list
25182641|NCT00783146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25182642|NCT00783146|Cholinergic Agents|cholinergic agents|mesh-ancestor
25182643|NCT00783146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25182644|NCT00783146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182645|NCT00783146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182646|NCT00783146|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25182647|NCT00783146|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25182648|NCT00783146|Histamine Antagonists|histamine antagonists|mesh-ancestor
25182649|NCT00783146|Histamine Agents|histamine agents|mesh-ancestor
25182650|NCT00783146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25182651|NCT00779740|Mometasone Furoate|mometasone furoate|mesh-list
25182652|NCT00779740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25182653|NCT00779740|Dermatologic Agents|dermatologic agents|mesh-ancestor
25182654|NCT00779740|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25182655|NCT00779545|Mometasone Furoate|mometasone furoate|mesh-list
25182656|NCT00779545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25182657|NCT00779545|Dermatologic Agents|dermatologic agents|mesh-ancestor
25182658|NCT00779545|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25182659|NCT00779532|Moxifloxacin|moxifloxacin|mesh-list
25182660|NCT00779532|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25182661|NCT00779532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25182662|NCT00779532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25182663|NCT00779532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25182664|NCT00779532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25182665|NCT00779532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25182666|NCT00779532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182667|NCT00779532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25182668|NCT00779532|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25182669|NCT00779532|Contraceptive Agents|contraceptive agents|mesh-ancestor
25182670|NCT00779532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25665624|NCT01686646|Acetaminophen|acetaminophen|mesh-list
25665625|NCT01686646|Caffeine|caffeine|mesh-list
25665626|NCT01686646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25409518|NCT03373851|Analgesics|analgesics|mesh-ancestor
25665627|NCT01686646|Analgesics|analgesics|mesh-ancestor
25665628|NCT01686646|Sensory System Agents|sensory system agents|mesh-ancestor
25182672|NCT00779532|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25182673|NCT00779532|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25182674|NCT00779532|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25182675|NCT00751218|Cetirizine|cetirizine|mesh-list
25182676|NCT00751218|Desloratadine|desloratadine|mesh-list
25182677|NCT00751218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25182678|NCT00751218|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24550515|NCT00720850|Growth Substances|growth substances|mesh-ancestor
24550516|NCT00720850|Growth Inhibitors|growth inhibitors|mesh-ancestor
25182679|NCT00751218|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25182680|NCT00751218|Histamine Antagonists|histamine antagonists|mesh-ancestor
25182681|NCT00751218|Histamine Agents|histamine agents|mesh-ancestor
25182682|NCT00751218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25182683|NCT00751218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182684|NCT00751218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182685|NCT00751218|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25182686|NCT00751218|Cholinergic Agents|cholinergic agents|mesh-ancestor
25182687|NCT00751166|Cetirizine|cetirizine|mesh-list
25182688|NCT00751166|Desloratadine|desloratadine|mesh-list
25182689|NCT00751166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25182690|NCT00751166|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25182691|NCT00751166|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25182692|NCT00751166|Histamine Antagonists|histamine antagonists|mesh-ancestor
25182693|NCT00751166|Histamine Agents|histamine agents|mesh-ancestor
25860341|NCT00083408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25182694|NCT00751166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25182695|NCT00751166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182696|NCT00751166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182697|NCT00751166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25182698|NCT00751166|Cholinergic Agents|cholinergic agents|mesh-ancestor
25182699|NCT00733005|Mometasone Furoate|mometasone furoate|mesh-list
25182700|NCT00733005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25182701|NCT00733005|Dermatologic Agents|dermatologic agents|mesh-ancestor
25182702|NCT00733005|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25182703|NCT00732381|Mometasone Furoate|mometasone furoate|mesh-list
25182704|NCT00732381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25182705|NCT00732381|Dermatologic Agents|dermatologic agents|mesh-ancestor
25182706|NCT00732381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25182707|NCT00732368|Mometasone Furoate|mometasone furoate|mesh-list
25182708|NCT00732368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25182709|NCT00732368|Dermatologic Agents|dermatologic agents|mesh-ancestor
25182710|NCT00732368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25182712|NCT00726856|Fenofibrate|fenofibrate|mesh-list
25182713|NCT00726856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25182714|NCT00726856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25182715|NCT00726856|Antimetabolites|antimetabolites|mesh-ancestor
25182716|NCT00726856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182717|NCT00726856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25182718|NCT00705211|Ezetimibe|ezetimibe|mesh-list
25182719|NCT00705211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25182720|NCT00705211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25182721|NCT00705211|Antimetabolites|antimetabolites|mesh-ancestor
25182722|NCT00705211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182723|NCT00705211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25182724|NCT00704444|Ezetimibe|ezetimibe|mesh-list
25182725|NCT00704444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25182726|NCT00704444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25182727|NCT00704444|Antimetabolites|antimetabolites|mesh-ancestor
25182728|NCT00704444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182729|NCT00704444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25182730|NCT00654095|Atorvastatin|atorvastatin|mesh-list
25182731|NCT00654095|Ezetimibe|ezetimibe|mesh-list
25182732|NCT00654095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25182733|NCT00654095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25182734|NCT00654095|Antimetabolites|antimetabolites|mesh-ancestor
25182735|NCT00654095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182736|NCT00654095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25182737|NCT00654095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25182738|NCT00654095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25182739|NCT00653913|Ezetimibe|ezetimibe|mesh-list
25182740|NCT00653913|Pitavastatin|pitavastatin|mesh-list
25182741|NCT00653913|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25182742|NCT00653913|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25182743|NCT00653913|Antimetabolites|antimetabolites|mesh-ancestor
25182744|NCT00653913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182745|NCT00653913|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25182754|NCT00653523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25182755|NCT00653523|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25182756|NCT00653523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25182757|NCT00652431|Niacin|niacin|mesh-list
25182758|NCT00652431|Niacinamide|niacinamide|mesh-list
25182759|NCT00652431|Nicotinic Acids|nicotinic acids|mesh-list
25182760|NCT00652431|Simvastatin|simvastatin|mesh-list
25182761|NCT00652431|Ezetimibe|ezetimibe|mesh-list
25182762|NCT00652431|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
25182763|NCT00652431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25182764|NCT00652431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24811724|NCT02048098|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25182765|NCT00652431|Antimetabolites|antimetabolites|mesh-ancestor
25182766|NCT00652431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138290|NCT02979392|Tubulin Modulators|tubulin modulators|mesh-ancestor
25138291|NCT02979392|Antimitotic Agents|antimitotic agents|mesh-ancestor
24405809|NCT00168480|Botulinum Toxins|botulinum toxins|mesh-list
24405810|NCT00168480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24405811|NCT00168480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24540770|NCT00669643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540771|NCT00669643|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24540772|NCT00669643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24540773|NCT00669643|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24540774|NCT00669643|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24811793|NCT02048358|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25182767|NCT00652431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25182768|NCT00652431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25182769|NCT00652431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25182770|NCT00652431|Vasodilator Agents|vasodilator agents|mesh-ancestor
25182771|NCT00652431|Vitamin B Complex|vitamin b complex|mesh-ancestor
25182772|NCT00652431|Vitamins|vitamins|mesh-ancestor
25182773|NCT00652431|Micronutrients|micronutrients|mesh-ancestor
25182774|NCT00652431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182775|NCT00651378|Atorvastatin|atorvastatin|mesh-list
25182776|NCT00651378|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25182777|NCT00651378|Ezetimibe|ezetimibe|mesh-list
25182778|NCT00651378|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25182779|NCT00651378|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25182780|NCT00651378|Antimetabolites|antimetabolites|mesh-ancestor
25182781|NCT00651378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182782|NCT00651378|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25182783|NCT00651378|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25182784|NCT00651378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25182785|NCT00651274|Ezetimibe|ezetimibe|mesh-list
25182786|NCT00651274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25182787|NCT00651274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25182788|NCT00651274|Antimetabolites|antimetabolites|mesh-ancestor
25182789|NCT00651274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182790|NCT00651274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25182791|NCT00650819|Simvastatin|simvastatin|mesh-list
25182792|NCT00650819|Ezetimibe|ezetimibe|mesh-list
25182793|NCT00650819|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25182795|NCT00650819|Antimetabolites|antimetabolites|mesh-ancestor
25182796|NCT00650819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182797|NCT00650819|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25182798|NCT00650819|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25182799|NCT00650819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25182800|NCT00599027|Mometasone Furoate|mometasone furoate|mesh-list
25182801|NCT00599027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25182802|NCT00599027|Dermatologic Agents|dermatologic agents|mesh-ancestor
25182803|NCT00599027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25182804|NCT00552032|Mometasone Furoate|mometasone furoate|mesh-list
25182805|NCT00552032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25182806|NCT00552032|Dermatologic Agents|dermatologic agents|mesh-ancestor
25182807|NCT00552032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25182808|NCT00546052|Losartan|losartan|mesh-list
25182809|NCT00546052|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25182810|NCT00546052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25182811|NCT00546052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25182812|NCT00546052|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25182813|NCT00546052|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25182814|NCT00546052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182815|NCT00546052|Diuretics|diuretics|mesh-ancestor
25182816|NCT00546052|Natriuretic Agents|natriuretic agents|mesh-ancestor
25182817|NCT00546052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182818|NCT00546052|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25182819|NCT00546052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25182820|NCT00442117|Mometasone Furoate|mometasone furoate|mesh-list
25182821|NCT00442117|Budesonide|budesonide|mesh-list
25182822|NCT00442117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25182823|NCT00442117|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25182824|NCT00442117|Autonomic Agents|autonomic agents|mesh-ancestor
25182825|NCT00442117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25182826|NCT00442117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182827|NCT00442117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25182828|NCT00442117|Respiratory System Agents|respiratory system agents|mesh-ancestor
25182829|NCT00442117|Glucocorticoids|glucocorticoids|mesh-ancestor
25182830|NCT00442117|Hormones|hormones|mesh-ancestor
25182831|NCT00442117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25182832|NCT00442117|Dermatologic Agents|dermatologic agents|mesh-ancestor
25182833|NCT00442117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25182834|NCT00424008|Fluticasone|fluticasone|mesh-list
25182835|NCT00424008|Xhance|xhance|mesh-list
25182836|NCT00424008|Mometasone Furoate|mometasone furoate|mesh-list
25182837|NCT00424008|Formoterol Fumarate|formoterol fumarate|mesh-list
25182838|NCT00424008|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25182839|NCT00424008|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25182840|NCT00424008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25182841|NCT00424008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25182842|NCT00424008|Autonomic Agents|autonomic agents|mesh-ancestor
25182843|NCT00424008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25182844|NCT00424008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182845|NCT00424008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25182846|NCT00424008|Respiratory System Agents|respiratory system agents|mesh-ancestor
25182847|NCT00424008|Dermatologic Agents|dermatologic agents|mesh-ancestor
25182848|NCT00424008|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25182849|NCT00424008|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25182850|NCT00424008|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25182851|NCT00424008|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25182852|NCT00424008|Adrenergic Agents|adrenergic agents|mesh-ancestor
25182853|NCT00424008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25182854|NCT00424008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182855|NCT00424008|Glucocorticoids|glucocorticoids|mesh-ancestor
25182856|NCT00424008|Hormones|hormones|mesh-ancestor
24413114|NCT00193141|Paclitaxel|paclitaxel|mesh-list
25182857|NCT00424008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25182858|NCT00424008|Sympathomimetics|sympathomimetics|mesh-ancestor
25182859|NCT00423995|Loratadine|loratadine|mesh-list
25182860|NCT00423995|Montelukast|montelukast|mesh-list
25182861|NCT00423995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25182862|NCT00423995|Respiratory System Agents|respiratory system agents|mesh-ancestor
25182863|NCT00423995|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25182864|NCT00423995|Hormone Antagonists|hormone antagonists|mesh-ancestor
25182865|NCT00423995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25182866|NCT00423995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182867|NCT00423995|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25182868|NCT00423995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25182869|NCT00423995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182870|NCT00423995|Antipruritics|antipruritics|mesh-ancestor
25182871|NCT00423995|Dermatologic Agents|dermatologic agents|mesh-ancestor
25182872|NCT00423995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25182873|NCT00423995|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25182874|NCT00423995|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25182875|NCT00423995|Histamine Antagonists|histamine antagonists|mesh-ancestor
25182876|NCT00423995|Histamine Agents|histamine agents|mesh-ancestor
25182877|NCT00423995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25182878|NCT00423176|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25182879|NCT00423176|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25182880|NCT00423176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25182881|NCT00423176|Antitubercular Agents|antitubercular agents|mesh-ancestor
25182882|NCT00383240|Mometasone Furoate|mometasone furoate|mesh-list
24406007|NCT00169013|Gabapentin|gabapentin|mesh-list
24406008|NCT00169013|Analgesics|analgesics|mesh-ancestor
24406012|NCT00169013|Anticonvulsants|anticonvulsants|mesh-ancestor
24406043|NCT00169039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24406059|NCT00169065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24406060|NCT00169065|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25182883|NCT00383240|Formoterol Fumarate|formoterol fumarate|mesh-list
25182884|NCT00383240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25182885|NCT00383240|Autonomic Agents|autonomic agents|mesh-ancestor
25182886|NCT00383240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25182887|NCT00383240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182888|NCT00383240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25182889|NCT00383240|Respiratory System Agents|respiratory system agents|mesh-ancestor
25182890|NCT00383240|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25182891|NCT00383240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25182892|NCT00383240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25182893|NCT00383240|Adrenergic Agents|adrenergic agents|mesh-ancestor
25182894|NCT00383240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25182895|NCT00383240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182896|NCT00383240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25182897|NCT00383240|Dermatologic Agents|dermatologic agents|mesh-ancestor
25182898|NCT00383240|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25182899|NCT00380627|Etoricoxib|etoricoxib|mesh-list
25182900|NCT00380627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25182901|NCT00380627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25182902|NCT00380627|Analgesics|analgesics|mesh-ancestor
25182903|NCT00380627|Sensory System Agents|sensory system agents|mesh-ancestor
25182904|NCT00380627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25182905|NCT00380627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182906|NCT00380627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25182907|NCT00380627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25182908|NCT00380627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25182909|NCT00380627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25182910|NCT00380627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25182911|NCT00380627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182912|NCT00380523|Etoricoxib|etoricoxib|mesh-list
25182913|NCT00380523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25182914|NCT00380523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25182915|NCT00380523|Analgesics|analgesics|mesh-ancestor
25182916|NCT00380523|Sensory System Agents|sensory system agents|mesh-ancestor
25182917|NCT00380523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25182918|NCT00380523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182919|NCT00380523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25182920|NCT00380523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25182921|NCT00380523|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25860342|NCT00083408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25860343|NCT00083408|Growth Substances|growth substances|mesh-ancestor
25182922|NCT00380523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25182923|NCT00380523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25182924|NCT00380523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182925|NCT00319995|Loratadine|loratadine|mesh-list
24540863|NCT00669812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540864|NCT00669812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25182926|NCT00319995|Montelukast|montelukast|mesh-list
25182927|NCT00319995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25182928|NCT00319995|Respiratory System Agents|respiratory system agents|mesh-ancestor
25182929|NCT00319995|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25860344|NCT00083408|Growth Inhibitors|growth inhibitors|mesh-ancestor
25182930|NCT00319995|Hormone Antagonists|hormone antagonists|mesh-ancestor
25182931|NCT00319995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25182932|NCT00319995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182933|NCT00319995|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25182934|NCT00319995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25182935|NCT00319995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182936|NCT00319995|Antipruritics|antipruritics|mesh-ancestor
25182937|NCT00319995|Dermatologic Agents|dermatologic agents|mesh-ancestor
25182938|NCT00319995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25182939|NCT00319995|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25182940|NCT00319995|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25182941|NCT00319995|Histamine Antagonists|histamine antagonists|mesh-ancestor
25182942|NCT00319995|Histamine Agents|histamine agents|mesh-ancestor
25182943|NCT00319995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25182944|NCT00311844|Desloratadine|desloratadine|mesh-list
25182945|NCT00311844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25182946|NCT00311844|Cholinergic Agents|cholinergic agents|mesh-ancestor
25182947|NCT00311844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25182948|NCT00311844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182949|NCT00311844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182950|NCT00311844|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25182951|NCT00311844|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25182952|NCT00311844|Histamine Antagonists|histamine antagonists|mesh-ancestor
25182953|NCT00311844|Histamine Agents|histamine agents|mesh-ancestor
25182954|NCT00212836|Olanzapine|olanzapine|mesh-list
25182955|NCT00212836|Asenapine|asenapine|mesh-list
25182956|NCT00212836|Antiemetics|antiemetics|mesh-ancestor
25182957|NCT00212836|Autonomic Agents|autonomic agents|mesh-ancestor
25182958|NCT00212836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25182959|NCT00212836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182960|NCT00212836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25182961|NCT00212836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25182962|NCT00212836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25182963|NCT00212836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25182964|NCT00212836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25182965|NCT00212836|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25182966|NCT00212836|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25182967|NCT00212836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25182968|NCT00212836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182969|NCT00212836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25182970|NCT00212836|Serotonin Agents|serotonin agents|mesh-ancestor
25182971|NCT00212784|Olanzapine|olanzapine|mesh-list
25182972|NCT00212784|Asenapine|asenapine|mesh-list
25182973|NCT00212784|Antiemetics|antiemetics|mesh-ancestor
25182974|NCT00212784|Autonomic Agents|autonomic agents|mesh-ancestor
25182975|NCT00212784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25182976|NCT00212784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182977|NCT00212784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25182978|NCT00212784|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25182979|NCT00212784|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25182980|NCT00212784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25182981|NCT00212784|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25182982|NCT00212784|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25182983|NCT00212784|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25182984|NCT00212784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25182985|NCT00212784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25182986|NCT00212784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25182987|NCT00212784|Serotonin Agents|serotonin agents|mesh-ancestor
25182988|NCT00212771|Olanzapine|olanzapine|mesh-list
25182989|NCT00212771|Asenapine|asenapine|mesh-list
25182990|NCT00212771|Antiemetics|antiemetics|mesh-ancestor
25182991|NCT00212771|Autonomic Agents|autonomic agents|mesh-ancestor
25182992|NCT00212771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25182993|NCT00212771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25182994|NCT00212771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25182995|NCT00212771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25182996|NCT00212771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25182997|NCT00212771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25182998|NCT00212771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25182999|NCT00212771|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25183000|NCT00212771|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25183001|NCT00212771|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25426870|NCT01950520|Appetite Depressants|appetite depressants|mesh-ancestor
25674397|NCT01771627|Cholinergic Agents|cholinergic agents|mesh-ancestor
25183002|NCT00212771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183003|NCT00212771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25183004|NCT00212771|Serotonin Agents|serotonin agents|mesh-ancestor
25183005|NCT00202904|Ezetimibe|ezetimibe|mesh-list
25183006|NCT00202904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25183007|NCT00202904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25183008|NCT00202904|Antimetabolites|antimetabolites|mesh-ancestor
25183009|NCT00202904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183010|NCT00202904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25183011|NCT00157924|Atorvastatin|atorvastatin|mesh-list
25183012|NCT00157924|Simvastatin|simvastatin|mesh-list
25183013|NCT00157924|Ezetimibe|ezetimibe|mesh-list
25183014|NCT00157924|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25183015|NCT00157924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25183016|NCT00157924|Antimetabolites|antimetabolites|mesh-ancestor
25183017|NCT00157924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183018|NCT00157924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25245789|NCT03719326|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25183019|NCT00157924|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25183020|NCT00157924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183021|NCT00157911|Simvastatin|simvastatin|mesh-list
25183022|NCT00157911|Ezetimibe|ezetimibe|mesh-list
25183023|NCT00157911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25183024|NCT00157911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25183025|NCT00157911|Antimetabolites|antimetabolites|mesh-ancestor
25183026|NCT00157911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183027|NCT00157911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25183028|NCT00157911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25183029|NCT00157911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183030|NCT00156117|Olanzapine|olanzapine|mesh-list
25183031|NCT00156117|Asenapine|asenapine|mesh-list
25183032|NCT00156117|Antiemetics|antiemetics|mesh-ancestor
25183033|NCT00156117|Autonomic Agents|autonomic agents|mesh-ancestor
25183034|NCT00156117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183035|NCT00156117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183036|NCT00156117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25183037|NCT00156117|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25183038|NCT00156117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25183039|NCT00156117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25183040|NCT00156117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25183041|NCT00156117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25183042|NCT00156117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25183043|NCT00156117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25183044|NCT00156117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183045|NCT00156117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25183046|NCT00156117|Serotonin Agents|serotonin agents|mesh-ancestor
25183047|NCT00156104|Haloperidol|haloperidol|mesh-list
25183048|NCT00156104|Haloperidol decanoate|haloperidol decanoate|mesh-list
25183049|NCT00156104|Asenapine|asenapine|mesh-list
25183050|NCT00156104|Antiemetics|antiemetics|mesh-ancestor
25183051|NCT00156104|Autonomic Agents|autonomic agents|mesh-ancestor
25183052|NCT00156104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183053|NCT00156104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183054|NCT00156104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25183055|NCT00156104|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25183056|NCT00156104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25183057|NCT00156104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25183058|NCT00156104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25183059|NCT00156104|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25183060|NCT00156104|Dopamine Agents|dopamine agents|mesh-ancestor
25183061|NCT00156104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25183062|NCT00156104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183063|NCT00156104|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25205393|NCT04829422|Lazertinib|lazertinib|mesh-list
25205394|NCT04829422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25205395|NCT04829422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205396|NCT04829422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205397|NCT04800822|Cetuximab|cetuximab|mesh-list
25205398|NCT04800822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25205399|NCT04800822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25205400|NCT04789928|Gentamicins|gentamicins|mesh-list
25205401|NCT04789928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25205402|NCT04789928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25205403|NCT04789928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25205404|NCT04789928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205405|NCT04789928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205410|NCT04747847|Antimetabolites|antimetabolites|mesh-ancestor
25205411|NCT04747847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205412|NCT04747847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25205413|NCT04747847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25205414|NCT04747847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205415|NCT04747847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25205416|NCT04741815|Carbon Fiber|carbon fiber|mesh-list
25205417|NCT04741815|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25205418|NCT04741815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25205419|NCT04712071|Ketamine|ketamine|mesh-list
25205420|NCT04712071|Analgesics|analgesics|mesh-ancestor
25205421|NCT04712071|Sensory System Agents|sensory system agents|mesh-ancestor
25208057|NCT03113409|Naltrexone|naltrexone|mesh-list
25183064|NCT00156091|Olanzapine|olanzapine|mesh-list
25183065|NCT00156091|Asenapine|asenapine|mesh-list
25183066|NCT00156091|Antiemetics|antiemetics|mesh-ancestor
25183067|NCT00156091|Autonomic Agents|autonomic agents|mesh-ancestor
25183068|NCT00156091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183069|NCT00156091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183070|NCT00156091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25183071|NCT00156091|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25183072|NCT00156091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25183073|NCT00156091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25183074|NCT00156091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25183075|NCT00156091|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25183076|NCT00156091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25183077|NCT00156091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25183078|NCT00156091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183079|NCT00156091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25183080|NCT00156091|Serotonin Agents|serotonin agents|mesh-ancestor
25183081|NCT00142558|Indomethacin|indomethacin|mesh-list
25183082|NCT00142558|Etoricoxib|etoricoxib|mesh-list
25183083|NCT00142558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183084|NCT00142558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183085|NCT00142558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183086|NCT00142558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25183087|NCT00142558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25183088|NCT00142558|Analgesics|analgesics|mesh-ancestor
25183089|NCT00142558|Sensory System Agents|sensory system agents|mesh-ancestor
25183090|NCT00142558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25183091|NCT00142558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25183092|NCT00142558|Gout Suppressants|gout suppressants|mesh-ancestor
25183093|NCT00142558|Tocolytic Agents|tocolytic agents|mesh-ancestor
25183094|NCT00142558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25183095|NCT00142558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25183096|NCT00142558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183097|NCT00142558|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25183098|NCT00140985|Losartan|losartan|mesh-list
25183100|NCT00140985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25183101|NCT00140985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25183102|NCT00140985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25183103|NCT00140985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183104|NCT00140985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25183105|NCT00140985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183106|NCT00140985|Vasodilator Agents|vasodilator agents|mesh-ancestor
25183107|NCT00140985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25183108|NCT00140985|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25183109|NCT00140985|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25183110|NCT00140972|Diclofenac|diclofenac|mesh-list
25183111|NCT00140972|Etoricoxib|etoricoxib|mesh-list
25183112|NCT00140972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25183113|NCT00140972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25665629|NCT01686646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25665630|NCT01686646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665631|NCT01686646|Antipyretics|antipyretics|mesh-ancestor
25665632|NCT01686646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25183115|NCT00140972|Sensory System Agents|sensory system agents|mesh-ancestor
25183116|NCT00140972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183117|NCT00140972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183118|NCT00140972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25183119|NCT00140972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25183120|NCT00140972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25183121|NCT00140972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183122|NCT00140972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183123|NCT00140972|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25183124|NCT00140959|Losartan|losartan|mesh-list
25183125|NCT00140959|Atenolol|atenolol|mesh-list
25183126|NCT00140959|Amlodipine|amlodipine|mesh-list
25183127|NCT00140959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25183128|NCT00140959|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25183129|NCT00140959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25183130|NCT00140959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183131|NCT00140959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25183132|NCT00140959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183133|NCT00140959|Vasodilator Agents|vasodilator agents|mesh-ancestor
24719055|NCT01558934|Lofexidine|lofexidine|mesh-list
25183134|NCT00140959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25183135|NCT00140959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25183136|NCT00140959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25183137|NCT00140959|Adrenergic Agents|adrenergic agents|mesh-ancestor
25183138|NCT00140959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25183140|NCT00140959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183141|NCT00140959|Sympatholytics|sympatholytics|mesh-ancestor
25183142|NCT00140959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25183143|NCT00140959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25183144|NCT00140959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25183145|NCT00140907|Losartan|losartan|mesh-list
25183146|NCT00140907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25183147|NCT00140907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25183148|NCT00140907|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25183149|NCT00140907|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25183150|NCT00140907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183151|NCT00132717|Atorvastatin|atorvastatin|mesh-list
25183152|NCT00132717|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25183153|NCT00132717|Simvastatin|simvastatin|mesh-list
25183154|NCT00132717|Ezetimibe|ezetimibe|mesh-list
25183155|NCT00132717|Pravastatin|pravastatin|mesh-list
25183156|NCT00132717|Lovastatin|lovastatin|mesh-list
25183157|NCT00132717|L 647318|l 647318|mesh-list
25183158|NCT00132717|Dihydromevinolin|dihydromevinolin|mesh-list
25183159|NCT00132717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25183160|NCT00132717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25183161|NCT00132717|Antimetabolites|antimetabolites|mesh-ancestor
25183162|NCT00132717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183163|NCT00132717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25183164|NCT00132717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25183165|NCT00132717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183166|NCT00127179|Finasteride|finasteride|mesh-list
25183167|NCT00127179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183168|NCT00127179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183536|NCT02841488|Analgesics|analgesics|mesh-ancestor
25183169|NCT00127179|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25183170|NCT00127179|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25183171|NCT00127179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183173|NCT00127179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25183175|NCT00110435|Atorvastatin|atorvastatin|mesh-list
25183176|NCT00110435|Simvastatin|simvastatin|mesh-list
25183177|NCT00110435|Ezetimibe|ezetimibe|mesh-list
25183178|NCT00110435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25183179|NCT00110435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25183180|NCT00110435|Antimetabolites|antimetabolites|mesh-ancestor
25183181|NCT00110435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183182|NCT00110435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25183183|NCT00110435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25183184|NCT00110435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24415368|NCT00199329|Dermatologic Agents|dermatologic agents|mesh-ancestor
24415379|NCT00199342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24415380|NCT00199342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415381|NCT00199355|Istradefylline|istradefylline|mesh-list
25860350|NCT00083460|Dexamethasone|dexamethasone|mesh-list
25860351|NCT00083460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25210512|NCT05324748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24415382|NCT00199355|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
24415383|NCT00199355|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25183185|NCT00095017|Etoricoxib|etoricoxib|mesh-list
25183186|NCT00095017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25183187|NCT00095017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25183188|NCT00095017|Analgesics|analgesics|mesh-ancestor
25183189|NCT00095017|Sensory System Agents|sensory system agents|mesh-ancestor
25183190|NCT00095017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183191|NCT00095017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183192|NCT00095017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25183193|NCT00095017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25183194|NCT00095017|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25183195|NCT00095017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25183196|NCT00095017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183197|NCT00095017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183198|NCT00093899|Simvastatin|simvastatin|mesh-list
25183199|NCT00093899|Ezetimibe|ezetimibe|mesh-list
25183200|NCT00093899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25183201|NCT00093899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25183202|NCT00093899|Antimetabolites|antimetabolites|mesh-ancestor
25183203|NCT00093899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183204|NCT00093899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25183205|NCT00093899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25183206|NCT00093899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183207|NCT00092898|Ezetimibe|ezetimibe|mesh-list
25183208|NCT00092898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25183209|NCT00092898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25183210|NCT00092898|Antimetabolites|antimetabolites|mesh-ancestor
24407358|NCT00174330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407360|NCT00174343|Exemestane|exemestane|mesh-list
24407361|NCT00174343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407362|NCT00174343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24407363|NCT00174343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24407395|NCT00174434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407397|NCT00174434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24407398|NCT00174434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407399|NCT00174473|Voriconazole|voriconazole|mesh-list
24407400|NCT00174473|Antifungal Agents|antifungal agents|mesh-ancestor
24407401|NCT00174473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24407402|NCT00174473|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24407403|NCT00174473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24407404|NCT00174473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407405|NCT00174473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407406|NCT00174473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24407407|NCT00174473|Hormone Antagonists|hormone antagonists|mesh-ancestor
25041734|NCT01591447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25102667|NCT03167164|Antidotes|antidotes|mesh-ancestor
25102668|NCT03167164|Protective Agents|protective agents|mesh-ancestor
25102669|NCT03167164|Vitamin B Complex|vitamin b complex|mesh-ancestor
25102670|NCT03167164|Vitamins|vitamins|mesh-ancestor
25102671|NCT03167164|Micronutrients|micronutrients|mesh-ancestor
25102672|NCT03166891|Chiauranib|chiauranib|mesh-list
25102673|NCT03166891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665633|NCT01686646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25665634|NCT01686646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665635|NCT01686646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665636|NCT01686646|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25665637|NCT01686646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25665638|NCT01686646|Purinergic Agents|purinergic agents|mesh-ancestor
25665639|NCT01686646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25665640|NCT01686828|Letrozole|letrozole|mesh-list
25665641|NCT01686828|Methyltestosterone|methyltestosterone|mesh-list
25665642|NCT01686828|Acyline|acyline|mesh-list
25665643|NCT01686828|Testosterone|testosterone|mesh-list
25860353|NCT00083460|Autonomic Agents|autonomic agents|mesh-ancestor
25860354|NCT00083460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25860355|NCT00083460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860356|NCT00083460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25102674|NCT03166891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25102738|NCT03166644|Sufentanil|sufentanil|mesh-list
25102739|NCT03166644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25102740|NCT03166644|Narcotics|narcotics|mesh-ancestor
25102741|NCT03166644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25102742|NCT03166644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102743|NCT03166644|Analgesics|analgesics|mesh-ancestor
24731118|NCT01632540|Beclomethasone|beclomethasone|mesh-list
25102744|NCT03166644|Sensory System Agents|sensory system agents|mesh-ancestor
25102745|NCT03166644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25102746|NCT03166644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25102747|NCT03166644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25102748|NCT03166644|Anesthetics, General|anesthetics, general|mesh-ancestor
25102749|NCT03166644|Anesthetics|anesthetics|mesh-ancestor
25102750|NCT03166865|Hyaluronic Acid|hyaluronic acid|mesh-list
25102751|NCT03166865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25102752|NCT03166865|Immunologic Factors|immunologic factors|mesh-ancestor
25102753|NCT03166865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102754|NCT03166865|Viscosupplements|viscosupplements|mesh-ancestor
24969270|NCT03744364|Oxytocics|oxytocics|mesh-ancestor
25103559|NCT03160651|Prednisolone phosphate|prednisolone phosphate|mesh-list
24719449|NCT01561404|Everolimus|everolimus|mesh-list
25103560|NCT03160651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25103561|NCT03160651|Antiemetics|antiemetics|mesh-ancestor
25103562|NCT03160651|Autonomic Agents|autonomic agents|mesh-ancestor
25103563|NCT03160651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25103564|NCT03160651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103565|NCT03160651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25103566|NCT03160651|Glucocorticoids|glucocorticoids|mesh-ancestor
25103567|NCT03160651|Hormones|hormones|mesh-ancestor
25183211|NCT00092898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183212|NCT00092898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25183213|NCT00092820|Ezetimibe|ezetimibe|mesh-list
25183214|NCT00092820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25183215|NCT00092820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25183216|NCT00092820|Antimetabolites|antimetabolites|mesh-ancestor
25183217|NCT00092820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183218|NCT00092820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25183219|NCT00092807|Ezetimibe|ezetimibe|mesh-list
25183220|NCT00092807|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25183221|NCT00092807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25183222|NCT00092807|Antimetabolites|antimetabolites|mesh-ancestor
25183223|NCT00092807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183224|NCT00092807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25183225|NCT00092781|Celecoxib|celecoxib|mesh-list
25183226|NCT00092781|Etoricoxib|etoricoxib|mesh-list
25183227|NCT00092781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25183228|NCT00092781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25183229|NCT00092781|Analgesics|analgesics|mesh-ancestor
25183230|NCT00092781|Sensory System Agents|sensory system agents|mesh-ancestor
25183231|NCT00092781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183232|NCT00092781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183233|NCT00092781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25183234|NCT00092781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25183235|NCT00092781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25183236|NCT00092781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25183237|NCT00092781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183238|NCT00092781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183239|NCT00092768|Celecoxib|celecoxib|mesh-list
25183240|NCT00092768|Etoricoxib|etoricoxib|mesh-list
25183241|NCT00092768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25183242|NCT00092768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25183243|NCT00092768|Analgesics|analgesics|mesh-ancestor
25183244|NCT00092768|Sensory System Agents|sensory system agents|mesh-ancestor
25665644|NCT01686828|Testosterone undecanoate|testosterone undecanoate|mesh-list
25665645|NCT01686828|Testosterone enanthate|testosterone enanthate|mesh-list
25665646|NCT01686828|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25665647|NCT01686828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25183245|NCT00092768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183246|NCT00092768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183247|NCT00092768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25665648|NCT01686828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25860357|NCT00083460|Glucocorticoids|glucocorticoids|mesh-ancestor
25860358|NCT00083460|Hormones|hormones|mesh-ancestor
25860359|NCT00083460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25183248|NCT00092768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25183249|NCT00092768|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25183250|NCT00092768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25183251|NCT00092768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183252|NCT00092768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183253|NCT00092755|Ibuprofen|ibuprofen|mesh-list
25183254|NCT00092755|Etoricoxib|etoricoxib|mesh-list
25183255|NCT00092755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25183256|NCT00092755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25183257|NCT00092755|Analgesics|analgesics|mesh-ancestor
25183258|NCT00092755|Sensory System Agents|sensory system agents|mesh-ancestor
25183259|NCT00092755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183260|NCT00092755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183261|NCT00092755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25183262|NCT00092755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25183263|NCT00092755|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25183264|NCT00092755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183265|NCT00092755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183266|NCT00092755|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25183267|NCT00092742|Diclofenac|diclofenac|mesh-list
25183268|NCT00092742|Etoricoxib|etoricoxib|mesh-list
25183269|NCT00092742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25183270|NCT00092742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25183271|NCT00092742|Analgesics|analgesics|mesh-ancestor
25183272|NCT00092742|Sensory System Agents|sensory system agents|mesh-ancestor
25183273|NCT00092742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183274|NCT00092742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183275|NCT00092742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25183276|NCT00092742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25183277|NCT00092742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25183278|NCT00092742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183279|NCT00092742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183280|NCT00092742|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25183281|NCT00092729|Naproxen|naproxen|mesh-list
25183282|NCT00092729|Etoricoxib|etoricoxib|mesh-list
25183283|NCT00092729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25183284|NCT00092729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25183285|NCT00092729|Analgesics|analgesics|mesh-ancestor
25183286|NCT00092729|Sensory System Agents|sensory system agents|mesh-ancestor
25183287|NCT00092729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183288|NCT00092729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183289|NCT00092729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25183290|NCT00092729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25183291|NCT00092729|Gout Suppressants|gout suppressants|mesh-ancestor
25183292|NCT00092729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25183293|NCT00092729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183294|NCT00092729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183295|NCT00092729|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25183296|NCT00092703|Diclofenac|diclofenac|mesh-list
25183297|NCT00092703|Etoricoxib|etoricoxib|mesh-list
25183298|NCT00092703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25183299|NCT00092703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25183300|NCT00092703|Analgesics|analgesics|mesh-ancestor
25183301|NCT00092703|Sensory System Agents|sensory system agents|mesh-ancestor
25183302|NCT00092703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183303|NCT00092703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183304|NCT00092703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25183305|NCT00092703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25183306|NCT00092703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25183307|NCT00092703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183308|NCT00092703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183309|NCT00092703|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25183311|NCT02844270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25183312|NCT02844270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25183313|NCT02844270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25183314|NCT02844270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25183315|NCT02844270|Antifungal Agents|antifungal agents|mesh-ancestor
25183316|NCT02844270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25665649|NCT01686828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25665650|NCT01686828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674398|NCT01771627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24516490|NCT00602173|Cilostazol|cilostazol|mesh-list
25183317|NCT02844270|Immunologic Factors|immunologic factors|mesh-ancestor
25183318|NCT02844270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183319|NCT02843984|Lactoferrin|lactoferrin|mesh-list
24416076|NCT00201981|Rebamipide|rebamipide|mesh-list
25183320|NCT02843984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25183321|NCT02844062|Cyclophosphamide|cyclophosphamide|mesh-list
25183322|NCT02844062|Fludarabine|fludarabine|mesh-list
25183323|NCT02844062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25183324|NCT02844062|Immunologic Factors|immunologic factors|mesh-ancestor
25183325|NCT02844062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183326|NCT02844062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25183327|NCT02844062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25183328|NCT02844062|Alkylating Agents|alkylating agents|mesh-ancestor
25183329|NCT02844062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183330|NCT02844062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25183331|NCT02844062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25183332|NCT02844114|Gemcitabine|gemcitabine|mesh-list
25183333|NCT02844114|Cisplatin|cisplatin|mesh-list
25183334|NCT02844114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25183335|NCT02844114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25183336|NCT02844114|Antimetabolites|antimetabolites|mesh-ancestor
25183337|NCT02844114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183339|NCT02844114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25183340|NCT02844114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183341|NCT02844114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25183342|NCT02844114|Immunologic Factors|immunologic factors|mesh-ancestor
25183343|NCT02844114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183344|NCT02843698|Dexmedetomidine|dexmedetomidine|mesh-list
25183345|NCT02843698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25183346|NCT02843698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25183347|NCT02843698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183348|NCT02843698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25183349|NCT02843698|Analgesics|analgesics|mesh-ancestor
25183350|NCT02843698|Sensory System Agents|sensory system agents|mesh-ancestor
25183351|NCT02843698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183352|NCT02843698|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25183353|NCT02843698|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25183354|NCT02843698|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25183355|NCT02843698|Adrenergic Agents|adrenergic agents|mesh-ancestor
25183356|NCT02843698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25183357|NCT02843698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183358|NCT02843685|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
25183359|NCT02843685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25183360|NCT02843438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25183361|NCT02843490|Ranibizumab|ranibizumab|mesh-list
25183362|NCT02843490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25183363|NCT02843490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25183364|NCT02843490|Growth Substances|growth substances|mesh-ancestor
25183365|NCT02843490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183366|NCT02843490|Growth Inhibitors|growth inhibitors|mesh-ancestor
25183367|NCT02843490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25183368|NCT02842983|Esmolol|esmolol|mesh-list
25183369|NCT02842983|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25183370|NCT02842983|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25183371|NCT02842983|Adrenergic Agents|adrenergic agents|mesh-ancestor
25183372|NCT02842983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25183373|NCT02842983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183374|NCT02842983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183375|NCT02842983|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24416416|NCT00203073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24416417|NCT00203073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416418|NCT00203073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946876|NCT03934333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946880|NCT03934333|Hormones|hormones|mesh-ancestor
25183376|NCT02843126|Trastuzumab|trastuzumab|mesh-list
25183377|NCT02843126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25183378|NCT02843126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25183380|NCT02843204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25183381|NCT02843204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25183382|NCT02843061|Rituximab|rituximab|mesh-list
25183383|NCT02843061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25183384|NCT02843061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860360|NCT00083460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25860361|NCT00083460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25183385|NCT02843061|Immunologic Factors|immunologic factors|mesh-ancestor
25183386|NCT02843061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183387|NCT02843061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25183388|NCT02842931|Prednisone|prednisone|mesh-list
25183389|NCT02842931|Cyclophosphamide|cyclophosphamide|mesh-list
25183390|NCT02842931|Doxorubicin|doxorubicin|mesh-list
25183391|NCT02842931|Etoposide|etoposide|mesh-list
25183392|NCT02842931|Vincristine|vincristine|mesh-list
25183393|NCT02842931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25183394|NCT02842931|Immunologic Factors|immunologic factors|mesh-ancestor
25183395|NCT02842931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183396|NCT02842931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25183397|NCT02842931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25183398|NCT02842931|Alkylating Agents|alkylating agents|mesh-ancestor
25183399|NCT02842931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183400|NCT02842931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25183401|NCT02842931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25183402|NCT02842931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25183403|NCT02842931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25183409|NCT02842931|Hormones|hormones|mesh-ancestor
25183410|NCT02842931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25183411|NCT02842931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25183412|NCT02842931|Tubulin Modulators|tubulin modulators|mesh-ancestor
25183413|NCT02842931|Antimitotic Agents|antimitotic agents|mesh-ancestor
25183414|NCT02842931|Mitosis Modulators|mitosis modulators|mesh-ancestor
25183420|NCT02842814|Hydroxychloroquine|hydroxychloroquine|mesh-list
25183421|NCT02842814|Glucocorticoids|glucocorticoids|mesh-list
25183422|NCT02842814|Antimalarials|antimalarials|mesh-ancestor
25183423|NCT02842814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25183424|NCT02842814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25183425|NCT02842814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25183426|NCT02842814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183427|NCT02842814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183428|NCT02842814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25183430|NCT02842814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25183431|NCT02842814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205422|NCT04712071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25205423|NCT04712071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205424|NCT04712071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25205425|NCT04712071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25205426|NCT04712071|Anesthetics, General|anesthetics, general|mesh-ancestor
25205427|NCT04712071|Anesthetics|anesthetics|mesh-ancestor
25205428|NCT04712071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25205429|NCT04712071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25205430|NCT04712071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25205431|NCT04712071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25205432|NCT04712071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205433|NCT04705844|Adalimumab|adalimumab|mesh-list
25205434|NCT04705844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25205435|NCT04705844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25205436|NCT04688814|Morphine|morphine|mesh-list
25205437|NCT04688814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25205438|NCT04688814|Narcotics|narcotics|mesh-ancestor
25205439|NCT04688814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25205440|NCT04688814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205441|NCT04688814|Analgesics|analgesics|mesh-ancestor
25205442|NCT04688814|Sensory System Agents|sensory system agents|mesh-ancestor
25183433|NCT02842567|Tocopherols|tocopherols|mesh-list
25183434|NCT02842567|alpha-Tocopherol|alpha-tocopherol|mesh-list
25183435|NCT02842567|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
25183436|NCT02842567|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
25183437|NCT02842567|Vitamins|vitamins|mesh-ancestor
25183438|NCT02842567|Micronutrients|micronutrients|mesh-ancestor
25183439|NCT02842567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183440|NCT02842567|Antioxidants|antioxidants|mesh-ancestor
25183441|NCT02842567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183442|NCT02842567|Protective Agents|protective agents|mesh-ancestor
25183443|NCT02842567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25183444|NCT02842567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25183445|NCT02842567|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25183446|NCT02842567|Disinfectants|disinfectants|mesh-ancestor
25183447|NCT02842580|Leucovorin|leucovorin|mesh-list
25183448|NCT02842580|Bevacizumab|bevacizumab|mesh-list
25183449|NCT02842580|Capecitabine|capecitabine|mesh-list
25183450|NCT02842580|Oxaliplatin|oxaliplatin|mesh-list
24449806|NCT00317031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24449807|NCT00317070|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
25860362|NCT00083460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25860363|NCT00083460|Immunologic Factors|immunologic factors|mesh-ancestor
25860364|NCT00083460|Leprostatic Agents|leprostatic agents|mesh-ancestor
25860365|NCT00083460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25210535|NCT05324618|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25183451|NCT02842580|Irinotecan|irinotecan|mesh-list
25183452|NCT02842580|Levoleucovorin|levoleucovorin|mesh-list
25183453|NCT02842580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25183454|NCT02842580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25183455|NCT02842580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25183456|NCT02842580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25183457|NCT02842580|Growth Substances|growth substances|mesh-ancestor
25183458|NCT02842580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183459|NCT02842580|Growth Inhibitors|growth inhibitors|mesh-ancestor
25183460|NCT02842580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25239493|NCT02541383|Autonomic Agents|autonomic agents|mesh-ancestor
25006264|NCT05203432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25183461|NCT02842580|Antimetabolites|antimetabolites|mesh-ancestor
25183462|NCT02842580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183463|NCT02842580|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25183464|NCT02842580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25183465|NCT02842580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183466|NCT02842580|Antidotes|antidotes|mesh-ancestor
25183467|NCT02842580|Protective Agents|protective agents|mesh-ancestor
25183468|NCT02842580|Vitamin B Complex|vitamin b complex|mesh-ancestor
25183469|NCT02842580|Vitamins|vitamins|mesh-ancestor
25183470|NCT02842580|Micronutrients|micronutrients|mesh-ancestor
25183471|NCT02842281|Levan|levan|mesh-list
25183472|NCT02842281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25183473|NCT02842294|Bevacizumab|bevacizumab|mesh-list
25183474|NCT02842294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25183475|NCT02842294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25183476|NCT02842294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25183477|NCT02842294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25183478|NCT02842294|Growth Substances|growth substances|mesh-ancestor
25183479|NCT02842294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183480|NCT02842294|Growth Inhibitors|growth inhibitors|mesh-ancestor
25183481|NCT02842437|Dexmedetomidine|dexmedetomidine|mesh-list
25183482|NCT02842437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25183483|NCT02842437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25183484|NCT02842437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183485|NCT02842437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25183486|NCT02842437|Analgesics|analgesics|mesh-ancestor
25183487|NCT02842437|Sensory System Agents|sensory system agents|mesh-ancestor
25183488|NCT02842437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183489|NCT02842437|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25183490|NCT02842437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25183491|NCT02842437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25183492|NCT02842437|Adrenergic Agents|adrenergic agents|mesh-ancestor
25183493|NCT02842437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25183494|NCT02842437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183495|NCT02842424|Ramipril|ramipril|mesh-list
25183496|NCT02842424|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25183497|NCT02842424|Protease Inhibitors|protease inhibitors|mesh-ancestor
25183498|NCT02842424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183499|NCT02842424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183500|NCT02842424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25183501|NCT02842125|Pembrolizumab|pembrolizumab|mesh-list
25183502|NCT02842125|Nivolumab|nivolumab|mesh-list
25183503|NCT02842125|Capecitabine|capecitabine|mesh-list
25183504|NCT02842125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25183505|NCT02842125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25183506|NCT02842125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25183507|NCT02842125|Antimetabolites|antimetabolites|mesh-ancestor
25183508|NCT02842125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665651|NCT01686828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665652|NCT01686828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25665653|NCT01686828|Hormone Antagonists|hormone antagonists|mesh-ancestor
25665654|NCT01686828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25665655|NCT01686828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665656|NCT01686828|Androgens|androgens|mesh-ancestor
25665657|NCT01686828|Hormones|hormones|mesh-ancestor
25210553|NCT05324462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210554|NCT05324462|Incretins|incretins|mesh-ancestor
25210556|NCT05324462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25860366|NCT00083460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25860367|NCT00083460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25860368|NCT00083460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25860369|NCT00083460|Growth Substances|growth substances|mesh-ancestor
25860370|NCT00083460|Growth Inhibitors|growth inhibitors|mesh-ancestor
25860371|NCT00083486|Epoetin Alfa|epoetin alfa|mesh-list
25860372|NCT00083486|Hematinics|hematinics|mesh-ancestor
25210574|NCT05323981|Pertuzumab|pertuzumab|mesh-list
25210575|NCT05323981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25665658|NCT01686828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25665659|NCT01686828|Anabolic Agents|anabolic agents|mesh-ancestor
25210576|NCT05323981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25210577|NCT05323955|Trastuzumab|trastuzumab|mesh-list
25183509|NCT02842125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25183510|NCT02841982|Morphine|morphine|mesh-list
25183511|NCT02841982|Ropivacaine|ropivacaine|mesh-list
25183512|NCT02841982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25183513|NCT02841982|Narcotics|narcotics|mesh-ancestor
25183514|NCT02841982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25183515|NCT02841982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183516|NCT02841982|Analgesics|analgesics|mesh-ancestor
25183517|NCT02841982|Sensory System Agents|sensory system agents|mesh-ancestor
25183518|NCT02841982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183519|NCT02841982|Anesthetics, Local|anesthetics, local|mesh-ancestor
25183520|NCT02841982|Anesthetics|anesthetics|mesh-ancestor
25183521|NCT02841839|Fluorides|fluorides|mesh-list
25183522|NCT02841839|Tin Fluorides|tin fluorides|mesh-list
25183523|NCT02841839|Cariostatic Agents|cariostatic agents|mesh-ancestor
25183524|NCT02841839|Protective Agents|protective agents|mesh-ancestor
25183525|NCT02841839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183526|NCT02841488|Fentanyl|fentanyl|mesh-list
25183527|NCT02841488|Ropivacaine|ropivacaine|mesh-list
25183528|NCT02841488|Anesthetics, Local|anesthetics, local|mesh-ancestor
25183529|NCT02841488|Anesthetics|anesthetics|mesh-ancestor
25183530|NCT02841488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25183531|NCT02841488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183532|NCT02841488|Sensory System Agents|sensory system agents|mesh-ancestor
25183533|NCT02841488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183534|NCT02841488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25183535|NCT02841488|Narcotics|narcotics|mesh-ancestor
25183537|NCT02841488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25183538|NCT02841488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25183539|NCT02841488|Anesthetics, General|anesthetics, general|mesh-ancestor
25183540|NCT02841722|Lenograstim|lenograstim|mesh-list
25183541|NCT02841722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25183542|NCT02841722|Immunologic Factors|immunologic factors|mesh-ancestor
25183543|NCT02841722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183544|NCT02841579|Osimertinib|osimertinib|mesh-list
25183545|NCT02841579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25183546|NCT02841579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25183547|NCT02841579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183548|NCT02841579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183549|NCT02841774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25183551|NCT02841774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25183552|NCT02841774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25183553|NCT02841774|Antimetabolites|antimetabolites|mesh-ancestor
25665660|NCT01686932|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25665661|NCT01686932|Vildagliptin|vildagliptin|mesh-list
25665662|NCT01686932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25665663|NCT01686932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665664|NCT01686932|Incretins|incretins|mesh-ancestor
25665665|NCT01686932|Hormones|hormones|mesh-ancestor
25665666|NCT01686932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25665667|NCT01686932|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25665668|NCT01686932|Protease Inhibitors|protease inhibitors|mesh-ancestor
25665669|NCT01686932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665670|NCT01686932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665671|NCT01687101|Menthol|menthol|mesh-list
25665672|NCT01687101|Antipruritics|antipruritics|mesh-ancestor
25665673|NCT01687101|Dermatologic Agents|dermatologic agents|mesh-ancestor
25665674|NCT01687166|Acifluorfen|acifluorfen|mesh-list
25665675|NCT01687166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183554|NCT02841774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860373|NCT00083525|Capecitabine|capecitabine|mesh-list
25183555|NCT02841774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25183556|NCT02841774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25183557|NCT02841774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183558|NCT02841800|Phenobarbital|phenobarbital|mesh-list
25183559|NCT02841800|Anticonvulsants|anticonvulsants|mesh-ancestor
25183560|NCT02841800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25183561|NCT02841800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25183562|NCT02841800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183563|NCT02841800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25183564|NCT02841800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25183565|NCT02841800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25183566|NCT02841800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183567|NCT02841800|GABA Modulators|gaba modulators|mesh-ancestor
25183568|NCT02841800|GABA Agents|gaba agents|mesh-ancestor
25183569|NCT02841800|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25183570|NCT02841800|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25183571|NCT02841800|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25183572|NCT02841306|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25183573|NCT02841306|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25183574|NCT02841306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25183575|NCT02841332|Misonidazole|misonidazole|mesh-list
25183576|NCT02841332|Bevacizumab|bevacizumab|mesh-list
25183577|NCT02841332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25183578|NCT02841332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25183579|NCT02841332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25183580|NCT02841332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25183581|NCT02841332|Growth Substances|growth substances|mesh-ancestor
25208058|NCT03113409|Buprenorphine|buprenorphine|mesh-list
24820234|NCT02099240|Neomycin|neomycin|mesh-list
24820235|NCT02099240|Cefotaxime|cefotaxime|mesh-list
24820240|NCT02099240|Cefixime|cefixime|mesh-list
24820241|NCT02099240|Polymyxin B|polymyxin b|mesh-list
24820242|NCT02099240|Cefdinir|cefdinir|mesh-list
24820243|NCT02099240|Penicillin G|penicillin g|mesh-list
24820244|NCT02099240|Penicillin G Benzathine|penicillin g benzathine|mesh-list
24820245|NCT02099240|Penicillin G Procaine|penicillin g procaine|mesh-list
24820246|NCT02099240|Cloxacillin|cloxacillin|mesh-list
24820247|NCT02099240|Norfloxacin|norfloxacin|mesh-list
24820248|NCT02099240|Cefprozil|cefprozil|mesh-list
24820249|NCT02099240|Cephalosporins|cephalosporins|mesh-list
24820250|NCT02099240|Oxacillin|oxacillin|mesh-list
24820251|NCT02099240|Nafcillin|nafcillin|mesh-list
24820252|NCT02099240|Streptomycin|streptomycin|mesh-list
24820253|NCT02099240|Ticarcillin|ticarcillin|mesh-list
24820254|NCT02099240|Methenamine hippurate|methenamine hippurate|mesh-list
24820255|NCT02099240|Methenamine mandelate|methenamine mandelate|mesh-list
24408541|NCT00178269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860374|NCT00083525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24408542|NCT00178373|Modafinil|modafinil|mesh-list
24408543|NCT00178373|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24408544|NCT00178373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408545|NCT00178373|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24408546|NCT00178373|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24408547|NCT00178373|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24408548|NCT00178373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408549|NCT00178451|Abciximab|abciximab|mesh-list
24408550|NCT00178451|Anticoagulants|anticoagulants|mesh-ancestor
24408551|NCT00178451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24408552|NCT00178620|Reteplase|reteplase|mesh-list
24408553|NCT00178620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25860375|NCT00083525|Antimetabolites|antimetabolites|mesh-ancestor
25103568|NCT03160651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25103569|NCT03160651|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25103570|NCT03160651|Protective Agents|protective agents|mesh-ancestor
25103571|NCT03160651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25103598|NCT03160001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25103740|NCT03158935|Interleukin-2|interleukin-2|mesh-list
25103741|NCT03158935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25103742|NCT03158935|Immunologic Factors|immunologic factors|mesh-ancestor
25183582|NCT02841332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183583|NCT02841332|Growth Inhibitors|growth inhibitors|mesh-ancestor
25183584|NCT02841332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25183585|NCT02841332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25183586|NCT02841332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25183587|NCT02840994|Pembrolizumab|pembrolizumab|mesh-list
25183588|NCT02840994|Nivolumab|nivolumab|mesh-list
25426871|NCT01950520|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25183596|NCT02841202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24449128|NCT00314509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25006296|NCT05198388|Endorphins|endorphins|mesh-list
25183597|NCT02841202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183598|NCT02841202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25205443|NCT04688814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25205444|NCT04678336|Cyclophosphamide|cyclophosphamide|mesh-list
25205445|NCT04678336|Fludarabine|fludarabine|mesh-list
25205446|NCT04678336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25205447|NCT04678336|Immunologic Factors|immunologic factors|mesh-ancestor
25205448|NCT04678336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205449|NCT04678336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25205450|NCT04678336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25205451|NCT04678336|Alkylating Agents|alkylating agents|mesh-ancestor
25205452|NCT04678336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205453|NCT04678336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25205454|NCT04678336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25183599|NCT02841137|Progesterone|progesterone|mesh-list
25183600|NCT02841137|Progestins|progestins|mesh-ancestor
25183601|NCT02841137|Hormones|hormones|mesh-ancestor
25183602|NCT02841137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25183603|NCT02841137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183604|NCT02841176|Golimumab|golimumab|mesh-list
25183605|NCT02841176|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25183606|NCT02841176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25183607|NCT02841176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25183608|NCT02841176|Immunologic Factors|immunologic factors|mesh-ancestor
25183609|NCT02841176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183610|NCT02840929|Esomeprazole|esomeprazole|mesh-list
25183611|NCT02840929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25183612|NCT02840929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25183613|NCT02840929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25183614|NCT02840929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183615|NCT02840929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183616|NCT02840708|Sargramostim|sargramostim|mesh-list
25183617|NCT02840708|Immunologic Factors|immunologic factors|mesh-ancestor
25183618|NCT02840708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183619|NCT02840539|Cytarabine|cytarabine|mesh-list
25183620|NCT02840539|Dexamethasone|dexamethasone|mesh-list
25183621|NCT02840539|Dexamethasone acetate|dexamethasone acetate|mesh-list
25183622|NCT02840539|Bortezomib|bortezomib|mesh-list
25183623|NCT02840539|BB 1101|bb 1101|mesh-list
25183624|NCT02840539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25183625|NCT02840539|Antiemetics|antiemetics|mesh-ancestor
25183626|NCT02840539|Autonomic Agents|autonomic agents|mesh-ancestor
25183627|NCT02840539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183628|NCT02840539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183629|NCT02840539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25183630|NCT02840539|Glucocorticoids|glucocorticoids|mesh-ancestor
25183631|NCT02840539|Hormones|hormones|mesh-ancestor
25183632|NCT02840539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25183633|NCT02840539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25183634|NCT02840539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665676|NCT01687166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665677|NCT01687179|Sirolimus|sirolimus|mesh-list
25665678|NCT01687179|Hydroxychloroquine|hydroxychloroquine|mesh-list
25665679|NCT01687179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25665680|NCT01687179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25665681|NCT01687179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25665682|NCT01687179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665683|NCT01687179|Antifungal Agents|antifungal agents|mesh-ancestor
25183640|NCT02840539|Antiviral Agents|antiviral agents|mesh-ancestor
25183641|NCT02840539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25183642|NCT02840539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25183643|NCT02840539|Immunologic Factors|immunologic factors|mesh-ancestor
25183644|NCT02840591|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
25183645|NCT02840591|Nootropic Agents|nootropic agents|mesh-ancestor
25183646|NCT02840240|Gabapentin|gabapentin|mesh-list
25183647|NCT02840240|Analgesics|analgesics|mesh-ancestor
25183648|NCT02840240|Sensory System Agents|sensory system agents|mesh-ancestor
25183649|NCT02840240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24721074|NCT01572116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25183650|NCT02840240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183651|NCT02840240|Anticonvulsants|anticonvulsants|mesh-ancestor
25183652|NCT02840240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25183653|NCT02840240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25183654|NCT02840240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25183655|NCT02840240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25183656|NCT02840240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25183657|NCT02840240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25183658|NCT02840240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25183659|NCT02840240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183660|NCT02840240|Antimanic Agents|antimanic agents|mesh-ancestor
25183661|NCT02840526|Acetaminophen|acetaminophen|mesh-list
25183663|NCT02840526|Bupivacaine|bupivacaine|mesh-list
25183664|NCT02840526|Propofol|propofol|mesh-list
25183665|NCT02840526|Sevoflurane|sevoflurane|mesh-list
25183666|NCT02840526|Anesthetics, Local|anesthetics, local|mesh-ancestor
25183667|NCT02840526|Anesthetics|anesthetics|mesh-ancestor
25183668|NCT02840526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25183669|NCT02840526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183670|NCT02840526|Sensory System Agents|sensory system agents|mesh-ancestor
25183671|NCT02840526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183672|NCT02840526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25183673|NCT02840526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25183674|NCT02840526|Anesthetics, General|anesthetics, general|mesh-ancestor
25183675|NCT02840526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25183676|NCT02840526|Narcotics|narcotics|mesh-ancestor
25183677|NCT02840526|Analgesics|analgesics|mesh-ancestor
25183678|NCT02840526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25183679|NCT02840526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25183680|NCT02840526|Antipyretics|antipyretics|mesh-ancestor
25183681|NCT02840526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25183682|NCT02840526|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25183683|NCT02840409|Bevacizumab|bevacizumab|mesh-list
25183684|NCT02840409|Vinblastine|vinblastine|mesh-list
25183685|NCT02840409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25183686|NCT02840409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25183687|NCT02840409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25183688|NCT02840409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25183689|NCT02840409|Growth Substances|growth substances|mesh-ancestor
25183690|NCT02840409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183691|NCT02840409|Growth Inhibitors|growth inhibitors|mesh-ancestor
25183692|NCT02840409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25183693|NCT02840409|Tubulin Modulators|tubulin modulators|mesh-ancestor
25183694|NCT02840409|Antimitotic Agents|antimitotic agents|mesh-ancestor
25183695|NCT02840409|Mitosis Modulators|mitosis modulators|mesh-ancestor
25183696|NCT02840409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183697|NCT02840175|Adalimumab|adalimumab|mesh-list
25183698|NCT02840175|Etanercept|etanercept|mesh-list
25183699|NCT02840175|Abatacept|abatacept|mesh-list
25183700|NCT02840175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25183701|NCT02840175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25665684|NCT01687179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25665685|NCT01687179|Immunologic Factors|immunologic factors|mesh-ancestor
25665686|NCT01687179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665687|NCT01687179|Antimalarials|antimalarials|mesh-ancestor
25665688|NCT01687179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25665689|NCT01687179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24519580|NCT05332353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519582|NCT05332314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24519611|NCT05332106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24519612|NCT05332106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519701|NCT05287360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24519702|NCT05287360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24519703|NCT05287360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519704|NCT05280743|Oxycodone|oxycodone|mesh-list
25183702|NCT02840175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25183703|NCT02840175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25183704|NCT02840175|Analgesics|analgesics|mesh-ancestor
25183705|NCT02840175|Sensory System Agents|sensory system agents|mesh-ancestor
24449129|NCT00314509|Adrenergic Agents|adrenergic agents|mesh-ancestor
25183706|NCT02840175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183707|NCT02840175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183708|NCT02840175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25183709|NCT02840175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25183710|NCT02840175|Immunologic Factors|immunologic factors|mesh-ancestor
25183711|NCT02840175|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25183712|NCT02840175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183713|NCT02840175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25183714|NCT02840162|Celecoxib|celecoxib|mesh-list
25183715|NCT02840162|Benzenesulfonamide|benzenesulfonamide|mesh-list
25183716|NCT02840162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25183717|NCT02840162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25183718|NCT02840162|Analgesics|analgesics|mesh-ancestor
25183719|NCT02840162|Sensory System Agents|sensory system agents|mesh-ancestor
25183720|NCT02840162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183721|NCT02840162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183722|NCT02840162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25183723|NCT02840162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25183724|NCT02840162|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25183725|NCT02840162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25183726|NCT02840162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183727|NCT02840162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183728|NCT02840162|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25183729|NCT02840006|Anesthetics|anesthetics|mesh-list
25183730|NCT02840006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25183731|NCT02840006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183732|NCT02839928|Ketamine|ketamine|mesh-list
25183733|NCT02839928|Analgesics|analgesics|mesh-list
25183734|NCT02839928|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25183735|NCT02839928|Sensory System Agents|sensory system agents|mesh-ancestor
25183736|NCT02839928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183737|NCT02839928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183738|NCT02839928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25183739|NCT02839928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25183740|NCT02839928|Anesthetics, General|anesthetics, general|mesh-ancestor
25183741|NCT02839928|Anesthetics|anesthetics|mesh-ancestor
25183742|NCT02839928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25183743|NCT02839928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25183744|NCT02839928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25183745|NCT02839928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25183746|NCT02839928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183747|NCT02839928|Anesthetics, Local|anesthetics, local|mesh-ancestor
25183748|NCT02839928|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25183749|NCT02839941|Mycophenolic Acid|mycophenolic acid|mesh-list
25183751|NCT02839941|Glucocorticoids|glucocorticoids|mesh-list
25183752|NCT02839941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25183753|NCT02839941|Immunologic Factors|immunologic factors|mesh-ancestor
25183754|NCT02839941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183755|NCT02839941|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25665690|NCT01687179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665691|NCT01687179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665692|NCT01687179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25665693|NCT01687218|Tenofovir|tenofovir|mesh-list
25665694|NCT01687218|Emtricitabine|emtricitabine|mesh-list
25665695|NCT01687218|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25665696|NCT01687218|Glycerol|glycerol|mesh-list
25665697|NCT01687218|Antiviral Agents|antiviral agents|mesh-ancestor
25665698|NCT01687218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25183757|NCT02839941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183758|NCT02839941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25183759|NCT02839941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25183760|NCT02839941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25183761|NCT02839941|Antitubercular Agents|antitubercular agents|mesh-ancestor
25183762|NCT02839941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25183763|NCT02839941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25183764|NCT02839941|Hormones|hormones|mesh-ancestor
25183765|NCT02839941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25183766|NCT02839694|Celecoxib|celecoxib|mesh-list
25183767|NCT02839694|Decitabine|decitabine|mesh-list
25183768|NCT02839694|Tetrahydrouridine|tetrahydrouridine|mesh-list
25183769|NCT02839694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25183770|NCT02839694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25183771|NCT02839694|Analgesics|analgesics|mesh-ancestor
25183772|NCT02839694|Sensory System Agents|sensory system agents|mesh-ancestor
25183773|NCT02839694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183774|NCT02839694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183775|NCT02839694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25183776|NCT02839694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25183777|NCT02839694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25183778|NCT02839694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25183779|NCT02839694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183780|NCT02839694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183790|NCT02839785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183791|NCT02839785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25183792|NCT02839785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25183793|NCT02839785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25183794|NCT02839785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183795|NCT02839785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183796|NCT02839668|Acetaminophen|acetaminophen|mesh-list
25183797|NCT02839668|Lidocaine|lidocaine|mesh-list
25183798|NCT02839668|Atropine|atropine|mesh-list
25183799|NCT02839668|Tramadol|tramadol|mesh-list
25183800|NCT02839668|Sevoflurane|sevoflurane|mesh-list
25183801|NCT02839668|Neostigmine|neostigmine|mesh-list
25183802|NCT02839668|Anesthetics, Local|anesthetics, local|mesh-ancestor
25183803|NCT02839668|Anesthetics|anesthetics|mesh-ancestor
25183804|NCT02839668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25183805|NCT02839668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183806|NCT02839668|Sensory System Agents|sensory system agents|mesh-ancestor
25183807|NCT02839668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183808|NCT02839668|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25183809|NCT02839668|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25183810|NCT02839668|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25183811|NCT02839668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25183812|NCT02839668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183813|NCT02839668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25183814|NCT02839668|Analgesics|analgesics|mesh-ancestor
25183815|NCT02839668|Antipyretics|antipyretics|mesh-ancestor
25183816|NCT02839668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25183817|NCT02839668|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25183818|NCT02839668|Anesthetics, General|anesthetics, general|mesh-ancestor
25183819|NCT02839668|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25183820|NCT02839668|Narcotics|narcotics|mesh-ancestor
25183821|NCT02839668|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25183822|NCT02839668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25183823|NCT02839668|Autonomic Agents|autonomic agents|mesh-ancestor
24408807|NCT00179699|Growth Inhibitors|growth inhibitors|mesh-ancestor
24408808|NCT00179712|Topotecan|topotecan|mesh-list
24408809|NCT00179712|Lenalidomide|lenalidomide|mesh-list
24408810|NCT00179712|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24408811|NCT00179712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24408812|NCT00179712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408813|NCT00179712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408814|NCT00179712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408815|NCT00179712|Immunologic Factors|immunologic factors|mesh-ancestor
24408816|NCT00179712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408817|NCT00179712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25183824|NCT02839668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25183825|NCT02839668|Respiratory System Agents|respiratory system agents|mesh-ancestor
25183826|NCT02839668|Mydriatics|mydriatics|mesh-ancestor
24520507|NCT00630565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24650862|NCT01228305|Acetaminophen|acetaminophen|mesh-list
25183827|NCT02839668|Parasympatholytics|parasympatholytics|mesh-ancestor
25183828|NCT02839668|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25183829|NCT02839668|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25183830|NCT02839668|Cholinergic Agents|cholinergic agents|mesh-ancestor
25183831|NCT02839668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25183832|NCT02839668|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25183833|NCT02839668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183834|NCT02839668|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25183844|NCT02839538|Anesthetics|anesthetics|mesh-list
25183939|NCT02838823|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25239579|NCT02541006|Autonomic Agents|autonomic agents|mesh-ancestor
25183852|NCT02839421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183853|NCT02839421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183854|NCT02839421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25183855|NCT02839356|Epinephrine|epinephrine|mesh-list
25183856|NCT02839356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25183857|NCT02839356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25183858|NCT02839356|Adrenergic Agents|adrenergic agents|mesh-ancestor
25183859|NCT02839356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25183860|NCT02839356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183861|NCT02839356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183862|NCT02839356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25183863|NCT02839356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25183864|NCT02839356|Autonomic Agents|autonomic agents|mesh-ancestor
25183865|NCT02839356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183866|NCT02839356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25183867|NCT02839356|Respiratory System Agents|respiratory system agents|mesh-ancestor
25183868|NCT02839356|Mydriatics|mydriatics|mesh-ancestor
25183869|NCT02839356|Sympathomimetics|sympathomimetics|mesh-ancestor
25183870|NCT02839356|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25183871|NCT02839408|Azithromycin|azithromycin|mesh-list
25183872|NCT02839408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25183873|NCT02839408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25183874|NCT02839239|Vitamin D|vitamin d|mesh-list
25183875|NCT02839239|Ergocalciferols|ergocalciferols|mesh-list
25183876|NCT02839239|Cholecalciferol|cholecalciferol|mesh-list
25183877|NCT02839239|Vitamins|vitamins|mesh-list
25183878|NCT02839239|Micronutrients|micronutrients|mesh-ancestor
25183879|NCT02839239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183880|NCT02839239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25183881|NCT02839239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25183882|NCT02839213|Scopolamine|scopolamine|mesh-list
25183883|NCT02839213|Bromides|bromides|mesh-list
25183884|NCT02839213|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25183885|NCT02839213|Anticonvulsants|anticonvulsants|mesh-ancestor
25183886|NCT02839213|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25183887|NCT02839213|Antiemetics|antiemetics|mesh-ancestor
25183888|NCT02839213|Autonomic Agents|autonomic agents|mesh-ancestor
25183889|NCT02839213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183890|NCT02839213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183891|NCT02839213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25183892|NCT02839213|Mydriatics|mydriatics|mesh-ancestor
25183893|NCT02839213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25183894|NCT02839213|Cholinergic Agents|cholinergic agents|mesh-ancestor
25183895|NCT02839213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25183896|NCT02839213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183897|NCT02839213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25183898|NCT02839213|Parasympatholytics|parasympatholytics|mesh-ancestor
25183899|NCT02839161|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25183900|NCT02839161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25183901|NCT02839161|Immunologic Factors|immunologic factors|mesh-ancestor
25183902|NCT02839161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183903|NCT02839161|Antacids|antacids|mesh-ancestor
25183904|NCT02839161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183905|NCT02839161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25205466|NCT04663555|Dexamethasone|dexamethasone|mesh-list
25205467|NCT04663555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25665699|NCT01687218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25665700|NCT01687218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25665701|NCT01687218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205468|NCT04663555|Antiemetics|antiemetics|mesh-ancestor
25205469|NCT04663555|Autonomic Agents|autonomic agents|mesh-ancestor
25205470|NCT04663555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25860376|NCT00083525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860377|NCT00083525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860378|NCT00083538|Thalidomide|thalidomide|mesh-list
24520932|NCT05237141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527614|NCT00617656|Tubulin Modulators|tubulin modulators|mesh-ancestor
24527615|NCT00617656|Antimitotic Agents|antimitotic agents|mesh-ancestor
25210692|NCT05322681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25210693|NCT05322681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25210694|NCT05322603|Diclofenac|diclofenac|mesh-list
25205471|NCT04663555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205472|NCT04663555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25205473|NCT04663555|Glucocorticoids|glucocorticoids|mesh-ancestor
25205474|NCT04663555|Hormones|hormones|mesh-ancestor
25205475|NCT04663555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25205476|NCT04663555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25205477|NCT04663555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25205478|NCT04649489|Bevacizumab|bevacizumab|mesh-list
25205479|NCT04649489|Atezolizumab|atezolizumab|mesh-list
25205480|NCT04649489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25205481|NCT04649489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25205482|NCT04649489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25205483|NCT04649489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25205484|NCT04649489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25205485|NCT04649489|Growth Substances|growth substances|mesh-ancestor
25205486|NCT04649489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205487|NCT04649489|Growth Inhibitors|growth inhibitors|mesh-ancestor
25205488|NCT04649489|Immunologic Factors|immunologic factors|mesh-ancestor
25205489|NCT04645719|Magnesium Sulfate|magnesium sulfate|mesh-list
25205490|NCT04645719|Analgesics|analgesics|mesh-ancestor
25205491|NCT04645719|Sensory System Agents|sensory system agents|mesh-ancestor
25205492|NCT04645719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25205493|NCT04645719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205494|NCT04645719|Anesthetics|anesthetics|mesh-ancestor
25205495|NCT04645719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25205496|NCT04645719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25205497|NCT04645719|Anticonvulsants|anticonvulsants|mesh-ancestor
25205498|NCT04645719|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25205499|NCT04645719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25205500|NCT04645719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421680|NCT00219895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25205501|NCT04645719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25205502|NCT04645719|Tocolytic Agents|tocolytic agents|mesh-ancestor
25205503|NCT04645719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25205504|NCT04641273|Pregabalin|pregabalin|mesh-list
25205505|NCT04641273|Analgesics|analgesics|mesh-ancestor
25205506|NCT04641273|Sensory System Agents|sensory system agents|mesh-ancestor
25205507|NCT04641273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25205508|NCT04641273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205509|NCT04641273|Anticonvulsants|anticonvulsants|mesh-ancestor
25205510|NCT04641273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25205511|NCT04641273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25208059|NCT03113409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25183907|NCT02839486|Cefoxitin|cefoxitin|mesh-list
25183908|NCT02839486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25183909|NCT02839486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25183910|NCT02839122|Tadalafil|tadalafil|mesh-list
25183911|NCT02839122|Dutasteride|dutasteride|mesh-list
25183912|NCT02839122|Vasodilator Agents|vasodilator agents|mesh-ancestor
25183913|NCT02839122|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25183914|NCT02839122|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25183915|NCT02839122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183916|NCT02839122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183917|NCT02839122|Urological Agents|urological agents|mesh-ancestor
25183918|NCT02839122|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25183919|NCT02839122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25183920|NCT02839122|Hormone Antagonists|hormone antagonists|mesh-ancestor
25665702|NCT01687218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665703|NCT01687218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25665704|NCT01687218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25665705|NCT01687218|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25665706|NCT01687218|Protective Agents|protective agents|mesh-ancestor
25665707|NCT01687218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665708|NCT01687257|Sofosbuvir|sofosbuvir|mesh-list
25665709|NCT01687257|Antiviral Agents|antiviral agents|mesh-ancestor
25665710|NCT01687257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25183926|NCT02839135|Antiemetics|antiemetics|mesh-ancestor
25183927|NCT02839135|Autonomic Agents|autonomic agents|mesh-ancestor
25183928|NCT02839135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183929|NCT02839135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183930|NCT02839135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25183931|NCT02839135|Mydriatics|mydriatics|mesh-ancestor
25183932|NCT02839135|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25183933|NCT02839135|Cholinergic Agents|cholinergic agents|mesh-ancestor
25183934|NCT02839135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25183935|NCT02839135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183936|NCT02839135|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25183937|NCT02839135|Parasympatholytics|parasympatholytics|mesh-ancestor
25183938|NCT02838823|Antibodies|antibodies|mesh-list
25183940|NCT02838823|Immunologic Factors|immunologic factors|mesh-ancestor
25183941|NCT02838823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183942|NCT02838992|Cyclosporine|cyclosporine|mesh-list
25183943|NCT02838992|Cyclophosphamide|cyclophosphamide|mesh-list
25183944|NCT02838992|Cyclosporins|cyclosporins|mesh-list
25183945|NCT02838992|Thymoglobulin|thymoglobulin|mesh-list
25183946|NCT02838992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25183947|NCT02838992|Immunologic Factors|immunologic factors|mesh-ancestor
25183948|NCT02838992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183949|NCT02838992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25183950|NCT02838992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25183951|NCT02838992|Alkylating Agents|alkylating agents|mesh-ancestor
25183952|NCT02838992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183953|NCT02838992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25183954|NCT02838992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25183955|NCT02838992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25183956|NCT02838992|Antifungal Agents|antifungal agents|mesh-ancestor
25183957|NCT02838992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25183958|NCT02838992|Dermatologic Agents|dermatologic agents|mesh-ancestor
25183959|NCT02838992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25183960|NCT02839044|Vitamin K 2|vitamin k 2|mesh-list
25183961|NCT02839044|Vitamin K|vitamin k|mesh-list
25183962|NCT02839044|Vitamin MK 7|vitamin mk 7|mesh-list
25183963|NCT02839044|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25183964|NCT02839044|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25183965|NCT02839044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183966|NCT02839044|Hemostatics|hemostatics|mesh-ancestor
25183967|NCT02839044|Coagulants|coagulants|mesh-ancestor
25183968|NCT02839044|Vitamins|vitamins|mesh-ancestor
25183969|NCT02839044|Micronutrients|micronutrients|mesh-ancestor
25183970|NCT02839044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183971|NCT02838940|Cefazolin|cefazolin|mesh-list
25183972|NCT02838940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25183973|NCT02838940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25183974|NCT02838758|Lidocaine|lidocaine|mesh-list
25183975|NCT02838758|Anesthetics, Local|anesthetics, local|mesh-ancestor
24421871|NCT00220350|Leuprolide|leuprolide|mesh-list
25183976|NCT02838758|Anesthetics|anesthetics|mesh-ancestor
25183977|NCT02838758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25183978|NCT02838758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408942|NCT00180089|Hormones|hormones|mesh-ancestor
25183979|NCT02838758|Sensory System Agents|sensory system agents|mesh-ancestor
25665711|NCT01687270|Sofosbuvir|sofosbuvir|mesh-list
25665712|NCT01687270|Ribavirin|ribavirin|mesh-list
25665713|NCT01687270|Antiviral Agents|antiviral agents|mesh-ancestor
25665714|NCT01687270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25665715|NCT01687270|Antimetabolites|antimetabolites|mesh-ancestor
25665716|NCT01687270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665717|NCT01687283|Fluticasone|fluticasone|mesh-list
25183980|NCT02838758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183981|NCT02838758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25665718|NCT01687283|Xhance|xhance|mesh-list
25665719|NCT01687283|Budesonide|budesonide|mesh-list
25860379|NCT00083538|Dexamethasone|dexamethasone|mesh-list
25860380|NCT00083538|Cyclophosphamide|cyclophosphamide|mesh-list
25183982|NCT02838758|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25183983|NCT02838758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25183984|NCT02838758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25183985|NCT02838758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25183986|NCT02838719|Dexamethasone|dexamethasone|mesh-list
25183987|NCT02838719|Dexamethasone acetate|dexamethasone acetate|mesh-list
25183988|NCT02838719|BB 1101|bb 1101|mesh-list
25184181|NCT02837614|Dexamethasone acetate|dexamethasone acetate|mesh-list
25183989|NCT02838719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25183990|NCT02838719|Antiemetics|antiemetics|mesh-ancestor
25183991|NCT02838719|Autonomic Agents|autonomic agents|mesh-ancestor
25183992|NCT02838719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25183993|NCT02838719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25183994|NCT02838719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25183995|NCT02838719|Glucocorticoids|glucocorticoids|mesh-ancestor
25183996|NCT02838719|Hormones|hormones|mesh-ancestor
25245790|NCT03719326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25183997|NCT02838719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25183998|NCT02838719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25183999|NCT02838719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184000|NCT02838719|Protease Inhibitors|protease inhibitors|mesh-ancestor
25184001|NCT02838719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184002|NCT02838719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184003|NCT02838537|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
25184004|NCT02838537|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25184005|NCT02838537|Serotonin Agents|serotonin agents|mesh-ancestor
25184006|NCT02838537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25184007|NCT02838537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184008|NCT02838537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184009|NCT02838589|Exenatide|exenatide|mesh-list
25184010|NCT02838589|Glucagon|glucagon|mesh-list
25184011|NCT02838589|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25184012|NCT02838589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25184013|NCT02838589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184014|NCT02838589|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25184015|NCT02838589|Incretins|incretins|mesh-ancestor
25184016|NCT02838589|Hormones|hormones|mesh-ancestor
25184017|NCT02838589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25184018|NCT02838589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25184019|NCT02838576|Estrogens|estrogens|mesh-list
25184020|NCT02838576|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25184021|NCT02838576|Hormones|hormones|mesh-ancestor
25184022|NCT02838576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25184023|NCT02838576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184024|NCT02838472|Ascorbic Acid|ascorbic acid|mesh-list
25184025|NCT02838472|Vitamins|vitamins|mesh-ancestor
25184026|NCT02838472|Micronutrients|micronutrients|mesh-ancestor
25184027|NCT02838472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184028|NCT02838472|Antioxidants|antioxidants|mesh-ancestor
25184029|NCT02838472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184030|NCT02838472|Protective Agents|protective agents|mesh-ancestor
25184031|NCT02838238|Capecitabine|capecitabine|mesh-list
25184032|NCT02838238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25184033|NCT02838238|Antimetabolites|antimetabolites|mesh-ancestor
25184034|NCT02838238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184035|NCT02838238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184036|NCT02838329|Ropivacaine|ropivacaine|mesh-list
25184037|NCT02838329|Anesthetics, Local|anesthetics, local|mesh-ancestor
25184038|NCT02838329|Anesthetics|anesthetics|mesh-ancestor
25184039|NCT02838329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25184040|NCT02838329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184041|NCT02838329|Sensory System Agents|sensory system agents|mesh-ancestor
25184042|NCT02838329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25184043|NCT02838342|Interferons|interferons|mesh-list
25184044|NCT02838342|Interferon-alpha|interferon-alpha|mesh-list
25184045|NCT02838342|Cyclophosphamide|cyclophosphamide|mesh-list
25184046|NCT02838342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25184047|NCT02838342|Immunologic Factors|immunologic factors|mesh-ancestor
25184048|NCT02838342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184049|NCT02838342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25184050|NCT02838342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24409022|NCT00180622|Autonomic Agents|autonomic agents|mesh-ancestor
25184051|NCT02838342|Alkylating Agents|alkylating agents|mesh-ancestor
25665720|NCT01687283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25860383|NCT00083538|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24465923|NCT00371111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24465924|NCT00371111|Glucocorticoids|glucocorticoids|mesh-ancestor
24456885|NCT00332553|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25184052|NCT02838342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184053|NCT02838342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184054|NCT02838342|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25184055|NCT02838342|Antiviral Agents|antiviral agents|mesh-ancestor
25184056|NCT02838342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25184057|NCT02838615|Dexamethasone|dexamethasone|mesh-list
25184058|NCT02838615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25184059|NCT02838615|Antiemetics|antiemetics|mesh-ancestor
25184060|NCT02838615|Autonomic Agents|autonomic agents|mesh-ancestor
25184061|NCT02838615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25184062|NCT02838615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184063|NCT02838615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25184064|NCT02838615|Glucocorticoids|glucocorticoids|mesh-ancestor
25245791|NCT03719326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184066|NCT02838615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25184067|NCT02838615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25184068|NCT02838615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184069|NCT02838225|Cyclophosphamide|cyclophosphamide|mesh-list
25184070|NCT02838225|Docetaxel|docetaxel|mesh-list
25184071|NCT02838225|Doxorubicin|doxorubicin|mesh-list
25184072|NCT02838225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25184073|NCT02838225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25184074|NCT02838225|Immunologic Factors|immunologic factors|mesh-ancestor
25184075|NCT02838225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184076|NCT02838225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25184077|NCT02838225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25184078|NCT02838225|Alkylating Agents|alkylating agents|mesh-ancestor
25184079|NCT02838225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184080|NCT02838225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184081|NCT02838225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25184082|NCT02838225|Tubulin Modulators|tubulin modulators|mesh-ancestor
25184083|NCT02838225|Antimitotic Agents|antimitotic agents|mesh-ancestor
25184084|NCT02838225|Mitosis Modulators|mitosis modulators|mesh-ancestor
25184085|NCT02838225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25184086|NCT02838225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25184087|NCT02838225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25184088|NCT02838225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184089|NCT02838264|Itraconazole|itraconazole|mesh-list
25184090|NCT02838264|Antifungal Agents|antifungal agents|mesh-ancestor
25184091|NCT02838264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25184092|NCT02838264|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25184093|NCT02838264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25184094|NCT02838264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184095|NCT02838264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184096|NCT02838264|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25184097|NCT02838264|Hormone Antagonists|hormone antagonists|mesh-ancestor
25184098|NCT02838264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25184099|NCT02838264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184100|NCT02838264|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25184101|NCT02837978|Methotrexate|methotrexate|mesh-list
25184102|NCT02837978|Tacrolimus|tacrolimus|mesh-list
25184103|NCT02837978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25184104|NCT02837978|Abortifacient Agents|abortifacient agents|mesh-ancestor
25184105|NCT02837978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25184106|NCT02837978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184107|NCT02837978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25184108|NCT02837978|Antimetabolites|antimetabolites|mesh-ancestor
25184109|NCT02837978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665721|NCT01687283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25665722|NCT01687283|Autonomic Agents|autonomic agents|mesh-ancestor
25665723|NCT01687283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25665724|NCT01687283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665725|NCT01687283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25665726|NCT01687283|Respiratory System Agents|respiratory system agents|mesh-ancestor
25665727|NCT01687283|Dermatologic Agents|dermatologic agents|mesh-ancestor
25665728|NCT01687283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25184112|NCT02837978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460122|NCT00347425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25184113|NCT02837978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25184114|NCT02837978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25184115|NCT02837978|Immunologic Factors|immunologic factors|mesh-ancestor
25184116|NCT02837978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25184117|NCT02837978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25184118|NCT02837978|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25184119|NCT02838121|Zoledronic Acid|zoledronic acid|mesh-list
25184120|NCT02838121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25184121|NCT02838121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184123|NCT02837965|Prednisone|prednisone|mesh-list
25184124|NCT02837965|Methotrexate|methotrexate|mesh-list
25184125|NCT02837965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24409092|NCT00180908|Doxorubicin|doxorubicin|mesh-list
24820569|NCT02100267|Cholinergic Agents|cholinergic agents|mesh-ancestor
24820570|NCT02100267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24820571|NCT02100267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820572|NCT02100293|Magnesium Sulfate|magnesium sulfate|mesh-list
24820573|NCT02100293|Analgesics|analgesics|mesh-ancestor
24820574|NCT02100293|Sensory System Agents|sensory system agents|mesh-ancestor
25245792|NCT03719326|Tubulin Modulators|tubulin modulators|mesh-ancestor
24820575|NCT02100293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24820576|NCT02100293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820577|NCT02100293|Anesthetics|anesthetics|mesh-ancestor
24820578|NCT02100293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24820579|NCT02100293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24820580|NCT02100293|Anticonvulsants|anticonvulsants|mesh-ancestor
24820581|NCT02100293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24820582|NCT02100293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24820583|NCT02100293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820584|NCT02100293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24820585|NCT02100293|Tocolytic Agents|tocolytic agents|mesh-ancestor
24820586|NCT02100293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24820588|NCT02100423|Cholecalciferol|cholecalciferol|mesh-list
24820589|NCT02100423|Curcumin|curcumin|mesh-list
24820590|NCT02100423|Vitamins|vitamins|mesh-ancestor
24820591|NCT02100423|Micronutrients|micronutrients|mesh-ancestor
24682063|NCT01383668|Gold Sodium Thiomalate|gold sodium thiomalate|mesh-list
24409165|NCT00181116|Nootropic Agents|nootropic agents|mesh-ancestor
25184126|NCT02837965|Glucocorticoids|glucocorticoids|mesh-ancestor
25184127|NCT02837965|Hormones|hormones|mesh-ancestor
25184128|NCT02837965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25184129|NCT02837965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184130|NCT02837965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25184131|NCT02837965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184132|NCT02837965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25184133|NCT02837965|Abortifacient Agents|abortifacient agents|mesh-ancestor
25184134|NCT02837965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25184135|NCT02837965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25184136|NCT02837965|Antimetabolites|antimetabolites|mesh-ancestor
25184137|NCT02837965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184138|NCT02837965|Dermatologic Agents|dermatologic agents|mesh-ancestor
25184139|NCT02837965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772482|NCT01833819|Analgesics|analgesics|mesh-ancestor
24772484|NCT01833819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25184140|NCT02837965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25184141|NCT02837965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25184142|NCT02837965|Immunologic Factors|immunologic factors|mesh-ancestor
25184143|NCT02837965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25184144|NCT02837965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25184145|NCT02837965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25184146|NCT02837965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25184147|NCT02837965|Antimalarials|antimalarials|mesh-ancestor
25184148|NCT02837965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25184149|NCT02837965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25184150|NCT02838173|Ropivacaine|ropivacaine|mesh-list
25665729|NCT01687283|Glucocorticoids|glucocorticoids|mesh-ancestor
25184151|NCT02838173|Anesthetics, Local|anesthetics, local|mesh-ancestor
25184152|NCT02838173|Anesthetics|anesthetics|mesh-ancestor
25860386|NCT00083538|Immunologic Factors|immunologic factors|mesh-ancestor
25184153|NCT02838173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25184154|NCT02838173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184155|NCT02838173|Sensory System Agents|sensory system agents|mesh-ancestor
25184156|NCT02838173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25184158|NCT02837874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25184159|NCT02838030|Aspirin|aspirin|mesh-list
25184160|NCT02838030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25184161|NCT02838030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25184162|NCT02838030|Analgesics|analgesics|mesh-ancestor
25184163|NCT02838030|Sensory System Agents|sensory system agents|mesh-ancestor
25184164|NCT02838030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25184165|NCT02838030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184166|NCT02838030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25184167|NCT02838030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25184168|NCT02838030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25184169|NCT02838030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24722086|NCT01578473|Vitamin D|vitamin d|mesh-list
25184170|NCT02838030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184171|NCT02838030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24409178|NCT00181220|Valproic Acid|valproic acid|mesh-list
25184172|NCT02838030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25184173|NCT02838030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184174|NCT02838030|Antipyretics|antipyretics|mesh-ancestor
25184175|NCT02837835|Ceftazidime|ceftazidime|mesh-list
25184176|NCT02837835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25184177|NCT02837835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25184178|NCT02837614|Acetaminophen|acetaminophen|mesh-list
25184179|NCT02837614|Amoxicillin|amoxicillin|mesh-list
25184180|NCT02837614|Dexamethasone|dexamethasone|mesh-list
25184182|NCT02837614|BB 1101|bb 1101|mesh-list
25184183|NCT02837614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25184184|NCT02837614|Antiemetics|antiemetics|mesh-ancestor
25184185|NCT02837614|Autonomic Agents|autonomic agents|mesh-ancestor
25184186|NCT02837614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25184187|NCT02837614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184188|NCT02837614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25184189|NCT02837614|Glucocorticoids|glucocorticoids|mesh-ancestor
25184190|NCT02837614|Hormones|hormones|mesh-ancestor
25184191|NCT02837614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25184192|NCT02837614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25184193|NCT02837614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184194|NCT02837614|Protease Inhibitors|protease inhibitors|mesh-ancestor
25184195|NCT02837614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184196|NCT02837614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184197|NCT02837614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25184198|NCT02837614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25184199|NCT02837614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25184200|NCT02837614|Analgesics|analgesics|mesh-ancestor
25184201|NCT02837614|Sensory System Agents|sensory system agents|mesh-ancestor
25184202|NCT02837614|Antipyretics|antipyretics|mesh-ancestor
25205512|NCT04641273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205513|NCT04641273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25205514|NCT04641273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25205515|NCT04641273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25205516|NCT04641273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25205517|NCT04641273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25205518|NCT04611139|Pembrolizumab|pembrolizumab|mesh-list
25205519|NCT04611139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25205520|NCT04611139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25205521|NCT04570644|Ibuprofen|ibuprofen|mesh-list
25205522|NCT04570644|Cromolyn Sodium|cromolyn sodium|mesh-list
25205523|NCT04570644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25205524|NCT04570644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25205525|NCT04570644|Analgesics|analgesics|mesh-ancestor
25205526|NCT04570644|Sensory System Agents|sensory system agents|mesh-ancestor
25205527|NCT04570644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25205528|NCT04570644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772494|NCT01834014|Cetuximab|cetuximab|mesh-list
25205529|NCT04570644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25205530|NCT04570644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25205531|NCT04570644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25205532|NCT04570644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205533|NCT04570644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665730|NCT01687283|Hormones|hormones|mesh-ancestor
25860387|NCT00083538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860388|NCT00083538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25860389|NCT00083538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25860390|NCT00083538|Alkylating Agents|alkylating agents|mesh-ancestor
25860391|NCT00083538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860392|NCT00083538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860393|NCT00083538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25860394|NCT00083538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25205534|NCT04570644|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
25205535|NCT04570644|Immunologic Factors|immunologic factors|mesh-ancestor
25205536|NCT04570644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25205537|NCT04570644|Respiratory System Agents|respiratory system agents|mesh-ancestor
25205538|NCT04570501|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
25205539|NCT04570501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25205540|NCT04570501|Vasodilator Agents|vasodilator agents|mesh-ancestor
25205541|NCT04570085|Caffeine|caffeine|mesh-list
25205542|NCT04570085|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25205543|NCT04570085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205544|NCT04570085|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25205545|NCT04570085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205546|NCT04570085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205547|NCT04570085|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25205548|NCT04570085|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25205549|NCT04570085|Purinergic Agents|purinergic agents|mesh-ancestor
25205550|NCT04570085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25205551|NCT04558216|Rifampin|rifampin|mesh-list
25205552|NCT04558216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25205553|NCT04558216|Antitubercular Agents|antitubercular agents|mesh-ancestor
25208060|NCT03113409|Narcotics|narcotics|mesh-ancestor
25184203|NCT02837640|Levodopa|levodopa|mesh-list
25184204|NCT02837640|Carbidopa|carbidopa|mesh-list
25184205|NCT02837640|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25184206|NCT02837640|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25184207|NCT02837640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25184208|NCT02837640|Dopamine Agents|dopamine agents|mesh-ancestor
25184209|NCT02837640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25184210|NCT02837640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184211|NCT02837640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184286|NCT02836977|Antimetabolites|antimetabolites|mesh-ancestor
25184212|NCT02837640|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25184213|NCT02837640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184214|NCT02837640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25184215|NCT02837640|Immunologic Factors|immunologic factors|mesh-ancestor
25184216|NCT02837640|Dopamine Agonists|dopamine agonists|mesh-ancestor
25184217|NCT02837770|Diclofenac|diclofenac|mesh-list
25184218|NCT02837770|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25184219|NCT02837770|Lubricant Eye Drops|lubricant eye drops|mesh-list
25184220|NCT02837770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25184221|NCT02837770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25184222|NCT02837770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25184223|NCT02837770|Analgesics|analgesics|mesh-ancestor
25184224|NCT02837770|Sensory System Agents|sensory system agents|mesh-ancestor
25184225|NCT02837770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25184226|NCT02837770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184227|NCT02837770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25184228|NCT02837770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25184229|NCT02837770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25184230|NCT02837770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184231|NCT02837770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184232|NCT02837146|Methotrexate|methotrexate|mesh-list
25184233|NCT02837146|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25184234|NCT02837146|Abortifacient Agents|abortifacient agents|mesh-ancestor
25184235|NCT02837146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25184236|NCT02837146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184237|NCT02837146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25665731|NCT01687283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25665732|NCT01687296|Fluticasone|fluticasone|mesh-list
25665733|NCT01687296|Xhance|xhance|mesh-list
25665734|NCT01687296|Prednisone|prednisone|mesh-list
25665735|NCT01687296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25665736|NCT01687296|Albuterol|albuterol|mesh-list
25665737|NCT01687296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25665738|NCT01687296|Glucocorticoids|glucocorticoids|mesh-ancestor
25184238|NCT02837146|Antimetabolites|antimetabolites|mesh-ancestor
25665739|NCT01687296|Hormones|hormones|mesh-ancestor
24468116|NCT00379886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468118|NCT00379951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25184239|NCT02837146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184240|NCT02837146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184241|NCT02837146|Dermatologic Agents|dermatologic agents|mesh-ancestor
25184242|NCT02837146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184243|NCT02837146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25184244|NCT02837146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25184245|NCT02837146|Immunologic Factors|immunologic factors|mesh-ancestor
25184246|NCT02837146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25184247|NCT02837146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25184248|NCT02837081|Anti-Infective Agents|anti-infective agents|mesh-list
25184249|NCT02837081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25184251|NCT02837185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25245793|NCT03719326|Antimitotic Agents|antimitotic agents|mesh-ancestor
25184252|NCT02837185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25184253|NCT02837185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184254|NCT02837185|Cholinergic Agents|cholinergic agents|mesh-ancestor
25184255|NCT02837185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25184256|NCT02837185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184257|NCT02837198|Dotinurad|dotinurad|mesh-list
25184258|NCT02837198|FYX-051|fyx-051|mesh-list
25184259|NCT02837198|Uricosuric Agents|uricosuric agents|mesh-ancestor
25184260|NCT02837198|Gout Suppressants|gout suppressants|mesh-ancestor
25184261|NCT02837198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25184262|NCT02837198|Renal Agents|renal agents|mesh-ancestor
25184263|NCT02837198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184264|NCT02837198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184265|NCT02837094|Insulin|insulin|mesh-list
25184266|NCT02837094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25184267|NCT02837094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184268|NCT02837003|Aspirin|aspirin|mesh-list
25184269|NCT02837003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25184270|NCT02837003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25184271|NCT02837003|Analgesics|analgesics|mesh-ancestor
25184272|NCT02837003|Sensory System Agents|sensory system agents|mesh-ancestor
25184273|NCT02837003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25184274|NCT02837003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184275|NCT02837003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25184276|NCT02837003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25184277|NCT02837003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25184278|NCT02837003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25184279|NCT02837003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184280|NCT02837003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25184281|NCT02837003|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25184282|NCT02837003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184283|NCT02837003|Antipyretics|antipyretics|mesh-ancestor
25184284|NCT02836977|Tegafur|tegafur|mesh-list
25184285|NCT02836977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25184287|NCT02836977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184288|NCT02836977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184289|NCT02836665|Dermatologic Agents|dermatologic agents|mesh-list
25184290|NCT02836639|Etoposide|etoposide|mesh-list
25184291|NCT02836639|Busulfan|busulfan|mesh-list
25184292|NCT02836639|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25184293|NCT02836639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25184294|NCT02836639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184295|NCT02836639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25184296|NCT02836639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25184297|NCT02836639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184298|NCT02836639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184299|NCT02836639|Alkylating Agents|alkylating agents|mesh-ancestor
25184300|NCT02836639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25184301|NCT02836639|Immunologic Factors|immunologic factors|mesh-ancestor
25184302|NCT02836639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184303|NCT02836639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25184304|NCT02836639|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25184305|NCT02836847|Trastuzumab|trastuzumab|mesh-list
25184306|NCT02836847|Cetuximab|cetuximab|mesh-list
25184307|NCT02836847|Everolimus|everolimus|mesh-list
25184308|NCT02836847|Sorafenib|sorafenib|mesh-list
25184309|NCT02836847|Lapatinib|lapatinib|mesh-list
25665740|NCT01687296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25665741|NCT01687296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471349|NCT00394693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25860395|NCT00083538|Antiemetics|antiemetics|mesh-ancestor
24471350|NCT00394745|Valsartan|valsartan|mesh-list
24471351|NCT00394745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24471353|NCT00394745|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24424055|NCT00227747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471372|NCT00394992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24471373|NCT00394992|Growth Substances|growth substances|mesh-ancestor
24519076|NCT03539952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24519077|NCT03513562|Venetoclax|venetoclax|mesh-list
25860396|NCT00083538|Autonomic Agents|autonomic agents|mesh-ancestor
24471453|NCT00395395|Calcitonin|calcitonin|mesh-list
24471454|NCT00395395|Salmon calcitonin|salmon calcitonin|mesh-list
24471455|NCT00395395|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
24471456|NCT00395395|Katacalcin|katacalcin|mesh-list
24476809|NCT00416533|Hormones|hormones|mesh-ancestor
25184310|NCT02836847|Gefitinib|gefitinib|mesh-list
25184311|NCT02836847|Crizotinib|crizotinib|mesh-list
25184312|NCT02836847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25184313|NCT02836847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184314|NCT02836847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25184315|NCT02836847|Immunologic Factors|immunologic factors|mesh-ancestor
25184316|NCT02836847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184317|NCT02836847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25184318|NCT02836847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184319|NCT02836847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184320|NCT02836821|Rifampin|rifampin|mesh-list
25184321|NCT02836821|Apatinib|apatinib|mesh-list
25184322|NCT02836821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184323|NCT02836821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25184324|NCT02836821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184325|NCT02836821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184326|NCT02836821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25184327|NCT02836821|Antitubercular Agents|antitubercular agents|mesh-ancestor
25184328|NCT02836821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25184329|NCT02836821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25184330|NCT02836821|Leprostatic Agents|leprostatic agents|mesh-ancestor
25184331|NCT02836821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25184332|NCT02836821|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25184333|NCT02836821|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25184334|NCT02836821|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25184335|NCT02836821|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25184336|NCT02836821|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25184337|NCT02836821|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25184338|NCT02836548|Vorinostat|vorinostat|mesh-list
25184339|NCT02836548|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25184340|NCT02836548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184341|NCT02836548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184342|NCT02836548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184343|NCT02836743|Melatonin|melatonin|mesh-list
25184344|NCT02836743|Antioxidants|antioxidants|mesh-ancestor
25184345|NCT02836743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184346|NCT02836743|Protective Agents|protective agents|mesh-ancestor
25184347|NCT02836743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184348|NCT02836743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25184349|NCT02836704|Metformin|metformin|mesh-list
25184350|NCT02836704|Insulin Glargine|insulin glargine|mesh-list
25184351|NCT02836704|Acarbose|acarbose|mesh-list
25184352|NCT02836704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25184353|NCT02836704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184354|NCT02836704|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25184355|NCT02836704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665742|NCT01687296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25665743|NCT01687296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665744|NCT01687296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25665745|NCT01687296|Autonomic Agents|autonomic agents|mesh-ancestor
25665746|NCT01687296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25665747|NCT01687296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25665748|NCT01687296|Respiratory System Agents|respiratory system agents|mesh-ancestor
25665749|NCT01687296|Dermatologic Agents|dermatologic agents|mesh-ancestor
25665750|NCT01687296|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25665751|NCT01687296|Tocolytic Agents|tocolytic agents|mesh-ancestor
25665752|NCT01687296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25665753|NCT01687296|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25665754|NCT01687296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24476902|NCT00416819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24477137|NCT00417430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477165|NCT00417677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477167|NCT00417677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25184356|NCT02836704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184357|NCT02836795|Antibodies|antibodies|mesh-list
25184358|NCT02836795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25184359|NCT02836795|Immunologic Factors|immunologic factors|mesh-ancestor
25184360|NCT02836795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184361|NCT02836509|Acetaminophen|acetaminophen|mesh-list
25184363|NCT02836509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25184364|NCT02836509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25184365|NCT02836509|Analgesics|analgesics|mesh-ancestor
25184366|NCT02836509|Sensory System Agents|sensory system agents|mesh-ancestor
25184367|NCT02836509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25184368|NCT02836509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184369|NCT02836509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25184370|NCT02836509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25184371|NCT02836509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25184372|NCT02836509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184373|NCT02836509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184374|NCT02836509|Antipyretics|antipyretics|mesh-ancestor
25184375|NCT02836483|Linezolid|linezolid|mesh-list
25184376|NCT02836483|Delpazolid|delpazolid|mesh-list
25184377|NCT02836483|Oxazolidinones|oxazolidinones|mesh-list
25184378|NCT02836483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25184379|NCT02836483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25184380|NCT02836483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25184381|NCT02836483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184382|NCT02836483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184383|NCT02836171|Itraconazole|itraconazole|mesh-list
25184384|NCT02836171|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
25184385|NCT02836171|Apatinib|apatinib|mesh-list
25184386|NCT02836171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184387|NCT02836171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25184388|NCT02836171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184428|NCT02836353|Rifaximin|rifaximin|mesh-list
25184389|NCT02836171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184390|NCT02836171|Antifungal Agents|antifungal agents|mesh-ancestor
25184391|NCT02836171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25184392|NCT02836171|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25184393|NCT02836171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25184394|NCT02836171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25184395|NCT02836171|Hormone Antagonists|hormone antagonists|mesh-ancestor
25184396|NCT02836171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25184397|NCT02836171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184398|NCT02836171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25184399|NCT02836288|Ketamine|ketamine|mesh-list
25184400|NCT02836288|Analgesics|analgesics|mesh-ancestor
25184401|NCT02836288|Sensory System Agents|sensory system agents|mesh-ancestor
25184402|NCT02836288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25184403|NCT02836288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184404|NCT02836288|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25184405|NCT02836288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25184406|NCT02836288|Anesthetics, General|anesthetics, general|mesh-ancestor
25184407|NCT02836288|Anesthetics|anesthetics|mesh-ancestor
25184408|NCT02836288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25184409|NCT02836288|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25184410|NCT02836288|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25184411|NCT02836288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25184412|NCT02836288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184413|NCT02836184|Niacin|niacin|mesh-list
25184414|NCT02836184|Nicotinic Acids|nicotinic acids|mesh-list
25184415|NCT02836184|Niacinamide|niacinamide|mesh-list
25184416|NCT02836184|Calcium Carbonate|calcium carbonate|mesh-list
25184417|NCT02836184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184418|NCT02836184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25184419|NCT02836184|Antimetabolites|antimetabolites|mesh-ancestor
25426872|NCT01950520|Sympathomimetics|sympathomimetics|mesh-ancestor
25665755|NCT01687296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25665756|NCT01687296|Adrenergic Agents|adrenergic agents|mesh-ancestor
25665757|NCT01687296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25665758|NCT01687296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665759|NCT01687387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25184420|NCT02836184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184421|NCT02836184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25184422|NCT02836184|Vasodilator Agents|vasodilator agents|mesh-ancestor
25184423|NCT02836184|Vitamin B Complex|vitamin b complex|mesh-ancestor
24820804|NCT02101892|Antidepressive Agents|antidepressive agents|mesh-ancestor
24820805|NCT02101892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24820806|NCT02101892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24820807|NCT02101892|Analgesics|analgesics|mesh-ancestor
24820808|NCT02101892|Sensory System Agents|sensory system agents|mesh-ancestor
24820809|NCT02101892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24820810|NCT02101892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820811|NCT02101892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24820812|NCT02101892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25205566|NCT04546113|Ropivacaine|ropivacaine|mesh-list
24820813|NCT02101892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24820814|NCT02101892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820815|NCT02101892|Adrenergic Agents|adrenergic agents|mesh-ancestor
24820816|NCT02101892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24820817|NCT02101931|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24820819|NCT02101931|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24820820|NCT02101931|Dermatologic Agents|dermatologic agents|mesh-ancestor
24820821|NCT02101931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820822|NCT02101931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820823|NCT02102048|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24820824|NCT02102048|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24820825|NCT02102048|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24820826|NCT02102048|Protease Inhibitors|protease inhibitors|mesh-ancestor
24820827|NCT02102048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820828|NCT02102048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820829|NCT02102048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24820831|NCT02102048|Antiviral Agents|antiviral agents|mesh-ancestor
24820832|NCT02102048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24820841|NCT02102152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24820842|NCT02102152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24820843|NCT02102295|Ascorbic Acid|ascorbic acid|mesh-list
24820844|NCT02102295|Ascorbate-2-phosphate|ascorbate-2-phosphate|mesh-list
24820845|NCT02102295|Fluorides|fluorides|mesh-list
24820846|NCT02102295|Cariostatic Agents|cariostatic agents|mesh-ancestor
25184425|NCT02836184|Micronutrients|micronutrients|mesh-ancestor
25184426|NCT02836184|Antacids|antacids|mesh-ancestor
25184427|NCT02836184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25184429|NCT02836353|Somatostatin|somatostatin|mesh-list
25184430|NCT02836353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25184431|NCT02836353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25184432|NCT02836353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25184433|NCT02836353|Hormones|hormones|mesh-ancestor
25184434|NCT02836353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25184435|NCT02836353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184436|NCT02836431|Dexmedetomidine|dexmedetomidine|mesh-list
25184437|NCT02836431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24425410|NCT00232908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24425411|NCT00232908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24425412|NCT00232908|Antiviral Agents|antiviral agents|mesh-ancestor
24425413|NCT00232908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24425422|NCT00232934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24425423|NCT00232934|Growth Substances|growth substances|mesh-ancestor
24425424|NCT00232934|Growth Inhibitors|growth inhibitors|mesh-ancestor
24425426|NCT00232947|Vaccines|vaccines|mesh-list
25184438|NCT02836431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25184439|NCT02836431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184440|NCT02836431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25184441|NCT02836431|Analgesics|analgesics|mesh-ancestor
25184442|NCT02836431|Sensory System Agents|sensory system agents|mesh-ancestor
25184443|NCT02836431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25184444|NCT02836431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25184445|NCT02836431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25184446|NCT02836431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25184447|NCT02836431|Adrenergic Agents|adrenergic agents|mesh-ancestor
25184448|NCT02836431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25184449|NCT02836431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184450|NCT02835794|Azacitidine|azacitidine|mesh-list
25184451|NCT02835794|Homoharringtonine|homoharringtonine|mesh-list
25184452|NCT02835794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25184453|NCT02835794|Antimetabolites|antimetabolites|mesh-ancestor
25184454|NCT02835794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184455|NCT02835794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184456|NCT02835794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184457|NCT02835794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25184458|NCT02835794|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25205554|NCT04558216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25205555|NCT04558216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25205556|NCT04558216|Leprostatic Agents|leprostatic agents|mesh-ancestor
25205557|NCT04558216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25205558|NCT04558216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184459|NCT02836028|Temozolomide|temozolomide|mesh-list
25184460|NCT02836028|Talazoparib|talazoparib|mesh-list
25184461|NCT02836028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25184462|NCT02836028|Alkylating Agents|alkylating agents|mesh-ancestor
25184463|NCT02836028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184464|NCT02836028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184465|NCT02836028|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25184466|NCT02836028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184467|NCT02835833|Bevacizumab|bevacizumab|mesh-list
25184469|NCT02835833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25184470|NCT02835833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184471|NCT02835833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25184472|NCT02835833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25184473|NCT02835833|Growth Substances|growth substances|mesh-ancestor
25184474|NCT02835833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184475|NCT02835833|Growth Inhibitors|growth inhibitors|mesh-ancestor
25184476|NCT02835833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25184477|NCT02835833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184478|NCT02835833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184479|NCT02836002|Pyrimethamine|pyrimethamine|mesh-list
25184480|NCT02836002|Piperaquine|piperaquine|mesh-list
25184481|NCT02836002|Sulfadoxine|sulfadoxine|mesh-list
25184482|NCT02836002|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25184483|NCT02836002|Atovaquone|atovaquone|mesh-list
25184484|NCT02836002|Proguanil|proguanil|mesh-list
25184485|NCT02836002|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
25184486|NCT02836002|Antimalarials|antimalarials|mesh-ancestor
25184487|NCT02836002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25184488|NCT02836002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25184489|NCT02836002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25184490|NCT02836002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25184492|NCT02836002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184493|NCT02836002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25184495|NCT02836002|Antimetabolites|antimetabolites|mesh-ancestor
25184496|NCT02835742|Sargramostim|sargramostim|mesh-list
25184497|NCT02835742|Immunologic Factors|immunologic factors|mesh-ancestor
25184498|NCT02835742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184499|NCT02835729|Cytarabine|cytarabine|mesh-list
25184500|NCT02835729|Idarubicin|idarubicin|mesh-list
25184501|NCT02835729|Tryptophan|tryptophan|mesh-list
25184502|NCT02835729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25184503|NCT02835729|Antimetabolites|antimetabolites|mesh-ancestor
25184504|NCT02835729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184505|NCT02835729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184506|NCT02835729|Antiviral Agents|antiviral agents|mesh-ancestor
25184507|NCT02835729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24425476|NCT00233337|Antimalarials|antimalarials|mesh-ancestor
25184508|NCT02835729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25184509|NCT02835729|Immunologic Factors|immunologic factors|mesh-ancestor
25184510|NCT02835729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184511|NCT02835729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25184512|NCT02835729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25184513|NCT02835729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25184514|NCT02835729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184515|NCT02835729|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25184516|NCT02835729|Antidepressive Agents|antidepressive agents|mesh-ancestor
25184517|NCT02835729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25184518|NCT02835716|Ustekinumab|ustekinumab|mesh-list
25184519|NCT02835716|Dermatologic Agents|dermatologic agents|mesh-ancestor
25184520|NCT02835651|Palmitic Acid|palmitic acid|mesh-list
25184521|NCT02835651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184522|NCT02835651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184523|NCT02835469|Menotropins|menotropins|mesh-list
25184524|NCT02835469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24481459|NCT00434824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25184525|NCT02835469|Fertility Agents|fertility agents|mesh-ancestor
25184526|NCT02835469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25184527|NCT02835469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184528|NCT02835664|Niacinamide|niacinamide|mesh-list
25184529|NCT02835664|Niacin|niacin|mesh-list
25184530|NCT02835664|Nicotinic Acids|nicotinic acids|mesh-list
25184531|NCT02835664|Vitamin B Complex|vitamin b complex|mesh-ancestor
25184532|NCT02835664|Vitamins|vitamins|mesh-ancestor
25184533|NCT02835664|Micronutrients|micronutrients|mesh-ancestor
25184534|NCT02835664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184535|NCT02835664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25184536|NCT02835664|Antimetabolites|antimetabolites|mesh-ancestor
25184537|NCT02835664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184538|NCT02835664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25184539|NCT02835664|Vasodilator Agents|vasodilator agents|mesh-ancestor
25184540|NCT02835586|Paclitaxel|paclitaxel|mesh-list
25184541|NCT02835586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25184542|NCT02835586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184543|NCT02835586|Tubulin Modulators|tubulin modulators|mesh-ancestor
25184544|NCT02835586|Antimitotic Agents|antimitotic agents|mesh-ancestor
25184545|NCT02835586|Mitosis Modulators|mitosis modulators|mesh-ancestor
25184546|NCT02835586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184547|NCT02835521|Triamcinolone|triamcinolone|mesh-list
25184548|NCT02835521|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25184549|NCT02835521|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25184550|NCT02835521|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25184551|NCT02835521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25184552|NCT02835521|Glucocorticoids|glucocorticoids|mesh-ancestor
25184553|NCT02835521|Hormones|hormones|mesh-ancestor
25184554|NCT02835521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24425576|NCT00233675|Tiagabine|tiagabine|mesh-list
25184555|NCT02835521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184556|NCT02835521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25184557|NCT02835521|Immunologic Factors|immunologic factors|mesh-ancestor
25184558|NCT02835521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184559|NCT02835521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184560|NCT02835404|Nedaplatin|nedaplatin|mesh-list
25184561|NCT02835404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184562|NCT02835391|Surgiflo|surgiflo|mesh-list
25184563|NCT02835391|Hemostatics|hemostatics|mesh-ancestor
25184564|NCT02835391|Coagulants|coagulants|mesh-ancestor
25184582|NCT02835183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184587|NCT02834676|Ethanol|ethanol|mesh-list
25184588|NCT02834676|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25184589|NCT02834676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25184590|NCT02834676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25184591|NCT02834676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184592|NCT02834637|Vaccines|vaccines|mesh-list
25184593|NCT02834637|Immunologic Factors|immunologic factors|mesh-ancestor
25184594|NCT02834637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184595|NCT02834754|Vedolizumab|vedolizumab|mesh-list
25184596|NCT02834754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25184597|NCT02834845|Sevoflurane|sevoflurane|mesh-list
25184598|NCT02834845|Desflurane|desflurane|mesh-list
25184599|NCT02834845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25184600|NCT02834845|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25184601|NCT02834845|Anesthetics, General|anesthetics, general|mesh-ancestor
25184602|NCT02834845|Anesthetics|anesthetics|mesh-ancestor
24947155|NCT03931863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425805|NCT00234403|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25184603|NCT02834845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25184604|NCT02834845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184605|NCT02834507|Levodopa|levodopa|mesh-list
25184606|NCT02834507|Carbidopa|carbidopa|mesh-list
25184607|NCT02834507|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25184608|NCT02834507|Entacapone|entacapone|mesh-list
24409744|NCT00182845|Donepezil|donepezil|mesh-list
25184609|NCT02834507|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25184610|NCT02834507|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25184611|NCT02834507|Dopamine Agents|dopamine agents|mesh-ancestor
25184612|NCT02834507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25184613|NCT02834507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184614|NCT02834507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184615|NCT02834507|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25665760|NCT01687400|Decitabine|decitabine|mesh-list
25665761|NCT01687400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24523745|NCT05340725|Dexmedetomidine|dexmedetomidine|mesh-list
24523746|NCT05340725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24523747|NCT05340725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24523748|NCT05340725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523749|NCT05340725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24523750|NCT05340725|Analgesics|analgesics|mesh-ancestor
24528058|NCT00619398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24528059|NCT00619398|Immunologic Factors|immunologic factors|mesh-ancestor
24528060|NCT00619398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184616|NCT02834507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184617|NCT02834507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25184618|NCT02834507|Immunologic Factors|immunologic factors|mesh-ancestor
25184619|NCT02834507|Dopamine Agonists|dopamine agonists|mesh-ancestor
25184620|NCT02834507|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25184621|NCT02834546|Sorafenib|sorafenib|mesh-list
25184622|NCT02834546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184623|NCT02834546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25184624|NCT02834546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184625|NCT02834546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205559|NCT04558216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205560|NCT04558216|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25205561|NCT04558216|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25205562|NCT04558216|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25205563|NCT04558216|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25205564|NCT04558216|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25205565|NCT04558216|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25205567|NCT04546113|Anesthetics, Local|anesthetics, local|mesh-ancestor
25205568|NCT04546113|Anesthetics|anesthetics|mesh-ancestor
25205569|NCT04546113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25205570|NCT04546113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205571|NCT04546113|Sensory System Agents|sensory system agents|mesh-ancestor
25205572|NCT04546113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25205573|NCT04539262|Remdesivir|remdesivir|mesh-list
25205574|NCT04539262|Antimetabolites|antimetabolites|mesh-ancestor
25205575|NCT04539262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205576|NCT04539262|Antiviral Agents|antiviral agents|mesh-ancestor
25205577|NCT04539262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25208061|NCT03113409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25208062|NCT03113409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208063|NCT03113409|Analgesics|analgesics|mesh-ancestor
25208064|NCT03113409|Sensory System Agents|sensory system agents|mesh-ancestor
25208065|NCT03113409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25208066|NCT03113409|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25208067|NCT03113409|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25208068|NCT03096275|Glucocorticoids|glucocorticoids|mesh-list
25208069|NCT03096275|Hormones|hormones|mesh-ancestor
25208070|NCT03096275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25208071|NCT03096275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208072|NCT03094052|Trastuzumab|trastuzumab|mesh-list
25208073|NCT03094052|Atropine|atropine|mesh-list
25208074|NCT03094052|Diphenoxylate|diphenoxylate|mesh-list
25208075|NCT03094052|Loperamide|loperamide|mesh-list
25208076|NCT03094052|Antidiarrheals|antidiarrheals|mesh-list
25208077|NCT03094052|Atropine sulfate-diphenoxylate hydrochloride drug combination|atropine sulfate-diphenoxylate hydrochloride drug combination|mesh-list
25208078|NCT03094052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25208079|NCT03094052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208080|NCT03094052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25208081|NCT03094052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25208082|NCT03094052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25208083|NCT03094052|Autonomic Agents|autonomic agents|mesh-ancestor
25208084|NCT03094052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25665762|NCT01687400|Antimetabolites|antimetabolites|mesh-ancestor
25665763|NCT01687400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665764|NCT01687400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665765|NCT01687400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665766|NCT01687413|Cisplatin|cisplatin|mesh-list
25665767|NCT01687413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665768|NCT01687478|Olanzapine|olanzapine|mesh-list
25665769|NCT01687478|Fluoxetine|fluoxetine|mesh-list
25665770|NCT01687478|Antiemetics|antiemetics|mesh-ancestor
25665771|NCT01687478|Autonomic Agents|autonomic agents|mesh-ancestor
25665772|NCT01687478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24523827|NCT05339802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24523828|NCT05339802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24523829|NCT05339802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24523865|NCT05339217|Aldesleukin|aldesleukin|mesh-list
24523914|NCT05338606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24483942|NCT00445965|Antibodies|antibodies|mesh-list
24483943|NCT00445965|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24484190|NCT00446953|Hormones|hormones|mesh-ancestor
24484191|NCT00446953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25208085|NCT03094052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208086|NCT03094052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25208087|NCT03094052|Respiratory System Agents|respiratory system agents|mesh-ancestor
25208088|NCT03094052|Mydriatics|mydriatics|mesh-ancestor
25208089|NCT03094052|Parasympatholytics|parasympatholytics|mesh-ancestor
25208090|NCT03094052|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25208091|NCT03094052|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25208092|NCT03094052|Cholinergic Agents|cholinergic agents|mesh-ancestor
25208093|NCT03094052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25208094|NCT03094052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208095|NCT03094052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24451856|NCT00325000|Amitriptyline|amitriptyline|mesh-list
24451879|NCT00325026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25184626|NCT02834260|Dexamethasone|dexamethasone|mesh-list
25184627|NCT02834260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25184628|NCT02834260|Antiemetics|antiemetics|mesh-ancestor
25184629|NCT02834260|Autonomic Agents|autonomic agents|mesh-ancestor
25184630|NCT02834260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25184631|NCT02834260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184632|NCT02834260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25184633|NCT02834260|Glucocorticoids|glucocorticoids|mesh-ancestor
25184634|NCT02834260|Hormones|hormones|mesh-ancestor
25184635|NCT02834260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25184636|NCT02834260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25184637|NCT02834260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184638|NCT02834286|Dexamethasone|dexamethasone|mesh-list
25184639|NCT02834286|Rituximab|rituximab|mesh-list
25184640|NCT02834286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25184641|NCT02834286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184642|NCT02834286|Immunologic Factors|immunologic factors|mesh-ancestor
25184643|NCT02834286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184644|NCT02834286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25184645|NCT02834286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25184646|NCT02834286|Antiemetics|antiemetics|mesh-ancestor
25184647|NCT02834286|Autonomic Agents|autonomic agents|mesh-ancestor
25184648|NCT02834286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25184649|NCT02834286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25184650|NCT02834286|Glucocorticoids|glucocorticoids|mesh-ancestor
25184651|NCT02834286|Hormones|hormones|mesh-ancestor
25184652|NCT02834286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25184653|NCT02834286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25184655|NCT02834052|Pembrolizumab|pembrolizumab|mesh-list
25184656|NCT02834052|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25184657|NCT02834052|Poly ICLC|poly iclc|mesh-list
25184658|NCT02834052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25184659|NCT02834052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184660|NCT02834052|Interferon Inducers|interferon inducers|mesh-ancestor
25184661|NCT02834052|Immunologic Factors|immunologic factors|mesh-ancestor
25184662|NCT02834052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184663|NCT02834052|Laxatives|laxatives|mesh-ancestor
25184664|NCT02834052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25184665|NCT02834052|Antiviral Agents|antiviral agents|mesh-ancestor
25184666|NCT02834052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25184667|NCT02833831|Moxifloxacin|moxifloxacin|mesh-list
25184668|NCT02833831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24426362|NCT00235898|Vitamins|vitamins|mesh-ancestor
25184669|NCT02833831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25665773|NCT01687478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665774|NCT01687478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25665775|NCT01687478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25665776|NCT01687478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25665777|NCT01687478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25665778|NCT01687478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25665779|NCT01687478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25665780|NCT01687478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25184670|NCT02833831|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25184671|NCT02833831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24523956|NCT05338476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523957|NCT05338476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24523994|NCT05338190|Rituximab|rituximab|mesh-list
24523995|NCT05338190|Belimumab|belimumab|mesh-list
24523996|NCT05338190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24523997|NCT05338190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24524027|NCT05322031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24524028|NCT05322031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184672|NCT02833831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184673|NCT02833831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184674|NCT02833831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184675|NCT02833987|Warfarin|warfarin|mesh-list
25184676|NCT02833987|Rivaroxaban|rivaroxaban|mesh-list
25184677|NCT02833987|Dabigatran|dabigatran|mesh-list
25184678|NCT02833987|Apixaban|apixaban|mesh-list
25184679|NCT02833987|Anticoagulants|anticoagulants|mesh-ancestor
25184680|NCT02833987|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25184681|NCT02833987|Antithrombins|antithrombins|mesh-ancestor
25184682|NCT02833987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25184683|NCT02833987|Protease Inhibitors|protease inhibitors|mesh-ancestor
25184684|NCT02833987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184685|NCT02833987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184686|NCT02833766|Doxorubicin|doxorubicin|mesh-list
25184687|NCT02833766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25184688|NCT02833766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184689|NCT02833766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25184690|NCT02833766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25184691|NCT02833766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184692|NCT02833766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184693|NCT02833610|Denosumab|denosumab|mesh-list
25184694|NCT02833610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25184695|NCT02833610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184696|NCT02833480|Fluticasone|fluticasone|mesh-list
25184697|NCT02833480|Budesonide|budesonide|mesh-list
25184698|NCT02833480|Formoterol Fumarate|formoterol fumarate|mesh-list
25184699|NCT02833480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25184700|NCT02833480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25184701|NCT02833480|Autonomic Agents|autonomic agents|mesh-ancestor
25205578|NCT04527757|Anesthetics|anesthetics|mesh-list
24821000|NCT02102828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24821001|NCT02102828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24821002|NCT02102828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821003|NCT02102828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24821004|NCT02102828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24821006|NCT02102828|Antipyretics|antipyretics|mesh-ancestor
25184702|NCT02833480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25184703|NCT02833480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427340|NCT00238004|Niacin|niacin|mesh-list
25184704|NCT02833480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25184705|NCT02833480|Respiratory System Agents|respiratory system agents|mesh-ancestor
25184706|NCT02833480|Dermatologic Agents|dermatologic agents|mesh-ancestor
25184707|NCT02833480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25184708|NCT02833480|Glucocorticoids|glucocorticoids|mesh-ancestor
25184709|NCT02833480|Hormones|hormones|mesh-ancestor
25184710|NCT02833480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25184711|NCT02833480|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25184712|NCT02833480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25184713|NCT02833480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25184714|NCT02833480|Adrenergic Agents|adrenergic agents|mesh-ancestor
25184715|NCT02833480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25184716|NCT02833480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184717|NCT02833506|Sirolimus|sirolimus|mesh-list
25184718|NCT02833506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25184719|NCT02833506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25184720|NCT02833506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25184721|NCT02833506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184722|NCT02833506|Antifungal Agents|antifungal agents|mesh-ancestor
25665781|NCT01687478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25665782|NCT01687478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665783|NCT01687478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25665784|NCT01687478|Serotonin Agents|serotonin agents|mesh-ancestor
25665785|NCT01687478|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25665786|NCT01687478|Antidepressive Agents|antidepressive agents|mesh-ancestor
25665787|NCT01687478|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25184723|NCT02833506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24524178|NCT05206110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24524179|NCT05206110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24524184|NCT05200988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24524185|NCT05200988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24524186|NCT05200988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524187|NCT05170685|Nivolumab|nivolumab|mesh-list
24524189|NCT05170685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24524209|NCT05158686|Paclitaxel|paclitaxel|mesh-list
24524210|NCT05158686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25184724|NCT02833506|Immunologic Factors|immunologic factors|mesh-ancestor
25184725|NCT02833506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184727|NCT02833701|Ascorbic Acid|ascorbic acid|mesh-list
25184728|NCT02833701|Bevacizumab|bevacizumab|mesh-list
25184729|NCT02833701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25184730|NCT02833701|Endothelial Growth Factors|endothelial growth factors|mesh-list
25184731|NCT02833701|Antibodies|antibodies|mesh-list
25184732|NCT02833701|Immunoglobulins|immunoglobulins|mesh-list
25184733|NCT02833701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25184734|NCT02833701|Immunoglobulin G|immunoglobulin g|mesh-list
25184735|NCT02833701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184736|NCT02833701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25184737|NCT02833701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25184738|NCT02833701|Growth Substances|growth substances|mesh-ancestor
25184739|NCT02833701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184740|NCT02833701|Growth Inhibitors|growth inhibitors|mesh-ancestor
25184741|NCT02833701|Micronutrients|micronutrients|mesh-ancestor
25184742|NCT02833701|Immunologic Factors|immunologic factors|mesh-ancestor
25184743|NCT02833701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184744|NCT02833701|Antioxidants|antioxidants|mesh-ancestor
25184745|NCT02833701|Protective Agents|protective agents|mesh-ancestor
25184746|NCT02833688|Dexmedetomidine|dexmedetomidine|mesh-list
25184747|NCT02833688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25184748|NCT02833688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25184749|NCT02833688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184750|NCT02833688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25184751|NCT02833688|Analgesics|analgesics|mesh-ancestor
25184752|NCT02833688|Sensory System Agents|sensory system agents|mesh-ancestor
24427409|NCT00238173|Mannitol|mannitol|mesh-list
25184753|NCT02833688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25184754|NCT02833688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25184755|NCT02833688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25184756|NCT02833688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25184757|NCT02833688|Adrenergic Agents|adrenergic agents|mesh-ancestor
25184758|NCT02833688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25184759|NCT02833688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184760|NCT02833376|Chlorhexidine|chlorhexidine|mesh-list
25184761|NCT02833376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25184762|NCT02833376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25184763|NCT02833376|Disinfectants|disinfectants|mesh-ancestor
25184764|NCT02833584|Acetaminophen|acetaminophen|mesh-list
25184765|NCT02833584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25184766|NCT02833584|Analgesics|analgesics|mesh-ancestor
25184767|NCT02833584|Sensory System Agents|sensory system agents|mesh-ancestor
25184768|NCT02833584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25184769|NCT02833584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184770|NCT02833584|Antipyretics|antipyretics|mesh-ancestor
25184771|NCT02833025|Thrombin|thrombin|mesh-list
25184772|NCT02833025|Hemostatics|hemostatics|mesh-ancestor
25184773|NCT02833025|Coagulants|coagulants|mesh-ancestor
25184774|NCT02833038|Magnesium Sulfate|magnesium sulfate|mesh-list
25184775|NCT02833038|Analgesics|analgesics|mesh-ancestor
25184776|NCT02833038|Sensory System Agents|sensory system agents|mesh-ancestor
25184777|NCT02833038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25184778|NCT02833038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184779|NCT02833038|Anesthetics|anesthetics|mesh-ancestor
25665788|NCT01687478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25665789|NCT01687478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665790|NCT01687673|Sirolimus|sirolimus|mesh-list
25665791|NCT01687673|Sorafenib|sorafenib|mesh-list
25665792|NCT01687673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665793|NCT01687673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25665794|NCT01687673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665795|NCT01687673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665796|NCT01687673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25665797|NCT01687673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24524498|NCT04792190|Dapagliflozin|dapagliflozin|mesh-list
24627396|NCT01092533|Prednisolone|prednisolone|mesh-list
24524499|NCT04792190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25051387|NCT00411385|Interferons|interferons|mesh-list
24493368|NCT00490711|Tubulin Modulators|tubulin modulators|mesh-ancestor
24493369|NCT00490711|Antimitotic Agents|antimitotic agents|mesh-ancestor
25184780|NCT02833038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25184781|NCT02833038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25184782|NCT02833038|Anticonvulsants|anticonvulsants|mesh-ancestor
25184783|NCT02833038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25184784|NCT02833038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25184785|NCT02833038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184786|NCT02833038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25184787|NCT02833038|Tocolytic Agents|tocolytic agents|mesh-ancestor
25245794|NCT03719326|Mitosis Modulators|mitosis modulators|mesh-ancestor
25184788|NCT02833038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25184789|NCT02833103|Pinaverium|pinaverium|mesh-list
25184790|NCT02833103|Bromides|bromides|mesh-list
25184791|NCT02833103|Anticonvulsants|anticonvulsants|mesh-ancestor
25184792|NCT02833103|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25184793|NCT02833103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25184794|NCT02833103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184795|NCT02833103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25184796|NCT02833103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184797|NCT02833103|Parasympatholytics|parasympatholytics|mesh-ancestor
25184798|NCT02833103|Autonomic Agents|autonomic agents|mesh-ancestor
25184799|NCT02833103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25184800|NCT02833155|Exemestane|exemestane|mesh-list
25184801|NCT02833155|Entinostat|entinostat|mesh-list
25184802|NCT02833155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184803|NCT02833155|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25184804|NCT02833155|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25184805|NCT02833155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184806|NCT02833155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184807|NCT02833155|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25184808|NCT02833155|Hormone Antagonists|hormone antagonists|mesh-ancestor
25184809|NCT02833155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25184810|NCT02833155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184811|NCT02833155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25184812|NCT02833116|Dexamethasone|dexamethasone|mesh-list
25184813|NCT02833116|Betamethasone|betamethasone|mesh-list
25184814|NCT02833116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25184815|NCT02833116|Antiemetics|antiemetics|mesh-ancestor
25184816|NCT02833116|Autonomic Agents|autonomic agents|mesh-ancestor
25184817|NCT02833116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25184818|NCT02833116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184819|NCT02833116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25184820|NCT02833116|Glucocorticoids|glucocorticoids|mesh-ancestor
25184821|NCT02833116|Hormones|hormones|mesh-ancestor
25184822|NCT02833116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25184823|NCT02833116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25184824|NCT02833116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25184825|NCT02833116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25184826|NCT02833116|Respiratory System Agents|respiratory system agents|mesh-ancestor
25184827|NCT02832973|Ramipril|ramipril|mesh-list
25184828|NCT02832973|Bisoprolol|bisoprolol|mesh-list
25184829|NCT02832973|Amiloride|amiloride|mesh-list
25184830|NCT02832973|Furosemide|furosemide|mesh-list
25184831|NCT02832973|Spironolactone|spironolactone|mesh-list
25184832|NCT02832973|Diuretics|diuretics|mesh-list
25184833|NCT02832973|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25184834|NCT02832973|Natriuretic Agents|natriuretic agents|mesh-ancestor
25184835|NCT02832973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184836|NCT02832973|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25184837|NCT02832973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25184838|NCT02832973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428301|NCT00240058|Vasodilator Agents|vasodilator agents|mesh-ancestor
25184839|NCT02832973|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25184840|NCT02832973|Hormone Antagonists|hormone antagonists|mesh-ancestor
25426873|NCT01950520|Autonomic Agents|autonomic agents|mesh-ancestor
25665798|NCT01687673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25665799|NCT01687673|Antifungal Agents|antifungal agents|mesh-ancestor
25665800|NCT01687673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25665801|NCT01687673|Immunologic Factors|immunologic factors|mesh-ancestor
25665802|NCT01687673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524518|NCT04771741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24524519|NCT04771741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457613|NCT00334763|Paclitaxel|paclitaxel|mesh-list
25184841|NCT02832973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25184842|NCT02832973|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25184843|NCT02832973|Protease Inhibitors|protease inhibitors|mesh-ancestor
25184844|NCT02832973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184845|NCT02832973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25184846|NCT02832973|Sympatholytics|sympatholytics|mesh-ancestor
25184847|NCT02832973|Autonomic Agents|autonomic agents|mesh-ancestor
25184848|NCT02832973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25184849|NCT02832973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25184850|NCT02832973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25184851|NCT02832973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25184852|NCT02832973|Adrenergic Agents|adrenergic agents|mesh-ancestor
25184853|NCT02832973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25184854|NCT02832973|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
25184855|NCT02832973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25184856|NCT02832973|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
25184858|NCT02832778|Lamivudine|lamivudine|mesh-list
25184859|NCT02832778|Zidovudine|zidovudine|mesh-list
25184860|NCT02832778|Emtricitabine|emtricitabine|mesh-list
25184861|NCT02832778|Efavirenz|efavirenz|mesh-list
25184862|NCT02832778|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25184863|NCT02832778|Isoniazid|isoniazid|mesh-list
25184864|NCT02832778|Antiviral Agents|antiviral agents|mesh-ancestor
25184865|NCT02832778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25184866|NCT02832778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25184867|NCT02832778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25184868|NCT02832778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184869|NCT02832778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184870|NCT02832778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25184871|NCT02832778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25184872|NCT02832778|Antimetabolites|antimetabolites|mesh-ancestor
25184873|NCT02832778|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25184874|NCT02832778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25184875|NCT02832778|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25184876|NCT02832778|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25184877|NCT02832778|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25184878|NCT02832778|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25184879|NCT02832778|Antitubercular Agents|antitubercular agents|mesh-ancestor
25184880|NCT02832778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25184881|NCT02832778|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25184882|NCT02832778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25184883|NCT02832778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25184884|NCT02832947|Rivaroxaban|rivaroxaban|mesh-list
25184885|NCT02832947|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25184886|NCT02832947|Antithrombins|antithrombins|mesh-ancestor
25184887|NCT02832947|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25184888|NCT02832947|Protease Inhibitors|protease inhibitors|mesh-ancestor
25184889|NCT02832947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184890|NCT02832947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184891|NCT02832947|Anticoagulants|anticoagulants|mesh-ancestor
25184892|NCT02832999|Liraglutide|liraglutide|mesh-list
25184893|NCT02832999|Vildagliptin|vildagliptin|mesh-list
25184894|NCT02832999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25184895|NCT02832999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184896|NCT02832999|Incretins|incretins|mesh-ancestor
25184898|NCT02832999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25184899|NCT02832999|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25184900|NCT02832999|Protease Inhibitors|protease inhibitors|mesh-ancestor
25184901|NCT02832999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184902|NCT02832999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205579|NCT04527757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25205580|NCT04527757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205581|NCT04519164|Eplerenone|eplerenone|mesh-list
25205582|NCT04519164|Chlorthalidone|chlorthalidone|mesh-list
25205583|NCT04519164|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25205584|NCT04519164|Hormone Antagonists|hormone antagonists|mesh-ancestor
25404104|NCT03684811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665803|NCT01687712|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25665804|NCT01687712|Hormones|hormones|mesh-ancestor
25860397|NCT00083538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24500457|NCT00524381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500458|NCT00524381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24500459|NCT00524381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24500460|NCT00524381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24500461|NCT00524381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25205585|NCT04519164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24663219|NCT01299558|Xhance|xhance|mesh-list
25205586|NCT04519164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205587|NCT04519164|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25205589|NCT04519164|Natriuretic Agents|natriuretic agents|mesh-ancestor
25205590|NCT04519164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25205591|NCT04519164|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24410435|NCT00185250|Interferon beta-1b|interferon beta-1b|mesh-list
24683452|NCT01392430|Azithromycin|azithromycin|mesh-list
25184903|NCT02832713|Botulinum Toxins|botulinum toxins|mesh-list
25184904|NCT02832713|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25184905|NCT02832713|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25184906|NCT02832713|Hyaluronic Acid|hyaluronic acid|mesh-list
25184907|NCT02832713|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25184908|NCT02832713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25184909|NCT02832713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184910|NCT02832713|Cholinergic Agents|cholinergic agents|mesh-ancestor
25184911|NCT02832713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25184912|NCT02832713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184913|NCT02832713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25184914|NCT02832713|Immunologic Factors|immunologic factors|mesh-ancestor
25184915|NCT02832713|Viscosupplements|viscosupplements|mesh-ancestor
25184916|NCT02832713|Protective Agents|protective agents|mesh-ancestor
25184917|NCT02832713|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25184918|NCT02832713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25184920|NCT02832700|Chelating Agents|chelating agents|mesh-ancestor
25184921|NCT02832700|Sequestering Agents|sequestering agents|mesh-ancestor
25184922|NCT02832700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184923|NCT02832726|Vitamin B 12|vitamin b 12|mesh-list
25184924|NCT02832726|Hydroxocobalamin|hydroxocobalamin|mesh-list
25184925|NCT02832726|Vitamins|vitamins|mesh-ancestor
25184926|NCT02832726|Micronutrients|micronutrients|mesh-ancestor
25184927|NCT02832726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184928|NCT02832726|Vitamin B Complex|vitamin b complex|mesh-ancestor
25184929|NCT02832726|Hematinics|hematinics|mesh-ancestor
25184930|NCT02832635|Temozolomide|temozolomide|mesh-list
25184931|NCT02832635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25184938|NCT02832336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25184940|NCT02832336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25184941|NCT02832336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184942|NCT02832336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25184943|NCT02832336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25184944|NCT02832336|Purinergic Agents|purinergic agents|mesh-ancestor
25184945|NCT02832336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25184946|NCT02832596|Norepinephrine|norepinephrine|mesh-list
25184947|NCT02832596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25184948|NCT02832596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25184949|NCT02832596|Adrenergic Agents|adrenergic agents|mesh-ancestor
25184950|NCT02832596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25184951|NCT02832596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184952|NCT02832596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184953|NCT02832596|Sympathomimetics|sympathomimetics|mesh-ancestor
25184954|NCT02832596|Autonomic Agents|autonomic agents|mesh-ancestor
25184955|NCT02832596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25184956|NCT02832596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25184964|NCT02832401|Caffeine|caffeine|mesh-list
25184965|NCT02832401|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25184966|NCT02832401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184967|NCT02832401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25184968|NCT02832401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184969|NCT02832401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184970|NCT02832401|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25184971|NCT02832401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25184972|NCT02832401|Purinergic Agents|purinergic agents|mesh-ancestor
25665805|NCT01687712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25665806|NCT01687712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665807|NCT01687998|Evacetrapib|evacetrapib|mesh-list
25665808|NCT01687998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24524580|NCT04688658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25184973|NCT02832401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25184974|NCT02832089|Carvedilol|carvedilol|mesh-list
25184975|NCT02832089|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25184976|NCT02832089|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25184977|NCT02832089|Adrenergic Agents|adrenergic agents|mesh-ancestor
25184978|NCT02832089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25184979|NCT02832089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25184980|NCT02832089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184981|NCT02832089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25184982|NCT02832089|Antioxidants|antioxidants|mesh-ancestor
25184983|NCT02832089|Protective Agents|protective agents|mesh-ancestor
25184984|NCT02832089|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25184985|NCT02832089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25184986|NCT02832089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25184987|NCT02832089|Vasodilator Agents|vasodilator agents|mesh-ancestor
25184988|NCT02832089|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25184989|NCT02832089|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25184990|NCT02831894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25184991|NCT02831894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25184992|NCT02831894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25184993|NCT02831972|Itraconazole|itraconazole|mesh-list
25184994|NCT02831972|Antifungal Agents|antifungal agents|mesh-ancestor
25184995|NCT02831972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25184996|NCT02831972|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25184997|NCT02831972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25184998|NCT02831972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25184999|NCT02831972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185000|NCT02831972|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25185001|NCT02831972|Hormone Antagonists|hormone antagonists|mesh-ancestor
25185002|NCT02831972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25185003|NCT02831972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185004|NCT02831972|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25185005|NCT02831933|Valacyclovir|valacyclovir|mesh-list
25185006|NCT02831933|Nivolumab|nivolumab|mesh-list
25185007|NCT02831933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25185008|NCT02831933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25185009|NCT02831933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25185010|NCT02831933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185011|NCT02831933|Antiviral Agents|antiviral agents|mesh-ancestor
25185012|NCT02831933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25185013|NCT02831842|Bevacizumab|bevacizumab|mesh-list
25185014|NCT02831842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25185015|NCT02831842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25185016|NCT02831842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25185017|NCT02831842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25185018|NCT02831842|Growth Substances|growth substances|mesh-ancestor
25185019|NCT02831842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185020|NCT02831842|Growth Inhibitors|growth inhibitors|mesh-ancestor
25185021|NCT02831751|Vaccines|vaccines|mesh-list
25185022|NCT02831751|Immunologic Factors|immunologic factors|mesh-ancestor
25185023|NCT02831751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185024|NCT02831712|Ferrous fumarate|ferrous fumarate|mesh-list
25185025|NCT02831712|Trace Elements|trace elements|mesh-ancestor
25185026|NCT02831712|Micronutrients|micronutrients|mesh-ancestor
25185027|NCT02831712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185028|NCT02831686|Dexamethasone|dexamethasone|mesh-list
25185029|NCT02831686|Ixazomib|ixazomib|mesh-list
25185030|NCT02831686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25185031|NCT02831686|Antiemetics|antiemetics|mesh-ancestor
25185032|NCT02831686|Autonomic Agents|autonomic agents|mesh-ancestor
25185033|NCT02831686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25185034|NCT02831686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185035|NCT02831686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25185036|NCT02831686|Glucocorticoids|glucocorticoids|mesh-ancestor
25185037|NCT02831686|Hormones|hormones|mesh-ancestor
25185038|NCT02831686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25185039|NCT02831686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25185040|NCT02831686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25185041|NCT02831686|Protease Inhibitors|protease inhibitors|mesh-ancestor
25185042|NCT02831686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185043|NCT02831686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665809|NCT01687998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25860404|NCT00083538|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25860405|NCT00083538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25860407|NCT00083538|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24511372|NCT00568412|Immunologic Factors|immunologic factors|mesh-ancestor
24511373|NCT00568412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24513670|NCT00584532|Genistein|genistein|mesh-list
25185044|NCT02831543|Mosapride|mosapride|mesh-list
25185045|NCT02831543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185046|NCT02831543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25185047|NCT02831543|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24410776|NCT00187057|Prednisone|prednisone|mesh-list
24410777|NCT00187057|Cyclophosphamide|cyclophosphamide|mesh-list
25185048|NCT02831543|Serotonin Agents|serotonin agents|mesh-ancestor
25185049|NCT02831543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25185050|NCT02831543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185051|NCT02831478|Sunscreening Agents|sunscreening agents|mesh-list
25185052|NCT02831478|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25185053|NCT02831478|Protective Agents|protective agents|mesh-ancestor
25185054|NCT02831478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185055|NCT02831478|Dermatologic Agents|dermatologic agents|mesh-ancestor
25185056|NCT02831361|Metformin|metformin|mesh-list
25185057|NCT02831361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25185058|NCT02831361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185059|NCT02831374|Anesthetics|anesthetics|mesh-list
25185060|NCT02831374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25185061|NCT02831374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185064|NCT02831205|Everolimus|everolimus|mesh-list
25185065|NCT02831205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25185066|NCT02831205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25185067|NCT02831205|Immunologic Factors|immunologic factors|mesh-ancestor
25185068|NCT02831205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185069|NCT02831205|Trace Elements|trace elements|mesh-ancestor
25185070|NCT02831205|Micronutrients|micronutrients|mesh-ancestor
25185071|NCT02831218|Aspirin|aspirin|mesh-list
25185072|NCT02831218|Clopidogrel|clopidogrel|mesh-list
25185073|NCT02831218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25185074|NCT02831218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25185075|NCT02831218|Analgesics|analgesics|mesh-ancestor
25185076|NCT02831218|Sensory System Agents|sensory system agents|mesh-ancestor
25185077|NCT02831218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25185078|NCT02831218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185079|NCT02831218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25185080|NCT02831218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25185081|NCT02831218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25185082|NCT02831218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25185083|NCT02831218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185084|NCT02831218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25185085|NCT02831218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25185086|NCT02831218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185087|NCT02831218|Antipyretics|antipyretics|mesh-ancestor
25665810|NCT01687998|Antimetabolites|antimetabolites|mesh-ancestor
25665811|NCT01687998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665812|NCT01687998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25665813|NCT01688037|Tetrabenazine|tetrabenazine|mesh-list
25665814|NCT01688037|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25665815|NCT01688037|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25665816|NCT01688037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25665817|NCT01688037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524873|NCT04243122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24524874|NCT04243122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24524875|NCT04243122|Analgesics|analgesics|mesh-ancestor
24524876|NCT04243122|Sensory System Agents|sensory system agents|mesh-ancestor
24524877|NCT04243122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24524878|NCT04243122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524879|NCT04243122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25211122|NCT04766008|Metformin|metformin|mesh-list
25211123|NCT04766008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24789556|NCT01937767|Anesthetics|anesthetics|mesh-ancestor
25211124|NCT04766008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211125|NCT04760132|Vaccines|vaccines|mesh-list
25211126|NCT04760132|Immunologic Factors|immunologic factors|mesh-ancestor
25185088|NCT02831218|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25185089|NCT02831218|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25185090|NCT02831218|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25185091|NCT02831218|Purinergic Agents|purinergic agents|mesh-ancestor
25185092|NCT02831218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25185093|NCT02831491|Docetaxel|docetaxel|mesh-list
25185094|NCT02831491|Ramucirumab|ramucirumab|mesh-list
25185095|NCT02831491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25185096|NCT02831491|Tubulin Modulators|tubulin modulators|mesh-ancestor
25185097|NCT02831491|Antimitotic Agents|antimitotic agents|mesh-ancestor
25185098|NCT02831491|Mitosis Modulators|mitosis modulators|mesh-ancestor
25185099|NCT02831491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185100|NCT02831101|Sufentanil|sufentanil|mesh-list
25185101|NCT02831101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25185102|NCT02831101|Narcotics|narcotics|mesh-ancestor
25185103|NCT02831101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25185104|NCT02831101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185105|NCT02831101|Analgesics|analgesics|mesh-ancestor
25185106|NCT02831101|Sensory System Agents|sensory system agents|mesh-ancestor
25185107|NCT02831101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25185108|NCT02831101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25185109|NCT02831101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25185110|NCT02831101|Anesthetics, General|anesthetics, general|mesh-ancestor
25185111|NCT02831101|Anesthetics|anesthetics|mesh-ancestor
25185112|NCT02831088|Salicylates|salicylates|mesh-list
25185113|NCT02831088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25185114|NCT02831088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25185115|NCT02831088|Analgesics|analgesics|mesh-ancestor
25185116|NCT02831088|Sensory System Agents|sensory system agents|mesh-ancestor
25185117|NCT02831088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25185118|NCT02831088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185119|NCT02831088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25185120|NCT02831088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25185121|NCT02831088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25185122|NCT02831088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185123|NCT02831088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185124|NCT02831179|Capecitabine|capecitabine|mesh-list
25185125|NCT02831179|Temozolomide|temozolomide|mesh-list
25185126|NCT02831179|Veliparib|veliparib|mesh-list
25185127|NCT02831179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25185128|NCT02831179|Antimetabolites|antimetabolites|mesh-ancestor
25185129|NCT02831179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185130|NCT02831179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25185131|NCT02831179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25185132|NCT02831179|Alkylating Agents|alkylating agents|mesh-ancestor
25185133|NCT02831179|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25185134|NCT02831179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205592|NCT04519164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25205593|NCT04519164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185307|NCT02829151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25665818|NCT01688037|Adrenergic Agents|adrenergic agents|mesh-ancestor
25665819|NCT01688037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25665820|NCT01688037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665821|NCT01688102|Vitamin D|vitamin d|mesh-list
25665822|NCT01688102|Cholecalciferol|cholecalciferol|mesh-list
25665823|NCT01688102|Vitamins|vitamins|mesh-ancestor
25665824|NCT01688102|Micronutrients|micronutrients|mesh-ancestor
25665825|NCT01688102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665826|NCT01688102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25665827|NCT01688102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25665828|NCT01688336|Leucovorin|leucovorin|mesh-list
25665829|NCT01688336|Oxaliplatin|oxaliplatin|mesh-list
25665830|NCT01688336|Irinotecan|irinotecan|mesh-list
25665831|NCT01688336|Folfirinox|folfirinox|mesh-list
25860408|NCT00083538|Leprostatic Agents|leprostatic agents|mesh-ancestor
25860409|NCT00083538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25860410|NCT00083538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25860411|NCT00083538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24457744|NCT00335114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457745|NCT00335114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24457746|NCT00335114|Immunologic Factors|immunologic factors|mesh-ancestor
24457747|NCT00335114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514104|NCT00587873|Dermatologic Agents|dermatologic agents|mesh-ancestor
25205610|NCT04470674|Durvalumab|durvalumab|mesh-list
25205611|NCT04470674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25205612|NCT04470674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205613|NCT04470674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205614|NCT04470674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25205615|NCT04470674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25205616|NCT04470674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25205617|NCT04457466|Mitogens|mitogens|mesh-list
25205618|NCT04457466|Mitosis Modulators|mitosis modulators|mesh-ancestor
25205619|NCT04457466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205620|NCT04457245|Fluorides|fluorides|mesh-list
25205621|NCT04457245|Cariostatic Agents|cariostatic agents|mesh-ancestor
25205622|NCT04457245|Protective Agents|protective agents|mesh-ancestor
25205623|NCT04457245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205631|NCT04403165|Norepinephrine|norepinephrine|mesh-list
25205632|NCT04403165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25205633|NCT04403165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25205634|NCT04403165|Adrenergic Agents|adrenergic agents|mesh-ancestor
25205635|NCT04403165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25205636|NCT04403165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205637|NCT04403165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205638|NCT04403165|Sympathomimetics|sympathomimetics|mesh-ancestor
25205639|NCT04403165|Autonomic Agents|autonomic agents|mesh-ancestor
25185135|NCT02831231|Xanomeline|xanomeline|mesh-list
25185136|NCT02831231|Trospium chloride|trospium chloride|mesh-list
25185137|NCT02831231|Parasympatholytics|parasympatholytics|mesh-ancestor
25185138|NCT02831231|Autonomic Agents|autonomic agents|mesh-ancestor
25185139|NCT02831231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25185140|NCT02831231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185141|NCT02831231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25185142|NCT02831231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25185143|NCT02831231|Cholinergic Agents|cholinergic agents|mesh-ancestor
25185144|NCT02831231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25185145|NCT02831231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185146|NCT02831231|Urological Agents|urological agents|mesh-ancestor
25185147|NCT02831231|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25185148|NCT02831231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25185149|NCT02831231|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25185150|NCT02831231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25185151|NCT02830906|Ondansetron|ondansetron|mesh-list
25185152|NCT02830906|Ramosetron|ramosetron|mesh-list
25185153|NCT02830906|Antiemetics|antiemetics|mesh-ancestor
25185154|NCT02830906|Autonomic Agents|autonomic agents|mesh-ancestor
25185155|NCT02830906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25185156|NCT02830906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185157|NCT02830906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25185158|NCT02830906|Antipruritics|antipruritics|mesh-ancestor
25185159|NCT02830906|Dermatologic Agents|dermatologic agents|mesh-ancestor
25185160|NCT02830906|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25185161|NCT02830906|Serotonin Agents|serotonin agents|mesh-ancestor
25185162|NCT02830906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25185163|NCT02830906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185164|NCT02830906|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25185165|NCT02830906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25185166|NCT02830906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25185167|NCT02830906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25185168|NCT02830906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25185169|NCT02830789|Calcium, Dietary|calcium, dietary|mesh-list
25665832|NCT01688336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665833|NCT01688336|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25665834|NCT01688336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25665835|NCT01688336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665836|NCT01688336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665837|NCT01688336|Antidotes|antidotes|mesh-ancestor
25665838|NCT01688336|Protective Agents|protective agents|mesh-ancestor
25185170|NCT02830789|Calcium Carbonate|calcium carbonate|mesh-list
25185171|NCT02830789|Calcium|calcium|mesh-list
24516899|NCT00604435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24516900|NCT00604435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24516901|NCT00604435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516902|NCT00604435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24516903|NCT00604435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24516904|NCT00604435|Growth Substances|growth substances|mesh-ancestor
24516905|NCT00604435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457765|NCT00335179|Immunologic Factors|immunologic factors|mesh-ancestor
25185172|NCT02830789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25185173|NCT02830789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185174|NCT02830789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25185175|NCT02830789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185176|NCT02830789|Antacids|antacids|mesh-ancestor
25185177|NCT02830789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25185178|NCT02831023|Pyrimethamine|pyrimethamine|mesh-list
25185179|NCT02831023|Piperaquine|piperaquine|mesh-list
25185180|NCT02831023|Primaquine|primaquine|mesh-list
25185181|NCT02831023|Sulfadoxine|sulfadoxine|mesh-list
25185182|NCT02831023|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25185183|NCT02831023|Artenimol|artenimol|mesh-list
25185184|NCT02831023|Amodiaquine|amodiaquine|mesh-list
25185185|NCT02831023|Methylene Blue|methylene blue|mesh-list
25185186|NCT02831023|Antimalarials|antimalarials|mesh-ancestor
25185187|NCT02831023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25185188|NCT02831023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25185189|NCT02831023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25185190|NCT02831023|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25185191|NCT02831023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185192|NCT02831023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185193|NCT02831023|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25185194|NCT02831023|Renal Agents|renal agents|mesh-ancestor
25185195|NCT02830932|Vaccines|vaccines|mesh-list
25185196|NCT02830932|Immunologic Factors|immunologic factors|mesh-ancestor
25185197|NCT02830932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185198|NCT02830347|Amoxicillin|amoxicillin|mesh-list
25185199|NCT02830347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25185200|NCT02830347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25185201|NCT02830230|Azithromycin|azithromycin|mesh-list
25185202|NCT02830230|Cefixime|cefixime|mesh-list
25185203|NCT02830230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25185204|NCT02830230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25185205|NCT02830243|Sevoflurane|sevoflurane|mesh-list
25185206|NCT02830243|Desflurane|desflurane|mesh-list
25185207|NCT02830243|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25185208|NCT02830243|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25185209|NCT02830243|Anesthetics, General|anesthetics, general|mesh-ancestor
25185210|NCT02830243|Anesthetics|anesthetics|mesh-ancestor
25185211|NCT02830243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25185212|NCT02830243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185213|NCT02830048|Glyburide|glyburide|mesh-list
25185214|NCT02830048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25185215|NCT02830048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185216|NCT02830126|Anesthetics|anesthetics|mesh-list
25185217|NCT02830126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25185218|NCT02830126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185219|NCT02829879|Listerine|listerine|mesh-list
25185220|NCT02829879|Fluorides|fluorides|mesh-list
25185221|NCT02829879|Sodium Fluoride|sodium fluoride|mesh-list
25185222|NCT02829879|Fluorophosphate|fluorophosphate|mesh-list
25185223|NCT02829879|Cariostatic Agents|cariostatic agents|mesh-ancestor
25185224|NCT02829879|Protective Agents|protective agents|mesh-ancestor
25185225|NCT02829879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185226|NCT02829879|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25185227|NCT02829879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24399146|NCT00146718|Pyrimethamine|pyrimethamine|mesh-list
25665839|NCT01688336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665840|NCT01688336|Vitamin B Complex|vitamin b complex|mesh-ancestor
25665841|NCT01688336|Vitamins|vitamins|mesh-ancestor
25665842|NCT01688336|Micronutrients|micronutrients|mesh-ancestor
25665843|NCT01688466|Pomalidomide|pomalidomide|mesh-list
25665844|NCT01688466|Immunologic Factors|immunologic factors|mesh-ancestor
25665845|NCT01688466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665846|NCT01688466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25665847|NCT01688466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25185228|NCT02829957|Rivaroxaban|rivaroxaban|mesh-list
25185229|NCT02829957|Apixaban|apixaban|mesh-list
25185230|NCT02829957|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25665848|NCT01688466|Growth Substances|growth substances|mesh-ancestor
24522262|NCT04081831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24522265|NCT04047251|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24522266|NCT04047251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24522267|NCT04047251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665849|NCT01688466|Growth Inhibitors|growth inhibitors|mesh-ancestor
24522268|NCT04047251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185231|NCT02829957|Antithrombins|antithrombins|mesh-ancestor
25185232|NCT02829957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25665850|NCT01688466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665851|NCT01688596|Bupivacaine|bupivacaine|mesh-list
25185233|NCT02829957|Protease Inhibitors|protease inhibitors|mesh-ancestor
25185234|NCT02829957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185235|NCT02829957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185236|NCT02829957|Anticoagulants|anticoagulants|mesh-ancestor
25185237|NCT02830139|Capecitabine|capecitabine|mesh-list
25185238|NCT02830139|Oxaliplatin|oxaliplatin|mesh-list
25185239|NCT02830139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25185240|NCT02830139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25185241|NCT02830139|Antimetabolites|antimetabolites|mesh-ancestor
25185242|NCT02830139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185243|NCT02829840|Azacitidine|azacitidine|mesh-list
25185244|NCT02829840|Ponatinib|ponatinib|mesh-list
25185245|NCT02829840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25185246|NCT02829840|Antimetabolites|antimetabolites|mesh-ancestor
25185247|NCT02829840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185248|NCT02829840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25185249|NCT02829840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185250|NCT02829840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25185251|NCT02829385|Apatinib|apatinib|mesh-list
25185252|NCT02829385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25185253|NCT02829385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25185254|NCT02829385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185255|NCT02829385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185256|NCT02829424|Methotrexate|methotrexate|mesh-list
25185257|NCT02829424|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25185258|NCT02829424|Abortifacient Agents|abortifacient agents|mesh-ancestor
25185259|NCT02829424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25185260|NCT02829424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185261|NCT02829424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25185262|NCT02829424|Antimetabolites|antimetabolites|mesh-ancestor
25185263|NCT02829424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185264|NCT02829424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25185265|NCT02829424|Dermatologic Agents|dermatologic agents|mesh-ancestor
25185266|NCT02829424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185267|NCT02829424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25185268|NCT02829424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25185269|NCT02829424|Immunologic Factors|immunologic factors|mesh-ancestor
25185270|NCT02829424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25185271|NCT02829424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25185272|NCT02829359|Entecavir|entecavir|mesh-list
25185273|NCT02829359|Antiviral Agents|antiviral agents|mesh-ancestor
25185274|NCT02829359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25185275|NCT02829372|Antibodies|antibodies|mesh-list
25185276|NCT02829372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25185277|NCT02829372|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25185278|NCT02829372|Immunologic Factors|immunologic factors|mesh-ancestor
25185279|NCT02829372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185280|NCT02829346|Tranexamic Acid|tranexamic acid|mesh-list
25185281|NCT02829346|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25185282|NCT02829346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25185283|NCT02829346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185284|NCT02829346|Hemostatics|hemostatics|mesh-ancestor
25185285|NCT02829346|Coagulants|coagulants|mesh-ancestor
25205640|NCT04403165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25205641|NCT04403165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25205642|NCT04393311|Urinastatin|urinastatin|mesh-list
25205643|NCT04393311|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24411028|NCT00187447|Sensory System Agents|sensory system agents|mesh-ancestor
24411029|NCT00187447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25665852|NCT01688596|Anesthetics, Local|anesthetics, local|mesh-ancestor
25665853|NCT01688596|Anesthetics|anesthetics|mesh-ancestor
25665854|NCT01688596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25665855|NCT01688596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665856|NCT01688596|Sensory System Agents|sensory system agents|mesh-ancestor
25665857|NCT01688596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24457805|NCT00335270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406457|NCT00170404|Protective Agents|protective agents|mesh-ancestor
24457806|NCT00335270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24397748|NCT00142493|Thiopental|thiopental|mesh-list
24523913|NCT05338606|Bimatoprost|bimatoprost|mesh-list
24524034|NCT05322031|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24524035|NCT05322031|Serotonin Agents|serotonin agents|mesh-ancestor
24411035|NCT00187447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24411036|NCT00187447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24411037|NCT00187447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411038|NCT00187447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821431|NCT02105155|Immunologic Factors|immunologic factors|mesh-ancestor
24683953|NCT01394796|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24411039|NCT00187499|Fluticasone|fluticasone|mesh-list
25185286|NCT02829333|Anesthetics|anesthetics|mesh-list
25185287|NCT02829333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25185288|NCT02829333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185289|NCT02829697|Ropivacaine|ropivacaine|mesh-list
25185290|NCT02829697|Anesthetics, Local|anesthetics, local|mesh-ancestor
25185291|NCT02829697|Anesthetics|anesthetics|mesh-ancestor
25185292|NCT02829697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25185293|NCT02829697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185294|NCT02829697|Sensory System Agents|sensory system agents|mesh-ancestor
25185295|NCT02829697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25185296|NCT02829151|Aspirin|aspirin|mesh-list
25185297|NCT02829151|Cilostazol|cilostazol|mesh-list
25185298|NCT02829151|Clopidogrel|clopidogrel|mesh-list
25185299|NCT02829151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25185300|NCT02829151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25185301|NCT02829151|Analgesics|analgesics|mesh-ancestor
25185302|NCT02829151|Sensory System Agents|sensory system agents|mesh-ancestor
25185303|NCT02829151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25185304|NCT02829151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185305|NCT02829151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25185306|NCT02829151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25185453|NCT02827877|Copper|copper|mesh-list
25185308|NCT02829151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25185309|NCT02829151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185310|NCT02829151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25185311|NCT02829151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25185312|NCT02829151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185313|NCT02829151|Antipyretics|antipyretics|mesh-ancestor
25185314|NCT02829151|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25185315|NCT02829151|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25185316|NCT02829151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25185317|NCT02829151|Purinergic Agents|purinergic agents|mesh-ancestor
25185318|NCT02829151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25185319|NCT02829151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25185320|NCT02829151|Autonomic Agents|autonomic agents|mesh-ancestor
25185321|NCT02829151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25185322|NCT02829151|Respiratory System Agents|respiratory system agents|mesh-ancestor
25185323|NCT02829151|Vasodilator Agents|vasodilator agents|mesh-ancestor
25185324|NCT02829151|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25185325|NCT02829151|Protective Agents|protective agents|mesh-ancestor
25185326|NCT02829151|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25185327|NCT02829151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25185328|NCT02829177|Allopurinol|allopurinol|mesh-list
25185329|NCT02829177|Antimetabolites|antimetabolites|mesh-ancestor
24590239|NCT00911287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185330|NCT02829177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185331|NCT02829177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185332|NCT02829177|Gout Suppressants|gout suppressants|mesh-ancestor
25185333|NCT02829177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25185334|NCT02829177|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25185335|NCT02829177|Antioxidants|antioxidants|mesh-ancestor
25185336|NCT02829177|Protective Agents|protective agents|mesh-ancestor
25185337|NCT02829177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185338|NCT02829281|Triamcinolone|triamcinolone|mesh-list
25665858|NCT01688609|Paclitaxel|paclitaxel|mesh-list
25665859|NCT01688609|Trastuzumab|trastuzumab|mesh-list
25665860|NCT01688609|Lapatinib|lapatinib|mesh-list
25665861|NCT01688609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25665862|NCT01688609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665863|NCT01688609|Tubulin Modulators|tubulin modulators|mesh-ancestor
25665864|NCT01688609|Antimitotic Agents|antimitotic agents|mesh-ancestor
25185339|NCT02829281|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25185340|NCT02829281|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25665865|NCT01688609|Mitosis Modulators|mitosis modulators|mesh-ancestor
24526269|NCT00290511|Autonomic Agents|autonomic agents|mesh-ancestor
25860412|NCT00083538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24526270|NCT00290511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24526670|NCT00612612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24526671|NCT00612612|Antimetabolites|antimetabolites|mesh-ancestor
24526692|NCT00612651|Temozolomide|temozolomide|mesh-list
25665866|NCT01688609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185341|NCT02829281|Botulinum Toxins|botulinum toxins|mesh-list
25185342|NCT02829281|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25185343|NCT02829281|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25185344|NCT02829281|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25185345|NCT02829281|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25185346|NCT02829281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25185347|NCT02829281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185348|NCT02829281|Cholinergic Agents|cholinergic agents|mesh-ancestor
25185349|NCT02829281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25185350|NCT02829281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185351|NCT02829281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25185352|NCT02829281|Glucocorticoids|glucocorticoids|mesh-ancestor
25185353|NCT02829281|Hormones|hormones|mesh-ancestor
25185354|NCT02829281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25185355|NCT02829281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25185356|NCT02829281|Immunologic Factors|immunologic factors|mesh-ancestor
25185357|NCT02829281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185358|NCT02829281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25185359|NCT02829281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25185360|NCT02829060|Gentamicins|gentamicins|mesh-list
25185361|NCT02829060|Ampicillin|ampicillin|mesh-list
25185362|NCT02829060|Nitrofurantoin|nitrofurantoin|mesh-list
25185363|NCT02829060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25185364|NCT02829060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25185365|NCT02829060|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25185366|NCT02829060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185367|NCT02829060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185368|NCT02829060|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25185369|NCT02829060|Renal Agents|renal agents|mesh-ancestor
25185370|NCT02829008|Bevacizumab|bevacizumab|mesh-list
25185371|NCT02829008|Pemetrexed|pemetrexed|mesh-list
25185372|NCT02829008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25185373|NCT02829008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25185374|NCT02829008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25185375|NCT02829008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25185376|NCT02829008|Growth Substances|growth substances|mesh-ancestor
25185377|NCT02829008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185378|NCT02829008|Growth Inhibitors|growth inhibitors|mesh-ancestor
25185379|NCT02829008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185380|NCT02829008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185381|NCT02829008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25185382|NCT02829008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25185383|NCT02828384|Psyllium|psyllium|mesh-list
25185384|NCT02828384|Cathartics|cathartics|mesh-ancestor
25185385|NCT02828384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25185386|NCT02828566|Ketamine|ketamine|mesh-list
25185387|NCT02828566|Analgesics|analgesics|mesh-ancestor
25185388|NCT02828566|Sensory System Agents|sensory system agents|mesh-ancestor
25185389|NCT02828566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25185390|NCT02828566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185391|NCT02828566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25185392|NCT02828566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25185393|NCT02828566|Anesthetics, General|anesthetics, general|mesh-ancestor
25185394|NCT02828566|Anesthetics|anesthetics|mesh-ancestor
25185395|NCT02828566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25185396|NCT02828566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25185397|NCT02828566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25185398|NCT02828566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25185399|NCT02828566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185400|NCT02828163|Triamcinolone|triamcinolone|mesh-list
25185401|NCT02828163|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24432467|NCT00254865|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25665867|NCT01688609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25665868|NCT01688609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25665869|NCT01688609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665870|NCT01688635|Insulin Glargine|insulin glargine|mesh-list
25665871|NCT01688635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24526918|NCT00613743|Sensory System Agents|sensory system agents|mesh-ancestor
24526919|NCT00613743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24526920|NCT00613769|Metronidazole|metronidazole|mesh-list
24526921|NCT00613769|Trimethoprim|trimethoprim|mesh-list
24526922|NCT00613769|Sulfamethoxazole|sulfamethoxazole|mesh-list
24526923|NCT00613769|Cefuroxime|cefuroxime|mesh-list
25185402|NCT02828163|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25185403|NCT02828163|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25185404|NCT02828163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25185405|NCT02828163|Glucocorticoids|glucocorticoids|mesh-ancestor
25185406|NCT02828163|Hormones|hormones|mesh-ancestor
25185407|NCT02828163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25185408|NCT02828163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185409|NCT02828163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25185410|NCT02828163|Immunologic Factors|immunologic factors|mesh-ancestor
25185411|NCT02828163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185412|NCT02828163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185413|NCT02828176|Anesthetics|anesthetics|mesh-list
25185414|NCT02828176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25185415|NCT02828176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185416|NCT02828059|Ropivacaine|ropivacaine|mesh-list
25185417|NCT02828059|Anesthetics, Local|anesthetics, local|mesh-ancestor
25185418|NCT02828059|Anesthetics|anesthetics|mesh-ancestor
25185420|NCT02828059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185421|NCT02828059|Sensory System Agents|sensory system agents|mesh-ancestor
25185422|NCT02828059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24411120|NCT00187915|Dermatologic Agents|dermatologic agents|mesh-ancestor
25185424|NCT02828228|Cholecalciferol|cholecalciferol|mesh-list
25185425|NCT02828228|Vitamins|vitamins|mesh-ancestor
25185426|NCT02828228|Micronutrients|micronutrients|mesh-ancestor
25185427|NCT02828228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185428|NCT02828228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25185429|NCT02828228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25185430|NCT02827903|Metformin|metformin|mesh-list
25185431|NCT02827903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25185432|NCT02827903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25185433|NCT02827903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185434|NCT02827903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25185435|NCT02827903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25185436|NCT02827903|Antimetabolites|antimetabolites|mesh-ancestor
25185437|NCT02827903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185438|NCT02827903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25185439|NCT02827903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25185440|NCT02827903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185441|NCT02828033|Rilonacept|rilonacept|mesh-list
25185442|NCT02828033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25185443|NCT02827890|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25185444|NCT02827890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25185445|NCT02827890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185446|NCT02827890|Incretins|incretins|mesh-ancestor
25185447|NCT02827890|Hormones|hormones|mesh-ancestor
25185448|NCT02827890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25185449|NCT02827890|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25185450|NCT02827890|Protease Inhibitors|protease inhibitors|mesh-ancestor
25185451|NCT02827890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185452|NCT02827890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185454|NCT02827877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25185455|NCT02827877|Trastuzumab|trastuzumab|mesh-list
25185456|NCT02827877|Pertuzumab|pertuzumab|mesh-list
25185457|NCT02827877|Antibodies|antibodies|mesh-list
25185458|NCT02827877|Immunoglobulins|immunoglobulins|mesh-list
25185459|NCT02827877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25185460|NCT02827877|Immunologic Factors|immunologic factors|mesh-ancestor
25185461|NCT02827877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185462|NCT02827877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25185463|NCT02827877|Trace Elements|trace elements|mesh-ancestor
25185464|NCT02827877|Micronutrients|micronutrients|mesh-ancestor
25185465|NCT02827643|Vitamin D|vitamin d|mesh-list
25185466|NCT02827643|Ergocalciferols|ergocalciferols|mesh-list
25185467|NCT02827643|Lamivudine|lamivudine|mesh-list
25185468|NCT02827643|Calcium|calcium|mesh-list
25185469|NCT02827643|Vitamins|vitamins|mesh-ancestor
25665872|NCT01688635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665873|NCT01688726|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25665874|NCT01688726|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25665875|NCT01688739|Erenumab|erenumab|mesh-list
25665876|NCT01688739|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25665877|NCT01688739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527457|NCT00616746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24527458|NCT00616746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185470|NCT02827643|Micronutrients|micronutrients|mesh-ancestor
25185471|NCT02827643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185472|NCT02827643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25185473|NCT02827643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25185474|NCT02827643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25185475|NCT02827643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25185476|NCT02827643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185477|NCT02827643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185478|NCT02827643|Antiviral Agents|antiviral agents|mesh-ancestor
25185479|NCT02827643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25185480|NCT02827643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25185481|NCT02827643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25185482|NCT02827656|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25185483|NCT02827656|Luteolytic Agents|luteolytic agents|mesh-ancestor
25185484|NCT02827656|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25185485|NCT02827656|Contraceptive Agents|contraceptive agents|mesh-ancestor
25185486|NCT02827656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25185487|NCT02827656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185488|NCT02827656|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25185489|NCT02827656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25185490|NCT02827656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25205644|NCT04393311|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25205645|NCT04393311|Protease Inhibitors|protease inhibitors|mesh-ancestor
25205646|NCT04393311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205647|NCT04393311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205648|NCT04385303|Lorecivivint|lorecivivint|mesh-list
25205649|NCT04385303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25205650|NCT04382586|Zanubrutinib|zanubrutinib|mesh-list
25205651|NCT04382586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25205652|NCT04382586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25185491|NCT02827747|Vitamin A|vitamin a|mesh-list
25185492|NCT02827747|Antioxidants|antioxidants|mesh-list
25185493|NCT02827747|Vitamins|vitamins|mesh-ancestor
25185494|NCT02827747|Micronutrients|micronutrients|mesh-ancestor
25185495|NCT02827747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185496|NCT02827747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185497|NCT02827747|Protective Agents|protective agents|mesh-ancestor
25185498|NCT02827578|Tamsulosin|tamsulosin|mesh-list
25185499|NCT02827578|Solifenacin Succinate|solifenacin succinate|mesh-list
25185500|NCT02827578|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25185501|NCT02827578|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25185502|NCT02827578|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25185503|NCT02827578|Adrenergic Agents|adrenergic agents|mesh-ancestor
25185504|NCT02827578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25185505|NCT02827578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185506|NCT02827578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185507|NCT02827578|Urological Agents|urological agents|mesh-ancestor
25185508|NCT02827578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25185509|NCT02827578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25185510|NCT02827578|Cholinergic Agents|cholinergic agents|mesh-ancestor
25185511|NCT02827682|Anesthetics|anesthetics|mesh-list
24590240|NCT00911287|Analgesics|analgesics|mesh-ancestor
25185512|NCT02827682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25185513|NCT02827682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185514|NCT02827487|Celecoxib|celecoxib|mesh-list
25185515|NCT02827487|Tramadol|tramadol|mesh-list
24449130|NCT00314509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25185516|NCT02827487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25185517|NCT02827487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25185518|NCT02827487|Analgesics|analgesics|mesh-ancestor
25185519|NCT02827487|Sensory System Agents|sensory system agents|mesh-ancestor
25185520|NCT02827487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25185521|NCT02827487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185522|NCT02827487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25185523|NCT02827487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25185524|NCT02827487|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25185525|NCT02827487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25185526|NCT02827487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404105|NCT03684811|Antiviral Agents|antiviral agents|mesh-ancestor
25665879|NCT01688739|Sensory System Agents|sensory system agents|mesh-ancestor
24528409|NCT00621036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24528410|NCT00621036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528411|NCT00621036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25185527|NCT02827487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185528|NCT02827487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25185529|NCT02827487|Narcotics|narcotics|mesh-ancestor
25185530|NCT02827487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25185531|NCT02827266|Epoetin Alfa|epoetin alfa|mesh-list
25185532|NCT02827266|Hematinics|hematinics|mesh-ancestor
25185533|NCT02827331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25185534|NCT02827331|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
25185535|NCT02827331|Antidepressive Agents|antidepressive agents|mesh-list
25185536|NCT02827331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25185537|NCT02827331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25185538|NCT02827331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185539|NCT02827331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25185540|NCT02827942|Amoxicillin|amoxicillin|mesh-list
25185541|NCT02827942|Metronidazole|metronidazole|mesh-list
25185542|NCT02827942|Clarithromycin|clarithromycin|mesh-list
25185543|NCT02827942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25185544|NCT02827942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25185545|NCT02827942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25185546|NCT02827942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25185547|NCT02827942|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25185548|NCT02827942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185549|NCT02827942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185550|NCT02827942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25185551|NCT02827942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25185552|NCT02827136|Lidocaine|lidocaine|mesh-list
25185553|NCT02827136|Anesthetics, Local|anesthetics, local|mesh-ancestor
25185554|NCT02827136|Anesthetics|anesthetics|mesh-ancestor
25185555|NCT02827136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24433426|NCT00258323|Antimetabolites|antimetabolites|mesh-ancestor
25185556|NCT02827136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185557|NCT02827136|Sensory System Agents|sensory system agents|mesh-ancestor
25185558|NCT02827136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25185559|NCT02827136|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25185560|NCT02827136|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25185561|NCT02827136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25185562|NCT02827136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25185563|NCT02827136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821493|NCT02106104|Linagliptin|linagliptin|mesh-list
25185564|NCT02826902|Remifentanil|remifentanil|mesh-list
25185565|NCT02826902|Propofol|propofol|mesh-list
25185566|NCT02826902|Desflurane|desflurane|mesh-list
25185567|NCT02826902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25185568|NCT02826902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25185569|NCT02826902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185570|NCT02826902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25185571|NCT02826902|Anesthetics, General|anesthetics, general|mesh-ancestor
25185572|NCT02826902|Anesthetics|anesthetics|mesh-ancestor
25185573|NCT02826902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25185574|NCT02826902|Narcotics|narcotics|mesh-ancestor
25185575|NCT02826902|Analgesics|analgesics|mesh-ancestor
25185576|NCT02826902|Sensory System Agents|sensory system agents|mesh-ancestor
24725552|NCT01598337|Aspirin|aspirin|mesh-list
25185577|NCT02826902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25185578|NCT02826902|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25185579|NCT02826564|Pembrolizumab|pembrolizumab|mesh-list
25185580|NCT02826564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25185581|NCT02826564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25185582|NCT02826616|Trimetazidine|trimetazidine|mesh-list
25185583|NCT02826616|Vasodilator Agents|vasodilator agents|mesh-ancestor
25185584|NCT02826772|Androgens|androgens|mesh-list
25185585|NCT02826772|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
25185586|NCT02826772|Hormones|hormones|mesh-ancestor
25185587|NCT02826772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25185588|NCT02826772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185589|NCT02826772|Androgen Antagonists|androgen antagonists|mesh-ancestor
25185590|NCT02826772|Hormone Antagonists|hormone antagonists|mesh-ancestor
25185591|NCT02826876|Ropivacaine|ropivacaine|mesh-list
25185592|NCT02826876|Anesthetics, Local|anesthetics, local|mesh-ancestor
25665880|NCT01688739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25665881|NCT01688739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665882|NCT01688830|Dabigatran|dabigatran|mesh-list
25185593|NCT02826876|Anesthetics|anesthetics|mesh-ancestor
25426952|NCT01946529|Growth Substances|growth substances|mesh-ancestor
25185594|NCT02826876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24433906|NCT00260520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25185595|NCT02826876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185596|NCT02826876|Sensory System Agents|sensory system agents|mesh-ancestor
25185597|NCT02826876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25185599|NCT02826759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25185600|NCT02826759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185601|NCT02826746|Magnesium Sulfate|magnesium sulfate|mesh-list
25185602|NCT02826746|Analgesics|analgesics|mesh-ancestor
25185603|NCT02826746|Sensory System Agents|sensory system agents|mesh-ancestor
25185604|NCT02826746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25185605|NCT02826746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185606|NCT02826746|Anesthetics|anesthetics|mesh-ancestor
25185607|NCT02826746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25185608|NCT02826746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25185609|NCT02826746|Anticonvulsants|anticonvulsants|mesh-ancestor
25185610|NCT02826746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25185611|NCT02826746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25185612|NCT02826746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185613|NCT02826746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25185614|NCT02826746|Tocolytic Agents|tocolytic agents|mesh-ancestor
25185615|NCT02826746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25185616|NCT02826837|Bevacizumab|bevacizumab|mesh-list
25185617|NCT02826837|Cetuximab|cetuximab|mesh-list
25185618|NCT02826837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25185619|NCT02826837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25185620|NCT02826837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25185621|NCT02826837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25185622|NCT02826837|Growth Substances|growth substances|mesh-ancestor
25185623|NCT02826837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185624|NCT02826837|Growth Inhibitors|growth inhibitors|mesh-ancestor
25185625|NCT02826408|Rabeprazole|rabeprazole|mesh-list
25185626|NCT02826408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25185627|NCT02826408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25185628|NCT02826408|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25185629|NCT02826408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185630|NCT02826408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185631|NCT02826434|Durvalumab|durvalumab|mesh-list
25185633|NCT02826434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25185634|NCT02826434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25185635|NCT02826434|Interferon Inducers|interferon inducers|mesh-ancestor
25185636|NCT02826434|Immunologic Factors|immunologic factors|mesh-ancestor
25185637|NCT02826434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185638|NCT02826343|Xenon|xenon|mesh-list
25185639|NCT02826343|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25185640|NCT02826343|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25185641|NCT02826343|Anesthetics, General|anesthetics, general|mesh-ancestor
24411508|NCT00189176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24411509|NCT00189176|Growth Substances|growth substances|mesh-ancestor
24411510|NCT00189176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411511|NCT00189176|Growth Inhibitors|growth inhibitors|mesh-ancestor
24411512|NCT00189176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411515|NCT00189345|Immunologic Factors|immunologic factors|mesh-ancestor
24411516|NCT00189345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411517|NCT00189345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24411518|NCT00189345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24411519|NCT00189358|Tamoxifen|tamoxifen|mesh-list
24411520|NCT00189358|Gefitinib|gefitinib|mesh-list
24411521|NCT00189358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24411522|NCT00189358|Hormone Antagonists|hormone antagonists|mesh-ancestor
24411523|NCT00189358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24411530|NCT00189358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24411531|NCT00189358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821571|NCT02106520|Growth Inhibitors|growth inhibitors|mesh-ancestor
24821572|NCT02106559|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
24821573|NCT02106559|Trioxsalen|trioxsalen|mesh-list
24821574|NCT02106559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24821575|NCT02106559|Dermatologic Agents|dermatologic agents|mesh-ancestor
24821576|NCT02106559|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24821577|NCT02106637|Varenicline|varenicline|mesh-list
24821578|NCT02106637|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24821579|NCT02106637|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24821580|NCT02106637|Cholinergic Agents|cholinergic agents|mesh-ancestor
24821581|NCT02106637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24531873|NCT00637468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24531876|NCT00637468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24531877|NCT00637468|Antipyretics|antipyretics|mesh-ancestor
24531878|NCT00637468|Anticonvulsants|anticonvulsants|mesh-ancestor
24531879|NCT00637468|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24531880|NCT00637468|Diuretics|diuretics|mesh-ancestor
24531881|NCT00637468|Natriuretic Agents|natriuretic agents|mesh-ancestor
24821582|NCT02106637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821583|NCT02106637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821584|NCT02106650|Leucovorin|leucovorin|mesh-list
25185642|NCT02826343|Anesthetics|anesthetics|mesh-ancestor
25185643|NCT02826343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25185644|NCT02826343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185645|NCT02826343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25185646|NCT02826343|Autonomic Agents|autonomic agents|mesh-ancestor
25185647|NCT02826343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25185648|NCT02826343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25185649|NCT02826343|Respiratory System Agents|respiratory system agents|mesh-ancestor
25185650|NCT02826343|Glucocorticoids|glucocorticoids|mesh-ancestor
25185651|NCT02826343|Hormones|hormones|mesh-ancestor
25185652|NCT02826343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25185653|NCT02826343|Sympathomimetics|sympathomimetics|mesh-ancestor
25185654|NCT02826252|Iloprost|iloprost|mesh-list
25185655|NCT02826252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25185656|NCT02826252|Vasodilator Agents|vasodilator agents|mesh-ancestor
25185657|NCT02826200|Acenocoumarol|acenocoumarol|mesh-list
25185658|NCT02826200|Anticoagulants|anticoagulants|mesh-ancestor
25205653|NCT04382586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205654|NCT04382586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205655|NCT04360044|Dronabinol|dronabinol|mesh-list
25205656|NCT04360044|Cannabidiol|cannabidiol|mesh-list
25205657|NCT04360044|Anticonvulsants|anticonvulsants|mesh-ancestor
25205658|NCT04360044|Hallucinogens|hallucinogens|mesh-ancestor
25205659|NCT04360044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205660|NCT04360044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25205661|NCT04360044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25205662|NCT04360044|Analgesics|analgesics|mesh-ancestor
25205663|NCT04360044|Sensory System Agents|sensory system agents|mesh-ancestor
25205664|NCT04360044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25205665|NCT04360044|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25205666|NCT04360044|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25205667|NCT04360044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25205668|NCT04360044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205669|NCT04360044|Hormones|hormones|mesh-ancestor
25205670|NCT04360044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25205671|NCT04356339|Interferons|interferons|mesh-list
25205672|NCT04356339|Interferon-beta|interferon-beta|mesh-list
25205673|NCT04356339|Interferon beta-1b|interferon beta-1b|mesh-list
25205674|NCT04356339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25205675|NCT04356339|Antiviral Agents|antiviral agents|mesh-ancestor
25205676|NCT04356339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25205677|NCT04356339|Immunologic Factors|immunologic factors|mesh-ancestor
25205678|NCT04356339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185659|NCT02825953|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25185660|NCT02825953|Respiratory System Agents|respiratory system agents|mesh-ancestor
25185661|NCT02826070|Adefovir|adefovir|mesh-list
25185662|NCT02826070|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25185663|NCT02826070|Telbivudine|telbivudine|mesh-list
25185664|NCT02826070|Antiviral Agents|antiviral agents|mesh-ancestor
25185665|NCT02826070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25185666|NCT02826070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25185667|NCT02826070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25185668|NCT02826070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185669|NCT02826070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185670|NCT02826226|Bronchodilator Agents|bronchodilator agents|mesh-list
25185671|NCT02826226|Autonomic Agents|autonomic agents|mesh-ancestor
25185672|NCT02826226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25185673|NCT02826226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185674|NCT02826226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25665883|NCT01688830|Antithrombins|antithrombins|mesh-ancestor
25665884|NCT01688830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25665885|NCT01688830|Protease Inhibitors|protease inhibitors|mesh-ancestor
25665886|NCT01688830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665887|NCT01688830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665888|NCT01688830|Anticoagulants|anticoagulants|mesh-ancestor
25665889|NCT01688921|Vaccines|vaccines|mesh-list
25860413|NCT00083538|Growth Substances|growth substances|mesh-ancestor
25860414|NCT00083538|Growth Inhibitors|growth inhibitors|mesh-ancestor
25860415|NCT00083577|Thalidomide|thalidomide|mesh-list
25860416|NCT00083577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25860417|NCT00083577|Immunologic Factors|immunologic factors|mesh-ancestor
24532563|NCT00640432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860418|NCT00083577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532565|NCT00640458|Vasodilator Agents|vasodilator agents|mesh-ancestor
24532566|NCT00640458|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25211316|NCT04521647|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25211317|NCT04521647|Autonomic Agents|autonomic agents|mesh-ancestor
25211318|NCT04521647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25211319|NCT04521647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211320|NCT04521647|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25211321|NCT04521647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25211322|NCT04521647|Cholinergic Agents|cholinergic agents|mesh-ancestor
25211323|NCT04521647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24526463|NCT00611754|Fluorouracil|fluorouracil|mesh-list
25185675|NCT02826226|Respiratory System Agents|respiratory system agents|mesh-ancestor
25185676|NCT02825979|Sotalol|sotalol|mesh-list
25185677|NCT02825979|Flecainide|flecainide|mesh-list
25185678|NCT02825979|Dronedarone|dronedarone|mesh-list
25185679|NCT02825979|Propafenone|propafenone|mesh-list
25185680|NCT02825979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
25185681|NCT02825979|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25185682|NCT02825979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25185683|NCT02825979|Adrenergic Agents|adrenergic agents|mesh-ancestor
25185684|NCT02825979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25185685|NCT02825979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185686|NCT02825979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185687|NCT02825979|Sympatholytics|sympatholytics|mesh-ancestor
25185688|NCT02825979|Autonomic Agents|autonomic agents|mesh-ancestor
25185689|NCT02825979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25185690|NCT02825979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25185691|NCT02825979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25185692|NCT02825979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25185693|NCT02826174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25185694|NCT02826174|Anesthetics|anesthetics|mesh-list
25185695|NCT02826174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25185696|NCT02826174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185697|NCT02826031|Hyaluronic Acid|hyaluronic acid|mesh-list
25185698|NCT02826031|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25185699|NCT02826031|Immunologic Factors|immunologic factors|mesh-ancestor
25185700|NCT02826031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185701|NCT02826031|Viscosupplements|viscosupplements|mesh-ancestor
25185702|NCT02826031|Protective Agents|protective agents|mesh-ancestor
25185703|NCT02825719|Tranexamic Acid|tranexamic acid|mesh-list
25185704|NCT02825719|Ulipristal acetate|ulipristal acetate|mesh-list
25185705|NCT02825719|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25185706|NCT02825719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25185707|NCT02825719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185708|NCT02825719|Hemostatics|hemostatics|mesh-ancestor
25185709|NCT02825719|Coagulants|coagulants|mesh-ancestor
25185710|NCT02825719|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25185711|NCT02825719|Contraceptive Agents|contraceptive agents|mesh-ancestor
24726256|NCT01602588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25185712|NCT02825719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25185713|NCT02825719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25426953|NCT01946529|Growth Inhibitors|growth inhibitors|mesh-ancestor
25665890|NCT01688921|Immunologic Factors|immunologic factors|mesh-ancestor
25665891|NCT01688921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665892|NCT01688973|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25665893|NCT01688973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665894|NCT01688973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25665895|NCT01688973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665896|NCT01688973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665897|NCT01689207|Aztreonam|aztreonam|mesh-list
25665898|NCT01689207|Avibactam|avibactam|mesh-list
25665899|NCT01689207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25665900|NCT01689207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25665901|NCT01689207|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25665902|NCT01689207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665903|NCT01689207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665904|NCT01689324|Vaccines|vaccines|mesh-list
25665905|NCT01689324|Immunologic Factors|immunologic factors|mesh-ancestor
25665906|NCT01689324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457921|NCT00335673|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24457922|NCT00335673|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24532717|NCT00640887|Protease Inhibitors|protease inhibitors|mesh-ancestor
24532827|NCT00641212|Budesonide|budesonide|mesh-list
24532828|NCT00641212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25185714|NCT02825719|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25185715|NCT02825914|Caseins|caseins|mesh-list
25185716|NCT02825914|Chelating Agents|chelating agents|mesh-ancestor
25185717|NCT02825914|Sequestering Agents|sequestering agents|mesh-ancestor
24434265|NCT00261820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24434266|NCT00261820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24434267|NCT00261820|Glucocorticoids|glucocorticoids|mesh-ancestor
25185718|NCT02825914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185719|NCT02825576|Glycopyrrolate|glycopyrrolate|mesh-list
25185720|NCT02825576|Neostigmine|neostigmine|mesh-list
25185721|NCT02825576|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25185722|NCT02825576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185723|NCT02825576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185724|NCT02825576|Cholinergic Agents|cholinergic agents|mesh-ancestor
25185725|NCT02825576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25185726|NCT02825576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185727|NCT02825576|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25185728|NCT02825576|Autonomic Agents|autonomic agents|mesh-ancestor
25185729|NCT02825576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25185730|NCT02825576|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24411598|NCT00189553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25185731|NCT02825576|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25185732|NCT02825576|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25185733|NCT02825797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25185735|NCT02825797|Immunoglobulins|immunoglobulins|mesh-list
25185736|NCT02825797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25185737|NCT02825797|Immunologic Factors|immunologic factors|mesh-ancestor
25185738|NCT02825797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185739|NCT02825797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25185740|NCT02825394|Ecarin|ecarin|mesh-list
25185741|NCT02825394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25185742|NCT02825394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25185743|NCT02825394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185744|NCT02825147|Dexamethasone|dexamethasone|mesh-list
25185745|NCT02825147|Methotrexate|methotrexate|mesh-list
25185746|NCT02825147|Etoposide|etoposide|mesh-list
25185747|NCT02825147|Pegaspargase|pegaspargase|mesh-list
25185748|NCT02825147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25185749|NCT02825147|Antiemetics|antiemetics|mesh-ancestor
25185750|NCT02825147|Autonomic Agents|autonomic agents|mesh-ancestor
25185751|NCT02825147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25185752|NCT02825147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185753|NCT02825147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25185754|NCT02825147|Glucocorticoids|glucocorticoids|mesh-ancestor
25185755|NCT02825147|Hormones|hormones|mesh-ancestor
25185756|NCT02825147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25185757|NCT02825147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25185758|NCT02825147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25185759|NCT02825147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25185760|NCT02825147|Abortifacient Agents|abortifacient agents|mesh-ancestor
25185761|NCT02825147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25185762|NCT02825147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25185763|NCT02825147|Antimetabolites|antimetabolites|mesh-ancestor
25185764|NCT02825147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185765|NCT02825147|Dermatologic Agents|dermatologic agents|mesh-ancestor
25185766|NCT02825147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185767|NCT02825147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25185768|NCT02825147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25185769|NCT02825147|Immunologic Factors|immunologic factors|mesh-ancestor
25185770|NCT02825147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25185771|NCT02825147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25185772|NCT02825147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25185773|NCT02825147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25185774|NCT02825147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25665907|NCT01689363|Histamine|histamine|mesh-list
25665908|NCT01689363|Histamine Agonists|histamine agonists|mesh-ancestor
25665909|NCT01689363|Histamine Agents|histamine agents|mesh-ancestor
25665910|NCT01689363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25665911|NCT01689363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860419|NCT00083577|Leprostatic Agents|leprostatic agents|mesh-ancestor
24533008|NCT00642057|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24533009|NCT00642057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24533010|NCT00642057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25211358|NCT04430894|Dexamethasone|dexamethasone|mesh-list
25211359|NCT04430894|Lenalidomide|lenalidomide|mesh-list
25211360|NCT04430894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25211361|NCT04430894|Antiemetics|antiemetics|mesh-ancestor
25185775|NCT02825290|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25185776|NCT02825290|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25185777|NCT02825290|Luteolytic Agents|luteolytic agents|mesh-ancestor
25185778|NCT02825290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25185779|NCT02825290|Contraceptive Agents|contraceptive agents|mesh-ancestor
25185780|NCT02825290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25185781|NCT02825290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185782|NCT02825290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25185783|NCT02825290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25185784|NCT02825290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25185785|NCT02825342|Citalopram|citalopram|mesh-list
25185786|NCT02825342|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25185787|NCT02825342|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25185788|NCT02825342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25185789|NCT02825342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25185790|NCT02825342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185791|NCT02825342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25185792|NCT02825342|Serotonin Agents|serotonin agents|mesh-ancestor
25185793|NCT02825342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185794|NCT02825342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25185795|NCT02825342|Antidepressive Agents|antidepressive agents|mesh-ancestor
25185796|NCT02825342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25185797|NCT02825342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185798|NCT02825225|Anesthetics|anesthetics|mesh-list
25185799|NCT02825225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25185800|NCT02825225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185801|NCT02825186|Dexamethasone|dexamethasone|mesh-list
25185802|NCT02825186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25185803|NCT02825186|Antiemetics|antiemetics|mesh-ancestor
25185804|NCT02825186|Autonomic Agents|autonomic agents|mesh-ancestor
25185805|NCT02825186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25185806|NCT02825186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185807|NCT02825186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25185808|NCT02825186|Glucocorticoids|glucocorticoids|mesh-ancestor
25185809|NCT02825186|Hormones|hormones|mesh-ancestor
25185810|NCT02825186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25185811|NCT02825186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25185812|NCT02825186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25185813|NCT02825095|Lidocaine|lidocaine|mesh-list
25185814|NCT02825095|Anesthetics, Local|anesthetics, local|mesh-ancestor
25185815|NCT02825095|Anesthetics|anesthetics|mesh-ancestor
25185816|NCT02825095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25185817|NCT02825095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185818|NCT02825095|Sensory System Agents|sensory system agents|mesh-ancestor
25185819|NCT02825095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25185820|NCT02825095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25185821|NCT02825095|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25185822|NCT02825095|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25185823|NCT02825095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25185824|NCT02825095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185825|NCT02825121|Iodine|iodine|mesh-list
25185826|NCT02825121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25185827|NCT02825121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25185828|NCT02825121|Trace Elements|trace elements|mesh-ancestor
25185829|NCT02825121|Micronutrients|micronutrients|mesh-ancestor
25185830|NCT02825121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185831|NCT02825199|Caffeine|caffeine|mesh-list
25185832|NCT02825199|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25185833|NCT02825199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185834|NCT02825199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25665912|NCT01689363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665913|NCT01689441|Calcitriol|calcitriol|mesh-list
25665914|NCT01689441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25665915|NCT01689441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665916|NCT01689441|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25665917|NCT01689441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25860420|NCT00083577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25185835|NCT02825199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185836|NCT02825199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185837|NCT02825199|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25185838|NCT02825199|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25185839|NCT02825199|Purinergic Agents|purinergic agents|mesh-ancestor
25185840|NCT02825199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25185842|NCT02824965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25185843|NCT02824965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25185844|NCT02825056|Morphine|morphine|mesh-list
25185845|NCT02825056|Bupivacaine|bupivacaine|mesh-list
25185846|NCT02825056|Anesthetics, Local|anesthetics, local|mesh-ancestor
25185847|NCT02825056|Anesthetics|anesthetics|mesh-ancestor
25185848|NCT02825056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25185849|NCT02825056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185850|NCT02825056|Sensory System Agents|sensory system agents|mesh-ancestor
25185851|NCT02825056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25185852|NCT02825056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25185853|NCT02825056|Narcotics|narcotics|mesh-ancestor
25185854|NCT02825056|Analgesics|analgesics|mesh-ancestor
25185855|NCT02824926|Ketoconazole|ketoconazole|mesh-list
25185856|NCT02824926|Antifungal Agents|antifungal agents|mesh-ancestor
25185857|NCT02824926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25185858|NCT02824926|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25185859|NCT02824926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25185860|NCT02824926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185861|NCT02824926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185862|NCT02824926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25185863|NCT02824926|Hormone Antagonists|hormone antagonists|mesh-ancestor
25185864|NCT02824926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25185865|NCT02824926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185866|NCT02824926|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25185867|NCT02824601|Calcium|calcium|mesh-list
25185868|NCT02824601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25185869|NCT02824601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185870|NCT02824770|Tramadol|tramadol|mesh-list
25185871|NCT02824770|Bupivacaine|bupivacaine|mesh-list
25185872|NCT02824770|Anesthetics, Local|anesthetics, local|mesh-ancestor
25185873|NCT02824770|Anesthetics|anesthetics|mesh-ancestor
25185874|NCT02824770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25185875|NCT02824770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185876|NCT02824770|Sensory System Agents|sensory system agents|mesh-ancestor
25185877|NCT02824770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24821714|NCT02107378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821755|NCT02107729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24821756|NCT02107729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24821757|NCT02107729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24821758|NCT02107729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24821759|NCT02107729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821760|NCT02107742|Lidocaine|lidocaine|mesh-list
24821761|NCT02107742|Anesthetics, Local|anesthetics, local|mesh-ancestor
24821762|NCT02107742|Anesthetics|anesthetics|mesh-ancestor
24821763|NCT02107742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24411864|NCT00190294|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24411865|NCT00190294|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24411866|NCT00190294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24411867|NCT00190294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24411868|NCT00190294|Contraceptive Agents|contraceptive agents|mesh-ancestor
24411869|NCT00190294|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24411870|NCT00190294|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24411871|NCT00190294|Hormone Antagonists|hormone antagonists|mesh-ancestor
24411872|NCT00190294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24411877|NCT00190307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24411878|NCT00190307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24411879|NCT00190307|Analgesics|analgesics|mesh-ancestor
24411880|NCT00190307|Sensory System Agents|sensory system agents|mesh-ancestor
24411906|NCT00190411|Celiprolol|celiprolol|mesh-list
25185878|NCT02824770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25185879|NCT02824770|Narcotics|narcotics|mesh-ancestor
25185880|NCT02824770|Analgesics|analgesics|mesh-ancestor
25185881|NCT02824536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25185882|NCT02824536|Antibodies|antibodies|mesh-list
25185887|NCT02824536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25211392|NCT04399356|Niclosamide|niclosamide|mesh-list
25211393|NCT04399356|Anticestodal Agents|anticestodal agents|mesh-ancestor
25211394|NCT04399356|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25211395|NCT04399356|Anthelmintics|anthelmintics|mesh-ancestor
25211399|NCT04397003|Durvalumab|durvalumab|mesh-list
25185888|NCT02824666|Fallypride|fallypride|mesh-list
25185889|NCT02824666|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25185890|NCT02824666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25185891|NCT02824666|Dopamine Agents|dopamine agents|mesh-ancestor
25185892|NCT02824666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25185893|NCT02824666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185894|NCT02824666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185895|NCT02824718|Teriparatide|teriparatide|mesh-list
25185896|NCT02824718|Alfacalcidol|alfacalcidol|mesh-list
25185897|NCT02824718|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
25185898|NCT02824718|Sodium Channel Blockers|sodium channel blockers|mesh-list
25185899|NCT02824718|Diuretics|diuretics|mesh-list
25185900|NCT02824718|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
25185901|NCT02824718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25185902|NCT02824718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185903|NCT02824718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25185904|NCT02824718|Natriuretic Agents|natriuretic agents|mesh-ancestor
25185905|NCT02824718|Vitamins|vitamins|mesh-ancestor
25185906|NCT02824718|Micronutrients|micronutrients|mesh-ancestor
25185907|NCT02824718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25185908|NCT02824718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185913|NCT02824874|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25185914|NCT02824874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25185915|NCT02824874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185916|NCT02824874|Incretins|incretins|mesh-ancestor
25185917|NCT02824874|Hormones|hormones|mesh-ancestor
25185918|NCT02824874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25185919|NCT02824874|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25185920|NCT02824874|Protease Inhibitors|protease inhibitors|mesh-ancestor
25185921|NCT02824874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185922|NCT02824874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185923|NCT02824614|Erythritol|erythritol|mesh-list
25185924|NCT02824614|Vasodilator Agents|vasodilator agents|mesh-ancestor
25205679|NCT04356339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25205680|NCT04353414|Bupivacaine|bupivacaine|mesh-list
25205681|NCT04353414|Anesthetics, Local|anesthetics, local|mesh-ancestor
25205682|NCT04353414|Anesthetics|anesthetics|mesh-ancestor
25185925|NCT02824510|Insulin|insulin|mesh-list
25185926|NCT02824510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25185927|NCT02824510|Insulin Aspart|insulin aspart|mesh-list
25185928|NCT02824510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25185929|NCT02824510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665918|NCT01689441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665919|NCT01689441|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25665920|NCT01689441|Vitamins|vitamins|mesh-ancestor
25665921|NCT01689441|Micronutrients|micronutrients|mesh-ancestor
25665922|NCT01689441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25665923|NCT01689532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25665924|NCT01689532|Immunologic Factors|immunologic factors|mesh-ancestor
25665925|NCT01689532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665926|NCT01689649|Topiramate|topiramate|mesh-list
25665927|NCT01689649|Anticonvulsants|anticonvulsants|mesh-ancestor
25665928|NCT01689649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25665929|NCT01689649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665930|NCT01689779|Vitamin D|vitamin d|mesh-list
25185951|NCT02824458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185953|NCT02824094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25185954|NCT02824094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25185963|NCT02824315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185965|NCT02824406|Anticonvulsants|anticonvulsants|mesh-ancestor
25185966|NCT02824406|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25185967|NCT02824406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25185968|NCT02824406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25185969|NCT02824406|Diuretics|diuretics|mesh-ancestor
25185970|NCT02824406|Natriuretic Agents|natriuretic agents|mesh-ancestor
25185971|NCT02824406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185972|NCT02824354|Nalmefene|nalmefene|mesh-list
24947311|NCT03930069|Coagulants|coagulants|mesh-ancestor
25185973|NCT02824354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25185974|NCT02824354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185975|NCT02824354|Sensory System Agents|sensory system agents|mesh-ancestor
25185976|NCT02824354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25185986|NCT02823977|Dexmedetomidine|dexmedetomidine|mesh-list
25185987|NCT02823977|Ketamine|ketamine|mesh-list
25185988|NCT02823977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25185989|NCT02823977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25185990|NCT02823977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25185991|NCT02823977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25185992|NCT02823977|Analgesics|analgesics|mesh-ancestor
25185993|NCT02823977|Sensory System Agents|sensory system agents|mesh-ancestor
25185994|NCT02823977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25185995|NCT02823977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24821774|NCT02107755|Antibodies|antibodies|mesh-list
25185996|NCT02823977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25185997|NCT02823977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25185998|NCT02823977|Adrenergic Agents|adrenergic agents|mesh-ancestor
25185999|NCT02823977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25186000|NCT02823977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186001|NCT02823977|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25186002|NCT02823977|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25186003|NCT02823977|Anesthetics, General|anesthetics, general|mesh-ancestor
25186004|NCT02823977|Anesthetics|anesthetics|mesh-ancestor
25186005|NCT02823977|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25186006|NCT02823977|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25186007|NCT02823808|Glimepiride|glimepiride|mesh-list
25186008|NCT02823808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25186009|NCT02823808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25186010|NCT02823808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186011|NCT02823808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25186012|NCT02823808|Immunologic Factors|immunologic factors|mesh-ancestor
25186013|NCT02823951|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25186014|NCT02823951|Dermatologic Agents|dermatologic agents|mesh-ancestor
25186015|NCT02823951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25186016|NCT02823951|Immunologic Factors|immunologic factors|mesh-ancestor
25186017|NCT02823951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186018|NCT02823912|Capsaicin|capsaicin|mesh-list
25186019|NCT02823912|Magnesium Oxide|magnesium oxide|mesh-list
25186020|NCT02823912|Antipruritics|antipruritics|mesh-ancestor
25665931|NCT01689779|Cholecalciferol|cholecalciferol|mesh-list
25665932|NCT01689779|Vitamins|vitamins|mesh-ancestor
25665933|NCT01689779|Micronutrients|micronutrients|mesh-ancestor
25665934|NCT01689779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211458|NCT04336748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25211459|NCT04336748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25211460|NCT04336748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186021|NCT02823912|Dermatologic Agents|dermatologic agents|mesh-ancestor
25186022|NCT02823912|Sensory System Agents|sensory system agents|mesh-ancestor
25186023|NCT02823912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25186024|NCT02823912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186025|NCT02823912|Antacids|antacids|mesh-ancestor
25186026|NCT02823912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186027|NCT02823912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25186028|NCT02823743|Aspirin|aspirin|mesh-list
25186043|NCT02823743|Antipyretics|antipyretics|mesh-ancestor
24435361|NCT00266097|Antiviral Agents|antiviral agents|mesh-ancestor
24435607|NCT00267254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435608|NCT00267254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24435610|NCT00267254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25186060|NCT02823626|Spironolactone|spironolactone|mesh-list
25186061|NCT02823626|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25186062|NCT02823626|Hormone Antagonists|hormone antagonists|mesh-ancestor
25186063|NCT02823626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25186064|NCT02823626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186065|NCT02823626|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25186066|NCT02823626|Diuretics|diuretics|mesh-ancestor
25186067|NCT02823626|Natriuretic Agents|natriuretic agents|mesh-ancestor
25186068|NCT02823925|Zoledronic Acid|zoledronic acid|mesh-list
25186069|NCT02823925|Pamidronate|pamidronate|mesh-list
25186070|NCT02823925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25186071|NCT02823925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186072|NCT02823496|Sunscreening Agents|sunscreening agents|mesh-list
25186073|NCT02823496|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25186074|NCT02823496|Protective Agents|protective agents|mesh-ancestor
25186075|NCT02823496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186076|NCT02823496|Dermatologic Agents|dermatologic agents|mesh-ancestor
25186077|NCT02823483|Sunscreening Agents|sunscreening agents|mesh-list
25186078|NCT02823483|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25186079|NCT02823483|Protective Agents|protective agents|mesh-ancestor
25186080|NCT02823483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186081|NCT02823483|Dermatologic Agents|dermatologic agents|mesh-ancestor
25186082|NCT02823691|Metformin|metformin|mesh-list
25186083|NCT02823691|Lanreotide|lanreotide|mesh-list
25186084|NCT02823691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25186085|NCT02823691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186086|NCT02823691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25186087|NCT02824042|Itraconazole|itraconazole|mesh-list
25186088|NCT02824042|Maytansine|maytansine|mesh-list
25186089|NCT02824042|Antifungal Agents|antifungal agents|mesh-ancestor
25186090|NCT02824042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25186091|NCT02824042|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25186092|NCT02824042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25186093|NCT02824042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25186094|NCT02824042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186095|NCT02824042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25186096|NCT02824042|Hormone Antagonists|hormone antagonists|mesh-ancestor
25186097|NCT02824042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25186098|NCT02824042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186103|NCT02824042|Antimitotic Agents|antimitotic agents|mesh-ancestor
25186104|NCT02824042|Mitosis Modulators|mitosis modulators|mesh-ancestor
25186105|NCT02823405|Pembrolizumab|pembrolizumab|mesh-list
25186106|NCT02823405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25186107|NCT02823405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25186108|NCT02823236|Triamcinolone|triamcinolone|mesh-list
25186109|NCT02823236|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25186110|NCT02823236|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25186111|NCT02823236|Pirfenidone|pirfenidone|mesh-list
25186112|NCT02823236|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25186113|NCT02823236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25186114|NCT02823236|Glucocorticoids|glucocorticoids|mesh-ancestor
25186115|NCT02823236|Hormones|hormones|mesh-ancestor
25186116|NCT02823236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25186117|NCT02823236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665935|NCT01689779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25665936|NCT01689779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25665937|NCT01690000|Melatonin|melatonin|mesh-list
25186118|NCT02823236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25211475|NCT04315350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25211476|NCT04315350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25211478|NCT04315350|Sensory System Agents|sensory system agents|mesh-ancestor
25211479|NCT04315350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25211480|NCT04315350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25211481|NCT04315350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211482|NCT04314219|Cyclophosphamide|cyclophosphamide|mesh-list
25211483|NCT04314219|Methotrexate|methotrexate|mesh-list
25211484|NCT04314219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25211485|NCT04314219|Immunologic Factors|immunologic factors|mesh-ancestor
25211486|NCT04314219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211487|NCT04314219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25186119|NCT02823236|Immunologic Factors|immunologic factors|mesh-ancestor
25186120|NCT02823236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25186121|NCT02823236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186122|NCT02823236|Analgesics|analgesics|mesh-ancestor
25186123|NCT02823236|Sensory System Agents|sensory system agents|mesh-ancestor
25186124|NCT02823236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25186125|NCT02823236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25186126|NCT02823236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25186127|NCT02823236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25186128|NCT02823236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25186130|NCT02823249|Tryptophan|tryptophan|mesh-list
25186131|NCT02823249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25186132|NCT02823249|Antidepressive Agents|antidepressive agents|mesh-ancestor
25186133|NCT02823249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25186134|NCT02823249|Vasodilator Agents|vasodilator agents|mesh-ancestor
24435852|NCT00268372|Docetaxel|docetaxel|mesh-list
25186140|NCT02823106|Verapamil|verapamil|mesh-list
25186141|NCT02823106|Choline|choline|mesh-list
25186142|NCT02823106|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
25186143|NCT02823106|Lipotropic Agents|lipotropic agents|mesh-ancestor
25186144|NCT02823106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25186145|NCT02823106|Antimetabolites|antimetabolites|mesh-ancestor
25186146|NCT02823106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186147|NCT02823106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25186148|NCT02823106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24821884|NCT02108548|Gout Suppressants|gout suppressants|mesh-ancestor
25186149|NCT02823106|Nootropic Agents|nootropic agents|mesh-ancestor
25186150|NCT02823106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25186151|NCT02823106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25186152|NCT02823106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25186153|NCT02823106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25186154|NCT02823106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186155|NCT02823106|Vasodilator Agents|vasodilator agents|mesh-ancestor
25205683|NCT04353414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25665938|NCT01690000|Antioxidants|antioxidants|mesh-ancestor
25665939|NCT01690000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665940|NCT01690000|Protective Agents|protective agents|mesh-ancestor
25665941|NCT01690000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665942|NCT01690000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25665943|NCT01690052|Pilocarpine|pilocarpine|mesh-list
25665944|NCT01690052|Cevimeline|cevimeline|mesh-list
25665945|NCT01690052|Miotics|miotics|mesh-ancestor
25665946|NCT01690052|Autonomic Agents|autonomic agents|mesh-ancestor
25665947|NCT01690052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25665948|NCT01690052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665949|NCT01690052|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25665950|NCT01690052|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25665951|NCT01690052|Cholinergic Agents|cholinergic agents|mesh-ancestor
25665952|NCT01690052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25665953|NCT01690052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665954|NCT01690052|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25427031|NCT01938248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24527268|NCT00615797|Penicillin V|penicillin v|mesh-list
24527269|NCT00615797|Haloperidol|haloperidol|mesh-list
24527270|NCT00615797|Haloperidol decanoate|haloperidol decanoate|mesh-list
24527279|NCT00615797|Autonomic Agents|autonomic agents|mesh-ancestor
24527280|NCT00615797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24527281|NCT00615797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24527282|NCT00615797|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24527283|NCT00615797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24527284|NCT00615797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24527287|NCT00615797|Dopamine Agents|dopamine agents|mesh-ancestor
25205684|NCT04353414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205685|NCT04353414|Sensory System Agents|sensory system agents|mesh-ancestor
25205686|NCT04353414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25205687|NCT04344795|Pembrolizumab|pembrolizumab|mesh-list
25205688|NCT04344795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25205689|NCT04344795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25205690|NCT04331145|Ticagrelor|ticagrelor|mesh-list
25205691|NCT04331145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25205692|NCT04331145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25205693|NCT04331145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25205694|NCT04331145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25205695|NCT04331145|Purinergic Agents|purinergic agents|mesh-ancestor
25205696|NCT04331145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25205697|NCT04331145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205698|NCT04331145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205700|NCT04325802|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25205701|NCT04325802|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25205702|NCT04325802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205703|NCT04325802|Sensory System Agents|sensory system agents|mesh-ancestor
25205704|NCT04325802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25205705|NCT04313088|Eluxadoline|eluxadoline|mesh-list
25205706|NCT04313088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25205707|NCT04302896|Tenofovir|tenofovir|mesh-list
25205708|NCT04302896|Lamivudine|lamivudine|mesh-list
25205709|NCT04302896|Emtricitabine|emtricitabine|mesh-list
25205710|NCT04302896|Dolutegravir|dolutegravir|mesh-list
25205711|NCT04302896|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25205712|NCT04302896|Antiviral Agents|antiviral agents|mesh-ancestor
25205713|NCT04302896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25205714|NCT04302896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25205715|NCT04302896|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25205716|NCT04302896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205717|NCT04302896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205718|NCT04302896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25205719|NCT04302896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25205720|NCT04302896|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25205721|NCT04302896|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25205722|NCT04298099|Ropivacaine|ropivacaine|mesh-list
25205723|NCT04298099|Anesthetics, Local|anesthetics, local|mesh-ancestor
25205724|NCT04298099|Anesthetics|anesthetics|mesh-ancestor
25205725|NCT04298099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25205726|NCT04298099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205727|NCT04298099|Sensory System Agents|sensory system agents|mesh-ancestor
25205728|NCT04298099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25205729|NCT04291820|Anesthetics|anesthetics|mesh-list
25205730|NCT04291820|Sevoflurane|sevoflurane|mesh-list
25205731|NCT04291820|Desflurane|desflurane|mesh-list
25205732|NCT04291820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25205733|NCT04291820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205734|NCT04291820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25205735|NCT04291820|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25205736|NCT04291820|Anesthetics, General|anesthetics, general|mesh-ancestor
25205737|NCT04275778|Hydroxychloroquine|hydroxychloroquine|mesh-list
25205738|NCT04275778|Antimalarials|antimalarials|mesh-ancestor
25205739|NCT04275778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25205740|NCT04275778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25665955|NCT01690143|Melphalan|melphalan|mesh-list
25665956|NCT01690143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25665957|NCT01690143|Alkylating Agents|alkylating agents|mesh-ancestor
25665958|NCT01690143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665959|NCT01690143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665960|NCT01690143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25665961|NCT01690143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25665962|NCT01690143|Immunologic Factors|immunologic factors|mesh-ancestor
25665963|NCT01690143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527346|NCT00616031|Mitosis Modulators|mitosis modulators|mesh-ancestor
24527347|NCT00616031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527367|NCT00616187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24527368|NCT00616187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25211571|NCT04147013|Celecoxib|celecoxib|mesh-list
25205741|NCT04275778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25205742|NCT04275778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208096|NCT03094052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25186161|NCT02822729|Timolol|timolol|mesh-list
25186162|NCT02822729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25186163|NCT02822729|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25186164|NCT02822729|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25186165|NCT02822729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25186166|NCT02822729|Adrenergic Agents|adrenergic agents|mesh-ancestor
25186167|NCT02822729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25186168|NCT02822729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186169|NCT02822729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186170|NCT02822729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25186171|NCT02822729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25186172|NCT02822742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25186173|NCT02822742|Latanoprost|latanoprost|mesh-list
25186174|NCT02822742|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25186175|NCT02822937|Triazolam|triazolam|mesh-list
25186176|NCT02822937|Methylphenidate|methylphenidate|mesh-list
25186177|NCT02822937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25186178|NCT02822937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186179|NCT02822937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25186180|NCT02822937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25186181|NCT02822937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25186182|NCT02822937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412546|NCT00191581|Insulin Lispro|insulin lispro|mesh-list
25186183|NCT02822937|Dopamine Agents|dopamine agents|mesh-ancestor
25186184|NCT02822937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25186185|NCT02822937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25186186|NCT02822937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25186187|NCT02822937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25186188|NCT02822937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25186189|NCT02822937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25186190|NCT02822937|GABA Modulators|gaba modulators|mesh-ancestor
25186191|NCT02822937|GABA Agents|gaba agents|mesh-ancestor
25186192|NCT02822482|Cetuximab|cetuximab|mesh-list
25186193|NCT02822482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25186194|NCT02822482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25186195|NCT02822547|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25186196|NCT02822547|Antiviral Agents|antiviral agents|mesh-ancestor
25186197|NCT02822547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25186198|NCT02822586|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25186199|NCT02822586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25186200|NCT02822586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25186201|NCT02822131|Sevelamer|sevelamer|mesh-list
25186202|NCT02822131|Chelating Agents|chelating agents|mesh-ancestor
25186203|NCT02822131|Sequestering Agents|sequestering agents|mesh-ancestor
25186204|NCT02822131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186205|NCT02821897|Anesthetics|anesthetics|mesh-list
25186206|NCT02821897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25186207|NCT02821897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186208|NCT02821858|Odalasvir|odalasvir|mesh-list
25186209|NCT02821858|Antiviral Agents|antiviral agents|mesh-ancestor
25186210|NCT02821858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25186211|NCT02822144|Lidocaine|lidocaine|mesh-list
25186212|NCT02822144|Remifentanil|remifentanil|mesh-list
25186213|NCT02822144|Propofol|propofol|mesh-list
25186214|NCT02822144|Etomidate|etomidate|mesh-list
25186215|NCT02822144|Succinylcholine|succinylcholine|mesh-list
25186216|NCT02822144|Anesthetics, Local|anesthetics, local|mesh-ancestor
25186217|NCT02822144|Anesthetics|anesthetics|mesh-ancestor
25665964|NCT01690520|Cyclosporine|cyclosporine|mesh-list
25665965|NCT01690520|Mycophenolic Acid|mycophenolic acid|mesh-list
25665966|NCT01690520|Cyclophosphamide|cyclophosphamide|mesh-list
25665967|NCT01690520|Thiotepa|thiotepa|mesh-list
25665968|NCT01690520|Fludarabine|fludarabine|mesh-list
25186218|NCT02822144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25186219|NCT02822144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665969|NCT01690520|Fludarabine phosphate|fludarabine phosphate|mesh-list
25665970|NCT01690520|Cyclosporins|cyclosporins|mesh-list
25665971|NCT01690520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25186220|NCT02822144|Sensory System Agents|sensory system agents|mesh-ancestor
25186221|NCT02822144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25186222|NCT02822144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25186223|NCT02822144|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25186224|NCT02822144|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25186225|NCT02822144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25186226|NCT02822144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186227|NCT02822144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25186228|NCT02822144|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25186229|NCT02822144|Anesthetics, General|anesthetics, general|mesh-ancestor
25186230|NCT02822144|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25186231|NCT02822144|Narcotics|narcotics|mesh-ancestor
25186232|NCT02822144|Analgesics|analgesics|mesh-ancestor
25186233|NCT02822144|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
25186234|NCT02822144|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24822002|NCT02109341|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24822003|NCT02109341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24822004|NCT02109341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822005|NCT02109341|Tubulin Modulators|tubulin modulators|mesh-ancestor
24412706|NCT00191841|Antiviral Agents|antiviral agents|mesh-ancestor
24412707|NCT00191841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24412708|NCT00191841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412709|NCT00191841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25186235|NCT02822144|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25186236|NCT02822196|Lidocaine|lidocaine|mesh-list
25186237|NCT02822196|Bupivacaine|bupivacaine|mesh-list
25186238|NCT02822196|Anesthetics, Local|anesthetics, local|mesh-ancestor
25186239|NCT02822196|Anesthetics|anesthetics|mesh-ancestor
25186240|NCT02822196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25186241|NCT02822196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186242|NCT02822196|Sensory System Agents|sensory system agents|mesh-ancestor
25186243|NCT02822196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25186244|NCT02822196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25186245|NCT02822196|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25186246|NCT02822196|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25186247|NCT02822196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25186248|NCT02822196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186249|NCT02822027|gamma-Globulins|gamma-globulins|mesh-list
25186250|NCT02822027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25186251|NCT02822027|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25186252|NCT02822027|Immunologic Factors|immunologic factors|mesh-ancestor
25186253|NCT02822027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186254|NCT02822157|Gemcitabine|gemcitabine|mesh-list
25186255|NCT02822157|Paclitaxel|paclitaxel|mesh-list
25186256|NCT02822157|Carboplatin|carboplatin|mesh-list
25186257|NCT02822157|Doxorubicin|doxorubicin|mesh-list
25186258|NCT02822157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25186259|NCT02822157|Topotecan|topotecan|mesh-list
25186260|NCT02822157|Olaparib|olaparib|mesh-list
25186261|NCT02822157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25186262|NCT02822157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25186263|NCT02822157|Tubulin Modulators|tubulin modulators|mesh-ancestor
25186264|NCT02822157|Antimitotic Agents|antimitotic agents|mesh-ancestor
25186265|NCT02822157|Mitosis Modulators|mitosis modulators|mesh-ancestor
25186266|NCT02822157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186267|NCT02822157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25186268|NCT02822157|Antimetabolites|antimetabolites|mesh-ancestor
25186269|NCT02822157|Antiviral Agents|antiviral agents|mesh-ancestor
25186270|NCT02822157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25186271|NCT02822157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25186272|NCT02822157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25186273|NCT02822157|Immunologic Factors|immunologic factors|mesh-ancestor
25186274|NCT02822157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186275|NCT02822157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25186276|NCT02822157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25186277|NCT02822157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25186278|NCT02822157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25186279|NCT02822157|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25186280|NCT02821689|Pirfenidone|pirfenidone|mesh-list
25186281|NCT02821689|Analgesics|analgesics|mesh-ancestor
25186282|NCT02821689|Sensory System Agents|sensory system agents|mesh-ancestor
25186283|NCT02821689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25186284|NCT02821689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412710|NCT00191841|Immunologic Factors|immunologic factors|mesh-ancestor
25186285|NCT02821689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25186287|NCT02821689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25186288|NCT02821689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25186289|NCT02821689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25186290|NCT02821520|Verteporfin|verteporfin|mesh-list
25186291|NCT02821520|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25186292|NCT02821520|Dermatologic Agents|dermatologic agents|mesh-ancestor
25186293|NCT02821533|Cisplatin|cisplatin|mesh-list
25186294|NCT02821533|Antineoplastic Agents|antineoplastic agents|mesh-list
25186295|NCT02821546|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25186296|NCT02821468|Acetaminophen|acetaminophen|mesh-list
25186297|NCT02821468|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
25186298|NCT02821468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25186299|NCT02821468|Analgesics|analgesics|mesh-ancestor
25186300|NCT02821468|Sensory System Agents|sensory system agents|mesh-ancestor
25186301|NCT02821468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25186302|NCT02821468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186303|NCT02821468|Antipyretics|antipyretics|mesh-ancestor
25186304|NCT02821468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25186305|NCT02821468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25186306|NCT02821468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186307|NCT02821468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25186308|NCT02821468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25186309|NCT02821468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25186310|NCT02821676|Anesthetics|anesthetics|mesh-list
25186311|NCT02821676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25186312|NCT02821676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186313|NCT02821559|Bevacizumab|bevacizumab|mesh-list
25186314|NCT02821559|Oxaliplatin|oxaliplatin|mesh-list
25186315|NCT02821559|Raltitrexed|raltitrexed|mesh-list
25186316|NCT02821559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25186317|NCT02821559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25186318|NCT02821559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25186319|NCT02821559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25186320|NCT02821559|Growth Substances|growth substances|mesh-ancestor
25186321|NCT02821559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186322|NCT02821559|Growth Inhibitors|growth inhibitors|mesh-ancestor
25186323|NCT02821559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25186324|NCT02821559|Antimetabolites|antimetabolites|mesh-ancestor
25186325|NCT02821559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186326|NCT02821559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25186327|NCT02821559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25186330|NCT02821390|Lubricant Eye Drops|lubricant eye drops|mesh-list
25186331|NCT02821390|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25186332|NCT02821390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25186333|NCT02821390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25186335|NCT02821390|Sensory System Agents|sensory system agents|mesh-ancestor
25186336|NCT02821390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25186337|NCT02821390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186338|NCT02821390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24436966|NCT00272324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25186339|NCT02821390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25186340|NCT02821312|DA-8010|da-8010|mesh-list
25186341|NCT02821312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25186342|NCT02821312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25186343|NCT02821312|Cholinergic Agents|cholinergic agents|mesh-ancestor
25186344|NCT02821312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25186345|NCT02821312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186346|NCT02821312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186347|NCT02821377|Furosemide|furosemide|mesh-list
25186348|NCT02821377|Diuretics|diuretics|mesh-ancestor
25186349|NCT02821377|Natriuretic Agents|natriuretic agents|mesh-ancestor
25186350|NCT02821377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186351|NCT02821377|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25186352|NCT02821377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25186353|NCT02821377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186354|NCT02820987|Meropenem|meropenem|mesh-list
25186355|NCT02820987|Tazobactam|tazobactam|mesh-list
25186356|NCT02820987|Piperacillin|piperacillin|mesh-list
25186357|NCT02820987|Cefepime|cefepime|mesh-list
25186358|NCT02820987|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25186359|NCT02820987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25665972|NCT01690520|Immunologic Factors|immunologic factors|mesh-ancestor
24527817|NCT00618397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24527818|NCT00618397|Anesthetics, General|anesthetics, general|mesh-ancestor
24527820|NCT00618397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24527821|NCT00618397|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24527822|NCT00618397|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24527823|NCT00618397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24527824|NCT00618397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527826|NCT00618423|Analgesics|analgesics|mesh-ancestor
24527834|NCT00618423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24527835|NCT00618423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25211650|NCT03969420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25186360|NCT02820987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25186362|NCT02820987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25186363|NCT02820987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186364|NCT02821156|Nitric Oxide|nitric oxide|mesh-list
25186365|NCT02821156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25186366|NCT02821156|Autonomic Agents|autonomic agents|mesh-ancestor
25186367|NCT02821156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25186368|NCT02821156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186369|NCT02821156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24947384|NCT03929094|Gemcitabine|gemcitabine|mesh-list
25186370|NCT02821156|Respiratory System Agents|respiratory system agents|mesh-ancestor
25186371|NCT02821156|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25186372|NCT02821156|Antioxidants|antioxidants|mesh-ancestor
24413064|NCT00193076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25186373|NCT02821156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186374|NCT02821156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25186375|NCT02821156|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25186376|NCT02821156|Vasodilator Agents|vasodilator agents|mesh-ancestor
25186377|NCT02821156|Gasotransmitters|gasotransmitters|mesh-ancestor
25186378|NCT02821156|Protective Agents|protective agents|mesh-ancestor
25186379|NCT02821169|Ropivacaine|ropivacaine|mesh-list
25186380|NCT02821169|Anesthetics, Local|anesthetics, local|mesh-ancestor
25186381|NCT02821169|Anesthetics|anesthetics|mesh-ancestor
25186382|NCT02821169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25186383|NCT02821169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186384|NCT02821169|Sensory System Agents|sensory system agents|mesh-ancestor
25186385|NCT02821169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25205743|NCT04275778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205744|NCT04275778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25205746|NCT04259658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25205747|NCT04259658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205750|NCT04246541|Acetaminophen|acetaminophen|mesh-list
25205751|NCT04246541|Ketorolac|ketorolac|mesh-list
25205752|NCT04246541|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25205753|NCT04246541|Oxycodone|oxycodone|mesh-list
25205754|NCT04246541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25205755|NCT04246541|Analgesics|analgesics|mesh-ancestor
25205756|NCT04246541|Sensory System Agents|sensory system agents|mesh-ancestor
24413394|NCT00193700|Hormones|hormones|mesh-ancestor
24413395|NCT00193700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24413396|NCT00193700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413397|NCT00193726|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24413398|NCT00193726|Estradiol|estradiol|mesh-list
25860421|NCT00083577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24413518|NCT00194064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413520|NCT00194064|Serotonin Agents|serotonin agents|mesh-ancestor
25186386|NCT02820935|Itraconazole|itraconazole|mesh-list
25186387|NCT02820935|Rifampin|rifampin|mesh-list
25186388|NCT02820935|Antifungal Agents|antifungal agents|mesh-ancestor
25665973|NCT01690520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665974|NCT01690520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25665975|NCT01690520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25665976|NCT01690520|Alkylating Agents|alkylating agents|mesh-ancestor
25665977|NCT01690520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25665978|NCT01690520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25665979|NCT01690520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25665980|NCT01690520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25665981|NCT01690520|Antimetabolites|antimetabolites|mesh-ancestor
25665982|NCT01690520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25665983|NCT01690520|Antifungal Agents|antifungal agents|mesh-ancestor
25665984|NCT01690520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25860422|NCT00083577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25860423|NCT00083577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25860424|NCT00083577|Growth Substances|growth substances|mesh-ancestor
24408800|NCT00179699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24408848|NCT00179751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408849|NCT00179751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408850|NCT00179751|Antiviral Agents|antiviral agents|mesh-ancestor
24408851|NCT00179751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24408852|NCT00179751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25186389|NCT02820935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25186390|NCT02820935|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25186391|NCT02820935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25186392|NCT02820935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590241|NCT00911287|Sensory System Agents|sensory system agents|mesh-ancestor
25186393|NCT02820935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186394|NCT02820935|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25186395|NCT02820935|Hormone Antagonists|hormone antagonists|mesh-ancestor
25186396|NCT02820935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25186397|NCT02820935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186398|NCT02820935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25186399|NCT02820935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25186400|NCT02820935|Antitubercular Agents|antitubercular agents|mesh-ancestor
25186401|NCT02820935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25186402|NCT02820935|Leprostatic Agents|leprostatic agents|mesh-ancestor
25186403|NCT02820935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25186404|NCT02820935|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25186405|NCT02820935|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25186406|NCT02820935|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25186407|NCT02820935|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25186408|NCT02820935|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25186409|NCT02820935|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25186410|NCT02821052|Insulin|insulin|mesh-list
25186411|NCT02821052|Insulin Aspart|insulin aspart|mesh-list
25186412|NCT02821052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25186413|NCT02821052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186414|NCT02820948|Vitamins|vitamins|mesh-list
25186415|NCT02820948|Vitamin E|vitamin e|mesh-list
25186416|NCT02820948|Tocopherols|tocopherols|mesh-list
25186417|NCT02820948|Tocotrienols|tocotrienols|mesh-list
25186418|NCT02820948|alpha-Tocopherol|alpha-tocopherol|mesh-list
25186419|NCT02820948|Micronutrients|micronutrients|mesh-ancestor
25186420|NCT02820948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186421|NCT02820948|Antioxidants|antioxidants|mesh-ancestor
25186422|NCT02820948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186423|NCT02820948|Protective Agents|protective agents|mesh-ancestor
25186424|NCT02820922|Anesthetics|anesthetics|mesh-list
25186425|NCT02820922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25186426|NCT02820922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186427|NCT02821247|Aflibercept|aflibercept|mesh-list
25186428|NCT02821247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25186429|NCT02821247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25186430|NCT02821247|Growth Substances|growth substances|mesh-ancestor
25186431|NCT02821247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186432|NCT02821247|Growth Inhibitors|growth inhibitors|mesh-ancestor
25186433|NCT02821247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25186434|NCT02820883|Vaccines|vaccines|mesh-list
25186435|NCT02820883|Immunologic Factors|immunologic factors|mesh-ancestor
25186436|NCT02820883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186437|NCT02820688|Bupivacaine|bupivacaine|mesh-list
25186438|NCT02820688|Prilocaine|prilocaine|mesh-list
25186439|NCT02820688|Anesthetics, Local|anesthetics, local|mesh-ancestor
25186440|NCT02820688|Anesthetics|anesthetics|mesh-ancestor
25186441|NCT02820688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25186442|NCT02820688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186443|NCT02820688|Sensory System Agents|sensory system agents|mesh-ancestor
25427185|NCT01920737|Protective Agents|protective agents|mesh-ancestor
25665985|NCT01690520|Dermatologic Agents|dermatologic agents|mesh-ancestor
25665986|NCT01690520|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25665987|NCT01690520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25665988|NCT01690520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25665989|NCT01690520|Antitubercular Agents|antitubercular agents|mesh-ancestor
25665990|NCT01690520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25665991|NCT01690546|Naltrexone|naltrexone|mesh-list
25665992|NCT01690546|Buprenorphine|buprenorphine|mesh-list
25665993|NCT01690546|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25860425|NCT00083577|Growth Inhibitors|growth inhibitors|mesh-ancestor
25186444|NCT02820688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25186445|NCT02820610|Magnesium Sulfate|magnesium sulfate|mesh-list
25186446|NCT02820610|Dexmedetomidine|dexmedetomidine|mesh-list
25186447|NCT02820610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25186448|NCT02820610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25186449|NCT02820610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186450|NCT02820610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25186451|NCT02820610|Analgesics|analgesics|mesh-ancestor
25186452|NCT02820610|Sensory System Agents|sensory system agents|mesh-ancestor
25186453|NCT02820610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25186454|NCT02820610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25186455|NCT02820610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25186456|NCT02820610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25186457|NCT02820610|Adrenergic Agents|adrenergic agents|mesh-ancestor
25186458|NCT02820610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25186459|NCT02820610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186460|NCT02820610|Anesthetics|anesthetics|mesh-ancestor
25186461|NCT02820610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25186462|NCT02820610|Anticonvulsants|anticonvulsants|mesh-ancestor
25186463|NCT02820610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25186464|NCT02820610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25186465|NCT02820610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25186466|NCT02820610|Tocolytic Agents|tocolytic agents|mesh-ancestor
25186467|NCT02820610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25186468|NCT02820493|Vedolizumab|vedolizumab|mesh-list
25186469|NCT02820493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25186470|NCT02820441|Zopiclone|zopiclone|mesh-list
25186471|NCT02820441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25186472|NCT02820441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25186473|NCT02820441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186474|NCT02820558|Substance P|substance p|mesh-list
25186475|NCT02820558|Neurokinin A|neurokinin a|mesh-list
25186476|NCT02820558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25186477|NCT02820558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186478|NCT02820558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186479|NCT02820259|Tacrolimus|tacrolimus|mesh-list
25186480|NCT02820259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25186481|NCT02820259|Immunologic Factors|immunologic factors|mesh-ancestor
25186482|NCT02820259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186483|NCT02820259|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25186484|NCT02820259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25186485|NCT02820259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186486|NCT02820077|Hemostatics|hemostatics|mesh-list
25186487|NCT02820077|Coagulants|coagulants|mesh-ancestor
25186488|NCT02819999|Etoposide|etoposide|mesh-list
25186489|NCT02819999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25186490|NCT02819999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25186491|NCT02819999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25186492|NCT02819999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25186493|NCT02819999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25186494|NCT02819999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186495|NCT02820025|Doxapram|doxapram|mesh-list
25186496|NCT02820025|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25186497|NCT02820025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186498|NCT02820025|Respiratory System Agents|respiratory system agents|mesh-ancestor
25186499|NCT02820051|Lidocaine|lidocaine|mesh-list
25186500|NCT02820051|Midazolam|midazolam|mesh-list
25186501|NCT02820051|Nalbuphine|nalbuphine|mesh-list
25186502|NCT02820051|Propofol|propofol|mesh-list
25186503|NCT02820051|Anesthetics, Local|anesthetics, local|mesh-ancestor
25186504|NCT02820051|Anesthetics|anesthetics|mesh-ancestor
25186505|NCT02820051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25186506|NCT02820051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186507|NCT02820051|Sensory System Agents|sensory system agents|mesh-ancestor
25186508|NCT02820051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25186509|NCT02820051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25186510|NCT02820051|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25186511|NCT02820051|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25186512|NCT02820051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25186513|NCT02820051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186514|NCT02820051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25186515|NCT02820051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25186516|NCT02820051|Anesthetics, General|anesthetics, general|mesh-ancestor
25665994|NCT01690546|Naloxone|naloxone|mesh-list
25860426|NCT00083577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860427|NCT00083590|Huperzine A|huperzine a|mesh-list
24820603|NCT02100423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820604|NCT02100423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820605|NCT02100462|Aspirin|aspirin|mesh-list
24820606|NCT02100462|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24820607|NCT02100462|Chlorthalidone|chlorthalidone|mesh-list
24820608|NCT02100462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24820609|NCT02100462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25186517|NCT02820051|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25186518|NCT02820051|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25186519|NCT02820051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25186520|NCT02820051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24822117|NCT02109861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25186521|NCT02820051|GABA Modulators|gaba modulators|mesh-ancestor
25186522|NCT02820051|GABA Agents|gaba agents|mesh-ancestor
25186523|NCT02820051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25186524|NCT02820051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25186525|NCT02820051|Narcotics|narcotics|mesh-ancestor
25186526|NCT02820051|Analgesics|analgesics|mesh-ancestor
25186527|NCT02819921|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24438530|NCT00276081|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24772738|NCT01835353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25186528|NCT02819921|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25186529|NCT02819921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25186530|NCT02819921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25186531|NCT02819921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186532|NCT02819921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25186533|NCT02819921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186534|NCT02819921|Antidepressive Agents|antidepressive agents|mesh-ancestor
25186535|NCT02819921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25186536|NCT02819856|Ebselen|ebselen|mesh-list
25186537|NCT02819856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25186538|NCT02819856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25186539|NCT02819856|Analgesics|analgesics|mesh-ancestor
25186540|NCT02819856|Sensory System Agents|sensory system agents|mesh-ancestor
25186541|NCT02819856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25186542|NCT02819856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186543|NCT02819856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25186544|NCT02819856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25186545|NCT02819856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25186546|NCT02819856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25186547|NCT02819856|Antioxidants|antioxidants|mesh-ancestor
25186557|NCT02819661|Narcotics|narcotics|mesh-ancestor
25186558|NCT02819661|Analgesics|analgesics|mesh-ancestor
25186559|NCT02819661|Sensory System Agents|sensory system agents|mesh-ancestor
25186560|NCT02819661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25186561|NCT02819869|Metformin|metformin|mesh-list
25186562|NCT02819869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25186563|NCT02819869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186564|NCT02819648|Prednisolone|prednisolone|mesh-list
25186565|NCT02819648|Glucocorticoids|glucocorticoids|mesh-list
25186566|NCT02819648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25186567|NCT02819648|Hormones|hormones|mesh-ancestor
24822168|NCT02110134|Protective Agents|protective agents|mesh-ancestor
25186568|NCT02819648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25186569|NCT02819648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186570|NCT02819648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25186571|NCT02819648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25186572|NCT02819414|Acetaminophen|acetaminophen|mesh-list
25186573|NCT02819414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25186574|NCT02819414|Analgesics|analgesics|mesh-ancestor
25186575|NCT02819414|Sensory System Agents|sensory system agents|mesh-ancestor
25665995|NCT01690546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25665996|NCT01690546|Narcotics|narcotics|mesh-ancestor
25665997|NCT01690546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25665998|NCT01690546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25665999|NCT01690546|Analgesics|analgesics|mesh-ancestor
25666000|NCT01690546|Sensory System Agents|sensory system agents|mesh-ancestor
25666001|NCT01690546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25666002|NCT01690546|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25666003|NCT01690546|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25186576|NCT02819414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25186577|NCT02819414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186578|NCT02819414|Antipyretics|antipyretics|mesh-ancestor
25186579|NCT02819544|Ropivacaine|ropivacaine|mesh-list
25211716|NCT03867344|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25211717|NCT03867344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666004|NCT01690663|Dexamethasone|dexamethasone|mesh-list
25666005|NCT01690663|Bupivacaine|bupivacaine|mesh-list
24399481|NCT00147875|Glucocorticoids|glucocorticoids|mesh-ancestor
25045579|NCT00944294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24527998|NCT00619034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527999|NCT00619034|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24528000|NCT00619034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24528001|NCT00619034|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24528004|NCT00619203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24528005|NCT00619203|Analgesics|analgesics|mesh-ancestor
24528006|NCT00619203|Sensory System Agents|sensory system agents|mesh-ancestor
24528007|NCT00619203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24528008|NCT00619203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528093|NCT00619697|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24528127|NCT00619944|Lopinavir|lopinavir|mesh-list
24528128|NCT00619944|Lumefantrine|lumefantrine|mesh-list
25186580|NCT02819544|Anesthetics, Local|anesthetics, local|mesh-ancestor
25186581|NCT02819544|Anesthetics|anesthetics|mesh-ancestor
25186582|NCT02819544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25186583|NCT02819544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186584|NCT02819544|Sensory System Agents|sensory system agents|mesh-ancestor
25186585|NCT02819544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25186586|NCT02819570|Ampicillin|ampicillin|mesh-list
25186587|NCT02819570|Cefuroxime|cefuroxime|mesh-list
25186588|NCT02819570|Cefuroxime axetil|cefuroxime axetil|mesh-list
25186589|NCT02819570|Roxithromycin|roxithromycin|mesh-list
25186590|NCT02819570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25186591|NCT02819570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25186592|NCT02819375|Ketamine|ketamine|mesh-list
25186593|NCT02819375|Remifentanil|remifentanil|mesh-list
25186594|NCT02819375|Propofol|propofol|mesh-list
25186595|NCT02819375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25186596|NCT02819375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25186597|NCT02819375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186598|NCT02819375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25186599|NCT02819375|Anesthetics, General|anesthetics, general|mesh-ancestor
25186600|NCT02819375|Anesthetics|anesthetics|mesh-ancestor
25186601|NCT02819375|Analgesics|analgesics|mesh-ancestor
25186602|NCT02819375|Sensory System Agents|sensory system agents|mesh-ancestor
25186603|NCT02819375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25186604|NCT02819375|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25186605|NCT02819375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25186606|NCT02819375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25186607|NCT02819375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25186608|NCT02819375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186609|NCT02819375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25186610|NCT02819375|Narcotics|narcotics|mesh-ancestor
25186611|NCT02819388|Contraceptive Agents|contraceptive agents|mesh-list
25186612|NCT02819388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25186613|NCT02819388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205782|NCT04230681|Fentanyl|fentanyl|mesh-list
25205796|NCT04225767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25205797|NCT04225767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205812|NCT04181996|Gout Suppressants|gout suppressants|mesh-ancestor
25205813|NCT04181996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25205814|NCT04181996|Tubulin Modulators|tubulin modulators|mesh-ancestor
25205815|NCT04181996|Antimitotic Agents|antimitotic agents|mesh-ancestor
25205816|NCT04181996|Mitosis Modulators|mitosis modulators|mesh-ancestor
25666006|NCT01690663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25666007|NCT01690663|Antiemetics|antiemetics|mesh-ancestor
25666008|NCT01690663|Autonomic Agents|autonomic agents|mesh-ancestor
25666009|NCT01690663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25666010|NCT01690663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666011|NCT01690663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25666012|NCT01690663|Glucocorticoids|glucocorticoids|mesh-ancestor
25666013|NCT01690663|Hormones|hormones|mesh-ancestor
25666014|NCT01690663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25666015|NCT01690663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25666016|NCT01690663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25666017|NCT01690663|Anesthetics, Local|anesthetics, local|mesh-ancestor
25666018|NCT01690663|Anesthetics|anesthetics|mesh-ancestor
25666019|NCT01690663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25666020|NCT01690663|Sensory System Agents|sensory system agents|mesh-ancestor
25666021|NCT01690988|Ketamine|ketamine|mesh-list
24528201|NCT00620347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24528202|NCT00620347|Growth Substances|growth substances|mesh-ancestor
24528203|NCT00620347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860428|NCT00083590|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25860429|NCT00083590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205817|NCT04181996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205818|NCT04181996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25205819|NCT04180943|Bupivacaine|bupivacaine|mesh-list
25205820|NCT04180943|Anesthetics, Local|anesthetics, local|mesh-ancestor
25205821|NCT04180943|Anesthetics|anesthetics|mesh-ancestor
25205822|NCT04180943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25205823|NCT04180943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205824|NCT04180943|Sensory System Agents|sensory system agents|mesh-ancestor
25205825|NCT04180943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25205827|NCT04175626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25205828|NCT04175626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25205829|NCT04175626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25205830|NCT04175626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25205831|NCT04175626|Antifungal Agents|antifungal agents|mesh-ancestor
25205832|NCT04175626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24414011|NCT00195793|Antimetabolites|antimetabolites|mesh-ancestor
24414012|NCT00195793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414013|NCT00195793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24414014|NCT00195793|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24822167|NCT02110134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822169|NCT02110134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822170|NCT02110134|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24822172|NCT02110303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24822173|NCT02110303|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24822174|NCT02110303|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24822175|NCT02110303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24822176|NCT02110303|Purinergic Agents|purinergic agents|mesh-ancestor
24822177|NCT02110303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24822178|NCT02110303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822179|NCT02110303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822180|NCT02110316|Voriconazole|voriconazole|mesh-list
24822181|NCT02110316|Antifungal Agents|antifungal agents|mesh-ancestor
24822182|NCT02110316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24414015|NCT00195793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414016|NCT00195806|Valproic Acid|valproic acid|mesh-list
24414017|NCT00195806|Anticonvulsants|anticonvulsants|mesh-ancestor
24414018|NCT00195806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414019|NCT00195806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414020|NCT00195806|GABA Agents|gaba agents|mesh-ancestor
24414021|NCT00195806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24414022|NCT00195806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414023|NCT00195806|Antimanic Agents|antimanic agents|mesh-ancestor
24543280|NCT00682955|Dermatologic Agents|dermatologic agents|mesh-ancestor
24414092|NCT00195923|Ampicillin|ampicillin|mesh-list
25186614|NCT02819115|Vaccines|vaccines|mesh-list
25186615|NCT02819115|Immunologic Factors|immunologic factors|mesh-ancestor
25186616|NCT02819115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186617|NCT02819102|Berotralstat|berotralstat|mesh-list
25186618|NCT02819102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25186619|NCT02819102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186620|NCT02818985|Dexamethasone|dexamethasone|mesh-list
25186621|NCT02818985|Dexmedetomidine|dexmedetomidine|mesh-list
25186622|NCT02818985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25186623|NCT02818985|Antiemetics|antiemetics|mesh-ancestor
25186624|NCT02818985|Autonomic Agents|autonomic agents|mesh-ancestor
25186625|NCT02818985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25186626|NCT02818985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186627|NCT02818985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25186628|NCT02818985|Glucocorticoids|glucocorticoids|mesh-ancestor
25186629|NCT02818985|Hormones|hormones|mesh-ancestor
25186630|NCT02818985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25186631|NCT02818985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25186632|NCT02818985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25666022|NCT01690988|Analgesics|analgesics|mesh-ancestor
25666023|NCT01690988|Sensory System Agents|sensory system agents|mesh-ancestor
25666024|NCT01690988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25666025|NCT01690988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409537|NCT00182429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409545|NCT00182442|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25186633|NCT02818985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25186634|NCT02818985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25186635|NCT02818985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25186636|NCT02818985|Analgesics|analgesics|mesh-ancestor
25186637|NCT02818985|Sensory System Agents|sensory system agents|mesh-ancestor
25186638|NCT02818985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25186639|NCT02818985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25186640|NCT02818985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25186641|NCT02818985|Adrenergic Agents|adrenergic agents|mesh-ancestor
25186642|NCT02818985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25186643|NCT02818985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186644|NCT02819180|Vaccines|vaccines|mesh-list
25186645|NCT02819180|Immunologic Factors|immunologic factors|mesh-ancestor
25186646|NCT02819180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186647|NCT02819089|Dexmedetomidine|dexmedetomidine|mesh-list
25186648|NCT02819089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25186649|NCT02819089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25186650|NCT02819089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186651|NCT02819089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25186652|NCT02819089|Analgesics|analgesics|mesh-ancestor
25186653|NCT02819089|Sensory System Agents|sensory system agents|mesh-ancestor
25186654|NCT02819089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25186655|NCT02819089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25186656|NCT02819089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25186657|NCT02819089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25186658|NCT02819089|Adrenergic Agents|adrenergic agents|mesh-ancestor
25186659|NCT02819089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25186660|NCT02819089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186661|NCT02818881|Methamphetamine|methamphetamine|mesh-list
25186662|NCT02818881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25186663|NCT02818881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186664|NCT02818881|Sympathomimetics|sympathomimetics|mesh-ancestor
25186665|NCT02818881|Autonomic Agents|autonomic agents|mesh-ancestor
25186666|NCT02818881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25186667|NCT02818881|Dopamine Agents|dopamine agents|mesh-ancestor
25186668|NCT02818881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25186669|NCT02818881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186670|NCT02818881|Adrenergic Agents|adrenergic agents|mesh-ancestor
25186671|NCT02818881|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25186672|NCT02818881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25186673|NCT02818881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25186674|NCT02818881|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25186675|NCT02818725|Cisplatin|cisplatin|mesh-list
25186676|NCT02818725|Doxorubicin|doxorubicin|mesh-list
25186677|NCT02818725|Methotrexate|methotrexate|mesh-list
25186678|NCT02818725|Panitumumab|panitumumab|mesh-list
25186679|NCT02818725|Vinblastine|vinblastine|mesh-list
25186680|NCT02818725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25186681|NCT02818725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25186903|NCT02817503|Amlodipine|amlodipine|mesh-list
25186682|NCT02818725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25186683|NCT02818725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25186684|NCT02818725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25186685|NCT02818725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186686|NCT02818725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25186687|NCT02818725|Abortifacient Agents|abortifacient agents|mesh-ancestor
25186688|NCT02818725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24729274|NCT01620944|Lamivudine|lamivudine|mesh-list
25186689|NCT02818725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186690|NCT02818725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25186691|NCT02818725|Antimetabolites|antimetabolites|mesh-ancestor
25186692|NCT02818725|Dermatologic Agents|dermatologic agents|mesh-ancestor
25186693|NCT02818725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25186694|NCT02818725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25186695|NCT02818725|Immunologic Factors|immunologic factors|mesh-ancestor
25186696|NCT02818725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25186697|NCT02818725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25186698|NCT02818725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25186699|NCT02818725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25186700|NCT02818725|Tubulin Modulators|tubulin modulators|mesh-ancestor
25666026|NCT01690988|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25666027|NCT01690988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25860430|NCT00083590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860431|NCT00083590|Cholinergic Agents|cholinergic agents|mesh-ancestor
25860432|NCT00083590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25860433|NCT00083590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860434|NCT00083590|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25186701|NCT02818725|Antimitotic Agents|antimitotic agents|mesh-ancestor
25186702|NCT02818725|Mitosis Modulators|mitosis modulators|mesh-ancestor
25186704|NCT02818803|Miconazole|miconazole|mesh-list
25186705|NCT02818803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25186706|NCT02818803|Antifungal Agents|antifungal agents|mesh-ancestor
25186707|NCT02818803|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25186708|NCT02818803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25186709|NCT02818803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25186710|NCT02818803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186711|NCT02818803|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25186712|NCT02818803|Hormone Antagonists|hormone antagonists|mesh-ancestor
25186713|NCT02818803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25186714|NCT02818803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439428|NCT00278460|Antimetabolites|antimetabolites|mesh-ancestor
25186715|NCT02818803|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25186716|NCT02818803|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25186717|NCT02818816|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25186718|NCT02818816|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25186719|NCT02818816|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25186720|NCT02818816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25186721|NCT02818816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25186722|NCT02818816|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25186723|NCT02818816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25186724|NCT02818816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25186725|NCT02818816|Adrenergic Agents|adrenergic agents|mesh-ancestor
25186726|NCT02818816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25186727|NCT02818816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186728|NCT02818816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186730|NCT02818816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25186731|NCT02818660|Cosyntropin|cosyntropin|mesh-list
25186732|NCT02818660|Hormones|hormones|mesh-ancestor
25186733|NCT02818660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25186734|NCT02818660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186735|NCT02818751|Citalopram|citalopram|mesh-list
25186736|NCT02818751|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25186737|NCT02818751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25186738|NCT02818751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25186739|NCT02818751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186740|NCT02818751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25186741|NCT02818751|Serotonin Agents|serotonin agents|mesh-ancestor
25186742|NCT02818751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186743|NCT02818751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25186744|NCT02818751|Antidepressive Agents|antidepressive agents|mesh-ancestor
25186745|NCT02818751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25186746|NCT02818621|Dexmedetomidine|dexmedetomidine|mesh-list
25186747|NCT02818621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25186748|NCT02818621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25186749|NCT02818621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186750|NCT02818621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25186751|NCT02818621|Analgesics|analgesics|mesh-ancestor
25186752|NCT02818621|Sensory System Agents|sensory system agents|mesh-ancestor
25186753|NCT02818621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25186754|NCT02818621|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25186755|NCT02818621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25186756|NCT02818621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25186757|NCT02818621|Adrenergic Agents|adrenergic agents|mesh-ancestor
25186758|NCT02818621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25186759|NCT02818621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186760|NCT02818556|Hyaluronic Acid|hyaluronic acid|mesh-list
24422262|NCT00221871|Ketamine|ketamine|mesh-list
25186761|NCT02818556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25186762|NCT02818556|Immunologic Factors|immunologic factors|mesh-ancestor
25666028|NCT01690988|Anesthetics, General|anesthetics, general|mesh-ancestor
25666029|NCT01690988|Anesthetics|anesthetics|mesh-ancestor
25666030|NCT01690988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25666031|NCT01690988|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25186763|NCT02818556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186764|NCT02818556|Viscosupplements|viscosupplements|mesh-ancestor
25186765|NCT02818556|Protective Agents|protective agents|mesh-ancestor
25186766|NCT02818491|Dexamethasone|dexamethasone|mesh-list
25186767|NCT02818491|Dexamethasone acetate|dexamethasone acetate|mesh-list
25186768|NCT02818491|Ropivacaine|ropivacaine|mesh-list
25186769|NCT02818491|BB 1101|bb 1101|mesh-list
25186770|NCT02818491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25186771|NCT02818491|Antiemetics|antiemetics|mesh-ancestor
25186772|NCT02818491|Autonomic Agents|autonomic agents|mesh-ancestor
25186773|NCT02818491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25186774|NCT02818491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186775|NCT02818491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25186776|NCT02818491|Glucocorticoids|glucocorticoids|mesh-ancestor
25186777|NCT02818491|Hormones|hormones|mesh-ancestor
25186778|NCT02818491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25186779|NCT02818491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25186780|NCT02818491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25186781|NCT02818491|Protease Inhibitors|protease inhibitors|mesh-ancestor
25186782|NCT02818491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25186783|NCT02818491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186784|NCT02818491|Anesthetics, Local|anesthetics, local|mesh-ancestor
25186785|NCT02818491|Anesthetics|anesthetics|mesh-ancestor
25186786|NCT02818491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25186787|NCT02818491|Sensory System Agents|sensory system agents|mesh-ancestor
25186788|NCT02818309|Lesogaberan|lesogaberan|mesh-list
25186789|NCT02818309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25186790|NCT02818309|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25186791|NCT02818309|GABA Agonists|gaba agonists|mesh-ancestor
25186792|NCT02818309|GABA Agents|gaba agents|mesh-ancestor
25186793|NCT02818309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25186794|NCT02818309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186795|NCT02818309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186796|NCT02818270|Acetylcysteine|acetylcysteine|mesh-list
25186797|NCT02818270|Albuterol|albuterol|mesh-list
25186798|NCT02818270|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25186799|NCT02818270|Antiviral Agents|antiviral agents|mesh-ancestor
25186800|NCT02818270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25186801|NCT02818270|Expectorants|expectorants|mesh-ancestor
25186802|NCT02818270|Respiratory System Agents|respiratory system agents|mesh-ancestor
25186803|NCT02818270|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25186804|NCT02818270|Antioxidants|antioxidants|mesh-ancestor
25186805|NCT02818270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186806|NCT02818270|Protective Agents|protective agents|mesh-ancestor
25186807|NCT02818270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186808|NCT02818270|Antidotes|antidotes|mesh-ancestor
25186809|NCT02818270|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25186810|NCT02818270|Autonomic Agents|autonomic agents|mesh-ancestor
25186811|NCT02818270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25186812|NCT02818270|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25186813|NCT02818270|Tocolytic Agents|tocolytic agents|mesh-ancestor
25186814|NCT02818270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25186815|NCT02818270|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25186816|NCT02818270|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25186817|NCT02818270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25186818|NCT02818270|Adrenergic Agents|adrenergic agents|mesh-ancestor
25186819|NCT02818270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25186820|NCT02818387|Midazolam|midazolam|mesh-list
25186821|NCT02818387|Remifentanil|remifentanil|mesh-list
25186822|NCT02818387|Propofol|propofol|mesh-list
25186823|NCT02818387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25186824|NCT02818387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25186825|NCT02818387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186826|NCT02818387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25186827|NCT02818387|Anesthetics, General|anesthetics, general|mesh-ancestor
25186828|NCT02818387|Anesthetics|anesthetics|mesh-ancestor
25186829|NCT02818387|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25186830|NCT02818387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25186831|NCT02818387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25186832|NCT02818387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25186833|NCT02818387|GABA Modulators|gaba modulators|mesh-ancestor
25186834|NCT02818387|GABA Agents|gaba agents|mesh-ancestor
25186835|NCT02818387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25186836|NCT02818387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186837|NCT02818387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25186838|NCT02818387|Narcotics|narcotics|mesh-ancestor
25186839|NCT02818387|Analgesics|analgesics|mesh-ancestor
25186840|NCT02818387|Sensory System Agents|sensory system agents|mesh-ancestor
25186841|NCT02818387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25186842|NCT02818348|Darunavir|darunavir|mesh-list
25186843|NCT02818348|Cobicistat|cobicistat|mesh-list
25186844|NCT02818348|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
25186845|NCT02818348|Etravirine|etravirine|mesh-list
25186846|NCT02818348|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25186847|NCT02818348|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25186848|NCT02818348|Protease Inhibitors|protease inhibitors|mesh-ancestor
25186849|NCT02818348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25186850|NCT02818348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186851|NCT02818348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25186852|NCT02818348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25186853|NCT02818348|Antiviral Agents|antiviral agents|mesh-ancestor
25186854|NCT02818348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25186855|NCT02818348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25186856|NCT02818348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25186857|NCT02818348|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25186858|NCT02818348|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25186859|NCT02818140|Ropivacaine|ropivacaine|mesh-list
25186860|NCT02818140|Anesthetics, Local|anesthetics, local|mesh-ancestor
25186861|NCT02818140|Anesthetics|anesthetics|mesh-ancestor
25186862|NCT02818140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25186863|NCT02818140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186864|NCT02818140|Sensory System Agents|sensory system agents|mesh-ancestor
25186865|NCT02818140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25186866|NCT02817932|Ranolazine|ranolazine|mesh-list
25186867|NCT02817932|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25186868|NCT02817932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25186869|NCT02817932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186870|NCT02818049|Dimercaprol|dimercaprol|mesh-list
25186871|NCT02818049|Chelating Agents|chelating agents|mesh-ancestor
25186872|NCT02818049|Sequestering Agents|sequestering agents|mesh-ancestor
25186873|NCT02818049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186874|NCT02817750|Zolpidem|zolpidem|mesh-list
25186875|NCT02817750|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24414172|NCT00196547|Hormone Antagonists|hormone antagonists|mesh-ancestor
25186876|NCT02817750|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25860435|NCT00083590|Protective Agents|protective agents|mesh-ancestor
25186877|NCT02817750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25186878|NCT02817750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186879|NCT02817750|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25186880|NCT02817750|GABA Agonists|gaba agonists|mesh-ancestor
25186881|NCT02817750|GABA Agents|gaba agents|mesh-ancestor
25186882|NCT02817750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25186883|NCT02817750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186890|NCT02817477|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25186891|NCT02817477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25186892|NCT02817477|Anesthetics, General|anesthetics, general|mesh-ancestor
25186893|NCT02817477|Anesthetics|anesthetics|mesh-ancestor
25186894|NCT02817477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25186895|NCT02817477|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25186896|NCT02817477|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25186897|NCT02817477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25186898|NCT02817477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186899|NCT02817477|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25186900|NCT02817477|Narcotics|narcotics|mesh-ancestor
25186901|NCT02817503|Folic Acid|folic acid|mesh-list
25186902|NCT02817503|Vitamin B Complex|vitamin b complex|mesh-list
25186905|NCT02817503|Enalapril|enalapril|mesh-list
25186906|NCT02817503|Enalaprilat|enalaprilat|mesh-list
25186907|NCT02817503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25186908|NCT02817503|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25186909|NCT02817503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25186910|NCT02817503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186911|NCT02817503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25186912|NCT02817503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186913|NCT02817503|Vasodilator Agents|vasodilator agents|mesh-ancestor
25186914|NCT02817503|Diuretics|diuretics|mesh-ancestor
25186915|NCT02817503|Natriuretic Agents|natriuretic agents|mesh-ancestor
25186916|NCT02817503|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25186917|NCT02817503|Hematinics|hematinics|mesh-ancestor
25186918|NCT02817503|Vitamins|vitamins|mesh-ancestor
25186919|NCT02817503|Micronutrients|micronutrients|mesh-ancestor
25186920|NCT02817503|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25186921|NCT02817503|Protease Inhibitors|protease inhibitors|mesh-ancestor
24542215|NCT00677664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25186922|NCT02817503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205833|NCT04175626|Immunologic Factors|immunologic factors|mesh-ancestor
25205834|NCT04175626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205835|NCT04170946|Talazoparib|talazoparib|mesh-list
25205836|NCT04170946|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25205837|NCT04170946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205838|NCT04170946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205839|NCT04170946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25205840|NCT04146571|Ensartinib|ensartinib|mesh-list
25205841|NCT04146571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25205842|NCT04146571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25205843|NCT04146571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205844|NCT04146571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205845|NCT04126473|Ivacaftor|ivacaftor|mesh-list
25205846|NCT04126473|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25205847|NCT04126473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25205848|NCT04126473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205849|NCT04120870|Ketamine|ketamine|mesh-list
25205850|NCT04120870|Etomidate|etomidate|mesh-list
25205851|NCT04120870|Analgesics|analgesics|mesh-ancestor
25205852|NCT04120870|Sensory System Agents|sensory system agents|mesh-ancestor
25205853|NCT04120870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25205854|NCT04120870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205855|NCT04120870|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25205856|NCT04120870|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25205857|NCT04120870|Anesthetics, General|anesthetics, general|mesh-ancestor
25205858|NCT04120870|Anesthetics|anesthetics|mesh-ancestor
25205859|NCT04120870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24414453|NCT00197613|Antimetabolites|antimetabolites|mesh-ancestor
24414454|NCT00197613|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24414455|NCT00197613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24414456|NCT00197613|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24414457|NCT00197613|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24414458|NCT00197613|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24414459|NCT00197613|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24414460|NCT00197639|Ritonavir|ritonavir|mesh-list
24414461|NCT00197639|Indinavir|indinavir|mesh-list
25186923|NCT02817321|Morphine|morphine|mesh-list
25186924|NCT02817321|Ropivacaine|ropivacaine|mesh-list
25186925|NCT02817321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25186926|NCT02817321|Narcotics|narcotics|mesh-ancestor
25186927|NCT02817321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25186928|NCT02817321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186929|NCT02817321|Analgesics|analgesics|mesh-ancestor
25186930|NCT02817321|Sensory System Agents|sensory system agents|mesh-ancestor
25186931|NCT02817321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25186932|NCT02817321|Anesthetics, Local|anesthetics, local|mesh-ancestor
25186933|NCT02817321|Anesthetics|anesthetics|mesh-ancestor
25186934|NCT02817360|Losartan|losartan|mesh-list
25186935|NCT02817360|Valsartan|valsartan|mesh-list
25186936|NCT02817360|Carvedilol|carvedilol|mesh-list
25186937|NCT02817360|Candesartan|candesartan|mesh-list
25186938|NCT02817360|Ramipril|ramipril|mesh-list
25186939|NCT02817360|Enalapril|enalapril|mesh-list
25186940|NCT02817360|Lisinopril|lisinopril|mesh-list
25186941|NCT02817360|Irbesartan|irbesartan|mesh-list
25186942|NCT02817360|Nebivolol|nebivolol|mesh-list
25186943|NCT02817360|Perindopril|perindopril|mesh-list
25186944|NCT02817360|Bisoprolol|bisoprolol|mesh-list
25186945|NCT02817360|Captopril|captopril|mesh-list
25186946|NCT02817360|Quinapril|quinapril|mesh-list
25186947|NCT02817360|Trandolapril|trandolapril|mesh-list
25186948|NCT02817360|Fosinopril|fosinopril|mesh-list
24439936|NCT00280930|Letrozole|letrozole|mesh-list
24414462|NCT00197639|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25186949|NCT02817360|Eprosartan|eprosartan|mesh-list
25186950|NCT02817360|Zofenopril|zofenopril|mesh-list
25186951|NCT02817360|Spirapril|spirapril|mesh-list
25186952|NCT02817360|Cilazapril|cilazapril|mesh-list
25186953|NCT02817360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25186954|NCT02817360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25186955|NCT02817360|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25186956|NCT02817360|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25186957|NCT02817360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186958|NCT02817360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25186959|NCT02817360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25186960|NCT02817360|Adrenergic Agents|adrenergic agents|mesh-ancestor
25666032|NCT01690988|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25186961|NCT02817360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25186962|NCT02817360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186963|NCT02817360|Antioxidants|antioxidants|mesh-ancestor
25186964|NCT02817360|Protective Agents|protective agents|mesh-ancestor
25186965|NCT02817360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25186966|NCT02817360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25186967|NCT02817360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25186968|NCT02817360|Vasodilator Agents|vasodilator agents|mesh-ancestor
25186969|NCT02817360|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25186970|NCT02817360|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25186971|NCT02817360|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25186972|NCT02817360|Protease Inhibitors|protease inhibitors|mesh-ancestor
25186973|NCT02817360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25186974|NCT02817360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25186975|NCT02817360|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25186976|NCT02817360|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25186977|NCT02817360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25186978|NCT02817360|Sympatholytics|sympatholytics|mesh-ancestor
25186979|NCT02817360|Autonomic Agents|autonomic agents|mesh-ancestor
25186980|NCT02817360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24440165|NCT00281931|Rituximab|rituximab|mesh-list
25186981|NCT02817360|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25186982|NCT02817360|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
25186983|NCT02816970|Vildagliptin|vildagliptin|mesh-list
25186984|NCT02816970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25186985|NCT02816970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822400|NCT02111434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25186986|NCT02816970|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25186987|NCT02816970|Protease Inhibitors|protease inhibitors|mesh-ancestor
25186988|NCT02816970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25186989|NCT02816970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25186990|NCT02817191|Tobramycin|tobramycin|mesh-list
25186991|NCT02817191|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
25186992|NCT02817191|Dexamethasone|dexamethasone|mesh-list
25186993|NCT02817191|Dexamethasone acetate|dexamethasone acetate|mesh-list
25186994|NCT02817191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25186995|NCT02817191|BB 1101|bb 1101|mesh-list
25186996|NCT02817191|Dipivefrin|dipivefrin|mesh-list
25186997|NCT02817191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25186998|NCT02817191|Antiemetics|antiemetics|mesh-ancestor
25186999|NCT02817191|Autonomic Agents|autonomic agents|mesh-ancestor
25187000|NCT02817191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187001|NCT02817191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187002|NCT02817191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25187003|NCT02817191|Glucocorticoids|glucocorticoids|mesh-ancestor
25187004|NCT02817191|Hormones|hormones|mesh-ancestor
25187005|NCT02817191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25187006|NCT02817191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25187007|NCT02817191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25187008|NCT02817191|Protease Inhibitors|protease inhibitors|mesh-ancestor
25187009|NCT02817191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25187010|NCT02817191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440212|NCT00281983|Alemtuzumab|alemtuzumab|mesh-list
25187011|NCT02817191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25187012|NCT02817191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25187013|NCT02817191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25187014|NCT02817191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25187015|NCT02817191|Adrenergic Agents|adrenergic agents|mesh-ancestor
25187016|NCT02817191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25187017|NCT02817217|Valsartan|valsartan|mesh-list
25187018|NCT02817217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25187019|NCT02817217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25187020|NCT02817217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25187021|NCT02817217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187022|NCT02817256|Vitamins|vitamins|mesh-list
25187023|NCT02817256|Micronutrients|micronutrients|mesh-ancestor
25187024|NCT02817256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187025|NCT02817243|Simvastatin|simvastatin|mesh-list
25187026|NCT02817243|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25187027|NCT02817243|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25187028|NCT02817243|Antimetabolites|antimetabolites|mesh-ancestor
25187029|NCT02817243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187030|NCT02817243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25187031|NCT02817243|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25187032|NCT02817243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25187033|NCT02817100|Itraconazole|itraconazole|mesh-list
25187034|NCT02817100|Antifungal Agents|antifungal agents|mesh-ancestor
25187035|NCT02817100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25187036|NCT02817100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25187037|NCT02817100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25187038|NCT02817100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25187039|NCT02817100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187040|NCT02817100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25187041|NCT02817100|Hormone Antagonists|hormone antagonists|mesh-ancestor
25187042|NCT02817100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25187043|NCT02817100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187044|NCT02817100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25187045|NCT02817113|Fluorouracil|fluorouracil|mesh-list
25187047|NCT02817113|Antimetabolites|antimetabolites|mesh-ancestor
25187048|NCT02817113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187049|NCT02817113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25187050|NCT02817113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25187051|NCT02817113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25187052|NCT02817113|Immunologic Factors|immunologic factors|mesh-ancestor
25187053|NCT02817113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187054|NCT02817113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25187055|NCT02816905|Fluorometholone|fluorometholone|mesh-list
25187056|NCT02816905|Dexamethasone|dexamethasone|mesh-list
25187057|NCT02816905|Rimexolone|rimexolone|mesh-list
25187058|NCT02816905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25187059|NCT02816905|Antiemetics|antiemetics|mesh-ancestor
25187060|NCT02816905|Autonomic Agents|autonomic agents|mesh-ancestor
25187061|NCT02816905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187062|NCT02816905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187063|NCT02816905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25187064|NCT02816905|Glucocorticoids|glucocorticoids|mesh-ancestor
25187065|NCT02816905|Hormones|hormones|mesh-ancestor
25187066|NCT02816905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25187067|NCT02816905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25187068|NCT02816905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25187069|NCT02816905|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25187070|NCT02816684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25187071|NCT02816684|Antiviral Agents|antiviral agents|mesh-ancestor
25187072|NCT02816684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25187073|NCT02816853|Moxifloxacin|moxifloxacin|mesh-list
25187074|NCT02816853|Domperidone|domperidone|mesh-list
25187075|NCT02816853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25187076|NCT02816853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25187077|NCT02816853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25187078|NCT02816853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25187079|NCT02816853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25187080|NCT02816853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187081|NCT02816853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25187082|NCT02816853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187083|NCT02816853|Antiemetics|antiemetics|mesh-ancestor
25187084|NCT02816853|Autonomic Agents|autonomic agents|mesh-ancestor
25187085|NCT02816853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187086|NCT02816853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25187087|NCT02816853|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25187088|NCT02816853|Dopamine Agents|dopamine agents|mesh-ancestor
25187089|NCT02816853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25187090|NCT02816476|Daratumumab|daratumumab|mesh-list
25187091|NCT02816476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25187092|NCT02816593|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25187093|NCT02816593|Carbamide Peroxide|carbamide peroxide|mesh-list
25187094|NCT02816593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25187095|NCT02816593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25187096|NCT02816567|Sufentanil|sufentanil|mesh-list
25187097|NCT02816567|Propofol|propofol|mesh-list
25187098|NCT02816567|Cisatracurium|cisatracurium|mesh-list
25187099|NCT02816567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25187100|NCT02816567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25187101|NCT02816567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187102|NCT02816567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25187103|NCT02816567|Anesthetics, General|anesthetics, general|mesh-ancestor
25187104|NCT02816567|Anesthetics|anesthetics|mesh-ancestor
25187105|NCT02816567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25187106|NCT02816567|Narcotics|narcotics|mesh-ancestor
25187107|NCT02816567|Analgesics|analgesics|mesh-ancestor
25187108|NCT02816567|Sensory System Agents|sensory system agents|mesh-ancestor
25187109|NCT02816567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187110|NCT02816567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25187111|NCT02816567|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25187112|NCT02816567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25187113|NCT02816112|Ciprofloxacin|ciprofloxacin|mesh-list
25187114|NCT02816112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25187115|NCT02816112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25187116|NCT02816112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25187117|NCT02816112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25187118|NCT02816112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25187119|NCT02816112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187120|NCT02816112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25187121|NCT02816112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24440672|NCT00284271|Cyclophosphamide|cyclophosphamide|mesh-list
24772798|NCT01836016|Fluticasone|fluticasone|mesh-list
25187122|NCT02816112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25187123|NCT02816164|Lenograstim|lenograstim|mesh-list
25187124|NCT02816164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25187125|NCT02816164|Immunologic Factors|immunologic factors|mesh-ancestor
25187126|NCT02816164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187127|NCT02816411|Caseins|caseins|mesh-list
25187128|NCT02816411|Chelating Agents|chelating agents|mesh-ancestor
25187129|NCT02816411|Sequestering Agents|sequestering agents|mesh-ancestor
25187130|NCT02816411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187131|NCT02815865|Oxytocin|oxytocin|mesh-list
25187132|NCT02815865|Dinoprostone|dinoprostone|mesh-list
25187133|NCT02815865|Oxytocics|oxytocics|mesh-ancestor
25187134|NCT02815865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25187135|NCT02815865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187136|NCT02815657|Valsartan|valsartan|mesh-list
25187137|NCT02815657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25187138|NCT02815657|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25187139|NCT02815657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25187140|NCT02815657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187141|NCT02815787|Glyburide|glyburide|mesh-list
25187142|NCT02815787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25187186|NCT02815410|Levetiracetam|levetiracetam|mesh-list
25187143|NCT02815787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187144|NCT02815722|Simvastatin|simvastatin|mesh-list
25187145|NCT02815722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25187146|NCT02815722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25187147|NCT02815722|Antimetabolites|antimetabolites|mesh-ancestor
25187148|NCT02815722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187149|NCT02815722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25187150|NCT02815722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25187151|NCT02815722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25187152|NCT02816151|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25187153|NCT02816151|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25187154|NCT02816151|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25187155|NCT02816151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187156|NCT02816151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187157|NCT02816151|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25187158|NCT02816151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25205876|NCT04083950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25205877|NCT04083950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25205878|NCT04083950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205879|NCT04083950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25205880|NCT04083950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25205881|NCT04083950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205882|NCT04083950|Antipyretics|antipyretics|mesh-ancestor
24414812|NCT00198718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415000|NCT00199017|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24415001|NCT00199017|Abortifacient Agents|abortifacient agents|mesh-ancestor
24415002|NCT00199017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24415003|NCT00199017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24415004|NCT00199017|Antimetabolites|antimetabolites|mesh-ancestor
24822499|NCT02112214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24822500|NCT02112292|Dronabinol|dronabinol|mesh-list
24822501|NCT02112292|Cannabidiol|cannabidiol|mesh-list
24822502|NCT02112292|Anticonvulsants|anticonvulsants|mesh-ancestor
24822503|NCT02112292|Hallucinogens|hallucinogens|mesh-ancestor
24822504|NCT02112292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822505|NCT02112292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24822506|NCT02112292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24822507|NCT02112292|Analgesics|analgesics|mesh-ancestor
24822508|NCT02112292|Sensory System Agents|sensory system agents|mesh-ancestor
24415013|NCT00199017|Antimitotic Agents|antimitotic agents|mesh-ancestor
24415014|NCT00199017|Mitosis Modulators|mitosis modulators|mesh-ancestor
24415015|NCT00199017|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24415016|NCT00199017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24415017|NCT00199017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24415018|NCT00199030|Alemtuzumab|alemtuzumab|mesh-list
24415019|NCT00199030|Cladribine|cladribine|mesh-list
25860436|NCT00083668|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24822516|NCT02112305|Magnesium Sulfate|magnesium sulfate|mesh-list
24822517|NCT02112305|Analgesics|analgesics|mesh-ancestor
24822518|NCT02112305|Sensory System Agents|sensory system agents|mesh-ancestor
24415027|NCT00199043|Antimetabolites|antimetabolites|mesh-ancestor
24415028|NCT00199043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187162|NCT02816203|Hemostatics|hemostatics|mesh-list
25187163|NCT02816203|Coagulants|coagulants|mesh-ancestor
25187164|NCT02815566|Tenofovir|tenofovir|mesh-list
25187165|NCT02815566|Emtricitabine|emtricitabine|mesh-list
25187166|NCT02815566|Antiviral Agents|antiviral agents|mesh-ancestor
25187167|NCT02815566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25187168|NCT02815566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25187169|NCT02815566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25187170|NCT02815566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25187171|NCT02815566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187172|NCT02815566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25187173|NCT02815566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25187174|NCT02815319|Dexamethasone|dexamethasone|mesh-list
25187175|NCT02815319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25187176|NCT02815319|Antiemetics|antiemetics|mesh-ancestor
24731724|NCT01636271|Darapladib|darapladib|mesh-list
25187177|NCT02815319|Autonomic Agents|autonomic agents|mesh-ancestor
25187178|NCT02815319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187179|NCT02815319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187180|NCT02815319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25187181|NCT02815319|Glucocorticoids|glucocorticoids|mesh-ancestor
25187182|NCT02815319|Hormones|hormones|mesh-ancestor
25187183|NCT02815319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25187184|NCT02815319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25187185|NCT02815319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25187187|NCT02815410|Anticonvulsants|anticonvulsants|mesh-ancestor
25187188|NCT02815410|Nootropic Agents|nootropic agents|mesh-ancestor
25187190|NCT02815475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24947507|NCT03927963|Propofol|propofol|mesh-list
25187191|NCT02815475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25187192|NCT02815475|Analgesics|analgesics|mesh-ancestor
25187193|NCT02815475|Sensory System Agents|sensory system agents|mesh-ancestor
25187194|NCT02815475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187195|NCT02815475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187196|NCT02815475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25187197|NCT02815475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25187198|NCT02815475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25187199|NCT02815475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25187200|NCT02815475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187202|NCT02815449|Trace Elements|trace elements|mesh-ancestor
25187203|NCT02815449|Micronutrients|micronutrients|mesh-ancestor
25187204|NCT02815449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187205|NCT02815332|Minocycline|minocycline|mesh-list
25187206|NCT02815332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25187207|NCT02815332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25187208|NCT02815189|Acetaminophen|acetaminophen|mesh-list
25187209|NCT02815189|Ibuprofen|ibuprofen|mesh-list
25187210|NCT02815189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25187211|NCT02815189|Analgesics|analgesics|mesh-ancestor
25187212|NCT02815189|Sensory System Agents|sensory system agents|mesh-ancestor
25187213|NCT02815189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187214|NCT02815189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187215|NCT02815189|Antipyretics|antipyretics|mesh-ancestor
25187216|NCT02815189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25187217|NCT02815189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25187218|NCT02815189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25187219|NCT02815189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25187220|NCT02815189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25187221|NCT02815189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187222|NCT02815111|Acetaminophen|acetaminophen|mesh-list
25187223|NCT02815111|Lidocaine|lidocaine|mesh-list
25187224|NCT02815111|Ketamine|ketamine|mesh-list
25187225|NCT02815111|Gabapentin|gabapentin|mesh-list
25187226|NCT02815111|Anesthetics, Local|anesthetics, local|mesh-ancestor
25211945|NCT03244059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25211946|NCT03244059|Immunologic Factors|immunologic factors|mesh-ancestor
25211947|NCT03244059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211948|NCT03170960|Atezolizumab|atezolizumab|mesh-list
25211949|NCT03170960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528974|NCT00624026|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25155875|NCT05243524|Cyclophosphamide|cyclophosphamide|mesh-list
25155876|NCT05243524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25155877|NCT05243524|Immunologic Factors|immunologic factors|mesh-ancestor
24821281|NCT02104284|Methacholine Chloride|methacholine chloride|mesh-list
24821286|NCT02104284|Miotics|miotics|mesh-ancestor
25187227|NCT02815111|Anesthetics|anesthetics|mesh-ancestor
25187228|NCT02815111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25187229|NCT02815111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187230|NCT02815111|Sensory System Agents|sensory system agents|mesh-ancestor
25187231|NCT02815111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187232|NCT02815111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25187233|NCT02815111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25187234|NCT02815111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25187235|NCT02815111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25187352|NCT02813135|Temozolomide|temozolomide|mesh-list
24590242|NCT00911287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187236|NCT02815111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187238|NCT02815111|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25187239|NCT02815111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24441254|NCT00286780|Gossypol acetic acid|gossypol acetic acid|mesh-list
25187240|NCT02815111|Anesthetics, General|anesthetics, general|mesh-ancestor
25187241|NCT02815111|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25187242|NCT02815111|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25187243|NCT02815111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25187244|NCT02815111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25187245|NCT02815111|Antipyretics|antipyretics|mesh-ancestor
25187246|NCT02815111|Anticonvulsants|anticonvulsants|mesh-ancestor
25187247|NCT02815111|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25187248|NCT02815111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25187249|NCT02815111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25187250|NCT02815111|Antimanic Agents|antimanic agents|mesh-ancestor
25187251|NCT02814994|Respiratory System Agents|respiratory system agents|mesh-list
25187252|NCT02815046|Botulinum Toxins|botulinum toxins|mesh-list
25187253|NCT02815046|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25187254|NCT02815046|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25187255|NCT02815046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25187256|NCT02815046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25187257|NCT02815046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187258|NCT02815046|Cholinergic Agents|cholinergic agents|mesh-ancestor
25187259|NCT02815046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25187260|NCT02815046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187261|NCT02815046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25187262|NCT02815046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187263|NCT02814877|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25187264|NCT02814877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25187265|NCT02815059|Prednisone|prednisone|mesh-list
25187266|NCT02815059|Dasatinib|dasatinib|mesh-list
25187267|NCT02815059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25187268|NCT02815059|Glucocorticoids|glucocorticoids|mesh-ancestor
25187269|NCT02815059|Hormones|hormones|mesh-ancestor
25187270|NCT02815059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25187271|NCT02815059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187272|NCT02815059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25187273|NCT02815059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25187274|NCT02815059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25187275|NCT02815059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25666033|NCT01690988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25666034|NCT01690988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666035|NCT01691092|Ketamine|ketamine|mesh-list
25666036|NCT01691092|Analgesics|analgesics|mesh-ancestor
25666037|NCT01691092|Sensory System Agents|sensory system agents|mesh-ancestor
25666038|NCT01691092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25666039|NCT01691092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666040|NCT01691092|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25666041|NCT01691092|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25666042|NCT01691092|Anesthetics, General|anesthetics, general|mesh-ancestor
25666043|NCT01691092|Anesthetics|anesthetics|mesh-ancestor
25860437|NCT00083668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25860438|NCT00083668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25666044|NCT01691092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25860439|NCT00083668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24821314|NCT02104323|Growth Substances|growth substances|mesh-ancestor
25187276|NCT02815059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187277|NCT02814500|Amlodipine|amlodipine|mesh-list
25187278|NCT02814500|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25187279|NCT02814500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25187280|NCT02814500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25187281|NCT02814500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25187282|NCT02814500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187283|NCT02814500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25187284|NCT02814500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187285|NCT02814500|Vasodilator Agents|vasodilator agents|mesh-ancestor
25187286|NCT02814500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25187287|NCT02814500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25187288|NCT02814500|Antimetabolites|antimetabolites|mesh-ancestor
25187289|NCT02814500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25187290|NCT02814500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25187291|NCT02814500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25187292|NCT02814669|Atezolizumab|atezolizumab|mesh-list
25187293|NCT02814669|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25187294|NCT02814669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25187295|NCT02814461|Axitinib|axitinib|mesh-list
25187296|NCT02814461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25187297|NCT02814461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25187298|NCT02814461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25187299|NCT02814461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187300|NCT02814409|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25187301|NCT02814409|Plasminogen|plasminogen|mesh-list
25187302|NCT02814409|Tenecteplase|tenecteplase|mesh-list
25187303|NCT02814409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25187304|NCT02814409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25187305|NCT02814409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187306|NCT02814630|Omalizumab|omalizumab|mesh-list
25187307|NCT02814630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25187308|NCT02814630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25187320|NCT02814110|Lenograstim|lenograstim|mesh-list
25187321|NCT02814110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25187322|NCT02814110|Immunologic Factors|immunologic factors|mesh-ancestor
25187323|NCT02814110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205917|NCT04079881|Insulin|insulin|mesh-list
25205918|NCT04079881|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25205919|NCT04079881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25205920|NCT04079881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205921|NCT04075526|Vancomycin|vancomycin|mesh-list
25205922|NCT04075526|Povidone-Iodine|povidone-iodine|mesh-list
25205923|NCT04075526|Povidone|povidone|mesh-list
25205924|NCT04075526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25205925|NCT04075526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25205926|NCT04075526|Plasma Substitutes|plasma substitutes|mesh-ancestor
25205927|NCT04075526|Blood Substitutes|blood substitutes|mesh-ancestor
25205928|NCT04075526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25205929|NCT04071119|Oxytocin|oxytocin|mesh-list
25205930|NCT04071119|Oxytocics|oxytocics|mesh-ancestor
25205931|NCT04071119|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25205932|NCT04071119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205933|NCT04050280|Cytarabine|cytarabine|mesh-list
25205934|NCT04050280|Cladribine|cladribine|mesh-list
25205935|NCT04050280|Gemtuzumab|gemtuzumab|mesh-list
25205936|NCT04050280|Lenograstim|lenograstim|mesh-list
25205937|NCT04050280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25205938|NCT04050280|Antimetabolites|antimetabolites|mesh-ancestor
25205939|NCT04050280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205940|NCT04050280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25205941|NCT04050280|Antiviral Agents|antiviral agents|mesh-ancestor
25187324|NCT02813863|Metformin|metformin|mesh-list
25187325|NCT02813863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25187326|NCT02813863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187327|NCT02813356|Naloxegol|naloxegol|mesh-list
25187328|NCT02813356|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25666045|NCT01691092|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25666046|NCT01691092|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25187329|NCT02813356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187330|NCT02813356|Sensory System Agents|sensory system agents|mesh-ancestor
25187331|NCT02813356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187332|NCT02813369|Naloxegol|naloxegol|mesh-list
25666048|NCT01691092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411316|NCT00188669|Tocopherols|tocopherols|mesh-list
24411337|NCT00188773|Anticoagulants|anticoagulants|mesh-ancestor
24821481|NCT02105714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24821482|NCT02105792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
24821483|NCT02105792|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24821484|NCT02105792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187333|NCT02813369|Laxatives|laxatives|mesh-list
25187334|NCT02813369|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25187335|NCT02813369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187336|NCT02813369|Sensory System Agents|sensory system agents|mesh-ancestor
25187337|NCT02813369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187338|NCT02813369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25187339|NCT02813382|Bupivacaine|bupivacaine|mesh-list
25187340|NCT02813382|Prilocaine|prilocaine|mesh-list
25187341|NCT02813382|Chloroprocaine|chloroprocaine|mesh-list
25187342|NCT02813382|Procaine|procaine|mesh-list
25187343|NCT02813382|Anesthetics, Local|anesthetics, local|mesh-ancestor
25187344|NCT02813382|Anesthetics|anesthetics|mesh-ancestor
25187345|NCT02813382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25187346|NCT02813382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187347|NCT02813382|Sensory System Agents|sensory system agents|mesh-ancestor
25187348|NCT02813382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187349|NCT02813135|Carboplatin|carboplatin|mesh-list
25187350|NCT02813135|Nivolumab|nivolumab|mesh-list
25187351|NCT02813135|Irinotecan|irinotecan|mesh-list
25187353|NCT02813135|Topotecan|topotecan|mesh-list
25187354|NCT02813135|Olaparib|olaparib|mesh-list
25187355|NCT02813135|Adavosertib|adavosertib|mesh-list
25187356|NCT02813135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25187357|NCT02813135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25187358|NCT02813135|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25187359|NCT02813135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187360|NCT02813135|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25187361|NCT02813135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25187362|NCT02813135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25187363|NCT02813135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25187364|NCT02813135|Alkylating Agents|alkylating agents|mesh-ancestor
25187365|NCT02813135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25187366|NCT02813486|Vaccines|vaccines|mesh-list
25187367|NCT02813486|Immunologic Factors|immunologic factors|mesh-ancestor
25187368|NCT02813486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187369|NCT02813239|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25187370|NCT02813239|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25187371|NCT02813239|Luteolytic Agents|luteolytic agents|mesh-ancestor
25187372|NCT02813239|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25187373|NCT02813239|Contraceptive Agents|contraceptive agents|mesh-ancestor
25187374|NCT02813239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25187375|NCT02813239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187376|NCT02813239|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25187377|NCT02813239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25187378|NCT02813239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25187379|NCT02813018|Ropivacaine|ropivacaine|mesh-list
25187380|NCT02813018|Anesthetics, Local|anesthetics, local|mesh-ancestor
25187381|NCT02813018|Anesthetics|anesthetics|mesh-ancestor
25187382|NCT02813018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25187383|NCT02813018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187384|NCT02813018|Sensory System Agents|sensory system agents|mesh-ancestor
25187385|NCT02813018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187386|NCT02813148|Naloxegol|naloxegol|mesh-list
25187387|NCT02813148|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25187388|NCT02813148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187389|NCT02813148|Sensory System Agents|sensory system agents|mesh-ancestor
25187390|NCT02813148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187391|NCT02813044|Anesthetics|anesthetics|mesh-list
25187392|NCT02813044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25187393|NCT02813044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187394|NCT02812888|Propranolol|propranolol|mesh-list
25666049|NCT01691248|Fidaxomicin|fidaxomicin|mesh-list
25666050|NCT01691248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25666051|NCT01691248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25666052|NCT01691313|Vanoxerine|vanoxerine|mesh-list
25666053|NCT01691313|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25666054|NCT01691313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24821534|NCT02106286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24542698|NCT00679744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24542699|NCT00679744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24542700|NCT00679744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24411503|NCT00189176|Chelating Agents|chelating agents|mesh-ancestor
24411504|NCT00189176|Sequestering Agents|sequestering agents|mesh-ancestor
24411505|NCT00189176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732528|NCT01640002|Bromides|bromides|mesh-list
24821555|NCT02106481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24821587|NCT02106650|Hydroxocobalamin|hydroxocobalamin|mesh-list
25187395|NCT02812888|Methimazole|methimazole|mesh-list
24415540|NCT00199940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25187396|NCT02812888|Propylthiouracil|propylthiouracil|mesh-list
25187397|NCT02812888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25187398|NCT02812888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25187399|NCT02812888|Adrenergic Agents|adrenergic agents|mesh-ancestor
24415694|NCT00200512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415696|NCT00200525|Emetics|emetics|mesh-ancestor
24415723|NCT00200551|Antifungal Agents|antifungal agents|mesh-ancestor
24415724|NCT00200551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24415725|NCT00200551|Dermatologic Agents|dermatologic agents|mesh-ancestor
24415735|NCT00200564|Sensory System Agents|sensory system agents|mesh-ancestor
24415736|NCT00200564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24415737|NCT00200564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415738|NCT00200564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24415739|NCT00200564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24415740|NCT00200564|Anesthetics, General|anesthetics, general|mesh-ancestor
24415741|NCT00200564|Anesthetics|anesthetics|mesh-ancestor
25142575|NCT02948920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25142576|NCT02948920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103743|NCT03158935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103744|NCT03158935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25103756|NCT03158935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25103757|NCT03158935|Antiviral Agents|antiviral agents|mesh-ancestor
25103943|NCT03156907|Analgesics|analgesics|mesh-ancestor
25103944|NCT03156907|Sensory System Agents|sensory system agents|mesh-ancestor
25103945|NCT03156907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25103946|NCT03156907|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25103947|NCT03156829|Betamethasone|betamethasone|mesh-list
25104748|NCT03151213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25104749|NCT03151382|Tandospirone|tandospirone|mesh-list
25104750|NCT03151382|Donepezil|donepezil|mesh-list
25104751|NCT03151382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998371|NCT03009201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442299|NCT00290667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442300|NCT00290667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24442301|NCT00290667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24998372|NCT03009201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187400|NCT02812888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25187401|NCT02812888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187402|NCT02812888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187403|NCT02812888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25187404|NCT02812888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25187405|NCT02812888|Vasodilator Agents|vasodilator agents|mesh-ancestor
25187406|NCT02812888|Antithyroid Agents|antithyroid agents|mesh-ancestor
25187407|NCT02812888|Hormone Antagonists|hormone antagonists|mesh-ancestor
25187408|NCT02812888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25187409|NCT02812888|Antimetabolites|antimetabolites|mesh-ancestor
25187410|NCT02812979|Albuterol|albuterol|mesh-list
25187411|NCT02812979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25187412|NCT02812979|Autonomic Agents|autonomic agents|mesh-ancestor
25187413|NCT02812979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187414|NCT02812979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666055|NCT01691313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25666056|NCT01691313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666057|NCT01691313|Dopamine Agents|dopamine agents|mesh-ancestor
25666058|NCT01691313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25666059|NCT01691313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666060|NCT01691326|Vaccines|vaccines|mesh-list
25666061|NCT01691326|Immunologic Factors|immunologic factors|mesh-ancestor
25666062|NCT01691326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666063|NCT01691339|Vaccines|vaccines|mesh-list
25666064|NCT01691339|Immunologic Factors|immunologic factors|mesh-ancestor
25860440|NCT00083668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860441|NCT00083668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25860442|NCT00083668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25860443|NCT00083668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25860444|NCT00083668|Serotonin Agents|serotonin agents|mesh-ancestor
25666065|NCT01691339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656810|NCT01264302|Finasteride|finasteride|mesh-list
24411709|NCT00189761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24411710|NCT00189761|Immunologic Factors|immunologic factors|mesh-ancestor
24411711|NCT00189761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411712|NCT00189761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24411713|NCT00189761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411714|NCT00189761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411715|NCT00189774|Nateglinide|nateglinide|mesh-list
24411716|NCT00189774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25187415|NCT02812979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25187416|NCT02812979|Respiratory System Agents|respiratory system agents|mesh-ancestor
25187417|NCT02812979|Tocolytic Agents|tocolytic agents|mesh-ancestor
25187418|NCT02812979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25187419|NCT02812979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25187420|NCT02812979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25187421|NCT02812979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25187422|NCT02812979|Adrenergic Agents|adrenergic agents|mesh-ancestor
25187423|NCT02812979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25187424|NCT02812979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187425|NCT02812940|Everolimus|everolimus|mesh-list
25187426|NCT02812940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25187427|NCT02812940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25187428|NCT02812940|Immunologic Factors|immunologic factors|mesh-ancestor
25187429|NCT02812940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187430|NCT02812654|Doxorubicin|doxorubicin|mesh-list
25187431|NCT02812654|Ifosfamide|ifosfamide|mesh-list
25187432|NCT02812654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25187433|NCT02812654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25187434|NCT02812654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25187435|NCT02812654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25187436|NCT02812654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25187437|NCT02812654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187438|NCT02812654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25187439|NCT02812654|Alkylating Agents|alkylating agents|mesh-ancestor
25187440|NCT02812719|Salicylic Acid|salicylic acid|mesh-list
25187441|NCT02812719|Salicylates|salicylates|mesh-list
25187442|NCT02812719|Glycolic acid|glycolic acid|mesh-list
25187443|NCT02812719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25187444|NCT02812719|Antifungal Agents|antifungal agents|mesh-ancestor
25187445|NCT02812719|Keratolytic Agents|keratolytic agents|mesh-ancestor
25187446|NCT02812719|Dermatologic Agents|dermatologic agents|mesh-ancestor
25187447|NCT02812719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25187448|NCT02812719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25187449|NCT02812719|Analgesics|analgesics|mesh-ancestor
25187450|NCT02812719|Sensory System Agents|sensory system agents|mesh-ancestor
25187451|NCT02812719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187452|NCT02812719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187453|NCT02812719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25187454|NCT02812719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25187455|NCT02812719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25187456|NCT02812719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25187457|NCT02812719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187458|NCT02812992|Gemcitabine|gemcitabine|mesh-list
25187459|NCT02812992|Paclitaxel|paclitaxel|mesh-list
25187460|NCT02812992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25666066|NCT01691482|Albuterol|albuterol|mesh-list
25666067|NCT01691482|Ipratropium|ipratropium|mesh-list
25666068|NCT01691482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25666069|NCT01691482|Autonomic Agents|autonomic agents|mesh-ancestor
25666070|NCT01691482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25666071|NCT01691482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666072|NCT01691482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25666073|NCT01691482|Respiratory System Agents|respiratory system agents|mesh-ancestor
25666074|NCT01691482|Tocolytic Agents|tocolytic agents|mesh-ancestor
25666075|NCT01691482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25666076|NCT01691482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25155353|NCT05411237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25666077|NCT01691482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25666078|NCT01691482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25666079|NCT01691482|Adrenergic Agents|adrenergic agents|mesh-ancestor
25860445|NCT00083668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25860446|NCT00083668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860447|NCT00083668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24542862|NCT00680602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24542863|NCT00680602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24542864|NCT00680602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542865|NCT00680602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24411978|NCT00190567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25187461|NCT02812992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25187462|NCT02812992|Tubulin Modulators|tubulin modulators|mesh-ancestor
25187463|NCT02812992|Antimitotic Agents|antimitotic agents|mesh-ancestor
25187464|NCT02812992|Mitosis Modulators|mitosis modulators|mesh-ancestor
25187465|NCT02812992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187466|NCT02812992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25187467|NCT02812992|Antimetabolites|antimetabolites|mesh-ancestor
25187468|NCT02812992|Antiviral Agents|antiviral agents|mesh-ancestor
25187469|NCT02812992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25187470|NCT02812992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25187471|NCT02812992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25187472|NCT02812992|Immunologic Factors|immunologic factors|mesh-ancestor
25187473|NCT02812992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187475|NCT02812693|Imatinib Mesylate|imatinib mesylate|mesh-list
25187476|NCT02812693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25187477|NCT02812693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25187478|NCT02812693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25187479|NCT02812693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25187480|NCT02812693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187481|NCT02812641|Bevacizumab|bevacizumab|mesh-list
25187482|NCT02812641|Cisplatin|cisplatin|mesh-list
25187483|NCT02812641|Fluorouracil|fluorouracil|mesh-list
25187484|NCT02812641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25187485|NCT02812641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25187486|NCT02812641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25187487|NCT02812641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25187488|NCT02812641|Growth Substances|growth substances|mesh-ancestor
25187489|NCT02812641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187490|NCT02812641|Growth Inhibitors|growth inhibitors|mesh-ancestor
25187491|NCT02812641|Antimetabolites|antimetabolites|mesh-ancestor
25187492|NCT02812641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187493|NCT02812641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25187494|NCT02812641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25187495|NCT02812641|Immunologic Factors|immunologic factors|mesh-ancestor
25187496|NCT02812602|Lidocaine|lidocaine|mesh-list
25187497|NCT02812602|Anesthetics, Local|anesthetics, local|mesh-ancestor
25187498|NCT02812602|Anesthetics|anesthetics|mesh-ancestor
25187499|NCT02812602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25187500|NCT02812602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187501|NCT02812602|Sensory System Agents|sensory system agents|mesh-ancestor
25187502|NCT02812602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187503|NCT02812602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25187504|NCT02812602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25187505|NCT02812602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25187506|NCT02812602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25187507|NCT02812602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187508|NCT02812368|Clonidine|clonidine|mesh-list
25187509|NCT02812368|Analgesics|analgesics|mesh-ancestor
25187510|NCT02812368|Sensory System Agents|sensory system agents|mesh-ancestor
25187511|NCT02812368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187512|NCT02812368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187513|NCT02812368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25187523|NCT02812394|Carbidopa|carbidopa|mesh-list
25187524|NCT02812394|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25187525|NCT02812394|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25666080|NCT01691482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25666081|NCT01691482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666082|NCT01691482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25666083|NCT01691482|Cholinergic Agents|cholinergic agents|mesh-ancestor
25666084|NCT01691508|Prednisone|prednisone|mesh-list
25666085|NCT01691508|Prednisolone|prednisolone|mesh-list
25666086|NCT01691508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25666087|NCT01691508|Glucocorticoids|glucocorticoids|mesh-ancestor
25666088|NCT01691508|Hormones|hormones|mesh-ancestor
25187526|NCT02812394|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25187529|NCT02812394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187531|NCT02812394|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25187532|NCT02812394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25187533|NCT02812394|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25187534|NCT02812394|Immunologic Factors|immunologic factors|mesh-ancestor
25187535|NCT02812394|Dopamine Agonists|dopamine agonists|mesh-ancestor
25205942|NCT04050280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25205943|NCT04050280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25205944|NCT04050280|Immunologic Factors|immunologic factors|mesh-ancestor
25205945|NCT04050280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205946|NCT04050280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25205947|NCT04050280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24822700|NCT02112916|Antimetabolites|antimetabolites|mesh-ancestor
25205957|NCT04005599|Magnesium Sulfate|magnesium sulfate|mesh-list
25205958|NCT04005599|Remifentanil|remifentanil|mesh-list
25205959|NCT04005599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25205960|NCT04005599|Narcotics|narcotics|mesh-ancestor
25205961|NCT04005599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25205962|NCT04005599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205963|NCT04005599|Analgesics|analgesics|mesh-ancestor
25205964|NCT04005599|Sensory System Agents|sensory system agents|mesh-ancestor
25205965|NCT04005599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25205966|NCT04005599|Anesthetics|anesthetics|mesh-ancestor
25187536|NCT02812199|Lidocaine|lidocaine|mesh-list
25187537|NCT02812199|Epinephrine|epinephrine|mesh-list
25187538|NCT02812199|Racepinephrine|racepinephrine|mesh-list
25187539|NCT02812199|Epinephryl borate|epinephryl borate|mesh-list
25187540|NCT02812199|Anesthetics, Local|anesthetics, local|mesh-ancestor
25187541|NCT02812199|Anesthetics|anesthetics|mesh-ancestor
25187542|NCT02812199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25187543|NCT02812199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187544|NCT02812199|Sensory System Agents|sensory system agents|mesh-ancestor
25187545|NCT02812199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187546|NCT02812199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25187547|NCT02812199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25187548|NCT02812199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25187549|NCT02812199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25187550|NCT02812199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187551|NCT02812199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25187552|NCT02812199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25187553|NCT02812199|Adrenergic Agents|adrenergic agents|mesh-ancestor
25187554|NCT02812199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25187555|NCT02812199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25187556|NCT02812199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25187557|NCT02812199|Autonomic Agents|autonomic agents|mesh-ancestor
25187558|NCT02812199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25187559|NCT02812199|Respiratory System Agents|respiratory system agents|mesh-ancestor
25187560|NCT02812199|Mydriatics|mydriatics|mesh-ancestor
25187561|NCT02812199|Sympathomimetics|sympathomimetics|mesh-ancestor
25187562|NCT02812199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25187566|NCT02812147|Droxidopa|droxidopa|mesh-list
25187567|NCT02812147|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25187568|NCT02812147|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25187569|NCT02812043|Amorolfine|amorolfine|mesh-list
25187570|NCT02812043|Antifungal Agents|antifungal agents|mesh-ancestor
25187571|NCT02812043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25187572|NCT02811978|Dexamethasone|dexamethasone|mesh-list
25187573|NCT02811978|Bortezomib|bortezomib|mesh-list
25187574|NCT02811978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25187575|NCT02811978|Antiemetics|antiemetics|mesh-ancestor
25187576|NCT02811978|Autonomic Agents|autonomic agents|mesh-ancestor
25187577|NCT02811978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187578|NCT02811978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187579|NCT02811978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25187580|NCT02811978|Glucocorticoids|glucocorticoids|mesh-ancestor
25187581|NCT02811978|Hormones|hormones|mesh-ancestor
25187582|NCT02811978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25187583|NCT02811978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25187584|NCT02811978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25187585|NCT02812355|Heparin|heparin|mesh-list
25187586|NCT02812355|Anticoagulants|anticoagulants|mesh-ancestor
25187587|NCT02812355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25187588|NCT02812355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25187589|NCT02812355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187590|NCT02811731|Amlodipine|amlodipine|mesh-list
25187591|NCT02811731|Candesartan|candesartan|mesh-list
25155974|NCT05208307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25155975|NCT05208307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25155976|NCT05208307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25155977|NCT05208307|Protease Inhibitors|protease inhibitors|mesh-ancestor
25155978|NCT05208307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25155979|NCT05208307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25155980|NCT05208307|Immunologic Factors|immunologic factors|mesh-ancestor
25155981|NCT05208307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25155982|NCT05208307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25155983|NCT05208307|Growth Substances|growth substances|mesh-ancestor
25155984|NCT05208307|Growth Inhibitors|growth inhibitors|mesh-ancestor
25155985|NCT05208307|Dermatologic Agents|dermatologic agents|mesh-ancestor
25155986|NCT05197322|Pembrolizumab|pembrolizumab|mesh-list
25212079|NCT02641873|Growth Inhibitors|growth inhibitors|mesh-ancestor
25212080|NCT02641873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25212081|NCT02641873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25212082|NCT02641873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212083|NCT02641873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212084|NCT02641873|Antidotes|antidotes|mesh-ancestor
25212085|NCT02641873|Protective Agents|protective agents|mesh-ancestor
25187592|NCT02811731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25187593|NCT02811731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25187594|NCT02811731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25187595|NCT02811731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187596|NCT02811731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25187597|NCT02811731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187598|NCT02811731|Vasodilator Agents|vasodilator agents|mesh-ancestor
25187599|NCT02811731|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25187600|NCT02811731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25187601|NCT02811809|Leuprolide|leuprolide|mesh-list
25187602|NCT02811809|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25187603|NCT02811809|Fertility Agents|fertility agents|mesh-ancestor
25187604|NCT02811809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25187605|NCT02811809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187606|NCT02811809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25187607|NCT02811809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25187608|NCT02811991|Acetaminophen|acetaminophen|mesh-list
24416252|NCT00202462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187609|NCT02811991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24822824|NCT02113631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822825|NCT02113631|Immunologic Factors|immunologic factors|mesh-ancestor
24822826|NCT02113631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822828|NCT02113657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24822829|NCT02113657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822830|NCT02113657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24822831|NCT02113657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822832|NCT02113735|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24822833|NCT02113735|Hormones|hormones|mesh-ancestor
24822839|NCT02113800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822840|NCT02113800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24822841|NCT02113800|Immunologic Factors|immunologic factors|mesh-ancestor
25666089|NCT01691508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25666090|NCT01691508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666091|NCT01691508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25666092|NCT01691508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25666093|NCT01691534|Pyrazinamide|pyrazinamide|mesh-list
25666094|NCT01691534|Clofazimine|clofazimine|mesh-list
25666095|NCT01691534|Antitubercular Agents|antitubercular agents|mesh-ancestor
25666096|NCT01691534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25666097|NCT01691534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25666098|NCT01691534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25666099|NCT01691534|Leprostatic Agents|leprostatic agents|mesh-ancestor
25666100|NCT01691560|Calcium, Dietary|calcium, dietary|mesh-list
25666101|NCT01691560|Listerine|listerine|mesh-list
25666102|NCT01691560|Calcium|calcium|mesh-list
25666103|NCT01691560|Fluorides|fluorides|mesh-list
25666104|NCT01691560|Sodium Fluoride|sodium fluoride|mesh-list
25666105|NCT01691560|Fluorophosphate|fluorophosphate|mesh-list
25666106|NCT01691560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25666107|NCT01691560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666108|NCT01691560|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25666109|NCT01691560|Cariostatic Agents|cariostatic agents|mesh-ancestor
24821927|NCT02108795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666110|NCT01691560|Protective Agents|protective agents|mesh-ancestor
25666111|NCT01691560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24821928|NCT02108795|Analgesics|analgesics|mesh-ancestor
24821929|NCT02108795|Sensory System Agents|sensory system agents|mesh-ancestor
24821943|NCT02108847|Anesthetics, Local|anesthetics, local|mesh-ancestor
24821944|NCT02108847|Anesthetics|anesthetics|mesh-ancestor
24821945|NCT02108847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24821946|NCT02108847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822842|NCT02113800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822843|NCT02113813|Naquotinib|naquotinib|mesh-list
24822844|NCT02113813|Midazolam|midazolam|mesh-list
24416725|NCT00203801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24416726|NCT00203801|Antiviral Agents|antiviral agents|mesh-ancestor
24416727|NCT00203801|Schistosomicides|schistosomicides|mesh-ancestor
24416728|NCT00203801|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24416729|NCT00203801|Anthelmintics|anthelmintics|mesh-ancestor
24416730|NCT00203801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24416731|NCT00203801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416732|NCT00203801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416733|NCT00203801|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24416734|NCT00203801|Renal Agents|renal agents|mesh-ancestor
24416735|NCT00203814|Artesunate|artesunate|mesh-list
24416736|NCT00203814|Pyrimethamine|pyrimethamine|mesh-list
24416737|NCT00203814|Sulfadoxine|sulfadoxine|mesh-list
24416738|NCT00203814|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25187610|NCT02811991|Analgesics|analgesics|mesh-ancestor
25187611|NCT02811991|Sensory System Agents|sensory system agents|mesh-ancestor
25187612|NCT02811991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187613|NCT02811991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187614|NCT02811991|Antipyretics|antipyretics|mesh-ancestor
25187615|NCT02811692|Aflibercept|aflibercept|mesh-list
25187616|NCT02811692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25187617|NCT02811692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25187618|NCT02811692|Growth Substances|growth substances|mesh-ancestor
25187619|NCT02811692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187620|NCT02811692|Growth Inhibitors|growth inhibitors|mesh-ancestor
25187621|NCT02811692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25187622|NCT02811627|Memantine|memantine|mesh-list
25187623|NCT02811627|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25187624|NCT02811627|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25187625|NCT02811627|Dopamine Agents|dopamine agents|mesh-ancestor
25187626|NCT02811627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25187627|NCT02811627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187628|NCT02811627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187629|NCT02811627|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25187630|NCT02811627|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25187631|NCT02811497|Azacitidine|azacitidine|mesh-list
25187633|NCT02811497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25187634|NCT02811497|Antimetabolites|antimetabolites|mesh-ancestor
25187635|NCT02811497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187636|NCT02811497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25187637|NCT02811497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25187638|NCT02811497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25187639|NCT02811484|Dapagliflozin|dapagliflozin|mesh-list
25187640|NCT02811484|Exenatide|exenatide|mesh-list
25187641|NCT02811484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25187642|NCT02811484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187643|NCT02811484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25187644|NCT02811484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187645|NCT02811484|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25187646|NCT02811484|Incretins|incretins|mesh-ancestor
25187647|NCT02811484|Hormones|hormones|mesh-ancestor
25187648|NCT02811484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25187649|NCT02811289|Mirabegron|mirabegron|mesh-list
25187650|NCT02811289|Glycerol|glycerol|mesh-list
25666112|NCT01691560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25674399|NCT01771627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674400|NCT01771666|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
25674401|NCT01771666|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25674402|NCT01771666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674403|NCT01771952|Hyaluronic Acid|hyaluronic acid|mesh-list
25674404|NCT01771952|Hylan|hylan|mesh-list
25187651|NCT02811289|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25187652|NCT02811289|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24412653|NCT00191711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24412654|NCT00191711|Immunologic Factors|immunologic factors|mesh-ancestor
24412655|NCT00191711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412663|NCT00191737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412664|NCT00191750|Pemetrexed|pemetrexed|mesh-list
24412665|NCT00191750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822018|NCT02109510|Rocuronium|rocuronium|mesh-list
24822019|NCT02109510|Anesthetics, Local|anesthetics, local|mesh-ancestor
24685261|NCT05274438|Imatinib Mesylate|imatinib mesylate|mesh-list
24657262|NCT01266512|Tubulin Modulators|tubulin modulators|mesh-ancestor
24657263|NCT01266512|Antimitotic Agents|antimitotic agents|mesh-ancestor
24657264|NCT01266512|Mitosis Modulators|mitosis modulators|mesh-ancestor
24657265|NCT01266512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657266|NCT01266655|Baclofen|baclofen|mesh-list
24412727|NCT00191893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25187654|NCT02811289|Adrenergic Agents|adrenergic agents|mesh-ancestor
25187655|NCT02811289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25187656|NCT02811289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187657|NCT02811289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187658|NCT02811289|Urological Agents|urological agents|mesh-ancestor
25187659|NCT02811289|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25187660|NCT02811289|Protective Agents|protective agents|mesh-ancestor
25187661|NCT02811185|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25187662|NCT02811185|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25187663|NCT02811185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187664|NCT02811341|Scopolamine|scopolamine|mesh-list
25187665|NCT02811341|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25187666|NCT02811341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25187667|NCT02811341|Antiemetics|antiemetics|mesh-ancestor
25187668|NCT02811341|Autonomic Agents|autonomic agents|mesh-ancestor
25187669|NCT02811341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187670|NCT02811341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187671|NCT02811341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25187672|NCT02811341|Mydriatics|mydriatics|mesh-ancestor
25187673|NCT02811341|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25187674|NCT02811341|Cholinergic Agents|cholinergic agents|mesh-ancestor
25187675|NCT02811341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25187676|NCT02811341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187677|NCT02811341|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25187678|NCT02811341|Parasympatholytics|parasympatholytics|mesh-ancestor
25187679|NCT02811354|Osimertinib|osimertinib|mesh-list
25187680|NCT02811354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25187681|NCT02811354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25187682|NCT02811354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25187683|NCT02811354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187684|NCT02811055|Aprepitant|aprepitant|mesh-list
25187685|NCT02811055|Antiemetics|antiemetics|mesh-ancestor
25187686|NCT02811055|Autonomic Agents|autonomic agents|mesh-ancestor
25187687|NCT02811055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187688|NCT02811055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187689|NCT02811055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25187690|NCT02811055|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25187691|NCT02811055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25187692|NCT02811055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187693|NCT02811016|Budesonide|budesonide|mesh-list
25187694|NCT02811016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25187695|NCT02811016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25187696|NCT02811016|Autonomic Agents|autonomic agents|mesh-ancestor
25187697|NCT02811016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187698|NCT02811016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666113|NCT01691690|Acetaminophen|acetaminophen|mesh-list
25666114|NCT01691690|Dexamethasone|dexamethasone|mesh-list
25666115|NCT01691690|Midazolam|midazolam|mesh-list
25666116|NCT01691690|Morphine|morphine|mesh-list
25666117|NCT01691690|Nitrous Oxide|nitrous oxide|mesh-list
25666118|NCT01691690|Ondansetron|ondansetron|mesh-list
25666119|NCT01691690|Propofol|propofol|mesh-list
25666120|NCT01691690|Sevoflurane|sevoflurane|mesh-list
25666121|NCT01691690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25666122|NCT01691690|Antiemetics|antiemetics|mesh-ancestor
25666123|NCT01691690|Autonomic Agents|autonomic agents|mesh-ancestor
25666124|NCT01691690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25666125|NCT01691690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666126|NCT01691690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25666127|NCT01691690|Glucocorticoids|glucocorticoids|mesh-ancestor
25666128|NCT01691690|Hormones|hormones|mesh-ancestor
25674405|NCT01771952|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25115030|NCT03118830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25115031|NCT03118830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25115032|NCT03118830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25115033|NCT03118830|Fertility Agents|fertility agents|mesh-ancestor
25115034|NCT03118830|Hormone Antagonists|hormone antagonists|mesh-ancestor
25212159|NCT02471911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25212160|NCT02471911|Alkylating Agents|alkylating agents|mesh-ancestor
25212161|NCT02432417|Chloroquine|chloroquine|mesh-list
25212162|NCT02432417|Amebicides|amebicides|mesh-ancestor
25212163|NCT02432417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25212164|NCT02432417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25212165|NCT02432417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25212166|NCT02432417|Antimalarials|antimalarials|mesh-ancestor
25212167|NCT02432417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25212168|NCT02407119|Amoxicillin|amoxicillin|mesh-list
25212169|NCT02407119|Clarithromycin|clarithromycin|mesh-list
25212171|NCT02407119|Rabeprazole|rabeprazole|mesh-list
25212172|NCT02407119|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25212173|NCT02407119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25212174|NCT02407119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25212182|NCT02364713|Gemcitabine|gemcitabine|mesh-list
25187699|NCT02811016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25187700|NCT02811016|Respiratory System Agents|respiratory system agents|mesh-ancestor
25187701|NCT02811016|Glucocorticoids|glucocorticoids|mesh-ancestor
25187702|NCT02811016|Hormones|hormones|mesh-ancestor
25187703|NCT02811016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25187704|NCT02810808|Ranibizumab|ranibizumab|mesh-list
25187705|NCT02810808|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25187706|NCT02810808|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25187707|NCT02810808|Growth Substances|growth substances|mesh-ancestor
25187708|NCT02810808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187709|NCT02810808|Growth Inhibitors|growth inhibitors|mesh-ancestor
25187710|NCT02810808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25187711|NCT02810886|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25187712|NCT02810886|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25187713|NCT02810886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187714|NCT02810782|Morphine|morphine|mesh-list
25187715|NCT02810782|Phenobarbital|phenobarbital|mesh-list
25187716|NCT02810782|Chlorpromazine|chlorpromazine|mesh-list
25187717|NCT02810782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25187718|NCT02810782|Narcotics|narcotics|mesh-ancestor
25187719|NCT02810782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25187720|NCT02810782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187721|NCT02810782|Analgesics|analgesics|mesh-ancestor
25187722|NCT02810782|Sensory System Agents|sensory system agents|mesh-ancestor
25187723|NCT02810782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187724|NCT02810782|Anticonvulsants|anticonvulsants|mesh-ancestor
25187725|NCT02810782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25187726|NCT02810782|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25187727|NCT02810782|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25187728|NCT02810782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25187729|NCT02810782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187730|NCT02810782|GABA Modulators|gaba modulators|mesh-ancestor
25187731|NCT02810782|GABA Agents|gaba agents|mesh-ancestor
25187732|NCT02810782|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25666129|NCT01691690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25666130|NCT01691690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25666131|NCT01691690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25666132|NCT01691690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25666133|NCT01691690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25666134|NCT01691690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25666135|NCT01691690|Anesthetics, General|anesthetics, general|mesh-ancestor
25666136|NCT01691690|Anesthetics|anesthetics|mesh-ancestor
25666137|NCT01691690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25666138|NCT01691690|Narcotics|narcotics|mesh-ancestor
25666139|NCT01691690|Analgesics|analgesics|mesh-ancestor
25666140|NCT01691690|Sensory System Agents|sensory system agents|mesh-ancestor
25666141|NCT01691690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25666142|NCT01691690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25666143|NCT01691690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25666144|NCT01691690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25666145|NCT01691690|GABA Modulators|gaba modulators|mesh-ancestor
25666146|NCT01691690|GABA Agents|gaba agents|mesh-ancestor
25666147|NCT01691690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25666148|NCT01691690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25156053|NCT05172791|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25156054|NCT05172791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25156055|NCT05172531|Cisatracurium|cisatracurium|mesh-list
25156056|NCT05172531|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25156057|NCT05172531|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25156058|NCT05172531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25156059|NCT05172531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25156066|NCT05168163|Atezolizumab|atezolizumab|mesh-list
25187733|NCT02810782|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25187734|NCT02810782|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25187735|NCT02810782|Antiemetics|antiemetics|mesh-ancestor
25187736|NCT02810782|Autonomic Agents|autonomic agents|mesh-ancestor
25187737|NCT02810782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25187738|NCT02810782|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25187739|NCT02810782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25187740|NCT02810782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25187741|NCT02810782|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25187742|NCT02810782|Dopamine Agents|dopamine agents|mesh-ancestor
25187743|NCT02810899|Dexmedetomidine|dexmedetomidine|mesh-list
25187744|NCT02810899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25187745|NCT02810899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25187746|NCT02810899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187747|NCT02810899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25187748|NCT02810899|Analgesics|analgesics|mesh-ancestor
25187749|NCT02810899|Sensory System Agents|sensory system agents|mesh-ancestor
25187750|NCT02810899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187751|NCT02810899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25187752|NCT02810899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25187753|NCT02810899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25187754|NCT02810899|Adrenergic Agents|adrenergic agents|mesh-ancestor
25187755|NCT02810899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25187756|NCT02810899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205967|NCT04005599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24416999|NCT00204646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25205982|NCT03991299|Cholinergic Agents|cholinergic agents|mesh-ancestor
25205983|NCT03991299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25205984|NCT03988257|Ascorbic Acid|ascorbic acid|mesh-list
25205985|NCT03988257|Vitamins|vitamins|mesh-ancestor
25205986|NCT03988257|Micronutrients|micronutrients|mesh-ancestor
25205987|NCT03988257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25205988|NCT03988257|Antioxidants|antioxidants|mesh-ancestor
25205989|NCT03988257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25205990|NCT03988257|Protective Agents|protective agents|mesh-ancestor
25187757|NCT02810587|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25187758|NCT02810587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25187760|NCT02810704|Warfarin|warfarin|mesh-list
25187761|NCT02810704|Rivaroxaban|rivaroxaban|mesh-list
25187762|NCT02810704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25187763|NCT02810704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25187764|NCT02810704|Analgesics|analgesics|mesh-ancestor
25187765|NCT02810704|Sensory System Agents|sensory system agents|mesh-ancestor
25187766|NCT02810704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187767|NCT02810704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187768|NCT02810704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25187769|NCT02810704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25187770|NCT02810704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25187771|NCT02810704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25187779|NCT02810704|Antithrombins|antithrombins|mesh-ancestor
25187780|NCT02810704|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25187781|NCT02810704|Protease Inhibitors|protease inhibitors|mesh-ancestor
25187782|NCT02810548|Mitogens|mitogens|mesh-list
25187783|NCT02810548|Mitosis Modulators|mitosis modulators|mesh-ancestor
25187784|NCT02810548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187785|NCT02810275|Leucovorin|leucovorin|mesh-list
25187786|NCT02810275|Folic Acid|folic acid|mesh-list
25187787|NCT02810275|Levoleucovorin|levoleucovorin|mesh-list
25666149|NCT01691690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25666150|NCT01691690|Antipyretics|antipyretics|mesh-ancestor
25666151|NCT01691690|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25666152|NCT01691690|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25666153|NCT01691690|Antipruritics|antipruritics|mesh-ancestor
25666154|NCT01691690|Dermatologic Agents|dermatologic agents|mesh-ancestor
25666155|NCT01691690|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25666156|NCT01691690|Serotonin Agents|serotonin agents|mesh-ancestor
25187788|NCT02810275|Antidotes|antidotes|mesh-ancestor
25187789|NCT02810275|Protective Agents|protective agents|mesh-ancestor
25187790|NCT02810275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25156084|NCT05163106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25156085|NCT05163106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25156086|NCT05163106|Hormone Antagonists|hormone antagonists|mesh-ancestor
24657465|NCT01267448|Metformin|metformin|mesh-list
25156087|NCT05163106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25156088|NCT05163106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25156089|NCT05163106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25156098|NCT05153317|Ivacaftor|ivacaftor|mesh-list
25156099|NCT05153317|Elexacaftor|elexacaftor|mesh-list
25156100|NCT05153317|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25156101|NCT05153317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25156102|NCT05153317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187791|NCT02810275|Vitamin B Complex|vitamin b complex|mesh-ancestor
25187792|NCT02810275|Vitamins|vitamins|mesh-ancestor
25187793|NCT02810275|Micronutrients|micronutrients|mesh-ancestor
25187794|NCT02810275|Hematinics|hematinics|mesh-ancestor
25187795|NCT02810483|Topiramate|topiramate|mesh-list
25187796|NCT02810483|Anticonvulsants|anticonvulsants|mesh-ancestor
25187797|NCT02810483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25187798|NCT02810483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187799|NCT02810132|Metformin|metformin|mesh-list
25187800|NCT02810132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25187801|NCT02810132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187802|NCT02810015|Botulinum Toxins|botulinum toxins|mesh-list
25187803|NCT02810015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25187804|NCT02810015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25187805|NCT02810015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25187806|NCT02810015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25187807|NCT02810015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187808|NCT02810015|Cholinergic Agents|cholinergic agents|mesh-ancestor
25187809|NCT02810015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25187810|NCT02810015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187811|NCT02810015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25187812|NCT02810015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187813|NCT02809781|Etanercept|etanercept|mesh-list
25187814|NCT02809781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25187815|NCT02809781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25187816|NCT02809781|Analgesics|analgesics|mesh-ancestor
25187817|NCT02809781|Sensory System Agents|sensory system agents|mesh-ancestor
25187818|NCT02809781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187819|NCT02809781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187820|NCT02809781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25187821|NCT02809781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25187822|NCT02809781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25187823|NCT02809781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25187824|NCT02809781|Immunologic Factors|immunologic factors|mesh-ancestor
25187825|NCT02809768|Itraconazole|itraconazole|mesh-list
25187826|NCT02809768|Fluconazole|fluconazole|mesh-list
25187827|NCT02809768|Rifampin|rifampin|mesh-list
25187828|NCT02809768|Antifungal Agents|antifungal agents|mesh-ancestor
25187829|NCT02809768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25187830|NCT02809768|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25187831|NCT02809768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25187832|NCT02809768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25187833|NCT02809768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417294|NCT00206154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417297|NCT00206167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24417298|NCT00206167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24417299|NCT00206167|Autonomic Agents|autonomic agents|mesh-ancestor
24417300|NCT00206167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24417301|NCT00206167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666157|NCT01691690|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25666158|NCT01691768|Tenofovir|tenofovir|mesh-list
25666159|NCT01691768|Antiviral Agents|antiviral agents|mesh-ancestor
25666160|NCT01691768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25666161|NCT01691768|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25666162|NCT01691768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25666163|NCT01691768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25666164|NCT01691768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666165|NCT01691768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25666166|NCT01691768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25666167|NCT01691781|Lisinopril|lisinopril|mesh-list
25666168|NCT01691781|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25666169|NCT01691781|Protease Inhibitors|protease inhibitors|mesh-ancestor
24412858|NCT00192595|Antimetabolites|antimetabolites|mesh-ancestor
24412913|NCT00192660|Lamivudine|lamivudine|mesh-list
24412914|NCT00192660|Zidovudine|zidovudine|mesh-list
24412915|NCT00192660|Nevirapine|nevirapine|mesh-list
24412916|NCT00192660|Abacavir|abacavir|mesh-list
24412917|NCT00192660|Stavudine|stavudine|mesh-list
24412918|NCT00192660|Didanosine|didanosine|mesh-list
24412919|NCT00192660|Tipranavir|tipranavir|mesh-list
24822029|NCT02109510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24417302|NCT00206167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24417303|NCT00206167|Respiratory System Agents|respiratory system agents|mesh-ancestor
24417305|NCT00206167|Hormones|hormones|mesh-ancestor
24417306|NCT00206167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24417307|NCT00206167|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25860448|NCT00083668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25187834|NCT02809768|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25187835|NCT02809768|Hormone Antagonists|hormone antagonists|mesh-ancestor
25187836|NCT02809768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25187837|NCT02809768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187838|NCT02809768|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25187839|NCT02809768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25187840|NCT02809768|Antitubercular Agents|antitubercular agents|mesh-ancestor
25187841|NCT02809768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25187842|NCT02809768|Leprostatic Agents|leprostatic agents|mesh-ancestor
25187843|NCT02809768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25187846|NCT02809768|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25187847|NCT02809768|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25187848|NCT02809768|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25187849|NCT02809768|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25187850|NCT02809768|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25187851|NCT02809768|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25187852|NCT02809937|Dexmedetomidine|dexmedetomidine|mesh-list
25187853|NCT02809937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25187854|NCT02809937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25187855|NCT02809937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187856|NCT02809937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25187857|NCT02809937|Analgesics|analgesics|mesh-ancestor
25187858|NCT02809937|Sensory System Agents|sensory system agents|mesh-ancestor
25187859|NCT02809937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187860|NCT02809937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25187861|NCT02809937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25187862|NCT02809937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25187863|NCT02809937|Adrenergic Agents|adrenergic agents|mesh-ancestor
25187864|NCT02809937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25187865|NCT02809937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187866|NCT02809963|Eplerenone|eplerenone|mesh-list
25187867|NCT02809963|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25187868|NCT02809963|Hormone Antagonists|hormone antagonists|mesh-ancestor
25187869|NCT02809963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25187870|NCT02809963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187871|NCT02809963|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25187872|NCT02809963|Diuretics|diuretics|mesh-ancestor
25187873|NCT02809963|Natriuretic Agents|natriuretic agents|mesh-ancestor
25187874|NCT02809963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25187875|NCT02809742|Ropivacaine|ropivacaine|mesh-list
25187876|NCT02809742|Anesthetics, Local|anesthetics, local|mesh-ancestor
25187877|NCT02809742|Anesthetics|anesthetics|mesh-ancestor
25187878|NCT02809742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25187879|NCT02809742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187880|NCT02809742|Sensory System Agents|sensory system agents|mesh-ancestor
25187881|NCT02809742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187882|NCT02809755|Lidocaine|lidocaine|mesh-list
25187883|NCT02809755|Anesthetics, Local|anesthetics, local|mesh-ancestor
25187884|NCT02809755|Anesthetics|anesthetics|mesh-ancestor
25187885|NCT02809755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25666170|NCT01691781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25666171|NCT01691781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666172|NCT01691781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25666173|NCT01691781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25666174|NCT01691781|Protective Agents|protective agents|mesh-ancestor
25666175|NCT01691781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666176|NCT01691794|Ritonavir|ritonavir|mesh-list
24413569|NCT00194402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24413570|NCT00194402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24413572|NCT00194402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413573|NCT00194402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24413574|NCT00194402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24413575|NCT00194402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413576|NCT00194402|Vasodilator Agents|vasodilator agents|mesh-ancestor
24413577|NCT00194402|Vitamin B Complex|vitamin b complex|mesh-ancestor
25187886|NCT02809755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187887|NCT02809755|Sensory System Agents|sensory system agents|mesh-ancestor
25187888|NCT02809755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187889|NCT02809755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25187890|NCT02809755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25187891|NCT02809755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25187892|NCT02809755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25187893|NCT02809755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187898|NCT02809729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25187899|NCT02809729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25187900|NCT02809573|Prednisone|prednisone|mesh-list
25187902|NCT02809573|Vincristine|vincristine|mesh-list
25187903|NCT02809573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25187904|NCT02809573|Immunologic Factors|immunologic factors|mesh-ancestor
25187905|NCT02809573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187906|NCT02809573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25187907|NCT02809573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25187908|NCT02809573|Alkylating Agents|alkylating agents|mesh-ancestor
25187909|NCT02809573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187910|NCT02809573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25187911|NCT02809573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25187912|NCT02809573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25187913|NCT02809573|Glucocorticoids|glucocorticoids|mesh-ancestor
25187914|NCT02809573|Hormones|hormones|mesh-ancestor
25187915|NCT02809573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25187916|NCT02809573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25187917|NCT02809573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25187918|NCT02809573|Tubulin Modulators|tubulin modulators|mesh-ancestor
25187919|NCT02809573|Antimitotic Agents|antimitotic agents|mesh-ancestor
25187920|NCT02809573|Mitosis Modulators|mitosis modulators|mesh-ancestor
25187921|NCT02809378|Remifentanil|remifentanil|mesh-list
25187922|NCT02809378|Thiopental|thiopental|mesh-list
25187923|NCT02809378|Palonosetron|palonosetron|mesh-list
25187924|NCT02809378|Propofol|propofol|mesh-list
25187925|NCT02809378|Sevoflurane|sevoflurane|mesh-list
25187926|NCT02809378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25187927|NCT02809378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25187928|NCT02809378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187929|NCT02809378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25187930|NCT02809378|Anesthetics, General|anesthetics, general|mesh-ancestor
25187931|NCT02809378|Anesthetics|anesthetics|mesh-ancestor
25187932|NCT02809378|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25187933|NCT02809378|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25187934|NCT02809378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25187935|NCT02809378|Narcotics|narcotics|mesh-ancestor
25187936|NCT02809378|Analgesics|analgesics|mesh-ancestor
25187937|NCT02809378|Sensory System Agents|sensory system agents|mesh-ancestor
25187938|NCT02809378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25187939|NCT02809378|Antiemetics|antiemetics|mesh-ancestor
25187940|NCT02809378|Autonomic Agents|autonomic agents|mesh-ancestor
25187941|NCT02809378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25187942|NCT02809378|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25187943|NCT02809378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25187944|NCT02809378|Serotonin Agents|serotonin agents|mesh-ancestor
25187945|NCT02809378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25187946|NCT02809378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187947|NCT02809378|Anticonvulsants|anticonvulsants|mesh-ancestor
25666177|NCT01691794|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25666178|NCT01691794|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25666179|NCT01691794|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25666180|NCT01691794|Protease Inhibitors|protease inhibitors|mesh-ancestor
25666181|NCT01691794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25666182|NCT01691794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666183|NCT01691794|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25666184|NCT01691794|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25212292|NCT01972035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24413801|NCT00195299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413802|NCT00195312|Bupivacaine|bupivacaine|mesh-list
24413803|NCT00195312|Anesthetics, Local|anesthetics, local|mesh-ancestor
24413804|NCT00195312|Anesthetics|anesthetics|mesh-ancestor
24413805|NCT00195312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24413806|NCT00195312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413807|NCT00195312|Sensory System Agents|sensory system agents|mesh-ancestor
24413809|NCT00195364|Etanercept|etanercept|mesh-list
25187948|NCT02809378|GABA Modulators|gaba modulators|mesh-ancestor
25187949|NCT02809378|GABA Agents|gaba agents|mesh-ancestor
25187950|NCT02809404|Everolimus|everolimus|mesh-list
25187951|NCT02809404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25187952|NCT02809404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25187953|NCT02809404|Immunologic Factors|immunologic factors|mesh-ancestor
25187954|NCT02809404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187956|NCT02809456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25187957|NCT02809456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25187958|NCT02809456|Vasodilator Agents|vasodilator agents|mesh-ancestor
25187959|NCT02809456|Vitamin B Complex|vitamin b complex|mesh-ancestor
25187960|NCT02809456|Vitamins|vitamins|mesh-ancestor
25187961|NCT02809456|Micronutrients|micronutrients|mesh-ancestor
25187962|NCT02809456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187963|NCT02809469|Apixaban|apixaban|mesh-list
25187964|NCT02809469|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25187965|NCT02809469|Antithrombins|antithrombins|mesh-ancestor
25187966|NCT02809469|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25187967|NCT02809469|Protease Inhibitors|protease inhibitors|mesh-ancestor
25187968|NCT02809469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25187969|NCT02809469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187970|NCT02809469|Anticoagulants|anticoagulants|mesh-ancestor
25187971|NCT02809079|Mycophenolic Acid|mycophenolic acid|mesh-list
25187972|NCT02809079|Prednisone|prednisone|mesh-list
25187973|NCT02809079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25187974|NCT02809079|Glucocorticoids|glucocorticoids|mesh-ancestor
25187975|NCT02809079|Hormones|hormones|mesh-ancestor
25187976|NCT02809079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25187977|NCT02809079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25187978|NCT02809079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25187979|NCT02809079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25187980|NCT02809079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25187981|NCT02809079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25187982|NCT02809079|Antitubercular Agents|antitubercular agents|mesh-ancestor
25187983|NCT02809079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25187984|NCT02809079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25187985|NCT02809079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25187986|NCT02809079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187987|NCT02809105|Linaclotide|linaclotide|mesh-list
25187988|NCT02809105|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25187989|NCT02809105|Enzyme Activators|enzyme activators|mesh-ancestor
25187990|NCT02809105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25187991|NCT02809105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25187992|NCT02808988|Zoledronic Acid|zoledronic acid|mesh-list
25187993|NCT02808988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25188002|NCT02809066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25188003|NCT02809066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188004|NCT02809066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25188015|NCT02808767|Ticagrelor|ticagrelor|mesh-list
25188016|NCT02808767|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25188017|NCT02808767|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25188018|NCT02808767|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25188019|NCT02808767|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25188020|NCT02808767|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25188021|NCT02808767|Purinergic Agents|purinergic agents|mesh-ancestor
25188022|NCT02808767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25188023|NCT02808767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666185|NCT01691794|Antiviral Agents|antiviral agents|mesh-ancestor
25666186|NCT01691794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25666187|NCT01691794|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25666188|NCT01691794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25666189|NCT01691885|Fluticasone|fluticasone|mesh-list
25666190|NCT01691885|Xhance|xhance|mesh-list
25666191|NCT01691885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25666192|NCT01691885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25666193|NCT01691885|Autonomic Agents|autonomic agents|mesh-ancestor
24543260|NCT00682760|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24543261|NCT00682760|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25188024|NCT02808767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188025|NCT02808741|Olorofim|olorofim|mesh-list
25188026|NCT02808741|Antifungal Agents|antifungal agents|mesh-ancestor
25188027|NCT02808741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25188028|NCT02808728|Bupivacaine|bupivacaine|mesh-list
25188029|NCT02808728|Ropivacaine|ropivacaine|mesh-list
25188030|NCT02808728|Anesthetics, Local|anesthetics, local|mesh-ancestor
25188031|NCT02808728|Anesthetics|anesthetics|mesh-ancestor
25188032|NCT02808728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25860449|NCT00083668|Dopamine Agents|dopamine agents|mesh-ancestor
25188033|NCT02808728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188034|NCT02808728|Sensory System Agents|sensory system agents|mesh-ancestor
25188035|NCT02808728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25188036|NCT02808676|Vitamin D|vitamin d|mesh-list
25188037|NCT02808676|Cholecalciferol|cholecalciferol|mesh-list
25188038|NCT02808676|Vitamins|vitamins|mesh-ancestor
25188040|NCT02808676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188041|NCT02808676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25188042|NCT02808676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25188043|NCT02808611|Propranolol|propranolol|mesh-list
25188044|NCT02808611|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25188045|NCT02808611|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25188046|NCT02808611|Adrenergic Agents|adrenergic agents|mesh-ancestor
25188047|NCT02808611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25188048|NCT02808611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188049|NCT02808611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188050|NCT02808611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25188051|NCT02808611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25188052|NCT02808611|Vasodilator Agents|vasodilator agents|mesh-ancestor
25188053|NCT02808533|Topiramate|topiramate|mesh-list
25188054|NCT02808533|Anticonvulsants|anticonvulsants|mesh-ancestor
25188055|NCT02808533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25188056|NCT02808533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188057|NCT02808325|Polygeline|polygeline|mesh-list
25188058|NCT02808325|Plasma Substitutes|plasma substitutes|mesh-ancestor
25188059|NCT02808325|Blood Substitutes|blood substitutes|mesh-ancestor
25188060|NCT02808247|Ifosfamide|ifosfamide|mesh-list
25188061|NCT02808247|Nintedanib|nintedanib|mesh-list
25188062|NCT02808247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25188063|NCT02808247|Alkylating Agents|alkylating agents|mesh-ancestor
25188064|NCT02808247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188065|NCT02808247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188066|NCT02808247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25188067|NCT02808247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25188068|NCT02808091|Bortezomib|bortezomib|mesh-list
25188069|NCT02808091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188070|NCT02808143|Pembrolizumab|pembrolizumab|mesh-list
25188071|NCT02808143|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25188072|NCT02808143|BCG Vaccine|bcg vaccine|mesh-list
25188073|NCT02808143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25188074|NCT02808143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188075|NCT02808143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25188076|NCT02808143|Immunologic Factors|immunologic factors|mesh-ancestor
25188077|NCT02808143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188078|NCT02808065|Mycophenolic Acid|mycophenolic acid|mesh-list
25188079|NCT02808065|Tacrolimus|tacrolimus|mesh-list
25188080|NCT02808065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25188081|NCT02808065|Immunologic Factors|immunologic factors|mesh-ancestor
25188082|NCT02808065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188083|NCT02808065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25188084|NCT02808065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25188085|NCT02808065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188086|NCT02808065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25188087|NCT02808065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188088|NCT02808065|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25188089|NCT02808065|Antitubercular Agents|antitubercular agents|mesh-ancestor
25188090|NCT02808065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25188091|NCT02808065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25188092|NCT02808117|Micronutrients|micronutrients|mesh-list
25188093|NCT02808117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188094|NCT02807909|Itraconazole|itraconazole|mesh-list
25188095|NCT02807909|Diltiazem|diltiazem|mesh-list
25188096|NCT02807909|Antifungal Agents|antifungal agents|mesh-ancestor
25666194|NCT01691885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25666195|NCT01691885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25156173|NCT05120141|Listerine|listerine|mesh-list
25156174|NCT05120141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25156175|NCT05120141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25156176|NCT05117398|Dalbavancin|dalbavancin|mesh-list
25156177|NCT05117398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25156178|NCT05117398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24414144|NCT00196378|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
24414145|NCT00196378|Estrogens, conjugated synthetic B|estrogens, conjugated synthetic b|mesh-list
24414146|NCT00196378|Hormones|hormones|mesh-ancestor
25188097|NCT02807909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25188098|NCT02807909|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25188099|NCT02807909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25188100|NCT02807909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25188101|NCT02807909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188102|NCT02807909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25188103|NCT02807909|Hormone Antagonists|hormone antagonists|mesh-ancestor
25188104|NCT02807909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25188105|NCT02807909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188106|NCT02807909|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25188107|NCT02807909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25188108|NCT02807909|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25188109|NCT02807909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25188110|NCT02807909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25188111|NCT02807909|Vasodilator Agents|vasodilator agents|mesh-ancestor
25188112|NCT02807922|Zopiclone|zopiclone|mesh-list
25188115|NCT02807922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188116|NCT02808104|Mazindol|mazindol|mesh-list
25188117|NCT02808104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25188118|NCT02808104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188119|NCT02808104|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25188120|NCT02808104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25188121|NCT02808104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25188122|NCT02808104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188123|NCT02808104|Adrenergic Agents|adrenergic agents|mesh-ancestor
25188124|NCT02808104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25188125|NCT02808104|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25188126|NCT02808104|Dopamine Agents|dopamine agents|mesh-ancestor
25188127|NCT02807870|Methylphenidate|methylphenidate|mesh-list
25188128|NCT02807870|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25188129|NCT02807870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188130|NCT02807870|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25188131|NCT02807870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25188132|NCT02807870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25188133|NCT02807870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860450|NCT00083681|Thalidomide|thalidomide|mesh-list
25860451|NCT00083681|Dexamethasone|dexamethasone|mesh-list
25860452|NCT00083681|Cisplatin|cisplatin|mesh-list
25860453|NCT00083681|Etoposide|etoposide|mesh-list
25860454|NCT00083681|Cyclophosphamide|cyclophosphamide|mesh-list
25860455|NCT00083681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188134|NCT02807870|Dopamine Agents|dopamine agents|mesh-ancestor
25188135|NCT02807870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25188136|NCT02807727|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25188137|NCT02807727|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25188138|NCT02807727|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24417795|NCT00207779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24417796|NCT00207779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24417797|NCT00207779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417798|NCT00207792|Lenograstim|lenograstim|mesh-list
24417799|NCT00207792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24417800|NCT00207792|Immunologic Factors|immunologic factors|mesh-ancestor
24417801|NCT00207792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666196|NCT01691885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25666197|NCT01691885|Respiratory System Agents|respiratory system agents|mesh-ancestor
25666198|NCT01691885|Dermatologic Agents|dermatologic agents|mesh-ancestor
25666199|NCT01691885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25666200|NCT01691898|Rituximab|rituximab|mesh-list
25666201|NCT01691898|Obinutuzumab|obinutuzumab|mesh-list
25666202|NCT01691898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25666203|NCT01691898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25666204|NCT01691898|Immunologic Factors|immunologic factors|mesh-ancestor
25860456|NCT00083681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25860457|NCT00083681|Antiemetics|antiemetics|mesh-ancestor
25272710|NCT02390505|Protective Agents|protective agents|mesh-ancestor
25272711|NCT02390440|Bupivacaine|bupivacaine|mesh-list
25156199|NCT05093205|Midazolam|midazolam|mesh-list
25860458|NCT00083681|Autonomic Agents|autonomic agents|mesh-ancestor
25860459|NCT00083681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24417857|NCT00208117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24417859|NCT00208117|Antidepressive Agents|antidepressive agents|mesh-ancestor
24417860|NCT00208117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24417861|NCT00208117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24417862|NCT00208117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24417863|NCT00208117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24417887|NCT00208156|Abortifacient Agents|abortifacient agents|mesh-ancestor
24417888|NCT00208156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24417889|NCT00208156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417890|NCT00208156|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24417891|NCT00208156|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24417892|NCT00208156|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24417893|NCT00208156|Contraceptive Agents|contraceptive agents|mesh-ancestor
24417894|NCT00208156|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24417895|NCT00208156|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24417896|NCT00208156|Hormone Antagonists|hormone antagonists|mesh-ancestor
24822962|NCT02114463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24822963|NCT02114463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24822964|NCT02114463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860460|NCT00083681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529774|NCT00627744|Hormones|hormones|mesh-ancestor
24975423|NCT03729245|Nivolumab|nivolumab|mesh-list
25188141|NCT02807610|Etomidate|etomidate|mesh-list
25188142|NCT02807610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25188143|NCT02807610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25188144|NCT02807610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188145|NCT02807610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25188146|NCT02807610|Anesthetics, General|anesthetics, general|mesh-ancestor
25188147|NCT02807610|Anesthetics|anesthetics|mesh-ancestor
25188148|NCT02807571|Anesthetics|anesthetics|mesh-list
25188149|NCT02807571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25188150|NCT02807571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188151|NCT02807441|Aspirin|aspirin|mesh-list
25188152|NCT02807441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25188153|NCT02807441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25188154|NCT02807441|Analgesics|analgesics|mesh-ancestor
25188155|NCT02807441|Sensory System Agents|sensory system agents|mesh-ancestor
25188156|NCT02807441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25188157|NCT02807441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188158|NCT02807441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25188159|NCT02807441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25188160|NCT02807441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25188161|NCT02807441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25188162|NCT02807441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188163|NCT02807441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25188164|NCT02807441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25188165|NCT02807441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25188166|NCT02807441|Antipyretics|antipyretics|mesh-ancestor
25188167|NCT02807285|Ocrelizumab|ocrelizumab|mesh-list
25188168|NCT02807285|Immunologic Factors|immunologic factors|mesh-ancestor
25188169|NCT02807285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188170|NCT02807415|Ivacaftor|ivacaftor|mesh-list
25188171|NCT02807415|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25188172|NCT02807415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25188173|NCT02807415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188174|NCT02807272|Tipifarnib|tipifarnib|mesh-list
25188175|NCT02807272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188176|NCT02807298|Lidocaine|lidocaine|mesh-list
24688724|NCT02719314|Antiemetics|antiemetics|mesh-ancestor
25188177|NCT02807298|Epinephrine|epinephrine|mesh-list
25188179|NCT02807298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25188180|NCT02807298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25188181|NCT02807298|Adrenergic Agents|adrenergic agents|mesh-ancestor
25188182|NCT02807298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25188183|NCT02807298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188184|NCT02807298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666205|NCT01691898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666206|NCT01691898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25666207|NCT01692197|Cytarabine|cytarabine|mesh-list
25860461|NCT00083681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25188185|NCT02807298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25188186|NCT02807298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25188187|NCT02807298|Autonomic Agents|autonomic agents|mesh-ancestor
25188188|NCT02807298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25188189|NCT02807298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25188190|NCT02807298|Respiratory System Agents|respiratory system agents|mesh-ancestor
25188191|NCT02807298|Mydriatics|mydriatics|mesh-ancestor
25188192|NCT02807298|Sympathomimetics|sympathomimetics|mesh-ancestor
25188193|NCT02807298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25188194|NCT02807298|Anesthetics, Local|anesthetics, local|mesh-ancestor
25188195|NCT02807298|Anesthetics|anesthetics|mesh-ancestor
25188196|NCT02807298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25188197|NCT02807298|Sensory System Agents|sensory system agents|mesh-ancestor
25188198|NCT02807298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25188199|NCT02807298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25188200|NCT02807298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25188201|NCT02807298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25188202|NCT02807207|Moxifloxacin|moxifloxacin|mesh-list
25188203|NCT02807207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25188204|NCT02807207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25188205|NCT02807207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25188206|NCT02807207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25188207|NCT02807207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25188208|NCT02807207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188209|NCT02807207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188210|NCT02806999|Insulin|insulin|mesh-list
25188211|NCT02806999|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25188212|NCT02806999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25188213|NCT02806999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188214|NCT02807103|Cyclophosphamide|cyclophosphamide|mesh-list
25188215|NCT02807103|Rituximab|rituximab|mesh-list
25860462|NCT00083681|Glucocorticoids|glucocorticoids|mesh-ancestor
25188226|NCT02807194|Anesthetics|anesthetics|mesh-list
25188227|NCT02807194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25188228|NCT02807194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188229|NCT02807116|Rifampin|rifampin|mesh-list
25188230|NCT02807116|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25188231|NCT02807116|Antitubercular Agents|antitubercular agents|mesh-ancestor
25188232|NCT02807116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25188233|NCT02807116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25188234|NCT02807116|Leprostatic Agents|leprostatic agents|mesh-ancestor
25188235|NCT02807116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25188236|NCT02807116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25188237|NCT02807116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188238|NCT02807116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25188239|NCT02807116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25188240|NCT02807116|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25188241|NCT02807116|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25188242|NCT02807116|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25188243|NCT02807116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25188244|NCT02807051|Clarithromycin|clarithromycin|mesh-list
25188245|NCT02807051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25188246|NCT02807051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25188247|NCT02807051|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25188248|NCT02807051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25188249|NCT02807051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188250|NCT02807051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25188251|NCT02807051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25188252|NCT02806882|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
25188253|NCT02806882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25188254|NCT02806882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25188255|NCT02806791|Lenograstim|lenograstim|mesh-list
25188256|NCT02806791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25188257|NCT02806791|Immunologic Factors|immunologic factors|mesh-ancestor
25188258|NCT02806791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188259|NCT02806817|Bevacizumab|bevacizumab|mesh-list
25188260|NCT02806817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25188261|NCT02806817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188262|NCT02806817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25188263|NCT02806817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25188264|NCT02806817|Growth Substances|growth substances|mesh-ancestor
25188265|NCT02806817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188266|NCT02806817|Growth Inhibitors|growth inhibitors|mesh-ancestor
25860463|NCT00083681|Hormones|hormones|mesh-ancestor
25860464|NCT00083681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25860465|NCT00083681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25666208|NCT01692197|Dexamethasone|dexamethasone|mesh-list
24658101|NCT01270438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24658102|NCT01270438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24658103|NCT01270438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24658104|NCT01270438|Growth Substances|growth substances|mesh-ancestor
24658105|NCT01270438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658106|NCT01270438|Growth Inhibitors|growth inhibitors|mesh-ancestor
24658107|NCT01270438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24658108|NCT01270438|Antimetabolites|antimetabolites|mesh-ancestor
24414943|NCT00199004|Antiemetics|antiemetics|mesh-ancestor
25188268|NCT02806804|Immunologic Factors|immunologic factors|mesh-ancestor
25188269|NCT02806804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188270|NCT02806648|Palbociclib|palbociclib|mesh-list
25188271|NCT02806648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188272|NCT02806648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25188273|NCT02806648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25188274|NCT02806648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188275|NCT02806752|Triamcinolone|triamcinolone|mesh-list
25188276|NCT02806752|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25188277|NCT02806752|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25188278|NCT02806752|Ranibizumab|ranibizumab|mesh-list
25188279|NCT02806752|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25188280|NCT02806752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25188281|NCT02806752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25188282|NCT02806752|Growth Substances|growth substances|mesh-ancestor
25188283|NCT02806752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188284|NCT02806752|Growth Inhibitors|growth inhibitors|mesh-ancestor
25188285|NCT02806752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188286|NCT02806752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25188287|NCT02806752|Glucocorticoids|glucocorticoids|mesh-ancestor
25188288|NCT02806752|Hormones|hormones|mesh-ancestor
25188289|NCT02806752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25188290|NCT02806752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25188291|NCT02806752|Immunologic Factors|immunologic factors|mesh-ancestor
25188292|NCT02806752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25188293|NCT02806752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188294|NCT02806596|Sevoflurane|sevoflurane|mesh-list
25188295|NCT02806596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25188296|NCT02806596|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25188297|NCT02806596|Anesthetics, General|anesthetics, general|mesh-ancestor
25188298|NCT02806596|Anesthetics|anesthetics|mesh-ancestor
25188299|NCT02806596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25188300|NCT02806596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188301|NCT02806492|Phenylephrine|phenylephrine|mesh-list
25188302|NCT02806492|Oxymetazoline|oxymetazoline|mesh-list
25188303|NCT02806492|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25188304|NCT02806492|Mydriatics|mydriatics|mesh-ancestor
25188305|NCT02806492|Autonomic Agents|autonomic agents|mesh-ancestor
25188306|NCT02806492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25188307|NCT02806492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188308|NCT02806492|Sympathomimetics|sympathomimetics|mesh-ancestor
25188309|NCT02806492|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25188310|NCT02806492|Nasal Decongestants|nasal decongestants|mesh-ancestor
25188311|NCT02806492|Respiratory System Agents|respiratory system agents|mesh-ancestor
25188312|NCT02806492|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25188313|NCT02806492|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25188314|NCT02806492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25188315|NCT02806492|Adrenergic Agents|adrenergic agents|mesh-ancestor
25188316|NCT02806492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25188317|NCT02806492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666209|NCT01692197|Idarubicin|idarubicin|mesh-list
25666210|NCT01692197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25666211|NCT01692197|Antiemetics|antiemetics|mesh-ancestor
25666212|NCT01692197|Autonomic Agents|autonomic agents|mesh-ancestor
25666213|NCT01692197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25666214|NCT01692197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666215|NCT01692197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25666216|NCT01692197|Glucocorticoids|glucocorticoids|mesh-ancestor
25666217|NCT01692197|Hormones|hormones|mesh-ancestor
25666218|NCT01692197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25666219|NCT01692197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25666220|NCT01692197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188318|NCT02806492|Protective Agents|protective agents|mesh-ancestor
25188319|NCT02806284|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25188320|NCT02806284|Immunologic Factors|immunologic factors|mesh-ancestor
25188321|NCT02806284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188322|NCT02806440|Naltrexone|naltrexone|mesh-list
25188323|NCT02806440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25188324|NCT02806440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25188325|NCT02806440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188326|NCT02806440|Sensory System Agents|sensory system agents|mesh-ancestor
25188327|NCT02806440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25188328|NCT02806375|Cyclophosphamide|cyclophosphamide|mesh-list
25188329|NCT02806375|Busulfan|busulfan|mesh-list
25188330|NCT02806375|Fludarabine|fludarabine|mesh-list
25188331|NCT02806375|Fludarabine phosphate|fludarabine phosphate|mesh-list
25188332|NCT02806375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25188333|NCT02806375|Immunologic Factors|immunologic factors|mesh-ancestor
25188334|NCT02806375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188335|NCT02806375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25188336|NCT02806375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25188337|NCT02806375|Alkylating Agents|alkylating agents|mesh-ancestor
25188338|NCT02806375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188339|NCT02806375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188340|NCT02806375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25188341|NCT02806375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25188342|NCT02806375|Antimetabolites|antimetabolites|mesh-ancestor
25188343|NCT02806349|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
25188344|NCT02806349|Cathartics|cathartics|mesh-ancestor
25188345|NCT02806349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25188346|NCT02806362|Ritonavir|ritonavir|mesh-list
25188347|NCT02806362|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25188348|NCT02806362|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25188349|NCT02806362|Protease Inhibitors|protease inhibitors|mesh-ancestor
25188350|NCT02806362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25188351|NCT02806362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188352|NCT02806362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25188353|NCT02806362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25188354|NCT02806362|Antiviral Agents|antiviral agents|mesh-ancestor
25188355|NCT02806362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25188356|NCT02806362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25188357|NCT02806362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25188358|NCT02806206|Prucalopride|prucalopride|mesh-list
25188359|NCT02806206|Laxatives|laxatives|mesh-ancestor
25188360|NCT02806206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25188361|NCT02806206|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
25188362|NCT02806206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25188363|NCT02806206|Serotonin Agents|serotonin agents|mesh-ancestor
25188364|NCT02806206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25188365|NCT02806206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188366|NCT02806206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188367|NCT02806141|Colistin|colistin|mesh-list
24822984|NCT02114502|Glucocorticoids|glucocorticoids|mesh-ancestor
25188368|NCT02806141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25188369|NCT02806141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25188370|NCT02806128|Kallikreins|kallikreins|mesh-list
24418291|NCT00209209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25188371|NCT02806128|Coagulants|coagulants|mesh-ancestor
25188372|NCT02806128|Fertility Agents, Male|fertility agents, male|mesh-ancestor
25188373|NCT02806128|Fertility Agents|fertility agents|mesh-ancestor
25188374|NCT02806128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25188375|NCT02806128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188376|NCT02806115|Acetic Acid|acetic acid|mesh-list
25188377|NCT02806115|Retinol acetate|retinol acetate|mesh-list
25188378|NCT02806115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25188379|NCT02806115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25188380|NCT02806115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25188381|NCT02806115|Immunologic Factors|immunologic factors|mesh-ancestor
25188382|NCT02806115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188383|NCT02806115|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25188384|NCT02806115|Protective Agents|protective agents|mesh-ancestor
25188385|NCT02806115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188386|NCT02806050|Letrozole|letrozole|mesh-list
25188387|NCT02806050|Palbociclib|palbociclib|mesh-list
25188388|NCT02806050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188389|NCT02806050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25188390|NCT02806050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25188391|NCT02806050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25427186|NCT01920737|Vitamin B Complex|vitamin b complex|mesh-ancestor
25188392|NCT02806050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188393|NCT02806050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25188394|NCT02806050|Hormone Antagonists|hormone antagonists|mesh-ancestor
25188395|NCT02806050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25188396|NCT02806050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188397|NCT02806050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25188398|NCT02805946|Posaconazole|posaconazole|mesh-list
25188399|NCT02805946|Antifungal Agents|antifungal agents|mesh-ancestor
25188400|NCT02805946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25188401|NCT02805946|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25188402|NCT02805946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25188403|NCT02805946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25188404|NCT02805946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25188405|NCT02805946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25188406|NCT02805946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25188407|NCT02805946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188422|NCT02805920|Anesthetics, Local|anesthetics, local|mesh-ancestor
25188423|NCT02805920|Anesthetics|anesthetics|mesh-ancestor
25188424|NCT02805920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25188425|NCT02805920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188426|NCT02805920|Sensory System Agents|sensory system agents|mesh-ancestor
25188427|NCT02805920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25188428|NCT02805608|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25188429|NCT02805608|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25188430|NCT02805608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188432|NCT02805842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25188433|NCT02805842|Immunologic Factors|immunologic factors|mesh-ancestor
25188434|NCT02805842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188435|NCT02805842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25188436|NCT02805842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25188437|NCT02805842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188438|NCT02805829|Trastuzumab|trastuzumab|mesh-list
25188439|NCT02805829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25188440|NCT02805829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188441|NCT02805725|Cyclophosphamide|cyclophosphamide|mesh-list
25188442|NCT02805725|Trabectedin|trabectedin|mesh-list
25188443|NCT02805725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25188444|NCT02805725|Immunologic Factors|immunologic factors|mesh-ancestor
25188445|NCT02805725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188446|NCT02805725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25188447|NCT02805725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25188448|NCT02805725|Alkylating Agents|alkylating agents|mesh-ancestor
25188449|NCT02805725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188450|NCT02805725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188451|NCT02805725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25188453|NCT02805868|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25188454|NCT02805868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188455|NCT02805868|Immunologic Factors|immunologic factors|mesh-ancestor
25188456|NCT02805868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188457|NCT02805556|Fostemsavir|fostemsavir|mesh-list
25188458|NCT02805556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25188459|NCT02805556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25188460|NCT02805556|Antiviral Agents|antiviral agents|mesh-ancestor
25188461|NCT02805556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25188462|NCT02805556|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25188463|NCT02805556|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25188464|NCT02805556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739241|NCT01680081|Adenosine|adenosine|mesh-list
25208149|NCT02997605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25208150|NCT02997605|Hormones|hormones|mesh-ancestor
25208151|NCT02997605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25208152|NCT02997605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208153|NCT02997605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25208154|NCT02997605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208155|NCT02988297|RNS60|rns60|mesh-list
25208156|NCT02988297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25208157|NCT02988297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25208158|NCT02988297|Analgesics|analgesics|mesh-ancestor
25208159|NCT02988297|Sensory System Agents|sensory system agents|mesh-ancestor
25208160|NCT02988297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25208161|NCT02988297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208162|NCT02988297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24415516|NCT00199784|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24415517|NCT00199784|Mydriatics|mydriatics|mesh-ancestor
24415590|NCT00200226|Pyridoxal|pyridoxal|mesh-list
25208163|NCT02988297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25208164|NCT02988297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25188465|NCT02805426|Misoprostol|misoprostol|mesh-list
25188466|NCT02805426|Tranexamic Acid|tranexamic acid|mesh-list
25188467|NCT02805426|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25188468|NCT02805426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25188469|NCT02805426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188470|NCT02805426|Hemostatics|hemostatics|mesh-ancestor
25188471|NCT02805426|Coagulants|coagulants|mesh-ancestor
25188472|NCT02805426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25188473|NCT02805426|Abortifacient Agents|abortifacient agents|mesh-ancestor
25188474|NCT02805426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25188475|NCT02805426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188476|NCT02805426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25188477|NCT02805426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25188478|NCT02805426|Oxytocics|oxytocics|mesh-ancestor
25188479|NCT02805452|Solifenacin Succinate|solifenacin succinate|mesh-list
25188480|NCT02805452|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25188481|NCT02805452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25188482|NCT02805452|Cholinergic Agents|cholinergic agents|mesh-ancestor
25188483|NCT02805452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25188484|NCT02805452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188485|NCT02805452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188486|NCT02805452|Urological Agents|urological agents|mesh-ancestor
25188487|NCT02805049|Caspofungin|caspofungin|mesh-list
25188489|NCT02805049|Echinocandins|echinocandins|mesh-list
25188490|NCT02805049|Antifungal Agents|antifungal agents|mesh-ancestor
25188491|NCT02805049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25188492|NCT02805049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25188493|NCT02805049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188494|NCT02805153|Lenograstim|lenograstim|mesh-list
25188495|NCT02805153|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25188496|NCT02805153|Immunologic Factors|immunologic factors|mesh-ancestor
25188497|NCT02805153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188498|NCT02805231|Vitamin D|vitamin d|mesh-list
25188499|NCT02805231|Vitamins|vitamins|mesh-ancestor
25188500|NCT02805231|Micronutrients|micronutrients|mesh-ancestor
25188501|NCT02805231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188502|NCT02805231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25188503|NCT02805010|Abatacept|abatacept|mesh-list
25188504|NCT02805010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25188505|NCT02805010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188506|NCT02805010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188507|NCT02805010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25188508|NCT02805010|Immunologic Factors|immunologic factors|mesh-ancestor
25188509|NCT02805010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188510|NCT02805010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25188512|NCT02804815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25188513|NCT02804815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25188514|NCT02804815|Analgesics|analgesics|mesh-ancestor
25188515|NCT02804815|Sensory System Agents|sensory system agents|mesh-ancestor
25188516|NCT02804815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25188517|NCT02804815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188518|NCT02804815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25188519|NCT02804815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25188520|NCT02804815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25188521|NCT02804815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25188522|NCT02804815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188523|NCT02804815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25188524|NCT02804815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25188525|NCT02804815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25188526|NCT02804815|Antipyretics|antipyretics|mesh-ancestor
25188527|NCT02804841|Vitamin D|vitamin d|mesh-list
25188528|NCT02804841|Ergocalciferols|ergocalciferols|mesh-list
25188529|NCT02804841|Cholecalciferol|cholecalciferol|mesh-list
25188530|NCT02804841|Vitamins|vitamins|mesh-list
25188531|NCT02804841|Micronutrients|micronutrients|mesh-ancestor
25188532|NCT02804841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188533|NCT02804841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25188534|NCT02804841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25188535|NCT02804711|Vaccines|vaccines|mesh-list
25666221|NCT01692197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25666222|NCT01692197|Antimetabolites|antimetabolites|mesh-ancestor
25860466|NCT00083681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24415784|NCT00200668|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25666223|NCT01692197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415785|NCT00200668|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24415786|NCT00200668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415787|NCT00200681|Bortezomib|bortezomib|mesh-list
24415788|NCT00200681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415789|NCT00200694|Valsartan|valsartan|mesh-list
24415790|NCT00200694|Ramipril|ramipril|mesh-list
24415791|NCT00200694|Furosemide|furosemide|mesh-list
25188536|NCT02804711|Immunologic Factors|immunologic factors|mesh-ancestor
25188537|NCT02804711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188538|NCT02804776|Gefitinib|gefitinib|mesh-list
25188539|NCT02804776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188540|NCT02804776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25188541|NCT02804776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25188542|NCT02804776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188543|NCT02804633|Acetaminophen|acetaminophen|mesh-list
25188544|NCT02804633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25188545|NCT02804633|Analgesics|analgesics|mesh-ancestor
25188546|NCT02804633|Sensory System Agents|sensory system agents|mesh-ancestor
25188547|NCT02804633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25188548|NCT02804633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188549|NCT02804633|Antipyretics|antipyretics|mesh-ancestor
25188550|NCT02804646|Carboplatin|carboplatin|mesh-list
25188551|NCT02804646|Pemetrexed|pemetrexed|mesh-list
25188552|NCT02804646|Endostatins|endostatins|mesh-list
25188553|NCT02804646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188554|NCT02804646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25188555|NCT02804646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188556|NCT02804646|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25188557|NCT02804646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25188558|NCT02804646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25188559|NCT02804646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25188560|NCT02804646|Growth Substances|growth substances|mesh-ancestor
25188561|NCT02804646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188562|NCT02804646|Growth Inhibitors|growth inhibitors|mesh-ancestor
25188563|NCT02804490|Vitamin A|vitamin a|mesh-list
25188564|NCT02804490|Beta Carotene|beta carotene|mesh-list
25188565|NCT02804490|Provitamins|provitamins|mesh-list
25188566|NCT02804490|Carotenoids|carotenoids|mesh-list
25188567|NCT02804490|Vitamins|vitamins|mesh-ancestor
25188568|NCT02804490|Micronutrients|micronutrients|mesh-ancestor
25188569|NCT02804490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188570|NCT02804490|Antioxidants|antioxidants|mesh-ancestor
25188571|NCT02804490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188572|NCT02804490|Protective Agents|protective agents|mesh-ancestor
25188573|NCT02804386|Sofosbuvir|sofosbuvir|mesh-list
25188574|NCT02804386|Antiviral Agents|antiviral agents|mesh-ancestor
25188575|NCT02804386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25188576|NCT02804360|Dexamethasone|dexamethasone|mesh-list
25188577|NCT02804360|Dexamethasone acetate|dexamethasone acetate|mesh-list
25188578|NCT02804360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25188579|NCT02804360|Antiemetics|antiemetics|mesh-ancestor
25188580|NCT02804360|Autonomic Agents|autonomic agents|mesh-ancestor
25188581|NCT02804360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25188587|NCT02804360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25188588|NCT02804360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188590|NCT02804373|Oxytocics|oxytocics|mesh-ancestor
25188591|NCT02804373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25188592|NCT02804373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188593|NCT02804126|Acetaminophen|acetaminophen|mesh-list
25188594|NCT02804126|Dipyrone|dipyrone|mesh-list
25188595|NCT02804126|Ketoprofen|ketoprofen|mesh-list
25188596|NCT02804126|Morphine|morphine|mesh-list
25188597|NCT02804126|Bupivacaine|bupivacaine|mesh-list
25188598|NCT02804126|Anesthetics, Local|anesthetics, local|mesh-ancestor
25188599|NCT02804126|Anesthetics|anesthetics|mesh-ancestor
25188600|NCT02804126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25666224|NCT01692197|Antiviral Agents|antiviral agents|mesh-ancestor
25666225|NCT01692197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25666226|NCT01692197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25666227|NCT01692197|Immunologic Factors|immunologic factors|mesh-ancestor
25666228|NCT01692197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25666229|NCT01692197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25666230|NCT01692197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25188601|NCT02804126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188602|NCT02804126|Sensory System Agents|sensory system agents|mesh-ancestor
25427187|NCT01920737|Vitamins|vitamins|mesh-ancestor
25188603|NCT02804126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25188604|NCT02804126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25188605|NCT02804126|Narcotics|narcotics|mesh-ancestor
25188606|NCT02804126|Analgesics|analgesics|mesh-ancestor
25188607|NCT02804126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25188608|NCT02804126|Antipyretics|antipyretics|mesh-ancestor
25188609|NCT02804126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25188610|NCT02804126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25188611|NCT02804126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25188612|NCT02804126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25188613|NCT02804126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25188614|NCT02804126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188615|NCT02803918|Metformin|metformin|mesh-list
25188616|NCT02803918|Lixisenatide|lixisenatide|mesh-list
25188617|NCT02803918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25188618|NCT02803918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188619|NCT02803944|Azithromycin|azithromycin|mesh-list
25188620|NCT02803944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25188621|NCT02803944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25206077|NCT03896685|Linezolid|linezolid|mesh-list
25206078|NCT03896685|Bedaquiline|bedaquiline|mesh-list
25206079|NCT03896685|Clofazimine|clofazimine|mesh-list
25206080|NCT03896685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25206081|NCT03896685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25206082|NCT03896685|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25206083|NCT03896685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25206084|NCT03896685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206085|NCT03896685|Antitubercular Agents|antitubercular agents|mesh-ancestor
25206086|NCT03896685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25206087|NCT03896685|Leprostatic Agents|leprostatic agents|mesh-ancestor
25206094|NCT03871491|Azithromycin|azithromycin|mesh-list
25206095|NCT03871491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25206096|NCT03871491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25206097|NCT03868839|Telmisartan|telmisartan|mesh-list
25206098|NCT03868839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25206099|NCT03868839|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25206100|NCT03868839|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25206101|NCT03868839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206102|NCT03862495|Azithromycin|azithromycin|mesh-list
25206103|NCT03862495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25206104|NCT03862495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25206105|NCT03859427|Dexamethasone|dexamethasone|mesh-list
25206106|NCT03859427|Lenalidomide|lenalidomide|mesh-list
25206107|NCT03859427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25206108|NCT03859427|Antiemetics|antiemetics|mesh-ancestor
25206109|NCT03859427|Autonomic Agents|autonomic agents|mesh-ancestor
25206110|NCT03859427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25206111|NCT03859427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206112|NCT03859427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25206113|NCT03859427|Glucocorticoids|glucocorticoids|mesh-ancestor
25206114|NCT03859427|Hormones|hormones|mesh-ancestor
25206115|NCT03859427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25206116|NCT03859427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25206117|NCT03859427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206118|NCT03859427|Immunologic Factors|immunologic factors|mesh-ancestor
25206119|NCT03859427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25206120|NCT03859427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25206121|NCT03859427|Growth Substances|growth substances|mesh-ancestor
25206122|NCT03859427|Growth Inhibitors|growth inhibitors|mesh-ancestor
25206123|NCT03848689|Fluoroquinolones|fluoroquinolones|mesh-list
25206124|NCT03848689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25206125|NCT03848689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25206126|NCT03848689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25206127|NCT03848689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25206128|NCT03848689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206129|NCT03842085|Antibodies|antibodies|mesh-list
25206130|NCT03842085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25206131|NCT03842085|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25206132|NCT03842085|Immunologic Factors|immunologic factors|mesh-ancestor
25206133|NCT03842085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206134|NCT03821246|Atezolizumab|atezolizumab|mesh-list
25206135|NCT03821246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25206136|NCT03821246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206137|NCT03821246|Immunologic Factors|immunologic factors|mesh-ancestor
25206138|NCT03821246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206139|NCT03815019|Megestrol|megestrol|mesh-list
25206140|NCT03815019|Megestrol Acetate|megestrol acetate|mesh-list
25212437|NCT01207011|Amrubicin|amrubicin|mesh-list
25206141|NCT03815019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25206142|NCT03815019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25206143|NCT03815019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25206144|NCT03815019|Contraceptive Agents|contraceptive agents|mesh-ancestor
25206145|NCT03815019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25206146|NCT03815019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206147|NCT03815019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25206148|NCT03815019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25188622|NCT02803892|Vildagliptin|vildagliptin|mesh-list
25188623|NCT02803892|Sirolimus|sirolimus|mesh-list
25188624|NCT02803892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25188625|NCT02803892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25188626|NCT02803892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25188627|NCT02803892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188628|NCT02803892|Antifungal Agents|antifungal agents|mesh-ancestor
25188629|NCT02803892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25188630|NCT02803892|Immunologic Factors|immunologic factors|mesh-ancestor
25188631|NCT02803892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188632|NCT02803892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25188633|NCT02803892|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25188634|NCT02803892|Protease Inhibitors|protease inhibitors|mesh-ancestor
25188635|NCT02803892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25188636|NCT02803892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860467|NCT00083681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25188637|NCT02803788|Dexamethasone|dexamethasone|mesh-list
25188638|NCT02803788|Ondansetron|ondansetron|mesh-list
25188639|NCT02803788|Ramosetron|ramosetron|mesh-list
25188640|NCT02803788|Antiemetics|antiemetics|mesh-list
25188641|NCT02803788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25188642|NCT02803788|Autonomic Agents|autonomic agents|mesh-ancestor
25188643|NCT02803788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25188644|NCT02803788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188645|NCT02803788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25188646|NCT02803788|Glucocorticoids|glucocorticoids|mesh-ancestor
25188647|NCT02803788|Hormones|hormones|mesh-ancestor
25188648|NCT02803788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25188649|NCT02803788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25188650|NCT02803788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188651|NCT02803788|Antipruritics|antipruritics|mesh-ancestor
25188652|NCT02803788|Dermatologic Agents|dermatologic agents|mesh-ancestor
25188653|NCT02803788|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25188654|NCT02803788|Serotonin Agents|serotonin agents|mesh-ancestor
25188655|NCT02803788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25188656|NCT02803788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188657|NCT02803788|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25188658|NCT02803788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25188659|NCT02803788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25188660|NCT02803788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25188661|NCT02803788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25188662|NCT02803502|Thrombin|thrombin|mesh-list
25188663|NCT02803502|Hemostatics|hemostatics|mesh-ancestor
25188664|NCT02803502|Coagulants|coagulants|mesh-ancestor
25188665|NCT02803385|Analgesics, Opioid|analgesics, opioid|mesh-list
25188666|NCT02803385|Anesthetics|anesthetics|mesh-list
25188667|NCT02803385|Anesthetics, Local|anesthetics, local|mesh-list
25188668|NCT02803385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25188669|NCT02803385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188670|NCT02803385|Narcotics|narcotics|mesh-ancestor
25188671|NCT02803385|Analgesics|analgesics|mesh-ancestor
25188672|NCT02803385|Sensory System Agents|sensory system agents|mesh-ancestor
25188673|NCT02803385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25188674|NCT02803216|Amoxicillin|amoxicillin|mesh-list
25188675|NCT02803216|Clarithromycin|clarithromycin|mesh-list
25188676|NCT02803216|Omeprazole|omeprazole|mesh-list
25188677|NCT02803216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25188678|NCT02803216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25188679|NCT02803216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25188680|NCT02803216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25188681|NCT02803216|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25188682|NCT02803216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25188683|NCT02803216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188684|NCT02803216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25188685|NCT02803216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25666231|NCT01692197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25188686|NCT02803216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25188687|NCT02802995|Thrombin|thrombin|mesh-list
24416591|NCT00203528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24416592|NCT00203528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24416593|NCT00203528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24416594|NCT00203528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25188689|NCT02802995|Coagulants|coagulants|mesh-ancestor
25188690|NCT02803073|Methyltestosterone|methyltestosterone|mesh-list
25188691|NCT02803073|Testosterone|testosterone|mesh-list
25188692|NCT02803073|Testosterone undecanoate|testosterone undecanoate|mesh-list
25188693|NCT02803073|Testosterone enanthate|testosterone enanthate|mesh-list
25188694|NCT02803073|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25188695|NCT02803073|Androgens|androgens|mesh-ancestor
25188696|NCT02803073|Hormones|hormones|mesh-ancestor
25188697|NCT02803073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25188698|NCT02803073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188699|NCT02803073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25188700|NCT02803073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188702|NCT02802943|Imiquimod|imiquimod|mesh-list
25188703|NCT02802943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25188704|NCT02802943|Immunologic Factors|immunologic factors|mesh-ancestor
25188705|NCT02802943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188706|NCT02802943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188707|NCT02802943|Interferon Inducers|interferon inducers|mesh-ancestor
25188708|NCT02802748|Letrozole|letrozole|mesh-list
25188709|NCT02802748|Vinorelbine|vinorelbine|mesh-list
25188710|NCT02802748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188711|NCT02802748|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25188712|NCT02802748|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25188713|NCT02802748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25188714|NCT02802748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188715|NCT02802748|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25188716|NCT02802748|Hormone Antagonists|hormone antagonists|mesh-ancestor
25188717|NCT02802748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25188718|NCT02802748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188719|NCT02802748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25188720|NCT02802748|Tubulin Modulators|tubulin modulators|mesh-ancestor
25188721|NCT02802748|Antimitotic Agents|antimitotic agents|mesh-ancestor
25188722|NCT02802748|Mitosis Modulators|mitosis modulators|mesh-ancestor
25188723|NCT02802631|Minocycline|minocycline|mesh-list
25188724|NCT02802631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25188725|NCT02802631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25188726|NCT02802722|Vitamin D|vitamin d|mesh-list
25188727|NCT02802722|Cholecalciferol|cholecalciferol|mesh-list
25188728|NCT02802722|Vitamins|vitamins|mesh-ancestor
25188729|NCT02802722|Micronutrients|micronutrients|mesh-ancestor
25188730|NCT02802722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188836|NCT02802137|Adrenergic Agents|adrenergic agents|mesh-ancestor
25188731|NCT02802722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25188732|NCT02802722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25188733|NCT02802644|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25188734|NCT02802644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25188735|NCT02802644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188736|NCT02802644|Incretins|incretins|mesh-ancestor
25188737|NCT02802644|Hormones|hormones|mesh-ancestor
25188738|NCT02802644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25188976|NCT02801201|GABA Agents|gaba agents|mesh-ancestor
25188739|NCT02802644|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25188740|NCT02802644|Protease Inhibitors|protease inhibitors|mesh-ancestor
25188741|NCT02802644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25188742|NCT02802644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188743|NCT02802683|Phenylephrine|phenylephrine|mesh-list
25188744|NCT02802683|Oxymetazoline|oxymetazoline|mesh-list
25188745|NCT02802683|Bupivacaine|bupivacaine|mesh-list
25188746|NCT02802683|Levobupivacaine|levobupivacaine|mesh-list
25188747|NCT02802683|Anesthetics, Local|anesthetics, local|mesh-ancestor
25188748|NCT02802683|Anesthetics|anesthetics|mesh-ancestor
25188749|NCT02802683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25188750|NCT02802683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188751|NCT02802683|Sensory System Agents|sensory system agents|mesh-ancestor
25188752|NCT02802683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25188753|NCT02802683|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25666232|NCT01692301|Amlodipine|amlodipine|mesh-list
25666233|NCT01692301|Valsartan|valsartan|mesh-list
25666234|NCT01692301|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25666235|NCT01692301|Olmesartan|olmesartan|mesh-list
25188754|NCT02802683|Mydriatics|mydriatics|mesh-ancestor
25666236|NCT01692301|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25666237|NCT01692301|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25666238|NCT01692301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25666239|NCT01692301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25666240|NCT01692301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24416943|NCT00204542|Sensory System Agents|sensory system agents|mesh-ancestor
24416944|NCT00204542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24416945|NCT00204542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25156311|NCT05073627|Dicloxacillin|dicloxacillin|mesh-list
25188755|NCT02802683|Autonomic Agents|autonomic agents|mesh-ancestor
25188756|NCT02802683|Sympathomimetics|sympathomimetics|mesh-ancestor
25188757|NCT02802683|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25188758|NCT02802683|Nasal Decongestants|nasal decongestants|mesh-ancestor
25188759|NCT02802683|Respiratory System Agents|respiratory system agents|mesh-ancestor
25188760|NCT02802683|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25188761|NCT02802683|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25188762|NCT02802683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25188763|NCT02802683|Adrenergic Agents|adrenergic agents|mesh-ancestor
25188764|NCT02802683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25188765|NCT02802683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188766|NCT02802683|Protective Agents|protective agents|mesh-ancestor
25188768|NCT02802696|Diuretics|diuretics|mesh-ancestor
25188769|NCT02802696|Natriuretic Agents|natriuretic agents|mesh-ancestor
25188770|NCT02802696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188771|NCT02802696|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25860468|NCT00083681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25188772|NCT02802696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25188773|NCT02802696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188775|NCT02802605|Anticoagulants|anticoagulants|mesh-ancestor
25188776|NCT02802540|Nabilone|nabilone|mesh-list
25188777|NCT02802540|Antiemetics|antiemetics|mesh-ancestor
25188778|NCT02802540|Autonomic Agents|autonomic agents|mesh-ancestor
25188779|NCT02802540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25188780|NCT02802540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188781|NCT02802540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25188782|NCT02802540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25188783|NCT02802540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25188784|NCT02802540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25188785|NCT02802540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25188786|NCT02802215|Folic Acid|folic acid|mesh-list
25188787|NCT02802215|Metformin|metformin|mesh-list
25188788|NCT02802215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25188789|NCT02802215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188790|NCT02802215|Hematinics|hematinics|mesh-ancestor
25188791|NCT02802215|Vitamin B Complex|vitamin b complex|mesh-ancestor
25188792|NCT02802215|Vitamins|vitamins|mesh-ancestor
25188793|NCT02802215|Micronutrients|micronutrients|mesh-ancestor
25188794|NCT02802163|Dexamethasone|dexamethasone|mesh-list
25188795|NCT02802163|Lenalidomide|lenalidomide|mesh-list
25188796|NCT02802163|Panobinostat|panobinostat|mesh-list
25188797|NCT02802163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25188798|NCT02802163|Antiemetics|antiemetics|mesh-ancestor
25188799|NCT02802163|Autonomic Agents|autonomic agents|mesh-ancestor
25188800|NCT02802163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25188801|NCT02802163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188802|NCT02802163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25188803|NCT02802163|Glucocorticoids|glucocorticoids|mesh-ancestor
25188804|NCT02802163|Hormones|hormones|mesh-ancestor
25188805|NCT02802163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25188806|NCT02802163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25188807|NCT02802163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188808|NCT02802163|Immunologic Factors|immunologic factors|mesh-ancestor
25188809|NCT02802163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25188810|NCT02802163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25188811|NCT02802163|Growth Substances|growth substances|mesh-ancestor
25188812|NCT02802163|Growth Inhibitors|growth inhibitors|mesh-ancestor
25188813|NCT02802163|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25188814|NCT02802163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25188815|NCT02802163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206151|NCT03815019|Appetite Stimulants|appetite stimulants|mesh-ancestor
25427188|NCT01920737|Micronutrients|micronutrients|mesh-ancestor
25666241|NCT01692301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666242|NCT01692301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25666243|NCT01692301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206152|NCT03815019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25206153|NCT03813992|Nitroglycerin|nitroglycerin|mesh-list
25206154|NCT03813992|Vasodilator Agents|vasodilator agents|mesh-ancestor
25206155|NCT03808740|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25206156|NCT03808740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25206157|NCT03808740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25206158|NCT03808740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25206159|NCT03808740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206160|NCT03808740|Adrenergic Agents|adrenergic agents|mesh-ancestor
25206161|NCT03808740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25206162|NCT03808740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206163|NCT03792256|Cytarabine|cytarabine|mesh-list
25206164|NCT03792256|Prednisone|prednisone|mesh-list
25206165|NCT03792256|Prednisolone|prednisolone|mesh-list
25206166|NCT03792256|Hydrocortisone|hydrocortisone|mesh-list
25206167|NCT03792256|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25206168|NCT03792256|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25206169|NCT03792256|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25206170|NCT03792256|Doxorubicin|doxorubicin|mesh-list
25206171|NCT03792256|Methotrexate|methotrexate|mesh-list
25206172|NCT03792256|Vincristine|vincristine|mesh-list
25206173|NCT03792256|Palbociclib|palbociclib|mesh-list
25206174|NCT03792256|Pegaspargase|pegaspargase|mesh-list
25206175|NCT03792256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25206176|NCT03792256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206177|NCT03792256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25206178|NCT03792256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25206179|NCT03792256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25206180|NCT03792256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206181|NCT03792256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24419547|NCT00212589|Protective Agents|protective agents|mesh-ancestor
24419548|NCT00212589|Vitamin B Complex|vitamin b complex|mesh-ancestor
24975560|NCT03476577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975562|NCT03476551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24975563|NCT03476551|Diuretics|diuretics|mesh-ancestor
24975564|NCT03476551|Natriuretic Agents|natriuretic agents|mesh-ancestor
24975565|NCT03476551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975566|NCT03476551|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24783480|NCT01902186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860469|NCT00083681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860470|NCT00083681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105579|NCT05255211|Anesthetics|anesthetics|mesh-ancestor
24976643|NCT05276492|Hormones|hormones|mesh-ancestor
24976670|NCT05275777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24976671|NCT05275777|Alkylating Agents|alkylating agents|mesh-ancestor
24976672|NCT05275777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24976720|NCT05274672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24976721|NCT05274672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24976722|NCT05274672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24976723|NCT05274672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24976724|NCT05274672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24976725|NCT05274672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976726|NCT05274672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976727|NCT05274672|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24976728|NCT05274672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24976729|NCT05274672|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24976730|NCT05274672|Renal Agents|renal agents|mesh-ancestor
24976758|NCT05222724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24976760|NCT05222724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976761|NCT05218629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24976762|NCT05218629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976763|NCT05218629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977113|NCT03541447|Octreotide|octreotide|mesh-list
24977114|NCT03541447|Tolvaptan|tolvaptan|mesh-list
24977115|NCT03541447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24977116|NCT03541447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24977117|NCT03541447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189234|NCT02799589|Anesthetics, Local|anesthetics, local|mesh-ancestor
24977120|NCT03541447|Natriuretic Agents|natriuretic agents|mesh-ancestor
24977121|NCT03541447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977122|NCT03469492|Insulin|insulin|mesh-list
24977123|NCT03469492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24977176|NCT03340896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427388|NCT01897441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24417567|NCT00206778|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24977178|NCT03340896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24977179|NCT03340896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25860471|NCT00083681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24443470|NCT00295035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24443471|NCT00295035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24443472|NCT00295035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443473|NCT00295035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443474|NCT00295035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24443475|NCT00295100|Tamoxifen|tamoxifen|mesh-list
24443476|NCT00295100|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25860472|NCT00083681|Immunologic Factors|immunologic factors|mesh-ancestor
24460657|NCT00349206|Sirolimus|sirolimus|mesh-list
24977180|NCT03340896|Immunologic Factors|immunologic factors|mesh-ancestor
24977181|NCT03340896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977185|NCT03330249|Cisplatin|cisplatin|mesh-list
24977186|NCT03330249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977187|NCT03316807|Vaccines|vaccines|mesh-list
24977188|NCT03316807|Immunologic Factors|immunologic factors|mesh-ancestor
24977189|NCT03316807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977190|NCT03304379|Celecoxib|celecoxib|mesh-list
24977191|NCT03304379|Diclofenac|diclofenac|mesh-list
24977192|NCT03304379|Fasinumab|fasinumab|mesh-list
24977193|NCT03304379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24977194|NCT03304379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24977284|NCT02807805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24977285|NCT02807805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977286|NCT02807805|Hormone Antagonists|hormone antagonists|mesh-ancestor
24977287|NCT02807805|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24977288|NCT02807805|Anticestodal Agents|anticestodal agents|mesh-ancestor
24977306|NCT02553473|Doxycycline|doxycycline|mesh-list
24977307|NCT02553473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25188816|NCT02802072|Aspirin|aspirin|mesh-list
25188817|NCT02802072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25188818|NCT02802072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25188819|NCT02802072|Analgesics|analgesics|mesh-ancestor
25188820|NCT02802072|Sensory System Agents|sensory system agents|mesh-ancestor
25188821|NCT02802072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25188822|NCT02802072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188823|NCT02802072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25188824|NCT02802072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25188825|NCT02802072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25188826|NCT02802072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25188827|NCT02802072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188828|NCT02802072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25188829|NCT02802072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25188830|NCT02802072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25188831|NCT02802072|Antipyretics|antipyretics|mesh-ancestor
25188832|NCT02802137|Timolol|timolol|mesh-list
25188833|NCT02802137|Dorzolamide|dorzolamide|mesh-list
24460668|NCT00349206|Immunologic Factors|immunologic factors|mesh-ancestor
24460669|NCT00349206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460670|NCT00349219|Gemcitabine|gemcitabine|mesh-list
24460671|NCT00349219|Cisplatin|cisplatin|mesh-list
24460675|NCT00349219|Antimetabolites|antimetabolites|mesh-ancestor
24460736|NCT00349375|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24460737|NCT00349375|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25188834|NCT02802137|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24852442|NCT02262546|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25188835|NCT02802137|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25188839|NCT02802137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188840|NCT02802137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25188841|NCT02802137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25188842|NCT02802137|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25188843|NCT02802137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25188844|NCT02801799|Ropivacaine|ropivacaine|mesh-list
25188845|NCT02801799|Anesthetics, Local|anesthetics, local|mesh-ancestor
25188846|NCT02801799|Anesthetics|anesthetics|mesh-ancestor
25188847|NCT02801799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25666244|NCT01692301|Vasodilator Agents|vasodilator agents|mesh-ancestor
25666245|NCT01692301|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25666246|NCT01692301|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25666247|NCT01692301|Diuretics|diuretics|mesh-ancestor
25666248|NCT01692301|Natriuretic Agents|natriuretic agents|mesh-ancestor
25666249|NCT01692301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25666250|NCT01692340|Lycopene|lycopene|mesh-list
25666251|NCT01692340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25115311|NCT03117023|Adrenergic Agents|adrenergic agents|mesh-ancestor
25156331|NCT05063734|Aflibercept|aflibercept|mesh-list
25156332|NCT05063734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25666252|NCT01692340|Antioxidants|antioxidants|mesh-ancestor
25666253|NCT01692340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25156333|NCT05063734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25156334|NCT05063734|Growth Substances|growth substances|mesh-ancestor
25156335|NCT05063734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946879|NCT03934333|Glucocorticoids|glucocorticoids|mesh-ancestor
24544375|NCT00688818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188848|NCT02801799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188849|NCT02801799|Sensory System Agents|sensory system agents|mesh-ancestor
25188850|NCT02801799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25188851|NCT02801786|Tamoxifen|tamoxifen|mesh-list
25188852|NCT02801786|Lidocaine|lidocaine|mesh-list
25188853|NCT02801786|Anesthetics, Local|anesthetics, local|mesh-ancestor
25188854|NCT02801786|Anesthetics|anesthetics|mesh-ancestor
25188855|NCT02801786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25188856|NCT02801786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188857|NCT02801786|Sensory System Agents|sensory system agents|mesh-ancestor
25188858|NCT02801786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25188859|NCT02801786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25188860|NCT02801786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25188861|NCT02801786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25188862|NCT02801786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25188863|NCT02801786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188864|NCT02801786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25188865|NCT02801786|Hormone Antagonists|hormone antagonists|mesh-ancestor
25188866|NCT02801786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25188867|NCT02801786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25188868|NCT02801786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188869|NCT02801786|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25188870|NCT02801786|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25188871|NCT02801786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25188872|NCT02801838|Morphine|morphine|mesh-list
25188873|NCT02801838|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25188874|NCT02801838|Narcotics|narcotics|mesh-ancestor
25188875|NCT02801838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25188876|NCT02801838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860473|NCT00083681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25860474|NCT00083681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25860475|NCT00083681|Alkylating Agents|alkylating agents|mesh-ancestor
25860476|NCT00083681|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25051524|NCT00397254|Rizatriptan|rizatriptan|mesh-list
25051525|NCT00397254|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25188877|NCT02801838|Analgesics|analgesics|mesh-ancestor
25188878|NCT02801838|Sensory System Agents|sensory system agents|mesh-ancestor
25188879|NCT02801838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25188880|NCT02802098|Bevacizumab|bevacizumab|mesh-list
25188881|NCT02802098|Durvalumab|durvalumab|mesh-list
25188882|NCT02802098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25188883|NCT02802098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188884|NCT02802098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25188885|NCT02802098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25188886|NCT02802098|Growth Substances|growth substances|mesh-ancestor
25188887|NCT02802098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188888|NCT02802098|Growth Inhibitors|growth inhibitors|mesh-ancestor
25188889|NCT02801487|Cisplatin|cisplatin|mesh-list
25188890|NCT02801487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188891|NCT02801526|Amlodipine|amlodipine|mesh-list
25188892|NCT02801526|Candesartan|candesartan|mesh-list
25188893|NCT02801526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25188894|NCT02801526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25427641|NCT01864018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25666254|NCT01692340|Protective Agents|protective agents|mesh-ancestor
25666255|NCT01692340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666256|NCT01692340|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25666257|NCT01692340|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25666258|NCT01692340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25666259|NCT01692626|Pimecrolimus|pimecrolimus|mesh-list
25666260|NCT01692626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25666261|NCT01692626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25666262|NCT01692626|Analgesics|analgesics|mesh-ancestor
25666263|NCT01692626|Sensory System Agents|sensory system agents|mesh-ancestor
25666264|NCT01692626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25666265|NCT01692626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418326|NCT00209222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24418327|NCT00209222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24418328|NCT00209222|Glucocorticoids|glucocorticoids|mesh-ancestor
24418329|NCT00209222|Hormones|hormones|mesh-ancestor
24707863|NCT01498406|Vitamin D|vitamin d|mesh-list
25188895|NCT02801526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25188896|NCT02801526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188897|NCT02801526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25188898|NCT02801526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188899|NCT02801526|Vasodilator Agents|vasodilator agents|mesh-ancestor
25188900|NCT02801526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25188901|NCT02801526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25188903|NCT02801357|Buprenorphine|buprenorphine|mesh-list
25188904|NCT02801357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25188905|NCT02801357|Narcotics|narcotics|mesh-ancestor
25188906|NCT02801357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25188907|NCT02801357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188908|NCT02801357|Analgesics|analgesics|mesh-ancestor
25188909|NCT02801357|Sensory System Agents|sensory system agents|mesh-ancestor
25188910|NCT02801357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25188911|NCT02801357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25188912|NCT02801357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25188913|NCT02801357|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25188914|NCT02801357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25188915|NCT02801357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25188916|NCT02801357|Adrenergic Agents|adrenergic agents|mesh-ancestor
25188917|NCT02801357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25188918|NCT02801357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188919|NCT02801383|Interferons|interferons|mesh-list
25188920|NCT02801383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25188921|NCT02801383|Antiviral Agents|antiviral agents|mesh-ancestor
25188922|NCT02801383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25188923|NCT02801409|Anesthetics|anesthetics|mesh-list
25188924|NCT02801409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25188925|NCT02801409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188926|NCT02801292|Ketamine|ketamine|mesh-list
25188927|NCT02801292|Analgesics|analgesics|mesh-ancestor
25188928|NCT02801292|Sensory System Agents|sensory system agents|mesh-ancestor
25188929|NCT02801292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25188930|NCT02801292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188931|NCT02801292|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25188932|NCT02801292|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25188933|NCT02801292|Anesthetics, General|anesthetics, general|mesh-ancestor
25188934|NCT02801292|Anesthetics|anesthetics|mesh-ancestor
25188935|NCT02801292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25188936|NCT02801292|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25188937|NCT02801292|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25188938|NCT02801292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25188939|NCT02801292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188940|NCT02801305|Diltiazem|diltiazem|mesh-list
25188941|NCT02801305|Nitroglycerin|nitroglycerin|mesh-list
25188942|NCT02801305|Petrolatum|petrolatum|mesh-list
25188943|NCT02801305|Vasodilator Agents|vasodilator agents|mesh-ancestor
25188944|NCT02801305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25188945|NCT02801305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25188946|NCT02801305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25188947|NCT02801305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188948|NCT02801305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25188949|NCT02801305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188950|NCT02801305|Emollients|emollients|mesh-ancestor
25188951|NCT02801305|Dermatologic Agents|dermatologic agents|mesh-ancestor
25188952|NCT02801227|Oxytocin|oxytocin|mesh-list
25188953|NCT02801227|Dinoprostone|dinoprostone|mesh-list
25188954|NCT02801227|Oxytocics|oxytocics|mesh-ancestor
25188955|NCT02801227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25188956|NCT02801227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666266|NCT01692626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25666267|NCT01692626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25666268|NCT01692626|Dermatologic Agents|dermatologic agents|mesh-ancestor
25666269|NCT01692626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25666270|NCT01692626|Immunologic Factors|immunologic factors|mesh-ancestor
24418561|NCT00209781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24418562|NCT00209781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24418563|NCT00209781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24418582|NCT00209807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24418583|NCT00209807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24418584|NCT00209807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418585|NCT00209807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25188957|NCT02801266|Contraceptive Agents|contraceptive agents|mesh-list
25188958|NCT02801266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25188959|NCT02801266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188960|NCT02801201|Midazolam|midazolam|mesh-list
25188961|NCT02801201|Bupivacaine|bupivacaine|mesh-list
25188962|NCT02801201|Anesthetics, Local|anesthetics, local|mesh-ancestor
25188963|NCT02801201|Anesthetics|anesthetics|mesh-ancestor
24419837|NCT00214266|Rituximab|rituximab|mesh-list
25188964|NCT02801201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25188965|NCT02801201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188966|NCT02801201|Sensory System Agents|sensory system agents|mesh-ancestor
25188967|NCT02801201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25188968|NCT02801201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25188969|NCT02801201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25188970|NCT02801201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25188971|NCT02801201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25188972|NCT02801201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25188973|NCT02801201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25188974|NCT02801201|Anesthetics, General|anesthetics, general|mesh-ancestor
25188975|NCT02801201|GABA Modulators|gaba modulators|mesh-ancestor
25188977|NCT02801201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25188978|NCT02801201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188980|NCT02801188|Bupivacaine|bupivacaine|mesh-list
25188981|NCT02801188|Anesthetics, Local|anesthetics, local|mesh-ancestor
25188982|NCT02801188|Anesthetics|anesthetics|mesh-ancestor
25188983|NCT02801188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25188984|NCT02801188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25188985|NCT02801188|Sensory System Agents|sensory system agents|mesh-ancestor
25188986|NCT02801188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25188987|NCT02801188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25188988|NCT02801188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25188989|NCT02801188|Analgesics|analgesics|mesh-ancestor
25188990|NCT02801188|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25188991|NCT02801188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25188992|NCT02801188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25188993|NCT02801188|Adrenergic Agents|adrenergic agents|mesh-ancestor
25188994|NCT02801188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25188995|NCT02801188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25188996|NCT02800902|Atorvastatin|atorvastatin|mesh-list
25188997|NCT02800902|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25188998|NCT02800902|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25188999|NCT02800902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25189000|NCT02800902|Antimetabolites|antimetabolites|mesh-ancestor
25189001|NCT02800902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189002|NCT02800902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25189003|NCT02800902|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25189004|NCT02800902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25189005|NCT02801032|Tadalafil|tadalafil|mesh-list
25189006|NCT02801032|Vasodilator Agents|vasodilator agents|mesh-ancestor
25189007|NCT02801032|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25189008|NCT02801032|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25189009|NCT02801032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25189010|NCT02801032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189011|NCT02801032|Urological Agents|urological agents|mesh-ancestor
25189012|NCT02800785|Moxifloxacin|moxifloxacin|mesh-list
25189013|NCT02800785|Metronidazole|metronidazole|mesh-list
25189014|NCT02800785|Ciprofloxacin|ciprofloxacin|mesh-list
25189015|NCT02800785|Levofloxacin|levofloxacin|mesh-list
25189016|NCT02800785|Cefazolin|cefazolin|mesh-list
25189017|NCT02800785|Ceftriaxone|ceftriaxone|mesh-list
25666271|NCT01692626|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25666272|NCT01692626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25666273|NCT01692626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666274|NCT01692756|Triamcinolone|triamcinolone|mesh-list
25666275|NCT01692756|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25666276|NCT01692756|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25666277|NCT01692756|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25666278|NCT01692756|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25860477|NCT00083681|Leprostatic Agents|leprostatic agents|mesh-ancestor
25860478|NCT00083681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24799344|NCT01968564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25860479|NCT00083681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25860480|NCT00083681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25189018|NCT02800785|Clavulanic Acids|clavulanic acids|mesh-list
25189019|NCT02800785|Clavulanic Acid|clavulanic acid|mesh-list
25189020|NCT02800785|Cefuroxime|cefuroxime|mesh-list
25189021|NCT02800785|Ertapenem|ertapenem|mesh-list
25189022|NCT02800785|Tigecycline|tigecycline|mesh-list
25051530|NCT00396357|Metformin|metformin|mesh-list
25189023|NCT02800785|Cefotaxime|cefotaxime|mesh-list
25189024|NCT02800785|Cefoxitin|cefoxitin|mesh-list
25189025|NCT02800785|Ticarcillin|ticarcillin|mesh-list
25189026|NCT02800785|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
25189027|NCT02800785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25189028|NCT02800785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25189029|NCT02800785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25189030|NCT02800785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25189031|NCT02800785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25189032|NCT02800785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189033|NCT02800785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189034|NCT02800785|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25189035|NCT02800785|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25189036|NCT02800785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25189037|NCT02800785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25189038|NCT02800785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25189039|NCT02800785|Renal Agents|renal agents|mesh-ancestor
25206182|NCT03792256|Glucocorticoids|glucocorticoids|mesh-ancestor
24420228|NCT00215397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24420230|NCT00215397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24420231|NCT00215397|Adrenergic Agents|adrenergic agents|mesh-ancestor
24420232|NCT00215397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24420233|NCT00215397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420234|NCT00215410|Formoterol Fumarate|formoterol fumarate|mesh-list
24420276|NCT00215449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24420277|NCT00215449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420278|NCT00215449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24420279|NCT00215449|Respiratory System Agents|respiratory system agents|mesh-ancestor
25189235|NCT02799589|Anesthetics|anesthetics|mesh-ancestor
24823153|NCT02115204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24823155|NCT02115243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24823156|NCT02115243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823157|NCT02115243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24690156|NCT01399853|Vaccines|vaccines|mesh-list
24420280|NCT00215449|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25860481|NCT00083681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25860482|NCT00083681|Growth Substances|growth substances|mesh-ancestor
25860483|NCT00083681|Growth Inhibitors|growth inhibitors|mesh-ancestor
25860484|NCT00083694|Thalidomide|thalidomide|mesh-list
25860485|NCT00083694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25860486|NCT00083694|Immunologic Factors|immunologic factors|mesh-ancestor
25860487|NCT00083694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860488|NCT00083694|Leprostatic Agents|leprostatic agents|mesh-ancestor
24977308|NCT02553473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24977309|NCT02553473|Antimalarials|antimalarials|mesh-ancestor
25105641|NCT05254405|Neurosteroids|neurosteroids|mesh-ancestor
25105642|NCT05254405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25105643|NCT05254405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105644|NCT05254405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105645|NCT05254405|GABA Modulators|gaba modulators|mesh-ancestor
25189040|NCT02800785|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25189041|NCT02800785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25189042|NCT02800889|Pixantrone|pixantrone|mesh-list
25189043|NCT02800889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25189044|NCT02800889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25189045|NCT02800889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25189046|NCT02800889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189047|NCT02800889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189048|NCT02800447|Procarbazine|procarbazine|mesh-list
25666279|NCT01692756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25666280|NCT01692756|Glucocorticoids|glucocorticoids|mesh-ancestor
25666281|NCT01692756|Hormones|hormones|mesh-ancestor
25189049|NCT02800447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189050|NCT02800408|Beta-Cryptoxanthin|beta-cryptoxanthin|mesh-list
25189051|NCT02800408|Provitamins|provitamins|mesh-ancestor
25189052|NCT02800408|Vitamins|vitamins|mesh-ancestor
25860489|NCT00083694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25860490|NCT00083694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24419314|NCT00211705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24419315|NCT00211705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24419316|NCT00211705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419317|NCT00211718|Botulinum Toxins|botulinum toxins|mesh-list
24419318|NCT00211718|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24419319|NCT00211718|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24419320|NCT00211718|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24419463|NCT00212108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24419464|NCT00212108|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24419465|NCT00212108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24419466|NCT00212108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419467|NCT00212108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419468|NCT00212108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419469|NCT00212108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24419473|NCT00212173|Sibutramine|sibutramine|mesh-list
25189053|NCT02800408|Micronutrients|micronutrients|mesh-ancestor
25189054|NCT02800408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189055|NCT02800772|Acetic Acid|acetic acid|mesh-list
25189056|NCT02800772|Retinol acetate|retinol acetate|mesh-list
25189057|NCT02800772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25189058|NCT02800772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25189059|NCT02800772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25189060|NCT02800772|Immunologic Factors|immunologic factors|mesh-ancestor
25189061|NCT02800772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189062|NCT02800772|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25189063|NCT02800772|Protective Agents|protective agents|mesh-ancestor
25189064|NCT02800772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189065|NCT02800590|Abp-700|abp-700|mesh-list
25189066|NCT02800590|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25189067|NCT02800590|GABA Agonists|gaba agonists|mesh-ancestor
25189068|NCT02800590|GABA Agents|gaba agents|mesh-ancestor
25189069|NCT02800590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25189070|NCT02800590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189071|NCT02800590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206183|NCT03792256|Hormones|hormones|mesh-ancestor
25206184|NCT03792256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25189072|NCT02800694|Fentanyl|fentanyl|mesh-list
25189073|NCT02800694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25189074|NCT02800694|Narcotics|narcotics|mesh-ancestor
25189075|NCT02800694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25189076|NCT02800694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189077|NCT02800694|Analgesics|analgesics|mesh-ancestor
25189078|NCT02800694|Sensory System Agents|sensory system agents|mesh-ancestor
25189079|NCT02800694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25189080|NCT02800694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25189081|NCT02800694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25189082|NCT02800694|Anesthetics, General|anesthetics, general|mesh-ancestor
25189083|NCT02800694|Anesthetics|anesthetics|mesh-ancestor
25189084|NCT02800486|Cetuximab|cetuximab|mesh-list
25189085|NCT02800486|Mannitol|mannitol|mesh-list
25189086|NCT02800486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25189087|NCT02800486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189088|NCT02800486|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25189089|NCT02800486|Diuretics|diuretics|mesh-ancestor
25189090|NCT02800486|Natriuretic Agents|natriuretic agents|mesh-ancestor
25666282|NCT01692756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25666283|NCT01692756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666284|NCT01692756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25666285|NCT01692756|Immunologic Factors|immunologic factors|mesh-ancestor
25666286|NCT01692756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25666287|NCT01692756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666288|NCT01693029|Epoetin Alfa|epoetin alfa|mesh-list
25666289|NCT01693029|Hematinics|hematinics|mesh-ancestor
25666290|NCT01693068|Dacarbazine|dacarbazine|mesh-list
25666291|NCT01693068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25666292|NCT01693068|Alkylating Agents|alkylating agents|mesh-ancestor
25666293|NCT01693068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666294|NCT01693068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25666295|NCT01693185|Midazolam|midazolam|mesh-list
25666296|NCT01693185|Meperidine|meperidine|mesh-list
25666297|NCT01693185|Remifentanil|remifentanil|mesh-list
25189091|NCT02800486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666298|NCT01693185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24419853|NCT00214318|Terbutaline|terbutaline|mesh-list
24419854|NCT00214318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24823138|NCT02115204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24823140|NCT02115204|Antimitotic Agents|antimitotic agents|mesh-ancestor
24419855|NCT00214318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24419856|NCT00214318|Sympatholytics|sympatholytics|mesh-ancestor
24419857|NCT00214318|Autonomic Agents|autonomic agents|mesh-ancestor
24419858|NCT00214318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24419859|NCT00214318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189092|NCT02800252|Aspirin|aspirin|mesh-list
25189093|NCT02800252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25189094|NCT02800252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25189095|NCT02800252|Analgesics|analgesics|mesh-ancestor
25189096|NCT02800252|Sensory System Agents|sensory system agents|mesh-ancestor
25189097|NCT02800252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25189098|NCT02800252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189099|NCT02800252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25189100|NCT02800252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25189101|NCT02800252|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25189102|NCT02800252|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25189103|NCT02800252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189104|NCT02800252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25189105|NCT02800252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25189106|NCT02800252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25189107|NCT02800252|Antipyretics|antipyretics|mesh-ancestor
25189108|NCT02800174|Aspirin|aspirin|mesh-list
25189109|NCT02800174|Clopidogrel|clopidogrel|mesh-list
25189110|NCT02800174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25189111|NCT02800174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25860491|NCT00083694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25189112|NCT02800174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25189113|NCT02800174|Analgesics|analgesics|mesh-ancestor
25189114|NCT02800174|Sensory System Agents|sensory system agents|mesh-ancestor
25189115|NCT02800174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25189116|NCT02800174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189117|NCT02800174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25189118|NCT02800174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25189119|NCT02800174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25189120|NCT02800174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25189121|NCT02800174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189122|NCT02800174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25189123|NCT02800174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25189124|NCT02800174|Antipyretics|antipyretics|mesh-ancestor
25189125|NCT02800174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25189126|NCT02800174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25189127|NCT02800174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25189128|NCT02800174|Purinergic Agents|purinergic agents|mesh-ancestor
25189129|NCT02800174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25189130|NCT02800330|Esomeprazole|esomeprazole|mesh-list
25189131|NCT02800330|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25189132|NCT02800330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25189133|NCT02800330|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25189134|NCT02800330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25189135|NCT02800330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189136|NCT02799862|Paclitaxel|paclitaxel|mesh-list
25189137|NCT02799862|Carboplatin|carboplatin|mesh-list
25189138|NCT02799862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25189139|NCT02799862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189140|NCT02799862|Tubulin Modulators|tubulin modulators|mesh-ancestor
25189141|NCT02799862|Antimitotic Agents|antimitotic agents|mesh-ancestor
24460886|NCT00350051|Sagopilone|sagopilone|mesh-list
24460888|NCT00350051|Glucocorticoids|glucocorticoids|mesh-ancestor
24439948|NCT00280956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189142|NCT02799862|Mitosis Modulators|mitosis modulators|mesh-ancestor
25189143|NCT02799862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189144|NCT02799927|Calcium|calcium|mesh-list
25666299|NCT01693185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25666300|NCT01693185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25666301|NCT01693185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666302|NCT01693185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25666303|NCT01693185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25666304|NCT01693185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25666305|NCT01693185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25666306|NCT01693185|Anesthetics, General|anesthetics, general|mesh-ancestor
25666307|NCT01693185|Anesthetics|anesthetics|mesh-ancestor
24420418|NCT00215995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24420419|NCT00215995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24420420|NCT00215995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420421|NCT00215995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420422|NCT00215995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24420423|NCT00216008|Docetaxel|docetaxel|mesh-list
24420424|NCT00216008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420425|NCT00216008|Tubulin Modulators|tubulin modulators|mesh-ancestor
24420426|NCT00216008|Antimitotic Agents|antimitotic agents|mesh-ancestor
24420427|NCT00216008|Mitosis Modulators|mitosis modulators|mesh-ancestor
24420429|NCT00216021|Capecitabine|capecitabine|mesh-list
25189145|NCT02799927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25189146|NCT02799927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189147|NCT02799888|Cyclosporine|cyclosporine|mesh-list
25189148|NCT02799888|Maraviroc|maraviroc|mesh-list
25189149|NCT02799888|Methotrexate|methotrexate|mesh-list
25189150|NCT02799888|Tacrolimus|tacrolimus|mesh-list
25189151|NCT02799888|Cyclosporins|cyclosporins|mesh-list
25189152|NCT02799888|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25189153|NCT02799888|Abortifacient Agents|abortifacient agents|mesh-ancestor
25189154|NCT02799888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25189155|NCT02799888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189156|NCT02799888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25189157|NCT02799888|Antimetabolites|antimetabolites|mesh-ancestor
25189236|NCT02799589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25189158|NCT02799888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189159|NCT02799888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189160|NCT02799888|Dermatologic Agents|dermatologic agents|mesh-ancestor
25189161|NCT02799888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25189162|NCT02799888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25189163|NCT02799888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25189164|NCT02799888|Immunologic Factors|immunologic factors|mesh-ancestor
25189165|NCT02799888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25189166|NCT02799888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25189167|NCT02799888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25189168|NCT02799888|Antifungal Agents|antifungal agents|mesh-ancestor
25189169|NCT02799888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25189170|NCT02799888|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25189171|NCT02799888|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25189172|NCT02799888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25189173|NCT02799888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25189174|NCT02799888|Antiviral Agents|antiviral agents|mesh-ancestor
25189175|NCT02799888|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25189176|NCT02800135|Furosemide|furosemide|mesh-list
25189177|NCT02800135|Diuretics|diuretics|mesh-ancestor
25189178|NCT02800135|Natriuretic Agents|natriuretic agents|mesh-ancestor
25189179|NCT02800135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189180|NCT02800135|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25189181|NCT02800135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25189182|NCT02800135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189183|NCT02799901|Nivolumab|nivolumab|mesh-list
25189184|NCT02799901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25189185|NCT02799901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189186|NCT02799901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25189187|NCT02799901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189188|NCT02800265|Sulforaphane|sulforaphane|mesh-list
25189189|NCT02800265|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25189190|NCT02800265|Protective Agents|protective agents|mesh-ancestor
25189191|NCT02800265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189192|NCT02800265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189193|NCT02799797|Sufentanil|sufentanil|mesh-list
25189194|NCT02799797|Dsuvia|dsuvia|mesh-list
25189195|NCT02799797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25189196|NCT02799797|Narcotics|narcotics|mesh-ancestor
25666308|NCT01693185|GABA Modulators|gaba modulators|mesh-ancestor
25666309|NCT01693185|GABA Agents|gaba agents|mesh-ancestor
25666310|NCT01693185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25666311|NCT01693185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666312|NCT01693185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25666313|NCT01693185|Narcotics|narcotics|mesh-ancestor
25666314|NCT01693185|Analgesics|analgesics|mesh-ancestor
25666315|NCT01693185|Sensory System Agents|sensory system agents|mesh-ancestor
25666316|NCT01693185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25666317|NCT01693523|Minocycline|minocycline|mesh-list
25427642|NCT01864018|Dermatologic Agents|dermatologic agents|mesh-ancestor
25666318|NCT01693523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24420583|NCT00216385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24420585|NCT00216385|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25189197|NCT02799797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25189198|NCT02799797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189199|NCT02799797|Analgesics|analgesics|mesh-ancestor
25189200|NCT02799797|Sensory System Agents|sensory system agents|mesh-ancestor
25189201|NCT02799797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25189202|NCT02799797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25189203|NCT02799797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25189204|NCT02799797|Anesthetics, General|anesthetics, general|mesh-ancestor
25189205|NCT02799797|Anesthetics|anesthetics|mesh-ancestor
25189206|NCT02799615|Infliximab|infliximab|mesh-list
25189207|NCT02799615|Dermatologic Agents|dermatologic agents|mesh-ancestor
25189208|NCT02799615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25189209|NCT02799615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25189210|NCT02799758|Pitavastatin|pitavastatin|mesh-list
25189211|NCT02799758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25189212|NCT02799758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25189213|NCT02799758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25189214|NCT02799758|Antimetabolites|antimetabolites|mesh-ancestor
25189215|NCT02799758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189216|NCT02799758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25189217|NCT02799758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25189218|NCT02799589|Dexmedetomidine|dexmedetomidine|mesh-list
25189219|NCT02799589|Remifentanil|remifentanil|mesh-list
25189220|NCT02799589|Ropivacaine|ropivacaine|mesh-list
25189221|NCT02799589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25189222|NCT02799589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25189223|NCT02799589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189224|NCT02799589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25189226|NCT02799589|Sensory System Agents|sensory system agents|mesh-ancestor
25189227|NCT02799589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25189228|NCT02799589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25189229|NCT02799589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25189230|NCT02799589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25189231|NCT02799589|Adrenergic Agents|adrenergic agents|mesh-ancestor
25189232|NCT02799589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25189233|NCT02799589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189237|NCT02799589|Narcotics|narcotics|mesh-ancestor
25189238|NCT02799459|Anesthetics|anesthetics|mesh-list
25189239|NCT02799459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25189240|NCT02799459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189241|NCT02799446|Reslizumab|reslizumab|mesh-list
25189242|NCT02799446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25189243|NCT02799446|Respiratory System Agents|respiratory system agents|mesh-ancestor
25189244|NCT02799355|Interferons|interferons|mesh-list
25189245|NCT02799355|Ribavirin|ribavirin|mesh-list
25189246|NCT02799355|Sofosbuvir|sofosbuvir|mesh-list
25189247|NCT02799355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189248|NCT02799355|Antiviral Agents|antiviral agents|mesh-ancestor
25189249|NCT02799355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25189250|NCT02799355|Antimetabolites|antimetabolites|mesh-ancestor
25189251|NCT02799355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189252|NCT02799498|Etanercept|etanercept|mesh-list
25189253|NCT02799498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25189254|NCT02799498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25189255|NCT02799498|Analgesics|analgesics|mesh-ancestor
25189256|NCT02799498|Sensory System Agents|sensory system agents|mesh-ancestor
25189257|NCT02799498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25189258|NCT02799498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189259|NCT02799498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25189260|NCT02799498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25189261|NCT02799498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25189262|NCT02799498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25189263|NCT02799498|Immunologic Factors|immunologic factors|mesh-ancestor
25189264|NCT02799316|Antibodies|antibodies|mesh-list
25189265|NCT02799316|Immunologic Factors|immunologic factors|mesh-ancestor
25189266|NCT02799316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189267|NCT02799238|Temozolomide|temozolomide|mesh-list
25189268|NCT02799238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25189269|NCT02799238|Alkylating Agents|alkylating agents|mesh-ancestor
25189270|NCT02799238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189271|NCT02799238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189272|NCT02799030|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25666319|NCT01693523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25666320|NCT01693562|Durvalumab|durvalumab|mesh-list
24421784|NCT00220194|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24421785|NCT00220194|Fertility Agents|fertility agents|mesh-ancestor
24421786|NCT00220194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25189273|NCT02799030|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25189274|NCT02799030|Dermatologic Agents|dermatologic agents|mesh-ancestor
25189275|NCT02799277|Testosterone|testosterone|mesh-list
25189276|NCT02799277|Androgens|androgens|mesh-ancestor
25189277|NCT02799277|Hormones|hormones|mesh-ancestor
25189278|NCT02799277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25189279|NCT02799277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189280|NCT02799147|Fludarabine|fludarabine|mesh-list
25189281|NCT02799147|Fludarabine phosphate|fludarabine phosphate|mesh-list
25189282|NCT02799147|Busulfan|busulfan|mesh-list
25189283|NCT02799147|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25189284|NCT02799147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189285|NCT02799147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25189286|NCT02799147|Antimetabolites|antimetabolites|mesh-ancestor
25189287|NCT02799147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189288|NCT02799147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25189289|NCT02799147|Immunologic Factors|immunologic factors|mesh-ancestor
25189290|NCT02799147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189291|NCT02799147|Alkylating Agents|alkylating agents|mesh-ancestor
25189292|NCT02799147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25189293|NCT02799147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25189294|NCT02798913|Clopidogrel|clopidogrel|mesh-list
25189295|NCT02798913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25189296|NCT02798913|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25189297|NCT02798913|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25189298|NCT02798913|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25189299|NCT02798913|Purinergic Agents|purinergic agents|mesh-ancestor
25189300|NCT02798913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25189301|NCT02798913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189302|NCT02798913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189304|NCT02798874|Ticagrelor|ticagrelor|mesh-list
25189305|NCT02798874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25189306|NCT02798874|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25189307|NCT02798874|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25189308|NCT02798874|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25189309|NCT02798874|Purinergic Agents|purinergic agents|mesh-ancestor
25189310|NCT02798874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25189311|NCT02798874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189321|NCT02799264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25206185|NCT03792256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206186|NCT03792256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25206187|NCT03792256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25206188|NCT03792256|Abortifacient Agents|abortifacient agents|mesh-ancestor
25206189|NCT03792256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25206190|NCT03792256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25206191|NCT03792256|Antimetabolites|antimetabolites|mesh-ancestor
25206192|NCT03792256|Dermatologic Agents|dermatologic agents|mesh-ancestor
25206193|NCT03792256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25206194|NCT03792256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25206195|NCT03792256|Immunologic Factors|immunologic factors|mesh-ancestor
25206196|NCT03792256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25206197|NCT03792256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25206198|NCT03792256|Antiviral Agents|antiviral agents|mesh-ancestor
25206199|NCT03792256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25206200|NCT03792256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25206201|NCT03792256|Tubulin Modulators|tubulin modulators|mesh-ancestor
25206202|NCT03792256|Antimitotic Agents|antimitotic agents|mesh-ancestor
25206203|NCT03792256|Mitosis Modulators|mitosis modulators|mesh-ancestor
25206204|NCT03792256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25206206|NCT03787095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25206207|NCT03787095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206208|NCT03779295|Clindamycin|clindamycin|mesh-list
25206209|NCT03779295|Clindamycin palmitate|clindamycin palmitate|mesh-list
25206210|NCT03779295|Clindamycin phosphate|clindamycin phosphate|mesh-list
25206211|NCT03779295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25666321|NCT01693562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25666322|NCT01693562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25666323|NCT01694108|BCG Vaccine|bcg vaccine|mesh-list
25206212|NCT03779295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25206213|NCT03779295|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25206214|NCT03779295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25206215|NCT03779295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206216|NCT03769155|Nivolumab|nivolumab|mesh-list
25206217|NCT03769155|Ipilimumab|ipilimumab|mesh-list
25206218|NCT03769155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25206219|NCT03769155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206220|NCT03769155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25206221|NCT03769155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206222|NCT03765788|Prednisolone|prednisolone|mesh-list
25206223|NCT03765788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25206224|NCT03765788|Glucocorticoids|glucocorticoids|mesh-ancestor
25206225|NCT03765788|Hormones|hormones|mesh-ancestor
25206226|NCT03765788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25206227|NCT03765788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206228|NCT03765788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25206229|NCT03765788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206230|NCT03765567|Vancomycin|vancomycin|mesh-list
25206231|NCT03765567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25206232|NCT03765567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25206233|NCT03762109|Dantrolene|dantrolene|mesh-list
25105650|NCT05254223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24877539|NCT02568553|Immunologic Factors|immunologic factors|mesh-ancestor
24783565|NCT01902550|Metoprolol|metoprolol|mesh-list
24977344|NCT01974609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977345|NCT01974609|Antipyretics|antipyretics|mesh-ancestor
24977437|NCT00159588|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24977438|NCT00159588|Analgesics|analgesics|mesh-ancestor
24977440|NCT00159588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24977441|NCT00159588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977442|NCT00159588|Anticonvulsants|anticonvulsants|mesh-ancestor
24977443|NCT00159588|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24977444|NCT00159588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24977445|NCT00159588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24977446|NCT00159588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24977447|NCT00159588|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24977448|NCT00159588|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24977449|NCT00159588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24970789|NCT03730766|Potassium Citrate|potassium citrate|mesh-list
24977563|NCT02818023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977564|NCT02818023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25189322|NCT02798653|Progesterone|progesterone|mesh-list
25189323|NCT02798653|Progestins|progestins|mesh-ancestor
25189324|NCT02798653|Hormones|hormones|mesh-ancestor
25189325|NCT02798653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25189326|NCT02798653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189327|NCT02798744|Empagliflozin|empagliflozin|mesh-list
25189328|NCT02798744|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25189329|NCT02798744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189330|NCT02798744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25189331|NCT02798744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189332|NCT02798406|Pembrolizumab|pembrolizumab|mesh-list
25189333|NCT02798406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25189334|NCT02798406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189335|NCT02798510|Gemcitabine|gemcitabine|mesh-list
25189337|NCT02798510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25189338|NCT02798510|Antimetabolites|antimetabolites|mesh-ancestor
25189339|NCT02798510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189340|NCT02798510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189341|NCT02798510|Antiviral Agents|antiviral agents|mesh-ancestor
25189342|NCT02798510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25189343|NCT02798510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25189344|NCT02798510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25189345|NCT02798510|Immunologic Factors|immunologic factors|mesh-ancestor
25189346|NCT02798510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189347|NCT02798757|Dapagliflozin|dapagliflozin|mesh-list
25189348|NCT02798757|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25189349|NCT02798757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189350|NCT02798757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25189351|NCT02798757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189352|NCT02798367|Melatonin|melatonin|mesh-list
25189353|NCT02798367|Antioxidants|antioxidants|mesh-ancestor
25189354|NCT02798367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189355|NCT02798367|Protective Agents|protective agents|mesh-ancestor
25189356|NCT02798367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189357|NCT02798367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25189358|NCT02798250|Insulin|insulin|mesh-list
25189359|NCT02798250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25189360|NCT02798250|Glucagon|glucagon|mesh-list
25189361|NCT02798250|Hormones|hormones|mesh-list
25189362|NCT02798250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25189363|NCT02798250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189364|NCT02798250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25189365|NCT02798250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25189366|NCT02798055|Bosentan|bosentan|mesh-list
25189367|NCT02798055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25189368|NCT02798055|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25189369|NCT02798055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189370|NCT02798159|Sildenafil Citrate|sildenafil citrate|mesh-list
25189371|NCT02798159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189372|NCT02798159|Vasodilator Agents|vasodilator agents|mesh-ancestor
25189373|NCT02798159|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25189374|NCT02798159|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25189375|NCT02798159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25189376|NCT02798159|Urological Agents|urological agents|mesh-ancestor
25189377|NCT02798172|Metformin|metformin|mesh-list
25189378|NCT02798172|Alogliptin|alogliptin|mesh-list
25189379|NCT02798172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25189380|NCT02798172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189381|NCT02798172|Incretins|incretins|mesh-ancestor
25189382|NCT02798172|Hormones|hormones|mesh-ancestor
25189383|NCT02798172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25189384|NCT02798172|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25189385|NCT02798172|Protease Inhibitors|protease inhibitors|mesh-ancestor
25189386|NCT02798172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25189387|NCT02798172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189388|NCT02798068|Methylprednisolone|methylprednisolone|mesh-list
25189389|NCT02798068|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25189390|NCT02798068|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25189391|NCT02798068|Prednisolone|prednisolone|mesh-list
25189392|NCT02798068|Prednisolone acetate|prednisolone acetate|mesh-list
25189393|NCT02798068|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25189394|NCT02798068|Prednisolone phosphate|prednisolone phosphate|mesh-list
25189395|NCT02798068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25189396|NCT02798068|Antiemetics|antiemetics|mesh-ancestor
25189397|NCT02798068|Autonomic Agents|autonomic agents|mesh-ancestor
25189398|NCT02798068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25189399|NCT02798068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189400|NCT02798068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25189401|NCT02798068|Glucocorticoids|glucocorticoids|mesh-ancestor
25189402|NCT02798068|Hormones|hormones|mesh-ancestor
25189403|NCT02798068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25189404|NCT02798068|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25189405|NCT02798068|Protective Agents|protective agents|mesh-ancestor
25189406|NCT02798068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25189407|NCT02798068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189408|NCT02797704|Aflibercept|aflibercept|mesh-list
25189409|NCT02797704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25189410|NCT02797704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25189411|NCT02797704|Growth Substances|growth substances|mesh-ancestor
25189412|NCT02797704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189413|NCT02797704|Growth Inhibitors|growth inhibitors|mesh-ancestor
25189414|NCT02797704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421231|NCT00218166|Baclofen|baclofen|mesh-list
25189415|NCT02797717|Prednisone|prednisone|mesh-list
25189416|NCT02797717|Cyclophosphamide|cyclophosphamide|mesh-list
25189417|NCT02797717|Dacarbazine|dacarbazine|mesh-list
25189418|NCT02797717|Doxorubicin|doxorubicin|mesh-list
25189419|NCT02797717|Etoposide|etoposide|mesh-list
25189420|NCT02797717|Vincristine|vincristine|mesh-list
25189421|NCT02797717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25189422|NCT02797717|Immunologic Factors|immunologic factors|mesh-ancestor
25189423|NCT02797717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189424|NCT02797717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25189425|NCT02797717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25189426|NCT02797717|Alkylating Agents|alkylating agents|mesh-ancestor
25189427|NCT02797717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189428|NCT02797717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189429|NCT02797717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25189430|NCT02797717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25189431|NCT02797717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25212629|NCT05368935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25212630|NCT05368805|Dabigatran|dabigatran|mesh-list
24799509|NCT01969357|Incretins|incretins|mesh-ancestor
25212631|NCT05368805|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24823716|NCT02118688|Dopamine Agents|dopamine agents|mesh-ancestor
24823717|NCT02118688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24823718|NCT02118688|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24823719|NCT02118688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24823720|NCT02118688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24823721|NCT02118688|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25189432|NCT02797717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25189433|NCT02797717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25189434|NCT02797717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25189435|NCT02797717|Glucocorticoids|glucocorticoids|mesh-ancestor
25189436|NCT02797717|Hormones|hormones|mesh-ancestor
25189437|NCT02797717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25189438|NCT02797717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25189439|NCT02797717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25189440|NCT02797717|Tubulin Modulators|tubulin modulators|mesh-ancestor
25189441|NCT02797717|Antimitotic Agents|antimitotic agents|mesh-ancestor
25189442|NCT02797717|Mitosis Modulators|mitosis modulators|mesh-ancestor
25189443|NCT02797860|Rocuronium|rocuronium|mesh-list
25189444|NCT02797860|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25189445|NCT02797860|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25189446|NCT02797860|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25189447|NCT02797860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25189448|NCT02797860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189449|NCT02797782|Antibodies|antibodies|mesh-list
25189450|NCT02797782|Immunologic Factors|immunologic factors|mesh-ancestor
25189451|NCT02797782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189452|NCT02797977|Gemcitabine|gemcitabine|mesh-list
25189453|NCT02797977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189454|NCT02797977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25189455|NCT02797977|Antimetabolites|antimetabolites|mesh-ancestor
25189456|NCT02797977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189457|NCT02797977|Antiviral Agents|antiviral agents|mesh-ancestor
25189458|NCT02797977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25189459|NCT02797977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25189460|NCT02797977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25189461|NCT02797977|Immunologic Factors|immunologic factors|mesh-ancestor
25189462|NCT02797977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189463|NCT02797587|Nicotine|nicotine|mesh-list
25189464|NCT02797587|Varenicline|varenicline|mesh-list
25189465|NCT02797587|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25189466|NCT02797587|Autonomic Agents|autonomic agents|mesh-ancestor
25189467|NCT02797587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25189468|NCT02797587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189469|NCT02797587|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25189470|NCT02797587|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25189471|NCT02797587|Cholinergic Agents|cholinergic agents|mesh-ancestor
25189472|NCT02797587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25189473|NCT02797587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189474|NCT02797548|Aspirin|aspirin|mesh-list
25189475|NCT02797548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25189476|NCT02797548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25189477|NCT02797548|Analgesics|analgesics|mesh-ancestor
25189478|NCT02797548|Sensory System Agents|sensory system agents|mesh-ancestor
25189479|NCT02797548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25189480|NCT02797548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189481|NCT02797548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25189482|NCT02797548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25189483|NCT02797548|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25189484|NCT02797548|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25666324|NCT01694108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25666325|NCT01694108|Immunologic Factors|immunologic factors|mesh-ancestor
25666326|NCT01694108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666327|NCT01694420|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25666328|NCT01694420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25666329|NCT01694420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25666330|NCT01694420|Antiviral Agents|antiviral agents|mesh-ancestor
25666331|NCT01694420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25666332|NCT01694433|Vitamin D|vitamin d|mesh-list
25666333|NCT01694433|Calcitriol|calcitriol|mesh-list
25189485|NCT02797548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25156489|NCT05018091|Dexamethasone acetate|dexamethasone acetate|mesh-list
25156490|NCT05018091|BB 1101|bb 1101|mesh-list
25189486|NCT02797548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25189487|NCT02797548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24823278|NCT02116348|Mitogens|mitogens|mesh-list
25189490|NCT02797236|Vaccines|vaccines|mesh-list
25189491|NCT02797236|Immunologic Factors|immunologic factors|mesh-ancestor
25189492|NCT02797236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189493|NCT02797249|Aspirin|aspirin|mesh-list
25189494|NCT02797249|Salicylic Acid|salicylic acid|mesh-list
25189495|NCT02797249|Salicylates|salicylates|mesh-list
25189496|NCT02797249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25189497|NCT02797249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25189498|NCT02797249|Analgesics|analgesics|mesh-ancestor
25189499|NCT02797249|Sensory System Agents|sensory system agents|mesh-ancestor
25189500|NCT02797249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25189501|NCT02797249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189502|NCT02797249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25189503|NCT02797249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25189504|NCT02797249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25189505|NCT02797249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25189506|NCT02797249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189507|NCT02797249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25189508|NCT02797249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25189509|NCT02797249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25189510|NCT02797249|Antipyretics|antipyretics|mesh-ancestor
25189511|NCT02797249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25189512|NCT02797249|Antifungal Agents|antifungal agents|mesh-ancestor
25189513|NCT02797249|Keratolytic Agents|keratolytic agents|mesh-ancestor
25189514|NCT02797249|Dermatologic Agents|dermatologic agents|mesh-ancestor
25189515|NCT02797340|Metformin|metformin|mesh-list
25189516|NCT02797340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25189517|NCT02797340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189518|NCT02797145|Digoxin|digoxin|mesh-list
25189519|NCT02797145|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25189520|NCT02797145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25189521|NCT02797145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25189522|NCT02797145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189523|NCT02797145|Protective Agents|protective agents|mesh-ancestor
25189524|NCT02797145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189525|NCT02797067|Indomethacin|indomethacin|mesh-list
25189526|NCT02797067|Glycerol|glycerol|mesh-list
25189527|NCT02797067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25189528|NCT02797067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25189529|NCT02797067|Analgesics|analgesics|mesh-ancestor
25189530|NCT02797067|Sensory System Agents|sensory system agents|mesh-ancestor
25189531|NCT02797067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25189532|NCT02797067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189533|NCT02797067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25189534|NCT02797067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25189535|NCT02797067|Gout Suppressants|gout suppressants|mesh-ancestor
25189536|NCT02797067|Tocolytic Agents|tocolytic agents|mesh-ancestor
25189537|NCT02797067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25189538|NCT02797067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25189539|NCT02797067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25189540|NCT02797067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189541|NCT02797067|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25189542|NCT02797067|Protective Agents|protective agents|mesh-ancestor
25189543|NCT02797028|Allopurinol|allopurinol|mesh-list
25189544|NCT02797028|Antimetabolites|antimetabolites|mesh-ancestor
25189545|NCT02797028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189546|NCT02797028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25189547|NCT02797028|Gout Suppressants|gout suppressants|mesh-ancestor
25189548|NCT02797028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25189549|NCT02797028|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25189550|NCT02797028|Antioxidants|antioxidants|mesh-ancestor
25189551|NCT02797028|Protective Agents|protective agents|mesh-ancestor
25189552|NCT02797028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189553|NCT02797015|Ozanimod|ozanimod|mesh-list
25189554|NCT02797015|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25189555|NCT02797015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189556|NCT02797015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25189557|NCT02797015|Immunologic Factors|immunologic factors|mesh-ancestor
25189558|NCT02797015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666334|NCT01694433|Calcipotriene|calcipotriene|mesh-list
25666335|NCT01694433|Vitamins|vitamins|mesh-ancestor
25189559|NCT02797041|Bortezomib|bortezomib|mesh-list
24423430|NCT00225914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24423431|NCT00225914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423432|NCT00225914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24423433|NCT00225914|Serotonin Agents|serotonin agents|mesh-ancestor
24423434|NCT00225914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823842|NCT02119273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823843|NCT02119273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24823844|NCT02119273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823845|NCT02119338|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24823846|NCT02119338|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24823847|NCT02119338|Dermatologic Agents|dermatologic agents|mesh-ancestor
24823858|NCT02119520|Atorvastatin|atorvastatin|mesh-list
24823859|NCT02119520|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24823860|NCT02119520|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24423437|NCT00225914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25189560|NCT02797041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206234|NCT03762109|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25206235|NCT03762109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189561|NCT02796794|Genistein|genistein|mesh-list
25189562|NCT02796794|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25189563|NCT02796794|Protective Agents|protective agents|mesh-ancestor
25189564|NCT02796794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189565|NCT02796794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189566|NCT02796794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25189567|NCT02796794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25189568|NCT02796794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189569|NCT02796794|Phytoestrogens|phytoestrogens|mesh-ancestor
25189570|NCT02796794|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25189571|NCT02796794|Estrogens|estrogens|mesh-ancestor
25189572|NCT02796794|Hormones|hormones|mesh-ancestor
25189573|NCT02796794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25189574|NCT02796833|SMOFlipid|smoflipid|mesh-list
25189575|NCT02796833|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25189576|NCT02796833|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25189577|NCT02796833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25189578|NCT02796950|Acipimox|acipimox|mesh-list
25189579|NCT02796950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25189580|NCT02796950|Antimetabolites|antimetabolites|mesh-ancestor
25189581|NCT02796950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189582|NCT02796950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25189583|NCT02796807|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25189584|NCT02796807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25189585|NCT02796807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189586|NCT02796859|Siltuximab|siltuximab|mesh-list
25189587|NCT02796859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189588|NCT02796547|Levobupivacaine|levobupivacaine|mesh-list
25189589|NCT02796547|Anesthetics, Local|anesthetics, local|mesh-ancestor
25189590|NCT02796547|Anesthetics|anesthetics|mesh-ancestor
25189591|NCT02796547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25189592|NCT02796547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189593|NCT02796547|Sensory System Agents|sensory system agents|mesh-ancestor
25189594|NCT02796547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25189595|NCT02796469|Pentoxifylline|pentoxifylline|mesh-list
25189596|NCT02796469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25189597|NCT02796469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25189598|NCT02796469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189599|NCT02796469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25189600|NCT02796469|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25666336|NCT01694433|Micronutrients|micronutrients|mesh-ancestor
25666337|NCT01694433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666338|NCT01694433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25666339|NCT01694433|Dermatologic Agents|dermatologic agents|mesh-ancestor
25666340|NCT01694433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25666341|NCT01694433|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25666342|NCT01694433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25666343|NCT01694433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666344|NCT01694433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25666345|NCT01694706|Omeprazole|omeprazole|mesh-list
25666346|NCT01694706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25666347|NCT01694706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25666348|NCT01694706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25666349|NCT01694706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25666350|NCT01694706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947084|NCT03932292|Calcium|calcium|mesh-list
24823909|NCT02120092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189601|NCT02796469|Protective Agents|protective agents|mesh-ancestor
25189602|NCT02796469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189605|NCT02796469|Antioxidants|antioxidants|mesh-ancestor
25189607|NCT02796378|Coenzyme Q10|coenzyme q10|mesh-list
25189608|NCT02796378|Simvastatin|simvastatin|mesh-list
25189609|NCT02796378|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25189610|NCT02796378|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25189611|NCT02796378|Antimetabolites|antimetabolites|mesh-ancestor
25189612|NCT02796378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189613|NCT02796378|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25189614|NCT02796378|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25189615|NCT02796378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25189616|NCT02796378|Micronutrients|micronutrients|mesh-ancestor
25189617|NCT02796378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189618|NCT02796378|Vitamins|vitamins|mesh-ancestor
25189619|NCT02796157|Everolimus|everolimus|mesh-list
25189620|NCT02796157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189621|NCT02796157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25189622|NCT02796157|Immunologic Factors|immunologic factors|mesh-ancestor
25189623|NCT02796157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189624|NCT02796196|Coal Tar|coal tar|mesh-list
25189625|NCT02796196|Keratolytic Agents|keratolytic agents|mesh-ancestor
25189626|NCT02796196|Dermatologic Agents|dermatologic agents|mesh-ancestor
25189627|NCT02796183|Bevacizumab|bevacizumab|mesh-list
25189628|NCT02796183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25189629|NCT02796183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189630|NCT02796183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25189631|NCT02796183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25189632|NCT02796183|Growth Substances|growth substances|mesh-ancestor
25189633|NCT02796183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189634|NCT02796183|Growth Inhibitors|growth inhibitors|mesh-ancestor
25189635|NCT02796105|Ganirelix|ganirelix|mesh-list
25189636|NCT02796105|Hormone Antagonists|hormone antagonists|mesh-ancestor
24977571|NCT02808572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977574|NCT02785224|Epinephrine|epinephrine|mesh-list
24977575|NCT02785224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24977576|NCT02785224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24977577|NCT02785224|Adrenergic Agents|adrenergic agents|mesh-ancestor
24977578|NCT02785224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24977579|NCT02785224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977580|NCT02785224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977581|NCT02785224|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24977582|NCT02785224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25860492|NCT00083694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24783571|NCT01902550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783572|NCT01902550|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24783573|NCT01902550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25105669|NCT05253781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25105671|NCT05253781|Sensory System Agents|sensory system agents|mesh-ancestor
25105672|NCT05253781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25105673|NCT05253781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105674|NCT05253781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25105675|NCT05253781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25105676|NCT05253781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25105677|NCT05253781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25105678|NCT05253781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977695|NCT02459392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24977766|NCT02177695|Dermatologic Agents|dermatologic agents|mesh-ancestor
24977767|NCT02177695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24977768|NCT02177695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24977823|NCT01973452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24977824|NCT01973452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24977825|NCT01973452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977826|NCT01973452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24977827|NCT01973452|Analgesics|analgesics|mesh-ancestor
24977828|NCT01973452|Sensory System Agents|sensory system agents|mesh-ancestor
24533960|NCT00645554|Cholinergic Agents|cholinergic agents|mesh-ancestor
24533961|NCT00645554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25860493|NCT00083694|Growth Substances|growth substances|mesh-ancestor
25860494|NCT00083694|Growth Inhibitors|growth inhibitors|mesh-ancestor
25666351|NCT01694771|Tiotropium Bromide|tiotropium bromide|mesh-list
25666352|NCT01694771|Olodaterol|olodaterol|mesh-list
25860495|NCT00083694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24423739|NCT00226746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25860496|NCT00083707|Thalidomide|thalidomide|mesh-list
25860497|NCT00083707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25860498|NCT00083707|Immunologic Factors|immunologic factors|mesh-ancestor
25860499|NCT00083707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860500|NCT00083707|Leprostatic Agents|leprostatic agents|mesh-ancestor
25860501|NCT00083707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25860502|NCT00083707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25189637|NCT02796105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25189638|NCT02796105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189639|NCT02795949|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25189640|NCT02795949|Amoxicillin|amoxicillin|mesh-list
25189641|NCT02795949|Ciprofloxacin|ciprofloxacin|mesh-list
25189642|NCT02795949|Meropenem|meropenem|mesh-list
25189643|NCT02795949|Tazobactam|tazobactam|mesh-list
25189644|NCT02795949|Piperacillin|piperacillin|mesh-list
25189645|NCT02795949|Clavulanic Acid|clavulanic acid|mesh-list
25189646|NCT02795949|Imipenem|imipenem|mesh-list
25189647|NCT02795949|Ceftazidime|ceftazidime|mesh-list
25189648|NCT02795949|Ampicillin|ampicillin|mesh-list
25189649|NCT02795949|Cefuroxime|cefuroxime|mesh-list
25189650|NCT02795949|Ertapenem|ertapenem|mesh-list
25189651|NCT02795949|Cefepime|cefepime|mesh-list
25189652|NCT02795949|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25189653|NCT02795949|Lactams|lactams|mesh-list
25189654|NCT02795949|Aztreonam|aztreonam|mesh-list
25189655|NCT02795949|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25189656|NCT02795949|beta-Lactams|beta-lactams|mesh-list
25189657|NCT02795949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25189658|NCT02795949|Trimethoprim|trimethoprim|mesh-list
25189659|NCT02795949|Sulfamethoxazole|sulfamethoxazole|mesh-list
25189660|NCT02795949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25189661|NCT02795949|Antitubercular Agents|antitubercular agents|mesh-ancestor
25189662|NCT02795949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25189663|NCT02795949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25189664|NCT02795949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25189665|NCT02795949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189666|NCT02795949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189667|NCT02795949|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25189668|NCT02795949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25189669|NCT02795949|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25189670|NCT02795949|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25189671|NCT02795949|Renal Agents|renal agents|mesh-ancestor
25189672|NCT02795949|Antimalarials|antimalarials|mesh-ancestor
25189673|NCT02795949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25189674|NCT02795949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25189675|NCT02795949|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25189676|NCT02795949|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25189677|NCT02795949|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25189678|NCT02795884|Cisplatin|cisplatin|mesh-list
25189679|NCT02795884|Pemetrexed|pemetrexed|mesh-list
25189680|NCT02795884|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25189681|NCT02795884|Vinorelbine|vinorelbine|mesh-list
25189682|NCT02795884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189683|NCT02795884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25189684|NCT02795884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189685|NCT02795884|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25189686|NCT02795884|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25189687|NCT02795884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25189688|NCT02795884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25189689|NCT02795884|Tubulin Modulators|tubulin modulators|mesh-ancestor
25189690|NCT02795884|Antimitotic Agents|antimitotic agents|mesh-ancestor
25189691|NCT02795884|Mitosis Modulators|mitosis modulators|mesh-ancestor
25189692|NCT02795572|Vitamin D|vitamin d|mesh-list
25189693|NCT02795572|Vitamins|vitamins|mesh-list
25189694|NCT02795572|Vitamin B 12|vitamin b 12|mesh-list
25189695|NCT02795572|Vitamin B 6|vitamin b 6|mesh-list
25189696|NCT02795572|Pyridoxal|pyridoxal|mesh-list
25189697|NCT02795572|Pyridoxine|pyridoxine|mesh-list
25666353|NCT01694771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25666354|NCT01694771|Autonomic Agents|autonomic agents|mesh-ancestor
25189698|NCT02795572|Vitamin B Complex|vitamin b complex|mesh-list
25189699|NCT02795572|Micronutrients|micronutrients|mesh-ancestor
25189700|NCT02795572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189701|NCT02795572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25189702|NCT02795754|Ritonavir|ritonavir|mesh-list
25189703|NCT02795754|GSK-2838232|gsk-2838232|mesh-list
25666355|NCT01694771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24423910|NCT00227409|Pentetic Acid|pentetic acid|mesh-list
24423911|NCT00227409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24423912|NCT00227409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423913|NCT00227409|Anticoagulants|anticoagulants|mesh-ancestor
24824096|NCT02121457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824097|NCT02121457|Protective Agents|protective agents|mesh-ancestor
24824098|NCT02121457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824099|NCT02121457|Trace Elements|trace elements|mesh-ancestor
24824100|NCT02121457|Micronutrients|micronutrients|mesh-ancestor
25189704|NCT02795754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25189705|NCT02795754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25189710|NCT02795754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25189711|NCT02795754|Antiviral Agents|antiviral agents|mesh-ancestor
25189712|NCT02795754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25189713|NCT02795754|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25189714|NCT02795754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25189715|NCT02795546|Alendronate|alendronate|mesh-list
25189716|NCT02795546|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24421959|NCT00220766|Antibodies|antibodies|mesh-list
25189717|NCT02795546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189718|NCT02795299|Folic Acid|folic acid|mesh-list
25189719|NCT02795299|Methotrexate|methotrexate|mesh-list
25189720|NCT02795299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25189721|NCT02795299|Abortifacient Agents|abortifacient agents|mesh-ancestor
25189722|NCT02795299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25189723|NCT02795299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189724|NCT02795299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25189725|NCT02795299|Antimetabolites|antimetabolites|mesh-ancestor
25189726|NCT02795299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189727|NCT02795299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189728|NCT02795299|Dermatologic Agents|dermatologic agents|mesh-ancestor
25189729|NCT02795299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25189730|NCT02795299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25189731|NCT02795299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25189732|NCT02795299|Immunologic Factors|immunologic factors|mesh-ancestor
25189733|NCT02795299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25189734|NCT02795299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25189735|NCT02795299|Hematinics|hematinics|mesh-ancestor
25189736|NCT02795299|Vitamin B Complex|vitamin b complex|mesh-ancestor
25189737|NCT02795299|Vitamins|vitamins|mesh-ancestor
25189738|NCT02795299|Micronutrients|micronutrients|mesh-ancestor
25189739|NCT02795143|Isotretinoin|isotretinoin|mesh-list
25189740|NCT02795143|Dermatologic Agents|dermatologic agents|mesh-ancestor
25189741|NCT02795429|Spartalizumab|spartalizumab|mesh-list
25189742|NCT02795429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25189743|NCT02795429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189744|NCT02795429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206236|NCT03762109|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25206237|NCT03762109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25206238|NCT03746951|Ropivacaine|ropivacaine|mesh-list
25206239|NCT03746951|Anesthetics, Local|anesthetics, local|mesh-ancestor
25206240|NCT03746951|Anesthetics|anesthetics|mesh-ancestor
25206241|NCT03746951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25206242|NCT03746951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206243|NCT03746951|Sensory System Agents|sensory system agents|mesh-ancestor
25206244|NCT03746951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25206245|NCT03746769|Gastrins|gastrins|mesh-list
25206246|NCT03746769|Hormones|hormones|mesh-ancestor
25206247|NCT03746769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25206248|NCT03746769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206249|NCT03699631|Methotrexate|methotrexate|mesh-list
25206250|NCT03699631|Tacrolimus|tacrolimus|mesh-list
25206251|NCT03699631|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25206252|NCT03699631|Abortifacient Agents|abortifacient agents|mesh-ancestor
25206253|NCT03699631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25427643|NCT01864018|Glycine Agents|glycine agents|mesh-ancestor
25666356|NCT01694771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666357|NCT01694771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25666358|NCT01694771|Respiratory System Agents|respiratory system agents|mesh-ancestor
25666359|NCT01694771|Parasympatholytics|parasympatholytics|mesh-ancestor
25666360|NCT01694771|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25666361|NCT01694771|Cholinergic Agents|cholinergic agents|mesh-ancestor
25666362|NCT01694771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25666363|NCT01694771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666364|NCT01694966|Methylene Blue|methylene blue|mesh-list
24824130|NCT02121951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24824131|NCT02121951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25206254|NCT03699631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206255|NCT03699631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25206256|NCT03699631|Antimetabolites|antimetabolites|mesh-ancestor
25206257|NCT03699631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206258|NCT03699631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206259|NCT03699631|Dermatologic Agents|dermatologic agents|mesh-ancestor
25206260|NCT03699631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25206261|NCT03699631|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25206262|NCT03699631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25206263|NCT03699631|Immunologic Factors|immunologic factors|mesh-ancestor
25206264|NCT03699631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25206265|NCT03699631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25206266|NCT03699631|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25189752|NCT02795039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189754|NCT02794922|Vitamins|vitamins|mesh-ancestor
25189755|NCT02794922|Micronutrients|micronutrients|mesh-ancestor
25189756|NCT02794922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189757|NCT02794948|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25189758|NCT02794948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25189759|NCT02794948|Immunologic Factors|immunologic factors|mesh-ancestor
25189760|NCT02794948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189761|NCT02795065|Enoxaparin|enoxaparin|mesh-list
25189762|NCT02795065|Bemiparin|bemiparin|mesh-list
25189763|NCT02795065|Anticoagulants|anticoagulants|mesh-ancestor
25189764|NCT02795065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25189765|NCT02795065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25189766|NCT02795065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189767|NCT02794792|Metformin|metformin|mesh-list
25189768|NCT02794792|Ipragliflozin|ipragliflozin|mesh-list
25189769|NCT02794792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25189770|NCT02794792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189771|NCT02794792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25189772|NCT02794792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189773|NCT02794779|Oxytocin|oxytocin|mesh-list
25189774|NCT02794779|Oxytocics|oxytocics|mesh-ancestor
25189775|NCT02794779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25189776|NCT02794779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189777|NCT02794714|Rocuronium|rocuronium|mesh-list
25189778|NCT02794714|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25189779|NCT02794714|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25189780|NCT02794714|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25189781|NCT02794714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25189782|NCT02794714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189783|NCT02794610|Tacrolimus|tacrolimus|mesh-list
25189784|NCT02794610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25189785|NCT02794610|Immunologic Factors|immunologic factors|mesh-ancestor
25189786|NCT02794610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189787|NCT02794610|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25189788|NCT02794610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25189789|NCT02794610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189799|NCT02794506|Propolis|propolis|mesh-list
25189800|NCT02794506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25189801|NCT02794584|Sufentanil|sufentanil|mesh-list
25189802|NCT02794584|Dsuvia|dsuvia|mesh-list
25189803|NCT02794584|Anesthetics|anesthetics|mesh-ancestor
25189804|NCT02794584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25189805|NCT02794584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189806|NCT02794584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25189808|NCT02794584|Analgesics|analgesics|mesh-ancestor
25189809|NCT02794584|Sensory System Agents|sensory system agents|mesh-ancestor
25189886|NCT02793843|Hormones|hormones|mesh-ancestor
25189810|NCT02794584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25189811|NCT02794584|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25189812|NCT02794584|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25189813|NCT02794584|Anesthetics, General|anesthetics, general|mesh-ancestor
25189814|NCT02794389|Acetylcysteine|acetylcysteine|mesh-list
25189815|NCT02794389|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25189816|NCT02794389|Antiviral Agents|antiviral agents|mesh-ancestor
25189817|NCT02794389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25189818|NCT02794389|Expectorants|expectorants|mesh-ancestor
25189819|NCT02794389|Respiratory System Agents|respiratory system agents|mesh-ancestor
25666365|NCT01694966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674406|NCT01771952|Immunologic Factors|immunologic factors|mesh-ancestor
25189820|NCT02794389|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25189821|NCT02794389|Antioxidants|antioxidants|mesh-ancestor
24824244|NCT02122484|Mitosis Modulators|mitosis modulators|mesh-ancestor
24824245|NCT02122484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212716|NCT05368181|Methylprednisolone|methylprednisolone|mesh-list
25189822|NCT02794389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189823|NCT02794389|Protective Agents|protective agents|mesh-ancestor
25189824|NCT02794389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189825|NCT02794389|Antidotes|antidotes|mesh-ancestor
25189826|NCT02794077|Cyclophosphamide|cyclophosphamide|mesh-list
25189827|NCT02794077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25189828|NCT02794077|Immunologic Factors|immunologic factors|mesh-ancestor
25189829|NCT02794077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189830|NCT02794077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25189831|NCT02794077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25189832|NCT02794077|Alkylating Agents|alkylating agents|mesh-ancestor
25189833|NCT02794077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189834|NCT02794077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189835|NCT02794077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25189836|NCT02793986|Dexmedetomidine|dexmedetomidine|mesh-list
25189837|NCT02793986|Propofol|propofol|mesh-list
25189838|NCT02793986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25189839|NCT02793986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25189840|NCT02793986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189841|NCT02793986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25189842|NCT02793986|Anesthetics, General|anesthetics, general|mesh-ancestor
25189843|NCT02793986|Anesthetics|anesthetics|mesh-ancestor
25189844|NCT02793986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25189845|NCT02793986|Analgesics|analgesics|mesh-ancestor
25189846|NCT02793986|Sensory System Agents|sensory system agents|mesh-ancestor
25189847|NCT02793986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25189848|NCT02793986|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25189849|NCT02793986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25189850|NCT02793986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25189851|NCT02793986|Adrenergic Agents|adrenergic agents|mesh-ancestor
25189852|NCT02793986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25189853|NCT02793986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189854|NCT02794025|Esmolol|esmolol|mesh-list
25189855|NCT02794025|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25189856|NCT02794025|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25189857|NCT02794025|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25189858|NCT02794025|Adrenergic Agents|adrenergic agents|mesh-ancestor
25189859|NCT02794025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25189860|NCT02794025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189861|NCT02794025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189862|NCT02794220|Nicotine|nicotine|mesh-list
25189863|NCT02794220|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25189864|NCT02794220|Autonomic Agents|autonomic agents|mesh-ancestor
25189865|NCT02794220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25189866|NCT02794220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189867|NCT02794220|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25189868|NCT02794220|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25189869|NCT02794220|Cholinergic Agents|cholinergic agents|mesh-ancestor
25189870|NCT02794220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25189871|NCT02794220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189872|NCT02794155|Insulin|insulin|mesh-list
25189873|NCT02794155|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25189874|NCT02794155|Insulin Lispro|insulin lispro|mesh-list
25189875|NCT02794155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25189876|NCT02794155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189877|NCT02793843|Dexamethasone|dexamethasone|mesh-list
25189878|NCT02793843|Ondansetron|ondansetron|mesh-list
25189879|NCT02793843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25189880|NCT02793843|Antiemetics|antiemetics|mesh-ancestor
25189889|NCT02793843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189890|NCT02793843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25189891|NCT02793843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823475|NCT02117453|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24823478|NCT02117466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24823479|NCT02117466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823480|NCT02117583|Oxycodone|oxycodone|mesh-list
24422473|NCT00222547|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25666366|NCT01694966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666367|NCT01695135|Prednisone|prednisone|mesh-list
25666368|NCT01695135|Abiraterone Acetate|abiraterone acetate|mesh-list
24422475|NCT00222547|Tubulin Modulators|tubulin modulators|mesh-ancestor
24422476|NCT00222547|Antimitotic Agents|antimitotic agents|mesh-ancestor
24422477|NCT00222547|Mitosis Modulators|mitosis modulators|mesh-ancestor
24422478|NCT00222573|Metoprolol|metoprolol|mesh-list
24422479|NCT00222573|Clopidogrel|clopidogrel|mesh-list
24422480|NCT00222573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24422481|NCT00222573|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24422482|NCT00222573|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24422488|NCT00222573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25189893|NCT02793843|Dermatologic Agents|dermatologic agents|mesh-ancestor
25189894|NCT02793843|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25189895|NCT02793843|Serotonin Agents|serotonin agents|mesh-ancestor
25189896|NCT02793843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25189897|NCT02793843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25189898|NCT02793843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25189899|NCT02793843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25189900|NCT02793843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25189901|NCT02793908|Progesterone|progesterone|mesh-list
25189902|NCT02793908|Progestins|progestins|mesh-ancestor
25189903|NCT02793908|Hormones|hormones|mesh-ancestor
25189904|NCT02793908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25189905|NCT02793908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189906|NCT02793687|Emoxypine succinate|emoxypine succinate|mesh-list
25189907|NCT02793687|Antioxidants|antioxidants|mesh-ancestor
25189908|NCT02793687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189909|NCT02793687|Protective Agents|protective agents|mesh-ancestor
25189910|NCT02793687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189911|NCT02793687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25189912|NCT02793687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25189913|NCT02793765|Docetaxel|docetaxel|mesh-list
25189914|NCT02793765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189915|NCT02793765|Tubulin Modulators|tubulin modulators|mesh-ancestor
25189916|NCT02793765|Antimitotic Agents|antimitotic agents|mesh-ancestor
25189917|NCT02793765|Mitosis Modulators|mitosis modulators|mesh-ancestor
25189918|NCT02793765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189919|NCT02793544|Mycophenolic Acid|mycophenolic acid|mesh-list
25189920|NCT02793544|Sirolimus|sirolimus|mesh-list
25189921|NCT02793544|Cyclophosphamide|cyclophosphamide|mesh-list
25189922|NCT02793544|Busulfan|busulfan|mesh-list
25189923|NCT02793544|Fludarabine|fludarabine|mesh-list
25189925|NCT02793544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25189926|NCT02793544|Immunologic Factors|immunologic factors|mesh-ancestor
25189927|NCT02793544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189928|NCT02793544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25189929|NCT02793544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25189930|NCT02793544|Alkylating Agents|alkylating agents|mesh-ancestor
25189931|NCT02793544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189932|NCT02793544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189933|NCT02793544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25189934|NCT02793544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25189935|NCT02793544|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24551050|NCT00723866|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25189936|NCT02793544|Antitubercular Agents|antitubercular agents|mesh-ancestor
25189937|NCT02793544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25189938|NCT02793544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25189939|NCT02793544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25189940|NCT02793544|Antifungal Agents|antifungal agents|mesh-ancestor
25189941|NCT02793544|Protective Agents|protective agents|mesh-ancestor
25189943|NCT02793388|Antimalarials|antimalarials|mesh-ancestor
25189944|NCT02793388|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25189945|NCT02793388|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25189946|NCT02793388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25189947|NCT02793648|Vitamins|vitamins|mesh-list
25189948|NCT02793648|Ascorbic Acid|ascorbic acid|mesh-list
25189949|NCT02793648|Vitamin E|vitamin e|mesh-list
25189950|NCT02793648|Tocopherols|tocopherols|mesh-list
25189951|NCT02793648|alpha-Tocopherol|alpha-tocopherol|mesh-list
25189952|NCT02793648|Micronutrients|micronutrients|mesh-ancestor
25189953|NCT02793648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189954|NCT02793648|Antioxidants|antioxidants|mesh-ancestor
25189955|NCT02793648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189956|NCT02793648|Protective Agents|protective agents|mesh-ancestor
25189957|NCT02793739|Hyaluronic Acid|hyaluronic acid|mesh-list
25189958|NCT02793739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25189959|NCT02793739|Immunologic Factors|immunologic factors|mesh-ancestor
25189960|NCT02793739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189961|NCT02793739|Viscosupplements|viscosupplements|mesh-ancestor
25189962|NCT02793739|Protective Agents|protective agents|mesh-ancestor
25189963|NCT02793323|Anesthetics|anesthetics|mesh-list
25189964|NCT02793323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25189965|NCT02793323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189966|NCT02793440|Cortivazol|cortivazol|mesh-list
25189967|NCT02793440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25206284|NCT03640949|Methylprednisolone|methylprednisolone|mesh-list
25206285|NCT03640949|Vasopressins|vasopressins|mesh-list
25206286|NCT03640949|Arginine Vasopressin|arginine vasopressin|mesh-list
25206287|NCT03640949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25206288|NCT03640949|Antiemetics|antiemetics|mesh-ancestor
25206289|NCT03640949|Autonomic Agents|autonomic agents|mesh-ancestor
25206290|NCT03640949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25206291|NCT03640949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206292|NCT03640949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25206293|NCT03640949|Glucocorticoids|glucocorticoids|mesh-ancestor
25206294|NCT03640949|Hormones|hormones|mesh-ancestor
25206295|NCT03640949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25206296|NCT03640949|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25206297|NCT03640949|Protective Agents|protective agents|mesh-ancestor
25206298|NCT03640949|Hemostatics|hemostatics|mesh-ancestor
25206299|NCT03640949|Coagulants|coagulants|mesh-ancestor
25206300|NCT03640949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25206301|NCT03640949|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25206302|NCT03640949|Natriuretic Agents|natriuretic agents|mesh-ancestor
25206303|NCT03621761|Modafinil|modafinil|mesh-list
25206304|NCT03621761|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25206305|NCT03621761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206306|NCT03621761|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25206307|NCT03621761|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24551051|NCT00723866|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25206308|NCT03621761|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25206309|NCT03621761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206310|NCT03619551|Busulfan|busulfan|mesh-list
25206311|NCT03619551|Alkylating Agents|alkylating agents|mesh-ancestor
25206312|NCT03619551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206313|NCT03619551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25206314|NCT03619551|Immunologic Factors|immunologic factors|mesh-ancestor
25206315|NCT03619551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206316|NCT03619551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25206317|NCT03619551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206318|NCT03619551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25206319|NCT03616886|Paclitaxel|paclitaxel|mesh-list
25206320|NCT03616886|Carboplatin|carboplatin|mesh-list
25206321|NCT03616886|Durvalumab|durvalumab|mesh-list
25206322|NCT03616886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25206323|NCT03616886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206324|NCT03616886|Tubulin Modulators|tubulin modulators|mesh-ancestor
25206325|NCT03616886|Antimitotic Agents|antimitotic agents|mesh-ancestor
24823500|NCT02117700|Acetylcysteine|acetylcysteine|mesh-list
25206326|NCT03616886|Mitosis Modulators|mitosis modulators|mesh-ancestor
25189968|NCT02793505|Metformin|metformin|mesh-list
25189969|NCT02793505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25189970|NCT02793505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189971|NCT02793193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25189972|NCT02793193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25189973|NCT02793193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25189974|NCT02793193|Antitubercular Agents|antitubercular agents|mesh-ancestor
25189975|NCT02793466|Durvalumab|durvalumab|mesh-list
25189976|NCT02793466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25189977|NCT02793466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25189978|NCT02793466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189979|NCT02793466|Immunologic Factors|immunologic factors|mesh-ancestor
25189980|NCT02793466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189981|NCT02793219|Docetaxel|docetaxel|mesh-list
25189982|NCT02793219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189983|NCT02793219|Tubulin Modulators|tubulin modulators|mesh-ancestor
25189984|NCT02793219|Antimitotic Agents|antimitotic agents|mesh-ancestor
25189985|NCT02793219|Mitosis Modulators|mitosis modulators|mesh-ancestor
25189986|NCT02793219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189987|NCT02793050|Trabectedin|trabectedin|mesh-list
25189988|NCT02793050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25189989|NCT02793050|Alkylating Agents|alkylating agents|mesh-ancestor
25189990|NCT02793050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25189991|NCT02793050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25189992|NCT02793011|Dexamethasone|dexamethasone|mesh-list
24424946|NCT00231452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24424947|NCT00231452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24425042|NCT00231738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25189993|NCT02793011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25189994|NCT02793011|Antiemetics|antiemetics|mesh-ancestor
25189995|NCT02793011|Autonomic Agents|autonomic agents|mesh-ancestor
25189996|NCT02793011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25189997|NCT02793011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25189998|NCT02793011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25189999|NCT02793011|Glucocorticoids|glucocorticoids|mesh-ancestor
25190000|NCT02793011|Hormones|hormones|mesh-ancestor
25190001|NCT02793011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25190002|NCT02793011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25190003|NCT02793011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25190004|NCT02792816|Artesunate|artesunate|mesh-list
25190005|NCT02792816|Artemether|artemether|mesh-list
25190006|NCT02792816|Piperaquine|piperaquine|mesh-list
25190007|NCT02792816|Artenimol|artenimol|mesh-list
25190008|NCT02792816|Mefloquine|mefloquine|mesh-list
25190009|NCT02792816|Antimalarials|antimalarials|mesh-list
25190010|NCT02792816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25190011|NCT02792816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25190012|NCT02792816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25190013|NCT02792816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25190014|NCT02792816|Antiviral Agents|antiviral agents|mesh-ancestor
25190015|NCT02792816|Schistosomicides|schistosomicides|mesh-ancestor
25190016|NCT02792816|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25190017|NCT02792816|Anthelmintics|anthelmintics|mesh-ancestor
25190018|NCT02792712|Clopidogrel|clopidogrel|mesh-list
25190019|NCT02792712|Ticagrelor|ticagrelor|mesh-list
25190020|NCT02792712|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25190021|NCT02792712|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25190022|NCT02792712|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25190023|NCT02792712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25190024|NCT02792712|Purinergic Agents|purinergic agents|mesh-ancestor
25190025|NCT02792712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25190026|NCT02792712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190027|NCT02792712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190028|NCT02792946|Ambroxol|ambroxol|mesh-list
25190029|NCT02792946|Expectorants|expectorants|mesh-ancestor
25190030|NCT02792946|Respiratory System Agents|respiratory system agents|mesh-ancestor
25190031|NCT02792491|Prednisone|prednisone|mesh-list
25190032|NCT02792491|Cyclophosphamide|cyclophosphamide|mesh-list
25190033|NCT02792491|Rituximab|rituximab|mesh-list
25190034|NCT02792491|Doxorubicin|doxorubicin|mesh-list
25190035|NCT02792491|Vincristine|vincristine|mesh-list
25190036|NCT02792491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25190037|NCT02792491|Immunologic Factors|immunologic factors|mesh-ancestor
25190038|NCT02792491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190039|NCT02792491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25190040|NCT02792491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25190041|NCT02792491|Alkylating Agents|alkylating agents|mesh-ancestor
25190042|NCT02792491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190043|NCT02792491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25190044|NCT02792491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25190061|NCT02792803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25190062|NCT02792673|Hyaluronic Acid|hyaluronic acid|mesh-list
25190063|NCT02792673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25190064|NCT02792673|Immunologic Factors|immunologic factors|mesh-ancestor
25190065|NCT02792673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190066|NCT02792673|Viscosupplements|viscosupplements|mesh-ancestor
25190067|NCT02792673|Protective Agents|protective agents|mesh-ancestor
25190068|NCT02792621|Acipimox|acipimox|mesh-list
25190069|NCT02792621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25190070|NCT02792621|Antimetabolites|antimetabolites|mesh-ancestor
24551467|NCT00726700|Mitosis Modulators|mitosis modulators|mesh-ancestor
25190071|NCT02792621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190072|NCT02792621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25190073|NCT02792426|Nicotine|nicotine|mesh-list
25190074|NCT02792426|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25190075|NCT02792426|Autonomic Agents|autonomic agents|mesh-ancestor
25190076|NCT02792426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25666369|NCT01695135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25666370|NCT01695135|Glucocorticoids|glucocorticoids|mesh-ancestor
25666371|NCT01695135|Hormones|hormones|mesh-ancestor
25190077|NCT02792426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674407|NCT01771952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425667|NCT00233935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425668|NCT00233935|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24425669|NCT00233935|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24425670|NCT00233935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24425680|NCT00234000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425682|NCT00234000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661446|NCT01289561|Quinine|quinine|mesh-list
24661447|NCT01289561|Caffeine|caffeine|mesh-list
25860503|NCT00083707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25190078|NCT02792426|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25190079|NCT02792426|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25190080|NCT02792426|Cholinergic Agents|cholinergic agents|mesh-ancestor
25190081|NCT02792426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25190082|NCT02792426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190083|NCT02792400|Empagliflozin|empagliflozin|mesh-list
25190084|NCT02792400|Linagliptin|linagliptin|mesh-list
25190085|NCT02792400|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25190086|NCT02792400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190087|NCT02792400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25190088|NCT02792400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190089|NCT02792400|Incretins|incretins|mesh-ancestor
25190090|NCT02792400|Hormones|hormones|mesh-ancestor
25190091|NCT02792400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25190092|NCT02792400|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25190093|NCT02792400|Protease Inhibitors|protease inhibitors|mesh-ancestor
25190094|NCT02792400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190095|NCT02792335|Warfarin|warfarin|mesh-list
25190096|NCT02792335|Rivaroxaban|rivaroxaban|mesh-list
25190097|NCT02792335|Dabigatran|dabigatran|mesh-list
25190098|NCT02792335|Apixaban|apixaban|mesh-list
25190099|NCT02792335|Anticoagulants|anticoagulants|mesh-ancestor
25190100|NCT02792335|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25190101|NCT02792335|Antithrombins|antithrombins|mesh-ancestor
25190102|NCT02792335|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25190103|NCT02792335|Protease Inhibitors|protease inhibitors|mesh-ancestor
25190104|NCT02792335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190105|NCT02792335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190115|NCT02792036|Carboplatin|carboplatin|mesh-list
25190116|NCT02792036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24422634|NCT00223288|Citalopram|citalopram|mesh-list
25190117|NCT02792153|Estradiol|estradiol|mesh-list
25190118|NCT02792153|Estrogens|estrogens|mesh-ancestor
25190119|NCT02792153|Hormones|hormones|mesh-ancestor
24823751|NCT02118870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24823752|NCT02118870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24823753|NCT02118870|Analgesics|analgesics|mesh-ancestor
24422842|NCT00223717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24422844|NCT00223717|Analgesics|analgesics|mesh-ancestor
24422856|NCT00223717|Antipyretics|antipyretics|mesh-ancestor
24823766|NCT02118870|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24823767|NCT02118870|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24459910|NCT00346827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24454102|NCT04432012|BB 1101|bb 1101|mesh-list
24551818|NCT04956627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24551819|NCT04956627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190136|NCT02791958|Ramipril|ramipril|mesh-list
25190137|NCT02791958|Atorvastatin|atorvastatin|mesh-list
25190138|NCT02791958|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25190139|NCT02791958|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25190140|NCT02791958|Antimetabolites|antimetabolites|mesh-ancestor
25190141|NCT02791958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190142|NCT02791958|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25190143|NCT02791958|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25190144|NCT02791958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190145|NCT02791958|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25190146|NCT02791958|Protease Inhibitors|protease inhibitors|mesh-ancestor
25190147|NCT02791958|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25666372|NCT01695135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25666373|NCT01695135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666374|NCT01695135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25666375|NCT01695135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25666376|NCT01695135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25666377|NCT01695135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25666378|NCT01695135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425954|NCT00234858|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24425955|NCT00234858|Protease Inhibitors|protease inhibitors|mesh-ancestor
24425956|NCT00234858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24425957|NCT00234871|Verapamil|verapamil|mesh-list
24425958|NCT00234871|Amlodipine|amlodipine|mesh-list
24425959|NCT00234871|Benazepril|benazepril|mesh-list
24823768|NCT02118870|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25190149|NCT02792140|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25190150|NCT02792140|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25190151|NCT02792140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190152|NCT02792140|Sensory System Agents|sensory system agents|mesh-ancestor
25190153|NCT02792140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25190154|NCT02791919|Cytarabine|cytarabine|mesh-list
25190155|NCT02791919|Fludarabine|fludarabine|mesh-list
25190156|NCT02791919|Fludarabine phosphate|fludarabine phosphate|mesh-list
25190157|NCT02791919|Lenograstim|lenograstim|mesh-list
25190158|NCT02791919|Adavosertib|adavosertib|mesh-list
25190163|NCT02791919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25190164|NCT02791919|Immunologic Factors|immunologic factors|mesh-ancestor
25190165|NCT02791919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190166|NCT02791919|Antiviral Agents|antiviral agents|mesh-ancestor
25190167|NCT02791919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25190168|NCT02791919|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25190169|NCT02791919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190170|NCT02791737|Coal Tar|coal tar|mesh-list
25190171|NCT02791737|Keratolytic Agents|keratolytic agents|mesh-ancestor
25190172|NCT02791737|Dermatologic Agents|dermatologic agents|mesh-ancestor
25241634|NCT05300477|Natriuretic Agents|natriuretic agents|mesh-ancestor
25206327|NCT03616886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206328|NCT03616886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25206334|NCT03615508|Phenylephrine|phenylephrine|mesh-list
25206335|NCT03615508|Oxymetazoline|oxymetazoline|mesh-list
25206336|NCT03615508|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25206337|NCT03615508|Mydriatics|mydriatics|mesh-ancestor
25206338|NCT03615508|Autonomic Agents|autonomic agents|mesh-ancestor
25206339|NCT03615508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25206340|NCT03615508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206341|NCT03615508|Sympathomimetics|sympathomimetics|mesh-ancestor
25206342|NCT03615508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25206343|NCT03615508|Nasal Decongestants|nasal decongestants|mesh-ancestor
25206344|NCT03615508|Respiratory System Agents|respiratory system agents|mesh-ancestor
25206345|NCT03615508|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25206346|NCT03615508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25206347|NCT03615508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25206348|NCT03615508|Adrenergic Agents|adrenergic agents|mesh-ancestor
25206349|NCT03615508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25206350|NCT03615508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206351|NCT03615508|Protective Agents|protective agents|mesh-ancestor
25206352|NCT03612791|Atezolizumab|atezolizumab|mesh-list
25206353|NCT03612791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206354|NCT03609840|Thiotepa|thiotepa|mesh-list
25206355|NCT03609840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-list
25206356|NCT03609840|Antineoplastic Agents|antineoplastic agents|mesh-list
25206357|NCT03609840|Alkylating Agents|alkylating agents|mesh-ancestor
25206358|NCT03609840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206359|NCT03609840|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25206360|NCT03609840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24552031|NCT04250883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24552069|NCT04213794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24552070|NCT04213794|Chelating Agents|chelating agents|mesh-ancestor
25206361|NCT03609840|Immunologic Factors|immunologic factors|mesh-ancestor
25206362|NCT03609840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206363|NCT03606642|Aspirin|aspirin|mesh-list
25206364|NCT03606642|Clopidogrel|clopidogrel|mesh-list
25206365|NCT03606642|Ticagrelor|ticagrelor|mesh-list
25206366|NCT03606642|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25206367|NCT03606642|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25206368|NCT03606642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25206369|NCT03606642|Analgesics|analgesics|mesh-ancestor
25206370|NCT03606642|Sensory System Agents|sensory system agents|mesh-ancestor
25206371|NCT03606642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25206372|NCT03606642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206373|NCT03606642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25666379|NCT01695135|Hormone Antagonists|hormone antagonists|mesh-ancestor
25666380|NCT01695135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25666381|NCT01695239|Adalimumab|adalimumab|mesh-list
25666382|NCT01695239|Ixekizumab|ixekizumab|mesh-list
25666383|NCT01695239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25666384|NCT01695239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24426423|NCT00236015|Tiagabine|tiagabine|mesh-list
25206374|NCT03606642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25206375|NCT03606642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25190174|NCT02791815|Midazolam|midazolam|mesh-list
25190175|NCT02791815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25190176|NCT02791815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25190177|NCT02791815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25190178|NCT02791815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190179|NCT02791815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25190180|NCT02791815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25190181|NCT02791815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25190182|NCT02791815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25190183|NCT02791815|Anesthetics, General|anesthetics, general|mesh-ancestor
25190187|NCT02791815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25190188|NCT02791815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190189|NCT02791815|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25190190|NCT02791594|Pembrolizumab|pembrolizumab|mesh-list
25190191|NCT02791594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25190192|NCT02791594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25190193|NCT02791243|Finasteride|finasteride|mesh-list
25190194|NCT02791243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25190195|NCT02791243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25190196|NCT02791243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190197|NCT02791243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190198|NCT02791243|Hormone Antagonists|hormone antagonists|mesh-ancestor
25190199|NCT02791243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25190200|NCT02791243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552071|NCT04213794|Sequestering Agents|sequestering agents|mesh-ancestor
24552143|NCT04144465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24552144|NCT04144465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552145|NCT04144465|Sympathomimetics|sympathomimetics|mesh-ancestor
24552180|NCT04120636|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24552181|NCT04120636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24552182|NCT04120636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24552183|NCT04120636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552184|NCT04098003|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24552185|NCT04098003|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25190201|NCT02791243|Urological Agents|urological agents|mesh-ancestor
25190202|NCT02791373|Gemcitabine|gemcitabine|mesh-list
25190203|NCT02791373|Vinorelbine|vinorelbine|mesh-list
25190204|NCT02791373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25190205|NCT02791373|Antimetabolites|antimetabolites|mesh-ancestor
25190206|NCT02791373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190207|NCT02791373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25190208|NCT02791373|Antiviral Agents|antiviral agents|mesh-ancestor
25190209|NCT02791373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25190210|NCT02791373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190211|NCT02791373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25190212|NCT02791373|Immunologic Factors|immunologic factors|mesh-ancestor
25190213|NCT02791373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190214|NCT02791373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25190215|NCT02791373|Tubulin Modulators|tubulin modulators|mesh-ancestor
25190216|NCT02791373|Antimitotic Agents|antimitotic agents|mesh-ancestor
25190217|NCT02791373|Mitosis Modulators|mitosis modulators|mesh-ancestor
25190219|NCT02791256|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25190220|NCT02791256|Antimetabolites|antimetabolites|mesh-ancestor
25190221|NCT02791256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190222|NCT02791256|Antiviral Agents|antiviral agents|mesh-ancestor
25190223|NCT02791256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25190224|NCT02790853|Proflavine|proflavine|mesh-list
25190225|NCT02790853|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25190226|NCT02790853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25190227|NCT02790957|Plerixafor|plerixafor|mesh-list
25190228|NCT02790957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25190229|NCT02790957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25190230|NCT02790957|Antiviral Agents|antiviral agents|mesh-ancestor
25190231|NCT02790957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25190232|NCT02790996|Vancomycin|vancomycin|mesh-list
25190233|NCT02790996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25190234|NCT02790996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25190235|NCT02791035|Ipragliflozin|ipragliflozin|mesh-list
25190236|NCT02791035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25190237|NCT02791035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190238|NCT02791035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25666385|NCT01695239|Dermatologic Agents|dermatologic agents|mesh-ancestor
24824404|NCT02123355|Sevoflurane|sevoflurane|mesh-list
24824405|NCT02123355|Vecuronium Bromide|vecuronium bromide|mesh-list
24824406|NCT02123355|Anesthetics|anesthetics|mesh-ancestor
24824407|NCT02123355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24824408|NCT02123355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824409|NCT02123355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24824410|NCT02123355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24426789|NCT00236639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426791|NCT00236652|Ofloxacin|ofloxacin|mesh-list
25241683|NCT05300334|Adenosine|adenosine|mesh-list
25190239|NCT02791035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190240|NCT02790840|Omeprazole|omeprazole|mesh-list
25190241|NCT02790840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25190242|NCT02790840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25190243|NCT02790840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25190244|NCT02790840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190245|NCT02790840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190264|NCT02790671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25190265|NCT02790671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190266|NCT02790671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190267|NCT02790671|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25190268|NCT02790671|Hormone Antagonists|hormone antagonists|mesh-ancestor
25190269|NCT02790671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25190270|NCT02790671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190271|NCT02790671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25190272|NCT02790671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25190274|NCT02790580|Doxorubicin|doxorubicin|mesh-list
25190275|NCT02790580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25190276|NCT02790580|Sunitinib|sunitinib|mesh-list
25190277|NCT02790580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25190278|NCT02790580|Immunologic Factors|immunologic factors|mesh-ancestor
25190279|NCT02790580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190280|NCT02790580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25190281|NCT02790580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25190282|NCT02790580|Alkylating Agents|alkylating agents|mesh-ancestor
25190283|NCT02790580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190284|NCT02790580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25190285|NCT02790580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25190286|NCT02790580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25190287|NCT02790580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25190288|NCT02790580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25190289|NCT02790580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190290|NCT02790580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25190291|NCT02790580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25190292|NCT02790580|Growth Substances|growth substances|mesh-ancestor
25190293|NCT02790580|Growth Inhibitors|growth inhibitors|mesh-ancestor
25190294|NCT02790580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25190295|NCT02790450|Benzbromarone|benzbromarone|mesh-list
25190296|NCT02790450|Uricosuric Agents|uricosuric agents|mesh-ancestor
25190297|NCT02790450|Gout Suppressants|gout suppressants|mesh-ancestor
25190298|NCT02790450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25190299|NCT02790450|Renal Agents|renal agents|mesh-ancestor
25190300|NCT02790632|Nimodipine|nimodipine|mesh-list
25190301|NCT02790632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25190302|NCT02790632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25190303|NCT02790632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25190304|NCT02790632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190305|NCT02790632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25190306|NCT02790632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190307|NCT02790632|Vasodilator Agents|vasodilator agents|mesh-ancestor
25190308|NCT02790528|Atorvastatin|atorvastatin|mesh-list
25190309|NCT02790528|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25190310|NCT02790528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25190311|NCT02790528|Antimetabolites|antimetabolites|mesh-ancestor
25190312|NCT02790528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190313|NCT02790528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25666386|NCT01695291|Minocycline|minocycline|mesh-list
25666387|NCT01695291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25666388|NCT01695291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25666389|NCT01695330|Bortezomib|bortezomib|mesh-list
25666390|NCT01695330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25666391|NCT01695668|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25666392|NCT01695668|Cyclosporine|cyclosporine|mesh-list
25666393|NCT01695668|Cyclosporins|cyclosporins|mesh-list
25666394|NCT01695668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674408|NCT01771952|Viscosupplements|viscosupplements|mesh-ancestor
24824425|NCT02123355|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24824426|NCT02123355|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24824427|NCT02123355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24824428|NCT02123355|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24426909|NCT00236821|Levofloxacin|levofloxacin|mesh-list
25190314|NCT02790528|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25190315|NCT02790528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190316|NCT02790099|Morphine|morphine|mesh-list
25190317|NCT02790099|Bupivacaine|bupivacaine|mesh-list
24823793|NCT02119000|Bisacodyl|bisacodyl|mesh-list
25190318|NCT02790099|Anesthetics, Local|anesthetics, local|mesh-ancestor
25190319|NCT02790099|Anesthetics|anesthetics|mesh-ancestor
24823801|NCT02119091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24823802|NCT02119091|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24823804|NCT02119091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823805|NCT02119091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423377|NCT00225706|Sensory System Agents|sensory system agents|mesh-ancestor
24423378|NCT00225706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24701926|NCT01462968|Heparin|heparin|mesh-list
24794278|NCT05304533|Antifungal Agents|antifungal agents|mesh-ancestor
25860504|NCT00083707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24534155|NCT00646191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24534157|NCT00646204|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24534158|NCT00646204|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24534159|NCT00646204|Dopamine Agents|dopamine agents|mesh-ancestor
24534160|NCT00646204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25860505|NCT00083707|Growth Substances|growth substances|mesh-ancestor
25860506|NCT00083707|Growth Inhibitors|growth inhibitors|mesh-ancestor
24971061|NCT03728894|Midazolam|midazolam|mesh-list
24459933|NCT00346866|Growth Substances|growth substances|mesh-ancestor
25860507|NCT00083707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860508|NCT00083772|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25860509|NCT00083772|Natriuretic Agents|natriuretic agents|mesh-ancestor
25860510|NCT00083772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860511|NCT00083785|Talaporfin|talaporfin|mesh-list
25860512|NCT00083785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860513|NCT00083785|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24534350|NCT00646750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24534352|NCT00646750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534353|NCT00646750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24534354|NCT00646750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24534355|NCT00646750|Alkylating Agents|alkylating agents|mesh-ancestor
24534356|NCT00646750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534357|NCT00646750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24534358|NCT00646750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24534359|NCT00646802|Progesterone|progesterone|mesh-list
24534360|NCT00646802|Progestins|progestins|mesh-ancestor
24534361|NCT00646802|Hormones|hormones|mesh-ancestor
24534362|NCT00646802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24534363|NCT00646802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534364|NCT00646815|Hormones|hormones|mesh-list
24534365|NCT00646815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24534375|NCT00646841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534376|NCT00646854|Cyclophosphamide|cyclophosphamide|mesh-list
24534377|NCT00646854|Alemtuzumab|alemtuzumab|mesh-list
24534378|NCT00646854|Doxorubicin|doxorubicin|mesh-list
24534379|NCT00646854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25860514|NCT00083785|Dermatologic Agents|dermatologic agents|mesh-ancestor
25860515|NCT00083824|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25860516|NCT00083824|Medroxyprogesterone|medroxyprogesterone|mesh-list
25860517|NCT00083824|Estrogens|estrogens|mesh-list
25860518|NCT00083824|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25190320|NCT02790099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25190321|NCT02790099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190322|NCT02790099|Sensory System Agents|sensory system agents|mesh-ancestor
25190323|NCT02790099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25190324|NCT02790099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25666395|NCT01695668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666396|NCT01695668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25666397|NCT01695668|Immunologic Factors|immunologic factors|mesh-ancestor
25666398|NCT01695668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666399|NCT01695668|Antifungal Agents|antifungal agents|mesh-ancestor
25666400|NCT01695668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25860519|NCT00083824|Hormones|hormones|mesh-ancestor
24427296|NCT00237913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24427317|NCT00237913|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25190325|NCT02790099|Narcotics|narcotics|mesh-ancestor
25190326|NCT02790099|Analgesics|analgesics|mesh-ancestor
25190327|NCT02790203|Celecoxib|celecoxib|mesh-list
25190328|NCT02790203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25190329|NCT02790203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25190330|NCT02790203|Analgesics|analgesics|mesh-ancestor
25190331|NCT02790203|Sensory System Agents|sensory system agents|mesh-ancestor
25190332|NCT02790203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25190334|NCT02790203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25190335|NCT02790203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25190336|NCT02790203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25190337|NCT02790203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25190338|NCT02790203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190339|NCT02790203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190340|NCT02790177|Hyaluronic Acid|hyaluronic acid|mesh-list
25190341|NCT02790177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25190342|NCT02790177|Immunologic Factors|immunologic factors|mesh-ancestor
25206382|NCT03606642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25206383|NCT03606642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25206384|NCT03606642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25206385|NCT03606642|Purinergic Agents|purinergic agents|mesh-ancestor
25206386|NCT03606642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25206387|NCT03586687|Triamcinolone|triamcinolone|mesh-list
25206388|NCT03586687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25206389|NCT03586687|Glucocorticoids|glucocorticoids|mesh-ancestor
25206391|NCT03586687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25206392|NCT03586687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206400|NCT03570437|Paclitaxel|paclitaxel|mesh-list
25206401|NCT03570437|Olaparib|olaparib|mesh-list
25206402|NCT03570437|Cediranib|cediranib|mesh-list
25206403|NCT03570437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25206404|NCT03570437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206405|NCT03570437|Tubulin Modulators|tubulin modulators|mesh-ancestor
25206406|NCT03570437|Antimitotic Agents|antimitotic agents|mesh-ancestor
25206407|NCT03570437|Mitosis Modulators|mitosis modulators|mesh-ancestor
25206408|NCT03570437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206409|NCT03570437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25206410|NCT03570437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25206411|NCT03570437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25206412|NCT03502070|Tobramycin|tobramycin|mesh-list
25206413|NCT03502070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25206414|NCT03502070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25206415|NCT03485911|Berotralstat|berotralstat|mesh-list
25206416|NCT03485911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25206417|NCT03485911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208173|NCT02953340|Cyclophosphamide|cyclophosphamide|mesh-list
25208174|NCT02953340|Docetaxel|docetaxel|mesh-list
25208175|NCT02953340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25208176|NCT02953340|Immunologic Factors|immunologic factors|mesh-ancestor
25208177|NCT02953340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208178|NCT02953340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25208179|NCT02953340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25208180|NCT02953340|Alkylating Agents|alkylating agents|mesh-ancestor
25208181|NCT02953340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947780|NCT03925818|Antacids|antacids|mesh-ancestor
25208182|NCT02953340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208183|NCT02953340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25208184|NCT02953340|Tubulin Modulators|tubulin modulators|mesh-ancestor
25208185|NCT02953340|Antimitotic Agents|antimitotic agents|mesh-ancestor
25208186|NCT02953340|Mitosis Modulators|mitosis modulators|mesh-ancestor
25190346|NCT02790164|Rocuronium|rocuronium|mesh-list
25190347|NCT02790164|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25190348|NCT02790164|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25190349|NCT02790164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25190350|NCT02790164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25190351|NCT02790164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190352|NCT02789969|Fentanyl|fentanyl|mesh-list
25190353|NCT02789969|Hydromorphone|hydromorphone|mesh-list
25666402|NCT01695668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25666403|NCT01695668|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25666404|NCT01695668|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25666405|NCT01695772|Bevacizumab|bevacizumab|mesh-list
25190354|NCT02789969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25190355|NCT02789969|Narcotics|narcotics|mesh-ancestor
25190356|NCT02789969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25190357|NCT02789969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190367|NCT02789982|Adrenergic Antagonists|adrenergic antagonists|mesh-list
25190368|NCT02789982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25190369|NCT02789982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25190370|NCT02789982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190371|NCT02789982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190372|NCT02789982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25190373|NCT02789982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25190374|NCT02789982|Vasodilator Agents|vasodilator agents|mesh-ancestor
25190384|NCT02789865|Metronidazole|metronidazole|mesh-list
25190385|NCT02789865|Levofloxacin|levofloxacin|mesh-list
25190387|NCT02789865|Ertapenem|ertapenem|mesh-list
25190388|NCT02789865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25190389|NCT02789865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25190390|NCT02789865|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25190391|NCT02789865|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25190392|NCT02789865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25190393|NCT02789865|Renal Agents|renal agents|mesh-ancestor
25190394|NCT02789865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25190395|NCT02789865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25190396|NCT02789865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190397|NCT02789865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190398|NCT02789865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25190399|NCT02789865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25190400|NCT02789865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25190401|NCT02789930|Anesthetics|anesthetics|mesh-list
25190402|NCT02789930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25190403|NCT02789930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190404|NCT02789813|Valproic Acid|valproic acid|mesh-list
25190405|NCT02789813|Anticonvulsants|anticonvulsants|mesh-ancestor
25190406|NCT02789813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190407|NCT02789813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190408|NCT02789813|GABA Agents|gaba agents|mesh-ancestor
25190409|NCT02789813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25190410|NCT02789813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190411|NCT02789813|Antimanic Agents|antimanic agents|mesh-ancestor
25190412|NCT02789813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25190413|NCT02789813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24552969|NCT00728585|Mitosis Modulators|mitosis modulators|mesh-ancestor
25190414|NCT02789813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25190415|NCT02789592|Clonazepam|clonazepam|mesh-list
25190416|NCT02789592|Melatonin|melatonin|mesh-list
25190417|NCT02789592|Antioxidants|antioxidants|mesh-ancestor
25190418|NCT02789592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190419|NCT02789592|Protective Agents|protective agents|mesh-ancestor
25190420|NCT02789592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206418|NCT03481660|Aflibercept|aflibercept|mesh-list
25190421|NCT02789592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25190422|NCT02789592|Anticonvulsants|anticonvulsants|mesh-ancestor
25190423|NCT02789592|GABA Modulators|gaba modulators|mesh-ancestor
25190424|NCT02789592|GABA Agents|gaba agents|mesh-ancestor
25190425|NCT02789592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25190426|NCT02789501|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25190427|NCT02789644|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25190428|NCT02789644|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25190429|NCT02789644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25190430|NCT02789579|Levofloxacin|levofloxacin|mesh-list
25190431|NCT02789579|Ofloxacin|ofloxacin|mesh-list
25190432|NCT02789579|Nitrofurantoin|nitrofurantoin|mesh-list
25190433|NCT02789579|Cefuroxime|cefuroxime|mesh-list
25190435|NCT02789579|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25190436|NCT02789579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25190437|NCT02789579|Renal Agents|renal agents|mesh-ancestor
25190438|NCT02789579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25190439|NCT02789579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25190440|NCT02789579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25190441|NCT02789579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190442|NCT02789579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190443|NCT02789579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25190444|NCT02789579|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25190445|NCT02789579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25190446|NCT02789150|Norepinephrine|norepinephrine|mesh-list
25860520|NCT00083824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25190447|NCT02789150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25190448|NCT02789150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25190449|NCT02789150|Adrenergic Agents|adrenergic agents|mesh-ancestor
25190450|NCT02789150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25190451|NCT02789150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190452|NCT02789150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190453|NCT02789150|Sympathomimetics|sympathomimetics|mesh-ancestor
25190454|NCT02789150|Autonomic Agents|autonomic agents|mesh-ancestor
25190455|NCT02789150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25190456|NCT02789150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25190457|NCT02789358|Adenosine|adenosine|mesh-list
25190458|NCT02789358|Analgesics|analgesics|mesh-ancestor
25190459|NCT02789358|Sensory System Agents|sensory system agents|mesh-ancestor
25190460|NCT02789358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25190461|NCT02789358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190462|NCT02789358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25190463|NCT02789358|Vasodilator Agents|vasodilator agents|mesh-ancestor
25190464|NCT02789358|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25190465|NCT02789358|Purinergic Agonists|purinergic agonists|mesh-ancestor
25190466|NCT02789358|Purinergic Agents|purinergic agents|mesh-ancestor
25190467|NCT02789358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25190468|NCT02789358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190469|NCT02789475|Amlodipine|amlodipine|mesh-list
25190470|NCT02789475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25190471|NCT02789475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25190472|NCT02789475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25190473|NCT02789475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25190474|NCT02789475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190475|NCT02789475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25190476|NCT02789475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190477|NCT02789475|Vasodilator Agents|vasodilator agents|mesh-ancestor
25190478|NCT02789475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25190479|NCT02789475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25190480|NCT02789475|Antimetabolites|antimetabolites|mesh-ancestor
25190481|NCT02789475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25190482|NCT02789475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25190483|NCT02789475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190484|NCT02789332|Paclitaxel|paclitaxel|mesh-list
25190485|NCT02789332|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25190486|NCT02789332|Cyclophosphamide|cyclophosphamide|mesh-list
25190487|NCT02789332|Carboplatin|carboplatin|mesh-list
25190488|NCT02789332|Epirubicin|epirubicin|mesh-list
25190489|NCT02789332|Olaparib|olaparib|mesh-list
25190490|NCT02789332|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25190491|NCT02789332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25190492|NCT02789332|Tubulin Modulators|tubulin modulators|mesh-ancestor
25190493|NCT02789332|Antimitotic Agents|antimitotic agents|mesh-ancestor
25190494|NCT02789332|Mitosis Modulators|mitosis modulators|mesh-ancestor
25190495|NCT02789332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423686|NCT00226551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423687|NCT00226551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423688|NCT00226551|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24423689|NCT00226551|Autonomic Agents|autonomic agents|mesh-ancestor
24423690|NCT00226551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24423691|NCT00226551|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24824009|NCT02120703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824010|NCT02120703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24824012|NCT02120703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24824013|NCT02120703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24824014|NCT02120703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24580346|NCT00861419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24824015|NCT02120703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24824016|NCT02120703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24824017|NCT02120703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24423692|NCT00226551|Respiratory System Agents|respiratory system agents|mesh-ancestor
24423719|NCT00226694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24423721|NCT00226694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24423722|NCT00226707|Pimecrolimus|pimecrolimus|mesh-list
25860521|NCT00083824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860522|NCT00083824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25666406|NCT01695772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24813085|NCT02056379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24813086|NCT02056379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25860523|NCT00083824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25860524|NCT00083824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25860525|NCT00083824|Contraceptive Agents|contraceptive agents|mesh-ancestor
25860526|NCT00083824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25860527|NCT00083824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25860528|NCT00083824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25860529|NCT00083824|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25860530|NCT00083824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25860531|NCT00083824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860532|NCT00083876|Thalidomide|thalidomide|mesh-list
25860533|NCT00083876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25860534|NCT00083876|Immunologic Factors|immunologic factors|mesh-ancestor
25190496|NCT02789332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25190497|NCT02789332|Immunologic Factors|immunologic factors|mesh-ancestor
25190498|NCT02789332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190499|NCT02789332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25190500|NCT02789332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25190501|NCT02789332|Alkylating Agents|alkylating agents|mesh-ancestor
25190502|NCT02789332|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25190503|NCT02789332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25190504|NCT02789332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25190505|NCT02789332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25190506|NCT02789332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190507|NCT02789332|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25190508|NCT02789397|Rituximab|rituximab|mesh-list
25190510|NCT02789397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25190511|NCT02789397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25190512|NCT02789397|Immunologic Factors|immunologic factors|mesh-ancestor
25190513|NCT02789397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190514|NCT02789397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25190515|NCT02789397|Antimetabolites|antimetabolites|mesh-ancestor
25190516|NCT02789397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190517|NCT02789397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25190518|NCT02789397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25190519|NCT02789566|Primaquine|primaquine|mesh-list
25190520|NCT02789566|Antimalarials|antimalarials|mesh-ancestor
25190521|NCT02789566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25190523|NCT02789566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25190524|NCT02789202|Fluorides|fluorides|mesh-list
25190525|NCT02789202|Sodium Fluoride|sodium fluoride|mesh-list
25190526|NCT02789202|Fluorides, Topical|fluorides, topical|mesh-list
25190527|NCT02789202|Cariostatic Agents|cariostatic agents|mesh-ancestor
25190528|NCT02789202|Protective Agents|protective agents|mesh-ancestor
25190529|NCT02789202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190530|NCT02789189|Gemcitabine|gemcitabine|mesh-list
25190531|NCT02789189|Nedaplatin|nedaplatin|mesh-list
25190532|NCT02789189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25190533|NCT02789189|Antimetabolites|antimetabolites|mesh-ancestor
25190534|NCT02789189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190535|NCT02789189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25190536|NCT02789189|Antiviral Agents|antiviral agents|mesh-ancestor
25190537|NCT02789189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25190538|NCT02789189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190539|NCT02789189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25190540|NCT02789189|Immunologic Factors|immunologic factors|mesh-ancestor
25190541|NCT02789189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190542|NCT02788864|Piperaquine|piperaquine|mesh-list
25190543|NCT02788864|Antimalarials|antimalarials|mesh-ancestor
25190544|NCT02788864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25190545|NCT02788864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25190546|NCT02788864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25190548|NCT02788851|Methylphenidate|methylphenidate|mesh-list
25190549|NCT02788851|Amphetamine|amphetamine|mesh-list
25190550|NCT02788851|Adderall|adderall|mesh-list
25190551|NCT02788851|Dextroamphetamine|dextroamphetamine|mesh-list
25190552|NCT02788851|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25190553|NCT02788851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25190554|NCT02788851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190555|NCT02788851|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25190556|NCT02788851|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25190557|NCT02788851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25404106|NCT03684811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25190558|NCT02788851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190559|NCT02788851|Dopamine Agents|dopamine agents|mesh-ancestor
25190560|NCT02788851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25190561|NCT02788851|Sympathomimetics|sympathomimetics|mesh-ancestor
25190562|NCT02788851|Autonomic Agents|autonomic agents|mesh-ancestor
25190563|NCT02788851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25190564|NCT02788851|Adrenergic Agents|adrenergic agents|mesh-ancestor
25190565|NCT02788851|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25190566|NCT02788851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25190567|NCT02788851|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25190568|NCT02788851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25190569|NCT02788851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25190570|NCT02788877|Aflibercept|aflibercept|mesh-list
25190571|NCT02788877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25190572|NCT02788877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25190573|NCT02788877|Growth Substances|growth substances|mesh-ancestor
25190574|NCT02788877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190575|NCT02788877|Growth Inhibitors|growth inhibitors|mesh-ancestor
25190576|NCT02788877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25190577|NCT02788786|Chlorhexidine|chlorhexidine|mesh-list
25190578|NCT02788786|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25190579|NCT02788786|Cetylpyridinium|cetylpyridinium|mesh-list
25190580|NCT02788786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25190581|NCT02788786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25190582|NCT02788786|Disinfectants|disinfectants|mesh-ancestor
25190583|NCT02788786|Dermatologic Agents|dermatologic agents|mesh-ancestor
25190584|NCT02788552|Vitamins|vitamins|mesh-list
25190585|NCT02788552|Thiamine|thiamine|mesh-list
25190586|NCT02788552|Micronutrients|micronutrients|mesh-ancestor
25190587|NCT02788552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190594|NCT02788305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25190595|NCT02788305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25190596|NCT02788305|Oxytocics|oxytocics|mesh-ancestor
25190597|NCT02788643|Dimercaprol|dimercaprol|mesh-list
25190598|NCT02788643|Chelating Agents|chelating agents|mesh-ancestor
25190600|NCT02788643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206419|NCT03481660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25206420|NCT03481660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25206421|NCT03481660|Growth Substances|growth substances|mesh-ancestor
25206422|NCT03481660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206423|NCT03481660|Growth Inhibitors|growth inhibitors|mesh-ancestor
25206424|NCT03481660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206425|NCT03459846|Durvalumab|durvalumab|mesh-list
25206426|NCT03459846|Olaparib|olaparib|mesh-list
25206427|NCT03459846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25206428|NCT03459846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206429|NCT03459846|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25206430|NCT03459846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25206431|NCT03459846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206432|NCT03403634|Interferons|interferons|mesh-list
25206433|NCT03403634|Interferon-alpha|interferon-alpha|mesh-list
25206434|NCT03403634|Interferon alpha-2|interferon alpha-2|mesh-list
25206435|NCT03403634|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
25206436|NCT03403634|Celecoxib|celecoxib|mesh-list
25206437|NCT03403634|Benzenesulfonamide|benzenesulfonamide|mesh-list
25206438|NCT03403634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206439|NCT03403634|Antiviral Agents|antiviral agents|mesh-ancestor
25206440|NCT03403634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25206449|NCT03403634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25206450|NCT03403634|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25206451|NCT03403634|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25206452|NCT03403634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25206453|NCT03403634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206454|NCT03403634|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25206455|NCT03382041|Carbon Fiber|carbon fiber|mesh-list
25206456|NCT03382041|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25206457|NCT03382041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25206458|NCT03369301|Immunoglobulins|immunoglobulins|mesh-list
25206459|NCT03369301|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25206460|NCT03369301|Antibodies|antibodies|mesh-list
25206461|NCT03369301|Immunologic Factors|immunologic factors|mesh-ancestor
25206462|NCT03369301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206472|NCT03342456|Amoxicillin|amoxicillin|mesh-list
25206473|NCT03342456|Doxycycline|doxycycline|mesh-list
25206474|NCT03342456|Furazolidone|furazolidone|mesh-list
25206475|NCT03342456|Potassium Citrate|potassium citrate|mesh-list
25206476|NCT03342456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428329|NCT00240214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24428330|NCT00240214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24428331|NCT00240214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24428332|NCT00240214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24428333|NCT00240214|Antifungal Agents|antifungal agents|mesh-ancestor
24428334|NCT00240214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24428335|NCT00240214|Immunologic Factors|immunologic factors|mesh-ancestor
24428336|NCT00240214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824819|NCT02125513|Tubulin Modulators|tubulin modulators|mesh-ancestor
25206477|NCT03342456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25206478|NCT03342456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25206479|NCT03342456|Antimalarials|antimalarials|mesh-ancestor
24553542|NCT00731861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24553543|NCT00731861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25206480|NCT03342456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25206481|NCT03342456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25206482|NCT03342456|Diuretics|diuretics|mesh-ancestor
25206483|NCT03342456|Natriuretic Agents|natriuretic agents|mesh-ancestor
25206484|NCT03342456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206485|NCT03342456|Expectorants|expectorants|mesh-ancestor
25206486|NCT03342456|Respiratory System Agents|respiratory system agents|mesh-ancestor
25206487|NCT03342456|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25206488|NCT03342456|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25206489|NCT03342456|Renal Agents|renal agents|mesh-ancestor
25206490|NCT03342456|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
24423832|NCT00226980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24423983|NCT00227656|Antiviral Agents|antiviral agents|mesh-ancestor
25860535|NCT00083876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857485|NCT02291874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24534665|NCT00647777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24534666|NCT00647777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534667|NCT00647777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24534668|NCT00647777|Serotonin Agents|serotonin agents|mesh-ancestor
25860536|NCT00083876|Leprostatic Agents|leprostatic agents|mesh-ancestor
25190735|NCT02786979|Analgesics|analgesics|mesh-ancestor
25860537|NCT00083876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25860538|NCT00083876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25860539|NCT00083876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25860540|NCT00083876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25860541|NCT00083876|Growth Substances|growth substances|mesh-ancestor
24613426|NCT01019083|Zinc|zinc|mesh-list
25860542|NCT00083876|Growth Inhibitors|growth inhibitors|mesh-ancestor
25860543|NCT00083876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860544|NCT00083902|Thalidomide|thalidomide|mesh-list
25860545|NCT00083902|Dexamethasone|dexamethasone|mesh-list
25860546|NCT00083902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25860547|NCT00083902|Antiemetics|antiemetics|mesh-ancestor
25860548|NCT00083902|Autonomic Agents|autonomic agents|mesh-ancestor
25190601|NCT02788240|Meropenem|meropenem|mesh-list
25190602|NCT02788240|Terlipressin|terlipressin|mesh-list
25190603|NCT02788240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25190604|NCT02788240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24553545|NCT00731926|Ascorbic Acid|ascorbic acid|mesh-list
25190605|NCT02788240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25190606|NCT02788240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25190607|NCT02788292|Acetylcysteine|acetylcysteine|mesh-list
25190608|NCT02788292|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25190609|NCT02788292|Antiviral Agents|antiviral agents|mesh-ancestor
25190610|NCT02788292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25190611|NCT02788292|Expectorants|expectorants|mesh-ancestor
25190612|NCT02788292|Respiratory System Agents|respiratory system agents|mesh-ancestor
25190613|NCT02788292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25666407|NCT01695772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25666408|NCT01695772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25666409|NCT01695772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25666410|NCT01695772|Growth Substances|growth substances|mesh-ancestor
25666411|NCT01695772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666412|NCT01695772|Growth Inhibitors|growth inhibitors|mesh-ancestor
25666413|NCT01695954|Ritonavir|ritonavir|mesh-list
25666414|NCT01695954|Darunavir|darunavir|mesh-list
25666415|NCT01695954|Efavirenz|efavirenz|mesh-list
25190614|NCT02788292|Antioxidants|antioxidants|mesh-ancestor
25190615|NCT02788292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190616|NCT02788292|Protective Agents|protective agents|mesh-ancestor
25666416|NCT01695954|Pitavastatin|pitavastatin|mesh-list
25666417|NCT01695954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25860549|NCT00083902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25860550|NCT00083902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860551|NCT00083902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25860552|NCT00083902|Glucocorticoids|glucocorticoids|mesh-ancestor
25666418|NCT01695954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25666419|NCT01695954|Protease Inhibitors|protease inhibitors|mesh-ancestor
25666420|NCT01695954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428834|NCT00241254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24428835|NCT00241254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24428836|NCT00241254|Glucocorticoids|glucocorticoids|mesh-ancestor
24428837|NCT00241254|Hormones|hormones|mesh-ancestor
24566161|NCT00784589|Rituximab|rituximab|mesh-list
25190617|NCT02788292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190618|NCT02788292|Antidotes|antidotes|mesh-ancestor
25080886|NCT03335085|Oxytocin|oxytocin|mesh-list
25190619|NCT02787824|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25190620|NCT02787824|Hematinics|hematinics|mesh-ancestor
25190621|NCT02787967|Beclomethasone|beclomethasone|mesh-list
25190622|NCT02787967|Formoterol Fumarate|formoterol fumarate|mesh-list
25190623|NCT02787967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25190624|NCT02787967|Autonomic Agents|autonomic agents|mesh-ancestor
24824124|NCT02121951|Analgesics|analgesics|mesh-ancestor
25190625|NCT02787967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25190626|NCT02787967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190627|NCT02787967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25190628|NCT02787967|Respiratory System Agents|respiratory system agents|mesh-ancestor
25190629|NCT02787967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25190630|NCT02787967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25190631|NCT02787967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25190632|NCT02787967|Adrenergic Agents|adrenergic agents|mesh-ancestor
25190633|NCT02787967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25190634|NCT02787967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190635|NCT02787967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25190636|NCT02787967|Glucocorticoids|glucocorticoids|mesh-ancestor
25190637|NCT02787967|Hormones|hormones|mesh-ancestor
25190638|NCT02787967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25190639|NCT02787928|Hydromorphone|hydromorphone|mesh-list
25190640|NCT02787928|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25190641|NCT02787928|Narcotics|narcotics|mesh-ancestor
24553638|NCT00732446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25190642|NCT02787928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25190643|NCT02787928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190644|NCT02787928|Analgesics|analgesics|mesh-ancestor
25190645|NCT02787928|Sensory System Agents|sensory system agents|mesh-ancestor
25190646|NCT02787928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25190647|NCT02788123|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
25190648|NCT02788123|Pantoprazole|pantoprazole|mesh-list
25190649|NCT02788123|Bismuth|bismuth|mesh-list
25190650|NCT02788123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25190651|NCT02788123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25190652|NCT02788123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25190653|NCT02788123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190654|NCT02788123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190655|NCT02788123|Antacids|antacids|mesh-ancestor
25190656|NCT02788123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25190657|NCT02788136|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25190658|NCT02788136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25190659|NCT02788136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190660|NCT02788058|Gefitinib|gefitinib|mesh-list
25190848|NCT02786446|Lidocaine|lidocaine|mesh-list
25190661|NCT02788058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25190662|NCT02788058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25190663|NCT02788058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190664|NCT02788058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190665|NCT02787642|Olaparib|olaparib|mesh-list
25190666|NCT02787642|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25190667|NCT02787642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190668|NCT02787642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190669|NCT02787642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25190670|NCT02787603|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25666421|NCT01695954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666422|NCT01695954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25666423|NCT01695954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25666424|NCT01695954|Antiviral Agents|antiviral agents|mesh-ancestor
25666425|NCT01695954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25666426|NCT01695954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25666427|NCT01695954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24627330|NCT01091870|Anticoagulants|anticoagulants|mesh-ancestor
24627331|NCT01091870|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24627332|NCT01091870|Chelating Agents|chelating agents|mesh-ancestor
24627333|NCT01091870|Sequestering Agents|sequestering agents|mesh-ancestor
24622262|NCT01066403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627334|NCT01091870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627335|NCT01091870|Vasodilator Agents|vasodilator agents|mesh-ancestor
24627336|NCT01091870|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24627338|NCT01091870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190671|NCT02787603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25190672|NCT02787746|Donepezil|donepezil|mesh-list
25190673|NCT02787746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25190674|NCT02787746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190675|NCT02787746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190676|NCT02787746|Cholinergic Agents|cholinergic agents|mesh-ancestor
25190677|NCT02787746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25190678|NCT02787746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190679|NCT02787746|Nootropic Agents|nootropic agents|mesh-ancestor
25190680|NCT02787798|Valsartan|valsartan|mesh-list
25190681|NCT02787798|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25190682|NCT02787798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25190683|NCT02787798|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25190684|NCT02787798|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25190685|NCT02787798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190686|NCT02787473|Docetaxel|docetaxel|mesh-list
25190687|NCT02787473|Pemetrexed|pemetrexed|mesh-list
25190688|NCT02787473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25190689|NCT02787473|Tubulin Modulators|tubulin modulators|mesh-ancestor
25190690|NCT02787473|Antimitotic Agents|antimitotic agents|mesh-ancestor
25190691|NCT02787473|Mitosis Modulators|mitosis modulators|mesh-ancestor
25190692|NCT02787473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190693|NCT02787473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190694|NCT02787473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25190695|NCT02787473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25190696|NCT02787447|Gefitinib|gefitinib|mesh-list
25190697|NCT02787447|Thymalfasin|thymalfasin|mesh-list
25190698|NCT02787447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25190699|NCT02787447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25190700|NCT02787447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190701|NCT02787447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190702|NCT02787447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25190703|NCT02787447|Immunologic Factors|immunologic factors|mesh-ancestor
25190704|NCT02787447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190705|NCT02787317|Heparin|heparin|mesh-list
25190706|NCT02787317|Bivalirudin|bivalirudin|mesh-list
25190707|NCT02787317|Anticoagulants|anticoagulants|mesh-ancestor
25190708|NCT02787317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25190709|NCT02787317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25190710|NCT02787317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190711|NCT02787317|Antithrombins|antithrombins|mesh-ancestor
25190712|NCT02787317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25190713|NCT02787317|Protease Inhibitors|protease inhibitors|mesh-ancestor
25190714|NCT02787317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190715|NCT02787356|Lidocaine|lidocaine|mesh-list
25190716|NCT02787356|Anesthetics, Local|anesthetics, local|mesh-ancestor
25190717|NCT02787356|Anesthetics|anesthetics|mesh-ancestor
25190718|NCT02787356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25190719|NCT02787356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190720|NCT02787356|Sensory System Agents|sensory system agents|mesh-ancestor
25190721|NCT02787356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25190722|NCT02787356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25190723|NCT02787356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25190724|NCT02787356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25190725|NCT02787356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25666428|NCT01695954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25666429|NCT01695954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25666430|NCT01695954|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25666431|NCT01695954|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25666432|NCT01695954|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25666433|NCT01695954|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25666434|NCT01695954|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25666435|NCT01695954|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25081335|NCT03330990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25081336|NCT03330990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25081337|NCT03330990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25081338|NCT03330990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774987|NCT01849094|Milrinone|milrinone|mesh-list
25190726|NCT02787356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190727|NCT02787278|Otaplimastat|otaplimastat|mesh-list
25190728|NCT02787278|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25190729|NCT02787278|Protective Agents|protective agents|mesh-ancestor
25190730|NCT02787278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190731|NCT02786979|Aspirin|aspirin|mesh-list
25190732|NCT02786979|Beraprost|beraprost|mesh-list
25190733|NCT02786979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25190734|NCT02786979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25190736|NCT02786979|Sensory System Agents|sensory system agents|mesh-ancestor
25190737|NCT02786979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25190738|NCT02786979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190739|NCT02786979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25190740|NCT02786979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25190741|NCT02786979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25190742|NCT02786979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25190743|NCT02786979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190744|NCT02786979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25190745|NCT02786979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25190746|NCT02786979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190747|NCT02786979|Antipyretics|antipyretics|mesh-ancestor
25190748|NCT02786979|Vasodilator Agents|vasodilator agents|mesh-ancestor
25190749|NCT02787226|Bupivacaine|bupivacaine|mesh-list
25190750|NCT02787226|Anesthetics, Local|anesthetics, local|mesh-ancestor
25190751|NCT02787226|Anesthetics|anesthetics|mesh-ancestor
25190752|NCT02787226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25190753|NCT02787226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190754|NCT02787226|Sensory System Agents|sensory system agents|mesh-ancestor
25190755|NCT02787226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25190756|NCT02787018|Dexamethasone|dexamethasone|mesh-list
25190757|NCT02787018|Dexmedetomidine|dexmedetomidine|mesh-list
25190758|NCT02787018|Ropivacaine|ropivacaine|mesh-list
25190759|NCT02787018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25190760|NCT02787018|Antiemetics|antiemetics|mesh-ancestor
25190761|NCT02787018|Autonomic Agents|autonomic agents|mesh-ancestor
25190762|NCT02787018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25190763|NCT02787018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190764|NCT02787018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25190765|NCT02787018|Glucocorticoids|glucocorticoids|mesh-ancestor
25190766|NCT02787018|Hormones|hormones|mesh-ancestor
25190767|NCT02787018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25190768|NCT02787018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25190769|NCT02787018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25190770|NCT02787018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25190771|NCT02787018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25190772|NCT02787018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25190773|NCT02787018|Analgesics|analgesics|mesh-ancestor
25190774|NCT02787018|Sensory System Agents|sensory system agents|mesh-ancestor
25190775|NCT02787018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25190776|NCT02787018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25190777|NCT02787018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25190778|NCT02787018|Adrenergic Agents|adrenergic agents|mesh-ancestor
25190779|NCT02787018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25190780|NCT02787018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190781|NCT02787018|Anesthetics, Local|anesthetics, local|mesh-ancestor
25190782|NCT02787018|Anesthetics|anesthetics|mesh-ancestor
25190783|NCT02787031|Anesthetics|anesthetics|mesh-list
25190784|NCT02787031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25190785|NCT02787031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190786|NCT02786992|Misoprostol|misoprostol|mesh-list
25190787|NCT02786992|Oxytocin|oxytocin|mesh-list
25190788|NCT02786992|Carbetocin|carbetocin|mesh-list
25190789|NCT02786992|Oxytocics|oxytocics|mesh-ancestor
25190790|NCT02786992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25666436|NCT01695954|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25666437|NCT01695954|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25666438|NCT01695954|Antimetabolites|antimetabolites|mesh-ancestor
25666439|NCT01695954|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25190791|NCT02786992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666440|NCT01696032|Gemcitabine|gemcitabine|mesh-list
25666441|NCT01696032|Paclitaxel|paclitaxel|mesh-list
24775044|NCT01849926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24775045|NCT01849926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190792|NCT02786992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25190793|NCT02786992|Abortifacient Agents|abortifacient agents|mesh-ancestor
25190794|NCT02786992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25190795|NCT02786992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25190797|NCT02786823|Vitamin B 12|vitamin b 12|mesh-list
25190798|NCT02786823|Metformin|metformin|mesh-list
25190799|NCT02786823|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25190800|NCT02786823|Vitamins|vitamins|mesh-ancestor
25190801|NCT02786823|Micronutrients|micronutrients|mesh-ancestor
25190802|NCT02786823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190803|NCT02786823|Hematinics|hematinics|mesh-ancestor
25190804|NCT02786823|Vitamin B Complex|vitamin b complex|mesh-ancestor
25190805|NCT02786732|Ustekinumab|ustekinumab|mesh-list
25190806|NCT02786732|Brodalumab|brodalumab|mesh-list
25190807|NCT02786732|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25190808|NCT02786732|Dermatologic Agents|dermatologic agents|mesh-ancestor
25190809|NCT02786732|Immunologic Factors|immunologic factors|mesh-ancestor
25190810|NCT02786732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206491|NCT03342456|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25206492|NCT03342456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25206493|NCT03322280|Chlorotrianisene|chlorotrianisene|mesh-list
25206520|NCT03277495|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25206521|NCT03277495|Cholinergic Agents|cholinergic agents|mesh-ancestor
25206522|NCT03277495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25206523|NCT03277495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860553|NCT00083902|Hormones|hormones|mesh-ancestor
25206524|NCT03201419|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25206525|NCT03201419|Hemostatics|hemostatics|mesh-ancestor
25206526|NCT03201419|Coagulants|coagulants|mesh-ancestor
25206527|NCT03201419|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25190812|NCT02786550|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25190813|NCT02786550|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25190814|NCT02786550|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25190815|NCT02786550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25190816|NCT02786550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190817|NCT02786550|Cholinergic Agents|cholinergic agents|mesh-ancestor
25190818|NCT02786550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25190819|NCT02786550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190820|NCT02786550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25190821|NCT02786550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25190822|NCT02786667|Rotigotine|rotigotine|mesh-list
25190823|NCT02786667|Dopamine Agonists|dopamine agonists|mesh-ancestor
25190824|NCT02786667|Dopamine Agents|dopamine agents|mesh-ancestor
25190825|NCT02786667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25190826|NCT02786667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190827|NCT02786667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190828|NCT02786407|Botulinum Toxins|botulinum toxins|mesh-list
25190829|NCT02786407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25190830|NCT02786407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25190831|NCT02786407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25190832|NCT02786407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25190833|NCT02786407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190834|NCT02786407|Cholinergic Agents|cholinergic agents|mesh-ancestor
25190835|NCT02786407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25190836|NCT02786407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190837|NCT02786407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25190838|NCT02786407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25190839|NCT02786641|Cisplatin|cisplatin|mesh-list
25190840|NCT02786641|Docetaxel|docetaxel|mesh-list
25190841|NCT02786641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25190842|NCT02786641|Tubulin Modulators|tubulin modulators|mesh-ancestor
25190843|NCT02786641|Antimitotic Agents|antimitotic agents|mesh-ancestor
25860554|NCT00083902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25860555|NCT00083902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25190844|NCT02786641|Mitosis Modulators|mitosis modulators|mesh-ancestor
25190845|NCT02786641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190846|NCT02786446|Naproxen|naproxen|mesh-list
25190847|NCT02786446|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25190849|NCT02786446|Anesthetics, Local|anesthetics, local|mesh-ancestor
25666442|NCT01696032|Carboplatin|carboplatin|mesh-list
25666443|NCT01696032|Doxorubicin|doxorubicin|mesh-list
25190850|NCT02786446|Anesthetics|anesthetics|mesh-ancestor
25190851|NCT02786446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25666444|NCT01696032|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24775198|NCT01850953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775199|NCT01850953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775201|NCT01850979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25190852|NCT02786446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190853|NCT02786446|Sensory System Agents|sensory system agents|mesh-ancestor
25190854|NCT02786446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25190855|NCT02786446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24852443|NCT02262546|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25190856|NCT02786446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25190857|NCT02786446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25190858|NCT02786446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25190859|NCT02786446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190860|NCT02786446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25190861|NCT02786446|Analgesics|analgesics|mesh-ancestor
25190862|NCT02786446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25190863|NCT02786446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25190864|NCT02786446|Gout Suppressants|gout suppressants|mesh-ancestor
25190865|NCT02786446|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25190866|NCT02786446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190867|NCT02786264|Fentanyl|fentanyl|mesh-list
25190868|NCT02786264|Midazolam|midazolam|mesh-list
25190869|NCT02786264|Dexmedetomidine|dexmedetomidine|mesh-list
25190870|NCT02786264|Propofol|propofol|mesh-list
25190871|NCT02786264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25190872|NCT02786264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25190873|NCT02786264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190874|NCT02786264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25190875|NCT02786264|Anesthetics, General|anesthetics, general|mesh-ancestor
25190876|NCT02786264|Anesthetics|anesthetics|mesh-ancestor
25190877|NCT02786264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25190878|NCT02786264|Analgesics|analgesics|mesh-ancestor
25190879|NCT02786264|Sensory System Agents|sensory system agents|mesh-ancestor
25190880|NCT02786264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25190881|NCT02786264|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25190882|NCT02786264|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25190883|NCT02786264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24824294|NCT02122692|Antifungal Agents|antifungal agents|mesh-ancestor
24424671|NCT00230399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424672|NCT00230399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424673|NCT00230399|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24424674|NCT00230399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24424675|NCT00230399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24424676|NCT00230399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24424677|NCT00230399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24424679|NCT00230399|Sensory System Agents|sensory system agents|mesh-ancestor
24424680|NCT00230399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24424681|NCT00230399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424682|NCT00230399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24424683|NCT00230399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24424684|NCT00230399|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24424694|NCT00230451|Antimetabolites|antimetabolites|mesh-ancestor
25146179|NCT02923869|Sensory System Agents|sensory system agents|mesh-ancestor
25860556|NCT00083902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860557|NCT00083902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25190884|NCT02786264|Adrenergic Agents|adrenergic agents|mesh-ancestor
25190885|NCT02786264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25190886|NCT02786264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190887|NCT02786264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25190888|NCT02786264|Narcotics|narcotics|mesh-ancestor
25190889|NCT02786264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25190890|NCT02786264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25190891|NCT02786264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25190892|NCT02786264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25190893|NCT02786264|GABA Modulators|gaba modulators|mesh-ancestor
25190894|NCT02786264|GABA Agents|gaba agents|mesh-ancestor
25190895|NCT02785978|Levodopa|levodopa|mesh-list
25190896|NCT02785978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25190897|NCT02785978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25190898|NCT02785978|Dopamine Agents|dopamine agents|mesh-ancestor
25190899|NCT02785978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25666445|NCT01696032|Topotecan|topotecan|mesh-list
25666446|NCT01696032|Guadecitabine|guadecitabine|mesh-list
25666447|NCT01696032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25666448|NCT01696032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25666449|NCT01696032|Tubulin Modulators|tubulin modulators|mesh-ancestor
25081360|NCT03330860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081361|NCT03330808|Anesthetics|anesthetics|mesh-list
25081362|NCT03330808|Ropivacaine|ropivacaine|mesh-list
25081363|NCT03330808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25081364|NCT03330808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081365|NCT03330808|Anesthetics, Local|anesthetics, local|mesh-ancestor
25081366|NCT03330808|Sensory System Agents|sensory system agents|mesh-ancestor
25081367|NCT03330808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25081368|NCT03330782|Remifentanil|remifentanil|mesh-list
25081369|NCT03330782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25190900|NCT02785978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190901|NCT02785978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190902|NCT02786212|Dexmedetomidine|dexmedetomidine|mesh-list
25190903|NCT02786212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25190904|NCT02786212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25190978|NCT02785718|Hemostatics|hemostatics|mesh-list
25190905|NCT02786212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190906|NCT02786212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25190907|NCT02786212|Analgesics|analgesics|mesh-ancestor
25190908|NCT02786212|Sensory System Agents|sensory system agents|mesh-ancestor
25190909|NCT02786212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25190910|NCT02786212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25190911|NCT02786212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25190912|NCT02786212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25190913|NCT02786212|Adrenergic Agents|adrenergic agents|mesh-ancestor
25190914|NCT02786212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25190915|NCT02786212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190916|NCT02786082|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25190917|NCT02786082|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25190918|NCT02786082|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25190919|NCT02786082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190920|NCT02785757|Thrombin|thrombin|mesh-list
25190921|NCT02785757|Hemostatics|hemostatics|mesh-ancestor
25190922|NCT02785757|Coagulants|coagulants|mesh-ancestor
25190923|NCT02785601|Trazodone|trazodone|mesh-list
25190924|NCT02785601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25190925|NCT02785601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25190926|NCT02785601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25190927|NCT02785601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190928|NCT02785601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25190929|NCT02785601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25190930|NCT02785601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25190931|NCT02785601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25190932|NCT02785601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190933|NCT02785601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25190934|NCT02785601|Serotonin Agents|serotonin agents|mesh-ancestor
25190935|NCT02785601|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25190936|NCT02785601|Antidepressive Agents|antidepressive agents|mesh-ancestor
25190937|NCT02785705|Vaccines|vaccines|mesh-list
25190938|NCT02785705|Immunologic Factors|immunologic factors|mesh-ancestor
25190939|NCT02785705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190940|NCT02785809|Contraceptive Agents|contraceptive agents|mesh-list
25190941|NCT02785809|Contraceptives, Oral|contraceptives, oral|mesh-list
25190942|NCT02785809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25190943|NCT02785809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190944|NCT02785809|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25190945|NCT02785666|Ribavirin|ribavirin|mesh-list
25190946|NCT02785666|Grazoprevir|grazoprevir|mesh-list
25190947|NCT02785666|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25190948|NCT02785666|Antimetabolites|antimetabolites|mesh-ancestor
25190949|NCT02785666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190950|NCT02785666|Antiviral Agents|antiviral agents|mesh-ancestor
25190951|NCT02785666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25666450|NCT01696032|Antimitotic Agents|antimitotic agents|mesh-ancestor
25666451|NCT01696032|Mitosis Modulators|mitosis modulators|mesh-ancestor
25666452|NCT01696032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666453|NCT01696032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25666454|NCT01696032|Antimetabolites|antimetabolites|mesh-ancestor
25666455|NCT01696032|Antiviral Agents|antiviral agents|mesh-ancestor
25666456|NCT01696032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25666457|NCT01696032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25666458|NCT01696032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25666459|NCT01696032|Immunologic Factors|immunologic factors|mesh-ancestor
24775360|NCT01851759|Cinepazide|cinepazide|mesh-list
24775361|NCT01851759|Vasodilator Agents|vasodilator agents|mesh-ancestor
24775362|NCT01851824|Vemurafenib|vemurafenib|mesh-list
24775363|NCT01851824|Acenocoumarol|acenocoumarol|mesh-list
24775364|NCT01851824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24775365|NCT01851824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24775366|NCT01851824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212870|NCT05367063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190952|NCT02785614|Trazodone|trazodone|mesh-list
25190953|NCT02785614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25190954|NCT02785614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25190955|NCT02785614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25190956|NCT02785614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190957|NCT02785614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25190958|NCT02785614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25190959|NCT02785614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25190960|NCT02785614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25190961|NCT02785614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190962|NCT02785614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25190963|NCT02785614|Serotonin Agents|serotonin agents|mesh-ancestor
25190964|NCT02785614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25190965|NCT02785614|Antidepressive Agents|antidepressive agents|mesh-ancestor
25190966|NCT02785653|Sevoflurane|sevoflurane|mesh-list
25190967|NCT02785653|Rocuronium|rocuronium|mesh-list
25190968|NCT02785653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25190969|NCT02785653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25190970|NCT02785653|Anesthetics, General|anesthetics, general|mesh-ancestor
25190971|NCT02785653|Anesthetics|anesthetics|mesh-ancestor
25190972|NCT02785653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25190973|NCT02785653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190974|NCT02785653|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25190975|NCT02785653|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25190976|NCT02785653|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25190977|NCT02785653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25190980|NCT02785549|Acetaminophen|acetaminophen|mesh-list
25190981|NCT02785549|Amoxicillin|amoxicillin|mesh-list
25190982|NCT02785549|Clavulanic Acids|clavulanic acids|mesh-list
25190983|NCT02785549|Clavulanic Acid|clavulanic acid|mesh-list
25190984|NCT02785549|Ibuprofen|ibuprofen|mesh-list
25190985|NCT02785549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25190986|NCT02785549|Analgesics|analgesics|mesh-ancestor
25190987|NCT02785549|Sensory System Agents|sensory system agents|mesh-ancestor
25190988|NCT02785549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25190989|NCT02785549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25190990|NCT02785549|Antipyretics|antipyretics|mesh-ancestor
25190991|NCT02785549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25190992|NCT02785549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25190993|NCT02785549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25190994|NCT02785549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25190995|NCT02785549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25190996|NCT02785549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25190997|NCT02785549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25190998|NCT02785549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25190999|NCT02785549|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25191000|NCT02785250|Cyclophosphamide|cyclophosphamide|mesh-list
25191001|NCT02785250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25191002|NCT02785250|Immunologic Factors|immunologic factors|mesh-ancestor
25191003|NCT02785250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191004|NCT02785250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25191005|NCT02785250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25191006|NCT02785250|Alkylating Agents|alkylating agents|mesh-ancestor
25191007|NCT02785250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191008|NCT02785250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25191009|NCT02785250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25191010|NCT02785146|Calcium, Dietary|calcium, dietary|mesh-list
25191011|NCT02785146|Leucovorin|leucovorin|mesh-list
25191012|NCT02785146|Fluorouracil|fluorouracil|mesh-list
25191013|NCT02785146|Oxaliplatin|oxaliplatin|mesh-list
25666460|NCT01696032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666461|NCT01696032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25666462|NCT01696032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25666463|NCT01696032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25666464|NCT01696032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25666465|NCT01696045|Ipilimumab|ipilimumab|mesh-list
25666466|NCT01696045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25191014|NCT02785146|Calcium|calcium|mesh-list
24775410|NCT01851993|Autonomic Agents|autonomic agents|mesh-ancestor
24775411|NCT01851993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24775431|NCT01852266|Vaccines|vaccines|mesh-list
24775432|NCT01852266|Immunologic Factors|immunologic factors|mesh-ancestor
24775433|NCT01852266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775434|NCT01852318|Fexofenadine|fexofenadine|mesh-list
24775435|NCT01852318|Pregabalin|pregabalin|mesh-list
24775437|NCT01852318|Sensory System Agents|sensory system agents|mesh-ancestor
24775438|NCT01852318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24775439|NCT01852318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775440|NCT01852318|Anticonvulsants|anticonvulsants|mesh-ancestor
24775441|NCT01852318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24775442|NCT01852318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24775444|NCT01852318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24775445|NCT01852318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24775446|NCT01852318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24775448|NCT01852318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25191015|NCT02785146|Levoleucovorin|levoleucovorin|mesh-list
25191016|NCT02785146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25191017|NCT02785146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191018|NCT02785146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25191019|NCT02785146|Antimetabolites|antimetabolites|mesh-ancestor
25191020|NCT02785146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191021|NCT02785146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25191022|NCT02785146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25191023|NCT02785146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25191024|NCT02785146|Immunologic Factors|immunologic factors|mesh-ancestor
25191025|NCT02785146|Antidotes|antidotes|mesh-ancestor
25191026|NCT02785146|Protective Agents|protective agents|mesh-ancestor
25191027|NCT02785146|Vitamin B Complex|vitamin b complex|mesh-ancestor
25191028|NCT02785146|Vitamins|vitamins|mesh-ancestor
25191029|NCT02785146|Micronutrients|micronutrients|mesh-ancestor
25191030|NCT02785393|Doxazosin|doxazosin|mesh-list
25191031|NCT02785393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25191032|NCT02785393|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25191033|NCT02785393|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25191034|NCT02785393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25191035|NCT02785393|Adrenergic Agents|adrenergic agents|mesh-ancestor
25191036|NCT02785393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25191037|NCT02785393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191038|NCT02785393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191039|NCT02785276|Ropivacaine|ropivacaine|mesh-list
25191040|NCT02785276|Anesthetics, Local|anesthetics, local|mesh-ancestor
25191041|NCT02785276|Anesthetics|anesthetics|mesh-ancestor
25191042|NCT02785276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25191043|NCT02785276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191044|NCT02785276|Sensory System Agents|sensory system agents|mesh-ancestor
25191045|NCT02785276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191046|NCT02784899|Iloprost|iloprost|mesh-list
25191047|NCT02784899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25191048|NCT02784899|Vasodilator Agents|vasodilator agents|mesh-ancestor
25191049|NCT02784860|Lidocaine|lidocaine|mesh-list
25191050|NCT02784860|Anesthetics, Local|anesthetics, local|mesh-ancestor
25191051|NCT02784860|Anesthetics|anesthetics|mesh-ancestor
25191052|NCT02784860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25191053|NCT02784860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191124|NCT02784717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25191054|NCT02784860|Sensory System Agents|sensory system agents|mesh-ancestor
25666467|NCT01696045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25666468|NCT01696045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25666469|NCT01696045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666470|NCT01696058|Tiotropium Bromide|tiotropium bromide|mesh-list
25666471|NCT01696058|Olodaterol|olodaterol|mesh-list
25666472|NCT01696058|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25666473|NCT01696058|Autonomic Agents|autonomic agents|mesh-ancestor
25666474|NCT01696058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25666475|NCT01696058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666476|NCT01696058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25666477|NCT01696058|Respiratory System Agents|respiratory system agents|mesh-ancestor
25666478|NCT01696058|Parasympatholytics|parasympatholytics|mesh-ancestor
25666479|NCT01696058|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25666480|NCT01696058|Cholinergic Agents|cholinergic agents|mesh-ancestor
25666481|NCT01696058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25666482|NCT01696058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212904|NCT05344963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25212905|NCT05344963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212906|NCT05344963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25212907|NCT05344963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775490|NCT01852565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775491|NCT01852565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24775492|NCT01852565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775493|NCT01852565|Vasodilator Agents|vasodilator agents|mesh-ancestor
25191055|NCT02784860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191056|NCT02784860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25191057|NCT02784860|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24554308|NCT00735527|Autonomic Agents|autonomic agents|mesh-ancestor
25191058|NCT02784860|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25191059|NCT02784860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25191060|NCT02784860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206528|NCT03201419|Natriuretic Agents|natriuretic agents|mesh-ancestor
25191166|NCT02784457|Hormone Antagonists|hormone antagonists|mesh-ancestor
25206529|NCT03201419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206530|NCT03197766|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
25206531|NCT03197766|Natriuretic Agents|natriuretic agents|mesh-ancestor
25206532|NCT03197766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206534|NCT05345327|Dapagliflozin|dapagliflozin|mesh-list
25191061|NCT02785055|Hydromorphone|hydromorphone|mesh-list
25191062|NCT02785055|Bupivacaine|bupivacaine|mesh-list
25191063|NCT02785055|Anesthetics, Local|anesthetics, local|mesh-ancestor
25191064|NCT02785055|Anesthetics|anesthetics|mesh-ancestor
25191065|NCT02785055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25191066|NCT02785055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191067|NCT02785055|Sensory System Agents|sensory system agents|mesh-ancestor
25191068|NCT02785055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191069|NCT02785055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25191070|NCT02785055|Narcotics|narcotics|mesh-ancestor
25191071|NCT02785055|Analgesics|analgesics|mesh-ancestor
25191072|NCT02785003|Acetaminophen|acetaminophen|mesh-list
25191074|NCT02785003|Morphine|morphine|mesh-list
25191075|NCT02785003|Narcotics|narcotics|mesh-list
25191076|NCT02785003|Alvimopan|alvimopan|mesh-list
25191077|NCT02785003|Analgesics|analgesics|mesh-ancestor
25191078|NCT02785003|Sensory System Agents|sensory system agents|mesh-ancestor
25191079|NCT02785003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191080|NCT02785003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191081|NCT02785003|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25191082|NCT02785003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25191083|NCT02785003|Anesthetics, General|anesthetics, general|mesh-ancestor
25191084|NCT02785003|Anesthetics|anesthetics|mesh-ancestor
25191085|NCT02785003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25191086|NCT02785003|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25191087|NCT02785003|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25191088|NCT02785003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25191089|NCT02785003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191090|NCT02785003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25191091|NCT02785003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25191092|NCT02785003|Antipyretics|antipyretics|mesh-ancestor
25191093|NCT02785003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25191094|NCT02785068|Leucovorin|leucovorin|mesh-list
25191095|NCT02785068|Fluorouracil|fluorouracil|mesh-list
25191096|NCT02785068|Antimetabolites|antimetabolites|mesh-ancestor
25191097|NCT02785068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191098|NCT02785068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25191099|NCT02785068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25191100|NCT02785068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25191101|NCT02785068|Immunologic Factors|immunologic factors|mesh-ancestor
25191102|NCT02785068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191103|NCT02785068|Antidotes|antidotes|mesh-ancestor
25666483|NCT01696071|Tiotropium Bromide|tiotropium bromide|mesh-list
25666484|NCT01696071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25666485|NCT01696071|Autonomic Agents|autonomic agents|mesh-ancestor
25666486|NCT01696071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25666487|NCT01696071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666488|NCT01696071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25666489|NCT01696071|Respiratory System Agents|respiratory system agents|mesh-ancestor
25666490|NCT01696071|Parasympatholytics|parasympatholytics|mesh-ancestor
25666491|NCT01696071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24775602|NCT01853787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775603|NCT01853787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24775604|NCT01853787|Respiratory System Agents|respiratory system agents|mesh-ancestor
24775605|NCT01853787|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25212916|NCT05321576|Analgesics, Opioid|analgesics, opioid|mesh-list
25212917|NCT05321576|Narcotics|narcotics|mesh-ancestor
25212918|NCT05321576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25212919|NCT05321576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212920|NCT05321576|Analgesics|analgesics|mesh-ancestor
25212921|NCT05321576|Sensory System Agents|sensory system agents|mesh-ancestor
25191104|NCT02785068|Protective Agents|protective agents|mesh-ancestor
25191105|NCT02785068|Vitamin B Complex|vitamin b complex|mesh-ancestor
25191106|NCT02785068|Vitamins|vitamins|mesh-ancestor
25191107|NCT02785068|Micronutrients|micronutrients|mesh-ancestor
25191108|NCT02784821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25191109|NCT02784821|Gentamicins|gentamicins|mesh-list
25191110|NCT02784821|Ampicillin|ampicillin|mesh-list
25191111|NCT02784821|Cefotaxime|cefotaxime|mesh-list
25191112|NCT02784821|Cefoxitin|cefoxitin|mesh-list
25191113|NCT02784821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25191114|NCT02784821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25191115|NCT02784821|Antitubercular Agents|antitubercular agents|mesh-ancestor
25191116|NCT02784821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25191117|NCT02784821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25191118|NCT02784821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191119|NCT02784717|Rivaroxaban|rivaroxaban|mesh-list
25191120|NCT02784717|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25191121|NCT02784717|Antithrombins|antithrombins|mesh-ancestor
25191122|NCT02784717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25191123|NCT02784717|Protease Inhibitors|protease inhibitors|mesh-ancestor
25191125|NCT02784717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191127|NCT02784795|Gemcitabine|gemcitabine|mesh-list
25191128|NCT02784795|Carboplatin|carboplatin|mesh-list
24554524|NCT00736905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24554525|NCT00736931|Levetiracetam|levetiracetam|mesh-list
24554526|NCT00736931|Lorazepam|lorazepam|mesh-list
25191129|NCT02784795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25191130|NCT02784795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25191131|NCT02784795|Antimetabolites|antimetabolites|mesh-ancestor
25191165|NCT02784457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191136|NCT02784795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25191137|NCT02784795|Immunologic Factors|immunologic factors|mesh-ancestor
25206535|NCT05345327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25860558|NCT00083902|Immunologic Factors|immunologic factors|mesh-ancestor
24425302|NCT00232661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24425303|NCT00232661|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24425304|NCT00232661|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24425305|NCT00232661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24425306|NCT00232661|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24425307|NCT00232661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24425308|NCT00232661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24425309|NCT00232661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425310|NCT00232674|Budesonide|budesonide|mesh-list
24425311|NCT00232674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24425312|NCT00232674|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24425313|NCT00232674|Autonomic Agents|autonomic agents|mesh-ancestor
25860559|NCT00083902|Leprostatic Agents|leprostatic agents|mesh-ancestor
25860560|NCT00083902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24425349|NCT00232700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24425350|NCT00232765|Sirolimus|sirolimus|mesh-list
24824333|NCT02122939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24824334|NCT02122939|Serotonin Agents|serotonin agents|mesh-ancestor
24824335|NCT02122939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425351|NCT00232765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24425352|NCT00232765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24425353|NCT00232765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24425354|NCT00232765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25666492|NCT01696071|Cholinergic Agents|cholinergic agents|mesh-ancestor
25666493|NCT01696071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25666494|NCT01696071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666495|NCT01696084|Cytarabine|cytarabine|mesh-list
25666496|NCT01696084|Daunorubicin|daunorubicin|mesh-list
25666497|NCT01696084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25666498|NCT01696084|Antimetabolites|antimetabolites|mesh-ancestor
25666499|NCT01696084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666500|NCT01696084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25666501|NCT01696084|Antiviral Agents|antiviral agents|mesh-ancestor
24775775|NCT01854762|Ritonavir|ritonavir|mesh-list
24425355|NCT00232765|Antifungal Agents|antifungal agents|mesh-ancestor
25860561|NCT00083902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24425371|NCT00232856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24554527|NCT00736931|Brivaracetam|brivaracetam|mesh-list
24554581|NCT00737139|Adrenergic Agents|adrenergic agents|mesh-ancestor
25191138|NCT02784795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191139|NCT02784808|Antirheumatic Agents|antirheumatic agents|mesh-list
25191140|NCT02784626|Dexmedetomidine|dexmedetomidine|mesh-list
25191141|NCT02784626|Propofol|propofol|mesh-list
24852444|NCT02262546|Dopamine Agonists|dopamine agonists|mesh-ancestor
25191142|NCT02784626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25191143|NCT02784626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25191144|NCT02784626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191145|NCT02784626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25191146|NCT02784626|Anesthetics, General|anesthetics, general|mesh-ancestor
25191147|NCT02784626|Anesthetics|anesthetics|mesh-ancestor
25191148|NCT02784626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25191149|NCT02784626|Analgesics|analgesics|mesh-ancestor
25191150|NCT02784626|Sensory System Agents|sensory system agents|mesh-ancestor
25191151|NCT02784626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191152|NCT02784626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25191153|NCT02784626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25191154|NCT02784626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25191155|NCT02784626|Adrenergic Agents|adrenergic agents|mesh-ancestor
25191156|NCT02784626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25191157|NCT02784626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191158|NCT02784652|Zoledronic Acid|zoledronic acid|mesh-list
25191159|NCT02784652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25191160|NCT02784652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191161|NCT02784457|Cetrorelix|cetrorelix|mesh-list
25191162|NCT02784457|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25191163|NCT02784457|Fertility Agents|fertility agents|mesh-ancestor
25191164|NCT02784457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25191167|NCT02784457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25191168|NCT02784743|Ivermectin|ivermectin|mesh-list
25191169|NCT02784743|Albendazole|albendazole|mesh-list
25191170|NCT02784743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25191171|NCT02784743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25191172|NCT02784743|Anthelmintics|anthelmintics|mesh-ancestor
25191173|NCT02784743|Anticestodal Agents|anticestodal agents|mesh-ancestor
25191174|NCT02784743|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25191175|NCT02784743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25191176|NCT02784743|Tubulin Modulators|tubulin modulators|mesh-ancestor
25191177|NCT02784743|Antimitotic Agents|antimitotic agents|mesh-ancestor
25191178|NCT02784743|Mitosis Modulators|mitosis modulators|mesh-ancestor
25191179|NCT02784743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191180|NCT02784743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25191181|NCT02784483|Atezolizumab|atezolizumab|mesh-list
25191182|NCT02784483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25191183|NCT02784561|Vidarabine|vidarabine|mesh-list
25191184|NCT02784561|Cytarabine|cytarabine|mesh-list
25191185|NCT02784561|Fludarabine|fludarabine|mesh-list
25191186|NCT02784561|Fludarabine phosphate|fludarabine phosphate|mesh-list
25191187|NCT02784561|Busulfan|busulfan|mesh-list
25191188|NCT02784561|Thymoglobulin|thymoglobulin|mesh-list
25191189|NCT02784561|Lenograstim|lenograstim|mesh-list
25191190|NCT02784561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25191191|NCT02784561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25191192|NCT02784561|Antimetabolites|antimetabolites|mesh-ancestor
25191193|NCT02784561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191194|NCT02784561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25191195|NCT02784561|Immunologic Factors|immunologic factors|mesh-ancestor
25191196|NCT02784561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191197|NCT02784561|Antiviral Agents|antiviral agents|mesh-ancestor
25191198|NCT02784561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25191199|NCT02784561|Alkylating Agents|alkylating agents|mesh-ancestor
25191200|NCT02784561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25191201|NCT02784561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25191202|NCT02784561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25666502|NCT01696084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25191203|NCT02784340|Dexamethasone|dexamethasone|mesh-list
25666503|NCT01696084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25666504|NCT01696084|Immunologic Factors|immunologic factors|mesh-ancestor
25666505|NCT01696084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666506|NCT01696084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25666507|NCT01696084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25666508|NCT01696084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24775899|NCT01855555|Anesthetics, General|anesthetics, general|mesh-ancestor
24775900|NCT01855555|Anesthetics|anesthetics|mesh-ancestor
24775901|NCT01855568|Methotrexate|methotrexate|mesh-list
24775902|NCT01855568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24775903|NCT01855568|Abortifacient Agents|abortifacient agents|mesh-ancestor
25212934|NCT05320705|Adrenergic Agents|adrenergic agents|mesh-ancestor
25212935|NCT05320705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25212936|NCT05320705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191204|NCT02784340|Dexamethasone acetate|dexamethasone acetate|mesh-list
25191205|NCT02784340|Bupivacaine|bupivacaine|mesh-list
25191206|NCT02784340|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25191207|NCT02784340|BB 1101|bb 1101|mesh-list
25191208|NCT02784340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25191209|NCT02784340|Antiemetics|antiemetics|mesh-ancestor
25191210|NCT02784340|Autonomic Agents|autonomic agents|mesh-ancestor
25191211|NCT02784340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191212|NCT02784340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191213|NCT02784340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25191214|NCT02784340|Glucocorticoids|glucocorticoids|mesh-ancestor
25191215|NCT02784340|Hormones|hormones|mesh-ancestor
25191216|NCT02784340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24554693|NCT00737724|Isoniazid|isoniazid|mesh-list
24554751|NCT00737971|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24554752|NCT00737971|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25191217|NCT02784340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25191218|NCT02784340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25191219|NCT02784340|Protease Inhibitors|protease inhibitors|mesh-ancestor
25191220|NCT02784340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25191221|NCT02784340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191222|NCT02784340|Anesthetics, Local|anesthetics, local|mesh-ancestor
25191223|NCT02784340|Anesthetics|anesthetics|mesh-ancestor
25191224|NCT02784340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25191225|NCT02784340|Sensory System Agents|sensory system agents|mesh-ancestor
25191226|NCT02784327|Ropivacaine|ropivacaine|mesh-list
25191227|NCT02784327|Anesthetics, Local|anesthetics, local|mesh-ancestor
25191228|NCT02784327|Anesthetics|anesthetics|mesh-ancestor
25191410|NCT02783144|Antiemetics|antiemetics|mesh-ancestor
25191229|NCT02784327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25191230|NCT02784327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191231|NCT02784327|Sensory System Agents|sensory system agents|mesh-ancestor
25191232|NCT02784327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191233|NCT02784223|Choline|choline|mesh-list
25191234|NCT02784223|Lipotropic Agents|lipotropic agents|mesh-ancestor
25191235|NCT02784223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25191236|NCT02784223|Antimetabolites|antimetabolites|mesh-ancestor
25191237|NCT02784223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191238|NCT02784223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25191239|NCT02784223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25191240|NCT02784223|Nootropic Agents|nootropic agents|mesh-ancestor
25191241|NCT02784392|Metoclopramide|metoclopramide|mesh-list
25191242|NCT02784392|Antiemetics|antiemetics|mesh-ancestor
25191243|NCT02784392|Autonomic Agents|autonomic agents|mesh-ancestor
25191244|NCT02784392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191245|NCT02784392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191246|NCT02784392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25191247|NCT02784392|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25191248|NCT02784392|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25191249|NCT02784392|Dopamine Agents|dopamine agents|mesh-ancestor
25191250|NCT02784392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25191251|NCT02784392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191252|NCT02784054|Cyclophosphamide|cyclophosphamide|mesh-list
25191253|NCT02784054|Melphalan|melphalan|mesh-list
25191256|NCT02784054|Etoposide|etoposide|mesh-list
25191257|NCT02784054|Bleomycin|bleomycin|mesh-list
25191258|NCT02784054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25191259|NCT02784054|Immunologic Factors|immunologic factors|mesh-ancestor
25191260|NCT02784054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191261|NCT02784054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24554753|NCT00737971|Bevacizumab|bevacizumab|mesh-list
25666509|NCT01696084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25666510|NCT01696214|Fluticasone|fluticasone|mesh-list
25666511|NCT01696214|Xhance|xhance|mesh-list
25666512|NCT01696214|Theophylline|theophylline|mesh-list
25666513|NCT01696214|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25666514|NCT01696214|Ipratropium|ipratropium|mesh-list
25666515|NCT01696214|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25666516|NCT01696214|Montelukast|montelukast|mesh-list
25666517|NCT01696214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25212939|NCT05297682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25212940|NCT05297682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212941|NCT05297682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25212942|NCT05297682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25212943|NCT05297682|Anesthetics, General|anesthetics, general|mesh-ancestor
25212944|NCT05296629|Doxycycline|doxycycline|mesh-list
24554821|NCT00738296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24554822|NCT00738335|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25191262|NCT02784054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25191263|NCT02784054|Alkylating Agents|alkylating agents|mesh-ancestor
25191264|NCT02784054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191265|NCT02784054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25191266|NCT02784054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25191267|NCT02784054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25191268|NCT02784054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25191269|NCT02784054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25191270|NCT02784054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25191271|NCT02784054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25191272|NCT02784080|Isoantibodies|isoantibodies|mesh-list
25191273|NCT02784080|Immunologic Factors|immunologic factors|mesh-ancestor
25191274|NCT02784080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191275|NCT02783924|Cholecalciferol|cholecalciferol|mesh-list
25191276|NCT02783924|Vitamin D|vitamin d|mesh-list
25191277|NCT02783924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25191278|NCT02783924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191279|NCT02783924|Vitamins|vitamins|mesh-ancestor
25191280|NCT02783924|Micronutrients|micronutrients|mesh-ancestor
25191281|NCT02783924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25191282|NCT02784015|Cyclophosphamide|cyclophosphamide|mesh-list
25191283|NCT02784015|Melphalan|melphalan|mesh-list
25191284|NCT02784015|Ifosfamide|ifosfamide|mesh-list
25191285|NCT02784015|Thiotepa|thiotepa|mesh-list
25191286|NCT02784015|Carboplatin|carboplatin|mesh-list
25191287|NCT02784015|Doxorubicin|doxorubicin|mesh-list
25191288|NCT02784015|Etoposide|etoposide|mesh-list
25191289|NCT02784015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25191290|NCT02784015|Immunologic Factors|immunologic factors|mesh-ancestor
25191291|NCT02784015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191292|NCT02784015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25191293|NCT02784015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25191294|NCT02784015|Alkylating Agents|alkylating agents|mesh-ancestor
25191295|NCT02784015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191296|NCT02784015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25191297|NCT02784015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25191298|NCT02784015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25191299|NCT02784015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24554823|NCT00738335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25191300|NCT02784015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25191301|NCT02784015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25191302|NCT02784015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25191303|NCT02783989|4-hydroxyphenylethanol|4-hydroxyphenylethanol|mesh-list
25191304|NCT02783989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25191306|NCT02783989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191307|NCT02783989|Protective Agents|protective agents|mesh-ancestor
25191308|NCT02783989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191309|NCT02783976|Sofosbuvir|sofosbuvir|mesh-list
25191310|NCT02783976|Antiviral Agents|antiviral agents|mesh-ancestor
25191311|NCT02783976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25191312|NCT02783937|Lenograstim|lenograstim|mesh-list
25191313|NCT02783937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25191314|NCT02783937|Immunologic Factors|immunologic factors|mesh-ancestor
25191315|NCT02783937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191316|NCT02783846|Dexmedetomidine|dexmedetomidine|mesh-list
25191317|NCT02783846|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25191318|NCT02783846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25191319|NCT02783846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191320|NCT02783846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25191322|NCT02783846|Sensory System Agents|sensory system agents|mesh-ancestor
25191323|NCT02783846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25666518|NCT01696214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25666519|NCT01696214|Autonomic Agents|autonomic agents|mesh-ancestor
25666520|NCT01696214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25666521|NCT01696214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666522|NCT01696214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25666523|NCT01696214|Respiratory System Agents|respiratory system agents|mesh-ancestor
25212955|NCT05271721|Dexamethasone|dexamethasone|mesh-list
24776064|NCT01856374|Antimetabolites|antimetabolites|mesh-ancestor
24776065|NCT01856374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776066|NCT01856374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24776067|NCT01856374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24776068|NCT01856374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776069|NCT01856374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776070|NCT01856374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24776071|NCT01856374|Immunologic Factors|immunologic factors|mesh-ancestor
24567371|NCT00790946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776080|NCT01856517|Clonidine|clonidine|mesh-list
25191324|NCT02783846|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25191325|NCT02783846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25191326|NCT02783846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25191327|NCT02783846|Adrenergic Agents|adrenergic agents|mesh-ancestor
25191328|NCT02783846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25191329|NCT02783846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191330|NCT02783378|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
25191331|NCT02783378|Antacids|antacids|mesh-ancestor
25191332|NCT02783378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191333|NCT02783378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25191334|NCT02783508|Meperidine|meperidine|mesh-list
25191335|NCT02783508|Nitrous Oxide|nitrous oxide|mesh-list
25191336|NCT02783508|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25191337|NCT02783508|Anesthetics, General|anesthetics, general|mesh-ancestor
25191338|NCT02783508|Anesthetics|anesthetics|mesh-ancestor
25191339|NCT02783508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25191340|NCT02783508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191341|NCT02783508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25191342|NCT02783508|Analgesics|analgesics|mesh-ancestor
25191343|NCT02783508|Sensory System Agents|sensory system agents|mesh-ancestor
25191344|NCT02783508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191345|NCT02783508|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25191346|NCT02783508|Narcotics|narcotics|mesh-ancestor
24554884|NCT00738621|Antiemetics|antiemetics|mesh-ancestor
25191347|NCT02783508|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25191348|NCT02783482|Immunoglobulins|immunoglobulins|mesh-list
25191349|NCT02783482|gamma-Globulins|gamma-globulins|mesh-list
25191350|NCT02783482|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25191351|NCT02783482|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25191352|NCT02783482|Immunologic Factors|immunologic factors|mesh-ancestor
25191353|NCT02783482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191354|NCT02783586|Bupivacaine|bupivacaine|mesh-list
25191355|NCT02783586|Anesthetics, Local|anesthetics, local|mesh-ancestor
25191356|NCT02783586|Anesthetics|anesthetics|mesh-ancestor
25191357|NCT02783586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25191358|NCT02783586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191359|NCT02783586|Sensory System Agents|sensory system agents|mesh-ancestor
25191360|NCT02783586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191361|NCT02783547|Azacitidine|azacitidine|mesh-list
25191362|NCT02783547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25191363|NCT02783547|Antimetabolites|antimetabolites|mesh-ancestor
25191364|NCT02783547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191365|NCT02783547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25191366|NCT02783547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25191367|NCT02783430|Ketamine|ketamine|mesh-list
25191368|NCT02783430|Milnacipran|milnacipran|mesh-list
25191369|NCT02783430|Levomilnacipran|levomilnacipran|mesh-list
25191370|NCT02783430|Analgesics|analgesics|mesh-ancestor
25191371|NCT02783430|Sensory System Agents|sensory system agents|mesh-ancestor
25191372|NCT02783430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191373|NCT02783430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666524|NCT01696214|Dermatologic Agents|dermatologic agents|mesh-ancestor
25666525|NCT01696214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25666526|NCT01696214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25666527|NCT01696214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25666528|NCT01696214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25666529|NCT01696214|Adrenergic Agents|adrenergic agents|mesh-ancestor
25666530|NCT01696214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25666531|NCT01696214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666532|NCT01696214|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25666533|NCT01696214|Hormone Antagonists|hormone antagonists|mesh-ancestor
25666534|NCT01696214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24776102|NCT01856621|Autonomic Agents|autonomic agents|mesh-ancestor
24776103|NCT01856621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24776104|NCT01856621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776105|NCT01856621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24776106|NCT01856621|Respiratory System Agents|respiratory system agents|mesh-ancestor
24776107|NCT01856621|Glucocorticoids|glucocorticoids|mesh-ancestor
24776108|NCT01856621|Hormones|hormones|mesh-ancestor
24776109|NCT01856621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25191374|NCT02783430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25191375|NCT02783430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25191376|NCT02783430|Anesthetics, General|anesthetics, general|mesh-ancestor
25191377|NCT02783430|Anesthetics|anesthetics|mesh-ancestor
25191378|NCT02783430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25191379|NCT02783430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25191380|NCT02783430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25191381|NCT02783430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25191382|NCT02783430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191383|NCT02783430|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25191384|NCT02783430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25191385|NCT02783430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25191386|NCT02783430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25191387|NCT02783430|Antidepressive Agents|antidepressive agents|mesh-ancestor
25191392|NCT02783638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191393|NCT02783638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191394|NCT02783638|Anticonvulsants|anticonvulsants|mesh-ancestor
25191395|NCT02783638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25191396|NCT02783638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25191397|NCT02783638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824359|NCT02123056|Adrenergic Agents|adrenergic agents|mesh-ancestor
25191398|NCT02783638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25191399|NCT02783638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24824368|NCT02123069|Mydriatics|mydriatics|mesh-ancestor
24824369|NCT02123069|Autonomic Agents|autonomic agents|mesh-ancestor
24426314|NCT00235781|Immunologic Factors|immunologic factors|mesh-ancestor
24426315|NCT00235781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426316|NCT00235781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24426318|NCT00235794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24426363|NCT00235898|Micronutrients|micronutrients|mesh-ancestor
24426364|NCT00235911|Budesonide|budesonide|mesh-list
24426365|NCT00235911|Formoterol Fumarate|formoterol fumarate|mesh-list
24426366|NCT00235911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24426367|NCT00235911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24426368|NCT00235911|Autonomic Agents|autonomic agents|mesh-ancestor
24426369|NCT00235911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24426370|NCT00235911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860562|NCT00083902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25860563|NCT00083902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24444302|NCT00297375|Antipyretics|antipyretics|mesh-ancestor
24444303|NCT00297375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25860564|NCT00083902|Growth Substances|growth substances|mesh-ancestor
24704135|NCT01476787|Growth Substances|growth substances|mesh-ancestor
24534885|NCT00648193|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25860565|NCT00083902|Growth Inhibitors|growth inhibitors|mesh-ancestor
25860566|NCT00083954|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24857546|NCT02292303|Trace Elements|trace elements|mesh-ancestor
24857547|NCT02292303|Micronutrients|micronutrients|mesh-ancestor
24857548|NCT02292303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742232|NCT05296005|Antidotes|antidotes|mesh-ancestor
25860567|NCT00083954|Antidepressive Agents|antidepressive agents|mesh-ancestor
25860568|NCT00083954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25860569|NCT00083954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25666535|NCT01696214|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25666536|NCT01696214|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25666537|NCT01696214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25666538|NCT01696214|Cholinergic Agents|cholinergic agents|mesh-ancestor
25666539|NCT01696214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25666540|NCT01696214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25666541|NCT01696214|Vasodilator Agents|vasodilator agents|mesh-ancestor
25666542|NCT01696214|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25666543|NCT01696214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25860570|NCT00083954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24776139|NCT01856959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776140|NCT01856959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24776141|NCT01856959|Respiratory System Agents|respiratory system agents|mesh-ancestor
24776142|NCT01856959|Tocolytic Agents|tocolytic agents|mesh-ancestor
24776143|NCT01856959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24776144|NCT01856959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24776145|NCT01856959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24776146|NCT01856959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25860571|NCT00083954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25860572|NCT00083954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860573|NCT00083980|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25860574|NCT00083980|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25860575|NCT00083980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25860576|NCT00083980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25191400|NCT02783638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25191401|NCT02783638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25191402|NCT02783638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25191403|NCT02783053|Metformin|metformin|mesh-list
25191404|NCT02783053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25191405|NCT02783053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191406|NCT02783144|Dexamethasone|dexamethasone|mesh-list
25191407|NCT02783144|Dexamethasone acetate|dexamethasone acetate|mesh-list
25191408|NCT02783144|BB 1101|bb 1101|mesh-list
25191409|NCT02783144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25191411|NCT02783144|Autonomic Agents|autonomic agents|mesh-ancestor
25191412|NCT02783144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191413|NCT02783144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191414|NCT02783144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25191415|NCT02783144|Glucocorticoids|glucocorticoids|mesh-ancestor
25191416|NCT02783144|Hormones|hormones|mesh-ancestor
25191417|NCT02783144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25191418|NCT02783144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25191419|NCT02783144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25191420|NCT02783144|Protease Inhibitors|protease inhibitors|mesh-ancestor
25191421|NCT02783144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25191454|NCT02783183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191422|NCT02783144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191423|NCT02783040|Digoxin|digoxin|mesh-list
25191424|NCT02783040|Midazolam|midazolam|mesh-list
25191425|NCT02783040|BI 425809|bi 425809|mesh-list
25191426|NCT02783040|Omeprazole|omeprazole|mesh-list
25191427|NCT02783040|Warfarin|warfarin|mesh-list
25191428|NCT02783040|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25191429|NCT02783040|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25191430|NCT02783040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25191431|NCT02783040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191432|NCT02783040|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25191433|NCT02783040|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25191434|NCT02783040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25191435|NCT02783040|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25191436|NCT02783040|Anesthetics, General|anesthetics, general|mesh-ancestor
25191437|NCT02783040|Anesthetics|anesthetics|mesh-ancestor
25191438|NCT02783040|GABA Modulators|gaba modulators|mesh-ancestor
25191439|NCT02783040|GABA Agents|gaba agents|mesh-ancestor
25191440|NCT02783040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25191441|NCT02783040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191442|NCT02783040|Anticoagulants|anticoagulants|mesh-ancestor
25191443|NCT02783040|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25191444|NCT02783040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25191445|NCT02783040|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25191446|NCT02783040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25191447|NCT02783040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25191448|NCT02783040|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25666544|NCT01696214|Purinergic Agents|purinergic agents|mesh-ancestor
25666545|NCT01696214|Glucocorticoids|glucocorticoids|mesh-ancestor
25666546|NCT01696214|Hormones|hormones|mesh-ancestor
25666547|NCT01696214|Sympathomimetics|sympathomimetics|mesh-ancestor
25666548|NCT01696279|Calcium Carbonate|calcium carbonate|mesh-list
25666549|NCT01696279|Calcium|calcium|mesh-list
25666550|NCT01696279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25666551|NCT01696279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191449|NCT02783040|Protective Agents|protective agents|mesh-ancestor
25191450|NCT02783040|Nootropic Agents|nootropic agents|mesh-ancestor
25206536|NCT05345327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206537|NCT05345327|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25666552|NCT01696279|Antacids|antacids|mesh-ancestor
24776210|NCT01857141|Adrenergic Agents|adrenergic agents|mesh-ancestor
24776211|NCT01857141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24776212|NCT01857141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776213|NCT01857154|Calcium, Dietary|calcium, dietary|mesh-list
24776214|NCT01857154|Vitamin D|vitamin d|mesh-list
24776215|NCT01857154|Cholecalciferol|cholecalciferol|mesh-list
24776216|NCT01857154|Calcium Carbonate|calcium carbonate|mesh-list
24776217|NCT01857154|Calcium|calcium|mesh-list
24776218|NCT01857154|Vitamins|vitamins|mesh-ancestor
24776219|NCT01857154|Micronutrients|micronutrients|mesh-ancestor
24776220|NCT01857154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206538|NCT05345327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206539|NCT05345236|Aflibercept|aflibercept|mesh-list
25206540|NCT05345236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25206541|NCT05345236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25206542|NCT05345236|Growth Substances|growth substances|mesh-ancestor
25206543|NCT05345236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206544|NCT05345236|Growth Inhibitors|growth inhibitors|mesh-ancestor
25206545|NCT05345236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206546|NCT05345210|Amoxicillin|amoxicillin|mesh-list
25206547|NCT05345210|Clarithromycin|clarithromycin|mesh-list
25206548|NCT05345210|Tetracycline|tetracycline|mesh-list
25206549|NCT05345210|Furazolidone|furazolidone|mesh-list
25206550|NCT05345210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25206551|NCT05345210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25206552|NCT05345210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25206553|NCT05345210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25206554|NCT05345210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206555|NCT05345210|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25206556|NCT05345210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25206557|NCT05345210|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25206558|NCT05345210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25206559|NCT05345210|Renal Agents|renal agents|mesh-ancestor
25206560|NCT05345210|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25206561|NCT05345210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25206562|NCT05345210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25206563|NCT05345210|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25206564|NCT05345132|Magnesium Sulfate|magnesium sulfate|mesh-list
25206565|NCT05345132|Nifedipine|nifedipine|mesh-list
25206566|NCT05345132|Analgesics|analgesics|mesh-ancestor
25206567|NCT05345132|Sensory System Agents|sensory system agents|mesh-ancestor
25206568|NCT05345132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25206569|NCT05345132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206570|NCT05345132|Anesthetics|anesthetics|mesh-ancestor
25206571|NCT05345132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25206572|NCT05345132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25206573|NCT05345132|Anticonvulsants|anticonvulsants|mesh-ancestor
25206574|NCT05345132|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25206575|NCT05345132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25206576|NCT05345132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206577|NCT05345132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25206578|NCT05345132|Tocolytic Agents|tocolytic agents|mesh-ancestor
25206579|NCT05345132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25191451|NCT02783183|Pregabalin|pregabalin|mesh-list
25191452|NCT02783183|Analgesics|analgesics|mesh-ancestor
25191453|NCT02783183|Sensory System Agents|sensory system agents|mesh-ancestor
24947969|NCT03924245|Olaparib|olaparib|mesh-list
25191455|NCT02783183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191456|NCT02783183|Anticonvulsants|anticonvulsants|mesh-ancestor
25191457|NCT02783183|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25191458|NCT02783183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25191459|NCT02783183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191460|NCT02783183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25191461|NCT02783183|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25191462|NCT02783183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25666553|NCT01696279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666554|NCT01696279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25666555|NCT01696695|Capecitabine|capecitabine|mesh-list
25666556|NCT01696695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25666557|NCT01696695|Antimetabolites|antimetabolites|mesh-ancestor
25666558|NCT01696695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666559|NCT01696695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25666560|NCT01696760|Aspirin|aspirin|mesh-list
25666561|NCT01696760|Enoxaparin|enoxaparin|mesh-list
25666562|NCT01696760|Enoxaparin sodium|enoxaparin sodium|mesh-list
24776306|NCT01857596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24776314|NCT01857609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24776315|NCT01857609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776316|NCT01857609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24776317|NCT01857609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24776318|NCT01857609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24776321|NCT01857726|Doxorubicin|doxorubicin|mesh-list
25191463|NCT02783183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25191464|NCT02783183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25191465|NCT02783196|Liraglutide|liraglutide|mesh-list
25191466|NCT02783196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25191467|NCT02783196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191468|NCT02783196|Incretins|incretins|mesh-ancestor
25191469|NCT02783196|Hormones|hormones|mesh-ancestor
25191470|NCT02783196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25191471|NCT02783222|Paclitaxel|paclitaxel|mesh-list
25191472|NCT02783222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25191473|NCT02783222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25191474|NCT02783222|Tubulin Modulators|tubulin modulators|mesh-ancestor
25191475|NCT02783222|Antimitotic Agents|antimitotic agents|mesh-ancestor
25191476|NCT02783222|Mitosis Modulators|mitosis modulators|mesh-ancestor
25191477|NCT02783222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191478|NCT02782819|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25191479|NCT02782897|Immunoglobulins|immunoglobulins|mesh-list
25191480|NCT02782897|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25191481|NCT02782897|Antibodies|antibodies|mesh-list
25191482|NCT02782897|Immunologic Factors|immunologic factors|mesh-ancestor
25191483|NCT02782897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191484|NCT02782624|Empagliflozin|empagliflozin|mesh-list
25191485|NCT02782624|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25191486|NCT02782624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191487|NCT02782624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25191488|NCT02782624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191489|NCT02782754|Cyclophosphamide|cyclophosphamide|mesh-list
25191490|NCT02782754|Carboplatin|carboplatin|mesh-list
25191491|NCT02782754|Etoposide|etoposide|mesh-list
25191492|NCT02782754|Bleomycin|bleomycin|mesh-list
25191493|NCT02782754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25191494|NCT02782754|Immunologic Factors|immunologic factors|mesh-ancestor
25191495|NCT02782754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191496|NCT02782754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25191497|NCT02782754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25191498|NCT02782754|Alkylating Agents|alkylating agents|mesh-ancestor
25191499|NCT02782754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191500|NCT02782754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25191501|NCT02782754|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25191502|NCT02782754|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25191503|NCT02782754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25191504|NCT02782754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25191505|NCT02782754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25191506|NCT02782754|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25191507|NCT02782559|Sildenafil Citrate|sildenafil citrate|mesh-list
25191508|NCT02782559|Vasodilator Agents|vasodilator agents|mesh-ancestor
25191509|NCT02782559|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25191510|NCT02782559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25191511|NCT02782559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25191512|NCT02782559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191513|NCT02782559|Urological Agents|urological agents|mesh-ancestor
25191514|NCT02782338|Diclofenac|diclofenac|mesh-list
25191530|NCT02782260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25191531|NCT02782260|Vasodilator Agents|vasodilator agents|mesh-ancestor
25191533|NCT02782273|Morphine|morphine|mesh-list
25191534|NCT02782273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25191535|NCT02782273|Narcotics|narcotics|mesh-ancestor
25191536|NCT02782273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25191537|NCT02782273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191538|NCT02782273|Analgesics|analgesics|mesh-ancestor
25191539|NCT02782273|Sensory System Agents|sensory system agents|mesh-ancestor
25666563|NCT01696760|Anticoagulants|anticoagulants|mesh-ancestor
25666564|NCT01696760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25666565|NCT01696760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25666566|NCT01696760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666567|NCT01696760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25666568|NCT01696760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25404107|NCT03684811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25213011|NCT05212311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25213012|NCT05212311|Chelating Agents|chelating agents|mesh-ancestor
25213013|NCT05212311|Sequestering Agents|sequestering agents|mesh-ancestor
25213015|NCT05212311|Coagulants|coagulants|mesh-ancestor
25213023|NCT05208892|Dexmedetomidine|dexmedetomidine|mesh-list
25213024|NCT05208892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24772730|NCT01835340|Anesthetics|anesthetics|mesh-list
25191540|NCT02782273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24590274|NCT00911651|Bromides|bromides|mesh-list
25191541|NCT02782273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25191542|NCT02782273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25191543|NCT02782273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25191544|NCT02782273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25191551|NCT02782312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191552|NCT02782312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191553|NCT02782312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25191554|NCT02782312|Respiratory System Agents|respiratory system agents|mesh-ancestor
25191555|NCT02782312|Glucocorticoids|glucocorticoids|mesh-ancestor
25191556|NCT02782312|Hormones|hormones|mesh-ancestor
25191557|NCT02782312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25191558|NCT02782312|Sympathomimetics|sympathomimetics|mesh-ancestor
25191559|NCT02782403|Axitinib|axitinib|mesh-list
25191560|NCT02782403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25191561|NCT02782403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25191562|NCT02782403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25191563|NCT02782403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191580|NCT02782481|Levodopa|levodopa|mesh-list
25191581|NCT02782481|Carbidopa|carbidopa|mesh-list
25191582|NCT02782481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25191583|NCT02782481|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25191584|NCT02782481|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25191585|NCT02782481|Dopamine Agents|dopamine agents|mesh-ancestor
25191586|NCT02782481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25191587|NCT02782481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191588|NCT02782481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191589|NCT02782481|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25191590|NCT02782481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25191591|NCT02782286|Ketorolac|ketorolac|mesh-list
25191592|NCT02782286|Morphine|morphine|mesh-list
25191593|NCT02782286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25191594|NCT02782286|Narcotics|narcotics|mesh-ancestor
25191595|NCT02782286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25191596|NCT02782286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426905|NCT00236808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426906|NCT00236808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24426934|NCT00236834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24426935|NCT00236834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24426937|NCT00236847|Anticonvulsants|anticonvulsants|mesh-ancestor
24426938|NCT00236847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24426939|NCT00236847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426994|NCT00237133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24426995|NCT00237133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24426996|NCT00237133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24426997|NCT00237133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25191597|NCT02782286|Analgesics|analgesics|mesh-ancestor
25191598|NCT02782286|Sensory System Agents|sensory system agents|mesh-ancestor
25191599|NCT02782286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191600|NCT02782286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25191601|NCT02782286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25191602|NCT02782286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25191603|NCT02782286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25191604|NCT02782286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25191605|NCT02782286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25191606|NCT02782286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191607|NCT02782429|Ketamine|ketamine|mesh-list
25191608|NCT02782429|Analgesics|analgesics|mesh-ancestor
25666569|NCT01696760|Analgesics|analgesics|mesh-ancestor
25666570|NCT01696760|Sensory System Agents|sensory system agents|mesh-ancestor
25666571|NCT01696760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25666572|NCT01696760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666573|NCT01696760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25666574|NCT01696760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25666575|NCT01696760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25666576|NCT01696760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24486616|NCT00458731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24486617|NCT00458731|Growth Substances|growth substances|mesh-ancestor
24486618|NCT00458731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486619|NCT00458731|Growth Inhibitors|growth inhibitors|mesh-ancestor
25191609|NCT02782429|Sensory System Agents|sensory system agents|mesh-ancestor
25191610|NCT02782429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191611|NCT02782429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191612|NCT02782429|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25191613|NCT02782429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25191614|NCT02782429|Anesthetics, General|anesthetics, general|mesh-ancestor
25191616|NCT02782429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25191617|NCT02782429|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25191618|NCT02782429|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25191619|NCT02782429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25191620|NCT02782429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191622|NCT02782221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25191623|NCT02782221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191624|NCT02782208|Acipimox|acipimox|mesh-list
25191625|NCT02782208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25191626|NCT02782208|Antimetabolites|antimetabolites|mesh-ancestor
25191627|NCT02782208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191628|NCT02782208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25191629|NCT02782182|Leucovorin|leucovorin|mesh-list
25191630|NCT02782182|Oxaliplatin|oxaliplatin|mesh-list
25191631|NCT02782182|Irinotecan|irinotecan|mesh-list
25191632|NCT02782182|Folfirinox|folfirinox|mesh-list
25191633|NCT02782182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25191634|NCT02782182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25191635|NCT02782182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25191636|NCT02782182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25191637|NCT02782182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191638|NCT02782182|Antidotes|antidotes|mesh-ancestor
25191639|NCT02782182|Protective Agents|protective agents|mesh-ancestor
25191640|NCT02782182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191641|NCT02782182|Vitamin B Complex|vitamin b complex|mesh-ancestor
25191642|NCT02782182|Vitamins|vitamins|mesh-ancestor
25191643|NCT02782182|Micronutrients|micronutrients|mesh-ancestor
25191644|NCT02782078|Clindamycin|clindamycin|mesh-list
25191645|NCT02782078|Clindamycin palmitate|clindamycin palmitate|mesh-list
25191646|NCT02782078|Clindamycin phosphate|clindamycin phosphate|mesh-list
25191647|NCT02782078|Rifampin|rifampin|mesh-list
25191648|NCT02782078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25191649|NCT02782078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25206580|NCT05345132|Vasodilator Agents|vasodilator agents|mesh-ancestor
25191650|NCT02782078|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25191651|NCT02782078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25191652|NCT02782078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191653|NCT02782078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25191654|NCT02782078|Antitubercular Agents|antitubercular agents|mesh-ancestor
25191655|NCT02782078|Leprostatic Agents|leprostatic agents|mesh-ancestor
25191656|NCT02782078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25191657|NCT02782078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25191658|NCT02782078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25191659|NCT02782078|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25191660|NCT02782078|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25191661|NCT02782078|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25191662|NCT02782078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25191663|NCT02782052|Bromides|bromides|mesh-list
25191664|NCT02782052|Albuterol|albuterol|mesh-list
25191665|NCT02782052|Ipratropium|ipratropium|mesh-list
25191666|NCT02782052|Anticonvulsants|anticonvulsants|mesh-ancestor
25191667|NCT02782052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25191668|NCT02782052|Autonomic Agents|autonomic agents|mesh-ancestor
25191669|NCT02782052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191670|NCT02782052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191671|NCT02782052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25191672|NCT02782052|Respiratory System Agents|respiratory system agents|mesh-ancestor
25191673|NCT02782052|Tocolytic Agents|tocolytic agents|mesh-ancestor
25666577|NCT01696760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25666578|NCT01696760|Antipyretics|antipyretics|mesh-ancestor
25666579|NCT01696877|Cyclophosphamide|cyclophosphamide|mesh-list
25666580|NCT01696877|Molgramostim|molgramostim|mesh-list
25191674|NCT02782052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25666581|NCT01696877|Sargramostim|sargramostim|mesh-list
25081485|NCT03329443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081486|NCT03329443|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25081487|NCT03329443|Diuretics|diuretics|mesh-ancestor
24486673|NCT00459264|Vitamins|vitamins|mesh-ancestor
25191675|NCT02782052|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25191676|NCT02782052|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25191677|NCT02782052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25191678|NCT02782052|Adrenergic Agents|adrenergic agents|mesh-ancestor
25191679|NCT02782052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25191680|NCT02782052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191681|NCT02782052|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25191682|NCT02782052|Cholinergic Agents|cholinergic agents|mesh-ancestor
25191683|NCT02781909|Ibuprofen|ibuprofen|mesh-list
25191684|NCT02781909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25191685|NCT02781909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25191686|NCT02781909|Analgesics|analgesics|mesh-ancestor
25191687|NCT02781909|Sensory System Agents|sensory system agents|mesh-ancestor
25191688|NCT02781909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191689|NCT02781909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191690|NCT02781909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25191691|NCT02781909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25191692|NCT02781909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25191693|NCT02781909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25191694|NCT02781909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191695|NCT02781766|Thrombin|thrombin|mesh-list
25191696|NCT02781766|Hemostatics|hemostatics|mesh-ancestor
25191697|NCT02781766|Coagulants|coagulants|mesh-ancestor
25191698|NCT02781597|Tranexamic Acid|tranexamic acid|mesh-list
25191699|NCT02781597|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25191700|NCT02781597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25191701|NCT02781597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191702|NCT02781597|Hemostatics|hemostatics|mesh-ancestor
25191703|NCT02781597|Coagulants|coagulants|mesh-ancestor
25191704|NCT02781805|Alendronate|alendronate|mesh-list
25191705|NCT02781805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25191706|NCT02781805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191707|NCT02781493|Prucalopride|prucalopride|mesh-list
25191708|NCT02781493|Laxatives|laxatives|mesh-ancestor
25191709|NCT02781493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25191710|NCT02781493|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24555361|NCT00741234|Azacitidine|azacitidine|mesh-list
25191711|NCT02781493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25191712|NCT02781493|Serotonin Agents|serotonin agents|mesh-ancestor
25191713|NCT02781493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25191714|NCT02781493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191715|NCT02781493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191716|NCT02781753|Interferons|interferons|mesh-list
24427044|NCT00237237|Vildagliptin|vildagliptin|mesh-list
25206581|NCT05345119|Sirolimus|sirolimus|mesh-list
25191723|NCT02781753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191724|NCT02781779|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25191725|NCT02781779|Laxatives|laxatives|mesh-ancestor
25191726|NCT02781779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25191727|NCT02781467|Cyclophosphamide|cyclophosphamide|mesh-list
25191728|NCT02781467|Fludarabine|fludarabine|mesh-list
25191729|NCT02781467|Interleukin-2|interleukin-2|mesh-list
25191730|NCT02781467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25191731|NCT02781467|Immunologic Factors|immunologic factors|mesh-ancestor
25191732|NCT02781467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191733|NCT02781467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25191734|NCT02781467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25191735|NCT02781467|Alkylating Agents|alkylating agents|mesh-ancestor
25191736|NCT02781467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191737|NCT02781467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25191738|NCT02781467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25191739|NCT02781467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25191740|NCT02781467|Analgesics|analgesics|mesh-ancestor
25191741|NCT02781467|Sensory System Agents|sensory system agents|mesh-ancestor
25191742|NCT02781467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191748|NCT02781415|Morphine|morphine|mesh-list
25191749|NCT02781415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25191750|NCT02781415|Narcotics|narcotics|mesh-ancestor
25191751|NCT02781415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25666582|NCT01696877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25666583|NCT01696877|Immunologic Factors|immunologic factors|mesh-ancestor
25666584|NCT01696877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486704|NCT00459563|Micronutrients|micronutrients|mesh-ancestor
24486705|NCT00459563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486706|NCT00459563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24486712|NCT00459615|Artesunate|artesunate|mesh-list
24486713|NCT00459615|Antimalarials|antimalarials|mesh-ancestor
24486714|NCT00459615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24486715|NCT00459615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25191752|NCT02781415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191753|NCT02781415|Analgesics|analgesics|mesh-ancestor
25191754|NCT02781415|Sensory System Agents|sensory system agents|mesh-ancestor
25191755|NCT02781415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191756|NCT02781246|Dexmedetomidine|dexmedetomidine|mesh-list
25191757|NCT02781246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25191758|NCT02781246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25191759|NCT02781246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191760|NCT02781246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25191761|NCT02781246|Analgesics|analgesics|mesh-ancestor
25191762|NCT02781246|Sensory System Agents|sensory system agents|mesh-ancestor
25191763|NCT02781246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191764|NCT02781246|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25191765|NCT02781246|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25191766|NCT02781246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25191767|NCT02781246|Adrenergic Agents|adrenergic agents|mesh-ancestor
25191768|NCT02781246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25191769|NCT02781246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206582|NCT05345119|Methylprednisolone|methylprednisolone|mesh-list
25206583|NCT05345119|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25206584|NCT05345119|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25206585|NCT05345119|Prednisolone|prednisolone|mesh-list
25206586|NCT05345119|Prednisolone acetate|prednisolone acetate|mesh-list
25206587|NCT05345119|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25206588|NCT05345119|Prednisolone phosphate|prednisolone phosphate|mesh-list
25206589|NCT05345119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25206590|NCT05345119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25206591|NCT05345119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25206592|NCT05345119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206593|NCT05345119|Antifungal Agents|antifungal agents|mesh-ancestor
25206594|NCT05345119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25206595|NCT05345119|Immunologic Factors|immunologic factors|mesh-ancestor
25206596|NCT05345119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206597|NCT05345119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25206598|NCT05345119|Antiemetics|antiemetics|mesh-ancestor
25206599|NCT05345119|Autonomic Agents|autonomic agents|mesh-ancestor
25206600|NCT05345119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25206601|NCT05345119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25206602|NCT05345119|Glucocorticoids|glucocorticoids|mesh-ancestor
25206603|NCT05345119|Hormones|hormones|mesh-ancestor
25206604|NCT05345119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25206605|NCT05345119|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25206606|NCT05345119|Protective Agents|protective agents|mesh-ancestor
25206607|NCT05345119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25206608|NCT05344911|Remifentanil|remifentanil|mesh-list
24427650|NCT00238667|Sensory System Agents|sensory system agents|mesh-ancestor
24427651|NCT00238667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24427652|NCT00238667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427653|NCT00238667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24427654|NCT00238667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24427655|NCT00238667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24427656|NCT00238667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24427657|NCT00238667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427658|NCT00238667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24427659|NCT00238667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24427660|NCT00238667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427661|NCT00238667|Antipyretics|antipyretics|mesh-ancestor
24427662|NCT00238667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25051593|NCT00393991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25666585|NCT01696877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25666586|NCT01696877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25666587|NCT01696877|Alkylating Agents|alkylating agents|mesh-ancestor
25666588|NCT01696877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666589|NCT01696877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25666590|NCT01696877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25666591|NCT01696942|Mesalamine|mesalamine|mesh-list
24486965|NCT00460733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24486966|NCT00460733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486968|NCT00460759|Rifapentine|rifapentine|mesh-list
24486969|NCT00460759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24486970|NCT00460759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25051594|NCT00393991|Adrenergic Agents|adrenergic agents|mesh-ancestor
24555637|NCT00742404|Dexamethasone|dexamethasone|mesh-list
24427678|NCT00238719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24427679|NCT00238732|Bazedoxifene|bazedoxifene|mesh-list
25191770|NCT02781064|Atorvastatin|atorvastatin|mesh-list
25191771|NCT02781064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25191772|NCT02781064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25191773|NCT02781064|Antimetabolites|antimetabolites|mesh-ancestor
25191774|NCT02781064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191775|NCT02781064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25191776|NCT02781064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25191777|NCT02781064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25191778|NCT02780804|Entinostat|entinostat|mesh-list
25191779|NCT02780804|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25191780|NCT02780804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25191781|NCT02780804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25191782|NCT02780804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191783|NCT02780882|Pasireotide|pasireotide|mesh-list
25191784|NCT02780882|Hormones|hormones|mesh-ancestor
25191785|NCT02780882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25191786|NCT02780882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191787|NCT02780778|Docetaxel|docetaxel|mesh-list
25191788|NCT02780778|Apatinib|apatinib|mesh-list
25191789|NCT02780778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25191790|NCT02780778|Tubulin Modulators|tubulin modulators|mesh-ancestor
25191791|NCT02780778|Antimitotic Agents|antimitotic agents|mesh-ancestor
25191792|NCT02780778|Mitosis Modulators|mitosis modulators|mesh-ancestor
25191793|NCT02780778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191794|NCT02780778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25191795|NCT02780778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25191796|NCT02780427|Dexmedetomidine|dexmedetomidine|mesh-list
25191797|NCT02780427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25191798|NCT02780427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25191799|NCT02780427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191800|NCT02780427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25191801|NCT02780427|Analgesics|analgesics|mesh-ancestor
25191802|NCT02780427|Sensory System Agents|sensory system agents|mesh-ancestor
25191803|NCT02780427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191804|NCT02780427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25191805|NCT02780427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25191806|NCT02780427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25191807|NCT02780427|Adrenergic Agents|adrenergic agents|mesh-ancestor
25191808|NCT02780427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25191809|NCT02780427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191810|NCT02780479|Dexamethasone|dexamethasone|mesh-list
25191811|NCT02780479|Prednisone|prednisone|mesh-list
25191812|NCT02780479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25191813|NCT02780479|Antiemetics|antiemetics|mesh-ancestor
25191814|NCT02780479|Autonomic Agents|autonomic agents|mesh-ancestor
25191815|NCT02780479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191816|NCT02780479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191817|NCT02780479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25191818|NCT02780479|Glucocorticoids|glucocorticoids|mesh-ancestor
25191819|NCT02780479|Hormones|hormones|mesh-ancestor
25191893|NCT02779959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25191837|NCT02780102|Dopamine Agents|dopamine agents|mesh-ancestor
25191838|NCT02780102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25191844|NCT02780245|Tranexamic Acid|tranexamic acid|mesh-list
25191845|NCT02780245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25191846|NCT02780245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25191847|NCT02780245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191848|NCT02780245|Hemostatics|hemostatics|mesh-ancestor
25191849|NCT02780245|Coagulants|coagulants|mesh-ancestor
25191850|NCT02780323|Celecoxib|celecoxib|mesh-list
25666592|NCT01696942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666593|NCT01696942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25666594|NCT01696942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25666595|NCT01696942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25666596|NCT01696942|Analgesics|analgesics|mesh-ancestor
25191851|NCT02780323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25156891|NCT04902443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25156892|NCT04902443|Growth Substances|growth substances|mesh-ancestor
25156893|NCT04902443|Growth Inhibitors|growth inhibitors|mesh-ancestor
25156895|NCT04899778|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25156896|NCT04899778|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25156897|NCT04899778|Contraceptive Agents|contraceptive agents|mesh-list
25156898|NCT04899778|Contraceptives, Oral|contraceptives, oral|mesh-list
25156899|NCT04899778|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25156900|NCT04899778|Estradiol|estradiol|mesh-list
24776567|NCT01858571|Sensory System Agents|sensory system agents|mesh-ancestor
25191852|NCT02780323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25191853|NCT02780323|Analgesics|analgesics|mesh-ancestor
25191854|NCT02780323|Sensory System Agents|sensory system agents|mesh-ancestor
25191855|NCT02780323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191856|NCT02780323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191857|NCT02780323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25191858|NCT02780323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25191859|NCT02780323|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25191860|NCT02780323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25191861|NCT02780323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25191862|NCT02780323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191876|NCT02780011|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25191877|NCT02780011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25191878|NCT02780011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25191879|NCT02779881|Caseins|caseins|mesh-list
25191880|NCT02779881|Chelating Agents|chelating agents|mesh-ancestor
25191881|NCT02779881|Sequestering Agents|sequestering agents|mesh-ancestor
25191882|NCT02779881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191883|NCT02779777|Tipifarnib|tipifarnib|mesh-list
25191884|NCT02779777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25191885|NCT02779959|Prochlorperazine|prochlorperazine|mesh-list
25191886|NCT02779959|Antiemetics|antiemetics|mesh-ancestor
25191887|NCT02779959|Autonomic Agents|autonomic agents|mesh-ancestor
25191888|NCT02779959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191889|NCT02779959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191890|NCT02779959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25191891|NCT02779959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25191892|NCT02779959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25191909|NCT02779608|Mitosis Modulators|mitosis modulators|mesh-ancestor
25191910|NCT02779608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206609|NCT05344911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25206610|NCT05344911|Narcotics|narcotics|mesh-ancestor
25206611|NCT05344911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25206612|NCT05344911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206613|NCT05344911|Analgesics|analgesics|mesh-ancestor
25206614|NCT05344911|Sensory System Agents|sensory system agents|mesh-ancestor
25206615|NCT05344911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25206616|NCT05344833|Lenalidomide|lenalidomide|mesh-list
25206617|NCT05344833|Immunologic Factors|immunologic factors|mesh-ancestor
25206618|NCT05344833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206619|NCT05344833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25206620|NCT05344833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25206621|NCT05344833|Growth Substances|growth substances|mesh-ancestor
25206622|NCT05344833|Growth Inhibitors|growth inhibitors|mesh-ancestor
25206623|NCT05344833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206624|NCT05344742|Paclitaxel|paclitaxel|mesh-list
25206625|NCT05344742|Capecitabine|capecitabine|mesh-list
25206627|NCT05344742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25206628|NCT05344742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206629|NCT05344742|Tubulin Modulators|tubulin modulators|mesh-ancestor
25206630|NCT05344742|Antimitotic Agents|antimitotic agents|mesh-ancestor
25206631|NCT05344742|Mitosis Modulators|mitosis modulators|mesh-ancestor
25206632|NCT05344742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206633|NCT05344742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25666597|NCT01696942|Sensory System Agents|sensory system agents|mesh-ancestor
25666598|NCT01696942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25666599|NCT01696942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25666600|NCT01696955|Cetuximab|cetuximab|mesh-list
25666601|NCT01696955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25666602|NCT01696955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25666603|NCT01697345|Testosterone|testosterone|mesh-list
25666604|NCT01697345|Androgens|androgens|mesh-ancestor
25666605|NCT01697345|Hormones|hormones|mesh-ancestor
25666606|NCT01697345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24776681|NCT01859234|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24776682|NCT01859234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776686|NCT01859377|Analgesics|analgesics|mesh-ancestor
25206634|NCT05344742|Antimetabolites|antimetabolites|mesh-ancestor
25206635|NCT05344742|Analgesics|analgesics|mesh-ancestor
25206636|NCT05344742|Sensory System Agents|sensory system agents|mesh-ancestor
25206637|NCT05344742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25206638|NCT05344742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206639|NCT05344742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25206640|NCT05344742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25206641|NCT05344742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25206656|NCT05344443|Lemborexant|lemborexant|mesh-list
25206657|NCT05344443|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25206658|NCT05344443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25206659|NCT05344443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206660|NCT05344443|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25206661|NCT05344443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25206662|NCT05344443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25206663|NCT05344443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206664|NCT05344248|Antibodies|antibodies|mesh-list
25206665|NCT05344248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25206666|NCT05344248|Immunologic Factors|immunologic factors|mesh-ancestor
24428080|NCT00239499|Fluticasone|fluticasone|mesh-list
24428081|NCT00239499|Tiotropium Bromide|tiotropium bromide|mesh-list
24428082|NCT00239499|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24428083|NCT00239499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24428084|NCT00239499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24428085|NCT00239499|Autonomic Agents|autonomic agents|mesh-ancestor
25191911|NCT02779582|Progesterone|progesterone|mesh-list
25191912|NCT02779582|Progestins|progestins|mesh-ancestor
25191913|NCT02779582|Hormones|hormones|mesh-ancestor
24555935|NCT00744354|Bortezomib|bortezomib|mesh-list
25191914|NCT02779582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25191915|NCT02779582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25191916|NCT02779387|Goserelin|goserelin|mesh-list
25191917|NCT02779387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25191918|NCT02779387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25191919|NCT02779283|Calcium, Dietary|calcium, dietary|mesh-list
25191920|NCT02779283|Leucovorin|leucovorin|mesh-list
25191921|NCT02779283|Folic Acid|folic acid|mesh-list
25191922|NCT02779283|Cytarabine|cytarabine|mesh-list
25191923|NCT02779283|Dexamethasone|dexamethasone|mesh-list
25191924|NCT02779283|Methylprednisolone|methylprednisolone|mesh-list
25191925|NCT02779283|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25191926|NCT02779283|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25191927|NCT02779283|Prednisolone|prednisolone|mesh-list
25191928|NCT02779283|Prednisolone acetate|prednisolone acetate|mesh-list
25191929|NCT02779283|Dexamethasone acetate|dexamethasone acetate|mesh-list
25191930|NCT02779283|Cyclophosphamide|cyclophosphamide|mesh-list
25191931|NCT02779283|Rituximab|rituximab|mesh-list
25191932|NCT02779283|Doxorubicin|doxorubicin|mesh-list
25191933|NCT02779283|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25191934|NCT02779283|Methotrexate|methotrexate|mesh-list
25191935|NCT02779283|Vincristine|vincristine|mesh-list
25191936|NCT02779283|Sorafenib|sorafenib|mesh-list
25191937|NCT02779283|Sunitinib|sunitinib|mesh-list
25191938|NCT02779283|Dasatinib|dasatinib|mesh-list
25191939|NCT02779283|Idarubicin|idarubicin|mesh-list
25191940|NCT02779283|Ponatinib|ponatinib|mesh-list
25191941|NCT02779283|Idelalisib|idelalisib|mesh-list
25191942|NCT02779283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25191943|NCT02779283|Antibodies|antibodies|mesh-list
25191944|NCT02779283|Immunoglobulins|immunoglobulins|mesh-list
25191945|NCT02779283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25191946|NCT02779283|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25191947|NCT02779283|Prednisolone phosphate|prednisolone phosphate|mesh-list
25191948|NCT02779283|BB 1101|bb 1101|mesh-list
25191949|NCT02779283|Calcium|calcium|mesh-list
25191950|NCT02779283|Levoleucovorin|levoleucovorin|mesh-list
25191951|NCT02779283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25191952|NCT02779283|Immunologic Factors|immunologic factors|mesh-ancestor
25191953|NCT02779283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666607|NCT01697345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666608|NCT01697579|Ondansetron|ondansetron|mesh-list
25191954|NCT02779283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25191955|NCT02779283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24555987|NCT00744549|Cholecalciferol|cholecalciferol|mesh-list
25191956|NCT02779283|Alkylating Agents|alkylating agents|mesh-ancestor
25191957|NCT02779283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25191958|NCT02779283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25666609|NCT01697579|Fosaprepitant|fosaprepitant|mesh-list
25666610|NCT01697579|Aprepitant|aprepitant|mesh-list
25191959|NCT02779283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25191960|NCT02779283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25191961|NCT02779283|Antiemetics|antiemetics|mesh-ancestor
25191962|NCT02779283|Autonomic Agents|autonomic agents|mesh-ancestor
25191963|NCT02779283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191964|NCT02779283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25191965|NCT02779283|Glucocorticoids|glucocorticoids|mesh-ancestor
24428086|NCT00239499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191966|NCT02779283|Hormones|hormones|mesh-ancestor
25191967|NCT02779283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25191968|NCT02779283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25191969|NCT02779283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25191970|NCT02779283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25191971|NCT02779283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25191972|NCT02779283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25191973|NCT02779283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25191974|NCT02779283|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25191975|NCT02779283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25191976|NCT02779283|Abortifacient Agents|abortifacient agents|mesh-ancestor
25191977|NCT02779283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25191978|NCT02779283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25191979|NCT02779283|Antimetabolites|antimetabolites|mesh-ancestor
25191980|NCT02779283|Dermatologic Agents|dermatologic agents|mesh-ancestor
25191981|NCT02779283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25191982|NCT02779283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25191984|NCT02779283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25191985|NCT02779283|Antidotes|antidotes|mesh-ancestor
25191986|NCT02779283|Protective Agents|protective agents|mesh-ancestor
25191987|NCT02779283|Vitamin B Complex|vitamin b complex|mesh-ancestor
25191988|NCT02779283|Vitamins|vitamins|mesh-ancestor
25191989|NCT02779283|Micronutrients|micronutrients|mesh-ancestor
25191990|NCT02779283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25191991|NCT02779283|Tubulin Modulators|tubulin modulators|mesh-ancestor
25191992|NCT02779283|Antimitotic Agents|antimitotic agents|mesh-ancestor
25191993|NCT02779283|Mitosis Modulators|mitosis modulators|mesh-ancestor
25191994|NCT02779283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25191995|NCT02779283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25191996|NCT02779283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25191997|NCT02779283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24556115|NCT00745043|Autonomic Agents|autonomic agents|mesh-ancestor
24556116|NCT00745043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25191998|NCT02779283|Growth Substances|growth substances|mesh-ancestor
25191999|NCT02779283|Growth Inhibitors|growth inhibitors|mesh-ancestor
25192000|NCT02779283|Hematinics|hematinics|mesh-ancestor
25192001|NCT02779283|Protease Inhibitors|protease inhibitors|mesh-ancestor
25192002|NCT02779413|Insulin|insulin|mesh-list
25192003|NCT02779413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25192004|NCT02779413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192005|NCT02779270|Sunscreening Agents|sunscreening agents|mesh-list
25192006|NCT02779270|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25192007|NCT02779270|Protective Agents|protective agents|mesh-ancestor
25192008|NCT02779270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192009|NCT02779270|Dermatologic Agents|dermatologic agents|mesh-ancestor
25192010|NCT02779465|Vitamin D|vitamin d|mesh-list
25192011|NCT02779465|Cholecalciferol|cholecalciferol|mesh-list
25192012|NCT02779465|Vitamins|vitamins|mesh-ancestor
25192013|NCT02779465|Micronutrients|micronutrients|mesh-ancestor
25192014|NCT02779465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192015|NCT02779465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25192016|NCT02779465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25192017|NCT02779530|Diclofenac|diclofenac|mesh-list
25192018|NCT02779530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25192019|NCT02779530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25192020|NCT02779530|Analgesics|analgesics|mesh-ancestor
25192021|NCT02779530|Sensory System Agents|sensory system agents|mesh-ancestor
25192022|NCT02779530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25192023|NCT02779530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192024|NCT02779530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25192025|NCT02779530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25192026|NCT02779530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25192027|NCT02779530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25192028|NCT02779530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192029|NCT02779192|Ebselen|ebselen|mesh-list
25192030|NCT02779192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24776846|NCT01860196|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24776847|NCT01860196|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24776848|NCT01860196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25192031|NCT02779192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25192032|NCT02779192|Analgesics|analgesics|mesh-ancestor
25192033|NCT02779192|Sensory System Agents|sensory system agents|mesh-ancestor
25192034|NCT02779192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25192035|NCT02779192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192036|NCT02779192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25192037|NCT02779192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25192038|NCT02779192|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25192039|NCT02779192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25192040|NCT02779192|Antioxidants|antioxidants|mesh-ancestor
24590275|NCT00911651|Albuterol|albuterol|mesh-list
25269288|NCT02410759|Ergonovine|ergonovine|mesh-list
25192041|NCT02779192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192042|NCT02779192|Protective Agents|protective agents|mesh-ancestor
25192043|NCT02779192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25192044|NCT02779192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25192045|NCT02779192|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25192046|NCT02778906|Abatacept|abatacept|mesh-list
25192047|NCT02778906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25192048|NCT02778906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192049|NCT02778906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25192050|NCT02778906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25192051|NCT02778906|Immunologic Factors|immunologic factors|mesh-ancestor
25192052|NCT02778906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192053|NCT02778906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25192054|NCT02779569|Decitabine|decitabine|mesh-list
25192055|NCT02779569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25192056|NCT02779569|Antimetabolites|antimetabolites|mesh-ancestor
25192057|NCT02779569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428536|NCT00240682|Cetuximab|cetuximab|mesh-list
24556142|NCT00745186|Glucagon|glucagon|mesh-list
24556190|NCT00745914|Pioglitazone|pioglitazone|mesh-list
25192058|NCT02779569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25192059|NCT02779569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25192061|NCT02778828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25192062|NCT02778828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25192063|NCT02778828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25192064|NCT02778828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25192065|NCT02778828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192066|NCT02778789|Adalimumab|adalimumab|mesh-list
25192067|NCT02778789|Etanercept|etanercept|mesh-list
25192068|NCT02778789|Golimumab|golimumab|mesh-list
25192069|NCT02778789|Infliximab|infliximab|mesh-list
25192070|NCT02778789|Certolizumab Pegol|certolizumab pegol|mesh-list
25192071|NCT02778789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25192072|NCT02778789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25192073|NCT02778789|Dermatologic Agents|dermatologic agents|mesh-ancestor
25192074|NCT02778789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25192075|NCT02778789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25192076|NCT02778789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25192077|NCT02778789|Analgesics|analgesics|mesh-ancestor
25192078|NCT02778789|Sensory System Agents|sensory system agents|mesh-ancestor
25192079|NCT02778789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25192080|NCT02778789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192081|NCT02778789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25192082|NCT02778789|Immunologic Factors|immunologic factors|mesh-ancestor
25192083|NCT02778789|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25192084|NCT02778958|Acetaminophen|acetaminophen|mesh-list
25192085|NCT02778958|Ibuprofen|ibuprofen|mesh-list
25192086|NCT02778958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25192087|NCT02778958|Analgesics|analgesics|mesh-ancestor
25192088|NCT02778958|Sensory System Agents|sensory system agents|mesh-ancestor
25192089|NCT02778958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25192090|NCT02778958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192091|NCT02778958|Antipyretics|antipyretics|mesh-ancestor
25192092|NCT02778958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25192093|NCT02778958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25192094|NCT02778958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25192095|NCT02778958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25192096|NCT02778958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25192097|NCT02778958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192098|NCT02778971|Flutemetamol|flutemetamol|mesh-list
25666611|NCT01697579|Serotonin|serotonin|mesh-list
25666612|NCT01697579|Antiemetics|antiemetics|mesh-ancestor
25666613|NCT01697579|Autonomic Agents|autonomic agents|mesh-ancestor
25666614|NCT01697579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24777018|NCT01861041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777019|NCT01861041|Sensory System Agents|sensory system agents|mesh-ancestor
24777020|NCT01861041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24777021|NCT01861145|Mometasone Furoate|mometasone furoate|mesh-list
24777022|NCT01861145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24777023|NCT01861145|Dermatologic Agents|dermatologic agents|mesh-ancestor
24777024|NCT01861145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24777025|NCT01861223|Afatinib|afatinib|mesh-list
25192099|NCT02778971|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25192100|NCT02778971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192101|NCT02778945|Rocuronium|rocuronium|mesh-list
25192102|NCT02778945|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24590277|NCT00911651|Anticonvulsants|anticonvulsants|mesh-ancestor
25192103|NCT02778945|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25192104|NCT02778945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25192105|NCT02778945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25192106|NCT02778945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192107|NCT02778776|Metformin|metformin|mesh-list
25192108|NCT02778776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25192109|NCT02778776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192110|NCT02779101|Pembrolizumab|pembrolizumab|mesh-list
25192111|NCT02779101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25192112|NCT02779101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25192113|NCT02778919|Leuprolide|leuprolide|mesh-list
25192114|NCT02778919|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25192115|NCT02778919|Fertility Agents|fertility agents|mesh-ancestor
25192116|NCT02778919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25192117|NCT02778919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192118|NCT02778919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25192119|NCT02778919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25192120|NCT02779153|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25192121|NCT02779153|Hormones|hormones|mesh-ancestor
25192122|NCT02779153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25192123|NCT02779153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192124|NCT02778893|Thalidomide|thalidomide|mesh-list
25192125|NCT02778893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25192126|NCT02778893|Immunologic Factors|immunologic factors|mesh-ancestor
25192127|NCT02778893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192128|NCT02778893|Leprostatic Agents|leprostatic agents|mesh-ancestor
25192129|NCT02778893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25192130|NCT02778893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25192131|NCT02778893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25192132|NCT02778893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25192133|NCT02778893|Growth Substances|growth substances|mesh-ancestor
25192134|NCT02778893|Growth Inhibitors|growth inhibitors|mesh-ancestor
25192135|NCT02778893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25192137|NCT02778659|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25192138|NCT02778659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25192139|NCT02778659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25192140|NCT02778659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192141|NCT02778659|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25192142|NCT02778659|GABA Agonists|gaba agonists|mesh-ancestor
25192143|NCT02778659|GABA Agents|gaba agents|mesh-ancestor
25192144|NCT02778659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25192145|NCT02778659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192147|NCT02778594|Benserazide|benserazide|mesh-list
25192148|NCT02778594|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24948016|NCT03923829|Zinc|zinc|mesh-list
25192149|NCT02778594|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25192150|NCT02778594|Dopamine Agents|dopamine agents|mesh-ancestor
25192151|NCT02778594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25192152|NCT02778594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192153|NCT02778594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192154|NCT02778594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25192155|NCT02778425|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25192156|NCT02778425|Somatostatin|somatostatin|mesh-list
25192157|NCT02778425|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25192158|NCT02778425|Adrenergic Agents|adrenergic agents|mesh-ancestor
25666615|NCT01697579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666616|NCT01697579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25666617|NCT01697579|Antipruritics|antipruritics|mesh-ancestor
25666618|NCT01697579|Dermatologic Agents|dermatologic agents|mesh-ancestor
25666619|NCT01697579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25666620|NCT01697579|Serotonin Agents|serotonin agents|mesh-ancestor
25666621|NCT01697579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25674409|NCT01771952|Protective Agents|protective agents|mesh-ancestor
24777063|NCT01861561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777064|NCT01861561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24777065|NCT01861561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24777066|NCT01861626|Isotretinoin|isotretinoin|mesh-list
24777067|NCT01861626|Dermatologic Agents|dermatologic agents|mesh-ancestor
24777068|NCT01861912|Arsenic Trioxide|arsenic trioxide|mesh-list
24777069|NCT01861912|Ethiodized Oil|ethiodized oil|mesh-list
24777070|NCT01861912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25192159|NCT02778425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25192160|NCT02778425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192161|NCT02778425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192162|NCT02778425|Hormones|hormones|mesh-ancestor
25192163|NCT02778425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25192164|NCT02778360|Methylphenidate|methylphenidate|mesh-list
25192165|NCT02778360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25192166|NCT02778360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192167|NCT02778360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25192168|NCT02778360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25192169|NCT02778360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25192170|NCT02778360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192171|NCT02778360|Dopamine Agents|dopamine agents|mesh-ancestor
25192172|NCT02778360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25192173|NCT02778308|Gemcitabine|gemcitabine|mesh-list
25192174|NCT02778308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25192175|NCT02778308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25192176|NCT02778308|Antimetabolites|antimetabolites|mesh-ancestor
25192177|NCT02778308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192184|NCT02778178|Clonidine|clonidine|mesh-list
25192185|NCT02778178|Ropivacaine|ropivacaine|mesh-list
25192186|NCT02778178|Anesthetics, Local|anesthetics, local|mesh-ancestor
25192187|NCT02778178|Anesthetics|anesthetics|mesh-ancestor
25192188|NCT02778178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25192189|NCT02778178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192190|NCT02778178|Sensory System Agents|sensory system agents|mesh-ancestor
25192191|NCT02778178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25192192|NCT02778178|Analgesics|analgesics|mesh-ancestor
25192193|NCT02778178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25192194|NCT02778178|Sympatholytics|sympatholytics|mesh-ancestor
25192195|NCT02778178|Autonomic Agents|autonomic agents|mesh-ancestor
25192196|NCT02778178|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25192197|NCT02778178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25192198|NCT02778178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25192199|NCT02778178|Adrenergic Agents|adrenergic agents|mesh-ancestor
25192200|NCT02778178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25192201|NCT02778178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192202|NCT02778191|Carboplatin|carboplatin|mesh-list
25192203|NCT02778191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25192204|NCT02777814|Entecavir|entecavir|mesh-list
25192205|NCT02777814|Antiviral Agents|antiviral agents|mesh-ancestor
24824865|NCT02125682|Atorvastatin|atorvastatin|mesh-list
25192206|NCT02777814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24428841|NCT00241254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24428843|NCT00241332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24428844|NCT00241332|Narcotics|narcotics|mesh-ancestor
24428845|NCT00241332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24428846|NCT00241332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428847|NCT00241332|Analgesics|analgesics|mesh-ancestor
24428848|NCT00241332|Sensory System Agents|sensory system agents|mesh-ancestor
24428849|NCT00241332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24428904|NCT00241488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24428905|NCT00241488|Antimetabolites|antimetabolites|mesh-ancestor
24428906|NCT00241488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428923|NCT00241527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24428924|NCT00241527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25860577|NCT00083980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428925|NCT00241527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25666622|NCT01697579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666623|NCT01697579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25666624|NCT01697579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25666625|NCT01697579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25666626|NCT01697579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25666627|NCT01697579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25666628|NCT01697579|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24777117|NCT01862081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428926|NCT00241527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428927|NCT00241527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192207|NCT02777866|Bupivacaine|bupivacaine|mesh-list
25192208|NCT02777866|Anesthetics, Local|anesthetics, local|mesh-ancestor
25192209|NCT02777866|Anesthetics|anesthetics|mesh-ancestor
25192210|NCT02777866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25192211|NCT02777866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192212|NCT02777866|Sensory System Agents|sensory system agents|mesh-ancestor
25192213|NCT02777866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25192214|NCT02777801|Entecavir|entecavir|mesh-list
25192215|NCT02777801|Antiviral Agents|antiviral agents|mesh-ancestor
25192216|NCT02777801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25192217|NCT02777788|Gemcitabine|gemcitabine|mesh-list
25192218|NCT02777788|Paclitaxel|paclitaxel|mesh-list
25192219|NCT02777788|Vinorelbine|vinorelbine|mesh-list
25192220|NCT02777788|Docetaxel|docetaxel|mesh-list
25192221|NCT02777788|Carboplatin|carboplatin|mesh-list
25192222|NCT02777788|Pemetrexed|pemetrexed|mesh-list
25192223|NCT02777788|Cisplatin|cisplatin|mesh-list
25192224|NCT02777788|Nedaplatin|nedaplatin|mesh-list
25192225|NCT02777788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25192226|NCT02777788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25192227|NCT02777788|Tubulin Modulators|tubulin modulators|mesh-ancestor
25192228|NCT02777788|Antimitotic Agents|antimitotic agents|mesh-ancestor
25192229|NCT02777788|Mitosis Modulators|mitosis modulators|mesh-ancestor
25192230|NCT02777788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192231|NCT02777788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25192232|NCT02777788|Antimetabolites|antimetabolites|mesh-ancestor
25192233|NCT02777788|Antiviral Agents|antiviral agents|mesh-ancestor
25192234|NCT02777788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25192235|NCT02777788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25192236|NCT02777788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25192237|NCT02777788|Immunologic Factors|immunologic factors|mesh-ancestor
25192238|NCT02777788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192239|NCT02777788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25192240|NCT02777788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25192241|NCT02777736|Methotrexate|methotrexate|mesh-list
25192242|NCT02777736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25192243|NCT02777736|Abortifacient Agents|abortifacient agents|mesh-ancestor
25192244|NCT02777736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25192245|NCT02777736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192246|NCT02777736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25192247|NCT02777736|Antimetabolites|antimetabolites|mesh-ancestor
25192248|NCT02777736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192249|NCT02777736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25192250|NCT02777736|Dermatologic Agents|dermatologic agents|mesh-ancestor
25192251|NCT02777736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25192252|NCT02777736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24556479|NCT00747968|Exenatide|exenatide|mesh-list
25192253|NCT02777736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25192254|NCT02777736|Immunologic Factors|immunologic factors|mesh-ancestor
25192255|NCT02777736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25192256|NCT02777736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25192271|NCT02777489|Protease Inhibitors|protease inhibitors|mesh-ancestor
25192272|NCT02777489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25192273|NCT02777489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192274|NCT02777489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25192287|NCT02777671|Gliclazide|gliclazide|mesh-list
25192288|NCT02777671|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25192289|NCT02777671|Anticonvulsants|anticonvulsants|mesh-ancestor
25192290|NCT02777671|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25192291|NCT02777671|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25192292|NCT02777671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25192293|NCT02777671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192294|NCT02777671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25192295|NCT02777671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192296|NCT02777619|Dexmedetomidine|dexmedetomidine|mesh-list
25192297|NCT02777619|Propofol|propofol|mesh-list
25192298|NCT02777619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25192299|NCT02777619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25192300|NCT02777619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192301|NCT02777619|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25192302|NCT02777619|Anesthetics, General|anesthetics, general|mesh-ancestor
25666629|NCT01697579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25666630|NCT01697696|Glycopyrrolate|glycopyrrolate|mesh-list
25192303|NCT02777619|Anesthetics|anesthetics|mesh-ancestor
25192304|NCT02777619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25192305|NCT02777619|Analgesics|analgesics|mesh-ancestor
25192306|NCT02777619|Sensory System Agents|sensory system agents|mesh-ancestor
25192307|NCT02777619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25192308|NCT02777619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25192309|NCT02777619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25192310|NCT02777619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25192311|NCT02777619|Adrenergic Agents|adrenergic agents|mesh-ancestor
25192312|NCT02777619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25192313|NCT02777619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192314|NCT02777320|Acetaminophen|acetaminophen|mesh-list
25192315|NCT02777320|Ibuprofen|ibuprofen|mesh-list
25192316|NCT02777320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25192317|NCT02777320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25192318|NCT02777320|Analgesics|analgesics|mesh-ancestor
25192319|NCT02777320|Sensory System Agents|sensory system agents|mesh-ancestor
25192320|NCT02777320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25192321|NCT02777320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192322|NCT02777320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25192323|NCT02777320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25192324|NCT02777320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25192325|NCT02777320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25192326|NCT02777320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192327|NCT02777320|Antipyretics|antipyretics|mesh-ancestor
25192328|NCT02777229|Tenofovir|tenofovir|mesh-list
25192329|NCT02777229|Lamivudine|lamivudine|mesh-list
25192330|NCT02777229|Efavirenz|efavirenz|mesh-list
25192331|NCT02777229|Dolutegravir|dolutegravir|mesh-list
25192335|NCT02777229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25192336|NCT02777229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25192337|NCT02777229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192338|NCT02777229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24556629|NCT00748423|Gasotransmitters|gasotransmitters|mesh-ancestor
25192339|NCT02777229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25192340|NCT02777229|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25192341|NCT02777229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25192342|NCT02777229|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25192343|NCT02777229|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25192344|NCT02777229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25192345|NCT02777229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25192346|NCT02777229|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25192347|NCT02777229|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25192348|NCT02777151|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
25192349|NCT02777151|Atoltivimab|atoltivimab|mesh-list
25192350|NCT02777151|Antiviral Agents|antiviral agents|mesh-ancestor
25192351|NCT02777151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25192352|NCT02777073|Liraglutide|liraglutide|mesh-list
25192353|NCT02777073|Dapagliflozin|dapagliflozin|mesh-list
25192354|NCT02777073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25192355|NCT02777073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192356|NCT02777073|Incretins|incretins|mesh-ancestor
25192357|NCT02777073|Hormones|hormones|mesh-ancestor
25192358|NCT02777073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25192359|NCT02777073|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25192360|NCT02777073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192361|NCT02776956|Atorvastatin|atorvastatin|mesh-list
25192362|NCT02776956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25192363|NCT02776956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25192364|NCT02776956|Antimetabolites|antimetabolites|mesh-ancestor
25192365|NCT02776956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192366|NCT02776956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25192367|NCT02776956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25192368|NCT02776956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25192369|NCT02776943|Hyaluronic Acid|hyaluronic acid|mesh-list
25192370|NCT02776943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25192371|NCT02776943|Immunologic Factors|immunologic factors|mesh-ancestor
25192372|NCT02776943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192373|NCT02776943|Viscosupplements|viscosupplements|mesh-ancestor
25192374|NCT02776943|Protective Agents|protective agents|mesh-ancestor
25192375|NCT02776748|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25192376|NCT02776748|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25192377|NCT02776748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25156963|NCT04877093|Adrenergic Agents|adrenergic agents|mesh-ancestor
24777296|NCT01863355|Anesthetics, General|anesthetics, general|mesh-ancestor
24777297|NCT01863355|Anesthetics|anesthetics|mesh-ancestor
24777298|NCT01863407|Metronidazole|metronidazole|mesh-list
24777299|NCT01863407|Dexamethasone|dexamethasone|mesh-list
25192378|NCT02776748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25192379|NCT02776748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192380|NCT02776748|Antiviral Agents|antiviral agents|mesh-ancestor
25192381|NCT02776748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25192382|NCT02776748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25192383|NCT02776748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25192384|NCT02776891|Citric Acid|citric acid|mesh-list
25192385|NCT02776891|Sodium Citrate|sodium citrate|mesh-list
25192386|NCT02776891|Gallium citrate|gallium citrate|mesh-list
25192387|NCT02776891|Anticoagulants|anticoagulants|mesh-ancestor
25192388|NCT02776891|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25192389|NCT02776891|Chelating Agents|chelating agents|mesh-ancestor
25192390|NCT02776891|Sequestering Agents|sequestering agents|mesh-ancestor
25192391|NCT02776891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192392|NCT02776891|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25192393|NCT02776722|Tagatose|tagatose|mesh-list
25192394|NCT02776722|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25192395|NCT02776722|Chelating Agents|chelating agents|mesh-ancestor
25192396|NCT02776722|Sequestering Agents|sequestering agents|mesh-ancestor
25192397|NCT02776722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192398|NCT02776813|Rituximab|rituximab|mesh-list
25192399|NCT02776813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25192400|NCT02776813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25192402|NCT02776813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429158|NCT00242814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25192403|NCT02776813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25192404|NCT02776761|Vaccines|vaccines|mesh-list
25192405|NCT02776761|Immunologic Factors|immunologic factors|mesh-ancestor
25192406|NCT02776761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192407|NCT02776878|Dasatinib|dasatinib|mesh-list
25192408|NCT02776878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25192409|NCT02776878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25192410|NCT02776878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25192411|NCT02776878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192412|NCT02776865|Lidocaine|lidocaine|mesh-list
25192413|NCT02776865|Anesthetics, Local|anesthetics, local|mesh-ancestor
25192414|NCT02776865|Anesthetics|anesthetics|mesh-ancestor
25192415|NCT02776865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25192416|NCT02776865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192417|NCT02776865|Sensory System Agents|sensory system agents|mesh-ancestor
25192418|NCT02776865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25192419|NCT02776865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25192420|NCT02776865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25192421|NCT02776865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25192422|NCT02776865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25192423|NCT02776865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192424|NCT02776540|Aspirin|aspirin|mesh-list
25192425|NCT02776540|Clopidogrel|clopidogrel|mesh-list
25192426|NCT02776540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25192427|NCT02776540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25192428|NCT02776540|Analgesics|analgesics|mesh-ancestor
25192429|NCT02776540|Sensory System Agents|sensory system agents|mesh-ancestor
24948050|NCT03923218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24948051|NCT03923218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25192430|NCT02776540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25192431|NCT02776540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192432|NCT02776540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25192433|NCT02776540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25192434|NCT02776540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25192435|NCT02776540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25192436|NCT02776540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192437|NCT02776540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25192438|NCT02776540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25192439|NCT02776540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25192440|NCT02776540|Antipyretics|antipyretics|mesh-ancestor
25192441|NCT02776540|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25666631|NCT01697696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25666632|NCT01697696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25666633|NCT01697696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25666634|NCT01697696|Cholinergic Agents|cholinergic agents|mesh-ancestor
24777364|NCT01863641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777366|NCT01863641|Vitamins|vitamins|mesh-ancestor
24777391|NCT01863810|Pregabalin|pregabalin|mesh-list
25192442|NCT02776540|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25192443|NCT02776540|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25192444|NCT02776540|Purinergic Agents|purinergic agents|mesh-ancestor
25192445|NCT02776540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25192446|NCT02776527|Apatinib|apatinib|mesh-list
25192447|NCT02776527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25192448|NCT02776527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25192449|NCT02776527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25192450|NCT02776527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192451|NCT02776163|Docetaxel|docetaxel|mesh-list
25192452|NCT02776163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556831|NCT00749853|Buserelin|buserelin|mesh-list
24556832|NCT00749853|Hormones|hormones|mesh-list
25192453|NCT02776163|Tubulin Modulators|tubulin modulators|mesh-ancestor
25192454|NCT02776163|Antimitotic Agents|antimitotic agents|mesh-ancestor
25192455|NCT02776163|Mitosis Modulators|mitosis modulators|mesh-ancestor
25192456|NCT02776163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192457|NCT02776202|Mycophenolic Acid|mycophenolic acid|mesh-list
24560533|NCT02369458|Mitomycins|mitomycins|mesh-list
24560534|NCT02369458|Mitomycin|mitomycin|mesh-list
24560535|NCT02369458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24560536|NCT02369458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24560537|NCT02369458|Alkylating Agents|alkylating agents|mesh-ancestor
25192458|NCT02776202|Sirolimus|sirolimus|mesh-list
25192459|NCT02776202|Fludarabine|fludarabine|mesh-list
25192460|NCT02776202|Fludarabine phosphate|fludarabine phosphate|mesh-list
25192461|NCT02776202|Melphalan|melphalan|mesh-list
25192462|NCT02776202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25192463|NCT02776202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25192464|NCT02776202|Antimetabolites|antimetabolites|mesh-ancestor
24429403|NCT00243815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24429405|NCT00243815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24429406|NCT00243815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429407|NCT00243815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429408|NCT00243854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24429409|NCT00243854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429410|NCT00243854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24429411|NCT00243854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429413|NCT00243880|Lovastatin|lovastatin|mesh-list
25192475|NCT02776202|Antifungal Agents|antifungal agents|mesh-ancestor
25192476|NCT02776202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25192477|NCT02776202|Alkylating Agents|alkylating agents|mesh-ancestor
25192478|NCT02776202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25192479|NCT02776189|Midazolam|midazolam|mesh-list
25192480|NCT02776189|Dexmedetomidine|dexmedetomidine|mesh-list
25192481|NCT02776189|Propofol|propofol|mesh-list
25192482|NCT02776189|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25192483|NCT02776189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25192484|NCT02776189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192485|NCT02776189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25192486|NCT02776189|Anesthetics, General|anesthetics, general|mesh-ancestor
25192487|NCT02776189|Anesthetics|anesthetics|mesh-ancestor
25192488|NCT02776189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25192489|NCT02776189|Analgesics|analgesics|mesh-ancestor
25192490|NCT02776189|Sensory System Agents|sensory system agents|mesh-ancestor
25192491|NCT02776189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25192492|NCT02776189|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25192493|NCT02776189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25192494|NCT02776189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25192495|NCT02776189|Adrenergic Agents|adrenergic agents|mesh-ancestor
25192496|NCT02776189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25192497|NCT02776189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192498|NCT02776189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25192499|NCT02776189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25192500|NCT02776189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25192501|NCT02776189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25192502|NCT02776189|GABA Modulators|gaba modulators|mesh-ancestor
25192503|NCT02776189|GABA Agents|gaba agents|mesh-ancestor
25192504|NCT02776137|Docetaxel|docetaxel|mesh-list
25666635|NCT01697696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25666636|NCT01697696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192505|NCT02776137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25192506|NCT02776137|Tubulin Modulators|tubulin modulators|mesh-ancestor
25192507|NCT02776137|Antimitotic Agents|antimitotic agents|mesh-ancestor
25666637|NCT01697696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777507|NCT01864551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24777508|NCT01864551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24777509|NCT01864551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24777543|NCT01864863|Bosentan|bosentan|mesh-list
24777544|NCT01864863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24777545|NCT01864863|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24777546|NCT01864863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777547|NCT01864915|Prucalopride|prucalopride|mesh-list
24777548|NCT01864915|Laxatives|laxatives|mesh-ancestor
24832626|NCT02171780|Olodaterol|olodaterol|mesh-list
24777549|NCT01864915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24777550|NCT01864915|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24777551|NCT01864915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24777552|NCT01864915|Serotonin Agents|serotonin agents|mesh-ancestor
24777553|NCT01864915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24569053|NCT00798876|Vitamin E|vitamin e|mesh-list
25192508|NCT02776137|Mitosis Modulators|mitosis modulators|mesh-ancestor
25192509|NCT02776137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206667|NCT05344248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206671|NCT05344027|Mitotane|mitotane|mesh-list
25206672|NCT05344027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25206673|NCT05344027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208200|NCT02874430|Metformin|metformin|mesh-list
25208201|NCT02874430|Doxycycline|doxycycline|mesh-list
25208202|NCT02874430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25208203|NCT02874430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208204|NCT02874430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25208205|NCT02874430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25208206|NCT02874430|Antimalarials|antimalarials|mesh-ancestor
25208207|NCT02874430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25208208|NCT02874430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25208209|NCT02855944|Gemcitabine|gemcitabine|mesh-list
25192510|NCT02776228|Brotizolam|brotizolam|mesh-list
25192511|NCT02776228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25192512|NCT02776228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25192513|NCT02776228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192514|NCT02776436|Dexamethasone|dexamethasone|mesh-list
25192515|NCT02776436|Prednisone|prednisone|mesh-list
25192516|NCT02776436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25192517|NCT02776436|Antiemetics|antiemetics|mesh-ancestor
25192518|NCT02776436|Autonomic Agents|autonomic agents|mesh-ancestor
25192519|NCT02776436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25192520|NCT02776436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192521|NCT02776436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25192522|NCT02776436|Glucocorticoids|glucocorticoids|mesh-ancestor
25192523|NCT02776436|Hormones|hormones|mesh-ancestor
25192524|NCT02776436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25192525|NCT02776436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25192526|NCT02776436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25192527|NCT02775773|Tranexamic Acid|tranexamic acid|mesh-list
25192528|NCT02775773|Oxytocin|oxytocin|mesh-list
25192529|NCT02775773|Oxytocics|oxytocics|mesh-ancestor
25192530|NCT02775773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25192531|NCT02775773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192532|NCT02775773|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25192533|NCT02775773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25192534|NCT02775773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192535|NCT02775773|Hemostatics|hemostatics|mesh-ancestor
24556966|NCT00750581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24556967|NCT00750581|Analgesics|analgesics|mesh-ancestor
25192536|NCT02775773|Coagulants|coagulants|mesh-ancestor
25192537|NCT02775968|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25666638|NCT01697709|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25666639|NCT01697709|Antidepressive Agents|antidepressive agents|mesh-ancestor
25666640|NCT01697709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25666641|NCT01697709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25666642|NCT01697709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25666643|NCT01697709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25666644|NCT01697709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666645|NCT01697956|Beclomethasone|beclomethasone|mesh-list
25666646|NCT01697956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25666647|NCT01697956|Glucocorticoids|glucocorticoids|mesh-ancestor
25666648|NCT01697956|Hormones|hormones|mesh-ancestor
25666649|NCT01697956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25666650|NCT01697956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666651|NCT01697956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25666652|NCT01697956|Respiratory System Agents|respiratory system agents|mesh-ancestor
25666653|NCT01697969|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
24627535|NCT01093235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24627536|NCT01093235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24627537|NCT01093235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24627538|NCT01093235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25081616|NCT03328364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081617|NCT03328312|Atropine|atropine|mesh-list
25081618|NCT03328312|Neostigmine|neostigmine|mesh-list
25081619|NCT03328312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25081620|NCT03328312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25081621|NCT03328312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25081622|NCT03328312|Autonomic Agents|autonomic agents|mesh-ancestor
25081623|NCT03328312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25081624|NCT03328312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081627|NCT03328312|Mydriatics|mydriatics|mesh-ancestor
25081628|NCT03328312|Parasympatholytics|parasympatholytics|mesh-ancestor
25192538|NCT02775968|Azithromycin|azithromycin|mesh-list
25192539|NCT02775968|Ceftriaxone|ceftriaxone|mesh-list
25192540|NCT02775968|Erythromycin|erythromycin|mesh-list
25192541|NCT02775968|Cephalosporins|cephalosporins|mesh-list
25192542|NCT02775968|Cefamandole|cefamandole|mesh-list
25192543|NCT02775968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25192544|NCT02775968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25192545|NCT02775968|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25192546|NCT02775968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25192547|NCT02775968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192548|NCT02776059|Prednisolone|prednisolone|mesh-list
25192549|NCT02776059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25192550|NCT02776059|Glucocorticoids|glucocorticoids|mesh-ancestor
25192551|NCT02776059|Hormones|hormones|mesh-ancestor
25192552|NCT02776059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25192553|NCT02776059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192554|NCT02776059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25192555|NCT02776059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25192556|NCT02775734|Acetylcysteine|acetylcysteine|mesh-list
25192557|NCT02775734|Clomiphene|clomiphene|mesh-list
25192558|NCT02775734|Enclomiphene|enclomiphene|mesh-list
25192559|NCT02775734|Zuclomiphene|zuclomiphene|mesh-list
25192560|NCT02775734|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25192561|NCT02775734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192562|NCT02775734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25192563|NCT02775734|Hormone Antagonists|hormone antagonists|mesh-ancestor
25192564|NCT02775734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25192565|NCT02775734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192566|NCT02775734|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25192567|NCT02775734|Fertility Agents|fertility agents|mesh-ancestor
25192568|NCT02775734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25192569|NCT02775734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25192570|NCT02775734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25192571|NCT02775734|Antiviral Agents|antiviral agents|mesh-ancestor
25192572|NCT02775734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25192573|NCT02775734|Expectorants|expectorants|mesh-ancestor
25192574|NCT02775734|Respiratory System Agents|respiratory system agents|mesh-ancestor
25192575|NCT02775734|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25192583|NCT02776397|Micronutrients|micronutrients|mesh-ancestor
25192584|NCT02776397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192585|NCT02776397|Antioxidants|antioxidants|mesh-ancestor
25192586|NCT02776397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192587|NCT02776397|Protective Agents|protective agents|mesh-ancestor
25192595|NCT02775877|Clomiphene|clomiphene|mesh-list
25666654|NCT01697969|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25666655|NCT01697969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25666656|NCT01697969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25666657|NCT01697969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25666658|NCT01697969|Analgesics|analgesics|mesh-ancestor
25666659|NCT01697969|Sensory System Agents|sensory system agents|mesh-ancestor
25666660|NCT01697969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25666661|NCT01697969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666662|NCT01697969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25666663|NCT01697969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25666664|NCT01697969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25666665|NCT01697969|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25666666|NCT01697969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25666667|NCT01697969|Histamine Antagonists|histamine antagonists|mesh-ancestor
25192596|NCT02775877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24777669|NCT01865630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24777670|NCT01865630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25192597|NCT02775877|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25192598|NCT02775877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25192599|NCT02775877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25192600|NCT02775877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192601|NCT02775877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25192602|NCT02775877|Hormone Antagonists|hormone antagonists|mesh-ancestor
25192603|NCT02775877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25192604|NCT02775877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192605|NCT02775877|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25192606|NCT02775877|Fertility Agents|fertility agents|mesh-ancestor
25192607|NCT02775877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25192608|NCT02775877|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25192609|NCT02775877|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25192611|NCT02775474|Methadone|methadone|mesh-list
25192612|NCT02775474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25192613|NCT02775474|Narcotics|narcotics|mesh-ancestor
25192614|NCT02775474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25192615|NCT02775474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192616|NCT02775474|Analgesics|analgesics|mesh-ancestor
25192617|NCT02775474|Sensory System Agents|sensory system agents|mesh-ancestor
25192618|NCT02775474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25192619|NCT02775474|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25192620|NCT02775474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25192621|NCT02775474|Anesthetics, General|anesthetics, general|mesh-ancestor
25192622|NCT02775474|Anesthetics|anesthetics|mesh-ancestor
25192623|NCT02775474|Antitussive Agents|antitussive agents|mesh-ancestor
25192624|NCT02775474|Respiratory System Agents|respiratory system agents|mesh-ancestor
25192625|NCT02775539|Mirabegron|mirabegron|mesh-list
25192626|NCT02775539|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25192627|NCT02775539|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25192628|NCT02775539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25192629|NCT02775539|Adrenergic Agents|adrenergic agents|mesh-ancestor
25192630|NCT02775539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25192631|NCT02775539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192632|NCT02775539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192633|NCT02775539|Urological Agents|urological agents|mesh-ancestor
25192634|NCT02775500|Apremilast|apremilast|mesh-list
25192635|NCT02775500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25192636|NCT02775500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25192637|NCT02775500|Analgesics|analgesics|mesh-ancestor
25192638|NCT02775500|Sensory System Agents|sensory system agents|mesh-ancestor
25192639|NCT02775500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25192640|NCT02775500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192641|NCT02775500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25192642|NCT02775500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25192643|NCT02775500|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25192644|NCT02775500|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25192645|NCT02775500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25192646|NCT02775500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192647|NCT02775318|Bupivacaine|bupivacaine|mesh-list
25192648|NCT02775318|Anesthetics, Local|anesthetics, local|mesh-ancestor
25192649|NCT02775318|Anesthetics|anesthetics|mesh-ancestor
25192650|NCT02775318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25192651|NCT02775318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192652|NCT02775318|Sensory System Agents|sensory system agents|mesh-ancestor
25192653|NCT02775318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25192654|NCT02775292|Aldesleukin|aldesleukin|mesh-list
25192655|NCT02775292|Cyclophosphamide|cyclophosphamide|mesh-list
25192656|NCT02775292|Nivolumab|nivolumab|mesh-list
25192657|NCT02775292|Fludarabine|fludarabine|mesh-list
25192658|NCT02775292|Fludarabine phosphate|fludarabine phosphate|mesh-list
25192659|NCT02775292|Interleukin-2|interleukin-2|mesh-list
25192660|NCT02775292|Vaccines|vaccines|mesh-list
25192661|NCT02775292|Immunologic Factors|immunologic factors|mesh-ancestor
25192662|NCT02775292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192663|NCT02775292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25192664|NCT02775292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24557189|NCT00751738|Azimilide|azimilide|mesh-list
24557226|NCT00751829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24557227|NCT00751829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25666668|NCT01697969|Histamine Agents|histamine agents|mesh-ancestor
25666669|NCT01697969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24569271|NCT00799838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24569272|NCT00799838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24777750|NCT01866397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24557228|NCT00751829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25192665|NCT02775292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25192666|NCT02775292|Alkylating Agents|alkylating agents|mesh-ancestor
25192667|NCT02775292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192668|NCT02775292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25192669|NCT02775292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25192670|NCT02775292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25192671|NCT02775292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25192672|NCT02775292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25192673|NCT02775292|Antimetabolites|antimetabolites|mesh-ancestor
25192674|NCT02775292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25192676|NCT02775292|Sensory System Agents|sensory system agents|mesh-ancestor
25192677|NCT02775292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25192678|NCT02775292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25192679|NCT02775292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25192680|NCT02775292|Antiviral Agents|antiviral agents|mesh-ancestor
25192681|NCT02775292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25192682|NCT02775370|Apatinib|apatinib|mesh-list
25192683|NCT02775370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25192684|NCT02775370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25192685|NCT02775370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25192686|NCT02775370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192687|NCT02775227|Hydrocortisone|hydrocortisone|mesh-list
25192688|NCT02775227|Pasireotide|pasireotide|mesh-list
25192689|NCT02775227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25192690|NCT02775227|Hormones|hormones|mesh-ancestor
25192691|NCT02775227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25192692|NCT02775227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192693|NCT02775110|Natalizumab|natalizumab|mesh-list
25192694|NCT02775110|Immunologic Factors|immunologic factors|mesh-ancestor
24948071|NCT03923075|Dexmedetomidine|dexmedetomidine|mesh-list
24557243|NCT00751959|Respiratory System Agents|respiratory system agents|mesh-ancestor
25192695|NCT02775110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557244|NCT00752011|Carboplatin|carboplatin|mesh-list
24557245|NCT00752011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25192696|NCT02775266|Thioctic Acid|thioctic acid|mesh-list
25192697|NCT02775266|Antioxidants|antioxidants|mesh-ancestor
25192698|NCT02775266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192699|NCT02775266|Protective Agents|protective agents|mesh-ancestor
25192700|NCT02775266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192701|NCT02775266|Vitamin B Complex|vitamin b complex|mesh-ancestor
25192702|NCT02775266|Vitamins|vitamins|mesh-ancestor
25192703|NCT02775266|Micronutrients|micronutrients|mesh-ancestor
25192704|NCT02774993|Doxycycline|doxycycline|mesh-list
25192705|NCT02774993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25192706|NCT02774993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25192707|NCT02774993|Antimalarials|antimalarials|mesh-ancestor
25192708|NCT02774993|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25192709|NCT02774993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25192710|NCT02775006|Docetaxel|docetaxel|mesh-list
25192711|NCT02775006|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25192712|NCT02775006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25192713|NCT02775006|Tubulin Modulators|tubulin modulators|mesh-ancestor
25192714|NCT02775006|Antimitotic Agents|antimitotic agents|mesh-ancestor
25192715|NCT02775006|Mitosis Modulators|mitosis modulators|mesh-ancestor
25192716|NCT02775006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192717|NCT02775006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25192718|NCT02775006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25192719|NCT02774902|Clarithromycin|clarithromycin|mesh-list
25192720|NCT02774902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25192721|NCT02774902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25192722|NCT02774902|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25192723|NCT02774902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25192724|NCT02774902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192725|NCT02774902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25192726|NCT02774902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25192727|NCT02774837|Tenofovir|tenofovir|mesh-list
25192728|NCT02774837|Telbivudine|telbivudine|mesh-list
25192729|NCT02774837|Antiviral Agents|antiviral agents|mesh-ancestor
25666670|NCT01697969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666671|NCT01698320|Albuterol|albuterol|mesh-list
25666672|NCT01698320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25192730|NCT02774837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24777866|NCT01867593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269490|NCT02410083|Analgesics|analgesics|mesh-ancestor
25192731|NCT02774837|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25192732|NCT02774837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25192733|NCT02774837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25192734|NCT02774837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192735|NCT02774837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25192736|NCT02774837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25192737|NCT02774876|Insulin|insulin|mesh-list
24825044|NCT02127034|Adrenergic Agents|adrenergic agents|mesh-ancestor
25192738|NCT02774876|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25192739|NCT02774876|Hormones|hormones|mesh-list
25192740|NCT02774876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25192741|NCT02774876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192742|NCT02774876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25192743|NCT02774811|Bimatoprost|bimatoprost|mesh-list
25192744|NCT02774811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25192745|NCT02774564|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25192746|NCT02774564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25192747|NCT02774564|Immunologic Factors|immunologic factors|mesh-ancestor
25192748|NCT02774564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557298|NCT00752141|Urological Agents|urological agents|mesh-ancestor
25192749|NCT02774564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25192750|NCT02774564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25192751|NCT02774564|Dopamine Agonists|dopamine agonists|mesh-ancestor
25192752|NCT02774564|Dopamine Agents|dopamine agents|mesh-ancestor
25192753|NCT02774564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25192754|NCT02774564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192755|NCT02774382|Vancomycin|vancomycin|mesh-list
25192756|NCT02774382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25192757|NCT02774382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25206674|NCT05343806|Magnesium Sulfate|magnesium sulfate|mesh-list
25206675|NCT05343806|Nifedipine|nifedipine|mesh-list
25206676|NCT05343806|Analgesics|analgesics|mesh-ancestor
25206677|NCT05343806|Sensory System Agents|sensory system agents|mesh-ancestor
25206678|NCT05343806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25206679|NCT05343806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206680|NCT05343806|Anesthetics|anesthetics|mesh-ancestor
25206681|NCT05343806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25206682|NCT05343806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25206683|NCT05343806|Anticonvulsants|anticonvulsants|mesh-ancestor
25206684|NCT05343806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25206685|NCT05343806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25206686|NCT05343806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206687|NCT05343806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25206688|NCT05343806|Tocolytic Agents|tocolytic agents|mesh-ancestor
25206689|NCT05343806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25206690|NCT05343806|Vasodilator Agents|vasodilator agents|mesh-ancestor
25206691|NCT05343728|Hemostatics|hemostatics|mesh-list
25206692|NCT05343728|Coagulants|coagulants|mesh-ancestor
25206693|NCT05343702|Rocuronium|rocuronium|mesh-list
25206694|NCT05343702|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25206695|NCT05343702|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25206696|NCT05343702|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25206697|NCT05343702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25206698|NCT05343702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206699|NCT05343637|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
25206700|NCT05343637|Vasodilator Agents|vasodilator agents|mesh-ancestor
25206701|NCT05343637|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25206702|NCT05343637|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25206703|NCT05343637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25206704|NCT05343637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206705|NCT05343637|Urological Agents|urological agents|mesh-ancestor
25206707|NCT05343546|Levonorgestrel|levonorgestrel|mesh-list
25206708|NCT05343546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25206709|NCT05343546|Contraceptive Agents|contraceptive agents|mesh-ancestor
25206710|NCT05343546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25192819|NCT02774291|Cyclophosphamide|cyclophosphamide|mesh-list
25206711|NCT05343546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206712|NCT05343546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25206713|NCT05343546|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25206714|NCT05343546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25206715|NCT05343546|Trace Elements|trace elements|mesh-ancestor
25666673|NCT01698320|Autonomic Agents|autonomic agents|mesh-ancestor
24777980|NCT01868438|Artesunate|artesunate|mesh-list
25206716|NCT05343546|Micronutrients|micronutrients|mesh-ancestor
25206717|NCT05343507|Ketamine|ketamine|mesh-list
25206718|NCT05343507|Analgesics|analgesics|mesh-ancestor
25206719|NCT05343507|Sensory System Agents|sensory system agents|mesh-ancestor
25206720|NCT05343507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25206721|NCT05343507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206722|NCT05343507|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25206723|NCT05343507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25206724|NCT05343507|Anesthetics, General|anesthetics, general|mesh-ancestor
25206725|NCT05343507|Anesthetics|anesthetics|mesh-ancestor
24430436|NCT00247702|Warfarin|warfarin|mesh-list
25208210|NCT02855944|Paclitaxel|paclitaxel|mesh-list
25192759|NCT02774460|Candesartan|candesartan|mesh-list
25192760|NCT02774460|Candesartan cilexetil|candesartan cilexetil|mesh-list
25192761|NCT02774460|Lisinopril|lisinopril|mesh-list
25192762|NCT02774460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25192763|NCT02774460|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25192764|NCT02774460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25192765|NCT02774460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192766|NCT02774460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25192767|NCT02774460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192768|NCT02774460|Vasodilator Agents|vasodilator agents|mesh-ancestor
25192769|NCT02774460|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25192770|NCT02774460|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25192771|NCT02774460|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25192772|NCT02774460|Protease Inhibitors|protease inhibitors|mesh-ancestor
25192773|NCT02774460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25192774|NCT02774460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25192775|NCT02774460|Protective Agents|protective agents|mesh-ancestor
25192776|NCT02774499|Methadone|methadone|mesh-list
25192777|NCT02774499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25192778|NCT02774499|Narcotics|narcotics|mesh-ancestor
25192779|NCT02774499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25192780|NCT02774499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192783|NCT02774499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25192784|NCT02774499|Antitussive Agents|antitussive agents|mesh-ancestor
25192785|NCT02774499|Respiratory System Agents|respiratory system agents|mesh-ancestor
25192786|NCT02774525|Ethanol|ethanol|mesh-list
25192787|NCT02774525|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25192788|NCT02774525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25192789|NCT02774525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25192790|NCT02774525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192791|NCT02774200|Apatinib|apatinib|mesh-list
25192792|NCT02774200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25192793|NCT02774200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25192794|NCT02774200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25192795|NCT02774200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192796|NCT02774044|Beractant|beractant|mesh-list
25192797|NCT02774044|Goat lung surfactant extract|goat lung surfactant extract|mesh-list
25192798|NCT02774044|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
25192799|NCT02774044|Respiratory System Agents|respiratory system agents|mesh-ancestor
25192800|NCT02774187|Leucovorin|leucovorin|mesh-list
25192801|NCT02774187|Fluorouracil|fluorouracil|mesh-list
25192802|NCT02774187|Oxaliplatin|oxaliplatin|mesh-list
25192803|NCT02774187|Sorafenib|sorafenib|mesh-list
25192804|NCT02774187|Antimetabolites|antimetabolites|mesh-ancestor
25192805|NCT02774187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192806|NCT02774187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25192807|NCT02774187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25192808|NCT02774187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25192809|NCT02774187|Immunologic Factors|immunologic factors|mesh-ancestor
25192810|NCT02774187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192811|NCT02774187|Antidotes|antidotes|mesh-ancestor
25192812|NCT02774187|Protective Agents|protective agents|mesh-ancestor
25192813|NCT02774187|Vitamin B Complex|vitamin b complex|mesh-ancestor
25192814|NCT02774187|Vitamins|vitamins|mesh-ancestor
25192815|NCT02774187|Micronutrients|micronutrients|mesh-ancestor
25192816|NCT02774187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25192817|NCT02774187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25192818|NCT02774291|Aldesleukin|aldesleukin|mesh-list
25192821|NCT02774291|Fludarabine phosphate|fludarabine phosphate|mesh-list
25192822|NCT02774291|Interleukin-2|interleukin-2|mesh-list
25192823|NCT02774291|Lenograstim|lenograstim|mesh-list
25192824|NCT02774291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25192825|NCT02774291|Immunologic Factors|immunologic factors|mesh-ancestor
25674410|NCT01772134|Fluticasone|fluticasone|mesh-list
25192826|NCT02774291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25156981|NCT04863950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25156982|NCT04863950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25156983|NCT04863950|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25156984|NCT04863950|Antidepressive Agents|antidepressive agents|mesh-ancestor
25156985|NCT04863950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25156986|NCT04863950|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25156987|NCT04863950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25156988|NCT04863950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25156989|NCT04863950|Adrenergic Agents|adrenergic agents|mesh-ancestor
25156990|NCT04863950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25156991|NCT04863950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947516|NCT03927963|Sensory System Agents|sensory system agents|mesh-ancestor
24778069|NCT01868945|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24778070|NCT01868945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24778072|NCT01868984|Heparin|heparin|mesh-list
24778074|NCT01868984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25192827|NCT02774291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25192828|NCT02774291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25192829|NCT02774291|Alkylating Agents|alkylating agents|mesh-ancestor
25192830|NCT02774291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192831|NCT02774291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24802083|NCT01987167|Hormones|hormones|mesh-ancestor
25192832|NCT02774291|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25192833|NCT02774291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24430837|NCT00249405|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24430838|NCT00249405|Antidepressive Agents|antidepressive agents|mesh-ancestor
24430839|NCT00249405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24430841|NCT00249431|Antidepressive Agents|antidepressive agents|mesh-ancestor
24430842|NCT00249431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24430854|NCT00249483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430856|NCT00249483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860578|NCT00083980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430857|NCT00249483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24430858|NCT00249483|Antidepressive Agents|antidepressive agents|mesh-ancestor
24430859|NCT00249483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24430861|NCT00249509|Nefazodone|nefazodone|mesh-list
24430862|NCT00249509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24430863|NCT00249509|Antidepressive Agents|antidepressive agents|mesh-ancestor
24857659|NCT02293330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860579|NCT00083980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860580|NCT00083980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25860581|NCT00083980|Antidepressive Agents|antidepressive agents|mesh-ancestor
25860582|NCT00083980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24451157|NCT00322543|Analgesics|analgesics|mesh-ancestor
24451158|NCT00322543|Sensory System Agents|sensory system agents|mesh-ancestor
24451159|NCT00322543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24451160|NCT00322543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451161|NCT00322543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24451162|NCT00322543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24451163|NCT00322543|Dermatologic Agents|dermatologic agents|mesh-ancestor
24451164|NCT00322543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24451165|NCT00322543|Immunologic Factors|immunologic factors|mesh-ancestor
24444658|NCT00298779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25860583|NCT00083993|Sirolimus|sirolimus|mesh-list
25666674|NCT01698320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25666675|NCT01698320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666676|NCT01698320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25666677|NCT01698320|Respiratory System Agents|respiratory system agents|mesh-ancestor
25666678|NCT01698320|Tocolytic Agents|tocolytic agents|mesh-ancestor
25666679|NCT01698320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25666680|NCT01698320|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25666681|NCT01698320|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25666682|NCT01698320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25666683|NCT01698320|Adrenergic Agents|adrenergic agents|mesh-ancestor
25666684|NCT01698320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25666685|NCT01698320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666686|NCT01698554|Bimatoprost|bimatoprost|mesh-list
25666687|NCT01698554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25666688|NCT01698554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25666689|NCT01698710|Paclitaxel|paclitaxel|mesh-list
25666690|NCT01698710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25860584|NCT00083993|Letrozole|letrozole|mesh-list
24778091|NCT01869023|Gemcitabine|gemcitabine|mesh-list
25860585|NCT00083993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860586|NCT00083993|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25666691|NCT01698710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24487190|NCT00461916|Luteolytic Agents|luteolytic agents|mesh-ancestor
24487191|NCT00461916|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25860587|NCT00083993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24451188|NCT00322569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24451189|NCT00322569|Immunologic Factors|immunologic factors|mesh-ancestor
24451190|NCT00322569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24451191|NCT00322569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451192|NCT00322595|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24536135|NCT00650403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706082|NCT01488526|Tenofovir|tenofovir|mesh-list
25860588|NCT00083993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706439|NCT01490047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706440|NCT01490047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557418|NCT00752479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706441|NCT01490047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25860589|NCT00083993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860590|NCT00083993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25860591|NCT00083993|Hormone Antagonists|hormone antagonists|mesh-ancestor
25192834|NCT02774291|Antimetabolites|antimetabolites|mesh-ancestor
25192835|NCT02774291|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25192836|NCT02774291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25192837|NCT02774291|Analgesics|analgesics|mesh-ancestor
25192838|NCT02774291|Sensory System Agents|sensory system agents|mesh-ancestor
25192839|NCT02774291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25192840|NCT02774291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25192841|NCT02774291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25192842|NCT02774291|Antiviral Agents|antiviral agents|mesh-ancestor
25192843|NCT02774291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25192844|NCT02774096|Xenon|xenon|mesh-list
25192845|NCT02774096|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25192846|NCT02774096|Anesthetics, General|anesthetics, general|mesh-ancestor
25192847|NCT02774096|Anesthetics|anesthetics|mesh-ancestor
25192848|NCT02774096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25192849|NCT02774096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192850|NCT02773979|Chloroquine|chloroquine|mesh-list
25192851|NCT02773979|Amebicides|amebicides|mesh-ancestor
25192852|NCT02773979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25192853|NCT02773979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25192854|NCT02773979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25192855|NCT02773979|Antimalarials|antimalarials|mesh-ancestor
25192856|NCT02773979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25192857|NCT02774005|Idebenone|idebenone|mesh-list
25192858|NCT02774005|Antioxidants|antioxidants|mesh-ancestor
25192859|NCT02774005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192860|NCT02774005|Protective Agents|protective agents|mesh-ancestor
25192861|NCT02774005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192862|NCT02773797|Dexmedetomidine|dexmedetomidine|mesh-list
25192863|NCT02773797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25192864|NCT02773797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24557507|NCT00752843|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25192865|NCT02773797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192866|NCT02773797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25192867|NCT02773797|Analgesics|analgesics|mesh-ancestor
25192868|NCT02773797|Sensory System Agents|sensory system agents|mesh-ancestor
25192869|NCT02773797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25192870|NCT02773797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25192871|NCT02773797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25192872|NCT02773797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25192873|NCT02773797|Adrenergic Agents|adrenergic agents|mesh-ancestor
25192874|NCT02773797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25192875|NCT02773797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192876|NCT02773875|Pancrelipase|pancrelipase|mesh-list
25192877|NCT02773875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25666692|NCT01698710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25666693|NCT01698710|Tubulin Modulators|tubulin modulators|mesh-ancestor
25666694|NCT01698710|Antimitotic Agents|antimitotic agents|mesh-ancestor
25666695|NCT01698710|Mitosis Modulators|mitosis modulators|mesh-ancestor
25666696|NCT01698710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666697|NCT01698775|Glipizide|glipizide|mesh-list
25192878|NCT02773927|Metformin|metformin|mesh-list
24778148|NCT01869556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24778149|NCT01869556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192880|NCT02773927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192881|NCT02773641|Botulinum Toxins|botulinum toxins|mesh-list
25192882|NCT02773641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25192883|NCT02773641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25192884|NCT02773641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25192885|NCT02773641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25192886|NCT02773641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192887|NCT02773641|Cholinergic Agents|cholinergic agents|mesh-ancestor
25192888|NCT02773641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25192889|NCT02773641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192890|NCT02773641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25192891|NCT02773641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25192892|NCT02773602|Dexamethasone|dexamethasone|mesh-list
25192893|NCT02773602|Clonidine|clonidine|mesh-list
25192894|NCT02773602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25192895|NCT02773602|Antiemetics|antiemetics|mesh-ancestor
25192896|NCT02773602|Autonomic Agents|autonomic agents|mesh-ancestor
25192897|NCT02773602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25192898|NCT02773602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192899|NCT02773602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25192900|NCT02773602|Glucocorticoids|glucocorticoids|mesh-ancestor
25192901|NCT02773602|Hormones|hormones|mesh-ancestor
25192902|NCT02773602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25192903|NCT02773602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25192904|NCT02773602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25192905|NCT02773602|Analgesics|analgesics|mesh-ancestor
25192906|NCT02773602|Sensory System Agents|sensory system agents|mesh-ancestor
25192907|NCT02773602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25192908|NCT02773602|Sympatholytics|sympatholytics|mesh-ancestor
25192909|NCT02773602|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25192910|NCT02773602|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25192911|NCT02773602|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25192912|NCT02773602|Adrenergic Agents|adrenergic agents|mesh-ancestor
25192913|NCT02773602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25192914|NCT02773602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192915|NCT02773459|Capecitabine|capecitabine|mesh-list
25192916|NCT02773459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25192917|NCT02773459|Antimetabolites|antimetabolites|mesh-ancestor
25192918|NCT02773459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192919|NCT02773459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25192920|NCT02773316|Morphine|morphine|mesh-list
25192921|NCT02773316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25192922|NCT02773316|Narcotics|narcotics|mesh-ancestor
25192923|NCT02773316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25192924|NCT02773316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192925|NCT02773316|Analgesics|analgesics|mesh-ancestor
25192926|NCT02773316|Sensory System Agents|sensory system agents|mesh-ancestor
25192927|NCT02773316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25192928|NCT02773199|Bupivacaine|bupivacaine|mesh-list
25192929|NCT02773199|Anesthetics, Local|anesthetics, local|mesh-ancestor
25192930|NCT02773199|Anesthetics|anesthetics|mesh-ancestor
25192931|NCT02773199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25192932|NCT02773199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192933|NCT02773199|Sensory System Agents|sensory system agents|mesh-ancestor
25192934|NCT02773199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25192935|NCT02773550|Prednisone|prednisone|mesh-list
25192936|NCT02773550|Bortezomib|bortezomib|mesh-list
25192937|NCT02773550|Melphalan|melphalan|mesh-list
25192938|NCT02773550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25192939|NCT02773550|Glucocorticoids|glucocorticoids|mesh-ancestor
25192940|NCT02773550|Hormones|hormones|mesh-ancestor
25192941|NCT02773550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25192942|NCT02773550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192943|NCT02773550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25192944|NCT02773550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25192945|NCT02773550|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25192946|NCT02773550|Alkylating Agents|alkylating agents|mesh-ancestor
25192947|NCT02773550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192948|NCT02773550|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25192949|NCT02773550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25666698|NCT01698775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25666699|NCT01698775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192950|NCT02773550|Immunologic Factors|immunologic factors|mesh-ancestor
25192951|NCT02773251|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25192952|NCT02773251|Hyaluronic Acid|hyaluronic acid|mesh-list
25192953|NCT02773251|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25192954|NCT02773251|Immunologic Factors|immunologic factors|mesh-ancestor
25192955|NCT02773251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192956|NCT02773251|Viscosupplements|viscosupplements|mesh-ancestor
25192957|NCT02773251|Protective Agents|protective agents|mesh-ancestor
25192959|NCT02773251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25192960|NCT02773407|Azithromycin|azithromycin|mesh-list
25192961|NCT02773407|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25192962|NCT02773407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25192963|NCT02773407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25192964|NCT02773407|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25192965|NCT02773407|Renal Agents|renal agents|mesh-ancestor
25192966|NCT02773407|Antimalarials|antimalarials|mesh-ancestor
25192967|NCT02773407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25192968|NCT02773407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25192969|NCT02773472|Morphine|morphine|mesh-list
25192970|NCT02773472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25192971|NCT02773472|Narcotics|narcotics|mesh-ancestor
25192972|NCT02773472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25192973|NCT02773472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192974|NCT02773472|Analgesics|analgesics|mesh-ancestor
25192975|NCT02773472|Sensory System Agents|sensory system agents|mesh-ancestor
25192976|NCT02773472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25192977|NCT02773355|Liraglutide|liraglutide|mesh-list
25192978|NCT02773355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25192979|NCT02773355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192980|NCT02773355|Incretins|incretins|mesh-ancestor
25192981|NCT02773355|Hormones|hormones|mesh-ancestor
25192982|NCT02773355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25192983|NCT02773095|Lactitol|lactitol|mesh-list
25192984|NCT02773095|Cathartics|cathartics|mesh-ancestor
25192985|NCT02773095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25192986|NCT02772926|Benphothiamine|benphothiamine|mesh-list
25192987|NCT02772926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25192988|NCT02772926|Immunologic Factors|immunologic factors|mesh-ancestor
25192989|NCT02772926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192990|NCT02772926|Chelating Agents|chelating agents|mesh-ancestor
25192991|NCT02772926|Sequestering Agents|sequestering agents|mesh-ancestor
25192992|NCT02772926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25192993|NCT02773017|Dexmedetomidine|dexmedetomidine|mesh-list
25192994|NCT02773017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25192995|NCT02773017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24557565|NCT00752947|Renal Agents|renal agents|mesh-ancestor
25192996|NCT02773017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25192997|NCT02773017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25192998|NCT02773017|Analgesics|analgesics|mesh-ancestor
25192999|NCT02773017|Sensory System Agents|sensory system agents|mesh-ancestor
25193000|NCT02773017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24431145|NCT00250562|Diuretics|diuretics|mesh-ancestor
25193001|NCT02773017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24825128|NCT02127593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24825129|NCT02127593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24607411|NCT04665037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825130|NCT02127593|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24825131|NCT02127593|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24698956|NCT01443806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431414|NCT00251654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24431415|NCT00251654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431416|NCT00251680|Atorvastatin|atorvastatin|mesh-list
25860592|NCT00083993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24431417|NCT00251680|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24431418|NCT00251680|Simvastatin|simvastatin|mesh-list
24431419|NCT00251680|Fenofibrate|fenofibrate|mesh-list
24431420|NCT00251680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24431421|NCT00251680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24431422|NCT00251680|Antimetabolites|antimetabolites|mesh-ancestor
24431423|NCT00251680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431424|NCT00251680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24431425|NCT00251680|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24431426|NCT00251680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706548|NCT01490476|Immunologic Factors|immunologic factors|mesh-ancestor
25157033|NCT04840342|Natriuretic Agents|natriuretic agents|mesh-ancestor
25081725|NCT03327558|Analgesics|analgesics|mesh-ancestor
25081726|NCT03327558|Sensory System Agents|sensory system agents|mesh-ancestor
25081727|NCT03327558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25081728|NCT03327558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081729|NCT03327558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25860593|NCT00083993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860594|NCT00083993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25860595|NCT00083993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25860596|NCT00083993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25860597|NCT00083993|Antifungal Agents|antifungal agents|mesh-ancestor
25860598|NCT00083993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24971770|NCT03722875|Apatinib|apatinib|mesh-list
25860599|NCT00083993|Immunologic Factors|immunologic factors|mesh-ancestor
24857822|NCT02294162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24857823|NCT02294162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540417|NCT00667927|Immunologic Factors|immunologic factors|mesh-ancestor
24540418|NCT00667927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540419|NCT00667927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24707460|NCT01495949|Anesthetics, General|anesthetics, general|mesh-ancestor
25193002|NCT02773017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25193003|NCT02773017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25193004|NCT02773017|Adrenergic Agents|adrenergic agents|mesh-ancestor
25193005|NCT02773017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25193006|NCT02773017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193007|NCT02773147|Pyridoxine|pyridoxine|mesh-list
25193008|NCT02773147|Vitamin B 12|vitamin b 12|mesh-list
25193009|NCT02773147|Hydroxocobalamin|hydroxocobalamin|mesh-list
25193010|NCT02773147|Hematinics|hematinics|mesh-ancestor
25193011|NCT02773147|Vitamin B Complex|vitamin b complex|mesh-ancestor
25193012|NCT02773147|Vitamins|vitamins|mesh-ancestor
25193013|NCT02773147|Micronutrients|micronutrients|mesh-ancestor
25193014|NCT02773147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206726|NCT05343507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25206727|NCT05343507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25206728|NCT05343507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25206729|NCT05343507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25206730|NCT05343507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206731|NCT05343481|Nivolumab|nivolumab|mesh-list
25206732|NCT05343481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25206733|NCT05343481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206734|NCT05343481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25206735|NCT05343481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206736|NCT05343338|Sivelestat|sivelestat|mesh-list
25206737|NCT05343338|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25206738|NCT05343338|Protease Inhibitors|protease inhibitors|mesh-ancestor
25193015|NCT02772822|Rituximab|rituximab|mesh-list
25193016|NCT02772822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25193017|NCT02772822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25193018|NCT02772822|Immunologic Factors|immunologic factors|mesh-ancestor
25193019|NCT02772822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193020|NCT02772822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25193021|NCT02772640|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25193022|NCT02772640|Ezetimibe|ezetimibe|mesh-list
25193023|NCT02772640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25193024|NCT02772640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25193025|NCT02772640|Antimetabolites|antimetabolites|mesh-ancestor
25193026|NCT02772640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193027|NCT02772640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25193028|NCT02772640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25193029|NCT02772640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193030|NCT02772744|Ribavirin|ribavirin|mesh-list
25193031|NCT02772744|Sofosbuvir|sofosbuvir|mesh-list
25193032|NCT02772744|Antimetabolites|antimetabolites|mesh-ancestor
25193033|NCT02772744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193034|NCT02772744|Antiviral Agents|antiviral agents|mesh-ancestor
25193035|NCT02772744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25193036|NCT02772653|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25193037|NCT02772653|Natriuretic Agents|natriuretic agents|mesh-ancestor
25666700|NCT01698801|Dexamethasone|dexamethasone|mesh-list
25666701|NCT01698801|Lenalidomide|lenalidomide|mesh-list
25666702|NCT01698801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25666703|NCT01698801|Antiemetics|antiemetics|mesh-ancestor
25666704|NCT01698801|Autonomic Agents|autonomic agents|mesh-ancestor
25666705|NCT01698801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25674411|NCT01772134|Xhance|xhance|mesh-list
24778344|NCT01870440|Dexamethasone acetate|dexamethasone acetate|mesh-list
24778345|NCT01870440|BB 1101|bb 1101|mesh-list
24778346|NCT01870440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24778347|NCT01870440|Antiemetics|antiemetics|mesh-ancestor
25193038|NCT02772653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193039|NCT02772354|Metoprolol|metoprolol|mesh-list
25193040|NCT02772354|Verapamil|verapamil|mesh-list
25193041|NCT02772354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25193042|NCT02772354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25193043|NCT02772354|Sympatholytics|sympatholytics|mesh-ancestor
25193044|NCT02772354|Autonomic Agents|autonomic agents|mesh-ancestor
25193045|NCT02772354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25193046|NCT02772354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193047|NCT02772354|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25193048|NCT02772354|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25193049|NCT02772354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25193050|NCT02772354|Adrenergic Agents|adrenergic agents|mesh-ancestor
25193051|NCT02772354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25193052|NCT02772354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193053|NCT02772354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25193054|NCT02772354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25193055|NCT02772354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25193056|NCT02772354|Vasodilator Agents|vasodilator agents|mesh-ancestor
25193058|NCT02772419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25193059|NCT02772419|Respiratory System Agents|respiratory system agents|mesh-ancestor
25193060|NCT02772497|Aflibercept|aflibercept|mesh-list
25193061|NCT02772497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25193062|NCT02772497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25193063|NCT02772497|Growth Substances|growth substances|mesh-ancestor
25193064|NCT02772497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193065|NCT02772497|Growth Inhibitors|growth inhibitors|mesh-ancestor
25193066|NCT02772497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25193067|NCT02772601|Metoprolol|metoprolol|mesh-list
25193068|NCT02772601|Midazolam|midazolam|mesh-list
25193069|NCT02772601|Caffeine|caffeine|mesh-list
25193070|NCT02772601|Omeprazole|omeprazole|mesh-list
25193071|NCT02772601|Warfarin|warfarin|mesh-list
25193072|NCT02772601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25193073|NCT02772601|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25193074|NCT02772601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25193075|NCT02772601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193076|NCT02772601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25193077|NCT02772601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25193078|NCT02772601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25193079|NCT02772601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25193080|NCT02772601|Anesthetics, General|anesthetics, general|mesh-ancestor
25193081|NCT02772601|Anesthetics|anesthetics|mesh-ancestor
25193082|NCT02772601|GABA Modulators|gaba modulators|mesh-ancestor
25193083|NCT02772601|GABA Agents|gaba agents|mesh-ancestor
25193084|NCT02772601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25193085|NCT02772601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193086|NCT02772601|Anticoagulants|anticoagulants|mesh-ancestor
25193087|NCT02772601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25193088|NCT02772601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25193089|NCT02772601|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25193090|NCT02772601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25206739|NCT05343338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193091|NCT02772601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25193092|NCT02772601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25193093|NCT02772601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25193094|NCT02772601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25193095|NCT02772601|Purinergic Agents|purinergic agents|mesh-ancestor
25193096|NCT02772601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25193097|NCT02772601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25193098|NCT02772601|Sympatholytics|sympatholytics|mesh-ancestor
25193099|NCT02772601|Autonomic Agents|autonomic agents|mesh-ancestor
25193100|NCT02772601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24557692|NCT00753467|Interferons|interferons|mesh-list
24456931|NCT00332735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25050850|NCT00464555|Sirolimus|sirolimus|mesh-list
24557745|NCT00753779|Simvastatin|simvastatin|mesh-list
25193101|NCT02772601|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25193102|NCT02772601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25193103|NCT02772601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25666706|NCT01698801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666707|NCT01698801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25666708|NCT01698801|Glucocorticoids|glucocorticoids|mesh-ancestor
25666709|NCT01698801|Hormones|hormones|mesh-ancestor
25193104|NCT02772601|Adrenergic Agents|adrenergic agents|mesh-ancestor
24778482|NCT01871363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778483|NCT01871376|Aflibercept|aflibercept|mesh-list
24778484|NCT01871376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24778485|NCT01871376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24778486|NCT01871376|Growth Substances|growth substances|mesh-ancestor
24778487|NCT01871376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778488|NCT01871376|Growth Inhibitors|growth inhibitors|mesh-ancestor
24778489|NCT01871376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24778490|NCT01871454|Pentoxifylline|pentoxifylline|mesh-list
24487243|NCT00462371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487244|NCT00462397|Paclitaxel|paclitaxel|mesh-list
24778491|NCT01871454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24778492|NCT01871454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24778493|NCT01871454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778494|NCT01871454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24778496|NCT01871454|Protective Agents|protective agents|mesh-ancestor
25193105|NCT02772718|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25193106|NCT02772718|Immunologic Factors|immunologic factors|mesh-ancestor
25193107|NCT02772718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193109|NCT02772107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25193110|NCT02772107|Alkylating Agents|alkylating agents|mesh-ancestor
25193111|NCT02772107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193112|NCT02772107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25193113|NCT02772237|Riboflavin|riboflavin|mesh-list
25193114|NCT02772237|Vitamins|vitamins|mesh-ancestor
25193115|NCT02772237|Micronutrients|micronutrients|mesh-ancestor
25193116|NCT02772237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193117|NCT02772237|Vitamin B Complex|vitamin b complex|mesh-ancestor
25193118|NCT02772237|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25193119|NCT02772237|Dermatologic Agents|dermatologic agents|mesh-ancestor
25193120|NCT02772211|Cycloserine|cycloserine|mesh-list
25193121|NCT02772211|Ketamine|ketamine|mesh-list
25193122|NCT02772211|Analgesics|analgesics|mesh-ancestor
25193123|NCT02772211|Sensory System Agents|sensory system agents|mesh-ancestor
25193124|NCT02772211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25193125|NCT02772211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193126|NCT02772211|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25193127|NCT02772211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25193128|NCT02772211|Anesthetics, General|anesthetics, general|mesh-ancestor
25193130|NCT02772211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25193131|NCT02772211|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25193132|NCT02772211|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25193133|NCT02772211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25193134|NCT02772211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193135|NCT02772211|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25193136|NCT02772211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25193137|NCT02772211|Renal Agents|renal agents|mesh-ancestor
25193138|NCT02772211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25193139|NCT02772211|Antitubercular Agents|antitubercular agents|mesh-ancestor
25193140|NCT02772211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25193141|NCT02772211|Antimetabolites|antimetabolites|mesh-ancestor
25193142|NCT02772120|Progesterone|progesterone|mesh-list
25193143|NCT02772120|Progestins|progestins|mesh-ancestor
25193144|NCT02772120|Hormones|hormones|mesh-ancestor
25193145|NCT02772120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25193146|NCT02772120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193147|NCT02772029|Apatinib|apatinib|mesh-list
25666710|NCT01698801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25666711|NCT01698801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25666712|NCT01698801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25666713|NCT01698801|Immunologic Factors|immunologic factors|mesh-ancestor
25666714|NCT01698801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25666715|NCT01698801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24456932|NCT00332761|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
25666716|NCT01698801|Growth Substances|growth substances|mesh-ancestor
25666717|NCT01698801|Growth Inhibitors|growth inhibitors|mesh-ancestor
25674412|NCT01772134|Bromides|bromides|mesh-list
25674413|NCT01772134|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25674414|NCT01772134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25674415|NCT01772134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25674416|NCT01772134|Autonomic Agents|autonomic agents|mesh-ancestor
25674417|NCT01772134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25674418|NCT01772134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674419|NCT01772134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25860600|NCT00084019|Ritonavir|ritonavir|mesh-list
25081748|NCT03327454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081749|NCT03327454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25081750|NCT03327454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25081751|NCT03327454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25081752|NCT03327454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25081762|NCT03327389|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25081764|NCT03327389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25193148|NCT02772029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25193149|NCT02772029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25193150|NCT02772029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193151|NCT02772029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193152|NCT02771925|Gabapentin|gabapentin|mesh-list
25193153|NCT02771925|Analgesics|analgesics|mesh-ancestor
25193154|NCT02771925|Sensory System Agents|sensory system agents|mesh-ancestor
25193155|NCT02771925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25193156|NCT02771925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193157|NCT02771925|Anticonvulsants|anticonvulsants|mesh-ancestor
25193158|NCT02771925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25193159|NCT02771925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25193160|NCT02771925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25193161|NCT02771925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25193162|NCT02771925|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25193163|NCT02771925|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24431723|NCT00252798|Tubulin Modulators|tubulin modulators|mesh-ancestor
25193164|NCT02771925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25193165|NCT02771925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193167|NCT02771860|Denosumab|denosumab|mesh-list
25193168|NCT02771860|Calcium|calcium|mesh-list
25193169|NCT02771860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25193170|NCT02771860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193171|NCT02771860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25193172|NCT02771782|Vaccines|vaccines|mesh-list
25193173|NCT02771782|BCG Vaccine|bcg vaccine|mesh-list
25193174|NCT02771782|Immunologic Factors|immunologic factors|mesh-ancestor
25193175|NCT02771782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193176|NCT02771782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25193177|NCT02771795|Trastuzumab|trastuzumab|mesh-list
25193178|NCT02771795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25193179|NCT02771795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24557788|NCT00753909|Tubulin Modulators|tubulin modulators|mesh-ancestor
24557789|NCT00753909|Antimitotic Agents|antimitotic agents|mesh-ancestor
24557813|NCT00754351|Gemcitabine|gemcitabine|mesh-list
25193180|NCT02771834|Vitamin D|vitamin d|mesh-list
25193181|NCT02771834|Vitamins|vitamins|mesh-ancestor
25193182|NCT02771834|Micronutrients|micronutrients|mesh-ancestor
25193183|NCT02771834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193184|NCT02771834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25193185|NCT02771717|Budesonide|budesonide|mesh-list
25193186|NCT02771717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25193187|NCT02771717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25193188|NCT02771717|Autonomic Agents|autonomic agents|mesh-ancestor
25193189|NCT02771717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25193190|NCT02771717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193191|NCT02771717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25193192|NCT02771717|Respiratory System Agents|respiratory system agents|mesh-ancestor
25193193|NCT02771717|Glucocorticoids|glucocorticoids|mesh-ancestor
25193194|NCT02771717|Hormones|hormones|mesh-ancestor
25193195|NCT02771717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25193196|NCT02771912|Propofol|propofol|mesh-list
25193197|NCT02771912|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25193198|NCT02771912|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25193199|NCT02771912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25193204|NCT02771912|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25193205|NCT02771912|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25193206|NCT02771912|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25193208|NCT02771457|Dermatologic Agents|dermatologic agents|mesh-ancestor
25193209|NCT02771457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25193210|NCT02771457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25666718|NCT01698814|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25666719|NCT01698814|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25666720|NCT01698814|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25666721|NCT01698814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25666722|NCT01698814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25666723|NCT01698814|Analgesics|analgesics|mesh-ancestor
25666724|NCT01698814|Sensory System Agents|sensory system agents|mesh-ancestor
24778572|NCT01871662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24778574|NCT01871675|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24778575|NCT01871675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24778576|NCT01871675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24778577|NCT01871675|Immunologic Factors|immunologic factors|mesh-ancestor
25193211|NCT02771392|Tetracaine|tetracaine|mesh-list
25193212|NCT02771392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25193213|NCT02771392|Anesthetics, Local|anesthetics, local|mesh-ancestor
25193214|NCT02771392|Anesthetics|anesthetics|mesh-ancestor
25193215|NCT02771392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25193216|NCT02771392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193217|NCT02771392|Sensory System Agents|sensory system agents|mesh-ancestor
25193218|NCT02771392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25193219|NCT02771509|Mitogens|mitogens|mesh-list
25193220|NCT02771509|Mitosis Modulators|mitosis modulators|mesh-ancestor
25193221|NCT02771509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193222|NCT02771379|Idebenone|idebenone|mesh-list
25193223|NCT02771379|Antioxidants|antioxidants|mesh-ancestor
25193224|NCT02771379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193225|NCT02771379|Protective Agents|protective agents|mesh-ancestor
25193226|NCT02771379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193227|NCT02771587|Ethanol|ethanol|mesh-list
25193228|NCT02771587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25193229|NCT02771587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25193230|NCT02771587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25193231|NCT02771587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193232|NCT02771704|Iodine|iodine|mesh-list
25193233|NCT02771704|Chlorhexidine|chlorhexidine|mesh-list
25193234|NCT02771704|Fluorides|fluorides|mesh-list
25193235|NCT02771704|Cariostatic Agents|cariostatic agents|mesh-ancestor
25193236|NCT02771704|Protective Agents|protective agents|mesh-ancestor
25193237|NCT02771704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193238|NCT02771704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24432112|NCT00253565|Antimetabolites|antimetabolites|mesh-ancestor
24432113|NCT00253565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432128|NCT00253591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432130|NCT00253617|Trioxsalen|trioxsalen|mesh-list
24432131|NCT00253617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432132|NCT00253617|Dermatologic Agents|dermatologic agents|mesh-ancestor
24432133|NCT00253617|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24432134|NCT00253721|Melphalan|melphalan|mesh-list
25860601|NCT00084019|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24432168|NCT00253903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432228|NCT00254020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432229|NCT00254020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24432230|NCT00254020|Antidepressive Agents|antidepressive agents|mesh-ancestor
24432231|NCT00254020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24432243|NCT00254046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24432244|NCT00254046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24432246|NCT00254046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432247|NCT00254046|Antiviral Agents|antiviral agents|mesh-ancestor
24432248|NCT00254046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24432249|NCT00254085|Insulin Aspart|insulin aspart|mesh-list
24432254|NCT00254137|Irinotecan|irinotecan|mesh-list
24432260|NCT00254137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25193239|NCT02771704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25193240|NCT02771704|Disinfectants|disinfectants|mesh-ancestor
25193241|NCT02771704|Trace Elements|trace elements|mesh-ancestor
25193242|NCT02771704|Micronutrients|micronutrients|mesh-ancestor
25193243|NCT02771743|Cyclophosphamide|cyclophosphamide|mesh-list
25193244|NCT02771743|Ifosfamide|ifosfamide|mesh-list
25193245|NCT02771743|Carboplatin|carboplatin|mesh-list
25193246|NCT02771743|Doxorubicin|doxorubicin|mesh-list
25193247|NCT02771743|Etoposide|etoposide|mesh-list
25666725|NCT01698814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25666726|NCT01698814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666727|NCT01698814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25666728|NCT01698814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25666729|NCT01698814|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25666730|NCT01698814|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25193248|NCT02771743|Interleukin-2|interleukin-2|mesh-list
25193249|NCT02771743|Isotretinoin|isotretinoin|mesh-list
25193250|NCT02771743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25193251|NCT02771743|Immunologic Factors|immunologic factors|mesh-ancestor
25666731|NCT01698814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25157075|NCT04824911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25157076|NCT04824911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193252|NCT02771743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193253|NCT02771743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25193254|NCT02771743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25193255|NCT02771743|Alkylating Agents|alkylating agents|mesh-ancestor
25193256|NCT02771743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193257|NCT02771743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25193258|NCT02771743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25193259|NCT02771743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25193260|NCT02771743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25193261|NCT02771743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25193262|NCT02771743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193263|NCT02771743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25193264|NCT02771743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25193265|NCT02771743|Analgesics|analgesics|mesh-ancestor
25193266|NCT02771743|Sensory System Agents|sensory system agents|mesh-ancestor
25193267|NCT02771743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25193268|NCT02771743|Dermatologic Agents|dermatologic agents|mesh-ancestor
25193269|NCT02771418|Anesthetics|anesthetics|mesh-list
25193270|NCT02771418|Propofol|propofol|mesh-list
25193271|NCT02771418|Sevoflurane|sevoflurane|mesh-list
25193272|NCT02771418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25193273|NCT02771418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193274|NCT02771418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25193275|NCT02771418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25193276|NCT02771418|Anesthetics, General|anesthetics, general|mesh-ancestor
25193277|NCT02771418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25193278|NCT02771418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25193279|NCT02771600|Anesthetics|anesthetics|mesh-list
25193280|NCT02771600|Anesthetics, Local|anesthetics, local|mesh-list
25193281|NCT02771600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25193282|NCT02771600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193283|NCT02771600|Sensory System Agents|sensory system agents|mesh-ancestor
25193284|NCT02771600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25193285|NCT02771405|Ribavirin|ribavirin|mesh-list
25193286|NCT02771405|Sofosbuvir|sofosbuvir|mesh-list
25193287|NCT02771405|Simeprevir|simeprevir|mesh-list
25193288|NCT02771405|Ledipasvir|ledipasvir|mesh-list
25193289|NCT02771405|Antimetabolites|antimetabolites|mesh-ancestor
25193290|NCT02771405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193291|NCT02771405|Antiviral Agents|antiviral agents|mesh-ancestor
25193292|NCT02771405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25193293|NCT02771405|Protease Inhibitors|protease inhibitors|mesh-ancestor
25193294|NCT02771405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193295|NCT02771314|Osimertinib|osimertinib|mesh-list
25193296|NCT02771314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25193297|NCT02771314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25193298|NCT02771314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193299|NCT02771314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193300|NCT02770950|Indomethacin|indomethacin|mesh-list
25193301|NCT02770950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25193302|NCT02770950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25193303|NCT02770950|Analgesics|analgesics|mesh-ancestor
25193304|NCT02770950|Sensory System Agents|sensory system agents|mesh-ancestor
25193305|NCT02770950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25193306|NCT02770950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193307|NCT02770950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25193308|NCT02770950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25193309|NCT02770950|Gout Suppressants|gout suppressants|mesh-ancestor
25193310|NCT02770950|Tocolytic Agents|tocolytic agents|mesh-ancestor
25193311|NCT02770950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25193312|NCT02770950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25193313|NCT02770950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193314|NCT02770950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206740|NCT05343338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206741|NCT05343325|Paclitaxel|paclitaxel|mesh-list
25206742|NCT05343325|Cisplatin|cisplatin|mesh-list
25206743|NCT05343325|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25206744|NCT05343325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25666732|NCT01698814|Histamine Antagonists|histamine antagonists|mesh-ancestor
25666733|NCT01698814|Histamine Agents|histamine agents|mesh-ancestor
25666734|NCT01698814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665970|NCT01316133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665971|NCT01316133|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24665972|NCT01316133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24665973|NCT01316133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665975|NCT01316445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24665976|NCT01316445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25206745|NCT05343325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206746|NCT05343325|Tubulin Modulators|tubulin modulators|mesh-ancestor
25206747|NCT05343325|Antimitotic Agents|antimitotic agents|mesh-ancestor
25206748|NCT05343325|Mitosis Modulators|mitosis modulators|mesh-ancestor
25193409|NCT02770378|Antiviral Agents|antiviral agents|mesh-ancestor
25206749|NCT05343325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206750|NCT05343312|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25206751|NCT05343312|Antimalarials|antimalarials|mesh-ancestor
25206752|NCT05343312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25206753|NCT05343312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25206754|NCT05343312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25206755|NCT05343299|Lidocaine|lidocaine|mesh-list
25206756|NCT05343299|Ropivacaine|ropivacaine|mesh-list
25206757|NCT05343299|Anesthetics|anesthetics|mesh-list
25206758|NCT05343299|Anesthetics, Local|anesthetics, local|mesh-ancestor
25206759|NCT05343299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25206760|NCT05343299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206761|NCT05343299|Sensory System Agents|sensory system agents|mesh-ancestor
25206762|NCT05343299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25206763|NCT05343299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25206764|NCT05343299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25206765|NCT05343299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25206766|NCT05343299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25206767|NCT05343299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206768|NCT05343169|Naloxone|naloxone|mesh-list
25206769|NCT05343169|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25206770|NCT05343169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206771|NCT05343169|Sensory System Agents|sensory system agents|mesh-ancestor
25206772|NCT05343169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25206773|NCT05343078|Dapagliflozin|dapagliflozin|mesh-list
25206774|NCT05343078|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25206775|NCT05343078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206776|NCT05343078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25206777|NCT05343078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206778|NCT05342870|Dexmedetomidine|dexmedetomidine|mesh-list
25206779|NCT05342870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25206780|NCT05342870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25206781|NCT05342870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206782|NCT05342870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25206783|NCT05342870|Analgesics|analgesics|mesh-ancestor
25193315|NCT02771158|Midodrine|midodrine|mesh-list
25193316|NCT02771158|Sympathomimetics|sympathomimetics|mesh-ancestor
25193317|NCT02771158|Autonomic Agents|autonomic agents|mesh-ancestor
25193318|NCT02771158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25193319|NCT02771158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193320|NCT02771158|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25193321|NCT02771158|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25193322|NCT02771158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25193323|NCT02771158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25193324|NCT02771158|Adrenergic Agents|adrenergic agents|mesh-ancestor
25269610|NCT02409004|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25193325|NCT02771158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25193326|NCT02771158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193327|NCT02770885|Dulaglutide|dulaglutide|mesh-list
25193328|NCT02770885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25193329|NCT02770885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193330|NCT02770651|Everolimus|everolimus|mesh-list
25193331|NCT02770651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25193332|NCT02770651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24558167|NCT00755573|Sensory System Agents|sensory system agents|mesh-ancestor
25666735|NCT01698814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666736|NCT01698879|Gemtuzumab|gemtuzumab|mesh-list
25666737|NCT01698879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25666738|NCT01698879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25666739|NCT01699022|CycloProvera|cycloprovera|mesh-list
25666740|NCT01699022|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25666741|NCT01699022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24558168|NCT00755573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25193333|NCT02770651|Immunologic Factors|immunologic factors|mesh-ancestor
25193334|NCT02770651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193335|NCT02770729|Moxifloxacin|moxifloxacin|mesh-list
25193336|NCT02770729|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25193337|NCT02770729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25193338|NCT02770729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25193339|NCT02770729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25193340|NCT02770729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25193341|NCT02770729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193342|NCT02770729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193343|NCT02770729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25193344|NCT02770729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25193345|NCT02770729|Contraceptive Agents|contraceptive agents|mesh-ancestor
25193346|NCT02770729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25193347|NCT02770729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193348|NCT02770729|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25193349|NCT02770729|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25193563|NCT02769936|Antimetabolites|antimetabolites|mesh-ancestor
25193350|NCT02770729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25193351|NCT02770794|Infliximab|infliximab|mesh-list
25193352|NCT02770794|Dermatologic Agents|dermatologic agents|mesh-ancestor
25193353|NCT02770794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25193354|NCT02770794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25193355|NCT02770690|Lidocaine|lidocaine|mesh-list
25193356|NCT02770690|Ethyl Chloride|ethyl chloride|mesh-list
25193357|NCT02770690|Anesthetics, Local|anesthetics, local|mesh-ancestor
25193358|NCT02770690|Anesthetics|anesthetics|mesh-ancestor
25193359|NCT02770690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25193360|NCT02770690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193361|NCT02770690|Sensory System Agents|sensory system agents|mesh-ancestor
25193362|NCT02770690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25193363|NCT02770690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25193364|NCT02770690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25193365|NCT02770690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25193366|NCT02770690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25193367|NCT02770690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193368|NCT02770404|Nafithromycin|nafithromycin|mesh-list
24558170|NCT00755573|Anticonvulsants|anticonvulsants|mesh-ancestor
25193369|NCT02770404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25193370|NCT02770404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25193371|NCT02770404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25193372|NCT02770404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193373|NCT02770404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193374|NCT02770508|Ritonavir|ritonavir|mesh-list
25193375|NCT02770508|Darunavir|darunavir|mesh-list
25193376|NCT02770508|Tenofovir|tenofovir|mesh-list
25193377|NCT02770508|Lamivudine|lamivudine|mesh-list
25193378|NCT02770508|Emtricitabine|emtricitabine|mesh-list
25193379|NCT02770508|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25193380|NCT02770508|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25193381|NCT02770508|Protease Inhibitors|protease inhibitors|mesh-ancestor
25193382|NCT02770508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193383|NCT02770508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193384|NCT02770508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25193385|NCT02770508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25193386|NCT02770508|Antiviral Agents|antiviral agents|mesh-ancestor
25193387|NCT02770508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25193388|NCT02770508|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24432729|NCT00255788|Immunologic Factors|immunologic factors|mesh-ancestor
24432730|NCT00255788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432731|NCT00255879|Olanzapine|olanzapine|mesh-list
24432732|NCT00255879|Risperidone|risperidone|mesh-list
24432733|NCT00255879|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24432734|NCT00255879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24558206|NCT00755833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24558207|NCT00755833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558208|NCT00755859|Prednisone|prednisone|mesh-list
24558209|NCT00755859|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24558210|NCT00755859|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24432735|NCT00255879|Serotonin Agents|serotonin agents|mesh-ancestor
24432736|NCT00255879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24432737|NCT00255879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432738|NCT00255879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432739|NCT00255879|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25081771|NCT03327272|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25081772|NCT03327272|Prednisolone|prednisolone|mesh-list
25081773|NCT03327272|Prednisolone acetate|prednisolone acetate|mesh-list
25081774|NCT03327272|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25081775|NCT03327272|Prednisolone phosphate|prednisolone phosphate|mesh-list
25081776|NCT03327272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25081777|NCT03327272|Antiemetics|antiemetics|mesh-ancestor
24432740|NCT00255879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24432741|NCT00255879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25193389|NCT02770508|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25193390|NCT02770508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25193391|NCT02770508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25193392|NCT02770378|Ritonavir|ritonavir|mesh-list
25193393|NCT02770378|Itraconazole|itraconazole|mesh-list
25193394|NCT02770378|Minocycline|minocycline|mesh-list
25193395|NCT02770378|Celecoxib|celecoxib|mesh-list
25193396|NCT02770378|Temozolomide|temozolomide|mesh-list
25193397|NCT02770378|Auranofin|auranofin|mesh-list
25193398|NCT02770378|Captopril|captopril|mesh-list
25193399|NCT02770378|Disulfiram|disulfiram|mesh-list
25193400|NCT02770378|Aprepitant|aprepitant|mesh-list
25193401|NCT02770378|Sertraline|sertraline|mesh-list
25193402|NCT02770378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25193403|NCT02770378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25193404|NCT02770378|Protease Inhibitors|protease inhibitors|mesh-ancestor
25193405|NCT02770378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193406|NCT02770378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193407|NCT02770378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25193408|NCT02770378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25193410|NCT02770378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25193411|NCT02770378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25193412|NCT02770378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25193413|NCT02770378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25193414|NCT02770378|Alkylating Agents|alkylating agents|mesh-ancestor
25193415|NCT02770378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24558244|NCT00755885|Abiraterone Acetate|abiraterone acetate|mesh-list
25193416|NCT02770378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25193417|NCT02770378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25193419|NCT02770378|Sensory System Agents|sensory system agents|mesh-ancestor
25193420|NCT02770378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25193421|NCT02770378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193422|NCT02770378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25193423|NCT02770378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24432742|NCT00255879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25193424|NCT02770378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25193425|NCT02770378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25193426|NCT02770378|Antifungal Agents|antifungal agents|mesh-ancestor
25193427|NCT02770378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25193428|NCT02770378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25193429|NCT02770378|Hormone Antagonists|hormone antagonists|mesh-ancestor
25193430|NCT02770378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25193431|NCT02770378|Antidepressive Agents|antidepressive agents|mesh-ancestor
25193432|NCT02770378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25193433|NCT02770378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25193434|NCT02770378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25193435|NCT02770378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25193436|NCT02770378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25193437|NCT02770378|Serotonin Agents|serotonin agents|mesh-ancestor
25193438|NCT02770378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25193439|NCT02770378|Antiemetics|antiemetics|mesh-ancestor
25193440|NCT02770378|Autonomic Agents|autonomic agents|mesh-ancestor
25193441|NCT02770378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25193442|NCT02770378|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25193443|NCT02770378|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25193444|NCT02770378|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25193445|NCT02770378|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25193446|NCT02770378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25193447|NCT02770261|Candesartan|candesartan|mesh-list
25666742|NCT01699022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25666743|NCT01699022|Contraceptive Agents|contraceptive agents|mesh-ancestor
25666744|NCT01699022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25666745|NCT01699022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666746|NCT01699022|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25666747|NCT01699022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25666748|NCT01699178|Methyltestosterone|methyltestosterone|mesh-list
24778980|NCT01873144|Epinephrine|epinephrine|mesh-list
24778981|NCT01873144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24778982|NCT01873144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25193448|NCT02770261|Candesartan cilexetil|candesartan cilexetil|mesh-list
25193449|NCT02770261|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25193450|NCT02770261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25193451|NCT02770261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25193452|NCT02770261|Antimetabolites|antimetabolites|mesh-ancestor
24558340|NCT00756340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25193453|NCT02770261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193454|NCT02770261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24432878|NCT00256711|Antimitotic Agents|antimitotic agents|mesh-ancestor
25193455|NCT02770261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25193456|NCT02770261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193457|NCT02770261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25193458|NCT02770261|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25193459|NCT02770261|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25193460|NCT02770430|Infliximab|infliximab|mesh-list
25193461|NCT02770430|Basiliximab|basiliximab|mesh-list
25193462|NCT02770430|Dermatologic Agents|dermatologic agents|mesh-ancestor
25193463|NCT02770430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25193464|NCT02770430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25193465|NCT02770430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25193466|NCT02770430|Immunologic Factors|immunologic factors|mesh-ancestor
25193467|NCT02770430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193468|NCT02770274|Aspirin|aspirin|mesh-list
25193469|NCT02770274|Cilostazol|cilostazol|mesh-list
25193470|NCT02770274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25193471|NCT02770274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25193472|NCT02770274|Analgesics|analgesics|mesh-ancestor
25193473|NCT02770274|Sensory System Agents|sensory system agents|mesh-ancestor
25193474|NCT02770274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25193475|NCT02770274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193476|NCT02770274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25193477|NCT02770274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25193478|NCT02770274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25193479|NCT02770274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25193480|NCT02770274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193481|NCT02770274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25193482|NCT02770274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25193483|NCT02770274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193484|NCT02770274|Antipyretics|antipyretics|mesh-ancestor
25193485|NCT02770274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25193486|NCT02770274|Autonomic Agents|autonomic agents|mesh-ancestor
25193487|NCT02770274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25193488|NCT02770274|Respiratory System Agents|respiratory system agents|mesh-ancestor
25193489|NCT02770274|Vasodilator Agents|vasodilator agents|mesh-ancestor
25193490|NCT02770274|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25193491|NCT02770274|Protective Agents|protective agents|mesh-ancestor
25193492|NCT02770274|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25193493|NCT02770274|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25193494|NCT02770222|Rifampin|rifampin|mesh-list
25193495|NCT02770222|Selexipag|selexipag|mesh-list
25193496|NCT02770222|Gemfibrozil|gemfibrozil|mesh-list
25193497|NCT02770222|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25193498|NCT02770222|Antitubercular Agents|antitubercular agents|mesh-ancestor
25193499|NCT02770222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25193500|NCT02770222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25193501|NCT02770222|Leprostatic Agents|leprostatic agents|mesh-ancestor
25193502|NCT02770222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25193503|NCT02770222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193504|NCT02770222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193505|NCT02770222|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25193506|NCT02770222|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25193507|NCT02770222|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25193508|NCT02770222|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25193509|NCT02770222|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25193510|NCT02770222|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25193511|NCT02770222|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25193512|NCT02770222|Antimetabolites|antimetabolites|mesh-ancestor
25193513|NCT02770222|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25193519|NCT02770443|Adrenergic Agents|adrenergic agents|mesh-ancestor
25666749|NCT01699178|Testosterone|testosterone|mesh-list
25666750|NCT01699178|Testosterone undecanoate|testosterone undecanoate|mesh-list
25666751|NCT01699178|Testosterone enanthate|testosterone enanthate|mesh-list
25206784|NCT05342870|Sensory System Agents|sensory system agents|mesh-ancestor
25193521|NCT02770443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193522|NCT02770443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193524|NCT02770105|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25193525|NCT02770105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193526|NCT02770105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25193527|NCT02770105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193528|NCT02770105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193529|NCT02770105|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25193530|NCT02770105|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25193531|NCT02770105|Purinergic Agents|purinergic agents|mesh-ancestor
25193532|NCT02770105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25193533|NCT02769832|Gemcitabine|gemcitabine|mesh-list
25193534|NCT02769832|Paclitaxel|paclitaxel|mesh-list
25193535|NCT02769832|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25193536|NCT02769832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25193537|NCT02769832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25193538|NCT02769832|Tubulin Modulators|tubulin modulators|mesh-ancestor
25193539|NCT02769832|Antimitotic Agents|antimitotic agents|mesh-ancestor
25193540|NCT02769832|Mitosis Modulators|mitosis modulators|mesh-ancestor
25193541|NCT02769832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193542|NCT02769832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25193543|NCT02769832|Antimetabolites|antimetabolites|mesh-ancestor
25193544|NCT02769832|Antiviral Agents|antiviral agents|mesh-ancestor
25193545|NCT02769832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25193546|NCT02769832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193547|NCT02769832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25193548|NCT02769832|Immunologic Factors|immunologic factors|mesh-ancestor
25193549|NCT02769832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193556|NCT02769936|Cycloserine|cycloserine|mesh-list
25193557|NCT02769936|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25193558|NCT02769936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25193559|NCT02769936|Renal Agents|renal agents|mesh-ancestor
25193560|NCT02769936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25193561|NCT02769936|Antitubercular Agents|antitubercular agents|mesh-ancestor
25193562|NCT02769936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25193564|NCT02769936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193565|NCT02769910|Capsaicin|capsaicin|mesh-list
25193566|NCT02769910|Antipruritics|antipruritics|mesh-ancestor
25193567|NCT02769910|Dermatologic Agents|dermatologic agents|mesh-ancestor
25193568|NCT02769910|Sensory System Agents|sensory system agents|mesh-ancestor
25193569|NCT02769910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25193570|NCT02769910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193571|NCT02769884|Pancrelipase|pancrelipase|mesh-list
25269639|NCT02409290|Antimetabolites|antimetabolites|mesh-ancestor
25193572|NCT02769884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25193573|NCT02769793|Levodopa|levodopa|mesh-list
25193574|NCT02769793|Benserazide|benserazide|mesh-list
25193575|NCT02769793|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
25193576|NCT02769793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25193577|NCT02769793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25193578|NCT02769793|Dopamine Agents|dopamine agents|mesh-ancestor
25193579|NCT02769793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25193580|NCT02769793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193581|NCT02769793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193582|NCT02769793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193583|NCT02769494|Riboflavin|riboflavin|mesh-list
25193584|NCT02769494|Flavin Mononucleotide|flavin mononucleotide|mesh-list
25193585|NCT02769494|Mesalamine|mesalamine|mesh-list
25193586|NCT02769494|Vitamin B Complex|vitamin b complex|mesh-ancestor
25193587|NCT02769494|Vitamins|vitamins|mesh-ancestor
25193588|NCT02769494|Micronutrients|micronutrients|mesh-ancestor
25193589|NCT02769494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433004|NCT00257257|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25193590|NCT02769494|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25193591|NCT02769494|Dermatologic Agents|dermatologic agents|mesh-ancestor
25193592|NCT02769494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25193593|NCT02769494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25193594|NCT02769494|Analgesics|analgesics|mesh-ancestor
24433160|NCT00257712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193595|NCT02769494|Sensory System Agents|sensory system agents|mesh-ancestor
25193596|NCT02769494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25193597|NCT02769494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25193598|NCT02769494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25193599|NCT02769689|Methylprednisolone|methylprednisolone|mesh-list
25193600|NCT02769689|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25193601|NCT02769689|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25193602|NCT02769689|Prednisolone|prednisolone|mesh-list
25193603|NCT02769689|Prednisolone acetate|prednisolone acetate|mesh-list
25193604|NCT02769689|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24558561|NCT00757874|Immunologic Factors|immunologic factors|mesh-ancestor
24558562|NCT00757874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558563|NCT00757874|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24558564|NCT00757874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24948197|NCT03921671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948198|NCT03921593|Pancrelipase|pancrelipase|mesh-list
24948199|NCT03921593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25193605|NCT02769689|Prednisolone phosphate|prednisolone phosphate|mesh-list
25193606|NCT02769689|Natalizumab|natalizumab|mesh-list
25193607|NCT02769689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25193608|NCT02769689|Antiemetics|antiemetics|mesh-ancestor
25193609|NCT02769689|Autonomic Agents|autonomic agents|mesh-ancestor
25193610|NCT02769689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25193611|NCT02769689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193612|NCT02769689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25193613|NCT02769689|Glucocorticoids|glucocorticoids|mesh-ancestor
25193614|NCT02769689|Hormones|hormones|mesh-ancestor
25193615|NCT02769689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25193616|NCT02769689|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25193617|NCT02769689|Protective Agents|protective agents|mesh-ancestor
25193618|NCT02769689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25193619|NCT02769689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25193620|NCT02769689|Immunologic Factors|immunologic factors|mesh-ancestor
25193621|NCT02769572|Diclofenac|diclofenac|mesh-list
25193622|NCT02769572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25193623|NCT02769572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25193624|NCT02769572|Analgesics|analgesics|mesh-ancestor
25193625|NCT02769572|Sensory System Agents|sensory system agents|mesh-ancestor
25193626|NCT02769572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25193627|NCT02769572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193628|NCT02769572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25193629|NCT02769572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25193630|NCT02769572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25193631|NCT02769572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193632|NCT02769572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193633|NCT02769325|Ketorolac|ketorolac|mesh-list
25193634|NCT02769325|Atropine|atropine|mesh-list
25193635|NCT02769325|Morphine|morphine|mesh-list
25193636|NCT02769325|Propofol|propofol|mesh-list
25193637|NCT02769325|Sevoflurane|sevoflurane|mesh-list
25193638|NCT02769325|Rocuronium|rocuronium|mesh-list
25193639|NCT02769325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25193640|NCT02769325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25193641|NCT02769325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193642|NCT02769325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25193643|NCT02769325|Anesthetics, General|anesthetics, general|mesh-ancestor
25193644|NCT02769325|Anesthetics|anesthetics|mesh-ancestor
25193645|NCT02769325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25193646|NCT02769325|Narcotics|narcotics|mesh-ancestor
25193647|NCT02769325|Analgesics|analgesics|mesh-ancestor
25193648|NCT02769325|Sensory System Agents|sensory system agents|mesh-ancestor
25193649|NCT02769325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25193650|NCT02769325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25193651|NCT02769325|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25193652|NCT02769325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25193653|NCT02769325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25193899|NCT02768168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25193654|NCT02769325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25193655|NCT02769325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25193656|NCT02769325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25193657|NCT02769325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193658|NCT02769325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193659|NCT02769325|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25193660|NCT02769325|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25193661|NCT02769325|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25193662|NCT02769325|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25193663|NCT02769325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25193664|NCT02769325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25193665|NCT02769325|Autonomic Agents|autonomic agents|mesh-ancestor
25193666|NCT02769325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25860602|NCT00084019|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24779228|NCT01874743|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24935829|NCT04047797|Glycine Agents|glycine agents|mesh-ancestor
24779229|NCT01874743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24779230|NCT01874743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24779231|NCT01874743|Antimetabolites|antimetabolites|mesh-ancestor
25193667|NCT02769325|Respiratory System Agents|respiratory system agents|mesh-ancestor
25193668|NCT02769325|Mydriatics|mydriatics|mesh-ancestor
25193669|NCT02769325|Parasympatholytics|parasympatholytics|mesh-ancestor
25193670|NCT02769325|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25193671|NCT02769325|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25193672|NCT02769325|Cholinergic Agents|cholinergic agents|mesh-ancestor
25193673|NCT02769325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25193674|NCT02769390|Clonidine|clonidine|mesh-list
25193675|NCT02769390|Diazepam|diazepam|mesh-list
25193676|NCT02769390|Analgesics|analgesics|mesh-ancestor
25193677|NCT02769390|Sensory System Agents|sensory system agents|mesh-ancestor
25193678|NCT02769390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25193679|NCT02769390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564135|NCT00775242|Estradiol|estradiol|mesh-list
24558628|NCT00758199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24558629|NCT00758199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24558639|NCT00758199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25193680|NCT02769390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25193681|NCT02769390|Sympatholytics|sympatholytics|mesh-ancestor
25193682|NCT02769390|Autonomic Agents|autonomic agents|mesh-ancestor
25193683|NCT02769390|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25193684|NCT02769390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25193685|NCT02769390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25193686|NCT02769390|Adrenergic Agents|adrenergic agents|mesh-ancestor
25193687|NCT02769390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25193688|NCT02769390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193689|NCT02769390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25193690|NCT02769390|Anticonvulsants|anticonvulsants|mesh-ancestor
25193691|NCT02769390|Antiemetics|antiemetics|mesh-ancestor
25193692|NCT02769390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25193693|NCT02769390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25193694|NCT02769390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25193695|NCT02769390|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25193696|NCT02769390|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25193697|NCT02769390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25193698|NCT02769390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25193699|NCT02769390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25193700|NCT02769390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25193701|NCT02769390|Anesthetics, General|anesthetics, general|mesh-ancestor
25193702|NCT02769390|Anesthetics|anesthetics|mesh-ancestor
25193704|NCT02769390|GABA Agents|gaba agents|mesh-ancestor
25206785|NCT05342870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24558644|NCT00758212|Vaccines|vaccines|mesh-list
25206786|NCT05342870|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25206787|NCT05342870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25206788|NCT05342870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25206789|NCT05342870|Adrenergic Agents|adrenergic agents|mesh-ancestor
25206790|NCT05342870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25206791|NCT05342870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206792|NCT05342857|Aflibercept|aflibercept|mesh-list
25206793|NCT05342857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25206794|NCT05342857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25206795|NCT05342857|Growth Substances|growth substances|mesh-ancestor
25206796|NCT05342857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206797|NCT05342857|Growth Inhibitors|growth inhibitors|mesh-ancestor
25206798|NCT05342857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206799|NCT05342818|Ondansetron|ondansetron|mesh-list
25206800|NCT05342818|Metoclopramide|metoclopramide|mesh-list
25206801|NCT05342818|Neostigmine|neostigmine|mesh-list
25206802|NCT05342818|Antiemetics|antiemetics|mesh-ancestor
25206803|NCT05342818|Autonomic Agents|autonomic agents|mesh-ancestor
25206804|NCT05342818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25193900|NCT02768168|Narcotics|narcotics|mesh-ancestor
25206805|NCT05342818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206807|NCT05342818|Antipruritics|antipruritics|mesh-ancestor
25206808|NCT05342818|Dermatologic Agents|dermatologic agents|mesh-ancestor
25666752|NCT01699178|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25666753|NCT01699178|Androgens|androgens|mesh-ancestor
25666754|NCT01699178|Hormones|hormones|mesh-ancestor
25666755|NCT01699178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25666756|NCT01699178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570995|NCT00807690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24570996|NCT00807690|Immunologic Factors|immunologic factors|mesh-ancestor
24570997|NCT00807690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570999|NCT00807690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25206809|NCT05342818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25206810|NCT05342818|Serotonin Agents|serotonin agents|mesh-ancestor
25206811|NCT05342818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25206812|NCT05342818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206813|NCT05342818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25206814|NCT05342818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25206815|NCT05342818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25206816|NCT05342818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25206817|NCT05342818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25206818|NCT05342818|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25206819|NCT05342818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25206820|NCT05342818|Cholinergic Agents|cholinergic agents|mesh-ancestor
25206821|NCT05342818|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25206822|NCT05342818|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25206823|NCT05342818|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25206824|NCT05342818|Dopamine Agents|dopamine agents|mesh-ancestor
25206825|NCT05342792|Capecitabine|capecitabine|mesh-list
25193705|NCT02769286|Osimertinib|osimertinib|mesh-list
25193706|NCT02769286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25193707|NCT02769286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25193708|NCT02769286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193709|NCT02769286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193710|NCT02769130|Losartan|losartan|mesh-list
25193711|NCT02769130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25193712|NCT02769130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25193713|NCT02769130|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25193714|NCT02769130|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25193715|NCT02769130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193716|NCT02769104|Docetaxel|docetaxel|mesh-list
25193717|NCT02769104|Letrozole|letrozole|mesh-list
25193718|NCT02769104|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25193719|NCT02769104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25193720|NCT02769104|Tubulin Modulators|tubulin modulators|mesh-ancestor
25193721|NCT02769104|Antimitotic Agents|antimitotic agents|mesh-ancestor
25193722|NCT02769104|Mitosis Modulators|mitosis modulators|mesh-ancestor
25193723|NCT02769104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193724|NCT02769104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25193725|NCT02769104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193726|NCT02769104|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25193727|NCT02769104|Hormone Antagonists|hormone antagonists|mesh-ancestor
25193728|NCT02769104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25193729|NCT02769104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193730|NCT02769169|Ranibizumab|ranibizumab|mesh-list
25193731|NCT02769169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25193732|NCT02769169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25193733|NCT02769169|Growth Substances|growth substances|mesh-ancestor
25193734|NCT02769169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193735|NCT02769169|Growth Inhibitors|growth inhibitors|mesh-ancestor
25193736|NCT02769169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25193737|NCT02768740|Hydrocortisone|hydrocortisone|mesh-list
25193738|NCT02768740|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25193739|NCT02768740|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25193740|NCT02768740|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25193741|NCT02768740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25193742|NCT02768961|Sofosbuvir|sofosbuvir|mesh-list
25193743|NCT02768961|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25193744|NCT02768961|Ledipasvir|ledipasvir|mesh-list
25193745|NCT02768961|Antiviral Agents|antiviral agents|mesh-ancestor
25193746|NCT02768961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25193747|NCT02769013|Praziquantel|praziquantel|mesh-list
25193748|NCT02769013|Anthelmintics|anthelmintics|mesh-ancestor
25193749|NCT02769013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25193750|NCT02769013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25193751|NCT02768688|Dexmedetomidine|dexmedetomidine|mesh-list
25193752|NCT02768688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25193753|NCT02768688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25193754|NCT02768688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666757|NCT01699178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25666758|NCT01699178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25666759|NCT01699178|Anabolic Agents|anabolic agents|mesh-ancestor
25666760|NCT01699607|Amphetamine|amphetamine|mesh-list
24779287|NCT01874964|Respiratory System Agents|respiratory system agents|mesh-ancestor
24779288|NCT01875107|Insulin|insulin|mesh-list
24779289|NCT01875107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24779290|NCT01875107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779291|NCT01875172|Bupropion|bupropion|mesh-list
24779292|NCT01875172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25213331|NCT04908800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213332|NCT04908800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24779293|NCT01875172|Antidepressive Agents|antidepressive agents|mesh-ancestor
24779294|NCT01875172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24779295|NCT01875172|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24718418|NCT01554852|Hormones|hormones|mesh-ancestor
25193755|NCT02768688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25193756|NCT02768688|Analgesics|analgesics|mesh-ancestor
25193757|NCT02768688|Sensory System Agents|sensory system agents|mesh-ancestor
25193758|NCT02768688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25193759|NCT02768688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25193760|NCT02768688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25193761|NCT02768688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25193762|NCT02768688|Adrenergic Agents|adrenergic agents|mesh-ancestor
25193763|NCT02768688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25193764|NCT02768688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193765|NCT02768805|Vaccines|vaccines|mesh-list
25193766|NCT02768805|Immunologic Factors|immunologic factors|mesh-ancestor
25193767|NCT02768805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193768|NCT02768649|Risperidone|risperidone|mesh-list
25193769|NCT02768649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25193770|NCT02768649|Serotonin Agents|serotonin agents|mesh-ancestor
25193771|NCT02768649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25193772|NCT02768649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193773|NCT02768649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193774|NCT02768649|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25193775|NCT02768649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25193776|NCT02768649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25193777|NCT02768649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25193778|NCT02768649|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25193779|NCT02768649|Dopamine Agents|dopamine agents|mesh-ancestor
25193780|NCT02768545|Ezetimibe|ezetimibe|mesh-list
25193781|NCT02768545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25193782|NCT02768545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25193783|NCT02768545|Antimetabolites|antimetabolites|mesh-ancestor
25193784|NCT02768545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193785|NCT02768545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25193786|NCT02768532|Vedolizumab|vedolizumab|mesh-list
25193787|NCT02768532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25193789|NCT02768519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25193790|NCT02768519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193791|NCT02768519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193792|NCT02769078|Warfarin|warfarin|mesh-list
25193793|NCT02769078|Rivaroxaban|rivaroxaban|mesh-list
25193794|NCT02769078|Dabigatran|dabigatran|mesh-list
25193795|NCT02769078|Apixaban|apixaban|mesh-list
25193796|NCT02769078|Anticoagulants|anticoagulants|mesh-ancestor
25193797|NCT02769078|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25193798|NCT02769078|Antithrombins|antithrombins|mesh-ancestor
25193799|NCT02769078|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25193800|NCT02769078|Protease Inhibitors|protease inhibitors|mesh-ancestor
25193801|NCT02769078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193802|NCT02769078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193803|NCT02768441|Dextroamphetamine|dextroamphetamine|mesh-list
25193804|NCT02768441|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25193805|NCT02768441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193806|NCT02768441|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25666761|NCT01699607|Dextroamphetamine|dextroamphetamine|mesh-list
25666762|NCT01699607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25666763|NCT01699607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666764|NCT01699607|Sympathomimetics|sympathomimetics|mesh-ancestor
25666765|NCT01699607|Autonomic Agents|autonomic agents|mesh-ancestor
25666766|NCT01699607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25666767|NCT01699607|Dopamine Agents|dopamine agents|mesh-ancestor
25666768|NCT01699607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25666769|NCT01699607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666770|NCT01699607|Adrenergic Agents|adrenergic agents|mesh-ancestor
25666771|NCT01699607|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24779361|NCT01875705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24779362|NCT01875705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25213339|NCT04840862|Rifabutin|rifabutin|mesh-list
25213340|NCT04840862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25213341|NCT04840862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25213342|NCT04840862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25213343|NCT04840862|Antitubercular Agents|antitubercular agents|mesh-ancestor
25193807|NCT02768441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25193808|NCT02768441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24558853|NCT05428293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558855|NCT05428293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24558856|NCT05428293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24558857|NCT05428293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24558858|NCT05428293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24558859|NCT05428293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24558860|NCT05428293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193809|NCT02768441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193810|NCT02768441|Dopamine Agents|dopamine agents|mesh-ancestor
25193811|NCT02768441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25193812|NCT02768610|Dexmedetomidine|dexmedetomidine|mesh-list
25193813|NCT02768610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25193814|NCT02768610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25193815|NCT02768610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193816|NCT02768610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25193817|NCT02768610|Analgesics|analgesics|mesh-ancestor
25193818|NCT02768610|Sensory System Agents|sensory system agents|mesh-ancestor
25193819|NCT02768610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25193820|NCT02768610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25193821|NCT02768610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25193822|NCT02768610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25193823|NCT02768610|Adrenergic Agents|adrenergic agents|mesh-ancestor
25193824|NCT02768610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25193825|NCT02768610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193826|NCT02768493|Ropivacaine|ropivacaine|mesh-list
25193827|NCT02768493|Anesthetics, Local|anesthetics, local|mesh-ancestor
25193828|NCT02768493|Anesthetics|anesthetics|mesh-ancestor
25193829|NCT02768493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25193830|NCT02768493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193831|NCT02768493|Sensory System Agents|sensory system agents|mesh-ancestor
25193832|NCT02768493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25193833|NCT02768415|Apatinib|apatinib|mesh-list
25193834|NCT02768415|Vinorelbine|vinorelbine|mesh-list
25193835|NCT02768415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25193836|NCT02768415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25193837|NCT02768415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193838|NCT02768415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193839|NCT02768415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25193840|NCT02768415|Tubulin Modulators|tubulin modulators|mesh-ancestor
25193841|NCT02768415|Antimitotic Agents|antimitotic agents|mesh-ancestor
25193842|NCT02768415|Mitosis Modulators|mitosis modulators|mesh-ancestor
25193843|NCT02768454|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25193844|NCT02768454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25193845|NCT02768337|Afatinib|afatinib|mesh-list
25193846|NCT02768337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25193847|NCT02768337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25193848|NCT02768337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193849|NCT02768337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193850|NCT02768571|Cerebrolysin|cerebrolysin|mesh-list
25193851|NCT02768571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24433926|NCT00260624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24825234|NCT02127853|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25193852|NCT02768571|Protective Agents|protective agents|mesh-ancestor
25193853|NCT02768571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193854|NCT02768571|Nootropic Agents|nootropic agents|mesh-ancestor
25193855|NCT02768376|Fentanyl|fentanyl|mesh-list
25193856|NCT02768376|Bupivacaine|bupivacaine|mesh-list
25193857|NCT02768376|Anesthetics|anesthetics|mesh-list
25666772|NCT01699607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25666773|NCT01699607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25666774|NCT01699607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25666775|NCT01699685|Glycopyrrolate|glycopyrrolate|mesh-list
25666776|NCT01699685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25666777|NCT01699685|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25666778|NCT01699685|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24779428|NCT01876121|Sensory System Agents|sensory system agents|mesh-ancestor
24779429|NCT01876121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24627680|NCT01094444|Vitamins|vitamins|mesh-ancestor
24627681|NCT01094444|Micronutrients|micronutrients|mesh-ancestor
24627682|NCT01094444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213347|NCT04834206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25213348|NCT04834206|Tubulin Modulators|tubulin modulators|mesh-ancestor
25213349|NCT04834206|Antimitotic Agents|antimitotic agents|mesh-ancestor
24626133|NCT01085708|Rabeprazole|rabeprazole|mesh-list
25193858|NCT02768376|Anesthetics, Local|anesthetics, local|mesh-ancestor
25193859|NCT02768376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25193860|NCT02768376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193861|NCT02768376|Sensory System Agents|sensory system agents|mesh-ancestor
25193862|NCT02768376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25193863|NCT02768376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25193864|NCT02768376|Narcotics|narcotics|mesh-ancestor
25193865|NCT02768376|Analgesics|analgesics|mesh-ancestor
25193866|NCT02768376|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25193867|NCT02768376|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25193868|NCT02768376|Anesthetics, General|anesthetics, general|mesh-ancestor
25193869|NCT02768363|Valacyclovir|valacyclovir|mesh-list
25193870|NCT02768363|Antiviral Agents|antiviral agents|mesh-ancestor
25193871|NCT02768363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25193872|NCT02768077|Melatonin|melatonin|mesh-list
25193873|NCT02768077|Antioxidants|antioxidants|mesh-ancestor
25193874|NCT02768077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193875|NCT02768077|Protective Agents|protective agents|mesh-ancestor
25193876|NCT02768077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193877|NCT02768077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25193879|NCT02768389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25193881|NCT02768389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25193882|NCT02768389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25193883|NCT02768389|Growth Substances|growth substances|mesh-ancestor
25193884|NCT02768389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193885|NCT02768389|Growth Inhibitors|growth inhibitors|mesh-ancestor
25193886|NCT02768220|Empagliflozin|empagliflozin|mesh-list
25193887|NCT02768220|Linagliptin|linagliptin|mesh-list
25193888|NCT02768220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25193889|NCT02768220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193890|NCT02768220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25193891|NCT02768220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193892|NCT02768220|Incretins|incretins|mesh-ancestor
25193893|NCT02768220|Hormones|hormones|mesh-ancestor
25193894|NCT02768220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25193895|NCT02768220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25193896|NCT02768220|Protease Inhibitors|protease inhibitors|mesh-ancestor
25193897|NCT02768220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193898|NCT02768168|Dezocine|dezocine|mesh-list
25193902|NCT02768168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193903|NCT02768168|Analgesics|analgesics|mesh-ancestor
25193904|NCT02768168|Sensory System Agents|sensory system agents|mesh-ancestor
25193905|NCT02768168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25193906|NCT02768207|Vemurafenib|vemurafenib|mesh-list
25193907|NCT02768207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25193908|NCT02768207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25193909|NCT02768207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193910|NCT02768207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193911|NCT02768116|Sirolimus|sirolimus|mesh-list
25193912|NCT02768116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25193913|NCT02768116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25193914|NCT02768116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25193915|NCT02768116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25193916|NCT02768116|Antifungal Agents|antifungal agents|mesh-ancestor
25193917|NCT02768116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25193918|NCT02768116|Immunologic Factors|immunologic factors|mesh-ancestor
25193919|NCT02768116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193920|NCT02767999|Fluoxetine|fluoxetine|mesh-list
25666779|NCT01699685|Cholinergic Agents|cholinergic agents|mesh-ancestor
25666780|NCT01699685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25666781|NCT01699685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666782|NCT01699685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666783|NCT01699815|Acetaminophen|acetaminophen|mesh-list
25666784|NCT01699815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25666785|NCT01699815|Analgesics|analgesics|mesh-ancestor
25666786|NCT01699815|Sensory System Agents|sensory system agents|mesh-ancestor
25213356|NCT04834206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193921|NCT02767999|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25193922|NCT02767999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25193923|NCT02767999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25193924|NCT02767999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193925|NCT02767999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24434328|NCT00262210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24434329|NCT00262210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24434330|NCT00262210|Alkylating Agents|alkylating agents|mesh-ancestor
24434331|NCT00262210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434332|NCT00262210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24434333|NCT00262210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24434334|NCT00262210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24434335|NCT00262210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24434336|NCT00262210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24434337|NCT00262210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434338|NCT00262210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24434339|NCT00262210|Glucocorticoids|glucocorticoids|mesh-ancestor
24434340|NCT00262210|Hormones|hormones|mesh-ancestor
24794354|NCT05259137|Enalaprilat|enalaprilat|mesh-list
25860603|NCT00084019|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25860604|NCT00084019|Protease Inhibitors|protease inhibitors|mesh-ancestor
25860605|NCT00084019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860606|NCT00084019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860607|NCT00084019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24542804|NCT00680433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542806|NCT00680433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25860608|NCT00084019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24542807|NCT00680433|Anesthetics, General|anesthetics, general|mesh-ancestor
24542808|NCT00680433|Anesthetics|anesthetics|mesh-ancestor
24542809|NCT00680433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24542810|NCT00680433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24708065|NCT01499641|Protective Agents|protective agents|mesh-ancestor
25860609|NCT00084019|Antiviral Agents|antiviral agents|mesh-ancestor
24971931|NCT03721614|Sirolimus|sirolimus|mesh-list
24857922|NCT02294357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24857924|NCT02294357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460407|NCT00348400|Latanoprost|latanoprost|mesh-list
25860610|NCT00084019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25860611|NCT00084019|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25860612|NCT00084019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24971977|NCT03721081|Lidocaine|lidocaine|mesh-list
24543074|NCT00681876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25193993|NCT02767713|Glucocorticoids|glucocorticoids|mesh-ancestor
24543075|NCT00681876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24543077|NCT00681876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543079|NCT00681902|Anesthetics, Local|anesthetics, local|mesh-ancestor
24543081|NCT00681902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24543082|NCT00681902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193926|NCT02767999|Serotonin Agents|serotonin agents|mesh-ancestor
25193927|NCT02767999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193928|NCT02767999|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25193929|NCT02767999|Antidepressive Agents|antidepressive agents|mesh-ancestor
25193930|NCT02767999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25193931|NCT02767999|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25193932|NCT02767999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25193933|NCT02767999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193934|NCT02767661|Capecitabine|capecitabine|mesh-list
25193935|NCT02767661|Letrozole|letrozole|mesh-list
25193936|NCT02767661|Anastrozole|anastrozole|mesh-list
25193937|NCT02767661|Exemestane|exemestane|mesh-list
25193938|NCT02767661|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25193939|NCT02767661|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25193940|NCT02767661|Antimetabolites|antimetabolites|mesh-ancestor
25206826|NCT05342792|Antibodies|antibodies|mesh-list
25193941|NCT02767661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193942|NCT02767661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25193943|NCT02767661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25193944|NCT02767661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193945|NCT02767661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25193946|NCT02767661|Hormone Antagonists|hormone antagonists|mesh-ancestor
25193947|NCT02767661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25666787|NCT01699815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25213367|NCT04788641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25213368|NCT04788641|Immunologic Factors|immunologic factors|mesh-ancestor
25213369|NCT04788641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213370|NCT04788641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25213371|NCT04788641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25213372|NCT04788641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213373|NCT04788641|Antifungal Agents|antifungal agents|mesh-ancestor
25193948|NCT02767661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193949|NCT02767661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25193950|NCT02767635|Triamcinolone|triamcinolone|mesh-list
25193951|NCT02767635|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25193952|NCT02767635|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25193953|NCT02767635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25193954|NCT02767635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25193955|NCT02767635|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25193956|NCT02767635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25193957|NCT02767635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25193958|NCT02767635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193959|NCT02767635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25193960|NCT02767635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25193961|NCT02767635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193962|NCT02767635|Cholinergic Agents|cholinergic agents|mesh-ancestor
25193963|NCT02767635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25193964|NCT02767635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25193965|NCT02767635|Glucocorticoids|glucocorticoids|mesh-ancestor
25193966|NCT02767635|Hormones|hormones|mesh-ancestor
25193967|NCT02767635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25193968|NCT02767635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25193969|NCT02767635|Immunologic Factors|immunologic factors|mesh-ancestor
25193970|NCT02767635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193971|NCT02767596|Lixisenatide|lixisenatide|mesh-list
25193972|NCT02767596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25193973|NCT02767596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193974|NCT02767752|Gemcitabine|gemcitabine|mesh-list
25193975|NCT02767752|Capecitabine|capecitabine|mesh-list
25193976|NCT02767752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25193977|NCT02767752|Antimetabolites|antimetabolites|mesh-ancestor
25193978|NCT02767752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25193979|NCT02767752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25193980|NCT02767752|Antiviral Agents|antiviral agents|mesh-ancestor
25193981|NCT02767752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25193982|NCT02767752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25193983|NCT02767752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25193984|NCT02767752|Immunologic Factors|immunologic factors|mesh-ancestor
25193985|NCT02767752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193986|NCT02767713|Dexamethasone|dexamethasone|mesh-list
25193987|NCT02767713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25193988|NCT02767713|Antiemetics|antiemetics|mesh-ancestor
25193989|NCT02767713|Autonomic Agents|autonomic agents|mesh-ancestor
25193990|NCT02767713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25193991|NCT02767713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25193992|NCT02767713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25193994|NCT02767713|Hormones|hormones|mesh-ancestor
25193995|NCT02767713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25193996|NCT02767713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25193997|NCT02767713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25193998|NCT02767674|Gemcitabine|gemcitabine|mesh-list
25193999|NCT02767674|Prednisone|prednisone|mesh-list
25194000|NCT02767674|Cyclophosphamide|cyclophosphamide|mesh-list
25194001|NCT02767674|Rituximab|rituximab|mesh-list
25194002|NCT02767674|Oxaliplatin|oxaliplatin|mesh-list
25194003|NCT02767674|Epirubicin|epirubicin|mesh-list
25194004|NCT02767674|Vindesine|vindesine|mesh-list
25194005|NCT02767674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25194006|NCT02767674|Immunologic Factors|immunologic factors|mesh-ancestor
25194007|NCT02767674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194008|NCT02767674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25194009|NCT02767674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25666788|NCT01699815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666789|NCT01699815|Antipyretics|antipyretics|mesh-ancestor
25666790|NCT01700036|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25666791|NCT01700036|Protein C Inhibitor|protein c inhibitor|mesh-list
25666792|NCT01700036|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25666793|NCT01700036|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25666794|NCT01700036|Protease Inhibitors|protease inhibitors|mesh-ancestor
25666795|NCT01700036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25213380|NCT04769362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25213381|NCT04769362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666815|NCT01321034|Vitamins|vitamins|mesh-ancestor
25213382|NCT04769362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213383|NCT04760743|Aluminum sulfate|aluminum sulfate|mesh-list
25213384|NCT04760743|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25213385|NCT04760743|Immunologic Factors|immunologic factors|mesh-ancestor
25213386|NCT04760743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25157183|NCT04794699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25194010|NCT02767674|Alkylating Agents|alkylating agents|mesh-ancestor
25194011|NCT02767674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194012|NCT02767674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25194013|NCT02767674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25194014|NCT02767674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24434344|NCT00262262|Levetiracetam|levetiracetam|mesh-list
25194015|NCT02767674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25194016|NCT02767674|Antimetabolites|antimetabolites|mesh-ancestor
25194017|NCT02767674|Antiviral Agents|antiviral agents|mesh-ancestor
25194018|NCT02767674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25194019|NCT02767674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194020|NCT02767674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25194021|NCT02767674|Glucocorticoids|glucocorticoids|mesh-ancestor
25194022|NCT02767674|Hormones|hormones|mesh-ancestor
25194023|NCT02767674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25194024|NCT02767674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25194025|NCT02767674|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25194026|NCT02767674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25194027|NCT02767674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25194028|NCT02767674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25194029|NCT02767674|Tubulin Modulators|tubulin modulators|mesh-ancestor
25194030|NCT02767674|Antimitotic Agents|antimitotic agents|mesh-ancestor
25194031|NCT02767674|Mitosis Modulators|mitosis modulators|mesh-ancestor
25206827|NCT05342792|Immunologic Factors|immunologic factors|mesh-ancestor
25206828|NCT05342792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206829|NCT05342792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25206830|NCT05342792|Antimetabolites|antimetabolites|mesh-ancestor
25206831|NCT05342792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206832|NCT05342792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206833|NCT05331911|Propofol|propofol|mesh-list
25206834|NCT05331911|Sevoflurane|sevoflurane|mesh-list
25206835|NCT05331911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25206836|NCT05331911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25206837|NCT05331911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206838|NCT05331911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25206839|NCT05331911|Anesthetics, General|anesthetics, general|mesh-ancestor
25206840|NCT05331911|Anesthetics|anesthetics|mesh-ancestor
24948240|NCT03921099|Micronutrients|micronutrients|mesh-ancestor
25206841|NCT05331911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25206842|NCT05331911|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25206843|NCT05321160|Ketamine|ketamine|mesh-list
25206844|NCT05321160|Sevoflurane|sevoflurane|mesh-list
25206845|NCT05321160|Esketamine|esketamine|mesh-list
25206846|NCT05321160|Analgesics|analgesics|mesh-ancestor
25206847|NCT05321160|Sensory System Agents|sensory system agents|mesh-ancestor
25206848|NCT05321160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25206849|NCT05321160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206850|NCT05321160|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25206851|NCT05321160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25206852|NCT05321160|Anesthetics, General|anesthetics, general|mesh-ancestor
25206853|NCT05321160|Anesthetics|anesthetics|mesh-ancestor
25206854|NCT05321160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25206855|NCT05321160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25206856|NCT05321160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25206857|NCT05321160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25206858|NCT05321160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666796|NCT01700036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666797|NCT01700179|Ribavirin|ribavirin|mesh-list
25666798|NCT01700179|Antimetabolites|antimetabolites|mesh-ancestor
25666799|NCT01700179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666800|NCT01700179|Antiviral Agents|antiviral agents|mesh-ancestor
25666801|NCT01700179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25666802|NCT01700192|Mometasone Furoate|mometasone furoate|mesh-list
25666803|NCT01700192|Loratadine|loratadine|mesh-list
25666804|NCT01700192|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25213395|NCT04740645|Coagulants|coagulants|mesh-ancestor
25213396|NCT04740645|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25213397|NCT04740645|Natriuretic Agents|natriuretic agents|mesh-ancestor
25213398|NCT04740645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25157194|NCT04784754|Protective Agents|protective agents|mesh-ancestor
25157195|NCT04784754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25157196|NCT04784754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24947663|NCT03927248|Nivolumab|nivolumab|mesh-list
24779647|NCT01877746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24779648|NCT01877746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24487928|NCT00465621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24487929|NCT00465673|Doxorubicin|doxorubicin|mesh-list
24487930|NCT00465673|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25206859|NCT05321160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25206860|NCT05321160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25206861|NCT05321160|Antidepressive Agents|antidepressive agents|mesh-ancestor
25206862|NCT05321160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25206863|NCT05278351|Irinotecan|irinotecan|mesh-list
25206864|NCT05278351|Cetuximab|cetuximab|mesh-list
25206865|NCT05278351|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25206866|NCT05278351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25206867|NCT05278351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25206868|NCT05278351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206869|NCT05278351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206870|NCT05278351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25208211|NCT02855944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25208212|NCT02855944|Cisplatin|cisplatin|mesh-list
25208213|NCT02855944|Carboplatin|carboplatin|mesh-list
25208214|NCT02855944|Rucaparib|rucaparib|mesh-list
25208215|NCT02855944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25208216|NCT02855944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208217|NCT02855944|Tubulin Modulators|tubulin modulators|mesh-ancestor
25208218|NCT02855944|Antimitotic Agents|antimitotic agents|mesh-ancestor
25208219|NCT02855944|Mitosis Modulators|mitosis modulators|mesh-ancestor
25208220|NCT02855944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208221|NCT02855944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25208222|NCT02855944|Antimetabolites|antimetabolites|mesh-ancestor
24564815|NCT00778011|Antiemetics|antiemetics|mesh-ancestor
24559343|NCT05011760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25208223|NCT02855944|Antiviral Agents|antiviral agents|mesh-ancestor
24434632|NCT00263016|Antimitotic Agents|antimitotic agents|mesh-ancestor
25194032|NCT02767258|Lubricant Eye Drops|lubricant eye drops|mesh-list
25194033|NCT02767258|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25194034|NCT02767258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25194035|NCT02767245|Thiamine|thiamine|mesh-list
25194036|NCT02767245|Vitamins|vitamins|mesh-ancestor
25194037|NCT02767245|Micronutrients|micronutrients|mesh-ancestor
25194038|NCT02767245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194039|NCT02767245|Vitamin B Complex|vitamin b complex|mesh-ancestor
25194040|NCT02767310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25194041|NCT02767310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25194042|NCT02767310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25194043|NCT02767310|Antimetabolites|antimetabolites|mesh-ancestor
25194044|NCT02767310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194045|NCT02767310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25194046|NCT02767310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25194047|NCT02767310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194048|NCT02767375|Fluorouracil|fluorouracil|mesh-list
25194049|NCT02767375|Oxaliplatin|oxaliplatin|mesh-list
25194050|NCT02767375|Antimetabolites|antimetabolites|mesh-ancestor
25194051|NCT02767375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194052|NCT02767375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25194053|NCT02767375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25666805|NCT01700192|Epinephrine|epinephrine|mesh-list
25666806|NCT01700192|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25666807|NCT01700192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25666808|NCT01700192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25666809|NCT01700192|Adrenergic Agents|adrenergic agents|mesh-ancestor
25666810|NCT01700192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25666811|NCT01700192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666812|NCT01700192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666813|NCT01700192|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25666814|NCT01700192|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25666815|NCT01700192|Autonomic Agents|autonomic agents|mesh-ancestor
25666816|NCT01700192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25860613|NCT00084032|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24779753|NCT01878578|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
24779754|NCT01878578|Phenytoin|phenytoin|mesh-list
24779755|NCT01878578|Anticonvulsants|anticonvulsants|mesh-ancestor
24779756|NCT01878578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24779757|NCT01878578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24779758|NCT01878578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24779759|NCT01878578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779760|NCT01878578|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25194054|NCT02767375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25194055|NCT02767375|Immunologic Factors|immunologic factors|mesh-ancestor
25194056|NCT02767375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194057|NCT02767362|Atorvastatin|atorvastatin|mesh-list
25194058|NCT02767362|Ezetimibe|ezetimibe|mesh-list
25194059|NCT02767362|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25194060|NCT02767362|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25194061|NCT02767362|Antimetabolites|antimetabolites|mesh-ancestor
25194062|NCT02767362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194063|NCT02767362|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25194064|NCT02767362|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25194065|NCT02767362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194066|NCT02767401|Aspirin|aspirin|mesh-list
25194067|NCT02767401|Metoprolol|metoprolol|mesh-list
25194068|NCT02767401|Clopidogrel|clopidogrel|mesh-list
25194069|NCT02767401|Ticagrelor|ticagrelor|mesh-list
25194070|NCT02767401|Atorvastatin|atorvastatin|mesh-list
25194071|NCT02767401|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25194072|NCT02767401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25194073|NCT02767401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25194074|NCT02767401|Analgesics|analgesics|mesh-ancestor
25194075|NCT02767401|Sensory System Agents|sensory system agents|mesh-ancestor
25194076|NCT02767401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25194077|NCT02767401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194078|NCT02767401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25194079|NCT02767401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25194080|NCT02767401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25194081|NCT02767401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24948262|NCT03920813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948263|NCT03920813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24948265|NCT03920878|Aflibercept|aflibercept|mesh-list
24590278|NCT00911651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25194082|NCT02767401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194083|NCT02767401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25194084|NCT02767401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25194085|NCT02767401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194086|NCT02767401|Antipyretics|antipyretics|mesh-ancestor
25194087|NCT02767401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25194088|NCT02767401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25194089|NCT02767401|Antimetabolites|antimetabolites|mesh-ancestor
25194090|NCT02767401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25194091|NCT02767401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25194092|NCT02767401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25194093|NCT02767401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25194094|NCT02767401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25194095|NCT02767401|Purinergic Agents|purinergic agents|mesh-ancestor
25194096|NCT02767401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25194097|NCT02767401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25194098|NCT02767401|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25194099|NCT02767401|Sympatholytics|sympatholytics|mesh-ancestor
25194100|NCT02767401|Autonomic Agents|autonomic agents|mesh-ancestor
25194101|NCT02767401|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25194102|NCT02767401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25194103|NCT02767401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25194104|NCT02767401|Adrenergic Agents|adrenergic agents|mesh-ancestor
25194105|NCT02767154|Mannitol|mannitol|mesh-list
24434814|NCT00263718|Dermatologic Agents|dermatologic agents|mesh-ancestor
25666817|NCT01700192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25666818|NCT01700192|Respiratory System Agents|respiratory system agents|mesh-ancestor
25666819|NCT01700192|Mydriatics|mydriatics|mesh-ancestor
25666820|NCT01700192|Sympathomimetics|sympathomimetics|mesh-ancestor
25666821|NCT01700192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25666822|NCT01700192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25666823|NCT01700192|Dermatologic Agents|dermatologic agents|mesh-ancestor
25666824|NCT01700192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25666825|NCT01700192|Antipruritics|antipruritics|mesh-ancestor
25860614|NCT00084032|Antiviral Agents|antiviral agents|mesh-ancestor
24798333|NCT01962636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24798334|NCT01962636|Immunologic Factors|immunologic factors|mesh-ancestor
24798335|NCT01962636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798336|NCT01962636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24798337|NCT01962636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24798338|NCT01962636|Alkylating Agents|alkylating agents|mesh-ancestor
24434816|NCT00263744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24434817|NCT00263744|Immunologic Factors|immunologic factors|mesh-ancestor
24434818|NCT00263744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434819|NCT00263744|Antacids|antacids|mesh-ancestor
24434820|NCT00263744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434822|NCT00263796|Oxytocin|oxytocin|mesh-list
24434823|NCT00263796|Oxytocics|oxytocics|mesh-ancestor
24825419|NCT02128321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825420|NCT02128321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24825421|NCT02128321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434849|NCT00264108|Darbepoetin alfa|darbepoetin alfa|mesh-list
24434850|NCT00264108|Hematinics|hematinics|mesh-ancestor
24434851|NCT00264134|Carboplatin|carboplatin|mesh-list
24434853|NCT00264134|Irinotecan|irinotecan|mesh-list
24434854|NCT00264134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24434855|NCT00264134|Tubulin Modulators|tubulin modulators|mesh-ancestor
24434856|NCT00264134|Antimitotic Agents|antimitotic agents|mesh-ancestor
24434857|NCT00264134|Mitosis Modulators|mitosis modulators|mesh-ancestor
24434858|NCT00264134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543083|NCT00681902|Sensory System Agents|sensory system agents|mesh-ancestor
25860615|NCT00084032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25860616|NCT00084058|Ritonavir|ritonavir|mesh-list
24972030|NCT03720665|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24543645|NCT00684827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543648|NCT00684853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543680|NCT00684957|Hormones|hormones|mesh-list
24543681|NCT00684957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25860617|NCT00084058|Lopinavir|lopinavir|mesh-list
25860618|NCT00084058|Saquinavir|saquinavir|mesh-list
25860619|NCT00084058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25860620|NCT00084058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25860621|NCT00084058|Protease Inhibitors|protease inhibitors|mesh-ancestor
24858009|NCT02294643|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24858010|NCT02294643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24858012|NCT02294643|Antipyretics|antipyretics|mesh-ancestor
25860622|NCT00084058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860623|NCT00084058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860624|NCT00084058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25860625|NCT00084058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25860626|NCT00084058|Antiviral Agents|antiviral agents|mesh-ancestor
25860627|NCT00084058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25860628|NCT00084058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25194106|NCT02767154|Dextrans|dextrans|mesh-list
25194107|NCT02767154|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25194108|NCT02767154|Diuretics|diuretics|mesh-ancestor
25194109|NCT02767154|Natriuretic Agents|natriuretic agents|mesh-ancestor
25194110|NCT02767154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194111|NCT02767154|Anticoagulants|anticoagulants|mesh-ancestor
25194112|NCT02767154|Plasma Substitutes|plasma substitutes|mesh-ancestor
25194113|NCT02767154|Blood Substitutes|blood substitutes|mesh-ancestor
25194114|NCT02767102|Melatonin|melatonin|mesh-list
25194115|NCT02767102|Antioxidants|antioxidants|mesh-ancestor
25194116|NCT02767102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194117|NCT02767102|Protective Agents|protective agents|mesh-ancestor
25194118|NCT02767102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194119|NCT02767102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25194120|NCT02767232|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25194121|NCT02767232|Plasminogen|plasminogen|mesh-list
25194122|NCT02767232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25666826|NCT01700192|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25666827|NCT01700192|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25666828|NCT01700192|Histamine Antagonists|histamine antagonists|mesh-ancestor
25666829|NCT01700192|Histamine Agents|histamine agents|mesh-ancestor
25666830|NCT01700192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25666831|NCT01700192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25194123|NCT02767232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25194124|NCT02767232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194125|NCT02767479|Esomeprazole|esomeprazole|mesh-list
24779857|NCT01879358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24779858|NCT01879358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24779859|NCT01879358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779860|NCT01879358|Antifungal Agents|antifungal agents|mesh-ancestor
24779861|NCT01879358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24779862|NCT01879358|Immunologic Factors|immunologic factors|mesh-ancestor
24779863|NCT01879358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194126|NCT02767479|Rabeprazole|rabeprazole|mesh-list
25194127|NCT02767479|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24549734|NCT00717379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434894|NCT00264212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194128|NCT02767479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25194129|NCT02767479|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25194130|NCT02767479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194131|NCT02767479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194132|NCT02767089|Prednisone|prednisone|mesh-list
25194133|NCT02767089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24559484|NCT04757584|Acebutolol|acebutolol|mesh-list
25194134|NCT02767089|Glucocorticoids|glucocorticoids|mesh-ancestor
25194135|NCT02767089|Hormones|hormones|mesh-ancestor
25194136|NCT02767089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25194137|NCT02767089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194138|NCT02767089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25194139|NCT02767089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25194140|NCT02767219|Dexamethasone|dexamethasone|mesh-list
25194141|NCT02767219|Bevacizumab|bevacizumab|mesh-list
25194142|NCT02767219|Fluorouracil|fluorouracil|mesh-list
25194143|NCT02767219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25194144|NCT02767219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25194145|NCT02767219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25194146|NCT02767219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25194147|NCT02767219|Growth Substances|growth substances|mesh-ancestor
25194148|NCT02767219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194149|NCT02767219|Growth Inhibitors|growth inhibitors|mesh-ancestor
25194150|NCT02767219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25194151|NCT02767219|Antiemetics|antiemetics|mesh-ancestor
25194152|NCT02767219|Autonomic Agents|autonomic agents|mesh-ancestor
25194153|NCT02767219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25194154|NCT02767219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25194155|NCT02767219|Glucocorticoids|glucocorticoids|mesh-ancestor
25194156|NCT02767219|Hormones|hormones|mesh-ancestor
25194157|NCT02767219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25194158|NCT02767219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25194159|NCT02767219|Antimetabolites|antimetabolites|mesh-ancestor
25194160|NCT02767219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194161|NCT02767219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25194162|NCT02767219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25194163|NCT02767219|Immunologic Factors|immunologic factors|mesh-ancestor
25194164|NCT02767076|Anesthetics|anesthetics|mesh-list
25194165|NCT02767076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25194166|NCT02767076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194167|NCT02767063|Pioglitazone|pioglitazone|mesh-list
25194168|NCT02767063|Avelumab|avelumab|mesh-list
25194169|NCT02767063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25194170|NCT02767063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194171|NCT02767063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25194172|NCT02767063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25194173|NCT02766764|Hormones|hormones|mesh-list
25194174|NCT02766764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25194175|NCT02766764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194176|NCT02766855|Cysteamine|cysteamine|mesh-list
25194177|NCT02766855|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
25194178|NCT02766855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194179|NCT02767024|Nitroprusside|nitroprusside|mesh-list
25194180|NCT02767024|Dobutamine|dobutamine|mesh-list
25666832|NCT01700192|Analgesics|analgesics|mesh-ancestor
25666833|NCT01700192|Sensory System Agents|sensory system agents|mesh-ancestor
25666834|NCT01700192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25666835|NCT01700192|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25666836|NCT01700387|Topiramate|topiramate|mesh-list
25666837|NCT01700387|Botulinum Toxins|botulinum toxins|mesh-list
25666838|NCT01700387|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25666839|NCT01700387|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25194181|NCT02767024|Furosemide|furosemide|mesh-list
24621028|NCT01060423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936006|NCT04045548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24936007|NCT04045548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936008|NCT04045522|Zoledronic Acid|zoledronic acid|mesh-list
24936009|NCT04045522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24936012|NCT04046185|Progesterone|progesterone|mesh-list
24621029|NCT01060423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24621030|NCT01060423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25194182|NCT02767024|Diuretics|diuretics|mesh-ancestor
25194183|NCT02767024|Natriuretic Agents|natriuretic agents|mesh-ancestor
25194184|NCT02767024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194185|NCT02767024|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25194186|NCT02767024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25194187|NCT02767024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194188|NCT02767024|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25194189|NCT02767024|Sympathomimetics|sympathomimetics|mesh-ancestor
25194190|NCT02767024|Autonomic Agents|autonomic agents|mesh-ancestor
25194191|NCT02767024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25194192|NCT02767024|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25194193|NCT02767024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25194194|NCT02767024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25194195|NCT02767024|Adrenergic Agents|adrenergic agents|mesh-ancestor
25194196|NCT02767024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25194197|NCT02767024|Protective Agents|protective agents|mesh-ancestor
25194198|NCT02767024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25194199|NCT02767024|Vasodilator Agents|vasodilator agents|mesh-ancestor
25194200|NCT02767024|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25194201|NCT02766803|Resveratrol|resveratrol|mesh-list
25194202|NCT02766803|Simvastatin|simvastatin|mesh-list
25194203|NCT02766803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25194204|NCT02766803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25194205|NCT02766803|Antimetabolites|antimetabolites|mesh-ancestor
25194206|NCT02766803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194207|NCT02766803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25194208|NCT02766803|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25194209|NCT02766803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194210|NCT02766803|Antioxidants|antioxidants|mesh-ancestor
25194211|NCT02766803|Protective Agents|protective agents|mesh-ancestor
25194212|NCT02766803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590279|NCT00911651|Autonomic Agents|autonomic agents|mesh-ancestor
25194213|NCT02766803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25194214|NCT02766725|Sildenafil Citrate|sildenafil citrate|mesh-list
25194215|NCT02766725|Vasodilator Agents|vasodilator agents|mesh-ancestor
25194216|NCT02766725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25194217|NCT02766725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25194218|NCT02766725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194219|NCT02766725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194220|NCT02766725|Urological Agents|urological agents|mesh-ancestor
25194221|NCT02766647|Lenograstim|lenograstim|mesh-list
25194222|NCT02766647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25194223|NCT02766647|Immunologic Factors|immunologic factors|mesh-ancestor
25194224|NCT02766647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194225|NCT02766634|Lenograstim|lenograstim|mesh-list
25194226|NCT02766634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25194227|NCT02766634|Immunologic Factors|immunologic factors|mesh-ancestor
25194228|NCT02766634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194229|NCT02766439|Etanercept|etanercept|mesh-list
25194230|NCT02766439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25194231|NCT02766439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25194232|NCT02766439|Analgesics|analgesics|mesh-ancestor
25194233|NCT02766439|Sensory System Agents|sensory system agents|mesh-ancestor
25194352|NCT02765594|Valsartan|valsartan|mesh-list
25194234|NCT02766439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25666840|NCT01700387|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25666841|NCT01700387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25666842|NCT01700387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666843|NCT01700387|Cholinergic Agents|cholinergic agents|mesh-ancestor
25666844|NCT01700387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25666845|NCT01700387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666846|NCT01700387|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25666847|NCT01700387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25666848|NCT01700387|Anticonvulsants|anticonvulsants|mesh-ancestor
24780010|NCT01880385|Growth Inhibitors|growth inhibitors|mesh-ancestor
24780011|NCT01880385|Tubulin Modulators|tubulin modulators|mesh-ancestor
24780012|NCT01880385|Antimitotic Agents|antimitotic agents|mesh-ancestor
25194235|NCT02766439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194236|NCT02766439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25194237|NCT02766439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25194238|NCT02766439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25194239|NCT02766439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25194240|NCT02766439|Immunologic Factors|immunologic factors|mesh-ancestor
25194241|NCT02766192|Ketamine|ketamine|mesh-list
25194242|NCT02766192|Analgesics|analgesics|mesh-ancestor
25194243|NCT02766192|Sensory System Agents|sensory system agents|mesh-ancestor
25194244|NCT02766192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25194245|NCT02766192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194246|NCT02766192|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25194247|NCT02766192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25194248|NCT02766192|Anesthetics, General|anesthetics, general|mesh-ancestor
25194249|NCT02766192|Anesthetics|anesthetics|mesh-ancestor
25206889|NCT05267873|Dopamine Agents|dopamine agents|mesh-ancestor
25194250|NCT02766192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24559639|NCT04581824|Pembrolizumab|pembrolizumab|mesh-list
25194251|NCT02766192|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25194252|NCT02766192|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25194253|NCT02766192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25194254|NCT02766192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194255|NCT02766270|Temozolomide|temozolomide|mesh-list
25194256|NCT02766270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25194257|NCT02766270|Alkylating Agents|alkylating agents|mesh-ancestor
25194258|NCT02766270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194259|NCT02766270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25194260|NCT02766556|Dexmedetomidine|dexmedetomidine|mesh-list
25194261|NCT02766556|Ropivacaine|ropivacaine|mesh-list
25194262|NCT02766556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25194263|NCT02766556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25194264|NCT02766556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194265|NCT02766556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25194266|NCT02766556|Analgesics|analgesics|mesh-ancestor
25194267|NCT02766556|Sensory System Agents|sensory system agents|mesh-ancestor
25194268|NCT02766556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25194269|NCT02766556|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25206871|NCT05268419|Ethanol|ethanol|mesh-list
25194270|NCT02766556|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25194271|NCT02766556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25194272|NCT02766556|Adrenergic Agents|adrenergic agents|mesh-ancestor
25194273|NCT02766556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25194274|NCT02766556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194275|NCT02766556|Anesthetics, Local|anesthetics, local|mesh-ancestor
25194276|NCT02766556|Anesthetics|anesthetics|mesh-ancestor
25194277|NCT02766348|Gemcitabine|gemcitabine|mesh-list
25194279|NCT02766348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25194280|NCT02766348|Antimetabolites|antimetabolites|mesh-ancestor
25194281|NCT02766348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194282|NCT02766348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25194283|NCT02766348|Antiviral Agents|antiviral agents|mesh-ancestor
25194284|NCT02766348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25194285|NCT02766348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194286|NCT02766348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25194287|NCT02766348|Immunologic Factors|immunologic factors|mesh-ancestor
25194288|NCT02766348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194289|NCT02766322|Ethanol|ethanol|mesh-list
25194290|NCT02766322|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25194291|NCT02766322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25194292|NCT02766322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25194293|NCT02766322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194294|NCT02766257|Anesthetics|anesthetics|mesh-list
25194295|NCT02766257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25194296|NCT02766257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194297|NCT02766140|Docetaxel|docetaxel|mesh-list
25194298|NCT02766140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25194299|NCT02766140|Tubulin Modulators|tubulin modulators|mesh-ancestor
25194300|NCT02766140|Antimitotic Agents|antimitotic agents|mesh-ancestor
25194301|NCT02766140|Mitosis Modulators|mitosis modulators|mesh-ancestor
25666849|NCT01700387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25666850|NCT01700517|Anesthetics|anesthetics|mesh-list
25666851|NCT01700517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24627733|NCT01094613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25194302|NCT02766140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206872|NCT05268419|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24559977|NCT03916419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25206873|NCT05268419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25206874|NCT05268419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25206875|NCT05268419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206876|NCT05267873|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25206877|NCT05267873|Vortioxetine|vortioxetine|mesh-list
25206878|NCT05267873|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25206879|NCT05267873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25206880|NCT05267873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25206881|NCT05267873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206882|NCT05267873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25206883|NCT05267873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206884|NCT05267873|Analgesics|analgesics|mesh-ancestor
25206885|NCT05267873|Sensory System Agents|sensory system agents|mesh-ancestor
25206886|NCT05267873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25206887|NCT05267873|Antidepressive Agents|antidepressive agents|mesh-ancestor
25206888|NCT05267873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25206895|NCT05267873|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25206896|NCT05267873|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25206897|NCT05267873|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25206898|NCT05267873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25206899|NCT05251233|Pantoprazole|pantoprazole|mesh-list
25206900|NCT05251233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25206901|NCT05251233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25206902|NCT05251233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25206903|NCT05251233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25206904|NCT05251233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194303|NCT02766036|Propolis|propolis|mesh-list
25194304|NCT02766036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24560065|NCT03668808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194305|NCT02765971|Picosulfate sodium|picosulfate sodium|mesh-list
25194306|NCT02765971|Cathartics|cathartics|mesh-ancestor
25194307|NCT02765971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25194308|NCT02765815|Ketorolac|ketorolac|mesh-list
25194309|NCT02765815|Epinephrine|epinephrine|mesh-list
25194310|NCT02765815|Racepinephrine|racepinephrine|mesh-list
25194311|NCT02765815|Morphine|morphine|mesh-list
25194312|NCT02765815|Bupivacaine|bupivacaine|mesh-list
25194313|NCT02765815|Epinephryl borate|epinephryl borate|mesh-list
25194314|NCT02765815|Anesthetics, Local|anesthetics, local|mesh-ancestor
25194315|NCT02765815|Anesthetics|anesthetics|mesh-ancestor
25194316|NCT02765815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25194317|NCT02765815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194318|NCT02765815|Sensory System Agents|sensory system agents|mesh-ancestor
25194319|NCT02765815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25194320|NCT02765815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25194321|NCT02765815|Narcotics|narcotics|mesh-ancestor
25194322|NCT02765815|Analgesics|analgesics|mesh-ancestor
25194323|NCT02765815|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25194324|NCT02765815|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25194325|NCT02765815|Adrenergic Agents|adrenergic agents|mesh-ancestor
25194326|NCT02765815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25194327|NCT02765815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194328|NCT02765815|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25194329|NCT02765815|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25194330|NCT02765815|Autonomic Agents|autonomic agents|mesh-ancestor
25194331|NCT02765815|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25194332|NCT02765815|Respiratory System Agents|respiratory system agents|mesh-ancestor
25194333|NCT02765815|Mydriatics|mydriatics|mesh-ancestor
25194334|NCT02765815|Sympathomimetics|sympathomimetics|mesh-ancestor
25194335|NCT02765815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25194336|NCT02765815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25194337|NCT02765815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25194338|NCT02765815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25194339|NCT02765815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25194340|NCT02765815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25194341|NCT02765815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194342|NCT02765633|Cangrelor|cangrelor|mesh-list
25194343|NCT02765633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25194344|NCT02765633|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25666852|NCT01700517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936059|NCT04044651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936060|NCT04044651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24780150|NCT01882075|Plasma Substitutes|plasma substitutes|mesh-ancestor
24780151|NCT01882075|Blood Substitutes|blood substitutes|mesh-ancestor
24780152|NCT01882127|Dexamethasone|dexamethasone|mesh-list
24780153|NCT01882127|Tretinoin|tretinoin|mesh-list
24780154|NCT01882127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24780155|NCT01882127|Antiemetics|antiemetics|mesh-ancestor
25194345|NCT02765633|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25194346|NCT02765633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25194347|NCT02765633|Purinergic Agents|purinergic agents|mesh-ancestor
25194348|NCT02765633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25194349|NCT02765633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194350|NCT02765633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194351|NCT02765594|Hydroxychloroquine|hydroxychloroquine|mesh-list
25194353|NCT02765594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25194354|NCT02765594|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25194355|NCT02765594|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25194356|NCT02765594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194357|NCT02765594|Antimalarials|antimalarials|mesh-ancestor
25194358|NCT02765594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25194359|NCT02765594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25194360|NCT02765594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25194361|NCT02765594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194362|NCT02765594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25194363|NCT02765347|Metformin|metformin|mesh-list
25194364|NCT02765347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25194365|NCT02765347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194366|NCT02765399|Liraglutide|liraglutide|mesh-list
25194367|NCT02765399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25194368|NCT02765399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194369|NCT02765399|Incretins|incretins|mesh-ancestor
25194370|NCT02765399|Hormones|hormones|mesh-ancestor
25194371|NCT02765399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25194372|NCT02765373|Letrozole|letrozole|mesh-list
25194373|NCT02765373|Anastrozole|anastrozole|mesh-list
25194374|NCT02765373|Exemestane|exemestane|mesh-list
25194375|NCT02765373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25194376|NCT02765373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25194377|NCT02765373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25194378|NCT02765373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194379|NCT02765373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194380|NCT02765373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25194381|NCT02765373|Hormone Antagonists|hormone antagonists|mesh-ancestor
25194382|NCT02765373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25194383|NCT02765373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194384|NCT02765373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25194385|NCT02765217|Amoxicillin|amoxicillin|mesh-list
25194386|NCT02765217|Clavulanic Acids|clavulanic acids|mesh-list
25194387|NCT02765217|Clavulanic Acid|clavulanic acid|mesh-list
25194388|NCT02765217|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25194389|NCT02765217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25194390|NCT02765217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25194391|NCT02765217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194392|NCT02765217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194393|NCT02765217|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25194394|NCT02765204|Dapagliflozin|dapagliflozin|mesh-list
25194395|NCT02765204|Saxagliptin|saxagliptin|mesh-list
25194396|NCT02765204|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25194397|NCT02765204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194398|NCT02765204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25194399|NCT02765204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194400|NCT02765204|Incretins|incretins|mesh-ancestor
25194401|NCT02765204|Hormones|hormones|mesh-ancestor
25194402|NCT02765204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25427795|NCT01844986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25666853|NCT01700530|Simvastatin|simvastatin|mesh-list
25666854|NCT01700530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
25666855|NCT01700530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25666856|NCT01700530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25666857|NCT01700530|Antimetabolites|antimetabolites|mesh-ancestor
25666858|NCT01700530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666859|NCT01700530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24780195|NCT01882361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24780196|NCT01882374|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
24780197|NCT01882374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25194403|NCT02765204|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25194404|NCT02765204|Protease Inhibitors|protease inhibitors|mesh-ancestor
25194405|NCT02765204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194406|NCT02765022|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25194407|NCT02765022|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
25194408|NCT02765022|beta-Endorphin|beta-endorphin|mesh-list
25194410|NCT02765022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25194411|NCT02765022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194412|NCT02765022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25194413|NCT02765022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194414|NCT02765009|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25194415|NCT02765009|Furosemide|furosemide|mesh-list
25194416|NCT02765009|Bumetanide|bumetanide|mesh-list
25194417|NCT02765009|Diuretics|diuretics|mesh-list
25194418|NCT02765009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25194419|NCT02765009|Natriuretic Agents|natriuretic agents|mesh-ancestor
25194420|NCT02765009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194421|NCT02765009|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25194422|NCT02765009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25194423|NCT02765009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194424|NCT02765009|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25194425|NCT02765126|Vaccines|vaccines|mesh-list
25194427|NCT02765126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194428|NCT02764619|Spironolactone|spironolactone|mesh-list
25194429|NCT02764619|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25194430|NCT02764619|Hormone Antagonists|hormone antagonists|mesh-ancestor
25194440|NCT02764515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194441|NCT02764515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25194442|NCT02764515|Antimetabolites|antimetabolites|mesh-ancestor
25194443|NCT02764515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194444|NCT02764515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25194445|NCT02764515|Dermatologic Agents|dermatologic agents|mesh-ancestor
25194446|NCT02764515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194447|NCT02764515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25194448|NCT02764515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25194449|NCT02764515|Immunologic Factors|immunologic factors|mesh-ancestor
25194450|NCT02764515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25194451|NCT02764515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25194452|NCT02764736|Atorvastatin|atorvastatin|mesh-list
25194453|NCT02764736|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25194454|NCT02764736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25194455|NCT02764736|Antimetabolites|antimetabolites|mesh-ancestor
25194456|NCT02764736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194457|NCT02764736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25194458|NCT02764736|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25194459|NCT02764736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194460|NCT02764723|Bupivacaine|bupivacaine|mesh-list
25194461|NCT02764723|Ropivacaine|ropivacaine|mesh-list
25194462|NCT02764723|Anesthetics, Local|anesthetics, local|mesh-ancestor
25194463|NCT02764723|Anesthetics|anesthetics|mesh-ancestor
25194464|NCT02764723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25194465|NCT02764723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194466|NCT02764723|Sensory System Agents|sensory system agents|mesh-ancestor
25194467|NCT02764723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25194468|NCT02764710|Amoxicillin|amoxicillin|mesh-list
25194469|NCT02764710|Clavulanic Acid|clavulanic acid|mesh-list
25194470|NCT02764710|Clavulanic Acids|clavulanic acids|mesh-list
25194471|NCT02764710|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25194472|NCT02764710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25194473|NCT02764710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25194474|NCT02764710|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25194475|NCT02764710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194476|NCT02764710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194478|NCT02764749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25194479|NCT02764749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25194480|NCT02764749|Disinfectants|disinfectants|mesh-ancestor
25666860|NCT01700530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25666861|NCT01700621|Vaccines|vaccines|mesh-list
25666862|NCT01700621|Immunologic Factors|immunologic factors|mesh-ancestor
24621039|NCT01060488|Hormones|hormones|mesh-ancestor
25194481|NCT02764749|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25194482|NCT02764749|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25194483|NCT02764593|Nivolumab|nivolumab|mesh-list
25194484|NCT02764593|Cetuximab|cetuximab|mesh-list
25194485|NCT02764593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25194486|NCT02764593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25194487|NCT02764593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25194488|NCT02764593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194489|NCT02764359|Vancomycin|vancomycin|mesh-list
25194490|NCT02764359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25194491|NCT02764359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25194610|NCT02763839|Immunologic Factors|immunologic factors|mesh-ancestor
25206936|NCT05244538|Anesthetics|anesthetics|mesh-ancestor
25206937|NCT05244538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25206938|NCT05244538|Narcotics|narcotics|mesh-ancestor
25206939|NCT05244538|Analgesics|analgesics|mesh-ancestor
25206940|NCT05244538|Sensory System Agents|sensory system agents|mesh-ancestor
25206941|NCT05244538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25206942|NCT05229445|Insulin|insulin|mesh-list
25206943|NCT05229445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25194492|NCT02764125|Levodopa|levodopa|mesh-list
25194493|NCT02764125|Carbidopa|carbidopa|mesh-list
25194494|NCT02764125|Entacapone|entacapone|mesh-list
25194495|NCT02764125|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25194496|NCT02764125|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25194497|NCT02764125|Dopamine Agents|dopamine agents|mesh-ancestor
25194498|NCT02764125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25194499|NCT02764125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194500|NCT02764125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194501|NCT02764125|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25194502|NCT02764125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194503|NCT02764125|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25194504|NCT02764281|Dexamethasone|dexamethasone|mesh-list
25194505|NCT02764281|Methotrexate|methotrexate|mesh-list
25194506|NCT02764281|Etoposide|etoposide|mesh-list
25194507|NCT02764281|Pegaspargase|pegaspargase|mesh-list
25194508|NCT02764281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25194509|NCT02764281|Antiemetics|antiemetics|mesh-ancestor
25194510|NCT02764281|Autonomic Agents|autonomic agents|mesh-ancestor
25194511|NCT02764281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25194512|NCT02764281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194513|NCT02764281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25194514|NCT02764281|Glucocorticoids|glucocorticoids|mesh-ancestor
25194515|NCT02764281|Hormones|hormones|mesh-ancestor
25194516|NCT02764281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25194517|NCT02764281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25194518|NCT02764281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25194519|NCT02764281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194520|NCT02764281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194521|NCT02764281|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25194522|NCT02764281|Abortifacient Agents|abortifacient agents|mesh-ancestor
25194523|NCT02764281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25194524|NCT02764281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25194525|NCT02764281|Antimetabolites|antimetabolites|mesh-ancestor
25194526|NCT02764281|Dermatologic Agents|dermatologic agents|mesh-ancestor
25194527|NCT02764281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25194528|NCT02764281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25194529|NCT02764281|Immunologic Factors|immunologic factors|mesh-ancestor
25194530|NCT02764281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25194531|NCT02764281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25194532|NCT02764281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25194533|NCT02764281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25194534|NCT02764281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25194535|NCT02764411|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25194536|NCT02764411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25194537|NCT02764411|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25194538|NCT02764411|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25194539|NCT02764411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25194540|NCT02764411|Adrenergic Agents|adrenergic agents|mesh-ancestor
25194541|NCT02764411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25194611|NCT02763839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194542|NCT02764411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194543|NCT02764411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194545|NCT02763969|Interferon-alpha|interferon-alpha|mesh-list
25666863|NCT01700621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488377|NCT00468234|Cholinergic Agents|cholinergic agents|mesh-ancestor
25194546|NCT02763969|Interferon alpha-2|interferon alpha-2|mesh-list
25194547|NCT02763969|Ustekinumab|ustekinumab|mesh-list
25194548|NCT02763969|Famotidine|famotidine|mesh-list
25194549|NCT02763969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25194550|NCT02763969|Antiviral Agents|antiviral agents|mesh-ancestor
25194551|NCT02763969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25194552|NCT02763969|Immunologic Factors|immunologic factors|mesh-ancestor
25194553|NCT02763969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194554|NCT02763969|Dermatologic Agents|dermatologic agents|mesh-ancestor
25194555|NCT02763969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25194556|NCT02763969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25194557|NCT02763969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25194558|NCT02763969|Histamine Antagonists|histamine antagonists|mesh-ancestor
25194559|NCT02763969|Histamine Agents|histamine agents|mesh-ancestor
25194560|NCT02763969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25194561|NCT02763969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194562|NCT02763852|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
24435951|NCT00268554|Dipyridamole|dipyridamole|mesh-list
25194563|NCT02763852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194564|NCT02763852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194565|NCT02763852|Dopamine Agents|dopamine agents|mesh-ancestor
25194566|NCT02763852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25194567|NCT02763852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194568|NCT02764021|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25194569|NCT02764021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194570|NCT02763722|Emollients|emollients|mesh-list
25194571|NCT02763722|Dermatologic Agents|dermatologic agents|mesh-ancestor
25194572|NCT02763592|Lidocaine|lidocaine|mesh-list
25194573|NCT02763592|Anesthetics, Local|anesthetics, local|mesh-ancestor
25194574|NCT02763592|Anesthetics|anesthetics|mesh-ancestor
25194575|NCT02763592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25194576|NCT02763592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194577|NCT02763592|Sensory System Agents|sensory system agents|mesh-ancestor
25194578|NCT02763592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25194579|NCT02763592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25194580|NCT02763592|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25194581|NCT02763592|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25194582|NCT02763592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25194583|NCT02763592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194584|NCT02763761|Prednisone|prednisone|mesh-list
25194585|NCT02763761|Methylprednisolone|methylprednisolone|mesh-list
25194586|NCT02763761|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25194587|NCT02763761|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25194588|NCT02763761|Prednisolone|prednisolone|mesh-list
25194589|NCT02763761|Prednisolone acetate|prednisolone acetate|mesh-list
25194590|NCT02763761|Infliximab|infliximab|mesh-list
25194591|NCT02763761|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25194592|NCT02763761|Prednisolone phosphate|prednisolone phosphate|mesh-list
25194593|NCT02763761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25194594|NCT02763761|Glucocorticoids|glucocorticoids|mesh-ancestor
25194595|NCT02763761|Hormones|hormones|mesh-ancestor
25194596|NCT02763761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25194597|NCT02763761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194598|NCT02763761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25194599|NCT02763761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25194600|NCT02763761|Antiemetics|antiemetics|mesh-ancestor
25194601|NCT02763761|Autonomic Agents|autonomic agents|mesh-ancestor
24560608|NCT02218164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560609|NCT02218164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24560610|NCT02218164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860629|NCT00084058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25194602|NCT02763761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25194603|NCT02763761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25194604|NCT02763761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25194605|NCT02763761|Protective Agents|protective agents|mesh-ancestor
25194606|NCT02763761|Dermatologic Agents|dermatologic agents|mesh-ancestor
25194607|NCT02763761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25194608|NCT02763839|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25194609|NCT02763839|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25194613|NCT02763839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25194614|NCT02763839|Dopamine Agonists|dopamine agonists|mesh-ancestor
25194615|NCT02763839|Dopamine Agents|dopamine agents|mesh-ancestor
25666864|NCT01700829|Midazolam|midazolam|mesh-list
25666865|NCT01700829|Ketamine|ketamine|mesh-list
25666866|NCT01700829|Analgesics|analgesics|mesh-ancestor
25194616|NCT02763839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25194617|NCT02763839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194620|NCT02764008|Anesthetics|anesthetics|mesh-ancestor
25194621|NCT02764008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25194622|NCT02764008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194623|NCT02764008|Sensory System Agents|sensory system agents|mesh-ancestor
25194624|NCT02764008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25194625|NCT02763475|Cyclophosphamide|cyclophosphamide|mesh-list
25194626|NCT02763475|Fludarabine|fludarabine|mesh-list
25194627|NCT02763475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25194628|NCT02763475|Immunologic Factors|immunologic factors|mesh-ancestor
25194629|NCT02763475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194630|NCT02763475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25194631|NCT02763475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25194632|NCT02763475|Alkylating Agents|alkylating agents|mesh-ancestor
25194633|NCT02763475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194634|NCT02763475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25194635|NCT02763475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25194636|NCT02763137|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25194637|NCT02763137|Carbidopa|carbidopa|mesh-list
25194638|NCT02763137|Levodopa|levodopa|mesh-list
24436121|NCT00269035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25194640|NCT02763137|Immunologic Factors|immunologic factors|mesh-ancestor
25194641|NCT02763137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194642|NCT02763137|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25194643|NCT02763137|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25194644|NCT02763137|Dopamine Agonists|dopamine agonists|mesh-ancestor
25194645|NCT02763137|Dopamine Agents|dopamine agents|mesh-ancestor
25194646|NCT02763137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25194721|NCT02762981|Paclitaxel|paclitaxel|mesh-list
25194647|NCT02763137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194648|NCT02763137|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25194649|NCT02763137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194650|NCT02762955|Adalimumab|adalimumab|mesh-list
25194651|NCT02762955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25194652|NCT02762955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25194653|NCT02763098|Remifentanil|remifentanil|mesh-list
25194654|NCT02763098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25194655|NCT02763098|Narcotics|narcotics|mesh-ancestor
25194656|NCT02763098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25194657|NCT02763098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194658|NCT02763098|Analgesics|analgesics|mesh-ancestor
25194659|NCT02763098|Sensory System Agents|sensory system agents|mesh-ancestor
25194660|NCT02763098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25194661|NCT02763059|Acetaminophen|acetaminophen|mesh-list
25194662|NCT02763059|Dexamethasone|dexamethasone|mesh-list
25194663|NCT02763059|Ibuprofen|ibuprofen|mesh-list
25194664|NCT02763059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25194665|NCT02763059|Antiemetics|antiemetics|mesh-ancestor
25194666|NCT02763059|Autonomic Agents|autonomic agents|mesh-ancestor
25194667|NCT02763059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25194668|NCT02763059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194669|NCT02763059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25194670|NCT02763059|Glucocorticoids|glucocorticoids|mesh-ancestor
25194671|NCT02763059|Hormones|hormones|mesh-ancestor
25194672|NCT02763059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25860630|NCT00084097|Omalizumab|omalizumab|mesh-list
25860631|NCT00084097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25194673|NCT02763059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25194674|NCT02763059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25194675|NCT02763059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25194676|NCT02763059|Analgesics|analgesics|mesh-ancestor
25194677|NCT02763059|Sensory System Agents|sensory system agents|mesh-ancestor
25194678|NCT02763059|Antipyretics|antipyretics|mesh-ancestor
25194679|NCT02763059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25194680|NCT02763059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25194681|NCT02763059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25194682|NCT02763059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194683|NCT02763059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194685|NCT02763007|Alogliptin|alogliptin|mesh-list
25194686|NCT02763007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25194687|NCT02763007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194688|NCT02763007|Incretins|incretins|mesh-ancestor
25194689|NCT02763007|Hormones|hormones|mesh-ancestor
25404108|NCT03684811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24780479|NCT01884506|Micronutrients|micronutrients|mesh-ancestor
24780480|NCT01884506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780481|NCT01884506|Antioxidants|antioxidants|mesh-ancestor
24667990|NCT05197049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456251|NCT00330772|Antipyretics|antipyretics|mesh-ancestor
24780482|NCT01884506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780483|NCT01884506|Protective Agents|protective agents|mesh-ancestor
24780484|NCT01884506|Vitamins|vitamins|mesh-ancestor
24780485|NCT01884558|Metformin|metformin|mesh-list
25194690|NCT02763007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25194691|NCT02763007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25194692|NCT02763007|Protease Inhibitors|protease inhibitors|mesh-ancestor
25194693|NCT02763007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194694|NCT02763007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194695|NCT02762838|Folic Acid|folic acid|mesh-list
25194696|NCT02762838|Methotrexate|methotrexate|mesh-list
25194697|NCT02762838|Infliximab|infliximab|mesh-list
25194698|NCT02762838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25194699|NCT02762838|Abortifacient Agents|abortifacient agents|mesh-ancestor
25194700|NCT02762838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25194701|NCT02762838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194702|NCT02762838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25194703|NCT02762838|Antimetabolites|antimetabolites|mesh-ancestor
25194704|NCT02762838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194705|NCT02762838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25194706|NCT02762838|Dermatologic Agents|dermatologic agents|mesh-ancestor
25194707|NCT02762838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194708|NCT02762838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25194709|NCT02762838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24436252|NCT00269568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25194710|NCT02762838|Immunologic Factors|immunologic factors|mesh-ancestor
25194711|NCT02762838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25194712|NCT02762838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25194713|NCT02762838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25194714|NCT02762838|Hematinics|hematinics|mesh-ancestor
25194715|NCT02762838|Vitamin B Complex|vitamin b complex|mesh-ancestor
25194716|NCT02762838|Vitamins|vitamins|mesh-ancestor
25194717|NCT02762838|Micronutrients|micronutrients|mesh-ancestor
25194718|NCT02762851|Vaccines|vaccines|mesh-list
25194719|NCT02762851|Immunologic Factors|immunologic factors|mesh-ancestor
25194720|NCT02762851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194722|NCT02762981|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25194723|NCT02762981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25194724|NCT02762981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25194725|NCT02762981|Tubulin Modulators|tubulin modulators|mesh-ancestor
25194726|NCT02762981|Antimitotic Agents|antimitotic agents|mesh-ancestor
25194727|NCT02762981|Mitosis Modulators|mitosis modulators|mesh-ancestor
25194728|NCT02762981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194729|NCT02762812|Infliximab|infliximab|mesh-list
25194730|NCT02762812|Dermatologic Agents|dermatologic agents|mesh-ancestor
25194731|NCT02762812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25194732|NCT02762812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25194733|NCT02762864|Aspirin|aspirin|mesh-list
25194734|NCT02762864|Clopidogrel|clopidogrel|mesh-list
25194735|NCT02762864|Ticagrelor|ticagrelor|mesh-list
25194736|NCT02762864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25194737|NCT02762864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25194738|NCT02762864|Analgesics|analgesics|mesh-ancestor
25194739|NCT02762864|Sensory System Agents|sensory system agents|mesh-ancestor
25194740|NCT02762864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25194741|NCT02762864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194742|NCT02762864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25194743|NCT02762864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25194744|NCT02762864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25666867|NCT01700829|Sensory System Agents|sensory system agents|mesh-ancestor
25666868|NCT01700829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25666869|NCT01700829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666870|NCT01700829|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25666871|NCT01700829|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25666872|NCT01700829|Anesthetics, General|anesthetics, general|mesh-ancestor
25666873|NCT01700829|Anesthetics|anesthetics|mesh-ancestor
25666874|NCT01700829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25194745|NCT02762864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25404109|NCT03684811|Immunologic Factors|immunologic factors|mesh-ancestor
24780564|NCT01884909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24780565|NCT01884909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24795532|NCT01812252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24780566|NCT01884909|Sympatholytics|sympatholytics|mesh-ancestor
24780567|NCT01884909|Autonomic Agents|autonomic agents|mesh-ancestor
24780568|NCT01884909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24780569|NCT01884909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194746|NCT02762864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194747|NCT02762864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25194748|NCT02762864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25194749|NCT02762864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194750|NCT02762864|Antipyretics|antipyretics|mesh-ancestor
25194751|NCT02762864|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25194752|NCT02762864|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25194753|NCT02762864|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25194754|NCT02762864|Purinergic Agents|purinergic agents|mesh-ancestor
25194755|NCT02762864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25194756|NCT02762890|Iodine|iodine|mesh-list
25194757|NCT02762890|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25194758|NCT02762890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25194759|NCT02762890|Trace Elements|trace elements|mesh-ancestor
25194760|NCT02762890|Micronutrients|micronutrients|mesh-ancestor
24561165|NCT00758433|Capsaicin|capsaicin|mesh-list
25194761|NCT02762890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194762|NCT02762942|Misoprostol|misoprostol|mesh-list
25194763|NCT02762942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25194764|NCT02762942|Abortifacient Agents|abortifacient agents|mesh-ancestor
25194765|NCT02762942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25194766|NCT02762942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194767|NCT02762942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25194768|NCT02762942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25194769|NCT02762942|Oxytocics|oxytocics|mesh-ancestor
25194770|NCT02762656|Lidocaine|lidocaine|mesh-list
25194771|NCT02762656|Anesthetics, Local|anesthetics, local|mesh-ancestor
25194772|NCT02762656|Anesthetics|anesthetics|mesh-ancestor
25194773|NCT02762656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25194774|NCT02762656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194775|NCT02762656|Sensory System Agents|sensory system agents|mesh-ancestor
25194776|NCT02762656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25194777|NCT02762656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25194778|NCT02762656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25194779|NCT02762656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25194780|NCT02762656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25194781|NCT02762656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194782|NCT02762643|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25194783|NCT02762643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25194784|NCT02762643|Hormone Antagonists|hormone antagonists|mesh-ancestor
25194785|NCT02762643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24825592|NCT02129231|Antimetabolites|antimetabolites|mesh-ancestor
25194786|NCT02762643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194787|NCT02762643|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25194788|NCT02762643|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25194789|NCT02762643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25206944|NCT05229445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206945|NCT05198791|Eplerenone|eplerenone|mesh-list
25206946|NCT05198791|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25206947|NCT05198791|Hormone Antagonists|hormone antagonists|mesh-ancestor
25206948|NCT05198791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25206949|NCT05198791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206950|NCT05198791|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25206951|NCT05198791|Diuretics|diuretics|mesh-ancestor
25206952|NCT05198791|Natriuretic Agents|natriuretic agents|mesh-ancestor
25206953|NCT05198791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25206954|NCT05176470|Cyclophosphamide|cyclophosphamide|mesh-list
25666875|NCT01700829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25666876|NCT01700829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25666877|NCT01700829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25666878|NCT01700829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666879|NCT01700829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25666880|NCT01700829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25666881|NCT01700829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25860632|NCT00084097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25666882|NCT01700829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24780684|NCT01885715|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24780685|NCT01885715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780686|NCT01885715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780687|NCT01885715|Cholinergic Agents|cholinergic agents|mesh-ancestor
24780688|NCT01885715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24780689|NCT01885715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780690|NCT01885715|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24780691|NCT01885715|Autonomic Agents|autonomic agents|mesh-ancestor
24780692|NCT01885715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24780694|NCT01885988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24780695|NCT01885988|Vasodilator Agents|vasodilator agents|mesh-ancestor
24780696|NCT01885988|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25206956|NCT05176470|Fludarabine|fludarabine|mesh-list
25206957|NCT05176470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25206958|NCT05176470|Immunologic Factors|immunologic factors|mesh-ancestor
25206959|NCT05176470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206960|NCT05176470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25206961|NCT05176470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25206962|NCT05176470|Alkylating Agents|alkylating agents|mesh-ancestor
25206963|NCT05176470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206964|NCT05176470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206965|NCT05176470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25206966|NCT05176470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25206967|NCT05162300|Botulinum Toxins|botulinum toxins|mesh-list
24561240|NCT00759083|Bivalirudin|bivalirudin|mesh-list
25206968|NCT05162300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25206969|NCT05162300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25206970|NCT05162300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206971|NCT05162300|Cholinergic Agents|cholinergic agents|mesh-ancestor
25206972|NCT05162300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25206973|NCT05162300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206974|NCT05141682|Azacitidine|azacitidine|mesh-list
25206975|NCT05141682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25206976|NCT05141682|Antimetabolites|antimetabolites|mesh-ancestor
25206977|NCT05141682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206978|NCT05141682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25206979|NCT05141682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25206980|NCT05136846|Paclitaxel|paclitaxel|mesh-list
25206981|NCT05136846|Carboplatin|carboplatin|mesh-list
25206982|NCT05136846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25206991|NCT05136846|Antimitotic Agents|antimitotic agents|mesh-ancestor
25206992|NCT05136846|Mitosis Modulators|mitosis modulators|mesh-ancestor
25206993|NCT05136846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25206994|NCT05136846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25206995|NCT05136846|Immunologic Factors|immunologic factors|mesh-ancestor
25206996|NCT05136846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25206997|NCT05136846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25206998|NCT05136846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25206999|NCT05136846|Vasodilator Agents|vasodilator agents|mesh-ancestor
25207000|NCT05136846|Urological Agents|urological agents|mesh-ancestor
25207002|NCT05078060|Immunologic Factors|immunologic factors|mesh-ancestor
25207003|NCT05078060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207004|NCT05073003|Vaccines|vaccines|mesh-list
25207005|NCT05073003|Immunologic Factors|immunologic factors|mesh-ancestor
25207006|NCT05073003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561364|NCT00759824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25666883|NCT01700829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25666884|NCT01700829|GABA Modulators|gaba modulators|mesh-ancestor
25666885|NCT01700829|GABA Agents|gaba agents|mesh-ancestor
25666886|NCT01700907|Sevoflurane|sevoflurane|mesh-list
25666887|NCT01700907|Desflurane|desflurane|mesh-list
25666888|NCT01700907|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25666889|NCT01700907|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25666890|NCT01700907|Anesthetics, General|anesthetics, general|mesh-ancestor
25666891|NCT01700907|Anesthetics|anesthetics|mesh-ancestor
25666892|NCT01700907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25666893|NCT01700907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666894|NCT01700959|Melatonin|melatonin|mesh-list
25666895|NCT01700959|Antioxidants|antioxidants|mesh-ancestor
25666896|NCT01700959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666897|NCT01700959|Protective Agents|protective agents|mesh-ancestor
24488835|NCT00470249|Carboplatin|carboplatin|mesh-list
24488836|NCT00470249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488837|NCT00470249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24488838|NCT00470249|Antimetabolites|antimetabolites|mesh-ancestor
24437063|NCT00272597|Risperidone|risperidone|mesh-list
25194791|NCT02762617|Antiviral Agents|antiviral agents|mesh-ancestor
25194792|NCT02762617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25194793|NCT02762617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25194794|NCT02762617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25194795|NCT02762617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194796|NCT02762617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194797|NCT02762617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25194798|NCT02762617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25194799|NCT02762591|Pimavanserin|pimavanserin|mesh-list
25194800|NCT02762591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25194801|NCT02762591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25194802|NCT02762591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25194803|NCT02762591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25194804|NCT02762591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25194805|NCT02762591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194806|NCT02762591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25194807|NCT02762591|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25194808|NCT02762591|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25194809|NCT02762591|Serotonin Agents|serotonin agents|mesh-ancestor
25194810|NCT02762591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25194890|NCT02761512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194811|NCT02762591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194812|NCT02762344|Heparin|heparin|mesh-list
25194813|NCT02762344|Anticoagulants|anticoagulants|mesh-ancestor
25194814|NCT02762344|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25194815|NCT02762344|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25194816|NCT02762344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194819|NCT02762474|Paclitaxel|paclitaxel|mesh-list
25194820|NCT02762474|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25194821|NCT02762474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25194822|NCT02762474|Tubulin Modulators|tubulin modulators|mesh-ancestor
25194823|NCT02762474|Antimitotic Agents|antimitotic agents|mesh-ancestor
25194824|NCT02762474|Mitosis Modulators|mitosis modulators|mesh-ancestor
25269831|NCT02408146|Celecoxib|celecoxib|mesh-list
25194825|NCT02762474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194826|NCT02762383|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25194827|NCT02762383|Antiviral Agents|antiviral agents|mesh-ancestor
25194828|NCT02762383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25194829|NCT02762448|Asunaprevir|asunaprevir|mesh-list
25194830|NCT02762448|Protease Inhibitors|protease inhibitors|mesh-ancestor
25194831|NCT02762448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194832|NCT02762448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194833|NCT02762253|Riboflavin|riboflavin|mesh-list
25194834|NCT02762253|Vitamin B Complex|vitamin b complex|mesh-ancestor
25194835|NCT02762253|Vitamins|vitamins|mesh-ancestor
25194836|NCT02762253|Micronutrients|micronutrients|mesh-ancestor
25194837|NCT02762253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194838|NCT02762253|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25194839|NCT02762253|Dermatologic Agents|dermatologic agents|mesh-ancestor
25194840|NCT02762006|Durvalumab|durvalumab|mesh-list
25194841|NCT02762006|Tremelimumab|tremelimumab|mesh-list
25194842|NCT02762006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25194843|NCT02762006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25194844|NCT02762123|Flurbiprofen|flurbiprofen|mesh-list
25194845|NCT02762123|Digoxin|digoxin|mesh-list
25194846|NCT02762123|Midazolam|midazolam|mesh-list
25194847|NCT02762123|Omeprazole|omeprazole|mesh-list
25194848|NCT02762123|Montelukast|montelukast|mesh-list
25194849|NCT02762123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25194850|NCT02762123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25194851|NCT02762123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25194852|NCT02762123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194853|NCT02762123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25194854|NCT02762123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25194855|NCT02762123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25194856|NCT02762123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25194857|NCT02762123|Anesthetics, General|anesthetics, general|mesh-ancestor
25666898|NCT01700959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666899|NCT01700959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25666900|NCT01701037|Trametinib|trametinib|mesh-list
25666901|NCT01701037|Dabrafenib|dabrafenib|mesh-list
25194858|NCT02762123|Anesthetics|anesthetics|mesh-ancestor
25194859|NCT02762123|GABA Modulators|gaba modulators|mesh-ancestor
25194860|NCT02762123|GABA Agents|gaba agents|mesh-ancestor
25194861|NCT02762123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25194862|NCT02762123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194863|NCT02762123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25194864|NCT02762123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25194865|NCT02762123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25194866|NCT02762123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194867|NCT02762123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25194868|NCT02762123|Respiratory System Agents|respiratory system agents|mesh-ancestor
25194869|NCT02762123|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25194870|NCT02762123|Hormone Antagonists|hormone antagonists|mesh-ancestor
25194871|NCT02762123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25194872|NCT02762123|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25194873|NCT02762123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25194874|NCT02762123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25194875|NCT02762123|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25194876|NCT02762123|Protective Agents|protective agents|mesh-ancestor
25194877|NCT02762123|Analgesics|analgesics|mesh-ancestor
25194878|NCT02762123|Sensory System Agents|sensory system agents|mesh-ancestor
25194879|NCT02762123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25194880|NCT02762123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25194881|NCT02762123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25194882|NCT02762123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25194883|NCT02762123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25194884|NCT02762123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25194885|NCT02761512|Lansoprazole|lansoprazole|mesh-list
25194886|NCT02761512|Dexlansoprazole|dexlansoprazole|mesh-list
25194887|NCT02761512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25194888|NCT02761512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25194889|NCT02761512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25194891|NCT02761512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194893|NCT02761486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25194894|NCT02761486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25194895|NCT02761486|Analgesics|analgesics|mesh-ancestor
25194896|NCT02761486|Sensory System Agents|sensory system agents|mesh-ancestor
25194897|NCT02761486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24590322|NCT00912119|Aminocaproic Acid|aminocaproic acid|mesh-list
25194898|NCT02761486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194899|NCT02761486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25194900|NCT02761486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25194901|NCT02761486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25194902|NCT02761486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25194903|NCT02761486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194904|NCT02761486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25194905|NCT02761486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25194906|NCT02761486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194907|NCT02761486|Antipyretics|antipyretics|mesh-ancestor
25194908|NCT02761577|Acetylcysteine|acetylcysteine|mesh-list
25194909|NCT02761577|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25194910|NCT02761577|Antiviral Agents|antiviral agents|mesh-ancestor
25194911|NCT02761577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25194912|NCT02761577|Expectorants|expectorants|mesh-ancestor
25194913|NCT02761577|Respiratory System Agents|respiratory system agents|mesh-ancestor
25194914|NCT02761577|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25194915|NCT02761577|Antioxidants|antioxidants|mesh-ancestor
25194916|NCT02761577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194917|NCT02761577|Protective Agents|protective agents|mesh-ancestor
25194918|NCT02761577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194919|NCT02761577|Antidotes|antidotes|mesh-ancestor
25194921|NCT02761161|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25194922|NCT02761161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25194923|NCT02761161|Adrenergic Agents|adrenergic agents|mesh-ancestor
25194924|NCT02761161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25194925|NCT02761161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194926|NCT02761161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194927|NCT02761161|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25194928|NCT02761161|Histamine Antagonists|histamine antagonists|mesh-ancestor
25194929|NCT02761161|Histamine Agents|histamine agents|mesh-ancestor
25194930|NCT02761161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25194931|NCT02761161|Serotonin Agents|serotonin agents|mesh-ancestor
25194932|NCT02761161|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25194933|NCT02761161|Antidepressive Agents|antidepressive agents|mesh-ancestor
25194934|NCT02761161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25194935|NCT02761174|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25194936|NCT02761174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25666902|NCT01701037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25666903|NCT01701037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25666904|NCT01701037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860633|NCT00084097|Respiratory System Agents|respiratory system agents|mesh-ancestor
25860634|NCT00084201|Amoxicillin|amoxicillin|mesh-list
25860635|NCT00084201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24489044|NCT00471185|Hormone Antagonists|hormone antagonists|mesh-ancestor
24533505|NCT00644215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24533506|NCT00644215|Alkylating Agents|alkylating agents|mesh-ancestor
25194937|NCT02761174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25194938|NCT02761174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25194939|NCT02761174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25194940|NCT02761174|Adrenergic Agents|adrenergic agents|mesh-ancestor
25194941|NCT02761174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25194942|NCT02761174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194943|NCT02761174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194944|NCT02761395|Deferasirox|deferasirox|mesh-list
25194945|NCT02761395|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25194946|NCT02761395|Chelating Agents|chelating agents|mesh-ancestor
25194947|NCT02761395|Sequestering Agents|sequestering agents|mesh-ancestor
25194948|NCT02761395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194950|NCT02761317|Cathartics|cathartics|mesh-ancestor
25194951|NCT02761317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25194952|NCT02761317|Laxatives|laxatives|mesh-ancestor
25194953|NCT02761070|Bevacizumab|bevacizumab|mesh-list
25194954|NCT02761070|Temozolomide|temozolomide|mesh-list
25194955|NCT02761070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25194956|NCT02761070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25194957|NCT02761070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25194958|NCT02761070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25194959|NCT02761070|Growth Substances|growth substances|mesh-ancestor
25194960|NCT02761070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194961|NCT02761070|Growth Inhibitors|growth inhibitors|mesh-ancestor
25194962|NCT02761070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25194963|NCT02761070|Alkylating Agents|alkylating agents|mesh-ancestor
25194964|NCT02761070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194965|NCT02760888|Diclofenac|diclofenac|mesh-list
25194966|NCT02760888|Tramadol|tramadol|mesh-list
25194967|NCT02760888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25194968|NCT02760888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25194969|NCT02760888|Analgesics|analgesics|mesh-ancestor
25194970|NCT02760888|Sensory System Agents|sensory system agents|mesh-ancestor
25194971|NCT02760888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25194972|NCT02760888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194973|NCT02760888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25194974|NCT02760888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25194975|NCT02760888|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25194976|NCT02760888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194977|NCT02760888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194978|NCT02760888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25194979|NCT02760888|Narcotics|narcotics|mesh-ancestor
25194980|NCT02760888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25194981|NCT02761291|Gemcitabine|gemcitabine|mesh-list
25194982|NCT02761291|Valganciclovir|valganciclovir|mesh-list
25194983|NCT02761291|Valproic Acid|valproic acid|mesh-list
25194984|NCT02761291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25194985|NCT02761291|Antimetabolites|antimetabolites|mesh-ancestor
25194986|NCT02761291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25194987|NCT02761291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24561660|NCT00762099|Pregabalin|pregabalin|mesh-list
25194988|NCT02761291|Antiviral Agents|antiviral agents|mesh-ancestor
25194989|NCT02761291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25194990|NCT02761291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25194991|NCT02761291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25194992|NCT02761291|Immunologic Factors|immunologic factors|mesh-ancestor
25194993|NCT02761291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25194994|NCT02761291|Anticonvulsants|anticonvulsants|mesh-ancestor
25666905|NCT01701037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666906|NCT01701063|Ribavirin|ribavirin|mesh-list
25666907|NCT01701063|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25666908|NCT01701063|Antimetabolites|antimetabolites|mesh-ancestor
25666909|NCT01701063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666910|NCT01701063|Antiviral Agents|antiviral agents|mesh-ancestor
25194995|NCT02761291|GABA Agents|gaba agents|mesh-ancestor
24780951|NCT01887340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780952|NCT01887379|Furosemide|furosemide|mesh-list
24780953|NCT01887379|Diuretics|diuretics|mesh-ancestor
24780954|NCT01887379|Natriuretic Agents|natriuretic agents|mesh-ancestor
24780955|NCT01887379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780956|NCT01887379|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24780957|NCT01887379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24780958|NCT01887379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780959|NCT01887405|Epinephrine|epinephrine|mesh-list
24780960|NCT01887405|Racepinephrine|racepinephrine|mesh-list
24780961|NCT01887405|Epinephryl borate|epinephryl borate|mesh-list
25194996|NCT02761291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25194997|NCT02761291|Antimanic Agents|antimanic agents|mesh-ancestor
25194998|NCT02761291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25194999|NCT02761291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25195000|NCT02761291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25195001|NCT02760992|Baclofen|baclofen|mesh-list
25195002|NCT02760992|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25195003|NCT02760992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195004|NCT02760992|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25195005|NCT02760992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25195006|NCT02760992|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25195007|NCT02760992|GABA Agonists|gaba agonists|mesh-ancestor
25195008|NCT02760992|GABA Agents|gaba agents|mesh-ancestor
25195009|NCT02760992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25195010|NCT02760992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195011|NCT02760979|Denosumab|denosumab|mesh-list
25195012|NCT02760979|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24470875|NCT00392314|Antimetabolites|antimetabolites|mesh-ancestor
25195013|NCT02760979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195014|NCT02760953|Epirubicin|epirubicin|mesh-list
25195015|NCT02760953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25195016|NCT02760953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195017|NCT02760953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25195018|NCT02760953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25195019|NCT02760953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25195020|NCT02760953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195021|NCT02760901|Acetylcysteine|acetylcysteine|mesh-list
25195022|NCT02760901|Mannitol|mannitol|mesh-list
25195023|NCT02760901|Acetazolamide|acetazolamide|mesh-list
25195024|NCT02760901|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25195025|NCT02760901|Antiviral Agents|antiviral agents|mesh-ancestor
25195026|NCT02760901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25195027|NCT02760901|Expectorants|expectorants|mesh-ancestor
25195028|NCT02760901|Respiratory System Agents|respiratory system agents|mesh-ancestor
25195029|NCT02760901|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25195030|NCT02760901|Antioxidants|antioxidants|mesh-ancestor
25195031|NCT02760901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195032|NCT02760901|Protective Agents|protective agents|mesh-ancestor
25195033|NCT02760901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195034|NCT02760901|Antidotes|antidotes|mesh-ancestor
25195035|NCT02760901|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25195036|NCT02760901|Diuretics|diuretics|mesh-ancestor
25195037|NCT02760901|Natriuretic Agents|natriuretic agents|mesh-ancestor
25195038|NCT02760901|Anticonvulsants|anticonvulsants|mesh-ancestor
25195039|NCT02760901|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25195040|NCT02760901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25195041|NCT02760823|Thioctic Acid|thioctic acid|mesh-list
25195042|NCT02760823|Antioxidants|antioxidants|mesh-ancestor
25195043|NCT02760823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195044|NCT02760823|Protective Agents|protective agents|mesh-ancestor
25195045|NCT02760823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195046|NCT02760823|Vitamin B Complex|vitamin b complex|mesh-ancestor
25195047|NCT02760823|Vitamins|vitamins|mesh-ancestor
25195048|NCT02760823|Micronutrients|micronutrients|mesh-ancestor
25195049|NCT02760667|Cisplatin|cisplatin|mesh-list
25666911|NCT01701063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25666912|NCT01701102|Fentanyl|fentanyl|mesh-list
25666913|NCT01701102|Mepivacaine|mepivacaine|mesh-list
25666914|NCT01701102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25666915|NCT01701102|Narcotics|narcotics|mesh-ancestor
25666916|NCT01701102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25666917|NCT01701102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666918|NCT01701102|Analgesics|analgesics|mesh-ancestor
25666919|NCT01701102|Sensory System Agents|sensory system agents|mesh-ancestor
25666920|NCT01701102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25666921|NCT01701102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25666922|NCT01701102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25860636|NCT00084201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25860637|NCT00084214|Paclitaxel|paclitaxel|mesh-list
24489162|NCT00471588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24489163|NCT00471588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24489164|NCT00471588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24489165|NCT00471588|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24489166|NCT00471588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24489178|NCT00471640|Hormones|hormones|mesh-ancestor
25195050|NCT02760667|Carboplatin|carboplatin|mesh-list
25195051|NCT02760667|Docetaxel|docetaxel|mesh-list
25195052|NCT02760667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195053|NCT02760667|Tubulin Modulators|tubulin modulators|mesh-ancestor
25195054|NCT02760667|Antimitotic Agents|antimitotic agents|mesh-ancestor
25195055|NCT02760667|Mitosis Modulators|mitosis modulators|mesh-ancestor
25195056|NCT02760667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195057|NCT02760420|Amoxicillin|amoxicillin|mesh-list
25195058|NCT02760420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25195059|NCT02760420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25195060|NCT02760342|Metformin|metformin|mesh-list
25195061|NCT02760342|Peficitinib|peficitinib|mesh-list
25195062|NCT02760342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25195063|NCT02760342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195064|NCT02760342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25195065|NCT02760342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195066|NCT02760342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25195067|NCT02760342|Immunologic Factors|immunologic factors|mesh-ancestor
25195068|NCT02760615|Losartan|losartan|mesh-list
25195069|NCT02760615|Midazolam|midazolam|mesh-list
25195070|NCT02760615|Dextromethorphan|dextromethorphan|mesh-list
25195071|NCT02760615|Caffeine|caffeine|mesh-list
25195072|NCT02760615|Omeprazole|omeprazole|mesh-list
25195073|NCT02760615|Vedolizumab|vedolizumab|mesh-list
25195074|NCT02760615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25195075|NCT02760615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25195076|NCT02760615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25195077|NCT02760615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195078|NCT02760615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25195079|NCT02760615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25195080|NCT02760615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25195081|NCT02760615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25195082|NCT02760615|Anesthetics, General|anesthetics, general|mesh-ancestor
25195083|NCT02760615|Anesthetics|anesthetics|mesh-ancestor
25195084|NCT02760615|GABA Modulators|gaba modulators|mesh-ancestor
25195085|NCT02760615|GABA Agents|gaba agents|mesh-ancestor
25195086|NCT02760615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25195087|NCT02760615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195088|NCT02760615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25195089|NCT02760615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25195090|NCT02760615|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25195091|NCT02760615|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25195092|NCT02760615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25195093|NCT02760615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25195094|NCT02760615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25195095|NCT02760615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25195096|NCT02760615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25195097|NCT02760615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25195098|NCT02760615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25195099|NCT02760615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25195100|NCT02760615|Purinergic Agents|purinergic agents|mesh-ancestor
25195101|NCT02760615|Antitussive Agents|antitussive agents|mesh-ancestor
25195102|NCT02760615|Respiratory System Agents|respiratory system agents|mesh-ancestor
25195103|NCT02760615|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25195104|NCT02760615|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25195106|NCT02760355|Sofosbuvir|sofosbuvir|mesh-list
25195107|NCT02760355|Ledipasvir|ledipasvir|mesh-list
25195108|NCT02760355|Antimetabolites|antimetabolites|mesh-ancestor
25666923|NCT01701102|Anesthetics, General|anesthetics, general|mesh-ancestor
25666924|NCT01701102|Anesthetics|anesthetics|mesh-ancestor
25666925|NCT01701102|Anesthetics, Local|anesthetics, local|mesh-ancestor
25666926|NCT01701115|Bupivacaine|bupivacaine|mesh-list
25666927|NCT01701115|Anesthetics, Local|anesthetics, local|mesh-list
25666928|NCT01701115|Mepivacaine|mepivacaine|mesh-list
25666929|NCT01701115|Anesthetics|anesthetics|mesh-list
25666930|NCT01701115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25195109|NCT02760355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195110|NCT02760355|Antiviral Agents|antiviral agents|mesh-ancestor
25195111|NCT02760355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25666931|NCT01701115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489405|NCT00473005|Everolimus|everolimus|mesh-list
24489406|NCT00473005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24489407|NCT00473005|Antimetabolites|antimetabolites|mesh-ancestor
24489408|NCT00473005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489494|NCT00473603|Heparin|heparin|mesh-list
25195112|NCT02760459|Dexamethasone|dexamethasone|mesh-list
25195113|NCT02760459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25195114|NCT02760459|Antiemetics|antiemetics|mesh-ancestor
25195115|NCT02760459|Autonomic Agents|autonomic agents|mesh-ancestor
25195116|NCT02760459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25195117|NCT02760459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195118|NCT02760459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25195119|NCT02760459|Glucocorticoids|glucocorticoids|mesh-ancestor
25195120|NCT02760459|Hormones|hormones|mesh-ancestor
25195195|NCT02760030|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25195121|NCT02760459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25195122|NCT02760459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25195123|NCT02760459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195124|NCT02760316|Prednisolone|prednisolone|mesh-list
25195125|NCT02760316|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25195126|NCT02760316|Methylprednisolone|methylprednisolone|mesh-list
25195127|NCT02760316|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25195128|NCT02760316|Prednisolone acetate|prednisolone acetate|mesh-list
25195129|NCT02760316|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25195130|NCT02760316|Prednisolone phosphate|prednisolone phosphate|mesh-list
25195131|NCT02760316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25195132|NCT02760316|Glucocorticoids|glucocorticoids|mesh-ancestor
25195133|NCT02760316|Hormones|hormones|mesh-ancestor
25195134|NCT02760316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25195135|NCT02760316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195136|NCT02760316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25195137|NCT02760316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195138|NCT02760316|Antiemetics|antiemetics|mesh-ancestor
25195139|NCT02760316|Autonomic Agents|autonomic agents|mesh-ancestor
25195140|NCT02760316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25195141|NCT02760316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25195142|NCT02760316|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25195143|NCT02760316|Protective Agents|protective agents|mesh-ancestor
25195144|NCT02760472|SMOFlipid|smoflipid|mesh-list
25195145|NCT02760472|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25195146|NCT02760472|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25195147|NCT02760472|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25195148|NCT02760381|Acetic Acid|acetic acid|mesh-list
25195149|NCT02760381|Retinol acetate|retinol acetate|mesh-list
25195150|NCT02760381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25195151|NCT02760381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25195152|NCT02760381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25195153|NCT02760381|Immunologic Factors|immunologic factors|mesh-ancestor
25195154|NCT02760381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195155|NCT02760381|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25195156|NCT02760381|Protective Agents|protective agents|mesh-ancestor
25195157|NCT02760381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195158|NCT02760225|Pembrolizumab|pembrolizumab|mesh-list
25195159|NCT02760225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25195160|NCT02760225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195161|NCT02760043|Dexamethasone|dexamethasone|mesh-list
25195162|NCT02760043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25195163|NCT02760043|Antiemetics|antiemetics|mesh-ancestor
24561858|NCT00763204|Glucocorticoids|glucocorticoids|mesh-ancestor
25195164|NCT02760043|Autonomic Agents|autonomic agents|mesh-ancestor
25195165|NCT02760043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24439250|NCT00278213|Alemtuzumab|alemtuzumab|mesh-list
25195166|NCT02760043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195167|NCT02760043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25195168|NCT02760043|Glucocorticoids|glucocorticoids|mesh-ancestor
25195169|NCT02760043|Hormones|hormones|mesh-ancestor
25195170|NCT02760043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25195171|NCT02760043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25195172|NCT02760043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25666932|NCT01701115|Sensory System Agents|sensory system agents|mesh-ancestor
25666933|NCT01701115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25666934|NCT01701258|Amisulpride|amisulpride|mesh-list
25666935|NCT01701258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25666936|NCT01701258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25666937|NCT01701258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24799321|NCT01968460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082004|NCT03325790|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25082005|NCT03325686|Vitamin D|vitamin d|mesh-list
25195173|NCT02759861|Sofosbuvir|sofosbuvir|mesh-list
25195174|NCT02759861|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25195175|NCT02759861|Ledipasvir|ledipasvir|mesh-list
25195176|NCT02759861|Antiviral Agents|antiviral agents|mesh-ancestor
25195177|NCT02759861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25195178|NCT02760121|Acetazolamide|acetazolamide|mesh-list
25195179|NCT02760121|Methazolamide|methazolamide|mesh-list
25195180|NCT02760121|Anticonvulsants|anticonvulsants|mesh-ancestor
25195181|NCT02760121|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25195182|NCT02760121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25195183|NCT02760121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195184|NCT02760121|Diuretics|diuretics|mesh-ancestor
25195185|NCT02760121|Natriuretic Agents|natriuretic agents|mesh-ancestor
25195186|NCT02760121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195187|NCT02759991|Vaccines|vaccines|mesh-list
25195188|NCT02759991|Immunologic Factors|immunologic factors|mesh-ancestor
25195189|NCT02759991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195190|NCT02759887|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25195191|NCT02759887|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25195192|NCT02759887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195193|NCT02760030|Fulvestrant|fulvestrant|mesh-list
25195194|NCT02760030|Palbociclib|palbociclib|mesh-list
25195196|NCT02760030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25195197|NCT02760030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195198|NCT02760030|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25195199|NCT02760030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25195200|NCT02760030|Hormone Antagonists|hormone antagonists|mesh-ancestor
25195201|NCT02760030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25195202|NCT02760030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195203|NCT02760030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25195204|NCT02760030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25195205|NCT02760030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195206|NCT02760030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25195207|NCT02760095|Vitamin A|vitamin a|mesh-list
25195208|NCT02760095|Acetic Acid|acetic acid|mesh-list
25195209|NCT02760095|Retinol acetate|retinol acetate|mesh-list
25195210|NCT02760095|Zinc Sulfate|zinc sulfate|mesh-list
25195211|NCT02760095|Vitamins|vitamins|mesh-ancestor
25195212|NCT02760095|Micronutrients|micronutrients|mesh-ancestor
25195213|NCT02760095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195214|NCT02760095|Protective Agents|protective agents|mesh-ancestor
25195215|NCT02760095|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25195216|NCT02760095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195217|NCT02760095|Astringents|astringents|mesh-ancestor
25195218|NCT02760095|Dermatologic Agents|dermatologic agents|mesh-ancestor
25195219|NCT02760095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25195220|NCT02760095|Immunologic Factors|immunologic factors|mesh-ancestor
25195221|NCT02760095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25195222|NCT02760095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25195223|NCT02759926|Quinine|quinine|mesh-list
25195224|NCT02759926|Denatonium|denatonium|mesh-list
25195225|NCT02759926|Antimalarials|antimalarials|mesh-ancestor
25195226|NCT02759926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25195227|NCT02759926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25195228|NCT02759926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25195229|NCT02759926|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25195230|NCT02759926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195231|NCT02759926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25195232|NCT02759926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25195233|NCT02759926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25195234|NCT02759926|Analgesics|analgesics|mesh-ancestor
25195235|NCT02759926|Sensory System Agents|sensory system agents|mesh-ancestor
25195236|NCT02759926|Aversive Agents|aversive agents|mesh-ancestor
25195237|NCT02759926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195238|NCT02759926|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
24439629|NCT00279565|Narcotics|narcotics|mesh-ancestor
25195239|NCT02759614|Bevacizumab|bevacizumab|mesh-list
25195240|NCT02759614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25195241|NCT02759614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25666938|NCT01701258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666939|NCT01701258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25666940|NCT01701258|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25195242|NCT02759614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195243|NCT02759614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24781109|NCT01888107|Serotonin Agents|serotonin agents|mesh-ancestor
24781110|NCT01888107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24781111|NCT01888107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615488|NCT01030042|Leucovorin|leucovorin|mesh-list
25195244|NCT02759614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24948355|NCT03920475|Sertraline|sertraline|mesh-list
25195245|NCT02759614|Growth Substances|growth substances|mesh-ancestor
25195246|NCT02759614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195247|NCT02759614|Growth Inhibitors|growth inhibitors|mesh-ancestor
25195248|NCT02759614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25195249|NCT02759614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25195250|NCT02759614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195251|NCT02759510|Phenylephrine|phenylephrine|mesh-list
25195252|NCT02759510|Oxymetazoline|oxymetazoline|mesh-list
25195253|NCT02759510|Norepinephrine|norepinephrine|mesh-list
25195254|NCT02759510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25195255|NCT02759510|Mydriatics|mydriatics|mesh-ancestor
25195256|NCT02759510|Autonomic Agents|autonomic agents|mesh-ancestor
25195257|NCT02759510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25195258|NCT02759510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835917|NCT02183584|Protease Inhibitors|protease inhibitors|mesh-ancestor
25195259|NCT02759510|Sympathomimetics|sympathomimetics|mesh-ancestor
25195260|NCT02759510|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25195261|NCT02759510|Nasal Decongestants|nasal decongestants|mesh-ancestor
25195262|NCT02759510|Respiratory System Agents|respiratory system agents|mesh-ancestor
25195263|NCT02759510|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25195264|NCT02759510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25195265|NCT02759510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25195266|NCT02759510|Adrenergic Agents|adrenergic agents|mesh-ancestor
25195267|NCT02759510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25195268|NCT02759510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195269|NCT02759510|Protective Agents|protective agents|mesh-ancestor
25195270|NCT02759224|Irsogladine|irsogladine|mesh-list
25195271|NCT02759224|Lafutidine|lafutidine|mesh-list
25195272|NCT02759224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195273|NCT02759224|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25195274|NCT02759224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25195275|NCT02759224|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25195276|NCT02759224|Histamine Antagonists|histamine antagonists|mesh-ancestor
25195277|NCT02759224|Histamine Agents|histamine agents|mesh-ancestor
25195278|NCT02759224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25195279|NCT02759224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195280|NCT02759224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195281|NCT02759224|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25195282|NCT02759224|Protective Agents|protective agents|mesh-ancestor
25195283|NCT02759224|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25195284|NCT02759393|Lansoprazole|lansoprazole|mesh-list
25195285|NCT02759393|Dexlansoprazole|dexlansoprazole|mesh-list
25195286|NCT02759393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25195287|NCT02759393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25195288|NCT02759393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25195294|NCT02759042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195295|NCT02759042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25195296|NCT02759042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25195297|NCT02759042|Antiviral Agents|antiviral agents|mesh-ancestor
25195298|NCT02759042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25195299|NCT02759107|Dulaglutide|dulaglutide|mesh-list
25195300|NCT02759107|Tirzepatide|tirzepatide|mesh-list
25195301|NCT02759107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25195302|NCT02759107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195303|NCT02759107|Incretins|incretins|mesh-ancestor
25195304|NCT02759107|Hormones|hormones|mesh-ancestor
25195305|NCT02759107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25195306|NCT02758951|Bevacizumab|bevacizumab|mesh-list
25195307|NCT02758951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25195308|NCT02758951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195309|NCT02758951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25195310|NCT02758951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25195311|NCT02758951|Growth Substances|growth substances|mesh-ancestor
25195312|NCT02758951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195313|NCT02758951|Growth Inhibitors|growth inhibitors|mesh-ancestor
25195314|NCT02758925|Cytarabine|cytarabine|mesh-list
25195315|NCT02758925|Rituximab|rituximab|mesh-list
25666941|NCT01701258|Dopamine Agents|dopamine agents|mesh-ancestor
25666942|NCT01701258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25666943|NCT01701258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666944|NCT01701258|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24781192|NCT01888536|Pregabalin|pregabalin|mesh-list
24781193|NCT01888536|Alprostadil|alprostadil|mesh-list
25195316|NCT02758925|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25195317|NCT02758925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25195318|NCT02758925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195319|NCT02758925|Immunologic Factors|immunologic factors|mesh-ancestor
25195320|NCT02758925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195321|NCT02758925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25195322|NCT02758925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25195323|NCT02758925|Antimetabolites|antimetabolites|mesh-ancestor
25195324|NCT02758925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195325|NCT02758925|Antiviral Agents|antiviral agents|mesh-ancestor
25195326|NCT02758925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25195327|NCT02758925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25195328|NCT02758925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25195329|NCT02758925|Alkylating Agents|alkylating agents|mesh-ancestor
25195330|NCT02758990|Vitamin D|vitamin d|mesh-list
25195331|NCT02758990|Cholecalciferol|cholecalciferol|mesh-list
25195332|NCT02758990|Vitamins|vitamins|mesh-list
25195333|NCT02758990|Ascorbic Acid|ascorbic acid|mesh-list
25195334|NCT02758990|Vitamin E|vitamin e|mesh-list
25195335|NCT02758990|Tocopherols|tocopherols|mesh-list
25195336|NCT02758990|Vitamin A|vitamin a|mesh-list
25195337|NCT02758990|Niacinamide|niacinamide|mesh-list
25195338|NCT02758990|Niacin|niacin|mesh-list
25195339|NCT02758990|Nicotinic Acids|nicotinic acids|mesh-list
25195340|NCT02758990|Pyridoxine|pyridoxine|mesh-list
25195341|NCT02758990|Pyridoxal|pyridoxal|mesh-list
25195342|NCT02758990|Vitamin B 6|vitamin b 6|mesh-list
25195344|NCT02758990|Micronutrients|micronutrients|mesh-ancestor
25195345|NCT02758990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195346|NCT02758990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25195347|NCT02758990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25195348|NCT02758990|Antioxidants|antioxidants|mesh-ancestor
25195349|NCT02758990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195350|NCT02758990|Protective Agents|protective agents|mesh-ancestor
24562102|NCT00764582|Renal Agents|renal agents|mesh-ancestor
25195351|NCT02758990|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25195426|NCT02758522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25195352|NCT02758990|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25195353|NCT02758990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25195354|NCT02758990|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25195355|NCT02758990|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25195356|NCT02758990|Purinergic Agents|purinergic agents|mesh-ancestor
25195357|NCT02758990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25195358|NCT02758990|Vitamin B Complex|vitamin b complex|mesh-ancestor
25195359|NCT02758990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25195360|NCT02758990|Antimetabolites|antimetabolites|mesh-ancestor
25195361|NCT02758990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25195362|NCT02758990|Vasodilator Agents|vasodilator agents|mesh-ancestor
25195363|NCT02759198|Celecoxib|celecoxib|mesh-list
25195364|NCT02759198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25195365|NCT02759198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25195366|NCT02759198|Analgesics|analgesics|mesh-ancestor
25195367|NCT02759198|Sensory System Agents|sensory system agents|mesh-ancestor
25195368|NCT02759198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25195369|NCT02759198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195370|NCT02759198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25195371|NCT02759198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25195372|NCT02759198|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25195373|NCT02759198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25195374|NCT02759198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25195375|NCT02759198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195376|NCT02758873|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25195377|NCT02758873|Montelukast|montelukast|mesh-list
25195378|NCT02758873|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25195379|NCT02758873|Autonomic Agents|autonomic agents|mesh-ancestor
25195380|NCT02758873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25195381|NCT02758873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195382|NCT02758873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25195383|NCT02758873|Respiratory System Agents|respiratory system agents|mesh-ancestor
25195384|NCT02758873|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25195385|NCT02758873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25195386|NCT02758873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25666945|NCT01701258|Antidepressive Agents|antidepressive agents|mesh-ancestor
25666946|NCT01701362|Pregabalin|pregabalin|mesh-list
25195387|NCT02758873|Adrenergic Agents|adrenergic agents|mesh-ancestor
25195388|NCT02758873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24799672|NCT01970072|Anesthetics|anesthetics|mesh-ancestor
24836051|NCT02184052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24836052|NCT02184052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836079|NCT02184078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24836080|NCT02184078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24799673|NCT01970072|GABA Modulators|gaba modulators|mesh-ancestor
24781264|NCT01888744|Hormone Antagonists|hormone antagonists|mesh-ancestor
25082013|NCT03325491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195389|NCT02758873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195390|NCT02758873|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25195391|NCT02758873|Hormone Antagonists|hormone antagonists|mesh-ancestor
25195392|NCT02758873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25195393|NCT02758873|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25195394|NCT02758873|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25195395|NCT02758769|Abatacept|abatacept|mesh-list
25195396|NCT02758769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25195397|NCT02758769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195398|NCT02758769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195399|NCT02758769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25195400|NCT02758769|Immunologic Factors|immunologic factors|mesh-ancestor
25195401|NCT02758769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195402|NCT02758769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25195403|NCT02758782|Celecoxib|celecoxib|mesh-list
25195404|NCT02758782|Golimumab|golimumab|mesh-list
25195405|NCT02758782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25195406|NCT02758782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25195407|NCT02758782|Analgesics|analgesics|mesh-ancestor
25195408|NCT02758782|Sensory System Agents|sensory system agents|mesh-ancestor
25195409|NCT02758782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25195410|NCT02758782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195411|NCT02758782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25195412|NCT02758782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25195413|NCT02758782|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25195414|NCT02758782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25195416|NCT02758782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195417|NCT02758782|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25195418|NCT02758782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25195419|NCT02758782|Immunologic Factors|immunologic factors|mesh-ancestor
24440474|NCT00283218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25195420|NCT02758665|Venetoclax|venetoclax|mesh-list
25195421|NCT02758665|Obinutuzumab|obinutuzumab|mesh-list
25195422|NCT02758665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195423|NCT02758665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25195424|NCT02758522|Insulin|insulin|mesh-list
25195425|NCT02758522|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25195427|NCT02758522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195428|NCT02758691|Insulin|insulin|mesh-list
25195429|NCT02758691|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25195430|NCT02758691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25195431|NCT02758691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195432|NCT02758587|Pembrolizumab|pembrolizumab|mesh-list
25195433|NCT02758587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25195434|NCT02758587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195435|NCT02758509|Interferons|interferons|mesh-list
25195436|NCT02758509|Ritonavir|ritonavir|mesh-list
25195437|NCT02758509|Ribavirin|ribavirin|mesh-list
25195438|NCT02758509|Interferon-alpha|interferon-alpha|mesh-list
25195439|NCT02758509|Interferon alpha-2|interferon alpha-2|mesh-list
25195440|NCT02758509|Sofosbuvir|sofosbuvir|mesh-list
25195441|NCT02758509|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25195442|NCT02758509|Ledipasvir|ledipasvir|mesh-list
25195443|NCT02758509|Simeprevir|simeprevir|mesh-list
25195444|NCT02758509|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25195445|NCT02758509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195446|NCT02758509|Antiviral Agents|antiviral agents|mesh-ancestor
25195447|NCT02758509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25195448|NCT02758509|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25195449|NCT02758509|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25195450|NCT02758509|Protease Inhibitors|protease inhibitors|mesh-ancestor
25195451|NCT02758509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25195452|NCT02758509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195453|NCT02758509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25195454|NCT02758509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25195455|NCT02758509|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25195456|NCT02758509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25666947|NCT01701362|Analgesics|analgesics|mesh-ancestor
25666948|NCT01701362|Sensory System Agents|sensory system agents|mesh-ancestor
25666949|NCT01701362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25666950|NCT01701362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781359|NCT01889004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24781360|NCT01889004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781361|NCT01889004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25195457|NCT02758509|Antimetabolites|antimetabolites|mesh-ancestor
25195458|NCT02758509|Immunologic Factors|immunologic factors|mesh-ancestor
25195459|NCT02758509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195460|NCT02758444|Micronutrients|micronutrients|mesh-list
25195461|NCT02758444|Trace Elements|trace elements|mesh-list
25195462|NCT02758444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195463|NCT02758340|Misoprostol|misoprostol|mesh-list
25195464|NCT02758340|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25195465|NCT02758340|Abortifacient Agents|abortifacient agents|mesh-ancestor
25195466|NCT02758340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25195467|NCT02758340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562334|NCT00766064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25195468|NCT02758340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25195469|NCT02758340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25195470|NCT02758340|Oxytocics|oxytocics|mesh-ancestor
25195472|NCT02758249|Sevoflurane|sevoflurane|mesh-list
25195473|NCT02758249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25195474|NCT02758249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25195475|NCT02758249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195476|NCT02758249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25195477|NCT02758249|Anesthetics, General|anesthetics, general|mesh-ancestor
25195478|NCT02758249|Anesthetics|anesthetics|mesh-ancestor
25195479|NCT02758249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25195480|NCT02758249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25195481|NCT02758366|Doxorubicin|doxorubicin|mesh-list
25195482|NCT02758366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25195483|NCT02758366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195484|NCT02758366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25195485|NCT02758366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25195486|NCT02758366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25195487|NCT02758366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195488|NCT02758405|Fentanyl|fentanyl|mesh-list
25195489|NCT02758405|Bupivacaine|bupivacaine|mesh-list
25195490|NCT02758405|Anesthetics, Local|anesthetics, local|mesh-ancestor
25195491|NCT02758405|Anesthetics|anesthetics|mesh-ancestor
25195492|NCT02758405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25195493|NCT02758405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195494|NCT02758405|Sensory System Agents|sensory system agents|mesh-ancestor
25195495|NCT02758405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25195496|NCT02758405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25195497|NCT02758405|Narcotics|narcotics|mesh-ancestor
25195498|NCT02758405|Analgesics|analgesics|mesh-ancestor
25195499|NCT02758405|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25195500|NCT02758405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25195501|NCT02758405|Anesthetics, General|anesthetics, general|mesh-ancestor
25195502|NCT02758470|Acetazolamide|acetazolamide|mesh-list
25195503|NCT02758470|Methazolamide|methazolamide|mesh-list
25195504|NCT02758470|Anticonvulsants|anticonvulsants|mesh-ancestor
25195505|NCT02758470|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25195506|NCT02758470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25195507|NCT02758470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195508|NCT02758470|Diuretics|diuretics|mesh-ancestor
25195509|NCT02758470|Natriuretic Agents|natriuretic agents|mesh-ancestor
25195510|NCT02758470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195511|NCT02758327|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25195512|NCT02758327|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25195513|NCT02758327|Lubricant Eye Drops|lubricant eye drops|mesh-list
25195514|NCT02758327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25195515|NCT02758327|Laxatives|laxatives|mesh-ancestor
25195516|NCT02758327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25195517|NCT02758015|Betaine|betaine|mesh-list
24441077|NCT00286013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195518|NCT02758015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25195519|NCT02758015|Lipotropic Agents|lipotropic agents|mesh-ancestor
24836159|NCT02184286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25195520|NCT02758015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25195521|NCT02758015|Antimetabolites|antimetabolites|mesh-ancestor
25195522|NCT02758015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195523|NCT02758015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25666951|NCT01701362|Anticonvulsants|anticonvulsants|mesh-ancestor
25666952|NCT01701362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25666953|NCT01701362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25195524|NCT02758067|Risperidone|risperidone|mesh-list
25195525|NCT02758067|Brexpiprazole|brexpiprazole|mesh-list
25195526|NCT02758067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25195527|NCT02758067|Serotonin Agents|serotonin agents|mesh-ancestor
25195528|NCT02758067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25195529|NCT02758067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195530|NCT02758067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195531|NCT02758067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25195532|NCT02758067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25195533|NCT02758067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25195534|NCT02758067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25195535|NCT02758067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25195536|NCT02758067|Dopamine Agents|dopamine agents|mesh-ancestor
25195537|NCT02758067|Dopamine Agonists|dopamine agonists|mesh-ancestor
25195538|NCT02757651|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25195539|NCT02757651|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25195540|NCT02757651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25195541|NCT02757703|Terlipressin|terlipressin|mesh-list
25195542|NCT02757703|Pantoprazole|pantoprazole|mesh-list
25195543|NCT02757703|Somatostatin|somatostatin|mesh-list
25195544|NCT02757703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25195545|NCT02757703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25195546|NCT02757703|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25195547|NCT02757703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25195548|NCT02757703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195549|NCT02757703|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25195550|NCT02757703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25195552|NCT02757703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25195553|NCT02757703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195554|NCT02757534|Domperidone|domperidone|mesh-list
25195555|NCT02757534|Antiemetics|antiemetics|mesh-ancestor
25195556|NCT02757534|Autonomic Agents|autonomic agents|mesh-ancestor
25195557|NCT02757534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25195558|NCT02757534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195559|NCT02757534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25195560|NCT02757534|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25195561|NCT02757534|Dopamine Agents|dopamine agents|mesh-ancestor
25195562|NCT02757534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25195563|NCT02757534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195564|NCT02757508|Vitamins|vitamins|mesh-list
25195565|NCT02757508|Micronutrients|micronutrients|mesh-ancestor
25195566|NCT02757508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195571|NCT02757495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25195572|NCT02757495|Analgesics|analgesics|mesh-ancestor
25195573|NCT02757495|Sensory System Agents|sensory system agents|mesh-ancestor
25195574|NCT02757495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25195575|NCT02757495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25195576|NCT02757495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25195577|NCT02757495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25195578|NCT02757495|Adrenergic Agents|adrenergic agents|mesh-ancestor
25195579|NCT02757495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25195580|NCT02757495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207039|NCT05042440|Coagulants|coagulants|mesh-ancestor
25207040|NCT05024760|Chlorhexidine|chlorhexidine|mesh-list
25207041|NCT05024760|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25207042|NCT05024760|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25207043|NCT05024760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25207044|NCT05024760|Disinfectants|disinfectants|mesh-ancestor
25195581|NCT02757209|Fluticasone|fluticasone|mesh-list
25195583|NCT02757209|Budesonide|budesonide|mesh-list
25195584|NCT02757209|Formoterol Fumarate|formoterol fumarate|mesh-list
25195585|NCT02757209|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25195586|NCT02757209|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25195587|NCT02757209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25195588|NCT02757209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25195589|NCT02757209|Autonomic Agents|autonomic agents|mesh-ancestor
25195590|NCT02757209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25195591|NCT02757209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195592|NCT02757209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25195593|NCT02757209|Respiratory System Agents|respiratory system agents|mesh-ancestor
25195594|NCT02757209|Dermatologic Agents|dermatologic agents|mesh-ancestor
25195595|NCT02757209|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25195596|NCT02757209|Glucocorticoids|glucocorticoids|mesh-ancestor
25195597|NCT02757209|Hormones|hormones|mesh-ancestor
25195598|NCT02757209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24562555|NCT00766909|Cyclosporins|cyclosporins|mesh-list
24562567|NCT00767091|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
24562575|NCT00767117|Ritonavir|ritonavir|mesh-list
25213538|NCT04551495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24781556|NCT01890629|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24948427|NCT03919942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24948428|NCT03919942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25666954|NCT01701362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860638|NCT00084214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24562584|NCT00767117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24562585|NCT00767117|Antiviral Agents|antiviral agents|mesh-ancestor
24562586|NCT00767117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25195599|NCT02757209|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25195600|NCT02757209|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25195601|NCT02757209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25195602|NCT02757209|Adrenergic Agents|adrenergic agents|mesh-ancestor
25195603|NCT02757209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25195604|NCT02757209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195605|NCT02757287|Desogestrel|desogestrel|mesh-list
25195606|NCT02757287|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25195607|NCT02757287|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25195608|NCT02757287|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25195609|NCT02757287|Contraceptive Agents|contraceptive agents|mesh-ancestor
25195610|NCT02757287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25195611|NCT02757287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195612|NCT02757287|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25195613|NCT02757287|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25195614|NCT02757287|Progestins|progestins|mesh-ancestor
25195615|NCT02757287|Hormones|hormones|mesh-ancestor
25195616|NCT02757287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25195617|NCT02757365|Aspirin|aspirin|mesh-list
25195618|NCT02757365|Levofloxacin|levofloxacin|mesh-list
25195619|NCT02757365|Ofloxacin|ofloxacin|mesh-list
25195623|NCT02757365|Sensory System Agents|sensory system agents|mesh-ancestor
25195624|NCT02757365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25195625|NCT02757365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195626|NCT02757365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24562595|NCT00767221|Budesonide|budesonide|mesh-list
24562603|NCT00767221|Glucocorticoids|glucocorticoids|mesh-ancestor
24562604|NCT00767221|Hormones|hormones|mesh-ancestor
24562605|NCT00767221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24562606|NCT00767260|Insulin|insulin|mesh-list
24562607|NCT00767260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25195627|NCT02757365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25195628|NCT02757365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25195629|NCT02757365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25195630|NCT02757365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195631|NCT02757365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25195632|NCT02757365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24836269|NCT02184858|Protease Inhibitors|protease inhibitors|mesh-ancestor
24836270|NCT02184858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639926|NCT01164826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836275|NCT02184858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836276|NCT02184897|Lenograstim|lenograstim|mesh-list
24836277|NCT02184897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24836278|NCT02184897|Immunologic Factors|immunologic factors|mesh-ancestor
24836280|NCT02184910|Gastrins|gastrins|mesh-list
25195633|NCT02757365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25195634|NCT02757365|Antipyretics|antipyretics|mesh-ancestor
25195635|NCT02757365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25195636|NCT02757365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25195637|NCT02757365|Renal Agents|renal agents|mesh-ancestor
25195638|NCT02757365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25195639|NCT02757365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25195640|NCT02757365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25195641|NCT02757365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195642|NCT02757365|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25195645|NCT02757469|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25195646|NCT02757469|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
25195647|NCT02757469|Estradiol|estradiol|mesh-list
25195648|NCT02757469|Estrogens|estrogens|mesh-ancestor
25195649|NCT02757469|Hormones|hormones|mesh-ancestor
25195650|NCT02757469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25195651|NCT02757469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195652|NCT02757469|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24562608|NCT00767260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860639|NCT00084214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860640|NCT00084214|Tubulin Modulators|tubulin modulators|mesh-ancestor
25860641|NCT00084214|Antimitotic Agents|antimitotic agents|mesh-ancestor
25860642|NCT00084214|Mitosis Modulators|mitosis modulators|mesh-ancestor
24562614|NCT00767286|Trace Elements|trace elements|mesh-ancestor
25195653|NCT02757469|Contraceptive Agents|contraceptive agents|mesh-ancestor
25666955|NCT01701362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25666956|NCT01701362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25666957|NCT01701362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24440546|NCT00283660|Zinc Oxide|zinc oxide|mesh-list
25213539|NCT04551495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24489592|NCT00474136|Sensory System Agents|sensory system agents|mesh-ancestor
24489593|NCT00474136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489594|NCT00474136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781654|NCT01891084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25195654|NCT02757469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25195655|NCT02757469|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25195656|NCT02757469|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25195657|NCT02757469|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25195658|NCT02757469|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25195659|NCT02757469|Hormone Antagonists|hormone antagonists|mesh-ancestor
25195660|NCT02757469|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25195661|NCT02757469|Diuretics|diuretics|mesh-ancestor
25195662|NCT02757469|Natriuretic Agents|natriuretic agents|mesh-ancestor
25195663|NCT02757404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25195664|NCT02757404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25195665|NCT02757404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25195666|NCT02757404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195667|NCT02757404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25195668|NCT02757404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25195669|NCT02757404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195670|NCT02757404|Cholinergic Agents|cholinergic agents|mesh-ancestor
25195671|NCT02757404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25195672|NCT02757391|Aldesleukin|aldesleukin|mesh-list
25195673|NCT02757391|Cyclophosphamide|cyclophosphamide|mesh-list
25195674|NCT02757391|Pembrolizumab|pembrolizumab|mesh-list
25195675|NCT02757391|Interleukin-2|interleukin-2|mesh-list
25195676|NCT02757391|Immunologic Factors|immunologic factors|mesh-list
25195677|NCT02757391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25195678|NCT02757391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195679|NCT02757391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25195680|NCT02757391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25195681|NCT02757391|Alkylating Agents|alkylating agents|mesh-ancestor
25195682|NCT02757391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195683|NCT02757391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195684|NCT02757391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25195685|NCT02757391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25195686|NCT02757391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25195687|NCT02757391|Analgesics|analgesics|mesh-ancestor
25195688|NCT02757391|Sensory System Agents|sensory system agents|mesh-ancestor
25195689|NCT02757391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25195690|NCT02757391|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25195691|NCT02757391|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25195692|NCT02757391|Antiviral Agents|antiviral agents|mesh-ancestor
25195693|NCT02757391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25195694|NCT02757196|Methylprednisolone|methylprednisolone|mesh-list
25195695|NCT02757196|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25195696|NCT02757196|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25195697|NCT02757196|Prednisolone|prednisolone|mesh-list
25195698|NCT02757196|Prednisolone acetate|prednisolone acetate|mesh-list
25195699|NCT02757196|Rituximab|rituximab|mesh-list
25195700|NCT02757196|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25195701|NCT02757196|Prednisolone phosphate|prednisolone phosphate|mesh-list
25195702|NCT02757196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25195703|NCT02757196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195704|NCT02757196|Immunologic Factors|immunologic factors|mesh-ancestor
25195705|NCT02757196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195706|NCT02757196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25195707|NCT02757196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25195708|NCT02757196|Antiemetics|antiemetics|mesh-ancestor
25195709|NCT02757196|Autonomic Agents|autonomic agents|mesh-ancestor
25195710|NCT02757196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25195711|NCT02757196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25195712|NCT02757196|Glucocorticoids|glucocorticoids|mesh-ancestor
25195713|NCT02757196|Hormones|hormones|mesh-ancestor
25195714|NCT02757196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25195715|NCT02757196|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25195716|NCT02757196|Protective Agents|protective agents|mesh-ancestor
25666958|NCT01701362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25666959|NCT01701362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25666960|NCT01701375|Palbociclib|palbociclib|mesh-list
25666961|NCT01701375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25666962|NCT01701375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25666963|NCT01701375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781684|NCT01891292|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24781686|NCT01891292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781687|NCT01891292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24781688|NCT01891435|Acetaminophen|acetaminophen|mesh-list
24781689|NCT01891435|Diclofenac|diclofenac|mesh-list
24781690|NCT01891435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24781691|NCT01891435|Analgesics|analgesics|mesh-ancestor
24781721|NCT01891513|Losartan|losartan|mesh-list
25195717|NCT02757196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25195718|NCT02757144|Esomeprazole|esomeprazole|mesh-list
25195719|NCT02757144|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25195720|NCT02757144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25195721|NCT02757144|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24562623|NCT00767468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562624|NCT00767468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562625|NCT00767481|Travoprost|travoprost|mesh-list
24562626|NCT00767481|Brinzolamide|brinzolamide|mesh-list
24562627|NCT00767481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25195722|NCT02757144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25195723|NCT02757144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195724|NCT02757248|Romidepsin|romidepsin|mesh-list
25195725|NCT02757248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25195726|NCT02757248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195727|NCT02757443|Phosphocreatine|phosphocreatine|mesh-list
25195728|NCT02757443|Anesthetics|anesthetics|mesh-list
25195729|NCT02757443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25195730|NCT02757443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195732|NCT02757443|Protective Agents|protective agents|mesh-ancestor
25195733|NCT02757261|Salicylic Acid|salicylic acid|mesh-list
25195734|NCT02757261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25195735|NCT02757261|Antifungal Agents|antifungal agents|mesh-ancestor
25195736|NCT02757261|Keratolytic Agents|keratolytic agents|mesh-ancestor
25195737|NCT02757261|Dermatologic Agents|dermatologic agents|mesh-ancestor
25195738|NCT02757040|Arsenic Trioxide|arsenic trioxide|mesh-list
25195739|NCT02757040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195740|NCT02757066|Melatonin|melatonin|mesh-list
25195741|NCT02757066|Antioxidants|antioxidants|mesh-ancestor
25195742|NCT02757066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836373|NCT02185456|Hormone Antagonists|hormone antagonists|mesh-ancestor
24836374|NCT02185456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24836375|NCT02185456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195743|NCT02757066|Protective Agents|protective agents|mesh-ancestor
25195744|NCT02757066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195745|NCT02757066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25195746|NCT02757079|Melatonin|melatonin|mesh-list
25195747|NCT02757079|Antioxidants|antioxidants|mesh-ancestor
25195748|NCT02757079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195749|NCT02757079|Protective Agents|protective agents|mesh-ancestor
25195750|NCT02757079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195751|NCT02757079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25195752|NCT02756598|Sufentanil|sufentanil|mesh-list
25195753|NCT02756598|Dsuvia|dsuvia|mesh-list
25195754|NCT02756598|Propofol|propofol|mesh-list
25195755|NCT02756598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25195756|NCT02756598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25195757|NCT02756598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195758|NCT02756598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25195759|NCT02756598|Anesthetics, General|anesthetics, general|mesh-ancestor
25195760|NCT02756598|Anesthetics|anesthetics|mesh-ancestor
25195761|NCT02756598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25195762|NCT02756598|Narcotics|narcotics|mesh-ancestor
25195763|NCT02756598|Analgesics|analgesics|mesh-ancestor
25195764|NCT02756598|Sensory System Agents|sensory system agents|mesh-ancestor
25195765|NCT02756598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25195766|NCT02756598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25195767|NCT02756728|Melphalan|melphalan|mesh-list
25195768|NCT02756728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25195769|NCT02756728|Alkylating Agents|alkylating agents|mesh-ancestor
24562631|NCT00767494|Travoprost|travoprost|mesh-list
25666964|NCT01701375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666965|NCT01701401|Sofosbuvir|sofosbuvir|mesh-list
25666966|NCT01701401|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25666967|NCT01701401|Ledipasvir|ledipasvir|mesh-list
25666968|NCT01701401|Antiviral Agents|antiviral agents|mesh-ancestor
25666969|NCT01701401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25666970|NCT01701414|Bupivacaine|bupivacaine|mesh-list
25666971|NCT01701414|Anesthetics, Local|anesthetics, local|mesh-ancestor
25195770|NCT02756728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195771|NCT02756728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24781762|NCT01891643|Immunologic Factors|immunologic factors|mesh-ancestor
25213547|NCT04494880|Bupivacaine|bupivacaine|mesh-list
25213548|NCT04494880|Anesthetics, Local|anesthetics, local|mesh-ancestor
25213549|NCT04494880|Anesthetics|anesthetics|mesh-ancestor
25213550|NCT04494880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24781763|NCT01891643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24781775|NCT01891812|Nitrous Oxide|nitrous oxide|mesh-list
25195772|NCT02756728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25195773|NCT02756728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25195774|NCT02756728|Immunologic Factors|immunologic factors|mesh-ancestor
25195775|NCT02756728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195776|NCT02756663|Dexamethasone|dexamethasone|mesh-list
25195777|NCT02756663|Panobinostat|panobinostat|mesh-list
25195778|NCT02756663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25195779|NCT02756663|Antiemetics|antiemetics|mesh-ancestor
25195780|NCT02756663|Autonomic Agents|autonomic agents|mesh-ancestor
25195781|NCT02756663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25195782|NCT02756663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195783|NCT02756663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25195784|NCT02756663|Glucocorticoids|glucocorticoids|mesh-ancestor
25195786|NCT02756663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25195787|NCT02756663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25195788|NCT02756663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195789|NCT02756663|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25195790|NCT02756663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25195791|NCT02756663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195792|NCT02756715|Propofol|propofol|mesh-list
25195793|NCT02756715|Desflurane|desflurane|mesh-list
25195794|NCT02756715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25195795|NCT02756715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25195796|NCT02756715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195797|NCT02756715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25195798|NCT02756715|Anesthetics, General|anesthetics, general|mesh-ancestor
25195799|NCT02756715|Anesthetics|anesthetics|mesh-ancestor
25195800|NCT02756715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25195801|NCT02756546|Hydroxychloroquine|hydroxychloroquine|mesh-list
24836430|NCT02185859|Anesthetics|anesthetics|mesh-ancestor
24836431|NCT02185859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25195802|NCT02756546|Hydrocortisone|hydrocortisone|mesh-list
25195803|NCT02756546|Cyclophosphamide|cyclophosphamide|mesh-list
25195804|NCT02756546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25195805|NCT02756546|Immunologic Factors|immunologic factors|mesh-ancestor
25195806|NCT02756546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195807|NCT02756546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25195808|NCT02756546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25195809|NCT02756546|Alkylating Agents|alkylating agents|mesh-ancestor
25195810|NCT02756546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195811|NCT02756546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195812|NCT02756546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25195813|NCT02756546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25195814|NCT02756546|Antimalarials|antimalarials|mesh-ancestor
25195815|NCT02756546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25195816|NCT02756546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25195817|NCT02756546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25195818|NCT02756546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25195819|NCT02756312|Anesthetics|anesthetics|mesh-list
25195820|NCT02756312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25195892|NCT02755545|Adapalene|adapalene|mesh-list
25195825|NCT02756377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25195826|NCT02756377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25195828|NCT02756377|Dermatologic Agents|dermatologic agents|mesh-ancestor
25195829|NCT02756104|Vitamin D|vitamin d|mesh-list
25195830|NCT02756104|Vitamins|vitamins|mesh-ancestor
25195831|NCT02756104|Micronutrients|micronutrients|mesh-ancestor
25195832|NCT02756104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195833|NCT02756104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25195834|NCT02756130|Carboplatin|carboplatin|mesh-list
25195835|NCT02756130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195836|NCT02756026|Micronutrients|micronutrients|mesh-list
25195837|NCT02756026|Trace Elements|trace elements|mesh-list
25195838|NCT02756026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195839|NCT02755753|Lansoprazole|lansoprazole|mesh-list
25195840|NCT02755753|Dexlansoprazole|dexlansoprazole|mesh-list
25666972|NCT01701414|Anesthetics|anesthetics|mesh-ancestor
25666973|NCT01701414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25666974|NCT01701414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666975|NCT01701414|Sensory System Agents|sensory system agents|mesh-ancestor
25666976|NCT01701414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25666977|NCT01701505|Phenylephrine|phenylephrine|mesh-list
25860643|NCT00084214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860644|NCT00084227|Azithromycin|azithromycin|mesh-list
25666978|NCT01701505|Oxymetazoline|oxymetazoline|mesh-list
25666979|NCT01701505|Tetracaine|tetracaine|mesh-list
25666980|NCT01701505|Anesthetics, Local|anesthetics, local|mesh-ancestor
25666981|NCT01701505|Anesthetics|anesthetics|mesh-ancestor
25860645|NCT00084227|Chloroquine|chloroquine|mesh-list
25195841|NCT02755753|Rebamipide|rebamipide|mesh-list
25195842|NCT02755753|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25195843|NCT02755753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25195844|NCT02755753|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25195845|NCT02755753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25195846|NCT02755753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195847|NCT02755753|Antioxidants|antioxidants|mesh-ancestor
25195848|NCT02755753|Protective Agents|protective agents|mesh-ancestor
25195849|NCT02755753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195850|NCT02755714|Bromides|bromides|mesh-list
25195851|NCT02755714|Ipratropium|ipratropium|mesh-list
25195852|NCT02755714|Anticonvulsants|anticonvulsants|mesh-ancestor
25195853|NCT02755714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25195854|NCT02755714|Autonomic Agents|autonomic agents|mesh-ancestor
25195855|NCT02755714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25195856|NCT02755714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195857|NCT02755714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25195858|NCT02755714|Respiratory System Agents|respiratory system agents|mesh-ancestor
25195859|NCT02755714|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25195860|NCT02755714|Cholinergic Agents|cholinergic agents|mesh-ancestor
25195861|NCT02755714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25195862|NCT02755714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195863|NCT02755909|Anesthetics|anesthetics|mesh-list
25195864|NCT02755909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25195865|NCT02755909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195866|NCT02756000|Dobutamine|dobutamine|mesh-list
25195867|NCT02756000|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25195868|NCT02756000|Sympathomimetics|sympathomimetics|mesh-ancestor
25195869|NCT02756000|Autonomic Agents|autonomic agents|mesh-ancestor
25195870|NCT02756000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25195871|NCT02756000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195872|NCT02756000|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25195873|NCT02756000|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25195874|NCT02756000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25195875|NCT02756000|Adrenergic Agents|adrenergic agents|mesh-ancestor
25195876|NCT02756000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25195877|NCT02756000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195878|NCT02756000|Protective Agents|protective agents|mesh-ancestor
25195879|NCT02755857|Itraconazole|itraconazole|mesh-list
25195880|NCT02755857|Antifungal Agents|antifungal agents|mesh-ancestor
24442835|NCT00292838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25195881|NCT02755857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25195882|NCT02755857|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25195883|NCT02755857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25195884|NCT02755857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25195885|NCT02755857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195886|NCT02755857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25195887|NCT02755857|Hormone Antagonists|hormone antagonists|mesh-ancestor
25195888|NCT02755857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25195889|NCT02755857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195890|NCT02755857|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25207100|NCT04891068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207102|NCT04891068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25207103|NCT04848753|Paclitaxel|paclitaxel|mesh-list
25207104|NCT04848753|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25207105|NCT04848753|Cisplatin|cisplatin|mesh-list
25207106|NCT04848753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25207107|NCT04848753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207108|NCT04848753|Tubulin Modulators|tubulin modulators|mesh-ancestor
25207109|NCT04848753|Antimitotic Agents|antimitotic agents|mesh-ancestor
25207110|NCT04848753|Mitosis Modulators|mitosis modulators|mesh-ancestor
24562824|NCT00768508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24562825|NCT00768508|Antiemetics|antiemetics|mesh-ancestor
25666982|NCT01701505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25666983|NCT01701505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25666984|NCT01701505|Sensory System Agents|sensory system agents|mesh-ancestor
25666985|NCT01701505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24781895|NCT01892787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562826|NCT00768508|Autonomic Agents|autonomic agents|mesh-ancestor
24562827|NCT00768508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24562828|NCT00768508|Antipruritics|antipruritics|mesh-ancestor
24562829|NCT00768508|Dermatologic Agents|dermatologic agents|mesh-ancestor
24562830|NCT00768508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24562831|NCT00768508|Serotonin Agents|serotonin agents|mesh-ancestor
24562832|NCT00768508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24562833|NCT00768508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562834|NCT00768508|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24562835|NCT00768508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24562836|NCT00768508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24562838|NCT00768508|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24562839|NCT00768573|Sildenafil Citrate|sildenafil citrate|mesh-list
25207111|NCT04848753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207112|NCT04827745|Blinatumomab|blinatumomab|mesh-list
25207113|NCT04827745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195891|NCT02755545|Salicylic Acid|salicylic acid|mesh-list
25195893|NCT02755545|Salicylates|salicylates|mesh-list
25195894|NCT02755545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25195895|NCT02755545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25195896|NCT02755545|Analgesics|analgesics|mesh-ancestor
25195897|NCT02755545|Sensory System Agents|sensory system agents|mesh-ancestor
25195898|NCT02755545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25195899|NCT02755545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195900|NCT02755545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25195901|NCT02755545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25195902|NCT02755545|Dermatologic Agents|dermatologic agents|mesh-ancestor
25195903|NCT02755545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25195904|NCT02755545|Antifungal Agents|antifungal agents|mesh-ancestor
25195905|NCT02755545|Keratolytic Agents|keratolytic agents|mesh-ancestor
25195906|NCT02755545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25195907|NCT02755545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25195908|NCT02755545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195909|NCT02755532|Bupivacaine|bupivacaine|mesh-list
24948459|NCT03919565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24948461|NCT03919253|Paclitaxel|paclitaxel|mesh-list
24562867|NCT00768677|Anticonvulsants|anticonvulsants|mesh-ancestor
24562868|NCT00768677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24562869|NCT00768677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562870|NCT00768690|Ketoconazole|ketoconazole|mesh-list
25195910|NCT02755532|Anesthetics, Local|anesthetics, local|mesh-ancestor
25195911|NCT02755532|Anesthetics|anesthetics|mesh-ancestor
25195912|NCT02755532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25195913|NCT02755532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195914|NCT02755532|Sensory System Agents|sensory system agents|mesh-ancestor
25195915|NCT02755532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25195916|NCT02755376|Hyaluronic Acid|hyaluronic acid|mesh-list
25195917|NCT02755376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25195918|NCT02755376|Immunologic Factors|immunologic factors|mesh-ancestor
25195919|NCT02755376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195920|NCT02755376|Viscosupplements|viscosupplements|mesh-ancestor
25195921|NCT02755376|Protective Agents|protective agents|mesh-ancestor
25195922|NCT02755298|Acetazolamide|acetazolamide|mesh-list
25195923|NCT02755298|Anticonvulsants|anticonvulsants|mesh-ancestor
25195924|NCT02755298|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25195925|NCT02755298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25195926|NCT02755298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195927|NCT02755298|Diuretics|diuretics|mesh-ancestor
25195928|NCT02755298|Natriuretic Agents|natriuretic agents|mesh-ancestor
25195929|NCT02755298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195930|NCT02755350|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25195931|NCT02755350|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25195932|NCT02755350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25195933|NCT02755350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25195934|NCT02755350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195935|NCT02755350|Antiviral Agents|antiviral agents|mesh-ancestor
25195936|NCT02755350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25195937|NCT02755350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25195938|NCT02755350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25195939|NCT02755311|Cisplatin|cisplatin|mesh-list
25195940|NCT02755311|Carboplatin|carboplatin|mesh-list
25666986|NCT01701505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25666987|NCT01701505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25860646|NCT00084227|Atovaquone|atovaquone|mesh-list
25860647|NCT00084227|Proguanil|proguanil|mesh-list
25860648|NCT00084227|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
25666988|NCT01701505|Adrenergic Agents|adrenergic agents|mesh-ancestor
25860649|NCT00084227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25860650|NCT00084227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25860651|NCT00084227|Amebicides|amebicides|mesh-ancestor
25860652|NCT00084227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25860653|NCT00084227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25860654|NCT00084227|Antimalarials|antimalarials|mesh-ancestor
25195941|NCT02755311|Fluorouracil|fluorouracil|mesh-list
25195942|NCT02755311|Epirubicin|epirubicin|mesh-list
25195943|NCT02755311|Ethiodized Oil|ethiodized oil|mesh-list
25195944|NCT02755311|Pirarubicin|pirarubicin|mesh-list
24948464|NCT03919253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24948465|NCT03919253|Tubulin Modulators|tubulin modulators|mesh-ancestor
24948466|NCT03919253|Antimitotic Agents|antimitotic agents|mesh-ancestor
24562894|NCT00768729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24562895|NCT00768729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25195945|NCT02755311|Doxorubicin|doxorubicin|mesh-list
25195946|NCT02755311|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
25195947|NCT02755311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195948|NCT02755311|Antimetabolites|antimetabolites|mesh-ancestor
25195949|NCT02755311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195950|NCT02755311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25195951|NCT02755311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25195952|NCT02755311|Immunologic Factors|immunologic factors|mesh-ancestor
25195953|NCT02755311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195954|NCT02755311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25195955|NCT02755311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25195956|NCT02755311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25195957|NCT02755311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25195958|NCT02755311|Hemostatics|hemostatics|mesh-ancestor
25195959|NCT02755311|Coagulants|coagulants|mesh-ancestor
25195960|NCT02755259|Acetazolamide|acetazolamide|mesh-list
25195961|NCT02755259|Anticonvulsants|anticonvulsants|mesh-ancestor
25195962|NCT02755259|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25195963|NCT02755259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25195964|NCT02755259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195965|NCT02755259|Diuretics|diuretics|mesh-ancestor
25195966|NCT02755259|Natriuretic Agents|natriuretic agents|mesh-ancestor
25195967|NCT02755259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195968|NCT02755142|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25195969|NCT02755142|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25195970|NCT02755142|Dermatologic Agents|dermatologic agents|mesh-ancestor
25195971|NCT02754882|Paclitaxel|paclitaxel|mesh-list
25195972|NCT02754882|Bevacizumab|bevacizumab|mesh-list
25195973|NCT02754882|Carboplatin|carboplatin|mesh-list
25195974|NCT02754882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25195975|NCT02754882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25195976|NCT02754882|Tubulin Modulators|tubulin modulators|mesh-ancestor
25195977|NCT02754882|Antimitotic Agents|antimitotic agents|mesh-ancestor
25195978|NCT02754882|Mitosis Modulators|mitosis modulators|mesh-ancestor
25195979|NCT02754882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195980|NCT02754882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25195981|NCT02754882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25195982|NCT02754882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25195983|NCT02754882|Growth Substances|growth substances|mesh-ancestor
25195984|NCT02754882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25195985|NCT02754882|Growth Inhibitors|growth inhibitors|mesh-ancestor
25195986|NCT02754765|Moxifloxacin|moxifloxacin|mesh-list
25195987|NCT02754765|Levofloxacin|levofloxacin|mesh-list
24562901|NCT00768859|Paclitaxel|paclitaxel|mesh-list
25195988|NCT02754765|Ofloxacin|ofloxacin|mesh-list
25195989|NCT02754765|Linezolid|linezolid|mesh-list
25195990|NCT02754765|Pyrazinamide|pyrazinamide|mesh-list
25195991|NCT02754765|Bedaquiline|bedaquiline|mesh-list
25195992|NCT02754765|Clofazimine|clofazimine|mesh-list
25195993|NCT02754765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25195994|NCT02754765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25195995|NCT02754765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25666989|NCT01701505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25666990|NCT01701505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25666991|NCT01701505|Sympathomimetics|sympathomimetics|mesh-ancestor
25666992|NCT01701505|Autonomic Agents|autonomic agents|mesh-ancestor
25666993|NCT01701505|Nasal Decongestants|nasal decongestants|mesh-ancestor
25666994|NCT01701505|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25195996|NCT02754765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25195997|NCT02754765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25082088|NCT03324828|Histamine Antagonists|histamine antagonists|mesh-ancestor
25082089|NCT03324828|Histamine Agents|histamine agents|mesh-ancestor
24781950|NCT01893177|Immunologic Factors|immunologic factors|mesh-ancestor
24781951|NCT01893177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781955|NCT01893229|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24781956|NCT01893229|Ziprasidone|ziprasidone|mesh-list
24781957|NCT01893229|Lithium Carbonate|lithium carbonate|mesh-list
24781958|NCT01893229|Antiemetics|antiemetics|mesh-ancestor
24781980|NCT01893229|GABA Agents|gaba agents|mesh-ancestor
25213561|NCT04489888|Mitosis Modulators|mitosis modulators|mesh-ancestor
25195998|NCT02754765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25195999|NCT02754765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25196000|NCT02754765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25196001|NCT02754765|Renal Agents|renal agents|mesh-ancestor
25196002|NCT02754765|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25196003|NCT02754765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25196004|NCT02754765|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25196005|NCT02754765|Antitubercular Agents|antitubercular agents|mesh-ancestor
25196006|NCT02754765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25196007|NCT02754765|Leprostatic Agents|leprostatic agents|mesh-ancestor
25196008|NCT02754817|Liraglutide|liraglutide|mesh-list
25196009|NCT02754817|Xultophy|xultophy|mesh-list
25196010|NCT02754817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25196011|NCT02754817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196012|NCT02754817|Incretins|incretins|mesh-ancestor
24452458|NCT05458765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25196013|NCT02754817|Hormones|hormones|mesh-ancestor
25196014|NCT02754817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24562913|NCT00768911|Alkylating Agents|alkylating agents|mesh-ancestor
24562914|NCT00768911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196015|NCT02754960|Thalidomide|thalidomide|mesh-list
25196016|NCT02754960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25196017|NCT02754960|Immunologic Factors|immunologic factors|mesh-ancestor
25196018|NCT02754960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196019|NCT02754960|Leprostatic Agents|leprostatic agents|mesh-ancestor
25196020|NCT02754960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25196021|NCT02754960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25196022|NCT02754960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25196023|NCT02754960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25196024|NCT02754960|Growth Substances|growth substances|mesh-ancestor
25196025|NCT02754960|Growth Inhibitors|growth inhibitors|mesh-ancestor
25196026|NCT02754960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25196027|NCT02755064|Erythromycin|erythromycin|mesh-list
25196028|NCT02755064|Erythromycin Estolate|erythromycin estolate|mesh-list
25196029|NCT02755064|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25196030|NCT02755064|Erythromycin stearate|erythromycin stearate|mesh-list
25196031|NCT02755064|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
25196032|NCT02755064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25196033|NCT02755064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25196034|NCT02755064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25196035|NCT02755064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25196036|NCT02755064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25196037|NCT02755064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196038|NCT02754726|Gemcitabine|gemcitabine|mesh-list
25196039|NCT02754726|Paclitaxel|paclitaxel|mesh-list
25196040|NCT02754726|Nivolumab|nivolumab|mesh-list
25196041|NCT02754726|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25207114|NCT04811625|Aspirin|aspirin|mesh-list
25196042|NCT02754726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25196043|NCT02754726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25196044|NCT02754726|Tubulin Modulators|tubulin modulators|mesh-ancestor
25196047|NCT02754726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196048|NCT02754726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25196049|NCT02754726|Antimetabolites|antimetabolites|mesh-ancestor
25196050|NCT02754726|Antiviral Agents|antiviral agents|mesh-ancestor
25196051|NCT02754726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25196052|NCT02754726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25196053|NCT02754726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25666995|NCT01701505|Respiratory System Agents|respiratory system agents|mesh-ancestor
25666996|NCT01701505|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25666997|NCT01701505|Mydriatics|mydriatics|mesh-ancestor
25666998|NCT01701505|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25666999|NCT01701505|Protective Agents|protective agents|mesh-ancestor
25667000|NCT01701973|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25667001|NCT01701973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25667002|NCT01701973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667003|NCT01701973|Incretins|incretins|mesh-ancestor
24627809|NCT01094990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24573998|NCT00822913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196054|NCT02754726|Immunologic Factors|immunologic factors|mesh-ancestor
25196055|NCT02754726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196056|NCT02754726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25196057|NCT02754726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25196058|NCT02754739|Pravastatin|pravastatin|mesh-list
25196059|NCT02754739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25196060|NCT02754739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25196061|NCT02754739|Antimetabolites|antimetabolites|mesh-ancestor
25196062|NCT02754739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196063|NCT02754739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25196064|NCT02754739|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25196065|NCT02754739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25196066|NCT02754583|Azithromycin|azithromycin|mesh-list
25196067|NCT02754583|Tetracycline|tetracycline|mesh-list
25196068|NCT02754583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25196069|NCT02754583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25196070|NCT02754583|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25196071|NCT02754583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25196072|NCT02754583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196073|NCT02754596|Timolol|timolol|mesh-list
25196074|NCT02754596|Travoprost|travoprost|mesh-list
25196075|NCT02754596|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25196076|NCT02754596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25196077|NCT02754596|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25196078|NCT02754596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25196079|NCT02754596|Adrenergic Agents|adrenergic agents|mesh-ancestor
25196080|NCT02754596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25196081|NCT02754596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196082|NCT02754596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196083|NCT02754596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25196084|NCT02754596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25196085|NCT02754687|Nandrolone Decanoate|nandrolone decanoate|mesh-list
25196086|NCT02754687|Nandrolone|nandrolone|mesh-list
24948475|NCT03919448|Bevacizumab|bevacizumab|mesh-list
25051667|NCT00389675|Adrenergic Agents|adrenergic agents|mesh-ancestor
25196087|NCT02754687|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
25196088|NCT02754687|Androgens|androgens|mesh-ancestor
25196089|NCT02754687|Hormones|hormones|mesh-ancestor
25196090|NCT02754687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25196091|NCT02754687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196092|NCT02754687|Anabolic Agents|anabolic agents|mesh-ancestor
25196093|NCT02754687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25196094|NCT02754362|Bevacizumab|bevacizumab|mesh-list
25196095|NCT02754362|Poly ICLC|poly iclc|mesh-list
25196096|NCT02754362|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
25196097|NCT02754362|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
25196098|NCT02754362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25196099|NCT02754362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25196100|NCT02754362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25196101|NCT02754362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25196102|NCT02754362|Growth Substances|growth substances|mesh-ancestor
25196103|NCT02754362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196104|NCT02754362|Growth Inhibitors|growth inhibitors|mesh-ancestor
25196107|NCT02754297|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25196108|NCT02754297|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25196109|NCT02754297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196110|NCT02754102|Sunscreening Agents|sunscreening agents|mesh-list
25196111|NCT02754102|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25196112|NCT02754102|Protective Agents|protective agents|mesh-ancestor
25196113|NCT02754102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196114|NCT02754102|Dermatologic Agents|dermatologic agents|mesh-ancestor
25196115|NCT02754258|Methylphenidate|methylphenidate|mesh-list
25196116|NCT02754258|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25196117|NCT02754258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196118|NCT02754258|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25196119|NCT02754258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25196120|NCT02754258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25196121|NCT02754258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196122|NCT02754258|Dopamine Agents|dopamine agents|mesh-ancestor
25667004|NCT01701973|Hormones|hormones|mesh-ancestor
25667005|NCT01701973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24782063|NCT01893658|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24782064|NCT01893658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24782065|NCT01893658|Respiratory System Agents|respiratory system agents|mesh-ancestor
24782066|NCT01893723|Remifentanil|remifentanil|mesh-list
24782067|NCT01893723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24782068|NCT01893723|Narcotics|narcotics|mesh-ancestor
25196123|NCT02754258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25196124|NCT02753803|Pioglitazone|pioglitazone|mesh-list
25196125|NCT02753803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25196126|NCT02753803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196127|NCT02753855|Telavancin|telavancin|mesh-list
25196128|NCT02753855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25196129|NCT02753855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25207115|NCT04811625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25207116|NCT04811625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25207117|NCT04811625|Analgesics|analgesics|mesh-ancestor
25207118|NCT04811625|Sensory System Agents|sensory system agents|mesh-ancestor
25207119|NCT04811625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25207120|NCT04811625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207121|NCT04811625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25207122|NCT04811625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25207123|NCT04811625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25207124|NCT04811625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25207125|NCT04811625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207126|NCT04811625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25207127|NCT04811625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25207128|NCT04811625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25207129|NCT04811625|Antipyretics|antipyretics|mesh-ancestor
25208224|NCT02855944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25208225|NCT02855944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208226|NCT02855944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25208227|NCT02855944|Immunologic Factors|immunologic factors|mesh-ancestor
25208228|NCT02855944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208229|NCT02855944|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25208230|NCT02851407|Defibrotide|defibrotide|mesh-list
25208231|NCT02851407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25208232|NCT02851407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25208233|NCT02851407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208234|NCT02851407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25208235|NCT02851290|Anesthetics|anesthetics|mesh-list
25208236|NCT02851290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25208237|NCT02851290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208238|NCT02803203|Bevacizumab|bevacizumab|mesh-list
25208239|NCT02803203|Osimertinib|osimertinib|mesh-list
25208240|NCT02803203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25208241|NCT02803203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208242|NCT02803203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25208243|NCT02803203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25208244|NCT02803203|Growth Substances|growth substances|mesh-ancestor
25208245|NCT02803203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208246|NCT02803203|Growth Inhibitors|growth inhibitors|mesh-ancestor
25208247|NCT02803203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25208248|NCT02803203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208249|NCT02803203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208253|NCT02737436|Oxytocin|oxytocin|mesh-list
25208254|NCT02737436|Oxytocics|oxytocics|mesh-ancestor
25208255|NCT02737436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25208260|NCT02727998|Sensory System Agents|sensory system agents|mesh-ancestor
25208261|NCT02727998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25208262|NCT02727998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208263|NCT02727998|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25208264|NCT02727998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25208265|NCT02727998|Anesthetics, General|anesthetics, general|mesh-ancestor
25196130|NCT02754180|Gemcitabine|gemcitabine|mesh-list
25196131|NCT02754180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25196132|NCT02754180|Antimetabolites|antimetabolites|mesh-ancestor
25196133|NCT02754180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196134|NCT02754180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25196135|NCT02754180|Antiviral Agents|antiviral agents|mesh-ancestor
25667006|NCT01701973|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25667007|NCT01701973|Protease Inhibitors|protease inhibitors|mesh-ancestor
25667008|NCT01701973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25667009|NCT01701973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667010|NCT01702025|Aminophylline|aminophylline|mesh-list
24782127|NCT01894334|Urinastatin|urinastatin|mesh-list
24782128|NCT01894334|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24574079|NCT00823550|Lamivudine|lamivudine|mesh-list
24782129|NCT01894334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24782130|NCT01894334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782131|NCT01894334|Hemostatics|hemostatics|mesh-ancestor
24782132|NCT01894334|Coagulants|coagulants|mesh-ancestor
24782134|NCT01894334|Antioxidants|antioxidants|mesh-ancestor
25196136|NCT02754180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25196137|NCT02754180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25196138|NCT02754180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25196139|NCT02754180|Immunologic Factors|immunologic factors|mesh-ancestor
25196140|NCT02754180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196144|NCT02753725|Fentanyl|fentanyl|mesh-list
25196145|NCT02753725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25196146|NCT02753725|Narcotics|narcotics|mesh-ancestor
25196147|NCT02753725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25196148|NCT02753725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196149|NCT02753725|Analgesics|analgesics|mesh-ancestor
25196150|NCT02753725|Sensory System Agents|sensory system agents|mesh-ancestor
25196151|NCT02753725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25196152|NCT02753725|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25196153|NCT02753725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25196154|NCT02753725|Anesthetics, General|anesthetics, general|mesh-ancestor
25196155|NCT02753725|Anesthetics|anesthetics|mesh-ancestor
25196156|NCT02753764|Prednisone|prednisone|mesh-list
25196157|NCT02753764|AZD7624|azd7624|mesh-list
25196158|NCT02753764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25196159|NCT02753764|Glucocorticoids|glucocorticoids|mesh-ancestor
25196160|NCT02753764|Hormones|hormones|mesh-ancestor
25196161|NCT02753764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25196162|NCT02753764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196163|NCT02753764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25196164|NCT02753764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25196165|NCT02753764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25196166|NCT02753764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25196167|NCT02753764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196168|NCT02753738|Citalopram|citalopram|mesh-list
25196169|NCT02753738|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25196170|NCT02753738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25196171|NCT02753738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25196172|NCT02753738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196173|NCT02753738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25196174|NCT02753738|Serotonin Agents|serotonin agents|mesh-ancestor
25196175|NCT02753738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196176|NCT02753738|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25196177|NCT02753738|Antidepressive Agents|antidepressive agents|mesh-ancestor
25196178|NCT02753738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25196179|NCT02753712|Fluticasone|fluticasone|mesh-list
25196180|NCT02753712|Xhance|xhance|mesh-list
25196181|NCT02753712|Formoterol Fumarate|formoterol fumarate|mesh-list
25196182|NCT02753712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25196183|NCT02753712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25196184|NCT02753712|Autonomic Agents|autonomic agents|mesh-ancestor
25196185|NCT02753712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25196186|NCT02753712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196187|NCT02753712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25196188|NCT02753712|Respiratory System Agents|respiratory system agents|mesh-ancestor
25196189|NCT02753712|Dermatologic Agents|dermatologic agents|mesh-ancestor
25196190|NCT02753712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25196191|NCT02753712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25196192|NCT02753712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25196193|NCT02753712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25196194|NCT02753712|Adrenergic Agents|adrenergic agents|mesh-ancestor
25196195|NCT02753712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25196196|NCT02753712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667011|NCT01702025|Methazolamide|methazolamide|mesh-list
25667012|NCT01702025|Theophylline|theophylline|mesh-list
25667013|NCT01702025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25667014|NCT01702025|Autonomic Agents|autonomic agents|mesh-ancestor
25667015|NCT01702025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25667016|NCT01702025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667017|NCT01702025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25667018|NCT01702025|Respiratory System Agents|respiratory system agents|mesh-ancestor
24782186|NCT01894711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24782187|NCT01894711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24782188|NCT01894789|Clopidogrel|clopidogrel|mesh-list
24782189|NCT01894789|Ticagrelor|ticagrelor|mesh-list
24782190|NCT01894789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24782191|NCT01894789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24782192|NCT01894789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24782193|NCT01894789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25196197|NCT02753647|Prednisone|prednisone|mesh-list
25051679|NCT00389155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051680|NCT00389155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25196198|NCT02753647|Cyclophosphamide|cyclophosphamide|mesh-list
25196199|NCT02753647|Rituximab|rituximab|mesh-list
25196200|NCT02753647|Doxorubicin|doxorubicin|mesh-list
25196201|NCT02753647|Vincristine|vincristine|mesh-list
25196202|NCT02753647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25196203|NCT02753647|Immunologic Factors|immunologic factors|mesh-ancestor
25196204|NCT02753647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196205|NCT02753647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25196206|NCT02753647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25196207|NCT02753647|Alkylating Agents|alkylating agents|mesh-ancestor
25196208|NCT02753647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196209|NCT02753647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25196210|NCT02753647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25196211|NCT02753647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25196212|NCT02753647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25196213|NCT02753647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25196214|NCT02753647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25196215|NCT02753647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25196216|NCT02753647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25196217|NCT02753647|Glucocorticoids|glucocorticoids|mesh-ancestor
25196218|NCT02753647|Hormones|hormones|mesh-ancestor
25196219|NCT02753647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25196220|NCT02753647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25196221|NCT02753647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25196222|NCT02753647|Tubulin Modulators|tubulin modulators|mesh-ancestor
25196223|NCT02753647|Antimitotic Agents|antimitotic agents|mesh-ancestor
25196224|NCT02753647|Mitosis Modulators|mitosis modulators|mesh-ancestor
25196225|NCT02753426|Doxycycline|doxycycline|mesh-list
25196226|NCT02753426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25196227|NCT02753426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25196228|NCT02753426|Antimalarials|antimalarials|mesh-ancestor
25196229|NCT02753426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25196230|NCT02753426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25196231|NCT02753387|Chlorhexidine|chlorhexidine|mesh-list
25196232|NCT02753387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25196233|NCT02753387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25196234|NCT02753387|Disinfectants|disinfectants|mesh-ancestor
25196235|NCT02753309|Sirolimus|sirolimus|mesh-list
25196236|NCT02753309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25196237|NCT02753309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25196238|NCT02753309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25196239|NCT02753309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25196240|NCT02753309|Antifungal Agents|antifungal agents|mesh-ancestor
25196241|NCT02753309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25196242|NCT02753309|Immunologic Factors|immunologic factors|mesh-ancestor
25196243|NCT02753309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196244|NCT02753140|Docetaxel|docetaxel|mesh-list
25196245|NCT02753140|Cetuximab|cetuximab|mesh-list
25196246|NCT02753140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25196247|NCT02753140|Tubulin Modulators|tubulin modulators|mesh-ancestor
25196248|NCT02753140|Antimitotic Agents|antimitotic agents|mesh-ancestor
25196249|NCT02753140|Mitosis Modulators|mitosis modulators|mesh-ancestor
25196250|NCT02753140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196251|NCT02753140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25196252|NCT02753114|Ketamine|ketamine|mesh-list
25196253|NCT02753114|Analgesics|analgesics|mesh-ancestor
25196254|NCT02753114|Sensory System Agents|sensory system agents|mesh-ancestor
25667019|NCT01702025|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25667020|NCT01702025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25667021|NCT01702025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667022|NCT01702025|Vasodilator Agents|vasodilator agents|mesh-ancestor
25667023|NCT01702025|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25667024|NCT01702025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25667025|NCT01702025|Purinergic Agents|purinergic agents|mesh-ancestor
25667026|NCT01702025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24782241|NCT01895023|Sensory System Agents|sensory system agents|mesh-ancestor
24782242|NCT01895023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24782243|NCT01895023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25050216|NCT00531622|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25050217|NCT00531622|Antidepressive Agents|antidepressive agents|mesh-ancestor
24782244|NCT01895023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24782245|NCT01895023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25196255|NCT02753114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25196256|NCT02753114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196257|NCT02753114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25196258|NCT02753114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25196259|NCT02753114|Anesthetics, General|anesthetics, general|mesh-ancestor
25196260|NCT02753114|Anesthetics|anesthetics|mesh-ancestor
25196261|NCT02753114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25196262|NCT02753114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25196263|NCT02753114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25196264|NCT02753114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25196265|NCT02753114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196266|NCT02753218|Midazolam|midazolam|mesh-list
25196267|NCT02753218|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25196268|NCT02753218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25196269|NCT02753218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25196270|NCT02753218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196271|NCT02753218|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25196272|NCT02753218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25196273|NCT02753218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25196274|NCT02753218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25196275|NCT02753218|Anesthetics, General|anesthetics, general|mesh-ancestor
25196276|NCT02753218|Anesthetics|anesthetics|mesh-ancestor
25196277|NCT02753218|GABA Modulators|gaba modulators|mesh-ancestor
25196278|NCT02753218|GABA Agents|gaba agents|mesh-ancestor
25196279|NCT02753218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25860655|NCT00084227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25196280|NCT02753218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196281|NCT02753205|Dexmedetomidine|dexmedetomidine|mesh-list
25196282|NCT02753205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25196283|NCT02753205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25196284|NCT02753205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196285|NCT02753205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25196287|NCT02753205|Sensory System Agents|sensory system agents|mesh-ancestor
25196288|NCT02753205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25196289|NCT02753205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25196290|NCT02753205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25196291|NCT02753205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25196292|NCT02753205|Adrenergic Agents|adrenergic agents|mesh-ancestor
25196371|NCT02752763|Plasma Substitutes|plasma substitutes|mesh-ancestor
25196294|NCT02753205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196295|NCT02752971|Diclofenac|diclofenac|mesh-list
25196296|NCT02752971|Bupivacaine|bupivacaine|mesh-list
25196297|NCT02752971|Anesthetics, Local|anesthetics, local|mesh-ancestor
25196298|NCT02752971|Anesthetics|anesthetics|mesh-ancestor
25196299|NCT02752971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25196300|NCT02752971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196301|NCT02752971|Sensory System Agents|sensory system agents|mesh-ancestor
25196302|NCT02752971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25196303|NCT02752971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25196304|NCT02752971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25196305|NCT02752971|Analgesics|analgesics|mesh-ancestor
25196306|NCT02752971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25196307|NCT02752971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25196308|NCT02752971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25196309|NCT02752971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25196310|NCT02752971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563399|NCT00771394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667027|NCT01702025|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25667028|NCT01702025|Protective Agents|protective agents|mesh-ancestor
25667029|NCT01702025|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25667030|NCT01702025|Diuretics|diuretics|mesh-ancestor
25667031|NCT01702025|Natriuretic Agents|natriuretic agents|mesh-ancestor
25667032|NCT01702233|Dexamethasone|dexamethasone|mesh-list
25667033|NCT01702233|Dexamethasone acetate|dexamethasone acetate|mesh-list
25667034|NCT01702233|BB 1101|bb 1101|mesh-list
25667035|NCT01702233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24952866|NCT03891433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24952867|NCT03891433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24574301|NCT00824863|Antifungal Agents|antifungal agents|mesh-ancestor
24574302|NCT00824863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24574303|NCT00824863|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24574304|NCT00824863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24574305|NCT00824863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574306|NCT00824863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563400|NCT00771394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563401|NCT00771394|Urological Agents|urological agents|mesh-ancestor
24563402|NCT00771394|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25196311|NCT02753166|Dexamethasone|dexamethasone|mesh-list
25196312|NCT02753166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25196313|NCT02753166|Antiemetics|antiemetics|mesh-ancestor
25196314|NCT02753166|Autonomic Agents|autonomic agents|mesh-ancestor
25196315|NCT02753166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24836847|NCT02187614|Diclofenac|diclofenac|mesh-list
25196316|NCT02753166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196317|NCT02753166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25196318|NCT02753166|Glucocorticoids|glucocorticoids|mesh-ancestor
25196319|NCT02753166|Hormones|hormones|mesh-ancestor
25196320|NCT02753166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25196321|NCT02753166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25196322|NCT02753166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25196323|NCT02752828|Insulin|insulin|mesh-list
25196324|NCT02752828|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25196325|NCT02752828|Insulin Glargine|insulin glargine|mesh-list
25196326|NCT02752828|Lixisenatide|lixisenatide|mesh-list
25196327|NCT02752828|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25196328|NCT02752828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196329|NCT02752815|Prednisone|prednisone|mesh-list
25196330|NCT02752815|Cyclophosphamide|cyclophosphamide|mesh-list
25196331|NCT02752815|Rituximab|rituximab|mesh-list
25196332|NCT02752815|Vincristine|vincristine|mesh-list
25860656|NCT00084227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443434|NCT00294931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24563420|NCT00771459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24563421|NCT00771498|Lopinavir|lopinavir|mesh-list
24563422|NCT00771498|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24563423|NCT00771498|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24563424|NCT00771498|Protease Inhibitors|protease inhibitors|mesh-ancestor
25196342|NCT02752815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25196343|NCT02752815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25196344|NCT02752815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25196345|NCT02752815|Glucocorticoids|glucocorticoids|mesh-ancestor
25196346|NCT02752815|Hormones|hormones|mesh-ancestor
25196347|NCT02752815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25196348|NCT02752815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25196349|NCT02752815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25860657|NCT00084227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196350|NCT02752815|Tubulin Modulators|tubulin modulators|mesh-ancestor
25196351|NCT02752815|Antimitotic Agents|antimitotic agents|mesh-ancestor
25196352|NCT02752815|Mitosis Modulators|mitosis modulators|mesh-ancestor
25196353|NCT02752815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25196354|NCT02752815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25196355|NCT02752815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25196356|NCT02752815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25196366|NCT02752763|Dextrans|dextrans|mesh-list
25196367|NCT02752763|Povidone|povidone|mesh-list
25196368|NCT02752763|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25196369|NCT02752763|Lubricant Eye Drops|lubricant eye drops|mesh-list
25196370|NCT02752763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24563427|NCT00771498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25051709|NCT00384904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25051710|NCT00384904|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25196372|NCT02752763|Blood Substitutes|blood substitutes|mesh-ancestor
25667036|NCT01702233|Antiemetics|antiemetics|mesh-ancestor
25667037|NCT01702233|Autonomic Agents|autonomic agents|mesh-ancestor
25667038|NCT01702233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25667039|NCT01702233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667040|NCT01702233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25667041|NCT01702233|Glucocorticoids|glucocorticoids|mesh-ancestor
25667042|NCT01702233|Hormones|hormones|mesh-ancestor
25667043|NCT01702233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25196373|NCT02752763|Anticoagulants|anticoagulants|mesh-ancestor
25196374|NCT02753062|Rituximab|rituximab|mesh-list
25196375|NCT02753062|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24621177|NCT01060904|Antimitotic Agents|antimitotic agents|mesh-ancestor
24621178|NCT01060904|Mitosis Modulators|mitosis modulators|mesh-ancestor
25196376|NCT02753062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25196377|NCT02753062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25196378|NCT02753062|Immunologic Factors|immunologic factors|mesh-ancestor
25196379|NCT02753062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196380|NCT02753062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25196381|NCT02753062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25196382|NCT02753062|Alkylating Agents|alkylating agents|mesh-ancestor
25196383|NCT02753062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196384|NCT02753088|Glatiramer Acetate|glatiramer acetate|mesh-list
25196385|NCT02753088|Mannitol|mannitol|mesh-list
25196386|NCT02753088|(T,G)-A-L|(t,g)-a-l|mesh-list
24643194|NCT01184443|Olanzapine|olanzapine|mesh-list
25196387|NCT02753088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25196388|NCT02753088|Diuretics|diuretics|mesh-ancestor
25196389|NCT02753088|Natriuretic Agents|natriuretic agents|mesh-ancestor
25196390|NCT02753088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196391|NCT02753088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25196392|NCT02753088|Immunologic Factors|immunologic factors|mesh-ancestor
25196393|NCT02753088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25196394|NCT02753088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25196395|NCT02752646|Ketorolac|ketorolac|mesh-list
25196396|NCT02752646|Nepafenac|nepafenac|mesh-list
25196397|NCT02752646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25196398|NCT02752646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25196399|NCT02752646|Analgesics|analgesics|mesh-ancestor
25196400|NCT02752646|Sensory System Agents|sensory system agents|mesh-ancestor
25196401|NCT02752646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25196402|NCT02752646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196403|NCT02752646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25196404|NCT02752646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24563492|NCT00772057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25196405|NCT02752646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25196406|NCT02752646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25196407|NCT02752646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196409|NCT02752841|Vitamins|vitamins|mesh-ancestor
25196410|NCT02752841|Micronutrients|micronutrients|mesh-ancestor
25196411|NCT02752841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196412|NCT02752841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25196413|NCT02752503|Nalmefene|nalmefene|mesh-list
25196414|NCT02752503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25196415|NCT02752503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196416|NCT02752503|Sensory System Agents|sensory system agents|mesh-ancestor
25196417|NCT02752503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25196418|NCT02752555|Antioxidants|antioxidants|mesh-list
25196419|NCT02752555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196420|NCT02752555|Protective Agents|protective agents|mesh-ancestor
25196421|NCT02752555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196422|NCT02752724|Ketamine|ketamine|mesh-list
25196423|NCT02752724|Methohexital|methohexital|mesh-list
25196424|NCT02752724|Analgesics|analgesics|mesh-ancestor
25196425|NCT02752724|Sensory System Agents|sensory system agents|mesh-ancestor
25196426|NCT02752724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25196427|NCT02752724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196428|NCT02752724|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25196429|NCT02752724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25196430|NCT02752724|Anesthetics, General|anesthetics, general|mesh-ancestor
25196432|NCT02752724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25196433|NCT02752724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25196434|NCT02752724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25196435|NCT02752724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25196436|NCT02752724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196437|NCT02752529|Tacrolimus|tacrolimus|mesh-list
25196438|NCT02752529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25196439|NCT02752529|Immunologic Factors|immunologic factors|mesh-ancestor
25196440|NCT02752529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196441|NCT02752529|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25196442|NCT02752529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25196443|NCT02752529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196444|NCT02752191|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25196445|NCT02752191|Hematinics|hematinics|mesh-ancestor
25196446|NCT02752191|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25196447|NCT02752191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25667044|NCT01702233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25860658|NCT00084227|Antimetabolites|antimetabolites|mesh-ancestor
24782334|NCT01895348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782335|NCT01895348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25196448|NCT02752113|Metformin|metformin|mesh-list
25196449|NCT02752113|Empagliflozin|empagliflozin|mesh-list
25196450|NCT02752113|Linagliptin|linagliptin|mesh-list
25196451|NCT02752113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25196452|NCT02752113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196453|NCT02752113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25196454|NCT02752113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196455|NCT02752113|Incretins|incretins|mesh-ancestor
25196456|NCT02752113|Hormones|hormones|mesh-ancestor
25196457|NCT02752113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25196458|NCT02752113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25196459|NCT02752113|Protease Inhibitors|protease inhibitors|mesh-ancestor
25196460|NCT02752113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25196461|NCT02752204|Rituximab|rituximab|mesh-list
25196462|NCT02752204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25196463|NCT02752204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25196464|NCT02752204|Immunologic Factors|immunologic factors|mesh-ancestor
25196465|NCT02752204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196466|NCT02752204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25196467|NCT02752308|Atropine|atropine|mesh-list
25196468|NCT02752308|Epinephrine|epinephrine|mesh-list
25196469|NCT02752308|Fentanyl|fentanyl|mesh-list
25196470|NCT02752308|Bupivacaine|bupivacaine|mesh-list
25196471|NCT02752308|Neostigmine|neostigmine|mesh-list
25196472|NCT02752308|Anesthetics, Local|anesthetics, local|mesh-ancestor
25196473|NCT02752308|Anesthetics|anesthetics|mesh-ancestor
25196474|NCT02752308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25196475|NCT02752308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196476|NCT02752308|Sensory System Agents|sensory system agents|mesh-ancestor
25196477|NCT02752308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25196490|NCT02752308|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25196491|NCT02752308|Autonomic Agents|autonomic agents|mesh-ancestor
25196492|NCT02752308|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25196493|NCT02752308|Respiratory System Agents|respiratory system agents|mesh-ancestor
25196494|NCT02752308|Mydriatics|mydriatics|mesh-ancestor
25196495|NCT02752308|Sympathomimetics|sympathomimetics|mesh-ancestor
25196496|NCT02752308|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25196497|NCT02752308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25196498|NCT02752308|Parasympatholytics|parasympatholytics|mesh-ancestor
25196499|NCT02752308|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25196500|NCT02752308|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25196501|NCT02752308|Cholinergic Agents|cholinergic agents|mesh-ancestor
25196502|NCT02752308|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25196503|NCT02752308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25196504|NCT02752308|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25207130|NCT04735861|Bevacizumab|bevacizumab|mesh-list
25207131|NCT04735861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25207132|NCT04735861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207133|NCT04735861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25207134|NCT04735861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25207135|NCT04735861|Growth Substances|growth substances|mesh-ancestor
25207136|NCT04735861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207137|NCT04735861|Growth Inhibitors|growth inhibitors|mesh-ancestor
25207150|NCT04717700|Dexamethasone|dexamethasone|mesh-list
25207151|NCT04717700|Lenalidomide|lenalidomide|mesh-list
25207152|NCT04717700|Bortezomib|bortezomib|mesh-list
25207153|NCT04717700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25207154|NCT04717700|Antiemetics|antiemetics|mesh-ancestor
25207155|NCT04717700|Autonomic Agents|autonomic agents|mesh-ancestor
25207156|NCT04717700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25207157|NCT04717700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207158|NCT04717700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25207159|NCT04717700|Glucocorticoids|glucocorticoids|mesh-ancestor
25207160|NCT04717700|Hormones|hormones|mesh-ancestor
25207161|NCT04717700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25207162|NCT04717700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25207163|NCT04717700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207164|NCT04717700|Immunologic Factors|immunologic factors|mesh-ancestor
25207165|NCT04717700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25207166|NCT04717700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25207167|NCT04717700|Growth Substances|growth substances|mesh-ancestor
25667045|NCT01702233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25667046|NCT01702233|Protease Inhibitors|protease inhibitors|mesh-ancestor
25207168|NCT04717700|Growth Inhibitors|growth inhibitors|mesh-ancestor
25667047|NCT01702233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25207169|NCT04692103|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25207170|NCT04692103|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25207171|NCT04692103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207172|NCT04686279|Tenofovir|tenofovir|mesh-list
25207173|NCT04686279|Antiviral Agents|antiviral agents|mesh-ancestor
25207174|NCT04686279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25207175|NCT04686279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25207176|NCT04686279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25207177|NCT04686279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25207178|NCT04686279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207179|NCT04686279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25207180|NCT04686279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25207181|NCT04665947|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
25207182|NCT04665947|Chelating Agents|chelating agents|mesh-ancestor
25207183|NCT04665947|Sequestering Agents|sequestering agents|mesh-ancestor
25207184|NCT04665947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207185|NCT04622839|Acetaminophen|acetaminophen|mesh-list
25207186|NCT04622839|Ibuprofen|ibuprofen|mesh-list
25207187|NCT04622839|Diclofenac|diclofenac|mesh-list
25207188|NCT04622839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25207189|NCT04622839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25207190|NCT04622839|Analgesics|analgesics|mesh-ancestor
25207191|NCT04622839|Sensory System Agents|sensory system agents|mesh-ancestor
25207192|NCT04622839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25207193|NCT04622839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207194|NCT04622839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25207195|NCT04622839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25207196|NCT04622839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25207197|NCT04622839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25207198|NCT04622839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207199|NCT04622839|Antipyretics|antipyretics|mesh-ancestor
25207200|NCT04594551|Vaccines|vaccines|mesh-list
25207201|NCT04594551|Immunoglobulins|immunoglobulins|mesh-list
25208266|NCT02727998|Anesthetics|anesthetics|mesh-ancestor
25196505|NCT02752334|Magnesium Sulfate|magnesium sulfate|mesh-list
25196506|NCT02752334|Bupivacaine|bupivacaine|mesh-list
25196507|NCT02752334|Anesthetics, Local|anesthetics, local|mesh-ancestor
25196508|NCT02752334|Anesthetics|anesthetics|mesh-ancestor
25196509|NCT02752334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25196510|NCT02752334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196511|NCT02752334|Sensory System Agents|sensory system agents|mesh-ancestor
25196512|NCT02752334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25196513|NCT02752334|Analgesics|analgesics|mesh-ancestor
25196514|NCT02752334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25196515|NCT02752334|Anticonvulsants|anticonvulsants|mesh-ancestor
25196516|NCT02752334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25196517|NCT02752334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25196518|NCT02752334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196519|NCT02752334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25196520|NCT02752334|Tocolytic Agents|tocolytic agents|mesh-ancestor
25196521|NCT02752334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25196522|NCT02751996|Tenofovir|tenofovir|mesh-list
25196523|NCT02751996|Antiviral Agents|antiviral agents|mesh-ancestor
25196524|NCT02751996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25196525|NCT02751996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25196526|NCT02751996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25196527|NCT02751996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25196528|NCT02751996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196529|NCT02751996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25196530|NCT02751996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25196531|NCT02751918|Doxorubicin|doxorubicin|mesh-list
25196532|NCT02751918|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25196533|NCT02751918|Maytansine|maytansine|mesh-list
25196534|NCT02751918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25196535|NCT02751918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25196536|NCT02751918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25196537|NCT02751918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25196538|NCT02751918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25196539|NCT02751918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196540|NCT02751918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25196541|NCT02751918|Tubulin Modulators|tubulin modulators|mesh-ancestor
25196542|NCT02751918|Antimitotic Agents|antimitotic agents|mesh-ancestor
25196543|NCT02751918|Mitosis Modulators|mitosis modulators|mesh-ancestor
25196544|NCT02751840|Caffeine|caffeine|mesh-list
25196545|NCT02751840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24606473|NCT00990600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25860659|NCT00084240|Azithromycin|azithromycin|mesh-list
25674420|NCT01772134|Respiratory System Agents|respiratory system agents|mesh-ancestor
25196546|NCT02751840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196547|NCT02751840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25196548|NCT02751840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25196549|NCT02751840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196550|NCT02751840|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25196551|NCT02751840|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25196552|NCT02751840|Purinergic Agents|purinergic agents|mesh-ancestor
25196553|NCT02751840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25196555|NCT02752477|Anesthetics, General|anesthetics, general|mesh-list
25196556|NCT02752477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25196557|NCT02752477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196559|NCT02752412|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25196560|NCT02752412|Metformin|metformin|mesh-list
25196561|NCT02752412|Insulin Glargine|insulin glargine|mesh-list
25196562|NCT02752412|Lixisenatide|lixisenatide|mesh-list
25196563|NCT02752412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25196564|NCT02752412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196565|NCT02751593|Dexamethasone|dexamethasone|mesh-list
25196566|NCT02751593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25196567|NCT02751593|Antiemetics|antiemetics|mesh-ancestor
25196568|NCT02751593|Autonomic Agents|autonomic agents|mesh-ancestor
25196569|NCT02751593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25196570|NCT02751593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196571|NCT02751593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25196572|NCT02751593|Glucocorticoids|glucocorticoids|mesh-ancestor
25196573|NCT02751593|Hormones|hormones|mesh-ancestor
25196574|NCT02751593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25196575|NCT02751593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25196576|NCT02751593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25196577|NCT02751632|Fluoxetine|fluoxetine|mesh-list
25196578|NCT02751632|Antidepressive Agents|antidepressive agents|mesh-list
25196579|NCT02751632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25196580|NCT02751632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25196581|NCT02751632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25196582|NCT02751632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196583|NCT02751632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25196584|NCT02751632|Serotonin Agents|serotonin agents|mesh-ancestor
25196585|NCT02751632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196586|NCT02751632|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25196587|NCT02751632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25196588|NCT02751632|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25196589|NCT02751632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25196590|NCT02751632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25196591|NCT02751619|Lidocaine|lidocaine|mesh-list
25196592|NCT02751619|Anesthetics, Local|anesthetics, local|mesh-ancestor
25196593|NCT02751619|Anesthetics|anesthetics|mesh-ancestor
25196594|NCT02751619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25196595|NCT02751619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196596|NCT02751619|Sensory System Agents|sensory system agents|mesh-ancestor
25196597|NCT02751619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25196598|NCT02751619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25196599|NCT02751619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25196600|NCT02751619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25196601|NCT02751619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25196602|NCT02751619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196603|NCT02751541|Sunscreening Agents|sunscreening agents|mesh-list
25196604|NCT02751541|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25196605|NCT02751541|Protective Agents|protective agents|mesh-ancestor
25196606|NCT02751541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196607|NCT02751541|Dermatologic Agents|dermatologic agents|mesh-ancestor
25196608|NCT02751476|Disinfectants|disinfectants|mesh-list
25196609|NCT02751476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25196610|NCT02751528|Vaccines|vaccines|mesh-list
25196611|NCT02751528|Immunologic Factors|immunologic factors|mesh-ancestor
25196612|NCT02751528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196613|NCT02751398|Dapagliflozin|dapagliflozin|mesh-list
25196614|NCT02751398|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25196615|NCT02751398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196616|NCT02751398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25196617|NCT02751398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674421|NCT01772134|Dermatologic Agents|dermatologic agents|mesh-ancestor
25196618|NCT02751294|Tafenoquine|tafenoquine|mesh-list
25196619|NCT02751294|Antimalarials|antimalarials|mesh-ancestor
25196620|NCT02751294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25196621|NCT02751294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25196622|NCT02751294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25196623|NCT02751307|Metformin|metformin|mesh-list
25196624|NCT02751307|Clozapine|clozapine|mesh-list
25196625|NCT02751307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25196626|NCT02751307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196627|NCT02751307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25196635|NCT02751307|GABA Antagonists|gaba antagonists|mesh-ancestor
25196636|NCT02751307|GABA Agents|gaba agents|mesh-ancestor
25196637|NCT05429775|Budesonide|budesonide|mesh-list
25196638|NCT05429775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25196639|NCT05429775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25196640|NCT05429775|Autonomic Agents|autonomic agents|mesh-ancestor
25196641|NCT05429775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25196642|NCT05429775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196643|NCT05429775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25196644|NCT05429775|Respiratory System Agents|respiratory system agents|mesh-ancestor
25196645|NCT05429775|Glucocorticoids|glucocorticoids|mesh-ancestor
25196646|NCT05429775|Hormones|hormones|mesh-ancestor
25196647|NCT05429775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24564380|NCT00776139|Cetirizine|cetirizine|mesh-list
25196655|NCT05429684|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25196656|NCT05429684|Capecitabine|capecitabine|mesh-list
25196657|NCT05429684|Trastuzumab|trastuzumab|mesh-list
25196659|NCT05429684|Letrozole|letrozole|mesh-list
25196660|NCT05429684|Palbociclib|palbociclib|mesh-list
25196661|NCT05429684|Pertuzumab|pertuzumab|mesh-list
25196662|NCT05429684|Antibodies|antibodies|mesh-list
25196663|NCT05429684|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25196664|NCT05429684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25196665|NCT05429684|Tubulin Modulators|tubulin modulators|mesh-ancestor
25196666|NCT05429684|Antimitotic Agents|antimitotic agents|mesh-ancestor
25196667|NCT05429684|Mitosis Modulators|mitosis modulators|mesh-ancestor
25196668|NCT05429684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196669|NCT05429684|Immunologic Factors|immunologic factors|mesh-ancestor
25196670|NCT05429684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196671|NCT05429684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25196672|NCT05429684|Antimetabolites|antimetabolites|mesh-ancestor
25196673|NCT05429684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25196674|NCT05429684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25196675|NCT05429684|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25196676|NCT05429684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25196677|NCT05429684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25196678|NCT05429684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25196679|NCT05429684|Hormone Antagonists|hormone antagonists|mesh-ancestor
25196680|NCT05429684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25196681|NCT05429684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25196682|NCT05429671|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25196683|NCT05429671|Gentamicins|gentamicins|mesh-list
25196684|NCT05429671|Tobramycin|tobramycin|mesh-list
25196685|NCT05429671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25196686|NCT05429671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25196687|NCT05429671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564494|NCT00776607|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24564495|NCT00776607|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24564496|NCT00776607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564497|NCT00776620|Glimepiride|glimepiride|mesh-list
24564498|NCT00776620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24564506|NCT00776633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24564632|NCT00777218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25196688|NCT05429671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196689|NCT05429580|Tranexamic Acid|tranexamic acid|mesh-list
25196690|NCT05429580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25196691|NCT05429580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25196692|NCT05429580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196693|NCT05429580|Hemostatics|hemostatics|mesh-ancestor
25196694|NCT05429580|Coagulants|coagulants|mesh-ancestor
25196695|NCT05429567|Fentanyl|fentanyl|mesh-list
25196696|NCT05429567|Bupivacaine|bupivacaine|mesh-list
25196706|NCT05429567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25196707|NCT05429567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25196708|NCT05429567|Anesthetics, General|anesthetics, general|mesh-ancestor
25196709|NCT05429554|Vildagliptin|vildagliptin|mesh-list
25196710|NCT05429554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25196711|NCT05429554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623905|NCT01073904|Norgestrel|norgestrel|mesh-list
25196712|NCT05429554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25196713|NCT05429554|Protease Inhibitors|protease inhibitors|mesh-ancestor
25196714|NCT05429554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25196715|NCT05429554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196725|NCT05429463|Paclitaxel|paclitaxel|mesh-list
25196726|NCT05429463|Carboplatin|carboplatin|mesh-list
25196727|NCT05429463|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25196728|NCT05429463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25196729|NCT05429463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24564634|NCT00777218|Anticonvulsants|anticonvulsants|mesh-ancestor
25196730|NCT05429463|Tubulin Modulators|tubulin modulators|mesh-ancestor
25196731|NCT05429463|Antimitotic Agents|antimitotic agents|mesh-ancestor
25196732|NCT05429463|Mitosis Modulators|mitosis modulators|mesh-ancestor
25196733|NCT05429463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196734|NCT05429294|Paclitaxel|paclitaxel|mesh-list
25196735|NCT05429294|Trastuzumab|trastuzumab|mesh-list
25196736|NCT05429294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25196737|NCT05429294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25196738|NCT05429294|Tubulin Modulators|tubulin modulators|mesh-ancestor
25196739|NCT05429294|Antimitotic Agents|antimitotic agents|mesh-ancestor
25196740|NCT05429294|Mitosis Modulators|mitosis modulators|mesh-ancestor
25196741|NCT05429294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196742|NCT05429294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25196751|NCT05429151|Acyclovir|acyclovir|mesh-list
25196752|NCT05429151|Antiviral Agents|antiviral agents|mesh-ancestor
25196753|NCT05429151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25196754|NCT05429086|Propofol|propofol|mesh-list
25196755|NCT05429086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25196756|NCT05429086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25196757|NCT05429086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196758|NCT05429086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25196759|NCT05429086|Anesthetics, General|anesthetics, general|mesh-ancestor
25196760|NCT05429086|Anesthetics|anesthetics|mesh-ancestor
25207202|NCT04594551|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25207203|NCT04594551|Antibodies|antibodies|mesh-list
25207204|NCT04594551|Immunologic Factors|immunologic factors|mesh-ancestor
25207205|NCT04594551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207206|NCT04593680|Tenofovir|tenofovir|mesh-list
25207207|NCT04593680|Emtricitabine|emtricitabine|mesh-list
25207208|NCT04593680|Antiviral Agents|antiviral agents|mesh-ancestor
25207209|NCT04593680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25207210|NCT04593680|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25207211|NCT04593680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25207212|NCT04593680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25207221|NCT04591808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207223|NCT04591808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25207224|NCT04591808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25207225|NCT04591808|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25207226|NCT04591808|Protease Inhibitors|protease inhibitors|mesh-ancestor
25207227|NCT04591808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25207228|NCT04590417|Cyproterone Acetate|cyproterone acetate|mesh-list
25207229|NCT04590417|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25207230|NCT04590417|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25207231|NCT04590417|Estradiol|estradiol|mesh-list
25207232|NCT04590417|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25207233|NCT04590417|Cyproterone|cyproterone|mesh-list
25207234|NCT04590417|Estrogens|estrogens|mesh-ancestor
25207235|NCT04590417|Hormones|hormones|mesh-ancestor
25207236|NCT04590417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25207237|NCT04590417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207238|NCT04590417|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25207239|NCT04590417|Contraceptive Agents|contraceptive agents|mesh-ancestor
25207240|NCT04590417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25207241|NCT04590417|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25207242|NCT04590417|Androgen Antagonists|androgen antagonists|mesh-ancestor
25207243|NCT04590417|Hormone Antagonists|hormone antagonists|mesh-ancestor
25196761|NCT05428826|Prednisone|prednisone|mesh-list
25196762|NCT05428826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24837144|NCT02189343|Antiemetics|antiemetics|mesh-ancestor
24837145|NCT02189343|Autonomic Agents|autonomic agents|mesh-ancestor
24837146|NCT02189343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24565159|NCT00779051|GABA Agents|gaba agents|mesh-ancestor
24565260|NCT00779454|Panitumumab|panitumumab|mesh-list
25196763|NCT05428826|Glucocorticoids|glucocorticoids|mesh-ancestor
25196764|NCT05428826|Hormones|hormones|mesh-ancestor
25196765|NCT05428826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25196766|NCT05428826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674422|NCT01772134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24491473|NCT00482690|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24491474|NCT00482690|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25196767|NCT05428826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25196768|NCT05428826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25196769|NCT05428670|Rituximab|rituximab|mesh-list
25196770|NCT05428670|Lenalidomide|lenalidomide|mesh-list
25196771|NCT05428670|Zanubrutinib|zanubrutinib|mesh-list
25196772|NCT05428670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25196773|NCT05428670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25196774|NCT05428670|Immunologic Factors|immunologic factors|mesh-ancestor
25196775|NCT05428670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196776|NCT05428670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25196777|NCT05428670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25196778|NCT05428670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25196779|NCT05428670|Growth Substances|growth substances|mesh-ancestor
25196780|NCT05428670|Growth Inhibitors|growth inhibitors|mesh-ancestor
25196781|NCT05428670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25196782|NCT05428670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25196783|NCT05428670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196784|NCT05428488|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
25196785|NCT05428488|Abatacept|abatacept|mesh-list
25196786|NCT05428488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25196787|NCT05428488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196788|NCT05428488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25196789|NCT05428488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25196790|NCT05428488|Immunologic Factors|immunologic factors|mesh-ancestor
25196791|NCT05428488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196792|NCT05428488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25196793|NCT05428488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25196827|NCT05411978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196841|NCT05318560|Lidocaine|lidocaine|mesh-list
25196842|NCT05318560|Anesthetics, Local|anesthetics, local|mesh-ancestor
25196843|NCT05318560|Anesthetics|anesthetics|mesh-ancestor
25196844|NCT05318560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25196845|NCT05318560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196846|NCT05318560|Sensory System Agents|sensory system agents|mesh-ancestor
25196847|NCT05318560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25196848|NCT05318560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25196849|NCT05318560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25196850|NCT05318560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25196851|NCT05318560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25196852|NCT05318560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196853|NCT05289687|Daratumumab|daratumumab|mesh-list
25196854|NCT05289687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25196855|NCT05289687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25196856|NCT05289687|Immunologic Factors|immunologic factors|mesh-ancestor
25196857|NCT05289687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196858|NCT05271578|Nicotine|nicotine|mesh-list
25196859|NCT05271578|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25196860|NCT05271578|Autonomic Agents|autonomic agents|mesh-ancestor
25196861|NCT05271578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25196862|NCT05271578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196863|NCT05271578|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25196864|NCT05271578|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25196865|NCT05271578|Cholinergic Agents|cholinergic agents|mesh-ancestor
25196866|NCT05271578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25196867|NCT05271578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207244|NCT04590417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207245|NCT04590417|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25207246|NCT04537208|Vaccines|vaccines|mesh-list
25207247|NCT04537208|Immunologic Factors|immunologic factors|mesh-ancestor
25207248|NCT04537208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207249|NCT04477759|Atezolizumab|atezolizumab|mesh-list
25207250|NCT04477759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207251|NCT04466618|Heparin|heparin|mesh-list
25207252|NCT04466618|Calcium heparin|calcium heparin|mesh-list
25207253|NCT04466618|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25207254|NCT04466618|Anticoagulants|anticoagulants|mesh-ancestor
25207255|NCT04466618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25207256|NCT04466618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25207257|NCT04466618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207258|NCT04466618|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25667048|NCT01702233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427872|NCT01823198|Fludarabine|fludarabine|mesh-list
25860660|NCT00084240|Chloroquine|chloroquine|mesh-list
25860661|NCT00084240|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
25860662|NCT00084240|Pyrimethamine|pyrimethamine|mesh-list
25860663|NCT00084240|Sulfadoxine|sulfadoxine|mesh-list
25860664|NCT00084240|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24782619|NCT01896960|Sensory System Agents|sensory system agents|mesh-ancestor
24782620|NCT01896960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24782621|NCT01896960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25860665|NCT00084240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25860666|NCT00084240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25050257|NCT00528333|Cytarabine|cytarabine|mesh-list
25207259|NCT04466618|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25207260|NCT04466618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25207261|NCT04461587|Pirfenidone|pirfenidone|mesh-list
25207262|NCT04461587|Analgesics|analgesics|mesh-ancestor
25207263|NCT04461587|Sensory System Agents|sensory system agents|mesh-ancestor
25207264|NCT04461587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25207265|NCT04461587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207266|NCT04461587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25207267|NCT04461587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25207268|NCT04461587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25207269|NCT04461587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25207270|NCT04461587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207271|NCT04457089|Simvastatin|simvastatin|mesh-list
25207272|NCT04457089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25207273|NCT04457089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25207274|NCT04457089|Antimetabolites|antimetabolites|mesh-ancestor
25207275|NCT04457089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207276|NCT04457089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25207277|NCT04457089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25207278|NCT04457089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25207279|NCT04416737|Insulin|insulin|mesh-list
25207280|NCT04416737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25207281|NCT04416737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207282|NCT04409860|Paclitaxel|paclitaxel|mesh-list
25207283|NCT04409860|Cisplatin|cisplatin|mesh-list
25207284|NCT04409860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25196868|NCT05256069|Propranolol|propranolol|mesh-list
25196869|NCT05256069|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25196870|NCT05256069|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25196871|NCT05256069|Adrenergic Agents|adrenergic agents|mesh-ancestor
25196872|NCT05256069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25196873|NCT05256069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196874|NCT05256069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196875|NCT05256069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25196876|NCT05256069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25196877|NCT05256069|Vasodilator Agents|vasodilator agents|mesh-ancestor
25196878|NCT05246111|Topotecan|topotecan|mesh-list
25196879|NCT05246111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25196880|NCT05246111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25196881|NCT05246111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565983|NCT00783653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565984|NCT00783731|Midazolam|midazolam|mesh-list
24565985|NCT00783731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24565986|NCT00783731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24565988|NCT00783731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196882|NCT05246111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196883|NCT05246111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25196884|NCT05215873|Misoprostol|misoprostol|mesh-list
25196885|NCT05215873|Oxytocin|oxytocin|mesh-list
25196886|NCT05215873|Oxytocics|oxytocics|mesh-ancestor
25196887|NCT05215873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25196888|NCT05215873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196889|NCT05215873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25196890|NCT05215873|Abortifacient Agents|abortifacient agents|mesh-ancestor
25196891|NCT05215873|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25196892|NCT05215873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25667049|NCT01702246|Simvastatin|simvastatin|mesh-list
25667050|NCT01702246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25667051|NCT01702246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25667052|NCT01702246|Antimetabolites|antimetabolites|mesh-ancestor
25667053|NCT01702246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667054|NCT01702246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25667055|NCT01702246|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25667056|NCT01702246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491558|NCT00483054|Nevirapine|nevirapine|mesh-list
24491559|NCT00483054|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24491560|NCT00483054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24491561|NCT00483054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491580|NCT00483067|Antiviral Agents|antiviral agents|mesh-ancestor
24491581|NCT00483067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24491582|NCT00483067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24491600|NCT00483132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491601|NCT00483132|Antiviral Agents|antiviral agents|mesh-ancestor
24491602|NCT00483132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24491603|NCT00483132|Immunologic Factors|immunologic factors|mesh-ancestor
24533888|NCT00645372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533889|NCT00645372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533890|NCT00645372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24533891|NCT00645372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25050276|NCT00526227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491604|NCT00483132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196893|NCT05215574|Pembrolizumab|pembrolizumab|mesh-list
25196894|NCT05215574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25196895|NCT05215574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25196896|NCT05195944|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25196897|NCT05195944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25196898|NCT05195944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196899|NCT05195944|Incretins|incretins|mesh-ancestor
25196900|NCT05195944|Hormones|hormones|mesh-ancestor
25196901|NCT05195944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25196902|NCT05195944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25196903|NCT05195944|Protease Inhibitors|protease inhibitors|mesh-ancestor
25196904|NCT05195944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25196905|NCT05195944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196906|NCT05177484|Ferric maltol|ferric maltol|mesh-list
25860667|NCT00084240|Amebicides|amebicides|mesh-ancestor
25196925|NCT05130086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196926|NCT05130086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25196927|NCT05130086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25196928|NCT05130086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25196930|NCT05112991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25196931|NCT05112991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25196932|NCT05112991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25196933|NCT05112991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25196934|NCT05075161|Pirfenidone|pirfenidone|mesh-list
25196935|NCT05075161|Analgesics|analgesics|mesh-ancestor
25196936|NCT05075161|Sensory System Agents|sensory system agents|mesh-ancestor
25196937|NCT05075161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25860668|NCT00084240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25196938|NCT05075161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196939|NCT05075161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25196940|NCT05075161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25196941|NCT05075161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25196942|NCT05075161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25196943|NCT05075161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25196944|NCT05060549|Cariprazine|cariprazine|mesh-list
25196945|NCT05060549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25196946|NCT05060549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25667057|NCT01702298|Metformin|metformin|mesh-list
25667058|NCT01702298|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25667059|NCT01702298|Simvastatin|simvastatin|mesh-list
25667060|NCT01702298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25667061|NCT01702298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667062|NCT01702298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25667063|NCT01702298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25667064|NCT01702298|Antimetabolites|antimetabolites|mesh-ancestor
25667065|NCT01702298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667066|NCT01702298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25667067|NCT01702298|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25667068|NCT01702298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25667069|NCT01702298|Incretins|incretins|mesh-ancestor
25667070|NCT01702298|Hormones|hormones|mesh-ancestor
25667071|NCT01702298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25667072|NCT01702298|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25667073|NCT01702298|Protease Inhibitors|protease inhibitors|mesh-ancestor
25667074|NCT01702311|Insulin Aspart|insulin aspart|mesh-list
25082138|NCT03324503|Glucocorticoids|glucocorticoids|mesh-list
24627848|NCT01095172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491646|NCT00483314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491648|NCT00483366|Gemcitabine|gemcitabine|mesh-list
24491649|NCT00483366|Capecitabine|capecitabine|mesh-list
24761278|NCT01762046|Metformin|metformin|mesh-list
24850406|NCT02252926|Sensory System Agents|sensory system agents|mesh-ancestor
24850407|NCT02252926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24850408|NCT02252926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24850409|NCT02252926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25860669|NCT00084240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24444792|NCT00299091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24444793|NCT00299091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24761280|NCT01762046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24761281|NCT01762046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761282|NCT01762150|Gemcitabine|gemcitabine|mesh-list
24761283|NCT01762150|Sorafenib|sorafenib|mesh-list
24761284|NCT01762150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761285|NCT01762150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25157457|NCT04704271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25157459|NCT04704271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25196947|NCT05060549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25196948|NCT05060549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25196949|NCT05060549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24566205|NCT00784797|Oxytocin|oxytocin|mesh-list
25197009|NCT04911062|Sensory System Agents|sensory system agents|mesh-ancestor
25197010|NCT04911062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25197011|NCT04911062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25667075|NCT01702311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25197012|NCT04911062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25197013|NCT04911062|Adrenergic Agents|adrenergic agents|mesh-ancestor
25197014|NCT04911062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25197015|NCT04911062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197016|NCT04911062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25197017|NCT04911062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25197018|NCT04911062|Autonomic Agents|autonomic agents|mesh-ancestor
25197019|NCT04911062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25197020|NCT04911062|Respiratory System Agents|respiratory system agents|mesh-ancestor
25197021|NCT04911062|Mydriatics|mydriatics|mesh-ancestor
25197022|NCT04911062|Sympathomimetics|sympathomimetics|mesh-ancestor
25197023|NCT04911062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25197026|NCT04876131|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25197027|NCT04876131|Gentamicins|gentamicins|mesh-list
25197028|NCT04876131|Cephalexin|cephalexin|mesh-list
25197029|NCT04876131|Penicillin G|penicillin g|mesh-list
25197030|NCT04876131|Penicillin G Benzathine|penicillin g benzathine|mesh-list
25197031|NCT04876131|Penicillin G Procaine|penicillin g procaine|mesh-list
25197032|NCT04876131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25197033|NCT04876131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25197034|NCT04876131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25197035|NCT04876131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197052|NCT04808999|Pembrolizumab|pembrolizumab|mesh-list
25197059|NCT04799626|Piperacillin|piperacillin|mesh-list
25197060|NCT04799626|Tigecycline|tigecycline|mesh-list
25197062|NCT04799626|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25667076|NCT01702311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667077|NCT01702428|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25667078|NCT01702428|Immunologic Factors|immunologic factors|mesh-ancestor
25667079|NCT01702428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667080|NCT01702519|Nicotine|nicotine|mesh-list
25667081|NCT01702519|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25667082|NCT01702519|Autonomic Agents|autonomic agents|mesh-ancestor
25667083|NCT01702519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25667084|NCT01702519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667085|NCT01702519|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25667086|NCT01702519|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25667087|NCT01702519|Cholinergic Agents|cholinergic agents|mesh-ancestor
25667088|NCT01702519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25667089|NCT01702519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667090|NCT01702532|Nicotine|nicotine|mesh-list
25667091|NCT01702532|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25667092|NCT01702532|Autonomic Agents|autonomic agents|mesh-ancestor
25667093|NCT01702532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25667094|NCT01702532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667095|NCT01702532|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24782762|NCT01897844|Hormones|hormones|mesh-ancestor
24782763|NCT01897844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24782764|NCT01897844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782765|NCT01898000|Chlorhexidine|chlorhexidine|mesh-list
24782766|NCT01898000|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24782767|NCT01898000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24782768|NCT01898000|Disinfectants|disinfectants|mesh-ancestor
24782777|NCT01898039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782778|NCT01898039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24782779|NCT01898039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24782780|NCT01898052|Anesthetics|anesthetics|mesh-list
25197063|NCT04799626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25197064|NCT04799626|Renal Agents|renal agents|mesh-ancestor
25197065|NCT04799626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25197066|NCT04799626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25197067|NCT04799626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25197068|NCT04799626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25197069|NCT04799626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197070|NCT04799626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197071|NCT04799626|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25197072|NCT04799626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25197073|NCT04799626|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25197074|NCT04799626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25197075|NCT04788043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25197076|NCT04788043|Pembrolizumab|pembrolizumab|mesh-list
25197077|NCT04788043|Magrolimab|magrolimab|mesh-list
25197078|NCT04788043|Antibodies|antibodies|mesh-list
25197079|NCT04788043|Immunoglobulins|immunoglobulins|mesh-list
25197080|NCT04788043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25197081|NCT04788043|Immunologic Factors|immunologic factors|mesh-ancestor
25197082|NCT04788043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197083|NCT04788043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860670|NCT00084240|Antimalarials|antimalarials|mesh-ancestor
25197090|NCT04731025|Vancomycin|vancomycin|mesh-list
25197092|NCT04731025|Cefazolin|cefazolin|mesh-list
25197093|NCT04731025|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25197094|NCT04731025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25197095|NCT04731025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25197096|NCT04731025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25197097|NCT04731025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197098|NCT04723004|Bevacizumab|bevacizumab|mesh-list
25197099|NCT04723004|Sorafenib|sorafenib|mesh-list
25197100|NCT04723004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25197101|NCT04723004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197102|NCT04723004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25197103|NCT04723004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25197104|NCT04723004|Growth Substances|growth substances|mesh-ancestor
25197105|NCT04723004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197106|NCT04723004|Growth Inhibitors|growth inhibitors|mesh-ancestor
25197107|NCT04723004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25197108|NCT04723004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25197109|NCT04723004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207285|NCT04409860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207286|NCT04409860|Tubulin Modulators|tubulin modulators|mesh-ancestor
25207287|NCT04409860|Antimitotic Agents|antimitotic agents|mesh-ancestor
25207288|NCT04409860|Mitosis Modulators|mitosis modulators|mesh-ancestor
25207289|NCT04409860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207290|NCT04371393|Remestemcel-l|remestemcel-l|mesh-list
25207291|NCT04371393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25207292|NCT04371393|Antiviral Agents|antiviral agents|mesh-ancestor
25207293|NCT04371393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25207294|NCT04363801|Capecitabine|capecitabine|mesh-list
25207295|NCT04363801|Oxaliplatin|oxaliplatin|mesh-list
25667096|NCT01702532|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25667097|NCT01702532|Cholinergic Agents|cholinergic agents|mesh-ancestor
25667098|NCT01702532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25667099|NCT01702532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667100|NCT01702558|Capecitabine|capecitabine|mesh-list
25667101|NCT01702558|Trastuzumab|trastuzumab|mesh-list
25667102|NCT01702558|Maytansine|maytansine|mesh-list
25667103|NCT01702558|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25667104|NCT01702558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25667105|NCT01702558|Antimetabolites|antimetabolites|mesh-ancestor
25667106|NCT01702558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207296|NCT04363801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24782790|NCT01898065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24782791|NCT01898065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24782792|NCT01898104|Capecitabine|capecitabine|mesh-list
24782793|NCT01898104|Valproic Acid|valproic acid|mesh-list
25207297|NCT04363801|Antimetabolites|antimetabolites|mesh-ancestor
25207298|NCT04363801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207299|NCT04363801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207300|NCT04349306|Rasburicase|rasburicase|mesh-list
25207301|NCT04349306|Gout Suppressants|gout suppressants|mesh-ancestor
25207302|NCT04349306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25207303|NCT04333654|Hydroxychloroquine|hydroxychloroquine|mesh-list
25207304|NCT04333654|Antimalarials|antimalarials|mesh-ancestor
25207305|NCT04333654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25207329|NCT04210349|Vaccines|vaccines|mesh-list
25207330|NCT04210349|Immunologic Factors|immunologic factors|mesh-ancestor
25207331|NCT04210349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207335|NCT04177693|Letrozole|letrozole|mesh-list
25207336|NCT04177693|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
25207337|NCT04177693|Clomiphene|clomiphene|mesh-list
25207338|NCT04177693|Enclomiphene|enclomiphene|mesh-list
25207339|NCT04177693|Zuclomiphene|zuclomiphene|mesh-list
25207340|NCT04177693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197111|NCT04696445|Oxycodone|oxycodone|mesh-list
25197112|NCT04696445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25197113|NCT04696445|Narcotics|narcotics|mesh-ancestor
25197114|NCT04696445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25197115|NCT04696445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197116|NCT04696445|Analgesics|analgesics|mesh-ancestor
25197117|NCT04696445|Sensory System Agents|sensory system agents|mesh-ancestor
25197118|NCT04696445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25197119|NCT04664023|Vaccines|vaccines|mesh-list
25197120|NCT04664023|Immunologic Factors|immunologic factors|mesh-ancestor
25197121|NCT04664023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197139|NCT04628572|Ceftazidime|ceftazidime|mesh-list
25197140|NCT04628572|Avibactam|avibactam|mesh-list
25197141|NCT04628572|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
25197142|NCT04628572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25197143|NCT04628572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25197144|NCT04628572|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25197145|NCT04628572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25197146|NCT04628572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197147|NCT04529135|Dexmedetomidine|dexmedetomidine|mesh-list
25197148|NCT04529135|Remifentanil|remifentanil|mesh-list
25197149|NCT04529135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25197150|NCT04529135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25197523|NCT03523273|Incretins|incretins|mesh-ancestor
25197164|NCT04527380|Adalimumab|adalimumab|mesh-list
25197165|NCT04527380|Ixekizumab|ixekizumab|mesh-list
25197166|NCT04527380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25197167|NCT04527380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25197168|NCT04527380|Dermatologic Agents|dermatologic agents|mesh-ancestor
25197169|NCT04523480|Methyltestosterone|methyltestosterone|mesh-list
24838371|NCT02197403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24838372|NCT02197403|Analgesics|analgesics|mesh-ancestor
24838373|NCT02197403|Sensory System Agents|sensory system agents|mesh-ancestor
24619068|NCT01050621|Protective Agents|protective agents|mesh-ancestor
25197170|NCT04523480|Testosterone|testosterone|mesh-list
25197171|NCT04523480|Testosterone undecanoate|testosterone undecanoate|mesh-list
25197172|NCT04523480|Testosterone enanthate|testosterone enanthate|mesh-list
25197173|NCT04523480|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25197174|NCT04523480|Androgens|androgens|mesh-ancestor
25197175|NCT04523480|Hormones|hormones|mesh-ancestor
25197176|NCT04523480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25197177|NCT04523480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197178|NCT04523480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25197179|NCT04523480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197180|NCT04523480|Anabolic Agents|anabolic agents|mesh-ancestor
25197194|NCT04460235|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25197195|NCT04460235|Immunologic Factors|immunologic factors|mesh-ancestor
25197196|NCT04460235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197197|NCT04454229|Penicillins|penicillins|mesh-list
25197198|NCT04454229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25197199|NCT04454229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25197200|NCT04384692|Mycophenolic Acid|mycophenolic acid|mesh-list
25197201|NCT04384692|Cyclophosphamide|cyclophosphamide|mesh-list
25197203|NCT04384692|Busulfan|busulfan|mesh-list
25197204|NCT04384692|Mechlorethamine|mechlorethamine|mesh-list
25667107|NCT01702558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25667108|NCT01702558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25667109|NCT01702558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25197205|NCT04384692|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25197206|NCT04384692|Methotrexate|methotrexate|mesh-list
25197207|NCT04384692|Fludarabine|fludarabine|mesh-list
25197216|NCT04384692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197217|NCT04384692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25197218|NCT04384692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25197219|NCT04384692|Abortifacient Agents|abortifacient agents|mesh-ancestor
25197220|NCT04384692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25197221|NCT04384692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25197222|NCT04384692|Antimetabolites|antimetabolites|mesh-ancestor
25197223|NCT04384692|Dermatologic Agents|dermatologic agents|mesh-ancestor
25197224|NCT04384692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25197225|NCT04384692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25197226|NCT04384692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25197234|NCT04359979|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25197235|NCT04359979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25197236|NCT04359979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25197237|NCT04359979|Adrenergic Agents|adrenergic agents|mesh-ancestor
25197238|NCT04359979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25197239|NCT04359979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197240|NCT04359979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197241|NCT04359979|Urological Agents|urological agents|mesh-ancestor
25197242|NCT04335292|Pemetrexed|pemetrexed|mesh-list
25197243|NCT04335292|Osimertinib|osimertinib|mesh-list
25197244|NCT04335292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197245|NCT04335292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567132|NCT00789646|Lidocaine|lidocaine|mesh-list
25197246|NCT04335292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197247|NCT04335292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25197248|NCT04335292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25197249|NCT04335292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25197250|NCT04281147|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25197251|NCT04281147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197252|NCT04278508|Progesterone|progesterone|mesh-list
25197253|NCT04278508|Progestins|progestins|mesh-ancestor
25197254|NCT04278508|Hormones|hormones|mesh-ancestor
25197255|NCT04278508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25197256|NCT04278508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197257|NCT04278144|Nivolumab|nivolumab|mesh-list
24826114|NCT02132416|Tramadol|tramadol|mesh-list
25197258|NCT04278144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25197259|NCT04278144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197260|NCT04278144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25197261|NCT04278144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197263|NCT04264208|Bombesin|bombesin|mesh-list
25197264|NCT04264208|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25197265|NCT04264208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197266|NCT04264208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25197267|NCT04264208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197286|NCT04180813|Linagliptin|linagliptin|mesh-list
25197287|NCT04180813|Acarbose|acarbose|mesh-list
25667112|NCT01702558|Mitosis Modulators|mitosis modulators|mesh-ancestor
25667113|NCT01702844|Paclitaxel|paclitaxel|mesh-list
25667114|NCT01702844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25667115|NCT01702844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812135|NCT02049801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24936744|NCT04036981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812151|NCT02049970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24812152|NCT02049970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24812153|NCT02049970|Adrenergic Agents|adrenergic agents|mesh-ancestor
24812154|NCT02049970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24812155|NCT02049970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213712|NCT04309773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25197288|NCT04180813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25197289|NCT04180813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197290|NCT04180813|Incretins|incretins|mesh-ancestor
25197291|NCT04180813|Hormones|hormones|mesh-ancestor
25197292|NCT04180813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25197293|NCT04180813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25197294|NCT04180813|Protease Inhibitors|protease inhibitors|mesh-ancestor
25197295|NCT04180813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25197296|NCT04180813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197297|NCT04180813|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25197298|NCT04163406|Ferrous fumarate|ferrous fumarate|mesh-list
25197299|NCT04163406|Trace Elements|trace elements|mesh-ancestor
25197300|NCT04163406|Micronutrients|micronutrients|mesh-ancestor
25197327|NCT04130152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25197328|NCT04130152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25197329|NCT04130152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197330|NCT04130152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25197331|NCT04130152|Hormone Antagonists|hormone antagonists|mesh-ancestor
25197332|NCT04130152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24567396|NCT00791011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25197333|NCT04130152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197334|NCT04130152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25197335|NCT04116775|Pembrolizumab|pembrolizumab|mesh-list
25197336|NCT04116775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25197337|NCT04116775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197338|NCT04088500|Nivolumab|nivolumab|mesh-list
25197339|NCT04088500|Ipilimumab|ipilimumab|mesh-list
25197340|NCT04088500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25197341|NCT04088500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197342|NCT04088500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25197343|NCT04088500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197344|NCT04088409|Adalimumab|adalimumab|mesh-list
25197345|NCT04088409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25197346|NCT04088409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25197347|NCT04066478|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25197348|NCT04066478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25197349|NCT04066478|Immunologic Factors|immunologic factors|mesh-ancestor
25197350|NCT04066478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197351|NCT04055012|Metformin|metformin|mesh-list
25197352|NCT04055012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25197353|NCT04055012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567544|NCT00791505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24567545|NCT00791505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25197524|NCT03523273|Hormones|hormones|mesh-ancestor
25197504|NCT03691064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25197505|NCT03691064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197511|NCT03553446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25197512|NCT03553446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25197513|NCT03553446|Anesthetics, General|anesthetics, general|mesh-ancestor
25197514|NCT03553446|Anesthetics|anesthetics|mesh-ancestor
25197515|NCT03553446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25197516|NCT03553446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197517|NCT03530189|Insulin|insulin|mesh-list
25197518|NCT03530189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25197519|NCT03530189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667116|NCT01702844|Tubulin Modulators|tubulin modulators|mesh-ancestor
25667117|NCT01702844|Antimitotic Agents|antimitotic agents|mesh-ancestor
25667118|NCT01702844|Mitosis Modulators|mitosis modulators|mesh-ancestor
25667119|NCT01702844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667120|NCT01702961|Cytarabine|cytarabine|mesh-list
25667121|NCT01702961|Etoposide|etoposide|mesh-list
25667122|NCT01702961|Rituximab|rituximab|mesh-list
25667123|NCT01702961|Melphalan|melphalan|mesh-list
25667124|NCT01702961|Carmustine|carmustine|mesh-list
24838952|NCT02201238|Analgesics|analgesics|mesh-ancestor
25667125|NCT01702961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25860672|NCT00084240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25860673|NCT00084240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24491793|NCT00484003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24491794|NCT00484003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24491795|NCT00484003|Analgesics|analgesics|mesh-ancestor
25860674|NCT00084240|Analgesics|analgesics|mesh-ancestor
25860675|NCT00084240|Sensory System Agents|sensory system agents|mesh-ancestor
25213719|NCT04285853|Oxycodone|oxycodone|mesh-list
25213720|NCT04285853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25197520|NCT03523273|Liraglutide|liraglutide|mesh-list
25197521|NCT03523273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25197522|NCT03523273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197529|NCT03508570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197530|NCT03508570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25197531|NCT03508570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197532|NCT03465774|Doxycycline|doxycycline|mesh-list
25197533|NCT03465774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25197534|NCT03465774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25197535|NCT03465774|Antimalarials|antimalarials|mesh-ancestor
25197536|NCT03465774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25197537|NCT03465774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25197538|NCT03464136|Adalimumab|adalimumab|mesh-list
25197539|NCT03464136|Ustekinumab|ustekinumab|mesh-list
25197540|NCT03464136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25197541|NCT03464136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25197542|NCT03464136|Dermatologic Agents|dermatologic agents|mesh-ancestor
25197543|NCT03454529|Simvastatin|simvastatin|mesh-list
25197544|NCT03454529|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25197545|NCT03454529|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25197546|NCT03454529|Antimetabolites|antimetabolites|mesh-ancestor
25197547|NCT03454529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197548|NCT03454529|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25197549|NCT03454529|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25197550|NCT03454529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25197551|NCT03450018|Gemcitabine|gemcitabine|mesh-list
25197552|NCT03450018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25197553|NCT03450018|Antimetabolites|antimetabolites|mesh-ancestor
25197554|NCT03450018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197555|NCT03450018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826225|NCT02133326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25197556|NCT03450018|Antiviral Agents|antiviral agents|mesh-ancestor
25197557|NCT03450018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25197558|NCT03450018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25197559|NCT03450018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25197560|NCT03450018|Immunologic Factors|immunologic factors|mesh-ancestor
25197561|NCT03450018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197563|NCT03449459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25197564|NCT03449459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25197565|NCT03317496|Gemcitabine|gemcitabine|mesh-list
25197566|NCT03317496|Cisplatin|cisplatin|mesh-list
25197567|NCT03317496|Carboplatin|carboplatin|mesh-list
25197568|NCT03317496|Pemetrexed|pemetrexed|mesh-list
25197569|NCT03317496|Avelumab|avelumab|mesh-list
25197570|NCT03317496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25197571|NCT03317496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197572|NCT03317496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25197573|NCT03317496|Antimetabolites|antimetabolites|mesh-ancestor
25197574|NCT03317496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197575|NCT03317496|Antiviral Agents|antiviral agents|mesh-ancestor
25197576|NCT03317496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25197577|NCT03317496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25197578|NCT03317496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25197579|NCT03317496|Immunologic Factors|immunologic factors|mesh-ancestor
25197580|NCT03317496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197581|NCT03317496|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25197582|NCT03317496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25197583|NCT03317496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25197588|NCT03260894|Pembrolizumab|pembrolizumab|mesh-list
25197589|NCT03260894|Sunitinib|sunitinib|mesh-list
25197590|NCT03260894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25667126|NCT01702961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25667127|NCT01702961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25667128|NCT01702961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25667129|NCT01702961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25667130|NCT01702961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25427873|NCT01823198|Fludarabine phosphate|fludarabine phosphate|mesh-list
24782996|NCT01899703|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24782997|NCT01899703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25213729|NCT04224701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272755|NCT02389842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272757|NCT02389972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272758|NCT02389972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25197591|NCT03260894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197592|NCT03260894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25197593|NCT03260894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25197594|NCT03260894|Growth Substances|growth substances|mesh-ancestor
25197595|NCT03260894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197596|NCT03260894|Growth Inhibitors|growth inhibitors|mesh-ancestor
25197597|NCT03260894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25197598|NCT03260894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25197600|NCT03215810|Cyclophosphamide|cyclophosphamide|mesh-list
25197601|NCT03215810|Nivolumab|nivolumab|mesh-list
25197602|NCT03215810|Fludarabine|fludarabine|mesh-list
25197603|NCT03215810|Interleukin-2|interleukin-2|mesh-list
25197604|NCT03215810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25197605|NCT03215810|Immunologic Factors|immunologic factors|mesh-ancestor
25197606|NCT03215810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197607|NCT03215810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25197608|NCT03215810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25197609|NCT03215810|Alkylating Agents|alkylating agents|mesh-ancestor
25197610|NCT03215810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197611|NCT03215810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197612|NCT03215810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25197613|NCT03215810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25197614|NCT03215810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24568466|NCT00796081|Dopamine Agents|dopamine agents|mesh-ancestor
25197615|NCT03215810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25197616|NCT03215810|Analgesics|analgesics|mesh-ancestor
25197617|NCT03215810|Sensory System Agents|sensory system agents|mesh-ancestor
25197618|NCT03215810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25197619|NCT03211338|Progesterone|progesterone|mesh-list
25197620|NCT03211338|Mitogens|mitogens|mesh-list
25197621|NCT03211338|Progestins|progestins|mesh-ancestor
25197622|NCT03211338|Hormones|hormones|mesh-ancestor
25197623|NCT03211338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25197624|NCT03211338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197625|NCT03211338|Mitosis Modulators|mitosis modulators|mesh-ancestor
25197626|NCT03211338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197627|NCT03154359|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25197628|NCT03154359|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25197629|NCT03154359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25197630|NCT03154359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25197631|NCT03154359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197632|NCT03154359|Adrenergic Agents|adrenergic agents|mesh-ancestor
25197633|NCT03154359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25197634|NCT03154359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197637|NCT03141034|Irinotecan|irinotecan|mesh-list
25197638|NCT03141034|Ramucirumab|ramucirumab|mesh-list
25197639|NCT03141034|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25197640|NCT03141034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25197641|NCT03141034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25197642|NCT03141034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197643|NCT03141034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197644|NCT03116126|Guanfacine|guanfacine|mesh-list
25197645|NCT03116126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25197646|NCT03116126|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25197647|NCT03116126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25197648|NCT03116126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25197649|NCT03116126|Adrenergic Agents|adrenergic agents|mesh-ancestor
25197650|NCT03116126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25197651|NCT03116126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667131|NCT01702961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25667132|NCT01702961|Antimetabolites|antimetabolites|mesh-ancestor
25667133|NCT01702961|Antiviral Agents|antiviral agents|mesh-ancestor
25667134|NCT01702961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25667135|NCT01702961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25667136|NCT01702961|Immunologic Factors|immunologic factors|mesh-ancestor
25667137|NCT01702961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213733|NCT04174196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213734|NCT04174196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25213736|NCT04174196|Growth Substances|growth substances|mesh-ancestor
25197652|NCT03116126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197653|NCT02983682|Lidocaine|lidocaine|mesh-list
25197654|NCT02983682|Anesthetics, Local|anesthetics, local|mesh-ancestor
25197655|NCT02983682|Anesthetics|anesthetics|mesh-ancestor
25197656|NCT02983682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25197657|NCT02983682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197658|NCT02983682|Sensory System Agents|sensory system agents|mesh-ancestor
25197659|NCT02983682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25197660|NCT02983682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25197661|NCT02983682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25197662|NCT02983682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25197663|NCT02983682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25197664|NCT02983682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197665|NCT02964078|Aldesleukin|aldesleukin|mesh-list
25197666|NCT02964078|Pembrolizumab|pembrolizumab|mesh-list
25197667|NCT02964078|Interleukin-2|interleukin-2|mesh-list
25197668|NCT02964078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25197669|NCT02964078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197670|NCT02964078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25197671|NCT02964078|Analgesics|analgesics|mesh-ancestor
25197691|NCT02789345|Necitumumab|necitumumab|mesh-list
25197692|NCT02789345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197693|NCT02789345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25197694|NCT02789345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25197695|NCT02789345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197696|NCT02789345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25197698|NCT02779855|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25197699|NCT02779855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25197700|NCT02779855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197701|NCT02779855|Tubulin Modulators|tubulin modulators|mesh-ancestor
25197702|NCT02779855|Antimitotic Agents|antimitotic agents|mesh-ancestor
24826355|NCT02134093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197703|NCT02779855|Mitosis Modulators|mitosis modulators|mesh-ancestor
25197704|NCT02779855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197705|NCT02779855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25197706|NCT02772965|Methotrexate|methotrexate|mesh-list
25197707|NCT02772965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25197708|NCT02772965|Abortifacient Agents|abortifacient agents|mesh-ancestor
25197709|NCT02772965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25197710|NCT02772965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197711|NCT02772965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25197712|NCT02772965|Antimetabolites|antimetabolites|mesh-ancestor
25197713|NCT02772965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197714|NCT02772965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197715|NCT02772965|Dermatologic Agents|dermatologic agents|mesh-ancestor
25197716|NCT02772965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25197717|NCT02772965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25197718|NCT02772965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25197719|NCT02772965|Immunologic Factors|immunologic factors|mesh-ancestor
25197720|NCT02772965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25197721|NCT02772965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25197722|NCT02735239|Leucovorin|leucovorin|mesh-list
25197723|NCT02735239|Paclitaxel|paclitaxel|mesh-list
25197724|NCT02735239|Docetaxel|docetaxel|mesh-list
25197725|NCT02735239|Carboplatin|carboplatin|mesh-list
25197726|NCT02735239|Fluorouracil|fluorouracil|mesh-list
25197727|NCT02735239|Capecitabine|capecitabine|mesh-list
25197728|NCT02735239|Oxaliplatin|oxaliplatin|mesh-list
25197729|NCT02735239|Durvalumab|durvalumab|mesh-list
25197730|NCT02735239|Tremelimumab|tremelimumab|mesh-list
25197731|NCT02735239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25197732|NCT02735239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197733|NCT02735239|Tubulin Modulators|tubulin modulators|mesh-ancestor
25197734|NCT02735239|Antimitotic Agents|antimitotic agents|mesh-ancestor
25197735|NCT02735239|Mitosis Modulators|mitosis modulators|mesh-ancestor
25197736|NCT02735239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197737|NCT02735239|Antimetabolites|antimetabolites|mesh-ancestor
25197738|NCT02735239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25667138|NCT01702961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25667139|NCT01702961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25667140|NCT01702961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24783073|NCT01900041|Minoxidil|minoxidil|mesh-list
25197739|NCT02735239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25197740|NCT02735239|Immunologic Factors|immunologic factors|mesh-ancestor
25197741|NCT02735239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197742|NCT02735239|Antidotes|antidotes|mesh-ancestor
25197743|NCT02735239|Protective Agents|protective agents|mesh-ancestor
25197744|NCT02735239|Vitamin B Complex|vitamin b complex|mesh-ancestor
25197745|NCT02735239|Vitamins|vitamins|mesh-ancestor
25197746|NCT02735239|Micronutrients|micronutrients|mesh-ancestor
25197747|NCT02735239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25197748|NCT02663271|Bevacizumab|bevacizumab|mesh-list
25197749|NCT02663271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25197750|NCT02663271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197751|NCT02663271|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25197752|NCT02663271|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25197753|NCT02663271|Growth Substances|growth substances|mesh-ancestor
25197754|NCT02663271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197755|NCT02663271|Growth Inhibitors|growth inhibitors|mesh-ancestor
25197756|NCT02655523|Dexamethasone|dexamethasone|mesh-list
25197757|NCT02655523|Triamcinolone|triamcinolone|mesh-list
25197758|NCT02655523|Bupivacaine|bupivacaine|mesh-list
25197759|NCT02655523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25197760|NCT02655523|Antiemetics|antiemetics|mesh-ancestor
25197761|NCT02655523|Autonomic Agents|autonomic agents|mesh-ancestor
25197762|NCT02655523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25197763|NCT02655523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197764|NCT02655523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25197765|NCT02655523|Glucocorticoids|glucocorticoids|mesh-ancestor
25197766|NCT02655523|Hormones|hormones|mesh-ancestor
25197767|NCT02655523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25197768|NCT02655523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25197769|NCT02655523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197770|NCT02655523|Anesthetics, Local|anesthetics, local|mesh-ancestor
25197771|NCT02655523|Anesthetics|anesthetics|mesh-ancestor
25197772|NCT02655523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25197773|NCT02655523|Sensory System Agents|sensory system agents|mesh-ancestor
25197774|NCT02644291|Mebendazole|mebendazole|mesh-list
25197775|NCT02644291|Piperazine|piperazine|mesh-list
25197776|NCT02644291|Piperazine citrate|piperazine citrate|mesh-list
25197777|NCT02644291|DMP 777|dmp 777|mesh-list
25197778|NCT02644291|Antinematodal Agents|antinematodal agents|mesh-ancestor
25197779|NCT02644291|Anthelmintics|anthelmintics|mesh-ancestor
24569068|NCT00798954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25197780|NCT02644291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25197781|NCT02644291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25197782|NCT02644291|Tubulin Modulators|tubulin modulators|mesh-ancestor
25197783|NCT02644291|Antimitotic Agents|antimitotic agents|mesh-ancestor
25197784|NCT02644291|Mitosis Modulators|mitosis modulators|mesh-ancestor
25197785|NCT02644291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197786|NCT02644291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197787|NCT02644291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25197788|NCT02573493|Paclitaxel|paclitaxel|mesh-list
25197789|NCT02573493|Cisplatin|cisplatin|mesh-list
25197790|NCT02573493|Cetuximab|cetuximab|mesh-list
25197791|NCT02573493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25197792|NCT02573493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197793|NCT02573493|Tubulin Modulators|tubulin modulators|mesh-ancestor
25197794|NCT02573493|Antimitotic Agents|antimitotic agents|mesh-ancestor
25197795|NCT02573493|Mitosis Modulators|mitosis modulators|mesh-ancestor
25197796|NCT02573493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197797|NCT02573493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25197799|NCT02499562|Antiviral Agents|antiviral agents|mesh-ancestor
25197800|NCT02499562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25197801|NCT02372409|Doxorubicin|doxorubicin|mesh-list
25197802|NCT02372409|Etoposide|etoposide|mesh-list
25197803|NCT02372409|Etoposide phosphate|etoposide phosphate|mesh-list
25197804|NCT02372409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25197805|NCT02372409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197806|NCT02372409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25197807|NCT02372409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25197808|NCT02372409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25197809|NCT02372409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197810|NCT02372409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25207342|NCT04177693|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25207343|NCT04177693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25207344|NCT04177693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25207345|NCT04177693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25667141|NCT01702961|Alkylating Agents|alkylating agents|mesh-ancestor
25667142|NCT01702961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25860676|NCT00084240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24492017|NCT00484926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492019|NCT00484926|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24492020|NCT00484926|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24936954|NCT04034368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25116496|NCT03108365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116497|NCT03108365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25116498|NCT03108365|Chelating Agents|chelating agents|mesh-ancestor
25207346|NCT04177693|Hormone Antagonists|hormone antagonists|mesh-ancestor
25207347|NCT04177693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25207348|NCT04177693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207349|NCT04177693|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25207350|NCT04177693|Fertility Agents|fertility agents|mesh-ancestor
25207351|NCT04177693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25207352|NCT04177693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25207353|NCT04177693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25207369|NCT04103385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25207370|NCT04103385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207371|NCT04103385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25207372|NCT04075513|Insulin|insulin|mesh-list
25207373|NCT04075513|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25207374|NCT04075513|Insulin Glargine|insulin glargine|mesh-list
25207375|NCT04075513|Insulin, Short-Acting|insulin, short-acting|mesh-list
25207376|NCT04075513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25207377|NCT04075513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207378|NCT04074187|Methylprednisolone|methylprednisolone|mesh-list
25207379|NCT04074187|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25207380|NCT04074187|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25207381|NCT04074187|Prednisolone|prednisolone|mesh-list
25207382|NCT04074187|Prednisolone acetate|prednisolone acetate|mesh-list
25207383|NCT04074187|Rituximab|rituximab|mesh-list
25207384|NCT04074187|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25207385|NCT04074187|Prednisolone phosphate|prednisolone phosphate|mesh-list
25197812|NCT02281981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25197813|NCT02281981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25197814|NCT02281981|Analgesics|analgesics|mesh-ancestor
25197815|NCT02281981|Sensory System Agents|sensory system agents|mesh-ancestor
25197816|NCT02281981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25197817|NCT02281981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197818|NCT02281981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25197819|NCT02281981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25197820|NCT02281981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197821|NCT02281981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25197822|NCT02281981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197837|NCT02251821|Mycophenolic Acid|mycophenolic acid|mesh-list
25197838|NCT02251821|Cyclophosphamide|cyclophosphamide|mesh-list
25197839|NCT02251821|Melphalan|melphalan|mesh-list
25197840|NCT02251821|Busulfan|busulfan|mesh-list
25197841|NCT02251821|Mechlorethamine|mechlorethamine|mesh-list
25197842|NCT02251821|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25197843|NCT02251821|Methotrexate|methotrexate|mesh-list
25197844|NCT02251821|Fludarabine|fludarabine|mesh-list
25197845|NCT02251821|Fludarabine phosphate|fludarabine phosphate|mesh-list
25197846|NCT02251821|Tacrolimus|tacrolimus|mesh-list
25197847|NCT02251821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25197848|NCT02251821|Immunologic Factors|immunologic factors|mesh-ancestor
25197849|NCT02251821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197850|NCT02251821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25197851|NCT02251821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25197852|NCT02251821|Alkylating Agents|alkylating agents|mesh-ancestor
25197853|NCT02251821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197854|NCT02251821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25667144|NCT01702987|Atorvastatin|atorvastatin|mesh-list
25667145|NCT01702987|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25667146|NCT01702987|Simvastatin|simvastatin|mesh-list
25667147|NCT01702987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25667148|NCT01702987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25667149|NCT01702987|Antimetabolites|antimetabolites|mesh-ancestor
25667150|NCT01702987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667151|NCT01702987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25667152|NCT01702987|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25667153|NCT01702987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25213795|NCT04117074|Bupivacaine|bupivacaine|mesh-list
25213796|NCT04117074|Anesthetics, Local|anesthetics, local|mesh-ancestor
25213797|NCT04117074|Anesthetics|anesthetics|mesh-ancestor
25213798|NCT04117074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25213799|NCT04117074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213800|NCT04117074|Sensory System Agents|sensory system agents|mesh-ancestor
25213801|NCT04117074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25213802|NCT04115189|Sunitinib|sunitinib|mesh-list
24948010|NCT03923556|Cholinergic Agents|cholinergic agents|mesh-ancestor
25213803|NCT04115189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25213804|NCT04115189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25213806|NCT04115189|Growth Substances|growth substances|mesh-ancestor
25197855|NCT02251821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25197898|NCT02139852|Sensory System Agents|sensory system agents|mesh-ancestor
25197899|NCT02139852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25197900|NCT02139852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197902|NCT02081326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25197903|NCT02081326|Immunologic Factors|immunologic factors|mesh-ancestor
25197904|NCT02081326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197905|NCT02041234|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25197906|NCT02041234|Liraglutide|liraglutide|mesh-list
25197907|NCT02041234|Empagliflozin|empagliflozin|mesh-list
25197908|NCT02041234|Linagliptin|linagliptin|mesh-list
25197909|NCT02041234|Canagliflozin|canagliflozin|mesh-list
25197910|NCT02041234|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25197911|NCT02041234|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25197912|NCT02041234|Orlistat|orlistat|mesh-list
25197913|NCT02041234|Incretins|incretins|mesh-list
25197914|NCT02041234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25197915|NCT02041234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197916|NCT02041234|Hormones|hormones|mesh-ancestor
25197917|NCT02041234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25197918|NCT02041234|Protease Inhibitors|protease inhibitors|mesh-ancestor
25197919|NCT02041234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25197920|NCT02041234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197921|NCT02041234|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25197922|NCT02041234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25197923|NCT02022098|Cisplatin|cisplatin|mesh-list
25197924|NCT02022098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197925|NCT01844505|Nivolumab|nivolumab|mesh-list
25197926|NCT01844505|Ipilimumab|ipilimumab|mesh-list
25197927|NCT01844505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25197928|NCT01844505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197929|NCT01844505|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25197930|NCT01844505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197931|NCT01701674|Aldesleukin|aldesleukin|mesh-list
25197932|NCT01701674|Cyclophosphamide|cyclophosphamide|mesh-list
25197933|NCT01701674|Fludarabine|fludarabine|mesh-list
25197934|NCT01701674|Ipilimumab|ipilimumab|mesh-list
25197935|NCT01701674|Interleukin-2|interleukin-2|mesh-list
25197936|NCT01701674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25197937|NCT01701674|Immunologic Factors|immunologic factors|mesh-ancestor
25197938|NCT01701674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197939|NCT01701674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25197940|NCT01701674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25197941|NCT01701674|Alkylating Agents|alkylating agents|mesh-ancestor
25197942|NCT01701674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197943|NCT01701674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197944|NCT01701674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25197945|NCT01701674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25197946|NCT01701674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25197947|NCT01701674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25197948|NCT01701674|Analgesics|analgesics|mesh-ancestor
25197949|NCT01701674|Sensory System Agents|sensory system agents|mesh-ancestor
25667154|NCT01702987|Micronutrients|micronutrients|mesh-ancestor
25667155|NCT01702987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667156|NCT01702987|Vitamins|vitamins|mesh-ancestor
25667157|NCT01703039|Riluzole|riluzole|mesh-list
25667158|NCT01703039|Sertraline|sertraline|mesh-list
25667159|NCT01703039|Antidepressive Agents|antidepressive agents|mesh-ancestor
25667160|NCT01703039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25667161|NCT01703039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25667162|NCT01703039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25667163|NCT01703039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25667164|NCT01703039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667165|NCT01703039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25197950|NCT01701674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25197951|NCT01701674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25197952|NCT01701674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25197953|NCT01701674|Antiviral Agents|antiviral agents|mesh-ancestor
25197954|NCT01701674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25197955|NCT01575860|Lenalidomide|lenalidomide|mesh-list
25197956|NCT01575860|Immunologic Factors|immunologic factors|mesh-ancestor
25197957|NCT01575860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197958|NCT01575860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25197959|NCT01575860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25197960|NCT01575860|Growth Substances|growth substances|mesh-ancestor
25197961|NCT01575860|Growth Inhibitors|growth inhibitors|mesh-ancestor
25197962|NCT01575860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25197963|NCT01442792|Rivaroxaban|rivaroxaban|mesh-list
25197964|NCT01442792|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25197965|NCT01442792|Antithrombins|antithrombins|mesh-ancestor
25197966|NCT01442792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25197967|NCT01442792|Protease Inhibitors|protease inhibitors|mesh-ancestor
25197968|NCT01442792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25197969|NCT01442792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25197970|NCT01442792|Anticoagulants|anticoagulants|mesh-ancestor
25197971|NCT01397201|Fluticasone|fluticasone|mesh-list
25197972|NCT01397201|Xhance|xhance|mesh-list
25197973|NCT01397201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25197974|NCT01397201|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25197976|NCT01397201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25197977|NCT01397201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197978|NCT01397201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25197979|NCT01397201|Respiratory System Agents|respiratory system agents|mesh-ancestor
25197980|NCT01397201|Dermatologic Agents|dermatologic agents|mesh-ancestor
25197981|NCT01397201|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25197982|NCT01397162|Fluticasone|fluticasone|mesh-list
25197983|NCT01397162|Xhance|xhance|mesh-list
25197984|NCT01397162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25197985|NCT01397162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25197986|NCT01397162|Autonomic Agents|autonomic agents|mesh-ancestor
25197987|NCT01397162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25197988|NCT01397162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25197989|NCT01397162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25197990|NCT01397162|Respiratory System Agents|respiratory system agents|mesh-ancestor
25197991|NCT01397162|Dermatologic Agents|dermatologic agents|mesh-ancestor
25197992|NCT01397162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25197993|NCT01396278|Fluticasone|fluticasone|mesh-list
25197994|NCT01396278|Xhance|xhance|mesh-list
25197995|NCT01396278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25197996|NCT01396278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25197997|NCT01396278|Autonomic Agents|autonomic agents|mesh-ancestor
25197998|NCT01396278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25197999|NCT01396278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198000|NCT01396278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25198001|NCT01396278|Respiratory System Agents|respiratory system agents|mesh-ancestor
25198002|NCT01396278|Dermatologic Agents|dermatologic agents|mesh-ancestor
25198003|NCT01396278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25198004|NCT01370512|Droxidopa|droxidopa|mesh-list
25198005|NCT01370512|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
25198006|NCT01370512|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25198007|NCT01370512|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25198008|NCT01370512|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25198009|NCT01370512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25198010|NCT01370512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198011|NCT01370512|Cholinergic Agents|cholinergic agents|mesh-ancestor
25198012|NCT01370512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25198013|NCT01370512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198014|NCT00783367|Dexamethasone|dexamethasone|mesh-list
25198015|NCT00783367|Dexamethasone acetate|dexamethasone acetate|mesh-list
25198016|NCT00783367|Rituximab|rituximab|mesh-list
25198017|NCT00783367|Lenalidomide|lenalidomide|mesh-list
25198018|NCT00783367|BB 1101|bb 1101|mesh-list
25198019|NCT00783367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24727229|NCT01608646|Oxaliplatin|oxaliplatin|mesh-list
25198020|NCT00783367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198021|NCT00783367|Immunologic Factors|immunologic factors|mesh-ancestor
25198022|NCT00783367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198023|NCT00783367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25198024|NCT00783367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25198025|NCT00783367|Antiemetics|antiemetics|mesh-ancestor
25198026|NCT00783367|Autonomic Agents|autonomic agents|mesh-ancestor
25198027|NCT00783367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24783206|NCT01900639|Sensory System Agents|sensory system agents|mesh-ancestor
24783207|NCT01900639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24783208|NCT01900639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783209|NCT01900639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24783210|NCT01900639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25213822|NCT04077437|Adrenergic Agents|adrenergic agents|mesh-ancestor
25051582|NCT00393991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24492064|NCT00485108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24492065|NCT00485108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24492066|NCT00485108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24492068|NCT00485108|Sensory System Agents|sensory system agents|mesh-ancestor
24492069|NCT00485108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25198028|NCT00783367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25198029|NCT00783367|Glucocorticoids|glucocorticoids|mesh-ancestor
25198030|NCT00783367|Hormones|hormones|mesh-ancestor
25860677|NCT00084240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570112|NCT00803335|Hormones|hormones|mesh-ancestor
25198031|NCT00783367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25198032|NCT00783367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25198033|NCT00783367|Protease Inhibitors|protease inhibitors|mesh-ancestor
25198034|NCT00783367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25198035|NCT00783367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198037|NCT00783367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25198038|NCT00783367|Growth Substances|growth substances|mesh-ancestor
25198039|NCT00783367|Growth Inhibitors|growth inhibitors|mesh-ancestor
25198040|NCT00716066|Cytarabine|cytarabine|mesh-list
25198041|NCT00716066|Prednisone|prednisone|mesh-list
25198042|NCT00716066|Cortisone|cortisone|mesh-list
25198043|NCT00716066|Etoposide|etoposide|mesh-list
25198044|NCT00716066|Etoposide phosphate|etoposide phosphate|mesh-list
25198045|NCT00716066|Melphalan|melphalan|mesh-list
25198046|NCT00716066|Mechlorethamine|mechlorethamine|mesh-list
25198047|NCT00716066|Carmustine|carmustine|mesh-list
25198048|NCT00716066|Podophyllotoxin|podophyllotoxin|mesh-list
25198049|NCT00716066|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25198050|NCT00716066|Thymoglobulin|thymoglobulin|mesh-list
25198051|NCT00716066|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25198052|NCT00716066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25198053|NCT00716066|Glucocorticoids|glucocorticoids|mesh-ancestor
25198054|NCT00716066|Hormones|hormones|mesh-ancestor
25198055|NCT00716066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25198056|NCT00716066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198057|NCT00716066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25198058|NCT00716066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198059|NCT00716066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25198060|NCT00716066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25198061|NCT00716066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25198062|NCT00716066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25198063|NCT00716066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198064|NCT00716066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25198065|NCT00716066|Antimetabolites|antimetabolites|mesh-ancestor
25198066|NCT00716066|Antiviral Agents|antiviral agents|mesh-ancestor
25198067|NCT00716066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25198068|NCT00716066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25198069|NCT00716066|Immunologic Factors|immunologic factors|mesh-ancestor
25198070|NCT00716066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25198071|NCT00716066|Alkylating Agents|alkylating agents|mesh-ancestor
25198072|NCT00716066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25198073|NCT00716066|Keratolytic Agents|keratolytic agents|mesh-ancestor
25198074|NCT00716066|Dermatologic Agents|dermatologic agents|mesh-ancestor
25198075|NCT00716066|Tubulin Modulators|tubulin modulators|mesh-ancestor
25198076|NCT00716066|Antimitotic Agents|antimitotic agents|mesh-ancestor
25667166|NCT01703039|Serotonin Agents|serotonin agents|mesh-ancestor
25667167|NCT01703039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667168|NCT01703039|Anticonvulsants|anticonvulsants|mesh-ancestor
25667169|NCT01703039|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25667170|NCT01703039|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25667171|NCT01703039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25667172|NCT01703039|Protective Agents|protective agents|mesh-ancestor
25667173|NCT01703091|Docetaxel|docetaxel|mesh-list
25667174|NCT01703091|Ramucirumab|ramucirumab|mesh-list
25667175|NCT01703091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25667176|NCT01703091|Tubulin Modulators|tubulin modulators|mesh-ancestor
25667177|NCT01703091|Antimitotic Agents|antimitotic agents|mesh-ancestor
25667178|NCT01703091|Mitosis Modulators|mitosis modulators|mesh-ancestor
24937152|NCT04032236|Purinergic Agents|purinergic agents|mesh-ancestor
24937153|NCT04032236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24783303|NCT01901003|Lorazepam|lorazepam|mesh-list
25198077|NCT00716066|Mitosis Modulators|mitosis modulators|mesh-ancestor
25198078|NCT00130442|Dacarbazine|dacarbazine|mesh-list
25198079|NCT00130442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25198080|NCT00130442|Alkylating Agents|alkylating agents|mesh-ancestor
25198081|NCT00130442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198082|NCT00130442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198083|NCT02751268|Ropivacaine|ropivacaine|mesh-list
25198084|NCT02751268|Anesthetics, Local|anesthetics, local|mesh-ancestor
25198085|NCT02751268|Anesthetics|anesthetics|mesh-ancestor
25198086|NCT02751268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25198087|NCT02751268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198088|NCT02751268|Sensory System Agents|sensory system agents|mesh-ancestor
25198089|NCT02751268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25198090|NCT02751151|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25198091|NCT02751151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25198092|NCT02751151|Dermatologic Agents|dermatologic agents|mesh-ancestor
25198093|NCT02750904|Nicotine|nicotine|mesh-list
25198094|NCT02750904|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25198095|NCT02750904|Autonomic Agents|autonomic agents|mesh-ancestor
25198096|NCT02750904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25198097|NCT02750904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198098|NCT02750904|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25198099|NCT02750904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25198100|NCT02750904|Cholinergic Agents|cholinergic agents|mesh-ancestor
25198101|NCT02750904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25198102|NCT02750904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198103|NCT02750969|Lidocaine|lidocaine|mesh-list
25198104|NCT02750969|Anesthetics, Local|anesthetics, local|mesh-ancestor
25198105|NCT02750969|Anesthetics|anesthetics|mesh-ancestor
25198106|NCT02750969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25198107|NCT02750969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198108|NCT02750969|Sensory System Agents|sensory system agents|mesh-ancestor
25198109|NCT02750969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25198110|NCT02750969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25860678|NCT00084240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25198111|NCT02750969|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25198112|NCT02750969|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25198113|NCT02750969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25198114|NCT02750969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198115|NCT02750917|Etoricoxib|etoricoxib|mesh-list
25198116|NCT02750917|Lornoxicam|lornoxicam|mesh-list
25198117|NCT02750917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25198118|NCT02750917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25198119|NCT02750917|Analgesics|analgesics|mesh-ancestor
25198120|NCT02750917|Sensory System Agents|sensory system agents|mesh-ancestor
25198121|NCT02750917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25198122|NCT02750917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198123|NCT02750917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25198124|NCT02750917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25198125|NCT02750917|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25198126|NCT02750917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25198127|NCT02750917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25198128|NCT02750917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198130|NCT02751034|Anesthetics, Local|anesthetics, local|mesh-ancestor
25198131|NCT02751034|Anesthetics|anesthetics|mesh-ancestor
25198132|NCT02751034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25198133|NCT02751034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198134|NCT02751034|Sensory System Agents|sensory system agents|mesh-ancestor
25198135|NCT02751034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25198136|NCT02751034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25198137|NCT02751034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25198138|NCT02751034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25198139|NCT02751034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25198140|NCT02751034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198141|NCT02750995|Azacitidine|azacitidine|mesh-list
25198142|NCT02750995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25198143|NCT02750995|Antimetabolites|antimetabolites|mesh-ancestor
25667179|NCT01703091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667180|NCT01703117|Riluzole|riluzole|mesh-list
25667181|NCT01703117|Anticonvulsants|anticonvulsants|mesh-ancestor
24492171|NCT00485550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24492172|NCT00485550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492174|NCT00485550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492175|NCT00485550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24492176|NCT00485550|Adrenergic Agents|adrenergic agents|mesh-ancestor
24492178|NCT00485576|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24492180|NCT00485576|Immunologic Factors|immunologic factors|mesh-ancestor
25198144|NCT02750995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198145|NCT02750995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198146|NCT02750995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25198147|NCT02750748|Naltrexone|naltrexone|mesh-list
25198148|NCT02750748|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25198149|NCT02750748|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25198150|NCT02750748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198151|NCT02750748|Sensory System Agents|sensory system agents|mesh-ancestor
25198152|NCT02750748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25198153|NCT02750696|Acetaminophen|acetaminophen|mesh-list
25198154|NCT02750696|Tramadol|tramadol|mesh-list
25198155|NCT02750696|Codeine|codeine|mesh-list
25198156|NCT02750696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25198157|NCT02750696|Analgesics|analgesics|mesh-ancestor
25207393|NCT04074187|Antiemetics|antiemetics|mesh-ancestor
25198158|NCT02750696|Sensory System Agents|sensory system agents|mesh-ancestor
25198159|NCT02750696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25198160|NCT02750696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198161|NCT02750696|Antipyretics|antipyretics|mesh-ancestor
25198162|NCT02750696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25198163|NCT02750696|Narcotics|narcotics|mesh-ancestor
25198164|NCT02750696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25198165|NCT02750696|Antitussive Agents|antitussive agents|mesh-ancestor
25198166|NCT02750696|Respiratory System Agents|respiratory system agents|mesh-ancestor
25198167|NCT02750670|Gemcitabine|gemcitabine|mesh-list
25198168|NCT02750670|Dexamethasone|dexamethasone|mesh-list
25198169|NCT02750670|Obinutuzumab|obinutuzumab|mesh-list
25198170|NCT02750670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198171|NCT02750670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25198172|NCT02750670|Antiemetics|antiemetics|mesh-ancestor
25198173|NCT02750670|Autonomic Agents|autonomic agents|mesh-ancestor
25198174|NCT02750670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25198175|NCT02750670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198176|NCT02750670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25198177|NCT02750670|Glucocorticoids|glucocorticoids|mesh-ancestor
25198178|NCT02750670|Hormones|hormones|mesh-ancestor
25198179|NCT02750670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25198180|NCT02750670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25198181|NCT02750670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25198182|NCT02750670|Antimetabolites|antimetabolites|mesh-ancestor
25198183|NCT02750670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198184|NCT02750670|Antiviral Agents|antiviral agents|mesh-ancestor
25198185|NCT02750670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25198186|NCT02750670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25198187|NCT02750670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25198188|NCT02750670|Immunologic Factors|immunologic factors|mesh-ancestor
25198189|NCT02750670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25198190|NCT02750475|Sunscreening Agents|sunscreening agents|mesh-list
25198191|NCT02750475|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25198192|NCT02750475|Protective Agents|protective agents|mesh-ancestor
25198193|NCT02750475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198194|NCT02750475|Dermatologic Agents|dermatologic agents|mesh-ancestor
25198195|NCT02750293|Cholecalciferol|cholecalciferol|mesh-list
25198196|NCT02750293|Vitamin D|vitamin d|mesh-list
25198197|NCT02750293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25198198|NCT02750293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198199|NCT02750293|Vitamins|vitamins|mesh-ancestor
25198200|NCT02750293|Micronutrients|micronutrients|mesh-ancestor
25198201|NCT02750293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25198202|NCT02750254|Plerixafor|plerixafor|mesh-list
25667182|NCT01703117|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25667183|NCT01703117|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25667184|NCT01703117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25667185|NCT01703117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667186|NCT01703117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667187|NCT01703117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25667188|NCT01703117|Protective Agents|protective agents|mesh-ancestor
25198203|NCT02750254|Cyclophosphamide|cyclophosphamide|mesh-list
25198205|NCT02750254|Busulfan|busulfan|mesh-list
25198206|NCT02750254|Fludarabine|fludarabine|mesh-list
25198207|NCT02750254|Fludarabine phosphate|fludarabine phosphate|mesh-list
25198208|NCT02750254|Azacitidine|azacitidine|mesh-list
25198209|NCT02750254|Lenograstim|lenograstim|mesh-list
25198210|NCT02750254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25198211|NCT02750254|Immunologic Factors|immunologic factors|mesh-ancestor
25198212|NCT02750254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198213|NCT02750254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25198214|NCT02750254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25198215|NCT02750254|Alkylating Agents|alkylating agents|mesh-ancestor
25198216|NCT02750254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198217|NCT02750254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198218|NCT02750254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25198219|NCT02750254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25198220|NCT02750254|Antimetabolites|antimetabolites|mesh-ancestor
25198221|NCT02750254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25198222|NCT02750254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25198223|NCT02750254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25198224|NCT02750254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25198225|NCT02750254|Antiviral Agents|antiviral agents|mesh-ancestor
25198226|NCT02750254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25207386|NCT04074187|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25207387|NCT04074187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25207388|NCT04074187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207389|NCT04074187|Immunologic Factors|immunologic factors|mesh-ancestor
24948621|NCT03918187|Sensory System Agents|sensory system agents|mesh-ancestor
25207390|NCT04074187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207391|NCT04074187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25207392|NCT04074187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25207394|NCT04074187|Autonomic Agents|autonomic agents|mesh-ancestor
25207395|NCT04074187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25207396|NCT04074187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25207397|NCT04074187|Glucocorticoids|glucocorticoids|mesh-ancestor
25207398|NCT04074187|Hormones|hormones|mesh-ancestor
25207399|NCT04074187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25207400|NCT04074187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25207401|NCT04074187|Protective Agents|protective agents|mesh-ancestor
25207402|NCT04074187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25207403|NCT04017546|Venetoclax|venetoclax|mesh-list
25207404|NCT04017546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207405|NCT04007991|Ecopipam|ecopipam|mesh-list
25207406|NCT04007991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25207407|NCT04007991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25207408|NCT04007991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25207409|NCT04007991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207410|NCT04007991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25207411|NCT04007991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25207412|NCT04007991|Dopamine Agents|dopamine agents|mesh-ancestor
25207413|NCT04007991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24709153|NCT01504256|Levoleucovorin|levoleucovorin|mesh-list
25207414|NCT04007991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208267|NCT02727998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25208268|NCT02727998|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25860679|NCT00084240|Filaricides|filaricides|mesh-ancestor
25198228|NCT02750202|Immunologic Factors|immunologic factors|mesh-ancestor
25198229|NCT02750202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198230|NCT02749994|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25198231|NCT02749994|Ezetimibe|ezetimibe|mesh-list
25198232|NCT02749994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25198233|NCT02749994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25198234|NCT02749994|Antimetabolites|antimetabolites|mesh-ancestor
25198235|NCT02749994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198236|NCT02749994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25198237|NCT02749994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25198238|NCT02749994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25198239|NCT02750137|Tetracaine|tetracaine|mesh-list
25198240|NCT02750137|Anesthetics, Local|anesthetics, local|mesh-ancestor
25198241|NCT02750137|Anesthetics|anesthetics|mesh-ancestor
25207481|NCT03822507|Cinacalcet|cinacalcet|mesh-list
25198242|NCT02750137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25198243|NCT02750137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198244|NCT02750137|Sensory System Agents|sensory system agents|mesh-ancestor
25198245|NCT02750137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25213852|NCT03983018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25198247|NCT02750059|Lamivudine|lamivudine|mesh-list
25198248|NCT02750059|Efavirenz|efavirenz|mesh-list
25198249|NCT02750059|Telmisartan|telmisartan|mesh-list
25198250|NCT02750059|Antiviral Agents|antiviral agents|mesh-ancestor
25198251|NCT02750059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25198252|NCT02750059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25198253|NCT02750059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25198254|NCT02750059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25198255|NCT02750059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198256|NCT02750059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25198257|NCT02750059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25198258|NCT02750059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25198259|NCT02750059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25198260|NCT02750059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25198261|NCT02750059|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25198262|NCT02750059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25198263|NCT02750059|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25198264|NCT02750059|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25198265|NCT02750059|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25198266|NCT02750059|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25198267|NCT02749825|Goserelin|goserelin|mesh-list
25198268|NCT02749825|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25198269|NCT02749825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25198270|NCT02749825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198271|NCT02749825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25198272|NCT02749825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198273|NCT02749825|Luteolytic Agents|luteolytic agents|mesh-ancestor
25198274|NCT02749825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25198275|NCT02749825|Contraceptive Agents|contraceptive agents|mesh-ancestor
25198276|NCT02749825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25198289|NCT02749747|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25198290|NCT02749747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25198291|NCT02749747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25198292|NCT02749747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198293|NCT02749747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25198294|NCT02749747|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25198295|NCT02749747|Dopamine Agents|dopamine agents|mesh-ancestor
25198296|NCT02749747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25198297|NCT02749747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198298|NCT02749747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25198299|NCT02749747|Antidepressive Agents|antidepressive agents|mesh-ancestor
25198311|NCT02749578|Atorvastatin|atorvastatin|mesh-list
25198312|NCT02749578|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25198313|NCT02749578|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25198314|NCT02749578|Antimetabolites|antimetabolites|mesh-ancestor
25198315|NCT02749578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198316|NCT02749578|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25198317|NCT02749578|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25198318|NCT02749578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25198319|NCT02749656|Desoximetasone|desoximetasone|mesh-list
25198320|NCT02749656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25198321|NCT02749656|Glucocorticoids|glucocorticoids|mesh-ancestor
25198322|NCT02749656|Hormones|hormones|mesh-ancestor
25198323|NCT02749656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25198324|NCT02749656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198325|NCT02749591|Botulinum Toxins|botulinum toxins|mesh-list
25198326|NCT02749591|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25198327|NCT02749591|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25198328|NCT02749591|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25198329|NCT02749591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25198330|NCT02749591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198331|NCT02749591|Cholinergic Agents|cholinergic agents|mesh-ancestor
25198332|NCT02749591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25198333|NCT02749591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198334|NCT02749591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25198335|NCT02749591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25198336|NCT02749292|Rituximab|rituximab|mesh-list
25198337|NCT02749292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25198338|NCT02749292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198339|NCT02749292|Immunologic Factors|immunologic factors|mesh-ancestor
25667189|NCT01703221|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25213866|NCT03967847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25213867|NCT03967847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25213869|NCT03944954|Dronabinol|dronabinol|mesh-list
25198340|NCT02749292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198341|NCT02749292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25198342|NCT02749409|Parecoxib|parecoxib|mesh-list
25198343|NCT02749409|Morphine|morphine|mesh-list
25198344|NCT02749409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25198345|NCT02749409|Narcotics|narcotics|mesh-ancestor
25198346|NCT02749409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24571103|NCT00808171|Prilocaine|prilocaine|mesh-list
25198347|NCT02749409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198348|NCT02749409|Analgesics|analgesics|mesh-ancestor
25198349|NCT02749409|Sensory System Agents|sensory system agents|mesh-ancestor
25198350|NCT02749409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25198351|NCT02749409|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25198352|NCT02749409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25198354|NCT02749409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198355|NCT02749409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25198356|NCT02749409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25198357|NCT02749409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25198358|NCT02749409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25198359|NCT02749396|Interferons|interferons|mesh-list
25198360|NCT02749396|Interferon-beta|interferon-beta|mesh-list
25198361|NCT02749396|Interferon beta-1a|interferon beta-1a|mesh-list
25198362|NCT02749396|Interferon beta-1b|interferon beta-1b|mesh-list
25198363|NCT02749396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198364|NCT02749396|Antiviral Agents|antiviral agents|mesh-ancestor
25198365|NCT02749396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25198366|NCT02749396|Immunologic Factors|immunologic factors|mesh-ancestor
25198367|NCT02749396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198368|NCT02749396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25198369|NCT02749123|Lidocaine|lidocaine|mesh-list
25198370|NCT02749123|Menthol|menthol|mesh-list
25198371|NCT02749123|Anesthetics, Local|anesthetics, local|mesh-ancestor
25198372|NCT02749123|Anesthetics|anesthetics|mesh-ancestor
25860680|NCT00084240|Antinematodal Agents|antinematodal agents|mesh-ancestor
25198373|NCT02749123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25198374|NCT02749123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198375|NCT02749123|Sensory System Agents|sensory system agents|mesh-ancestor
25198376|NCT02749123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25198377|NCT02749123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24948662|NCT03918135|Antipyretics|antipyretics|mesh-ancestor
25198378|NCT02749123|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25198379|NCT02749123|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25198380|NCT02749123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25198381|NCT02749123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198382|NCT02749123|Antipruritics|antipruritics|mesh-ancestor
25198383|NCT02749123|Dermatologic Agents|dermatologic agents|mesh-ancestor
25198384|NCT02749032|Metformin|metformin|mesh-list
25198385|NCT02749032|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25198386|NCT02749032|Vildagliptin|vildagliptin|mesh-list
25198387|NCT02749032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25198388|NCT02749032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198389|NCT02749032|Incretins|incretins|mesh-ancestor
25198390|NCT02749032|Hormones|hormones|mesh-ancestor
25198391|NCT02749032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25198392|NCT02749032|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25198393|NCT02749032|Protease Inhibitors|protease inhibitors|mesh-ancestor
25198394|NCT02749032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25198395|NCT02749032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198396|NCT02749162|Acetaminophen|acetaminophen|mesh-list
25198397|NCT02749162|Dexamethasone|dexamethasone|mesh-list
25198398|NCT02749162|Lidocaine|lidocaine|mesh-list
25198399|NCT02749162|Morphine|morphine|mesh-list
25198400|NCT02749162|Ropivacaine|ropivacaine|mesh-list
25198401|NCT02749162|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25198402|NCT02749162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25198403|NCT02749162|Antiemetics|antiemetics|mesh-ancestor
25198404|NCT02749162|Autonomic Agents|autonomic agents|mesh-ancestor
25198405|NCT02749162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25198406|NCT02749162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198407|NCT02749162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25667190|NCT01703221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25667191|NCT01703221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198408|NCT02749162|Glucocorticoids|glucocorticoids|mesh-ancestor
25198409|NCT02749162|Hormones|hormones|mesh-ancestor
25667192|NCT01703221|Incretins|incretins|mesh-ancestor
25198410|NCT02749162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25198411|NCT02749162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25198412|NCT02749162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198413|NCT02749162|Anesthetics, Local|anesthetics, local|mesh-ancestor
25198414|NCT02749162|Anesthetics|anesthetics|mesh-ancestor
24571262|NCT00808951|Amodiaquine|amodiaquine|mesh-list
25198415|NCT02749162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25198416|NCT02749162|Sensory System Agents|sensory system agents|mesh-ancestor
25198417|NCT02749162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25198418|NCT02749162|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25198419|NCT02749162|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25198420|NCT02749162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25198421|NCT02749162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198422|NCT02749162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25198423|NCT02749162|Narcotics|narcotics|mesh-ancestor
25198424|NCT02749162|Analgesics|analgesics|mesh-ancestor
25198425|NCT02749162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25198426|NCT02749162|Antipyretics|antipyretics|mesh-ancestor
25198427|NCT02749136|Gemcitabine|gemcitabine|mesh-list
25198428|NCT02749136|Folfirinox|folfirinox|mesh-list
25198429|NCT02749136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25198430|NCT02749136|Antimetabolites|antimetabolites|mesh-ancestor
25198431|NCT02749136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198432|NCT02749136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198433|NCT02749136|Antiviral Agents|antiviral agents|mesh-ancestor
25198434|NCT02749136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25198435|NCT02749136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25198436|NCT02749136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25198437|NCT02749136|Immunologic Factors|immunologic factors|mesh-ancestor
25198438|NCT02749136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198439|NCT02748772|Thalidomide|thalidomide|mesh-list
25198440|NCT02748772|Endostar protein|endostar protein|mesh-list
25198441|NCT02748772|Endostatins|endostatins|mesh-list
25198442|NCT02748772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25198443|NCT02748772|Immunologic Factors|immunologic factors|mesh-ancestor
25198444|NCT02748772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198445|NCT02748772|Leprostatic Agents|leprostatic agents|mesh-ancestor
25198446|NCT02748772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25198447|NCT02748772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25198448|NCT02748772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25198449|NCT02748772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25198450|NCT02748772|Growth Substances|growth substances|mesh-ancestor
25198451|NCT02748772|Growth Inhibitors|growth inhibitors|mesh-ancestor
25198452|NCT02748772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207415|NCT04003818|Teicoplanin|teicoplanin|mesh-list
25207416|NCT04003818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25207417|NCT04003818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25207418|NCT03958799|Vaccines|vaccines|mesh-list
25207419|NCT03958799|Immunologic Factors|immunologic factors|mesh-ancestor
25207420|NCT03958799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207421|NCT03951142|Losartan|losartan|mesh-list
25207422|NCT03951142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25207423|NCT03951142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25207424|NCT03951142|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25207425|NCT03951142|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25207426|NCT03951142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207427|NCT03945591|Cyclophosphamide|cyclophosphamide|mesh-list
25207428|NCT03945591|Bortezomib|bortezomib|mesh-list
25207429|NCT03945591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25207430|NCT03945591|Immunologic Factors|immunologic factors|mesh-ancestor
25207431|NCT03945591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207432|NCT03945591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25207433|NCT03945591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25207434|NCT03945591|Alkylating Agents|alkylating agents|mesh-ancestor
25207435|NCT03945591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207436|NCT03945591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207437|NCT03945591|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25207438|NCT03943875|Vaccines|vaccines|mesh-list
25207439|NCT03943875|Immunologic Factors|immunologic factors|mesh-ancestor
25207440|NCT03943875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207441|NCT03930446|Ethanol|ethanol|mesh-list
25207442|NCT03930446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25207443|NCT03930446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25207444|NCT03930446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25207445|NCT03930446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783819|NCT01904162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783833|NCT01904357|Cefazolin|cefazolin|mesh-list
24783834|NCT01904357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24783836|NCT01904487|Tiagabine|tiagabine|mesh-list
25207446|NCT03916601|Insulin|insulin|mesh-list
25207447|NCT03916601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25207448|NCT03916601|Insulin Aspart|insulin aspart|mesh-list
25207449|NCT03916601|Insulin, Long-Acting|insulin, long-acting|mesh-list
25207450|NCT03916601|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25207451|NCT03916601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25207452|NCT03916601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207453|NCT03909451|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25207454|NCT03909451|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25207455|NCT03909451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207456|NCT03909451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25207457|NCT03909451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207458|NCT03903016|Insulin|insulin|mesh-list
25207459|NCT03903016|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25198468|NCT02748265|Phenylephrine|phenylephrine|mesh-list
25198469|NCT02748265|Oxymetazoline|oxymetazoline|mesh-list
25198470|NCT02748265|Tezosentan|tezosentan|mesh-list
25198471|NCT02748265|Propofol|propofol|mesh-list
25198472|NCT02748265|Sevoflurane|sevoflurane|mesh-list
25198473|NCT02748265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25198474|NCT02748265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25198475|NCT02748265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198476|NCT02748265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25198477|NCT02748265|Anesthetics, General|anesthetics, general|mesh-ancestor
25198478|NCT02748265|Anesthetics|anesthetics|mesh-ancestor
25198479|NCT02748265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25198480|NCT02748265|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25198481|NCT02748265|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25198482|NCT02748265|Mydriatics|mydriatics|mesh-ancestor
25198483|NCT02748265|Autonomic Agents|autonomic agents|mesh-ancestor
25198484|NCT02748265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25198485|NCT02748265|Sympathomimetics|sympathomimetics|mesh-ancestor
25198486|NCT02748265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25198487|NCT02748265|Nasal Decongestants|nasal decongestants|mesh-ancestor
25198488|NCT02748265|Respiratory System Agents|respiratory system agents|mesh-ancestor
25198489|NCT02748265|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25198490|NCT02748265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25198491|NCT02748265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25198492|NCT02748265|Adrenergic Agents|adrenergic agents|mesh-ancestor
24948670|NCT03917784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24572190|NCT00813696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198493|NCT02748265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25198494|NCT02748265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198495|NCT02748265|Protective Agents|protective agents|mesh-ancestor
25198496|NCT02748265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25198497|NCT02748265|Vasodilator Agents|vasodilator agents|mesh-ancestor
25198498|NCT02748304|Aspirin|aspirin|mesh-list
25198499|NCT02748304|Sorafenib|sorafenib|mesh-list
25198500|NCT02748304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25198501|NCT02748304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25198502|NCT02748304|Analgesics|analgesics|mesh-ancestor
25198503|NCT02748304|Sensory System Agents|sensory system agents|mesh-ancestor
25198504|NCT02748304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25198505|NCT02748304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198506|NCT02748304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25198507|NCT02748304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25198508|NCT02748304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25198509|NCT02748304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25198510|NCT02748304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198511|NCT02748304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25198512|NCT02748304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25198513|NCT02748304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25198514|NCT02748304|Antipyretics|antipyretics|mesh-ancestor
25198515|NCT02748304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198516|NCT02748304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25198517|NCT02748395|Triamcinolone|triamcinolone|mesh-list
25198518|NCT02748395|Lidocaine|lidocaine|mesh-list
25667193|NCT01703221|Hormones|hormones|mesh-ancestor
25667194|NCT01703221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25667195|NCT01703221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24627907|NCT01095575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24784169|NCT01906762|Morphine|morphine|mesh-list
24784170|NCT01906762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24784171|NCT01906762|Narcotics|narcotics|mesh-ancestor
24784172|NCT01906762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25198519|NCT02748395|Anesthetics, Local|anesthetics, local|mesh-ancestor
25198520|NCT02748395|Anesthetics|anesthetics|mesh-ancestor
25198521|NCT02748395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25198522|NCT02748395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198523|NCT02748395|Sensory System Agents|sensory system agents|mesh-ancestor
25198524|NCT02748395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25198525|NCT02748395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25198526|NCT02748395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25198527|NCT02748395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25198528|NCT02748395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25198529|NCT02748395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198531|NCT02748395|Glucocorticoids|glucocorticoids|mesh-ancestor
25198532|NCT02748395|Hormones|hormones|mesh-ancestor
25198533|NCT02748395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25198534|NCT02748330|Aspirin|aspirin|mesh-list
25198535|NCT02748330|Clopidogrel|clopidogrel|mesh-list
25198536|NCT02748330|Ticagrelor|ticagrelor|mesh-list
25198537|NCT02748330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25198538|NCT02748330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25198539|NCT02748330|Analgesics|analgesics|mesh-ancestor
25198540|NCT02748330|Sensory System Agents|sensory system agents|mesh-ancestor
25198541|NCT02748330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25198542|NCT02748330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198543|NCT02748330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25198544|NCT02748330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25198545|NCT02748330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25198546|NCT02748330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25198547|NCT02748330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198548|NCT02748330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25198549|NCT02748330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25198550|NCT02748330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25198551|NCT02748330|Antipyretics|antipyretics|mesh-ancestor
25198552|NCT02748330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25198553|NCT02748330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25198554|NCT02748330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25198555|NCT02748330|Purinergic Agents|purinergic agents|mesh-ancestor
25198556|NCT02748330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25198557|NCT02748135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25198558|NCT02748135|Immunologic Factors|immunologic factors|mesh-ancestor
25198559|NCT02748135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198560|NCT02747953|Afatinib|afatinib|mesh-list
25198561|NCT02747953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198562|NCT02747953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25198563|NCT02747953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25198564|NCT02747953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198565|NCT02747940|Pregabalin|pregabalin|mesh-list
25198566|NCT02747940|Flunarizine|flunarizine|mesh-list
25198567|NCT02747940|Analgesics|analgesics|mesh-ancestor
25198568|NCT02747940|Sensory System Agents|sensory system agents|mesh-ancestor
25198569|NCT02747940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25198570|NCT02747940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198571|NCT02747940|Anticonvulsants|anticonvulsants|mesh-ancestor
25198572|NCT02747940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25198573|NCT02747940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25198574|NCT02747940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198575|NCT02747940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25198576|NCT02747940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25198577|NCT02747940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25198578|NCT02747940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25198579|NCT02747940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25198580|NCT02747940|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25198581|NCT02747940|Histamine Antagonists|histamine antagonists|mesh-ancestor
25667196|NCT01703221|Protease Inhibitors|protease inhibitors|mesh-ancestor
25667197|NCT01703221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25667198|NCT01703221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667199|NCT01703260|Pioglitazone|pioglitazone|mesh-list
25667200|NCT01703260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24784250|NCT01907061|Respiratory System Agents|respiratory system agents|mesh-ancestor
24784251|NCT01907061|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24784252|NCT01907061|Antioxidants|antioxidants|mesh-ancestor
25198582|NCT02747940|Histamine Agents|histamine agents|mesh-ancestor
25198583|NCT02747940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25198584|NCT02747940|Vasodilator Agents|vasodilator agents|mesh-ancestor
25198585|NCT02747732|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25198586|NCT02747732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198587|NCT02747732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25198588|NCT02747732|Alkylating Agents|alkylating agents|mesh-ancestor
25198589|NCT02747732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198590|NCT02747823|Bevacizumab|bevacizumab|mesh-list
25198591|NCT02747823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25198592|NCT02747823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198593|NCT02747823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25198594|NCT02747823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25198595|NCT02747823|Growth Substances|growth substances|mesh-ancestor
25198596|NCT02747823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198597|NCT02747823|Growth Inhibitors|growth inhibitors|mesh-ancestor
25198598|NCT02747511|Haloperidol|haloperidol|mesh-list
25198599|NCT02747511|Haloperidol decanoate|haloperidol decanoate|mesh-list
25198600|NCT02747511|Antiemetics|antiemetics|mesh-ancestor
25198601|NCT02747511|Autonomic Agents|autonomic agents|mesh-ancestor
25198602|NCT02747511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25198603|NCT02747511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198604|NCT02747511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25198605|NCT02747511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25198606|NCT02747511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25198607|NCT02747511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25198608|NCT02747511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25198609|NCT02747511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25198610|NCT02747511|Dopamine Agents|dopamine agents|mesh-ancestor
25198611|NCT02747511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25198612|NCT02747511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198613|NCT02747511|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25198615|NCT02747537|Sorafenib|sorafenib|mesh-list
25198616|NCT02747537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25198617|NCT02747537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25198618|NCT02747537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24572516|NCT00815256|Micronutrients|micronutrients|mesh-ancestor
25198619|NCT02747537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198620|NCT02747537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198621|NCT02747537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25198622|NCT02747381|Alfacalcidol|alfacalcidol|mesh-list
25198623|NCT02747381|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
25198624|NCT02747381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25198625|NCT02747381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198626|NCT02747381|Vitamins|vitamins|mesh-ancestor
25198627|NCT02747381|Micronutrients|micronutrients|mesh-ancestor
25198629|NCT02747316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25198630|NCT02747316|Trace Elements|trace elements|mesh-ancestor
25198631|NCT02747316|Micronutrients|micronutrients|mesh-ancestor
25198632|NCT02747316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198633|NCT02746848|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25198634|NCT02746848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25198635|NCT02746744|Rituximab|rituximab|mesh-list
25198636|NCT02746744|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25198637|NCT02746744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25198638|NCT02746744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198639|NCT02746744|Immunologic Factors|immunologic factors|mesh-ancestor
24843173|NCT02226068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24843174|NCT02226068|Immunologic Factors|immunologic factors|mesh-ancestor
25198640|NCT02746744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198641|NCT02746744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25198642|NCT02746744|Dermatologic Agents|dermatologic agents|mesh-ancestor
25198643|NCT02746744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25207482|NCT03822507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25207483|NCT03822507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207484|NCT03822507|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25207485|NCT03822507|Hormone Antagonists|hormone antagonists|mesh-ancestor
25207486|NCT03822507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25207487|NCT03802487|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25207488|NCT03802487|Charcoal|charcoal|mesh-list
25667201|NCT01703260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667202|NCT01703286|Glimepiride|glimepiride|mesh-list
25667203|NCT01703286|Linagliptin|linagliptin|mesh-list
24492671|NCT00487227|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24492672|NCT00487227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25207489|NCT03802487|Antidotes|antidotes|mesh-ancestor
25207490|NCT03802487|Protective Agents|protective agents|mesh-ancestor
25207491|NCT03802487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207492|NCT03802487|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25207493|NCT03802487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207494|NCT03802487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25207495|NCT03800836|Paclitaxel|paclitaxel|mesh-list
25207496|NCT03800836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25207497|NCT03800836|Atezolizumab|atezolizumab|mesh-list
25207498|NCT03800836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25207499|NCT03800836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207500|NCT03800836|Tubulin Modulators|tubulin modulators|mesh-ancestor
25207501|NCT03800836|Antimitotic Agents|antimitotic agents|mesh-ancestor
25207502|NCT03800836|Mitosis Modulators|mitosis modulators|mesh-ancestor
25207503|NCT03800836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207504|NCT03794336|Aspirin|aspirin|mesh-list
25207505|NCT03794336|Metformin|metformin|mesh-list
25207506|NCT03794336|Alogliptin|alogliptin|mesh-list
25207507|NCT03794336|Acarbose|acarbose|mesh-list
25207508|NCT03794336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25207509|NCT03794336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207510|NCT03794336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25207511|NCT03794336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25207512|NCT03794336|Analgesics|analgesics|mesh-ancestor
25198644|NCT02746783|Vaccines|vaccines|mesh-list
25198645|NCT02746783|Immunologic Factors|immunologic factors|mesh-ancestor
25198646|NCT02746783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198647|NCT02746250|Amitriptyline|amitriptyline|mesh-list
25198648|NCT02746250|Antidepressive Agents|antidepressive agents|mesh-list
25198649|NCT02746250|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
25198650|NCT02746250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25198651|NCT02746250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25198652|NCT02746250|Analgesics|analgesics|mesh-ancestor
25198653|NCT02746250|Sensory System Agents|sensory system agents|mesh-ancestor
25198654|NCT02746250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25198655|NCT02746250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198656|NCT02746250|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25198657|NCT02746250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25198658|NCT02746250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25198659|NCT02746250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198660|NCT02746250|Adrenergic Agents|adrenergic agents|mesh-ancestor
25198661|NCT02746250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25198663|NCT02746185|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25198664|NCT02746185|Tinzaparin|tinzaparin|mesh-list
25198665|NCT02746185|Dalteparin|dalteparin|mesh-list
25198666|NCT02746185|Rivaroxaban|rivaroxaban|mesh-list
25198667|NCT02746185|Anticoagulants|anticoagulants|mesh-ancestor
25198668|NCT02746185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25198669|NCT02746185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25198670|NCT02746185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198671|NCT02746185|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25198672|NCT02746185|Antithrombins|antithrombins|mesh-ancestor
25198673|NCT02746185|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25198674|NCT02746185|Protease Inhibitors|protease inhibitors|mesh-ancestor
25198675|NCT02746185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25198676|NCT02746276|Metronidazole|metronidazole|mesh-list
25198677|NCT02746276|Ceftriaxone|ceftriaxone|mesh-list
25198678|NCT02746276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24443827|NCT00296010|Doxorubicin|doxorubicin|mesh-list
25198679|NCT02746276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25198680|NCT02746276|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25198681|NCT02746276|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25198682|NCT02746380|Adalimumab|adalimumab|mesh-list
25198683|NCT02746380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25198684|NCT02746380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25198685|NCT02745990|Epoetin Alfa|epoetin alfa|mesh-list
25198686|NCT02745990|Hematinics|hematinics|mesh-ancestor
25198687|NCT02745925|Ibuprofen|ibuprofen|mesh-list
25198688|NCT02745925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25198689|NCT02745925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25198690|NCT02745925|Analgesics|analgesics|mesh-ancestor
25198691|NCT02745925|Sensory System Agents|sensory system agents|mesh-ancestor
25198692|NCT02745925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25198693|NCT02745925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667204|NCT01703286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25667205|NCT01703286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24784553|NCT01908556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784554|NCT01908556|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24784592|NCT01909063|Vitamin E|vitamin e|mesh-list
24784593|NCT01909063|Vitamin A|vitamin a|mesh-list
24784594|NCT01909063|Micronutrients|micronutrients|mesh-ancestor
24784642|NCT01909752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784643|NCT01909752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24784644|NCT01909752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25198694|NCT02745925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25198695|NCT02745925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25198696|NCT02745925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25198697|NCT02745925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25198698|NCT02745925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198699|NCT02745912|Metformin|metformin|mesh-list
25198700|NCT02745912|Naltrexone|naltrexone|mesh-list
25198701|NCT02745912|Bupropion|bupropion|mesh-list
25198702|NCT02745912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25198703|NCT02745912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198704|NCT02745912|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25198705|NCT02745912|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25198706|NCT02745912|Sensory System Agents|sensory system agents|mesh-ancestor
25198707|NCT02745912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25198708|NCT02745912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25198709|NCT02745912|Antidepressive Agents|antidepressive agents|mesh-ancestor
25198710|NCT02745912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25198711|NCT02745912|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25198712|NCT02745912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25198713|NCT02745912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25198714|NCT02745912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198715|NCT02745912|Dopamine Agents|dopamine agents|mesh-ancestor
25198716|NCT02745912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25198717|NCT02745912|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25198718|NCT02745912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25198719|NCT02745912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25198720|NCT02745886|Metformin|metformin|mesh-list
25198721|NCT02745886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25198722|NCT02745886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198723|NCT02745873|Ascorbic Acid|ascorbic acid|mesh-list
25198724|NCT02745873|Vitamins|vitamins|mesh-ancestor
25198725|NCT02745873|Micronutrients|micronutrients|mesh-ancestor
25198726|NCT02745873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198727|NCT02745873|Antioxidants|antioxidants|mesh-ancestor
25198728|NCT02745873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198729|NCT02745873|Protective Agents|protective agents|mesh-ancestor
25198730|NCT02745860|Selexipag|selexipag|mesh-list
25198731|NCT02745860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25198732|NCT02745639|Capecitabine|capecitabine|mesh-list
25198733|NCT02745639|Oxaliplatin|oxaliplatin|mesh-list
25198734|NCT02745639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25198735|NCT02745639|Antimetabolites|antimetabolites|mesh-ancestor
25198736|NCT02745639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198737|NCT02745639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198738|NCT02745756|Vaccines|vaccines|mesh-list
25198739|NCT02745756|Immunologic Factors|immunologic factors|mesh-ancestor
25198740|NCT02745756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648823|NCT01217034|Sorafenib|sorafenib|mesh-list
25198741|NCT02745717|Cyclosporine|cyclosporine|mesh-list
25198742|NCT02745717|Cyclosporins|cyclosporins|mesh-list
25198743|NCT02745717|Thymoglobulin|thymoglobulin|mesh-list
25198744|NCT02745717|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25198745|NCT02745717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25198746|NCT02745717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198747|NCT02745717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25198748|NCT02745717|Immunologic Factors|immunologic factors|mesh-ancestor
25198749|NCT02745717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198750|NCT02745717|Antifungal Agents|antifungal agents|mesh-ancestor
25198751|NCT02745717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25198752|NCT02745717|Dermatologic Agents|dermatologic agents|mesh-ancestor
25198753|NCT02745717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25667206|NCT01703286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667207|NCT01703286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25667208|NCT01703286|Immunologic Factors|immunologic factors|mesh-ancestor
25667209|NCT01703286|Incretins|incretins|mesh-ancestor
25667210|NCT01703286|Hormones|hormones|mesh-ancestor
25667211|NCT01703286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25667212|NCT01703286|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25667213|NCT01703286|Protease Inhibitors|protease inhibitors|mesh-ancestor
24784756|NCT01910259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24784757|NCT01910259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24784758|NCT01910259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784759|NCT01910259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24784765|NCT01910259|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24784766|NCT01910259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24784767|NCT01910259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24784768|NCT01910259|Anticonvulsants|anticonvulsants|mesh-ancestor
25198754|NCT02745717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25198756|NCT02745691|Crizotinib|crizotinib|mesh-list
25198757|NCT02745691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198758|NCT02745691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25198759|NCT02745691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25198760|NCT02745691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198761|NCT02745561|Oxaliplatin|oxaliplatin|mesh-list
25198762|NCT02745561|Endostatins|endostatins|mesh-list
25198763|NCT02745561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198764|NCT02745561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25198765|NCT02745561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25198766|NCT02745561|Growth Substances|growth substances|mesh-ancestor
25198767|NCT02745561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198768|NCT02745561|Growth Inhibitors|growth inhibitors|mesh-ancestor
25198769|NCT02745522|Oxytocin|oxytocin|mesh-list
25198770|NCT02745522|Oxytocics|oxytocics|mesh-ancestor
24573078|NCT00817739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198771|NCT02745522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25198772|NCT02745522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198773|NCT02745769|Ramucirumab|ramucirumab|mesh-list
25198774|NCT02745769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198775|NCT02745470|Lixisenatide|lixisenatide|mesh-list
25198776|NCT02745470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25198777|NCT02745470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198778|NCT02745431|Oxytocin|oxytocin|mesh-list
25198779|NCT02745431|Oxytocics|oxytocics|mesh-ancestor
25198780|NCT02745431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25198781|NCT02745431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198782|NCT02745054|Anticoagulants|anticoagulants|mesh-list
25198783|NCT02745093|Misoprostol|misoprostol|mesh-list
25198784|NCT02745093|Mifepristone|mifepristone|mesh-list
25198785|NCT02745093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25198786|NCT02745093|Abortifacient Agents|abortifacient agents|mesh-ancestor
25198787|NCT02745093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25198788|NCT02745093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198789|NCT02745093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25198790|NCT02745093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25198791|NCT02745093|Oxytocics|oxytocics|mesh-ancestor
25198792|NCT02745093|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25198793|NCT02745093|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25198794|NCT02745093|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25198795|NCT02745093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25198796|NCT02745093|Contraceptive Agents|contraceptive agents|mesh-ancestor
25198797|NCT02745093|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25860681|NCT00084240|Anthelmintics|anthelmintics|mesh-ancestor
25198798|NCT02745093|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25198799|NCT02745093|Hormone Antagonists|hormone antagonists|mesh-ancestor
25198800|NCT02745093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25198801|NCT02745093|Luteolytic Agents|luteolytic agents|mesh-ancestor
25198802|NCT02745093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25198803|NCT02745093|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25207513|NCT03794336|Sensory System Agents|sensory system agents|mesh-ancestor
25207514|NCT03794336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25207515|NCT03794336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25207516|NCT03794336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25207517|NCT03794336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25427874|NCT01823198|Busulfan|busulfan|mesh-list
25667214|NCT01703286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25667215|NCT01703286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667216|NCT01703507|Ipilimumab|ipilimumab|mesh-list
25667217|NCT01703507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25667218|NCT01703507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25667219|NCT01703507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25667220|NCT01703507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667221|NCT01703741|Testosterone|testosterone|mesh-list
25667222|NCT01703741|Androgens|androgens|mesh-ancestor
24785064|NCT01911728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24785065|NCT01911728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785066|NCT01911728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24785067|NCT01911728|Anticoagulants|anticoagulants|mesh-ancestor
24785068|NCT01911728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24785069|NCT01911728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24785070|NCT01911728|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24785071|NCT01911728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24785072|NCT01911949|Epinephrine|epinephrine|mesh-list
24785083|NCT01911949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24785085|NCT01911949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25207518|NCT03794336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25207519|NCT03794336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207520|NCT03794336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25207521|NCT03794336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25207522|NCT03794336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25207523|NCT03794336|Antipyretics|antipyretics|mesh-ancestor
25207524|NCT03794336|Incretins|incretins|mesh-ancestor
25207525|NCT03794336|Hormones|hormones|mesh-ancestor
25207526|NCT03794336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25207527|NCT03794336|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25207528|NCT03794336|Protease Inhibitors|protease inhibitors|mesh-ancestor
25207529|NCT03794336|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25207530|NCT03776227|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25207531|NCT03776227|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25207532|NCT03776227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207533|NCT03776227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25207534|NCT03776227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207535|NCT03774914|Alemtuzumab|alemtuzumab|mesh-list
25207536|NCT03774914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25207537|NCT03774914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207538|NCT03767543|Insulin Glargine|insulin glargine|mesh-list
25207539|NCT03767543|Lixisenatide|lixisenatide|mesh-list
25207540|NCT03767543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25207541|NCT03767543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207542|NCT03761134|Metformin|metformin|mesh-list
25207543|NCT03761134|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25207544|NCT03761134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25207545|NCT03761134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207546|NCT03761134|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25207547|NCT03761134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843821|NCT02229747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649163|NCT01218724|Diuretics|diuretics|mesh-ancestor
25270244|NCT02405988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270245|NCT02405988|Analgesics|analgesics|mesh-ancestor
25207548|NCT03760991|Insulin Glargine|insulin glargine|mesh-list
25207549|NCT03760991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25207550|NCT03760991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207551|NCT03760965|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25207552|NCT03760965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25207553|NCT03760965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207554|NCT03760965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25207555|NCT03760965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207556|NCT03743636|Niacinamide|niacinamide|mesh-list
25207557|NCT03743636|Niacin|niacin|mesh-list
25207558|NCT03743636|Nicotinic Acids|nicotinic acids|mesh-list
25207559|NCT03743636|Resveratrol|resveratrol|mesh-list
25207560|NCT03743636|Antioxidants|antioxidants|mesh-ancestor
25207561|NCT03743636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207562|NCT03743636|Protective Agents|protective agents|mesh-ancestor
25427875|NCT01823198|Interleukin-2|interleukin-2|mesh-list
25667223|NCT01703741|Hormones|hormones|mesh-ancestor
25667224|NCT01703741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25667225|NCT01703741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667226|NCT01703845|Tiotropium Bromide|tiotropium bromide|mesh-list
25667227|NCT01703845|Olodaterol|olodaterol|mesh-list
25667228|NCT01703845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25667229|NCT01703845|Autonomic Agents|autonomic agents|mesh-ancestor
25667230|NCT01703845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25667231|NCT01703845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667232|NCT01703845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25667233|NCT01703845|Respiratory System Agents|respiratory system agents|mesh-ancestor
24785205|NCT01912677|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24785206|NCT01912677|Sympatholytics|sympatholytics|mesh-ancestor
24785207|NCT01912677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24785208|NCT01912677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24785209|NCT01912677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24785211|NCT01912755|Epinephrine|epinephrine|mesh-list
24785212|NCT01912755|Racepinephrine|racepinephrine|mesh-list
25207563|NCT03743636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207564|NCT03743636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25207565|NCT03743636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25207566|NCT03743636|Vitamin B Complex|vitamin b complex|mesh-ancestor
25207567|NCT03743636|Vitamins|vitamins|mesh-ancestor
25207568|NCT03743636|Micronutrients|micronutrients|mesh-ancestor
25207569|NCT03743636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25207570|NCT03743636|Antimetabolites|antimetabolites|mesh-ancestor
25207571|NCT03743636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25207572|NCT03743636|Vasodilator Agents|vasodilator agents|mesh-ancestor
25207573|NCT03739554|Venetoclax|venetoclax|mesh-list
25207574|NCT03739554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198804|NCT02744690|Mitomycins|mitomycins|mesh-list
25198805|NCT02744690|Mitomycin|mitomycin|mesh-list
25198806|NCT02744690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25198807|NCT02744690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198808|NCT02744690|Alkylating Agents|alkylating agents|mesh-ancestor
25198809|NCT02744690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198810|NCT02744690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25198811|NCT02744690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25198812|NCT02744729|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
25198813|NCT02744729|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25198814|NCT02744729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198815|NCT02744716|Aspirin|aspirin|mesh-list
25198816|NCT02744716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25198817|NCT02744716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25198818|NCT02744716|Analgesics|analgesics|mesh-ancestor
25198819|NCT02744716|Sensory System Agents|sensory system agents|mesh-ancestor
25198820|NCT02744716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25198821|NCT02744716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198822|NCT02744716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25198823|NCT02744716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25198824|NCT02744716|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25198825|NCT02744716|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25198826|NCT02744716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198827|NCT02744716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25198828|NCT02744716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25198829|NCT02744716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25198830|NCT02744716|Antipyretics|antipyretics|mesh-ancestor
25198831|NCT02744768|Dasatinib|dasatinib|mesh-list
25198832|NCT02744768|Blinatumomab|blinatumomab|mesh-list
25198833|NCT02744768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198834|NCT02744768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25198835|NCT02744768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25198836|NCT02744768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198837|NCT02744872|Felodipine|felodipine|mesh-list
25198838|NCT02744872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25198839|NCT02744872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24573352|NCT00819572|Antibodies|antibodies|mesh-list
25198840|NCT02744872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25198841|NCT02744872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25198842|NCT02744872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198843|NCT02744872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25198844|NCT02744872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198845|NCT02744872|Vasodilator Agents|vasodilator agents|mesh-ancestor
25198846|NCT02744703|Capecitabine|capecitabine|mesh-list
25198847|NCT02744703|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25198848|NCT02744703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25198849|NCT02744703|Antimetabolites|antimetabolites|mesh-ancestor
25198850|NCT02744703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667234|NCT01703845|Parasympatholytics|parasympatholytics|mesh-ancestor
25667235|NCT01703845|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25667236|NCT01703845|Cholinergic Agents|cholinergic agents|mesh-ancestor
25667237|NCT01703845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25667238|NCT01703845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667239|NCT01703858|Pantoprazole|pantoprazole|mesh-list
25667240|NCT01703858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24785303|NCT01913379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198851|NCT02744703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198852|NCT02744638|Metronidazole|metronidazole|mesh-list
25198853|NCT02744638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25198854|NCT02744638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25198855|NCT02744638|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25198856|NCT02744638|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25198857|NCT02744937|Aspirin|aspirin|mesh-list
25198858|NCT02744937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25198859|NCT02744937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25198860|NCT02744937|Analgesics|analgesics|mesh-ancestor
25198861|NCT02744937|Sensory System Agents|sensory system agents|mesh-ancestor
25198862|NCT02744937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25198863|NCT02744937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198864|NCT02744937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25198865|NCT02744937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25198866|NCT02744937|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25198867|NCT02744937|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25198868|NCT02744937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198869|NCT02744937|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25198870|NCT02744937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25198871|NCT02744937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25198872|NCT02744937|Antipyretics|antipyretics|mesh-ancestor
25198873|NCT02744625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25198874|NCT02744625|Propofol|propofol|mesh-list
25198875|NCT02744625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25198876|NCT02744625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25198877|NCT02744625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198878|NCT02744625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25198879|NCT02744625|Anesthetics, General|anesthetics, general|mesh-ancestor
25198880|NCT02744625|Anesthetics|anesthetics|mesh-ancestor
25198881|NCT02744417|Bupropion|bupropion|mesh-list
25198882|NCT02744417|Nicotine|nicotine|mesh-list
25198883|NCT02744417|Varenicline|varenicline|mesh-list
25198884|NCT02744417|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25198885|NCT02744417|Autonomic Agents|autonomic agents|mesh-ancestor
25198886|NCT02744417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25198887|NCT02744417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198888|NCT02744417|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25198889|NCT02744417|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25198890|NCT02744417|Cholinergic Agents|cholinergic agents|mesh-ancestor
25198891|NCT02744417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25198892|NCT02744417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198893|NCT02744417|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25198894|NCT02744417|Antidepressive Agents|antidepressive agents|mesh-ancestor
25198895|NCT02744417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25198896|NCT02744417|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25198897|NCT02744417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25198898|NCT02744417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25198899|NCT02744417|Dopamine Agents|dopamine agents|mesh-ancestor
25198900|NCT02744417|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25198901|NCT02744417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25198902|NCT02744417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25198903|NCT02744339|Riociguat|riociguat|mesh-list
25198904|NCT02744339|Enzyme Activators|enzyme activators|mesh-ancestor
25198905|NCT02744339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198906|NCT02744508|Dexamethasone|dexamethasone|mesh-list
25198907|NCT02744508|Palonosetron|palonosetron|mesh-list
25198908|NCT02744508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25198909|NCT02744508|Antiemetics|antiemetics|mesh-ancestor
25198910|NCT02744508|Autonomic Agents|autonomic agents|mesh-ancestor
25198911|NCT02744508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25198912|NCT02744508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198913|NCT02744508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25198914|NCT02744508|Glucocorticoids|glucocorticoids|mesh-ancestor
25198915|NCT02744508|Hormones|hormones|mesh-ancestor
25198916|NCT02744508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25198917|NCT02744508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25198918|NCT02744508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198919|NCT02744508|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25198920|NCT02744508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25198921|NCT02744508|Serotonin Agents|serotonin agents|mesh-ancestor
25198922|NCT02744508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25667241|NCT01703858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25667242|NCT01703858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24785450|NCT01914432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24785451|NCT01914432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24785452|NCT01914432|Antimetabolites|antimetabolites|mesh-ancestor
24785481|NCT01914692|Hormones|hormones|mesh-ancestor
25198923|NCT02744508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198924|NCT02744378|Clobetasol|clobetasol|mesh-list
25198925|NCT02744378|Tacrolimus|tacrolimus|mesh-list
25198926|NCT02744378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25198927|NCT02744378|Immunologic Factors|immunologic factors|mesh-ancestor
25198928|NCT02744378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198929|NCT02744378|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25198930|NCT02744378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199003|NCT02744196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25198931|NCT02744378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198932|NCT02744378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25198933|NCT02744378|Glucocorticoids|glucocorticoids|mesh-ancestor
25198935|NCT02744378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25198936|NCT02744456|Losartan|losartan|mesh-list
25198937|NCT02744456|Amlodipine|amlodipine|mesh-list
25198938|NCT02744456|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25198939|NCT02744456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25198940|NCT02744456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25198941|NCT02744456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25198942|NCT02744456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198943|NCT02744456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25198944|NCT02744456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198945|NCT02744456|Vasodilator Agents|vasodilator agents|mesh-ancestor
25198946|NCT02744456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25198947|NCT02744456|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25198948|NCT02744456|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25198949|NCT02744456|Diuretics|diuretics|mesh-ancestor
25198950|NCT02744456|Natriuretic Agents|natriuretic agents|mesh-ancestor
25198951|NCT02744456|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25198952|NCT02744222|Interferons|interferons|mesh-list
25198953|NCT02744222|Interferon-beta|interferon-beta|mesh-list
25198954|NCT02744222|Interferon beta-1a|interferon beta-1a|mesh-list
25198955|NCT02744222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198956|NCT02744222|Antiviral Agents|antiviral agents|mesh-ancestor
25198957|NCT02744222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25198958|NCT02744222|Immunologic Factors|immunologic factors|mesh-ancestor
25198959|NCT02744222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198960|NCT02744222|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25198961|NCT02744482|Risedronic Acid|risedronic acid|mesh-list
25198962|NCT02744482|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25198963|NCT02744482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25198964|NCT02744482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198965|NCT02744482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25198966|NCT02744482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198967|NCT02744482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25198968|NCT02744495|Betamethasone|betamethasone|mesh-list
25198969|NCT02744495|Droperidol|droperidol|mesh-list
25198970|NCT02744495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25198971|NCT02744495|Glucocorticoids|glucocorticoids|mesh-ancestor
25198972|NCT02744495|Hormones|hormones|mesh-ancestor
25198973|NCT02744495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25198974|NCT02744495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198975|NCT02744495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25198976|NCT02744495|Respiratory System Agents|respiratory system agents|mesh-ancestor
25198977|NCT02744495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25198978|NCT02744495|Antiemetics|antiemetics|mesh-ancestor
25198979|NCT02744495|Autonomic Agents|autonomic agents|mesh-ancestor
25198980|NCT02744495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25198981|NCT02744495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25198982|NCT02744495|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25198983|NCT02744495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25198984|NCT02744495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25198985|NCT02744495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24573963|NCT00822744|Serotonin Agents|serotonin agents|mesh-ancestor
25198986|NCT02744495|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25198987|NCT02744495|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25198988|NCT02744495|Dopamine Agents|dopamine agents|mesh-ancestor
25667243|NCT01703858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25667244|NCT01703858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667245|NCT01704079|Calcifediol|calcifediol|mesh-list
24785625|NCT01915472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24785626|NCT01915472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24785627|NCT01915537|Infliximab|infliximab|mesh-list
24785628|NCT01915537|Dermatologic Agents|dermatologic agents|mesh-ancestor
24785629|NCT01915537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24785630|NCT01915537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24785631|NCT01915550|Insulin|insulin|mesh-list
24785632|NCT01915550|Metformin|metformin|mesh-list
24785633|NCT01915550|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25198989|NCT02744495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25198990|NCT02744495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25198991|NCT02744196|Methotrexate|methotrexate|mesh-list
25198992|NCT02744196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25198993|NCT02744196|Immunologic Factors|immunologic factors|mesh-ancestor
25198994|NCT02744196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25198995|NCT02744196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25198996|NCT02744196|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25198997|NCT02744196|Abortifacient Agents|abortifacient agents|mesh-ancestor
25198998|NCT02744196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25198999|NCT02744196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25199000|NCT02744196|Antimetabolites|antimetabolites|mesh-ancestor
25199001|NCT02744196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199002|NCT02744196|Dermatologic Agents|dermatologic agents|mesh-ancestor
25199010|NCT02744183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25199011|NCT02744183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199012|NCT02744183|Sensory System Agents|sensory system agents|mesh-ancestor
25199013|NCT02744183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25199015|NCT02744131|Cyproterone Acetate|cyproterone acetate|mesh-list
25199016|NCT02744131|Contraceptive Agents|contraceptive agents|mesh-list
25199017|NCT02744131|Contraceptives, Oral|contraceptives, oral|mesh-list
25199018|NCT02744131|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25199019|NCT02744131|Estradiol|estradiol|mesh-list
25199020|NCT02744131|Cyproterone|cyproterone|mesh-list
25199021|NCT02744131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25199022|NCT02744131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199023|NCT02744131|Estrogens|estrogens|mesh-ancestor
25199024|NCT02744131|Hormones|hormones|mesh-ancestor
25199025|NCT02744131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25199026|NCT02744131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25199027|NCT02744131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25199028|NCT02744131|Androgen Antagonists|androgen antagonists|mesh-ancestor
25199029|NCT02744131|Hormone Antagonists|hormone antagonists|mesh-ancestor
25199030|NCT02744131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199031|NCT02744131|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25199032|NCT02743975|Bevacizumab|bevacizumab|mesh-list
25199033|NCT02743975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25199034|NCT02743975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199035|NCT02743975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25199036|NCT02743975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25199037|NCT02743975|Growth Substances|growth substances|mesh-ancestor
25199038|NCT02743975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199039|NCT02743975|Growth Inhibitors|growth inhibitors|mesh-ancestor
25199041|NCT02743663|Bronchodilator Agents|bronchodilator agents|mesh-list
25199042|NCT02743663|Autonomic Agents|autonomic agents|mesh-ancestor
25199043|NCT02743663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25199044|NCT02743663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199045|NCT02743663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25199046|NCT02743663|Respiratory System Agents|respiratory system agents|mesh-ancestor
25199047|NCT02743663|Tocolytic Agents|tocolytic agents|mesh-ancestor
25199048|NCT02743663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25199049|NCT02743663|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25199050|NCT02743663|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25199051|NCT02743663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25199052|NCT02743663|Adrenergic Agents|adrenergic agents|mesh-ancestor
25199053|NCT02743663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25199054|NCT02743663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667246|NCT01704079|Vitamins|vitamins|mesh-ancestor
25667247|NCT01704079|Micronutrients|micronutrients|mesh-ancestor
25667248|NCT01704079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667249|NCT01704079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25667250|NCT01704261|Metformin|metformin|mesh-list
25667251|NCT01704261|Glimepiride|glimepiride|mesh-list
25667252|NCT01704261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25667253|NCT01704261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667254|NCT01704261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24785812|NCT01916642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24785813|NCT01916642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24785814|NCT01916642|Anesthetics, General|anesthetics, general|mesh-ancestor
24785815|NCT01916707|Enoxaparin|enoxaparin|mesh-list
24785816|NCT01916707|Anticoagulants|anticoagulants|mesh-ancestor
24785817|NCT01916707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24785818|NCT01916707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24785819|NCT01916707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785820|NCT01916733|Insulin|insulin|mesh-list
24785823|NCT01916785|Dasatinib|dasatinib|mesh-list
25199056|NCT02743572|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25199057|NCT02743572|Trace Elements|trace elements|mesh-ancestor
25199058|NCT02743572|Micronutrients|micronutrients|mesh-ancestor
25199059|NCT02743572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199060|NCT02743572|Hematinics|hematinics|mesh-ancestor
25199067|NCT02743260|Metformin|metformin|mesh-list
25199068|NCT02743260|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25199069|NCT02743260|Adefovir|adefovir|mesh-list
25199070|NCT02743260|Digoxin|digoxin|mesh-list
25199071|NCT02743260|Pitavastatin|pitavastatin|mesh-list
25199072|NCT02743260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25199073|NCT02743260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199074|NCT02743260|Incretins|incretins|mesh-ancestor
25199075|NCT02743260|Hormones|hormones|mesh-ancestor
25199076|NCT02743260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25199077|NCT02743260|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25199078|NCT02743260|Protease Inhibitors|protease inhibitors|mesh-ancestor
25199079|NCT02743260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199080|NCT02743260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199096|NCT02743182|Interferons|interferons|mesh-list
25199097|NCT02743182|Interferon-alpha|interferon-alpha|mesh-list
25199098|NCT02743182|Interferon alpha-2|interferon alpha-2|mesh-list
25199099|NCT02743182|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25199100|NCT02743182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199101|NCT02743182|Antiviral Agents|antiviral agents|mesh-ancestor
25199102|NCT02743182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25199103|NCT02743182|Immunologic Factors|immunologic factors|mesh-ancestor
25199104|NCT02743182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199105|NCT02743429|Dinutuximab|dinutuximab|mesh-list
25199106|NCT02743429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207578|NCT03703869|Insulin Glargine|insulin glargine|mesh-list
25207579|NCT03703869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25207580|NCT03703869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948820|NCT05402124|Aspirin|aspirin|mesh-list
25207598|NCT03681158|Valproic Acid|valproic acid|mesh-list
25207599|NCT03681158|Anticonvulsants|anticonvulsants|mesh-ancestor
25207600|NCT03681158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25207601|NCT03681158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207602|NCT03681158|GABA Agents|gaba agents|mesh-ancestor
25207603|NCT03681158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25207604|NCT03681158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207605|NCT03681158|Antimanic Agents|antimanic agents|mesh-ancestor
25207606|NCT03681158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25207607|NCT03681158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25207608|NCT03681158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25207609|NCT03670056|Nivolumab|nivolumab|mesh-list
25207610|NCT03670056|Ipilimumab|ipilimumab|mesh-list
25207611|NCT03670056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25207612|NCT03670056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207613|NCT03670056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25207614|NCT03670056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207615|NCT03666000|Cyclophosphamide|cyclophosphamide|mesh-list
25207616|NCT03666000|Fludarabine|fludarabine|mesh-list
25207617|NCT03666000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25207618|NCT03666000|Immunologic Factors|immunologic factors|mesh-ancestor
25207619|NCT03666000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207620|NCT03666000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25207622|NCT03666000|Alkylating Agents|alkylating agents|mesh-ancestor
25667255|NCT01704261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25667256|NCT01704261|Immunologic Factors|immunologic factors|mesh-ancestor
25667257|NCT01704287|Paclitaxel|paclitaxel|mesh-list
25667258|NCT01704287|Carboplatin|carboplatin|mesh-list
25667259|NCT01704287|Pembrolizumab|pembrolizumab|mesh-list
25667260|NCT01704287|Temozolomide|temozolomide|mesh-list
25667261|NCT01704287|Dacarbazine|dacarbazine|mesh-list
25667262|NCT01704287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25667263|NCT01704287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404110|NCT03684811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667264|NCT01704287|Tubulin Modulators|tubulin modulators|mesh-ancestor
24785916|NCT01917097|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24785917|NCT01917097|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24785919|NCT01917097|Adrenergic Agents|adrenergic agents|mesh-ancestor
24785920|NCT01917097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24785921|NCT01917097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785922|NCT01917149|Metoprolol|metoprolol|mesh-list
24785923|NCT01917149|Valsartan|valsartan|mesh-list
25207623|NCT03666000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207624|NCT03666000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207632|NCT03664882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25207633|NCT03664882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207634|NCT03664882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207636|NCT03630809|Immunologic Factors|immunologic factors|mesh-ancestor
25207637|NCT03630809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207638|NCT03583658|Ambroxol|ambroxol|mesh-list
25207639|NCT03583658|Expectorants|expectorants|mesh-ancestor
25207640|NCT03583658|Respiratory System Agents|respiratory system agents|mesh-ancestor
25207641|NCT03555968|Dronabinol|dronabinol|mesh-list
24826925|NCT02136823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24826926|NCT02136823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24826942|NCT02136875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24826943|NCT02136875|Adrenergic Agents|adrenergic agents|mesh-ancestor
24826944|NCT02136875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24826945|NCT02136875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860682|NCT00084240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25860683|NCT00084240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860684|NCT00084240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544300|NCT00688402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544345|NCT00688493|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24446676|NCT00305630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24446677|NCT00305630|Glucocorticoids|glucocorticoids|mesh-ancestor
25860685|NCT00084240|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24709837|NCT01507337|Liraglutide|liraglutide|mesh-list
25860686|NCT00084240|Renal Agents|renal agents|mesh-ancestor
25860687|NCT00084279|Interferons|interferons|mesh-list
25860688|NCT00084279|Ribavirin|ribavirin|mesh-list
24544419|NCT00688948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544420|NCT00688948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544421|NCT00688948|Urological Agents|urological agents|mesh-ancestor
24544423|NCT00688961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24544424|NCT00688961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24544425|NCT00688961|Analgesics|analgesics|mesh-ancestor
24544426|NCT00688961|Sensory System Agents|sensory system agents|mesh-ancestor
25860689|NCT00084279|Interferon-alpha|interferon-alpha|mesh-list
25860690|NCT00084279|Interferon-gamma|interferon-gamma|mesh-list
25860691|NCT00084279|Interferon alfacon-1|interferon alfacon-1|mesh-list
25860692|NCT00084279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860693|NCT00084279|Antiviral Agents|antiviral agents|mesh-ancestor
25860694|NCT00084279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25860695|NCT00084279|Antimetabolites|antimetabolites|mesh-ancestor
25860696|NCT00084279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860697|NCT00084279|Immunologic Factors|immunologic factors|mesh-ancestor
25860698|NCT00084279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860699|NCT00084370|Celecoxib|celecoxib|mesh-list
25860700|NCT00084370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25860701|NCT00084370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25860702|NCT00084370|Analgesics|analgesics|mesh-ancestor
24544626|NCT00689715|Tubulin Modulators|tubulin modulators|mesh-ancestor
24544627|NCT00689715|Antimitotic Agents|antimitotic agents|mesh-ancestor
24544628|NCT00689715|Mitosis Modulators|mitosis modulators|mesh-ancestor
24972513|NCT03717168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544669|NCT00689832|Autonomic Agents|autonomic agents|mesh-ancestor
24544670|NCT00689832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25860703|NCT00084370|Sensory System Agents|sensory system agents|mesh-ancestor
25667265|NCT01704287|Antimitotic Agents|antimitotic agents|mesh-ancestor
25667266|NCT01704287|Mitosis Modulators|mitosis modulators|mesh-ancestor
25667267|NCT01704287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667268|NCT01704287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25667269|NCT01704287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25667270|NCT01704287|Alkylating Agents|alkylating agents|mesh-ancestor
25667271|NCT01704521|Ribavirin|ribavirin|mesh-list
25667272|NCT01704521|Antimetabolites|antimetabolites|mesh-ancestor
24786016|NCT01917578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24786017|NCT01917578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24786018|NCT01917578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24786019|NCT01917578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24786020|NCT01917578|Antimetabolites|antimetabolites|mesh-ancestor
24786021|NCT01917578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24786022|NCT01917578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24786025|NCT01917617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25860704|NCT00084370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25860705|NCT00084370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199111|NCT02743247|Mycophenolic Acid|mycophenolic acid|mesh-list
25199112|NCT02743247|Tacrolimus|tacrolimus|mesh-list
25199113|NCT02743247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25199114|NCT02743247|Immunologic Factors|immunologic factors|mesh-ancestor
25199115|NCT02743247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199116|NCT02743247|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24972748|NCT03715478|Glucocorticoids|glucocorticoids|mesh-ancestor
25860706|NCT00084370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25860707|NCT00084370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25860708|NCT00084370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24411935|NCT00190476|Docetaxel|docetaxel|mesh-list
24747540|NCT00644228|Growth Substances|growth substances|mesh-ancestor
24747577|NCT00496795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25860709|NCT00084370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25860710|NCT00084370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860711|NCT00084370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860712|NCT00084396|Letrozole|letrozole|mesh-list
24710912|NCT01512316|Cycloserine|cycloserine|mesh-list
25860713|NCT00084396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860714|NCT00084396|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25860715|NCT00084396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25860716|NCT00084396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860717|NCT00084396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860718|NCT00084396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25860719|NCT00084396|Hormone Antagonists|hormone antagonists|mesh-ancestor
25860720|NCT00084396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25860721|NCT00084396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545073|NCT00691886|Dexmedetomidine|dexmedetomidine|mesh-list
24711154|NCT01513720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25876451|NCT03463460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876452|NCT03457142|Dexamethasone|dexamethasone|mesh-list
25876453|NCT03457142|Dexamethasone acetate|dexamethasone acetate|mesh-list
25876454|NCT03457142|Abatacept|abatacept|mesh-list
25876455|NCT03457142|Ixazomib|ixazomib|mesh-list
25876456|NCT03457142|Ichthammol|ichthammol|mesh-list
25876457|NCT03457142|BB 1101|bb 1101|mesh-list
25876458|NCT03457142|Glycine|glycine|mesh-list
25876459|NCT03457142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25876460|NCT03457142|Antiemetics|antiemetics|mesh-ancestor
24711195|NCT01513941|Immunologic Factors|immunologic factors|mesh-ancestor
25876461|NCT03457142|Autonomic Agents|autonomic agents|mesh-ancestor
25876462|NCT03457142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25876463|NCT03457142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876464|NCT03457142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25876465|NCT03457142|Glucocorticoids|glucocorticoids|mesh-ancestor
25876466|NCT03457142|Hormones|hormones|mesh-ancestor
25876467|NCT03457142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25876468|NCT03457142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24972952|NCT03713762|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24447315|NCT00308165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447316|NCT00308165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447317|NCT00308178|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24447318|NCT00308178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447319|NCT00308191|Bromides|bromides|mesh-list
24447320|NCT00308191|Formoterol Fumarate|formoterol fumarate|mesh-list
24447321|NCT00308191|Tiotropium Bromide|tiotropium bromide|mesh-list
25667273|NCT01704521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667274|NCT01704521|Antiviral Agents|antiviral agents|mesh-ancestor
25667275|NCT01704521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25667276|NCT01704599|Vitamins|vitamins|mesh-list
25667277|NCT01704599|Folic Acid|folic acid|mesh-list
25667278|NCT01704599|Vitamin B 12|vitamin b 12|mesh-list
25667279|NCT01704599|Pyridoxine|pyridoxine|mesh-list
25667280|NCT01704599|Vitamin B 6|vitamin b 6|mesh-list
25667281|NCT01704599|Vitamin B Complex|vitamin b complex|mesh-list
25667282|NCT01704599|Adalimumab|adalimumab|mesh-list
24921797|NCT04186702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921798|NCT04186702|Growth Inhibitors|growth inhibitors|mesh-ancestor
24921799|NCT04186702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921800|NCT04186936|Simethicone|simethicone|mesh-list
24921801|NCT04186936|Loperamide|loperamide|mesh-list
24921802|NCT04186936|Antidiarrheals|antidiarrheals|mesh-list
24447322|NCT00308191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24447323|NCT00308191|Autonomic Agents|autonomic agents|mesh-ancestor
24447324|NCT00308191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24447325|NCT00308191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447326|NCT00308191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25860722|NCT00084435|Cisplatin|cisplatin|mesh-list
25860723|NCT00084435|Docetaxel|docetaxel|mesh-list
25860724|NCT00084435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860725|NCT00084435|Tubulin Modulators|tubulin modulators|mesh-ancestor
24858212|NCT02295826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858213|NCT02295826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24858214|NCT02295826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24711442|NCT01515228|Autonomic Agents|autonomic agents|mesh-ancestor
24545327|NCT00693043|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24858233|NCT02295930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25040809|NCT02814019|Idebenone|idebenone|mesh-list
25040810|NCT02814019|Antioxidants|antioxidants|mesh-ancestor
25040812|NCT02814019|Protective Agents|protective agents|mesh-ancestor
24858234|NCT02295930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24858235|NCT02295930|Growth Substances|growth substances|mesh-ancestor
24858236|NCT02295930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858237|NCT02295930|Growth Inhibitors|growth inhibitors|mesh-ancestor
24858302|NCT02296203|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24858303|NCT02296203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24545371|NCT00693199|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25860726|NCT00084435|Antimitotic Agents|antimitotic agents|mesh-ancestor
25860727|NCT00084435|Mitosis Modulators|mitosis modulators|mesh-ancestor
25860728|NCT00084435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860729|NCT00084448|Celecoxib|celecoxib|mesh-list
25860730|NCT00084448|Paclitaxel|paclitaxel|mesh-list
25860731|NCT00084448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24545752|NCT00694733|Hormones|hormones|mesh-ancestor
24545753|NCT00694733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24545754|NCT00694733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545755|NCT00694733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25860732|NCT00084448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860733|NCT00084448|Tubulin Modulators|tubulin modulators|mesh-ancestor
25860734|NCT00084448|Antimitotic Agents|antimitotic agents|mesh-ancestor
24545756|NCT00694733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24545757|NCT00694733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24545758|NCT00694733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24545788|NCT00694915|Immunologic Factors|immunologic factors|mesh-ancestor
24545789|NCT00694915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948976|NCT05400902|Apatinib|apatinib|mesh-list
24858532|NCT02298166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24546023|NCT00696514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24546024|NCT00696514|Hematinics|hematinics|mesh-ancestor
24546025|NCT00696514|Vitamin B Complex|vitamin b complex|mesh-ancestor
25860735|NCT00084448|Mitosis Modulators|mitosis modulators|mesh-ancestor
25860736|NCT00084448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860737|NCT00084448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25860738|NCT00084448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24546282|NCT00697476|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24546283|NCT00697476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24546284|NCT00697476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860739|NCT00084448|Analgesics|analgesics|mesh-ancestor
25860740|NCT00084448|Sensory System Agents|sensory system agents|mesh-ancestor
24713119|NCT01524237|Anesthetics|anesthetics|mesh-ancestor
24546295|NCT00697554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667283|NCT01704599|Micronutrients|micronutrients|mesh-ancestor
25667284|NCT01704599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667285|NCT01704599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25667286|NCT01704599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25667287|NCT01704599|Hematinics|hematinics|mesh-ancestor
25667288|NCT01704651|Alvimopan|alvimopan|mesh-list
24546297|NCT00697567|Immunologic Factors|immunologic factors|mesh-ancestor
24546298|NCT00697567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667289|NCT01704651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25667290|NCT01704755|Ribavirin|ribavirin|mesh-list
25667291|NCT01704755|Antimetabolites|antimetabolites|mesh-ancestor
24786361|NCT01919346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24786362|NCT01919346|Immunologic Factors|immunologic factors|mesh-ancestor
24786363|NCT01919346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786364|NCT01919424|Methacholine Chloride|methacholine chloride|mesh-list
24786365|NCT01919424|Miotics|miotics|mesh-ancestor
24786366|NCT01919424|Autonomic Agents|autonomic agents|mesh-ancestor
24786367|NCT01919424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24786368|NCT01919424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786369|NCT01919424|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24786370|NCT01919424|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
24546299|NCT00697658|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24546300|NCT00697658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24546301|NCT00697658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24546302|NCT00697658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24546303|NCT00697658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546304|NCT00697658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24546305|NCT00697658|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24546306|NCT00697658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24546999|NCT00701831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547000|NCT00701857|Pemetrexed|pemetrexed|mesh-list
24547001|NCT00701857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199117|NCT02743247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199118|NCT02743247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199119|NCT02743247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24800506|NCT01976078|Anesthetics|anesthetics|mesh-ancestor
25199120|NCT02743247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826946|NCT02136888|Moxifloxacin|moxifloxacin|mesh-list
24802958|NCT01993472|Analgesics|analgesics|mesh-ancestor
24826947|NCT02136888|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24826948|NCT02136888|Ponesimod|ponesimod|mesh-list
24826949|NCT02136888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24826950|NCT02136888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24826951|NCT02136888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24826952|NCT02136888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24826953|NCT02136888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547136|NCT00702572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547158|NCT00702728|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24547159|NCT00702728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24973579|NCT03708497|Coagulants|coagulants|mesh-ancestor
24547280|NCT00703313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24547281|NCT00703313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24547282|NCT00703313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547283|NCT00703313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547284|NCT00703313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547299|NCT00703352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25860741|NCT00084448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25860742|NCT00084448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860743|NCT00084448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25860744|NCT00084448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25860745|NCT00084448|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25860746|NCT00084448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25860747|NCT00084448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860748|NCT00084461|Romidepsin|romidepsin|mesh-list
25860749|NCT00084461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25860750|NCT00084461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860751|NCT00084513|Trastuzumab|trastuzumab|mesh-list
24949055|NCT05327556|Epinephryl borate|epinephryl borate|mesh-list
25860752|NCT00084513|Imatinib Mesylate|imatinib mesylate|mesh-list
25860753|NCT00084513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24751636|NCT01705249|Estradiol|estradiol|mesh-list
25860754|NCT00084513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860755|NCT00084513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25860756|NCT00084513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25428027|NCT01797523|Everolimus|everolimus|mesh-list
25667292|NCT01704755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667293|NCT01704755|Antiviral Agents|antiviral agents|mesh-ancestor
25667294|NCT01704755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25667295|NCT01704781|Lenalidomide|lenalidomide|mesh-list
25667296|NCT01704781|Immunologic Factors|immunologic factors|mesh-ancestor
25667297|NCT01704781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667298|NCT01704781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25667299|NCT01704781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25667300|NCT01704781|Growth Substances|growth substances|mesh-ancestor
25667301|NCT01704781|Growth Inhibitors|growth inhibitors|mesh-ancestor
24786410|NCT01919892|Antidepressive Agents|antidepressive agents|mesh-ancestor
24786411|NCT01919892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24786412|NCT01919892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24786413|NCT01919892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786414|NCT01919892|Antimanic Agents|antimanic agents|mesh-ancestor
24786415|NCT01919892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24786416|NCT01919892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24786417|NCT01919892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199121|NCT02743247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25860757|NCT00084513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860758|NCT00084565|Paclitaxel|paclitaxel|mesh-list
25199122|NCT02743247|Antitubercular Agents|antitubercular agents|mesh-ancestor
25199123|NCT02743247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25199124|NCT02743247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25199125|NCT02743390|Infliximab|infliximab|mesh-list
25199126|NCT02743390|Dermatologic Agents|dermatologic agents|mesh-ancestor
25199127|NCT02743390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25199128|NCT02743390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25199129|NCT02743104|Lidocaine|lidocaine|mesh-list
25199130|NCT02743104|Atropine|atropine|mesh-list
25199131|NCT02743104|Midazolam|midazolam|mesh-list
25199132|NCT02743104|Ketamine|ketamine|mesh-list
25199137|NCT02743104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199138|NCT02743104|Sensory System Agents|sensory system agents|mesh-ancestor
24447494|NCT00308607|Interferon-alpha|interferon-alpha|mesh-list
24447495|NCT00308607|Interferon alpha-2|interferon alpha-2|mesh-list
24447497|NCT00308607|Dacarbazine|dacarbazine|mesh-list
24447498|NCT00308607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24447499|NCT00308607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447500|NCT00308607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24447501|NCT00308607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24447502|NCT00308607|Growth Substances|growth substances|mesh-ancestor
24447503|NCT00308607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447504|NCT00308607|Growth Inhibitors|growth inhibitors|mesh-ancestor
24447505|NCT00308607|Antiviral Agents|antiviral agents|mesh-ancestor
24447506|NCT00308607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24547424|NCT00703807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800782|NCT01978431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24800783|NCT01978431|Anesthetics, Local|anesthetics, local|mesh-ancestor
24800785|NCT01978431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24800786|NCT01978431|Sensory System Agents|sensory system agents|mesh-ancestor
24800787|NCT01978431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24800788|NCT01978431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24800790|NCT01978457|Cocaine|cocaine|mesh-list
24800791|NCT01978457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24548007|NCT00707135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25860759|NCT00084565|Topotecan|topotecan|mesh-list
25860760|NCT00084565|Estramustine|estramustine|mesh-list
25860761|NCT00084565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25860762|NCT00084565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860763|NCT00084565|Tubulin Modulators|tubulin modulators|mesh-ancestor
25860764|NCT00084565|Antimitotic Agents|antimitotic agents|mesh-ancestor
25860765|NCT00084565|Mitosis Modulators|mitosis modulators|mesh-ancestor
25860766|NCT00084565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800792|NCT01978457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24800793|NCT01978457|Adrenergic Agents|adrenergic agents|mesh-ancestor
24548104|NCT00707642|Immunologic Factors|immunologic factors|mesh-ancestor
24548105|NCT00707642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548106|NCT00707707|Paclitaxel|paclitaxel|mesh-list
24548107|NCT00707707|Olaparib|olaparib|mesh-list
24548108|NCT00707707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24548109|NCT00707707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24548110|NCT00707707|Tubulin Modulators|tubulin modulators|mesh-ancestor
25860767|NCT00084565|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25860768|NCT00084565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25860769|NCT00084565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25667302|NCT01704781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25667303|NCT01705145|Ivacaftor|ivacaftor|mesh-list
25667304|NCT01705145|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25667305|NCT01705145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25667306|NCT01705145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674423|NCT01772134|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25674424|NCT01772134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25674425|NCT01772134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24630676|NCT01113047|Amlodipine|amlodipine|mesh-list
24575054|NCT00829205|Etoposide|etoposide|mesh-list
24801113|NCT01980966|Oseltamivir|oseltamivir|mesh-list
24801114|NCT01980966|Antiviral Agents|antiviral agents|mesh-ancestor
24801115|NCT01980966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24786492|NCT01920334|Zolpidem|zolpidem|mesh-list
25860770|NCT00084565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24800961|NCT01979965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595166|NCT00937092|Natriuretic Agents|natriuretic agents|mesh-ancestor
24595167|NCT00937092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595168|NCT00937092|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24595169|NCT00937092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24595170|NCT00937092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595171|NCT00937092|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24595172|NCT00937092|Sympathomimetics|sympathomimetics|mesh-ancestor
25199139|NCT02743104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24595173|NCT00937092|Autonomic Agents|autonomic agents|mesh-ancestor
24595174|NCT00937092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25860771|NCT00084565|Alkylating Agents|alkylating agents|mesh-ancestor
25860772|NCT00084565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25860773|NCT00084578|Rosiglitazone|rosiglitazone|mesh-list
25860774|NCT00084578|Celecoxib|celecoxib|mesh-list
24715104|NCT01534494|Psilocybin|psilocybin|mesh-list
25039927|NCT03594058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447615|NCT00309218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24447617|NCT00309218|Autonomic Agents|autonomic agents|mesh-ancestor
24447618|NCT00309218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24447619|NCT00309218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801124|NCT01981278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24801125|NCT01981278|Narcotics|narcotics|mesh-ancestor
24801126|NCT01981278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24801127|NCT01981278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801128|NCT01981278|Analgesics|analgesics|mesh-ancestor
24801129|NCT01981278|Sensory System Agents|sensory system agents|mesh-ancestor
24801130|NCT01981278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24801131|NCT01981278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24801132|NCT01981278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24715488|NCT01536665|Hormones|hormones|mesh-ancestor
25860775|NCT00084578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25860776|NCT00084578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25860777|NCT00084578|Analgesics|analgesics|mesh-ancestor
25860778|NCT00084578|Sensory System Agents|sensory system agents|mesh-ancestor
25860779|NCT00084578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25860780|NCT00084578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860781|NCT00084578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25860782|NCT00084578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25860783|NCT00084578|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25860784|NCT00084578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25860785|NCT00084578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860786|NCT00084578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860787|NCT00084578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25860788|NCT00084591|Capecitabine|capecitabine|mesh-list
25860789|NCT00084591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25860790|NCT00084591|Antimetabolites|antimetabolites|mesh-ancestor
25860791|NCT00084591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860792|NCT00084591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860793|NCT00084604|Bevacizumab|bevacizumab|mesh-list
25860794|NCT00084604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25860795|NCT00084604|Cisplatin|cisplatin|mesh-list
25860796|NCT00084604|Irinotecan|irinotecan|mesh-list
25860797|NCT00084604|Antibodies|antibodies|mesh-list
25860798|NCT00084604|Immunoglobulins|immunoglobulins|mesh-list
25860799|NCT00084604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24446781|NCT00305903|Memantine|memantine|mesh-list
24548727|NCT00711854|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24548780|NCT00712049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548782|NCT00712049|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24548808|NCT00712205|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24548809|NCT00712205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24715820|NCT01538667|Ciprofloxacin|ciprofloxacin|mesh-list
24548851|NCT00712452|Cyclophosphamide|cyclophosphamide|mesh-list
25667307|NCT01705236|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25667308|NCT01705236|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25667309|NCT01705236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860800|NCT00084604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493109|NCT00489593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24493110|NCT00489593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24493111|NCT00489593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24548853|NCT00712452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24548854|NCT00712452|Immunologic Factors|immunologic factors|mesh-ancestor
24548855|NCT00712452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548868|NCT00712465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25860801|NCT00084604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25860802|NCT00084604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24715895|NCT01538901|Imiquimod|imiquimod|mesh-list
25860803|NCT00084604|Growth Substances|growth substances|mesh-ancestor
25860804|NCT00084604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553304|NCT00730249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24549049|NCT00713193|Cyclosporine|cyclosporine|mesh-list
24549051|NCT00713193|Cyclosporins|cyclosporins|mesh-list
24614994|NCT01027429|Penicillin G|penicillin g|mesh-list
25860805|NCT00084604|Growth Inhibitors|growth inhibitors|mesh-ancestor
25860806|NCT00084604|Immunologic Factors|immunologic factors|mesh-ancestor
25860807|NCT00084604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25860808|NCT00084604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25860809|NCT00084604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549207|NCT00713947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24549208|NCT00713947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24549209|NCT00713947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24549210|NCT00713947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24549211|NCT00713947|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24549212|NCT00713947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549213|NCT00713947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549214|NCT00713947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24794688|NCT04776850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24549449|NCT00715273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549451|NCT00715351|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24549452|NCT00715351|Insulin Detemir|insulin detemir|mesh-list
24549453|NCT00715351|Isophane Insulin, Human|isophane insulin, human|mesh-list
24549454|NCT00715351|Insulin, Isophane|insulin, isophane|mesh-list
24549455|NCT00715351|Isophane insulin, beef|isophane insulin, beef|mesh-list
24549456|NCT00715351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24549457|NCT00715351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549458|NCT00715377|Benztropine|benztropine|mesh-list
24549459|NCT00715377|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24549460|NCT00715377|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25860810|NCT00084604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860811|NCT00084630|Imatinib Mesylate|imatinib mesylate|mesh-list
25860812|NCT00084630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860813|NCT00084630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25860814|NCT00084630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860815|NCT00084630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860816|NCT00084643|Capecitabine|capecitabine|mesh-list
25860817|NCT00084643|Oxaliplatin|oxaliplatin|mesh-list
25860818|NCT00084643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25860819|NCT00084643|Antimetabolites|antimetabolites|mesh-ancestor
25860820|NCT00084643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860821|NCT00084643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860822|NCT00084669|Zolpidem|zolpidem|mesh-list
24549868|NCT00717808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24974538|NCT04481009|Gemcitabine|gemcitabine|mesh-list
24550120|NCT00719121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860823|NCT00084669|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25860824|NCT00084669|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25860825|NCT00084669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25860826|NCT00084669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25860827|NCT00084669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860828|NCT00084669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24974642|NCT05310344|Paclitaxel|paclitaxel|mesh-list
24550314|NCT00720174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550316|NCT00720174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550318|NCT00720265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25667310|NCT01705236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25667311|NCT01705236|Immunologic Factors|immunologic factors|mesh-ancestor
25667312|NCT01705236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667313|NCT01705288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24493167|NCT00489775|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25213984|NCT03847506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24550319|NCT00720265|Immunologic Factors|immunologic factors|mesh-ancestor
24550320|NCT00720265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550321|NCT00720265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24550322|NCT00720265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550323|NCT00720265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860829|NCT00084669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826968|NCT02136979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24826969|NCT02136979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24712431|NCT01520441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24826971|NCT02136979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24826972|NCT02136979|Anesthetics, General|anesthetics, general|mesh-ancestor
25199140|NCT02743104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25199141|NCT02743104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25199142|NCT02743104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25199143|NCT02743104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25199144|NCT02743104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199145|NCT02743104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25199146|NCT02743104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25199147|NCT02743104|Anesthetics, General|anesthetics, general|mesh-ancestor
25199148|NCT02743104|Analgesics|analgesics|mesh-ancestor
25199149|NCT02743104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25199150|NCT02743104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25199151|NCT02743104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25199152|NCT02743104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25199153|NCT02743104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25199154|NCT02743104|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25199155|NCT02743104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25199156|NCT02743104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25199157|NCT02743104|GABA Modulators|gaba modulators|mesh-ancestor
25199158|NCT02743104|GABA Agents|gaba agents|mesh-ancestor
25199159|NCT02743104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25199160|NCT02743104|Autonomic Agents|autonomic agents|mesh-ancestor
25199161|NCT02743104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25199162|NCT02743104|Respiratory System Agents|respiratory system agents|mesh-ancestor
25199163|NCT02743104|Mydriatics|mydriatics|mesh-ancestor
25199164|NCT02743104|Parasympatholytics|parasympatholytics|mesh-ancestor
25199165|NCT02743104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25199166|NCT02743104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25199167|NCT02743104|Cholinergic Agents|cholinergic agents|mesh-ancestor
25199168|NCT02743065|Doxorubicin|doxorubicin|mesh-list
25199169|NCT02743065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25199170|NCT02743065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199171|NCT02743065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25199172|NCT02743065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25199173|NCT02743065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199174|NCT02743065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199175|NCT02742909|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25199176|NCT02742909|Natriuretic Agents|natriuretic agents|mesh-ancestor
25199177|NCT02742909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199178|NCT02742948|Ceftriaxone|ceftriaxone|mesh-list
25199179|NCT02742948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25199180|NCT02742948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25199181|NCT02742675|Leuprolide|leuprolide|mesh-list
25199182|NCT02742675|Goserelin|goserelin|mesh-list
25199183|NCT02742675|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25199184|NCT02742675|Flutamide|flutamide|mesh-list
25199185|NCT02742675|Bicalutamide|bicalutamide|mesh-list
25199186|NCT02742675|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25199187|NCT02742675|Fertility Agents|fertility agents|mesh-ancestor
25860830|NCT00084669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25860831|NCT00084669|Antidepressive Agents|antidepressive agents|mesh-ancestor
25860832|NCT00084669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25860833|NCT00084669|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25860834|NCT00084669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25860835|NCT00084669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25860836|NCT00084669|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25860837|NCT00084669|GABA Agonists|gaba agonists|mesh-ancestor
25860838|NCT00084669|GABA Agents|gaba agents|mesh-ancestor
25860839|NCT00084695|Methylprednisolone|methylprednisolone|mesh-list
25860840|NCT00084695|Cyclophosphamide|cyclophosphamide|mesh-list
25860841|NCT00084695|Melphalan|melphalan|mesh-list
25667314|NCT01705288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25667315|NCT01705288|Morphine|morphine|mesh-list
24447859|NCT00309712|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24447863|NCT00309712|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24447864|NCT00309712|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24447865|NCT00309712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24447866|NCT00309725|Galantamine|galantamine|mesh-list
24447867|NCT00309725|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24447868|NCT00309725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717991|NCT01551394|Ampicillin|ampicillin|mesh-list
25860842|NCT00084695|Busulfan|busulfan|mesh-list
25860843|NCT00084695|Fludarabine|fludarabine|mesh-list
25860844|NCT00084695|Fludarabine phosphate|fludarabine phosphate|mesh-list
25860845|NCT00084695|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25860846|NCT00084695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25860847|NCT00084695|Immunologic Factors|immunologic factors|mesh-ancestor
25860848|NCT00084695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718658|NCT01556334|Erythromycin Estolate|erythromycin estolate|mesh-list
24801508|NCT01983800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801509|NCT01983800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24801510|NCT01983800|Anesthetics, General|anesthetics, general|mesh-ancestor
24801527|NCT01983943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24801528|NCT01984008|Picosulfate sodium|picosulfate sodium|mesh-list
24801529|NCT01984008|Magnesium Oxide|magnesium oxide|mesh-list
25860849|NCT00084695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24454279|NCT04207086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24454280|NCT04207086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24454281|NCT04207086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24454305|NCT04109482|Fludarabine|fludarabine|mesh-list
24454306|NCT04109482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25207642|NCT03555968|Hallucinogens|hallucinogens|mesh-ancestor
25041913|NCT01557777|Navitoclax|navitoclax|mesh-list
24719103|NCT01559272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24801561|NCT01984086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25083376|NCT03316352|Bupivacaine|bupivacaine|mesh-list
24447885|NCT00309816|Vasodilator Agents|vasodilator agents|mesh-ancestor
25667316|NCT01705288|Narcotics|narcotics|mesh-list
25667317|NCT01705288|Anesthetics|anesthetics|mesh-list
25667318|NCT01705288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25667319|NCT01705288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667320|NCT01705288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25860850|NCT00084695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25667324|NCT01705288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25667325|NCT01705288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24787278|NCT01924273|Talaporfin|talaporfin|mesh-list
24787279|NCT01924273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787280|NCT01924273|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24447886|NCT00309816|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24447887|NCT00309816|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24595792|NCT00940550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24801583|NCT01984099|Dermatologic Agents|dermatologic agents|mesh-ancestor
24801584|NCT01984099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24801585|NCT01984099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24801625|NCT01984567|Vitamins|vitamins|mesh-ancestor
25083554|NCT03315000|Xhance|xhance|mesh-list
25860851|NCT00084695|Alkylating Agents|alkylating agents|mesh-ancestor
25860852|NCT00084695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860853|NCT00084695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083581|NCT03314740|Cediranib|cediranib|mesh-list
25860854|NCT00084695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25860855|NCT00084695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25860856|NCT00084695|Antimetabolites|antimetabolites|mesh-ancestor
25860857|NCT00084695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25860858|NCT00084695|Antiemetics|antiemetics|mesh-ancestor
25860859|NCT00084695|Autonomic Agents|autonomic agents|mesh-ancestor
25860860|NCT00084695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25860861|NCT00084695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25860862|NCT00084695|Glucocorticoids|glucocorticoids|mesh-ancestor
25860863|NCT00084695|Hormones|hormones|mesh-ancestor
25860864|NCT00084695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25083756|NCT03313323|Ipilimumab|ipilimumab|mesh-list
25667326|NCT01705496|Fialuridine|fialuridine|mesh-list
25667327|NCT01705496|Antiviral Agents|antiviral agents|mesh-ancestor
25667328|NCT01705496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25667329|NCT01705496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25667330|NCT01705496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25667331|NCT01705496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667332|NCT01705509|Ranolazine|ranolazine|mesh-list
25667333|NCT01705509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25860865|NCT00084695|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25860866|NCT00084695|Protective Agents|protective agents|mesh-ancestor
25860868|NCT00084708|Dexamethasone|dexamethasone|mesh-list
25860869|NCT00084708|Gefitinib|gefitinib|mesh-list
25860870|NCT00084708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25860871|NCT00084708|Antiemetics|antiemetics|mesh-ancestor
25860872|NCT00084708|Autonomic Agents|autonomic agents|mesh-ancestor
25860873|NCT00084708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25860874|NCT00084708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199188|NCT02742675|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25039928|NCT03594058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860875|NCT00084708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25860876|NCT00084708|Glucocorticoids|glucocorticoids|mesh-ancestor
25860877|NCT00084708|Hormones|hormones|mesh-ancestor
25860878|NCT00084708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24720778|NCT01570582|Antimetabolites|antimetabolites|mesh-ancestor
25860879|NCT00084708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24882233|NCT02345850|Tacrolimus|tacrolimus|mesh-list
24399456|NCT00147862|Tranexamic Acid|tranexamic acid|mesh-list
25860880|NCT00084708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860881|NCT00084708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25860882|NCT00084708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860883|NCT00084708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860884|NCT00084708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25860885|NCT00084708|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25084048|NCT03310073|Vaccines|vaccines|mesh-list
24859008|NCT02301026|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25667334|NCT01705509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25667335|NCT01705509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667336|NCT01705574|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25667337|NCT01705574|Antiviral Agents|antiviral agents|mesh-ancestor
25667338|NCT01705574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25667339|NCT01705574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25667340|NCT01705574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25860887|NCT00084708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25084381|NCT03307603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270353|NCT02405156|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24454767|NCT03715972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24454768|NCT03715972|Anticonvulsants|anticonvulsants|mesh-ancestor
24454769|NCT03715972|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24454770|NCT03715972|Diuretics|diuretics|mesh-ancestor
24454771|NCT03715972|Natriuretic Agents|natriuretic agents|mesh-ancestor
24454772|NCT03715972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860888|NCT00084708|Vitamins|vitamins|mesh-ancestor
25860889|NCT00084708|Micronutrients|micronutrients|mesh-ancestor
25860890|NCT00084708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25860891|NCT00084721|Celecoxib|celecoxib|mesh-list
25860892|NCT00084721|Irinotecan|irinotecan|mesh-list
24550633|NCT00721526|Autonomic Agents|autonomic agents|mesh-ancestor
25084471|NCT03306732|Vitamins|vitamins|mesh-ancestor
25084557|NCT03305978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25860893|NCT00084721|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25860894|NCT00084721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25860895|NCT00084721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860896|NCT00084721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860897|NCT00084721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860898|NCT00084721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25860899|NCT00084721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25860900|NCT00084721|Analgesics|analgesics|mesh-ancestor
25860901|NCT00084721|Sensory System Agents|sensory system agents|mesh-ancestor
25860902|NCT00084721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25860903|NCT00084721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860904|NCT00084721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25667341|NCT01705587|Teriparatide|teriparatide|mesh-list
25667342|NCT01705587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25667343|NCT01705587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667344|NCT01705587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25667345|NCT01705691|Paclitaxel|paclitaxel|mesh-list
25667346|NCT01705691|Cyclophosphamide|cyclophosphamide|mesh-list
25860905|NCT00084721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25860906|NCT00084721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24787786|NCT01927484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860907|NCT00084721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25860908|NCT00084734|Cisplatin|cisplatin|mesh-list
25860909|NCT00084734|Docetaxel|docetaxel|mesh-list
25860910|NCT00084734|Capecitabine|capecitabine|mesh-list
25860911|NCT00084734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860912|NCT00084734|Tubulin Modulators|tubulin modulators|mesh-ancestor
25860913|NCT00084734|Antimitotic Agents|antimitotic agents|mesh-ancestor
25860914|NCT00084734|Mitosis Modulators|mitosis modulators|mesh-ancestor
25860915|NCT00084734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24454853|NCT03474029|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24454854|NCT03474029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25860916|NCT00084734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25860917|NCT00084734|Antimetabolites|antimetabolites|mesh-ancestor
25860918|NCT00084773|Fluorouracil|fluorouracil|mesh-list
25860919|NCT00084773|Cetuximab|cetuximab|mesh-list
25860920|NCT00084773|Antimetabolites|antimetabolites|mesh-ancestor
25860921|NCT00084773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826988|NCT02137083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860922|NCT00084773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24626175|NCT01085851|Chlorpheniramine|chlorpheniramine|mesh-list
24801822|NCT01985789|Cholinergic Agents|cholinergic agents|mesh-ancestor
25860923|NCT00084773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860924|NCT00084773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25860925|NCT00084773|Immunologic Factors|immunologic factors|mesh-ancestor
25860926|NCT00084773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25860927|NCT00084773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25860928|NCT00084786|Docetaxel|docetaxel|mesh-list
24801862|NCT01985893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24801863|NCT01985893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24801864|NCT01985893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860929|NCT00084786|Gefitinib|gefitinib|mesh-list
25667347|NCT01705691|Doxorubicin|doxorubicin|mesh-list
25667348|NCT01705691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25667349|NCT01705691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25667350|NCT01705691|Tubulin Modulators|tubulin modulators|mesh-ancestor
25667351|NCT01705691|Antimitotic Agents|antimitotic agents|mesh-ancestor
25667352|NCT01705691|Mitosis Modulators|mitosis modulators|mesh-ancestor
25667353|NCT01705691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667354|NCT01705691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25667355|NCT01705691|Immunologic Factors|immunologic factors|mesh-ancestor
25860930|NCT00084786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24801962|NCT01986582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24801963|NCT01986582|Adrenergic Agents|adrenergic agents|mesh-ancestor
24801964|NCT01986582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25860931|NCT00084786|Tubulin Modulators|tubulin modulators|mesh-ancestor
25860932|NCT00084786|Antimitotic Agents|antimitotic agents|mesh-ancestor
25860933|NCT00084786|Mitosis Modulators|mitosis modulators|mesh-ancestor
25860934|NCT00084786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860935|NCT00084786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25860936|NCT00084786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860937|NCT00084812|Cisplatin|cisplatin|mesh-list
25860938|NCT00084812|Safingol|safingol|mesh-list
25051839|NCT00370383|Satraplatin|satraplatin|mesh-list
25199189|NCT02742675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199190|NCT02742675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25199191|NCT02742675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199192|NCT02742675|Androgen Antagonists|androgen antagonists|mesh-ancestor
25199193|NCT02742675|Hormone Antagonists|hormone antagonists|mesh-ancestor
25199194|NCT02742675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25199195|NCT02742675|Luteolytic Agents|luteolytic agents|mesh-ancestor
25199196|NCT02742675|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25199197|NCT02742675|Contraceptive Agents|contraceptive agents|mesh-ancestor
25199198|NCT02742675|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25199199|NCT02742805|Vitamin D|vitamin d|mesh-list
25199200|NCT02742805|Ergocalciferols|ergocalciferols|mesh-list
25860939|NCT00084812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860940|NCT00084812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860941|NCT00084812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860942|NCT00084825|Docetaxel|docetaxel|mesh-list
25860943|NCT00084825|Imatinib Mesylate|imatinib mesylate|mesh-list
25860944|NCT00084825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860945|NCT00084825|Tubulin Modulators|tubulin modulators|mesh-ancestor
24563900|NCT00774280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563903|NCT00774319|Cisplatin|cisplatin|mesh-list
25860946|NCT00084825|Antimitotic Agents|antimitotic agents|mesh-ancestor
24725151|NCT01596647|GABA Agents|gaba agents|mesh-ancestor
25860947|NCT00084825|Mitosis Modulators|mitosis modulators|mesh-ancestor
25667356|NCT01705691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667357|NCT01705691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25667358|NCT01705691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25667359|NCT01705691|Alkylating Agents|alkylating agents|mesh-ancestor
25667360|NCT01705691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25667361|NCT01705691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25667362|NCT01705691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25667363|NCT01705691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25667364|NCT01705691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25082314|NCT03323567|Sensory System Agents|sensory system agents|mesh-ancestor
24787850|NCT01927913|Chelating Agents|chelating agents|mesh-ancestor
25860948|NCT00084825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860949|NCT00084825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25860950|NCT00084825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860952|NCT00084877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25860953|NCT00084877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24801984|NCT01986660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24801985|NCT01986660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25860954|NCT00084877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860955|NCT00084877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860956|NCT00084877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860957|NCT00084890|Carboplatin|carboplatin|mesh-list
25860958|NCT00084890|Docetaxel|docetaxel|mesh-list
25860959|NCT00084890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860960|NCT00084890|Tubulin Modulators|tubulin modulators|mesh-ancestor
25860961|NCT00084890|Antimitotic Agents|antimitotic agents|mesh-ancestor
25860962|NCT00084890|Mitosis Modulators|mitosis modulators|mesh-ancestor
25860963|NCT00084890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860964|NCT00084916|Sirolimus|sirolimus|mesh-list
25860965|NCT00084916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25860966|NCT00084916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25860967|NCT00084916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25860968|NCT00084916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860969|NCT00084916|Antifungal Agents|antifungal agents|mesh-ancestor
25085426|NCT03298373|Nandrolone|nandrolone|mesh-list
25085477|NCT03298074|Etoposide|etoposide|mesh-list
24454984|NCT03031483|Growth Substances|growth substances|mesh-ancestor
25050967|NCT00458276|Tezosentan|tezosentan|mesh-list
24454985|NCT03031483|Growth Inhibitors|growth inhibitors|mesh-ancestor
24454986|NCT03031483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24454987|NCT03031483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25860970|NCT00084916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25860971|NCT00084916|Immunologic Factors|immunologic factors|mesh-ancestor
25860972|NCT00084916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199201|NCT02742805|Cholecalciferol|cholecalciferol|mesh-list
25042638|NCT01407003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25860973|NCT00084942|Gemcitabine|gemcitabine|mesh-list
25860974|NCT00084942|Capecitabine|capecitabine|mesh-list
25860975|NCT00084942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24454988|NCT03031483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24454989|NCT03031483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24454990|NCT03031483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860976|NCT00084942|Antimetabolites|antimetabolites|mesh-ancestor
25860977|NCT00084942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25860978|NCT00084942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860979|NCT00084942|Antiviral Agents|antiviral agents|mesh-ancestor
25860980|NCT00084942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25860981|NCT00084942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860982|NCT00084942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25860983|NCT00084942|Immunologic Factors|immunologic factors|mesh-ancestor
25667365|NCT01705964|Epinephrine|epinephrine|mesh-list
25667366|NCT01705964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25667367|NCT01705964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25667368|NCT01705964|Adrenergic Agents|adrenergic agents|mesh-ancestor
25667369|NCT01705964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25667370|NCT01705964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667371|NCT01705964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667372|NCT01705964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25667373|NCT01705964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25860988|NCT00084981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25860990|NCT00084981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726418|NCT01603134|Antioxidants|antioxidants|mesh-ancestor
24448836|NCT00313235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448837|NCT00313235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24448838|NCT00313235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24448839|NCT00313235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25860991|NCT00084981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25860992|NCT00084981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25860993|NCT00084981|Anticonvulsants|anticonvulsants|mesh-ancestor
25860994|NCT00084981|GABA Agents|gaba agents|mesh-ancestor
25860995|NCT00084981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25860996|NCT00084981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802077|NCT01987128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24802078|NCT01987154|Caseins|caseins|mesh-list
24802079|NCT01987154|Chelating Agents|chelating agents|mesh-ancestor
24802080|NCT01987154|Sequestering Agents|sequestering agents|mesh-ancestor
25860997|NCT00084981|Antimanic Agents|antimanic agents|mesh-ancestor
25860998|NCT00084981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25860999|NCT00084981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25861000|NCT00084981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25861001|NCT00085020|Trastuzumab|trastuzumab|mesh-list
25199202|NCT02742805|Vitamins|vitamins|mesh-list
25199203|NCT02742805|Omalizumab|omalizumab|mesh-list
25042711|NCT01379209|Sirolimus|sirolimus|mesh-list
25667374|NCT01705964|Autonomic Agents|autonomic agents|mesh-ancestor
25667375|NCT01705964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25667376|NCT01705964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25667377|NCT01705964|Respiratory System Agents|respiratory system agents|mesh-ancestor
25667378|NCT01705964|Mydriatics|mydriatics|mesh-ancestor
25667379|NCT01705964|Sympathomimetics|sympathomimetics|mesh-ancestor
25667380|NCT01705964|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25861002|NCT00085020|Lapatinib|lapatinib|mesh-list
25861003|NCT00085020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25667381|NCT01706146|Rivaroxaban|rivaroxaban|mesh-list
24788142|NCT01929668|Ascorbic Acid|ascorbic acid|mesh-list
24802089|NCT01987297|Tretinoin|tretinoin|mesh-list
24802090|NCT01987297|Arsenic Trioxide|arsenic trioxide|mesh-list
24802091|NCT01987297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24802092|NCT01987297|Antimetabolites|antimetabolites|mesh-ancestor
24802093|NCT01987297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861004|NCT00085020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861005|NCT00085020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25861006|NCT00085020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474697|NCT00407017|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24949770|NCT03686488|Ramucirumab|ramucirumab|mesh-list
24949771|NCT03686488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861007|NCT00085020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861008|NCT00085111|Bevacizumab|bevacizumab|mesh-list
24449014|NCT00313924|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24727120|NCT01608139|Analgesics|analgesics|mesh-ancestor
25861009|NCT00085111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25861010|NCT00085111|Antibodies|antibodies|mesh-list
25861011|NCT00085111|Immunoglobulins|immunoglobulins|mesh-list
25861012|NCT00085111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25861013|NCT00085111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861014|NCT00085111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25861015|NCT00085111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25861016|NCT00085111|Growth Substances|growth substances|mesh-ancestor
25861017|NCT00085111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861018|NCT00085111|Growth Inhibitors|growth inhibitors|mesh-ancestor
25861019|NCT00085111|Immunologic Factors|immunologic factors|mesh-ancestor
25861020|NCT00085124|Cytarabine|cytarabine|mesh-list
24949819|NCT03585452|Dexmedetomidine|dexmedetomidine|mesh-list
25861021|NCT00085124|Daunorubicin|daunorubicin|mesh-list
25861022|NCT00085124|Oblimersen|oblimersen|mesh-list
24393276|NCT00129363|Antioxidants|antioxidants|mesh-ancestor
24393277|NCT00129363|Protective Agents|protective agents|mesh-ancestor
25667382|NCT01706146|Apixaban|apixaban|mesh-list
25667383|NCT01706146|Dabigatran|dabigatran|mesh-list
25667384|NCT01706146|Anticoagulants|anticoagulants|mesh-list
25667385|NCT01706146|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25667386|NCT01706146|Antithrombins|antithrombins|mesh-ancestor
25667387|NCT01706146|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25667388|NCT01706146|Protease Inhibitors|protease inhibitors|mesh-ancestor
25667389|NCT01706146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25667390|NCT01706146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667391|NCT01706198|Fluticasone|fluticasone|mesh-list
25667392|NCT01706198|Xhance|xhance|mesh-list
25667393|NCT01706198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25667394|NCT01706198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25667395|NCT01706198|Autonomic Agents|autonomic agents|mesh-ancestor
25667396|NCT01706198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25861023|NCT00085124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25861024|NCT00085124|Antimetabolites|antimetabolites|mesh-ancestor
25861025|NCT00085124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393279|NCT00129363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24393280|NCT00129363|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24393281|NCT00129363|Vasodilator Agents|vasodilator agents|mesh-ancestor
24393282|NCT00129363|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24802230|NCT01988961|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24802231|NCT01988961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24802232|NCT01988961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24596548|NCT00944307|Antiviral Agents|antiviral agents|mesh-ancestor
24802234|NCT01988961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199204|NCT02742805|Micronutrients|micronutrients|mesh-ancestor
25199213|NCT02742623|Antithrombins|antithrombins|mesh-ancestor
25199214|NCT02742623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25199215|NCT02742623|Protease Inhibitors|protease inhibitors|mesh-ancestor
25199216|NCT02742623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199217|NCT02742623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199218|NCT02742623|Anticoagulants|anticoagulants|mesh-ancestor
25199219|NCT02742285|Lumefantrine|lumefantrine|mesh-list
25199220|NCT02742285|Artemether|artemether|mesh-list
25199221|NCT02742285|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25199222|NCT02742285|Antimalarials|antimalarials|mesh-ancestor
25199223|NCT02742285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25199224|NCT02742285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25199225|NCT02742285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25199226|NCT02742480|Dabigatran|dabigatran|mesh-list
25199227|NCT02742480|Acenocoumarol|acenocoumarol|mesh-list
25199228|NCT02742480|Antithrombins|antithrombins|mesh-ancestor
25199229|NCT02742480|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25199230|NCT02742480|Protease Inhibitors|protease inhibitors|mesh-ancestor
25199231|NCT02742480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199232|NCT02742480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199233|NCT02742480|Anticoagulants|anticoagulants|mesh-ancestor
25199247|NCT02742233|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25199248|NCT02742233|Protease Inhibitors|protease inhibitors|mesh-ancestor
25199249|NCT02742233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199250|NCT02742233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199251|NCT02742233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25199252|NCT02742467|Amlodipine|amlodipine|mesh-list
25199253|NCT02742467|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25199254|NCT02742467|Perindopril|perindopril|mesh-list
25199255|NCT02742467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25199256|NCT02742467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25199257|NCT02742467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25199258|NCT02742467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199259|NCT02742467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25199260|NCT02742467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199261|NCT02742467|Vasodilator Agents|vasodilator agents|mesh-ancestor
25199262|NCT02742467|Diuretics|diuretics|mesh-ancestor
25042847|NCT01359566|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
24393552|NCT00130338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393553|NCT00130338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24393554|NCT00130338|Protective Agents|protective agents|mesh-ancestor
24393555|NCT00130351|Formoterol Fumarate|formoterol fumarate|mesh-list
24393556|NCT00130351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24393557|NCT00130351|Autonomic Agents|autonomic agents|mesh-ancestor
24393597|NCT00130455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667397|NCT01706198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667398|NCT01706198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25667399|NCT01706198|Respiratory System Agents|respiratory system agents|mesh-ancestor
25667400|NCT01706198|Dermatologic Agents|dermatologic agents|mesh-ancestor
25667401|NCT01706198|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24393598|NCT00130455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24788299|NCT01930734|Dobutamine|dobutamine|mesh-list
24788300|NCT01930734|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24393599|NCT00130455|Serotonin Agents|serotonin agents|mesh-ancestor
24393710|NCT00130819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24393712|NCT00130845|Octreotide|octreotide|mesh-list
24393713|NCT00130845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24393714|NCT00130845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24393715|NCT00130845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393716|NCT00130858|Carboplatin|carboplatin|mesh-list
24393737|NCT00130884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24393738|NCT00130884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086418|NCT03289429|Atorvastatin|atorvastatin|mesh-list
24455258|NCT02062944|Immunosuppressive Agents|immunosuppressive agents|mesh-list
24455259|NCT02062944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24394117|NCT00132184|Vitamin D|vitamin d|mesh-list
24394118|NCT00132184|Vitamins|vitamins|mesh-ancestor
24394119|NCT00132184|Micronutrients|micronutrients|mesh-ancestor
24394120|NCT00132184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394121|NCT00132184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24394122|NCT00132210|Interferons|interferons|mesh-list
25086532|NCT03288636|Ritonavir|ritonavir|mesh-list
24463001|NCT00358319|GABA Agents|gaba agents|mesh-ancestor
24463003|NCT00358319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463004|NCT00358319|Antimanic Agents|antimanic agents|mesh-ancestor
24463005|NCT00358319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24616582|NCT01038154|Pravastatin|pravastatin|mesh-list
25199317|NCT02741960|Metformin|metformin|mesh-list
25861026|NCT00085124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440572|NCT00283764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25861027|NCT00085124|Antiviral Agents|antiviral agents|mesh-ancestor
24463517|NCT00361309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24463519|NCT00361309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463520|NCT00361309|Growth Inhibitors|growth inhibitors|mesh-ancestor
24463521|NCT00361309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24463522|NCT00361309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24463523|NCT00361309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463524|NCT00361322|Clindamycin|clindamycin|mesh-list
24463525|NCT00361322|Clindamycin palmitate|clindamycin palmitate|mesh-list
24463526|NCT00361322|Clindamycin phosphate|clindamycin phosphate|mesh-list
24463527|NCT00361322|Salicylic Acid|salicylic acid|mesh-list
25667402|NCT01706250|Salicylic Acid|salicylic acid|mesh-list
25667403|NCT01706250|Salicylates|salicylates|mesh-list
25667404|NCT01706250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25667405|NCT01706250|Antifungal Agents|antifungal agents|mesh-ancestor
25667406|NCT01706250|Keratolytic Agents|keratolytic agents|mesh-ancestor
25667407|NCT01706250|Dermatologic Agents|dermatologic agents|mesh-ancestor
25667408|NCT01706250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25667409|NCT01706250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25667410|NCT01706250|Analgesics|analgesics|mesh-ancestor
24463528|NCT00361322|Salicylates|salicylates|mesh-list
25667411|NCT01706250|Sensory System Agents|sensory system agents|mesh-ancestor
25861028|NCT00085124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25861029|NCT00085124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24452977|NCT05378113|Antipruritics|antipruritics|mesh-ancestor
25861030|NCT00085124|Immunologic Factors|immunologic factors|mesh-ancestor
25861031|NCT00085124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861032|NCT00085124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25861033|NCT00085124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25861034|NCT00085124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25861035|NCT00085124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861036|NCT00085150|Immunotoxins|immunotoxins|mesh-list
25861037|NCT00085150|Immunologic Factors|immunologic factors|mesh-ancestor
25861038|NCT00085150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861039|NCT00085163|Leucovorin|leucovorin|mesh-list
24999546|NCT04052334|Interleukin-2|interleukin-2|mesh-list
24463555|NCT00361387|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24463556|NCT00361387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24463557|NCT00361387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463558|NCT00361387|Dopamine Agents|dopamine agents|mesh-ancestor
24463559|NCT00361387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24463561|NCT00361413|Dermatologic Agents|dermatologic agents|mesh-ancestor
24517908|NCT00610571|Topotecan|topotecan|mesh-list
24463571|NCT00361452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463572|NCT00361452|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24802499|NCT01990755|Chlordesmethyldiazepam|chlordesmethyldiazepam|mesh-list
24802501|NCT01990755|Antiemetics|antiemetics|mesh-ancestor
24802502|NCT01990755|Autonomic Agents|autonomic agents|mesh-ancestor
24802503|NCT01990755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24802504|NCT01990755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802505|NCT01990755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24802506|NCT01990755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24802507|NCT01990755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24802508|NCT01990755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24949960|NCT03172624|Nivolumab|nivolumab|mesh-list
24802509|NCT01990755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24802510|NCT01990755|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25199308|NCT02741947|Benserazide|benserazide|mesh-list
24463934|NCT00362765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24463935|NCT00362765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463936|NCT00362765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24463937|NCT00362765|Antimetabolites|antimetabolites|mesh-ancestor
24463938|NCT00362765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463939|NCT00362765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24464010|NCT00362960|Olmesartan|olmesartan|mesh-list
24464011|NCT00362960|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24464012|NCT00362960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25667412|NCT01706250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25667413|NCT01706250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667414|NCT01706250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25667415|NCT01706250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25667416|NCT01706250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25667417|NCT01706250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25667418|NCT01706250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667419|NCT01706263|Salicylic Acid|salicylic acid|mesh-list
25667420|NCT01706263|Salicylates|salicylates|mesh-list
24788409|NCT01931215|Autonomic Agents|autonomic agents|mesh-ancestor
24788410|NCT01931215|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24788411|NCT01931215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24788412|NCT01931215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25861043|NCT00085163|Levoleucovorin|levoleucovorin|mesh-list
25861044|NCT00085163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25861045|NCT00085163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464013|NCT00362960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24464014|NCT00362960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25087121|NCT03282513|Ivosidenib|ivosidenib|mesh-list
24464296|NCT00364052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464297|NCT00364091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25861046|NCT00085163|Antimetabolites|antimetabolites|mesh-ancestor
25199263|NCT02742467|Natriuretic Agents|natriuretic agents|mesh-ancestor
25199269|NCT02742181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25199270|NCT02742142|Fluorides|fluorides|mesh-list
25199271|NCT02742142|Cariostatic Agents|cariostatic agents|mesh-ancestor
25199272|NCT02742142|Protective Agents|protective agents|mesh-ancestor
25199273|NCT02742142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199274|NCT02742168|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
25199275|NCT02742168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25199276|NCT02742168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199277|NCT02742051|Cyclophosphamide|cyclophosphamide|mesh-list
25199278|NCT02742051|Fluorouracil|fluorouracil|mesh-list
25199279|NCT02742051|Everolimus|everolimus|mesh-list
25199280|NCT02742051|Letrozole|letrozole|mesh-list
25199281|NCT02742051|Epirubicin|epirubicin|mesh-list
25199282|NCT02742051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25199283|NCT02742051|Immunologic Factors|immunologic factors|mesh-ancestor
25199284|NCT02742051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199285|NCT02742051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25199286|NCT02742051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25199287|NCT02742051|Alkylating Agents|alkylating agents|mesh-ancestor
25199288|NCT02742051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199289|NCT02742051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199290|NCT02742051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25199291|NCT02742051|Antimetabolites|antimetabolites|mesh-ancestor
25199292|NCT02742051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25199293|NCT02742051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25199294|NCT02742051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25199295|NCT02742051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199296|NCT02742051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25667421|NCT01706263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25667422|NCT01706263|Antifungal Agents|antifungal agents|mesh-ancestor
25667423|NCT01706263|Keratolytic Agents|keratolytic agents|mesh-ancestor
25667424|NCT01706263|Dermatologic Agents|dermatologic agents|mesh-ancestor
25667425|NCT01706263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25667426|NCT01706263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25667427|NCT01706263|Analgesics|analgesics|mesh-ancestor
25667428|NCT01706263|Sensory System Agents|sensory system agents|mesh-ancestor
25667429|NCT01706263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25667430|NCT01706263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667431|NCT01706263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25667432|NCT01706263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25667433|NCT01706263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25667434|NCT01706263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861047|NCT00085163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788441|NCT01931332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788442|NCT01931332|Analgesics|analgesics|mesh-ancestor
24788443|NCT01931332|Sensory System Agents|sensory system agents|mesh-ancestor
24788444|NCT01931332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24788445|NCT01931384|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24788446|NCT01931384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24788447|NCT01931384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788448|NCT01931410|Misoprostol|misoprostol|mesh-list
24728116|NCT01614236|Pregabalin|pregabalin|mesh-list
25199297|NCT02742051|Hormone Antagonists|hormone antagonists|mesh-ancestor
25199298|NCT02742051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25199299|NCT02742051|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25199300|NCT02742051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25199301|NCT02742051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25199302|NCT02742038|Fluorides|fluorides|mesh-list
25199303|NCT02742038|Fluorides, Topical|fluorides, topical|mesh-list
25199304|NCT02742038|Cariostatic Agents|cariostatic agents|mesh-ancestor
25199305|NCT02742038|Protective Agents|protective agents|mesh-ancestor
25199306|NCT02742038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199307|NCT02741947|Levodopa|levodopa|mesh-list
25199310|NCT02741947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25199311|NCT02741947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25199312|NCT02741947|Dopamine Agents|dopamine agents|mesh-ancestor
25199313|NCT02741947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25199314|NCT02741947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199315|NCT02741947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199316|NCT02741947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199318|NCT02741960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25199319|NCT02741960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199320|NCT02741817|Aspirin|aspirin|mesh-list
25199321|NCT02741817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25199322|NCT02741817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25199323|NCT02741817|Analgesics|analgesics|mesh-ancestor
25199324|NCT02741817|Sensory System Agents|sensory system agents|mesh-ancestor
25199325|NCT02741817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25199326|NCT02741817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199327|NCT02741817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25199328|NCT02741817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25199329|NCT02741817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25199330|NCT02741817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25199331|NCT02741817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199332|NCT02741817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25861048|NCT00085163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24464609|NCT00365586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24464617|NCT00365612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24464618|NCT00365612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24731470|NCT01634893|Antimalarials|antimalarials|mesh-ancestor
24464661|NCT00365755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24464662|NCT00365755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24464663|NCT00365755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24464664|NCT00365755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464665|NCT00365755|Tubulin Modulators|tubulin modulators|mesh-ancestor
24464670|NCT00365820|Serotonin Agents|serotonin agents|mesh-ancestor
24464671|NCT00365820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24464672|NCT00365820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464673|NCT00365820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464675|NCT00365898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24464683|NCT00365924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25667435|NCT01706263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667436|NCT01706328|Fluticasone|fluticasone|mesh-list
25667437|NCT01706328|Xhance|xhance|mesh-list
25667438|NCT01706328|Albuterol|albuterol|mesh-list
25667439|NCT01706328|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25667440|NCT01706328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25667441|NCT01706328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25667442|NCT01706328|Autonomic Agents|autonomic agents|mesh-ancestor
25667443|NCT01706328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25667444|NCT01706328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667445|NCT01706328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24802573|NCT01990937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25667447|NCT01706328|Dermatologic Agents|dermatologic agents|mesh-ancestor
25667448|NCT01706328|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25667449|NCT01706328|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25667450|NCT01706328|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25667451|NCT01706328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25667452|NCT01706328|Adrenergic Agents|adrenergic agents|mesh-ancestor
25667453|NCT01706328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25861064|NCT00085163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24465016|NCT00367536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465017|NCT00367536|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25087544|NCT03278808|Analgesics|analgesics|mesh-ancestor
24465054|NCT00367653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24465055|NCT00367653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24465056|NCT00367653|Antimalarials|antimalarials|mesh-ancestor
24465057|NCT00367653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24465059|NCT00367718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465060|NCT00367731|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24465061|NCT00367731|Antiviral Agents|antiviral agents|mesh-ancestor
24617002|NCT01040286|Flurbiprofen|flurbiprofen|mesh-list
24802624|NCT01991275|Narcotics|narcotics|mesh-ancestor
24802625|NCT01991275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24802626|NCT01991275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802627|NCT01991275|Analgesics|analgesics|mesh-ancestor
24802628|NCT01991275|Sensory System Agents|sensory system agents|mesh-ancestor
24802629|NCT01991275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24802630|NCT01991288|Epinephrine|epinephrine|mesh-list
24802631|NCT01991288|Racepinephrine|racepinephrine|mesh-list
24802632|NCT01991288|Bupivacaine|bupivacaine|mesh-list
24802633|NCT01991288|Levobupivacaine|levobupivacaine|mesh-list
24802635|NCT01991288|Anesthetics, Local|anesthetics, local|mesh-ancestor
24572723|NCT00816426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24465105|NCT00367913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465106|NCT00367913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24465107|NCT00367913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24465109|NCT00367913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24465110|NCT00367913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465111|NCT00367913|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24465128|NCT00367939|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24846759|NCT02243644|Mitosis Modulators|mitosis modulators|mesh-ancestor
24846760|NCT02243644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846761|NCT02243644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465129|NCT00367939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465130|NCT00367939|Vasodilator Agents|vasodilator agents|mesh-ancestor
25087662|NCT03277755|Adafosbuvir|adafosbuvir|mesh-list
24465186|NCT00368160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24576480|NCT00838838|Testosterone enanthate|testosterone enanthate|mesh-list
24576481|NCT00838838|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24576499|NCT00838955|Immunologic Factors|immunologic factors|mesh-ancestor
25051870|NCT00367887|Antimetabolites|antimetabolites|mesh-ancestor
25051871|NCT00367887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051872|NCT00367887|Antiviral Agents|antiviral agents|mesh-ancestor
24789042|NCT01935492|Capecitabine|capecitabine|mesh-list
24789043|NCT01935492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25082360|NCT03323372|Listerine|listerine|mesh-list
25051873|NCT00367887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25051874|NCT00367887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051875|NCT00367887|Immunologic Factors|immunologic factors|mesh-ancestor
25051876|NCT00367887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051877|NCT00366795|Satavaptan|satavaptan|mesh-list
25051878|NCT00366795|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25051879|NCT00366795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051880|NCT00366795|Natriuretic Agents|natriuretic agents|mesh-ancestor
25051881|NCT00366795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861065|NCT00085163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25861066|NCT00085163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861067|NCT00085189|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
24465200|NCT00368238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24465201|NCT00368238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790584|NCT01943786|Cetuximab|cetuximab|mesh-list
24790585|NCT01943786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24790586|NCT01943786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24790587|NCT01943812|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24790588|NCT01943812|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24790589|NCT01943812|Estradiol|estradiol|mesh-list
24790590|NCT01943812|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24465202|NCT00368238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24465203|NCT00368238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24465204|NCT00368238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24465205|NCT00368238|Antipyretics|antipyretics|mesh-ancestor
24465206|NCT00368238|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24465207|NCT00368238|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24617126|NCT01041170|Rimonabant|rimonabant|mesh-list
25861068|NCT00085189|Freund's Adjuvant|freund's adjuvant|mesh-list
25861069|NCT00085189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25861070|NCT00085189|Immunologic Factors|immunologic factors|mesh-ancestor
24465240|NCT00368329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465241|NCT00368329|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24465242|NCT00368342|Azithromycin|azithromycin|mesh-list
24465243|NCT00368342|Clarithromycin|clarithromycin|mesh-list
24465244|NCT00368342|Erythromycin|erythromycin|mesh-list
25051882|NCT00366704|Risperidone|risperidone|mesh-list
25051883|NCT00366704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25051884|NCT00366704|Serotonin Agents|serotonin agents|mesh-ancestor
25051885|NCT00366704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25051886|NCT00366704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804384|NCT02002260|Estrogens|estrogens|mesh-ancestor
25051887|NCT00366704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465261|NCT00368498|Teicoplanin|teicoplanin|mesh-list
24465262|NCT00368498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24465263|NCT00368498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24465264|NCT00368589|Atorvastatin|atorvastatin|mesh-list
24465265|NCT00368589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24465266|NCT00368589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24465267|NCT00368589|Antimetabolites|antimetabolites|mesh-ancestor
24790600|NCT01943812|Progestins|progestins|mesh-ancestor
24465268|NCT00368589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465270|NCT00368589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24465273|NCT00368602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24465274|NCT00368602|Adrenergic Antagonists|adrenergic antagonists|mesh-list
24465275|NCT00368602|Adrenergic Agents|adrenergic agents|mesh-ancestor
25667454|NCT01706328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667455|NCT01706328|Tocolytic Agents|tocolytic agents|mesh-ancestor
25667456|NCT01706328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25667457|NCT01706575|Interferons|interferons|mesh-list
25667458|NCT01706575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465276|NCT00368602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24465277|NCT00368602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465278|NCT00368602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667459|NCT01706575|Antiviral Agents|antiviral agents|mesh-ancestor
25667460|NCT01706575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25667461|NCT01706588|Diclofenac|diclofenac|mesh-list
25861077|NCT00085228|Mitosis Modulators|mitosis modulators|mesh-ancestor
24465345|NCT00369044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465346|NCT00369044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25861078|NCT00085228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861079|NCT00085280|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25861080|NCT00085280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861081|NCT00085280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24802716|NCT01991873|Protective Agents|protective agents|mesh-ancestor
24802717|NCT01991873|Vitamin B Complex|vitamin b complex|mesh-ancestor
25861082|NCT00085280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24965401|NCT03777514|Micronutrients|micronutrients|mesh-ancestor
24465360|NCT00369239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24465361|NCT00369239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465398|NCT00369434|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24465400|NCT00369434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24465401|NCT00369434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465402|NCT00369434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25861083|NCT00085280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732837|NCT01641536|Entecavir|entecavir|mesh-list
25199333|NCT02741817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25043630|NCT01234025|Glucocorticoids|glucocorticoids|mesh-ancestor
24465432|NCT00369551|Mitosis Modulators|mitosis modulators|mesh-ancestor
25667462|NCT01706588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25667463|NCT01706588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25667464|NCT01706588|Analgesics|analgesics|mesh-ancestor
25667465|NCT01706588|Sensory System Agents|sensory system agents|mesh-ancestor
25667466|NCT01706588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25667467|NCT01706588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667468|NCT01706588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25667469|NCT01706588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25667470|NCT01706588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25861084|NCT00085306|Interferons|interferons|mesh-list
24790603|NCT01943942|Montelukast|montelukast|mesh-list
24790604|NCT01943942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24790605|NCT01943942|Respiratory System Agents|respiratory system agents|mesh-ancestor
25861088|NCT00085306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24465465|NCT00369798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465466|NCT00369811|Fentanyl|fentanyl|mesh-list
24465467|NCT00369811|Oxycodone|oxycodone|mesh-list
24465468|NCT00369811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24465469|NCT00369811|Narcotics|narcotics|mesh-ancestor
24802723|NCT01991951|Anticoagulants|anticoagulants|mesh-ancestor
24802724|NCT01992133|Vitamin D|vitamin d|mesh-list
24802725|NCT01992133|Cholecalciferol|cholecalciferol|mesh-list
24802726|NCT01992133|Vitamins|vitamins|mesh-ancestor
24802727|NCT01992133|Micronutrients|micronutrients|mesh-ancestor
24802728|NCT01992133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465516|NCT00369954|Antiviral Agents|antiviral agents|mesh-ancestor
24465517|NCT00369954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25861089|NCT00085306|Immunologic Factors|immunologic factors|mesh-ancestor
24802749|NCT01992198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24802770|NCT01992263|Micronutrients|micronutrients|mesh-ancestor
24597166|NCT00947388|Alemtuzumab|alemtuzumab|mesh-list
24802771|NCT01992263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802772|NCT01992263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24802773|NCT01992263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24802774|NCT01992328|Immunoglobulins|immunoglobulins|mesh-list
24803029|NCT01993979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24803030|NCT01993979|Antimetabolites|antimetabolites|mesh-ancestor
24803031|NCT01993979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803032|NCT01993979|Antiviral Agents|antiviral agents|mesh-ancestor
24803033|NCT01993979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24803034|NCT01993979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24803035|NCT01993979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24803036|NCT01993979|Immunologic Factors|immunologic factors|mesh-ancestor
24950245|NCT01883297|Analgesics|analgesics|mesh-ancestor
25861090|NCT00085306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861091|NCT00085332|Docetaxel|docetaxel|mesh-list
25861092|NCT00085332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861093|NCT00085332|Tubulin Modulators|tubulin modulators|mesh-ancestor
25861094|NCT00085332|Antimitotic Agents|antimitotic agents|mesh-ancestor
25861095|NCT00085332|Mitosis Modulators|mitosis modulators|mesh-ancestor
24590323|NCT00912119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24460568|NCT00348894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574590|NCT00826527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24466047|NCT00371696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24466048|NCT00371696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24466049|NCT00371696|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24466050|NCT00371696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466051|NCT00371696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466052|NCT00371735|Artesunate|artesunate|mesh-list
24466053|NCT00371735|Dapsone|dapsone|mesh-list
25199334|NCT02741817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733902|NCT01649479|Antibodies|antibodies|mesh-list
24803630|NCT01997658|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24803631|NCT01997658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24803632|NCT01997658|Prednisolone|prednisolone|mesh-list
24803633|NCT01997658|Prednisolone acetate|prednisolone acetate|mesh-list
24803634|NCT01997658|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24789316|NCT01936233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24789356|NCT01936532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24789357|NCT01936532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789392|NCT01937013|Oxytocin|oxytocin|mesh-list
24789393|NCT01937013|Oxytocics|oxytocics|mesh-ancestor
24789394|NCT01937013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24789395|NCT01937013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789396|NCT01937078|Famotidine|famotidine|mesh-list
24789397|NCT01937078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24789398|NCT01937078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24789399|NCT01937078|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24789400|NCT01937078|Histamine Antagonists|histamine antagonists|mesh-ancestor
24789401|NCT01937078|Histamine Agents|histamine agents|mesh-ancestor
24789402|NCT01937078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24789406|NCT01937104|Desflurane|desflurane|mesh-list
24803662|NCT01997788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24803663|NCT01997788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803665|NCT01997788|Sensory System Agents|sensory system agents|mesh-ancestor
24803666|NCT01997788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803668|NCT01997801|Analgesics|analgesics|mesh-ancestor
24803799|NCT01998685|Propofol|propofol|mesh-list
24803800|NCT01998685|Sevoflurane|sevoflurane|mesh-list
24803802|NCT01998685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24803803|NCT01998685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803804|NCT01998685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24803805|NCT01998685|Anesthetics, General|anesthetics, general|mesh-ancestor
24466241|NCT00372658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466244|NCT00372710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466245|NCT00372723|Infliximab|infliximab|mesh-list
24466246|NCT00372723|Dermatologic Agents|dermatologic agents|mesh-ancestor
24803964|NCT01999933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803966|NCT02000102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24803967|NCT02000102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24803968|NCT02000102|Growth Substances|growth substances|mesh-ancestor
24803969|NCT02000102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803970|NCT02000102|Growth Inhibitors|growth inhibitors|mesh-ancestor
24803971|NCT02000102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24803972|NCT02000193|Fulvestrant|fulvestrant|mesh-list
24803973|NCT02000193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24466247|NCT00372723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24803974|NCT02000193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24803975|NCT02000193|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24803976|NCT02000193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24803977|NCT02000193|Hormone Antagonists|hormone antagonists|mesh-ancestor
24466309|NCT00372892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24466310|NCT00372892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466311|NCT00372892|Immunologic Factors|immunologic factors|mesh-ancestor
24466312|NCT00372892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466313|NCT00372892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24466315|NCT00373048|Antimalarials|antimalarials|mesh-ancestor
24466316|NCT00373048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24804003|NCT02000336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24804004|NCT02000336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804005|NCT02000336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24804007|NCT02000375|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24804008|NCT02000375|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24804009|NCT02000375|Immunologic Factors|immunologic factors|mesh-ancestor
24804010|NCT02000375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804011|NCT02000388|Ketorolac|ketorolac|mesh-list
25667471|NCT01706588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25667472|NCT01706588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667473|NCT01706666|Dexamethasone|dexamethasone|mesh-list
25667474|NCT01706666|Cyclophosphamide|cyclophosphamide|mesh-list
25667475|NCT01706666|Lenalidomide|lenalidomide|mesh-list
25667476|NCT01706666|Bortezomib|bortezomib|mesh-list
25667477|NCT01706666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25667478|NCT01706666|Immunologic Factors|immunologic factors|mesh-ancestor
25667479|NCT01706666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667480|NCT01706666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25667481|NCT01706666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25667482|NCT01706666|Alkylating Agents|alkylating agents|mesh-ancestor
25667483|NCT01706666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667484|NCT01706666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25667485|NCT01706666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25861099|NCT00085345|Arsenic Trioxide|arsenic trioxide|mesh-list
24804012|NCT02000388|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24804013|NCT02000388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24804014|NCT02000388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24804015|NCT02000388|Analgesics|analgesics|mesh-ancestor
24466330|NCT00373126|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24466331|NCT00373126|Autonomic Agents|autonomic agents|mesh-ancestor
24466332|NCT00373126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24466333|NCT00373126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466334|NCT00373126|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24466335|NCT00373126|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24466336|NCT00373126|Cholinergic Agents|cholinergic agents|mesh-ancestor
24804070|NCT02000830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734466|NCT01652339|Amlodipine|amlodipine|mesh-list
24466371|NCT00373282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24466372|NCT00373282|Immunologic Factors|immunologic factors|mesh-ancestor
24466373|NCT00373282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199335|NCT02741817|Antipyretics|antipyretics|mesh-ancestor
25199336|NCT02741856|Paclitaxel|paclitaxel|mesh-list
24804278|NCT02001909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24804279|NCT02001909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24804280|NCT02001909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24804281|NCT02001909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804282|NCT02001935|Theophylline|theophylline|mesh-list
24804283|NCT02001935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24804284|NCT02001935|Autonomic Agents|autonomic agents|mesh-ancestor
24804285|NCT02001935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804286|NCT02001935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804287|NCT02001935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25088458|NCT04427904|Mydriatics|mydriatics|mesh-ancestor
24804381|NCT02002260|Contraceptives, Oral|contraceptives, oral|mesh-list
24804382|NCT02002260|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
24804383|NCT02002260|Estradiol|estradiol|mesh-list
24734750|NCT01653470|Vitamins|vitamins|mesh-ancestor
24804412|NCT02002325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24466448|NCT00373581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24466449|NCT00373581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804415|NCT02002377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25088525|NCT03854370|Povidone|povidone|mesh-list
24804688|NCT02004418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804690|NCT02004418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24804691|NCT02004418|Nootropic Agents|nootropic agents|mesh-ancestor
24804692|NCT02004509|Anticoagulants|anticoagulants|mesh-list
24804971|NCT02006277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804972|NCT02006277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24804974|NCT02006277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466900|NCT00375557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24735479|NCT01657240|Analgesics|analgesics|mesh-ancestor
24466906|NCT00375583|Anticestodal Agents|anticestodal agents|mesh-ancestor
24466907|NCT00375583|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24466908|NCT00375583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24998387|NCT02960646|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25667486|NCT01706666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25667487|NCT01706666|Antiemetics|antiemetics|mesh-ancestor
25667488|NCT01706666|Autonomic Agents|autonomic agents|mesh-ancestor
25667489|NCT01706666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25861100|NCT00085345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25861101|NCT00085345|Alkylating Agents|alkylating agents|mesh-ancestor
25861102|NCT00085345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861103|NCT00085345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861104|NCT00085345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25861105|NCT00085345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25861106|NCT00085345|Immunologic Factors|immunologic factors|mesh-ancestor
25861107|NCT00085345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861108|NCT00085345|Antioxidants|antioxidants|mesh-ancestor
25861109|NCT00085345|Protective Agents|protective agents|mesh-ancestor
24805231|NCT02008162|Parasympatholytics|parasympatholytics|mesh-ancestor
24805232|NCT02008162|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24805233|NCT02008162|Cholinergic Agents|cholinergic agents|mesh-ancestor
24805234|NCT02008162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24468342|NCT00381147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24468343|NCT00381147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24468344|NCT00381147|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24468345|NCT00381147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469278|NCT00385359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24469279|NCT00385359|Respiratory System Agents|respiratory system agents|mesh-ancestor
24469281|NCT00385359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24908562|NCT04319549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908563|NCT04319549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908564|NCT04319549|Disinfectants|disinfectants|mesh-ancestor
24908565|NCT04319549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24908567|NCT04319289|Ergocalciferols|ergocalciferols|mesh-list
24908568|NCT04319289|Cholecalciferol|cholecalciferol|mesh-list
24908569|NCT04319289|Vitamins|vitamins|mesh-list
24908570|NCT04319289|Micronutrients|micronutrients|mesh-ancestor
24911931|NCT04283058|Sensory System Agents|sensory system agents|mesh-ancestor
25109252|NCT03126461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25109253|NCT03126461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109254|NCT03126461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24917810|NCT04225611|Dexamethasone|dexamethasone|mesh-list
24492660|NCT00487175|Tramadol|tramadol|mesh-list
25051925|NCT00364247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25051927|NCT00363636|Rituximab|rituximab|mesh-list
24950457|NCT03915938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24950458|NCT03915938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24950459|NCT03915938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24950461|NCT03915366|Valganciclovir|valganciclovir|mesh-list
24924658|NCT04158388|Antidepressive Agents|antidepressive agents|mesh-ancestor
24924659|NCT04158388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24924660|NCT04158349|Oxaliplatin|oxaliplatin|mesh-list
24924661|NCT04158349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924662|NCT04157803|Acetic Acid|acetic acid|mesh-list
24924663|NCT04157803|Retinol acetate|retinol acetate|mesh-list
24924664|NCT04157803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24924665|NCT04157803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24924666|NCT04157803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24924667|NCT04157803|Immunologic Factors|immunologic factors|mesh-ancestor
24500411|NCT00524160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24500412|NCT00524160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24500414|NCT00524160|Anesthetics|anesthetics|mesh-ancestor
25861110|NCT00085345|Vitamins|vitamins|mesh-ancestor
25861111|NCT00085345|Micronutrients|micronutrients|mesh-ancestor
24624296|NCT01075581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24624297|NCT01075581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24624298|NCT01075581|Respiratory System Agents|respiratory system agents|mesh-ancestor
24624299|NCT01075581|Mydriatics|mydriatics|mesh-ancestor
24624300|NCT01075581|Sympathomimetics|sympathomimetics|mesh-ancestor
24624301|NCT01075581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24624302|NCT01075659|Nicotine|nicotine|mesh-list
24787510|NCT01925729|Pseudoephedrine|pseudoephedrine|mesh-list
24787511|NCT01925729|Oxymetazoline|oxymetazoline|mesh-list
24787512|NCT01925729|Ephedrine|ephedrine|mesh-list
24787513|NCT01925729|Histamine|histamine|mesh-list
24787514|NCT01925729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24787515|NCT01925729|Autonomic Agents|autonomic agents|mesh-ancestor
24787516|NCT01925729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24787517|NCT01925729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787518|NCT01925729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25667490|NCT01706666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25667491|NCT01706666|Glucocorticoids|glucocorticoids|mesh-ancestor
25667492|NCT01706666|Hormones|hormones|mesh-ancestor
25270496|NCT02404142|Curare|curare|mesh-list
25674426|NCT01772134|Adrenergic Agents|adrenergic agents|mesh-ancestor
24787525|NCT01925729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24787526|NCT01925729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787527|NCT01925729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24787528|NCT01925729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25199337|NCT02741856|Carboplatin|carboplatin|mesh-list
25199338|NCT02741856|Capecitabine|capecitabine|mesh-list
24787529|NCT01925729|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24787530|NCT01925729|Mydriatics|mydriatics|mesh-ancestor
24787531|NCT01925729|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24787532|NCT01925729|Protective Agents|protective agents|mesh-ancestor
24747023|NCT02203773|Decitabine|decitabine|mesh-list
24932487|NCT04079088|Interferons|interferons|mesh-list
24932488|NCT04079088|Interferon-beta|interferon-beta|mesh-list
24932489|NCT04079088|Glatiramer Acetate|glatiramer acetate|mesh-list
24932491|NCT04079088|Interferon beta-1b|interferon beta-1b|mesh-list
24932492|NCT04079088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24932493|NCT04079088|Antiviral Agents|antiviral agents|mesh-ancestor
24932494|NCT04079088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24932528|NCT04078659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24932529|NCT04078659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932530|NCT04078659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24932531|NCT04078659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24932532|NCT04078659|Anesthetics, General|anesthetics, general|mesh-ancestor
24932533|NCT04078659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24932534|NCT04078659|Narcotics|narcotics|mesh-ancestor
24508900|NCT00557700|Respiratory System Agents|respiratory system agents|mesh-ancestor
24932594|NCT04077827|Desflurane|desflurane|mesh-list
24932595|NCT04077827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24932596|NCT04077827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24932597|NCT04077827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932598|NCT04077827|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24670881|NCT01457781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24670882|NCT01457781|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24670883|NCT01457781|Vasodilator Agents|vasodilator agents|mesh-ancestor
24670885|NCT01457781|Protective Agents|protective agents|mesh-ancestor
24456602|NCT00331786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24456603|NCT00331786|Respiratory System Agents|respiratory system agents|mesh-ancestor
24456604|NCT00331786|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24456605|NCT00331786|Antioxidants|antioxidants|mesh-ancestor
24456606|NCT00331786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24748073|NCT02973321|Metformin|metformin|mesh-list
25861112|NCT00085358|Paclitaxel|paclitaxel|mesh-list
25861113|NCT00085358|Docetaxel|docetaxel|mesh-list
24403865|NCT00161759|Thrombin|thrombin|mesh-list
24403871|NCT00161837|Vaccines|vaccines|mesh-list
24455492|NCT00327522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25861114|NCT00085358|Bevacizumab|bevacizumab|mesh-list
25861115|NCT00085358|Carboplatin|carboplatin|mesh-list
25861116|NCT00085358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25861117|NCT00085358|Antibodies|antibodies|mesh-list
25861118|NCT00085358|Immunoglobulins|immunoglobulins|mesh-list
25861119|NCT00085358|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25861120|NCT00085358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25861121|NCT00085358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861122|NCT00085358|Tubulin Modulators|tubulin modulators|mesh-ancestor
24469470|NCT00385970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25091420|NCT03249025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25005020|NCT05170893|Vitamins|vitamins|mesh-ancestor
25005021|NCT05074121|Acetylcysteine|acetylcysteine|mesh-list
25861123|NCT00085358|Antimitotic Agents|antimitotic agents|mesh-ancestor
25005091|NCT04931641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861124|NCT00085358|Mitosis Modulators|mitosis modulators|mesh-ancestor
24789912|NCT01939691|Nepafenac|nepafenac|mesh-list
24789913|NCT01939691|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24789914|NCT01939691|Prednisolone phosphate|prednisolone phosphate|mesh-list
24789926|NCT01939691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25005092|NCT04878627|Cannabidiol|cannabidiol|mesh-list
25005093|NCT04878627|Anticonvulsants|anticonvulsants|mesh-ancestor
25005094|NCT04872426|Insulin|insulin|mesh-list
25005095|NCT04872426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25005096|NCT04872426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005097|NCT04856176|Paclitaxel|paclitaxel|mesh-list
25005098|NCT04856176|Carboplatin|carboplatin|mesh-list
25005099|NCT04856176|Pembrolizumab|pembrolizumab|mesh-list
25005100|NCT04856176|Pemetrexed|pemetrexed|mesh-list
25005246|NCT04364048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25005247|NCT04364048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005248|NCT04364048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25005249|NCT04364048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25005271|NCT04324606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005273|NCT04324606|Analgesics|analgesics|mesh-ancestor
25005274|NCT04324606|Sensory System Agents|sensory system agents|mesh-ancestor
25005275|NCT04324606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25005276|NCT04324606|Antipyretics|antipyretics|mesh-ancestor
25005277|NCT04320940|Phenobarbital|phenobarbital|mesh-list
25005278|NCT04320940|Anticonvulsants|anticonvulsants|mesh-ancestor
25005279|NCT04320940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25092079|NCT03244930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24526825|NCT00613457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24526827|NCT00613457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526828|NCT00613457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526829|NCT00613457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24526830|NCT00613457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24526831|NCT00613457|Antiemetics|antiemetics|mesh-ancestor
24526832|NCT00613457|Autonomic Agents|autonomic agents|mesh-ancestor
24702737|NCT01467414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702739|NCT01467518|Methadone|methadone|mesh-list
24702740|NCT01467518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24702741|NCT01467518|Narcotics|narcotics|mesh-ancestor
24791173|NCT05068063|Bupivacaine|bupivacaine|mesh-list
24713634|NCT01526850|Cyclosporins|cyclosporins|mesh-list
24555918|NCT00744224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24555919|NCT00744224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24555920|NCT00744224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24555921|NCT00744224|Protective Agents|protective agents|mesh-ancestor
24702742|NCT01467518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24702743|NCT01467518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702744|NCT01467518|Analgesics|analgesics|mesh-ancestor
24702745|NCT01467518|Sensory System Agents|sensory system agents|mesh-ancestor
24702746|NCT01467518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24702747|NCT01467518|Antitussive Agents|antitussive agents|mesh-ancestor
24702748|NCT01467518|Respiratory System Agents|respiratory system agents|mesh-ancestor
24702749|NCT01467518|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24702750|NCT01467518|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24703159|NCT01470040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754761|NCT01722630|Dopamine Agents|dopamine agents|mesh-ancestor
25092413|NCT03241875|Antimanic Agents|antimanic agents|mesh-ancestor
24707450|NCT01495910|Hormone Antagonists|hormone antagonists|mesh-ancestor
24707958|NCT01498939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24708096|NCT01499953|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24708098|NCT01499953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24708099|NCT01499953|Protease Inhibitors|protease inhibitors|mesh-ancestor
24708100|NCT01499953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708101|NCT01499953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708102|NCT01499953|Anticoagulants|anticoagulants|mesh-ancestor
24708103|NCT01499953|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24708117|NCT01500018|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24708118|NCT01500018|Anesthetics, General|anesthetics, general|mesh-ancestor
24708119|NCT01500018|Anesthetics|anesthetics|mesh-ancestor
24708120|NCT01500018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25005726|NCT02796261|Lomustine|lomustine|mesh-list
25005727|NCT02796261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25005728|NCT02796261|Alkylating Agents|alkylating agents|mesh-ancestor
24868618|NCT04093752|Insulin Glargine|insulin glargine|mesh-list
24614097|NCT01022528|BB 1101|bb 1101|mesh-list
24614098|NCT01022528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25667493|NCT01706666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25667494|NCT01706666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25667495|NCT01706666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24755749|NCT01728922|Vitamin D|vitamin d|mesh-list
25861125|NCT00085358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861126|NCT00085358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25082455|NCT03322488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25005789|NCT02560805|Nitroprusside|nitroprusside|mesh-list
25005790|NCT02560805|Phenylephrine|phenylephrine|mesh-list
25005791|NCT02560805|Oxymetazoline|oxymetazoline|mesh-list
25005792|NCT02560805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25005793|NCT02560805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24614231|NCT01023087|Antitubercular Agents|antitubercular agents|mesh-ancestor
24710424|NCT01510522|Metformin|metformin|mesh-list
25092627|NCT03240471|Calpastatin|calpastatin|mesh-list
24710938|NCT01512459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24710939|NCT01512459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044634|NCT01069692|Hematinics|hematinics|mesh-ancestor
24711353|NCT01514838|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24711355|NCT01514851|Calcium|calcium|mesh-list
24711356|NCT01514851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24711357|NCT01514851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711358|NCT01514851|Antacids|antacids|mesh-ancestor
24711359|NCT01514851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711360|NCT01514851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24497779|NCT00511849|Paclitaxel|paclitaxel|mesh-list
24711561|NCT01515839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713027|NCT01523574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24713028|NCT01523574|Antioxidants|antioxidants|mesh-ancestor
24713029|NCT01523574|Protective Agents|protective agents|mesh-ancestor
24713030|NCT01523639|Metformin|metformin|mesh-list
24557461|NCT00752635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713031|NCT01523639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24713032|NCT01523639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713033|NCT01523678|Paclitaxel|paclitaxel|mesh-list
24713034|NCT01523678|Carboplatin|carboplatin|mesh-list
24713065|NCT01524068|Rituximab|rituximab|mesh-list
25092781|NCT03239080|Denosumab|denosumab|mesh-list
24713533|NCT01526460|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24713534|NCT01526460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24713535|NCT01526460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24713536|NCT01526460|Antimetabolites|antimetabolites|mesh-ancestor
24713537|NCT01526460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713538|NCT01526460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24713539|NCT01526460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24713540|NCT01526460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24713631|NCT01526837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713636|NCT01526850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24713637|NCT01526850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713669|NCT01526980|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24713670|NCT01526980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24713671|NCT01526980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713672|NCT01527019|Cephalosporins|cephalosporins|mesh-list
24713673|NCT01527019|Norfloxacin|norfloxacin|mesh-list
24713674|NCT01527019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24713675|NCT01527019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24713676|NCT01527019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24713677|NCT01527019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24713844|NCT01527747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713845|NCT01527747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24713846|NCT01527747|Protease Inhibitors|protease inhibitors|mesh-ancestor
24713847|NCT01527747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24713848|NCT01527747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713875|NCT01527890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24713877|NCT01527890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24713878|NCT01527890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713879|NCT01527890|Analgesics|analgesics|mesh-ancestor
24713880|NCT01527890|Sensory System Agents|sensory system agents|mesh-ancestor
24713881|NCT01527890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24713882|NCT01527890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24713883|NCT01527890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24713884|NCT01527890|Anesthetics, General|anesthetics, general|mesh-ancestor
24614723|NCT01026116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667496|NCT01706666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25667497|NCT01706666|Growth Substances|growth substances|mesh-ancestor
25667498|NCT01706666|Growth Inhibitors|growth inhibitors|mesh-ancestor
24790079|NCT01940653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628090|NCT01096511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614724|NCT01026116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25051934|NCT00361582|Tapentadol|tapentadol|mesh-list
24614725|NCT01026116|Immunologic Factors|immunologic factors|mesh-ancestor
24614726|NCT01026116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614727|NCT01026116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24788892|NCT01934569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24788893|NCT01934569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24788894|NCT01934569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24788895|NCT01934569|Purinergic Agents|purinergic agents|mesh-ancestor
24788896|NCT01934569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24788897|NCT01934569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24788898|NCT01934569|Antimetabolites|antimetabolites|mesh-ancestor
24788899|NCT01934569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25199339|NCT02741856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25044771|NCT01038739|Mesalamine|mesalamine|mesh-list
24788900|NCT01934569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24788901|NCT01934634|Gemcitabine|gemcitabine|mesh-list
24788903|NCT01934634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24788904|NCT01934634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24788905|NCT01934634|Tubulin Modulators|tubulin modulators|mesh-ancestor
24788906|NCT01934634|Antimitotic Agents|antimitotic agents|mesh-ancestor
24788907|NCT01934634|Mitosis Modulators|mitosis modulators|mesh-ancestor
24788908|NCT01934634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788909|NCT01934634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24788910|NCT01934634|Antimetabolites|antimetabolites|mesh-ancestor
24788911|NCT01934634|Antiviral Agents|antiviral agents|mesh-ancestor
24714142|NCT01529190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714160|NCT01529229|Respiratory System Agents|respiratory system agents|mesh-ancestor
24714161|NCT01529229|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24714162|NCT01529229|Cholinergic Agents|cholinergic agents|mesh-ancestor
24714163|NCT01529229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24714164|NCT01529229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714165|NCT01529229|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24714166|NCT01529229|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24714167|NCT01529229|Histamine Antagonists|histamine antagonists|mesh-ancestor
24714168|NCT01529229|Histamine Agents|histamine agents|mesh-ancestor
24714169|NCT01529242|Prednisolone|prednisolone|mesh-list
24714170|NCT01529242|Betamethasone|betamethasone|mesh-list
24714171|NCT01529242|Desloratadine|desloratadine|mesh-list
24714172|NCT01529242|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
25092961|NCT03237637|Adrenergic Agents|adrenergic agents|mesh-ancestor
24714531|NCT01531166|Interferon alpha-2|interferon alpha-2|mesh-list
24714532|NCT01531166|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24714533|NCT01531166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24714534|NCT01531166|Antiviral Agents|antiviral agents|mesh-ancestor
24714602|NCT01531582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715351|NCT01536028|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24716422|NCT01541475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716660|NCT01543035|Antiviral Agents|antiviral agents|mesh-ancestor
24716661|NCT01543035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24716662|NCT01543061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24716663|NCT01543061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24716664|NCT01543139|Valproic Acid|valproic acid|mesh-list
24716665|NCT01543139|Anticonvulsants|anticonvulsants|mesh-ancestor
24716666|NCT01543139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716667|NCT01543139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716668|NCT01543139|GABA Agents|gaba agents|mesh-ancestor
24716669|NCT01543139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24716670|NCT01543139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716671|NCT01543139|Antimanic Agents|antimanic agents|mesh-ancestor
25861127|NCT00085358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24615101|NCT01027923|Antiviral Agents|antiviral agents|mesh-ancestor
24789095|NCT01935531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24789096|NCT01935531|Analgesics|analgesics|mesh-ancestor
24789097|NCT01935531|Sensory System Agents|sensory system agents|mesh-ancestor
24789098|NCT01935531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24789099|NCT01935531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789100|NCT01935531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24716836|NCT01544192|Vitamin E|vitamin e|mesh-list
24716837|NCT01544192|Tocotrienols|tocotrienols|mesh-list
24716838|NCT01544192|alpha-Tocopherol|alpha-tocopherol|mesh-list
25667499|NCT01706926|Mavrilimumab|mavrilimumab|mesh-list
25667500|NCT01706926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24716839|NCT01544192|Antioxidants|antioxidants|mesh-list
24582778|NCT00871533|Interferon-alpha|interferon-alpha|mesh-list
24582779|NCT00871533|Interferon alpha-2|interferon alpha-2|mesh-list
24582780|NCT00871533|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
24582781|NCT00871533|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24582782|NCT00871533|Antiviral Agents|antiviral agents|mesh-ancestor
24582783|NCT00871533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24582784|NCT00871533|Immunologic Factors|immunologic factors|mesh-ancestor
24582785|NCT00871533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474687|NCT00407017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24716969|NCT01544842|Tacrolimus|tacrolimus|mesh-list
24716970|NCT01544842|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24717320|NCT01547221|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24717321|NCT01547221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25006107|NCT05205317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25006108|NCT05205317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950731|NCT03912740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25006110|NCT05205200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25006111|NCT05205200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789165|NCT01935778|Docetaxel|docetaxel|mesh-list
24717721|NCT01549574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24717722|NCT01549574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24717723|NCT01549574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717724|NCT01549574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861128|NCT00085358|Growth Substances|growth substances|mesh-ancestor
25199340|NCT02741856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044893|NCT01023880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717735|NCT01549691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24717736|NCT01549691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24717737|NCT01549691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24717738|NCT01549691|GABA Modulators|gaba modulators|mesh-ancestor
24717739|NCT01549691|GABA Agents|gaba agents|mesh-ancestor
24717740|NCT01549691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24717847|NCT01550354|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24717849|NCT01550354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24717850|NCT01550354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24717851|NCT01550354|Narcotics|narcotics|mesh-ancestor
24717852|NCT01550354|Analgesics|analgesics|mesh-ancestor
24717853|NCT01550354|Sensory System Agents|sensory system agents|mesh-ancestor
24717854|NCT01550419|Atorvastatin|atorvastatin|mesh-list
24717855|NCT01550419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24717856|NCT01550419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24718189|NCT01552798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24718190|NCT01552798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718191|NCT01552798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24718192|NCT01552798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24718193|NCT01552798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24718194|NCT01552798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24718195|NCT01552798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718734|NCT01556815|Chlorotrianisene|chlorotrianisene|mesh-list
24718735|NCT01556815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718736|NCT01556815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24718737|NCT01556815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718772|NCT01557140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718808|NCT01557270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24950769|NCT03912415|Growth Inhibitors|growth inhibitors|mesh-ancestor
24718862|NCT01557478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24718864|NCT01557634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24718865|NCT01557634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718866|NCT01557647|Treprostinil|treprostinil|mesh-list
24718867|NCT01557647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24718868|NCT01557660|Treprostinil|treprostinil|mesh-list
24718869|NCT01557660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24718870|NCT01557712|Ketamine|ketamine|mesh-list
24718918|NCT01557829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718919|NCT01557907|Insulin|insulin|mesh-list
24789206|NCT01935830|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24789207|NCT01935830|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25093339|NCT03235609|Fentanyl|fentanyl|mesh-list
25667501|NCT01706926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25667502|NCT01706926|Immunologic Factors|immunologic factors|mesh-ancestor
25667503|NCT01706926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667504|NCT01706952|Epinephrine|epinephrine|mesh-list
25667505|NCT01706952|Racepinephrine|racepinephrine|mesh-list
25667506|NCT01706952|Cocaine|cocaine|mesh-list
25667507|NCT01706952|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25667508|NCT01706952|Epinephryl borate|epinephryl borate|mesh-list
24615320|NCT01028781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24790484|NCT01943058|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25861129|NCT00085358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720312|NCT01567657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24720313|NCT01567657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720314|NCT01567657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24720557|NCT01569113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24720559|NCT01569113|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
24720560|NCT01569113|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24720561|NCT01569113|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24615385|NCT01029275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24615452|NCT01029769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24615454|NCT01029769|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24615455|NCT01029769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24615456|NCT01029769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25861130|NCT00085358|Growth Inhibitors|growth inhibitors|mesh-ancestor
24721008|NCT01571882|Policosanol|policosanol|mesh-list
24721009|NCT01571882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24721010|NCT01571882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24721011|NCT01571882|Antimetabolites|antimetabolites|mesh-ancestor
24789336|NCT01936532|Dexamethasone|dexamethasone|mesh-list
24789337|NCT01936532|Lenalidomide|lenalidomide|mesh-list
24789338|NCT01936532|Ixazomib|ixazomib|mesh-list
24789339|NCT01936532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24789340|NCT01936532|Antiemetics|antiemetics|mesh-ancestor
24789341|NCT01936532|Autonomic Agents|autonomic agents|mesh-ancestor
24789342|NCT01936532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24789343|NCT01936532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199341|NCT02741856|Tubulin Modulators|tubulin modulators|mesh-ancestor
24789344|NCT01936532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24950794|NCT03911648|Lidocaine|lidocaine|mesh-list
24789345|NCT01936532|Glucocorticoids|glucocorticoids|mesh-ancestor
24721955|NCT01578161|Adrenergic Agents|adrenergic agents|mesh-ancestor
24721956|NCT01578161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24721957|NCT01578161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721987|NCT01578252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24721988|NCT01578252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721990|NCT01578252|Antipruritics|antipruritics|mesh-ancestor
24722435|NCT01580501|Tadalafil|tadalafil|mesh-list
24722436|NCT01580501|Vasodilator Agents|vasodilator agents|mesh-ancestor
24722437|NCT01580501|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24722438|NCT01580501|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24722439|NCT01580501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722440|NCT01580501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722441|NCT01580501|Urological Agents|urological agents|mesh-ancestor
24722442|NCT01580514|Exenatide|exenatide|mesh-list
24722443|NCT01580514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24722468|NCT01580865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24722469|NCT01580865|Immunologic Factors|immunologic factors|mesh-ancestor
24647231|NCT01207128|Voriconazole|voriconazole|mesh-list
24722470|NCT01580865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722471|NCT01580865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24722478|NCT01580865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24722479|NCT01580865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24722480|NCT01580878|Butenafine|butenafine|mesh-list
24722481|NCT01580878|Clotrimazole|clotrimazole|mesh-list
24722482|NCT01580878|Antifungal Agents|antifungal agents|mesh-ancestor
24722483|NCT01580878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24722484|NCT01580878|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24722485|NCT01580878|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24722486|NCT01580878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24722487|NCT01580878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722488|NCT01580878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950828|NCT03911271|Atropine|atropine|mesh-list
24722489|NCT01580878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24722490|NCT01580878|Hormone Antagonists|hormone antagonists|mesh-ancestor
24722491|NCT01580878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24722492|NCT01580878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722493|NCT01580891|Naftifine|naftifine|mesh-list
24722494|NCT01580891|Antifungal Agents|antifungal agents|mesh-ancestor
24722495|NCT01580891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24722496|NCT01580943|Chlorhexidine|chlorhexidine|mesh-list
24722497|NCT01580943|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24722498|NCT01580943|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25667509|NCT01706952|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24948310|NCT03920644|Mydriatics|mydriatics|mesh-ancestor
25082509|NCT03322098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082510|NCT03322098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25082511|NCT03322098|Respiratory System Agents|respiratory system agents|mesh-ancestor
25082512|NCT03322098|Mydriatics|mydriatics|mesh-ancestor
25082513|NCT03322098|Parasympatholytics|parasympatholytics|mesh-ancestor
25082514|NCT03322098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25082515|NCT03322098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25082516|NCT03322098|Cholinergic Agents|cholinergic agents|mesh-ancestor
25082517|NCT03322098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25082518|NCT03322098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802679|NCT01991574|Calcium|calcium|mesh-list
24802686|NCT01991587|Vaccines|vaccines|mesh-list
24790665|NCT01944176|Simvastatin|simvastatin|mesh-list
24790721|NCT01944683|Midazolam|midazolam|mesh-list
25861131|NCT00085358|Immunologic Factors|immunologic factors|mesh-ancestor
25006374|NCT05125523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006375|NCT05124678|Isoniazid|isoniazid|mesh-list
25006376|NCT05124678|Antitubercular Agents|antitubercular agents|mesh-ancestor
25006377|NCT05124678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25093608|NCT03233893|Calcium, Dietary|calcium, dietary|mesh-list
24722865|NCT01583036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722867|NCT01583036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24722869|NCT01583062|Clavulanic Acids|clavulanic acids|mesh-list
24722870|NCT01583062|Clavulanic Acid|clavulanic acid|mesh-list
24722871|NCT01583062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25861132|NCT00085384|Interferons|interferons|mesh-list
24722897|NCT01583426|Antimitotic Agents|antimitotic agents|mesh-ancestor
24722898|NCT01583426|Mitosis Modulators|mitosis modulators|mesh-ancestor
24722899|NCT01583426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722901|NCT01583439|Lopinavir|lopinavir|mesh-list
24722902|NCT01583439|Tenofovir|tenofovir|mesh-list
24722903|NCT01583439|Lamivudine|lamivudine|mesh-list
24722904|NCT01583439|Zidovudine|zidovudine|mesh-list
24722905|NCT01583439|Emtricitabine|emtricitabine|mesh-list
24722906|NCT01583439|Efavirenz|efavirenz|mesh-list
24722907|NCT01583439|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24722908|NCT01583439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24722909|NCT01583439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24722910|NCT01583439|Protease Inhibitors|protease inhibitors|mesh-ancestor
24722911|NCT01583439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24723263|NCT01586286|Nifedipine|nifedipine|mesh-list
24723264|NCT01586286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24723265|NCT01586286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25045085|NCT01001338|Renal Agents|renal agents|mesh-ancestor
24723266|NCT01586286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723267|NCT01586286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24723268|NCT01586286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723269|NCT01586286|Vasodilator Agents|vasodilator agents|mesh-ancestor
24723521|NCT01587638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723522|NCT01587638|Antioxidants|antioxidants|mesh-ancestor
24723523|NCT01587638|Protective Agents|protective agents|mesh-ancestor
24723524|NCT01587638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24723525|NCT01587638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24723526|NCT01587638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24723527|NCT01587638|Vasodilator Agents|vasodilator agents|mesh-ancestor
24723528|NCT01587638|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24723529|NCT01587638|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25861133|NCT00085384|Interferon-alpha|interferon-alpha|mesh-list
24723709|NCT01588847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24723710|NCT01588847|Narcotics|narcotics|mesh-ancestor
24615770|NCT01031732|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24723816|NCT01589354|Anesthetics, Local|anesthetics, local|mesh-ancestor
25667510|NCT01706952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25667511|NCT01706952|Adrenergic Agents|adrenergic agents|mesh-ancestor
25667512|NCT01706952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25667513|NCT01706952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667514|NCT01706952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667515|NCT01706952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25667516|NCT01706952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25667517|NCT01706952|Autonomic Agents|autonomic agents|mesh-ancestor
25667518|NCT01706952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25667519|NCT01706952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25667520|NCT01706952|Respiratory System Agents|respiratory system agents|mesh-ancestor
25667521|NCT01706952|Mydriatics|mydriatics|mesh-ancestor
25667522|NCT01706952|Sympathomimetics|sympathomimetics|mesh-ancestor
25667523|NCT01706952|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25861134|NCT00085384|Interferon alpha-2|interferon alpha-2|mesh-list
24790877|NCT01945801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24790878|NCT01945801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790879|NCT01945801|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24790880|NCT01945801|Hormone Antagonists|hormone antagonists|mesh-ancestor
24790881|NCT01945801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24790882|NCT01945801|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24723817|NCT01589354|Anesthetics|anesthetics|mesh-ancestor
24723818|NCT01589354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24723842|NCT01589419|Antimetabolites|antimetabolites|mesh-ancestor
24723843|NCT01589419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723844|NCT01589419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24723845|NCT01589419|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24723846|NCT01589419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24723847|NCT01589432|Lidocaine|lidocaine|mesh-list
24723848|NCT01589432|Anesthetics, Local|anesthetics, local|mesh-ancestor
24723984|NCT01590342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24647816|NCT01210911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723986|NCT01590342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723988|NCT01590537|Levonorgestrel|levonorgestrel|mesh-list
24723989|NCT01590537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24723990|NCT01590537|Contraceptive Agents|contraceptive agents|mesh-ancestor
24950926|NCT03910088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24950927|NCT03910088|Purinergic Agents|purinergic agents|mesh-ancestor
24950928|NCT03910088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576862|NCT00840684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576863|NCT00840684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24576864|NCT00840684|Alkylating Agents|alkylating agents|mesh-ancestor
24576865|NCT00840684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24576866|NCT00840684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24723991|NCT01590537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24723992|NCT01590537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723993|NCT01590537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24397308|NCT00141336|Sensory System Agents|sensory system agents|mesh-ancestor
24724041|NCT01590732|Mitosis Modulators|mitosis modulators|mesh-ancestor
24724042|NCT01590732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24724043|NCT01590823|Dabigatran|dabigatran|mesh-list
24615826|NCT01032057|Immunologic Factors|immunologic factors|mesh-ancestor
24615827|NCT01032057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615828|NCT01032083|Citalopram|citalopram|mesh-list
24615829|NCT01032083|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24724131|NCT01591148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724133|NCT01591148|Anesthetics, General|anesthetics, general|mesh-ancestor
24724134|NCT01591148|Anesthetics|anesthetics|mesh-ancestor
24724136|NCT01591226|Caffeine|caffeine|mesh-list
24724172|NCT01591421|Panitumumab|panitumumab|mesh-list
24724173|NCT01591421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24724174|NCT01591421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24724175|NCT01591434|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24724205|NCT01591850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24724206|NCT01591850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24724207|NCT01591850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24724208|NCT01591850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24724209|NCT01591850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24724210|NCT01591850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24724211|NCT01591850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24724253|NCT01592019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24724254|NCT01592019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25093875|NCT03230851|Aspirin|aspirin|mesh-list
24724340|NCT01592227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24724341|NCT01592227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199342|NCT02741856|Antimitotic Agents|antimitotic agents|mesh-ancestor
25045337|NCT00966953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24724342|NCT01592227|Antipyretics|antipyretics|mesh-ancestor
25667524|NCT01706952|Anesthetics, Local|anesthetics, local|mesh-ancestor
25667525|NCT01706952|Anesthetics|anesthetics|mesh-ancestor
25667526|NCT01706952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25667527|NCT01706952|Sensory System Agents|sensory system agents|mesh-ancestor
25667528|NCT01706952|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25667529|NCT01706952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25667530|NCT01706952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25667531|NCT01706952|Dopamine Agents|dopamine agents|mesh-ancestor
25214239|NCT02436707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25214240|NCT02436707|Immunologic Factors|immunologic factors|mesh-ancestor
24948318|NCT03920605|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24948319|NCT03920605|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24773604|NCT01840813|Misoprostol|misoprostol|mesh-list
24948320|NCT03920605|Antiviral Agents|antiviral agents|mesh-ancestor
24948321|NCT03920605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25861135|NCT00085384|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25861136|NCT00085384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861137|NCT00085384|Antiviral Agents|antiviral agents|mesh-ancestor
25861138|NCT00085384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25861139|NCT00085384|Immunologic Factors|immunologic factors|mesh-ancestor
25861140|NCT00085384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861141|NCT00085449|Cyclosporine|cyclosporine|mesh-list
25861142|NCT00085449|Mycophenolic Acid|mycophenolic acid|mesh-list
25861143|NCT00085449|Fludarabine|fludarabine|mesh-list
25667532|NCT01707004|Vidarabine|vidarabine|mesh-list
24724343|NCT01592253|Sirolimus|sirolimus|mesh-list
24724344|NCT01592253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24724345|NCT01592253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24724346|NCT01592253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24791405|NCT04487990|Anticoagulants|anticoagulants|mesh-ancestor
24791406|NCT04487990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24560775|NCT01451515|Mercaptopurine|mercaptopurine|mesh-list
24560776|NCT01451515|Clofarabine|clofarabine|mesh-list
24560777|NCT01451515|Pegaspargase|pegaspargase|mesh-list
24560778|NCT01451515|Thioguanine|thioguanine|mesh-list
24560779|NCT01451515|Antimetabolites|antimetabolites|mesh-list
25006486|NCT04984330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006487|NCT04984330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25006488|NCT04984330|Glucocorticoids|glucocorticoids|mesh-ancestor
24724578|NCT01593605|Resveratrol|resveratrol|mesh-list
24724579|NCT01593605|Antioxidants|antioxidants|mesh-ancestor
24724580|NCT01593605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724581|NCT01593605|Protective Agents|protective agents|mesh-ancestor
24724582|NCT01593605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724583|NCT01593605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724744|NCT01594489|Respiratory System Agents|respiratory system agents|mesh-ancestor
24724745|NCT01594489|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24724746|NCT01594489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24724747|NCT01594489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724748|NCT01594489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724749|NCT01594489|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24724750|NCT01594489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24724769|NCT01594619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724770|NCT01594619|Vasodilator Agents|vasodilator agents|mesh-ancestor
24724771|NCT01594619|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24725012|NCT01595984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24725013|NCT01595984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24725014|NCT01595984|Antitubercular Agents|antitubercular agents|mesh-ancestor
24789594|NCT01938092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24789595|NCT01938092|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24789596|NCT01938092|Anesthetics, General|anesthetics, general|mesh-ancestor
24789597|NCT01938092|Anesthetics|anesthetics|mesh-ancestor
24616001|NCT01033409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616003|NCT01033461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24616004|NCT01033461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616005|NCT01033500|Abatacept|abatacept|mesh-list
25667533|NCT01707004|Mycophenolic Acid|mycophenolic acid|mesh-list
25667534|NCT01707004|Cyclophosphamide|cyclophosphamide|mesh-list
25667535|NCT01707004|Busulfan|busulfan|mesh-list
25667536|NCT01707004|Fludarabine|fludarabine|mesh-list
25667537|NCT01707004|Fludarabine phosphate|fludarabine phosphate|mesh-list
25667538|NCT01707004|Azacitidine|azacitidine|mesh-list
25667539|NCT01707004|Decitabine|decitabine|mesh-list
25667540|NCT01707004|Tacrolimus|tacrolimus|mesh-list
25667541|NCT01707004|Lenograstim|lenograstim|mesh-list
25667542|NCT01707004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25667543|NCT01707004|Immunologic Factors|immunologic factors|mesh-ancestor
25667544|NCT01707004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667545|NCT01707004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25667546|NCT01707004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25667547|NCT01707004|Alkylating Agents|alkylating agents|mesh-ancestor
25667548|NCT01707004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725536|NCT01598051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725537|NCT01598051|Anticoagulants|anticoagulants|mesh-ancestor
24725538|NCT01598168|Rivaroxaban|rivaroxaban|mesh-list
25214254|NCT02436707|Glucocorticoids|glucocorticoids|mesh-ancestor
25214255|NCT02436707|Hormones|hormones|mesh-ancestor
25214256|NCT02436707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25214257|NCT02436707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25214258|NCT02436707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25214259|NCT02436707|Antimetabolites|antimetabolites|mesh-ancestor
25214260|NCT02436707|Antiviral Agents|antiviral agents|mesh-ancestor
25214261|NCT02436707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24725539|NCT01598168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24725540|NCT01598168|Antithrombins|antithrombins|mesh-ancestor
25006544|NCT04892420|Magnesium Sulfate|magnesium sulfate|mesh-list
24789598|NCT01938092|GABA Modulators|gaba modulators|mesh-ancestor
25094112|NCT03228732|Fluoxetine|fluoxetine|mesh-list
24725756|NCT01599364|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24725794|NCT01599871|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24725795|NCT01599871|Autonomic Agents|autonomic agents|mesh-ancestor
24725796|NCT01599871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25861144|NCT00085449|Fludarabine phosphate|fludarabine phosphate|mesh-list
24725818|NCT01599884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725821|NCT01599923|Immunologic Factors|immunologic factors|mesh-ancestor
24725822|NCT01599923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725823|NCT01599936|Antivenins|antivenins|mesh-list
24725824|NCT01599936|Immunologic Factors|immunologic factors|mesh-ancestor
24726093|NCT01601795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24726094|NCT01601795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726095|NCT01601899|Tenofovir|tenofovir|mesh-list
24726096|NCT01601899|Lamivudine|lamivudine|mesh-list
24726097|NCT01601899|Efavirenz|efavirenz|mesh-list
24726098|NCT01601899|Stavudine|stavudine|mesh-list
24726260|NCT01602588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726263|NCT01602640|Midazolam|midazolam|mesh-list
24726264|NCT01602640|Morphine|morphine|mesh-list
25199343|NCT02741856|Mitosis Modulators|mitosis modulators|mesh-ancestor
24726265|NCT01602640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24726266|NCT01602640|Narcotics|narcotics|mesh-ancestor
25114870|NCT03119857|Docetaxel|docetaxel|mesh-list
24726267|NCT01602640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24726268|NCT01602640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726269|NCT01602640|Analgesics|analgesics|mesh-ancestor
24426774|NCT00236600|Topiramate|topiramate|mesh-list
24727676|NCT01612078|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24403832|NCT00161668|Gemtuzumab|gemtuzumab|mesh-list
24616476|NCT01037491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24616477|NCT01037491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24616478|NCT01037491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24728068|NCT01614132|Vincristine|vincristine|mesh-list
24728069|NCT01614132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24404768|NCT00164775|Adrenergic Agents|adrenergic agents|mesh-ancestor
24728471|NCT01616407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24728472|NCT01616407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24728473|NCT01616407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728574|NCT01617135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24728575|NCT01617135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728576|NCT01617135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728577|NCT01617135|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24728578|NCT01617135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728731|NCT01617798|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24728732|NCT01617811|Anesthetics|anesthetics|mesh-list
24728733|NCT01617811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24576962|NCT00841191|Siltuximab|siltuximab|mesh-list
24728734|NCT01617811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728735|NCT01617824|Linagliptin|linagliptin|mesh-list
24728736|NCT01617824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24728737|NCT01617824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728738|NCT01617824|Incretins|incretins|mesh-ancestor
24728825|NCT01618513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24728826|NCT01618513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25667549|NCT01707004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25667550|NCT01707004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25667551|NCT01707004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25667552|NCT01707004|Antimetabolites|antimetabolites|mesh-ancestor
25667553|NCT01707004|Antiviral Agents|antiviral agents|mesh-ancestor
25667554|NCT01707004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25667555|NCT01707004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25667556|NCT01707004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728827|NCT01618513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24728828|NCT01618539|Propofol|propofol|mesh-list
24626899|NCT01089140|Coagulants|coagulants|mesh-ancestor
25082556|NCT03321890|Prednisone|prednisone|mesh-list
24802294|NCT01989312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24938275|NCT04020705|Nootropic Agents|nootropic agents|mesh-ancestor
24948329|NCT03920553|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24924221|NCT04161729|Magnesium Sulfate|magnesium sulfate|mesh-list
24791121|NCT05273567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791127|NCT05248321|Tranexamic Acid|tranexamic acid|mesh-list
24728829|NCT01618539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24728830|NCT01618539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24728831|NCT01618539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728832|NCT01618539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24728833|NCT01618539|Anesthetics, General|anesthetics, general|mesh-ancestor
25006589|NCT04876677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25006590|NCT04876677|Adrenergic Agents|adrenergic agents|mesh-ancestor
25006591|NCT04876677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25006592|NCT04876677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729213|NCT01620437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729216|NCT01620450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24729217|NCT01620450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729219|NCT01620463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24729220|NCT01620463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729221|NCT01620463|Incretins|incretins|mesh-ancestor
24729222|NCT01620463|Hormones|hormones|mesh-ancestor
24729223|NCT01620463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24729224|NCT01620476|Liraglutide|liraglutide|mesh-list
24729942|NCT01624766|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24729943|NCT01624766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730033|NCT01625351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24730034|NCT01625429|Paclitaxel|paclitaxel|mesh-list
24730036|NCT01625429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730037|NCT01625429|Tubulin Modulators|tubulin modulators|mesh-ancestor
24730038|NCT01625429|Antimitotic Agents|antimitotic agents|mesh-ancestor
24730039|NCT01625429|Mitosis Modulators|mitosis modulators|mesh-ancestor
25861145|NCT00085449|Melphalan|melphalan|mesh-list
24730054|NCT01625520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730204|NCT01627106|Amiodarone|amiodarone|mesh-list
24730205|NCT01627106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24730206|NCT01627106|Vasodilator Agents|vasodilator agents|mesh-ancestor
24730207|NCT01627106|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24730208|NCT01627106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24730209|NCT01627106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730210|NCT01627106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25861146|NCT00085449|Alemtuzumab|alemtuzumab|mesh-list
24616802|NCT01039194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207643|NCT03555968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616804|NCT01039194|Autonomic Agents|autonomic agents|mesh-ancestor
24616805|NCT01039194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24616806|NCT01039194|Nootropic Agents|nootropic agents|mesh-ancestor
24616807|NCT01039233|Bicalutamide|bicalutamide|mesh-list
24616808|NCT01039233|Androgen Antagonists|androgen antagonists|mesh-ancestor
24616809|NCT01039233|Hormone Antagonists|hormone antagonists|mesh-ancestor
24518593|NCT04786275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24730328|NCT01627431|Aspirin|aspirin|mesh-list
24730329|NCT01627431|Clopidogrel|clopidogrel|mesh-list
24730330|NCT01627431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24730364|NCT01627626|Autonomic Agents|autonomic agents|mesh-ancestor
24730365|NCT01627626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24730366|NCT01627626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730367|NCT01627626|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24730400|NCT01627834|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24730401|NCT01627834|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24731166|NCT01632826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24731167|NCT01632826|Growth Substances|growth substances|mesh-ancestor
24731507|NCT01635114|Protective Agents|protective agents|mesh-ancestor
24731767|NCT01636505|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24731768|NCT01636505|Fertility Agents|fertility agents|mesh-ancestor
25667557|NCT01707004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25667558|NCT01707004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25667559|NCT01707004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25667560|NCT01707004|Antitubercular Agents|antitubercular agents|mesh-ancestor
25667561|NCT01707004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25667562|NCT01707043|Calcitriol|calcitriol|mesh-list
25667563|NCT01707043|Betamethasone|betamethasone|mesh-list
25667564|NCT01707043|Betamethasone Valerate|betamethasone valerate|mesh-list
25214270|NCT02318095|Gemcitabine|gemcitabine|mesh-list
25214271|NCT02318095|Paclitaxel|paclitaxel|mesh-list
25214272|NCT02318095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25214273|NCT02318095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25214274|NCT02318095|Tubulin Modulators|tubulin modulators|mesh-ancestor
25214275|NCT02318095|Antimitotic Agents|antimitotic agents|mesh-ancestor
25214276|NCT02318095|Mitosis Modulators|mitosis modulators|mesh-ancestor
25214278|NCT02318095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24731770|NCT01636505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731799|NCT01636557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24731800|NCT01636557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24731801|NCT01636557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731802|NCT01636557|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24731803|NCT01636557|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25094522|NCT03225950|Antibodies|antibodies|mesh-list
24732334|NCT01638962|Diclofenac|diclofenac|mesh-list
24732335|NCT01638962|Naproxen|naproxen|mesh-list
24732654|NCT01640665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24732655|NCT01640665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732656|NCT01640691|Vaccines|vaccines|mesh-list
24459973|NCT00346970|Vitamins|vitamins|mesh-ancestor
24732738|NCT01641224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24733002|NCT01642862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24733003|NCT01642862|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24733004|NCT01642862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733005|NCT01642940|Ticagrelor|ticagrelor|mesh-list
24733006|NCT01642940|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24733007|NCT01642940|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24733008|NCT01642940|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24413873|NCT00195481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733081|NCT01643187|Micronutrients|micronutrients|mesh-ancestor
24733082|NCT01643187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733083|NCT01643252|Riboflavin|riboflavin|mesh-list
24733084|NCT01643252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24733085|NCT01643252|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24733086|NCT01643252|Vitamin B Complex|vitamin b complex|mesh-ancestor
24733087|NCT01643252|Vitamins|vitamins|mesh-ancestor
24734653|NCT01653041|Immunologic Factors|immunologic factors|mesh-ancestor
24734654|NCT01653041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734656|NCT01653067|Sirolimus|sirolimus|mesh-list
24734657|NCT01653067|Dexamethasone|dexamethasone|mesh-list
24734658|NCT01653067|Dexamethasone acetate|dexamethasone acetate|mesh-list
24734659|NCT01653067|Rituximab|rituximab|mesh-list
24416816|NCT00204074|Contraceptive Agents|contraceptive agents|mesh-ancestor
24734785|NCT01653717|Alkylating Agents|alkylating agents|mesh-ancestor
24734786|NCT01653717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734787|NCT01653717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24734788|NCT01653717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24734789|NCT01653717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24734790|NCT01653717|Antimetabolites|antimetabolites|mesh-ancestor
24577089|NCT00841919|Insulin|insulin|mesh-list
24951059|NCT03908580|Cholinergic Agents|cholinergic agents|mesh-ancestor
24734791|NCT01653717|Antiviral Agents|antiviral agents|mesh-ancestor
24734792|NCT01653717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24399072|NCT00146575|Sirolimus|sirolimus|mesh-list
24735284|NCT01656109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094648|NCT03224221|Immunologic Factors|immunologic factors|mesh-ancestor
24735827|NCT01658891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24735828|NCT01658891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24735829|NCT01658891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24735830|NCT01658891|Adrenergic Agents|adrenergic agents|mesh-ancestor
24735831|NCT01658891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25094684|NCT03223961|Epoetin Alfa|epoetin alfa|mesh-list
24789789|NCT01939093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24789790|NCT01939093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24400636|NCT00151047|Docetaxel|docetaxel|mesh-list
24736269|NCT01661192|Protein C Inhibitor|protein c inhibitor|mesh-list
25667565|NCT01707043|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25667566|NCT01707043|Betamethasone benzoate|betamethasone benzoate|mesh-list
25667567|NCT01707043|Calcipotriene|calcipotriene|mesh-list
25667568|NCT01707043|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25667569|NCT01707043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25667570|NCT01707043|Glucocorticoids|glucocorticoids|mesh-ancestor
25667571|NCT01707043|Hormones|hormones|mesh-ancestor
25094767|NCT03222960|Propolis|propolis|mesh-list
24736467|NCT01662401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24617824|NCT01045889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24617825|NCT01045889|Alkylating Agents|alkylating agents|mesh-ancestor
25861147|NCT00085449|Cyclosporins|cyclosporins|mesh-list
24791328|NCT04773392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24791329|NCT04773392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24791330|NCT04773392|Protective Agents|protective agents|mesh-ancestor
24791331|NCT04773392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24616720|NCT01038895|Ramipril|ramipril|mesh-list
25082563|NCT03321890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25082564|NCT03321890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25214281|NCT02318095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25214282|NCT02318095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617826|NCT01045889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617827|NCT01045889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617828|NCT01045889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24617829|NCT01045889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24617830|NCT01045889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24736736|NCT01664845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25094804|NCT03222518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24736960|NCT01666067|Antimetabolites|antimetabolites|mesh-ancestor
24736961|NCT01666067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736962|NCT01666067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24736963|NCT01666067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24736964|NCT01666067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24736965|NCT01666080|Fludarabine|fludarabine|mesh-list
24736966|NCT01666080|Busulfan|busulfan|mesh-list
24736967|NCT01666080|Levetiracetam|levetiracetam|mesh-list
24736968|NCT01666080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199344|NCT02741856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199345|NCT02741856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25199346|NCT02741856|Antimetabolites|antimetabolites|mesh-ancestor
25207644|NCT03555968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25207645|NCT03555968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25207646|NCT03555968|Analgesics|analgesics|mesh-ancestor
25207647|NCT03555968|Sensory System Agents|sensory system agents|mesh-ancestor
25207648|NCT03555968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25207649|NCT03555968|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25207650|NCT03555968|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25207651|NCT03555968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25207652|NCT03555968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207653|NCT03555968|Hormones|hormones|mesh-ancestor
25207654|NCT03555968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25207655|NCT03529123|Insulin|insulin|mesh-list
25207656|NCT03529123|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25207657|NCT03529123|Metformin|metformin|mesh-list
25207658|NCT03529123|Insulin Glargine|insulin glargine|mesh-list
25207659|NCT03529123|Insulin glulisine|insulin glulisine|mesh-list
25207660|NCT03529123|Lixisenatide|lixisenatide|mesh-list
24736969|NCT01666080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737788|NCT01670565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737789|NCT01670565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24737790|NCT01670565|Antitubercular Agents|antitubercular agents|mesh-ancestor
24617903|NCT01046006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617904|NCT01046006|Immunologic Factors|immunologic factors|mesh-ancestor
24617905|NCT01046006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617906|NCT01046006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24617907|NCT01046006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24617909|NCT01046006|Autonomic Agents|autonomic agents|mesh-ancestor
24617910|NCT01046006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24617911|NCT01046006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24617912|NCT01046006|Glucocorticoids|glucocorticoids|mesh-ancestor
24738204|NCT01674127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738206|NCT01674166|Laxatives|laxatives|mesh-ancestor
24738207|NCT01674166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24402758|NCT00158457|Tenofovir|tenofovir|mesh-list
24998389|NCT02960646|Fludarabine|fludarabine|mesh-list
25667572|NCT01707043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25667573|NCT01707043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667574|NCT01707043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25667575|NCT01707043|Respiratory System Agents|respiratory system agents|mesh-ancestor
25667576|NCT01707043|Dermatologic Agents|dermatologic agents|mesh-ancestor
25667577|NCT01707043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25667578|NCT01707043|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25667579|NCT01707043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25428028|NCT01797523|Letrozole|letrozole|mesh-list
25214285|NCT02318095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214286|NCT02200978|Cytarabine|cytarabine|mesh-list
25214287|NCT02200978|Methotrexate|methotrexate|mesh-list
25214288|NCT02200978|Mercaptopurine|mercaptopurine|mesh-list
25214289|NCT02200978|Mitoxantrone|mitoxantrone|mesh-list
25214290|NCT02200978|Tretinoin|tretinoin|mesh-list
25214291|NCT02200978|Arsenic Trioxide|arsenic trioxide|mesh-list
24829875|NCT02155088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24448784|NCT00313131|Clotrimazole|clotrimazole|mesh-list
24448785|NCT00313131|Miconazole|miconazole|mesh-list
24448786|NCT00313131|Tinidazole|tinidazole|mesh-list
24448787|NCT00313131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24448788|NCT00313131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24448789|NCT00313131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24448790|NCT00313131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24738562|NCT01675999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738563|NCT01675999|Antidotes|antidotes|mesh-ancestor
24738564|NCT01675999|Protective Agents|protective agents|mesh-ancestor
24738597|NCT01676285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24738598|NCT01676285|Sympatholytics|sympatholytics|mesh-ancestor
24738796|NCT01677468|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24789853|NCT01939457|Oxytocics|oxytocics|mesh-ancestor
24789854|NCT01939483|Irinotecan|irinotecan|mesh-list
24789855|NCT01939483|Camptothecin|camptothecin|mesh-list
24789856|NCT01939483|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24789857|NCT01939483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24789858|NCT01939483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24789859|NCT01939483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789860|NCT01939483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424109|NCT00227981|Fluoxetine|fluoxetine|mesh-list
24739504|NCT01681979|Dermatologic Agents|dermatologic agents|mesh-ancestor
24739505|NCT01681979|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24739506|NCT01681979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24739507|NCT01681979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24739508|NCT01681979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24739509|NCT01681979|Adrenergic Agents|adrenergic agents|mesh-ancestor
24739510|NCT01681979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24739511|NCT01681979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739512|NCT01682109|Valacyclovir|valacyclovir|mesh-list
24739513|NCT01682109|Antiviral Agents|antiviral agents|mesh-ancestor
24739514|NCT01682109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24739515|NCT01682161|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24739516|NCT01682161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24577248|NCT00842595|Analgesics|analgesics|mesh-ancestor
24739517|NCT01682161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24740060|NCT01686126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24740061|NCT01686126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24740156|NCT01686607|Hormone Antagonists|hormone antagonists|mesh-ancestor
25095025|NCT03221166|Growth Substances|growth substances|mesh-ancestor
24740897|NCT01690572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24740898|NCT01690572|Tubulin Modulators|tubulin modulators|mesh-ancestor
24740899|NCT01690572|Antimitotic Agents|antimitotic agents|mesh-ancestor
24742509|NCT05257447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24742510|NCT05257447|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24742511|NCT05257447|GABA Agonists|gaba agonists|mesh-ancestor
24742512|NCT05257447|GABA Agents|gaba agents|mesh-ancestor
24742513|NCT05257447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24742514|NCT05257447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199347|NCT02741232|Lidocaine|lidocaine|mesh-list
24742582|NCT05220826|Growth Substances|growth substances|mesh-ancestor
24742583|NCT05219799|Propranolol|propranolol|mesh-list
24742584|NCT05219799|Nitroprusside|nitroprusside|mesh-list
24742585|NCT05219799|Isoproterenol|isoproterenol|mesh-list
24742586|NCT05219799|Norepinephrine|norepinephrine|mesh-list
25667580|NCT01707043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667581|NCT01707043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25667582|NCT01707043|Vitamins|vitamins|mesh-ancestor
25667583|NCT01707043|Micronutrients|micronutrients|mesh-ancestor
25667584|NCT01707043|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25667585|NCT01707147|Linagliptin|linagliptin|mesh-list
25667586|NCT01707147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25667587|NCT01707147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667588|NCT01707147|Incretins|incretins|mesh-ancestor
25667589|NCT01707147|Hormones|hormones|mesh-ancestor
25667590|NCT01707147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25667591|NCT01707147|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24742587|NCT05219799|Acetylcholine|acetylcholine|mesh-list
24742588|NCT05219799|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24742589|NCT05219799|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24791490|NCT04150614|Autonomic Agents|autonomic agents|mesh-ancestor
24493320|NCT00490399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493321|NCT00490399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25214292|NCT02200978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24742590|NCT05219799|Adrenergic Agents|adrenergic agents|mesh-ancestor
24742591|NCT05219799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24742592|NCT05219799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742593|NCT05219799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742594|NCT05219799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24742595|NCT05219799|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24742810|NCT05150795|Fentanyl|fentanyl|mesh-list
24742811|NCT05150795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24742812|NCT05150795|Narcotics|narcotics|mesh-ancestor
24742813|NCT05150795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24742814|NCT05150795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742815|NCT05150795|Analgesics|analgesics|mesh-ancestor
24577317|NCT00842998|Trastuzumab|trastuzumab|mesh-list
24742816|NCT05150795|Sensory System Agents|sensory system agents|mesh-ancestor
24742817|NCT05150795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24742818|NCT05150795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24742819|NCT05150795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24742822|NCT05150795|Anticonvulsants|anticonvulsants|mesh-ancestor
24742823|NCT05150795|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24789877|NCT01939522|Immunologic Factors|immunologic factors|mesh-ancestor
24789878|NCT01939522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006850|NCT04606069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006851|NCT04606069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743073|NCT05013567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24743074|NCT05013567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24743075|NCT05013567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24743452|NCT04793867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24743453|NCT04793867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618434|NCT01048268|Hormones|hormones|mesh-ancestor
24618466|NCT01048385|Vitamins|vitamins|mesh-ancestor
24744057|NCT04523428|Acalabrutinib|acalabrutinib|mesh-list
24744058|NCT04523428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745457|NCT03770299|Tubulin Modulators|tubulin modulators|mesh-ancestor
24535307|NCT00648973|Diphenhydramine|diphenhydramine|mesh-list
24745458|NCT03770299|Antimitotic Agents|antimitotic agents|mesh-ancestor
24745459|NCT03770299|Mitosis Modulators|mitosis modulators|mesh-ancestor
24745460|NCT03770299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745461|NCT03770299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24745880|NCT03533712|Vitamin B Complex|vitamin b complex|mesh-ancestor
24745881|NCT03533712|Vitamins|vitamins|mesh-ancestor
24618562|NCT01048983|Sensory System Agents|sensory system agents|mesh-ancestor
24745882|NCT03533712|Micronutrients|micronutrients|mesh-ancestor
24745883|NCT03533712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745911|NCT03523520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25115213|NCT03117920|Alkylating Agents|alkylating agents|mesh-ancestor
24745912|NCT03523520|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24745913|NCT03521830|Nivolumab|nivolumab|mesh-list
24745914|NCT03521830|Ipilimumab|ipilimumab|mesh-list
24745915|NCT03521830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24745916|NCT03521830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095485|NCT03218657|Immunologic Factors|immunologic factors|mesh-ancestor
25006924|NCT04518046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789948|NCT01939743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24789949|NCT01939743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24789950|NCT01939743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24789951|NCT01939743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25095529|NCT03218722|Thrombin|thrombin|mesh-list
24747990|NCT03001011|Sequestering Agents|sequestering agents|mesh-ancestor
24748025|NCT02999633|Histamine Agents|histamine agents|mesh-ancestor
24748026|NCT02999633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24748027|NCT02999633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24748028|NCT02999633|Antipruritics|antipruritics|mesh-ancestor
24748029|NCT02999633|Dermatologic Agents|dermatologic agents|mesh-ancestor
24748030|NCT02999633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25667592|NCT01707147|Protease Inhibitors|protease inhibitors|mesh-ancestor
25667593|NCT01707147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25667594|NCT01707147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667595|NCT01707225|Octreotide|octreotide|mesh-list
25667596|NCT01707225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24748031|NCT02999633|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24748032|NCT02993757|Vaccines|vaccines|mesh-list
24748033|NCT02993757|Immunologic Factors|immunologic factors|mesh-ancestor
24748069|NCT02975934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24748071|NCT02975934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25095607|NCT03217760|Hydrocortisone|hydrocortisone|mesh-list
24748186|NCT02821754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24748187|NCT02821754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748400|NCT02623998|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24748401|NCT02623998|Protease Inhibitors|protease inhibitors|mesh-ancestor
24748402|NCT02623998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24748403|NCT02623998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748405|NCT02608684|Pembrolizumab|pembrolizumab|mesh-list
24748406|NCT02608684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748407|NCT02608684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24748408|NCT02608684|Antimetabolites|antimetabolites|mesh-ancestor
24748488|NCT02499367|Immunologic Factors|immunologic factors|mesh-ancestor
24577495|NCT00844350|Letrozole|letrozole|mesh-list
24748489|NCT02499367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748490|NCT02499367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24748491|NCT02499367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24748492|NCT02499367|Alkylating Agents|alkylating agents|mesh-ancestor
24564740|NCT00777673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24618746|NCT01049633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24748908|NCT01996267|Mitosis Modulators|mitosis modulators|mesh-ancestor
24432509|NCT00254956|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24749272|NCT01373281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749273|NCT01346787|Dexamethasone|dexamethasone|mesh-list
24749313|NCT01204242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24750337|NCT01697735|Antimetabolites|antimetabolites|mesh-ancestor
24750338|NCT01697735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750339|NCT01697735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24414367|NCT00197327|Bupivacaine|bupivacaine|mesh-list
24750340|NCT01697735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25199349|NCT02741232|Racepinephrine|racepinephrine|mesh-list
24751800|NCT01706354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24751801|NCT01706354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751802|NCT01706354|Sensory System Agents|sensory system agents|mesh-ancestor
24434584|NCT00262886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25007046|NCT04332211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007054|NCT04284657|Citric Acid|citric acid|mesh-list
25007055|NCT04284657|Sodium Citrate|sodium citrate|mesh-list
25007056|NCT04284657|Pravastatin|pravastatin|mesh-list
25007057|NCT04284657|Anticoagulants|anticoagulants|mesh-ancestor
25007058|NCT04284657|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25007059|NCT04284657|Chelating Agents|chelating agents|mesh-ancestor
24752261|NCT01709630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24752293|NCT01709682|Adrenergic Agents|adrenergic agents|mesh-ancestor
24752294|NCT01709682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24752295|NCT01709682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752296|NCT01709682|Sympatholytics|sympatholytics|mesh-ancestor
24752297|NCT01709682|Autonomic Agents|autonomic agents|mesh-ancestor
24752298|NCT01709682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24752299|NCT01709682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24416833|NCT00204230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24619175|NCT01051219|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24619176|NCT01051219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619177|NCT01051271|Midazolam|midazolam|mesh-list
24755183|NCT01725087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24755184|NCT01725087|Narcotics|narcotics|mesh-ancestor
24619612|NCT01053208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619614|NCT01053208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24755345|NCT01726075|Hormones|hormones|mesh-ancestor
24755869|NCT01729663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755870|NCT01729663|Antiviral Agents|antiviral agents|mesh-ancestor
24755909|NCT01730157|Ipilimumab|ipilimumab|mesh-list
24755910|NCT01730157|Antibodies|antibodies|mesh-list
24755911|NCT01730157|Immunoglobulins|immunoglobulins|mesh-list
24755912|NCT01730157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24756106|NCT01731184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24756981|NCT01736891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756982|NCT01736891|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24756983|NCT01736891|Protective Agents|protective agents|mesh-ancestor
24756984|NCT01736891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007148|NCT04111627|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24792004|NCT01100775|Autonomic Agents|autonomic agents|mesh-ancestor
24792005|NCT01100775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24792006|NCT01100775|Nootropic Agents|nootropic agents|mesh-ancestor
24792008|NCT00777036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007149|NCT04111627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25007150|NCT04111627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24757957|NCT01743118|Dermatologic Agents|dermatologic agents|mesh-ancestor
24757958|NCT01743144|Magnesium Sulfate|magnesium sulfate|mesh-list
24757959|NCT01743144|Analgesics|analgesics|mesh-ancestor
24757960|NCT01743144|Sensory System Agents|sensory system agents|mesh-ancestor
24757961|NCT01743144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24757962|NCT01743144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757963|NCT01743144|Anesthetics|anesthetics|mesh-ancestor
24757964|NCT01743144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24757965|NCT01743144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24757966|NCT01743144|Anticonvulsants|anticonvulsants|mesh-ancestor
24757967|NCT01743144|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25096162|NCT03213743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24758154|NCT01744184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24758155|NCT01744184|Anesthetics, General|anesthetics, general|mesh-ancestor
24758156|NCT01744184|Anesthetics|anesthetics|mesh-ancestor
24758157|NCT01744184|GABA Modulators|gaba modulators|mesh-ancestor
24758492|NCT01746277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24758493|NCT01746277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24758495|NCT01746485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24758496|NCT01746563|Ranibizumab|ranibizumab|mesh-list
24758497|NCT01746563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25861148|NCT00085449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861149|NCT00085449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25861150|NCT00085449|Antimetabolites|antimetabolites|mesh-ancestor
25861151|NCT00085449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861152|NCT00085449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25861153|NCT00085449|Immunologic Factors|immunologic factors|mesh-ancestor
25861154|NCT00085449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861155|NCT00085449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861156|NCT00085449|Antifungal Agents|antifungal agents|mesh-ancestor
25861157|NCT00085449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24396938|NCT00140452|Immunologic Factors|immunologic factors|mesh-ancestor
24396939|NCT00140452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396940|NCT00140452|Leprostatic Agents|leprostatic agents|mesh-ancestor
24396941|NCT00140452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24396942|NCT00140452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24396943|NCT00140452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24396944|NCT00140452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24396945|NCT00140452|Growth Substances|growth substances|mesh-ancestor
24396981|NCT00140517|Antimalarials|antimalarials|mesh-ancestor
24396982|NCT00140517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24396983|NCT00140517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24396984|NCT00140517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396985|NCT00140517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396986|NCT00140517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24397077|NCT00140725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24397105|NCT00140790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397107|NCT00140803|Verteporfin|verteporfin|mesh-list
24397108|NCT00140803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24397109|NCT00140803|Glucocorticoids|glucocorticoids|mesh-ancestor
24397110|NCT00140803|Hormones|hormones|mesh-ancestor
24397322|NCT00141362|Sensory System Agents|sensory system agents|mesh-ancestor
24397323|NCT00141362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24397324|NCT00141362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397354|NCT00141388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24397355|NCT00141388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24397356|NCT00141388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439848|NCT00280540|Valsartan|valsartan|mesh-list
24397490|NCT00141648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24397491|NCT00141648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24397492|NCT00141648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459841|NCT00346567|Antimetabolites|antimetabolites|mesh-ancestor
24397493|NCT00141648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24397494|NCT00141648|Tubulin Modulators|tubulin modulators|mesh-ancestor
25667597|NCT01707225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25667598|NCT01707225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25667599|NCT01707290|Ivacaftor|ivacaftor|mesh-list
25667600|NCT01707290|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24397498|NCT00141648|Glucocorticoids|glucocorticoids|mesh-ancestor
24398129|NCT00143559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398130|NCT00143572|Hydroxyurea|hydroxyurea|mesh-list
24398131|NCT00143572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24398132|NCT00143572|Antisickling Agents|antisickling agents|mesh-ancestor
24398133|NCT00143572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398737|NCT00145444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25007171|NCT04087395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400341|NCT00150371|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24400344|NCT00150384|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
24400345|NCT00150384|Atorvastatin|atorvastatin|mesh-list
24790145|NCT01941134|Levonorgestrel|levonorgestrel|mesh-list
24790146|NCT01941134|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24790147|NCT01941134|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
24790148|NCT01941134|Contraceptive Agents|contraceptive agents|mesh-list
25007192|NCT04055753|Doxorubicin|doxorubicin|mesh-list
24404759|NCT00164749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407465|NCT00174577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24407466|NCT00174577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24407467|NCT00174577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25199350|NCT02741232|Epinephryl borate|epinephryl borate|mesh-list
24790197|NCT01941264|Antimalarials|antimalarials|mesh-ancestor
24790198|NCT01941264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24790199|NCT01941264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24790200|NCT01941264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24407801|NCT00175565|Dermatologic Agents|dermatologic agents|mesh-ancestor
24483324|NCT00442793|Hematinics|hematinics|mesh-ancestor
24409201|NCT00181272|Azithromycin|azithromycin|mesh-list
25007299|NCT03797560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24414366|NCT00197249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414368|NCT00197327|Anesthetics, Local|anesthetics, local|mesh-ancestor
24414369|NCT00197327|Anesthetics|anesthetics|mesh-ancestor
24414370|NCT00197327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24414371|NCT00197327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414372|NCT00197327|Sensory System Agents|sensory system agents|mesh-ancestor
24414373|NCT00197327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24414526|NCT00197912|Interleukin-2|interleukin-2|mesh-list
24421314|NCT00218283|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24421315|NCT00218283|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24423262|NCT00225225|Rosiglitazone|rosiglitazone|mesh-list
24430184|NCT00246285|Dopamine Agents|dopamine agents|mesh-ancestor
24423528|NCT00226135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24423529|NCT00226135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423530|NCT00226135|Anticonvulsants|anticonvulsants|mesh-ancestor
24423555|NCT00226317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24424097|NCT00227942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424098|NCT00227955|Imipramine|imipramine|mesh-list
24424099|NCT00227955|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24424100|NCT00227955|Antidepressive Agents|antidepressive agents|mesh-ancestor
24425011|NCT00231595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24425012|NCT00231595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425013|NCT00231608|Topiramate|topiramate|mesh-list
24425014|NCT00231608|Anticonvulsants|anticonvulsants|mesh-ancestor
24425015|NCT00231608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24425016|NCT00231608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425527|NCT00233584|Autonomic Agents|autonomic agents|mesh-ancestor
24951151|NCT03908008|Cholinergic Agents|cholinergic agents|mesh-ancestor
24425528|NCT00233584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24460165|NCT00347555|Antacids|antacids|mesh-ancestor
24418372|NCT00209495|Pregabalin|pregabalin|mesh-list
24426328|NCT00235820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24426329|NCT00235859|Adalimumab|adalimumab|mesh-list
24426330|NCT00235859|Methotrexate|methotrexate|mesh-list
24426331|NCT00235859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24426332|NCT00235859|Abortifacient Agents|abortifacient agents|mesh-ancestor
24426333|NCT00235859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25667601|NCT01707290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24426334|NCT00235859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427095|NCT00237367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427753|NCT00238953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24429598|NCT00244452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24460218|NCT00347750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460219|NCT00347750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460221|NCT00347750|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24460222|NCT00347750|Antiviral Agents|antiviral agents|mesh-ancestor
24418892|NCT00210483|Serotonin Agents|serotonin agents|mesh-ancestor
24429600|NCT00244504|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24429602|NCT00244517|Sevoflurane|sevoflurane|mesh-list
24429604|NCT00244517|Isoflurane|isoflurane|mesh-list
24429605|NCT00244517|Anesthetics|anesthetics|mesh-ancestor
24429606|NCT00244517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25861158|NCT00085449|Dermatologic Agents|dermatologic agents|mesh-ancestor
24429634|NCT00244556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429635|NCT00244556|Dermatologic Agents|dermatologic agents|mesh-ancestor
24429636|NCT00244556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429637|NCT00244556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24429638|NCT00244556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24444057|NCT00296686|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24430886|NCT00249574|Analgesics|analgesics|mesh-ancestor
24430887|NCT00249574|Sensory System Agents|sensory system agents|mesh-ancestor
24430888|NCT00249574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24430889|NCT00249574|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24430890|NCT00249587|Methadone|methadone|mesh-list
24430891|NCT00249587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24430892|NCT00249587|Narcotics|narcotics|mesh-ancestor
24430893|NCT00249587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24430894|NCT00249587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430895|NCT00249587|Analgesics|analgesics|mesh-ancestor
24430896|NCT00249587|Sensory System Agents|sensory system agents|mesh-ancestor
24431069|NCT00250237|Haloperidol|haloperidol|mesh-list
24431070|NCT00250237|Haloperidol decanoate|haloperidol decanoate|mesh-list
24431071|NCT00250237|Antiemetics|antiemetics|mesh-ancestor
24431072|NCT00250237|Autonomic Agents|autonomic agents|mesh-ancestor
24431073|NCT00250237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24431074|NCT00250237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431075|NCT00250237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24431076|NCT00250237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24791754|NCT03122496|Durvalumab|durvalumab|mesh-list
24791755|NCT03122496|Tremelimumab|tremelimumab|mesh-list
24791756|NCT03122496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24791757|NCT03122496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791758|NCT03118232|Chlorhexidine|chlorhexidine|mesh-list
24791759|NCT03118232|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24791760|NCT03118232|Povidone-Iodine|povidone-iodine|mesh-list
24791761|NCT03118232|Povidone|povidone|mesh-list
25097091|NCT03206944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24432326|NCT00254371|Hormones|hormones|mesh-ancestor
24432327|NCT00254371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24433545|NCT00258791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24433546|NCT00258791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861159|NCT00085449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24434709|NCT00263276|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24434710|NCT00263276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434711|NCT00263302|Dexamethasone|dexamethasone|mesh-list
24434712|NCT00263302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24434713|NCT00263302|Antiemetics|antiemetics|mesh-ancestor
24434714|NCT00263302|Autonomic Agents|autonomic agents|mesh-ancestor
24434715|NCT00263302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24438443|NCT00275951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24438444|NCT00275951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438445|NCT00276003|Gemcitabine|gemcitabine|mesh-list
24438446|NCT00276003|Irinotecan|irinotecan|mesh-list
24438447|NCT00276003|Allopurinol|allopurinol|mesh-list
25861160|NCT00085449|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24438556|NCT00276146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24438557|NCT00276146|Vasodilator Agents|vasodilator agents|mesh-ancestor
24460358|NCT00348244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24460359|NCT00348244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24421774|NCT00220168|Capecitabine|capecitabine|mesh-list
24438670|NCT00276601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438671|NCT00276601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438672|NCT00276601|Dermatologic Agents|dermatologic agents|mesh-ancestor
24438673|NCT00276601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438707|NCT00276679|Temozolomide|temozolomide|mesh-list
24790451|NCT01942551|Hormone Antagonists|hormone antagonists|mesh-ancestor
24790452|NCT01942551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25199351|NCT02741232|Anesthetics, Local|anesthetics, local|mesh-ancestor
25199352|NCT02741232|Anesthetics|anesthetics|mesh-ancestor
24439022|NCT00277108|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24790458|NCT01942681|Autonomic Agents|autonomic agents|mesh-ancestor
24440577|NCT00283777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440579|NCT00283777|Chelating Agents|chelating agents|mesh-ancestor
24440580|NCT00283777|Sequestering Agents|sequestering agents|mesh-ancestor
24440581|NCT00283777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440583|NCT00283790|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24951190|NCT03907371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24440584|NCT00283790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24440585|NCT00283790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24442277|NCT00290641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442903|NCT00293176|Donepezil|donepezil|mesh-list
24442904|NCT00293176|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24442905|NCT00293176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442906|NCT00293176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442907|NCT00293176|Cholinergic Agents|cholinergic agents|mesh-ancestor
24442909|NCT00293176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442911|NCT00293228|Isoniazid|isoniazid|mesh-list
25861161|NCT00085449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25861162|NCT00085449|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25097407|NCT03204006|Analgesics|analgesics|mesh-ancestor
24442944|NCT00293345|Gemcitabine|gemcitabine|mesh-list
24442945|NCT00293345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24893837|NCT04445948|Metronidazole|metronidazole|mesh-list
24567285|NCT00790439|Daclizumab|daclizumab|mesh-list
24567312|NCT00790595|Growth Inhibitors|growth inhibitors|mesh-ancestor
24567313|NCT00790595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24567314|NCT00790595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567316|NCT00790608|Nitric Oxide|nitric oxide|mesh-list
24442946|NCT00293345|Antimetabolites|antimetabolites|mesh-ancestor
24442947|NCT00293345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861163|NCT00085449|Antitubercular Agents|antitubercular agents|mesh-ancestor
25861164|NCT00085449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25861165|NCT00085449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25861166|NCT00085449|Alkylating Agents|alkylating agents|mesh-ancestor
25861167|NCT00085449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25861168|NCT00085449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25861169|NCT00085462|Aldesleukin|aldesleukin|mesh-list
25861170|NCT00085462|Cyclophosphamide|cyclophosphamide|mesh-list
25861171|NCT00085462|Fludarabine|fludarabine|mesh-list
25861172|NCT00085462|Fludarabine phosphate|fludarabine phosphate|mesh-list
25861173|NCT00085462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25861174|NCT00085462|Immunologic Factors|immunologic factors|mesh-ancestor
25861175|NCT00085462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861176|NCT00085462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25861177|NCT00085462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25861178|NCT00085462|Alkylating Agents|alkylating agents|mesh-ancestor
25861179|NCT00085462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861180|NCT00085462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861181|NCT00085462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25861182|NCT00085462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25861183|NCT00085462|Antimetabolites|antimetabolites|mesh-ancestor
25861184|NCT00085462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25861185|NCT00085462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25861186|NCT00085462|Antiviral Agents|antiviral agents|mesh-ancestor
25097714|NCT03201796|Prulifloxacin|prulifloxacin|mesh-list
24790610|NCT01943942|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25097789|NCT03201380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25199353|NCT02741232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25207661|NCT03529123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24626867|NCT01088932|Natriuretic Agents|natriuretic agents|mesh-ancestor
24460525|NCT00348582|Nepafenac|nepafenac|mesh-list
24460526|NCT00348582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24426784|NCT00236626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25861187|NCT00085462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25861188|NCT00085475|Imatinib Mesylate|imatinib mesylate|mesh-list
25861189|NCT00085475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861190|NCT00085475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25214398|NCT01778946|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25214399|NCT01778946|Cholinergic Agents|cholinergic agents|mesh-ancestor
25214402|NCT01706692|Cyclosporine|cyclosporine|mesh-list
24438829|NCT00276809|Cytarabine|cytarabine|mesh-list
24567932|NCT00793559|Terlipressin|terlipressin|mesh-list
25861191|NCT00085475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861192|NCT00085475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861193|NCT00085501|Paclitaxel|paclitaxel|mesh-list
25861194|NCT00085501|Carboplatin|carboplatin|mesh-list
25861195|NCT00085501|Cetuximab|cetuximab|mesh-list
25861196|NCT00085501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25861197|NCT00085501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861198|NCT00085501|Tubulin Modulators|tubulin modulators|mesh-ancestor
24460582|NCT00348985|Bortezomib|bortezomib|mesh-list
24460583|NCT00348985|Belinostat|belinostat|mesh-list
24460585|NCT00348985|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24460586|NCT00348985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460587|NCT00348985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460588|NCT00348998|Bevacizumab|bevacizumab|mesh-list
24460589|NCT00348998|Goserelin|goserelin|mesh-list
24443460|NCT00295035|Celecoxib|celecoxib|mesh-list
25861199|NCT00085501|Antimitotic Agents|antimitotic agents|mesh-ancestor
25861200|NCT00085501|Mitosis Modulators|mitosis modulators|mesh-ancestor
25861201|NCT00085501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460634|NCT00349115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460635|NCT00349115|Leprostatic Agents|leprostatic agents|mesh-ancestor
25861202|NCT00085501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25861203|NCT00085527|Romidepsin|romidepsin|mesh-list
25861204|NCT00085527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25861205|NCT00085527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861206|NCT00085553|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25861207|NCT00085553|Tipifarnib|tipifarnib|mesh-list
25861208|NCT00085553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861209|NCT00085553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25861210|NCT00085553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861211|NCT00085553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861212|NCT00085579|Aldesleukin|aldesleukin|mesh-list
25861213|NCT00085579|Sargramostim|sargramostim|mesh-list
25861214|NCT00085579|Immunologic Factors|immunologic factors|mesh-ancestor
25861215|NCT00085579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861216|NCT00085579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861217|NCT00085579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24790633|NCT01944033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24790634|NCT01944033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790636|NCT01944033|Respiratory System Agents|respiratory system agents|mesh-ancestor
24790637|NCT01944033|Sympathomimetics|sympathomimetics|mesh-ancestor
24790638|NCT01944033|Tocolytic Agents|tocolytic agents|mesh-ancestor
24460802|NCT00349557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24460803|NCT00349557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460804|NCT00349557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24460805|NCT00349557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24460806|NCT00349557|Growth Substances|growth substances|mesh-ancestor
24460807|NCT00349557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460808|NCT00349557|Growth Inhibitors|growth inhibitors|mesh-ancestor
24578646|NCT00850122|Cefazolin|cefazolin|mesh-list
24460832|NCT00349635|Fenofibrate|fenofibrate|mesh-list
24460833|NCT00349635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24460834|NCT00349635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460835|NCT00349635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24460836|NCT00349635|Antimetabolites|antimetabolites|mesh-ancestor
25007712|NCT02880293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25007713|NCT02880293|Immunologic Factors|immunologic factors|mesh-ancestor
25007714|NCT02880293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007715|NCT02880293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25007716|NCT02880293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25007717|NCT02880293|Alkylating Agents|alkylating agents|mesh-ancestor
25667602|NCT01707290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667603|NCT01707381|Timolol|timolol|mesh-list
25404111|NCT03684811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25667604|NCT01707381|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25667605|NCT01707381|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25667606|NCT01707381|Adrenergic Agents|adrenergic agents|mesh-ancestor
25667607|NCT01707381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25667608|NCT01707381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667609|NCT01707381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667610|NCT01707381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24763162|NCT01771822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25214416|NCT01706692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25214417|NCT01706692|Dermatologic Agents|dermatologic agents|mesh-ancestor
25214418|NCT01706692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25214419|NCT01706692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25214420|NCT01706692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25214421|NCT01706692|Immunologic Factors|immunologic factors|mesh-ancestor
25214422|NCT01706692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25007718|NCT02880293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098155|NCT03199521|Hemostatics|hemostatics|mesh-ancestor
24460842|NCT00349674|Abortifacient Agents|abortifacient agents|mesh-ancestor
24460843|NCT00349674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24460844|NCT00349674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460845|NCT00349674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24460847|NCT00349674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460848|NCT00349674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460849|NCT00349674|Dermatologic Agents|dermatologic agents|mesh-ancestor
24460865|NCT00349739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460866|NCT00349739|Growth Inhibitors|growth inhibitors|mesh-ancestor
24460867|NCT00349739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460871|NCT00349791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24460872|NCT00349791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861218|NCT00085579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25861219|NCT00085579|Antiviral Agents|antiviral agents|mesh-ancestor
24443550|NCT00295412|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24443551|NCT00295412|Antidepressive Agents|antidepressive agents|mesh-ancestor
24443552|NCT00295412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24443553|NCT00295412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24443554|NCT00295412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25098493|NCT03197233|Vitamin D|vitamin d|mesh-list
24443555|NCT00295412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24443556|NCT00295412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861220|NCT00085579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25861221|NCT00085696|Rituximab|rituximab|mesh-list
25861222|NCT00085696|Bortezomib|bortezomib|mesh-list
25861223|NCT00085696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25861224|NCT00085696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861225|NCT00085696|Immunologic Factors|immunologic factors|mesh-ancestor
25861226|NCT00085696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861227|NCT00085696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25861228|NCT00085748|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25861229|NCT00085748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25861230|NCT00085748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25861231|NCT00085748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25861232|NCT00085748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861233|NCT00085748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25861234|NCT00085748|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25861235|NCT00085748|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25861236|NCT00085748|Serotonin Agents|serotonin agents|mesh-ancestor
25861237|NCT00085748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24443528|NCT00295347|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24443530|NCT00295347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25861238|NCT00085748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827036|NCT02137239|Tacrolimus|tacrolimus|mesh-list
24827037|NCT02137239|Thymoglobulin|thymoglobulin|mesh-list
25861239|NCT00085748|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25861240|NCT00085748|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25861241|NCT00085748|Dopamine Agents|dopamine agents|mesh-ancestor
25861242|NCT00085761|Capsaicin|capsaicin|mesh-list
25861243|NCT00085761|Antipruritics|antipruritics|mesh-ancestor
25861244|NCT00085761|Dermatologic Agents|dermatologic agents|mesh-ancestor
25861245|NCT00085761|Sensory System Agents|sensory system agents|mesh-ancestor
25861246|NCT00085761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25861247|NCT00085761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861248|NCT00085826|Sulindac sulfone|sulindac sulfone|mesh-list
25861249|NCT00085826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25667611|NCT01707381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25667612|NCT01707420|Gabapentin|gabapentin|mesh-list
25667613|NCT01707420|Analgesics|analgesics|mesh-ancestor
25667614|NCT01707420|Sensory System Agents|sensory system agents|mesh-ancestor
25667615|NCT01707420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25667616|NCT01707420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667617|NCT01707420|Anticonvulsants|anticonvulsants|mesh-ancestor
25667618|NCT01707420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25861250|NCT00085826|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24792366|NCT05280704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792367|NCT05280704|Sensory System Agents|sensory system agents|mesh-ancestor
24792373|NCT05280704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792376|NCT05275894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25214425|NCT01706692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25214426|NCT01706692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25214427|NCT01706692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25214428|NCT01706692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25214429|NCT01706692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25214430|NCT01706692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25214431|NCT01706692|Analgesics|analgesics|mesh-ancestor
25214432|NCT01706692|Sensory System Agents|sensory system agents|mesh-ancestor
25214433|NCT01706692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24829970|NCT02155777|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24829971|NCT02155777|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24829972|NCT02155803|Hormones|hormones|mesh-list
24829973|NCT02155803|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24829975|NCT02155803|beta-Endorphin|beta-endorphin|mesh-list
25861251|NCT00085826|Protective Agents|protective agents|mesh-ancestor
25861252|NCT00085826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861253|NCT00085826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25861254|NCT00085826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861255|NCT00085826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461107|NCT00351052|Analgesics|analgesics|mesh-ancestor
24461108|NCT00351052|Sensory System Agents|sensory system agents|mesh-ancestor
24461109|NCT00351052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24461110|NCT00351052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461111|NCT00351052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24461112|NCT00351052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24461113|NCT00351052|Dermatologic Agents|dermatologic agents|mesh-ancestor
24461114|NCT00351052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24461115|NCT00351052|Immunologic Factors|immunologic factors|mesh-ancestor
24461116|NCT00351052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24461117|NCT00351052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461118|NCT00351052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461119|NCT00351091|Risedronic Acid|risedronic acid|mesh-list
25861256|NCT00085826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25861257|NCT00085826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25861258|NCT00085826|Analgesics|analgesics|mesh-ancestor
25098369|NCT03197571|Growth Inhibitors|growth inhibitors|mesh-ancestor
24790698|NCT01944410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790700|NCT01944436|Donepezil|donepezil|mesh-list
25861259|NCT00085826|Sensory System Agents|sensory system agents|mesh-ancestor
25861260|NCT00085826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25861261|NCT00085826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25861262|NCT00085826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25861263|NCT00085891|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25861264|NCT00085891|Antidepressive Agents|antidepressive agents|mesh-ancestor
25861265|NCT00085891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25861266|NCT00085891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25861267|NCT00085891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25861268|NCT00085891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25667619|NCT01707420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25667620|NCT01707420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25667621|NCT01707420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25667622|NCT01707420|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25667623|NCT01707420|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25667624|NCT01707420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25667625|NCT01707420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667626|NCT01707420|Antimanic Agents|antimanic agents|mesh-ancestor
25667627|NCT01707667|Prucalopride|prucalopride|mesh-list
25667628|NCT01707667|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25667629|NCT01707667|Laxatives|laxatives|mesh-ancestor
25667630|NCT01707667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25667631|NCT01707667|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
25667632|NCT01707667|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25667633|NCT01707667|Serotonin Agents|serotonin agents|mesh-ancestor
25667634|NCT01707667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25667635|NCT01707667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667636|NCT01707667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667637|NCT01708122|Fentanyl|fentanyl|mesh-list
24493844|NCT00492518|Purinergic Agents|purinergic agents|mesh-ancestor
24493845|NCT00492518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24493846|NCT00492635|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24792534|NCT05070585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25214443|NCT01524926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25214444|NCT01524926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25214445|NCT01524926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272774|NCT02389868|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24829981|NCT02156336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24829982|NCT02156336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24829983|NCT02156336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861269|NCT00085891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861270|NCT00085943|Ritonavir|ritonavir|mesh-list
25861271|NCT00085943|Fosamprenavir|fosamprenavir|mesh-list
25861272|NCT00085943|Lamivudine|lamivudine|mesh-list
25861273|NCT00085943|Abacavir|abacavir|mesh-list
24461394|NCT00352196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461395|NCT00352196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461396|NCT00352196|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24461397|NCT00352196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24461441|NCT00352339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24461465|NCT00352378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24461466|NCT00352378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24461467|NCT00352378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461468|NCT00352378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24461469|NCT00352378|Antimetabolites|antimetabolites|mesh-ancestor
24461471|NCT00352430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24461472|NCT00352430|Autonomic Agents|autonomic agents|mesh-ancestor
24461473|NCT00352430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24461474|NCT00352430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461475|NCT00352430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25199354|NCT02741232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461477|NCT00352430|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24461479|NCT00352430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461480|NCT00352430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25007834|NCT02642965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25007835|NCT02642965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25007836|NCT02642965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25007837|NCT02642965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25007838|NCT02642965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25007840|NCT02632175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25007841|NCT02632175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25861274|NCT00085943|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25861275|NCT00085943|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25861276|NCT00085943|Protease Inhibitors|protease inhibitors|mesh-ancestor
25861277|NCT00085943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861278|NCT00085943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861279|NCT00085943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24550763|NCT00722176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24550764|NCT00722176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550765|NCT00722176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550766|NCT00722176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24550767|NCT00722176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24550768|NCT00722176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24550769|NCT00722176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24550770|NCT00722176|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24550771|NCT00722176|Dopamine Agents|dopamine agents|mesh-ancestor
24568972|NCT00798343|Immunologic Factors|immunologic factors|mesh-ancestor
24550773|NCT00722215|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-list
24550774|NCT00722215|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25667638|NCT01708122|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25667639|NCT01708122|Narcotics|narcotics|mesh-ancestor
25667640|NCT01708122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25667641|NCT01708122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667642|NCT01708122|Analgesics|analgesics|mesh-ancestor
25667643|NCT01708122|Sensory System Agents|sensory system agents|mesh-ancestor
25667644|NCT01708122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25667645|NCT01708122|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25667646|NCT01708122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25667647|NCT01708122|Anesthetics, General|anesthetics, general|mesh-ancestor
25667648|NCT01708122|Anesthetics|anesthetics|mesh-ancestor
25667649|NCT01708278|Folic Acid|folic acid|mesh-list
25667650|NCT01708278|Quercetin|quercetin|mesh-list
24792584|NCT04992312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24792585|NCT04992312|Hormones|hormones|mesh-ancestor
24792586|NCT04992312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24792608|NCT04917055|Glucocorticoids|glucocorticoids|mesh-ancestor
24792610|NCT04917055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24792611|NCT04917055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25214446|NCT01524926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214447|NCT01517802|Prednisone|prednisone|mesh-list
25214448|NCT01517802|Abiraterone Acetate|abiraterone acetate|mesh-list
25214449|NCT01517802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25214450|NCT01517802|Glucocorticoids|glucocorticoids|mesh-ancestor
25214451|NCT01517802|Hormones|hormones|mesh-ancestor
24550775|NCT00722215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24550922|NCT00723242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24550923|NCT00723268|Prednisolone|prednisolone|mesh-list
24550957|NCT00723385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24550958|NCT00723411|Aluminum sulfate|aluminum sulfate|mesh-list
24550959|NCT00723411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24550960|NCT00723411|Immunologic Factors|immunologic factors|mesh-ancestor
24550961|NCT00723411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759006|NCT01748929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861280|NCT00085943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24551228|NCT00724633|Dialysis Solutions|dialysis solutions|mesh-list
24551229|NCT00724633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24551230|NCT00724672|Adalimumab|adalimumab|mesh-list
24551231|NCT00724672|Etanercept|etanercept|mesh-list
24551232|NCT00724672|Infliximab|infliximab|mesh-list
24551233|NCT00724672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24551234|NCT00724672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24551324|NCT00725348|R 115866|r 115866|mesh-list
24551334|NCT00725439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551335|NCT00725478|Piribedil|piribedil|mesh-list
24551336|NCT00725478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25199355|NCT02741232|Sensory System Agents|sensory system agents|mesh-ancestor
24551337|NCT00725478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24551360|NCT00725777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24551361|NCT00725790|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24551363|NCT00725790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24551364|NCT00725790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24551365|NCT00725790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579358|NCT00854711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24551366|NCT00725790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551367|NCT00725790|Urological Agents|urological agents|mesh-ancestor
24551368|NCT00725829|Simvastatin|simvastatin|mesh-list
24551369|NCT00725829|Ezetimibe|ezetimibe|mesh-list
24551370|NCT00725829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24551371|NCT00725829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24551372|NCT00725829|Antimetabolites|antimetabolites|mesh-ancestor
24551373|NCT00725829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551423|NCT00726505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24551424|NCT00726505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551425|NCT00726570|Heparin|heparin|mesh-list
24551426|NCT00726570|Calcium heparin|calcium heparin|mesh-list
24551427|NCT00726570|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24551429|NCT00726570|Dalteparin|dalteparin|mesh-list
24551528|NCT05373277|Purinergic Agents|purinergic agents|mesh-ancestor
24551529|NCT05373277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24551530|NCT05373277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551531|NCT05373264|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24551551|NCT05373134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24551552|NCT05373134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551553|NCT05373134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25667651|NCT01708278|Hematinics|hematinics|mesh-ancestor
25667652|NCT01708278|Vitamin B Complex|vitamin b complex|mesh-ancestor
25667653|NCT01708278|Vitamins|vitamins|mesh-ancestor
25667654|NCT01708278|Micronutrients|micronutrients|mesh-ancestor
25667655|NCT01708278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667656|NCT01708278|Antioxidants|antioxidants|mesh-ancestor
25667657|NCT01708278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667658|NCT01708278|Protective Agents|protective agents|mesh-ancestor
25667659|NCT01708525|Deuterium Oxide|deuterium oxide|mesh-list
25667660|NCT01708525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25667661|NCT01708525|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25667662|NCT01708525|Protective Agents|protective agents|mesh-ancestor
25667663|NCT01708525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214453|NCT01517802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214454|NCT01517802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25214456|NCT01517802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25861281|NCT00085943|Antiviral Agents|antiviral agents|mesh-ancestor
24829992|NCT02156596|Ketoprofen|ketoprofen|mesh-list
24829993|NCT02156596|Morphine|morphine|mesh-list
24829994|NCT02156596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24493888|NCT00492765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493889|NCT00492765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24493891|NCT00492765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861282|NCT00085943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24551554|NCT05373134|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24551555|NCT05373134|Protective Agents|protective agents|mesh-ancestor
24551556|NCT05373134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442180|NCT00290264|Autonomic Agents|autonomic agents|mesh-ancestor
24551602|NCT05366062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24551603|NCT05366062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24551604|NCT05366062|Alkylating Agents|alkylating agents|mesh-ancestor
24551605|NCT05366062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551707|NCT05124275|Cholinergic Agents|cholinergic agents|mesh-ancestor
24551708|NCT05124275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24551940|NCT04541407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24551941|NCT04541407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24551942|NCT04541407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24551943|NCT04480463|Aflibercept|aflibercept|mesh-list
24551944|NCT04480463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24551945|NCT04480463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24551946|NCT04480463|Growth Substances|growth substances|mesh-ancestor
24551947|NCT04480463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551948|NCT04480463|Growth Inhibitors|growth inhibitors|mesh-ancestor
24552062|NCT04213794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24552063|NCT04213794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552064|NCT04213794|Protective Agents|protective agents|mesh-ancestor
24552065|NCT04213794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552066|NCT04213794|Antioxidants|antioxidants|mesh-ancestor
24552067|NCT04213794|Antitubercular Agents|antitubercular agents|mesh-ancestor
24552068|NCT04213794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24552124|NCT04176419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24552126|NCT04176419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24552127|NCT04176419|Antimanic Agents|antimanic agents|mesh-ancestor
24552146|NCT04144465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24552147|NCT04144465|Nasal Decongestants|nasal decongestants|mesh-ancestor
24552148|NCT04144465|Respiratory System Agents|respiratory system agents|mesh-ancestor
24552149|NCT04144465|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24552150|NCT04144465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24552151|NCT04144465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24552152|NCT04144465|Adrenergic Agents|adrenergic agents|mesh-ancestor
25098914|NCT03194685|FF-10101|ff-10101|mesh-list
25007996|NCT02343224|Interferons|interferons|mesh-list
25007997|NCT02343224|Interferon-alpha|interferon-alpha|mesh-list
25109822|NCT03121521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552163|NCT04130204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552165|NCT04126317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24552166|NCT04126317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24552167|NCT04126317|Growth Substances|growth substances|mesh-ancestor
24461255|NCT00351663|Enoxaparin|enoxaparin|mesh-list
24552272|NCT03728478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24552273|NCT03728478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24552274|NCT03728478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24552276|NCT03728478|Sensory System Agents|sensory system agents|mesh-ancestor
24552277|NCT03728478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25667664|NCT01708590|Brodalumab|brodalumab|mesh-list
25667665|NCT01708590|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25667666|NCT01708590|Dermatologic Agents|dermatologic agents|mesh-ancestor
25667667|NCT01708590|Immunologic Factors|immunologic factors|mesh-ancestor
25667668|NCT01708590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667669|NCT01708603|Ustekinumab|ustekinumab|mesh-list
25667670|NCT01708603|Brodalumab|brodalumab|mesh-list
25667671|NCT01708603|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25667672|NCT01708603|Dermatologic Agents|dermatologic agents|mesh-ancestor
25667673|NCT01708603|Immunologic Factors|immunologic factors|mesh-ancestor
25667674|NCT01708603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667675|NCT01708629|Ustekinumab|ustekinumab|mesh-list
25667676|NCT01708629|Brodalumab|brodalumab|mesh-list
24552278|NCT03728478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24552279|NCT03728478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24552281|NCT03702283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24552282|NCT03702283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24552312|NCT03583957|Purinergic Agents|purinergic agents|mesh-ancestor
24552313|NCT03583957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24552397|NCT03475004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24552398|NCT03475004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552399|NCT03475004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24552400|NCT03475004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24552401|NCT03475004|Growth Substances|growth substances|mesh-ancestor
24552402|NCT03475004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552403|NCT03475004|Growth Inhibitors|growth inhibitors|mesh-ancestor
24552534|NCT02704156|Immunologic Factors|immunologic factors|mesh-ancestor
24552535|NCT02704156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552536|NCT02704156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24552537|NCT02704156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24552539|NCT02688530|Dexamethasone acetate|dexamethasone acetate|mesh-list
24552569|NCT02383966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24552570|NCT02383966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24552571|NCT02383966|Immunologic Factors|immunologic factors|mesh-ancestor
24552572|NCT02383966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552573|NCT02383966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24552574|NCT02227927|Domperidone|domperidone|mesh-list
24552575|NCT02227927|Antiemetics|antiemetics|mesh-ancestor
24552576|NCT02227927|Autonomic Agents|autonomic agents|mesh-ancestor
24552577|NCT02227927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25008022|NCT02339740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25008024|NCT02339740|Hormones|hormones|mesh-ancestor
25008025|NCT02339740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25008026|NCT02339740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25008027|NCT02339740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008028|NCT02339740|Protease Inhibitors|protease inhibitors|mesh-ancestor
25099074|NCT03193788|Hormones|hormones|mesh-ancestor
24552680|NCT00726804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24552681|NCT00726804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552682|NCT00726804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24552695|NCT00726960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24552697|NCT00726960|Antiemetics|antiemetics|mesh-ancestor
24552698|NCT00726960|Autonomic Agents|autonomic agents|mesh-ancestor
24552699|NCT00726960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24552700|NCT00726960|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24552701|NCT00726960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24552702|NCT00726960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552703|NCT00726973|Ranibizumab|ranibizumab|mesh-list
24552704|NCT00726973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24552705|NCT00726973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24552706|NCT00726973|Growth Substances|growth substances|mesh-ancestor
24552707|NCT00726973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552708|NCT00726973|Growth Inhibitors|growth inhibitors|mesh-ancestor
24552709|NCT00726973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552762|NCT00727545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552763|NCT00727727|Piribedil|piribedil|mesh-list
24552764|NCT00727727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24552765|NCT00727727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24552766|NCT00727727|Dopamine Agonists|dopamine agonists|mesh-ancestor
24552767|NCT00727727|Dopamine Agents|dopamine agents|mesh-ancestor
24552768|NCT00727727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25008061|NCT02124902|Tubulin Modulators|tubulin modulators|mesh-ancestor
24552769|NCT00727727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552770|NCT00727727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552772|NCT00727753|Ranibizumab|ranibizumab|mesh-list
24552773|NCT00727753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24552774|NCT00727753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552775|NCT00727753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24552776|NCT00727753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24552777|NCT00727753|Growth Substances|growth substances|mesh-ancestor
24552787|NCT00727831|Calcium|calcium|mesh-list
24552788|NCT00727831|Levoleucovorin|levoleucovorin|mesh-list
24552789|NCT00727831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24552790|NCT00727831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552791|NCT00727831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25861283|NCT00085943|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25861284|NCT00085943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25667677|NCT01708629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24494126|NCT00493870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494127|NCT00493870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494128|NCT00493870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24494129|NCT00493870|Tubulin Modulators|tubulin modulators|mesh-ancestor
24494130|NCT00493870|Antimitotic Agents|antimitotic agents|mesh-ancestor
24494131|NCT00493870|Mitosis Modulators|mitosis modulators|mesh-ancestor
24494132|NCT00493870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24494133|NCT00493870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25214460|NCT01517802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24829998|NCT02156596|Analgesics|analgesics|mesh-ancestor
24552792|NCT00727831|Abortifacient Agents|abortifacient agents|mesh-ancestor
24552864|NCT00728000|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24552865|NCT00728000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24552866|NCT00728000|Antimetabolites|antimetabolites|mesh-ancestor
24888019|NCT04509440|Triamcinolone|triamcinolone|mesh-list
24552867|NCT00728000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552868|NCT00728000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552869|NCT00728000|Antiviral Agents|antiviral agents|mesh-ancestor
24552914|NCT00728195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24552916|NCT00728195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24552917|NCT00728195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24552918|NCT00728195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24552919|NCT00728195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552920|NCT00728195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24552921|NCT00728195|Serotonin Agents|serotonin agents|mesh-ancestor
24552922|NCT00728195|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24552923|NCT00728195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24552952|NCT00728546|Isoniazid|isoniazid|mesh-list
24552953|NCT00728546|Antitubercular Agents|antitubercular agents|mesh-ancestor
24552954|NCT00728546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24552955|NCT00728546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24552956|NCT00728546|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24552957|NCT00728546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24552958|NCT00728546|Antimetabolites|antimetabolites|mesh-ancestor
24552959|NCT00728546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552960|NCT00728546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24552961|NCT00728559|Bupivacaine|bupivacaine|mesh-list
24552962|NCT00728559|Anesthetics, Local|anesthetics, local|mesh-ancestor
24553047|NCT00729170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24553048|NCT00729170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553051|NCT00729222|Natriuretic Agents|natriuretic agents|mesh-ancestor
24553052|NCT00729222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553053|NCT00729274|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24553054|NCT00729287|Selenium|selenium|mesh-list
24553055|NCT00729287|Antioxidants|antioxidants|mesh-ancestor
24553056|NCT00729287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553057|NCT00729287|Protective Agents|protective agents|mesh-ancestor
24580280|NCT00861250|Hormones|hormones|mesh-ancestor
24553058|NCT00729287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553059|NCT00729287|Trace Elements|trace elements|mesh-ancestor
24553060|NCT00729287|Micronutrients|micronutrients|mesh-ancestor
24553061|NCT00729300|Disulfiram|disulfiram|mesh-list
24553062|NCT00729300|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24553063|NCT00729300|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
24553064|NCT00729300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462222|NCT00355576|Analgesics|analgesics|mesh-ancestor
24553066|NCT00729313|Lanreotide|lanreotide|mesh-list
25428029|NCT01797523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25667678|NCT01708629|Dermatologic Agents|dermatologic agents|mesh-ancestor
25667679|NCT01708629|Immunologic Factors|immunologic factors|mesh-ancestor
25667680|NCT01708629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667681|NCT01708902|Metformin|metformin|mesh-list
25667682|NCT01708902|Linagliptin|linagliptin|mesh-list
25667683|NCT01708902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25667684|NCT01708902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667685|NCT01708902|Incretins|incretins|mesh-ancestor
25667686|NCT01708902|Hormones|hormones|mesh-ancestor
25667687|NCT01708902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25667688|NCT01708902|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25667689|NCT01708902|Protease Inhibitors|protease inhibitors|mesh-ancestor
25667690|NCT01708902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25214479|NCT01269424|Temozolomide|temozolomide|mesh-list
25214480|NCT01269424|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
25214481|NCT01269424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25214482|NCT01269424|Alkylating Agents|alkylating agents|mesh-ancestor
25214483|NCT01269424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214484|NCT01269424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25214485|NCT01269424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24792880|NCT04475016|Paclitaxel|paclitaxel|mesh-list
24792881|NCT04475016|Ifosfamide|ifosfamide|mesh-list
24792882|NCT04475016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24553098|NCT00729495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24553099|NCT00729495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24479960|NCT00429234|Dasatinib|dasatinib|mesh-list
25861285|NCT00085943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25008063|NCT02124902|Mitosis Modulators|mitosis modulators|mesh-ancestor
25008064|NCT02124902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008066|NCT02113878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008067|NCT02097680|Letrozole|letrozole|mesh-list
24553410|NCT00731016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24553411|NCT00731016|Antimetabolites|antimetabolites|mesh-ancestor
24553412|NCT00731016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553413|NCT00731016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24553414|NCT00731016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24553415|NCT00731016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553417|NCT00731068|Mitosis Modulators|mitosis modulators|mesh-ancestor
24553620|NCT00732407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24553621|NCT00732407|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24553622|NCT00732407|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24553623|NCT00732407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553675|NCT00732511|Adrenergic Agents|adrenergic agents|mesh-ancestor
24553676|NCT00732511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24553677|NCT00732511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553678|NCT00732511|Antioxidants|antioxidants|mesh-ancestor
24553681|NCT00732511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24553682|NCT00732511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24553683|NCT00732511|Vasodilator Agents|vasodilator agents|mesh-ancestor
24553684|NCT00732511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24553685|NCT00732511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24553850|NCT00733083|Oxycodone|oxycodone|mesh-list
24553851|NCT00733083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24553852|NCT00733083|Antiemetics|antiemetics|mesh-ancestor
24554089|NCT00734123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24554090|NCT00734123|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24554091|NCT00734123|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24554093|NCT00734123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24554099|NCT00734279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554100|NCT00734279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24554102|NCT00734279|Hormone Antagonists|hormone antagonists|mesh-ancestor
24554103|NCT00734279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24554104|NCT00734318|Fluticasone|fluticasone|mesh-list
24554105|NCT00734318|Xhance|xhance|mesh-list
24554106|NCT00734318|Formoterol Fumarate|formoterol fumarate|mesh-list
24554107|NCT00734318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24554108|NCT00734318|Autonomic Agents|autonomic agents|mesh-ancestor
24554109|NCT00734318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24554110|NCT00734318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554111|NCT00734318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24759008|NCT01749072|Vinorelbine|vinorelbine|mesh-list
24554144|NCT00734669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554145|NCT00734682|Irinotecan|irinotecan|mesh-list
24554146|NCT00734682|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24554256|NCT00735124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24554257|NCT00735124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24951233|NCT03907111|Chitosan|chitosan|mesh-list
25667691|NCT01708902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667692|NCT01708915|Nicotinic Acids|nicotinic acids|mesh-list
25667693|NCT01708915|Capsaicin|capsaicin|mesh-list
25667694|NCT01708915|Nonivamide|nonivamide|mesh-list
25667695|NCT01708915|Sensory System Agents|sensory system agents|mesh-ancestor
25667696|NCT01708915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25667697|NCT01708915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667698|NCT01708915|Antipruritics|antipruritics|mesh-ancestor
25667699|NCT01708915|Dermatologic Agents|dermatologic agents|mesh-ancestor
25667700|NCT01708915|Vitamin B Complex|vitamin b complex|mesh-ancestor
24554258|NCT00735124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24554259|NCT00735124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554260|NCT00735124|Antimanic Agents|antimanic agents|mesh-ancestor
24554261|NCT00735228|Pancrelipase|pancrelipase|mesh-list
24554380|NCT00736294|Protease Inhibitors|protease inhibitors|mesh-ancestor
24554381|NCT00736294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24554382|NCT00736294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554383|NCT00736294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24554384|NCT00736320|Vincristine|vincristine|mesh-list
24554385|NCT00736320|Doxorubicin|doxorubicin|mesh-list
24554386|NCT00736320|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24554387|NCT00736320|Dacarbazine|dacarbazine|mesh-list
24554388|NCT00736320|Bleomycin|bleomycin|mesh-list
24554389|NCT00736320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24554390|NCT00736320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24554391|NCT00736320|Tubulin Modulators|tubulin modulators|mesh-ancestor
24554392|NCT00736320|Antimitotic Agents|antimitotic agents|mesh-ancestor
24554393|NCT00736320|Mitosis Modulators|mitosis modulators|mesh-ancestor
24554394|NCT00736320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551279|NCT00724880|Purinergic Agents|purinergic agents|mesh-ancestor
24554405|NCT00736346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554406|NCT00736346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24554407|NCT00736346|Serotonin Agents|serotonin agents|mesh-ancestor
24554408|NCT00736346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554409|NCT00736346|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24554410|NCT00736346|Antidepressive Agents|antidepressive agents|mesh-ancestor
24554411|NCT00736346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24554412|NCT00736346|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24554413|NCT00736346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24554414|NCT00736346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24554415|NCT00736463|Atorvastatin|atorvastatin|mesh-list
24554416|NCT00736463|Simvastatin|simvastatin|mesh-list
24554417|NCT00736463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24554418|NCT00736463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24791007|NCT05406895|Anesthetics|anesthetics|mesh-ancestor
24554419|NCT00736463|Antimetabolites|antimetabolites|mesh-ancestor
25099513|NCT03190642|Glucocorticoids|glucocorticoids|mesh-ancestor
24554451|NCT00736606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24462384|NCT00355953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24554653|NCT00737373|Micronutrients|micronutrients|mesh-ancestor
24554452|NCT00736606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24554453|NCT00736606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24554454|NCT00736619|Paclitaxel|paclitaxel|mesh-list
24554455|NCT00736619|Cetuximab|cetuximab|mesh-list
24554456|NCT00736619|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24554457|NCT00736619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24554458|NCT00736619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24554459|NCT00736619|Tubulin Modulators|tubulin modulators|mesh-ancestor
24554460|NCT00736619|Antimitotic Agents|antimitotic agents|mesh-ancestor
24554461|NCT00736619|Mitosis Modulators|mitosis modulators|mesh-ancestor
24554462|NCT00736619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554463|NCT00736619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24554476|NCT00736801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24554477|NCT00736801|Respiratory System Agents|respiratory system agents|mesh-ancestor
24554479|NCT00736801|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24554480|NCT00736801|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24554481|NCT00736801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24554482|NCT00736801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24554483|NCT00736801|Adrenergic Agents|adrenergic agents|mesh-ancestor
24554484|NCT00736801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24554485|NCT00736801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554532|NCT00736931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24554533|NCT00736931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554534|NCT00736931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24554535|NCT00736931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24554536|NCT00736931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24554537|NCT00736931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24554538|NCT00736931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25008116|NCT01759836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25008118|NCT01758328|Fludarabine|fludarabine|mesh-list
25008127|NCT01758328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25008128|NCT01758328|Alkylating Agents|alkylating agents|mesh-ancestor
25008129|NCT01758328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24551389|NCT00726011|Tetrodotoxin|tetrodotoxin|mesh-list
25861286|NCT00085943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25861287|NCT00085969|Exenatide|exenatide|mesh-list
25861288|NCT00085969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25861289|NCT00085969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861290|NCT00085969|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25861291|NCT00085969|Incretins|incretins|mesh-ancestor
25214494|NCT00455325|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
25214495|NCT00455325|Amebicides|amebicides|mesh-ancestor
25861292|NCT00085969|Hormones|hormones|mesh-ancestor
24393764|NCT00130936|Capecitabine|capecitabine|mesh-list
24830108|NCT02157311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24830109|NCT02157311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24830111|NCT02157311|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25008165|NCT01745588|Growth Substances|growth substances|mesh-ancestor
25008166|NCT01745588|Growth Inhibitors|growth inhibitors|mesh-ancestor
25008169|NCT01318486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25008170|NCT01318486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25008171|NCT01318486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554547|NCT00736970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24554548|NCT00736970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24554549|NCT00736970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24554606|NCT00737191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24554608|NCT00737191|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24554609|NCT00737191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24554610|NCT00737191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24554611|NCT00737191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554612|NCT00737191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24554613|NCT00737191|Serotonin Agents|serotonin agents|mesh-ancestor
24554614|NCT00737256|Aripiprazole|aripiprazole|mesh-list
24554615|NCT00737256|Perphenazine|perphenazine|mesh-list
24554620|NCT00737256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24554621|NCT00737256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554622|NCT00737256|Dopamine Agonists|dopamine agonists|mesh-ancestor
24554623|NCT00737256|Dopamine Agents|dopamine agents|mesh-ancestor
24554624|NCT00737256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24554625|NCT00737256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554626|NCT00737256|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24554627|NCT00737256|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24554628|NCT00737256|Serotonin Agents|serotonin agents|mesh-ancestor
24554629|NCT00737256|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24554630|NCT00737256|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24554631|NCT00737256|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24554632|NCT00737256|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24554634|NCT00737373|Folic Acid|folic acid|mesh-list
24554644|NCT00737373|Antimetabolites|antimetabolites|mesh-ancestor
24554645|NCT00737373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24554646|NCT00737373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24554647|NCT00737373|Immunologic Factors|immunologic factors|mesh-ancestor
24554648|NCT00737373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554650|NCT00737373|Protective Agents|protective agents|mesh-ancestor
24554651|NCT00737373|Vitamin B Complex|vitamin b complex|mesh-ancestor
24554652|NCT00737373|Vitamins|vitamins|mesh-ancestor
24554654|NCT00737373|Hematinics|hematinics|mesh-ancestor
24554655|NCT00737542|Lidocaine|lidocaine|mesh-list
24554673|NCT00737659|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24554674|NCT00737659|Antitubercular Agents|antitubercular agents|mesh-ancestor
24554675|NCT00737659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24554676|NCT00737659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24554943|NCT00738829|Fludarabine|fludarabine|mesh-list
24554944|NCT00738829|Fludarabine phosphate|fludarabine phosphate|mesh-list
24554945|NCT00738829|Lenalidomide|lenalidomide|mesh-list
24554946|NCT00738829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24554947|NCT00738829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24554948|NCT00738829|Immunologic Factors|immunologic factors|mesh-ancestor
25667701|NCT01708915|Vitamins|vitamins|mesh-ancestor
25667702|NCT01708915|Micronutrients|micronutrients|mesh-ancestor
25667703|NCT01709032|Deferasirox|deferasirox|mesh-list
25667704|NCT01709032|Deferiprone|deferiprone|mesh-list
25667705|NCT01709032|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25667706|NCT01709032|Chelating Agents|chelating agents|mesh-ancestor
25667707|NCT01709032|Sequestering Agents|sequestering agents|mesh-ancestor
25667708|NCT01709032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667709|NCT01709084|Tenofovir|tenofovir|mesh-list
25667710|NCT01709084|Emtricitabine|emtricitabine|mesh-list
25667711|NCT01709084|Efavirenz|efavirenz|mesh-list
25667712|NCT01709084|Rilpivirine|rilpivirine|mesh-list
25667713|NCT01709084|Antiviral Agents|antiviral agents|mesh-ancestor
25861293|NCT00085969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25861294|NCT00086034|Motexafin gadolinium|motexafin gadolinium|mesh-list
25861295|NCT00086034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25214508|NCT00455325|Filaricides|filaricides|mesh-ancestor
25861296|NCT00086034|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24494424|NCT00495183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494425|NCT00495183|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24494426|NCT00495183|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24554949|NCT00738829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554950|NCT00738829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24555327|NCT00741169|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24555328|NCT00741169|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24555329|NCT00741169|Antiviral Agents|antiviral agents|mesh-ancestor
24555330|NCT00741169|Protease Inhibitors|protease inhibitors|mesh-ancestor
24555331|NCT00741182|Teriparatide|teriparatide|mesh-list
24555332|NCT00741182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25008183|NCT01042522|Paclitaxel|paclitaxel|mesh-list
25008184|NCT01042522|Etoposide|etoposide|mesh-list
25008185|NCT01042522|Cisplatin|cisplatin|mesh-list
25008186|NCT01042522|Carboplatin|carboplatin|mesh-list
25008187|NCT01042522|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25008188|NCT01042522|Bleomycin|bleomycin|mesh-list
25008189|NCT01042522|Etoposide phosphate|etoposide phosphate|mesh-list
25008190|NCT01042522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25008191|NCT01042522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008192|NCT01042522|Tubulin Modulators|tubulin modulators|mesh-ancestor
25008193|NCT01042522|Antimitotic Agents|antimitotic agents|mesh-ancestor
24889017|NCT04498689|Paclitaxel|paclitaxel|mesh-list
24555333|NCT00741182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555367|NCT00741325|Plerixafor|plerixafor|mesh-list
24555453|NCT00741585|Autonomic Agents|autonomic agents|mesh-ancestor
24555454|NCT00741585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24555455|NCT00741585|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24555456|NCT00741663|Furosemide|furosemide|mesh-list
24555457|NCT00741663|Spironolactone|spironolactone|mesh-list
24555573|NCT00742092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581141|NCT00864526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25008234|NCT00826462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25008235|NCT00826462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008236|NCT00826462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25008237|NCT00826462|Glucocorticoids|glucocorticoids|mesh-ancestor
24555714|NCT00742846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24555738|NCT00742937|Micronutrients|micronutrients|mesh-ancestor
24555739|NCT00742937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555741|NCT00742976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24555742|NCT00742976|Insulin Detemir|insulin detemir|mesh-list
24555743|NCT00742976|Isophane Insulin, Human|isophane insulin, human|mesh-list
24555744|NCT00742976|Insulin, Isophane|insulin, isophane|mesh-list
24555745|NCT00742976|Isophane insulin, beef|isophane insulin, beef|mesh-list
25099857|NCT03187015|Entinostat|entinostat|mesh-list
24556490|NCT00748007|Cholinergic Agents|cholinergic agents|mesh-ancestor
24556491|NCT00748007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24556492|NCT00748007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556493|NCT00748007|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24556494|NCT00748007|Protective Agents|protective agents|mesh-ancestor
24556495|NCT00748046|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
24552404|NCT03448666|Pembrolizumab|pembrolizumab|mesh-list
24556722|NCT00749359|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24556723|NCT00749359|Antidepressive Agents|antidepressive agents|mesh-ancestor
24791183|NCT05049707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24791184|NCT05049707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791185|NCT05049707|Anesthetics|anesthetics|mesh-ancestor
24791186|NCT05049707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24791187|NCT05049707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24791188|NCT05049707|Anticonvulsants|anticonvulsants|mesh-ancestor
24791189|NCT05049707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24791190|NCT05049707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25008334|NCT00281658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25667714|NCT01709084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25667715|NCT01709084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25667716|NCT01709084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25667717|NCT01709084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25667718|NCT01709084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667719|NCT01709084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25667720|NCT01709084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24803405|NCT01996306|Protective Agents|protective agents|mesh-ancestor
25861297|NCT00086034|Dermatologic Agents|dermatologic agents|mesh-ancestor
24494473|NCT00495326|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24494474|NCT00495326|Antitubercular Agents|antitubercular agents|mesh-ancestor
24494475|NCT00495326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25861298|NCT00086086|Darbepoetin alfa|darbepoetin alfa|mesh-list
24494476|NCT00495326|Leprostatic Agents|leprostatic agents|mesh-ancestor
24494481|NCT00495326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24847637|NCT02248168|Antioxidants|antioxidants|mesh-ancestor
24494515|NCT00495547|Azacitidine|azacitidine|mesh-list
25008335|NCT00281658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008336|NCT00281658|Tubulin Modulators|tubulin modulators|mesh-ancestor
25008337|NCT00281658|Antimitotic Agents|antimitotic agents|mesh-ancestor
25008338|NCT00281658|Mitosis Modulators|mitosis modulators|mesh-ancestor
24556726|NCT00749359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24556728|NCT00749385|Naproxen|naproxen|mesh-list
24556729|NCT00749385|Esomeprazole|esomeprazole|mesh-list
24556730|NCT00749385|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24556776|NCT00749619|Sodium Citrate|sodium citrate|mesh-list
24556777|NCT00749619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24556778|NCT00749619|Anticoagulants|anticoagulants|mesh-ancestor
24556779|NCT00749619|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24556780|NCT00749619|Chelating Agents|chelating agents|mesh-ancestor
24556781|NCT00749619|Sequestering Agents|sequestering agents|mesh-ancestor
24556782|NCT00749619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556783|NCT00749619|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24556784|NCT00749619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24556785|NCT00749619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24556786|NCT00749619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24556787|NCT00749619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556788|NCT00749710|Clopidogrel|clopidogrel|mesh-list
24570597|NCT00805311|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24570598|NCT00805311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24556789|NCT00749710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24556790|NCT00749710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24556791|NCT00749710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24556792|NCT00749710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24556793|NCT00749710|Purinergic Agents|purinergic agents|mesh-ancestor
24581290|NCT00864838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24556794|NCT00749710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24556795|NCT00749710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556796|NCT00749710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556797|NCT00749723|Carboplatin|carboplatin|mesh-list
24556799|NCT00749723|Etoposide phosphate|etoposide phosphate|mesh-list
24556800|NCT00749723|Temozolomide|temozolomide|mesh-list
24556925|NCT00750386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556926|NCT00750386|Tubulin Modulators|tubulin modulators|mesh-ancestor
24556928|NCT00750386|Mitosis Modulators|mitosis modulators|mesh-ancestor
24556929|NCT00750386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556930|NCT00750399|Ranibizumab|ranibizumab|mesh-list
24557172|NCT00751556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24557173|NCT00751556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861299|NCT00086086|Hematinics|hematinics|mesh-ancestor
25861300|NCT00086099|Amifostine|amifostine|mesh-list
25861301|NCT00086099|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25861302|NCT00086099|Protective Agents|protective agents|mesh-ancestor
25861303|NCT00086099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557383|NCT00752466|Anticonvulsants|anticonvulsants|mesh-ancestor
24557384|NCT00752466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24557385|NCT00752466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557386|NCT00752466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24557387|NCT00752466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24557388|NCT00752466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557389|NCT00752466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24557390|NCT00752466|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24557391|NCT00752466|Histamine Antagonists|histamine antagonists|mesh-ancestor
24557392|NCT00752466|Histamine Agents|histamine agents|mesh-ancestor
24557393|NCT00752466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25667721|NCT01709084|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25667722|NCT01709084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25667723|NCT01709084|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25667724|NCT01709084|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25667725|NCT01709084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25667726|NCT01709084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25667727|NCT01709110|Vitamin D|vitamin d|mesh-list
24494651|NCT00496275|Antimetabolites|antimetabolites|mesh-ancestor
24793299|NCT03568604|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24793300|NCT03568604|Immunologic Factors|immunologic factors|mesh-ancestor
24793301|NCT03568604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793302|NCT03542695|Alendronate|alendronate|mesh-list
24536155|NCT00650416|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24793304|NCT03542695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24793305|NCT03542695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793306|NCT03542695|Trace Elements|trace elements|mesh-ancestor
24793307|NCT03542695|Micronutrients|micronutrients|mesh-ancestor
25214512|NCT00382200|Tretinoin|tretinoin|mesh-list
25214513|NCT00382200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25214514|NCT00382200|Antimetabolites|antimetabolites|mesh-ancestor
25214515|NCT00382200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214516|NCT00382200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25214517|NCT00382200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25214518|NCT00382200|Keratolytic Agents|keratolytic agents|mesh-ancestor
24557394|NCT00752466|Vasodilator Agents|vasodilator agents|mesh-ancestor
24557395|NCT00752479|Cyclosporine|cyclosporine|mesh-list
24557454|NCT00752635|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24557455|NCT00752635|Estradiol|estradiol|mesh-list
24557458|NCT00752635|Estrogens|estrogens|mesh-ancestor
24557730|NCT00753727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24557731|NCT00753727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25861304|NCT00086112|Risperidone|risperidone|mesh-list
24557787|NCT00753909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24557879|NCT00754689|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24557882|NCT00754689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557884|NCT00754689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24557885|NCT00754702|Vinorelbine|vinorelbine|mesh-list
24557886|NCT00754702|Lapatinib|lapatinib|mesh-list
24557887|NCT00754702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24557888|NCT00754702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24557889|NCT00754702|Tubulin Modulators|tubulin modulators|mesh-ancestor
24557890|NCT00754702|Antimitotic Agents|antimitotic agents|mesh-ancestor
24557891|NCT00754702|Mitosis Modulators|mitosis modulators|mesh-ancestor
24557892|NCT00754702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557894|NCT00754702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557895|NCT00754780|Pirfenidone|pirfenidone|mesh-list
24557896|NCT00754780|Analgesics|analgesics|mesh-ancestor
24557898|NCT00754780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24791236|NCT04908657|Sildenafil Citrate|sildenafil citrate|mesh-list
24791237|NCT04908657|Vasodilator Agents|vasodilator agents|mesh-ancestor
24791238|NCT04908657|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24791239|NCT04908657|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24791240|NCT04908657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24791241|NCT04908657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791242|NCT04908657|Urological Agents|urological agents|mesh-ancestor
24791243|NCT04887389|Listerine|listerine|mesh-list
24557950|NCT00754910|Dermatologic Agents|dermatologic agents|mesh-ancestor
24557951|NCT00754910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24558078|NCT00755313|Antimitotic Agents|antimitotic agents|mesh-ancestor
24558079|NCT00755313|Mitosis Modulators|mitosis modulators|mesh-ancestor
24558080|NCT00755313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24558100|NCT00755456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24558101|NCT00755495|Doxepin|doxepin|mesh-list
24558102|NCT00755495|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24558103|NCT00755495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25667728|NCT01709110|Teriparatide|teriparatide|mesh-list
25667729|NCT01709110|Risedronic Acid|risedronic acid|mesh-list
25667730|NCT01709110|Calcium|calcium|mesh-list
25667731|NCT01709110|Vitamins|vitamins|mesh-ancestor
25667732|NCT01709110|Micronutrients|micronutrients|mesh-ancestor
25667733|NCT01709110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667734|NCT01709110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25667735|NCT01709110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25667736|NCT01709110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25667737|NCT01709110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25667738|NCT01709110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667739|NCT01709149|Riluzole|riluzole|mesh-list
25667740|NCT01709149|Anticonvulsants|anticonvulsants|mesh-ancestor
25667741|NCT01709149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25667742|NCT01709149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25667743|NCT01709149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25674427|NCT01772134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24793451|NCT03467386|Cyclophosphamide|cyclophosphamide|mesh-list
25214521|NCT00321555|Immunologic Factors|immunologic factors|mesh-ancestor
25214522|NCT00321555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214523|NCT02696928|Lumefantrine|lumefantrine|mesh-list
25861305|NCT00086112|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25861306|NCT00086112|Serotonin Agents|serotonin agents|mesh-ancestor
25861307|NCT00086112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25861308|NCT00086112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861309|NCT00086112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25157990|NCT04537598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24558104|NCT00755495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24558105|NCT00755495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558106|NCT00755495|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24558107|NCT00755495|Antidepressive Agents|antidepressive agents|mesh-ancestor
25861310|NCT00086112|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25861311|NCT00086112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25861312|NCT00086112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25667744|NCT01709149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667745|NCT01709149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667746|NCT01709149|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25667747|NCT01709149|Protective Agents|protective agents|mesh-ancestor
24558108|NCT00755495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24558163|NCT00755560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558231|NCT00755859|Protective Agents|protective agents|mesh-ancestor
24558232|NCT00755859|Antiemetics|antiemetics|mesh-ancestor
24558233|NCT00755859|Autonomic Agents|autonomic agents|mesh-ancestor
24558234|NCT00755859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24558235|NCT00755859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24558504|NCT00757523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24558610|NCT00758199|Bromfenac|bromfenac|mesh-list
24671003|NCT01323101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24558680|NCT05436002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008399|NCT05208879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008401|NCT05208879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008402|NCT05208827|Vitamin D|vitamin d|mesh-list
25008403|NCT05208827|Ergocalciferols|ergocalciferols|mesh-list
25008404|NCT05208827|Cholecalciferol|cholecalciferol|mesh-list
25008405|NCT05208827|Vitamins|vitamins|mesh-list
25008406|NCT05208827|Micronutrients|micronutrients|mesh-ancestor
24558969|NCT05382338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24559004|NCT05343156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100333|NCT03184194|Alkylating Agents|alkylating agents|mesh-ancestor
24553100|NCT00729495|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24559105|NCT05291364|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24559106|NCT05291364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24559107|NCT05291221|Lidocaine|lidocaine|mesh-list
24559108|NCT05291221|Dexmedetomidine|dexmedetomidine|mesh-list
24559109|NCT05291221|Anesthetics, Local|anesthetics, local|mesh-ancestor
24559110|NCT05291221|Anesthetics|anesthetics|mesh-ancestor
24559111|NCT05291221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24559112|NCT05291221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24559113|NCT05291221|Sensory System Agents|sensory system agents|mesh-ancestor
24559459|NCT04767061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24559460|NCT04767061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24559461|NCT04767061|Vasodilator Agents|vasodilator agents|mesh-ancestor
24559462|NCT04767061|Sympatholytics|sympatholytics|mesh-ancestor
24559463|NCT04767061|Autonomic Agents|autonomic agents|mesh-ancestor
24559572|NCT04643574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24559573|NCT04643574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24559574|NCT04643574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24559575|NCT04643574|Alkylating Agents|alkylating agents|mesh-ancestor
24559576|NCT04643574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24559577|NCT04643574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24559578|NCT04643574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25100517|NCT03182374|Hylan|hylan|mesh-list
24559970|NCT03916419|Durvalumab|durvalumab|mesh-list
25667748|NCT01709162|Ipilimumab|ipilimumab|mesh-list
25667749|NCT01709162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25667750|NCT01709162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25667751|NCT01709162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25667752|NCT01709162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667753|NCT01709227|Furosemide|furosemide|mesh-list
25667754|NCT01709227|Diuretics|diuretics|mesh-ancestor
25667755|NCT01709227|Natriuretic Agents|natriuretic agents|mesh-ancestor
24636376|NCT01144988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25667756|NCT01709227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24559971|NCT03916419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24553461|NCT00731302|Aspirin|aspirin|mesh-list
24560330|NCT02915224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24560331|NCT02915224|Alkylating Agents|alkylating agents|mesh-ancestor
24560332|NCT02915224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560334|NCT02912572|Axitinib|axitinib|mesh-list
24560335|NCT02912572|Talazoparib|talazoparib|mesh-list
24560336|NCT02912572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24560337|NCT02912572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24560338|NCT02912572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24560365|NCT02870920|Tremelimumab|tremelimumab|mesh-list
24560487|NCT02476279|Analgesics|analgesics|mesh-ancestor
24560488|NCT02476279|Sensory System Agents|sensory system agents|mesh-ancestor
24560489|NCT02476279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24560490|NCT02476279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24560491|NCT02476279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24560492|NCT02476279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24560501|NCT02471833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24560502|NCT02471833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24560658|NCT02018861|Carboplatin|carboplatin|mesh-list
24560659|NCT02018861|Etoposide|etoposide|mesh-list
24561597|NCT00761644|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25861313|NCT00086112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25861314|NCT00086112|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25861315|NCT00086112|Dopamine Agents|dopamine agents|mesh-ancestor
25861316|NCT00086125|Sirolimus|sirolimus|mesh-list
25861317|NCT00086125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25861318|NCT00086125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25861319|NCT00086125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25861320|NCT00086125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861321|NCT00086125|Antifungal Agents|antifungal agents|mesh-ancestor
24561620|NCT00761670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561621|NCT00761670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100670|NCT03180775|Glycine|glycine|mesh-list
24561705|NCT00762398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24561706|NCT00762398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24561707|NCT00762567|Phenylephrine|phenylephrine|mesh-list
24561708|NCT00762567|Oxymetazoline|oxymetazoline|mesh-list
24561709|NCT00762567|Nasal Decongestants|nasal decongestants|mesh-list
24561710|NCT00762567|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24561711|NCT00762567|Mydriatics|mydriatics|mesh-ancestor
24561712|NCT00762567|Autonomic Agents|autonomic agents|mesh-ancestor
24561738|NCT00762658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561740|NCT00762658|Glucocorticoids|glucocorticoids|mesh-ancestor
24561741|NCT00762658|Hormones|hormones|mesh-ancestor
24561742|NCT00762658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24554020|NCT00733811|Siderophores|siderophores|mesh-ancestor
24561887|NCT00763568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24561888|NCT00763568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24561889|NCT00763620|Dimercaprol|dimercaprol|mesh-list
24561890|NCT00763620|Chelating Agents|chelating agents|mesh-ancestor
24561891|NCT00763620|Sequestering Agents|sequestering agents|mesh-ancestor
24561896|NCT00763633|Pyridoxine|pyridoxine|mesh-list
24561897|NCT00763633|Vitamin B Complex|vitamin b complex|mesh-list
24561898|NCT00763633|Micronutrients|micronutrients|mesh-ancestor
24561946|NCT00763789|Remifentanil|remifentanil|mesh-list
24561947|NCT00763789|Anesthetics|anesthetics|mesh-list
24561948|NCT00763789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24561949|NCT00763789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561950|NCT00763789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24561951|NCT00763789|Narcotics|narcotics|mesh-ancestor
24561952|NCT00763789|Analgesics|analgesics|mesh-ancestor
24561953|NCT00763789|Sensory System Agents|sensory system agents|mesh-ancestor
24561954|NCT00763789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24561955|NCT00763880|Lidocaine|lidocaine|mesh-list
24561956|NCT00763880|Anesthetics, Local|anesthetics, local|mesh-ancestor
24561957|NCT00763880|Anesthetics|anesthetics|mesh-ancestor
25667757|NCT01709227|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25667758|NCT01709227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25667759|NCT01709227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667760|NCT01709305|Metformin|metformin|mesh-list
25667761|NCT01709305|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25667762|NCT01709305|Glimepiride|glimepiride|mesh-list
25667763|NCT01709305|Acarbose|acarbose|mesh-list
25667764|NCT01709305|Repaglinide|repaglinide|mesh-list
25667765|NCT01709305|Gliclazide|gliclazide|mesh-list
25667766|NCT01709305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25667767|NCT01709305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861322|NCT00086125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24494891|NCT00497471|Antimalarials|antimalarials|mesh-ancestor
24494892|NCT00497471|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25861323|NCT00086125|Immunologic Factors|immunologic factors|mesh-ancestor
24564349|NCT00776022|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24561960|NCT00763880|Sensory System Agents|sensory system agents|mesh-ancestor
24561961|NCT00763880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24582164|NCT00868426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24562042|NCT00764244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562044|NCT00764374|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24562045|NCT00764374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562046|NCT00764374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562047|NCT00764374|Cholinergic Agents|cholinergic agents|mesh-ancestor
24562048|NCT00764374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24562283|NCT00765427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24562284|NCT00765427|Immunologic Factors|immunologic factors|mesh-ancestor
24562285|NCT00765427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562286|NCT00765427|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24791412|NCT04476979|Autonomic Agents|autonomic agents|mesh-ancestor
25008576|NCT05081206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008577|NCT05081206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25008578|NCT05081206|Anesthetics, General|anesthetics, general|mesh-ancestor
25008579|NCT05081206|Anesthetics|anesthetics|mesh-ancestor
25109853|NCT03121417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109854|NCT03121417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25109855|NCT03121417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109856|NCT03121313|Tegafur|tegafur|mesh-list
25109857|NCT03121313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25109858|NCT03121313|Antimetabolites|antimetabolites|mesh-ancestor
25109859|NCT03121313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562685|NCT00767715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24562730|NCT00767871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24562732|NCT00767871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24562734|NCT00767975|Isoniazid|isoniazid|mesh-list
24562735|NCT00767975|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24562736|NCT00767975|Antitubercular Agents|antitubercular agents|mesh-ancestor
24562737|NCT00767975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25861324|NCT00086125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861325|NCT00086177|Progesterone|progesterone|mesh-list
24562790|NCT00768209|Appetite Depressants|appetite depressants|mesh-ancestor
24562791|NCT00768209|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24562820|NCT00768508|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24562821|NCT00768508|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24562822|NCT00768508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562823|NCT00768508|Sensory System Agents|sensory system agents|mesh-ancestor
25861326|NCT00086177|Progestins|progestins|mesh-ancestor
24563081|NCT00769990|Phytoestrogens|phytoestrogens|mesh-ancestor
24563082|NCT00769990|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24563083|NCT00769990|Estrogens|estrogens|mesh-ancestor
24563084|NCT00769990|Hormones|hormones|mesh-ancestor
24563112|NCT00770172|Immunologic Factors|immunologic factors|mesh-ancestor
24563149|NCT00770406|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24563150|NCT00770406|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24563151|NCT00770406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24563186|NCT00770536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24563187|NCT00770536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24563188|NCT00770536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24563189|NCT00770536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563190|NCT00770536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791568|NCT03920007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791569|NCT03920007|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24791570|NCT03920007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24791571|NCT03920007|Renal Agents|renal agents|mesh-ancestor
24791572|NCT03920007|Antimalarials|antimalarials|mesh-ancestor
24791573|NCT03920007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24791574|NCT03920007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25667768|NCT01709305|Incretins|incretins|mesh-ancestor
25667769|NCT01709305|Hormones|hormones|mesh-ancestor
25667770|NCT01709305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25667771|NCT01709305|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25667772|NCT01709305|Protease Inhibitors|protease inhibitors|mesh-ancestor
25667773|NCT01709305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25667774|NCT01709305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791576|NCT03920007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564734|NCT00777673|Antimitotic Agents|antimitotic agents|mesh-ancestor
24791579|NCT03920007|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24791580|NCT03920007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24791581|NCT03920007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24563467|NCT00771680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563469|NCT00771706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24554586|NCT00737139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24563479|NCT00771823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25861327|NCT00086177|Hormones|hormones|mesh-ancestor
24563509|NCT00772135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563510|NCT00772135|Urological Agents|urological agents|mesh-ancestor
24563511|NCT00772161|Methylphenidate|methylphenidate|mesh-list
25008637|NCT04879368|Nivolumab|nivolumab|mesh-list
25008638|NCT04879368|Irinotecan|irinotecan|mesh-list
25008639|NCT04879368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25008640|NCT04879368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008641|NCT04879368|Tubulin Modulators|tubulin modulators|mesh-ancestor
25100970|NCT03178396|Melatonin|melatonin|mesh-list
24554691|NCT00737724|Efavirenz|efavirenz|mesh-list
24563699|NCT00772902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24563700|NCT00772902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24563701|NCT00772902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563702|NCT00772902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554748|NCT00737880|Pancrelipase|pancrelipase|mesh-list
25008666|NCT04720963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008667|NCT04720963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25008703|NCT04690192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25008704|NCT04690192|Immunologic Factors|immunologic factors|mesh-ancestor
25008705|NCT04690192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008706|NCT04690192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25008707|NCT04690192|Alkylating Agents|alkylating agents|mesh-ancestor
25008708|NCT04690192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24891683|NCT04468438|Estrogens|estrogens|mesh-list
24563879|NCT00774241|Docetaxel|docetaxel|mesh-list
24563880|NCT00774241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24563881|NCT00774241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24563892|NCT00774280|Busulfan|busulfan|mesh-list
24563893|NCT00774280|Fludarabine|fludarabine|mesh-list
24563894|NCT00774280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24563895|NCT00774280|Immunologic Factors|immunologic factors|mesh-ancestor
24563896|NCT00774280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563897|NCT00774280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24563898|NCT00774280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25861328|NCT00086177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25861329|NCT00086177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564014|NCT00774735|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24564015|NCT00774735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199356|NCT02741232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25117179|NCT05375188|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25117180|NCT05375188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25117185|NCT05374603|Durvalumab|durvalumab|mesh-list
24554990|NCT00739141|Immunologic Factors|immunologic factors|mesh-ancestor
24564120|NCT00775151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24628868|NCT01101698|Vitamins|vitamins|mesh-list
24628869|NCT01101698|Vitamin K|vitamin k|mesh-list
24628870|NCT01101698|Vitamin K 2|vitamin k 2|mesh-list
24564131|NCT00775177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24564291|NCT00775762|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24564293|NCT00775762|Purinergic Agents|purinergic agents|mesh-ancestor
24564294|NCT00775762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24564295|NCT00775814|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24564296|NCT00775814|Candesartan|candesartan|mesh-list
24564297|NCT00775814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24564320|NCT00775879|Anesthetics|anesthetics|mesh-ancestor
24564321|NCT00775879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24564322|NCT00775879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564323|NCT00775905|Amlodipine|amlodipine|mesh-list
24564324|NCT00775905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24778621|NCT01871740|Folic Acid|folic acid|mesh-list
25861330|NCT00086203|Rituximab|rituximab|mesh-list
25861331|NCT00086203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24564348|NCT00776022|Cetirizine|cetirizine|mesh-list
24564350|NCT00776022|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24564351|NCT00776022|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24564352|NCT00776022|Histamine Antagonists|histamine antagonists|mesh-ancestor
24555238|NCT00740493|Warfarin|warfarin|mesh-list
24564394|NCT00776217|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24564395|NCT00776217|Histamine Antagonists|histamine antagonists|mesh-ancestor
24564396|NCT00776217|Histamine Agents|histamine agents|mesh-ancestor
24564397|NCT00776217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24564398|NCT00776217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564399|NCT00776217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564400|NCT00776282|Loratadine|loratadine|mesh-list
24564401|NCT00776282|Antipruritics|antipruritics|mesh-ancestor
24564402|NCT00776282|Dermatologic Agents|dermatologic agents|mesh-ancestor
24564403|NCT00776282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24564404|NCT00776282|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24564405|NCT00776282|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24564406|NCT00776282|Histamine Antagonists|histamine antagonists|mesh-ancestor
24564407|NCT00776282|Histamine Agents|histamine agents|mesh-ancestor
24564408|NCT00776282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24564409|NCT00776282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564410|NCT00776282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564411|NCT00776334|Fosinopril|fosinopril|mesh-list
24564412|NCT00776334|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24564413|NCT00776334|Protease Inhibitors|protease inhibitors|mesh-ancestor
24564414|NCT00776334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564415|NCT00776334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564416|NCT00776334|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24564417|NCT00776347|Donepezil|donepezil|mesh-list
24564418|NCT00776347|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24776983|NCT01860833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24564419|NCT00776347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564420|NCT00776347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564421|NCT00776347|Cholinergic Agents|cholinergic agents|mesh-ancestor
24564422|NCT00776347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24564423|NCT00776347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564424|NCT00776347|Nootropic Agents|nootropic agents|mesh-ancestor
24564425|NCT00776360|Oxytocin|oxytocin|mesh-list
24564426|NCT00776360|Oxytocics|oxytocics|mesh-ancestor
24564427|NCT00776360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24564428|NCT00776360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564429|NCT00776425|Epoetin Alfa|epoetin alfa|mesh-list
25199357|NCT02741232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25199358|NCT02741232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24564430|NCT00776425|Hematinics|hematinics|mesh-ancestor
25199359|NCT02741232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24564642|NCT00777322|Riboflavin|riboflavin|mesh-list
24564643|NCT00777322|Dextrans|dextrans|mesh-list
24564644|NCT00777322|Vitamin B Complex|vitamin b complex|mesh-ancestor
24564645|NCT00777322|Vitamins|vitamins|mesh-ancestor
24564646|NCT00777322|Micronutrients|micronutrients|mesh-ancestor
24564647|NCT00777322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564648|NCT00777322|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24564649|NCT00777322|Dermatologic Agents|dermatologic agents|mesh-ancestor
24564650|NCT00777322|Anticoagulants|anticoagulants|mesh-ancestor
24564651|NCT00777322|Plasma Substitutes|plasma substitutes|mesh-ancestor
24564652|NCT00777322|Blood Substitutes|blood substitutes|mesh-ancestor
24564653|NCT00777413|Minocycline|minocycline|mesh-list
24564654|NCT00777413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24564655|NCT00777413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24564671|NCT00777478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564673|NCT00777478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24564674|NCT00777478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564675|NCT00777478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564676|NCT00777504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
24564677|NCT00777504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24564678|NCT00777504|Growth Substances|growth substances|mesh-ancestor
24564679|NCT00777504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564680|NCT00777504|Growth Inhibitors|growth inhibitors|mesh-ancestor
24564681|NCT00777504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24564695|NCT00777543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24564730|NCT00777673|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24564731|NCT00777673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24564732|NCT00777673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270969|NCT02402114|Hydrocortisone|hydrocortisone|mesh-list
24564733|NCT00777673|Tubulin Modulators|tubulin modulators|mesh-ancestor
24564735|NCT00777673|Mitosis Modulators|mitosis modulators|mesh-ancestor
24564736|NCT00777673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564737|NCT00777673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24564738|NCT00777673|Immunologic Factors|immunologic factors|mesh-ancestor
24564774|NCT00777959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24564775|NCT00777959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24564776|NCT00777959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24564777|NCT00777959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572340|NCT00814268|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24564778|NCT00777959|Antifungal Agents|antifungal agents|mesh-ancestor
24564779|NCT00777959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24564780|NCT00777959|Immunologic Factors|immunologic factors|mesh-ancestor
24564781|NCT00777959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564782|NCT00777972|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24564783|NCT00777972|Fosinopril|fosinopril|mesh-list
24564784|NCT00777972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24564785|NCT00777972|Diuretics|diuretics|mesh-ancestor
24564786|NCT00777972|Natriuretic Agents|natriuretic agents|mesh-ancestor
24564787|NCT00777972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564788|NCT00777972|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25101285|NCT03175926|Budesonide|budesonide|mesh-list
24564917|NCT00778193|Naproxen|naproxen|mesh-list
24564918|NCT00778193|Clopidogrel|clopidogrel|mesh-list
24564919|NCT00778193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25101358|NCT03175653|Oxycodone|oxycodone|mesh-list
24564989|NCT00778401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24564990|NCT00778401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24564991|NCT00778401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24564992|NCT00778401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24564993|NCT00778401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24564994|NCT00778401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24564999|NCT00778414|Clavulanic Acids|clavulanic acids|mesh-list
24565000|NCT00778414|Clavulanic Acid|clavulanic acid|mesh-list
24565001|NCT00778414|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24565002|NCT00778414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24565003|NCT00778414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24565004|NCT00778414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565005|NCT00778414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565006|NCT00778414|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25199360|NCT02741232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24565070|NCT00778674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24565072|NCT00778674|Natriuretic Agents|natriuretic agents|mesh-ancestor
24565073|NCT00778674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565074|NCT00778674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25861332|NCT00086203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24565075|NCT00778674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24565076|NCT00778674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565077|NCT00778674|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24565078|NCT00778674|Protease Inhibitors|protease inhibitors|mesh-ancestor
24565079|NCT00778674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24791647|NCT03659734|Analgesics|analgesics|mesh-ancestor
24791648|NCT03659734|Sensory System Agents|sensory system agents|mesh-ancestor
24791649|NCT03659734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24791651|NCT03649048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791652|NCT03623633|Denosumab|denosumab|mesh-list
24791653|NCT03623633|Alendronate|alendronate|mesh-list
24791654|NCT03623633|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
24791655|NCT03623633|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25101424|NCT03174860|Diclofenac|diclofenac|mesh-list
24566030|NCT00784017|Asparaginase|asparaginase|mesh-list
25008745|NCT04513860|Cenobamate|cenobamate|mesh-list
25008746|NCT04513860|Anticonvulsants|anticonvulsants|mesh-ancestor
25008747|NCT04503148|Propofol|propofol|mesh-list
25008748|NCT04503148|Anesthetics|anesthetics|mesh-list
25008749|NCT04503148|Anesthetics, General|anesthetics, general|mesh-list
25008750|NCT04503148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
25101470|NCT03174756|Disinfectants|disinfectants|mesh-ancestor
24565131|NCT00778778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24565132|NCT00778778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24565134|NCT00778791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24565164|NCT00779064|Antithrombins|antithrombins|mesh-ancestor
24565165|NCT00779064|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24565166|NCT00779064|Protease Inhibitors|protease inhibitors|mesh-ancestor
24565167|NCT00779064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565168|NCT00779064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565341|NCT00779805|Nasal Decongestants|nasal decongestants|mesh-ancestor
24565343|NCT00779805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24565344|NCT00779805|Sympathomimetics|sympathomimetics|mesh-ancestor
24565345|NCT00779805|Adrenergic Agents|adrenergic agents|mesh-ancestor
24565346|NCT00779805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24565347|NCT00779805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565349|NCT00779831|Ephedrine|ephedrine|mesh-list
24565350|NCT00779831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24565351|NCT00779831|Autonomic Agents|autonomic agents|mesh-ancestor
24565352|NCT00779831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24565353|NCT00779831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565354|NCT00779831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24565355|NCT00779831|Respiratory System Agents|respiratory system agents|mesh-ancestor
24565356|NCT00779831|Nasal Decongestants|nasal decongestants|mesh-ancestor
24565357|NCT00779831|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24565418|NCT00780182|Brincidofovir|brincidofovir|mesh-list
24565419|NCT00780182|Antiviral Agents|antiviral agents|mesh-ancestor
24565420|NCT00780182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25008762|NCT04498468|Glucocorticoids|glucocorticoids|mesh-ancestor
25008763|NCT04498468|Hormones|hormones|mesh-ancestor
25008764|NCT04498468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25008765|NCT04498468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25008766|NCT04498468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008767|NCT04474223|Dexamethasone|dexamethasone|mesh-list
24565454|NCT00780637|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
24565455|NCT00780637|Protease Inhibitors|protease inhibitors|mesh-ancestor
24565456|NCT00780637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565457|NCT00780637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565458|NCT00780650|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24565459|NCT00780650|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24565460|NCT00780650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24565461|NCT00780650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25101559|NCT03174041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24565585|NCT00781300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24565587|NCT00781300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24565588|NCT00781300|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24565589|NCT00781352|Nitrous Oxide|nitrous oxide|mesh-list
24565590|NCT00781352|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24565591|NCT00781352|Anesthetics, General|anesthetics, general|mesh-ancestor
24565592|NCT00781352|Anesthetics|anesthetics|mesh-ancestor
24565593|NCT00781352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24583702|NCT00876434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24583703|NCT00876434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24565594|NCT00781352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565595|NCT00781352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24565596|NCT00781352|Analgesics|analgesics|mesh-ancestor
24443139|NCT00293761|Travoprost|travoprost|mesh-list
24565621|NCT00781417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565622|NCT00781417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24556215|NCT00746031|Hormone Antagonists|hormone antagonists|mesh-ancestor
24565666|NCT00781586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24565667|NCT00781586|Purinergic Agents|purinergic agents|mesh-ancestor
24565668|NCT00781586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24565669|NCT00781625|Methenamine hippurate|methenamine hippurate|mesh-list
24565670|NCT00781625|Methenamine|methenamine|mesh-list
24565671|NCT00781625|Methenamine mandelate|methenamine mandelate|mesh-list
24565672|NCT00781625|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24565673|NCT00781625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24565674|NCT00781625|Renal Agents|renal agents|mesh-ancestor
24565675|NCT00781625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24565676|NCT00781755|Varenicline|varenicline|mesh-list
24565677|NCT00781755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24565816|NCT00782847|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24565817|NCT00782847|Contraceptive Agents|contraceptive agents|mesh-ancestor
24565818|NCT00782847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24565820|NCT00782951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24565821|NCT00782951|Narcotics|narcotics|mesh-ancestor
24556339|NCT00747110|Glucocorticoids|glucocorticoids|mesh-ancestor
24565870|NCT00783107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565871|NCT00783107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24565872|NCT00783107|Immunologic Factors|immunologic factors|mesh-ancestor
25101629|NCT03173235|Vitamin D|vitamin d|mesh-list
25008792|NCT04368910|Antiviral Agents|antiviral agents|mesh-ancestor
25008793|NCT04368910|Schistosomicides|schistosomicides|mesh-ancestor
25008797|NCT04368910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24565892|NCT00783172|Mitosis Modulators|mitosis modulators|mesh-ancestor
24565893|NCT00783172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24565894|NCT00783250|Albuterol|albuterol|mesh-list
24565895|NCT00783250|Tiotropium Bromide|tiotropium bromide|mesh-list
25861333|NCT00086203|Immunologic Factors|immunologic factors|mesh-ancestor
25861334|NCT00086203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082735|NCT03320486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25082736|NCT03320486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25082737|NCT03320486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793673|NCT02793375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24793674|NCT02793375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793675|NCT02793375|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24793676|NCT02793375|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24793677|NCT02793375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214587|NCT02696915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25214588|NCT02696915|Anesthetics, General|anesthetics, general|mesh-ancestor
25214589|NCT02696590|Vitamin D|vitamin d|mesh-list
24565896|NCT00783250|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24565897|NCT00783250|Autonomic Agents|autonomic agents|mesh-ancestor
24565898|NCT00783250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24565899|NCT00783250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565900|NCT00783250|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24565901|NCT00783250|Respiratory System Agents|respiratory system agents|mesh-ancestor
25667775|NCT01709305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24565902|NCT00783250|Parasympatholytics|parasympatholytics|mesh-ancestor
24565903|NCT00783250|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24565904|NCT00783250|Cholinergic Agents|cholinergic agents|mesh-ancestor
24565905|NCT00783250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24565906|NCT00783250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565907|NCT00783250|Tocolytic Agents|tocolytic agents|mesh-ancestor
24565908|NCT00783250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24565909|NCT00783250|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24565910|NCT00783250|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24565911|NCT00783250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24565912|NCT00783250|Adrenergic Agents|adrenergic agents|mesh-ancestor
24565913|NCT00783380|Vaccines|vaccines|mesh-list
24565914|NCT00783380|Immunologic Factors|immunologic factors|mesh-ancestor
24565923|NCT00783471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24444062|NCT00296686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444063|NCT00296686|Dopamine Agents|dopamine agents|mesh-ancestor
24444064|NCT00296686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24444065|NCT00296686|Antidepressive Agents|antidepressive agents|mesh-ancestor
24444066|NCT00296686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24444072|NCT00296699|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24444073|NCT00296699|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24444074|NCT00296699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25117575|NCT05020860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117576|NCT05020860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25117577|NCT05020860|Immunologic Factors|immunologic factors|mesh-ancestor
25117578|NCT05020860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117579|NCT05020860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25117588|NCT05012566|Botulinum Toxins|botulinum toxins|mesh-list
24565924|NCT00783471|Tubulin Modulators|tubulin modulators|mesh-ancestor
24565925|NCT00783471|Antimitotic Agents|antimitotic agents|mesh-ancestor
24566027|NCT00783926|Immunologic Factors|immunologic factors|mesh-ancestor
24566028|NCT00783926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566029|NCT00783926|Agglutinins|agglutinins|mesh-ancestor
24566036|NCT00784082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566270|NCT00784940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566271|NCT00784940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25667776|NCT01709305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25667777|NCT01709305|Immunologic Factors|immunologic factors|mesh-ancestor
25667778|NCT01709305|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25667779|NCT01709409|Poractant alfa|poractant alfa|mesh-list
25667780|NCT01709409|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
25667781|NCT01709409|Respiratory System Agents|respiratory system agents|mesh-ancestor
25667782|NCT01709422|Midazolam|midazolam|mesh-list
25667783|NCT01709422|Meperidine|meperidine|mesh-list
25667784|NCT01709422|Propofol|propofol|mesh-list
25667785|NCT01709422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25667786|NCT01709422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25667787|NCT01709422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667788|NCT01709422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25667789|NCT01709422|Anesthetics, General|anesthetics, general|mesh-ancestor
25667790|NCT01709422|Anesthetics|anesthetics|mesh-ancestor
25667791|NCT01709422|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24566273|NCT00784940|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24566274|NCT00784940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24566275|NCT00784940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24566276|NCT00784940|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24566278|NCT00784940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25101763|NCT03172793|Telavancin|telavancin|mesh-list
24566392|NCT00785434|Antidepressive Agents|antidepressive agents|mesh-ancestor
24566393|NCT00785434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24566394|NCT00785460|Benphothiamine|benphothiamine|mesh-list
24566395|NCT00785460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24566493|NCT00786110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566494|NCT00786136|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24566495|NCT00786136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24566496|NCT00786136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24566497|NCT00786136|Antimetabolites|antimetabolites|mesh-ancestor
25199361|NCT02741232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199362|NCT02741232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25199363|NCT02741232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25199364|NCT02741232|Adrenergic Agents|adrenergic agents|mesh-ancestor
25199365|NCT02741232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25199366|NCT02741232|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25199367|NCT02741232|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25199368|NCT02741232|Autonomic Agents|autonomic agents|mesh-ancestor
25199369|NCT02741232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25199370|NCT02741232|Respiratory System Agents|respiratory system agents|mesh-ancestor
25199371|NCT02741232|Mydriatics|mydriatics|mesh-ancestor
25199372|NCT02741232|Sympathomimetics|sympathomimetics|mesh-ancestor
25199373|NCT02741232|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25199374|NCT02741427|Carbamide Peroxide|carbamide peroxide|mesh-list
25199375|NCT02741427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25199376|NCT02741427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25199377|NCT02741414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25199378|NCT02741414|Amoxicillin|amoxicillin|mesh-list
25199379|NCT02741414|Metronidazole|metronidazole|mesh-list
25199380|NCT02741414|Clarithromycin|clarithromycin|mesh-list
25199381|NCT02741414|Levofloxacin|levofloxacin|mesh-list
25199382|NCT02741414|Ofloxacin|ofloxacin|mesh-list
25199383|NCT02741414|Tetracycline|tetracycline|mesh-list
25199384|NCT02741414|Furazolidone|furazolidone|mesh-list
25199385|NCT02741414|Esomeprazole|esomeprazole|mesh-list
24633089|NCT01127204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584056|NCT00878345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25117632|NCT04930458|Calcium|calcium|mesh-list
25117633|NCT04930458|Fluorides|fluorides|mesh-list
25117634|NCT04930458|Sodium Fluoride|sodium fluoride|mesh-list
25117635|NCT04930458|Fluorides, Topical|fluorides, topical|mesh-list
25117636|NCT04930458|Caseins|caseins|mesh-list
25117637|NCT04930458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25117638|NCT04930458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117639|NCT04930458|Cariostatic Agents|cariostatic agents|mesh-ancestor
24566498|NCT00786136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566499|NCT00786136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24566500|NCT00786136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24566501|NCT00786136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566502|NCT00786149|Varenicline|varenicline|mesh-list
24566503|NCT00786149|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24566504|NCT00786149|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24566505|NCT00786149|Cholinergic Agents|cholinergic agents|mesh-ancestor
24566506|NCT00786149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24556937|NCT00750425|Cediranib|cediranib|mesh-list
25101815|NCT03172234|Amantadine|amantadine|mesh-list
24566695|NCT00787436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25861335|NCT00086203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25861336|NCT00086255|Tiagabine|tiagabine|mesh-list
25861337|NCT00086255|Anticonvulsants|anticonvulsants|mesh-ancestor
25861338|NCT00086255|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
25861339|NCT00086255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24566696|NCT00787436|Growth Substances|growth substances|mesh-ancestor
24566716|NCT00787462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24566717|NCT00787462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24848371|NCT04553003|Protective Agents|protective agents|mesh-ancestor
24848372|NCT04553003|Lipotropic Agents|lipotropic agents|mesh-ancestor
24566718|NCT00787462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566719|NCT00787462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24566721|NCT00787462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24566722|NCT00787462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24566723|NCT00787462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24566724|NCT00787501|Citalopram|citalopram|mesh-list
24566725|NCT00787501|Fluoxetine|fluoxetine|mesh-list
24566726|NCT00787501|Sertraline|sertraline|mesh-list
24566727|NCT00787501|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24967697|NCT03757364|Abortifacient Agents|abortifacient agents|mesh-ancestor
24967698|NCT03757364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24967699|NCT03757364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566728|NCT00787501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24566729|NCT00787501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24566937|NCT00788606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24566938|NCT00788606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24566940|NCT00788606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566941|NCT00788606|Growth Inhibitors|growth inhibitors|mesh-ancestor
24566942|NCT00788606|Immunologic Factors|immunologic factors|mesh-ancestor
24566943|NCT00788606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24566944|NCT00788749|Fluticasone|fluticasone|mesh-list
24566945|NCT00788749|Xhance|xhance|mesh-list
24566946|NCT00788749|Prednisolone|prednisolone|mesh-list
24566947|NCT00788749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24566948|NCT00788749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24566949|NCT00788749|Autonomic Agents|autonomic agents|mesh-ancestor
24566950|NCT00788749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24567044|NCT00789308|Sensory System Agents|sensory system agents|mesh-ancestor
24567045|NCT00789308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24567046|NCT00789308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24567047|NCT00789308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24557131|NCT00751491|Clopidogrel|clopidogrel|mesh-list
24567204|NCT00790101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24626253|NCT01086332|Nelfinavir|nelfinavir|mesh-list
24584276|NCT00879307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584278|NCT00879372|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24584280|NCT00879372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24584379|NCT00880243|Cytarabine|cytarabine|mesh-list
25199386|NCT02741414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25199387|NCT02741414|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25199388|NCT02741414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25199389|NCT02741414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25199390|NCT02741414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25199391|NCT02741414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25199392|NCT02741414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199393|NCT02741414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199394|NCT02741414|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25199395|NCT02741414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24567205|NCT00790101|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24567207|NCT00790114|Midazolam|midazolam|mesh-list
24567208|NCT00790114|Caffeine|caffeine|mesh-list
24557273|NCT00752115|Paclitaxel|paclitaxel|mesh-list
24567368|NCT00790946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24567369|NCT00790946|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24567372|NCT00790985|Naproxen|naproxen|mesh-list
24567373|NCT00790985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24567374|NCT00790985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24567375|NCT00790985|Analgesics|analgesics|mesh-ancestor
24567376|NCT00790985|Sensory System Agents|sensory system agents|mesh-ancestor
24567377|NCT00790985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24567378|NCT00790985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567379|NCT00790985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24567380|NCT00790985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24567381|NCT00790985|Gout Suppressants|gout suppressants|mesh-ancestor
24567382|NCT00790985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24567383|NCT00790985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567384|NCT00790985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567385|NCT00790998|Ivermectin|ivermectin|mesh-list
24567386|NCT00790998|Moxidectin|moxidectin|mesh-list
24557358|NCT00752414|Renal Agents|renal agents|mesh-ancestor
24567439|NCT00791193|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24567459|NCT00791271|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24567462|NCT00791271|Antiviral Agents|antiviral agents|mesh-ancestor
24567463|NCT00791271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24584380|NCT00880243|Etoposide|etoposide|mesh-list
24584440|NCT00880373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24584441|NCT00880373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24584442|NCT00880373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25667792|NCT01709422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25667793|NCT01709422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25667794|NCT01709422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24584589|NCT00881127|Cetirizine|cetirizine|mesh-list
25667795|NCT01709422|GABA Modulators|gaba modulators|mesh-ancestor
25667796|NCT01709422|GABA Agents|gaba agents|mesh-ancestor
24936266|NCT04042441|Insulin|insulin|mesh-list
24584590|NCT00881127|Pseudoephedrine|pseudoephedrine|mesh-list
24584591|NCT00881127|Ephedrine|ephedrine|mesh-list
24584592|NCT00881127|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24584646|NCT00881166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24584647|NCT00881179|Clarithromycin|clarithromycin|mesh-list
24584648|NCT00881179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24568051|NCT00794209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568053|NCT00794209|Sensory System Agents|sensory system agents|mesh-ancestor
24568100|NCT00794638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25101957|NCT03171740|Anesthetics|anesthetics|mesh-ancestor
24568146|NCT00794885|Vitamins|vitamins|mesh-ancestor
24568150|NCT00794885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568151|NCT00794885|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24568152|NCT00794885|Protease Inhibitors|protease inhibitors|mesh-ancestor
24568153|NCT00794885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24568155|NCT00794898|Dermatologic Agents|dermatologic agents|mesh-ancestor
24568156|NCT00794898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24568157|NCT00794898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24568158|NCT00794976|Dexamethasone|dexamethasone|mesh-list
24568159|NCT00794976|Dexamethasone acetate|dexamethasone acetate|mesh-list
24568160|NCT00794976|BB 1101|bb 1101|mesh-list
24568161|NCT00794976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24568162|NCT00794976|Antiemetics|antiemetics|mesh-ancestor
24568163|NCT00794976|Autonomic Agents|autonomic agents|mesh-ancestor
24568164|NCT00794976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24568165|NCT00794976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568166|NCT00794976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24568167|NCT00794976|Glucocorticoids|glucocorticoids|mesh-ancestor
24568168|NCT00794976|Hormones|hormones|mesh-ancestor
24568169|NCT00794976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25102003|NCT03170895|Sorafenib|sorafenib|mesh-list
24568258|NCT00795444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24568259|NCT00795444|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24568261|NCT00795457|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24568262|NCT00795457|Vaccines|vaccines|mesh-list
24568272|NCT00795470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24568273|NCT00795483|Zoledronic Acid|zoledronic acid|mesh-list
24568274|NCT00795483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24568275|NCT00795483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568277|NCT00795496|Histamine Agonists|histamine agonists|mesh-ancestor
24568278|NCT00795496|Histamine Agents|histamine agents|mesh-ancestor
24568279|NCT00795496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24568280|NCT00795496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568297|NCT00795613|Doxorubicin|doxorubicin|mesh-list
24568316|NCT00795678|Doxorubicin|doxorubicin|mesh-list
24568317|NCT00795678|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24568318|NCT00795678|Capecitabine|capecitabine|mesh-list
24568319|NCT00795678|Trastuzumab|trastuzumab|mesh-list
24568320|NCT00795678|Lapatinib|lapatinib|mesh-list
25861340|NCT00086255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24568329|NCT00795678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568330|NCT00795678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24568331|NCT00795678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24568332|NCT00795678|Alkylating Agents|alkylating agents|mesh-ancestor
24568333|NCT00795678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24568334|NCT00795678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24568335|NCT00795678|Antimetabolites|antimetabolites|mesh-ancestor
24584809|NCT00881673|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24584810|NCT00881673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24584811|NCT00881673|Antiemetics|antiemetics|mesh-ancestor
24584812|NCT00881673|Autonomic Agents|autonomic agents|mesh-ancestor
24584859|NCT00881816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568336|NCT00795678|Antiviral Agents|antiviral agents|mesh-ancestor
24568337|NCT00795678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24568338|NCT00795678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24568339|NCT00795678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24568340|NCT00795678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24568341|NCT00795678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24568342|NCT00795678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24568343|NCT00795678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24568345|NCT00795756|Methotrexate|methotrexate|mesh-list
24568346|NCT00795756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24568347|NCT00795756|Abortifacient Agents|abortifacient agents|mesh-ancestor
24568348|NCT00795756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24568395|NCT00795899|Tubulin Modulators|tubulin modulators|mesh-ancestor
24568396|NCT00795899|Antimitotic Agents|antimitotic agents|mesh-ancestor
24568397|NCT00795899|Mitosis Modulators|mitosis modulators|mesh-ancestor
24568398|NCT00795899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568399|NCT00795899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24568400|NCT00795899|Immunologic Factors|immunologic factors|mesh-ancestor
24568499|NCT00796211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568500|NCT00796211|Adrenergic Agents|adrenergic agents|mesh-ancestor
24568501|NCT00796211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24568502|NCT00796211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861341|NCT00086255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568532|NCT00796263|Dolutegravir|dolutegravir|mesh-list
24568533|NCT00796263|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24568534|NCT00796263|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24568535|NCT00796263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24568536|NCT00796263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568818|NCT00797745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568819|NCT00797745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24568820|NCT00797745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24568821|NCT00797745|Antiviral Agents|antiviral agents|mesh-ancestor
25008919|NCT03837873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25008920|NCT03837873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25008921|NCT03837873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25008922|NCT03837873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25008923|NCT03837873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25008924|NCT03837873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25008925|NCT03837873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25008926|NCT03837873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25008927|NCT03837873|Antimetabolites|antimetabolites|mesh-ancestor
25008928|NCT03837873|Antiviral Agents|antiviral agents|mesh-ancestor
25008929|NCT03837873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24568876|NCT00797836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24568877|NCT00797836|Antiviral Agents|antiviral agents|mesh-ancestor
24568878|NCT00797836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24568879|NCT00797927|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24568880|NCT00797927|Antipsychotic Agents|antipsychotic agents|mesh-list
24568881|NCT00797927|Antidepressive Agents|antidepressive agents|mesh-ancestor
24569064|NCT00798915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24569066|NCT00798954|Sirolimus|sirolimus|mesh-list
24569067|NCT00798954|Paclitaxel|paclitaxel|mesh-list
25861342|NCT00086255|GABA Agents|gaba agents|mesh-ancestor
24569097|NCT00798993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24569098|NCT00799045|Clopidogrel|clopidogrel|mesh-list
24569099|NCT00799045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24569100|NCT00799045|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24584862|NCT00881855|Cefprozil|cefprozil|mesh-list
24584922|NCT00882232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584923|NCT00882232|Viscosupplements|viscosupplements|mesh-ancestor
24569101|NCT00799045|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24791876|NCT02553460|Methotrexate|methotrexate|mesh-list
24791877|NCT02553460|Etoposide|etoposide|mesh-list
24791878|NCT02553460|Vincristine|vincristine|mesh-list
24791879|NCT02553460|Bortezomib|bortezomib|mesh-list
24791880|NCT02553460|Asparaginase|asparaginase|mesh-list
24791881|NCT02553460|Mitoxantrone|mitoxantrone|mesh-list
24791882|NCT02553460|Mercaptopurine|mercaptopurine|mesh-list
25008944|NCT03775200|Hallucinogens|hallucinogens|mesh-ancestor
25008945|NCT03775200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008946|NCT03775200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24569309|NCT00800150|Alkylating Agents|alkylating agents|mesh-ancestor
24569310|NCT00800150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24569383|NCT00800358|Vitamins|vitamins|mesh-ancestor
24569384|NCT00800358|Micronutrients|micronutrients|mesh-ancestor
24569385|NCT00800358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24569386|NCT00800423|Timolol|timolol|mesh-list
24569387|NCT00800423|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24569388|NCT00800423|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24569389|NCT00800423|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24569390|NCT00800423|Adrenergic Agents|adrenergic agents|mesh-ancestor
24569393|NCT00800423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569394|NCT00800423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24791917|NCT02553460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24791919|NCT02553460|Protective Agents|protective agents|mesh-ancestor
24791920|NCT02553460|Vitamin B Complex|vitamin b complex|mesh-ancestor
24791922|NCT02553460|Micronutrients|micronutrients|mesh-ancestor
25009026|NCT03709355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25009027|NCT03709355|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25009028|NCT03709355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25009029|NCT03709355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24569400|NCT00800462|Oxybutynin|oxybutynin|mesh-list
24569401|NCT00800462|Darifenacin|darifenacin|mesh-list
24569402|NCT00800462|Anticonvulsants|anticonvulsants|mesh-ancestor
24569403|NCT00800462|Parasympatholytics|parasympatholytics|mesh-ancestor
24569404|NCT00800462|Autonomic Agents|autonomic agents|mesh-ancestor
24569417|NCT00800475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24569418|NCT00800475|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24569419|NCT00800475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24569420|NCT00800475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24569422|NCT00800527|Gabapentin|gabapentin|mesh-list
24569423|NCT00800527|Analgesics|analgesics|mesh-ancestor
24569539|NCT00800930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569541|NCT00800943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24897605|NCT04424017|Antibodies|antibodies|mesh-list
24569542|NCT00800943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24569543|NCT00801034|Calcium|calcium|mesh-list
24569544|NCT00801034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24569545|NCT00801034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569546|NCT00801047|Remifentanil|remifentanil|mesh-list
24569547|NCT00801047|Bupivacaine|bupivacaine|mesh-list
24569548|NCT00801047|Anesthetics, Local|anesthetics, local|mesh-ancestor
24569593|NCT00801268|Cathartics|cathartics|mesh-ancestor
24569594|NCT00801268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24569595|NCT00801268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24569596|NCT00801268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584925|NCT00882323|Cyclophosphamide|cyclophosphamide|mesh-list
24569597|NCT00801268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569598|NCT00801281|Prednisone|prednisone|mesh-list
24569599|NCT00801281|Cyclophosphamide|cyclophosphamide|mesh-list
24569600|NCT00801281|Rituximab|rituximab|mesh-list
24569601|NCT00801281|Doxorubicin|doxorubicin|mesh-list
24569602|NCT00801281|Vincristine|vincristine|mesh-list
24569603|NCT00801281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25009050|NCT03709355|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25009052|NCT03709355|Hormones|hormones|mesh-ancestor
25009053|NCT03709355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25009054|NCT03709355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25009055|NCT03709355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25009056|NCT03709355|Antiviral Agents|antiviral agents|mesh-ancestor
25009057|NCT03709355|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25861343|NCT00086255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25009065|NCT03700658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009066|NCT03700658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25009067|NCT03700658|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25009068|NCT03700658|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25009069|NCT03700658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25009070|NCT03700658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009074|NCT03669133|Vitamin E|vitamin e|mesh-list
25009075|NCT03669133|Vitamins|vitamins|mesh-ancestor
25009076|NCT03669133|Micronutrients|micronutrients|mesh-ancestor
25009077|NCT03669133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009078|NCT03669133|Antioxidants|antioxidants|mesh-ancestor
25009079|NCT03669133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569610|NCT00801281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24569611|NCT00801281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24569612|NCT00801281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24569613|NCT00801281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25102373|NCT03169426|Carvedilol|carvedilol|mesh-list
24569753|NCT00801853|Immunologic Factors|immunologic factors|mesh-ancestor
24569754|NCT00801853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569755|NCT00801853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24897738|NCT04422197|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24573907|NCT00822536|Analgesics|analgesics|mesh-ancestor
25271035|NCT02401594|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24573908|NCT00822536|Sensory System Agents|sensory system agents|mesh-ancestor
25009091|NCT03582618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25009092|NCT03582618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009093|NCT03498391|Ketamine|ketamine|mesh-list
25009094|NCT03498391|Propofol|propofol|mesh-list
24570258|NCT00804050|Micronutrients|micronutrients|mesh-ancestor
24951463|NCT03904355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951464|NCT03904368|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24966524|NCT03767296|Mydriatics|mydriatics|mesh-ancestor
24570259|NCT00804050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570260|NCT00804115|Timolol|timolol|mesh-list
24570261|NCT00804115|Latanoprost|latanoprost|mesh-list
24570262|NCT00804115|Pilocarpine|pilocarpine|mesh-list
24967969|NCT03755557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24967970|NCT03755557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24967971|NCT03755557|Autonomic Agents|autonomic agents|mesh-ancestor
25214604|NCT02696512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24938761|NCT04016090|Folic Acid|folic acid|mesh-list
24570263|NCT00804115|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24570302|NCT00804271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24570303|NCT00804271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24570304|NCT00804297|Octreotide|octreotide|mesh-list
24570305|NCT00804297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24570306|NCT00804297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24570307|NCT00804297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570308|NCT00804310|Lapatinib|lapatinib|mesh-list
24570309|NCT00804310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24792082|NCT05412706|Niraparib|niraparib|mesh-list
24792083|NCT05412706|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24792084|NCT05412706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24792085|NCT05412706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792086|NCT05412706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24792087|NCT05412589|Apatinib|apatinib|mesh-list
24792088|NCT05412589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24792089|NCT05412589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24792090|NCT05412589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24792091|NCT05412589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792092|NCT05412576|Lidocaine|lidocaine|mesh-list
24792093|NCT05412576|Anesthetics, Local|anesthetics, local|mesh-ancestor
24792094|NCT05412576|Anesthetics|anesthetics|mesh-ancestor
24895716|NCT03434041|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25009142|NCT03340727|Caffeine citrate|caffeine citrate|mesh-list
25009143|NCT03340727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009144|NCT03340727|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25199396|NCT02741414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25199397|NCT02741414|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24571175|NCT00808327|Analgesics|analgesics|mesh-ancestor
25009145|NCT03340727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009146|NCT03340727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25009147|NCT03340727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25009148|NCT03340727|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25009149|NCT03340727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24570353|NCT00804531|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24570354|NCT00804531|Methylprednisolone|methylprednisolone|mesh-list
24570355|NCT00804531|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24570356|NCT00804531|Prednisolone|prednisolone|mesh-list
25102634|NCT03166956|Vitamins|vitamins|mesh-ancestor
24570581|NCT00805311|Sensory System Agents|sensory system agents|mesh-ancestor
24570582|NCT00805311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24570584|NCT00805311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24570585|NCT00805311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24570586|NCT00805311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24570587|NCT00805311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24570588|NCT00805311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570589|NCT00805311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24570590|NCT00805311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24570591|NCT00805311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24570593|NCT00805311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24570594|NCT00805311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24570595|NCT00805311|Antimetabolites|antimetabolites|mesh-ancestor
24570596|NCT00805311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25009150|NCT03340727|Purinergic Agents|purinergic agents|mesh-ancestor
24570600|NCT00805311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24570601|NCT00805311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24570602|NCT00805311|Vasodilator Agents|vasodilator agents|mesh-ancestor
24570603|NCT00805311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24570604|NCT00805311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24570668|NCT00805649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24570669|NCT00805649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24570670|NCT00805649|Growth Substances|growth substances|mesh-ancestor
25102730|NCT03167177|Antimetabolites|antimetabolites|mesh-ancestor
25667797|NCT01709422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25667798|NCT01709422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667799|NCT01709422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25667800|NCT01709422|Narcotics|narcotics|mesh-ancestor
25667801|NCT01709422|Analgesics|analgesics|mesh-ancestor
24570800|NCT00806754|Histamine Antagonists|histamine antagonists|mesh-ancestor
24570801|NCT00806754|Histamine Agents|histamine agents|mesh-ancestor
24570802|NCT00806754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24570804|NCT00806767|Fludarabine phosphate|fludarabine phosphate|mesh-list
24570806|NCT00806767|Immunoglobulins|immunoglobulins|mesh-list
24570807|NCT00806767|Antibodies|antibodies|mesh-list
24570808|NCT00806767|gamma-Globulins|gamma-globulins|mesh-list
24570809|NCT00806767|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24570810|NCT00806767|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24570811|NCT00806767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570812|NCT00806767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24570813|NCT00806767|Antimetabolites|antimetabolites|mesh-ancestor
24570814|NCT00806767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570815|NCT00806767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24570816|NCT00806767|Immunologic Factors|immunologic factors|mesh-ancestor
24570817|NCT00806767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570818|NCT00806767|Alkylating Agents|alkylating agents|mesh-ancestor
24570819|NCT00806767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24570820|NCT00806767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24570821|NCT00806871|Methylprednisolone|methylprednisolone|mesh-list
24570822|NCT00806871|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24570823|NCT00806871|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24570824|NCT00806871|Prednisolone|prednisolone|mesh-list
24570825|NCT00806871|Prednisolone acetate|prednisolone acetate|mesh-list
24570848|NCT00806910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570849|NCT00806923|Gemcitabine|gemcitabine|mesh-list
24570850|NCT00806923|Bevacizumab|bevacizumab|mesh-list
25102776|NCT03166254|Vaccines|vaccines|mesh-list
24571083|NCT00808054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24571084|NCT00808054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24571085|NCT00808054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571087|NCT00808145|Cisplatin|cisplatin|mesh-list
24571088|NCT00808145|Sorafenib|sorafenib|mesh-list
24560143|NCT03492463|Autonomic Agents|autonomic agents|mesh-ancestor
24571169|NCT00808327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24951467|NCT03903952|Vitamin B 12|vitamin b 12|mesh-list
24571170|NCT00808327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571171|NCT00808327|Sensory System Agents|sensory system agents|mesh-ancestor
24571172|NCT00808327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24571173|NCT00808327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25118143|NCT04423211|Leuprolide|leuprolide|mesh-list
24571174|NCT00808327|Narcotics|narcotics|mesh-ancestor
24571176|NCT00808327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24571177|NCT00808327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24571178|NCT00808327|Anesthetics, General|anesthetics, general|mesh-ancestor
24571179|NCT00808366|Antifungal Agents|antifungal agents|mesh-list
24571180|NCT00808366|Clotrimazole|clotrimazole|mesh-list
24571181|NCT00808366|Miconazole|miconazole|mesh-list
24571182|NCT00808366|Keratolytic Agents|keratolytic agents|mesh-list
25009151|NCT03340727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25109931|NCT03120962|Oxycodone|oxycodone|mesh-list
24792095|NCT05412576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24571526|NCT00810589|Insulin Lispro|insulin lispro|mesh-list
24571527|NCT00810589|Insulin Detemir|insulin detemir|mesh-list
24571528|NCT00810589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24571551|NCT00810836|Dimethyl Fumarate|dimethyl fumarate|mesh-list
24571552|NCT00810836|Dermatologic Agents|dermatologic agents|mesh-ancestor
24571553|NCT00810836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24571554|NCT00810836|Immunologic Factors|immunologic factors|mesh-ancestor
24571555|NCT00810836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571556|NCT00810849|Prednisolone|prednisolone|mesh-list
24571557|NCT00810849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24571558|NCT00810849|Glucocorticoids|glucocorticoids|mesh-ancestor
24571560|NCT00810849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24571561|NCT00810849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671060|NCT01323452|Antiviral Agents|antiviral agents|mesh-ancestor
24571562|NCT00810849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24571605|NCT00811031|Prednisone|prednisone|mesh-list
24571606|NCT00811031|Docetaxel|docetaxel|mesh-list
24571607|NCT00811031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24571608|NCT00811031|Tubulin Modulators|tubulin modulators|mesh-ancestor
24571609|NCT00811031|Antimitotic Agents|antimitotic agents|mesh-ancestor
24792177|NCT05411744|Isoniazid|isoniazid|mesh-list
24792178|NCT05411744|Rifapentine|rifapentine|mesh-list
24792179|NCT05411744|Vitamins|vitamins|mesh-ancestor
24792180|NCT05411744|Micronutrients|micronutrients|mesh-ancestor
24792181|NCT05411744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792182|NCT05411744|Vitamin B Complex|vitamin b complex|mesh-ancestor
24792183|NCT05411744|Antitubercular Agents|antitubercular agents|mesh-ancestor
24627040|NCT01090167|Clofarabine|clofarabine|mesh-list
24968115|NCT03754387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24968116|NCT03754387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24968117|NCT03754179|Hydroxychloroquine|hydroxychloroquine|mesh-list
24968118|NCT03754179|Trametinib|trametinib|mesh-list
24792184|NCT05411744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25009211|NCT02933944|Pembrolizumab|pembrolizumab|mesh-list
25009212|NCT02933944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25009213|NCT02933944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009214|NCT02921997|Vaccines|vaccines|mesh-list
25009215|NCT02921997|Immunologic Factors|immunologic factors|mesh-ancestor
25009216|NCT02921997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009218|NCT02879162|Tremelimumab|tremelimumab|mesh-list
25009219|NCT02879162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25009220|NCT02879162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009221|NCT02822092|Risperidone|risperidone|mesh-list
25009222|NCT02822092|Aripiprazole|aripiprazole|mesh-list
25009223|NCT02822092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25009224|NCT02822092|Serotonin Agents|serotonin agents|mesh-ancestor
25009225|NCT02822092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25009226|NCT02822092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009227|NCT02822092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009228|NCT02822092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25009229|NCT02822092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25009257|NCT02520063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009258|NCT02520063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25009259|NCT02520063|Immunologic Factors|immunologic factors|mesh-ancestor
25009260|NCT02520063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009261|NCT02520063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25009262|NCT02520063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24571856|NCT00811993|Growth Inhibitors|growth inhibitors|mesh-ancestor
24571857|NCT00811993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25199398|NCT02741414|Renal Agents|renal agents|mesh-ancestor
25118272|NCT04274426|Paclitaxel|paclitaxel|mesh-list
24571858|NCT00811993|Antimetabolites|antimetabolites|mesh-ancestor
24571859|NCT00811993|Antiviral Agents|antiviral agents|mesh-ancestor
24571860|NCT00811993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571861|NCT00811993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571862|NCT00811993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25861344|NCT00086255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861345|NCT00086268|Zoledronic Acid|zoledronic acid|mesh-list
24443804|NCT00295997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572012|NCT00812669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24572017|NCT00812669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24572019|NCT00812669|Antimetabolites|antimetabolites|mesh-ancestor
24572427|NCT00814736|Urological Agents|urological agents|mesh-ancestor
24572020|NCT00812682|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24572021|NCT00812682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24585243|NCT00884546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24585244|NCT00884546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585245|NCT00884546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24585246|NCT00884546|Glucocorticoids|glucocorticoids|mesh-ancestor
24585247|NCT00884546|Hormones|hormones|mesh-ancestor
24585248|NCT00884546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24585249|NCT00884546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24585250|NCT00884546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585251|NCT00884546|Immunologic Factors|immunologic factors|mesh-ancestor
24585252|NCT00884546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24585253|NCT00884546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24585903|NCT00887770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009267|NCT02520063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25103064|NCT03164668|Menthol|menthol|mesh-list
24572067|NCT00812851|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24572068|NCT00812851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25271134|NCT02400879|Sufentanil|sufentanil|mesh-list
24572069|NCT00812851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572070|NCT00812851|Hormones|hormones|mesh-ancestor
24572071|NCT00812851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24572120|NCT00813228|Incretins|incretins|mesh-ancestor
24572122|NCT00813228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24572123|NCT00813228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24572124|NCT00813228|Protease Inhibitors|protease inhibitors|mesh-ancestor
25667802|NCT01709422|Sensory System Agents|sensory system agents|mesh-ancestor
25667803|NCT01709422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25667804|NCT01709474|Vitamin D|vitamin d|mesh-list
25861346|NCT00086268|Carboplatin|carboplatin|mesh-list
24572125|NCT00813228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24572126|NCT00813228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572128|NCT00813241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24572129|NCT00813241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24572130|NCT00813241|Analgesics|analgesics|mesh-ancestor
24572131|NCT00813241|Sensory System Agents|sensory system agents|mesh-ancestor
24572132|NCT00813241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24572133|NCT00813241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572134|NCT00813241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24572135|NCT00813241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24572136|NCT00813241|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24572137|NCT00813241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24572138|NCT00813241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24572139|NCT00813241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572141|NCT00813332|Endostar protein|endostar protein|mesh-list
24572142|NCT00813332|Endostatins|endostatins|mesh-list
24572143|NCT00813332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25103141|NCT03163914|Autonomic Agents|autonomic agents|mesh-ancestor
24572263|NCT00814021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24572264|NCT00814021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24572265|NCT00814021|Growth Substances|growth substances|mesh-ancestor
24572266|NCT00814021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572269|NCT00814021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24572270|NCT00814021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572271|NCT00814047|Yohimbine|yohimbine|mesh-list
24572272|NCT00814047|Mydriatics|mydriatics|mesh-ancestor
24572273|NCT00814047|Autonomic Agents|autonomic agents|mesh-ancestor
24572274|NCT00814047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24572275|NCT00814047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572276|NCT00814047|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25199399|NCT02741414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24572277|NCT00814047|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24572278|NCT00814047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24572280|NCT00814047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24572281|NCT00814047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572282|NCT00814047|Urological Agents|urological agents|mesh-ancestor
24572283|NCT00814086|Paclitaxel|paclitaxel|mesh-list
24572284|NCT00814086|Cisplatin|cisplatin|mesh-list
24572285|NCT00814086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25103183|NCT03163849|Sofosbuvir|sofosbuvir|mesh-list
24572423|NCT00814736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24572424|NCT00814736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24572425|NCT00814736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25009364|NCT01899144|Respiratory System Agents|respiratory system agents|mesh-ancestor
24572426|NCT00814736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792268|NCT05387525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24792270|NCT05387525|Sensory System Agents|sensory system agents|mesh-ancestor
24792271|NCT05387525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24792272|NCT05387525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792273|NCT05387525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24792274|NCT05387525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24792275|NCT05387525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24792276|NCT05387525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24792277|NCT05387525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572497|NCT00815048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572498|NCT00815048|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
24572499|NCT00815048|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24572500|NCT00815048|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24572501|NCT00815204|Dexamethasone|dexamethasone|mesh-list
24572502|NCT00815204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24572503|NCT00815204|Antiemetics|antiemetics|mesh-ancestor
24572504|NCT00815204|Autonomic Agents|autonomic agents|mesh-ancestor
24572505|NCT00815204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24572506|NCT00815204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572507|NCT00815204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24572508|NCT00815204|Glucocorticoids|glucocorticoids|mesh-ancestor
25861347|NCT00086268|Docetaxel|docetaxel|mesh-list
24586397|NCT00890539|Miotics|miotics|mesh-ancestor
24572525|NCT00815269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24572526|NCT00815269|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24572528|NCT00815269|Anesthetics|anesthetics|mesh-ancestor
24572529|NCT00815269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24572530|NCT00815269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572532|NCT00815282|Immunologic Factors|immunologic factors|mesh-ancestor
24572533|NCT00815282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572534|NCT00815373|Timolol|timolol|mesh-list
24572535|NCT00815373|Dorzolamide|dorzolamide|mesh-list
25009327|NCT02133573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25009328|NCT02133573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009329|NCT02054104|Celecoxib|celecoxib|mesh-list
25009330|NCT02054104|Cyclophosphamide|cyclophosphamide|mesh-list
25009331|NCT02054104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25009332|NCT02054104|Immunologic Factors|immunologic factors|mesh-ancestor
24572617|NCT00815893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24443824|NCT00295997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24443825|NCT00295997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24443828|NCT00296010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24443829|NCT00296010|Methotrexate|methotrexate|mesh-list
24572764|NCT00816634|Tubulin Modulators|tubulin modulators|mesh-ancestor
24572765|NCT00816634|Antimitotic Agents|antimitotic agents|mesh-ancestor
24572766|NCT00816634|Mitosis Modulators|mitosis modulators|mesh-ancestor
24572767|NCT00816634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572768|NCT00816634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24572769|NCT00816634|Antimetabolites|antimetabolites|mesh-ancestor
24572770|NCT00816660|Factor VIII|factor viii|mesh-list
24572771|NCT00816660|Coagulants|coagulants|mesh-ancestor
24572773|NCT00816673|Antioxidants|antioxidants|mesh-ancestor
24572774|NCT00816673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572775|NCT00816673|Protective Agents|protective agents|mesh-ancestor
24572776|NCT00816673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572777|NCT00816673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24572778|NCT00816699|Anesthetics|anesthetics|mesh-list
24572779|NCT00816699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24572780|NCT00816699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572781|NCT00816712|Methyltestosterone|methyltestosterone|mesh-list
24572782|NCT00816712|Testosterone|testosterone|mesh-list
24572783|NCT00816712|Testosterone undecanoate|testosterone undecanoate|mesh-list
24572784|NCT00816712|Testosterone enanthate|testosterone enanthate|mesh-list
24572785|NCT00816712|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24572786|NCT00816712|Androgens|androgens|mesh-ancestor
24572787|NCT00816712|Hormones|hormones|mesh-ancestor
24629510|NCT01105611|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24572788|NCT00816712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24572790|NCT00816712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25009392|NCT01468831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25009394|NCT01468831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25009395|NCT01468831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24573044|NCT00817661|Vitamin A|vitamin a|mesh-list
24573045|NCT00817661|Vitamins|vitamins|mesh-ancestor
24573046|NCT00817661|Micronutrients|micronutrients|mesh-ancestor
24573047|NCT00817661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573048|NCT00817687|Mycophenolic Acid|mycophenolic acid|mesh-list
24573049|NCT00817687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24573050|NCT00817687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24561602|NCT00761644|Growth Substances|growth substances|mesh-ancestor
25009464|NCT00603954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009465|NCT00603954|Antiviral Agents|antiviral agents|mesh-ancestor
25009466|NCT00603954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25009467|NCT00003777|Fluorouracil|fluorouracil|mesh-list
25009468|NCT00003777|Amifostine|amifostine|mesh-list
25009469|NCT00003777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009470|NCT00003777|Antimetabolites|antimetabolites|mesh-ancestor
25009471|NCT00003777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009472|NCT00003777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24792355|NCT05302986|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25009473|NCT00003777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25009474|NCT00003777|Immunologic Factors|immunologic factors|mesh-ancestor
24561673|NCT00762099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24573102|NCT00817765|Hormone Antagonists|hormone antagonists|mesh-ancestor
24573103|NCT00817765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25009637|NCT05211011|Fosfomycin|fosfomycin|mesh-list
24573104|NCT00817765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573106|NCT00817895|Fluorouracil|fluorouracil|mesh-list
24573107|NCT00817895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24573108|NCT00817895|Antimetabolites|antimetabolites|mesh-ancestor
24573109|NCT00817895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214656|NCT02696460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24573110|NCT00817895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24573111|NCT00817895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25103378|NCT03162120|Autonomic Agents|autonomic agents|mesh-ancestor
24561818|NCT00762957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561819|NCT00762983|Loratadine|loratadine|mesh-list
24561820|NCT00762983|Antipruritics|antipruritics|mesh-ancestor
24561821|NCT00762983|Dermatologic Agents|dermatologic agents|mesh-ancestor
24561822|NCT00762983|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24561823|NCT00762983|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24561830|NCT00763165|Triclosan|triclosan|mesh-list
24573368|NCT00819676|Vasodilator Agents|vasodilator agents|mesh-ancestor
24573369|NCT00819676|Gasotransmitters|gasotransmitters|mesh-ancestor
24573370|NCT00819676|Protective Agents|protective agents|mesh-ancestor
24573371|NCT00819728|Docetaxel|docetaxel|mesh-list
24573372|NCT00819728|Irinotecan|irinotecan|mesh-list
24573373|NCT00819728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24573374|NCT00819728|Tubulin Modulators|tubulin modulators|mesh-ancestor
24573375|NCT00819728|Antimitotic Agents|antimitotic agents|mesh-ancestor
24573376|NCT00819728|Mitosis Modulators|mitosis modulators|mesh-ancestor
24573377|NCT00819728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573378|NCT00819728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24573379|NCT00819728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24573380|NCT00819728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573381|NCT00819754|Bevacizumab|bevacizumab|mesh-list
24573382|NCT00819754|Capecitabine|capecitabine|mesh-list
24573383|NCT00819754|Oxaliplatin|oxaliplatin|mesh-list
24573384|NCT00819754|Irinotecan|irinotecan|mesh-list
24561901|NCT00763646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24561902|NCT00763646|Tubulin Modulators|tubulin modulators|mesh-ancestor
24561903|NCT00763646|Antimitotic Agents|antimitotic agents|mesh-ancestor
24561904|NCT00763646|Mitosis Modulators|mitosis modulators|mesh-ancestor
24573468|NCT00820118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24573469|NCT00820118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24573485|NCT00820326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24573487|NCT00820326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24573488|NCT00820326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573489|NCT00820352|Bosentan|bosentan|mesh-list
24573490|NCT00820352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24573491|NCT00820352|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24586556|NCT00891267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586560|NCT00891306|Cyclosporine|cyclosporine|mesh-list
24792715|NCT04777006|Analgesics|analgesics|mesh-ancestor
24586574|NCT00891306|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24586575|NCT00891306|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24573492|NCT00820352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573493|NCT00820404|BLI-489|bli-489|mesh-list
24573494|NCT00820404|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24573558|NCT00820690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24573560|NCT00820690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25103490|NCT03160872|Hormones|hormones|mesh-list
25009505|NCT05214157|Bupivacaine|bupivacaine|mesh-list
25009506|NCT05214157|Anesthetics, Local|anesthetics, local|mesh-ancestor
24573562|NCT00820690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24573563|NCT00820690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24573564|NCT00820690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562070|NCT00764413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562071|NCT00764426|Ethanol|ethanol|mesh-list
24562072|NCT00764426|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24562073|NCT00764426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24562074|NCT00764426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24562075|NCT00764426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562076|NCT00764439|Nicotine|nicotine|mesh-list
24562077|NCT00764439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24562078|NCT00764439|Autonomic Agents|autonomic agents|mesh-ancestor
24562079|NCT00764439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24631240|NCT01116596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24631260|NCT01116622|Bexarotene|bexarotene|mesh-list
24575509|NCT00832221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24575510|NCT00832221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575511|NCT00832221|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24575512|NCT00832221|Dopamine Agents|dopamine agents|mesh-ancestor
25199400|NCT02741414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25199401|NCT02741414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199402|NCT02741414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25199403|NCT02741414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25667805|NCT01709474|Ergocalciferols|ergocalciferols|mesh-list
25861348|NCT00086268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861349|NCT00086268|Tubulin Modulators|tubulin modulators|mesh-ancestor
25861350|NCT00086268|Antimitotic Agents|antimitotic agents|mesh-ancestor
25861351|NCT00086268|Mitosis Modulators|mitosis modulators|mesh-ancestor
25861352|NCT00086268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861353|NCT00086268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25861354|NCT00086268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861355|NCT00086294|Levodopa|levodopa|mesh-list
25861356|NCT00086294|Pimavanserin|pimavanserin|mesh-list
25861357|NCT00086294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24496184|NCT00503607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24496185|NCT00503620|Botulinum Toxins|botulinum toxins|mesh-list
24496186|NCT00503620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25214660|NCT02696330|Enoxaparin|enoxaparin|mesh-list
25214661|NCT02696330|Clopidogrel|clopidogrel|mesh-list
25214662|NCT02696330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24830316|NCT02158624|Growth Inhibitors|growth inhibitors|mesh-ancestor
24830317|NCT02158624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861358|NCT00086294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25199404|NCT02741414|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25199405|NCT02741414|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25199406|NCT02741531|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25199407|NCT02741219|Sufentanil|sufentanil|mesh-list
25199408|NCT02741219|Dexmedetomidine|dexmedetomidine|mesh-list
25199409|NCT02741219|Dsuvia|dsuvia|mesh-list
25199410|NCT02741219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25199411|NCT02741219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24575513|NCT00832221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24575515|NCT00832234|Dexamethasone|dexamethasone|mesh-list
24562080|NCT00764439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562152|NCT00764907|Dexamethasone|dexamethasone|mesh-list
24562153|NCT00764907|Prednisone|prednisone|mesh-list
24562154|NCT00764907|Cyclophosphamide|cyclophosphamide|mesh-list
24562155|NCT00764907|Ifosfamide|ifosfamide|mesh-list
24573803|NCT00822081|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24573804|NCT00822133|Lidocaine|lidocaine|mesh-list
24573915|NCT00822536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573916|NCT00822536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24573917|NCT00822536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24573918|NCT00822536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573920|NCT00822536|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24573921|NCT00822536|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24573922|NCT00822536|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24573923|NCT00822536|Purinergic Agents|purinergic agents|mesh-ancestor
24573924|NCT00822536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24574159|NCT00823940|Glucagon|glucagon|mesh-list
24574160|NCT00823940|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24574161|NCT00823940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24574162|NCT00823940|Hormones|hormones|mesh-ancestor
24671090|NCT01323465|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24574163|NCT00823940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24562524|NCT00766857|Incretins|incretins|mesh-ancestor
24562525|NCT00766857|Hormones|hormones|mesh-ancestor
24562526|NCT00766857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24574436|NCT00825188|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24574437|NCT00825188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24574438|NCT00825188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25667806|NCT01709474|Cholecalciferol|cholecalciferol|mesh-list
25667807|NCT01709474|Vitamins|vitamins|mesh-list
25667808|NCT01709474|Micronutrients|micronutrients|mesh-ancestor
25667809|NCT01709474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667810|NCT01709474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25667811|NCT01709474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25667812|NCT01709500|Atorvastatin|atorvastatin|mesh-list
25667813|NCT01709500|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25667814|NCT01709500|Simvastatin|simvastatin|mesh-list
25667815|NCT01709500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25667816|NCT01709500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25667817|NCT01709500|Antimetabolites|antimetabolites|mesh-ancestor
25667818|NCT01709500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667819|NCT01709500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25667820|NCT01709500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25667821|NCT01709500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25667822|NCT01709513|Atorvastatin|atorvastatin|mesh-list
25667823|NCT01709513|Ezetimibe|ezetimibe|mesh-list
25667824|NCT01709513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24574440|NCT00825188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24574441|NCT00825188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574442|NCT00825188|Vasodilator Agents|vasodilator agents|mesh-ancestor
24792525|NCT05085002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24792526|NCT05085002|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24792527|NCT05077800|Losartan|losartan|mesh-list
24792528|NCT05077800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24898083|NCT04418154|Tubulin Modulators|tubulin modulators|mesh-ancestor
24574670|NCT00826826|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24574723|NCT00827138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861359|NCT00086294|Dopamine Agents|dopamine agents|mesh-ancestor
24574724|NCT00827151|Estrogens|estrogens|mesh-list
24574725|NCT00827151|Hormones|hormones|mesh-ancestor
24574726|NCT00827151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24574818|NCT00827671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24574819|NCT00827684|Sirolimus|sirolimus|mesh-list
24574820|NCT00827684|Irinotecan|irinotecan|mesh-list
24574821|NCT00827684|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24574822|NCT00827684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24574823|NCT00827684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574824|NCT00827684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574825|NCT00827684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24574826|NCT00827684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24574827|NCT00827684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24574828|NCT00827684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24562763|NCT00768157|Lamivudine|lamivudine|mesh-list
24574923|NCT00828529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24574924|NCT00828594|Sorafenib|sorafenib|mesh-list
24574925|NCT00828594|Everolimus|everolimus|mesh-list
24574926|NCT00828594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24575777|NCT00834262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574927|NCT00828594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24574928|NCT00828594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574929|NCT00828594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574930|NCT00828594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24574931|NCT00828594|Immunologic Factors|immunologic factors|mesh-ancestor
24574932|NCT00828594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574934|NCT00828763|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24574935|NCT00828763|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24574936|NCT00828763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574937|NCT00828763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574938|NCT00828763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24574967|NCT00828802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574968|NCT00828802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24574969|NCT00828802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24574970|NCT00828802|Growth Substances|growth substances|mesh-ancestor
24575034|NCT00829023|Blood Substitutes|blood substitutes|mesh-ancestor
24575035|NCT00829114|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24575036|NCT00829114|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24575037|NCT00829114|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24575038|NCT00829114|Estradiol|estradiol|mesh-list
24575039|NCT00829114|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24575059|NCT00829205|Immunologic Factors|immunologic factors|mesh-ancestor
24575060|NCT00829205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575061|NCT00829205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24575116|NCT00829634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24575215|NCT00830297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575218|NCT00830323|Zanamivir|zanamivir|mesh-list
24575219|NCT00830323|Antiviral Agents|antiviral agents|mesh-ancestor
24586928|NCT00892801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24575220|NCT00830323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24575221|NCT00830323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575222|NCT00830323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575229|NCT00830323|Analgesics|analgesics|mesh-ancestor
24575230|NCT00830323|Sensory System Agents|sensory system agents|mesh-ancestor
24575231|NCT00830323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24575301|NCT00830505|Adrenergic Agents|adrenergic agents|mesh-ancestor
24575302|NCT00830505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24575303|NCT00830505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575304|NCT00830505|Glucocorticoids|glucocorticoids|mesh-ancestor
24575306|NCT00830505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24575308|NCT00830531|Bumetanide|bumetanide|mesh-list
24575309|NCT00830531|Diuretics|diuretics|mesh-ancestor
24575311|NCT00830531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575312|NCT00830531|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24575313|NCT00830531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24575314|NCT00830531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575315|NCT00830570|Warfarin|warfarin|mesh-list
24575316|NCT00830570|Anticoagulants|anticoagulants|mesh-ancestor
24575317|NCT00830609|Ribavirin|ribavirin|mesh-list
24575371|NCT00830882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24575372|NCT00830882|Respiratory System Agents|respiratory system agents|mesh-ancestor
24575373|NCT00830882|Tocolytic Agents|tocolytic agents|mesh-ancestor
25118687|NCT03954613|Nootropic Agents|nootropic agents|mesh-ancestor
24575374|NCT00830882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24575375|NCT00830882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24575376|NCT00830882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24575377|NCT00830882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24575378|NCT00830882|Adrenergic Agents|adrenergic agents|mesh-ancestor
24575379|NCT00830882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24575380|NCT00830882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792702|NCT04777006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24792703|NCT04777006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25009650|NCT05210517|Empagliflozin|empagliflozin|mesh-list
25009651|NCT05210517|Benzbromarone|benzbromarone|mesh-list
25009652|NCT05210517|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25009653|NCT05210517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009654|NCT05210517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24631129|NCT01116180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24575467|NCT00831857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24575468|NCT00831857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25104170|NCT03154814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575469|NCT00831857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24575470|NCT00831857|Growth Substances|growth substances|mesh-ancestor
24563230|NCT00770666|Dopamine Agents|dopamine agents|mesh-ancestor
24586931|NCT00892827|Rituximab|rituximab|mesh-list
24777169|NCT01862523|Antipruritics|antipruritics|mesh-ancestor
24777170|NCT01862523|Dermatologic Agents|dermatologic agents|mesh-ancestor
24777171|NCT01862523|Sensory System Agents|sensory system agents|mesh-ancestor
24777172|NCT01862523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24777173|NCT01862523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861360|NCT00086294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25861361|NCT00086294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587044|NCT00893256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587182|NCT00893724|Niacin|niacin|mesh-list
24631239|NCT01116596|Sensory System Agents|sensory system agents|mesh-ancestor
24575514|NCT00832221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575516|NCT00832234|Rituximab|rituximab|mesh-list
24575517|NCT00832234|Bortezomib|bortezomib|mesh-list
24575518|NCT00832234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24575519|NCT00832234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24575520|NCT00832234|Immunologic Factors|immunologic factors|mesh-ancestor
24575521|NCT00832234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575522|NCT00832234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24575628|NCT00832884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575630|NCT00833079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24575631|NCT00833079|Immunologic Factors|immunologic factors|mesh-ancestor
24575632|NCT00833079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575633|NCT00833079|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24575634|NCT00833079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575635|NCT00833079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575637|NCT00833157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24575638|NCT00833157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24575639|NCT00833157|Analgesics|analgesics|mesh-ancestor
24575736|NCT00833729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24563419|NCT00771459|Sensory System Agents|sensory system agents|mesh-ancestor
24575766|NCT00834184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24575767|NCT00834184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575768|NCT00834184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575769|NCT00834262|Insulin|insulin|mesh-list
24575770|NCT00834262|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24575771|NCT00834262|Insulin Aspart|insulin aspart|mesh-list
24575772|NCT00834262|Insulin, Long-Acting|insulin, long-acting|mesh-list
24968511|NCT03750721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24926703|NCT04138992|Bevacizumab|bevacizumab|mesh-list
24496477|NCT00504959|Ranibizumab|ranibizumab|mesh-list
24473516|NCT00403156|Growth Substances|growth substances|mesh-ancestor
24671112|NCT01323569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24671113|NCT01323569|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24575920|NCT00835471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575921|NCT00835471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24671114|NCT01323569|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24671115|NCT01323569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24575862|NCT00834847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24575863|NCT00834847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24575864|NCT00834847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575866|NCT00834860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24575867|NCT00834860|Antimetabolites|antimetabolites|mesh-ancestor
24575868|NCT00834860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575869|NCT00834860|Antiviral Agents|antiviral agents|mesh-ancestor
24575870|NCT00834860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24575881|NCT00835029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25199412|NCT02741219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587185|NCT00893724|Minocycline|minocycline|mesh-list
25861362|NCT00086294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861363|NCT00086294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24792708|NCT04777006|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24792710|NCT04777006|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24792711|NCT04777006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24792712|NCT04777006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24792713|NCT04777006|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24792714|NCT04777006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24792716|NCT04777006|Sensory System Agents|sensory system agents|mesh-ancestor
24792717|NCT04777006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24792718|NCT04777006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24792719|NCT04777006|Adrenergic Agents|adrenergic agents|mesh-ancestor
24792720|NCT04775082|Liraglutide|liraglutide|mesh-list
24792721|NCT04775082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24792722|NCT04775082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792723|NCT04775082|Incretins|incretins|mesh-ancestor
24792724|NCT04775082|Hormones|hormones|mesh-ancestor
24792725|NCT04775082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24792726|NCT04755244|Azacitidine|azacitidine|mesh-list
24792727|NCT04755244|Venetoclax|venetoclax|mesh-list
24575907|NCT00835393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24575937|NCT00835744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24575938|NCT00835744|Hormone Antagonists|hormone antagonists|mesh-ancestor
24575939|NCT00835744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24575940|NCT00835744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575941|NCT00835744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24575942|NCT00835744|Fertility Agents|fertility agents|mesh-ancestor
25199413|NCT02741219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25199414|NCT02741219|Analgesics|analgesics|mesh-ancestor
25199415|NCT02741219|Sensory System Agents|sensory system agents|mesh-ancestor
25199416|NCT02741219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25199417|NCT02741219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25199418|NCT02741219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25199419|NCT02741219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25199420|NCT02741219|Adrenergic Agents|adrenergic agents|mesh-ancestor
25199421|NCT02741219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25199422|NCT02741219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199423|NCT02741219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25199424|NCT02741219|Narcotics|narcotics|mesh-ancestor
25199425|NCT02741219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25199426|NCT02741219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25199427|NCT02741219|Anesthetics, General|anesthetics, general|mesh-ancestor
25199428|NCT02741219|Anesthetics|anesthetics|mesh-ancestor
25199429|NCT02740933|Demeclocycline|demeclocycline|mesh-list
25199430|NCT02740933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24576011|NCT00836212|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24576016|NCT00836212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24576017|NCT00836212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24576018|NCT00836212|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24576019|NCT00836316|Levobupivacaine|levobupivacaine|mesh-list
24563624|NCT00772616|Narcotics|narcotics|mesh-ancestor
25667825|NCT01709513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25667826|NCT01709513|Antimetabolites|antimetabolites|mesh-ancestor
25861364|NCT00086294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24576036|NCT00836368|Protective Agents|protective agents|mesh-ancestor
24576037|NCT00836381|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24576038|NCT00836381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24576039|NCT00836381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24576040|NCT00836381|Cholinergic Agents|cholinergic agents|mesh-ancestor
24576041|NCT00836381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576042|NCT00836381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576043|NCT00836381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576044|NCT00836381|Urological Agents|urological agents|mesh-ancestor
24576045|NCT00836485|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
24576047|NCT00836485|Lubricant Eye Drops|lubricant eye drops|mesh-list
24576075|NCT00836576|Protease Inhibitors|protease inhibitors|mesh-ancestor
24576076|NCT00836576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24576077|NCT00836576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576078|NCT00836576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24576079|NCT00836628|Busulfan|busulfan|mesh-list
24576080|NCT00836628|Alkylating Agents|alkylating agents|mesh-ancestor
24576081|NCT00836628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576082|NCT00836628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24576083|NCT00836628|Immunologic Factors|immunologic factors|mesh-ancestor
24576084|NCT00836628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576087|NCT00836628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24576088|NCT00836654|Catumaxomab|catumaxomab|mesh-list
24576089|NCT00836654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24792728|NCT04755244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24792729|NCT04755244|Antimetabolites|antimetabolites|mesh-ancestor
24576091|NCT00836667|Antidepressive Agents|antidepressive agents|mesh-ancestor
24576092|NCT00836667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24576093|NCT00836667|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24576094|NCT00836667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24576095|NCT00836667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24576096|NCT00836667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587309|NCT00894231|Levocetirizine|levocetirizine|mesh-list
24576118|NCT00836849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576136|NCT00837044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576137|NCT00837044|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24576138|NCT00837044|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24576139|NCT00837044|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24792730|NCT04755244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104019|NCT03156036|Capecitabine|capecitabine|mesh-list
24576212|NCT00837655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576214|NCT00837655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576216|NCT00837655|Chelating Agents|chelating agents|mesh-ancestor
24576217|NCT00837655|Sequestering Agents|sequestering agents|mesh-ancestor
24576218|NCT00837707|Aripiprazole|aripiprazole|mesh-list
24576239|NCT00837746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576292|NCT00837928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576294|NCT00837941|Diphenhydramine|diphenhydramine|mesh-list
24576295|NCT00837941|Promethazine|promethazine|mesh-list
24576296|NCT00837941|Pregabalin|pregabalin|mesh-list
24481832|NCT00436839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24736502|NCT01662674|Metformin|metformin|mesh-list
24848625|NCT03843463|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24848639|NCT03842709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24576297|NCT00837941|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24576298|NCT00837941|Analgesics|analgesics|mesh-ancestor
24576332|NCT00838032|Haloperidol|haloperidol|mesh-list
24576333|NCT00838032|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24576334|NCT00838032|Haloperidol decanoate|haloperidol decanoate|mesh-list
24576335|NCT00838032|Antidepressive Agents|antidepressive agents|mesh-ancestor
24576336|NCT00838032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24576337|NCT00838032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24576338|NCT00838032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24576339|NCT00838032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24576340|NCT00838032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576341|NCT00838032|Antiemetics|antiemetics|mesh-ancestor
24576342|NCT00838032|Autonomic Agents|autonomic agents|mesh-ancestor
25104087|NCT03155984|Antibodies|antibodies|mesh-list
24576398|NCT00838266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576400|NCT00838305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24576401|NCT00838305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24576402|NCT00838305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24576403|NCT00838305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576404|NCT00838305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576406|NCT00838305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576407|NCT00838305|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24926852|NCT04138238|Sirolimus|sirolimus|mesh-list
24576408|NCT00838305|Antidepressive Agents|antidepressive agents|mesh-ancestor
24576460|NCT00838669|Serotonin Agents|serotonin agents|mesh-ancestor
24576461|NCT00838669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576390|NCT00838240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24576391|NCT00838240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24576392|NCT00838266|Grape Seed Extract|grape seed extract|mesh-list
24576393|NCT00838266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24576462|NCT00838669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576463|NCT00838669|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24576464|NCT00838669|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24576465|NCT00838669|Dopamine Agents|dopamine agents|mesh-ancestor
24576506|NCT00838968|Immunologic Factors|immunologic factors|mesh-ancestor
25009776|NCT05188417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25009777|NCT05188417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104251|NCT03154385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24576711|NCT00840112|Micronutrients|micronutrients|mesh-ancestor
24576712|NCT00840112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576713|NCT00840112|Antioxidants|antioxidants|mesh-ancestor
24576732|NCT00840229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24576735|NCT00840229|Immunologic Factors|immunologic factors|mesh-ancestor
24576736|NCT00840229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24576737|NCT00840229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576753|NCT00840333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24576754|NCT00840333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24576755|NCT00840333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25104293|NCT03154125|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24576772|NCT00840385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576773|NCT00840385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24576774|NCT00840385|Immunologic Factors|immunologic factors|mesh-ancestor
24576775|NCT00840385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576776|NCT00840385|Antiviral Agents|antiviral agents|mesh-ancestor
24576777|NCT00840385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24576778|NCT00840398|Buspirone|buspirone|mesh-list
24576779|NCT00840398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24576780|NCT00840398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24576781|NCT00840398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24576782|NCT00840398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576783|NCT00840398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24576784|NCT00840398|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24576785|NCT00840398|Serotonin Agents|serotonin agents|mesh-ancestor
24576786|NCT00840398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576787|NCT00840398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576788|NCT00840489|Ribavirin|ribavirin|mesh-list
25119025|NCT03077620|Suvorexant|suvorexant|mesh-list
24576789|NCT00840489|Colchicine|colchicine|mesh-list
24576790|NCT00840489|Antimetabolites|antimetabolites|mesh-ancestor
24576791|NCT00840489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576792|NCT00840489|Antiviral Agents|antiviral agents|mesh-ancestor
24576793|NCT00840489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24576794|NCT00840489|Gout Suppressants|gout suppressants|mesh-ancestor
24576795|NCT00840489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24576796|NCT00840489|Tubulin Modulators|tubulin modulators|mesh-ancestor
24587511|NCT00895297|Dasatinib|dasatinib|mesh-list
24576797|NCT00840489|Antimitotic Agents|antimitotic agents|mesh-ancestor
24576798|NCT00840489|Mitosis Modulators|mitosis modulators|mesh-ancestor
24576799|NCT00840489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24576800|NCT00840580|Moxifloxacin|moxifloxacin|mesh-list
24564229|NCT00775632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24576807|NCT00840580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24576808|NCT00840580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25199479|NCT02740803|Cariostatic Agents|cariostatic agents|mesh-ancestor
24576817|NCT00840580|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24576849|NCT00840684|Melphalan|melphalan|mesh-list
24576850|NCT00840684|Busulfan|busulfan|mesh-list
24576851|NCT00840684|Daunorubicin|daunorubicin|mesh-list
24576852|NCT00840684|Mitoxantrone|mitoxantrone|mesh-list
24576656|NCT00839605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24576657|NCT00839605|Analgesics|analgesics|mesh-ancestor
24576658|NCT00839605|Sensory System Agents|sensory system agents|mesh-ancestor
24576659|NCT00839605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24576660|NCT00839605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24576661|NCT00839605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24577083|NCT00841880|Vasodilator Agents|vasodilator agents|mesh-ancestor
24577084|NCT00841893|Mechlorethamine|mechlorethamine|mesh-list
25861365|NCT00086294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24577085|NCT00841893|Alkylating Agents|alkylating agents|mesh-ancestor
25104399|NCT03153163|Maytansine|maytansine|mesh-list
24577237|NCT00842595|Glucocorticoids|glucocorticoids|mesh-ancestor
24577238|NCT00842595|Hormones|hormones|mesh-ancestor
24444035|NCT00296608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24444036|NCT00296608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199431|NCT02740933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25199432|NCT02740894|Gefitinib|gefitinib|mesh-list
25199433|NCT02740894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199434|NCT02740894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25199435|NCT02740894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199436|NCT02740894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199437|NCT02740829|Glucagon|glucagon|mesh-list
25199438|NCT02740829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25199439|NCT02740829|Hormones|hormones|mesh-ancestor
24577276|NCT00842686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577279|NCT00842894|Insulin Aspart|insulin aspart|mesh-list
24577280|NCT00842894|Insulin Detemir|insulin detemir|mesh-list
24577281|NCT00842894|Biphasic Insulins|biphasic insulins|mesh-list
24759024|NCT01749085|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25861366|NCT00086294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25861367|NCT00086294|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24792812|NCT04655391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792814|NCT04655391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24792818|NCT04609098|Piperaquine|piperaquine|mesh-list
24792819|NCT04609098|Artenimol|artenimol|mesh-list
24792820|NCT04609098|Tafenoquine|tafenoquine|mesh-list
24577348|NCT00843440|Bevacizumab|bevacizumab|mesh-list
24577349|NCT00843440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24577350|NCT00843440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577351|NCT00843440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24577387|NCT00843661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24577388|NCT00843661|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24577389|NCT00843661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577390|NCT00843791|Pioglitazone|pioglitazone|mesh-list
25009792|NCT05186454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24577391|NCT00843791|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
24577392|NCT00843791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24577393|NCT00843791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444037|NCT00296608|Antimetabolites|antimetabolites|mesh-ancestor
24577419|NCT00844012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25009793|NCT05186454|Antiemetics|antiemetics|mesh-ancestor
25009794|NCT05186454|Autonomic Agents|autonomic agents|mesh-ancestor
25009795|NCT05186454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25009796|NCT05186454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009798|NCT05186454|Glucocorticoids|glucocorticoids|mesh-ancestor
25009800|NCT05186454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25009801|NCT05186454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24577474|NCT00844285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24577475|NCT00844285|Immunologic Factors|immunologic factors|mesh-ancestor
24577476|NCT00844285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577477|NCT00844285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25009834|NCT05155137|Amlodipine|amlodipine|mesh-list
25009835|NCT05155137|Valsartan|valsartan|mesh-list
24951537|NCT03903367|Narcotics|narcotics|mesh-ancestor
25009836|NCT05155137|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25009837|NCT05155137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25009838|NCT05155137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25009839|NCT05155137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25009840|NCT05155137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009841|NCT05155137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25009842|NCT05155137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009843|NCT05155137|Vasodilator Agents|vasodilator agents|mesh-ancestor
25009844|NCT05155137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25009845|NCT05155137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25009846|NCT05155137|Antimetabolites|antimetabolites|mesh-ancestor
25009847|NCT05155137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24577695|NCT00845572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24577696|NCT00845572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24577697|NCT00845572|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24577698|NCT00845572|Dopamine Agents|dopamine agents|mesh-ancestor
24577701|NCT00845598|Azelastine|azelastine|mesh-list
24577702|NCT00845598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24577703|NCT00845598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24577704|NCT00845598|Autonomic Agents|autonomic agents|mesh-ancestor
24497061|NCT00507858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24497149|NCT00508365|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24497150|NCT00508365|Protease Inhibitors|protease inhibitors|mesh-ancestor
24497151|NCT00508365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497152|NCT00508365|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25861368|NCT00086294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25861369|NCT00086294|Serotonin Agents|serotonin agents|mesh-ancestor
24497153|NCT00508456|Temozolomide|temozolomide|mesh-list
24497154|NCT00508456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24497155|NCT00508456|Alkylating Agents|alkylating agents|mesh-ancestor
24497156|NCT00508456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861370|NCT00086320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25861371|NCT00086320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24577705|NCT00845598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25199440|NCT02740829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25199441|NCT02740829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199442|NCT02741063|Oxytocin|oxytocin|mesh-list
25199443|NCT02741063|Oxytocics|oxytocics|mesh-ancestor
24577772|NCT00845819|Micronutrients|micronutrients|mesh-ancestor
24577773|NCT00845819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577774|NCT00845819|Plasma Substitutes|plasma substitutes|mesh-ancestor
24577790|NCT00845884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577791|NCT00845884|Growth Inhibitors|growth inhibitors|mesh-ancestor
24577792|NCT00845884|Tubulin Modulators|tubulin modulators|mesh-ancestor
24577793|NCT00845884|Antimitotic Agents|antimitotic agents|mesh-ancestor
24577815|NCT00845936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24577816|NCT00845936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577817|NCT00845962|Bupivacaine|bupivacaine|mesh-list
24577818|NCT00845962|Chloroprocaine|chloroprocaine|mesh-list
24577819|NCT00845962|Anesthetics, Local|anesthetics, local|mesh-ancestor
24577820|NCT00845962|Anesthetics|anesthetics|mesh-ancestor
24577821|NCT00845962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24577822|NCT00845962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577823|NCT00845962|Sensory System Agents|sensory system agents|mesh-ancestor
24577824|NCT00845962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24577825|NCT00845988|Aripiprazole|aripiprazole|mesh-list
24577826|NCT00845988|Antidepressive Agents|antidepressive agents|mesh-ancestor
24577827|NCT00845988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24577828|NCT00845988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24577829|NCT00845988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24577830|NCT00845988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24577831|NCT00845988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577832|NCT00845988|Dopamine Agonists|dopamine agonists|mesh-ancestor
24577833|NCT00845988|Dopamine Agents|dopamine agents|mesh-ancestor
24577834|NCT00845988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24577835|NCT00845988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577935|NCT00846339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24577936|NCT00846339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861372|NCT00086320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24577966|NCT00846443|Cisplatin|cisplatin|mesh-list
24577967|NCT00846443|Pemetrexed|pemetrexed|mesh-list
24578021|NCT00846690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24578022|NCT00846690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24578023|NCT00846690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578024|NCT00846690|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24578025|NCT00846690|Mydriatics|mydriatics|mesh-ancestor
24578026|NCT00846690|Autonomic Agents|autonomic agents|mesh-ancestor
24578027|NCT00846690|Sympathomimetics|sympathomimetics|mesh-ancestor
24578028|NCT00846690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24578029|NCT00846690|Nasal Decongestants|nasal decongestants|mesh-ancestor
25104846|NCT03150576|Paclitaxel|paclitaxel|mesh-list
24578119|NCT00846950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24578120|NCT00846950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25199444|NCT02741063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25667827|NCT01709513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667828|NCT01709513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25667829|NCT01709513|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25667830|NCT01709513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25667831|NCT01709578|Hydroxychloroquine|hydroxychloroquine|mesh-list
25667832|NCT01709578|Sulfasalazine|sulfasalazine|mesh-list
25667833|NCT01709578|Methotrexate|methotrexate|mesh-list
25667834|NCT01709578|Leflunomide|leflunomide|mesh-list
25667835|NCT01709578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25667836|NCT01709578|Abortifacient Agents|abortifacient agents|mesh-ancestor
25667837|NCT01709578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25082875|NCT03319498|Dermatologic Agents|dermatologic agents|mesh-ancestor
25082876|NCT03319420|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25082877|NCT03319420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25082878|NCT03319238|Ketamine|ketamine|mesh-list
24805084|NCT02007408|Lidocaine|lidocaine|mesh-list
24793881|NCT00572169|Etoposide|etoposide|mesh-list
24578128|NCT00846950|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24578129|NCT00846950|Histamine Antagonists|histamine antagonists|mesh-ancestor
24578130|NCT00846950|Histamine Agents|histamine agents|mesh-ancestor
24578131|NCT00846963|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24578132|NCT00846963|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24578133|NCT00846963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24578134|NCT00846976|Bicalutamide|bicalutamide|mesh-list
24578245|NCT00847834|Diuretics|diuretics|mesh-ancestor
24578261|NCT00847860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24578262|NCT00847860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24578263|NCT00847860|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24578264|NCT00847860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24578265|NCT00847860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578266|NCT00847860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24578267|NCT00847860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24578268|NCT00847860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24578269|NCT00847860|Antipyretics|antipyretics|mesh-ancestor
25009873|NCT05113290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109986|NCT03120923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25109987|NCT03120923|Glucocorticoids|glucocorticoids|mesh-ancestor
25109988|NCT03120923|Hormones|hormones|mesh-ancestor
25109989|NCT03120923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25109990|NCT03120923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25109991|NCT03120923|Immunologic Factors|immunologic factors|mesh-ancestor
25109992|NCT03120923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25109993|NCT03120975|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25109994|NCT03120975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25109995|NCT03120728|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25109996|NCT03120728|Etonogestrel|etonogestrel|mesh-list
25109997|NCT03120728|NuvaRing|nuvaring|mesh-list
25110005|NCT03120728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25110006|NCT03120728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25110007|NCT03120728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25110008|NCT03120728|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25110009|NCT03120442|Fentanyl|fentanyl|mesh-list
25110010|NCT03120442|Dexmedetomidine|dexmedetomidine|mesh-list
24899788|NCT04399187|Eusol|eusol|mesh-list
25861373|NCT00086320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25110011|NCT03120442|Propofol|propofol|mesh-list
25110012|NCT03120442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25110013|NCT03120442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25110014|NCT03120442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110015|NCT03120442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25110016|NCT03120442|Anesthetics, General|anesthetics, general|mesh-ancestor
25110017|NCT03120442|Anesthetics|anesthetics|mesh-ancestor
25110018|NCT03120442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25110019|NCT03120442|Analgesics|analgesics|mesh-ancestor
25110020|NCT03120442|Sensory System Agents|sensory system agents|mesh-ancestor
25110048|NCT03120715|Tinzaparin|tinzaparin|mesh-list
25110049|NCT03120715|Dalteparin|dalteparin|mesh-list
25110050|NCT03120715|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25110051|NCT03120715|Progesterone|progesterone|mesh-list
25110052|NCT03120715|Estrogens|estrogens|mesh-list
25110053|NCT03120715|Anticoagulants|anticoagulants|mesh-ancestor
24578310|NCT00848432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24578311|NCT00848432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24578312|NCT00848432|Dopamine Agents|dopamine agents|mesh-ancestor
24578344|NCT00848679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24578345|NCT00848679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578347|NCT00848692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24578349|NCT00848692|Immunologic Factors|immunologic factors|mesh-ancestor
24578350|NCT00848692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578387|NCT00848861|Anesthetics|anesthetics|mesh-ancestor
24578388|NCT00848861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24578389|NCT00848861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25667838|NCT01709578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667839|NCT01709578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25667840|NCT01709578|Antimetabolites|antimetabolites|mesh-ancestor
25667841|NCT01709578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667842|NCT01709578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578390|NCT00848861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24578470|NCT00849095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24578472|NCT00849160|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24578473|NCT00849160|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24578474|NCT00849160|Protease Inhibitors|protease inhibitors|mesh-ancestor
24578475|NCT00849160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24578476|NCT00849160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578477|NCT00849160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24578478|NCT00849160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24578479|NCT00849160|Antiviral Agents|antiviral agents|mesh-ancestor
24578480|NCT00849160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24578481|NCT00849238|Mycophenolic Acid|mycophenolic acid|mesh-list
24578482|NCT00849238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24578483|NCT00849238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578511|NCT00849329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25105042|NCT03149393|Serotonin Agents|serotonin agents|mesh-ancestor
24578533|NCT00849368|Protective Agents|protective agents|mesh-ancestor
24578534|NCT00849368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578535|NCT00849368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24578536|NCT00849368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578537|NCT00849368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24578538|NCT00849368|Immunologic Factors|immunologic factors|mesh-ancestor
24578557|NCT00849537|Hormones|hormones|mesh-ancestor
24578558|NCT00849537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24578559|NCT00849537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578560|NCT00849550|Bevacizumab|bevacizumab|mesh-list
24578561|NCT00849550|Capecitabine|capecitabine|mesh-list
24578562|NCT00849550|Oxaliplatin|oxaliplatin|mesh-list
24578563|NCT00849550|Everolimus|everolimus|mesh-list
24578564|NCT00849550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24578577|NCT00849602|Amebicides|amebicides|mesh-ancestor
24578578|NCT00849602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24578579|NCT00849602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24578580|NCT00849602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24578581|NCT00849602|Antimalarials|antimalarials|mesh-ancestor
24578582|NCT00849602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24578583|NCT00849615|Leucovorin|leucovorin|mesh-list
24578584|NCT00849615|Folic Acid|folic acid|mesh-list
24578585|NCT00849615|Docetaxel|docetaxel|mesh-list
24578586|NCT00849615|Fluorouracil|fluorouracil|mesh-list
24578587|NCT00849615|Oxaliplatin|oxaliplatin|mesh-list
24578588|NCT00849615|Levoleucovorin|levoleucovorin|mesh-list
24578589|NCT00849615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578590|NCT00849615|Tubulin Modulators|tubulin modulators|mesh-ancestor
24578591|NCT00849615|Antimitotic Agents|antimitotic agents|mesh-ancestor
24578592|NCT00849615|Mitosis Modulators|mitosis modulators|mesh-ancestor
24578593|NCT00849615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578594|NCT00849615|Antimetabolites|antimetabolites|mesh-ancestor
24578634|NCT00850044|Ritonavir|ritonavir|mesh-list
24578635|NCT00850044|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24578636|NCT00850044|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24578638|NCT00850044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25009875|NCT05107778|Antiviral Agents|antiviral agents|mesh-ancestor
25009877|NCT05097716|Tolbutamide|tolbutamide|mesh-list
25009878|NCT05097716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25009879|NCT05097716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009880|NCT05095857|Ketamine|ketamine|mesh-list
25009881|NCT05095857|Esketamine|esketamine|mesh-list
25009882|NCT05095857|Analgesics|analgesics|mesh-ancestor
25009883|NCT05095857|Sensory System Agents|sensory system agents|mesh-ancestor
25009884|NCT05095857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25009885|NCT05095857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009886|NCT05095857|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25009887|NCT05095857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25009890|NCT05095857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25009891|NCT05095857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25009892|NCT05095857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25009893|NCT05095857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24792953|NCT04339101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24578642|NCT00850044|Antiviral Agents|antiviral agents|mesh-ancestor
24578643|NCT00850044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24578644|NCT00850044|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24578675|NCT00850668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24578676|NCT00850746|Moxifloxacin|moxifloxacin|mesh-list
24578678|NCT00850746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24578679|NCT00850746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24578680|NCT00850746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24578681|NCT00850746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24578682|NCT00850746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24578683|NCT00850746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578686|NCT00850746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24578687|NCT00850746|Cholinergic Agents|cholinergic agents|mesh-ancestor
24578688|NCT00850746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24578689|NCT00850746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24578725|NCT00851227|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24578726|NCT00851227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578728|NCT00851227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578729|NCT00851344|Cetirizine|cetirizine|mesh-list
24578730|NCT00851344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24578731|NCT00851344|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24578732|NCT00851344|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24578790|NCT00851942|Cosyntropin|cosyntropin|mesh-list
24578791|NCT00851942|Hormones|hormones|mesh-ancestor
24578792|NCT00851942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24578793|NCT00851942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578794|NCT00852046|Dexmedetomidine|dexmedetomidine|mesh-list
24578795|NCT00852046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24578796|NCT00852046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24578797|NCT00852046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578798|NCT00852046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24578799|NCT00852046|Analgesics|analgesics|mesh-ancestor
24578879|NCT00852371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24578880|NCT00852371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24578881|NCT00852371|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24578882|NCT00852371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24578883|NCT00852371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578884|NCT00852371|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24578885|NCT00852371|Renal Agents|renal agents|mesh-ancestor
24578887|NCT00852410|Epinephrine|epinephrine|mesh-list
24578888|NCT00852410|Racepinephrine|racepinephrine|mesh-list
24578889|NCT00852410|Epinephryl borate|epinephryl borate|mesh-list
24578890|NCT00852410|Anesthetics, Local|anesthetics, local|mesh-ancestor
24578891|NCT00852410|Anesthetics|anesthetics|mesh-ancestor
24578892|NCT00852410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24473088|NCT00401804|Glucocorticoids|glucocorticoids|mesh-ancestor
24578893|NCT00852410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578894|NCT00852410|Sensory System Agents|sensory system agents|mesh-ancestor
24578895|NCT00852410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24578896|NCT00852410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24578897|NCT00852410|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24578898|NCT00852410|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24578899|NCT00852410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24578900|NCT00852410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578901|NCT00852410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24578902|NCT00852410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24578903|NCT00852410|Adrenergic Agents|adrenergic agents|mesh-ancestor
24578904|NCT00852410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25110054|NCT03120715|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24578909|NCT00852410|Respiratory System Agents|respiratory system agents|mesh-ancestor
24578995|NCT00852956|Vasodilator Agents|vasodilator agents|mesh-ancestor
24578996|NCT00852956|Histamine Agonists|histamine agonists|mesh-ancestor
24578998|NCT00852956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24579019|NCT00853008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24579020|NCT00853008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24579021|NCT00853008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579029|NCT00853008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579030|NCT00853008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24579031|NCT00853008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24579032|NCT00853008|Immunologic Factors|immunologic factors|mesh-ancestor
24579033|NCT00853008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24579034|NCT00853008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24579035|NCT00853008|Antiviral Agents|antiviral agents|mesh-ancestor
24579036|NCT00853008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25105343|NCT03146689|Ibuprofen|ibuprofen|mesh-list
24579065|NCT00853190|Analgesics|analgesics|mesh-ancestor
24579066|NCT00853190|Sensory System Agents|sensory system agents|mesh-ancestor
24579067|NCT00853190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24579068|NCT00853190|Antitussive Agents|antitussive agents|mesh-ancestor
24579069|NCT00853190|Respiratory System Agents|respiratory system agents|mesh-ancestor
24579070|NCT00853190|Antipruritics|antipruritics|mesh-ancestor
24579071|NCT00853190|Dermatologic Agents|dermatologic agents|mesh-ancestor
24579072|NCT00853190|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24579073|NCT00853190|Histamine Antagonists|histamine antagonists|mesh-ancestor
25428256|NCT01745757|Paclitaxel|paclitaxel|mesh-list
24579098|NCT00853294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24579099|NCT00853294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579100|NCT00853294|Analgesics|analgesics|mesh-ancestor
24579101|NCT00853294|Sensory System Agents|sensory system agents|mesh-ancestor
24579102|NCT00853294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24579103|NCT00853294|Antitussive Agents|antitussive agents|mesh-ancestor
24579104|NCT00853294|Respiratory System Agents|respiratory system agents|mesh-ancestor
24579105|NCT00853294|Antipruritics|antipruritics|mesh-ancestor
24579106|NCT00853294|Dermatologic Agents|dermatologic agents|mesh-ancestor
24579127|NCT00853411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579128|NCT00853450|Clopidogrel|clopidogrel|mesh-list
24579129|NCT00853450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24579130|NCT00853450|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24579131|NCT00853450|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24579191|NCT00853736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579192|NCT00853736|Analgesics|analgesics|mesh-ancestor
24579193|NCT00853736|Sensory System Agents|sensory system agents|mesh-ancestor
24579194|NCT00853736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24579195|NCT00853866|Reboxetine|reboxetine|mesh-list
24579196|NCT00853866|Antidepressive Agents|antidepressive agents|mesh-ancestor
24579197|NCT00853866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24579198|NCT00853866|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24579199|NCT00853866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24579200|NCT00853866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24579201|NCT00853866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579202|NCT00853866|Adrenergic Agents|adrenergic agents|mesh-ancestor
24579203|NCT00853866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25045653|NCT00934180|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25119527|NCT05404516|Cytarabine|cytarabine|mesh-list
24579204|NCT00853866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579205|NCT00853879|Vitamins|vitamins|mesh-list
24579206|NCT00853879|Folic Acid|folic acid|mesh-list
24579207|NCT00853879|Hydroxocobalamin|hydroxocobalamin|mesh-list
24579208|NCT00853879|Vitamin B 12|vitamin b 12|mesh-list
24579265|NCT00854139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24579266|NCT00854139|Alkylating Agents|alkylating agents|mesh-ancestor
24579267|NCT00854139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579268|NCT00854139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579269|NCT00854139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24579270|NCT00854139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579271|NCT00854139|Antifungal Agents|antifungal agents|mesh-ancestor
24579272|NCT00854139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24794911|NCT04160052|Venetoclax|venetoclax|mesh-list
24579374|NCT00854763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24579375|NCT00854763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24579376|NCT00854763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579377|NCT00854776|Lansoprazole|lansoprazole|mesh-list
24579378|NCT00854776|Dexlansoprazole|dexlansoprazole|mesh-list
24579379|NCT00854776|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24579380|NCT00854776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24579381|NCT00854776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24579382|NCT00854776|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24579383|NCT00854776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579395|NCT00854802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24579396|NCT00854802|Antifungal Agents|antifungal agents|mesh-ancestor
24579397|NCT00854802|Dermatologic Agents|dermatologic agents|mesh-ancestor
24579398|NCT00854802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579399|NCT00854802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24579400|NCT00854802|Immunologic Factors|immunologic factors|mesh-ancestor
24579401|NCT00854802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579402|NCT00854802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24579403|NCT00854802|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24579404|NCT00854841|Imatinib Mesylate|imatinib mesylate|mesh-list
24579446|NCT00855101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579447|NCT00855101|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24579448|NCT00855101|Hormone Antagonists|hormone antagonists|mesh-ancestor
24579449|NCT00855101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24579450|NCT00855101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579451|NCT00855101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24579453|NCT00855114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579454|NCT00855114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24579455|NCT00855114|Immunologic Factors|immunologic factors|mesh-ancestor
24579456|NCT00855114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579457|NCT00855153|Cycloserine|cycloserine|mesh-list
24579458|NCT00855153|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24579516|NCT00855699|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24579517|NCT00855777|Ibuprofen|ibuprofen|mesh-list
24579518|NCT00855777|Etoricoxib|etoricoxib|mesh-list
24566045|NCT00784186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25009998|NCT04814355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25009999|NCT04814355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25010000|NCT04814355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110055|NCT03120715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25110056|NCT03120715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110057|NCT03120715|Progestins|progestins|mesh-ancestor
25110059|NCT03120715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25110060|NCT03120715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110061|NCT03120715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25110062|NCT03120533|Treprostinil|treprostinil|mesh-list
25110063|NCT03120533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25110064|NCT03120403|Morphine|morphine|mesh-list
25110065|NCT03120403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24579619|NCT00856570|Adrenergic Agents|adrenergic agents|mesh-ancestor
24579646|NCT00856687|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24579647|NCT00856687|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24579648|NCT00856687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579650|NCT00856700|Hormones|hormones|mesh-ancestor
24579651|NCT00856700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25199445|NCT02741063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199446|NCT02741115|Udenafil|udenafil|mesh-list
24579654|NCT00856804|Thalidomide|thalidomide|mesh-list
24579655|NCT00856804|Antimetabolites|antimetabolites|mesh-ancestor
24579656|NCT00856804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579657|NCT00856804|Antiviral Agents|antiviral agents|mesh-ancestor
24579658|NCT00856804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24579659|NCT00856804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24579660|NCT00856804|Immunologic Factors|immunologic factors|mesh-ancestor
24579661|NCT00856804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579662|NCT00856804|Leprostatic Agents|leprostatic agents|mesh-ancestor
24579663|NCT00856804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24579664|NCT00856804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24579665|NCT00856804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24579735|NCT00857324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579736|NCT00857324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579737|NCT00857376|Thioctic Acid|thioctic acid|mesh-list
24579739|NCT00857376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579741|NCT00857376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579742|NCT00857376|Vitamin B Complex|vitamin b complex|mesh-ancestor
24579743|NCT00857376|Vitamins|vitamins|mesh-ancestor
24579744|NCT00857376|Micronutrients|micronutrients|mesh-ancestor
24579745|NCT00857428|Oxymorphone|oxymorphone|mesh-list
24579746|NCT00857428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24579747|NCT00857428|Narcotics|narcotics|mesh-ancestor
24579748|NCT00857428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24579749|NCT00857428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579750|NCT00857428|Analgesics|analgesics|mesh-ancestor
24579774|NCT00857597|Esomeprazole|esomeprazole|mesh-list
24579775|NCT00857597|Omeprazole|omeprazole|mesh-list
24579776|NCT00857597|Rabeprazole|rabeprazole|mesh-list
24579777|NCT00857597|Pantoprazole|pantoprazole|mesh-list
24579778|NCT00857597|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24579779|NCT00857597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24579780|NCT00857597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24975353|NCT04005690|Olaparib|olaparib|mesh-list
24579839|NCT00858195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579840|NCT00858195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579841|NCT00858273|Insulin|insulin|mesh-list
24579842|NCT00858273|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24579843|NCT00858273|Antioxidants|antioxidants|mesh-list
24579844|NCT00858273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24579845|NCT00858273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579846|NCT00858273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579847|NCT00858273|Protective Agents|protective agents|mesh-ancestor
24579848|NCT00858299|Valsartan|valsartan|mesh-list
24579849|NCT00858299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24579851|NCT00858299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24579852|NCT00858299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579853|NCT00858325|Daptomycin|daptomycin|mesh-list
24579854|NCT00858325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24968947|NCT03746691|Serotonin Agents|serotonin agents|mesh-ancestor
24968948|NCT03746691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968951|NCT03746691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24578905|NCT00852410|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24578906|NCT00852410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24578907|NCT00852410|Autonomic Agents|autonomic agents|mesh-ancestor
24578908|NCT00852410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24579918|NCT00858715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579919|NCT00858715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24579920|NCT00858715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24579921|NCT00858715|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24579922|NCT00858715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24579929|NCT00858715|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24579930|NCT00858715|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24579931|NCT00858715|Purinergic Agents|purinergic agents|mesh-ancestor
24579932|NCT00858715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24579933|NCT00858754|Methylnaltrexone|methylnaltrexone|mesh-list
24579934|NCT00858754|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24579935|NCT00858754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579936|NCT00858754|Sensory System Agents|sensory system agents|mesh-ancestor
24951682|NCT03902249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24951683|NCT03902249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24951685|NCT03901716|Fentanyl|fentanyl|mesh-list
24579937|NCT00858754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24579960|NCT00858897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579962|NCT00859079|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24579963|NCT00859079|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24579964|NCT00859079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24579982|NCT00859183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24579983|NCT00859183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24579984|NCT00859183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24580015|NCT00859352|Anesthetics, General|anesthetics, general|mesh-ancestor
24580016|NCT00859352|Anesthetics|anesthetics|mesh-ancestor
24580017|NCT00859352|GABA Modulators|gaba modulators|mesh-ancestor
24580018|NCT00859352|GABA Agents|gaba agents|mesh-ancestor
24580019|NCT00859352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24580020|NCT00859352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580021|NCT00859534|Afamelanotide|afamelanotide|mesh-list
24580022|NCT00859534|Dermatologic Agents|dermatologic agents|mesh-ancestor
24580023|NCT00859703|Risedronic Acid|risedronic acid|mesh-list
24580029|NCT00859703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24580030|NCT00859807|Amodiaquine|amodiaquine|mesh-list
24580031|NCT00859807|Antimalarials|antimalarials|mesh-ancestor
24580032|NCT00859807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24580033|NCT00859807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24580034|NCT00859807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24580035|NCT00859872|Haloperidol|haloperidol|mesh-list
24580192|NCT00860977|Antiviral Agents|antiviral agents|mesh-ancestor
24580193|NCT00860977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24580194|NCT00861016|Metoprolol|metoprolol|mesh-list
24793094|NCT04225026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793095|NCT04225026|Protective Agents|protective agents|mesh-ancestor
24793096|NCT04225026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793097|NCT04210427|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24793098|NCT04210427|Laxatives|laxatives|mesh-ancestor
24793099|NCT04210427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24793108|NCT04128072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793109|NCT04126096|Lactams|lactams|mesh-list
24793110|NCT04126096|beta-Lactams|beta-lactams|mesh-list
24793111|NCT04126096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24793112|NCT04126096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25105390|NCT03146247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24805688|NCT02011737|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24580985|NCT00864149|Vasodilator Agents|vasodilator agents|mesh-ancestor
24444797|NCT00299091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24444798|NCT00299208|Azithromycin|azithromycin|mesh-list
24473509|NCT00403065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24473510|NCT00403065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24473512|NCT00403156|Ranibizumab|ranibizumab|mesh-list
24473513|NCT00403156|Imatinib Mesylate|imatinib mesylate|mesh-list
24473514|NCT00403156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24473515|NCT00403156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25861374|NCT00086320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667843|NCT01709578|Dermatologic Agents|dermatologic agents|mesh-ancestor
25667844|NCT01709578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25667845|NCT01709578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25861375|NCT00086320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25010012|NCT04789304|GABA Modulators|gaba modulators|mesh-ancestor
25010020|NCT04780724|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25010022|NCT04780724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010030|NCT04700007|Diphenhydramine|diphenhydramine|mesh-list
25010031|NCT04700007|Promethazine|promethazine|mesh-list
25010032|NCT04700007|Morphine|morphine|mesh-list
25010033|NCT04700007|Capsaicin|capsaicin|mesh-list
25010034|NCT04700007|Histamine|histamine|mesh-list
25010035|NCT04700007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25010036|NCT04700007|Narcotics|narcotics|mesh-ancestor
25010037|NCT04700007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25010038|NCT04700007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010039|NCT04700007|Analgesics|analgesics|mesh-ancestor
24566635|NCT00786734|Antimetabolites|antimetabolites|mesh-ancestor
24580240|NCT00861094|Leucovorin|leucovorin|mesh-list
24580241|NCT00861094|Folic Acid|folic acid|mesh-list
24580242|NCT00861094|Fluorouracil|fluorouracil|mesh-list
24580243|NCT00861094|Oxaliplatin|oxaliplatin|mesh-list
24580244|NCT00861094|Levoleucovorin|levoleucovorin|mesh-list
24580245|NCT00861094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24580246|NCT00861094|Antimetabolites|antimetabolites|mesh-ancestor
24580247|NCT00861094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580248|NCT00861094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24580249|NCT00861094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24580445|NCT00861874|Sirolimus|sirolimus|mesh-list
24580446|NCT00861874|Decitabine|decitabine|mesh-list
24580447|NCT00861874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24580448|NCT00861874|Antimetabolites|antimetabolites|mesh-ancestor
25199447|NCT02741115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25199448|NCT02741115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25199455|NCT02740868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25119768|NCT05258110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25119769|NCT05258110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25119772|NCT05258110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24580449|NCT00861874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580450|NCT00861874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24580451|NCT00861874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580452|NCT00861874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24580492|NCT00861939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24580493|NCT00861939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580494|NCT00861939|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25010071|NCT04681079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24473545|NCT00403286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24473546|NCT00403286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25861376|NCT00086320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24473567|NCT00403312|Cholinergic Agents|cholinergic agents|mesh-ancestor
24473568|NCT00403312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25010072|NCT04681079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010081|NCT04663282|Insulin|insulin|mesh-list
25010082|NCT04663282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25010083|NCT04663282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580536|NCT00862108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24580537|NCT00862108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580539|NCT00862108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24580540|NCT00862264|Beclomethasone|beclomethasone|mesh-list
24579277|NCT00854178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24580584|NCT00862394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24580635|NCT00862693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24580637|NCT00862706|Antiviral Agents|antiviral agents|mesh-ancestor
24580638|NCT00862706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24580639|NCT00862706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24580640|NCT00862706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580641|NCT00862706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580642|NCT00862875|Insulin|insulin|mesh-list
24580643|NCT00862875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24580644|NCT00862875|Insulin Detemir|insulin detemir|mesh-list
24580645|NCT00862875|Insulin, Long-Acting|insulin, long-acting|mesh-list
24580646|NCT00862875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24580647|NCT00862875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580648|NCT00862888|Sildenafil Citrate|sildenafil citrate|mesh-list
24580649|NCT00862888|Vasodilator Agents|vasodilator agents|mesh-ancestor
24580650|NCT00862888|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24975651|NCT03364244|Sildenafil Citrate|sildenafil citrate|mesh-list
25667846|NCT01709578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24580726|NCT00863395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24580728|NCT00863395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24580729|NCT00863395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24580730|NCT00863395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24580748|NCT00863460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24580749|NCT00863460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24580751|NCT00863460|Hormones|hormones|mesh-ancestor
24580752|NCT00863460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24580767|NCT00863460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24580768|NCT00863499|Methylphenidate|methylphenidate|mesh-list
24580795|NCT00863668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24580796|NCT00863668|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24580798|NCT00863668|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24580799|NCT00863668|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24580800|NCT00863668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24580801|NCT00863668|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24580802|NCT00863668|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24580805|NCT00863733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25199449|NCT02741115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199450|NCT02741115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199451|NCT02740868|Xenon|xenon|mesh-list
25199452|NCT02740868|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25199453|NCT02740868|Anesthetics, General|anesthetics, general|mesh-ancestor
25199454|NCT02740868|Anesthetics|anesthetics|mesh-ancestor
25119838|NCT05137262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25119839|NCT05137262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25119840|NCT05137262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25119841|NCT05137262|Hormone Antagonists|hormone antagonists|mesh-ancestor
25119842|NCT05137262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25119843|NCT05137262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25119844|NCT05137262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25119845|NCT05137262|Tubulin Modulators|tubulin modulators|mesh-ancestor
25119846|NCT05137262|Antimitotic Agents|antimitotic agents|mesh-ancestor
25119847|NCT05137262|Mitosis Modulators|mitosis modulators|mesh-ancestor
25119848|NCT05118620|Bupivacaine|bupivacaine|mesh-list
25119849|NCT05118620|Anesthetics, Local|anesthetics, local|mesh-ancestor
25119850|NCT05118620|Anesthetics|anesthetics|mesh-ancestor
25119851|NCT05118620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25119852|NCT05118620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119853|NCT05118620|Sensory System Agents|sensory system agents|mesh-ancestor
25119854|NCT05118620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25119855|NCT05110001|Chlorhexidine|chlorhexidine|mesh-list
25119856|NCT05110001|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24580806|NCT00863733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24580807|NCT00863733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24580808|NCT00863785|Acetylcysteine|acetylcysteine|mesh-list
24580809|NCT00863785|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24580810|NCT00863785|Antiviral Agents|antiviral agents|mesh-ancestor
24580811|NCT00863785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24580812|NCT00863785|Expectorants|expectorants|mesh-ancestor
24580813|NCT00863785|Respiratory System Agents|respiratory system agents|mesh-ancestor
24580814|NCT00863785|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24580815|NCT00863785|Antioxidants|antioxidants|mesh-ancestor
24580838|NCT00863889|Prednisolone acetate|prednisolone acetate|mesh-list
24580840|NCT00863889|Bupivacaine|bupivacaine|mesh-list
24580862|NCT00863889|Protective Agents|protective agents|mesh-ancestor
24580863|NCT00863889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24580864|NCT00863889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010104|NCT04643405|Tubulin Modulators|tubulin modulators|mesh-ancestor
25010105|NCT04643405|Antimitotic Agents|antimitotic agents|mesh-ancestor
24793189|NCT03817125|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24793190|NCT03817125|Vancomycin|vancomycin|mesh-list
24793191|NCT03817125|Nivolumab|nivolumab|mesh-list
24795062|NCT03783013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25010128|NCT04617821|Folfirinox|folfirinox|mesh-list
25010129|NCT04617821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25010130|NCT04617821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010131|NCT04617821|Tubulin Modulators|tubulin modulators|mesh-ancestor
25010132|NCT04617821|Antimitotic Agents|antimitotic agents|mesh-ancestor
25010133|NCT04617821|Mitosis Modulators|mitosis modulators|mesh-ancestor
25010134|NCT04617821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010135|NCT04617821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25010136|NCT04617821|Antimetabolites|antimetabolites|mesh-ancestor
25010137|NCT04617821|Antiviral Agents|antiviral agents|mesh-ancestor
25010138|NCT04617821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25199456|NCT02740868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199457|NCT02741154|Letrozole|letrozole|mesh-list
25199458|NCT02741154|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25199459|NCT02741154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199460|NCT02741154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25199461|NCT02741154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25199462|NCT02741154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588667|NCT00903838|Dopamine Agonists|dopamine agonists|mesh-ancestor
25199463|NCT02741154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199464|NCT02741154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25199465|NCT02741154|Hormone Antagonists|hormone antagonists|mesh-ancestor
25199466|NCT02741154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25199467|NCT02741154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199468|NCT02741154|Luteolytic Agents|luteolytic agents|mesh-ancestor
25199469|NCT02741154|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25199470|NCT02741154|Contraceptive Agents|contraceptive agents|mesh-ancestor
25199471|NCT02741154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25199472|NCT02741154|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25199473|NCT02741154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25199474|NCT02740803|Listerine|listerine|mesh-list
25199475|NCT02740803|Fluorides|fluorides|mesh-list
25010140|NCT04617821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25010141|NCT04617821|Immunologic Factors|immunologic factors|mesh-ancestor
24580917|NCT00864019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24580918|NCT00864019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580919|NCT00864019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24580921|NCT00864019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580923|NCT00864045|Sertindole|sertindole|mesh-list
24580949|NCT00864058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24580950|NCT00864058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24580951|NCT00864058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24580952|NCT00864058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580953|NCT00864058|Antimanic Agents|antimanic agents|mesh-ancestor
24580954|NCT00864071|Griseofulvin|griseofulvin|mesh-list
24580955|NCT00864071|Antifungal Agents|antifungal agents|mesh-ancestor
24580956|NCT00864071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24580957|NCT00864110|Deoxyglucose|deoxyglucose|mesh-list
24580958|NCT00864110|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24580959|NCT00864110|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24580960|NCT00864110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580961|NCT00864110|Antimetabolites|antimetabolites|mesh-ancestor
24580962|NCT00864110|Antiviral Agents|antiviral agents|mesh-ancestor
24580963|NCT00864110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24581003|NCT00864201|Bosentan|bosentan|mesh-list
24581004|NCT00864201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24581005|NCT00864201|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24581006|NCT00864201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581007|NCT00864214|Hormones|hormones|mesh-list
24581008|NCT00864214|Estradiol|estradiol|mesh-list
24581009|NCT00864214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25105454|NCT03145714|Anesthetics|anesthetics|mesh-list
24581165|NCT00864591|Sensory System Agents|sensory system agents|mesh-ancestor
24581166|NCT00864591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24581167|NCT00864591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581168|NCT00864591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24581169|NCT00864591|Vasodilator Agents|vasodilator agents|mesh-ancestor
24581170|NCT00864591|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24581171|NCT00864591|Purinergic Agonists|purinergic agonists|mesh-ancestor
24581172|NCT00864591|Purinergic Agents|purinergic agents|mesh-ancestor
24581173|NCT00864591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581174|NCT00864591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581175|NCT00864604|Nabumetone|nabumetone|mesh-list
24581226|NCT00864760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581227|NCT00864760|Anticonvulsants|anticonvulsants|mesh-ancestor
24581228|NCT00864760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24581333|NCT00864942|Immunologic Factors|immunologic factors|mesh-ancestor
24581334|NCT00864942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581335|NCT00864942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24581336|NCT00864942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25199476|NCT02740803|Sodium Fluoride|sodium fluoride|mesh-list
25199477|NCT02740803|Tin Fluorides|tin fluorides|mesh-list
25667847|NCT01709578|Immunologic Factors|immunologic factors|mesh-ancestor
25199478|NCT02740803|Fluorophosphate|fluorophosphate|mesh-list
25199480|NCT02740803|Protective Agents|protective agents|mesh-ancestor
25199481|NCT02740803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199482|NCT02740803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25199483|NCT02740803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25199484|NCT02741024|Artesunate|artesunate|mesh-list
25199485|NCT02741024|Lumefantrine|lumefantrine|mesh-list
25199486|NCT02741024|Artemether|artemether|mesh-list
24581339|NCT00864942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24581340|NCT00864942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24581341|NCT00864942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24581411|NCT00865085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581412|NCT00865085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581413|NCT00865085|Serotonin Agents|serotonin agents|mesh-ancestor
24581414|NCT00865085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581415|NCT00865085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24581416|NCT00865085|Antidepressive Agents|antidepressive agents|mesh-ancestor
24579797|NCT00857831|Vitamins|vitamins|mesh-ancestor
24579798|NCT00857831|Micronutrients|micronutrients|mesh-ancestor
24579813|NCT00857909|Diuretics|diuretics|mesh-ancestor
24581417|NCT00865085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24567597|NCT00791713|Dopamine Agents|dopamine agents|mesh-ancestor
24581444|NCT00865137|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24581445|NCT00865137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581446|NCT00865137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632894|NCT01126086|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24586364|NCT00890318|Hormone Antagonists|hormone antagonists|mesh-ancestor
24586365|NCT00890318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24586366|NCT00890318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586367|NCT00890318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24581475|NCT00865319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581478|NCT00865319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24581494|NCT00865384|Antidepressive Agents|antidepressive agents|mesh-ancestor
24581502|NCT00865384|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24581503|NCT00865384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24581504|NCT00865384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24581505|NCT00865384|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24581506|NCT00865384|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24581507|NCT00865384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24581508|NCT00865384|Adrenergic Agents|adrenergic agents|mesh-ancestor
24581509|NCT00865384|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24581510|NCT00865384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24581511|NCT00865384|Serotonin Agents|serotonin agents|mesh-ancestor
24581512|NCT00865384|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24581513|NCT00865397|Insulin Detemir|insulin detemir|mesh-list
24581514|NCT00865397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24581515|NCT00865397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581517|NCT00865410|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24581518|NCT00865410|Antidepressive Agents|antidepressive agents|mesh-ancestor
24581519|NCT00865410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24581520|NCT00865410|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24581521|NCT00865410|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24581522|NCT00865410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24581523|NCT00865410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581524|NCT00865410|Dopamine Agents|dopamine agents|mesh-ancestor
24581525|NCT00865410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581526|NCT00865410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581603|NCT00865540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24581605|NCT00865540|Sensory System Agents|sensory system agents|mesh-ancestor
24581606|NCT00865540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24581607|NCT00865540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24581646|NCT00865644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24581648|NCT00865657|Alprazolam|alprazolam|mesh-list
24581649|NCT00865657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24581650|NCT00865657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24581651|NCT00865657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581652|NCT00865657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24581653|NCT00865657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24581654|NCT00865657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24581655|NCT00865657|GABA Modulators|gaba modulators|mesh-ancestor
24581656|NCT00865657|GABA Agents|gaba agents|mesh-ancestor
25667848|NCT01709578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24581657|NCT00865657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581658|NCT00865657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581659|NCT00865670|Azithromycin|azithromycin|mesh-list
24581660|NCT00865670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24581661|NCT00865670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24581662|NCT00865696|Mirtazapine|mirtazapine|mesh-list
25861377|NCT00086320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25861378|NCT00086320|Serotonin Agents|serotonin agents|mesh-ancestor
25861379|NCT00086320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25861380|NCT00086320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861381|NCT00086320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25861382|NCT00086320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24580074|NCT00859885|Purinergic Agents|purinergic agents|mesh-ancestor
25861383|NCT00086320|Dopamine Agents|dopamine agents|mesh-ancestor
25861384|NCT00086333|Docetaxel|docetaxel|mesh-list
25010208|NCT04530305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581854|NCT00866528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24581855|NCT00866528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24581856|NCT00866528|Tubulin Modulators|tubulin modulators|mesh-ancestor
24581857|NCT00866528|Antimitotic Agents|antimitotic agents|mesh-ancestor
24581858|NCT00866528|Mitosis Modulators|mitosis modulators|mesh-ancestor
24581923|NCT00866684|Immunologic Factors|immunologic factors|mesh-ancestor
24581924|NCT00866684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581925|NCT00866684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24581986|NCT00866944|Protective Agents|protective agents|mesh-ancestor
24581987|NCT00866944|Vitamin B Complex|vitamin b complex|mesh-ancestor
24581989|NCT00866944|Micronutrients|micronutrients|mesh-ancestor
24581990|NCT00866983|Sildenafil Citrate|sildenafil citrate|mesh-list
24632825|NCT01125787|Ofatumumab|ofatumumab|mesh-list
24976163|NCT01155375|Hematinics|hematinics|mesh-ancestor
24582072|NCT00867737|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24582073|NCT00867737|Glucocorticoids|glucocorticoids|mesh-ancestor
24582074|NCT00867737|Hormones|hormones|mesh-ancestor
25271803|NCT02396563|Anesthetics, Local|anesthetics, local|mesh-ancestor
24582075|NCT00867737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24582076|NCT00867737|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24582077|NCT00867737|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24582078|NCT00867737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24582079|NCT00867737|Adrenergic Agents|adrenergic agents|mesh-ancestor
24582080|NCT00867737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24976214|NCT00233597|Hematinics|hematinics|mesh-ancestor
25110100|NCT03120273|Lansoprazole|lansoprazole|mesh-list
24582105|NCT00868023|Adrenergic Agents|adrenergic agents|mesh-ancestor
24582106|NCT00868023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24582107|NCT00868023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582108|NCT00868062|Polygeline|polygeline|mesh-list
24582109|NCT00868062|Plasma Substitutes|plasma substitutes|mesh-ancestor
24582110|NCT00868062|Blood Substitutes|blood substitutes|mesh-ancestor
24582111|NCT00868153|Levonorgestrel|levonorgestrel|mesh-list
24582141|NCT00868413|Alkylating Agents|alkylating agents|mesh-ancestor
24582142|NCT00868413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582143|NCT00868413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582144|NCT00868413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24582145|NCT00868413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24582146|NCT00868426|Budesonide|budesonide|mesh-list
24582147|NCT00868426|Formoterol Fumarate|formoterol fumarate|mesh-list
24582148|NCT00868426|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24582149|NCT00868426|Charcoal|charcoal|mesh-list
24582150|NCT00868426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24582151|NCT00868426|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24582270|NCT00868907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24582272|NCT00868946|Antimetabolites|antimetabolites|mesh-ancestor
24582273|NCT00868946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582274|NCT00868946|Antiviral Agents|antiviral agents|mesh-ancestor
24582275|NCT00868946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24582276|NCT00868985|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24582277|NCT00868985|Laxatives|laxatives|mesh-ancestor
24582278|NCT00868985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24582279|NCT00869063|Diclofenac|diclofenac|mesh-list
25199487|NCT02741024|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24582280|NCT00869063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24582281|NCT00869063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24582297|NCT00869180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582299|NCT00869180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24582300|NCT00869180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24976335|NCT04127968|Vitamin A|vitamin a|mesh-list
24582380|NCT00869310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24582381|NCT00869310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582382|NCT00869310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25010223|NCT04477265|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25010224|NCT04477265|Cholinergic Agents|cholinergic agents|mesh-ancestor
24582484|NCT00869973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24582485|NCT00869973|Glucocorticoids|glucocorticoids|mesh-ancestor
24582486|NCT00869973|Hormones|hormones|mesh-ancestor
24582487|NCT00869973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24582488|NCT00869973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24632891|NCT01126073|Micronutrients|micronutrients|mesh-ancestor
24632892|NCT01126073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632893|NCT01126086|Otamixaban|otamixaban|mesh-list
24582525|NCT00870272|Abortifacient Agents|abortifacient agents|mesh-ancestor
24582526|NCT00870272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24582596|NCT00870571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24582597|NCT00870571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582616|NCT00870714|Antifungal Agents|antifungal agents|mesh-ancestor
24582617|NCT00870714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24582618|NCT00870714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24582619|NCT00870714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24582620|NCT00870714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24582621|NCT00870714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24582622|NCT00870714|Hormone Antagonists|hormone antagonists|mesh-ancestor
24582623|NCT00870714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24976447|NCT03560193|Chlorhexidine|chlorhexidine|mesh-list
24582726|NCT00871247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24582728|NCT00871247|Urological Agents|urological agents|mesh-ancestor
24582729|NCT00871273|Capecitabine|capecitabine|mesh-list
24582730|NCT00871273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24582731|NCT00871273|Antimetabolites|antimetabolites|mesh-ancestor
24582732|NCT00871273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582733|NCT00871273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582734|NCT00871364|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24582735|NCT00871364|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24582836|NCT00872131|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24582862|NCT00872235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582863|NCT00872235|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24793439|NCT03504644|Antimitotic Agents|antimitotic agents|mesh-ancestor
24793440|NCT03504644|Mitosis Modulators|mitosis modulators|mesh-ancestor
24793441|NCT03504644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586531|NCT00891150|Oxytocin|oxytocin|mesh-list
24793443|NCT03485534|Antiviral Agents|antiviral agents|mesh-ancestor
24793444|NCT03485534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25010310|NCT04223661|Dexamethasone|dexamethasone|mesh-list
25010311|NCT04223661|Lenalidomide|lenalidomide|mesh-list
25010312|NCT04223661|Daratumumab|daratumumab|mesh-list
24583068|NCT00873275|Levoleucovorin|levoleucovorin|mesh-list
24583069|NCT00873275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24583070|NCT00873275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583071|NCT00873275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24583072|NCT00873275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24583073|NCT00873275|Growth Substances|growth substances|mesh-ancestor
24583074|NCT00873275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583075|NCT00873275|Growth Inhibitors|growth inhibitors|mesh-ancestor
24583076|NCT00873275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24583077|NCT00873275|Antimetabolites|antimetabolites|mesh-ancestor
24583097|NCT00873353|Capecitabine|capecitabine|mesh-list
24583098|NCT00873353|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24583099|NCT00873353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24583100|NCT00873353|Antimetabolites|antimetabolites|mesh-ancestor
24583101|NCT00873353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583153|NCT00873483|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24583155|NCT00873496|Antimalarials|antimalarials|mesh-ancestor
24583156|NCT00873496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24583200|NCT00873639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583201|NCT00873652|Vaccines|vaccines|mesh-list
24583202|NCT00873652|Immunologic Factors|immunologic factors|mesh-ancestor
24583203|NCT00873652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583215|NCT00873769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25428257|NCT01745757|Bevacizumab|bevacizumab|mesh-list
25667849|NCT01709578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24969138|NCT03745300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24969142|NCT03745261|Albuterol|albuterol|mesh-list
24969143|NCT03745261|Tiotropium Bromide|tiotropium bromide|mesh-list
24969144|NCT03745261|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24969145|NCT03745261|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24969146|NCT03745261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24969147|NCT03745261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24969148|NCT03745261|Autonomic Agents|autonomic agents|mesh-ancestor
24969149|NCT03745261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24499417|NCT00519298|Cholinergic Agents|cholinergic agents|mesh-ancestor
24499418|NCT00519298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24499499|NCT00519753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24499500|NCT00519753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499501|NCT00519753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499502|NCT00519753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24499503|NCT00519753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24583250|NCT00873808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583251|NCT00873808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24583253|NCT00873808|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24583254|NCT00873808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24583255|NCT00873808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583257|NCT00873834|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24583258|NCT00873834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24583259|NCT00873834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24583260|NCT00873834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583261|NCT00873834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24583262|NCT00873834|Serotonin Agents|serotonin agents|mesh-ancestor
24632968|NCT01126528|Vitamin D|vitamin d|mesh-list
24583263|NCT00873834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583264|NCT00873834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24583265|NCT00873834|Antidepressive Agents|antidepressive agents|mesh-ancestor
24583267|NCT00873834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24583277|NCT00873925|Micronutrients|micronutrients|mesh-ancestor
24583278|NCT00873925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583279|NCT00873925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24583280|NCT00873951|Caseins|caseins|mesh-list
24583281|NCT00873951|Chelating Agents|chelating agents|mesh-ancestor
24583282|NCT00873951|Sequestering Agents|sequestering agents|mesh-ancestor
24583283|NCT00873951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583284|NCT00874003|Mirtazapine|mirtazapine|mesh-list
24583285|NCT00874003|Antidepressive Agents|antidepressive agents|mesh-ancestor
24583286|NCT00874003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24583287|NCT00874003|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24583288|NCT00874003|Histamine Antagonists|histamine antagonists|mesh-ancestor
24583289|NCT00874003|Histamine Agents|histamine agents|mesh-ancestor
24583290|NCT00874003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25199488|NCT02741024|Amodiaquine|amodiaquine|mesh-list
25199489|NCT02741024|Antimalarials|antimalarials|mesh-ancestor
24583291|NCT00874003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583292|NCT00874003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793483|NCT03427736|Anesthetics, General|anesthetics, general|mesh-ancestor
24793498|NCT03395704|Hepcidins|hepcidins|mesh-list
24583456|NCT00874575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24583457|NCT00874575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24583458|NCT00874601|Valsartan|valsartan|mesh-list
25667850|NCT01709578|Antimalarials|antimalarials|mesh-ancestor
25667851|NCT01709578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25667852|NCT01709578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25667853|NCT01709578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25667854|NCT01709578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25667855|NCT01709578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25667856|NCT01709578|Analgesics|analgesics|mesh-ancestor
25667857|NCT01709578|Sensory System Agents|sensory system agents|mesh-ancestor
25667858|NCT01709578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25667859|NCT01709578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25667860|NCT01709578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25667861|NCT01709695|Guanfacine|guanfacine|mesh-list
25667862|NCT01709695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25667863|NCT01709695|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25667864|NCT01709695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25667865|NCT01709695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25667866|NCT01709695|Adrenergic Agents|adrenergic agents|mesh-ancestor
24499885|NCT00521430|Autonomic Agents|autonomic agents|mesh-ancestor
24499886|NCT00521430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24499887|NCT00521430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24499888|NCT00521430|Glucocorticoids|glucocorticoids|mesh-ancestor
24499889|NCT00521430|Hormones|hormones|mesh-ancestor
24793972|NCT05414721|Anesthetics|anesthetics|mesh-list
24583459|NCT00874601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24976789|NCT05200312|Vincristine|vincristine|mesh-list
24583656|NCT00876135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24583657|NCT00876135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583658|NCT00876135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24583659|NCT00876135|Respiratory System Agents|respiratory system agents|mesh-ancestor
24583660|NCT00876135|Tocolytic Agents|tocolytic agents|mesh-ancestor
24583676|NCT00876226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24583677|NCT00876226|Antidepressive Agents|antidepressive agents|mesh-ancestor
24793551|NCT03150329|Pembrolizumab|pembrolizumab|mesh-list
24793552|NCT03150329|Vorinostat|vorinostat|mesh-list
24793553|NCT03150329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24583846|NCT00877149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583848|NCT00877175|Oxymetazoline|oxymetazoline|mesh-list
24583849|NCT00877175|Tropicamide|tropicamide|mesh-list
24583850|NCT00877175|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24583851|NCT00877175|Mydriatics|mydriatics|mesh-ancestor
24583852|NCT00877175|Autonomic Agents|autonomic agents|mesh-ancestor
24583853|NCT00877175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24583854|NCT00877175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583855|NCT00877175|Sympathomimetics|sympathomimetics|mesh-ancestor
24583856|NCT00877175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24589974|NCT00910065|Analgesics|analgesics|mesh-ancestor
24583857|NCT00877175|Nasal Decongestants|nasal decongestants|mesh-ancestor
25861385|NCT00086333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584074|NCT00878371|Analgesics|analgesics|mesh-ancestor
24584075|NCT00878371|Sensory System Agents|sensory system agents|mesh-ancestor
24584076|NCT00878371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24584079|NCT00878449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584080|NCT00878449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24584081|NCT00878449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24584082|NCT00878449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24584083|NCT00878449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584123|NCT00878657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584126|NCT00878657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24584127|NCT00878657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584128|NCT00878657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24584129|NCT00878657|Immunologic Factors|immunologic factors|mesh-ancestor
24584130|NCT00878657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584131|NCT00878670|Evening primrose oil|evening primrose oil|mesh-list
24584132|NCT00878670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24584133|NCT00878670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24584134|NCT00878670|Analgesics|analgesics|mesh-ancestor
24584135|NCT00878670|Sensory System Agents|sensory system agents|mesh-ancestor
24584136|NCT00878670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24584137|NCT00878670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584156|NCT00878865|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24584157|NCT00878865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24584158|NCT00878865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584159|NCT00878865|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24584160|NCT00878865|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25110156|NCT05465135|Artenimol|artenimol|mesh-list
25110157|NCT05465135|Antimalarials|antimalarials|mesh-ancestor
25110158|NCT05465135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25110159|NCT05465135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25110160|NCT05465135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25110161|NCT05465031|Valsartan|valsartan|mesh-list
25110162|NCT05465031|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24634761|NCT01134926|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25110163|NCT05465031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25110164|NCT05465031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25110165|NCT05465031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25110166|NCT05465031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667867|NCT01709695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25667868|NCT01709695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667869|NCT01709695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667870|NCT01709708|Bupivacaine|bupivacaine|mesh-list
25667871|NCT01709708|Anesthetics, Local|anesthetics, local|mesh-ancestor
24793609|NCT02996825|Immunologic Factors|immunologic factors|mesh-ancestor
24633138|NCT01127360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24633139|NCT01127360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633145|NCT01127386|Lenalidomide|lenalidomide|mesh-list
24584187|NCT00878943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584188|NCT00878943|Urological Agents|urological agents|mesh-ancestor
24584189|NCT00879008|Moxifloxacin|moxifloxacin|mesh-list
24977125|NCT03448978|Cyclophosphamide|cyclophosphamide|mesh-list
24584377|NCT00880178|Micronutrients|micronutrients|mesh-ancestor
24584378|NCT00880178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633190|NCT01127555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633191|NCT01127555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24633192|NCT01127555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633193|NCT01127555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24633195|NCT01127555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584418|NCT00880321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24584419|NCT00880321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24584420|NCT00880321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24584421|NCT00880321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24584422|NCT00880321|Anesthetics, General|anesthetics, general|mesh-ancestor
24584424|NCT00880321|GABA Modulators|gaba modulators|mesh-ancestor
24584425|NCT00880321|GABA Agents|gaba agents|mesh-ancestor
24584426|NCT00880321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24584427|NCT00880321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584428|NCT00880321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584429|NCT00880321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24584430|NCT00880321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584445|NCT00880373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24584446|NCT00880373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584447|NCT00880373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584449|NCT00880386|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24584450|NCT00880386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24586739|NCT00892073|Diazoxide|diazoxide|mesh-list
24584582|NCT00881101|Tubulin Modulators|tubulin modulators|mesh-ancestor
24584583|NCT00881101|Antimitotic Agents|antimitotic agents|mesh-ancestor
24584584|NCT00881101|Mitosis Modulators|mitosis modulators|mesh-ancestor
25010438|NCT04065789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25010439|NCT04065789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010440|NCT04065789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25010441|NCT04065789|Glucocorticoids|glucocorticoids|mesh-ancestor
25010442|NCT04065789|Hormones|hormones|mesh-ancestor
25010450|NCT04065789|Growth Inhibitors|growth inhibitors|mesh-ancestor
25010451|NCT04047953|Paclitaxel|paclitaxel|mesh-list
24584618|NCT00881140|Contraceptive Agents|contraceptive agents|mesh-ancestor
24584619|NCT00881140|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24584620|NCT00881140|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24584621|NCT00881140|Hormone Antagonists|hormone antagonists|mesh-ancestor
24584622|NCT00881140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24584708|NCT00881387|Tubulin Modulators|tubulin modulators|mesh-ancestor
24584709|NCT00881387|Antimitotic Agents|antimitotic agents|mesh-ancestor
24584710|NCT00881387|Mitosis Modulators|mitosis modulators|mesh-ancestor
24805779|NCT02012075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24590287|NCT00911651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24584818|NCT00881673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24584819|NCT00881673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24584820|NCT00881673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584822|NCT00881686|Analgesics|analgesics|mesh-ancestor
24584823|NCT00881686|Sensory System Agents|sensory system agents|mesh-ancestor
24584824|NCT00881686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24584825|NCT00881686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584826|NCT00881686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24584827|NCT00881686|Vasodilator Agents|vasodilator agents|mesh-ancestor
24584828|NCT00881686|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24584829|NCT00881686|Purinergic Agonists|purinergic agonists|mesh-ancestor
24584830|NCT00881686|Purinergic Agents|purinergic agents|mesh-ancestor
24584831|NCT00881686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24584832|NCT00881686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584895|NCT00882076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24584933|NCT00882323|Alkylating Agents|alkylating agents|mesh-ancestor
24584934|NCT00882323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584935|NCT00882323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584962|NCT00882388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24584963|NCT00882388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584964|NCT00882388|Antipyretics|antipyretics|mesh-ancestor
24584965|NCT00882388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24584966|NCT00882388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24977451|NCT00159588|Antimanic Agents|antimanic agents|mesh-ancestor
24585066|NCT00882960|Anesthetics|anesthetics|mesh-ancestor
24585067|NCT00883064|Lisinopril|lisinopril|mesh-list
24585068|NCT00883064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24585069|NCT00883064|Protease Inhibitors|protease inhibitors|mesh-ancestor
24585070|NCT00883064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199490|NCT02741024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25199491|NCT02741024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24585073|NCT00883064|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24585074|NCT00883064|Protective Agents|protective agents|mesh-ancestor
24585075|NCT00883064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585077|NCT00883155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24585078|NCT00883155|Antidepressive Agents|antidepressive agents|mesh-ancestor
24585079|NCT00883155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24585080|NCT00883155|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24585081|NCT00883155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24585082|NCT00883155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24585083|NCT00883155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585084|NCT00883155|Dopamine Agents|dopamine agents|mesh-ancestor
24585085|NCT00883155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25271934|NCT02395926|Nootropic Agents|nootropic agents|mesh-ancestor
24585086|NCT00883155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585087|NCT00883155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24585088|NCT00883155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24585089|NCT00883155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24585090|NCT00883194|Ropivacaine|ropivacaine|mesh-list
24570773|NCT00806741|Nasal Decongestants|nasal decongestants|mesh-ancestor
24585135|NCT00883623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585136|NCT00883623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24585219|NCT00884442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585221|NCT00884442|Tocolytic Agents|tocolytic agents|mesh-ancestor
24585222|NCT00884442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24585223|NCT00884481|Natalizumab|natalizumab|mesh-list
25010461|NCT04031599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010462|NCT04031599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25010463|NCT04030559|Niraparib|niraparib|mesh-list
25199492|NCT02741024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25199493|NCT02741024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199494|NCT02741024|Antiviral Agents|antiviral agents|mesh-ancestor
25010465|NCT04030559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25010466|NCT04030559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010467|NCT04030559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010468|NCT04025658|Oxytocin|oxytocin|mesh-list
25010469|NCT04025658|Oxytocics|oxytocics|mesh-ancestor
25010470|NCT04025658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24585357|NCT00885274|Citric Acid|citric acid|mesh-list
24585359|NCT00885274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585360|NCT00885274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24585361|NCT00885274|Anticoagulants|anticoagulants|mesh-ancestor
24585362|NCT00885274|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24585363|NCT00885274|Chelating Agents|chelating agents|mesh-ancestor
24585364|NCT00885274|Sequestering Agents|sequestering agents|mesh-ancestor
24585365|NCT00885287|Lumefantrine|lumefantrine|mesh-list
24585367|NCT00885287|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24633317|NCT01128322|Vasodilator Agents|vasodilator agents|mesh-ancestor
24585368|NCT00885287|Antimalarials|antimalarials|mesh-ancestor
24585369|NCT00885287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24585370|NCT00885287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24585371|NCT00885287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24585374|NCT00885300|Anticoagulants|anticoagulants|mesh-ancestor
24585375|NCT00885300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24585376|NCT00885300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24585377|NCT00885300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590422|NCT00912457|Cholinergic Agents|cholinergic agents|mesh-ancestor
24585378|NCT00885300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24585379|NCT00885300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24585380|NCT00885326|Zoledronic Acid|zoledronic acid|mesh-list
24585381|NCT00885326|Cyclophosphamide|cyclophosphamide|mesh-list
24585389|NCT00885326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585391|NCT00885326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24585392|NCT00885326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24585393|NCT00885326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24585476|NCT00885781|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24585477|NCT00885781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24585478|NCT00885794|Ranibizumab|ranibizumab|mesh-list
24585479|NCT00885794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24585480|NCT00885794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24585481|NCT00885794|Growth Substances|growth substances|mesh-ancestor
24585482|NCT00885794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585720|NCT00886886|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24585721|NCT00886886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24585722|NCT00886886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24585723|NCT00886886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585724|NCT00886886|Adrenergic Agents|adrenergic agents|mesh-ancestor
24585725|NCT00886886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24585726|NCT00886886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585728|NCT00886990|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24585729|NCT00886990|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24633706|NCT01130909|Ketamine|ketamine|mesh-list
24585730|NCT00886990|Protease Inhibitors|protease inhibitors|mesh-ancestor
24585731|NCT00886990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24585732|NCT00886990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585733|NCT00886990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24585734|NCT00886990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24585735|NCT00886990|Antiviral Agents|antiviral agents|mesh-ancestor
24585736|NCT00886990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24585737|NCT00886990|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24585738|NCT00886990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24585759|NCT00887003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24585760|NCT00887003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24585761|NCT00887003|Protective Agents|protective agents|mesh-ancestor
24793654|NCT02856698|Sensory System Agents|sensory system agents|mesh-ancestor
24793655|NCT02856698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24793656|NCT02856698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24590585|NCT00913276|Propofol|propofol|mesh-list
24793657|NCT02856698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24793659|NCT02856698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24793660|NCT02856698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24793661|NCT02856698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24793662|NCT02856698|Anesthetics, General|anesthetics, general|mesh-ancestor
24793663|NCT02856698|Anesthetics|anesthetics|mesh-ancestor
24793664|NCT02856698|GABA Modulators|gaba modulators|mesh-ancestor
24793665|NCT02856698|GABA Agents|gaba agents|mesh-ancestor
24793666|NCT02856698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24904948|NCT04352062|Ofloxacin|ofloxacin|mesh-list
24585773|NCT00887029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585774|NCT00887029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24585775|NCT00887029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24585776|NCT00887029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25861386|NCT00086333|Tubulin Modulators|tubulin modulators|mesh-ancestor
24585777|NCT00887042|Fludarabine|fludarabine|mesh-list
24585778|NCT00887042|Busulfan|busulfan|mesh-list
24585779|NCT00887042|Thymoglobulin|thymoglobulin|mesh-list
24585780|NCT00887042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010471|NCT04025658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010472|NCT04019821|Insulin|insulin|mesh-list
25010473|NCT04019821|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25010474|NCT04019821|Insulin Aspart|insulin aspart|mesh-list
25010475|NCT04019821|Insulin Lispro|insulin lispro|mesh-list
25010476|NCT04019821|Insulin glulisine|insulin glulisine|mesh-list
25010477|NCT04019821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25010478|NCT04019821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010479|NCT03936933|Goserelin|goserelin|mesh-list
25010480|NCT03936933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25010481|NCT03936933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010482|NCT03936218|Goserelin|goserelin|mesh-list
25010483|NCT03936218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24585825|NCT00887211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24585826|NCT00887211|Immunologic Factors|immunologic factors|mesh-ancestor
24585827|NCT00887211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585828|NCT00887263|Budesonide|budesonide|mesh-list
24585829|NCT00887263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24585830|NCT00887263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24585831|NCT00887263|Autonomic Agents|autonomic agents|mesh-ancestor
24585832|NCT00887263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24585833|NCT00887263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585834|NCT00887263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24585835|NCT00887263|Respiratory System Agents|respiratory system agents|mesh-ancestor
24585836|NCT00887263|Glucocorticoids|glucocorticoids|mesh-ancestor
24585837|NCT00887263|Hormones|hormones|mesh-ancestor
25082961|NCT03318835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25082972|NCT03318770|Dasatinib|dasatinib|mesh-list
24585838|NCT00887263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24585839|NCT00887276|Amoxicillin|amoxicillin|mesh-list
24585840|NCT00887276|Moxifloxacin|moxifloxacin|mesh-list
24585841|NCT00887276|Ampicillin|ampicillin|mesh-list
24585842|NCT00887276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24585853|NCT00887328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585854|NCT00887367|Ethanol|ethanol|mesh-list
24585855|NCT00887367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24585856|NCT00887367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24585857|NCT00887367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24977843|NCT01863550|Antiemetics|antiemetics|mesh-ancestor
25010603|NCT03617731|Antiemetics|antiemetics|mesh-ancestor
25010604|NCT03617731|Autonomic Agents|autonomic agents|mesh-ancestor
25010605|NCT03617731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25010606|NCT03617731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010607|NCT03617731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25010608|NCT03617731|Glucocorticoids|glucocorticoids|mesh-ancestor
25010609|NCT03617731|Hormones|hormones|mesh-ancestor
24458242|NCT00337246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24590810|NCT00913874|Antimanic Agents|antimanic agents|mesh-ancestor
24520452|NCT01657500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520455|NCT01657500|Blood Substitutes|blood substitutes|mesh-ancestor
24819543|NCT02095899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24819544|NCT02095899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914816|NCT04251962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25065380|NCT03451110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25065381|NCT03451110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25065382|NCT03451110|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25065383|NCT03451110|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25065384|NCT03451110|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25065385|NCT03451110|Contraceptive Agents|contraceptive agents|mesh-ancestor
25065386|NCT03451110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25065387|NCT03451110|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24914818|NCT04251871|Interferons|interferons|mesh-list
24914823|NCT04251871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914824|NCT04251871|Antiviral Agents|antiviral agents|mesh-ancestor
24914825|NCT04251871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24914826|NCT04251871|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24914827|NCT04251871|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24914828|NCT04251871|Protease Inhibitors|protease inhibitors|mesh-ancestor
24914829|NCT04251871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24914830|NCT04251871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914831|NCT04251871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24914849|NCT04251832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914850|NCT04251832|Antioxidants|antioxidants|mesh-ancestor
24914867|NCT04251169|Tubulin Modulators|tubulin modulators|mesh-ancestor
24914868|NCT04251169|Antimitotic Agents|antimitotic agents|mesh-ancestor
24914869|NCT04251169|Mitosis Modulators|mitosis modulators|mesh-ancestor
24914870|NCT04251169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914871|NCT04251169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24914873|NCT04251364|Atorvastatin|atorvastatin|mesh-list
24914874|NCT04251364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24914875|NCT04251364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24914876|NCT04251364|Antimetabolites|antimetabolites|mesh-ancestor
24914877|NCT04251364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914878|NCT04251364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24914879|NCT04251364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24914880|NCT04251364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24914881|NCT04251364|Anticonvulsants|anticonvulsants|mesh-ancestor
24914882|NCT04251364|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24914883|NCT04251364|Diuretics|diuretics|mesh-ancestor
24914884|NCT04251364|Natriuretic Agents|natriuretic agents|mesh-ancestor
24914885|NCT04251364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914886|NCT04250948|Capecitabine|capecitabine|mesh-list
24914887|NCT04250948|Oxaliplatin|oxaliplatin|mesh-list
24914888|NCT04250948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24914889|NCT04250948|Antimetabolites|antimetabolites|mesh-ancestor
24914890|NCT04250948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914891|NCT04250948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25667872|NCT01709708|Anesthetics|anesthetics|mesh-ancestor
25667873|NCT01709708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25861387|NCT00086333|Antimitotic Agents|antimitotic agents|mesh-ancestor
25861388|NCT00086333|Mitosis Modulators|mitosis modulators|mesh-ancestor
25667874|NCT01709708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861389|NCT00086333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939117|NCT04013243|Tocolytic Agents|tocolytic agents|mesh-ancestor
24915001|NCT05251766|Tubulin Modulators|tubulin modulators|mesh-ancestor
24915002|NCT05251766|Antimitotic Agents|antimitotic agents|mesh-ancestor
25861390|NCT00086359|Ritonavir|ritonavir|mesh-list
25861391|NCT00086359|Lopinavir|lopinavir|mesh-list
25861392|NCT00086359|Lamivudine|lamivudine|mesh-list
24915172|NCT04173312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24915173|NCT04160325|Azathioprine|azathioprine|mesh-list
24915174|NCT04160325|Antimetabolites|antimetabolites|mesh-ancestor
24915175|NCT04160325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915176|NCT04160325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24915177|NCT04160325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915178|NCT04160325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24915179|NCT04160325|Immunologic Factors|immunologic factors|mesh-ancestor
24915180|NCT04160325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915181|NCT04160325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24915183|NCT04126083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24915184|NCT04126083|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24915185|NCT04126083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915186|NCT04126083|Sensory System Agents|sensory system agents|mesh-ancestor
24915187|NCT04126083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24915257|NCT03737370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065424|NCT05322499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25065425|NCT05322499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065426|NCT05322499|Tubulin Modulators|tubulin modulators|mesh-ancestor
25065427|NCT05322499|Antimitotic Agents|antimitotic agents|mesh-ancestor
25065428|NCT05322499|Mitosis Modulators|mitosis modulators|mesh-ancestor
25065429|NCT05322499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065430|NCT05322499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25065431|NCT05322499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25199514|NCT02740647|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25120839|NCT02514031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065433|NCT05322330|Cyclophosphamide|cyclophosphamide|mesh-list
25065434|NCT05322330|Fludarabine|fludarabine|mesh-list
25065435|NCT05322330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25065436|NCT05322330|Immunologic Factors|immunologic factors|mesh-ancestor
25065437|NCT05322330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065438|NCT05322330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25065439|NCT05322330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24827719|NCT02141087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827720|NCT02141087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24827721|NCT02141087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24819622|NCT02096250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819623|NCT02096250|Anticoagulants|anticoagulants|mesh-ancestor
24819624|NCT02096250|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24819625|NCT02096250|Hematinics|hematinics|mesh-ancestor
24819639|NCT02096328|Murepavadin|murepavadin|mesh-list
24819640|NCT02096328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24819641|NCT02096328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24616060|NCT01033760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24616061|NCT01033760|Antiviral Agents|antiviral agents|mesh-ancestor
24616062|NCT01033760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24616063|NCT01033760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24446925|NCT00306644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24446926|NCT00306644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915387|NCT03075423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915388|NCT03075423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24915389|NCT03075423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950180|NCT02287428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950182|NCT02243813|Hallucinogens|hallucinogens|mesh-ancestor
24950183|NCT02243813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950184|NCT02243813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24915529|NCT01583283|Growth Substances|growth substances|mesh-ancestor
24915530|NCT01583283|Growth Inhibitors|growth inhibitors|mesh-ancestor
24915531|NCT01583283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861393|NCT00086359|Zidovudine|zidovudine|mesh-list
24950339|NCT00632853|Carboplatin|carboplatin|mesh-list
24950340|NCT00632853|Etoposide|etoposide|mesh-list
25428333|NCT01738139|Imatinib Mesylate|imatinib mesylate|mesh-list
25667875|NCT01709708|Sensory System Agents|sensory system agents|mesh-ancestor
25667876|NCT01709708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969326|NCT03743883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969327|NCT03743883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950341|NCT00632853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950342|NCT00632853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24950343|NCT00632853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24915550|NCT00529113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24915551|NCT00529113|Antimetabolites|antimetabolites|mesh-ancestor
24915552|NCT00529113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591338|NCT00915915|Hormones|hormones|mesh-ancestor
24915644|NCT04249713|Dermatologic Agents|dermatologic agents|mesh-ancestor
24915645|NCT04249908|Maleic acid|maleic acid|mesh-list
24915646|NCT04249908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24915647|NCT04249908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915648|NCT04249882|Naltrexone|naltrexone|mesh-list
24915649|NCT04249882|Varenicline|varenicline|mesh-list
24915650|NCT04249882|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24915651|NCT04249882|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24915652|NCT04249882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915653|NCT04249882|Sensory System Agents|sensory system agents|mesh-ancestor
24915654|NCT04249882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25199515|NCT02740647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24827050|NCT02137239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24915655|NCT04249882|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24915656|NCT04249882|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24915657|NCT04249882|Cholinergic Agents|cholinergic agents|mesh-ancestor
24915658|NCT04249882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24915659|NCT04249882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915660|NCT04249570|Povidone-Iodine|povidone-iodine|mesh-list
24915661|NCT04249570|Povidone|povidone|mesh-list
24953434|NCT03885297|Hormones|hormones|mesh-ancestor
24915665|NCT04249570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24915666|NCT04249804|Magnesium Sulfate|magnesium sulfate|mesh-list
24915667|NCT04249804|Analgesics|analgesics|mesh-ancestor
24915668|NCT04249804|Sensory System Agents|sensory system agents|mesh-ancestor
24520479|NCT01497509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24520480|NCT01497509|Autonomic Agents|autonomic agents|mesh-ancestor
24520481|NCT01497509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24520482|NCT01497509|Respiratory System Agents|respiratory system agents|mesh-ancestor
24520483|NCT01497509|Mydriatics|mydriatics|mesh-ancestor
24915671|NCT04249804|Anesthetics|anesthetics|mesh-ancestor
24915672|NCT04249804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24915673|NCT04249804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24915674|NCT04249804|Anticonvulsants|anticonvulsants|mesh-ancestor
24915675|NCT04249804|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24915676|NCT04249804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24915677|NCT04249804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915678|NCT04249804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24915679|NCT04249804|Tocolytic Agents|tocolytic agents|mesh-ancestor
24915680|NCT04249804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24915681|NCT04249531|Amikacin|amikacin|mesh-list
24915682|NCT04249531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24915683|NCT04249531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24915688|NCT04249154|Leuprolide|leuprolide|mesh-list
24915689|NCT04249154|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24915690|NCT04249154|Fertility Agents|fertility agents|mesh-ancestor
24915691|NCT04249154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24915692|NCT04249154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915693|NCT04249154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24534165|NCT00646230|Fenretinide|fenretinide|mesh-list
24915752|NCT04248621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24915753|NCT04248621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915754|NCT04248621|Hormone Antagonists|hormone antagonists|mesh-ancestor
24915755|NCT04248621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24915756|NCT04248621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915758|NCT04248621|Luteolytic Agents|luteolytic agents|mesh-ancestor
24915759|NCT04248621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24915760|NCT04248621|Contraceptive Agents|contraceptive agents|mesh-ancestor
24915761|NCT04248621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24591510|NCT00917059|Dopamine Agents|dopamine agents|mesh-ancestor
24915762|NCT04248621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24915763|NCT04248621|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24915764|NCT04248621|Fertility Agents|fertility agents|mesh-ancestor
24915765|NCT04248608|Morphine|morphine|mesh-list
25667877|NCT01709721|Hydromorphone|hydromorphone|mesh-list
25667878|NCT01709721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25667879|NCT01709721|Narcotics|narcotics|mesh-ancestor
24969384|NCT03743428|Bevacizumab|bevacizumab|mesh-list
24697820|NCT01437462|Anesthetics, General|anesthetics, general|mesh-ancestor
24500803|NCT00525759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24915766|NCT04248608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24915767|NCT04248608|Narcotics|narcotics|mesh-ancestor
24915768|NCT04248608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24915769|NCT04248608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915795|NCT04248205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24915796|NCT04248205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25199516|NCT02740647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827051|NCT02137239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24915828|NCT04248179|Sensory System Agents|sensory system agents|mesh-ancestor
24915829|NCT04248179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24915830|NCT04248179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24915831|NCT04248179|Narcotics|narcotics|mesh-ancestor
24915832|NCT04248179|Analgesics|analgesics|mesh-ancestor
24915833|NCT04248179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24915834|NCT04248179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24915835|NCT04248179|Anesthetics, General|anesthetics, general|mesh-ancestor
24915836|NCT04247633|Palbociclib|palbociclib|mesh-list
24915839|NCT04247633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24915850|NCT04247815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24915909|NCT04246905|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24915910|NCT04246905|Protective Agents|protective agents|mesh-ancestor
25065510|NCT05321511|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25065511|NCT05321511|Hormones|hormones|mesh-ancestor
25065512|NCT05321511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25065513|NCT05321511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065514|NCT05321511|Luteolytic Agents|luteolytic agents|mesh-ancestor
25065515|NCT05321511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25065516|NCT05321511|Contraceptive Agents|contraceptive agents|mesh-ancestor
25065517|NCT05321511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24951861|NCT03900377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24951862|NCT03900377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951863|NCT03900377|Immunologic Factors|immunologic factors|mesh-ancestor
24916071|NCT04245046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916073|NCT04245046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24916074|NCT04245046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916075|NCT04245046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24916076|NCT04245046|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24739310|NCT01680406|Amebicides|amebicides|mesh-ancestor
24916077|NCT04245046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24916078|NCT04245046|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24916079|NCT04245046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819697|NCT02096913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819698|NCT02096913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819699|NCT02096926|Ibuprofen|ibuprofen|mesh-list
25861394|NCT00086359|Abacavir|abacavir|mesh-list
24819712|NCT02096965|Tolvaptan|tolvaptan|mesh-list
24819713|NCT02096965|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24819714|NCT02096965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819716|NCT02096965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819717|NCT02097004|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25065690|NCT05303311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25065691|NCT05303311|Glucocorticoids|glucocorticoids|mesh-ancestor
25065692|NCT05303311|Hormones|hormones|mesh-ancestor
25065693|NCT05303311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25065694|NCT05303311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25065695|NCT05303311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065696|NCT05303311|Anesthetics, Local|anesthetics, local|mesh-ancestor
25065697|NCT05303311|Anesthetics|anesthetics|mesh-ancestor
25065698|NCT05303311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25065699|NCT05303311|Sensory System Agents|sensory system agents|mesh-ancestor
25065700|NCT05303311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25065701|NCT05303311|Narcotics|narcotics|mesh-ancestor
24951865|NCT03900377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25065702|NCT05303311|Analgesics|analgesics|mesh-ancestor
25065703|NCT05303311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25065756|NCT05269381|Pembrolizumab|pembrolizumab|mesh-list
25199517|NCT02740712|Vitamin K|vitamin k|mesh-list
25121088|NCT00583778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25667880|NCT01709721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25667881|NCT01709721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065757|NCT05269381|Sargramostim|sargramostim|mesh-list
25065758|NCT05269381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25065759|NCT05269381|Immunologic Factors|immunologic factors|mesh-ancestor
25065760|NCT05269381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065761|NCT05269381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25065762|NCT05269381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25065763|NCT05269381|Alkylating Agents|alkylating agents|mesh-ancestor
25065783|NCT05260528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25065784|NCT05260528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25065785|NCT05260528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25065787|NCT05231603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25065788|NCT05231603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25065789|NCT05211635|Vitamin D|vitamin d|mesh-list
25065790|NCT05211635|Vitamins|vitamins|mesh-ancestor
25065791|NCT05211635|Micronutrients|micronutrients|mesh-ancestor
25065792|NCT05211635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065793|NCT05211635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25065794|NCT05202145|Cyclosporine|cyclosporine|mesh-list
25065795|NCT05202145|Tacrolimus|tacrolimus|mesh-list
25065796|NCT05202145|Cyclosporins|cyclosporins|mesh-list
25065804|NCT05202145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25065805|NCT05202145|Dermatologic Agents|dermatologic agents|mesh-ancestor
25065806|NCT05202145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25065808|NCT05198362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25065809|NCT05198362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25065810|NCT05198362|Sympatholytics|sympatholytics|mesh-ancestor
25065811|NCT05198362|Autonomic Agents|autonomic agents|mesh-ancestor
25065812|NCT05198362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25065813|NCT05198362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065814|NCT05198362|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25065815|NCT05198362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25065816|NCT05198362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25065817|NCT05198362|Adrenergic Agents|adrenergic agents|mesh-ancestor
25065818|NCT05198362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25065819|NCT05198362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065821|NCT05184335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25065822|NCT05184335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25065823|NCT05184335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25065824|NCT05184335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065825|NCT05184335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25065826|NCT05184335|Serotonin Agents|serotonin agents|mesh-ancestor
25065827|NCT05184335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25065828|NCT05184335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065829|NCT05147415|Metoprolol|metoprolol|mesh-list
25065830|NCT05147415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25065831|NCT05147415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25065832|NCT05147415|Sympatholytics|sympatholytics|mesh-ancestor
25065833|NCT05147415|Autonomic Agents|autonomic agents|mesh-ancestor
25065834|NCT05147415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25065835|NCT05147415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065836|NCT05147415|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25065837|NCT05147415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25065838|NCT05147415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24828210|NCT02144194|Docetaxel|docetaxel|mesh-list
25065840|NCT05147415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25065841|NCT05147415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916130|NCT04244708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916132|NCT04244448|Emtricitabine|emtricitabine|mesh-list
24916133|NCT04244448|Antiviral Agents|antiviral agents|mesh-ancestor
24916134|NCT04244448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24916135|NCT04244448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24916136|NCT04244448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24916137|NCT04244448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916138|NCT04244448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916139|NCT04244448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25199518|NCT02740712|Rucaparib|rucaparib|mesh-list
25199519|NCT02740712|Digoxin|digoxin|mesh-list
25121165|NCT03104621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25121166|NCT03104634|Bromides|bromides|mesh-list
25121167|NCT03104634|Formoterol Fumarate|formoterol fumarate|mesh-list
25121168|NCT03104634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24916140|NCT04244448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24916142|NCT04243954|Hydromorphone|hydromorphone|mesh-list
24916143|NCT04243954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24916144|NCT04243954|Narcotics|narcotics|mesh-ancestor
25861395|NCT00086359|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
24969490|NCT03742310|Calcitriol|calcitriol|mesh-list
24969491|NCT03742310|Vitamins|vitamins|mesh-ancestor
24969492|NCT03742310|Micronutrients|micronutrients|mesh-ancestor
24969493|NCT03742310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969494|NCT03742310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25861396|NCT00086359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24969495|NCT03742310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24969496|NCT03742310|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24520488|NCT00630565|Busulfan|busulfan|mesh-list
24916146|NCT04243954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916147|NCT04243954|Analgesics|analgesics|mesh-ancestor
24916148|NCT04243954|Sensory System Agents|sensory system agents|mesh-ancestor
24444691|NCT00298909|Niacin|niacin|mesh-list
25065923|NCT04768166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25065924|NCT04768166|Antiviral Agents|antiviral agents|mesh-ancestor
25065925|NCT04768166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25065926|NCT04768166|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25065927|NCT04768166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25065928|NCT04768166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065929|NCT04760041|Midazolam|midazolam|mesh-list
25065930|NCT04760041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25065931|NCT04760041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25065932|NCT04760041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25065933|NCT04760041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065934|NCT04760041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25065935|NCT04760041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25065936|NCT04760041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25861397|NCT00086359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25065962|NCT04637425|Broncho-Vaxom|broncho-vaxom|mesh-list
25065963|NCT04637425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25065964|NCT04637425|Immunologic Factors|immunologic factors|mesh-ancestor
25065965|NCT04637425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065972|NCT04628429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065973|NCT04622007|Pembrolizumab|pembrolizumab|mesh-list
25065974|NCT04622007|Pemetrexed|pemetrexed|mesh-list
25065975|NCT04622007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25065976|NCT04622007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065977|NCT04622007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25065978|NCT04622007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065979|NCT04622007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25065980|NCT04622007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25065981|NCT04614714|Niacinamide|niacinamide|mesh-list
25065983|NCT04614714|Nicotinic Acids|nicotinic acids|mesh-list
25065984|NCT04614714|Vitamin B Complex|vitamin b complex|mesh-ancestor
25065985|NCT04614714|Vitamins|vitamins|mesh-ancestor
25065986|NCT04614714|Micronutrients|micronutrients|mesh-ancestor
25065987|NCT04614714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065988|NCT04614714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25065989|NCT04614714|Antimetabolites|antimetabolites|mesh-ancestor
25065990|NCT04614714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065991|NCT04614714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25066039|NCT04375228|Immunologic Factors|immunologic factors|mesh-ancestor
25066040|NCT04375228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066041|NCT04375228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25066042|NCT04370145|Meropenem|meropenem|mesh-list
24828432|NCT02145585|Anesthetics|anesthetics|mesh-list
24828434|NCT02145585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916275|NCT04242914|GABA Modulators|gaba modulators|mesh-ancestor
24916276|NCT04242914|GABA Agents|gaba agents|mesh-ancestor
25199520|NCT02740712|Midazolam|midazolam|mesh-list
25199521|NCT02740712|Caffeine|caffeine|mesh-list
25199522|NCT02740712|Omeprazole|omeprazole|mesh-list
25199523|NCT02740712|Warfarin|warfarin|mesh-list
24916277|NCT04242927|Nicotinic Acids|nicotinic acids|mesh-list
24916278|NCT04242927|Niacin|niacin|mesh-list
24916279|NCT04242927|Niacinamide|niacinamide|mesh-list
24916280|NCT04242927|Vitamin B Complex|vitamin b complex|mesh-ancestor
24819732|NCT02097017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199524|NCT02740712|Vitamins|vitamins|mesh-ancestor
25066073|NCT04331067|Mitosis Modulators|mitosis modulators|mesh-ancestor
25667882|NCT01709721|Analgesics|analgesics|mesh-ancestor
25667883|NCT01709721|Sensory System Agents|sensory system agents|mesh-ancestor
25667884|NCT01709721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25667885|NCT01709747|Hydromorphone|hydromorphone|mesh-list
25667886|NCT01709747|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25667887|NCT01709747|Narcotics|narcotics|mesh-ancestor
25667888|NCT01709747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24916289|NCT04242433|Antiviral Agents|antiviral agents|mesh-list
25861398|NCT00086359|Protease Inhibitors|protease inhibitors|mesh-ancestor
25861399|NCT00086359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916290|NCT04242433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24916373|NCT04241523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24916374|NCT04241523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24916406|NCT04241276|Tubulin Modulators|tubulin modulators|mesh-ancestor
24916407|NCT04241276|Antimitotic Agents|antimitotic agents|mesh-ancestor
24916408|NCT04241276|Mitosis Modulators|mitosis modulators|mesh-ancestor
25066149|NCT04205786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066150|NCT04205786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25066151|NCT04205786|Hormone Antagonists|hormone antagonists|mesh-ancestor
24916418|NCT04241276|Keratolytic Agents|keratolytic agents|mesh-ancestor
24916419|NCT04241276|Dermatologic Agents|dermatologic agents|mesh-ancestor
25066152|NCT04205786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25066154|NCT04179032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25066155|NCT04179032|Immunologic Factors|immunologic factors|mesh-ancestor
25066156|NCT04179032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876469|NCT03457142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24819781|NCT02097173|Dermatologic Agents|dermatologic agents|mesh-ancestor
24819822|NCT02097342|Incretins|incretins|mesh-ancestor
24819823|NCT02097342|Hormones|hormones|mesh-ancestor
24819824|NCT02097342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24819825|NCT02097342|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24819826|NCT02097342|Protease Inhibitors|protease inhibitors|mesh-ancestor
24819827|NCT02097342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916562|NCT04239443|Apatinib|apatinib|mesh-list
24916563|NCT04239443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24916564|NCT04239443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24916679|NCT04238221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24916680|NCT04238221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916681|NCT04238221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916682|NCT04238169|Bevacizumab|bevacizumab|mesh-list
24916683|NCT04238169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24916721|NCT04237987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24916722|NCT04237987|Antiviral Agents|antiviral agents|mesh-ancestor
24916723|NCT04237922|Clopidogrel|clopidogrel|mesh-list
24916724|NCT04237922|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24916725|NCT04237922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25066236|NCT04037072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066237|NCT04037072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25066238|NCT04037072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25066240|NCT04033237|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25066241|NCT04033237|Autonomic Agents|autonomic agents|mesh-ancestor
24916736|NCT04237935|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24916738|NCT04237935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24916739|NCT04237935|Purinergic Agents|purinergic agents|mesh-ancestor
24916762|NCT04237675|Anesthetics|anesthetics|mesh-list
24916763|NCT04237675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24916764|NCT04237675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520491|NCT00630565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25066254|NCT04019873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25066255|NCT04019873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066256|NCT04019873|Antiviral Agents|antiviral agents|mesh-ancestor
25066257|NCT04019873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25066258|NCT04019873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25066259|NCT04019873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24916780|NCT04237376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24916782|NCT04237493|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24520521|NCT05337969|Metformin|metformin|mesh-list
24916800|NCT04237480|Micronutrients|micronutrients|mesh-ancestor
24916801|NCT04237480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916802|NCT04237480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24916803|NCT04237480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24916804|NCT04237129|Insulin Aspart|insulin aspart|mesh-list
24916805|NCT04237129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24491706|NCT00483743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491710|NCT00483743|Hormones|hormones|mesh-ancestor
24520541|NCT05337332|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24916956|NCT04235673|Antioxidants|antioxidants|mesh-ancestor
24491740|NCT00483834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24491741|NCT00483834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491742|NCT00483834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25066354|NCT03557619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25272132|NCT02393846|Ketoprofen|ketoprofen|mesh-list
25667889|NCT01709747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066355|NCT03557619|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25066356|NCT03557619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066357|NCT03557619|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25066384|NCT03443869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25066385|NCT03443869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066386|NCT03443869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066392|NCT03406247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066394|NCT03399539|Dexamethasone acetate|dexamethasone acetate|mesh-list
25066395|NCT03399539|Venetoclax|venetoclax|mesh-list
25066396|NCT03399539|Ixazomib|ixazomib|mesh-list
25066397|NCT03399539|Ichthammol|ichthammol|mesh-list
25066398|NCT03399539|BB 1101|bb 1101|mesh-list
25066399|NCT03399539|Glycine|glycine|mesh-list
25066400|NCT03399539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25066401|NCT03399539|Antiemetics|antiemetics|mesh-ancestor
25066402|NCT03399539|Autonomic Agents|autonomic agents|mesh-ancestor
25066403|NCT03399539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25066404|NCT03399539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066405|NCT03399539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25066406|NCT03399539|Glucocorticoids|glucocorticoids|mesh-ancestor
25066407|NCT03399539|Hormones|hormones|mesh-ancestor
25066408|NCT03399539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25066409|NCT03399539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25066410|NCT03399539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24916957|NCT04235673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199525|NCT02740712|Micronutrients|micronutrients|mesh-ancestor
25199526|NCT02740712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199527|NCT02740712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25121387|NCT03103022|Acetaminophen|acetaminophen|mesh-list
24916958|NCT04235673|Protective Agents|protective agents|mesh-ancestor
24916959|NCT04235673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916960|NCT04235673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24916962|NCT04235270|Macitentan|macitentan|mesh-list
24916963|NCT04235270|Vasodilator Agents|vasodilator agents|mesh-ancestor
24916964|NCT04235270|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24916965|NCT04235270|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24916966|NCT04235270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916972|NCT04235296|Mitogens|mitogens|mesh-list
24916973|NCT04235296|Mitosis Modulators|mitosis modulators|mesh-ancestor
24916974|NCT04235296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916975|NCT04235894|Propofol|propofol|mesh-list
24916976|NCT04235894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24916977|NCT04235894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24916978|NCT04235894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916979|NCT04235894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24916980|NCT04235894|Anesthetics, General|anesthetics, general|mesh-ancestor
24916981|NCT04235894|Anesthetics|anesthetics|mesh-ancestor
24916982|NCT04236050|Rocuronium|rocuronium|mesh-list
24491772|NCT00483964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520549|NCT05337332|Immunologic Factors|immunologic factors|mesh-ancestor
24520550|NCT05337332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24520551|NCT05337332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520552|NCT05337254|Dihydroergotamine|dihydroergotamine|mesh-list
24520553|NCT05337254|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24520554|NCT05337254|Dopamine Agonists|dopamine agonists|mesh-ancestor
24520555|NCT05337254|Dopamine Agents|dopamine agents|mesh-ancestor
24520556|NCT05337254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24520557|NCT05337254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951368|NCT03905564|Doxylamine succinate|doxylamine succinate|mesh-list
24951369|NCT03905564|Vitamin B Complex|vitamin b complex|mesh-ancestor
24951371|NCT03905564|Micronutrients|micronutrients|mesh-ancestor
24951372|NCT03905564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951373|NCT03905564|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24951374|NCT03905564|Histamine Antagonists|histamine antagonists|mesh-ancestor
24951375|NCT03905564|Histamine Agents|histamine agents|mesh-ancestor
24951376|NCT03905564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25272164|NCT02393898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951377|NCT03905564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951379|NCT03905564|Autonomic Agents|autonomic agents|mesh-ancestor
24951380|NCT03905564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24917058|NCT04234516|Sensory System Agents|sensory system agents|mesh-ancestor
24917059|NCT04234516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24951401|NCT03904680|Methotrexate|methotrexate|mesh-list
24951402|NCT03904680|Vitamins|vitamins|mesh-ancestor
24808088|NCT02025036|Capecitabine|capecitabine|mesh-list
24828864|NCT02147964|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25428410|NCT01722708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25861400|NCT00086359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861401|NCT00086359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25667890|NCT01709747|Analgesics|analgesics|mesh-ancestor
25667891|NCT01709747|Sensory System Agents|sensory system agents|mesh-ancestor
25861402|NCT00086359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25667892|NCT01709747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25861403|NCT00086359|Antiviral Agents|antiviral agents|mesh-ancestor
24501217|NCT00527449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24501282|NCT00527800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24736156|NCT01660477|Protease Inhibitors|protease inhibitors|mesh-ancestor
25214936|NCT02694146|Hylan|hylan|mesh-list
24917071|NCT04234191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25066446|NCT03205605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24917161|NCT04233021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24917162|NCT04233021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917163|NCT04233021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917164|NCT04232644|Amphetamine|amphetamine|mesh-list
24917165|NCT04232644|Dextroamphetamine|dextroamphetamine|mesh-list
24917166|NCT04232644|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25066506|NCT03047330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066507|NCT03047330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25066508|NCT03047330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199528|NCT02740712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24917207|NCT04231864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24917208|NCT04231864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917209|NCT04231864|Immunologic Factors|immunologic factors|mesh-ancestor
24917210|NCT04231864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917212|NCT04232033|Mitosis Modulators|mitosis modulators|mesh-ancestor
24917213|NCT04232033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917214|NCT04232085|Mycophenolic Acid|mycophenolic acid|mesh-list
24917215|NCT04232085|Cyclophosphamide|cyclophosphamide|mesh-list
24492073|NCT00485108|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24520722|NCT05334004|Antiviral Agents|antiviral agents|mesh-ancestor
24917217|NCT04232085|Fludarabine|fludarabine|mesh-list
24917218|NCT04232085|Alemtuzumab|alemtuzumab|mesh-list
24917219|NCT04232085|Tacrolimus|tacrolimus|mesh-list
24917220|NCT04232085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24917221|NCT04232085|Immunologic Factors|immunologic factors|mesh-ancestor
24917222|NCT04232085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917223|NCT04232085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24534888|NCT00648219|Olmesartan|olmesartan|mesh-list
25066540|NCT02951377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25066580|NCT02700451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25066582|NCT02700451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25066583|NCT02700451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25066584|NCT02700451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25066585|NCT02700451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066586|NCT02525692|TIC10 compound|tic10 compound|mesh-list
25066587|NCT02525692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917275|NCT04231682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917277|NCT04231448|Cyclophosphamide|cyclophosphamide|mesh-list
24917278|NCT04231448|Rituximab|rituximab|mesh-list
24917279|NCT04231448|Doxorubicin|doxorubicin|mesh-list
24917280|NCT04231448|Vincristine|vincristine|mesh-list
24520765|NCT05327647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951925|NCT03899337|Alkylating Agents|alkylating agents|mesh-ancestor
24520767|NCT05326425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24520768|NCT05326425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917281|NCT04231448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24917282|NCT04231448|Immunologic Factors|immunologic factors|mesh-ancestor
24917300|NCT04231448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24917302|NCT04231448|Antimitotic Agents|antimitotic agents|mesh-ancestor
24917303|NCT04231448|Mitosis Modulators|mitosis modulators|mesh-ancestor
24917304|NCT04231370|Lenalidomide|lenalidomide|mesh-list
24917305|NCT04231370|Immunologic Factors|immunologic factors|mesh-ancestor
25066607|NCT02366494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066608|NCT02366494|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25066609|NCT02366494|Fertility Agents|fertility agents|mesh-ancestor
25066610|NCT02366494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25667893|NCT01709838|Deferasirox|deferasirox|mesh-list
25667894|NCT01709838|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25667895|NCT01709838|Chelating Agents|chelating agents|mesh-ancestor
25667896|NCT01709838|Sequestering Agents|sequestering agents|mesh-ancestor
25667897|NCT01709838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667898|NCT01709864|Glycopyrrolate|glycopyrrolate|mesh-list
25667899|NCT01709864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25214950|NCT02693769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25214951|NCT02693769|Respiratory System Agents|respiratory system agents|mesh-ancestor
25214952|NCT02693769|Dermatologic Agents|dermatologic agents|mesh-ancestor
25214953|NCT02693769|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25214954|NCT02693769|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25214955|NCT02693769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25214956|NCT02693769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25214957|NCT02693769|Adrenergic Agents|adrenergic agents|mesh-ancestor
25214958|NCT02693769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25214959|NCT02693769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214961|NCT02693769|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25214962|NCT02693769|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25214963|NCT02693769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25214964|NCT02693769|Cholinergic Agents|cholinergic agents|mesh-ancestor
25066611|NCT02366494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066612|NCT02366494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25066613|NCT02366494|Androgen Antagonists|androgen antagonists|mesh-ancestor
25066614|NCT02366494|Hormone Antagonists|hormone antagonists|mesh-ancestor
25066615|NCT02366494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25066616|NCT02366494|Luteolytic Agents|luteolytic agents|mesh-ancestor
25066617|NCT02366494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25066618|NCT02366494|Contraceptive Agents|contraceptive agents|mesh-ancestor
25066619|NCT02366494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25066620|NCT02262923|Metoclopramide|metoclopramide|mesh-list
25066621|NCT02262923|Antiemetics|antiemetics|mesh-ancestor
25066622|NCT02262923|Autonomic Agents|autonomic agents|mesh-ancestor
24451094|NCT00321945|Protease Inhibitors|protease inhibitors|mesh-ancestor
24917378|NCT04230460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24917379|NCT04230460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917380|NCT04230330|Gemcitabine|gemcitabine|mesh-list
24917386|NCT04230330|Antiemetics|antiemetics|mesh-ancestor
24917390|NCT04230330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24917403|NCT04230330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24917407|NCT04230083|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24917408|NCT04230083|Contraceptive Agents|contraceptive agents|mesh-ancestor
24917409|NCT04230083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24917410|NCT04230083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917411|NCT04230083|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24917412|NCT04230083|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24917464|NCT04229719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24917467|NCT04229459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917468|NCT04229459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24917469|NCT04229459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25066670|NCT02168140|Vitamin B Complex|vitamin b complex|mesh-ancestor
25066671|NCT02168140|Vitamins|vitamins|mesh-ancestor
25066672|NCT02168140|Micronutrients|micronutrients|mesh-ancestor
25066673|NCT02099188|Leucovorin|leucovorin|mesh-list
25066674|NCT02099188|Docetaxel|docetaxel|mesh-list
25066675|NCT02099188|Fluorouracil|fluorouracil|mesh-list
25066676|NCT02099188|Etoposide|etoposide|mesh-list
25066677|NCT02099188|Doxorubicin|doxorubicin|mesh-list
25066678|NCT02099188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25066679|NCT02099188|Ifosfamide|ifosfamide|mesh-list
25066680|NCT02099188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066681|NCT02099188|Tubulin Modulators|tubulin modulators|mesh-ancestor
25066682|NCT02099188|Antimitotic Agents|antimitotic agents|mesh-ancestor
25066683|NCT02099188|Mitosis Modulators|mitosis modulators|mesh-ancestor
25066684|NCT02099188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066685|NCT02099188|Antimetabolites|antimetabolites|mesh-ancestor
25667900|NCT01709864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25667901|NCT01709864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25667902|NCT01709864|Cholinergic Agents|cholinergic agents|mesh-ancestor
25667903|NCT01709864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25272218|NCT02393599|Cocaine|cocaine|mesh-list
25667904|NCT01709864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667905|NCT01709864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667906|NCT01709903|Fluticasone|fluticasone|mesh-list
25667907|NCT01709903|Xhance|xhance|mesh-list
25667908|NCT01709903|Glycopyrrolate|glycopyrrolate|mesh-list
25667909|NCT01709903|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25667910|NCT01709903|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25667911|NCT01709903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25667912|NCT01709903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25667913|NCT01709903|Autonomic Agents|autonomic agents|mesh-ancestor
25667914|NCT01709903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25215001|NCT02693574|Esomeprazole|esomeprazole|mesh-list
25215002|NCT02693574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25215003|NCT02693574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25215004|NCT02693574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25215005|NCT02693574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25215006|NCT02693574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25215007|NCT02693574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215008|NCT02693574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951719|NCT03901768|Autonomic Agents|autonomic agents|mesh-ancestor
24917470|NCT04229459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917485|NCT04229264|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24917486|NCT04229264|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24917506|NCT04229355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917507|NCT04229355|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24917508|NCT04229355|Estrogens|estrogens|mesh-ancestor
24917509|NCT04229355|Hormones|hormones|mesh-ancestor
24917510|NCT04229355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24917511|NCT04229355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917512|NCT04229355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24917513|NCT04229602|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24917514|NCT04229602|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24534972|NCT00648349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24917791|NCT04226105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917811|NCT04225611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24917812|NCT04225611|Antiemetics|antiemetics|mesh-ancestor
24917813|NCT04225611|Autonomic Agents|autonomic agents|mesh-ancestor
24917814|NCT04225611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24917815|NCT04225611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917816|NCT04225611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24917817|NCT04225611|Glucocorticoids|glucocorticoids|mesh-ancestor
24917818|NCT04225611|Hormones|hormones|mesh-ancestor
24917819|NCT04225611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24917820|NCT04225611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24917821|NCT04225611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24535019|NCT00648427|Paroxetine|paroxetine|mesh-list
25066836|NCT03450161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066837|NCT03450161|Analgesics|analgesics|mesh-ancestor
25066838|NCT03450161|Sensory System Agents|sensory system agents|mesh-ancestor
25066839|NCT03450161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25066846|NCT03450109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917885|NCT04224922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917886|NCT04224922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24917887|NCT04224922|Immunologic Factors|immunologic factors|mesh-ancestor
25066872|NCT03449836|Fluticasone|fluticasone|mesh-list
25066873|NCT03449836|Mometasone Furoate|mometasone furoate|mesh-list
24917893|NCT04224922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24917894|NCT04224922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24917895|NCT04224922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24917896|NCT04224922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917897|NCT04225195|Amphotericin B|amphotericin b|mesh-list
24917898|NCT04225195|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24917899|NCT04225195|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
24917900|NCT04225195|Amebicides|amebicides|mesh-ancestor
24492834|NCT00488189|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24492835|NCT00488189|Piperacillin|piperacillin|mesh-list
24492836|NCT00488189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24492837|NCT00488189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24492838|NCT00488189|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24492839|NCT00488189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492841|NCT00488215|Prucalopride|prucalopride|mesh-list
24918095|NCT04223739|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24484958|NCT00450892|Docetaxel|docetaxel|mesh-list
24918096|NCT04223739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24918098|NCT04223739|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24918099|NCT04223739|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25667915|NCT01709903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667916|NCT01709903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25667917|NCT01709903|Respiratory System Agents|respiratory system agents|mesh-ancestor
25667918|NCT01709903|Dermatologic Agents|dermatologic agents|mesh-ancestor
25667919|NCT01709903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25667920|NCT01709903|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25667921|NCT01709903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25667922|NCT01709903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24918100|NCT04223739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24918154|NCT04222855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918156|NCT04222855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918157|NCT04222855|Vasodilator Agents|vasodilator agents|mesh-ancestor
24918191|NCT04222088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24918199|NCT04221906|Betamethasone|betamethasone|mesh-list
24918200|NCT04221906|Calcipotriene|calcipotriene|mesh-list
24918201|NCT04221906|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24918202|NCT04221906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24918214|NCT04221919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918258|NCT04221282|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
24918259|NCT04221282|Anticonvulsants|anticonvulsants|mesh-ancestor
24918260|NCT04221282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24918261|NCT04221282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24918262|NCT04221282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24918263|NCT04221282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918264|NCT04221256|Citalopram|citalopram|mesh-list
24918265|NCT04221256|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24918266|NCT04221256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24918267|NCT04221256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24535194|NCT00648778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24493202|NCT00489944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24493203|NCT00489944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25066883|NCT03449797|Hydrocortisone|hydrocortisone|mesh-list
25066884|NCT03449797|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24520855|NCT05304663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520856|NCT05304663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24918317|NCT04220996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918318|NCT04220996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24520904|NCT05243940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24520905|NCT05243940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520906|NCT05243940|Sensory System Agents|sensory system agents|mesh-ancestor
24520920|NCT05243940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24616907|NCT01039740|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24616908|NCT01039740|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24616909|NCT01039740|Adrenergic Agents|adrenergic agents|mesh-ancestor
24616910|NCT01039740|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24616911|NCT01039740|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24616912|NCT01039740|Serotonin Agents|serotonin agents|mesh-ancestor
24616913|NCT01039740|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24616915|NCT01039766|Oxytocics|oxytocics|mesh-ancestor
24918535|NCT04218513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24918555|NCT04218435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24918556|NCT04218435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24918557|NCT04218435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24918558|NCT04218435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918560|NCT04218760|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24918561|NCT04218760|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
24918562|NCT04218760|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24918563|NCT04218760|Diuretics|diuretics|mesh-ancestor
24918564|NCT04218760|Natriuretic Agents|natriuretic agents|mesh-ancestor
24918565|NCT04218760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918566|NCT04218760|Vasodilator Agents|vasodilator agents|mesh-ancestor
24918567|NCT04218760|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24918568|NCT04218760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918789|NCT04216355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857706|NCT02293668|Letrozole|letrozole|mesh-list
24919042|NCT04214626|Rituximab|rituximab|mesh-list
24919061|NCT04214626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24919107|NCT04214145|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24919108|NCT04214145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24919109|NCT04214145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24919110|NCT04214145|Adrenergic Agents|adrenergic agents|mesh-ancestor
24919111|NCT04214145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24919112|NCT04214145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919113|NCT04214145|Protective Agents|protective agents|mesh-ancestor
24919114|NCT04214145|Hemostatics|hemostatics|mesh-ancestor
25066968|NCT03448744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25066969|NCT03448744|Immunologic Factors|immunologic factors|mesh-ancestor
25066970|NCT03448744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066971|NCT03448731|Doxycycline|doxycycline|mesh-list
25066972|NCT03448731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25066973|NCT03448731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25066974|NCT03448731|Antimalarials|antimalarials|mesh-ancestor
25066975|NCT03448731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25066976|NCT03448731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25066977|NCT03448705|Vaccines|vaccines|mesh-list
25066978|NCT03448705|Immunologic Factors|immunologic factors|mesh-ancestor
25066979|NCT03448705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066980|NCT03448640|Tropicamide|tropicamide|mesh-list
25066981|NCT03448640|Mydriatics|mydriatics|mesh-ancestor
25066982|NCT03448640|Autonomic Agents|autonomic agents|mesh-ancestor
24829416|NCT02152306|Vasodilator Agents|vasodilator agents|mesh-ancestor
24919115|NCT04214145|Coagulants|coagulants|mesh-ancestor
24919158|NCT04213898|Paclitaxel|paclitaxel|mesh-list
24919170|NCT04213898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24919171|NCT04213833|Lidocaine|lidocaine|mesh-list
24919172|NCT04213833|Dexmedetomidine|dexmedetomidine|mesh-list
24919173|NCT04213833|Propofol|propofol|mesh-list
24919174|NCT04213833|Anesthetics, Local|anesthetics, local|mesh-ancestor
24919175|NCT04213833|Anesthetics|anesthetics|mesh-ancestor
24919179|NCT04213833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24919182|NCT04213833|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24919183|NCT04213833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24919184|NCT04213833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919185|NCT04213833|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24919186|NCT04213833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24919187|NCT04213833|Anesthetics, General|anesthetics, general|mesh-ancestor
24919188|NCT04213833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24952028|NCT03898882|Oxytocics|oxytocics|mesh-ancestor
24952029|NCT03898882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24952030|NCT03898882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952031|NCT03898635|Linezolid|linezolid|mesh-list
24952032|NCT03898635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24919244|NCT04213612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24919245|NCT04213612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24919246|NCT04213612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24919247|NCT04213612|Tubulin Modulators|tubulin modulators|mesh-ancestor
24919248|NCT04213612|Antimitotic Agents|antimitotic agents|mesh-ancestor
24919249|NCT04213612|Mitosis Modulators|mitosis modulators|mesh-ancestor
24919250|NCT04213495|Anesthetics|anesthetics|mesh-list
24919251|NCT04213495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24919259|NCT04213170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919260|NCT04213170|Growth Inhibitors|growth inhibitors|mesh-ancestor
24919262|NCT04213573|Cariostatic Agents|cariostatic agents|mesh-ancestor
24919263|NCT04213573|Protective Agents|protective agents|mesh-ancestor
24919264|NCT04213573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919265|NCT04213287|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
24919266|NCT04213287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536342|NCT00650897|Citalopram|citalopram|mesh-list
24919560|NCT04210765|Zuclomiphene|zuclomiphene|mesh-list
24919561|NCT04210765|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24919562|NCT04210765|Hormone Antagonists|hormone antagonists|mesh-ancestor
24919563|NCT04210765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24919564|NCT04210765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623792|NCT01073670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24623793|NCT01073670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617804|NCT01045876|Antiemetics|antiemetics|mesh-ancestor
24618104|NCT01046799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24618105|NCT01046838|Sildenafil Citrate|sildenafil citrate|mesh-list
24618106|NCT01046838|Vasodilator Agents|vasodilator agents|mesh-ancestor
24536874|NCT00652795|Doxycycline|doxycycline|mesh-list
25861404|NCT00086359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25067051|NCT03447691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25067052|NCT03447691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067053|NCT03447691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25067054|NCT03447691|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25067055|NCT03447691|Anesthetics, General|anesthetics, general|mesh-ancestor
25861405|NCT00086359|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25067079|NCT03447184|Hormone Antagonists|hormone antagonists|mesh-ancestor
24494909|NCT00497497|Growth Inhibitors|growth inhibitors|mesh-ancestor
24521478|NCT04756726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24521479|NCT04756726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24521480|NCT04756726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24521482|NCT04745975|Paclitaxel|paclitaxel|mesh-list
25272815|NCT02389543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272816|NCT02389543|Immunologic Factors|immunologic factors|mesh-ancestor
25272817|NCT02389543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25272818|NCT02389543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25272819|NCT02389543|Growth Substances|growth substances|mesh-ancestor
25272820|NCT02389543|Growth Inhibitors|growth inhibitors|mesh-ancestor
25272821|NCT02389400|Methotrexate|methotrexate|mesh-list
24969570|NCT03742180|Ketorolac|ketorolac|mesh-list
24919865|NCT04207632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919867|NCT04207632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24919868|NCT04207684|Testosterone|testosterone|mesh-list
24919869|NCT04207684|Androgens|androgens|mesh-ancestor
24919870|NCT04207684|Hormones|hormones|mesh-ancestor
24919871|NCT04207684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24857801|NCT02294084|Hormones|hormones|mesh-ancestor
24919893|NCT04207385|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24919894|NCT04207385|Antidepressive Agents|antidepressive agents|mesh-ancestor
24919895|NCT04207385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24919896|NCT04207515|Anesthetics|anesthetics|mesh-list
24919964|NCT04206631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24919965|NCT04206631|Antimalarials|antimalarials|mesh-ancestor
24919966|NCT04206631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24919967|NCT04206631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24919968|NCT04206228|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
24919969|NCT04206228|Hematinics|hematinics|mesh-ancestor
24919970|NCT04206358|Molgramostim|molgramostim|mesh-list
24521629|NCT04629534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521630|NCT04629534|Vitamins|vitamins|mesh-ancestor
24521631|NCT04629534|Micronutrients|micronutrients|mesh-ancestor
24919971|NCT04206358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919972|NCT04206046|Anesthetics|anesthetics|mesh-list
24919973|NCT04206046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24919974|NCT04206046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919976|NCT04206176|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24919977|NCT04206176|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24538636|NCT00660140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24521658|NCT04622904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24919993|NCT04205916|Glucocorticoids|glucocorticoids|mesh-ancestor
24920034|NCT04205890|Ketamine|ketamine|mesh-list
24920035|NCT04205890|Analgesics|analgesics|mesh-ancestor
24920036|NCT04205890|Sensory System Agents|sensory system agents|mesh-ancestor
24920037|NCT04205890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25861406|NCT00086359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24495167|NCT00498901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495168|NCT00498901|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24495169|NCT00498901|Hormone Antagonists|hormone antagonists|mesh-ancestor
25067127|NCT03446937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25067128|NCT03446937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067129|NCT03446911|Pembrolizumab|pembrolizumab|mesh-list
25067130|NCT03446911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24829599|NCT02153281|Phenelzine|phenelzine|mesh-list
24495170|NCT00498901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24409130|NCT00180960|Irinotecan|irinotecan|mesh-list
25067135|NCT03446872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623898|NCT01073891|Contraceptive Agents|contraceptive agents|mesh-ancestor
25067138|NCT03446872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25067139|NCT03446872|Immunologic Factors|immunologic factors|mesh-ancestor
24623899|NCT01073891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24623900|NCT01073891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623901|NCT01073891|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24623902|NCT01073891|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24623903|NCT01073891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24623906|NCT01073904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24623907|NCT01073904|Contraceptive Agents|contraceptive agents|mesh-ancestor
24623908|NCT01073904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24594137|NCT00932763|Vasodilator Agents|vasodilator agents|mesh-ancestor
24521783|NCT04519476|Prednisolone phosphate|prednisolone phosphate|mesh-list
25667923|NCT01709903|Adrenergic Agents|adrenergic agents|mesh-ancestor
25667924|NCT01709903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25667925|NCT01709903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667926|NCT01709903|Glucocorticoids|glucocorticoids|mesh-ancestor
25667927|NCT01709903|Hormones|hormones|mesh-ancestor
25667928|NCT01709903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25667929|NCT01709903|Sympathomimetics|sympathomimetics|mesh-ancestor
24539107|NCT00662337|Dermatologic Agents|dermatologic agents|mesh-ancestor
25215104|NCT02692248|Hormones|hormones|mesh-ancestor
25215114|NCT02692365|Manganese|manganese|mesh-list
24920161|NCT04204837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24920162|NCT04204837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920163|NCT04204980|Daratumumab|daratumumab|mesh-list
24920164|NCT04204980|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24920165|NCT04204980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25067163|NCT03446599|Hydroxocobalamin|hydroxocobalamin|mesh-list
25067164|NCT03446599|Vitamin B 12|vitamin b 12|mesh-list
25067165|NCT03446599|Methylene Blue|methylene blue|mesh-list
25067166|NCT03446599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25067167|NCT03446599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067168|NCT03446599|Hematinics|hematinics|mesh-ancestor
25067169|NCT03446599|Vitamin B Complex|vitamin b complex|mesh-ancestor
24920253|NCT04204044|Vitamin B Complex|vitamin b complex|mesh-list
24920254|NCT04204044|Inositol|inositol|mesh-list
24920255|NCT04204044|Metformin|metformin|mesh-list
24623918|NCT01073995|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24619205|NCT01051388|Rabeprazole|rabeprazole|mesh-list
24619353|NCT01052129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24619354|NCT01052129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619356|NCT01052129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24920289|NCT04203680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24920290|NCT04203680|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24521976|NCT04388683|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24521977|NCT04388683|Vasodilator Agents|vasodilator agents|mesh-ancestor
24521978|NCT04388683|Gasotransmitters|gasotransmitters|mesh-ancestor
24521979|NCT04388683|Protective Agents|protective agents|mesh-ancestor
24920343|NCT04203056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24920344|NCT04203056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920345|NCT04203056|Dopamine Agonists|dopamine agonists|mesh-ancestor
24920346|NCT04203056|Dopamine Agents|dopamine agents|mesh-ancestor
24920347|NCT04203056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24920353|NCT04203056|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24920354|NCT04203056|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24920355|NCT04203056|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24920356|NCT04203043|Pycnogenols|pycnogenols|mesh-list
24920357|NCT04203043|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24920358|NCT04203043|Immunologic Factors|immunologic factors|mesh-ancestor
25067192|NCT03445910|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25067193|NCT03445910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25067194|NCT03445910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522031|NCT04365257|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-list
24522032|NCT04365257|Adrenergic Antagonists|adrenergic antagonists|mesh-list
24522033|NCT04365257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24522034|NCT04365257|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24522035|NCT04365257|Adrenergic Agents|adrenergic agents|mesh-ancestor
24522036|NCT04365257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25199535|NCT02740712|Anesthetics|anesthetics|mesh-ancestor
25067226|NCT03445611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25067228|NCT03445611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25067229|NCT03445611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25067230|NCT03445611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25067231|NCT03445611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952311|NCT03895411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24952312|NCT03895411|Sympatholytics|sympatholytics|mesh-ancestor
24952313|NCT03895411|Autonomic Agents|autonomic agents|mesh-ancestor
24829667|NCT02153658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25040158|NCT03340974|Avasopasem manganese|avasopasem manganese|mesh-list
24952316|NCT03895411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24952317|NCT03895411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24952318|NCT03895411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24952319|NCT03895411|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24920473|NCT04202406|Codeine|codeine|mesh-list
24920474|NCT04202406|Caffeine|caffeine|mesh-list
24920475|NCT04202406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24920476|NCT04202406|Analgesics|analgesics|mesh-ancestor
24920477|NCT04202406|Sensory System Agents|sensory system agents|mesh-ancestor
25861407|NCT00086359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24920494|NCT04202224|Acetaminophen|acetaminophen|mesh-list
24920499|NCT04202224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24920500|NCT04202224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920501|NCT04202224|Antipyretics|antipyretics|mesh-ancestor
24542288|NCT00678145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24522285|NCT04004819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25667930|NCT01709903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25215157|NCT02691871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215158|NCT02691754|Acetaminophen|acetaminophen|mesh-list
25215159|NCT02691754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25215160|NCT02691754|Analgesics|analgesics|mesh-ancestor
24522286|NCT04004819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522287|NCT04004819|Immunologic Factors|immunologic factors|mesh-ancestor
24594544|NCT00934427|Nitroglycerin|nitroglycerin|mesh-list
24920591|NCT04201145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25067309|NCT03444636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25067310|NCT03444636|Anesthetics, General|anesthetics, general|mesh-ancestor
25067312|NCT03444519|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25067313|NCT03444519|Diuretics|diuretics|mesh-ancestor
25067314|NCT03444519|Natriuretic Agents|natriuretic agents|mesh-ancestor
25199536|NCT02740712|GABA Modulators|gaba modulators|mesh-ancestor
25199537|NCT02740712|GABA Agents|gaba agents|mesh-ancestor
25199538|NCT02740712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25199539|NCT02740712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199540|NCT02740712|Anticoagulants|anticoagulants|mesh-ancestor
25199541|NCT02740712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25199542|NCT02740712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25199543|NCT02740712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25199544|NCT02740712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199545|NCT02740712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25199546|NCT02740712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25199547|NCT02740712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25199548|NCT02740712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25067318|NCT03444506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25067319|NCT03444506|Analgesics|analgesics|mesh-ancestor
25067320|NCT03444506|Sensory System Agents|sensory system agents|mesh-ancestor
25067321|NCT03444506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25067322|NCT03444506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067323|NCT03444506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25067324|NCT03444506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25067325|NCT03444506|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25067326|NCT03444506|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25067327|NCT03444506|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25067328|NCT03444506|Histamine Antagonists|histamine antagonists|mesh-ancestor
24829768|NCT02154360|Antiemetics|antiemetics|mesh-ancestor
24829769|NCT02154360|Autonomic Agents|autonomic agents|mesh-ancestor
24829770|NCT02154360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24829771|NCT02154360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829772|NCT02154360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24829773|NCT02154360|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24829774|NCT02154360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24829776|NCT02154438|Ketamine|ketamine|mesh-list
24920592|NCT04201145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24920593|NCT04201249|Piroxicam|piroxicam|mesh-list
24920594|NCT04201249|Lidocaine|lidocaine|mesh-list
24920595|NCT04201249|Anesthetics, Local|anesthetics, local|mesh-ancestor
24920596|NCT04201249|Anesthetics|anesthetics|mesh-ancestor
24920597|NCT04201249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24920598|NCT04201249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920599|NCT04201249|Sensory System Agents|sensory system agents|mesh-ancestor
24920600|NCT04201249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24920601|NCT04201249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24920602|NCT04201249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24920603|NCT04201249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24920604|NCT04201249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25199555|NCT02740712|Hemostatics|hemostatics|mesh-ancestor
25199556|NCT02740712|Coagulants|coagulants|mesh-ancestor
25199557|NCT02740712|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25199558|NCT02740712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199559|NCT02740426|Pirarubicin|pirarubicin|mesh-list
25199560|NCT02740426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199561|NCT02740270|Spartalizumab|spartalizumab|mesh-list
25199562|NCT02740270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25199563|NCT02740270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199564|NCT02740270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199565|NCT02740101|Oxytocin|oxytocin|mesh-list
25067331|NCT03444506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920642|NCT04200235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25667931|NCT01709903|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25667932|NCT01709903|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25667933|NCT01709903|Cholinergic Agents|cholinergic agents|mesh-ancestor
25667934|NCT01710020|Tofacitinib|tofacitinib|mesh-list
24920643|NCT04200235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25215187|NCT02691325|Nemiralisib|nemiralisib|mesh-list
25215188|NCT02691325|Antidotes|antidotes|mesh-ancestor
25215189|NCT02691325|Protective Agents|protective agents|mesh-ancestor
25861408|NCT00086359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24920644|NCT04200235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861409|NCT00086359|Antimetabolites|antimetabolites|mesh-ancestor
25067361|NCT03444025|Goserelin|goserelin|mesh-list
25067362|NCT03444025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25067363|NCT03444025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25067364|NCT03444012|Ticagrelor|ticagrelor|mesh-list
25067365|NCT03444012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25067366|NCT03444012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25067367|NCT03444012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24952376|NCT03894683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067368|NCT03444012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25067369|NCT03444012|Purinergic Agents|purinergic agents|mesh-ancestor
25067370|NCT03444012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25067371|NCT03444012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067372|NCT03444012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067374|NCT03443999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25067375|NCT03443999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25861410|NCT00086463|Iloprost|iloprost|mesh-list
24996645|NCT03033095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25040100|NCT03427125|Sequestering Agents|sequestering agents|mesh-ancestor
25040101|NCT03427125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040102|NCT03423147|Chlorhexidine|chlorhexidine|mesh-list
25040103|NCT03423147|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25040104|NCT03423147|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25040105|NCT03423147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25040149|NCT03350035|GABA Modulators|gaba modulators|mesh-ancestor
25040150|NCT03350035|GABA Agents|gaba agents|mesh-ancestor
25040151|NCT03345082|Ranibizumab|ranibizumab|mesh-list
25040152|NCT03345082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25040153|NCT03345082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25040154|NCT03345082|Growth Substances|growth substances|mesh-ancestor
25040155|NCT03345082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040156|NCT03345082|Growth Inhibitors|growth inhibitors|mesh-ancestor
25040157|NCT03345082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25040242|NCT03263273|Minocycline|minocycline|mesh-list
25040243|NCT03263273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25040244|NCT03263273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24996847|NCT01465334|Glucocorticoids|glucocorticoids|mesh-ancestor
25040251|NCT03250117|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25040252|NCT03250117|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25040287|NCT03208985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040288|NCT03208985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25040291|NCT03198728|Hormones|hormones|mesh-ancestor
25040292|NCT03198728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25040293|NCT03198728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040294|NCT03196219|Anti-Infective Agents|anti-infective agents|mesh-list
25040295|NCT03196219|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25040296|NCT03191864|Fluticasone|fluticasone|mesh-list
25040298|NCT03191864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25040299|NCT03191864|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25040300|NCT03191864|Autonomic Agents|autonomic agents|mesh-ancestor
25040347|NCT03161093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25040348|NCT03161093|Gout Suppressants|gout suppressants|mesh-ancestor
25040349|NCT03161093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25040350|NCT03161093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25067411|NCT03443843|Loratadine|loratadine|mesh-list
24607104|NCT05213481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607105|NCT05213481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24607224|NCT04994561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24607255|NCT04941443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24637034|NCT01148446|Prednisone|prednisone|mesh-list
24609466|NCT00996866|Vitamin D|vitamin d|mesh-list
24671273|NCT01324596|Vincristine|vincristine|mesh-list
24671274|NCT01324596|Bortezomib|bortezomib|mesh-list
24607528|NCT04429152|Antiviral Agents|antiviral agents|mesh-ancestor
24607529|NCT04429152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24607530|NCT04429152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25667935|NCT01710020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25667936|NCT01710020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25667937|NCT01710020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853530|NCT02268773|Analgesics|analgesics|mesh-ancestor
24853531|NCT02268773|Sensory System Agents|sensory system agents|mesh-ancestor
24853532|NCT02268773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24853533|NCT02268773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853534|NCT02268773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24853535|NCT02268773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24853536|NCT02268773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24456328|NCT00330902|Anthelmintics|anthelmintics|mesh-ancestor
24607626|NCT04217694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607627|NCT04217694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24607628|NCT04217694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24607630|NCT04192266|Estrogens|estrogens|mesh-ancestor
24607632|NCT04192266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24607633|NCT04192266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607634|NCT04191135|Gemcitabine|gemcitabine|mesh-list
24607635|NCT04191135|Carboplatin|carboplatin|mesh-list
24607636|NCT04191135|Pembrolizumab|pembrolizumab|mesh-list
24607637|NCT04191135|Olaparib|olaparib|mesh-list
24607638|NCT04191135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609725|NCT00997958|Mycophenolic Acid|mycophenolic acid|mesh-list
24607711|NCT03971409|Immunoglobulin G|immunoglobulin g|mesh-list
24607712|NCT03971409|Immunologic Factors|immunologic factors|mesh-ancestor
24607713|NCT03971409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607714|NCT03971409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24607715|NCT03971409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607722|NCT03971409|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24607723|NCT03903640|Nivolumab|nivolumab|mesh-list
24607724|NCT03903640|Ipilimumab|ipilimumab|mesh-list
25861411|NCT00086463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24607811|NCT03606785|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24607812|NCT03606785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24607813|NCT03606785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607814|NCT03606785|Hemostatics|hemostatics|mesh-ancestor
24607815|NCT03606785|Coagulants|coagulants|mesh-ancestor
24607868|NCT03275818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607869|NCT03275818|Tubulin Modulators|tubulin modulators|mesh-ancestor
24607870|NCT03275818|Antimitotic Agents|antimitotic agents|mesh-ancestor
24607871|NCT03275818|Mitosis Modulators|mitosis modulators|mesh-ancestor
24607872|NCT03275818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607923|NCT03185208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607925|NCT03185208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24607926|NCT03185208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24607927|NCT03185208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607928|NCT03179449|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24607930|NCT03179449|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24607970|NCT03077698|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24607971|NCT03077698|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24609977|NCT00999297|Capsaicin|capsaicin|mesh-list
24607980|NCT02999022|Lithium Carbonate|lithium carbonate|mesh-list
24607981|NCT02999022|Antidepressive Agents|antidepressive agents|mesh-ancestor
24607982|NCT02999022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24607983|NCT02999022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24607984|NCT02999022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607985|NCT02999022|Antimanic Agents|antimanic agents|mesh-ancestor
24607986|NCT02999022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24607987|NCT02999022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24853581|NCT02269072|Androgens|androgens|mesh-ancestor
24853582|NCT02269072|Hormones|hormones|mesh-ancestor
25067413|NCT03443843|Ephedrine|ephedrine|mesh-list
25861412|NCT00086463|Vasodilator Agents|vasodilator agents|mesh-ancestor
24671316|NCT01324752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24671317|NCT01324752|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24635962|NCT01142258|Trazodone|trazodone|mesh-list
24671318|NCT01324752|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24671319|NCT01324752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608051|NCT02509312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24608052|NCT02509312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24608054|NCT02509312|Sensory System Agents|sensory system agents|mesh-ancestor
24608055|NCT02509312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24608056|NCT02509312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608057|NCT02509312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24608058|NCT02509312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24608059|NCT02509312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24608060|NCT02509312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608061|NCT02509312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543803|NCT00685542|Diacetylrhein|diacetylrhein|mesh-list
25215243|NCT02691078|Octreotide|octreotide|mesh-list
24608089|NCT02360280|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24608090|NCT02360280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24608091|NCT02360280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608114|NCT02315326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608131|NCT02097134|Melphalan|melphalan|mesh-list
24608132|NCT02097134|Mechlorethamine|mechlorethamine|mesh-list
24608133|NCT02097134|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
24608134|NCT02097134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24608135|NCT02097134|Alkylating Agents|alkylating agents|mesh-ancestor
25199566|NCT02740101|Oxytocics|oxytocics|mesh-ancestor
24608136|NCT02097134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608137|NCT02097134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608138|NCT02097134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24608139|NCT02097134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24608140|NCT02097134|Immunologic Factors|immunologic factors|mesh-ancestor
24608141|NCT02097134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608142|NCT02096588|Cyclophosphamide|cyclophosphamide|mesh-list
24608143|NCT02096588|Doxorubicin|doxorubicin|mesh-list
24608222|NCT01664182|Growth Inhibitors|growth inhibitors|mesh-ancestor
24608223|NCT01664182|Immunologic Factors|immunologic factors|mesh-ancestor
24608224|NCT01664182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24608225|NCT01664182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608226|NCT01664182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608227|NCT01661881|Cytarabine|cytarabine|mesh-list
24608228|NCT01661881|Rituximab|rituximab|mesh-list
24608229|NCT01661881|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24608230|NCT01661881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24608231|NCT01661881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608232|NCT01661881|Immunologic Factors|immunologic factors|mesh-ancestor
24608233|NCT01661881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608234|NCT01661881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24853634|NCT02269293|Mitosis Modulators|mitosis modulators|mesh-ancestor
24853635|NCT02269293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608329|NCT00991848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608330|NCT00991848|Sensory System Agents|sensory system agents|mesh-ancestor
24608331|NCT00991848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24608332|NCT00991848|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24608333|NCT00991848|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24671335|NCT01324960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861413|NCT00086489|Tremelimumab|tremelimumab|mesh-list
24608399|NCT00992082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24608400|NCT00992082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608427|NCT00992095|Narcotics|narcotics|mesh-ancestor
24608428|NCT00992095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24608429|NCT00992095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608430|NCT00992095|Analgesics|analgesics|mesh-ancestor
24608431|NCT00992095|Sensory System Agents|sensory system agents|mesh-ancestor
24608432|NCT00992095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24608433|NCT00992095|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24608434|NCT00992121|Bevacizumab|bevacizumab|mesh-list
24608435|NCT00992121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24608436|NCT00992121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608437|NCT00992121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24608462|NCT00992160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608463|NCT00992173|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24608464|NCT00992173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608465|NCT00992173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608466|NCT00992173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608467|NCT00992173|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24608469|NCT00992199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608470|NCT00992199|Antimetabolites|antimetabolites|mesh-ancestor
24608487|NCT00992329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608488|NCT00992329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608489|NCT00992329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608529|NCT00992381|Gout Suppressants|gout suppressants|mesh-ancestor
24608530|NCT00992381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24608531|NCT00992381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608532|NCT00992381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608533|NCT00992472|Prochlorperazine|prochlorperazine|mesh-list
24608568|NCT00992576|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24608569|NCT00992576|Narcotics|narcotics|mesh-ancestor
24608570|NCT00992576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25861414|NCT00086489|Ipilimumab|ipilimumab|mesh-list
24608571|NCT00992576|Analgesics|analgesics|mesh-ancestor
24608573|NCT00992654|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24608574|NCT00992654|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25861415|NCT00086489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608612|NCT00992771|Varenicline|varenicline|mesh-list
24608613|NCT00992771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24608614|NCT00992771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24608615|NCT00992771|Cholinergic Agents|cholinergic agents|mesh-ancestor
24608616|NCT00992771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24608617|NCT00992771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608618|NCT00992771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608619|NCT00992797|Vitamin D|vitamin d|mesh-list
24608620|NCT00992797|Cholecalciferol|cholecalciferol|mesh-list
24608621|NCT00992797|Vitamins|vitamins|mesh-ancestor
24608622|NCT00992797|Micronutrients|micronutrients|mesh-ancestor
24671578|NCT01326611|Clarithromycin|clarithromycin|mesh-list
25861416|NCT00086489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24608710|NCT00993122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608711|NCT00993122|Antiviral Agents|antiviral agents|mesh-ancestor
24608712|NCT00993122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24608713|NCT00993135|Methotrexate|methotrexate|mesh-list
24608724|NCT00993135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24608725|NCT00993135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24608727|NCT00993135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24608728|NCT00993135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24608729|NCT00993304|Liraglutide|liraglutide|mesh-list
24608730|NCT00993304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24608731|NCT00993304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608732|NCT00993304|Incretins|incretins|mesh-ancestor
24608733|NCT00993304|Hormones|hormones|mesh-ancestor
24608734|NCT00993304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24608735|NCT00993343|Cyclosporine|cyclosporine|mesh-list
24608805|NCT00993733|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24608806|NCT00993746|Lidocaine|lidocaine|mesh-list
24608807|NCT00993746|Bupivacaine|bupivacaine|mesh-list
24608808|NCT00993746|Anesthetics, Local|anesthetics, local|mesh-ancestor
24608809|NCT00993746|Anesthetics|anesthetics|mesh-ancestor
24608810|NCT00993746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24608811|NCT00993746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608859|NCT00994071|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24608860|NCT00994071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637172|NCT01149122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24637173|NCT01149122|Antimetabolites|antimetabolites|mesh-ancestor
24637174|NCT01149122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637175|NCT01149122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637176|NCT01149122|Antiviral Agents|antiviral agents|mesh-ancestor
24608861|NCT00994097|Gemcitabine|gemcitabine|mesh-list
24853683|NCT02269514|Cholinergic Agents|cholinergic agents|mesh-ancestor
24544107|NCT00687258|Vitamin E|vitamin e|mesh-list
24608999|NCT00994773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24609000|NCT00994773|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24609001|NCT00994773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24609064|NCT00994942|Analgesics|analgesics|mesh-ancestor
24609065|NCT00994942|Sensory System Agents|sensory system agents|mesh-ancestor
24609066|NCT00994942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24609067|NCT00994968|Cyclophosphamide|cyclophosphamide|mesh-list
24609068|NCT00994968|Docetaxel|docetaxel|mesh-list
24609069|NCT00994968|Doxorubicin|doxorubicin|mesh-list
24609070|NCT00994968|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24609071|NCT00994968|Tegafur|tegafur|mesh-list
24609116|NCT00994994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24609117|NCT00994994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24609118|NCT00994994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24609119|NCT00994994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609138|NCT00995059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609173|NCT00995293|Mitosis Modulators|mitosis modulators|mesh-ancestor
24609174|NCT00995293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609175|NCT00995293|Antimetabolites|antimetabolites|mesh-ancestor
24609176|NCT00995293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24637221|NCT01149330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24609195|NCT00995332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24609196|NCT00995332|Immunologic Factors|immunologic factors|mesh-ancestor
24609197|NCT00995332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609199|NCT00995332|Dermatologic Agents|dermatologic agents|mesh-ancestor
25667938|NCT01710033|Tofacitinib|tofacitinib|mesh-list
24609200|NCT00995332|Anticonvulsants|anticonvulsants|mesh-ancestor
24609201|NCT00995332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609202|NCT00995332|GABA Agents|gaba agents|mesh-ancestor
24609203|NCT00995332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24609222|NCT00995423|Tubulin Modulators|tubulin modulators|mesh-ancestor
24609223|NCT00995423|Antimitotic Agents|antimitotic agents|mesh-ancestor
24609224|NCT00995423|Mitosis Modulators|mitosis modulators|mesh-ancestor
24609225|NCT00995423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609226|NCT00995618|Tranilast|tranilast|mesh-list
24609227|NCT00995618|Febuxostat|febuxostat|mesh-list
24609309|NCT00996021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609311|NCT00996021|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24609312|NCT00996021|Contraceptive Agents|contraceptive agents|mesh-ancestor
24609313|NCT00996021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24609316|NCT00996021|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24609317|NCT00996021|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24609318|NCT00996021|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24609432|NCT00996697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24952060|NCT03898193|Montelukast|montelukast|mesh-list
24609433|NCT00996697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609434|NCT00996697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24609435|NCT00996697|Respiratory System Agents|respiratory system agents|mesh-ancestor
24609436|NCT00996697|Glucocorticoids|glucocorticoids|mesh-ancestor
24609438|NCT00996697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24609462|NCT00996788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609464|NCT00996788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609465|NCT00996788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609493|NCT00996983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609494|NCT00996983|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24609495|NCT00996983|Protective Agents|protective agents|mesh-ancestor
24609496|NCT00996983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24609497|NCT00996983|Analgesics|analgesics|mesh-ancestor
24609498|NCT00996983|Sensory System Agents|sensory system agents|mesh-ancestor
24609499|NCT00996983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24609500|NCT00997009|Paclitaxel|paclitaxel|mesh-list
24609501|NCT00997009|Carboplatin|carboplatin|mesh-list
24609502|NCT00997009|Cetuximab|cetuximab|mesh-list
24609503|NCT00997009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24609504|NCT00997009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609505|NCT00997009|Tubulin Modulators|tubulin modulators|mesh-ancestor
24853731|NCT02269696|Adrenergic Agents|adrenergic agents|mesh-ancestor
24853732|NCT02269696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24853733|NCT02269696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853735|NCT02269735|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24853737|NCT02269735|MK-2640|mk-2640|mesh-list
24609594|NCT00997477|Budesonide|budesonide|mesh-list
24699040|NCT01444586|Rivaroxaban|rivaroxaban|mesh-list
24609595|NCT00997477|Formoterol Fumarate|formoterol fumarate|mesh-list
24609596|NCT00997477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24609597|NCT00997477|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24609598|NCT00997477|Autonomic Agents|autonomic agents|mesh-ancestor
24609599|NCT00997477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24609600|NCT00997477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609601|NCT00997477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24609636|NCT00997581|Gout Suppressants|gout suppressants|mesh-ancestor
24609637|NCT00997581|Tocolytic Agents|tocolytic agents|mesh-ancestor
24609639|NCT00997581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24609640|NCT00997607|Vaccines|vaccines|mesh-list
24609641|NCT00997607|Immunologic Factors|immunologic factors|mesh-ancestor
24609642|NCT00997607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609644|NCT00997659|Picolinic acid|picolinic acid|mesh-list
24609676|NCT00997815|Botulinum Toxins|botulinum toxins|mesh-list
24609677|NCT00997815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24609678|NCT00997815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24609679|NCT00997815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24609680|NCT00997815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24609681|NCT00997815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609682|NCT00997815|Cholinergic Agents|cholinergic agents|mesh-ancestor
24609683|NCT00997815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24609684|NCT00997815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609728|NCT00997958|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24609729|NCT00997958|Antitubercular Agents|antitubercular agents|mesh-ancestor
24609730|NCT00997958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24609731|NCT00997958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24609733|NCT00997958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609734|NCT00997997|Moxifloxacin|moxifloxacin|mesh-list
24609735|NCT00997997|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24609804|NCT00998192|Carboplatin|carboplatin|mesh-list
24609805|NCT00998192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24609875|NCT00998686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24609876|NCT00998686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609877|NCT00998686|Incretins|incretins|mesh-ancestor
24609878|NCT00998686|Hormones|hormones|mesh-ancestor
24671443|NCT01325896|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24609879|NCT00998686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24609880|NCT00998686|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24672286|NCT01331421|Exemestane|exemestane|mesh-list
24609907|NCT00998933|Hormones|hormones|mesh-ancestor
24609908|NCT00998933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24609909|NCT00998933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609910|NCT00998972|Acetylcysteine|acetylcysteine|mesh-list
24609911|NCT00998972|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24609912|NCT00998972|Antiviral Agents|antiviral agents|mesh-ancestor
24609949|NCT00999219|GABA Agents|gaba agents|mesh-ancestor
24609950|NCT00999219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24609951|NCT00999219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609952|NCT00999232|Erythromycin|erythromycin|mesh-list
24609953|NCT00999232|Erythromycin Estolate|erythromycin estolate|mesh-list
24609954|NCT00999232|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24609955|NCT00999232|Erythromycin stearate|erythromycin stearate|mesh-list
24609956|NCT00999232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24609957|NCT00999232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24609958|NCT00999232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24609959|NCT00999232|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24609960|NCT00999232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609961|NCT00999232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609962|NCT00999258|Sirolimus|sirolimus|mesh-list
24610045|NCT00999557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24671381|NCT01325298|Vitamin B Complex|vitamin b complex|mesh-ancestor
24610046|NCT00999557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24610047|NCT00999700|Cisplatin|cisplatin|mesh-list
24610048|NCT00999700|Docetaxel|docetaxel|mesh-list
24610049|NCT00999700|Fluorouracil|fluorouracil|mesh-list
24610078|NCT00999752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24610079|NCT00999752|Adrenergic Agents|adrenergic agents|mesh-ancestor
24610080|NCT00999752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24610081|NCT00999791|Diclofenac|diclofenac|mesh-list
24610082|NCT00999791|Bevacizumab|bevacizumab|mesh-list
24853799|NCT02270424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853800|NCT02270424|Glucocorticoids|glucocorticoids|mesh-ancestor
24853801|NCT02270424|Hormones|hormones|mesh-ancestor
24849989|NCT02251184|Dipyridamole|dipyridamole|mesh-list
24853802|NCT02270424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24853803|NCT02270424|Sympathomimetics|sympathomimetics|mesh-ancestor
24853804|NCT02270437|Epinephrine|epinephrine|mesh-list
24853805|NCT02270437|Racepinephrine|racepinephrine|mesh-list
24853806|NCT02270437|Fentanyl|fentanyl|mesh-list
24853807|NCT02270437|Ropivacaine|ropivacaine|mesh-list
24853808|NCT02270437|Epinephryl borate|epinephryl borate|mesh-list
24853809|NCT02270437|Anesthetics, Local|anesthetics, local|mesh-ancestor
24853810|NCT02270437|Anesthetics|anesthetics|mesh-ancestor
24610101|NCT00999817|Antitussive Agents|antitussive agents|mesh-ancestor
24610102|NCT00999817|Respiratory System Agents|respiratory system agents|mesh-ancestor
24610103|NCT00999817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24610104|NCT00999817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24610105|NCT00999817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24610106|NCT00999817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610107|NCT00999817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610108|NCT00999843|Sorafenib|sorafenib|mesh-list
25199567|NCT02740101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25199568|NCT02740101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122770|NCT03090880|Dalteparin|dalteparin|mesh-list
24610109|NCT00999843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610110|NCT00999843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24853811|NCT02270437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24853812|NCT02270437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853813|NCT02270437|Sensory System Agents|sensory system agents|mesh-ancestor
24853814|NCT02270437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24671430|NCT01325779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671431|NCT01325818|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24671433|NCT01325818|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24671434|NCT01325818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24671435|NCT01325818|Antimetabolites|antimetabolites|mesh-ancestor
24616858|NCT01039545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24671436|NCT01325818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671437|NCT01325818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24671438|NCT01325818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24671439|NCT01325818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671440|NCT01325844|Anesthetics|anesthetics|mesh-list
24671441|NCT01325844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24671442|NCT01325844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671444|NCT01325896|Antiviral Agents|antiviral agents|mesh-ancestor
24671445|NCT01325896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24671446|NCT01325935|Clopidogrel|clopidogrel|mesh-list
24671447|NCT01325935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24637324|NCT01149902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853818|NCT02270437|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24637325|NCT01149902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672597|NCT01332617|Antiemetics|antiemetics|mesh-ancestor
24544452|NCT00689156|Epirubicin|epirubicin|mesh-list
24610247|NCT01000792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24610248|NCT01000792|Histamine Antagonists|histamine antagonists|mesh-ancestor
24610249|NCT01000792|Histamine Agents|histamine agents|mesh-ancestor
24610250|NCT01000792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24610251|NCT01000792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610252|NCT01000792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610253|NCT01000792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24812570|NCT02053597|Doxorubicin|doxorubicin|mesh-list
24812571|NCT02053597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24610290|NCT01001130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610291|NCT01001130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24597122|NCT00947141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610292|NCT01001130|Respiratory System Agents|respiratory system agents|mesh-ancestor
24671465|NCT01326000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24671467|NCT01326039|Anesthetics, Local|anesthetics, local|mesh-ancestor
24671468|NCT01326039|Anesthetics|anesthetics|mesh-ancestor
24671469|NCT01326039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24671470|NCT01326039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028250|NCT03612440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24671471|NCT01326039|Sensory System Agents|sensory system agents|mesh-ancestor
24671472|NCT01326039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24671473|NCT01326078|Propofol|propofol|mesh-list
24637352|NCT01149954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24853819|NCT02270437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24853820|NCT02270437|Anesthetics, General|anesthetics, general|mesh-ancestor
25861417|NCT00086489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24671509|NCT01326325|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24671510|NCT01326325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24671511|NCT01326325|Anesthetics, General|anesthetics, general|mesh-ancestor
24671512|NCT01326325|Anesthetics|anesthetics|mesh-ancestor
24671513|NCT01326325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24671557|NCT01326559|Mitosis Modulators|mitosis modulators|mesh-ancestor
24671961|NCT01328821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671558|NCT01326559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671559|NCT01326559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24671560|NCT01326585|Dexamethasone|dexamethasone|mesh-list
24671561|NCT01326585|Dexamethasone acetate|dexamethasone acetate|mesh-list
24671562|NCT01326585|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24671563|NCT01326585|BB 1101|bb 1101|mesh-list
24671564|NCT01326585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24671565|NCT01326585|Antiemetics|antiemetics|mesh-ancestor
24671566|NCT01326585|Autonomic Agents|autonomic agents|mesh-ancestor
24671567|NCT01326585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24671568|NCT01326585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671569|NCT01326585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25199569|NCT02740192|Bupivacaine|bupivacaine|mesh-list
24671570|NCT01326585|Glucocorticoids|glucocorticoids|mesh-ancestor
24671571|NCT01326585|Hormones|hormones|mesh-ancestor
24671572|NCT01326585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24671573|NCT01326585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24671574|NCT01326585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24853821|NCT02270437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24853823|NCT02270437|Adrenergic Agents|adrenergic agents|mesh-ancestor
24671672|NCT01327066|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24671673|NCT01327066|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24671675|NCT01327079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25667939|NCT01710033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25083019|NCT03318536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25083020|NCT03318536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083021|NCT03318536|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24671676|NCT01327079|Narcotics|narcotics|mesh-ancestor
24671677|NCT01327079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24671678|NCT01327079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671679|NCT01327079|Analgesics|analgesics|mesh-ancestor
24671680|NCT01327079|Sensory System Agents|sensory system agents|mesh-ancestor
24671681|NCT01327079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24671682|NCT01327079|Antitussive Agents|antitussive agents|mesh-ancestor
24671683|NCT01327079|Respiratory System Agents|respiratory system agents|mesh-ancestor
24671684|NCT01327118|Dinoprost|dinoprost|mesh-list
24671685|NCT01327118|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
24671686|NCT01327118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24671687|NCT01327118|Abortifacient Agents|abortifacient agents|mesh-ancestor
24544615|NCT00689702|Cetuximab|cetuximab|mesh-list
24610396|NCT01001780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610397|NCT01001780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610398|NCT01001780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24610399|NCT01001780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24610400|NCT01001780|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
24610401|NCT01001780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610403|NCT01001845|alpha-Tocopherol|alpha-tocopherol|mesh-list
24455810|NCT00329134|Quinine|quinine|mesh-list
24671801|NCT01327755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671802|NCT01327755|Protective Agents|protective agents|mesh-ancestor
24671803|NCT01327755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671804|NCT01327755|Trace Elements|trace elements|mesh-ancestor
24671805|NCT01327755|Micronutrients|micronutrients|mesh-ancestor
24671806|NCT01327859|Donepezil|donepezil|mesh-list
24672999|NCT01334684|Metformin|metformin|mesh-list
24671842|NCT01328145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24671843|NCT01328145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24671880|NCT01328236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24671881|NCT01328236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24671883|NCT01328236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671884|NCT01328236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671885|NCT01328301|Methamphetamine|methamphetamine|mesh-list
24671886|NCT01328301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24671887|NCT01328301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671888|NCT01328301|Sympathomimetics|sympathomimetics|mesh-ancestor
24671897|NCT01328301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24671898|NCT01328301|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24671899|NCT01328340|Methamphetamine|methamphetamine|mesh-list
24671900|NCT01328340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24671901|NCT01328340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671902|NCT01328340|Sympathomimetics|sympathomimetics|mesh-ancestor
24671903|NCT01328340|Autonomic Agents|autonomic agents|mesh-ancestor
24671904|NCT01328340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24671905|NCT01328340|Dopamine Agents|dopamine agents|mesh-ancestor
25861418|NCT00086489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671917|NCT01328392|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24671918|NCT01328392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671919|NCT01328392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671920|NCT01328457|Paromomycin|paromomycin|mesh-list
24671962|NCT01328821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671963|NCT01328821|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24637450|NCT01150344|Proguanil|proguanil|mesh-list
24673135|NCT01335386|Glycerol|glycerol|mesh-list
24671992|NCT01328990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24671993|NCT01328990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671994|NCT01328990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671995|NCT01328990|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24671996|NCT01328990|Renal Agents|renal agents|mesh-ancestor
24671997|NCT01329016|Metformin|metformin|mesh-list
24671998|NCT01329016|Glyburide|glyburide|mesh-list
24672000|NCT01329016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672001|NCT01329042|Citric Acid|citric acid|mesh-list
24672002|NCT01329042|Sodium Citrate|sodium citrate|mesh-list
25667940|NCT01710033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25667941|NCT01710033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667942|NCT01710046|Tofacitinib|tofacitinib|mesh-list
24672003|NCT01329042|Anticoagulants|anticoagulants|mesh-ancestor
24672004|NCT01329042|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24672005|NCT01329042|Chelating Agents|chelating agents|mesh-ancestor
24672006|NCT01329042|Sequestering Agents|sequestering agents|mesh-ancestor
24637458|NCT01150344|Antimetabolites|antimetabolites|mesh-ancestor
24853875|NCT02270788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853876|NCT02270788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24853877|NCT02270788|Dermatologic Agents|dermatologic agents|mesh-ancestor
24853878|NCT02270788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24853879|NCT02270788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24853880|NCT02270788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24853881|NCT02270788|Immunologic Factors|immunologic factors|mesh-ancestor
24672164|NCT01329887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672165|NCT01329887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672166|NCT01330082|Photosensitizing Agents|photosensitizing agents|mesh-list
24672167|NCT01330082|Dermatologic Agents|dermatologic agents|mesh-ancestor
24672168|NCT01330238|Zoledronic Acid|zoledronic acid|mesh-list
24672169|NCT01330238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24672172|NCT01330472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24672173|NCT01330472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24672174|NCT01330472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272429|NCT02392468|BI 409306|bi 409306|mesh-list
24672175|NCT01330472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24672176|NCT01330472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24672177|NCT01330472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24672178|NCT01330472|GABA Modulators|gaba modulators|mesh-ancestor
24672179|NCT01330472|GABA Agents|gaba agents|mesh-ancestor
24672180|NCT01330472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24672211|NCT01330615|Anesthetics|anesthetics|mesh-ancestor
24672212|NCT01330615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24672213|NCT01330615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672214|NCT01330615|Sensory System Agents|sensory system agents|mesh-ancestor
24672215|NCT01330615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24853911|NCT02270918|Apixaban|apixaban|mesh-list
24853912|NCT02270918|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24853913|NCT02270918|Antithrombins|antithrombins|mesh-ancestor
24853914|NCT02270918|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24853915|NCT02270918|Protease Inhibitors|protease inhibitors|mesh-ancestor
24672307|NCT01331447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672308|NCT01331447|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24672309|NCT01331447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24672310|NCT01331447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672311|NCT01331447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672312|NCT01331447|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24672313|NCT01331447|Hormone Antagonists|hormone antagonists|mesh-ancestor
24672314|NCT01331447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24672315|NCT01331447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672316|NCT01331525|Ipilimumab|ipilimumab|mesh-list
24672317|NCT01331525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24672318|NCT01331525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672319|NCT01331525|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24672320|NCT01331525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672321|NCT01331590|Dexamethasone|dexamethasone|mesh-list
24672322|NCT01331590|Etoposide|etoposide|mesh-list
24672323|NCT01331590|Ifosfamide|ifosfamide|mesh-list
24672344|NCT01331590|Alkylating Agents|alkylating agents|mesh-ancestor
24672345|NCT01331655|Tetrahydrofolates|tetrahydrofolates|mesh-list
24672346|NCT01331655|Drospirenone|drospirenone|mesh-list
24672347|NCT01331655|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24672348|NCT01331655|Hormone Antagonists|hormone antagonists|mesh-ancestor
25067414|NCT03443843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24672436|NCT01332097|Glucocorticoids|glucocorticoids|mesh-ancestor
24672437|NCT01332097|Hormones|hormones|mesh-ancestor
24672438|NCT01332097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24544760|NCT00690105|Autonomic Agents|autonomic agents|mesh-ancestor
24672527|NCT01332422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24672528|NCT01332422|Autonomic Agents|autonomic agents|mesh-ancestor
24672529|NCT01332422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24672530|NCT01332422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199570|NCT02740192|Ropivacaine|ropivacaine|mesh-list
24672615|NCT01332617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24672617|NCT01332617|Analgesics|analgesics|mesh-ancestor
24672618|NCT01332617|Sensory System Agents|sensory system agents|mesh-ancestor
24672619|NCT01332617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24672620|NCT01332617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24673630|NCT01339312|Vaccines|vaccines|mesh-list
24672641|NCT01332747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24672642|NCT01332747|Antimetabolites|antimetabolites|mesh-ancestor
25861419|NCT00086528|XL647|xl647|mesh-list
25861421|NCT00086528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25861422|NCT00086528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861423|NCT00086528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861424|NCT00086541|Interferons|interferons|mesh-list
24672643|NCT01332747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672644|NCT01332747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24672645|NCT01332747|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24672646|NCT01332747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672648|NCT01332786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24672649|NCT01332786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24672667|NCT01333085|Paclitaxel|paclitaxel|mesh-list
24672668|NCT01333085|Carboplatin|carboplatin|mesh-list
24672669|NCT01333085|Everolimus|everolimus|mesh-list
24672670|NCT01333085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24672671|NCT01333085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672672|NCT01333085|Tubulin Modulators|tubulin modulators|mesh-ancestor
24455808|NCT00329095|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24455811|NCT00329134|Antimalarials|antimalarials|mesh-ancestor
24455812|NCT00329134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24672785|NCT01333774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672786|NCT01333774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24672787|NCT01333774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672788|NCT01333800|Ciclesonide|ciclesonide|mesh-list
24672789|NCT01333800|Beclomethasone|beclomethasone|mesh-list
24672790|NCT01333800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24672791|NCT01333800|Glucocorticoids|glucocorticoids|mesh-ancestor
24672793|NCT01333800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24672794|NCT01333800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672795|NCT01333800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24672816|NCT01333891|Nitroprusside|nitroprusside|mesh-list
24672817|NCT01333891|Phenylephrine|phenylephrine|mesh-list
24672840|NCT01333917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24672841|NCT01333917|Analgesics|analgesics|mesh-ancestor
24672842|NCT01333917|Sensory System Agents|sensory system agents|mesh-ancestor
24672843|NCT01333917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24672844|NCT01333917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672845|NCT01333917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24672846|NCT01333917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24672873|NCT01334073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672874|NCT01334073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672875|NCT01334099|Tremelimumab|tremelimumab|mesh-list
24853959|NCT02271204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24853960|NCT02271204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853961|NCT02271282|Toremifene|toremifene|mesh-list
24853962|NCT02271282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24853963|NCT02271282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24853964|NCT02271282|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24853965|NCT02271282|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24853966|NCT02271282|Hormone Antagonists|hormone antagonists|mesh-ancestor
24672876|NCT01334099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672877|NCT01334112|Axitinib|axitinib|mesh-list
24672900|NCT01334268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24672902|NCT01334268|Tubulin Modulators|tubulin modulators|mesh-ancestor
24672903|NCT01334268|Antimitotic Agents|antimitotic agents|mesh-ancestor
24672904|NCT01334268|Mitosis Modulators|mitosis modulators|mesh-ancestor
24672905|NCT01334268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672906|NCT01334333|Tacrolimus|tacrolimus|mesh-list
24672907|NCT01334333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24672908|NCT01334333|Immunologic Factors|immunologic factors|mesh-ancestor
25199571|NCT02740192|Anesthetics, Local|anesthetics, local|mesh-ancestor
25199572|NCT02740192|Anesthetics|anesthetics|mesh-ancestor
24673168|NCT01335685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673183|NCT01336010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673202|NCT01336192|Antimetabolites|antimetabolites|mesh-ancestor
24853985|NCT02271360|Dopamine Agonists|dopamine agonists|mesh-ancestor
24853986|NCT02271360|Dopamine Agents|dopamine agents|mesh-ancestor
24853987|NCT02271360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24853988|NCT02271360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853990|NCT02271360|Coagulants|coagulants|mesh-ancestor
25667943|NCT01710046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25667944|NCT01710046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25667945|NCT01710046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853991|NCT02271399|Aspirin|aspirin|mesh-list
24456720|NCT00332059|Bimatoprost|bimatoprost|mesh-list
24456721|NCT00332059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24456722|NCT00332059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24673203|NCT01336192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673204|NCT01336192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673205|NCT01336192|Antiviral Agents|antiviral agents|mesh-ancestor
24850644|NCT02253849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24673206|NCT01336192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673207|NCT01336192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861425|NCT00086541|Ribavirin|ribavirin|mesh-list
24673231|NCT01336322|Hormones|hormones|mesh-ancestor
24673232|NCT01336322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24673233|NCT01336322|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24673234|NCT01336322|Protease Inhibitors|protease inhibitors|mesh-ancestor
24673235|NCT01336322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673236|NCT01336322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673247|NCT01336439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24673248|NCT01336439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673277|NCT01336582|Mitosis Modulators|mitosis modulators|mesh-ancestor
24673278|NCT01336582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673279|NCT01336595|Cobalt|cobalt|mesh-list
24673280|NCT01336595|Triamcinolone|triamcinolone|mesh-list
24673281|NCT01336595|Trace Elements|trace elements|mesh-ancestor
24674056|NCT01341834|Everolimus|everolimus|mesh-list
24673292|NCT01336660|Antivenins|antivenins|mesh-list
24673293|NCT01336660|Immunologic Factors|immunologic factors|mesh-ancestor
24673294|NCT01336660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673295|NCT01336751|Insulin|insulin|mesh-list
24673296|NCT01336751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24673309|NCT01336829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673311|NCT01336829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673312|NCT01336829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24673313|NCT01336829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24673314|NCT01336842|Pemetrexed|pemetrexed|mesh-list
24673315|NCT01336842|Panobinostat|panobinostat|mesh-list
24673316|NCT01336842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673317|NCT01336842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673318|NCT01336842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673319|NCT01336842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25199573|NCT02740192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25199574|NCT02740192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199575|NCT02740192|Sensory System Agents|sensory system agents|mesh-ancestor
25199576|NCT02740192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25199577|NCT02740166|Propranolol|propranolol|mesh-list
25199578|NCT02740166|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25199579|NCT02740166|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25199580|NCT02740166|Adrenergic Agents|adrenergic agents|mesh-ancestor
25199581|NCT02740166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25123166|NCT03087864|Paclitaxel|paclitaxel|mesh-list
24600270|NCT01529593|Metformin|metformin|mesh-list
24673320|NCT01336842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24673321|NCT01336842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24673322|NCT01336985|Irinotecan|irinotecan|mesh-list
24673323|NCT01336985|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24673324|NCT01336985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24673325|NCT01336985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673326|NCT01336985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673327|NCT01336985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673328|NCT01337219|Tobramycin|tobramycin|mesh-list
24673329|NCT01337219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24673330|NCT01337219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673331|NCT01337258|Dutasteride|dutasteride|mesh-list
24673332|NCT01337258|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24673333|NCT01337258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24673334|NCT01337258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199598|NCT02739880|Immunologic Factors|immunologic factors|mesh-ancestor
24673335|NCT01337258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673336|NCT01337258|Hormone Antagonists|hormone antagonists|mesh-ancestor
24673337|NCT01337258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24673338|NCT01337258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673339|NCT01337323|Fluticasone|fluticasone|mesh-list
24673341|NCT01337323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24673342|NCT01337323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24673343|NCT01337323|Autonomic Agents|autonomic agents|mesh-ancestor
25428411|NCT01722708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24830938|NCT02162134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24830939|NCT02162134|GABA Modulators|gaba modulators|mesh-ancestor
24830940|NCT02162134|GABA Agents|gaba agents|mesh-ancestor
24830941|NCT02162134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24673344|NCT01337323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24673345|NCT01337323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673346|NCT01337323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24673347|NCT01337323|Respiratory System Agents|respiratory system agents|mesh-ancestor
24447376|NCT00308334|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24610503|NCT01002703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24544896|NCT00690872|Antiviral Agents|antiviral agents|mesh-ancestor
24853993|NCT02271399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24853994|NCT02271399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24853995|NCT02271399|Analgesics|analgesics|mesh-ancestor
24853996|NCT02271399|Sensory System Agents|sensory system agents|mesh-ancestor
24853997|NCT02271399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24853998|NCT02271399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853999|NCT02271399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24854000|NCT02271399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25861426|NCT00086541|Interferon alfacon-1|interferon alfacon-1|mesh-list
24673402|NCT01337557|Bepotastine besilate|bepotastine besilate|mesh-list
24673403|NCT01337557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24673404|NCT01337570|Dapivirine|dapivirine|mesh-list
24673405|NCT01337570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24673406|NCT01337570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24673407|NCT01337570|Antiviral Agents|antiviral agents|mesh-ancestor
24673439|NCT01338090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673440|NCT01338090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24673441|NCT01338090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24673442|NCT01338090|Growth Substances|growth substances|mesh-ancestor
24673443|NCT01338090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673444|NCT01338090|Growth Inhibitors|growth inhibitors|mesh-ancestor
24673445|NCT01338090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24673446|NCT01338090|Immunologic Factors|immunologic factors|mesh-ancestor
24673447|NCT01338090|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24673448|NCT01338090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673449|NCT01338103|Rituximab|rituximab|mesh-list
24673450|NCT01338103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24673451|NCT01338103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673452|NCT01338103|Immunologic Factors|immunologic factors|mesh-ancestor
24673453|NCT01338103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673454|NCT01338103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24673455|NCT01338116|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24673456|NCT01338116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673457|NCT01338129|Ascorbic Acid|ascorbic acid|mesh-list
24673458|NCT01338129|Vitamins|vitamins|mesh-ancestor
24673459|NCT01338129|Micronutrients|micronutrients|mesh-ancestor
24673460|NCT01338129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673461|NCT01338129|Antioxidants|antioxidants|mesh-ancestor
24673462|NCT01338129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673463|NCT01338129|Protective Agents|protective agents|mesh-ancestor
24673464|NCT01338311|Albuterol|albuterol|mesh-list
24673465|NCT01338311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24673466|NCT01338311|Autonomic Agents|autonomic agents|mesh-ancestor
25207662|NCT03529123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861427|NCT00086541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673559|NCT01338896|Dopamine Agonists|dopamine agonists|mesh-ancestor
24673560|NCT01338896|Dopamine Agents|dopamine agents|mesh-ancestor
24673696|NCT01339663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24673697|NCT01339663|Analgesics|analgesics|mesh-ancestor
24673713|NCT01339741|Vitamins|vitamins|mesh-ancestor
24673714|NCT01339741|Micronutrients|micronutrients|mesh-ancestor
24673715|NCT01339741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673716|NCT01339741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24457811|NCT00335270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24673841|NCT01340599|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24673842|NCT01340599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673843|NCT01340599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24673844|NCT01340677|Canagliflozin|canagliflozin|mesh-list
24673845|NCT01340677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24673898|NCT01340950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24673921|NCT01341184|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25667946|NCT01710137|Varenicline|varenicline|mesh-list
25667947|NCT01710137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25667948|NCT01710137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25667949|NCT01710137|Cholinergic Agents|cholinergic agents|mesh-ancestor
24673922|NCT01341184|Antitubercular Agents|antitubercular agents|mesh-ancestor
24673986|NCT01341353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24673987|NCT01341353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854019|NCT02271412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854020|NCT02271412|Antidepressive Agents|antidepressive agents|mesh-ancestor
24854021|NCT02271412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24854023|NCT02271438|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24854024|NCT02271438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24854025|NCT02271438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24456748|NCT00332124|Choline|choline|mesh-list
24673988|NCT01341353|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24673989|NCT01341353|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24673990|NCT01341353|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24673991|NCT01341392|Amlodipine|amlodipine|mesh-list
24673992|NCT01341392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24673993|NCT01341392|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24673994|NCT01341392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24673995|NCT01341392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861428|NCT00086541|Antiviral Agents|antiviral agents|mesh-ancestor
24674009|NCT01341405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24637698|NCT01152723|Nicotine|nicotine|mesh-list
24674038|NCT01341717|Hormones|hormones|mesh-ancestor
24674039|NCT01341717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24674040|NCT01341717|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24674041|NCT01341717|Protease Inhibitors|protease inhibitors|mesh-ancestor
24674042|NCT01341717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674043|NCT01341717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674045|NCT01341717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24674134|NCT01342198|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24674135|NCT01342198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24674136|NCT01342198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674137|NCT01342198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24674138|NCT01342198|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24674139|NCT01342198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24674140|NCT01342198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24854034|NCT02271438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854035|NCT02271438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24854036|NCT02271438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24674141|NCT01342198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24674142|NCT01342198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24674143|NCT01342198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24674144|NCT01342198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24674145|NCT01342198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24674146|NCT01342198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674147|NCT01342224|Gemcitabine|gemcitabine|mesh-list
24674148|NCT01342224|Tadalafil|tadalafil|mesh-list
24674149|NCT01342224|Sargramostim|sargramostim|mesh-list
24674150|NCT01342224|Immunologic Factors|immunologic factors|mesh-ancestor
24674151|NCT01342224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674152|NCT01342224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24674153|NCT01342224|Antimetabolites|antimetabolites|mesh-ancestor
24458200|NCT00336960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24674251|NCT01342692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24674252|NCT01342692|Growth Substances|growth substances|mesh-ancestor
24674253|NCT01342692|Growth Inhibitors|growth inhibitors|mesh-ancestor
24854037|NCT02271438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24854038|NCT02271464|Cyclophosphamide|cyclophosphamide|mesh-list
24674254|NCT01342692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24674255|NCT01342692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24674256|NCT01342692|Antimetabolites|antimetabolites|mesh-ancestor
24674257|NCT01342692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674258|NCT01342692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674259|NCT01342692|Anticonvulsants|anticonvulsants|mesh-ancestor
24546169|NCT00697021|Analgesics|analgesics|mesh-ancestor
24674261|NCT01342692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24674262|NCT01342692|Antimanic Agents|antimanic agents|mesh-ancestor
24674263|NCT01342692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24674265|NCT01342692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24674284|NCT01342835|Anesthetics|anesthetics|mesh-ancestor
25861429|NCT00086541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24610512|NCT01002768|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24610513|NCT01002768|Insulin Glargine|insulin glargine|mesh-list
24610514|NCT01002768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24610515|NCT01002768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610516|NCT01002807|Metformin|metformin|mesh-list
24610517|NCT01002807|Dapagliflozin|dapagliflozin|mesh-list
24610518|NCT01002807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24610519|NCT01002807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858109|NCT02295189|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24674427|NCT05226442|Anticoagulants|anticoagulants|mesh-ancestor
24674428|NCT05226442|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24674429|NCT05226442|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24674430|NCT05226442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674431|NCT05226442|Antithrombins|antithrombins|mesh-ancestor
24674432|NCT05226442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24674433|NCT05226442|Protease Inhibitors|protease inhibitors|mesh-ancestor
24674434|NCT05226442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674435|NCT05226442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24674436|NCT05220319|Methylprednisolone|methylprednisolone|mesh-list
24674437|NCT05220319|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24854059|NCT02271542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24854060|NCT02271542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854061|NCT02271542|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24854062|NCT02271542|Anesthetics, General|anesthetics, general|mesh-ancestor
24854063|NCT02271542|Anesthetics|anesthetics|mesh-ancestor
24854064|NCT02271555|Remifentanil|remifentanil|mesh-list
24456775|NCT00332228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24547103|NCT00702442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24547104|NCT00702442|Antiemetics|antiemetics|mesh-ancestor
24674530|NCT05124691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24674531|NCT05124691|Tubulin Modulators|tubulin modulators|mesh-ancestor
24674532|NCT05124691|Antimitotic Agents|antimitotic agents|mesh-ancestor
24674533|NCT05124691|Mitosis Modulators|mitosis modulators|mesh-ancestor
24674612|NCT05027919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24674613|NCT05027919|Narcotics|narcotics|mesh-ancestor
25199582|NCT02740166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199583|NCT02740166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199584|NCT02740166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25199585|NCT02740166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25199586|NCT02740166|Vasodilator Agents|vasodilator agents|mesh-ancestor
24610602|NCT01003613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24610603|NCT01003613|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24610605|NCT01003613|Coagulants|coagulants|mesh-ancestor
24637728|NCT01152801|Everolimus|everolimus|mesh-list
24674667|NCT04920331|Erenumab|erenumab|mesh-list
24674668|NCT04920331|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
24674669|NCT04920331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674670|NCT04920331|Analgesics|analgesics|mesh-ancestor
24674671|NCT04920331|Sensory System Agents|sensory system agents|mesh-ancestor
25199588|NCT02739958|Isoflurane|isoflurane|mesh-list
25199589|NCT02739958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25199590|NCT02739958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25199591|NCT02739958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199592|NCT02739958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25199593|NCT02739958|Anesthetics, General|anesthetics, general|mesh-ancestor
25199594|NCT02739958|Anesthetics|anesthetics|mesh-ancestor
25199595|NCT02739958|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25199596|NCT02739880|Hyaluronic Acid|hyaluronic acid|mesh-list
25199597|NCT02739880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25199602|NCT02739906|Insulin|insulin|mesh-list
25199603|NCT02739906|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25199604|NCT02739906|Insulin Lispro|insulin lispro|mesh-list
25199605|NCT02739906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25199606|NCT02739906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199607|NCT02739815|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25199608|NCT02739815|Tranexamic Acid|tranexamic acid|mesh-list
25199609|NCT02739815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25199610|NCT02739815|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25199611|NCT02739815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25199612|NCT02739815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199613|NCT02739815|Hemostatics|hemostatics|mesh-ancestor
25199614|NCT02739815|Coagulants|coagulants|mesh-ancestor
25199616|NCT02739711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24674693|NCT04761848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24674694|NCT04761848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24674695|NCT04761848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674696|NCT04761848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24674697|NCT04761848|Vasodilator Agents|vasodilator agents|mesh-ancestor
24674698|NCT04761848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24674699|NCT04761848|Protective Agents|protective agents|mesh-ancestor
24674700|NCT04761848|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24674701|NCT04761848|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24458867|NCT00342849|Succimer|succimer|mesh-list
24674702|NCT04761848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674703|NCT04757571|Paroxetine|paroxetine|mesh-list
24674734|NCT04721132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24674736|NCT04721132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674737|NCT04721132|Growth Inhibitors|growth inhibitors|mesh-ancestor
24674738|NCT04721132|Immunologic Factors|immunologic factors|mesh-ancestor
24674739|NCT04705883|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24674740|NCT04705883|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24674741|NCT04705883|Immunologic Factors|immunologic factors|mesh-ancestor
24674742|NCT04705883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674743|NCT04693689|Vaccines|vaccines|mesh-list
24674827|NCT04346394|Autonomic Agents|autonomic agents|mesh-ancestor
24674828|NCT04346394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24674829|NCT04346394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674859|NCT04216134|Edetic Acid|edetic acid|mesh-list
24674860|NCT04216134|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
24674861|NCT04216134|Chelating Agents|chelating agents|mesh-ancestor
24674981|NCT03685188|Narcotics|narcotics|mesh-ancestor
24674982|NCT03685188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24674983|NCT03685188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674984|NCT03685188|Analgesics|analgesics|mesh-ancestor
24674985|NCT03685188|Sensory System Agents|sensory system agents|mesh-ancestor
24674986|NCT03685188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24545247|NCT00692614|Triamcinolone|triamcinolone|mesh-list
24675044|NCT03526432|Atezolizumab|atezolizumab|mesh-list
24675045|NCT03526432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24675046|NCT03526432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24675047|NCT03526432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24675048|NCT03526432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24675049|NCT03526432|Growth Substances|growth substances|mesh-ancestor
25861430|NCT00086541|Antimetabolites|antimetabolites|mesh-ancestor
24675070|NCT03363035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675072|NCT03363035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24675073|NCT03363035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24675136|NCT03004131|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24675137|NCT03004131|Autonomic Agents|autonomic agents|mesh-ancestor
24675257|NCT02225405|Cisplatin|cisplatin|mesh-list
24675155|NCT02959944|Glucocorticoids|glucocorticoids|mesh-ancestor
24675249|NCT02456012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675250|NCT02456012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675251|NCT02250157|Irinotecan|irinotecan|mesh-list
24675252|NCT02250157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24675253|NCT02250157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24675254|NCT02250157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678930|NCT01365117|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24675271|NCT01547117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24675272|NCT01547117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675273|NCT01431508|Losartan|losartan|mesh-list
24675305|NCT00739050|Simvastatin|simvastatin|mesh-list
24610657|NCT01004419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24610658|NCT01004419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610659|NCT01004419|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24610660|NCT01004419|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24858221|NCT02295826|Antipyretics|antipyretics|mesh-ancestor
24675337|NCT00536380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675338|NCT00536380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675339|NCT00536380|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24675341|NCT00536380|Histamine Antagonists|histamine antagonists|mesh-ancestor
24675344|NCT00536380|Dermatologic Agents|dermatologic agents|mesh-ancestor
24675345|NCT00536380|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24675435|NCT00101972|Immunologic Factors|immunologic factors|mesh-ancestor
24675436|NCT00101972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675437|NCT01343173|Imatinib Mesylate|imatinib mesylate|mesh-list
24675439|NCT01343173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24675440|NCT01343173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675441|NCT01343173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675442|NCT01343186|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24675443|NCT01343186|Interferon-alpha|interferon-alpha|mesh-list
24675472|NCT01343303|Naproxen|naproxen|mesh-list
24675484|NCT01343303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675485|NCT01343329|Propranolol|propranolol|mesh-list
24675486|NCT01343329|Esmolol|esmolol|mesh-list
24675487|NCT01343329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24675488|NCT01343329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24675489|NCT01343329|Adrenergic Agents|adrenergic agents|mesh-ancestor
24675490|NCT01343329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24675491|NCT01343329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675492|NCT01343329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675493|NCT01343329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24675494|NCT01343329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24675771|NCT01344954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675772|NCT01344967|Zoledronic Acid|zoledronic acid|mesh-list
24675773|NCT01344967|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24675774|NCT01344967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067415|NCT03443843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24676130|NCT01348308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854125|NCT02271997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854126|NCT02271997|Hematinics|hematinics|mesh-ancestor
24676199|NCT01349088|Capecitabine|capecitabine|mesh-list
24676200|NCT01349088|Motesanib diphosphate|motesanib diphosphate|mesh-list
24676201|NCT01349088|Imetelstat|imetelstat|mesh-list
24675985|NCT01347294|Bleomycin|bleomycin|mesh-list
24676218|NCT01349127|Micronutrients|micronutrients|mesh-ancestor
24676368|NCT01349764|Cholecalciferol|cholecalciferol|mesh-list
24676369|NCT01349764|Vitamins|vitamins|mesh-ancestor
24676370|NCT01349764|Micronutrients|micronutrients|mesh-ancestor
24858324|NCT02296333|Antipruritics|antipruritics|mesh-ancestor
24676465|NCT01350323|Growth Inhibitors|growth inhibitors|mesh-ancestor
24676466|NCT01350570|Loperamide|loperamide|mesh-list
24676467|NCT01350570|Antidiarrheals|antidiarrheals|mesh-list
24676468|NCT01350570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24676469|NCT01350596|Ibuprofen|ibuprofen|mesh-list
24676470|NCT01350596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24676471|NCT01350596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24676472|NCT01350596|Analgesics|analgesics|mesh-ancestor
24676489|NCT01350609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24676490|NCT01350609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24676491|NCT01350609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676492|NCT01350609|Vasodilator Agents|vasodilator agents|mesh-ancestor
24676494|NCT01350609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24676496|NCT01350622|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
24676497|NCT01350622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24610838|NCT01005433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24610839|NCT01005433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24610840|NCT01005433|Adrenergic Agents|adrenergic agents|mesh-ancestor
24610841|NCT01005433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24610842|NCT01005433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610843|NCT01005472|Temozolomide|temozolomide|mesh-list
24610844|NCT01005472|Sunitinib|sunitinib|mesh-list
24610845|NCT01005472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24610846|NCT01005472|Alkylating Agents|alkylating agents|mesh-ancestor
24610847|NCT01005472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199617|NCT02739711|Immunologic Factors|immunologic factors|mesh-ancestor
25123606|NCT03083210|Lanreotide|lanreotide|mesh-list
24610848|NCT01005472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610849|NCT01005472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25067416|NCT03443843|Autonomic Agents|autonomic agents|mesh-ancestor
24676626|NCT01351493|Autonomic Agents|autonomic agents|mesh-ancestor
24676627|NCT01351493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24676628|NCT01351493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676629|NCT01351493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24676630|NCT01351493|Respiratory System Agents|respiratory system agents|mesh-ancestor
24676631|NCT01351493|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24676632|NCT01351493|Antioxidants|antioxidants|mesh-ancestor
24676874|NCT01352650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24676876|NCT01352663|Insulin Glargine|insulin glargine|mesh-list
24676940|NCT01353378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25861431|NCT00086541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067417|NCT03443843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24854184|NCT02272517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24456886|NCT00332553|Medroxyprogesterone|medroxyprogesterone|mesh-list
24677090|NCT01354301|Antitubercular Agents|antitubercular agents|mesh-ancestor
24677091|NCT01354301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24677227|NCT01354886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677229|NCT01354925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24677230|NCT01354925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677231|NCT01355120|Ipilimumab|ipilimumab|mesh-list
24676690|NCT01352130|Antiemetics|antiemetics|mesh-ancestor
25861432|NCT00086593|Lamotrigine|lamotrigine|mesh-list
25861433|NCT00086593|Anticonvulsants|anticonvulsants|mesh-ancestor
25861434|NCT00086593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24677287|NCT01355445|Vincristine|vincristine|mesh-list
24677288|NCT01355445|Temozolomide|temozolomide|mesh-list
24677289|NCT01355445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24677290|NCT01355445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24677291|NCT01355445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24677292|NCT01355445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677293|NCT01355445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24677321|NCT01355939|Dermatologic Agents|dermatologic agents|mesh-ancestor
24677322|NCT01355939|Sunscreening Agents|sunscreening agents|mesh-ancestor
24677323|NCT01355939|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24677324|NCT01355939|Protective Agents|protective agents|mesh-ancestor
24677325|NCT01355939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677326|NCT01355952|Thioctic Acid|thioctic acid|mesh-list
24677328|NCT01355952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677329|NCT01355952|Protective Agents|protective agents|mesh-ancestor
24677330|NCT01355952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677331|NCT01355952|Vitamin B Complex|vitamin b complex|mesh-ancestor
24677333|NCT01355952|Micronutrients|micronutrients|mesh-ancestor
24677334|NCT01355991|Tiotropium Bromide|tiotropium bromide|mesh-list
24677335|NCT01355991|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24677336|NCT01355991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24677337|NCT01355991|Autonomic Agents|autonomic agents|mesh-ancestor
24677338|NCT01355991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24677339|NCT01355991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677340|NCT01355991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24677341|NCT01355991|Respiratory System Agents|respiratory system agents|mesh-ancestor
24858484|NCT02297945|Metyrapone|metyrapone|mesh-list
24854212|NCT02272647|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24854213|NCT02272647|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24854214|NCT02272647|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24677417|NCT01356225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24677419|NCT01356225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24677420|NCT01356225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24677421|NCT01356225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677422|NCT01356303|Docetaxel|docetaxel|mesh-list
24677423|NCT01356303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24677424|NCT01356303|Tubulin Modulators|tubulin modulators|mesh-ancestor
24677425|NCT01356303|Antimitotic Agents|antimitotic agents|mesh-ancestor
24677426|NCT01356303|Mitosis Modulators|mitosis modulators|mesh-ancestor
24829850|NCT02154932|Misoprostol|misoprostol|mesh-list
24545730|NCT00694694|Artemether|artemether|mesh-list
24677484|NCT01356524|Progestins|progestins|mesh-ancestor
24677486|NCT01356524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24677487|NCT01356524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677488|NCT01356615|Heparin|heparin|mesh-list
25207663|NCT03514732|Melatonin|melatonin|mesh-list
24677490|NCT01356615|Enoxaparin|enoxaparin|mesh-list
24677491|NCT01356615|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24677492|NCT01356615|Tinzaparin|tinzaparin|mesh-list
24677493|NCT01356615|Dalteparin|dalteparin|mesh-list
24677494|NCT01356615|Enoxaparin sodium|enoxaparin sodium|mesh-list
24677495|NCT01356615|Anticoagulants|anticoagulants|mesh-ancestor
24677496|NCT01356615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24677553|NCT01356745|Sensory System Agents|sensory system agents|mesh-ancestor
24677554|NCT01356745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24677555|NCT01356758|Adalimumab|adalimumab|mesh-list
24677556|NCT01356758|Etanercept|etanercept|mesh-list
24677557|NCT01356758|Infliximab|infliximab|mesh-list
24677558|NCT01356758|Ustekinumab|ustekinumab|mesh-list
24677583|NCT01356797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24677584|NCT01356797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24677585|NCT01356797|Anesthetics, General|anesthetics, general|mesh-ancestor
24677586|NCT01356862|Pasireotide|pasireotide|mesh-list
24677588|NCT01356862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24677590|NCT01356927|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24677591|NCT01356927|Etonogestrel|etonogestrel|mesh-list
24677592|NCT01356927|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24677638|NCT01357317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24677639|NCT01357317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677640|NCT01357317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24677641|NCT01357317|Chelating Agents|chelating agents|mesh-ancestor
24854231|NCT02272699|Nimotuzumab|nimotuzumab|mesh-list
24854232|NCT02272699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24854233|NCT02272699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24854234|NCT02272699|Tubulin Modulators|tubulin modulators|mesh-ancestor
24854235|NCT02272699|Antimitotic Agents|antimitotic agents|mesh-ancestor
24854236|NCT02272699|Mitosis Modulators|mitosis modulators|mesh-ancestor
24854237|NCT02272699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456915|NCT00332631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24467965|NCT00379405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677653|NCT01357486|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24677654|NCT01357486|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24462066|NCT00354809|Casopitant|casopitant|mesh-list
24677680|NCT01357798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677685|NCT01357811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24677686|NCT01357811|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24677687|NCT01357811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24677688|NCT01357811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677689|NCT01357811|Protective Agents|protective agents|mesh-ancestor
24677690|NCT01357811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610897|NCT01005758|Hydrocortisone|hydrocortisone|mesh-list
24677792|NCT01358253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24677794|NCT01358253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24677795|NCT01358253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24677796|NCT01358253|Tubulin Modulators|tubulin modulators|mesh-ancestor
24677893|NCT01359059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677942|NCT01359163|Contraceptive Agents|contraceptive agents|mesh-ancestor
24678009|NCT01359514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24678011|NCT01359514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24678012|NCT01359514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678013|NCT01359514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24678014|NCT01359514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24678147|NCT01360034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24543116|NCT00681980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24543118|NCT00681980|Antimanic Agents|antimanic agents|mesh-ancestor
24678148|NCT01360034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24678149|NCT01360034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678150|NCT01360034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24678151|NCT01360034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678153|NCT01360034|Tocolytic Agents|tocolytic agents|mesh-ancestor
24678154|NCT01360034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25199618|NCT02739711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678190|NCT01360086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24678191|NCT01360086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24678192|NCT01360086|Immunologic Factors|immunologic factors|mesh-ancestor
24678193|NCT01360086|Antidotes|antidotes|mesh-ancestor
24678194|NCT01360086|Protective Agents|protective agents|mesh-ancestor
24678195|NCT01360086|Vitamin B Complex|vitamin b complex|mesh-ancestor
24678196|NCT01360086|Vitamins|vitamins|mesh-ancestor
24678197|NCT01360086|Micronutrients|micronutrients|mesh-ancestor
24678198|NCT01360086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24854266|NCT02272764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24854267|NCT02272764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854268|NCT02272764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24854269|NCT02272829|Analgesics, Opioid|analgesics, opioid|mesh-list
24854270|NCT02272829|Narcotics|narcotics|mesh-ancestor
24610902|NCT01005758|Doxorubicin|doxorubicin|mesh-list
24610903|NCT01005758|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24610904|NCT01005758|Methotrexate|methotrexate|mesh-list
24610919|NCT01005758|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25428491|NCT01711541|Mitosis Modulators|mitosis modulators|mesh-ancestor
24610922|NCT01005758|Autonomic Agents|autonomic agents|mesh-ancestor
24678256|NCT01360476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678257|NCT01360476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24678258|NCT01360476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24678259|NCT01360658|Immunoglobulins|immunoglobulins|mesh-list
24678260|NCT01360658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24678261|NCT01360658|Antibodies|antibodies|mesh-list
24678262|NCT01360658|gamma-Globulins|gamma-globulins|mesh-list
24678263|NCT01360658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24678264|NCT01360658|Immunologic Factors|immunologic factors|mesh-ancestor
24678265|NCT01360658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678266|NCT01360671|Sildenafil Citrate|sildenafil citrate|mesh-list
24678267|NCT01360671|Vasodilator Agents|vasodilator agents|mesh-ancestor
24678268|NCT01360671|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24678269|NCT01360671|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24678270|NCT01360671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678271|NCT01360671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678272|NCT01360671|Urological Agents|urological agents|mesh-ancestor
24678273|NCT01360710|Irbesartan|irbesartan|mesh-list
24678274|NCT01360710|Moxonidine|moxonidine|mesh-list
24678275|NCT01360710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24678276|NCT01360710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24678277|NCT01360710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24678278|NCT01360710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638146|NCT01155037|Vaccines|vaccines|mesh-list
24678280|NCT01360749|Anesthetics, Local|anesthetics, local|mesh-ancestor
24678282|NCT01360749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24678283|NCT01360749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678284|NCT01360749|Sensory System Agents|sensory system agents|mesh-ancestor
24678285|NCT01360749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24678286|NCT01360749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24678287|NCT01360749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24678323|NCT01361022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199619|NCT02739711|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25199620|NCT02739711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199621|NCT02739711|Antiviral Agents|antiviral agents|mesh-ancestor
25199622|NCT02739711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25199623|NCT02739711|Interferon Inducers|interferon inducers|mesh-ancestor
25199624|NCT02739711|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25199625|NCT02739711|Protective Agents|protective agents|mesh-ancestor
25199626|NCT02739672|Amlodipine|amlodipine|mesh-list
25199627|NCT02739672|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24678324|NCT01361269|Clindamycin|clindamycin|mesh-list
24678325|NCT01361269|Clindamycin palmitate|clindamycin palmitate|mesh-list
24678326|NCT01361269|Clindamycin phosphate|clindamycin phosphate|mesh-list
24678327|NCT01361269|Fosmidomycin|fosmidomycin|mesh-list
24678398|NCT01361763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678399|NCT01361763|Anticoagulants|anticoagulants|mesh-ancestor
24678432|NCT01361841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24678433|NCT01361984|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24678434|NCT01361984|Formoterol Fumarate|formoterol fumarate|mesh-list
24678435|NCT01361984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24678436|NCT01361984|Autonomic Agents|autonomic agents|mesh-ancestor
24678437|NCT01361984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24678438|NCT01361984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678439|NCT01361984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24678440|NCT01361984|Respiratory System Agents|respiratory system agents|mesh-ancestor
24678441|NCT01361984|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24678442|NCT01361984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24678443|NCT01361984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24678579|NCT01363089|Autonomic Agents|autonomic agents|mesh-ancestor
24678580|NCT01363089|Nasal Decongestants|nasal decongestants|mesh-ancestor
24678581|NCT01363089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24678582|NCT01363089|Respiratory System Agents|respiratory system agents|mesh-ancestor
24678583|NCT01363089|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24678584|NCT01363089|Mydriatics|mydriatics|mesh-ancestor
24678585|NCT01363089|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24678586|NCT01363089|Protective Agents|protective agents|mesh-ancestor
24678587|NCT01363115|Vitamin D|vitamin d|mesh-list
24638182|NCT01155115|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24678613|NCT01363206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678615|NCT01363206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678617|NCT01363271|Linezolid|linezolid|mesh-list
24678620|NCT01363271|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24678622|NCT01363271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678623|NCT01363284|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24611020|NCT01006395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611021|NCT01006499|Pentoxifylline|pentoxifylline|mesh-list
24611022|NCT01006499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24678638|NCT01363310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24678744|NCT01363817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24678787|NCT01364220|Antimetabolites|antimetabolites|mesh-ancestor
24678788|NCT01364220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678789|NCT01364220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24678790|NCT01364220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24678791|NCT01364220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678792|NCT01364324|Antitubercular Agents|antitubercular agents|mesh-list
24678793|NCT01364324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24678794|NCT01364324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24678796|NCT01364376|Oxaliplatin|oxaliplatin|mesh-list
24678797|NCT01364376|Calcium|calcium|mesh-list
24678798|NCT01364376|Levoleucovorin|levoleucovorin|mesh-list
24678799|NCT01364376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24678859|NCT01364701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24678860|NCT01364701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24678861|NCT01364701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678862|NCT01364701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678863|NCT01364701|Urological Agents|urological agents|mesh-ancestor
24678864|NCT01364792|Valacyclovir|valacyclovir|mesh-list
24678865|NCT01364792|Antiviral Agents|antiviral agents|mesh-ancestor
24678866|NCT01364792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24678867|NCT01364805|Ascorbic Acid|ascorbic acid|mesh-list
24678868|NCT01364805|Gemcitabine|gemcitabine|mesh-list
24678869|NCT01364805|Vitamins|vitamins|mesh-ancestor
24678931|NCT01365117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24678932|NCT01365117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678933|NCT01365221|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24679044|NCT01366235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24679045|NCT01366235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24679047|NCT01366235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25199628|NCT02739672|Telmisartan|telmisartan|mesh-list
25123904|NCT03080740|Metronidazole|metronidazole|mesh-list
24679048|NCT01366235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24679049|NCT01366235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24679050|NCT01366235|Analgesics|analgesics|mesh-ancestor
24679119|NCT01366547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24679120|NCT01366547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24679121|NCT01366547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24679122|NCT01366547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678126|NCT01359930|Naltrexone|naltrexone|mesh-list
24679151|NCT01367210|Darunavir|darunavir|mesh-list
24679152|NCT01367210|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24679153|NCT01367210|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24679154|NCT01367210|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24679155|NCT01367210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679156|NCT01367210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24679157|NCT01367210|Antiviral Agents|antiviral agents|mesh-ancestor
24679158|NCT01367210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24679159|NCT01367210|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25861435|NCT00086593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24679222|NCT01367522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679225|NCT01367535|Paroxetine|paroxetine|mesh-list
24679226|NCT01367535|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24679227|NCT01367535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24679228|NCT01367535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24679229|NCT01367535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679230|NCT01367535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24679246|NCT01367548|Sensory System Agents|sensory system agents|mesh-ancestor
24679247|NCT01367548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679249|NCT01367561|Methylnaltrexone|methylnaltrexone|mesh-list
24678167|NCT01360060|Sensory System Agents|sensory system agents|mesh-ancestor
24679315|NCT01367756|Citalopram|citalopram|mesh-list
24679316|NCT01367756|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24679317|NCT01367756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24679318|NCT01367756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24679319|NCT01367756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863369|NCT05145543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863399|NCT05145270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24863400|NCT05145270|Cholinergic Agents|cholinergic agents|mesh-ancestor
24863401|NCT05145270|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24679320|NCT01367756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24679401|NCT01368328|Trace Elements|trace elements|mesh-ancestor
24812633|NCT02053818|Analgesics|analgesics|mesh-ancestor
24812634|NCT02053818|Sensory System Agents|sensory system agents|mesh-ancestor
24812635|NCT02053818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24854313|NCT02273128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854314|NCT02273128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24854349|NCT02273440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24854350|NCT02273440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854351|NCT02273440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854352|NCT02273440|Vasodilator Agents|vasodilator agents|mesh-ancestor
24854353|NCT02273440|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24854354|NCT02273440|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24854355|NCT02273440|Purinergic Agents|purinergic agents|mesh-ancestor
24854356|NCT02273440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24679475|NCT01368783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24679476|NCT01368783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24920677|NCT04199364|Poractant alfa|poractant alfa|mesh-list
24679587|NCT01369290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679588|NCT01369290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24679589|NCT01369290|Antidepressive Agents|antidepressive agents|mesh-ancestor
24679590|NCT01369290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24679591|NCT01369290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679592|NCT01369290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24679593|NCT01369290|Dopamine Agents|dopamine agents|mesh-ancestor
24679594|NCT01369290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24679595|NCT01369290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24679642|NCT01369576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24679643|NCT01369576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679644|NCT01369602|Nicotinic Acids|nicotinic acids|mesh-list
24679645|NCT01369602|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
24679646|NCT01369602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24679647|NCT01369602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199629|NCT02739672|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
24679648|NCT01369602|Vitamin B Complex|vitamin b complex|mesh-ancestor
24679650|NCT01369602|Micronutrients|micronutrients|mesh-ancestor
24679651|NCT01369602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679694|NCT01370096|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24679695|NCT01370096|Natriuretic Agents|natriuretic agents|mesh-ancestor
24679696|NCT01370096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679697|NCT01370096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24679698|NCT01370096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24679699|NCT01370096|Vasodilator Agents|vasodilator agents|mesh-ancestor
24679701|NCT01370135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24679737|NCT01370291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24679738|NCT01370291|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24679739|NCT01370291|Dopamine Agents|dopamine agents|mesh-ancestor
24679740|NCT01370304|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24679741|NCT01370304|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24863402|NCT05145270|Protective Agents|protective agents|mesh-ancestor
24863481|NCT04834362|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24863482|NCT04834362|Insulin Glargine|insulin glargine|mesh-list
24679742|NCT01370304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24679754|NCT01370343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24679755|NCT01370343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679756|NCT01370343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24679757|NCT01370343|Immunologic Factors|immunologic factors|mesh-ancestor
24679758|NCT01370343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679759|NCT01370343|Antifungal Agents|antifungal agents|mesh-ancestor
25216141|NCT02686047|Hyaluronic Acid|hyaluronic acid|mesh-list
25216143|NCT02686047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25216144|NCT02686047|Immunologic Factors|immunologic factors|mesh-ancestor
25216145|NCT02686047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216146|NCT02686047|Viscosupplements|viscosupplements|mesh-ancestor
25216147|NCT02686047|Protective Agents|protective agents|mesh-ancestor
25216148|NCT02685852|Exenatide|exenatide|mesh-list
25216149|NCT02685852|Acarbose|acarbose|mesh-list
25216150|NCT02685852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25216151|NCT02685852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216152|NCT02685852|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25216153|NCT02685852|Incretins|incretins|mesh-ancestor
24679760|NCT01370343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24679761|NCT01370343|Dermatologic Agents|dermatologic agents|mesh-ancestor
24679762|NCT01370343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24679763|NCT01370343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24679764|NCT01370343|Vitamin B Complex|vitamin b complex|mesh-ancestor
24854409|NCT02273505|Vasodilator Agents|vasodilator agents|mesh-ancestor
24854410|NCT02273518|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
24854411|NCT02273518|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24858843|NCT02299765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24679797|NCT01370772|Immunologic Factors|immunologic factors|mesh-ancestor
24679798|NCT01370772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679799|NCT01370772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24679800|NCT01370772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24679801|NCT01370772|Alkylating Agents|alkylating agents|mesh-ancestor
24679802|NCT01370772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679803|NCT01370772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24679821|NCT01370915|Sensory System Agents|sensory system agents|mesh-ancestor
24679832|NCT01371058|Clopidogrel|clopidogrel|mesh-list
24854427|NCT02273583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24854428|NCT02273583|Immunologic Factors|immunologic factors|mesh-ancestor
24676055|NCT01347983|Methotrexate|methotrexate|mesh-list
24854429|NCT02273583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854430|NCT02273583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24854431|NCT02273583|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24854432|NCT02273583|Alkylating Agents|alkylating agents|mesh-ancestor
24854433|NCT02273583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854434|NCT02273583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24854435|NCT02273583|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24854453|NCT02273609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24854454|NCT02273609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854456|NCT02273609|Coagulants|coagulants|mesh-ancestor
24679901|NCT01371461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24679902|NCT01371461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813190|NCT02056847|Calcium|calcium|mesh-list
24679961|NCT01372007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24679963|NCT01372111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24679964|NCT01372280|Galantamine|galantamine|mesh-list
24680024|NCT01372644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680055|NCT01372865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24680056|NCT01372865|Dermatologic Agents|dermatologic agents|mesh-ancestor
24680057|NCT01372865|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24680058|NCT01372904|Dexamethasone|dexamethasone|mesh-list
24680059|NCT01372904|Dexamethasone acetate|dexamethasone acetate|mesh-list
24680060|NCT01372904|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24680061|NCT01372904|BB 1101|bb 1101|mesh-list
24680123|NCT01373021|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24854473|NCT02273635|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24854474|NCT02273635|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24854475|NCT02273635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24854476|NCT02273635|Antiviral Agents|antiviral agents|mesh-ancestor
25667950|NCT01710137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25667951|NCT01710137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667952|NCT01710137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667953|NCT01710254|Regadenoson|regadenoson|mesh-list
25667954|NCT01710254|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25667955|NCT01710254|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25667956|NCT01710254|Purinergic Agonists|purinergic agonists|mesh-ancestor
25667957|NCT01710254|Purinergic Agents|purinergic agents|mesh-ancestor
25667958|NCT01710254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25667959|NCT01710254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854477|NCT02273635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24854478|NCT02273661|Amphotericin B|amphotericin b|mesh-list
24854479|NCT02273661|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24854480|NCT02273661|Amebicides|amebicides|mesh-ancestor
24854481|NCT02273661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24611105|NCT01006876|Anticoagulants|anticoagulants|mesh-ancestor
24680170|NCT01373359|Oxytocics|oxytocics|mesh-ancestor
24638648|NCT01157455|Anticoagulants|anticoagulants|mesh-ancestor
24680171|NCT01373359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24680172|NCT01373359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680173|NCT01373359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24680174|NCT01373359|Abortifacient Agents|abortifacient agents|mesh-ancestor
24854482|NCT02273661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24854483|NCT02273661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24854484|NCT02273661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24854485|NCT02273661|Antifungal Agents|antifungal agents|mesh-ancestor
24854486|NCT02273700|Rivaroxaban|rivaroxaban|mesh-list
24854487|NCT02273700|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24854488|NCT02273700|Antithrombins|antithrombins|mesh-ancestor
24680297|NCT01373970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680298|NCT01373983|Ziconotide|ziconotide|mesh-list
24680299|NCT01373983|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24680300|NCT01373983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24680301|NCT01373983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680302|NCT01373983|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24680303|NCT01373983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680304|NCT01373983|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24680305|NCT01373983|Protective Agents|protective agents|mesh-ancestor
24680306|NCT01373983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24680307|NCT01373983|Analgesics|analgesics|mesh-ancestor
24680308|NCT01373983|Sensory System Agents|sensory system agents|mesh-ancestor
24680309|NCT01373983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24680310|NCT01374126|Azithromycin|azithromycin|mesh-list
24680311|NCT01374126|Artesunate|artesunate|mesh-list
24680312|NCT01374126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24680375|NCT01374581|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24680376|NCT01374581|Anthelmintics|anthelmintics|mesh-ancestor
24680377|NCT01374581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24680378|NCT01374581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24680379|NCT01374581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680380|NCT01374581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680381|NCT01374581|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24680382|NCT01374581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680383|NCT01374581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24681076|NCT01378091|Glucocorticoids|glucocorticoids|mesh-ancestor
24680409|NCT01374633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24680410|NCT01374633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680412|NCT01374698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24854509|NCT02273765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457100|NCT00333112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24479470|NCT00426998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24479529|NCT00427232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24479530|NCT00427232|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24680547|NCT01375335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24680548|NCT01375335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680549|NCT01375335|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24680550|NCT01375335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24680551|NCT01375335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24680552|NCT01375335|Adrenergic Agents|adrenergic agents|mesh-ancestor
24680568|NCT01375361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680569|NCT01375361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24680570|NCT01375361|Respiratory System Agents|respiratory system agents|mesh-ancestor
24680571|NCT01375361|Tocolytic Agents|tocolytic agents|mesh-ancestor
24680572|NCT01375361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24680573|NCT01375361|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24680574|NCT01375361|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24680575|NCT01375361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25124139|NCT03079219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24680576|NCT01375361|Adrenergic Agents|adrenergic agents|mesh-ancestor
24680577|NCT01375361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24680578|NCT01375361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680580|NCT01375387|Anticonvulsants|anticonvulsants|mesh-ancestor
24546868|NCT00700921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24680643|NCT01375699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24680644|NCT01375699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861436|NCT00086593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861437|NCT00086593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25216201|NCT02685657|Docetaxel|docetaxel|mesh-list
25216202|NCT02685657|Doxorubicin|doxorubicin|mesh-list
24680645|NCT01375699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680646|NCT01375699|Vasodilator Agents|vasodilator agents|mesh-ancestor
24680647|NCT01375699|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24680648|NCT01375699|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24680649|NCT01375699|Urological Agents|urological agents|mesh-ancestor
24680651|NCT01375816|Bevacizumab|bevacizumab|mesh-list
24680652|NCT01375816|Fluorouracil|fluorouracil|mesh-list
24680654|NCT01375816|Calcium|calcium|mesh-list
24680655|NCT01375816|Levoleucovorin|levoleucovorin|mesh-list
24611106|NCT01007019|Esomeprazole|esomeprazole|mesh-list
24611107|NCT01007019|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24611108|NCT01007019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24611109|NCT01007019|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24611110|NCT01007019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611132|NCT01007500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24611133|NCT01007500|Antiemetics|antiemetics|mesh-ancestor
24465290|NCT00368719|Tacrolimus|tacrolimus|mesh-list
24680724|NCT01376076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680739|NCT01376076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24680740|NCT01376076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24680758|NCT01376128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24680850|NCT01376284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854545|NCT02273804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854546|NCT02273817|Ciclesonide|ciclesonide|mesh-list
24854547|NCT02273817|Glucocorticoids|glucocorticoids|mesh-ancestor
24680963|NCT01377285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24680964|NCT01377285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24680965|NCT01377285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854556|NCT02273843|Micronutrients|micronutrients|mesh-ancestor
24854557|NCT02273843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854558|NCT02273843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24854559|NCT02273843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24854560|NCT02273895|Scopolamine|scopolamine|mesh-list
24854561|NCT02273895|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24854562|NCT02273895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24854563|NCT02273895|Antiemetics|antiemetics|mesh-ancestor
24547078|NCT00702260|Ramipril|ramipril|mesh-list
24611209|NCT01007773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611210|NCT01007773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24611211|NCT01007773|Narcotics|narcotics|mesh-ancestor
24611212|NCT01007773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24611214|NCT01007799|Ergocalciferols|ergocalciferols|mesh-list
24611215|NCT01007799|Cholecalciferol|cholecalciferol|mesh-list
24611217|NCT01007799|Micronutrients|micronutrients|mesh-ancestor
24465683|NCT00370539|Hormones|hormones|mesh-ancestor
24681078|NCT01378091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24681079|NCT01378091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681080|NCT01378091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24681081|NCT01378091|Immunologic Factors|immunologic factors|mesh-ancestor
24681082|NCT01378091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24681083|NCT01378091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24681084|NCT01378091|Growth Substances|growth substances|mesh-ancestor
24681085|NCT01378091|Growth Inhibitors|growth inhibitors|mesh-ancestor
24681086|NCT01378143|Pentamidine|pentamidine|mesh-list
24681087|NCT01378143|Antifungal Agents|antifungal agents|mesh-ancestor
24681088|NCT01378143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24681089|NCT01378143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24547227|NCT00703144|Piperacillin|piperacillin|mesh-list
24681138|NCT01378546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681139|NCT01378546|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24681140|NCT01378546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24681141|NCT01378546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681142|NCT01378650|Cilostazol|cilostazol|mesh-list
24681143|NCT01378650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25199630|NCT02739672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24681144|NCT01378650|Autonomic Agents|autonomic agents|mesh-ancestor
24681145|NCT01378650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24681146|NCT01378650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667960|NCT01710254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667961|NCT01710332|Aflibercept|aflibercept|mesh-list
25667962|NCT01710332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24681147|NCT01378650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25667963|NCT01710332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25667964|NCT01710332|Growth Substances|growth substances|mesh-ancestor
25667965|NCT01710332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969735|NCT03740386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969736|NCT03740386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24969738|NCT03740373|Glycopyrrolate|glycopyrrolate|mesh-list
24969750|NCT03740373|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24681148|NCT01378650|Respiratory System Agents|respiratory system agents|mesh-ancestor
24681149|NCT01378650|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24681150|NCT01378650|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24681151|NCT01378650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681152|NCT01378650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24681153|NCT01378650|Vasodilator Agents|vasodilator agents|mesh-ancestor
24854595|NCT02274012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24854596|NCT02274012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854597|NCT02274051|Kinetin|kinetin|mesh-list
24854598|NCT02274051|Plant Growth Regulators|plant growth regulators|mesh-ancestor
24854599|NCT02274051|Growth Substances|growth substances|mesh-ancestor
24854600|NCT02274051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854601|NCT02274077|Bupivacaine|bupivacaine|mesh-list
24854602|NCT02274077|Anesthetics, Local|anesthetics, local|mesh-ancestor
24854603|NCT02274077|Anesthetics|anesthetics|mesh-ancestor
24854604|NCT02274077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24854605|NCT02274077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052267|NCT00313222|Bosentan|bosentan|mesh-list
24854606|NCT02274077|Sensory System Agents|sensory system agents|mesh-ancestor
24854607|NCT02274077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24854608|NCT02274090|Metformin|metformin|mesh-list
24854609|NCT02274090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25861438|NCT00086593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681188|NCT01378754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24681189|NCT01378754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681190|NCT01378754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24681191|NCT01378754|Anesthetics, General|anesthetics, general|mesh-ancestor
24681193|NCT01378832|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24681194|NCT01378832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24681195|NCT01378845|Bosentan|bosentan|mesh-list
24681196|NCT01378845|Alprostadil|alprostadil|mesh-list
25032117|NCT03583567|Chlorpheniramine|chlorpheniramine|mesh-list
24681197|NCT01378845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24681198|NCT01378845|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24681199|NCT01378845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681200|NCT01378845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24681201|NCT01378845|Vasodilator Agents|vasodilator agents|mesh-ancestor
24679718|NCT01370187|Montelukast|montelukast|mesh-list
24681218|NCT01378949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681219|NCT01378949|Sensory System Agents|sensory system agents|mesh-ancestor
24681220|NCT01378949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24681221|NCT01378949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24681222|NCT01378949|Narcotics|narcotics|mesh-ancestor
24681223|NCT01378949|Analgesics|analgesics|mesh-ancestor
24681226|NCT01379001|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24681245|NCT01379079|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
24681246|NCT01379079|Carbaspirin calcium|carbaspirin calcium|mesh-list
24681247|NCT01379079|Calcium|calcium|mesh-list
24681248|NCT01379079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24681249|NCT01379079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681250|NCT01379079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24681251|NCT01379079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24681252|NCT01379079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24681253|NCT01379079|Analgesics|analgesics|mesh-ancestor
24681254|NCT01379079|Sensory System Agents|sensory system agents|mesh-ancestor
24681255|NCT01379079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24681256|NCT01379079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24681257|NCT01379079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24681258|NCT01379079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24681260|NCT01379079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681261|NCT01379079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25667966|NCT01710332|Growth Inhibitors|growth inhibitors|mesh-ancestor
25667967|NCT01710332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25667968|NCT01710345|Sufentanil|sufentanil|mesh-list
25667969|NCT01710345|Dsuvia|dsuvia|mesh-list
25667970|NCT01710345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25667971|NCT01710345|Narcotics|narcotics|mesh-ancestor
25667972|NCT01710345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24681262|NCT01379079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24854618|NCT02274142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24854619|NCT02274142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854620|NCT02274142|Adrenergic Agents|adrenergic agents|mesh-ancestor
24854621|NCT02274142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24854622|NCT02274142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24854623|NCT02274142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24457193|NCT00333346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24681307|NCT01379482|Mitosis Modulators|mitosis modulators|mesh-ancestor
24681308|NCT01379482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681309|NCT01379482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24681310|NCT01379482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24681311|NCT01379482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24681312|NCT01379482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681313|NCT01379482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24681314|NCT01379547|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24681315|NCT01379547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24681316|NCT01379560|Isopropyl unoprostone|isopropyl unoprostone|mesh-list
24465925|NCT00371111|Hormones|hormones|mesh-ancestor
24681317|NCT01379560|Dinoprost|dinoprost|mesh-list
24681318|NCT01379560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24681319|NCT01379560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24681320|NCT01379560|Abortifacient Agents|abortifacient agents|mesh-ancestor
24681321|NCT01379560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24681322|NCT01379560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681323|NCT01379560|Oxytocics|oxytocics|mesh-ancestor
24681324|NCT01379677|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
24854638|NCT02274259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24854640|NCT02274259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681376|NCT01380275|Tubulin Modulators|tubulin modulators|mesh-ancestor
24681377|NCT01380275|Antimitotic Agents|antimitotic agents|mesh-ancestor
24681378|NCT01380275|Mitosis Modulators|mitosis modulators|mesh-ancestor
24681379|NCT01380275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681380|NCT01380275|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24681381|NCT01380275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24681397|NCT01380301|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24681398|NCT01380314|Miltefosine|miltefosine|mesh-list
24681399|NCT01380314|Imiquimod|imiquimod|mesh-list
24681436|NCT01380457|Analgesics|analgesics|mesh-ancestor
24681437|NCT01380457|Sensory System Agents|sensory system agents|mesh-ancestor
24681438|NCT01380457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24681439|NCT01380457|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24681440|NCT01380457|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24681441|NCT01380457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24681442|NCT01380457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681443|NCT01380457|Hormones|hormones|mesh-ancestor
24681444|NCT01380457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24681445|NCT01380483|Doxycycline|doxycycline|mesh-list
24681487|NCT01380678|Growth Substances|growth substances|mesh-ancestor
24611234|NCT01007864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611236|NCT01007864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611237|NCT01007864|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24611238|NCT01007864|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24611239|NCT01007864|Dopamine Agonists|dopamine agonists|mesh-ancestor
24611240|NCT01007864|Dopamine Agents|dopamine agents|mesh-ancestor
24611257|NCT01008046|Acetylcysteine|acetylcysteine|mesh-list
24611258|NCT01008046|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24611259|NCT01008046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24680026|NCT01372670|Antipruritics|antipruritics|mesh-ancestor
24611273|NCT01008098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24854657|NCT02274506|Vidarabine|vidarabine|mesh-list
24854658|NCT02274506|Cyclophosphamide|cyclophosphamide|mesh-list
24854659|NCT02274506|Fludarabine|fludarabine|mesh-list
24854660|NCT02274506|Fludarabine phosphate|fludarabine phosphate|mesh-list
24854661|NCT02274506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24854662|NCT02274506|Immunologic Factors|immunologic factors|mesh-ancestor
24457225|NCT00333489|Valsartan|valsartan|mesh-list
24611274|NCT01008098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611275|NCT01008098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24611276|NCT01008098|Serotonin Agents|serotonin agents|mesh-ancestor
24611277|NCT01008098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547609|NCT00704860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24681551|NCT01381185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24681561|NCT01381185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24681603|NCT01381354|Expectorants|expectorants|mesh-ancestor
24681604|NCT01381354|Respiratory System Agents|respiratory system agents|mesh-ancestor
24681605|NCT01381354|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24681684|NCT01381523|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24681685|NCT01381523|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24681686|NCT01381523|Serotonin Agents|serotonin agents|mesh-ancestor
24681687|NCT01381523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24681689|NCT01381536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24681690|NCT01381536|Immunologic Factors|immunologic factors|mesh-ancestor
24681691|NCT01381536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681692|NCT01381601|Bevacizumab|bevacizumab|mesh-list
24681694|NCT01381601|Sorafenib|sorafenib|mesh-list
24681695|NCT01381601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24681696|NCT01381601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681697|NCT01381601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24681698|NCT01381601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24681699|NCT01381601|Growth Substances|growth substances|mesh-ancestor
24681700|NCT01381601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681701|NCT01381601|Growth Inhibitors|growth inhibitors|mesh-ancestor
24681702|NCT01381601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24681703|NCT01381601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920678|NCT04199364|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
24854697|NCT02274961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854699|NCT02274974|Epinephrine|epinephrine|mesh-list
24854700|NCT02274974|Anesthetics, Local|anesthetics, local|mesh-list
24854701|NCT02274974|Anesthetics|anesthetics|mesh-list
24457253|NCT00333632|Anesthetics|anesthetics|mesh-ancestor
24457254|NCT00333632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24681762|NCT01381835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681788|NCT01382017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24681789|NCT01382017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681799|NCT01382134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24681800|NCT01382134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24681802|NCT01382134|Sensory System Agents|sensory system agents|mesh-ancestor
24681803|NCT01382134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24681804|NCT01382134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681805|NCT01382134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24681806|NCT01382134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24681891|NCT01382511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466469|NCT00373607|Artesunate|artesunate|mesh-list
24681892|NCT01382589|Afamelanotide|afamelanotide|mesh-list
24681893|NCT01382589|Dermatologic Agents|dermatologic agents|mesh-ancestor
24681894|NCT01382706|Docetaxel|docetaxel|mesh-list
24681895|NCT01382706|Lapatinib|lapatinib|mesh-list
24681896|NCT01382706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681897|NCT01382706|Tubulin Modulators|tubulin modulators|mesh-ancestor
24681898|NCT01382706|Antimitotic Agents|antimitotic agents|mesh-ancestor
24681899|NCT01382706|Mitosis Modulators|mitosis modulators|mesh-ancestor
24681900|NCT01382706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681901|NCT01382706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24681902|NCT01382706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681903|NCT01382732|Oxytocin|oxytocin|mesh-list
24681904|NCT01382732|Carbetocin|carbetocin|mesh-list
24681905|NCT01382732|Oxytocics|oxytocics|mesh-ancestor
24681906|NCT01382732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24681907|NCT01382732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854734|NCT02275039|Immunologic Factors|immunologic factors|mesh-ancestor
24854735|NCT02275039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854736|NCT02275039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24854737|NCT02275039|Antimetabolites|antimetabolites|mesh-ancestor
24681935|NCT01383044|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24681936|NCT01383148|Gemcitabine|gemcitabine|mesh-list
24681937|NCT01383148|Paclitaxel|paclitaxel|mesh-list
24681938|NCT01383148|Cisplatin|cisplatin|mesh-list
24681939|NCT01383148|Carboplatin|carboplatin|mesh-list
24681940|NCT01383148|Pemetrexed|pemetrexed|mesh-list
24681941|NCT01383148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24681942|NCT01383148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24989308|NCT05365555|Anesthetics|anesthetics|mesh-list
24681943|NCT01383148|Tubulin Modulators|tubulin modulators|mesh-ancestor
24681944|NCT01383148|Antimitotic Agents|antimitotic agents|mesh-ancestor
24681945|NCT01383148|Mitosis Modulators|mitosis modulators|mesh-ancestor
24681946|NCT01383148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681947|NCT01383148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681948|NCT01383148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24950149|NCT02348203|Aspirin|aspirin|mesh-list
24540425|NCT00667966|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
25207664|NCT03514732|Antioxidants|antioxidants|mesh-ancestor
24681950|NCT01383148|Antiviral Agents|antiviral agents|mesh-ancestor
24681951|NCT01383148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24681952|NCT01383148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611297|NCT01008384|Vitamin D|vitamin d|mesh-list
24611298|NCT01008384|Cholecalciferol|cholecalciferol|mesh-list
24611299|NCT01008384|Vitamins|vitamins|mesh-ancestor
24611300|NCT01008384|Micronutrients|micronutrients|mesh-ancestor
24611301|NCT01008384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611302|NCT01008384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24611303|NCT01008384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24611304|NCT01008488|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24611305|NCT01008488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24611306|NCT01008527|Poly ICLC|poly iclc|mesh-list
24611307|NCT01008527|Interferon Inducers|interferon inducers|mesh-ancestor
24611308|NCT01008527|Immunologic Factors|immunologic factors|mesh-ancestor
24611309|NCT01008527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611310|NCT01008566|Sorafenib|sorafenib|mesh-list
24854748|NCT02275130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24854749|NCT02275182|Dexmedetomidine|dexmedetomidine|mesh-list
24854750|NCT02275182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24854751|NCT02275182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24854752|NCT02275182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854753|NCT02275182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24854754|NCT02275182|Analgesics|analgesics|mesh-ancestor
24854755|NCT02275182|Sensory System Agents|sensory system agents|mesh-ancestor
24854756|NCT02275182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24681987|NCT01383343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24681988|NCT01383343|Antimetabolites|antimetabolites|mesh-ancestor
24681989|NCT01383343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681990|NCT01383343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24681991|NCT01383343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24681992|NCT01383343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24681993|NCT01383343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24681994|NCT01383343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681995|NCT01383343|Antidotes|antidotes|mesh-ancestor
24681996|NCT01383343|Protective Agents|protective agents|mesh-ancestor
24681997|NCT01383343|Vitamin B Complex|vitamin b complex|mesh-ancestor
24681998|NCT01383343|Vitamins|vitamins|mesh-ancestor
24681999|NCT01383343|Micronutrients|micronutrients|mesh-ancestor
24682000|NCT01383343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24682001|NCT01383343|Hematinics|hematinics|mesh-ancestor
24682002|NCT01383343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24682003|NCT01383395|Cilostazol|cilostazol|mesh-list
24682004|NCT01383395|Simvastatin|simvastatin|mesh-list
24680564|NCT01375361|Albuterol|albuterol|mesh-list
24682024|NCT01383395|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24682025|NCT01383395|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24682027|NCT01383460|Lenograstim|lenograstim|mesh-list
24466600|NCT00374192|Eszopiclone|eszopiclone|mesh-list
24682028|NCT01383460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24682051|NCT01383655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682052|NCT01383655|Anesthetics|anesthetics|mesh-ancestor
24682053|NCT01383655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24682054|NCT01383655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24682055|NCT01383655|Anticonvulsants|anticonvulsants|mesh-ancestor
24682056|NCT01383655|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24682057|NCT01383655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24682059|NCT01383655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24682060|NCT01383655|Tocolytic Agents|tocolytic agents|mesh-ancestor
24682061|NCT01383655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24682064|NCT01383668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24682065|NCT01383668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24682066|NCT01383668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24682067|NCT01383668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680675|NCT01375816|Vitamins|vitamins|mesh-ancestor
24682212|NCT01384773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682213|NCT01384773|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24682214|NCT01384773|Dermatologic Agents|dermatologic agents|mesh-ancestor
24682215|NCT01384799|Cisplatin|cisplatin|mesh-list
24682216|NCT01384799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199631|NCT02739672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25667973|NCT01710345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667974|NCT01710345|Analgesics|analgesics|mesh-ancestor
24682218|NCT01384812|Oxytocics|oxytocics|mesh-ancestor
24682239|NCT01384994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25216355|NCT02684799|Cenicriviroc|cenicriviroc|mesh-list
24682261|NCT01385059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682262|NCT01385059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682263|NCT01385124|Cannabidiol|cannabidiol|mesh-list
24682264|NCT01385124|Anticonvulsants|anticonvulsants|mesh-ancestor
24682265|NCT01385228|Prednisone|prednisone|mesh-list
24682266|NCT01385228|Docetaxel|docetaxel|mesh-list
24812648|NCT02053922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24812649|NCT02053922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812650|NCT02053922|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24812651|NCT02053922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24812652|NCT02053922|Oxytocics|oxytocics|mesh-ancestor
24682267|NCT01385228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24682268|NCT01385228|Tubulin Modulators|tubulin modulators|mesh-ancestor
24682331|NCT01385956|Gemcitabine|gemcitabine|mesh-list
24682332|NCT01385956|Pasireotide|pasireotide|mesh-list
24812655|NCT02053935|Sympathomimetics|sympathomimetics|mesh-ancestor
24812656|NCT02053935|Autonomic Agents|autonomic agents|mesh-ancestor
24812657|NCT02053935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24682335|NCT01385956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682336|NCT01385956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24682338|NCT01385956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24682339|NCT01385956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682340|NCT01385956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24682341|NCT01385956|Immunologic Factors|immunologic factors|mesh-ancestor
24682342|NCT01385956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682343|NCT01385956|Hormones|hormones|mesh-ancestor
24682344|NCT01385956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24682345|NCT01386086|Aripiprazole|aripiprazole|mesh-list
24682346|NCT01386086|Antidepressive Agents|antidepressive agents|mesh-ancestor
24682347|NCT01386086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24682348|NCT01386086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24457362|NCT00334126|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24457363|NCT00334126|Dopamine Agents|dopamine agents|mesh-ancestor
24483353|NCT00443170|Midazolam|midazolam|mesh-list
24682386|NCT01386229|Etomidate|etomidate|mesh-list
24682387|NCT01386229|Analgesics|analgesics|mesh-ancestor
24682388|NCT01386229|Sensory System Agents|sensory system agents|mesh-ancestor
24682389|NCT01386229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24680834|NCT01376271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24611351|NCT01008917|Sirolimus|sirolimus|mesh-list
24611352|NCT01008917|Sorafenib|sorafenib|mesh-list
24611353|NCT01008917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611354|NCT01008917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24611355|NCT01008917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611356|NCT01008917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611357|NCT01008917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24854809|NCT02275702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24854826|NCT02275806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854827|NCT02275806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24854828|NCT02275832|Minoxidil|minoxidil|mesh-list
24854829|NCT02275832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24854830|NCT02275832|Vasodilator Agents|vasodilator agents|mesh-ancestor
24854831|NCT02275845|Metformin|metformin|mesh-list
24854832|NCT02275845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24854833|NCT02275845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682513|NCT01386593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682514|NCT01386593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24682515|NCT01386593|Antidepressive Agents|antidepressive agents|mesh-ancestor
24682516|NCT01386593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24682517|NCT01386593|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24682518|NCT01386593|Antifungal Agents|antifungal agents|mesh-ancestor
24682519|NCT01386593|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24682520|NCT01386593|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24682540|NCT01386658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24682541|NCT01386658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682542|NCT01386658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24682543|NCT01386658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24854842|NCT02275897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854843|NCT02275897|Adrenergic Agents|adrenergic agents|mesh-ancestor
25199632|NCT02739672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24682556|NCT01386710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24682568|NCT01386853|Pitavastatin|pitavastatin|mesh-list
24682569|NCT01386853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24682570|NCT01386853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25667975|NCT01710345|Sensory System Agents|sensory system agents|mesh-ancestor
25667976|NCT01710345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25216416|NCT02684708|Prednisone|prednisone|mesh-list
24682571|NCT01386853|Antimetabolites|antimetabolites|mesh-ancestor
25861439|NCT00086593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24682586|NCT01386996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24682587|NCT01386996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24682588|NCT01386996|Autonomic Agents|autonomic agents|mesh-ancestor
24682589|NCT01386996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24682590|NCT01386996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682591|NCT01386996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24682592|NCT01386996|Respiratory System Agents|respiratory system agents|mesh-ancestor
24682593|NCT01386996|Glucocorticoids|glucocorticoids|mesh-ancestor
24682595|NCT01386996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24682596|NCT01386996|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24682597|NCT01386996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24682598|NCT01386996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24682599|NCT01386996|Adrenergic Agents|adrenergic agents|mesh-ancestor
24682600|NCT01386996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24682601|NCT01386996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854856|NCT02275962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854857|NCT02275962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24682603|NCT01387048|Azelaic acid|azelaic acid|mesh-list
24682604|NCT01387048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24611180|NCT01007695|Valproic Acid|valproic acid|mesh-list
24682664|NCT01387568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682666|NCT01387568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24682667|NCT01387568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24682668|NCT01387568|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24682669|NCT01387568|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24682670|NCT01387568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24639348|NCT01161147|Analgesics|analgesics|mesh-ancestor
24682671|NCT01387568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682672|NCT01387620|Hyaluronic Acid|hyaluronic acid|mesh-list
24682673|NCT01387620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24682674|NCT01387620|Immunologic Factors|immunologic factors|mesh-ancestor
24682675|NCT01387620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682676|NCT01387620|Viscosupplements|viscosupplements|mesh-ancestor
24682677|NCT01387620|Protective Agents|protective agents|mesh-ancestor
24682679|NCT01387880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24682680|NCT01387880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24682681|NCT01387880|Immunologic Factors|immunologic factors|mesh-ancestor
24682695|NCT01388036|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24682696|NCT01388036|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24682697|NCT01388036|Adrenergic Agents|adrenergic agents|mesh-ancestor
24682698|NCT01388036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25861440|NCT00086593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24682736|NCT01388101|Antibodies|antibodies|mesh-list
24682737|NCT01388101|Immunologic Factors|immunologic factors|mesh-ancestor
24682738|NCT01388101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682739|NCT01388114|Antibodies|antibodies|mesh-list
24682740|NCT01388114|Immunologic Factors|immunologic factors|mesh-ancestor
25861441|NCT00086593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24682751|NCT01388270|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24682752|NCT01388270|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24682753|NCT01388270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682755|NCT01388322|Anticoagulants|anticoagulants|mesh-ancestor
24863616|NCT04182997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24863619|NCT04182997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24682757|NCT01388322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25861442|NCT00086593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24682801|NCT01388582|Trace Elements|trace elements|mesh-ancestor
24682802|NCT01388582|Micronutrients|micronutrients|mesh-ancestor
24682803|NCT01388582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24682804|NCT01388582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24611380|NCT01009073|Irinotecan|irinotecan|mesh-list
24854869|NCT02275975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854879|NCT02275988|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24854880|NCT02275988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854881|NCT02275988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854882|NCT02275988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24549420|NCT00715039|GABA Agents|gaba agents|mesh-ancestor
24854883|NCT02275988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25124715|NCT03073265|Apixaban|apixaban|mesh-list
25861443|NCT00086593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25861444|NCT00086606|Omalizumab|omalizumab|mesh-list
25861445|NCT00086606|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25861446|NCT00086606|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25861447|NCT00086606|Respiratory System Agents|respiratory system agents|mesh-ancestor
25861448|NCT00086632|Oregovomab|oregovomab|mesh-list
25216449|NCT02684409|Serotonin Agents|serotonin agents|mesh-ancestor
25216450|NCT02684409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25216451|NCT02684409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854885|NCT02276001|Cyclosporins|cyclosporins|mesh-list
24854886|NCT02276001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854887|NCT02276001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595181|NCT00937131|Immunologic Factors|immunologic factors|mesh-ancestor
24682884|NCT01388959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24682886|NCT01388959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682887|NCT01388959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24682888|NCT01389024|Hydroxyurea|hydroxyurea|mesh-list
24682889|NCT01389024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24682890|NCT01389024|Antisickling Agents|antisickling agents|mesh-ancestor
24682976|NCT01389427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682978|NCT01389427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24682979|NCT01389427|Alkylating Agents|alkylating agents|mesh-ancestor
24682980|NCT01389427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682981|NCT01389427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24682982|NCT01389427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24682983|NCT01389427|Glucocorticoids|glucocorticoids|mesh-ancestor
24682984|NCT01389427|Hormones|hormones|mesh-ancestor
24682985|NCT01389427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24854902|NCT02276014|Provitamins|provitamins|mesh-ancestor
24854904|NCT02276014|Micronutrients|micronutrients|mesh-ancestor
24854905|NCT02276092|Anti-Infective Agents|anti-infective agents|mesh-list
24854906|NCT02276092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24854907|NCT02276196|Insulin glulisine|insulin glulisine|mesh-list
24854908|NCT02276196|Lixisenatide|lixisenatide|mesh-list
24854909|NCT02276196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24854910|NCT02276196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854911|NCT02276300|Cyclophosphamide|cyclophosphamide|mesh-list
24854913|NCT02276300|Sargramostim|sargramostim|mesh-list
24854914|NCT02276300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24854915|NCT02276300|Immunologic Factors|immunologic factors|mesh-ancestor
24854916|NCT02276300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854917|NCT02276300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24854918|NCT02276300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24683028|NCT01389544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24683029|NCT01389544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24683031|NCT01389544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24683032|NCT01389544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683034|NCT01389544|Sensory System Agents|sensory system agents|mesh-ancestor
24683035|NCT01389544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24683036|NCT01389544|Antitussive Agents|antitussive agents|mesh-ancestor
24683037|NCT01389544|Respiratory System Agents|respiratory system agents|mesh-ancestor
24683038|NCT01389557|Piperaquine|piperaquine|mesh-list
24683039|NCT01389557|Primaquine|primaquine|mesh-list
24683040|NCT01389557|Artenimol|artenimol|mesh-list
24683041|NCT01389557|Antimalarials|antimalarials|mesh-ancestor
24683042|NCT01389557|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24683043|NCT01389557|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24683044|NCT01389557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24683045|NCT01389609|Doxazosin|doxazosin|mesh-list
24683108|NCT01389908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683110|NCT01389908|Serotonin Agents|serotonin agents|mesh-ancestor
24683111|NCT01390012|Dexamethasone|dexamethasone|mesh-list
24683112|NCT01390012|Dexamethasone acetate|dexamethasone acetate|mesh-list
24683168|NCT01390337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24683169|NCT01390337|Immunologic Factors|immunologic factors|mesh-ancestor
24683170|NCT01390337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683207|NCT01390662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683208|NCT01390662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24683209|NCT01390662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25667977|NCT01710345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25667978|NCT01710345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25667979|NCT01710345|Anesthetics, General|anesthetics, general|mesh-ancestor
25667980|NCT01710345|Anesthetics|anesthetics|mesh-ancestor
25667981|NCT01710358|Adalimumab|adalimumab|mesh-list
25667982|NCT01710358|Methotrexate|methotrexate|mesh-list
25667983|NCT01710358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25861449|NCT00086632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25861450|NCT00086632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861452|NCT00086645|Citalopram|citalopram|mesh-list
25861453|NCT00086645|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24683226|NCT01390805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24683228|NCT01390883|Fondaparinux|fondaparinux|mesh-list
24683291|NCT01391052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683292|NCT01391052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24683293|NCT01391052|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24683294|NCT01391104|Sildenafil Citrate|sildenafil citrate|mesh-list
24683295|NCT01391104|Vasodilator Agents|vasodilator agents|mesh-ancestor
24683317|NCT01391221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199633|NCT02739672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199634|NCT02739672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24683342|NCT01391390|Antioxidants|antioxidants|mesh-ancestor
24683343|NCT01391390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683344|NCT01391390|Protective Agents|protective agents|mesh-ancestor
24683345|NCT01391390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683346|NCT01391390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24683347|NCT01391403|Artemisinins|artemisinins|mesh-list
24854974|NCT02276495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24854975|NCT02276495|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24854976|NCT02276495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854977|NCT02276495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24854978|NCT02276495|Sympatholytics|sympatholytics|mesh-ancestor
24683370|NCT01391598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683371|NCT01391598|Sensory System Agents|sensory system agents|mesh-ancestor
24683372|NCT01391598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24683373|NCT01391598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24683374|NCT01391598|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24683375|NCT01391598|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24683376|NCT01391598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24683377|NCT01391598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683378|NCT01391624|Mineral Oil|mineral oil|mesh-list
24683379|NCT01391624|Emollients|emollients|mesh-ancestor
24683380|NCT01391624|Dermatologic Agents|dermatologic agents|mesh-ancestor
24683381|NCT01391689|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
24683382|NCT01391689|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24683383|NCT01391689|Protective Agents|protective agents|mesh-ancestor
24683384|NCT01391689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683385|NCT01391689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24683386|NCT01391715|Rabeprazole|rabeprazole|mesh-list
24801137|NCT01981291|Anesthetics|anesthetics|mesh-list
24683439|NCT01392209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24854979|NCT02276495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24854981|NCT02276677|Oxytocics|oxytocics|mesh-ancestor
24854982|NCT02276677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24854983|NCT02276677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683518|NCT01392755|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24683519|NCT01392755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24683521|NCT01392755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24683523|NCT01392755|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24683524|NCT01392755|Histamine Antagonists|histamine antagonists|mesh-ancestor
24683525|NCT01392755|Histamine Agents|histamine agents|mesh-ancestor
24683526|NCT01392755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24683527|NCT01392755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683529|NCT01392768|Anticonvulsants|anticonvulsants|mesh-ancestor
24683530|NCT01392768|Nootropic Agents|nootropic agents|mesh-ancestor
24683532|NCT01392794|Antiemetics|antiemetics|mesh-ancestor
24683533|NCT01392794|Autonomic Agents|autonomic agents|mesh-ancestor
24683534|NCT01392794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24683535|NCT01392794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683536|NCT01392794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24683537|NCT01392794|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24683538|NCT01392794|Serotonin Agents|serotonin agents|mesh-ancestor
24488310|NCT00467662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24488311|NCT00467766|Donepezil|donepezil|mesh-list
24488312|NCT00467766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25667984|NCT01710358|Abortifacient Agents|abortifacient agents|mesh-ancestor
25667985|NCT01710358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25667986|NCT01710358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667987|NCT01710358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24683543|NCT01392807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683572|NCT01392833|Immunologic Factors|immunologic factors|mesh-ancestor
24683573|NCT01392833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24683631|NCT01393184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24683632|NCT01393288|Lorazepam|lorazepam|mesh-list
24683633|NCT01393288|Ondansetron|ondansetron|mesh-list
24683634|NCT01393288|Aprepitant|aprepitant|mesh-list
24683635|NCT01393288|Antiemetics|antiemetics|mesh-ancestor
24683636|NCT01393288|Autonomic Agents|autonomic agents|mesh-ancestor
24683637|NCT01393288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25110259|NCT05464745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683638|NCT01393288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110267|NCT05464680|Dimercaprol|dimercaprol|mesh-list
25052631|NCT00232752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052632|NCT00232752|Antifungal Agents|antifungal agents|mesh-ancestor
25052633|NCT00232752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25052634|NCT00232752|Immunologic Factors|immunologic factors|mesh-ancestor
25052635|NCT00232752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683639|NCT01393288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24683641|NCT01393288|Dermatologic Agents|dermatologic agents|mesh-ancestor
24683642|NCT01393288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24683643|NCT01393288|Serotonin Agents|serotonin agents|mesh-ancestor
24683644|NCT01393288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24611434|NCT01009502|Schistosomicides|schistosomicides|mesh-ancestor
24611457|NCT01009567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611458|NCT01009567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683757|NCT01393925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24683758|NCT01393925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683759|NCT01393925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24683760|NCT01393925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24683850|NCT01394419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683852|NCT01394419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683875|NCT01394458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24683876|NCT01394458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24683877|NCT01394458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24683878|NCT01394458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683879|NCT01394471|Oxytocin|oxytocin|mesh-list
24683880|NCT01394471|Oxytocics|oxytocics|mesh-ancestor
24683881|NCT01394471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24683882|NCT01394471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683883|NCT01394497|Acetylcysteine|acetylcysteine|mesh-list
24683884|NCT01394497|Antiviral Agents|antiviral agents|mesh-ancestor
24683885|NCT01394497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24683886|NCT01394497|Expectorants|expectorants|mesh-ancestor
24683943|NCT01394770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24683944|NCT01394770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683945|NCT01394770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24683946|NCT01394770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683947|NCT01394770|Vasodilator Agents|vasodilator agents|mesh-ancestor
24683948|NCT01394796|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24683949|NCT01394796|Antioxidants|antioxidants|mesh-ancestor
24683950|NCT01394796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683951|NCT01394796|Protective Agents|protective agents|mesh-ancestor
24457510|NCT00334646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24489612|NCT00474435|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24855020|NCT02276911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24855021|NCT02276911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24855022|NCT02276911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24855023|NCT02276911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855024|NCT02276911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684002|NCT01395069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24684003|NCT01395069|Analgesics|analgesics|mesh-ancestor
24684004|NCT01395069|Sensory System Agents|sensory system agents|mesh-ancestor
24684005|NCT01395069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24684006|NCT01395069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684007|NCT01395069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24684008|NCT01395069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24855029|NCT02276989|Micronutrients|micronutrients|mesh-ancestor
24855030|NCT02276989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855031|NCT02276989|Vitamin B Complex|vitamin b complex|mesh-ancestor
24684011|NCT01395069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667988|NCT01710358|Antimetabolites|antimetabolites|mesh-ancestor
25216581|NCT02683863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216582|NCT02683733|Aminosalicylic Acid|aminosalicylic acid|mesh-list
25216583|NCT02683733|Curcumin|curcumin|mesh-list
25216584|NCT02683733|Mesalamine|mesalamine|mesh-list
25216585|NCT02683733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25216586|NCT02683733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25216587|NCT02683733|Analgesics|analgesics|mesh-ancestor
25216588|NCT02683733|Sensory System Agents|sensory system agents|mesh-ancestor
25216589|NCT02683733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25216590|NCT02683733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216591|NCT02683733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25216592|NCT02683733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25216593|NCT02683733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25216594|NCT02683733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25216595|NCT02683733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684013|NCT01395147|Antidepressive Agents|antidepressive agents|mesh-ancestor
24684014|NCT01395147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24684110|NCT01395654|Antitubercular Agents|antitubercular agents|mesh-ancestor
24684111|NCT01395654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24684112|NCT01395654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24684113|NCT01395654|Leprostatic Agents|leprostatic agents|mesh-ancestor
24684114|NCT01395654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24684115|NCT01395654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855079|NCT02277171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684123|NCT01395654|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24684124|NCT01395654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24684125|NCT01395654|Antimetabolites|antimetabolites|mesh-ancestor
24684126|NCT01395654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24684127|NCT01395667|Leucovorin|leucovorin|mesh-list
24684205|NCT01395875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24684206|NCT01395875|Adrenergic Agents|adrenergic agents|mesh-ancestor
24548743|NCT00711854|Renal Agents|renal agents|mesh-ancestor
24684278|NCT01396642|Dermatologic Agents|dermatologic agents|mesh-ancestor
24684279|NCT01396655|Docetaxel|docetaxel|mesh-list
24684280|NCT01396655|Doxorubicin|doxorubicin|mesh-list
24684281|NCT01396655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684282|NCT01396655|Tubulin Modulators|tubulin modulators|mesh-ancestor
24684396|NCT01397214|Contraceptive Agents|contraceptive agents|mesh-ancestor
24684397|NCT01397214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24684398|NCT01397214|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24682240|NCT01384994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24684460|NCT05268562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24684461|NCT05268562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24684462|NCT05268562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684463|NCT05268237|Liraglutide|liraglutide|mesh-list
24684464|NCT05268237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24684465|NCT05268237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684466|NCT05268237|Incretins|incretins|mesh-ancestor
24684467|NCT05268237|Hormones|hormones|mesh-ancestor
24684468|NCT05268237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24684469|NCT05268185|Vaccines|vaccines|mesh-list
24684470|NCT05268185|Immunologic Factors|immunologic factors|mesh-ancestor
24855050|NCT02277041|Misoprostol|misoprostol|mesh-list
24855051|NCT02277041|Carbetocin|carbetocin|mesh-list
24855052|NCT02277041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25861454|NCT00086645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24684525|NCT05243251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24684526|NCT05243251|Serotonin Agents|serotonin agents|mesh-ancestor
24611534|NCT01009944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25667989|NCT01710358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25667990|NCT01710358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25667991|NCT01710358|Dermatologic Agents|dermatologic agents|mesh-ancestor
25667992|NCT01710358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25667993|NCT01710358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25667994|NCT01710358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25667995|NCT01710358|Immunologic Factors|immunologic factors|mesh-ancestor
25667996|NCT01710358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25667997|NCT01710358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25667998|NCT01710358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25667999|NCT01710501|Interferons|interferons|mesh-list
25668000|NCT01710501|Ribavirin|ribavirin|mesh-list
25668001|NCT01710501|Interferon-alpha|interferon-alpha|mesh-list
25668002|NCT01710501|Interferon alpha-2|interferon alpha-2|mesh-list
25668003|NCT01710501|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24611535|NCT01009944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24548899|NCT00712517|Propofol|propofol|mesh-list
25668004|NCT01710501|Grazoprevir|grazoprevir|mesh-list
25042110|NCT01508026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25216599|NCT02683655|Apatinib|apatinib|mesh-list
25216600|NCT02683655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25216601|NCT02683655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25216602|NCT02683655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25216603|NCT02683655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684617|NCT04965870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684695|NCT04695054|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24684696|NCT04695054|Anesthetics, Local|anesthetics, local|mesh-ancestor
24801222|NCT01981889|Prednisone|prednisone|mesh-list
24684785|NCT04182373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684786|NCT04182373|Anticoagulants|anticoagulants|mesh-ancestor
24684798|NCT04093596|Cyclophosphamide|cyclophosphamide|mesh-list
24684799|NCT04093596|Fludarabine|fludarabine|mesh-list
24684800|NCT04093596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24684801|NCT04093596|Immunologic Factors|immunologic factors|mesh-ancestor
24855077|NCT02277171|Autonomic Agents|autonomic agents|mesh-ancestor
24855078|NCT02277171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24855084|NCT02277171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855085|NCT02277171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24684955|NCT03129321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684956|NCT03129321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24684958|NCT03129321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24685029|NCT02871219|Lenalidomide|lenalidomide|mesh-list
24685030|NCT02871219|Obinutuzumab|obinutuzumab|mesh-list
24685031|NCT02871219|Immunologic Factors|immunologic factors|mesh-ancestor
24685032|NCT02871219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685033|NCT02871219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24685034|NCT02871219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24685230|NCT00703222|Interleukin-2|interleukin-2|mesh-list
24685231|NCT00703222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24685232|NCT00703222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24685233|NCT00703222|Analgesics|analgesics|mesh-ancestor
24685234|NCT00703222|Sensory System Agents|sensory system agents|mesh-ancestor
24685236|NCT00703222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685237|NCT00667329|Cyclophosphamide|cyclophosphamide|mesh-list
24685239|NCT00667329|Cladribine|cladribine|mesh-list
24685240|NCT00667329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24685241|NCT00667329|Immunologic Factors|immunologic factors|mesh-ancestor
25861455|NCT00086645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24685269|NCT05274139|Cytarabine|cytarabine|mesh-list
24685281|NCT05274139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24685282|NCT05274139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24685283|NCT05274139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24685284|NCT05274139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685285|NCT05274139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24685286|NCT05274139|Antimetabolites|antimetabolites|mesh-ancestor
24685287|NCT05274139|Antiviral Agents|antiviral agents|mesh-ancestor
24685288|NCT05274139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24685289|NCT05274139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24685290|NCT05274139|Immunologic Factors|immunologic factors|mesh-ancestor
24685291|NCT05274139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24685308|NCT05274113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24685348|NCT05273775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24685350|NCT05273775|Anticoagulants|anticoagulants|mesh-ancestor
24685375|NCT05273528|Immunologic Factors|immunologic factors|mesh-ancestor
24685376|NCT05273528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685377|NCT05273398|Diazepam|diazepam|mesh-list
24685378|NCT05273398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24685379|NCT05273398|Anticonvulsants|anticonvulsants|mesh-ancestor
24685380|NCT05273398|Antiemetics|antiemetics|mesh-ancestor
24685381|NCT05273398|Autonomic Agents|autonomic agents|mesh-ancestor
24685382|NCT05273398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24685383|NCT05273398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685384|NCT05273398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24549187|NCT00713765|Donepezil|donepezil|mesh-list
24685520|NCT05271253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25668005|NCT01710501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25668006|NCT01710501|Antiviral Agents|antiviral agents|mesh-ancestor
25668007|NCT01710501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25668008|NCT01710501|Antimetabolites|antimetabolites|mesh-ancestor
25668009|NCT01710501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668010|NCT01710501|Immunologic Factors|immunologic factors|mesh-ancestor
24685521|NCT05271253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25861456|NCT00086645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685550|NCT05271058|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24685552|NCT05271058|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24685553|NCT05271058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24685555|NCT05271058|Autonomic Agents|autonomic agents|mesh-ancestor
24685556|NCT05271058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24685557|NCT05271058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685595|NCT05270434|Antipyretics|antipyretics|mesh-ancestor
24685596|NCT05270421|Furosemide|furosemide|mesh-list
24685597|NCT05270421|Diuretics|diuretics|mesh-ancestor
24685598|NCT05270421|Natriuretic Agents|natriuretic agents|mesh-ancestor
24812697|NCT02054143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24812698|NCT02054143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812699|NCT02054182|Vitamin D|vitamin d|mesh-list
25199635|NCT02739672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685702|NCT05245760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24685703|NCT05245760|Tubulin Modulators|tubulin modulators|mesh-ancestor
24685704|NCT05245760|Antimitotic Agents|antimitotic agents|mesh-ancestor
24812702|NCT02054182|Micronutrients|micronutrients|mesh-ancestor
24812703|NCT02054182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812704|NCT02054182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24611593|NCT01010048|Adrenergic Agents|adrenergic agents|mesh-ancestor
24611594|NCT01010048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24685850|NCT05165875|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25034168|NCT03567369|Protease Inhibitors|protease inhibitors|mesh-ancestor
24685851|NCT05165875|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24812716|NCT02054299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24457610|NCT00334698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24685852|NCT05165875|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24685853|NCT05165875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24685854|NCT05165875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685855|NCT05165875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24685857|NCT05162118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24685858|NCT05162118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24685859|NCT05162118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24685860|NCT05162118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812717|NCT02054299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812718|NCT02054299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812719|NCT02054299|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24812720|NCT02054299|Antidepressive Agents|antidepressive agents|mesh-ancestor
24812721|NCT02054299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24549371|NCT00714883|Sirolimus|sirolimus|mesh-list
24686039|NCT05074056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24686040|NCT05074056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686041|NCT05074056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24686042|NCT05074056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24686043|NCT05074056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24686044|NCT05074056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24686045|NCT05074056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686046|NCT05067582|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
24686047|NCT05067582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24686048|NCT05067582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686049|NCT05067439|Efavirenz|efavirenz|mesh-list
24470949|NCT00392561|Trace Elements|trace elements|mesh-ancestor
24686074|NCT05067439|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24686075|NCT05067439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24686077|NCT05064137|Fluorides|fluorides|mesh-list
24686078|NCT05064137|Sodium Fluoride|sodium fluoride|mesh-list
24686240|NCT04968522|Dopamine Agents|dopamine agents|mesh-ancestor
24683453|NCT01392430|Dapsone|dapsone|mesh-list
24686264|NCT04949633|Oxytocin|oxytocin|mesh-list
24686265|NCT04949633|Oxytocics|oxytocics|mesh-ancestor
24855101|NCT02277223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855102|NCT02277223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24855103|NCT02277223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24855104|NCT02277223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855105|NCT02277223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855106|NCT02277223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855107|NCT02277457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24855109|NCT02277457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611663|NCT01010243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24686396|NCT04879823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686397|NCT04870333|Ciclesonide|ciclesonide|mesh-list
24686398|NCT04870333|Niclosamide|niclosamide|mesh-list
24686399|NCT04870333|Glucocorticoids|glucocorticoids|mesh-ancestor
24686401|NCT04870333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24686402|NCT04870333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686589|NCT04697719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686590|NCT04697719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24686591|NCT04697719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24686685|NCT04640636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24686686|NCT04640636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24686904|NCT04525755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24686905|NCT04525755|Cholinergic Agents|cholinergic agents|mesh-ancestor
24686906|NCT04525755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24686907|NCT04525755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641019|NCT01171365|Hormones|hormones|mesh-ancestor
24686989|NCT04454203|Mepivacaine|mepivacaine|mesh-list
24686990|NCT04454203|Anesthetics, Local|anesthetics, local|mesh-list
24686991|NCT04454203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25861457|NCT00086645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24683912|NCT01394731|Meperidine|meperidine|mesh-list
24687179|NCT04271956|Zanubrutinib|zanubrutinib|mesh-list
24687180|NCT04271956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24687181|NCT04271956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24687182|NCT04271956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861458|NCT00086645|Serotonin Agents|serotonin agents|mesh-ancestor
24687207|NCT04245644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24687208|NCT04245644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125272|NCT03070054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24687210|NCT04245644|Protease Inhibitors|protease inhibitors|mesh-ancestor
24687211|NCT04238845|Vitamin A|vitamin a|mesh-list
24687258|NCT04164199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24611703|NCT01010373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687704|NCT03777462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641280|NCT01172691|Antioxidants|antioxidants|mesh-ancestor
24687705|NCT03777462|Tubulin Modulators|tubulin modulators|mesh-ancestor
24687706|NCT03777462|Antimitotic Agents|antimitotic agents|mesh-ancestor
24611781|NCT01010672|Immunologic Factors|immunologic factors|mesh-ancestor
24611782|NCT01010672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611783|NCT01010698|Acyclovir|acyclovir|mesh-list
24611784|NCT01010698|Cimetidine|cimetidine|mesh-list
24593681|NCT00930566|Methoxsalen|methoxsalen|mesh-list
24611785|NCT01010698|Antiviral Agents|antiviral agents|mesh-ancestor
24611786|NCT01010698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24629517|NCT01105819|Chlorhexidine|chlorhexidine|mesh-list
24611787|NCT01010698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24611788|NCT01010698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24687749|NCT03733119|TIC10 compound|tic10 compound|mesh-list
24687750|NCT03733119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24687751|NCT03716921|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24687752|NCT03716921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24687753|NCT03716921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24687754|NCT03716921|Antitubercular Agents|antitubercular agents|mesh-ancestor
24687755|NCT03705962|Tobramycin|tobramycin|mesh-list
24687756|NCT03705962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24687757|NCT03705962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24687758|NCT03705338|Propofol|propofol|mesh-list
24688114|NCT03360214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688115|NCT03360214|Sensory System Agents|sensory system agents|mesh-ancestor
24688116|NCT03360214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24688118|NCT03359239|Poly ICLC|poly iclc|mesh-list
24688139|NCT03322293|Dermatologic Agents|dermatologic agents|mesh-ancestor
24688140|NCT03317405|Tamoxifen|tamoxifen|mesh-list
24688141|NCT03317405|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24688142|NCT03317405|Hormone Antagonists|hormone antagonists|mesh-ancestor
24920679|NCT04199364|Respiratory System Agents|respiratory system agents|mesh-ancestor
24684326|NCT01396720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24688236|NCT03254394|Lidocaine|lidocaine|mesh-list
24688237|NCT03254394|Anesthetics, Local|anesthetics, local|mesh-ancestor
24688238|NCT03254394|Anesthetics|anesthetics|mesh-ancestor
24688239|NCT03254394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24688240|NCT03254394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688241|NCT03254394|Sensory System Agents|sensory system agents|mesh-ancestor
24688242|NCT03254394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24688243|NCT03254394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24688273|NCT03203876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24688274|NCT03203876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688275|NCT03191240|Vasopressins|vasopressins|mesh-list
24688276|NCT03191240|Arginine Vasopressin|arginine vasopressin|mesh-list
25216750|NCT02682524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25216751|NCT02682524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216752|NCT02682524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25216753|NCT02682524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25216754|NCT02682485|Metronidazole|metronidazole|mesh-list
25216755|NCT02682485|Ciprofloxacin|ciprofloxacin|mesh-list
25216756|NCT02682485|Neomycin|neomycin|mesh-list
25216757|NCT02682485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24688277|NCT03191240|Hemostatics|hemostatics|mesh-ancestor
24688352|NCT03092011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24688353|NCT03092011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199636|NCT02739672|Vasodilator Agents|vasodilator agents|mesh-ancestor
25125344|NCT03069768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688354|NCT03091660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24688356|NCT03091660|BCG Vaccine|bcg vaccine|mesh-list
24684442|NCT05268627|Hormones|hormones|mesh-ancestor
24688850|NCT02636322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24688851|NCT02636322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24688853|NCT02636322|Antimitotic Agents|antimitotic agents|mesh-ancestor
24688854|NCT02636322|Mitosis Modulators|mitosis modulators|mesh-ancestor
24688855|NCT02636322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24688856|NCT02636322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24688881|NCT02619552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24688882|NCT02619552|Immunologic Factors|immunologic factors|mesh-ancestor
24920680|NCT04199325|Uric Acid|uric acid|mesh-list
24549712|NCT00717340|Paclitaxel|paclitaxel|mesh-list
24689055|NCT02427581|Interferon Inducers|interferon inducers|mesh-ancestor
24689056|NCT02427581|Immunologic Factors|immunologic factors|mesh-ancestor
25861459|NCT00086645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689183|NCT02293109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24689184|NCT02293109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689185|NCT02293109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24689186|NCT02293109|Abortifacient Agents|abortifacient agents|mesh-ancestor
24689187|NCT02293109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24689193|NCT02293109|Antiviral Agents|antiviral agents|mesh-ancestor
24689194|NCT02293109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24689195|NCT02293109|Antidotes|antidotes|mesh-ancestor
24689196|NCT02293109|Protective Agents|protective agents|mesh-ancestor
24689197|NCT02293109|Vitamin B Complex|vitamin b complex|mesh-ancestor
24689198|NCT02293109|Vitamins|vitamins|mesh-ancestor
24689199|NCT02293109|Micronutrients|micronutrients|mesh-ancestor
24689200|NCT02293109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24689312|NCT01740297|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
24689313|NCT01740297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24855207|NCT02277938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24855208|NCT02278081|Lansoprazole|lansoprazole|mesh-list
24855209|NCT02278081|Dexlansoprazole|dexlansoprazole|mesh-list
24855210|NCT02278081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25199637|NCT02739672|Diuretics|diuretics|mesh-ancestor
24855211|NCT02278081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24855212|NCT02278081|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24855213|NCT02278081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689447|NCT01515306|Paclitaxel|paclitaxel|mesh-list
24689448|NCT01515306|Ramucirumab|ramucirumab|mesh-list
24689449|NCT01515306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24689452|NCT01515306|Antimitotic Agents|antimitotic agents|mesh-ancestor
24689453|NCT01515306|Mitosis Modulators|mitosis modulators|mesh-ancestor
24689454|NCT01515306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689455|NCT01513187|Interferons|interferons|mesh-list
24689456|NCT01513187|Interferon-alpha|interferon-alpha|mesh-list
24689457|NCT01513187|Interferon alpha-2|interferon alpha-2|mesh-list
24689541|NCT01152541|Anticoagulants|anticoagulants|mesh-ancestor
24689542|NCT01152541|Plasma Substitutes|plasma substitutes|mesh-ancestor
24689543|NCT01152541|Blood Substitutes|blood substitutes|mesh-ancestor
24689544|NCT01112072|Riboflavin|riboflavin|mesh-list
24689545|NCT01112072|Vitamin B Complex|vitamin b complex|mesh-ancestor
24689546|NCT01112072|Vitamins|vitamins|mesh-ancestor
24689547|NCT01112072|Micronutrients|micronutrients|mesh-ancestor
24689548|NCT01112072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668011|NCT01710501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668012|NCT01710527|Metformin|metformin|mesh-list
25668013|NCT01710527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25668014|NCT01710527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668015|NCT01710657|Lacosamide|lacosamide|mesh-list
25668016|NCT01710657|Anticonvulsants|anticonvulsants|mesh-ancestor
25668017|NCT01710657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24689549|NCT01112072|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24689550|NCT01112072|Dermatologic Agents|dermatologic agents|mesh-ancestor
24689551|NCT01107717|Metformin|metformin|mesh-list
24689552|NCT01107717|Pioglitazone|pioglitazone|mesh-list
24689553|NCT01107717|Exenatide|exenatide|mesh-list
24689554|NCT01107717|Glyburide|glyburide|mesh-list
24855214|NCT02278081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855215|NCT02278172|Vitamin D|vitamin d|mesh-list
24689565|NCT01104350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689566|NCT01104350|Antiviral Agents|antiviral agents|mesh-ancestor
24689567|NCT01104350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24689593|NCT01085097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920681|NCT04199325|Antioxidants|antioxidants|mesh-ancestor
25861460|NCT00086645|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24689834|NCT00055731|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24689835|NCT00055731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689836|NCT00055731|Antipyretics|antipyretics|mesh-ancestor
24689837|NCT00055731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24689838|NCT00055731|Androgen Antagonists|androgen antagonists|mesh-ancestor
24689839|NCT00055731|Hormone Antagonists|hormone antagonists|mesh-ancestor
24689840|NCT00055731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24689854|NCT01397513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689855|NCT01397513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24689856|NCT01397513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25052805|NCT00138762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052806|NCT00135421|Citalopram|citalopram|mesh-list
25052807|NCT00135421|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25052808|NCT00135421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24690018|NCT01398384|Vasodilator Agents|vasodilator agents|mesh-ancestor
24690019|NCT01398384|Gasotransmitters|gasotransmitters|mesh-ancestor
24690020|NCT01398384|Protective Agents|protective agents|mesh-ancestor
24690021|NCT01398501|Sorafenib|sorafenib|mesh-list
24690022|NCT01398501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24690023|NCT01398501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24855224|NCT02278250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855226|NCT02278302|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
24549879|NCT00717821|Epoetin Alfa|epoetin alfa|mesh-list
24690099|NCT01399255|Insulin Lispro|insulin lispro|mesh-list
24593879|NCT00931398|Methylphenidate|methylphenidate|mesh-list
24690100|NCT01399255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24690101|NCT01399255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690103|NCT01399346|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24690104|NCT01399346|Insulin Aspart|insulin aspart|mesh-list
24690105|NCT01399346|Insulin, Long-Acting|insulin, long-acting|mesh-list
24690106|NCT01399346|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24690107|NCT01399346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24690108|NCT01399346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690109|NCT01399450|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24690110|NCT01399450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24690140|NCT01399515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24690141|NCT01399645|Insulin|insulin|mesh-list
24690142|NCT01399645|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24690143|NCT01399645|Metformin|metformin|mesh-list
24690144|NCT01399645|Insulin Glargine|insulin glargine|mesh-list
24690145|NCT01399645|Liraglutide|liraglutide|mesh-list
24690146|NCT01399645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24855251|NCT02278458|Gemcitabine|gemcitabine|mesh-list
24855252|NCT02278458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24855253|NCT02278458|Antimetabolites|antimetabolites|mesh-ancestor
24690406|NCT01401491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690407|NCT01401491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24690408|NCT01401491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24690409|NCT01401491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24690410|NCT01401491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24690411|NCT01401491|GABA Antagonists|gaba antagonists|mesh-ancestor
24690412|NCT01401491|GABA Agents|gaba agents|mesh-ancestor
24690413|NCT01401491|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24690414|NCT01401491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24690415|NCT01401491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24685292|NCT05274139|Alkylating Agents|alkylating agents|mesh-ancestor
24690438|NCT01401933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690439|NCT01401933|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24690440|NCT01401933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24690441|NCT01401933|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24690442|NCT01401933|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24690443|NCT01401933|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24690444|NCT01401933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24690446|NCT01402024|Antiemetics|antiemetics|mesh-ancestor
24690447|NCT01402024|Autonomic Agents|autonomic agents|mesh-ancestor
24690448|NCT01402024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24991845|NCT04871360|Laxatives|laxatives|mesh-ancestor
25216836|NCT02682225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216838|NCT02682225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25216839|NCT02682121|Metformin|metformin|mesh-list
25216840|NCT02682121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25216841|NCT02682121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690470|NCT01402076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24690471|NCT01402089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24690498|NCT01402089|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24690499|NCT01402089|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24690500|NCT01402089|Purinergic Agents|purinergic agents|mesh-ancestor
24690501|NCT01402180|Nimotuzumab|nimotuzumab|mesh-list
24690502|NCT01402180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24690503|NCT01402180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24690504|NCT01402193|Anastrozole|anastrozole|mesh-list
24690505|NCT01402193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24690506|NCT01402193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24690507|NCT01402193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24690508|NCT01402193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24690614|NCT01402882|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24690615|NCT01402882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24690616|NCT01402882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690644|NCT01403285|Cyclophosphamide|cyclophosphamide|mesh-list
24690653|NCT01403285|Alkylating Agents|alkylating agents|mesh-ancestor
24690654|NCT01403285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690655|NCT01403285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24690656|NCT01403285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24690657|NCT01403285|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24690658|NCT01403285|Interferon Inducers|interferon inducers|mesh-ancestor
24690659|NCT01403363|Fentanyl|fentanyl|mesh-list
24690660|NCT01403363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24690661|NCT01403363|Narcotics|narcotics|mesh-ancestor
24690662|NCT01403363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24690663|NCT01403363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690882|NCT01404312|Leprostatic Agents|leprostatic agents|mesh-ancestor
24690883|NCT01404338|Halobetasol|halobetasol|mesh-list
24690884|NCT01404338|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24690885|NCT01404364|Triamcinolone|triamcinolone|mesh-list
24690886|NCT01404364|Chlorpromazine|chlorpromazine|mesh-list
25125566|NCT03067896|Magnesium Sulfate|magnesium sulfate|mesh-list
24690887|NCT01404364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24690888|NCT01404364|Glucocorticoids|glucocorticoids|mesh-ancestor
24690889|NCT01404364|Hormones|hormones|mesh-ancestor
24690890|NCT01404364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24690891|NCT01404364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690892|NCT01404364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690893|NCT01404364|Antiemetics|antiemetics|mesh-ancestor
24690894|NCT01404364|Autonomic Agents|autonomic agents|mesh-ancestor
24690895|NCT01404364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24690896|NCT01404364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24690897|NCT01404364|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24690898|NCT01404364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24690899|NCT01404364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24690900|NCT01404364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24690901|NCT01404364|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24690902|NCT01404364|Dopamine Agents|dopamine agents|mesh-ancestor
24690903|NCT01404364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24690904|NCT01404377|Ropivacaine|ropivacaine|mesh-list
24690932|NCT01404442|GABA Agents|gaba agents|mesh-ancestor
24691002|NCT01404702|Analgesics|analgesics|mesh-ancestor
24691003|NCT01404702|Sensory System Agents|sensory system agents|mesh-ancestor
24641816|NCT01175525|Cromolyn Sodium|cromolyn sodium|mesh-list
24691004|NCT01404702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24691005|NCT01404702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691006|NCT01404702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24691007|NCT01404702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24691008|NCT01404702|Antiviral Agents|antiviral agents|mesh-ancestor
24691009|NCT01404702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25668018|NCT01710657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25668019|NCT01710657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25668020|NCT01710657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674428|NCT01772134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674429|NCT01772134|Anticonvulsants|anticonvulsants|mesh-ancestor
24691010|NCT01404702|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25042166|NCT01495013|Immunologic Factors|immunologic factors|mesh-ancestor
25042167|NCT01493505|Paclitaxel|paclitaxel|mesh-list
24691051|NCT01404806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24691053|NCT01404806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24691054|NCT01404819|Anesthetics|anesthetics|mesh-list
24691055|NCT01404819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24691056|NCT01404819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691057|NCT01404871|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24691058|NCT01404871|Citalopram|citalopram|mesh-list
24691059|NCT01404871|Clomipramine|clomipramine|mesh-list
24691060|NCT01404871|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24691061|NCT01404871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24691062|NCT01404871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24691063|NCT01404871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691064|NCT01404871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24691065|NCT01404871|Serotonin Agents|serotonin agents|mesh-ancestor
24691066|NCT01404871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691067|NCT01404871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24691068|NCT01404871|Antidepressive Agents|antidepressive agents|mesh-ancestor
24691069|NCT01404871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24691070|NCT01404871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24691071|NCT01404871|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24612084|NCT01011920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612086|NCT01011920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612087|NCT01011920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24612088|NCT01011920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24612089|NCT01011920|Abortifacient Agents|abortifacient agents|mesh-ancestor
24612090|NCT01011920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24612091|NCT01011920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24612092|NCT01011920|Antimetabolites|antimetabolites|mesh-ancestor
24612093|NCT01011920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855305|NCT02278861|Tretinoin|tretinoin|mesh-list
24855306|NCT02278861|Isotretinoin|isotretinoin|mesh-list
24612094|NCT01011920|Dermatologic Agents|dermatologic agents|mesh-ancestor
24612095|NCT01011920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612096|NCT01011920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24691299|NCT01406002|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24691300|NCT01406002|Antithrombins|antithrombins|mesh-ancestor
25199638|NCT02739672|Natriuretic Agents|natriuretic agents|mesh-ancestor
24691301|NCT01406002|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24691391|NCT01406392|Abortifacient Agents|abortifacient agents|mesh-ancestor
24691392|NCT01406392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24691444|NCT01406600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476763|NCT00416429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24691474|NCT01406704|Vitamin B Complex|vitamin b complex|mesh-ancestor
24691475|NCT01406704|Vitamins|vitamins|mesh-ancestor
24691476|NCT01406704|Micronutrients|micronutrients|mesh-ancestor
24691477|NCT01406782|Rituximab|rituximab|mesh-list
24691478|NCT01406782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24691479|NCT01406782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691480|NCT01406782|Immunologic Factors|immunologic factors|mesh-ancestor
24691481|NCT01406782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691578|NCT01408004|Everolimus|everolimus|mesh-list
24691579|NCT01408004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691580|NCT01408004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24691581|NCT01408004|Immunologic Factors|immunologic factors|mesh-ancestor
24691582|NCT01408004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691583|NCT01408056|Mupirocin|mupirocin|mesh-list
24691584|NCT01408056|Timolol|timolol|mesh-list
24691585|NCT01408056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24691586|NCT01408056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24691587|NCT01408056|Adrenergic Agents|adrenergic agents|mesh-ancestor
24691588|NCT01408056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24691589|NCT01408056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691590|NCT01408056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691591|NCT01408056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24691592|NCT01408056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24691593|NCT01408056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24691594|NCT01408056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24691796|NCT01409018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24691798|NCT01409018|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24691799|NCT01409122|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25668021|NCT01710709|Aripiprazole|aripiprazole|mesh-list
25668022|NCT01710709|Antidepressive Agents|antidepressive agents|mesh-ancestor
24691887|NCT01409603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24691888|NCT01409603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24691890|NCT01409603|Sensory System Agents|sensory system agents|mesh-ancestor
24691891|NCT01409603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24691892|NCT01409603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691893|NCT01409603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24691894|NCT01409603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24691895|NCT01409603|Gout Suppressants|gout suppressants|mesh-ancestor
24685926|NCT05138029|Ranibizumab|ranibizumab|mesh-list
24691964|NCT01409772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24692046|NCT01411072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24692047|NCT01411072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24692048|NCT01411072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24692049|NCT01411072|Immunologic Factors|immunologic factors|mesh-ancestor
24692050|NCT01411072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692052|NCT01411098|Etoposide phosphate|etoposide phosphate|mesh-list
24692053|NCT01411098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692054|NCT01411098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24692055|NCT01411098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24692058|NCT01411098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692059|NCT01411111|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24692060|NCT01411111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24692061|NCT01411111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24692095|NCT01411124|Antipruritics|antipruritics|mesh-ancestor
24855313|NCT02278861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692096|NCT01411124|Dermatologic Agents|dermatologic agents|mesh-ancestor
24813822|NCT02060604|Ranibizumab|ranibizumab|mesh-list
24692139|NCT01411423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24692140|NCT01411423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24692141|NCT01411423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692143|NCT01411436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692144|NCT01411436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25199639|NCT02739672|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24692145|NCT01411436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125712|NCT03067194|Sensory System Agents|sensory system agents|mesh-ancestor
24692146|NCT01411436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692147|NCT01411514|Prednisone|prednisone|mesh-list
24692148|NCT01411514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24692149|NCT01411514|Glucocorticoids|glucocorticoids|mesh-ancestor
24692150|NCT01411514|Hormones|hormones|mesh-ancestor
24692151|NCT01411514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24692152|NCT01411514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692153|NCT01411514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24692154|NCT01411514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447870|NCT00309725|Cholinergic Agents|cholinergic agents|mesh-ancestor
24692311|NCT01412671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24692312|NCT01412671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692313|NCT01412840|Diclofenac|diclofenac|mesh-list
24692357|NCT01413048|Antioxidants|antioxidants|mesh-ancestor
24692358|NCT01413048|Protective Agents|protective agents|mesh-ancestor
24692359|NCT01413048|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24692360|NCT01413048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24692361|NCT01413048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24692362|NCT01413048|Vasodilator Agents|vasodilator agents|mesh-ancestor
24692409|NCT01413620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692410|NCT01413620|Antioxidants|antioxidants|mesh-ancestor
24692411|NCT01413620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692412|NCT01413620|Protective Agents|protective agents|mesh-ancestor
24692413|NCT01413711|Vigabatrin|vigabatrin|mesh-list
24692414|NCT01413711|Anticonvulsants|anticonvulsants|mesh-ancestor
24692415|NCT01413711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24692416|NCT01413711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692422|NCT01413763|Immunologic Factors|immunologic factors|mesh-ancestor
24692461|NCT01414504|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24692463|NCT01414504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692464|NCT01414530|Contraceptive Agents|contraceptive agents|mesh-list
24692465|NCT01414530|Contraceptives, Oral|contraceptives, oral|mesh-list
24692466|NCT01414530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24692467|NCT01414530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692468|NCT01414530|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24692469|NCT01414556|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
24692472|NCT01414556|Hormones|hormones|mesh-ancestor
24692473|NCT01414556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24692474|NCT01414556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692475|NCT01414569|Dexamethasone|dexamethasone|mesh-list
24692652|NCT01415713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24692653|NCT01415713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24692654|NCT01415713|Immunologic Factors|immunologic factors|mesh-ancestor
24692655|NCT01415713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692657|NCT01415713|Protective Agents|protective agents|mesh-ancestor
24692658|NCT01415713|Vitamin B Complex|vitamin b complex|mesh-ancestor
24692659|NCT01415713|Vitamins|vitamins|mesh-ancestor
24692660|NCT01415713|Micronutrients|micronutrients|mesh-ancestor
24692661|NCT01415765|Prednisone|prednisone|mesh-list
24692724|NCT01416038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24692725|NCT01416038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24692726|NCT01416038|Alkylating Agents|alkylating agents|mesh-ancestor
24633777|NCT01131039|Antimetabolites|antimetabolites|mesh-ancestor
24855321|NCT02278926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692779|NCT01416337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692898|NCT01417065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692935|NCT01417390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24692936|NCT01417390|Immunologic Factors|immunologic factors|mesh-ancestor
24692937|NCT01417390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692938|NCT01417403|Hydroxychloroquine|hydroxychloroquine|mesh-list
24692939|NCT01417403|Antimalarials|antimalarials|mesh-ancestor
24855326|NCT02278978|Nintedanib|nintedanib|mesh-list
24855327|NCT02278978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208269|NCT02727998|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24855328|NCT02278978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24457798|NCT00335270|Ritonavir|ritonavir|mesh-list
24693180|NCT01418599|Urological Agents|urological agents|mesh-ancestor
24693181|NCT01418612|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24590324|NCT00912119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24693182|NCT01418612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24693183|NCT01418612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24693184|NCT01418612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24693185|NCT01418612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693186|NCT01418612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24864060|NCT01388491|Estrogens|estrogens|mesh-ancestor
24693187|NCT01418612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693188|NCT01418612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24693189|NCT01418612|Antidepressive Agents|antidepressive agents|mesh-ancestor
24693190|NCT01418612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24693191|NCT01418625|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24693502|NCT01420900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693503|NCT01420900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693504|NCT01420900|Cholinergic Agents|cholinergic agents|mesh-ancestor
25861461|NCT00086645|Antidepressive Agents|antidepressive agents|mesh-ancestor
24693529|NCT01421043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24693531|NCT01421043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24693532|NCT01421043|GABA Modulators|gaba modulators|mesh-ancestor
24693533|NCT01421043|GABA Agents|gaba agents|mesh-ancestor
24693769|NCT01422109|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24693770|NCT01422109|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24693771|NCT01422109|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24693772|NCT01422109|Purinergic Agents|purinergic agents|mesh-ancestor
24693773|NCT01422109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24693774|NCT01422122|Vitamin D|vitamin d|mesh-list
24693775|NCT01422122|Ergocalciferols|ergocalciferols|mesh-list
24693776|NCT01422122|Cholecalciferol|cholecalciferol|mesh-list
24693777|NCT01422122|Vitamins|vitamins|mesh-list
24693778|NCT01422122|Micronutrients|micronutrients|mesh-ancestor
24693779|NCT01422122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693780|NCT01422122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24693781|NCT01422122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24693782|NCT01422291|Acetaminophen|acetaminophen|mesh-list
24693783|NCT01422291|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
24693871|NCT01422616|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24693872|NCT01422616|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24693911|NCT01422785|Clindamycin|clindamycin|mesh-list
24612371|NCT01013558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24612372|NCT01013558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612373|NCT01013558|Analgesics|analgesics|mesh-ancestor
24693993|NCT01423292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24831342|NCT02164825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24831343|NCT02164825|Anesthetics, Local|anesthetics, local|mesh-ancestor
24831345|NCT02164838|Axitinib|axitinib|mesh-list
24831346|NCT02164838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24693995|NCT01423305|Formoterol Fumarate|formoterol fumarate|mesh-list
24693996|NCT01423305|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24694051|NCT01423539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24694052|NCT01423539|Alkylating Agents|alkylating agents|mesh-ancestor
24694053|NCT01423539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694056|NCT01423591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24694057|NCT01423591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24694058|NCT01423695|Paclitaxel|paclitaxel|mesh-list
24694059|NCT01423695|Trastuzumab|trastuzumab|mesh-list
24694060|NCT01423695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24694061|NCT01423695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694133|NCT01424111|Serotonin Agents|serotonin agents|mesh-ancestor
24694134|NCT01424111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694135|NCT01424111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24694950|NCT05020782|Belimumab|belimumab|mesh-list
25861462|NCT00086645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25861463|NCT00086645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25861464|NCT00086645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24695342|NCT03759028|Sensory System Agents|sensory system agents|mesh-ancestor
24695343|NCT03759028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24695344|NCT03759028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695345|NCT03759028|Antipyretics|antipyretics|mesh-ancestor
24696665|NCT01430806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24696668|NCT01430910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24696669|NCT01430910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24696670|NCT01430910|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24696671|NCT01430910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861465|NCT00086645|Parasympatholytics|parasympatholytics|mesh-ancestor
24696700|NCT01431092|Antioxidants|antioxidants|mesh-ancestor
24696701|NCT01431092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696702|NCT01431092|Protective Agents|protective agents|mesh-ancestor
24696703|NCT01431092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696942|NCT01431924|Autonomic Agents|autonomic agents|mesh-ancestor
24696943|NCT01431924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24697133|NCT01432977|Acetaminophen|acetaminophen|mesh-list
24697135|NCT01432977|Ondansetron|ondansetron|mesh-list
24697173|NCT01433328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697235|NCT01433887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24697236|NCT01433900|Latanoprost|latanoprost|mesh-list
24855349|NCT02279147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24855350|NCT02279147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697237|NCT01433900|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24697238|NCT01433900|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24697239|NCT01433952|Thiamine|thiamine|mesh-list
24697240|NCT01433952|Vitamin B Complex|vitamin b complex|mesh-ancestor
24697241|NCT01433952|Vitamins|vitamins|mesh-ancestor
24698327|NCT01440608|Anticestodal Agents|anticestodal agents|mesh-ancestor
24698328|NCT01440608|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24698407|NCT01440985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698408|NCT01440998|Paclitaxel|paclitaxel|mesh-list
24698409|NCT01440998|Carboplatin|carboplatin|mesh-list
24698410|NCT01440998|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24698411|NCT01440998|Dasatinib|dasatinib|mesh-list
24698412|NCT01440998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24698413|NCT01440998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698414|NCT01440998|Tubulin Modulators|tubulin modulators|mesh-ancestor
24698415|NCT01440998|Antimitotic Agents|antimitotic agents|mesh-ancestor
24483967|NCT00446017|Autonomic Agents|autonomic agents|mesh-ancestor
24698416|NCT01440998|Mitosis Modulators|mitosis modulators|mesh-ancestor
24698417|NCT01440998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698418|NCT01440998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24855357|NCT02279186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855358|NCT02279186|Hemostatics|hemostatics|mesh-ancestor
24698726|NCT01442727|Trace Elements|trace elements|mesh-ancestor
24698727|NCT01442727|Micronutrients|micronutrients|mesh-ancestor
24698728|NCT01442766|Donepezil|donepezil|mesh-list
25668023|NCT01710709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25668024|NCT01710709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25668025|NCT01710709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25668026|NCT01710709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25674430|NCT01772147|Fluticasone|fluticasone|mesh-list
24698729|NCT01442766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24698730|NCT01442766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698731|NCT01442766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698732|NCT01442766|Cholinergic Agents|cholinergic agents|mesh-ancestor
24698733|NCT01442766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24698734|NCT01442766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698735|NCT01442766|Nootropic Agents|nootropic agents|mesh-ancestor
24698736|NCT01442818|Hydromorphone|hydromorphone|mesh-list
25861466|NCT00086645|Autonomic Agents|autonomic agents|mesh-ancestor
25035909|NCT03552146|Anesthetics|anesthetics|mesh-ancestor
24698775|NCT01442935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698776|NCT01442935|Antidotes|antidotes|mesh-ancestor
24864141|NCT00602667|Etoposide|etoposide|mesh-list
24698928|NCT01443572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698929|NCT01443572|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24698931|NCT01443572|Anesthetics, General|anesthetics, general|mesh-ancestor
24698932|NCT01443624|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24855361|NCT02279316|Cholecalciferol|cholecalciferol|mesh-list
24855362|NCT02279316|Vitamins|vitamins|mesh-ancestor
24855363|NCT02279316|Micronutrients|micronutrients|mesh-ancestor
24855364|NCT02279316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855365|NCT02279316|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24633839|NCT01131364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855366|NCT02279316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24855377|NCT02279394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24855378|NCT02279394|Antiemetics|antiemetics|mesh-ancestor
24699483|NCT01447069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24855392|NCT02279394|Growth Inhibitors|growth inhibitors|mesh-ancestor
24855394|NCT02279511|Analgesics|analgesics|mesh-ancestor
24855395|NCT02279511|Sensory System Agents|sensory system agents|mesh-ancestor
24699484|NCT01447069|Respiratory System Agents|respiratory system agents|mesh-ancestor
24699713|NCT01448720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611718|NCT01010451|Calcium|calcium|mesh-list
24699752|NCT01448772|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24699753|NCT01448772|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24699754|NCT01448772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24699755|NCT01448772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485602|NCT00453908|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24855416|NCT02279563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24855417|NCT02279563|Autonomic Agents|autonomic agents|mesh-ancestor
24855418|NCT02279563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24700014|NCT01450163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24700015|NCT01450163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24700240|NCT01451489|Tacrolimus|tacrolimus|mesh-list
24700241|NCT01451489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24700242|NCT01451489|Immunologic Factors|immunologic factors|mesh-ancestor
24700243|NCT01451489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700244|NCT01451489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24855425|NCT02279563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855426|NCT02279563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700245|NCT01451489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24700308|NCT01451840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25861467|NCT00086645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24700445|NCT01452568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24700446|NCT01452568|Antifungal Agents|antifungal agents|mesh-ancestor
24700447|NCT01452568|Keratolytic Agents|keratolytic agents|mesh-ancestor
24700448|NCT01452568|Dermatologic Agents|dermatologic agents|mesh-ancestor
24700449|NCT01452607|Ebselen|ebselen|mesh-list
24700579|NCT01453400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24700580|NCT01453400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24700998|NCT01456312|Entecavir|entecavir|mesh-list
24700999|NCT01456312|Antiviral Agents|antiviral agents|mesh-ancestor
24701000|NCT01456312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24701001|NCT01456325|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24701002|NCT01456325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701003|NCT01456325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24701032|NCT01456481|Sympathomimetics|sympathomimetics|mesh-ancestor
24701033|NCT01456481|Autonomic Agents|autonomic agents|mesh-ancestor
24701034|NCT01456481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24701035|NCT01456481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701036|NCT01456481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24701037|NCT01456481|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25668027|NCT01710709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217043|NCT02680717|Hormones|hormones|mesh-ancestor
25217044|NCT02680717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25217045|NCT02680717|Dermatologic Agents|dermatologic agents|mesh-ancestor
25217046|NCT02680795|Belinostat|belinostat|mesh-list
24831366|NCT02165020|Viscosupplements|viscosupplements|mesh-ancestor
24831367|NCT02165020|Protective Agents|protective agents|mesh-ancestor
24831428|NCT02165332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24831429|NCT02165332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24701038|NCT01456481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24701039|NCT01456481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24701040|NCT01456481|Adrenergic Agents|adrenergic agents|mesh-ancestor
24701041|NCT01456481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24701042|NCT01456481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864215|NCT05147194|Vasodilator Agents|vasodilator agents|mesh-ancestor
24701043|NCT01456507|Naltrexone|naltrexone|mesh-list
24633772|NCT01131039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24633773|NCT01131039|Growth Substances|growth substances|mesh-ancestor
24633774|NCT01131039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633776|NCT01131039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25199640|NCT02739672|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25199641|NCT02739672|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25207665|NCT03514732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207666|NCT03514732|Protective Agents|protective agents|mesh-ancestor
25207667|NCT03514732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633778|NCT01131039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633779|NCT01131039|Antiviral Agents|antiviral agents|mesh-ancestor
24633780|NCT01131039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24633781|NCT01131039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633782|NCT01131039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24633783|NCT01131039|Immunologic Factors|immunologic factors|mesh-ancestor
24633784|NCT01131195|Paclitaxel|paclitaxel|mesh-list
24633785|NCT01131195|Cyclophosphamide|cyclophosphamide|mesh-list
24633843|NCT01131364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634096|NCT01132027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634138|NCT01132196|Valproic Acid|valproic acid|mesh-list
24634139|NCT01132196|Anticonvulsants|anticonvulsants|mesh-ancestor
24634140|NCT01132196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634141|NCT01132196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634142|NCT01132196|GABA Agents|gaba agents|mesh-ancestor
24634143|NCT01132196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24634144|NCT01132196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634145|NCT01132196|Antimanic Agents|antimanic agents|mesh-ancestor
24634146|NCT01132196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24634147|NCT01132196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24634148|NCT01132196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24634150|NCT01132222|Pseudoephedrine|pseudoephedrine|mesh-list
24634151|NCT01132222|Ephedrine|ephedrine|mesh-list
24634152|NCT01132222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24634366|NCT01133119|Sensory System Agents|sensory system agents|mesh-ancestor
24634367|NCT01133119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24634369|NCT01133210|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24634370|NCT01133210|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24634573|NCT01133925|Antifungal Agents|antifungal agents|mesh-ancestor
24634574|NCT01133925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24634575|NCT01133925|Immunologic Factors|immunologic factors|mesh-ancestor
24634576|NCT01133925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634577|NCT01134185|Prucalopride|prucalopride|mesh-list
24634578|NCT01134185|Laxatives|laxatives|mesh-ancestor
24634579|NCT01134185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24451916|NCT00325286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25668028|NCT01710709|Dopamine Agonists|dopamine agonists|mesh-ancestor
25668029|NCT01710709|Dopamine Agents|dopamine agents|mesh-ancestor
25668030|NCT01710709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25668031|NCT01710709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668032|NCT01710709|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25668033|NCT01710709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25668034|NCT01710709|Serotonin Agents|serotonin agents|mesh-ancestor
25668035|NCT01710709|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25668036|NCT01710709|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25674431|NCT01772147|Xhance|xhance|mesh-list
25217062|NCT02680548|Prednisolone phosphate|prednisolone phosphate|mesh-list
25217063|NCT02680548|Anesthetics, Local|anesthetics, local|mesh-ancestor
25217064|NCT02680548|Anesthetics|anesthetics|mesh-ancestor
25217065|NCT02680548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25217070|NCT02680548|Antiemetics|antiemetics|mesh-ancestor
24634595|NCT01134224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812753|NCT02054442|Methotrexate|methotrexate|mesh-list
24812755|NCT02054442|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24457854|NCT00335439|Ketorolac|ketorolac|mesh-list
24634596|NCT01134289|Bupivacaine|bupivacaine|mesh-list
24634597|NCT01134289|Levobupivacaine|levobupivacaine|mesh-list
24634598|NCT01134289|Anesthetics, Local|anesthetics, local|mesh-ancestor
24634599|NCT01134289|Anesthetics|anesthetics|mesh-ancestor
24634600|NCT01134289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24634601|NCT01134289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634602|NCT01134289|Sensory System Agents|sensory system agents|mesh-ancestor
24634603|NCT01134289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24634624|NCT01134432|Methylprednisolone|methylprednisolone|mesh-list
24634804|NCT01135446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634807|NCT01135472|Esomeprazole|esomeprazole|mesh-list
24634808|NCT01135472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24634809|NCT01135472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24634810|NCT01135472|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24634811|NCT01135472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634812|NCT01135472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634813|NCT01135550|Dexamethasone|dexamethasone|mesh-list
24634814|NCT01135550|Dexamethasone acetate|dexamethasone acetate|mesh-list
24634815|NCT01135550|BB 1101|bb 1101|mesh-list
24634816|NCT01135550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24634817|NCT01135550|Antiemetics|antiemetics|mesh-ancestor
24634818|NCT01135550|Autonomic Agents|autonomic agents|mesh-ancestor
24634825|NCT01135550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24634826|NCT01135550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24634827|NCT01135550|Protease Inhibitors|protease inhibitors|mesh-ancestor
24634828|NCT01135550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634829|NCT01135550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634830|NCT01135563|Sirolimus|sirolimus|mesh-list
24634831|NCT01135563|Vinblastine|vinblastine|mesh-list
24634832|NCT01135563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24634833|NCT01135563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24634834|NCT01135563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24634835|NCT01135563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24634836|NCT01135563|Antifungal Agents|antifungal agents|mesh-ancestor
24634837|NCT01135563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24634838|NCT01135563|Immunologic Factors|immunologic factors|mesh-ancestor
24864224|NCT05146713|Eusol|eusol|mesh-list
24864225|NCT05146713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24634841|NCT01135563|Tubulin Modulators|tubulin modulators|mesh-ancestor
24634842|NCT01135563|Antimitotic Agents|antimitotic agents|mesh-ancestor
24611811|NCT01010945|Paclitaxel|paclitaxel|mesh-list
24634884|NCT01135667|Purinergic Agents|purinergic agents|mesh-ancestor
24634885|NCT01135667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24634886|NCT01135667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634887|NCT01135667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634888|NCT01135680|Moxifloxacin|moxifloxacin|mesh-list
24634889|NCT01135680|Glycerol|glycerol|mesh-list
24634973|NCT01136278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24634974|NCT01136278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24634975|NCT01136278|Adrenergic Agents|adrenergic agents|mesh-ancestor
24634976|NCT01136278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24635008|NCT01136421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24635009|NCT01136421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24635010|NCT01136421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635011|NCT01136421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24635012|NCT01136421|Tocolytic Agents|tocolytic agents|mesh-ancestor
24635013|NCT01136421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24635120|NCT01137084|Prednisolone|prednisolone|mesh-list
24635121|NCT01137084|Prednisolone acetate|prednisolone acetate|mesh-list
24635122|NCT01137084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25668037|NCT01710709|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25668038|NCT01710709|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25668039|NCT01710787|Phenylephrine|phenylephrine|mesh-list
25668040|NCT01710787|Oxymetazoline|oxymetazoline|mesh-list
25668041|NCT01710787|Tetracaine|tetracaine|mesh-list
25668042|NCT01710787|Anesthetics, Local|anesthetics, local|mesh-ancestor
25668043|NCT01710787|Anesthetics|anesthetics|mesh-ancestor
24635124|NCT01137084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24635125|NCT01137084|Antiemetics|antiemetics|mesh-ancestor
24635126|NCT01137084|Autonomic Agents|autonomic agents|mesh-ancestor
24635127|NCT01137084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24635128|NCT01137084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635129|NCT01137084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24635130|NCT01137084|Glucocorticoids|glucocorticoids|mesh-ancestor
24635131|NCT01137084|Hormones|hormones|mesh-ancestor
24635132|NCT01137084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24635133|NCT01137084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24635134|NCT01137084|Protective Agents|protective agents|mesh-ancestor
24635135|NCT01137084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24635136|NCT01137084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24635629|NCT01140529|Dexmedetomidine|dexmedetomidine|mesh-list
24635630|NCT01140529|Haloperidol|haloperidol|mesh-list
24635631|NCT01140529|Haloperidol decanoate|haloperidol decanoate|mesh-list
24635899|NCT01141855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635900|NCT01141855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636072|NCT01142622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861468|NCT00086645|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25861469|NCT00086645|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24544216|NCT00687843|polysaccharide-K|polysaccharide-k|mesh-list
24544217|NCT00687843|Tegafur|tegafur|mesh-list
24636073|NCT01142622|Sensory System Agents|sensory system agents|mesh-ancestor
24636074|NCT01142622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24636077|NCT01142635|Anticonvulsants|anticonvulsants|mesh-ancestor
24636078|NCT01142635|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24636079|NCT01142635|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24636373|NCT01144988|Irinotecan|irinotecan|mesh-list
25861470|NCT00086645|Cholinergic Agents|cholinergic agents|mesh-ancestor
25861471|NCT00086710|Enfuvirtide|enfuvirtide|mesh-list
24636377|NCT01144988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24636378|NCT01144988|Growth Substances|growth substances|mesh-ancestor
24636379|NCT01144988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861472|NCT00086710|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25861473|NCT00086710|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25861474|NCT00086710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861475|NCT00086710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25861476|NCT00086710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25861477|NCT00086710|Antiviral Agents|antiviral agents|mesh-ancestor
25126218|NCT03063788|Copper|copper|mesh-list
25861478|NCT00086710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25861479|NCT00086736|Eflornithine|eflornithine|mesh-list
25861480|NCT00086736|Bicalutamide|bicalutamide|mesh-list
25861481|NCT00086736|Androgen Antagonists|androgen antagonists|mesh-ancestor
25861482|NCT00086736|Hormone Antagonists|hormone antagonists|mesh-ancestor
25861483|NCT00086736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24636642|NCT01146509|Nootropic Agents|nootropic agents|mesh-ancestor
24636644|NCT01146535|Interferon-alpha|interferon-alpha|mesh-list
24636646|NCT01146535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24636647|NCT01146535|Antiviral Agents|antiviral agents|mesh-ancestor
24636648|NCT01146535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24636649|NCT01146535|Immunologic Factors|immunologic factors|mesh-ancestor
24636661|NCT01146548|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24636662|NCT01146548|Antidepressive Agents|antidepressive agents|mesh-ancestor
24636663|NCT01146548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24636664|NCT01146548|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24636665|NCT01146548|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24636692|NCT01146977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24636693|NCT01146977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24636694|NCT01146977|Immunologic Factors|immunologic factors|mesh-ancestor
24636695|NCT01146977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636696|NCT01147016|Paclitaxel|paclitaxel|mesh-list
24636697|NCT01147016|Cyclophosphamide|cyclophosphamide|mesh-list
24636698|NCT01147016|Doxorubicin|doxorubicin|mesh-list
24636699|NCT01147016|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24689112|NCT02299999|Antimitotic Agents|antimitotic agents|mesh-ancestor
24636775|NCT01147276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636777|NCT01147289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25052884|NCT00134264|Torcetrapib|torcetrapib|mesh-list
25052885|NCT00134264|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25052886|NCT00134264|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25052887|NCT00134264|Antimetabolites|antimetabolites|mesh-ancestor
24636778|NCT01147289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24636780|NCT01147289|Sensory System Agents|sensory system agents|mesh-ancestor
24636782|NCT01147289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636783|NCT01147289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24636784|NCT01147289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24636785|NCT01147289|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24636786|NCT01147289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24636787|NCT01147289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636788|NCT01147289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636789|NCT01147354|Selenium|selenium|mesh-list
24636790|NCT01147354|Antioxidants|antioxidants|mesh-ancestor
25861484|NCT00086736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637055|NCT01148446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24637056|NCT01148446|Glucocorticoids|glucocorticoids|mesh-ancestor
24637057|NCT01148446|Hormones|hormones|mesh-ancestor
24637058|NCT01148446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24637195|NCT01149278|Benzocaine|benzocaine|mesh-list
24637206|NCT01149304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24637207|NCT01149304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24637208|NCT01149304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637216|NCT01149304|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24637217|NCT01149304|Antioxidants|antioxidants|mesh-ancestor
24637218|NCT01149304|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24855480|NCT02279875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24855482|NCT02279875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855483|NCT02279875|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24637233|NCT01149356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637235|NCT01149356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24637236|NCT01149356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637277|NCT01149577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24637278|NCT01149577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24637279|NCT01149577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24637280|NCT01149577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24637281|NCT01149577|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24637282|NCT01149577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24637300|NCT01149746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637301|NCT01149746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637306|NCT01149798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637307|NCT01149798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24637308|NCT01149798|Tubulin Modulators|tubulin modulators|mesh-ancestor
24637309|NCT01149798|Antimitotic Agents|antimitotic agents|mesh-ancestor
24637310|NCT01149798|Mitosis Modulators|mitosis modulators|mesh-ancestor
24689404|NCT01564537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637360|NCT01149967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24637361|NCT01149967|Serotonin Agents|serotonin agents|mesh-ancestor
25052891|NCT00134264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052892|NCT00134238|Atorvastatin|atorvastatin|mesh-list
25052893|NCT00134238|Torcetrapib|torcetrapib|mesh-list
25052894|NCT00134238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25052895|NCT00134238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25052896|NCT00134238|Antimetabolites|antimetabolites|mesh-ancestor
25052897|NCT00134238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637362|NCT01149967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637387|NCT01149980|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24637388|NCT01149980|Parasympatholytics|parasympatholytics|mesh-ancestor
24637390|NCT01149980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24637391|NCT01149980|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24637528|NCT01151241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637529|NCT01151241|Sensory System Agents|sensory system agents|mesh-ancestor
24637530|NCT01151241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24637532|NCT01151254|Sevoflurane|sevoflurane|mesh-list
24637533|NCT01151254|Isoflurane|isoflurane|mesh-list
24689513|NCT01216683|Lenalidomide|lenalidomide|mesh-list
24637602|NCT01151787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24637603|NCT01151787|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24637604|NCT01151787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637605|NCT01151787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24637606|NCT01151787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24637607|NCT01151787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24637608|NCT01151787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24637670|NCT01152346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637671|NCT01152346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637672|NCT01152346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637673|NCT01152372|Insulin|insulin|mesh-list
24637674|NCT01152372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24637675|NCT01152372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637677|NCT01152476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24637678|NCT01152476|Narcotics|narcotics|mesh-ancestor
24637702|NCT01152723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637703|NCT01152723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24637704|NCT01152723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24637705|NCT01152723|Cholinergic Agents|cholinergic agents|mesh-ancestor
24637706|NCT01152723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24637707|NCT01152723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861485|NCT00086736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637772|NCT01152931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24637774|NCT01152931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24637775|NCT01153100|Insulin Glargine|insulin glargine|mesh-list
24637776|NCT01153100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24637777|NCT01153100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637778|NCT01153165|Citalopram|citalopram|mesh-list
24637779|NCT01153165|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24637780|NCT01153165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25861486|NCT00086736|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24637783|NCT01153165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24637784|NCT01153165|Serotonin Agents|serotonin agents|mesh-ancestor
24637785|NCT01153165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637786|NCT01153165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24637880|NCT01153802|Serotonin|serotonin|mesh-list
24637881|NCT01153802|Neurotransmitter Agents|neurotransmitter agents|mesh-list
24637882|NCT01153802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25861487|NCT00086736|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24637939|NCT01154361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24637940|NCT01154361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24637941|NCT01154361|Analgesics|analgesics|mesh-ancestor
24637942|NCT01154361|Sensory System Agents|sensory system agents|mesh-ancestor
24637943|NCT01154361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24637976|NCT01154426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855499|NCT02279914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24855500|NCT02279914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24855501|NCT02279914|Oxytocics|oxytocics|mesh-ancestor
24855502|NCT02279953|Vortioxetine|vortioxetine|mesh-list
24855503|NCT02279953|Antidepressive Agents|antidepressive agents|mesh-ancestor
24855504|NCT02279953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24855510|NCT02279953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24855511|NCT02279953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24689795|NCT00309985|Hormones|hormones|mesh-ancestor
24638108|NCT01154881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638109|NCT01154907|Praziquantel|praziquantel|mesh-list
24638110|NCT01154907|Anthelmintics|anthelmintics|mesh-ancestor
24638111|NCT01154907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24638112|NCT01154907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24638158|NCT01155089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24638159|NCT01155089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638160|NCT01155102|Anastrozole|anastrozole|mesh-list
24638161|NCT01155102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24638162|NCT01155102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638163|NCT01155102|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24638164|NCT01155102|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24638165|NCT01155102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24638166|NCT01155102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638167|NCT01155102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25861488|NCT00086736|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24638200|NCT01155245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638448|NCT01156740|Penicillin G Procaine|penicillin g procaine|mesh-list
24638449|NCT01156740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24638450|NCT01156779|Exenatide|exenatide|mesh-list
24638808|NCT01158248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861489|NCT00086736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24638929|NCT01159236|Bevacizumab|bevacizumab|mesh-list
24638930|NCT01159236|Doxorubicin|doxorubicin|mesh-list
24638931|NCT01159236|Fluorouracil|fluorouracil|mesh-list
24638967|NCT01159275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25861490|NCT00086736|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
24638968|NCT01159275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24638970|NCT01159301|Entinostat|entinostat|mesh-list
24690201|NCT01400191|Metformin|metformin|mesh-list
24638997|NCT01159418|Mitosis Modulators|mitosis modulators|mesh-ancestor
24864370|NCT04742140|Magnesium Sulfate|magnesium sulfate|mesh-list
24864371|NCT04742140|Analgesics|analgesics|mesh-ancestor
24639025|NCT01159639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24639026|NCT01159639|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24639027|NCT01159639|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24639028|NCT01159639|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25861492|NCT00086736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639124|NCT01160315|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24639125|NCT01160315|Norethindrone|norethindrone|mesh-list
24639126|NCT01160315|Norethindrone Acetate|norethindrone acetate|mesh-list
24639127|NCT01160315|Luteolytic Agents|luteolytic agents|mesh-ancestor
24639128|NCT01160315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24639129|NCT01160315|Contraceptive Agents|contraceptive agents|mesh-ancestor
24639130|NCT01160315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24639131|NCT01160315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639325|NCT01161069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639327|NCT01161108|Antioxidants|antioxidants|mesh-ancestor
25861493|NCT00086775|Rituximab|rituximab|mesh-list
24639328|NCT01161108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639329|NCT01161108|Protective Agents|protective agents|mesh-ancestor
24639330|NCT01161108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639331|NCT01161108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24639332|NCT01161134|Meloxicam|meloxicam|mesh-list
24639333|NCT01161134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24639334|NCT01161134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24639335|NCT01161134|Analgesics|analgesics|mesh-ancestor
24639336|NCT01161134|Sensory System Agents|sensory system agents|mesh-ancestor
24639398|NCT01161277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24639399|NCT01161277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24639826|NCT01164345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24639827|NCT01164345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24639828|NCT01164345|Antiviral Agents|antiviral agents|mesh-ancestor
24639829|NCT01164345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24639830|NCT01164488|Ritonavir|ritonavir|mesh-list
24639831|NCT01164488|Ketoconazole|ketoconazole|mesh-list
24639963|NCT01165255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24639964|NCT01165255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24544285|NCT00688363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24544286|NCT00688363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24639965|NCT01165255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24639966|NCT01165255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639967|NCT01165255|Dopamine Agents|dopamine agents|mesh-ancestor
24639968|NCT01165255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24690749|NCT01403740|Cyclosporine|cyclosporine|mesh-list
24855621|NCT02280174|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24855622|NCT02280174|Protease Inhibitors|protease inhibitors|mesh-ancestor
24855623|NCT02280174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855624|NCT02280174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855625|NCT02280239|Acetaminophen|acetaminophen|mesh-list
24855626|NCT02280239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24855635|NCT02280447|Immunologic Factors|immunologic factors|mesh-ancestor
24855636|NCT02280447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855637|NCT02280486|Glimepiride|glimepiride|mesh-list
24855638|NCT02280486|Saxagliptin|saxagliptin|mesh-list
24855639|NCT02280486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24640108|NCT01166048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24640109|NCT01166048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855642|NCT02280486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24855643|NCT02280486|Immunologic Factors|immunologic factors|mesh-ancestor
24640254|NCT01167062|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24640255|NCT01167062|Adrenergic Agents|adrenergic agents|mesh-ancestor
24640256|NCT01167062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24640257|NCT01167062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855786|NCT02281006|Protective Agents|protective agents|mesh-ancestor
24640357|NCT01167738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640359|NCT01167738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24667558|NCT05384496|Axitinib|axitinib|mesh-list
24640360|NCT01167738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640361|NCT01167738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24640401|NCT01167920|Protease Inhibitors|protease inhibitors|mesh-ancestor
24640402|NCT01167920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640403|NCT01167920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640405|NCT01167920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24640406|NCT01167933|Simvastatin|simvastatin|mesh-list
24640519|NCT01168544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24640521|NCT01168739|Antioxidants|antioxidants|mesh-ancestor
24640522|NCT01168739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640525|NCT01168791|Doxorubicin|doxorubicin|mesh-list
24812761|NCT02054442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812770|NCT02054442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24812771|NCT02054468|Remifentanil|remifentanil|mesh-list
24812772|NCT02054468|Propofol|propofol|mesh-list
24812773|NCT02054468|Rocuronium|rocuronium|mesh-list
24812774|NCT02054468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24640686|NCT01169597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24640687|NCT01169597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640688|NCT01169688|Phenylephrine|phenylephrine|mesh-list
24640690|NCT01169688|Cyclopentolate|cyclopentolate|mesh-list
24640691|NCT01169688|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24640738|NCT01169805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24640739|NCT01169805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641002|NCT01171209|Interferon-beta|interferon-beta|mesh-list
24855703|NCT02280616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24855705|NCT02280629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24855706|NCT02280629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24855707|NCT02280629|Analgesics|analgesics|mesh-ancestor
24855708|NCT02280629|Sensory System Agents|sensory system agents|mesh-ancestor
24855709|NCT02280629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24855710|NCT02280629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861494|NCT00086775|Alemtuzumab|alemtuzumab|mesh-list
25861495|NCT00086775|Fludarabine|fludarabine|mesh-list
24855711|NCT02280629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24855712|NCT02280629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24855713|NCT02280694|Celecoxib|celecoxib|mesh-list
24855714|NCT02280694|Cyclophosphamide|cyclophosphamide|mesh-list
24855715|NCT02280694|Capecitabine|capecitabine|mesh-list
24641158|NCT01172223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24641159|NCT01172223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641160|NCT01172223|Tubulin Modulators|tubulin modulators|mesh-ancestor
24641161|NCT01172223|Antimitotic Agents|antimitotic agents|mesh-ancestor
24641191|NCT01172405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641192|NCT01172405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641193|NCT01172405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24641194|NCT01172405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24596166|NCT00942201|BB 1101|bb 1101|mesh-list
24641195|NCT01172405|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24813925|NCT02061124|Sequestering Agents|sequestering agents|mesh-ancestor
24813926|NCT02061124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813927|NCT02061137|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24641196|NCT01172405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24641431|NCT01173562|Piperazine|piperazine|mesh-list
24641432|NCT01173562|Piperazine citrate|piperazine citrate|mesh-list
24641433|NCT01173562|DMP 777|dmp 777|mesh-list
24641434|NCT01173562|Antinematodal Agents|antinematodal agents|mesh-ancestor
24641436|NCT01173562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24641437|NCT01173562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24641438|NCT01173562|Tubulin Modulators|tubulin modulators|mesh-ancestor
24641439|NCT01173562|Antimitotic Agents|antimitotic agents|mesh-ancestor
24641440|NCT01173562|Mitosis Modulators|mitosis modulators|mesh-ancestor
24855779|NCT02280993|Glucocorticoids|glucocorticoids|mesh-ancestor
24855781|NCT02280993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24855782|NCT02280993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24855783|NCT02280993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24855784|NCT02281006|Sodium thiosulfate|sodium thiosulfate|mesh-list
24855785|NCT02281006|Antidotes|antidotes|mesh-ancestor
24855787|NCT02281006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855788|NCT02281006|Antioxidants|antioxidants|mesh-ancestor
24641727|NCT01174927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641728|NCT01174927|Analgesics|analgesics|mesh-ancestor
24641729|NCT01174927|Sensory System Agents|sensory system agents|mesh-ancestor
24641730|NCT01174927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24641859|NCT01175772|Dermatologic Agents|dermatologic agents|mesh-ancestor
24641860|NCT01175772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641861|NCT01175772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24641862|NCT01175772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25861496|NCT00086775|Fludarabine phosphate|fludarabine phosphate|mesh-list
25217251|NCT02679092|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25217252|NCT02679092|Hormone Antagonists|hormone antagonists|mesh-ancestor
25217253|NCT02679092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25217254|NCT02679092|Luteolytic Agents|luteolytic agents|mesh-ancestor
25217255|NCT02679092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25217256|NCT02679092|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25217257|NCT02679040|Trastuzumab|trastuzumab|mesh-list
25217258|NCT02679040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25217259|NCT02679040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25217260|NCT02678949|Fluticasone|fluticasone|mesh-list
25217261|NCT02678949|Xhance|xhance|mesh-list
25217262|NCT02678949|Albuterol|albuterol|mesh-list
25217263|NCT02678949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24641863|NCT01175772|Immunologic Factors|immunologic factors|mesh-ancestor
24641864|NCT01175772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24641912|NCT01176708|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24641914|NCT01176708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641915|NCT01176708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641916|NCT01176708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24691977|NCT01410201|Antiemetics|antiemetics|mesh-ancestor
24855829|NCT02281279|Romidepsin|romidepsin|mesh-list
24855830|NCT02281279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24855831|NCT02281279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642043|NCT01177371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642044|NCT01177371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24642045|NCT01177371|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24642046|NCT01177371|Abortifacient Agents|abortifacient agents|mesh-ancestor
24692062|NCT01411111|Antimetabolites|antimetabolites|mesh-ancestor
24642060|NCT01177371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24642061|NCT01177371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24642062|NCT01177371|Glucocorticoids|glucocorticoids|mesh-ancestor
24642063|NCT01177371|Hormones|hormones|mesh-ancestor
25199643|NCT02739685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199644|NCT02739685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25199645|NCT02739685|Immunologic Factors|immunologic factors|mesh-ancestor
25199646|NCT02739685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199647|NCT02739633|Gemcitabine|gemcitabine|mesh-list
25199648|NCT02739633|Paclitaxel|paclitaxel|mesh-list
25199649|NCT02739633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25199650|NCT02739633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642064|NCT01177371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24642065|NCT01177371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24642066|NCT01177371|Protective Agents|protective agents|mesh-ancestor
24642067|NCT01177371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24642068|NCT01177423|Anesthetics|anesthetics|mesh-list
24642069|NCT01177423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24642070|NCT01177423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642071|NCT01177501|Topotecan|topotecan|mesh-list
24642072|NCT01177501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24642073|NCT01177501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24642074|NCT01177501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642075|NCT01177501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642076|NCT01177501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642106|NCT01177566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642108|NCT01177579|Trace Elements|trace elements|mesh-ancestor
24642109|NCT01177579|Micronutrients|micronutrients|mesh-ancestor
24642110|NCT01177579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642111|NCT01177683|Doxorubicin|doxorubicin|mesh-list
24642113|NCT01177683|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24642114|NCT01177683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24642115|NCT01177683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25668044|NCT01710787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25668045|NCT01710787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668046|NCT01710787|Sensory System Agents|sensory system agents|mesh-ancestor
25668047|NCT01710787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25668048|NCT01710787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25668049|NCT01710787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25668050|NCT01710787|Adrenergic Agents|adrenergic agents|mesh-ancestor
25668051|NCT01710787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25668052|NCT01710787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668053|NCT01710787|Sympathomimetics|sympathomimetics|mesh-ancestor
25668054|NCT01710787|Autonomic Agents|autonomic agents|mesh-ancestor
25668055|NCT01710787|Nasal Decongestants|nasal decongestants|mesh-ancestor
25668056|NCT01710787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24939617|NCT04008186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24642116|NCT01177683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24642117|NCT01177683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24642118|NCT01177683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642119|NCT01177683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855853|NCT02281305|Antimitotic Agents|antimitotic agents|mesh-ancestor
24692194|NCT01411969|Phenylephrine|phenylephrine|mesh-list
24642297|NCT01178710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24642298|NCT01178710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24642299|NCT01178710|Antimetabolites|antimetabolites|mesh-ancestor
25861497|NCT00086775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24642300|NCT01178710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642302|NCT01178710|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24642303|NCT01178710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642304|NCT01178788|Progesterone|progesterone|mesh-list
24642305|NCT01178788|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
24642306|NCT01178788|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
24642307|NCT01178788|Progestins|progestins|mesh-ancestor
24864508|NCT03719924|Mitosis Modulators|mitosis modulators|mesh-ancestor
24642309|NCT01178788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24642383|NCT01179152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24642384|NCT01179152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24642385|NCT01179152|Autonomic Agents|autonomic agents|mesh-ancestor
24642386|NCT01179152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24642387|NCT01179152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642388|NCT01179152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24642446|NCT01179438|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25861498|NCT00086775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642447|NCT01179438|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24642448|NCT01179438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24642449|NCT01179438|Adrenergic Agents|adrenergic agents|mesh-ancestor
24855889|NCT02281682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855891|NCT02281682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855892|NCT02281682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24855893|NCT02281682|Immunologic Factors|immunologic factors|mesh-ancestor
24855894|NCT02281682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855895|NCT02281682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24458315|NCT00337441|Hematinics|hematinics|mesh-ancestor
24642544|NCT01179971|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24642545|NCT01179971|Dermatologic Agents|dermatologic agents|mesh-ancestor
24642546|NCT01180062|Latanoprost|latanoprost|mesh-list
24642594|NCT01180205|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24642595|NCT01180205|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24642596|NCT01180205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24642597|NCT01180205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24642598|NCT01180205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642599|NCT01180205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24642600|NCT01180205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861499|NCT00086775|Immunologic Factors|immunologic factors|mesh-ancestor
24642601|NCT01180205|Vasodilator Agents|vasodilator agents|mesh-ancestor
24642816|NCT01181505|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24642818|NCT01181505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24642978|NCT01182662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643011|NCT01183247|Prednisone|prednisone|mesh-list
24643012|NCT01183247|Everolimus|everolimus|mesh-list
24643013|NCT01183247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24643015|NCT01183247|Hormones|hormones|mesh-ancestor
24643016|NCT01183247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24855915|NCT02281799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24855916|NCT02281799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855917|NCT02281799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24855918|NCT02281799|Immunologic Factors|immunologic factors|mesh-ancestor
24643017|NCT01183247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643115|NCT01183676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864589|NCT03238495|Metformin|metformin|mesh-list
24643204|NCT01184443|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24643205|NCT01184443|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24643453|NCT01185743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644211|NCT01189773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24644212|NCT01189773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25668057|NCT01710787|Respiratory System Agents|respiratory system agents|mesh-ancestor
24855963|NCT02282085|Olanzapine|olanzapine|mesh-list
24855964|NCT02282085|Risperidone|risperidone|mesh-list
24644476|NCT01191203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24645216|NCT01196559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645217|NCT01196559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24645218|NCT01196559|Antiviral Agents|antiviral agents|mesh-ancestor
24645219|NCT01196559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24645220|NCT01196559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24645221|NCT01196559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24645222|NCT01196559|Immunologic Factors|immunologic factors|mesh-ancestor
24645233|NCT01196754|Anesthetics, General|anesthetics, general|mesh-ancestor
24645234|NCT01196754|Anesthetics|anesthetics|mesh-ancestor
24645235|NCT01196754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24645236|NCT01196754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645237|NCT01196767|Ropivacaine|ropivacaine|mesh-list
24645300|NCT01197170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645301|NCT01197170|Growth Inhibitors|growth inhibitors|mesh-ancestor
24645302|NCT01197170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24645303|NCT01197170|Immunologic Factors|immunologic factors|mesh-ancestor
24645304|NCT01197170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24645305|NCT01197170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24645341|NCT01197781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24645458|NCT01198249|Natriuretic Agents|natriuretic agents|mesh-ancestor
24645459|NCT01198249|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24645460|NCT01198314|Immunosuppressive Agents|immunosuppressive agents|mesh-list
24645461|NCT01198314|Immunologic Factors|immunologic factors|mesh-ancestor
24645462|NCT01198314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645463|NCT01198340|Ropivacaine|ropivacaine|mesh-list
24645464|NCT01198340|Anesthetics, Local|anesthetics, local|mesh-list
24645465|NCT01198340|Anesthetics|anesthetics|mesh-list
24856707|NCT02286453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864698|NCT02799641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24864699|NCT02799641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24645486|NCT01198379|Sensory System Agents|sensory system agents|mesh-ancestor
24864700|NCT02799641|Anesthetics, General|anesthetics, general|mesh-ancestor
24645487|NCT01198379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24645488|NCT01198379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645489|NCT01198379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24645562|NCT01198665|Everolimus|everolimus|mesh-list
24544567|NCT00689559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24645563|NCT01198665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24645564|NCT01198665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24645632|NCT01199029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24645633|NCT01199081|Dronedarone|dronedarone|mesh-list
24645634|NCT01199081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24645635|NCT01199159|Vitamin B 6|vitamin b 6|mesh-list
24645636|NCT01199159|Pyridoxal|pyridoxal|mesh-list
24645637|NCT01199159|Pyridoxine|pyridoxine|mesh-list
24645762|NCT01199562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861500|NCT00086775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645763|NCT01199562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645764|NCT01199562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24645765|NCT01199614|Parathyroid Hormone|parathyroid hormone|mesh-list
25861501|NCT00086775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24812865|NCT02054988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812867|NCT02054988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812868|NCT02054988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856068|NCT02282657|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
24856069|NCT02282657|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24856070|NCT02282657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24856071|NCT02282657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856072|NCT02282683|Prednisone|prednisone|mesh-list
24856073|NCT02282683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24856168|NCT02283060|Antiviral Agents|antiviral agents|mesh-ancestor
24856169|NCT02283060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24693949|NCT01423032|Fludarabine|fludarabine|mesh-list
24646088|NCT01202032|Growth Inhibitors|growth inhibitors|mesh-ancestor
24646089|NCT01202058|Sirolimus|sirolimus|mesh-list
24646090|NCT01202058|Everolimus|everolimus|mesh-list
24646091|NCT01202058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24668850|NCT04551131|Glucocorticoids|glucocorticoids|mesh-ancestor
24646092|NCT01202058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24856221|NCT02283242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856257|NCT02283372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544570|NCT00689559|Dopamine Agonists|dopamine agonists|mesh-ancestor
24952282|NCT03895970|Pembrolizumab|pembrolizumab|mesh-list
24952283|NCT03895970|Lenvatinib|lenvatinib|mesh-list
24952284|NCT03895970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24952285|NCT03895970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24952286|NCT03895970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24856259|NCT02283424|Docetaxel|docetaxel|mesh-list
24856260|NCT02283424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24856370|NCT02283905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24856371|NCT02283905|Amebicides|amebicides|mesh-ancestor
24646725|NCT01205009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24646787|NCT01205139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856705|NCT02286453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24856706|NCT02286453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24856708|NCT02286453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812956|NCT02055456|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
24812957|NCT02055456|Androgens|androgens|mesh-ancestor
24812958|NCT02055456|Hormones|hormones|mesh-ancestor
24696219|NCT01428180|Analgesics|analgesics|mesh-ancestor
24650764|NCT01227876|Prednisolone acetate|prednisolone acetate|mesh-list
24650954|NCT01228604|Methylphenidate|methylphenidate|mesh-list
24650955|NCT01228604|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24650956|NCT01228604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650957|NCT01228604|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24650958|NCT01228604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24650959|NCT01228604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24650960|NCT01228604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650962|NCT01228604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24650963|NCT01228617|Nicotine|nicotine|mesh-list
24650964|NCT01228617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24650965|NCT01228617|Autonomic Agents|autonomic agents|mesh-ancestor
24650966|NCT01228617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24651734|NCT01233583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24612683|NCT01015066|Naltrexone|naltrexone|mesh-list
24652460|NCT01238393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652779|NCT01240096|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24652781|NCT01240109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24652874|NCT01240824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24652875|NCT01240824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24652876|NCT01240824|Purinergic Agents|purinergic agents|mesh-ancestor
24653706|NCT01245244|Sensory System Agents|sensory system agents|mesh-ancestor
24697097|NCT01432704|Vitamin D|vitamin d|mesh-list
24697290|NCT01434069|Vitamins|vitamins|mesh-ancestor
25199651|NCT02739633|Tubulin Modulators|tubulin modulators|mesh-ancestor
24655153|NCT01254617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655154|NCT01254617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655155|NCT01254617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24655156|NCT01254617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24655157|NCT01254617|Growth Substances|growth substances|mesh-ancestor
24655158|NCT01254617|Growth Inhibitors|growth inhibitors|mesh-ancestor
24655160|NCT00660673|Carbidopa|carbidopa|mesh-list
24655161|NCT00660673|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24655162|NCT00660673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24655163|NCT00660673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24655164|NCT00660673|Dopamine Agents|dopamine agents|mesh-ancestor
24655165|NCT00660673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24655166|NCT00660673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655167|NCT00660673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813055|NCT02056249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24813056|NCT02056249|Adrenergic Agents|adrenergic agents|mesh-ancestor
24813057|NCT02056249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24655168|NCT00660673|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24501845|NCT00531323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501846|NCT00531323|Antiviral Agents|antiviral agents|mesh-ancestor
24501847|NCT00531323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24443458|NCT00294996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501848|NCT00531336|Bevacizumab|bevacizumab|mesh-list
24501849|NCT00531336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24501850|NCT00531336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501851|NCT00531336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24501853|NCT00531336|Growth Substances|growth substances|mesh-ancestor
24697367|NCT01434173|Renal Agents|renal agents|mesh-ancestor
25861502|NCT00086775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24659432|NCT01277640|Antiviral Agents|antiviral agents|mesh-ancestor
24659433|NCT01277640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24659434|NCT01277705|Vaccines|vaccines|mesh-list
24659435|NCT01277705|Immunologic Factors|immunologic factors|mesh-ancestor
24660556|NCT01284413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24660557|NCT01284413|Immunologic Factors|immunologic factors|mesh-ancestor
24660558|NCT01284413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660559|NCT01284439|Hyaluronic Acid|hyaluronic acid|mesh-list
24660560|NCT01284439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24660561|NCT01284439|Immunologic Factors|immunologic factors|mesh-ancestor
25861503|NCT00086775|Antimetabolites|antimetabolites|mesh-ancestor
24661089|NCT01287741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24661090|NCT01287741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24661091|NCT01287741|Tubulin Modulators|tubulin modulators|mesh-ancestor
24661092|NCT01287741|Antimitotic Agents|antimitotic agents|mesh-ancestor
24661093|NCT01287741|Mitosis Modulators|mitosis modulators|mesh-ancestor
24661151|NCT01288157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661580|NCT01290003|Amikacin|amikacin|mesh-list
24661581|NCT01290003|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24661582|NCT01290003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24661583|NCT01290003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24661584|NCT01290003|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24612944|NCT01016002|Temoporfin|temoporfin|mesh-list
24661828|NCT01291199|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24661830|NCT01291199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661831|NCT01291199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661832|NCT01291199|Urological Agents|urological agents|mesh-ancestor
24661833|NCT01291212|Methyltestosterone|methyltestosterone|mesh-list
24661834|NCT01291212|Testosterone|testosterone|mesh-list
24661835|NCT01291212|Testosterone undecanoate|testosterone undecanoate|mesh-list
24661836|NCT01291212|Testosterone enanthate|testosterone enanthate|mesh-list
24661837|NCT01291212|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24661838|NCT01291212|Androgens|androgens|mesh-ancestor
24857281|NCT02290470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24857282|NCT02290470|Carboplatin|carboplatin|mesh-list
24857283|NCT02290470|Olanzapine|olanzapine|mesh-list
24857284|NCT02290470|Palonosetron|palonosetron|mesh-list
24662071|NCT01292343|Fluorides|fluorides|mesh-list
24662072|NCT01292343|Sodium Fluoride|sodium fluoride|mesh-list
24662073|NCT01292343|Cariostatic Agents|cariostatic agents|mesh-ancestor
24448039|NCT00310128|Cytarabine|cytarabine|mesh-list
24662315|NCT01293942|Growth Inhibitors|growth inhibitors|mesh-ancestor
24662316|NCT01293942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24662439|NCT01294969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24662440|NCT01294969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24662441|NCT01294969|Analgesics|analgesics|mesh-ancestor
24662442|NCT01294969|Sensory System Agents|sensory system agents|mesh-ancestor
24662814|NCT01297010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24662815|NCT01297010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662816|NCT01297010|Protease Inhibitors|protease inhibitors|mesh-ancestor
24662817|NCT01297010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199652|NCT02739633|Antimitotic Agents|antimitotic agents|mesh-ancestor
25668058|NCT01710787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25668059|NCT01710787|Mydriatics|mydriatics|mesh-ancestor
25668060|NCT01710787|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25668061|NCT01710787|Protective Agents|protective agents|mesh-ancestor
25668062|NCT01710800|Esomeprazole|esomeprazole|mesh-list
25668063|NCT01710800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25668064|NCT01710800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25668065|NCT01710800|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25668066|NCT01710800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25668067|NCT01710800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668068|NCT01710839|Ranibizumab|ranibizumab|mesh-list
25861504|NCT00086775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501860|NCT00531349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501861|NCT00531349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24542842|NCT00680511|Sympathomimetics|sympathomimetics|mesh-ancestor
24662818|NCT01297010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662905|NCT01297634|Botulinum Toxins|botulinum toxins|mesh-list
24662906|NCT01297634|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24801689|NCT01985061|Busulfan|busulfan|mesh-list
24663538|NCT01302132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663539|NCT01302132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24663540|NCT01302132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663543|NCT01302145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24663544|NCT01302145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663569|NCT01302236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24663570|NCT01302236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663572|NCT01302236|Diuretics|diuretics|mesh-ancestor
24663573|NCT01302236|Natriuretic Agents|natriuretic agents|mesh-ancestor
24663574|NCT01302236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24663575|NCT01302275|Oxcarbazepine|oxcarbazepine|mesh-list
24663725|NCT01303497|Growth Inhibitors|growth inhibitors|mesh-ancestor
24663726|NCT01303536|Ondansetron|ondansetron|mesh-list
24664254|NCT01305733|Levobupivacaine|levobupivacaine|mesh-list
24664255|NCT01305733|Epinephryl borate|epinephryl borate|mesh-list
24664256|NCT01305733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24664511|NCT01307475|Sensory System Agents|sensory system agents|mesh-ancestor
24664588|NCT01307865|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24664609|NCT01307969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24664610|NCT01307969|Adrenergic Agents|adrenergic agents|mesh-ancestor
24665000|NCT01309633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24665326|NCT01311739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665328|NCT01311765|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24665329|NCT01311765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24665330|NCT01311778|Fentanyl|fentanyl|mesh-list
24665331|NCT01311778|Cannabidiol|cannabidiol|mesh-list
24665520|NCT01313143|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24665521|NCT01313143|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24665522|NCT01313143|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24857346|NCT02291211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24857347|NCT02291341|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24665658|NCT01313845|Analgesics|analgesics|mesh-ancestor
24665659|NCT01313845|Sensory System Agents|sensory system agents|mesh-ancestor
24665660|NCT01313845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24665661|NCT01314027|Gemcitabine|gemcitabine|mesh-list
24665766|NCT01314677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665768|NCT01314781|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24665769|NCT01314781|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24665890|NCT01315691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24665891|NCT01315691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24864771|NCT02229136|Prednisolone|prednisolone|mesh-list
24665894|NCT01315704|Micronutrients|micronutrients|mesh-ancestor
24665895|NCT01315704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665896|NCT01315704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24665997|NCT01316718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24665998|NCT01316718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24665999|NCT01316718|Analgesics|analgesics|mesh-ancestor
24666000|NCT01316718|Sensory System Agents|sensory system agents|mesh-ancestor
24666235|NCT01318096|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24666729|NCT01320592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24666730|NCT01320592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666731|NCT01320709|Piroxicam|piroxicam|mesh-list
25199653|NCT02739633|Mitosis Modulators|mitosis modulators|mesh-ancestor
24666734|NCT01320709|Analgesics|analgesics|mesh-ancestor
24666735|NCT01320709|Sensory System Agents|sensory system agents|mesh-ancestor
24666736|NCT01320709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24700411|NCT01452477|Analgesics|analgesics|mesh-ancestor
24667701|NCT05323214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24667702|NCT05323214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24667703|NCT05323214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25668069|NCT01710839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25668070|NCT01710839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25668071|NCT01710839|Growth Substances|growth substances|mesh-ancestor
25668072|NCT01710839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667706|NCT05323214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24667707|NCT05323214|Adrenergic Agents|adrenergic agents|mesh-ancestor
24667708|NCT05323214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24667867|NCT05261516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25861505|NCT00086775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25199654|NCT02739633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199655|NCT02739633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25199656|NCT02739633|Antimetabolites|antimetabolites|mesh-ancestor
25199657|NCT02739633|Antiviral Agents|antiviral agents|mesh-ancestor
25199658|NCT02739633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25199659|NCT02739633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199660|NCT02739633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25199661|NCT02739633|Immunologic Factors|immunologic factors|mesh-ancestor
25199662|NCT02739633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199663|NCT02739477|Favipiravir|favipiravir|mesh-list
25199664|NCT02739477|Antiviral Agents|antiviral agents|mesh-ancestor
25861507|NCT00086801|Doxorubicin|doxorubicin|mesh-list
25861508|NCT00086801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25861509|NCT00086801|Vinblastine|vinblastine|mesh-list
25861510|NCT00086801|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25861511|NCT00086801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25861512|NCT00086801|Antimetabolites|antimetabolites|mesh-ancestor
25861513|NCT00086801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861514|NCT00086801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861515|NCT00086801|Antiviral Agents|antiviral agents|mesh-ancestor
25861516|NCT00086801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25861517|NCT00086801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861518|NCT00086801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25861519|NCT00086801|Immunologic Factors|immunologic factors|mesh-ancestor
25861520|NCT00086801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861521|NCT00086801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25861522|NCT00086801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24533755|NCT00645073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24701455|NCT01459146|Anthelmintics|anthelmintics|mesh-ancestor
25861523|NCT00086801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25861524|NCT00086801|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25861525|NCT00086801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25861526|NCT00086801|Tubulin Modulators|tubulin modulators|mesh-ancestor
25861527|NCT00086801|Antimitotic Agents|antimitotic agents|mesh-ancestor
24813995|NCT02061800|Methylprednisolone|methylprednisolone|mesh-list
24813996|NCT02061800|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24813997|NCT02061800|Cyclophosphamide|cyclophosphamide|mesh-list
25861528|NCT00086801|Mitosis Modulators|mitosis modulators|mesh-ancestor
25861529|NCT00086827|Romidepsin|romidepsin|mesh-list
25861530|NCT00086827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25861531|NCT00086827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861532|NCT00086840|Sirolimus|sirolimus|mesh-list
25861533|NCT00086840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25861534|NCT00086840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25861535|NCT00086840|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25861536|NCT00086840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861537|NCT00086840|Antifungal Agents|antifungal agents|mesh-ancestor
25861538|NCT00086840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25861539|NCT00086840|Immunologic Factors|immunologic factors|mesh-ancestor
25861540|NCT00086840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861541|NCT00086879|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25861542|NCT00086879|Temozolomide|temozolomide|mesh-list
25861543|NCT00086879|Carmustine|carmustine|mesh-list
25861544|NCT00086879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458359|NCT00337558|Cholinergic Agents|cholinergic agents|mesh-ancestor
24458360|NCT00337558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24404537|NCT00163969|Analgesics|analgesics|mesh-ancestor
25668073|NCT01710839|Growth Inhibitors|growth inhibitors|mesh-ancestor
25668074|NCT01710839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25668075|NCT01711177|Travoprost|travoprost|mesh-list
25668076|NCT01711177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25668077|NCT01711359|Folic Acid|folic acid|mesh-list
25668078|NCT01711359|Methotrexate|methotrexate|mesh-list
25668079|NCT01711359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25668080|NCT01711359|Abortifacient Agents|abortifacient agents|mesh-ancestor
25861545|NCT00086879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25861546|NCT00086879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861547|NCT00086879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861548|NCT00086879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25861549|NCT00086879|Alkylating Agents|alkylating agents|mesh-ancestor
25861550|NCT00086892|Carboplatin|carboplatin|mesh-list
25861551|NCT00086892|Cetuximab|cetuximab|mesh-list
25861552|NCT00086892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861553|NCT00086892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25861554|NCT00086931|Capecitabine|capecitabine|mesh-list
25861555|NCT00086931|Oxaliplatin|oxaliplatin|mesh-list
25861556|NCT00086931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25861557|NCT00086931|Antimetabolites|antimetabolites|mesh-ancestor
25861558|NCT00086931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861559|NCT00086931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861560|NCT00086944|Rituximab|rituximab|mesh-list
25861561|NCT00086944|Carboplatin|carboplatin|mesh-list
25861562|NCT00086944|Etoposide|etoposide|mesh-list
25861563|NCT00086944|Etoposide phosphate|etoposide phosphate|mesh-list
25861564|NCT00086944|Ifosfamide|ifosfamide|mesh-list
25861565|NCT00086944|Oblimersen|oblimersen|mesh-list
25861566|NCT00086944|Lenograstim|lenograstim|mesh-list
25861567|NCT00086944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25861568|NCT00086944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861569|NCT00086944|Immunologic Factors|immunologic factors|mesh-ancestor
25861570|NCT00086944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861571|NCT00086944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25861572|NCT00086944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25861573|NCT00086944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25861574|NCT00086944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25861575|NCT00086944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861576|NCT00086944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861577|NCT00086944|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25861578|NCT00086944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25861579|NCT00086944|Alkylating Agents|alkylating agents|mesh-ancestor
25861580|NCT00086970|Ifosfamide|ifosfamide|mesh-list
25861581|NCT00086970|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
25861582|NCT00086970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25861583|NCT00086970|Alkylating Agents|alkylating agents|mesh-ancestor
25861584|NCT00086970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861585|NCT00086970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861586|NCT00086970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861587|NCT00086983|Oxaliplatin|oxaliplatin|mesh-list
25861588|NCT00086983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861589|NCT00087009|Rituximab|rituximab|mesh-list
25861590|NCT00087009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25861591|NCT00087009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861592|NCT00087009|Immunologic Factors|immunologic factors|mesh-ancestor
25861593|NCT00087009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861594|NCT00087009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24450251|NCT00318318|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24450254|NCT00318318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24450255|NCT00318318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450256|NCT00318383|Vaccines|vaccines|mesh-list
24450257|NCT00318383|Immunologic Factors|immunologic factors|mesh-ancestor
24450258|NCT00318383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450259|NCT00318422|Liraglutide|liraglutide|mesh-list
24450260|NCT00318422|Glimepiride|glimepiride|mesh-list
24458362|NCT00337558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458364|NCT00337623|Prednisolone|prednisolone|mesh-list
24458365|NCT00337623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24458366|NCT00337623|Glucocorticoids|glucocorticoids|mesh-ancestor
25861595|NCT00087035|Docetaxel|docetaxel|mesh-list
25861596|NCT00087035|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25861597|NCT00087035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861598|NCT00087035|Tubulin Modulators|tubulin modulators|mesh-ancestor
25861599|NCT00087035|Antimitotic Agents|antimitotic agents|mesh-ancestor
25861600|NCT00087035|Mitosis Modulators|mitosis modulators|mesh-ancestor
25861601|NCT00087035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861602|NCT00087035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25861603|NCT00087035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861604|NCT00087048|Topotecan|topotecan|mesh-list
25861605|NCT00087048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25861606|NCT00087048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25861607|NCT00087048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861608|NCT00087048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451282|NCT00323011|Leucovorin|leucovorin|mesh-list
25668081|NCT01711359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25861610|NCT00087074|Sirolimus|sirolimus|mesh-list
25861611|NCT00087074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25861612|NCT00087074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25861613|NCT00087074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25861614|NCT00087074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861615|NCT00087074|Antifungal Agents|antifungal agents|mesh-ancestor
25861616|NCT00087074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25861617|NCT00087074|Immunologic Factors|immunologic factors|mesh-ancestor
25861618|NCT00087074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861619|NCT00087087|Pemetrexed|pemetrexed|mesh-list
25861620|NCT00087087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861621|NCT00087087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861622|NCT00087087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861623|NCT00087087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25861624|NCT00087087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25861625|NCT00087100|Pemetrexed|pemetrexed|mesh-list
25861626|NCT00087100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861627|NCT00087100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861628|NCT00087100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861629|NCT00087100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25861630|NCT00087100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25861631|NCT00087113|Pemetrexed|pemetrexed|mesh-list
25861632|NCT00087113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861633|NCT00087113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861634|NCT00087113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861635|NCT00087113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25861636|NCT00087113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25861637|NCT00087165|Prednisone|prednisone|mesh-list
25861638|NCT00087165|Docetaxel|docetaxel|mesh-list
25861639|NCT00087165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861640|NCT00087165|Tubulin Modulators|tubulin modulators|mesh-ancestor
25861641|NCT00087165|Antimitotic Agents|antimitotic agents|mesh-ancestor
25861642|NCT00087165|Mitosis Modulators|mitosis modulators|mesh-ancestor
25861643|NCT00087165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861644|NCT00087165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25861645|NCT00087165|Glucocorticoids|glucocorticoids|mesh-ancestor
25861646|NCT00087165|Hormones|hormones|mesh-ancestor
25861647|NCT00087165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25861648|NCT00087165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861649|NCT00087165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25861650|NCT00087191|Motexafin lutetium|motexafin lutetium|mesh-list
25861651|NCT00087191|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25861652|NCT00087191|Dermatologic Agents|dermatologic agents|mesh-ancestor
25861653|NCT00087217|Paclitaxel|paclitaxel|mesh-list
25861654|NCT00087217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24533963|NCT00645554|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25861655|NCT00087217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861656|NCT00087217|Tubulin Modulators|tubulin modulators|mesh-ancestor
25861657|NCT00087217|Antimitotic Agents|antimitotic agents|mesh-ancestor
25861658|NCT00087217|Mitosis Modulators|mitosis modulators|mesh-ancestor
25861659|NCT00087217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861660|NCT00087256|Celecoxib|celecoxib|mesh-list
25861661|NCT00087256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25861662|NCT00087256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25861663|NCT00087256|Analgesics|analgesics|mesh-ancestor
25861664|NCT00087256|Sensory System Agents|sensory system agents|mesh-ancestor
25861665|NCT00087256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25861666|NCT00087256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861667|NCT00087256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25861668|NCT00087256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25861669|NCT00087256|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25861670|NCT00087256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25861671|NCT00087256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25668082|NCT01711359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668083|NCT01711359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25668084|NCT01711359|Antimetabolites|antimetabolites|mesh-ancestor
25668085|NCT01711359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668086|NCT01711359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25668087|NCT01711359|Dermatologic Agents|dermatologic agents|mesh-ancestor
25668088|NCT01711359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861676|NCT00087269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861677|NCT00087269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861678|NCT00087282|Irinotecan|irinotecan|mesh-list
25861679|NCT00087282|Alvocidib|alvocidib|mesh-list
25861680|NCT00087282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25861681|NCT00087282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25861682|NCT00087282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861683|NCT00087282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861684|NCT00087282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861685|NCT00087282|Growth Inhibitors|growth inhibitors|mesh-ancestor
25861686|NCT00087282|Growth Substances|growth substances|mesh-ancestor
25861687|NCT00087282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861688|NCT00087282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25861689|NCT00087295|Romidepsin|romidepsin|mesh-list
25861690|NCT00087295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25861691|NCT00087295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861692|NCT00087334|Capecitabine|capecitabine|mesh-list
25861693|NCT00087334|Oxaliplatin|oxaliplatin|mesh-list
25861694|NCT00087334|Gefitinib|gefitinib|mesh-list
25861695|NCT00087334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25861696|NCT00087334|Antimetabolites|antimetabolites|mesh-ancestor
25861697|NCT00087334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861698|NCT00087334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861699|NCT00087334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25861700|NCT00087334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861701|NCT00087347|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25861702|NCT00087347|Hematinics|hematinics|mesh-ancestor
25861703|NCT00087347|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25861704|NCT00087347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25861705|NCT00087373|Metronidazole|metronidazole|mesh-list
25861706|NCT00087373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25861707|NCT00087373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25861708|NCT00087373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25861709|NCT00087373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25861710|NCT00087399|Gabapentin|gabapentin|mesh-list
25861711|NCT00087399|Antidepressive Agents|antidepressive agents|mesh-list
25861712|NCT00087399|Analgesics|analgesics|mesh-ancestor
25861713|NCT00087399|Sensory System Agents|sensory system agents|mesh-ancestor
25861714|NCT00087399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25861715|NCT00087399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861716|NCT00087399|Anticonvulsants|anticonvulsants|mesh-ancestor
25861717|NCT00087399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25861718|NCT00087399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25861719|NCT00087399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25861720|NCT00087399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25861721|NCT00087399|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25861722|NCT00087399|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25861723|NCT00087399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25861724|NCT00087399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861725|NCT00087399|Antimanic Agents|antimanic agents|mesh-ancestor
25861726|NCT00087412|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25668089|NCT01711359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25668090|NCT01711359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25668091|NCT01711359|Immunologic Factors|immunologic factors|mesh-ancestor
25668092|NCT01711359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25674432|NCT01772147|Bromides|bromides|mesh-list
25861727|NCT00087412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861728|NCT00087412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25668093|NCT01711359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25668094|NCT01711359|Hematinics|hematinics|mesh-ancestor
25668095|NCT01711359|Vitamin B Complex|vitamin b complex|mesh-ancestor
25861730|NCT00087412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502116|NCT05319639|Irinotecan|irinotecan|mesh-list
24502117|NCT05319639|Levoleucovorin|levoleucovorin|mesh-list
24502118|NCT05319639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24502119|NCT05319639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24502120|NCT05319639|Tubulin Modulators|tubulin modulators|mesh-ancestor
24502121|NCT05319639|Antimitotic Agents|antimitotic agents|mesh-ancestor
24502122|NCT05319639|Mitosis Modulators|mitosis modulators|mesh-ancestor
24502123|NCT05319639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502124|NCT05319639|Antimetabolites|antimetabolites|mesh-ancestor
24502125|NCT05319639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24502126|NCT05319639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25083080|NCT03318159|Antifungal Agents|antifungal agents|mesh-ancestor
24737659|NCT01670084|Antiemetics|antiemetics|mesh-ancestor
25861731|NCT00087425|Rituximab|rituximab|mesh-list
25861732|NCT00087425|Bryostatin 1|bryostatin 1|mesh-list
25861733|NCT00087425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25861734|NCT00087425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861735|NCT00087425|Immunologic Factors|immunologic factors|mesh-ancestor
25861736|NCT00087425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861737|NCT00087425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25861738|NCT00087425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25861739|NCT00087451|Sirolimus|sirolimus|mesh-list
25861740|NCT00087451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25861741|NCT00087451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25861742|NCT00087451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25861743|NCT00087451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861744|NCT00087451|Antifungal Agents|antifungal agents|mesh-ancestor
25861745|NCT00087451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24450320|NCT00318760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25861746|NCT00087451|Immunologic Factors|immunologic factors|mesh-ancestor
25861747|NCT00087451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861748|NCT00087464|Tenofovir|tenofovir|mesh-list
25053023|NCT00116116|Lamivudine|lamivudine|mesh-list
25861749|NCT00087464|Emtricitabine|emtricitabine|mesh-list
24686878|NCT04543682|Iloprost|iloprost|mesh-list
24864910|NCT05148208|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24864911|NCT05148169|Sulforaphane|sulforaphane|mesh-list
24864912|NCT05148169|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24864913|NCT05148169|Protective Agents|protective agents|mesh-ancestor
24864914|NCT05148169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861750|NCT00087464|Nevirapine|nevirapine|mesh-list
25861751|NCT00087464|Antiviral Agents|antiviral agents|mesh-ancestor
25861752|NCT00087464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25861753|NCT00087464|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25861754|NCT00087464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25861755|NCT00087464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861756|NCT00087464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861757|NCT00087464|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25861758|NCT00087464|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25861759|NCT00087464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25861760|NCT00087464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25861761|NCT00087542|Pimavanserin|pimavanserin|mesh-list
25861762|NCT00087542|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25861763|NCT00087542|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24635760|NCT01141036|GABA Modulators|gaba modulators|mesh-ancestor
25861764|NCT00087542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25861765|NCT00087542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25428568|NCT01700946|Aldesleukin|aldesleukin|mesh-list
25668096|NCT01711359|Vitamins|vitamins|mesh-ancestor
25668097|NCT01711359|Micronutrients|micronutrients|mesh-ancestor
25668098|NCT01711645|Aluminum phosphate|aluminum phosphate|mesh-list
25668099|NCT01711645|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25668100|NCT01711645|Immunologic Factors|immunologic factors|mesh-ancestor
25668101|NCT01711645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668102|NCT01711645|Antacids|antacids|mesh-ancestor
25668103|NCT01711645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668104|NCT01711645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25668105|NCT01711658|Cisplatin|cisplatin|mesh-list
25668106|NCT01711658|Lapatinib|lapatinib|mesh-list
25668107|NCT01711658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25668108|NCT01711658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25668109|NCT01711658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24502192|NCT05318248|Autonomic Agents|autonomic agents|mesh-ancestor
24502193|NCT05318248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24502194|NCT05318248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24502195|NCT05318248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24502196|NCT05318248|Adrenergic Agents|adrenergic agents|mesh-ancestor
24502197|NCT05318248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25861767|NCT00087542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083102|NCT03318029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083103|NCT03318029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25083104|NCT03318016|Cyclophosphamide|cyclophosphamide|mesh-list
25861768|NCT00087542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25861769|NCT00087542|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25861770|NCT00087542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24450217|NCT00317993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861771|NCT00087542|Serotonin Agents|serotonin agents|mesh-ancestor
25861772|NCT00087542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25861773|NCT00087542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861774|NCT00087581|Cyclosporine|cyclosporine|mesh-list
25861775|NCT00087581|Mycophenolic Acid|mycophenolic acid|mesh-list
25861776|NCT00087581|Tacrolimus|tacrolimus|mesh-list
25861777|NCT00087581|Cyclosporins|cyclosporins|mesh-list
25861778|NCT00087581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25861779|NCT00087581|Immunologic Factors|immunologic factors|mesh-ancestor
25861780|NCT00087581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861781|NCT00087581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25861782|NCT00087581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450366|NCT00318890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450368|NCT00318890|Protective Agents|protective agents|mesh-ancestor
24450369|NCT00318890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450370|NCT00318903|Docetaxel|docetaxel|mesh-list
24864915|NCT05148169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450371|NCT00318903|Irinotecan|irinotecan|mesh-list
24450372|NCT00318903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450373|NCT00318903|Tubulin Modulators|tubulin modulators|mesh-ancestor
24450374|NCT00318903|Antimitotic Agents|antimitotic agents|mesh-ancestor
24450375|NCT00318903|Mitosis Modulators|mitosis modulators|mesh-ancestor
25861783|NCT00087581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861784|NCT00087581|Antifungal Agents|antifungal agents|mesh-ancestor
25861785|NCT00087581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25861786|NCT00087581|Dermatologic Agents|dermatologic agents|mesh-ancestor
25861787|NCT00087581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25861788|NCT00087581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25861789|NCT00087581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861790|NCT00087581|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25861791|NCT00087581|Antitubercular Agents|antitubercular agents|mesh-ancestor
25861792|NCT00087581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25861793|NCT00087620|Capecitabine|capecitabine|mesh-list
25861794|NCT00087620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25861795|NCT00087620|Antimetabolites|antimetabolites|mesh-ancestor
25861796|NCT00087620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861797|NCT00087620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861798|NCT00087659|Zoledronic Acid|zoledronic acid|mesh-list
25861799|NCT00087659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25861800|NCT00087659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861801|NCT00087711|Gemcitabine|gemcitabine|mesh-list
25861802|NCT00087711|Cisplatin|cisplatin|mesh-list
25861803|NCT00087711|Pemetrexed|pemetrexed|mesh-list
25861804|NCT00087711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861805|NCT00087711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25861806|NCT00087711|Antimetabolites|antimetabolites|mesh-ancestor
25861807|NCT00087711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861808|NCT00087711|Antiviral Agents|antiviral agents|mesh-ancestor
25861809|NCT00087711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25668110|NCT01711658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668111|NCT01711853|Dabigatran|dabigatran|mesh-list
25668112|NCT01711853|Antithrombins|antithrombins|mesh-ancestor
25668113|NCT01711853|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25668114|NCT01711853|Protease Inhibitors|protease inhibitors|mesh-ancestor
25668115|NCT01711853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25668116|NCT01711853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668117|NCT01711853|Anticoagulants|anticoagulants|mesh-ancestor
25668118|NCT01711866|Rotigotine|rotigotine|mesh-list
25668119|NCT01711866|Dopamine Agonists|dopamine agonists|mesh-ancestor
25861811|NCT00087711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25861812|NCT00087711|Immunologic Factors|immunologic factors|mesh-ancestor
25861813|NCT00087711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861814|NCT00087711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25861815|NCT00087711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25861816|NCT00087737|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25861817|NCT00087737|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25861818|NCT00087737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25861819|NCT00087737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25861820|NCT00087737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861821|NCT00087737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25861822|NCT00087737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861823|NCT00087737|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25861824|NCT00087737|Antidepressive Agents|antidepressive agents|mesh-ancestor
25053048|NCT00115050|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25861825|NCT00087737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25861826|NCT00087750|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25861827|NCT00087750|Antidepressive Agents|antidepressive agents|mesh-ancestor
25861828|NCT00087750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25861829|NCT00087750|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25861830|NCT00087750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25861831|NCT00087750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25861832|NCT00087750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861833|NCT00087802|Gemcitabine|gemcitabine|mesh-list
25861834|NCT00087802|Paclitaxel|paclitaxel|mesh-list
25861835|NCT00087802|Carboplatin|carboplatin|mesh-list
25861836|NCT00087802|Oxaliplatin|oxaliplatin|mesh-list
25861837|NCT00087802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25861838|NCT00087802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861839|NCT00087802|Tubulin Modulators|tubulin modulators|mesh-ancestor
25861840|NCT00087802|Antimitotic Agents|antimitotic agents|mesh-ancestor
25861841|NCT00087802|Mitosis Modulators|mitosis modulators|mesh-ancestor
25861842|NCT00087802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534320|NCT00646659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534321|NCT00646659|Antimetabolites|antimetabolites|mesh-ancestor
25861843|NCT00087802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25861844|NCT00087802|Antimetabolites|antimetabolites|mesh-ancestor
25861845|NCT00087802|Antiviral Agents|antiviral agents|mesh-ancestor
25861846|NCT00087802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25861847|NCT00087802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861848|NCT00087802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25861849|NCT00087802|Immunologic Factors|immunologic factors|mesh-ancestor
25861850|NCT00087802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861851|NCT00087815|Dexamethasone|dexamethasone|mesh-list
25861852|NCT00087815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25861853|NCT00087815|Antiemetics|antiemetics|mesh-ancestor
25861854|NCT00087815|Autonomic Agents|autonomic agents|mesh-ancestor
25861855|NCT00087815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25861856|NCT00087815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861857|NCT00087815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25861858|NCT00087815|Glucocorticoids|glucocorticoids|mesh-ancestor
25861859|NCT00087815|Hormones|hormones|mesh-ancestor
25861860|NCT00087815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25861861|NCT00087815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25861862|NCT00087815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861863|NCT00087841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25053076|NCT00109538|Lonafarnib|lonafarnib|mesh-list
25861864|NCT00087841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24450406|NCT00318981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450407|NCT00318981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24450408|NCT00318981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24450409|NCT00318981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24450410|NCT00318981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450411|NCT00318981|Dopamine Agents|dopamine agents|mesh-ancestor
24450412|NCT00318981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25861865|NCT00087841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861866|NCT00087854|Amonafide|amonafide|mesh-list
25861867|NCT00087854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861868|NCT00087854|Antiviral Agents|antiviral agents|mesh-ancestor
25861869|NCT00087854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25861870|NCT00087854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25668120|NCT01711866|Dopamine Agents|dopamine agents|mesh-ancestor
25668121|NCT01711866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25861871|NCT00087854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502228|NCT05317676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24621901|NCT01064570|Keratolytic Agents|keratolytic agents|mesh-ancestor
24621902|NCT01064570|Dermatologic Agents|dermatologic agents|mesh-ancestor
24621904|NCT01064726|Xhance|xhance|mesh-list
24621905|NCT01064726|Ibuprofen|ibuprofen|mesh-list
24621906|NCT01064726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25861873|NCT00087867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861874|NCT00087880|Bupropion|bupropion|mesh-list
25861875|NCT00087880|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25861876|NCT00087880|Antidepressive Agents|antidepressive agents|mesh-ancestor
25861877|NCT00087880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25861878|NCT00087880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25861879|NCT00087880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24599807|NCT03866499|Gefitinib|gefitinib|mesh-list
25861880|NCT00087880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25861881|NCT00087880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861882|NCT00087880|Dopamine Agents|dopamine agents|mesh-ancestor
25861883|NCT00087880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25861884|NCT00087880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861885|NCT00087880|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25861886|NCT00087880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25861887|NCT00087880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861888|NCT00087945|Lamivudine|lamivudine|mesh-list
25861889|NCT00087945|Zidovudine|zidovudine|mesh-list
25861890|NCT00087945|Abacavir|abacavir|mesh-list
25861891|NCT00087945|Dideoxynucleosides|dideoxynucleosides|mesh-list
25861892|NCT00087945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25861893|NCT00087945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25861894|NCT00087945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861895|NCT00087945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861896|NCT00087945|Antiviral Agents|antiviral agents|mesh-ancestor
25861897|NCT00087945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25861898|NCT00087945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25861899|NCT00087945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25861900|NCT00087945|Antimetabolites|antimetabolites|mesh-ancestor
25861901|NCT00088036|Olanzapine|olanzapine|mesh-list
25861902|NCT00088036|Antiemetics|antiemetics|mesh-ancestor
25861903|NCT00088036|Autonomic Agents|autonomic agents|mesh-ancestor
25861904|NCT00088036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25861905|NCT00088036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861906|NCT00088036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25861907|NCT00088036|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25861908|NCT00088036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25861909|NCT00088036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25861910|NCT00088036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25861911|NCT00088036|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25861912|NCT00088036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25861913|NCT00088036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25861914|NCT00088036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861915|NCT00088036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25861916|NCT00088036|Serotonin Agents|serotonin agents|mesh-ancestor
25861917|NCT00088049|Olanzapine|olanzapine|mesh-list
25861918|NCT00088049|Aripiprazole|aripiprazole|mesh-list
25861919|NCT00088049|Antiemetics|antiemetics|mesh-ancestor
24451563|NCT00324298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451564|NCT00324298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24451565|NCT00324298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24451566|NCT00324298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25040598|NCT02997657|Autonomic Agents|autonomic agents|mesh-ancestor
25040599|NCT02997657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25040600|NCT02997657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040601|NCT02997657|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25040602|NCT02997657|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25040603|NCT02997657|Cholinergic Agents|cholinergic agents|mesh-ancestor
25040604|NCT02997657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25668122|NCT01711866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668123|NCT01711866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668124|NCT01711918|Domperidone|domperidone|mesh-list
25668125|NCT01711918|Antiemetics|antiemetics|mesh-ancestor
25668126|NCT01711918|Autonomic Agents|autonomic agents|mesh-ancestor
25668127|NCT01711918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25861920|NCT00088049|Autonomic Agents|autonomic agents|mesh-ancestor
24543873|NCT00685828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543874|NCT00685841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24543875|NCT00685841|Formoterol Fumarate|formoterol fumarate|mesh-list
24543876|NCT00685841|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25040605|NCT02997657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040606|NCT02997501|Osimertinib|osimertinib|mesh-list
25040607|NCT02997501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25040608|NCT02997501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25040609|NCT02997501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25040610|NCT02997501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040611|NCT02990806|Infliximab|infliximab|mesh-list
25040612|NCT02990806|Dermatologic Agents|dermatologic agents|mesh-ancestor
25861921|NCT00088049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25861922|NCT00088049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040297|NCT03191864|Xhance|xhance|mesh-list
24599956|NCT02985541|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25861923|NCT00088049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25861924|NCT00088049|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25861925|NCT00088049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25861926|NCT00088049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25861927|NCT00088049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25861928|NCT00088049|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25861929|NCT00088049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25861930|NCT00088049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25861931|NCT00088049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861932|NCT00088049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25861933|NCT00088049|Serotonin Agents|serotonin agents|mesh-ancestor
25861934|NCT00088049|Antidepressive Agents|antidepressive agents|mesh-ancestor
25861935|NCT00088049|Dopamine Agonists|dopamine agonists|mesh-ancestor
25861936|NCT00088049|Dopamine Agents|dopamine agents|mesh-ancestor
25053116|NCT00102466|Metformin|metformin|mesh-list
25861937|NCT00088049|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25861938|NCT00088049|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25861939|NCT00088049|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25861940|NCT00088049|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25861941|NCT00088049|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25861942|NCT00088049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25861943|NCT00088075|Risperidone|risperidone|mesh-list
25861944|NCT00088075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25861945|NCT00088075|Serotonin Agents|serotonin agents|mesh-ancestor
25861946|NCT00088075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25861947|NCT00088075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861948|NCT00088075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861949|NCT00088075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24534501|NCT00647192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24534503|NCT00647218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24534504|NCT00647218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24534505|NCT00647218|Tubulin Modulators|tubulin modulators|mesh-ancestor
24534506|NCT00647218|Antimitotic Agents|antimitotic agents|mesh-ancestor
24534509|NCT00647244|Tenofovir|tenofovir|mesh-list
25861950|NCT00088075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25861951|NCT00088075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25861952|NCT00088075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25861953|NCT00088075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25861954|NCT00088075|Dopamine Agents|dopamine agents|mesh-ancestor
25861955|NCT00088088|Paclitaxel|paclitaxel|mesh-list
24636970|NCT01148264|Serotonin Agents|serotonin agents|mesh-ancestor
25861956|NCT00088088|Carboplatin|carboplatin|mesh-list
25861957|NCT00088088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25861958|NCT00088088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861959|NCT00088088|Tubulin Modulators|tubulin modulators|mesh-ancestor
25668128|NCT01711918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668129|NCT01711918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25668130|NCT01711918|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25668131|NCT01711918|Dopamine Agents|dopamine agents|mesh-ancestor
25668132|NCT01711918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25668133|NCT01711918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668134|NCT01712009|Loratadine|loratadine|mesh-list
25668135|NCT01712009|Naproxen|naproxen|mesh-list
25674433|NCT01772147|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24970222|NCT03735264|Docetaxel|docetaxel|mesh-list
24970223|NCT03735264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970224|NCT03735264|Tubulin Modulators|tubulin modulators|mesh-ancestor
24970225|NCT03735264|Antimitotic Agents|antimitotic agents|mesh-ancestor
25217476|NCT02677597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217477|NCT02677584|Caffeine|caffeine|mesh-list
25217478|NCT02677584|Caffeine citrate|caffeine citrate|mesh-list
25217479|NCT02677584|Citric Acid|citric acid|mesh-list
25861960|NCT00088088|Antimitotic Agents|antimitotic agents|mesh-ancestor
25861961|NCT00088088|Mitosis Modulators|mitosis modulators|mesh-ancestor
25861962|NCT00088088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861963|NCT00088114|Paclitaxel|paclitaxel|mesh-list
25861964|NCT00088114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25861965|NCT00088114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861966|NCT00088114|Tubulin Modulators|tubulin modulators|mesh-ancestor
25861967|NCT00088114|Antimitotic Agents|antimitotic agents|mesh-ancestor
25861968|NCT00088114|Mitosis Modulators|mitosis modulators|mesh-ancestor
25861969|NCT00088114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861970|NCT00088231|Imatinib Mesylate|imatinib mesylate|mesh-list
25861971|NCT00088231|Vatalanib|vatalanib|mesh-list
25861972|NCT00088231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861973|NCT00088231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25861974|NCT00088231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861975|NCT00088231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861976|NCT00088270|Leucovorin|leucovorin|mesh-list
25861977|NCT00088270|Fluorouracil|fluorouracil|mesh-list
25861978|NCT00088270|Antimetabolites|antimetabolites|mesh-ancestor
25861979|NCT00088270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861980|NCT00088270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24450239|NCT00318201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24450274|NCT00318448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450275|NCT00318448|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24450276|NCT00318448|GABA Agonists|gaba agonists|mesh-ancestor
25861981|NCT00088270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25861982|NCT00088270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25861983|NCT00088270|Immunologic Factors|immunologic factors|mesh-ancestor
25861984|NCT00088270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861985|NCT00088270|Antidotes|antidotes|mesh-ancestor
25861986|NCT00088270|Protective Agents|protective agents|mesh-ancestor
25861987|NCT00088270|Vitamin B Complex|vitamin b complex|mesh-ancestor
25861988|NCT00088270|Vitamins|vitamins|mesh-ancestor
25861989|NCT00088270|Micronutrients|micronutrients|mesh-ancestor
25861990|NCT00088387|Valproic Acid|valproic acid|mesh-list
25861991|NCT00088387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25861992|NCT00088387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25861993|NCT00088387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25861994|NCT00088387|Antimanic Agents|antimanic agents|mesh-ancestor
25861995|NCT00088387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25861996|NCT00088387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25861997|NCT00088387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25861998|NCT00088387|Anticonvulsants|anticonvulsants|mesh-ancestor
25861999|NCT00088387|GABA Agents|gaba agents|mesh-ancestor
25862000|NCT00088387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25862001|NCT00088478|Olanzapine|olanzapine|mesh-list
25862002|NCT00088478|Antiemetics|antiemetics|mesh-ancestor
25862003|NCT00088478|Autonomic Agents|autonomic agents|mesh-ancestor
25862004|NCT00088478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25862005|NCT00088478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862006|NCT00088478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25862007|NCT00088478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25862008|NCT00088478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25862009|NCT00088478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25862010|NCT00088478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25862011|NCT00088478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25862012|NCT00088478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25862013|NCT00088478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25862014|NCT00088478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862015|NCT00088478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25668136|NCT01712009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25668137|NCT01712009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25668138|NCT01712009|Analgesics|analgesics|mesh-ancestor
25668139|NCT01712009|Sensory System Agents|sensory system agents|mesh-ancestor
25668140|NCT01712009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25668141|NCT01712009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668142|NCT01712009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25862018|NCT00088491|Antiemetics|antiemetics|mesh-ancestor
25862019|NCT00088491|Autonomic Agents|autonomic agents|mesh-ancestor
25862020|NCT00088491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25862021|NCT00088491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862022|NCT00088491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25862023|NCT00088491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25199665|NCT02739477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25862024|NCT00088491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25862025|NCT00088491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25862026|NCT00088491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25862027|NCT00088491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25862028|NCT00088491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25862029|NCT00088491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24548725|NCT00711854|Trimethoprim|trimethoprim|mesh-list
24548726|NCT00711854|Sulfamethoxazole|sulfamethoxazole|mesh-list
25862030|NCT00088491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548783|NCT00712049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548784|NCT00712049|Vitamin B Complex|vitamin b complex|mesh-ancestor
24548785|NCT00712049|Vitamins|vitamins|mesh-ancestor
24548786|NCT00712049|Micronutrients|micronutrients|mesh-ancestor
24548787|NCT00712049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548788|NCT00712049|Vasodilator Agents|vasodilator agents|mesh-ancestor
24548789|NCT00712062|Pemetrexed|pemetrexed|mesh-list
24548874|NCT00712478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25862031|NCT00088491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25862032|NCT00088491|Serotonin Agents|serotonin agents|mesh-ancestor
25862033|NCT00088504|Interferons|interferons|mesh-list
25862034|NCT00088504|Ribavirin|ribavirin|mesh-list
25862035|NCT00088504|Interferon-alpha|interferon-alpha|mesh-list
25862036|NCT00088504|Interferon alpha-2|interferon alpha-2|mesh-list
25862037|NCT00088504|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25862038|NCT00088504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862039|NCT00088504|Antiviral Agents|antiviral agents|mesh-ancestor
24625684|NCT01082848|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24625686|NCT01082926|Interleukin-2|interleukin-2|mesh-list
24625687|NCT01082926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862040|NCT00088504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25862041|NCT00088504|Antimetabolites|antimetabolites|mesh-ancestor
25862042|NCT00088504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862043|NCT00088504|Immunologic Factors|immunologic factors|mesh-ancestor
25862044|NCT00088504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876470|NCT03457142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876471|NCT03457142|Protease Inhibitors|protease inhibitors|mesh-ancestor
25876472|NCT03457142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876473|NCT03457142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25876474|NCT03457142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25876475|NCT03457142|Immunologic Factors|immunologic factors|mesh-ancestor
25876476|NCT03457142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25876477|NCT03457142|Dermatologic Agents|dermatologic agents|mesh-ancestor
25876478|NCT03457142|Glycine Agents|glycine agents|mesh-ancestor
25876479|NCT03457142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25876480|NCT03448107|Fluorides|fluorides|mesh-list
25876481|NCT03448107|Fluorides, Topical|fluorides, topical|mesh-list
24548908|NCT00712517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24548910|NCT00712556|Cariostatic Agents|cariostatic agents|mesh-ancestor
24548911|NCT00712556|Protective Agents|protective agents|mesh-ancestor
24548912|NCT00712556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548913|NCT00712595|Mifepristone|mifepristone|mesh-list
24548914|NCT00712595|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24548915|NCT00712595|Abortifacient Agents|abortifacient agents|mesh-ancestor
24548916|NCT00712595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25876482|NCT03448107|Cariostatic Agents|cariostatic agents|mesh-ancestor
25876483|NCT03448107|Protective Agents|protective agents|mesh-ancestor
25876484|NCT03448107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876485|NCT03442309|Fluorides|fluorides|mesh-list
25876486|NCT03442309|Fluorides, Topical|fluorides, topical|mesh-list
25876487|NCT03442309|Cariostatic Agents|cariostatic agents|mesh-ancestor
24447656|NCT00309335|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24447657|NCT00309335|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24447673|NCT00309374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24447674|NCT00309374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25876488|NCT03442309|Protective Agents|protective agents|mesh-ancestor
25876489|NCT03442309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876490|NCT03399838|Midazolam|midazolam|mesh-list
25876491|NCT03399838|Dexmedetomidine|dexmedetomidine|mesh-list
25217501|NCT02677571|Sensory System Agents|sensory system agents|mesh-ancestor
25217502|NCT02677571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25217508|NCT02677532|Dsuvia|dsuvia|mesh-list
24447675|NCT00309374|Antimetabolites|antimetabolites|mesh-ancestor
24447676|NCT00309374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199666|NCT02739581|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24827093|NCT02137395|Dexamethasone|dexamethasone|mesh-list
24827094|NCT02137395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24827095|NCT02137395|Antiemetics|antiemetics|mesh-ancestor
25127826|NCT03052569|Agerafenib|agerafenib|mesh-list
25862045|NCT00088543|Thymoglobulin|thymoglobulin|mesh-list
25862046|NCT00088543|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25862047|NCT00088543|Immunologic Factors|immunologic factors|mesh-ancestor
25862048|NCT00088543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862049|NCT00088543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25862050|NCT00088556|Paclitaxel|paclitaxel|mesh-list
25862051|NCT00088556|Carboplatin|carboplatin|mesh-list
24549012|NCT00712894|Diltiazem|diltiazem|mesh-list
24625694|NCT01082926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24625695|NCT01082926|Antiviral Agents|antiviral agents|mesh-ancestor
24549083|NCT00713336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549085|NCT00713336|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25862052|NCT00088556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24549100|NCT00713440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24549101|NCT00713440|Glucocorticoids|glucocorticoids|mesh-ancestor
24549102|NCT00713440|Hormones|hormones|mesh-ancestor
25199667|NCT02739581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25199668|NCT02739581|Adrenergic Agents|adrenergic agents|mesh-ancestor
25199669|NCT02739581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25199670|NCT02739581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199671|NCT02739581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199672|NCT02739516|Letrozole|letrozole|mesh-list
25199673|NCT02739516|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25199674|NCT02739516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199675|NCT02739516|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25199676|NCT02739516|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25199677|NCT02739516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199678|NCT02739516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199679|NCT02739516|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25199680|NCT02739516|Hormone Antagonists|hormone antagonists|mesh-ancestor
25199681|NCT02739516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25199682|NCT02739516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199683|NCT02739516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25199684|NCT02739399|Phenylephrine|phenylephrine|mesh-list
25199685|NCT02739399|Oxymetazoline|oxymetazoline|mesh-list
24814045|NCT02062034|Micronutrients|micronutrients|mesh-ancestor
24814046|NCT02062034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814048|NCT02062034|Protective Agents|protective agents|mesh-ancestor
25199686|NCT02739399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25199688|NCT02739399|Autonomic Agents|autonomic agents|mesh-ancestor
25199689|NCT02739399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25199690|NCT02739399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199691|NCT02739399|Sympathomimetics|sympathomimetics|mesh-ancestor
25199692|NCT02739399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25199693|NCT02739399|Nasal Decongestants|nasal decongestants|mesh-ancestor
25199694|NCT02739399|Respiratory System Agents|respiratory system agents|mesh-ancestor
24549120|NCT00713557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549121|NCT00713557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24549123|NCT00713622|Valproic Acid|valproic acid|mesh-list
24549124|NCT00713622|Anticonvulsants|anticonvulsants|mesh-ancestor
24549125|NCT00713622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549126|NCT00713622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549127|NCT00713622|GABA Agents|gaba agents|mesh-ancestor
24549128|NCT00713622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24549129|NCT00713622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549130|NCT00713622|Antimanic Agents|antimanic agents|mesh-ancestor
24549131|NCT00713622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24549132|NCT00713622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24549139|NCT00713674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25668143|NCT01712009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25668144|NCT01712009|Gout Suppressants|gout suppressants|mesh-ancestor
25668145|NCT01712009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25668146|NCT01712009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25862053|NCT00088556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862054|NCT00088556|Tubulin Modulators|tubulin modulators|mesh-ancestor
24549155|NCT00713726|Fentanyl|fentanyl|mesh-list
24549156|NCT00713726|Tramadol|tramadol|mesh-list
24549157|NCT00713726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24549158|NCT00713726|Narcotics|narcotics|mesh-ancestor
24549159|NCT00713726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24549160|NCT00713726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549161|NCT00713726|Analgesics|analgesics|mesh-ancestor
24549162|NCT00713726|Sensory System Agents|sensory system agents|mesh-ancestor
24549163|NCT00713726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24549164|NCT00713726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24549165|NCT00713726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24549166|NCT00713726|Anesthetics, General|anesthetics, general|mesh-ancestor
25862055|NCT00088556|Antimitotic Agents|antimitotic agents|mesh-ancestor
25862056|NCT00088556|Mitosis Modulators|mitosis modulators|mesh-ancestor
25862057|NCT00088556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862058|NCT00088582|Octreotide|octreotide|mesh-list
25862059|NCT00088582|Pasireotide|pasireotide|mesh-list
24549222|NCT00713986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549224|NCT00713999|Anthelmintics|anthelmintics|mesh-ancestor
24549225|NCT00713999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24549226|NCT00713999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24549227|NCT00714025|Everolimus|everolimus|mesh-list
24549228|NCT00714025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549229|NCT00714025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24549230|NCT00714025|Immunologic Factors|immunologic factors|mesh-ancestor
24549231|NCT00714025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549232|NCT00714064|Edetic Acid|edetic acid|mesh-list
24549233|NCT00714064|Pentetic Acid|pentetic acid|mesh-list
24549234|NCT00714064|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24625704|NCT01083017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940102|NCT04003688|Magnesium Sulfate|magnesium sulfate|mesh-list
24940103|NCT04003688|Analgesics|analgesics|mesh-ancestor
24625705|NCT01083212|Gemfibrozil|gemfibrozil|mesh-list
24625706|NCT01083212|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24625707|NCT01083212|Antimetabolites|antimetabolites|mesh-ancestor
24625708|NCT01083212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549243|NCT00714064|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24549244|NCT00714064|Immunologic Factors|immunologic factors|mesh-ancestor
25862060|NCT00088582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25862061|NCT00088582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25862062|NCT00088582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862063|NCT00088582|Hormones|hormones|mesh-ancestor
24549246|NCT00714090|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24549247|NCT00714090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24549248|NCT00714090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24549249|NCT00714090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549251|NCT00714090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549252|NCT00714090|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24549253|NCT00714090|Antidepressive Agents|antidepressive agents|mesh-ancestor
24549254|NCT00714090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24549256|NCT00714103|Analgesics|analgesics|mesh-ancestor
24549257|NCT00714103|Sensory System Agents|sensory system agents|mesh-ancestor
24549258|NCT00714103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24549277|NCT00714181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549278|NCT00714181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24549279|NCT00714246|Carboplatin|carboplatin|mesh-list
24549280|NCT00714246|Docetaxel|docetaxel|mesh-list
24549281|NCT00714246|Bortezomib|bortezomib|mesh-list
24549282|NCT00714246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549284|NCT00714246|Antimitotic Agents|antimitotic agents|mesh-ancestor
24940116|NCT04003688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24940118|NCT04003376|Triamcinolone|triamcinolone|mesh-list
24940119|NCT04003376|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24940120|NCT04003376|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24940121|NCT04003376|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24549322|NCT00714584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24549324|NCT00714623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25862064|NCT00088582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25862065|NCT00088582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862066|NCT00088608|Pasireotide|pasireotide|mesh-list
25862067|NCT00088608|Hormones|hormones|mesh-ancestor
25862068|NCT00088608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25862069|NCT00088608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862070|NCT00088686|Capsaicin|capsaicin|mesh-list
25862071|NCT00088686|Antipruritics|antipruritics|mesh-ancestor
24970400|NCT03733561|Rotigotine|rotigotine|mesh-list
25862072|NCT00088686|Dermatologic Agents|dermatologic agents|mesh-ancestor
25862073|NCT00088686|Sensory System Agents|sensory system agents|mesh-ancestor
25862074|NCT00088686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25862075|NCT00088686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862076|NCT00088816|Cisplatin|cisplatin|mesh-list
25862077|NCT00088816|Tegafur|tegafur|mesh-list
25862078|NCT00088816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862079|NCT00088816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25862080|NCT00088816|Antimetabolites|antimetabolites|mesh-ancestor
25862081|NCT00088816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862082|NCT00088855|Doxorubicin|doxorubicin|mesh-list
25862083|NCT00088855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25862084|NCT00088855|Bortezomib|bortezomib|mesh-list
24801894|NCT01986192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549392|NCT00715013|Antimitotic Agents|antimitotic agents|mesh-ancestor
24549393|NCT00715013|Mitosis Modulators|mitosis modulators|mesh-ancestor
24549394|NCT00715013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549395|NCT00715039|Lorazepam|lorazepam|mesh-list
24549396|NCT00715039|Paroxetine|paroxetine|mesh-list
24549397|NCT00715039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24549398|NCT00715039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24549399|NCT00715039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24549400|NCT00715039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549401|NCT00715039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24549402|NCT00715039|Serotonin Agents|serotonin agents|mesh-ancestor
24549403|NCT00715039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549404|NCT00715039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25862085|NCT00088855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25862086|NCT00088855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862087|NCT00088855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25862088|NCT00088855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25862089|NCT00088855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25862090|NCT00088855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862091|NCT00088894|Gemcitabine|gemcitabine|mesh-list
25862092|NCT00088894|Bevacizumab|bevacizumab|mesh-list
25862093|NCT00088894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24940145|NCT04003402|Sensory System Agents|sensory system agents|mesh-ancestor
24940146|NCT04003402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24940147|NCT04003402|GABA Modulators|gaba modulators|mesh-ancestor
24940148|NCT04003402|GABA Agents|gaba agents|mesh-ancestor
24940149|NCT04003402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24853569|NCT02269046|Simvastatin|simvastatin|mesh-list
25862094|NCT00088894|Antibodies|antibodies|mesh-list
25862095|NCT00088894|Immunoglobulins|immunoglobulins|mesh-list
25862096|NCT00088894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25862097|NCT00088894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862098|NCT00088894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25862099|NCT00088894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24549443|NCT00715273|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25862100|NCT00088894|Growth Substances|growth substances|mesh-ancestor
25862101|NCT00088894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128011|NCT03051373|Gemcitabine|gemcitabine|mesh-list
25053191|NCT00086723|Captopril|captopril|mesh-list
25862102|NCT00088894|Growth Inhibitors|growth inhibitors|mesh-ancestor
25862103|NCT00088894|Immunologic Factors|immunologic factors|mesh-ancestor
25862104|NCT00088894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25862105|NCT00088894|Antimetabolites|antimetabolites|mesh-ancestor
25862106|NCT00088894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862107|NCT00088894|Antiviral Agents|antiviral agents|mesh-ancestor
24940181|NCT04003350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24940182|NCT04003350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24940183|NCT04003350|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24940184|NCT04003350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24940185|NCT04003350|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24853579|NCT02269072|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24549510|NCT00715702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24549512|NCT00715715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24549513|NCT00715715|Glucocorticoids|glucocorticoids|mesh-ancestor
24549514|NCT00715715|Hormones|hormones|mesh-ancestor
24549515|NCT00715715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24549516|NCT00715715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549517|NCT00715715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25862108|NCT00088894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25862109|NCT00088894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25668147|NCT01712009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668148|NCT01712009|Antipruritics|antipruritics|mesh-ancestor
25668149|NCT01712009|Dermatologic Agents|dermatologic agents|mesh-ancestor
25668150|NCT01712009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24832126|NCT02170740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24832127|NCT02170740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832128|NCT02170740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862111|NCT00088933|Metronidazole|metronidazole|mesh-list
25862112|NCT00088933|Docetaxel|docetaxel|mesh-list
25862113|NCT00088933|Vaccines|vaccines|mesh-list
25862114|NCT00088933|Sargramostim|sargramostim|mesh-list
25862115|NCT00088933|Immunologic Factors|immunologic factors|mesh-ancestor
25862116|NCT00088933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862117|NCT00088933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549596|NCT00716183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549597|NCT00716183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549598|NCT00716183|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24549599|NCT00716248|Bucillamine|bucillamine|mesh-list
24549600|NCT00716248|Methotrexate|methotrexate|mesh-list
24549601|NCT00716248|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24549602|NCT00716248|Abortifacient Agents|abortifacient agents|mesh-ancestor
24549603|NCT00716248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25862118|NCT00088933|Tubulin Modulators|tubulin modulators|mesh-ancestor
25862119|NCT00088933|Antimitotic Agents|antimitotic agents|mesh-ancestor
25862120|NCT00088933|Mitosis Modulators|mitosis modulators|mesh-ancestor
25862121|NCT00088933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862122|NCT00088933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25862123|NCT00088933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25862124|NCT00088933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25862125|NCT00088933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25862126|NCT00088946|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25862127|NCT00088946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862128|NCT00088946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24936325|NCT04042142|Glucagon|glucagon|mesh-list
25862129|NCT00088946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25862130|NCT00088946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862131|NCT00088959|Celecoxib|celecoxib|mesh-list
25862132|NCT00088959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25862133|NCT00088959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862134|NCT00088959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25862135|NCT00088959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25862136|NCT00088959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862137|NCT00088959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25862138|NCT00088959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25199695|NCT02739399|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25862139|NCT00088959|Analgesics|analgesics|mesh-ancestor
25862140|NCT00088959|Sensory System Agents|sensory system agents|mesh-ancestor
24940210|NCT04003012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940212|NCT04003090|Nootropic Agents|nootropic agents|mesh-ancestor
24940213|NCT04002635|Letrozole|letrozole|mesh-list
24940214|NCT04002635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25050618|NCT00482092|Antiviral Agents|antiviral agents|mesh-ancestor
24956265|NCT03855826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24940215|NCT04002635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24940216|NCT04002635|Estradiol|estradiol|mesh-list
24853614|NCT02269202|Anesthetics|anesthetics|mesh-ancestor
24549719|NCT00717379|Mycophenolic Acid|mycophenolic acid|mesh-list
24549721|NCT00717379|Methylprednisolone|methylprednisolone|mesh-list
24549722|NCT00717379|Tacrolimus|tacrolimus|mesh-list
24549723|NCT00717379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24549724|NCT00717379|Glucocorticoids|glucocorticoids|mesh-ancestor
25862141|NCT00088959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25862142|NCT00088959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862143|NCT00088959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25862144|NCT00088959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25862145|NCT00088959|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25862146|NCT00088959|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25862147|NCT00088998|Bevacizumab|bevacizumab|mesh-list
25668151|NCT01712009|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25668152|NCT01712009|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25668153|NCT01712009|Histamine Antagonists|histamine antagonists|mesh-ancestor
25668154|NCT01712009|Histamine Agents|histamine agents|mesh-ancestor
25668155|NCT01712009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25668156|NCT01712178|Adalimumab|adalimumab|mesh-list
24970484|NCT03732703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970488|NCT03732703|Hormones|hormones|mesh-ancestor
25862148|NCT00088998|Docetaxel|docetaxel|mesh-list
25862149|NCT00088998|Capecitabine|capecitabine|mesh-list
25862150|NCT00088998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25862151|NCT00088998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862152|NCT00088998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25862153|NCT00088998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25862154|NCT00088998|Growth Substances|growth substances|mesh-ancestor
25862155|NCT00088998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862156|NCT00088998|Growth Inhibitors|growth inhibitors|mesh-ancestor
25862157|NCT00088998|Tubulin Modulators|tubulin modulators|mesh-ancestor
25862158|NCT00088998|Antimitotic Agents|antimitotic agents|mesh-ancestor
25862159|NCT00088998|Mitosis Modulators|mitosis modulators|mesh-ancestor
24549735|NCT00717379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24549736|NCT00717379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24549737|NCT00717379|Antitubercular Agents|antitubercular agents|mesh-ancestor
24549738|NCT00717379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24549739|NCT00717379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24940230|NCT04002635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24940231|NCT04002635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940232|NCT04002635|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25862160|NCT00088998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862161|NCT00088998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25862162|NCT00088998|Antimetabolites|antimetabolites|mesh-ancestor
25862163|NCT00089037|Sirolimus|sirolimus|mesh-list
25862164|NCT00089037|Methotrexate|methotrexate|mesh-list
25862165|NCT00089037|Tacrolimus|tacrolimus|mesh-list
25862166|NCT00089037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24549841|NCT00717704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25862167|NCT00089037|Abortifacient Agents|abortifacient agents|mesh-ancestor
25862168|NCT00089037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25862169|NCT00089037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862170|NCT00089037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25862171|NCT00089037|Antimetabolites|antimetabolites|mesh-ancestor
25862172|NCT00089037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862173|NCT00089037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862174|NCT00089037|Dermatologic Agents|dermatologic agents|mesh-ancestor
25862175|NCT00089037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25862176|NCT00089037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25862177|NCT00089037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25862178|NCT00089037|Immunologic Factors|immunologic factors|mesh-ancestor
25862179|NCT00089037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25862180|NCT00089037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25862181|NCT00089037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25862182|NCT00089037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25862183|NCT00089037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25862184|NCT00089037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25862185|NCT00089037|Antifungal Agents|antifungal agents|mesh-ancestor
25862186|NCT00089050|Cyclosporine|cyclosporine|mesh-list
25862187|NCT00089050|Gemtuzumab|gemtuzumab|mesh-list
25862188|NCT00089050|Cyclosporins|cyclosporins|mesh-list
25862189|NCT00089050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24940233|NCT04002635|Hormone Antagonists|hormone antagonists|mesh-ancestor
24940234|NCT04002635|Progestins|progestins|mesh-ancestor
24940235|NCT04002323|Lamivudine|lamivudine|mesh-list
24940236|NCT04002323|Dolutegravir|dolutegravir|mesh-list
24940237|NCT04002323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24940238|NCT04002323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24940239|NCT04002323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25862190|NCT00089050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862191|NCT00089050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25862192|NCT00089050|Immunologic Factors|immunologic factors|mesh-ancestor
25862193|NCT00089050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801948|NCT01986465|Hormones|hormones|mesh-ancestor
25668157|NCT01712178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25668158|NCT01712178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25668159|NCT01712204|Febuxostat|febuxostat|mesh-list
25668160|NCT01712204|Gout Suppressants|gout suppressants|mesh-ancestor
25668161|NCT01712204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25668162|NCT01712230|Leuprolide|leuprolide|mesh-list
25668163|NCT01712230|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25668164|NCT01712230|Fertility Agents|fertility agents|mesh-ancestor
25668165|NCT01712230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25668166|NCT01712230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832159|NCT02170792|Anticoagulants|anticoagulants|mesh-ancestor
25862194|NCT00089050|Antifungal Agents|antifungal agents|mesh-ancestor
24940245|NCT04002323|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24940246|NCT04002323|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24940247|NCT04002271|Propofol|propofol|mesh-list
24940248|NCT04002271|Sevoflurane|sevoflurane|mesh-list
24940249|NCT04002271|Anesthetics|anesthetics|mesh-ancestor
24940250|NCT04002271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24940251|NCT04002271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940252|NCT04002271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24940253|NCT04002271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24940254|NCT04002271|Anesthetics, General|anesthetics, general|mesh-ancestor
25862195|NCT00089050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25862196|NCT00089050|Dermatologic Agents|dermatologic agents|mesh-ancestor
25862197|NCT00089050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24549816|NCT00717652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24549817|NCT00717652|Glucocorticoids|glucocorticoids|mesh-ancestor
24549818|NCT00717652|Hormones|hormones|mesh-ancestor
24549819|NCT00717652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24549820|NCT00717652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549828|NCT00717678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549829|NCT00717678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24549830|NCT00717678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549831|NCT00717678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549832|NCT00717678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24549833|NCT00717678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862198|NCT00089050|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25862199|NCT00089050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24940259|NCT04002700|Antipsychotic Agents|antipsychotic agents|mesh-list
24940261|NCT04002700|Autonomic Agents|autonomic agents|mesh-ancestor
24940262|NCT04002700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24940263|NCT04002700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764965|NCT01785290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24940265|NCT04002700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24549840|NCT00717704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24549965|NCT00718354|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24549966|NCT00718354|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24549968|NCT00718406|Morphine|morphine|mesh-list
24549969|NCT00718406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24549970|NCT00718406|Narcotics|narcotics|mesh-ancestor
24549971|NCT00718406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24549972|NCT00718406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862200|NCT00089050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862201|NCT00089063|Sargramostim|sargramostim|mesh-list
25862202|NCT00089063|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25862203|NCT00089063|Freund's Adjuvant|freund's adjuvant|mesh-list
25862204|NCT00089063|Immunologic Factors|immunologic factors|mesh-ancestor
25862205|NCT00089063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862206|NCT00089063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25862207|NCT00089089|Decitabine|decitabine|mesh-list
25862208|NCT00089089|Azacitidine|azacitidine|mesh-list
24550087|NCT00719056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24550088|NCT00719056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550096|NCT00719095|Narcotics|narcotics|mesh-ancestor
24550215|NCT00719693|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24550216|NCT00719693|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24550220|NCT00719745|Immunologic Factors|immunologic factors|mesh-ancestor
24550221|NCT00719745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862209|NCT00089089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25862210|NCT00089089|Antimetabolites|antimetabolites|mesh-ancestor
24447819|NCT00309673|Sensory System Agents|sensory system agents|mesh-ancestor
25862211|NCT00089089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550300|NCT00720148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24550301|NCT00720148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550302|NCT00720148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550303|NCT00720161|Metformin|metformin|mesh-list
24550304|NCT00720161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24550305|NCT00720161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550306|NCT00720174|Doxorubicin|doxorubicin|mesh-list
24550307|NCT00720174|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25668167|NCT01712230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25668168|NCT01712230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25428569|NCT01700946|Dexamethasone|dexamethasone|mesh-list
25668169|NCT01712360|Naftifine|naftifine|mesh-list
24550326|NCT00720291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24550327|NCT00720291|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25862213|NCT00089089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25862214|NCT00089115|Rituximab|rituximab|mesh-list
25862215|NCT00089115|Immunoglobulins|immunoglobulins|mesh-list
25862216|NCT00089115|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25862217|NCT00089115|Antibodies|antibodies|mesh-list
25199696|NCT02739399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25862218|NCT00089115|Sargramostim|sargramostim|mesh-list
25862219|NCT00089115|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
25862220|NCT00089115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24550346|NCT00720408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24827097|NCT02137395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24550348|NCT00720408|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24550349|NCT00720408|Antitubercular Agents|antitubercular agents|mesh-ancestor
24550361|NCT00720421|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24550362|NCT00720421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24550363|NCT00720421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25862221|NCT00089115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862222|NCT00089115|Immunologic Factors|immunologic factors|mesh-ancestor
25862223|NCT00089115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940283|NCT04002349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24550406|NCT00720512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550407|NCT00720512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24550408|NCT00720512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24550410|NCT00720512|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24550411|NCT00720512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24550412|NCT00720512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550413|NCT00720512|Antidotes|antidotes|mesh-ancestor
24550414|NCT00720512|Protective Agents|protective agents|mesh-ancestor
24550415|NCT00720512|Vitamin B Complex|vitamin b complex|mesh-ancestor
24550437|NCT00720577|Losartan|losartan|mesh-list
25862224|NCT00089115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25862225|NCT00089154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25862226|NCT00089154|Antibodies|antibodies|mesh-list
25862227|NCT00089154|Immunoglobulins|immunoglobulins|mesh-list
25862228|NCT00089154|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25862229|NCT00089154|Immunologic Factors|immunologic factors|mesh-ancestor
25862230|NCT00089154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668170|NCT01712360|Antifungal Agents|antifungal agents|mesh-ancestor
25668171|NCT01712360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25668172|NCT01712399|Mavrilimumab|mavrilimumab|mesh-list
25668173|NCT01712399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25668174|NCT01712516|Glycopyrrolate|glycopyrrolate|mesh-list
25668175|NCT01712516|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25668176|NCT01712516|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25668177|NCT01712516|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25668178|NCT01712516|Cholinergic Agents|cholinergic agents|mesh-ancestor
25668179|NCT01712516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25674434|NCT01772147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25862231|NCT00089154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862232|NCT00089167|Thalidomide|thalidomide|mesh-list
24458268|NCT00337298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25862251|NCT00089167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25862252|NCT00089167|Leprostatic Agents|leprostatic agents|mesh-ancestor
25862253|NCT00089167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25862254|NCT00089167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25862255|NCT00089167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25862256|NCT00089167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25862257|NCT00089167|Growth Substances|growth substances|mesh-ancestor
25862258|NCT00089167|Growth Inhibitors|growth inhibitors|mesh-ancestor
25862259|NCT00089193|Sargramostim|sargramostim|mesh-list
24940335|NCT04001959|Cariostatic Agents|cariostatic agents|mesh-ancestor
24940336|NCT04001959|Protective Agents|protective agents|mesh-ancestor
25862260|NCT00089193|Freund's Adjuvant|freund's adjuvant|mesh-list
25862261|NCT00089193|Immunologic Factors|immunologic factors|mesh-ancestor
25862262|NCT00089193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862263|NCT00089193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24436922|NCT00272077|Insulin Glargine|insulin glargine|mesh-list
25862264|NCT00089206|Sargramostim|sargramostim|mesh-list
25862265|NCT00089206|Freund's Adjuvant|freund's adjuvant|mesh-list
25862266|NCT00089206|Immunologic Factors|immunologic factors|mesh-ancestor
25862267|NCT00089206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862268|NCT00089206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25862269|NCT00089219|Sargramostim|sargramostim|mesh-list
25862270|NCT00089219|Freund's Adjuvant|freund's adjuvant|mesh-list
25862271|NCT00089219|Immunologic Factors|immunologic factors|mesh-ancestor
25862272|NCT00089219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862273|NCT00089219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25862274|NCT00089258|Isotretinoin|isotretinoin|mesh-list
25862275|NCT00089258|Antibodies|antibodies|mesh-list
24437337|NCT00273442|Maleic acid|maleic acid|mesh-list
24437338|NCT00273442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25428570|NCT01700946|Hydrocortisone|hydrocortisone|mesh-list
25668186|NCT01712984|Antifungal Agents|antifungal agents|mesh-ancestor
25668187|NCT01712984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25668188|NCT01712984|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25668189|NCT01712984|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25668190|NCT01712984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25862276|NCT00089258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25862277|NCT00089258|Sargramostim|sargramostim|mesh-list
24437394|NCT00273507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862278|NCT00089258|Immunologic Factors|immunologic factors|mesh-ancestor
25862279|NCT00089258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862280|NCT00089258|Dermatologic Agents|dermatologic agents|mesh-ancestor
25862281|NCT00089349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25862282|NCT00089349|Alemtuzumab|alemtuzumab|mesh-list
24450061|NCT00317733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862283|NCT00089349|Methotrexate|methotrexate|mesh-list
25862284|NCT00089349|Mercaptopurine|mercaptopurine|mesh-list
25862285|NCT00089349|Antibodies|antibodies|mesh-list
25862286|NCT00089349|Immunoglobulins|immunoglobulins|mesh-list
25862287|NCT00089349|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25862288|NCT00089349|Immunologic Factors|immunologic factors|mesh-ancestor
25862289|NCT00089349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862290|NCT00089349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862291|NCT00089349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25862292|NCT00089349|Abortifacient Agents|abortifacient agents|mesh-ancestor
25862293|NCT00089349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25862294|NCT00089349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25862295|NCT00089349|Antimetabolites|antimetabolites|mesh-ancestor
25862296|NCT00089349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862297|NCT00089349|Dermatologic Agents|dermatologic agents|mesh-ancestor
25862298|NCT00089349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25862299|NCT00089349|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25862300|NCT00089349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25862301|NCT00089349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25862302|NCT00089349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25862303|NCT00089401|Melphalan|melphalan|mesh-list
25862304|NCT00089401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25862305|NCT00089401|Alkylating Agents|alkylating agents|mesh-ancestor
25862306|NCT00089401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862307|NCT00089401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862308|NCT00089401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25862309|NCT00089401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25862310|NCT00089401|Immunologic Factors|immunologic factors|mesh-ancestor
25862311|NCT00089401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940359|NCT04002024|Salicylic Acid|salicylic acid|mesh-list
24940360|NCT04002024|Salicylates|salicylates|mesh-list
24940361|NCT04002024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24940362|NCT04002024|Antifungal Agents|antifungal agents|mesh-ancestor
24940363|NCT04002024|Keratolytic Agents|keratolytic agents|mesh-ancestor
25862312|NCT00089427|Temozolomide|temozolomide|mesh-list
25862313|NCT00089427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25862314|NCT00089427|Alkylating Agents|alkylating agents|mesh-ancestor
25862315|NCT00089427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862316|NCT00089427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862317|NCT00089440|Aripiprazole|aripiprazole|mesh-list
25862318|NCT00089440|Antidepressive Agents|antidepressive agents|mesh-ancestor
25862319|NCT00089440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25862320|NCT00089440|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25862321|NCT00089440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25862322|NCT00089440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25862323|NCT00089440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862324|NCT00089440|Dopamine Agonists|dopamine agonists|mesh-ancestor
25862325|NCT00089440|Dopamine Agents|dopamine agents|mesh-ancestor
25862326|NCT00089440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25862327|NCT00089440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862328|NCT00089440|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25862329|NCT00089440|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25862330|NCT00089440|Serotonin Agents|serotonin agents|mesh-ancestor
25050620|NCT00481325|Citalopram|citalopram|mesh-list
24701707|NCT01460537|Antimetabolites|antimetabolites|mesh-ancestor
24701708|NCT01460537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701709|NCT01460537|Antiviral Agents|antiviral agents|mesh-ancestor
24701710|NCT01460537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24701711|NCT01460537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487376|NCT00462852|Gemcitabine|gemcitabine|mesh-list
24701712|NCT01460537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24701713|NCT01460537|Immunologic Factors|immunologic factors|mesh-ancestor
24701714|NCT01460537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701715|NCT01460563|Magnesium Sulfate|magnesium sulfate|mesh-list
24701738|NCT01460615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25050666|NCT00478972|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25050667|NCT00478972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050668|NCT00478972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050670|NCT00478972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25050671|NCT00478972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050672|NCT00478595|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25050674|NCT00478595|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25050675|NCT00478595|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
25050676|NCT00478595|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25199700|NCT02739399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199701|NCT02739399|Protective Agents|protective agents|mesh-ancestor
25199702|NCT02738983|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25199703|NCT02738983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862331|NCT00089440|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25862332|NCT00089440|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25862333|NCT00089440|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25862334|NCT00089440|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25862335|NCT00089453|Dexamethasone|dexamethasone|mesh-list
24701930|NCT01462968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014155|NCT04963816|Dexamethasone|dexamethasone|mesh-list
24701931|NCT01463046|Cytarabine|cytarabine|mesh-list
24701932|NCT01463046|Daunorubicin|daunorubicin|mesh-list
24701933|NCT01463046|Panobinostat|panobinostat|mesh-list
24701934|NCT01463046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24701935|NCT01463046|Antimetabolites|antimetabolites|mesh-ancestor
24702009|NCT01463332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24702010|NCT01463332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702011|NCT01463371|Azithromycin|azithromycin|mesh-list
24702012|NCT01463371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24702013|NCT01463371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24702015|NCT01463592|Interferons|interferons|mesh-list
24702016|NCT01463592|Ribavirin|ribavirin|mesh-list
24702017|NCT01463592|Interferon-alpha|interferon-alpha|mesh-list
24702018|NCT01463592|Interferon alpha-2|interferon alpha-2|mesh-list
24702019|NCT01463592|Cadexomer iodine|cadexomer iodine|mesh-list
24702020|NCT01463592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24702021|NCT01463592|Antiviral Agents|antiviral agents|mesh-ancestor
24613363|NCT01018485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24613364|NCT01018602|Vildagliptin|vildagliptin|mesh-list
24613365|NCT01018602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24613366|NCT01018602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613367|NCT01018602|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24613368|NCT01018602|Protease Inhibitors|protease inhibitors|mesh-ancestor
24613369|NCT01018602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613370|NCT01018602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613372|NCT01018615|Antioxidants|antioxidants|mesh-ancestor
24613373|NCT01018615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613374|NCT01018615|Protective Agents|protective agents|mesh-ancestor
24702035|NCT01463735|Micronutrients|micronutrients|mesh-ancestor
24702036|NCT01463735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702037|NCT01463735|Antioxidants|antioxidants|mesh-ancestor
24702038|NCT01463735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702084|NCT01464008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199707|NCT02739412|Aldesleukin|aldesleukin|mesh-list
25199708|NCT02739412|Interleukin-2|interleukin-2|mesh-list
25199709|NCT02739412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199710|NCT02739412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25199711|NCT02739412|Analgesics|analgesics|mesh-ancestor
25199712|NCT02739412|Sensory System Agents|sensory system agents|mesh-ancestor
25199713|NCT02739412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25199714|NCT02739412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199715|NCT02739412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25199716|NCT02739412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25199717|NCT02739412|Antiviral Agents|antiviral agents|mesh-ancestor
25199718|NCT02739412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25199719|NCT02739204|Celecoxib|celecoxib|mesh-list
24702241|NCT01464671|Anticoagulants|anticoagulants|mesh-ancestor
25862336|NCT00089453|Cyclophosphamide|cyclophosphamide|mesh-list
24702306|NCT01465009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702307|NCT01465009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24702352|NCT01465256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702353|NCT01465256|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25862337|NCT00089453|Melphalan|melphalan|mesh-list
24794170|NCT05413343|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
24794171|NCT05413343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24702354|NCT01465256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24702355|NCT01465256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702393|NCT01465685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24702394|NCT01465685|Hallucinogens|hallucinogens|mesh-ancestor
24702395|NCT01465685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24702396|NCT01465685|Serotonin Agents|serotonin agents|mesh-ancestor
24702397|NCT01465685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24702398|NCT01465685|Adrenergic Agents|adrenergic agents|mesh-ancestor
24702399|NCT01465815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24702400|NCT01465815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24702401|NCT01465815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24702402|NCT01465815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702403|NCT01465815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702405|NCT01465828|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24702444|NCT01465906|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24702445|NCT01465906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24702446|NCT01465906|Adrenergic Agents|adrenergic agents|mesh-ancestor
24449666|NCT00316472|Niacin|niacin|mesh-list
24702449|NCT01465919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24702450|NCT01465919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24702451|NCT01465919|Histamine Antagonists|histamine antagonists|mesh-ancestor
24488129|NCT00466622|Metformin|metformin|mesh-list
24702452|NCT01465919|Histamine Agents|histamine agents|mesh-ancestor
24702453|NCT01465919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24702474|NCT01466101|Pregabalin|pregabalin|mesh-list
24702488|NCT01466114|Norethindrone|norethindrone|mesh-list
24702489|NCT01466114|Norethindrone Acetate|norethindrone acetate|mesh-list
24702490|NCT01466114|Progestins|progestins|mesh-list
24702491|NCT01466114|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24702492|NCT01466114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24702493|NCT01466114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24702494|NCT01466114|Contraceptive Agents|contraceptive agents|mesh-ancestor
24702532|NCT01466452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702533|NCT01466452|Antipyretics|antipyretics|mesh-ancestor
24702534|NCT01466465|Vitamin D|vitamin d|mesh-list
24702535|NCT01466465|Cholecalciferol|cholecalciferol|mesh-list
24702536|NCT01466465|Vitamins|vitamins|mesh-ancestor
24702537|NCT01466465|Micronutrients|micronutrients|mesh-ancestor
24702538|NCT01466465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702547|NCT01466478|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24705717|NCT01486459|Lithium Carbonate|lithium carbonate|mesh-list
25053507|NCT00013897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25053508|NCT00013897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25053509|NCT00013897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24807778|NCT02023593|Irinotecan|irinotecan|mesh-list
24702548|NCT01466478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24702549|NCT01466478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702550|NCT01466478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24702552|NCT01466478|Micronutrients|micronutrients|mesh-ancestor
24702553|NCT01466478|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24702554|NCT01466478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24702555|NCT01466517|Ibuprofen|ibuprofen|mesh-list
24940390|NCT04001855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24940391|NCT04001855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24702606|NCT01466712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24702607|NCT01466712|Glucocorticoids|glucocorticoids|mesh-ancestor
24702608|NCT01466712|Hormones|hormones|mesh-ancestor
24702609|NCT01466712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24702610|NCT01466829|Hormones|hormones|mesh-list
24765192|NCT01786538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24765193|NCT01786538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24765194|NCT01786538|Immunologic Factors|immunologic factors|mesh-ancestor
25668191|NCT01712984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668192|NCT01712984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25668193|NCT01712984|Hormone Antagonists|hormone antagonists|mesh-ancestor
25668194|NCT01712984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24765195|NCT01786538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702783|NCT01467687|Verapamil|verapamil|mesh-list
24702784|NCT01467687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24702785|NCT01467687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24702786|NCT01467687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24702787|NCT01467687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702788|NCT01467687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24439577|NCT00279448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24765197|NCT01786538|Protective Agents|protective agents|mesh-ancestor
24765198|NCT01786538|Vitamin B Complex|vitamin b complex|mesh-ancestor
24765199|NCT01786538|Vitamins|vitamins|mesh-ancestor
24765200|NCT01786538|Micronutrients|micronutrients|mesh-ancestor
24765201|NCT01786616|Formoterol Fumarate|formoterol fumarate|mesh-list
24702893|NCT01468389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24702894|NCT01468389|Antimetabolites|antimetabolites|mesh-ancestor
24702895|NCT01468389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702896|NCT01468389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24702897|NCT01468415|Phenol|phenol|mesh-list
24702898|NCT01468415|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24702899|NCT01468415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24702900|NCT01468415|Disinfectants|disinfectants|mesh-ancestor
24702901|NCT01468415|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
24702902|NCT01468415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24702903|NCT01468441|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24702905|NCT01468441|Luteolytic Agents|luteolytic agents|mesh-ancestor
24604167|NCT00977405|Gentamicins|gentamicins|mesh-list
24702906|NCT01468441|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24702907|NCT01468441|Contraceptive Agents|contraceptive agents|mesh-ancestor
24702908|NCT01468441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24702909|NCT01468441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702945|NCT01468610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24702946|NCT01468688|Imatinib Mesylate|imatinib mesylate|mesh-list
25862338|NCT00089453|Fludarabine|fludarabine|mesh-list
24702968|NCT01468740|Vincristine|vincristine|mesh-list
24702970|NCT01468740|Vinblastine|vinblastine|mesh-list
24702971|NCT01468740|Procarbazine|procarbazine|mesh-list
24702972|NCT01468740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24702973|NCT01468740|Immunologic Factors|immunologic factors|mesh-ancestor
24702974|NCT01468740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702975|NCT01468740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24702976|NCT01468740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24702977|NCT01468740|Alkylating Agents|alkylating agents|mesh-ancestor
24702978|NCT01468740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702979|NCT01468740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703169|NCT01470053|Mometasone Furoate|mometasone furoate|mesh-list
24703170|NCT01470053|Azelastine|azelastine|mesh-list
24703171|NCT01470053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24703172|NCT01470053|Dermatologic Agents|dermatologic agents|mesh-ancestor
24703173|NCT01470053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24703174|NCT01470053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24703175|NCT01470053|Autonomic Agents|autonomic agents|mesh-ancestor
24940444|NCT04001231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703211|NCT01470157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24703212|NCT01470157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703214|NCT01470209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862339|NCT00089453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25862340|NCT00089453|Immunologic Factors|immunologic factors|mesh-ancestor
24703215|NCT01470209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24703216|NCT01470209|Immunologic Factors|immunologic factors|mesh-ancestor
24703217|NCT01470209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703218|NCT01470326|Bazedoxifene|bazedoxifene|mesh-list
24703219|NCT01470326|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24703220|NCT01470326|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24703221|NCT01470326|Hormone Antagonists|hormone antagonists|mesh-ancestor
24703222|NCT01470326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25862341|NCT00089453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703293|NCT01470794|Antimetabolites|antimetabolites|mesh-ancestor
24703294|NCT01470794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703295|NCT01470807|Pancrelipase|pancrelipase|mesh-list
24703296|NCT01470807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24703298|NCT01470937|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24703300|NCT01470937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703301|NCT01470937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24703302|NCT01470937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703303|NCT01471067|Mycophenolic Acid|mycophenolic acid|mesh-list
24703304|NCT01471067|Rituximab|rituximab|mesh-list
24644256|NCT01189929|Gemcitabine|gemcitabine|mesh-list
24703355|NCT01471158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703356|NCT01471158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24703357|NCT01471158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24739132|NCT01679327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25862342|NCT00089453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25862343|NCT00089453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25862344|NCT00089453|Alkylating Agents|alkylating agents|mesh-ancestor
25862345|NCT00089453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053551|NCT00005788|Aldesleukin|aldesleukin|mesh-list
25053552|NCT00005788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053553|NCT00005788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25053554|NCT00005788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25053555|NCT00005788|Antiviral Agents|antiviral agents|mesh-ancestor
25053556|NCT00005788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25053558|NCT00005608|Tegafur|tegafur|mesh-list
25053559|NCT00005608|Calcium|calcium|mesh-list
25053560|NCT00005608|Levoleucovorin|levoleucovorin|mesh-list
25053561|NCT00005608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25053562|NCT00005608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807812|NCT02023710|Tubulin Modulators|tubulin modulators|mesh-ancestor
24865293|NCT03962894|Glucocorticoids|glucocorticoids|mesh-ancestor
24940469|NCT04001374|Purinergic Agents|purinergic agents|mesh-ancestor
24940470|NCT04001374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24940471|NCT04001374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940472|NCT04001374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940473|NCT04001569|Paclitaxel|paclitaxel|mesh-list
24940474|NCT04001569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24703451|NCT01471847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703452|NCT01471847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703453|NCT01471847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24940525|NCT04000906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24940526|NCT04000906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24940527|NCT04000906|Tubulin Modulators|tubulin modulators|mesh-ancestor
24940528|NCT04000906|Antimitotic Agents|antimitotic agents|mesh-ancestor
24940529|NCT04000906|Mitosis Modulators|mitosis modulators|mesh-ancestor
24613422|NCT01019070|Asunaprevir|asunaprevir|mesh-list
24613423|NCT01019070|Protease Inhibitors|protease inhibitors|mesh-ancestor
24613424|NCT01019070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199720|NCT02739204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25199721|NCT02739204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25199722|NCT02739204|Analgesics|analgesics|mesh-ancestor
25199723|NCT02739204|Sensory System Agents|sensory system agents|mesh-ancestor
25199724|NCT02739204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25199725|NCT02739204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199726|NCT02739204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25199727|NCT02739204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25199728|NCT02739204|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25199729|NCT02739204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25199730|NCT02739204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703632|NCT01472978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24703634|NCT01472978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24703635|NCT01473043|Axitinib|axitinib|mesh-list
24703666|NCT01473251|Ranibizumab|ranibizumab|mesh-list
24703667|NCT01473251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24703668|NCT01473251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703669|NCT01473251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24703670|NCT01473251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24703671|NCT01473251|Growth Substances|growth substances|mesh-ancestor
24703727|NCT01473472|Emtricitabine|emtricitabine|mesh-list
24703728|NCT01473472|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24703729|NCT01473472|Antiviral Agents|antiviral agents|mesh-ancestor
24865294|NCT03962894|Hormones|hormones|mesh-ancestor
24865318|NCT03832010|Hormones|hormones|mesh-ancestor
24865319|NCT03832010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24703730|NCT01473472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24703772|NCT01474187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24703773|NCT01474187|Antimetabolites|antimetabolites|mesh-ancestor
25404112|NCT03684811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25668195|NCT01712984|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25668196|NCT01712984|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25668197|NCT01713283|Sofosbuvir|sofosbuvir|mesh-list
25668198|NCT01713283|Antiviral Agents|antiviral agents|mesh-ancestor
25668199|NCT01713283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25668200|NCT01713400|Sirolimus|sirolimus|mesh-list
25668201|NCT01713400|Ustekinumab|ustekinumab|mesh-list
25668202|NCT01713400|Tacrolimus|tacrolimus|mesh-list
24970801|NCT03730766|Antacids|antacids|mesh-ancestor
24703774|NCT01474187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703775|NCT01474187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703776|NCT01474187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24703777|NCT01474187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24703778|NCT01474187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703779|NCT01474265|Varenicline|varenicline|mesh-list
24703780|NCT01474265|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24703781|NCT01474265|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24703782|NCT01474265|Cholinergic Agents|cholinergic agents|mesh-ancestor
24703783|NCT01474265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24703784|NCT01474265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703785|NCT01474265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703817|NCT01474460|Hemostatics|hemostatics|mesh-ancestor
24703818|NCT01474460|Coagulants|coagulants|mesh-ancestor
24703819|NCT01474473|Calpastatin|calpastatin|mesh-list
24703820|NCT01474473|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
24703821|NCT01474473|Protease Inhibitors|protease inhibitors|mesh-ancestor
24489519|NCT00473915|Xhance|xhance|mesh-list
24703822|NCT01474473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703823|NCT01474473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703825|NCT01474499|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
24703826|NCT01474499|Glycerol|glycerol|mesh-list
25862346|NCT00089453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703927|NCT01475552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24703928|NCT01475552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703929|NCT01475552|Antipyretics|antipyretics|mesh-ancestor
24703930|NCT01475552|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24703931|NCT01475552|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24703932|NCT01475552|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24703933|NCT01475552|Purinergic Agents|purinergic agents|mesh-ancestor
24703934|NCT01475552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24703935|NCT01475552|Anticoagulants|anticoagulants|mesh-ancestor
24703936|NCT01475578|Ergoloid Mesylates|ergoloid mesylates|mesh-list
24703937|NCT01475578|Dihydroergotoxine|dihydroergotoxine|mesh-list
24703938|NCT01475578|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24703939|NCT01475578|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24703940|NCT01475578|Adrenergic Agents|adrenergic agents|mesh-ancestor
24703941|NCT01475578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24704004|NCT01476124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24704005|NCT01476124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704007|NCT01476124|Sensory System Agents|sensory system agents|mesh-ancestor
24940548|NCT04000633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940550|NCT04000386|Dermatologic Agents|dermatologic agents|mesh-ancestor
24940551|NCT04000386|Sunscreening Agents|sunscreening agents|mesh-ancestor
24853943|NCT02271126|Hemostatics|hemostatics|mesh-ancestor
24704012|NCT01476137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704013|NCT01476137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704014|NCT01476176|Acetaminophen|acetaminophen|mesh-list
24704015|NCT01476176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24704016|NCT01476176|Analgesics|analgesics|mesh-ancestor
24440967|NCT00285428|Antibodies|antibodies|mesh-list
24704048|NCT01476332|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24704050|NCT01476358|Retinol palmitate|retinol palmitate|mesh-list
24704051|NCT01476358|Vitamins|vitamins|mesh-ancestor
24704052|NCT01476358|Micronutrients|micronutrients|mesh-ancestor
24704053|NCT01476358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704054|NCT01476358|Antioxidants|antioxidants|mesh-ancestor
24704055|NCT01476358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704056|NCT01476358|Protective Agents|protective agents|mesh-ancestor
24704057|NCT01476358|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24704058|NCT01476358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613483|NCT01019382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940574|NCT04000126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940575|NCT04000126|Sensory System Agents|sensory system agents|mesh-ancestor
24940576|NCT04000126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24940577|NCT04000126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24940578|NCT04000126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24940579|NCT04000126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24940580|NCT04000126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24940581|NCT04000126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940583|NCT03999580|Cholecalciferol|cholecalciferol|mesh-list
24940584|NCT03999580|Vitamins|vitamins|mesh-ancestor
24940585|NCT03999580|Micronutrients|micronutrients|mesh-ancestor
24613530|NCT01019590|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24970952|NCT03729804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24970953|NCT03729804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24613531|NCT01019590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24613532|NCT01019590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613533|NCT01019590|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24613534|NCT01019590|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24613536|NCT01019603|Tazarotene|tazarotene|mesh-list
24613537|NCT01019603|Dermatologic Agents|dermatologic agents|mesh-ancestor
24613538|NCT01019603|Keratolytic Agents|keratolytic agents|mesh-ancestor
24613539|NCT01019603|Vitamin B Complex|vitamin b complex|mesh-ancestor
25862347|NCT00089453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24613540|NCT01019603|Vitamins|vitamins|mesh-ancestor
24613541|NCT01019603|Micronutrients|micronutrients|mesh-ancestor
24765457|NCT01788605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24765458|NCT01788605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765459|NCT01788670|Ethanol|ethanol|mesh-list
24765460|NCT01788670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24704146|NCT01476800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604858|NCT00981929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24704147|NCT01476800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704201|NCT01477112|Micronutrients|micronutrients|mesh-ancestor
24704202|NCT01477151|Anesthetics|anesthetics|mesh-list
24704203|NCT01477151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24704204|NCT01477151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704205|NCT01477190|Morphine|morphine|mesh-list
24704206|NCT01477190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24704207|NCT01477190|Narcotics|narcotics|mesh-ancestor
24704210|NCT01477190|Analgesics|analgesics|mesh-ancestor
24704212|NCT01477190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24704306|NCT01477632|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24704307|NCT01477632|Norethindrone|norethindrone|mesh-list
24704466|NCT01478490|Metoprolol|metoprolol|mesh-list
24704467|NCT01478490|Mirabegron|mirabegron|mesh-list
24704468|NCT01478490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24704469|NCT01478490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24704470|NCT01478490|Sympatholytics|sympatholytics|mesh-ancestor
24704471|NCT01478490|Autonomic Agents|autonomic agents|mesh-ancestor
24704472|NCT01478490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24704473|NCT01478490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053610|NCT00004912|Appetite Stimulants|appetite stimulants|mesh-ancestor
24704474|NCT01478490|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24704475|NCT01478490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24704476|NCT01478490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24449316|NCT00314990|Folic Acid|folic acid|mesh-list
24704543|NCT01478685|Tubulin Modulators|tubulin modulators|mesh-ancestor
24704544|NCT01478685|Antimitotic Agents|antimitotic agents|mesh-ancestor
24704545|NCT01478685|Mitosis Modulators|mitosis modulators|mesh-ancestor
24704546|NCT01478685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940626|NCT03999099|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
24940627|NCT03999099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24940628|NCT03999099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556299|NCT00746746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853984|NCT02271360|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24853989|NCT02271360|Hemostatics|hemostatics|mesh-ancestor
24613552|NCT01019655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24613553|NCT01019655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613554|NCT01019655|Anticoagulants|anticoagulants|mesh-ancestor
24613575|NCT01019785|Vitamins|vitamins|mesh-ancestor
24613576|NCT01019785|Micronutrients|micronutrients|mesh-ancestor
24613577|NCT01019785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24613578|NCT01019798|Docetaxel|docetaxel|mesh-list
24704667|NCT01479556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24704668|NCT01479556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24704670|NCT01479634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24704671|NCT01479634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24704672|NCT01479634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704673|NCT01479634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862348|NCT00089453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25862349|NCT00089453|Antiemetics|antiemetics|mesh-ancestor
25862350|NCT00089453|Autonomic Agents|autonomic agents|mesh-ancestor
24704709|NCT01479881|Simeprevir|simeprevir|mesh-list
25668203|NCT01713400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25668204|NCT01713400|Immunologic Factors|immunologic factors|mesh-ancestor
25668205|NCT01713400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862352|NCT00089453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25083235|NCT03317197|Racepinephrine|racepinephrine|mesh-list
25862353|NCT00089453|Glucocorticoids|glucocorticoids|mesh-ancestor
25668206|NCT01713400|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25668207|NCT01713400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25668208|NCT01713400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083236|NCT03317197|Epinephryl borate|epinephryl borate|mesh-list
25217684|NCT02675868|Phenylephrine|phenylephrine|mesh-list
24704710|NCT01479881|Tacrolimus|tacrolimus|mesh-list
24704711|NCT01479881|Cyclosporins|cyclosporins|mesh-list
24704712|NCT01479881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24704713|NCT01479881|Immunologic Factors|immunologic factors|mesh-ancestor
24704714|NCT01479881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704715|NCT01479881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24704767|NCT01480141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24704768|NCT01480141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704769|NCT01480141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704770|NCT01480323|Aldesleukin|aldesleukin|mesh-list
24704771|NCT01480323|Ipilimumab|ipilimumab|mesh-list
24704772|NCT01480323|Interleukin-2|interleukin-2|mesh-list
24704773|NCT01480323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24704774|NCT01480323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24820228|NCT02099240|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24611213|NCT01007799|Vitamin D|vitamin d|mesh-list
25207668|NCT03514732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24556300|NCT00746837|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
24865401|NCT03115294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24865402|NCT03115294|Autonomic Agents|autonomic agents|mesh-ancestor
24556302|NCT00746837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556305|NCT00746837|Antiviral Agents|antiviral agents|mesh-ancestor
24704775|NCT01480323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24704776|NCT01480323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704792|NCT01480336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704793|NCT01480336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24704794|NCT01480336|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24704795|NCT01480336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24704796|NCT01480336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704797|NCT01480336|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24704798|NCT01480336|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24704799|NCT01480336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24704800|NCT01480492|Telbivudine|telbivudine|mesh-list
24704801|NCT01480492|Antiviral Agents|antiviral agents|mesh-ancestor
24704802|NCT01480492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24704803|NCT01480492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24704881|NCT01480791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704884|NCT01480817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24704885|NCT01480817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704886|NCT01480817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704888|NCT01480869|Cholecalciferol|cholecalciferol|mesh-list
24704889|NCT01480869|Vitamin D|vitamin d|mesh-list
24704890|NCT01480869|Calcium|calcium|mesh-list
24704891|NCT01480869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24704892|NCT01480869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704893|NCT01480869|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24704894|NCT01480869|Vitamins|vitamins|mesh-ancestor
24704895|NCT01480869|Micronutrients|micronutrients|mesh-ancestor
24704896|NCT01480986|Irinotecan|irinotecan|mesh-list
24704897|NCT01480986|Octreotide|octreotide|mesh-list
24704967|NCT01481454|Vaccines|vaccines|mesh-list
24704975|NCT01481519|BB 1101|bb 1101|mesh-list
24705019|NCT01481714|Sodium Citrate|sodium citrate|mesh-list
24705020|NCT01481714|Citric Acid|citric acid|mesh-list
24705069|NCT01481870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705070|NCT01481870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705071|NCT01481870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25668209|NCT01713400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25668210|NCT01713400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25668211|NCT01713400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25668212|NCT01713400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705072|NCT01481870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24705073|NCT01481870|Growth Substances|growth substances|mesh-ancestor
24705074|NCT01481870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705075|NCT01481870|Growth Inhibitors|growth inhibitors|mesh-ancestor
24705076|NCT01481883|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
24705077|NCT01481883|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24705078|NCT01481883|Hormone Antagonists|hormone antagonists|mesh-ancestor
24705079|NCT01481883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24705080|NCT01481883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865409|NCT03115294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865410|NCT03115294|Vasodilator Agents|vasodilator agents|mesh-ancestor
24865411|NCT03115294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24865412|NCT03115294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24865413|NCT03115294|Purinergic Agents|purinergic agents|mesh-ancestor
24865414|NCT03115294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24865415|NCT03087656|Levofloxacin|levofloxacin|mesh-list
24865416|NCT03087656|Ofloxacin|ofloxacin|mesh-list
24865417|NCT03087656|Ceftriaxone|ceftriaxone|mesh-list
24705251|NCT01483248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24705252|NCT01483274|Vaccines|vaccines|mesh-list
25862354|NCT00089453|Hormones|hormones|mesh-ancestor
25862355|NCT00089453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24705254|NCT01483274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705256|NCT01483300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491062|NCT00481013|Valproic Acid|valproic acid|mesh-list
24705257|NCT01483365|Progesterone|progesterone|mesh-list
24613603|NCT01019876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24613605|NCT01019876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613606|NCT01019876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24613607|NCT01019876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24613608|NCT01019876|Alkylating Agents|alkylating agents|mesh-ancestor
24644450|NCT01191021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940641|NCT03999203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24940642|NCT03999203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940643|NCT03999203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24940644|NCT03999203|Respiratory System Agents|respiratory system agents|mesh-ancestor
24940645|NCT03999203|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25862356|NCT00089453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24705357|NCT01484327|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24705358|NCT01484327|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24705360|NCT01484457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24660516|NCT01284166|Timolol|timolol|mesh-list
24705379|NCT01484717|Cholinergic Agents|cholinergic agents|mesh-ancestor
24705380|NCT01484717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24705381|NCT01484717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705382|NCT01484756|Micronutrients|micronutrients|mesh-list
24705383|NCT01484756|Trace Elements|trace elements|mesh-list
24705411|NCT01485068|Tubulin Modulators|tubulin modulators|mesh-ancestor
24705412|NCT01485068|Antimitotic Agents|antimitotic agents|mesh-ancestor
24705413|NCT01485068|Mitosis Modulators|mitosis modulators|mesh-ancestor
24705414|NCT01485068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865419|NCT03087656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24865425|NCT03087656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865426|NCT03087656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865427|NCT03087656|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24705416|NCT01485081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24705417|NCT01485081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705418|NCT01485081|Tubulin Modulators|tubulin modulators|mesh-ancestor
24705419|NCT01485081|Antimitotic Agents|antimitotic agents|mesh-ancestor
24705420|NCT01485081|Mitosis Modulators|mitosis modulators|mesh-ancestor
24705421|NCT01485081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705460|NCT01485211|Micronutrients|micronutrients|mesh-ancestor
24705464|NCT01485224|Thalidomide|thalidomide|mesh-list
24705465|NCT01485224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24705466|NCT01485224|Immunologic Factors|immunologic factors|mesh-ancestor
24705467|NCT01485224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705468|NCT01485224|Leprostatic Agents|leprostatic agents|mesh-ancestor
24705469|NCT01485224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24705470|NCT01485224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24705471|NCT01485224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24705532|NCT01485692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25404113|NCT03684538|Zinc|zinc|mesh-list
25862357|NCT00089492|Enfuvirtide|enfuvirtide|mesh-list
24971358|NCT03726281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25217701|NCT02675868|Adrenergic Agents|adrenergic agents|mesh-ancestor
25217702|NCT02675868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25217703|NCT02675868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217704|NCT02675868|Protective Agents|protective agents|mesh-ancestor
25217705|NCT02675868|Hemostatics|hemostatics|mesh-ancestor
25217706|NCT02675868|Coagulants|coagulants|mesh-ancestor
25217707|NCT02675868|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24626222|NCT01086046|Tinzaparin|tinzaparin|mesh-list
24971359|NCT03726281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862358|NCT00089492|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24971404|NCT03726177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24971405|NCT03726177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24971406|NCT03726177|Antipyretics|antipyretics|mesh-ancestor
24971407|NCT03726125|Insulin|insulin|mesh-list
24971408|NCT03726125|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24705533|NCT01485692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24705534|NCT01485692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25129419|NCT03041506|GABA Modulators|gaba modulators|mesh-ancestor
24705535|NCT01485692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705537|NCT01485692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24705538|NCT01485692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24705539|NCT01485692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24705540|NCT01485692|Anesthetics, General|anesthetics, general|mesh-ancestor
24705541|NCT01485692|Anesthetics|anesthetics|mesh-ancestor
24705542|NCT01485692|GABA Modulators|gaba modulators|mesh-ancestor
24705543|NCT01485692|GABA Agents|gaba agents|mesh-ancestor
24940660|NCT03999190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940661|NCT03999190|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24705544|NCT01485692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24705545|NCT01485692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705546|NCT01485692|Antiemetics|antiemetics|mesh-ancestor
24705547|NCT01485692|Autonomic Agents|autonomic agents|mesh-ancestor
24705548|NCT01485692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24705549|NCT01485692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24705550|NCT01485692|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24705551|NCT01485692|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24705552|NCT01485692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24705587|NCT01485744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705588|NCT01485744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24705589|NCT01485744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705590|NCT01485744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24705591|NCT01485744|Immunologic Factors|immunologic factors|mesh-ancestor
24705666|NCT01486017|Peficitinib|peficitinib|mesh-list
24705667|NCT01486017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705668|NCT01486017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705669|NCT01486017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24705670|NCT01486017|Immunologic Factors|immunologic factors|mesh-ancestor
24705671|NCT01486017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705672|NCT01486082|Amoxicillin|amoxicillin|mesh-list
24705673|NCT01486082|Clarithromycin|clarithromycin|mesh-list
24705674|NCT01486082|Omeprazole|omeprazole|mesh-list
24705675|NCT01486082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24705676|NCT01486082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24705699|NCT01486433|Analgesics|analgesics|mesh-ancestor
24705700|NCT01486433|Sensory System Agents|sensory system agents|mesh-ancestor
24705701|NCT01486433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25668213|NCT01713400|Antifungal Agents|antifungal agents|mesh-ancestor
25668214|NCT01713400|Dermatologic Agents|dermatologic agents|mesh-ancestor
25668215|NCT01713530|Insulin|insulin|mesh-list
25668216|NCT01713530|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25668217|NCT01713530|Insulin Aspart|insulin aspart|mesh-list
25668218|NCT01713530|Insulin, Long-Acting|insulin, long-acting|mesh-list
25668219|NCT01713530|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25668220|NCT01713530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25668221|NCT01713530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668222|NCT01713608|Artefenomel|artefenomel|mesh-list
25668223|NCT01713608|Antimalarials|antimalarials|mesh-ancestor
25668224|NCT01713608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25668225|NCT01713608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25668226|NCT01713608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25668227|NCT01713621|Artefenomel|artefenomel|mesh-list
25668228|NCT01713621|Antimalarials|antimalarials|mesh-ancestor
25668229|NCT01713621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24705702|NCT01486433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705703|NCT01486433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24705704|NCT01486433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24705705|NCT01486433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24705706|NCT01486433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24705707|NCT01486433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705708|NCT01486433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24705710|NCT01486433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705711|NCT01486433|Antipyretics|antipyretics|mesh-ancestor
24705712|NCT01486433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24705713|NCT01486433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24705714|NCT01486433|Antimetabolites|antimetabolites|mesh-ancestor
24705715|NCT01486433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24705716|NCT01486433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24705725|NCT01486459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705726|NCT01486485|Nafamostat|nafamostat|mesh-list
24705727|NCT01486485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24705728|NCT01486485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24705729|NCT01486485|Analgesics|analgesics|mesh-ancestor
24705750|NCT01486563|Plasma Substitutes|plasma substitutes|mesh-ancestor
24705751|NCT01486563|Blood Substitutes|blood substitutes|mesh-ancestor
24705752|NCT01486576|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24705753|NCT01486576|Plasma Substitutes|plasma substitutes|mesh-ancestor
24705754|NCT01486576|Blood Substitutes|blood substitutes|mesh-ancestor
24705756|NCT01486602|Carboplatin|carboplatin|mesh-list
24705757|NCT01486602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24613652|NCT01020214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613653|NCT01020214|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24705798|NCT01486888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24705799|NCT01486888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705801|NCT01486901|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24705802|NCT01486901|Isophane Insulin, Human|isophane insulin, human|mesh-list
24705803|NCT01486901|Insulin, Isophane|insulin, isophane|mesh-list
24940702|NCT03999125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24940703|NCT03999125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24940722|NCT03998969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24940723|NCT03998969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705863|NCT01487226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24705864|NCT01487226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705865|NCT01487226|Tubulin Modulators|tubulin modulators|mesh-ancestor
24705866|NCT01487226|Antimitotic Agents|antimitotic agents|mesh-ancestor
24705867|NCT01487226|Mitosis Modulators|mitosis modulators|mesh-ancestor
24705868|NCT01487226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705944|NCT01487785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705945|NCT01487785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24705946|NCT01487785|Immunologic Factors|immunologic factors|mesh-ancestor
24705947|NCT01487785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705949|NCT01487798|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24705950|NCT01487798|Insulin Aspart|insulin aspart|mesh-list
24705951|NCT01487798|Biphasic Insulins|biphasic insulins|mesh-list
24705952|NCT01487798|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24705953|NCT01487798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24705954|NCT01487798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705973|NCT01488045|Narcotics|narcotics|mesh-ancestor
24705974|NCT01488045|Analgesics|analgesics|mesh-ancestor
24705975|NCT01488045|Sensory System Agents|sensory system agents|mesh-ancestor
24705976|NCT01488045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24706015|NCT01488266|Citalopram|citalopram|mesh-list
24706016|NCT01488266|Bupropion|bupropion|mesh-list
24706017|NCT01488266|Fluoxetine|fluoxetine|mesh-list
24706018|NCT01488266|Paroxetine|paroxetine|mesh-list
24706019|NCT01488266|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24706020|NCT01488266|Sertraline|sertraline|mesh-list
24706021|NCT01488266|Antidepressive Agents|antidepressive agents|mesh-list
24706043|NCT01488266|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24706044|NCT01488266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24706045|NCT01488266|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24706046|NCT01488266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24706047|NCT01488266|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24706048|NCT01488266|Analgesics|analgesics|mesh-ancestor
24706049|NCT01488266|Sensory System Agents|sensory system agents|mesh-ancestor
24706051|NCT01488266|Histamine Antagonists|histamine antagonists|mesh-ancestor
25668230|NCT01713621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24503774|NCT00532857|Trastuzumab|trastuzumab|mesh-list
24503782|NCT00532857|Antimetabolites|antimetabolites|mesh-ancestor
24503783|NCT00532857|Antiviral Agents|antiviral agents|mesh-ancestor
24503784|NCT00532857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24706052|NCT01488266|Histamine Agents|histamine agents|mesh-ancestor
25862359|NCT00089492|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25862360|NCT00089492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706137|NCT01488773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24706138|NCT01488773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706139|NCT01488773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24706140|NCT01488773|Respiratory System Agents|respiratory system agents|mesh-ancestor
24706141|NCT01488773|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24706146|NCT01488773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706148|NCT01488773|Hormone Antagonists|hormone antagonists|mesh-ancestor
24940740|NCT03998670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24940741|NCT03998670|Dopamine Agents|dopamine agents|mesh-ancestor
24940742|NCT03998670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24706151|NCT01488773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24706154|NCT01488955|Fosfomycin|fosfomycin|mesh-list
24706155|NCT01488955|Ibuprofen|ibuprofen|mesh-list
24706156|NCT01488955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24706157|NCT01488955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24706158|NCT01488955|Analgesics|analgesics|mesh-ancestor
24706159|NCT01488955|Sensory System Agents|sensory system agents|mesh-ancestor
24706160|NCT01488955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24706161|NCT01488955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706162|NCT01488955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24706163|NCT01488955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24706164|NCT01488955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24706165|NCT01488955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706166|NCT01488955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706188|NCT01489137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24706189|NCT01489137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706191|NCT01489137|Sensory System Agents|sensory system agents|mesh-ancestor
24706192|NCT01489137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24706193|NCT01489176|Regadenoson|regadenoson|mesh-list
24706194|NCT01489176|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
24706195|NCT01489176|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24706196|NCT01489176|Purinergic Agonists|purinergic agonists|mesh-ancestor
24706197|NCT01489176|Purinergic Agents|purinergic agents|mesh-ancestor
24613671|NCT01020279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24613672|NCT01020279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613673|NCT01020279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24956791|NCT03851172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24956793|NCT03851393|Sodium Citrate|sodium citrate|mesh-list
24613674|NCT01020279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24613675|NCT01020279|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24613676|NCT01020279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25199731|NCT02739204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862361|NCT00089492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24706291|NCT01489631|Sensory System Agents|sensory system agents|mesh-ancestor
24706292|NCT01489631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24706293|NCT01489631|Analgesics|analgesics|mesh-ancestor
25862362|NCT00089492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24706294|NCT01489631|Anticonvulsants|anticonvulsants|mesh-ancestor
24706295|NCT01489631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24706296|NCT01489631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24706297|NCT01489631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24706298|NCT01489631|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24706299|NCT01489631|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24706300|NCT01489631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24706301|NCT01489631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706302|NCT01489631|Antimanic Agents|antimanic agents|mesh-ancestor
25668231|NCT01713621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25668232|NCT01713946|Everolimus|everolimus|mesh-list
25668233|NCT01713946|Anticonvulsants|anticonvulsants|mesh-list
25668234|NCT01713946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25668235|NCT01713946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25668236|NCT01713946|Immunologic Factors|immunologic factors|mesh-ancestor
25668237|NCT01713946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862363|NCT00089492|Antiviral Agents|antiviral agents|mesh-ancestor
25668238|NCT01714310|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25668239|NCT01714310|Fluoxetine|fluoxetine|mesh-list
25862364|NCT00089492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24971607|NCT03723941|Mitotane|mitotane|mesh-list
24971608|NCT03723941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24971609|NCT03723941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24706356|NCT01489852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24706357|NCT01489865|Fluorouracil|fluorouracil|mesh-list
24706358|NCT01489865|Veliparib|veliparib|mesh-list
24706359|NCT01489865|Antimetabolites|antimetabolites|mesh-ancestor
24706360|NCT01489865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706361|NCT01489865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24706362|NCT01489865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706363|NCT01489865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24706364|NCT01489865|Immunologic Factors|immunologic factors|mesh-ancestor
24706365|NCT01489865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706366|NCT01489865|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24706442|NCT01490047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24706444|NCT01490047|Sensory System Agents|sensory system agents|mesh-ancestor
24706445|NCT01490047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24706446|NCT01490047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706447|NCT01490047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24706448|NCT01490047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24706468|NCT01490203|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24706469|NCT01490216|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
24706470|NCT01490216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24706471|NCT01490216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706472|NCT01490216|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24706473|NCT01490216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24706474|NCT01490216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24706475|NCT01490216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706477|NCT01490216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24706479|NCT01490229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24706480|NCT01490229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24706481|NCT01490229|Antimetabolites|antimetabolites|mesh-ancestor
24706482|NCT01490229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706531|NCT01490437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706532|NCT01490437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24706533|NCT01490437|Antiemetics|antiemetics|mesh-ancestor
24706534|NCT01490437|Autonomic Agents|autonomic agents|mesh-ancestor
24706535|NCT01490437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24706536|NCT01490437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24706537|NCT01490437|Glucocorticoids|glucocorticoids|mesh-ancestor
24706539|NCT01490437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24706540|NCT01490437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24706541|NCT01490437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706542|NCT01490437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706543|NCT01490437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24706594|NCT01490905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24706597|NCT01490905|Sensory System Agents|sensory system agents|mesh-ancestor
25050709|NCT00474188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25050710|NCT00474188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25050711|NCT00474188|Growth Substances|growth substances|mesh-ancestor
25050712|NCT00474188|Growth Inhibitors|growth inhibitors|mesh-ancestor
25050714|NCT00472693|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25050715|NCT00472693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25050716|NCT00472693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050717|NCT00472693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24706598|NCT01490905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24706599|NCT01490905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706611|NCT01490944|Micronutrients|micronutrients|mesh-ancestor
24706612|NCT01490944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706615|NCT01490996|Curcumin|curcumin|mesh-list
24706616|NCT01490996|Capecitabine|capecitabine|mesh-list
24706617|NCT01490996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25668240|NCT01714310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25668241|NCT01714310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25668242|NCT01714310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25668243|NCT01714310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668244|NCT01714310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24971704|NCT03723187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24706619|NCT01490996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706620|NCT01490996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706621|NCT01490996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24706622|NCT01490996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24706623|NCT01490996|Analgesics|analgesics|mesh-ancestor
24706624|NCT01490996|Sensory System Agents|sensory system agents|mesh-ancestor
25862365|NCT00089518|Valsartan|valsartan|mesh-list
24613705|NCT01020357|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24613706|NCT01020357|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25199732|NCT02739061|Fluvoxamine|fluvoxamine|mesh-list
24613720|NCT01020539|Isotretinoin|isotretinoin|mesh-list
24613721|NCT01020539|Thymoglobulin|thymoglobulin|mesh-list
24613722|NCT01020539|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24613723|NCT01020539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613724|NCT01020539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613725|NCT01020539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24613726|NCT01020539|Immunologic Factors|immunologic factors|mesh-ancestor
24613727|NCT01020539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613728|NCT01020539|Alkylating Agents|alkylating agents|mesh-ancestor
24613729|NCT01020539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24613730|NCT01020539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24940761|NCT03998826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940762|NCT03998826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24940763|NCT03998826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24940764|NCT03998826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24940765|NCT03998826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812596|NCT02053727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24706723|NCT01491295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24706724|NCT01491295|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25862366|NCT00089518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24706725|NCT01491295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25862367|NCT00089518|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24706812|NCT01492504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706848|NCT01492621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24706849|NCT01492712|Propofol|propofol|mesh-list
24706850|NCT01492712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24706851|NCT01492712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24706852|NCT01492712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706853|NCT01492712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24706854|NCT01492712|Anesthetics, General|anesthetics, general|mesh-ancestor
24706864|NCT01492881|Vorinostat|vorinostat|mesh-list
24706865|NCT01492881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24706866|NCT01492881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706867|NCT01492881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24706868|NCT01492881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24706869|NCT01492881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706876|NCT01492894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24706877|NCT01492894|Immunologic Factors|immunologic factors|mesh-ancestor
24706878|NCT01492894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706879|NCT01492894|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24706880|NCT01492894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706926|NCT01493050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24706927|NCT01493050|Chelating Agents|chelating agents|mesh-ancestor
24706928|NCT01493050|Sequestering Agents|sequestering agents|mesh-ancestor
24706929|NCT01493102|Vasopressins|vasopressins|mesh-list
24706959|NCT01493154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706960|NCT01493154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24707031|NCT01493648|Micronutrients|micronutrients|mesh-ancestor
24613747|NCT01020643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24613797|NCT01020734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24613798|NCT01020734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24613800|NCT01020734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24613801|NCT01020734|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24707085|NCT01493999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707086|NCT01494012|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24707087|NCT01494012|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24707088|NCT01494012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707132|NCT01494311|Anesthetics, Local|anesthetics, local|mesh-ancestor
25668245|NCT01714310|Serotonin Agents|serotonin agents|mesh-ancestor
25668246|NCT01714310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707149|NCT01494363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24971873|NCT03721744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24971874|NCT03721744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862368|NCT00089518|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25668247|NCT01714310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25668248|NCT01714310|Antidepressive Agents|antidepressive agents|mesh-ancestor
24971875|NCT03721744|Tubulin Modulators|tubulin modulators|mesh-ancestor
24971876|NCT03721744|Antimitotic Agents|antimitotic agents|mesh-ancestor
24971887|NCT03721679|Pembrolizumab|pembrolizumab|mesh-list
24971891|NCT03721679|Poly ICLC|poly iclc|mesh-list
24971892|NCT03721679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24971893|NCT03721679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24971894|NCT03721679|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24971895|NCT03721679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971896|NCT03721679|Interferon Inducers|interferon inducers|mesh-ancestor
24971897|NCT03721679|Immunologic Factors|immunologic factors|mesh-ancestor
24971898|NCT03721679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217765|NCT02675530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25217766|NCT02675530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25217767|NCT02675530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217768|NCT02675400|Methylphenidate|methylphenidate|mesh-list
25217769|NCT02675400|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25217770|NCT02675400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25217771|NCT02675400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217772|NCT02675400|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24707150|NCT01494363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24707151|NCT01494363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24452330|NCT00327145|Valsartan|valsartan|mesh-list
24802298|NCT01989312|Autonomic Agents|autonomic agents|mesh-ancestor
24707241|NCT01494727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24707242|NCT01494727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24707244|NCT01494740|Immunologic Factors|immunologic factors|mesh-ancestor
24707245|NCT01494740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707246|NCT01494805|Ranibizumab|ranibizumab|mesh-list
24707247|NCT01494805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24463252|NCT00359658|Hormones|hormones|mesh-ancestor
24707308|NCT01495156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707311|NCT01495169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24940774|NCT03998436|Adrenergic Agents|adrenergic agents|mesh-ancestor
24940775|NCT03998436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24940776|NCT03998436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940777|NCT03998436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707312|NCT01495169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24707313|NCT01495169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707314|NCT01495169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24707315|NCT01495195|Selegiline|selegiline|mesh-list
24707316|NCT01495195|Donepezil|donepezil|mesh-list
24707317|NCT01495195|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24707318|NCT01495195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707319|NCT01495195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707320|NCT01495195|Cholinergic Agents|cholinergic agents|mesh-ancestor
25668249|NCT01714310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25668250|NCT01714310|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25668251|NCT01714310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25668252|NCT01714310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25668253|NCT01714310|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25668254|NCT01714310|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25668255|NCT01714310|Dopamine Agents|dopamine agents|mesh-ancestor
25668256|NCT01714336|Tranexamic Acid|tranexamic acid|mesh-list
25668257|NCT01714336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25668258|NCT01714336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25668259|NCT01714336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668260|NCT01714336|Hemostatics|hemostatics|mesh-ancestor
25668261|NCT01714336|Coagulants|coagulants|mesh-ancestor
25668262|NCT01714544|Clocortolone pivalate|clocortolone pivalate|mesh-list
25668263|NCT01714544|Glucocorticoids|glucocorticoids|mesh-ancestor
25668264|NCT01714544|Hormones|hormones|mesh-ancestor
25668265|NCT01714544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25668266|NCT01714544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668267|NCT01714609|Sorafenib|sorafenib|mesh-list
25668268|NCT01714609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25668269|NCT01714609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25668270|NCT01714609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25862369|NCT00089518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862370|NCT00089557|Capsaicin|capsaicin|mesh-list
24794380|NCT05251493|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25862371|NCT00089557|Antipruritics|antipruritics|mesh-ancestor
25862372|NCT00089557|Dermatologic Agents|dermatologic agents|mesh-ancestor
24503905|NCT00533390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24503906|NCT00533390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24503907|NCT00533390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24503908|NCT00533390|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24503909|NCT00533390|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25217777|NCT02675400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24503910|NCT00533390|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25217778|NCT02675309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25217779|NCT02675309|Simvastatin|simvastatin|mesh-list
25217780|NCT02675309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25217781|NCT02675309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25217782|NCT02675309|Antimetabolites|antimetabolites|mesh-ancestor
25217783|NCT02675309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217784|NCT02675309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25217785|NCT02675309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25217786|NCT02675309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217787|NCT02675374|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
25217788|NCT02675374|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24707321|NCT01495195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24707322|NCT01495195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707323|NCT01495195|Nootropic Agents|nootropic agents|mesh-ancestor
24940784|NCT03997864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24613841|NCT01021176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613842|NCT01021176|Vasodilator Agents|vasodilator agents|mesh-ancestor
24707368|NCT01495338|Histamine Antagonists|histamine antagonists|mesh-ancestor
24707386|NCT01495403|Hydroxychloroquine|hydroxychloroquine|mesh-list
24707387|NCT01495403|Antimalarials|antimalarials|mesh-ancestor
24707388|NCT01495403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24707389|NCT01495403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24707390|NCT01495403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25862373|NCT00089557|Sensory System Agents|sensory system agents|mesh-ancestor
24707392|NCT01495403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707393|NCT01495403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24707394|NCT01495468|Hormones|hormones|mesh-list
24707395|NCT01495468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24707396|NCT01495468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707397|NCT01495520|Ranolazine|ranolazine|mesh-list
24707398|NCT01495520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24940790|NCT03997864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707504|NCT01496261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24707505|NCT01496261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24707506|NCT01496261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24707507|NCT01496261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24707508|NCT01496261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707509|NCT01496261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24707510|NCT01496261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25668271|NCT01714609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668272|NCT01715129|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25668273|NCT01715129|Luteolytic Agents|luteolytic agents|mesh-ancestor
25668274|NCT01715129|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25668275|NCT01715129|Contraceptive Agents|contraceptive agents|mesh-ancestor
25668276|NCT01715129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25668277|NCT01715129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668278|NCT01715129|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25668279|NCT01715129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25668280|NCT01715129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25668281|NCT01715207|Atenolol|atenolol|mesh-list
25668282|NCT01715207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25668283|NCT01715207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25668284|NCT01715207|Sympatholytics|sympatholytics|mesh-ancestor
25668285|NCT01715207|Autonomic Agents|autonomic agents|mesh-ancestor
25668286|NCT01715207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25668287|NCT01715207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668288|NCT01715207|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25668289|NCT01715207|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25668290|NCT01715207|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25668291|NCT01715207|Adrenergic Agents|adrenergic agents|mesh-ancestor
25668292|NCT01715207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25862375|NCT00089557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707511|NCT01496261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707512|NCT01496261|Antipyretics|antipyretics|mesh-ancestor
24707513|NCT01496261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25199733|NCT02739061|Sertraline|sertraline|mesh-list
24707514|NCT01496261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24707515|NCT01496261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24765536|NCT01789216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24940810|NCT03997292|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24940811|NCT03997292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24707581|NCT01496742|Carboplatin|carboplatin|mesh-list
24707583|NCT01496742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24707584|NCT01496742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24707585|NCT01496742|Tubulin Modulators|tubulin modulators|mesh-ancestor
24707586|NCT01496742|Antimitotic Agents|antimitotic agents|mesh-ancestor
24707587|NCT01496742|Mitosis Modulators|mitosis modulators|mesh-ancestor
24707588|NCT01496742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707589|NCT01496742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24707590|NCT01496742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24707639|NCT01497093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24707640|NCT01497093|Antiemetics|antiemetics|mesh-ancestor
24707641|NCT01497093|Autonomic Agents|autonomic agents|mesh-ancestor
24707642|NCT01497093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24707643|NCT01497093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707655|NCT01497093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24707656|NCT01497093|Leprostatic Agents|leprostatic agents|mesh-ancestor
24707657|NCT01497093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24707658|NCT01497093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24707659|NCT01497132|Vitamin D|vitamin d|mesh-list
24707712|NCT01497470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24707713|NCT01497470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24707714|NCT01497470|Tubulin Modulators|tubulin modulators|mesh-ancestor
24707715|NCT01497470|Antimitotic Agents|antimitotic agents|mesh-ancestor
24707716|NCT01497470|Mitosis Modulators|mitosis modulators|mesh-ancestor
24707717|NCT01497470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707719|NCT01497483|Pravastatin|pravastatin|mesh-list
24707720|NCT01497483|Cyclosporins|cyclosporins|mesh-list
24707721|NCT01497483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707722|NCT01497483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707723|NCT01497483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24707724|NCT01497483|Immunologic Factors|immunologic factors|mesh-ancestor
24707725|NCT01497483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707757|NCT01497548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24707759|NCT01497561|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24707760|NCT01497561|Insulin Detemir|insulin detemir|mesh-list
24707761|NCT01497561|Isophane Insulin, Human|isophane insulin, human|mesh-list
24707762|NCT01497561|Insulin, Isophane|insulin, isophane|mesh-list
24707810|NCT01497912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707811|NCT01497912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24707812|NCT01497912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24707813|NCT01497912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707815|NCT01497977|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24707816|NCT01497977|Estrogens|estrogens|mesh-ancestor
24707817|NCT01497977|Hormones|hormones|mesh-ancestor
24707818|NCT01497977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24940813|NCT03997292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940815|NCT03997279|Metronidazole|metronidazole|mesh-list
24940816|NCT03997279|Clarithromycin|clarithromycin|mesh-list
24940817|NCT03997279|Rabeprazole|rabeprazole|mesh-list
24940818|NCT03997279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24707908|NCT01498809|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24707909|NCT01498809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24707910|NCT01498809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24707911|NCT01498809|Adrenergic Agents|adrenergic agents|mesh-ancestor
24707912|NCT01498809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24707919|NCT01498835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707920|NCT01498835|Growth Inhibitors|growth inhibitors|mesh-ancestor
24707972|NCT01499069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668293|NCT01715207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668294|NCT01715233|Leucovorin|leucovorin|mesh-list
24707973|NCT01499069|Urological Agents|urological agents|mesh-ancestor
24707974|NCT01499069|Parasympatholytics|parasympatholytics|mesh-ancestor
24707976|NCT01499069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24707977|NCT01499108|Liraglutide|liraglutide|mesh-list
24707979|NCT01499108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707980|NCT01499108|Incretins|incretins|mesh-ancestor
24708026|NCT01499446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25862376|NCT00089570|Terlipressin|terlipressin|mesh-list
24708028|NCT01499485|Anticonvulsants|anticonvulsants|mesh-ancestor
24708029|NCT01499485|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24708030|NCT01499485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708031|NCT01499485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708033|NCT01499485|Natriuretic Agents|natriuretic agents|mesh-ancestor
24708034|NCT01499485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708035|NCT01499589|Anesthetics|anesthetics|mesh-list
24545488|NCT00693524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24708080|NCT01499758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24708082|NCT01499771|Atorvastatin|atorvastatin|mesh-list
24708083|NCT01499771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24708084|NCT01499771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24708085|NCT01499771|Antimetabolites|antimetabolites|mesh-ancestor
24708086|NCT01499771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708087|NCT01499771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24708088|NCT01499771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24708089|NCT01499771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708090|NCT01499875|Penicillin V|penicillin v|mesh-list
24708091|NCT01499875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24708092|NCT01499875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24708094|NCT01499953|Rivaroxaban|rivaroxaban|mesh-list
24613908|NCT01021579|Simvastatin|simvastatin|mesh-list
24613909|NCT01021579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24613910|NCT01021579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613911|NCT01021579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24644897|NCT01193621|Antiemetics|antiemetics|mesh-ancestor
24613916|NCT01021579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24613917|NCT01021579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613919|NCT01021592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613920|NCT01021696|Acetaminophen|acetaminophen|mesh-list
24613921|NCT01021696|Pregabalin|pregabalin|mesh-list
24940858|NCT03997006|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24940859|NCT03997006|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24940860|NCT03997006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24613922|NCT01021696|Morphine|morphine|mesh-list
24613923|NCT01021696|Buprenorphine|buprenorphine|mesh-list
24613924|NCT01021696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24613925|NCT01021696|Narcotics|narcotics|mesh-ancestor
24613926|NCT01021696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24708318|NCT01501084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708451|NCT01501370|Growth Substances|growth substances|mesh-ancestor
25862377|NCT00089570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25862378|NCT00089570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25862379|NCT00089622|Levodopa|levodopa|mesh-list
25862380|NCT00089622|Lisuride|lisuride|mesh-list
24708612|NCT01501760|Growth Substances|growth substances|mesh-ancestor
24708613|NCT01501760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708614|NCT01501760|Growth Inhibitors|growth inhibitors|mesh-ancestor
24708616|NCT01501786|Propofol|propofol|mesh-list
24708617|NCT01501786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24708618|NCT01501786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24708621|NCT01501786|Anesthetics, General|anesthetics, general|mesh-ancestor
24708622|NCT01501786|Anesthetics|anesthetics|mesh-ancestor
24708623|NCT01501786|Analgesics|analgesics|mesh-ancestor
24708624|NCT01501786|Sensory System Agents|sensory system agents|mesh-ancestor
24708625|NCT01501786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24708626|NCT01501786|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24708664|NCT01501916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25862381|NCT00089622|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25862382|NCT00089622|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24708688|NCT01502046|Anticonvulsants|anticonvulsants|mesh-ancestor
24708689|NCT01502046|Hallucinogens|hallucinogens|mesh-ancestor
24708690|NCT01502046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708691|NCT01502046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24708692|NCT01502046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25862383|NCT00089622|Dopamine Agents|dopamine agents|mesh-ancestor
24708831|NCT01503060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708881|NCT01503385|Analgesics|analgesics|mesh-ancestor
24708882|NCT01503385|Sensory System Agents|sensory system agents|mesh-ancestor
24503980|NCT00533611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503981|NCT00533611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24503983|NCT00533611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24708883|NCT01503385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24494934|NCT00497536|Insulin|insulin|mesh-list
24708884|NCT01503385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708885|NCT01503385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24708886|NCT01503385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24708887|NCT01503385|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24708888|NCT01503385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24708889|NCT01503385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708898|NCT01503398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24708899|NCT01503398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24940869|NCT03997058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24940870|NCT03997058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940871|NCT03997058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24765683|NCT01789892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24765684|NCT01789892|Glucocorticoids|glucocorticoids|mesh-ancestor
24765685|NCT01789892|Hormones|hormones|mesh-ancestor
24456889|NCT00332553|Estrogens|estrogens|mesh-list
24708930|NCT01503437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24709033|NCT01503801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24709088|NCT01503983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24709089|NCT01504074|Triamcinolone|triamcinolone|mesh-list
24709090|NCT01504074|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24709091|NCT01504074|Levobunolol|levobunolol|mesh-list
24709092|NCT01504074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24709112|NCT01504126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709113|NCT01504126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24709114|NCT01504126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24709115|NCT01504126|Vasodilator Agents|vasodilator agents|mesh-ancestor
24709116|NCT01504139|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24709117|NCT01504139|Estradiol|estradiol|mesh-list
24709118|NCT01504139|Progesterone|progesterone|mesh-list
24709119|NCT01504139|Estrogens|estrogens|mesh-ancestor
24709120|NCT01504139|Hormones|hormones|mesh-ancestor
24709121|NCT01504139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24709134|NCT01504178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709136|NCT01504178|Sensory System Agents|sensory system agents|mesh-ancestor
24709137|NCT01504178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24463740|NCT00361985|Esomeprazole|esomeprazole|mesh-list
24940898|NCT03996421|Ferrous fumarate|ferrous fumarate|mesh-list
24940899|NCT03996421|Trace Elements|trace elements|mesh-ancestor
24940900|NCT03996421|Micronutrients|micronutrients|mesh-ancestor
24709206|NCT01504503|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24709207|NCT01504503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709208|NCT01504503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709209|NCT01504503|Cholinergic Agents|cholinergic agents|mesh-ancestor
24709210|NCT01504503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24709211|NCT01504503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709212|NCT01504503|Nootropic Agents|nootropic agents|mesh-ancestor
24709342|NCT01505127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24709344|NCT01505127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24709379|NCT01505283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24709380|NCT01505283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24709381|NCT01505283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24709382|NCT01505283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709384|NCT01505283|Narcotics|narcotics|mesh-ancestor
24709385|NCT01505283|Analgesics|analgesics|mesh-ancestor
24709386|NCT01505283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24709387|NCT01505283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24709388|NCT01505283|Anesthetics, General|anesthetics, general|mesh-ancestor
24709389|NCT01505296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
24709390|NCT01505413|Gemcitabine|gemcitabine|mesh-list
24709391|NCT01505413|Oxaliplatin|oxaliplatin|mesh-list
24709409|NCT01505426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709411|NCT01505439|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24709412|NCT01505439|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24709413|NCT01505439|Cholinergic Agents|cholinergic agents|mesh-ancestor
24709414|NCT01505439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24709415|NCT01505439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668295|NCT01715233|Cisplatin|cisplatin|mesh-list
25668296|NCT01715233|Carboplatin|carboplatin|mesh-list
25668297|NCT01715233|Docetaxel|docetaxel|mesh-list
25668298|NCT01715233|Fluorouracil|fluorouracil|mesh-list
25668299|NCT01715233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24972324|NCT03719053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24972325|NCT03719053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24972326|NCT03718884|Mirikizumab|mirikizumab|mesh-list
24972327|NCT03718884|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24972328|NCT03718884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24709416|NCT01505439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709417|NCT01505439|Urological Agents|urological agents|mesh-ancestor
24709418|NCT01505504|Mirtazapine|mirtazapine|mesh-list
24709419|NCT01505504|Antidepressive Agents|antidepressive agents|mesh-ancestor
24709420|NCT01505504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24709581|NCT01506167|Micronutrients|micronutrients|mesh-ancestor
24709583|NCT01506336|Sunitinib|sunitinib|mesh-list
24709584|NCT01506336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24709585|NCT01506336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24709586|NCT01506336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24709587|NCT01506336|Growth Substances|growth substances|mesh-ancestor
24709588|NCT01506336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940913|NCT03996577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940915|NCT03996603|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24940916|NCT03996603|Hormones|hormones|mesh-ancestor
24940917|NCT03996603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24940918|NCT03996603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940919|NCT03996486|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
24940920|NCT03996486|Immunoglobulins|immunoglobulins|mesh-list
24940921|NCT03996486|Immunoglobulin G|immunoglobulin g|mesh-list
24940922|NCT03996486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24940923|NCT03996486|Myeloma Proteins|myeloma proteins|mesh-list
24940924|NCT03996486|Paraproteins|paraproteins|mesh-list
24940925|NCT03996486|Immunologic Factors|immunologic factors|mesh-ancestor
24940926|NCT03996486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940927|NCT03996486|Anticoagulants|anticoagulants|mesh-ancestor
25050718|NCT00472693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24709640|NCT01506544|Hydroxyurea|hydroxyurea|mesh-list
24709641|NCT01506544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24709664|NCT01506622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24709665|NCT01506622|Narcotics|narcotics|mesh-ancestor
24709666|NCT01506622|Analgesics|analgesics|mesh-ancestor
24709736|NCT01506791|Sympathomimetics|sympathomimetics|mesh-ancestor
24709737|NCT01506791|Adrenergic Agents|adrenergic agents|mesh-ancestor
24709738|NCT01506804|Methylprednisolone|methylprednisolone|mesh-list
25050719|NCT00472693|Growth Substances|growth substances|mesh-ancestor
25050720|NCT00472693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050721|NCT00472693|Growth Inhibitors|growth inhibitors|mesh-ancestor
25050722|NCT00468975|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24709803|NCT01507194|Autonomic Agents|autonomic agents|mesh-ancestor
24709804|NCT01507194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24709805|NCT01507194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709806|NCT01507194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24709807|NCT01507194|Antipruritics|antipruritics|mesh-ancestor
24709808|NCT01507194|Dermatologic Agents|dermatologic agents|mesh-ancestor
24709845|NCT01507363|Sensory System Agents|sensory system agents|mesh-ancestor
24709846|NCT01507363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24709847|NCT01507363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050729|NCT00468975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24709867|NCT01507428|Deoxyglucose|deoxyglucose|mesh-list
24709868|NCT01507428|Misonidazole|misonidazole|mesh-list
24709869|NCT01507428|Paclitaxel|paclitaxel|mesh-list
25862384|NCT00089622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24709876|NCT01507428|Antimitotic Agents|antimitotic agents|mesh-ancestor
24709877|NCT01507428|Mitosis Modulators|mitosis modulators|mesh-ancestor
24709878|NCT01507428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709879|NCT01507428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24709880|NCT01507428|Antimetabolites|antimetabolites|mesh-ancestor
24709881|NCT01507428|Antiviral Agents|antiviral agents|mesh-ancestor
24709882|NCT01507428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24709883|NCT01507428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24709919|NCT01507558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709920|NCT01507558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25668300|NCT01715233|Tubulin Modulators|tubulin modulators|mesh-ancestor
25668301|NCT01715233|Antimitotic Agents|antimitotic agents|mesh-ancestor
25668302|NCT01715233|Mitosis Modulators|mitosis modulators|mesh-ancestor
25668303|NCT01715233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668304|NCT01715233|Antimetabolites|antimetabolites|mesh-ancestor
25668305|NCT01715233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24709922|NCT01507558|Hormones|hormones|mesh-ancestor
24709923|NCT01507558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24709924|NCT01507558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24709925|NCT01507558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24709926|NCT01507558|Protease Inhibitors|protease inhibitors|mesh-ancestor
24709927|NCT01507558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709928|NCT01507558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709929|NCT01507571|Psychotropic Drugs|psychotropic drugs|mesh-list
24709930|NCT01507597|Glucagon|glucagon|mesh-list
24709931|NCT01507597|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24710033|NCT01507610|Sumatriptan|sumatriptan|mesh-list
24710034|NCT01507610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24710035|NCT01507610|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24710036|NCT01507610|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24710037|NCT01507610|Serotonin Agents|serotonin agents|mesh-ancestor
24710038|NCT01507610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24710039|NCT01507610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710103|NCT01508468|Calcium|calcium|mesh-list
24710104|NCT01508468|Diuretics|diuretics|mesh-list
24710105|NCT01508468|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25050744|NCT00468442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25050745|NCT00468442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24677990|NCT01359436|Antibodies|antibodies|mesh-list
24710106|NCT01508468|Enzyme Inhibitors|enzyme inhibitors|mesh-list
24710107|NCT01508468|Angiotensinogen|angiotensinogen|mesh-list
24710108|NCT01508468|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
24710109|NCT01508468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24710110|NCT01508468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24710111|NCT01508468|Immunologic Factors|immunologic factors|mesh-ancestor
25053833|NCT00004172|Carboplatin|carboplatin|mesh-list
25053834|NCT00004172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25053835|NCT00004172|Immunologic Factors|immunologic factors|mesh-ancestor
25053836|NCT00004172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053837|NCT00004172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25053838|NCT00004172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25053839|NCT00004172|Alkylating Agents|alkylating agents|mesh-ancestor
25053841|NCT00004172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24710125|NCT01508468|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24710126|NCT01508494|Galantamine|galantamine|mesh-list
24710127|NCT01508494|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24710128|NCT01508494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24710129|NCT01508494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710130|NCT01508494|Cholinergic Agents|cholinergic agents|mesh-ancestor
24710131|NCT01508494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24710132|NCT01508494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710133|NCT01508494|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24710134|NCT01508494|Autonomic Agents|autonomic agents|mesh-ancestor
24710135|NCT01508494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24710136|NCT01508494|Nootropic Agents|nootropic agents|mesh-ancestor
24710137|NCT01508572|Bevacizumab|bevacizumab|mesh-list
24710178|NCT01508845|Cholecalciferol|cholecalciferol|mesh-list
24710179|NCT01508845|Vitamins|vitamins|mesh-list
24710180|NCT01508845|Micronutrients|micronutrients|mesh-ancestor
24710181|NCT01508845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710291|NCT01509365|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24710292|NCT01509365|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24710294|NCT01509365|Purinergic Agents|purinergic agents|mesh-ancestor
24710295|NCT01509365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24710296|NCT01509365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710297|NCT01509365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710324|NCT01509521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710325|NCT01509521|Protective Agents|protective agents|mesh-ancestor
24710326|NCT01509521|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24710327|NCT01509521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24710328|NCT01509521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24710330|NCT01509560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24710331|NCT01509560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24710364|NCT01509976|Triclocarban|triclocarban|mesh-list
24710365|NCT01509976|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25199734|NCT02739061|Antidepressive Agents|antidepressive agents|mesh-ancestor
24710366|NCT01509976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25862385|NCT00089622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862387|NCT00089622|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25862388|NCT00089622|Serotonin Agents|serotonin agents|mesh-ancestor
25862389|NCT00089622|Dopamine Agonists|dopamine agonists|mesh-ancestor
25862390|NCT00089687|Vanoxerine|vanoxerine|mesh-list
24710367|NCT01509976|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24710368|NCT01509976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24710369|NCT01509976|Antimetabolites|antimetabolites|mesh-ancestor
24710370|NCT01509976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710371|NCT01509976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24710372|NCT01510015|Risperidone|risperidone|mesh-list
24614245|NCT01023230|Entecavir|entecavir|mesh-list
25050750|NCT00468403|Abatacept|abatacept|mesh-list
25050751|NCT00468403|Tacrolimus|tacrolimus|mesh-list
25050752|NCT00468403|Basiliximab|basiliximab|mesh-list
25050753|NCT00468403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25050754|NCT00468403|Immunologic Factors|immunologic factors|mesh-ancestor
25050755|NCT00468403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050756|NCT00468403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25050757|NCT00468403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24614248|NCT01023243|Aspirin|aspirin|mesh-list
25053875|NCT00004165|Immunologic Factors|immunologic factors|mesh-ancestor
25053876|NCT00004165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053877|NCT00004165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24710449|NCT01510574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710450|NCT01510574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24710451|NCT01510574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24710452|NCT01510574|Oxytocics|oxytocics|mesh-ancestor
24710453|NCT01510613|Dexamethasone|dexamethasone|mesh-list
24710454|NCT01510613|Pomalidomide|pomalidomide|mesh-list
24710455|NCT01510613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24710456|NCT01510613|Antiemetics|antiemetics|mesh-ancestor
24710457|NCT01510613|Autonomic Agents|autonomic agents|mesh-ancestor
24710458|NCT01510613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24710459|NCT01510613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710460|NCT01510613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24710461|NCT01510613|Glucocorticoids|glucocorticoids|mesh-ancestor
24710462|NCT01510613|Hormones|hormones|mesh-ancestor
24710463|NCT01510613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24710467|NCT01510613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24710536|NCT01511042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710538|NCT01511042|Autonomic Agents|autonomic agents|mesh-ancestor
24710539|NCT01511042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24710540|NCT01511042|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24710541|NCT01511042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24710542|NCT01511042|Protease Inhibitors|protease inhibitors|mesh-ancestor
24710543|NCT01511042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24710544|NCT01511146|Gemcitabine|gemcitabine|mesh-list
24710545|NCT01511146|Oxaliplatin|oxaliplatin|mesh-list
24710546|NCT01511146|Mitomycins|mitomycins|mesh-list
24710547|NCT01511146|Mitomycin|mitomycin|mesh-list
24710548|NCT01511146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24710549|NCT01511146|Antimetabolites|antimetabolites|mesh-ancestor
24710550|NCT01511146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710551|NCT01511146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24710557|NCT01511146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710558|NCT01511146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24710681|NCT01511471|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24710682|NCT01511471|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24710683|NCT01511471|Purinergic Agents|purinergic agents|mesh-ancestor
24710684|NCT01511471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24710685|NCT01511471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710686|NCT01511471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050760|NCT00468403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050761|NCT00468403|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25050762|NCT00468403|Antitubercular Agents|antitubercular agents|mesh-ancestor
24710847|NCT01511991|Sevoflurane|sevoflurane|mesh-list
24710859|NCT01512004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24710860|NCT01512004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668306|NCT01715233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25668307|NCT01715233|Immunologic Factors|immunologic factors|mesh-ancestor
25668308|NCT01715233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668309|NCT01715233|Antidotes|antidotes|mesh-ancestor
25404114|NCT03684538|Trace Elements|trace elements|mesh-ancestor
24972540|NCT03716804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24794468|NCT05149560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794469|NCT05149560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217842|NCT02675101|Antimetabolites|antimetabolites|mesh-ancestor
25217843|NCT02675101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217844|NCT02675101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25217845|NCT02675153|Sirolimus|sirolimus|mesh-list
25217846|NCT02675153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24710861|NCT01512004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710862|NCT01512004|Urological Agents|urological agents|mesh-ancestor
24710863|NCT01512004|Parasympatholytics|parasympatholytics|mesh-ancestor
24710864|NCT01512004|Autonomic Agents|autonomic agents|mesh-ancestor
25199735|NCT02739061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24710865|NCT01512004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24710866|NCT01512017|Petrolatum|petrolatum|mesh-list
24710867|NCT01512017|Emollients|emollients|mesh-ancestor
24710868|NCT01512017|Dermatologic Agents|dermatologic agents|mesh-ancestor
24710869|NCT01512147|Dexmedetomidine|dexmedetomidine|mesh-list
24710870|NCT01512147|Propofol|propofol|mesh-list
24710871|NCT01512147|Isoflurane|isoflurane|mesh-list
24710875|NCT01512147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24710876|NCT01512147|Anesthetics, General|anesthetics, general|mesh-ancestor
24710877|NCT01512147|Anesthetics|anesthetics|mesh-ancestor
24710878|NCT01512147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24710879|NCT01512147|Analgesics|analgesics|mesh-ancestor
24710880|NCT01512147|Sensory System Agents|sensory system agents|mesh-ancestor
24710924|NCT01512355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710925|NCT01512355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24710926|NCT01512355|Analgesics|analgesics|mesh-ancestor
24710927|NCT01512355|Sensory System Agents|sensory system agents|mesh-ancestor
24710928|NCT01512355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24710929|NCT01512355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24710930|NCT01512355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24710960|NCT01512511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24710962|NCT01512511|Sensory System Agents|sensory system agents|mesh-ancestor
24710963|NCT01512511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24710965|NCT01512537|Ergocalciferols|ergocalciferols|mesh-list
24710966|NCT01512537|Cholecalciferol|cholecalciferol|mesh-list
24710967|NCT01512537|Vitamins|vitamins|mesh-list
24710968|NCT01512537|Micronutrients|micronutrients|mesh-ancestor
24711027|NCT01513044|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24711028|NCT01513044|Antitubercular Agents|antitubercular agents|mesh-ancestor
24711029|NCT01513044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24711030|NCT01513044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24711031|NCT01513044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711032|NCT01513044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711033|NCT01513057|Mycophenolic Acid|mycophenolic acid|mesh-list
24711034|NCT01513057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24711035|NCT01513057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24711036|NCT01513057|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24711037|NCT01513057|Antitubercular Agents|antitubercular agents|mesh-ancestor
24711040|NCT01513057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24614293|NCT01023360|Purinergic Agents|purinergic agents|mesh-ancestor
24802543|NCT01990807|Idarubicin|idarubicin|mesh-list
24711129|NCT01513668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24711130|NCT01513668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711131|NCT01513668|Antipyretics|antipyretics|mesh-ancestor
24711132|NCT01513681|Lamotrigine|lamotrigine|mesh-list
24711133|NCT01513681|Anticonvulsants|anticonvulsants|mesh-ancestor
24711134|NCT01513681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25668310|NCT01715233|Protective Agents|protective agents|mesh-ancestor
25668311|NCT01715233|Vitamin B Complex|vitamin b complex|mesh-ancestor
25668312|NCT01715233|Vitamins|vitamins|mesh-ancestor
25668313|NCT01715233|Micronutrients|micronutrients|mesh-ancestor
25668314|NCT01715298|Glycopyrrolate|glycopyrrolate|mesh-list
25668315|NCT01715298|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25668316|NCT01715298|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25668317|NCT01715298|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25668318|NCT01715298|Cholinergic Agents|cholinergic agents|mesh-ancestor
25668319|NCT01715298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24711135|NCT01513681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25404115|NCT03684538|Micronutrients|micronutrients|mesh-ancestor
25668320|NCT01715298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972638|NCT03716115|Budesonide|budesonide|mesh-list
24504309|NCT00535158|Vitamin D|vitamin d|mesh-list
24711136|NCT01513681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711137|NCT01513681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24711138|NCT01513681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711139|NCT01513681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24711140|NCT01513681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24711141|NCT01513681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24711142|NCT01513681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24711143|NCT01513681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24711203|NCT01514019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711204|NCT01514019|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24711205|NCT01514019|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24711206|NCT01514019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24711207|NCT01514019|Adrenergic Agents|adrenergic agents|mesh-ancestor
24711208|NCT01514019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24956948|NCT03848767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24956949|NCT03848767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956950|NCT03848806|Calcitriol|calcitriol|mesh-list
24956951|NCT03848806|Calcipotriene|calcipotriene|mesh-list
24956952|NCT03848806|Dermatologic Agents|dermatologic agents|mesh-ancestor
24711209|NCT01514019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711210|NCT01514110|Paclitaxel|paclitaxel|mesh-list
24711211|NCT01514110|Carboplatin|carboplatin|mesh-list
24711212|NCT01514110|Everolimus|everolimus|mesh-list
24711213|NCT01514110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24711241|NCT01514175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711242|NCT01514175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711243|NCT01514188|Doxorubicin|doxorubicin|mesh-list
24711244|NCT01514188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24711245|NCT01514188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24711246|NCT01514188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24711296|NCT01514695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24614371|NCT01023919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614372|NCT01023945|Ipragliflozin|ipragliflozin|mesh-list
24614373|NCT01023945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24614374|NCT01023945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614375|NCT01023945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24614376|NCT01023945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711412|NCT01515020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24711413|NCT01515020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24711414|NCT01515137|Sulindac|sulindac|mesh-list
24711415|NCT01515137|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24711416|NCT01515137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24711417|NCT01515137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24711418|NCT01515137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711419|NCT01515137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711420|NCT01515137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24711421|NCT01515137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24711550|NCT01515826|Contraceptive Agents|contraceptive agents|mesh-ancestor
24711551|NCT01515826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24711552|NCT01515826|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24956956|NCT03848806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24956957|NCT03848806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711629|NCT01516372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24711631|NCT01516372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24711632|NCT01516372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711648|NCT01516554|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24711650|NCT01516554|Hormones|hormones|mesh-ancestor
24711651|NCT01516554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24711753|NCT01516814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711794|NCT01516996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24711795|NCT01517009|Docetaxel|docetaxel|mesh-list
24711796|NCT01517009|Capecitabine|capecitabine|mesh-list
24711797|NCT01517009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24711798|NCT01517009|Tubulin Modulators|tubulin modulators|mesh-ancestor
24711799|NCT01517009|Antimitotic Agents|antimitotic agents|mesh-ancestor
24711800|NCT01517009|Mitosis Modulators|mitosis modulators|mesh-ancestor
24711801|NCT01517009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711802|NCT01517009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25668321|NCT01715298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940935|NCT03996486|Antithrombins|antithrombins|mesh-ancestor
24711863|NCT01517399|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24711864|NCT01517399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24711865|NCT01517399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24711866|NCT01517399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24711867|NCT01517399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24711868|NCT01517399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24711869|NCT01517399|Anesthetics, General|anesthetics, general|mesh-ancestor
24711870|NCT01517399|Anesthetics|anesthetics|mesh-ancestor
24711871|NCT01517399|GABA Modulators|gaba modulators|mesh-ancestor
24711872|NCT01517399|GABA Agents|gaba agents|mesh-ancestor
24711873|NCT01517399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24711874|NCT01517399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711932|NCT01517724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24711933|NCT01517815|Tazobactam|tazobactam|mesh-list
24711934|NCT01517815|Piperacillin|piperacillin|mesh-list
24711935|NCT01517815|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24711936|NCT01517815|Doripenem|doripenem|mesh-list
24711937|NCT01517815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24711938|NCT01517815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24711939|NCT01517815|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24711940|NCT01517815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711941|NCT01517815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711942|NCT01517828|Midazolam|midazolam|mesh-list
24711997|NCT01518101|Liraglutide|liraglutide|mesh-list
24711998|NCT01518101|Vildagliptin|vildagliptin|mesh-list
24711999|NCT01518101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24712096|NCT01518569|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24712097|NCT01518569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24712098|NCT01518569|Protease Inhibitors|protease inhibitors|mesh-ancestor
24712099|NCT01518569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24712100|NCT01518569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712101|NCT01518595|Bosentan|bosentan|mesh-list
24712102|NCT01518595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24712103|NCT01518595|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24712104|NCT01518595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464383|NCT00364559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24614448|NCT01024322|Sensory System Agents|sensory system agents|mesh-ancestor
24614463|NCT01024322|Protective Agents|protective agents|mesh-ancestor
24712155|NCT01518855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712156|NCT01518855|Vasodilator Agents|vasodilator agents|mesh-ancestor
24712157|NCT01518855|Tocolytic Agents|tocolytic agents|mesh-ancestor
24712161|NCT01518933|Antioxidants|antioxidants|mesh-ancestor
24545639|NCT00694187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24545641|NCT00694187|GABA Modulators|gaba modulators|mesh-ancestor
24712162|NCT01518933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712163|NCT01518933|Protective Agents|protective agents|mesh-ancestor
24940946|NCT03996564|Antipyretics|antipyretics|mesh-ancestor
24940947|NCT03996564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24940948|NCT03996564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24712218|NCT01519154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712219|NCT01519154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24712220|NCT01519154|Anesthetics, General|anesthetics, general|mesh-ancestor
24712221|NCT01519154|Anesthetics|anesthetics|mesh-ancestor
24712222|NCT01519154|Analgesics|analgesics|mesh-ancestor
24712223|NCT01519154|Sensory System Agents|sensory system agents|mesh-ancestor
24712503|NCT01520896|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24712504|NCT01520896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24712505|NCT01520896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24712506|NCT01520896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940949|NCT03996564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24940950|NCT03996564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24812628|NCT02053818|Remifentanil|remifentanil|mesh-list
24712507|NCT01520896|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24712508|NCT01520896|Hormone Antagonists|hormone antagonists|mesh-ancestor
24712509|NCT01520896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24712510|NCT01520896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712511|NCT01520896|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24712512|NCT01520896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24712513|NCT01520896|Sensory System Agents|sensory system agents|mesh-ancestor
24712514|NCT01520896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24712515|NCT01521130|Levetiracetam|levetiracetam|mesh-list
24712517|NCT01521130|Nootropic Agents|nootropic agents|mesh-ancestor
24712518|NCT01521299|Hydroxyurea|hydroxyurea|mesh-list
24712519|NCT01521299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24712552|NCT01521377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24464550|NCT00365339|Ritonavir|ritonavir|mesh-list
24712673|NCT01522092|Antidepressive Agents|antidepressive agents|mesh-ancestor
24712674|NCT01522092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24712676|NCT01522105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24712677|NCT01522105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24712711|NCT01522534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24712712|NCT01522534|Anesthetics, Local|anesthetics, local|mesh-ancestor
24712713|NCT01522534|Anesthetics|anesthetics|mesh-ancestor
24712714|NCT01522547|Pomalidomide|pomalidomide|mesh-list
24712715|NCT01522547|Immunologic Factors|immunologic factors|mesh-ancestor
24712716|NCT01522547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712717|NCT01522547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24712718|NCT01522547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24712751|NCT01522729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24712752|NCT01522729|Narcotics|narcotics|mesh-ancestor
24712753|NCT01522729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24712754|NCT01522729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712755|NCT01522729|Analgesics|analgesics|mesh-ancestor
24712756|NCT01522729|Sensory System Agents|sensory system agents|mesh-ancestor
24712757|NCT01522729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24865728|NCT05108740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24865729|NCT05108740|Immunologic Factors|immunologic factors|mesh-ancestor
24545649|NCT00694200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24446084|NCT00303771|Immunologic Factors|immunologic factors|mesh-ancestor
24712758|NCT01522729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24712759|NCT01522729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24712760|NCT01522729|Anesthetics, General|anesthetics, general|mesh-ancestor
24712761|NCT01522729|Anesthetics|anesthetics|mesh-ancestor
24712816|NCT01522989|Antimetabolites|antimetabolites|mesh-ancestor
24712817|NCT01522989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464642|NCT00365742|Antimetabolites|antimetabolites|mesh-ancestor
24940969|NCT03996564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24940970|NCT03996564|Anesthetics, General|anesthetics, general|mesh-ancestor
24940971|NCT03996564|Anesthetics|anesthetics|mesh-ancestor
24940972|NCT03996564|GABA Modulators|gaba modulators|mesh-ancestor
24940973|NCT03996564|GABA Agents|gaba agents|mesh-ancestor
24940974|NCT03996564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24940975|NCT03996434|Cetrorelix|cetrorelix|mesh-list
24940976|NCT03996434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24940977|NCT03996434|Fertility Agents|fertility agents|mesh-ancestor
24940978|NCT03996434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24940979|NCT03996434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940980|NCT03996434|Hormone Antagonists|hormone antagonists|mesh-ancestor
24812631|NCT02053818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24712821|NCT01522989|Immunologic Factors|immunologic factors|mesh-ancestor
24712822|NCT01522989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712823|NCT01522989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24712824|NCT01522989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24712825|NCT01523002|Artesunate|artesunate|mesh-list
24712826|NCT01523002|Pyronaridine|pyronaridine|mesh-list
24712827|NCT01523002|Metoprolol|metoprolol|mesh-list
24712828|NCT01523002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24712829|NCT01523002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24712830|NCT01523002|Sympatholytics|sympatholytics|mesh-ancestor
25130857|NCT03031119|Atorvastatin|atorvastatin|mesh-list
24712831|NCT01523002|Autonomic Agents|autonomic agents|mesh-ancestor
24712832|NCT01523002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24712833|NCT01523002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712834|NCT01523002|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24712835|NCT01523002|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24940981|NCT03996434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24940983|NCT03996655|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24940984|NCT03996655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24940985|NCT03996655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940986|NCT03996655|Cholinergic Agents|cholinergic agents|mesh-ancestor
24614610|NCT01025349|Antimitotic Agents|antimitotic agents|mesh-ancestor
24614611|NCT01025349|Mitosis Modulators|mitosis modulators|mesh-ancestor
24614612|NCT01025349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614613|NCT01025466|Memantine|memantine|mesh-list
24614614|NCT01025466|Rivastigmine|rivastigmine|mesh-list
24937150|NCT04032236|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24547301|NCT00703352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24547303|NCT00703352|Natriuretic Agents|natriuretic agents|mesh-ancestor
24547304|NCT00703352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24547305|NCT00703365|Gemcitabine|gemcitabine|mesh-list
24547306|NCT00703365|Sorafenib|sorafenib|mesh-list
24972808|NCT03715101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24972809|NCT03715101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24972810|NCT03715101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24972811|NCT03715101|Antimetabolites|antimetabolites|mesh-ancestor
24972812|NCT03715101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972815|NCT03715101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24794986|NCT04070352|Fidaxomicin|fidaxomicin|mesh-list
24952374|NCT03894683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952375|NCT03894683|Protective Agents|protective agents|mesh-ancestor
24712916|NCT01523119|Dermatologic Agents|dermatologic agents|mesh-ancestor
24712917|NCT01523119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24712919|NCT01523119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24712920|NCT01523119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712921|NCT01523119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24712957|NCT01523379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24712990|NCT01523431|Protective Agents|protective agents|mesh-ancestor
24712991|NCT01523431|Vitamin B Complex|vitamin b complex|mesh-ancestor
24712993|NCT01523431|Micronutrients|micronutrients|mesh-ancestor
24712994|NCT01523483|Progesterone|progesterone|mesh-list
24713062|NCT01523860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24713063|NCT01523860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24713064|NCT01523860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24713102|NCT01524094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24713103|NCT01524094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24713104|NCT01524094|Immunologic Factors|immunologic factors|mesh-ancestor
24713107|NCT01524094|Protective Agents|protective agents|mesh-ancestor
24713108|NCT01524094|Vitamin B Complex|vitamin b complex|mesh-ancestor
24713109|NCT01524094|Vitamins|vitamins|mesh-ancestor
24713110|NCT01524094|Micronutrients|micronutrients|mesh-ancestor
24713111|NCT01524237|Ketamine|ketamine|mesh-list
24713112|NCT01524237|Analgesics|analgesics|mesh-ancestor
24941058|NCT03995147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24941059|NCT03995147|Immunologic Factors|immunologic factors|mesh-ancestor
24941060|NCT03995147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941061|NCT03995147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24854376|NCT02273466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24713159|NCT01524432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713160|NCT01524432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24713161|NCT01524432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24713163|NCT01524445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24713164|NCT01524497|Trazodone|trazodone|mesh-list
24713165|NCT01524497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24713166|NCT01524497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24713726|NCT01527305|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24713167|NCT01524497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24713168|NCT01524497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713169|NCT01524497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24713170|NCT01524497|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24713171|NCT01524497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24713172|NCT01524497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24941071|NCT03995147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24941072|NCT03995147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24941075|NCT03995147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25668322|NCT01715415|Ribavirin|ribavirin|mesh-list
25668323|NCT01715415|Antimetabolites|antimetabolites|mesh-ancestor
25668324|NCT01715415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668325|NCT01715415|Antiviral Agents|antiviral agents|mesh-ancestor
25668326|NCT01715415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25668327|NCT01715805|Cariprazine|cariprazine|mesh-list
25668328|NCT01715805|Antidepressive Agents|antidepressive agents|mesh-list
25668329|NCT01715805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25668330|NCT01715805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25668331|NCT01715805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25668332|NCT01715805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25668333|NCT01715805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713276|NCT01524874|Ergocalciferols|ergocalciferols|mesh-list
25668334|NCT01715896|Golimumab|golimumab|mesh-list
24972946|NCT03713762|Anesthetics, Local|anesthetics, local|mesh-ancestor
24972947|NCT03713762|Anesthetics|anesthetics|mesh-ancestor
24972948|NCT03713762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24972949|NCT03713762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972950|NCT03713762|Sensory System Agents|sensory system agents|mesh-ancestor
24632772|NCT01125683|Donepezil|donepezil|mesh-list
24504514|NCT00536692|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24504515|NCT00536692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24504516|NCT00536692|Cholinergic Agents|cholinergic agents|mesh-ancestor
24504517|NCT00536692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24713277|NCT01524874|Cholecalciferol|cholecalciferol|mesh-list
24713278|NCT01524874|Calcitriol|calcitriol|mesh-list
24713279|NCT01524874|Vitamins|vitamins|mesh-list
24713280|NCT01524874|Micronutrients|micronutrients|mesh-ancestor
24713281|NCT01524874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941082|NCT03995277|Vitamin B Complex|vitamin b complex|mesh-ancestor
24941083|NCT03995277|Vitamins|vitamins|mesh-ancestor
24713302|NCT01525043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24713303|NCT01525043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713304|NCT01525043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24713305|NCT01525043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25199737|NCT02739061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24713307|NCT01525043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24941120|NCT03994783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941121|NCT03994783|Immunologic Factors|immunologic factors|mesh-ancestor
24941122|NCT03994783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941123|NCT03994783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24766046|NCT01792037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24766048|NCT01792063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24713335|NCT01525537|Anesthetics, General|anesthetics, general|mesh-ancestor
24713336|NCT01525537|Anesthetics|anesthetics|mesh-ancestor
24713337|NCT01525680|Hydrocortisone|hydrocortisone|mesh-list
24713338|NCT01525680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24713339|NCT01525706|Ethanol|ethanol|mesh-list
24713340|NCT01525706|Paclitaxel|paclitaxel|mesh-list
24766058|NCT01792102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24713374|NCT01525836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713375|NCT01525836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24713376|NCT01525888|Enzyme Inhibitors|enzyme inhibitors|mesh-list
24713377|NCT01525888|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24713378|NCT01525888|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24713379|NCT01525888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713380|NCT01525888|Protease Inhibitors|protease inhibitors|mesh-ancestor
24713381|NCT01525914|Dutasteride|dutasteride|mesh-list
24713382|NCT01525914|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24713395|NCT01525966|Antimitotic Agents|antimitotic agents|mesh-ancestor
24713396|NCT01525966|Mitosis Modulators|mitosis modulators|mesh-ancestor
24713511|NCT01526317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24713513|NCT01526369|Paclitaxel|paclitaxel|mesh-list
24713514|NCT01526369|Trastuzumab|trastuzumab|mesh-list
24713515|NCT01526369|Lapatinib|lapatinib|mesh-list
24713516|NCT01526369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24713517|NCT01526369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24713518|NCT01526369|Tubulin Modulators|tubulin modulators|mesh-ancestor
24713519|NCT01526369|Antimitotic Agents|antimitotic agents|mesh-ancestor
24713520|NCT01526369|Mitosis Modulators|mitosis modulators|mesh-ancestor
24713521|NCT01526369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713522|NCT01526369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24713523|NCT01526369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24713524|NCT01526369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24713525|NCT01526395|Propofol|propofol|mesh-list
24713526|NCT01526395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24713527|NCT01526395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24713546|NCT01526499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25668336|NCT01715896|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25668337|NCT01715896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25668338|NCT01715896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25668339|NCT01715896|Immunologic Factors|immunologic factors|mesh-ancestor
25668340|NCT01715896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668341|NCT01715896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25668342|NCT01716039|Adalimumab|adalimumab|mesh-list
25668343|NCT01716039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25668344|NCT01716039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25668345|NCT01716156|Ribavirin|ribavirin|mesh-list
25668346|NCT01716156|Grazoprevir|grazoprevir|mesh-list
24713547|NCT01526499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24713548|NCT01526499|Alkylating Agents|alkylating agents|mesh-ancestor
24713549|NCT01526499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614706|NCT01025934|Growth Inhibitors|growth inhibitors|mesh-ancestor
24614707|NCT01026064|Azithromycin|azithromycin|mesh-list
24614708|NCT01026064|Cantharidin|cantharidin|mesh-list
24713667|NCT01526980|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24713727|NCT01527305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24713728|NCT01527305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24713729|NCT01527305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24713730|NCT01527305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713731|NCT01527305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24713732|NCT01527305|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24713733|NCT01527305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24713734|NCT01527305|Serotonin Agents|serotonin agents|mesh-ancestor
24713777|NCT01527448|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24713778|NCT01527448|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24713779|NCT01527448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24713780|NCT01527448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713781|NCT01527474|Citalopram|citalopram|mesh-list
24713782|NCT01527474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24713857|NCT01527786|Antidepressive Agents|antidepressive agents|mesh-ancestor
24713858|NCT01527786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24614739|NCT01026129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24614740|NCT01026129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614741|NCT01026129|Sensory System Agents|sensory system agents|mesh-ancestor
24614742|NCT01026129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24614744|NCT01026129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24614745|NCT01026129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24614746|NCT01026129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24614747|NCT01026129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625726|NCT01083264|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24625727|NCT01083264|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24625728|NCT01083264|Contraceptive Agents|contraceptive agents|mesh-ancestor
24625729|NCT01083264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24625730|NCT01083264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625731|NCT01083264|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24625732|NCT01083264|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24713923|NCT01528007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24713924|NCT01528137|Lactoferrin|lactoferrin|mesh-list
24545703|NCT00694460|Vaccines|vaccines|mesh-list
24713925|NCT01528137|Talactoferrin alfa|talactoferrin alfa|mesh-list
24713926|NCT01528137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24713927|NCT01528137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24713928|NCT01528163|Methotrexate|methotrexate|mesh-list
24713929|NCT01528163|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24713930|NCT01528163|Abortifacient Agents|abortifacient agents|mesh-ancestor
24713931|NCT01528163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24713936|NCT01528163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24713938|NCT01528163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24713939|NCT01528163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24713940|NCT01528163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24713941|NCT01528163|Immunologic Factors|immunologic factors|mesh-ancestor
24713942|NCT01528163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24713943|NCT01528163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24713944|NCT01528176|Cholecalciferol|cholecalciferol|mesh-list
24713946|NCT01528176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24713947|NCT01528176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713948|NCT01528176|Vitamins|vitamins|mesh-ancestor
24713993|NCT01528618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713994|NCT01528618|Antiviral Agents|antiviral agents|mesh-ancestor
24713995|NCT01528618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24713996|NCT01528618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24713997|NCT01528618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24714067|NCT01529125|Nevirapine|nevirapine|mesh-list
24714068|NCT01529125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24714069|NCT01529125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24714070|NCT01529125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24714071|NCT01529125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714072|NCT01529125|Antiviral Agents|antiviral agents|mesh-ancestor
24714120|NCT01529177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714121|NCT01529177|Anticoagulants|anticoagulants|mesh-ancestor
25428956|NCT01620788|Natriuretic Agents|natriuretic agents|mesh-ancestor
24741444|NCT05288829|Immunologic Factors|immunologic factors|mesh-ancestor
24504605|NCT00537173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973181|NCT03711279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24973182|NCT03711279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973183|NCT03711279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714122|NCT01529177|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24714123|NCT01529177|Chelating Agents|chelating agents|mesh-ancestor
25862391|NCT00089687|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24465092|NCT00367874|GABA Agents|gaba agents|mesh-ancestor
24714143|NCT01529190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24714145|NCT01529190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24714146|NCT01529190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24714147|NCT01529190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24714149|NCT01529229|Betamethasone|betamethasone|mesh-list
24714150|NCT01529229|Desloratadine|desloratadine|mesh-list
24714151|NCT01529229|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
24714152|NCT01529229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24714153|NCT01529229|Glucocorticoids|glucocorticoids|mesh-ancestor
24714155|NCT01529229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24714156|NCT01529229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714157|NCT01529229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25050767|NCT00468273|Immunoglobulins|immunoglobulins|mesh-list
25050769|NCT00468273|gamma-Globulins|gamma-globulins|mesh-list
25050770|NCT00468273|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25050771|NCT00468273|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25050772|NCT00468273|Immunologic Factors|immunologic factors|mesh-ancestor
25050773|NCT00468273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050774|NCT00468117|Etanercept|etanercept|mesh-list
25050775|NCT00468117|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25050776|NCT00468117|Basiliximab|basiliximab|mesh-list
25050779|NCT00468117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25050780|NCT00468117|Analgesics|analgesics|mesh-ancestor
25050781|NCT00468117|Sensory System Agents|sensory system agents|mesh-ancestor
25050782|NCT00468117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25050783|NCT00468117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854501|NCT02273765|Tenofovir|tenofovir|mesh-list
24714158|NCT01529229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24714175|NCT01529242|Hormones|hormones|mesh-ancestor
24714192|NCT01529255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714193|NCT01529255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24714194|NCT01529255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24714195|NCT01529255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714196|NCT01529294|Iloperidone|iloperidone|mesh-list
24714197|NCT01529294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24714198|NCT01529294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24533667|NCT00644748|Anticonvulsants|anticonvulsants|mesh-ancestor
24714199|NCT01529294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24714200|NCT01529294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714270|NCT01529710|Praziquantel|praziquantel|mesh-list
24714271|NCT01529710|Anthelmintics|anthelmintics|mesh-ancestor
24714272|NCT01529710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24714290|NCT01529892|Dopamine Agents|dopamine agents|mesh-ancestor
25050784|NCT00468117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25050785|NCT00468117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25050786|NCT00468117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25050787|NCT00468117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25050788|NCT00468117|Immunologic Factors|immunologic factors|mesh-ancestor
25050790|NCT00468039|Vildagliptin|vildagliptin|mesh-list
25050791|NCT00468039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25050792|NCT00468039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050793|NCT00468039|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25050794|NCT00468039|Protease Inhibitors|protease inhibitors|mesh-ancestor
25050795|NCT00468039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050796|NCT00468039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854511|NCT02273765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24714291|NCT01529892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24714292|NCT01529892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668347|NCT01716156|Antimetabolites|antimetabolites|mesh-ancestor
25668348|NCT01716156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668349|NCT01716156|Antiviral Agents|antiviral agents|mesh-ancestor
25668350|NCT01716156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25668351|NCT01716195|Paclitaxel|paclitaxel|mesh-list
25668352|NCT01716195|Carboplatin|carboplatin|mesh-list
25668353|NCT01716195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25668354|NCT01716195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862392|NCT00089687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25862393|NCT00089687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25862394|NCT00089687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862395|NCT00089687|Dopamine Agents|dopamine agents|mesh-ancestor
25862396|NCT00089687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25862397|NCT00089687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862398|NCT00089700|Ibalizumab|ibalizumab|mesh-list
25862399|NCT00089700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25862400|NCT00089700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24741542|NCT05288192|Hormones|hormones|mesh-ancestor
24504690|NCT00537836|Estrogens|estrogens|mesh-ancestor
24714293|NCT01529892|Adrenergic Agents|adrenergic agents|mesh-ancestor
24714294|NCT01529892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24714295|NCT01529892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24714296|NCT01529892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24714342|NCT01530217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24714343|NCT01530217|Analgesics|analgesics|mesh-ancestor
24714344|NCT01530217|Sensory System Agents|sensory system agents|mesh-ancestor
25050798|NCT00467402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24614773|NCT01026337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24614774|NCT01026337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24614775|NCT01026337|Growth Substances|growth substances|mesh-ancestor
24614777|NCT01026337|Growth Inhibitors|growth inhibitors|mesh-ancestor
24714410|NCT01530503|Mitomycin|mitomycin|mesh-list
24714411|NCT01530503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24714412|NCT01530503|Antimetabolites|antimetabolites|mesh-ancestor
24957198|NCT03846583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24854533|NCT02273791|Contraceptive Agents|contraceptive agents|mesh-ancestor
24714456|NCT01530620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714457|NCT01530620|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24714458|NCT01530620|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24714460|NCT01530620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24714461|NCT01530620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714462|NCT01530620|Urological Agents|urological agents|mesh-ancestor
24714463|NCT01530698|Vaccines|vaccines|mesh-list
24714464|NCT01530698|Immunologic Factors|immunologic factors|mesh-ancestor
24714465|NCT01530698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714466|NCT01530711|Terlipressin|terlipressin|mesh-list
24714467|NCT01530711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24714468|NCT01530711|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24714469|NCT01530737|Antithrombins|antithrombins|mesh-list
24714470|NCT01530737|Antithrombin III|antithrombin iii|mesh-list
24714512|NCT01531049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714541|NCT01531192|Antifungal Agents|antifungal agents|mesh-ancestor
24714542|NCT01531192|Ionophores|ionophores|mesh-ancestor
24714543|NCT01531192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24714544|NCT01531192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714545|NCT01531218|Azithromycin|azithromycin|mesh-list
24714546|NCT01531218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24714547|NCT01531218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714548|NCT01531244|Dactinomycin|dactinomycin|mesh-list
24714549|NCT01531244|Cactinomycin|cactinomycin|mesh-list
24714550|NCT01531244|Melphalan|melphalan|mesh-list
24714551|NCT01531244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24714552|NCT01531244|Alkylating Agents|alkylating agents|mesh-ancestor
24714553|NCT01531244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714554|NCT01531244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24957199|NCT03846583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24957200|NCT03846583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24957201|NCT03846583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24957202|NCT03846583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957203|NCT03846583|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24957204|NCT03846583|Hormone Antagonists|hormone antagonists|mesh-ancestor
24854538|NCT02273791|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25668355|NCT01716195|Tubulin Modulators|tubulin modulators|mesh-ancestor
25668356|NCT01716195|Antimitotic Agents|antimitotic agents|mesh-ancestor
25668357|NCT01716195|Mitosis Modulators|mitosis modulators|mesh-ancestor
25668358|NCT01716195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668359|NCT01716208|Ofatumumab|ofatumumab|mesh-list
25668360|NCT01716208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25668361|NCT01716221|Dexetimide|dexetimide|mesh-list
25668362|NCT01716221|Bupropion|bupropion|mesh-list
25668363|NCT01716221|Citalopram|citalopram|mesh-list
25668364|NCT01716221|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24714555|NCT01531244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24465211|NCT00368238|Hematinics|hematinics|mesh-ancestor
24714589|NCT01531569|Secoisolariciresinol|secoisolariciresinol|mesh-list
24714590|NCT01531569|Phytoestrogens|phytoestrogens|mesh-ancestor
24714591|NCT01531569|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24714592|NCT01531569|Estrogens|estrogens|mesh-ancestor
24714594|NCT01531569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24714595|NCT01531569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714596|NCT01531582|Minocycline|minocycline|mesh-list
24714597|NCT01531582|Tetracycline|tetracycline|mesh-list
24714598|NCT01531582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24714599|NCT01531582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714600|NCT01531582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24714601|NCT01531582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24714618|NCT01531647|Raltegravir Potassium|raltegravir potassium|mesh-list
24714641|NCT01531712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24714642|NCT01531712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24714643|NCT01531712|Immunologic Factors|immunologic factors|mesh-ancestor
24714644|NCT01531712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714645|NCT01531712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24714646|NCT01531764|Vinorelbine|vinorelbine|mesh-list
24714647|NCT01531764|Afatinib|afatinib|mesh-list
25862401|NCT00089700|Antiviral Agents|antiviral agents|mesh-ancestor
24614793|NCT01026363|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24714793|NCT01532856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24714794|NCT01532856|Alkylating Agents|alkylating agents|mesh-ancestor
24714795|NCT01532856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714796|NCT01532856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24714797|NCT01532856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24714798|NCT01532856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24714799|NCT01532856|Antiemetics|antiemetics|mesh-ancestor
24714800|NCT01532856|Autonomic Agents|autonomic agents|mesh-ancestor
24714801|NCT01532856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24714803|NCT01532856|Glucocorticoids|glucocorticoids|mesh-ancestor
24714805|NCT01532856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24714806|NCT01532856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24714807|NCT01532856|Protease Inhibitors|protease inhibitors|mesh-ancestor
25862402|NCT00089700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24941176|NCT03994211|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24714851|NCT01533155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714852|NCT01533155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24714854|NCT01533155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24714855|NCT01533155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24714856|NCT01533155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714857|NCT01533155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24714858|NCT01533155|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24714859|NCT01533155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24714860|NCT01533155|Cholinergic Agents|cholinergic agents|mesh-ancestor
24714861|NCT01533155|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24714862|NCT01533155|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24714875|NCT01533220|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24714876|NCT01533220|Respiratory System Agents|respiratory system agents|mesh-ancestor
24714877|NCT01533220|Antipruritics|antipruritics|mesh-ancestor
24714878|NCT01533220|Dermatologic Agents|dermatologic agents|mesh-ancestor
24941148|NCT03994692|Anesthetics|anesthetics|mesh-ancestor
25053953|NCT00002371|Lamivudine|lamivudine|mesh-list
24941149|NCT03994692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24941150|NCT03994692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714894|NCT01533272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24714895|NCT01533272|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24714896|NCT01533272|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24714898|NCT01533272|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24714899|NCT01533272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24714900|NCT01533272|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24714901|NCT01533272|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24714946|NCT01533545|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24714947|NCT01533545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24714948|NCT01533545|Adrenergic Agents|adrenergic agents|mesh-ancestor
24714949|NCT01533545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24714950|NCT01533545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714954|NCT01533545|Autonomic Agents|autonomic agents|mesh-ancestor
24714968|NCT01533558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404116|NCT03684538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714969|NCT01533558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714970|NCT01533662|Phenylephrine|phenylephrine|mesh-list
24714971|NCT01533662|Oxymetazoline|oxymetazoline|mesh-list
24714972|NCT01533662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24714973|NCT01533662|Mydriatics|mydriatics|mesh-ancestor
24714974|NCT01533662|Autonomic Agents|autonomic agents|mesh-ancestor
24714975|NCT01533662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24714976|NCT01533662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714977|NCT01533662|Sympathomimetics|sympathomimetics|mesh-ancestor
24714978|NCT01533662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24714979|NCT01533662|Nasal Decongestants|nasal decongestants|mesh-ancestor
24714980|NCT01533662|Respiratory System Agents|respiratory system agents|mesh-ancestor
24714981|NCT01533662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24714982|NCT01533662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24714983|NCT01533662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24714984|NCT01533662|Adrenergic Agents|adrenergic agents|mesh-ancestor
24715070|NCT01534247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24715071|NCT01534247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24715072|NCT01534247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24715073|NCT01534247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24715074|NCT01534312|Mesalamine|mesalamine|mesh-list
25862403|NCT00089726|Cyclophosphamide|cyclophosphamide|mesh-list
24614802|NCT01026376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24614804|NCT01026415|Ketoconazole|ketoconazole|mesh-list
24614805|NCT01026415|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24614806|NCT01026415|Midazolam|midazolam|mesh-list
24614807|NCT01026415|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24614808|NCT01026415|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24614809|NCT01026415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24614810|NCT01026415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24614811|NCT01026415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941167|NCT03994211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24501856|NCT00531349|Propofol|propofol|mesh-list
24941168|NCT03994211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941169|NCT03994211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24941170|NCT03994211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24941171|NCT03994211|Antitubercular Agents|antitubercular agents|mesh-ancestor
24941172|NCT03994211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24941174|NCT03994211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24941175|NCT03994211|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24941177|NCT03994211|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24941178|NCT03994211|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24597003|NCT00946764|Imipramine|imipramine|mesh-list
24715160|NCT01534845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24715161|NCT01534845|Alkylating Agents|alkylating agents|mesh-ancestor
24715162|NCT01534845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715163|NCT01534845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131390|NCT03026101|Nitroglycerin|nitroglycerin|mesh-list
24715164|NCT01534858|Polihexanide|polihexanide|mesh-list
24715165|NCT01534858|Betaine|betaine|mesh-list
24715166|NCT01534858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24715167|NCT01534858|Lipotropic Agents|lipotropic agents|mesh-ancestor
24715168|NCT01534858|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24715169|NCT01534858|Antimetabolites|antimetabolites|mesh-ancestor
24715170|NCT01534858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715171|NCT01534858|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24715172|NCT01534858|Disinfectants|disinfectants|mesh-ancestor
24715173|NCT01534858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24715174|NCT01534884|Rituximab|rituximab|mesh-list
25862404|NCT00089726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24715183|NCT01534949|Immunologic Factors|immunologic factors|mesh-ancestor
24715184|NCT01534949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715185|NCT01534949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24715186|NCT01535027|Alendronate|alendronate|mesh-list
24715187|NCT01535027|Teriparatide|teriparatide|mesh-list
24715188|NCT01535027|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
24715189|NCT01535027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24715190|NCT01535027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715195|NCT01535027|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24715196|NCT01535027|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24715198|NCT01535079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24715199|NCT01535079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24715200|NCT01535079|Analgesics|analgesics|mesh-ancestor
24715255|NCT01535469|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24715256|NCT01535469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24715257|NCT01535469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715258|NCT01535469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715259|NCT01535469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24715260|NCT01535469|Hormone Antagonists|hormone antagonists|mesh-ancestor
24715261|NCT01535469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24715328|NCT01535872|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24715329|NCT01535872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24715330|NCT01535872|Immunologic Factors|immunologic factors|mesh-ancestor
24715331|NCT01535872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715333|NCT01535989|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
24715334|NCT01535989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24715335|NCT01535989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24715336|NCT01535989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24715337|NCT01535989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715338|NCT01535989|Antifungal Agents|antifungal agents|mesh-ancestor
24941206|NCT03993431|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24941207|NCT03993431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941208|NCT03993431|Sympathomimetics|sympathomimetics|mesh-ancestor
24941209|NCT03993431|Autonomic Agents|autonomic agents|mesh-ancestor
24715386|NCT01536158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24715387|NCT01536158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24715388|NCT01536158|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24715389|NCT01536158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715390|NCT01536158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715393|NCT01536223|Docetaxel|docetaxel|mesh-list
24715394|NCT01536223|Fluorouracil|fluorouracil|mesh-list
24715395|NCT01536223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715396|NCT01536223|Tubulin Modulators|tubulin modulators|mesh-ancestor
24715397|NCT01536223|Antimitotic Agents|antimitotic agents|mesh-ancestor
24715398|NCT01536223|Mitosis Modulators|mitosis modulators|mesh-ancestor
24715403|NCT01536223|Immunologic Factors|immunologic factors|mesh-ancestor
24715404|NCT01536223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715405|NCT01536249|Pramipexole|pramipexole|mesh-list
24715406|NCT01536249|Cimetidine|cimetidine|mesh-list
24715407|NCT01536249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24715408|NCT01536249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24715409|NCT01536249|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24715410|NCT01536249|Histamine Antagonists|histamine antagonists|mesh-ancestor
24715411|NCT01536249|Histamine Agents|histamine agents|mesh-ancestor
24766215|NCT01793350|Chelating Agents|chelating agents|mesh-ancestor
24766216|NCT01793350|Sequestering Agents|sequestering agents|mesh-ancestor
24715425|NCT01536301|Oxycodone|oxycodone|mesh-list
24715426|NCT01536301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24715427|NCT01536301|Narcotics|narcotics|mesh-ancestor
24715428|NCT01536301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25199738|NCT02739061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24450137|NCT00317811|Vitamins|vitamins|mesh-ancestor
24715429|NCT01536301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715430|NCT01536301|Analgesics|analgesics|mesh-ancestor
24715431|NCT01536301|Sensory System Agents|sensory system agents|mesh-ancestor
24715432|NCT01536301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24715433|NCT01536314|Memantine|memantine|mesh-list
24715434|NCT01536314|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24715435|NCT01536314|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24614843|NCT01026415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24614844|NCT01026415|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24614845|NCT01026428|Levodopa|levodopa|mesh-list
24715470|NCT01536626|Biphasic Insulins|biphasic insulins|mesh-list
24715471|NCT01536626|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24715472|NCT01536626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24715473|NCT01536626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715474|NCT01536639|Insulin Aspart|insulin aspart|mesh-list
24715475|NCT01536639|Biphasic Insulins|biphasic insulins|mesh-list
24715561|NCT01537107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24715562|NCT01537107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24715574|NCT01537146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715575|NCT01537146|Sensory System Agents|sensory system agents|mesh-ancestor
24715576|NCT01537146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24715578|NCT01537250|Ofloxacin|ofloxacin|mesh-list
24715579|NCT01537250|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24715580|NCT01537250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24715581|NCT01537250|Renal Agents|renal agents|mesh-ancestor
24715582|NCT01537250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24715583|NCT01537250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24715584|NCT01537250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24973575|NCT03708497|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24715585|NCT01537250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715586|NCT01537250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715591|NCT01537354|Beractant|beractant|mesh-list
24715596|NCT01537380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24715617|NCT01537601|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24715618|NCT01537601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24715619|NCT01537640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24715620|NCT01537640|Immunologic Factors|immunologic factors|mesh-ancestor
24715621|NCT01537640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715622|NCT01537744|Azacitidine|azacitidine|mesh-list
24715623|NCT01537744|Romidepsin|romidepsin|mesh-list
24715624|NCT01537744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24715625|NCT01537744|Antimetabolites|antimetabolites|mesh-ancestor
24715641|NCT01537770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715642|NCT01537809|Vitamin D|vitamin d|mesh-list
24715643|NCT01537809|Ergocalciferols|ergocalciferols|mesh-list
24715644|NCT01537809|Cholecalciferol|cholecalciferol|mesh-list
24715645|NCT01537809|Vitamins|vitamins|mesh-list
24715646|NCT01537809|Micronutrients|micronutrients|mesh-ancestor
24715647|NCT01537809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715648|NCT01537809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24715649|NCT01537809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24715650|NCT01537861|Thalidomide|thalidomide|mesh-list
24715651|NCT01537861|Dexamethasone|dexamethasone|mesh-list
24715674|NCT01537861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24614865|NCT01026584|Dopamine Agonists|dopamine agonists|mesh-ancestor
24614892|NCT01026714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24614909|NCT01026714|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24614910|NCT01026714|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24614911|NCT01026714|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24614912|NCT01026714|Analgesics|analgesics|mesh-ancestor
24614913|NCT01026714|Sensory System Agents|sensory system agents|mesh-ancestor
24715681|NCT01537861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24715682|NCT01537861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24715684|NCT01538095|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24715724|NCT01538329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715725|NCT01538329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715728|NCT01538329|Sensory System Agents|sensory system agents|mesh-ancestor
24597303|NCT00948480|Sargramostim|sargramostim|mesh-list
24715800|NCT01538576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24715801|NCT01538576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715802|NCT01538589|Insulin Aspart|insulin aspart|mesh-list
24715803|NCT01538589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24715804|NCT01538589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715805|NCT01538641|Gemcitabine|gemcitabine|mesh-list
24715806|NCT01538641|Rituximab|rituximab|mesh-list
24715807|NCT01538641|Oxaliplatin|oxaliplatin|mesh-list
24715808|NCT01538641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24715809|NCT01538641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715810|NCT01538641|Immunologic Factors|immunologic factors|mesh-ancestor
24715811|NCT01538641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715812|NCT01538641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24715813|NCT01538641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24715814|NCT01538641|Antimetabolites|antimetabolites|mesh-ancestor
24715930|NCT01539044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24715994|NCT01539330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24715995|NCT01539330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715996|NCT01539330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24715997|NCT01539343|Anti-Infective Agents|anti-infective agents|mesh-list
24715998|NCT01539343|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24715999|NCT01539408|Misoprostol|misoprostol|mesh-list
24716000|NCT01539408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24766247|NCT01793636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941267|NCT03992911|Etoposide phosphate|etoposide phosphate|mesh-list
24941268|NCT03992911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941269|NCT03992911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24941270|NCT03992911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24941271|NCT03992911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24941272|NCT03992911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24941273|NCT03992911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941274|NCT03992820|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24941275|NCT03992820|Anesthetics, Local|anesthetics, local|mesh-ancestor
25668365|NCT01716221|Antidepressive Agents|antidepressive agents|mesh-ancestor
25218004|NCT02673866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218005|NCT02673866|Anticonvulsants|anticonvulsants|mesh-ancestor
24941277|NCT03992820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24941278|NCT03992820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941279|NCT03992820|Sensory System Agents|sensory system agents|mesh-ancestor
24941280|NCT03992820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24941281|NCT03992820|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24802933|NCT01993459|Midazolam|midazolam|mesh-list
24614969|NCT01027065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614971|NCT01027065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24614972|NCT01027117|Sildenafil Citrate|sildenafil citrate|mesh-list
24716080|NCT01539720|Contraceptive Agents|contraceptive agents|mesh-ancestor
24716081|NCT01539720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24941290|NCT03992586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941292|NCT03992586|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24941293|NCT03992586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24941294|NCT03992586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24941295|NCT03992586|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24716082|NCT01539720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941320|NCT03992261|Halobetasol|halobetasol|mesh-list
24941321|NCT03992261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24941322|NCT03992326|Cyclophosphamide|cyclophosphamide|mesh-list
24941323|NCT03992326|Fludarabine|fludarabine|mesh-list
24941324|NCT03992326|Interleukin-2|interleukin-2|mesh-list
24941325|NCT03992326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24941326|NCT03992326|Immunologic Factors|immunologic factors|mesh-ancestor
24941327|NCT03992326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941328|NCT03992326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24941329|NCT03992326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24941330|NCT03992326|Alkylating Agents|alkylating agents|mesh-ancestor
24941331|NCT03992326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941332|NCT03992326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941333|NCT03992326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24465884|NCT00371020|Heparin|heparin|mesh-list
24716239|NCT01540747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716240|NCT01540747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24716241|NCT01540747|Hematinics|hematinics|mesh-ancestor
24716242|NCT01540747|Vitamins|vitamins|mesh-ancestor
24716243|NCT01540747|Micronutrients|micronutrients|mesh-ancestor
24716244|NCT01540812|Cytarabine|cytarabine|mesh-list
24716245|NCT01540812|Dexamethasone|dexamethasone|mesh-list
24716246|NCT01540812|Dexamethasone acetate|dexamethasone acetate|mesh-list
24716247|NCT01540812|Prednisone|prednisone|mesh-list
24716248|NCT01540812|Hydrocortisone|hydrocortisone|mesh-list
24716249|NCT01540812|Fludarabine|fludarabine|mesh-list
24716250|NCT01540812|Vincristine|vincristine|mesh-list
24716251|NCT01540812|Daunorubicin|daunorubicin|mesh-list
24716295|NCT01540877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24716296|NCT01540877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716297|NCT01540877|Sensory System Agents|sensory system agents|mesh-ancestor
24716298|NCT01540877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24716299|NCT01540877|Antipruritics|antipruritics|mesh-ancestor
24716300|NCT01540877|Dermatologic Agents|dermatologic agents|mesh-ancestor
24716301|NCT01540877|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24716302|NCT01541059|Ropivacaine|ropivacaine|mesh-list
24716303|NCT01541059|Anesthetics, Local|anesthetics, local|mesh-ancestor
24716304|NCT01541059|Anesthetics|anesthetics|mesh-ancestor
24716305|NCT01541059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24716307|NCT01541059|Sensory System Agents|sensory system agents|mesh-ancestor
24716321|NCT01541085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24716322|NCT01541085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24716323|NCT01541085|Antiviral Agents|antiviral agents|mesh-ancestor
24941364|NCT03991845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941365|NCT03991910|Ramipril|ramipril|mesh-list
24941366|NCT03991910|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24716361|NCT01541189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716362|NCT01541267|Telmisartan|telmisartan|mesh-list
24716364|NCT01541267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24716365|NCT01541267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25668366|NCT01716221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25668367|NCT01716221|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24716366|NCT01541267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716367|NCT01541280|Azacitidine|azacitidine|mesh-list
24716368|NCT01541280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24941367|NCT03991910|Protease Inhibitors|protease inhibitors|mesh-ancestor
24941368|NCT03991910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24941369|NCT03991910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716425|NCT01541475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941375|NCT03991442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941376|NCT03991442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24941377|NCT03991442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941380|NCT03991364|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24941381|NCT03991364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941382|NCT03991364|Sympathomimetics|sympathomimetics|mesh-ancestor
24941383|NCT03991364|Autonomic Agents|autonomic agents|mesh-ancestor
24941384|NCT03991364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24716482|NCT01541943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24716483|NCT01541943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716484|NCT01541943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24716506|NCT01542099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24716507|NCT01542099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716508|NCT01542099|Analgesics|analgesics|mesh-ancestor
24716509|NCT01542099|Sensory System Agents|sensory system agents|mesh-ancestor
24716510|NCT01542099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24716511|NCT01542138|Niacinamide|niacinamide|mesh-list
24941397|NCT03991559|Immunologic Factors|immunologic factors|mesh-ancestor
24941398|NCT03991559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941399|NCT03991559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941400|NCT03991559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941401|NCT03991559|Trace Elements|trace elements|mesh-ancestor
24941402|NCT03991559|Micronutrients|micronutrients|mesh-ancestor
24716535|NCT01542190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24803286|NCT01995370|Clopidogrel|clopidogrel|mesh-list
24957473|NCT03844529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24957474|NCT03844529|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24957475|NCT03844529|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24957476|NCT03844529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24957477|NCT03844529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957478|NCT03844594|Eptifibatide|eptifibatide|mesh-list
24854792|NCT02275598|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24716558|NCT01542424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24941438|NCT03991130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941439|NCT03991130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24941440|NCT03991130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941441|NCT03991104|Oxaliplatin|oxaliplatin|mesh-list
24941442|NCT03991104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941443|NCT03990961|Pembrolizumab|pembrolizumab|mesh-list
24941446|NCT03990701|Metomidate|metomidate|mesh-list
24941447|NCT03990701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24941448|NCT03990701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24716700|NCT01543321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716702|NCT01543347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24716703|NCT01543347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24716727|NCT01543464|Temozolomide|temozolomide|mesh-list
24716728|NCT01543464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24716729|NCT01543464|Alkylating Agents|alkylating agents|mesh-ancestor
24716730|NCT01543464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716731|NCT01543464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24716732|NCT01543555|Atorvastatin|atorvastatin|mesh-list
24716733|NCT01543555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24716734|NCT01543555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24716735|NCT01543555|Antimetabolites|antimetabolites|mesh-ancestor
24716736|NCT01543555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716737|NCT01543555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24716738|NCT01543555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24716739|NCT01543555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716740|NCT01543724|Lithium Carbonate|lithium carbonate|mesh-list
24716741|NCT01543724|Antidepressive Agents|antidepressive agents|mesh-ancestor
24716742|NCT01543724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24716743|NCT01543724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716744|NCT01543724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668368|NCT01716221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24716745|NCT01543724|Antimanic Agents|antimanic agents|mesh-ancestor
24716746|NCT01543724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24716747|NCT01543724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24716748|NCT01543724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716764|NCT01543906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24716765|NCT01543906|Immunologic Factors|immunologic factors|mesh-ancestor
24716766|NCT01543906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716767|NCT01543906|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24716768|NCT01543906|Protective Agents|protective agents|mesh-ancestor
24716769|NCT01543906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24716770|NCT01543932|Clopidogrel|clopidogrel|mesh-list
24716771|NCT01543932|Ticagrelor|ticagrelor|mesh-list
24716772|NCT01543932|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24803474|NCT01996475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24716868|NCT01544283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24941485|NCT03990129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24941486|NCT03990129|Antipyretics|antipyretics|mesh-ancestor
24941487|NCT03990194|Leuprolide|leuprolide|mesh-list
24941488|NCT03990194|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24941489|NCT03990194|Fertility Agents|fertility agents|mesh-ancestor
24941490|NCT03990194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24941491|NCT03990194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941492|NCT03990194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24941493|NCT03990194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941494|NCT03990103|Paclitaxel|paclitaxel|mesh-list
24941495|NCT03990103|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24941496|NCT03990103|Bevacizumab|bevacizumab|mesh-list
24941497|NCT03990103|Oxaliplatin|oxaliplatin|mesh-list
25131773|NCT03023501|Sensory System Agents|sensory system agents|mesh-ancestor
24941498|NCT03990103|Tegafur|tegafur|mesh-list
25050805|NCT00467025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24803579|NCT01997164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24716900|NCT01544517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24716901|NCT01544517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24716902|NCT01544517|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24716903|NCT01544517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24716904|NCT01544517|Alkylating Agents|alkylating agents|mesh-ancestor
24716933|NCT01544725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24716934|NCT01544725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24716935|NCT01544725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716936|NCT01544725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24716937|NCT01544725|Anesthetics, General|anesthetics, general|mesh-ancestor
24716938|NCT01544725|Anesthetics|anesthetics|mesh-ancestor
24716939|NCT01544725|Analgesics|analgesics|mesh-ancestor
24716940|NCT01544725|Sensory System Agents|sensory system agents|mesh-ancestor
24716941|NCT01544725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24716984|NCT01544894|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
24716985|NCT01544894|Strontium ranelate|strontium ranelate|mesh-list
24716986|NCT01544894|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24717061|NCT01545297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24717062|NCT01545297|Analgesics|analgesics|mesh-ancestor
24615110|NCT01027923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24615111|NCT01028079|Aspirin|aspirin|mesh-list
24615112|NCT01028079|Ibuprofen|ibuprofen|mesh-list
24615113|NCT01028079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24615114|NCT01028079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24615115|NCT01028079|Analgesics|analgesics|mesh-ancestor
24615116|NCT01028079|Sensory System Agents|sensory system agents|mesh-ancestor
25862405|NCT00089726|Immunologic Factors|immunologic factors|mesh-ancestor
25862406|NCT00089726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862407|NCT00089726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24766557|NCT01795313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24766558|NCT01795313|Immunologic Factors|immunologic factors|mesh-ancestor
24766559|NCT01795313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615117|NCT01028079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24717092|NCT01545557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717093|NCT01545557|Sensory System Agents|sensory system agents|mesh-ancestor
24717094|NCT01545557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24717095|NCT01545557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24717096|NCT01545557|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24717097|NCT01545557|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24717098|NCT01545557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24717099|NCT01545557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717100|NCT01545557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24717101|NCT01545557|Immunologic Factors|immunologic factors|mesh-ancestor
24717102|NCT01545557|Viscosupplements|viscosupplements|mesh-ancestor
24717103|NCT01545557|Protective Agents|protective agents|mesh-ancestor
24973685|NCT03707795|Hormones|hormones|mesh-ancestor
24717104|NCT01545635|Thrombin|thrombin|mesh-list
24717105|NCT01545635|Hemostatics|hemostatics|mesh-ancestor
24717106|NCT01545635|Coagulants|coagulants|mesh-ancestor
24717107|NCT01545778|Oxycodone|oxycodone|mesh-list
24717108|NCT01545778|Tapentadol|tapentadol|mesh-list
24717109|NCT01545778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24717110|NCT01545778|Narcotics|narcotics|mesh-ancestor
24717111|NCT01545778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24717112|NCT01545778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717113|NCT01545778|Analgesics|analgesics|mesh-ancestor
24717114|NCT01545778|Sensory System Agents|sensory system agents|mesh-ancestor
24717115|NCT01545778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24717116|NCT01545778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24717117|NCT01545778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24717118|NCT01545778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24717120|NCT01545778|Adrenergic Agents|adrenergic agents|mesh-ancestor
24717123|NCT01545791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24717124|NCT01545791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803743|NCT01998295|Artemether|artemether|mesh-list
24717156|NCT01546051|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24717162|NCT01546090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24717163|NCT01546090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24717164|NCT01546090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717165|NCT01546090|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24717166|NCT01546090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24717167|NCT01546090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24717168|NCT01546090|GABA Modulators|gaba modulators|mesh-ancestor
24717169|NCT01546090|GABA Agents|gaba agents|mesh-ancestor
25199739|NCT02739061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717170|NCT01546090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24717171|NCT01546090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717172|NCT01546103|Vitamin D|vitamin d|mesh-list
24717173|NCT01546103|Ergocalciferols|ergocalciferols|mesh-list
24717174|NCT01546103|Cholecalciferol|cholecalciferol|mesh-list
24717175|NCT01546103|Vitamins|vitamins|mesh-list
24717176|NCT01546103|Micronutrients|micronutrients|mesh-ancestor
24717177|NCT01546103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717178|NCT01546103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24720420|NCT01568307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24814198|NCT02063139|Glucocorticoids|glucocorticoids|mesh-ancestor
24717299|NCT01547143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717300|NCT01547143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24717301|NCT01547143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25862408|NCT00089726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24625739|NCT01083290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24625740|NCT01083290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625741|NCT01083290|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24625742|NCT01083290|Diuretics|diuretics|mesh-ancestor
24625743|NCT01083290|Natriuretic Agents|natriuretic agents|mesh-ancestor
24625744|NCT01083329|Nicotinic Acids|nicotinic acids|mesh-list
24625746|NCT01083329|Niacinamide|niacinamide|mesh-list
24625747|NCT01083329|Vitamin B Complex|vitamin b complex|mesh-ancestor
24625748|NCT01083329|Vitamins|vitamins|mesh-ancestor
24625749|NCT01083329|Micronutrients|micronutrients|mesh-ancestor
24625750|NCT01083329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625751|NCT01083329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24625752|NCT01083329|Antimetabolites|antimetabolites|mesh-ancestor
24625753|NCT01083329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625754|NCT01083329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24625755|NCT01083329|Vasodilator Agents|vasodilator agents|mesh-ancestor
24625756|NCT01083381|Risperidone|risperidone|mesh-list
25862409|NCT00089726|Alkylating Agents|alkylating agents|mesh-ancestor
24717399|NCT01547494|Vitamins|vitamins|mesh-list
24717400|NCT01547494|Micronutrients|micronutrients|mesh-ancestor
24717401|NCT01547494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717402|NCT01547520|Meperidine|meperidine|mesh-list
24717403|NCT01547520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24717404|NCT01547520|Narcotics|narcotics|mesh-ancestor
24717405|NCT01547520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24717406|NCT01547520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717407|NCT01547520|Analgesics|analgesics|mesh-ancestor
24717433|NCT01548001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24717434|NCT01548027|Anesthetics|anesthetics|mesh-list
24717435|NCT01548027|Anesthetics, Local|anesthetics, local|mesh-list
24717436|NCT01548027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24717437|NCT01548027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832477|NCT02171546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24717438|NCT01548027|Sensory System Agents|sensory system agents|mesh-ancestor
24717439|NCT01548027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24717440|NCT01548066|Valproic Acid|valproic acid|mesh-list
24717448|NCT01548066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24717449|NCT01548066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24717450|NCT01548066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24717451|NCT01548079|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24717452|NCT01548079|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24717453|NCT01548079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24717454|NCT01548118|Vaccines|vaccines|mesh-list
24717455|NCT01548118|Immunologic Factors|immunologic factors|mesh-ancestor
24717456|NCT01548118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717457|NCT01548144|Pemetrexed|pemetrexed|mesh-list
24717458|NCT01548144|Crizotinib|crizotinib|mesh-list
24717459|NCT01548144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24717460|NCT01548144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24803940|NCT01999829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941586|NCT03989310|Gemcitabine|gemcitabine|mesh-list
24941587|NCT03989310|Paclitaxel|paclitaxel|mesh-list
24941588|NCT03989310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24941589|NCT03989310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24941649|NCT03989037|Carboplatin|carboplatin|mesh-list
24941650|NCT03989037|Docetaxel|docetaxel|mesh-list
24941651|NCT03989037|Trastuzumab|trastuzumab|mesh-list
24941652|NCT03989037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941653|NCT03989037|Tubulin Modulators|tubulin modulators|mesh-ancestor
24941654|NCT03989037|Antimitotic Agents|antimitotic agents|mesh-ancestor
24717480|NCT01548170|Growth Inhibitors|growth inhibitors|mesh-ancestor
24717481|NCT01548170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24717482|NCT01548170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717483|NCT01548170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717484|NCT01548170|Antifungal Agents|antifungal agents|mesh-ancestor
24717485|NCT01548170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24717486|NCT01548170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24717487|NCT01548170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24717488|NCT01548170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24717515|NCT01548248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24717516|NCT01548248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717517|NCT01548274|Sarpogrelate|sarpogrelate|mesh-list
24717518|NCT01548274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24717530|NCT01548326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717551|NCT01548521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717552|NCT01548560|Dapivirine|dapivirine|mesh-list
24717553|NCT01548560|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24717555|NCT01548560|Antiviral Agents|antiviral agents|mesh-ancestor
24717556|NCT01548560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24717557|NCT01548612|Nitroprusside|nitroprusside|mesh-list
24717558|NCT01548612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24717559|NCT01548612|Vasodilator Agents|vasodilator agents|mesh-ancestor
24717560|NCT01548612|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24717561|NCT01548612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717562|NCT01548677|Trastuzumab|trastuzumab|mesh-list
24717563|NCT01548677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24717564|NCT01548677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24717565|NCT01548703|BCI-838|bci-838|mesh-list
24717593|NCT01548859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24717595|NCT01548859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24717596|NCT01548859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24717660|NCT01549236|Benzonidazole|benzonidazole|mesh-list
24717661|NCT01549236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24717662|NCT01549236|Immunologic Factors|immunologic factors|mesh-ancestor
24717663|NCT01549236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717664|NCT01549236|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24717768|NCT01549743|Antioxidants|antioxidants|mesh-ancestor
24717769|NCT01549743|Protective Agents|protective agents|mesh-ancestor
24717770|NCT01549795|Capecitabine|capecitabine|mesh-list
24717771|NCT01549795|Liver Extracts|liver extracts|mesh-list
24717772|NCT01549795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24717773|NCT01549795|Antimetabolites|antimetabolites|mesh-ancestor
24717774|NCT01549795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717775|NCT01549795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24717776|NCT01549795|Hematinics|hematinics|mesh-ancestor
24717825|NCT01550146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24717826|NCT01550146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24717828|NCT01550146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25668369|NCT01716221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25862410|NCT00089726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862411|NCT00089726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24717829|NCT01550146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717859|NCT01550419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24717860|NCT01550419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24717915|NCT01550848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24717916|NCT01550848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24717917|NCT01550848|Antimetabolites|antimetabolites|mesh-ancestor
24717918|NCT01550848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717919|NCT01550848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24717920|NCT01550848|Antiviral Agents|antiviral agents|mesh-ancestor
24717965|NCT01551290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24717966|NCT01551290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24717968|NCT01551329|Analgesics|analgesics|mesh-ancestor
24717969|NCT01551329|Sensory System Agents|sensory system agents|mesh-ancestor
24717970|NCT01551329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24717971|NCT01551329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717972|NCT01551329|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24717973|NCT01551329|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24717974|NCT01551329|Anesthetics, General|anesthetics, general|mesh-ancestor
24717975|NCT01551329|Anesthetics|anesthetics|mesh-ancestor
24717992|NCT01551394|Cefotaxime|cefotaxime|mesh-list
24717993|NCT01551394|Cefoxitin|cefoxitin|mesh-list
24717994|NCT01551394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24717995|NCT01551394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24717996|NCT01551394|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24717997|NCT01551394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717998|NCT01551394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718000|NCT01551459|Dacarbazine|dacarbazine|mesh-list
24718001|NCT01551459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718002|NCT01551459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24718003|NCT01551459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24941684|NCT03988530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941685|NCT03988530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24941687|NCT03988530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24941688|NCT03988530|Cholinergic Agents|cholinergic agents|mesh-ancestor
24941689|NCT03988530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24941690|NCT03988530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941691|NCT03988530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24941692|NCT03988530|Parasympatholytics|parasympatholytics|mesh-ancestor
24615160|NCT01028248|Growth Inhibitors|growth inhibitors|mesh-ancestor
24615161|NCT01028248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24615163|NCT01028261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24615164|NCT01028261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24615166|NCT01028261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718089|NCT01551823|Vaccines|vaccines|mesh-list
24804235|NCT02001818|Interferons|interferons|mesh-list
24718137|NCT01552122|Antacids|antacids|mesh-ancestor
24718138|NCT01552122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050832|NCT00465803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050833|NCT00465803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25050834|NCT00465803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25050835|NCT00465517|Ganaxolone|ganaxolone|mesh-list
25050836|NCT00465517|Neurosteroids|neurosteroids|mesh-ancestor
25050837|NCT00465517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050838|NCT00465517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050839|NCT00465517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050840|NCT00465517|GABA Modulators|gaba modulators|mesh-ancestor
25050841|NCT00465517|GABA Agents|gaba agents|mesh-ancestor
24718145|NCT01552148|Analgesics|analgesics|mesh-ancestor
24718146|NCT01552148|Sensory System Agents|sensory system agents|mesh-ancestor
24718147|NCT01552148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24718213|NCT01552850|Sensory System Agents|sensory system agents|mesh-ancestor
24718214|NCT01552850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24718215|NCT01552863|Oxycodone|oxycodone|mesh-list
24718216|NCT01552863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24718217|NCT01552863|Narcotics|narcotics|mesh-ancestor
24718218|NCT01552863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24718219|NCT01552863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718220|NCT01552863|Analgesics|analgesics|mesh-ancestor
24718221|NCT01552863|Sensory System Agents|sensory system agents|mesh-ancestor
24718222|NCT01552863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25668370|NCT01716221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718223|NCT01552967|Capecitabine|capecitabine|mesh-list
24718224|NCT01552967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24718225|NCT01552967|Antimetabolites|antimetabolites|mesh-ancestor
24718226|NCT01552967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718227|NCT01552967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718228|NCT01552980|Oxaliplatin|oxaliplatin|mesh-list
24718298|NCT01553773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24718310|NCT01553903|Anastrozole|anastrozole|mesh-list
24718311|NCT01553903|Exemestane|exemestane|mesh-list
24718312|NCT01553903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718313|NCT01553903|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25050844|NCT00464633|Growth Inhibitors|growth inhibitors|mesh-ancestor
25050845|NCT00464633|Growth Substances|growth substances|mesh-ancestor
25050846|NCT00464633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050847|NCT00464633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25050848|NCT00464633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050849|NCT00464633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718314|NCT01553903|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24718315|NCT01553903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718316|NCT01553903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718317|NCT01553903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24718318|NCT01553903|Hormone Antagonists|hormone antagonists|mesh-ancestor
24718319|NCT01553903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25132085|NCT03021590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25132086|NCT03021590|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25132087|NCT03021590|Renal Agents|renal agents|mesh-ancestor
25132088|NCT03021590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25132089|NCT03021590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25132090|NCT03021590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718320|NCT01553903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718321|NCT01553903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24718322|NCT01553903|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24718323|NCT01553903|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24718324|NCT01553903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24718447|NCT01554930|Immunologic Factors|immunologic factors|mesh-ancestor
24804518|NCT02002858|Nicotine|nicotine|mesh-list
24718466|NCT01554995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718467|NCT01555008|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
24646041|NCT01201551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24718491|NCT01555112|Protective Agents|protective agents|mesh-ancestor
24718492|NCT01555112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24718493|NCT01555112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24718494|NCT01555112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718495|NCT01555112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804554|NCT02003209|Docetaxel|docetaxel|mesh-list
24718529|NCT01555398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24718530|NCT01555398|Antimetabolites|antimetabolites|mesh-ancestor
24718531|NCT01555398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718532|NCT01555398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25050867|NCT00464555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25050868|NCT00464555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25050869|NCT00464555|Analgesics|analgesics|mesh-ancestor
25050870|NCT00464555|Sensory System Agents|sensory system agents|mesh-ancestor
24466503|NCT00373659|Growth Substances|growth substances|mesh-ancestor
24718569|NCT01555658|Protease Inhibitors|protease inhibitors|mesh-ancestor
24718570|NCT01555658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718572|NCT01555710|Etoposide|etoposide|mesh-list
24718573|NCT01555710|Isophosphamide mustard|isophosphamide mustard|mesh-list
24718574|NCT01555710|Ifosfamide|ifosfamide|mesh-list
24718575|NCT01555710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718576|NCT01555710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24718577|NCT01555710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24718578|NCT01555710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24718579|NCT01555710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718580|NCT01555710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718581|NCT01555710|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24718621|NCT01555970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718622|NCT01555970|Protective Agents|protective agents|mesh-ancestor
24804592|NCT02003664|GABA Agonists|gaba agonists|mesh-ancestor
24718663|NCT01556334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24759387|NCT01751009|Vitamins|vitamins|mesh-list
24718664|NCT01556334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24718665|NCT01556334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718666|NCT01556334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718667|NCT01556477|Lenalidomide|lenalidomide|mesh-list
24718668|NCT01556477|Azacitidine|azacitidine|mesh-list
24718669|NCT01556477|Immunologic Factors|immunologic factors|mesh-ancestor
24718705|NCT01556698|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24718706|NCT01556698|Autonomic Agents|autonomic agents|mesh-ancestor
24718707|NCT01556698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24718708|NCT01556698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718709|NCT01556698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24718710|NCT01556698|Respiratory System Agents|respiratory system agents|mesh-ancestor
24718711|NCT01556698|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24718712|NCT01556698|Antioxidants|antioxidants|mesh-ancestor
25199740|NCT02739061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25199741|NCT02739061|Serotonin Agents|serotonin agents|mesh-ancestor
25199742|NCT02739061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199743|NCT02739061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25199744|NCT02739061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25199745|NCT02739061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25199746|NCT02739061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25132202|NCT03020329|Paclitaxel|paclitaxel|mesh-list
24718713|NCT01556698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718714|NCT01556698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24718715|NCT01556698|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24718716|NCT01556698|Vasodilator Agents|vasodilator agents|mesh-ancestor
24718717|NCT01556698|Gasotransmitters|gasotransmitters|mesh-ancestor
24804701|NCT02004574|Hormones|hormones|mesh-ancestor
24718761|NCT01557127|Sorafenib|sorafenib|mesh-list
24718762|NCT01557127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718763|NCT01557127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24718764|NCT01557127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718765|NCT01557127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718766|NCT01557140|Carvedilol|carvedilol|mesh-list
24718767|NCT01557140|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24718768|NCT01557140|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24718769|NCT01557140|Adrenergic Agents|adrenergic agents|mesh-ancestor
24718770|NCT01557140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24718771|NCT01557140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718773|NCT01557140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24718774|NCT01557140|Antioxidants|antioxidants|mesh-ancestor
24957741|NCT03842020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718890|NCT01557712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24718891|NCT01557764|Trastuzumab|trastuzumab|mesh-list
24718892|NCT01557764|Lapatinib|lapatinib|mesh-list
24718893|NCT01557764|Antibodies|antibodies|mesh-list
24957746|NCT03842020|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24957747|NCT03842020|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24957748|NCT03842020|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25050876|NCT00464243|Serotonin Agents|serotonin agents|mesh-ancestor
25050877|NCT00464243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24941725|NCT03988452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24941726|NCT03988452|Protease Inhibitors|protease inhibitors|mesh-ancestor
24941727|NCT03988452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718894|NCT01557764|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24718895|NCT01557764|Immunologic Factors|immunologic factors|mesh-ancestor
24718896|NCT01557764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718897|NCT01557764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24718898|NCT01557764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718899|NCT01557764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24718900|NCT01557764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718901|NCT01557764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718902|NCT01557816|Naproxen|naproxen|mesh-list
24718903|NCT01557816|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24718904|NCT01557816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24718924|NCT01557985|Anesthetics, Local|anesthetics, local|mesh-ancestor
24576065|NCT00836485|Antipruritics|antipruritics|mesh-ancestor
24719106|NCT01559272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24719107|NCT01559272|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25054269|NCT03530462|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24719108|NCT01559272|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25668371|NCT01716221|Dopamine Agents|dopamine agents|mesh-ancestor
24615259|NCT01028534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24615260|NCT01028534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24615261|NCT01028534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615262|NCT01028534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24719192|NCT01559753|Tobramycin|tobramycin|mesh-list
24719193|NCT01559753|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24719194|NCT01559753|Clavulanic Acids|clavulanic acids|mesh-list
24719195|NCT01559753|Clavulanic Acid|clavulanic acid|mesh-list
24719196|NCT01559753|Cefotaxime|cefotaxime|mesh-list
24719197|NCT01559753|Cefoxitin|cefoxitin|mesh-list
24719198|NCT01559753|Netilmicin|netilmicin|mesh-list
24719199|NCT01559753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24719200|NCT01559753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24719201|NCT01559753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24719202|NCT01559753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719203|NCT01559753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24719204|NCT01559974|Cholecalciferol|cholecalciferol|mesh-list
24719205|NCT01559974|Vitamin D|vitamin d|mesh-list
24719206|NCT01559974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24719207|NCT01559974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719208|NCT01559974|Vitamins|vitamins|mesh-ancestor
24719209|NCT01559974|Micronutrients|micronutrients|mesh-ancestor
24719210|NCT01559974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25199747|NCT02739061|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24719243|NCT01560065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719245|NCT01560091|Silodosin|silodosin|mesh-list
24719246|NCT01560091|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24719247|NCT01560091|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24719248|NCT01560091|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24719309|NCT01560546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24719310|NCT01560546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719311|NCT01560663|Carboplatin|carboplatin|mesh-list
24719312|NCT01560663|Docetaxel|docetaxel|mesh-list
24719313|NCT01560663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719314|NCT01560663|Tubulin Modulators|tubulin modulators|mesh-ancestor
24719359|NCT01560754|Cholinergic Agents|cholinergic agents|mesh-ancestor
24719360|NCT01560754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24719361|NCT01560754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719362|NCT01560962|Azithromycin|azithromycin|mesh-list
24719364|NCT01560962|Povidone-Iodine|povidone-iodine|mesh-list
24719365|NCT01560962|Povidone|povidone|mesh-list
24719366|NCT01560962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24719367|NCT01560962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24719368|NCT01560962|Plasma Substitutes|plasma substitutes|mesh-ancestor
24719369|NCT01560962|Blood Substitutes|blood substitutes|mesh-ancestor
24866051|NCT03789591|Antisickling Agents|antisickling agents|mesh-ancestor
24719370|NCT01560962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24719371|NCT01561014|Fluorouracil|fluorouracil|mesh-list
24719372|NCT01561014|Oxaliplatin|oxaliplatin|mesh-list
24719373|NCT01561014|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24719374|NCT01561014|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24719405|NCT01561092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719406|NCT01561092|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24719407|NCT01561092|Antidepressive Agents|antidepressive agents|mesh-ancestor
24719408|NCT01561092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24719409|NCT01561131|Calcium|calcium|mesh-list
24719414|NCT01561209|Antidepressive Agents|antidepressive agents|mesh-ancestor
24719415|NCT01561209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24719416|NCT01561209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24719417|NCT01561209|Analgesics|analgesics|mesh-ancestor
24719418|NCT01561209|Sensory System Agents|sensory system agents|mesh-ancestor
24719419|NCT01561209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24941740|NCT03988101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24719433|NCT01561222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24719434|NCT01561222|Vitamins|vitamins|mesh-ancestor
24719435|NCT01561222|Micronutrients|micronutrients|mesh-ancestor
24719436|NCT01561222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24719437|NCT01561235|Hormones|hormones|mesh-list
24719438|NCT01561235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24719439|NCT01561235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719440|NCT01561274|Bupivacaine|bupivacaine|mesh-list
24719441|NCT01561274|Anesthetics, Local|anesthetics, local|mesh-ancestor
24719456|NCT01561456|Tubulin Modulators|tubulin modulators|mesh-ancestor
24719457|NCT01561456|Antimitotic Agents|antimitotic agents|mesh-ancestor
24719458|NCT01561456|Mitosis Modulators|mitosis modulators|mesh-ancestor
25862414|NCT00089765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25862415|NCT00089765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25862416|NCT00089765|Growth Substances|growth substances|mesh-ancestor
25862417|NCT00089765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862418|NCT00089765|Growth Inhibitors|growth inhibitors|mesh-ancestor
24719459|NCT01561456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719460|NCT01561482|Metformin|metformin|mesh-list
24719461|NCT01561482|Simvastatin|simvastatin|mesh-list
24719462|NCT01561482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24719535|NCT01562301|Antimitotic Agents|antimitotic agents|mesh-ancestor
24719536|NCT01562301|Mitosis Modulators|mitosis modulators|mesh-ancestor
24719537|NCT01562301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719538|NCT01562405|Dexamethasone|dexamethasone|mesh-list
24719539|NCT01562405|Lenalidomide|lenalidomide|mesh-list
24719540|NCT01562405|Pomalidomide|pomalidomide|mesh-list
24719541|NCT01562405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24719542|NCT01562405|Antiemetics|antiemetics|mesh-ancestor
24719543|NCT01562405|Autonomic Agents|autonomic agents|mesh-ancestor
24719544|NCT01562405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24719549|NCT01562405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24719550|NCT01562405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24719551|NCT01562405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719552|NCT01562405|Immunologic Factors|immunologic factors|mesh-ancestor
24719553|NCT01562405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24719554|NCT01562405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24719555|NCT01562405|Growth Substances|growth substances|mesh-ancestor
24719633|NCT01562951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24719634|NCT01562951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24719636|NCT01562977|Rituximab|rituximab|mesh-list
24719637|NCT01562977|Oxaliplatin|oxaliplatin|mesh-list
24719638|NCT01562977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24941758|NCT03988010|Analgesics|analgesics|mesh-ancestor
24719692|NCT01563289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24719693|NCT01563289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24719694|NCT01563289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719695|NCT01563328|Dolutegravir|dolutegravir|mesh-list
24719696|NCT01563328|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24719697|NCT01563328|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24719698|NCT01563328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24719699|NCT01563328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719717|NCT01563614|Lomustine|lomustine|mesh-list
24719718|NCT01563614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24719719|NCT01563614|Antimetabolites|antimetabolites|mesh-ancestor
24719720|NCT01563614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719721|NCT01563614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719722|NCT01563614|Antiviral Agents|antiviral agents|mesh-ancestor
24719723|NCT01563614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24719724|NCT01563614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24719725|NCT01563614|Immunologic Factors|immunologic factors|mesh-ancestor
24719726|NCT01563614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719727|NCT01563614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24719728|NCT01563614|Alkylating Agents|alkylating agents|mesh-ancestor
24719729|NCT01563640|Permethrin|permethrin|mesh-list
24719730|NCT01563640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24719733|NCT01563718|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24719734|NCT01563718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24719785|NCT01564095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24719786|NCT01564095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719787|NCT01564095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24719788|NCT01564095|Antidepressive Agents|antidepressive agents|mesh-ancestor
24719789|NCT01564095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24719791|NCT01564108|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24719792|NCT01564108|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24719793|NCT01564108|Growth Substances|growth substances|mesh-ancestor
24719794|NCT01564108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719797|NCT01564199|Fluticasone|fluticasone|mesh-list
24719811|NCT01564199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24719812|NCT01564199|Adrenergic Agents|adrenergic agents|mesh-ancestor
25668372|NCT01716221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25668373|NCT01716221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668374|NCT01716221|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25668375|NCT01716221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25668376|NCT01716221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25862420|NCT00089804|Abetimus|abetimus|mesh-list
24548374|NCT00709254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24548375|NCT00709254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24548376|NCT00709254|Anesthetics, General|anesthetics, general|mesh-ancestor
24548377|NCT00709254|Anesthetics|anesthetics|mesh-ancestor
25862421|NCT00089804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25862422|NCT00089804|Immunologic Factors|immunologic factors|mesh-ancestor
25862423|NCT00089804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862424|NCT00089830|Squalamine|squalamine|mesh-list
25862425|NCT00089830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25862426|NCT00089830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24719813|NCT01564199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24719814|NCT01564199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719854|NCT01564329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719855|NCT01564355|Triamcinolone|triamcinolone|mesh-list
24719856|NCT01564355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24719857|NCT01564355|Glucocorticoids|glucocorticoids|mesh-ancestor
24719858|NCT01564355|Hormones|hormones|mesh-ancestor
24719859|NCT01564355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24719860|NCT01564355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719861|NCT01564381|Resveratrol|resveratrol|mesh-list
24719862|NCT01564381|Antioxidants|antioxidants|mesh-ancestor
24719863|NCT01564381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719864|NCT01564381|Protective Agents|protective agents|mesh-ancestor
24719865|NCT01564381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941770|NCT03987867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941771|NCT03987867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467118|NCT00376324|Tigecycline|tigecycline|mesh-list
24719905|NCT01564823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24719906|NCT01564823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719907|NCT01564823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24719908|NCT01564823|Immunologic Factors|immunologic factors|mesh-ancestor
24719909|NCT01564823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719910|NCT01564836|Imatinib Mesylate|imatinib mesylate|mesh-list
24719911|NCT01564836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24957824|NCT03841474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24957825|NCT03841136|Etoposide|etoposide|mesh-list
25862427|NCT00089830|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25862428|NCT00089830|Protective Agents|protective agents|mesh-ancestor
25862429|NCT00089830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862430|NCT00089830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862431|NCT00089830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25862432|NCT00089830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25132439|NCT03018626|Hormones|hormones|mesh-ancestor
24957826|NCT03841136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24957827|NCT03841136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24615297|NCT01028729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24615298|NCT01028729|Antimetabolites|antimetabolites|mesh-ancestor
24615299|NCT01028729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615300|NCT01028729|Antiviral Agents|antiviral agents|mesh-ancestor
24615301|NCT01028729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24615302|NCT01028729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615303|NCT01028729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24615304|NCT01028729|Immunologic Factors|immunologic factors|mesh-ancestor
24615305|NCT01028729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615306|NCT01028729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24615307|NCT01028729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24615308|NCT01028729|Growth Substances|growth substances|mesh-ancestor
24615309|NCT01028729|Growth Inhibitors|growth inhibitors|mesh-ancestor
24615310|NCT01028768|Teduglutide|teduglutide|mesh-list
24719945|NCT01565109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719947|NCT01565109|Antimitotic Agents|antimitotic agents|mesh-ancestor
24719948|NCT01565109|Mitosis Modulators|mitosis modulators|mesh-ancestor
24719949|NCT01565109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25429183|NCT01572506|Micronutrients|micronutrients|mesh-ancestor
25668377|NCT01716221|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25668378|NCT01716221|Serotonin Agents|serotonin agents|mesh-ancestor
25668379|NCT01716221|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25668380|NCT01716221|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25668381|NCT01716221|Parasympatholytics|parasympatholytics|mesh-ancestor
25668382|NCT01716221|Autonomic Agents|autonomic agents|mesh-ancestor
25668383|NCT01716221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25668384|NCT01716221|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25862433|NCT00089830|Growth Substances|growth substances|mesh-ancestor
25862434|NCT00089830|Growth Inhibitors|growth inhibitors|mesh-ancestor
25862435|NCT00089856|Prednisone|prednisone|mesh-list
25199748|NCT02739061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25199749|NCT02739061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25054326|NCT03530280|Pregabalin|pregabalin|mesh-list
25199750|NCT02739061|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25199751|NCT02738970|Trastuzumab|trastuzumab|mesh-list
25199752|NCT02738970|Pertuzumab|pertuzumab|mesh-list
25199753|NCT02738970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25199754|NCT02738970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199755|NCT02738918|Abatacept|abatacept|mesh-list
25199756|NCT02738918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25199757|NCT02738918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199758|NCT02738918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199759|NCT02738918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25199760|NCT02738918|Immunologic Factors|immunologic factors|mesh-ancestor
25199761|NCT02738918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199762|NCT02738918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25199763|NCT02738931|Lamivudine|lamivudine|mesh-list
25199764|NCT02738931|Dolutegravir|dolutegravir|mesh-list
25199765|NCT02738931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25199766|NCT02738931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25199767|NCT02738931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199768|NCT02738931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199769|NCT02738931|Antiviral Agents|antiviral agents|mesh-ancestor
25199770|NCT02738931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25199771|NCT02738931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25199772|NCT02738931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24719952|NCT01565200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24957828|NCT03841136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24957829|NCT03841136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24957830|NCT03841136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24719953|NCT01565200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719954|NCT01565200|Tubulin Modulators|tubulin modulators|mesh-ancestor
24719955|NCT01565200|Antimitotic Agents|antimitotic agents|mesh-ancestor
24719956|NCT01565200|Mitosis Modulators|mitosis modulators|mesh-ancestor
24467311|NCT00377052|Bortezomib|bortezomib|mesh-list
24720006|NCT01565720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720007|NCT01565720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720008|NCT01565720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720009|NCT01565720|Antifungal Agents|antifungal agents|mesh-ancestor
24720023|NCT01565759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24720024|NCT01565759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24720025|NCT01565759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720026|NCT01565772|Etoposide|etoposide|mesh-list
24720027|NCT01565772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720028|NCT01565772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24720029|NCT01565772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24720030|NCT01565772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24720031|NCT01565772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720032|NCT01565772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720061|NCT01566253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720062|NCT01566253|Analgesics|analgesics|mesh-ancestor
24720087|NCT01566292|Cholinergic Agents|cholinergic agents|mesh-ancestor
24720088|NCT01566292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24720089|NCT01566292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720090|NCT01566292|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24720091|NCT01566292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25862436|NCT00089856|Docetaxel|docetaxel|mesh-list
24805121|NCT02007798|Analgesics|analgesics|mesh-ancestor
24720119|NCT01566565|Bambuterol|bambuterol|mesh-list
24720120|NCT01566565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24720121|NCT01566565|Autonomic Agents|autonomic agents|mesh-ancestor
24720122|NCT01566565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24720123|NCT01566565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720124|NCT01566565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24720125|NCT01566565|Respiratory System Agents|respiratory system agents|mesh-ancestor
24720126|NCT01566565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24720127|NCT01566565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720129|NCT01566565|Vasodilator Agents|vasodilator agents|mesh-ancestor
24720133|NCT01566565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24720134|NCT01566578|Mitogens|mitogens|mesh-list
24720135|NCT01566578|Mitosis Modulators|mitosis modulators|mesh-ancestor
25668385|NCT01716221|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25668386|NCT01716221|Cholinergic Agents|cholinergic agents|mesh-ancestor
25218311|NCT02670954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25218313|NCT02670954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25218314|NCT02670954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25862437|NCT00089856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25862438|NCT00089856|Glucocorticoids|glucocorticoids|mesh-ancestor
25862439|NCT00089856|Hormones|hormones|mesh-ancestor
25862440|NCT00089856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24720136|NCT01566578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720137|NCT01566643|Metronidazole|metronidazole|mesh-list
24720142|NCT01566643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24720143|NCT01566643|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24720144|NCT01566643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24720145|NCT01566643|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24720146|NCT01566643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720147|NCT01566643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720148|NCT01566656|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24957837|NCT03840122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24957838|NCT03839888|Atropine|atropine|mesh-list
24957839|NCT03839888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24720149|NCT01566656|Immunologic Factors|immunologic factors|mesh-ancestor
24720150|NCT01566656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720210|NCT01567072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24720212|NCT01567072|Analgesics|analgesics|mesh-ancestor
24720218|NCT01567072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24720219|NCT01567072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720220|NCT01567072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720222|NCT01567111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24720223|NCT01567111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24720224|NCT01567111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720225|NCT01567124|Moxonidine|moxonidine|mesh-list
24720226|NCT01567124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24720227|NCT01567215|Ethanol|ethanol|mesh-list
24720228|NCT01567215|Silver Nitrate|silver nitrate|mesh-list
24720229|NCT01567215|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24720230|NCT01567215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24720231|NCT01567215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24720232|NCT01567215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720233|NCT01567358|Infliximab|infliximab|mesh-list
24720271|NCT01567501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720272|NCT01567501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720274|NCT01567540|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24720275|NCT01567540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24720340|NCT01567683|Interferon Inducers|interferon inducers|mesh-ancestor
24720341|NCT01567709|Vorinostat|vorinostat|mesh-list
24720342|NCT01567709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720343|NCT01567709|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24720344|NCT01567709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720345|NCT01567709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720346|NCT01567735|Simeprevir|simeprevir|mesh-list
24720347|NCT01567735|Antiviral Agents|antiviral agents|mesh-ancestor
24866151|NCT03356483|Nicotinic Acids|nicotinic acids|mesh-list
24866152|NCT03356483|Psilocybin|psilocybin|mesh-list
24866153|NCT03356483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24866154|NCT03356483|Antimetabolites|antimetabolites|mesh-ancestor
24720348|NCT01567735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24720370|NCT01567930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24720371|NCT01567930|Immunologic Factors|immunologic factors|mesh-ancestor
24720372|NCT01567930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720373|NCT01567995|Clobetasone butyrate|clobetasone butyrate|mesh-list
24720374|NCT01567995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24720375|NCT01567995|Glucocorticoids|glucocorticoids|mesh-ancestor
24720377|NCT01567995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24720416|NCT01568294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720417|NCT01568307|Antidepressive Agents|antidepressive agents|mesh-list
25668387|NCT01716234|Posaconazole|posaconazole|mesh-list
25668388|NCT01716234|Antifungal Agents|antifungal agents|mesh-ancestor
25668389|NCT01716234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25668390|NCT01716234|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25668391|NCT01716234|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25668392|NCT01716234|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25668393|NCT01716234|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25668394|NCT01716234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25668395|NCT01716234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548456|NCT00709553|GABA Agents|gaba agents|mesh-ancestor
24759428|NCT01751321|Incretins|incretins|mesh-ancestor
24759482|NCT01751854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24759483|NCT01751854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24759484|NCT01751854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759485|NCT01751854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24759486|NCT01751854|Serotonin Agents|serotonin agents|mesh-ancestor
24759487|NCT01751854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759488|NCT01751854|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24720418|NCT01568307|Serotonin|serotonin|mesh-list
24720419|NCT01568307|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
24720421|NCT01568307|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24720422|NCT01568307|Serotonin Agents|serotonin agents|mesh-ancestor
24507636|NCT00551239|Rituximab|rituximab|mesh-list
24720423|NCT01568307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24720424|NCT01568307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720447|NCT01568450|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25050879|NCT00464243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720449|NCT01568450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24720457|NCT01568632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720458|NCT01568632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24720461|NCT01568645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720462|NCT01568645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24720463|NCT01568645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720464|NCT01568645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720465|NCT01568645|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24720466|NCT01568645|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24720467|NCT01568645|Adrenergic Agents|adrenergic agents|mesh-ancestor
24720468|NCT01568645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24720469|NCT01568645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720470|NCT01568645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24720471|NCT01568645|Antioxidants|antioxidants|mesh-ancestor
24720472|NCT01568645|Protective Agents|protective agents|mesh-ancestor
24720473|NCT01568645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24720474|NCT01568645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24720514|NCT01568996|Sulforaphane|sulforaphane|mesh-list
24720515|NCT01568996|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24720525|NCT01569048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24720526|NCT01569048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720527|NCT01569048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24720528|NCT01569048|Anesthetics, General|anesthetics, general|mesh-ancestor
24720577|NCT01569204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199773|NCT02738931|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25132628|NCT03017768|Tryptophan|tryptophan|mesh-list
24720578|NCT01569204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24720579|NCT01569204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24720580|NCT01569204|Alkylating Agents|alkylating agents|mesh-ancestor
24720581|NCT01569204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720582|NCT01569204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720583|NCT01569204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24720584|NCT01569204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24720585|NCT01569204|Antiemetics|antiemetics|mesh-ancestor
24720586|NCT01569204|Autonomic Agents|autonomic agents|mesh-ancestor
24720587|NCT01569204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24720616|NCT01569633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720617|NCT01569659|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
24720618|NCT01569659|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24720619|NCT01569659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24720620|NCT01569659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24720621|NCT01569659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668396|NCT01716234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668397|NCT01716234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25668398|NCT01716234|Hormone Antagonists|hormone antagonists|mesh-ancestor
25668399|NCT01716234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25668400|NCT01716234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668401|NCT01716585|Ribavirin|ribavirin|mesh-list
25668402|NCT01716585|Antimetabolites|antimetabolites|mesh-ancestor
25668403|NCT01716585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668404|NCT01716585|Antiviral Agents|antiviral agents|mesh-ancestor
24759491|NCT01751919|Imatinib Mesylate|imatinib mesylate|mesh-list
24759492|NCT01751919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759543|NCT01752322|Lidocaine|lidocaine|mesh-list
24759544|NCT01752322|Anesthetics, Local|anesthetics, local|mesh-ancestor
24759545|NCT01752322|Anesthetics|anesthetics|mesh-ancestor
24720622|NCT01569659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24720623|NCT01569659|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24720624|NCT01569659|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24720625|NCT01569659|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25050889|NCT00463242|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25050890|NCT00463242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25050891|NCT00463242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720626|NCT01569659|Adrenergic Agents|adrenergic agents|mesh-ancestor
24720627|NCT01569659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24720628|NCT01569659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720629|NCT01569659|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24720630|NCT01569659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24720631|NCT01569659|Serotonin Agents|serotonin agents|mesh-ancestor
24720634|NCT01569659|Dopamine Agents|dopamine agents|mesh-ancestor
24720655|NCT01569919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467786|NCT00378716|Immunologic Factors|immunologic factors|mesh-ancestor
24720758|NCT01570569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24720759|NCT01570569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24720760|NCT01570569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24720761|NCT01570569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24720762|NCT01570569|Purinergic Agents|purinergic agents|mesh-ancestor
24720763|NCT01570569|Antitussive Agents|antitussive agents|mesh-ancestor
24720764|NCT01570569|Respiratory System Agents|respiratory system agents|mesh-ancestor
24720765|NCT01570569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24720777|NCT01570582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24720780|NCT01570582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24720781|NCT01570582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720817|NCT01570894|Antidepressive Agents|antidepressive agents|mesh-ancestor
24720818|NCT01570894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24720819|NCT01570894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24720820|NCT01570894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24720821|NCT01570894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24720878|NCT01571050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24720880|NCT01571063|Cholecalciferol|cholecalciferol|mesh-list
24720881|NCT01571063|Vitamins|vitamins|mesh-ancestor
24720882|NCT01571063|Micronutrients|micronutrients|mesh-ancestor
24720883|NCT01571063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720884|NCT01571063|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24615443|NCT01029769|Olanzapine|olanzapine|mesh-list
24615444|NCT01029769|Amisulpride|amisulpride|mesh-list
24615445|NCT01029769|Antiemetics|antiemetics|mesh-ancestor
24615446|NCT01029769|Autonomic Agents|autonomic agents|mesh-ancestor
24615447|NCT01029769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24615448|NCT01029769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866169|NCT03289650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615449|NCT01029769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24615450|NCT01029769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24615451|NCT01029769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24615453|NCT01029769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24615457|NCT01029769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615459|NCT01029769|Serotonin Agents|serotonin agents|mesh-ancestor
24615460|NCT01029769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24615461|NCT01029769|Dopamine Agents|dopamine agents|mesh-ancestor
24615462|NCT01029769|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25199774|NCT02738931|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24615493|NCT01030042|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24720919|NCT01571414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24615494|NCT01030042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24720920|NCT01571414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24720921|NCT01571414|Antiviral Agents|antiviral agents|mesh-ancestor
24720944|NCT01571570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720945|NCT01571583|Interferons|interferons|mesh-list
24720946|NCT01571583|Ribavirin|ribavirin|mesh-list
24720947|NCT01571583|Interferon-alpha|interferon-alpha|mesh-list
24720948|NCT01571583|Interferon alpha-2|interferon alpha-2|mesh-list
25668405|NCT01716585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25668406|NCT01716715|Paclitaxel|paclitaxel|mesh-list
25668407|NCT01716715|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25668408|NCT01716715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25668409|NCT01716715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720949|NCT01571583|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24720950|NCT01571583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720951|NCT01571583|Antiviral Agents|antiviral agents|mesh-ancestor
24720952|NCT01571583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24720953|NCT01571583|Antimetabolites|antimetabolites|mesh-ancestor
24720954|NCT01571583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720955|NCT01571583|Immunologic Factors|immunologic factors|mesh-ancestor
24720956|NCT01571583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720957|NCT01571609|Insulin|insulin|mesh-list
24720958|NCT01571609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24720959|NCT01571609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720960|NCT01571648|Azacitidine|azacitidine|mesh-list
24720961|NCT01571648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24720962|NCT01571648|Antimetabolites|antimetabolites|mesh-ancestor
24720997|NCT01571804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24720998|NCT01571804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720999|NCT01571804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24721000|NCT01571804|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24721001|NCT01571804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24721002|NCT01571804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24721003|NCT01571804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24721005|NCT01571856|Astringents|astringents|mesh-ancestor
24721006|NCT01571856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721007|NCT01571856|Dermatologic Agents|dermatologic agents|mesh-ancestor
24721029|NCT01571921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721030|NCT01571921|Vitamins|vitamins|mesh-ancestor
24721031|NCT01571921|Micronutrients|micronutrients|mesh-ancestor
24721032|NCT01571960|Vaccines|vaccines|mesh-list
24721100|NCT01572129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721102|NCT01572181|Busulfan|busulfan|mesh-list
24721103|NCT01572181|Thymoglobulin|thymoglobulin|mesh-list
24721109|NCT01572181|Alkylating Agents|alkylating agents|mesh-ancestor
24721168|NCT01572363|Sildenafil Citrate|sildenafil citrate|mesh-list
24721169|NCT01572363|Vasodilator Agents|vasodilator agents|mesh-ancestor
24721170|NCT01572363|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24721171|NCT01572363|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24721302|NCT01573286|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24721303|NCT01573286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24721305|NCT01573286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24721306|NCT01573286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721307|NCT01573286|Incretins|incretins|mesh-ancestor
24721308|NCT01573338|Carboplatin|carboplatin|mesh-list
24721309|NCT01573338|Etoposide|etoposide|mesh-list
24721359|NCT01573637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24721386|NCT01573741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24721387|NCT01573741|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24721388|NCT01573741|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24721460|NCT01574313|Antioxidants|antioxidants|mesh-ancestor
24721461|NCT01574313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721462|NCT01574313|Protective Agents|protective agents|mesh-ancestor
24721466|NCT01574313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24721467|NCT01574313|Antimetabolites|antimetabolites|mesh-ancestor
24721468|NCT01574313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24721469|NCT01574313|Vasodilator Agents|vasodilator agents|mesh-ancestor
24721470|NCT01574313|Vitamin B Complex|vitamin b complex|mesh-ancestor
24721471|NCT01574313|Antiemetics|antiemetics|mesh-ancestor
24721502|NCT01575158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24721506|NCT01575236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24721507|NCT01575236|Disinfectants|disinfectants|mesh-ancestor
24721508|NCT01575301|Liraglutide|liraglutide|mesh-list
24721510|NCT01575301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24721511|NCT01575301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941852|NCT03986762|Clavulanic Acids|clavulanic acids|mesh-list
24941853|NCT03986762|Clavulanic Acid|clavulanic acid|mesh-list
24855128|NCT02277600|Protease Inhibitors|protease inhibitors|mesh-ancestor
24721512|NCT01575301|Incretins|incretins|mesh-ancestor
24721567|NCT01575639|Prednisolone|prednisolone|mesh-list
24721568|NCT01575639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24721569|NCT01575639|Glucocorticoids|glucocorticoids|mesh-ancestor
24721571|NCT01575639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24721572|NCT01575639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721573|NCT01575639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24721575|NCT01575652|Lisinopril|lisinopril|mesh-list
24721583|NCT01575652|Protective Agents|protective agents|mesh-ancestor
25668410|NCT01716715|Tubulin Modulators|tubulin modulators|mesh-ancestor
25862441|NCT00089856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974114|NCT05174637|Immunoconjugates|immunoconjugates|mesh-list
24974115|NCT05174637|Immunologic Factors|immunologic factors|mesh-ancestor
24974116|NCT05174637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548646|NCT00711165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25862442|NCT00089856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24974117|NCT05173441|Immunoglobulins|immunoglobulins|mesh-list
24721644|NCT01576029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469288|NCT00385385|KRM 1648|krm 1648|mesh-list
24721724|NCT01576640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721725|NCT01576640|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24721726|NCT01576640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24721727|NCT01576640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24721728|NCT01576679|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24721729|NCT01576679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24721766|NCT01576770|Anesthetics|anesthetics|mesh-ancestor
24721767|NCT01576770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24721768|NCT01576770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941895|NCT03986294|Leucovorin|leucovorin|mesh-list
24941896|NCT03986294|Antidotes|antidotes|mesh-ancestor
24941897|NCT03986294|Protective Agents|protective agents|mesh-ancestor
24941898|NCT03986294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941899|NCT03986294|Vitamin B Complex|vitamin b complex|mesh-ancestor
24941900|NCT03986294|Vitamins|vitamins|mesh-ancestor
24941901|NCT03986294|Micronutrients|micronutrients|mesh-ancestor
24941902|NCT03986073|Linagliptin|linagliptin|mesh-list
24941903|NCT03986073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24941904|NCT03986073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941905|NCT03986073|Incretins|incretins|mesh-ancestor
24941906|NCT03986073|Hormones|hormones|mesh-ancestor
24615520|NCT01030094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615521|NCT01030094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615522|NCT01030094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615523|NCT01030094|GABA Agents|gaba agents|mesh-ancestor
24615524|NCT01030094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24615525|NCT01030094|Antimanic Agents|antimanic agents|mesh-ancestor
24721798|NCT01577095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721898|NCT01577862|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24721900|NCT01577914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24721901|NCT01577914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24721902|NCT01577914|Adrenergic Agents|adrenergic agents|mesh-ancestor
24721903|NCT01577914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24721904|NCT01577914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941909|NCT03986073|Protease Inhibitors|protease inhibitors|mesh-ancestor
24941910|NCT03986073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24721943|NCT01578109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721945|NCT01578161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24721949|NCT01578161|Analgesics|analgesics|mesh-ancestor
24721958|NCT01578174|Dexmedetomidine|dexmedetomidine|mesh-list
24721959|NCT01578174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24721960|NCT01578174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24721998|NCT01578252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24721999|NCT01578252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24722000|NCT01578252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24722008|NCT01578265|Dermatologic Agents|dermatologic agents|mesh-ancestor
24722009|NCT01578265|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24722010|NCT01578265|Serotonin Agents|serotonin agents|mesh-ancestor
24722011|NCT01578265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24722012|NCT01578265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722061|NCT01578434|Ergocalciferols|ergocalciferols|mesh-list
24722062|NCT01578434|Cholecalciferol|cholecalciferol|mesh-list
24470031|NCT00388635|Prednisone|prednisone|mesh-list
24722151|NCT01578668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24615623|NCT01030770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24615625|NCT01030796|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24615626|NCT01030796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016804|NCT04356495|Hormones|hormones|mesh-ancestor
25668411|NCT01716715|Antimitotic Agents|antimitotic agents|mesh-ancestor
25668412|NCT01716715|Mitosis Modulators|mitosis modulators|mesh-ancestor
25668413|NCT01716715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668414|NCT01716754|Omalizumab|omalizumab|mesh-list
25668415|NCT01716754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25668416|NCT01716754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25668417|NCT01716754|Respiratory System Agents|respiratory system agents|mesh-ancestor
24974257|NCT05035277|Analgesics|analgesics|mesh-ancestor
24974258|NCT05035277|Sensory System Agents|sensory system agents|mesh-ancestor
24974259|NCT05035277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24974260|NCT05035277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974261|NCT05035277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24974262|NCT05035277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24974263|NCT05035277|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24974264|NCT05035277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24974265|NCT05035277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24974266|NCT05035277|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24974267|NCT05035277|Antipyretics|antipyretics|mesh-ancestor
24974283|NCT05003037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615627|NCT01030796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24615628|NCT01030796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615629|NCT01030796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722186|NCT01579019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722187|NCT01579019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722188|NCT01579019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25862443|NCT00089856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862444|NCT00089856|Tubulin Modulators|tubulin modulators|mesh-ancestor
25862445|NCT00089856|Antimitotic Agents|antimitotic agents|mesh-ancestor
24470322|NCT00389701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24722342|NCT01579760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25862446|NCT00089856|Mitosis Modulators|mitosis modulators|mesh-ancestor
24722358|NCT01579838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722413|NCT01580163|Antitussive Agents|antitussive agents|mesh-ancestor
24722414|NCT01580163|Respiratory System Agents|respiratory system agents|mesh-ancestor
24722415|NCT01580202|Lamivudine|lamivudine|mesh-list
24722416|NCT01580202|Entecavir|entecavir|mesh-list
24722421|NCT01580202|Antiviral Agents|antiviral agents|mesh-ancestor
24722422|NCT01580202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24722423|NCT01580202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24722424|NCT01580202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24941939|NCT03985982|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24941940|NCT03985982|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24941941|NCT03985982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24855188|NCT02277847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722475|NCT01580865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24722550|NCT01581359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24722551|NCT01581359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24722553|NCT01581398|Interferon-alpha|interferon-alpha|mesh-list
24722554|NCT01581398|Antiviral Agents|antiviral agents|mesh-ancestor
24690226|NCT01400464|Glucocorticoids|glucocorticoids|mesh-ancestor
24722555|NCT01581398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24722556|NCT01581398|Immunologic Factors|immunologic factors|mesh-ancestor
25862447|NCT00089856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862448|NCT00089869|Olanzapine|olanzapine|mesh-list
25862449|NCT00089869|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25862450|NCT00089869|Antiemetics|antiemetics|mesh-ancestor
25862451|NCT00089869|Autonomic Agents|autonomic agents|mesh-ancestor
25862452|NCT00089869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25862453|NCT00089869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862454|NCT00089869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25862455|NCT00089869|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24722557|NCT01581398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722586|NCT01581515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24722587|NCT01581515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24722588|NCT01581515|Immunologic Factors|immunologic factors|mesh-ancestor
24722589|NCT01581515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668418|NCT01717040|Pioglitazone|pioglitazone|mesh-list
25668419|NCT01717040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25668420|NCT01717040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668421|NCT01717053|Prednisone|prednisone|mesh-list
25668422|NCT01717053|Abiraterone Acetate|abiraterone acetate|mesh-list
25668423|NCT01717053|Androgens|androgens|mesh-list
25668424|NCT01717053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25668425|NCT01717053|Glucocorticoids|glucocorticoids|mesh-ancestor
25668426|NCT01717053|Hormones|hormones|mesh-ancestor
25668427|NCT01717053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25668428|NCT01717053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668429|NCT01717053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25668430|NCT01717053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25668431|NCT01717053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24974333|NCT04944368|Myeloma Proteins|myeloma proteins|mesh-list
24974335|NCT04944368|Immunologic Factors|immunologic factors|mesh-ancestor
24974336|NCT04944368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461373|NCT00352170|Vitamin D|vitamin d|mesh-list
24461513|NCT00352495|Antimitotic Agents|antimitotic agents|mesh-ancestor
24461514|NCT00352495|Mitosis Modulators|mitosis modulators|mesh-ancestor
24974337|NCT04911361|Dexamethasone|dexamethasone|mesh-list
24974338|NCT04911361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24974339|NCT04911361|Antiemetics|antiemetics|mesh-ancestor
25862456|NCT00089869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24722669|NCT01581918|Antimanic Agents|antimanic agents|mesh-ancestor
24866256|NCT02286154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24866257|NCT02269917|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
24722670|NCT01581918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24722671|NCT01581918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24722672|NCT01581918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722673|NCT01581918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24722674|NCT01581918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24722675|NCT01581918|Analgesics|analgesics|mesh-ancestor
24722712|NCT01582230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722766|NCT01582555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24722767|NCT01582555|Expectorants|expectorants|mesh-ancestor
24722768|NCT01582555|Respiratory System Agents|respiratory system agents|mesh-ancestor
24615720|NCT01031368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615721|NCT01031459|Interferons|interferons|mesh-list
24615722|NCT01031459|Interferon-beta|interferon-beta|mesh-list
24615723|NCT01031459|Interferon beta-1b|interferon beta-1b|mesh-list
24615724|NCT01031459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24615725|NCT01031459|Antiviral Agents|antiviral agents|mesh-ancestor
24615726|NCT01031459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24615727|NCT01031459|Immunologic Factors|immunologic factors|mesh-ancestor
24615728|NCT01031459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615729|NCT01031459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24615730|NCT01031524|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
24615731|NCT01031524|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24615732|NCT01031524|Immunologic Factors|immunologic factors|mesh-ancestor
24615733|NCT01031524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615734|NCT01031589|Rilpivirine|rilpivirine|mesh-list
24722875|NCT01583062|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24722877|NCT01583114|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24722878|NCT01583114|Protease Inhibitors|protease inhibitors|mesh-ancestor
24722879|NCT01583114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722943|NCT01583621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24722944|NCT01583621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722945|NCT01583621|Vitamins|vitamins|mesh-ancestor
24722946|NCT01583621|Micronutrients|micronutrients|mesh-ancestor
24722947|NCT01583621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24722948|NCT01583660|Acetaminophen|acetaminophen|mesh-list
24722949|NCT01583660|Celecoxib|celecoxib|mesh-list
24722950|NCT01583660|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
24722951|NCT01583660|Oxycodone|oxycodone|mesh-list
24722952|NCT01583660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24722960|NCT01583660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24723066|NCT01584687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24723067|NCT01584687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24723068|NCT01584687|Respiratory System Agents|respiratory system agents|mesh-ancestor
24723069|NCT01584726|Magnesium Sulfate|magnesium sulfate|mesh-list
24723070|NCT01584726|Analgesics|analgesics|mesh-ancestor
24723071|NCT01584726|Sensory System Agents|sensory system agents|mesh-ancestor
24723072|NCT01584726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24723073|NCT01584726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723074|NCT01584726|Anesthetics|anesthetics|mesh-ancestor
24866262|NCT02269917|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24723075|NCT01584726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24723076|NCT01584726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24723195|NCT01585792|Glimepiride|glimepiride|mesh-list
24471612|NCT00396227|Rosiglitazone|rosiglitazone|mesh-list
25668432|NCT01717053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25668433|NCT01717053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668434|NCT01717053|Hormone Antagonists|hormone antagonists|mesh-ancestor
25668435|NCT01717053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25674435|NCT01772147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25674436|NCT01772147|Autonomic Agents|autonomic agents|mesh-ancestor
25674437|NCT01772147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25674438|NCT01772147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794758|NCT04711902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24794759|NCT04711902|Immunologic Factors|immunologic factors|mesh-ancestor
24794760|NCT04711902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794761|NCT04695080|Cladribine|cladribine|mesh-list
24794762|NCT04695080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24794763|NCT04695080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24794764|NCT04695080|Immunologic Factors|immunologic factors|mesh-ancestor
24794765|NCT04695080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618404|NCT01048177|Sensory System Agents|sensory system agents|mesh-ancestor
24461756|NCT00353665|Riluzole|riluzole|mesh-list
24723242|NCT01586169|Antimitotic Agents|antimitotic agents|mesh-ancestor
24723243|NCT01586169|Mitosis Modulators|mitosis modulators|mesh-ancestor
24723244|NCT01586169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723245|NCT01586169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24723246|NCT01586208|Phenytoin|phenytoin|mesh-list
24723247|NCT01586208|Valproic Acid|valproic acid|mesh-list
24723248|NCT01586208|Anticonvulsants|anticonvulsants|mesh-ancestor
24723249|NCT01586208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24723250|NCT01586208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723251|NCT01586208|GABA Agents|gaba agents|mesh-ancestor
24723252|NCT01586208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24941966|NCT03985735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941967|NCT03985722|Trabectedin|trabectedin|mesh-list
24723317|NCT01586533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24723318|NCT01586533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723319|NCT01586533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24723320|NCT01586533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24723321|NCT01586572|Vaccines|vaccines|mesh-list
24723322|NCT01586572|Immunologic Factors|immunologic factors|mesh-ancestor
24723323|NCT01586572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723324|NCT01586611|Leucovorin|leucovorin|mesh-list
24723325|NCT01586611|Gemcitabine|gemcitabine|mesh-list
24723326|NCT01586611|Oxaliplatin|oxaliplatin|mesh-list
24723367|NCT01587066|Antimanic Agents|antimanic agents|mesh-ancestor
24723369|NCT01587196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24723370|NCT01587196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24723371|NCT01587196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723600|NCT01588522|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24723601|NCT01588522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24723602|NCT01588522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723603|NCT01588522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24723604|NCT01588522|Vitamins|vitamins|mesh-ancestor
24723605|NCT01588522|Micronutrients|micronutrients|mesh-ancestor
24723606|NCT01588522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24723607|NCT01588587|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24723608|NCT01588587|Vildagliptin|vildagliptin|mesh-list
24723609|NCT01588587|Alogliptin|alogliptin|mesh-list
24723610|NCT01588587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24723611|NCT01588587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723612|NCT01588587|Incretins|incretins|mesh-ancestor
24723613|NCT01588587|Hormones|hormones|mesh-ancestor
24723647|NCT01588717|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24723648|NCT01588717|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24723649|NCT01588717|Cholinergic Agents|cholinergic agents|mesh-ancestor
24723650|NCT01588717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24647779|NCT01210638|Analgesics|analgesics|mesh-ancestor
24723651|NCT01588717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866277|NCT01109004|Lenalidomide|lenalidomide|mesh-list
24723652|NCT01588717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723653|NCT01588743|Insulin Aspart|insulin aspart|mesh-list
24723654|NCT01588743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24723655|NCT01588743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723656|NCT01588756|Mechlorethamine|mechlorethamine|mesh-list
24723657|NCT01588756|Goralatide|goralatide|mesh-list
24723658|NCT01588756|Alkylating Agents|alkylating agents|mesh-ancestor
25668436|NCT01717209|Epoprostenol|epoprostenol|mesh-list
25668437|NCT01717209|Nitric Oxide|nitric oxide|mesh-list
25668438|NCT01717209|Tezosentan|tezosentan|mesh-list
25668439|NCT01717209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25668440|NCT01717209|Autonomic Agents|autonomic agents|mesh-ancestor
25668441|NCT01717209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25668442|NCT01717209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668443|NCT01717209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25668444|NCT01717209|Respiratory System Agents|respiratory system agents|mesh-ancestor
24723659|NCT01588756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723660|NCT01588756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24723661|NCT01588756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25668445|NCT01717209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24723662|NCT01588756|Growth Inhibitors|growth inhibitors|mesh-ancestor
24723663|NCT01588756|Growth Substances|growth substances|mesh-ancestor
24723664|NCT01588756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723665|NCT01588756|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24723666|NCT01588756|Protective Agents|protective agents|mesh-ancestor
24723667|NCT01588782|Ketoconazole|ketoconazole|mesh-list
24723688|NCT01588795|Natriuretic Agents|natriuretic agents|mesh-ancestor
24723689|NCT01588795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723690|NCT01588847|Sufentanil|sufentanil|mesh-list
24723691|NCT01588847|Bupivacaine|bupivacaine|mesh-list
24723692|NCT01588847|Anesthetics|anesthetics|mesh-list
24723693|NCT01588847|Propofol|propofol|mesh-list
24723694|NCT01588847|Sevoflurane|sevoflurane|mesh-list
24723695|NCT01588847|Rocuronium|rocuronium|mesh-list
24723696|NCT01588847|Anesthetics, Local|anesthetics, local|mesh-ancestor
24723697|NCT01588847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24723698|NCT01588847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855229|NCT02278302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24855230|NCT02278302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855231|NCT02278302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24855244|NCT02278419|Sofosbuvir|sofosbuvir|mesh-list
24855245|NCT02278419|Simeprevir|simeprevir|mesh-list
24690260|NCT01400646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24941977|NCT03985319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24941978|NCT03985319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24941979|NCT03985319|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24723757|NCT01588925|Viscosupplements|viscosupplements|mesh-ancestor
24723758|NCT01588925|Protective Agents|protective agents|mesh-ancestor
24723760|NCT01589055|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24723776|NCT01589068|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24723777|NCT01589068|Cholinergic Agents|cholinergic agents|mesh-ancestor
24723778|NCT01589068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24723779|NCT01589068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723780|NCT01589068|Progestins|progestins|mesh-ancestor
24723781|NCT01589068|Hormones|hormones|mesh-ancestor
24723826|NCT01589367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24723827|NCT01589367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24723828|NCT01589367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24723829|NCT01589367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24723830|NCT01589367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723831|NCT01589367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24723832|NCT01589367|Hormone Antagonists|hormone antagonists|mesh-ancestor
24723833|NCT01589367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24723834|NCT01589393|Enoxaparin|enoxaparin|mesh-list
24723835|NCT01589393|Anticoagulants|anticoagulants|mesh-ancestor
24723937|NCT01590173|Hormones|hormones|mesh-ancestor
24723938|NCT01590173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24942015|NCT03985358|Analgesics, Opioid|analgesics, opioid|mesh-list
24724016|NCT01590693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24724069|NCT01590901|Protective Agents|protective agents|mesh-ancestor
24724070|NCT01590901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724071|NCT01590966|Certolizumab Pegol|certolizumab pegol|mesh-list
24724072|NCT01590966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24724073|NCT01590966|Immunologic Factors|immunologic factors|mesh-ancestor
24724074|NCT01590966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724075|NCT01590966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24724076|NCT01591031|Sevoflurane|sevoflurane|mesh-list
24724077|NCT01591031|Rocuronium|rocuronium|mesh-list
24724078|NCT01591031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24724079|NCT01591031|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24724080|NCT01591031|Anesthetics, General|anesthetics, general|mesh-ancestor
24724081|NCT01591031|Anesthetics|anesthetics|mesh-ancestor
24767114|NCT01798836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24767116|NCT01798836|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24724147|NCT01591226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724148|NCT01591226|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24724149|NCT01591226|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24724150|NCT01591226|Purinergic Agents|purinergic agents|mesh-ancestor
24724151|NCT01591226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24724152|NCT01591226|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24724153|NCT01591226|Diuretics|diuretics|mesh-ancestor
24724154|NCT01591226|Natriuretic Agents|natriuretic agents|mesh-ancestor
24724155|NCT01591291|Ondansetron|ondansetron|mesh-list
24724156|NCT01591291|Antiemetics|antiemetics|mesh-ancestor
24724157|NCT01591291|Autonomic Agents|autonomic agents|mesh-ancestor
24724158|NCT01591291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24724159|NCT01591291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724160|NCT01591291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24724227|NCT01591902|Growth Substances|growth substances|mesh-ancestor
24724278|NCT01592110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24724279|NCT01592110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24724280|NCT01592110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24724281|NCT01592110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25862457|NCT00089869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25862458|NCT00089869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25862459|NCT00089869|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25862460|NCT00089869|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25862461|NCT00089869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25862462|NCT00089869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862463|NCT00089869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24724374|NCT01592318|Ritonavir|ritonavir|mesh-list
24724375|NCT01592318|Lactams|lactams|mesh-list
24724376|NCT01592318|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24724377|NCT01592318|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24724378|NCT01592318|Protease Inhibitors|protease inhibitors|mesh-ancestor
24724379|NCT01592318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724380|NCT01592318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615873|NCT01032213|Sensory System Agents|sensory system agents|mesh-ancestor
24615874|NCT01032213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24615875|NCT01032213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615876|NCT01032213|Anesthetics|anesthetics|mesh-ancestor
24615877|NCT01032213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24615878|NCT01032213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24615879|NCT01032213|Anticonvulsants|anticonvulsants|mesh-ancestor
24615880|NCT01032213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24615881|NCT01032213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24647861|NCT01211171|Telmisartan|telmisartan|mesh-list
24615882|NCT01032213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615883|NCT01032213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24615884|NCT01032213|Tocolytic Agents|tocolytic agents|mesh-ancestor
24724460|NCT01593150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24724461|NCT01593150|Protease Inhibitors|protease inhibitors|mesh-ancestor
24724462|NCT01593150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724463|NCT01593150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724464|NCT01593150|Anticoagulants|anticoagulants|mesh-ancestor
24724465|NCT01593163|Ibuprofen|ibuprofen|mesh-list
24724466|NCT01593163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24724467|NCT01593163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24724468|NCT01593163|Analgesics|analgesics|mesh-ancestor
24724469|NCT01593163|Sensory System Agents|sensory system agents|mesh-ancestor
24724470|NCT01593163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24724471|NCT01593163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724472|NCT01593163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24724606|NCT01593774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24724607|NCT01593826|Budesonide|budesonide|mesh-list
24724608|NCT01593826|Formoterol Fumarate|formoterol fumarate|mesh-list
24724670|NCT01594099|Paclitaxel|paclitaxel|mesh-list
24724671|NCT01594099|Cisplatin|cisplatin|mesh-list
24724672|NCT01594099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24724673|NCT01594099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24724674|NCT01594099|Tubulin Modulators|tubulin modulators|mesh-ancestor
24724675|NCT01594099|Antimitotic Agents|antimitotic agents|mesh-ancestor
25199775|NCT02738905|Rifaximin|rifaximin|mesh-list
25199776|NCT02738905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25199777|NCT02738905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25199778|NCT02738905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25199779|NCT02738814|Propofol|propofol|mesh-list
25199780|NCT02738814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25199781|NCT02738814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25199782|NCT02738814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199783|NCT02738814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25199784|NCT02738814|Anesthetics, General|anesthetics, general|mesh-ancestor
25199785|NCT02738814|Anesthetics|anesthetics|mesh-ancestor
25199786|NCT02739386|Ipilimumab|ipilimumab|mesh-list
25199787|NCT02739386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25199788|NCT02739386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199789|NCT02739386|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25199790|NCT02739386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668446|NCT01717209|Antioxidants|antioxidants|mesh-ancestor
24724683|NCT01594177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24724684|NCT01594177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942069|NCT03984526|Parasympatholytics|parasympatholytics|mesh-ancestor
24942070|NCT03984526|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24942071|NCT03984526|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24691637|NCT01408186|Histamine Agents|histamine agents|mesh-ancestor
24724685|NCT01594177|Tubulin Modulators|tubulin modulators|mesh-ancestor
24724686|NCT01594177|Antimitotic Agents|antimitotic agents|mesh-ancestor
24724687|NCT01594177|Mitosis Modulators|mitosis modulators|mesh-ancestor
24724688|NCT01594177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724689|NCT01594177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24724711|NCT01594229|Alkylating Agents|alkylating agents|mesh-ancestor
24724712|NCT01594229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724713|NCT01594242|Bortezomib|bortezomib|mesh-list
24724714|NCT01594242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24724715|NCT01594255|Moxifloxacin|moxifloxacin|mesh-list
24724716|NCT01594255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24724717|NCT01594255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24724718|NCT01594255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24724719|NCT01594255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24724720|NCT01594255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724721|NCT01594255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724722|NCT01594255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24724723|NCT01594268|Everolimus|everolimus|mesh-list
24724724|NCT01594268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24724725|NCT01594268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24724726|NCT01594268|Immunologic Factors|immunologic factors|mesh-ancestor
24724727|NCT01594268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724729|NCT01594346|Tocopherols|tocopherols|mesh-list
24724730|NCT01594346|Tocotrienols|tocotrienols|mesh-list
24724731|NCT01594346|alpha-Tocopherol|alpha-tocopherol|mesh-list
24724732|NCT01594346|Vitamins|vitamins|mesh-ancestor
24724733|NCT01594346|Micronutrients|micronutrients|mesh-ancestor
24724734|NCT01594346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724735|NCT01594346|Antioxidants|antioxidants|mesh-ancestor
24615945|NCT01033097|Glucocorticoids|glucocorticoids|mesh-ancestor
24615946|NCT01033097|Hormones|hormones|mesh-ancestor
24615947|NCT01033097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24942075|NCT03984526|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24725073|NCT01596218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24725074|NCT01596296|Dinoprostone|dinoprostone|mesh-list
24725083|NCT01596387|Anesthetics, General|anesthetics, general|mesh-ancestor
24942076|NCT03984526|Sympathomimetics|sympathomimetics|mesh-ancestor
25054657|NCT03528785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942077|NCT03984526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24942078|NCT03984526|Adrenergic Agents|adrenergic agents|mesh-ancestor
24942079|NCT03984409|Potassium Citrate|potassium citrate|mesh-list
24725084|NCT01596387|Anesthetics|anesthetics|mesh-ancestor
24725085|NCT01596400|Granisetron|granisetron|mesh-list
24725207|NCT01596764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24725208|NCT01596764|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24725209|NCT01596764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24725210|NCT01596764|Analgesics|analgesics|mesh-ancestor
24725211|NCT01596764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24725212|NCT01596764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24725213|NCT01596777|Sulfasalazine|sulfasalazine|mesh-list
24725214|NCT01596777|Naltrexone|naltrexone|mesh-list
24725215|NCT01596777|Methylnaltrexone|methylnaltrexone|mesh-list
24615976|NCT01033305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24473279|NCT00402493|Ibuprofen|ibuprofen|mesh-list
24725416|NCT01597661|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24725417|NCT01597661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24725418|NCT01597661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24958038|NCT03838094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24958039|NCT03838094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050899|NCT00463242|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25050900|NCT00463242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725456|NCT01597765|Respiratory System Agents|respiratory system agents|mesh-ancestor
24725457|NCT01597765|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24725458|NCT01597765|Antioxidants|antioxidants|mesh-ancestor
24473536|NCT00403247|Vitamins|vitamins|mesh-ancestor
24616014|NCT01033526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24616016|NCT01033526|Analgesics|analgesics|mesh-ancestor
25199791|NCT02738619|Vitamin D|vitamin d|mesh-list
25668447|NCT01717209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668448|NCT01717209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25668449|NCT01717209|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25862464|NCT00089869|Serotonin Agents|serotonin agents|mesh-ancestor
25862465|NCT00089869|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25862466|NCT00089869|Adrenergic Agents|adrenergic agents|mesh-ancestor
25862467|NCT00089947|Thymoglobulin|thymoglobulin|mesh-list
25862468|NCT00089947|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25862469|NCT00089947|Immunologic Factors|immunologic factors|mesh-ancestor
25862470|NCT00089947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862471|NCT00089947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25218514|NCT02670109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218515|NCT02670109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218522|NCT02669719|Carboplatin|carboplatin|mesh-list
25050903|NCT00462202|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
25050904|NCT00462202|Anticoagulants|anticoagulants|mesh-ancestor
25050905|NCT00462202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24725567|NCT01598337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24725568|NCT01598337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24725569|NCT01598337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725571|NCT01598337|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24725572|NCT01598337|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24725573|NCT01598337|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24725574|NCT01598337|Purinergic Agents|purinergic agents|mesh-ancestor
24725575|NCT01598337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24725577|NCT01598363|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24725578|NCT01598363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24725579|NCT01598363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24725580|NCT01598363|Antimetabolites|antimetabolites|mesh-ancestor
24725581|NCT01598363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725582|NCT01598363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24725583|NCT01598363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24725642|NCT01598584|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24725644|NCT01598623|Oxytocics|oxytocics|mesh-ancestor
24725645|NCT01598623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24725646|NCT01598623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725647|NCT01598649|Mannitol|mannitol|mesh-list
24725648|NCT01598649|Caseins|caseins|mesh-list
24725649|NCT01598649|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24725650|NCT01598649|Diuretics|diuretics|mesh-ancestor
24725651|NCT01598649|Natriuretic Agents|natriuretic agents|mesh-ancestor
24725652|NCT01598649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725655|NCT01598649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725701|NCT01599013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24725702|NCT01599013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725703|NCT01599013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24725704|NCT01599013|Immunologic Factors|immunologic factors|mesh-ancestor
24725705|NCT01599013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725709|NCT01599013|Mitosis Modulators|mitosis modulators|mesh-ancestor
24725710|NCT01599078|Paclitaxel|paclitaxel|mesh-list
24725711|NCT01599078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24725717|NCT01599117|Udenafil|udenafil|mesh-list
24920682|NCT04199325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616102|NCT01033994|Mitosis Modulators|mitosis modulators|mesh-ancestor
24616103|NCT01033994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050907|NCT00462202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855331|NCT02279121|Taurolidine|taurolidine|mesh-list
24725777|NCT01599702|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
24725779|NCT01599728|Substance P|substance p|mesh-list
24725780|NCT01599728|Neurokinin A|neurokinin a|mesh-list
24725781|NCT01599728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24725782|NCT01599728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668450|NCT01717209|Vasodilator Agents|vasodilator agents|mesh-ancestor
25668451|NCT01717209|Gasotransmitters|gasotransmitters|mesh-ancestor
25668452|NCT01717209|Protective Agents|protective agents|mesh-ancestor
25668453|NCT01717209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25668454|NCT01717209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25668455|NCT01717287|Raltegravir Potassium|raltegravir potassium|mesh-list
25668456|NCT01717287|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25668457|NCT01717287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25668458|NCT01717287|Antiviral Agents|antiviral agents|mesh-ancestor
25668459|NCT01717287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25668460|NCT01717287|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24974612|NCT04370847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24974613|NCT04370847|Sympathomimetics|sympathomimetics|mesh-ancestor
24974614|NCT04370847|Autonomic Agents|autonomic agents|mesh-ancestor
24974615|NCT04370847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24974616|NCT04370847|Adrenergic Agents|adrenergic agents|mesh-ancestor
24974617|NCT04370847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24974618|NCT04370847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978244|NCT05011149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24978245|NCT05011149|Analgesics|analgesics|mesh-ancestor
24978246|NCT05011149|Sensory System Agents|sensory system agents|mesh-ancestor
24974634|NCT04353271|Hydroxychloroquine|hydroxychloroquine|mesh-list
24974635|NCT04353271|Antimalarials|antimalarials|mesh-ancestor
24974636|NCT04353271|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24974637|NCT04353271|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24743401|NCT04838743|Xultophy|xultophy|mesh-list
24974643|NCT05310344|Bevacizumab|bevacizumab|mesh-list
24725783|NCT01599728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725784|NCT01599819|Factor VIII|factor viii|mesh-list
24725785|NCT01599819|BAX 855|bax 855|mesh-list
24725786|NCT01599819|Coagulants|coagulants|mesh-ancestor
24725787|NCT01599858|Omeprazole|omeprazole|mesh-list
24725788|NCT01599858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24725789|NCT01599858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24725790|NCT01599858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24725791|NCT01599858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725792|NCT01599858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725793|NCT01599871|Theophylline|theophylline|mesh-list
24725860|NCT01600235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24725861|NCT01600235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725862|NCT01600235|Protective Agents|protective agents|mesh-ancestor
24725863|NCT01600274|Dienogest|dienogest|mesh-list
24725864|NCT01600274|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24725865|NCT01600274|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24725866|NCT01600274|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24725867|NCT01600274|Estradiol|estradiol|mesh-list
24725868|NCT01600274|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24725869|NCT01600274|Nandrolone|nandrolone|mesh-list
24725870|NCT01600274|Estrogens|estrogens|mesh-ancestor
24725871|NCT01600274|Hormones|hormones|mesh-ancestor
24725872|NCT01600274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24725873|NCT01600274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725874|NCT01600274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24726013|NCT01601184|Temozolomide|temozolomide|mesh-list
24726014|NCT01601184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24726015|NCT01601184|Alkylating Agents|alkylating agents|mesh-ancestor
24726023|NCT01601314|Anesthetics|anesthetics|mesh-ancestor
24726024|NCT01601314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24726025|NCT01601314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24726026|NCT01601314|Anticonvulsants|anticonvulsants|mesh-ancestor
24726027|NCT01601314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24726028|NCT01601314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24726029|NCT01601314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726030|NCT01601314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24726031|NCT01601314|Tocolytic Agents|tocolytic agents|mesh-ancestor
24726032|NCT01601314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24808988|NCT02030483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24667683|NCT05327296|Propofol|propofol|mesh-list
24726033|NCT01601327|Methyltestosterone|methyltestosterone|mesh-list
24726034|NCT01601327|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24726035|NCT01601327|Testosterone|testosterone|mesh-list
24726036|NCT01601327|Testosterone undecanoate|testosterone undecanoate|mesh-list
25668461|NCT01717287|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25668462|NCT01717287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25668463|NCT01717287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668464|NCT01717313|Metformin|metformin|mesh-list
25668465|NCT01717313|Glimepiride|glimepiride|mesh-list
25668466|NCT01717313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25668467|NCT01717313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668468|NCT01717313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25668469|NCT01717313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25668470|NCT01717313|Immunologic Factors|immunologic factors|mesh-ancestor
25668471|NCT01717326|Ribavirin|ribavirin|mesh-list
25668472|NCT01717326|Grazoprevir|grazoprevir|mesh-list
25668473|NCT01717326|Antimetabolites|antimetabolites|mesh-ancestor
25668474|NCT01717326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668475|NCT01717326|Antiviral Agents|antiviral agents|mesh-ancestor
25668476|NCT01717326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24974660|NCT05310331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24974665|NCT05310331|Immunologic Factors|immunologic factors|mesh-ancestor
24974666|NCT05310331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726037|NCT01601327|Testosterone enanthate|testosterone enanthate|mesh-list
24726038|NCT01601327|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24726039|NCT01601327|Androgens|androgens|mesh-ancestor
24726041|NCT01601327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24726079|NCT01601730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24726080|NCT01601730|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24726081|NCT01601730|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24726082|NCT01601730|Cholinergic Agents|cholinergic agents|mesh-ancestor
24726083|NCT01601730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24726084|NCT01601730|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24726085|NCT01601730|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24726086|NCT01601730|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24726087|NCT01601795|Sevoflurane|sevoflurane|mesh-list
24726088|NCT01601795|Isoflurane|isoflurane|mesh-list
24726089|NCT01601795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24726092|NCT01601795|Anesthetics|anesthetics|mesh-ancestor
24726105|NCT01601899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24958041|NCT03838133|Ropivacaine|ropivacaine|mesh-list
24958042|NCT03838133|Anesthetics, Local|anesthetics, local|mesh-ancestor
24958043|NCT03838133|Anesthetics|anesthetics|mesh-ancestor
24958044|NCT03838133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24855344|NCT02279147|Neostigmine|neostigmine|mesh-list
24616200|NCT01034956|Hyaluronic Acid|hyaluronic acid|mesh-list
24920683|NCT04199325|Protective Agents|protective agents|mesh-ancestor
24726156|NCT01602029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24726157|NCT01602029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24726158|NCT01602029|Antimetabolites|antimetabolites|mesh-ancestor
24805794|NCT02012088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24726231|NCT01602302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24726232|NCT01602302|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24726234|NCT01602406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24726391|NCT01603030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24726392|NCT01603030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24726393|NCT01603030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24726425|NCT01603173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24726426|NCT01603173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24726427|NCT01603173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726428|NCT01603186|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24726429|NCT01603186|Antidepressive Agents|antidepressive agents|mesh-ancestor
24726430|NCT01603186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24726474|NCT01603342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726476|NCT01603498|Methylprednisolone|methylprednisolone|mesh-list
24726477|NCT01603498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24726478|NCT01603498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24726479|NCT01603498|Prednisolone|prednisolone|mesh-list
24726635|NCT01604863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726636|NCT01604863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24726637|NCT01604863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24726638|NCT01604863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24726719|NCT01605344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726723|NCT01605344|Immunologic Factors|immunologic factors|mesh-ancestor
24726724|NCT01605344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726725|NCT01605344|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24726726|NCT01605344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24726727|NCT01605344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24726730|NCT01605344|Vitamin B Complex|vitamin b complex|mesh-ancestor
24726731|NCT01605344|Vitamins|vitamins|mesh-ancestor
24726759|NCT01605526|Doxorubicin|doxorubicin|mesh-list
24726760|NCT01605526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24726761|NCT01605526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24726762|NCT01605526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24726763|NCT01605526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24726764|NCT01605526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24726765|NCT01605526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726766|NCT01605721|Everolimus|everolimus|mesh-list
24726767|NCT01605721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24726768|NCT01605721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24726769|NCT01605721|Immunologic Factors|immunologic factors|mesh-ancestor
25668477|NCT01717456|Loperamide|loperamide|mesh-list
25668478|NCT01717456|Antidiarrheals|antidiarrheals|mesh-list
25668479|NCT01717456|Laxatives|laxatives|mesh-list
25668480|NCT01717456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25668481|NCT01717638|Vaccines|vaccines|mesh-list
24462329|NCT00355719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24462334|NCT00355771|Levocetirizine|levocetirizine|mesh-list
24726770|NCT01605721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726771|NCT01605734|Sorafenib|sorafenib|mesh-list
24726772|NCT01605734|Chlorotrianisene|chlorotrianisene|mesh-list
24726773|NCT01605734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942105|NCT03984357|Immunologic Factors|immunologic factors|mesh-ancestor
24942106|NCT03984357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942107|NCT03984357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24726797|NCT01605968|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24726798|NCT01605968|Laxatives|laxatives|mesh-ancestor
24726799|NCT01605968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24726801|NCT01605994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726802|NCT01605994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24726803|NCT01606046|Anesthetics|anesthetics|mesh-list
24726804|NCT01606046|Ethyl Chloride|ethyl chloride|mesh-list
24726805|NCT01606046|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24726815|NCT01606059|Analgesics|analgesics|mesh-ancestor
24726816|NCT01606059|Sensory System Agents|sensory system agents|mesh-ancestor
24726817|NCT01606059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24726818|NCT01606059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726819|NCT01606059|Antipyretics|antipyretics|mesh-ancestor
24726820|NCT01606059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24726821|NCT01606059|Narcotics|narcotics|mesh-ancestor
24726822|NCT01606059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24726823|NCT01606072|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24726824|NCT01606072|Hemostatics|hemostatics|mesh-ancestor
24726825|NCT01606072|Coagulants|coagulants|mesh-ancestor
24726826|NCT01606072|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24726827|NCT01606072|Natriuretic Agents|natriuretic agents|mesh-ancestor
24726834|NCT01606241|Cyclophosphamide|cyclophosphamide|mesh-list
24726835|NCT01606241|Vaccines|vaccines|mesh-list
24726836|NCT01606241|Immunologic Factors|immunologic factors|mesh-ancestor
24726837|NCT01606241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726838|NCT01606241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24726839|NCT01606241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24726840|NCT01606241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24726841|NCT01606241|Alkylating Agents|alkylating agents|mesh-ancestor
24726842|NCT01606241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726843|NCT01606241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24726844|NCT01606241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24726845|NCT01606345|Valrubicin|valrubicin|mesh-list
24942108|NCT03984357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24942109|NCT03984357|Antimetabolites|antimetabolites|mesh-ancestor
24942110|NCT03984357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474070|NCT00404794|Hormones|hormones|mesh-ancestor
24866383|NCT05152901|Racepinephrine|racepinephrine|mesh-list
24866384|NCT05152901|Epinephryl borate|epinephryl borate|mesh-list
25862472|NCT00089960|Motesanib diphosphate|motesanib diphosphate|mesh-list
24726915|NCT01606878|Crizotinib|crizotinib|mesh-list
24726916|NCT01606878|Dexrazoxane|dexrazoxane|mesh-list
24726917|NCT01606878|Razoxane|razoxane|mesh-list
24726918|NCT01606878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24726919|NCT01606878|Immunologic Factors|immunologic factors|mesh-ancestor
24726921|NCT01606878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24726922|NCT01606878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24726923|NCT01606878|Alkylating Agents|alkylating agents|mesh-ancestor
24726924|NCT01606878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726925|NCT01606878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24726926|NCT01606878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24726927|NCT01606878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24726999|NCT01607333|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24727000|NCT01607580|Methylprednisolone|methylprednisolone|mesh-list
24727001|NCT01607580|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24727049|NCT01607762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24727094|NCT01607983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727095|NCT01607983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24727096|NCT01607983|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24727097|NCT01607983|Vasodilator Agents|vasodilator agents|mesh-ancestor
24727098|NCT01607983|Gasotransmitters|gasotransmitters|mesh-ancestor
24727099|NCT01607983|Protective Agents|protective agents|mesh-ancestor
24727100|NCT01607996|Anesthetics|anesthetics|mesh-list
24727211|NCT01608464|Mitosis Modulators|mitosis modulators|mesh-ancestor
25668482|NCT01717638|Immunologic Factors|immunologic factors|mesh-ancestor
25668483|NCT01717638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727212|NCT01608464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862473|NCT00089960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25668484|NCT01717742|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25862474|NCT00089960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25862475|NCT00089960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862476|NCT00090012|Olanzapine|olanzapine|mesh-list
25862477|NCT00090012|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25862478|NCT00090012|Antiemetics|antiemetics|mesh-ancestor
25862479|NCT00090012|Autonomic Agents|autonomic agents|mesh-ancestor
25862480|NCT00090012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24974794|NCT05275569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974795|NCT05275569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24974796|NCT05254847|Capecitabine|capecitabine|mesh-list
24974798|NCT05254847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24974799|NCT05254847|Antimetabolites|antimetabolites|mesh-ancestor
24727213|NCT01608464|Antimetabolites|antimetabolites|mesh-ancestor
24727254|NCT01608711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727256|NCT01608711|Antiviral Agents|antiviral agents|mesh-ancestor
24727257|NCT01608711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24942136|NCT03983889|Midazolam|midazolam|mesh-list
24942137|NCT03983889|Dexmedetomidine|dexmedetomidine|mesh-list
24942138|NCT03983889|Remifentanil|remifentanil|mesh-list
24942139|NCT03983889|Propofol|propofol|mesh-list
24727280|NCT01608945|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24727281|NCT01608945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24727283|NCT01608958|Oxytocics|oxytocics|mesh-ancestor
24727284|NCT01608958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24727285|NCT01608958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727286|NCT01608984|Sufentanil|sufentanil|mesh-list
24727287|NCT01608984|Isoflurane|isoflurane|mesh-list
24727288|NCT01608984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24727289|NCT01608984|Narcotics|narcotics|mesh-ancestor
24727290|NCT01608984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24727291|NCT01608984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727326|NCT01609153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24727327|NCT01609153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24727328|NCT01609153|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24727329|NCT01609153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24727330|NCT01609153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24727331|NCT01609153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727332|NCT01609153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24727333|NCT01609153|Serotonin Agents|serotonin agents|mesh-ancestor
24866416|NCT05152667|Hormones|hormones|mesh-ancestor
24727334|NCT01609153|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24727335|NCT01609153|Dopamine Agents|dopamine agents|mesh-ancestor
24727336|NCT01609153|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24727337|NCT01609153|Antidepressive Agents|antidepressive agents|mesh-ancestor
24616409|NCT01037023|Topotecan|topotecan|mesh-list
24616410|NCT01037023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24616411|NCT01037023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24616412|NCT01037023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616413|NCT01037023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616414|NCT01037023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616415|NCT01037101|Cycloserine|cycloserine|mesh-list
24616416|NCT01037101|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24616417|NCT01037101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24727494|NCT01610401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24727495|NCT01610401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727496|NCT01610401|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24727497|NCT01610401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24727498|NCT01610401|Purinergic Agents|purinergic agents|mesh-ancestor
24727499|NCT01610401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24727515|NCT01610921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24727516|NCT01610921|Vasodilator Agents|vasodilator agents|mesh-ancestor
24727517|NCT01610921|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25199792|NCT02738619|Ergocalciferols|ergocalciferols|mesh-list
25668485|NCT01717742|Plasminogen|plasminogen|mesh-list
25668486|NCT01717742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25668487|NCT01717742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25668488|NCT01717742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668489|NCT01717768|Testosterone|testosterone|mesh-list
25668490|NCT01717768|Androgens|androgens|mesh-ancestor
25668491|NCT01717768|Hormones|hormones|mesh-ancestor
25668492|NCT01717768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25668493|NCT01717768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133659|NCT03011645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24832599|NCT02171741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24832600|NCT02171741|Tubulin Modulators|tubulin modulators|mesh-ancestor
24794832|NCT04354103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24794835|NCT04354103|Adrenergic Agents|adrenergic agents|mesh-ancestor
24727518|NCT01610921|Purinergic Agonists|purinergic agonists|mesh-ancestor
24727519|NCT01610921|Purinergic Agents|purinergic agents|mesh-ancestor
24727520|NCT01610921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24727521|NCT01610921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727522|NCT01610934|Liraglutide|liraglutide|mesh-list
24727523|NCT01610934|Glimepiride|glimepiride|mesh-list
24727524|NCT01610934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24727525|NCT01610934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727526|NCT01610934|Incretins|incretins|mesh-ancestor
24727527|NCT01610934|Hormones|hormones|mesh-ancestor
24727528|NCT01610934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24474286|NCT00405444|Fentanyl|fentanyl|mesh-list
24727628|NCT01611506|Cetuximab|cetuximab|mesh-list
24942151|NCT03983889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24942152|NCT03983889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24942153|NCT03983889|Adrenergic Agents|adrenergic agents|mesh-ancestor
24812732|NCT02054299|Vitamins|vitamins|mesh-ancestor
24727657|NCT01611909|Respiratory System Agents|respiratory system agents|mesh-ancestor
24727658|NCT01611961|Docetaxel|docetaxel|mesh-list
24727659|NCT01611961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727660|NCT01611961|Tubulin Modulators|tubulin modulators|mesh-ancestor
24727661|NCT01611961|Antimitotic Agents|antimitotic agents|mesh-ancestor
24727662|NCT01611961|Mitosis Modulators|mitosis modulators|mesh-ancestor
24727663|NCT01611961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616441|NCT01037348|Ranibizumab|ranibizumab|mesh-list
24727664|NCT01612052|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24727857|NCT01613079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24648655|NCT01216124|Docetaxel|docetaxel|mesh-list
24728064|NCT01614041|Serotonin Agents|serotonin agents|mesh-ancestor
24728065|NCT01614041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24728066|NCT01614041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728067|NCT01614132|Cisplatin|cisplatin|mesh-list
24728241|NCT01615055|Antidepressive Agents|antidepressive agents|mesh-ancestor
24728242|NCT01615055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24728243|NCT01615055|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24728244|NCT01615055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24728245|NCT01615055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728246|NCT01615081|Insulin|insulin|mesh-list
24728247|NCT01615081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24728248|NCT01615081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728249|NCT01615107|Oxytocin|oxytocin|mesh-list
24728250|NCT01615107|Oxytocics|oxytocics|mesh-ancestor
24728251|NCT01615107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24728252|NCT01615107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728253|NCT01615185|Amisulpride|amisulpride|mesh-list
24728264|NCT01615185|Antidepressive Agents|antidepressive agents|mesh-ancestor
24728265|NCT01615211|Letrozole|letrozole|mesh-list
24728266|NCT01615211|Trilostane|trilostane|mesh-list
24728718|NCT01617772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728719|NCT01617772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24728720|NCT01617772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24728722|NCT01617798|Metolazone|metolazone|mesh-list
24728752|NCT01617928|Mitosis Modulators|mitosis modulators|mesh-ancestor
24728753|NCT01617928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728754|NCT01617928|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24728755|NCT01617928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728756|NCT01618006|Aspirin|aspirin|mesh-list
24728757|NCT01618006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24728758|NCT01618006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24942188|NCT03983460|Betamethasone Valerate|betamethasone valerate|mesh-list
24728759|NCT01618006|Analgesics|analgesics|mesh-ancestor
24728760|NCT01618006|Sensory System Agents|sensory system agents|mesh-ancestor
24728761|NCT01618006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24728762|NCT01618006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728763|NCT01618006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24728764|NCT01618006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25668494|NCT01717872|Pyrithione zinc|pyrithione zinc|mesh-list
25668495|NCT01717872|Keratolytic Agents|keratolytic agents|mesh-ancestor
25668496|NCT01717872|Dermatologic Agents|dermatologic agents|mesh-ancestor
25668497|NCT01717898|Prednisone|prednisone|mesh-list
25668498|NCT01717898|Abiraterone Acetate|abiraterone acetate|mesh-list
25668499|NCT01717898|Dactolisib|dactolisib|mesh-list
25668500|NCT01717898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24974874|NCT05180591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24974875|NCT05180591|Immunologic Factors|immunologic factors|mesh-ancestor
24974876|NCT05180591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433412|NCT00258284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24462373|NCT00355927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24433469|NCT00258557|Darunavir|darunavir|mesh-list
24462374|NCT00355927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462375|NCT00355927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24728765|NCT01618006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24728766|NCT01618006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24728767|NCT01618006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728768|NCT01618006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25199793|NCT02738619|Cholecalciferol|cholecalciferol|mesh-list
24728769|NCT01618006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25199794|NCT02738619|Vitamins|vitamins|mesh-list
24728770|NCT01618006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728771|NCT01618006|Antipyretics|antipyretics|mesh-ancestor
24728772|NCT01618136|Paclitaxel|paclitaxel|mesh-list
24728773|NCT01618136|Carboplatin|carboplatin|mesh-list
24728774|NCT01618136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24728775|NCT01618136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24728776|NCT01618136|Tubulin Modulators|tubulin modulators|mesh-ancestor
24728777|NCT01618136|Antimitotic Agents|antimitotic agents|mesh-ancestor
24728778|NCT01618136|Mitosis Modulators|mitosis modulators|mesh-ancestor
24728779|NCT01618136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728780|NCT01618188|Insulin|insulin|mesh-list
24728781|NCT01618188|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24728794|NCT01618396|Midazolam|midazolam|mesh-list
24728795|NCT01618396|Propofol|propofol|mesh-list
24728796|NCT01618396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24728797|NCT01618396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24728798|NCT01618396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866569|NCT05259007|Clarithromycin|clarithromycin|mesh-list
24728799|NCT01618396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24728800|NCT01618396|Anesthetics, General|anesthetics, general|mesh-ancestor
24728809|NCT01618396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728810|NCT01618448|Tolvaptan|tolvaptan|mesh-list
24728811|NCT01618448|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24728812|NCT01618448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728813|NCT01618448|Natriuretic Agents|natriuretic agents|mesh-ancestor
24728814|NCT01618448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728815|NCT01618474|Docetaxel|docetaxel|mesh-list
24728942|NCT01619007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942193|NCT03983460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24942194|NCT03983460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767230|NCT01799356|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24942197|NCT03983239|Efavirenz|efavirenz|mesh-list
24942198|NCT03983239|Rifampin|rifampin|mesh-list
24942199|NCT03983239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24855448|NCT02279615|Adrenergic Agents|adrenergic agents|mesh-ancestor
24729054|NCT01619566|Antidepressive Agents|antidepressive agents|mesh-ancestor
24729055|NCT01619566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24729056|NCT01619566|Dopamine Agents|dopamine agents|mesh-ancestor
24729057|NCT01619644|Valproic Acid|valproic acid|mesh-list
24906379|NCT04341038|Hormones|hormones|mesh-ancestor
24729323|NCT01621165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24729324|NCT01621165|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24729325|NCT01621165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24729326|NCT01621165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24729327|NCT01621165|Adrenergic Agents|adrenergic agents|mesh-ancestor
24729328|NCT01621165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24729329|NCT01621165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729330|NCT01621165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429336|NCT01535053|Folic Acid|folic acid|mesh-list
25668501|NCT01717898|Glucocorticoids|glucocorticoids|mesh-ancestor
25668502|NCT01717898|Hormones|hormones|mesh-ancestor
25668503|NCT01717898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25668504|NCT01717898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668505|NCT01717898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25668506|NCT01717898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25668507|NCT01717898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25668508|NCT01717898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25862481|NCT00090012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862482|NCT00090012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25862483|NCT00090012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25862484|NCT00090012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24729332|NCT01621204|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24729333|NCT01621204|gamma-Globulins|gamma-globulins|mesh-list
24729442|NCT01621698|Fentanyl|fentanyl|mesh-list
24729443|NCT01621698|Bupivacaine|bupivacaine|mesh-list
24729458|NCT01621698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24616640|NCT01038388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616641|NCT01038388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616642|NCT01038453|Vitamin D|vitamin d|mesh-list
24616643|NCT01038453|Cholecalciferol|cholecalciferol|mesh-list
24616644|NCT01038453|Vitamins|vitamins|mesh-ancestor
24616645|NCT01038453|Micronutrients|micronutrients|mesh-ancestor
24616646|NCT01038453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616647|NCT01038453|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24906846|NCT04336566|Melatonin|melatonin|mesh-list
24729504|NCT01621971|Protective Agents|protective agents|mesh-ancestor
24729525|NCT01622322|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24729526|NCT01622322|Anesthetics, General|anesthetics, general|mesh-ancestor
24729527|NCT01622322|Anesthetics|anesthetics|mesh-ancestor
24729528|NCT01622322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24818753|NCT02090673|Incretins|incretins|mesh-ancestor
24636863|NCT01147705|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24818825|NCT02091180|Diuretics|diuretics|mesh-ancestor
24616710|NCT01038882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24616711|NCT01038882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24942265|NCT03982849|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24855472|NCT02279875|Linezolid|linezolid|mesh-list
24855473|NCT02279875|Pyrazinamide|pyrazinamide|mesh-list
24855474|NCT02279875|Ethambutol|ethambutol|mesh-list
24855475|NCT02279875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24855476|NCT02279875|Antitubercular Agents|antitubercular agents|mesh-ancestor
24729851|NCT01624116|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24729852|NCT01624129|Fluticasone|fluticasone|mesh-list
24729853|NCT01624129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24729854|NCT01624129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24729855|NCT01624129|Autonomic Agents|autonomic agents|mesh-ancestor
24729856|NCT01624129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24729857|NCT01624129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729858|NCT01624129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24729859|NCT01624129|Respiratory System Agents|respiratory system agents|mesh-ancestor
24729860|NCT01624129|Dermatologic Agents|dermatologic agents|mesh-ancestor
24729861|NCT01624129|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24729862|NCT01624207|Atorvastatin|atorvastatin|mesh-list
24729863|NCT01624207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24729864|NCT01624207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24729866|NCT01624207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729867|NCT01624207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24729869|NCT01624207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729870|NCT01624246|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
24729871|NCT01624246|Avibactam|avibactam|mesh-list
24729872|NCT01624246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24729873|NCT01624246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24729874|NCT01624246|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24729875|NCT01624246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729876|NCT01624246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050919|NCT00460317|Carboplatin|carboplatin|mesh-list
25050920|NCT00460317|Motesanib diphosphate|motesanib diphosphate|mesh-list
25050921|NCT00460317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25050922|NCT00460317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050923|NCT00460317|Tubulin Modulators|tubulin modulators|mesh-ancestor
25050924|NCT00460317|Antimitotic Agents|antimitotic agents|mesh-ancestor
24729930|NCT01624675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729931|NCT01624675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24729932|NCT01624675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24729953|NCT01624805|Prednisolone|prednisolone|mesh-list
24729954|NCT01624805|Prednisolone acetate|prednisolone acetate|mesh-list
24729955|NCT01624805|Lenograstim|lenograstim|mesh-list
24729956|NCT01624805|Cyclosporins|cyclosporins|mesh-list
24729957|NCT01624805|Thymoglobulin|thymoglobulin|mesh-list
25668509|NCT01717898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668510|NCT01717898|Hormone Antagonists|hormone antagonists|mesh-ancestor
24730011|NCT01625260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24730012|NCT01625260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24730013|NCT01625260|Immunologic Factors|immunologic factors|mesh-ancestor
24730014|NCT01625260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862485|NCT00090012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25668511|NCT01717898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25083350|NCT03316534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25083351|NCT03316534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24419676|NCT00213252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25083378|NCT03316352|Anesthetics, Local|anesthetics, local|mesh-ancestor
24866649|NCT05258136|Antibodies|antibodies|mesh-list
24730047|NCT01625494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24730049|NCT01625494|Vasodilator Agents|vasodilator agents|mesh-ancestor
24730050|NCT01625494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24730051|NCT01625494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24730052|NCT01625520|Everolimus|everolimus|mesh-list
24730053|NCT01625520|Pasireotide|pasireotide|mesh-list
24730062|NCT01625572|Narcotics|narcotics|mesh-ancestor
24730063|NCT01625572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24730064|NCT01625572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730065|NCT01625572|Analgesics|analgesics|mesh-ancestor
24730066|NCT01625572|Sensory System Agents|sensory system agents|mesh-ancestor
24730067|NCT01625572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24730068|NCT01625715|Ketotifen|ketotifen|mesh-list
24730069|NCT01625715|Antipruritics|antipruritics|mesh-ancestor
24730110|NCT01625936|Bevacizumab|bevacizumab|mesh-list
24730111|NCT01625936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25199795|NCT02738619|Micronutrients|micronutrients|mesh-ancestor
24730112|NCT01625936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25133920|NCT03009500|Antiemetics|antiemetics|mesh-ancestor
24730113|NCT01625936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24787132|NCT01923831|Anticonvulsants|anticonvulsants|mesh-ancestor
24730139|NCT01626339|Growth Inhibitors|growth inhibitors|mesh-ancestor
24730145|NCT01626443|Micronutrients|micronutrients|mesh-ancestor
24730146|NCT01626443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730148|NCT01626469|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24730149|NCT01626469|Protease Inhibitors|protease inhibitors|mesh-ancestor
24730150|NCT01626469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24730151|NCT01626469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730152|NCT01626469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24730153|NCT01626534|Clopidogrel|clopidogrel|mesh-list
24730154|NCT01626534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24730155|NCT01626534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24730156|NCT01626534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25050944|NCT00459277|Sensory System Agents|sensory system agents|mesh-ancestor
25050945|NCT00459277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25050946|NCT00459277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25050947|NCT00459277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25050948|NCT00459277|Anesthetics, General|anesthetics, general|mesh-ancestor
25050949|NCT00459277|Anesthetics|anesthetics|mesh-ancestor
25050950|NCT00458978|Cediranib|cediranib|mesh-list
25050951|NCT00458978|Maleic acid|maleic acid|mesh-list
25050952|NCT00458978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855484|NCT02279875|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24855485|NCT02279875|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24855486|NCT02279875|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24855487|NCT02279875|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24855488|NCT02279875|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24457891|NCT00335582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24637343|NCT01149954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24637344|NCT01149954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24637345|NCT01149954|Analgesics|analgesics|mesh-ancestor
24637433|NCT01150318|Iodine|iodine|mesh-list
24730157|NCT01626534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24730158|NCT01626534|Purinergic Agents|purinergic agents|mesh-ancestor
24730159|NCT01626534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24730160|NCT01626534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730161|NCT01626534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730162|NCT01626560|Vancomycin|vancomycin|mesh-list
24920684|NCT04199325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730187|NCT01626911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730189|NCT01627041|Decitabine|decitabine|mesh-list
25668513|NCT01718353|Docetaxel|docetaxel|mesh-list
25668514|NCT01718353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25668515|NCT01718353|Tubulin Modulators|tubulin modulators|mesh-ancestor
25668516|NCT01718353|Antimitotic Agents|antimitotic agents|mesh-ancestor
25668517|NCT01718353|Mitosis Modulators|mitosis modulators|mesh-ancestor
25674439|NCT01772147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25042392|NCT01455090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042393|NCT01455090|Antiviral Agents|antiviral agents|mesh-ancestor
25042394|NCT01455090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042395|NCT01455090|Protease Inhibitors|protease inhibitors|mesh-ancestor
25042396|NCT01455090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25083455|NCT03315533|Sensory System Agents|sensory system agents|mesh-ancestor
25083456|NCT03315533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25083457|NCT03315533|Antidepressive Agents|antidepressive agents|mesh-ancestor
25083458|NCT03315533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25083459|NCT03315533|Dopamine Agents|dopamine agents|mesh-ancestor
25083461|NCT03315520|Cyclophosphamide|cyclophosphamide|mesh-list
25083462|NCT03315520|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24730308|NCT01627353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24730309|NCT01627353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730310|NCT01627353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730311|NCT01627353|Anesthetics, Local|anesthetics, local|mesh-ancestor
24730312|NCT01627353|Anesthetics|anesthetics|mesh-ancestor
24518521|NCT04901689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24730313|NCT01627353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24730314|NCT01627353|Sensory System Agents|sensory system agents|mesh-ancestor
24730315|NCT01627353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24730316|NCT01627353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24730317|NCT01627353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24730318|NCT01627353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24730331|NCT01627431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24730332|NCT01627431|Analgesics|analgesics|mesh-ancestor
24730333|NCT01627431|Sensory System Agents|sensory system agents|mesh-ancestor
24730334|NCT01627431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24730335|NCT01627431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730336|NCT01627431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24730337|NCT01627431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24730338|NCT01627431|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24730339|NCT01627431|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24730340|NCT01627431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730341|NCT01627431|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24730342|NCT01627431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24730343|NCT01627431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24730344|NCT01627431|Antipyretics|antipyretics|mesh-ancestor
24730345|NCT01627431|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25199796|NCT02738619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133984|NCT03009045|Oxazolidinones|oxazolidinones|mesh-list
24730359|NCT01627587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24730360|NCT01627587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730361|NCT01627587|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24730362|NCT01627626|Pilocarpine|pilocarpine|mesh-list
24730363|NCT01627626|Miotics|miotics|mesh-ancestor
24730368|NCT01627626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24730369|NCT01627626|Cholinergic Agents|cholinergic agents|mesh-ancestor
24730370|NCT01627626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24730371|NCT01627626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730372|NCT01627639|Acetazolamide|acetazolamide|mesh-list
25050964|NCT00458601|Immunologic Factors|immunologic factors|mesh-ancestor
25050965|NCT00458601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050966|NCT00458601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24730373|NCT01627639|Anticonvulsants|anticonvulsants|mesh-ancestor
24730374|NCT01627639|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24730375|NCT01627639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920685|NCT04199143|Nitrous Oxide|nitrous oxide|mesh-list
24730399|NCT01627834|Ropinirole|ropinirole|mesh-list
24730407|NCT01627847|Ropinirole|ropinirole|mesh-list
25668518|NCT01718353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668519|NCT01718353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25668520|NCT01718353|Glucocorticoids|glucocorticoids|mesh-ancestor
25668521|NCT01718353|Hormones|hormones|mesh-ancestor
25668522|NCT01718353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25668523|NCT01718353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668524|NCT01718353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25668525|NCT01718483|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25668526|NCT01718483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25668527|NCT01718483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668528|NCT01718483|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24462508|NCT00356486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24462509|NCT00356486|Immunologic Factors|immunologic factors|mesh-ancestor
24795389|NCT02807454|Durvalumab|durvalumab|mesh-list
24394413|NCT00133237|Immunologic Factors|immunologic factors|mesh-ancestor
24394414|NCT00133237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730410|NCT01627847|Dopamine Agonists|dopamine agonists|mesh-ancestor
24730411|NCT01627847|Dopamine Agents|dopamine agents|mesh-ancestor
24730412|NCT01627847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24730413|NCT01627847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730414|NCT01627847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730416|NCT01627873|Remifentanil|remifentanil|mesh-list
24730417|NCT01627873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24730418|NCT01627873|Narcotics|narcotics|mesh-ancestor
24730433|NCT01627938|Razoxane|razoxane|mesh-list
24730461|NCT01628211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730462|NCT01628211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24730463|NCT01628211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730464|NCT01628211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24730465|NCT01628211|Immunologic Factors|immunologic factors|mesh-ancestor
24730466|NCT01628211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730467|NCT01628211|Antidotes|antidotes|mesh-ancestor
24730468|NCT01628211|Protective Agents|protective agents|mesh-ancestor
24730469|NCT01628211|Vitamin B Complex|vitamin b complex|mesh-ancestor
24730470|NCT01628211|Vitamins|vitamins|mesh-ancestor
24730471|NCT01628211|Micronutrients|micronutrients|mesh-ancestor
24730472|NCT01628211|Hematinics|hematinics|mesh-ancestor
24730473|NCT01628341|Insulin|insulin|mesh-list
24730474|NCT01628341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24730475|NCT01628341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730476|NCT01628354|Ranibizumab|ranibizumab|mesh-list
24730477|NCT01628354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24908344|NCT04321837|Vitamin D|vitamin d|mesh-list
24730502|NCT01628471|Estrogens|estrogens|mesh-ancestor
24730503|NCT01628471|Hormones|hormones|mesh-ancestor
24730504|NCT01628471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24730505|NCT01628562|Remifentanil|remifentanil|mesh-list
24730506|NCT01628562|Esmolol|esmolol|mesh-list
24730507|NCT01628562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24730508|NCT01628562|Narcotics|narcotics|mesh-ancestor
24730509|NCT01628562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24730510|NCT01628562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730514|NCT01628562|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24730515|NCT01628562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24730516|NCT01628562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24730517|NCT01628562|Adrenergic Agents|adrenergic agents|mesh-ancestor
24730518|NCT01628562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24730519|NCT01628562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730521|NCT01628640|Interferon-beta|interferon-beta|mesh-list
24730522|NCT01628640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730523|NCT01628640|Antiviral Agents|antiviral agents|mesh-ancestor
24730524|NCT01628640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24730525|NCT01628640|Immunologic Factors|immunologic factors|mesh-ancestor
24730526|NCT01628640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730527|NCT01628666|Vancomycin|vancomycin|mesh-list
24730528|NCT01628666|Cefazolin|cefazolin|mesh-list
24730529|NCT01628666|Cephalexin|cephalexin|mesh-list
24730530|NCT01628666|Bacitracin|bacitracin|mesh-list
24730531|NCT01628666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24730532|NCT01628666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24730533|NCT01628666|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25199797|NCT02738619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24730542|NCT01628731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24730599|NCT01629212|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24730600|NCT01629212|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24730601|NCT01629212|Cholinergic Agents|cholinergic agents|mesh-ancestor
24730602|NCT01629212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24730604|NCT01629225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24730605|NCT01629225|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24730606|NCT01629225|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24730607|NCT01629225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730608|NCT01629251|Insulin|insulin|mesh-list
24730609|NCT01629251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25668529|NCT01718483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25668530|NCT01718483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24730610|NCT01629251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730611|NCT01629277|Insulin|insulin|mesh-list
24730612|NCT01629277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24730662|NCT01629511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730664|NCT01629511|Antiviral Agents|antiviral agents|mesh-ancestor
24730665|NCT01629511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24730666|NCT01629511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24730667|NCT01629511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24730679|NCT01629511|Alkylating Agents|alkylating agents|mesh-ancestor
24730680|NCT01629511|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24730681|NCT01629511|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24730683|NCT01629628|Mercaptopurine|mercaptopurine|mesh-list
24730684|NCT01629628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24730685|NCT01629628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24730706|NCT01629758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24730707|NCT01629758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730723|NCT01630018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24730724|NCT01630018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24730725|NCT01630018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730726|NCT01630018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730727|NCT01630057|Zonisamide|zonisamide|mesh-list
24730728|NCT01630057|Anticonvulsants|anticonvulsants|mesh-ancestor
24730729|NCT01630057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24730730|NCT01630057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25862486|NCT00090012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24730740|NCT01630070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730742|NCT01630083|Oxaliplatin|oxaliplatin|mesh-list
24730743|NCT01630083|Epirubicin|epirubicin|mesh-list
24730744|NCT01630083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24730745|NCT01630083|Antimetabolites|antimetabolites|mesh-ancestor
24730746|NCT01630083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730747|NCT01630083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730748|NCT01630083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24730749|NCT01630083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24730768|NCT01630278|Sensory System Agents|sensory system agents|mesh-ancestor
24730769|NCT01630278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24730770|NCT01630278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730771|NCT01630278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24730772|NCT01630278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24730773|NCT01630278|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24730774|NCT01630278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24730775|NCT01630278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730776|NCT01630343|Acetaminophen|acetaminophen|mesh-list
24730777|NCT01630343|Tramadol|tramadol|mesh-list
24958218|NCT03835442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730814|NCT01630642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24730815|NCT01630642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24730816|NCT01630642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24730818|NCT01630642|Purinergic Agents|purinergic agents|mesh-ancestor
24730819|NCT01630642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24730820|NCT01630642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730821|NCT01630642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730823|NCT01630655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24730824|NCT01630655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24730825|NCT01630655|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24730826|NCT01630655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24730873|NCT01631058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25199798|NCT02738619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24730874|NCT01631058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730875|NCT01631058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24730876|NCT01631058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730877|NCT01631058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24730878|NCT01631058|Immunologic Factors|immunologic factors|mesh-ancestor
24730879|NCT01631058|Cathartics|cathartics|mesh-ancestor
24730880|NCT01631058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24730881|NCT01631136|Gemcitabine|gemcitabine|mesh-list
24730882|NCT01631136|Cisplatin|cisplatin|mesh-list
24730883|NCT01631136|Pemetrexed|pemetrexed|mesh-list
24730884|NCT01631136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730885|NCT01631136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24730886|NCT01631136|Antimetabolites|antimetabolites|mesh-ancestor
24730887|NCT01631136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730903|NCT01631305|Magnesium Oxide|magnesium oxide|mesh-list
24730904|NCT01631305|Calcium|calcium|mesh-list
24730905|NCT01631305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24730906|NCT01631305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730907|NCT01631305|Antacids|antacids|mesh-ancestor
24730908|NCT01631305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730909|NCT01631305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24730910|NCT01631357|Gemcitabine|gemcitabine|mesh-list
24731004|NCT01631513|Sensory System Agents|sensory system agents|mesh-ancestor
24731005|NCT01631513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24731006|NCT01631513|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24731007|NCT01631513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24731008|NCT01631513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24731009|NCT01631513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731011|NCT01631513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24731012|NCT01631526|Vitamin D|vitamin d|mesh-list
24731013|NCT01631526|Vitamins|vitamins|mesh-ancestor
24731014|NCT01631526|Micronutrients|micronutrients|mesh-ancestor
24731015|NCT01631526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731016|NCT01631526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24731044|NCT01631669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731045|NCT01631838|Tocotrienols|tocotrienols|mesh-list
24731046|NCT01631838|Vitamin E|vitamin e|mesh-list
24731047|NCT01631838|Tocopherols|tocopherols|mesh-list
24731048|NCT01631838|Tocovid|tocovid|mesh-list
24731049|NCT01631838|Antioxidants|antioxidants|mesh-ancestor
24731050|NCT01631838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731051|NCT01631838|Protective Agents|protective agents|mesh-ancestor
24731052|NCT01631838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731053|NCT01631838|Vitamins|vitamins|mesh-ancestor
24731093|NCT01632189|Cholinergic Agents|cholinergic agents|mesh-ancestor
24731094|NCT01632189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24731095|NCT01632189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731096|NCT01632189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731097|NCT01632371|Paclitaxel|paclitaxel|mesh-list
24731098|NCT01632371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24731099|NCT01632371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24731100|NCT01632371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731101|NCT01632371|Tubulin Modulators|tubulin modulators|mesh-ancestor
24731102|NCT01632371|Antimitotic Agents|antimitotic agents|mesh-ancestor
24731103|NCT01632371|Mitosis Modulators|mitosis modulators|mesh-ancestor
24731104|NCT01632371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050978|NCT00455559|Imatinib Mesylate|imatinib mesylate|mesh-list
24731106|NCT01632436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24731107|NCT01632436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24731108|NCT01632436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731109|NCT01632436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731112|NCT01632514|Vitamin D|vitamin d|mesh-list
24731128|NCT01632592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731129|NCT01632605|Sirolimus|sirolimus|mesh-list
24731130|NCT01632605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24731131|NCT01632605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24731132|NCT01632605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24731181|NCT01633086|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24731182|NCT01633086|Vasodilator Agents|vasodilator agents|mesh-ancestor
24731183|NCT01633086|Gasotransmitters|gasotransmitters|mesh-ancestor
24731184|NCT01633086|Protective Agents|protective agents|mesh-ancestor
24731186|NCT01633099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24731187|NCT01633099|Antimetabolites|antimetabolites|mesh-ancestor
25862487|NCT00090012|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25134237|NCT03007589|Dermatologic Agents|dermatologic agents|mesh-ancestor
24731188|NCT01633099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731189|NCT01633099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731190|NCT01633099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731191|NCT01633177|Vitamin D|vitamin d|mesh-list
24731192|NCT01633177|Ergocalciferols|ergocalciferols|mesh-list
24731193|NCT01633177|Cholecalciferol|cholecalciferol|mesh-list
24731194|NCT01633177|Vitamins|vitamins|mesh-list
24731195|NCT01633177|Micronutrients|micronutrients|mesh-ancestor
24731196|NCT01633177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731197|NCT01633177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24731198|NCT01633177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24616873|NCT01039558|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24731277|NCT01633970|Pemetrexed|pemetrexed|mesh-list
24731278|NCT01633970|Atezolizumab|atezolizumab|mesh-list
24731279|NCT01633970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24731280|NCT01633970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731281|NCT01633970|Tubulin Modulators|tubulin modulators|mesh-ancestor
24731282|NCT01633970|Antimitotic Agents|antimitotic agents|mesh-ancestor
24731283|NCT01633970|Mitosis Modulators|mitosis modulators|mesh-ancestor
24731284|NCT01633970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731285|NCT01633970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24731286|NCT01633970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24731287|NCT01633970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24731288|NCT01633970|Growth Substances|growth substances|mesh-ancestor
24731289|NCT01633970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731290|NCT01633970|Growth Inhibitors|growth inhibitors|mesh-ancestor
24731306|NCT01633983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731307|NCT01633983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733251|NCT01644773|Dasatinib|dasatinib|mesh-list
24731355|NCT01634373|Antidepressive Agents|antidepressive agents|mesh-ancestor
24731356|NCT01634373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25862488|NCT00090012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24485036|NCT00451139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24616932|NCT01039948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616933|NCT01039974|Ketoconazole|ketoconazole|mesh-list
24616934|NCT01039974|Antifungal Agents|antifungal agents|mesh-ancestor
24616935|NCT01039974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24616936|NCT01039974|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24616937|NCT01039974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24616938|NCT01039974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616939|NCT01039974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616940|NCT01039974|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24616941|NCT01039974|Hormone Antagonists|hormone antagonists|mesh-ancestor
24649364|NCT01219686|Dexetimide|dexetimide|mesh-list
24616942|NCT01039974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24616943|NCT01039974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616944|NCT01039974|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25050983|NCT00455156|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25050986|NCT00455156|Estrogens|estrogens|mesh-ancestor
25050987|NCT00455156|Hormones|hormones|mesh-ancestor
25050988|NCT00455156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25050989|NCT00455156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616945|NCT01040078|Vaccines|vaccines|mesh-list
24616948|NCT01040091|Tenofovir|tenofovir|mesh-list
24616956|NCT01040091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731397|NCT01634438|Anticoagulants|anticoagulants|mesh-ancestor
24731398|NCT01634438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24731399|NCT01634438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24731435|NCT01634685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24731436|NCT01634698|Vitamin A|vitamin a|mesh-list
24731437|NCT01634698|Retinol palmitate|retinol palmitate|mesh-list
24731438|NCT01634698|Vitamins|vitamins|mesh-ancestor
24731439|NCT01634698|Micronutrients|micronutrients|mesh-ancestor
24731440|NCT01634698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731441|NCT01634698|Antioxidants|antioxidants|mesh-ancestor
24731442|NCT01634698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731443|NCT01634698|Protective Agents|protective agents|mesh-ancestor
24731444|NCT01634698|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24731445|NCT01634698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731446|NCT01634763|Ceritinib|ceritinib|mesh-list
24731447|NCT01634763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731448|NCT01634763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25199799|NCT02738658|Everolimus|everolimus|mesh-list
24731449|NCT01634763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731450|NCT01634763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731451|NCT01634789|Bazedoxifene|bazedoxifene|mesh-list
24731456|NCT01634789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731457|NCT01634789|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24731472|NCT01634893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24731473|NCT01634893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24731474|NCT01634893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24731475|NCT01634906|Atorvastatin|atorvastatin|mesh-list
25109250|NCT03126461|Nivolumab|nivolumab|mesh-list
24731519|NCT01635296|Antiviral Agents|antiviral agents|mesh-ancestor
24731520|NCT01635296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24731521|NCT01635296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24731522|NCT01635296|Immunologic Factors|immunologic factors|mesh-ancestor
24731523|NCT01635296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731524|NCT01635400|Irinotecan|irinotecan|mesh-list
24731525|NCT01635400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24731526|NCT01635400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24731527|NCT01635400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731528|NCT01635400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731529|NCT01635400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731530|NCT01635426|Aspirin|aspirin|mesh-list
24731531|NCT01635426|Clopidogrel|clopidogrel|mesh-list
24731582|NCT01635686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24731583|NCT01635686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731584|NCT01635686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24731585|NCT01635686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24731612|NCT01635790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731613|NCT01635790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24731614|NCT01635790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25051003|NCT00451152|Hydrocortisone|hydrocortisone|mesh-list
25051005|NCT00451152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25051006|NCT00451152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24731615|NCT01635790|Growth Substances|growth substances|mesh-ancestor
24731616|NCT01635790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731617|NCT01635790|Growth Inhibitors|growth inhibitors|mesh-ancestor
24731618|NCT01635803|Bevacizumab|bevacizumab|mesh-list
24731619|NCT01635803|Ranibizumab|ranibizumab|mesh-list
24731620|NCT01635803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24731621|NCT01635803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731622|NCT01635803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24731623|NCT01635803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24731624|NCT01635803|Growth Substances|growth substances|mesh-ancestor
24731625|NCT01635803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731626|NCT01635803|Growth Inhibitors|growth inhibitors|mesh-ancestor
24731627|NCT01635816|Vaccines|vaccines|mesh-list
24731628|NCT01635816|Immunologic Factors|immunologic factors|mesh-ancestor
24731629|NCT01635816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731630|NCT01635829|Carbamazepine|carbamazepine|mesh-list
24731631|NCT01635829|Phenytoin|phenytoin|mesh-list
24731665|NCT01635972|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24731666|NCT01635972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24731667|NCT01635972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24952455|NCT03894007|Cyclophosphamide|cyclophosphamide|mesh-list
24731668|NCT01635972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731679|NCT01636037|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24731680|NCT01636037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24731681|NCT01636037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24731682|NCT01636037|Dopamine Agents|dopamine agents|mesh-ancestor
24731683|NCT01636037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24731687|NCT01636037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731688|NCT01636037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24731689|NCT01636037|Immunologic Factors|immunologic factors|mesh-ancestor
24731690|NCT01636037|Dopamine Agonists|dopamine agonists|mesh-ancestor
24731691|NCT01636128|Eflornithine|eflornithine|mesh-list
24731693|NCT01636128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731694|NCT01636128|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25051007|NCT00451152|Growth Substances|growth substances|mesh-ancestor
25051008|NCT00451152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731719|NCT01636180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912163|NCT04279106|Disinfectants|disinfectants|mesh-ancestor
24731786|NCT01636557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24731788|NCT01636557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24731789|NCT01636557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24731790|NCT01636557|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24731791|NCT01636557|Anesthetics, General|anesthetics, general|mesh-ancestor
24731792|NCT01636557|Anesthetics|anesthetics|mesh-ancestor
24731793|NCT01636557|GABA Modulators|gaba modulators|mesh-ancestor
24731794|NCT01636557|GABA Agents|gaba agents|mesh-ancestor
24731795|NCT01636557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24731796|NCT01636557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731797|NCT01636557|Anticoagulants|anticoagulants|mesh-ancestor
24731798|NCT01636557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24731809|NCT01636557|Hemostatics|hemostatics|mesh-ancestor
24731820|NCT01636596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731822|NCT01636609|Azacitidine|azacitidine|mesh-list
24731824|NCT01636609|Glycine|glycine|mesh-list
24731825|NCT01636609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24731826|NCT01636609|Antimetabolites|antimetabolites|mesh-ancestor
24731827|NCT01636609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731828|NCT01636609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731829|NCT01636609|Antiviral Agents|antiviral agents|mesh-ancestor
24731830|NCT01636609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24731831|NCT01636609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24731832|NCT01636609|Immunologic Factors|immunologic factors|mesh-ancestor
25083858|NCT03311984|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25083859|NCT03311984|Dalteparin|dalteparin|mesh-list
25083899|NCT03311789|Nivolumab|nivolumab|mesh-list
24731833|NCT01636609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731873|NCT01636895|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24731874|NCT01636895|Renal Agents|renal agents|mesh-ancestor
24731875|NCT01636908|Everolimus|everolimus|mesh-list
24731876|NCT01636908|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24731877|NCT01636908|Sorafenib|sorafenib|mesh-list
24731878|NCT01636908|Sunitinib|sunitinib|mesh-list
24731879|NCT01636908|Dasatinib|dasatinib|mesh-list
24731880|NCT01636908|Lapatinib|lapatinib|mesh-list
24731881|NCT01636908|Vemurafenib|vemurafenib|mesh-list
24731882|NCT01636908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731883|NCT01636908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24731884|NCT01636908|Immunologic Factors|immunologic factors|mesh-ancestor
24731885|NCT01636908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731886|NCT01636908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24731887|NCT01636908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731936|NCT01637233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
24731942|NCT01637233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24731966|NCT01637259|Protease Inhibitors|protease inhibitors|mesh-list
24731967|NCT01637259|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24731968|NCT01637259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24649423|NCT01219764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24731969|NCT01637259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731971|NCT01637259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24731972|NCT01637259|Antiviral Agents|antiviral agents|mesh-ancestor
24731997|NCT01637454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24731998|NCT01637532|Interferons|interferons|mesh-list
24731999|NCT01637532|Interferon-alpha|interferon-alpha|mesh-list
24732000|NCT01637532|Interferon alpha-2|interferon alpha-2|mesh-list
24732001|NCT01637532|Carboplatin|carboplatin|mesh-list
24732002|NCT01637532|Doxorubicin|doxorubicin|mesh-list
24732003|NCT01637532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732004|NCT01637532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24732005|NCT01637532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24732006|NCT01637532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24732007|NCT01637532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732008|NCT01637532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732009|NCT01637532|Antiviral Agents|antiviral agents|mesh-ancestor
24732010|NCT01637532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24732011|NCT01637532|Immunologic Factors|immunologic factors|mesh-ancestor
24732012|NCT01637532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732013|NCT01637545|Ramosetron|ramosetron|mesh-list
24732014|NCT01637545|Antiemetics|antiemetics|mesh-ancestor
24732015|NCT01637545|Autonomic Agents|autonomic agents|mesh-ancestor
24732018|NCT01637545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24732031|NCT01637558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24732032|NCT01637558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24732033|NCT01637558|Antiviral Agents|antiviral agents|mesh-ancestor
24732034|NCT01637558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24732035|NCT01637558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24616970|NCT01040195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24767393|NCT01800526|Expectorants|expectorants|mesh-ancestor
24767394|NCT01800526|Respiratory System Agents|respiratory system agents|mesh-ancestor
24616980|NCT01040195|Immunologic Factors|immunologic factors|mesh-ancestor
24616981|NCT01040195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24616982|NCT01040195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24616983|NCT01040195|Antimalarials|antimalarials|mesh-ancestor
24616984|NCT01040195|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24616985|NCT01040195|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24616986|NCT01040195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24616987|NCT01040234|Bupivacaine|bupivacaine|mesh-list
24616988|NCT01040234|Anesthetics, Local|anesthetics, local|mesh-ancestor
24616989|NCT01040234|Anesthetics|anesthetics|mesh-ancestor
24616990|NCT01040234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24616991|NCT01040234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732036|NCT01637558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24732037|NCT01637558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24732052|NCT01637636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24867226|NCT02940496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24867227|NCT02940496|Antimetabolites|antimetabolites|mesh-ancestor
24732053|NCT01637636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24732054|NCT01637636|Leprostatic Agents|leprostatic agents|mesh-ancestor
25668531|NCT01718483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668532|NCT01718483|Dopamine Agents|dopamine agents|mesh-ancestor
24732055|NCT01637636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24978683|NCT03410706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449435|NCT00315601|Chelating Agents|chelating agents|mesh-ancestor
24449436|NCT00315601|Sequestering Agents|sequestering agents|mesh-ancestor
24732056|NCT01637636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732057|NCT01637636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732058|NCT01637636|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24732059|NCT01637636|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24732060|NCT01637636|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24732061|NCT01637636|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24732062|NCT01637636|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24732063|NCT01637636|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24732064|NCT01637636|Antifungal Agents|antifungal agents|mesh-ancestor
24732102|NCT01637753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732103|NCT01637753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520439|NCT01928394|Nivolumab|nivolumab|mesh-list
24732105|NCT01637766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24732106|NCT01637766|Alkylating Agents|alkylating agents|mesh-ancestor
24732107|NCT01637766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732108|NCT01637766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862489|NCT00090012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24732121|NCT01637818|Antipyretics|antipyretics|mesh-ancestor
24732122|NCT01637818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24732123|NCT01637844|Telbivudine|telbivudine|mesh-list
24732124|NCT01637844|Antiviral Agents|antiviral agents|mesh-ancestor
24732126|NCT01637844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24732127|NCT01637844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732128|NCT01637844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732129|NCT01637883|Benzydamine|benzydamine|mesh-list
24732130|NCT01637883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24732131|NCT01637948|Listerine|listerine|mesh-list
24732132|NCT01637948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24732133|NCT01637948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24732134|NCT01638026|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24732135|NCT01638026|Luteolytic Agents|luteolytic agents|mesh-ancestor
24732136|NCT01638026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24732137|NCT01638026|Contraceptive Agents|contraceptive agents|mesh-ancestor
24913916|NCT04259476|Ketamine|ketamine|mesh-list
24732171|NCT01638234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24732172|NCT01638247|Tamoxifen|tamoxifen|mesh-list
24732173|NCT01638247|Goserelin|goserelin|mesh-list
24942307|NCT03982134|Panobinostat|panobinostat|mesh-list
24942308|NCT03982134|Spartalizumab|spartalizumab|mesh-list
24942309|NCT03982134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942310|NCT03982134|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24942311|NCT03982134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24942312|NCT03982134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942313|NCT03982134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24942314|NCT03982277|Rifampin|rifampin|mesh-list
24942315|NCT03982277|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24942316|NCT03982277|Antitubercular Agents|antitubercular agents|mesh-ancestor
24942317|NCT03982277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24942318|NCT03982277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24942319|NCT03982277|Leprostatic Agents|leprostatic agents|mesh-ancestor
24942320|NCT03982277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24942321|NCT03982277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24942322|NCT03982277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732175|NCT01638247|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24732176|NCT01638247|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24732178|NCT01638247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24732180|NCT01638247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24732181|NCT01638247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732182|NCT01638247|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24914076|NCT04258423|Tacrolimus|tacrolimus|mesh-list
24617017|NCT01040312|Cisplatin|cisplatin|mesh-list
24617018|NCT01040312|Carboplatin|carboplatin|mesh-list
24617019|NCT01040312|Nedaplatin|nedaplatin|mesh-list
24617020|NCT01040312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617021|NCT01040325|Vaccines|vaccines|mesh-list
24617022|NCT01040325|Immunologic Factors|immunologic factors|mesh-ancestor
24617023|NCT01040325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668533|NCT01718483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25668534|NCT01718509|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25668535|NCT01718509|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24617024|NCT01040338|Nicotine|nicotine|mesh-list
24617025|NCT01040338|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24617026|NCT01040338|Autonomic Agents|autonomic agents|mesh-ancestor
24732203|NCT01638273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24732204|NCT01638273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942323|NCT03982277|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24942324|NCT03982277|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24942325|NCT03982277|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24942326|NCT03982277|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24942327|NCT03982277|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24942328|NCT03982277|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24855633|NCT02280265|Coagulants|coagulants|mesh-ancestor
24732205|NCT01638273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24732206|NCT01638273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24732207|NCT01638273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24732208|NCT01638273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24732209|NCT01638273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24732210|NCT01638299|Insulin|insulin|mesh-list
24732211|NCT01638299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24732212|NCT01638299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732213|NCT01638325|Insulin|insulin|mesh-list
24732214|NCT01638325|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24732248|NCT01638624|Anesthetics, General|anesthetics, general|mesh-ancestor
24732249|NCT01638624|Anesthetics|anesthetics|mesh-ancestor
24732250|NCT01638650|Ritonavir|ritonavir|mesh-list
24732251|NCT01638650|Saquinavir|saquinavir|mesh-list
24732252|NCT01638650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
24732253|NCT01638650|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24732254|NCT01638650|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24732255|NCT01638650|Protease Inhibitors|protease inhibitors|mesh-ancestor
24732286|NCT01638689|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24732287|NCT01638689|Antidepressive Agents|antidepressive agents|mesh-ancestor
24617045|NCT01040429|Adrenergic Agents|adrenergic agents|mesh-ancestor
24617046|NCT01040429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24617047|NCT01040429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617049|NCT01040455|Dexlansoprazole|dexlansoprazole|mesh-list
24617050|NCT01040455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24617051|NCT01040455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24617052|NCT01040455|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24617053|NCT01040455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617063|NCT01040585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24617064|NCT01040585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24617065|NCT01040585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24743648|NCT04696380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617096|NCT01041027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617098|NCT01041040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24617099|NCT01041040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617101|NCT01041066|Nicardipine|nicardipine|mesh-list
24942360|NCT03981887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24942361|NCT03981887|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24732501|NCT01639885|Antiviral Agents|antiviral agents|mesh-ancestor
24732502|NCT01639885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24732503|NCT01639885|Immunologic Factors|immunologic factors|mesh-ancestor
24732504|NCT01639885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732505|NCT01639898|Dexamethasone|dexamethasone|mesh-list
24732506|NCT01639898|Dexamethasone acetate|dexamethasone acetate|mesh-list
24732507|NCT01639898|Lenalidomide|lenalidomide|mesh-list
24732510|NCT01639898|Antiemetics|antiemetics|mesh-ancestor
24928087|NCT04126330|Vitamin D|vitamin d|mesh-list
24732537|NCT01640002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732550|NCT01640210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732551|NCT01640275|Propofol|propofol|mesh-list
24732552|NCT01640275|Isoflurane|isoflurane|mesh-list
24617169|NCT01041378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24617171|NCT01041378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617172|NCT01041443|Tetrahydrouridine|tetrahydrouridine|mesh-list
24617173|NCT01041443|Antimetabolites|antimetabolites|mesh-ancestor
24617174|NCT01041443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617175|NCT01041482|Sorafenib|sorafenib|mesh-list
24617176|NCT01041482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617177|NCT01041482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24617178|NCT01041482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617179|NCT01041482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617180|NCT01041508|Cyclosporine|cyclosporine|mesh-list
24867477|NCT04339049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617181|NCT01041508|Mycophenolic Acid|mycophenolic acid|mesh-list
25084120|NCT03309566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24617182|NCT01041508|Clofarabine|clofarabine|mesh-list
24490092|NCT00476359|Lopinavir|lopinavir|mesh-list
24732808|NCT01641419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24732809|NCT01641419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732810|NCT01641419|Protease Inhibitors|protease inhibitors|mesh-ancestor
24732811|NCT01641419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732812|NCT01641419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732814|NCT01641458|Fluorouracil|fluorouracil|mesh-list
24732815|NCT01641458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24732816|NCT01641458|Antimetabolites|antimetabolites|mesh-ancestor
24732853|NCT01641575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732855|NCT01641666|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24732856|NCT01641666|Interferon-alpha|interferon-alpha|mesh-list
24732857|NCT01641666|Antimetabolites|antimetabolites|mesh-ancestor
24732858|NCT01641666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732859|NCT01641666|Antiviral Agents|antiviral agents|mesh-ancestor
24732860|NCT01641666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24732861|NCT01641666|Immunologic Factors|immunologic factors|mesh-ancestor
24732862|NCT01641666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915582|NCT04250519|Eusol|eusol|mesh-list
25109337|NCT03125772|Paclitaxel|paclitaxel|mesh-list
24732972|NCT01642745|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
24732973|NCT01642745|Respiratory System Agents|respiratory system agents|mesh-ancestor
24732974|NCT01642745|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24733019|NCT01642966|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24733021|NCT01642966|Purinergic Agents|purinergic agents|mesh-ancestor
24733022|NCT01642966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24733023|NCT01642966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067418|NCT03443843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767568|NCT01802268|Sirolimus|sirolimus|mesh-list
24767569|NCT01802268|Tacrolimus|tacrolimus|mesh-list
24819750|NCT02097147|Paroxetine|paroxetine|mesh-list
24942459|NCT03980379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942460|NCT03980379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24942462|NCT03980496|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24942463|NCT03980496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24942464|NCT03980496|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24942465|NCT03980496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24942466|NCT03980496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942467|NCT03980223|Doxycycline|doxycycline|mesh-list
24916481|NCT04240496|GABA Antagonists|gaba antagonists|mesh-ancestor
24733283|NCT01644838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24733285|NCT01644838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24733286|NCT01644838|Cholinergic Agents|cholinergic agents|mesh-ancestor
24733287|NCT01644838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24733288|NCT01644838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733289|NCT01644838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24491450|NCT00482573|Epinephrine|epinephrine|mesh-list
24733340|NCT01645384|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24733341|NCT01645384|Antimetabolites|antimetabolites|mesh-ancestor
24733342|NCT01645384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733391|NCT01645748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733402|NCT01645774|Nasal Decongestants|nasal decongestants|mesh-ancestor
24733403|NCT01645774|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24733404|NCT01645774|Respiratory System Agents|respiratory system agents|mesh-ancestor
24733405|NCT01645787|4-Aminopyridine|4-aminopyridine|mesh-list
24733407|NCT01645787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24917049|NCT04234516|Morphine|morphine|mesh-list
24733469|NCT01646437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24733470|NCT01646437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24733471|NCT01646437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24733472|NCT01646437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24733473|NCT01646437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051024|NCT00449605|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25051025|NCT00449605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25051026|NCT00449605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051027|NCT00449605|Hormones|hormones|mesh-ancestor
25051028|NCT00449605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25051029|NCT00448422|Prulifloxacin|prulifloxacin|mesh-list
25051030|NCT00448422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25051031|NCT00448422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25051032|NCT00448422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25668536|NCT01718509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051033|NCT00448422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25051034|NCT00448422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051035|NCT00448422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051036|NCT00448422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051037|NCT00448058|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25051038|NCT00448058|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25051039|NCT00448058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25051040|NCT00448058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25051051|NCT00447564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051052|NCT00447564|Analgesics|analgesics|mesh-ancestor
25051053|NCT00447564|Sensory System Agents|sensory system agents|mesh-ancestor
25051054|NCT00447564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25051055|NCT00447564|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24733551|NCT01646788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24733552|NCT01646788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733553|NCT01646788|Tubulin Modulators|tubulin modulators|mesh-ancestor
24733554|NCT01646788|Antimitotic Agents|antimitotic agents|mesh-ancestor
24733555|NCT01646788|Mitosis Modulators|mitosis modulators|mesh-ancestor
24617357|NCT01042704|Sensory System Agents|sensory system agents|mesh-ancestor
24617367|NCT01042704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24733623|NCT01647646|Respiratory System Agents|respiratory system agents|mesh-ancestor
24733633|NCT01647659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733656|NCT01647685|Protective Agents|protective agents|mesh-ancestor
24733657|NCT01647685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24733658|NCT01647685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733659|NCT01647828|Gemcitabine|gemcitabine|mesh-list
24733668|NCT01647828|Antimetabolites|antimetabolites|mesh-ancestor
24733677|NCT01647880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733678|NCT01647880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24733679|NCT01647880|Immunologic Factors|immunologic factors|mesh-ancestor
24733680|NCT01647880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733681|NCT01647893|Bivalirudin|bivalirudin|mesh-list
24733682|NCT01647893|Antithrombins|antithrombins|mesh-ancestor
24733683|NCT01647893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24733684|NCT01647893|Protease Inhibitors|protease inhibitors|mesh-ancestor
24733685|NCT01647893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733686|NCT01647893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733687|NCT01647893|Anticoagulants|anticoagulants|mesh-ancestor
24733728|NCT01648218|Insulin, Isophane|insulin, isophane|mesh-list
24733738|NCT01648231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24733739|NCT01648231|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24733740|NCT01648231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24733741|NCT01648231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733742|NCT01648231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25199800|NCT02738658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25134809|NCT03005145|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24733743|NCT01648231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733744|NCT01648231|Vasodilator Agents|vasodilator agents|mesh-ancestor
24733745|NCT01648231|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24733746|NCT01648231|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24733758|NCT01648465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733759|NCT01648465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24733761|NCT01648465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733762|NCT01648517|Gemcitabine|gemcitabine|mesh-list
24617392|NCT01042782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617393|NCT01042782|Alkylating Agents|alkylating agents|mesh-ancestor
24617394|NCT01042782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617395|NCT01042782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24742133|NCT05293171|Moxifloxacin|moxifloxacin|mesh-list
24733769|NCT01648517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733770|NCT01648517|Antiviral Agents|antiviral agents|mesh-ancestor
24733771|NCT01648517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24733772|NCT01648517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733773|NCT01648517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24733774|NCT01648517|Immunologic Factors|immunologic factors|mesh-ancestor
24733775|NCT01648517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733776|NCT01648517|Tubulin Modulators|tubulin modulators|mesh-ancestor
24733777|NCT01648517|Antimitotic Agents|antimitotic agents|mesh-ancestor
24733778|NCT01648517|Mitosis Modulators|mitosis modulators|mesh-ancestor
24733779|NCT01648517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24733781|NCT01648556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24733782|NCT01648556|Glucocorticoids|glucocorticoids|mesh-ancestor
24628844|NCT01101659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24628845|NCT01101659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084219|NCT03308708|Norepinephrine|norepinephrine|mesh-list
25084220|NCT03308708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25084221|NCT03308708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25084222|NCT03308708|Adrenergic Agents|adrenergic agents|mesh-ancestor
25084223|NCT03308708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25084224|NCT03308708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084225|NCT03308708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733783|NCT01648556|Hormones|hormones|mesh-ancestor
24733784|NCT01648556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24733785|NCT01648556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733786|NCT01648556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24733794|NCT01648595|Sensory System Agents|sensory system agents|mesh-ancestor
24733828|NCT01648777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24733829|NCT01648777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733830|NCT01648777|Sensory System Agents|sensory system agents|mesh-ancestor
24733831|NCT01648777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24733832|NCT01648829|Atorvastatin|atorvastatin|mesh-list
24733833|NCT01648829|Pitavastatin|pitavastatin|mesh-list
24733834|NCT01648829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24733835|NCT01648829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24733836|NCT01648829|Antimetabolites|antimetabolites|mesh-ancestor
24733837|NCT01648829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733838|NCT01648829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24733839|NCT01648829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24733840|NCT01648829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733841|NCT01648881|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24733843|NCT01648881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733845|NCT01648998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24733846|NCT01649024|Tremelimumab|tremelimumab|mesh-list
24733916|NCT01649544|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24733917|NCT01649544|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24733918|NCT01649544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24733919|NCT01649570|Insulin Aspart|insulin aspart|mesh-list
24733927|NCT01649635|Ciprofloxacin|ciprofloxacin|mesh-list
24733934|NCT01649635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733935|NCT01649635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24733936|NCT01649635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199801|NCT02738658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24588121|NCT00901069|Immunologic Factors|immunologic factors|mesh-ancestor
24733937|NCT01649635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24733938|NCT01649635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24867601|NCT03761277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867602|NCT03761277|Analgesics|analgesics|mesh-ancestor
24867603|NCT03761277|Sensory System Agents|sensory system agents|mesh-ancestor
24867604|NCT03761277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24867605|NCT03729258|Amantadine|amantadine|mesh-list
24733939|NCT01649635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24733940|NCT01649635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25109403|NCT03124524|Hormones|hormones|mesh-ancestor
24733959|NCT01649830|Temozolomide|temozolomide|mesh-list
24733960|NCT01649830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24733961|NCT01649830|Alkylating Agents|alkylating agents|mesh-ancestor
24733962|NCT01649830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733963|NCT01649830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733964|NCT01649895|Cycloserine|cycloserine|mesh-list
24733965|NCT01649895|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24733966|NCT01649895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25404117|NCT03684018|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25668537|NCT01718509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25668538|NCT01718509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25668539|NCT01718509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25668540|NCT01718509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668541|NCT01718509|Dopamine Agents|dopamine agents|mesh-ancestor
25668542|NCT01718509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25668543|NCT01718691|Rituximab|rituximab|mesh-list
25668544|NCT01718691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25668545|NCT01718691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25668546|NCT01718691|Immunologic Factors|immunologic factors|mesh-ancestor
25084302|NCT03308136|Lidocaine|lidocaine|mesh-list
24733972|NCT01649895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733973|NCT01649921|Interferons|interferons|mesh-list
24733990|NCT01650012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24733991|NCT01650012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733992|NCT01650012|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24733993|NCT01650012|Diuretics|diuretics|mesh-ancestor
24733994|NCT01650012|Natriuretic Agents|natriuretic agents|mesh-ancestor
24733995|NCT01650012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24733996|NCT01650090|Cisplatin|cisplatin|mesh-list
24733997|NCT01650090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24734114|NCT01650662|Immunologic Factors|immunologic factors|mesh-ancestor
24734115|NCT01650662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734116|NCT01650662|Antifungal Agents|antifungal agents|mesh-ancestor
24734117|NCT01650662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24734147|NCT01650740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24734148|NCT01650740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617460|NCT01043341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617461|NCT01043380|Atorvastatin|atorvastatin|mesh-list
24617463|NCT01043380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24617464|NCT01043380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24617465|NCT01043380|Antimetabolites|antimetabolites|mesh-ancestor
24617466|NCT01043380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617467|NCT01043380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24921067|NCT04194658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24734173|NCT01650883|Vitamin D|vitamin d|mesh-list
24734174|NCT01650883|Ergocalciferols|ergocalciferols|mesh-list
24734175|NCT01650883|Cholecalciferol|cholecalciferol|mesh-list
24734176|NCT01650883|Vitamins|vitamins|mesh-list
24734204|NCT01651169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24734205|NCT01651169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24734206|NCT01651169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24867606|NCT03729258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24867642|NCT03455764|Trametinib|trametinib|mesh-list
24867643|NCT03455764|Dabrafenib|dabrafenib|mesh-list
24867644|NCT03455764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24734207|NCT01651169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734208|NCT01651169|Dopamine Agents|dopamine agents|mesh-ancestor
24734209|NCT01651169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24734210|NCT01651182|Tranexamic Acid|tranexamic acid|mesh-list
24734237|NCT01651364|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24734238|NCT01651364|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24734239|NCT01651364|Dopamine Agonists|dopamine agonists|mesh-ancestor
24734297|NCT01651481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734299|NCT01651481|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24734307|NCT01651520|GABA Modulators|gaba modulators|mesh-ancestor
24734308|NCT01651520|GABA Agents|gaba agents|mesh-ancestor
24734309|NCT01651520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24734310|NCT01651520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734311|NCT01651572|Rocuronium|rocuronium|mesh-list
24734312|NCT01651572|Cisatracurium|cisatracurium|mesh-list
24942564|NCT03979664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942565|NCT03979664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24942566|NCT03979664|Glucocorticoids|glucocorticoids|mesh-ancestor
24942567|NCT03979664|Hormones|hormones|mesh-ancestor
24734366|NCT01651988|Propofol|propofol|mesh-list
24734367|NCT01651988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24734368|NCT01651988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25862490|NCT00090012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862491|NCT00090012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25862492|NCT00090012|Serotonin Agents|serotonin agents|mesh-ancestor
24922114|NCT04183361|Cortisone|cortisone|mesh-list
24734474|NCT01652339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734475|NCT01652339|Vasodilator Agents|vasodilator agents|mesh-ancestor
25199802|NCT02738658|Immunologic Factors|immunologic factors|mesh-ancestor
24734487|NCT01652378|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24734489|NCT01652378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24734741|NCT01653470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24734490|NCT01652378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734492|NCT01652378|Autonomic Agents|autonomic agents|mesh-ancestor
24617504|NCT01043575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24617505|NCT01043575|Antitubercular Agents|antitubercular agents|mesh-ancestor
24617506|NCT01043575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24617507|NCT01043575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25668547|NCT01718691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617508|NCT01043575|Leprostatic Agents|leprostatic agents|mesh-ancestor
24734618|NCT01652820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734620|NCT01652820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24734621|NCT01652820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734622|NCT01652820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24734623|NCT01652820|Immunologic Factors|immunologic factors|mesh-ancestor
24734624|NCT01652820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734625|NCT01652820|Tubulin Modulators|tubulin modulators|mesh-ancestor
24734626|NCT01652820|Antimitotic Agents|antimitotic agents|mesh-ancestor
24734627|NCT01652820|Mitosis Modulators|mitosis modulators|mesh-ancestor
24734628|NCT01652859|Amphotericin B|amphotericin b|mesh-list
24734629|NCT01652859|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24734630|NCT01652859|Amebicides|amebicides|mesh-ancestor
24734631|NCT01652859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24734632|NCT01652859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24734633|NCT01652859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24734634|NCT01652859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24734635|NCT01652859|Antifungal Agents|antifungal agents|mesh-ancestor
24734636|NCT01652898|Esmolol|esmolol|mesh-list
24734637|NCT01652898|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24734638|NCT01652898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24734639|NCT01652898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24734640|NCT01652898|Adrenergic Agents|adrenergic agents|mesh-ancestor
24734641|NCT01652898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24734642|NCT01652898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734667|NCT01653067|Autonomic Agents|autonomic agents|mesh-ancestor
24734668|NCT01653067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24734669|NCT01653067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24734670|NCT01653067|Glucocorticoids|glucocorticoids|mesh-ancestor
24734671|NCT01653067|Hormones|hormones|mesh-ancestor
24734672|NCT01653067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25067421|NCT03443843|Dermatologic Agents|dermatologic agents|mesh-ancestor
24734674|NCT01653067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734676|NCT01653067|Antimetabolites|antimetabolites|mesh-ancestor
24734677|NCT01653067|Antiviral Agents|antiviral agents|mesh-ancestor
24734678|NCT01653067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24734679|NCT01653067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24734680|NCT01653067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24734681|NCT01653067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24734682|NCT01653067|Antifungal Agents|antifungal agents|mesh-ancestor
24734683|NCT01653119|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24734684|NCT01653119|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24734685|NCT01653119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24734686|NCT01653119|Antimetabolites|antimetabolites|mesh-ancestor
24942580|NCT03979651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942581|NCT03979651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24942582|NCT03979456|Rituximab|rituximab|mesh-list
24855912|NCT02281799|Azathioprine|azathioprine|mesh-list
24734687|NCT01653119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734688|NCT01653119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24650087|NCT01223755|Antifungal Agents|antifungal agents|mesh-ancestor
24734689|NCT01653119|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24734692|NCT01653171|Simethicone|simethicone|mesh-list
24734693|NCT01653171|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24734694|NCT01653171|Antiviral Agents|antiviral agents|mesh-ancestor
24734712|NCT01653236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24734713|NCT01653314|Imatinib Mesylate|imatinib mesylate|mesh-list
24734725|NCT01653457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24734726|NCT01653457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24734728|NCT01653470|Paclitaxel|paclitaxel|mesh-list
24734729|NCT01653470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24734730|NCT01653470|Carboplatin|carboplatin|mesh-list
24734731|NCT01653470|Fluorouracil|fluorouracil|mesh-list
24734732|NCT01653470|Irinotecan|irinotecan|mesh-list
24734733|NCT01653470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24734734|NCT01653470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24734735|NCT01653470|Tubulin Modulators|tubulin modulators|mesh-ancestor
24734738|NCT01653470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734740|NCT01653470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24734742|NCT01653470|Immunologic Factors|immunologic factors|mesh-ancestor
24734743|NCT01653470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734744|NCT01653470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24734745|NCT01653470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24650110|NCT01224041|Tacrolimus|tacrolimus|mesh-list
24734746|NCT01653470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734751|NCT01653470|Micronutrients|micronutrients|mesh-ancestor
25862493|NCT00090012|Antidepressive Agents|antidepressive agents|mesh-ancestor
25862495|NCT00090025|Fluorouracil|fluorouracil|mesh-list
25862496|NCT00090025|Antimetabolites|antimetabolites|mesh-ancestor
25862497|NCT00090025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862498|NCT00090025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25862499|NCT00090025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862500|NCT00090025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24734752|NCT01653522|Doxycycline|doxycycline|mesh-list
24734753|NCT01653522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24734754|NCT01653522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24734755|NCT01653522|Antimalarials|antimalarials|mesh-ancestor
24734756|NCT01653522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24734757|NCT01653522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24734758|NCT01653561|Apatinib|apatinib|mesh-list
24734759|NCT01653561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25055039|NCT03525223|Dialysis Solutions|dialysis solutions|mesh-list
24734760|NCT01653561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24734761|NCT01653561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734762|NCT01653561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734807|NCT01653990|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24942583|NCT03979456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24942584|NCT03979456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942585|NCT03979456|Immunologic Factors|immunologic factors|mesh-ancestor
24942586|NCT03979456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942587|NCT03979456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24734808|NCT01653990|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24734809|NCT01653990|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24734810|NCT01654003|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
24734812|NCT01654081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24734813|NCT01654081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24734814|NCT01654081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734815|NCT01654081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734816|NCT01654081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24734818|NCT01654120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24734819|NCT01654120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734820|NCT01654120|Incretins|incretins|mesh-ancestor
24734837|NCT01654185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734838|NCT01654185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734839|NCT01654185|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24734840|NCT01654185|Hormone Antagonists|hormone antagonists|mesh-ancestor
24650156|NCT01224392|Capecitabine|capecitabine|mesh-list
24734841|NCT01654185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24787431|NCT01925287|Curcumin|curcumin|mesh-list
24734886|NCT01654562|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24734887|NCT01654562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734888|NCT01654575|Methotrexate|methotrexate|mesh-list
24734889|NCT01654575|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24734890|NCT01654575|Abortifacient Agents|abortifacient agents|mesh-ancestor
24399194|NCT00146900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24734892|NCT01654575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734893|NCT01654575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24734894|NCT01654575|Antimetabolites|antimetabolites|mesh-ancestor
24735175|NCT01655888|Tremelimumab|tremelimumab|mesh-list
24735176|NCT01655888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942631|NCT03979599|Analgesics|analgesics|mesh-ancestor
24942632|NCT03979599|Sensory System Agents|sensory system agents|mesh-ancestor
24942633|NCT03979599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24735223|NCT01656005|Adrenergic Agents|adrenergic agents|mesh-ancestor
24735224|NCT01656005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24735225|NCT01656005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735226|NCT01656005|Parasympatholytics|parasympatholytics|mesh-ancestor
24735227|NCT01656005|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24735228|NCT01656005|Cholinergic Agents|cholinergic agents|mesh-ancestor
24735229|NCT01656005|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25135108|NCT03002636|Anesthetics|anesthetics|mesh-list
24735230|NCT01656005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24735231|NCT01656005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25668548|NCT01718691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25668549|NCT01719003|Metformin|metformin|mesh-list
25668550|NCT01719003|Empagliflozin|empagliflozin|mesh-list
25668551|NCT01719003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25668552|NCT01719003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668553|NCT01719003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25084483|NCT03306602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084484|NCT03306602|Hormone Antagonists|hormone antagonists|mesh-ancestor
25084485|NCT03306602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25084486|NCT03306602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084487|NCT03306550|Aspirin|aspirin|mesh-list
25084489|NCT03306550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24735232|NCT01656005|Antioxidants|antioxidants|mesh-ancestor
24735233|NCT01656005|Protective Agents|protective agents|mesh-ancestor
24735234|NCT01656005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24735297|NCT01656122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24737211|NCT01667575|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24942640|NCT03979599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24942641|NCT03979599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942642|NCT03979599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24942643|NCT03979599|Tocolytic Agents|tocolytic agents|mesh-ancestor
24942644|NCT03979599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24942645|NCT03979599|Anesthetics, Local|anesthetics, local|mesh-ancestor
24735298|NCT01656122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24735299|NCT01656148|4-Aminopyridine|4-aminopyridine|mesh-list
24735300|NCT01656148|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24735301|NCT01656148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24735302|NCT01656148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735303|NCT01656226|Sunscreening Agents|sunscreening agents|mesh-list
24735304|NCT01656226|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24735305|NCT01656226|Protective Agents|protective agents|mesh-ancestor
24735306|NCT01656226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735307|NCT01656226|Dermatologic Agents|dermatologic agents|mesh-ancestor
24735308|NCT01656330|Rivaroxaban|rivaroxaban|mesh-list
24735309|NCT01656330|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24735310|NCT01656330|Antithrombins|antithrombins|mesh-ancestor
24735311|NCT01656330|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24735312|NCT01656330|Protease Inhibitors|protease inhibitors|mesh-ancestor
24735313|NCT01656330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25067423|NCT03443843|Antipruritics|antipruritics|mesh-ancestor
24925765|NCT04148183|Metformin|metformin|mesh-list
24735604|NCT01657838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24735605|NCT01657838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735606|NCT01657838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735607|NCT01657838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24735608|NCT01657838|Hormone Antagonists|hormone antagonists|mesh-ancestor
24735609|NCT01657838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24735610|NCT01657838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735611|NCT01657838|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24735612|NCT01657851|Tamsulosin|tamsulosin|mesh-list
24735705|NCT01658124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735706|NCT01658124|Hemostatics|hemostatics|mesh-ancestor
24735707|NCT01658124|Coagulants|coagulants|mesh-ancestor
24735708|NCT01658176|Exemestane|exemestane|mesh-list
24735709|NCT01658176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24735710|NCT01658176|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24735711|NCT01658176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24735712|NCT01658176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735713|NCT01658176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735714|NCT01658176|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24735715|NCT01658176|Hormone Antagonists|hormone antagonists|mesh-ancestor
24735716|NCT01658176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24650644|NCT01227174|Propofol|propofol|mesh-list
24735717|NCT01658176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735719|NCT01658202|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24735725|NCT01658202|Cholinergic Agents|cholinergic agents|mesh-ancestor
24735726|NCT01658202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24926893|NCT04137640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24735778|NCT01658527|Hormone Antagonists|hormone antagonists|mesh-ancestor
24617674|NCT01044888|Heparin|heparin|mesh-list
24617675|NCT01044888|Anticoagulants|anticoagulants|mesh-ancestor
24735914|NCT01659281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25668554|NCT01719003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668555|NCT01719172|Hemostatics|hemostatics|mesh-list
25668556|NCT01719172|Coagulants|coagulants|mesh-ancestor
25668557|NCT01719367|Atenolol|atenolol|mesh-list
25668558|NCT01719367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25668559|NCT01719367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25668560|NCT01719367|Sympatholytics|sympatholytics|mesh-ancestor
25668561|NCT01719367|Autonomic Agents|autonomic agents|mesh-ancestor
25862501|NCT00090025|Immunologic Factors|immunologic factors|mesh-ancestor
25862502|NCT00090025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862503|NCT00090025|Antidotes|antidotes|mesh-ancestor
24628982|NCT01102439|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24628983|NCT01102439|Purinergic Agents|purinergic agents|mesh-ancestor
24628984|NCT01102439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24628985|NCT01102465|Losartan|losartan|mesh-list
24628986|NCT01102465|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25199803|NCT02738658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867934|NCT04765137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24867935|NCT04765137|Antimetabolites|antimetabolites|mesh-ancestor
24867936|NCT04765137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867937|NCT04765137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24547958|NCT00706953|Doxorubicin|doxorubicin|mesh-list
25199804|NCT02738502|Ritonavir|ritonavir|mesh-list
25199805|NCT02738502|Darunavir|darunavir|mesh-list
25199806|NCT02738502|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25199807|NCT02738502|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25199808|NCT02738502|Protease Inhibitors|protease inhibitors|mesh-ancestor
24735915|NCT01659281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24735916|NCT01659281|Antiviral Agents|antiviral agents|mesh-ancestor
24735984|NCT01659437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24735985|NCT01659437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24735988|NCT01659476|Autonomic Agents|autonomic agents|mesh-ancestor
24617744|NCT01045369|Etravirine|etravirine|mesh-list
24617761|NCT01045538|Antimetabolites|antimetabolites|mesh-ancestor
24617936|NCT01046162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24617762|NCT01045538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617763|NCT01045538|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24617764|NCT01045538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617765|NCT01045642|Omeprazole|omeprazole|mesh-list
24617766|NCT01045642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24617767|NCT01045642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24617768|NCT01045642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24617769|NCT01045642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617770|NCT01045642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617771|NCT01045681|Dexamethasone|dexamethasone|mesh-list
24735989|NCT01659476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24735990|NCT01659476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735991|NCT01659476|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24735992|NCT01659476|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
24929454|NCT04112147|Ubiquinone|ubiquinone|mesh-list
24942690|NCT03978884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24942691|NCT03978884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24942692|NCT03978884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24736021|NCT01659775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24736022|NCT01659775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617778|NCT01045681|Autonomic Agents|autonomic agents|mesh-ancestor
24617779|NCT01045681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24617780|NCT01045681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617781|NCT01045681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24617782|NCT01045681|Glucocorticoids|glucocorticoids|mesh-ancestor
24617783|NCT01045681|Hormones|hormones|mesh-ancestor
24736038|NCT01659788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809345|NCT02033239|Insulin|insulin|mesh-list
24867939|NCT04765137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446547|NCT00305331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446548|NCT00305331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24446549|NCT00305331|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24446550|NCT00305331|Dopamine Agents|dopamine agents|mesh-ancestor
24446551|NCT00305331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24736040|NCT01659827|Bupivacaine|bupivacaine|mesh-list
24736041|NCT01659827|Anesthetics, Local|anesthetics, local|mesh-ancestor
24736042|NCT01659827|Anesthetics|anesthetics|mesh-ancestor
24736043|NCT01659827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24736044|NCT01659827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736045|NCT01659827|Sensory System Agents|sensory system agents|mesh-ancestor
24736062|NCT01659905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25668562|NCT01719367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25668563|NCT01719367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668564|NCT01719367|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25668565|NCT01719367|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25668566|NCT01719367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25668567|NCT01719367|Adrenergic Agents|adrenergic agents|mesh-ancestor
24736063|NCT01659905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862504|NCT00090025|Protective Agents|protective agents|mesh-ancestor
25862505|NCT00090025|Vitamin B Complex|vitamin b complex|mesh-ancestor
25862506|NCT00090025|Vitamins|vitamins|mesh-ancestor
25862507|NCT00090025|Micronutrients|micronutrients|mesh-ancestor
25862508|NCT00090038|Rituximab|rituximab|mesh-list
25862509|NCT00090038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24736064|NCT01659905|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24736065|NCT01659905|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24736070|NCT01659918|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24736071|NCT01659918|Hormone Antagonists|hormone antagonists|mesh-ancestor
24736072|NCT01659918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24736073|NCT01659918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736074|NCT01659918|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24736075|NCT01659918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24736076|NCT01659918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736077|NCT01659931|Montelukast|montelukast|mesh-list
24736078|NCT01659931|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24736079|NCT01659931|Respiratory System Agents|respiratory system agents|mesh-ancestor
24736080|NCT01659931|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24942695|NCT03978884|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24942696|NCT03979131|Avelumab|avelumab|mesh-list
24942697|NCT03979131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24942698|NCT03979131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942699|NCT03978845|Lidocaine|lidocaine|mesh-list
24736131|NCT01660386|Glimepiride|glimepiride|mesh-list
24736132|NCT01660386|Saxagliptin|saxagliptin|mesh-list
25051116|NCT00439738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25051117|NCT00439738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199809|NCT02738502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199810|NCT02738502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199811|NCT02738502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25199812|NCT02738502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25135282|NCT03000556|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25051118|NCT00439738|Vasodilator Agents|vasodilator agents|mesh-ancestor
25051119|NCT00439738|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24617937|NCT01046162|GABA Modulators|gaba modulators|mesh-ancestor
25051120|NCT00439738|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25051122|NCT00439738|Natriuretic Agents|natriuretic agents|mesh-ancestor
25051123|NCT00439738|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25051124|NCT00437112|Insulin|insulin|mesh-list
24929963|NCT04106752|Caffeine|caffeine|mesh-list
24942744|NCT03978559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24942746|NCT03978559|Hormones|hormones|mesh-ancestor
24942747|NCT03978559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24736191|NCT01660750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736192|NCT01660750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24932169|NCT04082598|Amoxicillin|amoxicillin|mesh-list
24446552|NCT00305331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868048|NCT03994172|Citric Acid|citric acid|mesh-list
24868049|NCT03994172|Sodium Citrate|sodium citrate|mesh-list
24868050|NCT03994172|Calcium|calcium|mesh-list
24736193|NCT01660750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24736194|NCT01660750|Alkylating Agents|alkylating agents|mesh-ancestor
24930226|NCT04103684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24736252|NCT01660997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24736253|NCT01660997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24930436|NCT04101578|Hormones|hormones|mesh-ancestor
24625786|NCT01083420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24625787|NCT01083420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24625788|NCT01083420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24625789|NCT01083537|Paclitaxel|paclitaxel|mesh-list
24625790|NCT01083537|Cisplatin|cisplatin|mesh-list
24506671|NCT00546507|Diclofenac|diclofenac|mesh-list
24942829|NCT03978234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24942830|NCT03978234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942831|NCT03978234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24942832|NCT03978234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24942833|NCT03977675|Ketamine|ketamine|mesh-list
24942834|NCT03977675|Analgesics|analgesics|mesh-ancestor
24942835|NCT03977675|Sensory System Agents|sensory system agents|mesh-ancestor
24942836|NCT03977675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24942837|NCT03977675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668568|NCT01719367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25668569|NCT01719367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668570|NCT01719380|Cetuximab|cetuximab|mesh-list
25668571|NCT01719380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24942838|NCT03977675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24942839|NCT03977675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24942840|NCT03977675|Anesthetics, General|anesthetics, general|mesh-ancestor
24942841|NCT03977675|Anesthetics|anesthetics|mesh-ancestor
24942842|NCT03977675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24942846|NCT03977675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736349|NCT01661439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24736350|NCT01661439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24736351|NCT01661439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736353|NCT01661530|Vitamins|vitamins|mesh-ancestor
24736354|NCT01661530|Micronutrients|micronutrients|mesh-ancestor
24736355|NCT01661530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736356|NCT01661530|Antioxidants|antioxidants|mesh-ancestor
24736357|NCT01661530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736358|NCT01661530|Protective Agents|protective agents|mesh-ancestor
24736359|NCT01661556|Miconazole|miconazole|mesh-list
24736360|NCT01661556|Hydroquinone|hydroquinone|mesh-list
24736361|NCT01661556|Antifungal Agents|antifungal agents|mesh-ancestor
24736362|NCT01661556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24736363|NCT01661556|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24736364|NCT01661556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24736365|NCT01661556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24736366|NCT01661556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736367|NCT01661556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24736368|NCT01661556|Hormone Antagonists|hormone antagonists|mesh-ancestor
24736395|NCT01661855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736396|NCT01661855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736397|NCT01661855|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24931368|NCT04089904|Pembrolizumab|pembrolizumab|mesh-list
24736491|NCT01662518|Hormones|hormones|mesh-ancestor
24736492|NCT01662518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24736493|NCT01662518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24736496|NCT01662622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24868086|NCT03829462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862510|NCT00090038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862511|NCT00090038|Immunologic Factors|immunologic factors|mesh-ancestor
25862512|NCT00090038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736541|NCT01662869|Fluorouracil|fluorouracil|mesh-list
24736542|NCT01662869|Levoleucovorin|levoleucovorin|mesh-list
25051155|NCT00434850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051156|NCT00434850|Antifungal Agents|antifungal agents|mesh-ancestor
25051157|NCT00434850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25051158|NCT00434850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25051160|NCT00434850|Sensory System Agents|sensory system agents|mesh-ancestor
25051161|NCT00434850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25051162|NCT00434850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24958906|NCT03829150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24958907|NCT03829150|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24942963|NCT03976037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24942964|NCT03976037|Oxytocics|oxytocics|mesh-ancestor
24942966|NCT03975374|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
24942967|NCT03975374|Dexamethasone|dexamethasone|mesh-list
24942968|NCT03975374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24942969|NCT03975374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24942970|NCT03975374|Antiemetics|antiemetics|mesh-ancestor
24942971|NCT03975374|Autonomic Agents|autonomic agents|mesh-ancestor
24942972|NCT03975374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25051182|NCT00434811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24736565|NCT01663038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24736566|NCT01663038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24736567|NCT01663038|Analgesics|analgesics|mesh-ancestor
24868163|NCT03021993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24868164|NCT03021993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736568|NCT01663038|Sensory System Agents|sensory system agents|mesh-ancestor
24736569|NCT01663038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24736570|NCT01663038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736571|NCT01663038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24736572|NCT01663038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24736573|NCT01663038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24736574|NCT01663038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24736575|NCT01663038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862513|NCT00090038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25862514|NCT00090090|Elsamicin A|elsamicin a|mesh-list
25862515|NCT00090090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25862516|NCT00090090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24736690|NCT01664650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24736691|NCT01664650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24736692|NCT01664650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24736694|NCT01664650|Phytoestrogens|phytoestrogens|mesh-ancestor
24736701|NCT01664676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736702|NCT01664676|Incretins|incretins|mesh-ancestor
24736782|NCT01665222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24617833|NCT01045889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24617835|NCT01045889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24617836|NCT01045889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24617837|NCT01045889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24617838|NCT01045889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617839|NCT01045889|Tubulin Modulators|tubulin modulators|mesh-ancestor
24617840|NCT01045889|Antimitotic Agents|antimitotic agents|mesh-ancestor
24617841|NCT01045889|Mitosis Modulators|mitosis modulators|mesh-ancestor
24617853|NCT01045902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24617854|NCT01045902|Contraceptive Agents|contraceptive agents|mesh-ancestor
24617855|NCT01045902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24617856|NCT01045902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943157|NCT03973775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943159|NCT03973879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943160|NCT03973957|Fentanyl|fentanyl|mesh-list
24943161|NCT03973957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24959077|NCT03827408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24959078|NCT03827408|Anesthetics, General|anesthetics, general|mesh-ancestor
24959079|NCT03827408|Anesthetics|anesthetics|mesh-ancestor
24959080|NCT03827408|GABA Modulators|gaba modulators|mesh-ancestor
24959081|NCT03827408|GABA Agents|gaba agents|mesh-ancestor
24959082|NCT03827070|Afatinib|afatinib|mesh-list
24736799|NCT01665235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24736800|NCT01665235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24736801|NCT01665235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24736802|NCT01665235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24736803|NCT01665235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736804|NCT01665235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24736805|NCT01665235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24736806|NCT01665235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24736807|NCT01665235|Antipyretics|antipyretics|mesh-ancestor
24736808|NCT01665235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24736809|NCT01665235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24736810|NCT01665235|Antimetabolites|antimetabolites|mesh-ancestor
24736811|NCT01665235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24736812|NCT01665235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24736850|NCT01665404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24736851|NCT01665404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24736852|NCT01665404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24736853|NCT01665404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736855|NCT01665404|Serotonin Agents|serotonin agents|mesh-ancestor
24736856|NCT01665404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24736857|NCT01665404|Antidepressive Agents|antidepressive agents|mesh-ancestor
24943173|NCT03974035|Anesthetics, Local|anesthetics, local|mesh-ancestor
24943174|NCT03974035|Anesthetics|anesthetics|mesh-ancestor
24943175|NCT03974035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24943176|NCT03974035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943177|NCT03974035|Sensory System Agents|sensory system agents|mesh-ancestor
25051184|NCT00434811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25051185|NCT00434811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25051186|NCT00434811|Analgesics|analgesics|mesh-ancestor
25051187|NCT00434811|Sensory System Agents|sensory system agents|mesh-ancestor
25051188|NCT00434811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25051189|NCT00434811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24943208|NCT03973567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24943209|NCT03973567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24943210|NCT03973567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25668572|NCT01719380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25668573|NCT01719653|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25668574|NCT01719653|Laxatives|laxatives|mesh-ancestor
25668575|NCT01719653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24934896|NCT04056949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25668576|NCT01719757|Oxycodone|oxycodone|mesh-list
25862517|NCT00090155|Ondansetron|ondansetron|mesh-list
25862519|NCT00090155|Antiemetics|antiemetics|mesh-ancestor
24736957|NCT01666067|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
24736958|NCT01666067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24736959|NCT01666067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24736975|NCT01666080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24736982|NCT01666223|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
24736983|NCT01666223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24736984|NCT01666223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24736985|NCT01666223|Antimetabolites|antimetabolites|mesh-ancestor
24935109|NCT04054531|Antimitotic Agents|antimitotic agents|mesh-ancestor
24943319|NCT03972683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24943320|NCT03972683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24943321|NCT03972683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24943322|NCT03972683|Parasympatholytics|parasympatholytics|mesh-ancestor
24943323|NCT03972683|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24617938|NCT01046162|GABA Agents|gaba agents|mesh-ancestor
24943327|NCT03972683|Sensory System Agents|sensory system agents|mesh-ancestor
24943328|NCT03972683|Vasodilator Agents|vasodilator agents|mesh-ancestor
24943329|NCT03972683|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24943330|NCT03972683|Purinergic Agonists|purinergic agonists|mesh-ancestor
24512647|NCT00576017|Narcotics|narcotics|mesh-ancestor
24943404|NCT03971279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24943405|NCT03971279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943406|NCT03971279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24943407|NCT03971279|Glucocorticoids|glucocorticoids|mesh-ancestor
24943409|NCT03971279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24943410|NCT03971279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24943411|NCT03971279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943412|NCT03971214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24737069|NCT01666600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24943413|NCT03971214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943417|NCT03970798|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24943418|NCT03970798|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24943419|NCT03970798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24943420|NCT03970798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24943421|NCT03970798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943422|NCT03970798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24943423|NCT03970798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24943424|NCT03970798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24943425|NCT03970798|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24943426|NCT03970798|Anesthetics, General|anesthetics, general|mesh-ancestor
24943427|NCT03970798|Anesthetics|anesthetics|mesh-ancestor
24943428|NCT03970798|GABA Modulators|gaba modulators|mesh-ancestor
24943429|NCT03970798|GABA Agents|gaba agents|mesh-ancestor
24943430|NCT03970798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24943438|NCT03970798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24943439|NCT03970798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24943440|NCT03970798|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24943441|NCT03970798|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24943442|NCT03970798|Purinergic Agents|purinergic agents|mesh-ancestor
24943443|NCT03971045|Cyclophosphamide|cyclophosphamide|mesh-list
24943445|NCT03971045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24943446|NCT03971045|Immunologic Factors|immunologic factors|mesh-ancestor
24943447|NCT03971045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943448|NCT03971045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24943449|NCT03971045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24943450|NCT03971045|Alkylating Agents|alkylating agents|mesh-ancestor
24943451|NCT03971045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943452|NCT03971045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943453|NCT03971045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24943454|NCT03971045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24943455|NCT03970772|Glucagon|glucagon|mesh-list
24768604|NCT01809340|Anesthetics|anesthetics|mesh-ancestor
24737181|NCT01667445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737182|NCT01667484|Adderall|adderall|mesh-list
24737183|NCT01667484|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24737184|NCT01667484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737185|NCT01667497|4-Aminopyridine|4-aminopyridine|mesh-list
24737186|NCT01667497|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24737187|NCT01667497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25404118|NCT03684018|Immunologic Factors|immunologic factors|mesh-ancestor
25668577|NCT01719757|Naloxone|naloxone|mesh-list
25668578|NCT01719757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24737188|NCT01667497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737190|NCT01667523|Capsaicin|capsaicin|mesh-list
24737191|NCT01667523|Antipruritics|antipruritics|mesh-ancestor
24737192|NCT01667523|Dermatologic Agents|dermatologic agents|mesh-ancestor
24737193|NCT01667523|Sensory System Agents|sensory system agents|mesh-ancestor
24737194|NCT01667523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25862520|NCT00090155|Autonomic Agents|autonomic agents|mesh-ancestor
24737202|NCT01667575|Clarithromycin|clarithromycin|mesh-list
24737203|NCT01667575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24737204|NCT01667575|Potassium Citrate|potassium citrate|mesh-list
24737205|NCT01667575|Esomeprazole|esomeprazole|mesh-list
24737206|NCT01667575|Bismuth|bismuth|mesh-list
24737207|NCT01667575|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24737208|NCT01667575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737209|NCT01667575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24737210|NCT01667575|Antitubercular Agents|antitubercular agents|mesh-ancestor
24768605|NCT01809340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24768606|NCT01809340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25045838|NCT00907907|Mycophenolic Acid|mycophenolic acid|mesh-list
24768607|NCT01809340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24768608|NCT01809340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24768609|NCT01809340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768610|NCT01809340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24768611|NCT01809340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24768613|NCT01809392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24768614|NCT01809392|Antimetabolites|antimetabolites|mesh-ancestor
24768615|NCT01809392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768616|NCT01809392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768617|NCT01809392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24768618|NCT01809444|Doxycycline|doxycycline|mesh-list
24768619|NCT01809444|Prednisone|prednisone|mesh-list
24768620|NCT01809444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24768621|NCT01809444|Glucocorticoids|glucocorticoids|mesh-ancestor
24768622|NCT01809444|Hormones|hormones|mesh-ancestor
24768623|NCT01809444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24768624|NCT01809444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768625|NCT01809444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24856776|NCT02286934|Carvedilol|carvedilol|mesh-list
24737217|NCT01667575|Antacids|antacids|mesh-ancestor
24737218|NCT01667575|Diuretics|diuretics|mesh-ancestor
24737219|NCT01667575|Natriuretic Agents|natriuretic agents|mesh-ancestor
24737220|NCT01667575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737221|NCT01667575|Expectorants|expectorants|mesh-ancestor
24737222|NCT01667575|Respiratory System Agents|respiratory system agents|mesh-ancestor
24768631|NCT01809444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24625850|NCT01083966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625851|NCT01083966|Growth Inhibitors|growth inhibitors|mesh-ancestor
24625865|NCT01084031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24625866|NCT01084031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625868|NCT01084031|Anesthetics, General|anesthetics, general|mesh-ancestor
24943456|NCT03970772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24943457|NCT03970772|Hormones|hormones|mesh-ancestor
24943458|NCT03970772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24943459|NCT03970772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943467|NCT03971019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24943468|NCT03971019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943473|NCT03971019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737323|NCT01668433|Methylene Blue|methylene blue|mesh-list
24737324|NCT01668433|Antimalarials|antimalarials|mesh-ancestor
24737325|NCT01668433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24737326|NCT01668433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24737327|NCT01668433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24943514|NCT03970239|Altanserin|altanserin|mesh-list
24943515|NCT03970239|Cariostatic Agents|cariostatic agents|mesh-ancestor
24943516|NCT03970239|Protective Agents|protective agents|mesh-ancestor
24943517|NCT03970239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943518|NCT03970239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24943519|NCT03970239|Serotonin Agents|serotonin agents|mesh-ancestor
24943520|NCT03970239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24800864|NCT01978873|Ascorbic Acid|ascorbic acid|mesh-list
24943521|NCT03970239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862521|NCT00090155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24548303|NCT00708812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25084863|NCT03302585|Vitamin D|vitamin d|mesh-list
24943522|NCT03970239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24548304|NCT00708812|Growth Substances|growth substances|mesh-ancestor
24548305|NCT00708812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868323|NCT05156892|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24943915|NCT03965767|Coagulants|coagulants|mesh-ancestor
24737338|NCT01668446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24737339|NCT01668446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737340|NCT01668446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862522|NCT00090155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862523|NCT00090155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25862524|NCT00090155|Antipruritics|antipruritics|mesh-ancestor
25199814|NCT02738502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25862525|NCT00090155|Dermatologic Agents|dermatologic agents|mesh-ancestor
25862526|NCT00090155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25862527|NCT00090155|Serotonin Agents|serotonin agents|mesh-ancestor
25862528|NCT00090155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25862529|NCT00090155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862530|NCT00090155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25862531|NCT00090155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25862532|NCT00090155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25862533|NCT00090155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25862534|NCT00090155|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24827107|NCT02137421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827108|NCT02137421|Protective Agents|protective agents|mesh-ancestor
24827109|NCT02137421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827110|NCT02137421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25862535|NCT00090155|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25862536|NCT00090194|Immunoglobulins|immunoglobulins|mesh-list
25862537|NCT00090194|Antibodies|antibodies|mesh-list
25862538|NCT00090194|gamma-Globulins|gamma-globulins|mesh-list
25862539|NCT00090194|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25862540|NCT00090194|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25862541|NCT00090194|Immunologic Factors|immunologic factors|mesh-ancestor
24548324|NCT00709137|Amiloride|amiloride|mesh-list
24868353|NCT05156541|Interferons|interferons|mesh-list
25862542|NCT00090194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862543|NCT00090207|Ondansetron|ondansetron|mesh-list
25862544|NCT00090207|Aprepitant|aprepitant|mesh-list
24737474|NCT01669083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25004768|NCT01858922|Antimetabolites|antimetabolites|mesh-ancestor
24943542|NCT03969758|Liver Extracts|liver extracts|mesh-list
24943543|NCT03969758|Hematinics|hematinics|mesh-ancestor
24943544|NCT03969758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24943545|NCT03969758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24943546|NCT03969758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25199815|NCT02738502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25199816|NCT02738502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25199817|NCT02738346|Carboplatin|carboplatin|mesh-list
25199818|NCT02738346|Etoposide|etoposide|mesh-list
25199819|NCT02738346|Topotecan|topotecan|mesh-list
25199820|NCT02738346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199821|NCT02738346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25199822|NCT02738346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25199823|NCT02738346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25199824|NCT02738346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199825|NCT02738346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199826|NCT02738346|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25199827|NCT02738632|Amlodipine|amlodipine|mesh-list
25199828|NCT02738632|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25199829|NCT02738632|Telmisartan|telmisartan|mesh-list
25199830|NCT02738632|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
25199831|NCT02738632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25199832|NCT02738632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25199833|NCT02738632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25199834|NCT02738632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199835|NCT02738632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25199836|NCT02738632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199837|NCT02738632|Vasodilator Agents|vasodilator agents|mesh-ancestor
25199838|NCT02738632|Diuretics|diuretics|mesh-ancestor
25199839|NCT02738632|Natriuretic Agents|natriuretic agents|mesh-ancestor
25199840|NCT02738632|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25199841|NCT02738632|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25199842|NCT02738632|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25199843|NCT02738177|Isosorbide|isosorbide|mesh-list
25862545|NCT00090207|Antiemetics|antiemetics|mesh-ancestor
25199846|NCT02738177|Misoprostol|misoprostol|mesh-list
25135675|NCT02996318|Sirolimus|sirolimus|mesh-list
24943547|NCT03969758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24943548|NCT03969758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24943549|NCT03969758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24943550|NCT03969758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24943551|NCT03969758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868354|NCT05156541|Interferon-gamma|interferon-gamma|mesh-list
25862546|NCT00090207|Autonomic Agents|autonomic agents|mesh-ancestor
25055100|NCT03524313|Carbon Monoxide|carbon monoxide|mesh-list
25055101|NCT03524313|Antimetabolites|antimetabolites|mesh-ancestor
25055102|NCT03524313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943574|NCT03968588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943575|NCT03968588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24943576|NCT03968588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943577|NCT03968588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24943578|NCT03968588|Antitubercular Agents|antitubercular agents|mesh-ancestor
24943579|NCT03968588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24943580|NCT03968588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24943582|NCT03968861|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24943583|NCT03968861|Anesthetics, General|anesthetics, general|mesh-ancestor
24943584|NCT03968861|Anesthetics|anesthetics|mesh-ancestor
24943585|NCT03968861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24943586|NCT03968861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943587|NCT03968263|Hydrocodone|hydrocodone|mesh-list
24943588|NCT03968263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24943589|NCT03968263|Narcotics|narcotics|mesh-ancestor
24737628|NCT01670071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24737629|NCT01670071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24737630|NCT01670071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24737631|NCT01670071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24737632|NCT01670071|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24737634|NCT01670071|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25051229|NCT00430508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25051230|NCT00430508|Diuretics|diuretics|mesh-ancestor
24959427|NCT03824743|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25051231|NCT00430508|Natriuretic Agents|natriuretic agents|mesh-ancestor
25051232|NCT00430508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943608|NCT03968146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24943609|NCT03968146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943611|NCT03968146|Sensory System Agents|sensory system agents|mesh-ancestor
24943612|NCT03968146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24943613|NCT03968146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24943614|NCT03968146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24943615|NCT03968146|Anesthetics, General|anesthetics, general|mesh-ancestor
24943616|NCT03968146|Anesthetics|anesthetics|mesh-ancestor
24943617|NCT03968146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24943618|NCT03968146|Antipyretics|antipyretics|mesh-ancestor
24943619|NCT03968146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24943620|NCT03968146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24943621|NCT03968146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24943622|NCT03968146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24943623|NCT03968146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24943624|NCT03968146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943626|NCT03968224|Dapagliflozin|dapagliflozin|mesh-list
24943627|NCT03968224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24943628|NCT03968224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943629|NCT03968224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24943641|NCT03968237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24943642|NCT03967964|Methyltestosterone|methyltestosterone|mesh-list
24943643|NCT03967964|Testosterone|testosterone|mesh-list
24943645|NCT03967964|Testosterone enanthate|testosterone enanthate|mesh-list
24943646|NCT03967964|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24943647|NCT03967964|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24943648|NCT03967964|Androgens|androgens|mesh-ancestor
24943649|NCT03967964|Hormones|hormones|mesh-ancestor
24943650|NCT03967964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24737702|NCT01670162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24737703|NCT01670162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25862547|NCT00090207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084934|NCT03302351|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25218909|NCT02666651|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25218910|NCT02666651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218911|NCT02666651|Natriuretic Agents|natriuretic agents|mesh-ancestor
25218912|NCT02666651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548358|NCT00709215|Cordycepin|cordycepin|mesh-list
24868386|NCT05155969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24868387|NCT05155969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868388|NCT05155969|Antidepressive Agents|antidepressive agents|mesh-ancestor
24868389|NCT05155969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24737756|NCT01670435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24737757|NCT01670435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24526611|NCT00612469|Chlorhexidine|chlorhexidine|mesh-list
24737758|NCT01670435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737759|NCT01670435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943651|NCT03967964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199847|NCT02738177|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24943652|NCT03967964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24943653|NCT03967964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943654|NCT03967964|Anabolic Agents|anabolic agents|mesh-ancestor
24943655|NCT03967964|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24943656|NCT03967964|Immunologic Factors|immunologic factors|mesh-ancestor
24943657|NCT03967977|Gemcitabine|gemcitabine|mesh-list
24943658|NCT03967977|Carboplatin|carboplatin|mesh-list
24943659|NCT03967977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943660|NCT03967977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24943661|NCT03967977|Antimetabolites|antimetabolites|mesh-ancestor
24943662|NCT03967977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943663|NCT03967977|Antiviral Agents|antiviral agents|mesh-ancestor
24943664|NCT03967977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24943665|NCT03967977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24943666|NCT03967977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24943667|NCT03967977|Immunologic Factors|immunologic factors|mesh-ancestor
24943668|NCT03967977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943684|NCT03968042|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24617898|NCT01045980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24617899|NCT01046006|Dexamethasone|dexamethasone|mesh-list
24617900|NCT01046006|Rituximab|rituximab|mesh-list
24617901|NCT01046006|Bortezomib|bortezomib|mesh-list
24617902|NCT01046006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24617913|NCT01046006|Hormones|hormones|mesh-ancestor
24737815|NCT01670773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24625874|NCT01084044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625875|NCT01084044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625876|NCT01084057|Vorinostat|vorinostat|mesh-list
24625877|NCT01084057|Epothilone B|epothilone b|mesh-list
24625878|NCT01084057|Epothilones|epothilones|mesh-list
24625879|NCT01084057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24625880|NCT01084057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24737826|NCT01670799|Analgesics|analgesics|mesh-ancestor
24625891|NCT01084187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24625892|NCT01084187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625893|NCT01084187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625894|NCT01084187|Urological Agents|urological agents|mesh-ancestor
24625895|NCT01084200|Propofol|propofol|mesh-list
24625896|NCT01084200|Sevoflurane|sevoflurane|mesh-list
24738071|NCT01672671|Mitosis Modulators|mitosis modulators|mesh-ancestor
24943730|NCT03967496|Atorvastatin|atorvastatin|mesh-list
24943731|NCT03967496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24943732|NCT03967496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737844|NCT01670812|Autonomic Agents|autonomic agents|mesh-ancestor
24737845|NCT01670812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737846|NCT01670812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24737857|NCT01670890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737858|NCT01670929|Progesterone|progesterone|mesh-list
24737859|NCT01670929|Progestins|progestins|mesh-ancestor
24737861|NCT01670929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24737862|NCT01670929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737863|NCT01670955|Folic Acid|folic acid|mesh-list
25668579|NCT01719757|Narcotics|narcotics|mesh-ancestor
25668580|NCT01719757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25668581|NCT01719757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668582|NCT01719757|Analgesics|analgesics|mesh-ancestor
25668583|NCT01719757|Sensory System Agents|sensory system agents|mesh-ancestor
25668584|NCT01719757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25085023|NCT03302039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24737864|NCT01670955|Hematinics|hematinics|mesh-ancestor
24469266|NCT00385307|Amibegron|amibegron|mesh-list
24737922|NCT01671787|Antiviral Agents|antiviral agents|mesh-ancestor
24943762|NCT03967327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24943763|NCT03967327|Narcotics|narcotics|mesh-ancestor
24943764|NCT03967327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24943765|NCT03967327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943766|NCT03967327|Analgesics|analgesics|mesh-ancestor
24943767|NCT03967327|Sensory System Agents|sensory system agents|mesh-ancestor
24943768|NCT03967327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24943769|NCT03967327|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25135746|NCT02995772|Anastrozole|anastrozole|mesh-list
24943779|NCT03967197|Lidocaine|lidocaine|mesh-list
24943780|NCT03967197|Anesthetics, Local|anesthetics, local|mesh-ancestor
24943781|NCT03967197|Anesthetics|anesthetics|mesh-ancestor
24943782|NCT03967197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24943783|NCT03967197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943784|NCT03967197|Sensory System Agents|sensory system agents|mesh-ancestor
24943785|NCT03967197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24943786|NCT03967197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25862548|NCT00090207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943787|NCT03967197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24943788|NCT03967197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24943789|NCT03967197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24943790|NCT03967197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737941|NCT01671813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737942|NCT01671813|Immunologic Factors|immunologic factors|mesh-ancestor
24737943|NCT01671813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737944|NCT01671852|Mometasone Furoate|mometasone furoate|mesh-list
24737980|NCT01672047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24737981|NCT01672047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24737982|NCT01672086|Calcium Carbonate|calcium carbonate|mesh-list
24737983|NCT01672086|Antacids|antacids|mesh-ancestor
24737984|NCT01672086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737985|NCT01672086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24943807|NCT03966560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943808|NCT03966560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943809|NCT03966560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24943810|NCT03966560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24943811|NCT03966560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24943812|NCT03966560|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24943813|NCT03966560|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24943814|NCT03966560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24943815|NCT03966560|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24943854|NCT03966898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943856|NCT03966898|Hormone Antagonists|hormone antagonists|mesh-ancestor
24738498|NCT01675895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943859|NCT03966898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24943889|NCT03966209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738070|NCT01672671|Antimitotic Agents|antimitotic agents|mesh-ancestor
24738072|NCT01672671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738073|NCT01672671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24738074|NCT01672671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24738075|NCT01672671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24738076|NCT01672671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24738078|NCT01672814|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24738079|NCT01672814|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24738080|NCT01672814|Vitamin B Complex|vitamin b complex|mesh-ancestor
24738082|NCT01672814|Micronutrients|micronutrients|mesh-ancestor
24738083|NCT01672814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738084|NCT01672814|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24738085|NCT01672814|Dermatologic Agents|dermatologic agents|mesh-ancestor
24738086|NCT01673087|Dexamethasone|dexamethasone|mesh-list
24738087|NCT01673087|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24738088|NCT01673087|Cosyntropin|cosyntropin|mesh-list
24738089|NCT01673087|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
24738267|NCT01674517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24738268|NCT01674517|Respiratory System Agents|respiratory system agents|mesh-ancestor
24738269|NCT01674517|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24738270|NCT01674517|Hormone Antagonists|hormone antagonists|mesh-ancestor
25668585|NCT01719757|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25668586|NCT01719783|Vaccines|vaccines|mesh-list
25199848|NCT02738177|Abortifacient Agents|abortifacient agents|mesh-ancestor
24738271|NCT01674517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24738272|NCT01674517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738288|NCT01674556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24738289|NCT01674556|Immunologic Factors|immunologic factors|mesh-ancestor
24738290|NCT01674556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738293|NCT01674686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24738294|NCT01674686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24738295|NCT01674686|Antimetabolites|antimetabolites|mesh-ancestor
24738296|NCT01674686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738297|NCT01674686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24738298|NCT01674686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24738299|NCT01674686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24738300|NCT01674686|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24738312|NCT01674738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24738313|NCT01674738|Growth Substances|growth substances|mesh-ancestor
24738314|NCT01674738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738315|NCT01674738|Growth Inhibitors|growth inhibitors|mesh-ancestor
24738316|NCT01674738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24738317|NCT01674738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738318|NCT01674738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24738319|NCT01674738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24738327|NCT01674855|Lenograstim|lenograstim|mesh-list
24738328|NCT01674855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24738329|NCT01674855|Immunologic Factors|immunologic factors|mesh-ancestor
24738330|NCT01674855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738331|NCT01674868|Fluoxetine|fluoxetine|mesh-list
24738332|NCT01674868|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24738333|NCT01674868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24738334|NCT01674868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24943891|NCT03966040|Vaccines|vaccines|mesh-list
24943892|NCT03966040|Immunologic Factors|immunologic factors|mesh-ancestor
24479593|NCT00427388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25862549|NCT00090207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25862550|NCT00090207|Antipruritics|antipruritics|mesh-ancestor
24617932|NCT01046162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24943893|NCT03966040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617933|NCT01046162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617934|NCT01046162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24617935|NCT01046162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24738544|NCT01675986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24521249|NCT04931602|Vitamins|vitamins|mesh-ancestor
24738578|NCT01676259|Gemcitabine|gemcitabine|mesh-list
24738579|NCT01676259|Paclitaxel|paclitaxel|mesh-list
24738580|NCT01676259|Folfirinox|folfirinox|mesh-list
24814508|NCT02064842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814546|NCT02065349|ASP8477|asp8477|mesh-list
24814547|NCT02065349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24814548|NCT02065349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814549|NCT02065388|Warfarin|warfarin|mesh-list
24938505|NCT04018157|Dexmedetomidine|dexmedetomidine|mesh-list
24738581|NCT01676259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24738582|NCT01676259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738583|NCT01676259|Tubulin Modulators|tubulin modulators|mesh-ancestor
24738584|NCT01676259|Antimitotic Agents|antimitotic agents|mesh-ancestor
24738585|NCT01676259|Mitosis Modulators|mitosis modulators|mesh-ancestor
24738586|NCT01676259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738587|NCT01676259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24738588|NCT01676259|Antimetabolites|antimetabolites|mesh-ancestor
24738589|NCT01676259|Antiviral Agents|antiviral agents|mesh-ancestor
24738590|NCT01676259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24738591|NCT01676259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24738592|NCT01676259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24738593|NCT01676259|Immunologic Factors|immunologic factors|mesh-ancestor
24738630|NCT01676493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24738631|NCT01676493|Antitussive Agents|antitussive agents|mesh-ancestor
24738632|NCT01676493|Respiratory System Agents|respiratory system agents|mesh-ancestor
24738633|NCT01676506|Ranibizumab|ranibizumab|mesh-list
24738634|NCT01676506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24738635|NCT01676506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24738636|NCT01676506|Growth Substances|growth substances|mesh-ancestor
24738637|NCT01676506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25429337|NCT01535053|Dactinomycin|dactinomycin|mesh-list
24738687|NCT01676649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24738688|NCT01676649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24738828|NCT01677650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24738829|NCT01677650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738831|NCT01677650|Sensory System Agents|sensory system agents|mesh-ancestor
24738832|NCT01677650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24738868|NCT01677949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617952|NCT01046214|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24617953|NCT01046214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24403521|NCT00160745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862551|NCT00090207|Dermatologic Agents|dermatologic agents|mesh-ancestor
24738979|NCT01678599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738980|NCT01678599|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24738981|NCT01678599|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24738982|NCT01678599|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24738983|NCT01678599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24738985|NCT01678612|Trace Elements|trace elements|mesh-ancestor
24738986|NCT01678612|Micronutrients|micronutrients|mesh-ancestor
24738987|NCT01678612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738988|NCT01678651|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24738989|NCT01678651|Hormones|hormones|mesh-ancestor
24738990|NCT01678651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24738991|NCT01678651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738992|NCT01678664|Doxorubicin|doxorubicin|mesh-list
24738993|NCT01678664|Everolimus|everolimus|mesh-list
24738994|NCT01678664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24487878|NCT00465439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24943911|NCT03965767|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24943912|NCT03965767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24739174|NCT01679639|Leprostatic Agents|leprostatic agents|mesh-ancestor
24739175|NCT01679639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24739176|NCT01679639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24739215|NCT01679860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943913|NCT03965767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943914|NCT03965767|Hemostatics|hemostatics|mesh-ancestor
24943917|NCT03965858|Antidepressive Agents|antidepressive agents|mesh-ancestor
24943918|NCT03965858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24739217|NCT01679899|Gliclazide|gliclazide|mesh-list
24739218|NCT01679899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24739219|NCT01679899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739220|NCT01679899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24739221|NCT01679899|Protease Inhibitors|protease inhibitors|mesh-ancestor
24403837|NCT00161681|Estradiol|estradiol|mesh-list
24943925|NCT03965819|Antipyretics|antipyretics|mesh-ancestor
24943926|NCT03966066|Erythromycin|erythromycin|mesh-list
24739402|NCT01681134|Tacrolimus|tacrolimus|mesh-list
24739403|NCT01681134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24739890|NCT01684969|Haloperidol|haloperidol|mesh-list
24739891|NCT01684969|Haloperidol decanoate|haloperidol decanoate|mesh-list
24739892|NCT01684969|Antiemetics|antiemetics|mesh-ancestor
24739932|NCT01685125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24739933|NCT01685125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739934|NCT01685125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24739939|NCT01685125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24739945|NCT01685333|Hematinics|hematinics|mesh-ancestor
24618092|NCT01046786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740263|NCT01687426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24740265|NCT01687426|Adrenergic Agents|adrenergic agents|mesh-ancestor
24740266|NCT01687426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24740267|NCT01687426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740268|NCT01687426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740270|NCT01687439|Endostar protein|endostar protein|mesh-list
24740271|NCT01687439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24404927|NCT00165178|Abortifacient Agents|abortifacient agents|mesh-ancestor
24409354|NCT00181870|Carbamazepine|carbamazepine|mesh-list
24740272|NCT01687439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24740273|NCT01687439|Tubulin Modulators|tubulin modulators|mesh-ancestor
24943940|NCT03965546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740643|NCT01689558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24740644|NCT01689558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24740645|NCT01689558|Growth Substances|growth substances|mesh-ancestor
25429338|NCT01535053|Methotrexate|methotrexate|mesh-list
24740646|NCT01689558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740647|NCT01689558|Growth Inhibitors|growth inhibitors|mesh-ancestor
24502687|NCT04642378|Insulin|insulin|mesh-list
24618200|NCT01047072|Antimetabolites|antimetabolites|mesh-ancestor
24618201|NCT01047072|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24618202|NCT01047072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618203|NCT01047072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24618204|NCT01047072|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24618205|NCT01047072|Antitubercular Agents|antitubercular agents|mesh-ancestor
24618206|NCT01047072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24618207|NCT01047072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24618209|NCT01047098|Trace Elements|trace elements|mesh-ancestor
24618210|NCT01047098|Micronutrients|micronutrients|mesh-ancestor
24740690|NCT01689766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740691|NCT01689870|Ipilimumab|ipilimumab|mesh-list
24740692|NCT01689870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24740730|NCT01689987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24740731|NCT01689987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24740732|NCT01689987|Antifungal Agents|antifungal agents|mesh-ancestor
24740733|NCT01689987|Antimalarials|antimalarials|mesh-ancestor
24740734|NCT01689987|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24740735|NCT01689987|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24740736|NCT01689987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24740737|NCT01689987|Protease Inhibitors|protease inhibitors|mesh-ancestor
24740738|NCT01689987|Dermatologic Agents|dermatologic agents|mesh-ancestor
24740739|NCT01690039|Fludrocortisone|fludrocortisone|mesh-list
24740745|NCT01690039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24740746|NCT01690039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740747|NCT01690039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24740748|NCT01690091|Metformin|metformin|mesh-list
25862552|NCT00090207|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24740869|NCT01690533|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24740870|NCT01690533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24740871|NCT01690533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24740872|NCT01690533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24740873|NCT01690533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24740874|NCT01690533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24740875|NCT01690533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740876|NCT01690533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24740877|NCT01690533|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24943963|NCT03965286|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
24857223|NCT02289768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24740878|NCT01690533|Contraceptive Agents|contraceptive agents|mesh-ancestor
24740879|NCT01690533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24740880|NCT01690533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742949|NCT05096065|Leuprolide|leuprolide|mesh-list
24740882|NCT01690533|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24740883|NCT01690533|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24740884|NCT01690559|Ciprofloxacin|ciprofloxacin|mesh-list
24740963|NCT01690780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24740964|NCT01690780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24740965|NCT01690780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24740966|NCT01690780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24740967|NCT01690780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24943965|NCT03965286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24943967|NCT03965117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24943968|NCT03965117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24740968|NCT01690780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740969|NCT01690832|Fenoldopam|fenoldopam|mesh-list
24740970|NCT01690832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24740971|NCT01690832|Vasodilator Agents|vasodilator agents|mesh-ancestor
24740972|NCT01690832|Dopamine Agonists|dopamine agonists|mesh-ancestor
24740973|NCT01690832|Dopamine Agents|dopamine agents|mesh-ancestor
24740974|NCT01690832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24740975|NCT01690832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868672|NCT03600714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548628|NCT00710788|Antacids|antacids|mesh-ancestor
24740976|NCT01690832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740977|NCT01690871|Dactolisib|dactolisib|mesh-list
24740978|NCT01690871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24740979|NCT01690884|Adenosine|adenosine|mesh-list
24740980|NCT01690884|Analgesics|analgesics|mesh-ancestor
24740981|NCT01690884|Sensory System Agents|sensory system agents|mesh-ancestor
24507052|NCT00548483|Glucocorticoids|glucocorticoids|mesh-ancestor
24741016|NCT01691053|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24741077|NCT01691651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741079|NCT01691651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24741106|NCT01691937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862553|NCT00090207|Serotonin Agents|serotonin agents|mesh-ancestor
25862554|NCT00090207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25862555|NCT00090207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862556|NCT00090207|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24741124|NCT01692132|Serotonin Agents|serotonin agents|mesh-ancestor
24741125|NCT01692132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24741242|NCT01692925|Coagulants|coagulants|mesh-ancestor
24741243|NCT01693003|Tiotropium Bromide|tiotropium bromide|mesh-list
24741261|NCT01693081|Dopamine Agonists|dopamine agonists|mesh-ancestor
24741266|NCT01693159|Hemostatics|hemostatics|mesh-ancestor
24741267|NCT01693159|Coagulants|coagulants|mesh-ancestor
24741275|NCT01693276|Mitosis Modulators|mitosis modulators|mesh-ancestor
24741276|NCT01693276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618236|NCT01047423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24741277|NCT01693276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24741278|NCT01693276|Antimetabolites|antimetabolites|mesh-ancestor
24741279|NCT01693276|Antiviral Agents|antiviral agents|mesh-ancestor
24741280|NCT01693276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24741281|NCT01693276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24741282|NCT01693276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24741283|NCT01693276|Immunologic Factors|immunologic factors|mesh-ancestor
24741284|NCT01693276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741285|NCT01693289|Metformin|metformin|mesh-list
25862557|NCT00090207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25862558|NCT00090207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25862559|NCT00090207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24741300|NCT01693302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741301|NCT01693328|Fentanyl|fentanyl|mesh-list
24741302|NCT01693328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24741303|NCT01693328|Narcotics|narcotics|mesh-ancestor
24741304|NCT01693328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24943978|NCT03965078|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24943979|NCT03965078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24741305|NCT01693328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741306|NCT01693328|Analgesics|analgesics|mesh-ancestor
24741307|NCT01693328|Sensory System Agents|sensory system agents|mesh-ancestor
24741308|NCT01693328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24741309|NCT01693328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24741396|NCT01693809|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24741397|NCT01693809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24809423|NCT02033603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809424|NCT02033603|Sensory System Agents|sensory system agents|mesh-ancestor
24809426|NCT02033681|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24809427|NCT02033707|Scopolamine|scopolamine|mesh-list
24491736|NCT00483795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491737|NCT00483834|Bevacizumab|bevacizumab|mesh-list
24741398|NCT01693809|Purinergic Agents|purinergic agents|mesh-ancestor
24741399|NCT01693809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24741401|NCT01693822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24741402|NCT01693822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24741424|NCT05289063|Antimetabolites|antimetabolites|mesh-ancestor
24741425|NCT05289063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741426|NCT05289063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24741427|NCT05289063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24741428|NCT05289063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24741464|NCT05288738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741465|NCT05288725|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24741466|NCT05288725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24741467|NCT05288725|Glucocorticoids|glucocorticoids|mesh-ancestor
24741469|NCT05288725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24741470|NCT05288725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741471|NCT05288725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24741472|NCT05288725|Immunologic Factors|immunologic factors|mesh-ancestor
24741473|NCT05288673|Ravulizumab|ravulizumab|mesh-list
24741474|NCT05288673|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24510497|NCT00564668|Insulin Aspart|insulin aspart|mesh-list
24741558|NCT05288179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24741560|NCT05288153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24741561|NCT05288153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741562|NCT05288127|Talazoparib|talazoparib|mesh-list
24741563|NCT05288127|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25219001|NCT02666053|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24741564|NCT05288127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24741565|NCT05288127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741566|NCT05288127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24741567|NCT05291455|Lacosamide|lacosamide|mesh-list
24741568|NCT05291455|Phenobarbital|phenobarbital|mesh-list
24741569|NCT05291455|Anticonvulsants|anticonvulsants|mesh-ancestor
24741570|NCT05291455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24741571|NCT05291455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24741572|NCT05291455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24741573|NCT05291455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741574|NCT05291455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24741575|NCT05291455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24741642|NCT05290948|Anticonvulsants|anticonvulsants|mesh-ancestor
24746819|NCT03435640|Nivolumab|nivolumab|mesh-list
24741670|NCT05290506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741671|NCT05290506|Incretins|incretins|mesh-ancestor
24741673|NCT05290506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24741674|NCT05290506|Protease Inhibitors|protease inhibitors|mesh-ancestor
24741676|NCT05290506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741677|NCT05290493|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
24741678|NCT05290493|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
24513443|NCT00581685|Analgesics|analgesics|mesh-ancestor
24618252|NCT01047488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24618254|NCT01047488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24618255|NCT01047488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24531281|NCT00634881|Alemtuzumab|alemtuzumab|mesh-list
24741854|NCT05291910|Paclitaxel|paclitaxel|mesh-list
24514202|NCT00588926|Narcotics|narcotics|mesh-ancestor
24741906|NCT05294887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741907|NCT05294887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741954|NCT05294640|Anesthetics, Local|anesthetics, local|mesh-list
24741955|NCT05294640|Anesthetics|anesthetics|mesh-list
24741956|NCT05294640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24741957|NCT05294640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741958|NCT05294640|Sensory System Agents|sensory system agents|mesh-ancestor
24741959|NCT05294640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24741960|NCT05294640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24741961|NCT05294640|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24741962|NCT05294640|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24741963|NCT05294640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24742014|NCT05294393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24944000|NCT03964935|Minocycline|minocycline|mesh-list
24944001|NCT03964935|Lycopene|lycopene|mesh-list
24944002|NCT03964935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24618303|NCT01047722|Sensory System Agents|sensory system agents|mesh-ancestor
24618304|NCT01047722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24618305|NCT01047722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618306|NCT01047722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25199849|NCT02738177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24618313|NCT01047722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618315|NCT01047748|Digoxin|digoxin|mesh-list
24618316|NCT01047748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24618317|NCT01047748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24618318|NCT01047748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618319|NCT01047748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618320|NCT01047748|Protective Agents|protective agents|mesh-ancestor
24618321|NCT01047748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618322|NCT01047774|Caseins|caseins|mesh-list
24618323|NCT01047774|Chelating Agents|chelating agents|mesh-ancestor
24618324|NCT01047774|Sequestering Agents|sequestering agents|mesh-ancestor
24618325|NCT01047774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618326|NCT01047891|Sorafenib|sorafenib|mesh-list
24618327|NCT01047891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862560|NCT00090207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24618328|NCT01047891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24618329|NCT01047891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618330|NCT01047891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618331|NCT01047956|Methadone|methadone|mesh-list
24618332|NCT01047956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24618333|NCT01047956|Narcotics|narcotics|mesh-ancestor
24618334|NCT01047956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25668587|NCT01719783|Immunologic Factors|immunologic factors|mesh-ancestor
25862561|NCT00090207|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25668588|NCT01719783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668589|NCT01719861|Desipramine|desipramine|mesh-list
24629449|NCT01105338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24629450|NCT01105338|Antioxidants|antioxidants|mesh-ancestor
24629451|NCT01105338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629452|NCT01105338|Protective Agents|protective agents|mesh-ancestor
24629453|NCT01105338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629454|NCT01105338|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24629455|NCT01105338|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24629456|NCT01105338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629457|NCT01105351|Folic Acid|folic acid|mesh-list
25219012|NCT02665806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25219013|NCT02665806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219014|NCT02665806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25219015|NCT02665806|Respiratory System Agents|respiratory system agents|mesh-ancestor
25862562|NCT00090246|Ondansetron|ondansetron|mesh-list
24618335|NCT01047956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618336|NCT01047956|Analgesics|analgesics|mesh-ancestor
24618337|NCT01047956|Sensory System Agents|sensory system agents|mesh-ancestor
24742192|NCT05296564|Antiviral Agents|antiviral agents|mesh-ancestor
25862563|NCT00090246|Aprepitant|aprepitant|mesh-list
25862564|NCT00090246|Antiemetics|antiemetics|mesh-ancestor
24746858|NCT03230097|BI 409306|bi 409306|mesh-list
24742480|NCT05264584|Antidotes|antidotes|mesh-ancestor
24742481|NCT05264584|Gout Suppressants|gout suppressants|mesh-ancestor
24742482|NCT05264584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24742579|NCT05220826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24742580|NCT05220826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742581|NCT05220826|Plant Growth Regulators|plant growth regulators|mesh-ancestor
24742597|NCT05219799|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24407269|NCT00174174|Modafinil|modafinil|mesh-list
24407270|NCT00174174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24407271|NCT00174174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407272|NCT00174174|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24742645|NCT05215548|Afatinib|afatinib|mesh-list
24742647|NCT05215548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24742648|NCT05215548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24742649|NCT05215548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618362|NCT01047995|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24618363|NCT01047995|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24618364|NCT01048034|Azacitidine|azacitidine|mesh-list
24618365|NCT01048034|Epoetin Alfa|epoetin alfa|mesh-list
24618366|NCT01048034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24742764|NCT05169268|Brexpiprazole|brexpiprazole|mesh-list
24742765|NCT05169268|Antidepressive Agents|antidepressive agents|mesh-ancestor
24742766|NCT05169268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24742767|NCT05169268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24527547|NCT00617370|Paclitaxel|paclitaxel|mesh-list
24742783|NCT05217706|Analgesics|analgesics|mesh-ancestor
24742784|NCT05217706|Sensory System Agents|sensory system agents|mesh-ancestor
24742785|NCT05217706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24742843|NCT05150756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24742845|NCT05150756|Analgesics|analgesics|mesh-ancestor
24742846|NCT05146778|Lidocaine|lidocaine|mesh-list
24742847|NCT05146778|Fentanyl|fentanyl|mesh-list
24742926|NCT05103696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24506206|NCT00544284|Bortezomib|bortezomib|mesh-list
24742945|NCT05098041|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24742948|NCT05096325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742950|NCT05096065|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24742951|NCT05096065|Fertility Agents|fertility agents|mesh-ancestor
24742952|NCT05096065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25668590|NCT01719861|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25668591|NCT01719861|Antidepressive Agents|antidepressive agents|mesh-ancestor
25668592|NCT01719861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25668593|NCT01719861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25668594|NCT01719861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668595|NCT01719861|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25668596|NCT01719861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25668597|NCT01719861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25668598|NCT01719861|Adrenergic Agents|adrenergic agents|mesh-ancestor
25668599|NCT01719861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25668600|NCT01719861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668601|NCT01720043|Bortezomib|bortezomib|mesh-list
25668602|NCT01720043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25668603|NCT01720173|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
25085317|NCT03299296|Protease Inhibitors|protease inhibitors|mesh-ancestor
25085318|NCT03299296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085354|NCT03298906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25085355|NCT03298906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25219016|NCT02665806|Dermatologic Agents|dermatologic agents|mesh-ancestor
24742953|NCT05096065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742954|NCT05096065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24742955|NCT05096065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24743019|NCT05035680|Immunologic Factors|immunologic factors|mesh-ancestor
24743020|NCT05035680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743022|NCT05033743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24743023|NCT05033743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24743024|NCT05033743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24743025|NCT05030025|Lamivudine|lamivudine|mesh-list
24743026|NCT05030025|Abacavir|abacavir|mesh-list
24618378|NCT01048047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618379|NCT01048047|Vasodilator Agents|vasodilator agents|mesh-ancestor
24618380|NCT01048086|Tretinoin|tretinoin|mesh-list
24618381|NCT01048086|Isotretinoin|isotretinoin|mesh-list
24618382|NCT01048086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618383|NCT01048086|Keratolytic Agents|keratolytic agents|mesh-ancestor
24618384|NCT01048086|Dermatologic Agents|dermatologic agents|mesh-ancestor
24618385|NCT01048138|Biperiden|biperiden|mesh-list
24618386|NCT01048138|Biperiden lactate|biperiden lactate|mesh-list
24618387|NCT01048138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24618388|NCT01048138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24618389|NCT01048138|Parasympatholytics|parasympatholytics|mesh-ancestor
24618390|NCT01048138|Autonomic Agents|autonomic agents|mesh-ancestor
24618391|NCT01048138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24618392|NCT01048138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618393|NCT01048138|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24743223|NCT04950868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24743224|NCT04950868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24743225|NCT04950868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743226|NCT04940767|Minocycline|minocycline|mesh-list
24743227|NCT04940767|Isotretinoin|isotretinoin|mesh-list
24743228|NCT04940767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24743229|NCT04940767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24743230|NCT04940767|Dermatologic Agents|dermatologic agents|mesh-ancestor
24743232|NCT04936854|Methylprednisolone|methylprednisolone|mesh-list
25862565|NCT00090246|Autonomic Agents|autonomic agents|mesh-ancestor
24743261|NCT04926181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522772|NCT03127592|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25005213|NCT04368559|Fluconazole|fluconazole|mesh-list
24743305|NCT04899687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24743306|NCT04899687|Antitussive Agents|antitussive agents|mesh-ancestor
24743307|NCT04899687|Respiratory System Agents|respiratory system agents|mesh-ancestor
24743308|NCT04899687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24743515|NCT04761159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24743516|NCT04761159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24743541|NCT04753216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24743542|NCT04753216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743552|NCT04750967|Lidocaine|lidocaine|mesh-list
24743553|NCT04750967|Amitriptyline|amitriptyline|mesh-list
24743554|NCT04750967|Anesthetics, Local|anesthetics, local|mesh-ancestor
24743560|NCT04750967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24743561|NCT04750967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24743562|NCT04750967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24743595|NCT04733547|Natriuretic Agents|natriuretic agents|mesh-ancestor
24743596|NCT04733547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743597|NCT04733547|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24743598|NCT04733547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24743673|NCT04671082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24743674|NCT04669587|Palbociclib|palbociclib|mesh-list
24743675|NCT04669587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24743676|NCT04669587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24743677|NCT04669587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24743678|NCT04669587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743679|NCT04659941|BCG Vaccine|bcg vaccine|mesh-list
24743680|NCT04659941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25668604|NCT01720173|Immunologic Factors|immunologic factors|mesh-ancestor
25668605|NCT01720173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668606|NCT01720225|Azacitidine|azacitidine|mesh-list
25668607|NCT01720225|Decitabine|decitabine|mesh-list
25668608|NCT01720225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25668609|NCT01720225|Antimetabolites|antimetabolites|mesh-ancestor
24652443|NCT01238237|Cetuximab|cetuximab|mesh-list
24743735|NCT04648241|Vaccines|vaccines|mesh-list
24743736|NCT04648241|Immunologic Factors|immunologic factors|mesh-ancestor
24408364|NCT00177528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24743743|NCT04640818|Immunologic Factors|immunologic factors|mesh-ancestor
24743744|NCT04640818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411317|NCT00188669|Vitamin E|vitamin e|mesh-list
24743745|NCT04640818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24743746|NCT04640818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24743747|NCT04640493|Dapagliflozin|dapagliflozin|mesh-list
24743748|NCT04640493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24743754|NCT04635098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24743755|NCT04635098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743756|NCT04635098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24397893|NCT00142974|Tegaserod|tegaserod|mesh-list
24743831|NCT04602078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24524572|NCT04701476|Pembrolizumab|pembrolizumab|mesh-list
24743919|NCT04569448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24743920|NCT04569448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743921|NCT04569448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743922|NCT04569448|Dopamine Agonists|dopamine agonists|mesh-ancestor
24743923|NCT04569448|Dopamine Agents|dopamine agents|mesh-ancestor
24743924|NCT04566887|Acalabrutinib|acalabrutinib|mesh-list
24743925|NCT04566887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24743927|NCT04564885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24743973|NCT04560972|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25862566|NCT00090246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24743974|NCT04560972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24743991|NCT04548648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24743992|NCT04545242|Dexamethasone|dexamethasone|mesh-list
24743993|NCT04545242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24743994|NCT04545242|Antiemetics|antiemetics|mesh-ancestor
24743995|NCT04545242|Autonomic Agents|autonomic agents|mesh-ancestor
24743996|NCT04545242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24743997|NCT04545242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743998|NCT04545242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24743999|NCT04545242|Glucocorticoids|glucocorticoids|mesh-ancestor
24744000|NCT04545242|Hormones|hormones|mesh-ancestor
24744001|NCT04545242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24744002|NCT04545242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24744003|NCT04545242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24744004|NCT04542980|Autoantibodies|autoantibodies|mesh-list
24744005|NCT04542980|Immunologic Factors|immunologic factors|mesh-ancestor
24744006|NCT04542980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744007|NCT04540133|Dexamethasone|dexamethasone|mesh-list
24744008|NCT04540133|Dexamethasone acetate|dexamethasone acetate|mesh-list
24744022|NCT04540133|Protease Inhibitors|protease inhibitors|mesh-ancestor
24744023|NCT04540133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24744024|NCT04540133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744148|NCT04490707|Immunologic Factors|immunologic factors|mesh-ancestor
24744149|NCT04490707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744150|NCT04490707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24744151|NCT04490707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24744152|NCT04490707|Growth Substances|growth substances|mesh-ancestor
24744153|NCT04490707|Growth Inhibitors|growth inhibitors|mesh-ancestor
24744154|NCT04490707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24744155|NCT04490707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24744156|NCT04490707|Antimetabolites|antimetabolites|mesh-ancestor
24744157|NCT04490707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744158|NCT04490707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24744198|NCT04464577|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24744199|NCT04464577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24744200|NCT04464577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24744201|NCT04464577|Antifungal Agents|antifungal agents|mesh-ancestor
24744202|NCT04464577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24744203|NCT04464577|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24744204|NCT04464577|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24744205|NCT04464577|Hormone Antagonists|hormone antagonists|mesh-ancestor
24744206|NCT04464577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24744207|NCT04464577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24744208|NCT04464577|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24525674|NCT02937766|Hormones|hormones|mesh-ancestor
24959883|NCT03821480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24944045|NCT03964324|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24788245|NCT01930552|Leucovorin|leucovorin|mesh-list
24744345|NCT04344262|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24944051|NCT03964324|Gasotransmitters|gasotransmitters|mesh-ancestor
24944052|NCT03964324|Protective Agents|protective agents|mesh-ancestor
24744346|NCT04344262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24744347|NCT04344262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24744348|NCT04344262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744349|NCT04344262|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24744350|NCT04344262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24744351|NCT04344262|Cholinergic Agents|cholinergic agents|mesh-ancestor
24744352|NCT04344262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24868942|NCT05158426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24744353|NCT04344262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744354|NCT04328012|Losartan|losartan|mesh-list
24744355|NCT04328012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24744356|NCT04328012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24744357|NCT04328012|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24744358|NCT04328012|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24744359|NCT04328012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744360|NCT04321993|Antiviral Agents|antiviral agents|mesh-list
24744361|NCT04321993|Remdesivir|remdesivir|mesh-list
24534103|NCT00646061|Parasympatholytics|parasympatholytics|mesh-ancestor
24744426|NCT04273932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24744427|NCT04273932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24744428|NCT04273932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744429|NCT04272606|Tranexamic Acid|tranexamic acid|mesh-list
24744430|NCT04272606|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24744431|NCT04272606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24744432|NCT04272606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744434|NCT04272606|Coagulants|coagulants|mesh-ancestor
24526219|NCT00621751|Anticonvulsants|anticonvulsants|mesh-ancestor
24744559|NCT04233112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744560|NCT04233112|Protective Agents|protective agents|mesh-ancestor
24744572|NCT04230304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24744574|NCT04224558|Diphenhydramine|diphenhydramine|mesh-list
24744575|NCT04224558|Promethazine|promethazine|mesh-list
24744576|NCT04224558|Methylprednisolone|methylprednisolone|mesh-list
24744577|NCT04224558|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24744578|NCT04224558|Cyclophosphamide|cyclophosphamide|mesh-list
24744579|NCT04224558|Fludarabine|fludarabine|mesh-list
24744580|NCT04224558|Thymoglobulin|thymoglobulin|mesh-list
24744581|NCT04224558|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24744582|NCT04224558|Immunoglobulins|immunoglobulins|mesh-list
24744583|NCT04224558|Antibodies|antibodies|mesh-list
24744584|NCT04224558|gamma-Globulins|gamma-globulins|mesh-list
24744585|NCT04224558|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24744586|NCT04224558|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24744587|NCT04224558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24744588|NCT04224558|Immunologic Factors|immunologic factors|mesh-ancestor
24744633|NCT04219774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24744634|NCT04219774|Analgesics|analgesics|mesh-ancestor
24744635|NCT04219774|Sensory System Agents|sensory system agents|mesh-ancestor
24744636|NCT04219774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25209719|NCT02701595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618501|NCT01048580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24534466|NCT00647127|Narcotics|narcotics|mesh-ancestor
24744674|NCT04200651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24744675|NCT04200651|Antiemetics|antiemetics|mesh-ancestor
24869015|NCT05080946|Antipyretics|antipyretics|mesh-ancestor
24744676|NCT04200651|Autonomic Agents|autonomic agents|mesh-ancestor
24744677|NCT04200651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24744678|NCT04200651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744679|NCT04200651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24744680|NCT04200651|Glucocorticoids|glucocorticoids|mesh-ancestor
24744681|NCT04200651|Hormones|hormones|mesh-ancestor
24744682|NCT04200651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24744683|NCT04200651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24744684|NCT04200651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24744685|NCT04200651|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24746010|NCT03460314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746011|NCT03460314|Analgesics|analgesics|mesh-ancestor
24746012|NCT03460314|Sensory System Agents|sensory system agents|mesh-ancestor
24746013|NCT03460314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24746083|NCT03408574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24746084|NCT03408574|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
24746085|NCT03408574|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25862567|NCT00090246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862568|NCT00090246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24629494|NCT01105598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24629495|NCT01105598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629496|NCT01105611|Ritonavir|ritonavir|mesh-list
24629497|NCT01105611|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25219038|NCT02666001|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25219039|NCT02666001|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25219040|NCT02666001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219041|NCT02665936|Dexamethasone|dexamethasone|mesh-list
25219042|NCT02665936|Dexamethasone acetate|dexamethasone acetate|mesh-list
25219043|NCT02665936|Levobupivacaine|levobupivacaine|mesh-list
25219044|NCT02665936|BB 1101|bb 1101|mesh-list
25219045|NCT02665936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25219046|NCT02665936|Antiemetics|antiemetics|mesh-ancestor
25219047|NCT02665936|Autonomic Agents|autonomic agents|mesh-ancestor
25862569|NCT00090246|Antipruritics|antipruritics|mesh-ancestor
24746086|NCT03408574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24746087|NCT03402945|Vancomycin|vancomycin|mesh-list
24746088|NCT03402945|Cefazolin|cefazolin|mesh-list
24746089|NCT03402945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24746090|NCT03402945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24746091|NCT03398655|Paclitaxel|paclitaxel|mesh-list
24746092|NCT03398655|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24618763|NCT01049633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24746093|NCT03398655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24746094|NCT03398655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746095|NCT03398655|Tubulin Modulators|tubulin modulators|mesh-ancestor
24746096|NCT03398655|Antimitotic Agents|antimitotic agents|mesh-ancestor
24746097|NCT03398655|Mitosis Modulators|mitosis modulators|mesh-ancestor
24746098|NCT03398655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746099|NCT03383380|Sirolimus|sirolimus|mesh-list
24746100|NCT03383380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24746101|NCT03383380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24746102|NCT03383380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24746103|NCT03383380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746105|NCT03383380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24746106|NCT03383380|Immunologic Factors|immunologic factors|mesh-ancestor
24746107|NCT03383380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531244|NCT00634686|Vitamin D|vitamin d|mesh-list
24746224|NCT03223974|Paclitaxel|paclitaxel|mesh-list
24746225|NCT03223974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24746226|NCT03223974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746227|NCT03223974|Tubulin Modulators|tubulin modulators|mesh-ancestor
24746228|NCT03223974|Antimitotic Agents|antimitotic agents|mesh-ancestor
24746229|NCT03223974|Mitosis Modulators|mitosis modulators|mesh-ancestor
24746230|NCT03223974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746231|NCT03216343|Chiauranib|chiauranib|mesh-list
24746569|NCT05006079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24746799|NCT03485287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746800|NCT03485287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24746801|NCT03485287|Serotonin Agents|serotonin agents|mesh-ancestor
24746802|NCT03485287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24746803|NCT03485287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746804|NCT03485287|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24746805|NCT03485287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24746806|NCT03485287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24746807|NCT03485287|Adrenergic Agents|adrenergic agents|mesh-ancestor
24746810|NCT03473925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654823|NCT01251718|Donepezil|donepezil|mesh-list
25668610|NCT01720225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668611|NCT01720225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25668612|NCT01720225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25668613|NCT01720264|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25668614|NCT01720264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25668615|NCT01720264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668616|NCT01720264|Incretins|incretins|mesh-ancestor
25668617|NCT01720264|Hormones|hormones|mesh-ancestor
25668618|NCT01720264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25668619|NCT01720264|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25668620|NCT01720264|Protease Inhibitors|protease inhibitors|mesh-ancestor
25668621|NCT01720264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25668622|NCT01720264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668623|NCT01720277|Vaccines|vaccines|mesh-list
24618684|NCT01049451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085603|NCT03296579|Adrenergic Agents|adrenergic agents|mesh-ancestor
25219048|NCT02665936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25219049|NCT02665936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219050|NCT02665936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24618685|NCT01049451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24618686|NCT01049451|Glucocorticoids|glucocorticoids|mesh-ancestor
24747913|NCT03015792|Lenalidomide|lenalidomide|mesh-list
24748045|NCT02978716|Antimetabolites|antimetabolites|mesh-ancestor
24748046|NCT02978716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748047|NCT02978716|Antiviral Agents|antiviral agents|mesh-ancestor
24748048|NCT02978716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24748049|NCT02978716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24748050|NCT02978716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24618737|NCT01049633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24618738|NCT01049633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24618739|NCT01049633|Analgesics|analgesics|mesh-ancestor
24944249|NCT03961867|Oxaliplatin|oxaliplatin|mesh-list
24748258|NCT02754011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24412645|NCT00191711|Gemcitabine|gemcitabine|mesh-list
25862570|NCT00090246|Dermatologic Agents|dermatologic agents|mesh-ancestor
24748316|NCT02713867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705165|NCT01482468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24748425|NCT02599324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24748426|NCT02599324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748427|NCT02599324|Tubulin Modulators|tubulin modulators|mesh-ancestor
24748436|NCT02595892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24748437|NCT02595892|Antimetabolites|antimetabolites|mesh-ancestor
24748438|NCT02595892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748439|NCT02595892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748440|NCT02595892|Antiviral Agents|antiviral agents|mesh-ancestor
24748441|NCT02595892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24748442|NCT02595892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24748443|NCT02595892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24869170|NCT04579783|Immunologic Factors|immunologic factors|mesh-ancestor
25862571|NCT00090246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24748444|NCT02595892|Immunologic Factors|immunologic factors|mesh-ancestor
24705899|NCT01487395|Cholinergic Agents|cholinergic agents|mesh-ancestor
24944280|NCT03961659|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24748483|NCT02512172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24748484|NCT02499367|Cyclophosphamide|cyclophosphamide|mesh-list
24748485|NCT02499367|Doxorubicin|doxorubicin|mesh-list
24748486|NCT02499367|Nivolumab|nivolumab|mesh-list
24618762|NCT01049633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24618764|NCT01049633|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24618765|NCT01049633|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24618766|NCT01049633|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24618767|NCT01049633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24618768|NCT01049633|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24618769|NCT01049633|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24618770|NCT01049633|Protective Agents|protective agents|mesh-ancestor
24618771|NCT01049633|Vasodilator Agents|vasodilator agents|mesh-ancestor
24618772|NCT01049633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24618773|NCT01049633|Antioxidants|antioxidants|mesh-ancestor
24618774|NCT01049633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24618775|NCT01049633|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24748507|NCT02497612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24748508|NCT02497131|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24748509|NCT02497131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24748510|NCT02497131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748511|NCT02491333|Metformin|metformin|mesh-list
24748512|NCT02491333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24748513|NCT02491333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748514|NCT02469987|Bevacizumab|bevacizumab|mesh-list
24748515|NCT02469987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24748516|NCT02469987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748517|NCT02469987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24748518|NCT02469987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24748519|NCT02469987|Growth Substances|growth substances|mesh-ancestor
24748520|NCT02469987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748521|NCT02469987|Growth Inhibitors|growth inhibitors|mesh-ancestor
24748522|NCT02452268|Spartalizumab|spartalizumab|mesh-list
25668624|NCT01720277|Immunologic Factors|immunologic factors|mesh-ancestor
25668625|NCT01720277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668626|NCT01720316|Glycine|glycine|mesh-list
25668627|NCT01720316|Glycine Agents|glycine agents|mesh-ancestor
25668628|NCT01720316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24748523|NCT02452268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24706999|NCT01493440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24748554|NCT02381652|Protective Agents|protective agents|mesh-ancestor
24748556|NCT02368301|Lenalidomide|lenalidomide|mesh-list
24748557|NCT02368301|Elotuzumab|elotuzumab|mesh-list
24748558|NCT02368301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24748559|NCT02368301|Antiemetics|antiemetics|mesh-ancestor
24748560|NCT02368301|Autonomic Agents|autonomic agents|mesh-ancestor
24748561|NCT02368301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24748562|NCT02368301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748563|NCT02368301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24748564|NCT02368301|Glucocorticoids|glucocorticoids|mesh-ancestor
24748565|NCT02368301|Hormones|hormones|mesh-ancestor
24748566|NCT02368301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24748577|NCT02367794|Atezolizumab|atezolizumab|mesh-list
24748578|NCT02367794|Antibodies|antibodies|mesh-list
24707143|NCT01494363|Leucovorin|leucovorin|mesh-list
24748678|NCT02251548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24748823|NCT02120079|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24748824|NCT02120079|Lubricant Eye Drops|lubricant eye drops|mesh-list
24748825|NCT02120079|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24748826|NCT02120079|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24748827|NCT02106195|Belumosudil|belumosudil|mesh-list
24748828|NCT02106195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24748829|NCT02106195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618800|NCT01049672|Anesthetics|anesthetics|mesh-ancestor
24618801|NCT01049685|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24618802|NCT01049685|Antiviral Agents|antiviral agents|mesh-ancestor
24618803|NCT01049685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24655236|NCT01255358|BB 1101|bb 1101|mesh-list
24618805|NCT01049711|Hematinics|hematinics|mesh-ancestor
24618806|NCT01049763|Oseltamivir|oseltamivir|mesh-list
24944345|NCT03961334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944346|NCT03961334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24748961|NCT01913730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748962|NCT01913730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24748963|NCT01913730|Glucocorticoids|glucocorticoids|mesh-ancestor
24749055|NCT01828840|Fentanyl|fentanyl|mesh-list
24749056|NCT01828840|Morphine|morphine|mesh-list
24749057|NCT01828840|Methadone|methadone|mesh-list
25055247|NCT03522649|Leucovorin|leucovorin|mesh-list
24749198|NCT01488890|Vaccines|vaccines|mesh-list
24749199|NCT01488890|Immunologic Factors|immunologic factors|mesh-ancestor
24749234|NCT01414777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24749235|NCT01411241|Vaccines|vaccines|mesh-list
24749236|NCT01411241|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24749237|NCT01411241|Immunologic Factors|immunologic factors|mesh-ancestor
24749238|NCT01411241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749239|NCT01407263|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24749240|NCT01407263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24749241|NCT01396408|Sirolimus|sirolimus|mesh-list
24749246|NCT01396408|Growth Substances|growth substances|mesh-ancestor
24749247|NCT01396408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618816|NCT01049815|Antacids|antacids|mesh-ancestor
24413645|NCT00194753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413646|NCT00194753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24749345|NCT01166113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749346|NCT01166113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749347|NCT01166113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24749348|NCT01166113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24749350|NCT01166113|Hormones|hormones|mesh-ancestor
24749420|NCT01096368|Alkylating Agents|alkylating agents|mesh-ancestor
24749421|NCT01096368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749422|NCT01096368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749423|NCT01096368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24749424|NCT01096368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24749464|NCT01054248|Antimalarials|antimalarials|mesh-ancestor
24749465|NCT01054248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24749516|NCT00942877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749517|NCT00942877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24749527|NCT00896389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749528|NCT00887146|Vincristine|vincristine|mesh-list
24749529|NCT00887146|Temozolomide|temozolomide|mesh-list
24749530|NCT00887146|Procarbazine|procarbazine|mesh-list
24749531|NCT00887146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24749532|NCT00887146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749533|NCT00887146|Tubulin Modulators|tubulin modulators|mesh-ancestor
24749534|NCT00887146|Antimitotic Agents|antimitotic agents|mesh-ancestor
25085639|NCT03296358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25085640|NCT03296358|Glucocorticoids|glucocorticoids|mesh-ancestor
24629635|NCT01106872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629636|NCT01106872|Antiviral Agents|antiviral agents|mesh-ancestor
24629637|NCT01106872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25219079|NCT02665832|Olmesartan|olmesartan|mesh-list
24749535|NCT00887146|Mitosis Modulators|mitosis modulators|mesh-ancestor
24618873|NCT01049932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24618874|NCT01049932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24618875|NCT01050036|Busulfan|busulfan|mesh-list
24618876|NCT01050036|Alkylating Agents|alkylating agents|mesh-ancestor
24618885|NCT01050114|Oxybutynin|oxybutynin|mesh-list
24618889|NCT01050114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618890|NCT01050114|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24618891|NCT01050114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24618892|NCT01050114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618893|NCT01050114|Cholinergic Agents|cholinergic agents|mesh-ancestor
24618894|NCT01050114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24618895|NCT01050114|Parasympatholytics|parasympatholytics|mesh-ancestor
24618896|NCT01050114|Autonomic Agents|autonomic agents|mesh-ancestor
24618897|NCT01050114|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24618898|NCT01050114|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24618899|NCT01050114|Urological Agents|urological agents|mesh-ancestor
24618900|NCT01050270|Acetylcysteine|acetylcysteine|mesh-list
24618901|NCT01050270|Ondansetron|ondansetron|mesh-list
24618902|NCT01050270|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24618903|NCT01050270|Antiemetics|antiemetics|mesh-ancestor
24618904|NCT01050270|Autonomic Agents|autonomic agents|mesh-ancestor
24618905|NCT01050270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24618906|NCT01050270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618907|NCT01050270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24618908|NCT01050270|Antipruritics|antipruritics|mesh-ancestor
24618909|NCT01050270|Dermatologic Agents|dermatologic agents|mesh-ancestor
24710210|NCT01508897|Incretins|incretins|mesh-ancestor
24857470|NCT02291705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24857472|NCT02291705|Analgesics|analgesics|mesh-ancestor
24749721|NCT00476606|Indinavir|indinavir|mesh-list
24749722|NCT00476606|Saquinavir|saquinavir|mesh-list
24749723|NCT00476606|Lamivudine|lamivudine|mesh-list
24749724|NCT00476606|Zidovudine|zidovudine|mesh-list
24749740|NCT00476606|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24749741|NCT00476606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24749743|NCT00476606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24749744|NCT00476606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24749745|NCT00476606|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24749746|NCT00476606|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24749747|NCT00476606|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24749748|NCT00379340|Dactinomycin|dactinomycin|mesh-list
24749749|NCT00379340|Cactinomycin|cactinomycin|mesh-list
24749750|NCT00379340|Cyclophosphamide|cyclophosphamide|mesh-list
24749751|NCT00379340|Doxorubicin|doxorubicin|mesh-list
24749876|NCT01694407|Antiviral Agents|antiviral agents|mesh-ancestor
24749877|NCT01694407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24749878|NCT01694407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24749892|NCT01694498|Coagulants|coagulants|mesh-ancestor
24749893|NCT01694498|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24749894|NCT01694498|Natriuretic Agents|natriuretic agents|mesh-ancestor
24749895|NCT01694498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749897|NCT01694576|Nedaplatin|nedaplatin|mesh-list
24749898|NCT01694576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24749899|NCT01694576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749907|NCT01694693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749908|NCT01694693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24749909|NCT01694693|Immunologic Factors|immunologic factors|mesh-ancestor
24749910|NCT01694693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668629|NCT01720316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668630|NCT01720316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668631|NCT01720524|Sildenafil Citrate|sildenafil citrate|mesh-list
25668632|NCT01720524|Vasodilator Agents|vasodilator agents|mesh-ancestor
25668633|NCT01720524|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25668634|NCT01720524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25668635|NCT01720524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24749911|NCT01694693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24749913|NCT01694732|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24749914|NCT01694732|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25219086|NCT02665832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219087|NCT02665832|Vasodilator Agents|vasodilator agents|mesh-ancestor
25219088|NCT02665832|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25219089|NCT02665832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25219091|NCT02665832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25219092|NCT02665832|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25219093|NCT02665832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219095|NCT02665832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24749915|NCT01694732|Cholinergic Agents|cholinergic agents|mesh-ancestor
24749916|NCT01694732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24749917|NCT01694732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749918|NCT01694732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749919|NCT01694797|Metoprolol|metoprolol|mesh-list
24749920|NCT01694797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24541765|NCT00675181|Protective Agents|protective agents|mesh-ancestor
24749939|NCT01695005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749940|NCT01695057|Vorinostat|vorinostat|mesh-list
24749941|NCT01695057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749942|NCT01695057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24749943|NCT01695057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24749944|NCT01695057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749945|NCT01695070|Melatonin|melatonin|mesh-list
24749946|NCT01695070|Antioxidants|antioxidants|mesh-ancestor
24749947|NCT01695070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749948|NCT01695070|Protective Agents|protective agents|mesh-ancestor
24749955|NCT01695109|Hormones|hormones|mesh-ancestor
24749967|NCT01695122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24749968|NCT01695148|Carotenoids|carotenoids|mesh-list
24749969|NCT01695148|Antioxidants|antioxidants|mesh-ancestor
24749970|NCT01695148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749971|NCT01695148|Protective Agents|protective agents|mesh-ancestor
24749972|NCT01695148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749974|NCT01695174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24749975|NCT01695174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24869392|NCT04217967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24749976|NCT01695174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24749977|NCT01695187|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
24749978|NCT01695187|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
24710809|NCT01511822|Micronutrients|micronutrients|mesh-ancestor
24750084|NCT01696461|Plerixafor|plerixafor|mesh-list
24750085|NCT01696461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24750086|NCT01696461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24750087|NCT01696461|Antiviral Agents|antiviral agents|mesh-ancestor
24750088|NCT01696461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24750181|NCT01697020|Immunologic Factors|immunologic factors|mesh-ancestor
24750182|NCT01697020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750183|NCT01697020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24750184|NCT01697020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750185|NCT01697046|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24750186|NCT01697046|Raltegravir Potassium|raltegravir potassium|mesh-list
24750187|NCT01697046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25209898|NCT02700685|Pycnogenols|pycnogenols|mesh-list
24750188|NCT01697046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24750189|NCT01697046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750190|NCT01697046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750191|NCT01697046|Antiviral Agents|antiviral agents|mesh-ancestor
24750192|NCT01697046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24750193|NCT01697046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24750194|NCT01697046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24750195|NCT01697046|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24750196|NCT01697046|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24750197|NCT01697059|Amoxicillin|amoxicillin|mesh-list
24750198|NCT01697059|Piperacillin|piperacillin|mesh-list
24750199|NCT01697059|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25668636|NCT01720524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668637|NCT01720524|Urological Agents|urological agents|mesh-ancestor
25668638|NCT01720602|Letrozole|letrozole|mesh-list
25668639|NCT01720602|Anastrozole|anastrozole|mesh-list
25668640|NCT01720602|Vorinostat|vorinostat|mesh-list
25668641|NCT01720602|Exemestane|exemestane|mesh-list
25668642|NCT01720602|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25668643|NCT01720602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25668644|NCT01720602|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25668645|NCT01720602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24424233|NCT00228397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24979259|NCT04966325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979261|NCT04938024|Vitamins|vitamins|mesh-ancestor
24979262|NCT04938024|Micronutrients|micronutrients|mesh-ancestor
24456385|NCT00331058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618918|NCT01050270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24750205|NCT01697098|Dexamethasone|dexamethasone|mesh-list
24618936|NCT01050322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24618937|NCT01050322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618938|NCT01050322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24618944|NCT01050322|Mitosis Modulators|mitosis modulators|mesh-ancestor
24618945|NCT01050322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24618946|NCT01050348|Atorvastatin|atorvastatin|mesh-list
24618948|NCT01050348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24618949|NCT01050348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618950|NCT01050348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24618951|NCT01050348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24618952|NCT01050348|Antimetabolites|antimetabolites|mesh-ancestor
24618953|NCT01050348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618954|NCT01050348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24750301|NCT01697618|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24750303|NCT01697618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750304|NCT01697631|Insulin|insulin|mesh-list
24750305|NCT01697631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24750306|NCT01697631|Insulin Aspart|insulin aspart|mesh-list
24750307|NCT01697631|Insulin, Long-Acting|insulin, long-acting|mesh-list
24750308|NCT01697631|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24750309|NCT01697631|Biphasic Insulins|biphasic insulins|mesh-list
24712174|NCT01518998|Amlodipine|amlodipine|mesh-list
24750498|NCT01698788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24750511|NCT01699113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750512|NCT01699113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750513|NCT01699126|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24750514|NCT01699126|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24750516|NCT01699126|Antimetabolites|antimetabolites|mesh-ancestor
24619009|NCT01050452|Antinematodal Agents|antinematodal agents|mesh-ancestor
24869481|NCT03423355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24869483|NCT03365635|Grazoprevir|grazoprevir|mesh-list
24869484|NCT03365635|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
24869485|NCT03365635|Antimetabolites|antimetabolites|mesh-ancestor
24869487|NCT03365635|Antiviral Agents|antiviral agents|mesh-ancestor
24619010|NCT01050452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24619011|NCT01050478|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24619012|NCT01050478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24619013|NCT01050478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24750665|NCT01699919|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24750666|NCT01699919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24750667|NCT01699919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750668|NCT01699932|Metformin|metformin|mesh-list
24750669|NCT01699932|Glimepiride|glimepiride|mesh-list
24750670|NCT01699932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24750671|NCT01699932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750672|NCT01699932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24750673|NCT01699932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24750674|NCT01699932|Immunologic Factors|immunologic factors|mesh-ancestor
24750675|NCT01699997|Oxytocin|oxytocin|mesh-list
24750676|NCT01699997|Oxytocics|oxytocics|mesh-ancestor
24750677|NCT01699997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24944411|NCT03960866|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24944412|NCT03960866|Adrenergic Agents|adrenergic agents|mesh-ancestor
24944413|NCT03960866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24944414|NCT03960866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944415|NCT03960866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944420|NCT03960801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24944421|NCT03960801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051248|NCT00429923|Hormones|hormones|mesh-ancestor
24788879|NCT01934569|GABA Modulators|gaba modulators|mesh-ancestor
24750771|NCT01700491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25668646|NCT01720602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25668647|NCT01720602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668648|NCT01720602|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25668649|NCT01720602|Hormone Antagonists|hormone antagonists|mesh-ancestor
25668650|NCT01720602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25051265|NCT00427440|Immunologic Factors|immunologic factors|mesh-ancestor
25051266|NCT00427440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051268|NCT00427154|Metformin|metformin|mesh-list
25051269|NCT00427154|Glimepiride|glimepiride|mesh-list
25051270|NCT00427154|Rosiglitazone|rosiglitazone|mesh-list
25051271|NCT00427154|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24750935|NCT01701219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24750936|NCT01701232|Rituximab|rituximab|mesh-list
24750950|NCT01701323|Cytarabine|cytarabine|mesh-list
24750951|NCT01701323|Fludarabine|fludarabine|mesh-list
24750952|NCT01701323|Fludarabine phosphate|fludarabine phosphate|mesh-list
24750953|NCT01701323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24750962|NCT01701336|Cloricromen|cloricromen|mesh-list
24750974|NCT01701349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750975|NCT01701453|Clopidogrel|clopidogrel|mesh-list
24750976|NCT01701453|Ticagrelor|ticagrelor|mesh-list
24750977|NCT01701453|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24750978|NCT01701453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24750979|NCT01701453|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24750980|NCT01701453|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24750981|NCT01701453|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24750982|NCT01701453|Purinergic Agents|purinergic agents|mesh-ancestor
24750983|NCT01701453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24750984|NCT01701453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750985|NCT01701453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750986|NCT01701466|Silver Sulfadiazine|silver sulfadiazine|mesh-list
25051272|NCT00427154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25051273|NCT00427154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051274|NCT00427154|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24619022|NCT01050478|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24619023|NCT01050478|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24619024|NCT01050478|Dopamine Agents|dopamine agents|mesh-ancestor
24944423|NCT03960801|Sensory System Agents|sensory system agents|mesh-ancestor
24944424|NCT03960801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24944425|NCT03960814|Insulin Detemir|insulin detemir|mesh-list
24944426|NCT03960814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24944427|NCT03960814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944428|NCT03960671|Midazolam|midazolam|mesh-list
24944429|NCT03960671|Diazepam|diazepam|mesh-list
24944430|NCT03960671|Propofol|propofol|mesh-list
24944431|NCT03960671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24944432|NCT03960671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24857588|NCT02292732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24619044|NCT01050556|Hematinics|hematinics|mesh-ancestor
24619045|NCT01050556|Vitamins|vitamins|mesh-ancestor
24619046|NCT01050556|Micronutrients|micronutrients|mesh-ancestor
24619047|NCT01050556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619048|NCT01050595|Naltrexone|naltrexone|mesh-list
24619049|NCT01050595|Bromides|bromides|mesh-list
24944433|NCT03960671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944434|NCT03960671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24944435|NCT03960671|Anesthetics, General|anesthetics, general|mesh-ancestor
24944436|NCT03960671|Anesthetics|anesthetics|mesh-ancestor
24944437|NCT03960671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24944438|NCT03960671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24944439|NCT03960671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24619050|NCT01050595|Methylnaltrexone|methylnaltrexone|mesh-list
24619051|NCT01050595|Anticonvulsants|anticonvulsants|mesh-ancestor
24619052|NCT01050595|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24619053|NCT01050595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619054|NCT01050595|Sensory System Agents|sensory system agents|mesh-ancestor
24750995|NCT01701479|Analgesics|analgesics|mesh-ancestor
24750996|NCT01701479|Sensory System Agents|sensory system agents|mesh-ancestor
24750997|NCT01701479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24751011|NCT01701518|Glucocorticoids|glucocorticoids|mesh-ancestor
24751013|NCT01701518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24751014|NCT01701518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24751015|NCT01701518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751016|NCT01701583|Omalizumab|omalizumab|mesh-list
24751017|NCT01701583|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24751018|NCT01701583|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24751019|NCT01701583|Respiratory System Agents|respiratory system agents|mesh-ancestor
24751020|NCT01701739|Digoxin|digoxin|mesh-list
24751021|NCT01701739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24751022|NCT01701739|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24751023|NCT01701739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24751024|NCT01701739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668652|NCT01720602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25085798|NCT03294967|Micronutrients|micronutrients|mesh-ancestor
25085799|NCT03294967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085800|NCT03294967|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24456394|NCT00331084|Moxifloxacin|moxifloxacin|mesh-list
24751025|NCT01701739|Protective Agents|protective agents|mesh-ancestor
24751026|NCT01701739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751027|NCT01701778|Dexmedetomidine|dexmedetomidine|mesh-list
24751028|NCT01701778|Sevoflurane|sevoflurane|mesh-list
24751029|NCT01701778|Levobupivacaine|levobupivacaine|mesh-list
24751030|NCT01701778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24751031|NCT01701778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24751032|NCT01701778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751033|NCT01701778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24751062|NCT01701856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751063|NCT01701856|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24751064|NCT01701882|Tenofovir|tenofovir|mesh-list
24751065|NCT01701882|Emtricitabine|emtricitabine|mesh-list
24751066|NCT01701882|Rilpivirine|rilpivirine|mesh-list
24751067|NCT01701882|Antiviral Agents|antiviral agents|mesh-ancestor
24751068|NCT01701882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24751070|NCT01701882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24751071|NCT01701882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24751072|NCT01701882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769572|NCT01814709|Itraconazole|itraconazole|mesh-list
24944440|NCT03960671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24944441|NCT03960671|GABA Modulators|gaba modulators|mesh-ancestor
24944442|NCT03960671|GABA Agents|gaba agents|mesh-ancestor
24944443|NCT03960671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24423471|NCT00226096|Sympatholytics|sympatholytics|mesh-ancestor
24751073|NCT01701882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24751074|NCT01701882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24751076|NCT01701921|Analgesics|analgesics|mesh-ancestor
24751077|NCT01701921|Sensory System Agents|sensory system agents|mesh-ancestor
24751078|NCT01701921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24751079|NCT01701921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751080|NCT01701921|Anticonvulsants|anticonvulsants|mesh-ancestor
24751081|NCT01701921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24751082|NCT01701921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24751085|NCT01701921|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24751086|NCT01701921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24751087|NCT01701921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24751088|NCT01701921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24751089|NCT01702038|Rituximab|rituximab|mesh-list
24751090|NCT01702038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24751091|NCT01702038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751092|NCT01702038|Immunologic Factors|immunologic factors|mesh-ancestor
24751093|NCT01702038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751197|NCT01702701|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24751198|NCT01702701|Hormone Antagonists|hormone antagonists|mesh-ancestor
24751200|NCT01702701|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24751201|NCT01702701|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24751202|NCT01702701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751205|NCT01702714|Carboplatin|carboplatin|mesh-list
24751206|NCT01702714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24751207|NCT01702714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751208|NCT01702714|Tubulin Modulators|tubulin modulators|mesh-ancestor
24751209|NCT01702714|Antimitotic Agents|antimitotic agents|mesh-ancestor
24751210|NCT01702714|Mitosis Modulators|mitosis modulators|mesh-ancestor
24751211|NCT01702714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751212|NCT01702714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24751213|NCT01702714|Antimetabolites|antimetabolites|mesh-ancestor
24751214|NCT01702714|Antiviral Agents|antiviral agents|mesh-ancestor
24751215|NCT01702714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24751216|NCT01702714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24751217|NCT01702714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24751218|NCT01702714|Immunologic Factors|immunologic factors|mesh-ancestor
24751219|NCT01702714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668653|NCT01720602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25668654|NCT01720602|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25668655|NCT01720667|Levetiracetam|levetiracetam|mesh-list
25668656|NCT01720667|Phenobarbital|phenobarbital|mesh-list
25668657|NCT01720667|Anticonvulsants|anticonvulsants|mesh-ancestor
25085857|NCT03294525|Serotonin Agents|serotonin agents|mesh-ancestor
25085858|NCT03294525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085859|NCT03294525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25085860|NCT03294525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24751220|NCT01702792|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
24751221|NCT01702792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24751222|NCT01702792|Immunologic Factors|immunologic factors|mesh-ancestor
24751223|NCT01702792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944449|NCT03960671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24751267|NCT01703104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24751268|NCT01703104|Antimetabolites|antimetabolites|mesh-ancestor
24751269|NCT01703104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751270|NCT01703130|Ropivacaine|ropivacaine|mesh-list
24751275|NCT01703130|Sensory System Agents|sensory system agents|mesh-ancestor
24751276|NCT01703130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24751278|NCT01703234|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24751279|NCT01703234|Protease Inhibitors|protease inhibitors|mesh-ancestor
24751282|NCT01703234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24751283|NCT01703312|Omalizumab|omalizumab|mesh-list
24751284|NCT01703312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24714397|NCT01530490|Cabergoline|cabergoline|mesh-list
24751561|NCT01704716|Sensory System Agents|sensory system agents|mesh-ancestor
24751562|NCT01704716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24751563|NCT01704716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24751687|NCT01705457|Vitamin A|vitamin a|mesh-list
24751688|NCT01705457|Retinol palmitate|retinol palmitate|mesh-list
24751689|NCT01705457|Vitamins|vitamins|mesh-ancestor
24751690|NCT01705457|Micronutrients|micronutrients|mesh-ancestor
24751711|NCT01705483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751714|NCT01705639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751715|NCT01705639|Protective Agents|protective agents|mesh-ancestor
24751716|NCT01705639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751717|NCT01705639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24751719|NCT01705743|Sevoflurane|sevoflurane|mesh-list
24751720|NCT01705743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24751721|NCT01705743|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24751722|NCT01705743|Anesthetics, General|anesthetics, general|mesh-ancestor
24751723|NCT01705743|Anesthetics|anesthetics|mesh-ancestor
24751724|NCT01705743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24751725|NCT01705743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751726|NCT01705743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24751727|NCT01705743|Analgesics|analgesics|mesh-ancestor
24751733|NCT01705769|Trace Elements|trace elements|mesh-list
24751734|NCT01705769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751735|NCT01705795|Antibodies|antibodies|mesh-list
24751736|NCT01705795|Immunologic Factors|immunologic factors|mesh-ancestor
24751737|NCT01705795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751738|NCT01705808|Protein C|protein c|mesh-list
24751739|NCT01705808|Anticoagulants|anticoagulants|mesh-ancestor
24751740|NCT01705808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24751741|NCT01705808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24751742|NCT01705808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751775|NCT01706120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751776|NCT01706120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24751777|NCT01706120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24751778|NCT01706120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24751779|NCT01706120|Growth Substances|growth substances|mesh-ancestor
24751955|NCT01707407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24751956|NCT01707407|Growth Substances|growth substances|mesh-ancestor
24751957|NCT01707407|Growth Inhibitors|growth inhibitors|mesh-ancestor
25006006|NCT05206721|Chlorhexidine|chlorhexidine|mesh-list
24752004|NCT01707732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24752005|NCT01707732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24752006|NCT01707732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752007|NCT01707745|Bevacizumab|bevacizumab|mesh-list
24752008|NCT01707745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24752009|NCT01707745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24752010|NCT01707745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24752011|NCT01707745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24752012|NCT01707745|Growth Substances|growth substances|mesh-ancestor
25668658|NCT01720667|Nootropic Agents|nootropic agents|mesh-ancestor
25668659|NCT01720667|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25668660|NCT01720667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25668661|NCT01720667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752013|NCT01707745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752014|NCT01707745|Growth Inhibitors|growth inhibitors|mesh-ancestor
24752015|NCT01707823|Aspirin|aspirin|mesh-list
24614901|NCT01026714|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24715836|NCT01538693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535548|NCT00649350|Metformin|metformin|mesh-list
24752335|NCT01709942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24752336|NCT01709955|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
24752337|NCT01709955|Cathartics|cathartics|mesh-ancestor
24752338|NCT01709955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24752339|NCT01709994|Aspirin|aspirin|mesh-list
24752340|NCT01709994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24752341|NCT01709994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24752342|NCT01709994|Analgesics|analgesics|mesh-ancestor
24752343|NCT01709994|Sensory System Agents|sensory system agents|mesh-ancestor
24752439|NCT01710462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752440|NCT01710462|Antiemetics|antiemetics|mesh-ancestor
24752441|NCT01710462|Autonomic Agents|autonomic agents|mesh-ancestor
24752442|NCT01710462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24752443|NCT01710462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752444|NCT01710462|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24752445|NCT01710462|Dopamine Agents|dopamine agents|mesh-ancestor
24752446|NCT01710462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24752447|NCT01710488|Levofloxacin|levofloxacin|mesh-list
24752448|NCT01710488|Ofloxacin|ofloxacin|mesh-list
24752449|NCT01710488|Prulifloxacin|prulifloxacin|mesh-list
24752450|NCT01710488|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24752451|NCT01710488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24752452|NCT01710488|Renal Agents|renal agents|mesh-ancestor
24752507|NCT01710696|Hormones|hormones|mesh-ancestor
24752508|NCT01710696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24752509|NCT01710696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752513|NCT01710696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24752515|NCT01710722|Pseudoephedrine|pseudoephedrine|mesh-list
24752516|NCT01710722|Caffeine|caffeine|mesh-list
25199850|NCT02738177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752517|NCT01710722|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25862572|NCT00090246|Serotonin Agents|serotonin agents|mesh-ancestor
25862573|NCT00090246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25862574|NCT00090246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752518|NCT01710722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752519|NCT01710722|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24752520|NCT01710722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752521|NCT01710722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752522|NCT01710722|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24869578|NCT02820961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24869579|NCT02820961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869580|NCT02820961|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24446757|NCT00305825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24752523|NCT01710722|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24625398|NCT01082003|Antioxidants|antioxidants|mesh-ancestor
24752524|NCT01710722|Purinergic Agents|purinergic agents|mesh-ancestor
24752525|NCT01710722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24752526|NCT01710722|Sympathomimetics|sympathomimetics|mesh-ancestor
24752527|NCT01710722|Autonomic Agents|autonomic agents|mesh-ancestor
24752528|NCT01710722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24752529|NCT01710722|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24752530|NCT01710722|Adrenergic Agents|adrenergic agents|mesh-ancestor
24752531|NCT01710722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24752532|NCT01710722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24752533|NCT01710722|Respiratory System Agents|respiratory system agents|mesh-ancestor
24944523|NCT03959969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944524|NCT03959969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25006096|NCT05205577|Iodine|iodine|mesh-list
25199851|NCT02738177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25199852|NCT02738177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25199853|NCT02738177|Oxytocics|oxytocics|mesh-ancestor
25199854|NCT02738177|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25199855|NCT02738177|Diuretics|diuretics|mesh-ancestor
25199856|NCT02738177|Natriuretic Agents|natriuretic agents|mesh-ancestor
25199857|NCT02738177|Vasodilator Agents|vasodilator agents|mesh-ancestor
25199858|NCT02738177|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25199859|NCT02738177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199860|NCT02738073|Tranexamic Acid|tranexamic acid|mesh-list
25862575|NCT00090246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25668662|NCT01720667|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25219180|NCT02665208|Nicotine|nicotine|mesh-list
25199861|NCT02738073|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25199862|NCT02738073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25199863|NCT02738073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199864|NCT02738073|Hemostatics|hemostatics|mesh-ancestor
25199865|NCT02738073|Coagulants|coagulants|mesh-ancestor
25199866|NCT02737943|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25199867|NCT02737943|Analgesics|analgesics|mesh-list
25199868|NCT02737943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25199869|NCT02737943|Sensory System Agents|sensory system agents|mesh-ancestor
25199870|NCT02737943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25199871|NCT02737943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199872|NCT02737709|Paclitaxel|paclitaxel|mesh-list
25199873|NCT02737709|Carboplatin|carboplatin|mesh-list
25199874|NCT02737709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25199875|NCT02737709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199876|NCT02737709|Tubulin Modulators|tubulin modulators|mesh-ancestor
25199877|NCT02737709|Antimitotic Agents|antimitotic agents|mesh-ancestor
24752604|NCT01711229|Analgesics|analgesics|mesh-ancestor
24752605|NCT01711229|Sensory System Agents|sensory system agents|mesh-ancestor
24752606|NCT01711229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24752607|NCT01711229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109712|NCT03121963|Antipyretics|antipyretics|mesh-ancestor
24752640|NCT01711463|Fluticasone|fluticasone|mesh-list
24752642|NCT01711463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24752643|NCT01711463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24752644|NCT01711463|Autonomic Agents|autonomic agents|mesh-ancestor
24752645|NCT01711463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24752686|NCT01711528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24752687|NCT01711528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24752689|NCT01711528|Protease Inhibitors|protease inhibitors|mesh-ancestor
24752690|NCT01711528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752691|NCT01711528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752692|NCT01711528|Dermatologic Agents|dermatologic agents|mesh-ancestor
24752693|NCT01711567|Tenofovir|tenofovir|mesh-list
24752694|NCT01711567|Entecavir|entecavir|mesh-list
24752695|NCT01711567|Antiviral Agents|antiviral agents|mesh-ancestor
24944560|NCT03959501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24944561|NCT03959501|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24857713|NCT02293668|Hormone Antagonists|hormone antagonists|mesh-ancestor
24619215|NCT01051401|Antimetabolites|antimetabolites|mesh-ancestor
24417286|NCT00206154|Glucocorticoids|glucocorticoids|mesh-ancestor
24417287|NCT00206154|Hormones|hormones|mesh-ancestor
24417295|NCT00206167|Budesonide|budesonide|mesh-list
25862576|NCT00090246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25862577|NCT00090246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25862578|NCT00090246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25862579|NCT00090246|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24619224|NCT01051479|Lipotropic Agents|lipotropic agents|mesh-ancestor
24619225|NCT01051479|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24752702|NCT01711567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24944562|NCT03959501|Protease Inhibitors|protease inhibitors|mesh-ancestor
24944563|NCT03959501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752714|NCT01711671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24752715|NCT01711671|Glucocorticoids|glucocorticoids|mesh-ancestor
24752716|NCT01711671|Hormones|hormones|mesh-ancestor
24752717|NCT01711671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24752718|NCT01711671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24752729|NCT01711697|Tubulin Modulators|tubulin modulators|mesh-ancestor
24752730|NCT01711697|Antimitotic Agents|antimitotic agents|mesh-ancestor
25199878|NCT02737709|Mitosis Modulators|mitosis modulators|mesh-ancestor
25862580|NCT00090246|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25862581|NCT00090272|Ertapenem|ertapenem|mesh-list
25862582|NCT00090272|Cefotetan|cefotetan|mesh-list
24752756|NCT01711827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25862583|NCT00090272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24417411|NCT00206414|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24869635|NCT02334722|Anticonvulsants|anticonvulsants|mesh-ancestor
25668663|NCT01720667|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25668664|NCT01720667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25668665|NCT01720667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668666|NCT01720667|GABA Modulators|gaba modulators|mesh-ancestor
25668667|NCT01720667|GABA Agents|gaba agents|mesh-ancestor
25668668|NCT01720667|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25668669|NCT01720667|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24417412|NCT00206414|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24752817|NCT01712139|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24752845|NCT01712321|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24752846|NCT01712321|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24752847|NCT01712347|Bevacizumab|bevacizumab|mesh-list
24752848|NCT01712347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24543078|NCT00681902|Lidocaine|lidocaine|mesh-list
24752849|NCT01712347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24752850|NCT01712347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24752854|NCT01712347|Growth Inhibitors|growth inhibitors|mesh-ancestor
24752855|NCT01712464|Oxytocin|oxytocin|mesh-list
24752856|NCT01712464|Oxytocics|oxytocics|mesh-ancestor
24752857|NCT01712464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24752858|NCT01712464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752859|NCT01712477|Midazolam|midazolam|mesh-list
24752860|NCT01712477|Propofol|propofol|mesh-list
24752861|NCT01712477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24752862|NCT01712477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24752863|NCT01712477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752864|NCT01712477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24752865|NCT01712477|Anesthetics, General|anesthetics, general|mesh-ancestor
24752978|NCT01713101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24752979|NCT01713101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24752980|NCT01713101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24752981|NCT01713101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752982|NCT01713127|Remifentanil|remifentanil|mesh-list
24752983|NCT01713127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24752984|NCT01713127|Narcotics|narcotics|mesh-ancestor
24752985|NCT01713127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24752986|NCT01713127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752987|NCT01713127|Analgesics|analgesics|mesh-ancestor
24752988|NCT01713127|Sensory System Agents|sensory system agents|mesh-ancestor
24718080|NCT01551797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24753028|NCT01713361|Anticoagulants|anticoagulants|mesh-ancestor
24944590|NCT03959176|Autonomic Agents|autonomic agents|mesh-ancestor
24944591|NCT03959176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24944592|NCT03959176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944597|NCT03959176|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24718199|NCT01552798|Antipyretics|antipyretics|mesh-ancestor
24619296|NCT01051934|Tubulin Modulators|tubulin modulators|mesh-ancestor
24619297|NCT01051934|Antimitotic Agents|antimitotic agents|mesh-ancestor
24753046|NCT01713426|Sensory System Agents|sensory system agents|mesh-ancestor
24753047|NCT01713426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24753048|NCT01713426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753049|NCT01713426|Anticonvulsants|anticonvulsants|mesh-ancestor
24753050|NCT01713426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24753051|NCT01713426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24753052|NCT01713426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753053|NCT01713426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24753054|NCT01713426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24753083|NCT01713738|Immunologic Factors|immunologic factors|mesh-ancestor
24753084|NCT01713738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753121|NCT01714011|Aripiprazole|aripiprazole|mesh-list
24753122|NCT01714011|Ziprasidone|ziprasidone|mesh-list
24753123|NCT01714011|Antidepressive Agents|antidepressive agents|mesh-ancestor
24753124|NCT01714011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24753125|NCT01714011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24753126|NCT01714011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24658826|NCT01274247|Benzocaine|benzocaine|mesh-list
24753127|NCT01714011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24753128|NCT01714011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753129|NCT01714011|Dopamine Agonists|dopamine agonists|mesh-ancestor
24753130|NCT01714011|Dopamine Agents|dopamine agents|mesh-ancestor
24753131|NCT01714011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24753132|NCT01714011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753133|NCT01714011|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24753134|NCT01714011|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24753135|NCT01714011|Serotonin Agents|serotonin agents|mesh-ancestor
25862584|NCT00090272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24753161|NCT01714089|RNS60|rns60|mesh-list
24753162|NCT01714089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24753163|NCT01714089|Antiviral Agents|antiviral agents|mesh-ancestor
24753164|NCT01714089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24753165|NCT01714089|Immunologic Factors|immunologic factors|mesh-ancestor
24753166|NCT01714089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862585|NCT00090311|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24753167|NCT01714089|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24753168|NCT01714089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24753169|NCT01714089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24753175|NCT01714089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24753176|NCT01714102|Resveratrol|resveratrol|mesh-list
24753177|NCT01714102|Antioxidants|antioxidants|mesh-ancestor
24753178|NCT01714102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753179|NCT01714102|Protective Agents|protective agents|mesh-ancestor
24753180|NCT01714102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753181|NCT01714102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753182|NCT01714102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24753183|NCT01714115|Aflibercept|aflibercept|mesh-list
24753184|NCT01714115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24753191|NCT01714128|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24753192|NCT01714128|Estradiol|estradiol|mesh-list
24753193|NCT01714128|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24753194|NCT01714128|Estrogens|estrogens|mesh-ancestor
24753195|NCT01714128|Hormones|hormones|mesh-ancestor
24753196|NCT01714128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24753197|NCT01714128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753198|NCT01714128|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24753199|NCT01714128|Contraceptive Agents|contraceptive agents|mesh-ancestor
24753219|NCT01714193|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24753220|NCT01714193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753221|NCT01714193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24753222|NCT01714193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24753231|NCT01714206|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24753232|NCT01714206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24753353|NCT01714856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24753380|NCT01715077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719153|NCT01559480|Progestins|progestins|mesh-ancestor
24753418|NCT01715259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753419|NCT01715259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24753420|NCT01715311|Tiotropium Bromide|tiotropium bromide|mesh-list
24719499|NCT01561911|Antibodies|antibodies|mesh-list
24753457|NCT01715519|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24753458|NCT01715519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24659295|NCT01276704|Hormones|hormones|mesh-ancestor
24753474|NCT01715584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24753475|NCT01715584|Analgesics|analgesics|mesh-ancestor
24753476|NCT01715584|Sensory System Agents|sensory system agents|mesh-ancestor
24753477|NCT01715584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24753478|NCT01715597|Ascorbic Acid|ascorbic acid|mesh-list
24753479|NCT01715597|Antioxidants|antioxidants|mesh-ancestor
24753480|NCT01715597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753481|NCT01715597|Protective Agents|protective agents|mesh-ancestor
24753519|NCT01715701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24753520|NCT01715701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24753521|NCT01715701|Trace Elements|trace elements|mesh-ancestor
24753522|NCT01715701|Micronutrients|micronutrients|mesh-ancestor
24944641|NCT03958513|Anesthetics, Local|anesthetics, local|mesh-ancestor
24719798|NCT01564199|Xhance|xhance|mesh-list
24753573|NCT01716260|Chloroquine|chloroquine|mesh-list
24753574|NCT01716260|Primaquine|primaquine|mesh-list
24753575|NCT01716260|Amebicides|amebicides|mesh-ancestor
24753576|NCT01716260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24753577|NCT01716260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24753578|NCT01716260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24753579|NCT01716260|Antimalarials|antimalarials|mesh-ancestor
24753580|NCT01716260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24753581|NCT01716273|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24659451|NCT01277731|Hormones|hormones|mesh-ancestor
24753582|NCT01716273|Laxatives|laxatives|mesh-ancestor
24753583|NCT01716273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24753584|NCT01716338|Glyburide|glyburide|mesh-list
24753585|NCT01716338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24753586|NCT01716338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055346|NCT03521960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24754299|NCT01719978|Epinephrine|epinephrine|mesh-list
24753646|NCT01716637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24753647|NCT01716637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753648|NCT01716637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24944654|NCT03958344|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24944655|NCT03958344|Prednisolone phosphate|prednisolone phosphate|mesh-list
24944656|NCT03958344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24944658|NCT03958344|Hormones|hormones|mesh-ancestor
25219320|NCT02663713|Clopidogrel|clopidogrel|mesh-list
24944659|NCT03958344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24944660|NCT03958344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753649|NCT01716637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24753651|NCT01716637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24753652|NCT01716637|Immunologic Factors|immunologic factors|mesh-ancestor
24753653|NCT01716637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24753654|NCT01716637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753655|NCT01716637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753656|NCT01716637|Antioxidants|antioxidants|mesh-ancestor
24753657|NCT01716637|Protective Agents|protective agents|mesh-ancestor
24753658|NCT01716637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24753659|NCT01716689|Cyclophosphamide|cyclophosphamide|mesh-list
24753660|NCT01716689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24753661|NCT01716689|Immunologic Factors|immunologic factors|mesh-ancestor
24753662|NCT01716689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753663|NCT01716689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24753664|NCT01716689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24753665|NCT01716689|Alkylating Agents|alkylating agents|mesh-ancestor
24753666|NCT01716689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720164|NCT01566669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24753701|NCT01717066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24753703|NCT01717118|Immunologic Factors|immunologic factors|mesh-ancestor
24753704|NCT01717118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753705|NCT01717157|Fentanyl|fentanyl|mesh-list
24753706|NCT01717157|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24753707|NCT01717157|Narcotics|narcotics|mesh-ancestor
25862586|NCT00090311|Antidepressive Agents|antidepressive agents|mesh-ancestor
24753708|NCT01717157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24753709|NCT01717157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753710|NCT01717157|Analgesics|analgesics|mesh-ancestor
24753711|NCT01717157|Sensory System Agents|sensory system agents|mesh-ancestor
24753712|NCT01717157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24753713|NCT01717157|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24753714|NCT01717157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24753715|NCT01717157|Anesthetics, General|anesthetics, general|mesh-ancestor
24753716|NCT01717157|Anesthetics|anesthetics|mesh-ancestor
24460306|NCT00348101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24538679|NCT00660270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753717|NCT01717222|Lidocaine|lidocaine|mesh-list
24753718|NCT01717222|Anesthetics, Local|anesthetics, local|mesh-ancestor
24944666|NCT03958344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24944669|NCT03958201|Rocuronium|rocuronium|mesh-list
24944670|NCT03958201|Neostigmine|neostigmine|mesh-list
24753799|NCT01717846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24753801|NCT01717846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511292|NCT00568152|Aspirin|aspirin|mesh-list
24753802|NCT01717846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24753803|NCT01717911|Metformin|metformin|mesh-list
24753804|NCT01717911|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24721016|NCT01571908|Succinylcholine|succinylcholine|mesh-list
24753856|NCT01718223|Dermatologic Agents|dermatologic agents|mesh-ancestor
24753857|NCT01718236|Rocuronium|rocuronium|mesh-list
24753938|NCT01718366|Antimetabolites|antimetabolites|mesh-ancestor
24753939|NCT01718366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659920|NCT01280734|Melatonin|melatonin|mesh-list
24753950|NCT01718379|Growth Substances|growth substances|mesh-ancestor
24753951|NCT01718379|Growth Inhibitors|growth inhibitors|mesh-ancestor
24753952|NCT01718379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24753953|NCT01718496|Morphine|morphine|mesh-list
24753954|NCT01718496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24753955|NCT01718496|Narcotics|narcotics|mesh-ancestor
25862587|NCT00090311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25199879|NCT02737709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753956|NCT01718496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24753984|NCT01718613|Coagulants|coagulants|mesh-ancestor
24753985|NCT01718613|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24753986|NCT01718613|Natriuretic Agents|natriuretic agents|mesh-ancestor
24753988|NCT01718626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24753993|NCT01718652|Canagliflozin|canagliflozin|mesh-list
24753994|NCT01718652|Cyclosporine|cyclosporine|mesh-list
24753995|NCT01718652|Cyclosporins|cyclosporins|mesh-list
24753996|NCT01718652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753997|NCT01718652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753998|NCT01718652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24753999|NCT01718652|Immunologic Factors|immunologic factors|mesh-ancestor
25668670|NCT01720667|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25219354|NCT02663700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219355|NCT02663700|Antiviral Agents|antiviral agents|mesh-ancestor
25219356|NCT02663700|Schistosomicides|schistosomicides|mesh-ancestor
24869668|NCT01023737|Vorinostat|vorinostat|mesh-list
24809596|NCT02035020|Interferons|interferons|mesh-list
24809597|NCT02035020|Interferon-gamma|interferon-gamma|mesh-list
24809598|NCT02035020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24754000|NCT01718652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754001|NCT01718652|Antifungal Agents|antifungal agents|mesh-ancestor
24754002|NCT01718652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24721361|NCT01573663|Ambroxol|ambroxol|mesh-list
24754190|NCT01719601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24754191|NCT01719614|Metformin|metformin|mesh-list
24754192|NCT01719614|Rilpivirine|rilpivirine|mesh-list
24754210|NCT01719627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24754211|NCT01719627|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24754213|NCT01719640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24754214|NCT01719640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754215|NCT01719692|Rituximab|rituximab|mesh-list
24754216|NCT01719692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24754217|NCT01719692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24754218|NCT01719692|Immunologic Factors|immunologic factors|mesh-ancestor
24754219|NCT01719692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754220|NCT01719692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24754221|NCT01719705|Pregabalin|pregabalin|mesh-list
24754222|NCT01719705|Analgesics|analgesics|mesh-ancestor
24754223|NCT01719705|Sensory System Agents|sensory system agents|mesh-ancestor
24754224|NCT01719705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24754225|NCT01719705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754226|NCT01719705|Anticonvulsants|anticonvulsants|mesh-ancestor
24754227|NCT01719705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24754228|NCT01719705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24754229|NCT01719705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754230|NCT01719705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24754231|NCT01719705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24615637|NCT01030900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24754279|NCT01719926|Indomethacin|indomethacin|mesh-list
24754280|NCT01719926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24754281|NCT01719926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24754296|NCT01719952|Oxytocics|oxytocics|mesh-ancestor
24754297|NCT01719952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24754298|NCT01719952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754300|NCT01719978|Racepinephrine|racepinephrine|mesh-list
24754301|NCT01719978|Mepivacaine|mepivacaine|mesh-list
24754302|NCT01719978|Epinephryl borate|epinephryl borate|mesh-list
24754303|NCT01719978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24754304|NCT01719978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24754305|NCT01719978|Adrenergic Agents|adrenergic agents|mesh-ancestor
24754306|NCT01719978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24754307|NCT01719978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754308|NCT01719978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754309|NCT01719978|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24754310|NCT01719978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24754311|NCT01719978|Autonomic Agents|autonomic agents|mesh-ancestor
24754312|NCT01719978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24754313|NCT01719978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24754314|NCT01719978|Respiratory System Agents|respiratory system agents|mesh-ancestor
24754315|NCT01719978|Mydriatics|mydriatics|mesh-ancestor
24754316|NCT01719978|Sympathomimetics|sympathomimetics|mesh-ancestor
24944713|NCT03958097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944714|NCT03957902|Aspirin|aspirin|mesh-list
24944715|NCT03957902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24944716|NCT03957902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24754337|NCT01720056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754338|NCT01720056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24754339|NCT01720056|Immunologic Factors|immunologic factors|mesh-ancestor
25199880|NCT02737813|Bupivacaine|bupivacaine|mesh-list
25199881|NCT02737813|Anesthetics, Local|anesthetics, local|mesh-ancestor
24754341|NCT01720056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24544533|NCT00689442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24544534|NCT00689442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24544536|NCT00689442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544537|NCT00689442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25429339|NCT01535053|Calcium|calcium|mesh-list
25668671|NCT01720797|Chlorhexidine|chlorhexidine|mesh-list
25668672|NCT01720797|Anesthetics|anesthetics|mesh-list
25668673|NCT01720797|Anesthetics, Local|anesthetics, local|mesh-list
24754342|NCT01720056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24544538|NCT00689442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24754343|NCT01720056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24754344|NCT01720056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24754345|NCT01720056|Vasodilator Agents|vasodilator agents|mesh-ancestor
24754350|NCT01720095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754351|NCT01720095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24754352|NCT01720095|Vasodilator Agents|vasodilator agents|mesh-ancestor
24754353|NCT01720095|Vitamin B Complex|vitamin b complex|mesh-ancestor
24754355|NCT01720095|Micronutrients|micronutrients|mesh-ancestor
24754356|NCT01720095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754366|NCT01720212|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24754367|NCT01720212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24754368|NCT01720212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24754369|NCT01720212|Adrenergic Agents|adrenergic agents|mesh-ancestor
24754370|NCT01720212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24944729|NCT03957902|Antipyretics|antipyretics|mesh-ancestor
24944731|NCT03958045|Rucaparib|rucaparib|mesh-list
24754411|NCT01720459|Protective Agents|protective agents|mesh-ancestor
24754412|NCT01720459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754413|NCT01720459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24754414|NCT01720459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24754415|NCT01720485|Prednisolone|prednisolone|mesh-list
24754416|NCT01720485|Betamethasone|betamethasone|mesh-list
24754417|NCT01720485|Desloratadine|desloratadine|mesh-list
24754418|NCT01720485|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
24660387|NCT01283204|Tubulin Modulators|tubulin modulators|mesh-ancestor
24754420|NCT01720485|Glucocorticoids|glucocorticoids|mesh-ancestor
24754421|NCT01720485|Hormones|hormones|mesh-ancestor
24754422|NCT01720485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24754423|NCT01720485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754424|NCT01720485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24754425|NCT01720485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24754426|NCT01720485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24754427|NCT01720485|Respiratory System Agents|respiratory system agents|mesh-ancestor
24754428|NCT01720485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24754429|NCT01720485|Cholinergic Agents|cholinergic agents|mesh-ancestor
24754430|NCT01720485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24419153|NCT00211367|Anecortave|anecortave|mesh-list
24754431|NCT01720485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754432|NCT01720485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24754433|NCT01720485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24754434|NCT01720485|Histamine Antagonists|histamine antagonists|mesh-ancestor
24754465|NCT01720615|Narcotics|narcotics|mesh-ancestor
24754466|NCT01720615|Analgesics|analgesics|mesh-ancestor
24754467|NCT01720615|Sensory System Agents|sensory system agents|mesh-ancestor
24754468|NCT01720615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24754469|NCT01720628|Angiogenin|angiogenin|mesh-list
24754470|NCT01720628|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
24944771|NCT03957499|Analgesics|analgesics|mesh-ancestor
24754473|NCT01720628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754474|NCT01720719|Vitamin E|vitamin e|mesh-list
24754475|NCT01720719|Atorvastatin|atorvastatin|mesh-list
24754476|NCT01720719|Vitamins|vitamins|mesh-ancestor
24754477|NCT01720719|Micronutrients|micronutrients|mesh-ancestor
24754478|NCT01720719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862588|NCT00090311|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24495041|NCT00498225|Gemcitabine|gemcitabine|mesh-list
24754479|NCT01720719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24754480|NCT01720719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25199882|NCT02737813|Anesthetics|anesthetics|mesh-ancestor
24944735|NCT03958045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944736|NCT03958045|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24944737|NCT03958045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24944738|NCT03957720|Penicillamine|penicillamine|mesh-list
24857846|NCT02294266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24857847|NCT02294266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25862589|NCT00090311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24722628|NCT01581814|Hormones|hormones|mesh-ancestor
24754491|NCT01720875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24754492|NCT01720875|Antiemetics|antiemetics|mesh-ancestor
24754493|NCT01720875|Autonomic Agents|autonomic agents|mesh-ancestor
24754505|NCT01720940|Vancomycin|vancomycin|mesh-list
24754506|NCT01720940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24754507|NCT01720940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24754508|NCT01721031|Tramadol|tramadol|mesh-list
24754509|NCT01721031|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24754510|NCT01721031|Narcotics|narcotics|mesh-ancestor
24660444|NCT01283724|Dienogest|dienogest|mesh-list
24754511|NCT01721031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24419244|NCT00211497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24944739|NCT03957720|Succimer|succimer|mesh-list
24944740|NCT03957720|Antidotes|antidotes|mesh-ancestor
24944741|NCT03957720|Protective Agents|protective agents|mesh-ancestor
24944742|NCT03957720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944743|NCT03957720|Chelating Agents|chelating agents|mesh-ancestor
24944744|NCT03957720|Sequestering Agents|sequestering agents|mesh-ancestor
24944745|NCT03957720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944746|NCT03957720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24944749|NCT03957668|Lactulose|lactulose|mesh-list
24857848|NCT02294279|Beclomethasone|beclomethasone|mesh-list
24857849|NCT02294279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24857850|NCT02294279|Glucocorticoids|glucocorticoids|mesh-ancestor
24754517|NCT01721135|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24754518|NCT01721135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24754519|NCT01721135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24944764|NCT03957499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24944765|NCT03957499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24944766|NCT03957499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24944768|NCT03957499|Anesthetics|anesthetics|mesh-ancestor
24754536|NCT01721291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754537|NCT01721291|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24754538|NCT01721291|Respiratory System Agents|respiratory system agents|mesh-ancestor
24754540|NCT01721291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24754541|NCT01721291|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24754542|NCT01721291|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24754543|NCT01721291|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24754544|NCT01721291|Adrenergic Agents|adrenergic agents|mesh-ancestor
24754545|NCT01721291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24754546|NCT01721291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869720|NCT00455403|Amebicides|amebicides|mesh-ancestor
24495083|NCT00498316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446761|NCT00305825|Growth Substances|growth substances|mesh-ancestor
24446762|NCT00305825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512820|NCT00576914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862590|NCT00090311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25862591|NCT00090311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862592|NCT00090324|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24944770|NCT03957499|Sensory System Agents|sensory system agents|mesh-ancestor
24944772|NCT03957499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25051297|NCT00424697|GABA Modulators|gaba modulators|mesh-ancestor
24960625|NCT03815279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24960626|NCT03815279|Glucocorticoids|glucocorticoids|mesh-ancestor
24960627|NCT03815279|Hormones|hormones|mesh-ancestor
24960629|NCT03815279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24944773|NCT03957499|Anticonvulsants|anticonvulsants|mesh-ancestor
25862593|NCT00090324|Antidepressive Agents|antidepressive agents|mesh-ancestor
24944774|NCT03957499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24944775|NCT03957499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24944776|NCT03957499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944777|NCT03957499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24944778|NCT03957499|Tocolytic Agents|tocolytic agents|mesh-ancestor
24944779|NCT03957499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24944780|NCT03957629|Interferons|interferons|mesh-list
24944781|NCT03957629|Tenofovir|tenofovir|mesh-list
24944782|NCT03957629|Interferon-alpha|interferon-alpha|mesh-list
24944784|NCT03957629|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24857862|NCT02294292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857863|NCT02294292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24857864|NCT02294292|Antioxidants|antioxidants|mesh-ancestor
25862594|NCT00090324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25862595|NCT00090324|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25862596|NCT00090324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25862597|NCT00090324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25862598|NCT00090324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862599|NCT00090428|Caseins|caseins|mesh-list
25862600|NCT00090428|Chelating Agents|chelating agents|mesh-ancestor
24723270|NCT01586286|Tocolytic Agents|tocolytic agents|mesh-ancestor
24754552|NCT01721382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24754553|NCT01721382|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24754554|NCT01721382|Protease Inhibitors|protease inhibitors|mesh-ancestor
25862601|NCT00090428|Sequestering Agents|sequestering agents|mesh-ancestor
24754555|NCT01721382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24754556|NCT01721382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754557|NCT01721434|Simendan|simendan|mesh-list
24754558|NCT01721434|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24754559|NCT01721434|Vasodilator Agents|vasodilator agents|mesh-ancestor
24754560|NCT01721434|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24754561|NCT01721434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24754562|NCT01721434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24754563|NCT01721434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754564|NCT01721434|Protective Agents|protective agents|mesh-ancestor
24754565|NCT01721434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754566|NCT01721525|Ribavirin|ribavirin|mesh-list
24754567|NCT01721525|Paclitaxel|paclitaxel|mesh-list
24754568|NCT01721525|Carboplatin|carboplatin|mesh-list
24754569|NCT01721525|Afatinib|afatinib|mesh-list
24723477|NCT01587508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24754617|NCT01721915|Vitamins|vitamins|mesh-ancestor
24754618|NCT01721915|Micronutrients|micronutrients|mesh-ancestor
24754619|NCT01721915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754620|NCT01721915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24754621|NCT01721993|Zoledronic Acid|zoledronic acid|mesh-list
24754622|NCT01721993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24754623|NCT01721993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754625|NCT01722110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24754626|NCT01722110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24754627|NCT01722110|Analgesics|analgesics|mesh-ancestor
24754628|NCT01722110|Sensory System Agents|sensory system agents|mesh-ancestor
24754629|NCT01722110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24754630|NCT01722110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944791|NCT03957629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944792|NCT03957629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24944802|NCT03957291|Povidone|povidone|mesh-list
24944803|NCT03957291|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24857868|NCT02294292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24857869|NCT02294292|Vasodilator Agents|vasodilator agents|mesh-ancestor
24857870|NCT02294292|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25862602|NCT00090428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862603|NCT00090480|Vaccines|vaccines|mesh-list
25862604|NCT00090480|Immunologic Factors|immunologic factors|mesh-ancestor
24754631|NCT01722110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24723531|NCT01587729|Serotonin|serotonin|mesh-list
24619455|NCT01052584|Chloroquine|chloroquine|mesh-list
24619456|NCT01052584|Lumefantrine|lumefantrine|mesh-list
24619457|NCT01052584|Artemether|artemether|mesh-list
24619460|NCT01052584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24619461|NCT01052584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24619462|NCT01052584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24619463|NCT01052584|Antimalarials|antimalarials|mesh-ancestor
24944804|NCT03957291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24944805|NCT03957291|Disinfectants|disinfectants|mesh-ancestor
24944806|NCT03957291|Dermatologic Agents|dermatologic agents|mesh-ancestor
24944807|NCT03957291|Plasma Substitutes|plasma substitutes|mesh-ancestor
24944808|NCT03957291|Blood Substitutes|blood substitutes|mesh-ancestor
24944809|NCT03957174|Rivastigmine|rivastigmine|mesh-list
24944810|NCT03957174|Reboxetine|reboxetine|mesh-list
24944811|NCT03957174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24944812|NCT03957174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24944813|NCT03957174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944814|NCT03957174|Cholinergic Agents|cholinergic agents|mesh-ancestor
24857871|NCT02294292|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24857872|NCT02294305|Vortioxetine|vortioxetine|mesh-list
24857873|NCT02294305|Antidepressive Agents|antidepressive agents|mesh-ancestor
25862605|NCT00090480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619464|NCT01052584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24619465|NCT01052597|Curcumin|curcumin|mesh-list
24944815|NCT03957174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24944816|NCT03957174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944817|NCT03957174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24944818|NCT03957174|Protective Agents|protective agents|mesh-ancestor
24944819|NCT03957174|Antidepressive Agents|antidepressive agents|mesh-ancestor
24944820|NCT03957174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24944821|NCT03957174|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24944822|NCT03957174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24944823|NCT03957174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24857874|NCT02294305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24857875|NCT02294305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24857876|NCT02294305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24857877|NCT02294305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24857878|NCT02294305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857879|NCT02294305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24857880|NCT02294305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24857881|NCT02294305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24460369|NCT00348296|Immunoglobulins|immunoglobulins|mesh-list
25862606|NCT00090558|Nitroglycerin|nitroglycerin|mesh-list
25862607|NCT00090558|Vasodilator Agents|vasodilator agents|mesh-ancestor
25862608|NCT00090623|Ranibizumab|ranibizumab|mesh-list
25862609|NCT00090623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25862610|NCT00090623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25862611|NCT00090623|Growth Substances|growth substances|mesh-ancestor
24542395|NCT00678483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24542396|NCT00678483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862612|NCT00090623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862613|NCT00090623|Growth Inhibitors|growth inhibitors|mesh-ancestor
24542498|NCT00678977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542499|NCT00678990|Heparin|heparin|mesh-list
24542500|NCT00678990|Anticoagulants|anticoagulants|mesh-ancestor
24542501|NCT00678990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24542502|NCT00678990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24542503|NCT00678990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542504|NCT00679068|Bosentan|bosentan|mesh-list
24944835|NCT03956966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24944836|NCT03956966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25051299|NCT00424697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25051300|NCT00424697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944837|NCT03956966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542514|NCT00679120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24542515|NCT00679120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542516|NCT00679120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542517|NCT00679120|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25199886|NCT02737813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25199895|NCT02737670|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
25199896|NCT02737670|Anticoagulants|anticoagulants|mesh-ancestor
25199897|NCT02737670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25199898|NCT02737670|Antimetabolites|antimetabolites|mesh-ancestor
25199899|NCT02737670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199901|NCT02737670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25199902|NCT02737670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25199903|NCT02737670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25199904|NCT02737670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199905|NCT02737800|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25199906|NCT02737800|Luteolytic Agents|luteolytic agents|mesh-ancestor
25199907|NCT02737800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25199908|NCT02737800|Contraceptive Agents|contraceptive agents|mesh-ancestor
25199909|NCT02737800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25199910|NCT02737800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199911|NCT02737800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24542519|NCT00679120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542521|NCT00679146|Colchicine|colchicine|mesh-list
25862614|NCT00090623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25055448|NCT03521024|Ether|ether|mesh-list
24542522|NCT00679146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24542523|NCT00679146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24542524|NCT00679146|Analgesics|analgesics|mesh-ancestor
24619467|NCT01052597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24619468|NCT01052597|Analgesics|analgesics|mesh-ancestor
24619469|NCT01052597|Sensory System Agents|sensory system agents|mesh-ancestor
24619470|NCT01052597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24619471|NCT01052597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619472|NCT01052597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24619473|NCT01052597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24619474|NCT01052597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24619488|NCT01052623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24619489|NCT01052623|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24544940|NCT00691067|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24944840|NCT03956966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24944841|NCT03956966|Sensory System Agents|sensory system agents|mesh-ancestor
24944842|NCT03957109|Anesthetics|anesthetics|mesh-list
24944843|NCT03957109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24944844|NCT03957109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944845|NCT03956953|BMS-986165|bms-986165|mesh-list
24944846|NCT03956953|Dermatologic Agents|dermatologic agents|mesh-ancestor
24944847|NCT03956953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24857886|NCT02294305|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24857887|NCT02294305|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24857888|NCT02294305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24857889|NCT02294344|Cyclophosphamide|cyclophosphamide|mesh-list
25862615|NCT00090675|Gefitinib|gefitinib|mesh-list
25862616|NCT00090675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862617|NCT00090675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25862618|NCT00090675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25862619|NCT00090675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542565|NCT00679250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542566|NCT00679250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542567|NCT00679250|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24542568|NCT00679315|Alfuzosin|alfuzosin|mesh-list
24542569|NCT00679315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24542570|NCT00679315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24754672|NCT01722305|Antiemetics|antiemetics|mesh-ancestor
24754673|NCT01722305|Autonomic Agents|autonomic agents|mesh-ancestor
24754674|NCT01722305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24754680|NCT01722305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24754681|NCT01722305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24754682|NCT01722305|Protease Inhibitors|protease inhibitors|mesh-ancestor
24754683|NCT01722305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24754684|NCT01722305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754685|NCT01722305|Immunologic Factors|immunologic factors|mesh-ancestor
24754686|NCT01722305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24754687|NCT01722305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24754688|NCT01722305|Growth Substances|growth substances|mesh-ancestor
24944848|NCT03956953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24944849|NCT03956953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944850|NCT03956732|Vitamin D|vitamin d|mesh-list
24944851|NCT03956732|Caseins|caseins|mesh-list
24944852|NCT03956732|Vitamins|vitamins|mesh-ancestor
24944853|NCT03956732|Micronutrients|micronutrients|mesh-ancestor
24944854|NCT03956732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944855|NCT03956732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24944857|NCT03956732|Sequestering Agents|sequestering agents|mesh-ancestor
24857890|NCT02294344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24857891|NCT02294344|Immunologic Factors|immunologic factors|mesh-ancestor
24857892|NCT02294344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857893|NCT02294344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25862620|NCT00090727|AQ4N|aq4n|mesh-list
25862621|NCT00090727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542579|NCT00679458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24542580|NCT00679458|Narcotics|narcotics|mesh-ancestor
24542589|NCT00679484|Olmesartan|olmesartan|mesh-list
24542590|NCT00679484|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24542591|NCT00679484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24542592|NCT00679484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24542593|NCT00679484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24542594|NCT00679484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754689|NCT01722305|Growth Inhibitors|growth inhibitors|mesh-ancestor
25876492|NCT03399838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24542606|NCT00679523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24542607|NCT00679536|Fludarabine|fludarabine|mesh-list
24542608|NCT00679536|Busulfan|busulfan|mesh-list
24542609|NCT00679536|Thymoglobulin|thymoglobulin|mesh-list
24542610|NCT00679536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542611|NCT00679536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542612|NCT00679536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24542613|NCT00679536|Immunologic Factors|immunologic factors|mesh-ancestor
24542614|NCT00679536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876493|NCT03399838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25876494|NCT03399838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876495|NCT03399838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24754696|NCT01722409|Dexmedetomidine|dexmedetomidine|mesh-list
24754697|NCT01722409|Sevoflurane|sevoflurane|mesh-list
24754698|NCT01722409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24754699|NCT01722409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24754700|NCT01722409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754701|NCT01722409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24754702|NCT01722409|Analgesics|analgesics|mesh-ancestor
24754703|NCT01722409|Sensory System Agents|sensory system agents|mesh-ancestor
24754707|NCT01722409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24754735|NCT01722539|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24944877|NCT03956888|Acetylcysteine|acetylcysteine|mesh-list
24944878|NCT03956888|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24944879|NCT03956888|Antiviral Agents|antiviral agents|mesh-ancestor
24944880|NCT03956888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24944881|NCT03956888|Expectorants|expectorants|mesh-ancestor
24542705|NCT00679770|Antifungal Agents|antifungal agents|mesh-ancestor
24542707|NCT00679835|Daptomycin|daptomycin|mesh-list
24944885|NCT03956888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944886|NCT03956888|Protective Agents|protective agents|mesh-ancestor
24944887|NCT03956888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944888|NCT03956888|Antidotes|antidotes|mesh-ancestor
24944889|NCT03956303|Levobupivacaine|levobupivacaine|mesh-list
24944890|NCT03956303|Anesthetics, Local|anesthetics, local|mesh-ancestor
24944891|NCT03956303|Anesthetics|anesthetics|mesh-ancestor
24944892|NCT03956303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24857908|NCT02294357|Pomalidomide|pomalidomide|mesh-list
24857909|NCT02294357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24857910|NCT02294357|Prednisolone phosphate|prednisolone phosphate|mesh-list
24857911|NCT02294357|BB 1101|bb 1101|mesh-list
24857912|NCT02294357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24857913|NCT02294357|Antiemetics|antiemetics|mesh-ancestor
24770076|NCT01817816|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24857914|NCT02294357|Autonomic Agents|autonomic agents|mesh-ancestor
24857915|NCT02294357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857916|NCT02294357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542743|NCT00680173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24542744|NCT00680173|Antimetabolites|antimetabolites|mesh-ancestor
24542745|NCT00680173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542769|NCT00680329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24542792|NCT00680394|Contraceptive Agents|contraceptive agents|mesh-ancestor
24542793|NCT00680394|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24542794|NCT00680394|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24542795|NCT00680394|Hormone Antagonists|hormone antagonists|mesh-ancestor
25862622|NCT00090896|Ipilimumab|ipilimumab|mesh-list
25862623|NCT00090896|Antibodies|antibodies|mesh-list
25862624|NCT00090896|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24944905|NCT03956017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944906|NCT03956017|Vitamins|vitamins|mesh-ancestor
24944907|NCT03955939|Midazolam|midazolam|mesh-list
24754783|NCT01722799|Paclitaxel|paclitaxel|mesh-list
24754784|NCT01722799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24754785|NCT01722799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24754786|NCT01722799|Tubulin Modulators|tubulin modulators|mesh-ancestor
24754787|NCT01722799|Antimitotic Agents|antimitotic agents|mesh-ancestor
24754788|NCT01722799|Mitosis Modulators|mitosis modulators|mesh-ancestor
24754796|NCT01722942|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24754798|NCT01722942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24754799|NCT01722942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24754800|NCT01722942|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24944910|NCT03955939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24944911|NCT03955939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944912|NCT03955939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24944913|NCT03955939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24944914|NCT03955939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24944915|NCT03955939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24944916|NCT03955939|Anesthetics, General|anesthetics, general|mesh-ancestor
24944918|NCT03955939|GABA Modulators|gaba modulators|mesh-ancestor
24944919|NCT03955939|GABA Agents|gaba agents|mesh-ancestor
24789559|NCT01937767|Analgesics|analgesics|mesh-ancestor
24754823|NCT01723059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24754824|NCT01723059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24754825|NCT01723059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24754826|NCT01723059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24754827|NCT01723059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24754828|NCT01723059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24754829|NCT01723059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754830|NCT01723059|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24754831|NCT01723059|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24754832|NCT01723059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24754833|NCT01723150|Ciprofloxacin|ciprofloxacin|mesh-list
24754834|NCT01723150|Ceftriaxone|ceftriaxone|mesh-list
24754835|NCT01723150|Ertapenem|ertapenem|mesh-list
24754836|NCT01723150|Trimethoprim|trimethoprim|mesh-list
24754912|NCT01723735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24754913|NCT01723748|Hormones|hormones|mesh-list
24754916|NCT01723800|Carboplatin|carboplatin|mesh-list
25862625|NCT00090896|Immunologic Factors|immunologic factors|mesh-ancestor
24629902|NCT01108588|Antipyretics|antipyretics|mesh-ancestor
24629903|NCT01108588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24629904|NCT01108588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24629905|NCT01108588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24629906|NCT01108588|Purinergic Agents|purinergic agents|mesh-ancestor
24629907|NCT01108588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25219548|NCT02662348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24754936|NCT01724086|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24754937|NCT01724086|Simeprevir|simeprevir|mesh-list
24754938|NCT01724086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24754939|NCT01724086|Antiviral Agents|antiviral agents|mesh-ancestor
24754940|NCT01724086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24754941|NCT01724086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24754942|NCT01724086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24754943|NCT01724086|Protease Inhibitors|protease inhibitors|mesh-ancestor
24754944|NCT01724086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24754945|NCT01724086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754946|NCT01724086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24619491|NCT01052623|Sensory System Agents|sensory system agents|mesh-ancestor
24619492|NCT01052623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24619495|NCT01052623|Autonomic Agents|autonomic agents|mesh-ancestor
24619496|NCT01052623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24619497|NCT01052623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24619498|NCT01052623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24619499|NCT01052623|Adrenergic Agents|adrenergic agents|mesh-ancestor
24619500|NCT01052623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24619501|NCT01052623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619502|NCT01052792|Naproxen|naproxen|mesh-list
24619503|NCT01052792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24619504|NCT01052792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24619505|NCT01052792|Analgesics|analgesics|mesh-ancestor
24619506|NCT01052792|Sensory System Agents|sensory system agents|mesh-ancestor
24619507|NCT01052792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24619525|NCT01052896|Analgesics|analgesics|mesh-ancestor
24619526|NCT01052896|Sensory System Agents|sensory system agents|mesh-ancestor
24754992|NCT01724268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24754993|NCT01724268|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24754994|NCT01724268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24754995|NCT01724268|Immunologic Factors|immunologic factors|mesh-ancestor
24754996|NCT01724268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24754997|NCT01724268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24754998|NCT01724268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24754999|NCT01724268|Glucocorticoids|glucocorticoids|mesh-ancestor
24755252|NCT01725477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24755001|NCT01724268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24755002|NCT01724268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25862626|NCT00090896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876496|NCT03399838|Analgesics|analgesics|mesh-ancestor
24755034|NCT01724372|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24755035|NCT01724372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24755036|NCT01724372|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24755037|NCT01724372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24755038|NCT01724372|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24755039|NCT01724372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24755040|NCT01724372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24755041|NCT01724372|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24755042|NCT01724372|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24755043|NCT01724372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24755044|NCT01724372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24755045|NCT01724385|Bevacizumab|bevacizumab|mesh-list
24755046|NCT01724385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24755047|NCT01724385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755101|NCT01724723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24755103|NCT01724788|Diuretics|diuretics|mesh-ancestor
24944954|NCT03956121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944955|NCT03956121|Anesthetics|anesthetics|mesh-ancestor
25668674|NCT01720797|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25668675|NCT01720797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25668676|NCT01720797|Disinfectants|disinfectants|mesh-ancestor
25668677|NCT01720797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25668678|NCT01720797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668679|NCT01720797|Sensory System Agents|sensory system agents|mesh-ancestor
25668680|NCT01720797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25219584|NCT02662374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25273029|NCT02387619|Telmisartan|telmisartan|mesh-list
24944956|NCT03956121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24944957|NCT03956121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24944958|NCT03956121|Anticonvulsants|anticonvulsants|mesh-ancestor
24944959|NCT03956121|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24944960|NCT03956121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24944961|NCT03956121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944962|NCT03956121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24755104|NCT01724788|Natriuretic Agents|natriuretic agents|mesh-ancestor
24755144|NCT01724983|Anesthetics, General|anesthetics, general|mesh-ancestor
24755145|NCT01724983|Anesthetics|anesthetics|mesh-ancestor
24755146|NCT01724983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24755147|NCT01724983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24755148|NCT01724983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24661172|NCT01288339|Oxaliplatin|oxaliplatin|mesh-list
24419927|NCT00214604|Pravastatin|pravastatin|mesh-list
24755156|NCT01725009|Nootropic Agents|nootropic agents|mesh-ancestor
24543128|NCT00681993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24543129|NCT00681993|Immunologic Factors|immunologic factors|mesh-ancestor
25862627|NCT00090896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25862628|NCT00090896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543130|NCT00681993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543131|NCT00681993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24543137|NCT00681993|Tubulin Modulators|tubulin modulators|mesh-ancestor
25862629|NCT00090896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24755170|NCT01725048|Histamine Antagonists|histamine antagonists|mesh-ancestor
24755171|NCT01725048|Histamine Agents|histamine agents|mesh-ancestor
24755172|NCT01725048|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24755173|NCT01725048|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24755174|NCT01725048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24755175|NCT01725048|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24543165|NCT00682149|Ascorbic Acid|ascorbic acid|mesh-list
24755201|NCT01725100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755202|NCT01725100|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24755203|NCT01725100|Protective Agents|protective agents|mesh-ancestor
24755204|NCT01725100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755205|NCT01725100|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24755206|NCT01725100|Antioxidants|antioxidants|mesh-ancestor
24755207|NCT01725113|Calcitriol|calcitriol|mesh-list
24755208|NCT01725113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24755209|NCT01725113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755212|NCT01725113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755213|NCT01725113|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24755214|NCT01725113|Vitamins|vitamins|mesh-ancestor
24755215|NCT01725113|Micronutrients|micronutrients|mesh-ancestor
25862630|NCT00090896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862631|NCT00090909|Gemcitabine|gemcitabine|mesh-list
24755249|NCT01725412|Micronutrients|micronutrients|mesh-ancestor
24755250|NCT01725412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755251|NCT01725477|Methylene Blue|methylene blue|mesh-list
24755254|NCT01725490|Metformin|metformin|mesh-list
24755255|NCT01725490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24944981|NCT03955406|Anesthetics|anesthetics|mesh-list
24944982|NCT03955406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24944983|NCT03955406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944984|NCT03955354|Apatinib|apatinib|mesh-list
24944985|NCT03955354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24944986|NCT03955354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24944987|NCT03955354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24944988|NCT03955354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944989|NCT03955341|Chlorhexidine|chlorhexidine|mesh-list
24857954|NCT02294552|Tacrolimus|tacrolimus|mesh-list
24543210|NCT00682383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24755283|NCT01725607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24755284|NCT01725607|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24755288|NCT01725607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24755289|NCT01725607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755290|NCT01725620|Etanercept|etanercept|mesh-list
24755291|NCT01725620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24755292|NCT01725620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25668681|NCT01721070|Ketoconazole|ketoconazole|mesh-list
24755293|NCT01725620|Analgesics|analgesics|mesh-ancestor
25668682|NCT01721070|Sufentanil|sufentanil|mesh-list
25668683|NCT01721070|Dsuvia|dsuvia|mesh-list
25219596|NCT02661893|Rifampin|rifampin|mesh-list
25219597|NCT02661893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25219598|NCT02661893|Antitubercular Agents|antitubercular agents|mesh-ancestor
25219599|NCT02661893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25219600|NCT02661893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25219601|NCT02661893|Leprostatic Agents|leprostatic agents|mesh-ancestor
25219602|NCT02661893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25219603|NCT02661893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273044|NCT02387619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25862632|NCT00090909|Dexamethasone|dexamethasone|mesh-list
24944990|NCT03955341|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24944991|NCT03955341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24944992|NCT03955341|Disinfectants|disinfectants|mesh-ancestor
24944993|NCT03955393|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
24944994|NCT03955393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24944995|NCT03955393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543321|NCT00683137|Analgesics|analgesics|mesh-ancestor
24543322|NCT00683137|Sensory System Agents|sensory system agents|mesh-ancestor
24543323|NCT00683137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25862633|NCT00090909|Cisplatin|cisplatin|mesh-list
24755294|NCT01725620|Sensory System Agents|sensory system agents|mesh-ancestor
24755295|NCT01725620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24755296|NCT01725620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755297|NCT01725620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25199912|NCT02737800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24755334|NCT01726075|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24755335|NCT01726075|Somatostatin|somatostatin|mesh-list
24755336|NCT01726075|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24755337|NCT01726075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24755338|NCT01726075|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24420120|NCT00215228|Analgesics|analgesics|mesh-ancestor
24945033|NCT03954873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24945035|NCT03954639|Bupivacaine|bupivacaine|mesh-list
24945036|NCT03954639|Anesthetics, Local|anesthetics, local|mesh-ancestor
24945037|NCT03954639|Anesthetics|anesthetics|mesh-ancestor
24945038|NCT03954639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24945039|NCT03954639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945040|NCT03954639|Sensory System Agents|sensory system agents|mesh-ancestor
24857959|NCT02294552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24619549|NCT01052961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619550|NCT01052974|Ropivacaine|ropivacaine|mesh-list
24619551|NCT01052974|Anesthetics, Local|anesthetics, local|mesh-ancestor
24619552|NCT01052974|Anesthetics|anesthetics|mesh-ancestor
24619553|NCT01052974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24619554|NCT01052974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862634|NCT00090909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543390|NCT00683319|Mitosis Modulators|mitosis modulators|mesh-ancestor
24543391|NCT00683345|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24755362|NCT01726205|Ropivacaine|ropivacaine|mesh-list
24755363|NCT01726205|Anesthetics, Local|anesthetics, local|mesh-ancestor
24755364|NCT01726205|Anesthetics|anesthetics|mesh-ancestor
24543448|NCT00683865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24857970|NCT02294552|Antitubercular Agents|antitubercular agents|mesh-ancestor
24857971|NCT02294552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24857972|NCT02294552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24543486|NCT00683969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24755422|NCT01726465|Antioxidants|antioxidants|mesh-ancestor
24755423|NCT01726465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755462|NCT01726582|Immunologic Factors|immunologic factors|mesh-ancestor
24755463|NCT01726582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727150|NCT01608269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24420486|NCT00216164|Gemcitabine|gemcitabine|mesh-list
24755649|NCT01727973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24755650|NCT01727973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24755651|NCT01728025|Ranolazine|ranolazine|mesh-list
25668684|NCT01721070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25668685|NCT01721070|Narcotics|narcotics|mesh-ancestor
25668686|NCT01721070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25668687|NCT01721070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668688|NCT01721070|Analgesics|analgesics|mesh-ancestor
25668689|NCT01721070|Sensory System Agents|sensory system agents|mesh-ancestor
25668690|NCT01721070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25668691|NCT01721070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25668692|NCT01721070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25862635|NCT00090909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25219606|NCT02661893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25219611|NCT02661711|Aflibercept|aflibercept|mesh-list
24755652|NCT01728025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24755771|NCT01728961|Lumefantrine|lumefantrine|mesh-list
24755833|NCT01729468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24727512|NCT01610921|Sensory System Agents|sensory system agents|mesh-ancestor
24755883|NCT01729806|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24755884|NCT01729806|Immunologic Factors|immunologic factors|mesh-ancestor
24755885|NCT01729806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755996|NCT01730664|Ertapenem|ertapenem|mesh-list
24755997|NCT01730664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24755998|NCT01730664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24755999|NCT01730677|Vinorelbine|vinorelbine|mesh-list
24756000|NCT01730677|Lapatinib|lapatinib|mesh-list
24756001|NCT01730677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24756002|NCT01730677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24756003|NCT01730677|Tubulin Modulators|tubulin modulators|mesh-ancestor
25862636|NCT00090909|Antiemetics|antiemetics|mesh-ancestor
25862637|NCT00090909|Autonomic Agents|autonomic agents|mesh-ancestor
25862638|NCT00090909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24756004|NCT01730677|Antimitotic Agents|antimitotic agents|mesh-ancestor
24756005|NCT01730677|Mitosis Modulators|mitosis modulators|mesh-ancestor
24756006|NCT01730677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756007|NCT01730677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24756008|NCT01730677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756009|NCT01730976|Vitamin D|vitamin d|mesh-list
24756010|NCT01730976|Vitamins|vitamins|mesh-list
24756011|NCT01730976|Micronutrients|micronutrients|mesh-ancestor
24756012|NCT01730976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728012|NCT01613963|Prednisolone|prednisolone|mesh-list
24756034|NCT01731067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756036|NCT01731067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24756037|NCT01731067|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24756038|NCT01731067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756039|NCT01731067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24756040|NCT01731067|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24756041|NCT01731067|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24756042|NCT01731067|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24420788|NCT00216788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24756161|NCT01731327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756162|NCT01731340|Calcium, Dietary|calcium, dietary|mesh-list
24756163|NCT01731340|Calcium|calcium|mesh-list
24420883|NCT00217152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24420884|NCT00217152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25199913|NCT02737800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420906|NCT00217204|Pancreatin|pancreatin|mesh-list
24420907|NCT00217204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24756164|NCT01731340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24756165|NCT01731340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756166|NCT01731340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24756167|NCT01731431|Glyburide|glyburide|mesh-list
24756168|NCT01731431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24945101|NCT03953677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24945102|NCT03953677|Analgesics|analgesics|mesh-ancestor
24945103|NCT03953677|Sensory System Agents|sensory system agents|mesh-ancestor
24756169|NCT01731431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756170|NCT01731457|Etanercept|etanercept|mesh-list
24756171|NCT01731457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24756172|NCT01731457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24756186|NCT01731561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756187|NCT01731561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24756188|NCT01731574|Dapivirine|dapivirine|mesh-list
24756189|NCT01731574|Miconazole|miconazole|mesh-list
24756190|NCT01731574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24756206|NCT01731587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24756207|NCT01731587|Immunologic Factors|immunologic factors|mesh-ancestor
24756208|NCT01731587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668693|NCT01721070|Anesthetics, General|anesthetics, general|mesh-ancestor
24756209|NCT01731587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25668694|NCT01721070|Anesthetics|anesthetics|mesh-ancestor
25668695|NCT01721070|Antifungal Agents|antifungal agents|mesh-ancestor
25668696|NCT01721070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25668697|NCT01721070|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25668698|NCT01721070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25668699|NCT01721070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25668700|NCT01721070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862639|NCT00090909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862640|NCT00090909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25862641|NCT00090909|Glucocorticoids|glucocorticoids|mesh-ancestor
25862642|NCT00090909|Hormones|hormones|mesh-ancestor
24832782|NCT02172235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24832783|NCT02172235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832784|NCT02172235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24832785|NCT02172235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862643|NCT00090909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25862644|NCT00090909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25862645|NCT00090909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25862646|NCT00090909|Antimetabolites|antimetabolites|mesh-ancestor
24430592|NCT00248339|Ribavirin|ribavirin|mesh-list
25862647|NCT00090909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862648|NCT00090909|Antiviral Agents|antiviral agents|mesh-ancestor
24465376|NCT00369356|Prednisone|prednisone|mesh-list
25862649|NCT00090909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25862650|NCT00090909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25862651|NCT00090909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25862652|NCT00090909|Immunologic Factors|immunologic factors|mesh-ancestor
25862653|NCT00091039|Metronidazole|metronidazole|mesh-list
25862654|NCT00091039|Paclitaxel|paclitaxel|mesh-list
25862655|NCT00091039|Carboplatin|carboplatin|mesh-list
25862656|NCT00091039|Vaccines|vaccines|mesh-list
25862657|NCT00091039|Immunologic Factors|immunologic factors|mesh-ancestor
25862658|NCT00091039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668701|NCT01721070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25668702|NCT01721070|Hormone Antagonists|hormone antagonists|mesh-ancestor
25668703|NCT01721070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25668704|NCT01721070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25668705|NCT01721109|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24756210|NCT01731587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24756211|NCT01731587|Alkylating Agents|alkylating agents|mesh-ancestor
24756212|NCT01731587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756213|NCT01731587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24756214|NCT01731587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24756216|NCT01731652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24756217|NCT01731652|Immunologic Factors|immunologic factors|mesh-ancestor
24756218|NCT01731652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756219|NCT01731652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24756220|NCT01731652|Interferon Inducers|interferon inducers|mesh-ancestor
24756221|NCT01731756|Salicylic Acid|salicylic acid|mesh-list
24756222|NCT01731756|Salicylates|salicylates|mesh-list
24756223|NCT01731756|Petrolatum|petrolatum|mesh-list
24756224|NCT01731756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24756225|NCT01731756|Antifungal Agents|antifungal agents|mesh-ancestor
24756226|NCT01731756|Keratolytic Agents|keratolytic agents|mesh-ancestor
24756227|NCT01731756|Dermatologic Agents|dermatologic agents|mesh-ancestor
24756228|NCT01731756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24756233|NCT01731756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668706|NCT01721109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25668707|NCT01721109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25668708|NCT01721109|Antiviral Agents|antiviral agents|mesh-ancestor
25668709|NCT01721109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25668710|NCT01721226|Opiate Alkaloids|opiate alkaloids|mesh-list
25668711|NCT01721226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25668712|NCT01721226|Narcotics|narcotics|mesh-ancestor
25668713|NCT01721226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25668714|NCT01721226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668715|NCT01721226|Analgesics|analgesics|mesh-ancestor
25668716|NCT01721226|Sensory System Agents|sensory system agents|mesh-ancestor
25668717|NCT01721226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25668718|NCT01721317|Ezogabine|ezogabine|mesh-list
25668719|NCT01721317|Anticonvulsants|anticonvulsants|mesh-ancestor
25668720|NCT01721317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25668721|NCT01721317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668722|NCT01721330|Naltrexone|naltrexone|mesh-list
25668723|NCT01721330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25668724|NCT01721330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25668725|NCT01721330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668726|NCT01721330|Sensory System Agents|sensory system agents|mesh-ancestor
25668727|NCT01721330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25668728|NCT01721408|Imipenem|imipenem|mesh-list
25219670|NCT02661438|Ciprofloxacin|ciprofloxacin|mesh-list
25219671|NCT02661438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25219672|NCT02661438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24756234|NCT01731756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24546640|NCT00699465|Enoxaparin|enoxaparin|mesh-list
24756235|NCT01731756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24756236|NCT01731756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24756237|NCT01731756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756238|NCT01731756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756239|NCT01731756|Emollients|emollients|mesh-ancestor
25862659|NCT00091039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25862660|NCT00091039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862661|NCT00091039|Tubulin Modulators|tubulin modulators|mesh-ancestor
24756282|NCT01732068|Luteolytic Agents|luteolytic agents|mesh-ancestor
24756283|NCT01732068|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24756284|NCT01732068|Contraceptive Agents|contraceptive agents|mesh-ancestor
24756285|NCT01732068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24756286|NCT01732068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756287|NCT01732068|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24728739|NCT01617824|Hormones|hormones|mesh-ancestor
24756362|NCT01732666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24756364|NCT01732744|Sodium Hypochlorite|sodium hypochlorite|mesh-list
24756366|NCT01732744|Castor Oil|castor oil|mesh-list
24756367|NCT01732744|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25006595|NCT04876677|Hormones|hormones|mesh-ancestor
24421207|NCT00218127|Narcotics|narcotics|mesh-ancestor
24421208|NCT00218127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24756494|NCT01733706|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24756495|NCT01733706|Cholinergic Agents|cholinergic agents|mesh-ancestor
24756496|NCT01733706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24756497|NCT01733706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756498|NCT01733823|Nimorazole|nimorazole|mesh-list
24756499|NCT01733823|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
24756500|NCT01733823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24756501|NCT01733823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24756502|NCT01733823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24756504|NCT01733836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24756505|NCT01733836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756506|NCT01733966|Amoxicillin|amoxicillin|mesh-list
24756507|NCT01733966|Clavulanic Acids|clavulanic acids|mesh-list
24756508|NCT01733966|Clavulanic Acid|clavulanic acid|mesh-list
24728981|NCT01619163|Hormones|hormones|mesh-ancestor
24756530|NCT01734044|Dexamethasone|dexamethasone|mesh-list
24756534|NCT01734044|Antiemetics|antiemetics|mesh-ancestor
24756535|NCT01734044|Autonomic Agents|autonomic agents|mesh-ancestor
24756536|NCT01734044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24756537|NCT01734044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862662|NCT00091039|Antimitotic Agents|antimitotic agents|mesh-ancestor
25862663|NCT00091039|Mitosis Modulators|mitosis modulators|mesh-ancestor
25862664|NCT00091039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756538|NCT01734044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24756539|NCT01734044|Glucocorticoids|glucocorticoids|mesh-ancestor
24756540|NCT01734044|Hormones|hormones|mesh-ancestor
24756541|NCT01734044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24814711|NCT02066103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24814712|NCT02066103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24814713|NCT02066103|Tubulin Modulators|tubulin modulators|mesh-ancestor
24869963|NCT05025293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24756542|NCT01734044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24756543|NCT01734044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24756544|NCT01734044|Protease Inhibitors|protease inhibitors|mesh-ancestor
24756545|NCT01734044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756546|NCT01734044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662257|NCT01293643|Amebicides|amebicides|mesh-ancestor
24756567|NCT01734096|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24756568|NCT01734096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756570|NCT01734252|Antithrombins|antithrombins|mesh-ancestor
24756571|NCT01734252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25668729|NCT01721408|Tigecycline|tigecycline|mesh-list
25668730|NCT01721408|Cilastatin|cilastatin|mesh-list
25668731|NCT01721408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24756572|NCT01734252|Protease Inhibitors|protease inhibitors|mesh-ancestor
24756573|NCT01734252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756588|NCT01734408|Aluminum sulfate|aluminum sulfate|mesh-list
25668732|NCT01721408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25668733|NCT01721408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24756589|NCT01734408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24756590|NCT01734408|Immunologic Factors|immunologic factors|mesh-ancestor
24756591|NCT01734408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756593|NCT01734408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756594|NCT01734408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24619661|NCT01053338|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24619662|NCT01053338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24619663|NCT01053338|Anesthetics, Local|anesthetics, local|mesh-ancestor
24619664|NCT01053338|Anesthetics|anesthetics|mesh-ancestor
24619703|NCT01053403|Hallucinogens|hallucinogens|mesh-ancestor
24619704|NCT01053403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619706|NCT01053403|Serotonin Agents|serotonin agents|mesh-ancestor
24619707|NCT01053403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24619743|NCT01053611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24757051|NCT01737359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24757052|NCT01737359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757053|NCT01737359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757054|NCT01737359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25199914|NCT02737774|Carboplatin|carboplatin|mesh-list
24827119|NCT02137525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25862665|NCT00091039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25862666|NCT00091039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24869991|NCT04499677|Ritonavir|ritonavir|mesh-list
25862667|NCT00091039|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25199915|NCT02737774|Pemetrexed|pemetrexed|mesh-list
25199916|NCT02737774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199917|NCT02737774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199918|NCT02737774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199919|NCT02737774|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25199920|NCT02737774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25199921|NCT02737696|Analgesics, Opioid|analgesics, opioid|mesh-list
25199922|NCT02737696|Narcotics|narcotics|mesh-ancestor
25199923|NCT02737696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25199924|NCT02737696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199925|NCT02737696|Analgesics|analgesics|mesh-ancestor
25199926|NCT02737696|Sensory System Agents|sensory system agents|mesh-ancestor
25199927|NCT02737696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25199928|NCT02737605|Moxifloxacin|moxifloxacin|mesh-list
25199929|NCT02737605|Esketamine|esketamine|mesh-list
25199930|NCT02737605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25199931|NCT02737605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25199932|NCT02737605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25199933|NCT02737605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25199934|NCT02737605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199935|NCT02737605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199936|NCT02737605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199937|NCT02737605|Antidepressive Agents|antidepressive agents|mesh-ancestor
25199938|NCT02737605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25199939|NCT02737371|Antifungal Agents|antifungal agents|mesh-list
25199940|NCT02737371|Clotrimazole|clotrimazole|mesh-list
25199941|NCT02737371|Miconazole|miconazole|mesh-list
25199942|NCT02737371|Olorofim|olorofim|mesh-list
25199943|NCT02737371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25199944|NCT02737371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25199945|NCT02737371|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25199946|NCT02737371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25199947|NCT02737371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199948|NCT02737371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199949|NCT02737371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25199950|NCT02737371|Hormone Antagonists|hormone antagonists|mesh-ancestor
25208270|NCT02727998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24625970|NCT01084837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25021432|NCT03671655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021433|NCT03671538|Pemetrexed|pemetrexed|mesh-list
24870009|NCT04491526|Adrenergic Agents|adrenergic agents|mesh-ancestor
24625971|NCT01084863|Paclitaxel|paclitaxel|mesh-list
24625972|NCT01084863|Trastuzumab|trastuzumab|mesh-list
24870010|NCT04491526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24870011|NCT04491526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625973|NCT01084863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25668734|NCT01721408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25668735|NCT01721408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668736|NCT01721408|Protease Inhibitors|protease inhibitors|mesh-ancestor
25219721|NCT02661035|Fludarabine|fludarabine|mesh-list
25862668|NCT00091039|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24757140|NCT01738100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24757141|NCT01738100|Narcotics|narcotics|mesh-ancestor
24757142|NCT01738100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24757143|NCT01738100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757144|NCT01738100|Analgesics|analgesics|mesh-ancestor
24757145|NCT01738100|Sensory System Agents|sensory system agents|mesh-ancestor
24757146|NCT01738100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24757147|NCT01738100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24757148|NCT01738100|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24757149|NCT01738100|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24757150|NCT01738100|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24757153|NCT01738100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757191|NCT01738295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757193|NCT01738295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24757194|NCT01738295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757195|NCT01738295|Nootropic Agents|nootropic agents|mesh-ancestor
24757196|NCT01738360|Arsenic Trioxide|arsenic trioxide|mesh-list
24757197|NCT01738360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24757198|NCT01738373|Plerixafor|plerixafor|mesh-list
24757199|NCT01738373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24757200|NCT01738373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24757201|NCT01738373|Antiviral Agents|antiviral agents|mesh-ancestor
24757202|NCT01738373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24757203|NCT01738425|Hydrogen Sulfide|hydrogen sulfide|mesh-list
24757204|NCT01738425|Gasotransmitters|gasotransmitters|mesh-ancestor
24757205|NCT01738425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24757212|NCT01738451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757213|NCT01738542|Bosentan|bosentan|mesh-list
24757214|NCT01738542|Antihypertensive Agents|antihypertensive agents|mesh-list
24757215|NCT01738542|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24757216|NCT01738542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862669|NCT00091052|Sargramostim|sargramostim|mesh-list
24421922|NCT00220584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421923|NCT00220584|Cholinergic Agents|cholinergic agents|mesh-ancestor
24757235|NCT01738724|Hormone Antagonists|hormone antagonists|mesh-ancestor
24757236|NCT01738724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24757237|NCT01738724|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24757238|NCT01738724|Progestins|progestins|mesh-ancestor
24757244|NCT01738763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757246|NCT01738802|Trace Elements|trace elements|mesh-list
24757247|NCT01738802|Antioxidants|antioxidants|mesh-list
24757248|NCT01738802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757249|NCT01738802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757250|NCT01738802|Protective Agents|protective agents|mesh-ancestor
24757251|NCT01738815|Valproic Acid|valproic acid|mesh-list
24649248|NCT01219088|Bupivacaine|bupivacaine|mesh-list
24625978|NCT01084863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625979|NCT01084863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24625981|NCT01084876|Trastuzumab|trastuzumab|mesh-list
24945119|NCT03953729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24757258|NCT01738815|Antimanic Agents|antimanic agents|mesh-ancestor
24757259|NCT01738815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24757260|NCT01738815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24757375|NCT01739556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757376|NCT01739556|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24757377|NCT01739556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24757378|NCT01739556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24619811|NCT01053871|Sensory System Agents|sensory system agents|mesh-ancestor
24619812|NCT01053871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24422143|NCT00221481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24422144|NCT00221481|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24757432|NCT01739920|Plasma Substitutes|plasma substitutes|mesh-ancestor
24757433|NCT01739920|Blood Substitutes|blood substitutes|mesh-ancestor
24757434|NCT01739920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24757435|NCT01739920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24757448|NCT01739985|Hormones|hormones|mesh-ancestor
24757478|NCT01740271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24757479|NCT01740271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24757480|NCT01740271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24757481|NCT01740271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25668737|NCT01721460|Dexmedetomidine|dexmedetomidine|mesh-list
24757681|NCT01741623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757683|NCT01741649|Plasma Substitutes|plasma substitutes|mesh-ancestor
24757684|NCT01741649|Blood Substitutes|blood substitutes|mesh-ancestor
24757685|NCT01741753|Prednisone|prednisone|mesh-list
24757686|NCT01741753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24757687|NCT01741753|Glucocorticoids|glucocorticoids|mesh-ancestor
24757688|NCT01741753|Hormones|hormones|mesh-ancestor
24422350|NCT00222183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422351|NCT00222183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24422352|NCT00222183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24422353|NCT00222183|Dermatologic Agents|dermatologic agents|mesh-ancestor
24422354|NCT00222183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24422355|NCT00222183|Immunologic Factors|immunologic factors|mesh-ancestor
25862670|NCT00091052|Immunologic Factors|immunologic factors|mesh-ancestor
25862671|NCT00091052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862672|NCT00091078|Imatinib Mesylate|imatinib mesylate|mesh-list
24945177|NCT03953001|Respiratory System Agents|respiratory system agents|mesh-ancestor
24945179|NCT03953001|Sympathomimetics|sympathomimetics|mesh-ancestor
24422468|NCT00222547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732229|NCT01638403|Modafinil|modafinil|mesh-list
24757940|NCT01743066|Vitamins|vitamins|mesh-ancestor
24758048|NCT01743508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758049|NCT01743508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24758103|NCT01743885|Autonomic Agents|autonomic agents|mesh-ancestor
24758104|NCT01743885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25208271|NCT02727998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208272|NCT02727998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25208273|NCT02727998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24758119|NCT01743911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758120|NCT01743911|Urological Agents|urological agents|mesh-ancestor
24733885|NCT01649258|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24758503|NCT01746602|Timolol|timolol|mesh-list
24758504|NCT01746602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24758505|NCT01746602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24734012|NCT01650181|Trace Elements|trace elements|mesh-ancestor
24758600|NCT01746992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24619989|NCT01055145|Ofloxacin|ofloxacin|mesh-list
24619990|NCT01055145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24619991|NCT01055145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24619992|NCT01055145|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24619993|NCT01055145|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24619995|NCT01055145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619996|NCT01055145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24619997|NCT01055145|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24619998|NCT01055145|Renal Agents|renal agents|mesh-ancestor
24945206|NCT03952715|Ibuprofen|ibuprofen|mesh-list
24758755|NCT01747616|Sequestering Agents|sequestering agents|mesh-ancestor
24545221|NCT00692510|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24545222|NCT00692510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24545223|NCT00692510|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25862673|NCT00091078|Oblimersen|oblimersen|mesh-list
25862674|NCT00091078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758756|NCT01747616|Hemostatics|hemostatics|mesh-ancestor
24758757|NCT01747616|Coagulants|coagulants|mesh-ancestor
24758758|NCT01747642|Sorafenib|sorafenib|mesh-list
24758759|NCT01747642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758760|NCT01747642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24758761|NCT01747642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758762|NCT01747642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758763|NCT01747668|Tocopherols|tocopherols|mesh-list
24758764|NCT01747668|alpha-Tocopherol|alpha-tocopherol|mesh-list
24758814|NCT01748084|Immunologic Factors|immunologic factors|mesh-ancestor
24758815|NCT01748084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758816|NCT01748084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24758817|NCT01748123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24758818|NCT01748123|Chlorthalidone|chlorthalidone|mesh-list
24758819|NCT01748123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24758820|NCT01748123|Diuretics|diuretics|mesh-ancestor
25862675|NCT00091078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24758821|NCT01748123|Natriuretic Agents|natriuretic agents|mesh-ancestor
24758822|NCT01748123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961119|NCT03811223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24961120|NCT03811223|Antimetabolites|antimetabolites|mesh-ancestor
24961121|NCT03811223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862676|NCT00091078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758838|NCT01748279|Atorvastatin|atorvastatin|mesh-list
24758839|NCT01748279|Formoterol Fumarate|formoterol fumarate|mesh-list
24758840|NCT01748279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24758841|NCT01748279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24758842|NCT01748279|Antimetabolites|antimetabolites|mesh-ancestor
24758843|NCT01748279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758844|NCT01748279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24758845|NCT01748279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24758846|NCT01748279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25862677|NCT00091078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862678|NCT00091104|Aldesleukin|aldesleukin|mesh-list
24758871|NCT01748344|Histamine Agents|histamine agents|mesh-ancestor
24758872|NCT01748344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24758873|NCT01748344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758874|NCT01748344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758875|NCT01748370|Vitamin D|vitamin d|mesh-list
24758876|NCT01748370|Ergocalciferols|ergocalciferols|mesh-list
24758877|NCT01748370|Cholecalciferol|cholecalciferol|mesh-list
24758878|NCT01748370|Vitamins|vitamins|mesh-list
24758879|NCT01748370|Micronutrients|micronutrients|mesh-ancestor
24758880|NCT01748370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758890|NCT01748396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24735002|NCT01655147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051364|NCT00412932|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25051365|NCT00412828|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
25051366|NCT00412828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24858205|NCT02295826|Aspirin|aspirin|mesh-list
24758897|NCT01748422|Capsaicin|capsaicin|mesh-list
24758898|NCT01748422|Antipruritics|antipruritics|mesh-ancestor
24758923|NCT01748487|Protease Inhibitors|protease inhibitors|mesh-ancestor
24758924|NCT01748487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758925|NCT01748487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758926|NCT01748500|Pantoprazole|pantoprazole|mesh-list
24758927|NCT01748500|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24758928|NCT01748500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24758929|NCT01748500|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24758930|NCT01748500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620041|NCT01055301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620043|NCT01055301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24620044|NCT01055301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24620045|NCT01055301|Antiemetics|antiemetics|mesh-ancestor
24620046|NCT01055301|Autonomic Agents|autonomic agents|mesh-ancestor
24423723|NCT00226707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24423724|NCT00226707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24423725|NCT00226707|Analgesics|analgesics|mesh-ancestor
24423726|NCT00226707|Sensory System Agents|sensory system agents|mesh-ancestor
24423727|NCT00226707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24620056|NCT01055301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620057|NCT01055301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24620058|NCT01055301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24620083|NCT01055379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620085|NCT01055392|Antidepressive Agents|antidepressive agents|mesh-ancestor
24758963|NCT01748630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24758964|NCT01748630|GABA Modulators|gaba modulators|mesh-ancestor
24758965|NCT01748630|GABA Agents|gaba agents|mesh-ancestor
24758966|NCT01748669|Allyl sulfide|allyl sulfide|mesh-list
24758967|NCT01748669|Antioxidants|antioxidants|mesh-ancestor
24735543|NCT01657487|Adrenergic Agents|adrenergic agents|mesh-ancestor
25862679|NCT00091104|Cyclophosphamide|cyclophosphamide|mesh-list
25862680|NCT00091104|Fludarabine|fludarabine|mesh-list
25862681|NCT00091104|Fludarabine phosphate|fludarabine phosphate|mesh-list
24735642|NCT01657929|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25862682|NCT00091104|Freund's Adjuvant|freund's adjuvant|mesh-list
25862683|NCT00091104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25862684|NCT00091104|Immunologic Factors|immunologic factors|mesh-ancestor
25862685|NCT00091104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862686|NCT00091104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25862687|NCT00091104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25862688|NCT00091104|Alkylating Agents|alkylating agents|mesh-ancestor
25862689|NCT00091104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862690|NCT00091104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862691|NCT00091104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25862692|NCT00091104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25086260|NCT03290625|Analgesics|analgesics|mesh-ancestor
24410584|NCT00186277|Docetaxel|docetaxel|mesh-list
24450829|NCT00320697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24450830|NCT00320697|Antidepressive Agents|antidepressive agents|mesh-ancestor
24450831|NCT00320697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24450835|NCT00320697|Dopamine Agents|dopamine agents|mesh-ancestor
25862693|NCT00091104|Antimetabolites|antimetabolites|mesh-ancestor
24945370|NCT03951207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24858316|NCT02296281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24813106|NCT02056418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862694|NCT00091104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25862695|NCT00091104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25862696|NCT00091104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25862697|NCT00091104|Antiviral Agents|antiviral agents|mesh-ancestor
24541766|NCT00675181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862698|NCT00091104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25862699|NCT00091117|Bortezomib|bortezomib|mesh-list
25862700|NCT00091117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862701|NCT00091130|Vaccines|vaccines|mesh-list
25862702|NCT00091130|Immunologic Factors|immunologic factors|mesh-ancestor
25862703|NCT00091130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862704|NCT00091143|Fludarabine|fludarabine|mesh-list
25862705|NCT00091143|Fludarabine phosphate|fludarabine phosphate|mesh-list
25862706|NCT00091143|Freund's Adjuvant|freund's adjuvant|mesh-list
25862707|NCT00091143|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
25862708|NCT00091143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862709|NCT00091143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25862710|NCT00091143|Antimetabolites|antimetabolites|mesh-ancestor
25862711|NCT00091143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862712|NCT00091143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25862713|NCT00091143|Immunologic Factors|immunologic factors|mesh-ancestor
24945385|NCT03950830|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25862714|NCT00091143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862715|NCT00091143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25862716|NCT00091156|Gefitinib|gefitinib|mesh-list
25862717|NCT00091156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862718|NCT00091156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25862719|NCT00091156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25862720|NCT00091156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862721|NCT00091182|Oxaliplatin|oxaliplatin|mesh-list
25862722|NCT00091182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459772|NCT00346359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24459773|NCT00346359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24410881|NCT00187083|Vincristine|vincristine|mesh-list
25862723|NCT00091195|Romidepsin|romidepsin|mesh-list
25862724|NCT00091195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25862725|NCT00091195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862726|NCT00091234|Gemtuzumab|gemtuzumab|mesh-list
25862727|NCT00091234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25862728|NCT00091234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862729|NCT00091247|Tetracycline|tetracycline|mesh-list
25862730|NCT00091247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25862731|NCT00091247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25862732|NCT00091247|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25862733|NCT00091247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24424192|NCT00228254|Vitamin A|vitamin a|mesh-list
25862734|NCT00091247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862735|NCT00091286|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25862736|NCT00091286|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25862737|NCT00091286|Immunologic Factors|immunologic factors|mesh-ancestor
24945401|NCT03951051|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24945402|NCT03951051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24945403|NCT03951051|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24945404|NCT03951051|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25862738|NCT00091286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862739|NCT00091299|Warfarin|warfarin|mesh-list
25862740|NCT00091299|Anticoagulants|anticoagulants|mesh-ancestor
25862741|NCT00091312|Leucovorin|leucovorin|mesh-list
25862742|NCT00091312|Fluorouracil|fluorouracil|mesh-list
25862743|NCT00091312|Irinotecan|irinotecan|mesh-list
25862744|NCT00091312|Calcium|calcium|mesh-list
25862745|NCT00091312|Levoleucovorin|levoleucovorin|mesh-list
25862746|NCT00091312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25862747|NCT00091312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862748|NCT00091312|Antimetabolites|antimetabolites|mesh-ancestor
25862749|NCT00091312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862750|NCT00091312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25219822|NCT02660762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25219823|NCT02660762|Antiviral Agents|antiviral agents|mesh-ancestor
25219824|NCT02660762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25219825|NCT02660762|Tubulin Modulators|tubulin modulators|mesh-ancestor
25219826|NCT02660762|Antimitotic Agents|antimitotic agents|mesh-ancestor
25219827|NCT02660762|Mitosis Modulators|mitosis modulators|mesh-ancestor
25219828|NCT02660762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25219829|NCT02660684|Cyclosporine|cyclosporine|mesh-list
25219830|NCT02660684|Methotrexate|methotrexate|mesh-list
25862751|NCT00091312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862752|NCT00091312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25862753|NCT00091312|Immunologic Factors|immunologic factors|mesh-ancestor
25862754|NCT00091312|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25862755|NCT00091312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25862756|NCT00091312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25862757|NCT00091312|Antidotes|antidotes|mesh-ancestor
25862758|NCT00091312|Protective Agents|protective agents|mesh-ancestor
25862759|NCT00091312|Vitamin B Complex|vitamin b complex|mesh-ancestor
25862761|NCT00091312|Micronutrients|micronutrients|mesh-ancestor
25862762|NCT00091325|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24945409|NCT03950700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24945410|NCT03950700|Anesthetics, Local|anesthetics, local|mesh-ancestor
24945411|NCT03950700|Anesthetics|anesthetics|mesh-ancestor
24945412|NCT03950700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24945413|NCT03950700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945414|NCT03950700|Sensory System Agents|sensory system agents|mesh-ancestor
25862763|NCT00091325|Antioxidants|antioxidants|mesh-ancestor
25862764|NCT00091325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862765|NCT00091325|Protective Agents|protective agents|mesh-ancestor
25862766|NCT00091325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862767|NCT00091325|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25862768|NCT00091325|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25862769|NCT00091325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862770|NCT00091325|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25862771|NCT00091338|Freund's Adjuvant|freund's adjuvant|mesh-list
24945446|NCT03950518|Immunologic Factors|immunologic factors|mesh-ancestor
24945447|NCT03950518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945469|NCT03950544|Tigecycline|tigecycline|mesh-list
24945470|NCT03950544|Polymyxins|polymyxins|mesh-list
24945471|NCT03950544|Polymyxin B|polymyxin b|mesh-list
24945472|NCT03950544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24945473|NCT03950544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24945507|NCT03950050|Expectorants|expectorants|mesh-ancestor
24814754|NCT02066610|Protective Agents|protective agents|mesh-ancestor
24814755|NCT02066610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862772|NCT00091338|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25862773|NCT00091338|Immunologic Factors|immunologic factors|mesh-ancestor
25862774|NCT00091338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055713|NCT03518112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945508|NCT03950050|Respiratory System Agents|respiratory system agents|mesh-ancestor
24945537|NCT03949842|Cholinergic Agents|cholinergic agents|mesh-list
24945538|NCT03949842|Muscarinic Antagonists|muscarinic antagonists|mesh-list
24945539|NCT03949842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24945540|NCT03949842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25862775|NCT00091377|Paclitaxel|paclitaxel|mesh-list
25862776|NCT00091377|Cisplatin|cisplatin|mesh-list
24459781|NCT00346385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24459782|NCT00346463|Allopurinol|allopurinol|mesh-list
24459783|NCT00346463|Antimetabolites|antimetabolites|mesh-ancestor
24459784|NCT00346463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459785|NCT00346463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411094|NCT00187746|Adefovir|adefovir|mesh-list
25862777|NCT00091377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25862778|NCT00091377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862779|NCT00091377|Tubulin Modulators|tubulin modulators|mesh-ancestor
25862780|NCT00091377|Antimitotic Agents|antimitotic agents|mesh-ancestor
25862781|NCT00091377|Mitosis Modulators|mitosis modulators|mesh-ancestor
25862782|NCT00091377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668738|NCT01721460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25668739|NCT01721460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25668740|NCT01721460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668741|NCT01721460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25668742|NCT01721460|Analgesics|analgesics|mesh-ancestor
25668743|NCT01721460|Sensory System Agents|sensory system agents|mesh-ancestor
25668744|NCT01721460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25862783|NCT00091429|Ranolazine|ranolazine|mesh-list
25086353|NCT03289871|Amorolfine|amorolfine|mesh-list
25862784|NCT00091429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25862785|NCT00091429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25208274|NCT02727998|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24459786|NCT00346463|Gout Suppressants|gout suppressants|mesh-ancestor
24459787|NCT00346463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24459788|NCT00346463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24394450|NCT00133328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24394451|NCT00133328|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24394452|NCT00133328|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24394453|NCT00133328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394454|NCT00133341|Parthenolide|parthenolide|mesh-list
24394455|NCT00133341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24394456|NCT00133341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24394457|NCT00133341|Analgesics|analgesics|mesh-ancestor
24394496|NCT00133380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24394497|NCT00133380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24394531|NCT00133419|Protective Agents|protective agents|mesh-ancestor
24394532|NCT00133419|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24394533|NCT00133419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24394535|NCT00133445|Immunologic Factors|immunologic factors|mesh-ancestor
24394536|NCT00133445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394538|NCT00133458|Anthelmintics|anthelmintics|mesh-ancestor
24394539|NCT00133458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24394540|NCT00133458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24424527|NCT00229632|Idebenone|idebenone|mesh-list
25862786|NCT00091429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055714|NCT03518112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25862787|NCT00091468|Nicotine|nicotine|mesh-list
24394607|NCT00133731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24394638|NCT00133770|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24394639|NCT00133770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24738140|NCT01673308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738433|NCT01675466|Anesthetics|anesthetics|mesh-list
24394903|NCT00134641|Antimetabolites|antimetabolites|mesh-ancestor
24394904|NCT00134641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394905|NCT00134641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24394906|NCT00134641|Antiviral Agents|antiviral agents|mesh-ancestor
24738599|NCT01676285|Autonomic Agents|autonomic agents|mesh-ancestor
24395002|NCT00134888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24395003|NCT00134888|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24395005|NCT00134914|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24395006|NCT00134914|Narcotics|narcotics|mesh-ancestor
24395007|NCT00134914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24395008|NCT00134914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395009|NCT00134914|Analgesics|analgesics|mesh-ancestor
25051405|NCT00411099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25051406|NCT00411099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051407|NCT00407303|Bortezomib|bortezomib|mesh-list
25051408|NCT00407303|Obatoclax|obatoclax|mesh-list
25051409|NCT00407303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858512|NCT02298101|Pentetic Acid|pentetic acid|mesh-list
24858513|NCT02298101|Antidotes|antidotes|mesh-ancestor
24858514|NCT02298101|Protective Agents|protective agents|mesh-ancestor
24858515|NCT02298101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858516|NCT02298101|Chelating Agents|chelating agents|mesh-ancestor
24858517|NCT02298101|Sequestering Agents|sequestering agents|mesh-ancestor
24545728|NCT00694694|Artesunate|artesunate|mesh-list
24455335|NCT01785459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24455336|NCT01785459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24455337|NCT01785459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24455338|NCT01785459|Dopamine Agents|dopamine agents|mesh-ancestor
24395190|NCT00135408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25208275|NCT02727998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24395191|NCT00135434|Ritonavir|ritonavir|mesh-list
24395192|NCT00135434|Lopinavir|lopinavir|mesh-list
24395193|NCT00135434|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24395194|NCT00135434|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24395196|NCT00135434|Protease Inhibitors|protease inhibitors|mesh-ancestor
24395277|NCT00135603|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25668745|NCT01721460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25668746|NCT01721460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25668747|NCT01721460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25668748|NCT01721460|Adrenergic Agents|adrenergic agents|mesh-ancestor
25668749|NCT01721460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25668750|NCT01721460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668751|NCT01721486|Acetaminophen|acetaminophen|mesh-list
25055746|NCT03518112|Vitamin B Complex|vitamin b complex|mesh-ancestor
25055763|NCT03517995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862789|NCT00091468|Autonomic Agents|autonomic agents|mesh-ancestor
24424811|NCT00230867|Antiviral Agents|antiviral agents|mesh-ancestor
24395278|NCT00135603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24395279|NCT00135603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24395280|NCT00135603|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24739233|NCT01680042|Phenytoin|phenytoin|mesh-list
25051416|NCT00406588|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25051417|NCT00406588|Dopamine Agents|dopamine agents|mesh-ancestor
24858520|NCT02298101|Anticoagulants|anticoagulants|mesh-ancestor
24395494|NCT00136175|Tubulin Modulators|tubulin modulators|mesh-ancestor
24395495|NCT00136175|Antimitotic Agents|antimitotic agents|mesh-ancestor
24395521|NCT00136266|Ferrous fumarate|ferrous fumarate|mesh-list
24395522|NCT00136266|Micronutrients|micronutrients|mesh-ancestor
24395523|NCT00136266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395524|NCT00136266|Trace Elements|trace elements|mesh-ancestor
24395578|NCT00136409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395580|NCT00136448|Interleukin-2|interleukin-2|mesh-list
24395581|NCT00136448|Daunorubicin|daunorubicin|mesh-list
24395582|NCT00136448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24395583|NCT00136448|Antimetabolites|antimetabolites|mesh-ancestor
24395584|NCT00136448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395585|NCT00136448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24395586|NCT00136448|Antiviral Agents|antiviral agents|mesh-ancestor
24395587|NCT00136448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24395588|NCT00136448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24395589|NCT00136448|Immunologic Factors|immunologic factors|mesh-ancestor
24395598|NCT00136448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395599|NCT00136461|Tretinoin|tretinoin|mesh-list
24395622|NCT00136487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395623|NCT00136487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395624|NCT00136526|Docetaxel|docetaxel|mesh-list
24395625|NCT00136526|Fosfestrol|fosfestrol|mesh-list
24395626|NCT00136526|Diethylstilbestrol|diethylstilbestrol|mesh-list
24395627|NCT00136526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24395628|NCT00136526|Tubulin Modulators|tubulin modulators|mesh-ancestor
24395629|NCT00136526|Antimitotic Agents|antimitotic agents|mesh-ancestor
24395664|NCT00136565|Doxorubicin|doxorubicin|mesh-list
24395665|NCT00136565|Bortezomib|bortezomib|mesh-list
24395666|NCT00136565|Bleomycin|bleomycin|mesh-list
24395667|NCT00136565|Vindesine|vindesine|mesh-list
24395668|NCT00136565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24395702|NCT00136617|GABA Modulators|gaba modulators|mesh-ancestor
24395703|NCT00136617|GABA Agents|gaba agents|mesh-ancestor
24395704|NCT00136617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24395705|NCT00136617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395737|NCT00136747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24395739|NCT00136773|Benazepril|benazepril|mesh-list
24395740|NCT00136773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24395741|NCT00136773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25051418|NCT00406588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25051419|NCT00406588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006825|NCT04608318|Venetoclax|venetoclax|mesh-list
24459818|NCT00346502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24459819|NCT00346502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25862790|NCT00091468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25862791|NCT00091468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051431|NCT00405743|Antimetabolites|antimetabolites|mesh-ancestor
25051432|NCT00405743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961462|NCT03808259|Antidepressive Agents|antidepressive agents|mesh-ancestor
24961463|NCT03808259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24961465|NCT03808129|Bupivacaine|bupivacaine|mesh-list
24961466|NCT03808129|Anesthetics, Local|anesthetics, local|mesh-ancestor
24961467|NCT03808129|Anesthetics|anesthetics|mesh-ancestor
24961468|NCT03808129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961469|NCT03808129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961470|NCT03808129|Sensory System Agents|sensory system agents|mesh-ancestor
24961471|NCT03808129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961472|NCT03808129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25862792|NCT00091468|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25862793|NCT00091468|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25862794|NCT00091468|Cholinergic Agents|cholinergic agents|mesh-ancestor
25862795|NCT00091468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25876497|NCT03399838|Sensory System Agents|sensory system agents|mesh-ancestor
24396125|NCT00137826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24396127|NCT00137826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396129|NCT00137852|Irinotecan|irinotecan|mesh-list
24396162|NCT00137995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24396163|NCT00137995|Glucocorticoids|glucocorticoids|mesh-ancestor
24396165|NCT00137995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24396166|NCT00137995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24396190|NCT00138060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24396242|NCT00138216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24537365|NCT00654407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24537366|NCT00654407|Antimetabolites|antimetabolites|mesh-ancestor
24396243|NCT00138216|Tubulin Modulators|tubulin modulators|mesh-ancestor
24961473|NCT03808129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24961474|NCT03808129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24961475|NCT03808129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24961476|NCT03808129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961477|NCT03808155|Tamsulosin|tamsulosin|mesh-list
24961478|NCT03808155|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24961479|NCT03808155|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24961480|NCT03808155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24961481|NCT03808155|Adrenergic Agents|adrenergic agents|mesh-ancestor
24961482|NCT03808155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24961483|NCT03808155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961484|NCT03808155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961485|NCT03808155|Urological Agents|urological agents|mesh-ancestor
25051434|NCT00405743|Antiviral Agents|antiviral agents|mesh-ancestor
25051435|NCT00405743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24945644|NCT03948685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945645|NCT03948685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24396293|NCT00138515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396294|NCT00138515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24459821|NCT00346502|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
24459822|NCT00346502|Hormone Antagonists|hormone antagonists|mesh-ancestor
24396295|NCT00138515|Protease Inhibitors|protease inhibitors|mesh-ancestor
24396296|NCT00138515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24870189|NCT03294304|Gemcitabine|gemcitabine|mesh-list
24396328|NCT00138593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24396329|NCT00138593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740379|NCT01688089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396443|NCT00139009|Dermatologic Agents|dermatologic agents|mesh-ancestor
24396444|NCT00139009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24396445|NCT00139009|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24396446|NCT00139035|Cyclosporine|cyclosporine|mesh-list
24396447|NCT00139035|Cyclosporins|cyclosporins|mesh-list
24396448|NCT00139035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396450|NCT00139035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24396454|NCT00139035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24396455|NCT00139035|Dermatologic Agents|dermatologic agents|mesh-ancestor
24945678|NCT03948243|Alprazolam|alprazolam|mesh-list
24945679|NCT03948243|Caffeine|caffeine|mesh-list
24945680|NCT03948243|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24945681|NCT03948243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945682|NCT03948243|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24945683|NCT03948243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24945684|NCT03948243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945691|NCT03948243|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24945692|NCT03948243|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24945693|NCT03948243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24945694|NCT03948243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24813166|NCT02056743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24396810|NCT00140010|Epoetin Alfa|epoetin alfa|mesh-list
24396811|NCT00140010|Hematinics|hematinics|mesh-ancestor
24396812|NCT00140023|Azithromycin|azithromycin|mesh-list
24396813|NCT00140023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24396814|NCT00140023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24396867|NCT00140218|Pramipexole|pramipexole|mesh-list
24396868|NCT00140218|Antioxidants|antioxidants|mesh-ancestor
24397036|NCT00140595|Alkylating Agents|alkylating agents|mesh-ancestor
24397068|NCT00140725|Interferons|interferons|mesh-list
24397069|NCT00140725|Interferon-alpha|interferon-alpha|mesh-list
24397070|NCT00140725|Lamivudine|lamivudine|mesh-list
24397071|NCT00140725|Interferon alpha-2|interferon alpha-2|mesh-list
24397072|NCT00140725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24397073|NCT00140725|Antiviral Agents|antiviral agents|mesh-ancestor
24397074|NCT00140725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25668752|NCT01721486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25086528|NCT03288675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086529|NCT03288675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086530|NCT03288675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24397075|NCT00140725|Immunologic Factors|immunologic factors|mesh-ancestor
24397076|NCT00140725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397148|NCT00140920|Analgesics|analgesics|mesh-ancestor
24397149|NCT00140920|Sensory System Agents|sensory system agents|mesh-ancestor
24397150|NCT00140920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24397151|NCT00140920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397152|NCT00140920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24397153|NCT00140920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24397154|NCT00140920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24397155|NCT00140920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876498|NCT03399838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24397156|NCT00140920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397157|NCT00140920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24397160|NCT00140933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24397161|NCT00140933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24397162|NCT00140933|Analgesics|analgesics|mesh-ancestor
24397163|NCT00140933|Sensory System Agents|sensory system agents|mesh-ancestor
24397190|NCT00141050|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24397196|NCT00141050|Dopamine Agents|dopamine agents|mesh-ancestor
24945695|NCT03948243|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24459837|NCT00346567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24397662|NCT00142207|Renal Agents|renal agents|mesh-ancestor
24397663|NCT00142233|N-Methylaspartate|n-methylaspartate|mesh-list
24397664|NCT00142233|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
24397698|NCT00142350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24397700|NCT00142350|Immunologic Factors|immunologic factors|mesh-ancestor
24397701|NCT00142350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397702|NCT00142350|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24397703|NCT00142350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24397704|NCT00142350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24397706|NCT00142402|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24945729|NCT03948178|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24945730|NCT03948178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24945731|NCT03948178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24945732|NCT03948178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398113|NCT00143533|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
24398114|NCT00143533|Irinotecan|irinotecan|mesh-list
24398115|NCT00143533|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24398116|NCT00143533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24398117|NCT00143533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398118|NCT00143533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398119|NCT00143533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24398120|NCT00143533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24398121|NCT00143533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24398122|NCT00143546|Defibrotide|defibrotide|mesh-list
24398123|NCT00143546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24398124|NCT00143546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24398125|NCT00143546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398180|NCT00143702|Vitamins|vitamins|mesh-ancestor
24398181|NCT00143702|Micronutrients|micronutrients|mesh-ancestor
24398216|NCT00143806|Alefacept|alefacept|mesh-list
24398217|NCT00143806|Cyclosporins|cyclosporins|mesh-list
24398218|NCT00143806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24945752|NCT03947242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945753|NCT03947229|Clopidogrel|clopidogrel|mesh-list
24945754|NCT03947229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24945755|NCT03947229|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24945756|NCT03947229|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25208276|NCT02727998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24945759|NCT03947229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24945760|NCT03947229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945773|NCT03947411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24945774|NCT03947411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24870255|NCT02896855|Trastuzumab|trastuzumab|mesh-list
25668753|NCT01721486|Analgesics|analgesics|mesh-ancestor
25668754|NCT01721486|Sensory System Agents|sensory system agents|mesh-ancestor
25668755|NCT01721486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25668756|NCT01721486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668757|NCT01721486|Antipyretics|antipyretics|mesh-ancestor
24945775|NCT03947411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945776|NCT03947125|Buprenorphine|buprenorphine|mesh-list
24945777|NCT03947125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24798764|NCT01964911|Anesthetics|anesthetics|mesh-ancestor
24798765|NCT01964911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24798766|NCT01964911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945778|NCT03947125|Narcotics|narcotics|mesh-ancestor
24459846|NCT00346580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24945788|NCT03946657|Anesthetics|anesthetics|mesh-list
24945789|NCT03946657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
24945790|NCT03946657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24945791|NCT03946657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945792|NCT03946657|Anesthetics, General|anesthetics, general|mesh-ancestor
24945793|NCT03946826|Halometasone|halometasone|mesh-list
24945795|NCT03946826|Emollients|emollients|mesh-ancestor
24945796|NCT03946826|Dermatologic Agents|dermatologic agents|mesh-ancestor
24398428|NCT00144352|Renal Agents|renal agents|mesh-ancestor
24398429|NCT00144365|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24398430|NCT00144365|Antiviral Agents|antiviral agents|mesh-ancestor
24398473|NCT00144456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398474|NCT00144456|Vitamins|vitamins|mesh-ancestor
24398475|NCT00144456|Micronutrients|micronutrients|mesh-ancestor
24398513|NCT00144755|Hematinics|hematinics|mesh-ancestor
24398514|NCT00144807|Cyclophosphamide|cyclophosphamide|mesh-list
24398515|NCT00144807|Rituximab|rituximab|mesh-list
24398544|NCT00144833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398545|NCT00144833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24398546|NCT00144833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24398547|NCT00144833|Antiviral Agents|antiviral agents|mesh-ancestor
24398548|NCT00144833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402746|NCT00158405|Antiviral Agents|antiviral agents|mesh-ancestor
24398549|NCT00144833|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24398550|NCT00144833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24398552|NCT00144846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24398553|NCT00144846|Autonomic Agents|autonomic agents|mesh-ancestor
24398554|NCT00144846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24398555|NCT00144846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398556|NCT00144846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24398557|NCT00144846|Respiratory System Agents|respiratory system agents|mesh-ancestor
24398558|NCT00144846|Tocolytic Agents|tocolytic agents|mesh-ancestor
24398559|NCT00144846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24398560|NCT00144846|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24459847|NCT00346580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459848|NCT00346580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24425720|NCT00234091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24425721|NCT00234117|Rabeprazole|rabeprazole|mesh-list
24398630|NCT00145171|Autonomic Agents|autonomic agents|mesh-ancestor
24398631|NCT00145171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24398632|NCT00145171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24945798|NCT03946826|Glucocorticoids|glucocorticoids|mesh-ancestor
24945799|NCT03946826|Hormones|hormones|mesh-ancestor
25055842|NCT03517670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055843|NCT03517670|Protective Agents|protective agents|mesh-ancestor
24770955|NCT01823523|Cefazolin|cefazolin|mesh-list
24398639|NCT00145184|Micronutrients|micronutrients|mesh-ancestor
24398640|NCT00145184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398641|NCT00145210|Atenolol|atenolol|mesh-list
24398642|NCT00145210|Nebivolol|nebivolol|mesh-list
24398643|NCT00145210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24398644|NCT00145210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24398645|NCT00145210|Sympatholytics|sympatholytics|mesh-ancestor
24398646|NCT00145210|Autonomic Agents|autonomic agents|mesh-ancestor
24398647|NCT00145210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24398648|NCT00145210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398676|NCT00145301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398677|NCT00145301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24398678|NCT00145301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24398681|NCT00145301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24398682|NCT00145301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139587|NCT02970097|Fentanyl|fentanyl|mesh-list
24398683|NCT00145301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24398684|NCT00145301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24398685|NCT00145314|Leucovorin|leucovorin|mesh-list
24398686|NCT00145314|Folic Acid|folic acid|mesh-list
24398687|NCT00145314|Fluorouracil|fluorouracil|mesh-list
24398688|NCT00145314|Oxaliplatin|oxaliplatin|mesh-list
24398689|NCT00145314|Cetuximab|cetuximab|mesh-list
24398690|NCT00145314|Levoleucovorin|levoleucovorin|mesh-list
24398691|NCT00145314|Antimetabolites|antimetabolites|mesh-ancestor
24398732|NCT00145444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24398733|NCT00145444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398734|NCT00145444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24398891|NCT00146042|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24398892|NCT00146042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398893|NCT00146068|Interferon beta-1a|interferon beta-1a|mesh-list
24398894|NCT00146068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24742831|NCT05150756|Morphine|morphine|mesh-list
24398932|NCT00146159|Sensory System Agents|sensory system agents|mesh-ancestor
24398933|NCT00146159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24398934|NCT00146159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398935|NCT00146159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24398936|NCT00146159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24398937|NCT00146159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24398962|NCT00146250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24398963|NCT00146276|Gemcitabine|gemcitabine|mesh-list
24398964|NCT00146276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24398965|NCT00146276|Antimetabolites|antimetabolites|mesh-ancestor
24398966|NCT00146276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398967|NCT00146276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24398968|NCT00146276|Antiviral Agents|antiviral agents|mesh-ancestor
24398969|NCT00146276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24398970|NCT00146276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398971|NCT00146276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24398972|NCT00146276|Immunologic Factors|immunologic factors|mesh-ancestor
24398973|NCT00146276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398974|NCT00146289|Telmisartan|telmisartan|mesh-list
24398979|NCT00146341|Telmisartan|telmisartan|mesh-list
24399018|NCT00146497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24399019|NCT00146497|Respiratory System Agents|respiratory system agents|mesh-ancestor
24399020|NCT00146497|Glucocorticoids|glucocorticoids|mesh-ancestor
24399021|NCT00146497|Hormones|hormones|mesh-ancestor
25862796|NCT00091468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862797|NCT00091520|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25862798|NCT00091520|Natriuretic Agents|natriuretic agents|mesh-ancestor
24870289|NCT02421341|Sensory System Agents|sensory system agents|mesh-ancestor
24459853|NCT00346619|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24459854|NCT00346619|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24459855|NCT00346619|Protease Inhibitors|protease inhibitors|mesh-ancestor
24399062|NCT00146562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399094|NCT00146588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24399095|NCT00146588|Alkylating Agents|alkylating agents|mesh-ancestor
24399096|NCT00146588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399135|NCT00146614|Antifungal Agents|antifungal agents|mesh-ancestor
24945872|NCT03945227|Spartalizumab|spartalizumab|mesh-list
24945873|NCT03945227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24945874|NCT03945227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945875|NCT03945227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399140|NCT00146627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24399141|NCT00146627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24399142|NCT00146627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24399143|NCT00146627|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
24399144|NCT00146627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208277|NCT02727998|GABA Modulators|gaba modulators|mesh-ancestor
25208278|NCT02727998|GABA Agents|gaba agents|mesh-ancestor
24399145|NCT00146627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399147|NCT00146718|Sulfadoxine|sulfadoxine|mesh-list
24399171|NCT00146731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24399172|NCT00146731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24399173|NCT00146731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399174|NCT00146731|Leprostatic Agents|leprostatic agents|mesh-ancestor
24399175|NCT00146731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24399176|NCT00146783|Pyrimethamine|pyrimethamine|mesh-list
24399177|NCT00146783|Sulfadoxine|sulfadoxine|mesh-list
24399178|NCT00146783|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24399179|NCT00146783|Amodiaquine|amodiaquine|mesh-list
24399180|NCT00146783|Antimalarials|antimalarials|mesh-ancestor
24399181|NCT00146783|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24550339|NCT00720408|Tacrolimus|tacrolimus|mesh-list
24870336|NCT01510184|Rituximab|rituximab|mesh-list
24870337|NCT01510184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24870338|NCT01510184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24870339|NCT01510184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862799|NCT00091520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219894|NCT02660008|Glucagon|glucagon|mesh-list
25862800|NCT00091559|Vorinostat|vorinostat|mesh-list
24399325|NCT00147394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24399326|NCT00147394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24399327|NCT00147394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24459857|NCT00346619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459859|NCT00346619|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24459860|NCT00346619|Antiviral Agents|antiviral agents|mesh-ancestor
24459861|NCT00346619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24459862|NCT00346645|Bortezomib|bortezomib|mesh-list
24945902|NCT03944889|Capsaicin|capsaicin|mesh-list
24945903|NCT03944889|Antipruritics|antipruritics|mesh-ancestor
24945904|NCT03944889|Dermatologic Agents|dermatologic agents|mesh-ancestor
24945905|NCT03944889|Sensory System Agents|sensory system agents|mesh-ancestor
24945916|NCT03944655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459868|NCT00346684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459869|NCT00346684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24399645|NCT00148330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24399646|NCT00148330|Glucocorticoids|glucocorticoids|mesh-ancestor
24399648|NCT00148330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24399649|NCT00148330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399650|NCT00148356|Paclitaxel|paclitaxel|mesh-list
24399651|NCT00148356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24399652|NCT00148356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399653|NCT00148356|Tubulin Modulators|tubulin modulators|mesh-ancestor
24399654|NCT00148356|Antimitotic Agents|antimitotic agents|mesh-ancestor
24399655|NCT00148356|Mitosis Modulators|mitosis modulators|mesh-ancestor
24399656|NCT00148356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399657|NCT00148382|Cetilistat|cetilistat|mesh-list
24399658|NCT00148382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24399659|NCT00148382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399660|NCT00148382|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24399661|NCT00148382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24399662|NCT00148395|Gemcitabine|gemcitabine|mesh-list
24399734|NCT00148551|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24399735|NCT00148551|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24400038|NCT00149539|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
24400040|NCT00149539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24400041|NCT00149539|Narcotics|narcotics|mesh-ancestor
24945939|NCT03944473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945940|NCT03944473|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24945941|NCT03944473|Autonomic Agents|autonomic agents|mesh-ancestor
24870340|NCT01510184|Immunologic Factors|immunologic factors|mesh-ancestor
24870341|NCT01510184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870352|NCT01471444|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24870354|NCT01471444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24870355|NCT01471444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870356|NCT01471444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24870357|NCT01471444|Antimetabolites|antimetabolites|mesh-ancestor
25055904|NCT03517020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24945942|NCT03944473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24945943|NCT03944317|Azithromycin|azithromycin|mesh-list
24400077|NCT00149604|Hormone Antagonists|hormone antagonists|mesh-ancestor
24400078|NCT00149604|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24400079|NCT00149604|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24400080|NCT00149604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24400082|NCT00149617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24400083|NCT00149617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24428102|NCT00239512|Indomethacin|indomethacin|mesh-list
24945947|NCT03944317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24945948|NCT03944317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24945949|NCT03944317|Antimalarials|antimalarials|mesh-ancestor
24945950|NCT03944317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24945951|NCT03944317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24945952|NCT03944317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24945953|NCT03944317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24945955|NCT03944317|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24400169|NCT00149981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24400170|NCT00149981|Immunologic Factors|immunologic factors|mesh-ancestor
24945992|NCT03943888|Mydriatics|mydriatics|mesh-ancestor
24945993|NCT03943888|Parasympatholytics|parasympatholytics|mesh-ancestor
24945994|NCT03943888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24945995|NCT03943888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24945996|NCT03943888|Cholinergic Agents|cholinergic agents|mesh-ancestor
25668758|NCT01721564|Bosentan|bosentan|mesh-list
25668759|NCT01721564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25219906|NCT02660060|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24945997|NCT03943888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24945998|NCT03943888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400418|NCT00150527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24400419|NCT00150527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24400420|NCT00150527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400421|NCT00150527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24400422|NCT00150527|Serotonin Agents|serotonin agents|mesh-ancestor
24400423|NCT00150527|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24400424|NCT00150527|Antidepressive Agents|antidepressive agents|mesh-ancestor
24400667|NCT00151073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400669|NCT00151073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400700|NCT00151138|Sympatholytics|sympatholytics|mesh-ancestor
24400701|NCT00151138|Autonomic Agents|autonomic agents|mesh-ancestor
24400702|NCT00151138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24400703|NCT00151138|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24400704|NCT00151138|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24400705|NCT00151138|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24400706|NCT00151138|Adrenergic Agents|adrenergic agents|mesh-ancestor
24400707|NCT00151138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24400708|NCT00151203|Clarithromycin|clarithromycin|mesh-list
24459876|NCT00346749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24400710|NCT00151203|Lenalidomide|lenalidomide|mesh-list
24400711|NCT00151203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24400737|NCT00151242|Tretinoin|tretinoin|mesh-list
24400738|NCT00151242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24400739|NCT00151242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862801|NCT00091559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870370|NCT01471444|Alkylating Agents|alkylating agents|mesh-ancestor
24400740|NCT00151242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24400741|NCT00151242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24400742|NCT00151242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400743|NCT00151242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400744|NCT00151242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24400745|NCT00151242|Antimetabolites|antimetabolites|mesh-ancestor
24400746|NCT00151242|Antiviral Agents|antiviral agents|mesh-ancestor
24400747|NCT00151242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24400748|NCT00151242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24400796|NCT00151346|Fentanyl|fentanyl|mesh-list
24400827|NCT00151450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24400828|NCT00151450|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24400829|NCT00151450|Antidepressive Agents|antidepressive agents|mesh-ancestor
24946011|NCT03943459|Atorvastatin|atorvastatin|mesh-list
24771361|NCT01826526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24771362|NCT01826526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771363|NCT01826747|Progesterone|progesterone|mesh-list
24771364|NCT01826747|Progestins|progestins|mesh-ancestor
24771366|NCT01826747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24771367|NCT01826747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771368|NCT01826773|Palmitic Acid|palmitic acid|mesh-list
24771369|NCT01826773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625998|NCT01084980|Immunologic Factors|immunologic factors|mesh-ancestor
25051446|NCT00403416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051447|NCT00403416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961928|NCT03804177|Hyaluronic Acid|hyaluronic acid|mesh-list
24961929|NCT03804177|Antioxidants|antioxidants|mesh-ancestor
24961930|NCT03804177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961931|NCT03804177|Protective Agents|protective agents|mesh-ancestor
24961932|NCT03804177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961933|NCT03804177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961934|NCT03804177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24961935|NCT03804177|Immunologic Factors|immunologic factors|mesh-ancestor
24401245|NCT00152581|Antiviral Agents|antiviral agents|mesh-ancestor
25139736|NCT02969252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24401355|NCT00152750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24401356|NCT00152750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946121|NCT03942991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24946122|NCT03942991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946123|NCT03942991|Sensory System Agents|sensory system agents|mesh-ancestor
24946124|NCT03942991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24946125|NCT03942757|Bilirubin|bilirubin|mesh-list
25862802|NCT00091559|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24630299|NCT01110785|Simvastatin|simvastatin|mesh-list
24630301|NCT01110785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24946147|NCT03942796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946148|NCT03942796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24946149|NCT03942796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24946150|NCT03942796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24946151|NCT03942796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24946152|NCT03942796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24946154|NCT03942601|Dexamethasone|dexamethasone|mesh-list
24946155|NCT03942601|Dexamethasone acetate|dexamethasone acetate|mesh-list
24946156|NCT03942601|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24946158|NCT03942601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24946160|NCT03942601|Autonomic Agents|autonomic agents|mesh-ancestor
24946161|NCT03942601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24946162|NCT03942601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946163|NCT03942601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24401509|NCT00153075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814812|NCT02066844|Betamethasone|betamethasone|mesh-list
24814813|NCT02066844|Betamethasone Valerate|betamethasone valerate|mesh-list
24814814|NCT02066844|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24401510|NCT00153075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24401511|NCT00153075|Respiratory System Agents|respiratory system agents|mesh-ancestor
24401512|NCT00153075|Sympathomimetics|sympathomimetics|mesh-ancestor
24401513|NCT00153075|Tocolytic Agents|tocolytic agents|mesh-ancestor
24401514|NCT00153075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24401515|NCT00153075|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24401545|NCT00153192|Analgesics|analgesics|mesh-ancestor
24401546|NCT00153192|Sensory System Agents|sensory system agents|mesh-ancestor
24401547|NCT00153192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24401548|NCT00153192|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24401549|NCT00153192|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24401550|NCT00153192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24401551|NCT00153192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401553|NCT00153192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24401554|NCT00153244|Lamotrigine|lamotrigine|mesh-list
24401555|NCT00153244|Anticonvulsants|anticonvulsants|mesh-ancestor
24401556|NCT00153244|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24401557|NCT00153244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24401867|NCT00154167|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24946164|NCT03942601|Glucocorticoids|glucocorticoids|mesh-ancestor
24946165|NCT03942601|Hormones|hormones|mesh-ancestor
24401868|NCT00154180|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24401869|NCT00154180|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24401870|NCT00154180|Estradiol|estradiol|mesh-list
24401871|NCT00154180|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24401872|NCT00154180|Estrogens|estrogens|mesh-list
24401968|NCT00154336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401969|NCT00154336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24401970|NCT00154336|Dermatologic Agents|dermatologic agents|mesh-ancestor
24401971|NCT00154336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402006|NCT00154414|Hormones|hormones|mesh-ancestor
24402007|NCT00154414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24402041|NCT00154687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24402042|NCT00154687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24402043|NCT00154687|Immunologic Factors|immunologic factors|mesh-ancestor
24402044|NCT00154687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402045|NCT00154700|Folic Acid|folic acid|mesh-list
24402046|NCT00154700|Paclitaxel|paclitaxel|mesh-list
24402122|NCT00154882|Paclitaxel|paclitaxel|mesh-list
24402140|NCT00155064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24402142|NCT00155064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402143|NCT00155233|Morphine|morphine|mesh-list
24402144|NCT00155233|Nalbuphine|nalbuphine|mesh-list
24402145|NCT00155233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24402155|NCT00155246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402195|NCT00155376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24402196|NCT00155376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24402197|NCT00155376|Hormones|hormones|mesh-ancestor
24402198|NCT00155376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24402237|NCT00156078|Pregabalin|pregabalin|mesh-list
24402238|NCT00156078|Analgesics|analgesics|mesh-ancestor
25006917|NCT04518501|Arsenic Trioxide|arsenic trioxide|mesh-list
24402437|NCT00157274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25668760|NCT01721564|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25862803|NCT00091559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24630312|NCT01110824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24630327|NCT01110824|Protease Inhibitors|protease inhibitors|mesh-ancestor
24630328|NCT01110824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24630330|NCT01110941|Oxaliplatin|oxaliplatin|mesh-list
24630332|NCT01110941|Antidotes|antidotes|mesh-ancestor
25219933|NCT02659761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25219934|NCT02659761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25219935|NCT02659761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25219936|NCT02659761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25219937|NCT02659917|Methamphetamine|methamphetamine|mesh-list
25219938|NCT02659917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25219939|NCT02659917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219940|NCT02659917|Sympathomimetics|sympathomimetics|mesh-ancestor
25219941|NCT02659917|Autonomic Agents|autonomic agents|mesh-ancestor
25219942|NCT02659917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25219943|NCT02659917|Dopamine Agents|dopamine agents|mesh-ancestor
25219944|NCT02659917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25219945|NCT02659917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814815|NCT02066844|Betamethasone benzoate|betamethasone benzoate|mesh-list
24870417|NCT05162183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24870418|NCT05162183|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24870419|NCT05162183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24870421|NCT05162001|Disulfiram|disulfiram|mesh-list
24402438|NCT00157274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402439|NCT00157300|Epoetin Alfa|epoetin alfa|mesh-list
24402440|NCT00157300|Hematinics|hematinics|mesh-ancestor
24402441|NCT00157326|Tadalafil|tadalafil|mesh-list
24402442|NCT00157326|Vasodilator Agents|vasodilator agents|mesh-ancestor
24403485|NCT00160511|Anticonvulsants|anticonvulsants|mesh-ancestor
24402443|NCT00157326|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24800465|NCT01975753|Sensory System Agents|sensory system agents|mesh-ancestor
25862804|NCT00091559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862805|NCT00091598|Ambrisentan|ambrisentan|mesh-list
24402707|NCT00158236|Buprenorphine|buprenorphine|mesh-list
24402715|NCT00158236|Sensory System Agents|sensory system agents|mesh-ancestor
24402716|NCT00158236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24402717|NCT00158236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24402718|NCT00158275|Antidepressive Agents|antidepressive agents|mesh-list
24402719|NCT00158275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24402734|NCT00158405|Ritonavir|ritonavir|mesh-list
24402735|NCT00158405|Indinavir|indinavir|mesh-list
24402736|NCT00158405|Lamivudine|lamivudine|mesh-list
24402737|NCT00158405|Zidovudine|zidovudine|mesh-list
24402738|NCT00158405|Efavirenz|efavirenz|mesh-list
24402739|NCT00158405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24402740|NCT00158405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24402741|NCT00158405|Protease Inhibitors|protease inhibitors|mesh-ancestor
24402742|NCT00158405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759001|NCT01748929|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24402743|NCT00158405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402745|NCT00158405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24402753|NCT00158405|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24402754|NCT00158405|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24402755|NCT00158405|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24402861|NCT00158574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402865|NCT00158574|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24402866|NCT00158574|Renal Agents|renal agents|mesh-ancestor
24403012|NCT00159081|Haloperidol|haloperidol|mesh-list
24403013|NCT00159081|Risperidone|risperidone|mesh-list
25668761|NCT01721564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668762|NCT01721603|Trametinib|trametinib|mesh-list
25668763|NCT01721603|Dabrafenib|dabrafenib|mesh-list
25668764|NCT01721603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25668765|NCT01721603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25668766|NCT01721603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25668767|NCT01721603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668768|NCT01721876|Cytarabine|cytarabine|mesh-list
25668769|NCT01721876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25668770|NCT01721876|Antimetabolites|antimetabolites|mesh-ancestor
25668771|NCT01721876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668772|NCT01721876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25668773|NCT01721876|Antiviral Agents|antiviral agents|mesh-ancestor
25668774|NCT01721876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25668775|NCT01721876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25668776|NCT01721876|Immunologic Factors|immunologic factors|mesh-ancestor
25668777|NCT01721876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219950|NCT02659917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25219951|NCT02659657|Interleukin-2|interleukin-2|mesh-list
25219952|NCT02659657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24832829|NCT02172300|Respiratory System Agents|respiratory system agents|mesh-ancestor
24832830|NCT02172300|Parasympatholytics|parasympatholytics|mesh-ancestor
24832835|NCT02172326|Tiotropium Bromide|tiotropium bromide|mesh-list
24403014|NCT00159081|Haloperidol decanoate|haloperidol decanoate|mesh-list
24426700|NCT00236522|Ofloxacin|ofloxacin|mesh-list
25862806|NCT00091598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25055917|NCT03516955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055918|NCT03516955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24403016|NCT00159081|Serotonin Agents|serotonin agents|mesh-ancestor
24403017|NCT00159081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24403235|NCT00159679|Analgesics|analgesics|mesh-ancestor
24403236|NCT00159679|Sensory System Agents|sensory system agents|mesh-ancestor
24403237|NCT00159679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24403238|NCT00159679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946174|NCT03942601|Immunologic Factors|immunologic factors|mesh-ancestor
24946175|NCT03942601|Protease Inhibitors|protease inhibitors|mesh-ancestor
24946176|NCT03942601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24946179|NCT03942354|Linezolid|linezolid|mesh-list
24946180|NCT03942354|Bedaquiline|bedaquiline|mesh-list
24946181|NCT03942354|Clofazimine|clofazimine|mesh-list
24946182|NCT03942354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24946183|NCT03942354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24946184|NCT03942354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24946185|NCT03942354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24403375|NCT00160043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403378|NCT00160069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403379|NCT00160069|Tubulin Modulators|tubulin modulators|mesh-ancestor
24403380|NCT00160069|Antimitotic Agents|antimitotic agents|mesh-ancestor
24403381|NCT00160069|Mitosis Modulators|mitosis modulators|mesh-ancestor
24403444|NCT00160342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24403446|NCT00160342|Anabolic Agents|anabolic agents|mesh-ancestor
24403447|NCT00160342|Androgens|androgens|mesh-ancestor
24403448|NCT00160355|Fludarabine|fludarabine|mesh-list
24403484|NCT00160511|Levetiracetam|levetiracetam|mesh-list
24403618|NCT00161070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24459891|NCT00346801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403834|NCT00161668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403835|NCT00161681|Levonorgestrel|levonorgestrel|mesh-list
24403836|NCT00161681|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24403869|NCT00161811|Immunologic Factors|immunologic factors|mesh-ancestor
24403870|NCT00161811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403873|NCT00161837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403874|NCT00161902|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24946255|NCT03942068|Apatinib|apatinib|mesh-list
24946256|NCT03942068|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24946257|NCT03942068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24946258|NCT03942068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24946259|NCT03942068|Tubulin Modulators|tubulin modulators|mesh-ancestor
24946260|NCT03942068|Antimitotic Agents|antimitotic agents|mesh-ancestor
24946261|NCT03942068|Mitosis Modulators|mitosis modulators|mesh-ancestor
24946284|NCT03941587|Aflibercept|aflibercept|mesh-list
24946285|NCT03941587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24547252|NCT00703196|Vitamins|vitamins|mesh-ancestor
24404919|NCT00165178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24404920|NCT00165178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24404921|NCT00165178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24405073|NCT00165451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405074|NCT00165451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405116|NCT00165490|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24405118|NCT00165490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405119|NCT00165490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405120|NCT00165490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24405121|NCT00165516|Sodium thiosulfate|sodium thiosulfate|mesh-list
25668778|NCT01721967|Ranolazine|ranolazine|mesh-list
25668779|NCT01721967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25668780|NCT01721967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25668781|NCT01721967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668782|NCT01722045|Aflibercept|aflibercept|mesh-list
25668783|NCT01722045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25668784|NCT01722045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25668785|NCT01722045|Growth Substances|growth substances|mesh-ancestor
25219965|NCT02659488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24436859|NCT00271635|Vitamins|vitamins|mesh-ancestor
24630506|NCT01111981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630507|NCT01111981|Dermatologic Agents|dermatologic agents|mesh-ancestor
24405122|NCT00165516|Antidotes|antidotes|mesh-ancestor
24405123|NCT00165516|Protective Agents|protective agents|mesh-ancestor
24405124|NCT00165516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405125|NCT00165516|Antioxidants|antioxidants|mesh-ancestor
24405126|NCT00165516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405127|NCT00165516|Antitubercular Agents|antitubercular agents|mesh-ancestor
24405128|NCT00165516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24405193|NCT00165750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405195|NCT00165763|Donepezil|donepezil|mesh-list
24405196|NCT00165763|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24962104|NCT03802422|Vitamin B 12|vitamin b 12|mesh-list
24946292|NCT03941535|Vitamins|vitamins|mesh-ancestor
24946293|NCT03941535|Micronutrients|micronutrients|mesh-ancestor
24946294|NCT03941535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946295|NCT03941535|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24946296|NCT03941535|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24946298|NCT03941535|Hemostatics|hemostatics|mesh-ancestor
24946343|NCT03940391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24946344|NCT03940391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24946347|NCT03940391|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24946348|NCT03940391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24946349|NCT03940391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24946350|NCT03940391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24946351|NCT03940391|Anesthetics, General|anesthetics, general|mesh-ancestor
24946352|NCT03940391|Anesthetics|anesthetics|mesh-ancestor
24406750|NCT00171132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24406751|NCT00171132|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24406752|NCT00171132|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24406753|NCT00171132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406754|NCT00171132|Diuretics|diuretics|mesh-ancestor
24406755|NCT00171132|Natriuretic Agents|natriuretic agents|mesh-ancestor
24406756|NCT00171132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406757|NCT00171132|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24406758|NCT00171132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24406759|NCT00171132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24406760|NCT00171132|Sympatholytics|sympatholytics|mesh-ancestor
24406902|NCT00171535|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24406935|NCT00171587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24406936|NCT00171587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406938|NCT00171600|Lisinopril|lisinopril|mesh-list
24406939|NCT00171600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24407059|NCT00171782|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24407060|NCT00171782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24407061|NCT00171782|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24407062|NCT00171782|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24407117|NCT00171899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407118|NCT00171899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407120|NCT00171912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407121|NCT00171912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24407122|NCT00171912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407144|NCT00172003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24407145|NCT00172003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407147|NCT00172016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24407148|NCT00172016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862807|NCT00091611|Cyclophosphamide|cyclophosphamide|mesh-list
25862808|NCT00091611|Fludarabine|fludarabine|mesh-list
25862809|NCT00091611|Interleukin-2|interleukin-2|mesh-list
24407153|NCT00172055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25051451|NCT00403169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24771667|NCT01828606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24771668|NCT01828606|Sodium Ionophores|sodium ionophores|mesh-ancestor
24771676|NCT01828736|Gemcitabine|gemcitabine|mesh-list
24771677|NCT01828736|Cisplatin|cisplatin|mesh-list
24771678|NCT01828736|Carboplatin|carboplatin|mesh-list
24771679|NCT01828736|Trastuzumab|trastuzumab|mesh-list
24407259|NCT00173888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407260|NCT00173888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25668786|NCT01722045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668787|NCT01722045|Growth Inhibitors|growth inhibitors|mesh-ancestor
25668788|NCT01722045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25668789|NCT01722071|Oxytocin|oxytocin|mesh-list
25862810|NCT00091611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24630581|NCT01112462|Protective Agents|protective agents|mesh-ancestor
24407261|NCT00173888|Immunologic Factors|immunologic factors|mesh-ancestor
24407262|NCT00173888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407263|NCT00173888|Tubulin Modulators|tubulin modulators|mesh-ancestor
24407390|NCT00174434|Mitosis Modulators|mitosis modulators|mesh-ancestor
24407461|NCT00174577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407462|NCT00174577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407463|NCT00174577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24407510|NCT00174642|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25006991|NCT04386811|Calcitriol|calcitriol|mesh-list
24541767|NCT00675181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24771683|NCT01828736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862811|NCT00091611|Immunologic Factors|immunologic factors|mesh-ancestor
25862812|NCT00091611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862813|NCT00091611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25862814|NCT00091611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24407872|NCT00175812|Valproic Acid|valproic acid|mesh-list
24748410|NCT02608684|Antiviral Agents|antiviral agents|mesh-ancestor
24408062|NCT00176449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24408064|NCT00176449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24408065|NCT00176449|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24408066|NCT00176449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24408067|NCT00176449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24408068|NCT00176449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408069|NCT00176449|Dopamine Agents|dopamine agents|mesh-ancestor
24408070|NCT00176449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24626016|NCT01085032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24626017|NCT01085032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626019|NCT01085032|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24626020|NCT01085032|Cholinergic Agents|cholinergic agents|mesh-ancestor
24626021|NCT01085032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24626022|NCT01085032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626023|NCT01085058|Lenograstim|lenograstim|mesh-list
24626024|NCT01085058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24946359|NCT03940391|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24946360|NCT03940391|Histamine Antagonists|histamine antagonists|mesh-ancestor
24427592|NCT00238407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427593|NCT00238407|Tubulin Modulators|tubulin modulators|mesh-ancestor
24427598|NCT00238459|Vaccines|vaccines|mesh-list
24408179|NCT00176774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24408180|NCT00176774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24408181|NCT00176774|Growth Substances|growth substances|mesh-ancestor
24408182|NCT00176774|Growth Inhibitors|growth inhibitors|mesh-ancestor
24408183|NCT00176787|Capecitabine|capecitabine|mesh-list
24408184|NCT00176787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24408209|NCT00176943|Imiquimod|imiquimod|mesh-list
24408210|NCT00176943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24408211|NCT00176943|Immunologic Factors|immunologic factors|mesh-ancestor
24408212|NCT00176943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668790|NCT01722071|Oxytocics|oxytocics|mesh-ancestor
25668791|NCT01722071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25668792|NCT01722071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668793|NCT01722097|Rocuronium|rocuronium|mesh-list
25668794|NCT01722097|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25668795|NCT01722097|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25668796|NCT01722097|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25668797|NCT01722097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25668798|NCT01722097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668799|NCT01722162|Bevacizumab|bevacizumab|mesh-list
24516158|NCT00600730|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25668800|NCT01722162|Capecitabine|capecitabine|mesh-list
25668801|NCT01722162|Levocetirizine|levocetirizine|mesh-list
25668802|NCT01722162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25668803|NCT01722162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25668804|NCT01722162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25668805|NCT01722162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25668806|NCT01722162|Growth Substances|growth substances|mesh-ancestor
25668807|NCT01722162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668808|NCT01722162|Growth Inhibitors|growth inhibitors|mesh-ancestor
25668809|NCT01722162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25668810|NCT01722162|Antimetabolites|antimetabolites|mesh-ancestor
25668811|NCT01722162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762219|NCT01766960|Analgesics|analgesics|mesh-ancestor
24427619|NCT00238563|Glucocorticoids|glucocorticoids|mesh-ancestor
24427620|NCT00238563|Hormones|hormones|mesh-ancestor
24946361|NCT03940391|Histamine Agents|histamine agents|mesh-ancestor
24946362|NCT03940391|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24946363|NCT03940430|Lactoferrin|lactoferrin|mesh-list
24946364|NCT03940430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25862815|NCT00091611|Alkylating Agents|alkylating agents|mesh-ancestor
25862816|NCT00091611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862817|NCT00091611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409288|NCT00181675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24409289|NCT00181675|Nootropic Agents|nootropic agents|mesh-ancestor
24409290|NCT00181688|Anastrozole|anastrozole|mesh-list
24409291|NCT00181688|Gefitinib|gefitinib|mesh-list
24409292|NCT00181688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24409293|NCT00181688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409294|NCT00181688|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24409302|NCT00181688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24409303|NCT00181727|Valproic Acid|valproic acid|mesh-list
24409304|NCT00181727|Anticonvulsants|anticonvulsants|mesh-ancestor
24409305|NCT00181727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459925|NCT00346853|Antidotes|antidotes|mesh-ancestor
24459926|NCT00346853|Protective Agents|protective agents|mesh-ancestor
24459927|NCT00346853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459928|NCT00346853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459929|NCT00346853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459930|NCT00346866|Anecortave|anecortave|mesh-list
24409473|NCT00182052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409475|NCT00182104|Anticoagulants|anticoagulants|mesh-ancestor
24409476|NCT00182143|Heparin|heparin|mesh-list
24409477|NCT00182143|Calcium heparin|calcium heparin|mesh-list
24409478|NCT00182143|Dalteparin|dalteparin|mesh-list
24409479|NCT00182143|Tinzaparin|tinzaparin|mesh-list
24409480|NCT00182143|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24409481|NCT00182143|Anticoagulants|anticoagulants|mesh-ancestor
24427898|NCT00239252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24427899|NCT00239278|Prednisolone|prednisolone|mesh-list
24409564|NCT00182455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24409565|NCT00182455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409566|NCT00182494|Metformin|metformin|mesh-list
24409567|NCT00182494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24946475|NCT03939273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24409577|NCT00182507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24409614|NCT00182572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24409615|NCT00182572|Narcotics|narcotics|mesh-ancestor
24409650|NCT00182663|Autonomic Agents|autonomic agents|mesh-ancestor
24409651|NCT00182663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24409652|NCT00182663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409653|NCT00182663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24409654|NCT00182663|Glucocorticoids|glucocorticoids|mesh-ancestor
24409655|NCT00182663|Hormones|hormones|mesh-ancestor
24409656|NCT00182663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24409691|NCT00182715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24409692|NCT00182715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24410409|NCT00185185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24410410|NCT00185198|Testosterone|testosterone|mesh-list
24410912|NCT00187083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24410913|NCT00187083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24946571|NCT03937544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24946572|NCT03937544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24946573|NCT03937544|Alkylating Agents|alkylating agents|mesh-ancestor
24946574|NCT03937544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946575|NCT03937544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24946624|NCT03936426|Micronutrients|micronutrients|mesh-ancestor
24946625|NCT03936426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946626|NCT03936062|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24946627|NCT03936062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24946628|NCT03936062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946629|NCT03936062|Incretins|incretins|mesh-ancestor
24946631|NCT03936062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24946632|NCT03936062|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24946633|NCT03936062|Protease Inhibitors|protease inhibitors|mesh-ancestor
24946634|NCT03936062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25668812|NCT01722162|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25668813|NCT01722162|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25668814|NCT01722162|Histamine Antagonists|histamine antagonists|mesh-ancestor
25668815|NCT01722162|Histamine Agents|histamine agents|mesh-ancestor
25086892|NCT03284749|Copper|copper|mesh-list
24434579|NCT00262886|Cyclophosphamide|cyclophosphamide|mesh-list
24411569|NCT00189397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411570|NCT00189397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24946653|NCT03936205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24946654|NCT03936205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24946655|NCT03936205|Adrenergic Agents|adrenergic agents|mesh-ancestor
24946656|NCT03936205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24946657|NCT03936205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946659|NCT03936049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24946660|NCT03936049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24946661|NCT03936049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946662|NCT03936049|Incretins|incretins|mesh-ancestor
24946663|NCT03936049|Hormones|hormones|mesh-ancestor
24946664|NCT03936049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24946665|NCT03936049|Protease Inhibitors|protease inhibitors|mesh-ancestor
24946666|NCT03936049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24946667|NCT03936049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428316|NCT00240123|Autonomic Agents|autonomic agents|mesh-ancestor
24412023|NCT00190632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412025|NCT00190632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412058|NCT00190736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24412059|NCT00190736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25862818|NCT00091611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24412325|NCT00191230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412326|NCT00191230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24412327|NCT00191230|Antimetabolites|antimetabolites|mesh-ancestor
24412358|NCT00191256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946685|NCT03936023|Saxagliptin|saxagliptin|mesh-list
24946686|NCT03936023|Incretins|incretins|mesh-ancestor
24946687|NCT03936023|Hormones|hormones|mesh-ancestor
24946688|NCT03936023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24946689|NCT03936023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946690|NCT03936023|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24946691|NCT03936023|Protease Inhibitors|protease inhibitors|mesh-ancestor
24946692|NCT03936023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24946693|NCT03936023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946694|NCT03936023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24946695|NCT03936010|Canagliflozin|canagliflozin|mesh-list
24946696|NCT03936010|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24946697|NCT03936010|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24946698|NCT03936010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946699|NCT03936010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24946700|NCT03936010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946701|NCT03936010|Protease Inhibitors|protease inhibitors|mesh-ancestor
24946702|NCT03936010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24946703|NCT03935685|Mirtazapine|mirtazapine|mesh-list
24946704|NCT03935685|Antidepressive Agents|antidepressive agents|mesh-ancestor
24595178|NCT00937131|Rituximab|rituximab|mesh-list
24412359|NCT00191256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25140194|NCT02966652|Androgens|androgens|mesh-ancestor
24412361|NCT00191256|Antiviral Agents|antiviral agents|mesh-ancestor
24412362|NCT00191256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24459951|NCT00346918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24459952|NCT00346918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459953|NCT00346918|Antifungal Agents|antifungal agents|mesh-ancestor
24412480|NCT00191490|Antimitotic Agents|antimitotic agents|mesh-ancestor
24412481|NCT00191490|Mitosis Modulators|mitosis modulators|mesh-ancestor
24412482|NCT00191503|Gemcitabine|gemcitabine|mesh-list
24412485|NCT00191503|Antimetabolites|antimetabolites|mesh-ancestor
24412491|NCT00191503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24412492|NCT00191503|Immunologic Factors|immunologic factors|mesh-ancestor
24412493|NCT00191503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412494|NCT00191503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24412495|NCT00191503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25668816|NCT01722162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25668817|NCT01722266|Liraglutide|liraglutide|mesh-list
25668818|NCT01722266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25668819|NCT01722266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219990|NCT02659384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25219991|NCT02659384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24412496|NCT00191516|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24412589|NCT00191620|Immunologic Factors|immunologic factors|mesh-ancestor
24412590|NCT00191620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412591|NCT00191633|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25862819|NCT00091611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24412592|NCT00191633|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24412593|NCT00191633|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412598|NCT00191633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412599|NCT00191659|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24412600|NCT00191659|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24412601|NCT00191659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412602|NCT00191659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412798|NCT00192062|Vinorelbine|vinorelbine|mesh-list
24412799|NCT00192062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24412800|NCT00192062|Antimetabolites|antimetabolites|mesh-ancestor
24412801|NCT00192062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412802|NCT00192062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412803|NCT00192062|Antiviral Agents|antiviral agents|mesh-ancestor
24412834|NCT00192569|Interferons|interferons|mesh-list
25862820|NCT00091611|Analgesics|analgesics|mesh-ancestor
25862821|NCT00091611|Sensory System Agents|sensory system agents|mesh-ancestor
25862822|NCT00091611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25862823|NCT00091624|Lenalidomide|lenalidomide|mesh-list
25862824|NCT00091624|Immunologic Factors|immunologic factors|mesh-ancestor
25862825|NCT00091624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862826|NCT00091624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25862827|NCT00091624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25862828|NCT00091624|Growth Substances|growth substances|mesh-ancestor
25862829|NCT00091624|Growth Inhibitors|growth inhibitors|mesh-ancestor
25862830|NCT00091624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862831|NCT00091650|Olanzapine|olanzapine|mesh-list
25862832|NCT00091650|Antiemetics|antiemetics|mesh-ancestor
25051465|NCT00402428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051476|NCT00401570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413030|NCT00193011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413031|NCT00193011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24413032|NCT00193011|Tubulin Modulators|tubulin modulators|mesh-ancestor
24548334|NCT00709137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24548339|NCT00709163|Natriuretic Agents|natriuretic agents|mesh-ancestor
24428488|NCT00240617|Serotonin Agents|serotonin agents|mesh-ancestor
25862833|NCT00091650|Autonomic Agents|autonomic agents|mesh-ancestor
24459972|NCT00346970|Vitamin B Complex|vitamin b complex|mesh-ancestor
25051479|NCT00401570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051480|NCT00401570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25051481|NCT00401570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25051482|NCT00401570|Growth Substances|growth substances|mesh-ancestor
25051483|NCT00401570|Growth Inhibitors|growth inhibitors|mesh-ancestor
25051484|NCT00401388|Allopurinol|allopurinol|mesh-list
24946777|NCT03935074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946778|NCT03935074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24946779|NCT03935074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24754660|NCT01722240|Liraglutide|liraglutide|mesh-list
24413215|NCT00193310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25208335|NCT02643420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862834|NCT00091650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25862835|NCT00091650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413216|NCT00193310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413868|NCT00195481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25668820|NCT01722266|Incretins|incretins|mesh-ancestor
25668821|NCT01722266|Hormones|hormones|mesh-ancestor
25668822|NCT01722266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25668823|NCT01722292|Carboplatin|carboplatin|mesh-list
25668824|NCT01722292|Etoposide|etoposide|mesh-list
25668825|NCT01722292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25668826|NCT01722292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25668827|NCT01722292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25668828|NCT01722292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25668829|NCT01722292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25668830|NCT01722292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219998|NCT02659254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25219999|NCT02659254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25220000|NCT02659254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25220001|NCT02659254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25220002|NCT02659254|Antifungal Agents|antifungal agents|mesh-ancestor
25220003|NCT02659254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25220004|NCT02659254|Immunologic Factors|immunologic factors|mesh-ancestor
25220005|NCT02659254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220006|NCT02659228|Anesthetics|anesthetics|mesh-list
25220007|NCT02659228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
25220008|NCT02659228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25220009|NCT02659228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220010|NCT02659228|Anesthetics, General|anesthetics, general|mesh-ancestor
24832846|NCT02172326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832848|NCT02172339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24832849|NCT02172339|Autonomic Agents|autonomic agents|mesh-ancestor
24413870|NCT00195481|Antifungal Agents|antifungal agents|mesh-ancestor
24413871|NCT00195481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24413872|NCT00195481|Immunologic Factors|immunologic factors|mesh-ancestor
24413874|NCT00195533|Tazobactam|tazobactam|mesh-list
24413875|NCT00195533|Piperacillin|piperacillin|mesh-list
24413876|NCT00195533|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24413877|NCT00195533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24413878|NCT00195533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24413879|NCT00195533|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24413881|NCT00195533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413883|NCT00195559|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24413884|NCT00195559|Estradiol|estradiol|mesh-list
24413992|NCT00195767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24413993|NCT00195767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24413994|NCT00195767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24413995|NCT00195780|Valproic Acid|valproic acid|mesh-list
25862836|NCT00091650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24414032|NCT00195845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24414065|NCT00195871|Dermatologic Agents|dermatologic agents|mesh-ancestor
24414066|NCT00195871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199951|NCT02737371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25199952|NCT02737371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199953|NCT02737371|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25199954|NCT02737371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25199955|NCT02737423|Vitamin D|vitamin d|mesh-list
25199956|NCT02737423|Cholecalciferol|cholecalciferol|mesh-list
25199957|NCT02737423|Vitamins|vitamins|mesh-ancestor
25199958|NCT02737423|Micronutrients|micronutrients|mesh-ancestor
25199959|NCT02737423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199960|NCT02737423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25199961|NCT02737423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25199962|NCT02737527|Levobupivacaine|levobupivacaine|mesh-list
25199963|NCT02737527|Anesthetics, Local|anesthetics, local|mesh-ancestor
25199964|NCT02737527|Anesthetics|anesthetics|mesh-ancestor
25199965|NCT02737527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25199966|NCT02737527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199967|NCT02737527|Sensory System Agents|sensory system agents|mesh-ancestor
25199968|NCT02737527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25199969|NCT02737319|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25199970|NCT02737319|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25668831|NCT01722318|Plecanatide|plecanatide|mesh-list
25668832|NCT01722318|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25668833|NCT01722318|Enzyme Activators|enzyme activators|mesh-ancestor
25668834|NCT01722318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668835|NCT01722318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25668836|NCT01722435|Opiate Alkaloids|opiate alkaloids|mesh-list
25668837|NCT01722435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25668838|NCT01722435|Narcotics|narcotics|mesh-ancestor
25668839|NCT01722435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25668840|NCT01722435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668841|NCT01722435|Analgesics|analgesics|mesh-ancestor
25668842|NCT01722435|Sensory System Agents|sensory system agents|mesh-ancestor
25668843|NCT01722435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25668844|NCT01722487|Chlorambucil|chlorambucil|mesh-list
25668845|NCT01722487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25668846|NCT01722487|Alkylating Agents|alkylating agents|mesh-ancestor
24871111|NCT05097651|Cannabidiol|cannabidiol|mesh-list
24871112|NCT05097651|Anticonvulsants|anticonvulsants|mesh-ancestor
25220014|NCT02659293|Dexamethasone|dexamethasone|mesh-list
25220015|NCT02659293|Lenalidomide|lenalidomide|mesh-list
25220016|NCT02659293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25220017|NCT02659293|Antiemetics|antiemetics|mesh-ancestor
25220018|NCT02659293|Autonomic Agents|autonomic agents|mesh-ancestor
25220019|NCT02659293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25220020|NCT02659293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862837|NCT00091650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24871113|NCT05080764|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24871114|NCT05080764|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24871115|NCT05080764|Dermatologic Agents|dermatologic agents|mesh-ancestor
24871116|NCT05040360|Capecitabine|capecitabine|mesh-list
24871117|NCT05040360|Temozolomide|temozolomide|mesh-list
24871118|NCT05040360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24871119|NCT05040360|Antimetabolites|antimetabolites|mesh-ancestor
25199971|NCT02737319|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25199972|NCT02737319|Antimetabolites|antimetabolites|mesh-ancestor
24414510|NCT00197834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24414511|NCT00197834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24414512|NCT00197834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24414513|NCT00197886|Norepinephrine|norepinephrine|mesh-list
24414514|NCT00197886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24459979|NCT00346996|Isophane Insulin, Human|isophane insulin, human|mesh-list
24459980|NCT00346996|Insulin, Isophane|insulin, isophane|mesh-list
24459981|NCT00346996|Isophane insulin, beef|isophane insulin, beef|mesh-list
24459982|NCT00346996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24415920|NCT00201435|Paclitaxel|paclitaxel|mesh-list
24414515|NCT00197886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24414516|NCT00197886|Adrenergic Agents|adrenergic agents|mesh-ancestor
24755643|NCT01727869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414794|NCT00198627|Antimalarials|antimalarials|mesh-ancestor
24414795|NCT00198627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24414796|NCT00198627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24414797|NCT00198640|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25862838|NCT00091650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25862839|NCT00091650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24414809|NCT00198718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414845|NCT00198978|Glucocorticoids|glucocorticoids|mesh-ancestor
24459983|NCT00346996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459984|NCT00347035|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24755944|NCT01730287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24414977|NCT00199017|Asparaginase|asparaginase|mesh-list
24414978|NCT00199017|Mercaptopurine|mercaptopurine|mesh-list
24414979|NCT00199017|Thioguanine|thioguanine|mesh-list
24414981|NCT00199017|Vindesine|vindesine|mesh-list
24414982|NCT00199017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24414983|NCT00199017|Immunologic Factors|immunologic factors|mesh-ancestor
24414984|NCT00199017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414992|NCT00199017|Antiemetics|antiemetics|mesh-ancestor
24946852|NCT03934047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946853|NCT03934047|Hemostatics|hemostatics|mesh-ancestor
24414993|NCT00199017|Autonomic Agents|autonomic agents|mesh-ancestor
24415334|NCT00199212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24415357|NCT00199316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415358|NCT00199316|Analgesics|analgesics|mesh-ancestor
24415359|NCT00199316|Sensory System Agents|sensory system agents|mesh-ancestor
24428842|NCT00241332|Fentanyl|fentanyl|mesh-list
24415361|NCT00199329|Ondansetron|ondansetron|mesh-list
24415362|NCT00199329|Antiemetics|antiemetics|mesh-ancestor
24415363|NCT00199329|Autonomic Agents|autonomic agents|mesh-ancestor
24415364|NCT00199329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24415365|NCT00199329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415366|NCT00199329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24415367|NCT00199329|Antipruritics|antipruritics|mesh-ancestor
24415457|NCT00199576|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25862840|NCT00091650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24415467|NCT00199576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25668847|NCT01722487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668848|NCT01722487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25668849|NCT01722604|Brinzolamide|brinzolamide|mesh-list
25668850|NCT01722604|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25668851|NCT01722604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25668852|NCT01722604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668853|NCT01722669|Quercetin|quercetin|mesh-list
25668854|NCT01722669|Antioxidants|antioxidants|mesh-ancestor
25220024|NCT02659293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25220025|NCT02659293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25862841|NCT00091650|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24451917|NCT00325286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451918|NCT00325286|Antimanic Agents|antimanic agents|mesh-ancestor
24451919|NCT00325286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24415468|NCT00199576|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24415567|NCT00199979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24415568|NCT00199979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24415603|NCT00200252|Oxytocin|oxytocin|mesh-list
24459989|NCT00347035|Adrenergic Agents|adrenergic agents|mesh-ancestor
24459990|NCT00347035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24459991|NCT00347035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459992|NCT00347035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459993|NCT00347048|Tacrolimus|tacrolimus|mesh-list
24459994|NCT00347048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24459995|NCT00347048|Immunologic Factors|immunologic factors|mesh-ancestor
24415604|NCT00200252|Oxytocics|oxytocics|mesh-ancestor
24415605|NCT00200252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25862842|NCT00091650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25862843|NCT00091650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24415666|NCT00200473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25862844|NCT00091650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415699|NCT00200525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24415701|NCT00200525|Dopamine Agonists|dopamine agonists|mesh-ancestor
24415702|NCT00200525|Dopamine Agents|dopamine agents|mesh-ancestor
24623325|NCT01070862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24623326|NCT01070862|Growth Substances|growth substances|mesh-ancestor
24623327|NCT01070862|Growth Inhibitors|growth inhibitors|mesh-ancestor
24623328|NCT01070862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24623329|NCT01070862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25055962|NCT03516656|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25055963|NCT03516656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24810203|NCT02038621|Antimetabolites|antimetabolites|mesh-ancestor
24871189|NCT04578600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24871191|NCT04578600|Growth Inhibitors|growth inhibitors|mesh-ancestor
24871192|NCT04578600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415703|NCT00200525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24756810|NCT01735864|Indirubin|indirubin|mesh-list
25862845|NCT00091650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25862846|NCT00091650|Serotonin Agents|serotonin agents|mesh-ancestor
24415906|NCT00201396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25199973|NCT02737319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415944|NCT00201630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24415945|NCT00201630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756866|NCT01736150|Sequestering Agents|sequestering agents|mesh-ancestor
24416064|NCT00201812|Sensory System Agents|sensory system agents|mesh-ancestor
24416065|NCT00201812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24416066|NCT00201812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24416067|NCT00201812|Immunologic Factors|immunologic factors|mesh-ancestor
24416069|NCT00201955|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24416070|NCT00201955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24946870|NCT03933956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416272|NCT00202592|Protease Inhibitors|protease inhibitors|mesh-ancestor
24416273|NCT00202592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25668855|NCT01722669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668856|NCT01722669|Protective Agents|protective agents|mesh-ancestor
25668857|NCT01722669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668858|NCT01723072|Omalizumab|omalizumab|mesh-list
25668859|NCT01723072|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25668860|NCT01723072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25668861|NCT01723072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25668862|NCT01723072|Respiratory System Agents|respiratory system agents|mesh-ancestor
25668863|NCT01723072|Immunologic Factors|immunologic factors|mesh-ancestor
25668864|NCT01723072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668865|NCT01723228|Rasagiline|rasagiline|mesh-list
25668866|NCT01723228|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25668867|NCT01723228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416274|NCT00202592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416275|NCT00202592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24416276|NCT00202605|Amphetamine|amphetamine|mesh-list
24416277|NCT00202605|Dextroamphetamine|dextroamphetamine|mesh-list
24871194|NCT04578600|Antimetabolites|antimetabolites|mesh-ancestor
24871244|NCT04287816|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24871245|NCT04287816|Protease Inhibitors|protease inhibitors|mesh-ancestor
24871246|NCT04287816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24871247|NCT04287816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871248|NCT04287816|Anticoagulants|anticoagulants|mesh-ancestor
24871249|NCT04220489|Ketamine|ketamine|mesh-list
24416278|NCT00202605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24416279|NCT00202605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416280|NCT00202605|Sympathomimetics|sympathomimetics|mesh-ancestor
24416281|NCT00202605|Autonomic Agents|autonomic agents|mesh-ancestor
24416282|NCT00202605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24416283|NCT00202605|Dopamine Agents|dopamine agents|mesh-ancestor
24416284|NCT00202605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24416285|NCT00202605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416319|NCT00202787|Fluorouracil|fluorouracil|mesh-list
24416320|NCT00202787|Oxaliplatin|oxaliplatin|mesh-list
24416321|NCT00202787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24416322|NCT00202787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24416323|NCT00202787|Antimetabolites|antimetabolites|mesh-ancestor
24416324|NCT00202787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416325|NCT00202787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24416326|NCT00202787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24416327|NCT00202787|Immunologic Factors|immunologic factors|mesh-ancestor
24416328|NCT00202787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416329|NCT00202787|Antidotes|antidotes|mesh-ancestor
24416330|NCT00202787|Protective Agents|protective agents|mesh-ancestor
24416331|NCT00202787|Vitamin B Complex|vitamin b complex|mesh-ancestor
24416332|NCT00202787|Vitamins|vitamins|mesh-ancestor
24416333|NCT00202787|Micronutrients|micronutrients|mesh-ancestor
24416334|NCT00202800|Gemcitabine|gemcitabine|mesh-list
24416335|NCT00202800|Etoposide|etoposide|mesh-list
24416336|NCT00202800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24416341|NCT00202800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24416343|NCT00202800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24416344|NCT00202800|Immunologic Factors|immunologic factors|mesh-ancestor
24416415|NCT00203073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24946896|NCT03933865|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24946897|NCT03933865|Anesthetics, General|anesthetics, general|mesh-ancestor
24946899|NCT03933865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24946900|NCT03933865|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24946901|NCT03933865|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24946902|NCT03933865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24801204|NCT01981811|Aripiprazole|aripiprazole|mesh-list
24416419|NCT00203073|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24416420|NCT00203073|Immunologic Factors|immunologic factors|mesh-ancestor
24757469|NCT01740245|Biguanides|biguanides|mesh-list
24416533|NCT00203359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24416534|NCT00203359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24416535|NCT00203359|Immunologic Factors|immunologic factors|mesh-ancestor
24416536|NCT00203372|Cyclophosphamide|cyclophosphamide|mesh-list
24416537|NCT00203372|Bevacizumab|bevacizumab|mesh-list
24416538|NCT00203372|Docetaxel|docetaxel|mesh-list
24416602|NCT00203554|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24416603|NCT00203554|Protective Agents|protective agents|mesh-ancestor
24416604|NCT00203554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416605|NCT00203567|Carbamazepine|carbamazepine|mesh-list
24416606|NCT00203567|Anticonvulsants|anticonvulsants|mesh-ancestor
24416607|NCT00203567|Antimanic Agents|antimanic agents|mesh-ancestor
24416608|NCT00203567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24416609|NCT00203567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24416610|NCT00203567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416712|NCT00203788|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24757850|NCT01742689|Analgesics|analgesics|mesh-ancestor
24416818|NCT00204074|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24416829|NCT00204230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24416830|NCT00204230|Antitubercular Agents|antitubercular agents|mesh-ancestor
24416831|NCT00204230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24416832|NCT00204230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24416867|NCT00204321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24416868|NCT00204321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24416869|NCT00204321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24416871|NCT00204321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24416872|NCT00204321|Immunologic Factors|immunologic factors|mesh-ancestor
24416978|NCT00204581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416979|NCT00204581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24416980|NCT00204581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24416981|NCT00204581|Antiviral Agents|antiviral agents|mesh-ancestor
24416982|NCT00204581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24416983|NCT00204620|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24416984|NCT00204620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24416985|NCT00204620|Alkylating Agents|alkylating agents|mesh-ancestor
24416986|NCT00204620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417949|NCT00208208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24417950|NCT00208208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24417951|NCT00208208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24417952|NCT00208208|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24417953|NCT00208208|Dopamine Agents|dopamine agents|mesh-ancestor
24417954|NCT00208221|Telmisartan|telmisartan|mesh-list
24758163|NCT01744184|Analgesics|analgesics|mesh-ancestor
24418084|NCT00208546|Growth Substances|growth substances|mesh-ancestor
24418085|NCT00208546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199974|NCT02737319|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25199975|NCT02737319|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25199976|NCT02737319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199977|NCT02737254|Oxytocin|oxytocin|mesh-list
25199978|NCT02737254|Oxytocics|oxytocics|mesh-ancestor
24424140|NCT00228020|Immunologic Factors|immunologic factors|mesh-ancestor
25140533|NCT02963168|Docetaxel|docetaxel|mesh-list
24418086|NCT00208546|Growth Inhibitors|growth inhibitors|mesh-ancestor
24418497|NCT00209703|Levoleucovorin|levoleucovorin|mesh-list
24418498|NCT00209703|Antimetabolites|antimetabolites|mesh-ancestor
24418499|NCT00209703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418500|NCT00209703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24418501|NCT00209703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24418502|NCT00209703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24418503|NCT00209703|Immunologic Factors|immunologic factors|mesh-ancestor
24418504|NCT00209703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418505|NCT00209703|Antidotes|antidotes|mesh-ancestor
24418506|NCT00209703|Protective Agents|protective agents|mesh-ancestor
24418507|NCT00209703|Vitamin B Complex|vitamin b complex|mesh-ancestor
24418510|NCT00209716|Cisplatin|cisplatin|mesh-list
24418511|NCT00209716|Docetaxel|docetaxel|mesh-list
24418512|NCT00209716|Fluorouracil|fluorouracil|mesh-list
24418513|NCT00209716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24418514|NCT00209716|Tubulin Modulators|tubulin modulators|mesh-ancestor
24418515|NCT00209716|Antimitotic Agents|antimitotic agents|mesh-ancestor
24418516|NCT00209716|Mitosis Modulators|mitosis modulators|mesh-ancestor
24423143|NCT00224809|Antipyretics|antipyretics|mesh-ancestor
25862847|NCT00091663|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25862848|NCT00091663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862849|NCT00091663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25862850|NCT00091663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24418873|NCT00210392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24418874|NCT00210405|Micronutrients|micronutrients|mesh-list
24418875|NCT00210405|Trace Elements|trace elements|mesh-list
24418876|NCT00210405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418877|NCT00210444|Botulinum Toxins|botulinum toxins|mesh-list
24418878|NCT00210444|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24418879|NCT00210444|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24418982|NCT00210743|Hematinics|hematinics|mesh-ancestor
24419409|NCT00212043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24419489|NCT00212199|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24419491|NCT00212212|Antioxidants|antioxidants|mesh-ancestor
24419492|NCT00212212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419493|NCT00212212|Protective Agents|protective agents|mesh-ancestor
24419494|NCT00212212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419495|NCT00212212|Trace Elements|trace elements|mesh-ancestor
24419496|NCT00212212|Micronutrients|micronutrients|mesh-ancestor
24419497|NCT00212277|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24419498|NCT00212277|Norethindrone|norethindrone|mesh-list
24419499|NCT00212277|Norethindrone Acetate|norethindrone acetate|mesh-list
24419757|NCT00213590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419789|NCT00214032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24419790|NCT00214032|Immunologic Factors|immunologic factors|mesh-ancestor
24419791|NCT00214032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419792|NCT00214032|Antioxidants|antioxidants|mesh-ancestor
25429340|NCT01535053|Levoleucovorin|levoleucovorin|mesh-list
24419793|NCT00214032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419794|NCT00214032|Protective Agents|protective agents|mesh-ancestor
24419795|NCT00214032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24419796|NCT00214058|Carboplatin|carboplatin|mesh-list
24419797|NCT00214058|Docetaxel|docetaxel|mesh-list
24419798|NCT00214058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419799|NCT00214058|Tubulin Modulators|tubulin modulators|mesh-ancestor
24419800|NCT00214058|Antimitotic Agents|antimitotic agents|mesh-ancestor
24419801|NCT00214058|Mitosis Modulators|mitosis modulators|mesh-ancestor
24419802|NCT00214058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419803|NCT00214084|Allopurinol|allopurinol|mesh-list
24419894|NCT00214331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24419895|NCT00214331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24419896|NCT00214370|Fentanyl|fentanyl|mesh-list
24419897|NCT00214370|Propofol|propofol|mesh-list
24419898|NCT00214370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24419899|NCT00214370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25862851|NCT00091663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946957|NCT03933280|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24946958|NCT03933280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24946960|NCT03933280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199983|NCT02737202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046820|NCT00835575|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24946961|NCT03933280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24460031|NCT00347139|Respiratory System Agents|respiratory system agents|mesh-ancestor
24420251|NCT00215423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946967|NCT03933280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24946968|NCT03933280|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24946969|NCT03933280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24946970|NCT03933280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24946971|NCT03933280|Adrenergic Agents|adrenergic agents|mesh-ancestor
24946972|NCT03933280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24946973|NCT03933280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946974|NCT03933280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24946975|NCT03933280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24946976|NCT03933280|Narcotics|narcotics|mesh-ancestor
24946977|NCT03933280|Anesthetics, Local|anesthetics, local|mesh-ancestor
24946979|NCT03933605|Palonosetron|palonosetron|mesh-list
24946980|NCT03933605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24946981|NCT03933605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24946982|NCT03933605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24946983|NCT03933605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946984|NCT03933605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24946985|NCT03933605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24946986|NCT03933605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24946987|NCT03933605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24946988|NCT03933605|Anesthetics, General|anesthetics, general|mesh-ancestor
25051489|NCT00401388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051490|NCT00401388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051491|NCT00401388|Gout Suppressants|gout suppressants|mesh-ancestor
25051492|NCT00401388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25051493|NCT00401388|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24420252|NCT00215423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24420253|NCT00215423|Respiratory System Agents|respiratory system agents|mesh-ancestor
25862852|NCT00091702|Vaccines|vaccines|mesh-list
24946990|NCT03933605|GABA Modulators|gaba modulators|mesh-ancestor
24772251|NCT01832571|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24946992|NCT03933605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24947023|NCT03932916|Donepezil|donepezil|mesh-list
24947024|NCT03932916|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24947025|NCT03932916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24947026|NCT03932916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947027|NCT03932916|Cholinergic Agents|cholinergic agents|mesh-ancestor
24416898|NCT00204438|Contraceptive Agents|contraceptive agents|mesh-ancestor
24871489|NCT02375555|Hormones|hormones|mesh-ancestor
24420847|NCT00216892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24420848|NCT00216892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420850|NCT00216892|Respiratory System Agents|respiratory system agents|mesh-ancestor
24420851|NCT00216892|Dermatologic Agents|dermatologic agents|mesh-ancestor
24420852|NCT00216918|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24420853|NCT00216918|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24420854|NCT00216918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24420855|NCT00216918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25429418|NCT01523977|Pegaspargase|pegaspargase|mesh-list
24420856|NCT00216918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420857|NCT00216918|Adrenergic Agents|adrenergic agents|mesh-ancestor
24420858|NCT00216918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24420859|NCT00216918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420861|NCT00216931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24420862|NCT00216931|Vasodilator Agents|vasodilator agents|mesh-ancestor
24420863|NCT00217009|Furocoumarins|furocoumarins|mesh-list
24420864|NCT00217009|Dermatologic Agents|dermatologic agents|mesh-ancestor
24420865|NCT00217009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24420866|NCT00217048|Yohimbine|yohimbine|mesh-list
24420867|NCT00217048|Mydriatics|mydriatics|mesh-ancestor
24420868|NCT00217048|Autonomic Agents|autonomic agents|mesh-ancestor
24947029|NCT03932916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947030|NCT03932916|Nootropic Agents|nootropic agents|mesh-ancestor
25051497|NCT00401388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24947031|NCT03932864|Plerixafor|plerixafor|mesh-list
24947032|NCT03932864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24947033|NCT03932864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25208336|NCT02643420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24947034|NCT03932864|Antiviral Agents|antiviral agents|mesh-ancestor
24947035|NCT03932864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24947037|NCT03932825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24947038|NCT03932825|Anesthetics, General|anesthetics, general|mesh-ancestor
24947039|NCT03932825|Anesthetics|anesthetics|mesh-ancestor
24421173|NCT00218049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24421174|NCT00218049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421316|NCT00218283|Cholinergic Agents|cholinergic agents|mesh-ancestor
24421317|NCT00218283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24421385|NCT00218504|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24421678|NCT00219895|Ibuprofen|ibuprofen|mesh-list
24421679|NCT00219895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24421864|NCT00220324|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24421866|NCT00220337|Anticonvulsants|anticonvulsants|mesh-ancestor
24421867|NCT00220337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24421868|NCT00220337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24421869|NCT00220337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24422756|NCT00223691|Anticonvulsants|anticonvulsants|mesh-ancestor
24422757|NCT00223691|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24422758|NCT00223691|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24422855|NCT00223717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422886|NCT00223717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24422888|NCT00223717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24422889|NCT00223717|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24422912|NCT00223769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422913|NCT00223769|Anabolic Agents|anabolic agents|mesh-ancestor
24396848|NCT00140114|Oxytocics|oxytocics|mesh-ancestor
24422963|NCT00224302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24422964|NCT00224302|Dopamine Agents|dopamine agents|mesh-ancestor
24422965|NCT00224315|Risperidone|risperidone|mesh-list
24422966|NCT00224315|Ziprasidone|ziprasidone|mesh-list
24422967|NCT00224315|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24422968|NCT00224315|Serotonin Agents|serotonin agents|mesh-ancestor
24422969|NCT00224315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24422970|NCT00224315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422971|NCT00224315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422972|NCT00224315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24460067|NCT00347204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24422973|NCT00224315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24422974|NCT00224315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24422975|NCT00224315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24423079|NCT00224588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24947050|NCT03932981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24947051|NCT03933098|Vaccines|vaccines|mesh-list
24947052|NCT03933098|Immunologic Factors|immunologic factors|mesh-ancestor
24947053|NCT03933098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947054|NCT03932578|Atropine|atropine|mesh-list
24947055|NCT03932578|Metoclopramide|metoclopramide|mesh-list
24947056|NCT03932578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24947057|NCT03932578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24947058|NCT03932578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24947059|NCT03932578|Autonomic Agents|autonomic agents|mesh-ancestor
24947060|NCT03932578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24947061|NCT03932578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947062|NCT03932578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24947063|NCT03932578|Respiratory System Agents|respiratory system agents|mesh-ancestor
24947064|NCT03932578|Mydriatics|mydriatics|mesh-ancestor
24947065|NCT03932578|Parasympatholytics|parasympatholytics|mesh-ancestor
24947066|NCT03932578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24947067|NCT03932578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24947068|NCT03932578|Cholinergic Agents|cholinergic agents|mesh-ancestor
24947069|NCT03932578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24947070|NCT03932578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947071|NCT03932578|Antiemetics|antiemetics|mesh-ancestor
24947072|NCT03932578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24947073|NCT03932578|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24460113|NCT00347425|Ziprasidone|ziprasidone|mesh-list
24460114|NCT00347425|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24460115|NCT00347425|Serotonin Agents|serotonin agents|mesh-ancestor
24460117|NCT00347425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460118|NCT00347425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460119|NCT00347425|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24460120|NCT00347425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24460121|NCT00347425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24430183|NCT00246285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24460133|NCT00347425|Dopamine Agonists|dopamine agonists|mesh-ancestor
24423101|NCT00224679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24423102|NCT00224679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24423129|NCT00224809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24423136|NCT00224809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24423138|NCT00224809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24423139|NCT00224809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24423140|NCT00224809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423141|NCT00224809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24423142|NCT00224809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24423251|NCT00225173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24423252|NCT00225173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24423253|NCT00225173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24423254|NCT00225173|Glucocorticoids|glucocorticoids|mesh-ancestor
24423256|NCT00225173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24947083|NCT03932721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24947085|NCT03932292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24947086|NCT03932292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772478|NCT01833819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24772479|NCT01833819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772480|NCT01833819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24772481|NCT01833819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24423460|NCT00226096|Hydralazine|hydralazine|mesh-list
24423461|NCT00226096|Labetalol|labetalol|mesh-list
24423462|NCT00226096|Nicardipine|nicardipine|mesh-list
24423463|NCT00226096|Phentolamine|phentolamine|mesh-list
24423464|NCT00226096|Urapidil|urapidil|mesh-list
24423465|NCT00226096|Enalaprilat|enalaprilat|mesh-list
24423466|NCT00226096|Nitroglycerin|nitroglycerin|mesh-list
24423467|NCT00226096|Esmolol|esmolol|mesh-list
24423468|NCT00226096|Glycerol|glycerol|mesh-list
24423469|NCT00226096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24423522|NCT00226122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423523|NCT00226122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423524|NCT00226135|Lamotrigine|lamotrigine|mesh-list
24423525|NCT00226135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24423526|NCT00226135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455484|NCT00107198|Glucocorticoids|glucocorticoids|mesh-ancestor
24947118|NCT03932123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424086|NCT00227942|Estrogens|estrogens|mesh-list
24424087|NCT00227942|Hormones|hormones|mesh-ancestor
24424088|NCT00227942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24424089|NCT00227942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424090|NCT00227942|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24424091|NCT00227942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24424092|NCT00227942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24424093|NCT00227942|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24424094|NCT00227942|GABA Agonists|gaba agonists|mesh-ancestor
24424095|NCT00227942|GABA Agents|gaba agents|mesh-ancestor
24424103|NCT00227955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24424104|NCT00227955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24424105|NCT00227955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424106|NCT00227955|Adrenergic Agents|adrenergic agents|mesh-ancestor
24827125|NCT02137525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24424107|NCT00227955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24631372|NCT01117220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24631373|NCT01117220|Serotonin Agents|serotonin agents|mesh-ancestor
24631408|NCT01117610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24665351|NCT01311804|Analgesics|analgesics|mesh-ancestor
24631412|NCT01117636|Aspirin|aspirin|mesh-list
24424108|NCT00227955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424110|NCT00227981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24424111|NCT00227981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25862853|NCT00091702|Immunologic Factors|immunologic factors|mesh-ancestor
24424132|NCT00228020|Hormones|hormones|mesh-ancestor
24424133|NCT00228020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24424134|NCT00228020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424135|NCT00228020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24424136|NCT00228020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424137|NCT00228020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24424138|NCT00228020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424139|NCT00228020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24424790|NCT00230776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424792|NCT00230776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24424793|NCT00230776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24424794|NCT00230776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24424918|NCT00231335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424919|NCT00231335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24424920|NCT00231335|Serotonin Agents|serotonin agents|mesh-ancestor
24424921|NCT00231335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424922|NCT00231335|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24424923|NCT00231335|Antidepressive Agents|antidepressive agents|mesh-ancestor
24424924|NCT00231335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24424925|NCT00231348|Nefazodone|nefazodone|mesh-list
24947127|NCT03932266|Mitosis Modulators|mitosis modulators|mesh-ancestor
24947128|NCT03932266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947129|NCT03932266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24947130|NCT03932266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24947131|NCT03932266|Growth Substances|growth substances|mesh-ancestor
24801344|NCT01982929|Sensory System Agents|sensory system agents|mesh-ancestor
24424926|NCT00231348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24424927|NCT00231348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24424928|NCT00231348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24424929|NCT00231348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424930|NCT00231348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24424951|NCT00231452|Schistosomicides|schistosomicides|mesh-ancestor
24424952|NCT00231452|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24424953|NCT00231452|Anthelmintics|anthelmintics|mesh-ancestor
24424954|NCT00231452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24460140|NCT00347490|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24424955|NCT00231452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24424956|NCT00231452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424957|NCT00231452|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24424958|NCT00231452|Renal Agents|renal agents|mesh-ancestor
24399862|NCT00148785|Protease Inhibitors|protease inhibitors|mesh-ancestor
24425320|NCT00232674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24425322|NCT00232687|Antidepressive Agents|antidepressive agents|mesh-ancestor
24425323|NCT00232687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24425324|NCT00232687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24425325|NCT00232687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24425326|NCT00232687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24460144|NCT00347503|Bromfenac|bromfenac|mesh-list
24947139|NCT03931915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947140|NCT03931915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24947141|NCT03931915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24425407|NCT00232908|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24425408|NCT00232908|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24425409|NCT00232908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425464|NCT00233051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24425465|NCT00233051|Adrenergic Agents|adrenergic agents|mesh-ancestor
25404119|NCT03684018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668868|NCT01723228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668869|NCT01723228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25668870|NCT01723228|Protective Agents|protective agents|mesh-ancestor
25668871|NCT01723228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668872|NCT01723254|Immunoglobulin E|immunoglobulin e|mesh-list
25668873|NCT01723254|Immunologic Factors|immunologic factors|mesh-ancestor
25042591|NCT01414920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25042592|NCT01414920|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25042593|NCT01414920|Protease Inhibitors|protease inhibitors|mesh-ancestor
25042594|NCT01414920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25042595|NCT01414920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631536|NCT01118793|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24631537|NCT01118793|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24631538|NCT01118793|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25199984|NCT02737202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140869|NCT02961816|Glucocorticoids|glucocorticoids|mesh-ancestor
24425466|NCT00233051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24425467|NCT00233051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425468|NCT00233155|Capsaicin|capsaicin|mesh-list
24425469|NCT00233155|Antipruritics|antipruritics|mesh-ancestor
24425470|NCT00233155|Dermatologic Agents|dermatologic agents|mesh-ancestor
25007199|NCT04029012|Methoxyflurane|methoxyflurane|mesh-list
24430827|NCT00249366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24460150|NCT00347503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460151|NCT00347503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24425634|NCT00233805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425636|NCT00233818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24425637|NCT00233818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24425638|NCT00233818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24425639|NCT00233818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24425640|NCT00233818|Antifungal Agents|antifungal agents|mesh-ancestor
24425641|NCT00233818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24425642|NCT00233818|Immunologic Factors|immunologic factors|mesh-ancestor
24425671|NCT00233935|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24425672|NCT00233961|Lenograstim|lenograstim|mesh-list
24425673|NCT00233961|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24425674|NCT00233961|Immunologic Factors|immunologic factors|mesh-ancestor
24425675|NCT00233961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425676|NCT00234000|Azacitidine|azacitidine|mesh-list
24425677|NCT00234000|Arsenic Trioxide|arsenic trioxide|mesh-list
24425679|NCT00234000|Antimetabolites|antimetabolites|mesh-ancestor
24427096|NCT00237393|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24427097|NCT00237393|Antidepressive Agents|antidepressive agents|mesh-ancestor
24427098|NCT00237393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24427099|NCT00237393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24427100|NCT00237393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24427101|NCT00237393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24427102|NCT00237393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427104|NCT00237419|Dermatologic Agents|dermatologic agents|mesh-ancestor
24427105|NCT00237419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24460169|NCT00347581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24460170|NCT00347581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460171|NCT00347581|Sympathomimetics|sympathomimetics|mesh-ancestor
24460172|NCT00347581|Autonomic Agents|autonomic agents|mesh-ancestor
24947164|NCT03931863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24947165|NCT03931863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24947166|NCT03931863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24947167|NCT03931863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24947168|NCT03931928|Tamoxifen|tamoxifen|mesh-list
24947169|NCT03931928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24947170|NCT03931928|Hormone Antagonists|hormone antagonists|mesh-ancestor
24801376|NCT01983371|Hematinics|hematinics|mesh-ancestor
24460173|NCT00347581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24460174|NCT00347581|Dopamine Agents|dopamine agents|mesh-ancestor
24460175|NCT00347581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24871886|NCT03934671|Protective Agents|protective agents|mesh-ancestor
24871887|NCT03934671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668874|NCT01723254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668875|NCT01723384|Naltrexone|naltrexone|mesh-list
25668876|NCT01723384|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25668877|NCT01723384|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25668878|NCT01723384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668879|NCT01723384|Sensory System Agents|sensory system agents|mesh-ancestor
25668880|NCT01723384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25668881|NCT01723514|Erenumab|erenumab|mesh-list
25668882|NCT01723514|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25668883|NCT01723514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427139|NCT00237510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25087319|NCT03280004|Moxifloxacin|moxifloxacin|mesh-list
25087321|NCT03280004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24427140|NCT00237510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427141|NCT00237510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427142|NCT00237510|Urological Agents|urological agents|mesh-ancestor
24460187|NCT00347685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24427144|NCT00237523|Cadexomer iodine|cadexomer iodine|mesh-list
24427145|NCT00237523|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24427146|NCT00237523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24427147|NCT00237523|Trace Elements|trace elements|mesh-ancestor
24427148|NCT00237523|Micronutrients|micronutrients|mesh-ancestor
24427149|NCT00237523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427179|NCT00237588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24427398|NCT00238160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427399|NCT00238160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24427400|NCT00238160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24427401|NCT00238160|Immunologic Factors|immunologic factors|mesh-ancestor
24427402|NCT00238160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427403|NCT00238173|Acetylcysteine|acetylcysteine|mesh-list
24427404|NCT00238173|Sodium thiosulfate|sodium thiosulfate|mesh-list
24427405|NCT00238173|Cyclophosphamide|cyclophosphamide|mesh-list
24427406|NCT00238173|Carboplatin|carboplatin|mesh-list
24427408|NCT00238173|Etoposide phosphate|etoposide phosphate|mesh-list
24427716|NCT00238797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25199985|NCT02737228|Gemcitabine|gemcitabine|mesh-list
25046882|NCT00835211|Hemostatics|hemostatics|mesh-ancestor
24427733|NCT00238927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24427734|NCT00238927|Autonomic Agents|autonomic agents|mesh-ancestor
24427735|NCT00238927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24427736|NCT00238927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427737|NCT00238927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24427741|NCT00238940|Mycophenolic Acid|mycophenolic acid|mesh-list
24427787|NCT00239018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24427814|NCT00239057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24427815|NCT00239057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427816|NCT00239057|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24427817|NCT00239057|Antitubercular Agents|antitubercular agents|mesh-ancestor
24427818|NCT00239057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24427819|NCT00239057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24427820|NCT00239057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427821|NCT00239057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427822|NCT00239070|Mycophenolic Acid|mycophenolic acid|mesh-list
24427823|NCT00239070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24427824|NCT00239070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427825|NCT00239070|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24427826|NCT00239070|Antitubercular Agents|antitubercular agents|mesh-ancestor
24427827|NCT00239070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24427828|NCT00239070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24428106|NCT00239512|Sensory System Agents|sensory system agents|mesh-ancestor
24428107|NCT00239512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24428108|NCT00239512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428109|NCT00239512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24428110|NCT00239512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24428211|NCT00239954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428291|NCT00240058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24428292|NCT00240058|Adrenergic Agents|adrenergic agents|mesh-ancestor
24428293|NCT00240058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24428294|NCT00240058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428295|NCT00240058|Protective Agents|protective agents|mesh-ancestor
24428296|NCT00240058|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24428297|NCT00240058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24428298|NCT00240058|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24408676|NCT00179062|Serotonin Agents|serotonin agents|mesh-ancestor
24428726|NCT00241059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24429038|NCT00242411|Glucocorticoids|glucocorticoids|mesh-ancestor
24429163|NCT00242814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429164|NCT00242814|Vasodilator Agents|vasodilator agents|mesh-ancestor
24429165|NCT00242814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24429166|NCT00242814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24429167|NCT00242853|Nitric Oxide|nitric oxide|mesh-list
24429168|NCT00242853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24429169|NCT00242853|Autonomic Agents|autonomic agents|mesh-ancestor
25668884|NCT01723514|Analgesics|analgesics|mesh-ancestor
24409234|NCT00181571|Methylphenidate|methylphenidate|mesh-list
25668885|NCT01723514|Sensory System Agents|sensory system agents|mesh-ancestor
25042610|NCT01410695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25220108|NCT02658773|Lidocaine|lidocaine|mesh-list
24460212|NCT00347737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460213|NCT00347737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24429289|NCT00243204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429290|NCT00243256|Cholecalciferol|cholecalciferol|mesh-list
24429291|NCT00243256|Vitamin D|vitamin d|mesh-list
24429292|NCT00243256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24429293|NCT00243256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429294|NCT00243256|Vitamins|vitamins|mesh-ancestor
24429322|NCT00243477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25862854|NCT00091702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429323|NCT00243477|Serotonin Agents|serotonin agents|mesh-ancestor
24429324|NCT00243477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429325|NCT00243477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24429326|NCT00243477|Antidepressive Agents|antidepressive agents|mesh-ancestor
24429327|NCT00243477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24429329|NCT00243646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429330|NCT00243646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429331|NCT00243646|Androgen Antagonists|androgen antagonists|mesh-ancestor
24429332|NCT00243646|Hormone Antagonists|hormone antagonists|mesh-ancestor
24429333|NCT00243646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24429335|NCT00243672|Gemfibrozil|gemfibrozil|mesh-list
24429336|NCT00243672|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24429713|NCT00244920|Protective Agents|protective agents|mesh-ancestor
24429714|NCT00244920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25199986|NCT02737228|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24429715|NCT00244920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24429717|NCT00244920|Growth Inhibitors|growth inhibitors|mesh-ancestor
24429718|NCT00244946|Cytarabine|cytarabine|mesh-list
24429719|NCT00244946|Etoposide|etoposide|mesh-list
24429720|NCT00244946|Melphalan|melphalan|mesh-list
24429721|NCT00244946|Carmustine|carmustine|mesh-list
25862855|NCT00091715|Bosentan|bosentan|mesh-list
25862856|NCT00091715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24429741|NCT00244959|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24429742|NCT00244959|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24429743|NCT00244959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429744|NCT00244959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429745|NCT00244959|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24429746|NCT00244959|Hormone Antagonists|hormone antagonists|mesh-ancestor
24429747|NCT00244959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24429748|NCT00244959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429749|NCT00244972|Sorafenib|sorafenib|mesh-list
24429750|NCT00244972|Tipifarnib|tipifarnib|mesh-list
24429751|NCT00244972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429752|NCT00244972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24429944|NCT00245596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24429946|NCT00245596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429947|NCT00245596|Urological Agents|urological agents|mesh-ancestor
24429950|NCT00245609|Analgesics|analgesics|mesh-ancestor
24429951|NCT00245609|Sensory System Agents|sensory system agents|mesh-ancestor
24429952|NCT00245609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24429969|NCT00245661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24947193|NCT03931343|Sensory System Agents|sensory system agents|mesh-ancestor
24947194|NCT03931343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24429970|NCT00245661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429972|NCT00245661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24429973|NCT00245661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24429974|NCT00245661|GABA Modulators|gaba modulators|mesh-ancestor
24429975|NCT00245661|GABA Agents|gaba agents|mesh-ancestor
24429976|NCT00245661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430802|NCT00249236|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24430803|NCT00249236|Dopamine Agents|dopamine agents|mesh-ancestor
24430804|NCT00249353|Methylphenidate|methylphenidate|mesh-list
24430805|NCT00249353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24430806|NCT00249353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430807|NCT00249353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24430808|NCT00249353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24947203|NCT03931343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24801409|NCT01983462|Analgesics|analgesics|mesh-ancestor
24460249|NCT00347828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431044|NCT00250094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25668886|NCT01723514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25862857|NCT00091715|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24431045|NCT00250094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431046|NCT00250094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431048|NCT00250120|Rubitecan|rubitecan|mesh-list
24431049|NCT00250120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24431050|NCT00250120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431117|NCT00250367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24431118|NCT00250367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24431119|NCT00250367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24431120|NCT00250367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24431121|NCT00250367|Dopamine Agents|dopamine agents|mesh-ancestor
24431122|NCT00250393|Istradefylline|istradefylline|mesh-list
24431123|NCT00250393|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
24431124|NCT00250393|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24431148|NCT00250562|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24460250|NCT00347828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431149|NCT00250562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24431151|NCT00250575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24431153|NCT00250575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431154|NCT00250575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431155|NCT00250575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431156|NCT00250575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25199987|NCT02737228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25141066|NCT02959905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24431354|NCT00251459|Growth Inhibitors|growth inhibitors|mesh-ancestor
24431355|NCT00251459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431357|NCT00251472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24947209|NCT03931239|Immunologic Factors|immunologic factors|mesh-ancestor
24947210|NCT03931239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431358|NCT00251472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431359|NCT00251472|Tubulin Modulators|tubulin modulators|mesh-ancestor
24431507|NCT00251940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24431508|NCT00251940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431509|NCT00251953|Metformin|metformin|mesh-list
24431788|NCT00252863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431789|NCT00252863|Vasodilator Agents|vasodilator agents|mesh-ancestor
24431790|NCT00252863|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24431818|NCT00253058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431819|NCT00253058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431820|NCT00253110|Haloperidol|haloperidol|mesh-list
24431821|NCT00253110|Risperidone|risperidone|mesh-list
24431822|NCT00253110|Haloperidol decanoate|haloperidol decanoate|mesh-list
24431823|NCT00253110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24431836|NCT00253110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24431837|NCT00253110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24431838|NCT00253110|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24431840|NCT00253123|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24460251|NCT00347828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460252|NCT00347841|Bimatoprost|bimatoprost|mesh-list
24460253|NCT00347841|Latanoprost|latanoprost|mesh-list
24460254|NCT00347841|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24460255|NCT00347841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24460256|NCT00347841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24460257|NCT00347854|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24460258|NCT00347854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24460259|NCT00347854|Lubricant Eye Drops|lubricant eye drops|mesh-list
24431841|NCT00253123|Serotonin Agents|serotonin agents|mesh-ancestor
24431982|NCT00253344|Mitosis Modulators|mitosis modulators|mesh-ancestor
24431983|NCT00253344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431984|NCT00253344|Immunologic Factors|immunologic factors|mesh-ancestor
24431985|NCT00253344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431986|NCT00253344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24431987|NCT00253344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24431988|NCT00253344|Growth Substances|growth substances|mesh-ancestor
24432018|NCT00253461|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24432019|NCT00253474|Interferons|interferons|mesh-list
24432093|NCT00253552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24432094|NCT00253552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24432095|NCT00253552|Abortifacient Agents|abortifacient agents|mesh-ancestor
24432096|NCT00253552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24432097|NCT00253552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24432099|NCT00253552|Dermatologic Agents|dermatologic agents|mesh-ancestor
24432100|NCT00253552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432101|NCT00253552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24432256|NCT00254137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24432257|NCT00254137|Antimetabolites|antimetabolites|mesh-ancestor
24419877|NCT00214318|Sympathomimetics|sympathomimetics|mesh-ancestor
24432335|NCT00254449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24432348|NCT00254475|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24432349|NCT00254553|Methyltestosterone|methyltestosterone|mesh-list
24432350|NCT00254553|Testosterone|testosterone|mesh-list
24432351|NCT00254553|Testosterone undecanoate|testosterone undecanoate|mesh-list
24432377|NCT00254631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24432378|NCT00254657|Levetiracetam|levetiracetam|mesh-list
24432379|NCT00254657|Anticonvulsants|anticonvulsants|mesh-ancestor
24432380|NCT00254657|Nootropic Agents|nootropic agents|mesh-ancestor
24432381|NCT00254670|Naltrexone|naltrexone|mesh-list
24432382|NCT00254670|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24432383|NCT00254670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24432384|NCT00254670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199988|NCT02737228|Antimetabolites|antimetabolites|mesh-ancestor
24432385|NCT00254670|Sensory System Agents|sensory system agents|mesh-ancestor
24432386|NCT00254670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24432387|NCT00254709|Sirolimus|sirolimus|mesh-list
24814963|NCT02067767|Lamivudine|lamivudine|mesh-list
24432388|NCT00254709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25046924|NCT00834977|Amlodipine|amlodipine|mesh-list
24432389|NCT00254709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24432428|NCT00254774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432429|NCT00254774|GABA Agents|gaba agents|mesh-ancestor
24432430|NCT00254774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24432448|NCT00254800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24432449|NCT00254800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432450|NCT00254800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24432451|NCT00254800|Contraceptive Agents|contraceptive agents|mesh-ancestor
24432452|NCT00254800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24947230|NCT03931135|Hormones|hormones|mesh-ancestor
24947231|NCT03931135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24947232|NCT03931135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24947233|NCT03931135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24947234|NCT03931135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24947235|NCT03931135|Narcotics|narcotics|mesh-ancestor
24801425|NCT01983501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24627930|NCT01095731|Glycine|glycine|mesh-list
24801426|NCT01983501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24801427|NCT01983514|Oxytocin|oxytocin|mesh-list
24801428|NCT01983514|Oxytocics|oxytocics|mesh-ancestor
24801429|NCT01983514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24432510|NCT00255073|Baclofen|baclofen|mesh-list
24947287|NCT03930433|Diltiazem|diltiazem|mesh-list
24432512|NCT00255073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432513|NCT00255073|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24432514|NCT00255073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24432515|NCT00255073|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24432516|NCT00255073|GABA Agonists|gaba agonists|mesh-ancestor
24432552|NCT00255268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24432553|NCT00255268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432554|NCT00255372|Lactulose|lactulose|mesh-list
24432555|NCT00255372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24432556|NCT00255385|Micronutrients|micronutrients|mesh-list
24432557|NCT00255385|Trace Elements|trace elements|mesh-list
24432558|NCT00255385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432559|NCT00255424|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24947243|NCT03931135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947244|NCT03930992|Zoledronic Acid|zoledronic acid|mesh-list
24947246|NCT03930992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947247|NCT03931369|Tolvaptan|tolvaptan|mesh-list
24422428|NCT00222482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24947248|NCT03931369|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24947249|NCT03931369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947250|NCT03931369|Natriuretic Agents|natriuretic agents|mesh-ancestor
24947251|NCT03931369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947252|NCT03930875|Aspirin|aspirin|mesh-list
24947253|NCT03930875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24801439|NCT01983527|Antiemetics|antiemetics|mesh-ancestor
24432796|NCT00256230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404120|NCT03683810|Lactoferrin|lactoferrin|mesh-list
24433194|NCT00257855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460282|NCT00348010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24947254|NCT03930875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24947255|NCT03930875|Analgesics|analgesics|mesh-ancestor
24947256|NCT03930875|Sensory System Agents|sensory system agents|mesh-ancestor
24947257|NCT03930875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25199989|NCT02737228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25199990|NCT02737228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25199991|NCT02737228|Antiviral Agents|antiviral agents|mesh-ancestor
25199992|NCT02737228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25199993|NCT02737228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25199994|NCT02737228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25199995|NCT02737228|Immunologic Factors|immunologic factors|mesh-ancestor
25199996|NCT02737228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25199997|NCT02737228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24433378|NCT00258245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24433379|NCT00258245|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24433380|NCT00258245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24433381|NCT00258245|Antipyretics|antipyretics|mesh-ancestor
24433761|NCT00259870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24433762|NCT00259870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24433763|NCT00259870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24433764|NCT00259870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460298|NCT00348062|Bimatoprost|bimatoprost|mesh-list
24460299|NCT00348062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24433765|NCT00259870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24433901|NCT00260416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24433902|NCT00260520|Dalteparin|dalteparin|mesh-list
24433903|NCT00260520|Tinzaparin|tinzaparin|mesh-list
24433904|NCT00260520|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24433905|NCT00260520|Anticoagulants|anticoagulants|mesh-ancestor
24460303|NCT00348101|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24947260|NCT03930875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25051498|NCT00401388|Autonomic Agents|autonomic agents|mesh-ancestor
24962953|NCT03794154|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24962954|NCT03794154|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24460304|NCT00348101|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24460305|NCT00348101|Adrenergic Agents|adrenergic agents|mesh-ancestor
24433917|NCT00260624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24433948|NCT00260988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24433949|NCT00260988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433950|NCT00261027|Exemestane|exemestane|mesh-list
24434005|NCT00261170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24434006|NCT00261170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434007|NCT00261170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24434014|NCT00261183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434015|NCT00261183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24434016|NCT00261222|Amodiaquine|amodiaquine|mesh-list
24872273|NCT05397834|Fluticasone|fluticasone|mesh-list
24434017|NCT00261222|Antimalarials|antimalarials|mesh-ancestor
24434018|NCT00261222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24434019|NCT00261222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24434020|NCT00261222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24434021|NCT00261261|Midazolam|midazolam|mesh-list
24434022|NCT00261261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24434023|NCT00261261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24434024|NCT00261261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24434025|NCT00261261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947261|NCT03930875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24947262|NCT03930875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24947263|NCT03930875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947264|NCT03930875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24947265|NCT03930875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24801463|NCT01983735|Amlodipine|amlodipine|mesh-list
24555988|NCT00744549|Vitamins|vitamins|mesh-list
24426988|NCT00237120|Imatinib Mesylate|imatinib mesylate|mesh-list
24434193|NCT00261612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24434194|NCT00261612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24434195|NCT00261612|Glucocorticoids|glucocorticoids|mesh-ancestor
25199998|NCT02737124|Acetaminophen|acetaminophen|mesh-list
25141237|NCT02958852|Hormone Antagonists|hormone antagonists|mesh-ancestor
24434196|NCT00261612|Hormones|hormones|mesh-ancestor
24434197|NCT00261612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25404121|NCT03683810|Epoetin Alfa|epoetin alfa|mesh-list
24434198|NCT00261612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24434199|NCT00261625|Alendronate|alendronate|mesh-list
24434200|NCT00261625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24434201|NCT00261625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434202|NCT00261677|Epoetin Alfa|epoetin alfa|mesh-list
24434203|NCT00261677|Hematinics|hematinics|mesh-ancestor
24434204|NCT00261703|Cisplatin|cisplatin|mesh-list
24434205|NCT00261703|Docetaxel|docetaxel|mesh-list
24434206|NCT00261703|Fluorouracil|fluorouracil|mesh-list
24434207|NCT00261703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24434208|NCT00261703|Tubulin Modulators|tubulin modulators|mesh-ancestor
24434209|NCT00261703|Antimitotic Agents|antimitotic agents|mesh-ancestor
24434210|NCT00261703|Mitosis Modulators|mitosis modulators|mesh-ancestor
24434211|NCT00261703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434212|NCT00261703|Antimetabolites|antimetabolites|mesh-ancestor
24434213|NCT00261703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24434214|NCT00261703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24434215|NCT00261703|Immunologic Factors|immunologic factors|mesh-ancestor
24947266|NCT03930875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24947267|NCT03930875|Antipyretics|antipyretics|mesh-ancestor
24947268|NCT03931161|Evolocumab|evolocumab|mesh-list
24947269|NCT03931161|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24434313|NCT00262132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24434314|NCT00262132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24947276|NCT03930706|Estradiol|estradiol|mesh-list
24947277|NCT03930706|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24947278|NCT03930706|Estrogens|estrogens|mesh-ancestor
24947279|NCT03930706|Hormones|hormones|mesh-ancestor
24947280|NCT03930706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24947281|NCT03930706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872275|NCT05397834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24947282|NCT03930706|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24947283|NCT03930706|Contraceptive Agents|contraceptive agents|mesh-ancestor
24947284|NCT03930706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24947285|NCT03930706|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24947286|NCT03930433|Nebivolol|nebivolol|mesh-list
24947289|NCT03930433|Vasodilator Agents|vasodilator agents|mesh-ancestor
24947290|NCT03930433|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24434315|NCT00262132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24428764|NCT00241137|Valsartan|valsartan|mesh-list
24434413|NCT00262418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24947291|NCT03930433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24947292|NCT03930433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24947293|NCT03930433|Adrenergic Agents|adrenergic agents|mesh-ancestor
24947294|NCT03930433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24947295|NCT03930433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947296|NCT03930433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947297|NCT03930433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24556162|NCT00745433|Metformin|metformin|mesh-list
25208337|NCT02643420|Tubulin Modulators|tubulin modulators|mesh-ancestor
24434564|NCT00262808|Levoleucovorin|levoleucovorin|mesh-list
24434565|NCT00262808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25862858|NCT00091715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434566|NCT00262808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434567|NCT00262808|Antimetabolites|antimetabolites|mesh-ancestor
24434575|NCT00262808|Vitamin B Complex|vitamin b complex|mesh-ancestor
24434576|NCT00262808|Vitamins|vitamins|mesh-ancestor
24434577|NCT00262808|Micronutrients|micronutrients|mesh-ancestor
24434578|NCT00262886|Mycophenolic Acid|mycophenolic acid|mesh-list
25862859|NCT00091728|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25862860|NCT00091728|Contraceptive Agents|contraceptive agents|mesh-list
24434585|NCT00262886|Immunologic Factors|immunologic factors|mesh-ancestor
24434586|NCT00262886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434587|NCT00262886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24434588|NCT00262886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25862861|NCT00091728|Medroxyprogesterone|medroxyprogesterone|mesh-list
24434642|NCT00263055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24434657|NCT00263094|Sensory System Agents|sensory system agents|mesh-ancestor
24434658|NCT00263094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24434659|NCT00263094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434662|NCT00263133|Sertraline|sertraline|mesh-list
24434663|NCT00263133|Antidepressive Agents|antidepressive agents|mesh-ancestor
24434664|NCT00263133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24434665|NCT00263133|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24434666|NCT00263133|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24434667|NCT00263133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25404122|NCT03683810|Hematinics|hematinics|mesh-ancestor
24434668|NCT00263133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434669|NCT00263133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24434690|NCT00263198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434692|NCT00263198|Hormone Antagonists|hormone antagonists|mesh-ancestor
24434693|NCT00263198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24434694|NCT00263198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434695|NCT00263198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24434696|NCT00263263|Sirolimus|sirolimus|mesh-list
24947308|NCT03930069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24947309|NCT03930069|Oxytocics|oxytocics|mesh-ancestor
24801511|NCT01983800|Anesthetics|anesthetics|mesh-ancestor
24434910|NCT00264251|Rosiglitazone|rosiglitazone|mesh-list
24434911|NCT00264251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24434947|NCT00264420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434949|NCT00264446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434981|NCT00264628|Casopitant|casopitant|mesh-list
24434985|NCT00264628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434986|NCT00264628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24434987|NCT00264628|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25862862|NCT00091728|Contraceptives, Oral|contraceptives, oral|mesh-list
24434988|NCT00264628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24434989|NCT00264628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435020|NCT00264680|Antimanic Agents|antimanic agents|mesh-ancestor
24435021|NCT00264719|Metoclopramide|metoclopramide|mesh-list
24435022|NCT00264719|Antiemetics|antiemetics|mesh-ancestor
24435023|NCT00264719|Autonomic Agents|autonomic agents|mesh-ancestor
24435024|NCT00264719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24435025|NCT00264719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435026|NCT00264719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24430981|NCT00249912|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24435113|NCT00265031|Tubulin Modulators|tubulin modulators|mesh-ancestor
24435114|NCT00265031|Antimitotic Agents|antimitotic agents|mesh-ancestor
24435115|NCT00265031|Mitosis Modulators|mitosis modulators|mesh-ancestor
24435116|NCT00265031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24435118|NCT00265070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435119|NCT00265070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24435120|NCT00265070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435121|NCT00265070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435122|NCT00265135|Siltuximab|siltuximab|mesh-list
24435123|NCT00265135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435124|NCT00265252|Alendronate|alendronate|mesh-list
24435279|NCT00265863|Mitomycin|mitomycin|mesh-list
24435280|NCT00265863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25199999|NCT02737124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25200000|NCT02737124|Analgesics|analgesics|mesh-ancestor
24460318|NCT00348166|Cyclopentolate|cyclopentolate|mesh-list
24460319|NCT00348166|Mydriatics|mydriatics|mesh-ancestor
25051499|NCT00401388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25051501|NCT00401011|Bortezomib|bortezomib|mesh-list
25051502|NCT00401011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25051503|NCT00401011|Antiemetics|antiemetics|mesh-ancestor
25051504|NCT00401011|Autonomic Agents|autonomic agents|mesh-ancestor
25051505|NCT00401011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25051506|NCT00401011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947310|NCT03930069|Hemostatics|hemostatics|mesh-ancestor
24435355|NCT00266097|Oxaliplatin|oxaliplatin|mesh-list
24435356|NCT00266097|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24435357|NCT00266097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24435358|NCT00266097|Antimetabolites|antimetabolites|mesh-ancestor
24435359|NCT00266097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435360|NCT00266097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435594|NCT00267215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24435595|NCT00267215|Analgesics|analgesics|mesh-ancestor
24435596|NCT00267215|Sensory System Agents|sensory system agents|mesh-ancestor
24435597|NCT00267215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24435598|NCT00267215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435599|NCT00267215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24435600|NCT00267215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24435601|NCT00267254|Atorvastatin|atorvastatin|mesh-list
24435602|NCT00267254|Simvastatin|simvastatin|mesh-list
24435603|NCT00267254|Torcetrapib|torcetrapib|mesh-list
24872389|NCT05394337|Atezolizumab|atezolizumab|mesh-list
24435604|NCT00267254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24435605|NCT00267254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24435606|NCT00267254|Antimetabolites|antimetabolites|mesh-ancestor
24435840|NCT00268359|Irinotecan|irinotecan|mesh-list
24435844|NCT00268359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25051507|NCT00401011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24435948|NCT00268528|Immunologic Factors|immunologic factors|mesh-ancestor
24435949|NCT00268528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24435950|NCT00268528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24435975|NCT00268567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24435977|NCT00268593|Prednisone|prednisone|mesh-list
24435978|NCT00268593|Docetaxel|docetaxel|mesh-list
24947324|NCT03929861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24947325|NCT03929861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24436038|NCT00268723|Respiratory System Agents|respiratory system agents|mesh-ancestor
24436039|NCT00268723|Tocolytic Agents|tocolytic agents|mesh-ancestor
24436040|NCT00268723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24436041|NCT00268723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24436042|NCT00268723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24436043|NCT00268723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24436044|NCT00268723|Adrenergic Agents|adrenergic agents|mesh-ancestor
24436075|NCT00268840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24436076|NCT00268840|Antiviral Agents|antiviral agents|mesh-ancestor
24436077|NCT00268840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24436078|NCT00268840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24436079|NCT00268840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24436273|NCT00269620|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24436274|NCT00269620|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24436276|NCT00269620|NuvaRing|nuvaring|mesh-list
24436277|NCT00269620|Norelgestromin|norelgestromin|mesh-list
24436278|NCT00269620|Ortho Evra|ortho evra|mesh-list
24436279|NCT00269620|Contraceptive Agents|contraceptive agents|mesh-list
24436280|NCT00269620|Estradiol|estradiol|mesh-list
24436281|NCT00269620|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25862863|NCT00091728|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
24436368|NCT00269802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436370|NCT00269802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24436371|NCT00269802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24436372|NCT00269802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436373|NCT00269802|Dopamine Agents|dopamine agents|mesh-ancestor
24436374|NCT00269802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24436375|NCT00269815|Methylphenidate|methylphenidate|mesh-list
24436376|NCT00269815|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24436377|NCT00269815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460334|NCT00348192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24460335|NCT00348192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460336|NCT00348192|Nootropic Agents|nootropic agents|mesh-ancestor
24436503|NCT00270322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24436504|NCT00270322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436506|NCT00270322|Sensory System Agents|sensory system agents|mesh-ancestor
24433781|NCT00259896|Exenatide|exenatide|mesh-list
24436715|NCT00270907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435266|NCT00265824|Bevacizumab|bevacizumab|mesh-list
25862864|NCT00091728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24872444|NCT05385705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872448|NCT05385705|Analgesics|analgesics|mesh-ancestor
24872449|NCT05385705|Sensory System Agents|sensory system agents|mesh-ancestor
24872450|NCT05385705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24872451|NCT05385523|Dexamethasone|dexamethasone|mesh-list
24872452|NCT05385523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24436963|NCT00272324|Sensory System Agents|sensory system agents|mesh-ancestor
24436964|NCT00272324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24436965|NCT00272324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947398|NCT03929094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24947399|NCT03929094|Immunologic Factors|immunologic factors|mesh-ancestor
24947400|NCT03929094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437174|NCT00272831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24437175|NCT00272831|Vasodilator Agents|vasodilator agents|mesh-ancestor
24437176|NCT00272831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25668887|NCT01723514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668888|NCT01723696|Vitamins|vitamins|mesh-list
25668889|NCT01723696|Ascorbic Acid|ascorbic acid|mesh-list
25862865|NCT00091728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631600|NCT01119014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24631601|NCT01119014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862866|NCT00091728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24665382|NCT01312064|Everolimus|everolimus|mesh-list
24631602|NCT01119014|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24631603|NCT01119014|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24437177|NCT00272831|Protective Agents|protective agents|mesh-ancestor
24437178|NCT00272831|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24437179|NCT00272831|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24437180|NCT00272831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438096|NCT00275015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24438097|NCT00275015|Immunologic Factors|immunologic factors|mesh-ancestor
24438098|NCT00275015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438134|NCT00275054|Immunologic Factors|immunologic factors|mesh-ancestor
24438135|NCT00275054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862867|NCT00091728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25862868|NCT00091728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25862869|NCT00091728|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25862870|NCT00091728|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25862871|NCT00091728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25862872|NCT00091728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438157|NCT00275080|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24438158|NCT00275093|Sirolimus|sirolimus|mesh-list
24438159|NCT00275093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24438314|NCT00275522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24438315|NCT00275522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24438316|NCT00275522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24438317|NCT00275522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438318|NCT00275522|Antifungal Agents|antifungal agents|mesh-ancestor
24438319|NCT00275522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24438320|NCT00275522|Immunologic Factors|immunologic factors|mesh-ancestor
24438411|NCT00275756|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24438491|NCT00276055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24438493|NCT00276055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24438527|NCT00276081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24438528|NCT00276081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24438529|NCT00276081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24438604|NCT00276445|Immunologic Factors|immunologic factors|mesh-ancestor
24438605|NCT00276445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872453|NCT05385523|Antiemetics|antiemetics|mesh-ancestor
24872454|NCT05385523|Autonomic Agents|autonomic agents|mesh-ancestor
24872471|NCT05370716|Sensory System Agents|sensory system agents|mesh-ancestor
24872472|NCT05370716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24872473|NCT05370716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872474|NCT05370716|Anticonvulsants|anticonvulsants|mesh-ancestor
24872475|NCT05370716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25056088|NCT03515577|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24438606|NCT00276497|Pioglitazone|pioglitazone|mesh-list
24438731|NCT00276705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24438732|NCT00276705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24460360|NCT00348244|Protective Agents|protective agents|mesh-ancestor
24460361|NCT00348244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24460362|NCT00348244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25200001|NCT02737124|Sensory System Agents|sensory system agents|mesh-ancestor
24438763|NCT00276731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438764|NCT00276731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24438765|NCT00276731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24471344|NCT00394628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438766|NCT00276731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24438768|NCT00276731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25668890|NCT01723696|Micronutrients|micronutrients|mesh-ancestor
25668891|NCT01723696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668892|NCT01723696|Antioxidants|antioxidants|mesh-ancestor
25668893|NCT01723696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668894|NCT01723696|Protective Agents|protective agents|mesh-ancestor
25668895|NCT01723722|Methadone|methadone|mesh-list
25668896|NCT01723722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25668897|NCT01723722|Narcotics|narcotics|mesh-ancestor
25668898|NCT01723722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25668899|NCT01723722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668900|NCT01723722|Analgesics|analgesics|mesh-ancestor
25668901|NCT01723722|Sensory System Agents|sensory system agents|mesh-ancestor
25668902|NCT01723722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24438774|NCT00276757|Methotrexate|methotrexate|mesh-list
24438775|NCT00276757|Vinblastine|vinblastine|mesh-list
24438776|NCT00276757|Calcium|calcium|mesh-list
24438777|NCT00276757|Levoleucovorin|levoleucovorin|mesh-list
24438778|NCT00276757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24438779|NCT00276757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438780|NCT00276757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24438937|NCT00276926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438938|NCT00276965|Lithium Carbonate|lithium carbonate|mesh-list
24438939|NCT00276965|Sertraline|sertraline|mesh-list
24438940|NCT00276965|Antidepressive Agents|antidepressive agents|mesh-ancestor
24438941|NCT00276965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24438942|NCT00276965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24438943|NCT00276965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24438944|NCT00276965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24460367|NCT00348244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462852|NCT00357682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24438945|NCT00276965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438946|NCT00276965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24438947|NCT00276965|Serotonin Agents|serotonin agents|mesh-ancestor
24438948|NCT00276965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438949|NCT00276965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438950|NCT00276965|Antimanic Agents|antimanic agents|mesh-ancestor
24438923|NCT00276900|Sertraline|sertraline|mesh-list
24438977|NCT00277017|Immunologic Factors|immunologic factors|mesh-ancestor
24438978|NCT00277017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438979|NCT00277017|Leprostatic Agents|leprostatic agents|mesh-ancestor
24438980|NCT00277017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24438981|NCT00277017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24438982|NCT00277017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24438983|NCT00277017|Growth Substances|growth substances|mesh-ancestor
24438985|NCT00277030|Pulmonary Surfactants|pulmonary surfactants|mesh-list
24438986|NCT00277030|Respiratory System Agents|respiratory system agents|mesh-ancestor
24438987|NCT00277043|Paclitaxel|paclitaxel|mesh-list
24438988|NCT00277043|Docetaxel|docetaxel|mesh-list
24438990|NCT00277043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24460368|NCT00348244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460370|NCT00348296|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24460372|NCT00348296|gamma-Globulins|gamma-globulins|mesh-list
24460373|NCT00348296|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24460374|NCT00348296|Immunologic Factors|immunologic factors|mesh-ancestor
24434539|NCT00262769|Gemcitabine|gemcitabine|mesh-list
24439193|NCT00277862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439427|NCT00278460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24439451|NCT00278772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24439453|NCT00278824|Fentanyl|fentanyl|mesh-list
24439454|NCT00278824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24439455|NCT00278824|Narcotics|narcotics|mesh-ancestor
24439465|NCT00278928|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24439467|NCT00278928|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25862873|NCT00091741|Etanercept|etanercept|mesh-list
24439497|NCT00279084|Chrysarobin|chrysarobin|mesh-list
24439498|NCT00279084|Epoetin Alfa|epoetin alfa|mesh-list
25200002|NCT02737124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25200003|NCT02737124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439500|NCT00279084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24439501|NCT00279084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24439502|NCT00279084|Analgesics|analgesics|mesh-ancestor
25862874|NCT00091741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25862875|NCT00091741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25862876|NCT00091741|Analgesics|analgesics|mesh-ancestor
25862877|NCT00091741|Sensory System Agents|sensory system agents|mesh-ancestor
25862878|NCT00091741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24460383|NCT00348335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24460384|NCT00348335|Immunologic Factors|immunologic factors|mesh-ancestor
24460385|NCT00348335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668903|NCT01723722|Antitussive Agents|antitussive agents|mesh-ancestor
25668904|NCT01723722|Respiratory System Agents|respiratory system agents|mesh-ancestor
25668905|NCT01723904|Rotigotine|rotigotine|mesh-list
25668907|NCT01723904|Dopamine Agents|dopamine agents|mesh-ancestor
24460386|NCT00348335|Antifungal Agents|antifungal agents|mesh-ancestor
24872582|NCT05309460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872590|NCT05309460|Adrenergic Agents|adrenergic agents|mesh-ancestor
24872591|NCT05309460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24872592|NCT05309460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24422338|NCT00222170|Rabeprazole|rabeprazole|mesh-list
24439552|NCT00279344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24439553|NCT00279344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439554|NCT00279344|Analgesics|analgesics|mesh-ancestor
24439555|NCT00279344|Sensory System Agents|sensory system agents|mesh-ancestor
24439556|NCT00279344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24434852|NCT00264134|Docetaxel|docetaxel|mesh-list
24439559|NCT00279344|Anesthetics, General|anesthetics, general|mesh-ancestor
24439560|NCT00279344|Anesthetics|anesthetics|mesh-ancestor
24439561|NCT00279383|Thrombin|thrombin|mesh-list
24439562|NCT00279383|Hemostatics|hemostatics|mesh-ancestor
24439563|NCT00279383|Coagulants|coagulants|mesh-ancestor
24439564|NCT00279422|Visilizumab|visilizumab|mesh-list
24439565|NCT00279422|Immunologic Factors|immunologic factors|mesh-ancestor
24439566|NCT00279422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439651|NCT00279734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24439652|NCT00279734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439653|NCT00279734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439654|NCT00279734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24439655|NCT00279734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24439656|NCT00279747|Naproxen|naproxen|mesh-list
24439657|NCT00279747|Meloxicam|meloxicam|mesh-list
24439658|NCT00279747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24439659|NCT00279747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24460387|NCT00348335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24439781|NCT00280358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24439782|NCT00280358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24439803|NCT00280423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439804|NCT00280423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24439805|NCT00280423|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24439806|NCT00280423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24439808|NCT00280436|Casopitant|casopitant|mesh-list
24439817|NCT00280462|Nifedipine|nifedipine|mesh-list
24441166|NCT00286273|Citric Acid|citric acid|mesh-list
24439851|NCT00280540|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24439852|NCT00280540|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24439853|NCT00280540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439854|NCT00280540|Diuretics|diuretics|mesh-ancestor
24439855|NCT00280540|Natriuretic Agents|natriuretic agents|mesh-ancestor
25200004|NCT02737124|Antipyretics|antipyretics|mesh-ancestor
24439890|NCT00280774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24439891|NCT00280774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439892|NCT00280774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439893|NCT00280774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24439894|NCT00280774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24439895|NCT00280787|Paclitaxel|paclitaxel|mesh-list
24439896|NCT00280787|Carboplatin|carboplatin|mesh-list
24439897|NCT00280787|Irinotecan|irinotecan|mesh-list
24439904|NCT00280787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24439905|NCT00280787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24439928|NCT00280878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24439929|NCT00280878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24439930|NCT00280878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24439931|NCT00280878|Tubulin Modulators|tubulin modulators|mesh-ancestor
24435722|NCT00267917|Fenoterol|fenoterol|mesh-list
24440666|NCT00284258|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24440667|NCT00284258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24440668|NCT00284258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24440669|NCT00284258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440670|NCT00284258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440857|NCT00285051|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24440858|NCT00285090|Calcium, Dietary|calcium, dietary|mesh-list
24440859|NCT00285090|Vitamin D|vitamin d|mesh-list
24440860|NCT00285090|Ergocalciferols|ergocalciferols|mesh-list
24440861|NCT00285090|Cholecalciferol|cholecalciferol|mesh-list
24815043|NCT02068170|Erythromycin Estolate|erythromycin estolate|mesh-list
24815044|NCT02068170|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24815045|NCT02068170|Erythromycin stearate|erythromycin stearate|mesh-list
24815046|NCT02068170|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24440866|NCT00285090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24440996|NCT00285662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24440997|NCT00285662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440998|NCT00285662|Antiviral Agents|antiviral agents|mesh-ancestor
24460418|NCT00348400|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24460419|NCT00348400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441000|NCT00285662|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24441013|NCT00285675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24441014|NCT00285675|Vitamins|vitamins|mesh-ancestor
24441015|NCT00285675|Micronutrients|micronutrients|mesh-ancestor
24441016|NCT00285675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24441017|NCT00285727|Ropinirole|ropinirole|mesh-list
24441018|NCT00285727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24441019|NCT00285727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24441020|NCT00285727|Dopamine Agonists|dopamine agonists|mesh-ancestor
24441040|NCT00285805|Natriuretic Agents|natriuretic agents|mesh-ancestor
24441041|NCT00285805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441160|NCT00286260|Nootropic Agents|nootropic agents|mesh-ancestor
24441161|NCT00286273|Heparin|heparin|mesh-list
24441164|NCT00286273|Dalteparin|dalteparin|mesh-list
24441165|NCT00286273|Nadroparin|nadroparin|mesh-list
24947503|NCT03928210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947504|NCT03928210|Protective Agents|protective agents|mesh-ancestor
24947505|NCT03928210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947506|NCT03927963|Dexmedetomidine|dexmedetomidine|mesh-list
24441221|NCT00286481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441222|NCT00286481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24435660|NCT00267540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441235|NCT00286611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441236|NCT00286624|Cyclosporine|cyclosporine|mesh-list
24441237|NCT00286624|Everolimus|everolimus|mesh-list
24441238|NCT00286624|Cyclosporins|cyclosporins|mesh-list
24441239|NCT00286624|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24441240|NCT00286624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441241|NCT00286624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441242|NCT00286624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24441243|NCT00286624|Immunologic Factors|immunologic factors|mesh-ancestor
24441244|NCT00286624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441245|NCT00286624|Antifungal Agents|antifungal agents|mesh-ancestor
24815047|NCT02068170|Itraconazole|itraconazole|mesh-list
25862879|NCT00091741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862880|NCT00091741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25862881|NCT00091741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25862882|NCT00091741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25862883|NCT00091741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25862884|NCT00091741|Immunologic Factors|immunologic factors|mesh-ancestor
25862885|NCT00091806|Panitumumab|panitumumab|mesh-list
25862886|NCT00091806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25862887|NCT00091806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441246|NCT00286624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24441247|NCT00286624|Dermatologic Agents|dermatologic agents|mesh-ancestor
24441248|NCT00286624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24441249|NCT00286624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24441250|NCT00286624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441252|NCT00286689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24441253|NCT00286689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441347|NCT00287209|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24441348|NCT00287209|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24441349|NCT00287209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24441458|NCT00287521|Latanoprost|latanoprost|mesh-list
24441459|NCT00287521|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25668908|NCT01723904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25668909|NCT01723904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668910|NCT01723904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668911|NCT01724021|Prednisone|prednisone|mesh-list
24441460|NCT00287521|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24441461|NCT00287521|Adrenergic Agents|adrenergic agents|mesh-ancestor
24441462|NCT00287521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25862888|NCT00091858|Darbepoetin alfa|darbepoetin alfa|mesh-list
24441640|NCT00287950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24441641|NCT00287950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24441642|NCT00287950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441643|NCT00287950|Tubulin Modulators|tubulin modulators|mesh-ancestor
24441644|NCT00287950|Antimitotic Agents|antimitotic agents|mesh-ancestor
24441901|NCT00288782|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24441902|NCT00288782|Histamine Antagonists|histamine antagonists|mesh-ancestor
24441903|NCT00288782|Histamine Agents|histamine agents|mesh-ancestor
24441904|NCT00288782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24441919|NCT00288873|Vitamin D|vitamin d|mesh-list
24441942|NCT00289250|Antiviral Agents|antiviral agents|mesh-ancestor
24441943|NCT00289250|Schistosomicides|schistosomicides|mesh-ancestor
24441944|NCT00289250|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24441945|NCT00289250|Anthelmintics|anthelmintics|mesh-ancestor
24441946|NCT00289250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24460433|NCT00348413|Antimetabolites|antimetabolites|mesh-ancestor
24460434|NCT00348413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423527|NCT00226135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24441947|NCT00289250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441948|NCT00289250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441949|NCT00289250|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24441951|NCT00289263|Paclitaxel|paclitaxel|mesh-list
24441952|NCT00289263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25200005|NCT02737150|Anesthetics|anesthetics|mesh-list
24441953|NCT00289263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441954|NCT00289263|Tubulin Modulators|tubulin modulators|mesh-ancestor
24441955|NCT00289263|Antimitotic Agents|antimitotic agents|mesh-ancestor
24441956|NCT00289263|Mitosis Modulators|mitosis modulators|mesh-ancestor
24947514|NCT03927963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24947515|NCT03927963|Analgesics|analgesics|mesh-ancestor
24441957|NCT00289263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441958|NCT00289354|Chromium|chromium|mesh-list
24441959|NCT00289354|Biotin|biotin|mesh-list
24441960|NCT00289354|Picolinic acid|picolinic acid|mesh-list
24441961|NCT00289354|Trace Elements|trace elements|mesh-ancestor
24441962|NCT00289354|Micronutrients|micronutrients|mesh-ancestor
24441963|NCT00289354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441964|NCT00289354|Vitamin B Complex|vitamin b complex|mesh-ancestor
24441991|NCT00289419|Anesthetics, Local|anesthetics, local|mesh-ancestor
24441992|NCT00289419|Anesthetics|anesthetics|mesh-ancestor
24441993|NCT00289419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24442012|NCT00289445|Leucovorin|leucovorin|mesh-list
24442013|NCT00289445|Folic Acid|folic acid|mesh-list
24442014|NCT00289445|Mitomycins|mitomycins|mesh-list
24442015|NCT00289445|Mitomycin|mitomycin|mesh-list
24442027|NCT00289445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442028|NCT00289445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24442029|NCT00289445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442030|NCT00289510|Vaccines|vaccines|mesh-list
24442031|NCT00289510|Immunologic Factors|immunologic factors|mesh-ancestor
24442032|NCT00289510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442033|NCT00289588|Mupirocin|mupirocin|mesh-list
24442034|NCT00289588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24442035|NCT00289588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24442077|NCT00289952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442078|NCT00289952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442079|NCT00289952|GABA Agents|gaba agents|mesh-ancestor
24442095|NCT00290017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24442097|NCT00290030|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24442103|NCT00290030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442104|NCT00290030|Urological Agents|urological agents|mesh-ancestor
24442105|NCT00290043|Insulin glulisine|insulin glulisine|mesh-list
24442106|NCT00290043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24442107|NCT00290043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442109|NCT00290069|Tacrolimus|tacrolimus|mesh-list
24442110|NCT00290069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24442111|NCT00290069|Immunologic Factors|immunologic factors|mesh-ancestor
24442112|NCT00290069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442113|NCT00290069|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24442114|NCT00290069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442115|NCT00290069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442116|NCT00290069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24558256|NCT00755898|Antiviral Agents|antiviral agents|mesh-ancestor
24442187|NCT00290264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24442188|NCT00290264|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24442189|NCT00290264|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24442190|NCT00290264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24442191|NCT00290264|Adrenergic Agents|adrenergic agents|mesh-ancestor
24442192|NCT00290264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24442193|NCT00290264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442194|NCT00290394|Rosiglitazone|rosiglitazone|mesh-list
24442195|NCT00290394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24442196|NCT00290394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442289|NCT00290641|Antitubercular Agents|antitubercular agents|mesh-ancestor
24442290|NCT00290641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24442293|NCT00290667|Rituximab|rituximab|mesh-list
24442294|NCT00290667|Doxorubicin|doxorubicin|mesh-list
24442295|NCT00290667|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24442296|NCT00290667|Vincristine|vincristine|mesh-list
24442297|NCT00290667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25862889|NCT00091858|Hematinics|hematinics|mesh-ancestor
24442459|NCT00291122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24442460|NCT00291122|Analgesics|analgesics|mesh-ancestor
24442461|NCT00291122|Sensory System Agents|sensory system agents|mesh-ancestor
24442462|NCT00291122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24442463|NCT00291122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442464|NCT00291122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24442465|NCT00291122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24442466|NCT00291122|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24442467|NCT00291122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25862890|NCT00091897|Rituximab|rituximab|mesh-list
24947517|NCT03927963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24947518|NCT03927963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24947519|NCT03927963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24947521|NCT03927963|Adrenergic Agents|adrenergic agents|mesh-ancestor
24947522|NCT03927963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24947523|NCT03927963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947524|NCT03928093|Pregabalin|pregabalin|mesh-list
24947525|NCT03928093|Analgesics|analgesics|mesh-ancestor
24947526|NCT03928093|Sensory System Agents|sensory system agents|mesh-ancestor
24947527|NCT03928093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24815054|NCT02068170|Haloperidol|haloperidol|mesh-list
24947528|NCT03928093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947529|NCT03928093|Anticonvulsants|anticonvulsants|mesh-ancestor
24947530|NCT03928093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24947531|NCT03928093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24947532|NCT03928093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947533|NCT03928093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24947534|NCT03928093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24622343|NCT01066689|Citric Acid|citric acid|mesh-list
24622344|NCT01066689|Sodium Citrate|sodium citrate|mesh-list
24622345|NCT01066689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25862891|NCT00091897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24947541|NCT03927807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24947542|NCT03927807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947543|NCT03927807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24947544|NCT03927807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24947545|NCT03927807|Oxytocics|oxytocics|mesh-ancestor
24564093|NCT00775086|Hormones|hormones|mesh-ancestor
24622346|NCT01066689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442602|NCT00291759|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24442603|NCT00291759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24442604|NCT00291759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442605|NCT00291759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442606|NCT00291772|Pramlintide|pramlintide|mesh-list
24442607|NCT00291772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24442608|NCT00291772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442655|NCT00291915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442657|NCT00291915|Dermatologic Agents|dermatologic agents|mesh-ancestor
24442658|NCT00291915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442677|NCT00292110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442678|NCT00292110|Analgesics|analgesics|mesh-ancestor
24442679|NCT00292110|Sensory System Agents|sensory system agents|mesh-ancestor
24442680|NCT00292110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24442681|NCT00292110|Antitussive Agents|antitussive agents|mesh-ancestor
24442682|NCT00292110|Respiratory System Agents|respiratory system agents|mesh-ancestor
24442683|NCT00292123|Methadone|methadone|mesh-list
24442718|NCT00292266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442719|NCT00292266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442721|NCT00292266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24442722|NCT00292279|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25208338|NCT02643420|Antimitotic Agents|antimitotic agents|mesh-ancestor
24442723|NCT00292279|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25862892|NCT00091897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442747|NCT00292409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24442748|NCT00292409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24442749|NCT00292409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24442750|NCT00292448|Tiotropium Bromide|tiotropium bromide|mesh-list
24442751|NCT00292448|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24462857|NCT00357682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24442752|NCT00292448|Autonomic Agents|autonomic agents|mesh-ancestor
24442759|NCT00292448|Cholinergic Agents|cholinergic agents|mesh-ancestor
24442760|NCT00292448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24442761|NCT00292448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442764|NCT00292526|Protease Inhibitors|protease inhibitors|mesh-ancestor
24442767|NCT00292526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24442769|NCT00292695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442770|NCT00292695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24442771|NCT00292695|Alkylating Agents|alkylating agents|mesh-ancestor
24442845|NCT00292929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24442846|NCT00292929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24442847|NCT00292929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442848|NCT00292929|Antiviral Agents|antiviral agents|mesh-ancestor
24815084|NCT02068170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24436521|NCT00270348|Glucocorticoids|glucocorticoids|mesh-ancestor
25862893|NCT00091897|Immunologic Factors|immunologic factors|mesh-ancestor
25862894|NCT00091897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862895|NCT00091897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25862896|NCT00091910|Epoetin Alfa|epoetin alfa|mesh-list
25862897|NCT00091910|Hematinics|hematinics|mesh-ancestor
25862898|NCT00091936|Lamivudine|lamivudine|mesh-list
25862899|NCT00091936|Efavirenz|efavirenz|mesh-list
25862900|NCT00091936|Didanosine|didanosine|mesh-list
25862901|NCT00091936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25862902|NCT00091936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25862903|NCT00091936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25862904|NCT00091936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862905|NCT00091936|Antiviral Agents|antiviral agents|mesh-ancestor
25862906|NCT00091936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25862907|NCT00091936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25862908|NCT00091936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25862909|NCT00091936|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25862910|NCT00091936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25862911|NCT00091936|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25862912|NCT00091936|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25862913|NCT00091936|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25862914|NCT00091936|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25862915|NCT00091936|Antimetabolites|antimetabolites|mesh-ancestor
25862916|NCT00092001|Sunitinib|sunitinib|mesh-list
25862917|NCT00092001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862918|NCT00092001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25862919|NCT00092001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25862920|NCT00092001|Growth Substances|growth substances|mesh-ancestor
25862921|NCT00092001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862922|NCT00092001|Growth Inhibitors|growth inhibitors|mesh-ancestor
25862923|NCT00092001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25141963|NCT02953210|Ketorolac|ketorolac|mesh-list
25862924|NCT00092001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25862925|NCT00092001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862926|NCT00092079|Cholecalciferol|cholecalciferol|mesh-list
25862927|NCT00092079|Vitamin D|vitamin d|mesh-list
25862928|NCT00092079|Alendronate|alendronate|mesh-list
25862929|NCT00092079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25862930|NCT00092079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862931|NCT00092079|Vitamins|vitamins|mesh-ancestor
24947607|NCT03927170|Incretins|incretins|mesh-ancestor
25862932|NCT00092079|Micronutrients|micronutrients|mesh-ancestor
25862933|NCT00092079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25862934|NCT00092170|Clavulanic Acid|clavulanic acid|mesh-list
25862935|NCT00092170|Clavulanic Acids|clavulanic acids|mesh-list
25862936|NCT00092170|Ertapenem|ertapenem|mesh-list
25862937|NCT00092170|Ticarcillin|ticarcillin|mesh-list
25862938|NCT00092170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25862939|NCT00092170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25862940|NCT00092170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862941|NCT00092170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25862942|NCT00092170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25862943|NCT00092183|Ondansetron|ondansetron|mesh-list
25862944|NCT00092183|Aprepitant|aprepitant|mesh-list
25862945|NCT00092183|Antiemetics|antiemetics|mesh-ancestor
25862946|NCT00092183|Autonomic Agents|autonomic agents|mesh-ancestor
25862947|NCT00092183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25862948|NCT00092183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862949|NCT00092183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25862950|NCT00092183|Antipruritics|antipruritics|mesh-ancestor
25862951|NCT00092183|Dermatologic Agents|dermatologic agents|mesh-ancestor
25862952|NCT00092183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25862953|NCT00092183|Serotonin Agents|serotonin agents|mesh-ancestor
25862954|NCT00092183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25862955|NCT00092183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947560|NCT03927729|Methoxyflurane|methoxyflurane|mesh-list
24947561|NCT03927729|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24947562|NCT03927729|Anesthetics, General|anesthetics, general|mesh-ancestor
24947563|NCT03927729|Anesthetics|anesthetics|mesh-ancestor
24947564|NCT03927729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24947565|NCT03927729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947566|NCT03927352|Adalimumab|adalimumab|mesh-list
24947567|NCT03927352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24947568|NCT03927352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24947569|NCT03927456|Fulvestrant|fulvestrant|mesh-list
25862956|NCT00092183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25862957|NCT00092183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25862958|NCT00092183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25862959|NCT00092183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25862960|NCT00092183|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25208339|NCT02643420|Mitosis Modulators|mitosis modulators|mesh-ancestor
25862961|NCT00092183|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25862962|NCT00092196|Aprepitant|aprepitant|mesh-list
25862963|NCT00092196|Antiemetics|antiemetics|mesh-ancestor
25862964|NCT00092196|Autonomic Agents|autonomic agents|mesh-ancestor
25862965|NCT00092196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25862966|NCT00092196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862967|NCT00092196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25862968|NCT00092196|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25862969|NCT00092196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25862970|NCT00092196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862971|NCT00092274|Ofatumumab|ofatumumab|mesh-list
25862972|NCT00092274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862973|NCT00092287|Lanreotide|lanreotide|mesh-list
25862974|NCT00092287|Octreotide|octreotide|mesh-list
25862975|NCT00092287|Somatostatin|somatostatin|mesh-list
25862976|NCT00092287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25862977|NCT00092287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25862978|NCT00092287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25862979|NCT00092287|Hormones|hormones|mesh-ancestor
24947570|NCT03927456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24947571|NCT03927456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24947572|NCT03927456|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24947573|NCT03927456|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24947574|NCT03927456|Hormone Antagonists|hormone antagonists|mesh-ancestor
24947575|NCT03927456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25862980|NCT00092287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25862981|NCT00092287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862982|NCT00092300|Valdecoxib|valdecoxib|mesh-list
25862983|NCT00092300|Rofecoxib|rofecoxib|mesh-list
25862984|NCT00092300|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25211009|NCT04897919|Artemether|artemether|mesh-list
25862985|NCT00092300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25862986|NCT00092300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25862987|NCT00092300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25862988|NCT00092300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25862989|NCT00092300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25862990|NCT00092300|Analgesics|analgesics|mesh-ancestor
25862991|NCT00092300|Sensory System Agents|sensory system agents|mesh-ancestor
25862992|NCT00092300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25862993|NCT00092300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25862994|NCT00092300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25862995|NCT00092300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24443523|NCT00295347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24443524|NCT00295347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443525|NCT00295347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24631913|NCT01121016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24631915|NCT01121042|Ondansetron|ondansetron|mesh-list
25862996|NCT00092313|Acetaminophen|acetaminophen|mesh-list
24460553|NCT00348725|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25862998|NCT00092313|Oxycodone|oxycodone|mesh-list
25862999|NCT00092313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25863000|NCT00092313|Analgesics|analgesics|mesh-ancestor
25863001|NCT00092313|Sensory System Agents|sensory system agents|mesh-ancestor
25863002|NCT00092313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25863003|NCT00092313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863004|NCT00092313|Antipyretics|antipyretics|mesh-ancestor
25863005|NCT00092313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25863006|NCT00092313|Narcotics|narcotics|mesh-ancestor
25863007|NCT00092313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25863008|NCT00092313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25863009|NCT00092313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25863010|NCT00092313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863011|NCT00092313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863012|NCT00092313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24947576|NCT03927456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947578|NCT03927495|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24947579|NCT03927495|Cisplatin|cisplatin|mesh-list
24947580|NCT03927495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24947581|NCT03927495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863013|NCT00092313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24460453|NCT00348413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24460454|NCT00348426|Antitoxins|antitoxins|mesh-list
25863014|NCT00092313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25863015|NCT00092326|Acetaminophen|acetaminophen|mesh-list
25863016|NCT00092326|Rofecoxib|rofecoxib|mesh-list
24442982|NCT00293371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442983|NCT00293410|Cyclophosphamide|cyclophosphamide|mesh-list
24442984|NCT00293410|Clofarabine|clofarabine|mesh-list
24443361|NCT00294606|Norepinephrine|norepinephrine|mesh-list
25863017|NCT00092326|Oxycodone|oxycodone|mesh-list
24872977|NCT05438706|Antimetabolites|antimetabolites|mesh-ancestor
25863018|NCT00092326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25863019|NCT00092326|Analgesics|analgesics|mesh-ancestor
25863020|NCT00092326|Sensory System Agents|sensory system agents|mesh-ancestor
25863021|NCT00092326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25863022|NCT00092326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863023|NCT00092326|Antipyretics|antipyretics|mesh-ancestor
25863024|NCT00092326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25863025|NCT00092326|Narcotics|narcotics|mesh-ancestor
25863026|NCT00092326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25863027|NCT00092326|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25863028|NCT00092326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25863029|NCT00092326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863030|NCT00092326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863031|NCT00092326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25863032|NCT00092326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24460456|NCT00348426|Immunologic Factors|immunologic factors|mesh-ancestor
25863033|NCT00092326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25863034|NCT00092339|Valdecoxib|valdecoxib|mesh-list
25863035|NCT00092339|Rofecoxib|rofecoxib|mesh-list
25863036|NCT00092339|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24947582|NCT03927495|Tubulin Modulators|tubulin modulators|mesh-ancestor
24947583|NCT03927495|Antimitotic Agents|antimitotic agents|mesh-ancestor
24947584|NCT03927495|Mitosis Modulators|mitosis modulators|mesh-ancestor
24947585|NCT03927495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668913|NCT01724021|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25668914|NCT01724021|Methylprednisolone|methylprednisolone|mesh-list
25668915|NCT01724021|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25668916|NCT01724021|Prednisolone acetate|prednisolone acetate|mesh-list
25668917|NCT01724021|Cyclophosphamide|cyclophosphamide|mesh-list
25668918|NCT01724021|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25668919|NCT01724021|Rituximab|rituximab|mesh-list
25668920|NCT01724021|Vincristine|vincristine|mesh-list
25668921|NCT01724021|Doxorubicin|doxorubicin|mesh-list
25668922|NCT01724021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25668923|NCT01724021|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25668924|NCT01724021|Prednisolone phosphate|prednisolone phosphate|mesh-list
25668925|NCT01724021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25863037|NCT00092339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24947608|NCT03927170|Hormones|hormones|mesh-ancestor
25863038|NCT00092339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863039|NCT00092339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863040|NCT00092339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25863041|NCT00092339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25863042|NCT00092339|Analgesics|analgesics|mesh-ancestor
25863043|NCT00092339|Sensory System Agents|sensory system agents|mesh-ancestor
25863044|NCT00092339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25863045|NCT00092339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863046|NCT00092339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25863047|NCT00092339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25863048|NCT00092352|Celecoxib|celecoxib|mesh-list
25863049|NCT00092352|Rofecoxib|rofecoxib|mesh-list
25863050|NCT00092352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25863051|NCT00092352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25863052|NCT00092352|Analgesics|analgesics|mesh-ancestor
25200006|NCT02737150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25863053|NCT00092352|Sensory System Agents|sensory system agents|mesh-ancestor
25863054|NCT00092352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25863055|NCT00092352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863056|NCT00092352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25863057|NCT00092352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25863058|NCT00092352|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25863059|NCT00092352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25863060|NCT00092352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863061|NCT00092352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863062|NCT00092365|Celecoxib|celecoxib|mesh-list
25863063|NCT00092365|Rofecoxib|rofecoxib|mesh-list
25863064|NCT00092365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25863065|NCT00092365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25863066|NCT00092365|Analgesics|analgesics|mesh-ancestor
25863067|NCT00092365|Sensory System Agents|sensory system agents|mesh-ancestor
25863068|NCT00092365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25863069|NCT00092365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863070|NCT00092365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25863071|NCT00092365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25863072|NCT00092365|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25863073|NCT00092365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25863074|NCT00092365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863075|NCT00092365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863076|NCT00092378|Diclofenac|diclofenac|mesh-list
25863077|NCT00092378|Rofecoxib|rofecoxib|mesh-list
25863078|NCT00092378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25863079|NCT00092378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25863080|NCT00092378|Analgesics|analgesics|mesh-ancestor
25863081|NCT00092378|Sensory System Agents|sensory system agents|mesh-ancestor
25863082|NCT00092378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25863083|NCT00092378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863084|NCT00092378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25863085|NCT00092378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25863086|NCT00092378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25863087|NCT00092378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863088|NCT00092378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443020|NCT00293475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24443021|NCT00293475|Antidotes|antidotes|mesh-list
25863089|NCT00092378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25863090|NCT00092391|Vaccines|vaccines|mesh-list
25863091|NCT00092391|Immunologic Factors|immunologic factors|mesh-ancestor
25863092|NCT00092391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863093|NCT00092404|Vaccines|vaccines|mesh-list
25863094|NCT00092404|Immunologic Factors|immunologic factors|mesh-ancestor
25863095|NCT00092404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462860|NCT00357708|Azacitidine|azacitidine|mesh-list
24947594|NCT03927118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24947595|NCT03927118|Glucocorticoids|glucocorticoids|mesh-ancestor
24947597|NCT03927118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24947598|NCT03927118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24947599|NCT03927118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24947600|NCT03927118|Protease Inhibitors|protease inhibitors|mesh-ancestor
24947601|NCT03927118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24947602|NCT03927118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947603|NCT03927170|Metformin|metformin|mesh-list
24947604|NCT03927170|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25863096|NCT00092508|Mesalamine|mesalamine|mesh-list
25088329|NCT04962022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25088330|NCT04962022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088343|NCT04878315|Captopril|captopril|mesh-list
25088344|NCT04878315|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25088345|NCT04878315|Protease Inhibitors|protease inhibitors|mesh-ancestor
25088346|NCT04878315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25088347|NCT04878315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088348|NCT04878315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25088357|NCT04877821|Paclitaxel|paclitaxel|mesh-list
24947605|NCT03927170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24947606|NCT03927170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863097|NCT00092508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24626091|NCT01085617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24626092|NCT01085617|Immunologic Factors|immunologic factors|mesh-ancestor
24626093|NCT01085617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626094|NCT01085617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24626095|NCT01085617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24626096|NCT01085617|Alkylating Agents|alkylating agents|mesh-ancestor
24626097|NCT01085617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626098|NCT01085617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626099|NCT01085617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24626100|NCT01085617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24621771|NCT01063920|Naproxen|naproxen|mesh-list
25863098|NCT00092508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25863099|NCT00092508|Analgesics|analgesics|mesh-ancestor
25863100|NCT00092508|Sensory System Agents|sensory system agents|mesh-ancestor
25863101|NCT00092508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25863102|NCT00092508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863103|NCT00092508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25863104|NCT00092508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25863105|NCT00092846|Lovastatin|lovastatin|mesh-list
25863106|NCT00092846|L 647318|l 647318|mesh-list
25863107|NCT00092846|Dihydromevinolin|dihydromevinolin|mesh-list
24626103|NCT01085617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24626104|NCT01085617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24626106|NCT01085617|Dermatologic Agents|dermatologic agents|mesh-ancestor
25863108|NCT00092846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25863109|NCT00092846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25863110|NCT00092846|Antimetabolites|antimetabolites|mesh-ancestor
25863111|NCT00092846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863112|NCT00092846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25863113|NCT00092846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25863114|NCT00092846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863115|NCT00092924|Mapatumumab|mapatumumab|mesh-list
25863116|NCT00092924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863117|NCT00092937|Busulfan|busulfan|mesh-list
25863118|NCT00092937|Alkylating Agents|alkylating agents|mesh-ancestor
25863119|NCT00092937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863120|NCT00092937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25863121|NCT00092937|Immunologic Factors|immunologic factors|mesh-ancestor
25863122|NCT00092937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863123|NCT00092937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25863124|NCT00092937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863125|NCT00092937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25007691|NCT02909036|Melphalan|melphalan|mesh-list
24443087|NCT00293631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25863126|NCT00092976|Factor VIII|factor viii|mesh-list
24443048|NCT00293501|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24443050|NCT00293501|Anticoagulants|anticoagulants|mesh-ancestor
24443051|NCT00293501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24443052|NCT00293501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24443053|NCT00293501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443055|NCT00293514|Hemostatics|hemostatics|mesh-ancestor
24443056|NCT00293514|Coagulants|coagulants|mesh-ancestor
25668926|NCT01724021|Immunologic Factors|immunologic factors|mesh-ancestor
25668927|NCT01724021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668928|NCT01724021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25668929|NCT01724021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25668930|NCT01724021|Alkylating Agents|alkylating agents|mesh-ancestor
25668931|NCT01724021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668932|NCT01724021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25668933|NCT01724021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25668934|NCT01724021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24443058|NCT00293527|Interferon-alpha|interferon-alpha|mesh-list
24443059|NCT00293527|Interferon alpha-2|interferon alpha-2|mesh-list
24443060|NCT00293527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24443061|NCT00293527|Antiviral Agents|antiviral agents|mesh-ancestor
24443062|NCT00293527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25863127|NCT00092976|Coagulants|coagulants|mesh-ancestor
25863128|NCT00093002|Fulvestrant|fulvestrant|mesh-list
25863129|NCT00093002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25863130|NCT00093002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208340|NCT02643303|Durvalumab|durvalumab|mesh-list
25863131|NCT00093002|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25863132|NCT00093002|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25863133|NCT00093002|Hormone Antagonists|hormone antagonists|mesh-ancestor
24460470|NCT00348452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24460471|NCT00348452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25863134|NCT00093002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25863135|NCT00093002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863136|NCT00093028|Bortezomib|bortezomib|mesh-list
25863137|NCT00093028|Lenalidomide|lenalidomide|mesh-list
25863138|NCT00093028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863139|NCT00093028|Immunologic Factors|immunologic factors|mesh-ancestor
25863140|NCT00093028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863141|NCT00093028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25863142|NCT00093028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25863143|NCT00093028|Growth Substances|growth substances|mesh-ancestor
25863144|NCT00093028|Growth Inhibitors|growth inhibitors|mesh-ancestor
25863145|NCT00093067|Daptomycin|daptomycin|mesh-list
25863146|NCT00093067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25863147|NCT00093067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25863148|NCT00093093|Interferons|interferons|mesh-list
25863149|NCT00093093|Ribavirin|ribavirin|mesh-list
25863150|NCT00093093|Interferon-alpha|interferon-alpha|mesh-list
25863151|NCT00093093|Interferon alpha-2|interferon alpha-2|mesh-list
25863152|NCT00093093|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25863153|NCT00093093|Taribavirin|taribavirin|mesh-list
25863154|NCT00093093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863155|NCT00093093|Antiviral Agents|antiviral agents|mesh-ancestor
25863156|NCT00093093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25863157|NCT00093093|Antimetabolites|antimetabolites|mesh-ancestor
25863158|NCT00093093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863159|NCT00093093|Immunologic Factors|immunologic factors|mesh-ancestor
25863160|NCT00093093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863161|NCT00093119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25863162|NCT00093119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863163|NCT00093158|Anticoagulants|anticoagulants|mesh-list
25863164|NCT00093158|Bivalirudin|bivalirudin|mesh-list
25863165|NCT00093158|Antithrombins|antithrombins|mesh-ancestor
25863166|NCT00093158|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25863167|NCT00093158|Protease Inhibitors|protease inhibitors|mesh-ancestor
25863168|NCT00093158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443082|NCT00293631|Analgesics|analgesics|mesh-ancestor
24443083|NCT00293631|Sensory System Agents|sensory system agents|mesh-ancestor
24443084|NCT00293631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24443085|NCT00293631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443086|NCT00293631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24443088|NCT00293631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24443089|NCT00293631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443090|NCT00293631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443091|NCT00293644|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
24443092|NCT00293644|Antiemetics|antiemetics|mesh-ancestor
24443093|NCT00293644|Autonomic Agents|autonomic agents|mesh-ancestor
24443094|NCT00293644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24443095|NCT00293644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443096|NCT00293644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24443097|NCT00293644|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24626114|NCT01085617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24626115|NCT01085617|Tubulin Modulators|tubulin modulators|mesh-ancestor
24626116|NCT01085617|Antimitotic Agents|antimitotic agents|mesh-ancestor
25863169|NCT00093158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460474|NCT00348452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460475|NCT00348452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863170|NCT00093184|Anticoagulants|anticoagulants|mesh-list
25863171|NCT00093184|Bivalirudin|bivalirudin|mesh-list
25863172|NCT00093184|Antithrombins|antithrombins|mesh-ancestor
25863175|NCT00093184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863176|NCT00093184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876499|NCT03399838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25876500|NCT03399838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25876501|NCT03399838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25208341|NCT02643303|Tremelimumab|tremelimumab|mesh-list
25876502|NCT03399838|Adrenergic Agents|adrenergic agents|mesh-ancestor
25876503|NCT03399838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25876504|NCT03399838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876505|NCT03399838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25876506|NCT03399838|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25876507|NCT03399838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25876508|NCT03399838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25876509|NCT03399838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25876510|NCT03399838|Anesthetics, General|anesthetics, general|mesh-ancestor
25876511|NCT03399838|Anesthetics|anesthetics|mesh-ancestor
25876512|NCT03399838|GABA Modulators|gaba modulators|mesh-ancestor
25876513|NCT03399838|GABA Agents|gaba agents|mesh-ancestor
25876514|NCT03346135|Melphalan|melphalan|mesh-list
25876515|NCT03346135|Mechlorethamine|mechlorethamine|mesh-list
25876516|NCT03346135|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25876517|NCT03346135|Daratumumab|daratumumab|mesh-list
25876518|NCT03346135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25876519|NCT03346135|Alkylating Agents|alkylating agents|mesh-ancestor
25876520|NCT03346135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876521|NCT03346135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876522|NCT03346135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25876523|NCT03346135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25876524|NCT03346135|Immunologic Factors|immunologic factors|mesh-ancestor
25876525|NCT03346135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876526|NCT03334617|Trastuzumab|trastuzumab|mesh-list
25876527|NCT03334617|Durvalumab|durvalumab|mesh-list
25876528|NCT03334617|Olaparib|olaparib|mesh-list
25876529|NCT03334617|Cediranib|cediranib|mesh-list
25876530|NCT03334617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25876531|NCT03334617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876532|NCT03334617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25876533|NCT03334617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876534|NCT03334617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876535|NCT03334617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25876536|NCT03289962|Atezolizumab|atezolizumab|mesh-list
25876537|NCT03289962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876538|NCT03281369|Leucovorin|leucovorin|mesh-list
25876539|NCT03281369|Linagliptin|linagliptin|mesh-list
25876540|NCT03281369|Fluorouracil|fluorouracil|mesh-list
25876541|NCT03281369|Oxaliplatin|oxaliplatin|mesh-list
25876542|NCT03281369|Atezolizumab|atezolizumab|mesh-list
25876543|NCT03281369|Ramucirumab|ramucirumab|mesh-list
25876544|NCT03281369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25876545|NCT03281369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876546|NCT03281369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876547|NCT03281369|Antimetabolites|antimetabolites|mesh-ancestor
25876548|NCT03281369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25876549|NCT03281369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24626122|NCT01085656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626123|NCT01085656|Tubulin Modulators|tubulin modulators|mesh-ancestor
24626124|NCT01085656|Antimitotic Agents|antimitotic agents|mesh-ancestor
24641360|NCT01173003|Oxytocics|oxytocics|mesh-ancestor
24626125|NCT01085656|Mitosis Modulators|mitosis modulators|mesh-ancestor
25876550|NCT03281369|Immunologic Factors|immunologic factors|mesh-ancestor
24460479|NCT00348491|Lumiracoxib|lumiracoxib|mesh-list
25876551|NCT03281369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876552|NCT03281369|Antidotes|antidotes|mesh-ancestor
24443558|NCT00295425|Mycophenolic Acid|mycophenolic acid|mesh-list
25668935|NCT01724021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25668936|NCT01724021|Glucocorticoids|glucocorticoids|mesh-ancestor
25668937|NCT01724021|Hormones|hormones|mesh-ancestor
25668938|NCT01724021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25668939|NCT01724021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25668940|NCT01724021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25668941|NCT01724021|Tubulin Modulators|tubulin modulators|mesh-ancestor
25668942|NCT01724021|Antimitotic Agents|antimitotic agents|mesh-ancestor
25668943|NCT01724021|Mitosis Modulators|mitosis modulators|mesh-ancestor
25863178|NCT00093223|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25863179|NCT00093223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25863180|NCT00093223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863181|NCT00093223|Tubulin Modulators|tubulin modulators|mesh-ancestor
25863182|NCT00093223|Antimitotic Agents|antimitotic agents|mesh-ancestor
25863183|NCT00093223|Mitosis Modulators|mitosis modulators|mesh-ancestor
25863184|NCT00093223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863185|NCT00093249|Clevidipine|clevidipine|mesh-list
25863186|NCT00093249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25863187|NCT00093249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25863188|NCT00093249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863189|NCT00093249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25863190|NCT00093249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863191|NCT00093262|Clevidipine|clevidipine|mesh-list
25863192|NCT00093262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24626131|NCT01085695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25200007|NCT02737150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863193|NCT00093262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25863194|NCT00093262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863195|NCT00093262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25863196|NCT00093262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863197|NCT00093288|Bupropion|bupropion|mesh-list
25863198|NCT00093288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25863199|NCT00093288|Antidepressive Agents|antidepressive agents|mesh-ancestor
25863200|NCT00093288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25863201|NCT00093288|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25863202|NCT00093288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25863203|NCT00093288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25863204|NCT00093288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863205|NCT00093288|Dopamine Agents|dopamine agents|mesh-ancestor
25863206|NCT00093288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25863207|NCT00093288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863208|NCT00093288|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25863209|NCT00093288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24443210|NCT00294008|Risperidone|risperidone|mesh-list
25863210|NCT00093288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863211|NCT00093301|Simendan|simendan|mesh-list
25863212|NCT00093301|Dobutamine|dobutamine|mesh-list
25863213|NCT00093301|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25863214|NCT00093301|Vasodilator Agents|vasodilator agents|mesh-ancestor
25863215|NCT00093301|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25863216|NCT00093301|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25863217|NCT00093301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863218|NCT00093301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443240|NCT00294164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863219|NCT00093301|Protective Agents|protective agents|mesh-ancestor
24460488|NCT00348491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24438186|NCT00275106|Alkylating Agents|alkylating agents|mesh-ancestor
24438187|NCT00275106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438188|NCT00275106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460494|NCT00348504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24626144|NCT01085721|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
24626145|NCT01085721|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
24626146|NCT01085721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24626147|NCT01085721|Autonomic Agents|autonomic agents|mesh-ancestor
25200011|NCT02737059|Narcotics|narcotics|mesh-ancestor
25200012|NCT02737059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25668944|NCT01724021|Antiemetics|antiemetics|mesh-ancestor
25668945|NCT01724021|Autonomic Agents|autonomic agents|mesh-ancestor
25668946|NCT01724021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25668947|NCT01724021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25668948|NCT01724021|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25668949|NCT01724021|Protective Agents|protective agents|mesh-ancestor
25668950|NCT01724021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25668951|NCT01724021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25668952|NCT01724021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25668953|NCT01724021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25668954|NCT01724177|Lenalidomide|lenalidomide|mesh-list
25668955|NCT01724177|Immunologic Factors|immunologic factors|mesh-ancestor
25200015|NCT02737059|Sensory System Agents|sensory system agents|mesh-ancestor
25200016|NCT02737059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25200017|NCT02737059|Antitussive Agents|antitussive agents|mesh-ancestor
25200018|NCT02737059|Respiratory System Agents|respiratory system agents|mesh-ancestor
25863220|NCT00093301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863221|NCT00093301|Sympathomimetics|sympathomimetics|mesh-ancestor
25863222|NCT00093301|Autonomic Agents|autonomic agents|mesh-ancestor
25863223|NCT00093301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25863224|NCT00093301|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25863225|NCT00093301|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25863226|NCT00093301|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24461138|NCT00351130|Amlodipine|amlodipine|mesh-list
25863227|NCT00093301|Adrenergic Agents|adrenergic agents|mesh-ancestor
25863228|NCT00093301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25863229|NCT00093314|Ofatumumab|ofatumumab|mesh-list
25863230|NCT00093314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863231|NCT00093353|Cefixime|cefixime|mesh-list
25863232|NCT00093353|Irinotecan|irinotecan|mesh-list
24460497|NCT00348504|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24460498|NCT00348504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24790701|NCT01944436|Galantamine|galantamine|mesh-list
24947666|NCT03927248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25051510|NCT00401011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25051511|NCT00401011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25051513|NCT00398879|Capecitabine|capecitabine|mesh-list
25863233|NCT00093353|Temozolomide|temozolomide|mesh-list
25200019|NCT02737059|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25863234|NCT00093353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25863235|NCT00093353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25863236|NCT00093353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863237|NCT00093353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863238|NCT00093353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863239|NCT00093353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25863240|NCT00093353|Alkylating Agents|alkylating agents|mesh-ancestor
25863241|NCT00093353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25863242|NCT00093353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25863243|NCT00093366|Etanercept|etanercept|mesh-list
25863244|NCT00093366|Arsenic Trioxide|arsenic trioxide|mesh-list
25863245|NCT00093366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25863246|NCT00093366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25863247|NCT00093366|Analgesics|analgesics|mesh-ancestor
24460511|NCT00348517|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25863248|NCT00093366|Sensory System Agents|sensory system agents|mesh-ancestor
25863249|NCT00093366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25863250|NCT00093366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863251|NCT00093366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25863252|NCT00093366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25863253|NCT00093366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25863254|NCT00093366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24443459|NCT00294996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443462|NCT00295035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24443463|NCT00295035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24443464|NCT00295035|Analgesics|analgesics|mesh-ancestor
24443465|NCT00295035|Sensory System Agents|sensory system agents|mesh-ancestor
24443466|NCT00295035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24443467|NCT00295035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443468|NCT00295035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24443469|NCT00295035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25863255|NCT00093366|Immunologic Factors|immunologic factors|mesh-ancestor
24523905|NCT05338658|Pembrolizumab|pembrolizumab|mesh-list
25863256|NCT00093366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25668956|NCT01724177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668957|NCT01724177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25668958|NCT01724177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25668959|NCT01724177|Growth Substances|growth substances|mesh-ancestor
25668960|NCT01724177|Growth Inhibitors|growth inhibitors|mesh-ancestor
25668961|NCT01724177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25668962|NCT01724359|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25668963|NCT01724359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25668964|NCT01724359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24832950|NCT02172443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25863258|NCT00093418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863259|NCT00093444|Doxorubicin|doxorubicin|mesh-list
24460756|NCT00349427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24460757|NCT00349427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200020|NCT02736760|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
24460759|NCT00349440|Cyclosporins|cyclosporins|mesh-list
24460760|NCT00349440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460761|NCT00349440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460762|NCT00349440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24460763|NCT00349440|Immunologic Factors|immunologic factors|mesh-ancestor
25863260|NCT00093444|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25863261|NCT00093444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24873602|NCT05118776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863262|NCT00093444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863263|NCT00093444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25863264|NCT00093444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25863265|NCT00093444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863266|NCT00093444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863267|NCT00093457|Sorafenib|sorafenib|mesh-list
25863268|NCT00093457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863269|NCT00093457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25863270|NCT00093457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460765|NCT00349440|Antifungal Agents|antifungal agents|mesh-ancestor
24461058|NCT00350857|Anticonvulsants|anticonvulsants|mesh-ancestor
24460767|NCT00349440|Dermatologic Agents|dermatologic agents|mesh-ancestor
25863271|NCT00093457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863272|NCT00093483|Cytarabine|cytarabine|mesh-list
25051527|NCT00397254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25863273|NCT00093483|Idarubicin|idarubicin|mesh-list
25863274|NCT00093483|Arsenic Trioxide|arsenic trioxide|mesh-list
25863275|NCT00093483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25863276|NCT00093483|Antimetabolites|antimetabolites|mesh-ancestor
25863277|NCT00093483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863278|NCT00093483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863279|NCT00093483|Antiviral Agents|antiviral agents|mesh-ancestor
25863280|NCT00093483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25863281|NCT00093483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25863282|NCT00093483|Immunologic Factors|immunologic factors|mesh-ancestor
25863283|NCT00093483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863284|NCT00093483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25863285|NCT00093483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25863286|NCT00093483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25863287|NCT00093483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460820|NCT00349583|Antifungal Agents|antifungal agents|mesh-ancestor
24460821|NCT00349583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24427808|NCT00239044|Antitubercular Agents|antitubercular agents|mesh-ancestor
24460822|NCT00349583|Dermatologic Agents|dermatologic agents|mesh-ancestor
24460823|NCT00349583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25863288|NCT00093509|Doxorubicin|doxorubicin|mesh-list
25863289|NCT00093509|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25863290|NCT00093509|Ifosfamide|ifosfamide|mesh-list
25863291|NCT00093509|Isophosphamide mustard|isophosphamide mustard|mesh-list
25863292|NCT00093509|Mesna|mesna|mesh-list
25863293|NCT00093509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25863294|NCT00093509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863295|NCT00093509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25142858|NCT02946359|Growth Substances|growth substances|mesh-ancestor
25668965|NCT01724359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25051536|NCT00396357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25668966|NCT01724359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668967|NCT01724359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25668968|NCT01724359|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25668969|NCT01724359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25668970|NCT01724359|Serotonin Agents|serotonin agents|mesh-ancestor
25668971|NCT01724359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25668972|NCT01724359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25668973|NCT01724359|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25668974|NCT01724359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25668975|NCT01724359|Dopamine Agents|dopamine agents|mesh-ancestor
25674440|NCT01772147|Respiratory System Agents|respiratory system agents|mesh-ancestor
25674441|NCT01772147|Dermatologic Agents|dermatologic agents|mesh-ancestor
25674442|NCT01772147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25674443|NCT01772147|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25051540|NCT00394563|Sensory System Agents|sensory system agents|mesh-ancestor
25051541|NCT00394563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25051542|NCT00394563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863297|NCT00093509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863298|NCT00093509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863299|NCT00093509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25863300|NCT00093509|Alkylating Agents|alkylating agents|mesh-ancestor
24460884|NCT00350038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24460939|NCT00350181|Etoposide|etoposide|mesh-list
24460940|NCT00350181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24460941|NCT00350181|Immunologic Factors|immunologic factors|mesh-ancestor
24460942|NCT00350181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863301|NCT00093509|Protective Agents|protective agents|mesh-ancestor
25863302|NCT00093509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863303|NCT00093522|Fludarabine|fludarabine|mesh-list
25863304|NCT00093522|Fludarabine phosphate|fludarabine phosphate|mesh-list
25863305|NCT00093522|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
25863306|NCT00093522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863307|NCT00093522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25863308|NCT00093522|Antimetabolites|antimetabolites|mesh-ancestor
25863309|NCT00093522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863310|NCT00093522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25863311|NCT00093522|Immunologic Factors|immunologic factors|mesh-ancestor
25863312|NCT00093522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790784|NCT01945268|Vaccines|vaccines|mesh-list
24460954|NCT00350181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24460955|NCT00350181|Antitubercular Agents|antitubercular agents|mesh-ancestor
24460956|NCT00350181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24460957|NCT00350181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24460958|NCT00350181|Antifungal Agents|antifungal agents|mesh-ancestor
24460960|NCT00350311|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24460961|NCT00350311|Autonomic Agents|autonomic agents|mesh-ancestor
24460972|NCT00350415|Analgesics|analgesics|mesh-ancestor
24460973|NCT00350415|Sensory System Agents|sensory system agents|mesh-ancestor
24460974|NCT00350415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25863313|NCT00093522|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25863314|NCT00093548|Vaccines|vaccines|mesh-list
25863315|NCT00093548|Sargramostim|sargramostim|mesh-list
25863316|NCT00093548|Immunologic Factors|immunologic factors|mesh-ancestor
25863317|NCT00093548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863318|NCT00093561|Lycopene|lycopene|mesh-list
25863319|NCT00093561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24460975|NCT00350415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460977|NCT00350415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24460978|NCT00350441|Sildenafil Citrate|sildenafil citrate|mesh-list
24460979|NCT00350441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051564|NCT00394121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25051565|NCT00394121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25051566|NCT00394121|Autonomic Agents|autonomic agents|mesh-ancestor
24963354|NCT03791762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963355|NCT03791723|Valsartan|valsartan|mesh-list
25863320|NCT00093561|Antioxidants|antioxidants|mesh-ancestor
25142938|NCT02946060|TEMPO|tempo|mesh-list
25863321|NCT00093561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863322|NCT00093561|Protective Agents|protective agents|mesh-ancestor
25863323|NCT00093561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863324|NCT00093561|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25863325|NCT00093561|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25668977|NCT01724489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25668978|NCT01724489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668979|NCT01724528|Allopurinol|allopurinol|mesh-list
25668980|NCT01724528|Febuxostat|febuxostat|mesh-list
25668981|NCT01724528|Antimetabolites|antimetabolites|mesh-ancestor
25668982|NCT01724528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088523|NCT03854370|Chlorhexidine|chlorhexidine|mesh-list
25088524|NCT03854370|Povidone-Iodine|povidone-iodine|mesh-list
25863326|NCT00093561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863327|NCT00093587|Cyclosporine|cyclosporine|mesh-list
25088526|NCT03854370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25863328|NCT00093587|Cyclophosphamide|cyclophosphamide|mesh-list
25668983|NCT01724528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863329|NCT00093587|Busulfan|busulfan|mesh-list
25088527|NCT03854370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25088528|NCT03854370|Disinfectants|disinfectants|mesh-ancestor
25863330|NCT00093587|Cyclosporins|cyclosporins|mesh-list
25863331|NCT00093587|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25863332|NCT00093587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25863333|NCT00093587|Immunologic Factors|immunologic factors|mesh-ancestor
25863334|NCT00093587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863335|NCT00093587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25863336|NCT00093587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25863337|NCT00093587|Alkylating Agents|alkylating agents|mesh-ancestor
25863338|NCT00093587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863339|NCT00093587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863340|NCT00093587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25863341|NCT00093587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461059|NCT00350857|Antimanic Agents|antimanic agents|mesh-ancestor
25863342|NCT00093587|Antifungal Agents|antifungal agents|mesh-ancestor
25863343|NCT00093587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25863344|NCT00093587|Dermatologic Agents|dermatologic agents|mesh-ancestor
25863345|NCT00093587|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25863346|NCT00093600|Cytarabine|cytarabine|mesh-list
25863347|NCT00093600|Daunorubicin|daunorubicin|mesh-list
25863348|NCT00093600|Midostaurin|midostaurin|mesh-list
25863349|NCT00093600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25863350|NCT00093600|Antimetabolites|antimetabolites|mesh-ancestor
25863351|NCT00093600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863352|NCT00093600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863353|NCT00093600|Antiviral Agents|antiviral agents|mesh-ancestor
25863354|NCT00093600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24963358|NCT03791723|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24873759|NCT05033756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24963359|NCT03791723|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24963360|NCT03791723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863355|NCT00093600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25863356|NCT00093600|Immunologic Factors|immunologic factors|mesh-ancestor
25863357|NCT00093600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863358|NCT00093600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25863359|NCT00093600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25863360|NCT00093600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24443599|NCT00295542|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24443600|NCT00295542|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24443601|NCT00295542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443602|NCT00295542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24443603|NCT00295542|Adrenergic Agents|adrenergic agents|mesh-ancestor
24443604|NCT00295542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24443605|NCT00295542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863361|NCT00093600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863362|NCT00093600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25863363|NCT00093613|Sorafenib|sorafenib|mesh-list
24461006|NCT00350467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24461007|NCT00350467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24461008|NCT00350467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461009|NCT00350467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25863364|NCT00093613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863365|NCT00093613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25863366|NCT00093613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863367|NCT00093613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863368|NCT00093626|Sorafenib|sorafenib|mesh-list
24461017|NCT00350480|Contraceptives, Oral|contraceptives, oral|mesh-list
25668984|NCT01724528|Gout Suppressants|gout suppressants|mesh-ancestor
25668985|NCT01724528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25668986|NCT01724528|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25668987|NCT01724528|Antioxidants|antioxidants|mesh-ancestor
25668988|NCT01724528|Protective Agents|protective agents|mesh-ancestor
25668989|NCT01724528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668990|NCT01725126|Metformin|metformin|mesh-list
25668991|NCT01725126|Liraglutide|liraglutide|mesh-list
25863369|NCT00093626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461020|NCT00350480|Contraceptive Agents|contraceptive agents|mesh-ancestor
24461021|NCT00350480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24963361|NCT03791515|Calcitonin|calcitonin|mesh-list
25863370|NCT00093626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25863371|NCT00093626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863372|NCT00093626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863373|NCT00093639|Everolimus|everolimus|mesh-list
25863374|NCT00093639|Imatinib Mesylate|imatinib mesylate|mesh-list
24461033|NCT00350662|Deferoxamine|deferoxamine|mesh-list
24461046|NCT00350753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461047|NCT00350753|Growth Inhibitors|growth inhibitors|mesh-ancestor
24461048|NCT00350753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24461049|NCT00350753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461050|NCT00350753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461051|NCT00350818|Azacitidine|azacitidine|mesh-list
24461052|NCT00350818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24461053|NCT00350818|Antimetabolites|antimetabolites|mesh-ancestor
24461054|NCT00350818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461055|NCT00350818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461056|NCT00350818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461057|NCT00350857|Carbamazepine|carbamazepine|mesh-list
25863375|NCT00093639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863376|NCT00093639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25863377|NCT00093639|Immunologic Factors|immunologic factors|mesh-ancestor
25863378|NCT00093639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863379|NCT00093639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25863380|NCT00093639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863381|NCT00093639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863382|NCT00093652|Oxaliplatin|oxaliplatin|mesh-list
25863383|NCT00093652|Gefitinib|gefitinib|mesh-list
25863384|NCT00093652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863385|NCT00093652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25863386|NCT00093652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863387|NCT00093652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863388|NCT00093665|Cisplatin|cisplatin|mesh-list
25863389|NCT00093665|Fluorouracil|fluorouracil|mesh-list
25863390|NCT00093665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863391|NCT00093665|Antimetabolites|antimetabolites|mesh-ancestor
25863392|NCT00093665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863393|NCT00093665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25863394|NCT00093665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25863395|NCT00093665|Immunologic Factors|immunologic factors|mesh-ancestor
24551533|NCT05373264|Diuretics|diuretics|mesh-ancestor
25863396|NCT00093665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863397|NCT00093678|Celecoxib|celecoxib|mesh-list
25863398|NCT00093678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25863399|NCT00093678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25863400|NCT00093678|Analgesics|analgesics|mesh-ancestor
24551625|NCT05292001|Dextrans|dextrans|mesh-list
25863401|NCT00093678|Sensory System Agents|sensory system agents|mesh-ancestor
25863402|NCT00093678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24947667|NCT03927248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863403|NCT00093678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863404|NCT00093678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25863405|NCT00093678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25863406|NCT00093678|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25863407|NCT00093678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25863408|NCT00093678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863409|NCT00093678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863410|NCT00093704|Ganciclovir|ganciclovir|mesh-list
25668992|NCT01725126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25668993|NCT01725126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25668994|NCT01725126|Incretins|incretins|mesh-ancestor
25668995|NCT01725126|Hormones|hormones|mesh-ancestor
25668996|NCT01725126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25668997|NCT01725282|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25668998|NCT01725282|Antidepressive Agents|antidepressive agents|mesh-ancestor
25668999|NCT01725282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25863411|NCT00093704|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25863412|NCT00093704|Bortezomib|bortezomib|mesh-list
25863413|NCT00093704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863414|NCT00093704|Antiviral Agents|antiviral agents|mesh-ancestor
24461120|NCT00351091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24461121|NCT00351091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24461122|NCT00351091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461123|NCT00351091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24461124|NCT00351091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461125|NCT00351091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24461126|NCT00351104|Ketoprofen|ketoprofen|mesh-list
24461127|NCT00351104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24461128|NCT00351104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24461129|NCT00351104|Analgesics|analgesics|mesh-ancestor
24461130|NCT00351104|Sensory System Agents|sensory system agents|mesh-ancestor
24461131|NCT00351104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24461132|NCT00351104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863415|NCT00093704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25863416|NCT00093704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25863417|NCT00093704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863418|NCT00093704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863419|NCT00093743|Cyclosporine|cyclosporine|mesh-list
25863420|NCT00093743|Mycophenolic Acid|mycophenolic acid|mesh-list
25863421|NCT00093743|Fludarabine|fludarabine|mesh-list
25863422|NCT00093743|Fludarabine phosphate|fludarabine phosphate|mesh-list
25863423|NCT00093743|Cyclosporins|cyclosporins|mesh-list
25863424|NCT00093743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863425|NCT00093743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25863426|NCT00093743|Antimetabolites|antimetabolites|mesh-ancestor
25863427|NCT00093743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863428|NCT00093743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25863429|NCT00093743|Immunologic Factors|immunologic factors|mesh-ancestor
25863430|NCT00093743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863431|NCT00093743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863432|NCT00093743|Antifungal Agents|antifungal agents|mesh-ancestor
25863433|NCT00093743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25863434|NCT00093743|Dermatologic Agents|dermatologic agents|mesh-ancestor
25863435|NCT00093743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25863436|NCT00093743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25863437|NCT00093743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25863438|NCT00093743|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25863439|NCT00093743|Antitubercular Agents|antitubercular agents|mesh-ancestor
24947680|NCT03926780|Antithrombins|antithrombins|mesh-ancestor
24947681|NCT03926780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24947682|NCT03926780|Protease Inhibitors|protease inhibitors|mesh-ancestor
25863440|NCT00093743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25863441|NCT00093769|Rituximab|rituximab|mesh-list
25863442|NCT00093769|Bortezomib|bortezomib|mesh-list
25863443|NCT00093769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25863444|NCT00093769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863445|NCT00093769|Immunologic Factors|immunologic factors|mesh-ancestor
25863446|NCT00093769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863447|NCT00093769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25863448|NCT00093834|Cyclophosphamide|cyclophosphamide|mesh-list
25863449|NCT00093834|Doxorubicin|doxorubicin|mesh-list
25863450|NCT00093834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25863451|NCT00093834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25863452|NCT00093834|Immunologic Factors|immunologic factors|mesh-ancestor
25863453|NCT00093834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863454|NCT00093834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24461179|NCT00351169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24461180|NCT00351169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24461181|NCT00351169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24461182|NCT00351182|Doxycycline|doxycycline|mesh-list
24461183|NCT00351182|Telithromycin|telithromycin|mesh-list
24552033|NCT04250883|Trace Elements|trace elements|mesh-ancestor
25863455|NCT00093834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25863456|NCT00093834|Alkylating Agents|alkylating agents|mesh-ancestor
25863457|NCT00093834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863458|NCT00093834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200024|NCT02736604|Anesthetics|anesthetics|mesh-list
25863459|NCT00093834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25863460|NCT00093834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25863461|NCT00093834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25669000|NCT01725282|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25669001|NCT01725282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24526256|NCT00290511|Vidarabine|vidarabine|mesh-list
25863462|NCT00093834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24947683|NCT03926780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24947692|NCT03926962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25863463|NCT00093834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863464|NCT00093860|Propranolol|propranolol|mesh-list
24461201|NCT00351286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24461202|NCT00351286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24461203|NCT00351286|Antimetabolites|antimetabolites|mesh-ancestor
24461204|NCT00351286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461205|NCT00351286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24440807|NCT00284791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24461411|NCT00352261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24947694|NCT03926962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947696|NCT03926936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24461251|NCT00351637|Sensory System Agents|sensory system agents|mesh-ancestor
24461252|NCT00351637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24461267|NCT00351702|Antimetabolites|antimetabolites|mesh-ancestor
24461268|NCT00351702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461269|NCT00351702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24461270|NCT00351715|Methadone|methadone|mesh-list
25863465|NCT00093860|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25863466|NCT00093860|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25863467|NCT00093860|Adrenergic Agents|adrenergic agents|mesh-ancestor
25863468|NCT00093860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25863469|NCT00093860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863470|NCT00093860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863471|NCT00093860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25863472|NCT00093860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25863473|NCT00093860|Vasodilator Agents|vasodilator agents|mesh-ancestor
25863474|NCT00093873|Motesanib diphosphate|motesanib diphosphate|mesh-list
25863475|NCT00093873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25863476|NCT00093873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863477|NCT00093873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863478|NCT00093886|Clevidipine|clevidipine|mesh-list
25863479|NCT00093886|Nitroglycerin|nitroglycerin|mesh-list
25863480|NCT00093886|Vasodilator Agents|vasodilator agents|mesh-ancestor
25863481|NCT00093886|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25863482|NCT00093886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25863483|NCT00093886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863484|NCT00093886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25863485|NCT00093886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863486|NCT00093912|Nitroprusside|nitroprusside|mesh-list
25863487|NCT00093912|Clevidipine|clevidipine|mesh-list
25863488|NCT00093912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25863489|NCT00093912|Vasodilator Agents|vasodilator agents|mesh-ancestor
25863490|NCT00093912|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25863491|NCT00093912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863492|NCT00093912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25863493|NCT00093912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25863494|NCT00093912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25200025|NCT02736604|Sevoflurane|sevoflurane|mesh-list
24461283|NCT00351832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24461284|NCT00351832|Protease Inhibitors|protease inhibitors|mesh-ancestor
24461285|NCT00351832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461286|NCT00351832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461288|NCT00351871|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24461289|NCT00351871|Antimetabolites|antimetabolites|mesh-ancestor
24552171|NCT04120636|Celecoxib|celecoxib|mesh-list
24461320|NCT00351910|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25863495|NCT00093912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863496|NCT00093925|Nicardipine|nicardipine|mesh-list
25863497|NCT00093925|Clevidipine|clevidipine|mesh-list
25863498|NCT00093925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25863499|NCT00093925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25876553|NCT03281369|Protective Agents|protective agents|mesh-ancestor
25669002|NCT01725282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25669003|NCT01725282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669004|NCT01725308|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25669005|NCT01725308|Antidepressive Agents|antidepressive agents|mesh-ancestor
25669006|NCT01725308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25669007|NCT01725308|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25088710|NCT03272477|Letrozole|letrozole|mesh-list
25088711|NCT03272477|Epirubicin|epirubicin|mesh-list
25088712|NCT03272477|Anastrozole|anastrozole|mesh-list
25088713|NCT03272477|Pertuzumab|pertuzumab|mesh-list
25088714|NCT03272477|Exemestane|exemestane|mesh-list
25863500|NCT00093925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863501|NCT00093925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25863502|NCT00093925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863503|NCT00093925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24461406|NCT00352235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461407|NCT00352261|Esomeprazole|esomeprazole|mesh-list
24461408|NCT00352261|Lansoprazole|lansoprazole|mesh-list
24461409|NCT00352261|Dexlansoprazole|dexlansoprazole|mesh-list
24461410|NCT00352261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24461412|NCT00352261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24461413|NCT00352261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461414|NCT00352261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461415|NCT00352287|Pioglitazone|pioglitazone|mesh-list
24461416|NCT00352287|Hormones|hormones|mesh-list
24462862|NCT00357708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25863504|NCT00093925|Vasodilator Agents|vasodilator agents|mesh-ancestor
25876554|NCT03281369|Vitamin B Complex|vitamin b complex|mesh-ancestor
24550734|NCT00722033|Tocolytic Agents|tocolytic agents|mesh-ancestor
24550735|NCT00722033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24550736|NCT00722033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24550737|NCT00722033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550738|NCT00722033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550739|NCT00722098|Cyclophosphamide|cyclophosphamide|mesh-list
24550772|NCT00722215|Nifedipine|nifedipine|mesh-list
24550781|NCT00722215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24550782|NCT00722215|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24550798|NCT00722475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550812|NCT00722631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24550813|NCT00722631|Immunologic Factors|immunologic factors|mesh-ancestor
24550814|NCT00722709|Ropivacaine|ropivacaine|mesh-list
24550815|NCT00722709|Anesthetics, Local|anesthetics, local|mesh-ancestor
24550816|NCT00722709|Anesthetics|anesthetics|mesh-ancestor
24550817|NCT00722709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24550818|NCT00722709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550819|NCT00722709|Sensory System Agents|sensory system agents|mesh-ancestor
24550820|NCT00722709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24550821|NCT00722735|Ciprofloxacin|ciprofloxacin|mesh-list
24550822|NCT00722735|Finafloxacin|finafloxacin|mesh-list
24550823|NCT00722735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24550824|NCT00722735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24550825|NCT00722735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24550826|NCT00722735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24550827|NCT00722735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550828|NCT00722735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550829|NCT00722735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550830|NCT00722735|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24550831|NCT00722735|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24550832|NCT00722735|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24550833|NCT00722735|Renal Agents|renal agents|mesh-ancestor
24550834|NCT00722839|Vaccines|vaccines|mesh-list
24550835|NCT00722839|Immunologic Factors|immunologic factors|mesh-ancestor
24550836|NCT00722839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550837|NCT00722852|Ketoprofen|ketoprofen|mesh-list
24550838|NCT00722852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24550839|NCT00722852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24550840|NCT00722852|Analgesics|analgesics|mesh-ancestor
24550841|NCT00722852|Sensory System Agents|sensory system agents|mesh-ancestor
24550851|NCT00722930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550852|NCT00722956|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
24550853|NCT00722956|Atorvastatin|atorvastatin|mesh-list
24947703|NCT03926663|Dexmedetomidine|dexmedetomidine|mesh-list
24947705|NCT03926663|Anesthetics, Local|anesthetics, local|mesh-ancestor
24947706|NCT03926663|Anesthetics|anesthetics|mesh-ancestor
24801799|NCT01985789|Cetirizine|cetirizine|mesh-list
25669008|NCT01725308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25669009|NCT01725308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25669010|NCT01725308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669011|NCT01725386|Capecitabine|capecitabine|mesh-list
25669012|NCT01725386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25669013|NCT01725386|Antimetabolites|antimetabolites|mesh-ancestor
25088799|NCT03272009|Entecavir|entecavir|mesh-list
25088800|NCT03272009|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25088801|NCT03272009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25088802|NCT03272009|Antiviral Agents|antiviral agents|mesh-ancestor
25088803|NCT03272009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25088804|NCT03272009|Immunologic Factors|immunologic factors|mesh-ancestor
25088806|NCT03271879|Empagliflozin|empagliflozin|mesh-list
24550854|NCT00722956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24550855|NCT00722956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24550856|NCT00722956|Antimetabolites|antimetabolites|mesh-ancestor
24550857|NCT00722956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790904|NCT05410314|Inositol|inositol|mesh-list
24550882|NCT00723060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550883|NCT00723060|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24550886|NCT00723086|Docetaxel|docetaxel|mesh-list
24550887|NCT00723086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550888|NCT00723086|Tubulin Modulators|tubulin modulators|mesh-ancestor
24550889|NCT00723086|Antimitotic Agents|antimitotic agents|mesh-ancestor
24550890|NCT00723086|Mitosis Modulators|mitosis modulators|mesh-ancestor
24550891|NCT00723086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550892|NCT00723164|Fentanyl|fentanyl|mesh-list
24550893|NCT00723164|Midazolam|midazolam|mesh-list
24550894|NCT00723164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24550896|NCT00723164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24550897|NCT00723164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550898|NCT00723164|Analgesics|analgesics|mesh-ancestor
24550899|NCT00723164|Sensory System Agents|sensory system agents|mesh-ancestor
24550900|NCT00723164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24550901|NCT00723164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24550902|NCT00723164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24550903|NCT00723164|Anesthetics, General|anesthetics, general|mesh-ancestor
24550904|NCT00723164|Anesthetics|anesthetics|mesh-ancestor
24550905|NCT00723164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24550906|NCT00723164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24550907|NCT00723164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24550908|NCT00723164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24550909|NCT00723164|GABA Modulators|gaba modulators|mesh-ancestor
24550910|NCT00723164|GABA Agents|gaba agents|mesh-ancestor
24550911|NCT00723164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24550925|NCT00723268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24550926|NCT00723268|Glucocorticoids|glucocorticoids|mesh-ancestor
24550927|NCT00723268|Hormones|hormones|mesh-ancestor
24550928|NCT00723268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24550929|NCT00723268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550942|NCT00723320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24550943|NCT00723320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24550944|NCT00723320|Antimetabolites|antimetabolites|mesh-ancestor
24550945|NCT00723320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550946|NCT00723320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24550947|NCT00723320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24550948|NCT00723320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550949|NCT00723346|Asparaginase|asparaginase|mesh-list
24550950|NCT00723346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550951|NCT00723385|Vitamin D|vitamin d|mesh-list
24550953|NCT00723385|Vitamins|vitamins|mesh-ancestor
24550972|NCT00723424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24550973|NCT00723424|Antiviral Agents|antiviral agents|mesh-ancestor
24550974|NCT00723424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24550975|NCT00723437|Acitretin|acitretin|mesh-list
24550976|NCT00723437|Keratolytic Agents|keratolytic agents|mesh-ancestor
25143351|NCT02943356|Tadalafil|tadalafil|mesh-list
24550977|NCT00723437|Dermatologic Agents|dermatologic agents|mesh-ancestor
24550978|NCT00723502|Amoxicillin|amoxicillin|mesh-list
24550979|NCT00723502|Finafloxacin|finafloxacin|mesh-list
24550980|NCT00723502|Fluoroquinolones|fluoroquinolones|mesh-list
24550981|NCT00723502|Esomeprazole|esomeprazole|mesh-list
24550982|NCT00723502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24550983|NCT00723502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24550984|NCT00723502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24550985|NCT00723502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25669014|NCT01725386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669015|NCT01725386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669016|NCT01725451|Testosterone|testosterone|mesh-list
25669017|NCT01725451|Androgens|androgens|mesh-ancestor
25669018|NCT01725451|Hormones|hormones|mesh-ancestor
25669019|NCT01725451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24550986|NCT00723502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24550987|NCT00723502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863506|NCT00093951|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25863507|NCT00093951|Protective Agents|protective agents|mesh-ancestor
25863508|NCT00093951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632021|NCT01121731|Interferons|interferons|mesh-list
24632022|NCT01121731|Interferon alpha-2|interferon alpha-2|mesh-list
24632023|NCT01121731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632024|NCT01121731|Antiviral Agents|antiviral agents|mesh-ancestor
24550988|NCT00723502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550994|NCT00723502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24551009|NCT00723658|Melphalan|melphalan|mesh-list
24551010|NCT00723658|Carmustine|carmustine|mesh-list
24551011|NCT00723658|Rituximab|rituximab|mesh-list
24551012|NCT00723658|Doxorubicin|doxorubicin|mesh-list
24551013|NCT00723658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24551014|NCT00723658|Etoposide|etoposide|mesh-list
24551015|NCT00723658|Bortezomib|bortezomib|mesh-list
24551016|NCT00723658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24461555|NCT00352651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551029|NCT00723658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24551031|NCT00723658|Glucocorticoids|glucocorticoids|mesh-ancestor
24551032|NCT00723658|Hormones|hormones|mesh-ancestor
24551033|NCT00723658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24551034|NCT00723658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24551035|NCT00723658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24551036|NCT00723658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24551037|NCT00723658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24551038|NCT00723658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24551039|NCT00723658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24551040|NCT00723658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24551041|NCT00723658|Antimetabolites|antimetabolites|mesh-ancestor
24551042|NCT00723658|Antiviral Agents|antiviral agents|mesh-ancestor
24551043|NCT00723658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24551044|NCT00723658|Leprostatic Agents|leprostatic agents|mesh-ancestor
24551045|NCT00723658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24947710|NCT03926663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24551063|NCT00723879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551064|NCT00723879|Antiviral Agents|antiviral agents|mesh-ancestor
24551065|NCT00723879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24551066|NCT00723918|Methadone|methadone|mesh-list
24551067|NCT00723918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24551068|NCT00723918|Narcotics|narcotics|mesh-ancestor
24551069|NCT00723918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24551070|NCT00723918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551093|NCT00724022|Tacrolimus|tacrolimus|mesh-list
24551094|NCT00724022|Thymoglobulin|thymoglobulin|mesh-list
24551095|NCT00724022|Basiliximab|basiliximab|mesh-list
24551096|NCT00724022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24551097|NCT00724022|Immunologic Factors|immunologic factors|mesh-ancestor
24551098|NCT00724022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551099|NCT00724022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24551100|NCT00724022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24551101|NCT00724022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551144|NCT00724113|Anesthetics, Local|anesthetics, local|mesh-ancestor
24551145|NCT00724113|Anesthetics|anesthetics|mesh-ancestor
24551146|NCT00724113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24551147|NCT00724113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551148|NCT00724113|Sensory System Agents|sensory system agents|mesh-ancestor
24551149|NCT00724113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24551151|NCT00724113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24551153|NCT00724113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24551154|NCT00724113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551155|NCT00724178|Vitamin D|vitamin d|mesh-list
24551156|NCT00724178|Cholecalciferol|cholecalciferol|mesh-list
24551157|NCT00724178|Calcium Carbonate|calcium carbonate|mesh-list
25669020|NCT01725451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669021|NCT01725529|Ribavirin|ribavirin|mesh-list
25669022|NCT01725529|Simeprevir|simeprevir|mesh-list
25669023|NCT01725529|Antimetabolites|antimetabolites|mesh-ancestor
25669024|NCT01725529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669025|NCT01725529|Antiviral Agents|antiviral agents|mesh-ancestor
25669026|NCT01725529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24551158|NCT00724178|Calcium|calcium|mesh-list
25088835|NCT03271905|Cholinergic Agents|cholinergic agents|mesh-ancestor
25088836|NCT03271749|Anesthetics|anesthetics|mesh-list
24551161|NCT00724178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551162|NCT00724178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25208342|NCT02643303|Poly ICLC|poly iclc|mesh-list
25863510|NCT00093951|GABA Agents|gaba agents|mesh-ancestor
24551163|NCT00724178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24551165|NCT00724178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551166|NCT00724178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24551167|NCT00724230|Ribavirin|ribavirin|mesh-list
24551168|NCT00724230|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24551169|NCT00724230|Interferon-alpha|interferon-alpha|mesh-list
24551170|NCT00724230|Antimetabolites|antimetabolites|mesh-ancestor
24551171|NCT00724230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551172|NCT00724230|Antiviral Agents|antiviral agents|mesh-ancestor
24551173|NCT00724230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24551174|NCT00724230|Immunologic Factors|immunologic factors|mesh-ancestor
24551175|NCT00724230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551287|NCT00725036|Insulin, Isophane|insulin, isophane|mesh-list
24551288|NCT00725036|Isophane insulin, beef|isophane insulin, beef|mesh-list
24551289|NCT00725036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24551290|NCT00725036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551291|NCT00725114|Tetrodotoxin|tetrodotoxin|mesh-list
24551292|NCT00725114|Anesthetics, Local|anesthetics, local|mesh-ancestor
24551293|NCT00725114|Anesthetics|anesthetics|mesh-ancestor
24551294|NCT00725114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24551295|NCT00725114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551296|NCT00725114|Sensory System Agents|sensory system agents|mesh-ancestor
24551297|NCT00725114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24551298|NCT00725114|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24551299|NCT00725114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25863511|NCT00093951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24551300|NCT00725114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551301|NCT00725218|Flurbiprofen|flurbiprofen|mesh-list
24551302|NCT00725218|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
24551325|NCT00725348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24551326|NCT00725348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24947711|NCT03926663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24947712|NCT03926663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24947713|NCT03926663|Analgesics|analgesics|mesh-ancestor
24801805|NCT01985789|Anesthetics, Local|anesthetics, local|mesh-ancestor
24551327|NCT00725348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551392|NCT00726011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24551393|NCT00726011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551395|NCT00726011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24551396|NCT00726011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24551397|NCT00726011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25200026|NCT02736604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25200027|NCT02736604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200028|NCT02736604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25200029|NCT02736604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25200030|NCT02736604|Anesthetics, General|anesthetics, general|mesh-ancestor
25200031|NCT02736604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25200032|NCT02736604|Analgesics|analgesics|mesh-ancestor
25200033|NCT02736604|Sensory System Agents|sensory system agents|mesh-ancestor
25200034|NCT02736604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25200035|NCT02736448|Capecitabine|capecitabine|mesh-list
24551449|NCT00726700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24551450|NCT00726700|Alkylating Agents|alkylating agents|mesh-ancestor
24551451|NCT00726700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551452|NCT00726700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24551453|NCT00726700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24551454|NCT00726700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24551455|NCT00726700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24551456|NCT00726700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24551457|NCT00726700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24551458|NCT00726700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24551459|NCT00726700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24551568|NCT05373004|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24430571|NCT00248261|Serotonin Agents|serotonin agents|mesh-ancestor
24551571|NCT05373004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669027|NCT01725529|Protease Inhibitors|protease inhibitors|mesh-ancestor
25669028|NCT01725529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24551572|NCT05373004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24551595|NCT05366621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551596|NCT05366621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24551597|NCT05366062|Cyclophosphamide|cyclophosphamide|mesh-list
24947714|NCT03926663|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24947715|NCT03926663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24947716|NCT03926663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24551598|NCT05366062|Pembrolizumab|pembrolizumab|mesh-list
24551599|NCT05366062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24551600|NCT05366062|Immunologic Factors|immunologic factors|mesh-ancestor
24551601|NCT05366062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551627|NCT05292001|Anticoagulants|anticoagulants|mesh-ancestor
24551628|NCT05292001|Plasma Substitutes|plasma substitutes|mesh-ancestor
24551629|NCT05292001|Blood Substitutes|blood substitutes|mesh-ancestor
24551630|NCT05292001|Hematinics|hematinics|mesh-ancestor
24790954|NCT05409820|Anesthetics|anesthetics|mesh-list
24551722|NCT05092828|Narcotics|narcotics|mesh-ancestor
24551723|NCT05092828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25200036|NCT02736448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24551724|NCT05092828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551725|NCT05092828|Analgesics|analgesics|mesh-ancestor
24551726|NCT05092828|Sensory System Agents|sensory system agents|mesh-ancestor
24551727|NCT05092828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24551729|NCT05072236|Anesthetics, Local|anesthetics, local|mesh-ancestor
24551730|NCT05072236|Anesthetics|anesthetics|mesh-ancestor
24551731|NCT05072236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24551732|NCT05072236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551733|NCT05072236|Sensory System Agents|sensory system agents|mesh-ancestor
24551817|NCT04956627|Hormone Antagonists|hormone antagonists|mesh-ancestor
24553148|NCT00729768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24551930|NCT04577404|Antioxidants|antioxidants|mesh-ancestor
24551931|NCT04577404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551932|NCT04577404|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24551933|NCT04577404|Protective Agents|protective agents|mesh-ancestor
24947719|NCT03926663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551934|NCT04577404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552130|NCT04163952|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
24552132|NCT04163952|Immunoglobulins|immunoglobulins|mesh-list
24552133|NCT04163952|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24552134|NCT04163952|Immunologic Factors|immunologic factors|mesh-ancestor
24552135|NCT04163952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552136|NCT04163952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552137|NCT04144465|Phenylephrine|phenylephrine|mesh-list
24552138|NCT04144465|Oxymetazoline|oxymetazoline|mesh-list
24552139|NCT04144465|Norepinephrine|norepinephrine|mesh-list
24552140|NCT04144465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24552141|NCT04144465|Mydriatics|mydriatics|mesh-ancestor
24552142|NCT04144465|Autonomic Agents|autonomic agents|mesh-ancestor
24790960|NCT05409339|Mannitol|mannitol|mesh-list
24552207|NCT03958565|Zoledronic Acid|zoledronic acid|mesh-list
24552208|NCT03958565|Denosumab|denosumab|mesh-list
25056297|NCT03513822|GABA Modulators|gaba modulators|mesh-ancestor
24552266|NCT03728478|Dermatologic Agents|dermatologic agents|mesh-ancestor
24552311|NCT03583957|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24552325|NCT03512418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552326|NCT03512418|Antiviral Agents|antiviral agents|mesh-ancestor
24552327|NCT03512418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24552376|NCT03499899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24552377|NCT03499899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552378|NCT03491540|Gentamicins|gentamicins|mesh-list
24552379|NCT03491540|Ornidazole|ornidazole|mesh-list
24552380|NCT03491540|Sennosides|sennosides|mesh-list
24552381|NCT03491540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24552382|NCT03491540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24552383|NCT03491540|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24552384|NCT03491540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24552385|NCT03491540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552386|NCT03491540|Laxatives|laxatives|mesh-ancestor
24552387|NCT03491540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24552432|NCT03149211|Antiviral Agents|antiviral agents|mesh-ancestor
24552433|NCT03149211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24552435|NCT03068624|Cyclophosphamide|cyclophosphamide|mesh-list
24552436|NCT03068624|Ipilimumab|ipilimumab|mesh-list
24552437|NCT03068624|Interleukin-2|interleukin-2|mesh-list
24552438|NCT03068624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24552439|NCT03068624|Immunologic Factors|immunologic factors|mesh-ancestor
24553624|NCT00732420|Topotecan|topotecan|mesh-list
24947762|NCT03926000|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24947763|NCT03926000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24947764|NCT03926000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24947765|NCT03926000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24947766|NCT03925818|Metronidazole|metronidazole|mesh-list
24947768|NCT03925818|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
24947769|NCT03925818|Pantoprazole|pantoprazole|mesh-list
24947771|NCT03925818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24947772|NCT03925818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24947773|NCT03925818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24947774|NCT03925818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24947775|NCT03925818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24947776|NCT03925818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24947777|NCT03925818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24947778|NCT03925818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24552645|NCT01951274|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24947781|NCT03925818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24947782|NCT03925714|Metformin|metformin|mesh-list
24552646|NCT01951274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24552647|NCT01951274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552648|NCT01951274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552649|NCT01487174|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24552749|NCT00727207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24552750|NCT00727207|Immunologic Factors|immunologic factors|mesh-ancestor
24552751|NCT00727207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552753|NCT00727233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552754|NCT00727233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24552755|NCT00727233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24552756|NCT00727233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552757|NCT00727493|Alendronate|alendronate|mesh-list
24552760|NCT00727545|Chelating Agents|chelating agents|mesh-list
24552820|NCT00727935|Sensory System Agents|sensory system agents|mesh-ancestor
24552821|NCT00727935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24552822|NCT00727935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24552823|NCT00727935|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24552824|NCT00727935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24552825|NCT00727935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24552826|NCT00727935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552827|NCT00727948|Aspirin|aspirin|mesh-list
24552828|NCT00727948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25876555|NCT03281369|Vitamins|vitamins|mesh-ancestor
24552829|NCT00727948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24552830|NCT00727948|Analgesics|analgesics|mesh-ancestor
24552831|NCT00727948|Sensory System Agents|sensory system agents|mesh-ancestor
24552832|NCT00727948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24552833|NCT00727948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552835|NCT00727948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24552874|NCT00728000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552875|NCT00728000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24552876|NCT00728013|Atorvastatin|atorvastatin|mesh-list
24552877|NCT00728013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24552878|NCT00728013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24552879|NCT00728013|Antimetabolites|antimetabolites|mesh-ancestor
24552890|NCT00728078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24552891|NCT00728078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24552896|NCT00728156|Clopidogrel|clopidogrel|mesh-list
24552924|NCT00728195|Dopamine Agents|dopamine agents|mesh-ancestor
24552925|NCT00728273|Micronutrients|micronutrients|mesh-list
24552926|NCT00728273|Trace Elements|trace elements|mesh-list
24552927|NCT00728273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552928|NCT00728312|Aripiprazole|aripiprazole|mesh-list
24552929|NCT00728312|Antidepressive Agents|antidepressive agents|mesh-ancestor
24552930|NCT00728312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24552931|NCT00728312|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24552932|NCT00728312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24552933|NCT00728312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25200037|NCT02736448|Antimetabolites|antimetabolites|mesh-ancestor
25143654|NCT02941224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24552934|NCT00728312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552935|NCT00728312|Dopamine Agonists|dopamine agonists|mesh-ancestor
24552936|NCT00728312|Dopamine Agents|dopamine agents|mesh-ancestor
24552937|NCT00728312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24552938|NCT00728312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552939|NCT00728312|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24552940|NCT00728312|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24980701|NCT05017025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24552941|NCT00728312|Serotonin Agents|serotonin agents|mesh-ancestor
24552942|NCT00728312|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24552943|NCT00728312|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24552944|NCT00728312|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24552945|NCT00728312|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24552946|NCT00728520|Azacitidine|azacitidine|mesh-list
24552947|NCT00728520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24552948|NCT00728520|Antimetabolites|antimetabolites|mesh-ancestor
24552949|NCT00728520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552950|NCT00728520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552951|NCT00728520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863512|NCT00093951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863513|NCT00093977|Darbepoetin alfa|darbepoetin alfa|mesh-list
24553068|NCT00729339|Mosapride|mosapride|mesh-list
24553069|NCT00729339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24553070|NCT00729339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24553071|NCT00729339|Serotonin Agents|serotonin agents|mesh-ancestor
24553072|NCT00729339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24553073|NCT00729339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553074|NCT00729339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553075|NCT00729404|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24553076|NCT00729404|Gestodene|gestodene|mesh-list
24553077|NCT00729404|Femovan|femovan|mesh-list
24553078|NCT00729404|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24553079|NCT00729404|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24553080|NCT00729404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24553081|NCT00729404|Contraceptive Agents|contraceptive agents|mesh-ancestor
24553082|NCT00729404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24553083|NCT00729404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553084|NCT00729404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24553085|NCT00729404|Estrogens|estrogens|mesh-ancestor
24553086|NCT00729404|Hormones|hormones|mesh-ancestor
24553096|NCT00729495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24553097|NCT00729495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553101|NCT00729495|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25863514|NCT00093977|Hematinics|hematinics|mesh-ancestor
24553154|NCT00729768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25863515|NCT00093990|Tipifarnib|tipifarnib|mesh-list
25863516|NCT00093990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863517|NCT00094003|Poly I-C|poly i-c|mesh-list
25863518|NCT00094003|Antiviral Agents|antiviral agents|mesh-ancestor
25863519|NCT00094003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25863520|NCT00094003|Interferon Inducers|interferon inducers|mesh-ancestor
24553155|NCT00729768|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24553156|NCT00729768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24553208|NCT00729911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24553209|NCT00729911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553210|NCT00729911|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24947787|NCT03925779|Propofol|propofol|mesh-list
24947788|NCT03925779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24947789|NCT03925779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24947790|NCT03925779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801840|NCT01985841|Tubulin Modulators|tubulin modulators|mesh-ancestor
24553211|NCT00729911|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24553212|NCT00729911|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24553213|NCT00729950|Ipilimumab|ipilimumab|mesh-list
24553214|NCT00729950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24553215|NCT00729950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24553216|NCT00729950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24553217|NCT00729950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553218|NCT00729963|Sibutramine|sibutramine|mesh-list
24553219|NCT00729963|Antidepressive Agents|antidepressive agents|mesh-ancestor
24553220|NCT00729963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25208343|NCT02643303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24553221|NCT00729963|Appetite Depressants|appetite depressants|mesh-ancestor
24553222|NCT00729963|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24553223|NCT00729976|Ibuprofen|ibuprofen|mesh-list
24553224|NCT00729976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24553225|NCT00729976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24553226|NCT00729976|Analgesics|analgesics|mesh-ancestor
24553227|NCT00729976|Sensory System Agents|sensory system agents|mesh-ancestor
25669029|NCT01726023|Metronidazole|metronidazole|mesh-list
25669030|NCT01726023|Meropenem|meropenem|mesh-list
25669031|NCT01726023|Ceftazidime|ceftazidime|mesh-list
25669032|NCT01726023|Avibactam|avibactam|mesh-list
25088936|NCT03269929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24553228|NCT00729976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24553229|NCT00729976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553230|NCT00729976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24553231|NCT00729976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24553232|NCT00729976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24553233|NCT00729976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863521|NCT00094003|Immunologic Factors|immunologic factors|mesh-ancestor
25863522|NCT00094003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553256|NCT00730067|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24553257|NCT00730067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553258|NCT00730067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553259|NCT00730067|Urological Agents|urological agents|mesh-ancestor
24553260|NCT00730093|Vitamin B 12|vitamin b 12|mesh-list
24553261|NCT00730093|Hydroxocobalamin|hydroxocobalamin|mesh-list
24553262|NCT00730093|Vitamins|vitamins|mesh-ancestor
24553263|NCT00730093|Micronutrients|micronutrients|mesh-ancestor
24553264|NCT00730093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553272|NCT00730197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24553273|NCT00730197|Respiratory System Agents|respiratory system agents|mesh-ancestor
24553274|NCT00730197|Tocolytic Agents|tocolytic agents|mesh-ancestor
24553275|NCT00730197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24553276|NCT00730197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24553277|NCT00730197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24553278|NCT00730197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24553279|NCT00730197|Adrenergic Agents|adrenergic agents|mesh-ancestor
24553280|NCT00730197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24553281|NCT00730197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553282|NCT00730210|Parathyroid Hormone|parathyroid hormone|mesh-list
24553283|NCT00730210|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24553284|NCT00730210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553300|NCT00730223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24553301|NCT00730249|Methylphenidate|methylphenidate|mesh-list
24553302|NCT00730249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24947791|NCT03925779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24947792|NCT03925779|Anesthetics, General|anesthetics, general|mesh-ancestor
24947793|NCT03925779|Anesthetics|anesthetics|mesh-ancestor
24947794|NCT03925779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24947795|NCT03925779|Analgesics|analgesics|mesh-ancestor
24947796|NCT03925779|Sensory System Agents|sensory system agents|mesh-ancestor
24553303|NCT00730249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446880|NCT00306410|Vitamins|vitamins|mesh-ancestor
24446881|NCT00306410|Micronutrients|micronutrients|mesh-ancestor
24446882|NCT00306410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24446883|NCT00306462|Magnesium Sulfate|magnesium sulfate|mesh-list
24446884|NCT00306462|Nifedipine|nifedipine|mesh-list
24446885|NCT00306462|Analgesics|analgesics|mesh-ancestor
24553341|NCT00730418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24553342|NCT00730418|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24553343|NCT00730418|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24553344|NCT00730418|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24553345|NCT00730418|Adrenergic Agents|adrenergic agents|mesh-ancestor
24432361|NCT00254618|Mesalamine|mesalamine|mesh-list
24553346|NCT00730418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24553347|NCT00730418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553348|NCT00730418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553349|NCT00730444|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24553350|NCT00730444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24553351|NCT00730444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553352|NCT00730444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553353|NCT00730444|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24553354|NCT00730509|Vitamin B 12|vitamin b 12|mesh-list
24553355|NCT00730509|Hydroxocobalamin|hydroxocobalamin|mesh-list
24553356|NCT00730509|Vitamins|vitamins|mesh-ancestor
24553357|NCT00730509|Micronutrients|micronutrients|mesh-ancestor
24553358|NCT00730509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553359|NCT00730509|Vitamin B Complex|vitamin b complex|mesh-ancestor
24553438|NCT00731276|Irinotecan|irinotecan|mesh-list
24553439|NCT00731276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24947798|NCT03925779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24947799|NCT03925779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24947800|NCT03925779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24947801|NCT03925779|Adrenergic Agents|adrenergic agents|mesh-ancestor
25429419|NCT01523977|Razoxane|razoxane|mesh-list
25863523|NCT00094029|Sunitinib|sunitinib|mesh-list
24947802|NCT03925779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24947803|NCT03925779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947804|NCT03925779|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24553440|NCT00731276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24553441|NCT00731276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553442|NCT00731276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553443|NCT00731276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24553444|NCT00731289|Triamcinolone|triamcinolone|mesh-list
24553445|NCT00731289|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24553446|NCT00731289|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24553447|NCT00731289|Hyaluronic Acid|hyaluronic acid|mesh-list
24553448|NCT00731289|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24553449|NCT00731289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24553450|NCT00731289|Glucocorticoids|glucocorticoids|mesh-ancestor
24553451|NCT00731289|Hormones|hormones|mesh-ancestor
24554323|NCT00735748|Narcotics|narcotics|mesh-ancestor
24553454|NCT00731289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24553455|NCT00731289|Immunologic Factors|immunologic factors|mesh-ancestor
24553460|NCT00731289|Protective Agents|protective agents|mesh-ancestor
24553462|NCT00731302|Meloxicam|meloxicam|mesh-list
24553463|NCT00731302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24553464|NCT00731302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24553465|NCT00731302|Analgesics|analgesics|mesh-ancestor
24553466|NCT00731302|Sensory System Agents|sensory system agents|mesh-ancestor
24553467|NCT00731302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24553468|NCT00731302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553488|NCT00731523|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24553489|NCT00731523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553491|NCT00731523|Immunologic Factors|immunologic factors|mesh-ancestor
24553500|NCT00731575|Prednisolone|prednisolone|mesh-list
24553501|NCT00731575|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24553502|NCT00731575|Methylprednisolone|methylprednisolone|mesh-list
24553503|NCT00731575|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24553504|NCT00731575|Prednisolone acetate|prednisolone acetate|mesh-list
24553505|NCT00731575|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24553506|NCT00731575|Prednisolone phosphate|prednisolone phosphate|mesh-list
24553507|NCT00731575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24553508|NCT00731575|Glucocorticoids|glucocorticoids|mesh-ancestor
24553509|NCT00731575|Hormones|hormones|mesh-ancestor
24553510|NCT00731575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24553511|NCT00731575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553512|NCT00731575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24553513|NCT00731575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24553514|NCT00731575|Antiemetics|antiemetics|mesh-ancestor
24553515|NCT00731575|Autonomic Agents|autonomic agents|mesh-ancestor
25863524|NCT00094029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863525|NCT00094029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24553538|NCT00731861|Tubulin Modulators|tubulin modulators|mesh-ancestor
24553539|NCT00731861|Antimitotic Agents|antimitotic agents|mesh-ancestor
24553540|NCT00731861|Mitosis Modulators|mitosis modulators|mesh-ancestor
24553541|NCT00731861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947807|NCT03925740|Fluorides|fluorides|mesh-list
24947808|NCT03925740|Sodium Fluoride|sodium fluoride|mesh-list
24773110|NCT01837498|Cholinergic Agents|cholinergic agents|mesh-ancestor
24947809|NCT03925740|Cariostatic Agents|cariostatic agents|mesh-ancestor
24947810|NCT03925740|Protective Agents|protective agents|mesh-ancestor
24947811|NCT03925740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947812|NCT03925740|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24947813|NCT03925740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25200038|NCT02736448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553589|NCT00732186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25863526|NCT00094029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24553592|NCT00732186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553593|NCT00732277|Hydrocortisone|hydrocortisone|mesh-list
24553594|NCT00732277|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24820378|NCT02099240|Dermatologic Agents|dermatologic agents|mesh-ancestor
25674444|NCT01772147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25674445|NCT01772147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25674446|NCT01772147|Adrenergic Agents|adrenergic agents|mesh-ancestor
25674447|NCT01772147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25674448|NCT01772147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674449|NCT01772147|Anticonvulsants|anticonvulsants|mesh-ancestor
24553595|NCT00732277|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24553596|NCT00732277|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24553597|NCT00732277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24553598|NCT00732290|Fluoxetine|fluoxetine|mesh-list
24553599|NCT00732290|Clopidogrel|clopidogrel|mesh-list
24553600|NCT00732290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24553601|NCT00732290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24553602|NCT00732290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24553603|NCT00732290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24553604|NCT00732290|Purinergic Agents|purinergic agents|mesh-ancestor
24553605|NCT00732290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24553702|NCT00732537|Gasotransmitters|gasotransmitters|mesh-ancestor
24553703|NCT00732537|Protective Agents|protective agents|mesh-ancestor
25863527|NCT00094029|Growth Substances|growth substances|mesh-ancestor
24553734|NCT00732693|Progesterone|progesterone|mesh-list
24553735|NCT00732693|Estrogens|estrogens|mesh-ancestor
24553736|NCT00732693|Hormones|hormones|mesh-ancestor
24553737|NCT00732693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24553738|NCT00732693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553739|NCT00732693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24553740|NCT00732693|Contraceptive Agents|contraceptive agents|mesh-ancestor
24553741|NCT00732693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24553783|NCT00732888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24555101|NCT00740064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553816|NCT00732927|Anticoagulants|anticoagulants|mesh-ancestor
24553817|NCT00732953|Paclitaxel|paclitaxel|mesh-list
24553818|NCT00732953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24553819|NCT00732953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143936|NCT02939833|Sensory System Agents|sensory system agents|mesh-ancestor
24553821|NCT00732953|Antimitotic Agents|antimitotic agents|mesh-ancestor
24553822|NCT00732953|Mitosis Modulators|mitosis modulators|mesh-ancestor
24553825|NCT00732966|Valsartan|valsartan|mesh-list
24553826|NCT00732966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24553827|NCT00732966|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24553828|NCT00732966|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24553829|NCT00732966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553891|NCT00733239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24553892|NCT00733239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553893|NCT00733239|Antimanic Agents|antimanic agents|mesh-ancestor
24553894|NCT00733239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24553895|NCT00733239|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24553896|NCT00733239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24553897|NCT00733239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24553898|NCT00733239|Vasodilator Agents|vasodilator agents|mesh-ancestor
24553899|NCT00733239|Tocolytic Agents|tocolytic agents|mesh-ancestor
24553900|NCT00733239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24553901|NCT00733239|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24563172|NCT00770497|Pioglitazone|pioglitazone|mesh-list
24553902|NCT00733239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24553903|NCT00733239|Renal Agents|renal agents|mesh-ancestor
24553904|NCT00733239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24553905|NCT00733239|Antitubercular Agents|antitubercular agents|mesh-ancestor
24555416|NCT00741585|Carvedilol|carvedilol|mesh-list
24553921|NCT00733317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24553922|NCT00733317|Autonomic Agents|autonomic agents|mesh-ancestor
24553923|NCT00733317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24553924|NCT00733317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553925|NCT00733317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24553926|NCT00733317|Respiratory System Agents|respiratory system agents|mesh-ancestor
24553927|NCT00733317|Glucocorticoids|glucocorticoids|mesh-ancestor
24553928|NCT00733317|Hormones|hormones|mesh-ancestor
24553929|NCT00733317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24553930|NCT00733434|Alprostadil|alprostadil|mesh-list
24553931|NCT00733434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24553932|NCT00733434|Vasodilator Agents|vasodilator agents|mesh-ancestor
24553933|NCT00733434|Urological Agents|urological agents|mesh-ancestor
24553960|NCT00733538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25669033|NCT01726023|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
25669034|NCT01726023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25669035|NCT01726023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25669036|NCT01726023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25669037|NCT01726023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25669038|NCT01726023|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24553961|NCT00733538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553963|NCT00733564|Propofol|propofol|mesh-list
24553964|NCT00733564|Sevoflurane|sevoflurane|mesh-list
24553965|NCT00733564|Anesthetics, Local|anesthetics, local|mesh-ancestor
24553966|NCT00733564|Anesthetics|anesthetics|mesh-ancestor
24947834|NCT03925662|Antinematodal Agents|antinematodal agents|mesh-ancestor
24947835|NCT03925662|Anthelmintics|anthelmintics|mesh-ancestor
24947836|NCT03925662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24947837|NCT03925662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24947838|NCT03925662|Tubulin Modulators|tubulin modulators|mesh-ancestor
24563246|NCT00770731|Sirolimus|sirolimus|mesh-list
24553979|NCT00733564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24553980|NCT00733564|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24553983|NCT00733616|Oxaliplatin|oxaliplatin|mesh-list
24553984|NCT00733616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200039|NCT02736448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200040|NCT02736591|Hormones|hormones|mesh-list
24553985|NCT00733616|Tubulin Modulators|tubulin modulators|mesh-ancestor
25863528|NCT00094029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554019|NCT00733811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554021|NCT00733850|Gemcitabine|gemcitabine|mesh-list
24554022|NCT00733850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24554023|NCT00733850|Antimetabolites|antimetabolites|mesh-ancestor
24554024|NCT00733850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554025|NCT00733850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24554026|NCT00733850|Antiviral Agents|antiviral agents|mesh-ancestor
24554027|NCT00733850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24554028|NCT00733850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24554029|NCT00733850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24554030|NCT00733850|Immunologic Factors|immunologic factors|mesh-ancestor
24554031|NCT00733850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554032|NCT00733889|Docetaxel|docetaxel|mesh-list
24554033|NCT00733889|Fluorouracil|fluorouracil|mesh-list
24554034|NCT00733889|Cetuximab|cetuximab|mesh-list
24554035|NCT00733889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24554036|NCT00733889|Tubulin Modulators|tubulin modulators|mesh-ancestor
24554037|NCT00733889|Antimitotic Agents|antimitotic agents|mesh-ancestor
24554038|NCT00733889|Mitosis Modulators|mitosis modulators|mesh-ancestor
24554151|NCT00734695|Vitamins|vitamins|mesh-list
24554152|NCT00734695|Ascorbic Acid|ascorbic acid|mesh-list
24554153|NCT00734695|Micronutrients|micronutrients|mesh-ancestor
24554154|NCT00734695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554155|NCT00734695|Antioxidants|antioxidants|mesh-ancestor
24554156|NCT00734695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554157|NCT00734695|Protective Agents|protective agents|mesh-ancestor
24554158|NCT00734773|Cytarabine|cytarabine|mesh-list
24554159|NCT00734773|Rituximab|rituximab|mesh-list
24554160|NCT00734773|Methotrexate|methotrexate|mesh-list
24554161|NCT00734773|Vincristine|vincristine|mesh-list
24554162|NCT00734773|Procarbazine|procarbazine|mesh-list
24554163|NCT00734773|Motexafin gadolinium|motexafin gadolinium|mesh-list
24554164|NCT00734773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24554165|NCT00734773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24554166|NCT00734773|Immunologic Factors|immunologic factors|mesh-ancestor
24554167|NCT00734773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554168|NCT00734773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24554169|NCT00734773|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24554170|NCT00734773|Abortifacient Agents|abortifacient agents|mesh-ancestor
24554171|NCT00734773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24554172|NCT00734773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24554173|NCT00734773|Antimetabolites|antimetabolites|mesh-ancestor
24554322|NCT00735748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24554325|NCT00735748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554326|NCT00735748|Analgesics|analgesics|mesh-ancestor
24554340|NCT00735852|Luteolytic Agents|luteolytic agents|mesh-ancestor
24554341|NCT00735852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24554342|NCT00735852|Contraceptive Agents|contraceptive agents|mesh-ancestor
24554343|NCT00735852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24554344|NCT00735852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554345|NCT00735852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24554346|NCT00735852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24554364|NCT00736021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554365|NCT00736021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24554367|NCT00736021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554368|NCT00736021|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24554369|NCT00736021|Antidepressive Agents|antidepressive agents|mesh-ancestor
24554370|NCT00736021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24554371|NCT00736164|Selenium|selenium|mesh-list
25863529|NCT00094029|Growth Inhibitors|growth inhibitors|mesh-ancestor
25863530|NCT00094029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24554425|NCT00736515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24554426|NCT00736515|Insulin Glargine|insulin glargine|mesh-list
24947844|NCT03925233|Toremifene|toremifene|mesh-list
24947845|NCT03925233|Gemcitabine|gemcitabine|mesh-list
24947846|NCT03925233|Vinorelbine|vinorelbine|mesh-list
24947847|NCT03925233|Cyclophosphamide|cyclophosphamide|mesh-list
24947848|NCT03925233|Bevacizumab|bevacizumab|mesh-list
24947849|NCT03925233|Carboplatin|carboplatin|mesh-list
24947850|NCT03925233|Doxorubicin|doxorubicin|mesh-list
24947851|NCT03925233|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24947853|NCT03925233|Capecitabine|capecitabine|mesh-list
24947854|NCT03925233|Methotrexate|methotrexate|mesh-list
24947855|NCT03925233|Trastuzumab|trastuzumab|mesh-list
24947856|NCT03925233|Letrozole|letrozole|mesh-list
24947857|NCT03925233|Apatinib|apatinib|mesh-list
24947858|NCT03925233|Epirubicin|epirubicin|mesh-list
24947859|NCT03925233|Olaparib|olaparib|mesh-list
24947885|NCT03925233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24554520|NCT00736905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554521|NCT00736905|Antiviral Agents|antiviral agents|mesh-ancestor
24554522|NCT00736905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24554523|NCT00736905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24554570|NCT00737113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554571|NCT00737126|Folic Acid|folic acid|mesh-list
24554572|NCT00737126|Hematinics|hematinics|mesh-ancestor
24554573|NCT00737126|Vitamin B Complex|vitamin b complex|mesh-ancestor
24554574|NCT00737126|Vitamins|vitamins|mesh-ancestor
24554575|NCT00737126|Micronutrients|micronutrients|mesh-ancestor
24554576|NCT00737126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554577|NCT00737139|Epinephrine|epinephrine|mesh-list
24554578|NCT00737139|Bupivacaine|bupivacaine|mesh-list
24554579|NCT00737139|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24554580|NCT00737139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24554602|NCT00737191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863531|NCT00094029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24554636|NCT00737373|Fluorouracil|fluorouracil|mesh-list
24554637|NCT00737373|Oxaliplatin|oxaliplatin|mesh-list
24554638|NCT00737373|Levoleucovorin|levoleucovorin|mesh-list
24554639|NCT00737373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24554640|NCT00737373|Tubulin Modulators|tubulin modulators|mesh-ancestor
24554641|NCT00737373|Antimitotic Agents|antimitotic agents|mesh-ancestor
24554642|NCT00737373|Mitosis Modulators|mitosis modulators|mesh-ancestor
24554643|NCT00737373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863532|NCT00094029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554689|NCT00737685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24554690|NCT00737685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24947934|NCT03925155|Disinfectants|disinfectants|mesh-ancestor
24947935|NCT03925155|Trace Elements|trace elements|mesh-ancestor
24947936|NCT03925155|Micronutrients|micronutrients|mesh-ancestor
24947937|NCT03925155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554808|NCT00738192|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24554809|NCT00738257|Pamidronate|pamidronate|mesh-list
24554810|NCT00738257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24554817|NCT00738296|Antimetabolites|antimetabolites|mesh-ancestor
24554818|NCT00738296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554819|NCT00738296|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24554820|NCT00738296|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24554872|NCT00738595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24554873|NCT00738595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24554874|NCT00738595|Cholinergic Agents|cholinergic agents|mesh-ancestor
24554875|NCT00738595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24554876|NCT00738595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554878|NCT00738621|Dexamethasone acetate|dexamethasone acetate|mesh-list
24554879|NCT00738621|Ondansetron|ondansetron|mesh-list
24554880|NCT00738621|Aprepitant|aprepitant|mesh-list
24554881|NCT00738621|Fosaprepitant|fosaprepitant|mesh-list
24554882|NCT00738621|BB 1101|bb 1101|mesh-list
24554883|NCT00738621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24947952|NCT03924596|Analgesics|analgesics|mesh-ancestor
24947953|NCT03924596|Sensory System Agents|sensory system agents|mesh-ancestor
24947954|NCT03924596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24563829|NCT00773812|Autonomic Agents|autonomic agents|mesh-ancestor
24554981|NCT00738985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24554982|NCT00738985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24791193|NCT05049707|Tocolytic Agents|tocolytic agents|mesh-ancestor
24555015|NCT00739388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24555016|NCT00739388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24555018|NCT00739414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24555019|NCT00739414|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24555020|NCT00739414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24555021|NCT00739414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555022|NCT00739453|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24555023|NCT00739453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24555024|NCT00739453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24555025|NCT00739453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24555026|NCT00739453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555027|NCT00739466|Alendronate|alendronate|mesh-list
24555028|NCT00739466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24555029|NCT00739466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555030|NCT00739505|Immunoglobulin G|immunoglobulin g|mesh-list
24555031|NCT00739505|Immunologic Factors|immunologic factors|mesh-ancestor
24555032|NCT00739505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555033|NCT00739531|Nitric Oxide|nitric oxide|mesh-list
25863533|NCT00094081|Cisplatin|cisplatin|mesh-list
25863534|NCT00094081|Tirapazamine|tirapazamine|mesh-list
25863535|NCT00094081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863536|NCT00094120|Squalamine|squalamine|mesh-list
25863537|NCT00094120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25863538|NCT00094120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25863539|NCT00094120|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25863540|NCT00094120|Protective Agents|protective agents|mesh-ancestor
25863541|NCT00094120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208344|NCT02643303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24947982|NCT03924492|GABA Modulators|gaba modulators|mesh-ancestor
24555082|NCT00739830|Antifungal Agents|antifungal agents|mesh-ancestor
24555083|NCT00739830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24555084|NCT00739830|Immunologic Factors|immunologic factors|mesh-ancestor
24555085|NCT00739986|Semapimod|semapimod|mesh-list
24555113|NCT00740090|Antacids|antacids|mesh-ancestor
24555114|NCT00740090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555115|NCT00740090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24555116|NCT00740103|Semapimod|semapimod|mesh-list
24555117|NCT00740103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24555118|NCT00740103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24555119|NCT00740103|Analgesics|analgesics|mesh-ancestor
24555120|NCT00740103|Sensory System Agents|sensory system agents|mesh-ancestor
24555121|NCT00740103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24555122|NCT00740103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555123|NCT00740103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24555124|NCT00740103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24555125|NCT00740103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25863542|NCT00094120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24555144|NCT00740194|Estrogens|estrogens|mesh-ancestor
24555145|NCT00740194|Hormones|hormones|mesh-ancestor
24555146|NCT00740194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24555147|NCT00740194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555148|NCT00740259|Flunarizine|flunarizine|mesh-list
24555149|NCT00740259|Anticonvulsants|anticonvulsants|mesh-ancestor
24555150|NCT00740259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24947984|NCT03924492|Anesthetics|anesthetics|mesh-ancestor
24947985|NCT03924492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24947986|NCT03923881|Cetuximab|cetuximab|mesh-list
24947987|NCT03923881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24947988|NCT03923881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24947989|NCT03923842|Denosumab|denosumab|mesh-list
24947990|NCT03923842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24947991|NCT03923842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555153|NCT00740259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24555154|NCT00740259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555155|NCT00740259|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25863543|NCT00094120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25863544|NCT00094120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25863545|NCT00094120|Growth Substances|growth substances|mesh-ancestor
25144268|NCT02937415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144269|NCT02937415|Protective Agents|protective agents|mesh-ancestor
25144270|NCT02937415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144271|NCT02937415|Antimetabolites|antimetabolites|mesh-ancestor
25144272|NCT02937415|Gasotransmitters|gasotransmitters|mesh-ancestor
25144273|NCT02937415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25144274|NCT02937363|Thioctic Acid|thioctic acid|mesh-list
25144275|NCT02937363|Antioxidants|antioxidants|mesh-ancestor
25144276|NCT02937363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144277|NCT02937363|Protective Agents|protective agents|mesh-ancestor
25144278|NCT02937363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144279|NCT02937363|Vitamin B Complex|vitamin b complex|mesh-ancestor
25144280|NCT02937363|Vitamins|vitamins|mesh-ancestor
25144281|NCT02937363|Micronutrients|micronutrients|mesh-ancestor
25144282|NCT02937285|Interferons|interferons|mesh-list
25144283|NCT02937285|Interferon-beta|interferon-beta|mesh-list
25863546|NCT00094120|Growth Inhibitors|growth inhibitors|mesh-ancestor
24874908|NCT04505774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
24564582|NCT00776802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24564583|NCT00776802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24564584|NCT00776802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24564585|NCT00776802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24564586|NCT00776802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24564587|NCT00776802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24564588|NCT00776802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564589|NCT00776802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564590|NCT00776828|Cilostazol|cilostazol|mesh-list
24564591|NCT00776828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24564592|NCT00776828|Autonomic Agents|autonomic agents|mesh-ancestor
24564593|NCT00776828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24564595|NCT00776828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24948000|NCT03923803|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
24948002|NCT03923803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24948003|NCT03923803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948004|NCT03923803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24555295|NCT00741078|Amlodipine|amlodipine|mesh-list
25200044|NCT02736513|Osimertinib|osimertinib|mesh-list
25200045|NCT02736513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200046|NCT02736513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25200047|NCT02736513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25200048|NCT02736513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200049|NCT02736500|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25200050|NCT02736500|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25200051|NCT02736500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200052|NCT02736435|Leuprolide|leuprolide|mesh-list
25200053|NCT02736435|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25200054|NCT02736435|Fertility Agents|fertility agents|mesh-ancestor
25200055|NCT02736435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25200056|NCT02736435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555171|NCT00740285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555172|NCT00740363|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24555186|NCT00740389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555187|NCT00740389|Antiviral Agents|antiviral agents|mesh-ancestor
24697393|NCT01434303|Lapatinib|lapatinib|mesh-list
25863547|NCT00094146|Octreotide|octreotide|mesh-list
25863548|NCT00094146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25863549|NCT00094146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24555188|NCT00740389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24555189|NCT00740415|Dexamethasone|dexamethasone|mesh-list
24555190|NCT00740415|Rituximab|rituximab|mesh-list
24555191|NCT00740415|Bortezomib|bortezomib|mesh-list
25863550|NCT00094146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24555192|NCT00740415|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24555193|NCT00740415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24555194|NCT00740415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24555195|NCT00740415|Immunologic Factors|immunologic factors|mesh-ancestor
24555220|NCT00740467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555225|NCT00740467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24555226|NCT00740467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24556394|NCT00747487|Antioxidants|antioxidants|mesh-ancestor
24555285|NCT00741052|Ciprofloxacin|ciprofloxacin|mesh-list
24555286|NCT00741052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24555287|NCT00741052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24555288|NCT00741052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24555289|NCT00741052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24555290|NCT00741052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24555291|NCT00741052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863551|NCT00094289|Disulfiram|disulfiram|mesh-list
25863552|NCT00094289|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25863553|NCT00094289|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25863554|NCT00094289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876556|NCT03281369|Micronutrients|micronutrients|mesh-ancestor
25863555|NCT00094289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863556|NCT00094315|Cocaine|cocaine|mesh-list
25863557|NCT00094315|Anesthetics, Local|anesthetics, local|mesh-ancestor
25051568|NCT00394121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051569|NCT00394121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25051570|NCT00394121|Respiratory System Agents|respiratory system agents|mesh-ancestor
25051571|NCT00394121|Dermatologic Agents|dermatologic agents|mesh-ancestor
25051572|NCT00394121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25051573|NCT00394121|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24558040|NCT00755170|Bevacizumab|bevacizumab|mesh-list
24555292|NCT00741052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056415|NCT03512860|Valproic Acid|valproic acid|mesh-list
24555293|NCT00741052|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24555294|NCT00741052|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24555296|NCT00741078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24555297|NCT00741078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24555298|NCT00741078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24670996|NCT01323062|Bavituximab|bavituximab|mesh-list
24555302|NCT00741078|Vasodilator Agents|vasodilator agents|mesh-ancestor
24555303|NCT00741117|Bilirubin|bilirubin|mesh-list
24555304|NCT00741117|Antioxidants|antioxidants|mesh-ancestor
24555334|NCT00741182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24555336|NCT00741195|Docetaxel|docetaxel|mesh-list
24555337|NCT00741195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24555338|NCT00741195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24555339|NCT00741195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24555340|NCT00741195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24555341|NCT00741195|Growth Substances|growth substances|mesh-ancestor
24555342|NCT00741195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555343|NCT00741195|Growth Inhibitors|growth inhibitors|mesh-ancestor
24555344|NCT00741195|Tubulin Modulators|tubulin modulators|mesh-ancestor
24555345|NCT00741195|Antimitotic Agents|antimitotic agents|mesh-ancestor
24555346|NCT00741195|Mitosis Modulators|mitosis modulators|mesh-ancestor
24555347|NCT00741195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555348|NCT00741221|Bevacizumab|bevacizumab|mesh-list
24555349|NCT00741221|Pemetrexed|pemetrexed|mesh-list
24555350|NCT00741221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24555407|NCT00741507|Ethanol|ethanol|mesh-list
24555408|NCT00741507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24555409|NCT00741507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24555410|NCT00741507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24555411|NCT00741507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555412|NCT00741585|Atenolol|atenolol|mesh-list
24555413|NCT00741585|Amlodipine|amlodipine|mesh-list
24555414|NCT00741585|Valsartan|valsartan|mesh-list
24555428|NCT00741585|Lercanidipine|lercanidipine|mesh-list
24555429|NCT00741585|Manidipine|manidipine|mesh-list
24555430|NCT00741585|Doxazosin|doxazosin|mesh-list
24555431|NCT00741585|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24555432|NCT00741585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24555433|NCT00741585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555434|NCT00741585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24555435|NCT00741585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555436|NCT00741585|Vasodilator Agents|vasodilator agents|mesh-ancestor
24555517|NCT00741884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24557287|NCT00752141|Mandelic Acids|mandelic acids|mesh-list
24555519|NCT00741884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555527|NCT00741897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555528|NCT00741897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555530|NCT00741910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24555531|NCT00741910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24555532|NCT00741910|Analgesics|analgesics|mesh-ancestor
24555533|NCT00741910|Sensory System Agents|sensory system agents|mesh-ancestor
24555534|NCT00741910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24555535|NCT00741910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555536|NCT00741910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24555537|NCT00741910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24555538|NCT00741910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24555539|NCT00741910|Immunologic Factors|immunologic factors|mesh-ancestor
24555540|NCT00741949|Propofol|propofol|mesh-list
24558505|NCT00757523|Dermatologic Agents|dermatologic agents|mesh-ancestor
24555591|NCT00742248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555592|NCT00742248|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24555593|NCT00742248|Respiratory System Agents|respiratory system agents|mesh-ancestor
24555594|NCT00742248|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24555595|NCT00742248|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24555596|NCT00742248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24555597|NCT00742248|Adrenergic Agents|adrenergic agents|mesh-ancestor
25208345|NCT02643303|Interferon Inducers|interferon inducers|mesh-ancestor
25863559|NCT00094315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25863560|NCT00094315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863561|NCT00094315|Sensory System Agents|sensory system agents|mesh-ancestor
25863562|NCT00094315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25863563|NCT00094315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24555598|NCT00742248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25200057|NCT02736435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25200058|NCT02736435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200059|NCT02736682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25200060|NCT02736682|Metronidazole|metronidazole|mesh-list
25200061|NCT02736682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25200062|NCT02736682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25200063|NCT02736682|Antitubercular Agents|antitubercular agents|mesh-ancestor
25200064|NCT02736682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25200065|NCT02736682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25200066|NCT02736279|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25200067|NCT02736279|Dermatologic Agents|dermatologic agents|mesh-ancestor
25200068|NCT02736279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25200069|NCT02736279|Immunologic Factors|immunologic factors|mesh-ancestor
25200070|NCT02736279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200071|NCT02736266|Pembrolizumab|pembrolizumab|mesh-list
25200072|NCT02736266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25200073|NCT02736266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200074|NCT02736240|Vaccines|vaccines|mesh-list
25200075|NCT02736240|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25200076|NCT02736240|Immunologic Factors|immunologic factors|mesh-ancestor
25200077|NCT02736240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200078|NCT02736227|Everolimus|everolimus|mesh-list
25200079|NCT02736227|Tacrolimus|tacrolimus|mesh-list
25200080|NCT02736227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25200081|NCT02736227|Immunologic Factors|immunologic factors|mesh-ancestor
25200082|NCT02736227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200083|NCT02736227|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25200084|NCT02736227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25200085|NCT02736227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200086|NCT02736227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200087|NCT02736032|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25200088|NCT02736032|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25200089|NCT02736032|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25200090|NCT02736032|Estradiol|estradiol|mesh-list
24555623|NCT00742339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24555624|NCT00742339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24555625|NCT00742339|Sympathomimetics|sympathomimetics|mesh-ancestor
24555626|NCT00742339|Autonomic Agents|autonomic agents|mesh-ancestor
24555627|NCT00742339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24555628|NCT00742339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555629|NCT00742339|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24555630|NCT00742339|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24555631|NCT00742339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24555632|NCT00742339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24555633|NCT00742339|Adrenergic Agents|adrenergic agents|mesh-ancestor
24555634|NCT00742339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24555635|NCT00742339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051588|NCT00393991|Respiratory System Agents|respiratory system agents|mesh-ancestor
25051589|NCT00393991|Dermatologic Agents|dermatologic agents|mesh-ancestor
25051590|NCT00393991|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25051591|NCT00393991|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25051592|NCT00393991|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24555642|NCT00742404|Antiemetics|antiemetics|mesh-ancestor
24555643|NCT00742404|Autonomic Agents|autonomic agents|mesh-ancestor
24555644|NCT00742404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24555645|NCT00742404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555646|NCT00742404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24670997|NCT01323062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25863564|NCT00094315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25863565|NCT00094315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25863566|NCT00094315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24555663|NCT00742638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25429497|NCT01516593|Cytarabine|cytarabine|mesh-list
24555664|NCT00742638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555666|NCT00742638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24555667|NCT00742638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555668|NCT00742638|GABA Agents|gaba agents|mesh-ancestor
24555669|NCT00742638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24555670|NCT00742638|Antimanic Agents|antimanic agents|mesh-ancestor
24555671|NCT00742690|Terlipressin|terlipressin|mesh-list
24555672|NCT00742690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24555673|NCT00742690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24555675|NCT00742768|Vitamin K|vitamin k|mesh-list
24555676|NCT00742768|Vitamin K 2|vitamin k 2|mesh-list
24555677|NCT00742768|Micronutrients|micronutrients|mesh-ancestor
24555678|NCT00742768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555679|NCT00742768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24555680|NCT00742768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24555682|NCT00742768|Hemostatics|hemostatics|mesh-ancestor
25863567|NCT00094315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555734|NCT00742911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24555735|NCT00742911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555736|NCT00742937|Vitamin A|vitamin a|mesh-list
24555737|NCT00742937|Vitamins|vitamins|mesh-ancestor
24555761|NCT00743470|Protease Inhibitors|protease inhibitors|mesh-ancestor
25863568|NCT00094315|Dopamine Agents|dopamine agents|mesh-ancestor
24555762|NCT00743470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24555763|NCT00743470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555764|NCT00743470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24555820|NCT00743834|Serotonin Agents|serotonin agents|mesh-ancestor
24555821|NCT00743834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24555824|NCT00743834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24555825|NCT00743834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24555826|NCT00743834|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24555827|NCT00743847|Varenicline|varenicline|mesh-list
24555828|NCT00743847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24555829|NCT00743847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24555830|NCT00743847|Cholinergic Agents|cholinergic agents|mesh-ancestor
24963641|NCT03790007|Bupivacaine|bupivacaine|mesh-list
24963642|NCT03790007|Anesthetics, Local|anesthetics, local|mesh-ancestor
24963643|NCT03790007|Anesthetics|anesthetics|mesh-ancestor
24622490|NCT01067274|Immunologic Factors|immunologic factors|mesh-ancestor
24622491|NCT01067274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622492|NCT01067274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622493|NCT01067274|Keratolytic Agents|keratolytic agents|mesh-ancestor
24622494|NCT01067274|Dermatologic Agents|dermatologic agents|mesh-ancestor
24555872|NCT00744016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555873|NCT00744016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24555874|NCT00744016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24555876|NCT00744081|Mitoxantrone|mitoxantrone|mesh-list
24555877|NCT00744081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24555878|NCT00744081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24555884|NCT00744081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24555885|NCT00744081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555886|NCT00744081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24555888|NCT00744107|Trace Elements|trace elements|mesh-ancestor
24555889|NCT00744107|Micronutrients|micronutrients|mesh-ancestor
24555890|NCT00744107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555891|NCT00744185|Propranolol|propranolol|mesh-list
24555927|NCT00744250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24555928|NCT00744302|Dialysis Solutions|dialysis solutions|mesh-list
24555929|NCT00744302|Calcium|calcium|mesh-list
24555930|NCT00744302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24555931|NCT00744302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555932|NCT00744302|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24555933|NCT00744354|Doxorubicin|doxorubicin|mesh-list
24555956|NCT00744406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24555957|NCT00744406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24555958|NCT00744406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555967|NCT00744419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24555968|NCT00744419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24555969|NCT00744419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555970|NCT00744445|Epoetin Alfa|epoetin alfa|mesh-list
24555971|NCT00744445|Hematinics|hematinics|mesh-ancestor
24555972|NCT00744536|Lenalidomide|lenalidomide|mesh-list
25863569|NCT00094315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25863570|NCT00094341|Etanercept|etanercept|mesh-list
25876557|NCT03281369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24632465|NCT01124058|Anticoagulants|anticoagulants|mesh-ancestor
24632466|NCT01124058|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24632469|NCT01124227|Icodextrin|icodextrin|mesh-list
25863571|NCT00094341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24555973|NCT00744536|Melphalan|melphalan|mesh-list
24555974|NCT00744536|Immunologic Factors|immunologic factors|mesh-ancestor
24556045|NCT00744770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24556089|NCT00744913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556091|NCT00744913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24556092|NCT00744913|Cholinergic Agents|cholinergic agents|mesh-ancestor
24556093|NCT00744913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24556145|NCT00745186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24556146|NCT00745186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556147|NCT00745199|Cromolyn Sodium|cromolyn sodium|mesh-list
24556148|NCT00745199|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
24556149|NCT00745199|Immunologic Factors|immunologic factors|mesh-ancestor
24556150|NCT00745199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556151|NCT00745199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24556152|NCT00745199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24556153|NCT00745199|Respiratory System Agents|respiratory system agents|mesh-ancestor
24556154|NCT00745225|Pioglitazone|pioglitazone|mesh-list
24556155|NCT00745225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24556156|NCT00745225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556157|NCT00745407|Fenofibrate|fenofibrate|mesh-list
24556158|NCT00745407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24556159|NCT00745407|Antimetabolites|antimetabolites|mesh-ancestor
24462507|NCT00356486|Antiviral Agents|antiviral agents|mesh-ancestor
24556160|NCT00745407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556161|NCT00745407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24556163|NCT00745433|Repaglinide|repaglinide|mesh-list
25863572|NCT00094341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24556168|NCT00745485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556169|NCT00745511|Bevacizumab|bevacizumab|mesh-list
24948011|NCT03923556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24948012|NCT03923556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948013|NCT03923556|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24948014|NCT03923556|Autonomic Agents|autonomic agents|mesh-ancestor
24802014|NCT01986764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24556170|NCT00745511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24556171|NCT00745511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556172|NCT00745511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24556173|NCT00745511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24556174|NCT00745511|Growth Substances|growth substances|mesh-ancestor
25863573|NCT00094341|Analgesics|analgesics|mesh-ancestor
24443137|NCT00293735|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24443140|NCT00293761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24443141|NCT00293787|Timolol|timolol|mesh-list
24556176|NCT00745511|Growth Inhibitors|growth inhibitors|mesh-ancestor
24556177|NCT00745589|Sevelamer|sevelamer|mesh-list
24556178|NCT00745589|Chelating Agents|chelating agents|mesh-ancestor
24556179|NCT00745589|Sequestering Agents|sequestering agents|mesh-ancestor
24556180|NCT00745589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556181|NCT00745693|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
24556182|NCT00745693|BQ 788|bq 788|mesh-list
24556183|NCT00745693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24556184|NCT00745693|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24556185|NCT00745693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821173|NCT02103725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24556186|NCT00745693|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
24556187|NCT00745810|Complement System Proteins|complement system proteins|mesh-list
24556188|NCT00745810|Immunologic Factors|immunologic factors|mesh-ancestor
24890182|NCT04485403|Ibuprofen|ibuprofen|mesh-list
24556240|NCT00746486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24556241|NCT00746486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556243|NCT00746486|Respiratory System Agents|respiratory system agents|mesh-ancestor
24556244|NCT00746486|Glucocorticoids|glucocorticoids|mesh-ancestor
24556245|NCT00746486|Hormones|hormones|mesh-ancestor
25208346|NCT02643303|Immunologic Factors|immunologic factors|mesh-ancestor
25863574|NCT00094341|Sensory System Agents|sensory system agents|mesh-ancestor
24556314|NCT00746993|Contraceptive Agents|contraceptive agents|mesh-list
24556315|NCT00746993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24556316|NCT00746993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556317|NCT00747097|Gemcitabine|gemcitabine|mesh-list
24556318|NCT00747097|Cetuximab|cetuximab|mesh-list
25669039|NCT01726023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25669040|NCT01726023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669041|NCT01726049|Sildenafil Citrate|sildenafil citrate|mesh-list
24556319|NCT00747097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24556321|NCT00747097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556322|NCT00747097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556323|NCT00747097|Antiviral Agents|antiviral agents|mesh-ancestor
24556324|NCT00747097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24556325|NCT00747097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556326|NCT00747097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24556327|NCT00747097|Immunologic Factors|immunologic factors|mesh-ancestor
24556328|NCT00747097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556329|NCT00747097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24556341|NCT00747110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24556342|NCT00747110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24556343|NCT00747110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24556344|NCT00747110|Analgesics|analgesics|mesh-ancestor
24556345|NCT00747110|Sensory System Agents|sensory system agents|mesh-ancestor
24556346|NCT00747110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24556380|NCT00747383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24556381|NCT00747383|Immunologic Factors|immunologic factors|mesh-ancestor
24556387|NCT00747409|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24948018|NCT03923829|Trace Elements|trace elements|mesh-ancestor
24948019|NCT03923829|Micronutrients|micronutrients|mesh-ancestor
25051599|NCT00393952|Formoterol Fumarate|formoterol fumarate|mesh-list
24556389|NCT00747409|Isophane Insulin, Human|isophane insulin, human|mesh-list
24556390|NCT00747409|Isophane insulin, beef|isophane insulin, beef|mesh-list
24556391|NCT00747409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24556392|NCT00747409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556393|NCT00747487|Idebenone|idebenone|mesh-list
24556397|NCT00747487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556398|NCT00747526|Rabeprazole|rabeprazole|mesh-list
24556399|NCT00747526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24556400|NCT00747526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24556401|NCT00747526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24556427|NCT00747669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24556428|NCT00747669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24556429|NCT00747669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556430|NCT00747695|Rabeprazole|rabeprazole|mesh-list
24556431|NCT00747695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24556432|NCT00747695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24556433|NCT00747695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24556434|NCT00747695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556543|NCT00748059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25863575|NCT00094341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25863576|NCT00094341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863577|NCT00094341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25863578|NCT00094341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25863579|NCT00094341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24556625|NCT00748423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008492|NCT05207436|Oxytocin|oxytocin|mesh-list
24556675|NCT00748943|Dental Disinfectants|dental disinfectants|mesh-ancestor
24556676|NCT00748943|Disinfectants|disinfectants|mesh-ancestor
24556677|NCT00748943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24556678|NCT00749021|Ranibizumab|ranibizumab|mesh-list
24556684|NCT00749021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556685|NCT00749047|Pioglitazone|pioglitazone|mesh-list
24556686|NCT00749047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24556687|NCT00749047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556711|NCT00749346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556713|NCT00749346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24556714|NCT00749359|Paroxetine|paroxetine|mesh-list
24556715|NCT00749359|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24556716|NCT00749359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24948032|NCT03923114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24948033|NCT03923166|Capecitabine|capecitabine|mesh-list
24948034|NCT03923166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24948035|NCT03923166|Antimetabolites|antimetabolites|mesh-ancestor
24948036|NCT03923166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948037|NCT03923166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24948038|NCT03923361|Propofol|propofol|mesh-list
24948039|NCT03923361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24802032|NCT01986894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875580|NCT04021108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056457|NCT03512574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25056458|NCT03512574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25056459|NCT03512574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24556717|NCT00749359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24556719|NCT00749359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24556732|NCT00749385|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24556733|NCT00749385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556734|NCT00749385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556735|NCT00749385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24556736|NCT00749385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24556737|NCT00749385|Analgesics|analgesics|mesh-ancestor
24556738|NCT00749385|Sensory System Agents|sensory system agents|mesh-ancestor
24556739|NCT00749385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24556740|NCT00749385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556741|NCT00749385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24556742|NCT00749385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24556743|NCT00749385|Gout Suppressants|gout suppressants|mesh-ancestor
24556744|NCT00749385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24556745|NCT00749450|Fluorouracil|fluorouracil|mesh-list
24556746|NCT00749450|Capecitabine|capecitabine|mesh-list
24556747|NCT00749450|Oxaliplatin|oxaliplatin|mesh-list
24556829|NCT00749814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863580|NCT00094341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24948041|NCT03923361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948042|NCT03923361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24948043|NCT03923361|Anesthetics, General|anesthetics, general|mesh-ancestor
24948046|NCT03923218|Cholecalciferol|cholecalciferol|mesh-list
24948047|NCT03923218|Vitamins|vitamins|mesh-ancestor
24948048|NCT03923218|Micronutrients|micronutrients|mesh-ancestor
24948049|NCT03923218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556908|NCT00750347|Rimonabant|rimonabant|mesh-list
24556909|NCT00750347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24556911|NCT00750347|Sensory System Agents|sensory system agents|mesh-ancestor
24948053|NCT03923140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24948054|NCT03923140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24948055|NCT03923140|Analgesics|analgesics|mesh-ancestor
24948056|NCT03923140|Sensory System Agents|sensory system agents|mesh-ancestor
24948057|NCT03923140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24948058|NCT03923140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948059|NCT03923140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24948060|NCT03923140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24556955|NCT00750529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556956|NCT00750529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556959|NCT00750529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556961|NCT00750529|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24556962|NCT00750529|Autonomic Agents|autonomic agents|mesh-ancestor
24556963|NCT00750529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24556964|NCT00750581|Indomethacin|indomethacin|mesh-list
24556965|NCT00750581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24557095|NCT00751205|Antimitotic Agents|antimitotic agents|mesh-ancestor
24557096|NCT00751205|Mitosis Modulators|mitosis modulators|mesh-ancestor
24557097|NCT00751205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557099|NCT00751257|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24557100|NCT00751257|Antiviral Agents|antiviral agents|mesh-ancestor
24557101|NCT00751257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24557102|NCT00751257|Expectorants|expectorants|mesh-ancestor
24557103|NCT00751257|Respiratory System Agents|respiratory system agents|mesh-ancestor
24557104|NCT00751257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24557105|NCT00751257|Antioxidants|antioxidants|mesh-ancestor
25863581|NCT00094341|Immunologic Factors|immunologic factors|mesh-ancestor
25863582|NCT00094367|Lamivudine|lamivudine|mesh-list
25863583|NCT00094367|Abacavir|abacavir|mesh-list
25863584|NCT00094367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25863585|NCT00094367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25863586|NCT00094367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557117|NCT00751374|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24557118|NCT00751374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557119|NCT00751374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557120|NCT00751478|Naltrexone|naltrexone|mesh-list
24557121|NCT00751478|Morphine|morphine|mesh-list
24557122|NCT00751478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24557123|NCT00751478|Narcotics|narcotics|mesh-ancestor
24561073|NCT00485693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25876558|NCT03281369|Incretins|incretins|mesh-ancestor
25863587|NCT00094367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632550|NCT01124500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24632580|NCT01124630|Antimetabolites|antimetabolites|mesh-ancestor
24632581|NCT01124630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632582|NCT01124630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25863588|NCT00094367|Antiviral Agents|antiviral agents|mesh-ancestor
24751343|NCT01703624|Bromides|bromides|mesh-list
25089240|NCT03267654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24765088|NCT01785979|Analgesics|analgesics|mesh-ancestor
24557225|NCT00751829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561308|NCT00759317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24557270|NCT00752063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24557271|NCT00752063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24557272|NCT00752063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557274|NCT00752115|Carboplatin|carboplatin|mesh-list
24557275|NCT00752115|Sildenafil Citrate|sildenafil citrate|mesh-list
24557276|NCT00752115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24557277|NCT00752115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24557278|NCT00752115|Tubulin Modulators|tubulin modulators|mesh-ancestor
24557279|NCT00752115|Antimitotic Agents|antimitotic agents|mesh-ancestor
24557280|NCT00752115|Mitosis Modulators|mitosis modulators|mesh-ancestor
24557281|NCT00752115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557282|NCT00752115|Vasodilator Agents|vasodilator agents|mesh-ancestor
24557283|NCT00752115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24557284|NCT00752115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24557285|NCT00752115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557286|NCT00752115|Urological Agents|urological agents|mesh-ancestor
24557350|NCT00752401|Micronutrients|micronutrients|mesh-ancestor
24557351|NCT00752401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557352|NCT00752401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24557353|NCT00752401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24557354|NCT00752414|Levofloxacin|levofloxacin|mesh-list
24557355|NCT00752414|Ofloxacin|ofloxacin|mesh-list
25863589|NCT00094367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25863590|NCT00094367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25863591|NCT00094367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24557356|NCT00752414|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24557357|NCT00752414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24557410|NCT00752479|Immunologic Factors|immunologic factors|mesh-ancestor
24557411|NCT00752479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557412|NCT00752479|Antifungal Agents|antifungal agents|mesh-ancestor
24557413|NCT00752479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24557414|NCT00752479|Dermatologic Agents|dermatologic agents|mesh-ancestor
24557415|NCT00752479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24557416|NCT00752479|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24562036|NCT00764244|Hormones|hormones|mesh-ancestor
24557422|NCT00752479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24557423|NCT00752479|Antiemetics|antiemetics|mesh-ancestor
24557424|NCT00752479|Autonomic Agents|autonomic agents|mesh-ancestor
24557425|NCT00752479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24557432|NCT00752479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24557433|NCT00752518|Bortezomib|bortezomib|mesh-list
24557434|NCT00752518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24557435|NCT00752544|Simeprevir|simeprevir|mesh-list
24557436|NCT00752544|Antiviral Agents|antiviral agents|mesh-ancestor
24557437|NCT00752544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24557438|NCT00752544|Protease Inhibitors|protease inhibitors|mesh-ancestor
24557439|NCT00752544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557440|NCT00752544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557441|NCT00752596|Azimilide|azimilide|mesh-list
24557442|NCT00752596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24557443|NCT00752596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24557444|NCT00752596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24875829|NCT03819465|Gemcitabine|gemcitabine|mesh-list
24875884|NCT03816332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25669042|NCT01726049|Vasodilator Agents|vasodilator agents|mesh-ancestor
25669043|NCT01726049|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25669044|NCT01726049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25669045|NCT01726049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25669046|NCT01726049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669047|NCT01726049|Urological Agents|urological agents|mesh-ancestor
25669048|NCT01726270|Tamsulosin|tamsulosin|mesh-list
25669049|NCT01726270|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24875886|NCT03816332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25863592|NCT00094380|Cyclophosphamide|cyclophosphamide|mesh-list
25863593|NCT00094380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25863594|NCT00094380|Immunologic Factors|immunologic factors|mesh-ancestor
25863595|NCT00094380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863596|NCT00094380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24948126|NCT03922815|Anesthetics, General|anesthetics, general|mesh-ancestor
24948127|NCT03922815|Anesthetics|anesthetics|mesh-ancestor
24948128|NCT03922815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24948130|NCT03922815|Analgesics|analgesics|mesh-ancestor
24948131|NCT03922815|Sensory System Agents|sensory system agents|mesh-ancestor
24562484|NCT00766662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557569|NCT00753038|Carboplatin|carboplatin|mesh-list
24557570|NCT00753038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24557571|NCT00753038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24557572|NCT00753038|Tubulin Modulators|tubulin modulators|mesh-ancestor
24557574|NCT00753038|Mitosis Modulators|mitosis modulators|mesh-ancestor
24557575|NCT00753038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557576|NCT00753051|Haloperidol|haloperidol|mesh-list
24557577|NCT00753051|Haloperidol decanoate|haloperidol decanoate|mesh-list
24557579|NCT00753051|Antiemetics|antiemetics|mesh-ancestor
24557580|NCT00753051|Autonomic Agents|autonomic agents|mesh-ancestor
24557581|NCT00753051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24557582|NCT00753051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557583|NCT00753051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24557584|NCT00753051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24557602|NCT00753064|Adrenergic Agents|adrenergic agents|mesh-ancestor
25109902|NCT03121261|Analgesics|analgesics|mesh-ancestor
24557616|NCT00753103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24557617|NCT00753103|Alkylating Agents|alkylating agents|mesh-ancestor
24557618|NCT00753103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557619|NCT00753103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24557620|NCT00753103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24557621|NCT00753103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24557622|NCT00753103|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24557623|NCT00753103|Antitubercular Agents|antitubercular agents|mesh-ancestor
24557624|NCT00753103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24557632|NCT00753103|Glucocorticoids|glucocorticoids|mesh-ancestor
24557633|NCT00753103|Hormones|hormones|mesh-ancestor
24557634|NCT00753103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24557635|NCT00753103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24557636|NCT00753103|Protective Agents|protective agents|mesh-ancestor
24443197|NCT00293930|Immunologic Factors|immunologic factors|mesh-ancestor
25863597|NCT00094380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25863598|NCT00094380|Alkylating Agents|alkylating agents|mesh-ancestor
24557637|NCT00753103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24557638|NCT00753103|Dermatologic Agents|dermatologic agents|mesh-ancestor
24557639|NCT00753103|Antimetabolites|antimetabolites|mesh-ancestor
24557640|NCT00753103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24557642|NCT00753168|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24557643|NCT00753168|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24557644|NCT00753168|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24557645|NCT00753168|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24557646|NCT00753168|Adrenergic Agents|adrenergic agents|mesh-ancestor
24557647|NCT00753168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24948144|NCT03923036|Antineoplastic Agents|antineoplastic agents|mesh-list
24948145|NCT03923036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24948146|NCT03923036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24557648|NCT00753168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557677|NCT00753402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25208347|NCT02643303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557683|NCT00753402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24557684|NCT00753402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24557685|NCT00753402|Autonomic Agents|autonomic agents|mesh-ancestor
24557686|NCT00753402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24557687|NCT00753402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24557688|NCT00753402|Respiratory System Agents|respiratory system agents|mesh-ancestor
24948147|NCT03923036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24948148|NCT03923036|Growth Substances|growth substances|mesh-ancestor
24948149|NCT03923036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948150|NCT03923036|Growth Inhibitors|growth inhibitors|mesh-ancestor
24948151|NCT03923036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24557691|NCT00753402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24948152|NCT03923036|Antimetabolites|antimetabolites|mesh-ancestor
24455141|NCT02676791|Povidone|povidone|mesh-list
24557751|NCT00753779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24557752|NCT00753779|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24557754|NCT00753792|Methylprednisolone|methylprednisolone|mesh-list
24557755|NCT00753792|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24557756|NCT00753792|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24557757|NCT00753792|Prednisolone|prednisolone|mesh-list
24557776|NCT00753883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24557777|NCT00753883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24557778|NCT00753883|Antimetabolites|antimetabolites|mesh-ancestor
24557779|NCT00753883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557780|NCT00753883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24557781|NCT00753883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24557782|NCT00753883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557783|NCT00753909|Paclitaxel|paclitaxel|mesh-list
24557784|NCT00753909|Bevacizumab|bevacizumab|mesh-list
24557785|NCT00753909|Carboplatin|carboplatin|mesh-list
24557786|NCT00753909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24948153|NCT03923036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948154|NCT03923036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24948155|NCT03923036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24948156|NCT03923036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557855|NCT00754429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24557856|NCT00754429|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24557857|NCT00754429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24557858|NCT00754429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563380|NCT00771368|Respiratory System Agents|respiratory system agents|mesh-ancestor
24557866|NCT00754507|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
24557875|NCT00754689|Rimonabant|rimonabant|mesh-list
24557876|NCT00754689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24557877|NCT00754689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557912|NCT00754819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24557913|NCT00754858|Belotecan|belotecan|mesh-list
24557914|NCT00754858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24557915|NCT00754858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24557916|NCT00754858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24557917|NCT00754858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557918|NCT00754858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557919|NCT00754871|Dienogest|dienogest|mesh-list
24557920|NCT00754871|Nandrolone|nandrolone|mesh-list
24557921|NCT00754871|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24557922|NCT00754871|Contraceptive Agents|contraceptive agents|mesh-ancestor
24557923|NCT00754871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24557924|NCT00754871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557958|NCT00754962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24557959|NCT00754962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557961|NCT00754962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24557962|NCT00754962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557964|NCT00755014|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24557965|NCT00755014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24821282|NCT02104284|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24557966|NCT00755014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24558002|NCT00755118|Bevacizumab|bevacizumab|mesh-list
24558003|NCT00755118|Cetuximab|cetuximab|mesh-list
24558004|NCT00755118|Fluorouracil|fluorouracil|mesh-list
24558005|NCT00755118|Oxaliplatin|oxaliplatin|mesh-list
24558006|NCT00755118|Irinotecan|irinotecan|mesh-list
24558007|NCT00755118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24558008|NCT00755118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24558009|NCT00755118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24558010|NCT00755118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24558011|NCT00755118|Growth Substances|growth substances|mesh-ancestor
24558012|NCT00755118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558013|NCT00755118|Growth Inhibitors|growth inhibitors|mesh-ancestor
24558014|NCT00755118|Antimetabolites|antimetabolites|mesh-ancestor
24558338|NCT00756340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25876559|NCT03281369|Hormones|hormones|mesh-ancestor
24563471|NCT00771719|Ceftobiprole|ceftobiprole|mesh-list
24558111|NCT00755495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24558112|NCT00755495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558114|NCT00755508|Analgesics|analgesics|mesh-ancestor
25221102|NCT02652312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25221103|NCT02652312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25221104|NCT02652312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25221110|NCT02652312|Narcotics|narcotics|mesh-ancestor
24558115|NCT00755508|Sensory System Agents|sensory system agents|mesh-ancestor
24558116|NCT00755508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24558117|NCT00755508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558118|NCT00755508|Anticonvulsants|anticonvulsants|mesh-ancestor
24558119|NCT00755508|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24558120|NCT00755508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24558121|NCT00755508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24558122|NCT00755508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24558123|NCT00755508|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24558124|NCT00755508|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24558125|NCT00755508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24558126|NCT00755508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558127|NCT00755508|Antimanic Agents|antimanic agents|mesh-ancestor
24948164|NCT03922373|Benzonatate|benzonatate|mesh-list
24948165|NCT03922373|Antitussive Agents|antitussive agents|mesh-ancestor
24558133|NCT00755521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24558134|NCT00755521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558135|NCT00755521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24558136|NCT00755521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24558137|NCT00755521|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24558138|NCT00755521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24558139|NCT00755521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24558140|NCT00755521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558141|NCT00755534|Capecitabine|capecitabine|mesh-list
24558142|NCT00755534|Oxaliplatin|oxaliplatin|mesh-list
24558143|NCT00755534|Irinotecan|irinotecan|mesh-list
24558144|NCT00755534|Cetuximab|cetuximab|mesh-list
24558145|NCT00755534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24558146|NCT00755534|Antimetabolites|antimetabolites|mesh-ancestor
24558147|NCT00755534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558148|NCT00755534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24558149|NCT00755534|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24558150|NCT00755534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24558151|NCT00755534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24558152|NCT00755534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24558154|NCT00755560|Anthelmintics|anthelmintics|mesh-ancestor
24558155|NCT00755560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24558156|NCT00755560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24558157|NCT00755560|Anticestodal Agents|anticestodal agents|mesh-ancestor
24558158|NCT00755560|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24558159|NCT00755560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24558160|NCT00755560|Tubulin Modulators|tubulin modulators|mesh-ancestor
24558161|NCT00755560|Antimitotic Agents|antimitotic agents|mesh-ancestor
24558162|NCT00755560|Mitosis Modulators|mitosis modulators|mesh-ancestor
24558164|NCT00755560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24558166|NCT00755573|Analgesics|analgesics|mesh-ancestor
24558205|NCT00755833|Biphasic Insulins|biphasic insulins|mesh-list
24558336|NCT00756340|Bevacizumab|bevacizumab|mesh-list
24671001|NCT01323101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24558337|NCT00756340|Everolimus|everolimus|mesh-list
24558358|NCT00756847|Tubulin Modulators|tubulin modulators|mesh-ancestor
24558359|NCT00756847|Antimitotic Agents|antimitotic agents|mesh-ancestor
24558360|NCT00756847|Mitosis Modulators|mitosis modulators|mesh-ancestor
24558361|NCT00756847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558362|NCT00756860|Sevelamer|sevelamer|mesh-list
24558363|NCT00756860|Chelating Agents|chelating agents|mesh-ancestor
24558364|NCT00756860|Sequestering Agents|sequestering agents|mesh-ancestor
24558366|NCT00756873|Etoricoxib|etoricoxib|mesh-list
24558367|NCT00756873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24558368|NCT00756873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24558395|NCT00757016|Immunologic Factors|immunologic factors|mesh-ancestor
24558396|NCT00757016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24558397|NCT00757016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558399|NCT00757029|Methylphenidate|methylphenidate|mesh-list
25669050|NCT01726270|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25669051|NCT01726270|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25669052|NCT01726270|Adrenergic Agents|adrenergic agents|mesh-ancestor
25669053|NCT01726270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25669054|NCT01726270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632755|NCT01125553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632756|NCT01125657|Darexaban|darexaban|mesh-list
25863599|NCT00094380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863600|NCT00094380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24558529|NCT00757692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24558530|NCT00757692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558590|NCT00758030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24558837|NCT05428306|Sensory System Agents|sensory system agents|mesh-ancestor
24558838|NCT05428306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24558839|NCT05428306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558840|NCT05428306|Antipyretics|antipyretics|mesh-ancestor
24558841|NCT05428306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24558842|NCT05428306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24558843|NCT05428306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24558849|NCT05428293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25863601|NCT00094380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24558852|NCT05428293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24558877|NCT05422612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24558878|NCT05422612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558879|NCT05422612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24558881|NCT05422612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558882|NCT05422612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24558883|NCT05422612|Antidepressive Agents|antidepressive agents|mesh-ancestor
24558884|NCT05422612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25863602|NCT00094406|Dimercaprol|dimercaprol|mesh-list
24876417|NCT03555916|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24558885|NCT05422612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24558886|NCT05422612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24558887|NCT05422612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24558888|NCT05422612|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24558889|NCT05422612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24773600|NCT01840800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24773601|NCT01840800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773602|NCT01840800|Sensory System Agents|sensory system agents|mesh-ancestor
24773603|NCT01840800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24626150|NCT01085721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24626151|NCT01085721|Respiratory System Agents|respiratory system agents|mesh-ancestor
24558971|NCT05382338|Alkylating Agents|alkylating agents|mesh-ancestor
24558972|NCT05382338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558973|NCT05382338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24564473|NCT00776516|Leprostatic Agents|leprostatic agents|mesh-ancestor
25863603|NCT00094406|Carbon Monoxide|carbon monoxide|mesh-list
24815388|NCT02070003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24815390|NCT02070003|Analgesics|analgesics|mesh-ancestor
25863604|NCT00094406|Chelating Agents|chelating agents|mesh-ancestor
25863605|NCT00094406|Sequestering Agents|sequestering agents|mesh-ancestor
25863606|NCT00094406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24559040|NCT05319730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24559041|NCT05319730|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24559042|NCT05319730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24559043|NCT05319730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24559044|NCT05319730|Immunologic Factors|immunologic factors|mesh-ancestor
24559045|NCT05319730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24559046|NCT05319730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24559048|NCT05319353|Antiviral Agents|antiviral agents|mesh-ancestor
24559049|NCT05319353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24559234|NCT05170009|Antiviral Agents|antiviral agents|mesh-ancestor
24559235|NCT05170009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24559236|NCT05170009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24559237|NCT05170009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24559241|NCT05169372|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
24559242|NCT05169372|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24559243|NCT05169372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24559244|NCT05167864|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24559245|NCT05167864|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24559246|NCT05167864|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24559247|NCT05167864|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24559248|NCT05167864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25669055|NCT01726270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669056|NCT01726270|Urological Agents|urological agents|mesh-ancestor
25089311|NCT03267199|Fibrinolytic Agents|fibrinolytic agents|mesh-list
24981121|NCT04420195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089312|NCT03267199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24456257|NCT00330785|Amlodipine|amlodipine|mesh-list
24632812|NCT01125761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24632813|NCT01125761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24559249|NCT05167864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24559250|NCT05167864|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24559251|NCT05167864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24559252|NCT05167864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863607|NCT00094406|Antimetabolites|antimetabolites|mesh-ancestor
24564742|NCT00777673|Alkylating Agents|alkylating agents|mesh-ancestor
24559442|NCT04767061|Atenolol|atenolol|mesh-list
24559443|NCT04767061|Sotalol|sotalol|mesh-list
24559444|NCT04767061|Nadolol|nadolol|mesh-list
24559445|NCT04767061|Acebutolol|acebutolol|mesh-list
24559446|NCT04767061|Carvedilol|carvedilol|mesh-list
24559477|NCT04767061|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24559478|NCT04767061|Serotonin Agents|serotonin agents|mesh-ancestor
24559479|NCT04757584|Propranolol|propranolol|mesh-list
24559480|NCT04757584|Metoprolol|metoprolol|mesh-list
24559481|NCT04757584|Atenolol|atenolol|mesh-list
24948269|NCT03920878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948270|NCT03920878|Growth Inhibitors|growth inhibitors|mesh-ancestor
24948271|NCT03920878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24948272|NCT03920618|Tenofovir|tenofovir|mesh-list
24948273|NCT03920618|Entecavir|entecavir|mesh-list
24948274|NCT03920618|Antiviral Agents|antiviral agents|mesh-ancestor
24948275|NCT03920618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24948276|NCT03920618|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24948277|NCT03920618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25863608|NCT00094406|Gasotransmitters|gasotransmitters|mesh-ancestor
25863609|NCT00094406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25863610|NCT00094406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24559482|NCT04757584|Sotalol|sotalol|mesh-list
24559483|NCT04757584|Nadolol|nadolol|mesh-list
24559502|NCT04757584|Autonomic Agents|autonomic agents|mesh-ancestor
24559503|NCT04757584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24559504|NCT04757584|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24559505|NCT04757584|Antioxidants|antioxidants|mesh-ancestor
24559506|NCT04757584|Protective Agents|protective agents|mesh-ancestor
24559507|NCT04757584|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24559508|NCT04757584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24559509|NCT04757584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24559510|NCT04757584|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24559511|NCT04757584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24559512|NCT04757584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24559513|NCT04757584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24559514|NCT04757584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24559515|NCT04757584|Sympathomimetics|sympathomimetics|mesh-ancestor
24559516|NCT04757584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25200095|NCT02736032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25145695|NCT02927951|Pregabalin|pregabalin|mesh-list
24559590|NCT04640168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24559591|NCT04640168|Glucocorticoids|glucocorticoids|mesh-ancestor
24559593|NCT04640168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24559594|NCT04640168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24559595|NCT04640168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24559596|NCT04640168|Antimetabolites|antimetabolites|mesh-ancestor
24559597|NCT04640168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24559598|NCT04640168|Antiviral Agents|antiviral agents|mesh-ancestor
24559599|NCT04640168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24559600|NCT04627246|Vaccines|vaccines|mesh-list
24559601|NCT04627246|Immunologic Factors|immunologic factors|mesh-ancestor
24559602|NCT04627246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863611|NCT00094432|Aripiprazole|aripiprazole|mesh-list
24559797|NCT04387136|Sensory System Agents|sensory system agents|mesh-ancestor
24559798|NCT04387136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24559799|NCT04387136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24559800|NCT04387136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25669057|NCT01726335|Risperidone|risperidone|mesh-list
25669058|NCT01726335|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25669059|NCT01726335|Serotonin Agents|serotonin agents|mesh-ancestor
25669060|NCT01726335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25669061|NCT01726335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669062|NCT01726335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221165|NCT02652091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24559801|NCT04387136|Anesthetics, General|anesthetics, general|mesh-ancestor
24559802|NCT04387136|Anesthetics|anesthetics|mesh-ancestor
25200096|NCT02736032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24559812|NCT04376268|Chlorhexidine|chlorhexidine|mesh-list
24559813|NCT04376268|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24561184|NCT00758732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24559848|NCT04249427|Sensory System Agents|sensory system agents|mesh-ancestor
24559849|NCT04249427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24559850|NCT04249427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24559894|NCT04128748|Antimetabolites|antimetabolites|mesh-ancestor
24559895|NCT04128748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24559896|NCT04128748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24559897|NCT04128748|Antiviral Agents|antiviral agents|mesh-ancestor
24559898|NCT04128748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24559899|NCT04128748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24559965|NCT03989466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24559966|NCT03963960|Dialysis Solutions|dialysis solutions|mesh-list
24559967|NCT03963960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24559968|NCT03916419|Paclitaxel|paclitaxel|mesh-list
24559969|NCT03916419|Carboplatin|carboplatin|mesh-list
25863612|NCT00094432|Antidepressive Agents|antidepressive agents|mesh-ancestor
24559974|NCT03916419|Antimitotic Agents|antimitotic agents|mesh-ancestor
24559975|NCT03916419|Mitosis Modulators|mitosis modulators|mesh-ancestor
24559976|NCT03916419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948293|NCT03920839|Antimetabolites|antimetabolites|mesh-ancestor
24948294|NCT03920839|Antiviral Agents|antiviral agents|mesh-ancestor
24393663|NCT00130585|Folic Acid|folic acid|mesh-list
24560059|NCT03680352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560060|NCT03668808|Insulin|insulin|mesh-list
24560061|NCT03668808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24560062|NCT03668808|Insulin Glargine|insulin glargine|mesh-list
24560063|NCT03668808|Insulin, Long-Acting|insulin, long-acting|mesh-list
24560064|NCT03668808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25863613|NCT00094432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24560149|NCT03492463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24560150|NCT03492463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560174|NCT03417687|Anesthetics|anesthetics|mesh-ancestor
24560175|NCT03417687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24560176|NCT03417687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145827|NCT02926859|Cannabidiol|cannabidiol|mesh-list
24560179|NCT03336619|Nitazoxanide|nitazoxanide|mesh-list
24560180|NCT03336619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24560187|NCT03321513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24560188|NCT03321513|Growth Substances|growth substances|mesh-ancestor
24560189|NCT03321513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24560190|NCT03321513|Growth Inhibitors|growth inhibitors|mesh-ancestor
24560197|NCT03274687|Androgens|androgens|mesh-list
24560198|NCT03274687|Hormones|hormones|mesh-ancestor
24560199|NCT03274687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24560201|NCT03245450|Irinotecan|irinotecan|mesh-list
24948306|NCT03920644|Autonomic Agents|autonomic agents|mesh-ancestor
24560306|NCT02981979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24560308|NCT02981979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24560309|NCT02981979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24560310|NCT02981979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24560311|NCT02981979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560312|NCT02981979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24560313|NCT02981979|Immunologic Factors|immunologic factors|mesh-ancestor
24560316|NCT02927847|Nicotine|nicotine|mesh-list
25863614|NCT00094432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25863615|NCT00094432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24791667|NCT03583710|Cisplatin|cisplatin|mesh-list
24560558|NCT02312245|Mitosis Modulators|mitosis modulators|mesh-ancestor
24560559|NCT02312245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560592|NCT02292238|Chelating Agents|chelating agents|mesh-ancestor
24560593|NCT02292238|Sequestering Agents|sequestering agents|mesh-ancestor
24560594|NCT02292238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560595|NCT02287818|Febuxostat|febuxostat|mesh-list
25669063|NCT01726335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25669064|NCT01726335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25669065|NCT01726335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25669066|NCT01726335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25669067|NCT01726335|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25669068|NCT01726335|Dopamine Agents|dopamine agents|mesh-ancestor
25669069|NCT01726517|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25089346|NCT03266731|Aspirin|aspirin|mesh-list
25221195|NCT02651792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24560596|NCT02287818|Gout Suppressants|gout suppressants|mesh-ancestor
24560597|NCT02287818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25145873|NCT02926170|Rivaroxaban|rivaroxaban|mesh-list
24948315|NCT03920644|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24948316|NCT03920644|Parasympatholytics|parasympatholytics|mesh-ancestor
24948317|NCT03920605|Tenofovir|tenofovir|mesh-list
24560598|NCT02255097|Pembrolizumab|pembrolizumab|mesh-list
24560599|NCT02255097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24560607|NCT02218164|Antimetabolites|antimetabolites|mesh-ancestor
24560809|NCT01451515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24560810|NCT01451515|Antiviral Agents|antiviral agents|mesh-ancestor
24560811|NCT01451515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24560812|NCT01451515|Tubulin Modulators|tubulin modulators|mesh-ancestor
24560813|NCT01451515|Antimitotic Agents|antimitotic agents|mesh-ancestor
24560814|NCT01451515|Mitosis Modulators|mitosis modulators|mesh-ancestor
24561174|NCT00758693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24561175|NCT00758693|Immunologic Factors|immunologic factors|mesh-ancestor
24561176|NCT00758693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561177|NCT00758693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24561178|NCT00758693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24561179|NCT00758693|Alkylating Agents|alkylating agents|mesh-ancestor
24561180|NCT00758693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561182|NCT00758732|Docetaxel|docetaxel|mesh-list
24561183|NCT00758732|Doxorubicin|doxorubicin|mesh-list
25863616|NCT00094432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25863617|NCT00094432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561197|NCT00758914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561198|NCT00758914|Antioxidants|antioxidants|mesh-ancestor
24561199|NCT00758914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561200|NCT00758914|Protective Agents|protective agents|mesh-ancestor
24561201|NCT00759005|Hydrocortisone|hydrocortisone|mesh-list
24561208|NCT00759005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561209|NCT00759005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24561210|NCT00759005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24561212|NCT00759005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24561213|NCT00759018|Remestemcel-l|remestemcel-l|mesh-list
24561214|NCT00759018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24561215|NCT00759018|Antiviral Agents|antiviral agents|mesh-ancestor
24561216|NCT00759018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24561218|NCT00759070|Lopinavir|lopinavir|mesh-list
24561219|NCT00759070|Tenofovir|tenofovir|mesh-list
24561220|NCT00759070|Emtricitabine|emtricitabine|mesh-list
24561221|NCT00759070|Efavirenz|efavirenz|mesh-list
24561222|NCT00759070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25051600|NCT00393952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25051601|NCT00393952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25051602|NCT00393952|Autonomic Agents|autonomic agents|mesh-ancestor
25051603|NCT00393952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25051604|NCT00393952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051605|NCT00393952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25051606|NCT00393952|Respiratory System Agents|respiratory system agents|mesh-ancestor
24877020|NCT02998645|Cyclosporine|cyclosporine|mesh-list
25051607|NCT00393952|Dermatologic Agents|dermatologic agents|mesh-ancestor
24596629|NCT00944502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24561244|NCT00759083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24561245|NCT00759083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561246|NCT00759083|Anticoagulants|anticoagulants|mesh-ancestor
24561247|NCT00759122|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24561248|NCT00759122|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24561249|NCT00759122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24561250|NCT00759122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24561251|NCT00759122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561252|NCT00759122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24561253|NCT00759122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561254|NCT00759122|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24561255|NCT00759122|Antidepressive Agents|antidepressive agents|mesh-ancestor
24561256|NCT00759122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25669070|NCT01726517|Antiviral Agents|antiviral agents|mesh-ancestor
24561257|NCT00759200|Interferons|interferons|mesh-list
24561258|NCT00759200|Interferon-alpha|interferon-alpha|mesh-list
24561259|NCT00759200|Interferon alpha-2|interferon alpha-2|mesh-list
25863618|NCT00094432|Dopamine Agonists|dopamine agonists|mesh-ancestor
25863619|NCT00094432|Dopamine Agents|dopamine agents|mesh-ancestor
25863620|NCT00094432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25863621|NCT00094432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863622|NCT00094432|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24561260|NCT00759200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200098|NCT02736032|Contraceptive Agents|contraceptive agents|mesh-ancestor
24561261|NCT00759200|Antiviral Agents|antiviral agents|mesh-ancestor
24561273|NCT00759226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561274|NCT00759226|Antiviral Agents|antiviral agents|mesh-ancestor
24561275|NCT00759226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24561276|NCT00759226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24561277|NCT00759226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24561278|NCT00759226|Immunologic Factors|immunologic factors|mesh-ancestor
24561279|NCT00759226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561280|NCT00759226|Antidotes|antidotes|mesh-ancestor
24561360|NCT00759824|Doxorubicin|doxorubicin|mesh-list
24561361|NCT00759824|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24561362|NCT00759824|Vindesine|vindesine|mesh-list
24561363|NCT00759824|Valproic Acid|valproic acid|mesh-list
24561383|NCT00759824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24561384|NCT00759824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24561385|NCT00759824|Tubulin Modulators|tubulin modulators|mesh-ancestor
24561386|NCT00759824|Antimitotic Agents|antimitotic agents|mesh-ancestor
24561387|NCT00759824|Mitosis Modulators|mitosis modulators|mesh-ancestor
24561388|NCT00759928|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24561389|NCT00759928|Sorafenib|sorafenib|mesh-list
24561390|NCT00759928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24561391|NCT00759928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24561395|NCT00759993|Trace Elements|trace elements|mesh-ancestor
24561396|NCT00759993|Micronutrients|micronutrients|mesh-ancestor
24561397|NCT00759993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561398|NCT00760032|Ciprofloxacin|ciprofloxacin|mesh-list
24561399|NCT00760032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24561400|NCT00760032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24561402|NCT00760032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24561433|NCT00760175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561434|NCT00760279|Azithromycin|azithromycin|mesh-list
24561435|NCT00760279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24561436|NCT00760279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24561437|NCT00760318|Levetiracetam|levetiracetam|mesh-list
24561438|NCT00760318|Anticonvulsants|anticonvulsants|mesh-ancestor
24561439|NCT00760318|Nootropic Agents|nootropic agents|mesh-ancestor
24561440|NCT00760370|Zoledronic Acid|zoledronic acid|mesh-list
25051612|NCT00393952|Adrenergic Agents|adrenergic agents|mesh-ancestor
24565994|NCT00783731|Anesthetics|anesthetics|mesh-ancestor
24561587|NCT00761501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561589|NCT00761540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24561590|NCT00761540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561591|NCT00761540|Incretins|incretins|mesh-ancestor
25051617|NCT00393068|Carboplatin|carboplatin|mesh-list
25051618|NCT00393068|Fluorouracil|fluorouracil|mesh-list
25051619|NCT00393068|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25051620|NCT00393068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25051621|NCT00393068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051622|NCT00393068|Tubulin Modulators|tubulin modulators|mesh-ancestor
25051623|NCT00393068|Antimitotic Agents|antimitotic agents|mesh-ancestor
25051624|NCT00393068|Mitosis Modulators|mitosis modulators|mesh-ancestor
24802268|NCT01989312|Lidocaine|lidocaine|mesh-list
24561593|NCT00761540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25051630|NCT00393068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051631|NCT00393068|Growth Inhibitors|growth inhibitors|mesh-ancestor
25051632|NCT00393068|Antimetabolites|antimetabolites|mesh-ancestor
25051633|NCT00393068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24561679|NCT00762190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561680|NCT00762255|Bevacizumab|bevacizumab|mesh-list
24561681|NCT00762255|Irinotecan|irinotecan|mesh-list
24561682|NCT00762255|Vorinostat|vorinostat|mesh-list
24561683|NCT00762255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24561718|NCT00762567|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24566157|NCT00784511|Micronutrients|micronutrients|mesh-ancestor
24561796|NCT00762775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24561798|NCT00762918|Cholecalciferol|cholecalciferol|mesh-list
24561803|NCT00762918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25669071|NCT01726517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24561805|NCT00762944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24561806|NCT00762944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24561807|NCT00762944|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24561809|NCT00762944|Histamine Agents|histamine agents|mesh-ancestor
24561810|NCT00762944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24561811|NCT00762944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561812|NCT00762944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051649|NCT00391209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051650|NCT00389779|Guanfacine|guanfacine|mesh-list
25051651|NCT00389779|Darusentan|darusentan|mesh-list
25051652|NCT00389779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25051653|NCT00389779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25051654|NCT00389779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25051655|NCT00389779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24802289|NCT01989312|Anesthetics, General|anesthetics, general|mesh-ancestor
24802290|NCT01989312|GABA Modulators|gaba modulators|mesh-ancestor
24561857|NCT00763204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24948341|NCT03920150|Micronutrients|micronutrients|mesh-ancestor
24948342|NCT03920150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948343|NCT03920150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24948344|NCT03920150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24948345|NCT03920137|Nicotine|nicotine|mesh-list
24561939|NCT00763763|Tubulin Modulators|tubulin modulators|mesh-ancestor
24561940|NCT00763763|Antimitotic Agents|antimitotic agents|mesh-ancestor
24561941|NCT00763763|Mitosis Modulators|mitosis modulators|mesh-ancestor
24561942|NCT00763763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561943|NCT00763763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24561944|NCT00763763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24561945|NCT00763763|Immunologic Factors|immunologic factors|mesh-ancestor
24561978|NCT00763906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561988|NCT00763997|Valdecoxib|valdecoxib|mesh-list
24561989|NCT00763997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24561990|NCT00763997|Analgesics|analgesics|mesh-ancestor
24562001|NCT00763997|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24562002|NCT00764036|Artesunate|artesunate|mesh-list
24562003|NCT00764036|Antimalarials|antimalarials|mesh-ancestor
24562004|NCT00764036|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24562005|NCT00764036|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24562019|NCT00764140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562021|NCT00764166|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24562022|NCT00764166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562023|NCT00764166|Tubulin Modulators|tubulin modulators|mesh-ancestor
24562024|NCT00764166|Antimitotic Agents|antimitotic agents|mesh-ancestor
24562025|NCT00764166|Mitosis Modulators|mitosis modulators|mesh-ancestor
24562121|NCT00764725|Antimetabolites|antimetabolites|mesh-ancestor
24562122|NCT00764725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863623|NCT00094432|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25863624|NCT00094432|Serotonin Agents|serotonin agents|mesh-ancestor
25863625|NCT00094432|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24562217|NCT00764972|Mitosis Modulators|mitosis modulators|mesh-ancestor
24562219|NCT00765011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24562220|NCT00765011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562221|NCT00765024|Ivermectin|ivermectin|mesh-list
24562222|NCT00765024|Albendazole|albendazole|mesh-list
24562223|NCT00765024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24562224|NCT00765024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24562225|NCT00765024|Anthelmintics|anthelmintics|mesh-ancestor
24562226|NCT00765024|Anticestodal Agents|anticestodal agents|mesh-ancestor
24562227|NCT00765024|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25863626|NCT00094432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25863627|NCT00094432|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24562306|NCT00765934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24562307|NCT00765934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24562308|NCT00765934|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24562309|NCT00765934|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24562310|NCT00765934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24562311|NCT00765934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562313|NCT00765973|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24562314|NCT00765973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24562316|NCT00765973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562550|NCT00766896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24562551|NCT00766896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562552|NCT00766896|Antipyretics|antipyretics|mesh-ancestor
24562553|NCT00766909|Cyclosporine|cyclosporine|mesh-list
24562554|NCT00766909|Tacrolimus|tacrolimus|mesh-list
24633063|NCT01127100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24948429|NCT03919942|Disinfectants|disinfectants|mesh-ancestor
24948430|NCT03919812|Cholecalciferol|cholecalciferol|mesh-list
24948431|NCT03919812|Vitamin D|vitamin d|mesh-list
25863628|NCT00094432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24562616|NCT00767286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562617|NCT00767286|Androgen Antagonists|androgen antagonists|mesh-ancestor
24562618|NCT00767286|Hormone Antagonists|hormone antagonists|mesh-ancestor
24562619|NCT00767286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24562620|NCT00767468|Sorafenib|sorafenib|mesh-list
25200099|NCT02736032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25200100|NCT02736032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25200101|NCT02736032|Progestins|progestins|mesh-ancestor
25200102|NCT02736032|Luteolytic Agents|luteolytic agents|mesh-ancestor
25200103|NCT02736032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25047753|NCT00765804|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24948432|NCT03919812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24948433|NCT03919812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948436|NCT03919812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24948437|NCT03919656|Dapagliflozin|dapagliflozin|mesh-list
24948438|NCT03919656|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24948439|NCT03919656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948440|NCT03919656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24948441|NCT03919656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948442|NCT03919552|Cisplatin|cisplatin|mesh-list
24948443|NCT03919552|Carboplatin|carboplatin|mesh-list
24948444|NCT03919552|Docetaxel|docetaxel|mesh-list
24948445|NCT03919552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24802432|NCT01990079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24802433|NCT01990079|Antidepressive Agents|antidepressive agents|mesh-ancestor
24567422|NCT00791167|Serotonin Agents|serotonin agents|mesh-ancestor
24948447|NCT03919552|Antimitotic Agents|antimitotic agents|mesh-ancestor
24562817|NCT00768456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24562819|NCT00768508|Ondansetron|ondansetron|mesh-list
24567666|NCT00792012|Alkylating Agents|alkylating agents|mesh-ancestor
24562912|NCT00768911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24567797|NCT00792766|Everolimus|everolimus|mesh-list
24671038|NCT01323296|Hematinics|hematinics|mesh-ancestor
24563102|NCT00770042|Hormone Antagonists|hormone antagonists|mesh-ancestor
24563103|NCT00770042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24563104|NCT00770042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563132|NCT00770302|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24563134|NCT00770302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563135|NCT00770302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563136|NCT00770302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25051668|NCT00389675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25051669|NCT00389675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051670|NCT00389675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051671|NCT00389675|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25051672|NCT00389155|Gemcitabine|gemcitabine|mesh-list
25051673|NCT00389155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25051674|NCT00389155|Antimetabolites|antimetabolites|mesh-ancestor
25212263|NCT01986114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25051675|NCT00389155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802476|NCT01990404|Nitrous Oxide|nitrous oxide|mesh-list
24563138|NCT00770354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24563139|NCT00770354|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24563140|NCT00770354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24563141|NCT00770354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563142|NCT00770354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563152|NCT00770406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563191|NCT00770536|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24563195|NCT00770536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563196|NCT00770536|Growth Inhibitors|growth inhibitors|mesh-ancestor
24563197|NCT00770575|Pioglitazone|pioglitazone|mesh-list
25669072|NCT01726621|Insulin|insulin|mesh-list
25669073|NCT01726621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24563198|NCT00770575|Atorvastatin|atorvastatin|mesh-list
25669074|NCT01726621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669075|NCT01726738|Trametinib|trametinib|mesh-list
25669076|NCT01726738|Dabrafenib|dabrafenib|mesh-list
25669077|NCT01726738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669078|NCT01726738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24633174|NCT01127529|Anticoagulants|anticoagulants|mesh-ancestor
24952395|NCT03894085|Paroxetine|paroxetine|mesh-list
24563199|NCT00770575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24563200|NCT00770575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24563201|NCT00770575|Antimetabolites|antimetabolites|mesh-ancestor
24563202|NCT00770575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563203|NCT00770575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24563204|NCT00770575|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24563205|NCT00770575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563206|NCT00770575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24563207|NCT00770575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563208|NCT00770640|Insulin|insulin|mesh-list
24563209|NCT00770640|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24563210|NCT00770640|Pioglitazone|pioglitazone|mesh-list
24563211|NCT00770640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24563212|NCT00770640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563214|NCT00770666|Nicotine|nicotine|mesh-list
24563215|NCT00770666|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24563216|NCT00770666|Autonomic Agents|autonomic agents|mesh-ancestor
24563217|NCT00770666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25051676|NCT00389155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051677|NCT00389155|Antiviral Agents|antiviral agents|mesh-ancestor
25051678|NCT00389155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24568121|NCT00794755|Vitamin K|vitamin k|mesh-list
24563282|NCT00770796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24563283|NCT00770796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24563284|NCT00770796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563286|NCT00770835|Pioglitazone|pioglitazone|mesh-list
24563287|NCT00770835|Glyburide|glyburide|mesh-list
24563288|NCT00770835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24563289|NCT00770835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563290|NCT00770900|Montelukast|montelukast|mesh-list
24563291|NCT00770900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24563292|NCT00770900|Respiratory System Agents|respiratory system agents|mesh-ancestor
24563293|NCT00770900|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24563294|NCT00770900|Hormone Antagonists|hormone antagonists|mesh-ancestor
25051684|NCT00388960|Amrubicin|amrubicin|mesh-list
25051685|NCT00388960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051686|NCT00388960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25051687|NCT00388960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25051688|NCT00388960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25051689|NCT00388960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051690|NCT00388960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051691|NCT00387907|Trastuzumab|trastuzumab|mesh-list
24802491|NCT01990586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24563317|NCT00771017|Bicalutamide|bicalutamide|mesh-list
24563318|NCT00771017|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24563319|NCT00771017|Fertility Agents|fertility agents|mesh-ancestor
24563320|NCT00771017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24563321|NCT00771017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563322|NCT00771017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24563323|NCT00771017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24563324|NCT00771017|Androgen Antagonists|androgen antagonists|mesh-ancestor
24563325|NCT00771017|Hormone Antagonists|hormone antagonists|mesh-ancestor
24563326|NCT00771017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24563327|NCT00771043|Natalizumab|natalizumab|mesh-list
24563328|NCT00771043|Immunologic Factors|immunologic factors|mesh-ancestor
24563348|NCT00771251|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24563349|NCT00771251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24563352|NCT00771251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563353|NCT00771303|Fibrin fragment D|fibrin fragment d|mesh-list
24563354|NCT00771303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24563356|NCT00771303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563357|NCT00771303|Hemostatics|hemostatics|mesh-ancestor
24563360|NCT00771342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24563361|NCT00771342|Autonomic Agents|autonomic agents|mesh-ancestor
24563362|NCT00771342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24563363|NCT00771342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563364|NCT00771342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25051692|NCT00387907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25051693|NCT00387907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051694|NCT00385515|Meclocycline|meclocycline|mesh-list
25669079|NCT01726738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25669080|NCT01726738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051695|NCT00385515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25051696|NCT00385515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25051697|NCT00384904|Ritonavir|ritonavir|mesh-list
24563365|NCT00771342|Respiratory System Agents|respiratory system agents|mesh-ancestor
24563366|NCT00771342|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24563367|NCT00771342|Antioxidants|antioxidants|mesh-ancestor
24563374|NCT00771368|Nitric Oxide|nitric oxide|mesh-list
24563391|NCT00771381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563392|NCT00771394|Tamsulosin|tamsulosin|mesh-list
24563393|NCT00771394|Solifenacin Succinate|solifenacin succinate|mesh-list
24563394|NCT00771394|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24563395|NCT00771394|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24563396|NCT00771394|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24563397|NCT00771394|Adrenergic Agents|adrenergic agents|mesh-ancestor
24563398|NCT00771394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24568281|NCT00795496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051703|NCT00384904|Protease Inhibitors|protease inhibitors|mesh-ancestor
25051704|NCT00384904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051705|NCT00384904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051706|NCT00384904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25051707|NCT00384904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25051708|NCT00384904|Antiviral Agents|antiviral agents|mesh-ancestor
24568370|NCT00795808|Hormone Antagonists|hormone antagonists|mesh-ancestor
24563514|NCT00772161|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24563515|NCT00772161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24563516|NCT00772161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24563517|NCT00772161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563518|NCT00772161|Dopamine Agents|dopamine agents|mesh-ancestor
24563519|NCT00772161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24563520|NCT00772174|Metformin|metformin|mesh-list
24563521|NCT00772174|Pioglitazone|pioglitazone|mesh-list
24563522|NCT00772174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24563523|NCT00772174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051726|NCT00384150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563788|NCT00773578|Protective Agents|protective agents|mesh-ancestor
24563789|NCT00773591|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24563790|NCT00773591|Botulinum Toxins|botulinum toxins|mesh-list
24563791|NCT00773591|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24563792|NCT00773591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24563795|NCT00773591|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24563796|NCT00773591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24563840|NCT00773916|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24564008|NCT00774722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24564009|NCT00774722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24564058|NCT00774982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564064|NCT00775047|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24564065|NCT00775047|Medroxyprogesterone|medroxyprogesterone|mesh-list
25200105|NCT02736071|Celecoxib|celecoxib|mesh-list
25200106|NCT02736071|Tramadol|tramadol|mesh-list
24564066|NCT00775047|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24564067|NCT00775047|Contraceptive Agents|contraceptive agents|mesh-ancestor
24564068|NCT00775047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24564091|NCT00775086|Estradiol|estradiol|mesh-list
24564092|NCT00775086|Estrogens|estrogens|mesh-ancestor
24628871|NCT01101698|Micronutrients|micronutrients|mesh-ancestor
24628872|NCT01101698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628873|NCT01101698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24628874|NCT01101698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24964093|NCT03785613|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24964094|NCT03785613|Narcotics|narcotics|mesh-ancestor
24628875|NCT01101698|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25863629|NCT00094484|Cinacalcet|cinacalcet|mesh-list
24564121|NCT00775151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564279|NCT00775762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24564280|NCT00775762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564281|NCT00775762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24564282|NCT00775762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24564283|NCT00775762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24564284|NCT00775762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24564339|NCT00775996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24564340|NCT00775996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24564341|NCT00775996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25669081|NCT01727024|Tiotropium Bromide|tiotropium bromide|mesh-list
25429575|NCT01485861|Prednisone|prednisone|mesh-list
25221269|NCT02651636|Folic Acid|folic acid|mesh-list
25221270|NCT02651636|Thioctic Acid|thioctic acid|mesh-list
25863630|NCT00094484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25863631|NCT00094484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564342|NCT00775996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564343|NCT00775996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24564344|NCT00775996|GABA Modulators|gaba modulators|mesh-ancestor
24564345|NCT00775996|GABA Agents|gaba agents|mesh-ancestor
25863632|NCT00094484|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24564455|NCT00776477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24564456|NCT00776490|Glimepiride|glimepiride|mesh-list
24564457|NCT00776490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24564458|NCT00776490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24564459|NCT00776490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564460|NCT00776490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24564461|NCT00776490|Immunologic Factors|immunologic factors|mesh-ancestor
24564462|NCT00776503|Vorinostat|vorinostat|mesh-list
24564467|NCT00776516|Rifampin|rifampin|mesh-list
24564487|NCT00776516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24564488|NCT00776516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564489|NCT00776516|Urological Agents|urological agents|mesh-ancestor
24564490|NCT00776542|Minocycline|minocycline|mesh-list
24564491|NCT00776542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24564492|NCT00776542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24564493|NCT00776568|Antihypertensive Agents|antihypertensive agents|mesh-list
24568938|NCT00798148|Etoposide|etoposide|mesh-list
24564806|NCT00777998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24564807|NCT00777998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24564809|NCT00777998|Growth Inhibitors|growth inhibitors|mesh-ancestor
24564810|NCT00777998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24564811|NCT00777998|Trace Elements|trace elements|mesh-ancestor
24564812|NCT00777998|Micronutrients|micronutrients|mesh-ancestor
24564867|NCT00778063|Sensory System Agents|sensory system agents|mesh-ancestor
24564947|NCT00778232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24564948|NCT00778232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24564949|NCT00778232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24569034|NCT00798616|Glucocorticoids|glucocorticoids|mesh-ancestor
24565253|NCT00779441|GABA Agonists|gaba agonists|mesh-ancestor
24565254|NCT00779441|GABA Agents|gaba agents|mesh-ancestor
24565255|NCT00779441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24565256|NCT00779441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565257|NCT00779454|Gemcitabine|gemcitabine|mesh-list
24565259|NCT00779454|Oxaliplatin|oxaliplatin|mesh-list
24565524|NCT00781105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565526|NCT00781131|Analgesics|analgesics|mesh-ancestor
24565527|NCT00781131|Sensory System Agents|sensory system agents|mesh-ancestor
24565528|NCT00781131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24565529|NCT00781131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565530|NCT00781131|Anticonvulsants|anticonvulsants|mesh-ancestor
24565531|NCT00781131|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24964102|NCT03785522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24964103|NCT03785522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414141|NCT00196365|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24948476|NCT03919448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24948478|NCT03919448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24948479|NCT03919448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24948480|NCT03919448|Growth Substances|growth substances|mesh-ancestor
24802535|NCT01990781|Anesthetics, Local|anesthetics, local|mesh-ancestor
24565761|NCT00782327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565762|NCT00782405|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24565763|NCT00782405|Mirtazapine|mirtazapine|mesh-list
24565764|NCT00782405|Antidepressive Agents|antidepressive agents|mesh-ancestor
24565765|NCT00782405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24565766|NCT00782405|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24565767|NCT00782405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24565768|NCT00782405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24565858|NCT00783081|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24565859|NCT00783081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565860|NCT00783081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24565861|NCT00783081|Vasodilator Agents|vasodilator agents|mesh-ancestor
24565982|NCT00783653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24569246|NCT00799539|Immunologic Factors|immunologic factors|mesh-ancestor
24566146|NCT00784498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566147|NCT00784498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25669082|NCT01727024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25669083|NCT01727024|Autonomic Agents|autonomic agents|mesh-ancestor
24566148|NCT00784498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25221278|NCT02651636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566202|NCT00784745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24566203|NCT00784745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24566204|NCT00784745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566263|NCT00784914|Immunologic Factors|immunologic factors|mesh-ancestor
24566264|NCT00784914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566299|NCT00785083|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24566300|NCT00785083|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24566301|NCT00785083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566303|NCT00785083|Immunologic Factors|immunologic factors|mesh-ancestor
24948500|NCT03919461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948501|NCT03919461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24948502|NCT03919461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24948503|NCT03919461|Vasodilator Agents|vasodilator agents|mesh-ancestor
24948504|NCT03919461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24948505|NCT03919461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24948506|NCT03919461|Analgesics|analgesics|mesh-ancestor
24948507|NCT03919461|Sensory System Agents|sensory system agents|mesh-ancestor
24948508|NCT03919461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24948509|NCT03919461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24566304|NCT00785083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566305|NCT00785109|Vitamin K|vitamin k|mesh-list
24566306|NCT00785109|Vitamins|vitamins|mesh-ancestor
24566307|NCT00785109|Micronutrients|micronutrients|mesh-ancestor
24566308|NCT00785109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566309|NCT00785109|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24566310|NCT00785109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24566311|NCT00785109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566312|NCT00785109|Hemostatics|hemostatics|mesh-ancestor
24566313|NCT00785109|Coagulants|coagulants|mesh-ancestor
24566314|NCT00785122|Cyclophosphamide|cyclophosphamide|mesh-list
24566315|NCT00785122|Molgramostim|molgramostim|mesh-list
24566437|NCT00785603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566453|NCT00785863|Parecoxib|parecoxib|mesh-list
25146561|NCT02920567|Octreotide|octreotide|mesh-list
24566469|NCT00785863|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24566470|NCT00785941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24566471|NCT00785941|Immunologic Factors|immunologic factors|mesh-ancestor
24566472|NCT00785941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566473|NCT00785967|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24566474|NCT00785967|Immunologic Factors|immunologic factors|mesh-ancestor
24566475|NCT00785967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566476|NCT00786058|Fluorouracil|fluorouracil|mesh-list
24566477|NCT00786058|Antimetabolites|antimetabolites|mesh-ancestor
24566478|NCT00786058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566479|NCT00786058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24566480|NCT00786058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566481|NCT00786058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24566482|NCT00786058|Immunologic Factors|immunologic factors|mesh-ancestor
24948510|NCT03919461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24773837|NCT01842256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773838|NCT01842256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24773839|NCT01842256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24773840|NCT01842256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24566607|NCT00786669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566608|NCT00786669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24566609|NCT00786669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24566610|NCT00786669|Growth Substances|growth substances|mesh-ancestor
24566611|NCT00786669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773848|NCT01842269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24773849|NCT01842269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24773850|NCT01842269|Antitubercular Agents|antitubercular agents|mesh-ancestor
24566713|NCT00787462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24566714|NCT00787462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566720|NCT00787462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25863633|NCT00094484|Hormone Antagonists|hormone antagonists|mesh-ancestor
24566751|NCT00787657|Interferons|interferons|mesh-list
24566752|NCT00787657|Interferon-beta|interferon-beta|mesh-list
24566753|NCT00787657|Interferon beta-1b|interferon beta-1b|mesh-list
24566754|NCT00787657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566755|NCT00787657|Antiviral Agents|antiviral agents|mesh-ancestor
25669084|NCT01727024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25221304|NCT02651350|Glucocorticoids|glucocorticoids|mesh-ancestor
24566756|NCT00787657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24566757|NCT00787657|Immunologic Factors|immunologic factors|mesh-ancestor
24566758|NCT00787657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566759|NCT00787657|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24566760|NCT00787774|Raltegravir Potassium|raltegravir potassium|mesh-list
24566761|NCT00787774|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24566762|NCT00787774|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24566763|NCT00787774|Antiviral Agents|antiviral agents|mesh-ancestor
24566764|NCT00787774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24566765|NCT00787774|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24566766|NCT00787774|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24566767|NCT00787774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566815|NCT00788047|Antitussive Agents|antitussive agents|mesh-ancestor
24566816|NCT00788047|Respiratory System Agents|respiratory system agents|mesh-ancestor
24566817|NCT00788047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24566818|NCT00788047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24566819|NCT00788047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24566820|NCT00788047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112727|NCT03919526|Cyclophosphamide|cyclophosphamide|mesh-list
24566821|NCT00788047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566823|NCT00788060|Sunitinib|sunitinib|mesh-list
24566824|NCT00788060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566825|NCT00788060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24773851|NCT01842269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24948511|NCT03919461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24948512|NCT03919461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24566826|NCT00788060|Immunologic Factors|immunologic factors|mesh-ancestor
24566827|NCT00788060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566829|NCT00788060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24566830|NCT00788060|Growth Substances|growth substances|mesh-ancestor
24566831|NCT00788060|Growth Inhibitors|growth inhibitors|mesh-ancestor
24566832|NCT00788060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24566960|NCT00788749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566961|NCT00788840|Isophane Insulin, Human|isophane insulin, human|mesh-list
24566962|NCT00788840|Insulin, Isophane|insulin, isophane|mesh-list
24566963|NCT00788840|Isophane insulin, beef|isophane insulin, beef|mesh-list
24566964|NCT00788840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24566965|NCT00788840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566966|NCT00788918|Interferons|interferons|mesh-list
24822454|NCT02112006|Bupivacaine|bupivacaine|mesh-list
24566968|NCT00788918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566969|NCT00788918|Antiviral Agents|antiviral agents|mesh-ancestor
24566970|NCT00788918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24566971|NCT00788918|Antimetabolites|antimetabolites|mesh-ancestor
24566972|NCT00788918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566973|NCT00788931|Paclitaxel|paclitaxel|mesh-list
24566974|NCT00788931|Trastuzumab|trastuzumab|mesh-list
24791969|NCT02138617|Vitamins|vitamins|mesh-ancestor
24948513|NCT03919461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24948515|NCT03919175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24948516|NCT03919175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24948517|NCT03919175|Immunologic Factors|immunologic factors|mesh-ancestor
24948518|NCT03919175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948519|NCT03919175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24948520|NCT03918993|Tadalafil|tadalafil|mesh-list
24948521|NCT03918993|Vasodilator Agents|vasodilator agents|mesh-ancestor
24948522|NCT03918993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24948523|NCT03918993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24948524|NCT03918993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24948525|NCT03918993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948526|NCT03918993|Urological Agents|urological agents|mesh-ancestor
24948527|NCT03918616|Dopamine|dopamine|mesh-list
24948528|NCT03918616|Memantine|memantine|mesh-list
24948529|NCT03918616|Dopamine Agonists|dopamine agonists|mesh-list
24948530|NCT03918616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24567069|NCT00789386|Sensory System Agents|sensory system agents|mesh-ancestor
24567070|NCT00789386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24567082|NCT00789464|Trimethoprim|trimethoprim|mesh-list
24567083|NCT00789464|Sulfamethoxazole|sulfamethoxazole|mesh-list
24567084|NCT00789464|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24567117|NCT00789568|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24567118|NCT00789568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24567119|NCT00789568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24567120|NCT00789620|Lidocaine|lidocaine|mesh-list
24567121|NCT00789620|Anesthetics, Local|anesthetics, local|mesh-ancestor
24567122|NCT00789620|Anesthetics|anesthetics|mesh-ancestor
25221329|NCT02651311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25221330|NCT02651311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221331|NCT02651311|Analgesics|analgesics|mesh-ancestor
25089524|NCT03265197|Lidocaine|lidocaine|mesh-list
24567123|NCT00789620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25200108|NCT02736071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25200109|NCT02736071|Analgesics|analgesics|mesh-ancestor
25200110|NCT02736071|Sensory System Agents|sensory system agents|mesh-ancestor
25200111|NCT02736071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25200112|NCT02736071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200113|NCT02736071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25200114|NCT02736071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25200115|NCT02736071|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25200116|NCT02736071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25200117|NCT02736071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146701|NCT02919501|Vortioxetine|vortioxetine|mesh-list
24567124|NCT00789620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567125|NCT00789620|Sensory System Agents|sensory system agents|mesh-ancestor
24567234|NCT00790179|Anesthetics|anesthetics|mesh-ancestor
24567235|NCT00790179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24567236|NCT00790179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567237|NCT00790179|Sensory System Agents|sensory system agents|mesh-ancestor
24567248|NCT00790244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567249|NCT00790244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24567250|NCT00790244|Alkylating Agents|alkylating agents|mesh-ancestor
24567390|NCT00790998|Antinematodal Agents|antinematodal agents|mesh-ancestor
24567391|NCT00791011|Bortezomib|bortezomib|mesh-list
24567392|NCT00791011|Vorinostat|vorinostat|mesh-list
24567393|NCT00791011|Conatumumab|conatumumab|mesh-list
24567452|NCT00791232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567453|NCT00791232|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24567454|NCT00791232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24567455|NCT00791232|Dopamine Agents|dopamine agents|mesh-ancestor
24567456|NCT00791271|Interferons|interferons|mesh-list
24567457|NCT00791271|Interferon-alpha|interferon-alpha|mesh-list
24567458|NCT00791271|Interferon alpha-2|interferon alpha-2|mesh-list
25876770|NCT02794571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567495|NCT00791349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24567500|NCT00791349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567502|NCT00791349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24567504|NCT00791401|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24567505|NCT00791401|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24567506|NCT00791401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24567507|NCT00791401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24567508|NCT00791401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567509|NCT00791401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24567510|NCT00791401|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24567523|NCT00791427|Growth Inhibitors|growth inhibitors|mesh-ancestor
24567524|NCT00791427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24567526|NCT00791505|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24567527|NCT00791505|Fluoroquinolones|fluoroquinolones|mesh-list
24567528|NCT00791505|Trimethoprim|trimethoprim|mesh-list
24567539|NCT00791505|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24567540|NCT00791505|Renal Agents|renal agents|mesh-ancestor
24567541|NCT00791505|Antimalarials|antimalarials|mesh-ancestor
24567542|NCT00791505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24567543|NCT00791505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24567821|NCT00792818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567822|NCT00792818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815653|NCT02071433|Iodine|iodine|mesh-list
24671031|NCT01323257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24567823|NCT00792818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24567824|NCT00792818|Antioxidants|antioxidants|mesh-ancestor
24567825|NCT00792818|Protective Agents|protective agents|mesh-ancestor
24567826|NCT00792857|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
24567827|NCT00792857|Vitamins|vitamins|mesh-ancestor
24567828|NCT00792857|Micronutrients|micronutrients|mesh-ancestor
24567908|NCT00793377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24567909|NCT00793377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24567910|NCT00793377|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25669085|NCT01727024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669086|NCT01727024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25669087|NCT01727024|Respiratory System Agents|respiratory system agents|mesh-ancestor
24567911|NCT00793377|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24567914|NCT00793429|Laxatives|laxatives|mesh-ancestor
24567915|NCT00793429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24567916|NCT00793429|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24567917|NCT00793429|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24567918|NCT00793429|Serotonin Agents|serotonin agents|mesh-ancestor
24567919|NCT00793429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24567920|NCT00793429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567921|NCT00793429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567922|NCT00793468|Nicotine|nicotine|mesh-list
24567923|NCT00793468|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24567924|NCT00793468|Autonomic Agents|autonomic agents|mesh-ancestor
24567925|NCT00793468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24567926|NCT00793468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567927|NCT00793468|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25200118|NCT02736071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863634|NCT00094484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25863635|NCT00094523|Fosamprenavir|fosamprenavir|mesh-list
25146765|NCT02919345|Glyburide|glyburide|mesh-list
24567949|NCT00793663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24568264|NCT00795457|Immunologic Factors|immunologic factors|mesh-ancestor
24568265|NCT00795457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568269|NCT00795457|Antiviral Agents|antiviral agents|mesh-ancestor
24568270|NCT00795457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24568271|NCT00795470|Anti-Infective Agents|anti-infective agents|mesh-list
24568321|NCT00795678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24568426|NCT00795925|Cholinergic Agents|cholinergic agents|mesh-ancestor
24568427|NCT00795925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24568428|NCT00795925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568429|NCT00795925|Urological Agents|urological agents|mesh-ancestor
24568431|NCT00795938|Vasodilator Agents|vasodilator agents|mesh-ancestor
24568432|NCT00795938|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24568433|NCT00795938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24568434|NCT00795938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24568435|NCT00795938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568436|NCT00795938|Urological Agents|urological agents|mesh-ancestor
24568438|NCT00795977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24568439|NCT00796029|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24568440|NCT00796029|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24568482|NCT00796185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24568483|NCT00796185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568484|NCT00796185|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24568485|NCT00796185|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24568487|NCT00796198|Latanoprost|latanoprost|mesh-list
24568504|NCT00796250|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24568505|NCT00796250|Methylprednisolone|methylprednisolone|mesh-list
24568506|NCT00796250|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24568507|NCT00796250|Prednisolone acetate|prednisolone acetate|mesh-list
24568508|NCT00796250|Azathioprine|azathioprine|mesh-list
24568509|NCT00796250|Infliximab|infliximab|mesh-list
24568510|NCT00796250|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24568511|NCT00796250|Prednisolone phosphate|prednisolone phosphate|mesh-list
24568512|NCT00796250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24568513|NCT00796250|Glucocorticoids|glucocorticoids|mesh-ancestor
24568514|NCT00796250|Hormones|hormones|mesh-ancestor
24568561|NCT00796432|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24568622|NCT00796640|Dopamine Agents|dopamine agents|mesh-ancestor
24568624|NCT00796692|Calcium heparin|calcium heparin|mesh-list
25669088|NCT01727024|Parasympatholytics|parasympatholytics|mesh-ancestor
25669089|NCT01727024|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24568625|NCT00796692|Nadroparin|nadroparin|mesh-list
24568626|NCT00796692|Anticoagulants|anticoagulants|mesh-ancestor
24568627|NCT00796692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25669090|NCT01727024|Cholinergic Agents|cholinergic agents|mesh-ancestor
25669091|NCT01727024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25669092|NCT01727024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669093|NCT01727089|Bevacizumab|bevacizumab|mesh-list
25669094|NCT01727089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25669095|NCT01727089|Endothelial Growth Factors|endothelial growth factors|mesh-list
25669096|NCT01727089|Antibodies|antibodies|mesh-list
25669097|NCT01727089|Immunoglobulins|immunoglobulins|mesh-list
25669098|NCT01727089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24568628|NCT00796692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24948552|NCT03918590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25200119|NCT02736071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25200120|NCT02736071|Narcotics|narcotics|mesh-ancestor
25200121|NCT02736071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25200122|NCT02736123|Nivolumab|nivolumab|mesh-list
25200123|NCT02736123|Ipilimumab|ipilimumab|mesh-list
25200124|NCT02736123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25200125|NCT02736123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200126|NCT02736123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24568629|NCT00796692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568630|NCT00796796|Sirolimus|sirolimus|mesh-list
24568631|NCT00796796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24568632|NCT00796796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24568633|NCT00796796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24568634|NCT00796796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24568635|NCT00796796|Antifungal Agents|antifungal agents|mesh-ancestor
24568636|NCT00796796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24568637|NCT00796796|Immunologic Factors|immunologic factors|mesh-ancestor
24568638|NCT00796796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568639|NCT00796835|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24568640|NCT00796835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24568641|NCT00796835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24568681|NCT00797017|Anesthetics|anesthetics|mesh-ancestor
24568682|NCT00797030|Cyclosporine|cyclosporine|mesh-list
24568683|NCT00797030|Cyclosporins|cyclosporins|mesh-list
24568684|NCT00797030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24568685|NCT00797030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568686|NCT00797030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24568687|NCT00797030|Immunologic Factors|immunologic factors|mesh-ancestor
24568740|NCT00797303|Bevacizumab|bevacizumab|mesh-list
24568741|NCT00797303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24568742|NCT00797303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24568743|NCT00797303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24568757|NCT00797420|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24568758|NCT00797420|Hormone Antagonists|hormone antagonists|mesh-ancestor
24568759|NCT00797420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24568760|NCT00797420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568761|NCT00797420|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24568762|NCT00797420|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24568775|NCT00797485|Leucovorin|leucovorin|mesh-list
24568776|NCT00797485|Bevacizumab|bevacizumab|mesh-list
24568777|NCT00797485|Fluorouracil|fluorouracil|mesh-list
24568778|NCT00797485|Capecitabine|capecitabine|mesh-list
24568780|NCT00797485|Calcium|calcium|mesh-list
24568781|NCT00797485|Levoleucovorin|levoleucovorin|mesh-list
24568782|NCT00797485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24568783|NCT00797485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24568784|NCT00797485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24568785|NCT00797485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24568786|NCT00797485|Growth Substances|growth substances|mesh-ancestor
24568787|NCT00797485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948558|NCT03918694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948560|NCT03918694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568788|NCT00797485|Growth Inhibitors|growth inhibitors|mesh-ancestor
24568789|NCT00797485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24568839|NCT00797784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24568840|NCT00797784|Immunologic Factors|immunologic factors|mesh-ancestor
24568841|NCT00797810|Cytarabine|cytarabine|mesh-list
24568842|NCT00797810|Dexamethasone|dexamethasone|mesh-list
24568843|NCT00797810|Prednisone|prednisone|mesh-list
24568844|NCT00797810|Cyclophosphamide|cyclophosphamide|mesh-list
24568845|NCT00797810|Ifosfamide|ifosfamide|mesh-list
24568846|NCT00797810|Rituximab|rituximab|mesh-list
24568847|NCT00797810|Vincristine|vincristine|mesh-list
24568864|NCT00797810|Hormones|hormones|mesh-ancestor
24568868|NCT00797810|Antimetabolites|antimetabolites|mesh-ancestor
24878370|NCT01861314|Decitabine|decitabine|mesh-list
24568891|NCT00798070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25669099|NCT01727089|Immunoglobulin G|immunoglobulin g|mesh-list
24568892|NCT00798070|Immunologic Factors|immunologic factors|mesh-ancestor
24568904|NCT00798070|Mitosis Modulators|mitosis modulators|mesh-ancestor
24568905|NCT00798070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24568906|NCT00798070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24568907|NCT00798070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24568908|NCT00798070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24568909|NCT00798083|Lidocaine|lidocaine|mesh-list
25200127|NCT02736123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200128|NCT02736019|Celecoxib|celecoxib|mesh-list
25200129|NCT02736019|Tramadol|tramadol|mesh-list
24568922|NCT00798083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568923|NCT00798083|Analgesics|analgesics|mesh-ancestor
24568924|NCT00798083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24568925|NCT00798083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24568926|NCT00798083|Anesthetics, General|anesthetics, general|mesh-ancestor
24568927|NCT00798083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24568928|NCT00798083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24568929|NCT00798083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24568930|NCT00798083|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24568931|NCT00798083|Antidepressive Agents|antidepressive agents|mesh-ancestor
25863636|NCT00094523|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24568941|NCT00798148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24568942|NCT00798148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24568943|NCT00798148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24568944|NCT00798148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24569007|NCT00798473|Zoledronic Acid|zoledronic acid|mesh-list
24569008|NCT00798473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24569009|NCT00798473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569010|NCT00798525|Lepirudin|lepirudin|mesh-list
24569011|NCT00798525|Argatroban|argatroban|mesh-list
24569012|NCT00798525|Antithrombins|antithrombins|mesh-ancestor
24569013|NCT00798525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24569014|NCT00798525|Protease Inhibitors|protease inhibitors|mesh-ancestor
24569015|NCT00798525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24569016|NCT00798525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569126|NCT00799136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24569127|NCT00799136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569128|NCT00799136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24569129|NCT00799136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24569130|NCT00799136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24569131|NCT00799136|Tubulin Modulators|tubulin modulators|mesh-ancestor
24569132|NCT00799136|Antimitotic Agents|antimitotic agents|mesh-ancestor
24569157|NCT00799149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24569158|NCT00799175|Ketorolac|ketorolac|mesh-list
24569159|NCT00799175|Epinephrine|epinephrine|mesh-list
24569160|NCT00799175|Ropivacaine|ropivacaine|mesh-list
24569161|NCT00799175|Anesthetics, Local|anesthetics, local|mesh-ancestor
24569162|NCT00799175|Anesthetics|anesthetics|mesh-ancestor
24569163|NCT00799175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24569164|NCT00799175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569167|NCT00799175|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24569168|NCT00799175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24569169|NCT00799175|Adrenergic Agents|adrenergic agents|mesh-ancestor
24569170|NCT00799175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24570358|NCT00804531|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24948564|NCT03918889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24948565|NCT03918889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24569470|NCT00800709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24569471|NCT00800709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24569473|NCT00800722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24569474|NCT00800722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24569475|NCT00800722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24569476|NCT00800722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24569478|NCT00800722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24569479|NCT00800722|Immunologic Factors|immunologic factors|mesh-ancestor
24569511|NCT00800826|Sensory System Agents|sensory system agents|mesh-ancestor
24569512|NCT00800826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24569513|NCT00800826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25200130|NCT02736019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25200131|NCT02736019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24569700|NCT00801515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24569701|NCT00801515|Antiviral Agents|antiviral agents|mesh-ancestor
24569702|NCT00801515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25863637|NCT00094523|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25863638|NCT00094523|Protease Inhibitors|protease inhibitors|mesh-ancestor
25863639|NCT00094523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863640|NCT00094523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569758|NCT00801866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24569759|NCT00801866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863641|NCT00094523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25669100|NCT01727089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24569760|NCT00801866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24569774|NCT00801905|Nepafenac|nepafenac|mesh-list
24569775|NCT00801905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25669101|NCT01727089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25669102|NCT01727089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24569776|NCT00801905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24569777|NCT00801905|Analgesics|analgesics|mesh-ancestor
24569778|NCT00801905|Sensory System Agents|sensory system agents|mesh-ancestor
24569779|NCT00801905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24569780|NCT00801905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569781|NCT00801905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24569783|NCT00801918|Cyclophosphamide|cyclophosphamide|mesh-list
24569784|NCT00801918|Ifosfamide|ifosfamide|mesh-list
24569785|NCT00801918|Etoposide|etoposide|mesh-list
24569786|NCT00801918|Denileukin diftitox|denileukin diftitox|mesh-list
24569787|NCT00801918|Interleukin-2|interleukin-2|mesh-list
24569788|NCT00801918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24569789|NCT00801918|Immunologic Factors|immunologic factors|mesh-ancestor
25863642|NCT00094523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25863643|NCT00094523|Antiviral Agents|antiviral agents|mesh-ancestor
24948566|NCT03918889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863644|NCT00094523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24569981|NCT00802594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24569982|NCT00802594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24569983|NCT00802594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24570058|NCT00802906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24570059|NCT00802906|Growth Substances|growth substances|mesh-ancestor
24570060|NCT00802906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570061|NCT00802906|Growth Inhibitors|growth inhibitors|mesh-ancestor
24570106|NCT00803309|Antimetabolites|antimetabolites|mesh-ancestor
24570107|NCT00803309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570108|NCT00803309|Immunologic Factors|immunologic factors|mesh-ancestor
24570109|NCT00803309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200132|NCT02736019|Analgesics|analgesics|mesh-ancestor
25200133|NCT02736019|Sensory System Agents|sensory system agents|mesh-ancestor
25200134|NCT02736019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25200135|NCT02736019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200136|NCT02736019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25200137|NCT02736019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25200138|NCT02736019|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25200139|NCT02736019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25200140|NCT02736019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24570157|NCT00803556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24570159|NCT00803699|Antioxidants|antioxidants|mesh-ancestor
24570160|NCT00803699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570161|NCT00803699|Protective Agents|protective agents|mesh-ancestor
24570162|NCT00803699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570163|NCT00803699|Trace Elements|trace elements|mesh-ancestor
24570164|NCT00803699|Micronutrients|micronutrients|mesh-ancestor
24570165|NCT00803725|Fentanyl|fentanyl|mesh-list
24570166|NCT00803725|Mepivacaine|mepivacaine|mesh-list
24570167|NCT00803725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24570168|NCT00803725|Narcotics|narcotics|mesh-ancestor
24570169|NCT00803725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24570170|NCT00803725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570171|NCT00803725|Analgesics|analgesics|mesh-ancestor
24570172|NCT00803725|Sensory System Agents|sensory system agents|mesh-ancestor
24570173|NCT00803725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24570174|NCT00803725|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24570175|NCT00803725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24570176|NCT00803725|Anesthetics, General|anesthetics, general|mesh-ancestor
24570205|NCT00803816|Immunologic Factors|immunologic factors|mesh-ancestor
24570206|NCT00803816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570207|NCT00803829|Sulfalene|sulfalene|mesh-list
24570208|NCT00803829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24570209|NCT00803829|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24570210|NCT00803829|Renal Agents|renal agents|mesh-ancestor
24570211|NCT00803829|Antimalarials|antimalarials|mesh-ancestor
24570212|NCT00803829|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25669103|NCT01727089|Growth Substances|growth substances|mesh-ancestor
25669104|NCT01727089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669105|NCT01727089|Growth Inhibitors|growth inhibitors|mesh-ancestor
24570213|NCT00803829|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24570233|NCT00803933|Pentamidine|pentamidine|mesh-list
25669106|NCT01727089|Immunologic Factors|immunologic factors|mesh-ancestor
25669107|NCT01727141|Glycopyrrolate|glycopyrrolate|mesh-list
24570236|NCT00803933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24570237|NCT00803933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24570286|NCT00804206|Growth Inhibitors|growth inhibitors|mesh-ancestor
24570288|NCT00804245|Lipotropic Agents|lipotropic agents|mesh-ancestor
24570289|NCT00804245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24570290|NCT00804245|Antimetabolites|antimetabolites|mesh-ancestor
24570291|NCT00804245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570292|NCT00804245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24570293|NCT00804245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24570294|NCT00804245|Nootropic Agents|nootropic agents|mesh-ancestor
24570326|NCT00804388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948587|NCT03918551|Gout Suppressants|gout suppressants|mesh-ancestor
24948588|NCT03918551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24570388|NCT00804674|Sensory System Agents|sensory system agents|mesh-ancestor
24570389|NCT00804674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24570391|NCT00804752|Ergocalciferols|ergocalciferols|mesh-list
24570392|NCT00804752|Cholecalciferol|cholecalciferol|mesh-list
24570393|NCT00804752|Vitamins|vitamins|mesh-list
24570394|NCT00804752|Micronutrients|micronutrients|mesh-ancestor
24570395|NCT00804752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570396|NCT00804752|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24570397|NCT00804752|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24570398|NCT00804791|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24570399|NCT00804791|Lubricant Eye Drops|lubricant eye drops|mesh-list
24570400|NCT00804791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24570401|NCT00804830|Bevacizumab|bevacizumab|mesh-list
24570402|NCT00804830|Doxorubicin|doxorubicin|mesh-list
24570403|NCT00804830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24570404|NCT00804830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570859|NCT00806923|Antimetabolites|antimetabolites|mesh-ancestor
24570577|NCT00805311|Atorvastatin|atorvastatin|mesh-list
24658941|NCT01274780|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24658942|NCT01274780|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24570578|NCT00805311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24570579|NCT00805311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24570580|NCT00805311|Analgesics|analgesics|mesh-ancestor
24570592|NCT00805311|Antipyretics|antipyretics|mesh-ancestor
24948616|NCT03918187|Bupivacaine|bupivacaine|mesh-list
24948617|NCT03918187|Anesthetics, Local|anesthetics, local|mesh-ancestor
24570642|NCT00805558|Metronidazole|metronidazole|mesh-list
24570643|NCT00805558|Ciprofloxacin|ciprofloxacin|mesh-list
25863645|NCT00094549|Valproic Acid|valproic acid|mesh-list
24570780|NCT00806741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570781|NCT00806741|Protective Agents|protective agents|mesh-ancestor
24570782|NCT00806741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24570783|NCT00806754|Ciclesonide|ciclesonide|mesh-list
24570785|NCT00806754|Glucocorticoids|glucocorticoids|mesh-ancestor
24570786|NCT00806754|Hormones|hormones|mesh-ancestor
24948618|NCT03918187|Anesthetics|anesthetics|mesh-ancestor
24948619|NCT03918187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24570878|NCT00807053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24570879|NCT00807066|Gefitinib|gefitinib|mesh-list
24570880|NCT00807066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570881|NCT00807066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24570882|NCT00807066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24570883|NCT00807066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570884|NCT00807079|Carboplatin|carboplatin|mesh-list
24570885|NCT00807079|Topotecan|topotecan|mesh-list
24570886|NCT00807079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570887|NCT00807079|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24570902|NCT00807196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24570903|NCT00807196|Immunologic Factors|immunologic factors|mesh-ancestor
24570904|NCT00807196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570905|NCT00807196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24570918|NCT00807222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570920|NCT00807222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24570922|NCT00807261|Docetaxel|docetaxel|mesh-list
24570923|NCT00807261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24570924|NCT00807261|Antimetabolites|antimetabolites|mesh-ancestor
24570925|NCT00807261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570926|NCT00807261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570927|NCT00807261|Antiviral Agents|antiviral agents|mesh-ancestor
24570928|NCT00807261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24570929|NCT00807261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24570930|NCT00807261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25863646|NCT00094549|Olanzapine|olanzapine|mesh-list
24833400|NCT02173808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24570990|NCT00807625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570991|NCT00807625|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24570992|NCT00807625|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24571039|NCT00807859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571040|NCT00807859|Growth Inhibitors|growth inhibitors|mesh-ancestor
24571042|NCT00807872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24948651|NCT03918135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24815683|NCT02071537|Analgesics|analgesics|mesh-ancestor
24948655|NCT03918135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24948656|NCT03918135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948657|NCT03918135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24948658|NCT03918135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24571043|NCT00807872|Immunologic Factors|immunologic factors|mesh-ancestor
24571044|NCT00807872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571045|NCT00807950|Simvastatin|simvastatin|mesh-list
24571046|NCT00807950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25200141|NCT02736019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200142|NCT02736019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25200143|NCT02736019|Narcotics|narcotics|mesh-ancestor
25200144|NCT02736019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25200145|NCT02735837|Doxycycline|doxycycline|mesh-list
25200146|NCT02735837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25200147|NCT02735837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571047|NCT00807950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24571048|NCT00807950|Antimetabolites|antimetabolites|mesh-ancestor
24571119|NCT00808171|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24571120|NCT00808184|Raltegravir Potassium|raltegravir potassium|mesh-list
25863647|NCT00094549|Antiemetics|antiemetics|mesh-ancestor
24571122|NCT00808184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24571123|NCT00808184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24571124|NCT00808184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24571125|NCT00808184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571126|NCT00808184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24571127|NCT00808184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24571128|NCT00808184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24571129|NCT00808184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24571130|NCT00808184|Anesthetics, General|anesthetics, general|mesh-ancestor
24571131|NCT00808184|Anesthetics|anesthetics|mesh-ancestor
24571147|NCT00808275|Calcium, Dietary|calcium, dietary|mesh-list
24571148|NCT00808275|Calcium|calcium|mesh-list
24571149|NCT00808275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24571162|NCT00808314|Purinergic Agents|purinergic agents|mesh-ancestor
24571163|NCT00808314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24571164|NCT00808314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571201|NCT00808418|Tubulin Modulators|tubulin modulators|mesh-ancestor
24571202|NCT00808418|Antimitotic Agents|antimitotic agents|mesh-ancestor
24571203|NCT00808418|Mitosis Modulators|mitosis modulators|mesh-ancestor
24571204|NCT00808418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571205|NCT00808678|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24571206|NCT00808678|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24571207|NCT00808678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24571208|NCT00808678|Antimetabolites|antimetabolites|mesh-ancestor
24571209|NCT00808678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571210|NCT00808678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24948659|NCT03918135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24571491|NCT00810381|Nitroglycerin|nitroglycerin|mesh-list
24571492|NCT00810381|Vasodilator Agents|vasodilator agents|mesh-ancestor
24571493|NCT00810381|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24571494|NCT00810381|Diuretics|diuretics|mesh-ancestor
24571495|NCT00810381|Natriuretic Agents|natriuretic agents|mesh-ancestor
24571496|NCT00810381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571497|NCT00810381|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24571587|NCT00810914|Sensory System Agents|sensory system agents|mesh-ancestor
24571588|NCT00810914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24571590|NCT00810940|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24571591|NCT00810940|Diuretics|diuretics|mesh-ancestor
24444260|NCT00297219|Calcium|calcium|mesh-list
24571634|NCT00811096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571635|NCT00811096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24571636|NCT00811096|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
24571637|NCT00811122|Corticosterone|corticosterone|mesh-list
24571638|NCT00811122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24671061|NCT01323452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24671063|NCT01323465|Ketoconazole|ketoconazole|mesh-list
25674450|NCT01772368|Fluticasone|fluticasone|mesh-list
24571693|NCT00811356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24571694|NCT00811356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24571695|NCT00811356|Antimetabolites|antimetabolites|mesh-ancestor
24571757|NCT00811486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571758|NCT00811603|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25863648|NCT00094549|Autonomic Agents|autonomic agents|mesh-ancestor
24571760|NCT00811603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571780|NCT00811837|Midazolam|midazolam|mesh-list
24571781|NCT00811837|Remifentanil|remifentanil|mesh-list
24571782|NCT00811837|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24571783|NCT00811837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24571786|NCT00811837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24571820|NCT00811967|Antimetabolites|antimetabolites|mesh-ancestor
24571821|NCT00811967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571822|NCT00811967|Antiviral Agents|antiviral agents|mesh-ancestor
24571823|NCT00811967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571824|NCT00811967|Immunologic Factors|immunologic factors|mesh-ancestor
24571825|NCT00811967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571826|NCT00811980|Vancomycin|vancomycin|mesh-list
24571827|NCT00811980|Linezolid|linezolid|mesh-list
25200148|NCT02735837|Antimalarials|antimalarials|mesh-ancestor
24571829|NCT00811980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571830|NCT00811980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24571863|NCT00811993|Immunologic Factors|immunologic factors|mesh-ancestor
25863649|NCT00094549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24571864|NCT00811993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24571865|NCT00811993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24571866|NCT00811993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24571867|NCT00811993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24571868|NCT00811993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24571869|NCT00811993|Alkylating Agents|alkylating agents|mesh-ancestor
24571871|NCT00812019|MF59 oil emulsion|mf59 oil emulsion|mesh-list
24571929|NCT00812318|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24571930|NCT00812318|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24571931|NCT00812318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571932|NCT00812318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571933|NCT00812318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24571934|NCT00812318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24571935|NCT00812318|Antiviral Agents|antiviral agents|mesh-ancestor
24571936|NCT00812318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571937|NCT00812344|Ketoconazole|ketoconazole|mesh-list
24571938|NCT00812344|Antifungal Agents|antifungal agents|mesh-ancestor
24571939|NCT00812344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571940|NCT00812344|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24571941|NCT00812344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24571610|NCT00811031|Mitosis Modulators|mitosis modulators|mesh-ancestor
24572411|NCT00814619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572413|NCT00814619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24572419|NCT00814723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572420|NCT00814723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24572421|NCT00814736|Sildenafil Citrate|sildenafil citrate|mesh-list
24572459|NCT00815022|Anesthetics, Local|anesthetics, local|mesh-ancestor
24572460|NCT00815022|Anesthetics|anesthetics|mesh-ancestor
24572461|NCT00815022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24572462|NCT00815022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572475|NCT00815048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24572476|NCT00815048|Narcotics|narcotics|mesh-ancestor
24572477|NCT00815048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24572478|NCT00815048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572479|NCT00815048|Analgesics|analgesics|mesh-ancestor
24572509|NCT00815204|Hormones|hormones|mesh-ancestor
24948671|NCT03917784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24948672|NCT03917784|Analgesics|analgesics|mesh-ancestor
24572510|NCT00815204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24572511|NCT00815204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24572512|NCT00815204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572513|NCT00815256|Riboflavin|riboflavin|mesh-list
24572514|NCT00815256|Vitamin B Complex|vitamin b complex|mesh-ancestor
24572515|NCT00815256|Vitamins|vitamins|mesh-ancestor
24572591|NCT00815646|Sildenafil Citrate|sildenafil citrate|mesh-list
24572592|NCT00815646|Vasodilator Agents|vasodilator agents|mesh-ancestor
24572593|NCT00815646|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25429576|NCT01485861|Prednisolone|prednisolone|mesh-list
24572594|NCT00815646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24948905|NCT05401110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24572618|NCT00815893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24572622|NCT00815893|Anesthetics|anesthetics|mesh-ancestor
24572623|NCT00815893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24572624|NCT00815893|Analgesics|analgesics|mesh-ancestor
24572625|NCT00815893|Sensory System Agents|sensory system agents|mesh-ancestor
24572626|NCT00815893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24572627|NCT00815893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24572628|NCT00815893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24572629|NCT00815893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24572630|NCT00815893|Adrenergic Agents|adrenergic agents|mesh-ancestor
24572631|NCT00815893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24572632|NCT00815893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572633|NCT00815945|Carboplatin|carboplatin|mesh-list
24572634|NCT00815945|Doxorubicin|doxorubicin|mesh-list
24572675|NCT00816218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24572676|NCT00816218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200149|NCT02735837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24572678|NCT00816244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24572715|NCT00816426|Moxifloxacin|moxifloxacin|mesh-list
24572716|NCT00816426|Rifampin|rifampin|mesh-list
24572717|NCT00816426|Isoniazid|isoniazid|mesh-list
24572718|NCT00816426|Pyrazinamide|pyrazinamide|mesh-list
24572719|NCT00816426|Kanamycin|kanamycin|mesh-list
24572720|NCT00816426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24572721|NCT00816426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24572722|NCT00816426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24572724|NCT00816426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24572725|NCT00816426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571717|NCT00811421|Pyrimethamine|pyrimethamine|mesh-list
24572758|NCT00816543|Mitosis Modulators|mitosis modulators|mesh-ancestor
24572759|NCT00816543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572760|NCT00816634|Paclitaxel|paclitaxel|mesh-list
24572761|NCT00816634|Capecitabine|capecitabine|mesh-list
24572762|NCT00816634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24572763|NCT00816634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572799|NCT00816790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24572800|NCT00816790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572801|NCT00816816|Docetaxel|docetaxel|mesh-list
24572803|NCT00816816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572804|NCT00816816|Tubulin Modulators|tubulin modulators|mesh-ancestor
24572805|NCT00816816|Antimitotic Agents|antimitotic agents|mesh-ancestor
24572806|NCT00816816|Mitosis Modulators|mitosis modulators|mesh-ancestor
24572807|NCT00816816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572808|NCT00816816|Antimetabolites|antimetabolites|mesh-ancestor
24948678|NCT03917784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24948679|NCT03917784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24948680|NCT03917784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572901|NCT00817011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24572902|NCT00817011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24572903|NCT00817011|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24572904|NCT00817011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24572906|NCT00817037|Sitaxsentan|sitaxsentan|mesh-list
24572907|NCT00817037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24572908|NCT00817037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24572909|NCT00817037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572910|NCT00817037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24572911|NCT00817037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948686|NCT03917758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24948687|NCT03917758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948688|NCT03917459|Enalapril|enalapril|mesh-list
24948689|NCT03917459|Enalaprilat|enalaprilat|mesh-list
24948690|NCT03917459|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24948691|NCT03917459|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24948692|NCT03917459|Protease Inhibitors|protease inhibitors|mesh-ancestor
24948693|NCT03917459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24948694|NCT03917459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948695|NCT03917459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24948696|NCT03917459|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24948697|NCT03917537|Nivolumab|nivolumab|mesh-list
24948698|NCT03917537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24633487|NCT01129570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24950713|NCT03912727|Vitamin B Complex|vitamin b complex|mesh-ancestor
24948699|NCT03917537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24948700|NCT03917537|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24948701|NCT03917537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571912|NCT00812266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24573250|NCT00818818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24573251|NCT00818818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24573252|NCT00818818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24573253|NCT00818870|Omeprazole|omeprazole|mesh-list
24573254|NCT00818870|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24573286|NCT00819078|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24573287|NCT00819078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24573288|NCT00819078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25200150|NCT02735837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25200151|NCT02735928|Doxorubicin|doxorubicin|mesh-list
24573289|NCT00819078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573290|NCT00819078|Dopamine Agents|dopamine agents|mesh-ancestor
24573291|NCT00819078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24573292|NCT00819078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573313|NCT00819104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24573314|NCT00819195|Glatiramer Acetate|glatiramer acetate|mesh-list
24573315|NCT00819195|(T,G)-A-L|(t,g)-a-l|mesh-list
24573316|NCT00819195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24573317|NCT00819195|Immunologic Factors|immunologic factors|mesh-ancestor
24573318|NCT00819195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573319|NCT00819195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24573320|NCT00819195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24573321|NCT00819325|Pioglitazone|pioglitazone|mesh-list
24573322|NCT00819325|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24573323|NCT00819325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573324|NCT00819351|Asparaginase|asparaginase|mesh-list
24573325|NCT00819351|Pegaspargase|pegaspargase|mesh-list
25863650|NCT00094549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863651|NCT00094549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25863652|NCT00094549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25863653|NCT00094549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24815701|NCT02071615|Modafinil|modafinil|mesh-list
25051816|NCT00374166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24573345|NCT00819520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24573346|NCT00819520|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24573347|NCT00819520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573348|NCT00819520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573421|NCT00819845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24573422|NCT00819845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24573423|NCT00819845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24573531|NCT00820547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24573533|NCT00820547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24573534|NCT00820547|Growth Substances|growth substances|mesh-ancestor
24573535|NCT00820547|Growth Inhibitors|growth inhibitors|mesh-ancestor
24573536|NCT00820547|Tubulin Modulators|tubulin modulators|mesh-ancestor
24573537|NCT00820547|Antimitotic Agents|antimitotic agents|mesh-ancestor
24573538|NCT00820547|Mitosis Modulators|mitosis modulators|mesh-ancestor
24573596|NCT00820963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24573597|NCT00820963|Alkylating Agents|alkylating agents|mesh-ancestor
25009286|NCT02425644|Ponesimod|ponesimod|mesh-list
24573741|NCT00821834|Ticlopidine|ticlopidine|mesh-list
24573742|NCT00821834|Clopidogrel|clopidogrel|mesh-list
24573743|NCT00821834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24573744|NCT00821834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24573745|NCT00821834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24573746|NCT00821834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24573747|NCT00821834|Purinergic Agents|purinergic agents|mesh-ancestor
24573748|NCT00821834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25404123|NCT03683810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25669108|NCT01727141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25669109|NCT01727141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25669110|NCT01727141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25669111|NCT01727141|Cholinergic Agents|cholinergic agents|mesh-ancestor
25669112|NCT01727141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25669113|NCT01727141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669114|NCT01727141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669115|NCT01727258|Fluorides|fluorides|mesh-list
25669116|NCT01727258|Cariostatic Agents|cariostatic agents|mesh-ancestor
24418243|NCT00209079|Docetaxel|docetaxel|mesh-list
25669117|NCT01727258|Protective Agents|protective agents|mesh-ancestor
24573749|NCT00821834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573750|NCT00821834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573751|NCT00821834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24573752|NCT00821834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24948707|NCT03917420|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24573753|NCT00821834|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24573754|NCT00821834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24573755|NCT00821834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573757|NCT00821912|Capecitabine|capecitabine|mesh-list
24573758|NCT00821912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24573759|NCT00821912|Tubulin Modulators|tubulin modulators|mesh-ancestor
24573778|NCT00822055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879042|NCT05102071|Metformin|metformin|mesh-list
24573779|NCT00822055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24573845|NCT00822315|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25200152|NCT02735928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24573846|NCT00822315|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25147450|NCT02913690|Antioxidants|antioxidants|mesh-ancestor
24573848|NCT00822315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573849|NCT00822315|Antiviral Agents|antiviral agents|mesh-ancestor
24573850|NCT00822315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24573851|NCT00822315|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24573852|NCT00822315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24573853|NCT00822315|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24573854|NCT00822315|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24573855|NCT00822315|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24573856|NCT00822315|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24573857|NCT00822315|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24573858|NCT00822315|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24573859|NCT00822315|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24573860|NCT00822315|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24573862|NCT00822380|Trace Elements|trace elements|mesh-list
24573863|NCT00822380|Folic Acid|folic acid|mesh-list
24573881|NCT00822393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24573882|NCT00822393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24573883|NCT00822419|Lidocaine|lidocaine|mesh-list
24573884|NCT00822419|Ketamine|ketamine|mesh-list
24573885|NCT00822419|Anesthetics, Local|anesthetics, local|mesh-ancestor
24573886|NCT00822419|Anesthetics|anesthetics|mesh-ancestor
24598737|NCT00957866|Ribavirin|ribavirin|mesh-list
24573887|NCT00822419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24573888|NCT00822419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573889|NCT00822419|Sensory System Agents|sensory system agents|mesh-ancestor
24573890|NCT00822419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24573891|NCT00822419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24573892|NCT00822419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24573893|NCT00822419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24573894|NCT00822419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24573895|NCT00822419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573896|NCT00822419|Analgesics|analgesics|mesh-ancestor
24573903|NCT00822536|Aspirin|aspirin|mesh-list
24573931|NCT00822549|Sensory System Agents|sensory system agents|mesh-ancestor
24573932|NCT00822549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24573934|NCT00822614|Morphine|morphine|mesh-list
24573935|NCT00822614|Oxycodone|oxycodone|mesh-list
24573936|NCT00822614|Hydromorphone|hydromorphone|mesh-list
24573937|NCT00822614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24573938|NCT00822614|Narcotics|narcotics|mesh-ancestor
24573939|NCT00822614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24573940|NCT00822614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561045|NCT00567580|Leuprolide|leuprolide|mesh-list
24574016|NCT00823004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24574017|NCT00823004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574018|NCT00823004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24574019|NCT00823004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25200153|NCT02735928|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24574020|NCT00823004|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24574023|NCT00823030|Anesthetics, Local|anesthetics, local|mesh-ancestor
24574024|NCT00823030|Anesthetics|anesthetics|mesh-ancestor
24574025|NCT00823030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24574038|NCT00823121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24561082|NCT00485693|Mydriatics|mydriatics|mesh-ancestor
25674451|NCT01772368|Xhance|xhance|mesh-list
25221596|NCT02649478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24574056|NCT00823290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574057|NCT00823290|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24574059|NCT00823342|Clevudine|clevudine|mesh-list
24574072|NCT00823381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574073|NCT00823381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24948713|NCT03917420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948715|NCT03917420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24948719|NCT03917004|Nitroglycerin|nitroglycerin|mesh-list
24948720|NCT03917004|Vasodilator Agents|vasodilator agents|mesh-ancestor
24948721|NCT03917095|Mesalamine|mesalamine|mesh-list
24948722|NCT03917095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24948723|NCT03917095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24948724|NCT03917095|Analgesics|analgesics|mesh-ancestor
24948725|NCT03917095|Sensory System Agents|sensory system agents|mesh-ancestor
24948726|NCT03917095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24948727|NCT03917095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948728|NCT03917095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24948729|NCT03917095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24948730|NCT03916926|Fluorides|fluorides|mesh-list
24948731|NCT03916926|Fluorides, Topical|fluorides, topical|mesh-list
24948732|NCT03916926|Cariostatic Agents|cariostatic agents|mesh-ancestor
24948733|NCT03916926|Protective Agents|protective agents|mesh-ancestor
24948734|NCT03916926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948735|NCT03917134|Metronidazole|metronidazole|mesh-list
24948736|NCT03917134|Cephalosporins|cephalosporins|mesh-list
24948737|NCT03917134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24948788|NCT05402553|Antiemetics|antiemetics|mesh-ancestor
24948789|NCT05402553|Autonomic Agents|autonomic agents|mesh-ancestor
24948790|NCT05402553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24948791|NCT05402553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948792|NCT05402553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24948793|NCT05402553|Antipruritics|antipruritics|mesh-ancestor
24574093|NCT00823576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574094|NCT00823576|Sensory System Agents|sensory system agents|mesh-ancestor
24574095|NCT00823576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24574096|NCT00823602|Buserelin|buserelin|mesh-list
24574097|NCT00823602|Ganirelix|ganirelix|mesh-list
24574136|NCT00823875|Cilostazol|cilostazol|mesh-list
24574137|NCT00823875|Probucol|probucol|mesh-list
24574165|NCT00823940|Incretins|incretins|mesh-ancestor
24574166|NCT00824057|Midazolam|midazolam|mesh-list
24574167|NCT00824057|Caffeine|caffeine|mesh-list
24574168|NCT00824057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24574169|NCT00824057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24574170|NCT00824057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24574171|NCT00824057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051736|NCT00383578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051738|NCT00383513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25051739|NCT00383513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051740|NCT00383422|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25051741|NCT00383422|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25051742|NCT00383422|Hormone Antagonists|hormone antagonists|mesh-ancestor
24948837|NCT05401812|Hormones|hormones|mesh-ancestor
24948838|NCT05401812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24948839|NCT05401812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948902|NCT05401110|Osimertinib|osimertinib|mesh-list
24948903|NCT05401110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24948904|NCT05401110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24948917|NCT05401071|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25863654|NCT00094549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24948919|NCT05401071|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24948921|NCT05401071|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24948922|NCT05401071|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24948925|NCT05401058|Antiemetics|antiemetics|mesh-ancestor
24948926|NCT05401058|Autonomic Agents|autonomic agents|mesh-ancestor
24948927|NCT05401058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24948928|NCT05401058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948929|NCT05401058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24948930|NCT05401058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24948931|NCT05401058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24948932|NCT05401058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24948933|NCT05401058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24574342|NCT00825058|Paroxetine|paroxetine|mesh-list
25669118|NCT01727258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574353|NCT00825058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24574354|NCT00825058|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24948942|NCT05401032|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24948943|NCT05401032|Adrenergic Agents|adrenergic agents|mesh-ancestor
24948944|NCT05401032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24948945|NCT05401032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948946|NCT05401032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948947|NCT05401032|Urological Agents|urological agents|mesh-ancestor
24948948|NCT05401019|Pramipexole|pramipexole|mesh-list
24948991|NCT05400148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24948992|NCT05400148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948994|NCT05400148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24774373|NCT01845246|Colistin|colistin|mesh-list
24949018|NCT05369351|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24949019|NCT05369351|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24949020|NCT05369351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24949021|NCT05369351|Adrenergic Agents|adrenergic agents|mesh-ancestor
24949022|NCT05369351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24949023|NCT05369351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949024|NCT05369351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949025|NCT05369351|Urological Agents|urological agents|mesh-ancestor
24949026|NCT05366049|Acetaminophen|acetaminophen|mesh-list
24949027|NCT05366049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24949028|NCT05366049|Analgesics|analgesics|mesh-ancestor
24949029|NCT05366049|Sensory System Agents|sensory system agents|mesh-ancestor
24949030|NCT05366049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24949031|NCT05366049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949032|NCT05366049|Antipyretics|antipyretics|mesh-ancestor
24949033|NCT05350943|Gemcitabine|gemcitabine|mesh-list
24949034|NCT05350943|Oxaliplatin|oxaliplatin|mesh-list
24949035|NCT05350943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24949036|NCT05350943|Antimetabolites|antimetabolites|mesh-ancestor
24949037|NCT05350943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949038|NCT05350943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24949039|NCT05350943|Antiviral Agents|antiviral agents|mesh-ancestor
24949040|NCT05350943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24949041|NCT05350943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24949054|NCT05327556|Racepinephrine|racepinephrine|mesh-list
24572793|NCT00816790|Tazobactam|tazobactam|mesh-list
24949113|NCT05255666|Pembrolizumab|pembrolizumab|mesh-list
24574753|NCT00827307|Goserelin|goserelin|mesh-list
24572828|NCT00816868|Antimetabolites|antimetabolites|mesh-ancestor
24574909|NCT00828477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574911|NCT00828477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24444621|NCT00298662|Interferons|interferons|mesh-list
24950232|NCT01883297|Aldesleukin|aldesleukin|mesh-list
24574989|NCT00828919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949158|NCT05189457|Leuprolide|leuprolide|mesh-list
24949159|NCT05189457|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24949160|NCT05189457|Hormones|hormones|mesh-list
24949161|NCT05189457|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24949162|NCT05189457|Relugolix|relugolix|mesh-list
24949163|NCT05189457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24949164|NCT05189457|Tubulin Modulators|tubulin modulators|mesh-ancestor
24949165|NCT05189457|Antimitotic Agents|antimitotic agents|mesh-ancestor
24949166|NCT05189457|Mitosis Modulators|mitosis modulators|mesh-ancestor
24949167|NCT05189457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572875|NCT00817011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24575096|NCT00829322|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24575097|NCT00829322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575098|NCT00829465|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24575099|NCT00829465|Immunologic Factors|immunologic factors|mesh-ancestor
24575100|NCT00829465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575101|NCT00829569|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24575102|NCT00829569|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24575103|NCT00829569|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24575104|NCT00829569|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24575105|NCT00829595|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24575106|NCT00829595|Immunologic Factors|immunologic factors|mesh-ancestor
24575107|NCT00829595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575108|NCT00829608|Vaccines|vaccines|mesh-list
24575109|NCT00829608|Immunologic Factors|immunologic factors|mesh-ancestor
24575110|NCT00829608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575111|NCT00829634|Methamphetamine|methamphetamine|mesh-list
25669119|NCT01727336|Axitinib|axitinib|mesh-list
25089647|NCT03264079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575112|NCT00829634|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24575144|NCT00829699|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24575166|NCT00829894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575167|NCT00829894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25051747|NCT00383422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25051749|NCT00382811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051751|NCT00382460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25051752|NCT00382460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25051753|NCT00382460|Antimetabolites|antimetabolites|mesh-ancestor
25051754|NCT00382460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051755|NCT00382460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25051789|NCT00375791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25051790|NCT00375791|Antiemetics|antiemetics|mesh-ancestor
24573057|NCT00817713|Ivermectin|ivermectin|mesh-list
24575199|NCT00830193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24949175|NCT05189457|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24949176|NCT05189457|Contraceptive Agents|contraceptive agents|mesh-ancestor
24949177|NCT05189457|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24949178|NCT05189457|Androgen Antagonists|androgen antagonists|mesh-ancestor
24949179|NCT05189457|Hormone Antagonists|hormone antagonists|mesh-ancestor
24949181|NCT05173688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24949182|NCT05173688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24949183|NCT05173688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949184|NCT05173688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24949185|NCT05173688|Anesthetics, General|anesthetics, general|mesh-ancestor
24949186|NCT05173688|Anesthetics|anesthetics|mesh-ancestor
24575256|NCT00830414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24575257|NCT00830414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200156|NCT02735928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575258|NCT00830414|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24575259|NCT00830414|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24575260|NCT00830414|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24575261|NCT00830414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24575262|NCT00830414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24575263|NCT00830466|Sirolimus|sirolimus|mesh-list
24949212|NCT05158998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24949213|NCT05158998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24949214|NCT05158998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949215|NCT05158998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24949216|NCT05158998|Anesthetics, General|anesthetics, general|mesh-ancestor
24949217|NCT05158998|Anesthetics|anesthetics|mesh-ancestor
24949218|NCT05158998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24949219|NCT05158998|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24949220|NCT05139914|Dapagliflozin|dapagliflozin|mesh-list
24949221|NCT05139914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24949222|NCT05139914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949224|NCT05139914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009476|NCT00003777|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24774763|NCT01847690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24774766|NCT01847768|Chelating Agents|chelating agents|mesh-ancestor
24774767|NCT01847768|Sequestering Agents|sequestering agents|mesh-ancestor
24774785|NCT01847872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774786|NCT01847976|Doxycycline|doxycycline|mesh-list
24774787|NCT01847976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24774788|NCT01847976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24774789|NCT01847976|Antimalarials|antimalarials|mesh-ancestor
24774790|NCT01847976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24774791|NCT01847976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24626156|NCT01085721|Adrenergic Agents|adrenergic agents|mesh-ancestor
24949377|NCT04904978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24949378|NCT04904978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25056787|NCT03509662|Micronutrients|micronutrients|mesh-ancestor
24949380|NCT04896489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24949381|NCT04880655|Bacitracin|bacitracin|mesh-list
24949382|NCT04880655|Petrolatum|petrolatum|mesh-list
24949391|NCT04865835|Metformin|metformin|mesh-list
24949392|NCT04865835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24806143|NCT02013986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24949398|NCT04814940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949402|NCT04813016|Dexmedetomidine|dexmedetomidine|mesh-list
25669120|NCT01727336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24949403|NCT04813016|Tramadol|tramadol|mesh-list
24949404|NCT04813016|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24949405|NCT04813016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25221661|NCT02648854|Metformin|metformin|mesh-list
25221662|NCT02648854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25221663|NCT02648854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949406|NCT04813016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949407|NCT04813016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24949408|NCT04813016|Analgesics|analgesics|mesh-ancestor
24949409|NCT04813016|Sensory System Agents|sensory system agents|mesh-ancestor
24949450|NCT04729543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24949451|NCT04729543|Analgesics|analgesics|mesh-ancestor
24949452|NCT04729543|Sensory System Agents|sensory system agents|mesh-ancestor
24949453|NCT04729543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24573386|NCT00819754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24949489|NCT04669457|Anesthetics, General|anesthetics, general|mesh-ancestor
24949490|NCT04669457|Anesthetics|anesthetics|mesh-ancestor
24949491|NCT04669457|GABA Modulators|gaba modulators|mesh-ancestor
24949492|NCT04669457|GABA Agents|gaba agents|mesh-ancestor
24949493|NCT04620382|Midodrine|midodrine|mesh-list
24949494|NCT04620382|Sympathomimetics|sympathomimetics|mesh-ancestor
24949495|NCT04620382|Autonomic Agents|autonomic agents|mesh-ancestor
24949496|NCT04620382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24949497|NCT04620382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949498|NCT04620382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24949499|NCT04620382|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24949500|NCT04620382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24949501|NCT04620382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24949502|NCT04620382|Adrenergic Agents|adrenergic agents|mesh-ancestor
24626165|NCT01085721|Histamine Antagonists|histamine antagonists|mesh-ancestor
24626166|NCT01085721|Histamine Agents|histamine agents|mesh-ancestor
24626167|NCT01085721|Antipruritics|antipruritics|mesh-ancestor
24626168|NCT01085721|Dermatologic Agents|dermatologic agents|mesh-ancestor
24626169|NCT01085721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24626170|NCT01085838|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24626171|NCT01085838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626172|NCT01085838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24949538|NCT04603911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949551|NCT04564157|Carboplatin|carboplatin|mesh-list
24949553|NCT04564157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24949554|NCT04564157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24949578|NCT04460183|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25051805|NCT00374296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051807|NCT00374166|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25051808|NCT00374166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25051809|NCT00374166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25051810|NCT00374166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051811|NCT00374166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25051812|NCT00374166|Serotonin Agents|serotonin agents|mesh-ancestor
25051813|NCT00374166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051814|NCT00374166|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25051815|NCT00374166|Antidepressive Agents|antidepressive agents|mesh-ancestor
25051818|NCT00374166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25051819|NCT00374166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051820|NCT00372944|Capecitabine|capecitabine|mesh-list
25051821|NCT00372944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25051822|NCT00372944|Antimetabolites|antimetabolites|mesh-ancestor
25051823|NCT00372944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051824|NCT00372944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051825|NCT00372437|Gemcitabine|gemcitabine|mesh-list
25051829|NCT00372437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669121|NCT01727336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25669122|NCT01727336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25669123|NCT01727336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669124|NCT01727414|Methylphenidate|methylphenidate|mesh-list
25669125|NCT01727414|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25669126|NCT01727414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669127|NCT01727414|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25669128|NCT01727414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25221677|NCT02649101|Thalidomide|thalidomide|mesh-list
25221678|NCT02649101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25221679|NCT02649101|Immunologic Factors|immunologic factors|mesh-ancestor
25221680|NCT02649101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221681|NCT02649101|Leprostatic Agents|leprostatic agents|mesh-ancestor
25221682|NCT02649101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25051830|NCT00372437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051831|NCT00372437|Antiviral Agents|antiviral agents|mesh-ancestor
24575643|NCT00833157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24575644|NCT00833157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24575645|NCT00833157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24575646|NCT00833157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575720|NCT00833534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24575721|NCT00833534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24575729|NCT00833729|Etanercept|etanercept|mesh-list
24949761|NCT03733145|Angiotensinogen|angiotensinogen|mesh-list
24949762|NCT03733145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24949763|NCT03733145|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24949764|NCT03733145|Protease Inhibitors|protease inhibitors|mesh-ancestor
24949765|NCT03733145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24949766|NCT03733145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949767|NCT03686904|Benzalkonium Compounds|benzalkonium compounds|mesh-list
24949768|NCT03686904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24949769|NCT03686904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24965117|NCT03778619|Cyclophosphamide|cyclophosphamide|mesh-list
24775312|NCT01851486|Sympatholytics|sympatholytics|mesh-ancestor
24775313|NCT01851486|Autonomic Agents|autonomic agents|mesh-ancestor
24775314|NCT01851486|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24775315|NCT01851486|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24775316|NCT01851486|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24775317|NCT01851486|Adrenergic Agents|adrenergic agents|mesh-ancestor
24775318|NCT01851486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24775319|NCT01851486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775320|NCT01851512|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24775321|NCT01851512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24949835|NCT03530800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949836|NCT03530800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24949837|NCT03530800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24949839|NCT03530800|Sensory System Agents|sensory system agents|mesh-ancestor
24949840|NCT03530800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24949841|NCT03530800|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24949842|NCT03530800|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24573899|NCT00822419|Anesthetics, General|anesthetics, general|mesh-ancestor
24949943|NCT03270462|Tacrolimus|tacrolimus|mesh-list
24949944|NCT03270462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24949945|NCT03270462|Immunologic Factors|immunologic factors|mesh-ancestor
24949946|NCT03270462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949947|NCT03270462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24575957|NCT00835939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575999|NCT00836212|Efavirenz|efavirenz|mesh-list
24576048|NCT00836485|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24576049|NCT00836485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24576050|NCT00836485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24576051|NCT00836485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24576052|NCT00836485|Analgesics|analgesics|mesh-ancestor
24576053|NCT00836485|Sensory System Agents|sensory system agents|mesh-ancestor
24576054|NCT00836485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24576055|NCT00836485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576056|NCT00836485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25863655|NCT00094549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24576057|NCT00836485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24576058|NCT00836485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24576059|NCT00836485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24576060|NCT00836485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24576061|NCT00836485|Histamine Antagonists|histamine antagonists|mesh-ancestor
24576069|NCT00836537|Protease Inhibitors|protease inhibitors|mesh-ancestor
24576070|NCT00836537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24576097|NCT00836667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576098|NCT00836667|Serotonin Agents|serotonin agents|mesh-ancestor
25669129|NCT01727414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25669130|NCT01727414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669131|NCT01727414|Dopamine Agents|dopamine agents|mesh-ancestor
25669132|NCT01727414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25669133|NCT01727700|Aripiprazole|aripiprazole|mesh-list
25669134|NCT01727700|Antidepressive Agents|antidepressive agents|mesh-ancestor
24619194|NCT01051284|Antimetabolites|antimetabolites|mesh-ancestor
24576099|NCT00836667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631869|NCT01120665|Estradiol|estradiol|mesh-list
24576101|NCT00836823|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24576102|NCT00836823|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24949972|NCT03114527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24949973|NCT03114527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24949974|NCT03114527|Immunologic Factors|immunologic factors|mesh-ancestor
24949975|NCT03114527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949976|NCT03113123|Tenofovir|tenofovir|mesh-list
24949977|NCT03113123|Emtricitabine|emtricitabine|mesh-list
24949978|NCT03113123|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24576112|NCT00836849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24574369|NCT00825071|Hormones|hormones|mesh-ancestor
24576189|NCT00837369|Regadenoson|regadenoson|mesh-list
24576190|NCT00837369|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
24576191|NCT00837369|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24576192|NCT00837369|Purinergic Agonists|purinergic agonists|mesh-ancestor
24576193|NCT00837369|Purinergic Agents|purinergic agents|mesh-ancestor
24576194|NCT00837369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576195|NCT00837369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576196|NCT00837369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576219|NCT00837707|Antidepressive Agents|antidepressive agents|mesh-ancestor
24576220|NCT00837707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24576221|NCT00837707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24576222|NCT00837707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24576223|NCT00837707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24576224|NCT00837707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576225|NCT00837707|Dopamine Agonists|dopamine agonists|mesh-ancestor
24576226|NCT00837707|Dopamine Agents|dopamine agents|mesh-ancestor
24576227|NCT00837707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576228|NCT00837707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823629|NCT02118285|Fludarabine|fludarabine|mesh-list
24576229|NCT00837707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24576230|NCT00837707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24576231|NCT00837707|Serotonin Agents|serotonin agents|mesh-ancestor
24576232|NCT00837707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24576233|NCT00837707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24576234|NCT00837707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24576235|NCT00837707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24576236|NCT00837746|Risedronic Acid|risedronic acid|mesh-list
24576237|NCT00837746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24576238|NCT00837746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24576266|NCT00837915|Loratadine|loratadine|mesh-list
24576267|NCT00837915|Pseudoephedrine|pseudoephedrine|mesh-list
24576268|NCT00837915|Ephedrine|ephedrine|mesh-list
24576269|NCT00837915|Antipruritics|antipruritics|mesh-ancestor
24576270|NCT00837915|Dermatologic Agents|dermatologic agents|mesh-ancestor
24671094|NCT01323491|Nicotine|nicotine|mesh-list
24950063|NCT02713386|Mitosis Modulators|mitosis modulators|mesh-ancestor
24950064|NCT02713386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950065|NCT02671890|Gemcitabine|gemcitabine|mesh-list
24950066|NCT02671890|Disulfiram|disulfiram|mesh-list
24950067|NCT02671890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24950068|NCT02671890|Antimetabolites|antimetabolites|mesh-ancestor
24950113|NCT02633059|Dermatologic Agents|dermatologic agents|mesh-ancestor
24950114|NCT02633059|Glycine Agents|glycine agents|mesh-ancestor
24950115|NCT02633059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24950116|NCT02623205|Citalopram|citalopram|mesh-list
24950117|NCT02623205|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24950118|NCT02623205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24950119|NCT02623205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24950120|NCT02623205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950121|NCT02623205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25109953|NCT03120936|Tenofovir|tenofovir|mesh-list
24950172|NCT02344680|Antiviral Agents|antiviral agents|mesh-ancestor
24950173|NCT02344680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24950174|NCT02287428|Pembrolizumab|pembrolizumab|mesh-list
24950175|NCT02287428|Temozolomide|temozolomide|mesh-list
24950176|NCT02287428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24950177|NCT02287428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950178|NCT02287428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24950179|NCT02287428|Alkylating Agents|alkylating agents|mesh-ancestor
24950193|NCT02024230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950195|NCT01967238|Immunologic Factors|immunologic factors|mesh-ancestor
25669135|NCT01727700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25863656|NCT00094549|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24950293|NCT01862315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24574731|NCT00827177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950361|NCT00458003|Nasal Decongestants|nasal decongestants|mesh-ancestor
24950362|NCT00458003|Respiratory System Agents|respiratory system agents|mesh-ancestor
24950363|NCT00458003|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24950364|NCT00458003|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24950365|NCT00458003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24950366|NCT00458003|Adrenergic Agents|adrenergic agents|mesh-ancestor
24950367|NCT00458003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24950368|NCT00458003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950369|NCT00458003|Protective Agents|protective agents|mesh-ancestor
24950370|NCT00458003|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24950372|NCT00393783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24950373|NCT00393783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24576575|NCT00839345|Purinergic Agents|purinergic agents|mesh-ancestor
24576576|NCT00839345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576577|NCT00839345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574775|NCT00827411|Aspirin|aspirin|mesh-list
24950400|NCT03916328|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24950401|NCT03916328|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24775841|NCT01855256|Oxybutynin|oxybutynin|mesh-list
24950406|NCT03916510|Antimetabolites|antimetabolites|mesh-ancestor
24950407|NCT03916510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950408|NCT03916510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950409|NCT03916432|Sirolimus|sirolimus|mesh-list
24950410|NCT03916432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24950412|NCT03916432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24950413|NCT03916432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950414|NCT03916432|Antifungal Agents|antifungal agents|mesh-ancestor
24950416|NCT03916432|Immunologic Factors|immunologic factors|mesh-ancestor
24950417|NCT03916432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950418|NCT03916406|Midazolam|midazolam|mesh-list
24950419|NCT03916406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24950420|NCT03916406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24950421|NCT03916406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24950422|NCT03916406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950551|NCT03914534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950552|NCT03914534|GABA Agents|gaba agents|mesh-ancestor
24950553|NCT03914534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24950554|NCT03914534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950555|NCT03914534|Antimanic Agents|antimanic agents|mesh-ancestor
24950556|NCT03914534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24950557|NCT03914534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24950558|NCT03914534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24950596|NCT03914235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626200|NCT01085981|Nicotinic Acids|nicotinic acids|mesh-list
24626201|NCT01085981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24626202|NCT01085981|Antimetabolites|antimetabolites|mesh-ancestor
24879745|NCT04496219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879746|NCT04489719|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
24879747|NCT04489719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24879748|NCT04489433|Trametinib|trametinib|mesh-list
24879749|NCT04489433|Dabrafenib|dabrafenib|mesh-list
24879750|NCT04489433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626203|NCT01085981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626204|NCT01085981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24626205|NCT01085981|Vasodilator Agents|vasodilator agents|mesh-ancestor
24626206|NCT01085981|Vitamin B Complex|vitamin b complex|mesh-ancestor
24626208|NCT01085981|Micronutrients|micronutrients|mesh-ancestor
24626209|NCT01085981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626210|NCT01086020|Atorvastatin|atorvastatin|mesh-list
24626211|NCT01086020|Ezetimibe|ezetimibe|mesh-list
24626212|NCT01086020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24626213|NCT01086020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24626214|NCT01086020|Antimetabolites|antimetabolites|mesh-ancestor
24626215|NCT01086020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626216|NCT01086020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24576633|NCT00839488|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24576634|NCT00839488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575176|NCT00830050|Analgesics|analgesics|mesh-ancestor
24950696|NCT03913182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25221732|NCT02648503|Rocuronium|rocuronium|mesh-list
24950697|NCT03913182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950698|NCT03913052|Viscosupplements|viscosupplements|mesh-list
24950699|NCT03913052|Protective Agents|protective agents|mesh-ancestor
24950700|NCT03913052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051928|NCT00363636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25051929|NCT00363636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051930|NCT00363636|Immunologic Factors|immunologic factors|mesh-ancestor
25051955|NCT00360035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051957|NCT00359450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051958|NCT00359437|Satavaptan|satavaptan|mesh-list
25051959|NCT00359437|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25051960|NCT00359437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051961|NCT00359437|Natriuretic Agents|natriuretic agents|mesh-ancestor
25051962|NCT00359437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051963|NCT00359086|Mocetinostat|mocetinostat|mesh-list
25051964|NCT00359086|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24950710|NCT03912727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950712|NCT03912727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576826|NCT00840606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24576827|NCT00840606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24576828|NCT00840606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950820|NCT03911570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24950822|NCT03911570|Antipyretics|antipyretics|mesh-ancestor
24950823|NCT03911570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24950824|NCT03911557|Durvalumab|durvalumab|mesh-list
24576830|NCT00840606|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24576831|NCT00840606|Serotonin Agents|serotonin agents|mesh-ancestor
24576832|NCT00840606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576833|NCT00840606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576834|NCT00840645|Mirabegron|mirabegron|mesh-list
24576835|NCT00840645|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24576836|NCT00840645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24576837|NCT00840645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24576838|NCT00840645|Adrenergic Agents|adrenergic agents|mesh-ancestor
24576839|NCT00840645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576840|NCT00840645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950826|NCT03911557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24950827|NCT03911557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950902|NCT03910088|Hydrocortisone|hydrocortisone|mesh-list
24950903|NCT03910088|Diclofenac|diclofenac|mesh-list
24950904|NCT03910088|Pregabalin|pregabalin|mesh-list
24950905|NCT03910088|Caffeine|caffeine|mesh-list
24950906|NCT03910088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24950907|NCT03910088|Analgesics|analgesics|mesh-ancestor
24950908|NCT03910088|Sensory System Agents|sensory system agents|mesh-ancestor
24950909|NCT03910088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24950910|NCT03910088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950911|NCT03910088|Antipyretics|antipyretics|mesh-ancestor
24950912|NCT03910088|Anticonvulsants|anticonvulsants|mesh-ancestor
24950913|NCT03910088|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24950914|NCT03910088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24950915|NCT03910088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950916|NCT03910088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24950917|NCT03910088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24950918|NCT03910088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24950919|NCT03910088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24950920|NCT03910088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24950921|NCT03910088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24950922|NCT03910088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24950923|NCT03910088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24950924|NCT03910088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950925|NCT03910088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24950963|NCT03909724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24951005|NCT03909269|Carbon Monoxide|carbon monoxide|mesh-list
24951006|NCT03909269|Antimetabolites|antimetabolites|mesh-ancestor
24577181|NCT00842400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24951007|NCT03909269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951008|NCT03909269|Gasotransmitters|gasotransmitters|mesh-ancestor
24951009|NCT03909269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24951010|NCT03909269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951011|NCT03909646|Fluorouracil|fluorouracil|mesh-list
25669136|NCT01727700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24951012|NCT03909646|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24951013|NCT03909646|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
24951014|NCT03909646|Antimetabolites|antimetabolites|mesh-ancestor
24576913|NCT00840931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24576914|NCT00840931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25863657|NCT00094549|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24576915|NCT00840931|Growth Substances|growth substances|mesh-ancestor
24576916|NCT00840931|Growth Inhibitors|growth inhibitors|mesh-ancestor
24576999|NCT00841581|Growth Inhibitors|growth inhibitors|mesh-ancestor
24577000|NCT00841581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776543|NCT01858441|Hormone Antagonists|hormone antagonists|mesh-ancestor
24951020|NCT03909646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951021|NCT03909646|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24951022|NCT03909646|Dermatologic Agents|dermatologic agents|mesh-ancestor
24577010|NCT00841633|Sympathomimetics|sympathomimetics|mesh-ancestor
24577011|NCT00841633|Autonomic Agents|autonomic agents|mesh-ancestor
24577012|NCT00841633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24577013|NCT00841633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24577014|NCT00841724|Fludarabine|fludarabine|mesh-list
24577015|NCT00841724|Busulfan|busulfan|mesh-list
24577016|NCT00841724|Thymoglobulin|thymoglobulin|mesh-list
24577017|NCT00841724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577018|NCT00841724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577019|NCT00841724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24577020|NCT00841724|Immunologic Factors|immunologic factors|mesh-ancestor
24577021|NCT00841724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577022|NCT00841724|Alkylating Agents|alkylating agents|mesh-ancestor
24577023|NCT00841724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24577024|NCT00841724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24577025|NCT00841789|Etanercept|etanercept|mesh-list
24577026|NCT00841789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24577027|NCT00841789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24577028|NCT00841789|Analgesics|analgesics|mesh-ancestor
24577029|NCT00841789|Sensory System Agents|sensory system agents|mesh-ancestor
24577030|NCT00841789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24577031|NCT00841789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577032|NCT00841789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24577067|NCT00841854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577068|NCT00841854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577070|NCT00841854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24577071|NCT00841880|Felodipine|felodipine|mesh-list
24951034|NCT03908944|Analgesics|analgesics|mesh-ancestor
24951035|NCT03908944|Sensory System Agents|sensory system agents|mesh-ancestor
24951036|NCT03908944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24951037|NCT03908944|Antitussive Agents|antitussive agents|mesh-ancestor
24951043|NCT03908619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24951044|NCT03908619|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24951045|NCT03908619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951046|NCT03908619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805001|NCT02006602|Candesartan|candesartan|mesh-list
24577073|NCT00841880|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24577074|NCT00841880|Protease Inhibitors|protease inhibitors|mesh-ancestor
24577075|NCT00841880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577162|NCT00842140|Hormone Antagonists|hormone antagonists|mesh-ancestor
24577163|NCT00842140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24577164|NCT00842140|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24577165|NCT00842140|Diuretics|diuretics|mesh-ancestor
24577166|NCT00842140|Natriuretic Agents|natriuretic agents|mesh-ancestor
24577167|NCT00842140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24577168|NCT00842192|Insulin Detemir|insulin detemir|mesh-list
25200157|NCT02735928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207676|NCT03492099|Buprenorphine|buprenorphine|mesh-list
24577169|NCT00842192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24577170|NCT00842192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577171|NCT00842205|Interferons|interferons|mesh-list
24577173|NCT00842205|Antiviral Agents|antiviral agents|mesh-ancestor
24577177|NCT00842400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24577178|NCT00842400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577179|NCT00842400|Uricosuric Agents|uricosuric agents|mesh-ancestor
24577180|NCT00842400|Gout Suppressants|gout suppressants|mesh-ancestor
24577183|NCT00842452|Topotecan|topotecan|mesh-list
24577184|NCT00842452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24577185|NCT00842452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24577186|NCT00842452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577187|NCT00842452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577188|NCT00842452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951052|NCT03908580|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24951053|NCT03908580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24951054|NCT03908580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24951055|NCT03908580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951056|NCT03908580|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24951057|NCT03908580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24577219|NCT00842556|Immunologic Factors|immunologic factors|mesh-ancestor
24577220|NCT00842582|Azacitidine|azacitidine|mesh-list
24577221|NCT00842582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24577222|NCT00842582|Antimetabolites|antimetabolites|mesh-ancestor
24577223|NCT00842582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577224|NCT00842582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577226|NCT00842595|Prednisone|prednisone|mesh-list
24577240|NCT00842595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24577241|NCT00842595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24577242|NCT00842595|Tubulin Modulators|tubulin modulators|mesh-ancestor
24577243|NCT00842595|Antimitotic Agents|antimitotic agents|mesh-ancestor
24577244|NCT00842595|Mitosis Modulators|mitosis modulators|mesh-ancestor
24577245|NCT00842595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575962|NCT00835939|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24805025|NCT02006966|Lidocaine|lidocaine|mesh-list
24805027|NCT02006966|Anesthetics|anesthetics|mesh-ancestor
24577269|NCT00842686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24577270|NCT00842686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24577271|NCT00842686|Growth Substances|growth substances|mesh-ancestor
24577272|NCT00842686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577273|NCT00842686|Growth Inhibitors|growth inhibitors|mesh-ancestor
24577274|NCT00842686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24577278|NCT00842894|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24577282|NCT00842894|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24577283|NCT00842894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24577284|NCT00842894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577286|NCT00842907|Isotretinoin|isotretinoin|mesh-list
24577287|NCT00842907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577288|NCT00842907|Keratolytic Agents|keratolytic agents|mesh-ancestor
24577289|NCT00842907|Dermatologic Agents|dermatologic agents|mesh-ancestor
24577290|NCT00842920|Simvastatin|simvastatin|mesh-list
24577291|NCT00842920|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24577292|NCT00842920|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24577293|NCT00842920|Antimetabolites|antimetabolites|mesh-ancestor
24577294|NCT00842920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577295|NCT00842920|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24577296|NCT00842920|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24577297|NCT00842920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577298|NCT00842933|Prednisone|prednisone|mesh-list
24577299|NCT00842933|Methylprednisolone|methylprednisolone|mesh-list
24577300|NCT00842933|Hydrocortisone|hydrocortisone|mesh-list
24577301|NCT00842933|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24577302|NCT00842933|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24577303|NCT00842933|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24577304|NCT00842933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24577305|NCT00842933|Glucocorticoids|glucocorticoids|mesh-ancestor
24577306|NCT00842933|Hormones|hormones|mesh-ancestor
24577307|NCT00842933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24577308|NCT00842933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056922|NCT03508817|Autonomic Agents|autonomic agents|mesh-ancestor
25148316|NCT05247268|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25148317|NCT05247268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25148318|NCT05247268|Appetite Stimulants|appetite stimulants|mesh-ancestor
24577309|NCT00842933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24577310|NCT00842933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577311|NCT00842933|Antiemetics|antiemetics|mesh-ancestor
24577312|NCT00842933|Autonomic Agents|autonomic agents|mesh-ancestor
25863658|NCT00094549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24576021|NCT00836316|Anesthetics|anesthetics|mesh-ancestor
24577325|NCT00843063|Famotidine|famotidine|mesh-list
24577326|NCT00843063|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24577327|NCT00843063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24577328|NCT00843063|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24577329|NCT00843063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577330|NCT00843063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577331|NCT00843063|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25221800|NCT02648633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221801|NCT02648633|Antimanic Agents|antimanic agents|mesh-ancestor
25221802|NCT02648633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25221803|NCT02648633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25221804|NCT02648633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25221805|NCT02648659|Amoxicillin|amoxicillin|mesh-list
24833978|NCT02176304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24833979|NCT02176304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833980|NCT02176304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24833981|NCT02176304|Antiemetics|antiemetics|mesh-ancestor
24833982|NCT02176304|Autonomic Agents|autonomic agents|mesh-ancestor
24833983|NCT02176304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24577332|NCT00843063|Histamine Antagonists|histamine antagonists|mesh-ancestor
24577333|NCT00843063|Histamine Agents|histamine agents|mesh-ancestor
24577352|NCT00843440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24577353|NCT00843440|Growth Substances|growth substances|mesh-ancestor
24577354|NCT00843440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577355|NCT00843440|Growth Inhibitors|growth inhibitors|mesh-ancestor
24577356|NCT00843453|Vitamin B 12|vitamin b 12|mesh-list
24577357|NCT00843453|Hydroxocobalamin|hydroxocobalamin|mesh-list
24577358|NCT00843453|Vitamin B Complex|vitamin b complex|mesh-ancestor
24577359|NCT00843453|Vitamins|vitamins|mesh-ancestor
24577360|NCT00843453|Micronutrients|micronutrients|mesh-ancestor
24577361|NCT00843453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577362|NCT00843453|Hematinics|hematinics|mesh-ancestor
24577363|NCT00843570|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24577364|NCT00843570|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24577365|NCT00843570|Nafarelin|nafarelin|mesh-list
24577366|NCT00843570|Estradiol|estradiol|mesh-list
24577367|NCT00843570|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24577368|NCT00843570|Progesterone|progesterone|mesh-list
24577369|NCT00843570|Estrogens|estrogens|mesh-ancestor
24577370|NCT00843570|Hormones|hormones|mesh-ancestor
24577371|NCT00843570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24577372|NCT00843570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577373|NCT00843570|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24577374|NCT00843570|Contraceptive Agents|contraceptive agents|mesh-ancestor
24577375|NCT00843570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24577376|NCT00843570|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24577377|NCT00843570|Progestins|progestins|mesh-ancestor
24577378|NCT00843570|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24577379|NCT00843570|Fertility Agents|fertility agents|mesh-ancestor
24577380|NCT00843661|Ezetimibe|ezetimibe|mesh-list
24577381|NCT00843661|Pravastatin|pravastatin|mesh-list
24577382|NCT00843661|Fenofibrate|fenofibrate|mesh-list
24951075|NCT03908528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24577441|NCT00844155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577443|NCT00844168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577444|NCT00844168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24577445|NCT00844168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577446|NCT00844168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577447|NCT00844207|Azithromycin|azithromycin|mesh-list
24577490|NCT00844337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24577511|NCT00844350|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24577512|NCT00844350|Fertility Agents|fertility agents|mesh-ancestor
24577591|NCT00844792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24577592|NCT00844792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24577593|NCT00844792|Antioxidants|antioxidants|mesh-ancestor
24577594|NCT00844792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577595|NCT00844792|Protective Agents|protective agents|mesh-ancestor
24577596|NCT00844792|Trace Elements|trace elements|mesh-ancestor
24577597|NCT00844792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24577598|NCT00844792|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25669137|NCT01727700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25669138|NCT01727700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25669139|NCT01727700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669140|NCT01727700|Dopamine Agonists|dopamine agonists|mesh-ancestor
25669141|NCT01727700|Dopamine Agents|dopamine agents|mesh-ancestor
25669142|NCT01727700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25669143|NCT01727700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669144|NCT01727700|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25669145|NCT01727700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25669146|NCT01727700|Serotonin Agents|serotonin agents|mesh-ancestor
25669147|NCT01727700|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24577599|NCT00844792|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25221834|NCT02648048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25221835|NCT02648048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042840|NCT01360853|Antiviral Agents|antiviral agents|mesh-ancestor
25042841|NCT01360853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042842|NCT01360853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25042848|NCT01359566|Baclofen|baclofen|mesh-list
24577600|NCT00844792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577602|NCT00845104|Rituximab|rituximab|mesh-list
24577603|NCT00845104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24577604|NCT00845104|Fludarabine|fludarabine|mesh-list
24577605|NCT00845104|Fludarabine phosphate|fludarabine phosphate|mesh-list
25200158|NCT02735876|Rituximab|rituximab|mesh-list
25200159|NCT02735876|Acalabrutinib|acalabrutinib|mesh-list
25200160|NCT02735876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25200161|NCT02735876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827145|NCT02137616|Antiemetics|antiemetics|mesh-ancestor
24827146|NCT02137616|Autonomic Agents|autonomic agents|mesh-ancestor
25148392|NCT05124067|BB 1101|bb 1101|mesh-list
24577606|NCT00845104|Antibodies|antibodies|mesh-list
24577607|NCT00845104|Immunoglobulins|immunoglobulins|mesh-list
24577608|NCT00845104|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24577629|NCT00845221|Imatinib Mesylate|imatinib mesylate|mesh-list
24577630|NCT00845221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577631|NCT00845221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24577632|NCT00845221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577633|NCT00845221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577635|NCT00845338|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24951076|NCT03908528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24951077|NCT03908528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24951102|NCT03908333|Gemcitabine|gemcitabine|mesh-list
24951103|NCT03908333|Paclitaxel|paclitaxel|mesh-list
24951104|NCT03908333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24951105|NCT03908333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24951106|NCT03908333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951107|NCT03908333|Tubulin Modulators|tubulin modulators|mesh-ancestor
24951108|NCT03908333|Antimitotic Agents|antimitotic agents|mesh-ancestor
24577645|NCT00845364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24577646|NCT00845364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24577647|NCT00845364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577648|NCT00845364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24577649|NCT00845364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577650|NCT00845364|Vasodilator Agents|vasodilator agents|mesh-ancestor
24577652|NCT00845533|Artenimol|artenimol|mesh-list
24577653|NCT00845533|Antimalarials|antimalarials|mesh-ancestor
24577654|NCT00845533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24577655|NCT00845533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24577656|NCT00845533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24577667|NCT00845546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24577668|NCT00845546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577672|NCT00845546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24577673|NCT00845546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24577674|NCT00845546|Respiratory System Agents|respiratory system agents|mesh-ancestor
24577675|NCT00845546|Nasal Decongestants|nasal decongestants|mesh-ancestor
24577676|NCT00845546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24577677|NCT00845546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24577678|NCT00845546|Sympathomimetics|sympathomimetics|mesh-ancestor
24577679|NCT00845546|Adrenergic Agents|adrenergic agents|mesh-ancestor
24577681|NCT00845559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24577682|NCT00845559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577683|NCT00845559|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24577684|NCT00845559|Incretins|incretins|mesh-ancestor
24577685|NCT00845559|Hormones|hormones|mesh-ancestor
24577686|NCT00845559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24577687|NCT00845572|Risperidone|risperidone|mesh-list
24577688|NCT00845572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24577689|NCT00845572|Serotonin Agents|serotonin agents|mesh-ancestor
24577690|NCT00845572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25669148|NCT01727700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25669149|NCT01727700|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25669150|NCT01727700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25669151|NCT01727713|Aripiprazole|aripiprazole|mesh-list
25669152|NCT01727713|Antidepressive Agents|antidepressive agents|mesh-ancestor
25669153|NCT01727713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25669154|NCT01727713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25669155|NCT01727713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24982018|NCT04454411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24577691|NCT00845572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577692|NCT00845572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577709|NCT00845598|Dermatologic Agents|dermatologic agents|mesh-ancestor
24577710|NCT00845598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24577711|NCT00845598|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24577712|NCT00845598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577713|NCT00845598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951113|NCT03908333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951114|NCT03908333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24951115|NCT03908333|Antimetabolites|antimetabolites|mesh-ancestor
24951116|NCT03908333|Antiviral Agents|antiviral agents|mesh-ancestor
24951117|NCT03908333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24951118|NCT03908333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951119|NCT03908333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24951120|NCT03908333|Immunologic Factors|immunologic factors|mesh-ancestor
24951122|NCT03908333|Protective Agents|protective agents|mesh-ancestor
25200162|NCT02735876|Immunologic Factors|immunologic factors|mesh-ancestor
25200163|NCT02735876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200164|NCT02735876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25048163|NCT00734292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048164|NCT00734292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25048165|NCT00734292|Respiratory System Agents|respiratory system agents|mesh-ancestor
24951123|NCT03908242|Salvianolic acid A|salvianolic acid a|mesh-list
24951124|NCT03908242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951125|NCT03908242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951126|NCT03908242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577729|NCT00845689|Vasodilator Agents|vasodilator agents|mesh-ancestor
24577730|NCT00845689|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24577731|NCT00845689|Purinergic Agonists|purinergic agonists|mesh-ancestor
24577732|NCT00845689|Purinergic Agents|purinergic agents|mesh-ancestor
24577733|NCT00845689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24577734|NCT00845689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577743|NCT00845754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24577744|NCT00845754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24577745|NCT00845754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951141|NCT03908372|Tubulin Modulators|tubulin modulators|mesh-ancestor
24951142|NCT03908372|Antimitotic Agents|antimitotic agents|mesh-ancestor
24951143|NCT03908372|Mitosis Modulators|mitosis modulators|mesh-ancestor
24951144|NCT03908372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577746|NCT00845754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577748|NCT00845780|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24577749|NCT00845780|Vasodilator Agents|vasodilator agents|mesh-ancestor
24577750|NCT00845780|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24577751|NCT00845780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24577766|NCT00845819|Povidone|povidone|mesh-list
24577782|NCT00845884|Cisplatin|cisplatin|mesh-list
24577794|NCT00845884|Mitosis Modulators|mitosis modulators|mesh-ancestor
24577795|NCT00845884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577796|NCT00845884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24577797|NCT00845884|Antimetabolites|antimetabolites|mesh-ancestor
24577798|NCT00845910|Bevacizumab|bevacizumab|mesh-list
24577799|NCT00845910|Docetaxel|docetaxel|mesh-list
24577800|NCT00845910|Capecitabine|capecitabine|mesh-list
24577801|NCT00845910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24577802|NCT00845910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577803|NCT00845910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24577804|NCT00845910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24577805|NCT00845910|Growth Substances|growth substances|mesh-ancestor
24577806|NCT00845910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577808|NCT00845910|Tubulin Modulators|tubulin modulators|mesh-ancestor
24577809|NCT00845910|Antimitotic Agents|antimitotic agents|mesh-ancestor
24577810|NCT00845910|Mitosis Modulators|mitosis modulators|mesh-ancestor
25876771|NCT02794571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24577852|NCT00846118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24577853|NCT00846118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24577854|NCT00846118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24577855|NCT00846118|Antimetabolites|antimetabolites|mesh-ancestor
24577856|NCT00846118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577857|NCT00846118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25669156|NCT01727713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24577858|NCT00846118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24577860|NCT00846131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24834175|NCT02177370|Tocolytic Agents|tocolytic agents|mesh-ancestor
24834176|NCT02177370|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24834177|NCT02177370|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24834178|NCT02177370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24834179|NCT02177370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24577861|NCT00846131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24577862|NCT00846131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577863|NCT00846131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577865|NCT00846144|Copper Sulfate|copper sulfate|mesh-list
24577866|NCT00846144|Trace Elements|trace elements|mesh-ancestor
24577867|NCT00846144|Micronutrients|micronutrients|mesh-ancestor
24577868|NCT00846144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577869|NCT00846144|Antidotes|antidotes|mesh-ancestor
24577871|NCT00846144|Emetics|emetics|mesh-ancestor
24577886|NCT00846235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577888|NCT00846248|Trace Elements|trace elements|mesh-ancestor
24577890|NCT00846248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577891|NCT00846274|Antithrombins|antithrombins|mesh-list
24577892|NCT00846274|Antithrombin III|antithrombin iii|mesh-list
24577893|NCT00846274|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25200165|NCT02735902|Aspirin|aspirin|mesh-list
25200166|NCT02735902|Vitamin K|vitamin k|mesh-list
25200167|NCT02735902|Anticoagulants|anticoagulants|mesh-list
24577894|NCT00846274|Protease Inhibitors|protease inhibitors|mesh-ancestor
24951145|NCT03908008|Botulinum Toxins|botulinum toxins|mesh-list
25200168|NCT02735902|Vitamins|vitamins|mesh-ancestor
24951146|NCT03908008|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24951147|NCT03908008|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24951148|NCT03908008|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24577940|NCT00846430|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24577942|NCT00846430|Vincristine|vincristine|mesh-list
24577943|NCT00846430|Temozolomide|temozolomide|mesh-list
24577944|NCT00846430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577945|NCT00846430|Antiviral Agents|antiviral agents|mesh-ancestor
24577946|NCT00846430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24577947|NCT00846430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24577948|NCT00846430|Tubulin Modulators|tubulin modulators|mesh-ancestor
24577949|NCT00846430|Antimitotic Agents|antimitotic agents|mesh-ancestor
24577950|NCT00846430|Mitosis Modulators|mitosis modulators|mesh-ancestor
24577951|NCT00846430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577952|NCT00846430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24577954|NCT00846430|Immunologic Factors|immunologic factors|mesh-ancestor
24577955|NCT00846430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577994|NCT00846625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577995|NCT00846625|Growth Inhibitors|growth inhibitors|mesh-ancestor
24577996|NCT00846625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578034|NCT00846690|Adrenergic Agents|adrenergic agents|mesh-ancestor
24578035|NCT00846690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24578036|NCT00846690|Protective Agents|protective agents|mesh-ancestor
24578051|NCT00846703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951186|NCT03907423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24805130|NCT02007837|Aspirin|aspirin|mesh-list
24578052|NCT00846703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24578053|NCT00846703|Abortifacient Agents|abortifacient agents|mesh-ancestor
25863659|NCT00094549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863660|NCT00094549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24578063|NCT00846703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24578064|NCT00846703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24578065|NCT00846703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24578066|NCT00846703|Tubulin Modulators|tubulin modulators|mesh-ancestor
24578067|NCT00846703|Antimitotic Agents|antimitotic agents|mesh-ancestor
24578094|NCT00846872|Natriuretic Agents|natriuretic agents|mesh-ancestor
24578095|NCT00846911|Moxifloxacin|moxifloxacin|mesh-list
24578096|NCT00846911|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25669157|NCT01727713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669158|NCT01727713|Dopamine Agonists|dopamine agonists|mesh-ancestor
25669159|NCT01727713|Dopamine Agents|dopamine agents|mesh-ancestor
25669160|NCT01727713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25669161|NCT01727713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578097|NCT00846911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24578098|NCT00846911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25669162|NCT01727713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25669163|NCT01727713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25669164|NCT01727713|Serotonin Agents|serotonin agents|mesh-ancestor
25674452|NCT01772368|Albuterol|albuterol|mesh-list
25674453|NCT01772368|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24834288|NCT02177539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24834289|NCT02177539|Nasal Decongestants|nasal decongestants|mesh-ancestor
24834290|NCT02177539|Respiratory System Agents|respiratory system agents|mesh-ancestor
24578099|NCT00846911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24578100|NCT00846911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24578101|NCT00846911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24578102|NCT00846911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578103|NCT00846911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578104|NCT00846911|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24578105|NCT00846911|Contraceptive Agents|contraceptive agents|mesh-ancestor
24578106|NCT00846911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24578107|NCT00846911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578108|NCT00846911|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24578109|NCT00846911|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24951187|NCT03907423|Immunologic Factors|immunologic factors|mesh-ancestor
24578140|NCT00847054|Antibodies|antibodies|mesh-list
24578141|NCT00847054|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24578142|NCT00847054|Immunologic Factors|immunologic factors|mesh-ancestor
24578143|NCT00847054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578144|NCT00847080|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24578145|NCT00847080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24578146|NCT00847080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578147|NCT00847080|Incretins|incretins|mesh-ancestor
24578148|NCT00847080|Hormones|hormones|mesh-ancestor
24578149|NCT00847080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24578150|NCT00847080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24578170|NCT00847119|Bevacizumab|bevacizumab|mesh-list
24578178|NCT00847119|Growth Inhibitors|growth inhibitors|mesh-ancestor
25863661|NCT00094549|Serotonin Agents|serotonin agents|mesh-ancestor
24578179|NCT00847119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24578180|NCT00847119|Antimetabolites|antimetabolites|mesh-ancestor
24578181|NCT00847119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578182|NCT00847223|Tipifarnib|tipifarnib|mesh-list
24578183|NCT00847223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578184|NCT00847262|Amlodipine|amlodipine|mesh-list
24578185|NCT00847262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24578186|NCT00847262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24578187|NCT00847262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24578188|NCT00847262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578189|NCT00847262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25863662|NCT00094549|Anticonvulsants|anticonvulsants|mesh-ancestor
25863663|NCT00094549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24578219|NCT00847639|Growth Inhibitors|growth inhibitors|mesh-ancestor
24578222|NCT00847678|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24578223|NCT00847678|Flucytosine|flucytosine|mesh-list
24578224|NCT00847678|Efungumab|efungumab|mesh-list
24578225|NCT00847678|Amebicides|amebicides|mesh-ancestor
24578226|NCT00847678|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24578227|NCT00847678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24578228|NCT00847678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24578229|NCT00847678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24578230|NCT00847678|Antifungal Agents|antifungal agents|mesh-ancestor
24578231|NCT00847678|Antimetabolites|antimetabolites|mesh-ancestor
24578232|NCT00847678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578233|NCT00847821|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
24578274|NCT00847860|Vasodilator Agents|vasodilator agents|mesh-ancestor
24578275|NCT00847860|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24578276|NCT00847860|Protective Agents|protective agents|mesh-ancestor
24578322|NCT00848562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24578323|NCT00848562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24578324|NCT00848562|Vasodilator Agents|vasodilator agents|mesh-ancestor
24578325|NCT00848562|Vitamin B Complex|vitamin b complex|mesh-ancestor
25669165|NCT01727713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25669166|NCT01727713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25669167|NCT01727713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25669168|NCT01727713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25669169|NCT01727726|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25669170|NCT01727726|Brexpiprazole|brexpiprazole|mesh-list
25669171|NCT01727726|Antidepressive Agents|antidepressive agents|mesh-ancestor
25669172|NCT01727726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25863664|NCT00094549|GABA Agents|gaba agents|mesh-ancestor
24578327|NCT00848562|Micronutrients|micronutrients|mesh-ancestor
24578328|NCT00848562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578330|NCT00848640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578331|NCT00848640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24578332|NCT00848640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24578437|NCT00849082|Cyproterone Acetate|cyproterone acetate|mesh-list
24578438|NCT00849082|Cyproterone|cyproterone|mesh-list
24578439|NCT00849082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24578440|NCT00849082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578441|NCT00849082|Androgen Antagonists|androgen antagonists|mesh-ancestor
24578442|NCT00849082|Hormone Antagonists|hormone antagonists|mesh-ancestor
24578443|NCT00849082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24578444|NCT00849082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578445|NCT00849082|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24444051|NCT00296634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578484|NCT00849238|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24578485|NCT00849238|Antitubercular Agents|antitubercular agents|mesh-ancestor
24578486|NCT00849238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24578487|NCT00849238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24578488|NCT00849238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24578489|NCT00849238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578490|NCT00849264|Fluorouracil|fluorouracil|mesh-list
25200169|NCT02735902|Micronutrients|micronutrients|mesh-ancestor
25200170|NCT02735902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200171|NCT02735902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25200172|NCT02735902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25200173|NCT02735902|Analgesics|analgesics|mesh-ancestor
25200174|NCT02735902|Sensory System Agents|sensory system agents|mesh-ancestor
25200175|NCT02735902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25200176|NCT02735902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24578492|NCT00849264|Antimetabolites|antimetabolites|mesh-ancestor
24578493|NCT00849264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578494|NCT00849264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24578495|NCT00849264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578496|NCT00849264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24578497|NCT00849264|Immunologic Factors|immunologic factors|mesh-ancestor
24578498|NCT00849264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578539|NCT00849459|Interleukin-12|interleukin-12|mesh-list
24578540|NCT00849459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24578541|NCT00849459|Immunologic Factors|immunologic factors|mesh-ancestor
24578542|NCT00849459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578543|NCT00849459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24578544|NCT00849459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24578545|NCT00849459|Growth Substances|growth substances|mesh-ancestor
24578549|NCT00849511|Antioxidants|antioxidants|mesh-ancestor
24578550|NCT00849511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578551|NCT00849511|Protective Agents|protective agents|mesh-ancestor
24578552|NCT00849511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578553|NCT00849511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24578554|NCT00849537|Triamcinolone|triamcinolone|mesh-list
24578555|NCT00849537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24578556|NCT00849537|Glucocorticoids|glucocorticoids|mesh-ancestor
24578609|NCT00849966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24578610|NCT00849966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24578611|NCT00849966|Analgesics|analgesics|mesh-ancestor
24578612|NCT00849966|Sensory System Agents|sensory system agents|mesh-ancestor
24578613|NCT00849966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24951207|NCT03907124|Psychotropic Drugs|psychotropic drugs|mesh-list
24951208|NCT03907215|Citalopram|citalopram|mesh-list
24951209|NCT03907215|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24951210|NCT03907215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24951211|NCT03907215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24951212|NCT03907215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578652|NCT00850161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24578653|NCT00850161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578654|NCT00850304|Arsenic Trioxide|arsenic trioxide|mesh-list
24578655|NCT00850304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578656|NCT00850382|Cytarabine|cytarabine|mesh-list
24578657|NCT00850382|Daunorubicin|daunorubicin|mesh-list
24578658|NCT00850382|Dasatinib|dasatinib|mesh-list
24578673|NCT00850668|Hypoxanthine arabinoside|hypoxanthine arabinoside|mesh-list
24578674|NCT00850668|Antiviral Agents|antiviral agents|mesh-ancestor
24578700|NCT00851136|Bevacizumab|bevacizumab|mesh-list
24578701|NCT00851136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24578702|NCT00851136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578703|NCT00851136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24578704|NCT00851136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25863665|NCT00094549|Antimanic Agents|antimanic agents|mesh-ancestor
24578705|NCT00851136|Growth Substances|growth substances|mesh-ancestor
24578706|NCT00851136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578707|NCT00851136|Growth Inhibitors|growth inhibitors|mesh-ancestor
24578709|NCT00851175|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24578710|NCT00851175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24578711|NCT00851175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24578712|NCT00851175|Antimetabolites|antimetabolites|mesh-ancestor
24578713|NCT00851175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578714|NCT00851175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24578715|NCT00851175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24578716|NCT00851175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24578717|NCT00851175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24578718|NCT00851175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578719|NCT00851175|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24578720|NCT00851175|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24578723|NCT00851175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24578724|NCT00851227|Conivaptan|conivaptan|mesh-list
24578727|NCT00851227|Natriuretic Agents|natriuretic agents|mesh-ancestor
24578750|NCT00851513|Anesthetics|anesthetics|mesh-ancestor
24578751|NCT00851513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24578752|NCT00851513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200177|NCT02735902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25863666|NCT00094614|Atropine|atropine|mesh-list
25148672|NCT04790045|Venetoclax|venetoclax|mesh-list
24578753|NCT00851513|Sensory System Agents|sensory system agents|mesh-ancestor
24578754|NCT00851513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24578755|NCT00851513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24578756|NCT00851513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24578757|NCT00851513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24951215|NCT03907215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951216|NCT03907215|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24951217|NCT03907215|Antidepressive Agents|antidepressive agents|mesh-ancestor
24951218|NCT03907215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24951219|NCT03907163|Dronabinol|dronabinol|mesh-list
25051989|NCT00356681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25051990|NCT00356681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25051991|NCT00356681|Growth Substances|growth substances|mesh-ancestor
25051992|NCT00356681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578826|NCT00852163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24578827|NCT00852163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24578828|NCT00852163|Antimetabolites|antimetabolites|mesh-ancestor
24578830|NCT00852189|Vitamin B Complex|vitamin b complex|mesh-list
24578831|NCT00852189|Vinca Alkaloids|vinca alkaloids|mesh-list
24578832|NCT00852189|Hematinics|hematinics|mesh-ancestor
24578833|NCT00852189|Vitamins|vitamins|mesh-ancestor
24578834|NCT00852189|Micronutrients|micronutrients|mesh-ancestor
24578835|NCT00852189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578837|NCT00852189|Tubulin Modulators|tubulin modulators|mesh-ancestor
24578858|NCT00852332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24578859|NCT00852332|Analgesics|analgesics|mesh-ancestor
24578860|NCT00852332|Sensory System Agents|sensory system agents|mesh-ancestor
24578862|NCT00852332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578863|NCT00852332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24578864|NCT00852332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24578865|NCT00852332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24578866|NCT00852345|Clofazimine|clofazimine|mesh-list
24578867|NCT00852345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24578868|NCT00852345|Leprostatic Agents|leprostatic agents|mesh-ancestor
24578869|NCT00852345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24578870|NCT00852345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24578871|NCT00852371|Pyrimethamine|pyrimethamine|mesh-list
24578872|NCT00852371|Piperaquine|piperaquine|mesh-list
24578873|NCT00852371|Sulfadoxine|sulfadoxine|mesh-list
24578874|NCT00852371|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24578875|NCT00852371|Amodiaquine|amodiaquine|mesh-list
24578876|NCT00852371|Artenimol|artenimol|mesh-list
24578877|NCT00852371|Antimalarials|antimalarials|mesh-ancestor
24578878|NCT00852371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24578916|NCT00852423|Piperaquine|piperaquine|mesh-list
24578917|NCT00852423|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25863667|NCT00094614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25863668|NCT00094614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25863669|NCT00094614|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25863670|NCT00094614|Autonomic Agents|autonomic agents|mesh-ancestor
25863671|NCT00094614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24578954|NCT00852670|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25052000|NCT00356109|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25052001|NCT00356109|Insulin Glargine|insulin glargine|mesh-list
25052002|NCT00356109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25052003|NCT00356109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052004|NCT00355849|Insulin|insulin|mesh-list
25052005|NCT00355849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25052006|NCT00355849|Insulin Glargine|insulin glargine|mesh-list
25052007|NCT00355849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25052008|NCT00355849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052009|NCT00355355|Talaporfin|talaporfin|mesh-list
25052010|NCT00355355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579005|NCT00853008|Methotrexate|methotrexate|mesh-list
24579006|NCT00853008|Vincristine|vincristine|mesh-list
24579007|NCT00853008|Daunorubicin|daunorubicin|mesh-list
24579008|NCT00853008|Mitoxantrone|mitoxantrone|mesh-list
24579009|NCT00853008|Mercaptopurine|mercaptopurine|mesh-list
24579010|NCT00853008|Teniposide|teniposide|mesh-list
24579011|NCT00853008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24579012|NCT00853008|Antiemetics|antiemetics|mesh-ancestor
25200178|NCT02735902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25200179|NCT02735902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25863672|NCT00094614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098239|NCT03198949|Everolimus|everolimus|mesh-list
24579013|NCT00853008|Autonomic Agents|autonomic agents|mesh-ancestor
24880610|NCT03560934|Dronabinol|dronabinol|mesh-list
24880611|NCT03560934|Hallucinogens|hallucinogens|mesh-ancestor
24880612|NCT03560934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579014|NCT00853008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24579015|NCT00853008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579059|NCT00853190|Hydrocodone|hydrocodone|mesh-list
24579060|NCT00853190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579061|NCT00853190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24579062|NCT00853190|Narcotics|narcotics|mesh-ancestor
24579063|NCT00853190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24579064|NCT00853190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579107|NCT00853294|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24579108|NCT00853294|Histamine Antagonists|histamine antagonists|mesh-ancestor
24579109|NCT00853294|Histamine Agents|histamine agents|mesh-ancestor
24579110|NCT00853294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24579111|NCT00853294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24579112|NCT00853320|Oxycodone|oxycodone|mesh-list
24579113|NCT00853320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24579114|NCT00853320|Narcotics|narcotics|mesh-ancestor
24579115|NCT00853320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24579116|NCT00853320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579117|NCT00853320|Analgesics|analgesics|mesh-ancestor
24579118|NCT00853320|Sensory System Agents|sensory system agents|mesh-ancestor
24579124|NCT00853411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24579126|NCT00853411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24579172|NCT00853697|Testosterone enanthate|testosterone enanthate|mesh-list
24579173|NCT00853697|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24579174|NCT00853697|Dutasteride|dutasteride|mesh-list
24579175|NCT00853697|Androgens|androgens|mesh-ancestor
24579176|NCT00853697|Hormones|hormones|mesh-ancestor
24579233|NCT00853944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24579234|NCT00853944|Protease Inhibitors|protease inhibitors|mesh-ancestor
24579235|NCT00853944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579236|NCT00853944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579296|NCT00854230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24579297|NCT00854256|Mitomycins|mitomycins|mesh-list
24579298|NCT00854256|Mitomycin|mitomycin|mesh-list
24579299|NCT00854256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24579300|NCT00854256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579301|NCT00854256|Alkylating Agents|alkylating agents|mesh-ancestor
24426689|NCT00236483|Narcotics|narcotics|mesh-ancestor
24579302|NCT00854256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579303|NCT00854256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24579304|NCT00854256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579305|NCT00854321|Rituximab|rituximab|mesh-list
24579306|NCT00854321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24579307|NCT00854321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579308|NCT00854321|Immunologic Factors|immunologic factors|mesh-ancestor
24579309|NCT00854321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669173|NCT01727726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24579310|NCT00854321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24579311|NCT00854425|Asparaginase|asparaginase|mesh-list
24579312|NCT00854425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579486|NCT00855361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579487|NCT00855361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579488|NCT00855387|Pancrelipase|pancrelipase|mesh-list
24579489|NCT00855387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24579490|NCT00855517|Latanoprost|latanoprost|mesh-list
24579491|NCT00855517|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24579492|NCT00855517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24579493|NCT00855530|Amibegron|amibegron|mesh-list
24579494|NCT00855530|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24880613|NCT03560934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25052016|NCT00353457|Capecitabine|capecitabine|mesh-list
25052017|NCT00353457|Oxaliplatin|oxaliplatin|mesh-list
25052018|NCT00353457|Cetuximab|cetuximab|mesh-list
25052019|NCT00353457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25052020|NCT00353457|Antimetabolites|antimetabolites|mesh-ancestor
25052021|NCT00353457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052022|NCT00353457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579495|NCT00855530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24579496|NCT00855530|Adrenergic Agents|adrenergic agents|mesh-ancestor
24579497|NCT00855530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24579498|NCT00855530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579523|NCT00855777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25200180|NCT02735902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579525|NCT00855777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24579526|NCT00855777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24579591|NCT00856362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24579592|NCT00856362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579593|NCT00856362|Anthelmintics|anthelmintics|mesh-ancestor
24579594|NCT00856362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24579595|NCT00856362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24579596|NCT00856362|Antinematodal Agents|antinematodal agents|mesh-ancestor
24579597|NCT00856401|Parathyroid Hormone|parathyroid hormone|mesh-list
24579598|NCT00856401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579599|NCT00856401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24579600|NCT00856505|Mycophenolic Acid|mycophenolic acid|mesh-list
24579601|NCT00856505|Everolimus|everolimus|mesh-list
24579602|NCT00856505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579603|NCT00856505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24579604|NCT00856505|Immunologic Factors|immunologic factors|mesh-ancestor
24579605|NCT00856505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579606|NCT00856505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24579607|NCT00856505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24579608|NCT00856505|Antitubercular Agents|antitubercular agents|mesh-ancestor
24579609|NCT00856505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24579610|NCT00856505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24579636|NCT00856622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579637|NCT00856622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24579638|NCT00856622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24579640|NCT00856687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24579641|NCT00856687|Respiratory System Agents|respiratory system agents|mesh-ancestor
24579642|NCT00856687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24579643|NCT00856687|Hormone Antagonists|hormone antagonists|mesh-ancestor
24579645|NCT00856687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579696|NCT00857077|Renal Agents|renal agents|mesh-ancestor
24579697|NCT00857116|Albendazole|albendazole|mesh-list
24579698|NCT00857116|Anthelmintics|anthelmintics|mesh-ancestor
24579699|NCT00857116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24579700|NCT00857116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24579701|NCT00857116|Anticestodal Agents|anticestodal agents|mesh-ancestor
24579702|NCT00857116|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24579703|NCT00857116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24426940|NCT00236860|Topiramate|topiramate|mesh-list
24579704|NCT00857116|Tubulin Modulators|tubulin modulators|mesh-ancestor
24579705|NCT00857116|Antimitotic Agents|antimitotic agents|mesh-ancestor
24579706|NCT00857116|Mitosis Modulators|mitosis modulators|mesh-ancestor
25052023|NCT00353457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24966309|NCT03769818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24579707|NCT00857116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404124|NCT03682978|Baclofen|baclofen|mesh-list
25669174|NCT01727726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25669175|NCT01727726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24579710|NCT00857142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24579711|NCT00857142|Narcotics|narcotics|mesh-ancestor
24579712|NCT00857142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24579713|NCT00857142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880658|NCT03525002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24579868|NCT00858429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24579869|NCT00858429|Antimetabolites|antimetabolites|mesh-ancestor
24579870|NCT00858429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579871|NCT00858429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579872|NCT00858429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24579873|NCT00858429|Immunologic Factors|immunologic factors|mesh-ancestor
24579926|NCT00858715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579928|NCT00858715|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25863673|NCT00094614|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25863674|NCT00094614|Respiratory System Agents|respiratory system agents|mesh-ancestor
25863675|NCT00094614|Mydriatics|mydriatics|mesh-ancestor
24579990|NCT00859235|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24579991|NCT00859235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24579992|NCT00859235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24579993|NCT00859235|Disinfectants|disinfectants|mesh-ancestor
24579994|NCT00859235|Dermatologic Agents|dermatologic agents|mesh-ancestor
24579995|NCT00859274|Budesonide|budesonide|mesh-list
24579996|NCT00859274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24579997|NCT00859274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25148885|NCT04531059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579998|NCT00859274|Autonomic Agents|autonomic agents|mesh-ancestor
24579999|NCT00859274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24580000|NCT00859274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580042|NCT00859872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580043|NCT00859872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24580044|NCT00859872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24580045|NCT00859872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24580046|NCT00859872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24580047|NCT00859872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24580048|NCT00859872|Dopamine Agents|dopamine agents|mesh-ancestor
24580049|NCT00859872|Antiemetics|antiemetics|mesh-ancestor
24580050|NCT00859872|Autonomic Agents|autonomic agents|mesh-ancestor
24580051|NCT00859872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24580052|NCT00859872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24580053|NCT00859872|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24580054|NCT00859885|Aspirin|aspirin|mesh-list
24580055|NCT00859885|Clopidogrel|clopidogrel|mesh-list
24580056|NCT00859885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24580057|NCT00859885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24580058|NCT00859885|Analgesics|analgesics|mesh-ancestor
24580101|NCT00860275|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24580102|NCT00860275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24580103|NCT00860275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580104|NCT00860275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580105|NCT00860275|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24580106|NCT00860275|Hormone Antagonists|hormone antagonists|mesh-ancestor
24580107|NCT00860275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24966321|NCT03769402|Citric Acid|citric acid|mesh-list
24966322|NCT03769402|Sodium Citrate|sodium citrate|mesh-list
24966323|NCT03769402|Anticoagulants|anticoagulants|mesh-ancestor
24966324|NCT03769402|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24966325|NCT03769402|Chelating Agents|chelating agents|mesh-ancestor
24966326|NCT03769402|Sequestering Agents|sequestering agents|mesh-ancestor
24966327|NCT03769402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966328|NCT03769129|Pembrolizumab|pembrolizumab|mesh-list
24966329|NCT03769129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24966330|NCT03769129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24966331|NCT03769103|Osimertinib|osimertinib|mesh-list
24966332|NCT03769103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24966333|NCT03769103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24966334|NCT03769103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24805188|NCT02008006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24805189|NCT02008006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24580108|NCT00860275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580109|NCT00860275|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24580110|NCT00860275|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24632590|NCT01124630|Antidotes|antidotes|mesh-ancestor
24580111|NCT00860275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24580112|NCT00860340|Spironolactone|spironolactone|mesh-list
24580169|NCT00860925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580170|NCT00860925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24580171|NCT00860925|Sympatholytics|sympatholytics|mesh-ancestor
24580172|NCT00860925|Autonomic Agents|autonomic agents|mesh-ancestor
24580173|NCT00860925|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24580174|NCT00860925|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24580175|NCT00860925|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24580176|NCT00860925|Adrenergic Agents|adrenergic agents|mesh-ancestor
24580177|NCT00860925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24580178|NCT00860925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580179|NCT00860964|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24580180|NCT00860964|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24580182|NCT00860964|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24580183|NCT00860964|Estrogens|estrogens|mesh-ancestor
24580184|NCT00860964|Hormones|hormones|mesh-ancestor
24966335|NCT03769103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966336|NCT03769064|Methylphenidate|methylphenidate|mesh-list
24966337|NCT03769064|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24966338|NCT03769064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966339|NCT03769064|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25200181|NCT02735902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24966340|NCT03769064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24966342|NCT03769064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805214|NCT02008123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805215|NCT02008136|Botulinum Toxins|botulinum toxins|mesh-list
24805219|NCT02008136|Cholinergic Agents|cholinergic agents|mesh-ancestor
24580185|NCT00860964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24580188|NCT00860964|Contraceptive Agents|contraceptive agents|mesh-ancestor
24580219|NCT00861029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580286|NCT00861276|Autonomic Agents|autonomic agents|mesh-ancestor
24580287|NCT00861276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24580288|NCT00861276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580289|NCT00861276|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24580290|NCT00861276|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24580291|NCT00861276|Cholinergic Agents|cholinergic agents|mesh-ancestor
24580292|NCT00861276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24580293|NCT00861276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580295|NCT00861315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24580296|NCT00861315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24580297|NCT00861328|Oxaliplatin|oxaliplatin|mesh-list
24580299|NCT00861328|Camptothecin|camptothecin|mesh-list
24580300|NCT00861328|ON 01910|on 01910|mesh-list
24580301|NCT00861328|Glycine|glycine|mesh-list
24580302|NCT00861328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24580333|NCT00861406|Immunologic Factors|immunologic factors|mesh-ancestor
24580334|NCT00861406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580335|NCT00861406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24580337|NCT00861406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24580338|NCT00861419|Niacinamide|niacinamide|mesh-list
24580339|NCT00861419|Bevacizumab|bevacizumab|mesh-list
24580340|NCT00861419|Sunitinib|sunitinib|mesh-list
24580341|NCT00861419|Trebananib|trebananib|mesh-list
24580342|NCT00861419|Sorafenib|sorafenib|mesh-list
24580403|NCT00861627|Antimitotic Agents|antimitotic agents|mesh-ancestor
24580405|NCT00861627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580406|NCT00861640|Omeprazole|omeprazole|mesh-list
24580407|NCT00861640|Rabeprazole|rabeprazole|mesh-list
24580408|NCT00861640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24580409|NCT00861640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24580454|NCT00861874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24580455|NCT00861874|Antifungal Agents|antifungal agents|mesh-ancestor
25863676|NCT00094614|Parasympatholytics|parasympatholytics|mesh-ancestor
24966343|NCT03769064|Dopamine Agents|dopamine agents|mesh-ancestor
24966344|NCT03769064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24951220|NCT03907163|Hallucinogens|hallucinogens|mesh-ancestor
24951221|NCT03907163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951222|NCT03907163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24951223|NCT03907163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24951225|NCT03907163|Sensory System Agents|sensory system agents|mesh-ancestor
24951226|NCT03907163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24951227|NCT03907163|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24951228|NCT03907163|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24951229|NCT03907163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24951230|NCT03907163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951231|NCT03907163|Hormones|hormones|mesh-ancestor
24577775|NCT00845819|Blood Substitutes|blood substitutes|mesh-ancestor
24951239|NCT03907111|Chelating Agents|chelating agents|mesh-ancestor
24951240|NCT03907111|Sequestering Agents|sequestering agents|mesh-ancestor
24951241|NCT03907111|Hemostatics|hemostatics|mesh-ancestor
24580456|NCT00861874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24580457|NCT00861874|Immunologic Factors|immunologic factors|mesh-ancestor
24580458|NCT00861874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580460|NCT00861887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24580461|NCT00861887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24580462|NCT00861926|Beclomethasone|beclomethasone|mesh-list
24580463|NCT00861926|Albuterol|albuterol|mesh-list
24580464|NCT00861926|Formoterol Fumarate|formoterol fumarate|mesh-list
24580465|NCT00861926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24580466|NCT00861926|Autonomic Agents|autonomic agents|mesh-ancestor
24580467|NCT00861926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24580468|NCT00861926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580469|NCT00861926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24580470|NCT00861926|Respiratory System Agents|respiratory system agents|mesh-ancestor
25200182|NCT02735902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25863677|NCT00094614|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24580533|NCT00862108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580534|NCT00862108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24580553|NCT00862264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24580554|NCT00862264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580555|NCT00862264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24580556|NCT00862264|Glucocorticoids|glucocorticoids|mesh-ancestor
24880903|NCT03213158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580558|NCT00862264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24580559|NCT00862264|Anesthetics|anesthetics|mesh-ancestor
24951243|NCT03906838|Ropivacaine|ropivacaine|mesh-list
24951244|NCT03906838|Anesthetics, Local|anesthetics, local|mesh-ancestor
24951245|NCT03906838|Anesthetics|anesthetics|mesh-ancestor
24951246|NCT03906838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24951247|NCT03906838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580560|NCT00862264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24580561|NCT00862329|Caseins|caseins|mesh-list
24580562|NCT00862329|Chelating Agents|chelating agents|mesh-ancestor
24580682|NCT00863161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580684|NCT00863187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24580685|NCT00863187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24580686|NCT00863187|Immunologic Factors|immunologic factors|mesh-ancestor
24580687|NCT00863187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580688|NCT00863187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24580689|NCT00863213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
24580690|NCT00863239|Interferons|interferons|mesh-list
24580691|NCT00863239|Ribavirin|ribavirin|mesh-list
24580692|NCT00863239|Interferon-alpha|interferon-alpha|mesh-list
24580693|NCT00863239|Interferon alpha-2|interferon alpha-2|mesh-list
25863678|NCT00094614|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25863679|NCT00094614|Cholinergic Agents|cholinergic agents|mesh-ancestor
25863680|NCT00094614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24580731|NCT00863395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580733|NCT00863460|Prednisone|prednisone|mesh-list
24580746|NCT00863460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580747|NCT00863460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24580750|NCT00863460|Glucocorticoids|glucocorticoids|mesh-ancestor
24446943|NCT00306696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25863681|NCT00094614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863682|NCT00094627|Gaboxadol|gaboxadol|mesh-list
24580778|NCT00863577|Anticoagulants|anticoagulants|mesh-ancestor
24580779|NCT00863629|Insulin|insulin|mesh-list
24580780|NCT00863629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24580781|NCT00863629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580782|NCT00863668|Tenofovir|tenofovir|mesh-list
24580850|NCT00863889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24580852|NCT00863889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24580853|NCT00863889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580854|NCT00863889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24580855|NCT00863889|Antiemetics|antiemetics|mesh-ancestor
24580856|NCT00863889|Autonomic Agents|autonomic agents|mesh-ancestor
25200183|NCT02735902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25200184|NCT02735902|Antipyretics|antipyretics|mesh-ancestor
25200185|NCT02735902|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25200186|NCT02735902|Hemostatics|hemostatics|mesh-ancestor
25200187|NCT02735902|Coagulants|coagulants|mesh-ancestor
25200188|NCT02735798|Trastuzumab|trastuzumab|mesh-list
25200189|NCT02735798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24580857|NCT00863889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24580858|NCT00863889|Glucocorticoids|glucocorticoids|mesh-ancestor
24580859|NCT00863889|Hormones|hormones|mesh-ancestor
24580860|NCT00863889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24580861|NCT00863889|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24580891|NCT00863941|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24580892|NCT00863941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24580893|NCT00863941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580895|NCT00863980|Candesartan|candesartan|mesh-list
24951248|NCT03906838|Sensory System Agents|sensory system agents|mesh-ancestor
24951249|NCT03906838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24951250|NCT03906669|Tamoxifen|tamoxifen|mesh-list
24951251|NCT03906669|Letrozole|letrozole|mesh-list
24805254|NCT02008214|Protective Agents|protective agents|mesh-ancestor
24580896|NCT00863980|Candesartan cilexetil|candesartan cilexetil|mesh-list
24580897|NCT00863980|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24580898|NCT00863980|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24580899|NCT00863980|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24580900|NCT00863980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580901|NCT00864006|Valproic Acid|valproic acid|mesh-list
24580926|NCT00864045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24580927|NCT00864045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580928|NCT00864045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24580929|NCT00864045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24580930|NCT00864045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24580931|NCT00864045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24580932|NCT00864045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24580933|NCT00864045|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24580992|NCT00864162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580994|NCT00864188|Beta Carotene|beta carotene|mesh-list
24580995|NCT00864188|Carotenoids|carotenoids|mesh-list
24580996|NCT00864188|Antioxidants|antioxidants|mesh-ancestor
24580997|NCT00864188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863683|NCT00094627|Analgesics|analgesics|mesh-ancestor
24446944|NCT00306696|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24446945|NCT00306696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25863684|NCT00094627|Sensory System Agents|sensory system agents|mesh-ancestor
25863685|NCT00094627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24581020|NCT00864279|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24581021|NCT00864279|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24581022|NCT00864279|Histamine Antagonists|histamine antagonists|mesh-ancestor
24581088|NCT00864396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581089|NCT00864409|Ropivacaine|ropivacaine|mesh-list
24581090|NCT00864409|Anesthetics, Local|anesthetics, local|mesh-ancestor
24581091|NCT00864409|Anesthetics|anesthetics|mesh-ancestor
24581092|NCT00864409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24581093|NCT00864409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581094|NCT00864409|Sensory System Agents|sensory system agents|mesh-ancestor
24581095|NCT00864409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24581096|NCT00864435|Carvedilol|carvedilol|mesh-list
24805263|NCT02008422|Tegafur|tegafur|mesh-list
24581097|NCT00864435|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24581098|NCT00864435|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24581099|NCT00864435|Adrenergic Agents|adrenergic agents|mesh-ancestor
24581100|NCT00864435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581101|NCT00864435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581102|NCT00864435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581103|NCT00864435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24581105|NCT00864435|Protective Agents|protective agents|mesh-ancestor
24581106|NCT00864435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24581107|NCT00864435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24581108|NCT00864435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24581109|NCT00864435|Vasodilator Agents|vasodilator agents|mesh-ancestor
24581110|NCT00864435|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24581111|NCT00864435|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24581112|NCT00864448|Ramipril|ramipril|mesh-list
24581113|NCT00864448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24581127|NCT00864500|Clobetasol|clobetasol|mesh-list
24581128|NCT00864500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24834958|NCT02181933|Antimetabolites|antimetabolites|mesh-ancestor
24581129|NCT00864500|Glucocorticoids|glucocorticoids|mesh-ancestor
24581137|NCT00864526|Analgesics|analgesics|mesh-ancestor
24581138|NCT00864526|Sensory System Agents|sensory system agents|mesh-ancestor
24578087|NCT00846872|Mannitol|mannitol|mesh-list
24581199|NCT00864643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24581200|NCT00864643|Antimetabolites|antimetabolites|mesh-ancestor
24581201|NCT00864643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581202|NCT00864643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25863686|NCT00094627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581203|NCT00864643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24581240|NCT00864799|Misoprostol|misoprostol|mesh-list
24581241|NCT00864799|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24581242|NCT00864799|Abortifacient Agents|abortifacient agents|mesh-ancestor
24581243|NCT00864799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24581248|NCT00864812|Fluticasone|fluticasone|mesh-list
24581249|NCT00864812|Xhance|xhance|mesh-list
24581250|NCT00864812|Tiotropium Bromide|tiotropium bromide|mesh-list
24581251|NCT00864812|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24581252|NCT00864812|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24581253|NCT00864812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24581254|NCT00864812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24581255|NCT00864812|Autonomic Agents|autonomic agents|mesh-ancestor
24581256|NCT00864812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24581257|NCT00864812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581258|NCT00864812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24581259|NCT00864812|Respiratory System Agents|respiratory system agents|mesh-ancestor
24581260|NCT00864812|Dermatologic Agents|dermatologic agents|mesh-ancestor
24951284|NCT03905837|Lidocaine|lidocaine|mesh-list
24951285|NCT03905837|Piperidine|piperidine|mesh-list
24581261|NCT00864812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24581262|NCT00864812|Parasympatholytics|parasympatholytics|mesh-ancestor
24581263|NCT00864812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24581264|NCT00864812|Cholinergic Agents|cholinergic agents|mesh-ancestor
24581265|NCT00864812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581266|NCT00864812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863687|NCT00094627|Anticonvulsants|anticonvulsants|mesh-ancestor
24581285|NCT00864838|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24581286|NCT00864838|Acetazolamide|acetazolamide|mesh-list
24581293|NCT00864838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581295|NCT00864838|Anticonvulsants|anticonvulsants|mesh-ancestor
24581296|NCT00864838|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24581297|NCT00864838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581298|NCT00864838|Diuretics|diuretics|mesh-ancestor
24581299|NCT00864838|Natriuretic Agents|natriuretic agents|mesh-ancestor
24581300|NCT00864864|Sunitinib|sunitinib|mesh-list
24581301|NCT00864864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24581302|NCT00864864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24581303|NCT00864864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24581304|NCT00864864|Growth Substances|growth substances|mesh-ancestor
24581305|NCT00864864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581306|NCT00864864|Growth Inhibitors|growth inhibitors|mesh-ancestor
24581318|NCT00864890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581319|NCT00864890|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24581320|NCT00864890|Antidepressive Agents|antidepressive agents|mesh-ancestor
24581321|NCT00864890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24581322|NCT00864890|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24581323|NCT00864890|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24581324|NCT00864890|Parasympatholytics|parasympatholytics|mesh-ancestor
24581325|NCT00864890|Autonomic Agents|autonomic agents|mesh-ancestor
24581326|NCT00864890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24581327|NCT00864890|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24581329|NCT00864890|Cholinergic Agents|cholinergic agents|mesh-ancestor
24581383|NCT00865007|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24581385|NCT00865033|Metformin|metformin|mesh-list
24581386|NCT00865033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24581387|NCT00865033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581388|NCT00865059|Gabapentin|gabapentin|mesh-list
24581389|NCT00865059|Analgesics|analgesics|mesh-ancestor
24581390|NCT00865059|Sensory System Agents|sensory system agents|mesh-ancestor
24581391|NCT00865059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24581392|NCT00865059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581393|NCT00865059|Anticonvulsants|anticonvulsants|mesh-ancestor
24581394|NCT00865059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25863688|NCT00094627|GABA Agonists|gaba agonists|mesh-ancestor
25863689|NCT00094627|GABA Agents|gaba agents|mesh-ancestor
25863690|NCT00094627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25863691|NCT00094627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581431|NCT00865111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24581432|NCT00865111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24581433|NCT00865111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581434|NCT00865111|Dopamine Agents|dopamine agents|mesh-ancestor
24581486|NCT00865371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581487|NCT00865371|Dopamine Agents|dopamine agents|mesh-ancestor
24581488|NCT00865371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581489|NCT00865371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951287|NCT03905837|Anesthetics, Local|anesthetics, local|mesh-ancestor
24951288|NCT03905837|Anesthetics|anesthetics|mesh-ancestor
24951289|NCT03905837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25863692|NCT00094640|Olanzapine|olanzapine|mesh-list
24581539|NCT00865423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24581540|NCT00865423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24581541|NCT00865423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24581542|NCT00865423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581543|NCT00865423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581544|NCT00865423|Antimanic Agents|antimanic agents|mesh-ancestor
24581545|NCT00865436|Metformin|metformin|mesh-list
24581546|NCT00865436|Glyburide|glyburide|mesh-list
24581580|NCT00865540|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24581581|NCT00865540|Methylprednisolone|methylprednisolone|mesh-list
24581582|NCT00865540|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24581583|NCT00865540|Prednisolone acetate|prednisolone acetate|mesh-list
24581584|NCT00865540|Ketorolac|ketorolac|mesh-list
24581585|NCT00865540|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24581586|NCT00865540|Nepafenac|nepafenac|mesh-list
24581587|NCT00865540|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24581588|NCT00865540|Prednisolone phosphate|prednisolone phosphate|mesh-list
24581589|NCT00865540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24581637|NCT00865631|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24581638|NCT00865631|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24581639|NCT00865631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581640|NCT00865631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581641|NCT00865631|Antimanic Agents|antimanic agents|mesh-ancestor
25863693|NCT00094640|Antiemetics|antiemetics|mesh-ancestor
24581683|NCT00865748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25863694|NCT00094640|Autonomic Agents|autonomic agents|mesh-ancestor
24581684|NCT00865748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581685|NCT00865761|Alprazolam|alprazolam|mesh-list
24581686|NCT00865761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24581687|NCT00865761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24581688|NCT00865761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578352|NCT00848770|Norepinephrine|norepinephrine|mesh-list
24581760|NCT00866008|Contraceptive Agents|contraceptive agents|mesh-ancestor
24581766|NCT00866008|Hormone Antagonists|hormone antagonists|mesh-ancestor
24581790|NCT00866060|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24581791|NCT00866060|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24581792|NCT00866060|Dopamine Agents|dopamine agents|mesh-ancestor
24581793|NCT00866060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24581794|NCT00866060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24581796|NCT00866073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24581797|NCT00866073|Antimetabolites|antimetabolites|mesh-ancestor
24632790|NCT01125696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24581798|NCT00866073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581799|NCT00866073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24581800|NCT00866073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581802|NCT00866216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24581803|NCT00866216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24581804|NCT00866229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24581805|NCT00866229|Simvastatin|simvastatin|mesh-list
24581806|NCT00866229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24581807|NCT00866229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24581808|NCT00866229|Antimetabolites|antimetabolites|mesh-ancestor
24581810|NCT00866229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25863695|NCT00094640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24581839|NCT00866463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581840|NCT00866463|Urological Agents|urological agents|mesh-ancestor
24581910|NCT00866645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24581912|NCT00866645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581913|NCT00866645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863696|NCT00094640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581915|NCT00866645|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24581916|NCT00866645|Antidepressive Agents|antidepressive agents|mesh-ancestor
24581918|NCT00866684|Sirolimus|sirolimus|mesh-list
25863697|NCT00094640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24581957|NCT00866853|Antiviral Agents|antiviral agents|mesh-ancestor
24581958|NCT00866853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24581959|NCT00866853|Protease Inhibitors|protease inhibitors|mesh-ancestor
24581980|NCT00866944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24581981|NCT00866944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951295|NCT03905837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24951296|NCT03905837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24951297|NCT03905837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951298|NCT03905837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24951300|NCT03905837|Analgesics|analgesics|mesh-ancestor
24951301|NCT03905837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24951302|NCT03905837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24951303|NCT03905941|Metformin|metformin|mesh-list
24805281|NCT02008461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805282|NCT02008578|Immunoglobulins|immunoglobulins|mesh-list
24805283|NCT02008578|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24581982|NCT00866944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24581983|NCT00866944|Immunologic Factors|immunologic factors|mesh-ancestor
24582002|NCT00866996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24582003|NCT00866996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24582004|NCT00866996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582005|NCT00866996|Dopamine Agents|dopamine agents|mesh-ancestor
24582006|NCT00866996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24582007|NCT00866996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24582008|NCT00866996|Adrenergic Agents|adrenergic agents|mesh-ancestor
24582010|NCT00867061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582011|NCT00867061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24582012|NCT00867061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24582013|NCT00867061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582015|NCT00867126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24582052|NCT00867672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24582053|NCT00867672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582054|NCT00867672|Antimanic Agents|antimanic agents|mesh-ancestor
24582055|NCT00867672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24582056|NCT00867672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24582114|NCT00868153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24582115|NCT00868153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582116|NCT00868153|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24582117|NCT00868153|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24582118|NCT00868153|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24582119|NCT00868179|Dabigatran|dabigatran|mesh-list
24582120|NCT00868179|Antithrombins|antithrombins|mesh-ancestor
24582121|NCT00868179|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24582122|NCT00868179|Protease Inhibitors|protease inhibitors|mesh-ancestor
24582123|NCT00868179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24582124|NCT00868179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582125|NCT00868179|Anticoagulants|anticoagulants|mesh-ancestor
24582126|NCT00868283|Cerebrolysin|cerebrolysin|mesh-list
24582127|NCT00868283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24582128|NCT00868283|Protective Agents|protective agents|mesh-ancestor
24582129|NCT00868283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582130|NCT00868283|Nootropic Agents|nootropic agents|mesh-ancestor
24951304|NCT03905941|Contraceptive Agents|contraceptive agents|mesh-list
24951305|NCT03905941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24951306|NCT03905941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951307|NCT03905941|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24951308|NCT03906123|3-n-butylphthalide|3-n-butylphthalide|mesh-list
24951309|NCT03906123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24951310|NCT03906123|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24951311|NCT03906123|Protective Agents|protective agents|mesh-ancestor
25052024|NCT00352560|Irbesartan|irbesartan|mesh-list
24966421|NCT03768258|Testosterone enanthate|testosterone enanthate|mesh-list
24951312|NCT03906123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582131|NCT00868413|Cyclophosphamide|cyclophosphamide|mesh-list
24582132|NCT00868413|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24582133|NCT00868413|Rituximab|rituximab|mesh-list
24582134|NCT00868413|Fludarabine|fludarabine|mesh-list
24582135|NCT00868413|Navitoclax|navitoclax|mesh-list
24582136|NCT00868413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24582137|NCT00868413|Immunologic Factors|immunologic factors|mesh-ancestor
24582138|NCT00868413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582139|NCT00868413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24582140|NCT00868413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24582158|NCT00868426|Hormones|hormones|mesh-ancestor
24582159|NCT00868426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24582160|NCT00868426|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24582162|NCT00868426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24582163|NCT00868426|Adrenergic Agents|adrenergic agents|mesh-ancestor
24582436|NCT00869700|Antimalarials|antimalarials|mesh-ancestor
24582437|NCT00869700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24582438|NCT00869700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24582439|NCT00869700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24632879|NCT01126008|Tubulin Modulators|tubulin modulators|mesh-ancestor
24582441|NCT00869752|Antibodies|antibodies|mesh-list
24582442|NCT00869752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24582443|NCT00869752|Immunologic Factors|immunologic factors|mesh-ancestor
24582444|NCT00869752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582445|NCT00869752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582446|NCT00869752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24582447|NCT00869752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24582448|NCT00869752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24582449|NCT00869752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951314|NCT03905967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951315|NCT03905967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24951316|NCT03905967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951317|NCT03905967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951318|NCT03905759|Colchicine|colchicine|mesh-list
24951319|NCT03905759|Amiodarone|amiodarone|mesh-list
24951320|NCT03905759|Dronedarone|dronedarone|mesh-list
24951321|NCT03905759|Gout Suppressants|gout suppressants|mesh-ancestor
24951322|NCT03905759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24951323|NCT03905759|Tubulin Modulators|tubulin modulators|mesh-ancestor
24951324|NCT03905759|Antimitotic Agents|antimitotic agents|mesh-ancestor
24951325|NCT03905759|Mitosis Modulators|mitosis modulators|mesh-ancestor
24582450|NCT00869752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582451|NCT00869765|Cycloserine|cycloserine|mesh-list
24582540|NCT00870298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24582541|NCT00870298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24582542|NCT00870298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24582543|NCT00870298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582544|NCT00870298|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24582545|NCT00870298|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24582546|NCT00870298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24582547|NCT00870311|Lithium Carbonate|lithium carbonate|mesh-list
24582548|NCT00870311|Antidepressive Agents|antidepressive agents|mesh-ancestor
24582549|NCT00870311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24582550|NCT00870311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24582551|NCT00870311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582552|NCT00870311|Antimanic Agents|antimanic agents|mesh-ancestor
24582553|NCT00870311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24632899|NCT01126086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632901|NCT01126112|Panitumumab|panitumumab|mesh-list
24632902|NCT01126112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24632903|NCT01126112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582558|NCT00870337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24582559|NCT00870337|Immunologic Factors|immunologic factors|mesh-ancestor
24582560|NCT00870337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582561|NCT00870402|Spironolactone|spironolactone|mesh-list
24582562|NCT00870402|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24582563|NCT00870402|Hormone Antagonists|hormone antagonists|mesh-ancestor
24582564|NCT00870402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24582565|NCT00870402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582573|NCT00870480|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24582574|NCT00870480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24582575|NCT00870480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24582576|NCT00870480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582577|NCT00870480|Hormone Antagonists|hormone antagonists|mesh-ancestor
24582578|NCT00870480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24582579|NCT00870480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582647|NCT00870961|Vitamin D|vitamin d|mesh-list
24951326|NCT03905759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089930|NCT03262363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25089931|NCT03262363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25089932|NCT03262363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24397039|NCT00140595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24397040|NCT00140595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24397041|NCT00140595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24397042|NCT00140595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24397043|NCT00140595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24397045|NCT00140647|Rosiglitazone|rosiglitazone|mesh-list
24951327|NCT03905759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951328|NCT03905759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24951329|NCT03905759|Vasodilator Agents|vasodilator agents|mesh-ancestor
24951330|NCT03905759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24951331|NCT03905759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24951332|NCT03905759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24582654|NCT00870987|Immunologic Factors|immunologic factors|mesh-ancestor
25009905|NCT05058872|Contraceptive Agents|contraceptive agents|mesh-ancestor
24582702|NCT00871156|Analgesics|analgesics|mesh-ancestor
24582703|NCT00871156|Sensory System Agents|sensory system agents|mesh-ancestor
24582707|NCT00871156|Filaricides|filaricides|mesh-ancestor
24582751|NCT00871442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24582752|NCT00871442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24582753|NCT00871442|Narcotics|narcotics|mesh-ancestor
24582754|NCT00871442|Analgesics|analgesics|mesh-ancestor
24582755|NCT00871442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24582756|NCT00871442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24582757|NCT00871442|Anesthetics, General|anesthetics, general|mesh-ancestor
24582758|NCT00871455|Baclofen|baclofen|mesh-list
24582759|NCT00871455|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24582760|NCT00871455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582761|NCT00871455|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24582762|NCT00871455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24582763|NCT00871455|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24582764|NCT00871455|GABA Agonists|gaba agonists|mesh-ancestor
24582798|NCT00871767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24582800|NCT00871767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24582801|NCT00871910|Dexamethasone|dexamethasone|mesh-list
24582826|NCT00871910|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24582827|NCT00871949|Oxazolidinones|oxazolidinones|mesh-list
24582868|NCT00872235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25200190|NCT02735798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25149516|NCT05466799|Oxaliplatin|oxaliplatin|mesh-list
25149517|NCT05466799|Irinotecan|irinotecan|mesh-list
25149518|NCT05466799|Folfirinox|folfirinox|mesh-list
25149519|NCT05466799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25149520|NCT05466799|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25149521|NCT05466799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25149522|NCT05466799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25149523|NCT05466799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582869|NCT00872248|Anesthetics|anesthetics|mesh-list
24951335|NCT03905759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951336|NCT03905759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24951337|NCT03905759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24951338|NCT03905759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24951339|NCT03905317|Bevacizumab|bevacizumab|mesh-list
24951340|NCT03905317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24582870|NCT00872248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24582871|NCT00872248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582872|NCT00872274|Sumatriptan|sumatriptan|mesh-list
24582873|NCT00872274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24582925|NCT00872625|Immunologic Factors|immunologic factors|mesh-ancestor
24582926|NCT00872625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582927|NCT00872625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24582928|NCT00872625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24582929|NCT00872625|Alkylating Agents|alkylating agents|mesh-ancestor
24582930|NCT00872625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669176|NCT01727726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669177|NCT01727726|Serotonin Agents|serotonin agents|mesh-ancestor
25669178|NCT01727726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25669179|NCT01727726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669180|NCT01727726|Dopamine Agonists|dopamine agonists|mesh-ancestor
25669181|NCT01727726|Dopamine Agents|dopamine agents|mesh-ancestor
25669182|NCT01727791|Pregabalin|pregabalin|mesh-list
25669183|NCT01727791|Analgesics|analgesics|mesh-ancestor
25669184|NCT01727791|Sensory System Agents|sensory system agents|mesh-ancestor
25669185|NCT01727791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25089947|NCT03261635|Indomethacin|indomethacin|mesh-list
25089948|NCT03261635|Ranibizumab|ranibizumab|mesh-list
25089949|NCT03261635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25089950|NCT03261635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25089951|NCT03261635|Growth Substances|growth substances|mesh-ancestor
25089952|NCT03261635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089953|NCT03261635|Growth Inhibitors|growth inhibitors|mesh-ancestor
24766017|NCT01792037|Midazolam|midazolam|mesh-list
24582931|NCT00872625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582932|NCT00872625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24582933|NCT00872625|Tubulin Modulators|tubulin modulators|mesh-ancestor
24582934|NCT00872625|Antimitotic Agents|antimitotic agents|mesh-ancestor
24582935|NCT00872625|Mitosis Modulators|mitosis modulators|mesh-ancestor
24582936|NCT00872625|Antimetabolites|antimetabolites|mesh-ancestor
24582986|NCT00872924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582987|NCT00872963|Vaccines|vaccines|mesh-list
24582988|NCT00872963|Immunologic Factors|immunologic factors|mesh-ancestor
24582989|NCT00872963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582990|NCT00872976|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24582991|NCT00872976|Dasatinib|dasatinib|mesh-list
24582992|NCT00872976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24582993|NCT00872976|Alkylating Agents|alkylating agents|mesh-ancestor
24443854|NCT00296023|Busulfan|busulfan|mesh-list
24582994|NCT00872976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582995|NCT00872976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582996|NCT00872976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24582997|NCT00872976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24582998|NCT00873002|Sorafenib|sorafenib|mesh-list
24582999|NCT00873002|Panobinostat|panobinostat|mesh-list
24583000|NCT00873002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583001|NCT00873002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25200191|NCT02735590|Isoniazid|isoniazid|mesh-list
25200192|NCT02735590|Rifapentine|rifapentine|mesh-list
25200193|NCT02735590|Antitubercular Agents|antitubercular agents|mesh-ancestor
25200194|NCT02735590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25200195|NCT02735590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25200196|NCT02735590|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25200197|NCT02735590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25200198|NCT02735590|Antimetabolites|antimetabolites|mesh-ancestor
25200199|NCT02735590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200200|NCT02735590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25200201|NCT02735590|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25200202|NCT02735590|Leprostatic Agents|leprostatic agents|mesh-ancestor
25200203|NCT02735694|Cycloserine|cycloserine|mesh-list
25200204|NCT02735694|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25200205|NCT02735694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25200206|NCT02735694|Renal Agents|renal agents|mesh-ancestor
25200207|NCT02735694|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25200208|NCT02735694|Antitubercular Agents|antitubercular agents|mesh-ancestor
25149583|NCT05466604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25149584|NCT05466604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149586|NCT05466604|Glucocorticoids|glucocorticoids|mesh-ancestor
24583002|NCT00873002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24583003|NCT00873002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583004|NCT00873002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24583005|NCT00873197|Granisetron|granisetron|mesh-list
24583006|NCT00873197|Antiemetics|antiemetics|mesh-ancestor
24583007|NCT00873197|Autonomic Agents|autonomic agents|mesh-ancestor
24583008|NCT00873197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24583028|NCT00873223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583029|NCT00873223|Incretins|incretins|mesh-ancestor
24583030|NCT00873223|Hormones|hormones|mesh-ancestor
24583031|NCT00873223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24583032|NCT00873236|Interferons|interferons|mesh-list
24583033|NCT00873236|Interferon-alpha|interferon-alpha|mesh-list
24583034|NCT00873236|Interferon alpha-2|interferon alpha-2|mesh-list
24632953|NCT01126450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24632954|NCT01126450|Cetuximab|cetuximab|mesh-list
25669186|NCT01727791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669187|NCT01727791|Anticonvulsants|anticonvulsants|mesh-ancestor
25669188|NCT01727791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25669189|NCT01727791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25669190|NCT01727791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669191|NCT01727791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24951341|NCT03905317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25429960|NCT01409200|Micronutrients|micronutrients|mesh-ancestor
25090006|NCT03261596|Mebendazole|mebendazole|mesh-list
24776978|NCT01860833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24776979|NCT01860833|Analgesics|analgesics|mesh-ancestor
24776980|NCT01860833|Sensory System Agents|sensory system agents|mesh-ancestor
24776981|NCT01860833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24583078|NCT00873275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583079|NCT00873275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24583080|NCT00873275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24583081|NCT00873275|Immunologic Factors|immunologic factors|mesh-ancestor
24583082|NCT00873275|Antidotes|antidotes|mesh-ancestor
24583083|NCT00873275|Protective Agents|protective agents|mesh-ancestor
24583084|NCT00873275|Vitamin B Complex|vitamin b complex|mesh-ancestor
24583085|NCT00873275|Vitamins|vitamins|mesh-ancestor
24583086|NCT00873275|Micronutrients|micronutrients|mesh-ancestor
24583087|NCT00873275|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24583088|NCT00873275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24583089|NCT00873340|Interferons|interferons|mesh-list
24583090|NCT00873340|Interferon beta-1b|interferon beta-1b|mesh-list
24583091|NCT00873340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583130|NCT00873392|Autonomic Agents|autonomic agents|mesh-ancestor
24583131|NCT00873392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24583132|NCT00873392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583133|NCT00873392|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24583134|NCT00873392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24583135|NCT00873392|Cholinergic Agents|cholinergic agents|mesh-ancestor
24583136|NCT00873392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24583137|NCT00873392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583138|NCT00873483|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24583141|NCT00873483|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24583142|NCT00873483|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24583143|NCT00873483|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24583144|NCT00873483|Contraceptive Agents|contraceptive agents|mesh-ancestor
24583145|NCT00873483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24583146|NCT00873483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583147|NCT00873483|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24583148|NCT00873483|Estrogens|estrogens|mesh-ancestor
24583149|NCT00873483|Hormones|hormones|mesh-ancestor
24583150|NCT00873483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24583151|NCT00873483|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24583164|NCT00873509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24583165|NCT00873509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24583166|NCT00873509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583167|NCT00873509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24583168|NCT00873509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24583180|NCT00873626|Levofloxacin|levofloxacin|mesh-list
24583181|NCT00873626|Ofloxacin|ofloxacin|mesh-list
24583182|NCT00873626|Fluoroquinolones|fluoroquinolones|mesh-list
24776987|NCT01860833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583190|NCT00873626|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25200209|NCT02735694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25200210|NCT02735694|Antimetabolites|antimetabolites|mesh-ancestor
25200211|NCT02735694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583191|NCT00873626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24583192|NCT00873626|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24583194|NCT00873626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24583195|NCT00873639|Insulin|insulin|mesh-list
24583196|NCT00873639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24583197|NCT00873639|Insulin Aspart|insulin aspart|mesh-list
24583273|NCT00873886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24583274|NCT00873886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583275|NCT00873925|Vitamin D|vitamin d|mesh-list
24583276|NCT00873925|Vitamins|vitamins|mesh-ancestor
24632973|NCT01126528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24632974|NCT01126528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24632975|NCT01126606|Glycerol|glycerol|mesh-list
24632976|NCT01126606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24632977|NCT01126606|Protective Agents|protective agents|mesh-ancestor
24632978|NCT01126606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632979|NCT01126645|Sorafenib|sorafenib|mesh-list
24583373|NCT00874315|Alkylating Agents|alkylating agents|mesh-ancestor
24583374|NCT00874315|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24583375|NCT00874315|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24583377|NCT00874328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583378|NCT00874328|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25669192|NCT01727791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24583379|NCT00874328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24583382|NCT00874393|Hydrocortisone|hydrocortisone|mesh-list
24583427|NCT00874484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583428|NCT00874523|Raltegravir Potassium|raltegravir potassium|mesh-list
24583429|NCT00874523|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24583430|NCT00874523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24583431|NCT00874523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24583432|NCT00874523|Antiviral Agents|antiviral agents|mesh-ancestor
24583433|NCT00874523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24583434|NCT00874523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24583435|NCT00874523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24583436|NCT00874523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881277|NCT02780609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25863698|NCT00094640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24583437|NCT00874523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583438|NCT00874523|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24583439|NCT00874523|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24583440|NCT00874523|Protease Inhibitors|protease inhibitors|mesh-ancestor
24583442|NCT00874562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24583443|NCT00874562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24583444|NCT00874562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24583445|NCT00874562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583446|NCT00874562|Antifungal Agents|antifungal agents|mesh-ancestor
24632991|NCT01126684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24583475|NCT00874679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24792979|NCT04321551|Hormone Antagonists|hormone antagonists|mesh-ancestor
24583527|NCT00875030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24583528|NCT00875030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583529|NCT00875030|Antiviral Agents|antiviral agents|mesh-ancestor
24583530|NCT00875030|Schistosomicides|schistosomicides|mesh-ancestor
24583531|NCT00875030|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24583532|NCT00875030|Anthelmintics|anthelmintics|mesh-ancestor
24583534|NCT00875069|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24583535|NCT00875069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24583604|NCT00875745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583605|NCT00875745|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24583606|NCT00875771|Bevacizumab|bevacizumab|mesh-list
24583607|NCT00875771|Capecitabine|capecitabine|mesh-list
24583608|NCT00875771|Irinotecan|irinotecan|mesh-list
24583609|NCT00875771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24583610|NCT00875771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583611|NCT00875771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24583612|NCT00875771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24583613|NCT00875771|Growth Substances|growth substances|mesh-ancestor
24583614|NCT00875771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583615|NCT00875771|Growth Inhibitors|growth inhibitors|mesh-ancestor
24583617|NCT00875771|Antimetabolites|antimetabolites|mesh-ancestor
24583618|NCT00875771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583619|NCT00875771|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24583620|NCT00875771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25200212|NCT02735395|Amoxicillin|amoxicillin|mesh-list
24583622|NCT00875784|Sumatriptan|sumatriptan|mesh-list
25863699|NCT00094640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25863700|NCT00094640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25863701|NCT00094640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24583649|NCT00876044|Growth Substances|growth substances|mesh-ancestor
24583650|NCT00876044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583651|NCT00876044|Growth Inhibitors|growth inhibitors|mesh-ancestor
24583652|NCT00876044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583653|NCT00876135|Albuterol|albuterol|mesh-list
24583668|NCT00876226|Citalopram|citalopram|mesh-list
24583696|NCT00876421|Cholinergic Agents|cholinergic agents|mesh-ancestor
24583697|NCT00876421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24583698|NCT00876421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583699|NCT00876421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583700|NCT00876421|Urological Agents|urological agents|mesh-ancestor
24583701|NCT00876434|Sirolimus|sirolimus|mesh-list
24583754|NCT00876772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24583755|NCT00876772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24583756|NCT00876772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24583758|NCT00876772|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24583759|NCT00876772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24626223|NCT01086046|Dalteparin|dalteparin|mesh-list
24626224|NCT01086046|Anticoagulants|anticoagulants|mesh-ancestor
24626225|NCT01086046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24549913|NCT00717990|Bevacizumab|bevacizumab|mesh-list
24455422|NCT00945724|Doxorubicin|doxorubicin|mesh-list
24455423|NCT00945724|Methotrexate|methotrexate|mesh-list
24455424|NCT00945724|Vincristine|vincristine|mesh-list
24626226|NCT01086046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24626227|NCT01086046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626228|NCT01086085|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24626229|NCT01086085|Interferon-alpha|interferon-alpha|mesh-list
24626230|NCT01086085|Adefovir|adefovir|mesh-list
24626231|NCT01086085|Antiviral Agents|antiviral agents|mesh-ancestor
24626232|NCT01086085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24626233|NCT01086085|Immunologic Factors|immunologic factors|mesh-ancestor
24626234|NCT01086085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583760|NCT00876772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24583826|NCT00877110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583884|NCT00877266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863702|NCT00094640|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25863703|NCT00094640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24583885|NCT00877266|Sensory System Agents|sensory system agents|mesh-ancestor
24583886|NCT00877266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24583887|NCT00877409|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24583888|NCT00877409|Dermatologic Agents|dermatologic agents|mesh-ancestor
24583889|NCT00877422|Vitamin D|vitamin d|mesh-list
24583890|NCT00877422|Cholecalciferol|cholecalciferol|mesh-list
24583891|NCT00877422|Vitamins|vitamins|mesh-ancestor
24583937|NCT00877591|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24583938|NCT00877591|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24583939|NCT00877591|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24583940|NCT00877591|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24583941|NCT00877591|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24583942|NCT00877591|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24583943|NCT00877656|Zanolimumab|zanolimumab|mesh-list
24583944|NCT00877656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24583945|NCT00877656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583947|NCT00877734|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25149767|NCT05459792|Lidocaine|lidocaine|mesh-list
25149768|NCT05459792|Bupivacaine|bupivacaine|mesh-list
25149769|NCT05459792|Anesthetics, Local|anesthetics, local|mesh-ancestor
25149770|NCT05459792|Anesthetics|anesthetics|mesh-ancestor
25149771|NCT05459792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24584028|NCT00878306|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24584029|NCT00878306|Efavirenz|efavirenz|mesh-list
24584030|NCT00878306|Disulfiram|disulfiram|mesh-list
24584031|NCT00878306|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24584032|NCT00878306|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24626235|NCT01086085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24626236|NCT01086085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24626237|NCT01086085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626238|NCT01086085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626239|NCT01086254|Gemcitabine|gemcitabine|mesh-list
24626240|NCT01086254|Iniparib|iniparib|mesh-list
24626241|NCT01086254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626242|NCT01086254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24626243|NCT01086254|Antimetabolites|antimetabolites|mesh-ancestor
24626244|NCT01086254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626245|NCT01086254|Antiviral Agents|antiviral agents|mesh-ancestor
24626246|NCT01086254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24626247|NCT01086254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626248|NCT01086254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24626249|NCT01086254|Immunologic Factors|immunologic factors|mesh-ancestor
25052025|NCT00352560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24626250|NCT01086254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626251|NCT01086254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24626252|NCT01086332|Gemcitabine|gemcitabine|mesh-list
24584033|NCT00878306|Protease Inhibitors|protease inhibitors|mesh-ancestor
24584034|NCT00878306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584035|NCT00878306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584036|NCT00878306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24584037|NCT00878306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25669193|NCT01727791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25669194|NCT01727791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25669195|NCT01727791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24584038|NCT00878306|Antiviral Agents|antiviral agents|mesh-ancestor
24584039|NCT00878306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24584040|NCT00878306|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25090096|NCT03260634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24584041|NCT00878306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24584042|NCT00878306|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24584050|NCT00878306|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25200213|NCT02735395|Metronidazole|metronidazole|mesh-list
25200214|NCT02735395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25200215|NCT02735395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25200216|NCT02735395|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25200217|NCT02735395|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25200218|NCT02735473|Choline|choline|mesh-list
25200219|NCT02735473|Lipotropic Agents|lipotropic agents|mesh-ancestor
25200220|NCT02735473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25200221|NCT02735473|Antimetabolites|antimetabolites|mesh-ancestor
25200222|NCT02735473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200223|NCT02735473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25200224|NCT02735473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25149832|NCT05442268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149834|NCT05442268|Antidepressive Agents|antidepressive agents|mesh-ancestor
25149836|NCT05442268|Dopamine Agents|dopamine agents|mesh-ancestor
25149846|NCT05440383|Leuprolide|leuprolide|mesh-list
24584054|NCT00878345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24584055|NCT00878345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626254|NCT01086332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24626255|NCT01086332|Antimetabolites|antimetabolites|mesh-ancestor
24626256|NCT01086332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626257|NCT01086332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626258|NCT01086332|Antiviral Agents|antiviral agents|mesh-ancestor
24626259|NCT01086332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24626260|NCT01086332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626261|NCT01086332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24626262|NCT01086332|Immunologic Factors|immunologic factors|mesh-ancestor
24626263|NCT01086332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626264|NCT01086332|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24626265|NCT01086332|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24626266|NCT01086332|Protease Inhibitors|protease inhibitors|mesh-ancestor
24951342|NCT03905317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24951343|NCT03905317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25863704|NCT00094640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24584116|NCT00878631|Dextrans|dextrans|mesh-list
24584175|NCT00878917|Dorzolamide|dorzolamide|mesh-list
24584176|NCT00878917|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24584177|NCT00878917|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24584178|NCT00878917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24671118|NCT01323569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24671120|NCT01323608|Cholecalciferol|cholecalciferol|mesh-list
24671121|NCT01323608|Vitamins|vitamins|mesh-ancestor
24671122|NCT01323608|Micronutrients|micronutrients|mesh-ancestor
25863705|NCT00094640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863706|NCT00094640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24584227|NCT00879073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584228|NCT00879073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584230|NCT00879099|Paroxetine|paroxetine|mesh-list
24584231|NCT00879099|Maleic acid|maleic acid|mesh-list
24584232|NCT00879099|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25200225|NCT02735473|Nootropic Agents|nootropic agents|mesh-ancestor
25200226|NCT02735343|Ketamine|ketamine|mesh-list
25200227|NCT02735343|Prochlorperazine|prochlorperazine|mesh-list
25863707|NCT00094640|Serotonin Agents|serotonin agents|mesh-ancestor
25200242|NCT02735343|Autonomic Agents|autonomic agents|mesh-ancestor
25200243|NCT02735343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25200244|NCT02735343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25200245|NCT02735343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25149898|NCT05422703|Analgesics|analgesics|mesh-list
25149899|NCT05422703|Sensory System Agents|sensory system agents|mesh-ancestor
25149900|NCT05422703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25149901|NCT05422703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149920|NCT05399173|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25149921|NCT05399173|Hemostatics|hemostatics|mesh-ancestor
25200246|NCT02735343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25200247|NCT02735343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25200248|NCT02735343|Dopamine Agents|dopamine agents|mesh-ancestor
25200249|NCT02735356|Itraconazole|itraconazole|mesh-list
25200250|NCT02735356|Antifungal Agents|antifungal agents|mesh-ancestor
25669196|NCT01728077|Brivaracetam|brivaracetam|mesh-list
25669197|NCT01728077|Anticonvulsants|anticonvulsants|mesh-ancestor
24937942|NCT04023760|Anticoagulants|anticoagulants|mesh-ancestor
25200251|NCT02735356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25200252|NCT02735356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25200253|NCT02735356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25200254|NCT02735356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25200255|NCT02735356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200256|NCT02735356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25200257|NCT02735356|Hormone Antagonists|hormone antagonists|mesh-ancestor
25200258|NCT02735356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25200259|NCT02735356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200260|NCT02735356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25200261|NCT02735603|Moxifloxacin|moxifloxacin|mesh-list
25200262|NCT02735603|Naltrexone|naltrexone|mesh-list
25200263|NCT02735603|Bupropion|bupropion|mesh-list
25200264|NCT02735603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25200265|NCT02735603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25200266|NCT02735603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25200267|NCT02735603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25200268|NCT02735603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25200269|NCT02735603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200270|NCT02735603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200271|NCT02735603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200272|NCT02735603|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25200273|NCT02735603|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25200274|NCT02735603|Sensory System Agents|sensory system agents|mesh-ancestor
25200275|NCT02735603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25200276|NCT02735603|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25200277|NCT02735603|Antidepressive Agents|antidepressive agents|mesh-ancestor
25200278|NCT02735603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25200280|NCT02735603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25200281|NCT02735603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24584233|NCT00879099|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24584234|NCT00879099|Adrenergic Agents|adrenergic agents|mesh-ancestor
24584235|NCT00879099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24584236|NCT00879099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584237|NCT00879099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584238|NCT00879099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24584239|NCT00879099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24633153|NCT01127464|Poly ICLC|poly iclc|mesh-list
24584273|NCT00879307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24584274|NCT00879307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24584275|NCT00879307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24584436|NCT00880373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24584438|NCT00880373|Analgesics|analgesics|mesh-ancestor
24584439|NCT00880373|Sensory System Agents|sensory system agents|mesh-ancestor
24584700|NCT00881387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24584750|NCT00881556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24584759|NCT00881556|Anticonvulsants|anticonvulsants|mesh-ancestor
24584805|NCT00881634|Sympathomimetics|sympathomimetics|mesh-ancestor
24584806|NCT00881634|Adrenergic Agents|adrenergic agents|mesh-ancestor
24951351|NCT03905486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951352|NCT03905486|Anticonvulsants|anticonvulsants|mesh-ancestor
24951353|NCT03905486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24951354|NCT03905486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24951355|NCT03905486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951356|NCT03905486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24951357|NCT03905486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24951358|NCT03905486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25669198|NCT01728194|Citalopram|citalopram|mesh-list
25669199|NCT01728194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25669200|NCT01728194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25669201|NCT01728194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25669202|NCT01728194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669203|NCT01728194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25669204|NCT01728194|Serotonin Agents|serotonin agents|mesh-ancestor
24951359|NCT03905486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24951362|NCT03905655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24951363|NCT03905655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24951364|NCT03905564|Pyridoxine|pyridoxine|mesh-list
24584807|NCT00881673|Dexamethasone|dexamethasone|mesh-list
24584808|NCT00881673|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24579521|NCT00855777|Analgesics|analgesics|mesh-ancestor
24584864|NCT00881855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24584865|NCT00881855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24584866|NCT00881907|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24584867|NCT00881907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24584897|NCT00882076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584898|NCT00882076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584899|NCT00882076|Analgesics|analgesics|mesh-ancestor
24584900|NCT00882076|Sensory System Agents|sensory system agents|mesh-ancestor
24584901|NCT00882076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25200282|NCT02735603|Dopamine Agents|dopamine agents|mesh-ancestor
25200283|NCT02735603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25200284|NCT02735603|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25200285|NCT02735603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25200286|NCT02735330|Ethanol|ethanol|mesh-list
25200287|NCT02735330|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25200288|NCT02735330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25200289|NCT02735330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24584903|NCT00882076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24584904|NCT00882076|Antimetabolites|antimetabolites|mesh-ancestor
24584905|NCT00882154|Cefdinir|cefdinir|mesh-list
24584906|NCT00882154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24584907|NCT00882154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24584908|NCT00882193|Ribavirin|ribavirin|mesh-list
24584909|NCT00882193|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24584910|NCT00882193|Betaine|betaine|mesh-list
24584911|NCT00882193|Antimetabolites|antimetabolites|mesh-ancestor
24584912|NCT00882193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633244|NCT01127724|Vitamins|vitamins|mesh-list
24584916|NCT00882193|Lipotropic Agents|lipotropic agents|mesh-ancestor
24584917|NCT00882193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24584918|NCT00882193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24584919|NCT00882232|Hyaluronic Acid|hyaluronic acid|mesh-list
24584920|NCT00882232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24584921|NCT00882232|Immunologic Factors|immunologic factors|mesh-ancestor
24951366|NCT03905564|Doxylamine|doxylamine|mesh-list
24951410|NCT03904680|Antimetabolites|antimetabolites|mesh-ancestor
25212960|NCT05271721|Autonomic Agents|autonomic agents|mesh-ancestor
24951411|NCT03904680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951412|NCT03904680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951413|NCT03904680|Dermatologic Agents|dermatologic agents|mesh-ancestor
24951414|NCT03904680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951415|NCT03904680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24585014|NCT00882739|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25863708|NCT00094666|Gaboxadol|gaboxadol|mesh-list
25863709|NCT00094666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24585046|NCT00882869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24585047|NCT00882869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24585048|NCT00882869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585049|NCT00882882|Metformin|metformin|mesh-list
24585050|NCT00882882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24585051|NCT00882882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585052|NCT00882947|Iloprost|iloprost|mesh-list
24585053|NCT00882947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24585054|NCT00882947|Vasodilator Agents|vasodilator agents|mesh-ancestor
24585055|NCT00882960|Fentanyl|fentanyl|mesh-list
24633259|NCT01127841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24585056|NCT00882960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24585057|NCT00882960|Narcotics|narcotics|mesh-ancestor
24585058|NCT00882960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24585059|NCT00882960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585100|NCT00883298|Bevacizumab|bevacizumab|mesh-list
24585101|NCT00883298|Temozolomide|temozolomide|mesh-list
24585102|NCT00883298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24585103|NCT00883298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951416|NCT03904680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24951417|NCT03904680|Immunologic Factors|immunologic factors|mesh-ancestor
24951418|NCT03904680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24951419|NCT03904680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24951420|NCT03904719|Vorolanib|vorolanib|mesh-list
24951421|NCT03904719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25200290|NCT02735330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200291|NCT02735317|Vitamin B 12|vitamin b 12|mesh-list
25200292|NCT02735317|Hydroxocobalamin|hydroxocobalamin|mesh-list
24951422|NCT03904719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25200293|NCT02735317|Gentamicins|gentamicins|mesh-list
25200294|NCT02735317|Dexamethasone|dexamethasone|mesh-list
24951423|NCT03904719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863710|NCT00094666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863711|NCT00094666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863712|NCT00094666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25863713|NCT00094666|Analgesics|analgesics|mesh-ancestor
24585139|NCT00883623|Growth Inhibitors|growth inhibitors|mesh-ancestor
24585140|NCT00883623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585141|NCT00883662|Levonorgestrel|levonorgestrel|mesh-list
24585142|NCT00883662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24585143|NCT00883662|Contraceptive Agents|contraceptive agents|mesh-ancestor
24585144|NCT00883662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24585145|NCT00883662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585146|NCT00883662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24585147|NCT00883662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24585149|NCT00883727|Plasma-lyte 148|plasma-lyte 148|mesh-list
25863714|NCT00094666|Sensory System Agents|sensory system agents|mesh-ancestor
25863715|NCT00094666|Anticonvulsants|anticonvulsants|mesh-ancestor
25863716|NCT00094666|GABA Agonists|gaba agonists|mesh-ancestor
24585192|NCT00884104|Cholinergic Agents|cholinergic agents|mesh-ancestor
24585193|NCT00884104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24585194|NCT00884104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585195|NCT00884104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585196|NCT00884104|Urological Agents|urological agents|mesh-ancestor
24585197|NCT00884260|Levonorgestrel|levonorgestrel|mesh-list
25150325|NCT05293600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24585334|NCT00884884|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24585335|NCT00884884|Serotonin Agents|serotonin agents|mesh-ancestor
24951430|NCT03904745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24951461|NCT03904355|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24951462|NCT03904355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24585382|NCT00885326|Bevacizumab|bevacizumab|mesh-list
24585383|NCT00885326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24585384|NCT00885326|Immunologic Factors|immunologic factors|mesh-ancestor
24585385|NCT00885326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585386|NCT00885326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24585387|NCT00885326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24585388|NCT00885326|Alkylating Agents|alkylating agents|mesh-ancestor
24585390|NCT00885326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585437|NCT00885625|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25863717|NCT00094666|GABA Agents|gaba agents|mesh-ancestor
25863718|NCT00094692|Atropine|atropine|mesh-list
25863719|NCT00094692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25200295|NCT02735317|Procaine|procaine|mesh-list
25200296|NCT02735317|Vitamins|vitamins|mesh-ancestor
25200297|NCT02735317|Micronutrients|micronutrients|mesh-ancestor
25200298|NCT02735317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200299|NCT02735317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25200300|NCT02735317|Antiemetics|antiemetics|mesh-ancestor
25200301|NCT02735317|Autonomic Agents|autonomic agents|mesh-ancestor
25200302|NCT02735317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25200303|NCT02735317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24585488|NCT00885820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24585489|NCT00885820|Glucocorticoids|glucocorticoids|mesh-ancestor
24585490|NCT00885820|Hormones|hormones|mesh-ancestor
24633472|NCT01129479|Galantamine|galantamine|mesh-list
24585491|NCT00885820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24585492|NCT00885820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585493|NCT00885820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24585494|NCT00885820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585495|NCT00885820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24585496|NCT00885820|Immunologic Factors|immunologic factors|mesh-ancestor
24585497|NCT00885820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24585498|NCT00885820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24585499|NCT00885820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585500|NCT00885820|Antiemetics|antiemetics|mesh-ancestor
24585501|NCT00885820|Autonomic Agents|autonomic agents|mesh-ancestor
24585502|NCT00885820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24585503|NCT00885820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25669205|NCT01728194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835204|NCT02182479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863720|NCT00094692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25863721|NCT00094692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24585539|NCT00886002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24585540|NCT00886002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585541|NCT00886002|Analgesics|analgesics|mesh-ancestor
24585542|NCT00886002|Sensory System Agents|sensory system agents|mesh-ancestor
24585543|NCT00886002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24585546|NCT00886002|Anesthetics, General|anesthetics, general|mesh-ancestor
24585577|NCT00886106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24585578|NCT00886132|Sunitinib|sunitinib|mesh-list
24585579|NCT00886132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585580|NCT00886132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24585581|NCT00886132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24585582|NCT00886132|Growth Substances|growth substances|mesh-ancestor
24585583|NCT00886132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585584|NCT00886132|Growth Inhibitors|growth inhibitors|mesh-ancestor
24585587|NCT00886132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585590|NCT00886275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24585591|NCT00886275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24585636|NCT00886457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24585637|NCT00886457|Immunologic Factors|immunologic factors|mesh-ancestor
24585638|NCT00886457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585639|NCT00886457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24585640|NCT00886457|Antimetabolites|antimetabolites|mesh-ancestor
24585641|NCT00886457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585642|NCT00886457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24585643|NCT00886496|Lectins|lectins|mesh-list
24585644|NCT00886496|Agglutinins|agglutinins|mesh-ancestor
24585645|NCT00886496|Immunologic Factors|immunologic factors|mesh-ancestor
24585646|NCT00886496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585647|NCT00886496|Coagulants|coagulants|mesh-ancestor
24585648|NCT00886509|Lenograstim|lenograstim|mesh-list
24585649|NCT00886509|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24585650|NCT00886509|Immunologic Factors|immunologic factors|mesh-ancestor
24585651|NCT00886509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585652|NCT00886574|Aspirin|aspirin|mesh-list
25863722|NCT00094692|Autonomic Agents|autonomic agents|mesh-ancestor
24585757|NCT00887003|Glucocorticoids|glucocorticoids|mesh-ancestor
24585764|NCT00887029|Timolol|timolol|mesh-list
24585795|NCT00887081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585796|NCT00887081|Antiviral Agents|antiviral agents|mesh-ancestor
24585797|NCT00887081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24585798|NCT00887081|Immunologic Factors|immunologic factors|mesh-ancestor
24585799|NCT00887081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585800|NCT00887081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585801|NCT00887107|Sorafenib|sorafenib|mesh-list
24585802|NCT00887107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585803|NCT00887107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24585804|NCT00887107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24585805|NCT00887107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585806|NCT00887120|Ritonavir|ritonavir|mesh-list
24585807|NCT00887120|Lopinavir|lopinavir|mesh-list
24585808|NCT00887120|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24585809|NCT00887120|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24585810|NCT00887120|Protease Inhibitors|protease inhibitors|mesh-ancestor
24585811|NCT00887120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24585812|NCT00887120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585813|NCT00887120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24585814|NCT00887120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24585815|NCT00887120|Antiviral Agents|antiviral agents|mesh-ancestor
24585816|NCT00887120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24585817|NCT00887120|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24585843|NCT00887276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24585900|NCT00887770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24585901|NCT00887770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24585902|NCT00887770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579938|NCT00858767|Vitamin K 2|vitamin k 2|mesh-list
24633789|NCT01131195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633791|NCT01131195|Antimitotic Agents|antimitotic agents|mesh-ancestor
24633792|NCT01131195|Mitosis Modulators|mitosis modulators|mesh-ancestor
24633793|NCT01131195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669206|NCT01728194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25669207|NCT01728194|Antidepressive Agents|antidepressive agents|mesh-ancestor
24397784|NCT00142571|Docetaxel|docetaxel|mesh-list
24633794|NCT01131195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24633795|NCT01131195|Immunologic Factors|immunologic factors|mesh-ancestor
24633797|NCT01131195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24585957|NCT00888394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24951475|NCT03904225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24951476|NCT03904225|Antimetabolites|antimetabolites|mesh-ancestor
24951477|NCT03904225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951478|NCT03904225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585958|NCT00888394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585959|NCT00888394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863723|NCT00094692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25863724|NCT00094692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863725|NCT00094692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25863726|NCT00094692|Respiratory System Agents|respiratory system agents|mesh-ancestor
24585975|NCT00888758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585976|NCT00888758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24586047|NCT00888901|Glucocorticoids|glucocorticoids|mesh-ancestor
24586100|NCT00889161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24586101|NCT00889161|Analgesics|analgesics|mesh-ancestor
24586102|NCT00889161|Sensory System Agents|sensory system agents|mesh-ancestor
24586103|NCT00889161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24586104|NCT00889161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586105|NCT00889161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24586106|NCT00889161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24586107|NCT00889161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586109|NCT00889161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863727|NCT00094692|Mydriatics|mydriatics|mesh-ancestor
25863728|NCT00094692|Parasympatholytics|parasympatholytics|mesh-ancestor
25863729|NCT00094692|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25863730|NCT00094692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24633969|NCT01131767|Analgesics|analgesics|mesh-ancestor
25200304|NCT02735317|Glucocorticoids|glucocorticoids|mesh-ancestor
24633970|NCT01131767|Sensory System Agents|sensory system agents|mesh-ancestor
24586298|NCT00890175|Dopamine Agents|dopamine agents|mesh-ancestor
24586299|NCT00890175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24586300|NCT00890175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586387|NCT00890500|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24586388|NCT00890500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24586389|NCT00890500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24586390|NCT00890500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24586391|NCT00890500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24586392|NCT00890500|Antifungal Agents|antifungal agents|mesh-ancestor
25863731|NCT00094692|Cholinergic Agents|cholinergic agents|mesh-ancestor
25863732|NCT00094692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25863733|NCT00094692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863734|NCT00094848|Mapatumumab|mapatumumab|mesh-list
24586393|NCT00890500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24586394|NCT00890500|Alkylating Agents|alkylating agents|mesh-ancestor
24586395|NCT00890500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24586396|NCT00890539|Methacholine Chloride|methacholine chloride|mesh-list
24586398|NCT00890539|Autonomic Agents|autonomic agents|mesh-ancestor
24568592|NCT00796497|Ondansetron|ondansetron|mesh-list
24951502|NCT03904056|Ranibizumab|ranibizumab|mesh-list
24951503|NCT03904056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24586399|NCT00890539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24586400|NCT00890539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634006|NCT01131780|Respiratory System Agents|respiratory system agents|mesh-ancestor
24586401|NCT00890539|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24586402|NCT00890539|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
24586403|NCT00890539|Respiratory System Agents|respiratory system agents|mesh-ancestor
24586434|NCT00890630|Oxytocics|oxytocics|mesh-ancestor
24586435|NCT00890630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24586444|NCT00890643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586445|NCT00890643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863735|NCT00094848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586484|NCT00890942|Naloxone|naloxone|mesh-list
24586485|NCT00890942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24586486|NCT00890942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951507|NCT03904056|Growth Inhibitors|growth inhibitors|mesh-ancestor
24951508|NCT03904056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586506|NCT00891072|Acetic Acid|acetic acid|mesh-list
24586507|NCT00891072|Paclitaxel|paclitaxel|mesh-list
25669208|NCT01728194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25669209|NCT01728246|Acetaminophen|acetaminophen|mesh-list
24586508|NCT00891072|Gossypol acetic acid|gossypol acetic acid|mesh-list
24586509|NCT00891072|Carboplatin|carboplatin|mesh-list
24586510|NCT00891072|Retinol acetate|retinol acetate|mesh-list
24586511|NCT00891072|Gossypol|gossypol|mesh-list
24586527|NCT00891072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24586528|NCT00891072|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24586529|NCT00891072|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
25200305|NCT02735317|Hormones|hormones|mesh-ancestor
25150312|NCT05293600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25150313|NCT05293600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150314|NCT05293600|Adrenergic Agents|adrenergic agents|mesh-ancestor
25150315|NCT05293600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25150316|NCT05293600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25150317|NCT05293600|Anticonvulsants|anticonvulsants|mesh-ancestor
25150318|NCT05293600|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25150319|NCT05293600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25150320|NCT05293600|Diuretics|diuretics|mesh-ancestor
25150321|NCT05293600|Natriuretic Agents|natriuretic agents|mesh-ancestor
25150322|NCT05293600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25150323|NCT05293600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25150324|NCT05293600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25150330|NCT05293600|Antidepressive Agents|antidepressive agents|mesh-ancestor
25150378|NCT05281185|Factor VIII|factor viii|mesh-list
25150379|NCT05281185|Coagulants|coagulants|mesh-ancestor
25150380|NCT05280106|Citric Acid|citric acid|mesh-list
25150381|NCT05280106|Sodium Citrate|sodium citrate|mesh-list
25150382|NCT05280106|Dialysis Solutions|dialysis solutions|mesh-list
25150383|NCT05280106|Anticoagulants|anticoagulants|mesh-ancestor
25150384|NCT05280106|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25150385|NCT05280106|Chelating Agents|chelating agents|mesh-ancestor
24586530|NCT00891072|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
24586532|NCT00891150|Oxytocics|oxytocics|mesh-ancestor
24586533|NCT00891150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24586534|NCT00891150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200306|NCT02735317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25200307|NCT02735317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25200308|NCT02735317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200309|NCT02735317|Vitamin B Complex|vitamin b complex|mesh-ancestor
25200310|NCT02735317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25200311|NCT02735317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25200312|NCT02735317|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25200313|NCT02735317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25200314|NCT02735317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200315|NCT02735317|Hematinics|hematinics|mesh-ancestor
25200316|NCT02735317|Anesthetics, Local|anesthetics, local|mesh-ancestor
25200317|NCT02735317|Anesthetics|anesthetics|mesh-ancestor
25200318|NCT02735317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25200319|NCT02735317|Sensory System Agents|sensory system agents|mesh-ancestor
25200321|NCT02735031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25200322|NCT02735031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200323|NCT02735031|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25200324|NCT02735031|Incretins|incretins|mesh-ancestor
25200325|NCT02735031|Hormones|hormones|mesh-ancestor
25200326|NCT02735031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25200327|NCT02734875|Anticoagulants|anticoagulants|mesh-list
25200328|NCT02735018|Epinephrine|epinephrine|mesh-list
25200329|NCT02735018|Racepinephrine|racepinephrine|mesh-list
25200330|NCT02735018|Epinephryl borate|epinephryl borate|mesh-list
25200331|NCT02735018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25200332|NCT02735018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25200333|NCT02735018|Adrenergic Agents|adrenergic agents|mesh-ancestor
25200334|NCT02735018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25200335|NCT02735018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200336|NCT02735018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200337|NCT02735018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25200338|NCT02735018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25200339|NCT02735018|Autonomic Agents|autonomic agents|mesh-ancestor
25207677|NCT03492099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25150388|NCT05280106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25150389|NCT05278676|Dotinurad|dotinurad|mesh-list
25150390|NCT05278676|Uricosuric Agents|uricosuric agents|mesh-ancestor
25150391|NCT05278676|Gout Suppressants|gout suppressants|mesh-ancestor
25150392|NCT05278676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25150393|NCT05278676|Renal Agents|renal agents|mesh-ancestor
24586536|NCT00891163|Tetracaine|tetracaine|mesh-list
24586537|NCT00891163|Anesthetics, Local|anesthetics, local|mesh-ancestor
24586538|NCT00891163|Anesthetics|anesthetics|mesh-ancestor
24586539|NCT00891163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24835297|NCT02182583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835298|NCT02182583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835299|NCT02182596|Gemtuzumab|gemtuzumab|mesh-list
24835300|NCT02182596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24586540|NCT00891163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586541|NCT00891163|Sensory System Agents|sensory system agents|mesh-ancestor
24586542|NCT00891163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24586543|NCT00891163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24586544|NCT00891163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24586545|NCT00891163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24586546|NCT00891163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24586547|NCT00891163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586549|NCT00891267|Olmesartan|olmesartan|mesh-list
24586550|NCT00891267|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24586553|NCT00891267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24586554|NCT00891267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586555|NCT00891267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24951510|NCT03903887|Immunologic Factors|immunologic factors|mesh-ancestor
24951511|NCT03903887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951512|NCT03904004|Botulinum Toxins|botulinum toxins|mesh-list
24951513|NCT03904004|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24951514|NCT03904004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24580278|NCT00861250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24586706|NCT00891696|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24586773|NCT00892125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24586775|NCT00892125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24586776|NCT00892125|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24586777|NCT00892125|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24586779|NCT00892190|Tretinoin|tretinoin|mesh-list
24586780|NCT00892190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586781|NCT00892190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24586782|NCT00892190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634066|NCT01131949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586820|NCT00892320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24586821|NCT00892320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24586822|NCT00892320|Dopamine Agents|dopamine agents|mesh-ancestor
24777166|NCT01862497|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24777167|NCT01862497|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25863736|NCT00094926|Risperidone|risperidone|mesh-list
25863737|NCT00094926|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24579783|NCT00857753|Fentanyl|fentanyl|mesh-list
24586823|NCT00892346|Thalidomide|thalidomide|mesh-list
24586824|NCT00892346|Melphalan|melphalan|mesh-list
25863738|NCT00094926|Serotonin Agents|serotonin agents|mesh-ancestor
25863739|NCT00094926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25863740|NCT00094926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863741|NCT00094926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863742|NCT00094926|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25863743|NCT00094926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25863744|NCT00094926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24586870|NCT00892450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586917|NCT00892658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586918|NCT00892658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24586919|NCT00892658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24586920|NCT00892658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586922|NCT00892736|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24586923|NCT00892736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24586924|NCT00892736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586925|NCT00892736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586926|NCT00892801|Everolimus|everolimus|mesh-list
24586927|NCT00892801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200340|NCT02735018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25200341|NCT02735018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25200342|NCT02735018|Respiratory System Agents|respiratory system agents|mesh-ancestor
25200343|NCT02735018|Mydriatics|mydriatics|mesh-ancestor
25200344|NCT02735018|Sympathomimetics|sympathomimetics|mesh-ancestor
25200345|NCT02735018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25669210|NCT01728246|Tramadol|tramadol|mesh-list
25669211|NCT01728246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25669212|NCT01728246|Analgesics|analgesics|mesh-ancestor
25669213|NCT01728246|Sensory System Agents|sensory system agents|mesh-ancestor
25669214|NCT01728246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835356|NCT02182713|Bromides|bromides|mesh-list
24835357|NCT02182713|Albuterol|albuterol|mesh-list
25090151|NCT03260166|Vitamin B Complex|vitamin b complex|mesh-ancestor
25090152|NCT03260166|Vitamins|vitamins|mesh-ancestor
25863745|NCT00094926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25863746|NCT00094926|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24587010|NCT00893061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587011|NCT00893061|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24587012|NCT00893061|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24587013|NCT00893061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587014|NCT00893061|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24587015|NCT00893061|Hormone Antagonists|hormone antagonists|mesh-ancestor
24587016|NCT00893061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24587017|NCT00893061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587018|NCT00893061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24587019|NCT00893061|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24587020|NCT00893061|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24634077|NCT01131975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24634080|NCT01131975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587025|NCT00893100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24587026|NCT00893100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587027|NCT00893100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24587028|NCT00893100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587048|NCT00893256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24816078|NCT02074150|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24816079|NCT02074150|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24816080|NCT02074150|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24587049|NCT00893256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24587128|NCT00893555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24587129|NCT00893555|Hormone Antagonists|hormone antagonists|mesh-ancestor
24587130|NCT00893555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24587131|NCT00893555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587132|NCT00893555|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24587136|NCT00893581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24587137|NCT00893581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24587138|NCT00893581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24587139|NCT00893581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587141|NCT00893594|Sumatriptan|sumatriptan|mesh-list
24587168|NCT00893607|Adrenergic Agents|adrenergic agents|mesh-ancestor
24587169|NCT00893607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24587170|NCT00893607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587171|NCT00893711|Vitamin D|vitamin d|mesh-list
24587172|NCT00893711|Vitamins|vitamins|mesh-ancestor
24587173|NCT00893711|Micronutrients|micronutrients|mesh-ancestor
24587174|NCT00893711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587175|NCT00893711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24587176|NCT00893724|Tocopherols|tocopherols|mesh-list
24587177|NCT00893724|Vitamin E|vitamin e|mesh-list
24587178|NCT00893724|Tocotrienols|tocotrienols|mesh-list
24587179|NCT00893724|alpha-Tocopherol|alpha-tocopherol|mesh-list
24587180|NCT00893724|Coenzyme Q10|coenzyme q10|mesh-list
24587181|NCT00893724|Niacinamide|niacinamide|mesh-list
24587183|NCT00893724|Nicotinic Acids|nicotinic acids|mesh-list
24587184|NCT00893724|Ubiquinone|ubiquinone|mesh-list
24626272|NCT01086345|Camptothecin|camptothecin|mesh-list
24626273|NCT01086345|Antibodies|antibodies|mesh-list
24626274|NCT01086345|Immunoglobulins|immunoglobulins|mesh-list
24626275|NCT01086345|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25200346|NCT02734732|Ciprofloxacin|ciprofloxacin|mesh-list
25200347|NCT02734732|Trimethoprim|trimethoprim|mesh-list
25200348|NCT02734732|Sulfamethoxazole|sulfamethoxazole|mesh-list
25200349|NCT02734732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25200350|NCT02734732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25200351|NCT02734732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25669215|NCT01728246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669216|NCT01728246|Antipyretics|antipyretics|mesh-ancestor
25669217|NCT01728246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25669218|NCT01728246|Narcotics|narcotics|mesh-ancestor
25669219|NCT01728246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25669220|NCT01728324|Ribavirin|ribavirin|mesh-list
25669221|NCT01728324|Antimetabolites|antimetabolites|mesh-ancestor
25669222|NCT01728324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669223|NCT01728324|Antiviral Agents|antiviral agents|mesh-ancestor
25200352|NCT02734732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25200353|NCT02734732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25150540|NCT05177146|Analgesics|analgesics|mesh-ancestor
24626277|NCT01086345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24626278|NCT01086345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24626279|NCT01086345|Growth Substances|growth substances|mesh-ancestor
24626280|NCT01086345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626281|NCT01086345|Growth Inhibitors|growth inhibitors|mesh-ancestor
24626282|NCT01086345|Immunologic Factors|immunologic factors|mesh-ancestor
24626283|NCT01086345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24626284|NCT01086345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24626285|NCT01086345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587215|NCT00893841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587216|NCT00893841|Protective Agents|protective agents|mesh-ancestor
24587217|NCT00893841|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24587218|NCT00893841|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25863747|NCT00094926|Dopamine Agents|dopamine agents|mesh-ancestor
25863748|NCT00094965|Oxaliplatin|oxaliplatin|mesh-list
25057144|NCT03507244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24587219|NCT00893841|Dopamine Agonists|dopamine agonists|mesh-ancestor
24587258|NCT00893919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587259|NCT00893919|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24587260|NCT00893919|Antitubercular Agents|antitubercular agents|mesh-ancestor
24587261|NCT00893919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24587262|NCT00893919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24587263|NCT00893919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587264|NCT00893919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587265|NCT00893958|Mycophenolic Acid|mycophenolic acid|mesh-list
24587266|NCT00893958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24587267|NCT00893958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587268|NCT00893958|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25863749|NCT00094965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587308|NCT00894088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487128|NCT00461747|Antiemetics|antiemetics|mesh-ancestor
24626291|NCT01086527|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24626292|NCT01086527|Hormone Antagonists|hormone antagonists|mesh-ancestor
24626293|NCT01086527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24626294|NCT01086527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587328|NCT00894283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587330|NCT00894374|Antimalarials|antimalarials|mesh-ancestor
24587331|NCT00894374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24587332|NCT00894374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24587335|NCT00894374|Antiviral Agents|antiviral agents|mesh-ancestor
24587354|NCT00894569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587355|NCT00894569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24587356|NCT00894608|Letrozole|letrozole|mesh-list
24587357|NCT00894608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587358|NCT00894608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24587359|NCT00894608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24587360|NCT00894608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587414|NCT00894751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24587415|NCT00894751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24587433|NCT00894959|Calcium heparin|calcium heparin|mesh-list
24587434|NCT00894959|Anticoagulants|anticoagulants|mesh-ancestor
24587435|NCT00894959|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25863750|NCT00094978|Alvocidib|alvocidib|mesh-list
24587456|NCT00895063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587457|NCT00895076|Dexamethasone|dexamethasone|mesh-list
24587458|NCT00895076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24587459|NCT00895076|Antiemetics|antiemetics|mesh-ancestor
24587460|NCT00895076|Autonomic Agents|autonomic agents|mesh-ancestor
24587461|NCT00895076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24587462|NCT00895076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587463|NCT00895076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25200354|NCT02734732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200355|NCT02734732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200356|NCT02734732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24626300|NCT01086553|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24798227|NCT01961752|Bupivacaine|bupivacaine|mesh-list
25100224|NCT03184805|Aspirin|aspirin|mesh-list
25150602|NCT05152004|Amoxicillin|amoxicillin|mesh-list
25150603|NCT05152004|Metronidazole|metronidazole|mesh-list
25150604|NCT05152004|Clarithromycin|clarithromycin|mesh-list
25150605|NCT05152004|Rabeprazole|rabeprazole|mesh-list
25669224|NCT01728324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25669225|NCT01728337|Botulinum Toxins|botulinum toxins|mesh-list
25150606|NCT05152004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25150607|NCT05152004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25150608|NCT05152004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24626302|NCT01086553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24626303|NCT01086553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626304|NCT01086553|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24626305|NCT01086553|Respiratory System Agents|respiratory system agents|mesh-ancestor
24626306|NCT01086553|Glucocorticoids|glucocorticoids|mesh-ancestor
24626307|NCT01086553|Hormones|hormones|mesh-ancestor
24626308|NCT01086553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24626309|NCT01086579|Paclitaxel|paclitaxel|mesh-list
24626310|NCT01086579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24626311|NCT01086579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24626312|NCT01086579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24805566|NCT02010944|Mirabegron|mirabegron|mesh-list
24587464|NCT00895076|Glucocorticoids|glucocorticoids|mesh-ancestor
24587465|NCT00895076|Hormones|hormones|mesh-ancestor
24587466|NCT00895076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24587467|NCT00895076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24587468|NCT00895076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587469|NCT00895089|Moxifloxacin|moxifloxacin|mesh-list
24587470|NCT00895089|Ceftriaxone|ceftriaxone|mesh-list
24587506|NCT00895167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24901617|NCT04382950|Tretinoin|tretinoin|mesh-list
25863751|NCT00094978|Romidepsin|romidepsin|mesh-list
25863752|NCT00094978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863753|NCT00094978|Growth Inhibitors|growth inhibitors|mesh-ancestor
25863754|NCT00094978|Growth Substances|growth substances|mesh-ancestor
25863755|NCT00094978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587615|NCT00895804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24587616|NCT00895804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24626313|NCT01086579|Tubulin Modulators|tubulin modulators|mesh-ancestor
24626314|NCT01086579|Antimitotic Agents|antimitotic agents|mesh-ancestor
24626315|NCT01086579|Mitosis Modulators|mitosis modulators|mesh-ancestor
24587617|NCT00895804|Serotonin Agents|serotonin agents|mesh-ancestor
24587618|NCT00895804|Vasodilator Agents|vasodilator agents|mesh-ancestor
24587619|NCT00895882|Interferons|interferons|mesh-list
24587620|NCT00895882|Ribavirin|ribavirin|mesh-list
24587621|NCT00895882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587622|NCT00895882|Antiviral Agents|antiviral agents|mesh-ancestor
24587623|NCT00895882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24587624|NCT00895882|Antimetabolites|antimetabolites|mesh-ancestor
24587626|NCT00895960|Temozolomide|temozolomide|mesh-list
24587729|NCT00896558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25200357|NCT02734732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25200358|NCT02734732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25200359|NCT02734732|Renal Agents|renal agents|mesh-ancestor
25200360|NCT02734732|Antimalarials|antimalarials|mesh-ancestor
25200361|NCT02734732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25200362|NCT02734732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25200363|NCT02734732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25200364|NCT02734732|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25200365|NCT02734732|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25200366|NCT02734524|Carboplatin|carboplatin|mesh-list
25200367|NCT02734524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200368|NCT02734511|Propofol|propofol|mesh-list
25200369|NCT02734511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24587730|NCT00896558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25150671|NCT05131997|Antimetabolites|antimetabolites|mesh-ancestor
25150672|NCT05131997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150673|NCT05131997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24587731|NCT00896558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24587732|NCT00896558|Anesthetics, General|anesthetics, general|mesh-ancestor
24587735|NCT00896558|GABA Agents|gaba agents|mesh-ancestor
24587736|NCT00896558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24587737|NCT00896558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587738|NCT00896571|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24587739|NCT00896571|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24587740|NCT00896571|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24587741|NCT00896571|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24587742|NCT00896571|Contraceptive Agents|contraceptive agents|mesh-ancestor
25863756|NCT00094978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24587834|NCT00897312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24587835|NCT00897377|Temozolomide|temozolomide|mesh-list
24587836|NCT00897377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24587837|NCT00897377|Alkylating Agents|alkylating agents|mesh-ancestor
25404125|NCT03682978|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25863757|NCT00094978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587838|NCT00897377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587839|NCT00897377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587840|NCT00897520|Interferons|interferons|mesh-list
24587841|NCT00897520|Interferon-alpha|interferon-alpha|mesh-list
24588015|NCT00900445|Prednisolone|prednisolone|mesh-list
24587854|NCT00897871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24587855|NCT00897871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24587856|NCT00897871|Alkylating Agents|alkylating agents|mesh-ancestor
24587857|NCT00897871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587858|NCT00897871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587859|NCT00897871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25863758|NCT00094978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863759|NCT00094978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24587889|NCT00898417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24587890|NCT00898417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587891|NCT00898417|Tubulin Modulators|tubulin modulators|mesh-ancestor
24587892|NCT00898417|Antimitotic Agents|antimitotic agents|mesh-ancestor
24634153|NCT01132222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24634154|NCT01132222|Analgesics|analgesics|mesh-ancestor
24634155|NCT01132222|Sensory System Agents|sensory system agents|mesh-ancestor
25200370|NCT02734511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25200371|NCT02734511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200372|NCT02734511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25200373|NCT02734511|Anesthetics, General|anesthetics, general|mesh-ancestor
25200374|NCT02734511|Anesthetics|anesthetics|mesh-ancestor
25200375|NCT02734420|Tolonium Chloride|tolonium chloride|mesh-list
25200376|NCT02734420|Hemostatics|hemostatics|mesh-ancestor
25200377|NCT02734420|Coagulants|coagulants|mesh-ancestor
25200378|NCT02734420|Heparin Antagonists|heparin antagonists|mesh-ancestor
25200379|NCT02734420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634156|NCT01132222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24634158|NCT01132222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25200380|NCT02734407|Aflibercept|aflibercept|mesh-list
24587894|NCT00898417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587896|NCT00898417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25863760|NCT00095043|Gaboxadol|gaboxadol|mesh-list
25863761|NCT00095043|Analgesics|analgesics|mesh-ancestor
25863762|NCT00095043|Sensory System Agents|sensory system agents|mesh-ancestor
25863763|NCT00095043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25863764|NCT00095043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863765|NCT00095043|Anticonvulsants|anticonvulsants|mesh-ancestor
24587968|NCT00899587|Protease Inhibitors|protease inhibitors|mesh-ancestor
24587969|NCT00899587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587970|NCT00899587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587971|NCT00899587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24587972|NCT00899821|Aldesleukin|aldesleukin|mesh-list
24587973|NCT00899821|Interleukin-12|interleukin-12|mesh-list
24587974|NCT00899821|Sargramostim|sargramostim|mesh-list
24587975|NCT00899821|Immunologic Factors|immunologic factors|mesh-ancestor
24587976|NCT00899821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587977|NCT00899821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587978|NCT00899821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24805594|NCT02010970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24587980|NCT00899821|Antiviral Agents|antiviral agents|mesh-ancestor
24587987|NCT00899951|Fentanyl|fentanyl|mesh-list
24588007|NCT00900172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588008|NCT00900172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24588009|NCT00900172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24588010|NCT00900172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24588011|NCT00900172|Growth Substances|growth substances|mesh-ancestor
24588012|NCT00900172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588013|NCT00900172|Growth Inhibitors|growth inhibitors|mesh-ancestor
24588014|NCT00900445|Prednisone|prednisone|mesh-list
24588017|NCT00900445|Methylprednisolone|methylprednisolone|mesh-list
24588018|NCT00900445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24588019|NCT00900445|Prednisolone acetate|prednisolone acetate|mesh-list
24588020|NCT00900445|Hydrocortisone|hydrocortisone|mesh-list
24588021|NCT00900445|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24588022|NCT00900445|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24588023|NCT00900445|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24588024|NCT00900445|Cortisone|cortisone|mesh-list
24588025|NCT00900445|Vincristine|vincristine|mesh-list
24588026|NCT00900445|Daunorubicin|daunorubicin|mesh-list
24588027|NCT00900445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24588028|NCT00900445|Prednisolone phosphate|prednisolone phosphate|mesh-list
25863766|NCT00095043|GABA Agonists|gaba agonists|mesh-ancestor
25054953|NCT03525925|Nivolumab|nivolumab|mesh-list
24588029|NCT00900445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24588030|NCT00900445|Glucocorticoids|glucocorticoids|mesh-ancestor
24588031|NCT00900445|Hormones|hormones|mesh-ancestor
24588032|NCT00900445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24588033|NCT00900445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200381|NCT02734407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25200382|NCT02734407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25200383|NCT02734407|Growth Substances|growth substances|mesh-ancestor
25200384|NCT02734407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200385|NCT02734407|Growth Inhibitors|growth inhibitors|mesh-ancestor
25200386|NCT02734407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200387|NCT02734173|Ritonavir|ritonavir|mesh-list
25200388|NCT02734173|Ribavirin|ribavirin|mesh-list
25150792|NCT05055726|Benzydamine|benzydamine|mesh-list
25150793|NCT05055726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25150799|NCT05047952|Vortioxetine|vortioxetine|mesh-list
25150800|NCT05047952|Antidepressive Agents|antidepressive agents|mesh-ancestor
25150801|NCT05047952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25150802|NCT05047952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25150803|NCT05047952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25150804|NCT05047952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25150805|NCT05047952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25150806|NCT05047952|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25150807|NCT05047952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24588066|NCT00900510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24588067|NCT00900744|Tamoxifen|tamoxifen|mesh-list
24588077|NCT00900874|Albuterol|albuterol|mesh-list
25863767|NCT00095043|GABA Agents|gaba agents|mesh-ancestor
24588094|NCT00900887|Nepafenac|nepafenac|mesh-list
24588095|NCT00900887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24588096|NCT00900887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24588110|NCT00900913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588144|NCT00901290|Contraceptives, Oral|contraceptives, oral|mesh-list
24588145|NCT00901290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24588146|NCT00901290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588147|NCT00901290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24588148|NCT00901368|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24588156|NCT00901368|Hormones|hormones|mesh-ancestor
24588168|NCT00901407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588169|NCT00901407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24588170|NCT00901407|Serotonin Agents|serotonin agents|mesh-ancestor
24588171|NCT00901407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588172|NCT00901407|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24588173|NCT00901407|Antidepressive Agents|antidepressive agents|mesh-ancestor
24588174|NCT00901407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24588175|NCT00901407|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24588176|NCT00901407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24588177|NCT00901407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588178|NCT00901407|Anticonvulsants|anticonvulsants|mesh-ancestor
24588179|NCT00901407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24588180|NCT00901407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24588181|NCT00901407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24588182|NCT00901407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24588183|NCT00901407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24588184|NCT00901407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24588185|NCT00901511|Molgramostim|molgramostim|mesh-list
24588186|NCT00901511|Sargramostim|sargramostim|mesh-list
24588187|NCT00901511|Immunologic Factors|immunologic factors|mesh-ancestor
24588188|NCT00901511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588189|NCT00901511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588190|NCT00901524|Interferons|interferons|mesh-list
25200389|NCT02734173|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25200390|NCT02734173|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25200391|NCT02734173|Protease Inhibitors|protease inhibitors|mesh-ancestor
25200392|NCT02734173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25200393|NCT02734173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200394|NCT02734173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24588535|NCT00903045|Autonomic Agents|autonomic agents|mesh-ancestor
25200399|NCT02734173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25200400|NCT02734173|Antimetabolites|antimetabolites|mesh-ancestor
25200401|NCT02734069|Carboplatin|carboplatin|mesh-list
25200402|NCT02734069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200403|NCT02734186|Praziquantel|praziquantel|mesh-list
25200404|NCT02734186|Anthelmintics|anthelmintics|mesh-ancestor
25863768|NCT00095043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24588193|NCT00901524|Interferon alpha-2|interferon alpha-2|mesh-list
24634180|NCT01132235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24588210|NCT00901550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24588277|NCT00901823|Antimetabolites|antimetabolites|mesh-ancestor
24588278|NCT00901823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588279|NCT00901823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24588280|NCT00901823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24588281|NCT00901823|Nootropic Agents|nootropic agents|mesh-ancestor
24588282|NCT00901823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24588283|NCT00901823|Vasodilator Agents|vasodilator agents|mesh-ancestor
24588284|NCT00901849|Sirolimus|sirolimus|mesh-list
24588285|NCT00901849|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24588287|NCT00901849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24588288|NCT00901849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24588351|NCT00902395|Analgesics|analgesics|mesh-ancestor
24588352|NCT00902395|Sensory System Agents|sensory system agents|mesh-ancestor
24588353|NCT00902395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588354|NCT00902395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588355|NCT00902395|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24588356|NCT00902395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24588357|NCT00902395|Anesthetics, General|anesthetics, general|mesh-ancestor
24588358|NCT00902395|Anesthetics|anesthetics|mesh-ancestor
24588359|NCT00902395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24588360|NCT00902395|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24588361|NCT00902395|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24588362|NCT00902395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24588363|NCT00902395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588364|NCT00902395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24588365|NCT00902395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24588366|NCT00902395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25863769|NCT00095043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588367|NCT00902395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24588368|NCT00902395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24588370|NCT00902395|GABA Agents|gaba agents|mesh-ancestor
24778471|NCT01871129|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24588371|NCT00902421|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
24588372|NCT00902421|Serotonin|serotonin|mesh-list
24588373|NCT00902421|Muscarinic Antagonists|muscarinic antagonists|mesh-list
24588374|NCT00902421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24951571|NCT03903653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951572|NCT03903653|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24951573|NCT03903653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24951579|NCT03903029|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24951580|NCT03903029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24951581|NCT03903029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24805610|NCT02010970|Hormone Antagonists|hormone antagonists|mesh-ancestor
24805611|NCT02010970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24805612|NCT02010970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24805613|NCT02010970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24805614|NCT02010970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24805615|NCT02010970|Vasodilator Agents|vasodilator agents|mesh-ancestor
24805616|NCT02011126|Imetelstat|imetelstat|mesh-list
24805617|NCT02011126|Motesanib diphosphate|motesanib diphosphate|mesh-list
24805618|NCT02011126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580459|NCT00861887|Vancomycin|vancomycin|mesh-list
24473080|NCT00401804|Doxorubicin|doxorubicin|mesh-list
24473081|NCT00401804|Bortezomib|bortezomib|mesh-list
24473087|NCT00401804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24805626|NCT02011321|Clevidipine|clevidipine|mesh-list
24805627|NCT02011321|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24805628|NCT02011321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25200464|NCT02733874|Dermatologic Agents|dermatologic agents|mesh-ancestor
24805629|NCT02011321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805630|NCT02011321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25863770|NCT00095069|Gaboxadol|gaboxadol|mesh-list
24473168|NCT00402259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24951592|NCT03903133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881818|NCT01236521|Analgesics|analgesics|mesh-list
24805636|NCT02011347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805637|NCT02011347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24805638|NCT02011347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24805640|NCT02011347|Anesthetics|anesthetics|mesh-ancestor
24805641|NCT02011347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24805642|NCT02011347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24805643|NCT02011347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24805644|NCT02011347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24805645|NCT02011347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805646|NCT02011594|Nimotuzumab|nimotuzumab|mesh-list
24473172|NCT00402259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473174|NCT00402272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473175|NCT00402272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24473176|NCT00402272|Immunologic Factors|immunologic factors|mesh-ancestor
24473177|NCT00402272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200406|NCT02734186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25200407|NCT02734160|Durvalumab|durvalumab|mesh-list
25200408|NCT02734160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25200409|NCT02734160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207678|NCT03492099|Narcotics|narcotics|mesh-ancestor
25207679|NCT03492099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25207680|NCT03492099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207681|NCT03492099|Analgesics|analgesics|mesh-ancestor
25207682|NCT03492099|Sensory System Agents|sensory system agents|mesh-ancestor
25207683|NCT03492099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25207684|NCT03492099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25207685|NCT03485547|Venetoclax|venetoclax|mesh-list
25207686|NCT03485547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207687|NCT03481959|Methylphenidate|methylphenidate|mesh-list
25207688|NCT03481959|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25207689|NCT03481959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207690|NCT03481959|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25207691|NCT03481959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25207692|NCT03481959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25207693|NCT03481959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207694|NCT03481959|Dopamine Agents|dopamine agents|mesh-ancestor
25207695|NCT03481959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25207696|NCT03479502|Doxycycline|doxycycline|mesh-list
24798243|NCT01961830|Arbekacin|arbekacin|mesh-list
24798244|NCT01961830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24798245|NCT01961843|Prednisone|prednisone|mesh-list
24798246|NCT01961843|Abiraterone Acetate|abiraterone acetate|mesh-list
24798247|NCT01961843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24798248|NCT01961843|Glucocorticoids|glucocorticoids|mesh-ancestor
24798249|NCT01961843|Hormones|hormones|mesh-ancestor
24798250|NCT01961843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24798251|NCT01961843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798252|NCT01961843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24798253|NCT01961843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24798254|NCT01961843|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24473178|NCT00402350|Fentanyl|fentanyl|mesh-list
24588375|NCT00902421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24951607|NCT03902925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951608|NCT03902925|Sensory System Agents|sensory system agents|mesh-ancestor
24951609|NCT03902925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24951610|NCT03902925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24951611|NCT03902925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24951612|NCT03902925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24951613|NCT03902925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24588536|NCT00903045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24951614|NCT03902925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951616|NCT03902782|Dexamethasone acetate|dexamethasone acetate|mesh-list
24951617|NCT03902782|Epinephrine|epinephrine|mesh-list
24951618|NCT03902782|Bupivacaine|bupivacaine|mesh-list
24805647|NCT02011594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24805648|NCT02011594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24805649|NCT02011620|Isosorbide|isosorbide|mesh-list
24805650|NCT02011620|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24588376|NCT00902421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588377|NCT00902421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24588378|NCT00902421|Serotonin Agents|serotonin agents|mesh-ancestor
24588386|NCT00902460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24588387|NCT00902460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24588403|NCT00902473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24588404|NCT00902473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588437|NCT00902707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24588438|NCT00902707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24588439|NCT00902707|Adrenergic Agents|adrenergic agents|mesh-ancestor
24588440|NCT00902707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24588441|NCT00902707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588442|NCT00902707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588443|NCT00902707|Appetite Depressants|appetite depressants|mesh-ancestor
24588444|NCT00902707|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24588445|NCT00902707|Sympathomimetics|sympathomimetics|mesh-ancestor
24588446|NCT00902707|Autonomic Agents|autonomic agents|mesh-ancestor
24588447|NCT00902707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588448|NCT00902707|Nasal Decongestants|nasal decongestants|mesh-ancestor
24588449|NCT00902707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24588451|NCT00902772|Anticonvulsants|anticonvulsants|mesh-ancestor
24588452|NCT00902772|Antiemetics|antiemetics|mesh-ancestor
24588453|NCT00902772|Autonomic Agents|autonomic agents|mesh-ancestor
24634217|NCT01132443|Dermatologic Agents|dermatologic agents|mesh-ancestor
24951619|NCT03902782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24951620|NCT03902782|Antiemetics|antiemetics|mesh-ancestor
24951621|NCT03902782|Autonomic Agents|autonomic agents|mesh-ancestor
24951622|NCT03902782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24951646|NCT03902522|Leronlimab|leronlimab|mesh-list
24951647|NCT03902522|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24951648|NCT03902522|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24951649|NCT03902522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951650|NCT03902522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25200410|NCT02733952|Tranexamic Acid|tranexamic acid|mesh-list
25200411|NCT02733952|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25200412|NCT02733952|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25200413|NCT02733952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200414|NCT02733952|Hemostatics|hemostatics|mesh-ancestor
25200415|NCT02733952|Coagulants|coagulants|mesh-ancestor
25200416|NCT02733809|Sorafenib|sorafenib|mesh-list
25200417|NCT02733809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200418|NCT02733809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25200419|NCT02733809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25200420|NCT02733809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200421|NCT02733640|Pantoprazole|pantoprazole|mesh-list
25151027|NCT04922983|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25151028|NCT04922983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25151037|NCT04914247|Selexipag|selexipag|mesh-list
24881836|NCT01092143|Autonomic Agents|autonomic agents|mesh-ancestor
25151038|NCT04914247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25151039|NCT04910100|Timolol|timolol|mesh-list
25151040|NCT04910100|Nebivolol|nebivolol|mesh-list
25151041|NCT04910100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25151042|NCT04910100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25151043|NCT04910100|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24951651|NCT03902522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24805660|NCT02011633|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24805661|NCT02011633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24805662|NCT02011633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805663|NCT02011633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24805664|NCT02011633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24805665|NCT02011633|Antimetabolites|antimetabolites|mesh-ancestor
24805666|NCT02011633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805667|NCT02011633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24805668|NCT02011633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24805669|NCT02011633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863771|NCT00095069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24473237|NCT00402441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24473238|NCT00402441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473239|NCT00402441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24588488|NCT00902915|Lenalidomide|lenalidomide|mesh-list
24588489|NCT00902915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24588490|NCT00902915|Antiemetics|antiemetics|mesh-ancestor
24588496|NCT00902915|Hormones|hormones|mesh-ancestor
24588497|NCT00902915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24588498|NCT00902915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24588499|NCT00902915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588500|NCT00902915|Immunologic Factors|immunologic factors|mesh-ancestor
24588501|NCT00902915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24588502|NCT00902915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24588503|NCT00902915|Growth Substances|growth substances|mesh-ancestor
24951652|NCT03902522|Antiviral Agents|antiviral agents|mesh-ancestor
24951653|NCT03902522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24951654|NCT03902106|Albuterol|albuterol|mesh-list
24951655|NCT03902106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24951656|NCT03902106|Autonomic Agents|autonomic agents|mesh-ancestor
24951657|NCT03902106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24951658|NCT03902106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951659|NCT03902106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24951660|NCT03902106|Respiratory System Agents|respiratory system agents|mesh-ancestor
24951661|NCT03902106|Tocolytic Agents|tocolytic agents|mesh-ancestor
24951662|NCT03902106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24805670|NCT02011659|Ramosetron|ramosetron|mesh-list
24805671|NCT02011659|Antiemetics|antiemetics|mesh-ancestor
24805672|NCT02011659|Autonomic Agents|autonomic agents|mesh-ancestor
24805673|NCT02011659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24805674|NCT02011659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805675|NCT02011659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24805676|NCT02011659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24805677|NCT02011659|Serotonin Agents|serotonin agents|mesh-ancestor
24805678|NCT02011659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24805679|NCT02011659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805680|NCT02011737|Naftopidil|naftopidil|mesh-list
24580804|NCT00863733|Vadimezan|vadimezan|mesh-list
24473317|NCT00402545|Antimitotic Agents|antimitotic agents|mesh-ancestor
25863772|NCT00095069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444777|NCT00299065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24444778|NCT00299065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24444779|NCT00299065|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25200422|NCT02733640|Ranitidine|ranitidine|mesh-list
25200423|NCT02733640|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
25200424|NCT02733640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25200425|NCT02733640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25200426|NCT02733640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25200427|NCT02733640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25200428|NCT02733640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200429|NCT02733640|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24444780|NCT00299065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473328|NCT00402558|Fludarabine phosphate|fludarabine phosphate|mesh-list
24473329|NCT00402558|Fludarabine|fludarabine|mesh-list
24473331|NCT00402558|Interleukin-2|interleukin-2|mesh-list
24473332|NCT00402558|Tacrolimus|tacrolimus|mesh-list
24473333|NCT00402558|Thymoglobulin|thymoglobulin|mesh-list
24473334|NCT00402558|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24473335|NCT00402558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24473356|NCT00402558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24473357|NCT00402558|Analgesics|analgesics|mesh-ancestor
24951663|NCT03902106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24951664|NCT03902106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24951665|NCT03902106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24951666|NCT03902106|Adrenergic Agents|adrenergic agents|mesh-ancestor
24951667|NCT03902106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24951668|NCT03902106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951669|NCT03902340|Analgesics|analgesics|mesh-list
24588511|NCT00902941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588513|NCT00902954|Anastrozole|anastrozole|mesh-list
24588514|NCT00902954|Exemestane|exemestane|mesh-list
24588515|NCT00902954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588516|NCT00902954|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24588517|NCT00902954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24588533|NCT00903045|Propiverine|propiverine|mesh-list
24588534|NCT00903045|Parasympatholytics|parasympatholytics|mesh-ancestor
24588537|NCT00903045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588538|NCT00903045|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24588539|NCT00903045|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24588541|NCT00903045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24588542|NCT00903045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588543|NCT00903045|Urological Agents|urological agents|mesh-ancestor
24588545|NCT00903084|Antiviral Agents|antiviral agents|mesh-ancestor
24588546|NCT00903084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24588547|NCT00903084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24951678|NCT03902249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951679|NCT03902249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24951680|NCT03902249|Glucocorticoids|glucocorticoids|mesh-ancestor
24951681|NCT03902249|Hormones|hormones|mesh-ancestor
25863773|NCT00095069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588548|NCT00903084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24588549|NCT00903084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588550|NCT00903084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588551|NCT00903084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24588552|NCT00903084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24588553|NCT00903188|Cyclosporine|cyclosporine|mesh-list
24588554|NCT00903188|Mycophenolic Acid|mycophenolic acid|mesh-list
24588555|NCT00903188|Methylprednisolone|methylprednisolone|mesh-list
25090236|NCT03259672|Anesthetics|anesthetics|mesh-ancestor
24588556|NCT00903188|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24588557|NCT00903188|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25863774|NCT00095069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25863775|NCT00095069|Analgesics|analgesics|mesh-ancestor
25863776|NCT00095069|Sensory System Agents|sensory system agents|mesh-ancestor
25200430|NCT02733640|Histamine Antagonists|histamine antagonists|mesh-ancestor
25200431|NCT02733640|Histamine Agents|histamine agents|mesh-ancestor
25200432|NCT02733640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25200433|NCT02733640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200434|NCT02733835|Remifentanil|remifentanil|mesh-list
25200435|NCT02733835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25200436|NCT02733835|Narcotics|narcotics|mesh-ancestor
25200437|NCT02733835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25200438|NCT02733835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200439|NCT02733835|Analgesics|analgesics|mesh-ancestor
25200440|NCT02733835|Sensory System Agents|sensory system agents|mesh-ancestor
25151174|NCT04858360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24951689|NCT03901716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24951691|NCT03901716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24951692|NCT03901716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808299|NCT02026479|BB 1101|bb 1101|mesh-list
24951721|NCT03901768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951722|NCT03901768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24951723|NCT03901768|Glucocorticoids|glucocorticoids|mesh-ancestor
24805686|NCT02011737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805687|NCT02011737|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24588566|NCT00903188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588568|NCT00903188|Immunologic Factors|immunologic factors|mesh-ancestor
24588569|NCT00903188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588570|NCT00903188|Antifungal Agents|antifungal agents|mesh-ancestor
24951725|NCT03901768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24951727|NCT03901768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951728|NCT03901482|Dihydroergotamine|dihydroergotamine|mesh-list
24951729|NCT03901482|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24951730|NCT03901482|Dopamine Agonists|dopamine agonists|mesh-ancestor
24951731|NCT03901482|Dopamine Agents|dopamine agents|mesh-ancestor
24805689|NCT02011737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24805690|NCT02011737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24805691|NCT02011737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24805692|NCT02011750|Valproic Acid|valproic acid|mesh-list
24805693|NCT02011750|Anticonvulsants|anticonvulsants|mesh-ancestor
24805694|NCT02011750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581081|NCT00864357|Narcotics|narcotics|mesh-ancestor
24588660|NCT00903838|Pramipexole|pramipexole|mesh-list
24588661|NCT00903838|Antioxidants|antioxidants|mesh-ancestor
24588662|NCT00903838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588663|NCT00903838|Protective Agents|protective agents|mesh-ancestor
24588664|NCT00903838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588665|NCT00903838|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24951732|NCT03901482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24951733|NCT03901482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951734|NCT03901482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951735|NCT03901482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24951736|NCT03901482|Analgesics|analgesics|mesh-ancestor
24951737|NCT03901482|Sensory System Agents|sensory system agents|mesh-ancestor
24951738|NCT03901482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24805695|NCT02011750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805696|NCT02011750|GABA Agents|gaba agents|mesh-ancestor
24805697|NCT02011750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24805698|NCT02011750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805699|NCT02011750|Antimanic Agents|antimanic agents|mesh-ancestor
24805700|NCT02011750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24805701|NCT02011750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24473569|NCT00403312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588666|NCT00903838|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24588674|NCT00903851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588675|NCT00903851|Sensory System Agents|sensory system agents|mesh-ancestor
24588676|NCT00903851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588677|NCT00903851|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24588678|NCT00903851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25669226|NCT01728337|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25669227|NCT01728337|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24588679|NCT00903851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24588680|NCT00903851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24588681|NCT00903851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588683|NCT00903942|Carboplatin|carboplatin|mesh-list
24588702|NCT00903994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588703|NCT00904020|Lidocaine|lidocaine|mesh-list
24588704|NCT00904020|Anesthetics, Local|anesthetics, local|mesh-ancestor
24588705|NCT00904020|Anesthetics|anesthetics|mesh-ancestor
24588706|NCT00904020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24588707|NCT00904020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588708|NCT00904020|Sensory System Agents|sensory system agents|mesh-ancestor
24588709|NCT00904020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588710|NCT00904020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25200441|NCT02733835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25863777|NCT00095069|Anticonvulsants|anticonvulsants|mesh-ancestor
24997388|NCT05027893|Cefixime|cefixime|mesh-list
24588711|NCT00904020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24588712|NCT00904020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24588713|NCT00904020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24588714|NCT00904020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588715|NCT00904059|Asunaprevir|asunaprevir|mesh-list
24588716|NCT00904059|Protease Inhibitors|protease inhibitors|mesh-ancestor
24588717|NCT00904059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588719|NCT00904085|Oxymorphone|oxymorphone|mesh-list
24588745|NCT00904111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588747|NCT00904176|Digoxin|digoxin|mesh-list
24588748|NCT00904176|Warfarin|warfarin|mesh-list
24588749|NCT00904176|Anticoagulants|anticoagulants|mesh-ancestor
25200442|NCT02733887|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25200443|NCT02733887|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25200444|NCT02733887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200445|NCT02733822|Naloxone|naloxone|mesh-list
25200446|NCT02733822|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25200447|NCT02733822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882018|NCT00006455|Antidotes|antidotes|mesh-ancestor
25200448|NCT02733822|Sensory System Agents|sensory system agents|mesh-ancestor
25200449|NCT02733822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25200450|NCT02733679|Metformin|metformin|mesh-list
25200451|NCT02733679|Pioglitazone|pioglitazone|mesh-list
25200452|NCT02733679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25200453|NCT02733679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200454|NCT02733874|Betamethasone|betamethasone|mesh-list
25200455|NCT02733874|Clobetasol|clobetasol|mesh-list
25200456|NCT02733874|Calcipotriene|calcipotriene|mesh-list
25200457|NCT02733874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25200458|NCT02733874|Glucocorticoids|glucocorticoids|mesh-ancestor
25200459|NCT02733874|Hormones|hormones|mesh-ancestor
25200460|NCT02733874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25200461|NCT02733874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200462|NCT02733874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25200463|NCT02733874|Respiratory System Agents|respiratory system agents|mesh-ancestor
24951739|NCT03901690|Imiquimod|imiquimod|mesh-list
24951740|NCT03901690|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24808370|NCT02026817|Metformin|metformin|mesh-list
24951741|NCT03901690|Immunologic Factors|immunologic factors|mesh-ancestor
24951742|NCT03901690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052030|NCT00345748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25052031|NCT00345748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052032|NCT00345748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052033|NCT00345748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25052034|NCT00345748|Immunologic Factors|immunologic factors|mesh-ancestor
25052035|NCT00345748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052036|NCT00345748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25052038|NCT00345618|Enoxaparin|enoxaparin|mesh-list
25052039|NCT00345618|Warfarin|warfarin|mesh-list
25052040|NCT00345618|Idraparinux|idraparinux|mesh-list
25052041|NCT00345618|Idrabiotaparinux|idrabiotaparinux|mesh-list
25052042|NCT00345618|Anticoagulants|anticoagulants|mesh-ancestor
24805702|NCT02011750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24805703|NCT02011828|Ergocalciferols|ergocalciferols|mesh-list
24805704|NCT02011828|Vitamin D|vitamin d|mesh-list
24805705|NCT02011828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24805706|NCT02011828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805707|NCT02011828|Vitamins|vitamins|mesh-ancestor
24805708|NCT02011828|Micronutrients|micronutrients|mesh-ancestor
24805709|NCT02011828|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24805710|NCT02011841|Ciprofloxacin|ciprofloxacin|mesh-list
24805711|NCT02011841|Rifaximin|rifaximin|mesh-list
24805712|NCT02011841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24805713|NCT02011841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24805714|NCT02011841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24588754|NCT00904176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24588755|NCT00904176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24588756|NCT00904176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588757|NCT00904176|Protective Agents|protective agents|mesh-ancestor
24588758|NCT00904202|Lidocaine|lidocaine|mesh-list
24588759|NCT00904202|Gabapentin|gabapentin|mesh-list
24588760|NCT00904202|Anesthetics, Local|anesthetics, local|mesh-ancestor
24588761|NCT00904202|Anesthetics|anesthetics|mesh-ancestor
24588762|NCT00904202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24634346|NCT01132911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052043|NCT00345618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25052044|NCT00345618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25052045|NCT00345618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052046|NCT00345618|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25052047|NCT00345618|Antithrombins|antithrombins|mesh-ancestor
25052048|NCT00345618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25052049|NCT00345618|Protease Inhibitors|protease inhibitors|mesh-ancestor
25052050|NCT00345618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052051|NCT00345618|Vitamin B Complex|vitamin b complex|mesh-ancestor
25052053|NCT00345618|Micronutrients|micronutrients|mesh-ancestor
25052054|NCT00345618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052055|NCT00344045|Acetaminophen|acetaminophen|mesh-list
25052056|NCT00344045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25052057|NCT00344045|Analgesics|analgesics|mesh-ancestor
25200474|NCT02733705|Narcotics|narcotics|mesh-ancestor
25200475|NCT02733705|Analgesics|analgesics|mesh-ancestor
25200476|NCT02733705|Sensory System Agents|sensory system agents|mesh-ancestor
25200477|NCT02733705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25200478|NCT02733705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25200479|NCT02733510|Methylprednisolone|methylprednisolone|mesh-list
24634360|NCT01133080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24634361|NCT01133119|Bupivacaine|bupivacaine|mesh-list
24588768|NCT00904202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24588769|NCT00904202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24588770|NCT00904202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588771|NCT00904202|Analgesics|analgesics|mesh-ancestor
24588772|NCT00904202|Anticonvulsants|anticonvulsants|mesh-ancestor
24588894|NCT00904631|Keratolytic Agents|keratolytic agents|mesh-ancestor
24588895|NCT00904631|Dermatologic Agents|dermatologic agents|mesh-ancestor
24588896|NCT00904631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24588897|NCT00904631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24588898|NCT00904631|Analgesics|analgesics|mesh-ancestor
24588899|NCT00904631|Sensory System Agents|sensory system agents|mesh-ancestor
24588900|NCT00904631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588901|NCT00904631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588902|NCT00904631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24588903|NCT00904631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24588904|NCT00904631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24588905|NCT00904631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588906|NCT00904631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588907|NCT00904644|Raltegravir Potassium|raltegravir potassium|mesh-list
24588908|NCT00904644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24588909|NCT00904644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25052065|NCT00343109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805720|NCT02011841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24805721|NCT02011841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24805722|NCT02011880|Corylifolin|corylifolin|mesh-list
24805723|NCT02011880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24805724|NCT02011880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863778|NCT00095069|GABA Agonists|gaba agonists|mesh-ancestor
24589004|NCT00905073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24589005|NCT00905073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24589006|NCT00905190|Ondansetron|ondansetron|mesh-list
24589007|NCT00905190|Antiemetics|antiemetics|mesh-ancestor
24589008|NCT00905190|Autonomic Agents|autonomic agents|mesh-ancestor
24589009|NCT00905190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24882105|NCT02735707|Vitamins|vitamins|mesh-list
25200486|NCT02733510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25200487|NCT02733510|Antiemetics|antiemetics|mesh-ancestor
25200488|NCT02733510|Autonomic Agents|autonomic agents|mesh-ancestor
25200489|NCT02733510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25200490|NCT02733510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151425|NCT04658849|Pioglitazone|pioglitazone|mesh-list
25151426|NCT04658849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25151427|NCT04658849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589010|NCT00905190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589011|NCT00905190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24589012|NCT00905190|Antipruritics|antipruritics|mesh-ancestor
24589013|NCT00905190|Dermatologic Agents|dermatologic agents|mesh-ancestor
24589014|NCT00905190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24589015|NCT00905190|Serotonin Agents|serotonin agents|mesh-ancestor
24589016|NCT00905190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24589067|NCT00905541|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24589068|NCT00905541|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24589069|NCT00905541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589070|NCT00905684|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
25052074|NCT00337532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052075|NCT00337532|Tubulin Modulators|tubulin modulators|mesh-ancestor
25052076|NCT00337532|Antimitotic Agents|antimitotic agents|mesh-ancestor
25052077|NCT00337532|Mitosis Modulators|mitosis modulators|mesh-ancestor
24581997|NCT00866996|Methylphenidate|methylphenidate|mesh-list
24805737|NCT02011906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805738|NCT02011906|Protective Agents|protective agents|mesh-ancestor
24805739|NCT02011958|Amphotericin B|amphotericin b|mesh-list
25863779|NCT00095069|GABA Agents|gaba agents|mesh-ancestor
24473711|NCT00403910|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24473713|NCT00403910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24473714|NCT00403910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052081|NCT00337454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25052082|NCT00337454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24777736|NCT01866254|Analgesics|analgesics|mesh-ancestor
25052083|NCT00337454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052084|NCT00333502|Camptothecin|camptothecin|mesh-list
25863780|NCT00095082|Insulin|insulin|mesh-list
25052085|NCT00333502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25200491|NCT02733510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25200492|NCT02733510|Glucocorticoids|glucocorticoids|mesh-ancestor
25200493|NCT02733510|Hormones|hormones|mesh-ancestor
25200494|NCT02733510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25200495|NCT02733510|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25200496|NCT02733510|Protective Agents|protective agents|mesh-ancestor
25200497|NCT02733510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25200498|NCT02733510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200499|NCT02733471|Lidocaine|lidocaine|mesh-list
25200500|NCT02733471|Anesthetics, Local|anesthetics, local|mesh-ancestor
25200501|NCT02733471|Anesthetics|anesthetics|mesh-ancestor
25200502|NCT02733471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25200503|NCT02733471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200504|NCT02733471|Sensory System Agents|sensory system agents|mesh-ancestor
25200505|NCT02733471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24997462|NCT04809116|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24997463|NCT04809116|Serotonin Agents|serotonin agents|mesh-ancestor
24997464|NCT04809116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24997465|NCT04809116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997476|NCT04799236|Amphotericin B|amphotericin b|mesh-list
24997477|NCT04799236|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24997478|NCT04799236|Miltefosine|miltefosine|mesh-list
24997481|NCT04799236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24997482|NCT04799236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24997483|NCT04799236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25052086|NCT00333502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052087|NCT00333502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25052088|NCT00333502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24589129|NCT00905931|Protective Agents|protective agents|mesh-ancestor
24589130|NCT00905931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589131|NCT00905931|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24589132|NCT00905931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24589133|NCT00905931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589134|NCT00905983|Gemcitabine|gemcitabine|mesh-list
24589232|NCT00906139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24589293|NCT00906529|Insulin Detemir|insulin detemir|mesh-list
24589294|NCT00906529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24589295|NCT00906529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200506|NCT02733471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25200507|NCT02733471|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25200508|NCT02733471|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25200509|NCT02733471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25429961|NCT01409200|Estrogens|estrogens|mesh-ancestor
25200510|NCT02733471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200511|NCT02733458|Gemcitabine|gemcitabine|mesh-list
25200512|NCT02733458|Dexamethasone|dexamethasone|mesh-list
25200513|NCT02733458|Etoposide|etoposide|mesh-list
25200514|NCT02733458|Pegaspargase|pegaspargase|mesh-list
25200515|NCT02733458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25200516|NCT02733458|Antiemetics|antiemetics|mesh-ancestor
25200517|NCT02733458|Autonomic Agents|autonomic agents|mesh-ancestor
25200518|NCT02733458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25200519|NCT02733458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200520|NCT02733458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25200521|NCT02733458|Glucocorticoids|glucocorticoids|mesh-ancestor
25200522|NCT02733458|Hormones|hormones|mesh-ancestor
25200523|NCT02733458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25200524|NCT02733458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25200525|NCT02733458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200526|NCT02733458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589296|NCT00906594|Latanoprost|latanoprost|mesh-list
24589297|NCT00906594|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24589298|NCT00906594|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24589299|NCT00906685|Bevacizumab|bevacizumab|mesh-list
24589300|NCT00906685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24589301|NCT00906685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589302|NCT00906685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24589343|NCT00906880|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
24589344|NCT00906880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589345|NCT00906880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863781|NCT00095082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24589347|NCT00907036|Fludarabine|fludarabine|mesh-list
24589348|NCT00907036|Fludarabine phosphate|fludarabine phosphate|mesh-list
24589349|NCT00907036|Melphalan|melphalan|mesh-list
24966785|NCT03765450|Dermatologic Agents|dermatologic agents|mesh-ancestor
24966786|NCT03765450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25863782|NCT00095082|Insulin Glargine|insulin glargine|mesh-list
25863783|NCT00095082|Insulin Aspart|insulin aspart|mesh-list
25863784|NCT00095082|Insulin Detemir|insulin detemir|mesh-list
25863785|NCT00095082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25863786|NCT00095082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876560|NCT03281369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24589384|NCT00907166|Antimetabolites|antimetabolites|mesh-ancestor
24589385|NCT00907166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589386|NCT00907166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589387|NCT00907166|Antiviral Agents|antiviral agents|mesh-ancestor
24589388|NCT00907166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24589389|NCT00907166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589390|NCT00907166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24589487|NCT00907829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24589488|NCT00907829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589489|NCT00907829|Sensory System Agents|sensory system agents|mesh-ancestor
24589490|NCT00907829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24589491|NCT00907829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24589492|NCT00907829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24589493|NCT00907829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25876561|NCT03281369|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25200527|NCT02733458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200528|NCT02733458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25200529|NCT02733458|Antimetabolites|antimetabolites|mesh-ancestor
25200530|NCT02733458|Antiviral Agents|antiviral agents|mesh-ancestor
25200531|NCT02733458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25200532|NCT02733458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25200533|NCT02733458|Immunologic Factors|immunologic factors|mesh-ancestor
25200534|NCT02733458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25200535|NCT02733458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25200536|NCT02733458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25200537|NCT02733445|Dasatinib|dasatinib|mesh-list
25200538|NCT02733445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200539|NCT02733445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25200540|NCT02733445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25200541|NCT02733445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200542|NCT02733159|Pembrolizumab|pembrolizumab|mesh-list
25200543|NCT02733159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25200544|NCT02733159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876562|NCT03281369|Protease Inhibitors|protease inhibitors|mesh-ancestor
24827155|NCT02137616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24827156|NCT02137616|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25863787|NCT00095134|Risperidone|risperidone|mesh-list
25863788|NCT00095134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25863789|NCT00095134|Serotonin Agents|serotonin agents|mesh-ancestor
25863790|NCT00095134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25863791|NCT00095134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589494|NCT00907829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24589495|NCT00907829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589548|NCT00908089|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24589549|NCT00908089|Prednisolone acetate|prednisolone acetate|mesh-list
24589551|NCT00908089|Naltrexone|naltrexone|mesh-list
24589552|NCT00908089|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24589556|NCT00908089|Hormones|hormones|mesh-ancestor
24589601|NCT00908180|Cyclosporins|cyclosporins|mesh-list
24589602|NCT00908180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24589603|NCT00908180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863792|NCT00095134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589616|NCT00908180|Dermatologic Agents|dermatologic agents|mesh-ancestor
24589660|NCT00908362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24589661|NCT00908362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589662|NCT00908362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24589663|NCT00908362|Respiratory System Agents|respiratory system agents|mesh-ancestor
24589664|NCT00908362|Dermatologic Agents|dermatologic agents|mesh-ancestor
24589665|NCT00908362|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24589666|NCT00908362|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24589667|NCT00908362|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24589668|NCT00908362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24589669|NCT00908362|Adrenergic Agents|adrenergic agents|mesh-ancestor
24589670|NCT00908362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24634682|NCT01134536|Tapentadol|tapentadol|mesh-list
24589671|NCT00908362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589674|NCT00908362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24589675|NCT00908362|Sympathomimetics|sympathomimetics|mesh-ancestor
24589676|NCT00908414|TMC-310911|tmc-310911|mesh-list
24589677|NCT00908414|Protease Inhibitors|protease inhibitors|mesh-ancestor
24589678|NCT00908414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589679|NCT00908414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966787|NCT03765450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24966788|NCT03765346|Oxycodone|oxycodone|mesh-list
24966789|NCT03765346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24966790|NCT03765346|Narcotics|narcotics|mesh-ancestor
24966791|NCT03765346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24966792|NCT03765346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966793|NCT03765346|Analgesics|analgesics|mesh-ancestor
24966794|NCT03765346|Sensory System Agents|sensory system agents|mesh-ancestor
24966795|NCT03765346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24589680|NCT00908453|Fosphenytoin|fosphenytoin|mesh-list
24589711|NCT00908713|Prednisolone|prednisolone|mesh-list
24589712|NCT00908713|Prednisolone acetate|prednisolone acetate|mesh-list
24589713|NCT00908713|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24589714|NCT00908713|Prednisolone phosphate|prednisolone phosphate|mesh-list
24589715|NCT00908713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24589786|NCT00909051|Acarbose|acarbose|mesh-list
24589787|NCT00909051|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24589788|NCT00909051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589789|NCT00909051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589790|NCT00909051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24589791|NCT00909051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589792|NCT00909077|Dexamethasone|dexamethasone|mesh-list
24589793|NCT00909077|Dexamethasone acetate|dexamethasone acetate|mesh-list
24589794|NCT00909077|Rituximab|rituximab|mesh-list
24589795|NCT00909077|BB 1101|bb 1101|mesh-list
24589796|NCT00909077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24634711|NCT01134692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25200545|NCT02733107|Etoposide|etoposide|mesh-list
25200546|NCT02733107|Apatinib|apatinib|mesh-list
25200547|NCT02733107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25863793|NCT00095134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25200548|NCT02733107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200549|NCT02733107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25200550|NCT02733107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25200551|NCT02733107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25200552|NCT02733107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25151659|NCT04547153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25151660|NCT04547153|Antimetabolites|antimetabolites|mesh-ancestor
25151661|NCT04547153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25151662|NCT04547153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25151663|NCT04547153|Immunologic Factors|immunologic factors|mesh-ancestor
25151664|NCT04547153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151665|NCT04546230|Anesthetics|anesthetics|mesh-list
25151666|NCT04546230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25151667|NCT04546230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863794|NCT00095134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24589820|NCT00909129|Antimetabolites|antimetabolites|mesh-ancestor
24589821|NCT00909129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589822|NCT00909129|Immunologic Factors|immunologic factors|mesh-ancestor
24589823|NCT00909129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589824|NCT00909142|Clodronic Acid|clodronic acid|mesh-list
24589825|NCT00909142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24589826|NCT00909142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589827|NCT00909168|Gemtuzumab|gemtuzumab|mesh-list
24589837|NCT00909311|Ritonavir|ritonavir|mesh-list
24589876|NCT00909519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24589877|NCT00909519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589878|NCT00909519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24589879|NCT00909519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24589880|NCT00909519|Gout Suppressants|gout suppressants|mesh-ancestor
24589881|NCT00909519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24589882|NCT00909519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589883|NCT00909519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589884|NCT00909519|Diuretics|diuretics|mesh-ancestor
24589885|NCT00909519|Natriuretic Agents|natriuretic agents|mesh-ancestor
24589886|NCT00909519|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24805771|NCT02012075|Sympatholytics|sympatholytics|mesh-ancestor
24805772|NCT02012075|Autonomic Agents|autonomic agents|mesh-ancestor
24805773|NCT02012075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24805774|NCT02012075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589989|NCT00910117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24589990|NCT00910195|Acetaminophen|acetaminophen|mesh-list
24589991|NCT00910195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24589992|NCT00910195|Analgesics|analgesics|mesh-ancestor
24589993|NCT00910195|Sensory System Agents|sensory system agents|mesh-ancestor
24882298|NCT01546948|Methadone|methadone|mesh-list
24589994|NCT00910195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24589995|NCT00910195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590025|NCT00910416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24590026|NCT00910416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24590027|NCT00910416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634759|NCT01134926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25200553|NCT02733107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25200554|NCT02733237|Oxytocin|oxytocin|mesh-list
25200555|NCT02733237|Oxytocics|oxytocics|mesh-ancestor
25200556|NCT02733237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25200557|NCT02733237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200558|NCT02733250|Paclitaxel|paclitaxel|mesh-list
25200559|NCT02733250|Pembrolizumab|pembrolizumab|mesh-list
25200560|NCT02733250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25200561|NCT02733250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200562|NCT02733250|Tubulin Modulators|tubulin modulators|mesh-ancestor
25200563|NCT02733250|Antimitotic Agents|antimitotic agents|mesh-ancestor
25200564|NCT02733250|Mitosis Modulators|mitosis modulators|mesh-ancestor
24997505|NCT04687631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24997506|NCT04687631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24997507|NCT04687631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24997508|NCT04687631|Growth Substances|growth substances|mesh-ancestor
24997509|NCT04687631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997510|NCT04687631|Growth Inhibitors|growth inhibitors|mesh-ancestor
24997529|NCT04630210|Atezolizumab|atezolizumab|mesh-list
24997530|NCT04630210|Letrozole|letrozole|mesh-list
24997531|NCT04630210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24634760|NCT01134926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590045|NCT00910416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590046|NCT00910442|Acetylcysteine|acetylcysteine|mesh-list
24590047|NCT00910442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24590048|NCT00910442|Antiviral Agents|antiviral agents|mesh-ancestor
24590049|NCT00910442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24951757|NCT03901118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24951758|NCT03901118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24951759|NCT03901118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090399|NCT03258294|Melatonin|melatonin|mesh-list
24951760|NCT03901118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24951761|NCT03901170|Letrozole|letrozole|mesh-list
24951762|NCT03901170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951763|NCT03901170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24951764|NCT03901170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24951765|NCT03901170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951766|NCT03901170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951767|NCT03901170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24951768|NCT03901170|Hormone Antagonists|hormone antagonists|mesh-ancestor
24582433|NCT00869700|Lumefantrine|lumefantrine|mesh-list
24590080|NCT00910637|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24590081|NCT00910637|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24590083|NCT00910637|Hormones|hormones|mesh-ancestor
25200565|NCT02733250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200566|NCT02733250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25200567|NCT02733419|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25200568|NCT02733419|Enfuvirtide|enfuvirtide|mesh-list
25200569|NCT02733419|Antiviral Agents|antiviral agents|mesh-ancestor
25200570|NCT02733419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25200571|NCT02733419|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25200572|NCT02733419|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25200573|NCT02733419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200574|NCT02733419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25200575|NCT02733393|Lidocaine|lidocaine|mesh-list
25200576|NCT02733393|Anesthetics, Local|anesthetics, local|mesh-ancestor
25200577|NCT02733393|Anesthetics|anesthetics|mesh-ancestor
25200578|NCT02733393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25200579|NCT02733393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200580|NCT02733393|Sensory System Agents|sensory system agents|mesh-ancestor
25200581|NCT02733393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25200582|NCT02733393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25200583|NCT02733393|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25200584|NCT02733393|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25200585|NCT02733393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25200586|NCT02733393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200587|NCT02733380|Thalidomide|thalidomide|mesh-list
25200588|NCT02733380|Dexamethasone|dexamethasone|mesh-list
25200589|NCT02733380|Doxorubicin|doxorubicin|mesh-list
25151744|NCT04511832|Diclofenac|diclofenac|mesh-list
25151745|NCT04511832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25151746|NCT04511832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25151747|NCT04511832|Analgesics|analgesics|mesh-ancestor
25151748|NCT04511832|Sensory System Agents|sensory system agents|mesh-ancestor
25151749|NCT04511832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25151750|NCT04511832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151751|NCT04511832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25151752|NCT04511832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25151753|NCT04511832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25151754|NCT04511832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25151755|NCT04511832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25151756|NCT04508023|Rivaroxaban|rivaroxaban|mesh-list
25151757|NCT04508023|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25151758|NCT04508023|Antithrombins|antithrombins|mesh-ancestor
25151763|NCT04508023|Anticoagulants|anticoagulants|mesh-ancestor
24590084|NCT00910637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24590085|NCT00910676|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24590086|NCT00910676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24590087|NCT00910741|Gemcitabine|gemcitabine|mesh-list
24590088|NCT00910741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24590089|NCT00910741|Antimetabolites|antimetabolites|mesh-ancestor
24590090|NCT00910741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590091|NCT00910741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24590092|NCT00910741|Antiviral Agents|antiviral agents|mesh-ancestor
24590093|NCT00910741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24590094|NCT00910741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863795|NCT00095134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25863796|NCT00095134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25863797|NCT00095134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24590153|NCT00910897|Dexamethasone|dexamethasone|mesh-list
24590154|NCT00910897|Dexamethasone acetate|dexamethasone acetate|mesh-list
24590156|NCT00910897|BB 1101|bb 1101|mesh-list
24590247|NCT00911313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669228|NCT01728337|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25863798|NCT00095134|Dopamine Agents|dopamine agents|mesh-ancestor
24400226|NCT00150085|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24400228|NCT00150111|Methimazole|methimazole|mesh-list
24400229|NCT00150111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24590249|NCT00911313|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24590250|NCT00911313|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24590251|NCT00911313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590252|NCT00911313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590253|NCT00911313|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24590254|NCT00911313|Hormone Antagonists|hormone antagonists|mesh-ancestor
24590255|NCT00911313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24634851|NCT01135602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634852|NCT01135615|Calcium|calcium|mesh-list
24634853|NCT01135615|Sevelamer|sevelamer|mesh-list
24590263|NCT00911339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590265|NCT00911573|Clindamycin|clindamycin|mesh-list
24590266|NCT00911573|Clindamycin palmitate|clindamycin palmitate|mesh-list
24590267|NCT00911573|Clindamycin phosphate|clindamycin phosphate|mesh-list
24590268|NCT00911573|Tigecycline|tigecycline|mesh-list
24590269|NCT00911573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24590270|NCT00911573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24590271|NCT00911573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24590272|NCT00911573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25200590|NCT02733380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25200591|NCT02733380|Vinorelbine|vinorelbine|mesh-list
25200592|NCT02733380|Mitoxantrone|mitoxantrone|mesh-list
25200593|NCT02733380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25200594|NCT02733380|Antiemetics|antiemetics|mesh-ancestor
25200595|NCT02733380|Autonomic Agents|autonomic agents|mesh-ancestor
25200596|NCT02733380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25200597|NCT02733380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200598|NCT02733380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25200599|NCT02733380|Glucocorticoids|glucocorticoids|mesh-ancestor
25200600|NCT02733380|Hormones|hormones|mesh-ancestor
25200601|NCT02733380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25200602|NCT02733380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25200603|NCT02733380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200604|NCT02733380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25200605|NCT02733380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25200606|NCT02733380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25200607|NCT02733380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25151818|NCT04428333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25151819|NCT04428333|Antimetabolites|antimetabolites|mesh-ancestor
25151820|NCT04428333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25151821|NCT04428333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25151822|NCT04428333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25151823|NCT04428333|Immunologic Factors|immunologic factors|mesh-ancestor
25151824|NCT04428333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582513|NCT00870220|Estradiol|estradiol|mesh-list
24590337|NCT00912145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24590338|NCT00912145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590340|NCT00912171|Montelukast|montelukast|mesh-list
24590341|NCT00912171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24590342|NCT00912171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24590343|NCT00912171|Autonomic Agents|autonomic agents|mesh-ancestor
24591183|NCT00915460|Immunologic Factors|immunologic factors|mesh-ancestor
24590344|NCT00912171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24590345|NCT00912171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590346|NCT00912171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24590347|NCT00912171|Respiratory System Agents|respiratory system agents|mesh-ancestor
24590348|NCT00912171|Glucocorticoids|glucocorticoids|mesh-ancestor
24590350|NCT00912171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24590351|NCT00912171|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24590378|NCT00912379|Analgesics|analgesics|mesh-ancestor
24590379|NCT00912379|Sensory System Agents|sensory system agents|mesh-ancestor
24777460|NCT01864161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777461|NCT01864187|Dexmedetomidine|dexmedetomidine|mesh-list
24777462|NCT01864187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24777463|NCT01864187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24777464|NCT01864187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777465|NCT01864187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24777466|NCT01864187|Analgesics|analgesics|mesh-ancestor
25669229|NCT01728337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25669230|NCT01728337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777467|NCT01864187|Sensory System Agents|sensory system agents|mesh-ancestor
24591924|NCT00919555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24777471|NCT01864187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24777472|NCT01864187|Adrenergic Agents|adrenergic agents|mesh-ancestor
24590380|NCT00912379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24634901|NCT01135758|Analgesics|analgesics|mesh-ancestor
24634902|NCT01135758|Sensory System Agents|sensory system agents|mesh-ancestor
24634903|NCT01135758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24582601|NCT00870636|Bevacizumab|bevacizumab|mesh-list
24590483|NCT00912756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863799|NCT00095186|Lactoferrin|lactoferrin|mesh-list
25863800|NCT00095186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25863801|NCT00095225|Bevacizumab|bevacizumab|mesh-list
25863802|NCT00095225|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25863803|NCT00095225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25863804|NCT00095225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863805|NCT00095225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25863806|NCT00095225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25863807|NCT00095225|Growth Substances|growth substances|mesh-ancestor
24590561|NCT00913224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24590562|NCT00913224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24590563|NCT00913224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24590564|NCT00913224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590565|NCT00913224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590567|NCT00913237|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24590568|NCT00913237|Antidepressive Agents|antidepressive agents|mesh-ancestor
25200608|NCT02733380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200609|NCT02733380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25200610|NCT02733380|Tubulin Modulators|tubulin modulators|mesh-ancestor
25200611|NCT02733380|Antimitotic Agents|antimitotic agents|mesh-ancestor
25200612|NCT02733380|Mitosis Modulators|mitosis modulators|mesh-ancestor
25200613|NCT02733380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25200614|NCT02733380|Immunologic Factors|immunologic factors|mesh-ancestor
25200615|NCT02733380|Leprostatic Agents|leprostatic agents|mesh-ancestor
25151903|NCT04345341|Anesthetics, Local|anesthetics, local|mesh-ancestor
25151904|NCT04345341|Anesthetics|anesthetics|mesh-ancestor
25151905|NCT04345341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25151906|NCT04345341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151907|NCT04345341|Sensory System Agents|sensory system agents|mesh-ancestor
25151908|NCT04345341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24590569|NCT00913237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24590570|NCT00913237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24777474|NCT01864187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808414|NCT02027064|Interferons|interferons|mesh-list
24777476|NCT01864213|Anesthetics, Local|anesthetics, local|mesh-ancestor
24777478|NCT01864213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24777479|NCT01864213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777480|NCT01864213|Sensory System Agents|sensory system agents|mesh-ancestor
24805822|NCT02012140|Purinergic Agents|purinergic agents|mesh-ancestor
24590571|NCT00913237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590572|NCT00913237|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24590796|NCT00913861|Anesthetics|anesthetics|mesh-ancestor
25863808|NCT00095225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590799|NCT00913861|Analgesics|analgesics|mesh-ancestor
24590800|NCT00913861|Sensory System Agents|sensory system agents|mesh-ancestor
24590801|NCT00913861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24590802|NCT00913861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24590803|NCT00913874|Valproic Acid|valproic acid|mesh-list
24590804|NCT00913874|Anticonvulsants|anticonvulsants|mesh-ancestor
24590805|NCT00913874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590806|NCT00913874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590807|NCT00913874|GABA Agents|gaba agents|mesh-ancestor
24590808|NCT00913874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24777484|NCT01864265|Certolizumab Pegol|certolizumab pegol|mesh-list
24777485|NCT01864265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24777486|NCT01864265|Immunologic Factors|immunologic factors|mesh-ancestor
24777487|NCT01864265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777488|NCT01864265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24626316|NCT01086579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805827|NCT02012166|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24805829|NCT02012166|Glucagon|glucagon|mesh-list
24805830|NCT02012166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24805831|NCT02012166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863809|NCT00095225|Growth Inhibitors|growth inhibitors|mesh-ancestor
24590901|NCT00914160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24590902|NCT00914160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590903|NCT00914160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24590904|NCT00914160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24590905|NCT00914160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24590906|NCT00914160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590907|NCT00914160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590908|NCT00914212|Sibutramine|sibutramine|mesh-list
24590909|NCT00914212|Antidepressive Agents|antidepressive agents|mesh-ancestor
24590910|NCT00914212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24590921|NCT00914368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24590922|NCT00914368|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24590923|NCT00914368|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24590940|NCT00914394|Respiratory System Agents|respiratory system agents|mesh-ancestor
24590941|NCT00914394|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24590942|NCT00914394|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24590943|NCT00914394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25200616|NCT02733380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25200617|NCT02733380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25200618|NCT02733380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25200619|NCT02733380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25200620|NCT02733380|Growth Substances|growth substances|mesh-ancestor
25200621|NCT02733380|Growth Inhibitors|growth inhibitors|mesh-ancestor
25200622|NCT02733380|Analgesics|analgesics|mesh-ancestor
25200623|NCT02733380|Sensory System Agents|sensory system agents|mesh-ancestor
25200624|NCT02733341|Ticagrelor|ticagrelor|mesh-list
25200625|NCT02733341|Cangrelor|cangrelor|mesh-list
25200626|NCT02733341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24590948|NCT00914394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590950|NCT00914420|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24590951|NCT00914420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590952|NCT00914420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590953|NCT00914420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24590954|NCT00914420|Vasodilator Agents|vasodilator agents|mesh-ancestor
24590955|NCT00914472|Heparin|heparin|mesh-list
24590956|NCT00914472|Calcium heparin|calcium heparin|mesh-list
24590957|NCT00914472|Anticoagulants|anticoagulants|mesh-ancestor
24590958|NCT00914472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24590959|NCT00914472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24590960|NCT00914472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805836|NCT02012166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24805837|NCT02012244|Fentanyl|fentanyl|mesh-list
24805838|NCT02012244|Anesthetics|anesthetics|mesh-list
24805839|NCT02012244|Anesthetics, Local|anesthetics, local|mesh-list
24805840|NCT02012244|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24805841|NCT02012244|Narcotics|narcotics|mesh-ancestor
24805842|NCT02012244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24591073|NCT00914888|Tigecycline|tigecycline|mesh-list
24591074|NCT00914888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24591075|NCT00914888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24591076|NCT00914888|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24591077|NCT00914888|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24591078|NCT00914888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24591181|NCT00915460|Antiviral Agents|antiviral agents|mesh-ancestor
24591182|NCT00915460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24591184|NCT00915460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591185|NCT00915460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24591186|NCT00915512|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24591187|NCT00915512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24591189|NCT00915512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24591190|NCT00915512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591191|NCT00915512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24591192|NCT00915512|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24582840|NCT00872131|Serotonin Agents|serotonin agents|mesh-ancestor
24591272|NCT00915733|Vasodilator Agents|vasodilator agents|mesh-ancestor
24591329|NCT00915915|Femovan|femovan|mesh-list
24591364|NCT00916045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25863810|NCT00095225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25863811|NCT00095225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876563|NCT03281369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591366|NCT00916045|Antiviral Agents|antiviral agents|mesh-ancestor
24591367|NCT00916045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24591368|NCT00916045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591369|NCT00916045|Antifungal Agents|antifungal agents|mesh-ancestor
24591370|NCT00916045|Dermatologic Agents|dermatologic agents|mesh-ancestor
24591371|NCT00916045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24591372|NCT00916045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24591373|NCT00916045|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24591374|NCT00916045|Antitubercular Agents|antitubercular agents|mesh-ancestor
24591375|NCT00916045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24591376|NCT00916097|Docetaxel|docetaxel|mesh-list
24591390|NCT00916123|Glucocorticoids|glucocorticoids|mesh-ancestor
24591407|NCT00916396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25152042|NCT04273776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25152043|NCT04273776|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25152053|NCT04269408|Nicardipine|nicardipine|mesh-list
25152054|NCT04269408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25152055|NCT04269408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25152056|NCT04269408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25152057|NCT04269408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25152058|NCT04269408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25152059|NCT04269408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25152060|NCT04269408|Vasodilator Agents|vasodilator agents|mesh-ancestor
25152090|NCT04261218|Paclitaxel|paclitaxel|mesh-list
25152091|NCT04261218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25152092|NCT04261218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591408|NCT00916409|Temozolomide|temozolomide|mesh-list
24591409|NCT00916409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24591410|NCT00916409|Alkylating Agents|alkylating agents|mesh-ancestor
24591411|NCT00916409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591463|NCT00916760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591464|NCT00916760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24591466|NCT00916890|Morphine|morphine|mesh-list
24591467|NCT00916890|Oxycodone|oxycodone|mesh-list
24591468|NCT00916890|Buprenorphine|buprenorphine|mesh-list
24591469|NCT00916890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24951807|NCT03900871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951808|NCT03900871|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24951809|NCT03900871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24951810|NCT03900871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951811|NCT03900871|Antipyretics|antipyretics|mesh-ancestor
24951812|NCT03900858|Isoniazid|isoniazid|mesh-list
24951813|NCT03900858|Rifapentine|rifapentine|mesh-list
24951814|NCT03900858|Rifampin|rifampin|mesh-list
24805858|NCT02012335|Ketamine|ketamine|mesh-list
24805859|NCT02012335|Analgesics|analgesics|mesh-ancestor
24600622|NCT00959582|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24591470|NCT00916890|Narcotics|narcotics|mesh-ancestor
24591471|NCT00916890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24591472|NCT00916890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591473|NCT00916890|Analgesics|analgesics|mesh-ancestor
25200627|NCT02733341|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25200628|NCT02733341|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25200629|NCT02733341|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25200630|NCT02733341|Purinergic Agents|purinergic agents|mesh-ancestor
25200631|NCT02733341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25200632|NCT02733341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200633|NCT02733341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200634|NCT02732795|Morphine|morphine|mesh-list
25200635|NCT02732795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25200637|NCT02732795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25200638|NCT02732795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200640|NCT02732795|Sensory System Agents|sensory system agents|mesh-ancestor
25200641|NCT02732795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25200642|NCT02732730|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25200643|NCT02732730|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25200644|NCT02732730|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25200645|NCT02732730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25200646|NCT02732730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200647|NCT02732730|Antiviral Agents|antiviral agents|mesh-ancestor
25200648|NCT02732730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25200649|NCT02732730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25863812|NCT00095225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863813|NCT00095251|Dexmedetomidine|dexmedetomidine|mesh-list
25863814|NCT00095251|Lorazepam|lorazepam|mesh-list
24591474|NCT00916890|Sensory System Agents|sensory system agents|mesh-ancestor
25430118|NCT01371201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591475|NCT00916890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24591476|NCT00916890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24591477|NCT00916890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24591478|NCT00916890|Anesthetics, General|anesthetics, general|mesh-ancestor
24591479|NCT00916890|Anesthetics|anesthetics|mesh-ancestor
24591480|NCT00916890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24591481|NCT00916942|Lidocaine|lidocaine|mesh-list
24591482|NCT00916942|Prilocaine|prilocaine|mesh-list
24591483|NCT00916942|Capsaicin|capsaicin|mesh-list
24591484|NCT00916942|Anesthetics, Local|anesthetics, local|mesh-ancestor
24591485|NCT00916942|Anesthetics|anesthetics|mesh-ancestor
24591518|NCT00917163|Immunologic Factors|immunologic factors|mesh-ancestor
24591519|NCT00917163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591520|NCT00917163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25863815|NCT00095251|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24591548|NCT00917345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591549|NCT00917345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24591551|NCT00917358|Interferon-alpha|interferon-alpha|mesh-list
24591552|NCT00917358|Interferon alpha-2|interferon alpha-2|mesh-list
24591553|NCT00917358|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24591554|NCT00917358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591555|NCT00917358|Antiviral Agents|antiviral agents|mesh-ancestor
24591556|NCT00917358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24591557|NCT00917358|Immunologic Factors|immunologic factors|mesh-ancestor
24591558|NCT00917358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591559|NCT00917397|Sertraline|sertraline|mesh-list
24591560|NCT00917397|Antidepressive Agents|antidepressive agents|mesh-ancestor
24591561|NCT00917397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24591562|NCT00917397|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24591564|NCT00917397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25863816|NCT00095251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25863817|NCT00095251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863818|NCT00095251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24591664|NCT00918177|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24591665|NCT00918177|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24591666|NCT00918177|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24591668|NCT00918177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24591669|NCT00918177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951815|NCT03900858|Antitubercular Agents|antitubercular agents|mesh-ancestor
24951816|NCT03900858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24951817|NCT03900858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24951818|NCT03900858|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24951819|NCT03900858|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24951820|NCT03900858|Antimetabolites|antimetabolites|mesh-ancestor
24951821|NCT03900858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951822|NCT03900858|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24591674|NCT00918177|Immunologic Factors|immunologic factors|mesh-ancestor
24591675|NCT00918177|Dopamine Agonists|dopamine agonists|mesh-ancestor
24591676|NCT00918190|Dexamethasone|dexamethasone|mesh-list
24591677|NCT00918190|Dexamethasone acetate|dexamethasone acetate|mesh-list
24591678|NCT00918190|Midazolam|midazolam|mesh-list
24591679|NCT00918190|Ondansetron|ondansetron|mesh-list
24591680|NCT00918190|BB 1101|bb 1101|mesh-list
24591681|NCT00918190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24591716|NCT00918307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24583048|NCT00873262|Estropipate|estropipate|mesh-list
24591748|NCT00918476|Contraceptive Agents|contraceptive agents|mesh-list
24591749|NCT00918476|Contraceptives, Oral|contraceptives, oral|mesh-list
25200650|NCT02732730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25200652|NCT02732756|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25200653|NCT02732756|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25200654|NCT02732756|Adrenergic Agents|adrenergic agents|mesh-ancestor
25200655|NCT02732756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25152186|NCT04199117|Nicotine|nicotine|mesh-list
25152187|NCT04199117|Varenicline|varenicline|mesh-list
25152188|NCT04199117|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25152189|NCT04199117|Autonomic Agents|autonomic agents|mesh-ancestor
25152190|NCT04199117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25152191|NCT04199117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25152192|NCT04199117|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25152193|NCT04199117|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25152194|NCT04199117|Cholinergic Agents|cholinergic agents|mesh-ancestor
25152195|NCT04199117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25152196|NCT04199117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591750|NCT00918476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24591751|NCT00918476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591752|NCT00918476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24591754|NCT00918489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591755|NCT00918489|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24591756|NCT00918489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591757|NCT00918489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591758|NCT00918528|Mitomycins|mitomycins|mesh-list
24591759|NCT00918528|Mitomycin|mitomycin|mesh-list
24951824|NCT03900858|Leprostatic Agents|leprostatic agents|mesh-ancestor
24951825|NCT03900858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24951826|NCT03900858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951859|NCT03900637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24591788|NCT00918632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591789|NCT00918632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591790|NCT00918840|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24591791|NCT00918840|Antiviral Agents|antiviral agents|mesh-ancestor
24591792|NCT00918840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24591793|NCT00918853|Pancrelipase|pancrelipase|mesh-list
24591794|NCT00918853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25863819|NCT00095251|Analgesics|analgesics|mesh-ancestor
25863820|NCT00095251|Sensory System Agents|sensory system agents|mesh-ancestor
25863821|NCT00095251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25863822|NCT00095251|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25863823|NCT00095251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25863824|NCT00095251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24591816|NCT00919243|Glucocorticoids|glucocorticoids|mesh-ancestor
24591818|NCT00919243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24591819|NCT00919243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591820|NCT00919243|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24591821|NCT00919243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200656|NCT02732756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200657|NCT02732756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200658|NCT02732756|Sympathomimetics|sympathomimetics|mesh-ancestor
25200659|NCT02732756|Autonomic Agents|autonomic agents|mesh-ancestor
25200660|NCT02732756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25200661|NCT02732756|Nasal Decongestants|nasal decongestants|mesh-ancestor
25200662|NCT02732756|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25200663|NCT02732756|Respiratory System Agents|respiratory system agents|mesh-ancestor
25200664|NCT02732522|Misoprostol|misoprostol|mesh-list
25200665|NCT02732522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25200666|NCT02732522|Abortifacient Agents|abortifacient agents|mesh-ancestor
25200667|NCT02732522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25200668|NCT02732522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200669|NCT02732522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25200670|NCT02732522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25200671|NCT02732522|Oxytocics|oxytocics|mesh-ancestor
25200672|NCT02732678|Propranolol|propranolol|mesh-list
25200673|NCT02732678|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25200674|NCT02732678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25200683|NCT02732405|Antiviral Agents|antiviral agents|mesh-ancestor
25200684|NCT02732405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25200685|NCT02732418|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25200686|NCT02732418|Contraceptive Agents|contraceptive agents|mesh-list
25200687|NCT02732418|Medroxyprogesterone|medroxyprogesterone|mesh-list
25200688|NCT02732418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25200689|NCT02732418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200690|NCT02732418|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25200691|NCT02732418|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25200692|NCT02732418|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25200693|NCT02732418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25200694|NCT02732418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200695|NCT02732418|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25200696|NCT02732418|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25200697|NCT02732418|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25200699|NCT02732197|Anticonvulsants|anticonvulsants|mesh-ancestor
25200700|NCT02732197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25200701|NCT02732197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25200702|NCT02732197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200703|NCT02732197|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25200704|NCT02732197|Anesthetics, General|anesthetics, general|mesh-ancestor
25200705|NCT02732197|Anesthetics|anesthetics|mesh-ancestor
25200706|NCT02732197|GABA Modulators|gaba modulators|mesh-ancestor
25200707|NCT02732197|GABA Agents|gaba agents|mesh-ancestor
25200708|NCT02732197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25200709|NCT02732197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25207697|NCT03479502|Prednisone|prednisone|mesh-list
25207698|NCT03479502|Methylprednisolone|methylprednisolone|mesh-list
25207699|NCT03479502|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25207700|NCT03479502|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25207701|NCT03479502|Prednisolone|prednisolone|mesh-list
25207702|NCT03479502|Prednisolone acetate|prednisolone acetate|mesh-list
25207703|NCT03479502|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25207704|NCT03479502|Prednisolone phosphate|prednisolone phosphate|mesh-list
25207705|NCT03479502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25207706|NCT03479502|Glucocorticoids|glucocorticoids|mesh-ancestor
25207707|NCT03479502|Hormones|hormones|mesh-ancestor
25207708|NCT03479502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25152295|NCT04156828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25152296|NCT04156828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25152297|NCT04156828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25152298|NCT04156828|Antiemetics|antiemetics|mesh-ancestor
25152299|NCT04156828|Autonomic Agents|autonomic agents|mesh-ancestor
25152300|NCT04156828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25152301|NCT04156828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25152302|NCT04156828|Glucocorticoids|glucocorticoids|mesh-ancestor
25152303|NCT04156828|Hormones|hormones|mesh-ancestor
25152304|NCT04156828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25152305|NCT04156828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24591925|NCT00919555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591926|NCT00919555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591927|NCT00919555|Keratolytic Agents|keratolytic agents|mesh-ancestor
24591928|NCT00919555|Dermatologic Agents|dermatologic agents|mesh-ancestor
24591929|NCT00919607|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24951872|NCT03899675|Caffeine|caffeine|mesh-list
24951874|NCT03899675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951875|NCT03899675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24951876|NCT03899675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951878|NCT03899675|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24591940|NCT00919776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591941|NCT00919776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24591942|NCT00919776|Immunologic Factors|immunologic factors|mesh-ancestor
24591943|NCT00919776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863825|NCT00095251|Adrenergic Agents|adrenergic agents|mesh-ancestor
24591998|NCT00920088|Darunavir|darunavir|mesh-list
24591999|NCT00920088|Flurbiprofen|flurbiprofen|mesh-list
24592000|NCT00920088|Midazolam|midazolam|mesh-list
24592001|NCT00920088|Dextromethorphan|dextromethorphan|mesh-list
24592002|NCT00920088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24592003|NCT00920088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25863826|NCT00095251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24592026|NCT00920088|Antitussive Agents|antitussive agents|mesh-ancestor
24592027|NCT00920088|Respiratory System Agents|respiratory system agents|mesh-ancestor
25863827|NCT00095251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863828|NCT00095251|Anticonvulsants|anticonvulsants|mesh-ancestor
25863829|NCT00095251|Antiemetics|antiemetics|mesh-ancestor
25863830|NCT00095251|Autonomic Agents|autonomic agents|mesh-ancestor
25863831|NCT00095251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25863832|NCT00095251|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25863833|NCT00095251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24592040|NCT00920101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24592041|NCT00920101|Antimetabolites|antimetabolites|mesh-ancestor
24592042|NCT00920101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635261|NCT01137994|Trastuzumab|trastuzumab|mesh-list
24592043|NCT00920101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24592044|NCT00920101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24592045|NCT00920101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592047|NCT00920153|Cytarabine|cytarabine|mesh-list
24592048|NCT00920153|Dexamethasone|dexamethasone|mesh-list
24592049|NCT00920153|Methylprednisolone|methylprednisolone|mesh-list
24592050|NCT00920153|Doxorubicin|doxorubicin|mesh-list
24592051|NCT00920153|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24592052|NCT00920153|Etoposide|etoposide|mesh-list
24592053|NCT00920153|Vincristine|vincristine|mesh-list
24951885|NCT03899610|Durvalumab|durvalumab|mesh-list
24592139|NCT00920296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592147|NCT00920413|Vitamins|vitamins|mesh-ancestor
24592175|NCT00920608|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25200710|NCT02732067|Anesthetics|anesthetics|mesh-list
25200711|NCT02732067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25200712|NCT02732067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200713|NCT02732262|Oxycodone|oxycodone|mesh-list
25200714|NCT02732262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25863834|NCT00095251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25200715|NCT02732262|Narcotics|narcotics|mesh-ancestor
25200716|NCT02732262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25200717|NCT02732262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200718|NCT02732262|Analgesics|analgesics|mesh-ancestor
25200719|NCT02732262|Sensory System Agents|sensory system agents|mesh-ancestor
25200720|NCT02732262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24592177|NCT00920608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24592178|NCT00920608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997545|NCT04592744|Vasopressins|vasopressins|mesh-list
24997546|NCT04592744|Epinephrine|epinephrine|mesh-list
24997547|NCT04592744|Norepinephrine|norepinephrine|mesh-list
24997548|NCT04592744|Angiotensin II|angiotensin ii|mesh-list
24997550|NCT04592744|Angiotensinogen|angiotensinogen|mesh-list
24997551|NCT04592744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24997552|NCT04592744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24997553|NCT04592744|Adrenergic Agents|adrenergic agents|mesh-ancestor
24997554|NCT04592744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24997555|NCT04592744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997556|NCT04592744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592179|NCT00920608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24592180|NCT00920608|Antimetabolites|antimetabolites|mesh-ancestor
24592181|NCT00920608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592182|NCT00920608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24592183|NCT00920608|Dermatologic Agents|dermatologic agents|mesh-ancestor
24592184|NCT00920608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25157110|NCT04805541|Tropicamide|tropicamide|mesh-list
24592185|NCT00920608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24592186|NCT00920608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24592187|NCT00920608|Immunologic Factors|immunologic factors|mesh-ancestor
24592188|NCT00920608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24592189|NCT00920608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24592190|NCT00920660|Prednisolone|prednisolone|mesh-list
24592191|NCT00920660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24592192|NCT00920660|Glucocorticoids|glucocorticoids|mesh-ancestor
24592193|NCT00920660|Hormones|hormones|mesh-ancestor
24592194|NCT00920660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24592195|NCT00920660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592196|NCT00920660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24592197|NCT00920660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24592198|NCT00920725|Insulin|insulin|mesh-list
24592199|NCT00920725|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24592200|NCT00920725|Insulin Aspart|insulin aspart|mesh-list
24592201|NCT00920725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24592202|NCT00920725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592203|NCT00920803|Resveratrol|resveratrol|mesh-list
24592204|NCT00920803|Antioxidants|antioxidants|mesh-ancestor
24592205|NCT00920803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592206|NCT00920803|Protective Agents|protective agents|mesh-ancestor
24592208|NCT00920803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592216|NCT00920868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24592217|NCT00920868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24592219|NCT00920868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592271|NCT00921102|Mydriatics|mydriatics|mesh-ancestor
24592272|NCT00921102|Parasympatholytics|parasympatholytics|mesh-ancestor
24592273|NCT00921102|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24592274|NCT00921102|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24592275|NCT00921102|Cholinergic Agents|cholinergic agents|mesh-ancestor
24592276|NCT00921102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24592277|NCT00921102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592278|NCT00921128|Muscimol|muscimol|mesh-list
24592279|NCT00921128|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24592280|NCT00921128|GABA Agonists|gaba agonists|mesh-ancestor
24592281|NCT00921128|GABA Agents|gaba agents|mesh-ancestor
24951886|NCT03899610|Tremelimumab|tremelimumab|mesh-list
24951887|NCT03899610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24951888|NCT03899610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951889|NCT03899506|Midazolam|midazolam|mesh-list
24951890|NCT03899506|Olanzapine|olanzapine|mesh-list
24951891|NCT03899506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24951892|NCT03899506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24951893|NCT03899506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25200721|NCT02732132|Fentanyl|fentanyl|mesh-list
25200722|NCT02732132|Midazolam|midazolam|mesh-list
25200723|NCT02732132|Ketamine|ketamine|mesh-list
25200724|NCT02732132|Propofol|propofol|mesh-list
25200725|NCT02732132|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25200726|NCT02732132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25200727|NCT02732132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200728|NCT02732132|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25200729|NCT02732132|Anesthetics, General|anesthetics, general|mesh-ancestor
25200730|NCT02732132|Anesthetics|anesthetics|mesh-ancestor
25200731|NCT02732132|Analgesics|analgesics|mesh-ancestor
25200732|NCT02732132|Sensory System Agents|sensory system agents|mesh-ancestor
25200733|NCT02732132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25152383|NCT04101227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25152384|NCT04101227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25152385|NCT04101227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25152386|NCT04101227|Antipruritics|antipruritics|mesh-ancestor
25152387|NCT04101227|Dermatologic Agents|dermatologic agents|mesh-ancestor
25152388|NCT04101227|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25152389|NCT04101227|Serotonin Agents|serotonin agents|mesh-ancestor
25152390|NCT04101227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24805872|NCT02012387|Omalizumab|omalizumab|mesh-list
24592282|NCT00921128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24592283|NCT00921128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592284|NCT00921128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592285|NCT00921154|Ivermectin|ivermectin|mesh-list
24592286|NCT00921154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24592287|NCT00921154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24592288|NCT00921167|Bevacizumab|bevacizumab|mesh-list
24592289|NCT00921167|Irinotecan|irinotecan|mesh-list
24592290|NCT00921167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24592291|NCT00921167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24592292|NCT00921167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24592293|NCT00921167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24592294|NCT00921167|Growth Substances|growth substances|mesh-ancestor
24592295|NCT00921167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863835|NCT00095251|GABA Modulators|gaba modulators|mesh-ancestor
24592305|NCT00921180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24592306|NCT00921180|Immunologic Factors|immunologic factors|mesh-ancestor
24592386|NCT00921570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24592387|NCT00921570|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24592388|NCT00921570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24592389|NCT00921570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592390|NCT00921570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24592391|NCT00921570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592392|NCT00921570|Vasodilator Agents|vasodilator agents|mesh-ancestor
24592393|NCT00921570|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24592394|NCT00921570|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24592395|NCT00921622|Vitamin D|vitamin d|mesh-list
24592396|NCT00921622|Vitamins|vitamins|mesh-list
24592409|NCT00921661|Growth Inhibitors|growth inhibitors|mesh-ancestor
24592410|NCT00921661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24592411|NCT00921674|Ivermectin|ivermectin|mesh-list
24592412|NCT00921674|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24635393|NCT01138904|Irinotecan|irinotecan|mesh-list
24635394|NCT01138904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24635395|NCT01138904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24635396|NCT01138904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24592460|NCT00921804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592461|NCT00921804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592462|NCT00921804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24592463|NCT00921804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25057257|NCT03506620|Sensory System Agents|sensory system agents|mesh-ancestor
24592467|NCT00921804|Dopamine Agents|dopamine agents|mesh-ancestor
24592535|NCT00922519|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24592536|NCT00922519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24592537|NCT00922532|Nitric Oxide|nitric oxide|mesh-list
24592538|NCT00922532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24592539|NCT00922532|Autonomic Agents|autonomic agents|mesh-ancestor
24951894|NCT03899506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951895|NCT03899506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24951896|NCT03899506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24951897|NCT03899506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24951898|NCT03899506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24951899|NCT03899506|Anesthetics, General|anesthetics, general|mesh-ancestor
24951900|NCT03899506|Anesthetics|anesthetics|mesh-ancestor
24951901|NCT03899506|GABA Modulators|gaba modulators|mesh-ancestor
24592540|NCT00922532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24592541|NCT00922532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200734|NCT02732132|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24592564|NCT00922844|Sevoflurane|sevoflurane|mesh-list
25200735|NCT02732132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25200736|NCT02732132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24402846|NCT00158561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200737|NCT02732132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25200738|NCT02732132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200739|NCT02732132|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25200740|NCT02732132|Narcotics|narcotics|mesh-ancestor
25200741|NCT02732132|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24592565|NCT00922844|Isoflurane|isoflurane|mesh-list
25863836|NCT00095251|GABA Agents|gaba agents|mesh-ancestor
24592566|NCT00922844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24592567|NCT00922844|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24592568|NCT00922844|Anesthetics, General|anesthetics, general|mesh-ancestor
24592570|NCT00922844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24635479|NCT01139671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24592578|NCT00922896|Antiviral Agents|antiviral agents|mesh-ancestor
24592619|NCT00923390|Aldesleukin|aldesleukin|mesh-list
24592620|NCT00923390|Cyclophosphamide|cyclophosphamide|mesh-list
24592621|NCT00923390|Fludarabine|fludarabine|mesh-list
24592622|NCT00923390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24592623|NCT00923390|Immunologic Factors|immunologic factors|mesh-ancestor
24592624|NCT00923390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592625|NCT00923390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24592626|NCT00923390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24592627|NCT00923390|Alkylating Agents|alkylating agents|mesh-ancestor
24592628|NCT00923390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592683|NCT00923806|Antiviral Agents|antiviral agents|mesh-ancestor
24592684|NCT00923806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24592685|NCT00923962|Adenosine|adenosine|mesh-list
24592686|NCT00923962|Glucagon|glucagon|mesh-list
24592687|NCT00923962|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24592688|NCT00923962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24592689|NCT00923962|Hormones|hormones|mesh-ancestor
24592690|NCT00923962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24592691|NCT00923962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592693|NCT00923962|Analgesics|analgesics|mesh-ancestor
24592694|NCT00923962|Sensory System Agents|sensory system agents|mesh-ancestor
24592695|NCT00923962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24592696|NCT00923962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24592697|NCT00923962|Vasodilator Agents|vasodilator agents|mesh-ancestor
24592698|NCT00923962|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24592699|NCT00923962|Purinergic Agonists|purinergic agonists|mesh-ancestor
25057259|NCT03506542|Mitomycins|mitomycins|mesh-list
24592700|NCT00923962|Purinergic Agents|purinergic agents|mesh-ancestor
24592701|NCT00923962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24592702|NCT00923962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951902|NCT03899506|GABA Agents|gaba agents|mesh-ancestor
24951903|NCT03899506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24951904|NCT03899506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951905|NCT03899506|Antiemetics|antiemetics|mesh-ancestor
24951906|NCT03899506|Autonomic Agents|autonomic agents|mesh-ancestor
24951907|NCT03899506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24951908|NCT03899506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24951909|NCT03899506|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24951910|NCT03899506|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24592705|NCT00924014|Diuretics|diuretics|mesh-ancestor
24592706|NCT00924014|Natriuretic Agents|natriuretic agents|mesh-ancestor
24592707|NCT00924014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592708|NCT00924014|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24592712|NCT00924079|Nalbuphine|nalbuphine|mesh-list
24592727|NCT00924222|Anesthetics|anesthetics|mesh-ancestor
24592738|NCT00924573|Metformin|metformin|mesh-list
24592739|NCT00924573|Glimepiride|glimepiride|mesh-list
24592740|NCT00924573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24592741|NCT00924573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592742|NCT00924573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24592743|NCT00924573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24592744|NCT00924573|Immunologic Factors|immunologic factors|mesh-ancestor
24592745|NCT00924586|Landiolol|landiolol|mesh-list
24592746|NCT00924586|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24592747|NCT00924586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24592784|NCT00925093|Vancomycin|vancomycin|mesh-list
24592785|NCT00925093|Linezolid|linezolid|mesh-list
24592786|NCT00925093|Teicoplanin|teicoplanin|mesh-list
25669231|NCT01728337|Cholinergic Agents|cholinergic agents|mesh-ancestor
24592787|NCT00925093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24592788|NCT00925093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25669232|NCT01728337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24592789|NCT00925093|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24592790|NCT00925093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592791|NCT00925093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592792|NCT00925106|Celecoxib|celecoxib|mesh-list
25200742|NCT02732132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25200743|NCT02732132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24592793|NCT00925106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24592794|NCT00925106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24592795|NCT00925106|Analgesics|analgesics|mesh-ancestor
24592796|NCT00925106|Sensory System Agents|sensory system agents|mesh-ancestor
24592848|NCT00925847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24592849|NCT00925847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24592850|NCT00925847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592852|NCT00925873|Fludarabine|fludarabine|mesh-list
24592853|NCT00925873|Fludarabine phosphate|fludarabine phosphate|mesh-list
24592854|NCT00925873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24592855|NCT00925873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24592856|NCT00925873|Antimetabolites|antimetabolites|mesh-ancestor
24951911|NCT03899506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24951912|NCT03899506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24951914|NCT03899337|Prednisolone|prednisolone|mesh-list
24592901|NCT00926107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24592902|NCT00926107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24592903|NCT00926107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24592905|NCT00926107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24592906|NCT00926107|Immunologic Factors|immunologic factors|mesh-ancestor
24592907|NCT00926107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592908|NCT00926302|Levetiracetam|levetiracetam|mesh-list
24592909|NCT00926302|Anticonvulsants|anticonvulsants|mesh-ancestor
24592910|NCT00926302|Nootropic Agents|nootropic agents|mesh-ancestor
24592911|NCT00926315|Calcitriol|calcitriol|mesh-list
24592912|NCT00926315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24592913|NCT00926315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592914|NCT00926315|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24592915|NCT00926315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24592916|NCT00926315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592917|NCT00926315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24592918|NCT00926315|Vitamins|vitamins|mesh-ancestor
24592919|NCT00926315|Micronutrients|micronutrients|mesh-ancestor
24592920|NCT00926315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24592930|NCT00926354|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24592931|NCT00926354|Immunologic Factors|immunologic factors|mesh-ancestor
24592932|NCT00926354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592933|NCT00926354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24592934|NCT00926354|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24592983|NCT00926666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24592984|NCT00926666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592985|NCT00926666|Sensory System Agents|sensory system agents|mesh-ancestor
24592986|NCT00926666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24951926|NCT03899337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951927|NCT03899337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24592987|NCT00926705|Fentanyl|fentanyl|mesh-list
24592988|NCT00926705|Dexmedetomidine|dexmedetomidine|mesh-list
24592989|NCT00926705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24592990|NCT00926705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24592991|NCT00926705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592992|NCT00926705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24592994|NCT00926705|Sensory System Agents|sensory system agents|mesh-ancestor
24592995|NCT00926705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24583593|NCT00875537|Capsaicin|capsaicin|mesh-list
25863837|NCT00095264|Darbepoetin alfa|darbepoetin alfa|mesh-list
25200745|NCT02732132|GABA Modulators|gaba modulators|mesh-ancestor
25200746|NCT02732132|GABA Agents|gaba agents|mesh-ancestor
25200747|NCT02732249|Metronidazole|metronidazole|mesh-list
25152617|NCT03912337|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25152618|NCT03912337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25152619|NCT03912337|Analgesics|analgesics|mesh-ancestor
25152620|NCT03912337|Sensory System Agents|sensory system agents|mesh-ancestor
25152621|NCT03912337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25152622|NCT03912337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200754|NCT02732249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25200755|NCT02732249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25200756|NCT02732249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25200757|NCT02732249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25200758|NCT02732249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25200759|NCT02732249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25200760|NCT02732249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25200761|NCT02732249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25200762|NCT02732249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25200763|NCT02732249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25200765|NCT02732249|Diuretics|diuretics|mesh-ancestor
25200766|NCT02732249|Natriuretic Agents|natriuretic agents|mesh-ancestor
25200767|NCT02732249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200768|NCT02732249|Expectorants|expectorants|mesh-ancestor
25200769|NCT02732249|Respiratory System Agents|respiratory system agents|mesh-ancestor
25200770|NCT02732314|Desonide|desonide|mesh-list
25200771|NCT02732314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25200772|NCT02732093|Lidocaine|lidocaine|mesh-list
25200773|NCT02732093|Anesthetics, Local|anesthetics, local|mesh-ancestor
25200774|NCT02732093|Anesthetics|anesthetics|mesh-ancestor
25200775|NCT02732093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25200776|NCT02732093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200777|NCT02732093|Sensory System Agents|sensory system agents|mesh-ancestor
25200778|NCT02732093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25200779|NCT02732093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25200780|NCT02732093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25863838|NCT00095264|Hematinics|hematinics|mesh-ancestor
25863839|NCT00095277|Darbepoetin alfa|darbepoetin alfa|mesh-list
25863840|NCT00095277|Hematinics|hematinics|mesh-ancestor
25863841|NCT00095316|Caspofungin|caspofungin|mesh-list
25863842|NCT00095316|Antifungal Agents|antifungal agents|mesh-ancestor
25200781|NCT02732093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25200782|NCT02732093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25152697|NCT03864068|Vitamin B Complex|vitamin b complex|mesh-ancestor
25152698|NCT03864068|Vitamins|vitamins|mesh-ancestor
25152699|NCT03864068|Micronutrients|micronutrients|mesh-ancestor
25152700|NCT03864068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25152708|NCT03831932|Osimertinib|osimertinib|mesh-list
25152709|NCT03831932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24593028|NCT00926731|Immunologic Factors|immunologic factors|mesh-ancestor
24593029|NCT00926731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593030|NCT00926757|Entecavir|entecavir|mesh-list
24593031|NCT00926757|Antiviral Agents|antiviral agents|mesh-ancestor
24593075|NCT00926835|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24593120|NCT00926926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593121|NCT00926926|Urological Agents|urological agents|mesh-ancestor
24593122|NCT00926965|Olanzapine|olanzapine|mesh-list
24593123|NCT00926965|Antipsychotic Agents|antipsychotic agents|mesh-list
24593124|NCT00926965|Amisulpride|amisulpride|mesh-list
24593175|NCT00927212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593176|NCT00927212|Antiviral Agents|antiviral agents|mesh-ancestor
24593177|NCT00927212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24593178|NCT00927225|Ropivacaine|ropivacaine|mesh-list
24593179|NCT00927225|Anesthetics, Local|anesthetics, local|mesh-ancestor
24593180|NCT00927225|Anesthetics|anesthetics|mesh-ancestor
24593181|NCT00927225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24593182|NCT00927225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593183|NCT00927225|Sensory System Agents|sensory system agents|mesh-ancestor
24593184|NCT00927225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24593185|NCT00927290|Pioglitazone|pioglitazone|mesh-list
24593194|NCT00927407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593269|NCT00927732|Autonomic Agents|autonomic agents|mesh-ancestor
24593270|NCT00927732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24593271|NCT00927732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593272|NCT00927732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24593273|NCT00927732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24593274|NCT00927732|Adrenergic Agents|adrenergic agents|mesh-ancestor
24593275|NCT00927732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24593276|NCT00927732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593277|NCT00927732|Antimalarials|antimalarials|mesh-ancestor
24593278|NCT00927732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24593279|NCT00927732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24593280|NCT00927732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24593281|NCT00927732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593282|NCT00927732|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24593310|NCT00927797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25863843|NCT00095316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24951932|NCT03899337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25863844|NCT00095316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951933|NCT03899337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951934|NCT03899337|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24951935|NCT03899337|Tubulin Modulators|tubulin modulators|mesh-ancestor
24951936|NCT03899337|Antimitotic Agents|antimitotic agents|mesh-ancestor
24951937|NCT03899337|Mitosis Modulators|mitosis modulators|mesh-ancestor
24951938|NCT03899337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24951939|NCT03899337|Glucocorticoids|glucocorticoids|mesh-ancestor
25863845|NCT00095316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816187|NCT02074878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951940|NCT03899337|Hormones|hormones|mesh-ancestor
24951941|NCT03899337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24951942|NCT03899337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24951943|NCT03899246|Capsaicin|capsaicin|mesh-list
25200783|NCT02732093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200784|NCT02732236|Rituximab|rituximab|mesh-list
25200785|NCT02732236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25200786|NCT02732236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200787|NCT02732236|Immunologic Factors|immunologic factors|mesh-ancestor
25200788|NCT02732236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200789|NCT02732236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25200790|NCT02731950|Magnesium Sulfate|magnesium sulfate|mesh-list
25200791|NCT02731950|Bupivacaine|bupivacaine|mesh-list
25200792|NCT02731950|Anesthetics, Local|anesthetics, local|mesh-ancestor
25200793|NCT02731950|Anesthetics|anesthetics|mesh-ancestor
25200794|NCT02731950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25152765|NCT03809442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25152766|NCT03809442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25152768|NCT03809442|Glucocorticoids|glucocorticoids|mesh-ancestor
25152769|NCT03809442|Hormones|hormones|mesh-ancestor
25152771|NCT03809442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24951944|NCT03899246|Antipruritics|antipruritics|mesh-ancestor
24951945|NCT03899246|Dermatologic Agents|dermatologic agents|mesh-ancestor
24951946|NCT03899246|Sensory System Agents|sensory system agents|mesh-ancestor
24951947|NCT03899246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25863846|NCT00095329|Sirolimus|sirolimus|mesh-list
24593311|NCT00927797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24593312|NCT00927797|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
24593313|NCT00927797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593314|NCT00927836|Lenograstim|lenograstim|mesh-list
24593315|NCT00927836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24593316|NCT00927836|Immunologic Factors|immunologic factors|mesh-ancestor
24593317|NCT00927836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593318|NCT00927875|Carboplatin|carboplatin|mesh-list
24593319|NCT00927875|Etoposide|etoposide|mesh-list
24593322|NCT00927875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24593323|NCT00927875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24593324|NCT00927875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593325|NCT00927875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593327|NCT00927966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24593328|NCT00927966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24593329|NCT00927966|Immunologic Factors|immunologic factors|mesh-ancestor
24593351|NCT00928148|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24593352|NCT00928161|Dexlansoprazole|dexlansoprazole|mesh-list
24593353|NCT00928161|Lansoprazole|lansoprazole|mesh-list
24593354|NCT00928161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24593355|NCT00928161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24593357|NCT00928161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593358|NCT00928161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593360|NCT00928213|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24593361|NCT00928213|Tinzaparin|tinzaparin|mesh-list
24593362|NCT00928213|Dalteparin|dalteparin|mesh-list
24593363|NCT00928213|Progesterone|progesterone|mesh-list
24593364|NCT00928213|Hormones|hormones|mesh-ancestor
24951948|NCT03899246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951949|NCT03899584|4-Aminopyridine|4-aminopyridine|mesh-list
24593365|NCT00928213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24593366|NCT00928213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593367|NCT00928213|Anticoagulants|anticoagulants|mesh-ancestor
24593368|NCT00928213|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24593369|NCT00928213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24593370|NCT00928213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593371|NCT00928213|Progestins|progestins|mesh-ancestor
24593372|NCT00928291|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24593373|NCT00928291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24593374|NCT00928330|Trastuzumab|trastuzumab|mesh-list
24593382|NCT00928525|Imatinib Mesylate|imatinib mesylate|mesh-list
24593452|NCT00929370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593453|NCT00929370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593454|NCT00929487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24593456|NCT00929591|Cyclophosphamide|cyclophosphamide|mesh-list
24593457|NCT00929591|Doxorubicin|doxorubicin|mesh-list
24593458|NCT00929591|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24593459|NCT00929591|Fluorouracil|fluorouracil|mesh-list
24593460|NCT00929591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24593461|NCT00929591|Immunologic Factors|immunologic factors|mesh-ancestor
24593462|NCT00929591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200795|NCT02731950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200796|NCT02731950|Sensory System Agents|sensory system agents|mesh-ancestor
25200797|NCT02731950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25200798|NCT02731950|Analgesics|analgesics|mesh-ancestor
25200799|NCT02731950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25200800|NCT02731950|Anticonvulsants|anticonvulsants|mesh-ancestor
25200801|NCT02731950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25152825|NCT03786081|Growth Substances|growth substances|mesh-ancestor
25152826|NCT03786081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25152827|NCT03786081|Growth Inhibitors|growth inhibitors|mesh-ancestor
25152830|NCT03781362|Capecitabine|capecitabine|mesh-list
25152831|NCT03781362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25152832|NCT03781362|Antimetabolites|antimetabolites|mesh-ancestor
25152833|NCT03781362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25152834|NCT03781362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25152857|NCT03760575|Pembrolizumab|pembrolizumab|mesh-list
25152858|NCT03760575|Pemetrexed|pemetrexed|mesh-list
25152859|NCT03760575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25152860|NCT03760575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25152861|NCT03760575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25152862|NCT03760575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25152863|NCT03760575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24593463|NCT00929591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24593464|NCT00929591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25863847|NCT00095329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24593516|NCT00929877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593521|NCT00929955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24593522|NCT00929955|Antimetabolites|antimetabolites|mesh-ancestor
25863848|NCT00095329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24593525|NCT00929955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24593526|NCT00929955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593527|NCT00929955|Antiemetics|antiemetics|mesh-ancestor
24593528|NCT00929955|Autonomic Agents|autonomic agents|mesh-ancestor
24593529|NCT00929955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24593530|NCT00929955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593531|NCT00929955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24593566|NCT00930072|Autonomic Agents|autonomic agents|mesh-ancestor
24593567|NCT00930072|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24593568|NCT00930072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24593569|NCT00930072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24593570|NCT00930072|Adrenergic Agents|adrenergic agents|mesh-ancestor
24593571|NCT00930072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24593572|NCT00930072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593573|NCT00930098|Clofarabine|clofarabine|mesh-list
24593574|NCT00930098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24593575|NCT00930098|Antimetabolites|antimetabolites|mesh-ancestor
24593576|NCT00930098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593577|NCT00930098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24593578|NCT00930189|Triamcinolone|triamcinolone|mesh-list
24593579|NCT00930189|Ranibizumab|ranibizumab|mesh-list
24593580|NCT00930189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24593581|NCT00930189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24593583|NCT00930189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593584|NCT00930189|Growth Inhibitors|growth inhibitors|mesh-ancestor
24593585|NCT00930189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200802|NCT02731950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25200803|NCT02731950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200804|NCT02731950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25200805|NCT02731950|Tocolytic Agents|tocolytic agents|mesh-ancestor
25200806|NCT02731950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25200807|NCT02731911|Dexamethasone|dexamethasone|mesh-list
25200808|NCT02731911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25200809|NCT02731911|Antiemetics|antiemetics|mesh-ancestor
25200810|NCT02731911|Autonomic Agents|autonomic agents|mesh-ancestor
25222813|NCT02643173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200811|NCT02731911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25200812|NCT02731911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200813|NCT02731911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25200814|NCT02731911|Glucocorticoids|glucocorticoids|mesh-ancestor
25200815|NCT02731911|Hormones|hormones|mesh-ancestor
25200816|NCT02731911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25200817|NCT02731911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25200818|NCT02731911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200819|NCT02731664|Glucagon|glucagon|mesh-list
25152907|NCT03678506|Apixaban|apixaban|mesh-list
25152908|NCT03678506|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25152909|NCT03678506|Antithrombins|antithrombins|mesh-ancestor
25152910|NCT03678506|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25152911|NCT03678506|Protease Inhibitors|protease inhibitors|mesh-ancestor
25152912|NCT03678506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25152913|NCT03678506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25152914|NCT03678506|Anticoagulants|anticoagulants|mesh-ancestor
25152915|NCT03669523|Denosumab|denosumab|mesh-list
25152916|NCT03669523|Nivolumab|nivolumab|mesh-list
25152917|NCT03669523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25152918|NCT03669523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25152919|NCT03669523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25152920|NCT03669523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25152921|NCT03669523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25152922|NCT03669523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593586|NCT00930189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24593587|NCT00930189|Glucocorticoids|glucocorticoids|mesh-ancestor
24593588|NCT00930189|Hormones|hormones|mesh-ancestor
24951950|NCT03899584|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24951951|NCT03899584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24593673|NCT00930488|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24593674|NCT00930488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24593675|NCT00930514|Rituximab|rituximab|mesh-list
24593676|NCT00930514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24593677|NCT00930514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24593678|NCT00930514|Immunologic Factors|immunologic factors|mesh-ancestor
24593714|NCT00930683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593716|NCT00930709|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24593717|NCT00930709|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24593718|NCT00930709|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24593719|NCT00930709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24593720|NCT00930709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593721|NCT00930709|Cholinergic Agents|cholinergic agents|mesh-ancestor
24593722|NCT00930709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24593723|NCT00930709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593724|NCT00930709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24593725|NCT00930709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24593727|NCT00930722|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24593728|NCT00930722|Protease Inhibitors|protease inhibitors|mesh-ancestor
24593768|NCT00930891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24951954|NCT03899571|Antiviral Agents|antiviral agents|mesh-ancestor
24951955|NCT03899571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24967027|NCT03763279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24593769|NCT00930891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24593770|NCT00930891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25200820|NCT02731664|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25200821|NCT02731664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25200822|NCT02731664|Hormones|hormones|mesh-ancestor
25200823|NCT02731664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25200824|NCT02731664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200825|NCT02731664|Incretins|incretins|mesh-ancestor
25200826|NCT02731846|Fluticasone|fluticasone|mesh-list
25200828|NCT02731846|Albuterol|albuterol|mesh-list
25200829|NCT02731846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25200830|NCT02731846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25200831|NCT02731846|Autonomic Agents|autonomic agents|mesh-ancestor
25200832|NCT02731846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25200833|NCT02731846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200834|NCT02731846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25200835|NCT02731846|Respiratory System Agents|respiratory system agents|mesh-ancestor
25669233|NCT01728337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200836|NCT02731846|Dermatologic Agents|dermatologic agents|mesh-ancestor
25222837|NCT02643212|Anticoagulants|anticoagulants|mesh-ancestor
25222839|NCT02642900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25222840|NCT02642900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24835983|NCT02183688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835984|NCT02183688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835985|NCT02183688|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24835986|NCT02183688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24836014|NCT02183779|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24836015|NCT02183805|Cyclophosphamide|cyclophosphamide|mesh-list
24836017|NCT02183805|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24836018|NCT02183805|Paclitaxel|paclitaxel|mesh-list
24836019|NCT02183805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24836020|NCT02183805|Immunologic Factors|immunologic factors|mesh-ancestor
24836021|NCT02183805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403269|NCT00159705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24403270|NCT00159718|Amlodipine|amlodipine|mesh-list
25200837|NCT02731846|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25200838|NCT02731846|Tocolytic Agents|tocolytic agents|mesh-ancestor
25200839|NCT02731846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25863849|NCT00095329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24593819|NCT00931073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24593820|NCT00931073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593821|NCT00931073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24593822|NCT00931086|Belimumab|belimumab|mesh-list
24593823|NCT00931086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24593824|NCT00931086|Immunologic Factors|immunologic factors|mesh-ancestor
24593825|NCT00931086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593826|NCT00931125|Ranibizumab|ranibizumab|mesh-list
24593827|NCT00931125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24593828|NCT00931125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24593829|NCT00931125|Growth Substances|growth substances|mesh-ancestor
24593830|NCT00931125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593831|NCT00931125|Growth Inhibitors|growth inhibitors|mesh-ancestor
24593832|NCT00931125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24593928|NCT00931645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24593929|NCT00931645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24593931|NCT00931645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593932|NCT00931645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24593933|NCT00931645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24593934|NCT00931645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24593935|NCT00931645|Antiemetics|antiemetics|mesh-ancestor
24593936|NCT00931645|Autonomic Agents|autonomic agents|mesh-ancestor
24593937|NCT00931645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25863850|NCT00095329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863851|NCT00095329|Antifungal Agents|antifungal agents|mesh-ancestor
25863852|NCT00095329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24635726|NCT01140984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25669234|NCT01728337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25669235|NCT01728337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25669236|NCT01728376|Daptomycin|daptomycin|mesh-list
25669237|NCT01728376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25669238|NCT01728376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25669239|NCT01728584|Bromides|bromides|mesh-list
25669240|NCT01728584|Rocuronium|rocuronium|mesh-list
25669241|NCT01728584|Anticonvulsants|anticonvulsants|mesh-ancestor
25669242|NCT01728584|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25669243|NCT01728584|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25669244|NCT01728584|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25669245|NCT01728584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25669246|NCT01728584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669247|NCT01728623|Lenvatinib|lenvatinib|mesh-list
25669248|NCT01728623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669249|NCT01728623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25669250|NCT01728623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25669251|NCT01728623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669252|NCT01728636|Tranexamic Acid|tranexamic acid|mesh-list
25669253|NCT01728636|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25669254|NCT01728636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25222853|NCT02642861|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24635727|NCT01140984|Prednisolone|prednisolone|mesh-list
24635728|NCT01140984|Prednisolone acetate|prednisolone acetate|mesh-list
24635729|NCT01140984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24635730|NCT01140984|Prednisolone phosphate|prednisolone phosphate|mesh-list
24635731|NCT01140984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24594127|NCT00932685|GABA Agents|gaba agents|mesh-ancestor
24594128|NCT00932685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24594129|NCT00932685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594130|NCT00932763|Amlodipine|amlodipine|mesh-list
24594131|NCT00932763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24594132|NCT00932763|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24967028|NCT03763279|Antimetabolites|antimetabolites|mesh-ancestor
24967029|NCT03763279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967030|NCT03763279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24967031|NCT03763227|Ranibizumab|ranibizumab|mesh-list
24967032|NCT03763227|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-list
24967033|NCT03763227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24967034|NCT03763227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24967035|NCT03763227|Growth Substances|growth substances|mesh-ancestor
24967036|NCT03763227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967037|NCT03763227|Growth Inhibitors|growth inhibitors|mesh-ancestor
24594133|NCT00932763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25863853|NCT00095329|Immunologic Factors|immunologic factors|mesh-ancestor
25863854|NCT00095329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594646|NCT00934817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24594134|NCT00932763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594135|NCT00932763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24594136|NCT00932763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25157166|NCT04794699|Docetaxel|docetaxel|mesh-list
24594281|NCT00933309|Hormone Antagonists|hormone antagonists|mesh-ancestor
24594282|NCT00933309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25200840|NCT02731846|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25200841|NCT02731846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25200842|NCT02731846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25200843|NCT02731846|Adrenergic Agents|adrenergic agents|mesh-ancestor
25200844|NCT02731846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25200845|NCT02731846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594325|NCT00933439|Sensory System Agents|sensory system agents|mesh-ancestor
24594326|NCT00933439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24594327|NCT00933439|Antidepressive Agents|antidepressive agents|mesh-ancestor
24594328|NCT00933439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24594329|NCT00933439|Dopamine Agents|dopamine agents|mesh-ancestor
24594330|NCT00933452|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24594331|NCT00933452|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24594332|NCT00933452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24594333|NCT00933452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24594334|NCT00933452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594335|NCT00933452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24594336|NCT00933452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594337|NCT00933452|Analgesics|analgesics|mesh-ancestor
24594338|NCT00933452|Sensory System Agents|sensory system agents|mesh-ancestor
24594339|NCT00933452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24594340|NCT00933452|Antidepressive Agents|antidepressive agents|mesh-ancestor
24594341|NCT00933452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24594342|NCT00933452|Dopamine Agents|dopamine agents|mesh-ancestor
24594344|NCT00933465|Antidiarrheals|antidiarrheals|mesh-list
24594345|NCT00933465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24594346|NCT00933517|Cyclophosphamide|cyclophosphamide|mesh-list
24594347|NCT00933517|Docetaxel|docetaxel|mesh-list
24594369|NCT00933582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24967038|NCT03763227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967039|NCT03763227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24967040|NCT03763227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967041|NCT03763123|Paclitaxel|paclitaxel|mesh-list
24967042|NCT03763123|Topotecan|topotecan|mesh-list
24967043|NCT03763123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24967044|NCT03763123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967045|NCT03763123|Tubulin Modulators|tubulin modulators|mesh-ancestor
25669255|NCT01728636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669256|NCT01728636|Hemostatics|hemostatics|mesh-ancestor
25669257|NCT01728636|Coagulants|coagulants|mesh-ancestor
24445301|NCT00301171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24403517|NCT00160745|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24403518|NCT00160745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24967046|NCT03763123|Antimitotic Agents|antimitotic agents|mesh-ancestor
24967047|NCT03763123|Mitosis Modulators|mitosis modulators|mesh-ancestor
24967048|NCT03763123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805971|NCT02013102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24805972|NCT02013102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594486|NCT00934154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24594487|NCT00934154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24594488|NCT00934154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24594489|NCT00934154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24594490|NCT00934154|Growth Substances|growth substances|mesh-ancestor
24594491|NCT00934154|Growth Inhibitors|growth inhibitors|mesh-ancestor
24594494|NCT00934167|Anticoagulants|anticoagulants|mesh-ancestor
24594495|NCT00934167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24594496|NCT00934167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24594538|NCT00934323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24793564|NCT03123913|Hormones|hormones|mesh-ancestor
24805986|NCT02013154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24805987|NCT02013154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24805988|NCT02013154|Tubulin Modulators|tubulin modulators|mesh-ancestor
24594583|NCT00934687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24594584|NCT00934687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24671127|NCT01323712|Cholecalciferol|cholecalciferol|mesh-list
24594585|NCT00934687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594586|NCT00934687|Cholinergic Agents|cholinergic agents|mesh-ancestor
24594587|NCT00934687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24594588|NCT00934687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594642|NCT00934752|Mitosis Modulators|mitosis modulators|mesh-ancestor
24594644|NCT00934817|Metformin|metformin|mesh-list
24594645|NCT00934817|Glimepiride|glimepiride|mesh-list
24594652|NCT00934830|Amoxicillin|amoxicillin|mesh-list
24594653|NCT00934830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24594654|NCT00934895|Paclitaxel|paclitaxel|mesh-list
24594655|NCT00934895|Everolimus|everolimus|mesh-list
24594711|NCT00935298|Tacrolimus|tacrolimus|mesh-list
24594712|NCT00935298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24594713|NCT00935298|Immunologic Factors|immunologic factors|mesh-ancestor
24594714|NCT00935298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594715|NCT00935298|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24594716|NCT00935298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24805992|NCT02013154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24805993|NCT02013219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24805995|NCT02013219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24805996|NCT02013219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24805997|NCT02013219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24805998|NCT02013219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805999|NCT02013232|Aripiprazole|aripiprazole|mesh-list
24583450|NCT00874575|Vitamin D|vitamin d|mesh-list
25863855|NCT00095355|Valproic Acid|valproic acid|mesh-list
24594776|NCT00935506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24594778|NCT00935506|Analgesics|analgesics|mesh-ancestor
24594779|NCT00935506|Sensory System Agents|sensory system agents|mesh-ancestor
24594780|NCT00935506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24594781|NCT00935506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594782|NCT00935506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24594787|NCT00935506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24594788|NCT00935506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24594832|NCT00935571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24594833|NCT00935571|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24594834|NCT00935571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24594836|NCT00935571|Analgesics|analgesics|mesh-ancestor
24594837|NCT00935571|Sensory System Agents|sensory system agents|mesh-ancestor
24594838|NCT00935571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24594840|NCT00935610|Chelating Agents|chelating agents|mesh-ancestor
24594841|NCT00935610|Sequestering Agents|sequestering agents|mesh-ancestor
24594842|NCT00935610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594843|NCT00935675|Citalopram|citalopram|mesh-list
25669258|NCT01728779|Nelfinavir|nelfinavir|mesh-list
25669259|NCT01728779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25669260|NCT01728779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24594844|NCT00935675|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25052106|NCT00332657|Anecortave|anecortave|mesh-list
25052107|NCT00332657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25052108|NCT00332657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25052110|NCT00332657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594880|NCT00935805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24594881|NCT00935805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24594882|NCT00935805|Protease Inhibitors|protease inhibitors|mesh-ancestor
24594883|NCT00935805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594884|NCT00935961|Docetaxel|docetaxel|mesh-list
24594885|NCT00935961|Everolimus|everolimus|mesh-list
24594886|NCT00935961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24594925|NCT00936182|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24594926|NCT00936182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24594927|NCT00936182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594928|NCT00936182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594929|NCT00936182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24635853|NCT01141452|Glucocorticoids|glucocorticoids|mesh-ancestor
24594930|NCT00936182|Hormone Antagonists|hormone antagonists|mesh-ancestor
24594931|NCT00936182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24594932|NCT00936182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594933|NCT00936182|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24594934|NCT00936182|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24594936|NCT00936195|Lopinavir|lopinavir|mesh-list
25200846|NCT02731612|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
24594937|NCT00936195|Tenofovir|tenofovir|mesh-list
24594938|NCT00936195|Lamivudine|lamivudine|mesh-list
25863856|NCT00095355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24594966|NCT00936234|Protease Inhibitors|protease inhibitors|mesh-ancestor
24951969|NCT03899324|Natriuretic Agents|natriuretic agents|mesh-ancestor
24951970|NCT03899324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594980|NCT00936390|Fertility Agents|fertility agents|mesh-ancestor
24594981|NCT00936390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24594982|NCT00936390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779628|NCT01877590|Thioctic Acid|thioctic acid|mesh-list
24594983|NCT00936390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24594984|NCT00936390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24594996|NCT00936429|Antacids|antacids|mesh-ancestor
24595019|NCT00936533|Cholinergic Agents|cholinergic agents|mesh-ancestor
24595020|NCT00936533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24595021|NCT00936533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595022|NCT00936533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24595023|NCT00936533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24595025|NCT00936546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24595026|NCT00936546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24595027|NCT00936546|Immunologic Factors|immunologic factors|mesh-ancestor
24595028|NCT00936546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595029|NCT00936546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24595030|NCT00936624|Montelukast|montelukast|mesh-list
24595031|NCT00936624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24595032|NCT00936624|Respiratory System Agents|respiratory system agents|mesh-ancestor
24595033|NCT00936624|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24595034|NCT00936624|Hormone Antagonists|hormone antagonists|mesh-ancestor
24595040|NCT00936650|Cinacalcet|cinacalcet|mesh-list
24595137|NCT00936923|Diuretics|diuretics|mesh-list
24595138|NCT00936923|Natriuretic Agents|natriuretic agents|mesh-ancestor
24584324|NCT00879918|Nicotine|nicotine|mesh-list
24597576|NCT00950066|Vasodilator Agents|vasodilator agents|mesh-ancestor
24951971|NCT03899324|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24951972|NCT03899324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24951973|NCT03899324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863857|NCT00095355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951974|NCT03899233|Tranexamic Acid|tranexamic acid|mesh-list
24951975|NCT03899233|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24951976|NCT03899233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24951977|NCT03899233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951978|NCT03899233|Hemostatics|hemostatics|mesh-ancestor
24951979|NCT03899233|Coagulants|coagulants|mesh-ancestor
24951980|NCT03899194|Citalopram|citalopram|mesh-list
25052114|NCT00330473|Insulin|insulin|mesh-list
25052115|NCT00330473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24793039|NCT04270175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24951981|NCT03899194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24951982|NCT03899194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24951983|NCT03899194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24951984|NCT03899194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806017|NCT02013258|Oxytocin|oxytocin|mesh-list
24595261|NCT00937625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24595262|NCT00937625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24595263|NCT00937625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24595264|NCT00937625|Antimetabolites|antimetabolites|mesh-ancestor
24595265|NCT00937625|Antiviral Agents|antiviral agents|mesh-ancestor
24595266|NCT00937625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24595313|NCT00937924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595314|NCT00937924|Anesthetics, Local|anesthetics, local|mesh-ancestor
24595378|NCT00938262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24595630|NCT00939848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595632|NCT00939848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24595633|NCT00939848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595634|NCT00939848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24595635|NCT00939848|Immunologic Factors|immunologic factors|mesh-ancestor
24951985|NCT03899194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24951986|NCT03899194|Serotonin Agents|serotonin agents|mesh-ancestor
24951987|NCT03899194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951988|NCT03899194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25153229|NCT03374956|Dopamine Agents|dopamine agents|mesh-ancestor
24951989|NCT03899194|Antidepressive Agents|antidepressive agents|mesh-ancestor
24951990|NCT03899194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24777639|NCT01865318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777641|NCT01865331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24777642|NCT01865331|Insulin Aspart|insulin aspart|mesh-list
24777643|NCT01865331|Insulin, Long-Acting|insulin, long-acting|mesh-list
24777644|NCT01865331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24777645|NCT01865331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777646|NCT01865500|Prednisolone|prednisolone|mesh-list
24777647|NCT01865500|Budesonide|budesonide|mesh-list
24777648|NCT01865500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24777649|NCT01865500|Glucocorticoids|glucocorticoids|mesh-ancestor
24777650|NCT01865500|Hormones|hormones|mesh-ancestor
24595636|NCT00939848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595637|NCT00939848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24595693|NCT00940238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24595694|NCT00940238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24595695|NCT00940238|Parasympatholytics|parasympatholytics|mesh-ancestor
24595696|NCT00940238|Autonomic Agents|autonomic agents|mesh-ancestor
24595697|NCT00940238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24595698|NCT00940238|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24595762|NCT00940524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595763|NCT00940524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24595798|NCT00940550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24595799|NCT00940550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24595874|NCT00940784|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25863858|NCT00095355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863859|NCT00095355|Antimanic Agents|antimanic agents|mesh-ancestor
25863860|NCT00095355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24595912|NCT00940836|Histamine Agents|histamine agents|mesh-ancestor
24595913|NCT00940836|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24595914|NCT00940862|Adalimumab|adalimumab|mesh-list
24595915|NCT00940862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24598903|NCT05351736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24777651|NCT01865500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24777652|NCT01865500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951991|NCT03899142|Immunoglobulins|immunoglobulins|mesh-list
24951992|NCT03899142|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24951993|NCT03899142|Antibodies|antibodies|mesh-list
24951994|NCT03899142|Immunologic Factors|immunologic factors|mesh-ancestor
24951995|NCT03899142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951996|NCT03899077|Goserelin|goserelin|mesh-list
24951997|NCT03899077|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24951998|NCT03899077|Leuprolide|leuprolide|mesh-list
24951999|NCT03899077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24952000|NCT03899077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24952001|NCT03899077|Luteolytic Agents|luteolytic agents|mesh-ancestor
24806054|NCT02013453|Carboplatin|carboplatin|mesh-list
24806055|NCT02013453|Fluorouracil|fluorouracil|mesh-list
24806056|NCT02013453|Pemetrexed|pemetrexed|mesh-list
24806057|NCT02013453|Omeprazole|omeprazole|mesh-list
24806058|NCT02013453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24806059|NCT02013453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24595974|NCT00941083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595976|NCT00941096|Bimatoprost|bimatoprost|mesh-list
24595977|NCT00941096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24584567|NCT00881088|PENTA|penta|mesh-list
24952002|NCT03899077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24952004|NCT03899077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24952005|NCT03899077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952043|NCT03898583|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24952044|NCT03898583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24952045|NCT03898583|Glucocorticoids|glucocorticoids|mesh-ancestor
24952046|NCT03898583|Hormones|hormones|mesh-ancestor
24806067|NCT02013453|Immunologic Factors|immunologic factors|mesh-ancestor
24596183|NCT00942214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596184|NCT00942253|Dopamine|dopamine|mesh-list
24596185|NCT00942253|Dopamine Agonists|dopamine agonists|mesh-list
24596186|NCT00942253|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24596187|NCT00942253|Sympathomimetics|sympathomimetics|mesh-ancestor
24596188|NCT00942253|Autonomic Agents|autonomic agents|mesh-ancestor
24596189|NCT00942253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24596190|NCT00942253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596191|NCT00942253|Dopamine Agents|dopamine agents|mesh-ancestor
25200847|NCT02731612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24596192|NCT00942253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24596193|NCT00942253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596194|NCT00942253|Protective Agents|protective agents|mesh-ancestor
24596195|NCT00942318|Insulin|insulin|mesh-list
24596196|NCT00942318|Metformin|metformin|mesh-list
24596197|NCT00942318|Insulin Aspart|insulin aspart|mesh-list
24596198|NCT00942318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24596199|NCT00942318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596200|NCT00942344|Losartan|losartan|mesh-list
24596201|NCT00942344|Amlodipine|amlodipine|mesh-list
24596202|NCT00942344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24596203|NCT00942344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24596204|NCT00942344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24444847|NCT00299364|Hormone Antagonists|hormone antagonists|mesh-ancestor
24596227|NCT00942487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24596228|NCT00942487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596229|NCT00942487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596230|NCT00942526|Nystatin|nystatin|mesh-list
24596231|NCT00942526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24596232|NCT00942526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24596233|NCT00942526|Antifungal Agents|antifungal agents|mesh-ancestor
24596234|NCT00942526|Ionophores|ionophores|mesh-ancestor
24596235|NCT00942526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24596236|NCT00942526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596237|NCT00942539|Midazolam|midazolam|mesh-list
24596274|NCT00942591|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24596275|NCT00942591|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24596276|NCT00942591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596277|NCT00942591|Immunologic Factors|immunologic factors|mesh-ancestor
24596278|NCT00942591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596279|NCT00942591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24596280|NCT00942617|Aspirin|aspirin|mesh-list
24596281|NCT00942617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24952047|NCT03898583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24952048|NCT03898583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952049|NCT03898583|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24952050|NCT03898583|Respiratory System Agents|respiratory system agents|mesh-ancestor
24952051|NCT03898583|Dermatologic Agents|dermatologic agents|mesh-ancestor
24952052|NCT03898583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24952053|NCT03898583|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24952054|NCT03898583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24952055|NCT03898583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952056|NCT03898583|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24952057|NCT03898583|Vitamins|vitamins|mesh-ancestor
24596353|NCT00943176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24596354|NCT00943176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596356|NCT00943228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24596357|NCT00943228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596358|NCT00943228|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24671141|NCT01324063|Sargramostim|sargramostim|mesh-list
24596391|NCT00943345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596392|NCT00943345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596393|NCT00943358|Vaccines|vaccines|mesh-list
24596394|NCT00943358|Immunologic Factors|immunologic factors|mesh-ancestor
25431027|NCT01212822|Leucovorin|leucovorin|mesh-list
25106683|NCT00069238|Etoposide|etoposide|mesh-list
24596395|NCT00943358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596396|NCT00943410|Trastuzumab|trastuzumab|mesh-list
24952067|NCT03898193|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24952068|NCT03898193|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24952069|NCT03898193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952070|NCT03898466|Fluticasone|fluticasone|mesh-list
24952071|NCT03898466|Xhance|xhance|mesh-list
24952072|NCT03898466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24952073|NCT03898466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24952081|NCT03898011|Lamotrigine|lamotrigine|mesh-list
24952082|NCT03898011|Anticonvulsants|anticonvulsants|mesh-ancestor
24952083|NCT03898011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24596504|NCT00943943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596505|NCT00943943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596506|NCT00943943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24596507|NCT00943943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24596508|NCT00943943|Antiviral Agents|antiviral agents|mesh-ancestor
24596509|NCT00943943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24596510|NCT00943956|Everolimus|everolimus|mesh-list
24596511|NCT00943956|Leuprolide|leuprolide|mesh-list
24596512|NCT00943956|Bicalutamide|bicalutamide|mesh-list
24596513|NCT00943956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596514|NCT00943956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24596515|NCT00943956|Immunologic Factors|immunologic factors|mesh-ancestor
24596516|NCT00943956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596542|NCT00944307|Raltegravir Potassium|raltegravir potassium|mesh-list
24596543|NCT00944307|Antacids|antacids|mesh-list
24636058|NCT01142518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24596544|NCT00944307|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
24596546|NCT00944307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24596547|NCT00944307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25863861|NCT00095355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24596549|NCT00944307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24596550|NCT00944307|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24596551|NCT00944307|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24596552|NCT00944307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596553|NCT00944307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952089|NCT03898011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24952090|NCT03898011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24952099|NCT03897660|Vitamins|vitamins|mesh-list
24952100|NCT03897660|Vitamin K|vitamin k|mesh-list
24952101|NCT03897660|Vitamin K 2|vitamin k 2|mesh-list
24952102|NCT03897660|Micronutrients|micronutrients|mesh-ancestor
24952103|NCT03897660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596554|NCT00944307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24596555|NCT00944307|Antioxidants|antioxidants|mesh-ancestor
24596556|NCT00944307|Protective Agents|protective agents|mesh-ancestor
24596700|NCT00944957|Efavirenz|efavirenz|mesh-list
24596701|NCT00944957|Raltegravir Potassium|raltegravir potassium|mesh-list
24596752|NCT00945178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24596753|NCT00945178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24596754|NCT00945178|Gout Suppressants|gout suppressants|mesh-ancestor
24596755|NCT00945178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24596756|NCT00945178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596757|NCT00945178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598904|NCT05351736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24596815|NCT00945789|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24596816|NCT00945789|Autonomic Agents|autonomic agents|mesh-ancestor
24596817|NCT00945789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24596818|NCT00945789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596819|NCT00945789|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24596820|NCT00945789|Respiratory System Agents|respiratory system agents|mesh-ancestor
24596821|NCT00945789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24596822|NCT00945789|Antioxidants|antioxidants|mesh-ancestor
24596823|NCT00945789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863862|NCT00095355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596824|NCT00945789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24596825|NCT00945789|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24596829|NCT00945789|Hematinics|hematinics|mesh-ancestor
24596872|NCT00946335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597029|NCT00946907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24597030|NCT00946907|Analgesics|analgesics|mesh-ancestor
24597031|NCT00946907|Sensory System Agents|sensory system agents|mesh-ancestor
25669261|NCT01728779|Protease Inhibitors|protease inhibitors|mesh-ancestor
24597032|NCT00946907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24404425|NCT00163410|Hormones|hormones|mesh-ancestor
25863863|NCT00095355|Anticonvulsants|anticonvulsants|mesh-ancestor
24597089|NCT00947076|Serotonin Agents|serotonin agents|mesh-ancestor
24597090|NCT00947076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597091|NCT00947076|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24597092|NCT00947076|Antidepressive Agents|antidepressive agents|mesh-ancestor
24597093|NCT00947076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24597094|NCT00947076|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24597095|NCT00947076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24952104|NCT03897660|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24952105|NCT03897660|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24408487|NCT00178035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25153427|NCT03090737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25153428|NCT03090737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25153429|NCT03090737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25153430|NCT03090737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153431|NCT03090165|Bicalutamide|bicalutamide|mesh-list
25153432|NCT03090165|Androgen Antagonists|androgen antagonists|mesh-ancestor
25153433|NCT03090165|Hormone Antagonists|hormone antagonists|mesh-ancestor
25153434|NCT03090165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25153436|NCT03090165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24952106|NCT03897660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952108|NCT03897660|Coagulants|coagulants|mesh-ancestor
24597096|NCT00947076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597097|NCT00947128|Ondansetron|ondansetron|mesh-list
24597098|NCT00947128|Antiemetics|antiemetics|mesh-ancestor
24597120|NCT00947141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24597121|NCT00947141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24597175|NCT00947388|Alkylating Agents|alkylating agents|mesh-ancestor
24597176|NCT00947388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597177|NCT00947453|Montelukast|montelukast|mesh-list
24597178|NCT00947453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24597227|NCT00947843|Sensory System Agents|sensory system agents|mesh-ancestor
24597228|NCT00947843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25863864|NCT00095355|GABA Agents|gaba agents|mesh-ancestor
24597366|NCT00948987|Analgesics|analgesics|mesh-ancestor
24597421|NCT00949247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24597422|NCT00949247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24597424|NCT00949247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952115|NCT03897413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24952116|NCT03897413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952117|NCT03897413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952118|NCT03897413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24952119|NCT03897452|Fentanyl|fentanyl|mesh-list
24952120|NCT03897452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24952121|NCT03897452|Narcotics|narcotics|mesh-ancestor
25200848|NCT02731612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25200849|NCT02731612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25200850|NCT02731612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200851|NCT02731612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25200852|NCT02731612|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25200853|NCT02731612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25200854|NCT02731612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25200855|NCT02731612|Adrenergic Agents|adrenergic agents|mesh-ancestor
25200856|NCT02731612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25200857|NCT02731612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200858|NCT02731612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25200859|NCT02731612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25200860|NCT02731612|Serotonin Agents|serotonin agents|mesh-ancestor
25200861|NCT02731612|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25200862|NCT02731612|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25200863|NCT02731612|Dopamine Agents|dopamine agents|mesh-ancestor
25200864|NCT02731560|Rituximab|rituximab|mesh-list
25200865|NCT02731560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24952122|NCT03897452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24952123|NCT03897452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952125|NCT03897452|Sensory System Agents|sensory system agents|mesh-ancestor
24597852|NCT00952159|O-demethyltramadol|o-demethyltramadol|mesh-list
24597853|NCT00952159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24597854|NCT00952159|Narcotics|narcotics|mesh-ancestor
25669262|NCT01728779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597855|NCT00952159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24597856|NCT00952159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597857|NCT00952159|Analgesics|analgesics|mesh-ancestor
24597858|NCT00952159|Sensory System Agents|sensory system agents|mesh-ancestor
24597859|NCT00952159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24597861|NCT00952185|Immunologic Factors|immunologic factors|mesh-ancestor
24597862|NCT00952185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597863|NCT00952302|Iron|iron|mesh-list
24597864|NCT00952302|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24597865|NCT00952302|Trace Elements|trace elements|mesh-ancestor
24597866|NCT00952302|Micronutrients|micronutrients|mesh-ancestor
24597867|NCT00952302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597868|NCT00952302|Hematinics|hematinics|mesh-ancestor
24597869|NCT00952432|Carbamazepine|carbamazepine|mesh-list
24597870|NCT00952432|Anticonvulsants|anticonvulsants|mesh-ancestor
24597877|NCT00952432|Analgesics|analgesics|mesh-ancestor
24597900|NCT00952575|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24597901|NCT00952575|gamma-Globulins|gamma-globulins|mesh-list
24597902|NCT00952575|Immunologic Factors|immunologic factors|mesh-ancestor
24597903|NCT00952575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597904|NCT00952627|Pycnogenols|pycnogenols|mesh-list
24597905|NCT00952627|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24597906|NCT00952627|Immunologic Factors|immunologic factors|mesh-ancestor
24597907|NCT00952627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636160|NCT01143545|Analgesics|analgesics|mesh-ancestor
24952126|NCT03897452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24952127|NCT03897452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24952128|NCT03897452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24952130|NCT03897452|Anesthetics|anesthetics|mesh-ancestor
24952131|NCT03896971|Cyclosporine|cyclosporine|mesh-list
24952132|NCT03896971|Cyclosporins|cyclosporins|mesh-list
24952133|NCT03896971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952134|NCT03896971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952135|NCT03896971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24952136|NCT03896971|Immunologic Factors|immunologic factors|mesh-ancestor
24952137|NCT03896971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952138|NCT03896971|Antifungal Agents|antifungal agents|mesh-ancestor
24952139|NCT03896971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24952140|NCT03896971|Dermatologic Agents|dermatologic agents|mesh-ancestor
24598461|NCT00956189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598462|NCT00956189|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24598463|NCT00956189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24598464|NCT00956189|Serotonin Agents|serotonin agents|mesh-ancestor
24598465|NCT00956189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24598466|NCT00956189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24598467|NCT00956189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24598468|NCT00956189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25200866|NCT02731560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25200867|NCT02731560|Immunologic Factors|immunologic factors|mesh-ancestor
25200868|NCT02731560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200869|NCT02731560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25200870|NCT02731378|Iron|iron|mesh-list
25200871|NCT02731378|Dextrans|dextrans|mesh-list
25200872|NCT02731378|Epoetin Alfa|epoetin alfa|mesh-list
25200873|NCT02731378|Iron-Dextran Complex|iron-dextran complex|mesh-list
25200874|NCT02731378|Trace Elements|trace elements|mesh-ancestor
25200875|NCT02731378|Micronutrients|micronutrients|mesh-ancestor
25200876|NCT02731378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153543|NCT02863419|Liraglutide|liraglutide|mesh-list
25153544|NCT02863419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25153546|NCT02863419|Incretins|incretins|mesh-ancestor
24598469|NCT00956189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24598473|NCT00956215|Aprepitant|aprepitant|mesh-list
24598491|NCT00956267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24598493|NCT00956306|Udenafil|udenafil|mesh-list
24598494|NCT00956306|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24598495|NCT00956306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24598496|NCT00956306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863865|NCT00095355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25863866|NCT00095368|Amoxicillin|amoxicillin|mesh-list
25863867|NCT00095368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25863868|NCT00095368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25863869|NCT00095433|Ranibizumab|ranibizumab|mesh-list
24598544|NCT00956462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24598545|NCT00956462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598546|NCT00956462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24598600|NCT00956982|Ribavirin|ribavirin|mesh-list
24598601|NCT00956982|Interferon-alpha|interferon-alpha|mesh-list
24598602|NCT00956982|Interferon alpha-2|interferon alpha-2|mesh-list
24952148|NCT03896932|Immunologic Factors|immunologic factors|mesh-ancestor
24952149|NCT03896932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952150|NCT03897062|Suvorexant|suvorexant|mesh-list
24952151|NCT03897062|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24952152|NCT03897062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24952153|NCT03897062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24952154|NCT03897062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806167|NCT02014103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24806168|NCT02014103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806169|NCT02014337|Mifepristone|mifepristone|mesh-list
24806170|NCT02014337|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24598900|NCT05351788|Carboplatin|carboplatin|mesh-list
24598901|NCT05351788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598902|NCT05351736|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
24636231|NCT01144065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24598908|NCT05351736|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24598916|NCT05351736|Serotonin Agents|serotonin agents|mesh-ancestor
24598947|NCT05351606|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25153752|NCT02430480|Goserelin|goserelin|mesh-list
24585092|NCT00883194|Anesthetics|anesthetics|mesh-ancestor
24599461|NCT04562129|Antiviral Agents|antiviral agents|mesh-ancestor
24599462|NCT04562129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24599465|NCT04534023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599466|NCT04534023|Protective Agents|protective agents|mesh-ancestor
24599467|NCT04534023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599523|NCT04444804|Protease Inhibitors|protease inhibitors|mesh-ancestor
24599524|NCT04444804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24599525|NCT04444804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599526|NCT04444804|Anticoagulants|anticoagulants|mesh-ancestor
25863870|NCT00095433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25863871|NCT00095433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25200877|NCT02731378|Hematinics|hematinics|mesh-ancestor
25200878|NCT02731378|Anticoagulants|anticoagulants|mesh-ancestor
25200879|NCT02731378|Plasma Substitutes|plasma substitutes|mesh-ancestor
25200880|NCT02731378|Blood Substitutes|blood substitutes|mesh-ancestor
25200881|NCT02731430|Morphine|morphine|mesh-list
25200882|NCT02731430|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25200883|NCT02731430|Narcotics|narcotics|mesh-ancestor
24569472|NCT00800722|Sirolimus|sirolimus|mesh-list
24643217|NCT01184495|Epoetin Alfa|epoetin alfa|mesh-list
24643303|NCT01185119|Glucagon|glucagon|mesh-list
24626330|NCT01086826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626331|NCT01086826|Tubulin Modulators|tubulin modulators|mesh-ancestor
24626332|NCT01086826|Antimitotic Agents|antimitotic agents|mesh-ancestor
24626333|NCT01086826|Mitosis Modulators|mitosis modulators|mesh-ancestor
24626334|NCT01086826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626335|NCT01086826|Antimetabolites|antimetabolites|mesh-ancestor
24626336|NCT01086826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24626337|NCT01086826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24626338|NCT01086826|Immunologic Factors|immunologic factors|mesh-ancestor
24626339|NCT01086826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626340|NCT01086826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24626341|NCT01086878|Trimethoprim|trimethoprim|mesh-list
24626342|NCT01086878|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24626343|NCT01086878|Sulfamethoxazole|sulfamethoxazole|mesh-list
24626344|NCT01086878|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24863070|NCT03601455|Immunologic Factors|immunologic factors|mesh-ancestor
24863071|NCT03601455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863072|NCT03601455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24863073|NCT03601455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863074|NCT03594162|Cyclophosphamide|cyclophosphamide|mesh-list
24863075|NCT03594162|Fludarabine|fludarabine|mesh-list
24863076|NCT03594162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24542857|NCT00680602|Paroxetine|paroxetine|mesh-list
24542858|NCT00680602|Citalopram|citalopram|mesh-list
24542859|NCT00680602|Antidepressive Agents|antidepressive agents|mesh-ancestor
24542860|NCT00680602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25863872|NCT00095433|Growth Substances|growth substances|mesh-ancestor
24626345|NCT01086878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24626346|NCT01086878|Renal Agents|renal agents|mesh-ancestor
24626347|NCT01086878|Antimalarials|antimalarials|mesh-ancestor
24626348|NCT01086878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24626349|NCT01086878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24863092|NCT03261830|Clindamycin palmitate|clindamycin palmitate|mesh-list
24863093|NCT03261830|Clindamycin phosphate|clindamycin phosphate|mesh-list
24863095|NCT03261830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24863096|NCT03261830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24863097|NCT03261830|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24863098|NCT03261830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24863099|NCT03261830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863101|NCT03219528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24863102|NCT03219528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24863103|NCT03219528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24863104|NCT03111732|Pembrolizumab|pembrolizumab|mesh-list
24863105|NCT03111732|Capecitabine|capecitabine|mesh-list
24863106|NCT03111732|Oxaliplatin|oxaliplatin|mesh-list
25153874|NCT02116335|Bosentan|bosentan|mesh-list
25153698|NCT02496585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25153699|NCT02496585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25153700|NCT02496585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25153701|NCT02496585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25153702|NCT02496585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153704|NCT02486367|Ticagrelor|ticagrelor|mesh-list
25153705|NCT02486367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25153706|NCT02486367|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25153707|NCT02486367|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25153708|NCT02486367|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25153709|NCT02486367|Purinergic Agents|purinergic agents|mesh-ancestor
25153710|NCT02486367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25153711|NCT02486367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153712|NCT02486367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048481|NCT00694382|Semuloparin|semuloparin|mesh-list
24997756|NCT04429685|Ketamine|ketamine|mesh-list
24451814|NCT00324831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24451815|NCT00324831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24451816|NCT00324831|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24451817|NCT00324831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24451818|NCT00324831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25200884|NCT02731430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25200885|NCT02731430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863873|NCT00095433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863874|NCT00095433|Growth Inhibitors|growth inhibitors|mesh-ancestor
25863875|NCT00095433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863876|NCT00095446|Insulin Aspart|insulin aspart|mesh-list
25200887|NCT02731430|Sensory System Agents|sensory system agents|mesh-ancestor
25200888|NCT02731430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25200889|NCT02731534|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25200890|NCT02731534|Hematinics|hematinics|mesh-ancestor
25200891|NCT02731287|Timolol|timolol|mesh-list
25200892|NCT02731287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25200893|NCT02731287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25200894|NCT02731287|Adrenergic Agents|adrenergic agents|mesh-ancestor
25200895|NCT02731287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25200896|NCT02731287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200897|NCT02731287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200898|NCT02731287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25200899|NCT02731287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25200900|NCT02731092|Lactoferrin|lactoferrin|mesh-list
25200901|NCT02731092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25200902|NCT02731105|Clindamycin|clindamycin|mesh-list
25200903|NCT02731105|Clindamycin palmitate|clindamycin palmitate|mesh-list
25200904|NCT02731105|Clindamycin phosphate|clindamycin phosphate|mesh-list
25200905|NCT02731105|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
25200906|NCT02731105|Tretinoin|tretinoin|mesh-list
25200907|NCT02731105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25200908|NCT02731105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25200909|NCT02731105|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25200910|NCT02731105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863877|NCT00095446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25863878|NCT00095446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863879|NCT00095459|Bevacizumab|bevacizumab|mesh-list
25863880|NCT00095459|Sorafenib|sorafenib|mesh-list
24585419|NCT00885586|Gabapentin|gabapentin|mesh-list
24626354|NCT01086878|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24626355|NCT01086878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24626356|NCT01086878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24626357|NCT01086956|Sufentanil|sufentanil|mesh-list
24806204|NCT02014506|Fludarabine|fludarabine|mesh-list
24451821|NCT00324831|Hormones|hormones|mesh-ancestor
24451867|NCT00325000|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24451868|NCT00325000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24451869|NCT00325000|Analgesics|analgesics|mesh-ancestor
24451870|NCT00325000|Sensory System Agents|sensory system agents|mesh-ancestor
24451871|NCT00325000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24451872|NCT00325000|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24585457|NCT00885690|Olanzapine|olanzapine|mesh-list
25200913|NCT02731105|Keratolytic Agents|keratolytic agents|mesh-ancestor
25200914|NCT02731105|Dermatologic Agents|dermatologic agents|mesh-ancestor
25200915|NCT02731105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25200916|NCT02731105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25200917|NCT02731105|Analgesics|analgesics|mesh-ancestor
25200918|NCT02731105|Sensory System Agents|sensory system agents|mesh-ancestor
25200919|NCT02731105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25153829|NCT02213068|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25669263|NCT01728779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669264|NCT01728779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25669265|NCT01728779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25669266|NCT01728779|Antiviral Agents|antiviral agents|mesh-ancestor
25669267|NCT01728779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25669268|NCT01729156|Metformin|metformin|mesh-list
25863884|NCT00095459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25863885|NCT00095459|Growth Substances|growth substances|mesh-ancestor
25863886|NCT00095459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863887|NCT00095459|Growth Inhibitors|growth inhibitors|mesh-ancestor
25863888|NCT00095459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24626365|NCT01086956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24626366|NCT01086956|Narcotics|narcotics|mesh-ancestor
24626367|NCT01086956|Analgesics|analgesics|mesh-ancestor
24542926|NCT00680940|Mitosis Modulators|mitosis modulators|mesh-ancestor
25200920|NCT02731105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200921|NCT02731105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25200922|NCT02731105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25200923|NCT02730936|Anti-Infective Agents|anti-infective agents|mesh-list
25200924|NCT02730936|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25200925|NCT02730949|Folic Acid|folic acid|mesh-list
25200926|NCT02730949|Inositol|inositol|mesh-list
25200927|NCT02730949|Hematinics|hematinics|mesh-ancestor
25200928|NCT02730949|Vitamin B Complex|vitamin b complex|mesh-ancestor
25200929|NCT02730949|Vitamins|vitamins|mesh-ancestor
25200939|NCT02730975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25200940|NCT02730975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25200941|NCT02730975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200942|NCT02730975|Hormone Antagonists|hormone antagonists|mesh-ancestor
25200943|NCT02730975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25200944|NCT02730975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25200945|NCT02730975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25200946|NCT02730845|Dexmedetomidine|dexmedetomidine|mesh-list
25863889|NCT00095459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863890|NCT00095459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057409|NCT03505411|Melatonin|melatonin|mesh-list
25057410|NCT03505411|Antioxidants|antioxidants|mesh-ancestor
25863891|NCT00095472|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
24600302|NCT01155388|Micronutrients|micronutrients|mesh-ancestor
24863186|NCT02934529|Protective Agents|protective agents|mesh-ancestor
24863187|NCT02934529|Vitamin B Complex|vitamin b complex|mesh-ancestor
24863189|NCT02934529|Micronutrients|micronutrients|mesh-ancestor
24863190|NCT02934529|Hematinics|hematinics|mesh-ancestor
24863191|NCT02816736|Valsartan|valsartan|mesh-list
24863192|NCT02816736|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24863193|NCT02816736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24863194|NCT02816736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24863195|NCT02816736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24863196|NCT02816736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863197|NCT02774421|Trastuzumab|trastuzumab|mesh-list
24863198|NCT02774421|Molgramostim|molgramostim|mesh-list
24863199|NCT02774421|Sargramostim|sargramostim|mesh-list
25669269|NCT01729156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25863892|NCT00095472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863893|NCT00095472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863894|NCT00095511|Aripiprazole|aripiprazole|mesh-list
25863895|NCT00095511|Antidepressive Agents|antidepressive agents|mesh-ancestor
25863896|NCT00095511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25863897|NCT00095511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25863898|NCT00095511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25863899|NCT00095511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24863227|NCT02590094|Growth Inhibitors|growth inhibitors|mesh-ancestor
24863228|NCT02431702|Haloperidol|haloperidol|mesh-list
24863229|NCT02431702|Olanzapine|olanzapine|mesh-list
24626376|NCT01087008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24643843|NCT01187719|Phenytoin|phenytoin|mesh-list
24626377|NCT01087008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626378|NCT01087099|Albendazole|albendazole|mesh-list
24626379|NCT01087099|Anthelmintics|anthelmintics|mesh-ancestor
25153959|NCT01964430|Mitosis Modulators|mitosis modulators|mesh-ancestor
24883448|NCT03850366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25153960|NCT01964430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153961|NCT01964430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25153962|NCT01964430|Antimetabolites|antimetabolites|mesh-ancestor
25153963|NCT01964430|Antiviral Agents|antiviral agents|mesh-ancestor
25153964|NCT01964430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25153965|NCT01964430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25153966|NCT01964430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25153967|NCT01964430|Immunologic Factors|immunologic factors|mesh-ancestor
25153968|NCT01964430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153969|NCT01933815|Bevacizumab|bevacizumab|mesh-list
25153970|NCT01933815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25153971|NCT01933815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626380|NCT01087099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24626381|NCT01087099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24626382|NCT01087099|Anticestodal Agents|anticestodal agents|mesh-ancestor
24626383|NCT01087099|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24626384|NCT01087099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24626385|NCT01087099|Tubulin Modulators|tubulin modulators|mesh-ancestor
24626386|NCT01087099|Antimitotic Agents|antimitotic agents|mesh-ancestor
24626387|NCT01087099|Mitosis Modulators|mitosis modulators|mesh-ancestor
24967244|NCT03761004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24863230|NCT02431702|Risperidone|risperidone|mesh-list
24863231|NCT02431702|Aripiprazole|aripiprazole|mesh-list
24863232|NCT02431702|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24863233|NCT02431702|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24863234|NCT02431702|Haloperidol decanoate|haloperidol decanoate|mesh-list
24863235|NCT02431702|Perphenazine|perphenazine|mesh-list
24863236|NCT02431702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24863237|NCT02431702|Serotonin Agents|serotonin agents|mesh-ancestor
24863238|NCT02431702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24863239|NCT02431702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863240|NCT02431702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863241|NCT02431702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24863242|NCT02431702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24863243|NCT02431702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24863244|NCT02431702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24863245|NCT02431702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24863246|NCT02431702|Dopamine Agents|dopamine agents|mesh-ancestor
24863247|NCT02431702|Antiemetics|antiemetics|mesh-ancestor
24863248|NCT02431702|Autonomic Agents|autonomic agents|mesh-ancestor
24863249|NCT02431702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24863250|NCT02431702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24863259|NCT02431702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24863260|NCT02431702|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24863262|NCT02136069|Etrolizumab|etrolizumab|mesh-list
24863263|NCT02136069|Dermatologic Agents|dermatologic agents|mesh-ancestor
24863264|NCT02136069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24863265|NCT02136069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24543026|NCT00681720|GABA Modulators|gaba modulators|mesh-ancestor
25863901|NCT00095511|Dopamine Agonists|dopamine agonists|mesh-ancestor
25057433|NCT03505008|Adalimumab|adalimumab|mesh-list
24863291|NCT01024608|Respiratory System Agents|respiratory system agents|mesh-ancestor
24863292|NCT00988247|Beclomethasone|beclomethasone|mesh-list
24863293|NCT00988247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24863294|NCT00988247|Glucocorticoids|glucocorticoids|mesh-ancestor
24863295|NCT00988247|Hormones|hormones|mesh-ancestor
24813645|NCT02059759|Interleukin-2|interleukin-2|mesh-list
25863902|NCT00095511|Dopamine Agents|dopamine agents|mesh-ancestor
24863338|NCT05146245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24863339|NCT05146245|Serotonin Agents|serotonin agents|mesh-ancestor
24813624|NCT02059694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813625|NCT02059694|Sensory System Agents|sensory system agents|mesh-ancestor
24543114|NCT00681980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543115|NCT00681980|GABA Agents|gaba agents|mesh-ancestor
25863903|NCT00095511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25863904|NCT00095511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863905|NCT00095511|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25669270|NCT01729156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669271|NCT01729338|Cyclophosphamide|cyclophosphamide|mesh-list
25863906|NCT00095511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25669272|NCT01729338|Lenalidomide|lenalidomide|mesh-list
25669273|NCT01729338|Bortezomib|bortezomib|mesh-list
25863907|NCT00095511|Serotonin Agents|serotonin agents|mesh-ancestor
25863908|NCT00095511|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25863909|NCT00095511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25863910|NCT00095511|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25863911|NCT00095511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25863912|NCT00095524|Aripiprazole|aripiprazole|mesh-list
25863913|NCT00095524|Antidepressive Agents|antidepressive agents|mesh-ancestor
25863914|NCT00095524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25863915|NCT00095524|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25863916|NCT00095524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24952199|NCT03896321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
24806265|NCT02014636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813626|NCT02059694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24813627|NCT02059694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24813628|NCT02059694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24813629|NCT02059694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24813630|NCT02059694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24813631|NCT02059694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813632|NCT02059694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24813633|NCT02059694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24813634|NCT02059694|Adrenergic Agents|adrenergic agents|mesh-ancestor
25200979|NCT02730689|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25200980|NCT02730689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25200981|NCT02730689|Antimetabolites|antimetabolites|mesh-ancestor
25200982|NCT02730689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200983|NCT02730689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25200984|NCT02730689|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25200985|NCT02730689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25200986|NCT02730533|Esomeprazole|esomeprazole|mesh-list
25200987|NCT02730533|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25200988|NCT02730533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25200989|NCT02730533|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25200990|NCT02730533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25200991|NCT02730533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25200992|NCT02730676|Menthol|menthol|mesh-list
25200993|NCT02730676|Antipruritics|antipruritics|mesh-ancestor
25200994|NCT02730676|Dermatologic Agents|dermatologic agents|mesh-ancestor
24952200|NCT03896256|Ketamine|ketamine|mesh-list
24952201|NCT03896256|Analgesics|analgesics|mesh-ancestor
24952202|NCT03896256|Sensory System Agents|sensory system agents|mesh-ancestor
24952203|NCT03896256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24952204|NCT03896256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952205|NCT03896256|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24952206|NCT03896256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24952207|NCT03896256|Anesthetics, General|anesthetics, general|mesh-ancestor
24952208|NCT03896256|Anesthetics|anesthetics|mesh-ancestor
24952209|NCT03896256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24952210|NCT03896256|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24952211|NCT03896256|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24952212|NCT03896256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24952213|NCT03896256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952214|NCT03896113|Celecoxib|celecoxib|mesh-list
24863367|NCT05145543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24863368|NCT05145543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24863370|NCT05145543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25669274|NCT01729338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25669275|NCT01729338|Immunologic Factors|immunologic factors|mesh-ancestor
25669276|NCT01729338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669277|NCT01729338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25669278|NCT01729338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25669279|NCT01729338|Alkylating Agents|alkylating agents|mesh-ancestor
24952221|NCT03896113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24952222|NCT03896113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24952223|NCT03896113|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25052120|NCT00330369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543173|NCT00682214|Cholecalciferol|cholecalciferol|mesh-list
24543174|NCT00682214|Vitamins|vitamins|mesh-ancestor
24543175|NCT00682214|Micronutrients|micronutrients|mesh-ancestor
24543176|NCT00682214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863371|NCT05145543|Narcotics|narcotics|mesh-ancestor
24863372|NCT05145543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24863373|NCT05145543|Analgesics|analgesics|mesh-ancestor
24863374|NCT05145543|Sensory System Agents|sensory system agents|mesh-ancestor
24863375|NCT05145543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24863376|NCT05145543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24863429|NCT05079620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24863430|NCT05079620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863431|NCT05079620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863432|NCT05079620|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24863433|NCT05079620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24863434|NCT05079620|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24863436|NCT05043805|Antitussive Agents|antitussive agents|mesh-ancestor
24863437|NCT05043805|Respiratory System Agents|respiratory system agents|mesh-ancestor
24863438|NCT05043805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24863478|NCT04907032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052122|NCT00327743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25052124|NCT00327743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052125|NCT00327743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052126|NCT00326287|Ceftriaxone|ceftriaxone|mesh-list
25052127|NCT00326287|Linezolid|linezolid|mesh-list
25052128|NCT00326287|Ceftobiprole|ceftobiprole|mesh-list
25052129|NCT00326287|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
25052130|NCT00326287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25052131|NCT00326287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25052132|NCT00326287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25052133|NCT00326287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052134|NCT00326287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052135|NCT00325650|Rimonabant|rimonabant|mesh-list
24806328|NCT02015260|Citric Acid|citric acid|mesh-list
24863479|NCT04907032|Urological Agents|urological agents|mesh-ancestor
24863480|NCT04834362|Insulin|insulin|mesh-list
24863490|NCT04826354|Antimetabolites|antimetabolites|mesh-ancestor
24863491|NCT04826354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863492|NCT04826354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24685321|NCT05273775|Vitamin K|vitamin k|mesh-list
24863493|NCT04826354|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24863494|NCT04826354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813679|NCT02059876|Tubulin Modulators|tubulin modulators|mesh-ancestor
24863495|NCT04802356|Dexamethasone|dexamethasone|mesh-list
24863496|NCT04802356|Lenalidomide|lenalidomide|mesh-list
25052137|NCT00325650|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
25052138|NCT00325650|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25052147|NCT00325364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052149|NCT00324220|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25052150|NCT00324220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052154|NCT00323037|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25052155|NCT00323037|Adrenergic Agents|adrenergic agents|mesh-ancestor
25052156|NCT00323037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25052157|NCT00323037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052158|NCT00323037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052159|NCT00323037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25052160|NCT00323037|Antioxidants|antioxidants|mesh-ancestor
25052161|NCT00323037|Protective Agents|protective agents|mesh-ancestor
25052162|NCT00323037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25863917|NCT00095524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25863918|NCT00095524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863919|NCT00095524|Dopamine Agonists|dopamine agonists|mesh-ancestor
25863920|NCT00095524|Dopamine Agents|dopamine agents|mesh-ancestor
25863921|NCT00095524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25863922|NCT00095524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863502|NCT04802356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863503|NCT04802356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24863504|NCT04802356|Glucocorticoids|glucocorticoids|mesh-ancestor
24863505|NCT04802356|Hormones|hormones|mesh-ancestor
25052163|NCT00323037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25052164|NCT00323037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25052165|NCT00323037|Vasodilator Agents|vasodilator agents|mesh-ancestor
25052166|NCT00323037|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25052167|NCT00323037|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25052168|NCT00322257|Insulin|insulin|mesh-list
25052169|NCT00322257|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25052170|NCT00322257|Insulin Aspart|insulin aspart|mesh-list
25052171|NCT00322257|Insulin Detemir|insulin detemir|mesh-list
25052172|NCT00322257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25052173|NCT00322257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052174|NCT00321815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25052175|NCT00321815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052176|NCT00321815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25052177|NCT00321815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052178|NCT00321815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052179|NCT00321308|Pemetrexed|pemetrexed|mesh-list
25052180|NCT00321308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052181|NCT00321308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052182|NCT00321308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052183|NCT00321308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25052184|NCT00321308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25052185|NCT00320203|Hydrocortisone|hydrocortisone|mesh-list
25052186|NCT00320203|Anecortave|anecortave|mesh-list
25052212|NCT00317486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052213|NCT00317395|Heparin|heparin|mesh-list
25052214|NCT00317395|Calcium heparin|calcium heparin|mesh-list
25052215|NCT00317395|Otamixaban|otamixaban|mesh-list
25052216|NCT00317395|Eptifibatide|eptifibatide|mesh-list
25207710|NCT03479502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25207711|NCT03479502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25207712|NCT03479502|Antiemetics|antiemetics|mesh-ancestor
25207713|NCT03479502|Autonomic Agents|autonomic agents|mesh-ancestor
25052217|NCT00317395|Anticoagulants|anticoagulants|mesh-ancestor
25052218|NCT00317395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25052219|NCT00317395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25052220|NCT00317395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052221|NCT00317395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25052222|NCT00317395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25052223|NCT00317395|Antithrombins|antithrombins|mesh-ancestor
25052224|NCT00317395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25052225|NCT00317395|Protease Inhibitors|protease inhibitors|mesh-ancestor
25052226|NCT00317395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052227|NCT00315757|Bortezomib|bortezomib|mesh-list
25052228|NCT00315757|Mapatumumab|mapatumumab|mesh-list
25052229|NCT00315757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25052230|NCT00315757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052231|NCT00315757|Immunologic Factors|immunologic factors|mesh-ancestor
25052232|NCT00315757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052233|NCT00315640|Hydrocortisone|hydrocortisone|mesh-list
25052234|NCT00315640|Anecortave|anecortave|mesh-list
25052235|NCT00315640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25052236|NCT00315640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25052237|NCT00315640|Growth Substances|growth substances|mesh-ancestor
25052248|NCT00313768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25052249|NCT00313768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052250|NCT00313768|Tubulin Modulators|tubulin modulators|mesh-ancestor
25052251|NCT00313768|Antimitotic Agents|antimitotic agents|mesh-ancestor
25052252|NCT00313768|Mitosis Modulators|mitosis modulators|mesh-ancestor
25052253|NCT00313768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052254|NCT00313768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25052255|NCT00313768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25052256|NCT00313768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25052257|NCT00313768|Growth Substances|growth substances|mesh-ancestor
25052258|NCT00313768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052259|NCT00313768|Growth Inhibitors|growth inhibitors|mesh-ancestor
25052261|NCT00313248|Epothilones|epothilones|mesh-list
25052262|NCT00313248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052263|NCT00313248|Tubulin Modulators|tubulin modulators|mesh-ancestor
25052278|NCT00312091|Nevirapine|nevirapine|mesh-list
25052279|NCT00312091|Stavudine|stavudine|mesh-list
25052280|NCT00312091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25052281|NCT00312091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25052282|NCT00312091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052283|NCT00312091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052284|NCT00312091|Antiviral Agents|antiviral agents|mesh-ancestor
25052285|NCT00312091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25052286|NCT00312091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25052287|NCT00312091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25052288|NCT00312091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25052289|NCT00312091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25052290|NCT00312091|Antimetabolites|antimetabolites|mesh-ancestor
25052291|NCT00311090|Idraparinux|idraparinux|mesh-list
25052292|NCT00311090|Idrabiotaparinux|idrabiotaparinux|mesh-list
25052293|NCT00311090|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25052294|NCT00311090|Antithrombins|antithrombins|mesh-ancestor
25052295|NCT00311090|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25052296|NCT00311090|Protease Inhibitors|protease inhibitors|mesh-ancestor
25052297|NCT00311090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052298|NCT00311090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052299|NCT00311090|Anticoagulants|anticoagulants|mesh-ancestor
25052300|NCT00310830|Bosentan|bosentan|mesh-list
25052301|NCT00310830|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25052302|NCT00310830|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25052303|NCT00310830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052304|NCT00309179|Cetuximab|cetuximab|mesh-list
25052305|NCT00309179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25052306|NCT00309179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052307|NCT00307398|Hydrocortisone|hydrocortisone|mesh-list
25052308|NCT00307398|Anecortave|anecortave|mesh-list
25052309|NCT00307398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25052310|NCT00307398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25052311|NCT00307398|Growth Substances|growth substances|mesh-ancestor
24935370|NCT04051567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25052312|NCT00307398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052313|NCT00307398|Growth Inhibitors|growth inhibitors|mesh-ancestor
25052314|NCT00307398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24997942|NCT04099641|Pembrolizumab|pembrolizumab|mesh-list
25052315|NCT00307398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25052317|NCT00305656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052318|NCT00305656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052319|NCT00305656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052320|NCT00305656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25052321|NCT00305188|Leucovorin|leucovorin|mesh-list
25052322|NCT00305188|Fluorouracil|fluorouracil|mesh-list
25052323|NCT00305188|Oxaliplatin|oxaliplatin|mesh-list
25052337|NCT00305188|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25052338|NCT00305188|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25052339|NCT00305188|Serotonin Agents|serotonin agents|mesh-ancestor
25052340|NCT00305188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25052341|NCT00303498|Sitaxsentan|sitaxsentan|mesh-list
25052344|NCT00301262|Sildenafil Citrate|sildenafil citrate|mesh-list
25052345|NCT00301262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052346|NCT00301262|Vasodilator Agents|vasodilator agents|mesh-ancestor
25052347|NCT00301262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25052348|NCT00301262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25052349|NCT00301262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052350|NCT00301262|Urological Agents|urological agents|mesh-ancestor
25052351|NCT00299715|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25052352|NCT00299715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25052353|NCT00299715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25052354|NCT00299715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25223082|NCT02641899|Exenatide|exenatide|mesh-list
25052355|NCT00299715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052356|NCT00299715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25052357|NCT00299715|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25052358|NCT00299715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25052359|NCT00299715|Serotonin Agents|serotonin agents|mesh-ancestor
25052360|NCT00299715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25052361|NCT00299715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052362|NCT00299715|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25052363|NCT00299715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25052364|NCT00299715|Dopamine Agents|dopamine agents|mesh-ancestor
25052365|NCT00299507|Hydrocortisone|hydrocortisone|mesh-list
25052367|NCT00299507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25052368|NCT00299507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25052369|NCT00299507|Growth Substances|growth substances|mesh-ancestor
25052370|NCT00299507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052371|NCT00299507|Growth Inhibitors|growth inhibitors|mesh-ancestor
25052372|NCT00299507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052373|NCT00299507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25052374|NCT00299325|Rimonabant|rimonabant|mesh-list
25052375|NCT00299325|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25052376|NCT00299325|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
25052377|NCT00299325|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24806562|NCT02016443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24863506|NCT04802356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24863507|NCT04802356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24863508|NCT04802356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863509|NCT04802356|Immunologic Factors|immunologic factors|mesh-ancestor
25052378|NCT00299325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25052379|NCT00299325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052380|NCT00299325|Hormones|hormones|mesh-ancestor
25052381|NCT00299325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25052401|NCT00297089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052403|NCT00297089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25052404|NCT00292396|Antibodies|antibodies|mesh-list
25052405|NCT00292396|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25052406|NCT00292396|Immunologic Factors|immunologic factors|mesh-ancestor
25052407|NCT00292396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052408|NCT00289640|Ipilimumab|ipilimumab|mesh-list
25052409|NCT00289640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25052410|NCT00289640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052411|NCT00289640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24883562|NCT05238012|Antimetabolites|antimetabolites|mesh-ancestor
25052416|NCT00287547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052417|NCT00287547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25052418|NCT00287547|Immunologic Factors|immunologic factors|mesh-ancestor
25052419|NCT00287547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25207714|NCT03479502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25052420|NCT00287547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25052421|NCT00286806|Gossypol acetic acid|gossypol acetic acid|mesh-list
25052422|NCT00286806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25052423|NCT00286806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052424|NCT00286806|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25052425|NCT00286806|Contraceptive Agents|contraceptive agents|mesh-ancestor
25052426|NCT00286806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25052427|NCT00286806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052428|NCT00286806|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
25052430|NCT00286806|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25052431|NCT00286793|Gossypol acetic acid|gossypol acetic acid|mesh-list
25052432|NCT00286793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25052433|NCT00286793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863510|NCT04802356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24863511|NCT04802356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24863512|NCT04802356|Growth Substances|growth substances|mesh-ancestor
24863513|NCT04802356|Growth Inhibitors|growth inhibitors|mesh-ancestor
24863514|NCT04785261|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24586015|NCT00888810|Topotecan|topotecan|mesh-list
24813694|NCT02059915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24813696|NCT02059915|Analgesics|analgesics|mesh-ancestor
24543309|NCT00683124|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25669280|NCT01729338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042991|NCT01338883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25042992|NCT01338883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543310|NCT00683124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24543311|NCT00683124|Adrenergic Agents|adrenergic agents|mesh-ancestor
24543312|NCT00683124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24543313|NCT00683124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543314|NCT00683137|Valdecoxib|valdecoxib|mesh-list
25052434|NCT00286793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25052435|NCT00286793|Contraceptive Agents|contraceptive agents|mesh-ancestor
25052436|NCT00286793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25052437|NCT00286793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052438|NCT00286793|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
25052439|NCT00286793|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
25052440|NCT00286793|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25052441|NCT00284128|Losartan|losartan|mesh-list
25052442|NCT00284128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25052443|NCT00284128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25052444|NCT00284128|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25052445|NCT00284128|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25052446|NCT00284128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052447|NCT00282867|Insulin|insulin|mesh-list
25052448|NCT00282867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25052449|NCT00282867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052450|NCT00275431|Gossypol acetic acid|gossypol acetic acid|mesh-list
25052451|NCT00275431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25052452|NCT00275431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052453|NCT00275431|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25052454|NCT00275431|Contraceptive Agents|contraceptive agents|mesh-ancestor
25052455|NCT00275431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25052456|NCT00275431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052457|NCT00275431|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
25052458|NCT00275431|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
25052459|NCT00275431|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25052460|NCT00273650|Vitamin B 12|vitamin b 12|mesh-list
25052461|NCT00273650|Vitamins|vitamins|mesh-ancestor
25052462|NCT00273650|Micronutrients|micronutrients|mesh-ancestor
25052478|NCT00267280|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25052479|NCT00267280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052499|NCT00263042|Hormones|hormones|mesh-ancestor
25052500|NCT00263042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25052502|NCT00262990|Doxorubicin|doxorubicin|mesh-list
25052503|NCT00262990|Epothilone B|epothilone b|mesh-list
25052504|NCT00262990|Epothilones|epothilones|mesh-list
25052505|NCT00262990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25052506|NCT00262990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052507|NCT00262990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24780944|NCT01887340|Carboplatin|carboplatin|mesh-list
25052508|NCT00262990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25052509|NCT00262990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24806712|NCT02017704|Antimetabolites|antimetabolites|mesh-ancestor
25052514|NCT00260156|Vildagliptin|vildagliptin|mesh-list
25052515|NCT00260156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25052516|NCT00260156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052517|NCT00260156|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25052518|NCT00260156|Protease Inhibitors|protease inhibitors|mesh-ancestor
25052519|NCT00260156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052520|NCT00260156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052521|NCT00260078|Ritonavir|ritonavir|mesh-list
25052522|NCT00260078|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25052523|NCT00260078|Darunavir|darunavir|mesh-list
25052524|NCT00260078|Tenofovir|tenofovir|mesh-list
25052525|NCT00260078|Nevirapine|nevirapine|mesh-list
25052526|NCT00260078|Efavirenz|efavirenz|mesh-list
25052527|NCT00260078|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24863527|NCT04681482|Protease Inhibitors|protease inhibitors|mesh-ancestor
24863528|NCT04681482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24863529|NCT04681482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863530|NCT04681482|Anticoagulants|anticoagulants|mesh-ancestor
24863531|NCT04635943|Ivermectin|ivermectin|mesh-list
24863532|NCT04635943|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24863550|NCT04537910|Bamlanivimab|bamlanivimab|mesh-list
24543373|NCT00683319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24444132|NCT00296777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052531|NCT00260078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052532|NCT00260078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25669281|NCT01729338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669282|NCT01729338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25052535|NCT00260078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25052536|NCT00260078|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25052537|NCT00260078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25052538|NCT00260078|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25052539|NCT00260078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24806764|NCT02018094|Clindamycin|clindamycin|mesh-list
24806766|NCT02018094|Teicoplanin|teicoplanin|mesh-list
24863559|NCT04478695|Pembrolizumab|pembrolizumab|mesh-list
24863560|NCT04478695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24863561|NCT04478695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863562|NCT04425447|Anesthetics|anesthetics|mesh-list
25863923|NCT00095524|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24543406|NCT00683436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25863924|NCT00095524|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25863925|NCT00095524|Serotonin Agents|serotonin agents|mesh-ancestor
25052544|NCT00260078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25052545|NCT00257205|Temozolomide|temozolomide|mesh-list
25052546|NCT00257205|Dacarbazine|dacarbazine|mesh-list
25052547|NCT00257205|Tremelimumab|tremelimumab|mesh-list
25052548|NCT00257205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25052549|NCT00257205|Alkylating Agents|alkylating agents|mesh-ancestor
25052550|NCT00257205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052571|NCT00254891|Paclitaxel|paclitaxel|mesh-list
25052579|NCT00254891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052580|NCT00254579|Tremelimumab|tremelimumab|mesh-list
25052581|NCT00254579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052583|NCT00253968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25052584|NCT00253968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25052585|NCT00253968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052586|NCT00253968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25052587|NCT00253968|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25052588|NCT00253968|Serotonin Agents|serotonin agents|mesh-ancestor
25052589|NCT00253968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25052590|NCT00253968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052591|NCT00252005|Apixaban|apixaban|mesh-list
25052592|NCT00252005|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25052593|NCT00252005|Antithrombins|antithrombins|mesh-ancestor
25052594|NCT00252005|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25052595|NCT00252005|Protease Inhibitors|protease inhibitors|mesh-ancestor
25052596|NCT00252005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052597|NCT00252005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685489|NCT05271448|Losartan|losartan|mesh-list
24863596|NCT04223024|Nimotuzumab|nimotuzumab|mesh-list
24863613|NCT04194554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24489276|NCT00471991|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24863614|NCT04194554|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25052598|NCT00252005|Anticoagulants|anticoagulants|mesh-ancestor
25052599|NCT00250822|Gemcitabine|gemcitabine|mesh-list
25052600|NCT00250822|Oxaliplatin|oxaliplatin|mesh-list
25052601|NCT00250822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25052602|NCT00250822|Antimetabolites|antimetabolites|mesh-ancestor
25052603|NCT00250822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052605|NCT00250822|Antiviral Agents|antiviral agents|mesh-ancestor
25052615|NCT00243906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863633|NCT04137354|Trace Elements|trace elements|mesh-ancestor
24863634|NCT04137354|Antioxidants|antioxidants|mesh-ancestor
24863635|NCT04137354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863636|NCT04137354|Protective Agents|protective agents|mesh-ancestor
24863637|NCT04137354|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24863638|NCT04137354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543481|NCT00683956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543482|NCT00683956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24543483|NCT00683956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24543484|NCT00683956|Anesthetics, General|anesthetics, general|mesh-ancestor
25052617|NCT00243867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24760301|NCT01757236|Renal Agents|renal agents|mesh-ancestor
24760302|NCT01757236|Antimalarials|antimalarials|mesh-ancestor
24760303|NCT01757236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24760304|NCT01757236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24760305|NCT01757236|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25669283|NCT01729338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25669284|NCT01729338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24760307|NCT01757236|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24760308|NCT01757236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24760309|NCT01757249|Contraceptive Agents|contraceptive agents|mesh-list
24760310|NCT01757249|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
24760311|NCT01757249|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
24760312|NCT01757249|Contraceptives, Oral|contraceptives, oral|mesh-list
24760313|NCT01757249|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
24760314|NCT01757249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24760315|NCT01757249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760316|NCT01757249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24760317|NCT01757249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24760318|NCT01757249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24760319|NCT01757249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24760320|NCT01757249|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
24760321|NCT01757249|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24760322|NCT01757249|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24793805|NCT02205047|Pertuzumab|pertuzumab|mesh-list
24952224|NCT03896113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24952225|NCT03896113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952226|NCT03896113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952227|NCT03896074|Bevacizumab|bevacizumab|mesh-list
24952228|NCT03896074|Atezolizumab|atezolizumab|mesh-list
24968070|NCT03754842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24952279|NCT03895528|Lonafarnib|lonafarnib|mesh-list
25052618|NCT00243867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052619|NCT00243867|Tubulin Modulators|tubulin modulators|mesh-ancestor
25052620|NCT00243867|Antimitotic Agents|antimitotic agents|mesh-ancestor
25052621|NCT00243867|Mitosis Modulators|mitosis modulators|mesh-ancestor
25052622|NCT00243867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052623|NCT00239694|Vaccines|vaccines|mesh-list
25052624|NCT00239694|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25052625|NCT00239694|Immunologic Factors|immunologic factors|mesh-ancestor
25052626|NCT00239694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052627|NCT00232752|Sirolimus|sirolimus|mesh-list
25052652|NCT00231257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25052653|NCT00231257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25052654|NCT00231257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052655|NCT00231257|Antifungal Agents|antifungal agents|mesh-ancestor
25052656|NCT00231257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25052657|NCT00231257|Immunologic Factors|immunologic factors|mesh-ancestor
25052658|NCT00231257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052660|NCT00231153|Povidone|povidone|mesh-list
25052661|NCT00231153|Plasma Substitutes|plasma substitutes|mesh-ancestor
25052662|NCT00231153|Blood Substitutes|blood substitutes|mesh-ancestor
25052663|NCT00231153|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25052664|NCT00231153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25052665|NCT00229008|Linezolid|linezolid|mesh-list
25052666|NCT00229008|Ceftazidime|ceftazidime|mesh-list
25052667|NCT00229008|Ceftobiprole|ceftobiprole|mesh-list
25052668|NCT00229008|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
25052669|NCT00229008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25052670|NCT00229008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25052671|NCT00229008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25052672|NCT00229008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052673|NCT00229008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052674|NCT00228176|Rimonabant|rimonabant|mesh-list
25052675|NCT00228176|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25052676|NCT00228176|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
25052677|NCT00228176|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25052678|NCT00228176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25052679|NCT00228176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052680|NCT00228176|Hormones|hormones|mesh-ancestor
24806938|NCT02018874|Immunologic Factors|immunologic factors|mesh-ancestor
24806940|NCT02018965|Vitamins|vitamins|mesh-list
25052681|NCT00228176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25052682|NCT00228176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052683|NCT00224003|Ferric gluconate|ferric gluconate|mesh-list
25052684|NCT00224003|Hematinics|hematinics|mesh-ancestor
24543557|NCT00684216|Antimetabolites|antimetabolites|mesh-ancestor
25052715|NCT00210964|Ceftazidime|ceftazidime|mesh-list
25052716|NCT00210964|Ceftobiprole|ceftobiprole|mesh-list
25052717|NCT00210964|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
25052718|NCT00210964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24836365|NCT02185456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25863926|NCT00095524|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25052737|NCT00196339|Contraceptive Agents|contraceptive agents|mesh-ancestor
25052738|NCT00196339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25052740|NCT00179400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25052741|NCT00179400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052742|NCT00174837|Tirapazamine|tirapazamine|mesh-list
25052743|NCT00174837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813746|NCT02060149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24863771|NCT03439046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052756|NCT00162292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25052758|NCT00162292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25052759|NCT00162292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25052761|NCT00162279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25052762|NCT00162279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052763|NCT00162279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052764|NCT00162279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25052765|NCT00162279|Immunologic Factors|immunologic factors|mesh-ancestor
25052766|NCT00162279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052767|NCT00162279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25052769|NCT00157339|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25052770|NCT00157339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25052771|NCT00157339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052772|NCT00145431|Atorvastatin|atorvastatin|mesh-list
25052773|NCT00145431|Torcetrapib|torcetrapib|mesh-list
25052774|NCT00145431|Fenofibrate|fenofibrate|mesh-list
25052775|NCT00145431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25052776|NCT00145431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25052778|NCT00145431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609399|NCT00996424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609400|NCT00996424|Protective Agents|protective agents|mesh-ancestor
24813719|NCT02060006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813720|NCT02060019|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
24813721|NCT02060019|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24813722|NCT02060019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24813723|NCT02060019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24813724|NCT02060019|Antimetabolites|antimetabolites|mesh-ancestor
24813725|NCT02060019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813726|NCT02060019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24813727|NCT02060019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24813728|NCT02060019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543631|NCT00684827|Albuterol|albuterol|mesh-list
24813743|NCT02060149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24813744|NCT02060149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24813745|NCT02060149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25052786|NCT00141284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24863824|NCT03277261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24863825|NCT03277261|Immunologic Factors|immunologic factors|mesh-ancestor
24863827|NCT03277248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24863828|NCT03277248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24863829|NCT03277248|Analgesics|analgesics|mesh-ancestor
24863830|NCT03277248|Sensory System Agents|sensory system agents|mesh-ancestor
24863831|NCT03277248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24543731|NCT00685126|Adrenergic Agents|adrenergic agents|mesh-ancestor
24543734|NCT00685191|Raltegravir Potassium|raltegravir potassium|mesh-list
25207715|NCT03479502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25207716|NCT03479502|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25207717|NCT03479502|Protective Agents|protective agents|mesh-ancestor
24995807|NCT04639115|Ozanimod|ozanimod|mesh-list
25011590|NCT04647084|Anesthetics, Local|anesthetics, local|mesh-ancestor
24863889|NCT03084549|Sensory System Agents|sensory system agents|mesh-ancestor
24863890|NCT03084549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24863891|NCT03064763|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
24863892|NCT03064763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24863893|NCT03064763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201002|NCT02730624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201003|NCT02730481|Paclitaxel|paclitaxel|mesh-list
25669285|NCT01729338|Growth Substances|growth substances|mesh-ancestor
25669286|NCT01729338|Growth Inhibitors|growth inhibitors|mesh-ancestor
25669287|NCT01729494|Mycophenolic Acid|mycophenolic acid|mesh-list
25669288|NCT01729494|Prednisone|prednisone|mesh-list
25669289|NCT01729494|Alemtuzumab|alemtuzumab|mesh-list
25669290|NCT01729494|Abatacept|abatacept|mesh-list
25669291|NCT01729494|Tacrolimus|tacrolimus|mesh-list
25052801|NCT00138762|Antimetabolites|antimetabolites|mesh-ancestor
25052802|NCT00138762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052803|NCT00138762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25052804|NCT00138762|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24863925|NCT02922985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863926|NCT02922985|Sensory System Agents|sensory system agents|mesh-ancestor
24863927|NCT02922985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24863928|NCT02922985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25011658|NCT04489108|Coagulants|coagulants|mesh-ancestor
24863958|NCT02786537|Ritonavir|ritonavir|mesh-list
24863959|NCT02786537|Ribavirin|ribavirin|mesh-list
24863960|NCT02786537|Sofosbuvir|sofosbuvir|mesh-list
24863961|NCT02786537|Grazoprevir|grazoprevir|mesh-list
24863962|NCT02786537|Ledipasvir|ledipasvir|mesh-list
24864009|NCT02338609|Immunologic Factors|immunologic factors|mesh-ancestor
25057586|NCT03504033|Anesthetics|anesthetics|mesh-ancestor
25201004|NCT02730481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25201005|NCT02730481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201006|NCT02730481|Tubulin Modulators|tubulin modulators|mesh-ancestor
25201007|NCT02730481|Antimitotic Agents|antimitotic agents|mesh-ancestor
25201008|NCT02730481|Mitosis Modulators|mitosis modulators|mesh-ancestor
24813776|NCT02060305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24813777|NCT02060305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813778|NCT02060305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24813779|NCT02060305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24813780|NCT02060305|Growth Substances|growth substances|mesh-ancestor
24813781|NCT02060305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052811|NCT00135421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25052812|NCT00135421|Serotonin Agents|serotonin agents|mesh-ancestor
25052813|NCT00135421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052814|NCT00135421|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25052815|NCT00135421|Antidepressive Agents|antidepressive agents|mesh-ancestor
25052816|NCT00135421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25052817|NCT00135395|Ritonavir|ritonavir|mesh-list
25052818|NCT00135395|Lopinavir|lopinavir|mesh-list
25052819|NCT00135395|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24807107|NCT02019810|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24813782|NCT02060305|Growth Inhibitors|growth inhibitors|mesh-ancestor
24813783|NCT02060318|Infliximab|infliximab|mesh-list
24813784|NCT02060318|Dermatologic Agents|dermatologic agents|mesh-ancestor
24813785|NCT02060318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24573188|NCT00818298|Dopamine Agents|dopamine agents|mesh-ancestor
25052820|NCT00135395|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25052821|NCT00135395|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25052822|NCT00135395|Protease Inhibitors|protease inhibitors|mesh-ancestor
25052823|NCT00135395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813799|NCT02060396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24813800|NCT02060396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24813801|NCT02060396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813804|NCT02060552|Colchicine|colchicine|mesh-list
24813805|NCT02060552|Febuxostat|febuxostat|mesh-list
24813817|NCT02060591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24813818|NCT02060591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813819|NCT02060591|Sensory System Agents|sensory system agents|mesh-ancestor
24813820|NCT02060591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24968695|NCT03749226|Aztreonam|aztreonam|mesh-list
24476750|NCT00416390|Protective Agents|protective agents|mesh-ancestor
24476751|NCT00416390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813828|NCT02060604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813829|NCT02060604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24864030|NCT02182687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24864031|NCT02182687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24864032|NCT02182687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864033|NCT02182687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864034|NCT01976273|Glycolic acid|glycolic acid|mesh-list
24864035|NCT01976273|Keratolytic Agents|keratolytic agents|mesh-ancestor
24864036|NCT01976273|Dermatologic Agents|dermatologic agents|mesh-ancestor
24864037|NCT01802086|Lidocaine|lidocaine|mesh-list
24864038|NCT01802086|Prilocaine|prilocaine|mesh-list
24864039|NCT01802086|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24864040|NCT01802086|Anesthetics, Local|anesthetics, local|mesh-ancestor
24864041|NCT01802086|Anesthetics|anesthetics|mesh-ancestor
24864042|NCT01802086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24543970|NCT00686179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24602123|NCT00967252|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25669292|NCT01729494|Thymoglobulin|thymoglobulin|mesh-list
24409885|NCT00183820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602124|NCT00967252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24602125|NCT00967291|Ifosfamide|ifosfamide|mesh-list
24476794|NCT00416533|Prednisone|prednisone|mesh-list
25863927|NCT00095524|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25011890|NCT03166761|Antiemetics|antiemetics|mesh-ancestor
24544009|NCT00686439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24544010|NCT00686478|Interferons|interferons|mesh-list
24544011|NCT00686478|Interferon-alpha|interferon-alpha|mesh-list
24544012|NCT00686478|Interferon alpha-2|interferon alpha-2|mesh-list
24544013|NCT00686478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544014|NCT00686478|Antiviral Agents|antiviral agents|mesh-ancestor
25863928|NCT00095524|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24864089|NCT01373151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24864090|NCT01274611|Botulinum Toxins|botulinum toxins|mesh-list
24864091|NCT01274611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24864092|NCT01274611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24864093|NCT01274611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24864094|NCT01274611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24864095|NCT01274611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864099|NCT01274611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24625800|NCT01083589|Tubulin Modulators|tubulin modulators|mesh-ancestor
24544035|NCT00686556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24544036|NCT00686556|Dermatologic Agents|dermatologic agents|mesh-ancestor
25052857|NCT00135369|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25052858|NCT00135369|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25052859|NCT00135369|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25052860|NCT00135369|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24864118|NCT00910650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864119|NCT00910650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24864121|NCT00910650|Sensory System Agents|sensory system agents|mesh-ancestor
24864122|NCT00910650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24864123|NCT00910650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864124|NCT00910650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24864125|NCT00910650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24864126|NCT00910650|Antiviral Agents|antiviral agents|mesh-ancestor
24864127|NCT00910650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24864128|NCT00756288|Photosensitizing Agents|photosensitizing agents|mesh-list
24864136|NCT00703326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864139|NCT00602667|Carboplatin|carboplatin|mesh-list
25863929|NCT00095524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25863930|NCT00095641|Capecitabine|capecitabine|mesh-list
25863931|NCT00095641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24864140|NCT00602667|Methotrexate|methotrexate|mesh-list
24864159|NCT00602667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24544086|NCT00687011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24544087|NCT00687011|Serotonin Agents|serotonin agents|mesh-ancestor
24544088|NCT00687011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24544089|NCT00687011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863932|NCT00095641|Antimetabolites|antimetabolites|mesh-ancestor
25863933|NCT00095641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863934|NCT00095641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863935|NCT00095654|Rosiglitazone|rosiglitazone|mesh-list
24544099|NCT00687206|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24544100|NCT00687206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544101|NCT00687245|Esomeprazole|esomeprazole|mesh-list
25052861|NCT00135369|Antimetabolites|antimetabolites|mesh-ancestor
25052862|NCT00135343|Ritonavir|ritonavir|mesh-list
25052863|NCT00135343|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25052864|NCT00135343|Efavirenz|efavirenz|mesh-list
24864171|NCT00602667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24864172|NCT00602667|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24864174|NCT00472186|Dexlansoprazole|dexlansoprazole|mesh-list
24864175|NCT00472186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24864176|NCT00472186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24864177|NCT00472186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24864178|NCT00472186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864179|NCT00472186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012103|NCT02250326|Cc-486|cc-486|mesh-list
24544143|NCT00687466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24544144|NCT00687466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544146|NCT00687518|Hematinics|hematinics|mesh-ancestor
24544147|NCT00687622|Trametinib|trametinib|mesh-list
25669293|NCT01729494|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25669294|NCT01729494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25669295|NCT01729494|Glucocorticoids|glucocorticoids|mesh-ancestor
25669296|NCT01729494|Hormones|hormones|mesh-ancestor
25863937|NCT00095654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24544178|NCT00687648|Hormones|hormones|mesh-ancestor
24544179|NCT00687648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24544180|NCT00687648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25052882|NCT00135343|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24864270|NCT05089565|Immunoglobulin G|immunoglobulin g|mesh-list
24864271|NCT05089565|Immunologic Factors|immunologic factors|mesh-ancestor
24864272|NCT05089565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864273|NCT05089565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864274|NCT05089565|Antiviral Agents|antiviral agents|mesh-ancestor
24864275|NCT05089565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24864276|NCT05085327|Sunscreening Agents|sunscreening agents|mesh-list
24864277|NCT05085327|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24864278|NCT05085327|Protective Agents|protective agents|mesh-ancestor
24864279|NCT05085327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864280|NCT05085327|Dermatologic Agents|dermatologic agents|mesh-ancestor
24544214|NCT00687817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544215|NCT00687817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25863938|NCT00095654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201013|NCT02730572|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25201014|NCT02730572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25863939|NCT00095654|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25034725|NCT03562975|Immunologic Factors|immunologic factors|mesh-ancestor
25034726|NCT03562975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863940|NCT00095654|Protease Inhibitors|protease inhibitors|mesh-ancestor
24864316|NCT04948463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24864341|NCT04817956|Pertuzumab|pertuzumab|mesh-list
24864342|NCT04817956|Atezolizumab|atezolizumab|mesh-list
24864343|NCT04817956|Vemurafenib|vemurafenib|mesh-list
24864344|NCT04817956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24864345|NCT04817956|Entrectinib|entrectinib|mesh-list
24445170|NCT00300716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25012394|NCT05217069|Vitamins|vitamins|mesh-ancestor
25863941|NCT00095654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864352|NCT04817956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445171|NCT00300716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544266|NCT00688207|Rosiglitazone|rosiglitazone|mesh-list
25052919|NCT00127634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25052920|NCT00127634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052922|NCT00126984|Immunologic Factors|immunologic factors|mesh-ancestor
25052923|NCT00126984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864382|NCT04742140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24864384|NCT04742140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24864385|NCT04715230|Lorazepam|lorazepam|mesh-list
25012485|NCT05141305|Antipyretics|antipyretics|mesh-ancestor
24544334|NCT00688493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24544335|NCT00688493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24813913|NCT02060955|Growth Inhibitors|growth inhibitors|mesh-ancestor
24813914|NCT02060955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24813915|NCT02060955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24813916|NCT02060955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813917|NCT02060955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813918|NCT02061007|Misonidazole|misonidazole|mesh-list
24813919|NCT02061007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813920|NCT02061007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24813921|NCT02061007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24813922|NCT02061007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24813923|NCT02061124|Sevelamer|sevelamer|mesh-list
24883887|NCT04631536|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24813924|NCT02061124|Chelating Agents|chelating agents|mesh-ancestor
24544400|NCT00688896|Antimetabolites|antimetabolites|mesh-ancestor
24544401|NCT00688896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864464|NCT04062279|Immunologic Factors|immunologic factors|mesh-ancestor
24864465|NCT04062279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864469|NCT03964207|Tiotropium Bromide|tiotropium bromide|mesh-list
24864505|NCT03719924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864506|NCT03719924|Tubulin Modulators|tubulin modulators|mesh-ancestor
24864507|NCT03719924|Antimitotic Agents|antimitotic agents|mesh-ancestor
24445266|NCT00301054|Pyrimethamine|pyrimethamine|mesh-list
24864554|NCT03475953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864556|NCT03447574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24864557|NCT03447574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25431028|NCT01212822|Bevacizumab|bevacizumab|mesh-list
25091225|NCT03250052|Hormones|hormones|mesh-ancestor
24864558|NCT03447574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24864579|NCT03276468|Venetoclax|venetoclax|mesh-list
24864580|NCT03276468|Obinutuzumab|obinutuzumab|mesh-list
24864581|NCT03276468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864582|NCT03276468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24864583|NCT03260881|Liraglutide|liraglutide|mesh-list
24864584|NCT03260881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24864585|NCT03260881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864586|NCT03260881|Incretins|incretins|mesh-ancestor
24864587|NCT03260881|Hormones|hormones|mesh-ancestor
24625486|NCT01082276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24625487|NCT01082276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625488|NCT01082276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24625489|NCT01082276|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24952280|NCT03895528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544480|NCT00689169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24544481|NCT00689169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864612|NCT03212963|Hormones|hormones|mesh-ancestor
25863942|NCT00095654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863943|NCT00095654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24864613|NCT03212963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24864614|NCT03212963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864615|NCT03135262|Rituximab|rituximab|mesh-list
24864616|NCT03135262|Obinutuzumab|obinutuzumab|mesh-list
24864617|NCT03135262|Venetoclax|venetoclax|mesh-list
24864618|NCT03135262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24864619|NCT03135262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864620|NCT03135262|Immunologic Factors|immunologic factors|mesh-ancestor
24864621|NCT03135262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864622|NCT03135262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24864623|NCT03104075|Vaccines|vaccines|mesh-list
24864624|NCT03104075|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24864625|NCT03104075|Immunologic Factors|immunologic factors|mesh-ancestor
24864626|NCT03104075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864627|NCT03072628|Nicotine|nicotine|mesh-list
24864684|NCT02799641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24952281|NCT03895528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864685|NCT02799641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24864686|NCT02799641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24864687|NCT02799641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864688|NCT02799641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24864690|NCT02799641|Antiemetics|antiemetics|mesh-ancestor
24864691|NCT02799641|Autonomic Agents|autonomic agents|mesh-ancestor
24864692|NCT02799641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24864693|NCT02799641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24864694|NCT02799641|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24864695|NCT02799641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24864696|NCT02799641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25012731|NCT04531176|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25863944|NCT00095667|Lapatinib|lapatinib|mesh-list
25863945|NCT00095667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864727|NCT02741388|Dexamethasone|dexamethasone|mesh-list
24864728|NCT02741388|Rituximab|rituximab|mesh-list
24864729|NCT02741388|Oxaliplatin|oxaliplatin|mesh-list
24864730|NCT02741388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544606|NCT00689624|Antidotes|antidotes|mesh-ancestor
24952299|NCT03895229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952300|NCT03895229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24952301|NCT03895229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952302|NCT03895411|Sotalol|sotalol|mesh-list
25863946|NCT00095667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25863947|NCT00095667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863948|NCT00095667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863949|NCT00095680|Bortezomib|bortezomib|mesh-list
25863950|NCT00095680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863951|NCT00095693|Sorafenib|sorafenib|mesh-list
25863952|NCT00095693|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25863953|NCT00095693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863954|NCT00095693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25863955|NCT00095693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863956|NCT00095693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952308|NCT03895411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24952309|NCT03895411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952310|NCT03895411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952330|NCT03894839|Chlorhexidine|chlorhexidine|mesh-list
24952331|NCT03894839|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24428373|NCT00240318|Calcium|calcium|mesh-list
25863957|NCT00095693|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25863958|NCT00095706|Bevacizumab|bevacizumab|mesh-list
24445508|NCT00301730|Paclitaxel|paclitaxel|mesh-list
24864819|NCT00943618|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24864821|NCT00943618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24544735|NCT00689858|Protective Agents|protective agents|mesh-ancestor
25863959|NCT00095706|Trastuzumab|trastuzumab|mesh-list
25863960|NCT00095706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25863961|NCT00095706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25863962|NCT00095706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24813998|NCT02061800|Melphalan|melphalan|mesh-list
24813999|NCT02061800|Busulfan|busulfan|mesh-list
24814000|NCT02061800|Thiotepa|thiotepa|mesh-list
24814001|NCT02061800|Fludarabine|fludarabine|mesh-list
24814002|NCT02061800|Alemtuzumab|alemtuzumab|mesh-list
24814003|NCT02061800|Tacrolimus|tacrolimus|mesh-list
24814004|NCT02061800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24814005|NCT02061800|Immunologic Factors|immunologic factors|mesh-ancestor
24814006|NCT02061800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814007|NCT02061800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24814008|NCT02061800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25863963|NCT00095706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25863964|NCT00095706|Growth Substances|growth substances|mesh-ancestor
24864845|NCT05149339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864846|NCT05149339|Vitamins|vitamins|mesh-ancestor
24864847|NCT05149339|Micronutrients|micronutrients|mesh-ancestor
24864848|NCT05149339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24864849|NCT05149170|Antibodies|antibodies|mesh-list
24864850|NCT05149170|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24864851|NCT05149170|Immunologic Factors|immunologic factors|mesh-ancestor
24864852|NCT05149170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864853|NCT05149092|Caseins|caseins|mesh-list
24864854|NCT05149092|Chelating Agents|chelating agents|mesh-ancestor
24864855|NCT05149092|Sequestering Agents|sequestering agents|mesh-ancestor
24864856|NCT05149092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864858|NCT05148910|Trace Elements|trace elements|mesh-ancestor
24864859|NCT05148910|Micronutrients|micronutrients|mesh-ancestor
24864860|NCT05148910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864861|NCT05148884|Befiradol|befiradol|mesh-list
24864862|NCT05148884|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24864863|NCT05148884|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24864864|NCT05148884|Serotonin Agents|serotonin agents|mesh-ancestor
24864865|NCT05148884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24864866|NCT05148884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544736|NCT00689858|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25013091|NCT03740334|Hormones|hormones|mesh-ancestor
25053003|NCT00116415|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25053004|NCT00116415|Antimetabolites|antimetabolites|mesh-ancestor
25053007|NCT00116298|Stavudine|stavudine|mesh-list
25053008|NCT00116298|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25053009|NCT00116298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25053010|NCT00116298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053011|NCT00116298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807292|NCT02021097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24807293|NCT02021097|Contraceptive Agents|contraceptive agents|mesh-ancestor
25053012|NCT00116298|Antiviral Agents|antiviral agents|mesh-ancestor
25053013|NCT00116298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25053014|NCT00116298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25053015|NCT00116298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25053038|NCT00116116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25053039|NCT00116116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25053040|NCT00116116|Antimetabolites|antimetabolites|mesh-ancestor
25053041|NCT00115050|Darunavir|darunavir|mesh-list
25053042|NCT00115050|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25053043|NCT00115050|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25053044|NCT00115050|Protease Inhibitors|protease inhibitors|mesh-ancestor
24807327|NCT02021240|Dexamethasone|dexamethasone|mesh-list
25053046|NCT00115050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053047|NCT00115050|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24864898|NCT05148689|Protective Agents|protective agents|mesh-ancestor
24864899|NCT05148442|Azacitidine|azacitidine|mesh-list
24864900|NCT05148442|Decitabine|decitabine|mesh-list
24864901|NCT05148442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24864902|NCT05148442|Antimetabolites|antimetabolites|mesh-ancestor
24410262|NCT00184951|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24410263|NCT00184951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864903|NCT05148442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864904|NCT05148442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201019|NCT02730442|Fluconazole|fluconazole|mesh-list
25201020|NCT02730442|Antifungal Agents|antifungal agents|mesh-list
25201021|NCT02730442|Clotrimazole|clotrimazole|mesh-list
25201023|NCT02730442|Olorofim|olorofim|mesh-list
24864937|NCT05145218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864939|NCT05136040|Anesthetics, Local|anesthetics, local|mesh-ancestor
24864941|NCT05136040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24864942|NCT05136040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864943|NCT05136040|Sensory System Agents|sensory system agents|mesh-ancestor
24807354|NCT02021422|Oxaliplatin|oxaliplatin|mesh-list
24807355|NCT02021422|Irinotecan|irinotecan|mesh-list
24807357|NCT02021422|Antimetabolites|antimetabolites|mesh-ancestor
24864945|NCT05121298|Upadacitinib|upadacitinib|mesh-list
24864946|NCT05121298|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
24864947|NCT05121298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24864948|NCT05121298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864949|NCT05121298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864950|NCT05121298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24864951|NCT05103644|Atorvastatin|atorvastatin|mesh-list
24864952|NCT05103644|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24864953|NCT05103644|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24864954|NCT05103644|Antimetabolites|antimetabolites|mesh-ancestor
24864955|NCT05103644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864956|NCT05103644|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24864957|NCT05103644|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24864958|NCT05103644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864959|NCT05100264|Acetic Acid|acetic acid|mesh-list
24864960|NCT05100264|Retinol acetate|retinol acetate|mesh-list
24864961|NCT05100264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24864962|NCT05100264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24864963|NCT05100264|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24864964|NCT05100264|Immunologic Factors|immunologic factors|mesh-ancestor
24864965|NCT05100264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544823|NCT00690521|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24544824|NCT00690521|Metolazone|metolazone|mesh-list
24600305|NCT01095003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25013271|NCT03161678|Clopidogrel|clopidogrel|mesh-list
25053115|NCT00103831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053117|NCT00102466|Vildagliptin|vildagliptin|mesh-list
25053119|NCT00102466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25053120|NCT00102466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807443|NCT02022163|Antacids|antacids|mesh-ancestor
25863965|NCT00095706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053124|NCT00102466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053126|NCT00101595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053127|NCT00101595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25053128|NCT00101595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053129|NCT00101595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053130|NCT00100711|Motexafin gadolinium|motexafin gadolinium|mesh-list
25053131|NCT00100711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053132|NCT00100711|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25053133|NCT00100711|Dermatologic Agents|dermatologic agents|mesh-ancestor
25053134|NCT00099853|Pioglitazone|pioglitazone|mesh-list
25053135|NCT00099853|Vildagliptin|vildagliptin|mesh-list
24865024|NCT04931511|Betamethasone|betamethasone|mesh-list
25057884|NCT03500874|Floxuridine|floxuridine|mesh-list
24936323|NCT04041856|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24936324|NCT04041856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25053137|NCT00099853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865025|NCT04931511|Betamethasone Valerate|betamethasone valerate|mesh-list
25053151|NCT00097357|Antithrombins|antithrombins|mesh-ancestor
25053152|NCT00097357|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25053153|NCT00097357|Protease Inhibitors|protease inhibitors|mesh-ancestor
25053154|NCT00097357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053155|NCT00095550|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25053156|NCT00095550|Irbesartan|irbesartan|mesh-list
25053157|NCT00095550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25053158|NCT00095550|Diuretics|diuretics|mesh-ancestor
25053159|NCT00095550|Natriuretic Agents|natriuretic agents|mesh-ancestor
25669297|NCT01729494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25431109|NCT01196390|Mitosis Modulators|mitosis modulators|mesh-ancestor
25053160|NCT00095550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053161|NCT00095550|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25201024|NCT02730442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24865042|NCT04901754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24865043|NCT04901754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865044|NCT04883437|Obinutuzumab|obinutuzumab|mesh-list
24865045|NCT04883437|Acalabrutinib|acalabrutinib|mesh-list
25863966|NCT00095706|Growth Inhibitors|growth inhibitors|mesh-ancestor
24814010|NCT02061800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814011|NCT02061800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24814012|NCT02061800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24814013|NCT02061800|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24814015|NCT02061800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24814016|NCT02061800|Antiemetics|antiemetics|mesh-ancestor
24814017|NCT02061800|Autonomic Agents|autonomic agents|mesh-ancestor
24814018|NCT02061800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24814019|NCT02061800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24814020|NCT02061800|Glucocorticoids|glucocorticoids|mesh-ancestor
24883976|NCT03861039|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24814022|NCT02061800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24814028|NCT02061878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24814029|NCT02061917|Lobeline|lobeline|mesh-list
25053162|NCT00095550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25053163|NCT00095550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053164|NCT00095550|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25053165|NCT00095550|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25053166|NCT00095394|Irbesartan|irbesartan|mesh-list
25053167|NCT00095394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24814031|NCT02061917|Autonomic Agents|autonomic agents|mesh-ancestor
24814032|NCT02061917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24814033|NCT02061917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814034|NCT02061917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24814035|NCT02061917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24814036|NCT02061917|Cholinergic Agents|cholinergic agents|mesh-ancestor
24814037|NCT02061917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24814038|NCT02061917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814039|NCT02061917|Respiratory System Agents|respiratory system agents|mesh-ancestor
24814040|NCT02062034|Vitamins|vitamins|mesh-list
24814041|NCT02062034|Vitamin E|vitamin e|mesh-list
24814042|NCT02062034|Coenzyme Q10|coenzyme q10|mesh-list
24814043|NCT02062034|Ubiquinone|ubiquinone|mesh-list
24814044|NCT02062034|Antioxidants|antioxidants|mesh-list
24814050|NCT02062047|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24814051|NCT02062047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24814052|NCT02062047|Disinfectants|disinfectants|mesh-ancestor
24814053|NCT02062112|Laxatives|laxatives|mesh-list
24814054|NCT02062112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24814055|NCT02062190|Resveratrol|resveratrol|mesh-list
24814056|NCT02062190|Antioxidants|antioxidants|mesh-ancestor
24814057|NCT02062190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814058|NCT02062190|Protective Agents|protective agents|mesh-ancestor
24814059|NCT02062190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814060|NCT02062190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24865066|NCT04682288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24865067|NCT04682288|Renal Agents|renal agents|mesh-ancestor
24865068|NCT04682288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24865069|NCT04682288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24865070|NCT04682288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24865071|NCT04682288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053170|NCT00095394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053172|NCT00095290|Irbesartan|irbesartan|mesh-list
25053173|NCT00095290|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25053181|NCT00093132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053182|NCT00089141|Mycophenolic Acid|mycophenolic acid|mesh-list
25053183|NCT00089141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25053184|NCT00089141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865080|NCT04608409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865081|NCT04608409|Tubulin Modulators|tubulin modulators|mesh-ancestor
24865082|NCT04608409|Antimitotic Agents|antimitotic agents|mesh-ancestor
24865083|NCT04608409|Mitosis Modulators|mitosis modulators|mesh-ancestor
25863967|NCT00095719|Aripiprazole|aripiprazole|mesh-list
24865084|NCT04608409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865085|NCT04608409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24865086|NCT04608409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24865087|NCT04583787|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
25863968|NCT00095719|Antidepressive Agents|antidepressive agents|mesh-ancestor
24410547|NCT00185939|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24410548|NCT00185939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24410549|NCT00185939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25863969|NCT00095719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25091269|NCT03249402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25223364|NCT02640313|Choline|choline|mesh-list
24865088|NCT04583787|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24865089|NCT04583787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865090|NCT04580992|Ajmaline|ajmaline|mesh-list
24865091|NCT04580992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25053185|NCT00089141|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25053186|NCT00089141|Antitubercular Agents|antitubercular agents|mesh-ancestor
25053187|NCT00089141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25863970|NCT00095719|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24544977|NCT00691262|Tacrolimus|tacrolimus|mesh-list
24544978|NCT00691262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25201025|NCT02730442|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25201026|NCT02730442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25201027|NCT02730442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201028|NCT02730442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201029|NCT02730442|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25201030|NCT02730442|Hormone Antagonists|hormone antagonists|mesh-ancestor
25201031|NCT02730442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25201042|NCT02730364|Vitamins|vitamins|mesh-ancestor
25201043|NCT02730364|Micronutrients|micronutrients|mesh-ancestor
25863971|NCT00095719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24865095|NCT04580992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865096|NCT04536467|Goserelin|goserelin|mesh-list
24865097|NCT04536467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24865098|NCT04536467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865099|NCT04469634|Antibodies|antibodies|mesh-list
24865100|NCT04469634|Immunologic Factors|immunologic factors|mesh-ancestor
24865101|NCT04469634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865102|NCT04455178|Indapamide|indapamide|mesh-list
24865103|NCT04455178|Spironolactone|spironolactone|mesh-list
24865104|NCT04455178|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24865105|NCT04455178|Hormone Antagonists|hormone antagonists|mesh-ancestor
24865106|NCT04455178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25053200|NCT00086723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25053201|NCT00086671|Antibodies|antibodies|mesh-list
25053202|NCT00086671|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24865108|NCT04455178|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24865109|NCT04455178|Diuretics|diuretics|mesh-ancestor
24865110|NCT04455178|Natriuretic Agents|natriuretic agents|mesh-ancestor
24544996|NCT00691275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24865111|NCT04455178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24865112|NCT04455178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24865113|NCT04455178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24865114|NCT04455178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865115|NCT04400110|Amoxicillin|amoxicillin|mesh-list
24865116|NCT04400110|Clavulanic Acids|clavulanic acids|mesh-list
24865117|NCT04400110|Clavulanic Acid|clavulanic acid|mesh-list
24865118|NCT04400110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24865119|NCT04400110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24865120|NCT04400110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24865121|NCT04400110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865122|NCT04400110|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24865123|NCT04388501|Atorvastatin|atorvastatin|mesh-list
25201044|NCT02730364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865125|NCT04388501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24865126|NCT04388501|Antimetabolites|antimetabolites|mesh-ancestor
24545011|NCT00691379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24545012|NCT00691379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25053213|NCT00084253|Ritonavir|ritonavir|mesh-list
24865137|NCT04308837|Famotidine|famotidine|mesh-list
24865138|NCT04308837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25669298|NCT01729494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669299|NCT01729494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25669300|NCT01729494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669301|NCT01729494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25669302|NCT01729494|Immunologic Factors|immunologic factors|mesh-ancestor
25669303|NCT01729494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25669304|NCT01729494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24865139|NCT04308837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865140|NCT04308837|Tubulin Modulators|tubulin modulators|mesh-ancestor
24865141|NCT04308837|Antimitotic Agents|antimitotic agents|mesh-ancestor
24865142|NCT04308837|Mitosis Modulators|mitosis modulators|mesh-ancestor
24865143|NCT04308837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865144|NCT04308837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24865145|NCT04308837|Antiemetics|antiemetics|mesh-ancestor
25053227|NCT00084253|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25053228|NCT00084253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25053229|NCT00083941|Interleukin-2|interleukin-2|mesh-list
25053230|NCT00083941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053231|NCT00083941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25053232|NCT00083941|Analgesics|analgesics|mesh-ancestor
25053233|NCT00083941|Sensory System Agents|sensory system agents|mesh-ancestor
25053234|NCT00083941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25013724|NCT05223010|Anesthetics|anesthetics|mesh-ancestor
25863972|NCT00095719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24865150|NCT04308837|Glucocorticoids|glucocorticoids|mesh-ancestor
24865152|NCT04308837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24865153|NCT04308837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24865154|NCT04308837|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24865155|NCT04308837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24865156|NCT04308837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24865157|NCT04308837|Anesthetics, Local|anesthetics, local|mesh-ancestor
24865158|NCT04308837|Anesthetics|anesthetics|mesh-ancestor
25201045|NCT02730364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24865159|NCT04308837|Sensory System Agents|sensory system agents|mesh-ancestor
24865161|NCT04308837|Histamine Antagonists|histamine antagonists|mesh-ancestor
24865162|NCT04308837|Histamine Agents|histamine agents|mesh-ancestor
24865163|NCT04308837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24865164|NCT04308837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24545045|NCT00691613|Epoetin Alfa|epoetin alfa|mesh-list
24545046|NCT00691613|Hematinics|hematinics|mesh-ancestor
24545047|NCT00691795|Clonidine|clonidine|mesh-list
25863973|NCT00095719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053255|NCT00079482|Etoposide|etoposide|mesh-list
25053256|NCT00079482|Mitoxantrone|mitoxantrone|mesh-list
25053257|NCT00079482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25053258|NCT00079482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053259|NCT00079482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25053260|NCT00079482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25053261|NCT00079482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053262|NCT00079482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057972|NCT03500367|Sirolimus|sirolimus|mesh-list
25863974|NCT00095719|Dopamine Agonists|dopamine agonists|mesh-ancestor
24865166|NCT04308837|Dermatologic Agents|dermatologic agents|mesh-ancestor
24865167|NCT04308837|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25053263|NCT00079482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25053264|NCT00079482|Antimetabolites|antimetabolites|mesh-ancestor
25053265|NCT00079482|Antiviral Agents|antiviral agents|mesh-ancestor
25053266|NCT00079482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25053293|NCT00073866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25053294|NCT00071461|Bosentan|bosentan|mesh-list
25053295|NCT00071461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25053296|NCT00071461|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25053297|NCT00071461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053298|NCT00070590|Bosentan|bosentan|mesh-list
25053299|NCT00070590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25053300|NCT00070590|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25053301|NCT00070590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053302|NCT00069745|Prednisone|prednisone|mesh-list
25053303|NCT00069745|Satraplatin|satraplatin|mesh-list
25053304|NCT00069745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25053305|NCT00069745|Glucocorticoids|glucocorticoids|mesh-ancestor
25053306|NCT00069745|Hormones|hormones|mesh-ancestor
25863975|NCT00095719|Dopamine Agents|dopamine agents|mesh-ancestor
25201046|NCT02730364|Analgesics|analgesics|mesh-ancestor
25201047|NCT02730364|Sensory System Agents|sensory system agents|mesh-ancestor
25053350|NCT00058266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25053352|NCT00057993|Exemestane|exemestane|mesh-list
24936462|NCT04039854|Propofol|propofol|mesh-list
25053353|NCT00057993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25053354|NCT00057993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053355|NCT00057993|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25053356|NCT00057993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25053357|NCT00057993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25223430|NCT02639741|Micronutrients|micronutrients|mesh-ancestor
25223431|NCT02639741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223432|NCT02639741|Antioxidants|antioxidants|mesh-ancestor
25223433|NCT02639741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223434|NCT02639741|Protective Agents|protective agents|mesh-ancestor
25223435|NCT02639741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25223436|NCT02639624|Dialysis Solutions|dialysis solutions|mesh-list
25223437|NCT02639624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25223438|NCT02639533|Pregabalin|pregabalin|mesh-list
25223439|NCT02639533|Analgesics|analgesics|mesh-ancestor
24836522|NCT02186145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24836523|NCT02186145|Antiemetics|antiemetics|mesh-ancestor
24836524|NCT02186145|Autonomic Agents|autonomic agents|mesh-ancestor
25053358|NCT00057993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053359|NCT00057993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25053360|NCT00057993|Hormone Antagonists|hormone antagonists|mesh-ancestor
25053371|NCT00057980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25053372|NCT00057980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25053373|NCT00057980|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25053374|NCT00057980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25053375|NCT00057980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053376|NCT00057980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053377|NCT00057980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25053378|NCT00057980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053379|NCT00057980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25053380|NCT00057980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25053388|NCT00055575|Scopolamine|scopolamine|mesh-list
25053389|NCT00055575|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25053390|NCT00055575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25053391|NCT00055575|Antiemetics|antiemetics|mesh-ancestor
25053392|NCT00055575|Autonomic Agents|autonomic agents|mesh-ancestor
25053393|NCT00055575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25053394|NCT00055575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053395|NCT00055575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25053396|NCT00055575|Mydriatics|mydriatics|mesh-ancestor
25053397|NCT00055575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25053398|NCT00055575|Cholinergic Agents|cholinergic agents|mesh-ancestor
25053399|NCT00055575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25053400|NCT00055575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053401|NCT00055575|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25053402|NCT00055575|Parasympatholytics|parasympatholytics|mesh-ancestor
25053403|NCT00052598|Aldesleukin|aldesleukin|mesh-list
25053404|NCT00052598|Interleukin-2|interleukin-2|mesh-list
25053405|NCT00052598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053406|NCT00052598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25053407|NCT00052598|Analgesics|analgesics|mesh-ancestor
25013877|NCT05221411|Tacrolimus|tacrolimus|mesh-list
25053415|NCT00052520|Aldesleukin|aldesleukin|mesh-list
25053416|NCT00052520|Interleukin-2|interleukin-2|mesh-list
25053417|NCT00052520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053418|NCT00052520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25053419|NCT00052520|Analgesics|analgesics|mesh-ancestor
25053420|NCT00052520|Sensory System Agents|sensory system agents|mesh-ancestor
25053421|NCT00052520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25053426|NCT00052520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25053427|NCT00051129|Hydrocortisone|hydrocortisone|mesh-list
25669305|NCT01729494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669306|NCT01729494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25669307|NCT01729494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25669308|NCT01729494|Antitubercular Agents|antitubercular agents|mesh-ancestor
25669309|NCT01729494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25669310|NCT01729494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25669311|NCT01729494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25669312|NCT01729494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25669313|NCT01729494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25669314|NCT01729559|Heparin|heparin|mesh-list
25669315|NCT01729559|Enoxaparin|enoxaparin|mesh-list
25669316|NCT01729559|Calcium heparin|calcium heparin|mesh-list
25669317|NCT01729559|Enoxaparin sodium|enoxaparin sodium|mesh-list
25669318|NCT01729559|Anticoagulants|anticoagulants|mesh-ancestor
25669319|NCT01729559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25053428|NCT00051129|Anecortave|anecortave|mesh-list
25053429|NCT00051129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25053430|NCT00051129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25091309|NCT03249311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091311|NCT03249311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091312|NCT03249311|Analgesics|analgesics|mesh-ancestor
25091313|NCT03249311|Sensory System Agents|sensory system agents|mesh-ancestor
25091326|NCT03249285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25223440|NCT02639533|Sensory System Agents|sensory system agents|mesh-ancestor
25223441|NCT02639533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25053431|NCT00051129|Growth Substances|growth substances|mesh-ancestor
25053432|NCT00051129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053433|NCT00051129|Growth Inhibitors|growth inhibitors|mesh-ancestor
25053434|NCT00051129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053435|NCT00051129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25053436|NCT00051038|Entecavir|entecavir|mesh-list
25053437|NCT00051038|Antiviral Agents|antiviral agents|mesh-ancestor
24807694|NCT02023164|Anesthetics|anesthetics|mesh-ancestor
25053438|NCT00051038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25053440|NCT00050102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25053441|NCT00050102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053442|NCT00050102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25053443|NCT00050102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053444|NCT00049959|Verteporfin|verteporfin|mesh-list
24445924|NCT00303056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24445925|NCT00303056|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
24445926|NCT00303056|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
24445927|NCT00303056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445943|NCT00303264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445945|NCT00303277|Pravastatin|pravastatin|mesh-list
24445946|NCT00303277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24445947|NCT00303277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24445948|NCT00303277|Antimetabolites|antimetabolites|mesh-ancestor
24445949|NCT00303277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445950|NCT00303277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24445951|NCT00303277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24445952|NCT00303277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445953|NCT00303290|Interferons|interferons|mesh-list
24445954|NCT00303290|Cytarabine|cytarabine|mesh-list
25863976|NCT00095719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25863977|NCT00095719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25863978|NCT00095719|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24814064|NCT02062203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24814065|NCT02062203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24782005|NCT01893424|Piperine|piperine|mesh-list
24814066|NCT02062203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24814067|NCT02062203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25053447|NCT00036608|Entecavir|entecavir|mesh-list
25053448|NCT00036608|Antiviral Agents|antiviral agents|mesh-ancestor
25053449|NCT00036608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25053453|NCT00035633|Entecavir|entecavir|mesh-list
25053454|NCT00035633|Antiviral Agents|antiviral agents|mesh-ancestor
25053455|NCT00035633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25053456|NCT00035568|Metformin|metformin|mesh-list
25053457|NCT00035568|Glyburide|glyburide|mesh-list
25053458|NCT00035568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25053459|NCT00035568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053460|NCT00035542|Metformin|metformin|mesh-list
25053461|NCT00035542|Glyburide|glyburide|mesh-list
25053462|NCT00035542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25053463|NCT00035542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053464|NCT00035529|Abatacept|abatacept|mesh-list
25053465|NCT00035529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25053466|NCT00035529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807722|NCT02023424|(T,G)-A-L|(t,g)-a-l|mesh-list
24814068|NCT02062203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24814069|NCT02062203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445961|NCT00303290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25863979|NCT00095719|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25863980|NCT00095719|Serotonin Agents|serotonin agents|mesh-ancestor
25669320|NCT01729559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25669321|NCT01729559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669322|NCT01729598|Valproic Acid|valproic acid|mesh-list
25669323|NCT01729598|Anticonvulsants|anticonvulsants|mesh-ancestor
25669324|NCT01729598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25669325|NCT01729598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669326|NCT01729598|GABA Agents|gaba agents|mesh-ancestor
24814077|NCT02062255|Analgesics|analgesics|mesh-ancestor
25053474|NCT00031512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25053475|NCT00028639|Bortezomib|bortezomib|mesh-list
25053476|NCT00028639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053477|NCT00028301|Ritonavir|ritonavir|mesh-list
25053478|NCT00028301|Lopinavir|lopinavir|mesh-list
25053479|NCT00028301|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25053480|NCT00028301|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25053481|NCT00028301|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25053482|NCT00028301|Protease Inhibitors|protease inhibitors|mesh-ancestor
25053483|NCT00028301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053484|NCT00028301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053485|NCT00028301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24865195|NCT04254549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24865196|NCT04252287|Canagliflozin|canagliflozin|mesh-list
24865197|NCT04252287|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25201048|NCT02730364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24865199|NCT04252287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24865200|NCT04252287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865201|NCT04231318|Triamcinolone|triamcinolone|mesh-list
25053486|NCT00028301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25053487|NCT00028301|Antiviral Agents|antiviral agents|mesh-ancestor
25053488|NCT00028301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25053489|NCT00028301|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25053490|NCT00028301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25053491|NCT00028067|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25053493|NCT00028067|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24865202|NCT04231318|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24865203|NCT04231318|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24865204|NCT04231318|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24865205|NCT04231318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24865206|NCT04231318|Glucocorticoids|glucocorticoids|mesh-ancestor
24545119|NCT00692016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24865208|NCT04231318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24865209|NCT04231318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865210|NCT04231318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24865220|NCT04177654|Anthelmintics|anthelmintics|mesh-ancestor
24865221|NCT04177654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24865222|NCT04177654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24865223|NCT04177654|Anticestodal Agents|anticestodal agents|mesh-ancestor
24505142|NCT00540098|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24884059|NCT03433183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24884061|NCT03433183|Antifungal Agents|antifungal agents|mesh-ancestor
24505147|NCT00540137|Nevirapine|nevirapine|mesh-list
24865224|NCT04177654|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24865225|NCT04177654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25053494|NCT00028067|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25053495|NCT00028067|Protease Inhibitors|protease inhibitors|mesh-ancestor
25053496|NCT00028067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053497|NCT00028067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053498|NCT00028067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25053499|NCT00028067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24936617|NCT04038307|Antipyretics|antipyretics|mesh-ancestor
25053500|NCT00028067|Antiviral Agents|antiviral agents|mesh-ancestor
25053501|NCT00028067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25053502|NCT00013897|Lamivudine|lamivudine|mesh-list
25053503|NCT00013897|Zidovudine|zidovudine|mesh-list
25053504|NCT00013897|Efavirenz|efavirenz|mesh-list
24687294|NCT04074512|Copper|copper|mesh-list
24865235|NCT04111419|Amlodipine|amlodipine|mesh-list
24865236|NCT04111419|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
24865237|NCT04111419|Atorvastatin|atorvastatin|mesh-list
24865238|NCT04111419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24865239|NCT04111419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24865240|NCT04111419|Antimetabolites|antimetabolites|mesh-ancestor
24865241|NCT04111419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865242|NCT04111419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25201049|NCT02730364|Antipyretics|antipyretics|mesh-ancestor
24865250|NCT04111419|Vasodilator Agents|vasodilator agents|mesh-ancestor
24865251|NCT04071613|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24865252|NCT04071613|Plasminogen|plasminogen|mesh-list
24865253|NCT04071613|Tenecteplase|tenecteplase|mesh-list
24865254|NCT04071613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25863981|NCT00095719|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25863982|NCT00095719|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24865262|NCT04040231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24865263|NCT04040231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865264|NCT04040231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25223468|NCT02639598|Histamine Antagonists|histamine antagonists|mesh-ancestor
25223469|NCT02639598|Histamine Agents|histamine agents|mesh-ancestor
25223470|NCT02639598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25223471|NCT02639598|Vasodilator Agents|vasodilator agents|mesh-ancestor
25223472|NCT02639520|Fosfomycin|fosfomycin|mesh-list
25223473|NCT02639520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25223474|NCT02639520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25223475|NCT02639143|Clopidogrel|clopidogrel|mesh-list
25223476|NCT02639143|Ticagrelor|ticagrelor|mesh-list
25223477|NCT02639143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25275730|NCT02369822|Vitamins|vitamins|mesh-ancestor
24984483|NCT04503668|Autonomic Agents|autonomic agents|mesh-ancestor
24452448|NCT05458765|Tenofovir|tenofovir|mesh-list
24452449|NCT05458765|Emtricitabine|emtricitabine|mesh-list
24865265|NCT04040231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865266|NCT04040231|Immunologic Factors|immunologic factors|mesh-ancestor
24865267|NCT04040231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865268|NCT04026191|Hyaluronic Acid|hyaluronic acid|mesh-list
24865269|NCT04026191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24865270|NCT04026191|Immunologic Factors|immunologic factors|mesh-ancestor
24545173|NCT00692263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545175|NCT00692263|Serotonin Agents|serotonin agents|mesh-ancestor
25053540|NCT00005918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25053541|NCT00005918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25053542|NCT00005918|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25053543|NCT00005918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25053544|NCT00005918|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25053545|NCT00005918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25053546|NCT00005918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25053547|NCT00005918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25053548|NCT00005918|Antimetabolites|antimetabolites|mesh-ancestor
25053549|NCT00005795|Arsenic Trioxide|arsenic trioxide|mesh-list
25053550|NCT00005795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865295|NCT03962894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25201050|NCT02730364|Antioxidants|antioxidants|mesh-ancestor
25201051|NCT02730364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201052|NCT02730364|Protective Agents|protective agents|mesh-ancestor
24865299|NCT03916627|Cemiplimab|cemiplimab|mesh-list
24865300|NCT03916627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25053570|NCT00005608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053571|NCT00005608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053572|NCT00005595|Arsenic Trioxide|arsenic trioxide|mesh-list
25053573|NCT00005595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053574|NCT00004916|Paclitaxel|paclitaxel|mesh-list
25053575|NCT00004916|Ifosfamide|ifosfamide|mesh-list
25053576|NCT00004916|Teniposide|teniposide|mesh-list
25058043|NCT03499743|Analgesics|analgesics|mesh-ancestor
25053577|NCT00004916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25053578|NCT00004916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053579|NCT00004916|Tubulin Modulators|tubulin modulators|mesh-ancestor
25053580|NCT00004916|Antimitotic Agents|antimitotic agents|mesh-ancestor
25053581|NCT00004916|Mitosis Modulators|mitosis modulators|mesh-ancestor
25053582|NCT00004916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669327|NCT01729598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25669328|NCT01729598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669329|NCT01729598|Antimanic Agents|antimanic agents|mesh-ancestor
25669330|NCT01729598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25669331|NCT01729598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25669332|NCT01729598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25669333|NCT01729728|Tapentadol|tapentadol|mesh-list
25669334|NCT01729728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25669335|NCT01729728|Narcotics|narcotics|mesh-ancestor
25669336|NCT01729728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25669337|NCT01729728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669338|NCT01729728|Analgesics|analgesics|mesh-ancestor
25669339|NCT01729728|Sensory System Agents|sensory system agents|mesh-ancestor
25669340|NCT01729728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25669341|NCT01729728|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25669342|NCT01729728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25053583|NCT00004916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25053584|NCT00004916|Alkylating Agents|alkylating agents|mesh-ancestor
25053593|NCT00004915|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25053594|NCT00004915|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24865325|NCT03625466|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24865326|NCT03625466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24865327|NCT03625466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053604|NCT00004912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25053605|NCT00004912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053606|NCT00004912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24865332|NCT03529890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865342|NCT03417479|Analgesics|analgesics|mesh-ancestor
24865343|NCT03417479|Sensory System Agents|sensory system agents|mesh-ancestor
24865350|NCT03417479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24865351|NCT03417479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24865352|NCT03417479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24865353|NCT03417479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24865354|NCT03417479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865360|NCT03400306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865361|NCT03400306|Tubulin Modulators|tubulin modulators|mesh-ancestor
24865362|NCT03400306|Antimitotic Agents|antimitotic agents|mesh-ancestor
24865363|NCT03400306|Mitosis Modulators|mitosis modulators|mesh-ancestor
25053617|NCT00004908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25053618|NCT00004908|Alkylating Agents|alkylating agents|mesh-ancestor
25053619|NCT00004908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053620|NCT00004908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053621|NCT00004908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25053622|NCT00004907|Cyclophosphamide|cyclophosphamide|mesh-list
25053624|NCT00004907|Etoposide|etoposide|mesh-list
25053625|NCT00004907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25053626|NCT00004907|Immunologic Factors|immunologic factors|mesh-ancestor
25053627|NCT00004907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053628|NCT00004907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25053629|NCT00004907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25053630|NCT00004907|Alkylating Agents|alkylating agents|mesh-ancestor
25053631|NCT00004907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053632|NCT00004907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053633|NCT00004907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24865364|NCT03400306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865365|NCT03400306|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24865366|NCT03400306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24865367|NCT03317795|Tranexamic Acid|tranexamic acid|mesh-list
24865369|NCT03317795|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24865380|NCT03317795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24505223|NCT00540501|Zanamivir|zanamivir|mesh-list
25053635|NCT00004907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25053636|NCT00004907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25053637|NCT00004907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053638|NCT00004902|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
25053639|NCT00004902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053640|NCT00004902|Immunologic Factors|immunologic factors|mesh-ancestor
25053653|NCT00004899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25053654|NCT00004899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25053655|NCT00004899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25053656|NCT00004898|Cyclophosphamide|cyclophosphamide|mesh-list
25053657|NCT00004898|Etoposide|etoposide|mesh-list
25053658|NCT00004898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25053659|NCT00004898|Immunologic Factors|immunologic factors|mesh-ancestor
25053660|NCT00004898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865403|NCT03115294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24865404|NCT03115294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865405|NCT03115294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24865406|NCT03115294|Respiratory System Agents|respiratory system agents|mesh-ancestor
24865407|NCT03115294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24865408|NCT03115294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24971135|NCT03728192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053664|NCT00004898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053665|NCT00004898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053666|NCT00004898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25053667|NCT00004898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25053668|NCT00004898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25053669|NCT00004898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25053670|NCT00004898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25014524|NCT04390945|Antimetabolites|antimetabolites|mesh-ancestor
25863983|NCT00095719|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24545353|NCT00693121|Dopamine Agents|dopamine agents|mesh-ancestor
25863984|NCT00095719|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25014570|NCT04291521|Anesthetics|anesthetics|mesh-ancestor
25201054|NCT02730364|Mydriatics|mydriatics|mesh-ancestor
25201055|NCT02730364|Autonomic Agents|autonomic agents|mesh-ancestor
25053688|NCT00004897|Antidotes|antidotes|mesh-ancestor
25053689|NCT00004897|Protective Agents|protective agents|mesh-ancestor
25053690|NCT00004897|Vitamin B Complex|vitamin b complex|mesh-ancestor
25053691|NCT00004897|Vitamins|vitamins|mesh-ancestor
25053692|NCT00004897|Micronutrients|micronutrients|mesh-ancestor
25053693|NCT00004897|Antisickling Agents|antisickling agents|mesh-ancestor
25053694|NCT00004897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053695|NCT00004897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25053696|NCT00004896|Cyclophosphamide|cyclophosphamide|mesh-list
25053697|NCT00004896|Busulfan|busulfan|mesh-list
24807946|NCT02024555|Ofloxacin|ofloxacin|mesh-list
24445972|NCT00303381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24865456|NCT02863770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24865457|NCT02609503|Pembrolizumab|pembrolizumab|mesh-list
24865458|NCT02609503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24865459|NCT02609503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865460|NCT02587598|Cytarabine|cytarabine|mesh-list
24865461|NCT02587598|Azacitidine|azacitidine|mesh-list
24865462|NCT02587598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24865463|NCT02587598|Antimetabolites|antimetabolites|mesh-ancestor
24865464|NCT02587598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814094|NCT02062333|Dexmedetomidine|dexmedetomidine|mesh-list
24814095|NCT02062333|Esmolol|esmolol|mesh-list
24814096|NCT02062333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24814097|NCT02062333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24814098|NCT02062333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814099|NCT02062333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24814100|NCT02062333|Analgesics|analgesics|mesh-ancestor
24814101|NCT02062333|Sensory System Agents|sensory system agents|mesh-ancestor
24545356|NCT00693121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545357|NCT00693121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24545358|NCT00693121|Analgesics|analgesics|mesh-ancestor
24545359|NCT00693121|Sensory System Agents|sensory system agents|mesh-ancestor
24545360|NCT00693121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25053723|NCT00004584|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25053724|NCT00004584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25053726|NCT00004231|Interferons|interferons|mesh-list
24936922|NCT04034836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24545372|NCT00693199|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24814116|NCT02062749|Oxaliplatin|oxaliplatin|mesh-list
24814117|NCT02062749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609782|NCT00998075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24609783|NCT00998075|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24609784|NCT00998088|Epoetin Alfa|epoetin alfa|mesh-list
24609785|NCT00998088|Hematinics|hematinics|mesh-ancestor
24609786|NCT00998101|Carboplatin|carboplatin|mesh-list
24609787|NCT00998101|Cetuximab|cetuximab|mesh-list
24545373|NCT00693199|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25863985|NCT00095745|Aripiprazole|aripiprazole|mesh-list
25863986|NCT00095745|Antidepressive Agents|antidepressive agents|mesh-list
25863987|NCT00095745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24936931|NCT04035031|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24807980|NCT02024568|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24609788|NCT00998101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609789|NCT00998101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24609790|NCT00998166|Bevacizumab|bevacizumab|mesh-list
24609791|NCT00998166|Pemetrexed|pemetrexed|mesh-list
24609792|NCT00998166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24609793|NCT00998166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609794|NCT00998166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24609795|NCT00998166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24814119|NCT02062892|Everolimus|everolimus|mesh-list
24814120|NCT02062892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24814121|NCT02062892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24814131|NCT02062996|Phenylephrine|phenylephrine|mesh-list
24814132|NCT02062996|Oxymetazoline|oxymetazoline|mesh-list
24814133|NCT02062996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24814134|NCT02062996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24814135|NCT02062996|Adrenergic Agents|adrenergic agents|mesh-ancestor
24814136|NCT02062996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24814137|NCT02062996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984632|NCT04296942|Maytansine|maytansine|mesh-list
24984633|NCT04296942|Entinostat|entinostat|mesh-list
24814138|NCT02062996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814140|NCT02062996|Autonomic Agents|autonomic agents|mesh-ancestor
24814141|NCT02062996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24814142|NCT02062996|Nasal Decongestants|nasal decongestants|mesh-ancestor
24814143|NCT02062996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25201056|NCT02730364|Sympathomimetics|sympathomimetics|mesh-ancestor
24687481|NCT03967925|Hormones|hormones|mesh-ancestor
24865465|NCT02587598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865466|NCT02587598|Antiviral Agents|antiviral agents|mesh-ancestor
24865467|NCT02587598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24865468|NCT02587598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24952345|NCT03894722|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24952347|NCT03894748|Botulinum Toxins|botulinum toxins|mesh-list
24952348|NCT03894748|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24952349|NCT03894748|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24952350|NCT03894748|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24865482|NCT02091934|Adrenergic Agents|adrenergic agents|mesh-ancestor
24865483|NCT02091934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24865484|NCT02091934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545424|NCT00693381|Immunologic Factors|immunologic factors|mesh-ancestor
24952363|NCT03894800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952365|NCT03894800|Sensory System Agents|sensory system agents|mesh-ancestor
25863988|NCT00095745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24865511|NCT01291004|Estradiol|estradiol|mesh-list
24865512|NCT01291004|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24865513|NCT01291004|Estrogens|estrogens|mesh-ancestor
24865514|NCT01291004|Hormones|hormones|mesh-ancestor
24576902|NCT00840918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865528|NCT01170702|Ropivacaine|ropivacaine|mesh-list
25053754|NCT00004231|Hormones|hormones|mesh-ancestor
25053755|NCT00004231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25053760|NCT00004231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25053762|NCT00004231|Dermatologic Agents|dermatologic agents|mesh-ancestor
25053763|NCT00004231|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25053764|NCT00004231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25053765|NCT00004231|Antiviral Agents|antiviral agents|mesh-ancestor
24865550|NCT00805961|Alkylating Agents|alkylating agents|mesh-ancestor
25201057|NCT02730364|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25201058|NCT02730364|Nasal Decongestants|nasal decongestants|mesh-ancestor
24545487|NCT00693524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015013|NCT03495388|Analgesics|analgesics|mesh-ancestor
25201059|NCT02730364|Respiratory System Agents|respiratory system agents|mesh-ancestor
24446006|NCT00303550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24446007|NCT00303550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446009|NCT00303550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24446024|NCT00303615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24446025|NCT00303615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446026|NCT00303615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446027|NCT00303615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24865552|NCT00374660|Oxaliplatin|oxaliplatin|mesh-list
24865553|NCT00374660|Irofulven|irofulven|mesh-list
24865554|NCT00374660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865555|NCT00374660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24446040|NCT00303732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505586|NCT00541489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505644|NCT00541814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25863989|NCT00095745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24865566|NCT00109668|Glucocorticoids|glucocorticoids|mesh-ancestor
24865567|NCT00109668|Hormones|hormones|mesh-ancestor
24865569|NCT00109668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865570|NCT00109668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24865571|NCT00109668|Respiratory System Agents|respiratory system agents|mesh-ancestor
25201066|NCT02730364|Dermatologic Agents|dermatologic agents|mesh-ancestor
24865592|NCT05152355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24545568|NCT00693849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24545569|NCT00693849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24545570|NCT00693849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053795|NCT00004182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25053796|NCT00004182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24941783|NCT03988075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25053797|NCT00004182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053798|NCT00004182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669343|NCT01729728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24411251|NCT00188552|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25053799|NCT00004181|Cyclophosphamide|cyclophosphamide|mesh-list
25053801|NCT00004181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25053802|NCT00004181|Immunologic Factors|immunologic factors|mesh-ancestor
25053803|NCT00004181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053804|NCT00004181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25053805|NCT00004181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25053811|NCT00004175|Docetaxel|docetaxel|mesh-list
25053812|NCT00004175|Doxorubicin|doxorubicin|mesh-list
25053813|NCT00004175|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25015116|NCT03126968|Epinephrine|epinephrine|mesh-list
25053815|NCT00004175|Immunologic Factors|immunologic factors|mesh-ancestor
25053816|NCT00004175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053817|NCT00004175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25053818|NCT00004175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25053819|NCT00004175|Alkylating Agents|alkylating agents|mesh-ancestor
25053820|NCT00004175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015157|NCT03051282|Enalapril|enalapril|mesh-list
24446047|NCT00303745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015192|NCT02980666|Teduglutide|teduglutide|mesh-list
25053847|NCT00004171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053848|NCT00004171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25053849|NCT00004171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25053850|NCT00004171|Alkylating Agents|alkylating agents|mesh-ancestor
25053851|NCT00004171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053852|NCT00004171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053853|NCT00004171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25053854|NCT00004169|Cyclophosphamide|cyclophosphamide|mesh-list
25053855|NCT00004169|Carboplatin|carboplatin|mesh-list
25053856|NCT00004169|Etoposide|etoposide|mesh-list
25053857|NCT00004169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25053858|NCT00004169|Immunologic Factors|immunologic factors|mesh-ancestor
25053859|NCT00004169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053860|NCT00004169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25053861|NCT00004169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25053862|NCT00004169|Alkylating Agents|alkylating agents|mesh-ancestor
25053863|NCT00004169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053864|NCT00004169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622846|NCT01068847|Renal Agents|renal agents|mesh-ancestor
25053867|NCT00004169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25201060|NCT02730364|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25201061|NCT02730364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25201062|NCT02730364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25201063|NCT02730364|Adrenergic Agents|adrenergic agents|mesh-ancestor
25201064|NCT02730364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25201065|NCT02730364|Antipruritics|antipruritics|mesh-ancestor
25863990|NCT00095745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24865671|NCT05151042|Salicylic Acid|salicylic acid|mesh-list
24865672|NCT05151042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24865673|NCT05151042|Antifungal Agents|antifungal agents|mesh-ancestor
24865674|NCT05151042|Keratolytic Agents|keratolytic agents|mesh-ancestor
24865675|NCT05151042|Dermatologic Agents|dermatologic agents|mesh-ancestor
24865676|NCT05151016|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24865677|NCT05151016|Mifepristone|mifepristone|mesh-list
24865678|NCT05151016|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24865679|NCT05151016|Abortifacient Agents|abortifacient agents|mesh-ancestor
24865680|NCT05151016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24865681|NCT05151016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25863991|NCT00095745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053889|NCT00004096|Vinorelbine|vinorelbine|mesh-list
25053890|NCT00004096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053891|NCT00004096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25053892|NCT00004096|Tubulin Modulators|tubulin modulators|mesh-ancestor
25053893|NCT00004096|Antimitotic Agents|antimitotic agents|mesh-ancestor
25053894|NCT00004096|Mitosis Modulators|mitosis modulators|mesh-ancestor
25053895|NCT00004096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053896|NCT00004093|Gemcitabine|gemcitabine|mesh-list
25053898|NCT00004093|Vinorelbine|vinorelbine|mesh-list
25053899|NCT00004093|Carboplatin|carboplatin|mesh-list
25053900|NCT00004093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25053901|NCT00004093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053902|NCT00004093|Tubulin Modulators|tubulin modulators|mesh-ancestor
25053903|NCT00004093|Antimitotic Agents|antimitotic agents|mesh-ancestor
25053904|NCT00004093|Mitosis Modulators|mitosis modulators|mesh-ancestor
25431185|NCT01168219|Azacitidine|azacitidine|mesh-list
25053905|NCT00004093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053906|NCT00004093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25053907|NCT00004093|Antimetabolites|antimetabolites|mesh-ancestor
25053908|NCT00004093|Antiviral Agents|antiviral agents|mesh-ancestor
25053909|NCT00004093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24808163|NCT02025465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808164|NCT02025465|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24808165|NCT02025465|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24808166|NCT02025465|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24808167|NCT02025465|Adrenergic Agents|adrenergic agents|mesh-ancestor
24808168|NCT02025465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25201069|NCT02730364|Histamine Agents|histamine agents|mesh-ancestor
25048864|NCT00662506|Antiviral Agents|antiviral agents|mesh-ancestor
24808169|NCT02025465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625559|NCT01082458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24625560|NCT01082458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625561|NCT01082458|Sensory System Agents|sensory system agents|mesh-ancestor
24625562|NCT01082458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937067|NCT04033055|Ropivacaine|ropivacaine|mesh-list
24937133|NCT04032834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937134|NCT04032834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24937135|NCT04032834|Respiratory System Agents|respiratory system agents|mesh-ancestor
25863992|NCT00095745|Dopamine Agonists|dopamine agonists|mesh-ancestor
24884212|NCT02687386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884213|NCT02678143|Mycophenolic Acid|mycophenolic acid|mesh-list
25863993|NCT00095745|Dopamine Agents|dopamine agents|mesh-ancestor
24865698|NCT05150899|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24865699|NCT05150899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24865700|NCT05150899|Adrenergic Agents|adrenergic agents|mesh-ancestor
24865701|NCT05150899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24865702|NCT05150899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865703|NCT05150899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865704|NCT05150899|Urological Agents|urological agents|mesh-ancestor
24865705|NCT05150899|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24814144|NCT02062996|Respiratory System Agents|respiratory system agents|mesh-ancestor
24865706|NCT05150899|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24865707|NCT05150899|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24545638|NCT00694187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24446058|NCT00303758|Antimetabolites|antimetabolites|mesh-ancestor
24446059|NCT00303758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446060|NCT00303758|Antiviral Agents|antiviral agents|mesh-ancestor
24782410|NCT01895998|Albuterol|albuterol|mesh-list
24446061|NCT00303758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446062|NCT00303758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446063|NCT00303758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24446064|NCT00303758|Immunologic Factors|immunologic factors|mesh-ancestor
25201070|NCT02730364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25201071|NCT02730117|Cephalosporins|cephalosporins|mesh-list
25201072|NCT02730117|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25201073|NCT02730117|Dobutamine|dobutamine|mesh-list
25201074|NCT02730117|Dopamine|dopamine|mesh-list
24446071|NCT00303758|Micronutrients|micronutrients|mesh-ancestor
24446072|NCT00303771|Leucovorin|leucovorin|mesh-list
24545685|NCT00694408|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25863994|NCT00095745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25863995|NCT00095745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545701|NCT00694408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25863996|NCT00095745|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25053931|NCT00002429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25053932|NCT00002429|Antimetabolites|antimetabolites|mesh-ancestor
25053933|NCT00002429|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25053934|NCT00002429|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25053935|NCT00002429|Protease Inhibitors|protease inhibitors|mesh-ancestor
25053937|NCT00002411|Zidovudine|zidovudine|mesh-list
25053938|NCT00002411|Stavudine|stavudine|mesh-list
25053939|NCT00002411|Didanosine|didanosine|mesh-list
25053940|NCT00002411|Nelfinavir|nelfinavir|mesh-list
25053941|NCT00002411|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24937151|NCT04032236|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25053942|NCT00002411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25053943|NCT00002411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201095|NCT02730117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25053987|NCT00002240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053988|NCT00002240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25053989|NCT00002240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25863997|NCT00095745|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25863998|NCT00095745|Serotonin Agents|serotonin agents|mesh-ancestor
25863999|NCT00095745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25864000|NCT00095745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25864001|NCT00095745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25864002|NCT00095745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25864004|NCT00095758|Antidepressive Agents|antidepressive agents|mesh-list
25864005|NCT00095758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25091538|NCT03248700|Protective Agents|protective agents|mesh-ancestor
25091539|NCT03248700|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25053990|NCT00002240|Antiviral Agents|antiviral agents|mesh-ancestor
25053991|NCT00002240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25053992|NCT00002240|Antimetabolites|antimetabolites|mesh-ancestor
25053993|NCT00002240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25053994|NCT00002240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25053995|NCT00002224|Stavudine|stavudine|mesh-list
25053996|NCT00002224|Didanosine|didanosine|mesh-list
25053997|NCT00002224|Nelfinavir|nelfinavir|mesh-list
25053998|NCT00002224|Antimetabolites|antimetabolites|mesh-ancestor
25053999|NCT00002224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058164|NCT03498963|Dimercaprol|dimercaprol|mesh-list
25201078|NCT02730117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25201079|NCT02730117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25201080|NCT02730117|Adrenergic Agents|adrenergic agents|mesh-ancestor
25201081|NCT02730117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25201082|NCT02730117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054036|NCT03532464|Azithromycin|azithromycin|mesh-list
25054037|NCT03532464|Doxycycline|doxycycline|mesh-list
25054038|NCT03532464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25054039|NCT03532464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25054040|NCT03532464|Antimalarials|antimalarials|mesh-ancestor
25054041|NCT03532464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25054061|NCT03532178|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25054062|NCT03532178|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25054063|NCT03532178|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25201085|NCT02730117|Autonomic Agents|autonomic agents|mesh-ancestor
25201086|NCT02730117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25201087|NCT02730117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25201088|NCT02730117|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25201089|NCT02730117|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25201090|NCT02730117|Protective Agents|protective agents|mesh-ancestor
25201091|NCT02730117|Dopamine Agents|dopamine agents|mesh-ancestor
25201092|NCT02730117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25201093|NCT02730117|Vasodilator Agents|vasodilator agents|mesh-ancestor
25201094|NCT02730117|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25201096|NCT02730117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201097|NCT02730117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25201098|NCT02730091|Letrozole|letrozole|mesh-list
25201099|NCT02730091|Vinorelbine|vinorelbine|mesh-list
25201100|NCT02730091|Anastrozole|anastrozole|mesh-list
25201101|NCT02730091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201103|NCT02730091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25201104|NCT02730091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201105|NCT02730091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201106|NCT02730091|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25201107|NCT02730091|Hormone Antagonists|hormone antagonists|mesh-ancestor
25201108|NCT02730091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25201109|NCT02730091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201110|NCT02730091|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25201111|NCT02730091|Tubulin Modulators|tubulin modulators|mesh-ancestor
25201112|NCT02730091|Antimitotic Agents|antimitotic agents|mesh-ancestor
25201113|NCT02730091|Mitosis Modulators|mitosis modulators|mesh-ancestor
25201114|NCT02730091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25201116|NCT02730026|Omeprazole|omeprazole|mesh-list
25201117|NCT02730026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25669344|NCT01729728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669345|NCT01729728|Adrenergic Agents|adrenergic agents|mesh-ancestor
25669346|NCT01729728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25669347|NCT01729819|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25669348|NCT01729819|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25669349|NCT01729819|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25201118|NCT02730026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25201119|NCT02730026|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25201120|NCT02730026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201121|NCT02730026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201122|NCT02730026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25201123|NCT02730026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25201124|NCT02730026|Analgesics|analgesics|mesh-ancestor
25201125|NCT02730026|Sensory System Agents|sensory system agents|mesh-ancestor
25201126|NCT02730026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25201127|NCT02730026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201128|NCT02730026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25201129|NCT02730026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25201130|NCT02730026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25201131|NCT02729961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25201132|NCT02729961|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25201133|NCT02729961|Ceritinib|ceritinib|mesh-list
25201134|NCT02729961|Antibodies|antibodies|mesh-list
25201135|NCT02729961|Immunoglobulins|immunoglobulins|mesh-list
25201136|NCT02729961|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25201137|NCT02729961|Immunoconjugates|immunoconjugates|mesh-list
25201138|NCT02729961|Immunologic Factors|immunologic factors|mesh-ancestor
25201139|NCT02729961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201140|NCT02729961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201141|NCT02729961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25201142|NCT02729961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201143|NCT02729961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201144|NCT02729662|Tolvaptan|tolvaptan|mesh-list
25207719|NCT03479502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25864006|NCT00095758|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25864007|NCT00095758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25864008|NCT00095758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24859908|NCT02306473|Mannitol|mannitol|mesh-list
25054064|NCT03532178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25054081|NCT03531970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25054082|NCT03531970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054083|NCT03531970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25054085|NCT03531970|Hormones|hormones|mesh-ancestor
25054086|NCT03531970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25054087|NCT03531970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25054088|NCT03531970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25054089|NCT03531970|Protease Inhibitors|protease inhibitors|mesh-ancestor
24937229|NCT04031859|Antipyretics|antipyretics|mesh-ancestor
25157399|NCT04730258|Decitabine|decitabine|mesh-list
25054090|NCT03531970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25054091|NCT03531970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054092|NCT03531970|Anesthetics, Local|anesthetics, local|mesh-ancestor
25054093|NCT03531970|Anesthetics|anesthetics|mesh-ancestor
25054094|NCT03531970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25054095|NCT03531970|Sensory System Agents|sensory system agents|mesh-ancestor
25054096|NCT03531970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25054097|NCT03531970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25054098|NCT03531970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24808427|NCT02027220|Bortezomib|bortezomib|mesh-list
24808428|NCT02027220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24865909|NCT04556370|Autonomic Agents|autonomic agents|mesh-ancestor
24865910|NCT04556370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24865911|NCT04556370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24865912|NCT04526821|Lactoferrin|lactoferrin|mesh-list
25054136|NCT03531918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25054137|NCT03531918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25054138|NCT03531918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25054139|NCT03531918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25054140|NCT03531918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25054171|NCT03531437|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25054172|NCT03531437|Progestins|progestins|mesh-ancestor
25054173|NCT03531372|Antacids|antacids|mesh-list
25054174|NCT03531372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054175|NCT03531372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25054176|NCT03531359|Midazolam|midazolam|mesh-list
25054177|NCT03531359|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25054178|NCT03531359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25054179|NCT03531359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25054180|NCT03531359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201145|NCT02729662|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25201146|NCT02729662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201147|NCT02729662|Natriuretic Agents|natriuretic agents|mesh-ancestor
25864009|NCT00095758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864010|NCT00095758|Dopamine Agonists|dopamine agonists|mesh-ancestor
25669350|NCT01729819|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25669351|NCT01729819|Cholinergic Agents|cholinergic agents|mesh-ancestor
24859993|NCT02307149|Ipilimumab|ipilimumab|mesh-list
25054181|NCT03531359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25054182|NCT03531359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25054183|NCT03531359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24622863|NCT01068925|Dolutegravir|dolutegravir|mesh-list
24622864|NCT01068925|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24622865|NCT01068925|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24622866|NCT01068925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25016054|NCT00519857|Anabolic Agents|anabolic agents|mesh-ancestor
25864011|NCT00095758|Dopamine Agents|dopamine agents|mesh-ancestor
25864012|NCT00095758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25054223|NCT03531281|Mitosis Modulators|mitosis modulators|mesh-ancestor
25864013|NCT00095758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864014|NCT00095758|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25864015|NCT00095758|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25864016|NCT00095758|Serotonin Agents|serotonin agents|mesh-ancestor
25864017|NCT00095758|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25864018|NCT00095758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25864019|NCT00095758|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25054184|NCT03531359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25054185|NCT03531359|Anesthetics, General|anesthetics, general|mesh-ancestor
25054186|NCT03531359|Anesthetics|anesthetics|mesh-ancestor
25054187|NCT03531359|GABA Modulators|gaba modulators|mesh-ancestor
25054188|NCT03531359|GABA Agents|gaba agents|mesh-ancestor
25054189|NCT03531359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25054190|NCT03531359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054191|NCT03531294|Aflibercept|aflibercept|mesh-list
25054192|NCT03531294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25054193|NCT03531294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25054194|NCT03531294|Growth Substances|growth substances|mesh-ancestor
25054195|NCT03531294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054196|NCT03531294|Growth Inhibitors|growth inhibitors|mesh-ancestor
25054197|NCT03531294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25054198|NCT03531281|Sirolimus|sirolimus|mesh-list
25054199|NCT03531281|Cyclophosphamide|cyclophosphamide|mesh-list
25054200|NCT03531281|Etoposide|etoposide|mesh-list
25054201|NCT03531281|Etoposide phosphate|etoposide phosphate|mesh-list
25054202|NCT03531281|Podophyllotoxin|podophyllotoxin|mesh-list
25054203|NCT03531281|Tacrolimus|tacrolimus|mesh-list
25054204|NCT03531281|Mitogens|mitogens|mesh-list
25864020|NCT00095758|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25864021|NCT00095771|Arsenic Trioxide|arsenic trioxide|mesh-list
24814182|NCT02063100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24814183|NCT02063100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24814184|NCT02063100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24814185|NCT02063100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24814186|NCT02063100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814187|NCT02063139|Fluticasone|fluticasone|mesh-list
24814188|NCT02063139|Beclomethasone|beclomethasone|mesh-list
24814189|NCT02063139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24814190|NCT02063139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24814191|NCT02063139|Autonomic Agents|autonomic agents|mesh-ancestor
24814192|NCT02063139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25207720|NCT03479502|Antimalarials|antimalarials|mesh-ancestor
24545871|NCT00695604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25054209|NCT03531281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24446119|NCT00303810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24446121|NCT00303810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446122|NCT00303810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446128|NCT00303810|Antimetabolites|antimetabolites|mesh-ancestor
24446140|NCT00303836|Cyclophosphamide|cyclophosphamide|mesh-list
25864022|NCT00095771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864023|NCT00095810|Aripiprazole|aripiprazole|mesh-list
25864024|NCT00095810|Antidepressive Agents|antidepressive agents|mesh-ancestor
25669352|NCT01729819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25669353|NCT01729819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054217|NCT03531281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25669354|NCT01729819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669355|NCT01729819|Urological Agents|urological agents|mesh-ancestor
25669356|NCT01729819|Hemostatics|hemostatics|mesh-ancestor
25669357|NCT01729819|Coagulants|coagulants|mesh-ancestor
25669358|NCT01729819|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25669359|NCT01729819|Natriuretic Agents|natriuretic agents|mesh-ancestor
25054219|NCT03531281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25054220|NCT03531281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25054221|NCT03531281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25054222|NCT03531281|Antifungal Agents|antifungal agents|mesh-ancestor
25054224|NCT03531281|Keratolytic Agents|keratolytic agents|mesh-ancestor
25054225|NCT03531281|Dermatologic Agents|dermatologic agents|mesh-ancestor
24808503|NCT02027454|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24808506|NCT02027493|Ribavirin|ribavirin|mesh-list
24808507|NCT02027493|Interferon-alpha|interferon-alpha|mesh-list
24808508|NCT02027493|Interferon alpha-2|interferon alpha-2|mesh-list
24808509|NCT02027493|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25864025|NCT00095810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25864026|NCT00095810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25864027|NCT00095810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25864028|NCT00095810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24865920|NCT04365088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24865937|NCT04234529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24865939|NCT04217954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24865941|NCT04217954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24865942|NCT04217954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24865943|NCT04217954|Growth Substances|growth substances|mesh-ancestor
24865944|NCT04217954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865945|NCT04217954|Growth Inhibitors|growth inhibitors|mesh-ancestor
25864029|NCT00095810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864030|NCT00095810|Dopamine Agonists|dopamine agonists|mesh-ancestor
25864031|NCT00095810|Dopamine Agents|dopamine agents|mesh-ancestor
25864032|NCT00095810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25054226|NCT03531281|Tubulin Modulators|tubulin modulators|mesh-ancestor
25054227|NCT03531281|Antimitotic Agents|antimitotic agents|mesh-ancestor
24937368|NCT04029675|Ascorbic Acid|ascorbic acid|mesh-list
25054229|NCT03531047|Vitamin B Complex|vitamin b complex|mesh-ancestor
25054230|NCT03531047|Vitamins|vitamins|mesh-ancestor
24808513|NCT02027493|Antimetabolites|antimetabolites|mesh-ancestor
24808514|NCT02027493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808515|NCT02027493|Immunologic Factors|immunologic factors|mesh-ancestor
24808516|NCT02027493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808517|NCT02027532|Vancomycin|vancomycin|mesh-list
24808518|NCT02027532|Cefazolin|cefazolin|mesh-list
24506476|NCT00545493|Tacrolimus|tacrolimus|mesh-list
24808519|NCT02027532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24808520|NCT02027532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24808521|NCT02027675|Micronutrients|micronutrients|mesh-list
24808522|NCT02027675|Trace Elements|trace elements|mesh-list
24808523|NCT02027675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808524|NCT02027753|Metformin|metformin|mesh-list
24808525|NCT02027753|Insulin Glargine|insulin glargine|mesh-list
25016260|NCT00092885|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24865952|NCT04182100|Analgesics|analgesics|mesh-ancestor
25054239|NCT03530670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054240|NCT03530670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25054241|NCT03530670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25054242|NCT03530670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25054243|NCT03530670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25054244|NCT03530670|Anesthetics, General|anesthetics, general|mesh-ancestor
25054245|NCT03530670|Anesthetics|anesthetics|mesh-ancestor
25054246|NCT03530670|GABA Modulators|gaba modulators|mesh-ancestor
25054247|NCT03530670|GABA Agents|gaba agents|mesh-ancestor
25054248|NCT03530670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24808527|NCT02027753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24808528|NCT02027753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808529|NCT02027753|Protease Inhibitors|protease inhibitors|mesh-ancestor
24808530|NCT02027753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484670|NCT00449527|Formoterol Fumarate|formoterol fumarate|mesh-list
24865953|NCT04182100|Sensory System Agents|sensory system agents|mesh-ancestor
24865954|NCT04182100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24865955|NCT04182100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865956|NCT04182100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24865957|NCT04182100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24865958|NCT04182100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24865959|NCT04182100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24865960|NCT04182100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865961|NCT04182100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24865962|NCT04182100|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24865963|NCT04182100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24865964|NCT04182100|Antipyretics|antipyretics|mesh-ancestor
24865965|NCT04179019|Amlodipine|amlodipine|mesh-list
24865966|NCT04179019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24865967|NCT04179019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24865968|NCT04179019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24865969|NCT04179019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865970|NCT04179019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24865971|NCT04179019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865972|NCT04179019|Vasodilator Agents|vasodilator agents|mesh-ancestor
24924466|NCT04160026|Renal Agents|renal agents|mesh-ancestor
24865973|NCT04084717|Crizotinib|crizotinib|mesh-list
24865974|NCT04084717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865975|NCT04084717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24865976|NCT04084717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24865977|NCT04084717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865978|NCT04056182|Lofexidine|lofexidine|mesh-list
24865979|NCT04056182|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25058289|NCT03498118|Anesthetics|anesthetics|mesh-ancestor
25876564|NCT03278925|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24446160|NCT00303836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24446162|NCT00303836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24446163|NCT00303836|Antiviral Agents|antiviral agents|mesh-ancestor
24446164|NCT00303836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446165|NCT00303888|Docetaxel|docetaxel|mesh-list
24446166|NCT00303888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446167|NCT00303888|Tubulin Modulators|tubulin modulators|mesh-ancestor
24446168|NCT00303888|Antimitotic Agents|antimitotic agents|mesh-ancestor
24446169|NCT00303888|Mitosis Modulators|mitosis modulators|mesh-ancestor
25054257|NCT03530488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25054258|NCT03530488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25054259|NCT03530488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25054260|NCT03530488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25054261|NCT03530488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054262|NCT03530462|Methylprednisolone|methylprednisolone|mesh-list
25054263|NCT03530462|Cyclophosphamide|cyclophosphamide|mesh-list
25054264|NCT03530462|Rituximab|rituximab|mesh-list
25054265|NCT03530462|Immunoglobulins|immunoglobulins|mesh-list
25054266|NCT03530462|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25054267|NCT03530462|Antibodies|antibodies|mesh-list
25054268|NCT03530462|gamma-Globulins|gamma-globulins|mesh-list
25157421|NCT04721457|Disinfectants|disinfectants|mesh-ancestor
24808543|NCT02027792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808544|NCT02027870|Sirolimus|sirolimus|mesh-list
24808545|NCT02027870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24808546|NCT02027870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24808547|NCT02027870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24808548|NCT02027870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808549|NCT02027870|Antifungal Agents|antifungal agents|mesh-ancestor
24808550|NCT02027870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24808551|NCT02027870|Immunologic Factors|immunologic factors|mesh-ancestor
24808552|NCT02027870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808554|NCT02027922|Cariostatic Agents|cariostatic agents|mesh-ancestor
24866031|NCT03921424|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24866032|NCT03921424|Immunologic Factors|immunologic factors|mesh-ancestor
24866033|NCT03921424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054277|NCT03530462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25054278|NCT03530462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25054279|NCT03530462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25054280|NCT03530462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25054282|NCT03530462|Autonomic Agents|autonomic agents|mesh-ancestor
25054283|NCT03530462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25201148|NCT02729662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443335|NCT00294567|Amlodipine|amlodipine|mesh-list
25054284|NCT03530462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25054285|NCT03530462|Glucocorticoids|glucocorticoids|mesh-ancestor
25054286|NCT03530462|Hormones|hormones|mesh-ancestor
25054287|NCT03530462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25054288|NCT03530462|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25054289|NCT03530462|Protective Agents|protective agents|mesh-ancestor
25054290|NCT03530436|Curcumin|curcumin|mesh-list
25054291|NCT03530436|Turmeric extract|turmeric extract|mesh-list
25054292|NCT03530436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25054293|NCT03530436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25054294|NCT03530436|Analgesics|analgesics|mesh-ancestor
25054295|NCT03530436|Sensory System Agents|sensory system agents|mesh-ancestor
25054296|NCT03530436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24808559|NCT02027961|Dabrafenib|dabrafenib|mesh-list
24866038|NCT03817554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866039|NCT03817554|Protective Agents|protective agents|mesh-ancestor
24866040|NCT03817554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866041|NCT03817554|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24866042|NCT03817554|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24866043|NCT03817554|Dopamine Agents|dopamine agents|mesh-ancestor
24866044|NCT03817554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24866045|NCT03817554|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24546056|NCT00696566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24546058|NCT00696566|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24546059|NCT00696566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24808587|NCT02028026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24808591|NCT02028078|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24866085|NCT03598777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866086|NCT03598777|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24866087|NCT03598777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24546066|NCT00696579|Antimetabolites|antimetabolites|mesh-ancestor
24546067|NCT00696579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546068|NCT00696579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25054319|NCT03530319|Azithromycin|azithromycin|mesh-list
25054320|NCT03530319|Doxycycline|doxycycline|mesh-list
25054321|NCT03530319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25054322|NCT03530319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25054323|NCT03530319|Antimalarials|antimalarials|mesh-ancestor
25054324|NCT03530319|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24446174|NCT00303927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446175|NCT00303927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24546078|NCT00696592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24546079|NCT00696592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24546080|NCT00696592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25864033|NCT00095810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864034|NCT00095810|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24446182|NCT00303992|Trastuzumab|trastuzumab|mesh-list
24446183|NCT00303992|Irinotecan|irinotecan|mesh-list
24446184|NCT00303992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25054327|NCT03530280|Bupivacaine|bupivacaine|mesh-list
25054328|NCT03530280|Anesthetics, Local|anesthetics, local|mesh-ancestor
25054329|NCT03530280|Anesthetics|anesthetics|mesh-ancestor
25054330|NCT03530280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25054331|NCT03530280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054332|NCT03530280|Sensory System Agents|sensory system agents|mesh-ancestor
25054333|NCT03530280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25054334|NCT03530280|Analgesics|analgesics|mesh-ancestor
25054335|NCT03530280|Anticonvulsants|anticonvulsants|mesh-ancestor
25054336|NCT03530280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25054337|NCT03530280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25054338|NCT03530280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054339|NCT03530280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25054340|NCT03530280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24937539|NCT04027829|Dexmedetomidine|dexmedetomidine|mesh-list
25054341|NCT03530280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25054342|NCT03530280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25054343|NCT03530228|Esomeprazole|esomeprazole|mesh-list
25054344|NCT03530228|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25054345|NCT03530228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25054346|NCT03530228|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24446185|NCT00303992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446186|NCT00303992|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24446187|NCT00303992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24446188|NCT00303992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25016537|NCT05137548|Tenofovir|tenofovir|mesh-list
25864035|NCT00095810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24866101|NCT03593252|Chelating Agents|chelating agents|mesh-ancestor
24866102|NCT03593252|Sequestering Agents|sequestering agents|mesh-ancestor
24866103|NCT03593252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866104|NCT03593252|Cathartics|cathartics|mesh-ancestor
24866105|NCT03593252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24866106|NCT03593252|Antacids|antacids|mesh-ancestor
24866107|NCT03593252|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25054347|NCT03530228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25054348|NCT03530228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054349|NCT03530215|Antineoplastic Agents|antineoplastic agents|mesh-list
25054351|NCT03530176|Fluorides|fluorides|mesh-list
25054352|NCT03530176|Sodium Fluoride|sodium fluoride|mesh-list
25054353|NCT03530176|Cariostatic Agents|cariostatic agents|mesh-ancestor
25054354|NCT03530176|Protective Agents|protective agents|mesh-ancestor
25054355|NCT03530176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091664|NCT03247868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25091665|NCT03247868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091674|NCT03247595|Magnesium citrate|magnesium citrate|mesh-list
25091675|NCT03247595|Bisacodyl|bisacodyl|mesh-list
25091676|NCT03247595|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25091677|NCT03247595|Cathartics|cathartics|mesh-ancestor
25091678|NCT03247595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25091679|NCT03247595|Laxatives|laxatives|mesh-ancestor
25091680|NCT03247452|Ascorbic Acid|ascorbic acid|mesh-list
24768065|NCT01805570|Ticagrelor|ticagrelor|mesh-list
25091681|NCT03247452|Antioxidants|antioxidants|mesh-ancestor
25091682|NCT03247452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223725|NCT02637830|Protective Agents|protective agents|mesh-ancestor
25223726|NCT02637830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223727|NCT02637648|Sodium Oxybate|sodium oxybate|mesh-list
25223728|NCT02637648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25223731|NCT02637648|Anesthetics|anesthetics|mesh-ancestor
25054356|NCT03530176|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25054357|NCT03530176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25054358|NCT03530150|Pirfenidone|pirfenidone|mesh-list
25054359|NCT03530150|Analgesics|analgesics|mesh-ancestor
25054360|NCT03530150|Sensory System Agents|sensory system agents|mesh-ancestor
25054361|NCT03530150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25054362|NCT03530150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054363|NCT03530150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25054364|NCT03530150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25054365|NCT03530150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25054366|NCT03530150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25054367|NCT03530150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25054368|NCT03530085|Fludarabine|fludarabine|mesh-list
25054369|NCT03530085|Busulfan|busulfan|mesh-list
25054370|NCT03530085|Decitabine|decitabine|mesh-list
25054371|NCT03530085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808642|NCT02028507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808643|NCT02028507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808687|NCT02028689|Metformin|metformin|mesh-list
24866108|NCT03593252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866109|NCT03582488|Corticosterone|corticosterone|mesh-list
24866128|NCT03574792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25054372|NCT03530085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25054374|NCT03530085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054380|NCT03530085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25054381|NCT03530085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25054382|NCT03530033|Lidocaine|lidocaine|mesh-list
25054383|NCT03530033|Anesthetics, Local|anesthetics, local|mesh-ancestor
25054384|NCT03530033|Anesthetics|anesthetics|mesh-ancestor
25054385|NCT03530033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24546090|NCT00696644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866129|NCT03574792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866130|NCT03574792|Antimanic Agents|antimanic agents|mesh-ancestor
24866131|NCT03574792|Antitussive Agents|antitussive agents|mesh-ancestor
24866132|NCT03574792|Respiratory System Agents|respiratory system agents|mesh-ancestor
24866133|NCT03574792|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24866134|NCT03574792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24866135|NCT03574792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24866136|NCT03574792|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24866137|NCT03574792|Antidepressive Agents|antidepressive agents|mesh-ancestor
24866143|NCT03391479|Avelumab|avelumab|mesh-list
25431186|NCT01168219|Fludarabine|fludarabine|mesh-list
25669361|NCT01729845|Etoposide|etoposide|mesh-list
25669362|NCT01729845|Podophyllotoxin|podophyllotoxin|mesh-list
25669363|NCT01729845|Mitoxantrone|mitoxantrone|mesh-list
25669364|NCT01729845|Etoposide phosphate|etoposide phosphate|mesh-list
25669365|NCT01729845|Decitabine|decitabine|mesh-list
25669366|NCT01729845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25669367|NCT01729845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669368|NCT01729845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25669369|NCT01729845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25669370|NCT01729845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25669371|NCT01729845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669372|NCT01729845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25669373|NCT01729845|Antimetabolites|antimetabolites|mesh-ancestor
25669374|NCT01729845|Antiviral Agents|antiviral agents|mesh-ancestor
25669375|NCT01729845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25669376|NCT01729845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24866144|NCT03391479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24866145|NCT03391479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866146|NCT03368066|Cosyntropin|cosyntropin|mesh-list
24866147|NCT03368066|Hormones|hormones|mesh-ancestor
24866148|NCT03368066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24866149|NCT03368066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054390|NCT03530033|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25054391|NCT03530033|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25054392|NCT03530033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25054393|NCT03530033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054394|NCT03530020|Lithium Carbonate|lithium carbonate|mesh-list
25054395|NCT03530020|Antidepressive Agents|antidepressive agents|mesh-ancestor
25054396|NCT03530020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25054397|NCT03530020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058368|NCT03497702|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25054398|NCT03530020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054399|NCT03530020|Antimanic Agents|antimanic agents|mesh-ancestor
25054400|NCT03530020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25054401|NCT03530020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25054402|NCT03530020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054403|NCT03530007|Ondansetron|ondansetron|mesh-list
25054404|NCT03530007|Antiemetics|antiemetics|mesh-ancestor
25054405|NCT03530007|Autonomic Agents|autonomic agents|mesh-ancestor
25054406|NCT03530007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25054407|NCT03530007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054408|NCT03530007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25054409|NCT03530007|Antipruritics|antipruritics|mesh-ancestor
25054410|NCT03530007|Dermatologic Agents|dermatologic agents|mesh-ancestor
25054411|NCT03530007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25054412|NCT03530007|Serotonin Agents|serotonin agents|mesh-ancestor
25054413|NCT03530007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25054414|NCT03530007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054415|NCT03530007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25054416|NCT03530007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24866157|NCT03356483|Vasodilator Agents|vasodilator agents|mesh-ancestor
24866158|NCT03356483|Vitamin B Complex|vitamin b complex|mesh-ancestor
24866159|NCT03356483|Vitamins|vitamins|mesh-ancestor
24866160|NCT03356483|Micronutrients|micronutrients|mesh-ancestor
24866161|NCT03356483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866162|NCT03356483|Hallucinogens|hallucinogens|mesh-ancestor
24866163|NCT03356483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24866164|NCT03289650|Tacrolimus|tacrolimus|mesh-list
24866165|NCT03289650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24866166|NCT03289650|Immunologic Factors|immunologic factors|mesh-ancestor
25016667|NCT04822467|Ethanol|ethanol|mesh-list
24866173|NCT03219437|Methotrexate|methotrexate|mesh-list
24866174|NCT03219437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24814246|NCT02063425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814247|NCT02063425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24814248|NCT02063425|Serotonin Agents|serotonin agents|mesh-ancestor
24814249|NCT02063425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814250|NCT02063425|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24814251|NCT02063425|Antidepressive Agents|antidepressive agents|mesh-ancestor
24814252|NCT02063425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24814253|NCT02063425|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24814254|NCT02063425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24814255|NCT02063425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24814256|NCT02063529|Leucovorin|leucovorin|mesh-list
24814257|NCT02063529|Fluorouracil|fluorouracil|mesh-list
24814258|NCT02063529|Oxaliplatin|oxaliplatin|mesh-list
24814259|NCT02063529|Irinotecan|irinotecan|mesh-list
24814260|NCT02063529|Cetuximab|cetuximab|mesh-list
24814261|NCT02063529|Levoleucovorin|levoleucovorin|mesh-list
24814277|NCT02063529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24814278|NCT02063568|Oxytocin|oxytocin|mesh-list
24814279|NCT02063568|Oxytocics|oxytocics|mesh-ancestor
25864036|NCT00095810|Serotonin Agents|serotonin agents|mesh-ancestor
24446218|NCT00304135|Gemcitabine|gemcitabine|mesh-list
24446219|NCT00304135|Oxaliplatin|oxaliplatin|mesh-list
24446220|NCT00304135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669377|NCT01729845|Immunologic Factors|immunologic factors|mesh-ancestor
25054444|NCT03529929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054445|NCT03529929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25054446|NCT03529929|Glucocorticoids|glucocorticoids|mesh-ancestor
25054448|NCT03529929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25054449|NCT03529929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25054450|NCT03529929|Protective Agents|protective agents|mesh-ancestor
25054451|NCT03529929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25054452|NCT03529929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25054454|NCT03529643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25054455|NCT03529643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25054456|NCT03529643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054457|NCT03529643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25054458|NCT03529643|Analgesics|analgesics|mesh-ancestor
25054459|NCT03529643|Sensory System Agents|sensory system agents|mesh-ancestor
24814281|NCT02063568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814282|NCT02063620|Ketamine|ketamine|mesh-list
24814283|NCT02063620|Analgesics|analgesics|mesh-ancestor
24814284|NCT02063620|Sensory System Agents|sensory system agents|mesh-ancestor
25016741|NCT04544280|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24866221|NCT02830477|Factor VIII|factor viii|mesh-list
24546233|NCT00697151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25054462|NCT03529643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25054463|NCT03529643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25054464|NCT03529643|Adrenergic Agents|adrenergic agents|mesh-ancestor
25054465|NCT03529643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25054466|NCT03529643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866222|NCT02830477|Coagulants|coagulants|mesh-ancestor
24866223|NCT02703220|Acetazolamide|acetazolamide|mesh-list
24866224|NCT02703220|Finasteride|finasteride|mesh-list
24866225|NCT02703220|Anticonvulsants|anticonvulsants|mesh-ancestor
24866226|NCT02703220|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24866227|NCT02703220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866228|NCT02703220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866229|NCT02703220|Diuretics|diuretics|mesh-ancestor
24866230|NCT02703220|Natriuretic Agents|natriuretic agents|mesh-ancestor
24866231|NCT02703220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201150|NCT02729766|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24982788|NCT00398541|Losartan|losartan|mesh-list
24866232|NCT02703220|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24866244|NCT02499900|Glatiramer Acetate|glatiramer acetate|mesh-list
24866245|NCT02499900|(T,G)-A-L|(t,g)-a-l|mesh-list
24866246|NCT02499900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24937663|NCT04026451|Anesthetics|anesthetics|mesh-ancestor
24866247|NCT02499900|Immunologic Factors|immunologic factors|mesh-ancestor
24866248|NCT02499900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866249|NCT02499900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24866250|NCT02499900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24866251|NCT02286154|Hydroxyurea|hydroxyurea|mesh-list
24866252|NCT02286154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866253|NCT02286154|Antisickling Agents|antisickling agents|mesh-ancestor
24866254|NCT02286154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866255|NCT02286154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054490|NCT03529331|Acetaminophen|acetaminophen|mesh-list
25054491|NCT03529331|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25054493|NCT03529331|Oxycodone|oxycodone|mesh-list
25054494|NCT03529331|Hydrocodone|hydrocodone|mesh-list
25054495|NCT03529331|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25054496|NCT03529331|Narcotics|narcotics|mesh-ancestor
25054497|NCT03529331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25054498|NCT03529331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054499|NCT03529331|Analgesics|analgesics|mesh-ancestor
25054505|NCT03529331|Respiratory System Agents|respiratory system agents|mesh-ancestor
25054506|NCT03529331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25054507|NCT03529331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25054508|NCT03529331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25054509|NCT03529266|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25054510|NCT03529266|Hemostatics|hemostatics|mesh-ancestor
25054511|NCT03529266|Coagulants|coagulants|mesh-ancestor
25016871|NCT03918915|Autonomic Agents|autonomic agents|mesh-ancestor
24866292|NCT01109004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24866293|NCT01109004|Growth Substances|growth substances|mesh-ancestor
24866294|NCT01109004|Growth Inhibitors|growth inhibitors|mesh-ancestor
24866295|NCT01067521|Glatiramer Acetate|glatiramer acetate|mesh-list
24866296|NCT01067521|(T,G)-A-L|(t,g)-a-l|mesh-list
24866297|NCT01067521|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25054512|NCT03529253|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25054513|NCT03529253|Calcium|calcium|mesh-list
25054514|NCT03529253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25054515|NCT03529253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054516|NCT03529253|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25669378|NCT01729845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411797|NCT00190021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411798|NCT00190021|Nootropic Agents|nootropic agents|mesh-ancestor
25054517|NCT03529253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25054518|NCT03529253|Antimetabolites|antimetabolites|mesh-ancestor
25054519|NCT03529253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054520|NCT03529253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25054521|NCT03529253|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25054522|NCT03529253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25054523|NCT03529201|Fentanyl|fentanyl|mesh-list
25054524|NCT03529201|Oxycodone|oxycodone|mesh-list
25054525|NCT03529201|Sevoflurane|sevoflurane|mesh-list
25054526|NCT03529201|Rocuronium|rocuronium|mesh-list
25207723|NCT03462069|Empagliflozin|empagliflozin|mesh-list
25864037|NCT00095810|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25054527|NCT03529201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25054528|NCT03529201|Narcotics|narcotics|mesh-ancestor
25054529|NCT03529201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25054530|NCT03529201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054531|NCT03529201|Analgesics|analgesics|mesh-ancestor
24973535|NCT03708822|Docetaxel|docetaxel|mesh-list
24603971|NCT00976469|Vaccines|vaccines|mesh-list
24603972|NCT00976469|Immunologic Factors|immunologic factors|mesh-ancestor
24622896|NCT01069055|Antipyretics|antipyretics|mesh-ancestor
24866298|NCT01067521|Immunologic Factors|immunologic factors|mesh-ancestor
24546288|NCT00697502|Capecitabine|capecitabine|mesh-list
24866302|NCT00593905|Bosentan|bosentan|mesh-list
24866303|NCT00593905|Ambrisentan|ambrisentan|mesh-list
24866304|NCT00593905|Sitaxsentan|sitaxsentan|mesh-list
24866305|NCT00593905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24866306|NCT00593905|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25054541|NCT03529201|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25054542|NCT03529201|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25054544|NCT03529175|Paclitaxel|paclitaxel|mesh-list
25054545|NCT03529175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25054546|NCT03529175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25054547|NCT03529175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25054548|NCT03529175|Tubulin Modulators|tubulin modulators|mesh-ancestor
25054549|NCT03529175|Antimitotic Agents|antimitotic agents|mesh-ancestor
25054550|NCT03529175|Mitosis Modulators|mitosis modulators|mesh-ancestor
25054551|NCT03529175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054552|NCT03529175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25054553|NCT03529175|Antimetabolites|antimetabolites|mesh-ancestor
25054554|NCT03529175|Antiviral Agents|antiviral agents|mesh-ancestor
25054555|NCT03529175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25054556|NCT03529175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25054557|NCT03529175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25054558|NCT03529175|Immunologic Factors|immunologic factors|mesh-ancestor
25054559|NCT03529175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054560|NCT03529149|Diltiazem|diltiazem|mesh-list
24937810|NCT04025203|Ibuprofen|ibuprofen|mesh-list
25054561|NCT03529149|Urapidil|urapidil|mesh-list
25054562|NCT03529149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25054563|NCT03529149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24622930|NCT01069159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24622932|NCT01069159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866307|NCT00593905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866308|NCT00548912|Spironolactone|spironolactone|mesh-list
24866309|NCT00548912|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24866310|NCT00548912|Hormone Antagonists|hormone antagonists|mesh-ancestor
25054565|NCT03529149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054566|NCT03529149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25054587|NCT03529097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25054588|NCT03529097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25054589|NCT03529097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25054590|NCT03529097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25054591|NCT03529097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622946|NCT01069198|Anticestodal Agents|anticestodal agents|mesh-ancestor
24808831|NCT02029456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622947|NCT01069198|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24622948|NCT01069198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24622949|NCT01069198|Tubulin Modulators|tubulin modulators|mesh-ancestor
24622950|NCT01069198|Antimitotic Agents|antimitotic agents|mesh-ancestor
24866311|NCT00548912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25404126|NCT03682978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669379|NCT01729845|Analgesics|analgesics|mesh-ancestor
25223847|NCT02636803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25201151|NCT02729766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866312|NCT00548912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866314|NCT00548912|Diuretics|diuretics|mesh-ancestor
24866315|NCT00548912|Natriuretic Agents|natriuretic agents|mesh-ancestor
25054592|NCT03529097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054593|NCT03529097|Antipyretics|antipyretics|mesh-ancestor
25054594|NCT03529084|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25054595|NCT03529084|Gefitinib|gefitinib|mesh-list
25054596|NCT03529084|Nazartinib|nazartinib|mesh-list
25054597|NCT03529084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25054598|NCT03529084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25054599|NCT03529084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25054600|NCT03529084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054601|NCT03529032|Methadone|methadone|mesh-list
25054602|NCT03529032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25054603|NCT03529032|Narcotics|narcotics|mesh-ancestor
25054604|NCT03529032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25054605|NCT03529032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054606|NCT03529032|Analgesics|analgesics|mesh-ancestor
25054607|NCT03529032|Sensory System Agents|sensory system agents|mesh-ancestor
25054608|NCT03529032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25054623|NCT03528967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054624|NCT03528967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25054625|NCT03528967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25054627|NCT03528967|Antipyretics|antipyretics|mesh-ancestor
25054628|NCT03528967|Anticoagulants|anticoagulants|mesh-ancestor
25054629|NCT03528954|Propofol|propofol|mesh-list
25054630|NCT03528954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25054631|NCT03528954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24808883|NCT02029599|Analgesics|analgesics|mesh-ancestor
25864038|NCT00095810|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25864039|NCT00095810|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24446253|NCT00304226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446254|NCT00304226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25201152|NCT02729766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24446255|NCT00304226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446256|NCT00304226|Vasodilator Agents|vasodilator agents|mesh-ancestor
24446257|NCT00304226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24446258|NCT00304226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24446259|NCT00304239|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24446260|NCT00304239|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
24446261|NCT00304239|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24446262|NCT00304239|Dermatologic Agents|dermatologic agents|mesh-ancestor
25054632|NCT03528954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054633|NCT03528954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25054634|NCT03528954|Anesthetics, General|anesthetics, general|mesh-ancestor
25054635|NCT03528954|Anesthetics|anesthetics|mesh-ancestor
25054636|NCT03528915|Rifamycins|rifamycins|mesh-list
25054637|NCT03528915|Rifamycin SV|rifamycin sv|mesh-list
25054638|NCT03528915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25054639|NCT03528915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25054640|NCT03528915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25054641|NCT03528824|Diclofenac|diclofenac|mesh-list
25054642|NCT03528824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25054643|NCT03528824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25054644|NCT03528824|Analgesics|analgesics|mesh-ancestor
25054645|NCT03528824|Sensory System Agents|sensory system agents|mesh-ancestor
25054646|NCT03528824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25054647|NCT03528824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054648|NCT03528824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25054649|NCT03528824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25054650|NCT03528824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25054651|NCT03528824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25054652|NCT03528824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054653|NCT03528785|Leucovorin|leucovorin|mesh-list
25054654|NCT03528785|Oxaliplatin|oxaliplatin|mesh-list
25054655|NCT03528785|Irinotecan|irinotecan|mesh-list
25054656|NCT03528785|Levoleucovorin|levoleucovorin|mesh-list
25669380|NCT01729845|Sensory System Agents|sensory system agents|mesh-ancestor
25054662|NCT03528785|Antidotes|antidotes|mesh-ancestor
25054663|NCT03528785|Protective Agents|protective agents|mesh-ancestor
25054664|NCT03528785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669381|NCT01729845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25669382|NCT01729845|Keratolytic Agents|keratolytic agents|mesh-ancestor
25054665|NCT03528785|Vitamin B Complex|vitamin b complex|mesh-ancestor
25054666|NCT03528785|Vitamins|vitamins|mesh-ancestor
25054667|NCT03528785|Micronutrients|micronutrients|mesh-ancestor
25054668|NCT03528772|Minoxidil|minoxidil|mesh-list
25054669|NCT03528772|Nitroglycerin|nitroglycerin|mesh-list
25054670|NCT03528772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25054671|NCT03528772|Vasodilator Agents|vasodilator agents|mesh-ancestor
25054672|NCT03528616|Propranolol|propranolol|mesh-list
25054673|NCT03528616|Digoxin|digoxin|mesh-list
25054674|NCT03528616|Adenosine|adenosine|mesh-list
25054675|NCT03528616|Amiodarone|amiodarone|mesh-list
25054676|NCT03528616|Flecainide|flecainide|mesh-list
25054677|NCT03528616|Procainamide|procainamide|mesh-list
25054678|NCT03528616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25054679|NCT03528616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25054688|NCT03528616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25054689|NCT03528616|Protective Agents|protective agents|mesh-ancestor
25054690|NCT03528616|Analgesics|analgesics|mesh-ancestor
25054691|NCT03528616|Sensory System Agents|sensory system agents|mesh-ancestor
25054692|NCT03528616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25054693|NCT03528616|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25054694|NCT03528616|Purinergic Agonists|purinergic agonists|mesh-ancestor
25054695|NCT03528616|Purinergic Agents|purinergic agents|mesh-ancestor
25054696|NCT03528616|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25054701|NCT03528616|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25054702|NCT03528616|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25054703|NCT03528616|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25054704|NCT03528616|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25054705|NCT03528564|Epoetin Alfa|epoetin alfa|mesh-list
25054706|NCT03528564|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25054707|NCT03528564|Hematinics|hematinics|mesh-ancestor
25054708|NCT03528538|Fenugreek seed meal|fenugreek seed meal|mesh-list
25054709|NCT03528538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25054718|NCT03528421|Alkylating Agents|alkylating agents|mesh-ancestor
24808965|NCT02030054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808966|NCT02030054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24808967|NCT02030054|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24808968|NCT02030054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25054719|NCT03528421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054720|NCT03528421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25054721|NCT03528421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25054722|NCT03528070|Tranilast|tranilast|mesh-list
25054723|NCT03528070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25054724|NCT03528070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25054725|NCT03528070|Analgesics|analgesics|mesh-ancestor
25054726|NCT03528070|Sensory System Agents|sensory system agents|mesh-ancestor
25054727|NCT03528070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24808985|NCT02030483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24808986|NCT02030483|Glucocorticoids|glucocorticoids|mesh-ancestor
24808987|NCT02030483|Hormones|hormones|mesh-ancestor
24446284|NCT00304317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24866346|NCT05153486|Ethanol|ethanol|mesh-list
24688451|NCT03061643|Docetaxel|docetaxel|mesh-list
24866347|NCT05153486|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24866348|NCT05153486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24866349|NCT05153486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24866350|NCT05153486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866351|NCT05153304|Nivolumab|nivolumab|mesh-list
24446288|NCT00304317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864040|NCT00095810|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25864041|NCT00095823|Aripiprazole|aripiprazole|mesh-list
25864042|NCT00095823|Antidepressive Agents|antidepressive agents|mesh-list
25864043|NCT00095823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25864044|NCT00095823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24866852|NCT04468087|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25054728|NCT03528070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054729|NCT03528070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25054731|NCT03528070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25054732|NCT03528070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25054733|NCT03528070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054734|NCT03528070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25054735|NCT03528070|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25054736|NCT03528070|Histamine Antagonists|histamine antagonists|mesh-ancestor
25054737|NCT03528070|Histamine Agents|histamine agents|mesh-ancestor
24866373|NCT05153070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24866374|NCT05153070|Dermatologic Agents|dermatologic agents|mesh-ancestor
25864045|NCT00095823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25864046|NCT00095823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25864047|NCT00095823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864048|NCT00095823|Dopamine Agonists|dopamine agonists|mesh-ancestor
25864049|NCT00095823|Dopamine Agents|dopamine agents|mesh-ancestor
25864050|NCT00095823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25876565|NCT03278925|Antioxidants|antioxidants|mesh-ancestor
25054738|NCT03528070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25054739|NCT03528070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25054740|NCT03528070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25054741|NCT03528057|Hemostatics|hemostatics|mesh-list
25054742|NCT03528057|Coagulants|coagulants|mesh-ancestor
24809002|NCT02030639|ON 01910|on 01910|mesh-list
24809003|NCT02030639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809004|NCT02030639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24866389|NCT05152901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866391|NCT05152901|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24866392|NCT05152901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24866393|NCT05152901|Autonomic Agents|autonomic agents|mesh-ancestor
24866394|NCT05152901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24866395|NCT05152901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24866396|NCT05152901|Respiratory System Agents|respiratory system agents|mesh-ancestor
24866397|NCT05152901|Mydriatics|mydriatics|mesh-ancestor
24814327|NCT02064010|Calcium|calcium|mesh-list
24814328|NCT02064010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24814329|NCT02064010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814330|NCT02064010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24814331|NCT02064010|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24814332|NCT02064023|Insulin|insulin|mesh-list
24814333|NCT02064023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24814334|NCT02064023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24866456|NCT04947631|Tadalafil|tadalafil|mesh-list
24866457|NCT04947631|Dutasteride|dutasteride|mesh-list
24866458|NCT04947631|Vasodilator Agents|vasodilator agents|mesh-ancestor
24866459|NCT04947631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24866460|NCT04947631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24866461|NCT04947631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866462|NCT04947631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866463|NCT04947631|Urological Agents|urological agents|mesh-ancestor
24866464|NCT04947631|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24866465|NCT04947631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24866467|NCT04947631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25054752|NCT03527836|Anesthetics|anesthetics|mesh-ancestor
25054753|NCT03527836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25054754|NCT03527836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486582|NCT00458510|Analgesics|analgesics|mesh-ancestor
24587948|NCT00898950|Antipyretics|antipyretics|mesh-ancestor
24866489|NCT04778267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24866490|NCT04778267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866491|NCT04778267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24866492|NCT04778267|Glucocorticoids|glucocorticoids|mesh-ancestor
24866513|NCT04702256|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24866514|NCT04702256|Prednisolone|prednisolone|mesh-list
24866515|NCT04702256|Prednisolone acetate|prednisolone acetate|mesh-list
24866516|NCT04702256|Obinutuzumab|obinutuzumab|mesh-list
24866517|NCT04702256|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24866518|NCT04702256|Prednisolone phosphate|prednisolone phosphate|mesh-list
24866519|NCT04702256|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
24866520|NCT04702256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24866521|NCT04702256|Glucocorticoids|glucocorticoids|mesh-ancestor
24866522|NCT04702256|Hormones|hormones|mesh-ancestor
24866523|NCT04702256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24866525|NCT04702256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24866526|NCT04702256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866527|NCT04702256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24866528|NCT04702256|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24866529|NCT04702256|Antitubercular Agents|antitubercular agents|mesh-ancestor
24866530|NCT04702256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24866531|NCT04702256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24866532|NCT04702256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866533|NCT04702256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866534|NCT04702256|Antiemetics|antiemetics|mesh-ancestor
24866535|NCT04702256|Autonomic Agents|autonomic agents|mesh-ancestor
24866536|NCT04702256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24866537|NCT04702256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24866538|NCT04702256|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24866539|NCT04702256|Protective Agents|protective agents|mesh-ancestor
24866540|NCT04702256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24866541|NCT04702256|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24866552|NCT05259319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866556|NCT05259098|Sufentanil|sufentanil|mesh-list
24866557|NCT05259098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24866558|NCT05259098|Narcotics|narcotics|mesh-ancestor
24866559|NCT05259098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24866560|NCT05259098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866561|NCT05259098|Analgesics|analgesics|mesh-ancestor
24866562|NCT05259098|Sensory System Agents|sensory system agents|mesh-ancestor
24866563|NCT05259098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24866564|NCT05259098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24866565|NCT05259098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24866589|NCT05258799|Cytarabine|cytarabine|mesh-list
24866590|NCT05258799|Decitabine|decitabine|mesh-list
24866591|NCT05258799|Aclarubicin|aclarubicin|mesh-list
24866592|NCT05258799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24866593|NCT05258799|Antimetabolites|antimetabolites|mesh-ancestor
24866594|NCT05258799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866595|NCT05258799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866596|NCT05258799|Antiviral Agents|antiviral agents|mesh-ancestor
24866597|NCT05258799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24866598|NCT05258799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24866599|NCT05258799|Immunologic Factors|immunologic factors|mesh-ancestor
24866600|NCT05258799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866601|NCT05258799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866602|NCT05258799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24866603|NCT05258799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24866604|NCT05258799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24866605|NCT05258721|Fluorides|fluorides|mesh-list
24866606|NCT05258721|Cariostatic Agents|cariostatic agents|mesh-ancestor
25864051|NCT00095823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546675|NCT00699634|Nabilone|nabilone|mesh-list
24446310|NCT00304421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446311|NCT00304434|Oseltamivir|oseltamivir|mesh-list
24446312|NCT00304434|Probenecid|probenecid|mesh-list
24446313|NCT00304434|Antiviral Agents|antiviral agents|mesh-ancestor
24446325|NCT00304460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446326|NCT00304460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24446327|NCT00304460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24446328|NCT00304460|Antiviral Agents|antiviral agents|mesh-ancestor
24446329|NCT00304460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446330|NCT00304473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24866661|NCT05257148|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24866662|NCT05257148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24866663|NCT05257148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24866664|NCT05257148|Adrenergic Agents|adrenergic agents|mesh-ancestor
25201154|NCT02729714|Suvorexant|suvorexant|mesh-list
24866665|NCT05257148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24866666|NCT05257148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866667|NCT05257148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866668|NCT05257148|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24866669|NCT05257148|Protease Inhibitors|protease inhibitors|mesh-ancestor
24866670|NCT05257148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866671|NCT05212389|Contraceptive Agents|contraceptive agents|mesh-list
25054755|NCT03527836|Sensory System Agents|sensory system agents|mesh-ancestor
25054756|NCT03527836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25054757|NCT03527836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25054758|NCT03527836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24866672|NCT05212389|Contraceptives, Oral|contraceptives, oral|mesh-list
24866673|NCT05212389|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
24866676|NCT05212389|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24866691|NCT05195450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24866692|NCT05195450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24866693|NCT05195450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24866715|NCT05084599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24866716|NCT05084599|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24866717|NCT05084599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24866718|NCT05084599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24866719|NCT05084599|Adrenergic Agents|adrenergic agents|mesh-ancestor
24866720|NCT05084599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24446331|NCT00304473|Antidepressive Agents|antidepressive agents|mesh-ancestor
24446332|NCT00304473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24446333|NCT00304473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25864052|NCT00095823|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25669383|NCT01729845|Dermatologic Agents|dermatologic agents|mesh-ancestor
25669384|NCT01729845|Tubulin Modulators|tubulin modulators|mesh-ancestor
25091766|NCT03246919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25091767|NCT03246919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091769|NCT03246776|Halometasone|halometasone|mesh-list
25091770|NCT03246776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25864053|NCT00095823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24866721|NCT05084599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866740|NCT05012644|Hormone Antagonists|hormone antagonists|mesh-ancestor
24866741|NCT05012644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24866742|NCT05012644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866744|NCT05008003|Cholecalciferol|cholecalciferol|mesh-list
24866745|NCT05008003|Vitamins|vitamins|mesh-ancestor
24866746|NCT05008003|Micronutrients|micronutrients|mesh-ancestor
24866747|NCT05008003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866748|NCT05008003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24866785|NCT04827953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054762|NCT03527732|Ivermectin|ivermectin|mesh-list
25054763|NCT03527732|Albendazole|albendazole|mesh-list
25054764|NCT03527732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25054765|NCT03527732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25054766|NCT03527732|Anthelmintics|anthelmintics|mesh-ancestor
24809015|NCT02030717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24809016|NCT02030717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809017|NCT02030717|Analgesics|analgesics|mesh-ancestor
24809018|NCT02030717|Sensory System Agents|sensory system agents|mesh-ancestor
24809019|NCT02030717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24487035|NCT00461084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487039|NCT00461149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25864054|NCT00095823|Serotonin Agents|serotonin agents|mesh-ancestor
25864055|NCT00095823|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25864056|NCT00095823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25864057|NCT00095823|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25864058|NCT00095823|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25864059|NCT00095862|Interferons|interferons|mesh-list
25864060|NCT00095862|Interferon-alpha|interferon-alpha|mesh-list
24866814|NCT04754386|Antibodies|antibodies|mesh-list
24866815|NCT04754386|Immunologic Factors|immunologic factors|mesh-ancestor
25054773|NCT03527732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054774|NCT03527732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25054775|NCT03527628|Cyclophosphamide|cyclophosphamide|mesh-list
25054777|NCT03527628|Doxorubicin|doxorubicin|mesh-list
25054778|NCT03527628|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25054779|NCT03527628|Bleomycin|bleomycin|mesh-list
25054780|NCT03527628|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25054781|NCT03527628|Vinblastine|vinblastine|mesh-list
25054782|NCT03527628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25054783|NCT03527628|Immunologic Factors|immunologic factors|mesh-ancestor
25054784|NCT03527628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054785|NCT03527628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25054786|NCT03527628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25054787|NCT03527628|Alkylating Agents|alkylating agents|mesh-ancestor
25054788|NCT03527628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054789|NCT03527628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25054790|NCT03527628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25054791|NCT03527628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25054792|NCT03527628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25054793|NCT03527628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25054794|NCT03527628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809020|NCT02030717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24866851|NCT04468087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866853|NCT04468087|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24866854|NCT04468087|Antiviral Agents|antiviral agents|mesh-ancestor
24866855|NCT04468087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24866856|NCT04401553|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25669385|NCT01729845|Antimitotic Agents|antimitotic agents|mesh-ancestor
25669386|NCT01729845|Mitosis Modulators|mitosis modulators|mesh-ancestor
25669387|NCT01729871|Vitamin K|vitamin k|mesh-list
25669388|NCT01729871|Rivaroxaban|rivaroxaban|mesh-list
25669389|NCT01729871|Vitamins|vitamins|mesh-ancestor
25669390|NCT01729871|Micronutrients|micronutrients|mesh-ancestor
25669391|NCT01729871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054816|NCT03527355|Immunologic Factors|immunologic factors|mesh-ancestor
24411997|NCT00190606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411998|NCT00190606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24411999|NCT00190606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412000|NCT00190606|Analgesics|analgesics|mesh-ancestor
24412001|NCT00190606|Sensory System Agents|sensory system agents|mesh-ancestor
25054817|NCT03527355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054818|NCT03527251|Ipilimumab|ipilimumab|mesh-list
25201155|NCT02729714|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25201156|NCT02729714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25201157|NCT02729714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25201158|NCT02729714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201159|NCT02729714|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25201160|NCT02729714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25201161|NCT02729714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201162|NCT02729870|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25054819|NCT03527251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25054820|NCT03527251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25054821|NCT03527251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25054822|NCT03527251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866867|NCT04370418|Antimetabolites|antimetabolites|mesh-ancestor
24952780|NCT03892213|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24866868|NCT04370418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938119|NCT04022291|Insulin|insulin|mesh-list
24938128|NCT04022135|Hematinics|hematinics|mesh-ancestor
24938129|NCT04022135|Vitamin B Complex|vitamin b complex|mesh-ancestor
24938131|NCT04022135|Micronutrients|micronutrients|mesh-ancestor
24569761|NCT00801866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25017720|NCT03704753|Ropivacaine|ropivacaine|mesh-list
24952412|NCT03894345|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24952414|NCT03894345|Adrenergic Agents|adrenergic agents|mesh-ancestor
24952415|NCT03894345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24952416|NCT03894345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952417|NCT03894345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952418|NCT03894280|Fluticasone|fluticasone|mesh-list
24866958|NCT03865940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24866959|NCT03865940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24866960|NCT03865940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866961|NCT03865940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24820774|NCT02101567|Oxytocics|oxytocics|mesh-ancestor
24866962|NCT03865940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24866963|NCT03865940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24866964|NCT03865940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24866965|NCT03865940|Adrenergic Agents|adrenergic agents|mesh-ancestor
24866966|NCT03865940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24814353|NCT02064088|Levobupivacaine|levobupivacaine|mesh-list
24814354|NCT02064088|Anesthetics, Local|anesthetics, local|mesh-ancestor
24814355|NCT02064088|Anesthetics|anesthetics|mesh-ancestor
24814356|NCT02064088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24814357|NCT02064088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814383|NCT02064374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864061|NCT00095862|Cyclophosphamide|cyclophosphamide|mesh-list
25864062|NCT00095862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25864063|NCT00095862|Immunologic Factors|immunologic factors|mesh-ancestor
25864064|NCT00095862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864065|NCT00095862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25864066|NCT00095862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25864067|NCT00095862|Alkylating Agents|alkylating agents|mesh-ancestor
25864068|NCT00095862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814384|NCT02064374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814385|NCT02064374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24814386|NCT02064374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24814387|NCT02064374|Antiviral Agents|antiviral agents|mesh-ancestor
24814388|NCT02064374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24814389|NCT02064465|Lamotrigine|lamotrigine|mesh-list
24814390|NCT02064465|Anticonvulsants|anticonvulsants|mesh-list
24814391|NCT02064465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24814392|NCT02064465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24952420|NCT03894280|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25669392|NCT01729871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25669393|NCT01729871|Antithrombins|antithrombins|mesh-ancestor
25669394|NCT01729871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25669395|NCT01729871|Protease Inhibitors|protease inhibitors|mesh-ancestor
25669396|NCT01729871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952421|NCT03894280|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24952422|NCT03894280|Charcoal|charcoal|mesh-list
24952423|NCT03894280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24952424|NCT03894280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24952425|NCT03894280|Autonomic Agents|autonomic agents|mesh-ancestor
24867018|NCT03765619|Antipyretics|antipyretics|mesh-ancestor
24867019|NCT03739593|Dexamethasone|dexamethasone|mesh-list
24867020|NCT03739593|Dexamethasone acetate|dexamethasone acetate|mesh-list
24867021|NCT03739593|BB 1101|bb 1101|mesh-list
24867022|NCT03739593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24867023|NCT03739593|Antiemetics|antiemetics|mesh-ancestor
24867024|NCT03739593|Autonomic Agents|autonomic agents|mesh-ancestor
24867025|NCT03739593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24867026|NCT03739593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867027|NCT03739593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24867028|NCT03739593|Glucocorticoids|glucocorticoids|mesh-ancestor
24867029|NCT03739593|Hormones|hormones|mesh-ancestor
24867030|NCT03739593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24867031|NCT03739593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24867032|NCT03739593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24867033|NCT03739593|Protease Inhibitors|protease inhibitors|mesh-ancestor
24867034|NCT03739593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24867062|NCT03655197|Doxycycline|doxycycline|mesh-list
24867063|NCT03655197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24952432|NCT03894280|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24952433|NCT03894280|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24952434|NCT03894280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24952435|NCT03894280|Adrenergic Agents|adrenergic agents|mesh-ancestor
24952436|NCT03894280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24952437|NCT03894280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952439|NCT03894280|Hormones|hormones|mesh-ancestor
25201163|NCT02729870|Laxatives|laxatives|mesh-ancestor
25201164|NCT02729870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25201165|NCT02729805|Ketamine|ketamine|mesh-list
25201166|NCT02729805|Analgesics|analgesics|mesh-ancestor
25201167|NCT02729805|Sensory System Agents|sensory system agents|mesh-ancestor
25201168|NCT02729805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25201169|NCT02729805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201170|NCT02729805|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24952440|NCT03894280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24952441|NCT03894280|Sympathomimetics|sympathomimetics|mesh-ancestor
24952442|NCT03894280|Antidotes|antidotes|mesh-ancestor
25017833|NCT03703427|Capecitabine|capecitabine|mesh-list
24867079|NCT03614728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24867080|NCT03535272|Bismuth|bismuth|mesh-list
24867081|NCT03535272|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
24867082|NCT03535272|Antacids|antacids|mesh-ancestor
24867083|NCT03535272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867084|NCT03535272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24867085|NCT03535272|Antidiarrheals|antidiarrheals|mesh-ancestor
24867086|NCT03520842|Methotrexate|methotrexate|mesh-list
24867087|NCT03520842|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24867088|NCT03520842|Abortifacient Agents|abortifacient agents|mesh-ancestor
24867089|NCT03520842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24867090|NCT03520842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867091|NCT03520842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24867092|NCT03520842|Antimetabolites|antimetabolites|mesh-ancestor
24446225|NCT00304135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25054866|NCT03526575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054867|NCT03526575|Anticonvulsants|anticonvulsants|mesh-ancestor
25054868|NCT03526575|GABA Modulators|gaba modulators|mesh-ancestor
25054869|NCT03526536|Insulin|insulin|mesh-list
25054870|NCT03526536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25054871|NCT03526536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25054872|NCT03526536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054873|NCT03526445|Glucagon|glucagon|mesh-list
25054874|NCT03526445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25054875|NCT03526445|Hormones|hormones|mesh-ancestor
25054876|NCT03526445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25054877|NCT03526445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054878|NCT03526419|Bupivacaine|bupivacaine|mesh-list
25054879|NCT03526419|Anesthetics, Local|anesthetics, local|mesh-ancestor
25054880|NCT03526419|Anesthetics|anesthetics|mesh-ancestor
25054881|NCT03526419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25054882|NCT03526419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054883|NCT03526419|Sensory System Agents|sensory system agents|mesh-ancestor
25054884|NCT03526419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25091812|NCT03246620|Olanzapine|olanzapine|mesh-list
25054885|NCT03526367|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25054886|NCT03526367|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25054897|NCT03526276|Fluorides|fluorides|mesh-list
25054913|NCT03526224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25054920|NCT03526159|Gentamicins|gentamicins|mesh-list
25054921|NCT03526159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25054922|NCT03526159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25054923|NCT03526159|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25054924|NCT03526159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25054925|NCT03526159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054926|NCT03526107|Theobromine|theobromine|mesh-list
25054927|NCT03526107|Caffeine|caffeine|mesh-list
25054928|NCT03526107|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25054929|NCT03526107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867167|NCT03306979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24867168|NCT03306979|Expectorants|expectorants|mesh-ancestor
24867169|NCT03306979|Respiratory System Agents|respiratory system agents|mesh-ancestor
24867170|NCT03306979|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24867171|NCT03306979|Antioxidants|antioxidants|mesh-ancestor
24867172|NCT03306979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867173|NCT03306979|Protective Agents|protective agents|mesh-ancestor
24867174|NCT03306979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867175|NCT03306979|Antidotes|antidotes|mesh-ancestor
25864069|NCT00095862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864070|NCT00095862|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24867203|NCT03150732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867204|NCT03150732|Analgesics|analgesics|mesh-ancestor
24867205|NCT03150732|Sensory System Agents|sensory system agents|mesh-ancestor
25201171|NCT02729805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25864071|NCT00095862|Antiviral Agents|antiviral agents|mesh-ancestor
24867206|NCT03150732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25864072|NCT00095862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24867217|NCT03015740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867218|NCT02986269|Anesthetics|anesthetics|mesh-list
24867219|NCT02986269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24867220|NCT02986269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867221|NCT02940496|Ribavirin|ribavirin|mesh-list
24867222|NCT02940496|Grazoprevir|grazoprevir|mesh-list
24867223|NCT02940496|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
24867224|NCT02940496|Pembrolizumab|pembrolizumab|mesh-list
24867225|NCT02940496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24809255|NCT02032290|Clopidogrel|clopidogrel|mesh-list
24809257|NCT02032290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24595393|NCT00938262|Hormone Antagonists|hormone antagonists|mesh-ancestor
24487964|NCT00466089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24487965|NCT00466089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24867265|NCT02549092|Immunologic Factors|immunologic factors|mesh-ancestor
24867266|NCT02549092|Dopamine Agonists|dopamine agonists|mesh-ancestor
24867267|NCT02518555|Vaccines|vaccines|mesh-list
24867268|NCT02518555|Immunologic Factors|immunologic factors|mesh-ancestor
24867269|NCT02518555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867270|NCT02515773|Metformin|metformin|mesh-list
24867271|NCT02515773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24867272|NCT02515773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867273|NCT02478788|Amphetamine|amphetamine|mesh-list
24867361|NCT00821587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24867362|NCT00821587|Immunologic Factors|immunologic factors|mesh-ancestor
24867363|NCT00821587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867364|NCT00821587|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24867365|NCT00821587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24867366|NCT00821587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867367|NCT00821587|Antifungal Agents|antifungal agents|mesh-ancestor
24547395|NCT00703703|Urological Agents|urological agents|mesh-ancestor
25018002|NCT03702491|Oxaliplatin|oxaliplatin|mesh-list
25054957|NCT03525925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054959|NCT03525912|Analgesics|analgesics|mesh-list
25054960|NCT03525912|Sensory System Agents|sensory system agents|mesh-ancestor
25054961|NCT03525912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25055000|NCT03525730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25054962|NCT03525912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054963|NCT03525912|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25054964|NCT03525912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25054965|NCT03525912|Anesthetics, General|anesthetics, general|mesh-ancestor
25054966|NCT03525912|Anesthetics|anesthetics|mesh-ancestor
25669397|NCT01729871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091819|NCT03246620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25091820|NCT03246620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25091821|NCT03246620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25091822|NCT03246620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25091823|NCT03246620|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24454647|NCT03878524|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24454648|NCT03878524|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24454649|NCT03878524|Antioxidants|antioxidants|mesh-ancestor
24454650|NCT03878524|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24454651|NCT03878524|Keratolytic Agents|keratolytic agents|mesh-ancestor
24454652|NCT03878524|Dermatologic Agents|dermatologic agents|mesh-ancestor
24412180|NCT00190905|Antidepressive Agents|antidepressive agents|mesh-ancestor
24412181|NCT00190905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24412182|NCT00190905|Dopamine Agents|dopamine agents|mesh-ancestor
25054967|NCT03525912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25054968|NCT03525912|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25054969|NCT03525912|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25054970|NCT03525912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25054971|NCT03525912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938206|NCT04021017|Hormones|hormones|mesh-ancestor
25054972|NCT03525821|Ketamine|ketamine|mesh-list
25054973|NCT03525821|Analgesics|analgesics|mesh-ancestor
25054974|NCT03525821|Sensory System Agents|sensory system agents|mesh-ancestor
25054975|NCT03525821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25054976|NCT03525821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054977|NCT03525821|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25054978|NCT03525821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25018063|NCT03701984|Lidocaine|lidocaine|mesh-list
24809290|NCT02032654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24809292|NCT02032784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24809293|NCT02032784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24595515|NCT00939133|Tretinoin|tretinoin|mesh-list
24488099|NCT00466596|Vitamin E|vitamin e|mesh-list
24488100|NCT00466596|Tocopherols|tocopherols|mesh-list
24488101|NCT00466596|Tocotrienols|tocotrienols|mesh-list
24488102|NCT00466596|alpha-Tocopherol|alpha-tocopherol|mesh-list
24488103|NCT00466596|gamma-Tocopherol|gamma-tocopherol|mesh-list
24488104|NCT00466596|Micronutrients|micronutrients|mesh-ancestor
25058763|NCT03493061|Floxuridine|floxuridine|mesh-list
25201172|NCT02729805|Anesthetics, General|anesthetics, general|mesh-ancestor
25201173|NCT02729805|Anesthetics|anesthetics|mesh-ancestor
24488107|NCT00466596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488108|NCT00466596|Protective Agents|protective agents|mesh-ancestor
25864073|NCT00095888|Gemcitabine|gemcitabine|mesh-list
24867435|NCT04457323|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24867436|NCT04457323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24867437|NCT04457323|Adrenergic Agents|adrenergic agents|mesh-ancestor
24867438|NCT04457323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24867439|NCT04457323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867440|NCT04448431|Vortioxetine|vortioxetine|mesh-list
24867441|NCT04448431|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25669398|NCT01729871|Anticoagulants|anticoagulants|mesh-ancestor
25669399|NCT01729871|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25669400|NCT01729871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25669401|NCT01729871|Hemostatics|hemostatics|mesh-ancestor
25669402|NCT01729871|Coagulants|coagulants|mesh-ancestor
25669403|NCT01729923|Celecoxib|celecoxib|mesh-list
25669404|NCT01729923|Capecitabine|capecitabine|mesh-list
25669405|NCT01729923|Benzenesulfonamide|benzenesulfonamide|mesh-list
25669406|NCT01729923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25669407|NCT01729923|Antimetabolites|antimetabolites|mesh-ancestor
25669408|NCT01729923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669409|NCT01729923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669410|NCT01729923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25669411|NCT01729923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25669412|NCT01729923|Analgesics|analgesics|mesh-ancestor
25669413|NCT01729923|Sensory System Agents|sensory system agents|mesh-ancestor
25669414|NCT01729923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25669415|NCT01729923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669416|NCT01729923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25669417|NCT01729923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24867442|NCT04448431|Antidepressive Agents|antidepressive agents|mesh-ancestor
24867443|NCT04448431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24867444|NCT04448431|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24867445|NCT04448431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24547469|NCT00704223|Biphasic Insulins|biphasic insulins|mesh-list
24867446|NCT04448431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24867447|NCT04448431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867448|NCT04448431|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25018099|NCT03701880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25864074|NCT00095888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25864075|NCT00095888|Antimetabolites|antimetabolites|mesh-ancestor
25864076|NCT00095888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867510|NCT04243629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24867511|NCT04243629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867512|NCT04243629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24867513|NCT04194528|Acetaminophen|acetaminophen|mesh-list
24867514|NCT04194528|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
24867515|NCT04194528|Oxycodone|oxycodone|mesh-list
24867516|NCT04194528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24867517|NCT04194528|Analgesics|analgesics|mesh-ancestor
24867518|NCT04194528|Sensory System Agents|sensory system agents|mesh-ancestor
24867519|NCT04194528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24867520|NCT04194528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018152|NCT03701503|Hormones|hormones|mesh-list
24867551|NCT04070573|Antipyretics|antipyretics|mesh-ancestor
24867552|NCT04070443|Imatinib Mesylate|imatinib mesylate|mesh-list
24867553|NCT04070443|Ponatinib|ponatinib|mesh-list
25054996|NCT03525730|GABA Agents|gaba agents|mesh-ancestor
25054997|NCT03525730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25054998|NCT03525730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054999|NCT03525730|Antimanic Agents|antimanic agents|mesh-ancestor
25055003|NCT03525704|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25055004|NCT03525652|Vaccines|vaccines|mesh-list
24809307|NCT02032927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24488385|NCT00468260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488386|NCT00468351|Triamcinolone|triamcinolone|mesh-list
24488387|NCT00468351|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24488388|NCT00468351|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24488389|NCT00468351|Bevacizumab|bevacizumab|mesh-list
24488390|NCT00468351|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24488391|NCT00468351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24488392|NCT00468351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488393|NCT00468351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24488394|NCT00468351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24488395|NCT00468351|Growth Substances|growth substances|mesh-ancestor
24867556|NCT04070443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055012|NCT03525561|Anticonvulsants|anticonvulsants|mesh-ancestor
25055013|NCT03525561|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25055014|NCT03525561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055015|NCT03525561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809308|NCT02032927|Analgesics|analgesics|mesh-ancestor
24809309|NCT02032927|Sensory System Agents|sensory system agents|mesh-ancestor
24809310|NCT02032927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24809311|NCT02032927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809312|NCT02032927|Antipyretics|antipyretics|mesh-ancestor
24809313|NCT02032927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24809314|NCT02032927|Narcotics|narcotics|mesh-ancestor
24488495|NCT00468988|Latanoprost|latanoprost|mesh-list
24488496|NCT00468988|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24488497|NCT00468988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24488498|NCT00468988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24488499|NCT00469053|Buprenorphine|buprenorphine|mesh-list
24488500|NCT00469053|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24488501|NCT00469053|Narcotics|narcotics|mesh-ancestor
24488504|NCT00469053|Analgesics|analgesics|mesh-ancestor
24547573|NCT00704691|Growth Substances|growth substances|mesh-ancestor
24547574|NCT00704691|Growth Inhibitors|growth inhibitors|mesh-ancestor
24547575|NCT00704691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547576|NCT00704704|Thalidomide|thalidomide|mesh-list
24547577|NCT00704704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25669418|NCT01729923|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24867594|NCT03842696|Antitubercular Agents|antitubercular agents|mesh-ancestor
25669419|NCT01729923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25669420|NCT01729923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25669421|NCT01729923|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25669422|NCT01730040|Atorvastatin|atorvastatin|mesh-list
24867595|NCT03842696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24867596|NCT03842696|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24867598|NCT03761277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24867600|NCT03761277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24867631|NCT03527238|Immunologic Factors|immunologic factors|mesh-ancestor
24867632|NCT03527238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867633|NCT03527238|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24867634|NCT03527238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24867635|NCT03527238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867637|NCT03490864|Antioxidants|antioxidants|mesh-ancestor
24867638|NCT03490864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867639|NCT03490864|Protective Agents|protective agents|mesh-ancestor
24867640|NCT03490864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867641|NCT03490864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24867651|NCT03380507|Micronutrients|micronutrients|mesh-ancestor
24867652|NCT03380507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867653|NCT03380507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24867654|NCT03380507|Vitamin B Complex|vitamin b complex|mesh-ancestor
24867665|NCT03194165|Raltegravir Potassium|raltegravir potassium|mesh-list
24867666|NCT03194165|Nevirapine|nevirapine|mesh-list
24867667|NCT03194165|Dolutegravir|dolutegravir|mesh-list
24867668|NCT03194165|Rilpivirine|rilpivirine|mesh-list
24867669|NCT03194165|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24867670|NCT03194165|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24867671|NCT03194165|Protease Inhibitors|protease inhibitors|mesh-ancestor
24867672|NCT03194165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24867673|NCT03194165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867682|NCT03194165|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24867689|NCT03179475|Narcotics|narcotics|mesh-ancestor
24446473|NCT00304811|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25055029|NCT03525509|Methadone|methadone|mesh-list
25055030|NCT03525509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25055031|NCT03525509|Narcotics|narcotics|mesh-ancestor
25055032|NCT03525509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25055033|NCT03525509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055034|NCT03525509|Analgesics|analgesics|mesh-ancestor
25055035|NCT03525509|Sensory System Agents|sensory system agents|mesh-ancestor
25055036|NCT03525509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25055037|NCT03525509|Antitussive Agents|antitussive agents|mesh-ancestor
25018266|NCT03700645|Allopurinol|allopurinol|mesh-list
24547723|NCT00705419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446481|NCT00304850|Analgesics|analgesics|mesh-ancestor
24446482|NCT00304850|Sensory System Agents|sensory system agents|mesh-ancestor
24446483|NCT00304850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24446484|NCT00304850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547740|NCT00705510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24547741|NCT00705510|Immunologic Factors|immunologic factors|mesh-ancestor
24547742|NCT00705510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547743|NCT00705510|Antifungal Agents|antifungal agents|mesh-ancestor
24867745|NCT02555657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24867746|NCT02555657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24867748|NCT02555657|Antimitotic Agents|antimitotic agents|mesh-ancestor
24867749|NCT02555657|Mitosis Modulators|mitosis modulators|mesh-ancestor
24867750|NCT02457156|Octreotide|octreotide|mesh-list
24867751|NCT02457156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24867752|NCT02457156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24867753|NCT02457156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24867754|NCT02272348|Insulin|insulin|mesh-list
25201174|NCT02729805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24867755|NCT02272348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24867756|NCT02272348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867757|NCT02190721|Lenograstim|lenograstim|mesh-list
24867758|NCT02190721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24867759|NCT02190721|Immunologic Factors|immunologic factors|mesh-ancestor
24867760|NCT02190721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610157|NCT01000220|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24610158|NCT01000220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24610159|NCT01000220|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24610160|NCT01000220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610161|NCT01000220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610163|NCT01000233|Vitamin B Complex|vitamin b complex|mesh-ancestor
24610164|NCT01000233|Vitamins|vitamins|mesh-ancestor
25055040|NCT03525223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25055041|NCT03524950|Dexmedetomidine|dexmedetomidine|mesh-list
25864077|NCT00095888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864078|NCT00095888|Antiviral Agents|antiviral agents|mesh-ancestor
25055042|NCT03524950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24547793|NCT00705770|Anecortave|anecortave|mesh-list
24867794|NCT00308516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867795|NCT00308516|Growth Inhibitors|growth inhibitors|mesh-ancestor
24867796|NCT00308516|Antimetabolites|antimetabolites|mesh-ancestor
24867797|NCT00308516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867798|NCT00308516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25058864|NCT03492593|Beta Carotene|beta carotene|mesh-list
24867799|NCT00308516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24867800|NCT00308516|Immunologic Factors|immunologic factors|mesh-ancestor
24867801|NCT00308516|Antidotes|antidotes|mesh-ancestor
24867802|NCT00308516|Protective Agents|protective agents|mesh-ancestor
24867803|NCT00308516|Vitamin B Complex|vitamin b complex|mesh-ancestor
24867804|NCT00308516|Vitamins|vitamins|mesh-ancestor
24867805|NCT00308516|Micronutrients|micronutrients|mesh-ancestor
24867806|NCT02325960|Insulin Glargine|insulin glargine|mesh-list
24867807|NCT02325960|Exenatide|exenatide|mesh-list
24867808|NCT02325960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24867809|NCT02325960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867810|NCT02325960|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25864079|NCT00095888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24867811|NCT02325960|Incretins|incretins|mesh-ancestor
24867812|NCT02325960|Hormones|hormones|mesh-ancestor
24974861|NCT05207709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24867834|NCT05154747|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
25055043|NCT03524950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25055045|NCT03524950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24938376|NCT04019652|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24938377|NCT04019652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24938378|NCT04019652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24938379|NCT04019652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24938380|NCT04019652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24938381|NCT04019652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24867835|NCT05154747|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24867836|NCT05154747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25201175|NCT02729805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24867857|NCT05154682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24867858|NCT05154682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24867859|NCT05154682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24867860|NCT05154682|Gout Suppressants|gout suppressants|mesh-ancestor
24867861|NCT05154682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24867862|NCT05154682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24867863|NCT05154682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867872|NCT05154396|Loperamide|loperamide|mesh-list
24867873|NCT05154396|Antidiarrheals|antidiarrheals|mesh-ancestor
24867874|NCT05154396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24867878|NCT05154370|Immunoglobulins|immunoglobulins|mesh-list
24867879|NCT05154370|Immunologic Factors|immunologic factors|mesh-ancestor
24547910|NCT00706680|Glucocorticoids|glucocorticoids|mesh-ancestor
24547911|NCT00706680|Hormones|hormones|mesh-ancestor
24867931|NCT04849650|Antidepressive Agents|antidepressive agents|mesh-ancestor
24867932|NCT04765137|Atorvastatin|atorvastatin|mesh-list
24867933|NCT04765137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25055058|NCT03524937|Protective Agents|protective agents|mesh-ancestor
25055059|NCT03524937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055060|NCT03524937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25055061|NCT03524872|Analgesics|analgesics|mesh-list
24446558|NCT00305370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24446559|NCT00305370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867996|NCT04285684|Ketamine|ketamine|mesh-list
24867997|NCT04285684|Analgesics|analgesics|mesh-ancestor
24867998|NCT04285684|Sensory System Agents|sensory system agents|mesh-ancestor
24867999|NCT04285684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24868000|NCT04285684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868001|NCT04285684|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24868002|NCT04285684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24868003|NCT04285684|Anesthetics, General|anesthetics, general|mesh-ancestor
24868004|NCT04285684|Anesthetics|anesthetics|mesh-ancestor
24868005|NCT04285684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24868006|NCT04285684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24548015|NCT00707187|Vasodilator Agents|vasodilator agents|mesh-ancestor
25669423|NCT01730040|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24548016|NCT00707187|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24548017|NCT00707187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24548018|NCT00707187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201176|NCT02729805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24548021|NCT00707252|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24868047|NCT03994172|Teriparatide|teriparatide|mesh-list
24548092|NCT00707551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548094|NCT00707551|Hormone Antagonists|hormone antagonists|mesh-ancestor
24548095|NCT00707551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24548096|NCT00707551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548098|NCT00707551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24868104|NCT03643965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24868105|NCT03643965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24868106|NCT03643965|Autonomic Agents|autonomic agents|mesh-ancestor
24868107|NCT03643965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25864080|NCT00095888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24868139|NCT03336541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868140|NCT03336541|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24868141|NCT03336541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24868143|NCT03336541|Anesthetics|anesthetics|mesh-ancestor
24868144|NCT03336541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25055062|NCT03524872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055063|NCT03524872|Sensory System Agents|sensory system agents|mesh-ancestor
25055064|NCT03524872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25055065|NCT03524846|Vitamins|vitamins|mesh-list
24809364|NCT02033408|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24868145|NCT03336541|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24868146|NCT03336541|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24548116|NCT00707772|Ribavirin|ribavirin|mesh-list
24548124|NCT00707772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868147|NCT03336541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24868148|NCT03336541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868149|NCT03230916|Relebactam|relebactam|mesh-list
24868150|NCT03230916|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24868151|NCT03230916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24868152|NCT03230916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201177|NCT02729805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25201178|NCT02729805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201179|NCT02729935|Parecoxib|parecoxib|mesh-list
25201180|NCT02729935|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25201181|NCT02729935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25201182|NCT02729935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24868157|NCT03202667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868158|NCT03202667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24868159|NCT03202667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868160|NCT03021993|Nivolumab|nivolumab|mesh-list
24868161|NCT03021993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24868162|NCT03021993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24884682|NCT03746301|Anticoagulants|anticoagulants|mesh-ancestor
25864081|NCT00095888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24868212|NCT02523313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24868225|NCT02088632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868226|NCT02088632|Cholinergic Agents|cholinergic agents|mesh-ancestor
24868227|NCT02088632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24868228|NCT01602666|Carboplatin|carboplatin|mesh-list
24868229|NCT01602666|Etoposide|etoposide|mesh-list
24868230|NCT01602666|Etoposide phosphate|etoposide phosphate|mesh-list
24868231|NCT01602666|Ifosfamide|ifosfamide|mesh-list
24690455|NCT01402076|Midazolam|midazolam|mesh-list
24868232|NCT01602666|Isophosphamide mustard|isophosphamide mustard|mesh-list
24868233|NCT01602666|Podophyllotoxin|podophyllotoxin|mesh-list
24868234|NCT01602666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24868235|NCT01602666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24868236|NCT01602666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24868237|NCT01602666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24868238|NCT01602666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24868239|NCT01602666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868253|NCT01489813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24868254|NCT01489813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868255|NCT01489813|Phytoestrogens|phytoestrogens|mesh-ancestor
24868262|NCT01375959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868264|NCT01375959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814455|NCT02064556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814457|NCT02064556|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24814458|NCT02064556|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24814459|NCT02064621|Amlodipine|amlodipine|mesh-list
24814460|NCT02064621|Candesartan|candesartan|mesh-list
24814461|NCT02064621|Candesartan cilexetil|candesartan cilexetil|mesh-list
24814462|NCT02064621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24814463|NCT02064621|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24814483|NCT02064725|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
24814485|NCT02064725|Immunologic Factors|immunologic factors|mesh-ancestor
24814486|NCT02064725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814487|NCT02064777|Tacrolimus|tacrolimus|mesh-list
24814488|NCT02064777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24814489|NCT02064777|Immunologic Factors|immunologic factors|mesh-ancestor
24814490|NCT02064777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814491|NCT02064777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24814492|NCT02064777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690530|NCT01402297|Analgesics|analgesics|mesh-ancestor
24868265|NCT01375959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24868266|NCT01375959|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24868267|NCT00380653|Sapacitabine|sapacitabine|mesh-list
25055078|NCT03524833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25055079|NCT03524833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25055080|NCT03524833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25055081|NCT03524833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25055082|NCT03524833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25055083|NCT03524833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055084|NCT03524833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868268|NCT00380653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24868270|NCT00354835|Cyclophosphamide|cyclophosphamide|mesh-list
24868271|NCT00354835|Irinotecan|irinotecan|mesh-list
24868272|NCT00354835|Vincristine|vincristine|mesh-list
24868273|NCT00354835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24548262|NCT00708591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24548263|NCT00708591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548264|NCT00708591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548265|NCT00708591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24868274|NCT00354835|Immunologic Factors|immunologic factors|mesh-ancestor
24868275|NCT00354835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868276|NCT00354835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24868277|NCT00354835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24868278|NCT00354835|Alkylating Agents|alkylating agents|mesh-ancestor
25864082|NCT00095888|Immunologic Factors|immunologic factors|mesh-ancestor
25864083|NCT00095888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864084|NCT00095901|Capecitabine|capecitabine|mesh-list
25864085|NCT00095901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25864086|NCT00095901|Antimetabolites|antimetabolites|mesh-ancestor
25201187|NCT02729935|Sensory System Agents|sensory system agents|mesh-ancestor
25201188|NCT02729935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25201189|NCT02729935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201190|NCT02729935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25864087|NCT00095901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864088|NCT00095901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864089|NCT00095914|Paclitaxel|paclitaxel|mesh-list
25864090|NCT00095914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24868309|NCT05156970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24868310|NCT05156892|Tamoxifen|tamoxifen|mesh-list
24868311|NCT05156892|Itraconazole|itraconazole|mesh-list
24868316|NCT05156892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24868317|NCT05156892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24868318|NCT05156892|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24868319|NCT05156892|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24868320|NCT05156892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24868321|NCT05156892|Antifungal Agents|antifungal agents|mesh-ancestor
24868322|NCT05156892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25018784|NCT03697018|Lithium Carbonate|lithium carbonate|mesh-list
25201191|NCT02729935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25201192|NCT02729285|Ketorolac|ketorolac|mesh-list
25201193|NCT02729285|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25201194|NCT02729285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25201195|NCT02729285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25201196|NCT02729285|Analgesics|analgesics|mesh-ancestor
25201197|NCT02729285|Sensory System Agents|sensory system agents|mesh-ancestor
25201198|NCT02729285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24868364|NCT05156450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091990|NCT03245554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25091991|NCT03245554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412458|NCT00191438|Antimitotic Agents|antimitotic agents|mesh-ancestor
24412459|NCT00191438|Mitosis Modulators|mitosis modulators|mesh-ancestor
24412462|NCT00191464|Metformin|metformin|mesh-list
24868365|NCT05156450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24868366|NCT05156450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24868367|NCT05156450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24868368|NCT05156450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24868369|NCT05156450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868370|NCT05156450|Hormone Antagonists|hormone antagonists|mesh-ancestor
24868371|NCT05156450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24868372|NCT05156385|Antihypertensive Agents|antihypertensive agents|mesh-list
24884712|NCT03697876|Viscosupplements|viscosupplements|mesh-ancestor
24868373|NCT05155969|Ketamine|ketamine|mesh-list
24868374|NCT05155969|Esketamine|esketamine|mesh-list
25018876|NCT03695887|Nitrous Oxide|nitrous oxide|mesh-list
25864091|NCT00095914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25864092|NCT00095914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864093|NCT00095914|Tubulin Modulators|tubulin modulators|mesh-ancestor
25864094|NCT00095914|Antimitotic Agents|antimitotic agents|mesh-ancestor
25864095|NCT00095914|Mitosis Modulators|mitosis modulators|mesh-ancestor
25864096|NCT00095914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864097|NCT00095927|Paclitaxel|paclitaxel|mesh-list
25018915|NCT03695705|Rifaximin|rifaximin|mesh-list
24868394|NCT05112913|Immunologic Factors|immunologic factors|mesh-ancestor
24868395|NCT05112913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868396|NCT05112549|Nivolumab|nivolumab|mesh-list
24868415|NCT04843423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24868416|NCT04843423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24868417|NCT04843423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24868418|NCT04843423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868419|NCT04843423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25055113|NCT03524261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055114|NCT03524079|Ajmaline|ajmaline|mesh-list
25055115|NCT03524079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24784695|NCT01910090|Flurbiprofen|flurbiprofen|mesh-list
25055116|NCT03524079|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25055117|NCT03524079|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25055118|NCT03524079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24868920|NCT05158699|Protective Agents|protective agents|mesh-ancestor
24868467|NCT04549051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24868468|NCT04549051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868469|NCT04549051|Sensory System Agents|sensory system agents|mesh-ancestor
24868470|NCT04549051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25055119|NCT03524079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491073|NCT00481143|Deferasirox|deferasirox|mesh-list
25201199|NCT02729285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868511|NCT04456153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24868512|NCT04456153|Antimalarials|antimalarials|mesh-ancestor
24868513|NCT04456153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24868514|NCT04456153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24868515|NCT04456153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864098|NCT00095927|Carboplatin|carboplatin|mesh-list
25864099|NCT00095927|Amifostine|amifostine|mesh-list
25201200|NCT02729285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25201201|NCT02729285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25201202|NCT02729285|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25201203|NCT02729285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201204|NCT02729285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201205|NCT02729441|Ramipril|ramipril|mesh-list
25201206|NCT02729441|Perindopril|perindopril|mesh-list
25201207|NCT02729441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25201208|NCT02729441|Protease Inhibitors|protease inhibitors|mesh-ancestor
25864100|NCT00095927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25864101|NCT00095927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864102|NCT00095927|Tubulin Modulators|tubulin modulators|mesh-ancestor
25864103|NCT00095927|Antimitotic Agents|antimitotic agents|mesh-ancestor
25669424|NCT01730040|Ezetimibe|ezetimibe|mesh-list
25669425|NCT01730040|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25669426|NCT01730040|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25669427|NCT01730040|Antimetabolites|antimetabolites|mesh-ancestor
25669428|NCT01730040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404127|NCT03682978|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25669429|NCT01730040|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25669430|NCT01730040|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25669431|NCT01730040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25669432|NCT01730053|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24787740|NCT01926860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864104|NCT00095927|Mitosis Modulators|mitosis modulators|mesh-ancestor
24814550|NCT02065388|Anticoagulants|anticoagulants|mesh-ancestor
24814551|NCT02065401|Magnesium Hydroxide|magnesium hydroxide|mesh-list
24814552|NCT02065401|Antacids|antacids|mesh-ancestor
24814567|NCT02065466|Mitosis Modulators|mitosis modulators|mesh-ancestor
24814568|NCT02065466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814569|NCT02065466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24814570|NCT02065466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24814571|NCT02065466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24814572|NCT02065466|Growth Substances|growth substances|mesh-ancestor
24814573|NCT02065466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814574|NCT02065466|Growth Inhibitors|growth inhibitors|mesh-ancestor
24814594|NCT02065739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24814595|NCT02065739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548538|NCT00710099|Urological Agents|urological agents|mesh-ancestor
24814596|NCT02065739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24814597|NCT02065739|Hormone Antagonists|hormone antagonists|mesh-ancestor
24814598|NCT02065739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24814599|NCT02065739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868921|NCT05158647|Magnesium Sulfate|magnesium sulfate|mesh-list
24868572|NCT04321174|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24868573|NCT04321174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24868574|NCT04318145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24868575|NCT04206761|Mometasone Furoate|mometasone furoate|mesh-list
24868576|NCT04206761|Glycopyrrolate|glycopyrrolate|mesh-list
24952906|NCT03890809|BMS-986165|bms-986165|mesh-list
24868594|NCT04194814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24868595|NCT04194814|Glucocorticoids|glucocorticoids|mesh-ancestor
24868597|NCT04194814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24868598|NCT04194814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491464|NCT00482573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24491465|NCT00482573|Respiratory System Agents|respiratory system agents|mesh-ancestor
24491512|NCT00482807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491514|NCT00482846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24491515|NCT00482846|Alkylating Agents|alkylating agents|mesh-ancestor
25201209|NCT02729441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201210|NCT02729441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201211|NCT02729441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25201212|NCT02729376|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
25201213|NCT02729376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201214|NCT02729376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201215|NCT02729467|Itraconazole|itraconazole|mesh-list
25201216|NCT02729467|Rifampin|rifampin|mesh-list
25201217|NCT02729467|Antifungal Agents|antifungal agents|mesh-ancestor
25201218|NCT02729467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24868604|NCT04143204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24868605|NCT04143204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548594|NCT00710437|Dexmedetomidine|dexmedetomidine|mesh-list
24548595|NCT00710437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24548596|NCT00710437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25111307|NCT04965506|Dulaglutide|dulaglutide|mesh-list
24868615|NCT04118036|Pembrolizumab|pembrolizumab|mesh-list
24868616|NCT04118036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24868617|NCT04118036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24868619|NCT04093752|Tirzepatide|tirzepatide|mesh-list
24868636|NCT03925246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24548615|NCT00710736|Capecitabine|capecitabine|mesh-list
24548616|NCT00710736|Antimetabolites|antimetabolites|mesh-ancestor
24548617|NCT00710736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548618|NCT00710736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24548619|NCT00710736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24548620|NCT00710736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24548621|NCT00710736|Immunologic Factors|immunologic factors|mesh-ancestor
25669433|NCT01730053|Ezetimibe|ezetimibe|mesh-list
25669434|NCT01730053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25669435|NCT01730053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25669436|NCT01730053|Antimetabolites|antimetabolites|mesh-ancestor
25669437|NCT01730053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548622|NCT00710736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548623|NCT00710788|Calcium Carbonate|calcium carbonate|mesh-list
24548625|NCT00710788|Sevelamer|sevelamer|mesh-list
24548626|NCT00710788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24868638|NCT03925246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24868639|NCT03925246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201219|NCT02729467|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25201220|NCT02729467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25201221|NCT02729467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201222|NCT02729467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868922|NCT05158647|Analgesics|analgesics|mesh-ancestor
25201223|NCT02729467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25201224|NCT02729467|Hormone Antagonists|hormone antagonists|mesh-ancestor
25201225|NCT02729467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25201226|NCT02729467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201227|NCT02729467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25201228|NCT02729467|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25055130|NCT03523832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25055131|NCT03523832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25055132|NCT03523832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25055133|NCT03523832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24868642|NCT03743402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24868643|NCT03743402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868644|NCT03743402|Analgesics|analgesics|mesh-ancestor
24868645|NCT03743402|Sensory System Agents|sensory system agents|mesh-ancestor
24868646|NCT03743402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24868647|NCT03668639|Dexamethasone|dexamethasone|mesh-list
24868648|NCT03668639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25864105|NCT00095927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864106|NCT00095927|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24868728|NCT03379389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24868729|NCT03377803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24868730|NCT03377803|Cantharidin|cantharidin|mesh-list
24868731|NCT03377803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24868732|NCT03377803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868733|NCT03283371|Natalizumab|natalizumab|mesh-list
24868734|NCT03283371|Immunologic Factors|immunologic factors|mesh-ancestor
24868735|NCT03283371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868736|NCT03257254|Polidocanol|polidocanol|mesh-list
24868737|NCT03257254|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25055134|NCT03523832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25055135|NCT03523832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25055136|NCT03523832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25055137|NCT03523832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25055138|NCT03523832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25055139|NCT03523832|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25055140|NCT03523832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25055141|NCT03523832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055143|NCT03523754|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25055144|NCT03523754|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
24809417|NCT02033551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24809422|NCT02033603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25055149|NCT03523754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055150|NCT03523754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25055151|NCT03523754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25055152|NCT03523754|Oxytocics|oxytocics|mesh-ancestor
25055153|NCT03523754|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25055154|NCT03523754|Diuretics|diuretics|mesh-ancestor
24809428|NCT02033707|Hallucinogens|hallucinogens|mesh-list
24491825|NCT00484120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24491826|NCT00484120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24491827|NCT00484120|Analgesics|analgesics|mesh-ancestor
24868743|NCT03084718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24868744|NCT03084718|Glucocorticoids|glucocorticoids|mesh-ancestor
24868745|NCT03084718|Hormones|hormones|mesh-ancestor
24868746|NCT03084718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24868747|NCT03084718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868748|NCT03084718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24868749|NCT03084718|Respiratory System Agents|respiratory system agents|mesh-ancestor
25055155|NCT03523754|Natriuretic Agents|natriuretic agents|mesh-ancestor
25055156|NCT03523754|Vasodilator Agents|vasodilator agents|mesh-ancestor
25669438|NCT01730053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24413014|NCT00192959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24413017|NCT00192959|Anesthetics, General|anesthetics, general|mesh-ancestor
25055157|NCT03523754|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25055158|NCT03523754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055159|NCT03523741|Clozapine|clozapine|mesh-list
25055160|NCT03523741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25055161|NCT03523741|Serotonin Agents|serotonin agents|mesh-ancestor
25055162|NCT03523741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24809440|NCT02033707|Antiemetics|antiemetics|mesh-ancestor
24809441|NCT02033707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24809442|NCT02033707|Mydriatics|mydriatics|mesh-ancestor
24809443|NCT02033707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24809444|NCT02033707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24809445|NCT02033707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24868750|NCT03059511|Nalbuphine|nalbuphine|mesh-list
24868751|NCT03059511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24868752|NCT03059511|Narcotics|narcotics|mesh-ancestor
24868753|NCT03059511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24868754|NCT03059511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868755|NCT03059511|Analgesics|analgesics|mesh-ancestor
24868756|NCT03059511|Sensory System Agents|sensory system agents|mesh-ancestor
25864107|NCT00095927|Protective Agents|protective agents|mesh-ancestor
24548705|NCT00711841|Dexamethasone|dexamethasone|mesh-list
24868757|NCT03059511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24868759|NCT02944578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24868760|NCT02944578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24868761|NCT02944578|Analgesics|analgesics|mesh-ancestor
24868762|NCT02944578|Sensory System Agents|sensory system agents|mesh-ancestor
24868763|NCT02944578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24868764|NCT02944578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868765|NCT02944578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24868766|NCT02944578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25055163|NCT03523741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055164|NCT03523741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055166|NCT03523741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25055167|NCT03523741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25055168|NCT03523741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25055169|NCT03523741|GABA Antagonists|gaba antagonists|mesh-ancestor
25055170|NCT03523741|GABA Agents|gaba agents|mesh-ancestor
25055171|NCT03523650|Propranolol|propranolol|mesh-list
24809448|NCT02033733|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
24597447|NCT00949377|Bromides|bromides|mesh-list
24491996|NCT00484822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864108|NCT00095927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864109|NCT00095966|Gemcitabine|gemcitabine|mesh-list
25864110|NCT00095966|Sorafenib|sorafenib|mesh-list
25864111|NCT00095966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25864112|NCT00095966|Antimetabolites|antimetabolites|mesh-ancestor
25864113|NCT00095966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864114|NCT00095966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864115|NCT00095966|Antiviral Agents|antiviral agents|mesh-ancestor
25864116|NCT00095966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25864117|NCT00095966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864118|NCT00095966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25864119|NCT00095966|Immunologic Factors|immunologic factors|mesh-ancestor
25864120|NCT00095966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491997|NCT00484900|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24491998|NCT00484900|Antimalarials|antimalarials|mesh-ancestor
24868779|NCT02824679|Scopolamine|scopolamine|mesh-list
24868780|NCT02824679|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24868781|NCT02824679|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24868782|NCT02824679|Antiemetics|antiemetics|mesh-ancestor
24868783|NCT02824679|Autonomic Agents|autonomic agents|mesh-ancestor
24868784|NCT02824679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24868785|NCT02824679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669439|NCT01730053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25669440|NCT01730053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25669441|NCT01730378|Vaccines|vaccines|mesh-list
25669442|NCT01730378|Immunologic Factors|immunologic factors|mesh-ancestor
25669443|NCT01730378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669444|NCT01730534|Dapagliflozin|dapagliflozin|mesh-list
25669445|NCT01730534|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25669446|NCT01730534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669447|NCT01730534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24868787|NCT02824679|Mydriatics|mydriatics|mesh-ancestor
24868788|NCT02824679|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24868789|NCT02824679|Cholinergic Agents|cholinergic agents|mesh-ancestor
24868790|NCT02824679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24868791|NCT02824679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868792|NCT02824679|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25059093|NCT03491098|Antiemetics|antiemetics|mesh-ancestor
24868793|NCT02824679|Parasympatholytics|parasympatholytics|mesh-ancestor
25201234|NCT02729467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25201235|NCT02729467|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25201236|NCT02729467|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25201237|NCT02729467|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25201238|NCT02729467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25201239|NCT02729324|Protective Agents|protective agents|mesh-list
25201240|NCT02729324|Radiation-Protective Agents|radiation-protective agents|mesh-list
25201241|NCT02729324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201242|NCT02729064|Insulin|insulin|mesh-list
25201243|NCT02729064|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25201244|NCT02729064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25201245|NCT02729064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201246|NCT02728869|Vaccines|vaccines|mesh-list
25201247|NCT02728869|Immunologic Factors|immunologic factors|mesh-ancestor
25201248|NCT02728869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201249|NCT02729012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24868831|NCT01147822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25055172|NCT03523650|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25055173|NCT03523650|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25055174|NCT03523650|Adrenergic Agents|adrenergic agents|mesh-ancestor
25055175|NCT03523650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25055176|NCT03523650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055177|NCT03523650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055178|NCT03523650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25055179|NCT03523650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24809449|NCT02033733|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24809450|NCT02033733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24492974|NCT00488787|Anesthetics|anesthetics|mesh-ancestor
24809451|NCT02033733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492049|NCT00485030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24492071|NCT00485108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24868832|NCT01147822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24868833|NCT01147822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24868834|NCT01147822|Growth Substances|growth substances|mesh-ancestor
25019377|NCT03691688|Antipyretics|antipyretics|mesh-ancestor
24868869|NCT00328653|Dermatologic Agents|dermatologic agents|mesh-ancestor
24868870|NCT00328653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24868871|NCT00328653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24868872|NCT05158777|Vaccines|vaccines|mesh-list
24868873|NCT05158777|Immunologic Factors|immunologic factors|mesh-ancestor
24868874|NCT05158777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868875|NCT05158699|Dexamethasone|dexamethasone|mesh-list
24868876|NCT05158699|Dexamethasone acetate|dexamethasone acetate|mesh-list
24868877|NCT05158699|Triamcinolone|triamcinolone|mesh-list
24868909|NCT05158699|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24868910|NCT05158699|Mydriatics|mydriatics|mesh-ancestor
24868911|NCT05158699|Sympathomimetics|sympathomimetics|mesh-ancestor
24868912|NCT05158699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24868913|NCT05158699|Nasal Decongestants|nasal decongestants|mesh-ancestor
24868914|NCT05158699|Respiratory System Agents|respiratory system agents|mesh-ancestor
24868915|NCT05158699|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24868916|NCT05158699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24868917|NCT05158699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24868918|NCT05158699|Adrenergic Agents|adrenergic agents|mesh-ancestor
24868919|NCT05158699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25864121|NCT00095966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25864122|NCT00096005|Bortezomib|bortezomib|mesh-list
25864123|NCT00096005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864124|NCT00096057|Antibodies|antibodies|mesh-list
25864125|NCT00096057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25864126|NCT00096057|Immunologic Factors|immunologic factors|mesh-ancestor
25864127|NCT00096057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864128|NCT00096070|Gemcitabine|gemcitabine|mesh-list
25864129|NCT00096070|Fluorouracil|fluorouracil|mesh-list
25864130|NCT00096070|Oxaliplatin|oxaliplatin|mesh-list
25864131|NCT00096070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25864132|NCT00096070|Antimetabolites|antimetabolites|mesh-ancestor
25876772|NCT02794571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24784829|NCT01910480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24784830|NCT01910480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24784831|NCT01910480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784832|NCT01910480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25092141|NCT03244462|Antimetabolites|antimetabolites|mesh-ancestor
25092142|NCT03244462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092143|NCT03244462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864133|NCT00096070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864134|NCT00096070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864135|NCT00096070|Antiviral Agents|antiviral agents|mesh-ancestor
24868938|NCT05158426|Propofol|propofol|mesh-list
25201250|NCT02728856|Sunscreening Agents|sunscreening agents|mesh-list
24868939|NCT05158426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24868940|NCT05158426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25201251|NCT02728856|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24868941|NCT05158426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814602|NCT02065752|Canagliflozin|canagliflozin|mesh-list
24814611|NCT02065804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814612|NCT02065804|Sensory System Agents|sensory system agents|mesh-ancestor
24814613|NCT02065804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25864136|NCT00096070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25864137|NCT00096070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864138|NCT00096070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25864139|NCT00096070|Immunologic Factors|immunologic factors|mesh-ancestor
25864140|NCT00096070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864141|NCT00096083|Melphalan|melphalan|mesh-list
25864142|NCT00096083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25864143|NCT00096083|Alkylating Agents|alkylating agents|mesh-ancestor
24868958|NCT05158348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24868959|NCT05158348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24868961|NCT05158348|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24868962|NCT05158348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24868963|NCT05158348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24868964|NCT05158348|Adrenergic Agents|adrenergic agents|mesh-ancestor
24868965|NCT05158348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24868966|NCT05157893|Analgesics|analgesics|mesh-list
24868967|NCT05157893|Sensory System Agents|sensory system agents|mesh-ancestor
24868968|NCT05157893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24868975|NCT05157542|Paclitaxel|paclitaxel|mesh-list
24868980|NCT05157542|Tubulin Modulators|tubulin modulators|mesh-ancestor
24868981|NCT05157542|Antimitotic Agents|antimitotic agents|mesh-ancestor
24868982|NCT05157542|Mitosis Modulators|mitosis modulators|mesh-ancestor
24868983|NCT05157542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868984|NCT05157542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24868986|NCT05157360|Hydrocortisone|hydrocortisone|mesh-list
25864144|NCT00096083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864145|NCT00096083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864146|NCT00096083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25864147|NCT00096083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25864148|NCT00096083|Immunologic Factors|immunologic factors|mesh-ancestor
24869108|NCT04761614|Immunologic Factors|immunologic factors|mesh-ancestor
25864149|NCT00096083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548964|NCT00712686|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24548965|NCT00712686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25055184|NCT03523572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25055185|NCT03523572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25055186|NCT03523572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055187|NCT03523455|Iron protein succinylate|iron protein succinylate|mesh-list
25055191|NCT03523390|Avelumab|avelumab|mesh-list
25055192|NCT03523390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25055193|NCT03523390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25055195|NCT03523221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25055196|NCT03523221|Antiemetics|antiemetics|mesh-ancestor
25055197|NCT03523221|Autonomic Agents|autonomic agents|mesh-ancestor
25055198|NCT03523221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25669448|NCT01730534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669449|NCT01730586|Paclitaxel|paclitaxel|mesh-list
25669450|NCT01730586|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25669451|NCT01730586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25669452|NCT01730586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669453|NCT01730586|Tubulin Modulators|tubulin modulators|mesh-ancestor
25669454|NCT01730586|Antimitotic Agents|antimitotic agents|mesh-ancestor
25669455|NCT01730586|Mitosis Modulators|mitosis modulators|mesh-ancestor
25092204|NCT03243864|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24548966|NCT00712686|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24548967|NCT00712686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24869002|NCT05080946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24869004|NCT05080946|Sensory System Agents|sensory system agents|mesh-ancestor
25201252|NCT02728856|Protective Agents|protective agents|mesh-ancestor
25864150|NCT00096096|Mycophenolic Acid|mycophenolic acid|mesh-list
25864151|NCT00096096|Tacrolimus|tacrolimus|mesh-list
24869005|NCT05080946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24869006|NCT05080946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869007|NCT05080946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24869008|NCT05080946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24869009|NCT05080946|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24869010|NCT05080946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24869011|NCT05080946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869012|NCT05080946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24869013|NCT05080946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24869062|NCT04947592|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24869063|NCT04947592|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24869064|NCT04865939|Gemcitabine|gemcitabine|mesh-list
24869065|NCT04865939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24869066|NCT04865939|Antimetabolites|antimetabolites|mesh-ancestor
24869067|NCT04865939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869068|NCT04865939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25055199|NCT03523221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055200|NCT03523221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25055202|NCT03523221|Hormones|hormones|mesh-ancestor
25055203|NCT03523221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25055204|NCT03523221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25055205|NCT03523221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25055206|NCT03522987|Citalopram|citalopram|mesh-list
25055207|NCT03522987|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25055208|NCT03522987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25055209|NCT03522987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25055210|NCT03522987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055211|NCT03522987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25055212|NCT03522987|Serotonin Agents|serotonin agents|mesh-ancestor
24869078|NCT04831892|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24869079|NCT04831892|Diuretics|diuretics|mesh-ancestor
24869080|NCT04831892|Natriuretic Agents|natriuretic agents|mesh-ancestor
24869081|NCT04831892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869082|NCT04831892|Vasodilator Agents|vasodilator agents|mesh-ancestor
24869096|NCT04761614|Antibodies|antibodies|mesh-list
24869097|NCT04761614|Immunoglobulins|immunoglobulins|mesh-list
24869098|NCT04761614|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24869099|NCT04761614|Immunoglobulin G|immunoglobulin g|mesh-list
24869100|NCT04761614|Calcium|calcium|mesh-list
24869101|NCT04761614|Levoleucovorin|levoleucovorin|mesh-list
24869102|NCT04761614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24869103|NCT04761614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24869104|NCT04761614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24869105|NCT04761614|Growth Substances|growth substances|mesh-ancestor
24869106|NCT04761614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869107|NCT04761614|Growth Inhibitors|growth inhibitors|mesh-ancestor
25055269|NCT03522428|Vitamin B 12|vitamin b 12|mesh-list
24869109|NCT04761614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24869110|NCT04761614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24869112|NCT04761614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869113|NCT04761614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24869114|NCT04761614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24869115|NCT04761614|Antidotes|antidotes|mesh-ancestor
24604637|NCT00980551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055223|NCT03522935|Protease Inhibitors|protease inhibitors|mesh-ancestor
25055224|NCT03522935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055225|NCT03522935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055226|NCT03522922|Ascorbic Acid|ascorbic acid|mesh-list
25055228|NCT03522922|Micronutrients|micronutrients|mesh-ancestor
25055229|NCT03522922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055230|NCT03522922|Antioxidants|antioxidants|mesh-ancestor
25055231|NCT03522922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604638|NCT00980551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25669456|NCT01730586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869116|NCT04761614|Protective Agents|protective agents|mesh-ancestor
24869117|NCT04761614|Vitamin B Complex|vitamin b complex|mesh-ancestor
24869118|NCT04761614|Vitamins|vitamins|mesh-ancestor
25201253|NCT02728856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869120|NCT04761614|Hematinics|hematinics|mesh-ancestor
24869121|NCT04761614|Anticonvulsants|anticonvulsants|mesh-ancestor
24869122|NCT04761614|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25864152|NCT00096096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25864153|NCT00096096|Immunologic Factors|immunologic factors|mesh-ancestor
25864154|NCT00096096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864155|NCT00096096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25864156|NCT00096096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864157|NCT00096096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864158|NCT00096096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25864159|NCT00096096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864160|NCT00096096|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25864161|NCT00096096|Antitubercular Agents|antitubercular agents|mesh-ancestor
25864162|NCT00096096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25864163|NCT00096096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25864164|NCT00096148|Cytarabine|cytarabine|mesh-list
25864165|NCT00096148|Bevacizumab|bevacizumab|mesh-list
25864166|NCT00096148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24869161|NCT04579783|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25055232|NCT03522922|Protective Agents|protective agents|mesh-ancestor
25055233|NCT03522688|Dexmedetomidine|dexmedetomidine|mesh-list
25055234|NCT03522688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25055235|NCT03522688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25055236|NCT03522688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055237|NCT03522688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25055238|NCT03522688|Analgesics|analgesics|mesh-ancestor
25055239|NCT03522688|Sensory System Agents|sensory system agents|mesh-ancestor
24869162|NCT04579783|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24869163|NCT04579783|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24948121|NCT03922815|Propofol|propofol|mesh-list
24869164|NCT04579783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24869166|NCT04579783|Hormones|hormones|mesh-ancestor
24869167|NCT04579783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24869168|NCT04579783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869169|NCT04579783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24814631|NCT02065947|Racepinephrine|racepinephrine|mesh-list
24814632|NCT02065947|Fentanyl|fentanyl|mesh-list
24814633|NCT02065947|Midazolam|midazolam|mesh-list
24814643|NCT02065947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814644|NCT02065947|Sensory System Agents|sensory system agents|mesh-ancestor
24814645|NCT02065947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24814646|NCT02065947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24814647|NCT02065947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24814648|NCT02065947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24814649|NCT02065947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24446721|NCT00305786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24446722|NCT00305786|Antimetabolites|antimetabolites|mesh-ancestor
24446723|NCT00305786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446724|NCT00305786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446725|NCT00305786|Antiviral Agents|antiviral agents|mesh-ancestor
25864167|NCT00096148|Idarubicin|idarubicin|mesh-list
25864168|NCT00096148|Antibodies|antibodies|mesh-list
25864169|NCT00096148|Immunoglobulins|immunoglobulins|mesh-list
25864170|NCT00096148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25055250|NCT03522649|Antimetabolites|antimetabolites|mesh-ancestor
25055251|NCT03522649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055252|NCT03522649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25055253|NCT03522649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864171|NCT00096148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864172|NCT00096148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25055254|NCT03522649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25055255|NCT03522649|Immunologic Factors|immunologic factors|mesh-ancestor
25055256|NCT03522649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622970|NCT01069328|Carboplatin|carboplatin|mesh-list
24622971|NCT01069328|Sorafenib|sorafenib|mesh-list
24869236|NCT04278404|Sertraline|sertraline|mesh-list
24869237|NCT04278404|Tranexamic Acid|tranexamic acid|mesh-list
24869238|NCT04278404|Aminocaproic Acid|aminocaproic acid|mesh-list
24869239|NCT04278404|Terbutaline|terbutaline|mesh-list
24869240|NCT04278404|Sevelamer|sevelamer|mesh-list
24869241|NCT04278404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24869242|NCT04278404|Antiemetics|antiemetics|mesh-ancestor
24869243|NCT04278404|Autonomic Agents|autonomic agents|mesh-ancestor
24869244|NCT04278404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25864173|NCT00096148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24869276|NCT04278404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24869278|NCT04278404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24869279|NCT04278404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24869280|NCT04278404|Respiratory System Agents|respiratory system agents|mesh-ancestor
24869281|NCT04278404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24869282|NCT04278404|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24869283|NCT04278404|Hemostatics|hemostatics|mesh-ancestor
24869284|NCT04278404|Coagulants|coagulants|mesh-ancestor
24869285|NCT04278404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24869286|NCT04278404|Narcotics|narcotics|mesh-ancestor
24869287|NCT04278404|Anticonvulsants|anticonvulsants|mesh-ancestor
24869288|NCT04278404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24869289|NCT04278404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25019775|NCT03688191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24869302|NCT04278404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24869303|NCT04278404|Diuretics|diuretics|mesh-ancestor
24869304|NCT04278404|Natriuretic Agents|natriuretic agents|mesh-ancestor
24869305|NCT04278404|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24869306|NCT04278404|Gout Suppressants|gout suppressants|mesh-ancestor
24869307|NCT04278404|Tubulin Modulators|tubulin modulators|mesh-ancestor
24508722|NCT00556621|Antimetabolites|antimetabolites|mesh-ancestor
24869308|NCT04278404|Antimitotic Agents|antimitotic agents|mesh-ancestor
24869309|NCT04278404|Mitosis Modulators|mitosis modulators|mesh-ancestor
24869310|NCT04278404|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24869311|NCT04278404|Hormone Antagonists|hormone antagonists|mesh-ancestor
25864174|NCT00096148|Growth Substances|growth substances|mesh-ancestor
25864175|NCT00096148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864176|NCT00096148|Growth Inhibitors|growth inhibitors|mesh-ancestor
25864177|NCT00096148|Immunologic Factors|immunologic factors|mesh-ancestor
25864178|NCT00096148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25864179|NCT00096148|Antimetabolites|antimetabolites|mesh-ancestor
25213965|NCT03863587|Ramucirumab|ramucirumab|mesh-list
25864180|NCT00096148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864181|NCT00096148|Antiviral Agents|antiviral agents|mesh-ancestor
25864182|NCT00096148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25055257|NCT03522649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25055258|NCT03522649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25055259|NCT03522649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055260|NCT03522649|Antidotes|antidotes|mesh-ancestor
25055261|NCT03522649|Protective Agents|protective agents|mesh-ancestor
25055262|NCT03522649|Vitamin B Complex|vitamin b complex|mesh-ancestor
25055263|NCT03522649|Vitamins|vitamins|mesh-ancestor
25055268|NCT03522532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055272|NCT03522428|Micronutrients|micronutrients|mesh-ancestor
25055273|NCT03522428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055274|NCT03522428|Vitamin B Complex|vitamin b complex|mesh-ancestor
25055275|NCT03522428|Hematinics|hematinics|mesh-ancestor
25055276|NCT03522402|Sevoflurane|sevoflurane|mesh-list
24622975|NCT01069328|Antimitotic Agents|antimitotic agents|mesh-ancestor
24622976|NCT01069328|Mitosis Modulators|mitosis modulators|mesh-ancestor
24598106|NCT00954005|Rituximab|rituximab|mesh-list
24493206|NCT00489944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25864183|NCT00096148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24493241|NCT00490113|Vitamin B Complex|vitamin b complex|mesh-ancestor
24493242|NCT00490113|Vitamins|vitamins|mesh-ancestor
24493243|NCT00490113|Micronutrients|micronutrients|mesh-ancestor
25201254|NCT02728856|Dermatologic Agents|dermatologic agents|mesh-ancestor
25201255|NCT02728947|Rotigotine|rotigotine|mesh-list
25201256|NCT02728947|Dopamine Agonists|dopamine agonists|mesh-ancestor
24493244|NCT00490113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442996|NCT00293436|Celecoxib|celecoxib|mesh-list
24493245|NCT00490178|Metformin|metformin|mesh-list
25019831|NCT03687268|Naloxone|naloxone|mesh-list
25864184|NCT00096148|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25864185|NCT00096148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25864186|NCT00096148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25864187|NCT00096148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864188|NCT00096187|Pemetrexed|pemetrexed|mesh-list
25055277|NCT03522402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25055278|NCT03522402|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25055279|NCT03522402|Anesthetics, General|anesthetics, general|mesh-ancestor
25055280|NCT03522402|Anesthetics|anesthetics|mesh-ancestor
25055281|NCT03522402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25055282|NCT03522402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622977|NCT01069328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995281|NCT05410496|Tenofovir|tenofovir|mesh-list
24622978|NCT01069328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24622979|NCT01069328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24622980|NCT01069328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24598204|NCT00954525|Antioxidants|antioxidants|mesh-ancestor
24493425|NCT00490880|Immunologic Factors|immunologic factors|mesh-ancestor
24493426|NCT00490880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493459|NCT00490997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24493460|NCT00490997|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24493461|NCT00490997|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25864189|NCT00096187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864190|NCT00096187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864191|NCT00096187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864192|NCT00096187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25864193|NCT00096187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25864194|NCT00096291|Paclitaxel|paclitaxel|mesh-list
25864195|NCT00096291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25864196|NCT00096291|Doxorubicin|doxorubicin|mesh-list
24869380|NCT04234477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24869381|NCT04234477|Vasodilator Agents|vasodilator agents|mesh-ancestor
24869382|NCT04217967|Lenalidomide|lenalidomide|mesh-list
24869383|NCT04217967|Ixazomib|ixazomib|mesh-list
24869384|NCT04217967|Immunologic Factors|immunologic factors|mesh-ancestor
24869385|NCT04217967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869386|NCT04217967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24869387|NCT04217967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24869388|NCT04217967|Growth Substances|growth substances|mesh-ancestor
24869389|NCT04217967|Growth Inhibitors|growth inhibitors|mesh-ancestor
24869390|NCT04217967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24869391|NCT04217967|Protease Inhibitors|protease inhibitors|mesh-ancestor
25864197|NCT00096291|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25055287|NCT03522207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25055288|NCT03522207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24786425|NCT01919918|Sensory System Agents|sensory system agents|mesh-ancestor
25055289|NCT03522207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25055291|NCT03522207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24622981|NCT01069328|Growth Substances|growth substances|mesh-ancestor
24622982|NCT01069328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864198|NCT00096291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25864199|NCT00096291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864200|NCT00096291|Tubulin Modulators|tubulin modulators|mesh-ancestor
25864201|NCT00096291|Antimitotic Agents|antimitotic agents|mesh-ancestor
25864202|NCT00096291|Mitosis Modulators|mitosis modulators|mesh-ancestor
25864203|NCT00096291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864204|NCT00096291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25864205|NCT00096291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25864206|NCT00096291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25864207|NCT00096291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864208|NCT00096304|Docetaxel|docetaxel|mesh-list
25864209|NCT00096304|Epirubicin|epirubicin|mesh-list
25864210|NCT00096304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864211|NCT00096304|Tubulin Modulators|tubulin modulators|mesh-ancestor
25864212|NCT00096304|Antimitotic Agents|antimitotic agents|mesh-ancestor
25864213|NCT00096304|Mitosis Modulators|mitosis modulators|mesh-ancestor
24446727|NCT00305786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864214|NCT00096304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864215|NCT00096304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25864216|NCT00096304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25055293|NCT03522207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25055294|NCT03522207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25055295|NCT03522207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055296|NCT03522207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25055298|NCT03522207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25055299|NCT03522207|Antidepressive Agents|antidepressive agents|mesh-ancestor
25055300|NCT03522194|Propofol|propofol|mesh-list
25055301|NCT03522194|Sevoflurane|sevoflurane|mesh-list
25055302|NCT03522194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25055303|NCT03522194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25055304|NCT03522194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055305|NCT03522194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25055306|NCT03522194|Anesthetics, General|anesthetics, general|mesh-ancestor
24869498|NCT03238534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24869499|NCT03238534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869500|NCT03223350|Capsaicin|capsaicin|mesh-list
24869501|NCT03223350|Antipruritics|antipruritics|mesh-ancestor
24869502|NCT03223350|Dermatologic Agents|dermatologic agents|mesh-ancestor
24869503|NCT03223350|Sensory System Agents|sensory system agents|mesh-ancestor
24869504|NCT03223350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25055308|NCT03522194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25055309|NCT03522194|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25055310|NCT03522181|Insulin|insulin|mesh-list
24869505|NCT03223350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869506|NCT03197467|Pembrolizumab|pembrolizumab|mesh-list
24814654|NCT02065947|Analgesics|analgesics|mesh-ancestor
24814655|NCT02065947|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24814656|NCT02065947|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24814657|NCT02065947|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24814662|NCT02065947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24814663|NCT02065947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24814664|NCT02065947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24814665|NCT02065947|GABA Modulators|gaba modulators|mesh-ancestor
24814666|NCT02065947|GABA Agents|gaba agents|mesh-ancestor
25864217|NCT00096304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25864218|NCT00096304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864219|NCT00096317|Ketoconazole|ketoconazole|mesh-list
25864220|NCT00096317|Antifungal Agents|antifungal agents|mesh-ancestor
25864221|NCT00096317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25864222|NCT00096317|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25864223|NCT00096317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25864224|NCT00096317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864225|NCT00096317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864226|NCT00096317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25055311|NCT03522181|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25055312|NCT03522181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24809481|NCT02033967|Protective Agents|protective agents|mesh-ancestor
25864227|NCT00096317|Hormone Antagonists|hormone antagonists|mesh-ancestor
25864228|NCT00096317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25864229|NCT00096317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864230|NCT00096317|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25864231|NCT00096330|Folic Acid|folic acid|mesh-list
25864232|NCT00096330|Hematinics|hematinics|mesh-ancestor
25864233|NCT00096330|Vitamin B Complex|vitamin b complex|mesh-ancestor
25864234|NCT00096330|Vitamins|vitamins|mesh-ancestor
25864235|NCT00096330|Micronutrients|micronutrients|mesh-ancestor
25864236|NCT00096330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201257|NCT02728947|Dopamine Agents|dopamine agents|mesh-ancestor
25201258|NCT02728947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25201259|NCT02728947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201260|NCT02728947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201262|NCT02728934|Infliximab|infliximab|mesh-list
25201263|NCT02728934|Dermatologic Agents|dermatologic agents|mesh-ancestor
24814673|NCT02065947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24814674|NCT02065947|Autonomic Agents|autonomic agents|mesh-ancestor
24814675|NCT02065947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24869507|NCT03197467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24869509|NCT03193931|Pembrolizumab|pembrolizumab|mesh-list
24869518|NCT03193931|Antimetabolites|antimetabolites|mesh-ancestor
24869519|NCT03193931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869520|NCT03193931|Dermatologic Agents|dermatologic agents|mesh-ancestor
24869521|NCT03193931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24869522|NCT03193931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24869523|NCT03193931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24869524|NCT03193931|Immunologic Factors|immunologic factors|mesh-ancestor
24446756|NCT00305825|Letrozole|letrozole|mesh-list
25864237|NCT00096343|Paclitaxel|paclitaxel|mesh-list
25055313|NCT03522181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938724|NCT04016740|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24938725|NCT04016740|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24938726|NCT04016740|Anesthetics, Local|anesthetics, local|mesh-ancestor
24938727|NCT04016740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24938728|NCT04016740|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24938729|NCT04016740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24938730|NCT04016740|Narcotics|narcotics|mesh-ancestor
24549486|NCT00715637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549487|NCT00715637|Antiviral Agents|antiviral agents|mesh-ancestor
24549488|NCT00715637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24549489|NCT00715637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25201264|NCT02728934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25201265|NCT02728934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25201266|NCT02728934|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25201267|NCT02728934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25201268|NCT02728934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25201269|NCT02728934|Immunologic Factors|immunologic factors|mesh-ancestor
25431187|NCT01168219|Busulfan|busulfan|mesh-list
25864238|NCT00096343|Carboplatin|carboplatin|mesh-list
25092573|NCT03241017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25092579|NCT03240822|Antibodies|antibodies|mesh-list
25092580|NCT03240822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25092581|NCT03240822|Tacrolimus|tacrolimus|mesh-list
25092582|NCT03240822|Immunologic Factors|immunologic factors|mesh-ancestor
25092583|NCT03240822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092584|NCT03240822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25201270|NCT02728934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201271|NCT02729103|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25201272|NCT02729103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864239|NCT00096343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25864240|NCT00096343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864241|NCT00096343|Tubulin Modulators|tubulin modulators|mesh-ancestor
24549490|NCT00715637|Immunologic Factors|immunologic factors|mesh-ancestor
24549491|NCT00715637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549492|NCT00715637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24869525|NCT03193931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24869526|NCT03193931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24869527|NCT03181828|Acetohydroxamic acid|acetohydroxamic acid|mesh-list
24869528|NCT03181828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24869529|NCT03181828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869530|NCT03181529|Psilocybin|psilocybin|mesh-list
24869531|NCT03181529|Hallucinogens|hallucinogens|mesh-ancestor
24869532|NCT03181529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869535|NCT03164928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24869536|NCT03164928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869551|NCT02891538|Antioxidants|antioxidants|mesh-ancestor
24952463|NCT03894007|Tubulin Modulators|tubulin modulators|mesh-ancestor
24952464|NCT03894007|Antimitotic Agents|antimitotic agents|mesh-ancestor
24952465|NCT03894007|Mitosis Modulators|mitosis modulators|mesh-ancestor
24952466|NCT03894007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952467|NCT03894007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24952468|NCT03894007|Immunologic Factors|immunologic factors|mesh-ancestor
24952469|NCT03894007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809492|NCT02034071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24809493|NCT02034071|Vasodilator Agents|vasodilator agents|mesh-ancestor
24809494|NCT02034097|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24809495|NCT02034097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24869557|NCT02891538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24869558|NCT02891538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24869559|NCT02840136|Meropenem|meropenem|mesh-list
24869560|NCT02840136|Tazobactam|tazobactam|mesh-list
24869561|NCT02840136|Piperacillin|piperacillin|mesh-list
24869562|NCT02840136|Ceftazidime|ceftazidime|mesh-list
25201273|NCT02728843|Deferiprone|deferiprone|mesh-list
25201274|NCT02728843|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25201275|NCT02728843|Chelating Agents|chelating agents|mesh-ancestor
25201276|NCT02728843|Sequestering Agents|sequestering agents|mesh-ancestor
25201277|NCT02728843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201278|NCT02728518|Amikacin|amikacin|mesh-list
25201279|NCT02728518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25201280|NCT02728518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25201281|NCT02728700|Mycophenolic Acid|mycophenolic acid|mesh-list
25201282|NCT02728700|Sirolimus|sirolimus|mesh-list
25201283|NCT02728700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25201284|NCT02728700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201285|NCT02728700|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25201286|NCT02728700|Antitubercular Agents|antitubercular agents|mesh-ancestor
24869566|NCT02840136|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24952477|NCT03894007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24952478|NCT03894007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24778144|NCT01869556|Oxytocin|oxytocin|mesh-list
24952480|NCT03893695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24952481|NCT03893695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809496|NCT02034097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24809497|NCT02034097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25669457|NCT01730729|Cabergoline|cabergoline|mesh-list
25669458|NCT01730729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25669459|NCT01730729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25669460|NCT01730729|Dopamine Agonists|dopamine agonists|mesh-ancestor
25669461|NCT01730729|Dopamine Agents|dopamine agents|mesh-ancestor
25669462|NCT01730729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25669463|NCT01730729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25431188|NCT01168219|Tacrolimus|tacrolimus|mesh-list
25669464|NCT01730729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669465|NCT01730846|Doxazosin|doxazosin|mesh-list
25669466|NCT01730846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25092628|NCT03240471|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
24809499|NCT02034201|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
24869568|NCT02840136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869569|NCT02820961|Exemestane|exemestane|mesh-list
24869570|NCT02820961|Entinostat|entinostat|mesh-list
24869571|NCT02820961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24869572|NCT02820961|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24869573|NCT02820961|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24869574|NCT02820961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952538|NCT03893526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24869596|NCT02704390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24952482|NCT03893695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24952514|NCT03893630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24952515|NCT03893630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952517|NCT03893630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24952518|NCT03893630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24869597|NCT02704390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869598|NCT02704390|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24869599|NCT02704390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24869600|NCT02704390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24869601|NCT02704390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869602|NCT02704390|Dopamine Agents|dopamine agents|mesh-ancestor
24869603|NCT02704390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24869605|NCT02643381|Etomidate|etomidate|mesh-list
24869606|NCT02643381|Analgesics|analgesics|mesh-ancestor
24869607|NCT02643381|Sensory System Agents|sensory system agents|mesh-ancestor
24869608|NCT02643381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25864242|NCT00096343|Antimitotic Agents|antimitotic agents|mesh-ancestor
24869630|NCT02595372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24869631|NCT02595372|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24869643|NCT01952288|Simvastatin|simvastatin|mesh-list
24869644|NCT01952288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24869645|NCT01952288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24869646|NCT01952288|Antimetabolites|antimetabolites|mesh-ancestor
24869647|NCT01952288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869648|NCT01952288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24869649|NCT01952288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24869650|NCT01952288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864243|NCT00096343|Mitosis Modulators|mitosis modulators|mesh-ancestor
25864244|NCT00096343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864245|NCT00096369|Tamoxifen|tamoxifen|mesh-list
25864246|NCT00096369|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25864247|NCT00096369|Hormone Antagonists|hormone antagonists|mesh-ancestor
24952519|NCT03893630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24952520|NCT03893630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952521|NCT03893630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24952522|NCT03893630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24952524|NCT03893630|Antipyretics|antipyretics|mesh-ancestor
24952525|NCT03893747|Vaccines|vaccines|mesh-list
24952526|NCT03893747|Immunologic Factors|immunologic factors|mesh-ancestor
24952527|NCT03893747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952528|NCT03893526|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24952529|NCT03893526|Valsartan|valsartan|mesh-list
24952530|NCT03893526|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24952531|NCT03893526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24952532|NCT03893526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952533|NCT03893526|Incretins|incretins|mesh-ancestor
24952534|NCT03893526|Hormones|hormones|mesh-ancestor
24952535|NCT03893526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24952536|NCT03893526|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24952537|NCT03893526|Protease Inhibitors|protease inhibitors|mesh-ancestor
25020291|NCT03681548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952548|NCT03893435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952549|NCT03893097|Artesunate|artesunate|mesh-list
24952550|NCT03893097|Mefloquine|mefloquine|mesh-list
25669467|NCT01730846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25669468|NCT01730846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25669469|NCT01730846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25669470|NCT01730846|Adrenergic Agents|adrenergic agents|mesh-ancestor
25669471|NCT01730846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25669472|NCT01730846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092696|NCT03239964|Antiemetics|antiemetics|mesh-ancestor
25092697|NCT03239964|Autonomic Agents|autonomic agents|mesh-ancestor
25092701|NCT03239964|Glucocorticoids|glucocorticoids|mesh-ancestor
25092702|NCT03239964|Hormones|hormones|mesh-ancestor
25092703|NCT03239964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24985544|NCT03187769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24985545|NCT03187769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24985546|NCT03187769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24985547|NCT03187769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24985548|NCT03187769|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24985549|NCT03187769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25092751|NCT03239314|Hormones|hormones|mesh-ancestor
24952551|NCT03893097|Praziquantel|praziquantel|mesh-list
25020355|NCT03680638|Allopurinol|allopurinol|mesh-list
25055333|NCT03522077|Hemostatics|hemostatics|mesh-list
25055334|NCT03522077|Coagulants|coagulants|mesh-ancestor
25055335|NCT03522051|Calcium|calcium|mesh-list
24809555|NCT02034500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809556|NCT02034604|Tamsulosin|tamsulosin|mesh-list
24809557|NCT02034604|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24809558|NCT02034604|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24809560|NCT02034604|Adrenergic Agents|adrenergic agents|mesh-ancestor
24809561|NCT02034604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24809562|NCT02034604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809563|NCT02034604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494639|NCT00496223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494640|NCT00496223|Growth Inhibitors|growth inhibitors|mesh-ancestor
24494641|NCT00496223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24494642|NCT00496223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24494643|NCT00496223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864248|NCT00096369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25864249|NCT00096369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494661|NCT00496275|Antimitotic Agents|antimitotic agents|mesh-ancestor
24494662|NCT00496275|Mitosis Modulators|mitosis modulators|mesh-ancestor
24494663|NCT00496301|Gemcitabine|gemcitabine|mesh-list
24494664|NCT00496301|Capecitabine|capecitabine|mesh-list
24494665|NCT00496301|Sorafenib|sorafenib|mesh-list
24494666|NCT00496301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24494667|NCT00496301|Antimetabolites|antimetabolites|mesh-ancestor
24494685|NCT00496392|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24494686|NCT00496392|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24494687|NCT00496392|Anesthetics, General|anesthetics, general|mesh-ancestor
24494689|NCT00496405|Bevacizumab|bevacizumab|mesh-list
24494690|NCT00496405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24494691|NCT00496405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201289|NCT02728700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809620|NCT02035215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201291|NCT02728700|Antifungal Agents|antifungal agents|mesh-ancestor
25201292|NCT02728700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25201293|NCT02728700|Immunologic Factors|immunologic factors|mesh-ancestor
25201294|NCT02728700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864250|NCT00096369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24809583|NCT02034838|Antiviral Agents|antiviral agents|mesh-ancestor
24809584|NCT02034838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24809585|NCT02034838|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24809587|NCT02034890|Hyaluronic Acid|hyaluronic acid|mesh-list
25055361|NCT03521726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25055362|NCT03521726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055363|NCT03521726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055364|NCT03521713|Epoetin Alfa|epoetin alfa|mesh-list
25055365|NCT03521713|Hematinics|hematinics|mesh-ancestor
25055366|NCT03521700|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25055367|NCT03521700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25669473|NCT01730846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669474|NCT01730872|Prednisolone|prednisolone|mesh-list
25669475|NCT01730872|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25669476|NCT01730872|Methylprednisolone|methylprednisolone|mesh-list
25669477|NCT01730872|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25669478|NCT01730872|Prednisolone acetate|prednisolone acetate|mesh-list
25669479|NCT01730872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25669480|NCT01730872|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25669481|NCT01730872|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25669482|NCT01730872|Prednisolone phosphate|prednisolone phosphate|mesh-list
25669483|NCT01730872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25669484|NCT01730872|Glucocorticoids|glucocorticoids|mesh-ancestor
25669485|NCT01730872|Hormones|hormones|mesh-ancestor
25092799|NCT03238703|Toremifene|toremifene|mesh-list
25092800|NCT03238703|Letrozole|letrozole|mesh-list
25092801|NCT03238703|Anastrozole|anastrozole|mesh-list
25092802|NCT03238703|Exemestane|exemestane|mesh-list
25092803|NCT03238703|Citric Acid|citric acid|mesh-list
25092804|NCT03238703|Sodium Citrate|sodium citrate|mesh-list
25092805|NCT03238703|Anticoagulants|anticoagulants|mesh-ancestor
25092806|NCT03238703|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25092807|NCT03238703|Chelating Agents|chelating agents|mesh-ancestor
25092808|NCT03238703|Sequestering Agents|sequestering agents|mesh-ancestor
25092810|NCT03238703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25092817|NCT03238703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055368|NCT03521700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25055369|NCT03521700|Antimetabolites|antimetabolites|mesh-ancestor
24809589|NCT02034890|Immunologic Factors|immunologic factors|mesh-ancestor
24809590|NCT02034890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809591|NCT02034890|Viscosupplements|viscosupplements|mesh-ancestor
24809592|NCT02034890|Protective Agents|protective agents|mesh-ancestor
24809594|NCT02034968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24809595|NCT02034968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494818|NCT00497172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24494819|NCT00497172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494820|NCT00497172|Antifungal Agents|antifungal agents|mesh-ancestor
24494821|NCT00497172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24494822|NCT00497172|Immunologic Factors|immunologic factors|mesh-ancestor
24494823|NCT00497172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494824|NCT00497224|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24494825|NCT00497224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494826|NCT00497224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24494827|NCT00497224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864251|NCT00096369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864252|NCT00096369|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25864253|NCT00096369|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25864254|NCT00096369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24494913|NCT00497497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494914|NCT00497523|Beclomethasone|beclomethasone|mesh-list
25864255|NCT00096395|Gemcitabine|gemcitabine|mesh-list
25864256|NCT00096395|Sorafenib|sorafenib|mesh-list
25864257|NCT00096395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25864258|NCT00096395|Antimetabolites|antimetabolites|mesh-ancestor
25864259|NCT00096395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864260|NCT00096395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25055372|NCT03521700|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25055373|NCT03521700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055374|NCT03521492|Vitamin D|vitamin d|mesh-list
25055375|NCT03521492|Calcium|calcium|mesh-list
25055376|NCT03521492|Parathyroid Hormone|parathyroid hormone|mesh-list
25055377|NCT03521492|Hormones|hormones|mesh-list
25864261|NCT00096395|Antiviral Agents|antiviral agents|mesh-ancestor
25201295|NCT02728453|Empagliflozin|empagliflozin|mesh-list
25201296|NCT02728453|Glimepiride|glimepiride|mesh-list
25201297|NCT02728453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25201298|NCT02728453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869675|NCT01023737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24869676|NCT01023737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24869677|NCT01023737|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24869678|NCT00741988|Bevacizumab|bevacizumab|mesh-list
24869679|NCT00741988|Carboplatin|carboplatin|mesh-list
24869680|NCT00741988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25864262|NCT00096395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25864263|NCT00096395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864264|NCT00096395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25864265|NCT00096395|Immunologic Factors|immunologic factors|mesh-ancestor
25669486|NCT01730872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25669487|NCT01730872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669488|NCT01730872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25669489|NCT01730872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669490|NCT01730872|Antiemetics|antiemetics|mesh-ancestor
25669491|NCT01730872|Autonomic Agents|autonomic agents|mesh-ancestor
25669492|NCT01730872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25669493|NCT01730872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25669494|NCT01730872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25669495|NCT01730872|Protective Agents|protective agents|mesh-ancestor
25864266|NCT00096395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864267|NCT00096395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25864268|NCT00096434|Sorafenib|sorafenib|mesh-list
24985596|NCT03110380|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24985597|NCT03110380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092922|NCT03238092|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25864269|NCT00096434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864270|NCT00096434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25864271|NCT00096434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055379|NCT03521492|Micronutrients|micronutrients|mesh-ancestor
25055380|NCT03521492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055381|NCT03521492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25055382|NCT03521492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25055383|NCT03521492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25055384|NCT03521414|Sevoflurane|sevoflurane|mesh-list
25055385|NCT03521414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25055386|NCT03521414|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24809605|NCT02035072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864272|NCT00096434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864273|NCT00096473|Donepezil|donepezil|mesh-list
25864274|NCT00096473|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25864275|NCT00096473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864276|NCT00096473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869691|NCT00568997|Sensory System Agents|sensory system agents|mesh-ancestor
24869692|NCT00568997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24869693|NCT00568997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869694|NCT00568997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24869695|NCT00568997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24869696|NCT00568997|Dermatologic Agents|dermatologic agents|mesh-ancestor
24869697|NCT00568997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24869698|NCT00568997|Immunologic Factors|immunologic factors|mesh-ancestor
24869699|NCT00568997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24869700|NCT00568997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24869701|NCT00568997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869702|NCT00563576|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24869703|NCT00563576|Medroxyprogesterone|medroxyprogesterone|mesh-list
25864277|NCT00096473|Cholinergic Agents|cholinergic agents|mesh-ancestor
25201299|NCT02728453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25201300|NCT02728453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201301|NCT02728453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25201302|NCT02728453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25201303|NCT02728453|Immunologic Factors|immunologic factors|mesh-ancestor
25201304|NCT02728622|Tamoxifen|tamoxifen|mesh-list
25201305|NCT02728622|Paclitaxel|paclitaxel|mesh-list
25201306|NCT02728622|Doxorubicin|doxorubicin|mesh-list
25055390|NCT03521414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055392|NCT03521245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25055393|NCT03521245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25055394|NCT03521219|Apatinib|apatinib|mesh-list
25055395|NCT03521219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24938733|NCT04016740|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25055396|NCT03521219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24809613|NCT02035215|Atorvastatin|atorvastatin|mesh-list
24809614|NCT02035215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24809615|NCT02035215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24809616|NCT02035215|Antimetabolites|antimetabolites|mesh-ancestor
24809617|NCT02035215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809618|NCT02035215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24495037|NCT00498134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24495038|NCT00498134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495039|NCT00498134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24495040|NCT00498134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25020627|NCT03678792|Tramadol|tramadol|mesh-list
24549686|NCT00716924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25055397|NCT03521219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055398|NCT03521219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055400|NCT03521167|Lidocaine|lidocaine|mesh-list
25055401|NCT03521167|Dexmedetomidine|dexmedetomidine|mesh-list
25055402|NCT03521167|Ketamine|ketamine|mesh-list
25055403|NCT03521167|Gabapentin|gabapentin|mesh-list
25055404|NCT03521167|Anesthetics, Local|anesthetics, local|mesh-ancestor
25055405|NCT03521167|Anesthetics|anesthetics|mesh-ancestor
25055406|NCT03521167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25669496|NCT01730950|Bevacizumab|bevacizumab|mesh-list
25669497|NCT01730950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25669498|NCT01730950|Antibodies|antibodies|mesh-list
25669499|NCT01730950|Immunoglobulins|immunoglobulins|mesh-list
25669500|NCT01730950|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25093033|NCT03237416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25093034|NCT03237416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093035|NCT03237416|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25093036|NCT03237416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25093043|NCT03237416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25093044|NCT03237416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093045|NCT03237416|Antithrombins|antithrombins|mesh-ancestor
25093046|NCT03237416|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25093047|NCT03237416|Protease Inhibitors|protease inhibitors|mesh-ancestor
25093049|NCT03237416|Anticoagulants|anticoagulants|mesh-ancestor
25055407|NCT03521167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809619|NCT02035215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24809622|NCT02035371|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24809623|NCT02035371|Insulin Aspart|insulin aspart|mesh-list
24809624|NCT02035371|Insulin, Long-Acting|insulin, long-acting|mesh-list
24809625|NCT02035371|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24809626|NCT02035371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24809627|NCT02035371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809628|NCT02035397|Botulinum Toxins|botulinum toxins|mesh-list
24495077|NCT00498316|Clofarabine|clofarabine|mesh-list
24495078|NCT00498316|Tacrolimus|tacrolimus|mesh-list
24495079|NCT00498316|Thymoglobulin|thymoglobulin|mesh-list
24495080|NCT00498316|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24495081|NCT00498316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24884924|NCT03193333|Timolol|timolol|mesh-list
25201307|NCT02728622|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25201308|NCT02728622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25201309|NCT02728622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201310|NCT02728622|Tubulin Modulators|tubulin modulators|mesh-ancestor
25201311|NCT02728622|Antimitotic Agents|antimitotic agents|mesh-ancestor
25201312|NCT02728622|Mitosis Modulators|mitosis modulators|mesh-ancestor
25201313|NCT02728622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201314|NCT02728622|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24809629|NCT02035397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24809630|NCT02035397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24809631|NCT02035397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24809632|NCT02035397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24809655|NCT02035709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24599593|NCT04237012|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25864278|NCT00096473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25864279|NCT00096473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864280|NCT00096473|Nootropic Agents|nootropic agents|mesh-ancestor
25864281|NCT00096512|Sorafenib|sorafenib|mesh-list
25864282|NCT00096512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24869747|NCT05160623|Blood Substitutes|blood substitutes|mesh-ancestor
24869748|NCT05160623|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24869749|NCT05160623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24869750|NCT05160506|Hydrocortisone|hydrocortisone|mesh-list
24869751|NCT05160506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24869752|NCT05160298|Ropivacaine|ropivacaine|mesh-list
24869753|NCT05160298|Anesthetics, Local|anesthetics, local|mesh-ancestor
24869754|NCT05160298|Anesthetics|anesthetics|mesh-ancestor
24869755|NCT05160298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24869756|NCT05160298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869757|NCT05160298|Sensory System Agents|sensory system agents|mesh-ancestor
24869758|NCT05160298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24869759|NCT05160285|Nivolumab|nivolumab|mesh-list
24869780|NCT05159674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24869782|NCT05159674|Sensory System Agents|sensory system agents|mesh-ancestor
25055416|NCT03521167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25055417|NCT03521167|Analgesics|analgesics|mesh-ancestor
25055418|NCT03521167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25055419|NCT03521167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25055420|NCT03521167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25669501|NCT01730950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669502|NCT01730950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25669503|NCT01730950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25669504|NCT01730950|Growth Substances|growth substances|mesh-ancestor
25669505|NCT01730950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669506|NCT01730950|Growth Inhibitors|growth inhibitors|mesh-ancestor
25669507|NCT01730950|Immunologic Factors|immunologic factors|mesh-ancestor
25669508|NCT01731002|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25669509|NCT01731002|Latanoprost|latanoprost|mesh-list
25669510|NCT01731002|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25669511|NCT01731041|Ticagrelor|ticagrelor|mesh-list
25864283|NCT00096512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25055421|NCT03521167|Adrenergic Agents|adrenergic agents|mesh-ancestor
25055422|NCT03521167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25055423|NCT03521167|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24809657|NCT02035709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24809659|NCT02035709|Analgesics|analgesics|mesh-ancestor
24869783|NCT05159674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24869784|NCT05159674|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24869785|NCT05159674|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24869786|NCT05159674|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24869787|NCT05159674|Adrenergic Agents|adrenergic agents|mesh-ancestor
24869788|NCT05159674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24869789|NCT05159674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869790|NCT05159531|Tenofovir|tenofovir|mesh-list
24869791|NCT05159531|Emtricitabine|emtricitabine|mesh-list
24869792|NCT05159531|Antiviral Agents|antiviral agents|mesh-ancestor
24869793|NCT05159531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25864284|NCT00096512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055424|NCT03521167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25055425|NCT03521167|Anesthetics, General|anesthetics, general|mesh-ancestor
25055454|NCT03521024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25055426|NCT03521167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25055427|NCT03521167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25055428|NCT03521167|Anticonvulsants|anticonvulsants|mesh-ancestor
25055429|NCT03521167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25864285|NCT00096512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864286|NCT00096525|Lenalidomide|lenalidomide|mesh-list
24869798|NCT05159531|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24869799|NCT05159531|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24869800|NCT05159284|Hydrocortisone|hydrocortisone|mesh-list
24869801|NCT05159284|Lubricant Eye Drops|lubricant eye drops|mesh-list
24869802|NCT05159284|Hyaluronic Acid|hyaluronic acid|mesh-list
24869803|NCT05159284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24869804|NCT05159284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24869805|NCT05159284|Immunologic Factors|immunologic factors|mesh-ancestor
24869806|NCT05159284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869807|NCT05159284|Viscosupplements|viscosupplements|mesh-ancestor
24869808|NCT05159284|Protective Agents|protective agents|mesh-ancestor
24869809|NCT05159284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24869810|NCT05159284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25864287|NCT00096525|Immunologic Factors|immunologic factors|mesh-ancestor
25864288|NCT00096525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864289|NCT00096525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25055437|NCT03521063|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25055438|NCT03521063|Autonomic Agents|autonomic agents|mesh-ancestor
25055439|NCT03521063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25055440|NCT03521063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055441|NCT03521063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25055442|NCT03521063|Respiratory System Agents|respiratory system agents|mesh-ancestor
25055443|NCT03521063|Glucocorticoids|glucocorticoids|mesh-ancestor
25055444|NCT03521063|Hormones|hormones|mesh-ancestor
24809666|NCT02035800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24809667|NCT02035800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24809668|NCT02035891|Colchicine|colchicine|mesh-list
24809669|NCT02035891|Gout Suppressants|gout suppressants|mesh-ancestor
24809670|NCT02035891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24809671|NCT02035891|Tubulin Modulators|tubulin modulators|mesh-ancestor
24809672|NCT02035891|Antimitotic Agents|antimitotic agents|mesh-ancestor
25864290|NCT00096525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25864291|NCT00096525|Growth Substances|growth substances|mesh-ancestor
25864292|NCT00096525|Growth Inhibitors|growth inhibitors|mesh-ancestor
24869818|NCT05150431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24869819|NCT05150431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869820|NCT05150431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24869821|NCT05150431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24869823|NCT05150431|Sensory System Agents|sensory system agents|mesh-ancestor
24869824|NCT05150431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24869825|NCT05150431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055445|NCT03521063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25055446|NCT03521063|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
25055449|NCT03521024|Antidepressive Agents|antidepressive agents|mesh-ancestor
25055450|NCT03521024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25055451|NCT03521024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055452|NCT03521024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809673|NCT02035891|Mitosis Modulators|mitosis modulators|mesh-ancestor
25404128|NCT03682978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24809674|NCT02035891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809675|NCT02035891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495334|NCT00499642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495335|NCT00499668|Ondansetron|ondansetron|mesh-list
24495336|NCT00499668|Aprepitant|aprepitant|mesh-list
24495337|NCT00499668|Antiemetics|antiemetics|mesh-ancestor
24495338|NCT00499668|Autonomic Agents|autonomic agents|mesh-ancestor
24495339|NCT00499668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24495340|NCT00499668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495341|NCT00499668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24495342|NCT00499668|Antipruritics|antipruritics|mesh-ancestor
24495350|NCT00499668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24495352|NCT00499668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24495353|NCT00499668|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24495354|NCT00499707|Metformin|metformin|mesh-list
24495355|NCT00499707|Rosiglitazone|rosiglitazone|mesh-list
24495356|NCT00499707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24495357|NCT00499707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864293|NCT00096525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25055453|NCT03521024|Antimanic Agents|antimanic agents|mesh-ancestor
25055456|NCT03521024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055457|NCT03521024|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25055458|NCT03521024|Anesthetics, General|anesthetics, general|mesh-ancestor
25055459|NCT03521024|Anesthetics|anesthetics|mesh-ancestor
25055460|NCT03520985|Dexamethasone|dexamethasone|mesh-list
25201315|NCT02728622|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25201316|NCT02728622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25201317|NCT02728622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201322|NCT02728622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25201323|NCT02728622|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24869858|NCT05142098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24869859|NCT05142098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869860|NCT05141669|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25055468|NCT03520985|Glucocorticoids|glucocorticoids|mesh-ancestor
25055469|NCT03520985|Hormones|hormones|mesh-ancestor
25055470|NCT03520985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25055472|NCT03520985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25055473|NCT03520985|Immunologic Factors|immunologic factors|mesh-ancestor
25055474|NCT03520985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25864294|NCT00096551|Metronidazole|metronidazole|mesh-list
25864295|NCT00096551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25864296|NCT00096551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25864297|NCT00096551|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24869861|NCT05141669|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24869862|NCT05141669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869863|NCT05141669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24869864|NCT05141669|Immunologic Factors|immunologic factors|mesh-ancestor
24869865|NCT05141669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864298|NCT00096551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25864299|NCT00096616|Albuterol|albuterol|mesh-list
25864300|NCT00096616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25864301|NCT00096616|Autonomic Agents|autonomic agents|mesh-ancestor
25864302|NCT00096616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25864303|NCT00096616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864304|NCT00096616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25864305|NCT00096616|Respiratory System Agents|respiratory system agents|mesh-ancestor
25055484|NCT03520595|Sensory System Agents|sensory system agents|mesh-ancestor
25055485|NCT03520595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24809686|NCT02035904|Anesthetics|anesthetics|mesh-ancestor
24809687|NCT02035930|Dexmedetomidine|dexmedetomidine|mesh-list
24809688|NCT02035930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24495672|NCT00501566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869868|NCT05141240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24869870|NCT05141240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864306|NCT00096616|Tocolytic Agents|tocolytic agents|mesh-ancestor
25055486|NCT03520595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055489|NCT03520595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25055490|NCT03520595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055491|NCT03520595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055492|NCT03520543|Clonidine|clonidine|mesh-list
25055493|NCT03520543|Yohimbine|yohimbine|mesh-list
25055494|NCT03520543|Analgesics|analgesics|mesh-ancestor
24809689|NCT02035930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25093362|NCT03235531|GABA Agents|gaba agents|mesh-ancestor
25093364|NCT03235531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093365|NCT03235531|Antimanic Agents|antimanic agents|mesh-ancestor
25093366|NCT03235531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25093367|NCT03235531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25093368|NCT03235531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25093369|NCT03235531|Antiemetics|antiemetics|mesh-ancestor
25093370|NCT03235531|Autonomic Agents|autonomic agents|mesh-ancestor
25093371|NCT03235531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25093372|NCT03235531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25093373|NCT03235531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25093374|NCT03235531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24869886|NCT05117450|Heparin|heparin|mesh-list
24869887|NCT05117450|Anticoagulants|anticoagulants|mesh-ancestor
24869888|NCT05117450|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24869889|NCT05117450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24869890|NCT05117450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869891|NCT05116930|Atropine|atropine|mesh-list
24869892|NCT05116930|Neostigmine|neostigmine|mesh-list
24869893|NCT05116930|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24869907|NCT05116930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869908|NCT05116930|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24869909|NCT05116930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24869910|NCT05116930|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25055495|NCT03520543|Sensory System Agents|sensory system agents|mesh-ancestor
25055496|NCT03520543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25055497|NCT03520543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055498|NCT03520543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25055499|NCT03520543|Sympatholytics|sympatholytics|mesh-ancestor
25055500|NCT03520543|Autonomic Agents|autonomic agents|mesh-ancestor
25055501|NCT03520543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25055502|NCT03520543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25055503|NCT03520543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25055504|NCT03520543|Adrenergic Agents|adrenergic agents|mesh-ancestor
25055505|NCT03520543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24809692|NCT02035930|Analgesics|analgesics|mesh-ancestor
24809693|NCT02035930|Sensory System Agents|sensory system agents|mesh-ancestor
24809694|NCT02035930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24809695|NCT02035930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24809696|NCT02035930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24809697|NCT02035930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24809698|NCT02035930|Adrenergic Agents|adrenergic agents|mesh-ancestor
24809699|NCT02035930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24809700|NCT02035930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809701|NCT02035943|Insulin|insulin|mesh-list
25055515|NCT03520478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25055516|NCT03520478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055517|NCT03520478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25055518|NCT03520439|Mifepristone|mifepristone|mesh-list
25055519|NCT03520439|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25055520|NCT03520439|Abortifacient Agents|abortifacient agents|mesh-ancestor
24869911|NCT05111431|Dexmedetomidine|dexmedetomidine|mesh-list
24869912|NCT05111431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24869913|NCT05111431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24869914|NCT05111431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869915|NCT05111431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24869916|NCT05111431|Analgesics|analgesics|mesh-ancestor
24869917|NCT05111431|Sensory System Agents|sensory system agents|mesh-ancestor
24869920|NCT05111431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24869921|NCT05111431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24869922|NCT05111431|Adrenergic Agents|adrenergic agents|mesh-ancestor
25669512|NCT01731041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25669513|NCT01731041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25669514|NCT01731041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25669515|NCT01731041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25669516|NCT01731041|Purinergic Agents|purinergic agents|mesh-ancestor
25669517|NCT01731041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25669518|NCT01731041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669519|NCT01731041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669520|NCT01731119|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25669521|NCT01731119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25669522|NCT01731119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24869923|NCT05111431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24869924|NCT05111431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869925|NCT05096039|Valsartan|valsartan|mesh-list
24869926|NCT05096039|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24869927|NCT05096039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24869928|NCT05096039|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24869929|NCT05096039|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24869930|NCT05096039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869931|NCT05070650|Acetaminophen|acetaminophen|mesh-list
24623286|NCT01070823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623287|NCT01070836|Natalizumab|natalizumab|mesh-list
24623288|NCT01070836|Immunologic Factors|immunologic factors|mesh-ancestor
25055549|NCT03520049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623289|NCT01070836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623290|NCT01070862|Thalidomide|thalidomide|mesh-list
24623291|NCT01070862|Dexamethasone|dexamethasone|mesh-list
24623292|NCT01070862|Dexamethasone acetate|dexamethasone acetate|mesh-list
24623293|NCT01070862|Doxorubicin|doxorubicin|mesh-list
24623294|NCT01070862|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24623296|NCT01070862|Cyclophosphamide|cyclophosphamide|mesh-list
24623297|NCT01070862|Vincristine|vincristine|mesh-list
24623298|NCT01070862|BB 1101|bb 1101|mesh-list
24509398|NCT00560170|Simvastatin|simvastatin|mesh-list
25055521|NCT03520439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25055522|NCT03520439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055523|NCT03520439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25055524|NCT03520439|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25055525|NCT03520439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25055526|NCT03520439|Contraceptive Agents|contraceptive agents|mesh-ancestor
25055527|NCT03520439|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24809720|NCT02035982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24809721|NCT02035982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24809722|NCT02035982|Protective Agents|protective agents|mesh-ancestor
24809723|NCT02036008|Liver Extracts|liver extracts|mesh-list
24809724|NCT02036008|Hematinics|hematinics|mesh-ancestor
24809725|NCT02036060|Prednisone|prednisone|mesh-list
24809726|NCT02036060|Docetaxel|docetaxel|mesh-list
24600472|NCT00958854|Antimetabolites|antimetabolites|mesh-ancestor
24495919|NCT00502567|Cetuximab|cetuximab|mesh-list
24495920|NCT00502567|Cediranib|cediranib|mesh-list
24623302|NCT01070862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24623303|NCT01070862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623304|NCT01070862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24623305|NCT01070862|Glucocorticoids|glucocorticoids|mesh-ancestor
24623306|NCT01070862|Hormones|hormones|mesh-ancestor
24623307|NCT01070862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24623308|NCT01070862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24814695|NCT02065986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24814696|NCT02065986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24814697|NCT02066038|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24814698|NCT02066038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24814699|NCT02066038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24814700|NCT02066038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24814701|NCT02066038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814703|NCT02066077|Etomidate|etomidate|mesh-list
24814704|NCT02066077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24814705|NCT02066077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24814706|NCT02066077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814707|NCT02066077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24814708|NCT02066077|Anesthetics, General|anesthetics, general|mesh-ancestor
25055528|NCT03520439|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25055529|NCT03520439|Hormone Antagonists|hormone antagonists|mesh-ancestor
25055530|NCT03520439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25055531|NCT03520439|Luteolytic Agents|luteolytic agents|mesh-ancestor
25055532|NCT03520439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25055533|NCT03520439|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25055534|NCT03520361|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25055535|NCT03520257|Apatinib|apatinib|mesh-list
25055536|NCT03520257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25055539|NCT03520257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055541|NCT03520062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24809727|NCT02036060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809728|NCT02036060|Tubulin Modulators|tubulin modulators|mesh-ancestor
24809729|NCT02036060|Antimitotic Agents|antimitotic agents|mesh-ancestor
24809730|NCT02036060|Mitosis Modulators|mitosis modulators|mesh-ancestor
25093607|NCT03233815|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25093609|NCT03233893|Calcium|calcium|mesh-list
25093610|NCT03233893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25093611|NCT03233893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809746|NCT02036125|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24809747|NCT02036125|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24809749|NCT02036125|Prednisolone acetate|prednisolone acetate|mesh-list
24809750|NCT02036125|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24809751|NCT02036125|Prednisolone phosphate|prednisolone phosphate|mesh-list
24809752|NCT02036125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24809753|NCT02036125|Antiemetics|antiemetics|mesh-ancestor
24809754|NCT02036125|Autonomic Agents|autonomic agents|mesh-ancestor
24809755|NCT02036125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24814709|NCT02066077|Anesthetics|anesthetics|mesh-ancestor
25111668|NCT04727307|Bevacizumab|bevacizumab|mesh-list
25055545|NCT03520062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25055546|NCT03520049|Oseltamivir|oseltamivir|mesh-list
25055547|NCT03520049|Antiviral Agents|antiviral agents|mesh-ancestor
25055548|NCT03520049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24809760|NCT02036125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24809762|NCT02036125|Protective Agents|protective agents|mesh-ancestor
24809763|NCT02036125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24809764|NCT02036125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809765|NCT02036151|Fluorides|fluorides|mesh-list
24809766|NCT02036151|Fluorides, Topical|fluorides, topical|mesh-list
24809767|NCT02036151|Cariostatic Agents|cariostatic agents|mesh-ancestor
25864307|NCT00096616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24869975|NCT04859582|Immunologic Factors|immunologic factors|mesh-ancestor
24869976|NCT04859582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869977|NCT04713137|Erythritol|erythritol|mesh-list
24869978|NCT04713137|Vasodilator Agents|vasodilator agents|mesh-ancestor
24869979|NCT04682847|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24869980|NCT04682847|Hematinics|hematinics|mesh-ancestor
24869981|NCT04682847|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24869982|NCT04682847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24869983|NCT04622553|Mexiletine|mexiletine|mesh-list
24869984|NCT04622553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24869985|NCT04622553|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24869986|NCT04622553|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24869992|NCT04499677|Lopinavir|lopinavir|mesh-list
24869993|NCT04499677|Favipiravir|favipiravir|mesh-list
24869994|NCT04499677|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25055552|NCT03519776|Progestins|progestins|mesh-ancestor
25055553|NCT03519776|Hormones|hormones|mesh-ancestor
25055554|NCT03519776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25055555|NCT03519776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055556|NCT03519750|Melatonin|melatonin|mesh-list
25055557|NCT03519750|Antioxidants|antioxidants|mesh-ancestor
24870039|NCT04274361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25055565|NCT03519724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055566|NCT03519724|Cholinergic Agents|cholinergic agents|mesh-ancestor
25055567|NCT03519724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25055568|NCT03519724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201324|NCT02728622|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24809769|NCT02036151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869995|NCT04499677|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24869996|NCT04499677|Protease Inhibitors|protease inhibitors|mesh-ancestor
24869997|NCT04499677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24869998|NCT04499677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869999|NCT04499677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24870000|NCT04499677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24870001|NCT04499677|Antiviral Agents|antiviral agents|mesh-ancestor
24885017|NCT02955758|Pembrolizumab|pembrolizumab|mesh-list
24870002|NCT04499677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24870003|NCT04499677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24870004|NCT04499677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24870005|NCT04491526|Tamsulosin|tamsulosin|mesh-list
24870006|NCT04491526|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24870007|NCT04491526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24870008|NCT04491526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25669523|NCT01731119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25669524|NCT01731119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669525|NCT01731119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25669526|NCT01731119|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25055578|NCT03519633|Neostigmine|neostigmine|mesh-list
25055579|NCT03519633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25055580|NCT03519633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055581|NCT03519633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055582|NCT03519633|Cholinergic Agents|cholinergic agents|mesh-ancestor
25055583|NCT03519633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25055584|NCT03519633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604945|NCT00982540|Antifungal Agents|antifungal agents|mesh-list
24604946|NCT00982540|Clotrimazole|clotrimazole|mesh-list
24604947|NCT00982540|Miconazole|miconazole|mesh-list
24809779|NCT02036229|Ivermectin|ivermectin|mesh-list
24809781|NCT02036229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24809782|NCT02036242|Sufentanil|sufentanil|mesh-list
24809783|NCT02036242|Ropivacaine|ropivacaine|mesh-list
24809784|NCT02036242|Anesthetics, Local|anesthetics, local|mesh-list
24809785|NCT02036242|Anesthetics|anesthetics|mesh-list
24809786|NCT02036242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24809787|NCT02036242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809788|NCT02036242|Sensory System Agents|sensory system agents|mesh-ancestor
24809789|NCT02036242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25055586|NCT03519633|Autonomic Agents|autonomic agents|mesh-ancestor
25055587|NCT03519633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25055588|NCT03519542|Sunitinib|sunitinib|mesh-list
25055589|NCT03519542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25055590|NCT03519542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25055591|NCT03519542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25055592|NCT03519542|Growth Substances|growth substances|mesh-ancestor
25055593|NCT03519542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055594|NCT03519542|Growth Inhibitors|growth inhibitors|mesh-ancestor
25055595|NCT03519542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25055596|NCT03519542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055597|NCT03519542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870020|NCT04328961|Hydroxychloroquine|hydroxychloroquine|mesh-list
24870021|NCT04328961|Antimalarials|antimalarials|mesh-ancestor
24870035|NCT04274361|Sensory System Agents|sensory system agents|mesh-ancestor
24870036|NCT04274361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24870037|NCT04274361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870038|NCT04274361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25055619|NCT03519152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055620|NCT03519152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055621|NCT03519061|Budesonide|budesonide|mesh-list
25059683|NCT03486184|Cystatins|cystatins|mesh-list
25055622|NCT03519061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25055623|NCT03519061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25055624|NCT03519061|Autonomic Agents|autonomic agents|mesh-ancestor
25055625|NCT03519061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25055626|NCT03519061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055627|NCT03519061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25055628|NCT03519061|Respiratory System Agents|respiratory system agents|mesh-ancestor
25055629|NCT03519061|Glucocorticoids|glucocorticoids|mesh-ancestor
25055630|NCT03519061|Hormones|hormones|mesh-ancestor
25055631|NCT03519061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25055632|NCT03519022|Cocaine|cocaine|mesh-list
25055633|NCT03519022|Methylphenidate|methylphenidate|mesh-list
25055634|NCT03519022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25055635|NCT03519022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055636|NCT03519022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24870045|NCT04274361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24870046|NCT04274361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870047|NCT04259996|Estradiol|estradiol|mesh-list
24870048|NCT04259996|Progesterone|progesterone|mesh-list
24870049|NCT04259996|Estrogens|estrogens|mesh-ancestor
24870050|NCT04259996|Hormones|hormones|mesh-ancestor
24870051|NCT04259996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24870052|NCT04259996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870053|NCT04259996|Progestins|progestins|mesh-ancestor
25055637|NCT03519022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25055638|NCT03519022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25055639|NCT03519022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055641|NCT03519022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25055642|NCT03519022|Anesthetics, Local|anesthetics, local|mesh-ancestor
25055643|NCT03519022|Anesthetics|anesthetics|mesh-ancestor
25055702|NCT03518112|Muromonab-CD3|muromonab-cd3|mesh-list
25055646|NCT03519022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25055647|NCT03519022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24870087|NCT03945448|Antifungal Agents|antifungal agents|mesh-ancestor
24870088|NCT03945448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24870089|NCT03945448|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24870090|NCT03945448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24870091|NCT03945448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24870092|NCT03945448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870093|NCT03945448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24870094|NCT03945448|Hormone Antagonists|hormone antagonists|mesh-ancestor
24870095|NCT03945448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25201327|NCT02728687|Menthol|menthol|mesh-list
24814722|NCT02066207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864308|NCT00096616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25864309|NCT00096616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25864310|NCT00096616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25864311|NCT00096616|Adrenergic Agents|adrenergic agents|mesh-ancestor
25864312|NCT00096616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25055650|NCT03518528|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25055651|NCT03518528|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25055653|NCT03518528|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25055654|NCT03518528|Estrogens|estrogens|mesh-ancestor
25055655|NCT03518528|Hormones|hormones|mesh-ancestor
25055656|NCT03518528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25055657|NCT03518528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055658|NCT03518528|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25055659|NCT03518528|Contraceptive Agents|contraceptive agents|mesh-ancestor
25055660|NCT03518528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25055661|NCT03518528|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25055662|NCT03518502|Sorafenib|sorafenib|mesh-list
25055663|NCT03518502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809862|NCT02036489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24939077|NCT04013386|Adrenergic Agents|adrenergic agents|mesh-ancestor
24939078|NCT04013386|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24939079|NCT04013386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24939080|NCT04013386|Serotonin Agents|serotonin agents|mesh-ancestor
24939081|NCT04013386|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24939082|NCT04013438|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24952552|NCT03893097|Antimalarials|antimalarials|mesh-ancestor
24952553|NCT03893097|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24952554|NCT03893097|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24952555|NCT03893097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24952556|NCT03893097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24952557|NCT03893097|Antiviral Agents|antiviral agents|mesh-ancestor
24952558|NCT03893097|Schistosomicides|schistosomicides|mesh-ancestor
24952559|NCT03893097|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24952560|NCT03893097|Anthelmintics|anthelmintics|mesh-ancestor
24952562|NCT03893032|Amphetamine|amphetamine|mesh-list
24952563|NCT03893032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24952564|NCT03893032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952565|NCT03893032|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24952566|NCT03893032|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24809884|NCT02036528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24809885|NCT02036528|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24809886|NCT02036554|Mycophenolic Acid|mycophenolic acid|mesh-list
24809887|NCT02036554|Everolimus|everolimus|mesh-list
24809888|NCT02036554|Tacrolimus|tacrolimus|mesh-list
24952572|NCT03893032|Dopamine Agents|dopamine agents|mesh-ancestor
24952573|NCT03893032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24952574|NCT03893032|Adrenergic Agents|adrenergic agents|mesh-ancestor
25201328|NCT02728687|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25055703|NCT03518112|Antibodies|antibodies|mesh-list
24952575|NCT03893032|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24952576|NCT03893032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24952577|NCT03893032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24952578|NCT03893032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24952579|NCT03893136|Leflunomide|leflunomide|mesh-list
24952580|NCT03893136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952581|NCT03893136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952582|NCT03893136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24952583|NCT03893136|Immunologic Factors|immunologic factors|mesh-ancestor
24952584|NCT03893136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952585|NCT03893045|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24952586|NCT03893045|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24952587|NCT03893045|Hematinics|hematinics|mesh-ancestor
25431189|NCT01168219|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24770489|NCT01820858|Paclitaxel|paclitaxel|mesh-list
25093919|NCT03230474|Sensory System Agents|sensory system agents|mesh-ancestor
25093920|NCT03230474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24952588|NCT03893045|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24952589|NCT03893045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24952590|NCT03893240|Antibodies|antibodies|mesh-list
24814724|NCT02066207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24814725|NCT02066207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24814726|NCT02066350|Pancrelipase|pancrelipase|mesh-list
24814727|NCT02066350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24814734|NCT02066454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24814735|NCT02066454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814737|NCT02066532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24814738|NCT02066532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24814739|NCT02066558|Carbon Monoxide|carbon monoxide|mesh-list
24814740|NCT02066558|Antimetabolites|antimetabolites|mesh-ancestor
24814741|NCT02066558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814742|NCT02066558|Gasotransmitters|gasotransmitters|mesh-ancestor
24814743|NCT02066558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24814744|NCT02066558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814745|NCT02066571|Droxidopa|droxidopa|mesh-list
24814746|NCT02066571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24814747|NCT02066571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24814748|NCT02066610|Selenium|selenium|mesh-list
24814749|NCT02066610|Selenious Acid|selenious acid|mesh-list
24814750|NCT02066610|Sodium Selenite|sodium selenite|mesh-list
24814751|NCT02066610|Selenic Acid|selenic acid|mesh-list
24814752|NCT02066610|Antioxidants|antioxidants|mesh-ancestor
24814753|NCT02066610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952591|NCT03893240|Antibodies, Blocking|antibodies, blocking|mesh-list
24952592|NCT03893240|Immunologic Factors|immunologic factors|mesh-ancestor
24952593|NCT03893240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952594|NCT03892902|Zopiclone|zopiclone|mesh-list
24952595|NCT03892902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24952596|NCT03892902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25055678|NCT03518320|Antimetabolites|antimetabolites|mesh-ancestor
25055679|NCT03518320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055680|NCT03518320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25055681|NCT03518320|Antiviral Agents|antiviral agents|mesh-ancestor
25055682|NCT03518320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25055683|NCT03518320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055684|NCT03518320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24939083|NCT04013438|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25055685|NCT03518320|Immunologic Factors|immunologic factors|mesh-ancestor
25055686|NCT03518320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055687|NCT03518320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24809930|NCT02036736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809931|NCT02036736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24809953|NCT02036879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24809954|NCT02036879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24809955|NCT02036879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24809956|NCT02036879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25055688|NCT03518320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25055691|NCT03518112|Folic Acid|folic acid|mesh-list
25055692|NCT03518112|Cytarabine|cytarabine|mesh-list
25055693|NCT03518112|Dexamethasone|dexamethasone|mesh-list
25055694|NCT03518112|Dexamethasone acetate|dexamethasone acetate|mesh-list
25055695|NCT03518112|Cyclophosphamide|cyclophosphamide|mesh-list
25055696|NCT03518112|Rituximab|rituximab|mesh-list
25201329|NCT02728687|Diuretics|diuretics|mesh-ancestor
25201330|NCT02728687|Natriuretic Agents|natriuretic agents|mesh-ancestor
25055697|NCT03518112|Methotrexate|methotrexate|mesh-list
25055698|NCT03518112|Vincristine|vincristine|mesh-list
25055699|NCT03518112|Mercaptopurine|mercaptopurine|mesh-list
25055700|NCT03518112|Blinatumomab|blinatumomab|mesh-list
25055701|NCT03518112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24809982|NCT02037035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809984|NCT02037191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24809985|NCT02037191|Abortifacient Agents|abortifacient agents|mesh-ancestor
24809986|NCT02037191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24809987|NCT02037191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809988|NCT02037191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24809989|NCT02037191|Antimetabolites|antimetabolites|mesh-ancestor
25669527|NCT01731119|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25669528|NCT01731119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25669529|NCT01731119|Adrenergic Agents|adrenergic agents|mesh-ancestor
25431266|NCT01142388|Paclitaxel|paclitaxel|mesh-list
25094028|NCT03229889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25094029|NCT03229889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094031|NCT03229616|Busulfan|busulfan|mesh-list
25094032|NCT03229616|Etoposide|etoposide|mesh-list
24809990|NCT02037191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496508|NCT00505167|Memantine|memantine|mesh-list
25055725|NCT03518112|Glucocorticoids|glucocorticoids|mesh-ancestor
25055726|NCT03518112|Hormones|hormones|mesh-ancestor
25055727|NCT03518112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25055728|NCT03518112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25055729|NCT03518112|Protease Inhibitors|protease inhibitors|mesh-ancestor
25055730|NCT03518112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055731|NCT03518112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25055732|NCT03518112|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25055733|NCT03518112|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25055734|NCT03518112|Abortifacient Agents|abortifacient agents|mesh-ancestor
25055735|NCT03518112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25055736|NCT03518112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25055737|NCT03518112|Antimetabolites|antimetabolites|mesh-ancestor
25055738|NCT03518112|Dermatologic Agents|dermatologic agents|mesh-ancestor
25055739|NCT03518112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25055740|NCT03518112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25055741|NCT03518112|Antiviral Agents|antiviral agents|mesh-ancestor
25055742|NCT03518112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25055743|NCT03518112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24810002|NCT02037399|Autonomic Agents|autonomic agents|mesh-ancestor
24810003|NCT02037399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24810004|NCT02037399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810005|NCT02037399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24814756|NCT02066610|Trace Elements|trace elements|mesh-ancestor
25055744|NCT03518112|Antidotes|antidotes|mesh-ancestor
25055745|NCT03518112|Protective Agents|protective agents|mesh-ancestor
25021733|NCT03668860|Betamethasone|betamethasone|mesh-list
24692471|NCT01414556|Incretins|incretins|mesh-ancestor
24870109|NCT03829722|Paclitaxel|paclitaxel|mesh-list
24870110|NCT03829722|Carboplatin|carboplatin|mesh-list
24870111|NCT03829722|Nivolumab|nivolumab|mesh-list
24870112|NCT03829722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24870113|NCT03829722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870114|NCT03829722|Tubulin Modulators|tubulin modulators|mesh-ancestor
24870115|NCT03829722|Antimitotic Agents|antimitotic agents|mesh-ancestor
24870116|NCT03829722|Mitosis Modulators|mitosis modulators|mesh-ancestor
24870117|NCT03829722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870118|NCT03829722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24870119|NCT03829722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24870120|NCT03782636|Aldesleukin|aldesleukin|mesh-list
24870121|NCT03782636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870122|NCT03782636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24870123|NCT03782636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24870124|NCT03782636|Antiviral Agents|antiviral agents|mesh-ancestor
24870125|NCT03782636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24870167|NCT03576261|Polygeline|polygeline|mesh-list
24870168|NCT03576261|Plasma Substitutes|plasma substitutes|mesh-ancestor
24870169|NCT03576261|Blood Substitutes|blood substitutes|mesh-ancestor
24870170|NCT03527186|Risperidone|risperidone|mesh-list
24870179|NCT03527186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24870180|NCT03527186|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24870182|NCT03361865|Pembrolizumab|pembrolizumab|mesh-list
24870183|NCT03361865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24870184|NCT03361865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870185|NCT03320070|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24870186|NCT03320070|Hormones|hormones|mesh-ancestor
24870187|NCT03320070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25111742|NCT04665531|Ropivacaine|ropivacaine|mesh-list
25055782|NCT03517943|Histamine Agents|histamine agents|mesh-ancestor
25055783|NCT03517943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25055784|NCT03517943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055785|NCT03517943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055786|NCT03517943|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25669530|NCT01731119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25669531|NCT01731119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669532|NCT01731119|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25055787|NCT03517943|Autonomic Agents|autonomic agents|mesh-ancestor
25055788|NCT03517943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25094082|NCT03228797|Ropivacaine|ropivacaine|mesh-list
25094083|NCT03228797|Anesthetics, Local|anesthetics, local|mesh-ancestor
25094084|NCT03228797|Anesthetics|anesthetics|mesh-ancestor
25094085|NCT03228797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25094086|NCT03228797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094087|NCT03228797|Sensory System Agents|sensory system agents|mesh-ancestor
25094088|NCT03228797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25094089|NCT03228628|Nitrous Oxide|nitrous oxide|mesh-list
25094090|NCT03228628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25094091|NCT03228628|Anesthetics, General|anesthetics, general|mesh-ancestor
25094092|NCT03228628|Anesthetics|anesthetics|mesh-ancestor
25094093|NCT03228628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25224292|NCT02633969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055789|NCT03517943|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25055790|NCT03517943|Respiratory System Agents|respiratory system agents|mesh-ancestor
25055791|NCT03517943|Nasal Decongestants|nasal decongestants|mesh-ancestor
25055792|NCT03517943|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24509734|NCT00561899|Antimalarials|antimalarials|mesh-ancestor
25055793|NCT03517943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25055794|NCT03517943|Sympathomimetics|sympathomimetics|mesh-ancestor
25055795|NCT03517943|Adrenergic Agents|adrenergic agents|mesh-ancestor
25055796|NCT03517930|Loratadine|loratadine|mesh-list
25055797|NCT03517930|Pseudoephedrine|pseudoephedrine|mesh-list
25055798|NCT03517930|Ephedrine|ephedrine|mesh-list
24870197|NCT03294304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24870198|NCT03294304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24870199|NCT03294304|Immunologic Factors|immunologic factors|mesh-ancestor
24870200|NCT03294304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870201|NCT03294304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24870202|NCT03294304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24870217|NCT03122431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24870219|NCT03122431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870220|NCT03122431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24870221|NCT03122431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24870222|NCT03122431|Immunologic Factors|immunologic factors|mesh-ancestor
24496760|NCT00506571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24496761|NCT00506571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496762|NCT00506571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496765|NCT00506623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24496766|NCT00506623|Antimetabolites|antimetabolites|mesh-ancestor
24496768|NCT00506623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870246|NCT02982083|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
24870247|NCT02982083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24870248|NCT02982083|Hormone Antagonists|hormone antagonists|mesh-ancestor
25055808|NCT03517930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055809|NCT03517930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25055811|NCT03517930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24870263|NCT02871778|Ivacaftor|ivacaftor|mesh-list
24870264|NCT02871778|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24870265|NCT02871778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24870266|NCT02871778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870267|NCT02756208|Vaccines|vaccines|mesh-list
24870268|NCT02756208|Immunologic Factors|immunologic factors|mesh-ancestor
24870269|NCT02756208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870273|NCT02621151|Antimetabolites|antimetabolites|mesh-ancestor
24870276|NCT02621151|Antiviral Agents|antiviral agents|mesh-ancestor
24870277|NCT02621151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24870278|NCT02621151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24870279|NCT02621151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25669533|NCT01731119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25669534|NCT01731119|Serotonin Agents|serotonin agents|mesh-ancestor
25669535|NCT01731119|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25669536|NCT01731119|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25669537|NCT01731119|Dopamine Agents|dopamine agents|mesh-ancestor
25669538|NCT01731691|Protease Inhibitors|protease inhibitors|mesh-list
25669539|NCT01731691|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25669540|NCT01731691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25669541|NCT01731691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669542|NCT01731691|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25669543|NCT01731691|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25669544|NCT01731886|Dexamethasone|dexamethasone|mesh-list
25669545|NCT01731886|Cyclophosphamide|cyclophosphamide|mesh-list
25669546|NCT01731886|Melphalan|melphalan|mesh-list
25669547|NCT01731886|Lenalidomide|lenalidomide|mesh-list
25864313|NCT00096616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864314|NCT00096629|Vaccines|vaccines|mesh-list
25864315|NCT00096629|Immunologic Factors|immunologic factors|mesh-ancestor
25055849|NCT03517631|Immunologic Factors|immunologic factors|mesh-ancestor
25055850|NCT03517631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055851|NCT03517631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25055852|NCT03517631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25055853|NCT03517631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25055854|NCT03517618|Leucovorin|leucovorin|mesh-list
25055855|NCT03517618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055856|NCT03517618|Antidotes|antidotes|mesh-ancestor
25055857|NCT03517618|Protective Agents|protective agents|mesh-ancestor
25055858|NCT03517618|Vitamin B Complex|vitamin b complex|mesh-ancestor
25055859|NCT03517618|Vitamins|vitamins|mesh-ancestor
25055860|NCT03517618|Micronutrients|micronutrients|mesh-ancestor
25055861|NCT03517462|Ivermectin|ivermectin|mesh-list
25055862|NCT03517462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25055863|NCT03517462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25055864|NCT03517423|Brivaracetam|brivaracetam|mesh-list
25055865|NCT03517423|Anticonvulsants|anticonvulsants|mesh-ancestor
25055866|NCT03517319|Botulinum Toxins|botulinum toxins|mesh-list
25055867|NCT03517319|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25055868|NCT03517319|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25055869|NCT03517319|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25055870|NCT03517319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25055871|NCT03517319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055872|NCT03517319|Cholinergic Agents|cholinergic agents|mesh-ancestor
25055873|NCT03517319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25055874|NCT03517319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055875|NCT03517319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25055876|NCT03517319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25055882|NCT03517176|Antimitotic Agents|antimitotic agents|mesh-ancestor
25055883|NCT03517176|Mitosis Modulators|mitosis modulators|mesh-ancestor
25055884|NCT03517176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055885|NCT03517176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25055886|NCT03517176|Antimetabolites|antimetabolites|mesh-ancestor
25055887|NCT03517176|Antiviral Agents|antiviral agents|mesh-ancestor
25055888|NCT03517176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25055889|NCT03517176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055890|NCT03517176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25055891|NCT03517176|Immunologic Factors|immunologic factors|mesh-ancestor
25055892|NCT03517176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055894|NCT03517033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25055895|NCT03517033|Vasodilator Agents|vasodilator agents|mesh-ancestor
25055896|NCT03517033|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25055897|NCT03517033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24623012|NCT01069796|Paclitaxel|paclitaxel|mesh-list
25864316|NCT00096629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055908|NCT03517020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24939278|NCT04011124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24939279|NCT04011124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24939280|NCT04011124|Leprostatic Agents|leprostatic agents|mesh-ancestor
24939281|NCT04011124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24939282|NCT04011124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623031|NCT01069822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24870359|NCT01471444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870360|NCT01471444|Dermatologic Agents|dermatologic agents|mesh-ancestor
24870361|NCT01471444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24870362|NCT01471444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24870363|NCT01471444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24870364|NCT01471444|Immunologic Factors|immunologic factors|mesh-ancestor
24870365|NCT01471444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24870374|NCT05162872|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24870376|NCT05162872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870377|NCT05162872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870378|NCT05162625|Moxifloxacin|moxifloxacin|mesh-list
24814760|NCT02066649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24814761|NCT02066649|Adrenergic Agents|adrenergic agents|mesh-ancestor
24814762|NCT02066649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24814763|NCT02066649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814764|NCT02066649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201331|NCT02728687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814765|NCT02066649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24814766|NCT02066649|Antioxidants|antioxidants|mesh-ancestor
24814783|NCT02066675|Trabectedin|trabectedin|mesh-list
24814786|NCT02066675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814787|NCT02066675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24814788|NCT02066688|Calcium, Dietary|calcium, dietary|mesh-list
24814789|NCT02066688|Vitamin D|vitamin d|mesh-list
24814790|NCT02066688|Folic Acid|folic acid|mesh-list
24814791|NCT02066688|Vitamin B Complex|vitamin b complex|mesh-list
24814792|NCT02066688|Calcium|calcium|mesh-list
24814793|NCT02066688|Vitamins|vitamins|mesh-ancestor
24814794|NCT02066688|Micronutrients|micronutrients|mesh-ancestor
24814795|NCT02066688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814796|NCT02066688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24814797|NCT02066688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24814798|NCT02066688|Hematinics|hematinics|mesh-ancestor
24814799|NCT02066818|Lidocaine|lidocaine|mesh-list
24814800|NCT02066818|Tetracaine|tetracaine|mesh-list
24814801|NCT02066818|Anesthetics, Local|anesthetics, local|mesh-ancestor
24814802|NCT02066818|Anesthetics|anesthetics|mesh-ancestor
24814803|NCT02066818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24814804|NCT02066818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814805|NCT02066818|Sensory System Agents|sensory system agents|mesh-ancestor
24814806|NCT02066818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24814807|NCT02066818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24814808|NCT02066818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24814809|NCT02066818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24814810|NCT02066818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24814811|NCT02066818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870409|NCT05162417|Coagulants|coagulants|mesh-ancestor
24870410|NCT05162417|Heparin Antagonists|heparin antagonists|mesh-ancestor
24870411|NCT05162183|Liraglutide|liraglutide|mesh-list
24870412|NCT05162183|Glimepiride|glimepiride|mesh-list
24870413|NCT05162183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24870414|NCT05162183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870415|NCT05162183|Incretins|incretins|mesh-ancestor
24870416|NCT05162183|Hormones|hormones|mesh-ancestor
24939286|NCT04011124|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24939287|NCT04011124|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24939288|NCT04011124|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24939289|NCT04011124|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24939291|NCT04010955|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24939292|NCT04010955|Antithrombins|antithrombins|mesh-ancestor
24939293|NCT04010955|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24939294|NCT04010955|Protease Inhibitors|protease inhibitors|mesh-ancestor
24810147|NCT02038257|Emollients|emollients|mesh-ancestor
24810148|NCT02038257|Dermatologic Agents|dermatologic agents|mesh-ancestor
24810149|NCT02038335|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25055914|NCT03516955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25055915|NCT03516955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25055916|NCT03516955|Antimetabolites|antimetabolites|mesh-ancestor
25022275|NCT03664414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24870456|NCT05161221|Sensory System Agents|sensory system agents|mesh-ancestor
24870457|NCT05161221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24870459|NCT05161221|Narcotics|narcotics|mesh-ancestor
24870460|NCT05161221|Analgesics|analgesics|mesh-ancestor
24870461|NCT05161221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24870462|NCT05161221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24870463|NCT05161221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24870464|NCT05161221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24870465|NCT05161221|Gout Suppressants|gout suppressants|mesh-ancestor
24870466|NCT05161221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24870467|NCT05161221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610627|NCT01004068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25669548|NCT01731886|Lenograstim|lenograstim|mesh-list
25669549|NCT01731886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25669550|NCT01731886|Immunologic Factors|immunologic factors|mesh-ancestor
24870468|NCT05161221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870469|NCT05161221|Antipyretics|antipyretics|mesh-ancestor
24870472|NCT05141838|Vitamin D|vitamin d|mesh-list
25094298|NCT03227705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25094299|NCT03227705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094300|NCT03227653|Ritonavir|ritonavir|mesh-list
25094301|NCT03227653|Lopinavir|lopinavir|mesh-list
25094302|NCT03227653|Nevirapine|nevirapine|mesh-list
25094303|NCT03227653|Efavirenz|efavirenz|mesh-list
25094304|NCT03227653|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25094305|NCT03227653|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25094306|NCT03227653|Protease Inhibitors|protease inhibitors|mesh-ancestor
24870473|NCT05141838|Vitamins|vitamins|mesh-ancestor
24870474|NCT05141838|Micronutrients|micronutrients|mesh-ancestor
24870475|NCT05141838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870476|NCT05141838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24870477|NCT05137886|Decitabine|decitabine|mesh-list
25059776|NCT03485404|Folic Acid|folic acid|mesh-list
24870478|NCT05137886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24870479|NCT05137886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24870480|NCT05137886|Antimetabolites|antimetabolites|mesh-ancestor
24870481|NCT05137886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870482|NCT05137886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870483|NCT05137886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24870484|NCT05132231|Brodalumab|brodalumab|mesh-list
24870485|NCT05132231|Dermatologic Agents|dermatologic agents|mesh-ancestor
24870486|NCT05104099|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
24870487|NCT05104099|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24870488|NCT05104099|Dermatologic Agents|dermatologic agents|mesh-ancestor
24870498|NCT05067270|Insulin Lispro|insulin lispro|mesh-list
24870499|NCT05067270|Treprostinil|treprostinil|mesh-list
24870500|NCT05067270|Citric Acid|citric acid|mesh-list
25055919|NCT03516955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25055920|NCT03516955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055921|NCT03516903|Folic Acid|folic acid|mesh-list
25055922|NCT03516903|Methotrexate|methotrexate|mesh-list
24870551|NCT04998786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870552|NCT04998786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24870553|NCT04998786|Glucocorticoids|glucocorticoids|mesh-ancestor
24870555|NCT04998786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24870556|NCT04998786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24870557|NCT04998786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870596|NCT04867798|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24870597|NCT04867798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24870599|NCT04867798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870600|NCT04867798|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24870601|NCT04867798|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24870602|NCT04821284|Leucovorin|leucovorin|mesh-list
24870603|NCT04821284|Gemcitabine|gemcitabine|mesh-list
24870604|NCT04821284|Paclitaxel|paclitaxel|mesh-list
24870605|NCT04821284|Fluorouracil|fluorouracil|mesh-list
24870606|NCT04821284|Oxaliplatin|oxaliplatin|mesh-list
24870607|NCT04821284|Irinotecan|irinotecan|mesh-list
24870608|NCT04821284|Calcium|calcium|mesh-list
24870609|NCT04821284|Levoleucovorin|levoleucovorin|mesh-list
24870610|NCT04821284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24870611|NCT04821284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870612|NCT04821284|Tubulin Modulators|tubulin modulators|mesh-ancestor
24870613|NCT04821284|Antimitotic Agents|antimitotic agents|mesh-ancestor
24870614|NCT04821284|Mitosis Modulators|mitosis modulators|mesh-ancestor
24870615|NCT04821284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055926|NCT03516903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055927|NCT03516903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25055928|NCT03516903|Antimetabolites|antimetabolites|mesh-ancestor
25055929|NCT03516903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814844|NCT02067065|Propofol|propofol|mesh-list
24814845|NCT02067065|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24814846|NCT02067065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25669551|NCT01731886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669552|NCT01731886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25669553|NCT01731886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25669554|NCT01731886|Alkylating Agents|alkylating agents|mesh-ancestor
25669555|NCT01731886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669556|NCT01731886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669557|NCT01731886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25669558|NCT01731886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24814847|NCT02067065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814848|NCT02067065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24814849|NCT02067065|Anesthetics, General|anesthetics, general|mesh-ancestor
25094376|NCT03227016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094377|NCT03227016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25094378|NCT03226717|Antiviral Agents|antiviral agents|mesh-list
25094379|NCT03226717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25864318|NCT00096655|Dermatologic Agents|dermatologic agents|mesh-ancestor
25094411|NCT03226522|Bupropion|bupropion|mesh-list
25094412|NCT03226522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25094413|NCT03226522|Antidepressive Agents|antidepressive agents|mesh-ancestor
25094414|NCT03226522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25094415|NCT03226522|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24814850|NCT02067065|Anesthetics|anesthetics|mesh-ancestor
24814851|NCT02067078|Dexamethasone|dexamethasone|mesh-list
24814852|NCT02067078|Dexamethasone acetate|dexamethasone acetate|mesh-list
24814853|NCT02067078|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24610549|NCT01003054|Busulfan|busulfan|mesh-list
24610614|NCT01003847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610615|NCT01003847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24610616|NCT01004055|Anti-Infective Agents|anti-infective agents|mesh-list
24610617|NCT01004055|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24610619|NCT01004068|Enclomiphene|enclomiphene|mesh-list
24610620|NCT01004068|Zuclomiphene|zuclomiphene|mesh-list
24610621|NCT01004068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24610622|NCT01004068|Hormone Antagonists|hormone antagonists|mesh-ancestor
24610623|NCT01004068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24610625|NCT01004068|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24610629|NCT01004068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24610630|NCT01004198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24623309|NCT01070862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623310|NCT01070862|Protease Inhibitors|protease inhibitors|mesh-ancestor
24623311|NCT01070862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623312|NCT01070862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623313|NCT01070862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24623314|NCT01070862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24623315|NCT01070862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24623316|NCT01070862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24870670|NCT04577690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870671|NCT04577690|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24870672|NCT04577690|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24870674|NCT04577690|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24870675|NCT04577690|Respiratory System Agents|respiratory system agents|mesh-ancestor
24870722|NCT04361799|Insulin|insulin|mesh-list
24870723|NCT04361799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24870724|NCT04361799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870725|NCT04306510|Antibodies|antibodies|mesh-list
24870726|NCT04306510|Immunoglobulins|immunoglobulins|mesh-list
24816375|NCT02076685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24870731|NCT04132817|Nivolumab|nivolumab|mesh-list
24870732|NCT04132817|Ipilimumab|ipilimumab|mesh-list
24870733|NCT04132817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24870734|NCT04132817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870735|NCT04132817|Tubulin Modulators|tubulin modulators|mesh-ancestor
24870736|NCT04132817|Antimitotic Agents|antimitotic agents|mesh-ancestor
24870737|NCT04132817|Mitosis Modulators|mitosis modulators|mesh-ancestor
24870738|NCT04132817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870739|NCT04132817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24870740|NCT04132817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24870741|NCT04101890|Zinc Oxide|zinc oxide|mesh-list
24870742|NCT04101890|Dermatologic Agents|dermatologic agents|mesh-ancestor
24870743|NCT04101890|Sunscreening Agents|sunscreening agents|mesh-ancestor
24870744|NCT04101890|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24870745|NCT04101890|Protective Agents|protective agents|mesh-ancestor
25111831|NCT04608474|Antimetabolites|antimetabolites|mesh-ancestor
24870781|NCT03942224|Glucocorticoids|glucocorticoids|mesh-ancestor
24870782|NCT03942224|Hormones|hormones|mesh-ancestor
25669559|NCT01731886|Antiemetics|antiemetics|mesh-ancestor
25669560|NCT01731886|Autonomic Agents|autonomic agents|mesh-ancestor
25669561|NCT01731886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25669562|NCT01731886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25669563|NCT01731886|Glucocorticoids|glucocorticoids|mesh-ancestor
25669564|NCT01731886|Hormones|hormones|mesh-ancestor
25669565|NCT01731886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25669566|NCT01731886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25669567|NCT01731886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25669568|NCT01731886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24870784|NCT03942224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24870785|NCT03942224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870786|NCT03942224|Protease Inhibitors|protease inhibitors|mesh-ancestor
25055939|NCT03516903|Vitamin B Complex|vitamin b complex|mesh-ancestor
25055941|NCT03516903|Micronutrients|micronutrients|mesh-ancestor
25055942|NCT03516773|Parathyroid Hormone|parathyroid hormone|mesh-list
24870787|NCT03942224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24870788|NCT03942224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870789|NCT03856359|Rifaximin|rifaximin|mesh-list
24870790|NCT03856359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24870791|NCT03856359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24870792|NCT03856359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24870793|NCT03846505|Oxytocin|oxytocin|mesh-list
24870794|NCT03846505|Oxytocics|oxytocics|mesh-ancestor
24870795|NCT03846505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24870796|NCT03846505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870797|NCT03837015|Estradiol|estradiol|mesh-list
24870798|NCT03837015|Estrogens|estrogens|mesh-ancestor
25201333|NCT02728687|Dermatologic Agents|dermatologic agents|mesh-ancestor
24870827|NCT03462290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24870828|NCT03406286|Tolvaptan|tolvaptan|mesh-list
24870829|NCT03406286|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24870830|NCT03406286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870831|NCT03406286|Natriuretic Agents|natriuretic agents|mesh-ancestor
24870832|NCT03406286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870833|NCT03376763|Aripiprazole|aripiprazole|mesh-list
24870834|NCT03376763|Antidepressive Agents|antidepressive agents|mesh-ancestor
24870835|NCT03376763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24870836|NCT03376763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24870837|NCT03376763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24870838|NCT03376763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24870839|NCT03376763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870841|NCT03376763|Dopamine Agents|dopamine agents|mesh-ancestor
24870842|NCT03376763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24870843|NCT03376763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864319|NCT00096655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25864320|NCT00096655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25864321|NCT00096668|Paclitaxel|paclitaxel|mesh-list
25864322|NCT00096668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25864323|NCT00096668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864324|NCT00096668|Tubulin Modulators|tubulin modulators|mesh-ancestor
25055943|NCT03516773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25055944|NCT03516773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055945|NCT03516747|Hormones|hormones|mesh-list
24870964|NCT00983437|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24870965|NCT00983437|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24870975|NCT00805129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870976|NCT00805129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24870977|NCT00805129|Immunologic Factors|immunologic factors|mesh-ancestor
24870978|NCT00805129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870979|NCT00708448|Bevacizumab|bevacizumab|mesh-list
25055946|NCT03516747|Parathyroid Hormone|parathyroid hormone|mesh-list
25055947|NCT03516747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24870980|NCT00708448|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24870981|NCT00708448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24870982|NCT00708448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870983|NCT00708448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24870984|NCT00708448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24870985|NCT00708448|Growth Substances|growth substances|mesh-ancestor
24870986|NCT00708448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201334|NCT02728466|Proanthocyanidin|proanthocyanidin|mesh-list
25201335|NCT02728466|Procyanidin|procyanidin|mesh-list
25201336|NCT02728466|Antioxidants|antioxidants|mesh-ancestor
24870987|NCT00708448|Growth Inhibitors|growth inhibitors|mesh-ancestor
24870988|NCT00708448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24870989|NCT00708448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24870990|NCT00708448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870991|NCT05164614|Teriparatide|teriparatide|mesh-list
24870992|NCT05164614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24870993|NCT05164614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870994|NCT05164614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25094694|NCT03223896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25094695|NCT03223896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094696|NCT03223896|Sensory System Agents|sensory system agents|mesh-ancestor
25094697|NCT03223896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24771400|NCT01827020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24771402|NCT01827020|Analgesics|analgesics|mesh-ancestor
25094698|NCT03223519|Ascorbic Acid|ascorbic acid|mesh-list
24870995|NCT05164198|Adalimumab|adalimumab|mesh-list
24870996|NCT05164198|Etanercept|etanercept|mesh-list
24871006|NCT05164198|Sensory System Agents|sensory system agents|mesh-ancestor
24871007|NCT05164198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24871008|NCT05164198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623321|NCT01070862|Leprostatic Agents|leprostatic agents|mesh-ancestor
24871009|NCT05164198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24871010|NCT05164198|Immunologic Factors|immunologic factors|mesh-ancestor
24871011|NCT05164198|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24871026|NCT05163704|Dexmedetomidine|dexmedetomidine|mesh-list
24871032|NCT05163704|Sensory System Agents|sensory system agents|mesh-ancestor
24871033|NCT05163704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24871034|NCT05163704|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24871035|NCT05163704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24871036|NCT05163704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25864325|NCT00096668|Antimitotic Agents|antimitotic agents|mesh-ancestor
24871103|NCT05141422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24871104|NCT05141422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24871106|NCT05137678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24871107|NCT05137678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871108|NCT05101018|Denosumab|denosumab|mesh-list
24871109|NCT05101018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24871110|NCT05101018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871130|NCT04809051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24871132|NCT04735367|Palbociclib|palbociclib|mesh-list
24871133|NCT04735367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871134|NCT04735367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24871146|NCT04698603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25864326|NCT00096668|Mitosis Modulators|mitosis modulators|mesh-ancestor
24871165|NCT04598009|Imatinib Mesylate|imatinib mesylate|mesh-list
24871166|NCT04598009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201337|NCT02728466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201338|NCT02728466|Protective Agents|protective agents|mesh-ancestor
25201339|NCT02728466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201340|NCT02728466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24871168|NCT04598009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24871169|NCT04598009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871170|NCT04587687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24871171|NCT04587687|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24871172|NCT04587687|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24871174|NCT04587687|Immunoglobulins|immunoglobulins|mesh-list
24871175|NCT04587687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24871176|NCT04587687|Immunoconjugates|immunoconjugates|mesh-list
24871177|NCT04587687|Immunologic Factors|immunologic factors|mesh-ancestor
24871178|NCT04587687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871179|NCT04587687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871180|NCT04587687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24871181|NCT04587687|Alkylating Agents|alkylating agents|mesh-ancestor
24871182|NCT04587687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871184|NCT04578600|Azacitidine|azacitidine|mesh-list
24871185|NCT04578600|Obinutuzumab|obinutuzumab|mesh-list
24871186|NCT04578600|Immunologic Factors|immunologic factors|mesh-ancestor
24871187|NCT04578600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871188|NCT04578600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24623322|NCT01070862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24623323|NCT01070862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24623324|NCT01070862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25111875|NCT04569747|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24871195|NCT04578600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669569|NCT01731886|Growth Substances|growth substances|mesh-ancestor
25669570|NCT01731886|Growth Inhibitors|growth inhibitors|mesh-ancestor
25669571|NCT01731886|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25669572|NCT01731938|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25669573|NCT01731938|Hemostatics|hemostatics|mesh-ancestor
25669574|NCT01731938|Coagulants|coagulants|mesh-ancestor
25669575|NCT01731951|Imetelstat|imetelstat|mesh-list
25669576|NCT01731951|Motesanib diphosphate|motesanib diphosphate|mesh-list
25094790|NCT03222687|Glucocorticoids|glucocorticoids|mesh-ancestor
24871196|NCT04578600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24871197|NCT04578600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24871198|NCT04565392|Famotidine|famotidine|mesh-list
24871199|NCT04565392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24871200|NCT04565392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24871228|NCT04373707|Nadroparin|nadroparin|mesh-list
24871229|NCT04373707|Enoxaparin sodium|enoxaparin sodium|mesh-list
24871230|NCT04373707|Anticoagulants|anticoagulants|mesh-ancestor
24871231|NCT04373707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24871232|NCT04373707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24871233|NCT04373707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871234|NCT04363697|Dapagliflozin|dapagliflozin|mesh-list
24871235|NCT04363697|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24871236|NCT04363697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871237|NCT04363697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24871238|NCT04363697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864327|NCT00096668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871242|NCT04287816|Antithrombin III|antithrombin iii|mesh-list
24871253|NCT04220489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871254|NCT04220489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24871255|NCT04220489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24871256|NCT04220489|Anesthetics, General|anesthetics, general|mesh-ancestor
24871257|NCT04220489|Anesthetics|anesthetics|mesh-ancestor
24871258|NCT04220489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24871259|NCT04220489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24871260|NCT04220489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24871261|NCT04220489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24693637|NCT01421693|Ceftriaxone|ceftriaxone|mesh-list
25201341|NCT02728466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25201342|NCT02728466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25201343|NCT02728492|Gemcitabine|gemcitabine|mesh-list
24962396|NCT03799315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24871262|NCT04220489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871264|NCT04218786|Gout Suppressants|gout suppressants|mesh-ancestor
24871265|NCT04218786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24871266|NCT04218786|Tubulin Modulators|tubulin modulators|mesh-ancestor
25055964|NCT03516656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055966|NCT03516630|Trazodone|trazodone|mesh-list
25055967|NCT03516630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25055968|NCT03516630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25055969|NCT03516630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25055970|NCT03516630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25055971|NCT03516630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055972|NCT03516630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055973|NCT03516630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25055974|NCT03516630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055975|NCT03516630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25055976|NCT03516630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25055977|NCT03516630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25055978|NCT03516630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25059837|NCT03484611|Cetrorelix|cetrorelix|mesh-list
25055979|NCT03516630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24871267|NCT04218786|Antimitotic Agents|antimitotic agents|mesh-ancestor
24871268|NCT04218786|Mitosis Modulators|mitosis modulators|mesh-ancestor
24871269|NCT04218786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871306|NCT03940690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24871307|NCT03940690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871308|NCT03940690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24871309|NCT03940690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24871310|NCT03940690|Growth Substances|growth substances|mesh-ancestor
24871311|NCT03940690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871312|NCT03940690|Growth Inhibitors|growth inhibitors|mesh-ancestor
24871314|NCT03901144|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24871315|NCT03901144|Protective Agents|protective agents|mesh-ancestor
24871316|NCT03901144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871347|NCT03548246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24871348|NCT03548246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871349|NCT03548246|Hormone Antagonists|hormone antagonists|mesh-ancestor
25055980|NCT03516630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25055981|NCT03516630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25055982|NCT03516630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25669577|NCT01731951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25669578|NCT01731951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094911|NCT03221907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25094912|NCT03221907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25094913|NCT03221907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25094916|NCT03221881|Docetaxel|docetaxel|mesh-list
25094938|NCT03221946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094939|NCT03221946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094940|NCT03221998|Acetaminophen|acetaminophen|mesh-list
25094941|NCT03221998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25094942|NCT03221998|Analgesics|analgesics|mesh-ancestor
25094943|NCT03221998|Sensory System Agents|sensory system agents|mesh-ancestor
25094944|NCT03221998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25094945|NCT03221998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224358|NCT02633852|Aflibercept|aflibercept|mesh-list
25055983|NCT03516630|Serotonin Agents|serotonin agents|mesh-ancestor
25055984|NCT03516630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25055985|NCT03516630|Antidepressive Agents|antidepressive agents|mesh-ancestor
24587339|NCT00894439|Piperacillin|piperacillin|mesh-list
24871372|NCT03166085|Mitosis Modulators|mitosis modulators|mesh-ancestor
24871373|NCT03166085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871374|NCT03161054|Prednisone|prednisone|mesh-list
24871375|NCT03161054|Cyclophosphamide|cyclophosphamide|mesh-list
24871376|NCT03161054|Rituximab|rituximab|mesh-list
24871377|NCT03161054|Etoposide|etoposide|mesh-list
24871378|NCT03161054|Vinorelbine|vinorelbine|mesh-list
24871557|NCT05165914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24871383|NCT03161054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24871385|NCT03161054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871386|NCT03161054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871387|NCT03161054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24871388|NCT03161054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24871389|NCT03161054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24871390|NCT03161054|Glucocorticoids|glucocorticoids|mesh-ancestor
24871391|NCT03161054|Hormones|hormones|mesh-ancestor
24871414|NCT03050814|Antimetabolites|antimetabolites|mesh-ancestor
25201344|NCT02728492|Paclitaxel|paclitaxel|mesh-list
24871416|NCT03050814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24871417|NCT03050814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24871418|NCT03050814|Immunologic Factors|immunologic factors|mesh-ancestor
24871419|NCT03050814|Antidotes|antidotes|mesh-ancestor
24871420|NCT03050814|Protective Agents|protective agents|mesh-ancestor
24871421|NCT03050814|Vitamin B Complex|vitamin b complex|mesh-ancestor
24871422|NCT03050814|Vitamins|vitamins|mesh-ancestor
24871423|NCT03050814|Micronutrients|micronutrients|mesh-ancestor
24871424|NCT02724241|Nicotine|nicotine|mesh-list
24871425|NCT02724241|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24871426|NCT02724241|Autonomic Agents|autonomic agents|mesh-ancestor
24871427|NCT02724241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24871428|NCT02724241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871429|NCT02724241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24871430|NCT02724241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24871431|NCT02724241|Cholinergic Agents|cholinergic agents|mesh-ancestor
24871432|NCT02724241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24871433|NCT02724241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871434|NCT02639910|Venetoclax|venetoclax|mesh-list
24871435|NCT02639910|Idelalisib|idelalisib|mesh-list
24871436|NCT02639910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871451|NCT02492867|Paclitaxel|paclitaxel|mesh-list
24871452|NCT02492867|Carboplatin|carboplatin|mesh-list
24871453|NCT02492867|Durvalumab|durvalumab|mesh-list
24871454|NCT02492867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24871455|NCT02492867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871456|NCT02492867|Tubulin Modulators|tubulin modulators|mesh-ancestor
25669579|NCT01731951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25669580|NCT01732445|Danazol|danazol|mesh-list
25669581|NCT01732445|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
25669582|NCT01732445|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25669583|NCT01732445|Hormone Antagonists|hormone antagonists|mesh-ancestor
25669584|NCT01732445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25669585|NCT01732445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669586|NCT01732445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25669587|NCT01732445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25669588|NCT01732445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669589|NCT01732458|Ondansetron|ondansetron|mesh-list
25669590|NCT01732458|Aprepitant|aprepitant|mesh-list
24871457|NCT02492867|Antimitotic Agents|antimitotic agents|mesh-ancestor
24872115|NCT05398757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25095038|NCT03221231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095039|NCT03221231|Antidotes|antidotes|mesh-ancestor
25095040|NCT03221621|Adalimumab|adalimumab|mesh-list
25095043|NCT03221023|Vancomycin|vancomycin|mesh-list
24871503|NCT02124824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871504|NCT01772004|Avelumab|avelumab|mesh-list
24871505|NCT01772004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24871506|NCT01772004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871507|NCT01633541|Carboplatin|carboplatin|mesh-list
24871508|NCT01633541|Docetaxel|docetaxel|mesh-list
24871509|NCT01633541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871510|NCT01633541|Tubulin Modulators|tubulin modulators|mesh-ancestor
24871511|NCT01633541|Antimitotic Agents|antimitotic agents|mesh-ancestor
24871520|NCT01285102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24871521|NCT01285102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24871522|NCT01285102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623341|NCT01070927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623342|NCT01070940|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
24623343|NCT01070940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623344|NCT01070940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623345|NCT01071005|Leuprolide|leuprolide|mesh-list
24623346|NCT01071005|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24623347|NCT01071005|Fertility Agents|fertility agents|mesh-ancestor
24623348|NCT01071005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24814854|NCT02067078|Clonidine|clonidine|mesh-list
24871550|NCT05165914|Anesthetics|anesthetics|mesh-list
24871551|NCT05165914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24871552|NCT05165914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871553|NCT05165914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24871554|NCT05165914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24871555|NCT05165914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24871556|NCT05165914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24871558|NCT05165914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24871568|NCT05165641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24871569|NCT05165641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871571|NCT05165615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24871572|NCT05165615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871574|NCT05165303|Propofol|propofol|mesh-list
24871575|NCT05165303|Anesthetics, Local|anesthetics, local|mesh-ancestor
25056002|NCT03516526|Immunologic Factors|immunologic factors|mesh-ancestor
25056003|NCT03516526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056004|NCT03516500|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25201345|NCT02728492|Carboplatin|carboplatin|mesh-list
25056005|NCT03516500|Hematinics|hematinics|mesh-ancestor
25056006|NCT03516188|Antacids|antacids|mesh-list
24871576|NCT05165303|Anesthetics|anesthetics|mesh-ancestor
24871613|NCT05164770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24871614|NCT05164770|Alkylating Agents|alkylating agents|mesh-ancestor
24871615|NCT05164770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24871616|NCT05164770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24871617|NCT05164770|Glucocorticoids|glucocorticoids|mesh-ancestor
24871618|NCT05164770|Hormones|hormones|mesh-ancestor
24871619|NCT05164770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25059931|NCT03484091|Hylan|hylan|mesh-list
24871620|NCT05164770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24871621|NCT05164770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24871622|NCT05164770|Tubulin Modulators|tubulin modulators|mesh-ancestor
24871623|NCT05164770|Antimitotic Agents|antimitotic agents|mesh-ancestor
24871624|NCT05164770|Mitosis Modulators|mitosis modulators|mesh-ancestor
24871625|NCT05164770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24871626|NCT05164770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24871627|NCT05164770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24871628|NCT05164770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24871629|NCT05164627|Magnesium Sulfate|magnesium sulfate|mesh-list
24871630|NCT05164627|Dexmedetomidine|dexmedetomidine|mesh-list
24871631|NCT05164627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24871632|NCT05164627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24871633|NCT05164627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871634|NCT05164627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24871635|NCT05164627|Analgesics|analgesics|mesh-ancestor
24871688|NCT05110209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24871690|NCT05110209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871691|NCT05110209|Growth Inhibitors|growth inhibitors|mesh-ancestor
25669591|NCT01732458|Fosaprepitant|fosaprepitant|mesh-list
25669592|NCT01732458|Antiemetics|antiemetics|mesh-ancestor
25669593|NCT01732458|Autonomic Agents|autonomic agents|mesh-ancestor
25669594|NCT01732458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25095144|NCT03220321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224369|NCT02633774|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25224370|NCT02633774|Protease Inhibitors|protease inhibitors|mesh-ancestor
25224371|NCT02633774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25224372|NCT02633774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224373|NCT02633774|Anticoagulants|anticoagulants|mesh-ancestor
25224374|NCT02633774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24871692|NCT05096143|Valsartan|valsartan|mesh-list
24871693|NCT05096143|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24871694|NCT05096143|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24871695|NCT05096143|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24871696|NCT05096143|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24872116|NCT05398757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871699|NCT05072444|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24871700|NCT05072444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24871701|NCT05072444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871702|NCT05072444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24871725|NCT05007145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871726|NCT04968951|Metronidazole|metronidazole|mesh-list
24871727|NCT04968951|Vancomycin|vancomycin|mesh-list
24871728|NCT04968951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24871729|NCT04968951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24871730|NCT04968951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24871731|NCT04968951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24871741|NCT04923295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871742|NCT04923295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24871743|NCT04923295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871744|NCT04825262|Tacrolimus|tacrolimus|mesh-list
24871745|NCT04825262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24871746|NCT04825262|Immunologic Factors|immunologic factors|mesh-ancestor
24871747|NCT04825262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871748|NCT04825262|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24871749|NCT04825262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24871750|NCT04825262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871751|NCT04821830|Levodopa|levodopa|mesh-list
24871752|NCT04821830|Carbidopa|carbidopa|mesh-list
24871753|NCT04821830|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24871754|NCT04821830|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24871806|NCT04518124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871807|NCT04518124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871808|NCT04518124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25864328|NCT00096694|Levonorgestrel|levonorgestrel|mesh-list
24871815|NCT04511052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871816|NCT04433858|Psilocybin|psilocybin|mesh-list
24871817|NCT04433858|Hallucinogens|hallucinogens|mesh-ancestor
24871818|NCT04433858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871819|NCT04433858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24871820|NCT04282070|Gemcitabine|gemcitabine|mesh-list
24871821|NCT04282070|Paclitaxel|paclitaxel|mesh-list
24871822|NCT04282070|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24871823|NCT04282070|Cisplatin|cisplatin|mesh-list
24810280|NCT02039362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24871845|NCT04246554|Acetaminophen|acetaminophen|mesh-list
24871846|NCT04246554|Ketorolac|ketorolac|mesh-list
24871847|NCT04246554|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
24871848|NCT04246554|Oxycodone|oxycodone|mesh-list
24694220|NCT01424449|Aripiprazole|aripiprazole|mesh-list
24871849|NCT04246554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24871850|NCT04246554|Analgesics|analgesics|mesh-ancestor
24871851|NCT04246554|Sensory System Agents|sensory system agents|mesh-ancestor
24871852|NCT04246554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24871853|NCT04246554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871854|NCT04246554|Antipyretics|antipyretics|mesh-ancestor
24871855|NCT04246554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24871856|NCT04246554|Narcotics|narcotics|mesh-ancestor
24871857|NCT04246554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24871858|NCT04246554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25669595|NCT01732458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669596|NCT01732458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25669597|NCT01732458|Antipruritics|antipruritics|mesh-ancestor
25669598|NCT01732458|Dermatologic Agents|dermatologic agents|mesh-ancestor
25669599|NCT01732458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25669600|NCT01732458|Serotonin Agents|serotonin agents|mesh-ancestor
25669601|NCT01732458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25864329|NCT00096694|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25224380|NCT02633709|Antifungal Agents|antifungal agents|mesh-ancestor
25224381|NCT02633709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25224382|NCT02633709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25224383|NCT02633709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25224384|NCT02633709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25224385|NCT02633709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224386|NCT02633709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25043137|NCT01318252|Latanoprost|latanoprost|mesh-list
25043138|NCT01318252|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24871859|NCT04246554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24871860|NCT04246554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24871861|NCT04246554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24871862|NCT04246554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24871863|NCT04246554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814925|NCT02067338|Coagulants|coagulants|mesh-ancestor
24814926|NCT02067377|Immunoglobulins|immunoglobulins|mesh-list
24814927|NCT02067377|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24814928|NCT02067377|Antibodies|antibodies|mesh-list
24814929|NCT02067377|Immunologic Factors|immunologic factors|mesh-ancestor
24814930|NCT02067377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814931|NCT02067416|Paclitaxel|paclitaxel|mesh-list
24814932|NCT02067416|Docetaxel|docetaxel|mesh-list
24814933|NCT02067416|Epirubicin|epirubicin|mesh-list
24814935|NCT02067416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24814936|NCT02067416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872117|NCT05398757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24871885|NCT03934671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871921|NCT03592212|Albuterol|albuterol|mesh-list
24871922|NCT03592212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24871923|NCT03592212|Autonomic Agents|autonomic agents|mesh-ancestor
24871924|NCT03592212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25056019|NCT03515798|Paclitaxel|paclitaxel|mesh-list
25056020|NCT03515798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25056021|NCT03515798|Cyclophosphamide|cyclophosphamide|mesh-list
24871949|NCT03465540|Hormones|hormones|mesh-ancestor
24963441|NCT03790787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963465|NCT03790345|Vitamins|vitamins|mesh-list
24871950|NCT03465540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24871951|NCT03465540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24871952|NCT03465540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871953|NCT03465540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24871957|NCT03436199|Amantadine|amantadine|mesh-list
24871961|NCT03436199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24871962|NCT03436199|Dopamine Agents|dopamine agents|mesh-ancestor
24871963|NCT03436199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24871964|NCT03436199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871965|NCT03436199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871966|NCT03436199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24871967|NCT03436199|Analgesics|analgesics|mesh-ancestor
24871968|NCT03436199|Sensory System Agents|sensory system agents|mesh-ancestor
24871969|NCT03436199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24871970|NCT03353233|Ropivacaine|ropivacaine|mesh-list
24871971|NCT03353233|Anesthetics, Local|anesthetics, local|mesh-ancestor
24871972|NCT03353233|Anesthetics|anesthetics|mesh-ancestor
24871973|NCT03353233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24871974|NCT03353233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871984|NCT03273322|Protease Inhibitors|protease inhibitors|mesh-ancestor
24871985|NCT03273322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24871986|NCT03273322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871987|NCT03273322|Anticoagulants|anticoagulants|mesh-ancestor
24872002|NCT03217136|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
24872003|NCT03217136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25669602|NCT01732458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669603|NCT01732458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25669604|NCT01732458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25669605|NCT01732458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25669606|NCT01732458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25669607|NCT01732458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25669608|NCT01732458|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25669609|NCT01732536|Mometasone Furoate|mometasone furoate|mesh-list
25669610|NCT01732536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25669611|NCT01732536|Dermatologic Agents|dermatologic agents|mesh-ancestor
25224387|NCT02633709|Hormone Antagonists|hormone antagonists|mesh-ancestor
25224388|NCT02633709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25224389|NCT02633709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224390|NCT02633709|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25043142|NCT01314222|Sensory System Agents|sensory system agents|mesh-ancestor
25043143|NCT01314222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25043144|NCT01314222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043145|NCT01314222|Anticonvulsants|anticonvulsants|mesh-ancestor
25043146|NCT01314222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24872004|NCT03217136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24872005|NCT03217136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24872006|NCT03217136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24872007|NCT03217136|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25056023|NCT03515798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25056024|NCT03515798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979817|NCT05241028|Ensartinib|ensartinib|mesh-list
24872040|NCT05400070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872041|NCT05400070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872042|NCT05399732|Cyclosporine|cyclosporine|mesh-list
24872043|NCT05399732|Luspatercept|luspatercept|mesh-list
24872044|NCT05399732|Cyclosporins|cyclosporins|mesh-list
24872045|NCT05399732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24872046|NCT05399732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872047|NCT05399732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24872048|NCT05399732|Immunologic Factors|immunologic factors|mesh-ancestor
24872049|NCT05399732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872050|NCT05399732|Antifungal Agents|antifungal agents|mesh-ancestor
24872051|NCT05399732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24872052|NCT05399732|Dermatologic Agents|dermatologic agents|mesh-ancestor
24872062|NCT05399576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25112042|NCT04527055|Metronidazole|metronidazole|mesh-list
24872101|NCT05398861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25201347|NCT02728492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201348|NCT02728492|Tubulin Modulators|tubulin modulators|mesh-ancestor
24872106|NCT05398770|Vitamin D|vitamin d|mesh-list
24872107|NCT05398770|Vitamins|vitamins|mesh-ancestor
24814969|NCT02067767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814970|NCT02067767|Antiviral Agents|antiviral agents|mesh-ancestor
24814971|NCT02067767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24815000|NCT02067936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24815001|NCT02067936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815002|NCT02067936|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24791300|NCT04773392|Prednisone|prednisone|mesh-list
24815003|NCT02067936|Anesthetics, General|anesthetics, general|mesh-ancestor
24872109|NCT05398770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872110|NCT05398770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24872112|NCT05398757|Dexmedetomidine|dexmedetomidine|mesh-list
24872113|NCT05398757|Propofol|propofol|mesh-list
24872114|NCT05398757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24872118|NCT05398757|Anesthetics, General|anesthetics, general|mesh-ancestor
24872119|NCT05398757|Anesthetics|anesthetics|mesh-ancestor
24872120|NCT05398757|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24872121|NCT05398757|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25056034|NCT03515798|Alkylating Agents|alkylating agents|mesh-ancestor
25056035|NCT03515798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25056036|NCT03515798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25056037|NCT03515772|Darunavir|darunavir|mesh-list
25056038|NCT03515772|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25056039|NCT03515772|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25056040|NCT03515772|Protease Inhibitors|protease inhibitors|mesh-ancestor
24872137|NCT05398679|Moxifloxacin|moxifloxacin|mesh-list
24872138|NCT05398679|Ciprofloxacin|ciprofloxacin|mesh-list
24872139|NCT05398679|Levofloxacin|levofloxacin|mesh-list
24872141|NCT05398679|Clindamycin|clindamycin|mesh-list
25669612|NCT01732536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25674454|NCT01772368|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25674455|NCT01772368|Adrenergic Agonists|adrenergic agonists|mesh-list
25674456|NCT01772368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25674457|NCT01772368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25674458|NCT01772368|Autonomic Agents|autonomic agents|mesh-ancestor
25674459|NCT01772368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25674460|NCT01772368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674461|NCT01772368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24872142|NCT05398679|Clindamycin palmitate|clindamycin palmitate|mesh-list
24872151|NCT05398679|Trimethoprim|trimethoprim|mesh-list
24872152|NCT05398679|Sulfamethoxazole|sulfamethoxazole|mesh-list
25864330|NCT00096694|Contraceptive Agents|contraceptive agents|mesh-ancestor
24872153|NCT05398679|Oxazolidinones|oxazolidinones|mesh-list
24872154|NCT05398679|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24872155|NCT05398679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24872156|NCT05398679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24872157|NCT05398679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24872158|NCT05398679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24872159|NCT05398679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24872160|NCT05398679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872161|NCT05398679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872162|NCT05398679|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24872163|NCT05398679|Contraceptive Agents|contraceptive agents|mesh-ancestor
24872164|NCT05398679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24872165|NCT05398679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872166|NCT05398679|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24872167|NCT05398679|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24872168|NCT05398679|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24872169|NCT05398679|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24872170|NCT05398679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24872171|NCT05398679|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24872172|NCT05398679|Renal Agents|renal agents|mesh-ancestor
24872173|NCT05398679|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24872174|NCT05398679|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24872175|NCT05398679|Antitubercular Agents|antitubercular agents|mesh-ancestor
24510609|NCT00565175|Famotidine|famotidine|mesh-list
24872178|NCT05398679|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24872179|NCT05398679|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24872180|NCT05398679|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25201349|NCT02728492|Antimitotic Agents|antimitotic agents|mesh-ancestor
24872194|NCT05398653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24872195|NCT05398653|Immunologic Factors|immunologic factors|mesh-ancestor
24872196|NCT05398653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872197|NCT05398653|Antifungal Agents|antifungal agents|mesh-ancestor
24872442|NCT05385705|Alkylating Agents|alkylating agents|mesh-ancestor
24872200|NCT05398653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24872201|NCT05398653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24872207|NCT05398393|Amlodipine|amlodipine|mesh-list
24872221|NCT05398393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24872222|NCT05398393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25864331|NCT00096694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24872234|NCT05398289|Antitubercular Agents|antitubercular agents|mesh-ancestor
24872235|NCT05398224|Rituximab|rituximab|mesh-list
24872236|NCT05398224|Methotrexate|methotrexate|mesh-list
24872237|NCT05398224|Zanubrutinib|zanubrutinib|mesh-list
24872238|NCT05398224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24872239|NCT05398224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872240|NCT05398224|Immunologic Factors|immunologic factors|mesh-ancestor
24872241|NCT05398224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872242|NCT05398224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24872243|NCT05398224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24872244|NCT05398224|Abortifacient Agents|abortifacient agents|mesh-ancestor
24872245|NCT05398224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24872246|NCT05398224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24872247|NCT05398224|Antimetabolites|antimetabolites|mesh-ancestor
24872248|NCT05398224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872249|NCT05398224|Dermatologic Agents|dermatologic agents|mesh-ancestor
24872250|NCT05398224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24872251|NCT05398224|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24872252|NCT05398224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24872253|NCT05398224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24872254|NCT05398224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24872255|NCT05398081|Ceftriaxone|ceftriaxone|mesh-list
24872256|NCT05398081|Cefuroxime|cefuroxime|mesh-list
24872257|NCT05398081|Cefuroxime axetil|cefuroxime axetil|mesh-list
24872258|NCT05398081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24872259|NCT05398081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24872260|NCT05398055|Azithromycin|azithromycin|mesh-list
24872261|NCT05398055|Doxycycline|doxycycline|mesh-list
24872262|NCT05398055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24872263|NCT05398055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24872264|NCT05398055|Antimalarials|antimalarials|mesh-ancestor
25864332|NCT00096694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864333|NCT00096694|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24872287|NCT05397795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24872288|NCT05397795|Contraceptive Agents|contraceptive agents|mesh-ancestor
24872289|NCT05397795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25095508|NCT03218553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24872290|NCT05397795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201350|NCT02728492|Mitosis Modulators|mitosis modulators|mesh-ancestor
25864334|NCT00096694|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25864335|NCT00096694|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25864336|NCT00096707|Deoxyglucose|deoxyglucose|mesh-list
25864337|NCT00096707|Antimetabolites|antimetabolites|mesh-ancestor
25864338|NCT00096707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872291|NCT05397795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24872292|NCT05397795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24872293|NCT05397795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872294|NCT05397652|Tranexamic Acid|tranexamic acid|mesh-list
24872295|NCT05397652|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24872296|NCT05397652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24872297|NCT05397652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872298|NCT05397652|Hemostatics|hemostatics|mesh-ancestor
24872299|NCT05397652|Coagulants|coagulants|mesh-ancestor
24872300|NCT05397262|Fluorouracil|fluorouracil|mesh-list
24872301|NCT05397262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872302|NCT05397262|Antimetabolites|antimetabolites|mesh-ancestor
24872303|NCT05397262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872304|NCT05397262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24872305|NCT05397262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24872306|NCT05397262|Immunologic Factors|immunologic factors|mesh-ancestor
24872323|NCT05397236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24872324|NCT05397236|Sensory System Agents|sensory system agents|mesh-ancestor
24872325|NCT05396937|Bevacizumab|bevacizumab|mesh-list
24872326|NCT05396937|Atezolizumab|atezolizumab|mesh-list
24952968|NCT03890406|Rocuronium|rocuronium|mesh-list
24872327|NCT05396937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24872328|NCT05396937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872329|NCT05396937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24872330|NCT05396937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24872331|NCT05396937|Growth Substances|growth substances|mesh-ancestor
24872332|NCT05396937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872333|NCT05396937|Growth Inhibitors|growth inhibitors|mesh-ancestor
24872334|NCT05396859|Decitabine|decitabine|mesh-list
24872335|NCT05396859|Entrectinib|entrectinib|mesh-list
24872336|NCT05396859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24872337|NCT05396859|Antimetabolites|antimetabolites|mesh-ancestor
24872338|NCT05396859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112077|NCT04488367|Tranexamic Acid|tranexamic acid|mesh-list
24872378|NCT05396118|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24872379|NCT05396118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201351|NCT02728492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201352|NCT02728492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25201353|NCT02728492|Antimetabolites|antimetabolites|mesh-ancestor
25201354|NCT02728492|Antiviral Agents|antiviral agents|mesh-ancestor
25201355|NCT02728492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25201356|NCT02728492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201357|NCT02728492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25201358|NCT02728492|Immunologic Factors|immunologic factors|mesh-ancestor
25201359|NCT02728492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201360|NCT02728440|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25201361|NCT02728440|Menotropins|menotropins|mesh-list
25056070|NCT03515668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056071|NCT03515668|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25056072|NCT03515668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25056073|NCT03515668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24939377|NCT04010669|Hormones|hormones|mesh-ancestor
25056074|NCT03515668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815025|NCT02068079|Sequestering Agents|sequestering agents|mesh-ancestor
24815033|NCT02068131|Capecitabine|capecitabine|mesh-list
24815034|NCT02068131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24815035|NCT02068131|Antimetabolites|antimetabolites|mesh-ancestor
25669613|NCT01732588|Artefenomel|artefenomel|mesh-list
25669614|NCT01732588|Antimalarials|antimalarials|mesh-ancestor
25669615|NCT01732588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25669616|NCT01732588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25669617|NCT01732588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25669618|NCT01732640|Paclitaxel|paclitaxel|mesh-list
25669619|NCT01732640|Cisplatin|cisplatin|mesh-list
25669620|NCT01732640|Carboplatin|carboplatin|mesh-list
25669621|NCT01732640|Afatinib|afatinib|mesh-list
24815036|NCT02068131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872433|NCT05385705|Cyclophosphamide|cyclophosphamide|mesh-list
24872435|NCT05385705|Interleukin-2|interleukin-2|mesh-list
24872436|NCT05385705|Pertuzumab|pertuzumab|mesh-list
24872437|NCT05385705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24872438|NCT05385705|Immunologic Factors|immunologic factors|mesh-ancestor
24872439|NCT05385705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872440|NCT05385705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24872441|NCT05385705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24872485|NCT05363553|Sequestering Agents|sequestering agents|mesh-ancestor
24872486|NCT05363553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872487|NCT05359315|Interferons|interferons|mesh-list
24872488|NCT05359315|Interferon-gamma|interferon-gamma|mesh-list
24872489|NCT05359315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872502|NCT05341180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24872553|NCT05315479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24872554|NCT05315479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24872555|NCT05315479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872556|NCT05314374|Bile Acids and Salts|bile acids and salts|mesh-list
24872557|NCT05314374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24872558|NCT05313659|Ketamine|ketamine|mesh-list
24872559|NCT05313659|Analgesics|analgesics|mesh-ancestor
24872560|NCT05313659|Sensory System Agents|sensory system agents|mesh-ancestor
24872561|NCT05313659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24872562|NCT05313659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056095|NCT03515382|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25056096|NCT03515382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25056097|NCT03515382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24872563|NCT05313659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24872571|NCT05313659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872572|NCT05311033|Tranexamic Acid|tranexamic acid|mesh-list
24872573|NCT05311033|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24872574|NCT05311033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24695049|NCT04698525|GABA Agents|gaba agents|mesh-ancestor
24872575|NCT05311033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872577|NCT05311033|Coagulants|coagulants|mesh-ancestor
24872578|NCT05309460|Labetalol|labetalol|mesh-list
24872579|NCT05309460|Nifedipine|nifedipine|mesh-list
24872580|NCT05309460|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24872581|NCT05309460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24872642|NCT05298670|Immunologic Factors|immunologic factors|mesh-ancestor
24872643|NCT05298670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24872644|NCT05293548|Vaccines|vaccines|mesh-list
24872645|NCT05293548|Immunologic Factors|immunologic factors|mesh-ancestor
24872656|NCT05293249|Autonomic Agents|autonomic agents|mesh-ancestor
24872657|NCT05293249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24872658|NCT05293249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872659|NCT05293249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24872660|NCT05293249|Glucocorticoids|glucocorticoids|mesh-ancestor
24872661|NCT05293249|Hormones|hormones|mesh-ancestor
24872666|NCT05293249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872667|NCT05280340|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24872668|NCT05280340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24872669|NCT05275738|Niacinamide|niacinamide|mesh-list
24872671|NCT05275738|Nicotinic Acids|nicotinic acids|mesh-list
24872672|NCT05275738|Vitamin B Complex|vitamin b complex|mesh-ancestor
24872673|NCT05275738|Vitamins|vitamins|mesh-ancestor
24872713|NCT05238844|Antiviral Agents|antiviral agents|mesh-ancestor
24872714|NCT05238844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25056103|NCT03515382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25056105|NCT03515369|Hematinics|hematinics|mesh-ancestor
25056106|NCT03515213|Fenofibrate|fenofibrate|mesh-list
25056107|NCT03515213|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25056108|NCT03515213|Antimetabolites|antimetabolites|mesh-ancestor
25056109|NCT03515213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872732|NCT05232461|Ciprofloxacin|ciprofloxacin|mesh-list
24872734|NCT05232461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24872735|NCT05232461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24872736|NCT05232461|Analgesics|analgesics|mesh-ancestor
24872737|NCT05232461|Sensory System Agents|sensory system agents|mesh-ancestor
24872738|NCT05232461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24872739|NCT05232461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872740|NCT05232461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24872752|NCT05232461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25056116|NCT03515200|Bortezomib|bortezomib|mesh-list
25056117|NCT03515200|Dasatinib|dasatinib|mesh-list
24872794|NCT05209347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24872797|NCT05440487|Sequestering Agents|sequestering agents|mesh-ancestor
25864339|NCT00096707|Antiviral Agents|antiviral agents|mesh-ancestor
25112115|NCT04415840|Immunologic Factors|immunologic factors|mesh-ancestor
24872833|NCT05439798|Dermatologic Agents|dermatologic agents|mesh-ancestor
24872834|NCT05439798|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24872835|NCT05439798|Serotonin Agents|serotonin agents|mesh-ancestor
24872836|NCT05439798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24872837|NCT05439798|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24872838|NCT05439798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24872839|NCT05439798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24872840|NCT05439798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24872841|NCT05439798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24872848|NCT05439772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24815064|NCT02068170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24815065|NCT02068170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24815066|NCT02068170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24815067|NCT02068170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24815068|NCT02068170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815069|NCT02068170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24815071|NCT02068170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24815072|NCT02068170|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24815073|NCT02068170|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24815074|NCT02068170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24815075|NCT02068170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24815076|NCT02068170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25864340|NCT00096707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25864341|NCT00096720|Levodopa|levodopa|mesh-list
25864342|NCT00096720|Pramipexole|pramipexole|mesh-list
25864343|NCT00096720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25864344|NCT00096720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25864345|NCT00096720|Dopamine Agents|dopamine agents|mesh-ancestor
25864346|NCT00096720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24815077|NCT02068170|Growth Substances|growth substances|mesh-ancestor
24815078|NCT02068170|Growth Inhibitors|growth inhibitors|mesh-ancestor
24815079|NCT02068170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25864347|NCT00096720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815080|NCT02068170|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24815081|NCT02068170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24815082|NCT02068170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24815083|NCT02068170|Antifungal Agents|antifungal agents|mesh-ancestor
25056124|NCT03515200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25056125|NCT03515200|Glucocorticoids|glucocorticoids|mesh-ancestor
25056126|NCT03515200|Hormones|hormones|mesh-ancestor
25056127|NCT03515200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25056128|NCT03515200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25056129|NCT03515200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864348|NCT00096720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864349|NCT00096720|Antioxidants|antioxidants|mesh-ancestor
24872906|NCT05439408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24872907|NCT05439408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24872908|NCT05439408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872909|NCT05439278|Temozolomide|temozolomide|mesh-list
24872910|NCT05439278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24872911|NCT05439278|Alkylating Agents|alkylating agents|mesh-ancestor
24872912|NCT05439278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872913|NCT05439278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872927|NCT05439213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25056131|NCT03515200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25056132|NCT03515200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25056133|NCT03515200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25056134|NCT03515200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056135|NCT03515200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25056136|NCT03515200|Abortifacient Agents|abortifacient agents|mesh-ancestor
25056137|NCT03515200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25056138|NCT03515200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24872928|NCT05439213|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24872936|NCT05438992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24872937|NCT05438992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872938|NCT05438992|Sensory System Agents|sensory system agents|mesh-ancestor
25431496|NCT01064466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864350|NCT00096720|Protective Agents|protective agents|mesh-ancestor
24872939|NCT05438992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24695407|NCT03666065|Insulin|insulin|mesh-list
24872965|NCT05438758|Anesthetics|anesthetics|mesh-ancestor
24872966|NCT05438758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24872967|NCT05438758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24872968|NCT05438758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24872969|NCT05438758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24872970|NCT05438758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872971|NCT05438758|Antidepressive Agents|antidepressive agents|mesh-ancestor
24872972|NCT05438758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24872973|NCT05438706|Carboplatin|carboplatin|mesh-list
24872974|NCT05438706|Capecitabine|capecitabine|mesh-list
24872975|NCT05438706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872999|NCT05434624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25201364|NCT02728440|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25201365|NCT02728440|Fertility Agents|fertility agents|mesh-ancestor
24966271|NCT03770013|Sympatholytics|sympatholytics|mesh-ancestor
25864351|NCT00096720|Dopamine Agonists|dopamine agonists|mesh-ancestor
25864352|NCT00096798|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
25864353|NCT00096798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25864354|NCT00096798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25864355|NCT00096811|Entecavir|entecavir|mesh-list
25864356|NCT00096811|Antiviral Agents|antiviral agents|mesh-ancestor
25864357|NCT00096811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25864358|NCT00096837|Motexafin gadolinium|motexafin gadolinium|mesh-list
25864359|NCT00096837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864360|NCT00096837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25864361|NCT00096837|Dermatologic Agents|dermatologic agents|mesh-ancestor
25864362|NCT00096850|Ritonavir|ritonavir|mesh-list
25864363|NCT00096850|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25864364|NCT00096850|Rifampin|rifampin|mesh-list
25864365|NCT00096850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25864366|NCT00096850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25864367|NCT00096850|Protease Inhibitors|protease inhibitors|mesh-ancestor
25864368|NCT00096850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24873009|NCT05434624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24873010|NCT05432804|Temozolomide|temozolomide|mesh-list
24873011|NCT05432804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25024028|NCT03649334|Narcotics|narcotics|mesh-ancestor
25864369|NCT00096850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864370|NCT00096850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25864371|NCT00096850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25864372|NCT00096850|Antiviral Agents|antiviral agents|mesh-ancestor
25864373|NCT00096850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25864374|NCT00096850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24873027|NCT05430893|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25056142|NCT03515200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25056143|NCT03515200|Immunologic Factors|immunologic factors|mesh-ancestor
25056144|NCT03515200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25024112|NCT03648684|Caffeine|caffeine|mesh-list
25864375|NCT00096850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25864376|NCT00096850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25864377|NCT00096850|Antitubercular Agents|antitubercular agents|mesh-ancestor
25864378|NCT00096850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25864379|NCT00096850|Leprostatic Agents|leprostatic agents|mesh-ancestor
25864380|NCT00096850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25864381|NCT00096850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25864382|NCT00096850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25864383|NCT00096850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24936293|NCT04042714|Trifluridine|trifluridine|mesh-list
24815128|NCT02068235|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24815129|NCT02068235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815131|NCT02068235|Immunologic Factors|immunologic factors|mesh-ancestor
24815132|NCT02068235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864384|NCT00096850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25056158|NCT03515187|Protective Agents|protective agents|mesh-ancestor
25056159|NCT03515018|Imatinib Mesylate|imatinib mesylate|mesh-list
25056160|NCT03515018|Hydroxyurea|hydroxyurea|mesh-list
25056161|NCT03515018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056162|NCT03515018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25056163|NCT03515018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25056164|NCT03515018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815143|NCT02068339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24815144|NCT02068339|Schistosomicides|schistosomicides|mesh-ancestor
24815145|NCT02068339|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24837578|NCT02192203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24837579|NCT02192203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837580|NCT02192203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24837581|NCT02192203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24815146|NCT02068339|Anthelmintics|anthelmintics|mesh-ancestor
24815147|NCT02068339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25201367|NCT02728323|Anesthetics, Local|anesthetics, local|mesh-ancestor
25201368|NCT02728323|Anesthetics|anesthetics|mesh-ancestor
25201369|NCT02728323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25201370|NCT02728323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201371|NCT02728323|Sensory System Agents|sensory system agents|mesh-ancestor
25201372|NCT02728323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25201373|NCT02728310|Levobupivacaine|levobupivacaine|mesh-list
25201374|NCT02728310|Anesthetics, Local|anesthetics, local|mesh-ancestor
25201375|NCT02728310|Anesthetics|anesthetics|mesh-ancestor
25201376|NCT02728310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25201377|NCT02728310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201378|NCT02728310|Sensory System Agents|sensory system agents|mesh-ancestor
24815148|NCT02068339|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24815149|NCT02068339|Protective Agents|protective agents|mesh-ancestor
24815150|NCT02068339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815151|NCT02068339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815152|NCT02068339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24815153|NCT02068339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25864385|NCT00096850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25864386|NCT00096850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25864387|NCT00096863|Haloperidol|haloperidol|mesh-list
25864388|NCT00096863|Haloperidol decanoate|haloperidol decanoate|mesh-list
24873177|NCT05339334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24873178|NCT05339334|Protease Inhibitors|protease inhibitors|mesh-ancestor
24873179|NCT05339334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24873180|NCT05339334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24873181|NCT05339334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24873182|NCT05339334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24873183|NCT05339334|Antiviral Agents|antiviral agents|mesh-ancestor
24873184|NCT05339334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24873185|NCT05339334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24873186|NCT05339334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24873187|NCT05330143|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24873188|NCT05330143|Antiviral Agents|antiviral agents|mesh-ancestor
24873189|NCT05330143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25056165|NCT03515018|Antisickling Agents|antisickling agents|mesh-ancestor
24873526|NCT05181124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25056166|NCT03515018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24764357|NCT01780883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056167|NCT03514979|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25056168|NCT03514979|Immunologic Factors|immunologic factors|mesh-ancestor
25056169|NCT03514979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056170|NCT03514836|Cyclophosphamide|cyclophosphamide|mesh-list
25056171|NCT03514836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24873190|NCT05330130|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24873192|NCT05330130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24873193|NCT05330130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24873197|NCT05328154|Diphosphonates|diphosphonates|mesh-list
24827397|NCT02138773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827398|NCT02138773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24873318|NCT05279131|Tirbanibulin|tirbanibulin|mesh-list
24873319|NCT05279131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24873320|NCT05279131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24873321|NCT05274789|Dexmedetomidine|dexmedetomidine|mesh-list
24873322|NCT05274789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24873323|NCT05274789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24873324|NCT05274789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24873325|NCT05274789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24873326|NCT05274789|Analgesics|analgesics|mesh-ancestor
24873327|NCT05274789|Sensory System Agents|sensory system agents|mesh-ancestor
24873328|NCT05274789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24873329|NCT05274789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25669622|NCT01732640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25669623|NCT01732640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669624|NCT01732640|Tubulin Modulators|tubulin modulators|mesh-ancestor
25669625|NCT01732640|Antimitotic Agents|antimitotic agents|mesh-ancestor
24837611|NCT02192320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25864389|NCT00096863|Ziprasidone|ziprasidone|mesh-list
25056177|NCT03514836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056178|NCT03514836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056179|NCT03514836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25864390|NCT00096863|Antiemetics|antiemetics|mesh-ancestor
25864391|NCT00096863|Autonomic Agents|autonomic agents|mesh-ancestor
25864392|NCT00096863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25864393|NCT00096863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864394|NCT00096863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25864395|NCT00096863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25864396|NCT00096863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25864397|NCT00096863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24873408|NCT05251090|Coagulants|coagulants|mesh-ancestor
24873409|NCT05243862|Atezolizumab|atezolizumab|mesh-list
24873410|NCT05243862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885665|NCT04991662|Protective Agents|protective agents|mesh-ancestor
24873430|NCT05234580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25056181|NCT03514810|Sertraline|sertraline|mesh-list
25056182|NCT03514810|Antidepressive Agents|antidepressive agents|mesh-ancestor
25056183|NCT03514810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25056184|NCT03514810|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24623047|NCT01069874|Micronutrients|micronutrients|mesh-ancestor
24873461|NCT05215236|Sensory System Agents|sensory system agents|mesh-ancestor
24873462|NCT05215236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25864398|NCT00096863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25864399|NCT00096863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25864400|NCT00096863|Dopamine Agents|dopamine agents|mesh-ancestor
25864401|NCT00096863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25864402|NCT00096863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864403|NCT00096863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25864404|NCT00096863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25201384|NCT02728037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24827401|NCT02138799|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24827402|NCT02138799|Antitubercular Agents|antitubercular agents|mesh-ancestor
25864405|NCT00096863|Serotonin Agents|serotonin agents|mesh-ancestor
25864406|NCT00096915|Darbepoetin alfa|darbepoetin alfa|mesh-list
25864407|NCT00096915|Hematinics|hematinics|mesh-ancestor
25024414|NCT03646292|Pioglitazone|pioglitazone|mesh-list
25056187|NCT03514810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056188|NCT03514810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24873487|NCT05204134|Insulin|insulin|mesh-list
24873488|NCT05204134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24873489|NCT05204134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24873522|NCT05181124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24873523|NCT05181124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24873524|NCT05181124|Gout Suppressants|gout suppressants|mesh-ancestor
24873525|NCT05181124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25864408|NCT00096967|Bevacizumab|bevacizumab|mesh-list
25864409|NCT00096967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25864410|NCT00096967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864411|NCT00096967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25056190|NCT03514810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056191|NCT03514810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25056192|NCT03514810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25201385|NCT02728037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201386|NCT02728037|Sensory System Agents|sensory system agents|mesh-ancestor
24873579|NCT05129748|Sodium thiosulfate|sodium thiosulfate|mesh-list
24873580|NCT05129748|Mannitol|mannitol|mesh-list
24873581|NCT05129748|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25056193|NCT03514810|Analgesics|analgesics|mesh-ancestor
25056194|NCT03514810|Sensory System Agents|sensory system agents|mesh-ancestor
25056195|NCT03514810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25056196|NCT03514810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25669626|NCT01732640|Mitosis Modulators|mitosis modulators|mesh-ancestor
25669627|NCT01732640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669628|NCT01732640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25669629|NCT01732640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25669630|NCT01732718|Atorvastatin|atorvastatin|mesh-list
25669631|NCT01732718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25669632|NCT01732718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25669633|NCT01732718|Antimetabolites|antimetabolites|mesh-ancestor
25669634|NCT01732718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669635|NCT01732718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25056197|NCT03514810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25056198|NCT03514810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25056199|NCT03514810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25056200|NCT03514771|Valacyclovir|valacyclovir|mesh-list
24873582|NCT05129748|Diuretics|diuretics|mesh-ancestor
24873583|NCT05129748|Natriuretic Agents|natriuretic agents|mesh-ancestor
24873584|NCT05129748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24873585|NCT05129748|Antidotes|antidotes|mesh-ancestor
24873586|NCT05129748|Protective Agents|protective agents|mesh-ancestor
24885808|NCT04537026|BB 1101|bb 1101|mesh-list
24873587|NCT05129748|Antioxidants|antioxidants|mesh-ancestor
24815154|NCT02068339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24696063|NCT01427127|Ramosetron|ramosetron|mesh-list
24873597|NCT05121246|Palivizumab|palivizumab|mesh-list
24873598|NCT05121246|Antiviral Agents|antiviral agents|mesh-ancestor
24873599|NCT05121246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24873600|NCT05118776|Bevacizumab|bevacizumab|mesh-list
25024638|NCT03643874|Tocolytic Agents|tocolytic agents|mesh-ancestor
25864412|NCT00096967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25864413|NCT00096967|Growth Substances|growth substances|mesh-ancestor
24873726|NCT05049213|Povidone-Iodine|povidone-iodine|mesh-list
24873747|NCT05033769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24873748|NCT05033769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24873767|NCT05030155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24873769|NCT05030155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864414|NCT00096967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24873779|NCT05025423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201387|NCT02728037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25056216|NCT03514667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056221|NCT03514576|Pasireotide|pasireotide|mesh-list
25056222|NCT03514576|Hormones|hormones|mesh-ancestor
25056223|NCT03514576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25056224|NCT03514576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056225|NCT03514550|Propofol|propofol|mesh-list
25056226|NCT03514550|Sevoflurane|sevoflurane|mesh-list
24810421|NCT02040220|Aflibercept|aflibercept|mesh-list
25864415|NCT00096967|Growth Inhibitors|growth inhibitors|mesh-ancestor
25864416|NCT00097019|Bevacizumab|bevacizumab|mesh-list
25864417|NCT00097019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25864418|NCT00097019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864419|NCT00097019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25864420|NCT00097019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25864421|NCT00097019|Growth Substances|growth substances|mesh-ancestor
25864422|NCT00097019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864423|NCT00097019|Growth Inhibitors|growth inhibitors|mesh-ancestor
25864424|NCT00097032|Risperidone|risperidone|mesh-list
25864425|NCT00097032|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25864426|NCT00097032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25864427|NCT00097032|Serotonin Agents|serotonin agents|mesh-ancestor
25864428|NCT00097032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25864429|NCT00097032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864430|NCT00097032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864431|NCT00097032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25864432|NCT00097032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25864433|NCT00097032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25864434|NCT00097032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25864435|NCT00097032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25864436|NCT00097032|Dopamine Agents|dopamine agents|mesh-ancestor
25864437|NCT00097032|Antidepressive Agents|antidepressive agents|mesh-ancestor
25876566|NCT03278925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876567|NCT03278925|Protective Agents|protective agents|mesh-ancestor
24511187|NCT00567710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25876568|NCT03278925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876569|NCT03278925|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25876570|NCT03278925|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25876571|NCT03278925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876572|NCT03278925|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25056228|NCT03514550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25056229|NCT03514550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876573|NCT03269669|Prednisone|prednisone|mesh-list
25876574|NCT03269669|Cortisone|cortisone|mesh-list
25876575|NCT03269669|Cyclophosphamide|cyclophosphamide|mesh-list
25876576|NCT03269669|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25876577|NCT03269669|Doxorubicin|doxorubicin|mesh-list
25876578|NCT03269669|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25876579|NCT03269669|Vincristine|vincristine|mesh-list
25876580|NCT03269669|Lenalidomide|lenalidomide|mesh-list
25864439|NCT00097045|Ribavirin|ribavirin|mesh-list
25864440|NCT00097045|Interferon omega 1|interferon omega 1|mesh-list
25864441|NCT00097045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864442|NCT00097045|Antiviral Agents|antiviral agents|mesh-ancestor
25864443|NCT00097045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25864444|NCT00097045|Antimetabolites|antimetabolites|mesh-ancestor
25864445|NCT00097045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864446|NCT00097071|Insulin|insulin|mesh-list
25864447|NCT00097071|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25864448|NCT00097071|Insulin Aspart|insulin aspart|mesh-list
25864449|NCT00097071|Insulin Lispro|insulin lispro|mesh-list
25864450|NCT00097071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25864451|NCT00097071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864452|NCT00097084|Insulin|insulin|mesh-list
25864453|NCT00097084|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25864454|NCT00097084|Insulin Glargine|insulin glargine|mesh-list
25864455|NCT00097084|Insulin Aspart|insulin aspart|mesh-list
25864456|NCT00097084|Insulin Detemir|insulin detemir|mesh-list
25864457|NCT00097084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25864458|NCT00097084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864459|NCT00097110|Ascorbic Acid|ascorbic acid|mesh-list
25864460|NCT00097110|Vitamins|vitamins|mesh-ancestor
25864461|NCT00097110|Micronutrients|micronutrients|mesh-ancestor
25864462|NCT00097110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24873809|NCT05015387|Protective Agents|protective agents|mesh-ancestor
24873810|NCT05015387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24873811|NCT05015387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24873812|NCT05015387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25864463|NCT00097110|Antioxidants|antioxidants|mesh-ancestor
25864464|NCT00097110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864465|NCT00097110|Protective Agents|protective agents|mesh-ancestor
25864466|NCT00097123|Misoprostol|misoprostol|mesh-list
25864467|NCT00097123|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25864468|NCT00097123|Abortifacient Agents|abortifacient agents|mesh-ancestor
25864469|NCT00097123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25864470|NCT00097123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864471|NCT00097123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25864472|NCT00097123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25864473|NCT00097123|Oxytocics|oxytocics|mesh-ancestor
25864474|NCT00097188|Rituximab|rituximab|mesh-list
25864475|NCT00097188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25864476|NCT00097188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056231|NCT03514550|Anesthetics, General|anesthetics, general|mesh-ancestor
25056232|NCT03514550|Anesthetics|anesthetics|mesh-ancestor
25056233|NCT03514550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25056234|NCT03514550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25056235|NCT03514446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25056236|NCT03514446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25056237|NCT03514381|Doxorubicin|doxorubicin|mesh-list
25056238|NCT03514381|Ifosfamide|ifosfamide|mesh-list
24939686|NCT04008043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24939687|NCT04008043|Analgesics|analgesics|mesh-ancestor
24939688|NCT04008043|Sensory System Agents|sensory system agents|mesh-ancestor
24939689|NCT04008043|Antipyretics|antipyretics|mesh-ancestor
24939690|NCT04008043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24939691|NCT04008043|Narcotics|narcotics|mesh-ancestor
24939692|NCT04008043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24939693|NCT04008043|Antitussive Agents|antitussive agents|mesh-ancestor
24939694|NCT04008043|Respiratory System Agents|respiratory system agents|mesh-ancestor
24939695|NCT04008043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24939696|NCT04008043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25056239|NCT03514381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24810434|NCT02040285|Antiemetics|antiemetics|mesh-ancestor
25864477|NCT00097188|Immunologic Factors|immunologic factors|mesh-ancestor
25864478|NCT00097188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864479|NCT00097188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25864480|NCT00097214|Carboplatin|carboplatin|mesh-list
25864481|NCT00097214|Cetuximab|cetuximab|mesh-list
25056240|NCT03514381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056241|NCT03514381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25056242|NCT03514381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25674462|NCT01772368|Respiratory System Agents|respiratory system agents|mesh-ancestor
25674463|NCT01772368|Dermatologic Agents|dermatologic agents|mesh-ancestor
25674464|NCT01772368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25674465|NCT01772368|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25674466|NCT01772368|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25674467|NCT01772368|Adrenergic Agents|adrenergic agents|mesh-ancestor
25674468|NCT01772368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25864483|NCT00097214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25864484|NCT00097227|Paclitaxel|paclitaxel|mesh-list
25864485|NCT00097227|Carboplatin|carboplatin|mesh-list
25864486|NCT00097227|Cetuximab|cetuximab|mesh-list
25864487|NCT00097227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25864488|NCT00097227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864489|NCT00097227|Tubulin Modulators|tubulin modulators|mesh-ancestor
25864490|NCT00097227|Antimitotic Agents|antimitotic agents|mesh-ancestor
25864491|NCT00097227|Mitosis Modulators|mitosis modulators|mesh-ancestor
25864492|NCT00097227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864493|NCT00097227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25864494|NCT00097266|Haloperidol|haloperidol|mesh-list
24885893|NCT04282239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25864495|NCT00097266|Aripiprazole|aripiprazole|mesh-list
25864496|NCT00097266|Haloperidol decanoate|haloperidol decanoate|mesh-list
25864497|NCT00097266|Antidepressive Agents|antidepressive agents|mesh-ancestor
25864498|NCT00097266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25864499|NCT00097266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25864500|NCT00097266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25864501|NCT00097266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25864502|NCT00097266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815175|NCT02068482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25864503|NCT00097266|Dopamine Agonists|dopamine agonists|mesh-ancestor
24815181|NCT02068560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864504|NCT00097266|Dopamine Agents|dopamine agents|mesh-ancestor
25864505|NCT00097266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25864506|NCT00097266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864507|NCT00097266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25864508|NCT00097266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25056243|NCT03514381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25056244|NCT03514381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056245|NCT03514381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25056246|NCT03514381|Alkylating Agents|alkylating agents|mesh-ancestor
25056247|NCT03514342|Ropivacaine|ropivacaine|mesh-list
25056248|NCT03514342|Anesthetics, Local|anesthetics, local|mesh-ancestor
25864509|NCT00097266|Serotonin Agents|serotonin agents|mesh-ancestor
25864510|NCT00097266|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25864511|NCT00097266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25864512|NCT00097266|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25864513|NCT00097266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25864514|NCT00097266|Antiemetics|antiemetics|mesh-ancestor
25864515|NCT00097266|Autonomic Agents|autonomic agents|mesh-ancestor
25864516|NCT00097266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25864517|NCT00097266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25864518|NCT00097266|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25864519|NCT00097279|Metformin|metformin|mesh-list
25864520|NCT00097279|Pioglitazone|pioglitazone|mesh-list
25864521|NCT00097279|Insulin Aspart|insulin aspart|mesh-list
25864522|NCT00097279|Biphasic Insulins|biphasic insulins|mesh-list
25864523|NCT00097279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25864524|NCT00097279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864525|NCT00097318|Interferons|interferons|mesh-list
25864526|NCT00097318|Interferon-beta|interferon-beta|mesh-list
25864527|NCT00097318|Interferon beta-1a|interferon beta-1a|mesh-list
25864528|NCT00097318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864529|NCT00097318|Antiviral Agents|antiviral agents|mesh-ancestor
25864530|NCT00097318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25864531|NCT00097318|Immunologic Factors|immunologic factors|mesh-ancestor
25864532|NCT00097318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864533|NCT00097318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25864534|NCT00097344|Toremifene|toremifene|mesh-list
25864535|NCT00097344|Letrozole|letrozole|mesh-list
25864536|NCT00097344|Hormones|hormones|mesh-list
25864537|NCT00097344|Atamestane|atamestane|mesh-list
25864538|NCT00097344|Estrogen Antagonists|estrogen antagonists|mesh-list
25864539|NCT00097344|Estrogens|estrogens|mesh-list
25864540|NCT00097344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
25864541|NCT00097344|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
25864542|NCT00097344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25864543|NCT00097344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864544|NCT00097344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864545|NCT00097344|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25864546|NCT00097344|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25864547|NCT00097344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876581|NCT03269669|Obinutuzumab|obinutuzumab|mesh-list
25096235|NCT03213249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096236|NCT03213249|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25096237|NCT03213145|Rifampin|rifampin|mesh-list
25096242|NCT03213145|Leprostatic Agents|leprostatic agents|mesh-ancestor
25096243|NCT03213145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25096244|NCT03213145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25096245|NCT03213145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864548|NCT00097344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056254|NCT03514251|Parathyroid Hormone|parathyroid hormone|mesh-list
25056255|NCT03514251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25056256|NCT03514251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056259|NCT03514108|Isosorbide|isosorbide|mesh-list
25056260|NCT03514108|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25864549|NCT00097344|Hormone Antagonists|hormone antagonists|mesh-ancestor
25864550|NCT00097344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25864551|NCT00097344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25864552|NCT00097344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25864553|NCT00097383|Epirubicin|epirubicin|mesh-list
25864554|NCT00097383|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25864555|NCT00097383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864556|NCT00097383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25864557|NCT00097383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25025041|NCT03640247|Ibuprofen|ibuprofen|mesh-list
25864558|NCT00097383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24873944|NCT04960618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25056272|NCT03514030|Immunologic Factors|immunologic factors|mesh-ancestor
24873945|NCT04960618|Immunologic Factors|immunologic factors|mesh-ancestor
24873946|NCT04960618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24873947|NCT04960618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25864559|NCT00097383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864560|NCT00097435|Ribavirin|ribavirin|mesh-list
25864561|NCT00097435|Antimetabolites|antimetabolites|mesh-ancestor
25864562|NCT00097435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864563|NCT00097435|Antiviral Agents|antiviral agents|mesh-ancestor
25864564|NCT00097435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25864565|NCT00097734|Ertapenem|ertapenem|mesh-list
25864566|NCT00097734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25864567|NCT00097734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25864568|NCT00097760|Natalizumab|natalizumab|mesh-list
25864569|NCT00097760|Immunologic Factors|immunologic factors|mesh-ancestor
25864570|NCT00097760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815207|NCT02068690|BI 425809|bi 425809|mesh-list
24815208|NCT02068690|Nootropic Agents|nootropic agents|mesh-ancestor
24815209|NCT02068859|Diclofenac|diclofenac|mesh-list
24815210|NCT02068859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24815211|NCT02068859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25864571|NCT00097799|Ritonavir|ritonavir|mesh-list
25864572|NCT00097799|Tipranavir|tipranavir|mesh-list
25864573|NCT00097799|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25864574|NCT00097799|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25864575|NCT00097799|Protease Inhibitors|protease inhibitors|mesh-ancestor
25864576|NCT00097799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864577|NCT00097799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864578|NCT00097799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25864579|NCT00097799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25864580|NCT00097799|Antiviral Agents|antiviral agents|mesh-ancestor
25056306|NCT03513575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25056307|NCT03513575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25056308|NCT03513575|Disinfectants|disinfectants|mesh-ancestor
25056309|NCT03513549|Loxapine|loxapine|mesh-list
25056310|NCT03513549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25056311|NCT03513549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25864581|NCT00097799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25864582|NCT00097799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25864583|NCT00097799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25864584|NCT00097812|Zoledronic Acid|zoledronic acid|mesh-list
25864585|NCT00097812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25669636|NCT01732718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25669637|NCT01732718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25669638|NCT01732757|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25669639|NCT01732757|Dextrans|dextrans|mesh-list
25669640|NCT01732757|Alcaftadine|alcaftadine|mesh-list
25669641|NCT01732757|Anticoagulants|anticoagulants|mesh-ancestor
25669642|NCT01732757|Plasma Substitutes|plasma substitutes|mesh-ancestor
25669643|NCT01732757|Blood Substitutes|blood substitutes|mesh-ancestor
25864586|NCT00097812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864588|NCT00097825|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25864589|NCT00097825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864590|NCT00097877|Insulin|insulin|mesh-list
25864591|NCT00097877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24874370|NCT04777994|Mitosis Modulators|mitosis modulators|mesh-ancestor
24874378|NCT04774965|Diphenhydramine|diphenhydramine|mesh-list
24874380|NCT04774965|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24874381|NCT04774965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24874382|NCT04774965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24874383|NCT04774965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24874384|NCT04774965|Anesthetics, Local|anesthetics, local|mesh-ancestor
24874385|NCT04774965|Anesthetics|anesthetics|mesh-ancestor
24874386|NCT04774965|Sensory System Agents|sensory system agents|mesh-ancestor
24874387|NCT04774965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24874388|NCT04774965|Antiemetics|antiemetics|mesh-ancestor
24874389|NCT04774965|Autonomic Agents|autonomic agents|mesh-ancestor
24696832|NCT01431326|GABA Modulators|gaba modulators|mesh-ancestor
24874390|NCT04774965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24874391|NCT04774965|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25056327|NCT03513471|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25056328|NCT03513471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25056329|NCT03513458|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25056330|NCT03513458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24874395|NCT04774965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24874397|NCT04774965|Antipruritics|antipruritics|mesh-ancestor
24874406|NCT04767984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24874407|NCT04767984|Antimetabolites|antimetabolites|mesh-ancestor
24874408|NCT04767984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24874410|NCT04767984|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24874411|NCT04767984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24874412|NCT04767594|Palbociclib|palbociclib|mesh-list
24874413|NCT04767594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24874419|NCT04751500|Clindamycin|clindamycin|mesh-list
24874420|NCT04751500|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24874421|NCT04751500|Misoprostol|misoprostol|mesh-list
24874422|NCT04751500|Mifepristone|mifepristone|mesh-list
24874423|NCT04751500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24874424|NCT04751500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24874425|NCT04751500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24874426|NCT04751500|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24874427|NCT04751500|Abortifacient Agents|abortifacient agents|mesh-ancestor
24874428|NCT04751500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24874429|NCT04751500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24874430|NCT04751500|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24874446|NCT04751500|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24874448|NCT04751500|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24874455|NCT04750616|Niacinamide|niacinamide|mesh-list
24874456|NCT04750616|Niacin|niacin|mesh-list
24874457|NCT04750616|Nicotinic Acids|nicotinic acids|mesh-list
25864592|NCT00097877|Insulin Glargine|insulin glargine|mesh-list
25864593|NCT00097877|Insulin Aspart|insulin aspart|mesh-list
25864594|NCT00097877|Biphasic Insulins|biphasic insulins|mesh-list
24810564|NCT02040818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24810566|NCT02040831|Vaccines|vaccines|mesh-list
24810567|NCT02040831|Immunologic Factors|immunologic factors|mesh-ancestor
24810569|NCT02040883|Olanzapine|olanzapine|mesh-list
25864595|NCT00097877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25864596|NCT00097877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24874473|NCT04740307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864597|NCT00097903|Camptothecin|camptothecin|mesh-list
24886115|NCT03099863|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24886116|NCT03099863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25864598|NCT00097903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25864599|NCT00097903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864600|NCT00097903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24874524|NCT04673422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24874525|NCT04673422|Respiratory System Agents|respiratory system agents|mesh-ancestor
24874526|NCT04673422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24874527|NCT04673422|Hormone Antagonists|hormone antagonists|mesh-ancestor
24874528|NCT04673422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25864601|NCT00097903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25096373|NCT03212352|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24874529|NCT04673422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24874530|NCT04673422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24874531|NCT04673422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24874532|NCT04673422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056348|NCT03513328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056349|NCT03513328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056350|NCT03513328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25056351|NCT03513328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25056352|NCT03513328|Immunologic Factors|immunologic factors|mesh-ancestor
25056353|NCT03513328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056354|NCT03513276|Epinephrine|epinephrine|mesh-list
25056355|NCT03513276|Racepinephrine|racepinephrine|mesh-list
25056356|NCT03513276|Ropivacaine|ropivacaine|mesh-list
25056357|NCT03513276|Epinephryl borate|epinephryl borate|mesh-list
25056358|NCT03513276|Anesthetics, Local|anesthetics, local|mesh-ancestor
25056359|NCT03513276|Anesthetics|anesthetics|mesh-ancestor
25056360|NCT03513276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24788391|NCT01931189|Infliximab|infliximab|mesh-list
24815218|NCT02068859|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24815219|NCT02068859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815220|NCT02068859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815222|NCT02068937|Diuretics|diuretics|mesh-ancestor
24815223|NCT02068937|Natriuretic Agents|natriuretic agents|mesh-ancestor
24815224|NCT02068937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815225|NCT02068937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24815226|NCT02068937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24511311|NCT00568217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24815227|NCT02068937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815238|NCT02069145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24815239|NCT02069145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815240|NCT02069145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201389|NCT02728037|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25201390|NCT02728037|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24866429|NCT05132985|Pemetrexed|pemetrexed|mesh-list
24815241|NCT02069145|Immunologic Factors|immunologic factors|mesh-ancestor
24874692|NCT04592809|Analgesics|analgesics|mesh-ancestor
24874693|NCT04592809|Sensory System Agents|sensory system agents|mesh-ancestor
24874694|NCT04592809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24874695|NCT04592809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24874696|NCT04592809|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24874697|NCT04592809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24874698|NCT04592809|Anesthetics, General|anesthetics, general|mesh-ancestor
25056378|NCT03513172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25056379|NCT03513172|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25056380|NCT03513172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25056381|NCT03513172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25056382|NCT03513172|Adrenergic Agents|adrenergic agents|mesh-ancestor
25056383|NCT03513172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25056384|NCT03513172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056385|NCT03513172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056386|NCT03513055|Insulin|insulin|mesh-list
25056387|NCT03513055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25056388|NCT03513055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056389|NCT03512990|Bupivacaine|bupivacaine|mesh-list
25056390|NCT03512990|Anesthetics, Local|anesthetics, local|mesh-ancestor
24874761|NCT04576104|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24874762|NCT04576104|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24874763|NCT04576104|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24874764|NCT04576104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24874765|NCT04576104|Appetite Stimulants|appetite stimulants|mesh-ancestor
24874766|NCT04576104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25201391|NCT02728037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24874770|NCT04575961|Pembrolizumab|pembrolizumab|mesh-list
24874771|NCT04575961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24874772|NCT04575961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24874773|NCT04563507|Letrozole|letrozole|mesh-list
25864602|NCT00097903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25669644|NCT01732757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25669645|NCT01732757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24837731|NCT02192853|Incretins|incretins|mesh-ancestor
25864603|NCT00097903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864604|NCT00097916|Memantine|memantine|mesh-list
24874824|NCT04534582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24874825|NCT04534582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511488|NCT00568971|Antimitotic Agents|antimitotic agents|mesh-ancestor
25056397|NCT03512873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25056398|NCT03512873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25056399|NCT03512873|Analgesics|analgesics|mesh-ancestor
25056400|NCT03512873|Sensory System Agents|sensory system agents|mesh-ancestor
25864605|NCT00097916|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24874897|NCT04508803|Trastuzumab|trastuzumab|mesh-list
24874898|NCT04508803|Niraparib|niraparib|mesh-list
24874899|NCT04508803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24874900|NCT04508803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24874901|NCT04508803|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24874902|NCT04508803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24874903|NCT04508803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697315|NCT01434147|Bevacizumab|bevacizumab|mesh-list
24874904|NCT04505774|Dapagliflozin|dapagliflozin|mesh-list
24874905|NCT04505774|Empagliflozin|empagliflozin|mesh-list
24874906|NCT04505774|Canagliflozin|canagliflozin|mesh-list
24874907|NCT04505774|Ertugliflozin|ertugliflozin|mesh-list
24874921|NCT04505774|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24874922|NCT04505774|Purinergic Agents|purinergic agents|mesh-ancestor
24874923|NCT04505774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24874924|NCT04505774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24874925|NCT04505774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24874926|NCT04505774|Anticoagulants|anticoagulants|mesh-ancestor
24874927|NCT04505774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24874940|NCT04497584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24874941|NCT04497584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815272|NCT02069301|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24815273|NCT02069301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24815274|NCT02069301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815275|NCT02069340|Zoledronic Acid|zoledronic acid|mesh-list
24815276|NCT02069340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24815277|NCT02069340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056401|NCT03512873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25056402|NCT03512873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056403|NCT03512873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25056404|NCT03512873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24815292|NCT02069418|Alovudine|alovudine|mesh-list
24815293|NCT02069418|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24815294|NCT02069418|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24815295|NCT02069418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815296|NCT02069418|Antiviral Agents|antiviral agents|mesh-ancestor
24815297|NCT02069418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24815298|NCT02069431|Oxytocin|oxytocin|mesh-list
24815299|NCT02069431|Oxytocics|oxytocics|mesh-ancestor
24815300|NCT02069431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24815301|NCT02069431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24875018|NCT04481204|Vitamins|vitamins|mesh-ancestor
24886248|NCT02432378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864606|NCT00097916|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25864607|NCT00097916|Dopamine Agents|dopamine agents|mesh-ancestor
25864608|NCT00097916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25864609|NCT00097916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025917|NCT03632876|Antioxidants|antioxidants|mesh-ancestor
24875120|NCT04439136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056417|NCT03512860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25056418|NCT03512860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056419|NCT03512860|GABA Agents|gaba agents|mesh-ancestor
25056420|NCT03512860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25056421|NCT03512860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056422|NCT03512860|Antimanic Agents|antimanic agents|mesh-ancestor
25056423|NCT03512860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25056424|NCT03512860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25056425|NCT03512860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25056426|NCT03512834|Paclitaxel|paclitaxel|mesh-list
25056427|NCT03512834|Avelumab|avelumab|mesh-list
25056428|NCT03512834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25056429|NCT03512834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056430|NCT03512834|Tubulin Modulators|tubulin modulators|mesh-ancestor
24875121|NCT04439136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24875122|NCT04439136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24875123|NCT04439136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864610|NCT00097916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864611|NCT00097916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25864612|NCT00097916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24875204|NCT04329325|Methotrexate|methotrexate|mesh-list
24815302|NCT02069522|Carotenoids|carotenoids|mesh-list
24815303|NCT02069522|Antioxidants|antioxidants|mesh-ancestor
24815304|NCT02069522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815305|NCT02069522|Protective Agents|protective agents|mesh-ancestor
24815306|NCT02069522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815307|NCT02069665|Ribavirin|ribavirin|mesh-list
24815340|NCT02069665|Appetite Depressants|appetite depressants|mesh-ancestor
24815341|NCT02069665|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24815342|NCT02069665|Sympathomimetics|sympathomimetics|mesh-ancestor
24815343|NCT02069665|Nasal Decongestants|nasal decongestants|mesh-ancestor
24815344|NCT02069665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24815346|NCT02069808|Menotropins|menotropins|mesh-list
24875224|NCT04329325|Dermatologic Agents|dermatologic agents|mesh-ancestor
24875225|NCT04329325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24875246|NCT04316702|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24875248|NCT04316702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24875249|NCT04316702|Antidepressive Agents|antidepressive agents|mesh-ancestor
24875250|NCT04316702|Dopamine Agents|dopamine agents|mesh-ancestor
25864613|NCT00097929|Vorinostat|vorinostat|mesh-list
24875267|NCT04281017|Anesthetics|anesthetics|mesh-list
24875268|NCT04281017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24875269|NCT04281017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24875287|NCT04253964|Tubulin Modulators|tubulin modulators|mesh-ancestor
24875288|NCT04253964|Antimitotic Agents|antimitotic agents|mesh-ancestor
24875289|NCT04253964|Mitosis Modulators|mitosis modulators|mesh-ancestor
24875290|NCT04253964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875291|NCT04253964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24875292|NCT04253964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25026057|NCT03632304|Anesthetics|anesthetics|mesh-list
24875357|NCT04220008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24875359|NCT04220008|Antiviral Agents|antiviral agents|mesh-ancestor
24875360|NCT04220008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24875361|NCT04220008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939937|NCT04005430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939938|NCT04005430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24939939|NCT04005430|Glucocorticoids|glucocorticoids|mesh-ancestor
24939940|NCT04005430|Hormones|hormones|mesh-ancestor
24939941|NCT04005430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24939942|NCT04005430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24875362|NCT04220008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24875363|NCT04220008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24875364|NCT04220008|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25864614|NCT00097929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25060507|NCT03479411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25864615|NCT00097929|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25864616|NCT00097929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24875422|NCT04181333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25201392|NCT02728037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939944|NCT04005430|Protease Inhibitors|protease inhibitors|mesh-ancestor
24939945|NCT04005430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939946|NCT04005430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939947|NCT04005365|Propranolol|propranolol|mesh-list
24939948|NCT04005365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24875477|NCT04163978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24875478|NCT04163978|Autonomic Agents|autonomic agents|mesh-ancestor
24875479|NCT04163978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24875480|NCT04163978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24875481|NCT04163978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24875482|NCT04163978|Respiratory System Agents|respiratory system agents|mesh-ancestor
24875483|NCT04163978|Glucocorticoids|glucocorticoids|mesh-ancestor
24875484|NCT04163978|Hormones|hormones|mesh-ancestor
24875485|NCT04163978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24875486|NCT04163978|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24875487|NCT04163978|Antioxidants|antioxidants|mesh-ancestor
24875488|NCT04163978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875536|NCT04088591|Ascorbic Acid|ascorbic acid|mesh-list
24875537|NCT04088591|Antioxidants|antioxidants|mesh-ancestor
24939949|NCT04005365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24939950|NCT04005365|Adrenergic Agents|adrenergic agents|mesh-ancestor
24939951|NCT04005365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25201393|NCT02728037|Analgesics|analgesics|mesh-ancestor
25201394|NCT02728037|Anticonvulsants|anticonvulsants|mesh-ancestor
25201395|NCT02728037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25201396|NCT02728037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25864617|NCT00097929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864619|NCT00097942|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25864620|NCT00097942|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24939953|NCT04005365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056449|NCT03512574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25056450|NCT03512574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24591106|NCT00915200|Acetylcysteine|acetylcysteine|mesh-list
24875578|NCT04021108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24875579|NCT04021108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25864621|NCT00097942|Dopamine Agents|dopamine agents|mesh-ancestor
25864622|NCT00097942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25864623|NCT00097942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864624|NCT00097942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511757|NCT00570726|Growth Inhibitors|growth inhibitors|mesh-ancestor
24875680|NCT03936777|Fenfluramine|fenfluramine|mesh-list
24875681|NCT03936777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24875682|NCT03936777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24875683|NCT03936777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24875684|NCT03936777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201403|NCT02728245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201404|NCT02728245|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25201405|NCT02728245|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25201406|NCT02728245|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25201407|NCT02728245|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25201408|NCT02728245|Hormone Antagonists|hormone antagonists|mesh-ancestor
25864625|NCT00097942|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25864626|NCT00097942|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25864627|NCT00097968|Everolimus|everolimus|mesh-list
24457960|NCT00335920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24875689|NCT03907475|Paclitaxel|paclitaxel|mesh-list
24875690|NCT03907475|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24875691|NCT03907475|Carboplatin|carboplatin|mesh-list
24875692|NCT03907475|Doxorubicin|doxorubicin|mesh-list
24875693|NCT03907475|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24875694|NCT03907475|Capecitabine|capecitabine|mesh-list
24875695|NCT03907475|Durvalumab|durvalumab|mesh-list
24875696|NCT03907475|Immunoglobulins|immunoglobulins|mesh-list
24875697|NCT03907475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24875698|NCT03907475|Immunoglobulin G|immunoglobulin g|mesh-list
24875699|NCT03907475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24875700|NCT03907475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815355|NCT02069808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24815357|NCT02069886|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24815358|NCT02069886|Chelating Agents|chelating agents|mesh-ancestor
24875711|NCT03907475|Immunologic Factors|immunologic factors|mesh-ancestor
24875712|NCT03907475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056465|NCT03512548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25056466|NCT03512548|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25056467|NCT03512548|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24875727|NCT03896269|Cytarabine|cytarabine|mesh-list
24875758|NCT03866525|Irinotecan|irinotecan|mesh-list
24875759|NCT03866525|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24875760|NCT03866525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24875761|NCT03866525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24875762|NCT03866525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875763|NCT03866525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24875764|NCT03848754|Gemtuzumab|gemtuzumab|mesh-list
24875765|NCT03848754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24875766|NCT03848754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24875767|NCT03846427|Zanubrutinib|zanubrutinib|mesh-list
24875768|NCT03846427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24875769|NCT03846427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25669646|NCT01732757|Analgesics|analgesics|mesh-ancestor
25669647|NCT01732757|Sensory System Agents|sensory system agents|mesh-ancestor
25096699|NCT03209908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25096700|NCT03209908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25096701|NCT03209908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096702|NCT03209908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25096703|NCT03209908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24875770|NCT03846427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24875771|NCT03846427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875777|NCT03839823|Paclitaxel|paclitaxel|mesh-list
25056471|NCT03512548|Hormone Antagonists|hormone antagonists|mesh-ancestor
25056472|NCT03512548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25056473|NCT03512548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056474|NCT03512548|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24875878|NCT03816332|Nivolumab|nivolumab|mesh-list
24875879|NCT03816332|Ipilimumab|ipilimumab|mesh-list
24875880|NCT03816332|Tacrolimus|tacrolimus|mesh-list
24875881|NCT03816332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24875882|NCT03816332|Glucocorticoids|glucocorticoids|mesh-ancestor
24875883|NCT03816332|Hormones|hormones|mesh-ancestor
24591315|NCT00915837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24875901|NCT03813147|Fludarabine phosphate|fludarabine phosphate|mesh-list
24875902|NCT03813147|Azacitidine|azacitidine|mesh-list
24875903|NCT03813147|Fludarabine|fludarabine|mesh-list
24875904|NCT03813147|Enzyme Inhibitors|enzyme inhibitors|mesh-list
24875905|NCT03813147|Pevonedistat|pevonedistat|mesh-list
24875906|NCT03813147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24875907|NCT03813147|Abortifacient Agents|abortifacient agents|mesh-ancestor
24875908|NCT03813147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24875909|NCT03813147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026389|NCT03629262|Narcotics|narcotics|mesh-ancestor
24591403|NCT00916253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591405|NCT00916396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24591406|NCT00916396|Immunologic Factors|immunologic factors|mesh-ancestor
25056478|NCT03512496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25056479|NCT03512496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606023|NCT00988715|Fludarabine phosphate|fludarabine phosphate|mesh-list
25864628|NCT00097968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864629|NCT00097968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25864630|NCT00097968|Immunologic Factors|immunologic factors|mesh-ancestor
25864631|NCT00097968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864632|NCT00098007|Everolimus|everolimus|mesh-list
25864633|NCT00098007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864634|NCT00098007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25864635|NCT00098007|Immunologic Factors|immunologic factors|mesh-ancestor
25864636|NCT00098007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864637|NCT00098033|Clofarabine|clofarabine|mesh-list
25864638|NCT00098033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25864639|NCT00098033|Antimetabolites|antimetabolites|mesh-ancestor
25864640|NCT00098033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864641|NCT00098033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864642|NCT00098046|Famciclovir|famciclovir|mesh-list
25864643|NCT00098046|Antiviral Agents|antiviral agents|mesh-ancestor
25201414|NCT02727712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201415|NCT02727647|Factor VIII|factor viii|mesh-list
25201416|NCT02727647|Coagulants|coagulants|mesh-ancestor
25201417|NCT02727881|Squalamine|squalamine|mesh-list
24876025|NCT03776812|Antimitotic Agents|antimitotic agents|mesh-ancestor
24876026|NCT03776812|Mitosis Modulators|mitosis modulators|mesh-ancestor
24876027|NCT03776812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815364|NCT02069977|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24876036|NCT03766126|Cyclophosphamide|cyclophosphamide|mesh-list
24815368|NCT02069977|Dopamine Agonists|dopamine agonists|mesh-ancestor
24815369|NCT02069977|Dopamine Agents|dopamine agents|mesh-ancestor
24815370|NCT02069977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25056501|NCT03512171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25056502|NCT03512171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24512006|NCT00572065|Antimetabolites|antimetabolites|mesh-ancestor
24815384|NCT02069990|Micronutrients|micronutrients|mesh-ancestor
24698564|NCT01441934|Sildenafil Citrate|sildenafil citrate|mesh-list
24876122|NCT03722680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25669648|NCT01732757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25669649|NCT01732757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669650|NCT01732757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25669651|NCT01732757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25669652|NCT01732757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25864644|NCT00098046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24876123|NCT03722680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24876124|NCT03722680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24876125|NCT03722680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24876126|NCT03722680|Protective Agents|protective agents|mesh-ancestor
24876127|NCT03719001|Clevidipine|clevidipine|mesh-list
24876128|NCT03719001|Phenylephrine|phenylephrine|mesh-list
24876129|NCT03719001|Oxymetazoline|oxymetazoline|mesh-list
24876130|NCT03719001|Dexmedetomidine|dexmedetomidine|mesh-list
24876132|NCT03719001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25201419|NCT02727881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24876141|NCT03719001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24876142|NCT03719001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24876143|NCT03719001|Adrenergic Agents|adrenergic agents|mesh-ancestor
24876144|NCT03719001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24876145|NCT03719001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24876146|NCT03719001|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24876147|NCT03719001|Mydriatics|mydriatics|mesh-ancestor
24876148|NCT03719001|Autonomic Agents|autonomic agents|mesh-ancestor
24876149|NCT03719001|Sympathomimetics|sympathomimetics|mesh-ancestor
24876150|NCT03719001|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24876151|NCT03719001|Nasal Decongestants|nasal decongestants|mesh-ancestor
24876152|NCT03719001|Respiratory System Agents|respiratory system agents|mesh-ancestor
24876156|NCT03719001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24876157|NCT03704298|Cyclophosphamide|cyclophosphamide|mesh-list
24876158|NCT03704298|Fludarabine|fludarabine|mesh-list
24876159|NCT03704298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24810725|NCT02042196|Hormone Antagonists|hormone antagonists|mesh-ancestor
24810726|NCT02042222|Hydroxyurea|hydroxyurea|mesh-list
24876201|NCT03678688|Bedaquiline|bedaquiline|mesh-list
24876202|NCT03678688|Diarylquinolines|diarylquinolines|mesh-list
24876203|NCT03678688|Antitubercular Agents|antitubercular agents|mesh-ancestor
24876204|NCT03678688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24876205|NCT03678688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24876214|NCT03661320|Gemcitabine|gemcitabine|mesh-list
24876215|NCT03661320|Nivolumab|nivolumab|mesh-list
24876216|NCT03661320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24876217|NCT03661320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24876218|NCT03661320|Antimetabolites|antimetabolites|mesh-ancestor
24876260|NCT03646123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24876261|NCT03646123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24876263|NCT03646123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24876264|NCT03646123|Tubulin Modulators|tubulin modulators|mesh-ancestor
24876265|NCT03646123|Antimitotic Agents|antimitotic agents|mesh-ancestor
24876266|NCT03646123|Mitosis Modulators|mitosis modulators|mesh-ancestor
24793466|NCT03439345|Fenofibrate|fenofibrate|mesh-list
24876267|NCT03623750|Cyclophosphamide|cyclophosphamide|mesh-list
24876268|NCT03623750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24876269|NCT03623750|Immunologic Factors|immunologic factors|mesh-ancestor
24876270|NCT03623750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24876273|NCT03623750|Alkylating Agents|alkylating agents|mesh-ancestor
24876401|NCT03579446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24876404|NCT03579446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25056524|NCT03511846|Sensory System Agents|sensory system agents|mesh-ancestor
25056525|NCT03511846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25056526|NCT03511846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24876405|NCT03579446|Antitussive Agents|antitussive agents|mesh-ancestor
24876406|NCT03579446|Respiratory System Agents|respiratory system agents|mesh-ancestor
24876407|NCT03579446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24876513|NCT03484819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24876514|NCT03484819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24876522|NCT03463876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24876523|NCT03463876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24876529|NCT03436654|Prednisone|prednisone|mesh-list
24876530|NCT03436654|Abiraterone Acetate|abiraterone acetate|mesh-list
24876531|NCT03436654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24876532|NCT03436654|Glucocorticoids|glucocorticoids|mesh-ancestor
24876533|NCT03436654|Hormones|hormones|mesh-ancestor
24876534|NCT03436654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24876535|NCT03436654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24876536|NCT03436654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24512077|NCT00572650|Protease Inhibitors|protease inhibitors|mesh-ancestor
24876537|NCT03436654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24876538|NCT03436654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24876539|NCT03436654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24876540|NCT03436654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24876541|NCT03436654|Hormone Antagonists|hormone antagonists|mesh-ancestor
24876542|NCT03436654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24876543|NCT03413202|3-n-butylphthalide|3-n-butylphthalide|mesh-list
24876544|NCT03413202|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24876545|NCT03413202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24876546|NCT03413202|Protective Agents|protective agents|mesh-ancestor
25026739|NCT03625518|Oxytocin|oxytocin|mesh-list
24876576|NCT03378479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24876577|NCT03378479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24876578|NCT03378479|Hormone Antagonists|hormone antagonists|mesh-ancestor
24876599|NCT03344965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24876600|NCT03344965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24876602|NCT03333343|Trametinib|trametinib|mesh-list
24876603|NCT03333343|Nazartinib|nazartinib|mesh-list
24876604|NCT03333343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24876605|NCT03333343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24876606|NCT03333343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24876607|NCT03333343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056537|NCT03511833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25056538|NCT03511833|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25056539|NCT03511833|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25056540|NCT03511833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24876700|NCT03300544|Leucovorin|leucovorin|mesh-list
24876701|NCT03300544|Fluorouracil|fluorouracil|mesh-list
24876702|NCT03300544|Capecitabine|capecitabine|mesh-list
24876703|NCT03300544|Oxaliplatin|oxaliplatin|mesh-list
24876704|NCT03300544|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
24876705|NCT03300544|Antimetabolites|antimetabolites|mesh-ancestor
24876706|NCT03300544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201420|NCT02727881|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24876707|NCT03300544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24876708|NCT03300544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24876709|NCT03300544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24876710|NCT03300544|Immunologic Factors|immunologic factors|mesh-ancestor
24876762|NCT03233204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056541|NCT03511833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056542|NCT03511833|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25056543|NCT03511833|Narcotics|narcotics|mesh-ancestor
25056544|NCT03511820|Amphotericin B|amphotericin b|mesh-list
25056545|NCT03511820|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25056546|NCT03511820|Amebicides|amebicides|mesh-ancestor
24810794|NCT02042599|Sevoflurane|sevoflurane|mesh-list
24815427|NCT02070198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24815428|NCT02070198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24815429|NCT02070198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24815441|NCT02070406|Interleukin-2|interleukin-2|mesh-list
24611241|NCT01007864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24611242|NCT01007968|Panobinostat|panobinostat|mesh-list
24611243|NCT01007968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611244|NCT01007968|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24611245|NCT01007968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611246|NCT01007968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611247|NCT01008020|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24611248|NCT01008020|Antioxidants|antioxidants|mesh-ancestor
24876816|NCT03206047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24876817|NCT03206047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24876887|NCT03126539|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24876888|NCT03126539|Protective Agents|protective agents|mesh-ancestor
24876889|NCT03126539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24876890|NCT03126539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24876891|NCT03102320|Gemcitabine|gemcitabine|mesh-list
24876892|NCT03102320|Maytansine|maytansine|mesh-list
24876893|NCT03102320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24876894|NCT03102320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24876895|NCT03102320|Antimetabolites|antimetabolites|mesh-ancestor
24876896|NCT03102320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24876897|NCT03102320|Antiviral Agents|antiviral agents|mesh-ancestor
24876898|NCT03102320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24876899|NCT03102320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24876900|NCT03102320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25669653|NCT01732757|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24876901|NCT03102320|Immunologic Factors|immunologic factors|mesh-ancestor
24876902|NCT03102320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096929|NCT03208218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25096930|NCT03208413|Thalidomide|thalidomide|mesh-list
25096931|NCT03208413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25096932|NCT03208413|Immunologic Factors|immunologic factors|mesh-ancestor
25096933|NCT03208413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096934|NCT03208413|Leprostatic Agents|leprostatic agents|mesh-ancestor
25096935|NCT03208413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25096936|NCT03208413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25096937|NCT03208413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25096938|NCT03208413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25096939|NCT03208413|Growth Substances|growth substances|mesh-ancestor
25096940|NCT03208413|Growth Inhibitors|growth inhibitors|mesh-ancestor
25096941|NCT03208413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25096942|NCT03208257|Esmolol|esmolol|mesh-list
25096943|NCT03208257|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25096944|NCT03208257|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25096945|NCT03208257|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25096946|NCT03208257|Adrenergic Agents|adrenergic agents|mesh-ancestor
25096947|NCT03208257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24876903|NCT03102320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24876904|NCT03102320|Tubulin Modulators|tubulin modulators|mesh-ancestor
24876905|NCT03102320|Antimitotic Agents|antimitotic agents|mesh-ancestor
24876906|NCT03102320|Mitosis Modulators|mitosis modulators|mesh-ancestor
25056553|NCT03511768|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
25056554|NCT03511768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25056555|NCT03511768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25056556|NCT03511768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24877114|NCT02935205|Sensory System Agents|sensory system agents|mesh-ancestor
24877115|NCT02935205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24877116|NCT02935205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24877117|NCT02935205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24623412|NCT01071304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623413|NCT01071304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24623414|NCT01071304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25056559|NCT03511755|Neurotransmitter Agents|neurotransmitter agents|mesh-list
25056560|NCT03511755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056561|NCT03511755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056562|NCT03511703|Apatinib|apatinib|mesh-list
25056563|NCT03511703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056564|NCT03511703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25056565|NCT03511703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25056566|NCT03511703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056567|NCT03511560|Tacrolimus|tacrolimus|mesh-list
25056568|NCT03511560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25214543|NCT02696694|Hormones|hormones|mesh-ancestor
25056569|NCT03511560|Immunologic Factors|immunologic factors|mesh-ancestor
24623415|NCT01071304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24623416|NCT01071304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24623417|NCT01071304|Anesthetics, General|anesthetics, general|mesh-ancestor
24623418|NCT01071304|Anesthetics|anesthetics|mesh-ancestor
24623419|NCT01071304|GABA Modulators|gaba modulators|mesh-ancestor
24623420|NCT01071304|GABA Agents|gaba agents|mesh-ancestor
24815442|NCT02070406|Vaccines|vaccines|mesh-list
24815443|NCT02070406|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24815444|NCT02070406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24815496|NCT02070510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815498|NCT02070510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25669654|NCT01732757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25669655|NCT01732757|Histamine Antagonists|histamine antagonists|mesh-ancestor
25669656|NCT01732757|Histamine Agents|histamine agents|mesh-ancestor
25669657|NCT01732757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25669658|NCT01732757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669659|NCT01732770|Zoledronic Acid|zoledronic acid|mesh-list
25669660|NCT01732770|Denosumab|denosumab|mesh-list
25669661|NCT01732770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25669662|NCT01732770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669663|NCT01732783|Panitumumab|panitumumab|mesh-list
25669664|NCT01732783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25669665|NCT01732783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669666|NCT01732796|Ribavirin|ribavirin|mesh-list
25669667|NCT01732796|Antimetabolites|antimetabolites|mesh-ancestor
25669668|NCT01732796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669669|NCT01732796|Antiviral Agents|antiviral agents|mesh-ancestor
25669670|NCT01732796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25669671|NCT05317325|Vaccines|vaccines|mesh-list
25669672|NCT05317325|Immunologic Factors|immunologic factors|mesh-ancestor
24815499|NCT02070510|Protective Agents|protective agents|mesh-ancestor
24815500|NCT02070510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815501|NCT02070653|Ticagrelor|ticagrelor|mesh-list
24815502|NCT02070653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25056570|NCT03511560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056571|NCT03511560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25027029|NCT03623256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24815554|NCT02071043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24815555|NCT02071043|Antimetabolites|antimetabolites|mesh-ancestor
24815556|NCT02071043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815557|NCT02071043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815558|NCT02071069|Fluorouracil|fluorouracil|mesh-list
24815560|NCT02071069|Cetuximab|cetuximab|mesh-list
24815561|NCT02071069|Antimetabolites|antimetabolites|mesh-ancestor
24815562|NCT02071069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815563|NCT02071069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24815564|NCT02071069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815565|NCT02071069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24815566|NCT02071069|Immunologic Factors|immunologic factors|mesh-ancestor
24815567|NCT02071069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815568|NCT02071069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24815569|NCT02071069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24815570|NCT02071069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600309|NCT01026220|Prednisone|prednisone|mesh-list
24877393|NCT02756013|Mitosis Modulators|mitosis modulators|mesh-ancestor
24877394|NCT02756013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864645|NCT00098046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25864646|NCT00098046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864647|NCT00098046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864648|NCT00098111|Azathioprine|azathioprine|mesh-list
25864649|NCT00098111|Antimetabolites|antimetabolites|mesh-ancestor
25864650|NCT00098111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864651|NCT00098111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24702294|NCT01465009|Aspirin|aspirin|mesh-list
24877401|NCT02712905|Tretinoin|tretinoin|mesh-list
24877402|NCT02712905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24877403|NCT02712905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24877404|NCT02712905|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24877405|NCT02712905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24877406|NCT02712905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24877407|NCT02712905|Antimetabolites|antimetabolites|mesh-ancestor
24877408|NCT02712905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24877409|NCT02712905|Keratolytic Agents|keratolytic agents|mesh-ancestor
24877410|NCT02712905|Dermatologic Agents|dermatologic agents|mesh-ancestor
25864652|NCT00098111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864653|NCT00098111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25056582|NCT03511261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25056583|NCT03511261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25056584|NCT03511261|Analgesics|analgesics|mesh-ancestor
25056585|NCT03511261|Sensory System Agents|sensory system agents|mesh-ancestor
25056586|NCT03511261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25056587|NCT03511261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056588|NCT03511261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25056589|NCT03511261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25056590|NCT03511261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24877497|NCT02620150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24877498|NCT02620150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24877499|NCT02620150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24877500|NCT02620150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24877501|NCT02620150|Serotonin Agents|serotonin agents|mesh-ancestor
24877502|NCT02620150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24877503|NCT02620150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24877504|NCT02620150|Antidepressive Agents|antidepressive agents|mesh-ancestor
24877505|NCT02620150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24877506|NCT02596126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25201421|NCT02727881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25201422|NCT02727881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25201423|NCT02727881|Growth Substances|growth substances|mesh-ancestor
25201424|NCT02727881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201425|NCT02727881|Growth Inhibitors|growth inhibitors|mesh-ancestor
25201426|NCT02727881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201427|NCT02727881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25201428|NCT02727881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24768456|NCT01808300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24768457|NCT01808300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24877586|NCT02529852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24877587|NCT02529852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24877588|NCT02529852|Glucocorticoids|glucocorticoids|mesh-ancestor
24877590|NCT02529852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24877594|NCT02529852|Antimitotic Agents|antimitotic agents|mesh-ancestor
25056591|NCT03511261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25056592|NCT03511261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056593|NCT03511222|Pembrolizumab|pembrolizumab|mesh-list
25056596|NCT03511222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25056597|NCT03511222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056598|NCT03511222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25056599|NCT03511222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24877595|NCT02529852|Mitosis Modulators|mitosis modulators|mesh-ancestor
24877596|NCT02529852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24877597|NCT02529852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24877598|NCT02529852|Growth Substances|growth substances|mesh-ancestor
24877599|NCT02529852|Growth Inhibitors|growth inhibitors|mesh-ancestor
24877600|NCT02529852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24877601|NCT02529813|Cyclophosphamide|cyclophosphamide|mesh-list
24877602|NCT02529813|Fludarabine|fludarabine|mesh-list
24877603|NCT02529813|Fludarabine phosphate|fludarabine phosphate|mesh-list
24877604|NCT02529813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24877605|NCT02529813|Immunologic Factors|immunologic factors|mesh-ancestor
24877606|NCT02529813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24877607|NCT02529813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24877608|NCT02529813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24877609|NCT02529813|Alkylating Agents|alkylating agents|mesh-ancestor
24877610|NCT02529813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886692|NCT04523623|Analgesics|analgesics|mesh-ancestor
24877611|NCT02529813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24877612|NCT02529813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24699988|NCT01450046|Antioxidants|antioxidants|mesh-ancestor
24877613|NCT02529813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24877614|NCT02529813|Antimetabolites|antimetabolites|mesh-ancestor
25201429|NCT02727881|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25201430|NCT02727881|Protective Agents|protective agents|mesh-ancestor
24702621|NCT01466959|Acetic Acid|acetic acid|mesh-list
25056614|NCT03510975|Natriuretic Agents|natriuretic agents|mesh-ancestor
24967475|NCT03759262|Vitamin D|vitamin d|mesh-list
25056615|NCT03510975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24877729|NCT02473042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25060611|NCT03478345|Endocrine Disruptors|endocrine disruptors|mesh-list
24877732|NCT02473042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24877733|NCT02473042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24877734|NCT02473042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24877735|NCT02473042|Antipruritics|antipruritics|mesh-ancestor
24877736|NCT02473042|Dermatologic Agents|dermatologic agents|mesh-ancestor
24877742|NCT02473042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24877743|NCT02473042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24877744|NCT02473042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24877745|NCT02473042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24877746|NCT02473042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24877747|NCT02473042|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24877748|NCT02473042|Histamine Antagonists|histamine antagonists|mesh-ancestor
24877749|NCT02473042|Histamine Agents|histamine agents|mesh-ancestor
25056618|NCT03510962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25056619|NCT03510962|Disinfectants|disinfectants|mesh-ancestor
25056620|NCT03510871|Nivolumab|nivolumab|mesh-list
25056621|NCT03510871|Ipilimumab|ipilimumab|mesh-list
25056622|NCT03510871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25056623|NCT03510871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056624|NCT03510871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25056625|NCT03510871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056626|NCT03510793|Anesthetics|anesthetics|mesh-list
25056627|NCT03510793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24877764|NCT02460588|Glucocorticoids|glucocorticoids|mesh-ancestor
24877765|NCT02460588|Hormones|hormones|mesh-ancestor
24600310|NCT01026220|Cyclophosphamide|cyclophosphamide|mesh-list
24815609|NCT02071316|Hemostatics|hemostatics|mesh-ancestor
24815610|NCT02071316|Coagulants|coagulants|mesh-ancestor
24815619|NCT02071342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815621|NCT02071355|Antiviral Agents|antiviral agents|mesh-ancestor
25097226|NCT03206008|Sensory System Agents|sensory system agents|mesh-ancestor
25097227|NCT03206008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25097253|NCT03205228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25097254|NCT03205228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25097257|NCT03205228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24815622|NCT02071355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24815623|NCT02071355|Protease Inhibitors|protease inhibitors|mesh-ancestor
25201431|NCT02727738|Selenium|selenium|mesh-list
24815624|NCT02071355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815625|NCT02071355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815626|NCT02071368|Metformin|metformin|mesh-list
24815627|NCT02071368|Canagliflozin|canagliflozin|mesh-list
25864654|NCT00098111|Immunologic Factors|immunologic factors|mesh-ancestor
25112732|NCT03919526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25864655|NCT00098111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864656|NCT00098111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25864657|NCT00098124|Milnacipran|milnacipran|mesh-list
25864658|NCT00098124|Levomilnacipran|levomilnacipran|mesh-list
25864659|NCT00098124|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25864660|NCT00098124|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25864661|NCT00098124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25864662|NCT00098124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864663|NCT00098124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25864664|NCT00098124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864665|NCT00098124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25864666|NCT00098124|Analgesics|analgesics|mesh-ancestor
25027330|NCT03620825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25056631|NCT03510611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25056632|NCT03510611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25056633|NCT03510611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056634|NCT03510546|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
25056635|NCT03510546|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25056636|NCT03510546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25056637|NCT03510546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056638|NCT03510546|Cholinergic Agents|cholinergic agents|mesh-ancestor
25056639|NCT03510546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25056640|NCT03510546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056641|NCT03510533|Autoantibodies|autoantibodies|mesh-list
25056642|NCT03510533|alpha-MSH|alpha-msh|mesh-list
25056643|NCT03510533|Immunologic Factors|immunologic factors|mesh-ancestor
25056644|NCT03510533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056645|NCT03510533|Hormones|hormones|mesh-ancestor
25056646|NCT03510533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25056647|NCT03510416|Apatinib|apatinib|mesh-list
25864667|NCT00098124|Sensory System Agents|sensory system agents|mesh-ancestor
25864668|NCT00098124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25864669|NCT00098124|Antidepressive Agents|antidepressive agents|mesh-ancestor
25864670|NCT00098124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25864671|NCT00098137|Olmesartan|olmesartan|mesh-list
25864672|NCT00098137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25864673|NCT00098137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24940161|NCT04003350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940163|NCT04003350|Sensory System Agents|sensory system agents|mesh-ancestor
24940164|NCT04003350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24940165|NCT04003350|Anticonvulsants|anticonvulsants|mesh-ancestor
24940166|NCT04003350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24940167|NCT04003350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24940168|NCT04003350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24940169|NCT04003350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24940170|NCT04003350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24940171|NCT04003350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25669673|NCT05317325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669674|NCT05317260|Antiviral Agents|antiviral agents|mesh-list
25669675|NCT05317260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25669676|NCT05317039|Calcium|calcium|mesh-list
25669677|NCT05317039|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25669678|NCT05317039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669679|NCT05316883|Clozapine|clozapine|mesh-list
25669680|NCT05316883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24512358|NCT00574483|Quinacrine|quinacrine|mesh-list
24877893|NCT02237183|Vasodilator Agents|vasodilator agents|mesh-ancestor
24877903|NCT02231749|Growth Substances|growth substances|mesh-ancestor
24877904|NCT02231749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24877905|NCT02231749|Growth Inhibitors|growth inhibitors|mesh-ancestor
24877906|NCT02231749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24877907|NCT02231749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24877921|NCT02227199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24877922|NCT02227199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24877923|NCT02227199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24877924|NCT02227199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24877925|NCT02227199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24877926|NCT02227199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24877927|NCT02227199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24877928|NCT02227199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25027481|NCT03619876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24952613|NCT03892928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24952614|NCT03892928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815631|NCT02071368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815638|NCT02071407|Midazolam|midazolam|mesh-list
24815639|NCT02071407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24815640|NCT02071407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24815641|NCT02071407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24815642|NCT02071407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610162|NCT01000233|Inositol|inositol|mesh-list
24815643|NCT02071407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24815644|NCT02071407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24815645|NCT02071407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24815646|NCT02071407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24815647|NCT02071407|Anesthetics, General|anesthetics, general|mesh-ancestor
24952628|NCT03892499|Itraconazole|itraconazole|mesh-list
24952629|NCT03892499|Antifungal Agents|antifungal agents|mesh-ancestor
25864674|NCT00098137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25864675|NCT00098137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864676|NCT00098241|Everolimus|everolimus|mesh-list
25864677|NCT00098241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864678|NCT00098241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25864679|NCT00098241|Immunologic Factors|immunologic factors|mesh-ancestor
25864680|NCT00098241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864681|NCT00098280|Eculizumab|eculizumab|mesh-list
25864682|NCT00098280|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25864683|NCT00098280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24495534|NCT00500864|Analgesics|analgesics|mesh-ancestor
25864684|NCT00098280|Immunologic Factors|immunologic factors|mesh-ancestor
25864685|NCT00098280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24878312|NCT01935921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24878313|NCT01935921|Cetuximab|cetuximab|mesh-list
24878314|NCT01935921|Ipilimumab|ipilimumab|mesh-list
24878315|NCT01935921|Antibodies|antibodies|mesh-list
24952642|NCT03892447|Alprostadil|alprostadil|mesh-list
24952643|NCT03892447|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24952644|NCT03892447|Sympathomimetics|sympathomimetics|mesh-ancestor
24952645|NCT03892447|Autonomic Agents|autonomic agents|mesh-ancestor
24952646|NCT03892447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25056648|NCT03510416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056649|NCT03510416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25056650|NCT03510416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25056651|NCT03510416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056652|NCT03510351|Tazobactam|tazobactam|mesh-list
24878368|NCT01861314|Bortezomib|bortezomib|mesh-list
24878369|NCT01861314|Sorafenib|sorafenib|mesh-list
25056661|NCT03510351|Renal Agents|renal agents|mesh-ancestor
25056662|NCT03510338|Sildenafil Citrate|sildenafil citrate|mesh-list
24810955|NCT02043886|Acarbose|acarbose|mesh-list
25864686|NCT00098319|Folic Acid|folic acid|mesh-list
25864687|NCT00098319|Hematinics|hematinics|mesh-ancestor
25201432|NCT02727738|Methimazole|methimazole|mesh-list
25864688|NCT00098319|Vitamin B Complex|vitamin b complex|mesh-ancestor
24703882|NCT01475279|Warfarin|warfarin|mesh-list
25864689|NCT00098319|Vitamins|vitamins|mesh-ancestor
25864690|NCT00098319|Micronutrients|micronutrients|mesh-ancestor
25864691|NCT00098319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864692|NCT00098358|Zileuton|zileuton|mesh-list
25864693|NCT00098358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25864694|NCT00098358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25864696|NCT00098358|Sensory System Agents|sensory system agents|mesh-ancestor
25864697|NCT00098358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25864698|NCT00098358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864699|NCT00098358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24878474|NCT01709123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24878489|NCT01660971|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24878490|NCT01660971|Dasatinib|dasatinib|mesh-list
24878491|NCT01660971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24878492|NCT01660971|Antimetabolites|antimetabolites|mesh-ancestor
24886979|NCT04521075|Nivolumab|nivolumab|mesh-list
24878493|NCT01660971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878494|NCT01660971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24878495|NCT01660971|Antiviral Agents|antiviral agents|mesh-ancestor
24878496|NCT01660971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24878574|NCT01410942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25201433|NCT02727738|Antioxidants|antioxidants|mesh-ancestor
25056676|NCT03510325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25056677|NCT03510325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056678|NCT03510325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056679|NCT03510325|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25056680|NCT03510325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25027720|NCT03617471|Sensory System Agents|sensory system agents|mesh-ancestor
24887023|NCT04520646|Empagliflozin|empagliflozin|mesh-list
24878657|NCT01301807|Panobinostat|panobinostat|mesh-list
24878658|NCT01301807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24878689|NCT01160211|Hormone Antagonists|hormone antagonists|mesh-ancestor
24878690|NCT01160211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24878691|NCT01160211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24878700|NCT01139970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24878701|NCT01139970|Alkylating Agents|alkylating agents|mesh-ancestor
24878702|NCT01139970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878703|NCT01139970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24878704|NCT01139970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24878705|NCT01139970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24878706|NCT01098955|Varenicline|varenicline|mesh-list
24878707|NCT01098955|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24878708|NCT01098955|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24878709|NCT01098955|Cholinergic Agents|cholinergic agents|mesh-ancestor
24878710|NCT01098955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24878711|NCT01098955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878712|NCT01098955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24878721|NCT01093573|Midostaurin|midostaurin|mesh-list
24878722|NCT01093573|Staurosporine|staurosporine|mesh-list
24878723|NCT01093573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24878724|NCT01093573|Antimetabolites|antimetabolites|mesh-ancestor
24878725|NCT01093573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878726|NCT01093573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24878727|NCT01093573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24878728|NCT01093573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25056694|NCT03510325|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24611484|NCT01009801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24611485|NCT01009801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864700|NCT00098358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25864701|NCT00098358|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25864702|NCT00098358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887054|NCT04520230|Autonomic Agents|autonomic agents|mesh-ancestor
24878831|NCT00669734|Metronidazole|metronidazole|mesh-list
24878832|NCT00669734|Tricyclodecane-9-yl-xanthogenate|tricyclodecane-9-yl-xanthogenate|mesh-list
24878834|NCT00669734|Sargramostim|sargramostim|mesh-list
24878835|NCT00669734|Immunologic Factors|immunologic factors|mesh-ancestor
24878836|NCT00669734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864703|NCT00098358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112878|NCT03866174|Niacin|niacin|mesh-list
24878855|NCT00588991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24878856|NCT00588991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24878857|NCT00588991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878858|NCT00588991|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25112889|NCT03866174|Hallucinogens|hallucinogens|mesh-ancestor
25056700|NCT03510221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056701|NCT03510221|Protective Agents|protective agents|mesh-ancestor
25056704|NCT03510208|Panitumumab|panitumumab|mesh-list
24878906|NCT00329043|Sunitinib|sunitinib|mesh-list
25864704|NCT00098358|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25864705|NCT00098358|Hormone Antagonists|hormone antagonists|mesh-ancestor
25864706|NCT00098358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25864707|NCT00098384|Rifaximin|rifaximin|mesh-list
25864708|NCT00098384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24878965|NCT00045201|Irinotecan|irinotecan|mesh-list
24878966|NCT00045201|Camptothecin|camptothecin|mesh-list
24878967|NCT00045201|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24878968|NCT00045201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24878969|NCT00045201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25864709|NCT00098384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25864710|NCT00098384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24879020|NCT05140954|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25864711|NCT00098397|Romidepsin|romidepsin|mesh-list
25864712|NCT00098397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24611487|NCT01009801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24611488|NCT01009801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815693|NCT02071589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815694|NCT02071589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24815695|NCT02071589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815726|NCT02071641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815727|NCT02071641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815728|NCT02071680|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24815729|NCT02071680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815730|NCT02071680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815731|NCT02071680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815732|NCT02071680|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25864713|NCT00098397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864714|NCT00098423|Cytarabine|cytarabine|mesh-list
25864715|NCT00098423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25864716|NCT00098423|Antimetabolites|antimetabolites|mesh-ancestor
24815746|NCT02071888|Dexamethasone acetate|dexamethasone acetate|mesh-list
25056710|NCT03510208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815747|NCT02071888|Pomalidomide|pomalidomide|mesh-list
24815749|NCT02071888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24815750|NCT02071888|Antiemetics|antiemetics|mesh-ancestor
24815751|NCT02071888|Autonomic Agents|autonomic agents|mesh-ancestor
24815752|NCT02071888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24815753|NCT02071888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815754|NCT02071888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24815755|NCT02071888|Glucocorticoids|glucocorticoids|mesh-ancestor
24815756|NCT02071888|Hormones|hormones|mesh-ancestor
24701304|NCT01458067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24879034|NCT05112848|Vaccines|vaccines|mesh-list
24879035|NCT05112848|Immunologic Factors|immunologic factors|mesh-ancestor
24879036|NCT05112848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879037|NCT05105633|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24879038|NCT05105633|Tenecteplase|tenecteplase|mesh-list
24879039|NCT05105633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24879040|NCT05105633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24879041|NCT05105633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864717|NCT00098423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864718|NCT00098423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864719|NCT00098423|Antiviral Agents|antiviral agents|mesh-ancestor
25864720|NCT00098423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25864721|NCT00098423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25864722|NCT00098423|Immunologic Factors|immunologic factors|mesh-ancestor
25864723|NCT00098423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864724|NCT00098436|Temozolomide|temozolomide|mesh-list
24879089|NCT05062174|Hormone Antagonists|hormone antagonists|mesh-ancestor
24879090|NCT05062174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24879091|NCT05062174|Luteolytic Agents|luteolytic agents|mesh-ancestor
24879092|NCT05062174|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24879093|NCT05062174|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24879094|NCT05054868|Ketorolac|ketorolac|mesh-list
24879095|NCT05054868|Oxycodone|oxycodone|mesh-list
24879096|NCT05054868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24879097|NCT05054868|Narcotics|narcotics|mesh-ancestor
24879098|NCT05054868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24879099|NCT05054868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879101|NCT05054868|Sensory System Agents|sensory system agents|mesh-ancestor
24879102|NCT05054868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25864725|NCT00098436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25864726|NCT00098436|Alkylating Agents|alkylating agents|mesh-ancestor
25864727|NCT00098436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864728|NCT00098436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864729|NCT00098462|Sirolimus|sirolimus|mesh-list
25864730|NCT00098462|Gefitinib|gefitinib|mesh-list
25864731|NCT00098462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25056723|NCT03510000|Hormones|hormones|mesh-list
25056724|NCT03510000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25056725|NCT03510000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056726|NCT03510000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25056727|NCT03510000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056728|NCT03510000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25056729|NCT03510000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25056730|NCT03509922|Sarpogrelate|sarpogrelate|mesh-list
25056731|NCT03509922|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25056732|NCT03509922|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25056733|NCT03509922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056734|NCT03509922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25056735|NCT03509922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25056736|NCT03509922|Serotonin Agents|serotonin agents|mesh-ancestor
25056737|NCT03509922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24879193|NCT04962893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701528|NCT01459406|Levan|levan|mesh-list
24879202|NCT04956042|Cytarabine|cytarabine|mesh-list
24879203|NCT04956042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24879204|NCT04956042|Antimetabolites|antimetabolites|mesh-ancestor
24879205|NCT04956042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879206|NCT04956042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24879207|NCT04956042|Antiviral Agents|antiviral agents|mesh-ancestor
24879208|NCT04956042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24879209|NCT04956042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24879210|NCT04956042|Immunologic Factors|immunologic factors|mesh-ancestor
24879211|NCT04956042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864732|NCT00098462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24879220|NCT04937543|Beclomethasone|beclomethasone|mesh-list
24879221|NCT04937543|Glycopyrrolate|glycopyrrolate|mesh-list
24879222|NCT04937543|Formoterol Fumarate|formoterol fumarate|mesh-list
24879223|NCT04937543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24879224|NCT04937543|Autonomic Agents|autonomic agents|mesh-ancestor
24879225|NCT04937543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24879226|NCT04937543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879227|NCT04937543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24879228|NCT04937543|Respiratory System Agents|respiratory system agents|mesh-ancestor
24879229|NCT04937543|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24879230|NCT04937543|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24879231|NCT04937543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24879232|NCT04937543|Adrenergic Agents|adrenergic agents|mesh-ancestor
24879233|NCT04937543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24879234|NCT04937543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879235|NCT04937543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24879236|NCT04937543|Glucocorticoids|glucocorticoids|mesh-ancestor
24879237|NCT04937543|Hormones|hormones|mesh-ancestor
24985088|NCT03694002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24879255|NCT04923737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24879256|NCT04923737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879257|NCT04921943|Azithromycin|azithromycin|mesh-list
24879258|NCT04921943|Rifampin|rifampin|mesh-list
24879259|NCT04921943|Ethambutol|ethambutol|mesh-list
24879260|NCT04921943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24879261|NCT04921943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24879265|NCT04921943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24701545|NCT01459445|Estrogens|estrogens|mesh-ancestor
24879266|NCT04921943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24879267|NCT04921943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879268|NCT04921943|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25864733|NCT00098462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24887243|NCT04518540|Micronutrients|micronutrients|mesh-ancestor
25056748|NCT03509831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056749|NCT03509831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056750|NCT03509831|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25056751|NCT03509831|Protective Agents|protective agents|mesh-ancestor
25056752|NCT03509831|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25056753|NCT03509740|Acetaminophen|acetaminophen|mesh-list
25056755|NCT03509740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25056756|NCT03509740|Analgesics|analgesics|mesh-ancestor
24623090|NCT01070160|Hormones|hormones|mesh-ancestor
24879298|NCT04901208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24879299|NCT04901208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879300|NCT04901208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24879301|NCT04901208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24879302|NCT04901208|Cholinergic Agents|cholinergic agents|mesh-ancestor
24879303|NCT04901208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24879304|NCT04901208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879306|NCT04892017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864734|NCT00098462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864735|NCT00098462|Antifungal Agents|antifungal agents|mesh-ancestor
24879320|NCT04862338|Vitamins|vitamins|mesh-ancestor
24879321|NCT04862338|Micronutrients|micronutrients|mesh-ancestor
24879322|NCT04862338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879323|NCT04862338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24879324|NCT04862338|Antimetabolites|antimetabolites|mesh-ancestor
24879325|NCT04862338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879326|NCT04862338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24879327|NCT04862338|Vasodilator Agents|vasodilator agents|mesh-ancestor
25864736|NCT00098462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25864737|NCT00098462|Immunologic Factors|immunologic factors|mesh-ancestor
25864738|NCT00098462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815812|NCT02072083|Anesthetics|anesthetics|mesh-ancestor
24815813|NCT02072083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24815814|NCT02072083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24815815|NCT02072135|Bupivacaine|bupivacaine|mesh-list
24815816|NCT02072135|Anesthetics, Local|anesthetics, local|mesh-ancestor
24815817|NCT02072135|Anesthetics|anesthetics|mesh-ancestor
24815818|NCT02072135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24879376|NCT04796454|Immunologic Factors|immunologic factors|mesh-ancestor
24887332|NCT04517227|Durvalumab|durvalumab|mesh-list
24879377|NCT04796454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879378|NCT04796454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24879379|NCT04796454|Alkylating Agents|alkylating agents|mesh-ancestor
25056758|NCT03509740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25056759|NCT03509740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056760|NCT03509740|Antipyretics|antipyretics|mesh-ancestor
25056761|NCT03509740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25056762|NCT03509740|Narcotics|narcotics|mesh-ancestor
25056763|NCT03509740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25056764|NCT03509714|Ascorbic Acid|ascorbic acid|mesh-list
25056765|NCT03509714|Antioxidants|antioxidants|mesh-ancestor
25056766|NCT03509714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879433|NCT04765709|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24879456|NCT04752813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24879457|NCT04752813|Alkylating Agents|alkylating agents|mesh-ancestor
24879458|NCT04752813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879459|NCT04752813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864739|NCT00098462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25864740|NCT00098462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864741|NCT00098462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864742|NCT00098488|Rituximab|rituximab|mesh-list
24879481|NCT04740580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879482|NCT04740580|Protective Agents|protective agents|mesh-ancestor
24879483|NCT04740580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879484|NCT04740580|Antidotes|antidotes|mesh-ancestor
24879485|NCT04740580|Glycine Agents|glycine agents|mesh-ancestor
24879486|NCT04740580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25056767|NCT03509714|Protective Agents|protective agents|mesh-ancestor
25056768|NCT03509714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056770|NCT03509714|Micronutrients|micronutrients|mesh-ancestor
25056771|NCT03509701|Antibodies|antibodies|mesh-list
25056772|NCT03509701|Immunologic Factors|immunologic factors|mesh-ancestor
25056773|NCT03509701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056774|NCT03509688|Entecavir|entecavir|mesh-list
25056781|NCT03509688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056782|NCT03509688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25056783|NCT03509688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25056784|NCT03509662|Ascorbic Acid|ascorbic acid|mesh-list
25056785|NCT03509662|Thiamine|thiamine|mesh-list
25056786|NCT03509662|Vitamins|vitamins|mesh-ancestor
24879499|NCT04715633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864743|NCT00098488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25056804|NCT03509545|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25056806|NCT03509545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864744|NCT00098488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24879574|NCT04660240|Immunologic Factors|immunologic factors|mesh-ancestor
24879575|NCT04660240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864745|NCT00098488|Immunologic Factors|immunologic factors|mesh-ancestor
25864746|NCT00098488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864747|NCT00098488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25864748|NCT00098501|Sirolimus|sirolimus|mesh-list
25864749|NCT00098501|EKB 569|ekb 569|mesh-list
25864750|NCT00098501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25864751|NCT00098501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25864752|NCT00098501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25056807|NCT03509545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25056808|NCT03509324|Insulin Lispro|insulin lispro|mesh-list
25056809|NCT03509324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25056810|NCT03509324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056811|NCT03509298|Antibodies|antibodies|mesh-list
25056812|NCT03509298|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25056813|NCT03509298|Immunologic Factors|immunologic factors|mesh-ancestor
25056814|NCT03509298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056815|NCT03509285|Cenobamate|cenobamate|mesh-list
25056816|NCT03509285|Alprazolam|alprazolam|mesh-list
25056817|NCT03509285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25056818|NCT03509285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25056819|NCT03509285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056820|NCT03509285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25056821|NCT03509285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25056822|NCT03509285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25056823|NCT03509285|GABA Modulators|gaba modulators|mesh-ancestor
25056824|NCT03509285|GABA Agents|gaba agents|mesh-ancestor
25056825|NCT03509285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25056826|NCT03509285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056827|NCT03509285|Anticonvulsants|anticonvulsants|mesh-ancestor
25056828|NCT03509246|Doxorubicin|doxorubicin|mesh-list
25028405|NCT03610945|Antimalarials|antimalarials|mesh-ancestor
24879593|NCT04640402|Immunologic Factors|immunologic factors|mesh-ancestor
24879594|NCT04640402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879595|NCT04640376|Acetaminophen|acetaminophen|mesh-list
24879632|NCT04614545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879634|NCT04613206|Immunologic Factors|immunologic factors|mesh-ancestor
24879635|NCT04613206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879636|NCT04595981|Cisplatin|cisplatin|mesh-list
24879637|NCT04595981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24454933|NCT03161353|Pertuzumab|pertuzumab|mesh-list
25864753|NCT00098501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864754|NCT00098501|Antifungal Agents|antifungal agents|mesh-ancestor
25864755|NCT00098501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25864756|NCT00098501|Immunologic Factors|immunologic factors|mesh-ancestor
25864757|NCT00098501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879689|NCT04551521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24879690|NCT04551521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056846|NCT03509142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25056847|NCT03509142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25056848|NCT03509142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25056849|NCT03509142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056851|NCT03509142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25056852|NCT03509142|Immunologic Factors|immunologic factors|mesh-ancestor
25056853|NCT03509142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056855|NCT03508999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25056856|NCT03508999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25056857|NCT03508999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25056858|NCT03508999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24879692|NCT04530656|Immunologic Factors|immunologic factors|mesh-ancestor
24879693|NCT04530656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879695|NCT04528680|Carboplatin|carboplatin|mesh-list
25864758|NCT00098501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25864759|NCT00098501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864760|NCT00098501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864761|NCT00098527|Romidepsin|romidepsin|mesh-list
25864762|NCT00098527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25864763|NCT00098527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864764|NCT00098540|Sorafenib|sorafenib|mesh-list
25864765|NCT00098540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864766|NCT00098540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25864767|NCT00098540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24879720|NCT04526730|Nivolumab|nivolumab|mesh-list
24879721|NCT04526730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24879722|NCT04526730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24879723|NCT04526730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24879724|NCT04526730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879726|NCT04511728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25864768|NCT00098540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864769|NCT00098553|Everolimus|everolimus|mesh-list
24815858|NCT02072291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24815859|NCT02072317|Raltitrexed|raltitrexed|mesh-list
24815860|NCT02072317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24815861|NCT02072317|Antimetabolites|antimetabolites|mesh-ancestor
24815862|NCT02072317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815863|NCT02072317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815864|NCT02072317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24815865|NCT02072317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815866|NCT02072330|Amlodipine|amlodipine|mesh-list
24815867|NCT02072330|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24815868|NCT02072330|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
24815869|NCT02072330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24815870|NCT02072330|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24811122|NCT02045017|Dexamethasone|dexamethasone|mesh-list
24815871|NCT02072330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24815872|NCT02072330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864770|NCT00098553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864771|NCT00098553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25864772|NCT00098553|Immunologic Factors|immunologic factors|mesh-ancestor
25864773|NCT00098553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864774|NCT00098579|Doxorubicin|doxorubicin|mesh-list
25864775|NCT00098579|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25864776|NCT00098579|Alvocidib|alvocidib|mesh-list
25864777|NCT00098579|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25864778|NCT00098579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864779|NCT00098579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25864780|NCT00098579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24815874|NCT02072330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815875|NCT02072330|Vasodilator Agents|vasodilator agents|mesh-ancestor
24815877|NCT02072330|Natriuretic Agents|natriuretic agents|mesh-ancestor
24815878|NCT02072330|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24815879|NCT02072330|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24815880|NCT02072330|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24815881|NCT02072382|Metformin|metformin|mesh-list
24815882|NCT02072382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24879743|NCT04496219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25056885|NCT03508895|Caseins|caseins|mesh-list
25056886|NCT03508895|Chelating Agents|chelating agents|mesh-ancestor
25056887|NCT03508895|Sequestering Agents|sequestering agents|mesh-ancestor
25056888|NCT03508895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056889|NCT03508882|Botulinum Toxins|botulinum toxins|mesh-list
25056890|NCT03508882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25056891|NCT03508882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25056892|NCT03508882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25864781|NCT00098579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24879769|NCT04439799|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24879770|NCT04439799|Androgens|androgens|mesh-ancestor
25864782|NCT00098579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879794|NCT04420585|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24879795|NCT04420585|Hemostatics|hemostatics|mesh-ancestor
24879796|NCT04420585|Coagulants|coagulants|mesh-ancestor
24879797|NCT04420585|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24879798|NCT04420585|Natriuretic Agents|natriuretic agents|mesh-ancestor
24879799|NCT04420585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879800|NCT04410042|Tranexamic Acid|tranexamic acid|mesh-list
24879801|NCT04410042|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24879802|NCT04410042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24879803|NCT04410042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879804|NCT04410042|Hemostatics|hemostatics|mesh-ancestor
24879805|NCT04410042|Coagulants|coagulants|mesh-ancestor
24879806|NCT04402138|Acalabrutinib|acalabrutinib|mesh-list
24879844|NCT04369014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25864783|NCT00098579|Growth Inhibitors|growth inhibitors|mesh-ancestor
25864784|NCT00098579|Growth Substances|growth substances|mesh-ancestor
25864785|NCT00098579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056894|NCT03508882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056895|NCT03508882|Cholinergic Agents|cholinergic agents|mesh-ancestor
25056896|NCT03508882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25056897|NCT03508882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879868|NCT04327024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879869|NCT04327024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24879870|NCT04327024|Gout Suppressants|gout suppressants|mesh-ancestor
24879871|NCT04327024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24879872|NCT04327024|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24879874|NCT04327024|Protective Agents|protective agents|mesh-ancestor
24879875|NCT04327024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864786|NCT00098579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24879878|NCT04326478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24879879|NCT04322643|Pembrolizumab|pembrolizumab|mesh-list
24879880|NCT04322643|Nivolumab|nivolumab|mesh-list
24879881|NCT04322643|Durvalumab|durvalumab|mesh-list
24879882|NCT04322643|Avelumab|avelumab|mesh-list
24879883|NCT04322643|Atezolizumab|atezolizumab|mesh-list
24879884|NCT04322643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24879885|NCT04322643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24879886|NCT04322643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24879887|NCT04322643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879888|NCT04311099|Ropivacaine|ropivacaine|mesh-list
24879889|NCT04311099|Anesthetics, Local|anesthetics, local|mesh-ancestor
24879890|NCT04311099|Anesthetics|anesthetics|mesh-ancestor
24879891|NCT04311099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24879892|NCT04311099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879893|NCT04311099|Sensory System Agents|sensory system agents|mesh-ancestor
24879894|NCT04311099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24879930|NCT04294225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24879931|NCT04294225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24879932|NCT04294225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879933|NCT04294225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24879934|NCT04294225|Hormone Antagonists|hormone antagonists|mesh-ancestor
24879935|NCT04294225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24879936|NCT04294225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879937|NCT04294225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25864787|NCT00098605|Lapatinib|lapatinib|mesh-list
25864788|NCT00098605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864789|NCT00098605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25864790|NCT00098605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864791|NCT00098605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056920|NCT03508817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25056921|NCT03508817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25669681|NCT05316883|Serotonin Agents|serotonin agents|mesh-ancestor
25056938|NCT03508804|Anesthetics|anesthetics|mesh-ancestor
25056939|NCT03508804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24879957|NCT04273737|Amantadine|amantadine|mesh-list
24879958|NCT04273737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24879959|NCT04273737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24879960|NCT04273737|Antiviral Agents|antiviral agents|mesh-ancestor
24879961|NCT04273737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24879962|NCT04273737|Dopamine Agents|dopamine agents|mesh-ancestor
24879963|NCT04273737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24879964|NCT04273737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879965|NCT04273737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879966|NCT04273737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24879977|NCT04266795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24879978|NCT04256824|Triclosan|triclosan|mesh-list
24879979|NCT04256824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24879980|NCT04256824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24879981|NCT04256824|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24879982|NCT04256824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24879983|NCT04256824|Antimetabolites|antimetabolites|mesh-ancestor
24879984|NCT04256824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879986|NCT04255381|Pancrelipase|pancrelipase|mesh-list
24879998|NCT04245280|Ropivacaine|ropivacaine|mesh-list
25056940|NCT03508804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940405|NCT04001725|Glucocorticoids|glucocorticoids|mesh-ancestor
24940481|NCT04001348|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24940483|NCT04001348|Antiemetics|antiemetics|mesh-ancestor
24940484|NCT04001348|Autonomic Agents|autonomic agents|mesh-ancestor
24880003|NCT04245280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880004|NCT04245280|Sensory System Agents|sensory system agents|mesh-ancestor
24880005|NCT04245280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24880047|NCT04155632|Respiratory System Agents|respiratory system agents|mesh-ancestor
24880048|NCT04155632|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24880049|NCT04155632|Antioxidants|antioxidants|mesh-ancestor
24880050|NCT04155632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880051|NCT04155632|Protective Agents|protective agents|mesh-ancestor
24880052|NCT04155632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880053|NCT04155632|Antidotes|antidotes|mesh-ancestor
24880055|NCT04145518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24880056|NCT04145518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24880057|NCT04145518|Analgesics|analgesics|mesh-ancestor
24815885|NCT02072408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24815886|NCT02072408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24815887|NCT02072408|Growth Substances|growth substances|mesh-ancestor
24816701|NCT02078336|Mydriatics|mydriatics|mesh-ancestor
24815888|NCT02072408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815889|NCT02072408|Growth Inhibitors|growth inhibitors|mesh-ancestor
24815890|NCT02072408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880063|NCT04145518|Gout Suppressants|gout suppressants|mesh-ancestor
24880064|NCT04145518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24880065|NCT04145518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24880066|NCT04145518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880067|NCT04131829|Fluoxetine|fluoxetine|mesh-list
24880068|NCT04131829|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24880069|NCT04131829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24880070|NCT04131829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24880071|NCT04131829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880072|NCT04131829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24880073|NCT04131829|Serotonin Agents|serotonin agents|mesh-ancestor
24880074|NCT04131829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952647|NCT03892447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952648|NCT03892447|Dopamine Agents|dopamine agents|mesh-ancestor
24952649|NCT03892447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24952650|NCT03892447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952651|NCT03892447|Protective Agents|protective agents|mesh-ancestor
24952663|NCT03892447|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24952664|NCT03892447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24952666|NCT03892447|Antioxidants|antioxidants|mesh-ancestor
24952667|NCT03892512|Dexmedetomidine|dexmedetomidine|mesh-list
24952668|NCT03892512|Esmolol|esmolol|mesh-list
24952669|NCT03892512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24952670|NCT03892512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24952671|NCT03892512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880078|NCT04131829|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24778444|NCT01870895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24778445|NCT01870895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778446|NCT01870895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24778447|NCT01870895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24778449|NCT01870895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24811228|NCT02045849|Antifungal Agents|antifungal agents|mesh-ancestor
24880096|NCT04116203|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24880097|NCT04116203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880098|NCT04100135|Clopidogrel|clopidogrel|mesh-list
24880099|NCT04100135|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24880100|NCT04100135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24880101|NCT04100135|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24880102|NCT04100135|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25067424|NCT03443843|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24880163|NCT04016753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24880164|NCT04016753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880165|NCT04016753|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24880168|NCT04016753|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24880170|NCT03988933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24880171|NCT03988933|Antitubercular Agents|antitubercular agents|mesh-ancestor
24880172|NCT03988933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24880173|NCT03988933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24880174|NCT03988933|Leprostatic Agents|leprostatic agents|mesh-ancestor
24880175|NCT03988933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24880176|NCT03988933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24880177|NCT03988933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880178|NCT03988933|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25864792|NCT00098618|Interferons|interferons|mesh-list
25864793|NCT00098618|Interferon-alpha|interferon-alpha|mesh-list
25864794|NCT00098618|Interferon alpha-2|interferon alpha-2|mesh-list
25864795|NCT00098618|Sorafenib|sorafenib|mesh-list
25864796|NCT00098618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864797|NCT00098618|Antiviral Agents|antiviral agents|mesh-ancestor
24778450|NCT01870895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778451|NCT01870908|Tacrolimus|tacrolimus|mesh-list
24778452|NCT01870908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24778453|NCT01870908|Immunologic Factors|immunologic factors|mesh-ancestor
24778454|NCT01870908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888075|NCT04509219|Hormones|hormones|mesh-ancestor
24778455|NCT01870908|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24778456|NCT01870908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24778457|NCT01870908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778458|NCT01870986|Adalimumab|adalimumab|mesh-list
24880254|NCT03943173|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
24880255|NCT03943173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25028970|NCT03606577|Dexamethasone|dexamethasone|mesh-list
24880288|NCT03897998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24880289|NCT03892642|Avelumab|avelumab|mesh-list
24880290|NCT03892642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24880291|NCT03892642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880292|NCT03875573|Durvalumab|durvalumab|mesh-list
24880293|NCT03875573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24880294|NCT03875573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880295|NCT03874325|Durvalumab|durvalumab|mesh-list
24880296|NCT03874325|Letrozole|letrozole|mesh-list
24880297|NCT03874325|Anastrozole|anastrozole|mesh-list
24880298|NCT03874325|Exemestane|exemestane|mesh-list
24880299|NCT03874325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24880300|NCT03874325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880301|NCT03874325|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24880302|NCT03874325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24880303|NCT03874325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25056962|NCT03508635|Hormones|hormones|mesh-ancestor
24811261|NCT02045953|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25864798|NCT00098618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24880354|NCT03829371|Hormones|hormones|mesh-ancestor
24880355|NCT03829371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24880356|NCT03829371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24880357|NCT03829371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880358|NCT03829371|Immunologic Factors|immunologic factors|mesh-ancestor
24880359|NCT03829371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24594775|NCT00935506|Clopidogrel|clopidogrel|mesh-list
25201437|NCT02727738|Trace Elements|trace elements|mesh-ancestor
25201438|NCT02727738|Micronutrients|micronutrients|mesh-ancestor
25056969|NCT03508635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25864799|NCT00098618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25098494|NCT03197233|Vitamins|vitamins|mesh-list
25056970|NCT03508635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25056971|NCT03508635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25056972|NCT03508635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25056973|NCT03508635|Contraceptive Agents|contraceptive agents|mesh-ancestor
24811268|NCT02045992|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24880443|NCT03757897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24880444|NCT03757897|Analgesics|analgesics|mesh-ancestor
24880445|NCT03757897|Sensory System Agents|sensory system agents|mesh-ancestor
24880446|NCT03757897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24880447|NCT03757897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24880448|NCT03757897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24880449|NCT03757897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24880450|NCT03757897|Adrenergic Agents|adrenergic agents|mesh-ancestor
24880451|NCT03757897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24880452|NCT03757897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880453|NCT03735095|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
24880454|NCT03735095|Trioxsalen|trioxsalen|mesh-list
24880455|NCT03735095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880456|NCT03735095|Dermatologic Agents|dermatologic agents|mesh-ancestor
24880457|NCT03735095|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24880458|NCT03712943|Nivolumab|nivolumab|mesh-list
24880459|NCT03712943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24880460|NCT03712943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880461|NCT03712943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24880462|NCT03712943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880463|NCT03712098|Liraglutide|liraglutide|mesh-list
24880464|NCT03712098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24880465|NCT03712098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880466|NCT03712098|Incretins|incretins|mesh-ancestor
24880467|NCT03712098|Hormones|hormones|mesh-ancestor
24880468|NCT03712098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24880469|NCT03654274|Norethindrone|norethindrone|mesh-list
24880470|NCT03654274|Norethindrone Acetate|norethindrone acetate|mesh-list
24880475|NCT03654274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24880476|NCT03654274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880477|NCT03654274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24880530|NCT03605719|Glucocorticoids|glucocorticoids|mesh-ancestor
24880531|NCT03605719|Hormones|hormones|mesh-ancestor
24880532|NCT03605719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24880533|NCT03605719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24880534|NCT03605719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880535|NCT03605719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24880536|NCT03605719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24880537|NCT03605719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880573|NCT03591380|Belimumab|belimumab|mesh-list
24880574|NCT03591380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24456528|NCT00331526|Aldesleukin|aldesleukin|mesh-list
24880575|NCT03591380|Immunologic Factors|immunologic factors|mesh-ancestor
24880576|NCT03591380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880577|NCT03590054|Pembrolizumab|pembrolizumab|mesh-list
24880581|NCT03590054|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24880582|NCT03590054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24880583|NCT03590054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880587|NCT03569839|Propofol|propofol|mesh-list
24880588|NCT03569839|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24880589|NCT03569839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24880590|NCT03569839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880591|NCT03569839|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24880592|NCT03569839|Anesthetics, General|anesthetics, general|mesh-ancestor
24880593|NCT03569839|Anesthetics|anesthetics|mesh-ancestor
24880594|NCT03564093|Dexmedetomidine|dexmedetomidine|mesh-list
24880595|NCT03564093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24880596|NCT03564093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24880597|NCT03564093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880599|NCT03564093|Analgesics|analgesics|mesh-ancestor
24880600|NCT03564093|Sensory System Agents|sensory system agents|mesh-ancestor
24880601|NCT03564093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24880602|NCT03564093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24600313|NCT01026220|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24880606|NCT03564093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24880607|NCT03564093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864800|NCT00098618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24880619|NCT03560934|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24880620|NCT03560934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24880621|NCT03560934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880623|NCT03560934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24880625|NCT03557840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24880626|NCT03557840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24880634|NCT03541902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24880635|NCT03541902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24880636|NCT03541902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880642|NCT03529422|Durvalumab|durvalumab|mesh-list
24880643|NCT03529422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24880644|NCT03529422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880645|NCT03526354|Antipsychotic Agents|antipsychotic agents|mesh-list
24880646|NCT03526354|Brexpiprazole|brexpiprazole|mesh-list
25056981|NCT03508440|Prednisolone|prednisolone|mesh-list
25056982|NCT03508440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25056983|NCT03508440|Glucocorticoids|glucocorticoids|mesh-ancestor
25056984|NCT03508440|Hormones|hormones|mesh-ancestor
25056985|NCT03508440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24880647|NCT03526354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24880648|NCT03526354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24880649|NCT03526354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880652|NCT03526354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25201439|NCT02727738|Antithyroid Agents|antithyroid agents|mesh-ancestor
24880657|NCT03525002|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24880675|NCT03469999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24880676|NCT03469999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24880677|NCT03463993|Tranexamic Acid|tranexamic acid|mesh-list
24880678|NCT03463993|Oxytocin|oxytocin|mesh-list
24880679|NCT03463993|Oxytocics|oxytocics|mesh-ancestor
24880680|NCT03463993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24880681|NCT03463993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880682|NCT03463993|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24880690|NCT03418038|Cytarabine|cytarabine|mesh-list
24880691|NCT03418038|Dexamethasone|dexamethasone|mesh-list
24880692|NCT03418038|Dexamethasone acetate|dexamethasone acetate|mesh-list
24880693|NCT03418038|Cisplatin|cisplatin|mesh-list
24880694|NCT03418038|Rituximab|rituximab|mesh-list
24880695|NCT03418038|Carboplatin|carboplatin|mesh-list
24880696|NCT03418038|Oxaliplatin|oxaliplatin|mesh-list
24880697|NCT03418038|Etoposide|etoposide|mesh-list
24880698|NCT03418038|Etoposide phosphate|etoposide phosphate|mesh-list
24880699|NCT03418038|Ifosfamide|ifosfamide|mesh-list
24880700|NCT03418038|Isophosphamide mustard|isophosphamide mustard|mesh-list
24880701|NCT03418038|Podophyllotoxin|podophyllotoxin|mesh-list
24880702|NCT03418038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24880703|NCT03418038|Antibodies|antibodies|mesh-list
24880704|NCT03418038|Immunoglobulins|immunoglobulins|mesh-list
24880705|NCT03418038|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24880706|NCT03418038|BB 1101|bb 1101|mesh-list
24880707|NCT03418038|Micronutrients|micronutrients|mesh-ancestor
24880708|NCT03418038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880709|NCT03418038|Immunologic Factors|immunologic factors|mesh-ancestor
24880710|NCT03418038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880711|NCT03418038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24880712|NCT03418038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24880713|NCT03418038|Antiemetics|antiemetics|mesh-ancestor
24880714|NCT03418038|Autonomic Agents|autonomic agents|mesh-ancestor
24880715|NCT03418038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24880716|NCT03418038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24880717|NCT03418038|Glucocorticoids|glucocorticoids|mesh-ancestor
24880718|NCT03418038|Hormones|hormones|mesh-ancestor
25864801|NCT00098618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864802|NCT00098618|Immunologic Factors|immunologic factors|mesh-ancestor
24880765|NCT03395314|GABA Agents|gaba agents|mesh-ancestor
24880767|NCT03391869|Ipilimumab|ipilimumab|mesh-list
24880768|NCT03391869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24880769|NCT03391869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880770|NCT03391869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24880796|NCT03336398|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24880798|NCT03336398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24880799|NCT03336398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864803|NCT00098618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864804|NCT00098631|Lapatinib|lapatinib|mesh-list
25864805|NCT00098631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864806|NCT00098631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25864807|NCT00098631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864808|NCT00098631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864810|NCT00098683|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25864811|NCT00098683|Protective Agents|protective agents|mesh-ancestor
25864812|NCT00098683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864813|NCT00098735|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25864814|NCT00098735|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24880892|NCT03221257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880893|NCT03221257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24880894|NCT03221257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24880895|NCT03221257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24880896|NCT03221257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24880897|NCT03220893|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
24880898|NCT03220893|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25864815|NCT00098735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864816|NCT00098735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25864817|NCT00098735|Immunologic Factors|immunologic factors|mesh-ancestor
25864818|NCT00098735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864819|NCT00098800|Fenretinide|fenretinide|mesh-list
25864820|NCT00098800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25113182|NCT03401398|Hydrocortisone|hydrocortisone|mesh-list
24880917|NCT03179904|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
24880918|NCT03179904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24880919|NCT03179904|Antibodies|antibodies|mesh-list
24880920|NCT03179904|Immunoglobulins|immunoglobulins|mesh-list
24880921|NCT03179904|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24880922|NCT03179904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24880923|NCT03179904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201440|NCT02727738|Hormone Antagonists|hormone antagonists|mesh-ancestor
24880929|NCT03179904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880930|NCT03179904|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24880931|NCT03179904|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24880932|NCT03179904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24880933|NCT03179904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25864821|NCT00098800|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25864822|NCT00098800|Protective Agents|protective agents|mesh-ancestor
25864823|NCT00098800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864824|NCT00098852|Rosiglitazone|rosiglitazone|mesh-list
25864825|NCT00098852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25864826|NCT00098852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880949|NCT03177291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880951|NCT03177291|Antimitotic Agents|antimitotic agents|mesh-ancestor
24880952|NCT03177291|Mitosis Modulators|mitosis modulators|mesh-ancestor
24880953|NCT03177291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880954|NCT03177291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24880955|NCT03177291|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24880956|NCT03177291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24880957|NCT03177291|Analgesics|analgesics|mesh-ancestor
25864827|NCT00098878|Carboplatin|carboplatin|mesh-list
25864828|NCT00098878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864829|NCT00098891|Entinostat|entinostat|mesh-list
25864830|NCT00098891|Isotretinoin|isotretinoin|mesh-list
25864831|NCT00098891|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25864832|NCT00098891|Dermatologic Agents|dermatologic agents|mesh-ancestor
25864833|NCT00098891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880962|NCT03177291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24880963|NCT03177291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24880964|NCT03177291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24880965|NCT03174275|Paclitaxel|paclitaxel|mesh-list
24880966|NCT03174275|Carboplatin|carboplatin|mesh-list
24880967|NCT03174275|Durvalumab|durvalumab|mesh-list
25864834|NCT00098891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864835|NCT00098891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864836|NCT00098917|Vaccines|vaccines|mesh-list
25864837|NCT00098917|Immunologic Factors|immunologic factors|mesh-ancestor
25864838|NCT00098917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876582|NCT03269669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25876583|NCT03269669|Immunologic Factors|immunologic factors|mesh-ancestor
25876584|NCT03269669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876585|NCT03269669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25876586|NCT03269669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25876587|NCT03269669|Alkylating Agents|alkylating agents|mesh-ancestor
25098953|NCT03194594|Sensory System Agents|sensory system agents|mesh-ancestor
25098954|NCT03194594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25098955|NCT03194594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25098957|NCT03194594|Anesthetics|anesthetics|mesh-ancestor
25864839|NCT00098969|Resveratrol|resveratrol|mesh-list
25864840|NCT00098969|Antioxidants|antioxidants|mesh-ancestor
25056994|NCT03508102|Analgesics|analgesics|mesh-ancestor
25056995|NCT03508102|Sensory System Agents|sensory system agents|mesh-ancestor
25056996|NCT03508102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25056998|NCT03507842|Daunorubicin|daunorubicin|mesh-list
25056999|NCT03507842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25057000|NCT03507842|Antimetabolites|antimetabolites|mesh-ancestor
24811297|NCT02046304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600315|NCT01026220|Vincristine|vincristine|mesh-list
24880974|NCT03174275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24880976|NCT03173053|Povidone-Iodine|povidone-iodine|mesh-list
24880977|NCT03173053|Clarithromycin|clarithromycin|mesh-list
24880978|NCT03173053|Doxycycline|doxycycline|mesh-list
24880979|NCT03173053|Ciprofloxacin|ciprofloxacin|mesh-list
24880981|NCT03173053|Clindamycin|clindamycin|mesh-list
24880982|NCT03173053|Trimethoprim|trimethoprim|mesh-list
24880983|NCT03173053|Sulfamethoxazole|sulfamethoxazole|mesh-list
24880984|NCT03173053|Mupirocin|mupirocin|mesh-list
24880985|NCT03173053|Fusidic Acid|fusidic acid|mesh-list
24880986|NCT03173053|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24880987|NCT03173053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24880988|NCT03173053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24880989|NCT03173053|Disinfectants|disinfectants|mesh-ancestor
24880990|NCT03173053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24880991|NCT03173053|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24880992|NCT03173053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24880993|NCT03173053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880994|NCT03173053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24880995|NCT03173053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24880996|NCT03173053|Antimalarials|antimalarials|mesh-ancestor
24880997|NCT03173053|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24880998|NCT03173053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24880999|NCT03173053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24881000|NCT03173053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24881001|NCT03173053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881019|NCT03122639|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24881024|NCT03122639|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25057001|NCT03507842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057003|NCT03507842|Antiviral Agents|antiviral agents|mesh-ancestor
25057004|NCT03507842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25057005|NCT03507842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25876773|NCT02794571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24881025|NCT03122639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881026|NCT03109795|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24881027|NCT03109795|Clonidine|clonidine|mesh-list
24881028|NCT03109795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24881029|NCT03109795|Diuretics|diuretics|mesh-ancestor
24881030|NCT03109795|Natriuretic Agents|natriuretic agents|mesh-ancestor
24881031|NCT03109795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881032|NCT03109795|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24881040|NCT03109795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24881042|NCT03109795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24881043|NCT03109795|Adrenergic Agents|adrenergic agents|mesh-ancestor
24881044|NCT03109795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24881045|NCT03105102|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24881046|NCT03105102|Immunologic Factors|immunologic factors|mesh-ancestor
24888647|NCT04501900|Purinergic Agents|purinergic agents|mesh-ancestor
24881047|NCT03105102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881048|NCT03104842|Dexamethasone|dexamethasone|mesh-list
24881049|NCT03104842|Lenalidomide|lenalidomide|mesh-list
24881050|NCT03104842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24881051|NCT03104842|Antiemetics|antiemetics|mesh-ancestor
24881052|NCT03104842|Autonomic Agents|autonomic agents|mesh-ancestor
24881053|NCT03104842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24881054|NCT03104842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881055|NCT03104842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24881056|NCT03104842|Glucocorticoids|glucocorticoids|mesh-ancestor
24881057|NCT03104842|Hormones|hormones|mesh-ancestor
25669682|NCT05316883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25669683|NCT05316883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669684|NCT05316883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669685|NCT05316883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24881058|NCT03104842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24881059|NCT03104842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24881060|NCT03104842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881061|NCT03104842|Immunologic Factors|immunologic factors|mesh-ancestor
24881062|NCT03104842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24881063|NCT03104842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24881090|NCT03069638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24881091|NCT03069638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057006|NCT03507842|Immunologic Factors|immunologic factors|mesh-ancestor
25057007|NCT03507842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057008|NCT03507842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25057009|NCT03507842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25057010|NCT03507842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25057011|NCT03507842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881092|NCT03069638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25029564|NCT03602027|Gefitinib|gefitinib|mesh-list
24710753|NCT01511718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24881094|NCT03069638|Sensory System Agents|sensory system agents|mesh-ancestor
24881095|NCT03069638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24881096|NCT03069638|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24881097|NCT03069638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24881098|NCT03069638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25057012|NCT03507829|Insulin|insulin|mesh-list
25057013|NCT03507829|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25057014|NCT03507829|Insulin Lispro|insulin lispro|mesh-list
25057015|NCT03507829|Isophane Insulin, Human|isophane insulin, human|mesh-list
25057016|NCT03507829|Insulin, Isophane|insulin, isophane|mesh-list
25057017|NCT03507829|Isophane insulin, beef|isophane insulin, beef|mesh-list
25057018|NCT03507829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25057019|NCT03507829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057020|NCT03507751|Meropenem|meropenem|mesh-list
25057021|NCT03507751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25057022|NCT03507751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24881099|NCT03069638|Adrenergic Agents|adrenergic agents|mesh-ancestor
24881100|NCT03069638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24881104|NCT03052608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24881105|NCT03052608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881106|NCT03052608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881108|NCT03015610|Dexlansoprazole|dexlansoprazole|mesh-list
24881109|NCT03015610|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24881110|NCT03015610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25060844|NCT03475862|Analgesics|analgesics|mesh-ancestor
25864841|NCT00098969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864842|NCT00098969|Protective Agents|protective agents|mesh-ancestor
25864843|NCT00098969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864844|NCT00098969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864845|NCT00098969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25864846|NCT00098982|Leucovorin|leucovorin|mesh-list
24881119|NCT03003962|Durvalumab|durvalumab|mesh-list
24881120|NCT03003962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24881121|NCT03003962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881122|NCT03003962|Tubulin Modulators|tubulin modulators|mesh-ancestor
24881123|NCT03003962|Antimitotic Agents|antimitotic agents|mesh-ancestor
24881124|NCT03003962|Mitosis Modulators|mitosis modulators|mesh-ancestor
24881125|NCT03003962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881132|NCT03003962|Immunologic Factors|immunologic factors|mesh-ancestor
25057023|NCT03507634|Lidocaine|lidocaine|mesh-list
25057024|NCT03507634|Fentanyl|fentanyl|mesh-list
25057025|NCT03507634|Dexmedetomidine|dexmedetomidine|mesh-list
25057026|NCT03507634|Remifentanil|remifentanil|mesh-list
25057027|NCT03507634|Analgesics, Opioid|analgesics, opioid|mesh-list
25057028|NCT03507634|Anesthetics|anesthetics|mesh-list
25057029|NCT03507634|Anesthetics, Local|anesthetics, local|mesh-ancestor
25864847|NCT00098982|Fluorouracil|fluorouracil|mesh-list
25864848|NCT00098982|Oxaliplatin|oxaliplatin|mesh-list
25864849|NCT00098982|Bortezomib|bortezomib|mesh-list
25864850|NCT00098982|Calcium|calcium|mesh-list
25864851|NCT00098982|Levoleucovorin|levoleucovorin|mesh-list
25864852|NCT00098982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25864853|NCT00098982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864854|NCT00098982|Antimetabolites|antimetabolites|mesh-ancestor
25864855|NCT00098982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864856|NCT00098982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25864857|NCT00098982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864858|NCT00098982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25864859|NCT00098982|Immunologic Factors|immunologic factors|mesh-ancestor
25864860|NCT00098982|Antidotes|antidotes|mesh-ancestor
25099213|NCT03192943|Nivolumab|nivolumab|mesh-list
25864861|NCT00098982|Protective Agents|protective agents|mesh-ancestor
25864862|NCT00098982|Vitamin B Complex|vitamin b complex|mesh-ancestor
25864863|NCT00098982|Vitamins|vitamins|mesh-ancestor
25864864|NCT00098982|Micronutrients|micronutrients|mesh-ancestor
25864865|NCT00098995|Cisplatin|cisplatin|mesh-list
25864866|NCT00098995|Tirapazamine|tirapazamine|mesh-list
25864867|NCT00098995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864868|NCT00099008|Genistein|genistein|mesh-list
25057030|NCT03507634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25057031|NCT03507634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057032|NCT03507634|Sensory System Agents|sensory system agents|mesh-ancestor
25057033|NCT03507634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25057034|NCT03507634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25057035|NCT03507634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25864869|NCT00099008|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25864870|NCT00099008|Protective Agents|protective agents|mesh-ancestor
25864871|NCT00099008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864872|NCT00099008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864873|NCT00099008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25864874|NCT00099008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864875|NCT00099008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864876|NCT00099008|Phytoestrogens|phytoestrogens|mesh-ancestor
25864877|NCT00099008|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25864878|NCT00099008|Estrogens|estrogens|mesh-ancestor
25864879|NCT00099008|Hormones|hormones|mesh-ancestor
25864880|NCT00099008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25864881|NCT00099060|Lapatinib|lapatinib|mesh-list
25864882|NCT00099060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864883|NCT00099060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25864884|NCT00099060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864885|NCT00099060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864886|NCT00099125|Irinotecan|irinotecan|mesh-list
25864887|NCT00099125|Temozolomide|temozolomide|mesh-list
25864888|NCT00099125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25864889|NCT00099125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25864890|NCT00099125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864891|NCT00099125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864892|NCT00099125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864893|NCT00099125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25864894|NCT00099125|Alkylating Agents|alkylating agents|mesh-ancestor
25864895|NCT00099164|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
25864896|NCT00099164|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
25864897|NCT00099164|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25864898|NCT00099164|Hormone Antagonists|hormone antagonists|mesh-ancestor
25864899|NCT00099164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25057036|NCT03507634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25057037|NCT03507634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25057038|NCT03507634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881209|NCT02921893|Dexamethasone|dexamethasone|mesh-list
24881210|NCT02921893|Dexamethasone acetate|dexamethasone acetate|mesh-list
24881211|NCT02921893|Lenalidomide|lenalidomide|mesh-list
24881213|NCT02921893|Ichthammol|ichthammol|mesh-list
24881214|NCT02921893|BB 1101|bb 1101|mesh-list
24881215|NCT02921893|Glycine|glycine|mesh-list
24881216|NCT02921893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24881217|NCT02921893|Antiemetics|antiemetics|mesh-ancestor
24881218|NCT02921893|Autonomic Agents|autonomic agents|mesh-ancestor
24881219|NCT02921893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24881220|NCT02921893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881221|NCT02921893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24881222|NCT02921893|Glucocorticoids|glucocorticoids|mesh-ancestor
24881223|NCT02921893|Hormones|hormones|mesh-ancestor
24881224|NCT02921893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24881225|NCT02921893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25431651|NCT01015833|Sorafenib|sorafenib|mesh-list
25669686|NCT05316883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25669687|NCT05316883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25669688|NCT05316883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25669689|NCT05316883|GABA Antagonists|gaba antagonists|mesh-ancestor
25669690|NCT05316883|GABA Agents|gaba agents|mesh-ancestor
25669691|NCT05316857|Itraconazole|itraconazole|mesh-list
25669692|NCT05316857|Rifampin|rifampin|mesh-list
25669693|NCT05316857|Antifungal Agents|antifungal agents|mesh-ancestor
25669694|NCT05316857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25669695|NCT05316857|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24838031|NCT02194829|Antiviral Agents|antiviral agents|mesh-ancestor
24881229|NCT02921893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864900|NCT00099164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864901|NCT00099164|Progestins|progestins|mesh-ancestor
24881239|NCT02900443|Azathioprine|azathioprine|mesh-list
25029842|NCT03600493|Sensory System Agents|sensory system agents|mesh-ancestor
24881247|NCT02900443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881248|NCT02900443|Antimetabolites|antimetabolites|mesh-ancestor
24881249|NCT02900443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24881250|NCT02900443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24881251|NCT02900443|Immunologic Factors|immunologic factors|mesh-ancestor
24881252|NCT02900443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881253|NCT02900443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24881254|NCT02841995|Belumosudil|belumosudil|mesh-list
24881255|NCT02841995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24881256|NCT02841995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881257|NCT02841995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815969|NCT02072967|Alkylating Agents|alkylating agents|mesh-ancestor
24815971|NCT02073084|Moxifloxacin|moxifloxacin|mesh-list
24815984|NCT02073149|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24815986|NCT02073149|Sequestering Agents|sequestering agents|mesh-ancestor
24815987|NCT02073149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815989|NCT02073227|Canagliflozin|canagliflozin|mesh-list
24815990|NCT02073227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24815991|NCT02073227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815992|NCT02073227|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24815993|NCT02073227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815994|NCT02073357|Anesthetics|anesthetics|mesh-list
25864902|NCT00099164|Hormones|hormones|mesh-ancestor
25864903|NCT00099177|Zoledronic Acid|zoledronic acid|mesh-list
25864904|NCT00099177|Ibandronic Acid|ibandronic acid|mesh-list
25864905|NCT00099177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25864906|NCT00099177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864907|NCT00099190|Beta-lapachone|beta-lapachone|mesh-list
25864908|NCT00099190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25864909|NCT00099190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25864910|NCT00099190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25864911|NCT00099190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864912|NCT00099190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864913|NCT00099190|Antiviral Agents|antiviral agents|mesh-ancestor
25864914|NCT00099203|Zoledronic Acid|zoledronic acid|mesh-list
25864915|NCT00099203|Ibandronic Acid|ibandronic acid|mesh-list
25864916|NCT00099203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25864917|NCT00099203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864918|NCT00099216|Rivastigmine|rivastigmine|mesh-list
25029903|NCT03599778|Apatinib|apatinib|mesh-list
25057044|NCT03507634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25057045|NCT03507634|Adrenergic Agents|adrenergic agents|mesh-ancestor
25057046|NCT03507634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25057047|NCT03507634|Narcotics|narcotics|mesh-ancestor
25057048|NCT03507634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25057049|NCT03507634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25057050|NCT03507634|Anesthetics, General|anesthetics, general|mesh-ancestor
24815998|NCT02073474|Analgesics|analgesics|mesh-ancestor
24815999|NCT02073474|Sensory System Agents|sensory system agents|mesh-ancestor
24816000|NCT02073474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816001|NCT02073474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816002|NCT02073526|Adalimumab|adalimumab|mesh-list
24816003|NCT02073526|Infliximab|infliximab|mesh-list
24881258|NCT02833753|Oxaliplatin|oxaliplatin|mesh-list
24881264|NCT02805257|Alkylating Agents|alkylating agents|mesh-ancestor
24881265|NCT02805257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881266|NCT02805257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24881267|NCT02805257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881268|NCT02780609|Dexamethasone|dexamethasone|mesh-list
24881269|NCT02780609|Melphalan|melphalan|mesh-list
24881270|NCT02780609|Fosaprepitant|fosaprepitant|mesh-list
24881271|NCT02780609|Aprepitant|aprepitant|mesh-list
24881272|NCT02780609|Antiemetics|antiemetics|mesh-list
24881273|NCT02780609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25864919|NCT00099216|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25864920|NCT00099216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864921|NCT00099216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864922|NCT00099216|Cholinergic Agents|cholinergic agents|mesh-ancestor
25864923|NCT00099216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25864924|NCT00099216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864925|NCT00099216|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25864926|NCT00099216|Protective Agents|protective agents|mesh-ancestor
25864927|NCT00099242|Rivastigmine|rivastigmine|mesh-list
25864928|NCT00099242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25864929|NCT00099242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864930|NCT00099242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881274|NCT02780609|Autonomic Agents|autonomic agents|mesh-ancestor
24881275|NCT02780609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24881284|NCT02780609|Alkylating Agents|alkylating agents|mesh-ancestor
24881285|NCT02780609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881286|NCT02780609|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25864931|NCT00099242|Cholinergic Agents|cholinergic agents|mesh-ancestor
25864932|NCT00099242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25864933|NCT00099242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864934|NCT00099242|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25864935|NCT00099242|Protective Agents|protective agents|mesh-ancestor
25864936|NCT00099320|Exenatide|exenatide|mesh-list
25864937|NCT00099320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25864938|NCT00099320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864939|NCT00099320|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25864940|NCT00099320|Incretins|incretins|mesh-ancestor
25057058|NCT03507556|Metronidazole|metronidazole|mesh-list
25057059|NCT03507556|Ciprofloxacin|ciprofloxacin|mesh-list
25057060|NCT03507556|Minocycline|minocycline|mesh-list
25057062|NCT03507556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25057063|NCT03507556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25057064|NCT03507556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25864941|NCT00099320|Hormones|hormones|mesh-ancestor
25864942|NCT00099320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25864943|NCT00099333|Exenatide|exenatide|mesh-list
25864944|NCT00099333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24881352|NCT02639065|Durvalumab|durvalumab|mesh-list
24881353|NCT02639065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24889077|NCT04498234|Bupivacaine|bupivacaine|mesh-list
24881354|NCT02639065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881365|NCT02576574|Avelumab|avelumab|mesh-list
24881366|NCT02576574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24881367|NCT02576574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24796522|NCT01950507|Glucocorticoids|glucocorticoids|mesh-ancestor
25864945|NCT00099333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057074|NCT03507556|Sunscreening Agents|sunscreening agents|mesh-ancestor
25057075|NCT03507556|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25057076|NCT03507556|Protective Agents|protective agents|mesh-ancestor
25057077|NCT03507556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057078|NCT03507465|Capecitabine|capecitabine|mesh-list
25057079|NCT03507465|Letrozole|letrozole|mesh-list
25057080|NCT03507465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25057081|NCT03507465|Antimetabolites|antimetabolites|mesh-ancestor
24623152|NCT01070472|Abortifacient Agents|abortifacient agents|mesh-ancestor
24881395|NCT02564263|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24881396|NCT02564263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24881407|NCT02537197|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24881408|NCT02537197|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24881423|NCT02451423|Atezolizumab|atezolizumab|mesh-list
24881424|NCT02451423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201441|NCT02727738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24712370|NCT01520181|Lactams|lactams|mesh-list
24881425|NCT02432547|Aflibercept|aflibercept|mesh-list
24881426|NCT02432547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24881427|NCT02432547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24881428|NCT02432547|Growth Substances|growth substances|mesh-ancestor
24881429|NCT02432547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881430|NCT02432547|Growth Inhibitors|growth inhibitors|mesh-ancestor
24881431|NCT02432547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864946|NCT00099333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25864947|NCT00099333|Incretins|incretins|mesh-ancestor
25864948|NCT00099333|Hormones|hormones|mesh-ancestor
25057082|NCT03507465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057083|NCT03507465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25057084|NCT03507465|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25057085|NCT03507465|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25057086|NCT03507465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057087|NCT03507465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25057088|NCT03507465|Hormone Antagonists|hormone antagonists|mesh-ancestor
24811324|NCT02046421|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24881442|NCT02367456|Antimetabolites|antimetabolites|mesh-ancestor
24881445|NCT02367456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881446|NCT02345733|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24881448|NCT02345733|Metronidazole|metronidazole|mesh-list
24881449|NCT02345733|Doxycycline|doxycycline|mesh-list
24881450|NCT02345733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24881451|NCT02345733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24881452|NCT02345733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24881453|NCT02345733|Antimalarials|antimalarials|mesh-ancestor
24881472|NCT02245087|Atorvastatin|atorvastatin|mesh-list
24881473|NCT02245087|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24881474|NCT02245087|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24881475|NCT02245087|Antimetabolites|antimetabolites|mesh-ancestor
24881491|NCT02170090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881492|NCT02170090|Antiviral Agents|antiviral agents|mesh-ancestor
24881493|NCT02170090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24881494|NCT02170090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881495|NCT02170090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24881496|NCT02170090|Immunologic Factors|immunologic factors|mesh-ancestor
24881497|NCT02170090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881498|NCT02101853|Calcium, Dietary|calcium, dietary|mesh-list
24881499|NCT02101853|Leucovorin|leucovorin|mesh-list
24881500|NCT02101853|Folic Acid|folic acid|mesh-list
24816004|NCT02073526|Certolizumab Pegol|certolizumab pegol|mesh-list
24816005|NCT02073526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24816006|NCT02073526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24816007|NCT02073526|Dermatologic Agents|dermatologic agents|mesh-ancestor
24816008|NCT02073526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24816009|NCT02073526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24816010|NCT02073526|Immunologic Factors|immunologic factors|mesh-ancestor
24816011|NCT02073526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816012|NCT02073552|Ascorbic Acid|ascorbic acid|mesh-list
25864949|NCT00099333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25201442|NCT02727907|Interferons|interferons|mesh-list
24816019|NCT02073552|Micronutrients|micronutrients|mesh-ancestor
24816041|NCT02073773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24816043|NCT02073773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25864950|NCT00099450|INS 50589|ins 50589|mesh-list
25864951|NCT00099450|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24816050|NCT02073838|Antiviral Agents|antiviral agents|mesh-ancestor
24816056|NCT02073916|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24816058|NCT02073916|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24816059|NCT02073916|Lapatinib|lapatinib|mesh-list
25057091|NCT03507426|Ketamine|ketamine|mesh-list
25057092|NCT03507426|Analgesics|analgesics|mesh-ancestor
25057093|NCT03507426|Sensory System Agents|sensory system agents|mesh-ancestor
25057094|NCT03507426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25201443|NCT02727907|Interferon-beta|interferon-beta|mesh-list
24881512|NCT02101853|Etoposide phosphate|etoposide phosphate|mesh-list
24881527|NCT02101853|Calcium|calcium|mesh-list
24881528|NCT02101853|2-Aminopurine|2-aminopurine|mesh-list
24881529|NCT02101853|Levoleucovorin|levoleucovorin|mesh-list
24881530|NCT02101853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24881531|NCT02101853|Immunologic Factors|immunologic factors|mesh-ancestor
24881532|NCT02101853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881533|NCT02101853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25057104|NCT03507426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057108|NCT03507387|Phenylephrine|phenylephrine|mesh-list
25057109|NCT03507387|Oxymetazoline|oxymetazoline|mesh-list
24881539|NCT02101853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24881540|NCT02101853|Antiemetics|antiemetics|mesh-ancestor
24881541|NCT02101853|Autonomic Agents|autonomic agents|mesh-ancestor
24881542|NCT02101853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24881543|NCT02101853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24881544|NCT02101853|Glucocorticoids|glucocorticoids|mesh-ancestor
24881545|NCT02101853|Hormones|hormones|mesh-ancestor
25201444|NCT02727907|Interferon beta-1a|interferon beta-1a|mesh-list
24788864|NCT01934569|Losartan|losartan|mesh-list
24881546|NCT02101853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24881547|NCT02101853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24881548|NCT02101853|Protease Inhibitors|protease inhibitors|mesh-ancestor
24881549|NCT02101853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881550|NCT02101853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24881551|NCT02101853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24838080|NCT02195180|Asparaginase|asparaginase|mesh-list
24838081|NCT02195180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24838082|NCT02195180|Antimetabolites|antimetabolites|mesh-ancestor
24838083|NCT02195180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838084|NCT02195180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810690|NCT02041481|Vitamins|vitamins|mesh-ancestor
24881560|NCT02101853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24881598|NCT02022059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24881599|NCT02022059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24881600|NCT02022059|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24881601|NCT02022059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24881602|NCT02022059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24881603|NCT02022059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201445|NCT02727907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25030428|NCT03595930|Dermatologic Agents|dermatologic agents|mesh-ancestor
24881649|NCT01887522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057127|NCT03507387|Adrenergic Agents|adrenergic agents|mesh-ancestor
25057128|NCT03507387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25057129|NCT03507387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057130|NCT03507387|Protective Agents|protective agents|mesh-ancestor
25057131|NCT03507348|Rituximab|rituximab|mesh-list
25057132|NCT03507348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25057133|NCT03507348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201446|NCT02727907|Antiviral Agents|antiviral agents|mesh-ancestor
25067426|NCT03443843|Histamine Antagonists|histamine antagonists|mesh-ancestor
25061103|NCT03473639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25057134|NCT03507348|Immunologic Factors|immunologic factors|mesh-ancestor
25057135|NCT03507348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057136|NCT03507348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24881729|NCT01434602|Immunologic Factors|immunologic factors|mesh-ancestor
24881730|NCT01434602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881731|NCT01434602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24881732|NCT01434602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881733|NCT01434602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816071|NCT02074137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24816072|NCT02074137|Glucocorticoids|glucocorticoids|mesh-ancestor
24816073|NCT02074137|Hormones|hormones|mesh-ancestor
24816074|NCT02074137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24816075|NCT02074137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816076|NCT02074137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25876774|NCT02794571|Growth Substances|growth substances|mesh-ancestor
24816091|NCT02074163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816092|NCT02074163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816093|NCT02074163|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24816094|NCT02074163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24816095|NCT02074163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816096|NCT02074163|Cholinergic Agents|cholinergic agents|mesh-ancestor
24816097|NCT02074163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24940705|NCT03999125|Growth Inhibitors|growth inhibitors|mesh-ancestor
24940706|NCT03998982|Dexamethasone|dexamethasone|mesh-list
24940707|NCT03998982|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
24940708|NCT03998982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24940709|NCT03998982|Antiemetics|antiemetics|mesh-ancestor
24940710|NCT03998982|Autonomic Agents|autonomic agents|mesh-ancestor
24940711|NCT03998982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24940712|NCT03998982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940713|NCT03998982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24940714|NCT03998982|Glucocorticoids|glucocorticoids|mesh-ancestor
24940715|NCT03998982|Hormones|hormones|mesh-ancestor
24940716|NCT03998982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24811388|NCT02046538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25067427|NCT03443843|Histamine Agents|histamine agents|mesh-ancestor
24881765|NCT01358877|Paclitaxel|paclitaxel|mesh-list
24881766|NCT01358877|Docetaxel|docetaxel|mesh-list
24881767|NCT01358877|Cyclophosphamide|cyclophosphamide|mesh-list
24881768|NCT01358877|Carboplatin|carboplatin|mesh-list
24881769|NCT01358877|Doxorubicin|doxorubicin|mesh-list
24881770|NCT01358877|Fluorouracil|fluorouracil|mesh-list
25669696|NCT05316857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25669697|NCT05316857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25669698|NCT05316857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669699|NCT05316857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25669700|NCT05316857|Hormone Antagonists|hormone antagonists|mesh-ancestor
24881772|NCT01358877|Epirubicin|epirubicin|mesh-list
24881773|NCT01358877|Pertuzumab|pertuzumab|mesh-list
24881783|NCT01358877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24778465|NCT01871129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24881784|NCT01358877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24881785|NCT01358877|Alkylating Agents|alkylating agents|mesh-ancestor
24881786|NCT01358877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24881787|NCT01358877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24881788|NCT01358877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24881789|NCT01358877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24881790|NCT01358877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881791|NCT01358877|Antimetabolites|antimetabolites|mesh-ancestor
24881792|NCT01358877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24881793|NCT01358877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24881794|NCT01239797|Dexamethasone|dexamethasone|mesh-list
25201447|NCT02727907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24778468|NCT01871129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24778469|NCT01871129|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24778470|NCT01871129|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24881799|NCT01239797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24881827|NCT01103349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24952693|NCT03892434|Growth Substances|growth substances|mesh-ancestor
24952676|NCT03892512|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24811419|NCT02046590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25864952|NCT00099450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25864953|NCT00099450|Purinergic Agents|purinergic agents|mesh-ancestor
25864954|NCT00099450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24881851|NCT01025089|Alkylating Agents|alkylating agents|mesh-ancestor
24881852|NCT01025089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881853|NCT01025089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881854|NCT01025089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24881855|NCT01025089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24881856|NCT01025089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24881857|NCT01025089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24881858|NCT01025089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881859|NCT01025089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24881860|NCT01004029|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
24881861|NCT01004029|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
25876775|NCT02794571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881866|NCT01004029|Progestins|progestins|mesh-ancestor
24881868|NCT00940940|Vaccines|vaccines|mesh-list
24881869|NCT00940940|Immunologic Factors|immunologic factors|mesh-ancestor
24881870|NCT00940940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881871|NCT00754260|Caffeine|caffeine|mesh-list
24881872|NCT00754260|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24881873|NCT00754260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881874|NCT00754260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24881875|NCT00754260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881876|NCT00754260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881890|NCT00715988|Respiratory System Agents|respiratory system agents|mesh-ancestor
24881891|NCT00593567|Levofloxacin|levofloxacin|mesh-list
24881892|NCT00593567|Ofloxacin|ofloxacin|mesh-list
24881893|NCT00593567|Gentamicins|gentamicins|mesh-list
25201449|NCT02727907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881943|NCT00389870|Antifungal Agents|antifungal agents|mesh-ancestor
24881944|NCT00389870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24952682|NCT03892512|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24952683|NCT03892512|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24952684|NCT03892512|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24881945|NCT00389870|Dermatologic Agents|dermatologic agents|mesh-ancestor
24881946|NCT00389870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24881947|NCT00389870|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24881948|NCT00389870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24881949|NCT00295646|Tamoxifen|tamoxifen|mesh-list
24881950|NCT00295646|Zoledronic Acid|zoledronic acid|mesh-list
24881951|NCT00295646|Anastrozole|anastrozole|mesh-list
24881952|NCT00295646|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24881953|NCT00295646|Hormone Antagonists|hormone antagonists|mesh-ancestor
24881954|NCT00295646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24881957|NCT00295646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881958|NCT00295646|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24881959|NCT00295646|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25099940|NCT03186482|Rifampin|rifampin|mesh-list
24881960|NCT00295646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24881961|NCT00295646|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24881962|NCT00295646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24881963|NCT00295646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881964|NCT00295646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881965|NCT00254423|Dasatinib|dasatinib|mesh-list
24881966|NCT00254423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881967|NCT00254423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24881968|NCT00254423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881969|NCT00254423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881970|NCT00006455|Leucovorin|leucovorin|mesh-list
24881971|NCT00006455|Cytarabine|cytarabine|mesh-list
24882007|NCT00006455|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24882008|NCT00006455|Abortifacient Agents|abortifacient agents|mesh-ancestor
25864955|NCT00099450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952691|NCT03892434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24952692|NCT03892434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24882016|NCT00006455|Antiviral Agents|antiviral agents|mesh-ancestor
24882038|NCT02979977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882039|NCT02979977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24882040|NCT02979977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24882041|NCT02979977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882042|NCT02975492|Vitamin D|vitamin d|mesh-list
24882043|NCT02975492|Ergocalciferols|ergocalciferols|mesh-list
24882044|NCT02975492|Cholecalciferol|cholecalciferol|mesh-list
24882045|NCT02975492|Vitamins|vitamins|mesh-list
24882049|NCT02975492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24882050|NCT02866682|Tacrolimus|tacrolimus|mesh-list
24882051|NCT02866682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24882066|NCT02855229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24882074|NCT02827526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24882075|NCT02827526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882076|NCT02827526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24882077|NCT02827526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24882078|NCT02827526|Anesthetics, General|anesthetics, general|mesh-ancestor
24882080|NCT02827526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24882093|NCT02743923|Mitosis Modulators|mitosis modulators|mesh-ancestor
24882094|NCT02743923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057153|NCT03507244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25057155|NCT03507166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25057156|NCT03507166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25057157|NCT03507127|Varenicline|varenicline|mesh-list
25057158|NCT03507127|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25057159|NCT03507127|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25057160|NCT03507127|Cholinergic Agents|cholinergic agents|mesh-ancestor
25057161|NCT03507127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24882100|NCT02743923|Growth Inhibitors|growth inhibitors|mesh-ancestor
24882101|NCT02743923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24882102|NCT02743923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24882103|NCT02743923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24882106|NCT02735707|Ascorbic Acid|ascorbic acid|mesh-list
24882107|NCT02735707|Interferons|interferons|mesh-list
24882108|NCT02735707|Ritonavir|ritonavir|mesh-list
24882126|NCT02735707|Apremilast|apremilast|mesh-list
24882127|NCT02735707|Hydrocortisone|hydrocortisone|mesh-list
24882128|NCT02735707|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24882134|NCT02735707|Telmisartan|telmisartan|mesh-list
24882135|NCT02735707|Candesartan|candesartan|mesh-list
24882136|NCT02735707|Ramipril|ramipril|mesh-list
24882137|NCT02735707|Olmesartan|olmesartan|mesh-list
24882138|NCT02735707|Enalapril|enalapril|mesh-list
24882139|NCT02735707|Lisinopril|lisinopril|mesh-list
24787643|NCT01926236|Folic Acid|folic acid|mesh-list
24882140|NCT02735707|Irbesartan|irbesartan|mesh-list
24882141|NCT02735707|Perindopril|perindopril|mesh-list
24882142|NCT02735707|Captopril|captopril|mesh-list
25669701|NCT05316857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25669702|NCT05316857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882143|NCT02735707|Trandolapril|trandolapril|mesh-list
24882144|NCT02735707|Clopidogrel|clopidogrel|mesh-list
24816112|NCT02074228|Methylphenidate|methylphenidate|mesh-list
25669703|NCT05316857|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24816113|NCT02074228|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25057162|NCT03507127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057163|NCT03507127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057165|NCT03507062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25031306|NCT03588715|Interferon-alpha|interferon-alpha|mesh-list
24612072|NCT01011751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612073|NCT01011751|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24612074|NCT01011751|Fertility Agents|fertility agents|mesh-ancestor
24612075|NCT01011751|Androgen Antagonists|androgen antagonists|mesh-ancestor
24612076|NCT01011751|Hormone Antagonists|hormone antagonists|mesh-ancestor
24623433|NCT01071369|Sensory System Agents|sensory system agents|mesh-ancestor
24882145|NCT02735707|Ticagrelor|ticagrelor|mesh-list
24882146|NCT02735707|Simvastatin|simvastatin|mesh-list
24882147|NCT02735707|Enzyme Inhibitors|enzyme inhibitors|mesh-list
24882148|NCT02735707|Immunoglobulins|immunoglobulins|mesh-list
24882149|NCT02735707|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24882150|NCT02735707|Antibodies|antibodies|mesh-list
24882151|NCT02735707|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24882152|NCT02735707|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24882154|NCT02735707|Micronutrients|micronutrients|mesh-ancestor
24882155|NCT02735707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882156|NCT02735707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882157|NCT02735707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24882158|NCT02735707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24882159|NCT02735707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24882168|NCT02735707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24882169|NCT02735707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24882170|NCT02735707|Antipyretics|antipyretics|mesh-ancestor
24882171|NCT02735707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24882172|NCT02735707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24882173|NCT02735707|Protease Inhibitors|protease inhibitors|mesh-ancestor
25057166|NCT03507062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25057167|NCT03506997|Pembrolizumab|pembrolizumab|mesh-list
25057168|NCT03506997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25057169|NCT03506997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882189|NCT02735707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24882190|NCT02735707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24882191|NCT02735707|Immunologic Factors|immunologic factors|mesh-ancestor
24882192|NCT02735707|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24882193|NCT02735707|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24882194|NCT02735707|Antimalarials|antimalarials|mesh-ancestor
24882195|NCT02735707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25201452|NCT02727621|Propofol|propofol|mesh-list
24882200|NCT02735707|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25864956|NCT00099450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882201|NCT02735707|Renal Agents|renal agents|mesh-ancestor
24882202|NCT02735707|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24882203|NCT02735707|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24882204|NCT02735707|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24882205|NCT02735707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24882206|NCT02735707|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24882207|NCT02735707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24882228|NCT02397226|Anesthetics|anesthetics|mesh-list
24882229|NCT02397226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24882230|NCT02397226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882231|NCT02345850|Cyclophosphamide|cyclophosphamide|mesh-list
24882232|NCT02345850|Methotrexate|methotrexate|mesh-list
25201453|NCT02727621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24882237|NCT02345850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24882238|NCT02345850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24882239|NCT02345850|Alkylating Agents|alkylating agents|mesh-ancestor
24882240|NCT02345850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882258|NCT02109081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882259|NCT02109081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24882260|NCT02109081|Glucocorticoids|glucocorticoids|mesh-ancestor
25864957|NCT00099489|Interferons|interferons|mesh-list
25864958|NCT00099489|Interferon-beta|interferon-beta|mesh-list
25864959|NCT00099489|Interferon beta-1a|interferon beta-1a|mesh-list
25864960|NCT00099489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864961|NCT00099489|Antiviral Agents|antiviral agents|mesh-ancestor
25864962|NCT00099489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25864963|NCT00099489|Immunologic Factors|immunologic factors|mesh-ancestor
25864964|NCT00099489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882273|NCT01962792|Hormones|hormones|mesh-ancestor
25431729|NCT00995150|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25876776|NCT02794571|Growth Inhibitors|growth inhibitors|mesh-ancestor
24882274|NCT01962792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24882275|NCT01962792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24882276|NCT01962792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882277|NCT01850108|Mycophenolic Acid|mycophenolic acid|mesh-list
24882279|NCT01850108|Cyclophosphamide|cyclophosphamide|mesh-list
24882280|NCT01850108|Fludarabine|fludarabine|mesh-list
24882281|NCT01850108|Thymoglobulin|thymoglobulin|mesh-list
25057176|NCT03506919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25057177|NCT03506919|Antioxidants|antioxidants|mesh-ancestor
25057178|NCT03506919|Protective Agents|protective agents|mesh-ancestor
24882282|NCT01850108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25201454|NCT02727621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24882288|NCT01850108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882289|NCT01850108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882290|NCT01850108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24882291|NCT01850108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24882292|NCT01850108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24882293|NCT01850108|Antitubercular Agents|antitubercular agents|mesh-ancestor
24882294|NCT01850108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24882295|NCT01850108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25864965|NCT00099489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25061370|NCT03471819|Serotonin|serotonin|mesh-list
24882308|NCT01546948|Respiratory System Agents|respiratory system agents|mesh-ancestor
24882321|NCT01464164|Prednisone|prednisone|mesh-list
24882322|NCT01464164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24882323|NCT01464164|Glucocorticoids|glucocorticoids|mesh-ancestor
24882324|NCT01464164|Hormones|hormones|mesh-ancestor
24882325|NCT01464164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24882326|NCT01464164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882327|NCT01464164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24882328|NCT01464164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882345|NCT01111565|Aripiprazole|aripiprazole|mesh-list
24882346|NCT01111565|Citalopram|citalopram|mesh-list
24882347|NCT01111565|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24882348|NCT01111565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24882349|NCT01111565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25864966|NCT00099502|Interferons|interferons|mesh-list
25057179|NCT03506919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057180|NCT03506841|Cerebrolysin|cerebrolysin|mesh-list
25057181|NCT03506841|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25057182|NCT03506841|Protective Agents|protective agents|mesh-ancestor
24401485|NCT00153023|Valsartan|valsartan|mesh-list
24882394|NCT00489307|Dexamethasone|dexamethasone|mesh-list
24882395|NCT00489307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24882396|NCT00489307|Antiemetics|antiemetics|mesh-ancestor
24882397|NCT00489307|Autonomic Agents|autonomic agents|mesh-ancestor
24882398|NCT00489307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24882399|NCT00489307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882400|NCT00489307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24882401|NCT00489307|Glucocorticoids|glucocorticoids|mesh-ancestor
24882402|NCT00489307|Hormones|hormones|mesh-ancestor
25864967|NCT00099502|Interferon-beta|interferon-beta|mesh-list
25864968|NCT00099502|Glatiramer Acetate|glatiramer acetate|mesh-list
25864969|NCT00099502|Interferon beta-1b|interferon beta-1b|mesh-list
25864970|NCT00099502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25057183|NCT03506841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057184|NCT03506841|Nootropic Agents|nootropic agents|mesh-ancestor
25057186|NCT03506828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25057187|NCT03506828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25057188|NCT03506828|Disinfectants|disinfectants|mesh-ancestor
24882403|NCT00489307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25864971|NCT00099502|Antiviral Agents|antiviral agents|mesh-ancestor
25864972|NCT00099502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25864973|NCT00099502|Immunologic Factors|immunologic factors|mesh-ancestor
25864974|NCT00099502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864975|NCT00099502|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25864976|NCT00099502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25864977|NCT00099502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24882411|NCT00072410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882412|NCT00072410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882413|NCT05171400|Insulin|insulin|mesh-list
24882414|NCT05171400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25057190|NCT03506828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25057191|NCT03506815|Rivaroxaban|rivaroxaban|mesh-list
25057192|NCT03506815|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25864978|NCT00099541|Zoledronic Acid|zoledronic acid|mesh-list
24838138|NCT02195466|Antiviral Agents|antiviral agents|mesh-ancestor
25057193|NCT03506815|Antithrombins|antithrombins|mesh-ancestor
24882431|NCT05171179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882432|NCT05171179|Sensory System Agents|sensory system agents|mesh-ancestor
24882433|NCT05171179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24882434|NCT05171179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24882435|NCT05171179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24882436|NCT05171179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24882437|NCT05171179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24498280|NCT00513877|Bortezomib|bortezomib|mesh-list
24882438|NCT05171179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882439|NCT05170828|Mycophenolic Acid|mycophenolic acid|mesh-list
24623439|NCT01071369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623440|NCT01071369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24623441|NCT01071369|Glucocorticoids|glucocorticoids|mesh-ancestor
24623442|NCT01071369|Hormones|hormones|mesh-ancestor
24623443|NCT01071369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24623444|NCT01071369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25057194|NCT03506815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25057195|NCT03506815|Protease Inhibitors|protease inhibitors|mesh-ancestor
25057196|NCT03506815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057197|NCT03506815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623445|NCT01071369|Respiratory System Agents|respiratory system agents|mesh-ancestor
24623446|NCT01071499|Morphine|morphine|mesh-list
24623447|NCT01071499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24623448|NCT01071499|Narcotics|narcotics|mesh-ancestor
24623449|NCT01071499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24623450|NCT01071499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623451|NCT01071499|Analgesics|analgesics|mesh-ancestor
24816125|NCT02074267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882454|NCT05170828|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24882455|NCT05170828|Antitubercular Agents|antitubercular agents|mesh-ancestor
24882456|NCT05170828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24882457|NCT05170828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24882458|NCT05170828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24882459|NCT05170828|Antifungal Agents|antifungal agents|mesh-ancestor
24882460|NCT05170607|Antibodies|antibodies|mesh-list
24882461|NCT05170607|Immunologic Factors|immunologic factors|mesh-ancestor
24882462|NCT05170607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882463|NCT05170594|Bevacizumab|bevacizumab|mesh-list
24882464|NCT05170594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
24882465|NCT05170594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24882466|NCT05170594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882467|NCT05170594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24882468|NCT05170594|Growth Substances|growth substances|mesh-ancestor
24882469|NCT05170594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882470|NCT05170594|Growth Inhibitors|growth inhibitors|mesh-ancestor
24882471|NCT05170581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24882472|NCT05170581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882473|NCT05170581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864979|NCT00099541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25864980|NCT00099541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864981|NCT00099554|Etanercept|etanercept|mesh-list
24882474|NCT05170555|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
24882475|NCT05170555|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
24882476|NCT05170555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24598324|NCT00955240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24882510|NCT05169801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24882512|NCT05169801|Tubulin Modulators|tubulin modulators|mesh-ancestor
24882513|NCT05169801|Antimitotic Agents|antimitotic agents|mesh-ancestor
24882514|NCT05169801|Mitosis Modulators|mitosis modulators|mesh-ancestor
24882515|NCT05169801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882516|NCT05169801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24882517|NCT05169801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24882518|NCT05169801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24882545|NCT05169554|Leprostatic Agents|leprostatic agents|mesh-ancestor
24882546|NCT05169554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24882547|NCT05169554|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25669704|NCT05316857|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25669705|NCT05316857|Antitubercular Agents|antitubercular agents|mesh-ancestor
25669706|NCT05316857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25669707|NCT05316857|Leprostatic Agents|leprostatic agents|mesh-ancestor
25669708|NCT05316857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24882549|NCT05169554|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24882550|NCT05169554|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24882551|NCT05169554|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25031941|NCT03585036|Narcotics|narcotics|mesh-ancestor
24882563|NCT05169112|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24882564|NCT05169112|Fertility Agents|fertility agents|mesh-ancestor
25057219|NCT03506802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25057220|NCT03506802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25057221|NCT03506802|Analgesics|analgesics|mesh-ancestor
25057222|NCT03506802|Sensory System Agents|sensory system agents|mesh-ancestor
25057223|NCT03506802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25057224|NCT03506802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25057225|NCT03506802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25057226|NCT03506802|Antiviral Agents|antiviral agents|mesh-ancestor
25057227|NCT03506802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25864982|NCT00099554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25864983|NCT00099554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25864984|NCT00099554|Analgesics|analgesics|mesh-ancestor
24882581|NCT05169021|Micronutrients|micronutrients|mesh-ancestor
24882582|NCT05168787|Valsartan|valsartan|mesh-list
24882583|NCT05168787|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24882584|NCT05168787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24882585|NCT05168787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24882586|NCT05168787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24882587|NCT05168787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882588|NCT05168475|Rituximab|rituximab|mesh-list
24882589|NCT05168475|Infliximab|infliximab|mesh-list
24882590|NCT05168475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24882591|NCT05168475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882592|NCT05168475|Immunologic Factors|immunologic factors|mesh-ancestor
24882593|NCT05168475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882594|NCT05168475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24882595|NCT05168475|Dermatologic Agents|dermatologic agents|mesh-ancestor
24882596|NCT05168475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24704882|NCT01480817|Sorafenib|sorafenib|mesh-list
24882598|NCT05168176|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24882599|NCT05168176|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24882600|NCT05168176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24882601|NCT05168176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882614|NCT05168059|Clevidipine|clevidipine|mesh-list
24882622|NCT05168007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24882623|NCT05168007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24505453|NCT00541125|Antidotes|antidotes|mesh-ancestor
25057237|NCT03506789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25057238|NCT03506789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25057240|NCT03506763|Diclofenac|diclofenac|mesh-list
25057241|NCT03506763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25057242|NCT03506763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25057243|NCT03506763|Analgesics|analgesics|mesh-ancestor
25057244|NCT03506763|Sensory System Agents|sensory system agents|mesh-ancestor
24623167|NCT01070524|Budesonide|budesonide|mesh-list
24988827|NCT00033293|Glucocorticoids|glucocorticoids|mesh-ancestor
25201456|NCT02727621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25201457|NCT02727621|Anesthetics, General|anesthetics, general|mesh-ancestor
25201458|NCT02727621|Anesthetics|anesthetics|mesh-ancestor
25864985|NCT00099554|Sensory System Agents|sensory system agents|mesh-ancestor
25864986|NCT00099554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25057246|NCT03506763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864987|NCT00099554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25864988|NCT00099554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25864989|NCT00099554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25864990|NCT00099554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25057247|NCT03506763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25057248|NCT03506763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25057249|NCT03506763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24402493|NCT00157547|Citalopram|citalopram|mesh-list
24505844|NCT00542802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24882712|NCT05067920|Antibodies|antibodies|mesh-list
24882713|NCT05067920|Immunologic Factors|immunologic factors|mesh-ancestor
24882714|NCT05067920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516891|NCT00604435|Epirubicin|epirubicin|mesh-list
24882724|NCT05051189|Fentanyl|fentanyl|mesh-list
24882725|NCT05051189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24882726|NCT05051189|Narcotics|narcotics|mesh-ancestor
25669709|NCT05316857|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25669710|NCT05316857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25669711|NCT05316857|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25669712|NCT05316857|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24882727|NCT05051189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24882737|NCT05031078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882739|NCT05031078|Anesthetics|anesthetics|mesh-ancestor
24882740|NCT05031078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24882741|NCT05031078|Sensory System Agents|sensory system agents|mesh-ancestor
24882742|NCT05031078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24882743|NCT05031078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24882744|NCT05031078|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24882745|NCT05031078|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24882746|NCT05031078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24882747|NCT05031078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882748|NCT05024188|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24882749|NCT05024188|Metronidazole|metronidazole|mesh-list
24882750|NCT05024188|Ciprofloxacin|ciprofloxacin|mesh-list
24882751|NCT05024188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24882752|NCT05024188|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24505985|NCT00543634|Estrogens|estrogens|mesh-ancestor
24882761|NCT05002244|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24882762|NCT05002244|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
24882763|NCT05002244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24882764|NCT05002244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25057253|NCT03506620|Anesthetics, Local|anesthetics, local|mesh-ancestor
25057254|NCT03506620|Anesthetics|anesthetics|mesh-ancestor
25057255|NCT03506620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25057256|NCT03506620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623185|NCT01070615|Serotonin Agents|serotonin agents|mesh-ancestor
25201461|NCT02727621|Sensory System Agents|sensory system agents|mesh-ancestor
24882812|NCT04957368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25864991|NCT00099554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25032383|NCT03580967|Vortioxetine|vortioxetine|mesh-list
25057262|NCT03506542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25057263|NCT03506542|Alkylating Agents|alkylating agents|mesh-ancestor
25864992|NCT00099554|Immunologic Factors|immunologic factors|mesh-ancestor
25864993|NCT00099606|Dasatinib|dasatinib|mesh-list
25864994|NCT00099606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25864995|NCT00099606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25864996|NCT00099606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25864997|NCT00099606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25864998|NCT00099619|Insulin|insulin|mesh-list
25864999|NCT00099619|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25865000|NCT00099619|Insulin Glargine|insulin glargine|mesh-list
25865001|NCT00099619|Exenatide|exenatide|mesh-list
24816156|NCT02074319|Antimetabolites|antimetabolites|mesh-ancestor
24816157|NCT02074319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816158|NCT02074319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816159|NCT02074319|Dermatologic Agents|dermatologic agents|mesh-ancestor
24816160|NCT02074319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816161|NCT02074319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24816162|NCT02074319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25865002|NCT00099619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25865003|NCT00099619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865004|NCT00099619|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25865005|NCT00099619|Incretins|incretins|mesh-ancestor
25865006|NCT00099619|Hormones|hormones|mesh-ancestor
25865007|NCT00099619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25865008|NCT00099645|Mifepristone|mifepristone|mesh-list
25865009|NCT00099645|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25865010|NCT00099645|Abortifacient Agents|abortifacient agents|mesh-ancestor
25865011|NCT00099645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25865012|NCT00099645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865013|NCT00099645|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25865014|NCT00099645|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25865015|NCT00099645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25865016|NCT00099645|Contraceptive Agents|contraceptive agents|mesh-ancestor
25669713|NCT05316857|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25669714|NCT05316857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25669715|NCT05316831|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25865017|NCT00099645|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25865018|NCT00099645|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25865019|NCT00099645|Hormone Antagonists|hormone antagonists|mesh-ancestor
25057274|NCT03506399|Contraceptive Agents|contraceptive agents|mesh-list
25057275|NCT03506399|Contraceptives, Oral|contraceptives, oral|mesh-list
25057276|NCT03506399|Estradiol|estradiol|mesh-list
25057277|NCT03506399|Estrogens|estrogens|mesh-ancestor
25057278|NCT03506399|Hormones|hormones|mesh-ancestor
25057279|NCT03506399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24811499|NCT02046915|Growth Substances|growth substances|mesh-ancestor
25865020|NCT00099645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24816168|NCT02074605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816177|NCT02074800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816178|NCT02074878|Sunitinib|sunitinib|mesh-list
24816179|NCT02074878|Crizotinib|crizotinib|mesh-list
24816180|NCT02074878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816181|NCT02074878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24816182|NCT02074878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24816183|NCT02074878|Growth Substances|growth substances|mesh-ancestor
24816184|NCT02074878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816185|NCT02074878|Growth Inhibitors|growth inhibitors|mesh-ancestor
24816186|NCT02074878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25865021|NCT00099645|Luteolytic Agents|luteolytic agents|mesh-ancestor
25865022|NCT00099645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24816192|NCT02074891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24816193|NCT02074891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24705239|NCT01483053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882864|NCT04847206|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
24882865|NCT04847206|3,4-Methylenedioxyamphetamine|3,4-methylenedioxyamphetamine|mesh-list
24882867|NCT04847206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882868|NCT04847206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24882869|NCT04847206|Serotonin Agents|serotonin agents|mesh-ancestor
24882870|NCT04847206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25865023|NCT00099645|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25057280|NCT03506399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057281|NCT03506399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25057282|NCT03506399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24811508|NCT02047006|Anticoagulants|anticoagulants|mesh-ancestor
25865024|NCT00099684|Ezetimibe|ezetimibe|mesh-list
25865025|NCT00099684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25061653|NCT03469310|Antipyretics|antipyretics|mesh-ancestor
25865026|NCT00099684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24882899|NCT04780204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24882900|NCT04780204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882902|NCT04780204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25057283|NCT03506399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25057284|NCT03506399|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24882942|NCT04726969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24882943|NCT04726969|Anthelmintics|anthelmintics|mesh-ancestor
24882951|NCT04726969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882952|NCT04726969|Antinematodal Agents|antinematodal agents|mesh-ancestor
24882967|NCT04679012|Alkylating Agents|alkylating agents|mesh-ancestor
25865027|NCT00099684|Antimetabolites|antimetabolites|mesh-ancestor
24882968|NCT04679012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882969|NCT04679012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882970|NCT04679012|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24882971|NCT04679012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24882972|NCT04679012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24882973|NCT04679012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24882974|NCT04679012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24882975|NCT04679012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24882976|NCT04679012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25057295|NCT03506256|Norfloxacin|norfloxacin|mesh-list
25057296|NCT03506256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25057297|NCT03506256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25057298|NCT03506256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25057299|NCT03506256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25057300|NCT03506256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057301|NCT03506256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811516|NCT02047019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24882985|NCT04673617|Interleukin-2|interleukin-2|mesh-list
24882986|NCT04673617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24882987|NCT04673617|Immunologic Factors|immunologic factors|mesh-ancestor
25201465|NCT02727621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25032747|NCT03578900|Chelating Agents|chelating agents|mesh-ancestor
25057309|NCT03506178|Dermatologic Agents|dermatologic agents|mesh-ancestor
25057310|NCT03506178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24811529|NCT02047149|Zileuton|zileuton|mesh-list
25061689|NCT03469128|Sertraline|sertraline|mesh-list
24393418|NCT00130000|Eculizumab|eculizumab|mesh-list
25865028|NCT00099684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865029|NCT00099684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25865030|NCT00099710|Curcumin|curcumin|mesh-list
25865031|NCT00099710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25865032|NCT00099710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25865033|NCT00099710|Analgesics|analgesics|mesh-ancestor
25865034|NCT00099710|Sensory System Agents|sensory system agents|mesh-ancestor
25865035|NCT00099710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25865036|NCT00099710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865037|NCT00099710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25865038|NCT00099710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25865039|NCT00099710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865040|NCT00099710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201466|NCT02727621|Adrenergic Agents|adrenergic agents|mesh-ancestor
24972320|NCT03719053|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24883036|NCT04645212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24883037|NCT04645212|Growth Substances|growth substances|mesh-ancestor
24883038|NCT04645212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883050|NCT04620187|Cisplatin|cisplatin|mesh-list
24883051|NCT04620187|Carboplatin|carboplatin|mesh-list
24883052|NCT04620187|Trastuzumab|trastuzumab|mesh-list
24883053|NCT04620187|Maytansine|maytansine|mesh-list
24883054|NCT04620187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24883055|NCT04620187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24883056|NCT04620187|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24883057|NCT04620187|Tubulin Modulators|tubulin modulators|mesh-ancestor
24705359|NCT01484457|Pancrelipase|pancrelipase|mesh-list
24883058|NCT04620187|Antimitotic Agents|antimitotic agents|mesh-ancestor
25865041|NCT00099710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883059|NCT04620187|Mitosis Modulators|mitosis modulators|mesh-ancestor
24883060|NCT04620187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883061|NCT04608019|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24883062|NCT04608019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24883063|NCT04588818|Adalimumab|adalimumab|mesh-list
24883064|NCT04588818|Methotrexate|methotrexate|mesh-list
24883065|NCT04588818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25201462|NCT02727621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25201463|NCT02727621|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25201464|NCT02727621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25201468|NCT02727621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201469|NCT02727608|Eculizumab|eculizumab|mesh-list
25201470|NCT02727608|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25201471|NCT02727608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25201472|NCT02727608|Immunologic Factors|immunologic factors|mesh-ancestor
24883066|NCT04588818|Abortifacient Agents|abortifacient agents|mesh-ancestor
25057321|NCT03506178|Respiratory System Agents|respiratory system agents|mesh-ancestor
25057322|NCT03506178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25057323|NCT03506178|Mydriatics|mydriatics|mesh-ancestor
25057324|NCT03506178|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25057325|NCT03506178|Protective Agents|protective agents|mesh-ancestor
24883072|NCT04588818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24883073|NCT04588818|Dermatologic Agents|dermatologic agents|mesh-ancestor
24883074|NCT04588818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24883075|NCT04588818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24883076|NCT04588818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24883077|NCT04588818|Immunologic Factors|immunologic factors|mesh-ancestor
24883078|NCT04588818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25865042|NCT00099736|Cyclosporine|cyclosporine|mesh-list
25865043|NCT00099736|Cyclosporins|cyclosporins|mesh-list
25865044|NCT00099736|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24816202|NCT02075034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816203|NCT02075086|Bevacizumab|bevacizumab|mesh-list
24816204|NCT02075086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24816205|NCT02075086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816206|NCT02075086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25865045|NCT00099736|Antifungal Agents|antifungal agents|mesh-ancestor
25865046|NCT00099736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25865047|NCT00099736|Dermatologic Agents|dermatologic agents|mesh-ancestor
25865048|NCT00099736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876777|NCT02794571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25865049|NCT00099736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865050|NCT00099736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25865051|NCT00099736|Immunologic Factors|immunologic factors|mesh-ancestor
25865052|NCT00099736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865053|NCT00099736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25865054|NCT00099736|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25865055|NCT00099736|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24507107|NCT00548704|Dexrazoxane|dexrazoxane|mesh-list
24816233|NCT02075242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816234|NCT02075242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24816235|NCT02075242|Antitubercular Agents|antitubercular agents|mesh-ancestor
24816236|NCT02075242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25865056|NCT00099749|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25865057|NCT00099749|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25865058|NCT00099749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865059|NCT00099749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25865060|NCT00099749|Immunologic Factors|immunologic factors|mesh-ancestor
25865061|NCT00099749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865062|NCT00099775|Caspofungin|caspofungin|mesh-list
25865063|NCT00099775|Antifungal Agents|antifungal agents|mesh-ancestor
25865064|NCT00099775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25865065|NCT00099775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865066|NCT00099775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816237|NCT02075242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24816238|NCT02075268|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24705430|NCT01485185|Gabapentin|gabapentin|mesh-list
25057331|NCT03506061|Elexacaftor|elexacaftor|mesh-list
25057332|NCT03506061|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25057333|NCT03506061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25057334|NCT03506061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057335|NCT03506048|Lenvatinib|lenvatinib|mesh-list
25057336|NCT03506048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25057337|NCT03506048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25057338|NCT03506048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057339|NCT03506048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057340|NCT03506009|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25057341|NCT03506009|Argatroban|argatroban|mesh-list
25057342|NCT03506009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25057343|NCT03506009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25057344|NCT03506009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057347|NCT03506009|Protease Inhibitors|protease inhibitors|mesh-ancestor
25057348|NCT03506009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057349|NCT03506009|Anticoagulants|anticoagulants|mesh-ancestor
25057350|NCT03506009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25057351|NCT03505788|Acetazolamide|acetazolamide|mesh-list
24883091|NCT04539730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24883092|NCT04539730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883093|NCT04539730|Sensory System Agents|sensory system agents|mesh-ancestor
24883094|NCT04539730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24883096|NCT04535791|Cholecalciferol|cholecalciferol|mesh-list
24883097|NCT04535791|Vitamins|vitamins|mesh-ancestor
24883098|NCT04535791|Micronutrients|micronutrients|mesh-ancestor
25061767|NCT03468790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24883099|NCT04535791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883100|NCT04535791|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24883101|NCT04535791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24883102|NCT04523246|Vaccines|vaccines|mesh-list
24883103|NCT04523246|Immunologic Factors|immunologic factors|mesh-ancestor
24883104|NCT04523246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883105|NCT04517058|Antidepressive Agents|antidepressive agents|mesh-list
24883106|NCT04517058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25057352|NCT03505788|Anticonvulsants|anticonvulsants|mesh-ancestor
25057353|NCT03505788|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25057354|NCT03505788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057355|NCT03505788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057356|NCT03505788|Diuretics|diuretics|mesh-ancestor
25057357|NCT03505788|Natriuretic Agents|natriuretic agents|mesh-ancestor
25865067|NCT00099788|Ranolazine|ranolazine|mesh-list
25865068|NCT00099788|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25865069|NCT00099788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25865070|NCT00099788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865071|NCT00099801|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25876778|NCT02794571|Antimetabolites|antimetabolites|mesh-ancestor
25100951|NCT03178292|Renal Agents|renal agents|mesh-ancestor
25865072|NCT00099801|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25865073|NCT00099801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865074|NCT00099801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25865075|NCT00099801|Immunologic Factors|immunologic factors|mesh-ancestor
25865076|NCT00099801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865077|NCT00099840|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25865078|NCT00099840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25865079|NCT00099866|Metformin|metformin|mesh-list
25865080|NCT00099866|Vildagliptin|vildagliptin|mesh-list
25865081|NCT00099866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25865082|NCT00099866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865083|NCT00099866|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25865084|NCT00099866|Protease Inhibitors|protease inhibitors|mesh-ancestor
25865085|NCT00099866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865086|NCT00099866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865087|NCT00099892|Vildagliptin|vildagliptin|mesh-list
25865088|NCT00099892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25865089|NCT00099892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865090|NCT00099892|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25865091|NCT00099892|Protease Inhibitors|protease inhibitors|mesh-ancestor
25865092|NCT00099892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865093|NCT00099892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865094|NCT00099905|Vildagliptin|vildagliptin|mesh-list
25865095|NCT00099905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25865096|NCT00099905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865097|NCT00099905|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25865098|NCT00099905|Protease Inhibitors|protease inhibitors|mesh-ancestor
25865099|NCT00099905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865100|NCT00099905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865101|NCT00099918|Vildagliptin|vildagliptin|mesh-list
25865102|NCT00099918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25865103|NCT00099918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057360|NCT03505736|Regadenoson|regadenoson|mesh-list
25057361|NCT03505736|Analgesics|analgesics|mesh-ancestor
25057380|NCT03505528|Mitosis Modulators|mitosis modulators|mesh-ancestor
25865104|NCT00099918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25865105|NCT00099918|Protease Inhibitors|protease inhibitors|mesh-ancestor
25865106|NCT00099918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24883168|NCT04363840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24883169|NCT04363840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24883170|NCT04363840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24883171|NCT04363840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883172|NCT04363840|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24883173|NCT04363840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24883174|NCT04363840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24883175|NCT04363840|Antipyretics|antipyretics|mesh-ancestor
24883176|NCT04337060|Lidocaine|lidocaine|mesh-list
24883177|NCT04337060|Morphine|morphine|mesh-list
24883178|NCT04337060|Bupivacaine|bupivacaine|mesh-list
24883179|NCT04337060|Anesthetics, Local|anesthetics, local|mesh-ancestor
24883180|NCT04337060|Anesthetics|anesthetics|mesh-ancestor
24883181|NCT04337060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25865107|NCT00099918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865108|NCT00099931|Vildagliptin|vildagliptin|mesh-list
25865109|NCT00099931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25865110|NCT00099931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865111|NCT00099931|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25865112|NCT00099931|Protease Inhibitors|protease inhibitors|mesh-ancestor
25865113|NCT00099931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865114|NCT00099931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865115|NCT00099944|Glimepiride|glimepiride|mesh-list
25865116|NCT00099944|Vildagliptin|vildagliptin|mesh-list
24883182|NCT04337060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669716|NCT05316831|Immunologic Factors|immunologic factors|mesh-ancestor
25669717|NCT05316831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669718|NCT05316675|Isotretinoin|isotretinoin|mesh-list
25669719|NCT05316675|Dermatologic Agents|dermatologic agents|mesh-ancestor
25669720|NCT05316649|Chrysarobin|chrysarobin|mesh-list
25669721|NCT05316649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25669722|NCT05316649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25669723|NCT05316649|Analgesics|analgesics|mesh-ancestor
25101072|NCT03177980|Narcotics|narcotics|mesh-ancestor
25101073|NCT03177980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25101074|NCT03177980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101075|NCT03177980|Analgesics|analgesics|mesh-ancestor
25101076|NCT03177980|Sensory System Agents|sensory system agents|mesh-ancestor
25865117|NCT00099944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25865118|NCT00099944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25865119|NCT00099944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865120|NCT00099944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25865121|NCT00099944|Immunologic Factors|immunologic factors|mesh-ancestor
25865122|NCT00099944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25865123|NCT00099944|Protease Inhibitors|protease inhibitors|mesh-ancestor
25865124|NCT00099944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865125|NCT00099944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865126|NCT00099957|Vildagliptin|vildagliptin|mesh-list
25865127|NCT00099957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25865128|NCT00099957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865129|NCT00099957|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25057363|NCT03505736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25057364|NCT03505736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811582|NCT02047201|Antimitotic Agents|antimitotic agents|mesh-ancestor
25865130|NCT00099957|Protease Inhibitors|protease inhibitors|mesh-ancestor
25865131|NCT00099957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865132|NCT00099957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865133|NCT00099970|Dacarbazine|dacarbazine|mesh-list
25865134|NCT00099970|Volociximab|volociximab|mesh-list
25865135|NCT00099970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25865136|NCT00099970|Alkylating Agents|alkylating agents|mesh-ancestor
25865137|NCT00099970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865138|NCT00099970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865139|NCT00099970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25865140|NCT00099970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25865141|NCT00099970|Growth Substances|growth substances|mesh-ancestor
25865142|NCT00099970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865143|NCT00099970|Growth Inhibitors|growth inhibitors|mesh-ancestor
24883201|NCT04330183|Anesthetics|anesthetics|mesh-ancestor
24883202|NCT04330183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24883203|NCT04330183|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24883204|NCT04330183|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24883205|NCT04330183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24883206|NCT04330183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883210|NCT04300595|Anesthetics|anesthetics|mesh-list
25865144|NCT00099996|Ezetimibe|ezetimibe|mesh-list
25033115|NCT03576378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865145|NCT00099996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25865146|NCT00099996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25865147|NCT00099996|Antimetabolites|antimetabolites|mesh-ancestor
25865148|NCT00099996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865149|NCT00099996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25865150|NCT00100009|Triamcinolone|triamcinolone|mesh-list
25865151|NCT00100009|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25865152|NCT00100009|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24883221|NCT04297293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24883222|NCT04297293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883224|NCT04295863|Nivolumab|nivolumab|mesh-list
24883225|NCT04295863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24883226|NCT04295863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24883227|NCT04295863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24883228|NCT04295863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883229|NCT04249297|Dydrogesterone|dydrogesterone|mesh-list
24883230|NCT04249297|Progestins|progestins|mesh-ancestor
24883231|NCT04249297|Hormones|hormones|mesh-ancestor
24507418|NCT00550433|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25057365|NCT03505736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25669724|NCT05316649|Sensory System Agents|sensory system agents|mesh-ancestor
25669725|NCT05316649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25669726|NCT05316649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669727|NCT05316649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25669728|NCT05316649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25669729|NCT05316480|Nimotuzumab|nimotuzumab|mesh-list
25669730|NCT05316480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25669731|NCT05316480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24838312|NCT02197143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24838313|NCT02197143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24838315|NCT02197143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057366|NCT03505736|Vasodilator Agents|vasodilator agents|mesh-ancestor
25057367|NCT03505736|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25057368|NCT03505736|Purinergic Agonists|purinergic agonists|mesh-ancestor
25057369|NCT03505736|Purinergic Agents|purinergic agents|mesh-ancestor
25057370|NCT03505736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25057371|NCT03505736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057372|NCT03505736|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25057373|NCT03505528|Paclitaxel|paclitaxel|mesh-list
25057374|NCT03505528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25057375|NCT03505528|Phenelzine|phenelzine|mesh-list
25057376|NCT03505528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24811585|NCT02047201|Antimetabolites|antimetabolites|mesh-ancestor
24393669|NCT00130676|Mifepristone|mifepristone|mesh-list
25865153|NCT00100009|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25865154|NCT00100009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25865155|NCT00100009|Glucocorticoids|glucocorticoids|mesh-ancestor
25865156|NCT00100009|Hormones|hormones|mesh-ancestor
25865157|NCT00100009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25865158|NCT00100009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865159|NCT00100009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25865160|NCT00100009|Immunologic Factors|immunologic factors|mesh-ancestor
25865161|NCT00100009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865162|NCT00100009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468720|NCT00382980|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25865163|NCT00100074|Lobeline|lobeline|mesh-list
25865164|NCT00100074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25865165|NCT00100074|Autonomic Agents|autonomic agents|mesh-ancestor
24507444|NCT00550628|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25865166|NCT00100074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25865167|NCT00100074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507508|NCT00550992|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25865168|NCT00100074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25865169|NCT00100074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25865170|NCT00100074|Cholinergic Agents|cholinergic agents|mesh-ancestor
25865171|NCT00100074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25865172|NCT00100074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865173|NCT00100074|Respiratory System Agents|respiratory system agents|mesh-ancestor
25865174|NCT00100100|Modafinil|modafinil|mesh-list
25865175|NCT00100100|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25865176|NCT00100100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865177|NCT00100100|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25865178|NCT00100100|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25865179|NCT00100100|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25865180|NCT00100100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865181|NCT00100113|Vanoxerine|vanoxerine|mesh-list
25865182|NCT00100113|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24883290|NCT04035837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057377|NCT03505528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25057378|NCT03505528|Tubulin Modulators|tubulin modulators|mesh-ancestor
24940877|NCT03996772|Apixaban|apixaban|mesh-list
25057379|NCT03505528|Antimitotic Agents|antimitotic agents|mesh-ancestor
24883318|NCT03991403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24883320|NCT03991403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24883321|NCT03991403|Growth Substances|growth substances|mesh-ancestor
24883322|NCT03991403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883323|NCT03991403|Growth Inhibitors|growth inhibitors|mesh-ancestor
24883324|NCT03991403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24883325|NCT03991403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24883326|NCT03991403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25669732|NCT05316376|Paclitaxel|paclitaxel|mesh-list
25669733|NCT05316376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25669734|NCT05316376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25669735|NCT05316376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669736|NCT05316376|Tubulin Modulators|tubulin modulators|mesh-ancestor
25669737|NCT05316376|Antimitotic Agents|antimitotic agents|mesh-ancestor
25669738|NCT05316376|Mitosis Modulators|mitosis modulators|mesh-ancestor
25669739|NCT05316376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669740|NCT05316298|Gentamicins|gentamicins|mesh-list
25669741|NCT05316298|Calcium|calcium|mesh-list
25669742|NCT05316298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25669743|NCT05316298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838317|NCT02197143|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24838318|NCT02197143|Histamine Antagonists|histamine antagonists|mesh-ancestor
24838320|NCT02197143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25056552|NCT03511768|Octreotide|octreotide|mesh-list
25101368|NCT03175341|Micronutrients|micronutrients|mesh-ancestor
25101369|NCT03175341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101370|NCT03175341|Antioxidants|antioxidants|mesh-ancestor
25101371|NCT03175341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101372|NCT03175341|Protective Agents|protective agents|mesh-ancestor
25101386|NCT03175380|BCG Vaccine|bcg vaccine|mesh-list
25101387|NCT03175380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25101388|NCT03175380|Immunologic Factors|immunologic factors|mesh-ancestor
25865183|NCT00100113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25865184|NCT00100113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25865185|NCT00100113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865186|NCT00100113|Dopamine Agents|dopamine agents|mesh-ancestor
25865187|NCT00100113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25865188|NCT00100113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865189|NCT00100126|Amoxicillin|amoxicillin|mesh-list
25865190|NCT00100126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25865191|NCT00100126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25057383|NCT03505528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25057384|NCT03505528|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25057385|NCT03505528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057387|NCT03505502|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25057388|NCT03505502|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25865192|NCT00100139|Paclitaxel|paclitaxel|mesh-list
25865193|NCT00100139|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25865194|NCT00100139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25865195|NCT00100139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865196|NCT00100139|Tubulin Modulators|tubulin modulators|mesh-ancestor
25865197|NCT00100139|Antimitotic Agents|antimitotic agents|mesh-ancestor
25865198|NCT00100139|Mitosis Modulators|mitosis modulators|mesh-ancestor
25865199|NCT00100139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865200|NCT00100243|Abarelix|abarelix|mesh-list
25865201|NCT00100243|Hormone Antagonists|hormone antagonists|mesh-ancestor
25865202|NCT00100243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25865203|NCT00100243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865204|NCT00100269|Antioxidants|antioxidants|mesh-list
25865205|NCT00100269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865206|NCT00100269|Protective Agents|protective agents|mesh-ancestor
25865207|NCT00100269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865208|NCT00100308|Heparin|heparin|mesh-list
25865209|NCT00100308|Anticoagulants|anticoagulants|mesh-ancestor
25865210|NCT00100308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25865211|NCT00100308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25865212|NCT00100308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892036|NCT04466085|Immunologic Factors|immunologic factors|mesh-ancestor
25865213|NCT00100412|Phenylephrine|phenylephrine|mesh-list
25865214|NCT00100412|Dobutamine|dobutamine|mesh-list
25865215|NCT00100412|Oxymetazoline|oxymetazoline|mesh-list
25865216|NCT00100412|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25865217|NCT00100412|Mydriatics|mydriatics|mesh-ancestor
25865218|NCT00100412|Autonomic Agents|autonomic agents|mesh-ancestor
25865219|NCT00100412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25865220|NCT00100412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865221|NCT00100412|Sympathomimetics|sympathomimetics|mesh-ancestor
25865222|NCT00100412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25865223|NCT00100412|Nasal Decongestants|nasal decongestants|mesh-ancestor
25865224|NCT00100412|Respiratory System Agents|respiratory system agents|mesh-ancestor
25865225|NCT00100412|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25669744|NCT05316298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25669745|NCT05316298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25669746|NCT05316298|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25669747|NCT05316298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25669748|NCT05316298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669749|NCT05316246|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25669750|NCT05316246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25669751|NCT05316246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669752|NCT05316168|Dexamethasone|dexamethasone|mesh-list
25669753|NCT05316168|Bupivacaine|bupivacaine|mesh-list
25669754|NCT05316168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25669755|NCT05316168|Antiemetics|antiemetics|mesh-ancestor
25865226|NCT00100412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25865227|NCT00100412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24838321|NCT02197143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838355|NCT02197286|Vitamin D|vitamin d|mesh-list
25865228|NCT00100412|Adrenergic Agents|adrenergic agents|mesh-ancestor
25865229|NCT00100412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25865230|NCT00100412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990092|NCT03869866|Vaccines|vaccines|mesh-list
25865231|NCT00100412|Protective Agents|protective agents|mesh-ancestor
25865232|NCT00100412|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25865233|NCT00100412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25865234|NCT00100464|Paroxetine|paroxetine|mesh-list
25865235|NCT00100464|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25865236|NCT00100464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25865237|NCT00100464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25865238|NCT00100464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883371|NCT03926624|Idarubicin|idarubicin|mesh-list
24883372|NCT03926624|Cladribine|cladribine|mesh-list
24405012|NCT00165308|Tamoxifen|tamoxifen|mesh-list
25865239|NCT00100464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25865240|NCT00100464|Serotonin Agents|serotonin agents|mesh-ancestor
25865241|NCT00100464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865242|NCT00100464|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25865243|NCT00100464|Antidepressive Agents|antidepressive agents|mesh-ancestor
25865244|NCT00100464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25865245|NCT00100464|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25865246|NCT00100464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25865247|NCT00100464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865248|NCT00100477|Etoposide|etoposide|mesh-list
25865249|NCT00100477|Mitoxantrone|mitoxantrone|mesh-list
25865250|NCT00100477|Topotecan|topotecan|mesh-list
25865251|NCT00100477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24883383|NCT03926624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24883385|NCT03926624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24883386|NCT03926624|Analgesics|analgesics|mesh-ancestor
24883387|NCT03926624|Sensory System Agents|sensory system agents|mesh-ancestor
24883388|NCT03926624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24883389|NCT03926624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24883390|NCT03905902|Vaccines|vaccines|mesh-list
25865252|NCT00100477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865253|NCT00100477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25865254|NCT00100477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25865255|NCT00100477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507850|NCT00552682|Dopamine Agents|dopamine agents|mesh-ancestor
25865256|NCT00100477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865257|NCT00100477|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25865258|NCT00100477|Analgesics|analgesics|mesh-ancestor
25865259|NCT00100477|Sensory System Agents|sensory system agents|mesh-ancestor
25865260|NCT00100477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25865261|NCT00100477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057393|NCT03505489|Methacholine Chloride|methacholine chloride|mesh-list
25057394|NCT03505489|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24883394|NCT03878927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24883395|NCT03878927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24883396|NCT03858049|Dydrogesterone|dydrogesterone|mesh-list
24883397|NCT03858049|Progestins|progestins|mesh-ancestor
25201473|NCT02727608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883398|NCT03858049|Hormones|hormones|mesh-ancestor
24883399|NCT03858049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24883400|NCT03858049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883412|NCT03852888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24883413|NCT03852888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24883414|NCT03852888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24883415|NCT03852888|Immunologic Factors|immunologic factors|mesh-ancestor
24883416|NCT03852888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24883417|NCT03852888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24883418|NCT03850418|Azacitidine|azacitidine|mesh-list
25669756|NCT05316168|Autonomic Agents|autonomic agents|mesh-ancestor
25669757|NCT05316168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25669758|NCT05316168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669759|NCT05316168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25669760|NCT05316168|Glucocorticoids|glucocorticoids|mesh-ancestor
25669761|NCT05316168|Hormones|hormones|mesh-ancestor
25669762|NCT05316168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25669763|NCT05316168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24838362|NCT02197286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24838363|NCT02197403|Dexmedetomidine|dexmedetomidine|mesh-list
24838364|NCT02197403|Propofol|propofol|mesh-list
24838365|NCT02197403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24838366|NCT02197403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24838367|NCT02197403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838368|NCT02197403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24393854|NCT00131053|Antiemetics|antiemetics|mesh-ancestor
25865262|NCT00100555|Zoledronic Acid|zoledronic acid|mesh-list
25865263|NCT00100555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25865264|NCT00100555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865265|NCT00100568|Lamivudine|lamivudine|mesh-list
25865266|NCT00100568|Zidovudine|zidovudine|mesh-list
25865267|NCT00100568|Efavirenz|efavirenz|mesh-list
25865268|NCT00100568|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25865269|NCT00100568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25865270|NCT00100568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25865271|NCT00100568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865272|NCT00100568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865273|NCT00100568|Antiviral Agents|antiviral agents|mesh-ancestor
25865274|NCT00100568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25865275|NCT00100568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25865276|NCT00100568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25865277|NCT00100568|Antimetabolites|antimetabolites|mesh-ancestor
24883419|NCT03850418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24883420|NCT03850418|Antimetabolites|antimetabolites|mesh-ancestor
24883421|NCT03850418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883422|NCT03850418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24883423|NCT03850418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865278|NCT00100568|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25865279|NCT00100568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25865280|NCT00100568|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25865281|NCT00100568|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25865282|NCT00100568|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24892484|NCT04462666|Etoricoxib|etoricoxib|mesh-list
25865283|NCT00100568|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25057397|NCT03505489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057398|NCT03505489|Miotics|miotics|mesh-ancestor
25057399|NCT03505489|Autonomic Agents|autonomic agents|mesh-ancestor
25057400|NCT03505489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25057401|NCT03505489|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25057402|NCT03505489|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
25865284|NCT00100581|Interferons|interferons|mesh-list
25865285|NCT00100581|Ritonavir|ritonavir|mesh-list
25865286|NCT00100581|Tenofovir|tenofovir|mesh-list
25865287|NCT00100581|Ribavirin|ribavirin|mesh-list
25865288|NCT00100581|Interferon-alpha|interferon-alpha|mesh-list
25865289|NCT00100581|Lamivudine|lamivudine|mesh-list
25865290|NCT00100581|Interferon alpha-2|interferon alpha-2|mesh-list
25865291|NCT00100581|Efavirenz|efavirenz|mesh-list
25865292|NCT00100581|Lopinavir|lopinavir|mesh-list
24883443|NCT03850366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24883444|NCT03850366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25201474|NCT02727491|Dextromethorphan|dextromethorphan|mesh-list
24883445|NCT03850366|Alkylating Agents|alkylating agents|mesh-ancestor
24883446|NCT03850366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865293|NCT00100581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25865294|NCT00100581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865295|NCT00100581|Antiviral Agents|antiviral agents|mesh-ancestor
25865296|NCT00100581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25865297|NCT00100581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25865298|NCT00100581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25057403|NCT03505489|Respiratory System Agents|respiratory system agents|mesh-ancestor
25057404|NCT03505489|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25057405|NCT03505489|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25057406|NCT03505489|Cholinergic Agents|cholinergic agents|mesh-ancestor
25669764|NCT05316168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669765|NCT05316168|Anesthetics, Local|anesthetics, local|mesh-ancestor
25669766|NCT05316168|Anesthetics|anesthetics|mesh-ancestor
25669767|NCT05316168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25669768|NCT05316168|Sensory System Agents|sensory system agents|mesh-ancestor
25669769|NCT05315999|Palonosetron|palonosetron|mesh-list
25669770|NCT05315999|Antiemetics|antiemetics|mesh-ancestor
25669771|NCT05315999|Autonomic Agents|autonomic agents|mesh-ancestor
25865299|NCT00100581|Protease Inhibitors|protease inhibitors|mesh-ancestor
25865300|NCT00100581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865301|NCT00100581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838380|NCT02197403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056572|NCT03511560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057407|NCT03505489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25057408|NCT03505489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508109|NCT00554177|Hormone Antagonists|hormone antagonists|mesh-ancestor
25865302|NCT00100581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24883466|NCT03819114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24883467|NCT03804268|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24883469|NCT03804268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24883471|NCT03804268|Autonomic Agents|autonomic agents|mesh-ancestor
24883472|NCT03804268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24883473|NCT03804268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883474|NCT03804268|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24883475|NCT03804268|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24883476|NCT03804268|Cholinergic Agents|cholinergic agents|mesh-ancestor
24883477|NCT03804268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24883478|NCT03804268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883479|NCT05239390|Dronabinol|dronabinol|mesh-list
24883480|NCT05239390|Hallucinogens|hallucinogens|mesh-ancestor
25057413|NCT03505411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057414|NCT03505411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25057415|NCT03505255|Neostigmine|neostigmine|mesh-list
25057416|NCT03505255|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25057417|NCT03505255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057418|NCT03505255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057419|NCT03505255|Cholinergic Agents|cholinergic agents|mesh-ancestor
25057420|NCT03505255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25865303|NCT00100581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25865304|NCT00100581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25865305|NCT00100581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25865306|NCT00100581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25865307|NCT00100581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25865308|NCT00100581|Antimetabolites|antimetabolites|mesh-ancestor
25865309|NCT00100581|Immunologic Factors|immunologic factors|mesh-ancestor
25865310|NCT00100581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865311|NCT00100581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25865312|NCT00100581|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25865313|NCT00100581|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25865314|NCT00100581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25865315|NCT00100581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25865316|NCT00100594|Lamivudine|lamivudine|mesh-list
25201475|NCT02727491|Antitussive Agents|antitussive agents|mesh-ancestor
25865317|NCT00100594|Zidovudine|zidovudine|mesh-list
25865318|NCT00100594|Efavirenz|efavirenz|mesh-list
25865319|NCT00100594|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25865320|NCT00100594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25865321|NCT00100594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25865322|NCT00100594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865323|NCT00100594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865324|NCT00100594|Antiviral Agents|antiviral agents|mesh-ancestor
25865325|NCT00100594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25865326|NCT00100594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25865327|NCT00100594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25865328|NCT00100594|Antimetabolites|antimetabolites|mesh-ancestor
25865329|NCT00100594|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25865330|NCT00100594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25865331|NCT00100594|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25865332|NCT00100594|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25865333|NCT00100594|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25865334|NCT00100594|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25865335|NCT00100620|Zoledronic Acid|zoledronic acid|mesh-list
25669772|NCT05315999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25669773|NCT05315999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669774|NCT05315999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25669775|NCT05315999|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25669776|NCT05315999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25669777|NCT05315999|Serotonin Agents|serotonin agents|mesh-ancestor
25669778|NCT05315999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25669779|NCT05315999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669780|NCT05315830|Vaccines|vaccines|mesh-list
25057421|NCT03505255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057422|NCT03505255|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25057423|NCT03505255|Autonomic Agents|autonomic agents|mesh-ancestor
24892709|NCT04460521|Antidotes|antidotes|mesh-ancestor
25057424|NCT03505255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25057425|NCT03505151|BI 409306|bi 409306|mesh-list
25057426|NCT03505151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25057427|NCT03505151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057428|NCT03505151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057430|NCT03505047|Trace Elements|trace elements|mesh-ancestor
25057431|NCT03505047|Micronutrients|micronutrients|mesh-ancestor
25057432|NCT03505047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865336|NCT00100620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25865337|NCT00100620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883492|NCT05239390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24883493|NCT05239312|Anti-Infective Agents|anti-infective agents|mesh-list
24883497|NCT05239286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883498|NCT05239078|Anesthetics|anesthetics|mesh-list
24883499|NCT05239078|Anesthetics, Local|anesthetics, local|mesh-list
24883500|NCT05239078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25865338|NCT00100646|Ritonavir|ritonavir|mesh-list
25865339|NCT00100646|Lopinavir|lopinavir|mesh-list
25865340|NCT00100646|Lamivudine|lamivudine|mesh-list
25865341|NCT00100646|Stavudine|stavudine|mesh-list
25865342|NCT00100646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25865343|NCT00100646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25865344|NCT00100646|Protease Inhibitors|protease inhibitors|mesh-ancestor
25865345|NCT00100646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865346|NCT00100646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865347|NCT00100646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25865348|NCT00100646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25865349|NCT00100646|Antiviral Agents|antiviral agents|mesh-ancestor
25865350|NCT00100646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25865351|NCT00100646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25865352|NCT00100646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25865353|NCT00100646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25865354|NCT00100646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25865355|NCT00100646|Antimetabolites|antimetabolites|mesh-ancestor
25865356|NCT00100685|Volociximab|volociximab|mesh-list
25865357|NCT00100685|Antibodies|antibodies|mesh-list
25865358|NCT00100685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25865359|NCT00100685|Immunologic Factors|immunologic factors|mesh-ancestor
25865360|NCT00100685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865361|NCT00100685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25865362|NCT00100685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25865363|NCT00100685|Growth Substances|growth substances|mesh-ancestor
25057444|NCT03505008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057445|NCT03505008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25057446|NCT03505008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25057447|NCT03505008|Immunologic Factors|immunologic factors|mesh-ancestor
24892809|NCT04458558|Mifepristone|mifepristone|mesh-list
25057448|NCT03505008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25061854|NCT05390710|Tubulin Modulators|tubulin modulators|mesh-ancestor
25865364|NCT00100685|Growth Inhibitors|growth inhibitors|mesh-ancestor
25865365|NCT00100685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865366|NCT00100737|Rituximab|rituximab|mesh-list
25865367|NCT00100737|Interleukin-2|interleukin-2|mesh-list
25865368|NCT00100737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25865369|NCT00100737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24883528|NCT05238467|Immunologic Factors|immunologic factors|mesh-ancestor
24883529|NCT05238467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883530|NCT05238220|Valganciclovir|valganciclovir|mesh-list
24883531|NCT05238220|Antiviral Agents|antiviral agents|mesh-ancestor
24883532|NCT05238220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24883536|NCT05238064|Cyclophosphamide|cyclophosphamide|mesh-list
24883538|NCT05238064|Vincristine|vincristine|mesh-list
25865370|NCT00100737|Immunologic Factors|immunologic factors|mesh-ancestor
25865371|NCT00100737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865372|NCT00100737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25865373|NCT00100737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25865374|NCT00100737|Analgesics|analgesics|mesh-ancestor
25865375|NCT00100737|Sensory System Agents|sensory system agents|mesh-ancestor
25865376|NCT00100737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25865377|NCT00100750|Gemcitabine|gemcitabine|mesh-list
25865378|NCT00100750|Tipifarnib|tipifarnib|mesh-list
25865379|NCT00100750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25865380|NCT00100750|Antimetabolites|antimetabolites|mesh-ancestor
25057479|NCT03504735|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
25057480|NCT03504735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25057481|NCT03504735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25057482|NCT03504735|Antimetabolites|antimetabolites|mesh-ancestor
25057483|NCT03504735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057484|NCT03504735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25057485|NCT03504735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25057486|NCT03504735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25057487|NCT03504735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25057488|NCT03504735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25057489|NCT03504735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623190|NCT01070628|Carbidopa|carbidopa|mesh-list
24623192|NCT01070628|Entacapone|entacapone|mesh-list
25865381|NCT00100750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865382|NCT00100750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865383|NCT00100750|Antiviral Agents|antiviral agents|mesh-ancestor
25865384|NCT00100750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25865385|NCT00100750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865386|NCT00100750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25865387|NCT00100750|Immunologic Factors|immunologic factors|mesh-ancestor
25865388|NCT00100750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865389|NCT00100776|Olanzapine|olanzapine|mesh-list
25865390|NCT00100776|Antiemetics|antiemetics|mesh-ancestor
25865391|NCT00100776|Autonomic Agents|autonomic agents|mesh-ancestor
25865392|NCT00100776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25067428|NCT03443843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25865393|NCT00100776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865394|NCT00100776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24508401|NCT00555373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25865395|NCT00100776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25057490|NCT03504735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25057491|NCT03504735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057493|NCT03504566|Linagliptin|linagliptin|mesh-list
25057494|NCT03504566|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
25057495|NCT03504566|Telmisartan|telmisartan|mesh-list
25057496|NCT03504566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25057497|NCT03504566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25057498|NCT03504566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25057499|NCT03504566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057500|NCT03504566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25057501|NCT03504566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25057502|NCT03504566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057503|NCT03504566|Incretins|incretins|mesh-ancestor
25057505|NCT03504566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25057506|NCT03504566|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25057507|NCT03504566|Protease Inhibitors|protease inhibitors|mesh-ancestor
25057508|NCT03504566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057509|NCT03504566|Anticoagulants|anticoagulants|mesh-ancestor
25057510|NCT03504566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25057511|NCT03504566|Antimetabolites|antimetabolites|mesh-ancestor
25057512|NCT03504566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25865396|NCT00100776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25865397|NCT00100776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25865398|NCT00100776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25865399|NCT00100776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25865400|NCT00100776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25865401|NCT00100776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25033834|NCT03570710|Tranexamic Acid|tranexamic acid|mesh-list
25057513|NCT03504566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25057514|NCT03504566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25057516|NCT03504527|Bromides|bromides|mesh-list
25057517|NCT03504527|Tiotropium Bromide|tiotropium bromide|mesh-list
25057518|NCT03504527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25669781|NCT05315830|Immunologic Factors|immunologic factors|mesh-ancestor
25669782|NCT05315830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669783|NCT05315557|Terlipressin|terlipressin|mesh-list
25669784|NCT05315557|Vasopressins|vasopressins|mesh-list
25669785|NCT05315557|Arginine Vasopressin|arginine vasopressin|mesh-list
25669786|NCT05315557|Hemostatics|hemostatics|mesh-ancestor
25669787|NCT05315557|Coagulants|coagulants|mesh-ancestor
25669788|NCT05315557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25669789|NCT05315557|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25057519|NCT03504527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25057520|NCT03504527|Autonomic Agents|autonomic agents|mesh-ancestor
25057521|NCT03504527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25057522|NCT03504527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941124|NCT03994783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24765969|NCT01791751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24941125|NCT03994783|Antiemetics|antiemetics|mesh-ancestor
24941126|NCT03994783|Autonomic Agents|autonomic agents|mesh-ancestor
24941127|NCT03994783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24766042|NCT01792037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24766043|NCT01792037|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24766044|NCT01792037|Protective Agents|protective agents|mesh-ancestor
24798709|NCT01964586|Autonomic Agents|autonomic agents|mesh-ancestor
24952695|NCT03892434|Growth Inhibitors|growth inhibitors|mesh-ancestor
24952696|NCT03892434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24952697|NCT03892434|Antiemetics|antiemetics|mesh-ancestor
24952698|NCT03892434|Autonomic Agents|autonomic agents|mesh-ancestor
24952699|NCT03892434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24952700|NCT03892434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24952701|NCT03892434|Glucocorticoids|glucocorticoids|mesh-ancestor
24952702|NCT03892434|Hormones|hormones|mesh-ancestor
24952703|NCT03892434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24952704|NCT03892434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24952705|NCT03892434|Protease Inhibitors|protease inhibitors|mesh-ancestor
24952706|NCT03892434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811713|NCT02048085|Clopidogrel|clopidogrel|mesh-list
25865402|NCT00100776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865403|NCT00100776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24811745|NCT02048215|Sympathomimetics|sympathomimetics|mesh-ancestor
25865404|NCT00100776|Serotonin Agents|serotonin agents|mesh-ancestor
24883548|NCT05238064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24883549|NCT05238064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24883550|NCT05238064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24883551|NCT05238064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24883552|NCT05238064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24883553|NCT05238064|Tubulin Modulators|tubulin modulators|mesh-ancestor
24883554|NCT05238064|Antimitotic Agents|antimitotic agents|mesh-ancestor
24883555|NCT05238064|Mitosis Modulators|mitosis modulators|mesh-ancestor
24883556|NCT05238012|Atorvastatin|atorvastatin|mesh-list
24883557|NCT05238012|Calcium|calcium|mesh-list
24883558|NCT05238012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24883559|NCT05238012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883560|NCT05238012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24883561|NCT05238012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25087155|NCT03282006|Renal Agents|renal agents|mesh-ancestor
25865405|NCT00100854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25865406|NCT00100854|Fulvestrant|fulvestrant|mesh-list
25865407|NCT00100854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865408|NCT00100854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25865409|NCT00100854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865410|NCT00100854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865411|NCT00100854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25865412|NCT00100854|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25865413|NCT00100854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25865414|NCT00100854|Hormone Antagonists|hormone antagonists|mesh-ancestor
25865415|NCT00100854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25865416|NCT00100854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865417|NCT00100880|Lenalidomide|lenalidomide|mesh-list
24952721|NCT03892330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952722|NCT03892330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24952723|NCT03892330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24952724|NCT03892330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24952725|NCT03892330|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24952726|NCT03892330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24952727|NCT03892330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952728|NCT03892330|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24952729|NCT03892330|Tubulin Modulators|tubulin modulators|mesh-ancestor
24883571|NCT05237843|Analgesics|analgesics|mesh-ancestor
24883572|NCT05237843|Sensory System Agents|sensory system agents|mesh-ancestor
24883573|NCT05237843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24883574|NCT05237843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883575|NCT05237843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24883576|NCT05237843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24883577|NCT05237843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24883578|NCT05237843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24883579|NCT05237843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883580|NCT05237843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25865418|NCT00100880|Immunologic Factors|immunologic factors|mesh-ancestor
25865419|NCT00100880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865420|NCT00100880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25865421|NCT00100880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25865422|NCT00100880|Growth Substances|growth substances|mesh-ancestor
25865423|NCT00100880|Growth Inhibitors|growth inhibitors|mesh-ancestor
25865424|NCT00100880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865425|NCT00100893|Proanthocyanidin|proanthocyanidin|mesh-list
25865427|NCT00100893|Antioxidants|antioxidants|mesh-ancestor
25865428|NCT00100893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865429|NCT00100893|Protective Agents|protective agents|mesh-ancestor
25865430|NCT00100893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865431|NCT00100893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25865432|NCT00100893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24816990|NCT02080169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25865433|NCT00100893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25865434|NCT00100906|Aldesleukin|aldesleukin|mesh-list
25865435|NCT00100906|Interleukin-2|interleukin-2|mesh-list
25865436|NCT00100906|Tretinoin|tretinoin|mesh-list
25865437|NCT00100906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865438|NCT00100906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25865439|NCT00100906|Analgesics|analgesics|mesh-ancestor
25865440|NCT00100906|Sensory System Agents|sensory system agents|mesh-ancestor
25865441|NCT00100906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25865442|NCT00100906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865443|NCT00100906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24883581|NCT05237843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24883582|NCT05237843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201476|NCT02727491|Respiratory System Agents|respiratory system agents|mesh-ancestor
24952731|NCT03892330|Mitosis Modulators|mitosis modulators|mesh-ancestor
24952732|NCT03892330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24883594|NCT05237791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24883596|NCT05237791|Anticonvulsants|anticonvulsants|mesh-ancestor
24883597|NCT05237791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24394033|NCT00131742|Antiviral Agents|antiviral agents|mesh-ancestor
25865444|NCT00100906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25865445|NCT00100906|Antiviral Agents|antiviral agents|mesh-ancestor
25865446|NCT00100906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25865447|NCT00100906|Keratolytic Agents|keratolytic agents|mesh-ancestor
25865448|NCT00100906|Dermatologic Agents|dermatologic agents|mesh-ancestor
25865449|NCT00100945|Gefitinib|gefitinib|mesh-list
25865450|NCT00100945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865451|NCT00100945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25865452|NCT00100945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865453|NCT00100945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865454|NCT00100958|Indole-3-carbinol|indole-3-carbinol|mesh-list
25865455|NCT00100958|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25865456|NCT00100958|Protective Agents|protective agents|mesh-ancestor
25865457|NCT00100958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865458|NCT00100958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865459|NCT00100971|Vaccines|vaccines|mesh-list
25865460|NCT00100971|Immunologic Factors|immunologic factors|mesh-ancestor
24600321|NCT01026220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865461|NCT00100971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865462|NCT00100984|Enfuvirtide|enfuvirtide|mesh-list
24893101|NCT04454281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24893102|NCT04453930|Irinotecan|irinotecan|mesh-list
25865463|NCT00100984|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25865464|NCT00100984|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25865465|NCT00100984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865466|NCT00100984|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25865467|NCT00100984|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25865468|NCT00100984|Antiviral Agents|antiviral agents|mesh-ancestor
25865469|NCT00100984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25865470|NCT00101062|Celecoxib|celecoxib|mesh-list
25865471|NCT00101062|Letrozole|letrozole|mesh-list
25865472|NCT00101062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865473|NCT00101062|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25865474|NCT00101062|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25865475|NCT00101062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865476|NCT00101062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865477|NCT00101062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25102370|NCT03169504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25865478|NCT00101062|Hormone Antagonists|hormone antagonists|mesh-ancestor
25865479|NCT00101062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25865480|NCT00101062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865481|NCT00101062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25865482|NCT00101062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25865483|NCT00101062|Analgesics|analgesics|mesh-ancestor
25865484|NCT00101062|Sensory System Agents|sensory system agents|mesh-ancestor
25865485|NCT00101062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25865486|NCT00101062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24952750|NCT03892421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24952751|NCT03892421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24952752|NCT03892421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25057523|NCT03504527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24893103|NCT04453930|Apatinib|apatinib|mesh-list
25865487|NCT00101062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25865488|NCT00101062|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25865489|NCT00101062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25865490|NCT00101075|Capecitabine|capecitabine|mesh-list
25865491|NCT00101075|Oxaliplatin|oxaliplatin|mesh-list
25865492|NCT00101075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25865493|NCT00101075|Antimetabolites|antimetabolites|mesh-ancestor
25057527|NCT03504527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25057528|NCT03504527|Parasympatholytics|parasympatholytics|mesh-ancestor
25057529|NCT03504527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25057530|NCT03504527|Cholinergic Agents|cholinergic agents|mesh-ancestor
25057531|NCT03504527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25865494|NCT00101075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865495|NCT00101075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865496|NCT00101088|Sirolimus|sirolimus|mesh-list
25865497|NCT00101088|Imatinib Mesylate|imatinib mesylate|mesh-list
24883677|NCT05181527|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
24883678|NCT05181527|Antitussive Agents|antitussive agents|mesh-ancestor
24883679|NCT05181527|Respiratory System Agents|respiratory system agents|mesh-ancestor
24883680|NCT05181527|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24883681|NCT05181527|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25865498|NCT00101088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865499|NCT00101088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25865500|NCT00101088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865501|NCT00101088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865502|NCT00101088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25865503|NCT00101088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25057537|NCT03504475|Paroxetine|paroxetine|mesh-list
25057538|NCT03504475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25057539|NCT03504475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25034218|NCT03566394|Anticonvulsants|anticonvulsants|mesh-ancestor
24883682|NCT05181527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24883683|NCT05181527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883684|NCT05181527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883685|NCT05181527|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24883686|NCT05181527|Serotonin Agents|serotonin agents|mesh-ancestor
24883687|NCT05181527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24883688|NCT05181527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24883690|NCT05131204|Ravulizumab|ravulizumab|mesh-list
24883691|NCT05131204|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25669790|NCT05315557|Natriuretic Agents|natriuretic agents|mesh-ancestor
25669791|NCT05315557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669792|NCT05315557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25669793|NCT05315388|Vitamins|vitamins|mesh-list
25669794|NCT05315388|Micronutrients|micronutrients|mesh-ancestor
25669795|NCT05315388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669796|NCT05315206|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
25669797|NCT05315206|Nootropic Agents|nootropic agents|mesh-ancestor
25674469|NCT01772368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674470|NCT01772368|Tocolytic Agents|tocolytic agents|mesh-ancestor
25674471|NCT01772368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25674472|NCT01772368|Glucocorticoids|glucocorticoids|mesh-ancestor
25674473|NCT01772368|Hormones|hormones|mesh-ancestor
25674474|NCT01772368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25674475|NCT01772368|Sympathomimetics|sympathomimetics|mesh-ancestor
25224982|NCT02630108|Epirubicin|epirubicin|mesh-list
24883692|NCT05131204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24455247|NCT02244125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24455248|NCT02244125|Growth Substances|growth substances|mesh-ancestor
24883711|NCT05097768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24883712|NCT05097768|Analgesics|analgesics|mesh-ancestor
24601259|NCT00963690|Coagulants|coagulants|mesh-ancestor
24883762|NCT04874480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883763|NCT04874480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24883764|NCT04874480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24883766|NCT04861584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24883767|NCT04861584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25201477|NCT02727491|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24789350|NCT01936532|Immunologic Factors|immunologic factors|mesh-ancestor
25057545|NCT03504475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25057546|NCT03504475|Antidepressive Agents|antidepressive agents|mesh-ancestor
25057547|NCT03504475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25057548|NCT03504475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25057549|NCT03504475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25057550|NCT03504475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24766045|NCT01792037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25057551|NCT03504345|Progesterone|progesterone|mesh-list
25057552|NCT03504345|Progestins|progestins|mesh-ancestor
25057553|NCT03504345|Hormones|hormones|mesh-ancestor
25057567|NCT03504072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25057569|NCT03504072|Analgesics|analgesics|mesh-ancestor
25057570|NCT03504072|Sensory System Agents|sensory system agents|mesh-ancestor
25057571|NCT03504072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25057572|NCT03504072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057573|NCT03504072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24394167|NCT00132431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24394169|NCT00132444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24394170|NCT00132444|Antiviral Agents|antiviral agents|mesh-ancestor
24394171|NCT00132444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24394172|NCT00132535|Chloroquine|chloroquine|mesh-list
24394173|NCT00132535|Pyrimethamine|pyrimethamine|mesh-list
24394174|NCT00132535|Sulfadoxine|sulfadoxine|mesh-list
24394175|NCT00132535|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24394176|NCT00132535|Amebicides|amebicides|mesh-ancestor
24394177|NCT00132535|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24394178|NCT00132535|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24394179|NCT00132535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24394180|NCT00132535|Antimalarials|antimalarials|mesh-ancestor
24394181|NCT00132535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25865504|NCT00101088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25057574|NCT03504072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25057575|NCT03504072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25057576|NCT03504072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25057577|NCT03504072|Immunologic Factors|immunologic factors|mesh-ancestor
25057578|NCT03504072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25057579|NCT03504072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057580|NCT03504072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057581|NCT03504046|Pancrelipase|pancrelipase|mesh-list
25057582|NCT03504046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25865505|NCT00101088|Antifungal Agents|antifungal agents|mesh-ancestor
25865506|NCT00101088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25865507|NCT00101088|Immunologic Factors|immunologic factors|mesh-ancestor
25865508|NCT00101088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394187|NCT00132548|Artesunate|artesunate|mesh-list
24394188|NCT00132548|Pyrimethamine|pyrimethamine|mesh-list
25057583|NCT03504033|Desflurane|desflurane|mesh-list
25057584|NCT03504033|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25057585|NCT03504033|Anesthetics, General|anesthetics, general|mesh-ancestor
25669798|NCT05315128|Methotrexate|methotrexate|mesh-list
25669799|NCT05315128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25669800|NCT05315128|Abortifacient Agents|abortifacient agents|mesh-ancestor
25669801|NCT05315128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25669802|NCT05315128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669803|NCT05315128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25669804|NCT05315128|Antimetabolites|antimetabolites|mesh-ancestor
25669805|NCT05315128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669806|NCT05315128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669807|NCT05315128|Dermatologic Agents|dermatologic agents|mesh-ancestor
25669808|NCT05315128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25669809|NCT05315128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25102535|NCT03168100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24414430|NCT00197587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24414431|NCT00197587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414432|NCT00197587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414433|NCT00197587|Antiviral Agents|antiviral agents|mesh-ancestor
25224992|NCT02630121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25224993|NCT02630121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25224994|NCT02630121|Adrenergic Agents|adrenergic agents|mesh-ancestor
25224995|NCT02630121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25224996|NCT02630121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224997|NCT02630121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224998|NCT02630121|Sympathomimetics|sympathomimetics|mesh-ancestor
25224999|NCT02630121|Autonomic Agents|autonomic agents|mesh-ancestor
25225000|NCT02630121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25225001|NCT02630121|Nasal Decongestants|nasal decongestants|mesh-ancestor
25201478|NCT02727491|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25865509|NCT00101114|Interferons|interferons|mesh-list
25865510|NCT00101114|Interferon-alpha|interferon-alpha|mesh-list
25865511|NCT00101114|Interferon alpha-2|interferon alpha-2|mesh-list
24883796|NCT04770012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24883797|NCT04770012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883798|NCT04770012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24883799|NCT04770012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24883800|NCT04770012|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24883801|NCT04770012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24883802|NCT04770012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883803|NCT04770012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24883804|NCT04770012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24883805|NCT04770012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057634|NCT03503604|Vitamin B Complex|vitamin b complex|mesh-ancestor
25057635|NCT03503604|Vitamins|vitamins|mesh-ancestor
25057636|NCT03503604|Micronutrients|micronutrients|mesh-ancestor
25057641|NCT03503227|Aspirin|aspirin|mesh-list
25057642|NCT03503227|Salicylic Acid|salicylic acid|mesh-list
25057643|NCT03503227|Prednisolone|prednisolone|mesh-list
25057644|NCT03503227|Salicylates|salicylates|mesh-list
24893367|NCT04450680|Lactams|lactams|mesh-list
25057645|NCT03503227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24811889|NCT02048852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811890|NCT02048852|Antipruritics|antipruritics|mesh-ancestor
24811891|NCT02048852|Dermatologic Agents|dermatologic agents|mesh-ancestor
24811892|NCT02048865|Apixaban|apixaban|mesh-list
24811893|NCT02048865|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25865512|NCT00101114|Sorafenib|sorafenib|mesh-list
24462864|NCT00357708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865513|NCT00101114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865514|NCT00101114|Antiviral Agents|antiviral agents|mesh-ancestor
25865515|NCT00101114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25865516|NCT00101114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25865517|NCT00101114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865518|NCT00101114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865519|NCT00101114|Immunologic Factors|immunologic factors|mesh-ancestor
25865520|NCT00101114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865521|NCT00101127|Gemcitabine|gemcitabine|mesh-list
25865522|NCT00101127|Docetaxel|docetaxel|mesh-list
25865523|NCT00101127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25865524|NCT00101127|Antimetabolites|antimetabolites|mesh-ancestor
25669810|NCT05315128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25214991|NCT02693808|Hyaluronic Acid|hyaluronic acid|mesh-list
25669811|NCT05315128|Immunologic Factors|immunologic factors|mesh-ancestor
25669812|NCT05315128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25669813|NCT05315128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25669814|NCT05314933|Deoxyglucose|deoxyglucose|mesh-list
25669815|NCT05314933|Antimetabolites|antimetabolites|mesh-ancestor
25669816|NCT05314933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669817|NCT05314933|Antiviral Agents|antiviral agents|mesh-ancestor
25669818|NCT05314933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25669819|NCT05309564|Botulinum Toxins|botulinum toxins|mesh-list
25669820|NCT05309564|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25669821|NCT05309564|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25669822|NCT05309564|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25669823|NCT05309564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25669824|NCT05309564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669825|NCT05309564|Cholinergic Agents|cholinergic agents|mesh-ancestor
25865525|NCT00101127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225006|NCT02630121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25225007|NCT02630121|Protective Agents|protective agents|mesh-ancestor
25865526|NCT00101127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865527|NCT00101127|Antiviral Agents|antiviral agents|mesh-ancestor
25865528|NCT00101127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25865529|NCT00101127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865530|NCT00101127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24883815|NCT04760626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24883816|NCT04760626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883817|NCT04755972|Acetylcysteine|acetylcysteine|mesh-list
24883818|NCT04755972|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24883819|NCT04755972|Antiviral Agents|antiviral agents|mesh-ancestor
24883820|NCT04755972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24883822|NCT04755972|Respiratory System Agents|respiratory system agents|mesh-ancestor
24883823|NCT04755972|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24462881|NCT00357747|Antimitotic Agents|antimitotic agents|mesh-ancestor
24462882|NCT00357747|Mitosis Modulators|mitosis modulators|mesh-ancestor
25201479|NCT02727491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24722858|NCT01583036|Digoxin|digoxin|mesh-list
24462883|NCT00357747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865531|NCT00101127|Immunologic Factors|immunologic factors|mesh-ancestor
25865532|NCT00101127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865533|NCT00101127|Tubulin Modulators|tubulin modulators|mesh-ancestor
25865534|NCT00101127|Antimitotic Agents|antimitotic agents|mesh-ancestor
25865535|NCT00101127|Mitosis Modulators|mitosis modulators|mesh-ancestor
25057646|NCT03503227|Glucocorticoids|glucocorticoids|mesh-ancestor
25057678|NCT03503136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865536|NCT00101140|Fludarabine|fludarabine|mesh-list
25865537|NCT00101140|Fludarabine phosphate|fludarabine phosphate|mesh-list
25865538|NCT00101140|Thiotepa|thiotepa|mesh-list
24811932|NCT02048943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24811933|NCT02048943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25057679|NCT03503136|Tubulin Modulators|tubulin modulators|mesh-ancestor
25057680|NCT03503136|Antimitotic Agents|antimitotic agents|mesh-ancestor
25034509|NCT03564106|Hormones|hormones|mesh-ancestor
25057698|NCT03502824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25865539|NCT00101140|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25865540|NCT00101140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865541|NCT00101140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25865542|NCT00101140|Antimetabolites|antimetabolites|mesh-ancestor
25865543|NCT00101140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865544|NCT00101140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25865545|NCT00101140|Immunologic Factors|immunologic factors|mesh-ancestor
25865546|NCT00101140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865547|NCT00101140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25865548|NCT00101140|Alkylating Agents|alkylating agents|mesh-ancestor
25865549|NCT00101140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25865550|NCT00101153|Cytarabine|cytarabine|mesh-list
25865551|NCT00101153|Daunorubicin|daunorubicin|mesh-list
25865552|NCT00101153|Tipifarnib|tipifarnib|mesh-list
25865553|NCT00101153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25865554|NCT00101153|Antimetabolites|antimetabolites|mesh-ancestor
24883824|NCT04755972|Antioxidants|antioxidants|mesh-ancestor
24883825|NCT04755972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057705|NCT03502642|Morphine|morphine|mesh-list
25057706|NCT03502642|Ropivacaine|ropivacaine|mesh-list
25057707|NCT03502642|Anesthetics|anesthetics|mesh-ancestor
25057708|NCT03502642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25057709|NCT03502642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057710|NCT03502642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25057711|NCT03502642|Narcotics|narcotics|mesh-ancestor
25057712|NCT03502642|Analgesics|analgesics|mesh-ancestor
25057713|NCT03502642|Sensory System Agents|sensory system agents|mesh-ancestor
25057714|NCT03502642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25057715|NCT03502642|Anesthetics, Local|anesthetics, local|mesh-ancestor
25057716|NCT03502551|Ketamine|ketamine|mesh-list
25057717|NCT03502551|Analgesics|analgesics|mesh-ancestor
25057718|NCT03502551|Sensory System Agents|sensory system agents|mesh-ancestor
25034545|NCT03563937|Apixaban|apixaban|mesh-list
24883833|NCT04709250|Anesthetics, Local|anesthetics, local|mesh-ancestor
24883834|NCT04709250|Anesthetics|anesthetics|mesh-ancestor
24883835|NCT04709250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24883836|NCT04709250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883837|NCT04709250|Sensory System Agents|sensory system agents|mesh-ancestor
24883838|NCT04709250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25669826|NCT05309564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25669827|NCT05309564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669828|NCT05309564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24883855|NCT04652245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462922|NCT00357942|Morphine|morphine|mesh-list
25865555|NCT00101153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201480|NCT02727491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865556|NCT00101153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865557|NCT00101153|Antiviral Agents|antiviral agents|mesh-ancestor
25865558|NCT00101153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25865559|NCT00101153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25865560|NCT00101153|Immunologic Factors|immunologic factors|mesh-ancestor
25865561|NCT00101153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034659|NCT03563170|Vitamins|vitamins|mesh-ancestor
25865562|NCT00101153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25865563|NCT00101153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25865564|NCT00101153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25865565|NCT00101153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057772|NCT03502343|Antimetabolites|antimetabolites|mesh-ancestor
25057773|NCT03502343|Antiviral Agents|antiviral agents|mesh-ancestor
25057774|NCT03502343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25057775|NCT03502343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057776|NCT03502343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24883865|NCT04647643|Tubulin Modulators|tubulin modulators|mesh-ancestor
24883866|NCT04647643|Antimitotic Agents|antimitotic agents|mesh-ancestor
24883867|NCT04647643|Mitosis Modulators|mitosis modulators|mesh-ancestor
24883868|NCT04647643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865566|NCT00101179|Azacitidine|azacitidine|mesh-list
25865567|NCT00101179|Entinostat|entinostat|mesh-list
25865568|NCT00101179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25865569|NCT00101179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25865570|NCT00101179|Antimetabolites|antimetabolites|mesh-ancestor
25865571|NCT00101179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883879|NCT04631536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24883882|NCT04631536|Vitamins|vitamins|mesh-ancestor
24883883|NCT04631536|Micronutrients|micronutrients|mesh-ancestor
24883884|NCT04631536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883885|NCT04631536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24883886|NCT04631536|Vasodilator Agents|vasodilator agents|mesh-ancestor
25865572|NCT00101179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865573|NCT00101179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865574|NCT00101205|Oxaliplatin|oxaliplatin|mesh-list
25865575|NCT00101205|Etoposide|etoposide|mesh-list
25865576|NCT00101205|Etoposide phosphate|etoposide phosphate|mesh-list
25865577|NCT00101205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865578|NCT00101205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24883900|NCT04565600|Etoricoxib|etoricoxib|mesh-list
24883901|NCT04565600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24883902|NCT04565600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24883903|NCT04565600|Analgesics|analgesics|mesh-ancestor
24883904|NCT04565600|Sensory System Agents|sensory system agents|mesh-ancestor
24883905|NCT04565600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24883906|NCT04565600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462956|NCT00358176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865579|NCT00101205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24941457|NCT03990922|Sensory System Agents|sensory system agents|mesh-ancestor
24941459|NCT03990922|Anesthetics, Local|anesthetics, local|mesh-ancestor
24941466|NCT03990480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941467|NCT03990480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24941468|NCT03990480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941469|NCT03990480|Vasodilator Agents|vasodilator agents|mesh-ancestor
24941470|NCT03990480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25034813|NCT03562169|Thalidomide|thalidomide|mesh-list
24883910|NCT04565600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24883911|NCT04565600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865580|NCT00101205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25865581|NCT00101205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865582|NCT00101205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865583|NCT00101231|Alvocidib|alvocidib|mesh-list
25865584|NCT00101231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865585|NCT00101231|Growth Inhibitors|growth inhibitors|mesh-ancestor
25865586|NCT00101231|Growth Substances|growth substances|mesh-ancestor
25865587|NCT00101231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865588|NCT00101231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25865589|NCT00101231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865590|NCT00101231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865591|NCT00101270|Oxaliplatin|oxaliplatin|mesh-list
25865592|NCT00101270|Irinotecan|irinotecan|mesh-list
25201481|NCT02727491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865593|NCT00101270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865594|NCT00101270|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25865595|NCT00101270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25865596|NCT00101270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865597|NCT00101270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865598|NCT00101296|Tipifarnib|tipifarnib|mesh-list
25865599|NCT00101296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865600|NCT00101309|Aldesleukin|aldesleukin|mesh-list
25865601|NCT00101309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865602|NCT00101309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25865603|NCT00101309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25865604|NCT00101309|Antiviral Agents|antiviral agents|mesh-ancestor
25865605|NCT00101309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25865606|NCT00101335|Celecoxib|celecoxib|mesh-list
25865607|NCT00101335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24941478|NCT03990129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24941479|NCT03990129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25865608|NCT00101335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25865609|NCT00101335|Analgesics|analgesics|mesh-ancestor
25865610|NCT00101335|Sensory System Agents|sensory system agents|mesh-ancestor
25865611|NCT00101335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25201482|NCT02727504|Dobutamine|dobutamine|mesh-list
25201483|NCT02727504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25201484|NCT02727504|Sympathomimetics|sympathomimetics|mesh-ancestor
25201485|NCT02727504|Autonomic Agents|autonomic agents|mesh-ancestor
25201486|NCT02727504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25201487|NCT02727504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201488|NCT02727504|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25201489|NCT02727504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25201490|NCT02727504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25201491|NCT02727504|Adrenergic Agents|adrenergic agents|mesh-ancestor
25034905|NCT03561402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057813|NCT03502005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25057814|NCT03502005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25057815|NCT03502005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25057816|NCT03502005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057817|NCT03502005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057818|NCT03502005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25057819|NCT03502005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25057820|NCT03501901|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25057823|NCT03501680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25057824|NCT03501680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057825|NCT03501615|Immunotoxin HA22|immunotoxin ha22|mesh-list
25057826|NCT03501615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25057830|NCT03501459|Rituximab|rituximab|mesh-list
25057831|NCT03501459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25057832|NCT03501459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25057833|NCT03501459|Immunologic Factors|immunologic factors|mesh-ancestor
25057834|NCT03501459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057835|NCT03501459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25057836|NCT03501433|Niacinamide|niacinamide|mesh-list
25057837|NCT03501433|Niacin|niacin|mesh-list
25057838|NCT03501433|Nicotinic Acids|nicotinic acids|mesh-list
25057839|NCT03501433|Vitamin B Complex|vitamin b complex|mesh-ancestor
25057840|NCT03501433|Vitamins|vitamins|mesh-ancestor
25057841|NCT03501433|Micronutrients|micronutrients|mesh-ancestor
25057842|NCT03501433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669829|NCT05309564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25669830|NCT05302011|Cisplatin|cisplatin|mesh-list
25669831|NCT05302011|Carboplatin|carboplatin|mesh-list
25669832|NCT05302011|Docetaxel|docetaxel|mesh-list
25669833|NCT05302011|Pembrolizumab|pembrolizumab|mesh-list
25669834|NCT05302011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669835|NCT05302011|Tubulin Modulators|tubulin modulators|mesh-ancestor
25669836|NCT05302011|Antimitotic Agents|antimitotic agents|mesh-ancestor
25669837|NCT05302011|Mitosis Modulators|mitosis modulators|mesh-ancestor
25669838|NCT05302011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669839|NCT05302011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25669840|NCT05220748|Pembrolizumab|pembrolizumab|mesh-list
25669841|NCT05220748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25865612|NCT00101335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865613|NCT00101335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25865614|NCT00101335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25865615|NCT00101335|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25865616|NCT00101335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25865617|NCT00101335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865618|NCT00101335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865619|NCT00101348|Bevacizumab|bevacizumab|mesh-list
24883939|NCT04330430|Nivolumab|nivolumab|mesh-list
24883940|NCT04330430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24883941|NCT04330430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24883942|NCT04330430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24883943|NCT04330430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883944|NCT04315636|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25057843|NCT03501433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25057844|NCT03501433|Antimetabolites|antimetabolites|mesh-ancestor
25057845|NCT03501433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057846|NCT03501433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25057847|NCT03501433|Vasodilator Agents|vasodilator agents|mesh-ancestor
25057848|NCT03501251|Albendazole|albendazole|mesh-list
25057849|NCT03501251|Moxidectin|moxidectin|mesh-list
25057850|NCT03501251|Anthelmintics|anthelmintics|mesh-ancestor
25057851|NCT03501251|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25057852|NCT03501251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25057853|NCT03501251|Anticestodal Agents|anticestodal agents|mesh-ancestor
25057854|NCT03501251|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25057855|NCT03501251|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25057856|NCT03501251|Tubulin Modulators|tubulin modulators|mesh-ancestor
25057857|NCT03501251|Antimitotic Agents|antimitotic agents|mesh-ancestor
25865620|NCT00101348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25865621|NCT00101348|Cetuximab|cetuximab|mesh-list
25865622|NCT00101348|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25865623|NCT00101348|Antibodies|antibodies|mesh-list
25865624|NCT00101348|Immunoglobulins|immunoglobulins|mesh-list
25865625|NCT00101348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25201492|NCT02727504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25865626|NCT00101348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865627|NCT00101348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25865628|NCT00101348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25865629|NCT00101348|Growth Substances|growth substances|mesh-ancestor
25865630|NCT00101348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865631|NCT00101348|Growth Inhibitors|growth inhibitors|mesh-ancestor
25865632|NCT00101348|Immunologic Factors|immunologic factors|mesh-ancestor
25865633|NCT00101348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25865634|NCT00101348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865635|NCT00101348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865636|NCT00101374|Leflunomide|leflunomide|mesh-list
25865637|NCT00101374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865638|NCT00101374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865639|NCT00101374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25057860|NCT03501251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25057861|NCT03501251|Antinematodal Agents|antinematodal agents|mesh-ancestor
25057862|NCT03501212|Anesthetics|anesthetics|mesh-list
25057863|NCT03501212|Anesthetics, Local|anesthetics, local|mesh-list
25057867|NCT03501212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25865640|NCT00101374|Immunologic Factors|immunologic factors|mesh-ancestor
25865641|NCT00101374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865642|NCT00101426|Ranirestat|ranirestat|mesh-list
25865643|NCT00101426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865644|NCT00101426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865645|NCT00101569|Aripiprazole|aripiprazole|mesh-list
25865646|NCT00101569|Antidepressive Agents|antidepressive agents|mesh-ancestor
25865647|NCT00101569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25865648|NCT00101569|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25865649|NCT00101569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25865650|NCT00101569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25865651|NCT00101569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865652|NCT00101569|Dopamine Agonists|dopamine agonists|mesh-ancestor
25057876|NCT03500900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25057877|NCT03500900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057878|NCT03500900|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25057879|NCT03500900|Protease Inhibitors|protease inhibitors|mesh-ancestor
25057880|NCT03500900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057881|NCT03500900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865653|NCT00101569|Dopamine Agents|dopamine agents|mesh-ancestor
25225060|NCT02629718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25225061|NCT02629718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225062|NCT02629718|Tubulin Modulators|tubulin modulators|mesh-ancestor
25225063|NCT02629718|Antimitotic Agents|antimitotic agents|mesh-ancestor
25225064|NCT02629718|Mitosis Modulators|mitosis modulators|mesh-ancestor
25225065|NCT02629718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225066|NCT02629536|Acetylcysteine|acetylcysteine|mesh-list
25225067|NCT02629536|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25225068|NCT02629536|Antiviral Agents|antiviral agents|mesh-ancestor
25225069|NCT02629536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25225070|NCT02629536|Expectorants|expectorants|mesh-ancestor
25225073|NCT02629536|Antioxidants|antioxidants|mesh-ancestor
25057882|NCT03500874|Leucovorin|leucovorin|mesh-list
25057883|NCT03500874|Fluorouracil|fluorouracil|mesh-list
24463023|NCT00358358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24613163|NCT01017393|Anesthetics|anesthetics|mesh-ancestor
25865654|NCT00101569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25865655|NCT00101569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865656|NCT00101569|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25865657|NCT00101569|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25865658|NCT00101569|Serotonin Agents|serotonin agents|mesh-ancestor
25865659|NCT00101569|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25865660|NCT00101569|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25865661|NCT00101569|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25865662|NCT00101569|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25865663|NCT00101634|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25865664|NCT00101634|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25865665|NCT00101634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25865666|NCT00101634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25865667|NCT00101634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035127|NCT03559725|Dermatologic Agents|dermatologic agents|mesh-ancestor
25865668|NCT00101634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25865669|NCT00101634|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25865670|NCT00101634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25865671|NCT00101634|Serotonin Agents|serotonin agents|mesh-ancestor
25865672|NCT00101634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25865673|NCT00101634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865674|NCT00101634|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25865675|NCT00101634|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25865676|NCT00101634|Dopamine Agents|dopamine agents|mesh-ancestor
25865677|NCT00101673|Vildagliptin|vildagliptin|mesh-list
25865678|NCT00101673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25865679|NCT00101673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865680|NCT00101673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25865681|NCT00101673|Protease Inhibitors|protease inhibitors|mesh-ancestor
25865682|NCT00101673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865683|NCT00101673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865684|NCT00101712|Vildagliptin|vildagliptin|mesh-list
25865685|NCT00101712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25865686|NCT00101712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865687|NCT00101712|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25865688|NCT00101712|Protease Inhibitors|protease inhibitors|mesh-ancestor
25865689|NCT00101712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201493|NCT02727504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876779|NCT02794571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25061938|NCT05389813|Oxycodone|oxycodone|mesh-list
24816279|NCT02075671|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24816280|NCT02075671|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24816281|NCT02075671|Dermatologic Agents|dermatologic agents|mesh-ancestor
24816282|NCT02075749|Triamcinolone|triamcinolone|mesh-list
24816283|NCT02075749|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24816284|NCT02075749|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24816285|NCT02075749|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25669842|NCT05220748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669843|NCT05213169|Apomorphine|apomorphine|mesh-list
25669844|NCT05213169|Emetics|emetics|mesh-ancestor
25669845|NCT05213169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669846|NCT05213169|Autonomic Agents|autonomic agents|mesh-ancestor
25669847|NCT05213169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25669848|NCT05213169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25669849|NCT05213169|Dopamine Agonists|dopamine agonists|mesh-ancestor
25669850|NCT05213169|Dopamine Agents|dopamine agents|mesh-ancestor
25669851|NCT05213169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25669852|NCT05213169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669853|NCT05212623|Vaccines|vaccines|mesh-list
24816286|NCT02075749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24816287|NCT02075749|Glucocorticoids|glucocorticoids|mesh-ancestor
24816289|NCT02075749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24816290|NCT02075749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816296|NCT02075970|Hematinics|hematinics|mesh-ancestor
24816297|NCT02076191|Decitabine|decitabine|mesh-list
24816298|NCT02076191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25057952|NCT03500445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25057954|NCT03500445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25057955|NCT03500445|Immunologic Factors|immunologic factors|mesh-ancestor
25057956|NCT03500445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25057957|NCT03500445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25057958|NCT03500445|Growth Substances|growth substances|mesh-ancestor
25057959|NCT03500445|Growth Inhibitors|growth inhibitors|mesh-ancestor
25057960|NCT03500432|Lidocaine|lidocaine|mesh-list
25057961|NCT03500432|Anesthetics, Local|anesthetics, local|mesh-ancestor
25057962|NCT03500432|Anesthetics|anesthetics|mesh-ancestor
25057963|NCT03500432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25057964|NCT03500432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057965|NCT03500432|Sensory System Agents|sensory system agents|mesh-ancestor
25057966|NCT03500432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25057967|NCT03500432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24575421|NCT00831506|Digoxin|digoxin|mesh-list
25865690|NCT00101712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865691|NCT00101738|Mycophenolic Acid|mycophenolic acid|mesh-list
25865692|NCT00101738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25865693|NCT00101738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865694|NCT00101738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25865695|NCT00101738|Antitubercular Agents|antitubercular agents|mesh-ancestor
25865696|NCT00101738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25865697|NCT00101738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25865698|NCT00101738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865699|NCT00101738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865700|NCT00101751|Insulin Aspart|insulin aspart|mesh-list
25865701|NCT00101751|Biphasic Insulins|biphasic insulins|mesh-list
25865702|NCT00101751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25865703|NCT00101751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865704|NCT00101764|Triamcinolone|triamcinolone|mesh-list
25865705|NCT00101764|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25865706|NCT00101764|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25865707|NCT00101764|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25865708|NCT00101764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25865709|NCT00101764|Glucocorticoids|glucocorticoids|mesh-ancestor
25865710|NCT00101764|Hormones|hormones|mesh-ancestor
25865711|NCT00101764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25865712|NCT00101764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865713|NCT00101764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25865714|NCT00101764|Immunologic Factors|immunologic factors|mesh-ancestor
25865715|NCT00101764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865716|NCT00101764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816309|NCT02076373|Hematinics|hematinics|mesh-ancestor
24816310|NCT02076386|Dolutegravir|dolutegravir|mesh-list
24816311|NCT02076386|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24816312|NCT02076386|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24501423|NCT00528515|Propofol|propofol|mesh-list
24816313|NCT02076386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865717|NCT00101790|Pamidronate|pamidronate|mesh-list
25057993|NCT03500133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057995|NCT03500133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25057996|NCT03500133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25057997|NCT03500133|Immunologic Factors|immunologic factors|mesh-ancestor
25057998|NCT03500133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057999|NCT03500133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24406968|NCT00171652|Diclofenac|diclofenac|mesh-list
24884006|NCT03717623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463108|NCT00358748|Hydrocortisone|hydrocortisone|mesh-list
25058006|NCT03500133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25058007|NCT03500133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24884015|NCT03613506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24884016|NCT03571633|Paclitaxel|paclitaxel|mesh-list
24884017|NCT03571633|Trastuzumab|trastuzumab|mesh-list
24884018|NCT03571633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24884019|NCT03571633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865718|NCT00101790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25865719|NCT00101790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103180|NCT03164161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25103181|NCT03164161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865720|NCT00101803|Vildagliptin|vildagliptin|mesh-list
25865721|NCT00101803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25865722|NCT00101803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865723|NCT00101803|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25865724|NCT00101803|Protease Inhibitors|protease inhibitors|mesh-ancestor
25865725|NCT00101803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865726|NCT00101803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865727|NCT00101829|Rituximab|rituximab|mesh-list
25865728|NCT00101829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25865729|NCT00101829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865730|NCT00101829|Immunologic Factors|immunologic factors|mesh-ancestor
25865731|NCT00101829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884021|NCT03571633|Antimitotic Agents|antimitotic agents|mesh-ancestor
25865732|NCT00101829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25865733|NCT00101842|Gemcitabine|gemcitabine|mesh-list
25865734|NCT00101842|Pemetrexed|pemetrexed|mesh-list
25865735|NCT00101842|Cisplatin|cisplatin|mesh-list
25865736|NCT00101842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25865737|NCT00101842|Antimetabolites|antimetabolites|mesh-ancestor
25865738|NCT00101842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865739|NCT00101842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865740|NCT00101842|Antiviral Agents|antiviral agents|mesh-ancestor
25865741|NCT00101842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25865742|NCT00101842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865743|NCT00101842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25865744|NCT00101842|Immunologic Factors|immunologic factors|mesh-ancestor
25201495|NCT02727309|Apatinib|apatinib|mesh-list
25201496|NCT02727309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865745|NCT00101842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865746|NCT00101842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25058030|NCT03499886|Anesthetics, General|anesthetics, general|mesh-ancestor
24820048|NCT02098499|Dermatologic Agents|dermatologic agents|mesh-ancestor
24820049|NCT02098499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24820050|NCT02098499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24820051|NCT02098499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24820052|NCT02098499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25865747|NCT00101842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25865748|NCT00101894|Panitumumab|panitumumab|mesh-list
25865749|NCT00101894|Motesanib diphosphate|motesanib diphosphate|mesh-list
25865750|NCT00101894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25865751|NCT00101894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865752|NCT00101894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25865753|NCT00101894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865754|NCT00101894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865755|NCT00101998|Alvimopan|alvimopan|mesh-list
25865756|NCT00101998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24884048|NCT03439085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884049|NCT03439085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24884050|NCT03439085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865757|NCT00102050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
25865758|NCT00102050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505139|NCT00540098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24505141|NCT00540098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24588766|NCT00904202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24505157|NCT00540137|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24505158|NCT00540137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24505161|NCT00540137|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24505162|NCT00540137|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24505165|NCT00540202|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25669854|NCT05212623|Immunologic Factors|immunologic factors|mesh-ancestor
25669855|NCT05212623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669856|NCT05192265|Artesunate|artesunate|mesh-list
25669857|NCT05192265|Lumefantrine|lumefantrine|mesh-list
25669858|NCT05192265|Artemether|artemether|mesh-list
25669859|NCT05192265|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25669860|NCT05192265|Pyronaridine|pyronaridine|mesh-list
25669861|NCT05192265|Antimalarials|antimalarials|mesh-list
25669862|NCT05192265|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25669863|NCT05192265|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25669864|NCT05192265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25669865|NCT05192265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669866|NCT05192265|Antiviral Agents|antiviral agents|mesh-ancestor
25669867|NCT05192265|Schistosomicides|schistosomicides|mesh-ancestor
25103357|NCT03162367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25103362|NCT03162185|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25103363|NCT03162185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24505166|NCT00540202|Quinine|quinine|mesh-list
24505167|NCT00540202|Antimalarials|antimalarials|mesh-ancestor
24505168|NCT00540202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24505169|NCT00540202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24505170|NCT00540202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24505171|NCT00540202|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24505172|NCT00540202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505173|NCT00540202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25058038|NCT03499743|Scopolamine|scopolamine|mesh-list
25058039|NCT03499743|Bromides|bromides|mesh-list
25058040|NCT03499743|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25058041|NCT03499743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24505174|NCT00540202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25865759|NCT00102050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865760|NCT00102115|Talaporfin|talaporfin|mesh-list
25865761|NCT00102115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865762|NCT00102115|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25865763|NCT00102115|Dermatologic Agents|dermatologic agents|mesh-ancestor
24884081|NCT03367156|Dexamethasone|dexamethasone|mesh-list
24884082|NCT03367156|Dexamethasone acetate|dexamethasone acetate|mesh-list
25865764|NCT00102141|Drospirenone|drospirenone|mesh-list
25865765|NCT00102141|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25865766|NCT00102141|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25865767|NCT00102141|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24884086|NCT03367156|Antiemetics|antiemetics|mesh-ancestor
24884087|NCT03367156|Autonomic Agents|autonomic agents|mesh-ancestor
24884088|NCT03367156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24884089|NCT03367156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884090|NCT03367156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24884091|NCT03367156|Glucocorticoids|glucocorticoids|mesh-ancestor
24884092|NCT03367156|Hormones|hormones|mesh-ancestor
24884093|NCT03367156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24505196|NCT00540345|Ribavirin|ribavirin|mesh-list
24505197|NCT00540345|Interferon-alpha|interferon-alpha|mesh-list
24505198|NCT00540345|Interferon alpha-2|interferon alpha-2|mesh-list
25058042|NCT03499743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25865768|NCT00102141|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
25865769|NCT00102141|Estradiol|estradiol|mesh-list
25865770|NCT00102141|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25865771|NCT00102141|Estrogens|estrogens|mesh-ancestor
25865772|NCT00102141|Hormones|hormones|mesh-ancestor
25865773|NCT00102141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25865774|NCT00102141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865775|NCT00102141|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25865776|NCT00102141|Contraceptive Agents|contraceptive agents|mesh-ancestor
25865777|NCT00102141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25865778|NCT00102141|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25865779|NCT00102141|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25865780|NCT00102141|Hormone Antagonists|hormone antagonists|mesh-ancestor
25865781|NCT00102141|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25865782|NCT00102141|Diuretics|diuretics|mesh-ancestor
25865783|NCT00102141|Natriuretic Agents|natriuretic agents|mesh-ancestor
25865784|NCT00102141|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25865785|NCT00102141|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25865786|NCT00102154|Gaboxadol|gaboxadol|mesh-list
24505240|NCT00540605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24505241|NCT00540605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24505242|NCT00540696|Darbepoetin alfa|darbepoetin alfa|mesh-list
24505243|NCT00540696|Hematinics|hematinics|mesh-ancestor
24505244|NCT00540709|Insulin Glargine|insulin glargine|mesh-list
25669868|NCT05192265|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25669869|NCT05192265|Anthelmintics|anthelmintics|mesh-ancestor
25669870|NCT05176509|Pembrolizumab|pembrolizumab|mesh-list
25669871|NCT05176509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24505245|NCT00540709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24505246|NCT00540709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505290|NCT00540800|Capecitabine|capecitabine|mesh-list
24505291|NCT00540800|Epirubicin|epirubicin|mesh-list
25669872|NCT05176509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669873|NCT05167643|Anastrozole|anastrozole|mesh-list
25669874|NCT05167643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25669875|NCT05167643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669876|NCT05167643|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24838648|NCT02199327|Mitomycins|mitomycins|mesh-list
24505292|NCT00540800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505293|NCT00540800|Tubulin Modulators|tubulin modulators|mesh-ancestor
24505294|NCT00540800|Antimitotic Agents|antimitotic agents|mesh-ancestor
24505295|NCT00540800|Mitosis Modulators|mitosis modulators|mesh-ancestor
24884097|NCT03367156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24884098|NCT03367156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884099|NCT03367156|Dermatologic Agents|dermatologic agents|mesh-ancestor
24884102|NCT03252925|Acetylcysteine|acetylcysteine|mesh-list
24884103|NCT03252925|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24884104|NCT03252925|Antiviral Agents|antiviral agents|mesh-ancestor
24884105|NCT03252925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24884106|NCT03252925|Expectorants|expectorants|mesh-ancestor
24884107|NCT03252925|Respiratory System Agents|respiratory system agents|mesh-ancestor
24884108|NCT03252925|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24884109|NCT03252925|Antioxidants|antioxidants|mesh-ancestor
24884110|NCT03252925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884111|NCT03252925|Protective Agents|protective agents|mesh-ancestor
24884112|NCT03252925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884113|NCT03252925|Antidotes|antidotes|mesh-ancestor
25058056|NCT03499743|Autonomic Agents|autonomic agents|mesh-ancestor
25058057|NCT03499743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25058063|NCT03499743|Parasympatholytics|parasympatholytics|mesh-ancestor
25058064|NCT03499730|Midazolam|midazolam|mesh-list
25058065|NCT03499730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25058066|NCT03499730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25058067|NCT03499730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25058068|NCT03499730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058069|NCT03499730|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25058070|NCT03499730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25058071|NCT03499730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25058072|NCT03499730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25058073|NCT03499730|Anesthetics, General|anesthetics, general|mesh-ancestor
25058074|NCT03499730|Anesthetics|anesthetics|mesh-ancestor
25058075|NCT03499730|GABA Modulators|gaba modulators|mesh-ancestor
24505336|NCT00540956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24505337|NCT00540956|Antimetabolites|antimetabolites|mesh-ancestor
25865787|NCT00102154|Analgesics|analgesics|mesh-ancestor
25865788|NCT00102154|Sensory System Agents|sensory system agents|mesh-ancestor
25865789|NCT00102154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25865790|NCT00102154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865791|NCT00102154|Anticonvulsants|anticonvulsants|mesh-ancestor
25865792|NCT00102154|GABA Agonists|gaba agonists|mesh-ancestor
25058076|NCT03499730|GABA Agents|gaba agents|mesh-ancestor
25058077|NCT03499730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25058078|NCT03499730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058080|NCT03499639|Ribavirin|ribavirin|mesh-list
25058081|NCT03499639|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25058082|NCT03499639|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25058083|NCT03499639|Protease Inhibitors|protease inhibitors|mesh-ancestor
25058084|NCT03499639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820099|NCT02098785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25201497|NCT02727309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25094551|NCT03225352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24820100|NCT02098785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24820101|NCT02098785|Purinergic Agents|purinergic agents|mesh-ancestor
24820102|NCT02098785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24820104|NCT02098824|Galantamine|galantamine|mesh-list
24820105|NCT02098824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24407665|NCT00174928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24884117|NCT03092453|Immunologic Factors|immunologic factors|mesh-ancestor
24884118|NCT03092453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884119|NCT03092453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24884120|NCT03092453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25035723|NCT03553433|Apremilast|apremilast|mesh-list
24505366|NCT00541021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505367|NCT00541021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24505369|NCT00541047|Goserelin|goserelin|mesh-list
24505370|NCT00541047|Bicalutamide|bicalutamide|mesh-list
24505371|NCT00541047|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25674476|NCT01772537|Propofol|propofol|mesh-list
25674477|NCT01772537|Isoflurane|isoflurane|mesh-list
25674478|NCT01772537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25674479|NCT01772537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25674480|NCT01772537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674481|NCT01772537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25674482|NCT01772537|Anesthetics, General|anesthetics, general|mesh-ancestor
25674483|NCT01772537|Anesthetics|anesthetics|mesh-ancestor
25103591|NCT03160001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25103592|NCT03160001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24505372|NCT00541047|Fertility Agents|fertility agents|mesh-ancestor
24505373|NCT00541047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24505374|NCT00541047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058085|NCT03499639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058086|NCT03499639|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25058087|NCT03499639|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25058088|NCT03499639|Antiviral Agents|antiviral agents|mesh-ancestor
25058089|NCT03499639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25058090|NCT03499639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24680650|NCT01375816|Leucovorin|leucovorin|mesh-list
24505375|NCT00541047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24505376|NCT00541047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505377|NCT00541047|Androgen Antagonists|androgen antagonists|mesh-ancestor
24505378|NCT00541047|Hormone Antagonists|hormone antagonists|mesh-ancestor
25865793|NCT00102154|GABA Agents|gaba agents|mesh-ancestor
24884128|NCT02976337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884130|NCT02976337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24884131|NCT02963714|Vaccines|vaccines|mesh-list
24505444|NCT00541125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24505478|NCT00541164|Vitamins|vitamins|mesh-ancestor
24505479|NCT00541177|Atropine|atropine|mesh-list
24505480|NCT00541177|Tropicamide|tropicamide|mesh-list
24505498|NCT00541216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505499|NCT00541216|Sympathomimetics|sympathomimetics|mesh-ancestor
24505500|NCT00541216|Autonomic Agents|autonomic agents|mesh-ancestor
24505501|NCT00541216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24505502|NCT00541216|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24505503|NCT00541216|Adrenergic Agents|adrenergic agents|mesh-ancestor
24505564|NCT00541463|Indinavir|indinavir|mesh-list
24505581|NCT00541489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505582|NCT00541489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24505583|NCT00541489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24505584|NCT00541489|Gout Suppressants|gout suppressants|mesh-ancestor
24505585|NCT00541489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24894355|NCT04441918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24505606|NCT00541554|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24505607|NCT00541554|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24505608|NCT00541554|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24505610|NCT00541567|Ibipinabant|ibipinabant|mesh-list
24505611|NCT00541567|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24505612|NCT00541567|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24505613|NCT00541567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24505614|NCT00541567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505619|NCT00541710|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24505620|NCT00541710|Protective Agents|protective agents|mesh-ancestor
24505621|NCT00541710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884168|NCT02817789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24884169|NCT02813200|Tiotropium Bromide|tiotropium bromide|mesh-list
24884170|NCT02813200|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25201498|NCT02727309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24884171|NCT02813200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24463265|NCT00359697|Natriuretic Agents|natriuretic agents|mesh-ancestor
24505633|NCT00541723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24941777|NCT03988075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24941778|NCT03988075|Analgesics|analgesics|mesh-ancestor
24766781|NCT01796730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766782|NCT01796730|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24766783|NCT01796730|Respiratory System Agents|respiratory system agents|mesh-ancestor
24766784|NCT01796782|Capecitabine|capecitabine|mesh-list
24505634|NCT00541723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505635|NCT00541723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24505636|NCT00541723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24505637|NCT00541723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505638|NCT00541723|Cholinergic Agents|cholinergic agents|mesh-ancestor
24505639|NCT00541723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24505640|NCT00541736|Nitroglycerin|nitroglycerin|mesh-list
24505641|NCT00541736|Vasodilator Agents|vasodilator agents|mesh-ancestor
24505642|NCT00541814|Cyclosporine|cyclosporine|mesh-list
24505643|NCT00541814|Cyclosporins|cyclosporins|mesh-list
24884180|NCT02813200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25669877|NCT05167643|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25669878|NCT05167643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865794|NCT00102154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24884181|NCT02813200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884182|NCT02813200|Glucocorticoids|glucocorticoids|mesh-ancestor
24884184|NCT02813200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24884185|NCT02813200|Sympathomimetics|sympathomimetics|mesh-ancestor
25865795|NCT00102154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865796|NCT00102167|Gaboxadol|gaboxadol|mesh-list
25865797|NCT00102167|Analgesics|analgesics|mesh-ancestor
25865798|NCT00102167|Sensory System Agents|sensory system agents|mesh-ancestor
25865799|NCT00102167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24505707|NCT00542074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24505709|NCT00542126|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24505710|NCT00542126|Luteolytic Agents|luteolytic agents|mesh-ancestor
24505711|NCT00542126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24505712|NCT00542126|Contraceptive Agents|contraceptive agents|mesh-ancestor
24505713|NCT00542126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24505714|NCT00542126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505715|NCT00542126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24505716|NCT00542126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24884341|NCT01258803|Mometasone Furoate|mometasone furoate|mesh-list
24505717|NCT00542126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505718|NCT00542139|Betamethasone|betamethasone|mesh-list
24766785|NCT01796782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24766786|NCT01796782|Antimetabolites|antimetabolites|mesh-ancestor
24766787|NCT01796782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941781|NCT03988075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941782|NCT03988075|Antipyretics|antipyretics|mesh-ancestor
24505752|NCT00542243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865800|NCT00102167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865801|NCT00102167|Anticonvulsants|anticonvulsants|mesh-ancestor
24505767|NCT00542347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24505768|NCT00542347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24505769|NCT00542347|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25865802|NCT00102167|GABA Agonists|gaba agonists|mesh-ancestor
24941786|NCT03988075|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24941787|NCT03988075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24941788|NCT03988075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941789|NCT03988075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24941790|NCT03988075|Narcotics|narcotics|mesh-ancestor
24941791|NCT03988075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24941792|NCT03988075|Antitussive Agents|antitussive agents|mesh-ancestor
25058097|NCT03499444|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25058098|NCT03499444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058099|NCT03499444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058100|NCT03499444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25058101|NCT03499379|Levonorgestrel|levonorgestrel|mesh-list
25058102|NCT03499379|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25058103|NCT03499379|Contraceptive Agents|contraceptive agents|mesh-ancestor
25058104|NCT03499379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25058105|NCT03499379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865803|NCT00102167|GABA Agents|gaba agents|mesh-ancestor
24724780|NCT01594697|Metformin|metformin|mesh-list
25058106|NCT03499379|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25058107|NCT03499379|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25058108|NCT03499379|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25865804|NCT00102167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25865805|NCT00102167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865806|NCT00102206|Ritonavir|ritonavir|mesh-list
25865807|NCT00102206|Lopinavir|lopinavir|mesh-list
25865808|NCT00102206|Saquinavir|saquinavir|mesh-list
25865809|NCT00102206|Tenofovir|tenofovir|mesh-list
25865810|NCT00102206|Lamivudine|lamivudine|mesh-list
25865811|NCT00102206|Zidovudine|zidovudine|mesh-list
25865812|NCT00102206|Emtricitabine|emtricitabine|mesh-list
25036012|NCT03551171|Niraparib|niraparib|mesh-list
24505778|NCT00542412|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24884195|NCT02744742|Alkylating Agents|alkylating agents|mesh-ancestor
24884196|NCT02744742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884197|NCT02744742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24884198|NCT02744742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24884199|NCT02744742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24884200|NCT02744742|Antimetabolites|antimetabolites|mesh-ancestor
24884201|NCT02744742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24884202|NCT02744742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25865813|NCT00102206|Abacavir|abacavir|mesh-list
24884204|NCT02687386|Analgesics|analgesics|mesh-ancestor
24884205|NCT02687386|Sensory System Agents|sensory system agents|mesh-ancestor
24884206|NCT02687386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25865814|NCT00102206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24505842|NCT00542802|Nootropic Agents|nootropic agents|mesh-ancestor
24505843|NCT00542802|Antimanic Agents|antimanic agents|mesh-ancestor
25865815|NCT00102206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24505880|NCT00543023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505881|NCT00543023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24505882|NCT00543023|Vasodilator Agents|vasodilator agents|mesh-ancestor
24505883|NCT00543049|Sunitinib|sunitinib|mesh-list
24505884|NCT00543049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505885|NCT00543049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24505886|NCT00543049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24505887|NCT00543049|Growth Substances|growth substances|mesh-ancestor
24505888|NCT00543049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505889|NCT00543049|Growth Inhibitors|growth inhibitors|mesh-ancestor
24505890|NCT00543049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24505891|NCT00543049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505892|NCT00543049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505893|NCT00543075|Oblimersen|oblimersen|mesh-list
24505938|NCT00543335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505939|NCT00543335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24505940|NCT00543335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058122|NCT03499223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25058123|NCT03499223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25058124|NCT03499223|Growth Substances|growth substances|mesh-ancestor
25058125|NCT03499223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058126|NCT03499223|Growth Inhibitors|growth inhibitors|mesh-ancestor
25058127|NCT03499223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25058128|NCT03499184|Metronidazole|metronidazole|mesh-list
25058129|NCT03499184|Amoxicillin|amoxicillin|mesh-list
25058130|NCT03499184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25058131|NCT03499184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25058132|NCT03499184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25058133|NCT03499184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25201499|NCT02727309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505941|NCT00543335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505943|NCT00543361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24884240|NCT02628405|Etoposide phosphate|etoposide phosphate|mesh-list
24884241|NCT02628405|Ifosfamide|ifosfamide|mesh-list
24884242|NCT02628405|Isophosphamide mustard|isophosphamide mustard|mesh-list
24884243|NCT02628405|Podophyllotoxin|podophyllotoxin|mesh-list
24884244|NCT02628405|Antibodies|antibodies|mesh-list
24884245|NCT02628405|Immunoglobulins|immunoglobulins|mesh-list
24884246|NCT02628405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24884247|NCT02628405|Immunologic Factors|immunologic factors|mesh-ancestor
24884248|NCT02628405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884249|NCT02628405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24884276|NCT02479646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24884277|NCT02479646|Immunologic Factors|immunologic factors|mesh-ancestor
24884278|NCT02479646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505948|NCT00543413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505949|NCT00543413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505950|NCT00543413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25058135|NCT03499171|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25058136|NCT03499171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25083011|NCT03318536|Serotonin|serotonin|mesh-list
25058137|NCT03499171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25058138|NCT03499171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058139|NCT03499171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25865816|NCT00102206|Protease Inhibitors|protease inhibitors|mesh-ancestor
25865817|NCT00102206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865818|NCT00102206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865819|NCT00102206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25865820|NCT00102206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25865821|NCT00102206|Antiviral Agents|antiviral agents|mesh-ancestor
25865822|NCT00102206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25865823|NCT00102206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25865824|NCT00102206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25865825|NCT00102206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24884287|NCT02472964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884288|NCT02472964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24506003|NCT00543686|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24506004|NCT00543686|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24506005|NCT00543686|Hormone Antagonists|hormone antagonists|mesh-ancestor
24506006|NCT00543686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24506007|NCT00543686|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24506008|NCT00543686|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24506009|NCT00543686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506010|NCT00543829|Tamoxifen|tamoxifen|mesh-list
24506011|NCT00543829|Docetaxel|docetaxel|mesh-list
24506012|NCT00543829|Doxorubicin|doxorubicin|mesh-list
25058152|NCT03499106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25058153|NCT03499106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25058154|NCT03499106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058155|NCT03499106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058156|NCT03499106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25058157|NCT03499106|Hormone Antagonists|hormone antagonists|mesh-ancestor
25058158|NCT03499106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25058159|NCT03499106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506017|NCT00543829|Mitosis Modulators|mitosis modulators|mesh-ancestor
24506018|NCT00543829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506019|NCT00543829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24506020|NCT00543829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24506021|NCT00543829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24506022|NCT00543829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506023|NCT00543829|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24506024|NCT00543829|Hormone Antagonists|hormone antagonists|mesh-ancestor
24506025|NCT00543829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24506026|NCT00543829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506027|NCT00543829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24506097|NCT00544063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506098|NCT00544063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24506099|NCT00544063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24506100|NCT00544063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506101|NCT00544063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506102|NCT00544128|Ritonavir|ritonavir|mesh-list
24506103|NCT00544128|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24506104|NCT00544128|Tenofovir|tenofovir|mesh-list
24506105|NCT00544128|Lamivudine|lamivudine|mesh-list
24506106|NCT00544128|Emtricitabine|emtricitabine|mesh-list
24506107|NCT00544128|Abacavir|abacavir|mesh-list
24506108|NCT00544128|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24506109|NCT00544128|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24506110|NCT00544128|Protease Inhibitors|protease inhibitors|mesh-ancestor
24506111|NCT00544128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506112|NCT00544128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506113|NCT00544128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24884290|NCT02467868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24884291|NCT02467868|Immunologic Factors|immunologic factors|mesh-ancestor
25058160|NCT03499106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25058161|NCT03499106|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
24506122|NCT00544154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24506124|NCT00544154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506125|NCT00544154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24506126|NCT00544180|Risedronic Acid|risedronic acid|mesh-list
24506127|NCT00544180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24506128|NCT00544180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24506129|NCT00544180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506130|NCT00544180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24506131|NCT00544180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506132|NCT00544180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24506134|NCT00544193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24506135|NCT00544193|Antimetabolites|antimetabolites|mesh-ancestor
25058192|NCT03498534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25058193|NCT03498534|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24820230|NCT02099240|Polymyxins|polymyxins|mesh-list
24820231|NCT02099240|Nitrofurantoin|nitrofurantoin|mesh-list
24884300|NCT02402920|Etoposide|etoposide|mesh-list
24884301|NCT02402920|Etoposide phosphate|etoposide phosphate|mesh-list
24884302|NCT02402920|Podophyllotoxin|podophyllotoxin|mesh-list
24884303|NCT02402920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25036295|NCT03549026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25058199|NCT03498456|Clarithromycin|clarithromycin|mesh-list
25058200|NCT03498456|Lansoprazole|lansoprazole|mesh-list
25058202|NCT03498456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25058203|NCT03498456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25058204|NCT03498456|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25058205|NCT03498456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058206|NCT03498456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058207|NCT03498456|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25058208|NCT03498456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25058209|NCT03498456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25058210|NCT03498456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25058211|NCT03498456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24820256|NCT02099240|Dicloxacillin|dicloxacillin|mesh-list
24506254|NCT00544505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506255|NCT00544505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25865826|NCT00102206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24884319|NCT01889303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24884320|NCT01889303|Tubulin Modulators|tubulin modulators|mesh-ancestor
24884321|NCT01889303|Antimitotic Agents|antimitotic agents|mesh-ancestor
24884322|NCT01889303|Mitosis Modulators|mitosis modulators|mesh-ancestor
24506258|NCT00544505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506260|NCT00544505|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24506261|NCT00544505|Antimetabolites|antimetabolites|mesh-ancestor
24506262|NCT00544505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24506263|NCT00544505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24506264|NCT00544505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25058213|NCT03498417|Immunologic Factors|immunologic factors|mesh-ancestor
25058214|NCT03498417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058215|NCT03498326|Gemcitabine|gemcitabine|mesh-list
25058216|NCT03498326|Celecoxib|celecoxib|mesh-list
25058217|NCT03498326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25058218|NCT03498326|Antimetabolites|antimetabolites|mesh-ancestor
25058224|NCT03498326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25058225|NCT03498326|Immunologic Factors|immunologic factors|mesh-ancestor
25058226|NCT03498326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513820|NCT00585442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058227|NCT03498326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25058228|NCT03498326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25058229|NCT03498326|Analgesics|analgesics|mesh-ancestor
25058230|NCT03498326|Sensory System Agents|sensory system agents|mesh-ancestor
25058231|NCT03498326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24506265|NCT00544505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25865827|NCT00102206|Antimetabolites|antimetabolites|mesh-ancestor
25865828|NCT00102219|Doxorubicin|doxorubicin|mesh-list
25865829|NCT00102219|Pemetrexed|pemetrexed|mesh-list
25865830|NCT00102219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25865831|NCT00102219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865832|NCT00102219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25865833|NCT00102219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25865834|NCT00102219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506274|NCT00544518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24506275|NCT00544518|Appetite Depressants|appetite depressants|mesh-ancestor
24506276|NCT00544518|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24506277|NCT00544570|Cyclophosphamide|cyclophosphamide|mesh-list
24506279|NCT00544570|Carmustine|carmustine|mesh-list
24506280|NCT00544570|Etoposide|etoposide|mesh-list
24506281|NCT00544570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25865835|NCT00102219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865836|NCT00102219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25865837|NCT00102219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25058232|NCT03498326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25058233|NCT03498326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25058234|NCT03498326|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25058235|NCT03498326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25058237|NCT03498261|Analgesics|analgesics|mesh-ancestor
25058238|NCT03498261|Sensory System Agents|sensory system agents|mesh-ancestor
25058239|NCT03498261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25058240|NCT03498261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058241|NCT03498261|Anticonvulsants|anticonvulsants|mesh-ancestor
25058242|NCT03498261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25058243|NCT03498261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25058244|NCT03498261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25058245|NCT03498261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25058246|NCT03498261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25865838|NCT00102258|Hormones|hormones|mesh-list
25104296|NCT03154125|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25104297|NCT03154125|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25104298|NCT03154125|Contraceptive Agents|contraceptive agents|mesh-ancestor
25104299|NCT03154125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25104310|NCT03153813|Antipruritics|antipruritics|mesh-ancestor
25104311|NCT03153813|Dermatologic Agents|dermatologic agents|mesh-ancestor
25104312|NCT03153813|Sensory System Agents|sensory system agents|mesh-ancestor
25104313|NCT03153813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25104314|NCT03153813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058247|NCT03498261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25058248|NCT03498261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25865839|NCT00102258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25865840|NCT00102258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865841|NCT00102271|Oxypurinol|oxypurinol|mesh-list
24506308|NCT00544596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24506309|NCT00544596|Immunologic Factors|immunologic factors|mesh-ancestor
24506310|NCT00544596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506311|NCT00544596|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25036388|NCT03547895|Hemostatics|hemostatics|mesh-ancestor
25058252|NCT03498248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25058253|NCT03498248|Immunologic Factors|immunologic factors|mesh-ancestor
25058254|NCT03498248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058256|NCT03498235|Sevoflurane|sevoflurane|mesh-list
25058257|NCT03498235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25058258|NCT03498235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25058259|NCT03498235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058260|NCT03498235|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25058261|NCT03498235|Anesthetics, General|anesthetics, general|mesh-ancestor
25058262|NCT03498235|Anesthetics|anesthetics|mesh-ancestor
25058263|NCT03498235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25058264|NCT03498235|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25058265|NCT03498222|Carboplatin|carboplatin|mesh-list
25058266|NCT03498222|Pemetrexed|pemetrexed|mesh-list
25058267|NCT03498222|Atezolizumab|atezolizumab|mesh-list
25058268|NCT03498222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506432|NCT00545246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506433|NCT00545246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24506446|NCT00545389|Mesalamine|mesalamine|mesh-list
24506447|NCT00545389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24506448|NCT00545389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24506449|NCT00545389|Analgesics|analgesics|mesh-ancestor
24506450|NCT00545389|Sensory System Agents|sensory system agents|mesh-ancestor
24506451|NCT00545389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24506452|NCT00545389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506453|NCT00545389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25865842|NCT00102271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506457|NCT00545467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24506458|NCT00545467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24506459|NCT00545467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24506460|NCT00545467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25058269|NCT03498222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058270|NCT03498222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058271|NCT03498222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25058272|NCT03498222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25058273|NCT03498170|Itraconazole|itraconazole|mesh-list
25058274|NCT03498170|Acumapimod|acumapimod|mesh-list
25058275|NCT03498170|Antifungal Agents|antifungal agents|mesh-ancestor
25058276|NCT03498170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25058277|NCT03498170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24506461|NCT00545467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506462|NCT00545467|Dopamine Agonists|dopamine agonists|mesh-ancestor
24506463|NCT00545467|Dopamine Agents|dopamine agents|mesh-ancestor
24884358|NCT01104922|Cetuximab|cetuximab|mesh-list
24884359|NCT01104922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24884360|NCT01104922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24884361|NCT00862251|Atorvastatin|atorvastatin|mesh-list
25669879|NCT05167643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669880|NCT05167643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25669881|NCT05167643|Hormone Antagonists|hormone antagonists|mesh-ancestor
25669882|NCT05167643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25669883|NCT05167643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669884|NCT05161338|Estradiol|estradiol|mesh-list
25669885|NCT05161338|Progesterone|progesterone|mesh-list
25669886|NCT05161338|Estrogens|estrogens|mesh-ancestor
25669887|NCT05161338|Hormones|hormones|mesh-ancestor
25104438|NCT03152955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24884362|NCT00862251|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24884363|NCT00862251|Simvastatin|simvastatin|mesh-list
24884364|NCT00862251|Ezetimibe|ezetimibe|mesh-list
24884365|NCT00862251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24884366|NCT00862251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24506480|NCT00545493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24506481|NCT00545493|Immunologic Factors|immunologic factors|mesh-ancestor
24506482|NCT00545493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865843|NCT00102271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865844|NCT00102284|Levodopa|levodopa|mesh-list
25865845|NCT00102284|Modafinil|modafinil|mesh-list
25865846|NCT00102284|Rivastigmine|rivastigmine|mesh-list
24511536|NCT00569452|Insulin|insulin|mesh-list
24506497|NCT00545558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24506498|NCT00545558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506499|NCT00545558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506500|NCT00545558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24506501|NCT00545558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24506502|NCT00545558|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24506503|NCT00545558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24506504|NCT00545558|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24506505|NCT00545558|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24506506|NCT00545558|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24884368|NCT00862251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816324|NCT02076477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24884369|NCT00862251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24884370|NCT00862251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25058278|NCT03498170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25058279|NCT03498170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058280|NCT03498170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058281|NCT03498170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25058282|NCT03498170|Hormone Antagonists|hormone antagonists|mesh-ancestor
25058283|NCT03498170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25058284|NCT03498170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058285|NCT03498170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25058286|NCT03498170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25058288|NCT03498118|Anesthetics, Local|anesthetics, local|mesh-ancestor
24884381|NCT00782184|Atorvastatin|atorvastatin|mesh-list
24506507|NCT00545558|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24506508|NCT00545675|Valproic Acid|valproic acid|mesh-list
24506509|NCT00545675|Aripiprazole|aripiprazole|mesh-list
24511610|NCT00569816|Anesthetics|anesthetics|mesh-ancestor
24506520|NCT00545675|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24506521|NCT00545675|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24506523|NCT00545675|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24506524|NCT00545675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24506525|NCT00545675|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24506526|NCT00545675|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24506527|NCT00545675|Anticonvulsants|anticonvulsants|mesh-ancestor
24506528|NCT00545675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506537|NCT00545857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506539|NCT00545870|Ranibizumab|ranibizumab|mesh-list
24506540|NCT00545870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24884383|NCT00782184|Ezetimibe|ezetimibe|mesh-list
24884384|NCT00782184|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
25058295|NCT03498092|Bupivacaine|bupivacaine|mesh-list
25058296|NCT03498092|Anesthetics, Local|anesthetics, local|mesh-ancestor
25058297|NCT03498092|Anesthetics|anesthetics|mesh-ancestor
25058298|NCT03498092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25058299|NCT03498092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058300|NCT03498092|Sensory System Agents|sensory system agents|mesh-ancestor
25058301|NCT03498092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25058302|NCT03498092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25058303|NCT03498092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25058304|NCT03498092|Analgesics|analgesics|mesh-ancestor
25058305|NCT03498092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25058306|NCT03498092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25058307|NCT03498092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25058308|NCT03498092|Adrenergic Agents|adrenergic agents|mesh-ancestor
25058309|NCT03498092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25674484|NCT01772537|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25865847|NCT00102284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25225163|NCT02628704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225164|NCT02628847|Sildenafil Citrate|sildenafil citrate|mesh-list
25225165|NCT02628847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225166|NCT02628847|Vasodilator Agents|vasodilator agents|mesh-ancestor
25225167|NCT02628847|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24506544|NCT00545870|Growth Substances|growth substances|mesh-ancestor
24506545|NCT00545870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506546|NCT00545870|Growth Inhibitors|growth inhibitors|mesh-ancestor
24506547|NCT00545909|Ibandronic Acid|ibandronic acid|mesh-list
24506548|NCT00545909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24506549|NCT00545909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506550|NCT00545935|Artesunate|artesunate|mesh-list
24506551|NCT00545935|Amodiaquine|amodiaquine|mesh-list
24506552|NCT00545935|Antimalarials|antimalarials|mesh-ancestor
24506553|NCT00545935|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24506554|NCT00545935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24506555|NCT00545935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24506556|NCT00545935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506557|NCT00545935|Antiviral Agents|antiviral agents|mesh-ancestor
24506558|NCT00545935|Schistosomicides|schistosomicides|mesh-ancestor
25058315|NCT03497923|Magnesium Sulfate|magnesium sulfate|mesh-list
25058316|NCT03497923|Analgesics|analgesics|mesh-ancestor
25058317|NCT03497923|Sensory System Agents|sensory system agents|mesh-ancestor
25058318|NCT03497923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25058319|NCT03497923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058320|NCT03497923|Anesthetics|anesthetics|mesh-ancestor
25058321|NCT03497923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25058322|NCT03497923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25058323|NCT03497923|Anticonvulsants|anticonvulsants|mesh-ancestor
25058324|NCT03497923|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25058325|NCT03497923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25036637|NCT03545347|Anabolic Agents|anabolic agents|mesh-ancestor
24513870|NCT00585871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24506596|NCT00546130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058342|NCT03497715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25058344|NCT03497715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25058345|NCT03497715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058346|NCT03497715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058347|NCT03497702|Cyclophosphamide|cyclophosphamide|mesh-list
25058348|NCT03497702|Docetaxel|docetaxel|mesh-list
24506600|NCT00546130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24506601|NCT00546130|Antiviral Agents|antiviral agents|mesh-ancestor
24506602|NCT00546130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24506603|NCT00546130|Interferon Inducers|interferon inducers|mesh-ancestor
24506604|NCT00546130|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24506605|NCT00546130|Protective Agents|protective agents|mesh-ancestor
24506606|NCT00546143|Omalizumab|omalizumab|mesh-list
24506607|NCT00546143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24506608|NCT00546143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24506636|NCT00546286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506637|NCT00546286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24506638|NCT00546286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24506639|NCT00546286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506640|NCT00546286|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24506642|NCT00546325|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24506643|NCT00546325|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24506644|NCT00546325|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24506645|NCT00546325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24506646|NCT00546325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506648|NCT00546325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24506649|NCT00546325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506650|NCT00546403|Modafinil|modafinil|mesh-list
24506651|NCT00546403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24506652|NCT00546403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506653|NCT00546403|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24506654|NCT00546403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24506655|NCT00546403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24506656|NCT00546403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669888|NCT05161338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25669889|NCT05161338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669890|NCT05161338|Progestins|progestins|mesh-ancestor
25669891|NCT05127928|Vitamins|vitamins|mesh-list
25669892|NCT05127928|Ascorbic Acid|ascorbic acid|mesh-list
25669893|NCT05127928|Vitamin E|vitamin e|mesh-list
24506657|NCT00546442|Metformin|metformin|mesh-list
24506658|NCT00546442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24506659|NCT00546442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506660|NCT00546494|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24506672|NCT00546507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24506673|NCT00546507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24506674|NCT00546507|Analgesics|analgesics|mesh-ancestor
24506675|NCT00546507|Sensory System Agents|sensory system agents|mesh-ancestor
24884409|NCT00635882|Respiratory System Agents|respiratory system agents|mesh-ancestor
24884410|NCT00635882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24884411|NCT00635882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24884412|NCT00635882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24884413|NCT00635882|Adrenergic Agents|adrenergic agents|mesh-ancestor
24884414|NCT00635882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24884415|NCT00635882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058349|NCT03497702|Doxorubicin|doxorubicin|mesh-list
25058351|NCT03497702|Leuprolide|leuprolide|mesh-list
25058352|NCT03497702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25058353|NCT03497702|Immunologic Factors|immunologic factors|mesh-ancestor
25058354|NCT03497702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506734|NCT00546650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506736|NCT00546676|Telithromycin|telithromycin|mesh-list
24506737|NCT00546676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24506738|NCT00546676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24506739|NCT00546741|Metformin|metformin|mesh-list
24506740|NCT00546741|Dapagliflozin|dapagliflozin|mesh-list
24506741|NCT00546741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24894545|NCT04439773|Lidocaine|lidocaine|mesh-list
24506760|NCT00546923|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24506761|NCT00546923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24506762|NCT00546923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24506763|NCT00546923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506764|NCT00546923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24506765|NCT00546923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506766|NCT00546923|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24506767|NCT00546923|Antidepressive Agents|antidepressive agents|mesh-ancestor
24506768|NCT00546923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24506769|NCT00546936|Ranibizumab|ranibizumab|mesh-list
24506770|NCT00546936|Verteporfin|verteporfin|mesh-list
24506771|NCT00546936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25865848|NCT00102284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24884438|NCT00545324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24884440|NCT00545324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24884441|NCT00540839|Fluticasone|fluticasone|mesh-list
24884443|NCT00540839|Montelukast|montelukast|mesh-list
24884444|NCT00540839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24884445|NCT00540839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24884446|NCT00540839|Autonomic Agents|autonomic agents|mesh-ancestor
24884447|NCT00540839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24884448|NCT00540839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058365|NCT03497702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25058367|NCT03497702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588821|NCT00904436|Ipratropium|ipratropium|mesh-list
24506872|NCT00547287|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24506873|NCT00547287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24506874|NCT00547287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506875|NCT00547287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506876|NCT00547287|Urological Agents|urological agents|mesh-ancestor
24506877|NCT00547352|Sildenafil Citrate|sildenafil citrate|mesh-list
24506886|NCT00547417|Vasodilator Agents|vasodilator agents|mesh-ancestor
24884449|NCT00540839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24884450|NCT00540839|Respiratory System Agents|respiratory system agents|mesh-ancestor
24884451|NCT00540839|Dermatologic Agents|dermatologic agents|mesh-ancestor
24894631|NCT04438811|Anesthetics|anesthetics|mesh-list
24884452|NCT00540839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24884453|NCT00540839|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25058380|NCT03497442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25058381|NCT03497442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25058382|NCT03497442|Adrenergic Agents|adrenergic agents|mesh-ancestor
25058383|NCT03497442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25058384|NCT03497442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058385|NCT03497442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058387|NCT03497364|Ropivacaine|ropivacaine|mesh-list
25058388|NCT03497364|Anesthetics, Local|anesthetics, local|mesh-ancestor
25058389|NCT03497364|Anesthetics|anesthetics|mesh-ancestor
25058390|NCT03497364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25058391|NCT03497364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058392|NCT03497364|Sensory System Agents|sensory system agents|mesh-ancestor
25058393|NCT03497364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25058394|NCT03497351|Nicardipine|nicardipine|mesh-list
25058395|NCT03497351|Urapidil|urapidil|mesh-list
25058396|NCT03497351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25058397|NCT03497351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24820448|NCT02099604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820449|NCT02099604|Immunologic Factors|immunologic factors|mesh-ancestor
24884454|NCT00540839|Hormone Antagonists|hormone antagonists|mesh-ancestor
24884455|NCT00540839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24884456|NCT00540839|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24884457|NCT00540839|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24884458|NCT00540839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884459|NCT00535405|Atorvastatin|atorvastatin|mesh-list
24884460|NCT00535405|Simvastatin|simvastatin|mesh-list
24884461|NCT00535405|Ezetimibe|ezetimibe|mesh-list
24884462|NCT00535405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24884463|NCT00535405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24884464|NCT00535405|Antimetabolites|antimetabolites|mesh-ancestor
24463485|NCT00361153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24506887|NCT00547417|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24506888|NCT00547417|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24506889|NCT00547417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506890|NCT00547417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506891|NCT00547417|Urological Agents|urological agents|mesh-ancestor
24506892|NCT00547443|Paclitaxel|paclitaxel|mesh-list
25865849|NCT00102284|Dopamine Agents|dopamine agents|mesh-ancestor
24506893|NCT00547443|Carboplatin|carboplatin|mesh-list
24506894|NCT00547443|Sorafenib|sorafenib|mesh-list
24506895|NCT00547443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24506896|NCT00547443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506915|NCT00547508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506918|NCT00547547|Capecitabine|capecitabine|mesh-list
24506919|NCT00547547|Irinotecan|irinotecan|mesh-list
25062231|NCT05085782|Propranolol|propranolol|mesh-list
24942210|NCT03983239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24942211|NCT03983239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24942212|NCT03983239|Antitubercular Agents|antitubercular agents|mesh-ancestor
24506920|NCT00547547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24506931|NCT00547547|Micronutrients|micronutrients|mesh-ancestor
24506932|NCT00547573|Tadalafil|tadalafil|mesh-list
24506933|NCT00547573|Vasodilator Agents|vasodilator agents|mesh-ancestor
24506934|NCT00547573|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25865850|NCT00102284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25865851|NCT00102284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884465|NCT00535405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884466|NCT00535405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24942213|NCT03983239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24942214|NCT03983239|Leprostatic Agents|leprostatic agents|mesh-ancestor
24942215|NCT03983239|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25865852|NCT00102284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865853|NCT00102284|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25865854|NCT00102284|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25865855|NCT00102284|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25865856|NCT00102284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25865857|NCT00102284|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25865858|NCT00102284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865859|NCT00102284|Cholinergic Agents|cholinergic agents|mesh-ancestor
25865860|NCT00102284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25865861|NCT00102284|Protective Agents|protective agents|mesh-ancestor
25865862|NCT00102310|Z 338|z 338|mesh-list
24506935|NCT00547573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24506936|NCT00547573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506937|NCT00547573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952753|NCT03892421|Antimetabolites|antimetabolites|mesh-ancestor
24952754|NCT03892421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952755|NCT03892421|Antiviral Agents|antiviral agents|mesh-ancestor
24952756|NCT03892421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24952757|NCT03892421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24952758|NCT03892122|Dexmedetomidine|dexmedetomidine|mesh-list
24952759|NCT03892122|Propofol|propofol|mesh-list
24952760|NCT03892122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24952761|NCT03892122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25058410|NCT03496870|Levodopa|levodopa|mesh-list
25058411|NCT03496870|Carbidopa|carbidopa|mesh-list
25058412|NCT03496870|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25058413|NCT03496870|Opicapone|opicapone|mesh-list
25058414|NCT03496870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25058415|NCT03496870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25058416|NCT03496870|Dopamine Agents|dopamine agents|mesh-ancestor
25865863|NCT00102310|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25058417|NCT03496870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25058418|NCT03496870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058419|NCT03496870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058420|NCT03496870|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25058421|NCT03496870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506964|NCT00547664|Sensory System Agents|sensory system agents|mesh-ancestor
24884482|NCT00462748|Ezetimibe|ezetimibe|mesh-list
24884483|NCT00462748|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24884484|NCT00462748|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24506998|NCT00548002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24511930|NCT00571714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24507017|NCT00548067|Diuretics|diuretics|mesh-ancestor
25058431|NCT03496831|Ustekinumab|ustekinumab|mesh-list
25058432|NCT03496831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25058433|NCT03496831|Immunologic Factors|immunologic factors|mesh-ancestor
25058434|NCT03496831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058435|NCT03496831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25058436|NCT03496831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25058437|NCT03496831|Dermatologic Agents|dermatologic agents|mesh-ancestor
25058438|NCT03496831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25058439|NCT03496831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25058440|NCT03496831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25058441|NCT03496831|Analgesics|analgesics|mesh-ancestor
25058442|NCT03496831|Sensory System Agents|sensory system agents|mesh-ancestor
25058443|NCT03496831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24942241|NCT03982862|Cholinergic Agents|cholinergic agents|mesh-ancestor
25058444|NCT03496831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25058445|NCT03496831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25058446|NCT03496831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058447|NCT03496831|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25058448|NCT03496779|Gemcitabine|gemcitabine|mesh-list
25058449|NCT03496779|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25058450|NCT03496779|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24820532|NCT02099955|Vitamins|vitamins|mesh-ancestor
24884504|NCT00445107|Hormone Antagonists|hormone antagonists|mesh-ancestor
24463539|NCT00361322|Analgesics|analgesics|mesh-ancestor
24507021|NCT00548080|Antifungal Agents|antifungal agents|mesh-ancestor
24507022|NCT00548080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24507023|NCT00548080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507024|NCT00548080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507025|NCT00548288|Pamidronate|pamidronate|mesh-list
24507055|NCT00548483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24507056|NCT00548483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507057|NCT00548509|Vitamin K|vitamin k|mesh-list
24507058|NCT00548509|Vitamin K 2|vitamin k 2|mesh-list
24507059|NCT00548509|Menatetrenone|menatetrenone|mesh-list
24507060|NCT00548509|Vitamins|vitamins|mesh-ancestor
24507061|NCT00548509|Micronutrients|micronutrients|mesh-ancestor
24507062|NCT00548509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507063|NCT00548509|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25058451|NCT03496779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25058453|NCT03496779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058481|NCT03496519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25058482|NCT03496519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25058484|NCT03496519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507064|NCT00548509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24507065|NCT00548509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507066|NCT00548509|Hemostatics|hemostatics|mesh-ancestor
24507067|NCT00548509|Coagulants|coagulants|mesh-ancestor
24507068|NCT00548561|Dexrazoxane|dexrazoxane|mesh-list
25058485|NCT03496519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25058486|NCT03496519|Alkylating Agents|alkylating agents|mesh-ancestor
25058487|NCT03496519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058488|NCT03496506|Selexipag|selexipag|mesh-list
25058489|NCT03496506|Clopidogrel|clopidogrel|mesh-list
25058490|NCT03496506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25225220|NCT02628574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25225221|NCT02628574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058491|NCT03496506|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25058492|NCT03496506|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25058493|NCT03496506|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25058494|NCT03496506|Purinergic Agents|purinergic agents|mesh-ancestor
24507071|NCT00548561|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24507072|NCT00548561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24726543|NCT01604135|Dextrans|dextrans|mesh-list
24507073|NCT00548561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24507074|NCT00548561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865864|NCT00102310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865865|NCT00102310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865866|NCT00102310|Cholinergic Agents|cholinergic agents|mesh-ancestor
24884508|NCT00445107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24463542|NCT00361322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507097|NCT00548678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507098|NCT00548678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24507099|NCT00548678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24507100|NCT00548678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24507101|NCT00548678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24507102|NCT00548678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507103|NCT00548678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24507106|NCT00548678|Antipyretics|antipyretics|mesh-ancestor
25865867|NCT00102310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25865868|NCT00102310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865869|NCT00102310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25876588|NCT03269669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876589|NCT03269669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25058507|NCT03496389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25058508|NCT03496389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25058509|NCT03496389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25058510|NCT03496389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25058511|NCT03496389|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25058512|NCT03496389|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25058513|NCT03496389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25058514|NCT03496389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058515|NCT03496389|Antimanic Agents|antimanic agents|mesh-ancestor
25058516|NCT03496389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25058517|NCT03496389|Narcotics|narcotics|mesh-ancestor
25058518|NCT03496389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24894935|NCT05373433|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24894936|NCT05373433|Protease Inhibitors|protease inhibitors|mesh-ancestor
24514072|NCT00587665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058519|NCT03496389|Antipyretics|antipyretics|mesh-ancestor
25058521|NCT03496246|Calcifediol|calcifediol|mesh-list
25058522|NCT03496246|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
25058523|NCT03496246|Alfacalcidol|alfacalcidol|mesh-list
25058525|NCT03496246|Vitamins|vitamins|mesh-ancestor
25058526|NCT03496246|Micronutrients|micronutrients|mesh-ancestor
25058527|NCT03496246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058528|NCT03496246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24507189|NCT00549120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24507190|NCT00549120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24507191|NCT00549120|Respiratory System Agents|respiratory system agents|mesh-ancestor
24507192|NCT00549120|Tocolytic Agents|tocolytic agents|mesh-ancestor
24507193|NCT00549120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24507194|NCT00549120|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24884509|NCT00445107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884510|NCT00418834|Atorvastatin|atorvastatin|mesh-list
24884512|NCT00418834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24884513|NCT00418834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24884514|NCT00418834|Antimetabolites|antimetabolites|mesh-ancestor
24463547|NCT00361348|Anticoagulants|anticoagulants|mesh-ancestor
25669894|NCT05127928|Tocopherols|tocopherols|mesh-list
25669895|NCT05127928|Micronutrients|micronutrients|mesh-ancestor
25669896|NCT05127928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669897|NCT05127928|Antioxidants|antioxidants|mesh-ancestor
25669898|NCT05127928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669899|NCT05127928|Protective Agents|protective agents|mesh-ancestor
25669900|NCT05115409|Rituximab|rituximab|mesh-list
25669901|NCT05115409|Antibodies|antibodies|mesh-list
25669902|NCT05115409|Immunologic Factors|immunologic factors|mesh-ancestor
25058531|NCT03496233|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25058532|NCT03496233|Antiviral Agents|antiviral agents|mesh-ancestor
25058533|NCT03496233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25058535|NCT03495804|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25058536|NCT03495804|Diuretics|diuretics|mesh-ancestor
25058537|NCT03495804|Natriuretic Agents|natriuretic agents|mesh-ancestor
25058538|NCT03495804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201501|NCT02727296|Sevoflurane|sevoflurane|mesh-list
25058539|NCT03495765|Ranibizumab|ranibizumab|mesh-list
25058540|NCT03495765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25058541|NCT03495765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25058542|NCT03495765|Growth Substances|growth substances|mesh-ancestor
25058543|NCT03495765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058544|NCT03495765|Growth Inhibitors|growth inhibitors|mesh-ancestor
25058545|NCT03495765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25058546|NCT03495739|Dabigatran|dabigatran|mesh-list
25058547|NCT03495739|Antithrombins|antithrombins|mesh-ancestor
25058548|NCT03495739|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25058549|NCT03495739|Protease Inhibitors|protease inhibitors|mesh-ancestor
25058550|NCT03495739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058685|NCT03493841|Vitamins|vitamins|mesh-ancestor
25058551|NCT03495739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058553|NCT03495609|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25058554|NCT03495609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25062280|NCT05009901|Vitamins|vitamins|mesh-ancestor
24820632|NCT02100553|Itraconazole|itraconazole|mesh-list
24512052|NCT00572364|Olaparib|olaparib|mesh-list
24507203|NCT00549133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507206|NCT00549146|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24507207|NCT00549146|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24507208|NCT00549146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24507209|NCT00549146|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24507210|NCT00549146|Autonomic Agents|autonomic agents|mesh-ancestor
24507211|NCT00549146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25037153|NCT03539887|Anesthetics, General|anesthetics, general|mesh-ancestor
25058558|NCT03495466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058560|NCT03495232|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25058561|NCT03495232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25058562|NCT03495232|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25058563|NCT03495232|Histamine Antagonists|histamine antagonists|mesh-ancestor
25058564|NCT03495232|Histamine Agents|histamine agents|mesh-ancestor
25058565|NCT03495232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25058566|NCT03495232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058567|NCT03495232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058568|NCT03495232|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25058569|NCT03495232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25058570|NCT03495232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058571|NCT03495206|Edaravone|edaravone|mesh-list
25058572|NCT03495206|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25058573|NCT03495206|Antioxidants|antioxidants|mesh-ancestor
25058574|NCT03495206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058575|NCT03495206|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25058576|NCT03495206|Protective Agents|protective agents|mesh-ancestor
25058577|NCT03495206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942389|NCT03981523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25058578|NCT03495063|Caffeine|caffeine|mesh-list
25058579|NCT03495063|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25058580|NCT03495063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058581|NCT03495063|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25058582|NCT03495063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058583|NCT03495063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058584|NCT03495063|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24507254|NCT00549419|Sympathomimetics|sympathomimetics|mesh-ancestor
24507255|NCT00549419|Autonomic Agents|autonomic agents|mesh-ancestor
24507256|NCT00549419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24507276|NCT00549536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507277|NCT00549536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24507278|NCT00549588|Sunscreening Agents|sunscreening agents|mesh-list
24507279|NCT00549588|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24507280|NCT00549588|Protective Agents|protective agents|mesh-ancestor
24507282|NCT00549588|Dermatologic Agents|dermatologic agents|mesh-ancestor
24507302|NCT00549666|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24989428|NCT05261321|Sensory System Agents|sensory system agents|mesh-ancestor
25225252|NCT02628522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507303|NCT00549666|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24507305|NCT00549666|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24507306|NCT00549666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24507307|NCT00549666|Dopamine Agents|dopamine agents|mesh-ancestor
24507308|NCT00549666|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24507309|NCT00549666|Contraceptive Agents|contraceptive agents|mesh-ancestor
24507310|NCT00549666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24507311|NCT00549666|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24507312|NCT00549666|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25865871|NCT00102375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24507313|NCT00549666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24507314|NCT00549666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24507315|NCT00549666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24507316|NCT00549666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24507317|NCT00549666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24507318|NCT00549666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865872|NCT00102375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25865873|NCT00102375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058686|NCT03493841|Micronutrients|micronutrients|mesh-ancestor
24507335|NCT00549926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24507336|NCT00549926|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24507337|NCT00549926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507339|NCT00549965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24507387|NCT00550199|Antimetabolites|antimetabolites|mesh-ancestor
25058599|NCT03494972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058600|NCT03494972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058601|NCT03494907|Moxifloxacin|moxifloxacin|mesh-list
25058602|NCT03494907|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25058603|NCT03494907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25058604|NCT03494907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25058605|NCT03494907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25058606|NCT03494907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25058607|NCT03494907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058608|NCT03494907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058609|NCT03494907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25058610|NCT03494907|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25058611|NCT03494907|Contraceptive Agents|contraceptive agents|mesh-ancestor
25058612|NCT03494907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25058613|NCT03494907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058614|NCT03494907|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25058615|NCT03494907|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25058616|NCT03494907|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25058617|NCT03494686|Anesthetics|anesthetics|mesh-list
25058618|NCT03494686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25058619|NCT03494686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058620|NCT03494517|Magnesium Sulfate|magnesium sulfate|mesh-list
25058621|NCT03494517|Analgesics|analgesics|mesh-ancestor
25058622|NCT03494517|Sensory System Agents|sensory system agents|mesh-ancestor
25058623|NCT03494517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25058624|NCT03494517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058625|NCT03494517|Anesthetics|anesthetics|mesh-ancestor
25876590|NCT03269669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24507399|NCT00550303|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24507401|NCT00550303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24507406|NCT00550303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24507409|NCT00550329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507410|NCT00550342|Rituximab|rituximab|mesh-list
24507411|NCT00550342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24507412|NCT00550342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507413|NCT00550342|Immunologic Factors|immunologic factors|mesh-ancestor
25058626|NCT03494517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25669903|NCT05115409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669904|NCT05115409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25669905|NCT05115409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669906|NCT05115409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25669907|NCT05113186|Lenvatinib|lenvatinib|mesh-list
25669908|NCT05113186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669909|NCT05113186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25669910|NCT05113186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674485|NCT01772758|Antioxidants|antioxidants|mesh-list
25105013|NCT03149679|Alkylating Agents|alkylating agents|mesh-ancestor
25105014|NCT03149679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105015|NCT03149679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105016|NCT03149679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25105017|NCT03149575|Carboplatin|carboplatin|mesh-list
25105018|NCT03149575|Temozolomide|temozolomide|mesh-list
25105019|NCT03149575|Lomustine|lomustine|mesh-list
25105020|NCT03149575|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
25105021|NCT03149575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105022|NCT03149575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25105043|NCT03149393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25105044|NCT03149393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225279|NCT02628002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058627|NCT03494517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25058628|NCT03494517|Anticonvulsants|anticonvulsants|mesh-ancestor
25058629|NCT03494517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25058630|NCT03494517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25058631|NCT03494517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058632|NCT03494517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25058633|NCT03494517|Tocolytic Agents|tocolytic agents|mesh-ancestor
25201502|NCT02727296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25058634|NCT03494517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25058635|NCT03494426|Pregabalin|pregabalin|mesh-list
25876591|NCT03269669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24884547|NCT00394160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24884548|NCT00394160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884549|NCT00394160|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24884550|NCT00394160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24884551|NCT00394160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884553|NCT00380705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24884554|NCT00380705|Respiratory System Agents|respiratory system agents|mesh-ancestor
24884556|NCT00380705|Hormone Antagonists|hormone antagonists|mesh-ancestor
24507476|NCT00550810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507477|NCT00550810|Growth Inhibitors|growth inhibitors|mesh-ancestor
24507478|NCT00550810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24507479|NCT00550810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507480|NCT00550810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507481|NCT00550901|Dexrazoxane|dexrazoxane|mesh-list
24507482|NCT00550901|Razoxane|razoxane|mesh-list
24507483|NCT00550901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507484|NCT00550901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24507485|NCT00550901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24507486|NCT00550901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24507487|NCT00550901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24884563|NCT00276484|Ezetimibe|ezetimibe|mesh-list
24884564|NCT00276484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24507489|NCT00550901|Protective Agents|protective agents|mesh-ancestor
24507490|NCT00550901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507491|NCT00550901|Antimitotic Agents|antimitotic agents|mesh-ancestor
24507492|NCT00550901|Mitosis Modulators|mitosis modulators|mesh-ancestor
25058636|NCT03494426|Tramadol|tramadol|mesh-list
25058637|NCT03494426|Antidepressive Agents|antidepressive agents|mesh-list
24507499|NCT00550927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507500|NCT00550927|Growth Inhibitors|growth inhibitors|mesh-ancestor
24507501|NCT00550992|Leucovorin|leucovorin|mesh-list
24507502|NCT00550992|Cytarabine|cytarabine|mesh-list
24507503|NCT00550992|Cyclosporine|cyclosporine|mesh-list
24507504|NCT00550992|Prednisone|prednisone|mesh-list
24507505|NCT00550992|Prednisolone|prednisolone|mesh-list
24507506|NCT00550992|Hydrocortisone|hydrocortisone|mesh-list
24507534|NCT00550992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24507535|NCT00550992|Glucocorticoids|glucocorticoids|mesh-ancestor
24507536|NCT00550992|Hormones|hormones|mesh-ancestor
25669911|NCT05113186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669912|NCT05111808|Methylene Blue|methylene blue|mesh-list
25669913|NCT05111808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25669914|NCT05111808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669915|NCT05093140|Prednisone|prednisone|mesh-list
25669916|NCT05093140|Cyclophosphamide|cyclophosphamide|mesh-list
25669917|NCT05093140|Vincristine|vincristine|mesh-list
25669918|NCT05093140|Doxorubicin|doxorubicin|mesh-list
25669919|NCT05093140|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25669920|NCT05093140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25669921|NCT05093140|Immunologic Factors|immunologic factors|mesh-ancestor
25669922|NCT05093140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669923|NCT05093140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25105098|NCT03148574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25105100|NCT03148535|Antidepressive Agents|antidepressive agents|mesh-list
25105101|NCT03148535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25105102|NCT03148535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25105103|NCT03148535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105104|NCT03148535|Antimanic Agents|antimanic agents|mesh-ancestor
24427439|NCT00238199|Calcitriol|calcitriol|mesh-list
25105140|NCT03148522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25105141|NCT03148522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105142|NCT03148522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25105143|NCT03148522|Serotonin Agents|serotonin agents|mesh-ancestor
24838862|NCT02200848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24838863|NCT02200848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507537|NCT00550992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25865874|NCT00102375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865875|NCT00102375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865876|NCT00102388|Vildagliptin|vildagliptin|mesh-list
25865877|NCT00102388|Gliclazide|gliclazide|mesh-list
25865878|NCT00102388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25865879|NCT00102388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507562|NCT00550992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24507563|NCT00550992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24507564|NCT00550992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24507565|NCT00550992|Analgesics|analgesics|mesh-ancestor
24507566|NCT00550992|Sensory System Agents|sensory system agents|mesh-ancestor
24507567|NCT00551005|Celecoxib|celecoxib|mesh-list
24507568|NCT00551005|Etoposide|etoposide|mesh-list
24507590|NCT00551018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24507591|NCT00551018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507592|NCT00551018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507593|NCT00551018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24507594|NCT00551018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24952764|NCT03892122|Anesthetics, General|anesthetics, general|mesh-ancestor
24952765|NCT03892122|Anesthetics|anesthetics|mesh-ancestor
24507596|NCT00551044|Androgen Antagonists|androgen antagonists|mesh-ancestor
24507597|NCT00551044|Hormone Antagonists|hormone antagonists|mesh-ancestor
24884579|NCT00276458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24884580|NCT00271817|Niacin|niacin|mesh-list
24507614|NCT00551109|Nootropic Agents|nootropic agents|mesh-ancestor
24507615|NCT00551122|Gemcitabine|gemcitabine|mesh-list
24507616|NCT00551122|Paclitaxel|paclitaxel|mesh-list
24507617|NCT00551122|Ifosfamide|ifosfamide|mesh-list
24507618|NCT00551122|Lenograstim|lenograstim|mesh-list
25865880|NCT00102388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25865881|NCT00102388|Protease Inhibitors|protease inhibitors|mesh-ancestor
25865882|NCT00102388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865883|NCT00102388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865884|NCT00102414|Gemcitabine|gemcitabine|mesh-list
25865885|NCT00102414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25865886|NCT00102414|Antimetabolites|antimetabolites|mesh-ancestor
25865887|NCT00102414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865888|NCT00102414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865889|NCT00102414|Antiviral Agents|antiviral agents|mesh-ancestor
25865890|NCT00102414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25865891|NCT00102414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865892|NCT00102414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24507619|NCT00551122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24507621|NCT00551122|Tubulin Modulators|tubulin modulators|mesh-ancestor
25669924|NCT05093140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25669925|NCT05093140|Alkylating Agents|alkylating agents|mesh-ancestor
25669926|NCT05093140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669927|NCT05093140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669928|NCT05093140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25669929|NCT05093140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25669930|NCT05093140|Glucocorticoids|glucocorticoids|mesh-ancestor
25669931|NCT05093140|Hormones|hormones|mesh-ancestor
25669932|NCT05093140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25669933|NCT05093140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25669934|NCT05093140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25669935|NCT05093140|Tubulin Modulators|tubulin modulators|mesh-ancestor
25669936|NCT05093140|Antimitotic Agents|antimitotic agents|mesh-ancestor
25669937|NCT05093140|Mitosis Modulators|mitosis modulators|mesh-ancestor
25865893|NCT00102414|Immunologic Factors|immunologic factors|mesh-ancestor
25105206|NCT03147677|Alfacalcidol|alfacalcidol|mesh-list
24507622|NCT00551122|Antimitotic Agents|antimitotic agents|mesh-ancestor
24507623|NCT00551122|Mitosis Modulators|mitosis modulators|mesh-ancestor
24507624|NCT00551122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507625|NCT00551122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24507646|NCT00551239|Antimetabolites|antimetabolites|mesh-ancestor
24507647|NCT00551239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507648|NCT00551239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24507649|NCT00551239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24507650|NCT00551239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24507651|NCT00551239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507652|NCT00551252|Gemcitabine|gemcitabine|mesh-list
24507653|NCT00551252|Imatinib Mesylate|imatinib mesylate|mesh-list
24507654|NCT00551252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24507659|NCT00551252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24507660|NCT00551252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507661|NCT00551252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24507662|NCT00551252|Immunologic Factors|immunologic factors|mesh-ancestor
24507692|NCT00551356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24507693|NCT00551356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507694|NCT00551382|Montelukast|montelukast|mesh-list
24507696|NCT00551382|Respiratory System Agents|respiratory system agents|mesh-ancestor
24507697|NCT00551382|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24952776|NCT03892213|Benzonidazole|benzonidazole|mesh-list
24952777|NCT03892213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24952778|NCT03892213|Immunologic Factors|immunologic factors|mesh-ancestor
24952779|NCT03892213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952784|NCT03892148|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24952786|NCT03892148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24820764|NCT02101476|Analgesics|analgesics|mesh-ancestor
24507698|NCT00551382|Hormone Antagonists|hormone antagonists|mesh-ancestor
24507699|NCT00551382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24507700|NCT00551382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865894|NCT00102414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507701|NCT00551382|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24507702|NCT00551382|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24507703|NCT00551382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865895|NCT00102453|Pentoxifylline|pentoxifylline|mesh-list
25865896|NCT00102453|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25865897|NCT00102453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865898|NCT00102453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216130|NCT02686086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25865899|NCT00102453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25865900|NCT00102453|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24507725|NCT00551590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24507726|NCT00551590|Protease Inhibitors|protease inhibitors|mesh-ancestor
24507727|NCT00551590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507728|NCT00551590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507730|NCT00551733|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24507732|NCT00551733|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
24507733|NCT00551733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24507734|NCT00551733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507735|NCT00551733|Tubulin Modulators|tubulin modulators|mesh-ancestor
24507736|NCT00551733|Antimitotic Agents|antimitotic agents|mesh-ancestor
24816329|NCT02076477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816330|NCT02076477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24816331|NCT02076477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24816332|NCT02076529|Ramosetron|ramosetron|mesh-list
24816333|NCT02076529|Antiemetics|antiemetics|mesh-ancestor
24816334|NCT02076529|Autonomic Agents|autonomic agents|mesh-ancestor
24816335|NCT02076529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816336|NCT02076529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816337|NCT02076529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24816338|NCT02076529|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24816339|NCT02076529|Serotonin Agents|serotonin agents|mesh-ancestor
25669938|NCT05093140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25669939|NCT05093140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25669940|NCT05093140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25669941|NCT05093140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25669942|NCT05058404|Prednisone|prednisone|mesh-list
25669943|NCT05058404|Rituximab|rituximab|mesh-list
25669944|NCT05058404|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25669945|NCT05058404|Cyclophosphamide|cyclophosphamide|mesh-list
25669946|NCT05058404|Vincristine|vincristine|mesh-list
25105332|NCT03146533|Cyclophosphamide|cyclophosphamide|mesh-list
25105334|NCT03146533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25105344|NCT03146689|Capsaicin|capsaicin|mesh-list
24507737|NCT00551733|Mitosis Modulators|mitosis modulators|mesh-ancestor
24507738|NCT00551733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507739|NCT00551824|Mitomycins|mitomycins|mesh-list
24507740|NCT00551824|Mitomycin|mitomycin|mesh-list
24507741|NCT00551824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24507742|NCT00551824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507743|NCT00551824|Alkylating Agents|alkylating agents|mesh-ancestor
24507744|NCT00551824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507745|NCT00551824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24952788|NCT03892148|Natriuretic Agents|natriuretic agents|mesh-ancestor
24952789|NCT03892148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952790|NCT03892148|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24952791|NCT03892148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24952793|NCT03892148|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24952794|NCT03891979|Metronidazole|metronidazole|mesh-list
24952795|NCT03891979|Ciprofloxacin|ciprofloxacin|mesh-list
24952796|NCT03891979|Pembrolizumab|pembrolizumab|mesh-list
24952797|NCT03891979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25037444|NCT03537326|Budesonide|budesonide|mesh-list
24507758|NCT00551889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24507773|NCT00551954|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24507788|NCT00552227|Ruboxistaurin|ruboxistaurin|mesh-list
24507789|NCT00552227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507791|NCT00552266|Methylphenidate|methylphenidate|mesh-list
24507806|NCT00552461|Immunologic Factors|immunologic factors|mesh-ancestor
24507807|NCT00552461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507808|NCT00552461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24507809|NCT00552500|Valproic Acid|valproic acid|mesh-list
24507810|NCT00552500|Anticonvulsants|anticonvulsants|mesh-ancestor
24507811|NCT00552500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507812|NCT00552500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507813|NCT00552500|GABA Agents|gaba agents|mesh-ancestor
24507814|NCT00552500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24507815|NCT00552500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507816|NCT00552500|Antimanic Agents|antimanic agents|mesh-ancestor
24507817|NCT00552500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24816340|NCT02076529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24816341|NCT02076529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816342|NCT02076594|Docetaxel|docetaxel|mesh-list
24816343|NCT02076594|Capecitabine|capecitabine|mesh-list
24952807|NCT03891979|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24952808|NCT03891979|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24952809|NCT03892070|Mannitol|mannitol|mesh-list
24952810|NCT03892070|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24952811|NCT03892070|Diuretics|diuretics|mesh-ancestor
24952812|NCT03892070|Natriuretic Agents|natriuretic agents|mesh-ancestor
24952813|NCT03892070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952814|NCT03892161|Ritonavir|ritonavir|mesh-list
24952815|NCT03892161|Darunavir|darunavir|mesh-list
25058661|NCT03494387|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25058662|NCT03494387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058663|NCT03494387|Protective Agents|protective agents|mesh-ancestor
25058664|NCT03494387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058665|NCT03494387|Vitamins|vitamins|mesh-ancestor
25058666|NCT03494387|Micronutrients|micronutrients|mesh-ancestor
25058667|NCT03494257|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25058668|NCT03494257|Brinzolamide|brinzolamide|mesh-list
25058670|NCT03494257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25058671|NCT03494257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25058672|NCT03494257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25058673|NCT03494257|Adrenergic Agents|adrenergic agents|mesh-ancestor
25058674|NCT03494257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25058675|NCT03494257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058676|NCT03494257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058677|NCT03494257|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25058678|NCT03494257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058680|NCT03493841|Antioxidants|antioxidants|mesh-ancestor
25058681|NCT03493841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669947|NCT05058404|Doxorubicin|doxorubicin|mesh-list
25669948|NCT05058404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25669949|NCT05058404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24975065|NCT04776499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24975075|NCT04756427|Sodium Citrate|sodium citrate|mesh-list
24975076|NCT04756427|Anticoagulants|anticoagulants|mesh-list
24989562|NCT05008887|Methotrexate|methotrexate|mesh-list
24975077|NCT04756427|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24975078|NCT04756427|Chelating Agents|chelating agents|mesh-ancestor
24975079|NCT04756427|Sequestering Agents|sequestering agents|mesh-ancestor
25225335|NCT02627950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25058682|NCT03493841|Protective Agents|protective agents|mesh-ancestor
25058683|NCT03493841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058684|NCT03493841|Vitamin B Complex|vitamin b complex|mesh-ancestor
25058688|NCT03493568|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25058689|NCT03493568|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25058690|NCT03493568|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25058691|NCT03493568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820830|NCT02102048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24816344|NCT02076594|Oxaliplatin|oxaliplatin|mesh-list
24816345|NCT02076594|Epirubicin|epirubicin|mesh-list
24816346|NCT02076594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507823|NCT00552630|Protective Agents|protective agents|mesh-ancestor
24507824|NCT00552630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507825|NCT00552630|Chelating Agents|chelating agents|mesh-ancestor
24507826|NCT00552630|Sequestering Agents|sequestering agents|mesh-ancestor
24507827|NCT00552630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507828|NCT00552630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24507829|NCT00552656|Sirolimus|sirolimus|mesh-list
24507830|NCT00552656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25058692|NCT03493568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058693|NCT03493568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25058694|NCT03493568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25058695|NCT03493568|Antiviral Agents|antiviral agents|mesh-ancestor
25058696|NCT03493568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25058697|NCT03493503|Albuterol|albuterol|mesh-list
25058698|NCT03493503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25058699|NCT03493503|Autonomic Agents|autonomic agents|mesh-ancestor
25058700|NCT03493503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25058701|NCT03493503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058702|NCT03493503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25058703|NCT03493503|Respiratory System Agents|respiratory system agents|mesh-ancestor
25058704|NCT03493503|Tocolytic Agents|tocolytic agents|mesh-ancestor
25058705|NCT03493503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25058706|NCT03493503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25058707|NCT03493503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25058708|NCT03493503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25058709|NCT03493503|Adrenergic Agents|adrenergic agents|mesh-ancestor
25058710|NCT03493503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25058711|NCT03493503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058712|NCT03493490|Diclofenac|diclofenac|mesh-list
25058713|NCT03493490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25058714|NCT03493490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25058715|NCT03493490|Analgesics|analgesics|mesh-ancestor
24895100|NCT05016076|Hormones|hormones|mesh-ancestor
25058716|NCT03493490|Sensory System Agents|sensory system agents|mesh-ancestor
25058717|NCT03493490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25058718|NCT03493490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058719|NCT03493490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25058720|NCT03493490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25058721|NCT03493490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24820869|NCT02102438|Paclitaxel|paclitaxel|mesh-list
24507831|NCT00552656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24507832|NCT00552656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24507861|NCT00552799|Penicillin V|penicillin v|mesh-list
24507862|NCT00552799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24507863|NCT00552799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25669950|NCT05058404|Immunologic Factors|immunologic factors|mesh-ancestor
25669951|NCT05058404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669952|NCT05058404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25669953|NCT05058404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25669954|NCT05058404|Alkylating Agents|alkylating agents|mesh-ancestor
25669955|NCT05058404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669956|NCT05058404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25669957|NCT05058404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24816359|NCT02076659|Abortifacient Agents|abortifacient agents|mesh-ancestor
24794926|NCT04146935|Immunologic Factors|immunologic factors|mesh-ancestor
24794927|NCT04146935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105387|NCT03146390|Protective Agents|protective agents|mesh-ancestor
24820139|NCT02098889|Mydriatics|mydriatics|mesh-ancestor
24975144|NCT04698031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24975145|NCT04698031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24975146|NCT04698031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225345|NCT02627950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25225346|NCT02627950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25225347|NCT02627950|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25225348|NCT02627950|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25225349|NCT02627950|Dopamine Agents|dopamine agents|mesh-ancestor
25225350|NCT02627807|Gemcitabine|gemcitabine|mesh-list
25225351|NCT02627807|Cisplatin|cisplatin|mesh-list
24816360|NCT02076659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24816361|NCT02076659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507874|NCT00553020|Insulin Glargine|insulin glargine|mesh-list
24507955|NCT00553553|Sensory System Agents|sensory system agents|mesh-ancestor
24507956|NCT00553553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816362|NCT02076659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24816364|NCT02076659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816365|NCT02076659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816366|NCT02076659|Dermatologic Agents|dermatologic agents|mesh-ancestor
24884590|NCT00271817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24884591|NCT00271817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24884592|NCT00271817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24884593|NCT00271817|Vasodilator Agents|vasodilator agents|mesh-ancestor
24884594|NCT00271817|Vitamin B Complex|vitamin b complex|mesh-ancestor
24507957|NCT00553618|Aldesleukin|aldesleukin|mesh-list
24507958|NCT00553618|Dacarbazine|dacarbazine|mesh-list
24507959|NCT00553618|Interleukin-2|interleukin-2|mesh-list
24507960|NCT00553618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24507961|NCT00553618|Alkylating Agents|alkylating agents|mesh-ancestor
24507962|NCT00553618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507964|NCT00553618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24507965|NCT00553618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25058755|NCT03493087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058756|NCT03493087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25058757|NCT03493087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25058758|NCT03493087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058759|NCT03493087|Hemostatics|hemostatics|mesh-ancestor
25058760|NCT03493087|Coagulants|coagulants|mesh-ancestor
25058761|NCT03493061|Oxaliplatin|oxaliplatin|mesh-list
24508029|NCT00553943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24508030|NCT00553943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508031|NCT00553943|Immunologic Factors|immunologic factors|mesh-ancestor
24508032|NCT00553943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508033|NCT00553943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24508034|NCT00553943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24508035|NCT00553943|Antimetabolites|antimetabolites|mesh-ancestor
24508036|NCT00553943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058781|NCT03493048|Immunologic Factors|immunologic factors|mesh-ancestor
25058782|NCT03493048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058808|NCT03492931|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24884597|NCT00271817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884598|NCT00157937|Theophylline|theophylline|mesh-list
24884599|NCT00157937|Montelukast|montelukast|mesh-list
24884600|NCT00157937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24884601|NCT00157937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884602|NCT00157937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669958|NCT05058404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25669959|NCT05058404|Glucocorticoids|glucocorticoids|mesh-ancestor
25669960|NCT05058404|Hormones|hormones|mesh-ancestor
25669961|NCT05058404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25669962|NCT05058404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25669963|NCT05058404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25669964|NCT05058404|Tubulin Modulators|tubulin modulators|mesh-ancestor
25669965|NCT05058404|Antimitotic Agents|antimitotic agents|mesh-ancestor
25669966|NCT05058404|Mitosis Modulators|mitosis modulators|mesh-ancestor
25669967|NCT05058404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25669968|NCT05058404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25669969|NCT05058404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25669970|NCT05058404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24975277|NCT04401384|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
24884603|NCT00157937|Autonomic Agents|autonomic agents|mesh-ancestor
24884604|NCT00157937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24884605|NCT00157937|Respiratory System Agents|respiratory system agents|mesh-ancestor
24884606|NCT00157937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24884607|NCT00157937|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24884608|NCT00157937|Hormone Antagonists|hormone antagonists|mesh-ancestor
24884609|NCT00157937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24508045|NCT00553995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25058810|NCT03492931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25058811|NCT03492931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058812|NCT03492931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058813|NCT03492866|Gentamicins|gentamicins|mesh-list
24994449|NCT04138277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24884612|NCT00157937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24884613|NCT00157937|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24884614|NCT00157937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24884615|NCT00157937|Vasodilator Agents|vasodilator agents|mesh-ancestor
24884616|NCT00157937|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24884617|NCT00157937|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24884618|NCT00157937|Purinergic Agents|purinergic agents|mesh-ancestor
24884619|NCT00127647|Montelukast|montelukast|mesh-list
24884620|NCT00127647|Pranlukast|pranlukast|mesh-list
24884621|NCT00127647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24884622|NCT00127647|Respiratory System Agents|respiratory system agents|mesh-ancestor
25201503|NCT02727296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24508165|NCT00554424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24508167|NCT00554424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24508168|NCT00554424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508169|NCT00554450|Dapagliflozin|dapagliflozin|mesh-list
24508170|NCT00554450|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24508171|NCT00554450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508172|NCT00554450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24508173|NCT00554450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508174|NCT00554476|Triamcinolone|triamcinolone|mesh-list
24508175|NCT00554476|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24508176|NCT00554476|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24508177|NCT00554476|Indomethacin|indomethacin|mesh-list
24508198|NCT00554502|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24508199|NCT00554502|Immunosuppressive Agents|immunosuppressive agents|mesh-list
24508200|NCT00554502|Protease Inhibitors|protease inhibitors|mesh-ancestor
24508201|NCT00554502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508202|NCT00554502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058886|NCT03492580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058887|NCT03492580|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25058888|NCT03492580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058889|NCT03492580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25058890|NCT03492580|Hormones|hormones|mesh-ancestor
25058891|NCT03492580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25058892|NCT03492580|Incretins|incretins|mesh-ancestor
24508215|NCT00554528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24508216|NCT00554528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508217|NCT00554528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508218|NCT00554632|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24508219|NCT00554632|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24508220|NCT00554632|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24508221|NCT00554632|Norgestimate|norgestimate|mesh-list
24508222|NCT00554632|Norelgestromin|norelgestromin|mesh-list
24508224|NCT00554632|Estradiol|estradiol|mesh-list
24508225|NCT00554632|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24508226|NCT00554632|Estrogens|estrogens|mesh-ancestor
24508227|NCT00554632|Hormones|hormones|mesh-ancestor
24508228|NCT00554632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24508229|NCT00554632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884660|NCT03754153|Parasympatholytics|parasympatholytics|mesh-ancestor
25058909|NCT03492385|Ticagrelor|ticagrelor|mesh-list
25058910|NCT03492385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25058911|NCT03492385|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25058912|NCT03492385|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25431730|NCT00992901|Atropine|atropine|mesh-list
25669971|NCT04955236|Fentanyl|fentanyl|mesh-list
25669972|NCT04955236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24975370|NCT03968822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24975371|NCT03968822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25225366|NCT02627625|Tiotropium Bromide|tiotropium bromide|mesh-list
25225367|NCT02627625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25225368|NCT02627625|Autonomic Agents|autonomic agents|mesh-ancestor
25225369|NCT02627625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25225370|NCT02627625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225371|NCT02627625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25225372|NCT02627625|Respiratory System Agents|respiratory system agents|mesh-ancestor
25225373|NCT02627625|Parasympatholytics|parasympatholytics|mesh-ancestor
25225374|NCT02627625|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25225375|NCT02627625|Cholinergic Agents|cholinergic agents|mesh-ancestor
25225376|NCT02627625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25225377|NCT02627625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225378|NCT02627573|Mycophenolic Acid|mycophenolic acid|mesh-list
25058913|NCT03492385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25058914|NCT03492385|Purinergic Agents|purinergic agents|mesh-ancestor
24508230|NCT00554632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25865901|NCT00102453|Protective Agents|protective agents|mesh-ancestor
25865902|NCT00102453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865903|NCT00102453|Vasodilator Agents|vasodilator agents|mesh-ancestor
25865904|NCT00102453|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25865906|NCT00102479|Aripiprazole|aripiprazole|mesh-list
25865907|NCT00102479|Antidepressive Agents|antidepressive agents|mesh-ancestor
25865908|NCT00102479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25865909|NCT00102479|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25865910|NCT00102479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25865911|NCT00102479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25058936|NCT03492255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25058937|NCT03492255|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25058939|NCT03492255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24884672|NCT03753074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884673|NCT03753074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24884674|NCT03753074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24884675|NCT03746301|Rivaroxaban|rivaroxaban|mesh-list
24884676|NCT03746301|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24884677|NCT03746301|Antithrombins|antithrombins|mesh-ancestor
24884678|NCT03746301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24884679|NCT03746301|Protease Inhibitors|protease inhibitors|mesh-ancestor
24884680|NCT03746301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058940|NCT03492255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25058941|NCT03492255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058943|NCT03492255|Autonomic Agents|autonomic agents|mesh-ancestor
25058944|NCT03492255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25058945|NCT03492255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25058946|NCT03492255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25058947|NCT03492255|Protective Agents|protective agents|mesh-ancestor
25058948|NCT03492242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25058949|NCT03492242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058950|NCT03492242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25058951|NCT03492138|Dexamethasone|dexamethasone|mesh-list
25058952|NCT03492138|Ixazomib|ixazomib|mesh-list
25058953|NCT03492138|TIC10 compound|tic10 compound|mesh-list
25058954|NCT03492138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25058955|NCT03492138|Antiemetics|antiemetics|mesh-ancestor
25058956|NCT03492138|Autonomic Agents|autonomic agents|mesh-ancestor
25058957|NCT03492138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25669973|NCT04955236|Narcotics|narcotics|mesh-ancestor
25669974|NCT04955236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25669975|NCT04955236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669976|NCT04955236|Analgesics|analgesics|mesh-ancestor
25669977|NCT04955236|Sensory System Agents|sensory system agents|mesh-ancestor
25669978|NCT04955236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25669979|NCT04955236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25669980|NCT04955236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25669981|NCT04955236|Anesthetics, General|anesthetics, general|mesh-ancestor
25669982|NCT04955236|Anesthetics|anesthetics|mesh-ancestor
25669983|NCT04903652|Vinorelbine|vinorelbine|mesh-list
25669984|NCT04903652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25669985|NCT04903652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669986|NCT04903652|Tubulin Modulators|tubulin modulators|mesh-ancestor
25669987|NCT04903652|Antimitotic Agents|antimitotic agents|mesh-ancestor
25669988|NCT04903652|Mitosis Modulators|mitosis modulators|mesh-ancestor
25865912|NCT00102479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058958|NCT03492138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058959|NCT03492138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25058960|NCT03492138|Glucocorticoids|glucocorticoids|mesh-ancestor
25058961|NCT03492138|Hormones|hormones|mesh-ancestor
25058962|NCT03492138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25058963|NCT03492138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25058964|NCT03492138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25058965|NCT03492138|Protease Inhibitors|protease inhibitors|mesh-ancestor
25201504|NCT02727296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100244|NCT03184649|Analgesics|analgesics|mesh-ancestor
25058966|NCT03492138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058967|NCT03492138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058968|NCT03492047|Acetylcysteine|acetylcysteine|mesh-list
24508240|NCT00554658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24508241|NCT00554658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24508242|NCT00554658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24508243|NCT00554658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508244|NCT00554710|Methylprednisolone|methylprednisolone|mesh-list
24508245|NCT00554710|Budesonide|budesonide|mesh-list
24508246|NCT00554710|Azathioprine|azathioprine|mesh-list
24508247|NCT00554710|Infliximab|infliximab|mesh-list
24508248|NCT00554710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24508249|NCT00554710|Antiemetics|antiemetics|mesh-ancestor
24508250|NCT00554710|Autonomic Agents|autonomic agents|mesh-ancestor
24508251|NCT00554710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24508252|NCT00554710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508253|NCT00554710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24508262|NCT00554710|Respiratory System Agents|respiratory system agents|mesh-ancestor
24508263|NCT00554710|Dermatologic Agents|dermatologic agents|mesh-ancestor
25865913|NCT00102479|Dopamine Agonists|dopamine agonists|mesh-ancestor
25058970|NCT03492047|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24508270|NCT00554775|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24508271|NCT00554775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508272|NCT00554775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24508273|NCT00554775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24895197|NCT04843462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24508274|NCT00554775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508276|NCT00554827|Folic Acid|folic acid|mesh-list
24508277|NCT00554827|Vitamin B 12|vitamin b 12|mesh-list
24884687|NCT03727633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24884688|NCT03727633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24884689|NCT03727633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24884690|NCT03727633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24884691|NCT03727633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24884692|NCT03727633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508278|NCT00554827|Vitamin B Complex|vitamin b complex|mesh-list
24508279|NCT00554827|10-deazaaminopterin|10-deazaaminopterin|mesh-list
24508280|NCT00554827|Aminopterin|aminopterin|mesh-list
24508281|NCT00554827|Micronutrients|micronutrients|mesh-ancestor
24508282|NCT00554827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508283|NCT00554827|Hematinics|hematinics|mesh-ancestor
24508284|NCT00554827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24508285|NCT00554827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508286|NCT00554827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508287|NCT00554827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508288|NCT00554918|Zoledronic Acid|zoledronic acid|mesh-list
24508289|NCT00554918|Prednisolone|prednisolone|mesh-list
24508290|NCT00554918|Docetaxel|docetaxel|mesh-list
24508291|NCT00554918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508292|NCT00554918|Tubulin Modulators|tubulin modulators|mesh-ancestor
24508293|NCT00554918|Antimitotic Agents|antimitotic agents|mesh-ancestor
24508294|NCT00554918|Mitosis Modulators|mitosis modulators|mesh-ancestor
24508295|NCT00554918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508296|NCT00554918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24508297|NCT00554918|Glucocorticoids|glucocorticoids|mesh-ancestor
24508298|NCT00554918|Hormones|hormones|mesh-ancestor
24394203|NCT00132548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865914|NCT00102479|Dopamine Agents|dopamine agents|mesh-ancestor
25865915|NCT00102479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24508299|NCT00554918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24508300|NCT00554918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508301|NCT00554918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25669989|NCT04903652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25669990|NCT04894188|Goserelin|goserelin|mesh-list
24508302|NCT00554918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24508305|NCT00555022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24508306|NCT00555022|Autonomic Agents|autonomic agents|mesh-ancestor
25201505|NCT02727296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24508307|NCT00555022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24508316|NCT00555022|Anticonvulsants|anticonvulsants|mesh-ancestor
25058977|NCT03492047|Antiviral Agents|antiviral agents|mesh-ancestor
25058978|NCT03492047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25058979|NCT03492047|Expectorants|expectorants|mesh-ancestor
25058980|NCT03492047|Respiratory System Agents|respiratory system agents|mesh-ancestor
24884701|NCT03713086|Immunologic Factors|immunologic factors|mesh-ancestor
24884702|NCT03713086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884704|NCT03699540|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24884705|NCT03699540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24463769|NCT00362089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25865916|NCT00102479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865917|NCT00102479|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25865918|NCT00102479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25865919|NCT00102479|Serotonin Agents|serotonin agents|mesh-ancestor
24589053|NCT00905528|Telmisartan|telmisartan|mesh-list
24952832|NCT03892161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24952833|NCT03892161|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24952834|NCT03892161|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24952835|NCT03892161|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24952836|NCT03892161|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24952837|NCT03892161|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24952838|NCT03892161|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24952839|NCT03891615|Niraparib|niraparib|mesh-list
24952840|NCT03891615|Osimertinib|osimertinib|mesh-list
24952841|NCT03891615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24952842|NCT03891615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952843|NCT03891615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952844|NCT03891615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24952845|NCT03891615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24952846|NCT03891472|Fluorouracil|fluorouracil|mesh-list
24952847|NCT03891472|Oxaliplatin|oxaliplatin|mesh-list
24952848|NCT03891472|Irinotecan|irinotecan|mesh-list
24952849|NCT03891472|Antimetabolites|antimetabolites|mesh-ancestor
24952850|NCT03891472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952851|NCT03891472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24952852|NCT03891472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24952853|NCT03891472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24952854|NCT03891472|Immunologic Factors|immunologic factors|mesh-ancestor
24952855|NCT03891472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952879|NCT03891316|Sevoflurane|sevoflurane|mesh-list
24952880|NCT03891316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24952881|NCT03891316|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24952882|NCT03891316|Anesthetics, General|anesthetics, general|mesh-ancestor
24952884|NCT03891316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24952885|NCT03891316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952886|NCT03891277|Ferrous succinate|ferrous succinate|mesh-list
24952887|NCT03891277|Hematinics|hematinics|mesh-ancestor
24952889|NCT03891095|Oxytocics|oxytocics|mesh-ancestor
24952890|NCT03891095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24952891|NCT03891095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952892|NCT03891238|Avelumab|avelumab|mesh-list
24952893|NCT03891238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24821189|NCT02103764|Desogestrel|desogestrel|mesh-list
24394204|NCT00132548|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25865920|NCT00102479|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25865921|NCT00102479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25865922|NCT00102479|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25865923|NCT00102479|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25865924|NCT00102492|Casopitant|casopitant|mesh-list
25865925|NCT00102492|Antiemetics|antiemetics|mesh-ancestor
25865926|NCT00102492|Autonomic Agents|autonomic agents|mesh-ancestor
25865927|NCT00102492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25865928|NCT00102492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865929|NCT00102492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25865930|NCT00102492|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25865931|NCT00102492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24508388|NCT00555334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508389|NCT00555334|Antiviral Agents|antiviral agents|mesh-ancestor
24508390|NCT00555334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24508391|NCT00555334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24508392|NCT00555334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24508393|NCT00555347|Modafinil|modafinil|mesh-list
24508394|NCT00555347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24508395|NCT00555347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508396|NCT00555347|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24952894|NCT03891238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24952895|NCT03890952|Bevacizumab|bevacizumab|mesh-list
24952896|NCT03890952|Nivolumab|nivolumab|mesh-list
24952897|NCT03890952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
24952907|NCT03890809|Dermatologic Agents|dermatologic agents|mesh-ancestor
24952908|NCT03890809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24952909|NCT03890809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952910|NCT03890809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952911|NCT03891121|Botulinum Toxins|botulinum toxins|mesh-list
24952912|NCT03891121|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25058982|NCT03492047|Antioxidants|antioxidants|mesh-ancestor
25058983|NCT03492047|Protective Agents|protective agents|mesh-ancestor
25058984|NCT03492047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058985|NCT03492047|Antidotes|antidotes|mesh-ancestor
25058986|NCT03491969|Thioctic Acid|thioctic acid|mesh-list
25058988|NCT03491969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058989|NCT03491969|Protective Agents|protective agents|mesh-ancestor
25058990|NCT03491969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058991|NCT03491969|Vitamin B Complex|vitamin b complex|mesh-ancestor
25058992|NCT03491969|Vitamins|vitamins|mesh-ancestor
25058993|NCT03491969|Micronutrients|micronutrients|mesh-ancestor
25058994|NCT03491904|Fasinumab|fasinumab|mesh-list
24821201|NCT02103764|Progestins|progestins|mesh-ancestor
24884731|NCT03658304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24884732|NCT03658304|Alkylating Agents|alkylating agents|mesh-ancestor
25216434|NCT02684708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24884733|NCT03658304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508399|NCT00555347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508406|NCT00555373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24508408|NCT00555373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508409|NCT00555386|Selenium|selenium|mesh-list
24508410|NCT00555386|Antioxidants|antioxidants|mesh-ancestor
24508411|NCT00555386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508412|NCT00555386|Protective Agents|protective agents|mesh-ancestor
25058995|NCT03491904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25058997|NCT03491904|Sensory System Agents|sensory system agents|mesh-ancestor
25058998|NCT03491904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25058999|NCT03491904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059000|NCT03491761|Hyaluronic Acid|hyaluronic acid|mesh-list
25059001|NCT03491761|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25059002|NCT03491761|Immunologic Factors|immunologic factors|mesh-ancestor
25059003|NCT03491761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059004|NCT03491761|Viscosupplements|viscosupplements|mesh-ancestor
25059005|NCT03491761|Protective Agents|protective agents|mesh-ancestor
25059006|NCT03491748|Cefpodoxime|cefpodoxime|mesh-list
25059007|NCT03491748|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
25059008|NCT03491748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25059009|NCT03491748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25059011|NCT03491709|Antibodies|antibodies|mesh-list
25059012|NCT03491709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24508413|NCT00555386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508414|NCT00555386|Trace Elements|trace elements|mesh-ancestor
24508415|NCT00555386|Micronutrients|micronutrients|mesh-ancestor
24508416|NCT00555399|Temozolomide|temozolomide|mesh-list
24508417|NCT00555399|Vorinostat|vorinostat|mesh-list
24508418|NCT00555399|Isotretinoin|isotretinoin|mesh-list
25865932|NCT00102492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865933|NCT00102505|Motexafin gadolinium|motexafin gadolinium|mesh-list
25038223|NCT05262608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508422|NCT00555399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508424|NCT00555399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508425|NCT00555399|Dermatologic Agents|dermatologic agents|mesh-ancestor
24508426|NCT00555412|Loxapine|loxapine|mesh-list
24508427|NCT00555412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24508428|NCT00555412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24508429|NCT00555412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24508430|NCT00555412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508431|NCT00555412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24508432|NCT00555412|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24508433|NCT00555412|Dopamine Agents|dopamine agents|mesh-ancestor
24508434|NCT00555412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24975638|NCT03425838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975639|NCT03425838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24975640|NCT03425838|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24975652|NCT03364244|Vasodilator Agents|vasodilator agents|mesh-ancestor
24975653|NCT03364244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24975654|NCT03364244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24975655|NCT03364244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225438|NCT02627417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25225439|NCT02627417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508435|NCT00555412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508436|NCT00555542|Rituximab|rituximab|mesh-list
24508437|NCT00555542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24508438|NCT00555542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508439|NCT00555542|Immunologic Factors|immunologic factors|mesh-ancestor
24508440|NCT00555542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508441|NCT00555542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25059013|NCT03491709|Immunologic Factors|immunologic factors|mesh-ancestor
25059014|NCT03491709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059015|NCT03491709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25059016|NCT03491709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25059018|NCT03491696|Antimetabolites|antimetabolites|mesh-ancestor
24514814|NCT00593060|Cetuximab|cetuximab|mesh-list
25059019|NCT03491696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059020|NCT03491696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059021|NCT03491631|Apatinib|apatinib|mesh-list
25059022|NCT03491631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25059023|NCT03491631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25059024|NCT03491631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059025|NCT03491631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059026|NCT03491579|Cytarabine|cytarabine|mesh-list
24508442|NCT00555594|Bevacizumab|bevacizumab|mesh-list
24394206|NCT00132561|Artesunate|artesunate|mesh-list
24513038|NCT00578370|Cyclosporine|cyclosporine|mesh-list
25865934|NCT00102505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865935|NCT00102505|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24508443|NCT00555594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24508444|NCT00555594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508445|NCT00555594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24884758|NCT03629340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884761|NCT03618134|Durvalumab|durvalumab|mesh-list
24884762|NCT03618134|Ipilimumab|ipilimumab|mesh-list
24884763|NCT03618134|Tremelimumab|tremelimumab|mesh-list
24884764|NCT03618134|Immunoglobulins|immunoglobulins|mesh-list
24884765|NCT03618134|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24463830|NCT00362323|Metformin|metformin|mesh-list
24508477|NCT00555854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865936|NCT00102505|Dermatologic Agents|dermatologic agents|mesh-ancestor
25865937|NCT00102557|Hydroxychloroquine|hydroxychloroquine|mesh-list
24508478|NCT00555854|Sensory System Agents|sensory system agents|mesh-ancestor
24508479|NCT00555854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24508480|NCT00555867|Anastrozole|anastrozole|mesh-list
25059027|NCT03491579|Cladribine|cladribine|mesh-list
25059028|NCT03491579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25059029|NCT03491579|Antimetabolites|antimetabolites|mesh-ancestor
25059030|NCT03491579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059031|NCT03491579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25059032|NCT03491579|Antiviral Agents|antiviral agents|mesh-ancestor
25059033|NCT03491579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25059034|NCT03491579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25059035|NCT03491579|Immunologic Factors|immunologic factors|mesh-ancestor
25059036|NCT03491579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059037|NCT03491527|Salicylic Acid|salicylic acid|mesh-list
25059038|NCT03491527|Pemetrexed|pemetrexed|mesh-list
25059039|NCT03491527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669991|NCT04894188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25669992|NCT04894188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25669993|NCT04887285|Anesthetics|anesthetics|mesh-list
25669994|NCT04887285|Anesthetics, Local|anesthetics, local|mesh-list
25669995|NCT04887285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25669996|NCT04887285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25669997|NCT04887285|Sensory System Agents|sensory system agents|mesh-ancestor
25669998|NCT04887285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25669999|NCT04867135|Amikacin|amikacin|mesh-list
25670000|NCT04867135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25670001|NCT04867135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25865938|NCT00102557|Antimalarials|antimalarials|mesh-ancestor
24795065|NCT03783013|Protective Agents|protective agents|mesh-ancestor
24795066|NCT03783013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795067|NCT03783013|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24795068|NCT03783013|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24795069|NCT03783013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25059040|NCT03491527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24942848|NCT03977792|Antiviral Agents|antiviral agents|mesh-ancestor
25059054|NCT03491410|Aspirin|aspirin|mesh-list
25059055|NCT03491410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25059056|NCT03491410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25059057|NCT03491410|Analgesics|analgesics|mesh-ancestor
25059058|NCT03491410|Sensory System Agents|sensory system agents|mesh-ancestor
24821291|NCT02104284|Respiratory System Agents|respiratory system agents|mesh-ancestor
24821292|NCT02104284|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24821293|NCT02104284|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24821294|NCT02104284|Cholinergic Agents|cholinergic agents|mesh-ancestor
25059064|NCT03491410|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25059065|NCT03491410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059066|NCT03491410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25059067|NCT03491410|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25059068|NCT03491410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059070|NCT03491371|Apatinib|apatinib|mesh-list
25059071|NCT03491371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25059072|NCT03491371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25059073|NCT03491371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059074|NCT03491371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059078|NCT03491098|Mometasone Furoate|mometasone furoate|mesh-list
25059079|NCT03491098|Prednisolone|prednisolone|mesh-list
25059080|NCT03491098|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25059081|NCT03491098|Methylprednisolone|methylprednisolone|mesh-list
25059082|NCT03491098|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25059083|NCT03491098|Prednisolone acetate|prednisolone acetate|mesh-list
25059084|NCT03491098|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25059085|NCT03491098|Prednisolone phosphate|prednisolone phosphate|mesh-list
25059086|NCT03491098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25059087|NCT03491098|Glucocorticoids|glucocorticoids|mesh-ancestor
25059088|NCT03491098|Hormones|hormones|mesh-ancestor
24821295|NCT02104284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24821297|NCT02104297|Remifentanil|remifentanil|mesh-list
24508481|NCT00555867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24508482|NCT00555867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508483|NCT00555867|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24508484|NCT00555867|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24508485|NCT00555867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508486|NCT00555867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508487|NCT00555867|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24884772|NCT03618134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884774|NCT03603509|Immunologic Factors|immunologic factors|mesh-ancestor
24884775|NCT03603509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884776|NCT03580161|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
24884777|NCT03580161|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
25038380|NCT05190315|Temozolomide|temozolomide|mesh-list
24884779|NCT03580161|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
24884780|NCT03580161|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24884781|NCT03580161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884782|NCT03571334|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24884783|NCT03571334|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24884784|NCT03571334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24884785|NCT03571334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101194|NCT03176758|Anesthetics, General|anesthetics, general|mesh-list
24463835|NCT00362323|Antimetabolites|antimetabolites|mesh-ancestor
25865939|NCT00102557|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25865940|NCT00102557|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25865941|NCT00102557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24508513|NCT00556023|Antiviral Agents|antiviral agents|mesh-ancestor
24508514|NCT00556023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25059112|NCT03491072|Narcotics|narcotics|mesh-ancestor
25059113|NCT03491072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25431807|NCT00980460|Antimitotic Agents|antimitotic agents|mesh-ancestor
25670002|NCT04860661|Esketamine|esketamine|mesh-list
25670003|NCT04860661|Antidepressive Agents|antidepressive agents|mesh-ancestor
25670004|NCT04860661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25670005|NCT04858776|Dexamethasone|dexamethasone|mesh-list
25670006|NCT04858776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25670007|NCT04858776|Antiemetics|antiemetics|mesh-ancestor
25865942|NCT00102557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059114|NCT03491072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059115|NCT03491072|Analgesics|analgesics|mesh-ancestor
25059116|NCT03491072|Sensory System Agents|sensory system agents|mesh-ancestor
25059117|NCT03491072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25059118|NCT03491072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25059119|NCT03491072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25059120|NCT03491072|Anesthetics, General|anesthetics, general|mesh-ancestor
25059121|NCT03491072|Anesthetics|anesthetics|mesh-ancestor
25059122|NCT03490994|Warfarin|warfarin|mesh-list
25059123|NCT03490994|Rivaroxaban|rivaroxaban|mesh-list
25059124|NCT03490994|Anticoagulants|anticoagulants|mesh-ancestor
25059125|NCT03490994|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25059126|NCT03490994|Antithrombins|antithrombins|mesh-ancestor
25059128|NCT03490994|Protease Inhibitors|protease inhibitors|mesh-ancestor
25059129|NCT03490994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059130|NCT03490994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059131|NCT03490825|Melatonin|melatonin|mesh-list
24410850|NCT00187070|Hormones|hormones|mesh-ancestor
24508515|NCT00556023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508516|NCT00556023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24508517|NCT00556023|Immunologic Factors|immunologic factors|mesh-ancestor
24508518|NCT00556023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508519|NCT00556062|Vaccines|vaccines|mesh-list
24508520|NCT00556062|Immunologic Factors|immunologic factors|mesh-ancestor
24508521|NCT00556062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508522|NCT00556088|Paclitaxel|paclitaxel|mesh-list
24508523|NCT00556088|Bevacizumab|bevacizumab|mesh-list
24508524|NCT00556088|Carboplatin|carboplatin|mesh-list
24508525|NCT00556088|Panobinostat|panobinostat|mesh-list
24508526|NCT00556088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25059138|NCT03490708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25059139|NCT03490708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25059140|NCT03490708|Analgesics|analgesics|mesh-ancestor
25059141|NCT03490708|Sensory System Agents|sensory system agents|mesh-ancestor
25059142|NCT03490708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25059143|NCT03490708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059144|NCT03490708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25059145|NCT03490708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25059146|NCT03490708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25059147|NCT03490708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25059148|NCT03490708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059149|NCT03490708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25059150|NCT03490708|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25059151|NCT03490708|Histamine Antagonists|histamine antagonists|mesh-ancestor
25059152|NCT03490708|Histamine Agents|histamine agents|mesh-ancestor
25059153|NCT03490708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25059154|NCT03490708|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24508575|NCT00556127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24508577|NCT00556127|Antiviral Agents|antiviral agents|mesh-ancestor
24508578|NCT00556127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24508579|NCT00556127|Tubulin Modulators|tubulin modulators|mesh-ancestor
25059158|NCT03490617|Abortifacient Agents|abortifacient agents|mesh-ancestor
25059159|NCT03490617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25059160|NCT03490617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059161|NCT03490617|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25059162|NCT03490617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25059163|NCT03490617|Oxytocics|oxytocics|mesh-ancestor
25059164|NCT03490539|Mycophenolic Acid|mycophenolic acid|mesh-list
25059165|NCT03490539|Azathioprine|azathioprine|mesh-list
25059166|NCT03490539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25059167|NCT03490539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25059168|NCT03490539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25201506|NCT02727296|Anesthetics, General|anesthetics, general|mesh-ancestor
25059169|NCT03490539|Antitubercular Agents|antitubercular agents|mesh-ancestor
25201507|NCT02727296|Anesthetics|anesthetics|mesh-ancestor
25059170|NCT03490539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25059171|NCT03490539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25059172|NCT03490539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059173|NCT03490539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059174|NCT03490539|Antimetabolites|antimetabolites|mesh-ancestor
25059175|NCT03490539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25059176|NCT03490539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24514940|NCT00593502|Oseltamivir|oseltamivir|mesh-list
24514991|NCT00593710|Autonomic Agents|autonomic agents|mesh-ancestor
25059177|NCT03490539|Immunologic Factors|immunologic factors|mesh-ancestor
25059178|NCT03490539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059179|NCT03490539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25059180|NCT03490487|Prednisolone|prednisolone|mesh-list
25059181|NCT03490487|Carbamazepine|carbamazepine|mesh-list
25059182|NCT03490487|Oxcarbazepine|oxcarbazepine|mesh-list
25059183|NCT03490487|Levetiracetam|levetiracetam|mesh-list
25059184|NCT03490487|Valproic Acid|valproic acid|mesh-list
25059185|NCT03490487|Anticonvulsants|anticonvulsants|mesh-list
25059186|NCT03490487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25059187|NCT03490487|Glucocorticoids|glucocorticoids|mesh-ancestor
25059188|NCT03490487|Hormones|hormones|mesh-ancestor
25059189|NCT03490487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25059190|NCT03490487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508614|NCT00556257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24508615|NCT00556257|Dermatologic Agents|dermatologic agents|mesh-ancestor
24508616|NCT00556257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24508617|NCT00556257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24508619|NCT00556270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24508621|NCT00556270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24508622|NCT00556270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508623|NCT00556270|Analgesics|analgesics|mesh-ancestor
24884800|NCT03493126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24884801|NCT03493126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884804|NCT03460015|Propofol|propofol|mesh-list
24884805|NCT03460015|Sevoflurane|sevoflurane|mesh-list
24884806|NCT03460015|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24884807|NCT03460015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24508637|NCT00556296|Dopamine Agents|dopamine agents|mesh-ancestor
24508669|NCT00556387|Anesthetics|anesthetics|mesh-ancestor
25865943|NCT00102557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831264|NCT02164578|Aspirin|aspirin|mesh-list
25865944|NCT00102557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25865945|NCT00102583|Cyclosporine|cyclosporine|mesh-list
25865946|NCT00102583|Cyclosporins|cyclosporins|mesh-list
24508676|NCT00556413|Fluorouracil|fluorouracil|mesh-list
24508677|NCT00556413|Oxaliplatin|oxaliplatin|mesh-list
24508678|NCT00556413|Irinotecan|irinotecan|mesh-list
24508679|NCT00556413|Cetuximab|cetuximab|mesh-list
24884812|NCT03460015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24884813|NCT03460015|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24884815|NCT03459859|Pevonedistat|pevonedistat|mesh-list
24508680|NCT00556413|Calcium|calcium|mesh-list
25865947|NCT00102583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865948|NCT00102583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865949|NCT00102583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25865950|NCT00102583|Immunologic Factors|immunologic factors|mesh-ancestor
25865951|NCT00102583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865952|NCT00102583|Antifungal Agents|antifungal agents|mesh-ancestor
25865953|NCT00102583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25865954|NCT00102583|Dermatologic Agents|dermatologic agents|mesh-ancestor
25865955|NCT00102583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25865956|NCT00102583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25865957|NCT00102609|Dexamethasone|dexamethasone|mesh-list
25865958|NCT00102609|Doxorubicin|doxorubicin|mesh-list
25865959|NCT00102609|Trabectedin|trabectedin|mesh-list
25101584|NCT03173781|Droxidopa|droxidopa|mesh-list
25865960|NCT00102609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25865961|NCT00102609|Antiemetics|antiemetics|mesh-ancestor
25865962|NCT00102609|Autonomic Agents|autonomic agents|mesh-ancestor
25865963|NCT00102609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25865964|NCT00102609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25865965|NCT00102609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25865966|NCT00102609|Glucocorticoids|glucocorticoids|mesh-ancestor
24508705|NCT00556465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24508706|NCT00556465|Antioxidants|antioxidants|mesh-ancestor
24508707|NCT00556465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508708|NCT00556465|Protective Agents|protective agents|mesh-ancestor
24508709|NCT00556465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508710|NCT00556465|Antidotes|antidotes|mesh-ancestor
24943011|NCT03975166|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24943012|NCT03975166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24768091|NCT01805700|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24768092|NCT01805700|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25038544|NCT04961619|Trametinib|trametinib|mesh-list
24508747|NCT00556699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508748|NCT00556699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24508749|NCT00556959|Clonidine|clonidine|mesh-list
24508754|NCT00556959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24508755|NCT00556959|Sympatholytics|sympatholytics|mesh-ancestor
24508756|NCT00556959|Autonomic Agents|autonomic agents|mesh-ancestor
24508757|NCT00556959|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25865967|NCT00102609|Hormones|hormones|mesh-ancestor
24975918|NCT02573233|Glucocorticoids|glucocorticoids|mesh-ancestor
24975919|NCT02573233|Hormones|hormones|mesh-ancestor
24975920|NCT02573233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24975921|NCT02573233|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24975922|NCT02573233|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24975923|NCT02573233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24975924|NCT02573233|Adrenergic Agents|adrenergic agents|mesh-ancestor
24975936|NCT02439658|Sympatholytics|sympatholytics|mesh-ancestor
24975937|NCT02439658|Autonomic Agents|autonomic agents|mesh-ancestor
24975938|NCT02439658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24508764|NCT00557011|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
24394209|NCT00132561|Antimalarials|antimalarials|mesh-ancestor
25865968|NCT00102609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25865969|NCT00102609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25865970|NCT00102609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865971|NCT00102609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25865972|NCT00102609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24508766|NCT00557011|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24508767|NCT00557011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508768|NCT00557011|Sympathomimetics|sympathomimetics|mesh-ancestor
24508769|NCT00557011|Autonomic Agents|autonomic agents|mesh-ancestor
25038603|NCT04873583|Antiemetics|antiemetics|mesh-ancestor
24943019|NCT03975166|Dermatologic Agents|dermatologic agents|mesh-ancestor
24895499|NCT04006210|Levodopa|levodopa|mesh-list
24943020|NCT03975166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24943021|NCT03975166|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24943022|NCT03975166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24943023|NCT03975166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24943024|NCT03975166|Adrenergic Agents|adrenergic agents|mesh-ancestor
25059202|NCT03490487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25059203|NCT03490487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25059204|NCT03490487|Analgesics|analgesics|mesh-ancestor
25059205|NCT03490487|Sensory System Agents|sensory system agents|mesh-ancestor
25059206|NCT03490487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25059207|NCT03490487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25059208|NCT03490487|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25059209|NCT03490487|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25059210|NCT03490487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25059211|NCT03490396|Povidone|povidone|mesh-list
25059212|NCT03490396|Hyaluronic Acid|hyaluronic acid|mesh-list
25201508|NCT02727296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24729821|NCT01624064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059213|NCT03490396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25059214|NCT03490396|Immunologic Factors|immunologic factors|mesh-ancestor
25059215|NCT03490396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059216|NCT03490396|Viscosupplements|viscosupplements|mesh-ancestor
25059217|NCT03490396|Protective Agents|protective agents|mesh-ancestor
25059218|NCT03490396|Plasma Substitutes|plasma substitutes|mesh-ancestor
25059219|NCT03490396|Blood Substitutes|blood substitutes|mesh-ancestor
25059220|NCT03490279|Lactoferrin|lactoferrin|mesh-list
25059221|NCT03490279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25059222|NCT03490123|Azithromycin|azithromycin|mesh-list
25059223|NCT03490123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24508776|NCT00557011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24508777|NCT00557011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24508778|NCT00557011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24508779|NCT00557102|Leucovorin|leucovorin|mesh-list
24508780|NCT00557102|Fluorouracil|fluorouracil|mesh-list
25059224|NCT03490123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25059225|NCT03490097|Sofosbuvir|sofosbuvir|mesh-list
25059226|NCT03490097|Simvastatin|simvastatin|mesh-list
25059227|NCT03490097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25059228|NCT03490097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25059229|NCT03490097|Antimetabolites|antimetabolites|mesh-ancestor
25059230|NCT03490097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670008|NCT04858776|Autonomic Agents|autonomic agents|mesh-ancestor
25670009|NCT04858776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25670010|NCT04858776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670011|NCT04858776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25670012|NCT04858776|Glucocorticoids|glucocorticoids|mesh-ancestor
25670013|NCT04858776|Hormones|hormones|mesh-ancestor
25670014|NCT04858776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25670015|NCT04858776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25670016|NCT04858776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670017|NCT04838717|Doxycycline|doxycycline|mesh-list
25059231|NCT03490097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25059232|NCT03490097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25059233|NCT03490097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059234|NCT03490097|Antiviral Agents|antiviral agents|mesh-ancestor
25059235|NCT03490097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24884859|NCT03339284|Dexamethasone acetate|dexamethasone acetate|mesh-list
24884860|NCT03339284|Ropivacaine|ropivacaine|mesh-list
24884861|NCT03339284|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24508816|NCT00557180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508817|NCT00557180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24508818|NCT00557180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24508819|NCT00557180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24508820|NCT00557180|Adrenergic Agents|adrenergic agents|mesh-ancestor
24508821|NCT00557180|Anticonvulsants|anticonvulsants|mesh-ancestor
24508822|NCT00557180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24508823|NCT00557180|Glucocorticoids|glucocorticoids|mesh-ancestor
24508824|NCT00557180|Hormones|hormones|mesh-ancestor
24508825|NCT00557180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24508826|NCT00557206|Docetaxel|docetaxel|mesh-list
24508827|NCT00557206|Oxaliplatin|oxaliplatin|mesh-list
24508828|NCT00557206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508829|NCT00557206|Tubulin Modulators|tubulin modulators|mesh-ancestor
24508830|NCT00557206|Antimitotic Agents|antimitotic agents|mesh-ancestor
24508831|NCT00557206|Mitosis Modulators|mitosis modulators|mesh-ancestor
25059244|NCT03489928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059245|NCT03489928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25059246|NCT03489928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25059247|NCT03489928|Oxytocics|oxytocics|mesh-ancestor
25059248|NCT03489889|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25059249|NCT03489889|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25059250|NCT03489889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25059272|NCT03489629|Trimethoprim|trimethoprim|mesh-list
25059273|NCT03489629|Sulfamethoxazole|sulfamethoxazole|mesh-list
25059274|NCT03489629|Mupirocin|mupirocin|mesh-list
24884888|NCT03301857|Immunoglobulin G|immunoglobulin g|mesh-list
24508832|NCT00557206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508855|NCT00557427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24508856|NCT00557427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24508857|NCT00557427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508858|NCT00557427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24508860|NCT00557427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508861|NCT00557427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24508862|NCT00557427|Antidepressive Agents|antidepressive agents|mesh-ancestor
24508863|NCT00557427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24508864|NCT00557427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24508865|NCT00557427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24508866|NCT00557427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508867|NCT00557453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25059275|NCT03489629|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25059276|NCT03489629|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25201509|NCT02727296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25865973|NCT00102609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25059277|NCT03489629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25059278|NCT03489629|Disinfectants|disinfectants|mesh-ancestor
25059279|NCT03489629|Dermatologic Agents|dermatologic agents|mesh-ancestor
25059280|NCT03489629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25059281|NCT03489629|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25059282|NCT03489629|Renal Agents|renal agents|mesh-ancestor
25059283|NCT03489629|Antimalarials|antimalarials|mesh-ancestor
25059284|NCT03489629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25059285|NCT03489629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25059286|NCT03489629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25059287|NCT03489629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821517|NCT02106130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24508868|NCT00557453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24508869|NCT00557453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24508870|NCT00557453|Antitubercular Agents|antitubercular agents|mesh-ancestor
24508877|NCT00557544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24508878|NCT00557544|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24508879|NCT00557544|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24508880|NCT00557544|Dopamine Agents|dopamine agents|mesh-ancestor
24508881|NCT00557544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24508882|NCT00557544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508883|NCT00557544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24976123|NCT01336634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795107|NCT03626922|Antiemetics|antiemetics|mesh-ancestor
24976124|NCT01312857|Panitumumab|panitumumab|mesh-list
24976125|NCT01312857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24976126|NCT01312857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508884|NCT00557544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24508885|NCT00557544|Analgesics|analgesics|mesh-ancestor
24508886|NCT00557544|Sensory System Agents|sensory system agents|mesh-ancestor
24508902|NCT00557700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24508903|NCT00557700|Cholinergic Agents|cholinergic agents|mesh-ancestor
24508904|NCT00557700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24508905|NCT00557700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508906|NCT00557700|Anticonvulsants|anticonvulsants|mesh-ancestor
24508907|NCT00557713|Bevacizumab|bevacizumab|mesh-list
24508908|NCT00557713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24508909|NCT00557713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508910|NCT00557713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24508911|NCT00557713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24508912|NCT00557713|Growth Substances|growth substances|mesh-ancestor
24508913|NCT00557713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508914|NCT00557713|Growth Inhibitors|growth inhibitors|mesh-ancestor
24508915|NCT00557739|Mometasone Furoate|mometasone furoate|mesh-list
24508916|NCT00557739|Nortriptyline|nortriptyline|mesh-list
25059288|NCT03489629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059289|NCT03489629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25059290|NCT03489629|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25059291|NCT03489629|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25059292|NCT03489629|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25059293|NCT03489616|Pemetrexed|pemetrexed|mesh-list
25059294|NCT03489616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25059295|NCT03489616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059296|NCT03489616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059297|NCT03489616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25059298|NCT03489616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24943047|NCT03975010|Analgesics|analgesics|mesh-ancestor
25059299|NCT03489395|Edoxaban|edoxaban|mesh-list
24884885|NCT03316586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884887|NCT03301857|Immunoglobulins|immunoglobulins|mesh-list
24884890|NCT03301857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884891|NCT03301857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24884893|NCT03277066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24884894|NCT03277066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24884895|NCT03277066|Analgesics|analgesics|mesh-ancestor
24884896|NCT03277066|Sensory System Agents|sensory system agents|mesh-ancestor
24884897|NCT03277066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25865974|NCT00102609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865975|NCT00102609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865976|NCT00102609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25865977|NCT00102609|Alkylating Agents|alkylating agents|mesh-ancestor
25865978|NCT00102622|Paclitaxel|paclitaxel|mesh-list
25201510|NCT02727348|Anesthetics|anesthetics|mesh-list
24508945|NCT00557843|Sensory System Agents|sensory system agents|mesh-ancestor
24508946|NCT00557843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24508948|NCT00557921|Omeprazole|omeprazole|mesh-list
24508949|NCT00557921|Clopidogrel|clopidogrel|mesh-list
24508950|NCT00557921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25059308|NCT03489317|Amlodipine|amlodipine|mesh-list
25059309|NCT03489317|Simvastatin|simvastatin|mesh-list
25059310|NCT03489317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25059311|NCT03489317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059312|NCT03489317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25059313|NCT03489317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25059314|NCT03489317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25059315|NCT03489317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059316|NCT03489317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25670018|NCT04838717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25670019|NCT04838717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25670020|NCT04838717|Antimalarials|antimalarials|mesh-ancestor
25670021|NCT04838717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25670022|NCT04838717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25670023|NCT04834557|Digoxin|digoxin|mesh-list
25670024|NCT04834557|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24976221|NCT04335669|Capecitabine|capecitabine|mesh-list
24976222|NCT04335669|Epirubicin|epirubicin|mesh-list
24976223|NCT04335669|Taxane|taxane|mesh-list
24839107|NCT02202239|Propofol|propofol|mesh-list
25059317|NCT03489317|Vasodilator Agents|vasodilator agents|mesh-ancestor
25059318|NCT03489317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25059319|NCT03489317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25059320|NCT03489317|Antimetabolites|antimetabolites|mesh-ancestor
25059321|NCT03489317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25059322|NCT03489317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25059323|NCT03489317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059324|NCT03489265|Eluxadoline|eluxadoline|mesh-list
25059325|NCT03489265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25059326|NCT03489239|Tenofovir|tenofovir|mesh-list
25038782|NCT04528563|Analgesics|analgesics|mesh-ancestor
25865979|NCT00102622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25865980|NCT00102622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865981|NCT00102622|Tubulin Modulators|tubulin modulators|mesh-ancestor
25865982|NCT00102622|Antimitotic Agents|antimitotic agents|mesh-ancestor
25865983|NCT00102622|Mitosis Modulators|mitosis modulators|mesh-ancestor
25865984|NCT00102622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508999|NCT00557960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24509000|NCT00557960|Dopamine Agents|dopamine agents|mesh-ancestor
24816368|NCT02076659|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24816369|NCT02076659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24612375|NCT01013558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24612376|NCT01013571|Insulin|insulin|mesh-list
24612377|NCT01013571|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24612378|NCT01013571|Insulin Glargine|insulin glargine|mesh-list
24509001|NCT00557960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24509002|NCT00558051|Vaccines|vaccines|mesh-list
24509003|NCT00558051|Immunologic Factors|immunologic factors|mesh-ancestor
25059329|NCT03489239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25059330|NCT03489239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25059331|NCT03489239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059332|NCT03489239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059333|NCT03489239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25059334|NCT03489239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25059335|NCT03489161|Buprenorphine|buprenorphine|mesh-list
25059336|NCT03489161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25059337|NCT03489161|Narcotics|narcotics|mesh-ancestor
25059338|NCT03489161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25059339|NCT03489161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059340|NCT03489161|Analgesics|analgesics|mesh-ancestor
25059341|NCT03489161|Sensory System Agents|sensory system agents|mesh-ancestor
25059342|NCT03489161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25059343|NCT03489161|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25059344|NCT03489044|Levetiracetam|levetiracetam|mesh-list
25059345|NCT03489044|Anticonvulsants|anticonvulsants|mesh-ancestor
25059346|NCT03489044|Nootropic Agents|nootropic agents|mesh-ancestor
25059350|NCT03489005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25059351|NCT03489005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24509004|NCT00558051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509005|NCT00558077|Metformin|metformin|mesh-list
24509006|NCT00558077|Clomiphene|clomiphene|mesh-list
24509007|NCT00558077|Enclomiphene|enclomiphene|mesh-list
24509008|NCT00558077|Zuclomiphene|zuclomiphene|mesh-list
24509023|NCT00558090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509025|NCT00558090|Sensory System Agents|sensory system agents|mesh-ancestor
24509026|NCT00558090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24509027|NCT00558142|Acetylcysteine|acetylcysteine|mesh-list
24509028|NCT00558142|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24509045|NCT00558181|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25059352|NCT03489005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25059353|NCT03489005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059354|NCT03489005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059355|NCT03489005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670025|NCT04834557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25670026|NCT04834557|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25670027|NCT04834557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059356|NCT03488888|Bupivacaine|bupivacaine|mesh-list
25670028|NCT04834557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670029|NCT04834557|Protective Agents|protective agents|mesh-ancestor
25670030|NCT04834557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670031|NCT04834557|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25670032|NCT04834557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25670033|NCT04826692|Metformin|metformin|mesh-list
25670034|NCT04826692|Biguanides|biguanides|mesh-list
24976299|NCT04188028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24976300|NCT04188028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976301|NCT04188028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24976302|NCT04188028|Serotonin Agents|serotonin agents|mesh-ancestor
24976303|NCT04188028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976304|NCT04188028|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25059357|NCT03488888|Anesthetics, Local|anesthetics, local|mesh-ancestor
25059358|NCT03488888|Anesthetics|anesthetics|mesh-ancestor
25059359|NCT03488888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25059360|NCT03488888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059361|NCT03488888|Sensory System Agents|sensory system agents|mesh-ancestor
25059362|NCT03488888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25059363|NCT03488810|Hormones|hormones|mesh-list
25059364|NCT03488810|Androgens|androgens|mesh-list
25059365|NCT03488810|Androgen Antagonists|androgen antagonists|mesh-list
25059366|NCT03488810|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
25059367|NCT03488810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24821599|NCT02106767|Antimetabolites|antimetabolites|mesh-ancestor
24509046|NCT00558181|Prednisolone phosphate|prednisolone phosphate|mesh-list
24509047|NCT00558181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24509048|NCT00558181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509049|NCT00558181|Immunologic Factors|immunologic factors|mesh-ancestor
24509050|NCT00558181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509053|NCT00558181|Antiemetics|antiemetics|mesh-ancestor
25042159|NCT01495013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24509077|NCT00558337|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24509078|NCT00558337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24509079|NCT00558337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24509080|NCT00558337|Dopamine Agents|dopamine agents|mesh-ancestor
24509081|NCT00558337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24509082|NCT00558337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509083|NCT00558337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059382|NCT03488719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059384|NCT03488485|Antiviral Agents|antiviral agents|mesh-list
25059385|NCT03488485|Ledipasvir|ledipasvir|mesh-list
25059386|NCT03488485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25059387|NCT03488316|Calcium|calcium|mesh-list
25059388|NCT03488316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25059389|NCT03488316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059401|NCT03488186|Lansoprazole|lansoprazole|mesh-list
25059402|NCT03488186|Dexlansoprazole|dexlansoprazole|mesh-list
25059403|NCT03488186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25059404|NCT03488186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25059405|NCT03488186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25865985|NCT00102635|Fenretinide|fenretinide|mesh-list
25865986|NCT00102635|Lonafarnib|lonafarnib|mesh-list
25059406|NCT03488186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059407|NCT03488186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059408|NCT03488173|Lansoprazole|lansoprazole|mesh-list
25059409|NCT03488173|Dexlansoprazole|dexlansoprazole|mesh-list
25059410|NCT03488173|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25059415|NCT03488147|Esomeprazole|esomeprazole|mesh-list
25059416|NCT03488147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25059417|NCT03488147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25059418|NCT03488147|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25059419|NCT03488147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865987|NCT00102635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25059420|NCT03488147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059421|NCT03487939|Fluorouracil|fluorouracil|mesh-list
25059422|NCT03487939|Oxaliplatin|oxaliplatin|mesh-list
25059423|NCT03487939|Irinotecan|irinotecan|mesh-list
25059424|NCT03487939|Antimetabolites|antimetabolites|mesh-ancestor
25059425|NCT03487939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059426|NCT03487939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25059427|NCT03487939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25059428|NCT03487939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25059429|NCT03487939|Immunologic Factors|immunologic factors|mesh-ancestor
25059430|NCT03487939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670035|NCT04826692|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25670036|NCT04826692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670037|NCT04826237|Dexamethasone|dexamethasone|mesh-list
25670038|NCT04826237|Methylprednisolone|methylprednisolone|mesh-list
25670039|NCT04826237|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25670040|NCT04826237|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25670041|NCT04826237|Prednisolone|prednisolone|mesh-list
25670042|NCT04826237|Prednisolone acetate|prednisolone acetate|mesh-list
25059432|NCT03487939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25059433|NCT03487939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059434|NCT03487874|Ropivacaine|ropivacaine|mesh-list
25059435|NCT03487874|Anesthetics, Local|anesthetics, local|mesh-ancestor
25059436|NCT03487874|Anesthetics|anesthetics|mesh-ancestor
25059437|NCT03487874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25059447|NCT03487809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25059448|NCT03487809|Respiratory System Agents|respiratory system agents|mesh-ancestor
24768357|NCT01807494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768358|NCT01807494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768359|NCT01807494|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24768360|NCT01807494|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24768362|NCT01807611|Mycophenolic Acid|mycophenolic acid|mesh-list
24943281|NCT03973047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943282|NCT03973047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24943283|NCT03973047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24943284|NCT03973047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24943285|NCT03973047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24943286|NCT03973047|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24821686|NCT02107365|Ribavirin|ribavirin|mesh-list
24821687|NCT02107365|Interferon-alpha|interferon-alpha|mesh-list
24821688|NCT02107365|Interferon alpha-2|interferon alpha-2|mesh-list
24623459|NCT01071525|Vasodilator Agents|vasodilator agents|mesh-ancestor
24623460|NCT01071525|Vitamin B Complex|vitamin b complex|mesh-ancestor
24623461|NCT01071525|Vitamins|vitamins|mesh-ancestor
24623462|NCT01071525|Micronutrients|micronutrients|mesh-ancestor
24623463|NCT01071525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623464|NCT01071564|R04929097|r04929097|mesh-list
24623465|NCT01071564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623466|NCT01071564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623467|NCT01071655|Fluorouracil|fluorouracil|mesh-list
24623468|NCT01071655|Antimetabolites|antimetabolites|mesh-ancestor
24623469|NCT01071655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623470|NCT01071655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24623471|NCT01071655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623472|NCT01071655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24509144|NCT00558961|Imatinib Mesylate|imatinib mesylate|mesh-list
24509146|NCT00558961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943288|NCT03972592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24943289|NCT03972592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24943290|NCT03972592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24943291|NCT03972592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943292|NCT03972592|Antifungal Agents|antifungal agents|mesh-ancestor
24943293|NCT03972592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24943294|NCT03972592|Immunologic Factors|immunologic factors|mesh-ancestor
24943295|NCT03972592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943296|NCT03972683|Atropine|atropine|mesh-list
24943297|NCT03972683|Adenosine|adenosine|mesh-list
24943298|NCT03972683|Nitroprusside|nitroprusside|mesh-list
25201511|NCT02727348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25201512|NCT02727348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943299|NCT03972683|Phenylephrine|phenylephrine|mesh-list
24943300|NCT03972683|Oxymetazoline|oxymetazoline|mesh-list
24943301|NCT03972683|Acetylcholine|acetylcholine|mesh-list
24943302|NCT03972683|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24943303|NCT03972683|Mydriatics|mydriatics|mesh-ancestor
24943304|NCT03972683|Autonomic Agents|autonomic agents|mesh-ancestor
24943305|NCT03972683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24943306|NCT03972683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943307|NCT03972683|Sympathomimetics|sympathomimetics|mesh-ancestor
24943308|NCT03972683|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24943309|NCT03972683|Nasal Decongestants|nasal decongestants|mesh-ancestor
24821706|NCT02107378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509147|NCT00558961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24509148|NCT00558961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24509149|NCT00558961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509150|NCT00558961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24509151|NCT00558961|Alkylating Agents|alkylating agents|mesh-ancestor
24623474|NCT01071655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623476|NCT01071681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24623477|NCT01071681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24623478|NCT01071681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24623479|NCT01071681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976478|NCT03557242|Anticoagulants|anticoagulants|mesh-ancestor
24976490|NCT03508739|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24976491|NCT03508739|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24976492|NCT03508739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976493|NCT03473561|Racecadotril|racecadotril|mesh-list
24976494|NCT03473561|Antidiarrheals|antidiarrheals|mesh-ancestor
24976495|NCT03473561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24976496|NCT03473561|Protease Inhibitors|protease inhibitors|mesh-ancestor
24976497|NCT03473561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225513|NCT02626845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225514|NCT02626845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25225515|NCT02626364|Crenolanib|crenolanib|mesh-list
25225516|NCT02626364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225517|NCT02626559|Bupivacaine|bupivacaine|mesh-list
24623480|NCT01071694|Interferons|interferons|mesh-list
24623481|NCT01071694|Interferon-beta|interferon-beta|mesh-list
24623482|NCT01071694|Interferon beta-1b|interferon beta-1b|mesh-list
24623483|NCT01071694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623485|NCT01071694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24623486|NCT01071694|Immunologic Factors|immunologic factors|mesh-ancestor
24623487|NCT01071694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623488|NCT01071694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24623490|NCT01071772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24623491|NCT01071772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623492|NCT01071889|Flumazenil|flumazenil|mesh-list
24623493|NCT01071889|Antidotes|antidotes|mesh-ancestor
24623494|NCT01071889|Protective Agents|protective agents|mesh-ancestor
25039077|NCT04161456|Apremilast|apremilast|mesh-list
25059456|NCT03487783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25059457|NCT03487783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25059458|NCT03487783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25059459|NCT03487783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059460|NCT03487783|Dopamine Agonists|dopamine agonists|mesh-ancestor
25059461|NCT03487783|Dopamine Agents|dopamine agents|mesh-ancestor
25059462|NCT03487783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25059463|NCT03487783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059464|NCT03487783|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25059465|NCT03487783|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25059466|NCT03487783|Serotonin Agents|serotonin agents|mesh-ancestor
25059467|NCT03487783|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25059468|NCT03487783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25059469|NCT03487783|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25059470|NCT03487783|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24816372|NCT02076659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24884903|NCT03277066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884906|NCT03268811|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24884907|NCT03268811|Protective Agents|protective agents|mesh-ancestor
24884908|NCT03268811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884909|NCT03267433|Rituximab|rituximab|mesh-list
24884910|NCT03267433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24884911|NCT03267433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24884912|NCT03267433|Immunologic Factors|immunologic factors|mesh-ancestor
24509196|NCT00559312|Dermatologic Agents|dermatologic agents|mesh-ancestor
24509197|NCT00559312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24509198|NCT00559312|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24509199|NCT00559312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24509200|NCT00559312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24509201|NCT00559312|Adrenergic Agents|adrenergic agents|mesh-ancestor
24509202|NCT00559312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24509203|NCT00559312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670043|NCT04826237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
25670044|NCT04826237|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25670045|NCT04826237|Prednisolone phosphate|prednisolone phosphate|mesh-list
25670046|NCT04826237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25670047|NCT04826237|Antiemetics|antiemetics|mesh-ancestor
25670048|NCT04826237|Autonomic Agents|autonomic agents|mesh-ancestor
25670049|NCT04826237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25670050|NCT04826237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670051|NCT04826237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25670052|NCT04826237|Glucocorticoids|glucocorticoids|mesh-ancestor
25670053|NCT04826237|Hormones|hormones|mesh-ancestor
25670054|NCT04826237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25670055|NCT04826237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25670056|NCT04826237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25273296|NCT02386150|Immunologic Factors|immunologic factors|mesh-ancestor
24509204|NCT00559312|Glucocorticoids|glucocorticoids|mesh-ancestor
24509205|NCT00559312|Hormones|hormones|mesh-ancestor
25059471|NCT03487770|Aripiprazole|aripiprazole|mesh-list
25059472|NCT03487770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25201513|NCT02726919|Clobazam|clobazam|mesh-list
25865988|NCT00102635|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24509257|NCT00559481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24509258|NCT00559481|Glucocorticoids|glucocorticoids|mesh-ancestor
24509259|NCT00559481|Hormones|hormones|mesh-ancestor
24509260|NCT00559481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24509261|NCT00559481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24509262|NCT00559481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509268|NCT00559481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509269|NCT00559481|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25059489|NCT03487770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24943326|NCT03972683|Analgesics|analgesics|mesh-ancestor
25059490|NCT03487562|Amoxicillin|amoxicillin|mesh-list
25059491|NCT03487562|Clarithromycin|clarithromycin|mesh-list
25059492|NCT03487562|Lansoprazole|lansoprazole|mesh-list
25059493|NCT03487562|Dexlansoprazole|dexlansoprazole|mesh-list
25059494|NCT03487562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25059495|NCT03487562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25059533|NCT03487354|Oxytocics|oxytocics|mesh-ancestor
25059496|NCT03487562|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25059497|NCT03487562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059498|NCT03487562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059499|NCT03487562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25059500|NCT03487562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25059501|NCT03487562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25059502|NCT03487562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25059503|NCT03487562|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25059505|NCT03487406|Ticagrelor|ticagrelor|mesh-list
25059506|NCT03487406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25059507|NCT03487406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25059508|NCT03487406|Analgesics|analgesics|mesh-ancestor
25059509|NCT03487406|Sensory System Agents|sensory system agents|mesh-ancestor
25059510|NCT03487406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25059511|NCT03487406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059512|NCT03487406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25059513|NCT03487406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24821773|NCT02107755|Ipilimumab|ipilimumab|mesh-list
24884928|NCT03193333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24515252|NCT00596050|Narcotics|narcotics|mesh-ancestor
24884929|NCT03193333|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24884930|NCT03193333|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24509286|NCT00559676|Fluorouracil|fluorouracil|mesh-list
25865989|NCT00102635|Protective Agents|protective agents|mesh-ancestor
25670057|NCT04826237|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25670058|NCT04826237|Protective Agents|protective agents|mesh-ancestor
25670059|NCT04826237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25670060|NCT04826237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25670061|NCT04826237|Antimetabolites|antimetabolites|mesh-ancestor
25670062|NCT04826237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670063|NCT04826237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25670064|NCT04826237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25670065|NCT04825990|Pembrolizumab|pembrolizumab|mesh-list
25670066|NCT04825990|Olaparib|olaparib|mesh-list
25670067|NCT04825990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25670068|NCT04825990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670069|NCT04825990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25670070|NCT04825990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865990|NCT00102635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976559|NCT03171480|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24976560|NCT03171480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976561|NCT03164655|Leucovorin|leucovorin|mesh-list
24976571|NCT03164655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25225527|NCT02626247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225528|NCT02626169|Clopidogrel|clopidogrel|mesh-list
25225529|NCT02626169|Ticagrelor|ticagrelor|mesh-list
25225530|NCT02626169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25225531|NCT02626169|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25225532|NCT02626169|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24839133|NCT02202239|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25865991|NCT00102635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25865992|NCT00102635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25865993|NCT00102661|Alemtuzumab|alemtuzumab|mesh-list
25865994|NCT00102661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25059514|NCT03487406|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25059515|NCT03487406|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24821795|NCT02107950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24821796|NCT02107950|Antimetabolites|antimetabolites|mesh-ancestor
24821797|NCT02107950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821798|NCT02107950|Antiviral Agents|antiviral agents|mesh-ancestor
24821799|NCT02107950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24821800|NCT02107950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821804|NCT02108002|Vorinostat|vorinostat|mesh-list
25865995|NCT00102661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25865996|NCT00102674|Cangrelor|cangrelor|mesh-list
25865997|NCT00102674|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25865998|NCT00102674|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25865999|NCT00102674|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25201514|NCT02726919|Anticonvulsants|anticonvulsants|mesh-ancestor
25201515|NCT02726919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24509287|NCT00559676|Capecitabine|capecitabine|mesh-list
24509288|NCT00559676|Oxaliplatin|oxaliplatin|mesh-list
24509289|NCT00559676|Irinotecan|irinotecan|mesh-list
24509290|NCT00559676|Calcium|calcium|mesh-list
24509291|NCT00559676|Levoleucovorin|levoleucovorin|mesh-list
24509300|NCT00559676|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24509301|NCT00559676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24509302|NCT00559676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059528|NCT03487354|Abortifacient Agents|abortifacient agents|mesh-ancestor
25059529|NCT03487354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25059530|NCT03487354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059531|NCT03487354|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25059532|NCT03487354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25059534|NCT03487211|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25059536|NCT03487211|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25059537|NCT03487211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25059538|NCT03487211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25059539|NCT03487211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509309|NCT00559689|Beclomethasone|beclomethasone|mesh-list
24509310|NCT00559689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24509311|NCT00559689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24509312|NCT00559689|Autonomic Agents|autonomic agents|mesh-ancestor
24509313|NCT00559689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24509314|NCT00559689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670071|NCT04825990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670072|NCT04812626|Triamcinolone|triamcinolone|mesh-list
25670073|NCT04812626|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25670074|NCT04812626|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25670075|NCT04812626|Fluorouracil|fluorouracil|mesh-list
25670076|NCT04812626|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25670077|NCT04812626|Antimetabolites|antimetabolites|mesh-ancestor
25670078|NCT04812626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670079|NCT04812626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25670080|NCT04812626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670081|NCT04812626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25670082|NCT04812626|Immunologic Factors|immunologic factors|mesh-ancestor
25670083|NCT04812626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670084|NCT04812626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25670085|NCT04812626|Glucocorticoids|glucocorticoids|mesh-ancestor
24976641|NCT05276492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24976642|NCT05276492|Glucocorticoids|glucocorticoids|mesh-ancestor
24976644|NCT05276492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25225533|NCT02626169|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25225534|NCT02626169|Purinergic Agents|purinergic agents|mesh-ancestor
25225535|NCT02626169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25225536|NCT02626169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509315|NCT00559689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24509316|NCT00559689|Respiratory System Agents|respiratory system agents|mesh-ancestor
24509317|NCT00559689|Glucocorticoids|glucocorticoids|mesh-ancestor
25866000|NCT00102674|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25866001|NCT00102674|Purinergic Agents|purinergic agents|mesh-ancestor
25866002|NCT00102674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25059544|NCT03487211|Antidepressive Agents|antidepressive agents|mesh-ancestor
25059545|NCT03487211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25059546|NCT03487211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25059547|NCT03487211|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25059549|NCT03487211|Sensory System Agents|sensory system agents|mesh-ancestor
25059550|NCT03487211|Dopamine Agents|dopamine agents|mesh-ancestor
25059551|NCT03487198|Brexpiprazole|brexpiprazole|mesh-list
25059552|NCT03487198|Serotonin Agents|serotonin agents|mesh-ancestor
24625853|NCT01083992|Vildagliptin|vildagliptin|mesh-list
24625855|NCT01083992|Micronutrients|micronutrients|mesh-ancestor
24821825|NCT02108301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25866003|NCT00102674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866004|NCT00102674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866005|NCT00102700|Gemcitabine|gemcitabine|mesh-list
25866006|NCT00102700|Beta-lapachone|beta-lapachone|mesh-list
25866007|NCT00102700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25866008|NCT00102700|Antimetabolites|antimetabolites|mesh-ancestor
25866009|NCT00102700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866010|NCT00102700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866011|NCT00102700|Antiviral Agents|antiviral agents|mesh-ancestor
24884950|NCT03093246|Aspirin|aspirin|mesh-list
24884951|NCT03093246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24884952|NCT03093246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24884953|NCT03093246|Analgesics|analgesics|mesh-ancestor
24884954|NCT03093246|Sensory System Agents|sensory system agents|mesh-ancestor
24884955|NCT03093246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24884956|NCT03093246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884957|NCT03093246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24884958|NCT03093246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24884959|NCT03093246|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25866012|NCT00102700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25866013|NCT00102700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866014|NCT00102700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25866015|NCT00102700|Immunologic Factors|immunologic factors|mesh-ancestor
25866016|NCT00102700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866017|NCT00102700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24509367|NCT00560079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509368|NCT00560079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24509369|NCT00560079|Gout Suppressants|gout suppressants|mesh-ancestor
24509370|NCT00560079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24625856|NCT01083992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625857|NCT01083992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24625858|NCT01083992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24625859|NCT01083992|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25059569|NCT03487133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059570|NCT03487133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25059572|NCT03487133|Hormones|hormones|mesh-ancestor
25062511|NCT04481919|Diuretics|diuretics|mesh-list
25059573|NCT03487133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24821846|NCT02108366|Sensory System Agents|sensory system agents|mesh-ancestor
24509381|NCT00560092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25670086|NCT04812626|Hormones|hormones|mesh-ancestor
25670087|NCT04812626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25670088|NCT04812626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25670089|NCT04810494|Lidocaine|lidocaine|mesh-list
25670090|NCT04810494|Anesthetics, Local|anesthetics, local|mesh-ancestor
25670091|NCT04810494|Anesthetics|anesthetics|mesh-ancestor
25670092|NCT04810494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25670093|NCT04810494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509382|NCT00560092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509383|NCT00560092|Anesthetics|anesthetics|mesh-ancestor
24509384|NCT00560092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24509385|NCT00560092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24509386|NCT00560092|Anticonvulsants|anticonvulsants|mesh-ancestor
24509387|NCT00560092|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24884960|NCT03093246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24884961|NCT03093246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884962|NCT03093246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24884963|NCT03093246|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24884964|NCT03093246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24884965|NCT03093246|Antipyretics|antipyretics|mesh-ancestor
24884967|NCT03090997|Ascorbic Acid|ascorbic acid|mesh-list
24884968|NCT03090997|Resveratrol|resveratrol|mesh-list
24884969|NCT03090997|Micronutrients|micronutrients|mesh-ancestor
24884970|NCT03090997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707338|NCT01495260|Vitamin E|vitamin e|mesh-list
25059574|NCT03487133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25059576|NCT03487107|Sofosbuvir|sofosbuvir|mesh-list
25059577|NCT03487107|Yimitasvir|yimitasvir|mesh-list
25059578|NCT03487107|Antiviral Agents|antiviral agents|mesh-ancestor
25059579|NCT03487107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25059580|NCT03487042|Bimatoprost|bimatoprost|mesh-list
25059581|NCT03487042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25059582|NCT03487042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25059583|NCT03487042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25059584|NCT03487029|Oxymetazoline|oxymetazoline|mesh-list
25059585|NCT03487029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25059586|NCT03487029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25059587|NCT03487029|Adrenergic Agents|adrenergic agents|mesh-ancestor
25059588|NCT03487029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25059589|NCT03487029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059590|NCT03487029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059591|NCT03487029|Sympathomimetics|sympathomimetics|mesh-ancestor
25059592|NCT03487029|Autonomic Agents|autonomic agents|mesh-ancestor
25059593|NCT03487029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25059594|NCT03487029|Nasal Decongestants|nasal decongestants|mesh-ancestor
25059595|NCT03487029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25059596|NCT03487029|Respiratory System Agents|respiratory system agents|mesh-ancestor
24625863|NCT01084031|Propofol|propofol|mesh-list
24625864|NCT01084031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24509427|NCT00560300|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
24509428|NCT00560300|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
24509429|NCT00560300|Calcium Carbonate|calcium carbonate|mesh-list
24509430|NCT00560300|Calcium|calcium|mesh-list
24509431|NCT00560300|Sevelamer|sevelamer|mesh-list
24509432|NCT00560300|Vitamins|vitamins|mesh-ancestor
24509433|NCT00560300|Micronutrients|micronutrients|mesh-ancestor
24509434|NCT00560300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866018|NCT00102700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24509436|NCT00560300|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24509438|NCT00560300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509439|NCT00560300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24884981|NCT02991599|Vaccines|vaccines|mesh-list
24884982|NCT02991599|Immunologic Factors|immunologic factors|mesh-ancestor
24884983|NCT02991599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884984|NCT02970500|Methylphenidate|methylphenidate|mesh-list
24884985|NCT02970500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24884986|NCT02970500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884987|NCT02970500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24884988|NCT02970500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24884989|NCT02970500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24884990|NCT02970500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039409|NCT03856047|Hormones|hormones|mesh-ancestor
25059633|NCT03486561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25059634|NCT03486561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25059635|NCT03486561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059636|NCT03486548|Dexamethasone|dexamethasone|mesh-list
25059637|NCT03486548|Lidocaine|lidocaine|mesh-list
25059638|NCT03486548|Bupivacaine|bupivacaine|mesh-list
25201516|NCT02726919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24821914|NCT02108743|Adrenergic Agents|adrenergic agents|mesh-ancestor
24394211|NCT00132561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25866019|NCT00102713|Valproic Acid|valproic acid|mesh-list
25866020|NCT00102713|Anticonvulsants|anticonvulsants|mesh-ancestor
25866021|NCT00102713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621975|NCT01065038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25225552|NCT02626234|Antimetabolites|antimetabolites|mesh-ancestor
25866022|NCT00102713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866023|NCT00102713|GABA Agents|gaba agents|mesh-ancestor
25866024|NCT00102713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25866025|NCT00102713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866026|NCT00102713|Antimanic Agents|antimanic agents|mesh-ancestor
25866027|NCT00102713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24509441|NCT00560300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24509442|NCT00560300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24509444|NCT00560300|Sequestering Agents|sequestering agents|mesh-ancestor
24509445|NCT00560326|Tacrolimus|tacrolimus|mesh-list
24509446|NCT00560326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24509447|NCT00560326|Immunologic Factors|immunologic factors|mesh-ancestor
24509448|NCT00560326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885005|NCT02968446|Vitamin D|vitamin d|mesh-list
24885006|NCT02968446|Cholecalciferol|cholecalciferol|mesh-list
24885007|NCT02968446|Mechlorethamine|mechlorethamine|mesh-list
24885008|NCT02968446|Vitamins|vitamins|mesh-ancestor
24885009|NCT02968446|Micronutrients|micronutrients|mesh-ancestor
24885010|NCT02968446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885011|NCT02968446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24885012|NCT02968446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24885013|NCT02968446|Alkylating Agents|alkylating agents|mesh-ancestor
24885014|NCT02968446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059646|NCT03486548|Hormones|hormones|mesh-ancestor
25059647|NCT03486548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25059648|NCT03486548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25059649|NCT03486548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25059650|NCT03486548|Anesthetics, Local|anesthetics, local|mesh-ancestor
25059651|NCT03486548|Anesthetics|anesthetics|mesh-ancestor
25059652|NCT03486548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25059653|NCT03486548|Sensory System Agents|sensory system agents|mesh-ancestor
25059654|NCT03486548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25059655|NCT03486548|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25059656|NCT03486548|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25059657|NCT03486548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25059658|NCT03486548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059659|NCT03486509|Afatinib|afatinib|mesh-list
25059660|NCT03486509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25059661|NCT03486509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25059662|NCT03486509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059663|NCT03486509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059664|NCT03486496|Gefitinib|gefitinib|mesh-list
25059665|NCT03486496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25059666|NCT03486496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25059668|NCT03486496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059669|NCT03486457|Tofacitinib|tofacitinib|mesh-list
25059670|NCT03486457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24509451|NCT00560326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509452|NCT00560378|Tacrolimus|tacrolimus|mesh-list
24509453|NCT00560378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24509454|NCT00560378|Immunologic Factors|immunologic factors|mesh-ancestor
24509455|NCT00560378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509456|NCT00560378|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24509471|NCT00560443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509472|NCT00560443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24509473|NCT00560443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25059671|NCT03486457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059672|NCT03486457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059673|NCT03486353|Azacitidine|azacitidine|mesh-list
25059674|NCT03486353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25670094|NCT04810494|Sensory System Agents|sensory system agents|mesh-ancestor
25670095|NCT04810494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25670096|NCT04810494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25670097|NCT04810494|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25670098|NCT04810494|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25670099|NCT04810494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25670100|NCT04810494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670101|NCT04803747|Tranexamic Acid|tranexamic acid|mesh-list
25225557|NCT02626234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25225558|NCT02626234|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25225559|NCT02626234|Protective Agents|protective agents|mesh-ancestor
25225560|NCT02626234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225561|NCT02626481|Dexamethasone|dexamethasone|mesh-list
25043402|NCT01265901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043403|NCT01265901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25043404|NCT01265901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25059675|NCT03486353|Antimetabolites|antimetabolites|mesh-ancestor
25059676|NCT03486353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059677|NCT03486353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25059678|NCT03486353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059679|NCT03486236|Ivacaftor|ivacaftor|mesh-list
25059680|NCT03486236|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25059681|NCT03486236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25059682|NCT03486236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509481|NCT00560495|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
24509483|NCT00560495|Sequestering Agents|sequestering agents|mesh-ancestor
24509484|NCT00560495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509485|NCT00560495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24509486|NCT00560495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24509487|NCT00560495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24509505|NCT00560586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24509506|NCT00560599|Chlorhexidine|chlorhexidine|mesh-list
24509507|NCT00560599|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24885019|NCT02955758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885020|NCT02939183|Dexamethasone|dexamethasone|mesh-list
24885021|NCT02939183|Pomalidomide|pomalidomide|mesh-list
24885022|NCT02939183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24885023|NCT02939183|Antiemetics|antiemetics|mesh-ancestor
24885024|NCT02939183|Autonomic Agents|autonomic agents|mesh-ancestor
24885025|NCT02939183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24885026|NCT02939183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885027|NCT02939183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24885028|NCT02939183|Glucocorticoids|glucocorticoids|mesh-ancestor
24885029|NCT02939183|Hormones|hormones|mesh-ancestor
24885030|NCT02939183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24885031|NCT02939183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24885032|NCT02939183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885033|NCT02939183|Immunologic Factors|immunologic factors|mesh-ancestor
24885034|NCT02939183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24885035|NCT02939183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24885036|NCT02939183|Growth Substances|growth substances|mesh-ancestor
24885037|NCT02939183|Growth Inhibitors|growth inhibitors|mesh-ancestor
24885038|NCT02907996|Sofosbuvir|sofosbuvir|mesh-list
24885039|NCT02907996|Antiviral Agents|antiviral agents|mesh-ancestor
24509509|NCT00560599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24509510|NCT00560599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24509512|NCT00560599|Dermatologic Agents|dermatologic agents|mesh-ancestor
24509513|NCT00560599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25059688|NCT03486119|Nivolumab|nivolumab|mesh-list
25059689|NCT03486119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25059690|NCT03486119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25059691|NCT03486119|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25059692|NCT03486119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059693|NCT03486106|Propofol|propofol|mesh-list
25059694|NCT03486106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25059695|NCT03486106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25059696|NCT03486106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059697|NCT03486106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24943524|NCT03970044|Dapagliflozin|dapagliflozin|mesh-list
25059698|NCT03486106|Anesthetics, General|anesthetics, general|mesh-ancestor
25059699|NCT03486106|Anesthetics|anesthetics|mesh-ancestor
25670102|NCT04803747|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25670103|NCT04803747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25670104|NCT04803747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670105|NCT04803747|Hemostatics|hemostatics|mesh-ancestor
25670106|NCT04803747|Coagulants|coagulants|mesh-ancestor
25670107|NCT04797156|Tranexamic Acid|tranexamic acid|mesh-list
25670108|NCT04797156|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25670109|NCT04797156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25670110|NCT04797156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059700|NCT03486080|Lenograstim|lenograstim|mesh-list
24976925|NCT04817189|Serotonin Agents|serotonin agents|mesh-ancestor
24976926|NCT04817189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24976927|NCT04817189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976928|NCT04817189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24976929|NCT04817189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25225562|NCT02626481|Daratumumab|daratumumab|mesh-list
25225563|NCT02626481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25225564|NCT02626481|Antiemetics|antiemetics|mesh-ancestor
25059701|NCT03486080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25059702|NCT03486080|Immunologic Factors|immunologic factors|mesh-ancestor
25059703|NCT03486080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059704|NCT03485846|Ritonavir|ritonavir|mesh-list
25059705|NCT03485846|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25059706|NCT03485846|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25059707|NCT03485846|Protease Inhibitors|protease inhibitors|mesh-ancestor
25059708|NCT03485846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25062538|NCT04370301|Mycophenolic Acid|mycophenolic acid|mesh-list
25866028|NCT00102713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25866029|NCT00102713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25866030|NCT00102752|Gemcitabine|gemcitabine|mesh-list
24885054|NCT02728752|gamma-Globulins|gamma-globulins|mesh-list
24885055|NCT02728752|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25059716|NCT03485703|Azithromycin|azithromycin|mesh-list
25059717|NCT03485703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25059718|NCT03485703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25059719|NCT03485625|Acetaminophen|acetaminophen|mesh-list
25059720|NCT03485625|Ketorolac|ketorolac|mesh-list
25059721|NCT03485625|Lidocaine|lidocaine|mesh-list
25059722|NCT03485625|Anesthetics, Local|anesthetics, local|mesh-ancestor
25059723|NCT03485625|Anesthetics|anesthetics|mesh-ancestor
25059724|NCT03485625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25059725|NCT03485625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059726|NCT03485625|Sensory System Agents|sensory system agents|mesh-ancestor
25059727|NCT03485625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25059728|NCT03485625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24822006|NCT02109341|Antimitotic Agents|antimitotic agents|mesh-ancestor
24464110|NCT00363350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464112|NCT00363376|Zonisamide|zonisamide|mesh-list
25866031|NCT00102752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25866032|NCT00102752|Antimetabolites|antimetabolites|mesh-ancestor
25866033|NCT00102752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866034|NCT00102752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866035|NCT00102752|Antiviral Agents|antiviral agents|mesh-ancestor
25866036|NCT00102752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25866037|NCT00102752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866038|NCT00102752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24509528|NCT00560690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509529|NCT00560820|Deferasirox|deferasirox|mesh-list
24509530|NCT00560820|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25866039|NCT00102752|Immunologic Factors|immunologic factors|mesh-ancestor
25866040|NCT00102752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866041|NCT00102765|Fluticasone|fluticasone|mesh-list
25866042|NCT00102765|Xhance|xhance|mesh-list
24509552|NCT00561054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25039656|NCT03724825|Hormones|hormones|mesh-ancestor
24509587|NCT00561093|Antioxidants|antioxidants|mesh-ancestor
24509588|NCT00561106|Valacyclovir|valacyclovir|mesh-list
24509589|NCT00561106|Prednisone|prednisone|mesh-list
24509590|NCT00561106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24509591|NCT00561106|Glucocorticoids|glucocorticoids|mesh-ancestor
24509592|NCT00561106|Hormones|hormones|mesh-ancestor
25039908|NCT03603288|Idebenone|idebenone|mesh-list
24509593|NCT00561106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24509594|NCT00561106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509595|NCT00561106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24509596|NCT00561106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670111|NCT04797156|Hemostatics|hemostatics|mesh-ancestor
25670112|NCT04797156|Coagulants|coagulants|mesh-ancestor
25670113|NCT04790175|Tolvaptan|tolvaptan|mesh-list
25670114|NCT04790175|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25670115|NCT04790175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670116|NCT04790175|Natriuretic Agents|natriuretic agents|mesh-ancestor
25670117|NCT04790175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670118|NCT04778904|Nivolumab|nivolumab|mesh-list
25866043|NCT00102765|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24509598|NCT00561106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25225569|NCT02626481|Glucocorticoids|glucocorticoids|mesh-ancestor
25225570|NCT02626481|Hormones|hormones|mesh-ancestor
25225571|NCT02626481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25225572|NCT02626481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25225573|NCT02626481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24839159|NCT02202512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24839160|NCT02202512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839161|NCT02202512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24839162|NCT02202512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24839163|NCT02202512|Gout Suppressants|gout suppressants|mesh-ancestor
24839164|NCT02202512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24839195|NCT02202603|Teriparatide|teriparatide|mesh-list
24839196|NCT02202603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24839197|NCT02202603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839198|NCT02202603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24839199|NCT02202707|Gabapentin|gabapentin|mesh-list
24839200|NCT02202707|Analgesics|analgesics|mesh-ancestor
24839201|NCT02202707|Sensory System Agents|sensory system agents|mesh-ancestor
25057061|NCT03507556|Zinc Oxide|zinc oxide|mesh-list
24414706|NCT00198445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24414708|NCT00198523|Prednisolone|prednisolone|mesh-list
24414709|NCT00198523|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24414710|NCT00198523|Methylprednisolone|methylprednisolone|mesh-list
24414711|NCT00198523|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24509599|NCT00561119|Gemcitabine|gemcitabine|mesh-list
24509600|NCT00561119|Paclitaxel|paclitaxel|mesh-list
24509601|NCT00561119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24509602|NCT00561119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509603|NCT00561119|Tubulin Modulators|tubulin modulators|mesh-ancestor
24509604|NCT00561119|Antimitotic Agents|antimitotic agents|mesh-ancestor
24509605|NCT00561119|Mitosis Modulators|mitosis modulators|mesh-ancestor
24509606|NCT00561119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509607|NCT00561119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24509608|NCT00561119|Antimetabolites|antimetabolites|mesh-ancestor
24509609|NCT00561119|Antiviral Agents|antiviral agents|mesh-ancestor
24509610|NCT00561119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24509611|NCT00561119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24509612|NCT00561119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24509637|NCT00561223|Vasodilator Agents|vasodilator agents|mesh-ancestor
24509638|NCT00561288|Acetaminophen|acetaminophen|mesh-list
24509639|NCT00561288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24509640|NCT00561288|Analgesics|analgesics|mesh-ancestor
24509641|NCT00561288|Sensory System Agents|sensory system agents|mesh-ancestor
24509642|NCT00561288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24509643|NCT00561288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509644|NCT00561288|Antipyretics|antipyretics|mesh-ancestor
25670119|NCT04778904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25670120|NCT04778904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670121|NCT04778904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25670122|NCT04778904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670123|NCT04771481|Metoclopramide|metoclopramide|mesh-list
25670124|NCT04771481|Antiemetics|antiemetics|mesh-ancestor
25670125|NCT04771481|Autonomic Agents|autonomic agents|mesh-ancestor
25670126|NCT04771481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25670127|NCT04771481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670128|NCT04771481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25670129|NCT04771481|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25670130|NCT04771481|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25670131|NCT04771481|Dopamine Agents|dopamine agents|mesh-ancestor
25670132|NCT04771481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25670133|NCT04771481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670134|NCT04764162|Choline|choline|mesh-list
25670135|NCT04764162|Lipotropic Agents|lipotropic agents|mesh-ancestor
25670136|NCT04764162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25670137|NCT04764162|Antimetabolites|antimetabolites|mesh-ancestor
25670138|NCT04764162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670139|NCT04764162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25670140|NCT04764162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25670141|NCT04764162|Nootropic Agents|nootropic agents|mesh-ancestor
25670142|NCT04728217|Factor VIII|factor viii|mesh-list
25670143|NCT04728217|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
24509646|NCT00561327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24509647|NCT00561327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24783537|NCT01902498|Antipyretics|antipyretics|mesh-ancestor
24509648|NCT00561327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24509649|NCT00561327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24509650|NCT00561327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509651|NCT00561379|Rituximab|rituximab|mesh-list
24509652|NCT00561379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24509653|NCT00561379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509654|NCT00561379|Immunologic Factors|immunologic factors|mesh-ancestor
25866044|NCT00102765|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24509656|NCT00561379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24509658|NCT00561496|Antiviral Agents|antiviral agents|mesh-ancestor
24509659|NCT00561496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24509660|NCT00561496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24509661|NCT00561496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24509662|NCT00561496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24509663|NCT00561496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509664|NCT00561496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24509665|NCT00561496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24509666|NCT00561509|Antidepressive Agents|antidepressive agents|mesh-list
24509667|NCT00561509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24509668|NCT00561522|Capecitabine|capecitabine|mesh-list
25059733|NCT03485625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25059734|NCT03485625|Analgesics|analgesics|mesh-ancestor
25059735|NCT03485625|Antipyretics|antipyretics|mesh-ancestor
25059736|NCT03485625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25059737|NCT03485625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25059738|NCT03485625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25059739|NCT03485625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24996395|NCT03568422|Paclitaxel|paclitaxel|mesh-list
24509671|NCT00561522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509672|NCT00561522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509673|NCT00561587|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24509674|NCT00561587|Antidepressive Agents|antidepressive agents|mesh-ancestor
24509675|NCT00561587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24885074|NCT02710331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885075|NCT02710331|Hormones|hormones|mesh-ancestor
24885076|NCT02710331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24509676|NCT00561587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24509677|NCT00561587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24509708|NCT00561717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24509710|NCT00561717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24509711|NCT00561717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24509712|NCT00561717|Respiratory System Agents|respiratory system agents|mesh-ancestor
24509713|NCT00561717|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24509721|NCT00561886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25059747|NCT03485482|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25059748|NCT03485482|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25059749|NCT03485482|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25059750|NCT03485482|Adrenergic Agents|adrenergic agents|mesh-ancestor
25059751|NCT03485482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25059752|NCT03485482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059754|NCT03485456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24509722|NCT00561886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509723|NCT00561886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24509724|NCT00561886|Respiratory System Agents|respiratory system agents|mesh-ancestor
25201517|NCT02726919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25103905|NCT03157388|Meropenem|meropenem|mesh-list
24509725|NCT00561886|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24509726|NCT00561886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24509727|NCT00561886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24509728|NCT00561886|Adrenergic Agents|adrenergic agents|mesh-ancestor
24509729|NCT00561886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24509730|NCT00561886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509731|NCT00561899|Piperaquine|piperaquine|mesh-list
24509732|NCT00561899|Amodiaquine|amodiaquine|mesh-list
24509733|NCT00561899|Artenimol|artenimol|mesh-list
25670144|NCT04728217|Coagulants|coagulants|mesh-ancestor
25670145|NCT04728217|Immunologic Factors|immunologic factors|mesh-ancestor
25670146|NCT04728217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670147|NCT04724772|Tranexamic Acid|tranexamic acid|mesh-list
25670148|NCT04724772|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25670149|NCT04724772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25225583|NCT02625948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25225584|NCT02625948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839207|NCT02202707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24839219|NCT02202720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24839220|NCT02202720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839222|NCT02202889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25866045|NCT00102765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25866046|NCT00102765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25866047|NCT00102765|Autonomic Agents|autonomic agents|mesh-ancestor
25866048|NCT00102765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25866049|NCT00102765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866050|NCT00102765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24885109|NCT02593123|Sargramostim|sargramostim|mesh-list
24885110|NCT02593123|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24885111|NCT02593123|Immunologic Factors|immunologic factors|mesh-ancestor
25201518|NCT02726919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201519|NCT02726919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25866051|NCT00102765|Respiratory System Agents|respiratory system agents|mesh-ancestor
24509758|NCT00562068|Cyclophosphamide|cyclophosphamide|mesh-list
24509759|NCT00562068|Doxorubicin|doxorubicin|mesh-list
24509760|NCT00562068|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24509761|NCT00562068|Vincristine|vincristine|mesh-list
24509762|NCT00562068|Alemtuzumab|alemtuzumab|mesh-list
24509763|NCT00562068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24509764|NCT00562068|Immunologic Factors|immunologic factors|mesh-ancestor
24509765|NCT00562068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509766|NCT00562068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24509767|NCT00562068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24509768|NCT00562068|Alkylating Agents|alkylating agents|mesh-ancestor
24509789|NCT00562133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24509790|NCT00562133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509792|NCT00562172|Insulin Glargine|insulin glargine|mesh-list
24509793|NCT00562172|Glimepiride|glimepiride|mesh-list
24509794|NCT00562172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24509795|NCT00562172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509796|NCT00562172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24509797|NCT00562172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24509798|NCT00562172|Immunologic Factors|immunologic factors|mesh-ancestor
25059775|NCT03485404|Vitamins|vitamins|mesh-list
24501763|NCT00530972|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24943671|NCT03967886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24943675|NCT03968042|Thiamine|thiamine|mesh-list
24625897|NCT01084200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24943705|NCT03967392|Lidocaine|lidocaine|mesh-list
24822060|NCT02109627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822061|NCT02109627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822062|NCT02109627|Antiviral Agents|antiviral agents|mesh-ancestor
24822063|NCT02109627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24509799|NCT00562185|Carboplatin|carboplatin|mesh-list
24509800|NCT00562185|Doxorubicin|doxorubicin|mesh-list
24509801|NCT00562185|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24509802|NCT00562185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885119|NCT02593123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885120|NCT02593123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885121|NCT02591147|Fluorides|fluorides|mesh-list
24885122|NCT02591147|Cariostatic Agents|cariostatic agents|mesh-ancestor
24885123|NCT02591147|Protective Agents|protective agents|mesh-ancestor
24509878|NCT00562419|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24509879|NCT00562419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24509881|NCT00562419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896105|NCT02378805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25866052|NCT00102765|Dermatologic Agents|dermatologic agents|mesh-ancestor
24509882|NCT00562419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509883|NCT00562458|Anastrozole|anastrozole|mesh-list
24509884|NCT00562458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24509885|NCT00562458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509886|NCT00562458|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24943706|NCT03967392|Anesthetics, Local|anesthetics, local|mesh-ancestor
25670150|NCT04724772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670151|NCT04724772|Hemostatics|hemostatics|mesh-ancestor
25670152|NCT04724772|Coagulants|coagulants|mesh-ancestor
25670153|NCT04721691|Cannabidiol|cannabidiol|mesh-list
25670154|NCT04721691|Anticonvulsants|anticonvulsants|mesh-ancestor
25670155|NCT04669002|Olaparib|olaparib|mesh-list
25670156|NCT04669002|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25670157|NCT04669002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24977221|NCT03085056|Paclitaxel|paclitaxel|mesh-list
24943707|NCT03967392|Anesthetics|anesthetics|mesh-ancestor
24943708|NCT03967392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24943709|NCT03967392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943710|NCT03967392|Sensory System Agents|sensory system agents|mesh-ancestor
24943711|NCT03967392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24952916|NCT03891121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952917|NCT03891121|Cholinergic Agents|cholinergic agents|mesh-ancestor
24952918|NCT03891121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24952919|NCT03891121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952920|NCT03891121|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24822072|NCT02109666|Immunologic Factors|immunologic factors|mesh-ancestor
24509887|NCT00562458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24885128|NCT02527798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885129|NCT02527798|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24885130|NCT02527798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24885131|NCT02527798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885132|NCT02383992|Hydrogen Peroxide|hydrogen peroxide|mesh-list
24885133|NCT02383992|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25201520|NCT02726919|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24876458|NCT03512756|Sirolimus|sirolimus|mesh-list
24885134|NCT02383992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24885135|NCT02346630|Levodopa|levodopa|mesh-list
24885136|NCT02346630|Carbidopa|carbidopa|mesh-list
24885150|NCT01964807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24464190|NCT00363753|Aspirin|aspirin|mesh-list
24509888|NCT00562458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952921|NCT03891121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24952923|NCT03891043|Antioxidants|antioxidants|mesh-ancestor
24952924|NCT03891043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952925|NCT03891043|Protective Agents|protective agents|mesh-ancestor
24952926|NCT03891043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952927|NCT03891043|Trace Elements|trace elements|mesh-ancestor
24952928|NCT03891043|Micronutrients|micronutrients|mesh-ancestor
24952929|NCT03890770|BMS-986165|bms-986165|mesh-list
24952930|NCT03890770|Dermatologic Agents|dermatologic agents|mesh-ancestor
24952931|NCT03890770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24952932|NCT03890770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952933|NCT03890770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952934|NCT03890341|Drospirenone|drospirenone|mesh-list
24952935|NCT03890341|Midazolam|midazolam|mesh-list
24952936|NCT03890341|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24952937|NCT03890341|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
24952938|NCT03890341|Betadex|betadex|mesh-list
24952939|NCT03890341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24952940|NCT03890341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24509893|NCT00562458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509894|NCT00562510|Raltegravir Potassium|raltegravir potassium|mesh-list
24509895|NCT00562510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24509896|NCT00562510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24509897|NCT00562510|Antiviral Agents|antiviral agents|mesh-ancestor
24509898|NCT00562510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24509899|NCT00562510|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24509900|NCT00562510|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24509901|NCT00562510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24509902|NCT00562510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509903|NCT00562523|Sorafenib|sorafenib|mesh-list
24509904|NCT00562523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509905|NCT00562523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25866053|NCT00102765|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24509907|NCT00562523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509908|NCT00562640|Cyclophosphamide|cyclophosphamide|mesh-list
24509909|NCT00562640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24885155|NCT01964807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24885156|NCT01964807|Cholinergic Agents|cholinergic agents|mesh-ancestor
24885157|NCT01964807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25059778|NCT03485404|Vitamin B Complex|vitamin b complex|mesh-list
25059779|NCT03485404|Micronutrients|micronutrients|mesh-ancestor
25059780|NCT03485404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059781|NCT03485404|Hematinics|hematinics|mesh-ancestor
25059783|NCT03485300|Anticoagulants|anticoagulants|mesh-ancestor
25059784|NCT03485170|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25059785|NCT03485170|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25059786|NCT03485170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059787|NCT03485118|Rituximab|rituximab|mesh-list
25866054|NCT00102765|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25225599|NCT02625753|Respiratory System Agents|respiratory system agents|mesh-ancestor
24839244|NCT02203097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25059788|NCT03485118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25059789|NCT03485118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25059790|NCT03485118|Immunologic Factors|immunologic factors|mesh-ancestor
25059791|NCT03485118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059792|NCT03485118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24822121|NCT02109900|Hormones|hormones|mesh-ancestor
24885158|NCT01964807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885159|NCT01941446|Moxifloxacin|moxifloxacin|mesh-list
24885160|NCT01941446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24885161|NCT01941446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24885162|NCT01941446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24885163|NCT01941446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24885164|NCT01941446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885165|NCT01941446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885166|NCT01941446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201521|NCT02726919|GABA Agonists|gaba agonists|mesh-ancestor
24582087|NCT00868010|Donepezil|donepezil|mesh-list
24885170|NCT01907360|Methylphenidate|methylphenidate|mesh-list
24885171|NCT01907360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24509910|NCT00562640|Immunologic Factors|immunologic factors|mesh-ancestor
24509950|NCT00562913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509951|NCT00562913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24885177|NCT01907360|Dopamine Agents|dopamine agents|mesh-ancestor
24885178|NCT01907360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24885179|NCT01873170|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24885180|NCT01873170|Contraceptive Agents|contraceptive agents|mesh-list
24885181|NCT01873170|Levonorgestrel|levonorgestrel|mesh-list
24885182|NCT01873170|Etonogestrel|etonogestrel|mesh-list
24509957|NCT00562939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509958|NCT00562952|Telmisartan|telmisartan|mesh-list
24509959|NCT00562952|Bisoprolol|bisoprolol|mesh-list
24509960|NCT00562952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24509961|NCT00562952|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24509962|NCT00562952|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24509963|NCT00562952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510001|NCT00563056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25866055|NCT00102765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25059794|NCT03485092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25059795|NCT03485092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059796|NCT03485092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25059797|NCT03485092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059798|NCT03484962|Antibodies|antibodies|mesh-list
25059799|NCT03484962|Antibodies, Bispecific|antibodies, bispecific|mesh-list
24822134|NCT02109913|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24822135|NCT02109913|Hormone Antagonists|hormone antagonists|mesh-ancestor
24822136|NCT02109913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24822137|NCT02109965|Midazolam|midazolam|mesh-list
25866056|NCT00102765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25866057|NCT00102765|Adrenergic Agents|adrenergic agents|mesh-ancestor
24510003|NCT00563069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24510004|NCT00563069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24510005|NCT00563069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24510006|NCT00563069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510007|NCT00563069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24510008|NCT00563069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24510009|NCT00563069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24510010|NCT00563069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24510011|NCT00563069|Anesthetics, General|anesthetics, general|mesh-ancestor
24510013|NCT00563069|GABA Modulators|gaba modulators|mesh-ancestor
24510014|NCT00563069|GABA Agents|gaba agents|mesh-ancestor
24510015|NCT00563069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24510016|NCT00563069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510017|NCT00563095|Interferons|interferons|mesh-list
24510018|NCT00563095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510019|NCT00563095|Antiviral Agents|antiviral agents|mesh-ancestor
25670158|NCT04669002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670159|NCT04669002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670160|NCT04660799|Diphenhydramine|diphenhydramine|mesh-list
25670161|NCT04660799|Promethazine|promethazine|mesh-list
25670162|NCT04660799|Prednisone|prednisone|mesh-list
25670163|NCT04660799|Cyclophosphamide|cyclophosphamide|mesh-list
25670164|NCT04660799|Rituximab|rituximab|mesh-list
25670165|NCT04660799|Doxorubicin|doxorubicin|mesh-list
25670166|NCT04660799|Vincristine|vincristine|mesh-list
24839253|NCT02203175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24977348|NCT01974609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24885183|NCT01873170|Desogestrel|desogestrel|mesh-list
24885184|NCT01873170|Contraceptives, Oral|contraceptives, oral|mesh-list
24816380|NCT02076685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059801|NCT03484962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059803|NCT03484845|Lactoferrin|lactoferrin|mesh-list
25059804|NCT03484845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25059805|NCT03484845|Trace Elements|trace elements|mesh-ancestor
25059806|NCT03484845|Micronutrients|micronutrients|mesh-ancestor
25059807|NCT03484845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059808|NCT03484832|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25059809|NCT03484832|Ethyl Chloride|ethyl chloride|mesh-list
25059810|NCT03484832|Anesthetics, Local|anesthetics, local|mesh-ancestor
25201522|NCT02726919|GABA Agents|gaba agents|mesh-ancestor
25059811|NCT03484832|Anesthetics|anesthetics|mesh-ancestor
24822142|NCT02109965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822143|NCT02109965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24413718|NCT00194974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24413720|NCT00194974|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24896191|NCT01404754|Serotonin Agents|serotonin agents|mesh-ancestor
24510073|NCT00563342|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24510074|NCT00563342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24510075|NCT00563342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24510076|NCT00563342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510077|NCT00563355|Epoetin Alfa|epoetin alfa|mesh-list
24510078|NCT00563355|Hematinics|hematinics|mesh-ancestor
24510079|NCT00563394|Ofloxacin|ofloxacin|mesh-list
24510080|NCT00563394|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24510081|NCT00563394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24510082|NCT00563394|Renal Agents|renal agents|mesh-ancestor
24510083|NCT00563394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24510112|NCT00563472|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24510113|NCT00563472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24510114|NCT00563472|Contraceptive Agents|contraceptive agents|mesh-ancestor
24510115|NCT00563472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24510116|NCT00563472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24510117|NCT00563472|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24510118|NCT00563485|Doxazosin|doxazosin|mesh-list
24510119|NCT00563485|Terazosin|terazosin|mesh-list
24510120|NCT00563485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24510147|NCT00563589|Immunologic Factors|immunologic factors|mesh-ancestor
24510162|NCT00563615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059812|NCT03484832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25059813|NCT03484832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059814|NCT03484832|Sensory System Agents|sensory system agents|mesh-ancestor
25059815|NCT03484832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25059816|NCT03484832|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24510164|NCT00563641|Respiratory System Agents|respiratory system agents|mesh-ancestor
24510165|NCT00563654|Alfuzosin|alfuzosin|mesh-list
24510166|NCT00563654|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24510167|NCT00563654|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24510168|NCT00563654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24816382|NCT02076750|Vitamin D|vitamin d|mesh-list
24816383|NCT02076750|Cholecalciferol|cholecalciferol|mesh-list
24816384|NCT02076750|Vitamins|vitamins|mesh-ancestor
24816385|NCT02076750|Micronutrients|micronutrients|mesh-ancestor
24816386|NCT02076750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040220|NCT03315143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24510177|NCT00563758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24510189|NCT00563849|Leflunomide|leflunomide|mesh-list
24510190|NCT00563849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510191|NCT00563849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510192|NCT00563849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24510193|NCT00563849|Immunologic Factors|immunologic factors|mesh-ancestor
24510194|NCT00563849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510195|NCT00563862|Fluorouracil|fluorouracil|mesh-list
24510196|NCT00563862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510197|NCT00563862|Antimetabolites|antimetabolites|mesh-ancestor
24510198|NCT00563862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670167|NCT04660799|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25670168|NCT04660799|Histamine Antagonists|histamine antagonists|mesh-list
25670169|NCT04660799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24510199|NCT00563862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24839256|NCT02203175|Anesthetics, General|anesthetics, general|mesh-ancestor
24839258|NCT02203175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24795200|NCT03578276|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24795201|NCT03578276|Prednisolone acetate|prednisolone acetate|mesh-list
24510200|NCT00563862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24510233|NCT00563953|Doxorubicin|doxorubicin|mesh-list
24510234|NCT00563953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24510235|NCT00563953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510236|NCT00563953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24510237|NCT00563953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24510238|NCT00563953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885192|NCT01873170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24885193|NCT01873170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885194|NCT01873170|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24885196|NCT01873170|Hormones|hormones|mesh-ancestor
24885197|NCT01873170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25866058|NCT00102765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24510239|NCT00563953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510240|NCT00563992|Valproic Acid|valproic acid|mesh-list
24510241|NCT00563992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24510242|NCT00563992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510243|NCT00563992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510244|NCT00563992|Antimanic Agents|antimanic agents|mesh-ancestor
25059828|NCT03484650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059829|NCT03484650|Sensory System Agents|sensory system agents|mesh-ancestor
24822149|NCT02109965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24822150|NCT02109965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24510245|NCT00563992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24510246|NCT00563992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24510247|NCT00563992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510248|NCT00563992|Anticonvulsants|anticonvulsants|mesh-ancestor
24510249|NCT00563992|GABA Agents|gaba agents|mesh-ancestor
24510250|NCT00563992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24510251|NCT00564031|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24510252|NCT00564031|Medroxyprogesterone|medroxyprogesterone|mesh-list
24510253|NCT00564031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24510254|NCT00564031|Contraceptive Agents|contraceptive agents|mesh-ancestor
24510255|NCT00564031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24510256|NCT00564031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515625|NCT00598533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510262|NCT00564031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24510263|NCT00564031|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24510264|NCT00564057|Candesartan|candesartan|mesh-list
24510265|NCT00564057|Lercanidipine|lercanidipine|mesh-list
24510266|NCT00564057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24885207|NCT01481272|Methotrexate|methotrexate|mesh-list
24885208|NCT01481272|Etoposide|etoposide|mesh-list
24885209|NCT01481272|Ofatumumab|ofatumumab|mesh-list
24885210|NCT01481272|Lenograstim|lenograstim|mesh-list
25059830|NCT03484650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25059831|NCT03484650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25059832|NCT03484650|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25059833|NCT03484650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24885211|NCT01481272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24885213|NCT01481272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24885214|NCT01481272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464271|NCT00363948|Incretins|incretins|mesh-ancestor
25040308|NCT03187834|Azithromycin|azithromycin|mesh-list
24510288|NCT00564174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24510290|NCT00564174|Sensory System Agents|sensory system agents|mesh-ancestor
24510291|NCT00564174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24510292|NCT00564174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25431808|NCT00980460|Mitosis Modulators|mitosis modulators|mesh-ancestor
25670170|NCT04660799|Immunologic Factors|immunologic factors|mesh-ancestor
25670171|NCT04660799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670172|NCT04660799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25670173|NCT04660799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25670174|NCT04660799|Alkylating Agents|alkylating agents|mesh-ancestor
25670175|NCT04660799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670176|NCT04660799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670177|NCT04660799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25670178|NCT04660799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24839281|NCT02203253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24839282|NCT02203253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24839283|NCT02203253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24915445|NCT02387099|Everolimus|everolimus|mesh-list
24977470|NCT03051217|Certolizumab Pegol|certolizumab pegol|mesh-list
24977471|NCT03051217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24977472|NCT03051217|Immunologic Factors|immunologic factors|mesh-ancestor
24977473|NCT03051217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510293|NCT00564174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24510294|NCT00564174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24510295|NCT00564174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24510324|NCT00564200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24885215|NCT01481272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24885217|NCT01481272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885218|NCT01481272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885219|NCT01481272|Dermatologic Agents|dermatologic agents|mesh-ancestor
24885220|NCT01481272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885221|NCT01481272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24885222|NCT01481272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24885223|NCT01481272|Immunologic Factors|immunologic factors|mesh-ancestor
24885224|NCT01481272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24885225|NCT01481272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24885226|NCT01481272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25201523|NCT02726919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25866059|NCT00102765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866060|NCT00102765|Glucocorticoids|glucocorticoids|mesh-ancestor
25866061|NCT00102765|Hormones|hormones|mesh-ancestor
24896305|NCT04438434|Chlorhexidine|chlorhexidine|mesh-list
24969977|NCT03738059|Analgesics|analgesics|mesh-ancestor
25866062|NCT00102765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25866063|NCT00102765|Sympathomimetics|sympathomimetics|mesh-ancestor
25866064|NCT00102778|Ritonavir|ritonavir|mesh-list
25866065|NCT00102778|Lopinavir|lopinavir|mesh-list
25866066|NCT00102778|Aplaviroc|aplaviroc|mesh-list
24827413|NCT02138799|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24827414|NCT02138799|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24827416|NCT02138812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24716763|NCT01543906|Retinol acetate|retinol acetate|mesh-list
25866067|NCT00102778|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25866068|NCT00102778|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25866069|NCT00102778|Protease Inhibitors|protease inhibitors|mesh-ancestor
25866070|NCT00102778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866071|NCT00102778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446968|NCT00306774|Cholecalciferol|cholecalciferol|mesh-list
25866072|NCT00102778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24885227|NCT01481272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24885228|NCT01481272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24885229|NCT01481272|Antiviral Agents|antiviral agents|mesh-ancestor
24885230|NCT01481272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24885231|NCT01481272|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24885232|NCT01481272|Antidotes|antidotes|mesh-ancestor
24510325|NCT00564200|Immunologic Factors|immunologic factors|mesh-ancestor
24510326|NCT00564200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24510327|NCT00564200|Alkylating Agents|alkylating agents|mesh-ancestor
24510328|NCT00564200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24510351|NCT00564330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510353|NCT00564408|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24510354|NCT00564408|Miotics|miotics|mesh-ancestor
24510355|NCT00564408|Autonomic Agents|autonomic agents|mesh-ancestor
24510356|NCT00564408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24510357|NCT00564408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510397|NCT00564525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510398|NCT00564525|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24885235|NCT01481272|Vitamins|vitamins|mesh-ancestor
24885236|NCT01481272|Micronutrients|micronutrients|mesh-ancestor
24885237|NCT01380028|Prednisone|prednisone|mesh-list
24885238|NCT01380028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24885239|NCT01380028|Glucocorticoids|glucocorticoids|mesh-ancestor
25670179|NCT04660799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25670180|NCT04660799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25670181|NCT04660799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25670182|NCT04660799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25670183|NCT04660799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25670184|NCT04660799|Glucocorticoids|glucocorticoids|mesh-ancestor
25670185|NCT04660799|Hormones|hormones|mesh-ancestor
25866073|NCT00102778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25866074|NCT00102778|Antiviral Agents|antiviral agents|mesh-ancestor
24839289|NCT02203253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24839290|NCT02203253|Growth Substances|growth substances|mesh-ancestor
24839291|NCT02203253|Growth Inhibitors|growth inhibitors|mesh-ancestor
24839292|NCT02203253|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24839293|NCT02203253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24885240|NCT01380028|Hormones|hormones|mesh-ancestor
24817474|NCT02084303|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24885241|NCT01380028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25059909|NCT03484221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059910|NCT03484221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25201524|NCT02726919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201526|NCT02727205|Dopamine Agonists|dopamine agonists|mesh-ancestor
25201527|NCT02727205|Dopamine Agents|dopamine agents|mesh-ancestor
25201528|NCT02727205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25201529|NCT02727205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201530|NCT02727205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201531|NCT02726867|Lacosamide|lacosamide|mesh-list
25201532|NCT02726867|Ketamine|ketamine|mesh-list
25201533|NCT02726867|Levetiracetam|levetiracetam|mesh-list
25201534|NCT02726867|Phenobarbital|phenobarbital|mesh-list
25201535|NCT02726867|Analgesics|analgesics|mesh-ancestor
25201536|NCT02726867|Sensory System Agents|sensory system agents|mesh-ancestor
25201537|NCT02726867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25201538|NCT02726867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201539|NCT02726867|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25201540|NCT02726867|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25201541|NCT02726867|Anesthetics, General|anesthetics, general|mesh-ancestor
25201542|NCT02726867|Anesthetics|anesthetics|mesh-ancestor
25201543|NCT02726867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25201544|NCT02726867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25059933|NCT03484091|Protective Agents|protective agents|mesh-ancestor
25059934|NCT03484091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059935|NCT03483948|Azacitidine|azacitidine|mesh-list
25059936|NCT03483948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25059937|NCT03483948|Antimetabolites|antimetabolites|mesh-ancestor
25059938|NCT03483948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059939|NCT03483948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25059940|NCT03483948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866075|NCT00102778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25866076|NCT00102778|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25866077|NCT00102778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25866078|NCT00102778|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25866079|NCT00102778|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25866080|NCT00102830|Trebananib|trebananib|mesh-list
25866081|NCT00102830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24510408|NCT00564538|Immunologic Factors|immunologic factors|mesh-ancestor
24510409|NCT00564538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510410|NCT00564538|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24510411|NCT00564538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510412|NCT00564538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510413|NCT00564551|Calcium, Dietary|calcium, dietary|mesh-list
24510415|NCT00564551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24510416|NCT00564551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059955|NCT03483870|Granisetron|granisetron|mesh-list
25059956|NCT03483870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25059957|NCT03483870|Narcotics|narcotics|mesh-ancestor
25059958|NCT03483870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24822276|NCT02110719|Antimanic Agents|antimanic agents|mesh-ancestor
25670186|NCT04660799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25670187|NCT04660799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25670188|NCT04660799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25670189|NCT04660799|Tubulin Modulators|tubulin modulators|mesh-ancestor
25670190|NCT04660799|Antimitotic Agents|antimitotic agents|mesh-ancestor
25670191|NCT04660799|Mitosis Modulators|mitosis modulators|mesh-ancestor
25670192|NCT04660799|Sensory System Agents|sensory system agents|mesh-ancestor
25670193|NCT04660799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25670194|NCT04660799|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25670195|NCT04660799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25670196|NCT04660799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25670197|NCT04660799|Anesthetics, Local|anesthetics, local|mesh-ancestor
24839304|NCT02203396|Immunologic Factors|immunologic factors|mesh-ancestor
24839305|NCT02203396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783581|NCT01902641|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24783582|NCT01902641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24783583|NCT01902641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24783584|NCT01902641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783585|NCT01902641|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
24783586|NCT01902771|Imiquimod|imiquimod|mesh-list
24783587|NCT01902771|Vaccines|vaccines|mesh-list
24977619|NCT02670044|Venetoclax|venetoclax|mesh-list
25866082|NCT00102830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25866083|NCT00102830|Growth Substances|growth substances|mesh-ancestor
25866084|NCT00102830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866085|NCT00102830|Growth Inhibitors|growth inhibitors|mesh-ancestor
25866086|NCT00102830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866087|NCT00102843|Folic Acid|folic acid|mesh-list
25866088|NCT00102843|Betaine|betaine|mesh-list
25866089|NCT00102843|Hematinics|hematinics|mesh-ancestor
24510426|NCT00564564|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24510427|NCT00564564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24510428|NCT00564564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24510429|NCT00564564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24510443|NCT00564590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885265|NCT01164995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885266|NCT01123707|Aripiprazole|aripiprazole|mesh-list
24885268|NCT01123707|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24885269|NCT01123707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24885270|NCT01123707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24885271|NCT01123707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885272|NCT01123707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24885273|NCT01123707|Serotonin Agents|serotonin agents|mesh-ancestor
24885274|NCT01123707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885275|NCT01123707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24885276|NCT01123707|Antidepressive Agents|antidepressive agents|mesh-ancestor
24885277|NCT01123707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24510444|NCT00564603|Dexamethasone|dexamethasone|mesh-list
24510445|NCT00564603|Dexamethasone acetate|dexamethasone acetate|mesh-list
25040552|NCT03011450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25059966|NCT03483870|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25059968|NCT03483870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25059969|NCT03483870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059970|NCT03483818|Antiviral Agents|antiviral agents|mesh-list
25059971|NCT03483818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25059972|NCT03483753|Vasopressins|vasopressins|mesh-list
25059973|NCT03483753|Arginine Vasopressin|arginine vasopressin|mesh-list
25059974|NCT03483753|Norepinephrine|norepinephrine|mesh-list
25059975|NCT03483753|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25059976|NCT03483753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24768985|NCT01812018|Gemcitabine|gemcitabine|mesh-list
25866090|NCT00102843|Vitamin B Complex|vitamin b complex|mesh-ancestor
25059977|NCT03483753|Adrenergic Agents|adrenergic agents|mesh-ancestor
25059978|NCT03483753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25059979|NCT03483753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059980|NCT03483753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510460|NCT00564603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510461|NCT00564603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510462|NCT00564642|Acetylcysteine|acetylcysteine|mesh-list
24510463|NCT00564642|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24510464|NCT00564642|Antiviral Agents|antiviral agents|mesh-ancestor
24885284|NCT01123707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24885285|NCT01123707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24885286|NCT01123707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24885287|NCT01123707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24885288|NCT01123707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25670198|NCT04660799|Anesthetics|anesthetics|mesh-ancestor
25670199|NCT04660799|Antiemetics|antiemetics|mesh-ancestor
25670200|NCT04660799|Autonomic Agents|autonomic agents|mesh-ancestor
25670201|NCT04660799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25670202|NCT04660799|Histamine Agents|histamine agents|mesh-ancestor
25670203|NCT04660799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25670204|NCT04660799|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25670205|NCT04660799|Antipruritics|antipruritics|mesh-ancestor
25670206|NCT04660799|Dermatologic Agents|dermatologic agents|mesh-ancestor
25670207|NCT04642287|Fluorouracil|fluorouracil|mesh-list
25670208|NCT04642287|Calcipotriene|calcipotriene|mesh-list
25670209|NCT04642287|Petrolatum|petrolatum|mesh-list
24977678|NCT02459392|Prednisolone acetate|prednisolone acetate|mesh-list
24977679|NCT02459392|Hyaluronic Acid|hyaluronic acid|mesh-list
24977680|NCT02459392|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24977681|NCT02459392|Prednisolone phosphate|prednisolone phosphate|mesh-list
24977682|NCT02459392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24885289|NCT00999401|Roscovitine|roscovitine|mesh-list
24885290|NCT00999401|Sapacitabine|sapacitabine|mesh-list
24885291|NCT00999401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885292|NCT00999401|Antiviral Agents|antiviral agents|mesh-ancestor
24885293|NCT00999401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24885294|NCT00999401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24885295|NCT00999401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059981|NCT03483753|Sympathomimetics|sympathomimetics|mesh-ancestor
25059982|NCT03483753|Autonomic Agents|autonomic agents|mesh-ancestor
25059983|NCT03483753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25059984|NCT03483753|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25059985|NCT03483753|Hemostatics|hemostatics|mesh-ancestor
25059986|NCT03483753|Coagulants|coagulants|mesh-ancestor
25059987|NCT03483753|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25059988|NCT03483753|Natriuretic Agents|natriuretic agents|mesh-ancestor
25059989|NCT03483636|Lemborexant|lemborexant|mesh-list
25059990|NCT03483636|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25059991|NCT03483636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25059992|NCT03483636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059993|NCT03483636|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25059994|NCT03483636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25059995|NCT03483636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25059996|NCT03483636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059997|NCT03483545|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25059998|NCT03483545|Hormones|hormones|mesh-ancestor
25059999|NCT03483545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25060000|NCT03483545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510506|NCT00564707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510507|NCT00564707|Cholinergic Agents|cholinergic agents|mesh-ancestor
24510508|NCT00564707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24510509|NCT00564707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510510|NCT00564707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24510511|NCT00564707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24510512|NCT00564720|Gemcitabine|gemcitabine|mesh-list
24510513|NCT00564720|Oxaliplatin|oxaliplatin|mesh-list
24510525|NCT00564720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24510526|NCT00564772|Ritonavir|ritonavir|mesh-list
24510527|NCT00564772|Lopinavir|lopinavir|mesh-list
24510528|NCT00564772|Raltegravir Potassium|raltegravir potassium|mesh-list
24510529|NCT00564772|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24510530|NCT00564772|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24510531|NCT00564772|Protease Inhibitors|protease inhibitors|mesh-ancestor
24510532|NCT00564772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510533|NCT00564772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885303|NCT00725127|Sensory System Agents|sensory system agents|mesh-ancestor
24885304|NCT00725127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24885305|NCT00725127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510549|NCT00564824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25060001|NCT03483415|Morphine|morphine|mesh-list
25060002|NCT03483415|Bupivacaine|bupivacaine|mesh-list
25866091|NCT00102843|Vitamins|vitamins|mesh-ancestor
25060003|NCT03483415|Anesthetics, Local|anesthetics, local|mesh-ancestor
25060004|NCT03483415|Anesthetics|anesthetics|mesh-ancestor
25060005|NCT03483415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25060006|NCT03483415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578421|NCT00849030|Tamoxifen|tamoxifen|mesh-list
24510550|NCT00564824|Purinergic Agents|purinergic agents|mesh-ancestor
24510552|NCT00564941|Deferasirox|deferasirox|mesh-list
24510553|NCT00564941|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24510554|NCT00564941|Chelating Agents|chelating agents|mesh-ancestor
24510555|NCT00564941|Sequestering Agents|sequestering agents|mesh-ancestor
24510556|NCT00564941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510557|NCT00564993|Dobutamine|dobutamine|mesh-list
24510558|NCT00564993|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24510559|NCT00564993|Sympathomimetics|sympathomimetics|mesh-ancestor
24510560|NCT00564993|Autonomic Agents|autonomic agents|mesh-ancestor
25404129|NCT03682978|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25670210|NCT04642287|Antimetabolites|antimetabolites|mesh-ancestor
25670211|NCT04642287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670212|NCT04642287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25670213|NCT04642287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866092|NCT00102843|Micronutrients|micronutrients|mesh-ancestor
24415125|NCT00199069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24415126|NCT00199069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24415127|NCT00199069|Antiviral Agents|antiviral agents|mesh-ancestor
24415128|NCT00199069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24415129|NCT00199069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24415130|NCT00199069|Tubulin Modulators|tubulin modulators|mesh-ancestor
24415131|NCT00199069|Antimitotic Agents|antimitotic agents|mesh-ancestor
24510568|NCT00564993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510569|NCT00564993|Protective Agents|protective agents|mesh-ancestor
24510588|NCT00565019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510590|NCT00565097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510593|NCT00565123|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24510594|NCT00565123|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24510595|NCT00565123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24510596|NCT00565123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24510597|NCT00565123|Renal Agents|renal agents|mesh-ancestor
24510598|NCT00565123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24510599|NCT00565123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24510600|NCT00565123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24510601|NCT00565123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510602|NCT00565123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510603|NCT00565123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510604|NCT00565123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24510605|NCT00565123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24510606|NCT00565162|Insulin Glargine|insulin glargine|mesh-list
24510607|NCT00565162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24607225|NCT04994561|Vitamin B Complex|vitamin b complex|mesh-ancestor
24510632|NCT00565214|Selenium|selenium|mesh-list
24510633|NCT00565214|Micronutrients|micronutrients|mesh-ancestor
24510634|NCT00565214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510635|NCT00565214|Antioxidants|antioxidants|mesh-ancestor
25060007|NCT03483415|Sensory System Agents|sensory system agents|mesh-ancestor
25060008|NCT03483415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060009|NCT03483415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25060010|NCT03483415|Narcotics|narcotics|mesh-ancestor
25060011|NCT03483415|Analgesics|analgesics|mesh-ancestor
25060013|NCT03483389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25060014|NCT03483389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25060015|NCT03483389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25060016|NCT03483389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060017|NCT03483376|Anti-Infective Agents|anti-infective agents|mesh-list
25060018|NCT03483376|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24510636|NCT00565214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510637|NCT00565214|Protective Agents|protective agents|mesh-ancestor
24510638|NCT00565214|Trace Elements|trace elements|mesh-ancestor
24510639|NCT00565227|Docetaxel|docetaxel|mesh-list
24510640|NCT00565227|Vorinostat|vorinostat|mesh-list
24885335|NCT00248287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24885336|NCT00248287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885337|NCT00248287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885338|NCT00248287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24885339|NCT00225095|Hyaluronic Acid|hyaluronic acid|mesh-list
24885340|NCT00225095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24885341|NCT00225095|Immunologic Factors|immunologic factors|mesh-ancestor
24464370|NCT00364455|Epoetin Alfa|epoetin alfa|mesh-list
24510680|NCT00565253|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24510681|NCT00565253|Vasodilator Agents|vasodilator agents|mesh-ancestor
24510682|NCT00565253|Gasotransmitters|gasotransmitters|mesh-ancestor
24510683|NCT00565253|Protective Agents|protective agents|mesh-ancestor
25060041|NCT03483350|Antiemetics|antiemetics|mesh-ancestor
25060042|NCT03483350|Autonomic Agents|autonomic agents|mesh-ancestor
25060043|NCT03483350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25201545|NCT02726867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25060044|NCT03483350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25670214|NCT04642287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25670215|NCT04642287|Immunologic Factors|immunologic factors|mesh-ancestor
25670216|NCT04642287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670217|NCT04642287|Dermatologic Agents|dermatologic agents|mesh-ancestor
25670218|NCT04642287|Emollients|emollients|mesh-ancestor
25670219|NCT04639960|Risperidone|risperidone|mesh-list
25670220|NCT04639960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25670221|NCT04639960|Serotonin Agents|serotonin agents|mesh-ancestor
25060045|NCT03483350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25670222|NCT04639960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24977845|NCT01863550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24977846|NCT01863550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977847|NCT01863550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24977858|NCT01863550|Protease Inhibitors|protease inhibitors|mesh-ancestor
24977859|NCT01863550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24977860|NCT01863550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977861|NCT01863550|Dermatologic Agents|dermatologic agents|mesh-ancestor
25060046|NCT03483350|Serotonin Agents|serotonin agents|mesh-ancestor
25060048|NCT03483207|Warfarin|warfarin|mesh-list
25866093|NCT00102843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060049|NCT03483207|Anticoagulants|anticoagulants|mesh-ancestor
25060050|NCT03483207|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25060051|NCT03483207|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25060052|NCT03483207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060053|NCT03483181|Enoxaparin|enoxaparin|mesh-list
25060054|NCT03483181|Rivaroxaban|rivaroxaban|mesh-list
25060055|NCT03483181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24943950|NCT03965442|Adrenergic Agents|adrenergic agents|mesh-ancestor
24801358|NCT01982929|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24952943|NCT03890341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24952944|NCT03890341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24952945|NCT03890341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24952946|NCT03890341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24952947|NCT03890341|Anesthetics, General|anesthetics, general|mesh-ancestor
24952948|NCT03890341|Anesthetics|anesthetics|mesh-ancestor
24952949|NCT03890341|GABA Modulators|gaba modulators|mesh-ancestor
24952950|NCT03890341|GABA Agents|gaba agents|mesh-ancestor
24952951|NCT03890341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24952952|NCT03890341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952954|NCT03890341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24952955|NCT03890341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24952956|NCT03890341|Contraceptive Agents|contraceptive agents|mesh-ancestor
24952957|NCT03890341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24952958|NCT03890341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24952960|NCT03890341|Hormones|hormones|mesh-ancestor
25866094|NCT00102843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25866095|NCT00102843|Lipotropic Agents|lipotropic agents|mesh-ancestor
24510692|NCT00565318|Immunologic Factors|immunologic factors|mesh-ancestor
24510693|NCT00565318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510694|NCT00565318|Chelating Agents|chelating agents|mesh-ancestor
24510695|NCT00565318|Sequestering Agents|sequestering agents|mesh-ancestor
24510696|NCT00565318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510697|NCT00565331|Rituximab|rituximab|mesh-list
24510698|NCT00565331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24952972|NCT03890406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24952973|NCT03890406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952974|NCT03890510|Anesthetics|anesthetics|mesh-list
24952975|NCT03890510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24952976|NCT03890510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952977|NCT03890094|Sufentanil|sufentanil|mesh-list
24952979|NCT03890094|Narcotics|narcotics|mesh-ancestor
24952980|NCT03890094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24952981|NCT03890094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952982|NCT03890094|Analgesics|analgesics|mesh-ancestor
24952983|NCT03890094|Sensory System Agents|sensory system agents|mesh-ancestor
24952984|NCT03890094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24952985|NCT03890094|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24822410|NCT02111551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24510699|NCT00565331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885354|NCT05174195|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24885355|NCT05174195|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24885356|NCT05174195|Contraceptive Agents|contraceptive agents|mesh-ancestor
24885357|NCT05174195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24885358|NCT05174195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885359|NCT05174195|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24885360|NCT05174195|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24885361|NCT05174195|Progestins|progestins|mesh-ancestor
25404130|NCT03682978|GABA Agonists|gaba agonists|mesh-ancestor
25670223|NCT04639960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670224|NCT04639960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670225|NCT04639960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25670226|NCT04639960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25670227|NCT04639960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25670228|NCT04639960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25670229|NCT04639960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24415211|NCT00199095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24415212|NCT00199095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24415213|NCT00199095|Abortifacient Agents|abortifacient agents|mesh-ancestor
24415214|NCT00199095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24415215|NCT00199095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24415216|NCT00199095|Antimetabolites|antimetabolites|mesh-ancestor
24415217|NCT00199095|Dermatologic Agents|dermatologic agents|mesh-ancestor
24415218|NCT00199095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24415219|NCT00199095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24415220|NCT00199095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24885363|NCT05174195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24510739|NCT00565487|Capecitabine|capecitabine|mesh-list
24510740|NCT00565487|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24510741|NCT00565487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24510742|NCT00565487|Antimetabolites|antimetabolites|mesh-ancestor
24510743|NCT00565487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510744|NCT00565487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510745|NCT00565487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24510746|NCT00565487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510747|NCT00565500|Ibuprofen|ibuprofen|mesh-list
24510748|NCT00565500|Celecoxib|celecoxib|mesh-list
24510749|NCT00565500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24510750|NCT00565500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24510751|NCT00565500|Analgesics|analgesics|mesh-ancestor
24510752|NCT00565500|Sensory System Agents|sensory system agents|mesh-ancestor
24510753|NCT00565500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24510780|NCT00565630|Moxifloxacin|moxifloxacin|mesh-list
25866096|NCT00102843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24952986|NCT03890094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24952987|NCT03890094|Anesthetics, General|anesthetics, general|mesh-ancestor
24952988|NCT03890094|Anesthetics|anesthetics|mesh-ancestor
24952990|NCT03889717|Vitamins|vitamins|mesh-ancestor
24952991|NCT03889717|Micronutrients|micronutrients|mesh-ancestor
24952992|NCT03889717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952993|NCT03889717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24952994|NCT03889808|Antitoxins|antitoxins|mesh-list
24952995|NCT03889808|Immunologic Factors|immunologic factors|mesh-ancestor
24952996|NCT03889808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952997|NCT03890042|Dienogest|dienogest|mesh-list
24952998|NCT03890042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24952999|NCT03890042|Gestodene|gestodene|mesh-list
24953000|NCT03890042|Femovan|femovan|mesh-list
24953001|NCT03890042|Estradiol|estradiol|mesh-list
24953002|NCT03890042|Estrogens|estrogens|mesh-ancestor
24953003|NCT03890042|Hormones|hormones|mesh-ancestor
25866097|NCT00102843|Antimetabolites|antimetabolites|mesh-ancestor
24953004|NCT03890042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24953005|NCT03890042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953006|NCT03890042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24953007|NCT03890042|Contraceptive Agents|contraceptive agents|mesh-ancestor
24953008|NCT03890042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24953009|NCT03890042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24953010|NCT03890042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24953011|NCT03890042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24953012|NCT03890042|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25060056|NCT03483181|Antithrombins|antithrombins|mesh-ancestor
24953013|NCT03890042|Hormone Antagonists|hormone antagonists|mesh-ancestor
24953014|NCT03890042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24953015|NCT03890042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24953016|NCT03890042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25060061|NCT03483181|Anticoagulants|anticoagulants|mesh-ancestor
25060062|NCT03483181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25060063|NCT03483181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25060065|NCT03483142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25060066|NCT03483142|Abortifacient Agents|abortifacient agents|mesh-ancestor
25670230|NCT04639960|Dopamine Agents|dopamine agents|mesh-ancestor
25670231|NCT04581343|Gemcitabine|gemcitabine|mesh-list
25670232|NCT04581343|Paclitaxel|paclitaxel|mesh-list
25670233|NCT04581343|Spartalizumab|spartalizumab|mesh-list
25670234|NCT04581343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25670235|NCT04581343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670236|NCT04581343|Tubulin Modulators|tubulin modulators|mesh-ancestor
25670237|NCT04581343|Antimitotic Agents|antimitotic agents|mesh-ancestor
25670238|NCT04581343|Mitosis Modulators|mitosis modulators|mesh-ancestor
25670239|NCT04581343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670240|NCT04581343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24783608|NCT01902862|Rituximab|rituximab|mesh-list
24783609|NCT01902862|Bortezomib|bortezomib|mesh-list
24783610|NCT01902862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25866098|NCT00102843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866099|NCT00102843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25866100|NCT00102856|Pramipexole|pramipexole|mesh-list
25866101|NCT00102856|Rivastigmine|rivastigmine|mesh-list
25866102|NCT00102856|Antioxidants|antioxidants|mesh-ancestor
24510793|NCT00565630|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24464417|NCT00364806|Autonomic Agents|autonomic agents|mesh-ancestor
24464418|NCT00364806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24885383|NCT05173584|Adrenergic Agents|adrenergic agents|mesh-ancestor
24885384|NCT05173584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24885385|NCT05173584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885386|NCT05173545|Mitoxantrone|mitoxantrone|mesh-list
24885387|NCT05173545|Analgesics|analgesics|mesh-ancestor
24885388|NCT05173545|Sensory System Agents|sensory system agents|mesh-ancestor
24885389|NCT05173545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24885390|NCT05173545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885391|NCT05173545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885392|NCT05173545|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24885393|NCT05173545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24885394|NCT05173545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885395|NCT05173545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885396|NCT05173337|Nefopam|nefopam|mesh-list
24885397|NCT05173337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24885398|NCT05173337|Analgesics|analgesics|mesh-ancestor
24885399|NCT05173337|Sensory System Agents|sensory system agents|mesh-ancestor
24885400|NCT05173337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24885401|NCT05173337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885402|NCT05173246|Paclitaxel|paclitaxel|mesh-list
24885403|NCT05173246|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24885404|NCT05173246|Cisplatin|cisplatin|mesh-list
24885405|NCT05173246|Carboplatin|carboplatin|mesh-list
24885406|NCT05173246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24885422|NCT05172934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885425|NCT05172739|Analgesics, Opioid|analgesics, opioid|mesh-list
24885426|NCT05172739|Anesthetics|anesthetics|mesh-list
24885427|NCT05172739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24885428|NCT05172739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885429|NCT05172739|Narcotics|narcotics|mesh-ancestor
24885430|NCT05172739|Analgesics|analgesics|mesh-ancestor
24885431|NCT05172739|Sensory System Agents|sensory system agents|mesh-ancestor
24885432|NCT05172739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24885434|NCT05172570|Analgesics|analgesics|mesh-ancestor
24885435|NCT05172570|Sensory System Agents|sensory system agents|mesh-ancestor
24885436|NCT05172570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24510807|NCT00565682|Analgesics|analgesics|mesh-ancestor
24510808|NCT00565682|Sensory System Agents|sensory system agents|mesh-ancestor
24510809|NCT00565682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24514923|NCT00593463|Antimanic Agents|antimanic agents|mesh-ancestor
25866103|NCT00102856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866104|NCT00102856|Protective Agents|protective agents|mesh-ancestor
25866105|NCT00102856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866106|NCT00102856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24885438|NCT05172570|Anticonvulsants|anticonvulsants|mesh-ancestor
24885439|NCT05172570|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24885440|NCT05172570|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24885441|NCT05172570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24885442|NCT05172570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24885443|NCT05172570|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24885444|NCT05172570|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24885445|NCT05172570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24464436|NCT00364871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24464437|NCT00364871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24510860|NCT00565981|Antimetabolites|antimetabolites|mesh-ancestor
24510861|NCT00565981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510862|NCT00565981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25670241|NCT04581343|Antimetabolites|antimetabolites|mesh-ancestor
25670242|NCT04581343|Antiviral Agents|antiviral agents|mesh-ancestor
25670243|NCT04581343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25670244|NCT04581343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25670245|NCT04581343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25670246|NCT04581343|Immunologic Factors|immunologic factors|mesh-ancestor
25670247|NCT04581343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510863|NCT00565981|Immunologic Factors|immunologic factors|mesh-ancestor
24510864|NCT00565981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510865|NCT00565981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24510867|NCT00566046|Anticonvulsants|anticonvulsants|mesh-ancestor
24510868|NCT00566046|Nootropic Agents|nootropic agents|mesh-ancestor
24510870|NCT00566124|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24510871|NCT00566124|Insulin Glargine|insulin glargine|mesh-list
25866107|NCT00102856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25866108|NCT00102856|Dopamine Agonists|dopamine agonists|mesh-ancestor
25866109|NCT00102856|Dopamine Agents|dopamine agents|mesh-ancestor
25866110|NCT00102856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25866111|NCT00102856|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24853539|NCT02268773|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25060074|NCT03482960|Anesthetics, General|anesthetics, general|mesh-ancestor
25060076|NCT03482960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25060077|NCT03482960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060078|NCT03482752|Molgramostim|molgramostim|mesh-list
25201546|NCT02726867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24975568|NCT03476551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060079|NCT03482752|Sargramostim|sargramostim|mesh-list
25060080|NCT03482752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25060081|NCT03482752|Immunologic Factors|immunologic factors|mesh-ancestor
24822464|NCT02112032|Pembrolizumab|pembrolizumab|mesh-list
24885453|NCT05172518|Capecitabine|capecitabine|mesh-list
24885455|NCT05172518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24464442|NCT00364871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24464443|NCT00364871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464444|NCT00364871|Dopamine Agents|dopamine agents|mesh-ancestor
24464445|NCT00364871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24464446|NCT00364871|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24464447|NCT00364871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24464448|NCT00364871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510908|NCT00566553|Grape Seed Extract|grape seed extract|mesh-list
24510915|NCT00566592|Ethanol|ethanol|mesh-list
24510916|NCT00566592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24515021|NCT00593996|Vitamin D|vitamin d|mesh-list
24885457|NCT05172518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885459|NCT05172440|Axitinib|axitinib|mesh-list
24885460|NCT05172440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885461|NCT05172440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24885462|NCT05172440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885463|NCT05172440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510927|NCT00566644|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24510929|NCT00566683|Diazepam|diazepam|mesh-list
24510930|NCT00566683|Alfentanil|alfentanil|mesh-list
24510931|NCT00566683|Propofol|propofol|mesh-list
24510932|NCT00566683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25060082|NCT03482752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060084|NCT03482544|Analgesics|analgesics|mesh-ancestor
25060085|NCT03482544|Sensory System Agents|sensory system agents|mesh-ancestor
25060086|NCT03482544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060087|NCT03482544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060088|NCT03482544|Anticonvulsants|anticonvulsants|mesh-ancestor
25060089|NCT03482544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25060090|NCT03482544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25060091|NCT03482544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816409|NCT02076841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060103|NCT03482492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060104|NCT03482492|Antipyretics|antipyretics|mesh-ancestor
25060105|NCT03482492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25060106|NCT03482492|Narcotics|narcotics|mesh-ancestor
25060107|NCT03482492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25060108|NCT03482440|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
25060109|NCT03482440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25060110|NCT03482440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25217504|NCT02677571|Anesthetics|anesthetics|mesh-ancestor
25201547|NCT02726867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201548|NCT02726867|Anticonvulsants|anticonvulsants|mesh-ancestor
25060111|NCT03482440|Analgesics|analgesics|mesh-ancestor
24822481|NCT02112162|Deoxyglucose|deoxyglucose|mesh-list
24510933|NCT00566683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24510934|NCT00566683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510935|NCT00566683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24510956|NCT00566683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415757|NCT00200590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24415758|NCT00200590|Antipyretics|antipyretics|mesh-ancestor
24415765|NCT00200629|Analgesics|analgesics|mesh-ancestor
24510957|NCT00566761|Triamcinolone|triamcinolone|mesh-list
24510958|NCT00566761|Bevacizumab|bevacizumab|mesh-list
24510959|NCT00566761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24510960|NCT00566761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510961|NCT00566761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24510962|NCT00566761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24510963|NCT00566761|Growth Substances|growth substances|mesh-ancestor
24510964|NCT00566761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060113|NCT03482440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060114|NCT03482440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707846|NCT01498081|Cholinergic Agents|cholinergic agents|mesh-ancestor
24885478|NCT05172310|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24885479|NCT05172310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885482|NCT05172115|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24885483|NCT05172115|Tinzaparin|tinzaparin|mesh-list
24885484|NCT05172115|Dalteparin|dalteparin|mesh-list
24885485|NCT05172115|Plasminogen|plasminogen|mesh-list
24885486|NCT05172115|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24885487|NCT05172115|Anticoagulants|anticoagulants|mesh-ancestor
24885488|NCT05172115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24885489|NCT05172115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24885490|NCT05172115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885491|NCT05171985|Dexmedetomidine|dexmedetomidine|mesh-list
24885492|NCT05171985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24885493|NCT05171985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24885494|NCT05171985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885495|NCT05171985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24885496|NCT05171985|Analgesics|analgesics|mesh-ancestor
24885497|NCT05171985|Sensory System Agents|sensory system agents|mesh-ancestor
24885498|NCT05171985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816403|NCT02076841|Interferon-beta|interferon-beta|mesh-list
24816404|NCT02076841|Interferon beta-1a|interferon beta-1a|mesh-list
24816405|NCT02076841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816406|NCT02076841|Antiviral Agents|antiviral agents|mesh-ancestor
24816407|NCT02076841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24816408|NCT02076841|Immunologic Factors|immunologic factors|mesh-ancestor
25060132|NCT03482232|Expectorants|expectorants|mesh-list
25060133|NCT03482232|Antitubercular Agents|antitubercular agents|mesh-ancestor
25060134|NCT03482232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25060135|NCT03482232|Analgesics|analgesics|mesh-ancestor
24822519|NCT02112305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24822520|NCT02112305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822521|NCT02112305|Anesthetics|anesthetics|mesh-ancestor
24822522|NCT02112305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24511027|NCT00567047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511028|NCT00567047|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24511029|NCT00567047|Protease Inhibitors|protease inhibitors|mesh-ancestor
24511030|NCT00567047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24511031|NCT00567047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511033|NCT00567060|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24511034|NCT00567060|Protective Agents|protective agents|mesh-ancestor
24511035|NCT00567060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511036|NCT00567060|Nootropic Agents|nootropic agents|mesh-ancestor
24816415|NCT02076893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24816416|NCT02076893|Analgesics|analgesics|mesh-ancestor
24816417|NCT02076893|Sensory System Agents|sensory system agents|mesh-ancestor
24816418|NCT02076893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816419|NCT02076893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816420|NCT02076893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24816421|NCT02076893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24816422|NCT02076893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24816423|NCT02076893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816424|NCT02076893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816425|NCT02076893|Anticonvulsants|anticonvulsants|mesh-ancestor
24816426|NCT02076893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24816427|NCT02076893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25866112|NCT00102856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885511|NCT05171751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670248|NCT04581343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25670249|NCT04580771|Cisplatin|cisplatin|mesh-list
24885513|NCT05171660|Oxaliplatin|oxaliplatin|mesh-list
25670250|NCT04580771|Vaccines|vaccines|mesh-list
24885514|NCT05171660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885515|NCT05171660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24885517|NCT05171660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885520|NCT05171530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885521|NCT05171530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24885522|NCT05171530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885523|NCT05171530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885524|NCT05164653|Valsartan|valsartan|mesh-list
24885525|NCT05164653|Angiotensin II|angiotensin ii|mesh-list
24885526|NCT05164653|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24885527|NCT05164653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
25866113|NCT00102856|Cholinergic Agents|cholinergic agents|mesh-ancestor
25060136|NCT03482232|Sensory System Agents|sensory system agents|mesh-ancestor
25060137|NCT03482232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060138|NCT03482232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060139|NCT03482232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25060140|NCT03482232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25060141|NCT03482232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25060142|NCT03482232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060151|NCT03482180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25060152|NCT03482180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25060153|NCT03482180|Antimetabolites|antimetabolites|mesh-ancestor
25060154|NCT03482180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060155|NCT03482180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25060156|NCT03482180|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25060157|NCT03482180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25060163|NCT03482115|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
24822530|NCT02112305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24885528|NCT05164653|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24885531|NCT05164653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885532|NCT05164653|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24885533|NCT05164653|Protease Inhibitors|protease inhibitors|mesh-ancestor
24885534|NCT05164653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885542|NCT05151588|Docetaxel|docetaxel|mesh-list
24885557|NCT05142969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24885558|NCT05142969|Disinfectants|disinfectants|mesh-ancestor
24885559|NCT05137938|Ketamine|ketamine|mesh-list
24885560|NCT05137938|Analgesics|analgesics|mesh-ancestor
24885561|NCT05137938|Sensory System Agents|sensory system agents|mesh-ancestor
24885562|NCT05137938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24885563|NCT05137938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060164|NCT03482115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060169|NCT03482024|Tirzepatide|tirzepatide|mesh-list
25060170|NCT03482024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25062658|NCT04231877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25060171|NCT03482024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060172|NCT03482024|Incretins|incretins|mesh-ancestor
25060173|NCT03482024|Hormones|hormones|mesh-ancestor
25060174|NCT03482024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25060175|NCT03481998|Letrozole|letrozole|mesh-list
25060176|NCT03481998|Fulvestrant|fulvestrant|mesh-list
25060177|NCT03481998|Anastrozole|anastrozole|mesh-list
25060178|NCT03481998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822561|NCT02112578|Meclizine|meclizine|mesh-list
24885564|NCT05137938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24885565|NCT05137938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24885566|NCT05137938|Anesthetics, General|anesthetics, general|mesh-ancestor
24885567|NCT05137938|Anesthetics|anesthetics|mesh-ancestor
24885568|NCT05137938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24885569|NCT05137938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24885570|NCT05137938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24885571|NCT05137938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24885572|NCT05137938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511043|NCT00567099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511044|NCT00567099|Dopamine Agonists|dopamine agonists|mesh-ancestor
24511045|NCT00567099|Dopamine Agents|dopamine agents|mesh-ancestor
24511046|NCT00567099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24885621|NCT05027425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885623|NCT05024513|Oxaliplatin|oxaliplatin|mesh-list
25866114|NCT00102856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25866115|NCT00102869|Levodopa|levodopa|mesh-list
25866116|NCT00102869|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24977947|NCT01222754|Growth Substances|growth substances|mesh-ancestor
24977948|NCT01222754|Growth Inhibitors|growth inhibitors|mesh-ancestor
24977949|NCT01222754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977950|NCT01150890|Brodalumab|brodalumab|mesh-list
24416355|NCT00202865|Infliximab|infliximab|mesh-list
24885648|NCT04991662|Norepinephrine|norepinephrine|mesh-list
25060179|NCT03481998|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25060180|NCT03481998|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24944147|NCT03963128|Cholecalciferol|cholecalciferol|mesh-list
25060181|NCT03481998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25060182|NCT03481998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885649|NCT04991662|Metaraminol|metaraminol|mesh-list
24885650|NCT04991662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24885651|NCT04991662|Mydriatics|mydriatics|mesh-ancestor
24885652|NCT04991662|Autonomic Agents|autonomic agents|mesh-ancestor
24885653|NCT04991662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24885654|NCT04991662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885655|NCT04991662|Sympathomimetics|sympathomimetics|mesh-ancestor
24885656|NCT04991662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24885657|NCT04991662|Nasal Decongestants|nasal decongestants|mesh-ancestor
24885658|NCT04991662|Respiratory System Agents|respiratory system agents|mesh-ancestor
24885659|NCT04991662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24885660|NCT04991662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24885661|NCT04991662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24885662|NCT04991662|Adrenergic Agents|adrenergic agents|mesh-ancestor
24885663|NCT04991662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24885710|NCT04671030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885711|NCT04671030|Cholinergic Agents|cholinergic agents|mesh-ancestor
24885712|NCT04671030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24885713|NCT04671030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885714|NCT04671030|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24885715|NCT04671030|Autonomic Agents|autonomic agents|mesh-ancestor
24464808|NCT00366938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885722|NCT04660890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24885723|NCT04660890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25866117|NCT00102869|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25866118|NCT00102869|Dopamine Agents|dopamine agents|mesh-ancestor
25866119|NCT00102869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25866120|NCT00102869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608165|NCT02044497|Narcotics|narcotics|mesh-ancestor
24464702|NCT00366067|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24464703|NCT00366067|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24464704|NCT00366067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24511071|NCT00567216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24511072|NCT00567216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511073|NCT00567216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511074|NCT00567216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24511078|NCT00567216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24511079|NCT00567372|Bevacizumab|bevacizumab|mesh-list
24511121|NCT00567528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511122|NCT00567528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24464715|NCT00366119|Protease Inhibitors|protease inhibitors|mesh-ancestor
24464716|NCT00366119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885744|NCT04652206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24885746|NCT04652206|Antiviral Agents|antiviral agents|mesh-ancestor
24885747|NCT04652206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24885748|NCT04652206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885749|NCT04652206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24885750|NCT04652206|Immunologic Factors|immunologic factors|mesh-ancestor
24885751|NCT04652206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885752|NCT04647903|Amphetamine|amphetamine|mesh-list
24885753|NCT04647903|Dextroamphetamine|dextroamphetamine|mesh-list
24885754|NCT04647903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24885755|NCT04647903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060185|NCT03481998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25060187|NCT03481998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25060188|NCT03481998|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25670251|NCT04580771|Immunologic Factors|immunologic factors|mesh-ancestor
25670252|NCT04580771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670253|NCT04580771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670254|NCT04579120|Corticosterone|corticosterone|mesh-list
25670255|NCT04579120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25674486|NCT01772758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674487|NCT01772758|Protective Agents|protective agents|mesh-ancestor
25060189|NCT03481920|Avelumab|avelumab|mesh-list
25060190|NCT03481920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25060191|NCT03481920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25060192|NCT03481790|Folic Acid|folic acid|mesh-list
25060193|NCT03481790|Lactoferrin|lactoferrin|mesh-list
25060194|NCT03481790|Vitamins|vitamins|mesh-ancestor
25060195|NCT03481790|Micronutrients|micronutrients|mesh-ancestor
24415601|NCT00200226|Oxytocics|oxytocics|mesh-ancestor
24511168|NCT00567658|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24511169|NCT00567658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24511170|NCT00567658|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24511171|NCT00567658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24511172|NCT00567658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885769|NCT04632264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24885770|NCT04632264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464731|NCT00366262|Gout Suppressants|gout suppressants|mesh-ancestor
25866121|NCT00102869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885818|NCT04537026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24885820|NCT04537026|Protease Inhibitors|protease inhibitors|mesh-ancestor
24885821|NCT04537026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25060196|NCT03481790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060197|NCT03481790|Hematinics|hematinics|mesh-ancestor
25060198|NCT03481790|Vitamin B Complex|vitamin b complex|mesh-ancestor
25060199|NCT03481790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25060200|NCT03481582|Nitroglycerin|nitroglycerin|mesh-list
25060201|NCT03481582|Vasodilator Agents|vasodilator agents|mesh-ancestor
25060202|NCT03481569|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25060203|NCT03481569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25060204|NCT03481517|Bupivacaine|bupivacaine|mesh-list
24736313|NCT01661335|Dexamethasone|dexamethasone|mesh-list
25060205|NCT03481517|Anesthetics, Local|anesthetics, local|mesh-ancestor
25060206|NCT03481517|Anesthetics|anesthetics|mesh-ancestor
25060207|NCT03481517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25060208|NCT03481517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060209|NCT03481517|Sensory System Agents|sensory system agents|mesh-ancestor
25060210|NCT03481517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060211|NCT03481400|Calcitonin|calcitonin|mesh-list
25060212|NCT03481400|Salmon calcitonin|salmon calcitonin|mesh-list
25060213|NCT03481400|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
25060214|NCT03481400|Katacalcin|katacalcin|mesh-list
25060215|NCT03481400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24822591|NCT02112643|Selenium|selenium|mesh-list
24464772|NCT00366834|Dexamethasone|dexamethasone|mesh-list
24464773|NCT00366834|Dexamethasone acetate|dexamethasone acetate|mesh-list
24464774|NCT00366834|Ondansetron|ondansetron|mesh-list
24464775|NCT00366834|Casopitant|casopitant|mesh-list
25060216|NCT03481400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060217|NCT03481400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25060218|NCT03481400|Vasodilator Agents|vasodilator agents|mesh-ancestor
25060219|NCT03481036|Antiviral Agents|antiviral agents|mesh-list
25060220|NCT03481036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25060221|NCT03480997|Bromides|bromides|mesh-list
25060222|NCT03480997|Albuterol|albuterol|mesh-list
25060223|NCT03480997|Ipratropium|ipratropium|mesh-list
24853636|NCT02269319|Linezolid|linezolid|mesh-list
25060238|NCT03480997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060240|NCT03480997|Cholinergic Agents|cholinergic agents|mesh-ancestor
25060241|NCT03480958|Morphine|morphine|mesh-list
25060242|NCT03480958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25060243|NCT03480958|Narcotics|narcotics|mesh-ancestor
25060244|NCT03480958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25060245|NCT03480958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060246|NCT03480958|Analgesics|analgesics|mesh-ancestor
25060247|NCT03480958|Sensory System Agents|sensory system agents|mesh-ancestor
24464776|NCT00366834|BB 1101|bb 1101|mesh-list
24464777|NCT00366834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24464778|NCT00366834|Antiemetics|antiemetics|mesh-ancestor
24464779|NCT00366834|Autonomic Agents|autonomic agents|mesh-ancestor
24511181|NCT00567710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24511182|NCT00567710|Serotonin Agents|serotonin agents|mesh-ancestor
24511183|NCT00567710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25866122|NCT00102882|Fluticasone|fluticasone|mesh-list
25866124|NCT00102882|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24511184|NCT00567710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511185|NCT00567710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060248|NCT03480958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060250|NCT03480945|Serotonin|serotonin|mesh-list
25060251|NCT03480945|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25060252|NCT03480945|Serotonin Agents|serotonin agents|mesh-ancestor
24416844|NCT00204243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24416845|NCT00204243|Analgesics|analgesics|mesh-ancestor
25060253|NCT03480945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25060254|NCT03480945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060255|NCT03480945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060256|NCT03480945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25060257|NCT03480945|Vasodilator Agents|vasodilator agents|mesh-ancestor
24944297|NCT03961503|Daptomycin|daptomycin|mesh-list
24944298|NCT03961503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24944299|NCT03961503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24944300|NCT03961698|Paclitaxel|paclitaxel|mesh-list
24944301|NCT03961698|Bevacizumab|bevacizumab|mesh-list
24944302|NCT03961698|Atezolizumab|atezolizumab|mesh-list
24944303|NCT03961698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24944304|NCT03961698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24944305|NCT03961698|Tubulin Modulators|tubulin modulators|mesh-ancestor
24944322|NCT03961360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24944323|NCT03961360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24944324|NCT03961360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24944325|NCT03961360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24822640|NCT02112903|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24511186|NCT00567710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24464799|NCT00366834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24464800|NCT00366834|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25201549|NCT02726867|Nootropic Agents|nootropic agents|mesh-ancestor
24511193|NCT00567762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24511194|NCT00567762|Immunologic Factors|immunologic factors|mesh-ancestor
24816457|NCT02077010|Protective Agents|protective agents|mesh-ancestor
24816458|NCT02077010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976759|NCT05222724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24944326|NCT03961360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944327|NCT03961360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24944328|NCT03961360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24944329|NCT03961360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25060258|NCT03480945|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25060259|NCT03480906|Latanoprost|latanoprost|mesh-list
25060260|NCT03480906|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25060261|NCT03480906|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25060262|NCT03480867|Temozolomide|temozolomide|mesh-list
25060263|NCT03480867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25060264|NCT03480867|Alkylating Agents|alkylating agents|mesh-ancestor
25060265|NCT03480867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060266|NCT03480867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25060267|NCT03480789|Dexmedetomidine|dexmedetomidine|mesh-list
25060268|NCT03480789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25060269|NCT03480789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25060270|NCT03480789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060271|NCT03480789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25060272|NCT03480789|Analgesics|analgesics|mesh-ancestor
25060273|NCT03480789|Sensory System Agents|sensory system agents|mesh-ancestor
24970533|NCT03732482|Temozolomide|temozolomide|mesh-list
25060274|NCT03480789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060275|NCT03480789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24944331|NCT03960970|Azithromycin|azithromycin|mesh-list
24816501|NCT02077478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24816502|NCT02077478|Anesthetics, General|anesthetics, general|mesh-ancestor
24816503|NCT02077478|Anesthetics|anesthetics|mesh-ancestor
24816504|NCT02077478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24816505|NCT02077478|Narcotics|narcotics|mesh-ancestor
24816506|NCT02077478|Analgesics|analgesics|mesh-ancestor
24816507|NCT02077478|Sensory System Agents|sensory system agents|mesh-ancestor
24816508|NCT02077478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816509|NCT02077556|Mycophenolic Acid|mycophenolic acid|mesh-list
24816510|NCT02077556|Methylprednisolone|methylprednisolone|mesh-list
24816511|NCT02077556|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24816512|NCT02077556|Prednisolone|prednisolone|mesh-list
24464805|NCT00366938|Lumiracoxib|lumiracoxib|mesh-list
25060280|NCT03480789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060282|NCT03480646|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
25060283|NCT03480646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25060284|NCT03480646|Glucocorticoids|glucocorticoids|mesh-ancestor
25060285|NCT03480646|Hormones|hormones|mesh-ancestor
25060286|NCT03480646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25670256|NCT04566016|Anesthetics|anesthetics|mesh-list
25670257|NCT04566016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25060287|NCT03480646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060288|NCT03480646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25060289|NCT03480646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25060290|NCT03480646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25060291|NCT03480646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060292|NCT03480607|Dexamethasone|dexamethasone|mesh-list
24822697|NCT02112916|Abortifacient Agents|abortifacient agents|mesh-ancestor
24464806|NCT00366938|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24464807|NCT00366938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25866125|NCT00102882|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25866126|NCT00102882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25866127|NCT00102882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25866128|NCT00102882|Autonomic Agents|autonomic agents|mesh-ancestor
25866129|NCT00102882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25866130|NCT00102882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866131|NCT00102882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25866132|NCT00102882|Respiratory System Agents|respiratory system agents|mesh-ancestor
25866133|NCT00102882|Dermatologic Agents|dermatologic agents|mesh-ancestor
25866134|NCT00102882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25866135|NCT00102882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25866136|NCT00102882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24464824|NCT00367068|GABA Agonists|gaba agonists|mesh-ancestor
24885883|NCT04282239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24885884|NCT04282239|Adrenergic Agents|adrenergic agents|mesh-ancestor
24885885|NCT04282239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24885886|NCT04282239|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24885887|NCT04282239|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24885888|NCT04282239|Autonomic Agents|autonomic agents|mesh-ancestor
24885889|NCT04282239|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24885890|NCT04282239|Respiratory System Agents|respiratory system agents|mesh-ancestor
24885891|NCT04282239|Mydriatics|mydriatics|mesh-ancestor
24885892|NCT04282239|Sympathomimetics|sympathomimetics|mesh-ancestor
25060304|NCT03480607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25060305|NCT03480607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25060306|NCT03480607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25060307|NCT03480607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25866137|NCT00102882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25866138|NCT00102882|Adrenergic Agents|adrenergic agents|mesh-ancestor
25866139|NCT00102882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24885900|NCT04232072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885901|NCT04232072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24885902|NCT04232072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24885903|NCT04232072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24885904|NCT04232072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885905|NCT04232072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885906|NCT04219254|Pembrolizumab|pembrolizumab|mesh-list
24885907|NCT04219254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24885908|NCT04219254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885909|NCT04182633|Vancomycin|vancomycin|mesh-list
24885910|NCT04182633|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24885911|NCT04182633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24885912|NCT04182633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24464834|NCT00367081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24464835|NCT00367081|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24464836|NCT00367081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464837|NCT00367081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464838|NCT00367081|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24464839|NCT00367081|Renal Agents|renal agents|mesh-ancestor
24511204|NCT00567788|Latanoprost|latanoprost|mesh-list
24511205|NCT00567788|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24511206|NCT00567788|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24511207|NCT00567788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24511208|NCT00567814|Oxazepam|oxazepam|mesh-list
25060318|NCT03480568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822729|NCT02112981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24822733|NCT02113072|Beclomethasone|beclomethasone|mesh-list
24511228|NCT00567866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511229|NCT00567918|Tacrolimus|tacrolimus|mesh-list
24511230|NCT00567918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24511231|NCT00567918|Immunologic Factors|immunologic factors|mesh-ancestor
24464846|NCT00367094|Natriuretic Agents|natriuretic agents|mesh-ancestor
24464847|NCT00367094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464848|NCT00367094|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24885913|NCT04182633|Laxatives|laxatives|mesh-ancestor
25866140|NCT00102882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885914|NCT04182633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24885915|NCT04143477|Peficitinib|peficitinib|mesh-list
24885916|NCT04143477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885917|NCT04143477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885918|NCT04143477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24885919|NCT04143477|Immunologic Factors|immunologic factors|mesh-ancestor
24885920|NCT04143477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885950|NCT04097470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24885953|NCT04054999|Methylene Blue|methylene blue|mesh-list
24885954|NCT04054999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885955|NCT04054999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885956|NCT04054999|Hematinics|hematinics|mesh-ancestor
25060320|NCT03480516|Sodium Fluoride|sodium fluoride|mesh-list
25060321|NCT03480516|Fluorides, Topical|fluorides, topical|mesh-list
25060322|NCT03480516|Cariostatic Agents|cariostatic agents|mesh-ancestor
25060323|NCT03480516|Protective Agents|protective agents|mesh-ancestor
25060324|NCT03480516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060328|NCT03480360|Cyclophosphamide|cyclophosphamide|mesh-list
25060329|NCT03480360|Fludarabine|fludarabine|mesh-list
25060330|NCT03480360|Tacrolimus|tacrolimus|mesh-list
25060331|NCT03480360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25060332|NCT03480360|Immunologic Factors|immunologic factors|mesh-ancestor
25060333|NCT03480360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060334|NCT03480360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25060335|NCT03480360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24515917|NCT00599950|Mitomycins|mitomycins|mesh-list
25060336|NCT03480360|Alkylating Agents|alkylating agents|mesh-ancestor
25060337|NCT03480360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060338|NCT03480360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25060339|NCT03480360|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25060340|NCT03480360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25060341|NCT03480360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24822745|NCT02113150|Ketamine|ketamine|mesh-list
24885957|NCT04054999|Vitamin B Complex|vitamin b complex|mesh-ancestor
24885958|NCT04054999|Vitamins|vitamins|mesh-ancestor
24885959|NCT04054999|Micronutrients|micronutrients|mesh-ancestor
25060342|NCT03480360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25060343|NCT03480360|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25060344|NCT03480360|Antitubercular Agents|antitubercular agents|mesh-ancestor
25060345|NCT03480360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25060346|NCT03480360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25060352|NCT03480321|Cilostazol|cilostazol|mesh-list
25060353|NCT03480321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25060354|NCT03480321|Autonomic Agents|autonomic agents|mesh-ancestor
25060355|NCT03480321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060356|NCT03480321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060357|NCT03480321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25060358|NCT03480321|Respiratory System Agents|respiratory system agents|mesh-ancestor
25060359|NCT03480321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25060360|NCT03480321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24608812|NCT00993746|Sensory System Agents|sensory system agents|mesh-ancestor
24886012|NCT03700541|Narcotics|narcotics|mesh-ancestor
24886013|NCT03700541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24886014|NCT03700541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060363|NCT03480321|Vasodilator Agents|vasodilator agents|mesh-ancestor
25060364|NCT03480321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25060365|NCT03480321|Protective Agents|protective agents|mesh-ancestor
25060366|NCT03480321|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25060367|NCT03480321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25060368|NCT03480321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25060369|NCT03480308|Dexamethasone|dexamethasone|mesh-list
25060370|NCT03480308|Fentanyl|fentanyl|mesh-list
25060371|NCT03480308|Bupivacaine|bupivacaine|mesh-list
25060372|NCT03480308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25060373|NCT03480308|Antiemetics|antiemetics|mesh-ancestor
25060374|NCT03480308|Autonomic Agents|autonomic agents|mesh-ancestor
25060375|NCT03480308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24886027|NCT03691051|Capecitabine|capecitabine|mesh-list
24886028|NCT03691051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24886029|NCT03691051|Antimetabolites|antimetabolites|mesh-ancestor
24464912|NCT00367276|Diuretics|diuretics|mesh-ancestor
24464913|NCT00367276|Natriuretic Agents|natriuretic agents|mesh-ancestor
24464941|NCT00367393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24464942|NCT00367393|Analgesics|analgesics|mesh-ancestor
24433987|NCT00261131|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24464943|NCT00367393|Sensory System Agents|sensory system agents|mesh-ancestor
24511250|NCT00567983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24511251|NCT00567983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417313|NCT00206180|Esomeprazole|esomeprazole|mesh-list
24511253|NCT00567983|Immunologic Factors|immunologic factors|mesh-ancestor
24511254|NCT00567983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511255|NCT00567983|Antifungal Agents|antifungal agents|mesh-ancestor
24511256|NCT00567983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24464944|NCT00367393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24464945|NCT00367393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464946|NCT00367393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24464947|NCT00367393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24464948|NCT00367393|Dermatologic Agents|dermatologic agents|mesh-ancestor
24886047|NCT03595917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24886048|NCT03595917|Glucocorticoids|glucocorticoids|mesh-ancestor
24886050|NCT03595917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25060380|NCT03480308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25060381|NCT03480308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25060382|NCT03480308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25060383|NCT03480308|Anesthetics, Local|anesthetics, local|mesh-ancestor
25060384|NCT03480308|Anesthetics|anesthetics|mesh-ancestor
25060385|NCT03480308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25060386|NCT03480308|Sensory System Agents|sensory system agents|mesh-ancestor
25060387|NCT03480308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25060388|NCT03480308|Narcotics|narcotics|mesh-ancestor
25060389|NCT03480308|Analgesics|analgesics|mesh-ancestor
25060390|NCT03480308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25060404|NCT03480165|Anesthetics, Local|anesthetics, local|mesh-ancestor
25060405|NCT03480165|Anesthetics|anesthetics|mesh-ancestor
25060406|NCT03480165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25060407|NCT03480165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060408|NCT03480165|Sensory System Agents|sensory system agents|mesh-ancestor
25060409|NCT03480165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060410|NCT03480165|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25060411|NCT03480165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25060412|NCT03480165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25060413|NCT03480165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060415|NCT03480165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25060418|NCT03480165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25060419|NCT03480100|Xylometazoline|xylometazoline|mesh-list
25060420|NCT03480100|Nasal Decongestants|nasal decongestants|mesh-ancestor
25060421|NCT03480100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25060422|NCT03480100|Respiratory System Agents|respiratory system agents|mesh-ancestor
24822836|NCT02113774|Anti-Infective Agents|anti-infective agents|mesh-list
24822837|NCT02113774|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24886051|NCT03595917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886065|NCT03446612|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
24886066|NCT03446612|Hematinics|hematinics|mesh-ancestor
24886067|NCT03446612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24886068|NCT03446612|Vasodilator Agents|vasodilator agents|mesh-ancestor
24886069|NCT03446612|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24855142|NCT02277678|Narcotics|narcotics|mesh-ancestor
24886070|NCT03446612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886071|NCT03446612|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24886072|NCT03446612|Cholinergic Agents|cholinergic agents|mesh-ancestor
24886085|NCT03408886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24886086|NCT03408886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24886087|NCT03387774|Urinastatin|urinastatin|mesh-list
24886088|NCT03387774|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24822845|NCT02113813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24822846|NCT02113813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24822849|NCT02113813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24886098|NCT03255512|Isosorbide|isosorbide|mesh-list
24886099|NCT03255512|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24886100|NCT03255512|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
24886101|NCT03255512|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24886102|NCT03255512|Diuretics|diuretics|mesh-ancestor
24886103|NCT03255512|Natriuretic Agents|natriuretic agents|mesh-ancestor
24886104|NCT03255512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886105|NCT03255512|Vasodilator Agents|vasodilator agents|mesh-ancestor
24886106|NCT03255512|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24886107|NCT03255512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886108|NCT03230266|Insulin|insulin|mesh-list
24886109|NCT03230266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24886110|NCT03230266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886111|NCT03111212|Iloprost|iloprost|mesh-list
24886112|NCT03111212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24886113|NCT03111212|Vasodilator Agents|vasodilator agents|mesh-ancestor
25866141|NCT00102882|Glucocorticoids|glucocorticoids|mesh-ancestor
24886114|NCT03099863|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
24886133|NCT02997358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886134|NCT02997358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24886135|NCT02997358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24886137|NCT02997358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515475|NCT00597597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24886170|NCT02903160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25060437|NCT03479996|Bupivacaine|bupivacaine|mesh-list
25060438|NCT03479996|Anesthetics, Local|anesthetics, local|mesh-ancestor
25060439|NCT03479996|Anesthetics|anesthetics|mesh-ancestor
25060440|NCT03479996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25060441|NCT03479996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060442|NCT03479996|Sensory System Agents|sensory system agents|mesh-ancestor
25060443|NCT03479996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060444|NCT03479918|Prednisone|prednisone|mesh-list
25060445|NCT03479918|Cyclophosphamide|cyclophosphamide|mesh-list
25060446|NCT03479918|Doxorubicin|doxorubicin|mesh-list
25060447|NCT03479918|Etoposide|etoposide|mesh-list
24511279|NCT00568074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511280|NCT00568113|Acetylcysteine|acetylcysteine|mesh-list
24511281|NCT00568113|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24511305|NCT00568152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24511306|NCT00568152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24511308|NCT00568217|Acetaminophen|acetaminophen|mesh-list
24511309|NCT00568217|Ibuprofen|ibuprofen|mesh-list
24511310|NCT00568217|Diclofenac|diclofenac|mesh-list
24511387|NCT00568503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511389|NCT00568503|Respiratory System Agents|respiratory system agents|mesh-ancestor
24511390|NCT00568503|Parasympatholytics|parasympatholytics|mesh-ancestor
24511392|NCT00568503|Cholinergic Agents|cholinergic agents|mesh-ancestor
24511393|NCT00568503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24511396|NCT00568529|Capecitabine|capecitabine|mesh-list
24511397|NCT00568529|Oxaliplatin|oxaliplatin|mesh-list
24822865|NCT02113891|Immunologic Factors|immunologic factors|mesh-ancestor
24511404|NCT00568568|Hormones|hormones|mesh-list
24511405|NCT00568568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25866142|NCT00102882|Hormones|hormones|mesh-ancestor
24511406|NCT00568568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511407|NCT00568672|Olanzapine|olanzapine|mesh-list
24511408|NCT00568672|Antiemetics|antiemetics|mesh-ancestor
25876592|NCT03269669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24511418|NCT00568672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24511419|NCT00568672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24511420|NCT00568672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511421|NCT00568672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24511422|NCT00568672|Serotonin Agents|serotonin agents|mesh-ancestor
24511423|NCT00568711|Doxycycline|doxycycline|mesh-list
24511424|NCT00568711|Rifampin|rifampin|mesh-list
24511425|NCT00568711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24511428|NCT00568711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24511429|NCT00568711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24886176|NCT02903160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24886177|NCT02903160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24886178|NCT02903160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886179|NCT02903160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886180|NCT02903160|Hormone Antagonists|hormone antagonists|mesh-ancestor
24886181|NCT02903160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24886196|NCT02766335|Docetaxel|docetaxel|mesh-list
24886197|NCT02766335|Durvalumab|durvalumab|mesh-list
24886198|NCT02766335|Immunoglobulins|immunoglobulins|mesh-list
24886199|NCT02766335|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24886200|NCT02766335|Immunoglobulin G|immunoglobulin g|mesh-list
24886201|NCT02766335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886202|NCT02766335|Tubulin Modulators|tubulin modulators|mesh-ancestor
24511430|NCT00568711|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24511431|NCT00568711|Antitubercular Agents|antitubercular agents|mesh-ancestor
24511432|NCT00568711|Leprostatic Agents|leprostatic agents|mesh-ancestor
24511433|NCT00568711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24511434|NCT00568711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24511435|NCT00568711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511436|NCT00568711|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24511437|NCT00568711|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24511438|NCT00568711|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24511439|NCT00568711|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24511440|NCT00568711|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24978094|NCT05179070|Antioxidants|antioxidants|mesh-ancestor
24511441|NCT00568711|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24511448|NCT00568750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866143|NCT00102882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25866144|NCT00102882|Sympathomimetics|sympathomimetics|mesh-ancestor
25866145|NCT00102908|Zoledronic Acid|zoledronic acid|mesh-list
25866146|NCT00102908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25060464|NCT03479918|Glucocorticoids|glucocorticoids|mesh-ancestor
25060465|NCT03479918|Hormones|hormones|mesh-ancestor
25060466|NCT03479918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25060467|NCT03479918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25060468|NCT03479918|Tubulin Modulators|tubulin modulators|mesh-ancestor
25060469|NCT03479918|Antimitotic Agents|antimitotic agents|mesh-ancestor
25060470|NCT03479918|Mitosis Modulators|mitosis modulators|mesh-ancestor
25060471|NCT03479879|Misoprostol|misoprostol|mesh-list
25060472|NCT03479879|Estradiol|estradiol|mesh-list
25060473|NCT03479879|Estrogens|estrogens|mesh-ancestor
25060474|NCT03479879|Hormones|hormones|mesh-ancestor
25060475|NCT03479879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25060476|NCT03479879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060477|NCT03479879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25060478|NCT03479879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25060479|NCT03479879|Abortifacient Agents|abortifacient agents|mesh-ancestor
24511463|NCT00568815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24511464|NCT00568815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511465|NCT00568815|Immunologic Factors|immunologic factors|mesh-ancestor
24511466|NCT00568815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511467|NCT00568815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24511468|NCT00568841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25866147|NCT00102908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866148|NCT00102934|Enfuvirtide|enfuvirtide|mesh-list
25866149|NCT00102934|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25866150|NCT00102934|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25866151|NCT00102934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866152|NCT00102934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25866153|NCT00102934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25866154|NCT00102934|Antiviral Agents|antiviral agents|mesh-ancestor
25866155|NCT00102934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24511478|NCT00568880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24511479|NCT00568880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24511480|NCT00568880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24511481|NCT00568880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511482|NCT00568880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24511485|NCT00568971|Docetaxel|docetaxel|mesh-list
24511486|NCT00568971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511487|NCT00568971|Tubulin Modulators|tubulin modulators|mesh-ancestor
24609626|NCT00997581|Analgesics|analgesics|mesh-ancestor
24886232|NCT02493426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511526|NCT00569335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511527|NCT00569335|Growth Inhibitors|growth inhibitors|mesh-ancestor
24511528|NCT00569335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24511529|NCT00569335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24511530|NCT00569335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24511531|NCT00569335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511533|NCT00569400|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24511534|NCT00569400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25866156|NCT00102947|Daptomycin|daptomycin|mesh-list
25866157|NCT00102947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25866158|NCT00102947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25866159|NCT00102973|Carboplatin|carboplatin|mesh-list
25866160|NCT00102973|Doxorubicin|doxorubicin|mesh-list
25866161|NCT00102973|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25866162|NCT00102973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866163|NCT00102973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24511557|NCT00569699|Bevacizumab|bevacizumab|mesh-list
24511558|NCT00569699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24511559|NCT00569699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511560|NCT00569699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24511561|NCT00569699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24511562|NCT00569699|Growth Substances|growth substances|mesh-ancestor
24511563|NCT00569699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511564|NCT00569699|Growth Inhibitors|growth inhibitors|mesh-ancestor
25866164|NCT00102973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25866165|NCT00102973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24511566|NCT00569712|Formoterol Fumarate|formoterol fumarate|mesh-list
24511567|NCT00569712|Dimercaprol|dimercaprol|mesh-list
24511577|NCT00569712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24511578|NCT00569712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24511579|NCT00569712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24511580|NCT00569712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24511581|NCT00569712|Adrenergic Agents|adrenergic agents|mesh-ancestor
24511582|NCT00569712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24511583|NCT00569712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060489|NCT03479736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25060490|NCT03479736|Fluoroquinolones|fluoroquinolones|mesh-list
25060491|NCT03479736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25060493|NCT03479736|Antitubercular Agents|antitubercular agents|mesh-ancestor
25060494|NCT03479736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25060495|NCT03479736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25060496|NCT03479736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511584|NCT00569712|Chelating Agents|chelating agents|mesh-ancestor
24511585|NCT00569712|Sequestering Agents|sequestering agents|mesh-ancestor
24511586|NCT00569751|Paclitaxel|paclitaxel|mesh-list
24511587|NCT00569751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24511588|NCT00569751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511589|NCT00569751|Tubulin Modulators|tubulin modulators|mesh-ancestor
24511590|NCT00569751|Antimitotic Agents|antimitotic agents|mesh-ancestor
24511591|NCT00569751|Mitosis Modulators|mitosis modulators|mesh-ancestor
24511592|NCT00569751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511593|NCT00569790|Bevacizumab|bevacizumab|mesh-list
24511594|NCT00569790|Irinotecan|irinotecan|mesh-list
24511595|NCT00569790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24511596|NCT00569790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511597|NCT00569790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24511598|NCT00569790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24511599|NCT00569790|Growth Substances|growth substances|mesh-ancestor
24886246|NCT02432378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24886247|NCT02432378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25866166|NCT00102973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866167|NCT00102973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866168|NCT00102986|Ritonavir|ritonavir|mesh-list
25866169|NCT00102986|Lopinavir|lopinavir|mesh-list
25866170|NCT00102986|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25866171|NCT00102986|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25060504|NCT03479411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24822911|NCT02114073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24609819|NCT00998322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25866172|NCT00102986|Protease Inhibitors|protease inhibitors|mesh-ancestor
24511684|NCT00570219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24511685|NCT00570245|Nitric Oxide|nitric oxide|mesh-list
24511686|NCT00570245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24511687|NCT00570245|Autonomic Agents|autonomic agents|mesh-ancestor
24511688|NCT00570245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24511689|NCT00570245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511690|NCT00570245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24511691|NCT00570245|Respiratory System Agents|respiratory system agents|mesh-ancestor
24511692|NCT00570245|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24511693|NCT00570245|Antioxidants|antioxidants|mesh-ancestor
24511694|NCT00570245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511695|NCT00570245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25866173|NCT00102986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886262|NCT02090998|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24465027|NCT00367562|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25060505|NCT03479411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866174|NCT00102986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866175|NCT00102986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25866176|NCT00102986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25866177|NCT00102986|Antiviral Agents|antiviral agents|mesh-ancestor
25866178|NCT00102986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24511788|NCT00570895|Antioxidants|antioxidants|mesh-ancestor
25866179|NCT00102986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25866180|NCT00102986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25866181|NCT00103051|Gemcitabine|gemcitabine|mesh-list
25866182|NCT00103051|Cisplatin|cisplatin|mesh-list
24511699|NCT00570245|Protective Agents|protective agents|mesh-ancestor
24511700|NCT00570284|Panobinostat|panobinostat|mesh-list
25866183|NCT00103051|Gefitinib|gefitinib|mesh-list
24511701|NCT00570284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511702|NCT00570284|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24511703|NCT00570284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24511704|NCT00570284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511705|NCT00570375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24511706|NCT00570375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511707|NCT00570375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24511708|NCT00570375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24511709|NCT00570375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511710|NCT00570440|Levonorgestrel|levonorgestrel|mesh-list
24511711|NCT00570440|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24511712|NCT00570440|Contraceptive Agents|contraceptive agents|mesh-list
24511713|NCT00570440|Contraceptives, Oral|contraceptives, oral|mesh-list
24511715|NCT00570440|Estrogens|estrogens|mesh-ancestor
24511716|NCT00570440|Hormones|hormones|mesh-ancestor
24886290|NCT01900002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24511717|NCT00570440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24511718|NCT00570440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866184|NCT00103051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866185|NCT00103051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25866186|NCT00103051|Antimetabolites|antimetabolites|mesh-ancestor
25866187|NCT00103051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866188|NCT00103051|Antiviral Agents|antiviral agents|mesh-ancestor
25866189|NCT00103051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25866190|NCT00103051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866191|NCT00103051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25866192|NCT00103051|Immunologic Factors|immunologic factors|mesh-ancestor
25866193|NCT00103051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866194|NCT00103051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25866195|NCT00103103|Leucovorin|leucovorin|mesh-list
24515639|NCT00598572|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24886271|NCT02090998|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24465034|NCT00367614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866196|NCT00103103|Fluorouracil|fluorouracil|mesh-list
24511744|NCT00570622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24511745|NCT00570622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511746|NCT00570648|Hyaluronic Acid|hyaluronic acid|mesh-list
24511747|NCT00570648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24511748|NCT00570648|Immunologic Factors|immunologic factors|mesh-ancestor
24511749|NCT00570648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511750|NCT00570648|Viscosupplements|viscosupplements|mesh-ancestor
24511751|NCT00570648|Protective Agents|protective agents|mesh-ancestor
24511752|NCT00570726|Ranibizumab|ranibizumab|mesh-list
24511753|NCT00570726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24511754|NCT00570726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24511755|NCT00570726|Growth Substances|growth substances|mesh-ancestor
24886280|NCT02051309|Adrenergic Agents|adrenergic agents|mesh-ancestor
24886281|NCT02051309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24886282|NCT02051309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886283|NCT02051309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886285|NCT02001623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25866197|NCT00103103|Bortezomib|bortezomib|mesh-list
24886286|NCT02001623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886287|NCT01900002|Sorafenib|sorafenib|mesh-list
24886288|NCT01900002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25060521|NCT03479320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25060522|NCT03479320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25060523|NCT03479320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25060524|NCT03479320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25060525|NCT03479320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060526|NCT03479086|Topiramate|topiramate|mesh-list
25060527|NCT03479086|Naltrexone|naltrexone|mesh-list
25060528|NCT03479086|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24511776|NCT00570882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24511777|NCT00570882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24511785|NCT00570895|Vitamins|vitamins|mesh-ancestor
24511786|NCT00570895|Micronutrients|micronutrients|mesh-ancestor
24511787|NCT00570895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511790|NCT00570895|Protective Agents|protective agents|mesh-ancestor
24511791|NCT00570934|Calcium, Dietary|calcium, dietary|mesh-list
24511792|NCT00570934|Cholecalciferol|cholecalciferol|mesh-list
24511795|NCT00570934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24511796|NCT00570934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866198|NCT00103103|Calcium|calcium|mesh-list
24417544|NCT00206765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24417545|NCT00206765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417546|NCT00206765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417547|NCT00206765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24417548|NCT00206765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24417549|NCT00206765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24978138|NCT05178745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24511797|NCT00570934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24511799|NCT00570934|Micronutrients|micronutrients|mesh-ancestor
24511800|NCT00570999|Mitogens|mitogens|mesh-list
24511801|NCT00570999|Mitosis Modulators|mitosis modulators|mesh-ancestor
24511802|NCT00570999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511803|NCT00571116|Arsenic Trioxide|arsenic trioxide|mesh-list
24511804|NCT00571116|Disulfiram|disulfiram|mesh-list
24511805|NCT00571116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511806|NCT00571116|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24610056|NCT00999700|Antimetabolites|antimetabolites|mesh-ancestor
24511815|NCT00571129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511816|NCT00571129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24511818|NCT00571142|Bevacizumab|bevacizumab|mesh-list
24511819|NCT00571142|Temazepam|temazepam|mesh-list
24511820|NCT00571142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24886289|NCT01900002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24886291|NCT01900002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886293|NCT01595061|Cisplatin|cisplatin|mesh-list
24886294|NCT01595061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886295|NCT01595061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24886296|NCT01595061|Antimetabolites|antimetabolites|mesh-ancestor
24886304|NCT00902044|Cyclophosphamide|cyclophosphamide|mesh-list
24511821|NCT00571142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511822|NCT00571142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24511823|NCT00571142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24511824|NCT00571142|Growth Substances|growth substances|mesh-ancestor
24511825|NCT00571142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511826|NCT00571142|Growth Inhibitors|growth inhibitors|mesh-ancestor
25866199|NCT00103103|Levoleucovorin|levoleucovorin|mesh-list
24511828|NCT00571142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24511829|NCT00571142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24511830|NCT00571142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24511831|NCT00571142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24511832|NCT00571142|GABA Modulators|gaba modulators|mesh-ancestor
25060530|NCT03479086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060531|NCT03479086|Sensory System Agents|sensory system agents|mesh-ancestor
25060532|NCT03479086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060533|NCT03479086|Anticonvulsants|anticonvulsants|mesh-ancestor
25060534|NCT03479086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25060535|NCT03478709|Norepinephrine|norepinephrine|mesh-list
25060536|NCT03478709|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25060537|NCT03478709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25060538|NCT03478709|Adrenergic Agents|adrenergic agents|mesh-ancestor
25060539|NCT03478709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24473811|NCT00404261|Autonomic Agents|autonomic agents|mesh-ancestor
25060540|NCT03478709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511834|NCT00571142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24740234|NCT01687205|Tenofovir|tenofovir|mesh-list
24511835|NCT00571142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511836|NCT00571155|Levetiracetam|levetiracetam|mesh-list
24511837|NCT00571155|Anticonvulsants|anticonvulsants|mesh-ancestor
24511838|NCT00571155|Nootropic Agents|nootropic agents|mesh-ancestor
24511839|NCT00571246|Topiramate|topiramate|mesh-list
24511840|NCT00571246|Lamotrigine|lamotrigine|mesh-list
24511841|NCT00571246|Anticonvulsants|anticonvulsants|mesh-ancestor
24511842|NCT00571246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24511843|NCT00571246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511844|NCT00571246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24511845|NCT00571246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25670258|NCT04566016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670259|NCT04552795|Lamivudine|lamivudine|mesh-list
25670260|NCT04552795|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25670261|NCT04552795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25670262|NCT04552795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25670263|NCT04552795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670264|NCT04552795|Antiviral Agents|antiviral agents|mesh-ancestor
25670265|NCT04552795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25670266|NCT04552795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25225772|NCT02624726|Leucovorin|leucovorin|mesh-list
25225774|NCT02624726|Irinotecan|irinotecan|mesh-list
24511846|NCT00571246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866200|NCT00103103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25866201|NCT00103103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866202|NCT00103103|Antimetabolites|antimetabolites|mesh-ancestor
25866203|NCT00103103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886314|NCT00902044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24886315|NCT00165724|Donepezil|donepezil|mesh-list
24886316|NCT00165724|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24886317|NCT00165724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816519|NCT02077556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866204|NCT00103103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25866205|NCT00103103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866206|NCT00103103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25866207|NCT00103103|Immunologic Factors|immunologic factors|mesh-ancestor
25866208|NCT00103103|Antidotes|antidotes|mesh-ancestor
25866209|NCT00103103|Protective Agents|protective agents|mesh-ancestor
24511869|NCT00571298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24511870|NCT00571298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866210|NCT00103103|Vitamin B Complex|vitamin b complex|mesh-ancestor
25866211|NCT00103103|Vitamins|vitamins|mesh-ancestor
25060541|NCT03478709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060543|NCT03478709|Autonomic Agents|autonomic agents|mesh-ancestor
25060544|NCT03478709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060545|NCT03478709|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24944527|NCT03959865|Glucagon|glucagon|mesh-list
24944605|NCT03959176|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24822950|NCT02114463|Analgesics|analgesics|mesh-list
25866212|NCT00103103|Micronutrients|micronutrients|mesh-ancestor
25866213|NCT00103168|Imatinib Mesylate|imatinib mesylate|mesh-list
25866214|NCT00103168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866215|NCT00103168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25866216|NCT00103168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866217|NCT00103168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866218|NCT00103233|Trastuzumab|trastuzumab|mesh-list
25866219|NCT00103233|Vinorelbine|vinorelbine|mesh-list
25866220|NCT00103233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25866221|NCT00103233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610123|NCT00999869|Cholinergic Agents|cholinergic agents|mesh-ancestor
24511871|NCT00571298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24511872|NCT00571298|Immunologic Factors|immunologic factors|mesh-ancestor
24511880|NCT00571298|Chelating Agents|chelating agents|mesh-ancestor
24511881|NCT00571298|Sequestering Agents|sequestering agents|mesh-ancestor
24511882|NCT00571337|Infliximab|infliximab|mesh-list
24511883|NCT00571337|Dermatologic Agents|dermatologic agents|mesh-ancestor
24511884|NCT00571337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24511885|NCT00571337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24511886|NCT00571506|Pioglitazone|pioglitazone|mesh-list
24511887|NCT00571506|Rosiglitazone|rosiglitazone|mesh-list
24511888|NCT00571506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24511889|NCT00571506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511890|NCT00571558|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24511891|NCT00571558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24511892|NCT00571558|Dermatologic Agents|dermatologic agents|mesh-ancestor
25201550|NCT02726867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24511893|NCT00571636|Fentanyl|fentanyl|mesh-list
24511894|NCT00571636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24511895|NCT00571636|Narcotics|narcotics|mesh-ancestor
24511896|NCT00571636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24511897|NCT00571636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511898|NCT00571636|Analgesics|analgesics|mesh-ancestor
24511899|NCT00571636|Sensory System Agents|sensory system agents|mesh-ancestor
24511900|NCT00571636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24511901|NCT00571636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24511902|NCT00571636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24511903|NCT00571636|Anesthetics, General|anesthetics, general|mesh-ancestor
24511904|NCT00571636|Anesthetics|anesthetics|mesh-ancestor
24944606|NCT03959176|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24944607|NCT03959176|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25670267|NCT04552795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25670268|NCT04537234|Vaccines|vaccines|mesh-list
25670269|NCT04537234|Immunologic Factors|immunologic factors|mesh-ancestor
25670270|NCT04537234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670271|NCT04514653|Ranibizumab|ranibizumab|mesh-list
25670272|NCT04514653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25670273|NCT04514653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25670274|NCT04514653|Growth Substances|growth substances|mesh-ancestor
24944608|NCT03959176|Cholinergic Agents|cholinergic agents|mesh-ancestor
24511906|NCT00571675|Docetaxel|docetaxel|mesh-list
24511907|NCT00571675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511908|NCT00571675|Tubulin Modulators|tubulin modulators|mesh-ancestor
24511909|NCT00571675|Antimitotic Agents|antimitotic agents|mesh-ancestor
25866222|NCT00103233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25866223|NCT00103233|Tubulin Modulators|tubulin modulators|mesh-ancestor
24511910|NCT00571675|Mitosis Modulators|mitosis modulators|mesh-ancestor
24637326|NCT01149902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24886335|NCT04527133|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832300|NCT02171039|Protease Inhibitors|protease inhibitors|mesh-ancestor
24886336|NCT04527133|Protease Inhibitors|protease inhibitors|mesh-ancestor
24886337|NCT04527133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24511916|NCT00571675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511917|NCT00571675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24511918|NCT00571714|Ribavirin|ribavirin|mesh-list
24511919|NCT00571714|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24511920|NCT00571714|Interferon-alpha|interferon-alpha|mesh-list
24511921|NCT00571714|Betaine|betaine|mesh-list
24511922|NCT00571714|Antimetabolites|antimetabolites|mesh-ancestor
24511923|NCT00571714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511924|NCT00571714|Antiviral Agents|antiviral agents|mesh-ancestor
24511977|NCT00571870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24511978|NCT00571870|Fertility Agents|fertility agents|mesh-ancestor
24511984|NCT00571935|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24511986|NCT00571935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24511987|NCT00571935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511988|NCT00572013|Rituximab|rituximab|mesh-list
24511989|NCT00572013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24511990|NCT00572013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511991|NCT00572013|Immunologic Factors|immunologic factors|mesh-ancestor
24511992|NCT00572013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511993|NCT00572013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24512001|NCT00572026|Dopamine Agents|dopamine agents|mesh-ancestor
24512002|NCT00572026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24512003|NCT00572065|Cytarabine|cytarabine|mesh-list
24512004|NCT00572065|Arsenic Trioxide|arsenic trioxide|mesh-list
24512005|NCT00572065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24610254|NCT01000831|Vaccines|vaccines|mesh-list
24769794|NCT01816321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769795|NCT01816334|Methylprednisolone|methylprednisolone|mesh-list
24822958|NCT02114463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24822959|NCT02114463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24822960|NCT02114463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24822961|NCT02114463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25866224|NCT00103233|Antimitotic Agents|antimitotic agents|mesh-ancestor
24512035|NCT00572299|Prednisone|prednisone|mesh-list
24512036|NCT00572299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24512037|NCT00572299|Glucocorticoids|glucocorticoids|mesh-ancestor
24512038|NCT00572299|Hormones|hormones|mesh-ancestor
24512039|NCT00572299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24512040|NCT00572299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512041|NCT00572299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24512042|NCT00572299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886364|NCT04526951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24886365|NCT04526951|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24886366|NCT04526951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24886367|NCT04526951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886368|NCT04526951|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24886369|NCT04526951|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24886370|NCT04526951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886371|NCT04526951|Antipyretics|antipyretics|mesh-ancestor
24886372|NCT04527068|Bevacizumab|bevacizumab|mesh-list
24886373|NCT04527068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24886374|NCT04527068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886375|NCT04527068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24886376|NCT04527068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24886377|NCT04527068|Growth Substances|growth substances|mesh-ancestor
24886378|NCT04527068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886379|NCT04527068|Growth Inhibitors|growth inhibitors|mesh-ancestor
24886380|NCT04526470|Paclitaxel|paclitaxel|mesh-list
24515738|NCT00598962|Rifampin|rifampin|mesh-list
24886387|NCT04526353|Oxybutynin|oxybutynin|mesh-list
24886388|NCT04526353|Parasympatholytics|parasympatholytics|mesh-ancestor
24886389|NCT04526353|Autonomic Agents|autonomic agents|mesh-ancestor
24886405|NCT04526210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24886406|NCT04526210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24418103|NCT00208572|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24886407|NCT04526210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886408|NCT04526210|Dopamine Agents|dopamine agents|mesh-ancestor
24886409|NCT04526210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24886410|NCT04526210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886411|NCT04526210|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24886412|NCT04526210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24886413|NCT04526210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886414|NCT04526210|Lipotropic Agents|lipotropic agents|mesh-ancestor
24886415|NCT04526210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24886416|NCT04526210|Antimetabolites|antimetabolites|mesh-ancestor
24886417|NCT04526210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24886418|NCT04526210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24512072|NCT00572637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512074|NCT00572650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24886441|NCT04526119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886442|NCT04526119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886443|NCT04526119|Cholinergic Agents|cholinergic agents|mesh-ancestor
24671586|NCT01326650|Vitamin D|vitamin d|mesh-list
24465161|NCT00368056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465162|NCT00368121|Dexamethasone|dexamethasone|mesh-list
24465163|NCT00368121|Cetuximab|cetuximab|mesh-list
24465164|NCT00368121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24465165|NCT00368121|Antiemetics|antiemetics|mesh-ancestor
24465166|NCT00368121|Autonomic Agents|autonomic agents|mesh-ancestor
24465167|NCT00368121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24465168|NCT00368121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465169|NCT00368121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24886458|NCT04525820|Ergocalciferols|ergocalciferols|mesh-list
24886459|NCT04525820|Cholecalciferol|cholecalciferol|mesh-list
24886460|NCT04525820|Vitamins|vitamins|mesh-list
24886461|NCT04525820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24886462|NCT04525820|Micronutrients|micronutrients|mesh-ancestor
24886463|NCT04525820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886464|NCT04525820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24886465|NCT04525820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24465170|NCT00368121|Glucocorticoids|glucocorticoids|mesh-ancestor
24465171|NCT00368121|Hormones|hormones|mesh-ancestor
24465173|NCT00368121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24886497|NCT04525495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886498|NCT04525495|Protective Agents|protective agents|mesh-ancestor
24886506|NCT04525066|Hyaluronic Acid|hyaluronic acid|mesh-list
24886524|NCT04525235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24512128|NCT00573001|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24512130|NCT00573001|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24512131|NCT00573001|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24512132|NCT00573001|Protease Inhibitors|protease inhibitors|mesh-ancestor
24512133|NCT00573001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886525|NCT04525235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24886526|NCT04525235|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24886530|NCT04525235|GABA Agents|gaba agents|mesh-ancestor
24886531|NCT04525235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24886532|NCT04525235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886533|NCT04525235|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24886534|NCT04525235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24886535|NCT04525235|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24886536|NCT04525235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886537|NCT04525235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24886538|NCT04525235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24886539|NCT04525235|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24886540|NCT04525235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24886541|NCT04525235|Purinergic Agents|purinergic agents|mesh-ancestor
24886542|NCT04525235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24886543|NCT04525235|Antitubercular Agents|antitubercular agents|mesh-ancestor
24886544|NCT04525235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25060573|NCT03478605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25060574|NCT03478605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25060575|NCT03478605|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24886584|NCT04525326|Cetuximab|cetuximab|mesh-list
24886585|NCT04525326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24886586|NCT04525326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886587|NCT04525326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25670275|NCT04514653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886588|NCT04525326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25866225|NCT00103233|Mitosis Modulators|mitosis modulators|mesh-ancestor
24465216|NCT00368303|Paroxetine|paroxetine|mesh-list
24512134|NCT00573001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512135|NCT00573001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24512136|NCT00573001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24512137|NCT00573001|Antiviral Agents|antiviral agents|mesh-ancestor
24512138|NCT00573001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24886593|NCT04525300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24886594|NCT04525300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886595|NCT04525300|Incretins|incretins|mesh-ancestor
24886596|NCT04525300|Hormones|hormones|mesh-ancestor
24886597|NCT04525300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24886598|NCT04524728|Letrozole|letrozole|mesh-list
24886599|NCT04524728|Fulvestrant|fulvestrant|mesh-list
24886602|NCT04524728|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24886603|NCT04524728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24886604|NCT04524728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886605|NCT04524728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886606|NCT04524728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24886607|NCT04524728|Hormone Antagonists|hormone antagonists|mesh-ancestor
25060577|NCT03478540|Antiviral Agents|antiviral agents|mesh-ancestor
25060578|NCT03478540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25060579|NCT03478475|Cholecalciferol|cholecalciferol|mesh-list
25060580|NCT03478475|Vitamin D|vitamin d|mesh-list
25060581|NCT03478475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25866226|NCT00103233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866227|NCT00103246|Silicon|silicon|mesh-list
25866228|NCT00103246|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
25866229|NCT00103246|Trace Elements|trace elements|mesh-ancestor
25866230|NCT00103246|Micronutrients|micronutrients|mesh-ancestor
25866231|NCT00103246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060582|NCT03478475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060583|NCT03478475|Vitamins|vitamins|mesh-ancestor
24886608|NCT04524728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24886609|NCT04524728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886610|NCT04524728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24886611|NCT04524728|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25866232|NCT00103246|Antimalarials|antimalarials|mesh-ancestor
24512161|NCT00573404|Imatinib Mesylate|imatinib mesylate|mesh-list
24512162|NCT00573404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512163|NCT00573404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24512165|NCT00573404|Growth Substances|growth substances|mesh-ancestor
24512166|NCT00573404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512167|NCT00573404|Growth Inhibitors|growth inhibitors|mesh-ancestor
24512168|NCT00573404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25866233|NCT00103246|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25866234|NCT00103246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25866235|NCT00103246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25866236|NCT00103246|Antiviral Agents|antiviral agents|mesh-ancestor
25866237|NCT00103246|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25866238|NCT00103246|Dermatologic Agents|dermatologic agents|mesh-ancestor
25866239|NCT00103272|Bortezomib|bortezomib|mesh-list
25866240|NCT00103272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866241|NCT00103298|Leucovorin|leucovorin|mesh-list
25866242|NCT00103298|Fluorouracil|fluorouracil|mesh-list
25866243|NCT00103298|Oxaliplatin|oxaliplatin|mesh-list
25866244|NCT00103298|Melphalan|melphalan|mesh-list
25866245|NCT00103298|Calcium|calcium|mesh-list
25866246|NCT00103298|Levoleucovorin|levoleucovorin|mesh-list
25866247|NCT00103298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25866248|NCT00103298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866249|NCT00103298|Antimetabolites|antimetabolites|mesh-ancestor
25866250|NCT00103298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060584|NCT03478475|Micronutrients|micronutrients|mesh-ancestor
25060585|NCT03478475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24465258|NCT00368394|Insulin glulisine|insulin glulisine|mesh-list
24465259|NCT00368394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24512216|NCT00573599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24512217|NCT00573599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24512224|NCT00573664|Gabapentin|gabapentin|mesh-list
24512225|NCT00573664|Analgesics|analgesics|mesh-ancestor
24512226|NCT00573664|Sensory System Agents|sensory system agents|mesh-ancestor
24512227|NCT00573664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24512228|NCT00573664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866251|NCT00103298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25866252|NCT00103298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512229|NCT00573664|Anticonvulsants|anticonvulsants|mesh-ancestor
24512230|NCT00573664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24512231|NCT00573664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24512232|NCT00573664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24512233|NCT00573664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24512234|NCT00573664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25062865|NCT03664024|Pemetrexed|pemetrexed|mesh-list
24512235|NCT00573664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24512236|NCT00573664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25201551|NCT02726867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25201554|NCT02726867|GABA Modulators|gaba modulators|mesh-ancestor
25201555|NCT02726867|GABA Agents|gaba agents|mesh-ancestor
25201556|NCT02726867|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25201557|NCT02726867|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25201558|NCT02726867|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25866253|NCT00103298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25866254|NCT00103298|Immunologic Factors|immunologic factors|mesh-ancestor
25866255|NCT00103298|Antidotes|antidotes|mesh-ancestor
24512237|NCT00573664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512238|NCT00573664|Antimanic Agents|antimanic agents|mesh-ancestor
24512239|NCT00573690|Carboplatin|carboplatin|mesh-list
24512240|NCT00573690|Etoposide|etoposide|mesh-list
24512241|NCT00573690|Pemetrexed|pemetrexed|mesh-list
24512242|NCT00573690|Sorafenib|sorafenib|mesh-list
25060603|NCT03478423|Respiratory System Agents|respiratory system agents|mesh-ancestor
24823021|NCT02114528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24512259|NCT00573885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512260|NCT00573885|Protective Agents|protective agents|mesh-ancestor
24512261|NCT00573885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512262|NCT00573885|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24512263|NCT00573885|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25866256|NCT00103298|Protective Agents|protective agents|mesh-ancestor
25866257|NCT00103298|Vitamin B Complex|vitamin b complex|mesh-ancestor
25866258|NCT00103298|Vitamins|vitamins|mesh-ancestor
24465271|NCT00368589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816569|NCT02077751|Micronutrients|micronutrients|mesh-ancestor
24816570|NCT02077751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816572|NCT02077777|Mesalamine|mesalamine|mesh-list
24816573|NCT02077777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24816574|NCT02077777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24816575|NCT02077777|Analgesics|analgesics|mesh-ancestor
24816576|NCT02077777|Sensory System Agents|sensory system agents|mesh-ancestor
24816577|NCT02077777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816578|NCT02077777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866259|NCT00103298|Micronutrients|micronutrients|mesh-ancestor
25866260|NCT00103298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25866261|NCT00103298|Alkylating Agents|alkylating agents|mesh-ancestor
24512264|NCT00573885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512265|NCT00573885|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24512266|NCT00573924|Lansoprazole|lansoprazole|mesh-list
24512267|NCT00573924|Dexlansoprazole|dexlansoprazole|mesh-list
24512268|NCT00573924|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24512269|NCT00573924|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24512270|NCT00573924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24512271|NCT00573924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512272|NCT00573924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512274|NCT00573950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24672026|NCT01329289|Antiemetics|antiemetics|mesh-ancestor
24886673|NCT04523792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24886674|NCT04523792|Narcotics|narcotics|mesh-ancestor
24886675|NCT04523792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24886676|NCT04523792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886677|NCT04523792|Analgesics|analgesics|mesh-ancestor
24886678|NCT04523792|Sensory System Agents|sensory system agents|mesh-ancestor
24886679|NCT04523792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24886680|NCT04523792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24886681|NCT04523740|Acetaminophen|acetaminophen|mesh-list
24886682|NCT04523740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24886683|NCT04523740|Analgesics|analgesics|mesh-ancestor
24886684|NCT04523740|Sensory System Agents|sensory system agents|mesh-ancestor
25866262|NCT00103298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24886685|NCT04523740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24886686|NCT04523740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201559|NCT02726984|Listerine|listerine|mesh-list
25201560|NCT02726984|Fluorides|fluorides|mesh-list
25201561|NCT02726984|Sodium Fluoride|sodium fluoride|mesh-list
25201562|NCT02726984|Cariostatic Agents|cariostatic agents|mesh-ancestor
25866263|NCT00103324|Lapatinib|lapatinib|mesh-list
24418411|NCT00209573|Fospropofol|fospropofol|mesh-list
24418412|NCT00209573|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24418429|NCT00209612|Mitosis Modulators|mitosis modulators|mesh-ancestor
24418430|NCT00209612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201563|NCT02726984|Protective Agents|protective agents|mesh-ancestor
25866264|NCT00103324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886687|NCT04523740|Antipyretics|antipyretics|mesh-ancestor
24886688|NCT04523623|Ibuprofen|ibuprofen|mesh-list
24886689|NCT04523623|Oxycodone|oxycodone|mesh-list
24886690|NCT04523623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24709081|NCT01503983|Capecitabine|capecitabine|mesh-list
24886719|NCT04523675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886721|NCT04523688|Temozolomide|temozolomide|mesh-list
24886722|NCT04523688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24886723|NCT04523688|Alkylating Agents|alkylating agents|mesh-ancestor
24886724|NCT04523688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886725|NCT04523688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886726|NCT04523467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
24886727|NCT04523467|Ginsenoside Rg3|ginsenoside rg3|mesh-list
24886728|NCT04523467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24886729|NCT04523467|Growth Substances|growth substances|mesh-ancestor
24886730|NCT04523467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886731|NCT04523467|Growth Inhibitors|growth inhibitors|mesh-ancestor
24886732|NCT04523467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886770|NCT04522661|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24886771|NCT04522661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25866265|NCT00103324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25866266|NCT00103324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512310|NCT00574015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24512311|NCT00574015|Narcotics|narcotics|mesh-ancestor
24672208|NCT01330615|Prilocaine|prilocaine|mesh-list
24886787|NCT04522336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886788|NCT04522336|Tubulin Modulators|tubulin modulators|mesh-ancestor
24886789|NCT04522336|Antimitotic Agents|antimitotic agents|mesh-ancestor
24886790|NCT04522336|Mitosis Modulators|mitosis modulators|mesh-ancestor
24886791|NCT04522336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886792|NCT04522336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24512343|NCT00574366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512344|NCT00574366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24512346|NCT00574366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512352|NCT00574470|Dermatologic Agents|dermatologic agents|mesh-ancestor
24512353|NCT00574470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24512354|NCT00574470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24512355|NCT00574470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24512375|NCT00574639|Alprazolam|alprazolam|mesh-list
24512376|NCT00574639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24886802|NCT04522466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24886803|NCT04522466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886804|NCT04522466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886805|NCT04522466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24886806|NCT04522297|Octreotide|octreotide|mesh-list
24886807|NCT04522297|Epinephrine|epinephrine|mesh-list
24886808|NCT04522297|Midodrine|midodrine|mesh-list
24886809|NCT04522297|Norepinephrine|norepinephrine|mesh-list
24886810|NCT04522297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24886811|NCT04522297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24886812|NCT04522297|Adrenergic Agents|adrenergic agents|mesh-ancestor
24886813|NCT04522297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24886814|NCT04522297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886815|NCT04522297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201564|NCT02726984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886816|NCT04522297|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24886817|NCT04522297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24886818|NCT04522297|Autonomic Agents|autonomic agents|mesh-ancestor
24886819|NCT04522297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24886820|NCT04522297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25670277|NCT04514653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670278|NCT04514393|Methotrexate|methotrexate|mesh-list
25670279|NCT04514393|Temozolomide|temozolomide|mesh-list
25670280|NCT04514393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25670281|NCT04514393|Abortifacient Agents|abortifacient agents|mesh-ancestor
25670282|NCT04514393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25670283|NCT04514393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670284|NCT04514393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25225843|NCT02624570|Midostaurin|midostaurin|mesh-list
25225844|NCT02624570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225846|NCT02624570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886821|NCT04522297|Respiratory System Agents|respiratory system agents|mesh-ancestor
24886822|NCT04522297|Mydriatics|mydriatics|mesh-ancestor
25060619|NCT03478306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060620|NCT03478306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25060621|NCT03478280|Brodalumab|brodalumab|mesh-list
25060622|NCT03478280|Dermatologic Agents|dermatologic agents|mesh-ancestor
25060623|NCT03478150|Zinc Oxide|zinc oxide|mesh-list
25060624|NCT03478150|Dermatologic Agents|dermatologic agents|mesh-ancestor
25060625|NCT03478150|Sunscreening Agents|sunscreening agents|mesh-ancestor
25060626|NCT03478150|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25060627|NCT03478150|Protective Agents|protective agents|mesh-ancestor
25060628|NCT03478150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060629|NCT03478111|Methotrexate|methotrexate|mesh-list
25060630|NCT03478111|Infliximab|infliximab|mesh-list
24886823|NCT04522297|Sympathomimetics|sympathomimetics|mesh-ancestor
24886824|NCT04522297|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25866267|NCT00103324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060631|NCT03478111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25060632|NCT03478111|Abortifacient Agents|abortifacient agents|mesh-ancestor
25060633|NCT03478111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25060634|NCT03478111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896828|NCT04432688|Serotonin Agents|serotonin agents|mesh-ancestor
25060635|NCT03478111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25060636|NCT03478111|Antimetabolites|antimetabolites|mesh-ancestor
25060637|NCT03478111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060638|NCT03478111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25060639|NCT03478111|Dermatologic Agents|dermatologic agents|mesh-ancestor
25060640|NCT03478111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25060641|NCT03478111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25201565|NCT02726984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25201566|NCT02726984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24886921|NCT04521569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24886922|NCT04521569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886923|NCT04521569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886925|NCT04521556|Tramadol|tramadol|mesh-list
24886926|NCT04521556|Anesthetics|anesthetics|mesh-list
24886927|NCT04521556|Ropivacaine|ropivacaine|mesh-list
24886928|NCT04521556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24886929|NCT04521556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886930|NCT04521556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24886931|NCT04521556|Narcotics|narcotics|mesh-ancestor
24886932|NCT04521556|Analgesics|analgesics|mesh-ancestor
24886933|NCT04521556|Sensory System Agents|sensory system agents|mesh-ancestor
24886934|NCT04521556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24886935|NCT04521556|Anesthetics, Local|anesthetics, local|mesh-ancestor
24887018|NCT04521049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24886967|NCT04521491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886968|NCT04521491|Antidotes|antidotes|mesh-ancestor
24512377|NCT00574639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24512379|NCT00574639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24512380|NCT00574639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24512381|NCT00574639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24512382|NCT00574639|GABA Modulators|gaba modulators|mesh-ancestor
24512383|NCT00574639|GABA Agents|gaba agents|mesh-ancestor
24512399|NCT00574730|Antiviral Agents|antiviral agents|mesh-ancestor
24512400|NCT00574730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24512401|NCT00574743|Mycophenolic Acid|mycophenolic acid|mesh-list
24512402|NCT00574743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24512403|NCT00574743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512404|NCT00574743|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24512405|NCT00574743|Antitubercular Agents|antitubercular agents|mesh-ancestor
24512406|NCT00574743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24512407|NCT00574743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25670285|NCT04514393|Antimetabolites|antimetabolites|mesh-ancestor
25670286|NCT04514393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404131|NCT03682978|GABA Agents|gaba agents|mesh-ancestor
25670287|NCT04514393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670288|NCT04514393|Dermatologic Agents|dermatologic agents|mesh-ancestor
25670289|NCT04514393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25670290|NCT04514393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25670291|NCT04514393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25670292|NCT04514393|Immunologic Factors|immunologic factors|mesh-ancestor
25670293|NCT04514393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25866268|NCT00103519|3,5-diiodothyropropionic acid|3,5-diiodothyropropionic acid|mesh-list
25866269|NCT00103519|Hormones|hormones|mesh-ancestor
25866270|NCT00103519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25866271|NCT00103519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866272|NCT00103545|Abagovomab|abagovomab|mesh-list
25866273|NCT00103545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25866274|NCT00103545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866275|NCT00103571|Olanzapine|olanzapine|mesh-list
24672414|NCT01331967|Pioglitazone|pioglitazone|mesh-list
25060654|NCT03478033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25060655|NCT03478033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25060656|NCT03478033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060657|NCT03478033|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24886996|NCT04521140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886997|NCT04521140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24886999|NCT04521140|Hormones|hormones|mesh-ancestor
24887000|NCT04521140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24512409|NCT00574743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512411|NCT00574756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24512412|NCT00574756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24512413|NCT00574756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512414|NCT00574769|Bevacizumab|bevacizumab|mesh-list
24512415|NCT00574769|Docetaxel|docetaxel|mesh-list
25201567|NCT02726854|Apatinib|apatinib|mesh-list
25866276|NCT00103571|Aripiprazole|aripiprazole|mesh-list
24512416|NCT00574769|Everolimus|everolimus|mesh-list
25866277|NCT00103571|Antiemetics|antiemetics|mesh-ancestor
24512417|NCT00574769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24512418|NCT00574769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887001|NCT04521140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24887002|NCT04521140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887003|NCT04521140|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24887005|NCT04521309|Antibodies|antibodies|mesh-list
24887006|NCT04521309|Immunologic Factors|immunologic factors|mesh-ancestor
24887007|NCT04521309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887008|NCT04521153|Apatinib|apatinib|mesh-list
24887009|NCT04521153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887010|NCT04521153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24887011|NCT04521153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887012|NCT04521153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887013|NCT04521049|Saxagliptin|saxagliptin|mesh-list
24887014|NCT04521049|Incretins|incretins|mesh-ancestor
24887015|NCT04521049|Hormones|hormones|mesh-ancestor
24887016|NCT04521049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24887017|NCT04521049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887019|NCT04521049|Protease Inhibitors|protease inhibitors|mesh-ancestor
24816606|NCT02077933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24816609|NCT02077946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24816610|NCT02077946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816611|NCT02077946|Incretins|incretins|mesh-ancestor
24816612|NCT02077946|Hormones|hormones|mesh-ancestor
24816613|NCT02077946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24816614|NCT02077946|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24887070|NCT04520230|Cholinergic Agents|cholinergic agents|mesh-ancestor
24887071|NCT04520490|Exenatide|exenatide|mesh-list
24887072|NCT04520490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24887073|NCT04520490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887074|NCT04520490|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24887075|NCT04520490|Incretins|incretins|mesh-ancestor
24887076|NCT04520490|Hormones|hormones|mesh-ancestor
24887077|NCT04520490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24887094|NCT04520178|Carbidopa|carbidopa|mesh-list
24887095|NCT04520178|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
24887112|NCT04520126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887113|NCT04520126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24512419|NCT00574769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24512420|NCT00574769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24512421|NCT00574769|Growth Substances|growth substances|mesh-ancestor
24512422|NCT00574769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512423|NCT00574769|Growth Inhibitors|growth inhibitors|mesh-ancestor
24512424|NCT00574769|Tubulin Modulators|tubulin modulators|mesh-ancestor
24512425|NCT00574769|Antimitotic Agents|antimitotic agents|mesh-ancestor
24512462|NCT00575354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25431809|NCT00980460|Hematinics|hematinics|mesh-ancestor
25866278|NCT00103571|Autonomic Agents|autonomic agents|mesh-ancestor
25866279|NCT00103571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25866280|NCT00103571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866281|NCT00103571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25866282|NCT00103571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24533870|NCT00645307|Dopamine Agents|dopamine agents|mesh-ancestor
25866283|NCT00103571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25866284|NCT00103571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25107503|NCT03139253|Ofloxacin|ofloxacin|mesh-list
24512463|NCT00575354|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24512464|NCT00575354|Anesthetics, General|anesthetics, general|mesh-ancestor
24512465|NCT00575354|Anesthetics|anesthetics|mesh-ancestor
24512480|NCT00575406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24512481|NCT00575406|Alkylating Agents|alkylating agents|mesh-ancestor
25060664|NCT03478020|Contraceptives, Oral|contraceptives, oral|mesh-list
25060665|NCT03478020|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25060666|NCT03478020|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25060667|NCT03478020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672622|NCT01332617|Alkylating Agents|alkylating agents|mesh-ancestor
24887127|NCT04519983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887128|NCT04519983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24887129|NCT04519983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887130|NCT04519983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887131|NCT04520035|Paclitaxel|paclitaxel|mesh-list
24887132|NCT04520035|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24887133|NCT04520035|Cisplatin|cisplatin|mesh-list
25201568|NCT02726854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887134|NCT04520035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24887135|NCT04520035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887136|NCT04520035|Tubulin Modulators|tubulin modulators|mesh-ancestor
24672729|NCT01333410|Tacrolimus|tacrolimus|mesh-list
25060680|NCT03477994|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25060681|NCT03477994|Adrenergic Agents|adrenergic agents|mesh-ancestor
25060682|NCT03477994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25060683|NCT03477994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060684|NCT03477994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25060686|NCT03477994|Autonomic Agents|autonomic agents|mesh-ancestor
25060687|NCT03477955|Silicon|silicon|mesh-list
25060688|NCT03477955|Trace Elements|trace elements|mesh-ancestor
25060689|NCT03477955|Micronutrients|micronutrients|mesh-ancestor
25060690|NCT03477955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060691|NCT03477929|Cetrorelix|cetrorelix|mesh-list
25060692|NCT03477929|Ganirelix|ganirelix|mesh-list
25060693|NCT03477929|Hormone Antagonists|hormone antagonists|mesh-ancestor
25060694|NCT03477929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25060695|NCT03477929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060696|NCT03477929|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25060697|NCT03477929|Fertility Agents|fertility agents|mesh-ancestor
24887165|NCT04519125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24887200|NCT04518852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887201|NCT04518852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887202|NCT04518735|Anticoagulants|anticoagulants|mesh-list
24887203|NCT04518618|Fentanyl|fentanyl|mesh-list
24887204|NCT04518618|Naloxone|naloxone|mesh-list
24887205|NCT04518618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24887206|NCT04518618|Narcotics|narcotics|mesh-ancestor
24887207|NCT04518618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24887208|NCT04518618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887209|NCT04518618|Analgesics|analgesics|mesh-ancestor
24887220|NCT04518982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24887221|NCT04518982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24512520|NCT00575523|Mydriatics|mydriatics|mesh-ancestor
24512521|NCT00575523|Parasympatholytics|parasympatholytics|mesh-ancestor
24512522|NCT00575523|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24512523|NCT00575523|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25670294|NCT04514393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25670295|NCT04514393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25670296|NCT04514393|Alkylating Agents|alkylating agents|mesh-ancestor
25670297|NCT04507711|Palonosetron|palonosetron|mesh-list
25670298|NCT04507711|Antiemetics|antiemetics|mesh-ancestor
25670299|NCT04507711|Autonomic Agents|autonomic agents|mesh-ancestor
25670300|NCT04507711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24887234|NCT04518553|Antiviral Agents|antiviral agents|mesh-list
24887235|NCT04518553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24887236|NCT04518540|Thioctic Acid|thioctic acid|mesh-list
24887237|NCT04518540|Antioxidants|antioxidants|mesh-ancestor
25670301|NCT04507711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887238|NCT04518540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060711|NCT03477461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25060712|NCT03477461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25060713|NCT03477448|Bleomycin|bleomycin|mesh-list
25060714|NCT03477448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25060715|NCT03477448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25060716|NCT03477422|Meropenem|meropenem|mesh-list
25060717|NCT03477422|Ceftriaxone|ceftriaxone|mesh-list
25060718|NCT03477422|Sulbactam|sulbactam|mesh-list
25060719|NCT03477422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25060720|NCT03477422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25060721|NCT03477422|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25060722|NCT03477422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823127|NCT02115204|Fluorouracil|fluorouracil|mesh-list
24887239|NCT04518540|Protective Agents|protective agents|mesh-ancestor
24887240|NCT04518540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887241|NCT04518540|Vitamin B Complex|vitamin b complex|mesh-ancestor
25201569|NCT02726854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25866285|NCT00103571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24887242|NCT04518540|Vitamins|vitamins|mesh-ancestor
24887282|NCT04517890|Anesthetics, Local|anesthetics, local|mesh-ancestor
24887283|NCT04517890|Anesthetics|anesthetics|mesh-ancestor
24887284|NCT04517890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24887285|NCT04517890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887286|NCT04517890|Sensory System Agents|sensory system agents|mesh-ancestor
24887287|NCT04517890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24887288|NCT04517890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24887289|NCT04517890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24887293|NCT04518176|Oxytocin|oxytocin|mesh-list
24887315|NCT04517526|Growth Inhibitors|growth inhibitors|mesh-ancestor
24887316|NCT04517526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887317|NCT04517526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887318|NCT04517526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24887319|NCT04517526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24887320|NCT04517292|Gemcitabine|gemcitabine|mesh-list
24887321|NCT04517292|Cisplatin|cisplatin|mesh-list
24887322|NCT04517292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887323|NCT04517292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24887324|NCT04517292|Antimetabolites|antimetabolites|mesh-ancestor
24887325|NCT04517292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887326|NCT04517292|Antiviral Agents|antiviral agents|mesh-ancestor
24816624|NCT02077959|Growth Substances|growth substances|mesh-ancestor
24887365|NCT04516850|Steroid delta-isomerase|steroid delta-isomerase|mesh-list
24887393|NCT04517162|Plasma Substitutes|plasma substitutes|mesh-ancestor
24887394|NCT04517162|Blood Substitutes|blood substitutes|mesh-ancestor
24887395|NCT04516616|Paclitaxel|paclitaxel|mesh-list
24887396|NCT04516616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24887397|NCT04516616|Cisplatin|cisplatin|mesh-list
24887398|NCT04516616|Antibodies|antibodies|mesh-list
24887399|NCT04516616|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24887400|NCT04516616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24887401|NCT04516616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887402|NCT04516616|Tubulin Modulators|tubulin modulators|mesh-ancestor
24887403|NCT04516616|Antimitotic Agents|antimitotic agents|mesh-ancestor
24887404|NCT04516616|Mitosis Modulators|mitosis modulators|mesh-ancestor
24887405|NCT04516616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887406|NCT04516616|Immunologic Factors|immunologic factors|mesh-ancestor
24887421|NCT04516655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24887422|NCT04516655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24887423|NCT04516655|Abortifacient Agents|abortifacient agents|mesh-ancestor
24887424|NCT04516655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24887436|NCT04516603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887438|NCT04516304|Phytoestrogens|phytoestrogens|mesh-ancestor
25060725|NCT03477344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25060726|NCT03477344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25060727|NCT03477344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060728|NCT03477344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25060729|NCT03477344|Analgesics|analgesics|mesh-ancestor
25060730|NCT03477344|Sensory System Agents|sensory system agents|mesh-ancestor
24823141|NCT02115204|Mitosis Modulators|mitosis modulators|mesh-ancestor
24887439|NCT04516304|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24887440|NCT04516304|Estrogens|estrogens|mesh-ancestor
24887441|NCT04516304|Hormones|hormones|mesh-ancestor
24887442|NCT04516304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24887443|NCT04516304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201570|NCT02726854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866286|NCT00103571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25866287|NCT00103571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25866288|NCT00103571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25866289|NCT00103571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866290|NCT00103571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25866291|NCT00103571|Serotonin Agents|serotonin agents|mesh-ancestor
24887444|NCT04516174|Dexmedetomidine|dexmedetomidine|mesh-list
24887487|NCT04515966|Prednisolone phosphate|prednisolone phosphate|mesh-list
24887488|NCT04515966|Anesthetics, Local|anesthetics, local|mesh-ancestor
24887489|NCT04515966|Anesthetics|anesthetics|mesh-ancestor
24887490|NCT04515966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24887491|NCT04515966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887492|NCT04515966|Sensory System Agents|sensory system agents|mesh-ancestor
24887493|NCT04515966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24887494|NCT04515966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24887495|NCT04515966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24887496|NCT04515966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24887497|NCT04515966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24887498|NCT04515966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887499|NCT04515966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24887500|NCT04515966|Antiemetics|antiemetics|mesh-ancestor
24887501|NCT04515966|Autonomic Agents|autonomic agents|mesh-ancestor
24887502|NCT04515966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24887503|NCT04515966|Glucocorticoids|glucocorticoids|mesh-ancestor
24887504|NCT04515966|Hormones|hormones|mesh-ancestor
24887505|NCT04515966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24887506|NCT04515966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24887507|NCT04515966|Protective Agents|protective agents|mesh-ancestor
24887508|NCT04515966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24887566|NCT04514835|Antimetabolites|antimetabolites|mesh-ancestor
24887567|NCT04514835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887568|NCT04514770|Misoprostol|misoprostol|mesh-list
25060731|NCT03477344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060732|NCT03477344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25060733|NCT03477344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25060734|NCT03477344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24690085|NCT01399151|Micronutrients|micronutrients|mesh-ancestor
24465748|NCT00370656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24465749|NCT00370656|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24465750|NCT00370656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24465751|NCT00370656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24465752|NCT00370656|Antidepressive Agents|antidepressive agents|mesh-ancestor
24465753|NCT00370656|Dopamine Agents|dopamine agents|mesh-ancestor
24887569|NCT04514770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24887570|NCT04514770|Abortifacient Agents|abortifacient agents|mesh-ancestor
24887571|NCT04514770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24887572|NCT04514770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887573|NCT04514770|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24887574|NCT04514770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24887576|NCT04514731|Magnesium Sulfate|magnesium sulfate|mesh-list
24887577|NCT04514731|Analgesics|analgesics|mesh-ancestor
24887578|NCT04514731|Sensory System Agents|sensory system agents|mesh-ancestor
24887579|NCT04514731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24887580|NCT04514731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887581|NCT04514731|Anesthetics|anesthetics|mesh-ancestor
24887582|NCT04514731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24887583|NCT04514731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24887584|NCT04514731|Anticonvulsants|anticonvulsants|mesh-ancestor
24887585|NCT04514731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24887591|NCT04514796|Adalimumab|adalimumab|mesh-list
24673186|NCT01336049|Nimotuzumab|nimotuzumab|mesh-list
24887631|NCT04514029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25201571|NCT02726854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887632|NCT04514029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887633|NCT04514029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24887644|NCT04514081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887645|NCT04514081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887646|NCT04514081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25670302|NCT04507711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25670303|NCT04507711|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25670304|NCT04507711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25670305|NCT04507711|Serotonin Agents|serotonin agents|mesh-ancestor
24865341|NCT03417479|Gabapentin|gabapentin|mesh-list
24991573|NCT05129644|Antiviral Agents|antiviral agents|mesh-ancestor
25866292|NCT00103571|Antidepressive Agents|antidepressive agents|mesh-ancestor
25866293|NCT00103571|Dopamine Agonists|dopamine agonists|mesh-ancestor
24887647|NCT04513821|Ethanol|ethanol|mesh-list
24887648|NCT04513821|Minocycline|minocycline|mesh-list
24887649|NCT04513821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24887650|NCT04513821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24887651|NCT04513821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24887652|NCT04513821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887653|NCT04513821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24887693|NCT04513509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24887694|NCT04513509|Adrenergic Agents|adrenergic agents|mesh-ancestor
24887695|NCT04513509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24887696|NCT04513509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887697|NCT04513509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887698|NCT04513509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24887699|NCT04513509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24887700|NCT04513509|Vasodilator Agents|vasodilator agents|mesh-ancestor
24887701|NCT04513509|Sympatholytics|sympatholytics|mesh-ancestor
24887702|NCT04513509|Autonomic Agents|autonomic agents|mesh-ancestor
24816631|NCT02078063|Anesthetics, Local|anesthetics, local|mesh-ancestor
24816632|NCT02078063|Anesthetics|anesthetics|mesh-ancestor
24816633|NCT02078063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24887766|NCT04513184|Protease Inhibitors|protease inhibitors|mesh-ancestor
24887767|NCT04513184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887768|NCT04513184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816634|NCT02078063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887770|NCT04512872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24887771|NCT04512872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887772|NCT04512638|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24887773|NCT04512638|Amoxicillin|amoxicillin|mesh-list
24887774|NCT04512638|Chlorhexidine|chlorhexidine|mesh-list
24887775|NCT04512638|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24887776|NCT04512638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24887777|NCT04512638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25060744|NCT03477266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25060745|NCT03477266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201572|NCT02726828|Ketamine|ketamine|mesh-list
25201573|NCT02726828|Morphine|morphine|mesh-list
25201574|NCT02726828|Analgesics|analgesics|mesh-ancestor
25201575|NCT02726828|Sensory System Agents|sensory system agents|mesh-ancestor
25201576|NCT02726828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060746|NCT03477266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060748|NCT03477136|Vitamins|vitamins|mesh-ancestor
25060749|NCT03477136|Micronutrients|micronutrients|mesh-ancestor
24673362|NCT01337401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24512551|NCT00575614|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24512552|NCT00575614|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24887784|NCT04512404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887785|NCT04512404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887786|NCT04512404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24817585|NCT02084576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24887788|NCT04512313|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24887789|NCT04512313|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24887790|NCT04512313|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24887791|NCT04512313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24887792|NCT04512313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887793|NCT04512105|Venetoclax|venetoclax|mesh-list
24887794|NCT04512105|Pitavastatin|pitavastatin|mesh-list
24887795|NCT04512105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887796|NCT04512105|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24887797|NCT04512105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24887798|NCT04512105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24887799|NCT04512105|Antimetabolites|antimetabolites|mesh-ancestor
24972511|NCT03717168|Hormones|hormones|mesh-list
24887800|NCT04512105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887802|NCT04512105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24887836|NCT04511715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24887837|NCT04511715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670306|NCT04507711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25670307|NCT04507711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670308|NCT04504123|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25670309|NCT04504123|Doxycycline|doxycycline|mesh-list
25670310|NCT04504123|Tetracycline|tetracycline|mesh-list
24887838|NCT04511715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24887839|NCT04511715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24887840|NCT04511715|Growth Substances|growth substances|mesh-ancestor
25060762|NCT03476941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25060763|NCT03476941|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25060764|NCT03476941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25060765|NCT03476941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060777|NCT03476616|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25060778|NCT03476616|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24887841|NCT04511715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887842|NCT04511715|Growth Inhibitors|growth inhibitors|mesh-ancestor
24887843|NCT04511897|Expectorants|expectorants|mesh-list
24887844|NCT04511897|Respiratory System Agents|respiratory system agents|mesh-ancestor
24887845|NCT04511650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24887846|NCT04511923|Heparin|heparin|mesh-list
24887847|NCT04511923|Anticoagulants|anticoagulants|mesh-ancestor
24887848|NCT04511923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24887849|NCT04511923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24887850|NCT04511923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887851|NCT04511637|Rivaroxaban|rivaroxaban|mesh-list
24887852|NCT04511637|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24887853|NCT04511637|Antithrombins|antithrombins|mesh-ancestor
24887854|NCT04511637|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24887855|NCT04511637|Protease Inhibitors|protease inhibitors|mesh-ancestor
24887856|NCT04511637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887857|NCT04511637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887858|NCT04511637|Anticoagulants|anticoagulants|mesh-ancestor
24887859|NCT04511468|Ascorbic Acid|ascorbic acid|mesh-list
24887860|NCT04511468|Copper|copper|mesh-list
24887861|NCT04511468|Chromium|chromium|mesh-list
24887862|NCT04511468|Vitamins|vitamins|mesh-ancestor
24887863|NCT04511468|Micronutrients|micronutrients|mesh-ancestor
24887864|NCT04511468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887888|NCT04511000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887889|NCT04510935|Anesthetics|anesthetics|mesh-list
24512566|NCT00575627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866294|NCT00103571|Dopamine Agents|dopamine agents|mesh-ancestor
25866295|NCT00103571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25866296|NCT00103571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25866297|NCT00103571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25866298|NCT00103571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25866299|NCT00103571|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25866300|NCT00103571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25866301|NCT00103597|Fludrocortisone|fludrocortisone|mesh-list
25866302|NCT00103597|Domperidone|domperidone|mesh-list
25866303|NCT00103597|Antiemetics|antiemetics|mesh-ancestor
25866304|NCT00103597|Autonomic Agents|autonomic agents|mesh-ancestor
25060779|NCT03476616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060780|NCT03476616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25060781|NCT03476616|Hormone Antagonists|hormone antagonists|mesh-ancestor
25060782|NCT03476616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25060783|NCT03476616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060784|NCT03476616|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25866305|NCT00103597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25866306|NCT00103597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866307|NCT00103597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25866308|NCT00103597|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24887912|NCT04510623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887914|NCT04510649|Rabeprazole|rabeprazole|mesh-list
24887915|NCT04510649|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24887916|NCT04510649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24887917|NCT04510649|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24887918|NCT04510649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866309|NCT00103597|Dopamine Agents|dopamine agents|mesh-ancestor
24465976|NCT00371410|Immunologic Factors|immunologic factors|mesh-ancestor
24887930|NCT04510649|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24887931|NCT04510649|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24887933|NCT04510818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24887935|NCT04510818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887936|NCT04510818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887937|NCT04510610|Decitabine|decitabine|mesh-list
24887938|NCT04510610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24887939|NCT04510610|Antimetabolites|antimetabolites|mesh-ancestor
25866310|NCT00103597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25866311|NCT00103597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866312|NCT00103597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24887940|NCT04510610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887941|NCT04510610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816636|NCT02078063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816637|NCT02078089|Oxcarbazepine|oxcarbazepine|mesh-list
24816638|NCT02078089|Morphine|morphine|mesh-list
24816639|NCT02078089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24816640|NCT02078089|Narcotics|narcotics|mesh-ancestor
24816658|NCT02078167|Policosanol|policosanol|mesh-list
24816659|NCT02078167|Red yeast rice|red yeast rice|mesh-list
24816660|NCT02078167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24816661|NCT02078167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24816662|NCT02078167|Antimetabolites|antimetabolites|mesh-ancestor
25060785|NCT03476616|Diuretics|diuretics|mesh-ancestor
25060786|NCT03476616|Natriuretic Agents|natriuretic agents|mesh-ancestor
25060787|NCT03476564|Pentoxifylline|pentoxifylline|mesh-list
25060788|NCT03476564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25060789|NCT03476564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25060790|NCT03476564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673600|NCT01339065|Ketamine|ketamine|mesh-list
24816692|NCT02078336|GABA Agents|gaba agents|mesh-ancestor
24816693|NCT02078336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24816694|NCT02078336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816695|NCT02078336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24816696|NCT02078336|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24466058|NCT00371735|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24466059|NCT00371735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24466061|NCT00371735|Antiviral Agents|antiviral agents|mesh-ancestor
24512627|NCT00575913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512634|NCT00575952|Tubulin Modulators|tubulin modulators|mesh-ancestor
24512635|NCT00575952|Antimitotic Agents|antimitotic agents|mesh-ancestor
24512642|NCT00575978|Hydralazine|hydralazine|mesh-list
24512700|NCT00576225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24512701|NCT00576225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512702|NCT00576225|Tubulin Modulators|tubulin modulators|mesh-ancestor
25866313|NCT00103623|Abarelix|abarelix|mesh-list
25866314|NCT00103623|Hormone Antagonists|hormone antagonists|mesh-ancestor
24512712|NCT00576238|Glucocorticoids|glucocorticoids|mesh-ancestor
24512714|NCT00576238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24512715|NCT00576238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512716|NCT00576238|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24512717|NCT00576238|Respiratory System Agents|respiratory system agents|mesh-ancestor
24512718|NCT00576329|Ketorolac|ketorolac|mesh-list
24512719|NCT00576329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24512720|NCT00576329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24466077|NCT00371813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816697|NCT02078336|Autonomic Agents|autonomic agents|mesh-ancestor
24673700|NCT01339663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25060796|NCT03476564|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25060797|NCT03476564|Antioxidants|antioxidants|mesh-ancestor
24816706|NCT02078336|Anticonvulsants|anticonvulsants|mesh-ancestor
24887942|NCT04510610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887947|NCT04510662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887964|NCT04510337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24887965|NCT04510337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24887966|NCT04510337|Anticonvulsants|anticonvulsants|mesh-ancestor
24887967|NCT04510337|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24887968|NCT04510337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24887969|NCT04510337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887970|NCT04510337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24887971|NCT04510337|Tocolytic Agents|tocolytic agents|mesh-ancestor
24887972|NCT04510337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24887973|NCT04510337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24887974|NCT04510337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24887975|NCT04510337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24887976|NCT04510233|Ivermectin|ivermectin|mesh-list
24887977|NCT04510233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24887978|NCT04510233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24887979|NCT04510402|Povidone-Iodine|povidone-iodine|mesh-list
24887980|NCT04510402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25670311|NCT04504123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25670312|NCT04504123|Antimalarials|antimalarials|mesh-ancestor
25670313|NCT04504123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24887981|NCT04510402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24887982|NCT04510012|Complement System Proteins|complement system proteins|mesh-list
24887983|NCT04510012|Immunologic Factors|immunologic factors|mesh-ancestor
24887984|NCT04510012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887985|NCT04509999|Bicalutamide|bicalutamide|mesh-list
24887986|NCT04509999|Androgen Antagonists|androgen antagonists|mesh-ancestor
24887987|NCT04509999|Hormone Antagonists|hormone antagonists|mesh-ancestor
25201577|NCT02726828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887988|NCT04509999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24887989|NCT04509999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887990|NCT04509999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25060804|NCT03476356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060805|NCT03476356|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24823205|NCT02115594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823206|NCT02115659|Triptolide|triptolide|mesh-list
24823207|NCT02115659|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
24823208|NCT02115659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823209|NCT02115659|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24823210|NCT02115659|Contraceptive Agents|contraceptive agents|mesh-ancestor
24823211|NCT02115659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24420849|NCT00216892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24420885|NCT00217152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420886|NCT00217152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420915|NCT00217243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24420916|NCT00217243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24420917|NCT00217243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24420918|NCT00217243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24888012|NCT04509661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24888013|NCT04509661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888014|NCT04509661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24888015|NCT04509661|Respiratory System Agents|respiratory system agents|mesh-ancestor
24888016|NCT04509635|Cetuximab|cetuximab|mesh-list
24897000|NCT04430933|Pemetrexed|pemetrexed|mesh-list
24466143|NCT00372229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466144|NCT00372294|Clindamycin|clindamycin|mesh-list
24888050|NCT04508946|Ascorbic Acid|ascorbic acid|mesh-list
24888051|NCT04508946|Thiamine|thiamine|mesh-list
24888052|NCT04508946|Hydrocortisone|hydrocortisone|mesh-list
24888053|NCT04508946|Vitamins|vitamins|mesh-ancestor
24888054|NCT04508946|Micronutrients|micronutrients|mesh-ancestor
24888055|NCT04508946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888056|NCT04508946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24888057|NCT04508946|Antioxidants|antioxidants|mesh-ancestor
24888058|NCT04508946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888059|NCT04508946|Protective Agents|protective agents|mesh-ancestor
24888060|NCT04508946|Vitamin B Complex|vitamin b complex|mesh-ancestor
24888061|NCT04509219|Methylprednisolone|methylprednisolone|mesh-list
24888062|NCT04509219|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24888063|NCT04509219|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24888064|NCT04509219|Prednisolone|prednisolone|mesh-list
24888065|NCT04509219|Prednisolone acetate|prednisolone acetate|mesh-list
24888066|NCT04509219|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24888084|NCT04509232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888085|NCT04509258|Acetylcarnitine|acetylcarnitine|mesh-list
24888086|NCT04509258|Acetylcysteine|acetylcysteine|mesh-list
24888087|NCT04509258|Ondansetron|ondansetron|mesh-list
24888088|NCT04509258|Mineral Oil|mineral oil|mesh-list
24888089|NCT04509258|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24888090|NCT04509258|Antiemetics|antiemetics|mesh-ancestor
24888091|NCT04509258|Autonomic Agents|autonomic agents|mesh-ancestor
24888092|NCT04509258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24888093|NCT04509258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888094|NCT04509258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24888095|NCT04509258|Antipruritics|antipruritics|mesh-ancestor
24888096|NCT04509258|Dermatologic Agents|dermatologic agents|mesh-ancestor
24888097|NCT04509258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24888098|NCT04509258|Serotonin Agents|serotonin agents|mesh-ancestor
24888099|NCT04509258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24888100|NCT04509258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060820|NCT03476109|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24888139|NCT04508894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24888140|NCT04508894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24888141|NCT04508894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24888142|NCT04508894|Adrenergic Agents|adrenergic agents|mesh-ancestor
24888143|NCT04508894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24888144|NCT04508894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888145|NCT04508894|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24888146|NCT04508894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24888147|NCT04508894|Anesthetics, General|anesthetics, general|mesh-ancestor
24888148|NCT04508894|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25201578|NCT02726828|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24888149|NCT04508894|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24888150|NCT04508686|Capecitabine|capecitabine|mesh-list
24888186|NCT04508400|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24888187|NCT04508400|Serotonin Agents|serotonin agents|mesh-ancestor
24888188|NCT04508400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24888189|NCT04508400|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24888190|NCT04508400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24888199|NCT04508452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24888201|NCT04508452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24888202|NCT04508452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24888203|NCT04508452|Growth Substances|growth substances|mesh-ancestor
24888204|NCT04508452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888205|NCT04508452|Growth Inhibitors|growth inhibitors|mesh-ancestor
24888206|NCT04508452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24888207|NCT04508452|Antimetabolites|antimetabolites|mesh-ancestor
24888208|NCT04508452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888209|NCT04508452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24888214|NCT04508166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24888215|NCT04508166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24888216|NCT04508166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888217|NCT04508166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24888218|NCT04508166|Analgesics|analgesics|mesh-ancestor
24888219|NCT04508166|Sensory System Agents|sensory system agents|mesh-ancestor
24888220|NCT04508166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24888221|NCT04508166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24888222|NCT04508166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24888223|NCT04508166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24888224|NCT04508166|Adrenergic Agents|adrenergic agents|mesh-ancestor
24888225|NCT04508166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24888226|NCT04508166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888227|NCT04508166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24888228|NCT04508166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24888229|NCT04508166|Anesthetics, General|anesthetics, general|mesh-ancestor
24888230|NCT04508166|Anesthetics|anesthetics|mesh-ancestor
24888231|NCT04508140|Pembrolizumab|pembrolizumab|mesh-list
25060821|NCT03476109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25060822|NCT03476109|Respiratory System Agents|respiratory system agents|mesh-ancestor
25060823|NCT03476083|Tenofovir|tenofovir|mesh-list
25060824|NCT03476083|Antiviral Agents|antiviral agents|mesh-ancestor
25060825|NCT03476083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25060826|NCT03476083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25060827|NCT03476083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25060828|NCT03476083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25060829|NCT03476083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060830|NCT03476083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24888274|NCT04507750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24888275|NCT04507750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24888276|NCT04507750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24888277|NCT04507750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888280|NCT04507217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24888281|NCT04507217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24888282|NCT04507217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888283|NCT04507217|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24888284|NCT04507217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24888285|NCT04507165|Analgesics, Opioid|analgesics, opioid|mesh-list
24888286|NCT04507165|Anesthetics|anesthetics|mesh-list
24512741|NCT00576433|Immunologic Factors|immunologic factors|mesh-ancestor
24512742|NCT00576433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512743|NCT00576433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24512744|NCT00576433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24512745|NCT00576433|Abortifacient Agents|abortifacient agents|mesh-ancestor
24512746|NCT00576433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24512747|NCT00576433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24512748|NCT00576433|Antimetabolites|antimetabolites|mesh-ancestor
24512749|NCT00576433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060836|NCT03476044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060837|NCT03476044|Trace Elements|trace elements|mesh-ancestor
25060838|NCT03476044|Micronutrients|micronutrients|mesh-ancestor
25060839|NCT03475862|Oxycodone|oxycodone|mesh-list
24944922|NCT03955809|Ketamine|ketamine|mesh-list
24944923|NCT03955809|Analgesics|analgesics|mesh-ancestor
24944924|NCT03955809|Sensory System Agents|sensory system agents|mesh-ancestor
24944925|NCT03955809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24944926|NCT03955809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953017|NCT03890042|Progestins|progestins|mesh-ancestor
24953018|NCT03890042|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24888291|NCT04507165|Sensory System Agents|sensory system agents|mesh-ancestor
24888292|NCT04507165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24888293|NCT04506957|Chrysarobin|chrysarobin|mesh-list
24888294|NCT04506957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24888295|NCT04506957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24888296|NCT04506957|Analgesics|analgesics|mesh-ancestor
24888297|NCT04506957|Sensory System Agents|sensory system agents|mesh-ancestor
24888298|NCT04506957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24888299|NCT04506957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888300|NCT04506957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24888301|NCT04506957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24888302|NCT04506827|Hyaluronic Acid|hyaluronic acid|mesh-list
24888303|NCT04506827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24888304|NCT04506827|Immunologic Factors|immunologic factors|mesh-ancestor
24888305|NCT04506827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888306|NCT04506827|Viscosupplements|viscosupplements|mesh-ancestor
24888307|NCT04506827|Protective Agents|protective agents|mesh-ancestor
24888308|NCT04506554|Nivolumab|nivolumab|mesh-list
24888309|NCT04506554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24888310|NCT04506554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24888311|NCT04506554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24888312|NCT04506554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888313|NCT04506567|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
24710789|NCT01511822|Inositol|inositol|mesh-list
24888314|NCT04506567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24888315|NCT04506567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888316|NCT04506450|Anesthetics|anesthetics|mesh-list
24888317|NCT04506450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24888318|NCT04506450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888319|NCT04506034|Lidocaine|lidocaine|mesh-list
24888320|NCT04506034|Anesthetics, Local|anesthetics, local|mesh-ancestor
24888321|NCT04506034|Anesthetics|anesthetics|mesh-ancestor
24888322|NCT04506034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24888350|NCT04505943|Misoprostol|misoprostol|mesh-list
24888686|NCT04501289|Anticonvulsants|anticonvulsants|mesh-ancestor
24888351|NCT04505943|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24888354|NCT04505943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888355|NCT04505943|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24888356|NCT04505943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24888357|NCT04505943|Oxytocics|oxytocics|mesh-ancestor
24888358|NCT04505943|Antitubercular Agents|antitubercular agents|mesh-ancestor
25876593|NCT03269669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24953021|NCT03890003|Insulin Lispro|insulin lispro|mesh-list
24953022|NCT03890003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24888359|NCT04505943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24888360|NCT04505943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24888361|NCT04505943|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24888364|NCT04505943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888365|NCT04505943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24888366|NCT04505995|Azacitidine|azacitidine|mesh-list
24888367|NCT04505995|Homoharringtonine|homoharringtonine|mesh-list
24888368|NCT04505995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24888369|NCT04505995|Antimetabolites|antimetabolites|mesh-ancestor
24888370|NCT04505995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888371|NCT04505995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24888372|NCT04505995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24888402|NCT04505917|Oxytocics|oxytocics|mesh-ancestor
24888403|NCT04505683|Ertapenem|ertapenem|mesh-list
24888404|NCT04505683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24888405|NCT04505683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24888406|NCT04505657|Celecoxib|celecoxib|mesh-list
24888407|NCT04505657|Lidocaine|lidocaine|mesh-list
24888408|NCT04505657|Anesthetics, Local|anesthetics, local|mesh-ancestor
24888409|NCT04505657|Anesthetics|anesthetics|mesh-ancestor
24888410|NCT04505657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24888411|NCT04505657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888412|NCT04505657|Sensory System Agents|sensory system agents|mesh-ancestor
25225943|NCT02623881|Progestins|progestins|mesh-ancestor
24888413|NCT04505657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24888414|NCT04505657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24854046|NCT02271464|Alkylating Agents|alkylating agents|mesh-ancestor
24953028|NCT03889288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953029|NCT03889288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953054|NCT03889366|Antiemetics|antiemetics|mesh-ancestor
24953055|NCT03889366|Autonomic Agents|autonomic agents|mesh-ancestor
24953056|NCT03889366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953057|NCT03889366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953058|NCT03889366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24953059|NCT03889366|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24953061|NCT03889366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953062|NCT03888924|Vaccines|vaccines|mesh-list
24953063|NCT03888924|BCG Vaccine|bcg vaccine|mesh-list
24953064|NCT03888924|Immunologic Factors|immunologic factors|mesh-ancestor
24888428|NCT04505189|Hallucinogens|hallucinogens|mesh-ancestor
24888429|NCT04505189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888430|NCT04505189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24888431|NCT04505202|Chlorhexidine|chlorhexidine|mesh-list
24888432|NCT04505202|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24888433|NCT04505202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24888434|NCT04505202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24888435|NCT04505202|Disinfectants|disinfectants|mesh-ancestor
24888436|NCT04505202|Dermatologic Agents|dermatologic agents|mesh-ancestor
24888437|NCT04505228|Atropine|atropine|mesh-list
24888438|NCT04505228|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24888439|NCT04505228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24888475|NCT04504851|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24888476|NCT04504851|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24888477|NCT04504851|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24888478|NCT04504851|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24888479|NCT04504851|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24888481|NCT04504552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24888482|NCT04504552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24888483|NCT04504110|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24888484|NCT04504110|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24888485|NCT04504110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888506|NCT04503629|Rabeprazole|rabeprazole|mesh-list
24888507|NCT04503629|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24888508|NCT04503629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24888640|NCT04501991|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25866315|NCT00103623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24512757|NCT00576459|Glucocorticoids|glucocorticoids|mesh-ancestor
24512760|NCT00576459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512761|NCT00576511|Prucalopride|prucalopride|mesh-list
24512762|NCT00576511|Laxatives|laxatives|mesh-ancestor
24674403|NCT05249712|Hormones|hormones|mesh-ancestor
24888532|NCT04503460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24888533|NCT04503460|Sympathomimetics|sympathomimetics|mesh-ancestor
24888568|NCT04502849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888569|NCT04502849|Protective Agents|protective agents|mesh-ancestor
24888571|NCT04502641|Fluorouracil|fluorouracil|mesh-list
24888572|NCT04502641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24888573|NCT04502641|Tubulin Modulators|tubulin modulators|mesh-ancestor
24888574|NCT04502641|Antimitotic Agents|antimitotic agents|mesh-ancestor
24888575|NCT04502641|Mitosis Modulators|mitosis modulators|mesh-ancestor
24888586|NCT04502368|Sequestering Agents|sequestering agents|mesh-ancestor
24888587|NCT04502368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778878|NCT01872858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24778879|NCT01872858|Autonomic Agents|autonomic agents|mesh-ancestor
24778880|NCT01872858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24778881|NCT01872858|Respiratory System Agents|respiratory system agents|mesh-ancestor
24778882|NCT01872858|Vasodilator Agents|vasodilator agents|mesh-ancestor
24778883|NCT01872858|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24778884|NCT01872858|Protective Agents|protective agents|mesh-ancestor
24778885|NCT01872858|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24778886|NCT01872858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24888599|NCT04502303|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24888600|NCT04502303|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24888601|NCT04502303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888602|NCT04502277|Fluconazole|fluconazole|mesh-list
25670314|NCT04504123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25670315|NCT04504123|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25866316|NCT00103623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888603|NCT04502277|Antifungal Agents|antifungal agents|mesh-ancestor
24512768|NCT00576511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512769|NCT00576511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512770|NCT00576550|Betamethasone|betamethasone|mesh-list
24512771|NCT00576550|Betamethasone Valerate|betamethasone valerate|mesh-list
24512772|NCT00576550|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24888624|NCT04502017|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24888625|NCT04502017|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24888626|NCT04502017|Purinergic Agents|purinergic agents|mesh-ancestor
24888627|NCT04502017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24888628|NCT04502017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888629|NCT04502017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888630|NCT04501965|Azithromycin|azithromycin|mesh-list
24888631|NCT04501965|Hydroxychloroquine|hydroxychloroquine|mesh-list
24778887|NCT01872871|Acetaminophen|acetaminophen|mesh-list
24778888|NCT01872871|Anesthetics|anesthetics|mesh-list
24778889|NCT01872871|Anesthetics, Local|anesthetics, local|mesh-list
24778890|NCT01872871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24778891|NCT01872871|Analgesics|analgesics|mesh-ancestor
24778892|NCT01872871|Sensory System Agents|sensory system agents|mesh-ancestor
24778893|NCT01872871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24778894|NCT01872871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778895|NCT01872871|Antipyretics|antipyretics|mesh-ancestor
24778896|NCT01872871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24778897|NCT01872884|Remifentanil|remifentanil|mesh-list
24674539|NCT05119101|Analgesics|analgesics|mesh-ancestor
24888667|NCT04501523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24888670|NCT04501224|Antiviral Agents|antiviral agents|mesh-ancestor
24888671|NCT04501224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24888672|NCT04501224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24888673|NCT04501224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24888674|NCT04501224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24888675|NCT04501224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888676|NCT04501224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24888677|NCT04501224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24888678|NCT04501289|Magnesium Sulfate|magnesium sulfate|mesh-list
24888679|NCT04501289|Analgesics|analgesics|mesh-ancestor
24888680|NCT04501289|Sensory System Agents|sensory system agents|mesh-ancestor
24888681|NCT04501289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24888682|NCT04501289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888683|NCT04501289|Anesthetics|anesthetics|mesh-ancestor
24888684|NCT04501289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24888685|NCT04501289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24888688|NCT04501289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24888689|NCT04501289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888690|NCT04501289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24888691|NCT04501289|Tocolytic Agents|tocolytic agents|mesh-ancestor
24888692|NCT04501289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24888693|NCT04501367|Dexamethasone|dexamethasone|mesh-list
24888694|NCT04501367|Dexamethasone acetate|dexamethasone acetate|mesh-list
24888695|NCT04501367|Prednisone|prednisone|mesh-list
24888696|NCT04501367|BB 1101|bb 1101|mesh-list
24888697|NCT04501367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24888698|NCT04501367|Antiemetics|antiemetics|mesh-ancestor
24888699|NCT04501367|Autonomic Agents|autonomic agents|mesh-ancestor
24973202|NCT03711240|Growth Substances|growth substances|mesh-ancestor
24888700|NCT04501367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24888704|NCT04501367|Hormones|hormones|mesh-ancestor
24888705|NCT04501367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24778898|NCT01872884|Sevoflurane|sevoflurane|mesh-list
24778899|NCT01872884|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24778900|NCT01872884|Narcotics|narcotics|mesh-ancestor
24953066|NCT03888924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24953068|NCT03888846|Pentoxifylline|pentoxifylline|mesh-list
24953069|NCT03888846|Gout Suppressants|gout suppressants|mesh-ancestor
24816743|NCT02078583|Anesthetics, General|anesthetics, general|mesh-ancestor
24816744|NCT02078583|Anesthetics|anesthetics|mesh-ancestor
24888730|NCT04500808|Macitentan|macitentan|mesh-list
24888731|NCT04500808|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
24888732|NCT04500808|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24888733|NCT04500808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888734|NCT04500808|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
24888735|NCT04500717|Carboplatin|carboplatin|mesh-list
24888736|NCT04500717|Pemetrexed|pemetrexed|mesh-list
24888737|NCT04500717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24888738|NCT04500717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24888739|NCT04500717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888740|NCT04500717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24888741|NCT04500717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24888742|NCT04500496|Isoniazid|isoniazid|mesh-list
24888743|NCT04500496|Dinoprostone|dinoprostone|mesh-list
24888744|NCT04500496|Oxytocics|oxytocics|mesh-ancestor
24888745|NCT04500496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24888746|NCT04500496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888747|NCT04500496|Antitubercular Agents|antitubercular agents|mesh-ancestor
24888748|NCT04500496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24888749|NCT04500496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24888750|NCT04500496|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24888751|NCT04500496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24953077|NCT03888846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25060840|NCT03475862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25060841|NCT03475862|Narcotics|narcotics|mesh-ancestor
24888756|NCT04500704|Pemetrexed|pemetrexed|mesh-list
24888757|NCT04500704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24888758|NCT04500704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24888759|NCT04500704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888760|NCT04500704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24888762|NCT04500743|Leuprolide|leuprolide|mesh-list
24888764|NCT04500743|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24888765|NCT04500743|Fertility Agents|fertility agents|mesh-ancestor
24888766|NCT04500743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24888767|NCT04500743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888768|NCT04500743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24888769|NCT04500743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24888770|NCT04500743|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24888771|NCT04500743|Contraceptive Agents|contraceptive agents|mesh-ancestor
24888780|NCT04500522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24888781|NCT04500522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24888782|NCT04500522|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24888783|NCT04500522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24888784|NCT04500522|Antimetabolites|antimetabolites|mesh-ancestor
24888785|NCT04500522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201579|NCT02726828|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25866317|NCT00103649|Xaliproden|xaliproden|mesh-list
25866318|NCT00103649|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25876594|NCT03269669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24888786|NCT04500522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24888787|NCT04500561|Gemcitabine|gemcitabine|mesh-list
24888788|NCT04500561|Oxaliplatin|oxaliplatin|mesh-list
24516532|NCT00602342|Terbinafine|terbinafine|mesh-list
24888789|NCT04500561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24888790|NCT04500561|Antimetabolites|antimetabolites|mesh-ancestor
24888791|NCT04500561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888792|NCT04500561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24888793|NCT04500561|Antiviral Agents|antiviral agents|mesh-ancestor
24888794|NCT04500561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24888795|NCT04500561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24888796|NCT04500561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25060858|NCT03475810|GABA Modulators|gaba modulators|mesh-ancestor
24466669|NCT00374478|Scopolamine|scopolamine|mesh-list
25217953|NCT02674139|Copper|copper|mesh-list
24888803|NCT04499989|Antitubercular Agents|antitubercular agents|mesh-ancestor
24888804|NCT04499989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24888805|NCT04499989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24888806|NCT04499989|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24888807|NCT04499989|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24888808|NCT04499989|Antimetabolites|antimetabolites|mesh-ancestor
24888809|NCT04499989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888810|NCT04499989|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24888811|NCT04500067|Immunoglobulins|immunoglobulins|mesh-list
24888812|NCT04500067|Immunologic Factors|immunologic factors|mesh-ancestor
24888813|NCT04500067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888840|NCT04500002|Misoprostol|misoprostol|mesh-list
24888841|NCT04500002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24466674|NCT00374478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24888842|NCT04500002|Abortifacient Agents|abortifacient agents|mesh-ancestor
24888843|NCT04500002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24888844|NCT04500002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888845|NCT04500002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24888846|NCT04500002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24888847|NCT04500002|Oxytocics|oxytocics|mesh-ancestor
24888848|NCT04500002|Antitubercular Agents|antitubercular agents|mesh-ancestor
24888849|NCT04500002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24888850|NCT04500002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24888851|NCT04500002|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24888852|NCT04500002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24888853|NCT04500002|Antimetabolites|antimetabolites|mesh-ancestor
24888854|NCT04500002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888880|NCT04499586|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24888881|NCT04499586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24888882|NCT04499586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674807|NCT04409964|Analgesics|analgesics|mesh-ancestor
24888897|NCT04499573|Dexamethasone|dexamethasone|mesh-list
24888898|NCT04499573|Cyclophosphamide|cyclophosphamide|mesh-list
24888899|NCT04499573|Fludarabine|fludarabine|mesh-list
24888900|NCT04499573|Etoposide|etoposide|mesh-list
24888901|NCT04499573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24888902|NCT04499573|Immunologic Factors|immunologic factors|mesh-ancestor
24888903|NCT04499573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888904|NCT04499573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24888905|NCT04499573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24888906|NCT04499573|Alkylating Agents|alkylating agents|mesh-ancestor
24888907|NCT04499573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466693|NCT00374621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24466694|NCT00374621|Oxytocics|oxytocics|mesh-ancestor
24466702|NCT00374647|Sirolimus|sirolimus|mesh-list
24512773|NCT00576550|Betamethasone benzoate|betamethasone benzoate|mesh-list
24512774|NCT00576550|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25866319|NCT00103649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24674876|NCT04091022|Eflornithine|eflornithine|mesh-list
24888930|NCT04499976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24888931|NCT04499976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888932|NCT04499976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24888933|NCT04499976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24888934|NCT04499976|Oxytocics|oxytocics|mesh-ancestor
24888935|NCT04499118|Paclitaxel|paclitaxel|mesh-list
25201580|NCT02726828|Anesthetics, General|anesthetics, general|mesh-ancestor
25201581|NCT02726828|Anesthetics|anesthetics|mesh-ancestor
25201582|NCT02726828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25866320|NCT00103649|Serotonin Agents|serotonin agents|mesh-ancestor
25866321|NCT00103649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25866322|NCT00103649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827417|NCT02138812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866323|NCT00103649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866324|NCT00103701|Dasatinib|dasatinib|mesh-list
25866325|NCT00103701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816786|NCT02078791|Cholinergic Agents|cholinergic agents|mesh-ancestor
25866326|NCT00103701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25060882|NCT03475693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060883|NCT03475693|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25060884|NCT03475693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25060885|NCT03475693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25060886|NCT03475693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24888936|NCT04499118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24888937|NCT04499118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24888938|NCT04499118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24888939|NCT04499118|Tubulin Modulators|tubulin modulators|mesh-ancestor
24888940|NCT04499118|Antimitotic Agents|antimitotic agents|mesh-ancestor
24888941|NCT04499118|Mitosis Modulators|mitosis modulators|mesh-ancestor
24888942|NCT04499118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888947|NCT04499313|Prednisolone|prednisolone|mesh-list
24888948|NCT04499313|Prednisolone acetate|prednisolone acetate|mesh-list
24888949|NCT04499313|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24888950|NCT04499313|Prednisolone phosphate|prednisolone phosphate|mesh-list
24888951|NCT04499313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24888952|NCT04499313|Antiemetics|antiemetics|mesh-ancestor
24888953|NCT04499313|Autonomic Agents|autonomic agents|mesh-ancestor
24888954|NCT04499313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24888955|NCT04499313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888956|NCT04499313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24888957|NCT04499313|Glucocorticoids|glucocorticoids|mesh-ancestor
24888958|NCT04499313|Hormones|hormones|mesh-ancestor
24888959|NCT04499313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24888960|NCT04499313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24888961|NCT04499313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24888962|NCT04499313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24888963|NCT04499313|Protective Agents|protective agents|mesh-ancestor
24512789|NCT00576615|Anesthetics, General|anesthetics, general|mesh-ancestor
24512790|NCT00576615|Anesthetics|anesthetics|mesh-ancestor
25670316|NCT04504123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24888978|NCT04499209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24888980|NCT04499209|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24888981|NCT04499209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24466778|NCT00374881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24466779|NCT00374881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512791|NCT00576706|Misoprostol|misoprostol|mesh-list
24512792|NCT00576706|Rebamipide|rebamipide|mesh-list
24512793|NCT00576706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24512794|NCT00576706|Abortifacient Agents|abortifacient agents|mesh-ancestor
24512795|NCT00576706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24512796|NCT00576706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512797|NCT00576706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24512798|NCT00576706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24512799|NCT00576706|Oxytocics|oxytocics|mesh-ancestor
24512800|NCT00576706|Antioxidants|antioxidants|mesh-ancestor
24512801|NCT00576706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512802|NCT00576706|Protective Agents|protective agents|mesh-ancestor
24512803|NCT00576706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512804|NCT00576784|Pioglitazone|pioglitazone|mesh-list
24512805|NCT00576784|Glimepiride|glimepiride|mesh-list
24512806|NCT00576784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24512807|NCT00576784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512808|NCT00576784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24512809|NCT00576784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25201583|NCT02726828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25201584|NCT02726828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25201585|NCT02726828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25201586|NCT02726828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201587|NCT02726828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25201588|NCT02726828|Narcotics|narcotics|mesh-ancestor
25201589|NCT02726503|Lenvatinib|lenvatinib|mesh-list
25201590|NCT02726503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201591|NCT02726503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25866327|NCT00103701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512810|NCT00576784|Immunologic Factors|immunologic factors|mesh-ancestor
24512811|NCT00576862|Insulin Glargine|insulin glargine|mesh-list
24512812|NCT00576862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25060887|NCT03475693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25060888|NCT03475693|Antacids|antacids|mesh-ancestor
25060889|NCT03475680|Gentamicins|gentamicins|mesh-list
25060890|NCT03475680|Ornidazole|ornidazole|mesh-list
25060891|NCT03475680|Sennosides|sennosides|mesh-list
25060892|NCT03475680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25060893|NCT03475680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25060894|NCT03475680|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25060895|NCT03475680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25060896|NCT03475680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060897|NCT03475680|Laxatives|laxatives|mesh-ancestor
25060898|NCT03475680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24823366|NCT02116868|Urapidil|urapidil|mesh-list
24512813|NCT00576862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512814|NCT00576914|Endostatins|endostatins|mesh-list
24512815|NCT00576914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24512816|NCT00576914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24512843|NCT00577109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24512844|NCT00577109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512845|NCT00577109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24512846|NCT00577109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24888988|NCT04499209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24888990|NCT04498936|Sofosbuvir|sofosbuvir|mesh-list
24888991|NCT04498936|Ledipasvir|ledipasvir|mesh-list
24719944|NCT01565109|Docetaxel|docetaxel|mesh-list
24888992|NCT04498936|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
24888993|NCT04498936|Nitazoxanide|nitazoxanide|mesh-list
24889030|NCT04498689|Immunologic Factors|immunologic factors|mesh-ancestor
24889031|NCT04498689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889032|NCT04498793|Paclitaxel|paclitaxel|mesh-list
24889033|NCT04498793|Cyclophosphamide|cyclophosphamide|mesh-list
24889034|NCT04498793|Doxorubicin|doxorubicin|mesh-list
24889035|NCT04498793|Epirubicin|epirubicin|mesh-list
25670317|NCT04504123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889036|NCT04498793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24889037|NCT04498793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24889038|NCT04498793|Tubulin Modulators|tubulin modulators|mesh-ancestor
25060899|NCT03475680|Amebicides|amebicides|mesh-ancestor
24839704|NCT02205931|Clobazam|clobazam|mesh-list
25060900|NCT03475680|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25060901|NCT03475680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25060902|NCT03475680|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25060903|NCT03475628|Daratumumab|daratumumab|mesh-list
25060904|NCT03475628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25060905|NCT03475615|Paclitaxel|paclitaxel|mesh-list
25060906|NCT03475615|Oxaliplatin|oxaliplatin|mesh-list
25060907|NCT03475615|Tegafur|tegafur|mesh-list
24889052|NCT04498793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889053|NCT04498884|Insulin|insulin|mesh-list
24889054|NCT04498884|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24889055|NCT04498884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24889056|NCT04498884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889057|NCT04498325|Antibodies|antibodies|mesh-list
25866328|NCT00103701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512866|NCT00577161|Immunologic Factors|immunologic factors|mesh-ancestor
24512867|NCT00577161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512868|NCT00577161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24512869|NCT00577161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24512870|NCT00577161|Antimetabolites|antimetabolites|mesh-ancestor
24512871|NCT00577161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512872|NCT00577161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24512873|NCT00577161|Antiviral Agents|antiviral agents|mesh-ancestor
24512874|NCT00577161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24512875|NCT00577161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24512876|NCT00577161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24512877|NCT00577161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512889|NCT00577200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24512890|NCT00577200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24512892|NCT00577200|GABA Agents|gaba agents|mesh-ancestor
24512893|NCT00577200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24512894|NCT00577200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512895|NCT00577200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24512896|NCT00577200|Narcotics|narcotics|mesh-ancestor
24512897|NCT00577200|Analgesics|analgesics|mesh-ancestor
24512898|NCT00577200|Sensory System Agents|sensory system agents|mesh-ancestor
24816773|NCT02078648|Immunologic Factors|immunologic factors|mesh-ancestor
24816774|NCT02078648|Antiviral Agents|antiviral agents|mesh-ancestor
25201592|NCT02726503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816778|NCT02078791|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24816779|NCT02078791|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24816780|NCT02078791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24816781|NCT02078791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816782|NCT02078791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816783|NCT02078791|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25866329|NCT00103727|Risperidone|risperidone|mesh-list
24816784|NCT02078791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24816785|NCT02078791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816787|NCT02078791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24816788|NCT02078869|Progesterone|progesterone|mesh-list
24816789|NCT02078869|Progestins|progestins|mesh-ancestor
24816791|NCT02078869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24816792|NCT02078869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816793|NCT02078895|Botulinum Toxins|botulinum toxins|mesh-list
24816794|NCT02078895|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24612836|NCT01015495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24711565|NCT01515839|Vitamins|vitamins|mesh-ancestor
24889061|NCT04498286|Immunologic Factors|immunologic factors|mesh-ancestor
24889062|NCT04498286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889070|NCT04498520|Hormone Antagonists|hormone antagonists|mesh-ancestor
24889071|NCT04498520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24889072|NCT04498520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889073|NCT04498520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24889074|NCT04498520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889075|NCT04498520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060919|NCT03475589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25060920|NCT03475589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060921|NCT03475524|Metformin|metformin|mesh-list
25060922|NCT03475524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25060923|NCT03475524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060924|NCT03475459|Melatonin|melatonin|mesh-list
25060925|NCT03475459|Antioxidants|antioxidants|mesh-ancestor
25060926|NCT03475459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060927|NCT03475459|Protective Agents|protective agents|mesh-ancestor
25432044|NCT00885664|Protease Inhibitors|protease inhibitors|mesh-ancestor
25060929|NCT03475459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25060931|NCT03475407|Dexamethasone acetate|dexamethasone acetate|mesh-list
25060932|NCT03475407|BB 1101|bb 1101|mesh-list
25060933|NCT03475407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25060934|NCT03475407|Antiemetics|antiemetics|mesh-ancestor
25060935|NCT03475407|Autonomic Agents|autonomic agents|mesh-ancestor
25060936|NCT03475407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060937|NCT03475407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060938|NCT03475407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25060939|NCT03475407|Glucocorticoids|glucocorticoids|mesh-ancestor
25060940|NCT03475407|Hormones|hormones|mesh-ancestor
24889118|NCT04497766|Tocolytic Agents|tocolytic agents|mesh-ancestor
24889119|NCT04497766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24889120|NCT04497792|Metformin|metformin|mesh-list
24889121|NCT04497792|Empagliflozin|empagliflozin|mesh-list
24889122|NCT04497792|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24889123|NCT04497792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866331|NCT00103727|Serotonin Agents|serotonin agents|mesh-ancestor
25866332|NCT00103727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24889136|NCT04496921|Vitamins|vitamins|mesh-list
24889137|NCT04496921|Vitamin K|vitamin k|mesh-list
24889138|NCT04496921|Micronutrients|micronutrients|mesh-ancestor
24897213|NCT04427618|Coagulants|coagulants|mesh-ancestor
24889139|NCT04496921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889140|NCT04496921|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24889141|NCT04496921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25201593|NCT02726503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889148|NCT04496882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24889149|NCT04496882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24889150|NCT04496882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889151|NCT04496882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889152|NCT04496882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24889164|NCT04496492|Antioxidants|antioxidants|mesh-ancestor
24889165|NCT04496492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889181|NCT04496050|Vasodilator Agents|vasodilator agents|mesh-ancestor
24889182|NCT04496050|Urological Agents|urological agents|mesh-ancestor
24889184|NCT04495894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24889185|NCT04495894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24889186|NCT04495894|Analgesics|analgesics|mesh-ancestor
24889187|NCT04495894|Sensory System Agents|sensory system agents|mesh-ancestor
24889188|NCT04495894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24889189|NCT04495894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889190|NCT04495894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24889191|NCT04495894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24512938|NCT00577668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24512939|NCT00577668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24512940|NCT00577668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24512941|NCT00577668|Growth Substances|growth substances|mesh-ancestor
24512942|NCT00577668|Growth Inhibitors|growth inhibitors|mesh-ancestor
24512943|NCT00577681|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24512944|NCT00577681|Antiviral Agents|antiviral agents|mesh-ancestor
24512945|NCT00577681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24512946|NCT00577694|Clofarabine|clofarabine|mesh-list
24512947|NCT00577694|Gemtuzumab|gemtuzumab|mesh-list
24512948|NCT00577694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24512958|NCT00577798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25060945|NCT03475407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25060946|NCT03475407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060948|NCT03475394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24817629|NCT02084615|Antipyretics|antipyretics|mesh-ancestor
24474327|NCT00405574|Growth Substances|growth substances|mesh-ancestor
24474329|NCT00405574|Growth Inhibitors|growth inhibitors|mesh-ancestor
25060949|NCT03475394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25060950|NCT03475394|Disinfectants|disinfectants|mesh-ancestor
25060951|NCT03475225|Cholecalciferol|cholecalciferol|mesh-list
25060952|NCT03475225|Vitamin D|vitamin d|mesh-list
25060953|NCT03475225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25060954|NCT03475225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060955|NCT03475225|Vitamins|vitamins|mesh-ancestor
25060956|NCT03475225|Micronutrients|micronutrients|mesh-ancestor
25060957|NCT03475225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25060958|NCT03475160|Sildenafil Citrate|sildenafil citrate|mesh-list
25060959|NCT03475160|Citric Acid|citric acid|mesh-list
25060960|NCT03475160|Sodium Citrate|sodium citrate|mesh-list
25060961|NCT03475160|Anticoagulants|anticoagulants|mesh-ancestor
25060962|NCT03475160|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25060963|NCT03475160|Chelating Agents|chelating agents|mesh-ancestor
25060964|NCT03475160|Sequestering Agents|sequestering agents|mesh-ancestor
25060965|NCT03475160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060966|NCT03475160|Vasodilator Agents|vasodilator agents|mesh-ancestor
25060975|NCT03475121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060976|NCT03475121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25060978|NCT03475017|Piperine|piperine|mesh-list
25060979|NCT03475017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25060980|NCT03475017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25060981|NCT03475017|Analgesics|analgesics|mesh-ancestor
25060982|NCT03475017|Sensory System Agents|sensory system agents|mesh-ancestor
25060983|NCT03475017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060984|NCT03475017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060985|NCT03475017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25060986|NCT03475017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25060987|NCT03475017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25060988|NCT03475017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25060989|NCT03475017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060990|NCT03475017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25060991|NCT03474939|Midazolam|midazolam|mesh-list
25060992|NCT03474939|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25060993|NCT03474939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25060994|NCT03474939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25060995|NCT03474939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060996|NCT03474939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25060997|NCT03474939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25060998|NCT03474939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25060999|NCT03474939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25061000|NCT03474939|Anesthetics, General|anesthetics, general|mesh-ancestor
24512979|NCT00577967|Sensory System Agents|sensory system agents|mesh-ancestor
25061015|NCT03474614|Propranolol|propranolol|mesh-list
25061016|NCT03474614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25061017|NCT03474614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24823474|NCT02117453|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24512980|NCT00577967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24512981|NCT00577967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512982|NCT00577967|Anticonvulsants|anticonvulsants|mesh-ancestor
24512983|NCT00577967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24512984|NCT00577967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24512985|NCT00577967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24512986|NCT00577967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24512987|NCT00577967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24512988|NCT00577967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24512989|NCT00577967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24512990|NCT00577967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512992|NCT00577980|Testosterone|testosterone|mesh-list
24466948|NCT00375661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889221|NCT04496024|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24889222|NCT04496024|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24889223|NCT04495569|Antibodies|antibodies|mesh-list
24889224|NCT04495569|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24889225|NCT04495569|Immunologic Factors|immunologic factors|mesh-ancestor
24889226|NCT04495569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889227|NCT04495478|Ramucirumab|ramucirumab|mesh-list
24889228|NCT04495478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24889229|NCT04495478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24889230|NCT04495478|Immunologic Factors|immunologic factors|mesh-ancestor
24889231|NCT04495478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889232|NCT04495504|Ropivacaine|ropivacaine|mesh-list
24889233|NCT04495504|Anesthetics, Local|anesthetics, local|mesh-ancestor
24889234|NCT04495504|Anesthetics|anesthetics|mesh-ancestor
24889235|NCT04495504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24889238|NCT04495504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24889239|NCT04495101|Protease Inhibitors|protease inhibitors|mesh-list
24889240|NCT04495101|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
24889241|NCT04495101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889242|NCT04495101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512993|NCT00577980|Androgens|androgens|mesh-ancestor
24512994|NCT00577980|Hormones|hormones|mesh-ancestor
25432045|NCT00885664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512995|NCT00577980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24512996|NCT00577980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512997|NCT00578097|Botulinum Toxins|botulinum toxins|mesh-list
24812607|NCT02053766|Analgesics|analgesics|mesh-ancestor
25061037|NCT03474341|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25061038|NCT03474341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061039|NCT03474263|Antibodies|antibodies|mesh-list
25061040|NCT03474263|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25061041|NCT03474263|Immunologic Factors|immunologic factors|mesh-ancestor
25061042|NCT03474263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061043|NCT03474237|Hormones|hormones|mesh-list
24945128|NCT03953716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24945129|NCT03953716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201594|NCT02726555|Atorvastatin|atorvastatin|mesh-list
24945130|NCT03953716|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24945131|NCT03953716|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24945132|NCT03953716|Progestins|progestins|mesh-ancestor
24945134|NCT03953716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24945135|NCT03953326|Nitroprusside|nitroprusside|mesh-list
24889244|NCT04495101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24675653|NCT01344304|Aprepitant|aprepitant|mesh-list
25061050|NCT03474198|Pyrazinamide|pyrazinamide|mesh-list
25061051|NCT03474198|Ethambutol|ethambutol|mesh-list
25061052|NCT03474198|Rifapentine|rifapentine|mesh-list
25061053|NCT03474198|Bedaquiline|bedaquiline|mesh-list
25061054|NCT03474198|Clofazimine|clofazimine|mesh-list
25061055|NCT03474198|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25061056|NCT03474198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25061057|NCT03474198|Renal Agents|renal agents|mesh-ancestor
25061058|NCT03474198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25061059|NCT03474198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25061060|NCT03474198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25061061|NCT03474198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25061062|NCT03474198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061063|NCT03474198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25061064|NCT03474198|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25061065|NCT03474198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25061066|NCT03474198|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25061067|NCT03474198|Antitubercular Agents|antitubercular agents|mesh-ancestor
25061068|NCT03474198|Leprostatic Agents|leprostatic agents|mesh-ancestor
25061069|NCT03474198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25061070|NCT03474198|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25061071|NCT03474198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25061072|NCT03474198|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25061073|NCT03474198|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25061074|NCT03474198|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25061077|NCT03474198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25061080|NCT03474198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25061081|NCT03474198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24945139|NCT03953326|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25061082|NCT03474146|Chlorhexidine|chlorhexidine|mesh-list
25061083|NCT03474146|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25061084|NCT03474146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25061085|NCT03474146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25061086|NCT03474146|Disinfectants|disinfectants|mesh-ancestor
25061087|NCT03474146|Dermatologic Agents|dermatologic agents|mesh-ancestor
25061088|NCT03474133|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25061089|NCT03474133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25061090|NCT03474133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25061091|NCT03473964|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25061092|NCT03473964|Hormones|hormones|mesh-ancestor
25061093|NCT03473964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25061096|NCT03473691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25061097|NCT03473691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25061098|NCT03473639|Capecitabine|capecitabine|mesh-list
25061100|NCT03473639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25061101|NCT03473639|Antimetabolites|antimetabolites|mesh-ancestor
25061102|NCT03473639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675705|NCT01344564|Fertility Agents|fertility agents|mesh-ancestor
24823596|NCT02118051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24823597|NCT02118064|Irinotecan|irinotecan|mesh-list
24823598|NCT02118064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24823599|NCT02118064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24823603|NCT02118090|Chloroquine|chloroquine|mesh-list
24889250|NCT04495010|Nivolumab|nivolumab|mesh-list
24889251|NCT04495010|Ipilimumab|ipilimumab|mesh-list
24889252|NCT04495010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24889253|NCT04495010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24889254|NCT04495010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24889255|NCT04495010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889257|NCT04494659|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24466966|NCT00375778|Memantine|memantine|mesh-list
24889258|NCT04494659|Antitubercular Agents|antitubercular agents|mesh-ancestor
24889259|NCT04494659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24889260|NCT04494659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24889261|NCT04494659|Leprostatic Agents|leprostatic agents|mesh-ancestor
24889262|NCT04494659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24889263|NCT04494659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889264|NCT04494659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866333|NCT00103727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889265|NCT04494659|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24889266|NCT04494659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24889267|NCT04494659|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24889268|NCT04494659|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24889289|NCT04494828|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24889290|NCT04494828|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24889338|NCT04494100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24889339|NCT04494100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889340|NCT04494100|Sensory System Agents|sensory system agents|mesh-ancestor
24889341|NCT04494100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24889342|NCT04494100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24889343|NCT04494100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24889367|NCT04494243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24889377|NCT04494399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24889378|NCT04494399|Antimetabolites|antimetabolites|mesh-ancestor
24889379|NCT04494399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889380|NCT04494399|Immunologic Factors|immunologic factors|mesh-ancestor
24889381|NCT04494399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889382|NCT04494399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24889383|NCT04494126|Tranexamic Acid|tranexamic acid|mesh-list
24889384|NCT04494126|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24889385|NCT04494126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24889386|NCT04494126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889387|NCT04494126|Hemostatics|hemostatics|mesh-ancestor
24513056|NCT00578370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24513057|NCT00578370|Respiratory System Agents|respiratory system agents|mesh-ancestor
25061143|NCT03473431|Anesthetics, General|anesthetics, general|mesh-ancestor
25061144|NCT03473431|Anesthetics|anesthetics|mesh-ancestor
25061145|NCT03473431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25201598|NCT02726555|Antimetabolites|antimetabolites|mesh-ancestor
25061146|NCT03473431|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25061147|NCT03473431|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25061148|NCT03473431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25061149|NCT03473431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061150|NCT03473418|Ketoconazole|ketoconazole|mesh-list
24823624|NCT02118142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24823625|NCT02118142|Antimetabolites|antimetabolites|mesh-ancestor
25866334|NCT00103727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866335|NCT00103727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25866336|NCT00103727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24889399|NCT04493515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24889400|NCT04493515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889401|NCT04493489|Propranolol|propranolol|mesh-list
24889402|NCT04493489|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24889403|NCT04493489|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25866337|NCT00103727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25866338|NCT00103727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25866339|NCT00103727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25866340|NCT00103727|Dopamine Agents|dopamine agents|mesh-ancestor
25866341|NCT00103753|Deferiprone|deferiprone|mesh-list
25866342|NCT00103753|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25866343|NCT00103753|Chelating Agents|chelating agents|mesh-ancestor
25866344|NCT00103753|Sequestering Agents|sequestering agents|mesh-ancestor
25866345|NCT00103753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866346|NCT00103766|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25866347|NCT00103766|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24534704|NCT00647868|Testosterone|testosterone|mesh-list
25866348|NCT00103766|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25866349|NCT00103766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866350|NCT00103779|Dacetuzumab|dacetuzumab|mesh-list
25866351|NCT00103779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25866352|NCT00103779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24889412|NCT04493528|Anesthetics, Local|anesthetics, local|mesh-ancestor
24889413|NCT04493528|Anesthetics|anesthetics|mesh-ancestor
24889414|NCT04493528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24889415|NCT04493528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889416|NCT04493528|Sensory System Agents|sensory system agents|mesh-ancestor
25061151|NCT03473418|Terconazole|terconazole|mesh-list
25061152|NCT03473418|Antifungal Agents|antifungal agents|mesh-ancestor
25061153|NCT03473418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24676032|NCT01347944|Lenalidomide|lenalidomide|mesh-list
25061214|NCT03473093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25061215|NCT03473093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25061216|NCT03473093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25061217|NCT03472976|Imiquimod|imiquimod|mesh-list
25061218|NCT03472976|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25061219|NCT03472976|Immunologic Factors|immunologic factors|mesh-ancestor
25061220|NCT03472976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061221|NCT03472976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25061222|NCT03472976|Interferon Inducers|interferon inducers|mesh-ancestor
25061223|NCT03472963|Darunavir|darunavir|mesh-list
25061224|NCT03472963|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25061225|NCT03472963|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25061226|NCT03472963|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25061227|NCT03472963|Protease Inhibitors|protease inhibitors|mesh-ancestor
25061228|NCT03472963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823704|NCT02118688|Risperidone|risperidone|mesh-list
24889417|NCT04493528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24889418|NCT04493528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24889419|NCT04493528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24889420|NCT04493528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24889421|NCT04493528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24889422|NCT04493528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889423|NCT04493229|Oxytocin|oxytocin|mesh-list
24889424|NCT04493229|Oxytocics|oxytocics|mesh-ancestor
24889425|NCT04493229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24889426|NCT04493229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889427|NCT04493125|Mosapride|mosapride|mesh-list
24889428|NCT04493125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897357|NCT04425993|Diuretics|diuretics|mesh-ancestor
24889429|NCT04493125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24889430|NCT04493125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24889431|NCT04493125|Serotonin Agents|serotonin agents|mesh-ancestor
24889432|NCT04493125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24889433|NCT04493125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889434|NCT04493398|Erythritol|erythritol|mesh-list
24889435|NCT04493398|Vasodilator Agents|vasodilator agents|mesh-ancestor
24889436|NCT04493463|Methylprednisolone|methylprednisolone|mesh-list
24889437|NCT04493463|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24889438|NCT04493463|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25061243|NCT03472872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25061244|NCT03472872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061246|NCT03472872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25061247|NCT03472872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25061248|NCT03472872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25061249|NCT03472872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25061250|NCT03472872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25061251|NCT03472872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889459|NCT04493463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24889460|NCT04493463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24889461|NCT04493281|Edaravone|edaravone|mesh-list
24889462|NCT04493281|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24889463|NCT04493281|Antioxidants|antioxidants|mesh-ancestor
24711992|NCT01518062|Estrogens|estrogens|mesh-list
25432121|NCT00878163|Antiviral Agents|antiviral agents|mesh-ancestor
25670318|NCT04499274|Ondansetron|ondansetron|mesh-list
25670319|NCT04499274|Antiemetics|antiemetics|mesh-ancestor
25670320|NCT04499274|Autonomic Agents|autonomic agents|mesh-ancestor
25670321|NCT04499274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25670322|NCT04499274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670323|NCT04499274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24889464|NCT04493281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889465|NCT04493281|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24889466|NCT04493281|Protective Agents|protective agents|mesh-ancestor
24889467|NCT04493281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889468|NCT04493099|Decitabine|decitabine|mesh-list
24889469|NCT04493099|Venetoclax|venetoclax|mesh-list
25201595|NCT02726555|Red yeast rice|red yeast rice|mesh-list
24858753|NCT02299310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24858754|NCT02299310|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24858755|NCT02299310|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24858756|NCT02299310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889470|NCT04493099|Alvocidib|alvocidib|mesh-list
24889471|NCT04493099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24889472|NCT04493099|Antimetabolites|antimetabolites|mesh-ancestor
24889475|NCT04493099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889497|NCT04492774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24889498|NCT04492774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24889499|NCT04492774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24889501|NCT04492813|Propofol|propofol|mesh-list
24889502|NCT04492813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24889503|NCT04492813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24889504|NCT04492813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889505|NCT04492813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25061263|NCT03472651|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
25061264|NCT03472651|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25061265|NCT03472651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25061266|NCT03472651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25061267|NCT03472651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061268|NCT03472651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25061269|NCT03472651|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25061270|NCT03472651|Dopamine Agents|dopamine agents|mesh-ancestor
25061271|NCT03472651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25061272|NCT03472651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889510|NCT04492813|Analgesics|analgesics|mesh-ancestor
24889511|NCT04492813|Sensory System Agents|sensory system agents|mesh-ancestor
24889512|NCT04492813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24889513|NCT04492709|Midazolam|midazolam|mesh-list
24889514|NCT04492709|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24889515|NCT04492709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24889516|NCT04492709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24889517|NCT04492709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889518|NCT04492709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24889519|NCT04492709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24889520|NCT04492709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24889521|NCT04492709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24889522|NCT04492709|Anesthetics, General|anesthetics, general|mesh-ancestor
24889523|NCT04492709|Anesthetics|anesthetics|mesh-ancestor
24889524|NCT04492709|GABA Modulators|gaba modulators|mesh-ancestor
24889525|NCT04492709|GABA Agents|gaba agents|mesh-ancestor
24889526|NCT04492709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25201597|NCT02726555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25201599|NCT02726555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201600|NCT02726555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24889559|NCT04492358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889561|NCT04492501|Antimetabolites|antimetabolites|mesh-ancestor
24889562|NCT04492501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889563|NCT04492501|Antiviral Agents|antiviral agents|mesh-ancestor
24889564|NCT04492501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24889566|NCT04491773|Vasodilator Agents|vasodilator agents|mesh-ancestor
24889567|NCT04491773|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24889586|NCT04491786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889588|NCT04491786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25061303|NCT03472378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25061304|NCT03472378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24676313|NCT01349452|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24467242|NCT00376701|Growth Substances|growth substances|mesh-ancestor
24467243|NCT00376701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467244|NCT00376701|Growth Inhibitors|growth inhibitors|mesh-ancestor
24467246|NCT00376727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24467247|NCT00376727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467248|NCT00376740|Zoledronic Acid|zoledronic acid|mesh-list
24467251|NCT00376766|Levetiracetam|levetiracetam|mesh-list
25866353|NCT00103792|Mycophenolic Acid|mycophenolic acid|mesh-list
25866354|NCT00103792|Cyclophosphamide|cyclophosphamide|mesh-list
25866355|NCT00103792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25866356|NCT00103792|Immunologic Factors|immunologic factors|mesh-ancestor
25866357|NCT00103792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866358|NCT00103792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25866359|NCT00103792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24513075|NCT00578526|Growth Inhibitors|growth inhibitors|mesh-ancestor
24513076|NCT00578526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24513077|NCT00578526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866360|NCT00103792|Alkylating Agents|alkylating agents|mesh-ancestor
24513089|NCT00578721|Sensory System Agents|sensory system agents|mesh-ancestor
24513090|NCT00578721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25061305|NCT03472378|Analgesics|analgesics|mesh-ancestor
25866361|NCT00103792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866362|NCT00103792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866363|NCT00103792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25866364|NCT00103792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25866365|NCT00103792|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25866366|NCT00103792|Antitubercular Agents|antitubercular agents|mesh-ancestor
24513112|NCT00578760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513113|NCT00578760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24513114|NCT00578760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24513115|NCT00578760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24513116|NCT00578760|Antipyretics|antipyretics|mesh-ancestor
24513117|NCT00578825|Ritonavir|ritonavir|mesh-list
24513118|NCT00578825|Lopinavir|lopinavir|mesh-list
24513119|NCT00578825|Ribavirin|ribavirin|mesh-list
24513120|NCT00578825|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24513121|NCT00578825|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24513122|NCT00578825|Protease Inhibitors|protease inhibitors|mesh-ancestor
24513123|NCT00578825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889662|NCT04490967|Salicylic Acid|salicylic acid|mesh-list
25866367|NCT00103792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25866368|NCT00103792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25866369|NCT00103792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866370|NCT00103805|Levodopa|levodopa|mesh-list
25866371|NCT00103805|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25866372|NCT00103805|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25866373|NCT00103805|Dopamine Agents|dopamine agents|mesh-ancestor
25866374|NCT00103805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25866375|NCT00103805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866376|NCT00103805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866377|NCT00103818|Gaboxadol|gaboxadol|mesh-list
25866378|NCT00103818|Analgesics|analgesics|mesh-ancestor
25866379|NCT00103818|Sensory System Agents|sensory system agents|mesh-ancestor
25866380|NCT00103818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25866381|NCT00103818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866382|NCT00103818|Anticonvulsants|anticonvulsants|mesh-ancestor
25866383|NCT00103818|GABA Agonists|gaba agonists|mesh-ancestor
25866384|NCT00103818|GABA Agents|gaba agents|mesh-ancestor
25866385|NCT00103818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25866386|NCT00103818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889696|NCT04490980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24889697|NCT04490980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889698|NCT04490980|Analgesics|analgesics|mesh-ancestor
24889699|NCT04490980|Sensory System Agents|sensory system agents|mesh-ancestor
24889700|NCT04490980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24889701|NCT04490980|Antitussive Agents|antitussive agents|mesh-ancestor
24889702|NCT04490980|Respiratory System Agents|respiratory system agents|mesh-ancestor
24889703|NCT04490980|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24889705|NCT04490694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24889706|NCT04490694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24889707|NCT04490694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889708|NCT04490694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889709|NCT04490590|Etoposide|etoposide|mesh-list
24513156|NCT00579475|Contraceptive Agents|contraceptive agents|mesh-ancestor
25061318|NCT03472339|Analgesics|analgesics|mesh-ancestor
25061319|NCT03472339|Sensory System Agents|sensory system agents|mesh-ancestor
25061320|NCT03472339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25061321|NCT03472339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061322|NCT03472339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25061323|NCT03472339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25061324|NCT03472339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25061325|NCT03472339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25061326|NCT03472339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513163|NCT00579475|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24513164|NCT00579592|Mycophenolic Acid|mycophenolic acid|mesh-list
24513165|NCT00579592|Rituximab|rituximab|mesh-list
24513177|NCT00579592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889710|NCT04490590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24889711|NCT04490590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24889712|NCT04490590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24889713|NCT04490590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24889714|NCT04490590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889715|NCT04490590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889716|NCT04490434|Celecoxib|celecoxib|mesh-list
24889717|NCT04490434|Naproxen|naproxen|mesh-list
24889718|NCT04490434|Meloxicam|meloxicam|mesh-list
24889719|NCT04490434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24889720|NCT04490434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24889721|NCT04490434|Analgesics|analgesics|mesh-ancestor
24889722|NCT04490434|Sensory System Agents|sensory system agents|mesh-ancestor
24889723|NCT04490434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24889724|NCT04490434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889725|NCT04490434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24889726|NCT04490434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24889727|NCT04490434|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24889728|NCT04490434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24889729|NCT04490434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889730|NCT04490434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889731|NCT04490434|Gout Suppressants|gout suppressants|mesh-ancestor
24889732|NCT04489979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24889733|NCT04489979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24889734|NCT04490421|Etoposide|etoposide|mesh-list
24889735|NCT04490421|Apatinib|apatinib|mesh-list
24889736|NCT04490421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24889737|NCT04490421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24889738|NCT04490421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24889739|NCT04490421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24889743|NCT04490031|Ketamine|ketamine|mesh-list
24623511|NCT01072045|Hormones|hormones|mesh-ancestor
24953101|NCT03888677|Epirubicin|epirubicin|mesh-list
24623512|NCT01072045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24623514|NCT01072045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25061327|NCT03472261|Botulinum Toxins|botulinum toxins|mesh-list
25061328|NCT03472261|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25061329|NCT03472261|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25061332|NCT03472261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061333|NCT03472261|Cholinergic Agents|cholinergic agents|mesh-ancestor
25061334|NCT03472261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25061335|NCT03472261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061336|NCT03472261|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24513189|NCT00579644|Dermatologic Agents|dermatologic agents|mesh-ancestor
24513190|NCT00579644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24513191|NCT00579644|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24513192|NCT00579644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24513193|NCT00579644|Immunologic Factors|immunologic factors|mesh-ancestor
24513194|NCT00579644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24623572|NCT01072318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623573|NCT01072318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24889749|NCT04490031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24889750|NCT04490031|Anesthetics, General|anesthetics, general|mesh-ancestor
24889751|NCT04490031|Anesthetics|anesthetics|mesh-ancestor
24889752|NCT04490031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24889753|NCT04490031|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25061350|NCT03472144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25061351|NCT03472144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061352|NCT03472144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25061353|NCT03472144|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25061354|NCT03472144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24623574|NCT01072318|Hormone Antagonists|hormone antagonists|mesh-ancestor
24889800|NCT04489797|Acalabrutinib|acalabrutinib|mesh-list
24889801|NCT04489797|Rabeprazole|rabeprazole|mesh-list
24889802|NCT04489797|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24889804|NCT04489797|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24889805|NCT04489797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889806|NCT04489797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889807|NCT04489797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24889808|NCT04489849|Apixaban|apixaban|mesh-list
24889809|NCT04489849|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24889810|NCT04489849|Antithrombins|antithrombins|mesh-ancestor
24889811|NCT04489849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24889812|NCT04489849|Protease Inhibitors|protease inhibitors|mesh-ancestor
24945527|NCT03949686|Bupivacaine|bupivacaine|mesh-list
24854166|NCT02272478|Antimetabolites|antimetabolites|mesh-ancestor
24953088|NCT03889145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24953089|NCT03889145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24953090|NCT03889145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24953091|NCT03889145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953092|NCT03889145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24953093|NCT03889145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953094|NCT03889145|Vasodilator Agents|vasodilator agents|mesh-ancestor
24953095|NCT03889145|Diuretics|diuretics|mesh-ancestor
24889813|NCT04489849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889814|NCT04489849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889815|NCT04489849|Anticoagulants|anticoagulants|mesh-ancestor
24889816|NCT04489459|Meropenem|meropenem|mesh-list
24889817|NCT04489459|Colistin|colistin|mesh-list
24889818|NCT04489459|Tigecycline|tigecycline|mesh-list
24889841|NCT04489381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24889842|NCT04489381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24889843|NCT04489160|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
24889844|NCT04489160|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24889845|NCT04489160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24889846|NCT04489160|Immunologic Factors|immunologic factors|mesh-ancestor
24889847|NCT04489160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889848|NCT04488705|Albuterol|albuterol|mesh-list
24889849|NCT04488705|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24889850|NCT04488705|Autonomic Agents|autonomic agents|mesh-ancestor
24953096|NCT03889145|Natriuretic Agents|natriuretic agents|mesh-ancestor
24953097|NCT03889145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24953098|NCT03889145|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24953099|NCT03889145|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24953100|NCT03888677|Cyclophosphamide|cyclophosphamide|mesh-list
24953102|NCT03888677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24467412|NCT00377546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25061385|NCT03471585|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25061386|NCT03471585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25061387|NCT03471585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061388|NCT03471585|Hormones|hormones|mesh-ancestor
25061389|NCT03471585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25866387|NCT00103922|Cilomilast|cilomilast|mesh-list
25061390|NCT03471559|Cannabidiol|cannabidiol|mesh-list
25061391|NCT03471559|Anticonvulsants|anticonvulsants|mesh-ancestor
25061404|NCT03471455|Itraconazole|itraconazole|mesh-list
25061405|NCT03471455|Terbinafine|terbinafine|mesh-list
25061406|NCT03471455|Isotretinoin|isotretinoin|mesh-list
25061407|NCT03471455|Antifungal Agents|antifungal agents|mesh-ancestor
24889854|NCT04488705|Respiratory System Agents|respiratory system agents|mesh-ancestor
24889855|NCT04488705|Tocolytic Agents|tocolytic agents|mesh-ancestor
24889856|NCT04488705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24889891|NCT04488926|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24889892|NCT04488926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24889893|NCT04488926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889895|NCT04488926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24889897|NCT04488601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24889898|NCT04488601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25061408|NCT03471455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25061409|NCT03471455|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25061410|NCT03471455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25061411|NCT03471455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25061412|NCT03471455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061413|NCT03471455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25061414|NCT03471455|Hormone Antagonists|hormone antagonists|mesh-ancestor
25061415|NCT03471455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25061416|NCT03471455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061417|NCT03471455|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25061418|NCT03471455|Dermatologic Agents|dermatologic agents|mesh-ancestor
25061428|NCT03471351|Pembrolizumab|pembrolizumab|mesh-list
25061429|NCT03471351|Tenalisib|tenalisib|mesh-list
25061430|NCT03471351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25061431|NCT03471351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25061432|NCT03471351|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
24839871|NCT02206477|Antioxidants|antioxidants|mesh-ancestor
25061433|NCT03471351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889929|NCT04488081|Immunologic Factors|immunologic factors|mesh-ancestor
24889930|NCT04488081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889931|NCT04488081|Antifungal Agents|antifungal agents|mesh-ancestor
24889932|NCT04488081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24889933|NCT04488081|Dermatologic Agents|dermatologic agents|mesh-ancestor
24889934|NCT04488081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24889935|NCT04488081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24889936|NCT04488081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24889937|NCT04488081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24889938|NCT04488081|Analgesics|analgesics|mesh-ancestor
24889939|NCT04488081|Sensory System Agents|sensory system agents|mesh-ancestor
24897576|NCT04423926|Lenalidomide|lenalidomide|mesh-list
24889940|NCT04488081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24889946|NCT04488081|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24889947|NCT04488081|Histamine Antagonists|histamine antagonists|mesh-ancestor
24889948|NCT04488081|Histamine Agents|histamine agents|mesh-ancestor
24467462|NCT00377793|Urological Agents|urological agents|mesh-ancestor
24513195|NCT00579644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24513196|NCT00579644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24513197|NCT00579644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24513198|NCT00579956|Meropenem|meropenem|mesh-list
24513199|NCT00579956|Ceftazidime|ceftazidime|mesh-list
24513200|NCT00579956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24513201|NCT00579956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24513202|NCT00579969|Timolol|timolol|mesh-list
24513203|NCT00579969|Latanoprost|latanoprost|mesh-list
24513204|NCT00579969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24513205|NCT00579969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24513206|NCT00579969|Adrenergic Agents|adrenergic agents|mesh-ancestor
24889949|NCT04488081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24889950|NCT04488081|Antimetabolites|antimetabolites|mesh-ancestor
24889951|NCT04488081|Antiviral Agents|antiviral agents|mesh-ancestor
24889952|NCT04488172|Vitamins|vitamins|mesh-list
24889953|NCT04488172|Micronutrients|micronutrients|mesh-ancestor
24889954|NCT04488172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513210|NCT00579969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24677118|NCT01354470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513238|NCT00580112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25866388|NCT00103922|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24890016|NCT04486690|Sensory System Agents|sensory system agents|mesh-ancestor
24890017|NCT04486690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24890018|NCT04486690|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24623575|NCT01072318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25201601|NCT02726555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24623576|NCT01072318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623577|NCT01072578|Dapagliflozin|dapagliflozin|mesh-list
24623578|NCT01072578|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24623579|NCT01072578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061489|NCT03470727|Dialysis Solutions|dialysis solutions|mesh-list
25061490|NCT03470727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25061491|NCT03470649|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25061492|NCT03470649|Hematinics|hematinics|mesh-ancestor
25061493|NCT03470610|Estradiol|estradiol|mesh-list
25061494|NCT03470610|Progesterone|progesterone|mesh-list
25061495|NCT03470610|Estrogens|estrogens|mesh-ancestor
25061496|NCT03470610|Hormones|hormones|mesh-ancestor
25061497|NCT03470610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25061498|NCT03470610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061499|NCT03470610|Progestins|progestins|mesh-ancestor
25061500|NCT03470597|Iodine|iodine|mesh-list
24824008|NCT02120703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24824011|NCT02120703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24513254|NCT00580190|GABA Modulators|gaba modulators|mesh-ancestor
24513255|NCT00580190|GABA Agents|gaba agents|mesh-ancestor
24513256|NCT00580190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24513257|NCT00580190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513258|NCT00580242|Lenalidomide|lenalidomide|mesh-list
24513259|NCT00580242|Bortezomib|bortezomib|mesh-list
24513260|NCT00580242|Immunologic Factors|immunologic factors|mesh-ancestor
24816810|NCT02079064|Desflurane|desflurane|mesh-list
24816811|NCT02079064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24816812|NCT02079064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24816813|NCT02079064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816814|NCT02079064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25670324|NCT04499274|Antipruritics|antipruritics|mesh-ancestor
25866389|NCT00103922|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24816815|NCT02079064|Anesthetics, General|anesthetics, general|mesh-ancestor
24816816|NCT02079064|Anesthetics|anesthetics|mesh-ancestor
24816817|NCT02079064|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24712566|NCT01521455|Hormones|hormones|mesh-ancestor
24890019|NCT04486690|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24890020|NCT04486690|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24890032|NCT04486508|Enoxaparin sodium|enoxaparin sodium|mesh-list
24890033|NCT04486508|Atorvastatin|atorvastatin|mesh-list
24890034|NCT04486508|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
24890035|NCT04486508|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24513273|NCT00580359|Capecitabine|capecitabine|mesh-list
24513274|NCT00580359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24513275|NCT00580359|Antimetabolites|antimetabolites|mesh-ancestor
25866390|NCT00103922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866391|NCT00103922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890036|NCT04486508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24890037|NCT04486508|Antimetabolites|antimetabolites|mesh-ancestor
24890038|NCT04486508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890039|NCT04486508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24890040|NCT04486508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24890041|NCT04486508|Anticoagulants|anticoagulants|mesh-ancestor
24890042|NCT04486508|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25061501|NCT03470597|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25061502|NCT03470597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25061504|NCT03470597|Micronutrients|micronutrients|mesh-ancestor
25061505|NCT03470597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061507|NCT03470532|Racepinephrine|racepinephrine|mesh-list
25061508|NCT03470532|Mepivacaine|mepivacaine|mesh-list
25061509|NCT03470532|Carticaine|carticaine|mesh-list
25061510|NCT03470532|Epinephryl borate|epinephryl borate|mesh-list
25061511|NCT03470532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25061512|NCT03470532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25061513|NCT03470532|Adrenergic Agents|adrenergic agents|mesh-ancestor
25061515|NCT03470532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061516|NCT03470532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061517|NCT03470532|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24824018|NCT02120703|Antimanic Agents|antimanic agents|mesh-ancestor
24824019|NCT02120859|Paclitaxel|paclitaxel|mesh-list
24824020|NCT02120859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24824021|NCT02120859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24824022|NCT02120859|Tubulin Modulators|tubulin modulators|mesh-ancestor
24824023|NCT02120859|Antimitotic Agents|antimitotic agents|mesh-ancestor
24824024|NCT02120859|Mitosis Modulators|mitosis modulators|mesh-ancestor
24890043|NCT04486508|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24548378|NCT00709267|Folic Acid|folic acid|mesh-list
24890063|NCT04486521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24890064|NCT04486092|Valproic Acid|valproic acid|mesh-list
24890065|NCT04486092|Anticonvulsants|anticonvulsants|mesh-ancestor
24890066|NCT04486092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24890067|NCT04486092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866392|NCT00103935|Exenatide|exenatide|mesh-list
25866393|NCT00103935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25866394|NCT00103935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866395|NCT00103935|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25866396|NCT00103935|Incretins|incretins|mesh-ancestor
24513276|NCT00580359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061522|NCT03470532|Respiratory System Agents|respiratory system agents|mesh-ancestor
25061523|NCT03470532|Mydriatics|mydriatics|mesh-ancestor
25061524|NCT03470532|Sympathomimetics|sympathomimetics|mesh-ancestor
25061525|NCT03470532|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25061526|NCT03470532|Anesthetics, Local|anesthetics, local|mesh-ancestor
25061527|NCT03470532|Anesthetics|anesthetics|mesh-ancestor
25061528|NCT03470532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25061529|NCT03470532|Sensory System Agents|sensory system agents|mesh-ancestor
25061530|NCT03470480|Methamphetamine|methamphetamine|mesh-list
24945761|NCT03947229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945762|NCT03947489|Sarpogrelate|sarpogrelate|mesh-list
24945763|NCT03947489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24945764|NCT03947489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24945765|NCT03947489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945766|NCT03947489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24945767|NCT03947489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24945768|NCT03947489|Serotonin Agents|serotonin agents|mesh-ancestor
24945769|NCT03947489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24890083|NCT04485845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670325|NCT04499274|Dermatologic Agents|dermatologic agents|mesh-ancestor
24890084|NCT04485845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24890085|NCT04485845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24890086|NCT04485988|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24890087|NCT04485988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24890088|NCT04485988|Adrenergic Agents|adrenergic agents|mesh-ancestor
24890089|NCT04485988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24513280|NCT00580424|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24513281|NCT00580424|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24513282|NCT00580424|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24513283|NCT00580424|Contraceptive Agents|contraceptive agents|mesh-ancestor
24513284|NCT00580424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24513285|NCT00580424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513286|NCT00580424|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24513287|NCT00580424|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24513288|NCT00580437|Dobutamine|dobutamine|mesh-list
24513289|NCT00580437|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25061533|NCT03470480|Sympathomimetics|sympathomimetics|mesh-ancestor
25061534|NCT03470480|Autonomic Agents|autonomic agents|mesh-ancestor
25061535|NCT03470480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25061536|NCT03470480|Dopamine Agents|dopamine agents|mesh-ancestor
25061537|NCT03470480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25061541|NCT03470480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25061542|NCT03470480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25061543|NCT03470480|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25061544|NCT03470454|Linagliptin|linagliptin|mesh-list
24890107|NCT04485702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24890108|NCT04485702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890109|NCT04485702|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24890110|NCT04485702|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24890111|NCT04485702|Anesthetics, General|anesthetics, general|mesh-ancestor
24890112|NCT04485702|Anesthetics|anesthetics|mesh-ancestor
24890116|NCT04485702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24467610|NCT00378196|Ranibizumab|ranibizumab|mesh-list
25866397|NCT00103935|Hormones|hormones|mesh-ancestor
24548226|NCT00708396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24548227|NCT00708396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25866398|NCT00103935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25866399|NCT00103948|Donepezil|donepezil|mesh-list
25866400|NCT00103948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25866401|NCT00103948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866402|NCT00103948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866403|NCT00103948|Cholinergic Agents|cholinergic agents|mesh-ancestor
25866404|NCT00103948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25866405|NCT00103948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866406|NCT00103948|Nootropic Agents|nootropic agents|mesh-ancestor
25866407|NCT00104013|Xaliproden|xaliproden|mesh-list
25866408|NCT00104013|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25866409|NCT00104013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25061551|NCT03470454|Protease Inhibitors|protease inhibitors|mesh-ancestor
25061552|NCT03470454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25061553|NCT03470454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061555|NCT03470363|Bupivacaine|bupivacaine|mesh-list
25061556|NCT03470363|Sevoflurane|sevoflurane|mesh-list
25061557|NCT03470363|Anesthetics, Local|anesthetics, local|mesh-ancestor
25061558|NCT03470363|Anesthetics|anesthetics|mesh-ancestor
25061559|NCT03470363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25061560|NCT03470363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061561|NCT03470363|Sensory System Agents|sensory system agents|mesh-ancestor
25061562|NCT03470363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25061563|NCT03470363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25061564|NCT03470363|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25061565|NCT03470363|Anesthetics, General|anesthetics, general|mesh-ancestor
25061566|NCT03470363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25061567|NCT03470363|Narcotics|narcotics|mesh-ancestor
25061568|NCT03470363|Analgesics|analgesics|mesh-ancestor
25061569|NCT03470363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25061570|NCT03470363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25061571|NCT03470350|Capecitabine|capecitabine|mesh-list
24890130|NCT04485585|Adrenergic Agents|adrenergic agents|mesh-ancestor
24890131|NCT04485585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24890132|NCT04485585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890133|NCT04485585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513299|NCT00580437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866410|NCT00104013|Serotonin Agents|serotonin agents|mesh-ancestor
24513300|NCT00580437|Protective Agents|protective agents|mesh-ancestor
24513301|NCT00580450|Thymalfasin|thymalfasin|mesh-list
24513302|NCT00580450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24513303|NCT00580450|Immunologic Factors|immunologic factors|mesh-ancestor
24513304|NCT00580450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061580|NCT03470311|Benralizumab|benralizumab|mesh-list
25061581|NCT03470311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25061582|NCT03470311|Respiratory System Agents|respiratory system agents|mesh-ancestor
25061583|NCT03470103|Aflibercept|aflibercept|mesh-list
25061584|NCT03470103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25061585|NCT03470103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25061586|NCT03470103|Growth Substances|growth substances|mesh-ancestor
25061587|NCT03470103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061588|NCT03470103|Growth Inhibitors|growth inhibitors|mesh-ancestor
25061589|NCT03470103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201602|NCT02726555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201603|NCT02726490|Metformin|metformin|mesh-list
25061590|NCT03470077|Nalbuphine|nalbuphine|mesh-list
25866411|NCT00104013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25201604|NCT02726490|Glyburide|glyburide|mesh-list
25866412|NCT00104013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866413|NCT00104013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866414|NCT00104130|Desoxyepothilone B|desoxyepothilone b|mesh-list
25866415|NCT00104130|Tubulin Modulators|tubulin modulators|mesh-ancestor
25866416|NCT00104130|Antimitotic Agents|antimitotic agents|mesh-ancestor
25866417|NCT00104130|Mitosis Modulators|mitosis modulators|mesh-ancestor
24890158|NCT04485429|Autonomic Agents|autonomic agents|mesh-ancestor
24890159|NCT04485429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24890160|NCT04485429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890161|NCT04485429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24890162|NCT04485429|Glucocorticoids|glucocorticoids|mesh-ancestor
24890163|NCT04485429|Hormones|hormones|mesh-ancestor
24890164|NCT04485429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24890165|NCT04485429|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24890166|NCT04485429|Protective Agents|protective agents|mesh-ancestor
24467642|NCT00378313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24467652|NCT00378417|Immunologic Factors|immunologic factors|mesh-ancestor
25061591|NCT03470077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25061592|NCT03470077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061593|NCT03470077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25061595|NCT03470077|Analgesics|analgesics|mesh-ancestor
25063265|NCT02457221|Prednisone|prednisone|mesh-list
25061596|NCT03470077|Sensory System Agents|sensory system agents|mesh-ancestor
24890177|NCT04485299|Cariostatic Agents|cariostatic agents|mesh-ancestor
24890178|NCT04485299|Protective Agents|protective agents|mesh-ancestor
24890179|NCT04485299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866418|NCT00104130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866419|NCT00104130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866420|NCT00104169|Epoetin Alfa|epoetin alfa|mesh-list
25866421|NCT00104169|Hematinics|hematinics|mesh-ancestor
25876595|NCT03269669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25876596|NCT03269669|Glucocorticoids|glucocorticoids|mesh-ancestor
25876597|NCT03269669|Hormones|hormones|mesh-ancestor
25876598|NCT03269669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25876599|NCT03269669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25876600|NCT03269669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24890185|NCT04485403|Analgesics|analgesics|mesh-ancestor
24890186|NCT04485403|Sensory System Agents|sensory system agents|mesh-ancestor
24890187|NCT04485403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24890188|NCT04485403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890189|NCT04485403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24890190|NCT04485403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24890191|NCT04485403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24890192|NCT04485403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24890193|NCT04485403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890194|NCT04485312|Chlorhexidine|chlorhexidine|mesh-list
24890195|NCT04485312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24467966|NCT00379405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25061608|NCT03469895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25061609|NCT03469895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25061610|NCT03469895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061611|NCT03469856|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25061612|NCT03469856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25061613|NCT03469804|Pembrolizumab|pembrolizumab|mesh-list
25061614|NCT03469804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24839967|NCT02206789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25226165|NCT02622802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25226166|NCT02622802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25226167|NCT02622802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25226168|NCT02622802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226169|NCT02622477|Pirfenidone|pirfenidone|mesh-list
25061615|NCT03469804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24890200|NCT04485117|Sevoflurane|sevoflurane|mesh-list
24890201|NCT04485117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24890202|NCT04485117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890203|NCT04485117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24890204|NCT04485117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24890205|NCT04485117|Anesthetics, General|anesthetics, general|mesh-ancestor
24890206|NCT04485117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24890207|NCT04485117|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24890246|NCT04484688|Autonomic Agents|autonomic agents|mesh-ancestor
24890247|NCT04484688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24890248|NCT04484688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890249|NCT04484688|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24890250|NCT04484688|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24890251|NCT04484688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24890252|NCT04484688|Adrenergic Agents|adrenergic agents|mesh-ancestor
24890253|NCT04484688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24890254|NCT04484688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890255|NCT04484688|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24890256|NCT04484688|Protease Inhibitors|protease inhibitors|mesh-ancestor
24890257|NCT04484688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866422|NCT00104182|Insulin|insulin|mesh-list
25866423|NCT00104182|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25866424|NCT00104182|Insulin Detemir|insulin detemir|mesh-list
25866425|NCT00104182|Isophane Insulin, Human|isophane insulin, human|mesh-list
25866426|NCT00104182|Insulin, Isophane|insulin, isophane|mesh-list
25866427|NCT00104182|Isophane insulin, beef|isophane insulin, beef|mesh-list
25866428|NCT00104182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25866429|NCT00104182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866430|NCT00104260|Verapamil|verapamil|mesh-list
25866431|NCT00104260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25866432|NCT00104260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25866433|NCT00104260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25866434|NCT00104260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866435|NCT00104260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25866436|NCT00104260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890259|NCT04484779|Insulin Glargine|insulin glargine|mesh-list
24890260|NCT04484779|Insulin Lispro|insulin lispro|mesh-list
24890286|NCT04484506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890287|NCT04484506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866437|NCT00104260|Vasodilator Agents|vasodilator agents|mesh-ancestor
25061616|NCT03469700|Anesthetics|anesthetics|mesh-list
24516818|NCT00603824|Lepirudin|lepirudin|mesh-list
25061617|NCT03469700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24677717|NCT01358045|Analgesics|analgesics|mesh-ancestor
25061634|NCT03469531|Nimotuzumab|nimotuzumab|mesh-list
25061635|NCT03469531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25061636|NCT03469531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25061637|NCT03469375|Folfirinox|folfirinox|mesh-list
25061638|NCT03469375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866438|NCT00104273|Rasagiline|rasagiline|mesh-list
25866439|NCT00104273|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25866440|NCT00104273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866441|NCT00104273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866442|NCT00104273|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25866443|NCT00104273|Protective Agents|protective agents|mesh-ancestor
25866444|NCT00104273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866445|NCT00104286|Troxacitabine|troxacitabine|mesh-list
24801189|NCT01981707|Choline|choline|mesh-list
25432123|NCT00878163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25670326|NCT04499274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25670327|NCT04499274|Serotonin Agents|serotonin agents|mesh-ancestor
25670328|NCT04499274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25670329|NCT04499274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670330|NCT04499274|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25670331|NCT04499274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25670332|NCT04499274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25670333|NCT04499274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25226207|NCT02622126|Analgesics|analgesics|mesh-ancestor
25866446|NCT00104286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866447|NCT00104286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25866448|NCT00104286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24890288|NCT04484506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24890289|NCT04484506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24890290|NCT04484506|Glucocorticoids|glucocorticoids|mesh-ancestor
24890291|NCT04484506|Hormones|hormones|mesh-ancestor
24890292|NCT04484506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24890293|NCT04484506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24517100|NCT00605930|Antimetabolites|antimetabolites|mesh-ancestor
25866449|NCT00104286|Antiviral Agents|antiviral agents|mesh-ancestor
25866450|NCT00104286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25866451|NCT00104403|Dexamethasone|dexamethasone|mesh-list
25866452|NCT00104403|Dexamethasone acetate|dexamethasone acetate|mesh-list
25866453|NCT00104403|Ondansetron|ondansetron|mesh-list
25866454|NCT00104403|Casopitant|casopitant|mesh-list
25061640|NCT03469323|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
25061641|NCT03469323|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25061642|NCT03469323|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25061643|NCT03469323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25061644|NCT03469323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061645|NCT03469310|Acetaminophen|acetaminophen|mesh-list
25061646|NCT03469310|Tramadol|tramadol|mesh-list
25061647|NCT03469310|Codeine|codeine|mesh-list
24890333|NCT04484259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24890334|NCT04484259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25866455|NCT00104403|BB 1101|bb 1101|mesh-list
24890335|NCT04484259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890336|NCT04484259|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24890337|NCT04484259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24890338|NCT04484259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24890340|NCT04484259|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24890341|NCT04484259|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24890342|NCT04484259|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24890343|NCT04484259|Purinergic Agents|purinergic agents|mesh-ancestor
24890344|NCT04484259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24890345|NCT04483830|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
24890363|NCT04483596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24890364|NCT04483427|Ketorolac|ketorolac|mesh-list
24890365|NCT04483427|Nalbuphine|nalbuphine|mesh-list
24890366|NCT04483427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24890367|NCT04483427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24890368|NCT04483427|Analgesics|analgesics|mesh-ancestor
24890369|NCT04483427|Sensory System Agents|sensory system agents|mesh-ancestor
24890370|NCT04483427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24890371|NCT04483427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816827|NCT02079194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816829|NCT02079194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24816843|NCT02079220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890379|NCT04483427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24890380|NCT04483635|Vitamin D|vitamin d|mesh-list
25201605|NCT02726490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24890381|NCT04483635|Cholecalciferol|cholecalciferol|mesh-list
24890382|NCT04483635|Vitamins|vitamins|mesh-ancestor
25061648|NCT03469310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25061649|NCT03469310|Analgesics|analgesics|mesh-ancestor
25061650|NCT03469310|Sensory System Agents|sensory system agents|mesh-ancestor
24677921|NCT01359098|Autonomic Agents|autonomic agents|mesh-ancestor
24824169|NCT02122055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24824170|NCT02122055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824171|NCT02122055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24824172|NCT02122055|Anesthetics, General|anesthetics, general|mesh-ancestor
24824173|NCT02122055|Anesthetics|anesthetics|mesh-ancestor
25866456|NCT00104403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24890383|NCT04483635|Micronutrients|micronutrients|mesh-ancestor
24890384|NCT04483635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890385|NCT04483635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24890386|NCT04483635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25866457|NCT00104403|Antiemetics|antiemetics|mesh-ancestor
25866458|NCT00104403|Autonomic Agents|autonomic agents|mesh-ancestor
25866459|NCT00104403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25866460|NCT00104403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866461|NCT00104403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25866462|NCT00104403|Glucocorticoids|glucocorticoids|mesh-ancestor
25866463|NCT00104403|Hormones|hormones|mesh-ancestor
25866465|NCT00104403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25061664|NCT03469271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25061665|NCT03469271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061666|NCT03469271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25061668|NCT03469271|Micronutrients|micronutrients|mesh-ancestor
25061669|NCT03469271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25061670|NCT03469167|Epinephrine|epinephrine|mesh-list
25061671|NCT03469167|CEGP-003|cegp-003|mesh-list
25061672|NCT03469167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25061673|NCT03469167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25061674|NCT03469167|Adrenergic Agents|adrenergic agents|mesh-ancestor
24824182|NCT02122055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25061681|NCT03469167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25061682|NCT03469167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25061683|NCT03469167|Respiratory System Agents|respiratory system agents|mesh-ancestor
24678059|NCT01359657|Hormones|hormones|mesh-ancestor
25061704|NCT03469089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061705|NCT03469089|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25061706|NCT03469089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25061708|NCT03469089|Anesthetics|anesthetics|mesh-ancestor
25061709|NCT03469089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25061710|NCT03469089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25061711|NCT03469089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25061712|NCT03469089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25061713|NCT03469089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061714|NCT03469089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25061715|NCT03469089|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25061716|NCT03469089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24516928|NCT00604682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25061717|NCT03469089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25061718|NCT03469011|Imatinib Mesylate|imatinib mesylate|mesh-list
25061719|NCT03469011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25061720|NCT03469011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25061721|NCT03469011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25061722|NCT03469011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061723|NCT03468972|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25061724|NCT03468972|Immunologic Factors|immunologic factors|mesh-ancestor
25061725|NCT03468972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061727|NCT03468946|Citric Acid|citric acid|mesh-list
25061728|NCT03468946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25061729|NCT03468946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061730|NCT03468946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25061731|NCT03468946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25061732|NCT03468946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061733|NCT03468946|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25061734|NCT03468946|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25061735|NCT03468946|Purinergic Agents|purinergic agents|mesh-ancestor
25061736|NCT03468946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25061737|NCT03468946|Anticoagulants|anticoagulants|mesh-ancestor
24890481|NCT04482881|Abortifacient Agents|abortifacient agents|mesh-ancestor
25061740|NCT03468946|Sequestering Agents|sequestering agents|mesh-ancestor
25061742|NCT03468907|Telbivudine|telbivudine|mesh-list
25061743|NCT03468907|Antiviral Agents|antiviral agents|mesh-ancestor
25061744|NCT03468907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24890482|NCT04482881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24890483|NCT04482881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890484|NCT04482881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24890485|NCT04482881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24890486|NCT04482881|Oxytocics|oxytocics|mesh-ancestor
24890487|NCT04482881|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25670334|NCT04499274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25670335|NCT04484025|Ebselen|ebselen|mesh-list
25670336|NCT04484025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25670337|NCT04484025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25670338|NCT04484025|Analgesics|analgesics|mesh-ancestor
25670339|NCT04484025|Sensory System Agents|sensory system agents|mesh-ancestor
25670340|NCT04484025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25670341|NCT04484025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670342|NCT04484025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25670343|NCT04484025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25866466|NCT00104403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24840121|NCT02207699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24840122|NCT02207699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24840123|NCT02207699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24840124|NCT02207699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24840125|NCT02207699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866467|NCT00104403|Protease Inhibitors|protease inhibitors|mesh-ancestor
24890488|NCT04482881|Diuretics|diuretics|mesh-ancestor
24890489|NCT04482881|Natriuretic Agents|natriuretic agents|mesh-ancestor
24890490|NCT04482881|Vasodilator Agents|vasodilator agents|mesh-ancestor
24890491|NCT04482881|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24890492|NCT04482881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890494|NCT04482985|Antiemetics|antiemetics|mesh-ancestor
24890495|NCT04482985|Autonomic Agents|autonomic agents|mesh-ancestor
24890589|NCT04481815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24890590|NCT04481815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25201606|NCT02726490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201607|NCT02726737|Lidocaine|lidocaine|mesh-list
24890591|NCT04481815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24890592|NCT04481815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24890593|NCT04481815|Growth Substances|growth substances|mesh-ancestor
24890594|NCT04481815|Growth Inhibitors|growth inhibitors|mesh-ancestor
24890596|NCT04481841|Vitamin E|vitamin e|mesh-list
24890597|NCT04481841|Riboflavin|riboflavin|mesh-list
24890598|NCT04481841|Micronutrients|micronutrients|mesh-ancestor
24890599|NCT04481841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890600|NCT04481841|Vitamin B Complex|vitamin b complex|mesh-ancestor
24890601|NCT04481841|Antioxidants|antioxidants|mesh-ancestor
24890602|NCT04481841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890603|NCT04481841|Protective Agents|protective agents|mesh-ancestor
24890604|NCT04481841|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24890605|NCT04481841|Dermatologic Agents|dermatologic agents|mesh-ancestor
24890606|NCT04481724|Evening primrose oil|evening primrose oil|mesh-list
24890607|NCT04481724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25866468|NCT00104403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866469|NCT00104403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866470|NCT00104403|Antipruritics|antipruritics|mesh-ancestor
25866471|NCT00104403|Dermatologic Agents|dermatologic agents|mesh-ancestor
25866472|NCT00104403|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24890608|NCT04481724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24890610|NCT04481724|Sensory System Agents|sensory system agents|mesh-ancestor
24890611|NCT04481724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24890612|NCT04481724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890613|NCT04481724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24890614|NCT04481724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24890615|NCT04481724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24890616|NCT04481724|Antimetabolites|antimetabolites|mesh-ancestor
25061747|NCT03468907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25061748|NCT03468907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061749|NCT03468907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25061750|NCT03468907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25061752|NCT03468829|Antiviral Agents|antiviral agents|mesh-ancestor
25061753|NCT03468829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24824262|NCT02122536|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24890617|NCT04481724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890618|NCT04481724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24890619|NCT04481724|Dermatologic Agents|dermatologic agents|mesh-ancestor
24890620|NCT04481971|Prednisolone|prednisolone|mesh-list
24890621|NCT04481971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24890622|NCT04481971|Glucocorticoids|glucocorticoids|mesh-ancestor
24897934|NCT04420247|Hydroxychloroquine|hydroxychloroquine|mesh-list
24897936|NCT04420247|Antimalarials|antimalarials|mesh-ancestor
24897937|NCT04420247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24897938|NCT04420247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24897939|NCT04420247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24897940|NCT04420247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24897941|NCT04420247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670344|NCT04484025|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25670345|NCT04484025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25670346|NCT04484025|Antioxidants|antioxidants|mesh-ancestor
25670347|NCT04484025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670348|NCT04484025|Protective Agents|protective agents|mesh-ancestor
25670349|NCT04484025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24897942|NCT04420247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25432437|NCT00792948|Dasatinib|dasatinib|mesh-list
25670350|NCT04484025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25670351|NCT04484025|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25866473|NCT00104403|Serotonin Agents|serotonin agents|mesh-ancestor
25866474|NCT00104403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25866475|NCT00104403|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25866476|NCT00104403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25866477|NCT00104403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25866478|NCT00104403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25866479|NCT00104403|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25866480|NCT00104403|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25866481|NCT00104429|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
24534931|NCT00648297|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24857622|NCT02293148|Glycine|glycine|mesh-list
24890624|NCT04481971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24890625|NCT04481971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890626|NCT04481971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24890627|NCT04481971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24890631|NCT04481750|Edaravone|edaravone|mesh-list
24890632|NCT04481750|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24890633|NCT04481750|Antioxidants|antioxidants|mesh-ancestor
24890634|NCT04481750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890635|NCT04481750|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24890636|NCT04481750|Protective Agents|protective agents|mesh-ancestor
24890668|NCT04481282|Autonomic Agents|autonomic agents|mesh-ancestor
24890669|NCT04481282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24890670|NCT04481282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890671|NCT04481282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24890721|NCT04480775|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24890722|NCT04480775|Prednisolone phosphate|prednisolone phosphate|mesh-list
25061754|NCT03468790|Fluticasone|fluticasone|mesh-list
25061755|NCT03468790|Xhance|xhance|mesh-list
25061756|NCT03468790|Budesonide|budesonide|mesh-list
25061757|NCT03468790|Albuterol|albuterol|mesh-list
25061758|NCT03468790|Formoterol Fumarate|formoterol fumarate|mesh-list
25061759|NCT03468790|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25061760|NCT03468790|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25061761|NCT03468790|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25061762|NCT03468790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25201608|NCT02726737|Anesthetics, Local|anesthetics, local|mesh-ancestor
24824270|NCT02122536|Cholinergic Agents|cholinergic agents|mesh-ancestor
24824271|NCT02122536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24824272|NCT02122601|Hyaluronic Acid|hyaluronic acid|mesh-list
24824273|NCT02122601|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24824274|NCT02122601|Immunologic Factors|immunologic factors|mesh-ancestor
24890723|NCT04480775|Anesthetics, Local|anesthetics, local|mesh-ancestor
24890724|NCT04480775|Anesthetics|anesthetics|mesh-ancestor
24951748|NCT03901118|Paclitaxel|paclitaxel|mesh-list
24890725|NCT04480775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24897943|NCT04420247|Amebicides|amebicides|mesh-ancestor
24678288|NCT01360749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24890748|NCT04480281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890749|NCT04480281|Sensory System Agents|sensory system agents|mesh-ancestor
24890750|NCT04480281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24890751|NCT04480281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24890752|NCT04480281|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24890753|NCT04480281|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24890754|NCT04480281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24890755|NCT04480281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890756|NCT04480268|Gemcitabine|gemcitabine|mesh-list
24890757|NCT04480268|Paclitaxel|paclitaxel|mesh-list
24890758|NCT04480268|Capecitabine|capecitabine|mesh-list
24890759|NCT04480268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24890760|NCT04480268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24890761|NCT04480268|Tubulin Modulators|tubulin modulators|mesh-ancestor
24890762|NCT04480268|Antimitotic Agents|antimitotic agents|mesh-ancestor
24890763|NCT04480268|Mitosis Modulators|mitosis modulators|mesh-ancestor
24890825|NCT04479865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890826|NCT04479865|Nootropic Agents|nootropic agents|mesh-ancestor
24890827|NCT04479891|Itraconazole|itraconazole|mesh-list
25061763|NCT03468790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25670352|NCT04483973|Ebselen|ebselen|mesh-list
25670353|NCT04483973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25670354|NCT04483973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25670355|NCT04483973|Analgesics|analgesics|mesh-ancestor
25670356|NCT04483973|Sensory System Agents|sensory system agents|mesh-ancestor
25670357|NCT04483973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25061764|NCT03468790|Autonomic Agents|autonomic agents|mesh-ancestor
25061765|NCT03468790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24771203|NCT01825395|Amifampridine|amifampridine|mesh-list
24513397|NCT00581139|Midazolam|midazolam|mesh-list
24513398|NCT00581139|Anesthetics|anesthetics|mesh-ancestor
24513399|NCT00581139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24513400|NCT00581139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866482|NCT00104429|Aplaviroc|aplaviroc|mesh-list
25866483|NCT00104429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25866484|NCT00104429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24513411|NCT00581139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513413|NCT00581165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24513414|NCT00581165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24513415|NCT00581165|Analgesics|analgesics|mesh-ancestor
24513416|NCT00581165|Sensory System Agents|sensory system agents|mesh-ancestor
24513417|NCT00581165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24517482|NCT00608179|Glyburide|glyburide|mesh-list
24891099|NCT04476121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891100|NCT04476121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24891101|NCT04476121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24891102|NCT04476121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24891104|NCT04476173|Morphine|morphine|mesh-list
24891105|NCT04476173|Methoxyflurane|methoxyflurane|mesh-list
24891106|NCT04476173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24891107|NCT04476173|Narcotics|narcotics|mesh-ancestor
25061773|NCT03468790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25061774|NCT03468790|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25061775|NCT03468790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25061776|NCT03468790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25061777|NCT03468790|Adrenergic Agents|adrenergic agents|mesh-ancestor
25061778|NCT03468790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24891147|NCT04475276|Vitamin B Complex|vitamin b complex|mesh-ancestor
24891148|NCT04475276|Vitamins|vitamins|mesh-ancestor
24891149|NCT04475276|Micronutrients|micronutrients|mesh-ancestor
24891150|NCT04475614|Vitamin B Complex|vitamin b complex|mesh-list
24891151|NCT04475614|Vitamins|vitamins|mesh-ancestor
24891157|NCT04475107|Artesunate|artesunate|mesh-list
24891158|NCT04475107|Pyronaridine|pyronaridine|mesh-list
24891159|NCT04475107|Antimalarials|antimalarials|mesh-ancestor
24513461|NCT00581685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24513463|NCT00581789|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24513464|NCT00581789|Sunitinib|sunitinib|mesh-list
24513465|NCT00581789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513466|NCT00581789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24513493|NCT00582634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891259|NCT04473989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24891260|NCT04473911|Mycophenolic Acid|mycophenolic acid|mesh-list
24468542|NCT00382083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24513508|NCT00583063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24513509|NCT00583063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24513510|NCT00583063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513511|NCT00583063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24513525|NCT00583193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24891262|NCT04473911|Cyclophosphamide|cyclophosphamide|mesh-list
24891263|NCT04473911|Melphalan|melphalan|mesh-list
24891264|NCT04473911|Fludarabine|fludarabine|mesh-list
24891265|NCT04473911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24891266|NCT04473911|Immunologic Factors|immunologic factors|mesh-ancestor
24891267|NCT04473911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891268|NCT04473911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25866485|NCT00104429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25061782|NCT03468790|Sympathomimetics|sympathomimetics|mesh-ancestor
24424647|NCT00230204|Antibodies|antibodies|mesh-list
24891324|NCT04473053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891326|NCT04473053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24891328|NCT04473053|Anticoagulants|anticoagulants|mesh-ancestor
24891329|NCT04473053|Protease Inhibitors|protease inhibitors|mesh-ancestor
24468626|NCT00382421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24468627|NCT00382421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24468628|NCT00382421|Adrenergic Agents|adrenergic agents|mesh-ancestor
24468629|NCT00382421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24468630|NCT00382421|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24468631|NCT00382499|Lidocaine|lidocaine|mesh-list
24468632|NCT00382499|Anesthetics, Local|anesthetics, local|mesh-ancestor
24468633|NCT00382499|Anesthetics|anesthetics|mesh-ancestor
24468634|NCT00382499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25432438|NCT00792948|Podophyllotoxin|podophyllotoxin|mesh-list
25866486|NCT00104429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670358|NCT04483973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866487|NCT00104429|Antiviral Agents|antiviral agents|mesh-ancestor
25866488|NCT00104429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24468635|NCT00382499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891330|NCT04473053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24891331|NCT04473053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891332|NCT04473053|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24891333|NCT04473053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24891334|NCT04473053|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24891335|NCT04473053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24891336|NCT04473053|Immunologic Factors|immunologic factors|mesh-ancestor
24891468|NCT04470544|Camostat|camostat|mesh-list
24891469|NCT04470544|Protease Inhibitors|protease inhibitors|mesh-ancestor
24891470|NCT04470544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24891471|NCT04470544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891472|NCT04470544|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24891473|NCT04470544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24891474|NCT04470791|Antivenins|antivenins|mesh-list
24891500|NCT04470401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891501|NCT04470401|Cholinergic Agents|cholinergic agents|mesh-ancestor
24891502|NCT04470401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24891503|NCT04470401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061784|NCT03468777|Dexlansoprazole|dexlansoprazole|mesh-list
25061785|NCT03468777|Ranitidine|ranitidine|mesh-list
25061786|NCT03468777|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
25061787|NCT03468777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25061788|NCT03468777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25201609|NCT02726737|Anesthetics|anesthetics|mesh-ancestor
25061789|NCT03468777|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25061790|NCT03468777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24898029|NCT04419025|Acetylcysteine|acetylcysteine|mesh-list
24891548|NCT04470050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891549|NCT04470050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24891550|NCT04470050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24891590|NCT04469283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891591|NCT04469283|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24517712|NCT00609544|Rilonacept|rilonacept|mesh-list
24891712|NCT04467892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891713|NCT04467892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891727|NCT04467931|Verapamil|verapamil|mesh-list
24891728|NCT04467931|Felodipine|felodipine|mesh-list
24891729|NCT04467931|Nadolol|nadolol|mesh-list
24891730|NCT04467931|Acebutolol|acebutolol|mesh-list
24891731|NCT04467931|Amlodipine|amlodipine|mesh-list
24891732|NCT04467931|Valsartan|valsartan|mesh-list
24891733|NCT04467931|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24891761|NCT04467931|Nicardipine|nicardipine|mesh-list
24891762|NCT04467931|Quinapril|quinapril|mesh-list
24824303|NCT02122692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824304|NCT02122692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24824305|NCT02122705|Remifentanil|remifentanil|mesh-list
24824306|NCT02122705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24891807|NCT04467931|Autonomic Agents|autonomic agents|mesh-ancestor
24891808|NCT04467931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891809|NCT04467931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24891810|NCT04467931|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24891811|NCT04467931|Analgesics|analgesics|mesh-ancestor
24891812|NCT04467931|Sensory System Agents|sensory system agents|mesh-ancestor
24891813|NCT04467931|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24891814|NCT04467931|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24898096|NCT04418154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24891815|NCT04467931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24891816|NCT04467931|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24891851|NCT04467463|Anesthetics|anesthetics|mesh-ancestor
24891852|NCT04467463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25670359|NCT04483973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25670360|NCT04483973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25670361|NCT04483973|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25670362|NCT04483973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25670363|NCT04483973|Antioxidants|antioxidants|mesh-ancestor
25670364|NCT04483973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670365|NCT04483973|Protective Agents|protective agents|mesh-ancestor
25670366|NCT04483973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25670367|NCT04483973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866489|NCT00104429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24891853|NCT04467463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891888|NCT04467125|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24891889|NCT04467086|Propranolol|propranolol|mesh-list
24891890|NCT04467086|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24891891|NCT04467086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24891892|NCT04467086|Adrenergic Agents|adrenergic agents|mesh-ancestor
24891893|NCT04467086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24891894|NCT04467086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891895|NCT04467086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891896|NCT04467086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24891897|NCT04467086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24891898|NCT04467086|Vasodilator Agents|vasodilator agents|mesh-ancestor
24891899|NCT04466904|Dulaglutide|dulaglutide|mesh-list
24891900|NCT04466904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24891901|NCT04466904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891903|NCT04466917|Bevacizumab|bevacizumab|mesh-list
24891904|NCT04466917|Carboplatin|carboplatin|mesh-list
24891905|NCT04466917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24891906|NCT04466917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24891907|NCT04466917|Tubulin Modulators|tubulin modulators|mesh-ancestor
24891908|NCT04466917|Antimitotic Agents|antimitotic agents|mesh-ancestor
24891909|NCT04466917|Mitosis Modulators|mitosis modulators|mesh-ancestor
24891910|NCT04466917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714539|NCT01531192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24891911|NCT04466917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24891929|NCT04466670|Sensory System Agents|sensory system agents|mesh-ancestor
24891930|NCT04466670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891990|NCT04466176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891991|NCT04466176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892021|NCT04466241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24892022|NCT04466241|Antiviral Agents|antiviral agents|mesh-ancestor
24892023|NCT04466241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24892024|NCT04466241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24898097|NCT04418154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516999|NCT00605371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517023|NCT00605605|Dextromethorphan|dextromethorphan|mesh-list
25218500|NCT02670135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24892025|NCT04466241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24892026|NCT04466241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24892027|NCT04466241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24892028|NCT04466241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24816909|NCT02079727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24816910|NCT02079727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24816911|NCT02079727|Analgesics|analgesics|mesh-ancestor
24816912|NCT02079727|Sensory System Agents|sensory system agents|mesh-ancestor
24816913|NCT02079727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816914|NCT02079727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816915|NCT02079727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24816916|NCT02079727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24816933|NCT02080026|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24816934|NCT02080026|Atovaquone|atovaquone|mesh-list
24816935|NCT02080026|Proguanil|proguanil|mesh-list
24816936|NCT02080026|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
24816937|NCT02080026|Amebicides|amebicides|mesh-ancestor
24816938|NCT02080026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24816939|NCT02080026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24816940|NCT02080026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24892029|NCT04465968|Durvalumab|durvalumab|mesh-list
24892030|NCT04465968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24892031|NCT04465968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24892032|NCT04465968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24892033|NCT04465968|Immunologic Factors|immunologic factors|mesh-ancestor
24892034|NCT04465968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892035|NCT04466085|Vaccines|vaccines|mesh-list
25061811|NCT05390905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25061812|NCT05390905|Narcotics|narcotics|mesh-ancestor
25061813|NCT05390905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25061814|NCT05390905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061815|NCT05390905|Analgesics|analgesics|mesh-ancestor
25061816|NCT05390905|Sensory System Agents|sensory system agents|mesh-ancestor
25061817|NCT05390905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24892145|NCT04465357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892175|NCT04465396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816941|NCT02080026|Antimalarials|antimalarials|mesh-ancestor
25226320|NCT02621359|Ofloxacin|ofloxacin|mesh-list
25226321|NCT02621359|Nitazoxanide|nitazoxanide|mesh-list
25226322|NCT02621359|Omeprazole|omeprazole|mesh-list
24892177|NCT04465383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24892178|NCT04465383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24892179|NCT04465383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892180|NCT04465383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24892181|NCT04465383|Anesthetics, General|anesthetics, general|mesh-ancestor
24892182|NCT04465383|Anesthetics|anesthetics|mesh-ancestor
24892183|NCT04465071|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24892184|NCT04465071|Lubricant Eye Drops|lubricant eye drops|mesh-list
24892185|NCT04465071|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24892186|NCT04464967|Trastuzumab|trastuzumab|mesh-list
24892187|NCT04464967|Cetuximab|cetuximab|mesh-list
24892188|NCT04464967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24892189|NCT04464967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24892190|NCT04464759|Hydroxychloroquine|hydroxychloroquine|mesh-list
24892191|NCT04464759|Nivolumab|nivolumab|mesh-list
24892192|NCT04464759|Ipilimumab|ipilimumab|mesh-list
24892193|NCT04464759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24892194|NCT04464759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866490|NCT00104429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24757129|NCT01738087|Dermatologic Agents|dermatologic agents|mesh-ancestor
24892195|NCT04464759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24517953|NCT00610818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517954|NCT00610870|Atorvastatin|atorvastatin|mesh-list
24892355|NCT04463784|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24892356|NCT04463784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24892370|NCT04463966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892371|NCT04463966|Hemostatics|hemostatics|mesh-ancestor
24892405|NCT04463459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892406|NCT04463459|Protective Agents|protective agents|mesh-ancestor
24892407|NCT04463342|Methamphetamine|methamphetamine|mesh-list
24892408|NCT04463342|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24892409|NCT04463342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892410|NCT04463342|Sympathomimetics|sympathomimetics|mesh-ancestor
24892411|NCT04463342|Autonomic Agents|autonomic agents|mesh-ancestor
24892429|NCT04463264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24892430|NCT04463264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24892432|NCT04463056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24892433|NCT04463056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24892434|NCT04463056|Immunologic Factors|immunologic factors|mesh-ancestor
24892435|NCT04463056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678970|NCT01365676|Hypericin|hypericin|mesh-list
24892539|NCT04462094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892541|NCT04462003|Apixaban|apixaban|mesh-list
24892543|NCT04462003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24892544|NCT04462003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24892545|NCT04462003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892546|NCT04462003|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24892547|NCT04462003|Antithrombins|antithrombins|mesh-ancestor
24892548|NCT04462003|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24892549|NCT04462003|Protease Inhibitors|protease inhibitors|mesh-ancestor
24892550|NCT04462003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24892551|NCT04461925|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24892552|NCT04461925|Azithromycin|azithromycin|mesh-list
24892553|NCT04461925|Ceftriaxone|ceftriaxone|mesh-list
24892554|NCT04461925|Dexamethasone|dexamethasone|mesh-list
24892555|NCT04461925|Enoxaparin|enoxaparin|mesh-list
24892556|NCT04461925|Anticoagulants|anticoagulants|mesh-list
24892557|NCT04461925|Hormones|hormones|mesh-list
24892558|NCT04461925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24892559|NCT04461925|Antiemetics|antiemetics|mesh-ancestor
24892560|NCT04461925|Autonomic Agents|autonomic agents|mesh-ancestor
24446811|NCT00306046|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24446812|NCT00306046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892661|NCT04460807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24892662|NCT04460807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892663|NCT04460651|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
24892664|NCT04460651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25201610|NCT02726737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25201611|NCT02726737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892665|NCT04460651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25670368|NCT04483973|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25670369|NCT04471714|Baclofen|baclofen|mesh-list
25866491|NCT00104429|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24892678|NCT04460547|Interferons|interferons|mesh-list
24892679|NCT04460547|Interferon-beta|interferon-beta|mesh-list
24892680|NCT04460547|Interferon beta-1a|interferon beta-1a|mesh-list
24892681|NCT04460547|Hydroxychloroquine|hydroxychloroquine|mesh-list
24892682|NCT04460547|Ivermectin|ivermectin|mesh-list
24446825|NCT00306137|Protease Inhibitors|protease inhibitors|mesh-ancestor
24513574|NCT00583518|Hormones|hormones|mesh-list
24892683|NCT04460547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24892684|NCT04460547|Antiviral Agents|antiviral agents|mesh-ancestor
24892685|NCT04460547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24892686|NCT04460547|Antimalarials|antimalarials|mesh-ancestor
24892687|NCT04460547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24892688|NCT04460547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24892689|NCT04460547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24892690|NCT04460547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892691|NCT04460547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24892692|NCT04460547|Immunologic Factors|immunologic factors|mesh-ancestor
24892693|NCT04460547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892694|NCT04460547|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24892707|NCT04460521|Protective Agents|protective agents|mesh-ancestor
24892708|NCT04460521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061828|NCT05390749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061829|NCT05390749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25061830|NCT05390749|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25061831|NCT05390749|Abortifacient Agents|abortifacient agents|mesh-ancestor
24892729|NCT04460079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892730|NCT04459663|Axitinib|axitinib|mesh-list
24892731|NCT04459663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24892732|NCT04459663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24892733|NCT04459663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24892734|NCT04459663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892735|NCT04459702|Ritonavir|ritonavir|mesh-list
24892736|NCT04459702|Lopinavir|lopinavir|mesh-list
24892737|NCT04459702|Azithromycin|azithromycin|mesh-list
24892738|NCT04459702|Hydroxychloroquine|hydroxychloroquine|mesh-list
24892739|NCT04459702|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24892740|NCT04459702|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24892741|NCT04459702|Protease Inhibitors|protease inhibitors|mesh-ancestor
24892742|NCT04459702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816965|NCT02080078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816966|NCT02080078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24816967|NCT02080078|Respiratory System Agents|respiratory system agents|mesh-ancestor
24816968|NCT02080078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24892769|NCT04459078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892771|NCT04458948|Hydroxychloroquine|hydroxychloroquine|mesh-list
24892772|NCT04458948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24892773|NCT04458948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24892774|NCT04458948|Antimalarials|antimalarials|mesh-ancestor
24892775|NCT04458948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24892776|NCT04458948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24892777|NCT04458948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24892778|NCT04458948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892779|NCT04458948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24892780|NCT04459377|Ketamine|ketamine|mesh-list
25201612|NCT02726737|Sensory System Agents|sensory system agents|mesh-ancestor
25866492|NCT00104429|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24892781|NCT04459377|Esketamine|esketamine|mesh-list
24892782|NCT04459377|Analgesics|analgesics|mesh-ancestor
24892783|NCT04459377|Sensory System Agents|sensory system agents|mesh-ancestor
24892784|NCT04459377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24892785|NCT04459377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892786|NCT04459377|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24892787|NCT04459377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24892788|NCT04459377|Anesthetics, General|anesthetics, general|mesh-ancestor
24892789|NCT04459377|Anesthetics|anesthetics|mesh-ancestor
24892790|NCT04459377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24892791|NCT04459377|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24892792|NCT04459377|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24513583|NCT00583869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513584|NCT00583869|Anticonvulsants|anticonvulsants|mesh-ancestor
24513585|NCT00583869|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24513586|NCT00583869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24513587|NCT00583869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898299|NCT04415567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24513588|NCT00583869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24513589|NCT00583869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24679254|NCT01367574|Methylnaltrexone|methylnaltrexone|mesh-list
24892813|NCT04458558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892814|NCT04458558|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24892815|NCT04458558|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24892816|NCT04458558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24892817|NCT04458558|Contraceptive Agents|contraceptive agents|mesh-ancestor
24892818|NCT04458558|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24892819|NCT04458558|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24892820|NCT04458558|Hormone Antagonists|hormone antagonists|mesh-ancestor
24892821|NCT04458558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24892822|NCT04458558|Luteolytic Agents|luteolytic agents|mesh-ancestor
24892823|NCT04458558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24892824|NCT04458558|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24892826|NCT04458636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24892827|NCT04458636|Glucocorticoids|glucocorticoids|mesh-ancestor
24892841|NCT04458324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24892842|NCT04458324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892844|NCT04458285|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24892845|NCT04458285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24892846|NCT04458285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24892847|NCT04458285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24892848|NCT04458285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892849|NCT04458116|Curcumin|curcumin|mesh-list
24892850|NCT04458116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24892851|NCT04458116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24892852|NCT04458116|Analgesics|analgesics|mesh-ancestor
24892853|NCT04458116|Sensory System Agents|sensory system agents|mesh-ancestor
24892854|NCT04458116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24892855|NCT04458116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898302|NCT04415320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24892878|NCT04457765|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24892879|NCT04457765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24892883|NCT04457050|Ribavirin|ribavirin|mesh-list
24892884|NCT04457050|Sofosbuvir|sofosbuvir|mesh-list
24892885|NCT04457050|Ledipasvir|ledipasvir|mesh-list
24892886|NCT04457050|Antimetabolites|antimetabolites|mesh-ancestor
24892887|NCT04457050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061845|NCT05390736|Vitamin D|vitamin d|mesh-list
25061846|NCT05390736|Vitamins|vitamins|mesh-ancestor
24892901|NCT04457180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24892902|NCT04457180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24892903|NCT04457180|Dopamine Agents|dopamine agents|mesh-ancestor
24892904|NCT04457180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25201613|NCT02726737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25201614|NCT02726737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24892905|NCT04457180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892906|NCT04457180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24892907|NCT04457180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24892908|NCT04457180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24892909|NCT04456985|Folic Acid|folic acid|mesh-list
24892910|NCT04456985|Vitamin B 12|vitamin b 12|mesh-list
24892911|NCT04456985|Hydroxocobalamin|hydroxocobalamin|mesh-list
24513590|NCT00583869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24513591|NCT00583869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24513592|NCT00583869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24513593|NCT00583986|Albuterol|albuterol|mesh-list
24513594|NCT00583986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24513595|NCT00583986|Autonomic Agents|autonomic agents|mesh-ancestor
24892921|NCT04456829|Resveratrol|resveratrol|mesh-list
24892922|NCT04456829|Antioxidants|antioxidants|mesh-ancestor
24892923|NCT04456829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892924|NCT04456829|Protective Agents|protective agents|mesh-ancestor
24892925|NCT04456829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892926|NCT04456829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24892927|NCT04456829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24892928|NCT04456777|Vortioxetine|vortioxetine|mesh-list
24892929|NCT04456777|Antidepressive Agents|antidepressive agents|mesh-ancestor
24892930|NCT04456777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24892931|NCT04456777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24892932|NCT04456777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24892933|NCT04456777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24892934|NCT04456777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892935|NCT04456777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25866493|NCT00104442|Rivastigmine|rivastigmine|mesh-list
24892936|NCT04456777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24679418|NCT01368341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24892937|NCT04456777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24892938|NCT04456777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892939|NCT04456777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24892940|NCT04456777|Serotonin Agents|serotonin agents|mesh-ancestor
24892941|NCT04456777|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24892942|NCT04456777|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25061847|NCT05390736|Micronutrients|micronutrients|mesh-ancestor
25061848|NCT05390736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061849|NCT05390736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24892943|NCT04456777|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24892944|NCT04456777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24892945|NCT04456712|Ciprofloxacin|ciprofloxacin|mesh-list
24892946|NCT04456712|Levofloxacin|levofloxacin|mesh-list
24892948|NCT04456712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24892949|NCT04456712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24892950|NCT04456712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24892951|NCT04456712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24892952|NCT04456712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24892959|NCT04456387|Factor VIII|factor viii|mesh-list
24892960|NCT04456387|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
24892961|NCT04456387|Coagulants|coagulants|mesh-ancestor
24892962|NCT04456387|Immunologic Factors|immunologic factors|mesh-ancestor
24892963|NCT04456387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892964|NCT04455932|Liver Extracts|liver extracts|mesh-list
24892965|NCT04455932|Hematinics|hematinics|mesh-ancestor
24892966|NCT04455802|Morphine|morphine|mesh-list
24892967|NCT04455802|Buprenorphine|buprenorphine|mesh-list
24892968|NCT04455802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24892969|NCT04455802|Narcotics|narcotics|mesh-ancestor
24892970|NCT04455802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24469973|NCT00388193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25866494|NCT00104442|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25866495|NCT00104442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24892971|NCT04455802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892973|NCT04455802|Sensory System Agents|sensory system agents|mesh-ancestor
24470052|NCT00388661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24470053|NCT00388687|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
24470054|NCT00388687|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24470055|NCT00388687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893018|NCT04455594|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24893019|NCT04455594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24893020|NCT04455594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517137|NCT00606203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24898382|NCT04414956|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24893021|NCT04455594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893022|NCT04455594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25061850|NCT05390710|Paclitaxel|paclitaxel|mesh-list
25061851|NCT05390710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25061852|NCT05390710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25061853|NCT05390710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816985|NCT02080169|Analgesics|analgesics|mesh-ancestor
24816986|NCT02080169|Sensory System Agents|sensory system agents|mesh-ancestor
24816987|NCT02080169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816988|NCT02080169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24816999|NCT02080169|Anesthetics|anesthetics|mesh-ancestor
24817000|NCT02080169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24817004|NCT02080169|GABA Agents|gaba agents|mesh-ancestor
24817015|NCT02080182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817021|NCT02080234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24817023|NCT02080234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817024|NCT02080234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24817025|NCT02080234|Antiviral Agents|antiviral agents|mesh-ancestor
24817026|NCT02080234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24946189|NCT03942354|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24946190|NCT03942354|Antitubercular Agents|antitubercular agents|mesh-ancestor
24946191|NCT03942354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24946192|NCT03942354|Leprostatic Agents|leprostatic agents|mesh-ancestor
25670370|NCT04471714|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25670371|NCT04471714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670372|NCT04471714|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25670373|NCT04471714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24946193|NCT03942289|Norepinephrine|norepinephrine|mesh-list
24946194|NCT03942289|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24946195|NCT03942289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24946196|NCT03942289|Adrenergic Agents|adrenergic agents|mesh-ancestor
24824354|NCT02123056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24824355|NCT02123056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824356|NCT02123056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24824357|NCT02123056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24817027|NCT02080234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817028|NCT02080234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24817029|NCT02080234|Immunologic Factors|immunologic factors|mesh-ancestor
24817030|NCT02080234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817031|NCT02080377|Glyburide|glyburide|mesh-list
24817032|NCT02080377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24613146|NCT01017380|Sensory System Agents|sensory system agents|mesh-ancestor
24715683|NCT01538095|Trebananib|trebananib|mesh-list
24893040|NCT04455243|Acetylcysteine|acetylcysteine|mesh-list
24893041|NCT04455243|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24893042|NCT04455243|Antiviral Agents|antiviral agents|mesh-ancestor
24893043|NCT04455243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24893044|NCT04455243|Expectorants|expectorants|mesh-ancestor
24893045|NCT04455243|Respiratory System Agents|respiratory system agents|mesh-ancestor
24893046|NCT04455243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24893047|NCT04455243|Antioxidants|antioxidants|mesh-ancestor
24893048|NCT04455243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893049|NCT04455243|Protective Agents|protective agents|mesh-ancestor
24893050|NCT04455243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893051|NCT04455243|Antidotes|antidotes|mesh-ancestor
24893052|NCT04454775|Protein C|protein c|mesh-list
24893053|NCT04454775|Antithrombins|antithrombins|mesh-list
24898385|NCT04414956|Hemostatics|hemostatics|mesh-ancestor
24893054|NCT04454775|Antithrombin III|antithrombin iii|mesh-list
24893055|NCT04454775|Protein S|protein s|mesh-list
24893056|NCT04454775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24893057|NCT04454775|Protease Inhibitors|protease inhibitors|mesh-ancestor
24893061|NCT04454775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24893062|NCT04454775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24893064|NCT04454840|Anticonvulsants|anticonvulsants|mesh-ancestor
24893065|NCT04454840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24893066|NCT04454840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24893067|NCT04454840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24893068|NCT04454840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893069|NCT04454840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893090|NCT04454307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893092|NCT04454307|Sensory System Agents|sensory system agents|mesh-ancestor
24893093|NCT04454307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24893094|NCT04454151|Azithromycin|azithromycin|mesh-list
24893095|NCT04454151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24893096|NCT04454151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24893097|NCT04454281|Naloxone|naloxone|mesh-list
24893098|NCT04454281|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24893099|NCT04454281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893100|NCT04454281|Sensory System Agents|sensory system agents|mesh-ancestor
24513638|NCT00584168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24513639|NCT00584168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24513640|NCT00584168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513642|NCT00584298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24513662|NCT00584389|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24893119|NCT04453735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24893120|NCT04453735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893121|NCT04453761|Vitamin B Complex|vitamin b complex|mesh-list
24893122|NCT04453761|Vitamins|vitamins|mesh-ancestor
24893123|NCT04453761|Micronutrients|micronutrients|mesh-ancestor
24893124|NCT04453761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893125|NCT04453280|Antibodies|antibodies|mesh-list
24953129|NCT03888183|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24953130|NCT03888183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24893126|NCT04453280|Immunologic Factors|immunologic factors|mesh-ancestor
24893127|NCT04453280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893128|NCT04453423|Carboplatin|carboplatin|mesh-list
24893129|NCT04453423|Pemetrexed|pemetrexed|mesh-list
24893130|NCT04453423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24893131|NCT04453423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893132|NCT04453423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893133|NCT04453423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24893134|NCT04453423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24840341|NCT02209441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840351|NCT02209649|Telmisartan|telmisartan|mesh-list
24840352|NCT02209649|Lacidipine|lacidipine|mesh-list
24840353|NCT02209649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24840372|NCT02209740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24840373|NCT02209831|Pantoprazole|pantoprazole|mesh-list
24840374|NCT02209831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24840375|NCT02209831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24840376|NCT02209831|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24893148|NCT04453345|Glucocorticoids|glucocorticoids|mesh-ancestor
24893150|NCT04453345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24893151|NCT04453345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893152|NCT04453345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24893153|NCT04453345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513663|NCT00584389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24513671|NCT00584532|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24513672|NCT00584532|Protective Agents|protective agents|mesh-ancestor
24513673|NCT00584532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513674|NCT00584532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898449|NCT04414579|Insulin|insulin|mesh-list
24893154|NCT04453345|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24893155|NCT04453345|Abortifacient Agents|abortifacient agents|mesh-ancestor
24893156|NCT04453345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24893157|NCT04453345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24893158|NCT04453345|Antimetabolites|antimetabolites|mesh-ancestor
24893159|NCT04453345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893160|NCT04453345|Dermatologic Agents|dermatologic agents|mesh-ancestor
24893161|NCT04453345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893162|NCT04453345|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24893163|NCT04453345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24893164|NCT04453345|Immunologic Factors|immunologic factors|mesh-ancestor
24893165|NCT04453345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24894246|NCT04443049|Lenvatinib|lenvatinib|mesh-list
24893166|NCT04453345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24893167|NCT04453345|Leprostatic Agents|leprostatic agents|mesh-ancestor
24893168|NCT04453345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24893169|NCT04453345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24893170|NCT04453345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24893416|NCT04449718|Vitamin D|vitamin d|mesh-list
24893179|NCT04453436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24893204|NCT04453189|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24893205|NCT04453189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24893218|NCT04453111|Immunologic Factors|immunologic factors|mesh-ancestor
24893219|NCT04453111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893220|NCT04453111|Viscosupplements|viscosupplements|mesh-ancestor
24893221|NCT04453111|Protective Agents|protective agents|mesh-ancestor
24893222|NCT04452838|Fesoterodine|fesoterodine|mesh-list
24893223|NCT04452838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24893224|NCT04452838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24893225|NCT04452838|Cholinergic Agents|cholinergic agents|mesh-ancestor
24893226|NCT04452838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24893227|NCT04452838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513682|NCT00584532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24513684|NCT00584571|Citalopram|citalopram|mesh-list
24513685|NCT00584571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24513686|NCT00584571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24513687|NCT00584571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24513688|NCT00584571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513689|NCT00584571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24898500|NCT04414137|Daptomycin|daptomycin|mesh-list
25866496|NCT00104442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866497|NCT00104442|Cholinergic Agents|cholinergic agents|mesh-ancestor
25866498|NCT00104442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25866499|NCT00104442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670374|NCT04471714|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25670375|NCT04471714|GABA Agonists|gaba agonists|mesh-ancestor
25670376|NCT04471714|GABA Agents|gaba agents|mesh-ancestor
25670377|NCT04471714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25670378|NCT04471714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670379|NCT04454567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
25670380|NCT04454567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25670381|NCT04454567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866500|NCT00104442|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25866501|NCT00104442|Protective Agents|protective agents|mesh-ancestor
25866502|NCT00104468|Troxacitabine|troxacitabine|mesh-list
25866503|NCT00104468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24893228|NCT04452838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893229|NCT04452838|Urological Agents|urological agents|mesh-ancestor
24893230|NCT04453046|Pembrolizumab|pembrolizumab|mesh-list
24893231|NCT04453046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24893232|NCT04453046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24893234|NCT04452929|Salmon calcitonin|salmon calcitonin|mesh-list
24893235|NCT04452929|Cilostazol|cilostazol|mesh-list
24893236|NCT04452929|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
24893237|NCT04452929|Erenumab|erenumab|mesh-list
24893238|NCT04452929|Katacalcin|katacalcin|mesh-list
24893239|NCT04452929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24893240|NCT04452929|Autonomic Agents|autonomic agents|mesh-ancestor
24893241|NCT04452929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24893242|NCT04452929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893243|NCT04452929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24893244|NCT04452929|Respiratory System Agents|respiratory system agents|mesh-ancestor
24893245|NCT04452929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24893257|NCT04452929|Sensory System Agents|sensory system agents|mesh-ancestor
24893258|NCT04452929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24893259|NCT04452929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24893260|NCT04452669|Epoprostenol|epoprostenol|mesh-list
24893261|NCT04452669|Tezosentan|tezosentan|mesh-list
24893262|NCT04452669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24893263|NCT04452669|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24893264|NCT04452669|Vasodilator Agents|vasodilator agents|mesh-ancestor
24893265|NCT04452370|Etoposide|etoposide|mesh-list
24893266|NCT04452370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24953142|NCT03888144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953143|NCT03888144|Analgesics|analgesics|mesh-ancestor
24953144|NCT03888144|Sensory System Agents|sensory system agents|mesh-ancestor
24953145|NCT03888144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953146|NCT03888144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24893315|NCT04451200|Alkylating Agents|alkylating agents|mesh-ancestor
24893316|NCT04451200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893317|NCT04451200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24893318|NCT04451200|Immunologic Factors|immunologic factors|mesh-ancestor
24893329|NCT04451239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893330|NCT04451239|Antifungal Agents|antifungal agents|mesh-ancestor
24893331|NCT04451239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24893332|NCT04451239|Dermatologic Agents|dermatologic agents|mesh-ancestor
24893355|NCT04451122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24893357|NCT04451083|Protease Inhibitors|protease inhibitors|mesh-ancestor
24893358|NCT04451083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893359|NCT04451083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893360|NCT04451083|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24893361|NCT04451083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24953155|NCT03887884|Immunologic Factors|immunologic factors|mesh-ancestor
25866504|NCT00104468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24953156|NCT03887884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824374|NCT02123069|Nasal Decongestants|nasal decongestants|mesh-ancestor
24824375|NCT02123069|Respiratory System Agents|respiratory system agents|mesh-ancestor
24824376|NCT02123069|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24824377|NCT02123069|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24824378|NCT02123069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24426558|NCT00236301|Hormones|hormones|mesh-ancestor
24893377|NCT04450576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893378|NCT04450576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24893379|NCT04450576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24893380|NCT04450446|Heparin|heparin|mesh-list
24893381|NCT04450446|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24893382|NCT04450446|Tinzaparin|tinzaparin|mesh-list
24893383|NCT04450446|Dalteparin|dalteparin|mesh-list
24893384|NCT04450446|Anticoagulants|anticoagulants|mesh-ancestor
24893385|NCT04450446|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24893401|NCT04450134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893402|NCT04450134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893403|NCT04450134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24893404|NCT04450134|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24893405|NCT04450134|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24893406|NCT04450095|Ambrisentan|ambrisentan|mesh-list
24893407|NCT04450095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24893409|NCT04449952|Sodium Fluoride|sodium fluoride|mesh-list
25866505|NCT00104468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25057647|NCT03503227|Hormones|hormones|mesh-ancestor
24893410|NCT04449952|Cariostatic Agents|cariostatic agents|mesh-ancestor
24893411|NCT04449952|Protective Agents|protective agents|mesh-ancestor
24893412|NCT04449952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893413|NCT04449952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24893414|NCT04449952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24893415|NCT04449757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24893419|NCT04449718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893420|NCT04449718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24893441|NCT04449224|Analgesics|analgesics|mesh-ancestor
24893442|NCT04449224|Sensory System Agents|sensory system agents|mesh-ancestor
24953157|NCT03887884|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24953158|NCT03887884|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24953159|NCT03887884|Dopamine Agonists|dopamine agonists|mesh-ancestor
24953160|NCT03887884|Dopamine Agents|dopamine agents|mesh-ancestor
24953161|NCT03887884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24953162|NCT03887884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953163|NCT03887650|Dexamethasone|dexamethasone|mesh-list
24953164|NCT03887650|Epinephrine|epinephrine|mesh-list
24953165|NCT03887650|Bupivacaine|bupivacaine|mesh-list
25201615|NCT02726737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24824379|NCT02123069|Adrenergic Agents|adrenergic agents|mesh-ancestor
24893451|NCT04449224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893452|NCT04449224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866506|NCT00104468|Antiviral Agents|antiviral agents|mesh-ancestor
24893453|NCT04449224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24893454|NCT04449224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893455|NCT04449289|Lidocaine|lidocaine|mesh-list
24716033|NCT01539577|Hormones|hormones|mesh-ancestor
24893456|NCT04449289|Ropivacaine|ropivacaine|mesh-list
24893457|NCT04449289|Anesthetics, Local|anesthetics, local|mesh-ancestor
24893458|NCT04449289|Anesthetics|anesthetics|mesh-ancestor
24893459|NCT04449289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24893460|NCT04449289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893461|NCT04449289|Sensory System Agents|sensory system agents|mesh-ancestor
24893462|NCT04449289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24893463|NCT04449289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24893464|NCT04449289|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24893465|NCT04449289|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24893466|NCT04449289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24893467|NCT04449289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893468|NCT04449471|Naproxen|naproxen|mesh-list
24893469|NCT04449471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24893473|NCT04449471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24893474|NCT04449471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893475|NCT04449471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24893476|NCT04449471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24893477|NCT04449471|Gout Suppressants|gout suppressants|mesh-ancestor
24893478|NCT04449471|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24893479|NCT04449471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893486|NCT04449185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893487|NCT04449185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893488|NCT04449185|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24893489|NCT04449185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24893490|NCT04449380|Interferons|interferons|mesh-list
24893491|NCT04449380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24893492|NCT04449380|Antiviral Agents|antiviral agents|mesh-ancestor
24893493|NCT04449380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24613156|NCT01017393|Analgesics|analgesics|mesh-ancestor
24613157|NCT01017393|Sensory System Agents|sensory system agents|mesh-ancestor
24613158|NCT01017393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24613159|NCT01017393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613160|NCT01017393|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24893515|NCT04448587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24893517|NCT04448587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893518|NCT04448587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893519|NCT04448496|Dexamethasone|dexamethasone|mesh-list
24893520|NCT04448496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24893521|NCT04448496|Antiemetics|antiemetics|mesh-ancestor
25061865|NCT05390359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25061866|NCT05390359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061867|NCT05390359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061868|NCT05390359|Sympathomimetics|sympathomimetics|mesh-ancestor
25876601|NCT03269669|Tubulin Modulators|tubulin modulators|mesh-ancestor
25226490|NCT02620163|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
25226491|NCT02620163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25226492|NCT02620163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25226493|NCT02620163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25226494|NCT02620163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226495|NCT02620163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25226496|NCT02620163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226497|NCT02620163|Vasodilator Agents|vasodilator agents|mesh-ancestor
25226498|NCT02620163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25226499|NCT02620163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25226500|NCT02620163|Diuretics|diuretics|mesh-ancestor
25226501|NCT02620163|Natriuretic Agents|natriuretic agents|mesh-ancestor
25061869|NCT05390359|Autonomic Agents|autonomic agents|mesh-ancestor
25061870|NCT05390359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25061871|NCT05390359|Nasal Decongestants|nasal decongestants|mesh-ancestor
25061872|NCT05390359|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24893655|NCT04447092|Oxaliplatin|oxaliplatin|mesh-list
25061887|NCT05390255|Omalizumab|omalizumab|mesh-list
25061888|NCT05390255|Hormones|hormones|mesh-list
25061889|NCT05390255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25061891|NCT05390255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25061892|NCT05390255|Dermatologic Agents|dermatologic agents|mesh-ancestor
25061893|NCT05390255|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25061894|NCT05390255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25201616|NCT02726737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25866507|NCT00104468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25061895|NCT05390255|Respiratory System Agents|respiratory system agents|mesh-ancestor
25061896|NCT05390203|Testosterone|testosterone|mesh-list
25061897|NCT05390203|Androgens|androgens|mesh-ancestor
25061898|NCT05390203|Hormones|hormones|mesh-ancestor
24893529|NCT04448496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24893530|NCT04448496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24893531|NCT04448457|Sufentanil|sufentanil|mesh-list
24893532|NCT04448457|Oxycodone|oxycodone|mesh-list
24893533|NCT04448457|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24893534|NCT04448457|Narcotics|narcotics|mesh-ancestor
24893535|NCT04448457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24893536|NCT04448457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893611|NCT04447326|Endostar protein|endostar protein|mesh-list
24893612|NCT04447326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24893613|NCT04447326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24893614|NCT04447326|Growth Substances|growth substances|mesh-ancestor
24893615|NCT04447326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893616|NCT04447326|Growth Inhibitors|growth inhibitors|mesh-ancestor
24893617|NCT04447326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24893618|NCT04447274|Apatinib|apatinib|mesh-list
24893619|NCT04447274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519476|NCT01134250|Tubulin Modulators|tubulin modulators|mesh-ancestor
24513704|NCT00584610|Levonorgestrel|levonorgestrel|mesh-list
24513705|NCT00584610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24513706|NCT00584610|Contraceptive Agents|contraceptive agents|mesh-ancestor
25063401|NCT01670500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063402|NCT01670500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24898785|NCT04411030|Antifungal Agents|antifungal agents|mesh-ancestor
24898786|NCT04411030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24475786|NCT00411372|Autonomic Agents|autonomic agents|mesh-ancestor
24513707|NCT00584610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24513708|NCT00584610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513710|NCT00584610|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24893646|NCT04447560|Anesthetics|anesthetics|mesh-ancestor
24893647|NCT04447560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24893648|NCT04447560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670382|NCT04454567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670383|NCT04454567|Antiviral Agents|antiviral agents|mesh-ancestor
25670384|NCT04454567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25670385|NCT04428866|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25670386|NCT04428866|Glucagon|glucagon|mesh-list
25670387|NCT04428866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25670388|NCT04428866|Hormones|hormones|mesh-ancestor
25670389|NCT04428866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25670390|NCT04428866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670391|NCT04425239|Leucovorin|leucovorin|mesh-list
25670392|NCT04425239|Folic Acid|folic acid|mesh-list
25670393|NCT04425239|Fluorouracil|fluorouracil|mesh-list
25670394|NCT04425239|Irinotecan|irinotecan|mesh-list
25670395|NCT04425239|Panitumumab|panitumumab|mesh-list
25226531|NCT02620215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226532|NCT02620345|Dydrogesterone|dydrogesterone|mesh-list
25226533|NCT02620345|Progestins|progestins|mesh-ancestor
25226535|NCT02620345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25226537|NCT02620293|Emollients|emollients|mesh-list
24893649|NCT04447560|Sensory System Agents|sensory system agents|mesh-ancestor
24893650|NCT04447560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24893651|NCT04447092|Leucovorin|leucovorin|mesh-list
24893652|NCT04447092|Gemcitabine|gemcitabine|mesh-list
24893653|NCT04447092|Paclitaxel|paclitaxel|mesh-list
24893654|NCT04447092|Pembrolizumab|pembrolizumab|mesh-list
24893656|NCT04447092|Irinotecan|irinotecan|mesh-list
24893672|NCT04447092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24893673|NCT04447092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24893674|NCT04447092|Antidotes|antidotes|mesh-ancestor
24893685|NCT04447378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893686|NCT04447378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893687|NCT04447378|Anticoagulants|anticoagulants|mesh-ancestor
24893688|NCT04447378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24893689|NCT04447378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24893690|NCT04447625|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24893691|NCT04447625|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24893692|NCT04447625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24893693|NCT04447625|Antitubercular Agents|antitubercular agents|mesh-ancestor
25061905|NCT05390073|Mitosis Modulators|mitosis modulators|mesh-ancestor
25061906|NCT05390073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061907|NCT05390021|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25061908|NCT05390021|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25061909|NCT05390021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061910|NCT05389943|Vitamin D|vitamin d|mesh-list
25061911|NCT05389943|Ergocalciferols|ergocalciferols|mesh-list
25061912|NCT05389943|Cholecalciferol|cholecalciferol|mesh-list
25061913|NCT05389943|Vitamins|vitamins|mesh-list
25061914|NCT05389943|Micronutrients|micronutrients|mesh-ancestor
25201617|NCT02726737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25061915|NCT05389943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061916|NCT05389943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24824418|NCT02123355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24824419|NCT02123355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824422|NCT02123355|Anesthetics, General|anesthetics, general|mesh-ancestor
24893694|NCT04447105|Anesthetics|anesthetics|mesh-list
24893696|NCT04447105|Desflurane|desflurane|mesh-list
24893697|NCT04447105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24420286|NCT00215462|Vinorelbine|vinorelbine|mesh-list
24513715|NCT00584636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24513716|NCT00584636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24513717|NCT00584636|Autonomic Agents|autonomic agents|mesh-ancestor
24513718|NCT00584636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25866508|NCT00104546|Vitamin K|vitamin k|mesh-list
25866509|NCT00104546|Vitamins|vitamins|mesh-ancestor
24893698|NCT04447105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893700|NCT04447105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24893701|NCT04447105|Anesthetics, General|anesthetics, general|mesh-ancestor
24893702|NCT04447105|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24893703|NCT04446923|Propranolol|propranolol|mesh-list
24893704|NCT04446923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24893705|NCT04446923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24893707|NCT04446923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24893752|NCT04446533|Disinfectants|disinfectants|mesh-ancestor
24893753|NCT04446533|Dermatologic Agents|dermatologic agents|mesh-ancestor
24893754|NCT04446533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24893755|NCT04446533|Immunologic Factors|immunologic factors|mesh-ancestor
24893756|NCT04446533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893757|NCT04446533|Viscosupplements|viscosupplements|mesh-ancestor
24893758|NCT04446533|Protective Agents|protective agents|mesh-ancestor
24893760|NCT04446637|Ipratropium|ipratropium|mesh-list
25061917|NCT05389943|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25061918|NCT05389930|Ethanol|ethanol|mesh-list
25061919|NCT05389930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25670396|NCT04425239|Levoleucovorin|levoleucovorin|mesh-list
25670397|NCT04425239|Antimetabolites|antimetabolites|mesh-ancestor
25670398|NCT04425239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670399|NCT04425239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25670400|NCT04425239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25061920|NCT05389930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25061921|NCT05389930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24840737|NCT02212210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24840739|NCT02212210|Protective Agents|protective agents|mesh-ancestor
24840742|NCT02212223|Vitamin D|vitamin d|mesh-list
25061922|NCT05389930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893761|NCT04446637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24893762|NCT04446637|Autonomic Agents|autonomic agents|mesh-ancestor
24893763|NCT04446637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24893764|NCT04446637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893765|NCT04446637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24893766|NCT04446637|Respiratory System Agents|respiratory system agents|mesh-ancestor
24519638|NCT05331781|Morphine|morphine|mesh-list
24893798|NCT04445922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893799|NCT04445922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893800|NCT04445922|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24893801|NCT04445922|Hormone Antagonists|hormone antagonists|mesh-ancestor
24893802|NCT04445922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24893803|NCT04445922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893804|NCT04446234|Risperidone|risperidone|mesh-list
24817039|NCT02080416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817041|NCT02080416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24817061|NCT02080715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24817062|NCT02080715|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24817063|NCT02080715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817064|NCT02080715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866510|NCT00104546|Micronutrients|micronutrients|mesh-ancestor
24817066|NCT02080728|Anesthetics, Local|anesthetics, local|mesh-ancestor
24817067|NCT02080728|Anesthetics|anesthetics|mesh-ancestor
24817068|NCT02080728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24817069|NCT02080728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817070|NCT02080728|Sensory System Agents|sensory system agents|mesh-ancestor
24817071|NCT02080728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24817072|NCT02080845|Theobromine|theobromine|mesh-list
24817073|NCT02080845|Caffeine|caffeine|mesh-list
24817074|NCT02080845|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24817075|NCT02080845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898837|NCT04410094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824437|NCT02123381|Cetuximab|cetuximab|mesh-list
24817076|NCT02080845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24817077|NCT02080845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817078|NCT02080845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817079|NCT02080845|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24817080|NCT02080845|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24817081|NCT02080845|Purinergic Agents|purinergic agents|mesh-ancestor
24817082|NCT02080845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25061937|NCT05389813|Pregabalin|pregabalin|mesh-list
24893899|NCT04446091|Irinotecan|irinotecan|mesh-list
24893900|NCT04446091|Apatinib|apatinib|mesh-list
24893901|NCT04446091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
24893902|NCT04446091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24893903|NCT04446091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24893905|NCT04446091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893906|NCT04446091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24893907|NCT04446091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24893908|NCT04446091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24893909|NCT04446091|Growth Substances|growth substances|mesh-ancestor
24893910|NCT04446091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893911|NCT04446091|Growth Inhibitors|growth inhibitors|mesh-ancestor
24893912|NCT04446104|Ascorbic Acid|ascorbic acid|mesh-list
24893913|NCT04446104|Hydroxychloroquine|hydroxychloroquine|mesh-list
24893925|NCT04446104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893926|NCT04446104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24893927|NCT04446104|Antioxidants|antioxidants|mesh-ancestor
24893928|NCT04446104|Protective Agents|protective agents|mesh-ancestor
24893929|NCT04446104|Plasma Substitutes|plasma substitutes|mesh-ancestor
24893930|NCT04446104|Blood Substitutes|blood substitutes|mesh-ancestor
24893931|NCT04446104|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24893932|NCT04445935|Bivalirudin|bivalirudin|mesh-list
25670401|NCT04425239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25670402|NCT04425239|Immunologic Factors|immunologic factors|mesh-ancestor
25670403|NCT04425239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670404|NCT04425239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24893933|NCT04445935|Antithrombins|antithrombins|mesh-ancestor
25201618|NCT02726737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893934|NCT04445935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24893943|NCT04446130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24893944|NCT04446130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893946|NCT04445857|Salmon calcitonin|salmon calcitonin|mesh-list
24893947|NCT04445857|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
24893949|NCT04445857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24893950|NCT04445857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893951|NCT04445857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24893952|NCT04445857|Vasodilator Agents|vasodilator agents|mesh-ancestor
24893953|NCT04445727|Ascorbic Acid|ascorbic acid|mesh-list
24893954|NCT04445727|Vitamins|vitamins|mesh-ancestor
24894247|NCT04443049|DMP 777|dmp 777|mesh-list
24893980|NCT04445636|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24893981|NCT04445636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24893982|NCT04445636|Adrenergic Agents|adrenergic agents|mesh-ancestor
24893983|NCT04445636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24893984|NCT04445636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893985|NCT04445636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24893986|NCT04445636|Narcotics|narcotics|mesh-ancestor
24893987|NCT04445506|Dexamethasone|dexamethasone|mesh-list
24893988|NCT04445506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24893989|NCT04445506|Antiemetics|antiemetics|mesh-ancestor
24893990|NCT04445506|Autonomic Agents|autonomic agents|mesh-ancestor
24893991|NCT04445506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24893992|NCT04445506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893993|NCT04445506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24893994|NCT04445506|Glucocorticoids|glucocorticoids|mesh-ancestor
24893995|NCT04445506|Hormones|hormones|mesh-ancestor
24590325|NCT00912119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893996|NCT04445506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24893997|NCT04445506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24893998|NCT04445506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24893999|NCT04445623|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24894000|NCT04445623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24894001|NCT04445311|Ivermectin|ivermectin|mesh-list
24894002|NCT04445311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24894003|NCT04445311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24894014|NCT04444986|Favipiravir|favipiravir|mesh-list
24894015|NCT04444986|Antiviral Agents|antiviral agents|mesh-ancestor
24894016|NCT04444986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24894017|NCT04444635|Fentanyl|fentanyl|mesh-list
24894018|NCT04444635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24680604|NCT01375452|Letrozole|letrozole|mesh-list
24894055|NCT04444817|Immunologic Factors|immunologic factors|mesh-ancestor
24894056|NCT04444817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894057|NCT04444817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24894058|NCT04444817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24894059|NCT04444817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817095|NCT02080858|Purinergic Agents|purinergic agents|mesh-ancestor
24894061|NCT04444167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894062|NCT04444167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24894063|NCT04444167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24894064|NCT04444167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894065|NCT04444349|Ubiquinone|ubiquinone|mesh-list
24894066|NCT04444349|Coenzyme Q10|coenzyme q10|mesh-list
24894067|NCT04444349|Micronutrients|micronutrients|mesh-ancestor
24894068|NCT04444349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894069|NCT04444349|Vitamins|vitamins|mesh-ancestor
24894070|NCT04444284|Vaccines|vaccines|mesh-list
24894071|NCT04444284|Immunologic Factors|immunologic factors|mesh-ancestor
24894072|NCT04444284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894073|NCT04444440|Ciprofloxacin|ciprofloxacin|mesh-list
24894074|NCT04444440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24894075|NCT04444440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24894076|NCT04444440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24894077|NCT04444440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24894078|NCT04444440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24894079|NCT04444440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894080|NCT04444440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894081|NCT04444440|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24894082|NCT04444440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24894083|NCT04444193|Durvalumab|durvalumab|mesh-list
24471147|NCT00393471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25866511|NCT00104546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866512|NCT00104546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24716637|NCT01542827|Analgesics|analgesics|mesh-list
25866513|NCT00104546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24894103|NCT04443946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24894104|NCT04443946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894105|NCT04443946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24894106|NCT04443946|Anesthetics, General|anesthetics, general|mesh-ancestor
24894107|NCT04443946|Anesthetics|anesthetics|mesh-ancestor
25061952|NCT05389813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25061954|NCT05389722|Itraconazole|itraconazole|mesh-list
25061955|NCT05389722|Rifampin|rifampin|mesh-list
25061956|NCT05389722|Digoxin|digoxin|mesh-list
25061957|NCT05389722|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25061958|NCT05389722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25061959|NCT05389722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25061960|NCT05389722|Antimetabolites|antimetabolites|mesh-ancestor
24824465|NCT02123563|Listerine|listerine|mesh-list
24894108|NCT04443946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24894109|NCT04443946|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24894110|NCT04443946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24894111|NCT04443946|Narcotics|narcotics|mesh-ancestor
24894112|NCT04443946|Analgesics|analgesics|mesh-ancestor
24894113|NCT04443946|Sensory System Agents|sensory system agents|mesh-ancestor
24894114|NCT04443946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24894115|NCT04443946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24894116|NCT04443725|Hydroxychloroquine|hydroxychloroquine|mesh-list
24894117|NCT04443725|Sofosbuvir|sofosbuvir|mesh-list
24894118|NCT04443725|Antimalarials|antimalarials|mesh-ancestor
24894119|NCT04443725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24513763|NCT00584779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513765|NCT00585000|Tremelimumab|tremelimumab|mesh-list
24513766|NCT00585000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894120|NCT04443725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24894121|NCT04443725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24894122|NCT04443725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24894123|NCT04443725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894124|NCT04443725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24894125|NCT04443725|Antiviral Agents|antiviral agents|mesh-ancestor
24817126|NCT02081287|Anticonvulsants|anticonvulsants|mesh-ancestor
24817127|NCT02081287|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24817128|NCT02081287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24817129|NCT02081287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817130|NCT02081287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24817131|NCT02081287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817132|NCT02081287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24817133|NCT02081287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24520065|NCT03980769|Antiviral Agents|antiviral agents|mesh-ancestor
24817146|NCT02081339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817147|NCT02081339|Growth Inhibitors|growth inhibitors|mesh-ancestor
24817148|NCT02081339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24817149|NCT02081339|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24817150|NCT02081339|Dermatologic Agents|dermatologic agents|mesh-ancestor
24817151|NCT02081391|Tapentadol|tapentadol|mesh-list
24817152|NCT02081391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24817153|NCT02081391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24894144|NCT04443556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25061961|NCT05389722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061962|NCT05389722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24894348|NCT04442633|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24894146|NCT04443556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24894154|NCT04443634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24894155|NCT04443634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894156|NCT04443634|Sensory System Agents|sensory system agents|mesh-ancestor
24894157|NCT04443634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24513774|NCT00585091|Sympathomimetics|sympathomimetics|mesh-ancestor
24513775|NCT00585091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24513776|NCT00585091|Nasal Decongestants|nasal decongestants|mesh-ancestor
24513777|NCT00585091|Respiratory System Agents|respiratory system agents|mesh-ancestor
24894192|NCT04443387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25876602|NCT03269669|Antimitotic Agents|antimitotic agents|mesh-ancestor
24894193|NCT04443543|Fluorouracil|fluorouracil|mesh-list
24894194|NCT04443543|Capecitabine|capecitabine|mesh-list
24894195|NCT04443543|Oxaliplatin|oxaliplatin|mesh-list
24894196|NCT04443543|Irinotecan|irinotecan|mesh-list
24894197|NCT04443543|Antimetabolites|antimetabolites|mesh-ancestor
24894198|NCT04443543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894199|NCT04443543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24894200|NCT04443543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894201|NCT04443543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24894202|NCT04443543|Immunologic Factors|immunologic factors|mesh-ancestor
24894203|NCT04443543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894204|NCT04443543|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24894236|NCT04443036|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24894237|NCT04443036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24894238|NCT04443036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894239|NCT04443036|Tubulin Modulators|tubulin modulators|mesh-ancestor
24894240|NCT04443036|Antimitotic Agents|antimitotic agents|mesh-ancestor
24894241|NCT04443036|Mitosis Modulators|mitosis modulators|mesh-ancestor
24894242|NCT04443036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894243|NCT04443049|Mebendazole|mebendazole|mesh-list
24894244|NCT04443049|Piperazine|piperazine|mesh-list
24894245|NCT04443049|Piperazine citrate|piperazine citrate|mesh-list
24894300|NCT04442984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894301|NCT04442984|Antidotes|antidotes|mesh-ancestor
24894302|NCT04442984|Protective Agents|protective agents|mesh-ancestor
24894303|NCT04442984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894304|NCT04442984|Vitamin B Complex|vitamin b complex|mesh-ancestor
24894305|NCT04442984|Vitamins|vitamins|mesh-ancestor
24894306|NCT04442984|Micronutrients|micronutrients|mesh-ancestor
24894307|NCT04442984|Antimetabolites|antimetabolites|mesh-ancestor
24894308|NCT04442984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24894309|NCT04442984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24894310|NCT04442984|Immunologic Factors|immunologic factors|mesh-ancestor
24894311|NCT04442906|Fentanyl|fentanyl|mesh-list
24894312|NCT04442906|Dexmedetomidine|dexmedetomidine|mesh-list
24894313|NCT04442906|Bupivacaine|bupivacaine|mesh-list
24894314|NCT04442906|Anesthetics, Local|anesthetics, local|mesh-ancestor
24894315|NCT04442906|Anesthetics|anesthetics|mesh-ancestor
24894316|NCT04442906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24894317|NCT04442906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894318|NCT04442906|Sensory System Agents|sensory system agents|mesh-ancestor
24894319|NCT04442906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24894344|NCT04442633|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24894345|NCT04442633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24894346|NCT04442633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24894347|NCT04442633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894350|NCT04442633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24894352|NCT04442633|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24894353|NCT04442633|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24894354|NCT04441918|Antibodies|antibodies|mesh-list
25061971|NCT05389722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24894389|NCT04441112|Glucocorticoids|glucocorticoids|mesh-ancestor
24894390|NCT04441112|Hormones|hormones|mesh-ancestor
24894391|NCT04441112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24894392|NCT04441112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894393|NCT04441112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24894394|NCT04441112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894395|NCT04441112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24894396|NCT04441112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24894399|NCT04441112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24894400|NCT04441112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24894401|NCT04441112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24476068|NCT00412698|Hormones|hormones|mesh-ancestor
24894403|NCT04440917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24894404|NCT04440917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894405|NCT04440917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24894406|NCT04440917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24894407|NCT04440917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894408|NCT04441021|Penicillins|penicillins|mesh-list
24894409|NCT04441021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24894410|NCT04441021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24513780|NCT00585091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24513781|NCT00585091|Adrenergic Agents|adrenergic agents|mesh-ancestor
24513782|NCT00585091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24513783|NCT00585091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513784|NCT00585091|Protective Agents|protective agents|mesh-ancestor
24513785|NCT00585143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24513786|NCT00585143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24513787|NCT00585143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24513788|NCT00585143|Antimetabolites|antimetabolites|mesh-ancestor
24894466|NCT04440267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513789|NCT00585143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894458|NCT04440267|Mercaptopurine|mercaptopurine|mesh-list
24471518|NCT00395681|Anesthetics|anesthetics|mesh-ancestor
24513800|NCT00585156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24513801|NCT00585156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25061973|NCT05389722|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25061974|NCT05389722|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25061975|NCT05389722|Antitubercular Agents|antitubercular agents|mesh-ancestor
25061976|NCT05389722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25061977|NCT05389722|Leprostatic Agents|leprostatic agents|mesh-ancestor
25061978|NCT05389722|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25061979|NCT05389722|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25061980|NCT05389722|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25061981|NCT05389722|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25061982|NCT05389722|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25061983|NCT05389722|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25061984|NCT05389722|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25061985|NCT05389722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25061986|NCT05389722|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25061987|NCT05389722|Protective Agents|protective agents|mesh-ancestor
25061988|NCT05389514|Gemcitabine|gemcitabine|mesh-list
25061989|NCT05389514|Cyclophosphamide|cyclophosphamide|mesh-list
25061990|NCT05389514|Pembrolizumab|pembrolizumab|mesh-list
25061991|NCT05389514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24824487|NCT02123589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24824488|NCT02123589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824489|NCT02123615|Immunoglobulins|immunoglobulins|mesh-list
24824491|NCT02123615|gamma-Globulins|gamma-globulins|mesh-list
24824492|NCT02123615|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24824493|NCT02123615|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24824494|NCT02123615|Immunoglobulin G|immunoglobulin g|mesh-list
24824495|NCT02123615|Immunologic Factors|immunologic factors|mesh-ancestor
24824497|NCT02123628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24513802|NCT00585156|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24513803|NCT00585156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25062003|NCT05389514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24824509|NCT02123628|Sulfamethoxazole|sulfamethoxazole|mesh-list
24824510|NCT02123628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24824511|NCT02123628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24824512|NCT02123628|Antitubercular Agents|antitubercular agents|mesh-ancestor
24824513|NCT02123628|Antimalarials|antimalarials|mesh-ancestor
24824514|NCT02123628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24824515|NCT02123628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24824516|NCT02123628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24824517|NCT02123628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24824518|NCT02123628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824519|NCT02123628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824520|NCT02123628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866514|NCT00104546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866515|NCT00104546|Hemostatics|hemostatics|mesh-ancestor
25866516|NCT00104546|Coagulants|coagulants|mesh-ancestor
25866517|NCT00104598|Bupropion|bupropion|mesh-list
25866518|NCT00104598|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25866519|NCT00104598|Antidepressive Agents|antidepressive agents|mesh-ancestor
25866520|NCT00104598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25866521|NCT00104598|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25866522|NCT00104598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25866523|NCT00104598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25876603|NCT03269669|Mitosis Modulators|mitosis modulators|mesh-ancestor
25062008|NCT05389176|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25062009|NCT05389176|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25062010|NCT05389176|Adrenergic Agents|adrenergic agents|mesh-ancestor
25062011|NCT05389176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25062012|NCT05389176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062013|NCT05389176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062015|NCT05389150|Tramadol|tramadol|mesh-list
25062016|NCT05389150|Analgesics|analgesics|mesh-ancestor
25062017|NCT05389150|Sensory System Agents|sensory system agents|mesh-ancestor
25062018|NCT05389150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25062019|NCT05389150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062020|NCT05389150|Anticonvulsants|anticonvulsants|mesh-ancestor
25062021|NCT05389150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24946302|NCT03941340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25062022|NCT05389150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25226643|NCT02619448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25226644|NCT02619448|Tubulin Modulators|tubulin modulators|mesh-ancestor
25226645|NCT02619448|Antimitotic Agents|antimitotic agents|mesh-ancestor
25226646|NCT02619448|Mitosis Modulators|mitosis modulators|mesh-ancestor
25226647|NCT02619448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062024|NCT05389150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25062025|NCT05389150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25062026|NCT05389150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25062027|NCT05389150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25062028|NCT05389150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25062029|NCT05389150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25062030|NCT05389150|Narcotics|narcotics|mesh-ancestor
25062031|NCT05382806|Flumazenil|flumazenil|mesh-list
25062032|NCT05382806|Antidotes|antidotes|mesh-ancestor
25062033|NCT05382806|Protective Agents|protective agents|mesh-ancestor
24824524|NCT02123628|Renal Agents|renal agents|mesh-ancestor
24817174|NCT02081482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817176|NCT02081495|Doxorubicin|doxorubicin|mesh-list
24817177|NCT02081495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24817178|NCT02081495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24817179|NCT02081495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24817180|NCT02081495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24817181|NCT02081495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817182|NCT02081495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817183|NCT02081560|Colistin|colistin|mesh-list
24817184|NCT02081560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25062034|NCT05382806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062035|NCT05382806|GABA Modulators|gaba modulators|mesh-ancestor
25062036|NCT05382806|GABA Agents|gaba agents|mesh-ancestor
25062109|NCT05303805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25062110|NCT05303805|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24476101|NCT00413023|Autonomic Agents|autonomic agents|mesh-ancestor
25062111|NCT05303805|Anesthetics, General|anesthetics, general|mesh-ancestor
25062112|NCT05303805|Anesthetics|anesthetics|mesh-ancestor
25062113|NCT05303805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25062114|NCT05303805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062115|NCT05295212|Atezolizumab|atezolizumab|mesh-list
25062116|NCT05295212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25062117|NCT05286060|Pembrolizumab|pembrolizumab|mesh-list
25062118|NCT05286060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25062119|NCT05286060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24946411|NCT03939923|Rocuronium|rocuronium|mesh-list
25062120|NCT05282706|Peppermint oil|peppermint oil|mesh-list
24817185|NCT02081560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24513807|NCT00585260|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24513808|NCT00585260|Diuretics|diuretics|mesh-ancestor
24513809|NCT00585260|Natriuretic Agents|natriuretic agents|mesh-ancestor
24946486|NCT03939273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24946487|NCT03939273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946488|NCT03939273|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24946489|NCT03939273|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24946491|NCT03938740|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24946492|NCT03938740|Insulin Lispro|insulin lispro|mesh-list
24946493|NCT03938740|Insulin, Long-Acting|insulin, long-acting|mesh-list
24946494|NCT03938740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24946495|NCT03938740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946496|NCT03938883|Hyaluronic Acid|hyaluronic acid|mesh-list
24946497|NCT03938883|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24946498|NCT03938883|Immunologic Factors|immunologic factors|mesh-ancestor
24946499|NCT03938883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946500|NCT03938883|Viscosupplements|viscosupplements|mesh-ancestor
24946501|NCT03938883|Protective Agents|protective agents|mesh-ancestor
24946502|NCT03938662|Choline|choline|mesh-list
24946503|NCT03938662|Lipotropic Agents|lipotropic agents|mesh-ancestor
24946504|NCT03938662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24946505|NCT03938662|Antimetabolites|antimetabolites|mesh-ancestor
24513814|NCT00585442|Micronutrients|micronutrients|mesh-ancestor
24471557|NCT00395915|Antidepressive Agents|antidepressive agents|mesh-ancestor
24471558|NCT00395915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24817205|NCT02081885|Chitosan|chitosan|mesh-list
24817206|NCT02081885|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25670405|NCT04425239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25670406|NCT04425239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25670407|NCT04425239|Antidotes|antidotes|mesh-ancestor
25670408|NCT04425239|Protective Agents|protective agents|mesh-ancestor
25670409|NCT04425239|Vitamin B Complex|vitamin b complex|mesh-ancestor
24817207|NCT02081885|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25670410|NCT04425239|Vitamins|vitamins|mesh-ancestor
24817208|NCT02081885|Antimetabolites|antimetabolites|mesh-ancestor
24520498|NCT00630565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513816|NCT00585442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24513817|NCT00585442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24513818|NCT00585442|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24513819|NCT00585442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24894465|NCT04440267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476102|NCT00413023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25062162|NCT05236231|Tadalafil|tadalafil|mesh-list
25062163|NCT05236231|Macitentan|macitentan|mesh-list
25062164|NCT05236231|Vasodilator Agents|vasodilator agents|mesh-ancestor
25062165|NCT05236231|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25866524|NCT00104598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866525|NCT00104598|Dopamine Agents|dopamine agents|mesh-ancestor
25866526|NCT00104598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24517773|NCT00609960|Midazolam|midazolam|mesh-list
24517774|NCT00609960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24899125|NCT04406883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25062166|NCT05236231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25062167|NCT05236231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25062168|NCT05236231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894474|NCT04440267|Hormones|hormones|mesh-ancestor
24894475|NCT04440267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24894476|NCT04440267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24894477|NCT04440267|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24894478|NCT04440267|Abortifacient Agents|abortifacient agents|mesh-ancestor
24471581|NCT00396045|Immunologic Factors|immunologic factors|mesh-ancestor
24471582|NCT00396045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681335|NCT01379846|Vaccines|vaccines|mesh-list
25062169|NCT05236231|Urological Agents|urological agents|mesh-ancestor
25062170|NCT05236231|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25062171|NCT05236231|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25062172|NCT05236231|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25062173|NCT05234697|Remifentanil|remifentanil|mesh-list
25062174|NCT05234697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25062175|NCT05234697|Narcotics|narcotics|mesh-ancestor
25866527|NCT00104598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866528|NCT00104598|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25866529|NCT00104598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25866530|NCT00104598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24513823|NCT00585455|Antidepressive Agents|antidepressive agents|mesh-ancestor
24513825|NCT00585455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24513826|NCT00585455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24520559|NCT05337254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24513834|NCT00585520|Hormones|hormones|mesh-ancestor
24894493|NCT04440436|Cyclophosphamide|cyclophosphamide|mesh-list
24894494|NCT04440436|Fludarabine|fludarabine|mesh-list
24513839|NCT00585559|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24513840|NCT00585559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24513841|NCT00585559|Analgesics|analgesics|mesh-ancestor
24513842|NCT00585559|Sensory System Agents|sensory system agents|mesh-ancestor
25062177|NCT05234697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062179|NCT05234697|Sensory System Agents|sensory system agents|mesh-ancestor
25062180|NCT05234697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24824741|NCT02125227|Metformin|metformin|mesh-list
24824747|NCT02125227|Antimetabolites|antimetabolites|mesh-ancestor
24513857|NCT00585741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24513859|NCT00585754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24513860|NCT00585754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25062203|NCT05165290|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24513861|NCT00585754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24513862|NCT00585754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24513863|NCT00585754|Adrenergic Agents|adrenergic agents|mesh-ancestor
24513864|NCT00585754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24899191|NCT04405843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24899192|NCT04405921|Azithromycin|azithromycin|mesh-list
24513865|NCT00585754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513866|NCT00585754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513867|NCT00585871|Metoprolol|metoprolol|mesh-list
24513868|NCT00585871|Clonidine|clonidine|mesh-list
24513869|NCT00585871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24681500|NCT01380717|Adrenergic Agents|adrenergic agents|mesh-ancestor
24894515|NCT04440085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432439|NCT00792948|Tacrolimus|tacrolimus|mesh-list
24840945|NCT02213302|Midazolam|midazolam|mesh-list
24894517|NCT04439929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24894518|NCT04439929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24894520|NCT04439890|Pemetrexed|pemetrexed|mesh-list
24894521|NCT04439890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894522|NCT04439890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24894523|NCT04439890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894524|NCT04439890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24894525|NCT04439890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24894526|NCT04439786|Lidocaine|lidocaine|mesh-list
24894527|NCT04439786|Anesthetics, Local|anesthetics, local|mesh-ancestor
24894528|NCT04439786|Anesthetics|anesthetics|mesh-ancestor
24894529|NCT04439786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24894530|NCT04439786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894531|NCT04439786|Sensory System Agents|sensory system agents|mesh-ancestor
24894532|NCT04439786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24894533|NCT04439786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24894534|NCT04439786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24513899|NCT00586118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24513900|NCT00586118|Anesthetics, General|anesthetics, general|mesh-ancestor
24513901|NCT00586118|Anesthetics|anesthetics|mesh-ancestor
24513902|NCT00586118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24513903|NCT00586118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24513904|NCT00586131|Citric Acid|citric acid|mesh-list
24513905|NCT00586131|Sodium Citrate|sodium citrate|mesh-list
24513906|NCT00586131|Anticoagulants|anticoagulants|mesh-ancestor
24513907|NCT00586131|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24513908|NCT00586131|Chelating Agents|chelating agents|mesh-ancestor
24513909|NCT00586131|Sequestering Agents|sequestering agents|mesh-ancestor
24513910|NCT00586131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513911|NCT00586274|Fludarabine|fludarabine|mesh-list
25866531|NCT00104624|Docetaxel|docetaxel|mesh-list
25866532|NCT00104624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866533|NCT00104624|Tubulin Modulators|tubulin modulators|mesh-ancestor
25866534|NCT00104624|Antimitotic Agents|antimitotic agents|mesh-ancestor
25866535|NCT00104624|Mitosis Modulators|mitosis modulators|mesh-ancestor
24513912|NCT00586274|Alemtuzumab|alemtuzumab|mesh-list
24899193|NCT04405921|Hydroxychloroquine|hydroxychloroquine|mesh-list
24894537|NCT04439786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894539|NCT04439825|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24894540|NCT04439825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25062205|NCT05165290|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25062207|NCT05133674|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25062208|NCT05133674|Hormone Antagonists|hormone antagonists|mesh-ancestor
25062209|NCT05133674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25062210|NCT05133674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062211|NCT05133674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25062212|NCT05133674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25062213|NCT05133674|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25062214|NCT05133674|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24824772|NCT02125344|Mitosis Modulators|mitosis modulators|mesh-ancestor
24611261|NCT01008046|Antiviral Agents|antiviral agents|mesh-ancestor
24513915|NCT00586287|Phenprocoumon|phenprocoumon|mesh-list
24513916|NCT00586287|Anticoagulants|anticoagulants|mesh-ancestor
24513917|NCT00586365|Naproxen|naproxen|mesh-list
24513918|NCT00586365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25866536|NCT00104624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894564|NCT04439305|Dasatinib|dasatinib|mesh-list
24894565|NCT04439305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894566|NCT04439305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24894567|NCT04439305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24894568|NCT04439305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894569|NCT04439487|Anesthetics|anesthetics|mesh-list
24894570|NCT04439487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24894571|NCT04439487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894572|NCT04439396|Ketorolac|ketorolac|mesh-list
24894573|NCT04439396|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24894574|NCT04439396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24894575|NCT04439396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24894576|NCT04439396|Analgesics|analgesics|mesh-ancestor
24894577|NCT04439396|Sensory System Agents|sensory system agents|mesh-ancestor
24894578|NCT04439396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24894579|NCT04439396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670411|NCT04425239|Micronutrients|micronutrients|mesh-ancestor
25670412|NCT04425239|Hematinics|hematinics|mesh-ancestor
24894589|NCT04438980|Prednisolone acetate|prednisolone acetate|mesh-list
24894612|NCT04438837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24894622|NCT04438733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894628|NCT04438733|Hormone Antagonists|hormone antagonists|mesh-ancestor
25062215|NCT05133674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25062218|NCT05131867|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24946508|NCT03938662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25062219|NCT05131867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25062220|NCT05131867|Vasodilator Agents|vasodilator agents|mesh-ancestor
25062221|NCT05131867|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25062222|NCT05131867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25062223|NCT05131867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25062224|NCT05131867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062225|NCT05131867|Protective Agents|protective agents|mesh-ancestor
25062226|NCT05131867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062227|NCT05131867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24824782|NCT02125344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24681552|NCT01381185|Analgesics|analgesics|mesh-ancestor
24894645|NCT04438720|Vasodilator Agents|vasodilator agents|mesh-ancestor
24894646|NCT04438720|Tocolytic Agents|tocolytic agents|mesh-ancestor
24894647|NCT04438720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24894648|NCT04438772|Anesthetics|anesthetics|mesh-list
24894649|NCT04438772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24894650|NCT04438772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062228|NCT05131867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25062229|NCT05131867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25062230|NCT05131867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24894683|NCT05388942|Nitrous Oxide|nitrous oxide|mesh-list
24894684|NCT05388942|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24894685|NCT05388942|Anesthetics, General|anesthetics, general|mesh-ancestor
24894686|NCT05388942|Anesthetics|anesthetics|mesh-ancestor
24894687|NCT05388942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24894688|NCT05388942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894689|NCT05388942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24894690|NCT05388942|Analgesics|analgesics|mesh-ancestor
24894691|NCT05388942|Sensory System Agents|sensory system agents|mesh-ancestor
24894692|NCT05388942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24894695|NCT05388747|Cefuroxime|cefuroxime|mesh-list
24894696|NCT05388747|Cefuroxime axetil|cefuroxime axetil|mesh-list
24894697|NCT05388747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24894698|NCT05388747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24513942|NCT00586430|GABA Modulators|gaba modulators|mesh-ancestor
24513944|NCT00586430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24513945|NCT00586430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513946|NCT00586443|Bevacizumab|bevacizumab|mesh-list
24513947|NCT00586443|Panitumumab|panitumumab|mesh-list
24899274|NCT04405245|Latanoprost|latanoprost|mesh-list
25866537|NCT00104663|Quinacrine|quinacrine|mesh-list
25866538|NCT00104663|Anticestodal Agents|anticestodal agents|mesh-ancestor
25866539|NCT00104663|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25866540|NCT00104663|Anthelmintics|anthelmintics|mesh-ancestor
25866541|NCT00104663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25866542|NCT00104663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24894709|NCT05388448|Amoxicillin|amoxicillin|mesh-list
24894710|NCT05388448|Rifampin|rifampin|mesh-list
24894711|NCT05388448|Clavulanic Acids|clavulanic acids|mesh-list
24894712|NCT05388448|Clavulanic Acid|clavulanic acid|mesh-list
24894716|NCT05388448|Antitubercular Agents|antitubercular agents|mesh-ancestor
25866543|NCT00104663|Antimalarials|antimalarials|mesh-ancestor
24535786|NCT00649688|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24894724|NCT05388448|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25062235|NCT05085782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25062236|NCT05085782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062237|NCT05085782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062238|NCT05085782|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25062239|NCT05085782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25062240|NCT05085782|Vasodilator Agents|vasodilator agents|mesh-ancestor
24626069|NCT01085487|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24894725|NCT05388448|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24894726|NCT05388448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24894727|NCT05388448|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24894728|NCT05388188|Sufentanil|sufentanil|mesh-list
24894729|NCT05388188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24894730|NCT05388188|Narcotics|narcotics|mesh-ancestor
24894731|NCT05388188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24471787|NCT00396747|Hormones|hormones|mesh-ancestor
24514060|NCT00587496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25866544|NCT00104663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25866545|NCT00104663|Antinematodal Agents|antinematodal agents|mesh-ancestor
25866546|NCT00104663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866547|NCT00104663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24882597|NCT05168176|Dolutegravir|dolutegravir|mesh-list
24514061|NCT00587496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24514062|NCT00587496|Antipyretics|antipyretics|mesh-ancestor
24514063|NCT00587496|Antiviral Agents|antiviral agents|mesh-ancestor
24514064|NCT00587496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24514065|NCT00587548|Diethylenetriamine|diethylenetriamine|mesh-list
24899318|NCT04404881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899319|NCT04404881|Growth Inhibitors|growth inhibitors|mesh-ancestor
24899320|NCT04404855|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24514066|NCT00587548|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24514067|NCT00587548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514068|NCT00587665|Ketamine|ketamine|mesh-list
24514069|NCT00587665|Analgesics|analgesics|mesh-ancestor
24514070|NCT00587665|Sensory System Agents|sensory system agents|mesh-ancestor
24514071|NCT00587665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24894732|NCT05388188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894734|NCT05388188|Sensory System Agents|sensory system agents|mesh-ancestor
25218754|NCT02668094|Analgesics|analgesics|mesh-ancestor
24521062|NCT05133895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894752|NCT05387967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24894753|NCT05387967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24894754|NCT05387967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24894755|NCT05387967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894757|NCT05387954|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
24894758|NCT05387954|Antithrombins|antithrombins|mesh-ancestor
24894759|NCT05387954|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24894760|NCT05387954|Protease Inhibitors|protease inhibitors|mesh-ancestor
24894761|NCT05387954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24894762|NCT05387954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894763|NCT05387941|Dexamethasone|dexamethasone|mesh-list
24894764|NCT05387941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24894765|NCT05387941|Antiemetics|antiemetics|mesh-ancestor
24894771|NCT05387941|Hormones|hormones|mesh-ancestor
24894772|NCT05387941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24894773|NCT05387941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24471823|NCT00396799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24471824|NCT00396851|Metformin|metformin|mesh-list
24471825|NCT00396851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24471826|NCT00396851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471827|NCT00396929|Paclitaxel|paclitaxel|mesh-list
24894820|NCT05387187|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24894821|NCT05387187|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24894822|NCT05387187|Protective Agents|protective agents|mesh-ancestor
24894823|NCT05387187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894824|NCT05387187|Vasodilator Agents|vasodilator agents|mesh-ancestor
24894917|NCT05374057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25670413|NCT04425239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25670414|NCT04417166|Pembrolizumab|pembrolizumab|mesh-list
25670415|NCT04417166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25670416|NCT04417166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24535897|NCT00649948|Metformin|metformin|mesh-list
24535898|NCT00649948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24535899|NCT00649948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062253|NCT05038228|Apixaban|apixaban|mesh-list
25062254|NCT05038228|Dabigatran|dabigatran|mesh-list
25062255|NCT05038228|Vitamins|vitamins|mesh-ancestor
25062256|NCT05038228|Micronutrients|micronutrients|mesh-ancestor
25062257|NCT05038228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062258|NCT05038228|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25062260|NCT05038228|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25062261|NCT05038228|Protease Inhibitors|protease inhibitors|mesh-ancestor
25062262|NCT05038228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25062263|NCT05038228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062264|NCT05038228|Anticoagulants|anticoagulants|mesh-ancestor
25062265|NCT05038228|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25062266|NCT05038228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25062267|NCT05038228|Hemostatics|hemostatics|mesh-ancestor
25062268|NCT05038228|Coagulants|coagulants|mesh-ancestor
25062269|NCT05012787|Vaccines|vaccines|mesh-list
25062270|NCT05012787|1018 oligonucleotide|1018 oligonucleotide|mesh-list
25062271|NCT05012787|Immunologic Factors|immunologic factors|mesh-ancestor
25062272|NCT05012787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062273|NCT05012787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25062274|NCT05009901|Thioctic Acid|thioctic acid|mesh-list
25062275|NCT05009901|Antioxidants|antioxidants|mesh-ancestor
25062276|NCT05009901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062277|NCT05009901|Protective Agents|protective agents|mesh-ancestor
24894918|NCT05374057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24894919|NCT05374057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24894920|NCT05374057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894921|NCT05373446|Ritonavir|ritonavir|mesh-list
24894922|NCT05373446|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24894923|NCT05373446|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24894944|NCT05373433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25062278|NCT05009901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062279|NCT05009901|Vitamin B Complex|vitamin b complex|mesh-ancestor
25062281|NCT05009901|Micronutrients|micronutrients|mesh-ancestor
25062282|NCT04997850|Lenvatinib|lenvatinib|mesh-list
25062283|NCT04997850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25062284|NCT04997850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25062285|NCT04997850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824844|NCT02125617|Prednisolone|prednisolone|mesh-list
25866548|NCT00104663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894948|NCT05367869|Methylene Blue|methylene blue|mesh-list
24894949|NCT05367869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24894950|NCT05367869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894951|NCT05363462|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24894952|NCT05363462|Vancomycin|vancomycin|mesh-list
24894953|NCT05363462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24817211|NCT02081885|Chelating Agents|chelating agents|mesh-ancestor
24817212|NCT02081885|Sequestering Agents|sequestering agents|mesh-ancestor
24817213|NCT02081885|Hemostatics|hemostatics|mesh-ancestor
24817214|NCT02081885|Coagulants|coagulants|mesh-ancestor
24817215|NCT02082054|Chlorpheniramine|chlorpheniramine|mesh-list
24817216|NCT02082054|Atropine|atropine|mesh-list
24817217|NCT02082054|Pseudoephedrine|pseudoephedrine|mesh-list
24514081|NCT00587665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514083|NCT00587717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24514084|NCT00587717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24514085|NCT00587717|Antimetabolites|antimetabolites|mesh-ancestor
24514086|NCT00587717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514087|NCT00587717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24817227|NCT02082054|Mydriatics|mydriatics|mesh-ancestor
24817228|NCT02082054|Parasympatholytics|parasympatholytics|mesh-ancestor
24817229|NCT02082054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24817230|NCT02082054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24817231|NCT02082054|Cholinergic Agents|cholinergic agents|mesh-ancestor
24817232|NCT02082054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25866549|NCT00104689|Capecitabine|capecitabine|mesh-list
24514154|NCT00588523|Temozolomide|temozolomide|mesh-list
24514155|NCT00588523|Busulfan|busulfan|mesh-list
25670417|NCT04413344|Bromocriptine|bromocriptine|mesh-list
25670418|NCT04413344|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25670419|NCT04413344|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24514156|NCT00588523|Thiotepa|thiotepa|mesh-list
24514157|NCT00588523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24514158|NCT00588523|Alkylating Agents|alkylating agents|mesh-ancestor
25404132|NCT03682978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25670420|NCT04413344|Hormone Antagonists|hormone antagonists|mesh-ancestor
25226750|NCT02619019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25226751|NCT02619019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226752|NCT02619019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25226754|NCT02619019|Hormones|hormones|mesh-ancestor
25226755|NCT02619019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25226759|NCT02619019|Narcotics|narcotics|mesh-ancestor
24514159|NCT00588523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514160|NCT00588523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514161|NCT00588523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24514162|NCT00588523|Immunologic Factors|immunologic factors|mesh-ancestor
24514163|NCT00588523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514164|NCT00588523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24514165|NCT00588835|Dexamethasone|dexamethasone|mesh-list
24514166|NCT00588835|Ondansetron|ondansetron|mesh-list
24514167|NCT00588835|Aprepitant|aprepitant|mesh-list
24514168|NCT00588835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25062287|NCT04991324|Vitamin D|vitamin d|mesh-list
25062288|NCT04991324|Cholecalciferol|cholecalciferol|mesh-list
25062289|NCT04991324|Vitamins|vitamins|mesh-ancestor
25062290|NCT04991324|Micronutrients|micronutrients|mesh-ancestor
24824847|NCT02125617|Hormones|hormones|mesh-ancestor
24514170|NCT00588835|Autonomic Agents|autonomic agents|mesh-ancestor
24514171|NCT00588835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24514189|NCT00588835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25866550|NCT00104689|Oxaliplatin|oxaliplatin|mesh-list
24514240|NCT00589238|Antimitotic Agents|antimitotic agents|mesh-ancestor
24514241|NCT00589238|Mitosis Modulators|mitosis modulators|mesh-ancestor
24514242|NCT00589238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514243|NCT00589238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24514244|NCT00589238|Immunologic Factors|immunologic factors|mesh-ancestor
24514245|NCT00589238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514246|NCT00589238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24514247|NCT00589238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24514248|NCT00589238|Alkylating Agents|alkylating agents|mesh-ancestor
24514249|NCT00589238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25866551|NCT00104689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25866552|NCT00104689|Antimetabolites|antimetabolites|mesh-ancestor
25866553|NCT00104689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514260|NCT00589264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866554|NCT00104689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866555|NCT00104715|Docetaxel|docetaxel|mesh-list
25866556|NCT00104715|Goserelin|goserelin|mesh-list
25866557|NCT00104715|Androgen Antagonists|androgen antagonists|mesh-list
25866558|NCT00104715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866559|NCT00104715|Tubulin Modulators|tubulin modulators|mesh-ancestor
25866560|NCT00104715|Antimitotic Agents|antimitotic agents|mesh-ancestor
25866561|NCT00104715|Mitosis Modulators|mitosis modulators|mesh-ancestor
24514295|NCT00589381|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24514296|NCT00589381|Protective Agents|protective agents|mesh-ancestor
24514297|NCT00589381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514298|NCT00589394|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25062292|NCT04991324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25062293|NCT04991324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25201636|NCT02726646|Antimalarials|antimalarials|mesh-ancestor
25201637|NCT02726646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25062295|NCT04936399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25062296|NCT04936399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24428525|NCT00240656|Antioxidants|antioxidants|mesh-ancestor
24514307|NCT00589732|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24514308|NCT00589732|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24514309|NCT00589732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514310|NCT00589862|Clopidogrel|clopidogrel|mesh-list
24514311|NCT00589862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24817247|NCT02082067|Anesthetics|anesthetics|mesh-list
24817248|NCT02082067|Ropivacaine|ropivacaine|mesh-list
25670421|NCT04413344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25670422|NCT04413344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670423|NCT04413344|Dopamine Agonists|dopamine agonists|mesh-ancestor
25670424|NCT04413344|Dopamine Agents|dopamine agents|mesh-ancestor
25670425|NCT04413344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25670426|NCT04413344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670427|NCT04386057|Hydroxychloroquine|hydroxychloroquine|mesh-list
25670428|NCT04386057|Antimalarials|antimalarials|mesh-ancestor
25226771|NCT02619032|Sensory System Agents|sensory system agents|mesh-ancestor
25226772|NCT02619032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25226773|NCT02619032|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25226774|NCT02619032|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25226775|NCT02619032|Anesthetics, General|anesthetics, general|mesh-ancestor
25226776|NCT02619032|Anesthetics|anesthetics|mesh-ancestor
24817249|NCT02082067|Levobupivacaine|levobupivacaine|mesh-list
24817250|NCT02082067|Anesthetics, Local|anesthetics, local|mesh-list
24514327|NCT00589901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894978|NCT05301634|Bupivacaine|bupivacaine|mesh-list
24894979|NCT05301634|Anesthetics, Local|anesthetics, local|mesh-ancestor
24894980|NCT05301634|Anesthetics|anesthetics|mesh-ancestor
24894981|NCT05301634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24894982|NCT05301634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894983|NCT05301634|Sensory System Agents|sensory system agents|mesh-ancestor
24895006|NCT05231382|Immunologic Factors|immunologic factors|mesh-ancestor
24895007|NCT05231382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895008|NCT05231382|Antidotes|antidotes|mesh-ancestor
24895009|NCT05231382|Protective Agents|protective agents|mesh-ancestor
24895010|NCT05231382|Vitamin B Complex|vitamin b complex|mesh-ancestor
24895011|NCT05231382|Vitamins|vitamins|mesh-ancestor
24895012|NCT05231382|Micronutrients|micronutrients|mesh-ancestor
24895013|NCT05231382|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24895014|NCT05231382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24895021|NCT05214599|Budesonide|budesonide|mesh-list
24895022|NCT05214599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24895023|NCT05214599|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24895024|NCT05214599|Autonomic Agents|autonomic agents|mesh-ancestor
24514355|NCT00590070|Analgesics|analgesics|mesh-ancestor
24514356|NCT00590070|Sensory System Agents|sensory system agents|mesh-ancestor
24514357|NCT00590070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24514358|NCT00590070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514359|NCT00590070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24514360|NCT00590070|Vasodilator Agents|vasodilator agents|mesh-ancestor
24514361|NCT00590070|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24514362|NCT00590070|Purinergic Agonists|purinergic agonists|mesh-ancestor
24514363|NCT00590070|Purinergic Agents|purinergic agents|mesh-ancestor
24514364|NCT00590070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24895037|NCT05191875|Doxycycline|doxycycline|mesh-list
24895038|NCT05191875|Furazolidone|furazolidone|mesh-list
24895039|NCT05191875|Bismuth|bismuth|mesh-list
24895040|NCT05191875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24899429|NCT04403568|Curcumin|curcumin|mesh-list
24895041|NCT05191875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24895042|NCT05191875|Antimalarials|antimalarials|mesh-ancestor
24895043|NCT05191875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24895044|NCT05191875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24895045|NCT05191875|Antacids|antacids|mesh-ancestor
24895046|NCT05191875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514372|NCT00590122|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24514373|NCT00590122|Dopamine Agents|dopamine agents|mesh-ancestor
24514374|NCT00590122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24514375|NCT00590122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514400|NCT00590174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24514403|NCT00590174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24514404|NCT00590213|Bicalutamide|bicalutamide|mesh-list
24514405|NCT00590213|Androgen Antagonists|androgen antagonists|mesh-ancestor
24514406|NCT00590213|Hormone Antagonists|hormone antagonists|mesh-ancestor
25866562|NCT00104715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514407|NCT00590213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24514408|NCT00590213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514409|NCT00590213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514410|NCT00590278|Raltitrexed|raltitrexed|mesh-list
24514411|NCT00590278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24514412|NCT00590278|Antimetabolites|antimetabolites|mesh-ancestor
24514413|NCT00590278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514414|NCT00590278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514415|NCT00590278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24514416|NCT00590278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24514417|NCT00590343|Vatalanib|vatalanib|mesh-list
25670429|NCT04386057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25670430|NCT04386057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25670431|NCT04386057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25670432|NCT04386057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25670433|NCT04386057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670434|NCT04386057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24514422|NCT00590408|Coenzyme Q10|coenzyme q10|mesh-list
24514423|NCT00590408|Micronutrients|micronutrients|mesh-ancestor
24514424|NCT00590408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514425|NCT00590408|Vitamins|vitamins|mesh-ancestor
24514426|NCT00590447|Rituximab|rituximab|mesh-list
25062317|NCT04928183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062319|NCT04928183|Antimetabolites|antimetabolites|mesh-ancestor
25062320|NCT04928183|Gasotransmitters|gasotransmitters|mesh-ancestor
25062321|NCT04928183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25062322|NCT04928183|Vasodilator Agents|vasodilator agents|mesh-ancestor
25062323|NCT04928183|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25062325|NCT04923659|Carbamazepine|carbamazepine|mesh-list
25062326|NCT04923659|Lorazepam|lorazepam|mesh-list
25062327|NCT04923659|Dextromethorphan|dextromethorphan|mesh-list
24518326|NCT05291403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24518327|NCT05291403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24817821|NCT02085655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24817822|NCT02085655|Dermatologic Agents|dermatologic agents|mesh-ancestor
25062328|NCT04923659|Antitussive Agents|antitussive agents|mesh-ancestor
25062329|NCT04923659|Respiratory System Agents|respiratory system agents|mesh-ancestor
24854781|NCT02275299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24514447|NCT00590629|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24514448|NCT00590629|Vasodilator Agents|vasodilator agents|mesh-ancestor
24514449|NCT00590629|Vitamin B Complex|vitamin b complex|mesh-ancestor
24514450|NCT00590629|Vitamins|vitamins|mesh-ancestor
24514451|NCT00590629|Micronutrients|micronutrients|mesh-ancestor
24514452|NCT00590629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514454|NCT00590694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24514455|NCT00590694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24514456|NCT00590694|Growth Substances|growth substances|mesh-ancestor
24514457|NCT00590694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062334|NCT04923659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062335|NCT04923659|Anticonvulsants|anticonvulsants|mesh-ancestor
25062336|NCT04923659|Antiemetics|antiemetics|mesh-ancestor
25062337|NCT04923659|Autonomic Agents|autonomic agents|mesh-ancestor
25062338|NCT04923659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24824888|NCT02125890|Hemostatics|hemostatics|mesh-ancestor
24514458|NCT00590694|Growth Inhibitors|growth inhibitors|mesh-ancestor
25866563|NCT00104715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25866564|NCT00104715|Hormone Antagonists|hormone antagonists|mesh-ancestor
25866565|NCT00104715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25866566|NCT00104715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866567|NCT00104741|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25866568|NCT00104741|Flutamide|flutamide|mesh-list
25866569|NCT00104741|Luteolytic Agents|luteolytic agents|mesh-ancestor
25866570|NCT00104741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25866571|NCT00104741|Contraceptive Agents|contraceptive agents|mesh-ancestor
25866572|NCT00104741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25866573|NCT00104741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866574|NCT00104741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25866575|NCT00104741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25866576|NCT00104741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24895085|NCT05069298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895086|NCT05053659|Venetoclax|venetoclax|mesh-list
24895087|NCT05053659|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
24895088|NCT05053659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24895089|NCT05053659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24895090|NCT05029960|Brivaracetam|brivaracetam|mesh-list
24812644|NCT02053922|Oxytocin|oxytocin|mesh-list
25866577|NCT00104741|Androgen Antagonists|androgen antagonists|mesh-ancestor
25201638|NCT02726646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25201639|NCT02726308|Dexamethasone|dexamethasone|mesh-list
25201640|NCT02726308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25866578|NCT00104741|Hormone Antagonists|hormone antagonists|mesh-ancestor
25866579|NCT00104741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25866580|NCT00104767|Celecoxib|celecoxib|mesh-list
25866581|NCT00104767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25866582|NCT00104767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25866583|NCT00104767|Analgesics|analgesics|mesh-ancestor
25866584|NCT00104767|Sensory System Agents|sensory system agents|mesh-ancestor
25866585|NCT00104767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25866586|NCT00104767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866587|NCT00104767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24824893|NCT02125903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24824894|NCT02125903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866588|NCT00104767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25866589|NCT00104767|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25866590|NCT00104767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25866591|NCT00104767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866592|NCT00104767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866594|NCT00104780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25866595|NCT00104780|Immunologic Factors|immunologic factors|mesh-ancestor
25866596|NCT00104780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514505|NCT00590928|Histamine Agents|histamine agents|mesh-ancestor
24514506|NCT00590928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24514507|NCT00590928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514509|NCT00591162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24895120|NCT05014919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24895121|NCT04973150|Anesthetics|anesthetics|mesh-list
24895122|NCT04973150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24895123|NCT04973150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895124|NCT04955470|Midazolam|midazolam|mesh-list
24895125|NCT04955470|Ketamine|ketamine|mesh-list
24895126|NCT04955470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24895138|NCT04955470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24514511|NCT00591162|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24514512|NCT00591162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24514513|NCT00591162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514515|NCT00591188|Interferon-alpha|interferon-alpha|mesh-list
24514516|NCT00591188|Capecitabine|capecitabine|mesh-list
24514517|NCT00591188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24514518|NCT00591188|Antimetabolites|antimetabolites|mesh-ancestor
24514519|NCT00591188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514520|NCT00591188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514521|NCT00591188|Antiviral Agents|antiviral agents|mesh-ancestor
24514522|NCT00591188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24514523|NCT00591188|Immunologic Factors|immunologic factors|mesh-ancestor
25866597|NCT00104793|Carboplatin|carboplatin|mesh-list
25866598|NCT00104793|Irinotecan|irinotecan|mesh-list
24514534|NCT00591383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24514535|NCT00591383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201641|NCT02726308|Antiemetics|antiemetics|mesh-ancestor
25201642|NCT02726308|Autonomic Agents|autonomic agents|mesh-ancestor
25201643|NCT02726308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25201644|NCT02726308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514536|NCT00591383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514538|NCT00591487|Anesthetics, Local|anesthetics, local|mesh-ancestor
25062352|NCT04923659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25062353|NCT04923659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25062354|NCT04923659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25062355|NCT04923659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25062356|NCT04923659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25062357|NCT04923659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25062358|NCT04923659|Vasodilator Agents|vasodilator agents|mesh-ancestor
25062363|NCT04893798|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25062364|NCT04893798|Medroxyprogesterone|medroxyprogesterone|mesh-list
25062365|NCT04893798|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24824903|NCT02125968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514603|NCT00591708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514605|NCT00591916|Hyaluronic Acid|hyaluronic acid|mesh-list
24514606|NCT00591916|Hemostatics|hemostatics|mesh-ancestor
24514607|NCT00591916|Coagulants|coagulants|mesh-ancestor
24514608|NCT00591916|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24514609|NCT00591916|Immunologic Factors|immunologic factors|mesh-ancestor
24514610|NCT00591916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514611|NCT00591916|Viscosupplements|viscosupplements|mesh-ancestor
24514612|NCT00591916|Protective Agents|protective agents|mesh-ancestor
24514613|NCT00591994|Piribedil|piribedil|mesh-list
24514614|NCT00591994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24514615|NCT00591994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24514616|NCT00591994|Dopamine Agonists|dopamine agonists|mesh-ancestor
24514617|NCT00591994|Dopamine Agents|dopamine agents|mesh-ancestor
24514625|NCT00592111|Doxorubicin|doxorubicin|mesh-list
24514626|NCT00592111|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24514627|NCT00592111|Bleomycin|bleomycin|mesh-list
24826031|NCT02131948|Insulin|insulin|mesh-list
24514628|NCT00592111|Vinblastine|vinblastine|mesh-list
24514629|NCT00592111|Procarbazine|procarbazine|mesh-list
24514630|NCT00592111|Mitogens|mitogens|mesh-list
24514631|NCT00592111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24514632|NCT00592111|Immunologic Factors|immunologic factors|mesh-ancestor
24514633|NCT00592111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514634|NCT00592111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24514635|NCT00592111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24895192|NCT04879550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25062366|NCT04893798|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25062367|NCT04893798|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25062368|NCT04893798|Contraceptive Agents|contraceptive agents|mesh-ancestor
25062369|NCT04893798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25062370|NCT04893798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062371|NCT04893798|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25062372|NCT04893798|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25062373|NCT04893798|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24895193|NCT04879550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895194|NCT04879550|Anticoagulants|anticoagulants|mesh-ancestor
24895226|NCT04729387|Tubulin Modulators|tubulin modulators|mesh-ancestor
24895227|NCT04729387|Antimitotic Agents|antimitotic agents|mesh-ancestor
24895228|NCT04729387|Mitosis Modulators|mitosis modulators|mesh-ancestor
24895229|NCT04729387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895230|NCT04729387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24895231|NCT04729387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24895232|NCT04729387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24895233|NCT04729387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24895234|NCT04729387|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24895235|NCT04699591|Domperidone|domperidone|mesh-list
24895236|NCT04699591|Antiemetics|antiemetics|mesh-ancestor
24895237|NCT04699591|Autonomic Agents|autonomic agents|mesh-ancestor
24895238|NCT04699591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24895239|NCT04699591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895240|NCT04699591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24895241|NCT04699591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24514647|NCT00592111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24514648|NCT00592111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24514649|NCT00592111|Tubulin Modulators|tubulin modulators|mesh-ancestor
24514650|NCT00592111|Antimitotic Agents|antimitotic agents|mesh-ancestor
24514651|NCT00592111|Mitosis Modulators|mitosis modulators|mesh-ancestor
24514652|NCT00592111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25866599|NCT00104793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514653|NCT00592137|Calcium, Dietary|calcium, dietary|mesh-list
25062374|NCT04893798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25062375|NCT04893798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697427|NCT01434849|Timolol|timolol|mesh-list
24514654|NCT00592137|Calcium|calcium|mesh-list
24514655|NCT00592137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24514656|NCT00592137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514657|NCT00592137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24895251|NCT04650074|Sensory System Agents|sensory system agents|mesh-ancestor
24895252|NCT04650074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24895253|NCT04650074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24895254|NCT04650074|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24682495|NCT01386593|Ciprofloxacin|ciprofloxacin|mesh-list
24895266|NCT04647721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895267|NCT04647721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24895268|NCT04647721|Immunologic Factors|immunologic factors|mesh-ancestor
24514743|NCT00592618|Expectorants|expectorants|mesh-ancestor
24514744|NCT00592618|Respiratory System Agents|respiratory system agents|mesh-ancestor
24514745|NCT00592618|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24514746|NCT00592618|Antioxidants|antioxidants|mesh-ancestor
24514747|NCT00592618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895271|NCT04604366|Alprostadil|alprostadil|mesh-list
24895272|NCT04604366|Misoprostol|misoprostol|mesh-list
24895273|NCT04604366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24895274|NCT04604366|Abortifacient Agents|abortifacient agents|mesh-ancestor
24895275|NCT04604366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24895276|NCT04604366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895277|NCT04604366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24895278|NCT04604366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24895279|NCT04604366|Oxytocics|oxytocics|mesh-ancestor
24895280|NCT04604366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24895281|NCT04604366|Vasodilator Agents|vasodilator agents|mesh-ancestor
24895282|NCT04604366|Urological Agents|urological agents|mesh-ancestor
24895283|NCT04594213|Botulinum Toxins|botulinum toxins|mesh-list
24895284|NCT04594213|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24895285|NCT04594213|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24895287|NCT04594213|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24895288|NCT04594213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24895289|NCT04594213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895290|NCT04594213|Cholinergic Agents|cholinergic agents|mesh-ancestor
24895291|NCT04594213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24895292|NCT04594213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895293|NCT04594213|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24895294|NCT04594213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24895297|NCT04585711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24895298|NCT04585711|Analgesics|analgesics|mesh-ancestor
24895299|NCT04585711|Sensory System Agents|sensory system agents|mesh-ancestor
24895300|NCT04585711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24895301|NCT04585711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895302|NCT04585711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24895303|NCT04585711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24895304|NCT04585711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24472288|NCT00398749|Epoetin Alfa|epoetin alfa|mesh-list
24514748|NCT00592618|Protective Agents|protective agents|mesh-ancestor
24514749|NCT00592618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895305|NCT04585711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25062378|NCT04862650|Paclitaxel|paclitaxel|mesh-list
25062379|NCT04862650|Carboplatin|carboplatin|mesh-list
25062380|NCT04862650|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24895329|NCT04537715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24895330|NCT04537715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895331|NCT04537715|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24895332|NCT04537715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24895333|NCT04537715|Antitubercular Agents|antitubercular agents|mesh-ancestor
24895334|NCT04537715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24895335|NCT04537715|Leprostatic Agents|leprostatic agents|mesh-ancestor
24472334|NCT00398892|Vitamins|vitamins|mesh-ancestor
24514750|NCT00592618|Antidotes|antidotes|mesh-ancestor
24514752|NCT00592670|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24514753|NCT00592670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24590326|NCT00912119|Hemostatics|hemostatics|mesh-ancestor
24514754|NCT00592670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25866600|NCT00104793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24895336|NCT04537715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24895337|NCT04537715|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24895338|NCT04537715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24895339|NCT04537715|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24895340|NCT04537715|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24895341|NCT04537715|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24895342|NCT04537715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24895343|NCT04523493|Lenvatinib|lenvatinib|mesh-list
24895344|NCT04523493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24895345|NCT04523493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24895346|NCT04523493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24895347|NCT04523493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895348|NCT04478734|Thiamine|thiamine|mesh-list
24895350|NCT04478734|Vitamin B Complex|vitamin b complex|mesh-ancestor
24895351|NCT04478734|Vitamins|vitamins|mesh-ancestor
24895352|NCT04478734|Micronutrients|micronutrients|mesh-ancestor
24895353|NCT04478734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895354|NCT04460781|Vaccines|vaccines|mesh-list
24895355|NCT04460781|Immunologic Factors|immunologic factors|mesh-ancestor
24895356|NCT04460781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895357|NCT04456517|Ranolazine|ranolazine|mesh-list
24895358|NCT04456517|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24895359|NCT04456517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24895360|NCT04456517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895361|NCT04447755|Lenvatinib|lenvatinib|mesh-list
24895362|NCT04447755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24895363|NCT04447755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25062388|NCT04862650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25062389|NCT04838301|Pregnanolone|pregnanolone|mesh-list
24899561|NCT04402671|Glutaral|glutaral|mesh-list
24514837|NCT00593099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476467|NCT00415103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476468|NCT00415103|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24476469|NCT00415103|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24476470|NCT00415103|Serotonin Agents|serotonin agents|mesh-ancestor
24824923|NCT02126267|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24824924|NCT02126267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24514762|NCT00592670|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24514763|NCT00592670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24514764|NCT00592670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24514765|NCT00592917|Cholecalciferol|cholecalciferol|mesh-list
24514768|NCT00592917|Calcium|calcium|mesh-list
24514769|NCT00592917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24514770|NCT00592917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514771|NCT00592917|Vitamins|vitamins|mesh-ancestor
24514772|NCT00592917|Micronutrients|micronutrients|mesh-ancestor
24718012|NCT01551485|Zolpidem|zolpidem|mesh-list
24817287|NCT02082405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817288|NCT02082405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24817289|NCT02082405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24613435|NCT01019083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24613436|NCT01019083|Anticestodal Agents|anticestodal agents|mesh-ancestor
24613437|NCT01019083|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24613438|NCT01019083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24613439|NCT01019083|Tubulin Modulators|tubulin modulators|mesh-ancestor
24613440|NCT01019083|Antimitotic Agents|antimitotic agents|mesh-ancestor
24613441|NCT01019083|Mitosis Modulators|mitosis modulators|mesh-ancestor
24613442|NCT01019083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613443|NCT01019083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613444|NCT01019083|Astringents|astringents|mesh-ancestor
24613445|NCT01019083|Dermatologic Agents|dermatologic agents|mesh-ancestor
24613447|NCT01019109|Trace Elements|trace elements|mesh-ancestor
24613448|NCT01019109|Micronutrients|micronutrients|mesh-ancestor
24613449|NCT01019109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613450|NCT01019174|Cyclophosphamide|cyclophosphamide|mesh-list
24613451|NCT01019174|Lenalidomide|lenalidomide|mesh-list
24613452|NCT01019174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24613453|NCT01019174|Immunologic Factors|immunologic factors|mesh-ancestor
24613454|NCT01019174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613455|NCT01019174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24514773|NCT00592917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24514774|NCT00592917|Antacids|antacids|mesh-ancestor
24514775|NCT00592917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514776|NCT00592917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24514777|NCT00592930|Olanzapine|olanzapine|mesh-list
24514778|NCT00592930|Antiemetics|antiemetics|mesh-ancestor
24514779|NCT00592930|Autonomic Agents|autonomic agents|mesh-ancestor
24514780|NCT00592930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24514781|NCT00592930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514782|NCT00592930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24514783|NCT00592930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24514784|NCT00592930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24514793|NCT00592969|Metformin|metformin|mesh-list
24514794|NCT00592969|Insulin Aspart|insulin aspart|mesh-list
24623602|NCT01072695|Antiviral Agents|antiviral agents|mesh-ancestor
24623603|NCT01072695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24514821|NCT00593060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24514822|NCT00593060|Immunologic Factors|immunologic factors|mesh-ancestor
24514823|NCT00593060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514825|NCT00593099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24514826|NCT00593099|Antidepressive Agents|antidepressive agents|mesh-ancestor
24514827|NCT00593099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24514828|NCT00593099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24514829|NCT00593099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24514830|NCT00593099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24514831|NCT00593099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514832|NCT00593099|Dopamine Agents|dopamine agents|mesh-ancestor
24514833|NCT00593099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24514834|NCT00593099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514835|NCT00593099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24514836|NCT00593099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24514844|NCT00593138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514845|NCT00593138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24514846|NCT00593138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24514847|NCT00593138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24514848|NCT00593138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201645|NCT02726308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25201646|NCT02726308|Glucocorticoids|glucocorticoids|mesh-ancestor
24514850|NCT00593138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25201647|NCT02726308|Hormones|hormones|mesh-ancestor
24472432|NCT00399152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24472433|NCT00399152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623604|NCT01072734|Vaccines|vaccines|mesh-list
24518407|NCT05069935|Antibodies|antibodies|mesh-list
24623605|NCT01072734|Immunologic Factors|immunologic factors|mesh-ancestor
24514870|NCT00593164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24514871|NCT00593164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514872|NCT00593164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24514873|NCT00593164|Tocolytic Agents|tocolytic agents|mesh-ancestor
24514874|NCT00593164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24514875|NCT00593177|Parathyroid Hormone|parathyroid hormone|mesh-list
24514876|NCT00593177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24514877|NCT00593177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514879|NCT00593255|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25062392|NCT04838301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062393|NCT04807972|Folfirinox|folfirinox|mesh-list
24946786|NCT03935347|Pembrolizumab|pembrolizumab|mesh-list
24946787|NCT03935347|Fludarabine|fludarabine|mesh-list
24946788|NCT03935347|Fludarabine phosphate|fludarabine phosphate|mesh-list
24946789|NCT03935347|Interleukin-2|interleukin-2|mesh-list
24946790|NCT03935347|Immunoglobulins|immunoglobulins|mesh-list
24514880|NCT00593255|Insulin Aspart|insulin aspart|mesh-list
24514881|NCT00593255|Isophane Insulin, Human|isophane insulin, human|mesh-list
24514882|NCT00593255|Insulin, Isophane|insulin, isophane|mesh-list
24514883|NCT00593255|Isophane insulin, beef|isophane insulin, beef|mesh-list
24514884|NCT00593255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24514885|NCT00593255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514886|NCT00593294|Drospirenone|drospirenone|mesh-list
24514887|NCT00593294|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24514888|NCT00593294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514889|NCT00593294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24514890|NCT00593294|Hormone Antagonists|hormone antagonists|mesh-ancestor
24514895|NCT00593294|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24514896|NCT00593294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24514897|NCT00593294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24514898|NCT00593294|Contraceptive Agents|contraceptive agents|mesh-ancestor
24514899|NCT00593294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24590327|NCT00912119|Coagulants|coagulants|mesh-ancestor
24514900|NCT00593294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24514901|NCT00593294|Estrogens|estrogens|mesh-ancestor
24514902|NCT00593294|Hormones|hormones|mesh-ancestor
24514903|NCT00593463|Cycloserine|cycloserine|mesh-list
24895407|NCT04278053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895414|NCT04132661|Bisacodyl|bisacodyl|mesh-list
24817318|NCT02082652|Contraceptive Agents|contraceptive agents|mesh-ancestor
24615148|NCT01028170|Furosemide|furosemide|mesh-list
24895415|NCT04132661|Cathartics|cathartics|mesh-ancestor
24895416|NCT04132661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24895417|NCT04132661|Laxatives|laxatives|mesh-ancestor
24895419|NCT04129788|Cathartics|cathartics|mesh-ancestor
24895420|NCT04129788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24895421|NCT04129788|Laxatives|laxatives|mesh-ancestor
24895422|NCT04125927|Cysteamine|cysteamine|mesh-list
24895423|NCT04125927|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
24522599|NCT03628066|Hormone Antagonists|hormone antagonists|mesh-ancestor
24895430|NCT04119180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895431|NCT04119180|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24895432|NCT04119180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24895433|NCT04119180|Anesthetics, General|anesthetics, general|mesh-ancestor
24724947|NCT01595789|Hormones|hormones|mesh-ancestor
24895434|NCT04119180|Anesthetics|anesthetics|mesh-ancestor
24946791|NCT03935347|Immunoglobulin G|immunoglobulin g|mesh-list
24946792|NCT03935347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24946793|NCT03935347|Immunologic Factors|immunologic factors|mesh-ancestor
24946794|NCT03935347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946795|NCT03935347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24824941|NCT02126332|Sensory System Agents|sensory system agents|mesh-ancestor
24895435|NCT04119180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24895436|NCT04119180|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24895437|NCT04119180|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24895438|NCT04119180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24895439|NCT04119180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536506|NCT00651547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25226889|NCT02618057|Renal Agents|renal agents|mesh-ancestor
24895440|NCT04119180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24895441|NCT04119180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24895442|NCT04119180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24472478|NCT00399282|Vitamin E|vitamin e|mesh-list
25866601|NCT00104793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25866602|NCT00104793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866603|NCT00104793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866604|NCT00104806|Cholecalciferol|cholecalciferol|mesh-list
25866605|NCT00104806|Vitamin D|vitamin d|mesh-list
25866606|NCT00104806|Arsenic Trioxide|arsenic trioxide|mesh-list
25866607|NCT00104806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25866608|NCT00104806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866609|NCT00104806|Vitamins|vitamins|mesh-ancestor
25866610|NCT00104806|Micronutrients|micronutrients|mesh-ancestor
25866611|NCT00104806|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24514932|NCT00593463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24514933|NCT00593463|Renal Agents|renal agents|mesh-ancestor
24514934|NCT00593463|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24514935|NCT00593463|Antitubercular Agents|antitubercular agents|mesh-ancestor
24514936|NCT00593463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24514937|NCT00593463|Antimetabolites|antimetabolites|mesh-ancestor
24514963|NCT00593619|Blood Substitutes|blood substitutes|mesh-ancestor
24895443|NCT04119180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24895444|NCT04119180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24895445|NCT04119180|GABA Modulators|gaba modulators|mesh-ancestor
24472485|NCT00399295|Naltrexone|naltrexone|mesh-list
24514964|NCT00593658|Pentoxifylline|pentoxifylline|mesh-list
24946796|NCT03935347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24946798|NCT03935347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946799|NCT03935347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514970|NCT00593658|Protective Agents|protective agents|mesh-ancestor
24514971|NCT00593658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514972|NCT00593658|Vasodilator Agents|vasodilator agents|mesh-ancestor
24725243|NCT01596868|Cisplatin|cisplatin|mesh-list
24514973|NCT00593658|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24514974|NCT00593658|Antioxidants|antioxidants|mesh-ancestor
24514975|NCT00593697|Docetaxel|docetaxel|mesh-list
24514976|NCT00593697|Trastuzumab|trastuzumab|mesh-list
24514977|NCT00593697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514987|NCT00593710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24514988|NCT00593710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24514989|NCT00593710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514990|NCT00593710|Sympatholytics|sympatholytics|mesh-ancestor
24676533|NCT01350882|Rituximab|rituximab|mesh-list
25062414|NCT04742777|Antifungal Agents|antifungal agents|mesh-ancestor
24895480|NCT04022057|Ropivacaine|ropivacaine|mesh-list
24895481|NCT04022057|Anesthetics, Local|anesthetics, local|mesh-ancestor
24895482|NCT04022057|Anesthetics|anesthetics|mesh-ancestor
24895483|NCT04022057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24895484|NCT04022057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472502|NCT00399399|Azathioprine|azathioprine|mesh-list
24515016|NCT00593879|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24515017|NCT00593879|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24515018|NCT00593879|Cholinergic Agents|cholinergic agents|mesh-ancestor
24515019|NCT00593879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24515020|NCT00593879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515030|NCT00594087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24515031|NCT00594087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515032|NCT00594126|Imetelstat|imetelstat|mesh-list
24515033|NCT00594126|Motesanib diphosphate|motesanib diphosphate|mesh-list
24895489|NCT04020601|Anesthetics|anesthetics|mesh-ancestor
24895490|NCT04020601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24895491|NCT04020601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895493|NCT04020601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24895494|NCT04019093|Ethanol|ethanol|mesh-list
24683056|NCT01389713|Enclomiphene|enclomiphene|mesh-list
24895503|NCT04006210|Dopamine Agents|dopamine agents|mesh-ancestor
25062415|NCT04742777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25062416|NCT04742777|Immunologic Factors|immunologic factors|mesh-ancestor
25670435|NCT04381936|Aspirin|aspirin|mesh-list
25062417|NCT04742777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670436|NCT04381936|Empagliflozin|empagliflozin|mesh-list
25670437|NCT04381936|Ritonavir|ritonavir|mesh-list
25670438|NCT04381936|Lopinavir|lopinavir|mesh-list
25670439|NCT04381936|Azithromycin|azithromycin|mesh-list
25670440|NCT04381936|Hydroxychloroquine|hydroxychloroquine|mesh-list
25670441|NCT04381936|Colchicine|colchicine|mesh-list
25866612|NCT00104806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24895506|NCT04006210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895507|NCT04006210|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24895508|NCT04006210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24895510|NCT04003805|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24895511|NCT04003805|Autonomic Agents|autonomic agents|mesh-ancestor
24895512|NCT04003805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24895513|NCT04003805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895514|NCT04003805|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24895515|NCT04003805|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24895516|NCT04003805|Cholinergic Agents|cholinergic agents|mesh-ancestor
24895517|NCT04003805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24895518|NCT04003805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895519|NCT03970356|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24472530|NCT00399464|Adrenergic Agents|adrenergic agents|mesh-ancestor
24515043|NCT00594191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24515044|NCT00594191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515045|NCT00594217|Progesterone|progesterone|mesh-list
24895537|NCT03900949|Midostaurin|midostaurin|mesh-list
24895538|NCT03900949|Calicheamicins|calicheamicins|mesh-list
24895539|NCT03900949|Staurosporine|staurosporine|mesh-list
24895540|NCT03900949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24895541|NCT03900949|Antimetabolites|antimetabolites|mesh-ancestor
24895542|NCT03900949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895543|NCT03900949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24895544|NCT03900949|Antiviral Agents|antiviral agents|mesh-ancestor
24895545|NCT03900949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24895546|NCT03900949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24895547|NCT03900949|Immunologic Factors|immunologic factors|mesh-ancestor
24522902|NCT03049735|Norethindrone|norethindrone|mesh-list
24817328|NCT02082665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817329|NCT02082665|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24817330|NCT02082665|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24817331|NCT02082665|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24817332|NCT02082665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24817333|NCT02082665|Anesthetics, General|anesthetics, general|mesh-ancestor
24817334|NCT02082665|Anesthetics|anesthetics|mesh-ancestor
24817335|NCT02082665|GABA Modulators|gaba modulators|mesh-ancestor
24817336|NCT02082665|GABA Agents|gaba agents|mesh-ancestor
24817337|NCT02082665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24817338|NCT02082665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817340|NCT02082665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24817341|NCT02082665|Antimetabolites|antimetabolites|mesh-ancestor
24817342|NCT02082665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24817343|NCT02082665|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24817344|NCT02082665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899863|NCT04399343|Analgesics|analgesics|mesh-ancestor
24817345|NCT02082665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24817346|NCT02082665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24817347|NCT02083055|Nitroglycerin|nitroglycerin|mesh-list
24895564|NCT03895099|Progestins|progestins|mesh-ancestor
24895566|NCT03895099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24895567|NCT03878199|Cytarabine|cytarabine|mesh-list
24515046|NCT00594217|Progestins|progestins|mesh-ancestor
24515047|NCT00594217|Hormones|hormones|mesh-ancestor
24515048|NCT00594217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24515049|NCT00594217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515050|NCT00594269|Risperidone|risperidone|mesh-list
24515051|NCT00594269|Citalopram|citalopram|mesh-list
24515052|NCT00594269|Sertraline|sertraline|mesh-list
24515053|NCT00594269|Paroxetine|paroxetine|mesh-list
24515054|NCT00594269|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24515055|NCT00594269|Serotonin Agents|serotonin agents|mesh-ancestor
24895569|NCT03878199|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
24895570|NCT03878199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24895571|NCT03878199|Antimetabolites|antimetabolites|mesh-ancestor
24895572|NCT03878199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895573|NCT03878199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24895574|NCT03878199|Antiviral Agents|antiviral agents|mesh-ancestor
24895575|NCT03878199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24895576|NCT03878199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24895577|NCT03878199|Immunologic Factors|immunologic factors|mesh-ancestor
24895578|NCT03878199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895579|NCT03878199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24895593|NCT03840967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25674488|NCT01772758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895594|NCT03820466|Aspirin|aspirin|mesh-list
24472631|NCT00399867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25866613|NCT00104819|Immunoglobulins|immunoglobulins|mesh-list
25866614|NCT00104819|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25866615|NCT00104819|Antibodies|antibodies|mesh-list
25866616|NCT00104819|Sargramostim|sargramostim|mesh-list
25866617|NCT00104819|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
25866618|NCT00104819|Immunologic Factors|immunologic factors|mesh-ancestor
25866619|NCT00104819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866620|NCT00104845|Vaccines|vaccines|mesh-list
24895601|NCT03820466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895602|NCT03820466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24895603|NCT03820466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24895604|NCT03820466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24895605|NCT03820466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24895606|NCT03820466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895607|NCT03820466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24895608|NCT03820466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24895609|NCT03820466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24895610|NCT03820466|Antipyretics|antipyretics|mesh-ancestor
24895611|NCT03820466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24895612|NCT03820466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24895613|NCT03820466|Antimetabolites|antimetabolites|mesh-ancestor
24899960|NCT04398589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24895614|NCT03820466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24895615|NCT03820466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24895616|NCT03797924|Ropivacaine|ropivacaine|mesh-list
24895617|NCT03797924|Anesthetics, Local|anesthetics, local|mesh-ancestor
24895618|NCT03797924|Anesthetics|anesthetics|mesh-ancestor
24895619|NCT03797924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24895620|NCT03797924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472670|NCT00400088|Serotonin Agents|serotonin agents|mesh-ancestor
24895621|NCT03797924|Sensory System Agents|sensory system agents|mesh-ancestor
24895622|NCT03797924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24895623|NCT03787628|Cannabidiol|cannabidiol|mesh-list
24895624|NCT03787628|Anticonvulsants|anticonvulsants|mesh-ancestor
24895625|NCT03786614|Antidepressive Agents|antidepressive agents|mesh-list
24895626|NCT03786614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24895627|NCT03772574|Nicotine|nicotine|mesh-list
24895628|NCT03772574|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24895629|NCT03772574|Autonomic Agents|autonomic agents|mesh-ancestor
24895630|NCT03772574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24895631|NCT03772574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895632|NCT03772574|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24895633|NCT03772574|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24895634|NCT03772574|Cholinergic Agents|cholinergic agents|mesh-ancestor
24895635|NCT03772574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24895636|NCT03772574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895637|NCT03694808|Vaccines|vaccines|mesh-list
24895638|NCT03694808|Immunologic Factors|immunologic factors|mesh-ancestor
24895639|NCT03694808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895640|NCT03675893|Letrozole|letrozole|mesh-list
24895641|NCT03675893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24895642|NCT03675893|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24895643|NCT03675893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24523113|NCT02584309|Razoxane|razoxane|mesh-list
24895655|NCT03643367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24895656|NCT03643367|Anesthetics, General|anesthetics, general|mesh-ancestor
24895657|NCT03643367|Anesthetics|anesthetics|mesh-ancestor
24895662|NCT03632044|Anesthetics|anesthetics|mesh-ancestor
24895663|NCT03632044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25201648|NCT02726308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25866621|NCT00104845|Immunologic Factors|immunologic factors|mesh-ancestor
25866622|NCT00104845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866623|NCT00104910|Cisplatin|cisplatin|mesh-list
25866624|NCT00104910|Cetuximab|cetuximab|mesh-list
25866625|NCT00104910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866626|NCT00104910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24515070|NCT00594269|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24515071|NCT00594269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24899961|NCT04398589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25866627|NCT00104923|Fenretinide|fenretinide|mesh-list
25866628|NCT00104923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866629|NCT00104923|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25866630|NCT00104923|Protective Agents|protective agents|mesh-ancestor
25866631|NCT00104923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866632|NCT00104949|Trastuzumab|trastuzumab|mesh-list
25866633|NCT00104949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24895664|NCT03632044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895665|NCT03632044|Sensory System Agents|sensory system agents|mesh-ancestor
24895666|NCT03632044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24895667|NCT03598426|Dexamethasone|dexamethasone|mesh-list
24895668|NCT03598426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24895669|NCT03598426|Antiemetics|antiemetics|mesh-ancestor
24895670|NCT03598426|Autonomic Agents|autonomic agents|mesh-ancestor
24895671|NCT03598426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24895672|NCT03598426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895673|NCT03598426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24895674|NCT03598426|Glucocorticoids|glucocorticoids|mesh-ancestor
24895675|NCT03598426|Hormones|hormones|mesh-ancestor
24895676|NCT03598426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24895677|NCT03598426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25866634|NCT00104949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866635|NCT00104962|Lenalidomide|lenalidomide|mesh-list
25866636|NCT00104962|Immunologic Factors|immunologic factors|mesh-ancestor
25866637|NCT00104962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866638|NCT00104962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25866639|NCT00104962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25866640|NCT00104962|Growth Substances|growth substances|mesh-ancestor
25866641|NCT00104962|Growth Inhibitors|growth inhibitors|mesh-ancestor
25866642|NCT00104962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866643|NCT00104975|Fludarabine|fludarabine|mesh-list
25866644|NCT00104975|Fludarabine phosphate|fludarabine phosphate|mesh-list
25866645|NCT00104975|Melphalan|melphalan|mesh-list
25866646|NCT00104975|Alemtuzumab|alemtuzumab|mesh-list
25866647|NCT00104975|Thiotepa|thiotepa|mesh-list
25866648|NCT00104975|Tacrolimus|tacrolimus|mesh-list
24515115|NCT00594555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062452|NCT04642261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25062453|NCT04642261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062454|NCT04614636|Cyclophosphamide|cyclophosphamide|mesh-list
25062455|NCT04614636|Fludarabine|fludarabine|mesh-list
25062456|NCT04614636|Daratumumab|daratumumab|mesh-list
25062457|NCT04614636|Elotuzumab|elotuzumab|mesh-list
25062458|NCT04614636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25062459|NCT04614636|Immunologic Factors|immunologic factors|mesh-ancestor
25062460|NCT04614636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515116|NCT00594555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24515117|NCT00594555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515118|NCT00594633|Donepezil|donepezil|mesh-list
24515119|NCT00594633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24515120|NCT00594633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515121|NCT00594633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895683|NCT03533452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895684|NCT03533452|Sensory System Agents|sensory system agents|mesh-ancestor
24895685|NCT03533452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24895686|NCT03486964|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24895687|NCT03486964|Protease Inhibitors|protease inhibitors|mesh-ancestor
24895688|NCT03486964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24895689|NCT03486964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895690|NCT03486964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24895691|NCT03486964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895692|NCT03480672|Pembrolizumab|pembrolizumab|mesh-list
25866649|NCT00104975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866650|NCT00104975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25866651|NCT00104975|Antimetabolites|antimetabolites|mesh-ancestor
24790366|NCT01942187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895693|NCT03480672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24895694|NCT03480672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24895695|NCT03474276|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24895696|NCT03474276|Azithromycin|azithromycin|mesh-list
24895697|NCT03474276|Albendazole|albendazole|mesh-list
24515127|NCT00594737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24515128|NCT00594737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24515129|NCT00594737|Dopamine Agents|dopamine agents|mesh-ancestor
24895714|NCT03434041|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24895715|NCT03434041|Citalopram|citalopram|mesh-list
24895717|NCT03434041|Sertraline|sertraline|mesh-list
24895718|NCT03434041|Antidepressive Agents|antidepressive agents|mesh-list
24895719|NCT03434041|Esketamine|esketamine|mesh-list
24895720|NCT03434041|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25404893|NCT03644485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866652|NCT00104975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866653|NCT00104975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24895721|NCT03434041|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24895722|NCT03434041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24895723|NCT03434041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895729|NCT03434041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24895730|NCT03434041|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24895731|NCT03434041|Analgesics|analgesics|mesh-ancestor
24895732|NCT03434041|Sensory System Agents|sensory system agents|mesh-ancestor
24515130|NCT00594737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24515131|NCT00594737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515132|NCT00594737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515133|NCT00594737|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24515134|NCT00594737|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24515135|NCT00594867|Aspirin|aspirin|mesh-list
25062461|NCT04614636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25062462|NCT04614636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25062463|NCT04614636|Alkylating Agents|alkylating agents|mesh-ancestor
25062464|NCT04614636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062465|NCT04614636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25062466|NCT04614636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25062467|NCT04602533|Durvalumab|durvalumab|mesh-list
24515136|NCT00594867|Acetaminophen|acetaminophen|mesh-list
24515137|NCT00594867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24515138|NCT00594867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24515139|NCT00594867|Analgesics|analgesics|mesh-ancestor
24515140|NCT00594867|Sensory System Agents|sensory system agents|mesh-ancestor
24895752|NCT03215706|Ipilimumab|ipilimumab|mesh-list
24895753|NCT03215706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24895754|NCT03215706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24895755|NCT03215706|Tubulin Modulators|tubulin modulators|mesh-ancestor
24895756|NCT03215706|Antimitotic Agents|antimitotic agents|mesh-ancestor
24472778|NCT00400530|Alendronate|alendronate|mesh-list
25866654|NCT00104975|Immunologic Factors|immunologic factors|mesh-ancestor
25866655|NCT00104975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866656|NCT00104975|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24590328|NCT00912145|Alprazolam|alprazolam|mesh-list
24895763|NCT03215706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24895765|NCT03151057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24895766|NCT03151057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866657|NCT00104975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866658|NCT00104975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25866659|NCT00104975|Alkylating Agents|alkylating agents|mesh-ancestor
25866660|NCT00104975|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25866661|NCT00104975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25866662|NCT00104988|Thalidomide|thalidomide|mesh-list
25201649|NCT02726308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25201650|NCT02726308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201651|NCT02726269|Ofloxacin|ofloxacin|mesh-list
25201652|NCT02726269|Levofloxacin|levofloxacin|mesh-list
25201653|NCT02726269|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25866663|NCT00104988|Temozolomide|temozolomide|mesh-list
25866664|NCT00104988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24900104|NCT04397458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25866665|NCT00104988|Alkylating Agents|alkylating agents|mesh-ancestor
25866666|NCT00104988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866667|NCT00104988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866668|NCT00104988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25866669|NCT00104988|Immunologic Factors|immunologic factors|mesh-ancestor
25866670|NCT00104988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866671|NCT00104988|Leprostatic Agents|leprostatic agents|mesh-ancestor
25866672|NCT00104988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24515200|NCT00595543|Sensory System Agents|sensory system agents|mesh-ancestor
25866673|NCT00104988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24523451|NCT00467142|Levoleucovorin|levoleucovorin|mesh-list
24895781|NCT03060434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24895782|NCT03060434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895783|NCT03060434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24472807|NCT00400621|Acetaminophen|acetaminophen|mesh-list
25866674|NCT00104988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25866675|NCT00104988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25866676|NCT00104988|Growth Substances|growth substances|mesh-ancestor
25866677|NCT00104988|Growth Inhibitors|growth inhibitors|mesh-ancestor
24895784|NCT03060434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24895785|NCT03060434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25866678|NCT00105040|Levetiracetam|levetiracetam|mesh-list
25866679|NCT00105040|Anticonvulsants|anticonvulsants|mesh-ancestor
25866680|NCT00105040|Nootropic Agents|nootropic agents|mesh-ancestor
25866681|NCT00105105|Mifepristone|mifepristone|mesh-list
25866682|NCT00105105|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25866683|NCT00105105|Abortifacient Agents|abortifacient agents|mesh-ancestor
25866684|NCT00105105|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25866685|NCT00105105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866686|NCT00105105|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24895786|NCT03060434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24895787|NCT03060434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895788|NCT03060434|Anticonvulsants|anticonvulsants|mesh-ancestor
24900206|NCT04396977|Histamine Agents|histamine agents|mesh-ancestor
24895789|NCT03060434|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24895814|NCT03022097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25866687|NCT00105105|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25866688|NCT00105105|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25866689|NCT00105105|Contraceptive Agents|contraceptive agents|mesh-ancestor
25866690|NCT00105105|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25866691|NCT00105105|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25866692|NCT00105105|Hormone Antagonists|hormone antagonists|mesh-ancestor
25866693|NCT00105105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25866694|NCT00105105|Luteolytic Agents|luteolytic agents|mesh-ancestor
25866695|NCT00105105|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25866696|NCT00105105|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25866697|NCT00105144|Caspofungin|caspofungin|mesh-list
24895815|NCT03022097|Adrenergic Agents|adrenergic agents|mesh-ancestor
24895816|NCT03022097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24895817|NCT03022097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895818|NCT03022097|Anticonvulsants|anticonvulsants|mesh-ancestor
24895819|NCT03006705|Capecitabine|capecitabine|mesh-list
24895821|NCT03006705|Oxaliplatin|oxaliplatin|mesh-list
24895822|NCT03006705|Nivolumab|nivolumab|mesh-list
24895823|NCT03006705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25201654|NCT02726269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25201655|NCT02726269|Renal Agents|renal agents|mesh-ancestor
25062473|NCT04594915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25062474|NCT04594915|Protease Inhibitors|protease inhibitors|mesh-ancestor
25062475|NCT04594915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25062476|NCT04594915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062477|NCT04594915|Anticoagulants|anticoagulants|mesh-ancestor
25062478|NCT04586062|Plasminogen|plasminogen|mesh-list
25062479|NCT04586062|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24825030|NCT02127034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25866698|NCT00105144|Micafungin|micafungin|mesh-list
24515216|NCT00595972|Growth Substances|growth substances|mesh-ancestor
24515217|NCT00595972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515218|NCT00595972|Growth Inhibitors|growth inhibitors|mesh-ancestor
24515219|NCT00595972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24515220|NCT00595985|Sorafenib|sorafenib|mesh-list
24515221|NCT00595985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24515222|NCT00595985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24515240|NCT00596050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24817348|NCT02083055|Dexmedetomidine|dexmedetomidine|mesh-list
24895840|NCT02960763|Lithium Carbonate|lithium carbonate|mesh-list
24895841|NCT02960763|Bupropion|bupropion|mesh-list
24895842|NCT02960763|Nortriptyline|nortriptyline|mesh-list
24895843|NCT02960763|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24895844|NCT02960763|Antidepressive Agents|antidepressive agents|mesh-ancestor
24895845|NCT02960763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24895846|NCT02960763|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24895847|NCT02960763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25670442|NCT04381936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25670443|NCT04381936|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25670444|NCT04381936|Antibodies|antibodies|mesh-list
25670445|NCT04381936|Immunoglobulins|immunoglobulins|mesh-list
25670446|NCT04381936|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25670447|NCT04381936|Immunologic Factors|immunologic factors|mesh-ancestor
25670448|NCT04381936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670449|NCT04381936|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25670450|NCT04381936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25670451|NCT04381936|Analgesics|analgesics|mesh-ancestor
25670452|NCT04381936|Sensory System Agents|sensory system agents|mesh-ancestor
25670453|NCT04381936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25670454|NCT04381936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25670455|NCT04381936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24515243|NCT00596050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515244|NCT00596050|Analgesics|analgesics|mesh-ancestor
24515245|NCT00596050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24515246|NCT00596050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24515247|NCT00596050|Anesthetics, General|anesthetics, general|mesh-ancestor
24515248|NCT00596050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24515249|NCT00596050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24515250|NCT00596050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24825038|NCT02127034|Cholinergic Agents|cholinergic agents|mesh-ancestor
24515254|NCT00596050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24515255|NCT00596050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24515256|NCT00596050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24515257|NCT00596050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24515258|NCT00596050|GABA Modulators|gaba modulators|mesh-ancestor
24515260|NCT00596063|Insulin|insulin|mesh-list
24515272|NCT00596115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24515273|NCT00596128|Insulin|insulin|mesh-list
24515274|NCT00596128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24515286|NCT00596154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515287|NCT00596154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24515288|NCT00596154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24515289|NCT00596154|Alkylating Agents|alkylating agents|mesh-ancestor
24515290|NCT00596154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515291|NCT00596154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24895848|NCT02960763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24895849|NCT02960763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895850|NCT02960763|Dopamine Agents|dopamine agents|mesh-ancestor
24895851|NCT02960763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24895853|NCT02960763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24895854|NCT02960763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24895855|NCT02960763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24895856|NCT02960763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24895857|NCT02960763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24895858|NCT02960763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24895859|NCT02960763|Dopamine Agonists|dopamine agonists|mesh-ancestor
24895860|NCT02960763|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24895861|NCT02960763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24895862|NCT02960763|Serotonin Agents|serotonin agents|mesh-ancestor
24895863|NCT02960763|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24895864|NCT02960763|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24895865|NCT02960763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24895866|NCT02960763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24895867|NCT02960763|Antimanic Agents|antimanic agents|mesh-ancestor
24515292|NCT00596154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25866700|NCT00105144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25866701|NCT00105144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866702|NCT00105144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866703|NCT00105209|Aspirin|aspirin|mesh-list
24684128|NCT01395667|Fluorouracil|fluorouracil|mesh-list
24895884|NCT02918084|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24895885|NCT02918084|Hormone Antagonists|hormone antagonists|mesh-ancestor
24895886|NCT02918084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24895887|NCT02918084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866704|NCT00105209|Clopidogrel|clopidogrel|mesh-list
25866705|NCT00105209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25866706|NCT00105209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25866707|NCT00105209|Analgesics|analgesics|mesh-ancestor
25866708|NCT00105209|Sensory System Agents|sensory system agents|mesh-ancestor
25866709|NCT00105209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25866710|NCT00105209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866711|NCT00105209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25866712|NCT00105209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25063656|NCT03466775|Protease Inhibitors|protease inhibitors|mesh-ancestor
24515297|NCT00596154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24895902|NCT02871297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24895903|NCT02871297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895904|NCT02871297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24895905|NCT02871297|Serotonin Agents|serotonin agents|mesh-ancestor
25866713|NCT00105209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25866714|NCT00105209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25866715|NCT00105209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866716|NCT00105209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25866717|NCT00105209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25866718|NCT00105209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866719|NCT00105209|Antipyretics|antipyretics|mesh-ancestor
25866720|NCT00105209|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25866721|NCT00105209|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24895907|NCT02871297|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24895908|NCT02871297|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24895909|NCT02871297|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24895910|NCT02835222|Cytarabine|cytarabine|mesh-list
24895911|NCT02835222|Daunorubicin|daunorubicin|mesh-list
24895912|NCT02835222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24895913|NCT02835222|Antimetabolites|antimetabolites|mesh-ancestor
24900455|NCT04393610|Lidocaine|lidocaine|mesh-list
24900456|NCT04393610|Magnesium Sulfate|magnesium sulfate|mesh-list
24900457|NCT04393610|Fentanyl|fentanyl|mesh-list
24900458|NCT04393610|Anesthetics, Local|anesthetics, local|mesh-ancestor
24900459|NCT04393610|Anesthetics|anesthetics|mesh-ancestor
24900462|NCT04393610|Sensory System Agents|sensory system agents|mesh-ancestor
24895914|NCT02835222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895915|NCT02835222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24895916|NCT02835222|Antiviral Agents|antiviral agents|mesh-ancestor
24895917|NCT02835222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24895918|NCT02835222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24895919|NCT02835222|Immunologic Factors|immunologic factors|mesh-ancestor
24895920|NCT02835222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895921|NCT02835222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24895922|NCT02835222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24895923|NCT02835222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24895924|NCT02835222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24472954|NCT00401219|Estrogens|estrogens|mesh-list
24515320|NCT00596219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515321|NCT00596219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25062515|NCT04459065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24515348|NCT00596375|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25866722|NCT00105209|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25866723|NCT00105209|Purinergic Agents|purinergic agents|mesh-ancestor
25866724|NCT00105209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25866725|NCT00105287|Fentanyl|fentanyl|mesh-list
25866726|NCT00105287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25866727|NCT00105287|Narcotics|narcotics|mesh-ancestor
25866728|NCT00105287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25866729|NCT00105287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062529|NCT04421339|Melatonin|melatonin|mesh-list
25062530|NCT04421339|Antioxidants|antioxidants|mesh-ancestor
25062531|NCT04421339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062532|NCT04421339|Protective Agents|protective agents|mesh-ancestor
25062533|NCT04421339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825087|NCT02127320|Ezetimibe|ezetimibe|mesh-list
25063670|NCT03466645|Cefazolin|cefazolin|mesh-list
24515373|NCT00596414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24515374|NCT00596479|Lenograstim|lenograstim|mesh-list
24515375|NCT00596479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24515376|NCT00596479|Immunologic Factors|immunologic factors|mesh-ancestor
24515377|NCT00596479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515378|NCT00596531|Acamprosate|acamprosate|mesh-list
24515379|NCT00596531|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25201656|NCT02726269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24684209|NCT01395875|Cholinergic Agents|cholinergic agents|mesh-ancestor
24895947|NCT02794896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895948|NCT02794896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24895949|NCT02794896|Anesthetics, General|anesthetics, general|mesh-ancestor
25670456|NCT04381936|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25670457|NCT04381936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25670458|NCT04381936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670459|NCT04381936|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25670460|NCT04381936|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25670461|NCT04381936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25670462|NCT04381936|Antipyretics|antipyretics|mesh-ancestor
25670463|NCT04381936|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25670464|NCT04381936|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25670465|NCT04381936|Protease Inhibitors|protease inhibitors|mesh-ancestor
25670466|NCT04381936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25670467|NCT04381936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25670468|NCT04381936|Antiviral Agents|antiviral agents|mesh-ancestor
25670469|NCT04381936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24895951|NCT02794896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24895952|NCT02794896|Narcotics|narcotics|mesh-ancestor
24895953|NCT02794896|Analgesics|analgesics|mesh-ancestor
25866731|NCT00105287|Sensory System Agents|sensory system agents|mesh-ancestor
25866732|NCT00105287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25866733|NCT00105287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25866734|NCT00105287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25866735|NCT00105287|Anesthetics, General|anesthetics, general|mesh-ancestor
25062534|NCT04421339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25866736|NCT00105287|Anesthetics|anesthetics|mesh-ancestor
25866737|NCT00105300|Adalimumab|adalimumab|mesh-list
25866738|NCT00105300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25866739|NCT00105300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25866740|NCT00105326|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24684319|NCT01396707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866741|NCT00105326|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25866742|NCT00105326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25866743|NCT00105326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25866744|NCT00105326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866745|NCT00105326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25866746|NCT00105326|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25866747|NCT00105326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25866748|NCT00105326|Serotonin Agents|serotonin agents|mesh-ancestor
25866749|NCT00105326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25866750|NCT00105326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866751|NCT00105326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25866752|NCT00105326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25866753|NCT00105326|Dopamine Agents|dopamine agents|mesh-ancestor
25866754|NCT00105352|Glucagon|glucagon|mesh-list
25866755|NCT00105352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25866756|NCT00105352|Hormones|hormones|mesh-ancestor
24895954|NCT02794896|Sensory System Agents|sensory system agents|mesh-ancestor
24895955|NCT02794896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24895956|NCT02794896|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24895957|NCT02794896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24895958|NCT02794896|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24895960|NCT02783404|Clavulanic Acid|clavulanic acid|mesh-list
24895961|NCT02783404|Clavulanic Acids|clavulanic acids|mesh-list
24895962|NCT02783404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24895963|NCT02783404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24895964|NCT02783404|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24895965|NCT02783404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24895966|NCT02783404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895968|NCT02728531|Rituximab|rituximab|mesh-list
24895969|NCT02728531|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24895970|NCT02728531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24895971|NCT02728531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24895972|NCT02728531|Immunologic Factors|immunologic factors|mesh-ancestor
24895973|NCT02728531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684406|NCT01397331|Propofol|propofol|mesh-list
24895985|NCT02693184|Vitamins|vitamins|mesh-ancestor
24895986|NCT02693184|Micronutrients|micronutrients|mesh-ancestor
24895987|NCT02693184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895988|NCT02693184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24515427|NCT00597064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515428|NCT00597064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24515443|NCT00597233|Isophane insulin, beef|isophane insulin, beef|mesh-list
24515444|NCT00597233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24515445|NCT00597233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515446|NCT00597259|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24515448|NCT00597259|Antiviral Agents|antiviral agents|mesh-ancestor
25670470|NCT04381936|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25670471|NCT04381936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25670472|NCT04381936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25670473|NCT04381936|Antimalarials|antimalarials|mesh-ancestor
25670474|NCT04381936|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25670475|NCT04381936|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25670476|NCT04381936|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25670477|NCT04381936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25670478|NCT04381936|Gout Suppressants|gout suppressants|mesh-ancestor
25670479|NCT04381936|Tubulin Modulators|tubulin modulators|mesh-ancestor
25670480|NCT04381936|Antimitotic Agents|antimitotic agents|mesh-ancestor
25670481|NCT04381936|Mitosis Modulators|mitosis modulators|mesh-ancestor
25670482|NCT04381936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24895995|NCT02677181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24895996|NCT02677181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895997|NCT02677181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24948226|NCT03921775|Anesthetics|anesthetics|mesh-ancestor
24515465|NCT00597415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24515466|NCT00597415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515467|NCT00597415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24515468|NCT00597415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24515469|NCT00597415|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24515470|NCT00597415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24515471|NCT00597415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515472|NCT00597415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896016|NCT02640664|Growth Substances|growth substances|mesh-ancestor
24896017|NCT02640664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896018|NCT02640664|Growth Inhibitors|growth inhibitors|mesh-ancestor
24896019|NCT02640664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24896020|NCT02621944|Melatonin|melatonin|mesh-list
24896021|NCT02621944|Antioxidants|antioxidants|mesh-ancestor
25201657|NCT02726269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25866757|NCT00105352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25866758|NCT00105352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866759|NCT00105404|Triamcinolone|triamcinolone|mesh-list
24896022|NCT02621944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896023|NCT02621944|Protective Agents|protective agents|mesh-ancestor
24896024|NCT02621944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896025|NCT02621944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24896026|NCT02601313|Cyclophosphamide|cyclophosphamide|mesh-list
24896027|NCT02601313|Fludarabine|fludarabine|mesh-list
24524598|NCT04666961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062552|NCT04370301|Alkylating Agents|alkylating agents|mesh-ancestor
25062553|NCT04370301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062554|NCT04370301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25062555|NCT04370301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25062556|NCT04370301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25062557|NCT04370301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063754|NCT03466320|Fludarabine|fludarabine|mesh-list
25062558|NCT04370301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25062559|NCT04370301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25062560|NCT04370301|Antitubercular Agents|antitubercular agents|mesh-ancestor
25062561|NCT04370301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25062562|NCT04370301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25062563|NCT04370301|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25062564|NCT04370301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24515518|NCT00598156|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24515519|NCT00598156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24515520|NCT00598156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24515521|NCT00598156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24515522|NCT00598156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24515523|NCT00598156|Growth Substances|growth substances|mesh-ancestor
24817365|NCT02083068|Immunologic Factors|immunologic factors|mesh-ancestor
25201658|NCT02726269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25201659|NCT02726269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201660|NCT02726269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434718|NCT00263302|Glucocorticoids|glucocorticoids|mesh-ancestor
24817366|NCT02083068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817370|NCT02083211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24817371|NCT02083276|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
24817372|NCT02083276|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24817373|NCT02083276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25866760|NCT00105404|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25866761|NCT00105404|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25866762|NCT00105404|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25866763|NCT00105404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25866764|NCT00105404|Glucocorticoids|glucocorticoids|mesh-ancestor
25866765|NCT00105404|Hormones|hormones|mesh-ancestor
25866766|NCT00105404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25866767|NCT00105404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866768|NCT00105404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25866769|NCT00105404|Immunologic Factors|immunologic factors|mesh-ancestor
25866770|NCT00105404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866771|NCT00105404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25432440|NCT00792948|Lenograstim|lenograstim|mesh-list
24817391|NCT02083328|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24817392|NCT02083328|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24817393|NCT02083328|Purinergic Agents|purinergic agents|mesh-ancestor
24817394|NCT02083328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24817395|NCT02083328|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24817396|NCT02083328|Diuretics|diuretics|mesh-ancestor
24817397|NCT02083328|Natriuretic Agents|natriuretic agents|mesh-ancestor
24817398|NCT02083484|Pembrolizumab|pembrolizumab|mesh-list
24817399|NCT02083484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24817400|NCT02083484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24817401|NCT02083510|Colchicine|colchicine|mesh-list
24817402|NCT02083510|Gout Suppressants|gout suppressants|mesh-ancestor
24817403|NCT02083510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24817404|NCT02083510|Tubulin Modulators|tubulin modulators|mesh-ancestor
24817405|NCT02083510|Antimitotic Agents|antimitotic agents|mesh-ancestor
24817406|NCT02083510|Mitosis Modulators|mitosis modulators|mesh-ancestor
24817407|NCT02083510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817408|NCT02083510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063774|NCT03466242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25063775|NCT03466242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25063776|NCT03466242|Adrenergic Agents|adrenergic agents|mesh-ancestor
25063777|NCT03466242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25063778|NCT03466242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063779|NCT03466242|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25063780|NCT03466242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25063781|NCT03466242|Anesthetics, General|anesthetics, general|mesh-ancestor
25063782|NCT03466242|Anesthetics|anesthetics|mesh-ancestor
25063783|NCT03466242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25063784|NCT03466242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25063786|NCT03466216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25063789|NCT03466021|Liraglutide|liraglutide|mesh-list
24817409|NCT02083536|Docetaxel|docetaxel|mesh-list
24817410|NCT02083536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866772|NCT00105495|Deferiprone|deferiprone|mesh-list
25866773|NCT00105495|Deferoxamine|deferoxamine|mesh-list
25062578|NCT04341116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25062579|NCT04341116|Antiviral Agents|antiviral agents|mesh-ancestor
25062580|NCT04341116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24515547|NCT00598169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24515548|NCT00598169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24515549|NCT00598169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24515550|NCT00598169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24515551|NCT00598169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24896097|NCT02378805|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
24896099|NCT02378805|Spironolactone|spironolactone|mesh-list
24896100|NCT02378805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24896101|NCT02378805|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24896102|NCT02378805|Hormone Antagonists|hormone antagonists|mesh-ancestor
24473167|NCT00402259|Omeprazole|omeprazole|mesh-list
24900728|NCT04391621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24473208|NCT00402376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25866774|NCT00105495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25866775|NCT00105495|Chelating Agents|chelating agents|mesh-ancestor
24473171|NCT00402259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896129|NCT02067819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24896130|NCT02067819|Antifungal Agents|antifungal agents|mesh-ancestor
24896131|NCT02067819|Keratolytic Agents|keratolytic agents|mesh-ancestor
24896132|NCT02067819|Dermatologic Agents|dermatologic agents|mesh-ancestor
24515573|NCT00598234|Analgesics|analgesics|mesh-ancestor
24518612|NCT04675866|Antimitotic Agents|antimitotic agents|mesh-ancestor
24515574|NCT00598234|Sensory System Agents|sensory system agents|mesh-ancestor
24515575|NCT00598234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24515576|NCT00598234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515577|NCT00598234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24515578|NCT00598234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24515579|NCT00598234|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24515580|NCT00598234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24515581|NCT00598234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24524990|NCT04140266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896139|NCT01668719|Dexamethasone acetate|dexamethasone acetate|mesh-list
24896140|NCT01668719|Lenalidomide|lenalidomide|mesh-list
24896141|NCT01668719|Bortezomib|bortezomib|mesh-list
24896142|NCT01668719|Elotuzumab|elotuzumab|mesh-list
24896143|NCT01668719|Ichthammol|ichthammol|mesh-list
24896144|NCT01668719|BB 1101|bb 1101|mesh-list
24896145|NCT01668719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25866776|NCT00105495|Sequestering Agents|sequestering agents|mesh-ancestor
24896146|NCT01668719|Antiemetics|antiemetics|mesh-ancestor
24896147|NCT01668719|Autonomic Agents|autonomic agents|mesh-ancestor
24896148|NCT01668719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24896149|NCT01668719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866777|NCT00105495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866778|NCT00105495|Siderophores|siderophores|mesh-ancestor
25866779|NCT00105547|Flurbiprofen|flurbiprofen|mesh-list
25866780|NCT00105547|Analgesics|analgesics|mesh-ancestor
25866781|NCT00105547|Sensory System Agents|sensory system agents|mesh-ancestor
24896160|NCT01668719|Growth Inhibitors|growth inhibitors|mesh-ancestor
24896161|NCT01668719|Protease Inhibitors|protease inhibitors|mesh-ancestor
24896162|NCT01668719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896163|NCT01668719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896164|NCT01668719|Dermatologic Agents|dermatologic agents|mesh-ancestor
24896173|NCT01515748|Docetaxel|docetaxel|mesh-list
24896174|NCT01515748|Fluorouracil|fluorouracil|mesh-list
24896184|NCT01515748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24896185|NCT01515748|Immunologic Factors|immunologic factors|mesh-ancestor
24896186|NCT01515748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896187|NCT01404754|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
24896188|NCT01404754|Hallucinogens|hallucinogens|mesh-ancestor
25866782|NCT00105547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25866783|NCT00105547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219063|NCT02665871|Vaccines|vaccines|mesh-list
25866784|NCT00105547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25866785|NCT00105547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25866786|NCT00105547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25866787|NCT00105547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25866788|NCT00105547|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25866789|NCT00105547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866790|NCT00105547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866791|NCT00105937|Fentanyl|fentanyl|mesh-list
25866792|NCT00105937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25866793|NCT00105937|Narcotics|narcotics|mesh-ancestor
25866794|NCT00105937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25866795|NCT00105937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896195|NCT01404754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24896196|NCT01404754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24896198|NCT01261247|Panobinostat|panobinostat|mesh-list
24896199|NCT01261247|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
24896200|NCT01261247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24896201|NCT01261247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896202|NCT01261247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896204|NCT01169259|Ergocalciferols|ergocalciferols|mesh-list
24896205|NCT01169259|Cholecalciferol|cholecalciferol|mesh-list
24896207|NCT01169259|Micronutrients|micronutrients|mesh-ancestor
24896208|NCT01169259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896209|NCT01169259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25201662|NCT02726269|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24896210|NCT01169259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24896212|NCT01117441|Dexamethasone|dexamethasone|mesh-list
24896213|NCT01117441|Prednisone|prednisone|mesh-list
24896214|NCT01117441|Cyclophosphamide|cyclophosphamide|mesh-list
24896215|NCT01117441|Ifosfamide|ifosfamide|mesh-list
24896216|NCT01117441|Doxorubicin|doxorubicin|mesh-list
24896217|NCT01117441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24896218|NCT01117441|Methotrexate|methotrexate|mesh-list
24896219|NCT01117441|Fludarabine|fludarabine|mesh-list
24896220|NCT01117441|Etoposide|etoposide|mesh-list
24896221|NCT01117441|Vincristine|vincristine|mesh-list
24896230|NCT01117441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896231|NCT01117441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24896232|NCT01117441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24896244|NCT01117441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24896245|NCT01117441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24896246|NCT01117441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24896247|NCT01117441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24896248|NCT01117441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24896249|NCT01117441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896250|NCT01117441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24896251|NCT01117441|Abortifacient Agents|abortifacient agents|mesh-ancestor
24896252|NCT01117441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24896253|NCT01117441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25866796|NCT00105937|Analgesics|analgesics|mesh-ancestor
25866797|NCT00105937|Sensory System Agents|sensory system agents|mesh-ancestor
25866798|NCT00105937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25866799|NCT00105937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25866800|NCT00105937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25866801|NCT00105937|Anesthetics, General|anesthetics, general|mesh-ancestor
25866802|NCT00105937|Anesthetics|anesthetics|mesh-ancestor
25866803|NCT00105950|Lapatinib|lapatinib|mesh-list
25866804|NCT00105950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866805|NCT00105950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25866806|NCT00105950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866807|NCT00105950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876604|NCT03269669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25876605|NCT03269669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24896266|NCT00790933|Vedolizumab|vedolizumab|mesh-list
24896267|NCT00790933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24896269|NCT00127673|Antidepressive Agents|antidepressive agents|mesh-ancestor
24896270|NCT00127673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24896271|NCT00127673|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24896272|NCT00127673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24896273|NCT00127673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25876606|NCT03269669|Growth Substances|growth substances|mesh-ancestor
24515614|NCT00598403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24515615|NCT00598403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24515616|NCT00598429|Alprostadil|alprostadil|mesh-list
24515617|NCT00598429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24515618|NCT00598429|Vasodilator Agents|vasodilator agents|mesh-ancestor
24515619|NCT00598429|Urological Agents|urological agents|mesh-ancestor
24896284|NCT04438421|Disinfectants|disinfectants|mesh-ancestor
24896285|NCT04438421|Dermatologic Agents|dermatologic agents|mesh-ancestor
24896286|NCT04438421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24896287|NCT04438421|Immunologic Factors|immunologic factors|mesh-ancestor
24896288|NCT04438421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896289|NCT04438421|Viscosupplements|viscosupplements|mesh-ancestor
24896290|NCT04438421|Protective Agents|protective agents|mesh-ancestor
24896291|NCT04438577|Lidocaine|lidocaine|mesh-list
24896292|NCT04438577|Anesthetics, Local|anesthetics, local|mesh-ancestor
24473322|NCT00402545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24473323|NCT00402545|Immunologic Factors|immunologic factors|mesh-ancestor
24515620|NCT00598533|Sirolimus|sirolimus|mesh-list
24515621|NCT00598533|Probucol|probucol|mesh-list
24515622|NCT00598533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24515623|NCT00598533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24812671|NCT02054000|Tirofiban|tirofiban|mesh-list
24515633|NCT00598533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438431|NCT00275938|Interferons|interferons|mesh-list
24515634|NCT00598533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24515635|NCT00598533|Antioxidants|antioxidants|mesh-ancestor
24515636|NCT00598533|Protective Agents|protective agents|mesh-ancestor
24515637|NCT00598572|Deferoxamine|deferoxamine|mesh-list
25062599|NCT04311489|Diuretics|diuretics|mesh-ancestor
25062600|NCT04311489|Natriuretic Agents|natriuretic agents|mesh-ancestor
25062601|NCT04308304|Donepezil|donepezil|mesh-list
24515638|NCT00598572|Siderophores|siderophores|mesh-ancestor
25876607|NCT03269669|Growth Inhibitors|growth inhibitors|mesh-ancestor
25876608|NCT03269669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24896293|NCT04438577|Anesthetics|anesthetics|mesh-ancestor
25062617|NCT04280848|Alkylating Agents|alkylating agents|mesh-ancestor
24896294|NCT04438577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24896295|NCT04438577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817437|NCT02083640|Palbociclib|palbociclib|mesh-list
24817438|NCT02083640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24817439|NCT02083640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24817440|NCT02083640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817441|NCT02083640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817442|NCT02083692|Metformin|metformin|mesh-list
24817443|NCT02083692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24473330|NCT00402558|Busulfan|busulfan|mesh-list
25876609|NCT03257631|Thalidomide|thalidomide|mesh-list
25876610|NCT03257631|Pomalidomide|pomalidomide|mesh-list
25876611|NCT03257631|Immunologic Factors|immunologic factors|mesh-ancestor
25876612|NCT03257631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876613|NCT03257631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24817460|NCT02084043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24817461|NCT02084043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24817462|NCT02084225|Lidocaine|lidocaine|mesh-list
24817463|NCT02084225|Anesthetics, Local|anesthetics, local|mesh-ancestor
24817464|NCT02084225|Anesthetics|anesthetics|mesh-ancestor
25432748|NCT00687765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876614|NCT03257631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25876615|NCT03257631|Growth Substances|growth substances|mesh-ancestor
24817465|NCT02084225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24817466|NCT02084225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817467|NCT02084225|Sensory System Agents|sensory system agents|mesh-ancestor
24817468|NCT02084225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24817469|NCT02084225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24817470|NCT02084225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24817471|NCT02084225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24817472|NCT02084225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24817473|NCT02084225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613543|NCT01019642|Cholecalciferol|cholecalciferol|mesh-list
24515653|NCT00598611|Histamine Agents|histamine agents|mesh-ancestor
24515654|NCT00598611|Antipruritics|antipruritics|mesh-ancestor
24515655|NCT00598611|Dermatologic Agents|dermatologic agents|mesh-ancestor
24515656|NCT00598611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24817483|NCT02084342|Hemostatics|hemostatics|mesh-ancestor
24817484|NCT02084342|Coagulants|coagulants|mesh-ancestor
24817485|NCT02084342|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24817486|NCT02084342|Natriuretic Agents|natriuretic agents|mesh-ancestor
24817487|NCT02084342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817489|NCT02084355|Oxycodone|oxycodone|mesh-list
24817490|NCT02084355|Hydromorphone|hydromorphone|mesh-list
24817491|NCT02084355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25201663|NCT02726269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24817492|NCT02084355|Narcotics|narcotics|mesh-ancestor
24817493|NCT02084355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24817494|NCT02084355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817495|NCT02084355|Analgesics|analgesics|mesh-ancestor
24817496|NCT02084355|Sensory System Agents|sensory system agents|mesh-ancestor
24817497|NCT02084355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24817498|NCT02084355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24896314|NCT04438434|Immunologic Factors|immunologic factors|mesh-ancestor
24896315|NCT04438434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896316|NCT04438434|Viscosupplements|viscosupplements|mesh-ancestor
24896317|NCT04438434|Protective Agents|protective agents|mesh-ancestor
24896318|NCT04437836|Rifampin|rifampin|mesh-list
25062604|NCT04308304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062605|NCT04308304|Cholinergic Agents|cholinergic agents|mesh-ancestor
25062606|NCT04308304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24515671|NCT00598676|Immunologic Factors|immunologic factors|mesh-ancestor
24515672|NCT00598676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515673|NCT00598676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24515674|NCT00598676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24515675|NCT00598676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25866809|NCT00106054|Bevacizumab|bevacizumab|mesh-list
25866810|NCT00106054|Irinotecan|irinotecan|mesh-list
24896363|NCT04437004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062615|NCT04280848|Temozolomide|temozolomide|mesh-list
25866811|NCT00106054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25866812|NCT00106054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866813|NCT00106054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25866814|NCT00106054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24525840|NCT02644369|Pembrolizumab|pembrolizumab|mesh-list
24896390|NCT04437160|Cyclophosphamide|cyclophosphamide|mesh-list
24896391|NCT04437160|Epirubicin|epirubicin|mesh-list
24896392|NCT04437160|Pirarubicin|pirarubicin|mesh-list
24896393|NCT04437160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24896394|NCT04437160|Immunologic Factors|immunologic factors|mesh-ancestor
24896395|NCT04437160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896396|NCT04437160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24896397|NCT04437160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24896398|NCT04437160|Alkylating Agents|alkylating agents|mesh-ancestor
24473480|NCT00403013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201664|NCT02726126|Fentanyl|fentanyl|mesh-list
24685651|NCT05250141|Levodopa|levodopa|mesh-list
25866815|NCT00106054|Growth Substances|growth substances|mesh-ancestor
25866816|NCT00106054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866817|NCT00106054|Growth Inhibitors|growth inhibitors|mesh-ancestor
25866818|NCT00106054|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25866819|NCT00106054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25866820|NCT00106054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866821|NCT00106054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896402|NCT04437160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24896403|NCT04437160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24896404|NCT04437160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25866822|NCT00106054|Antidotes|antidotes|mesh-ancestor
25866823|NCT00106054|Protective Agents|protective agents|mesh-ancestor
25866824|NCT00106054|Vitamin B Complex|vitamin b complex|mesh-ancestor
25866825|NCT00106054|Vitamins|vitamins|mesh-ancestor
24515724|NCT00598897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24515725|NCT00598897|Antitubercular Agents|antitubercular agents|mesh-ancestor
24515727|NCT00598923|Phenytoin|phenytoin|mesh-list
24515728|NCT00598923|Anticonvulsants|anticonvulsants|mesh-ancestor
24515729|NCT00598923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24515730|NCT00598923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515731|NCT00598923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24515732|NCT00598923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24515733|NCT00598923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24515734|NCT00598923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866826|NCT00106054|Micronutrients|micronutrients|mesh-ancestor
25866827|NCT00106132|Triamcinolone|triamcinolone|mesh-list
25866828|NCT00106132|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25866829|NCT00106132|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25866830|NCT00106132|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25866831|NCT00106132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25866832|NCT00106132|Glucocorticoids|glucocorticoids|mesh-ancestor
25866833|NCT00106132|Hormones|hormones|mesh-ancestor
25866834|NCT00106132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25866835|NCT00106132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866836|NCT00106132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25866837|NCT00106132|Immunologic Factors|immunologic factors|mesh-ancestor
25866838|NCT00106132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866839|NCT00106132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866840|NCT00106171|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25866841|NCT00106171|Antiviral Agents|antiviral agents|mesh-ancestor
25866842|NCT00106171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25866843|NCT00106197|Bupropion|bupropion|mesh-list
25866844|NCT00106197|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25866845|NCT00106197|Antidepressive Agents|antidepressive agents|mesh-ancestor
25866846|NCT00106197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25866847|NCT00106197|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25866848|NCT00106197|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25866849|NCT00106197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25866850|NCT00106197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866851|NCT00106197|Dopamine Agents|dopamine agents|mesh-ancestor
25866852|NCT00106197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25866853|NCT00106197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866854|NCT00106197|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25866855|NCT00106197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25866856|NCT00106197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866857|NCT00106262|Irinotecan|irinotecan|mesh-list
25866858|NCT00106262|Bortezomib|bortezomib|mesh-list
25866859|NCT00106262|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25866860|NCT00106262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25866861|NCT00106262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866862|NCT00106262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866863|NCT00106262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866864|NCT00106288|Amphotericin B|amphotericin b|mesh-list
24526301|NCT00248703|Tubulin Modulators|tubulin modulators|mesh-ancestor
24896411|NCT04436419|Antioxidants|antioxidants|mesh-ancestor
24896412|NCT04436419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896413|NCT04436419|Protective Agents|protective agents|mesh-ancestor
24896414|NCT04436419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896415|NCT04436419|Vitamin B Complex|vitamin b complex|mesh-ancestor
24896416|NCT04436419|Vitamins|vitamins|mesh-ancestor
24896417|NCT04436419|Micronutrients|micronutrients|mesh-ancestor
24896418|NCT04436536|Methamphetamine|methamphetamine|mesh-list
24896419|NCT04436536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24896420|NCT04436536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896421|NCT04436536|Sympathomimetics|sympathomimetics|mesh-ancestor
24896422|NCT04436536|Autonomic Agents|autonomic agents|mesh-ancestor
24896423|NCT04436536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24896424|NCT04436536|Dopamine Agents|dopamine agents|mesh-ancestor
24896425|NCT04436536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24896426|NCT04436536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896427|NCT04436536|Adrenergic Agents|adrenergic agents|mesh-ancestor
25866865|NCT00106288|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25866866|NCT00106288|Micafungin|micafungin|mesh-list
25866867|NCT00106288|Amebicides|amebicides|mesh-ancestor
25866868|NCT00106288|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25866869|NCT00106288|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24896428|NCT04436536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25201665|NCT02726126|Melatonin|melatonin|mesh-list
25201666|NCT02726126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24463295|NCT00359853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515747|NCT00598962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515748|NCT00598962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24515749|NCT00598962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24515750|NCT00598962|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24515751|NCT00598962|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24515752|NCT00598962|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24515753|NCT00598962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24515765|NCT00599235|Sildenafil Citrate|sildenafil citrate|mesh-list
24515766|NCT00599235|Vasodilator Agents|vasodilator agents|mesh-ancestor
24686012|NCT05087771|Naltrexone|naltrexone|mesh-list
25866870|NCT00106288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25062632|NCT04270877|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25062633|NCT04270877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062634|NCT04270877|Sensory System Agents|sensory system agents|mesh-ancestor
25062635|NCT04270877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25062636|NCT04231877|Prednisone|prednisone|mesh-list
25062637|NCT04231877|Cortisone|cortisone|mesh-list
25062638|NCT04231877|Cyclophosphamide|cyclophosphamide|mesh-list
25062639|NCT04231877|Rituximab|rituximab|mesh-list
25866871|NCT00106288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25866872|NCT00106288|Antifungal Agents|antifungal agents|mesh-ancestor
25866873|NCT00106301|Romidepsin|romidepsin|mesh-list
25866874|NCT00106301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25866875|NCT00106301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866876|NCT00106314|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25866877|NCT00106314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25866878|NCT00106314|Immunologic Factors|immunologic factors|mesh-ancestor
25866879|NCT00106314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866880|NCT00106366|Insulin|insulin|mesh-list
25866881|NCT00106366|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25201667|NCT02726126|Narcotics|narcotics|mesh-ancestor
25866882|NCT00106366|Insulin Glargine|insulin glargine|mesh-list
25866883|NCT00106366|Insulin Aspart|insulin aspart|mesh-list
25866884|NCT00106366|Insulin Detemir|insulin detemir|mesh-list
25866885|NCT00106366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25866886|NCT00106366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866887|NCT00106379|Tenofovir|tenofovir|mesh-list
25866888|NCT00106379|Emtricitabine|emtricitabine|mesh-list
25866889|NCT00106379|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25866890|NCT00106379|Antiviral Agents|antiviral agents|mesh-ancestor
24515783|NCT00599287|Haloperidol decanoate|haloperidol decanoate|mesh-list
24515785|NCT00599287|Rivastigmine|rivastigmine|mesh-list
24515786|NCT00599287|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24515787|NCT00599287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515788|NCT00599287|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24515789|NCT00599287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24515790|NCT00599287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24515791|NCT00599287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515792|NCT00599287|Dopamine Agents|dopamine agents|mesh-ancestor
24515793|NCT00599287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25866891|NCT00106379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25866892|NCT00106379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25866893|NCT00106379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24896473|NCT04435925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896474|NCT04435925|Analgesics|analgesics|mesh-ancestor
24896475|NCT04435925|Sensory System Agents|sensory system agents|mesh-ancestor
24896476|NCT04435925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24896477|NCT04435925|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24896478|NCT04435925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24896479|NCT04435925|Anesthetics, General|anesthetics, general|mesh-ancestor
24896482|NCT04435743|Immunologic Factors|immunologic factors|mesh-ancestor
24896483|NCT04435743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896484|NCT04435743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24896485|NCT04435743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24896486|NCT04435743|Growth Substances|growth substances|mesh-ancestor
24896487|NCT04435743|Growth Inhibitors|growth inhibitors|mesh-ancestor
24896488|NCT04435743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866894|NCT00106379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866895|NCT00106379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866896|NCT00106379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25866897|NCT00106379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25866898|NCT00106405|Memantine|memantine|mesh-list
25866899|NCT00106405|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25866900|NCT00106405|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25866901|NCT00106405|Dopamine Agents|dopamine agents|mesh-ancestor
25866902|NCT00106405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25062647|NCT04231877|Immunoglobulins|immunoglobulins|mesh-list
25062648|NCT04231877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25062650|NCT04231877|Immunoconjugates|immunoconjugates|mesh-list
25062651|NCT04231877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25062652|NCT04231877|Immunologic Factors|immunologic factors|mesh-ancestor
25062653|NCT04231877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515819|NCT00599534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515820|NCT00599534|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25201668|NCT02726126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24896499|NCT04435587|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24896500|NCT04435587|Protease Inhibitors|protease inhibitors|mesh-ancestor
24896501|NCT04435587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896502|NCT04435587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896503|NCT04435587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24896504|NCT04435587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24896505|NCT04435587|Antiviral Agents|antiviral agents|mesh-ancestor
24896506|NCT04435587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24896507|NCT04435587|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24896508|NCT04435587|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24896509|NCT04435587|Antimalarials|antimalarials|mesh-ancestor
24896510|NCT04435587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24896511|NCT04435587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24896512|NCT04435587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24896513|NCT04435652|Paclitaxel|paclitaxel|mesh-list
24896514|NCT04435652|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24896515|NCT04435652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24896516|NCT04435652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24896517|NCT04435652|Tubulin Modulators|tubulin modulators|mesh-ancestor
24515821|NCT00599534|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24515823|NCT00599560|Vasopressins|vasopressins|mesh-list
24515824|NCT00599560|Arginine Vasopressin|arginine vasopressin|mesh-list
24515825|NCT00599560|Hemostatics|hemostatics|mesh-ancestor
24515826|NCT00599560|Coagulants|coagulants|mesh-ancestor
25866903|NCT00106405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866904|NCT00106405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866905|NCT00106405|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25866906|NCT00106405|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25866907|NCT00106418|Romidepsin|romidepsin|mesh-list
25866908|NCT00106418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25866909|NCT00106418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866910|NCT00106496|Tacrolimus|tacrolimus|mesh-list
25866911|NCT00106496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24686324|NCT04907825|Warfarin|warfarin|mesh-list
25866912|NCT00106496|Immunologic Factors|immunologic factors|mesh-ancestor
25866913|NCT00106496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866914|NCT00106496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25866915|NCT00106496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866916|NCT00106496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866917|NCT00106522|Methotrexate|methotrexate|mesh-list
25866918|NCT00106522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25866919|NCT00106522|Abortifacient Agents|abortifacient agents|mesh-ancestor
25866920|NCT00106522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25866921|NCT00106522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866922|NCT00106522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25866923|NCT00106522|Antimetabolites|antimetabolites|mesh-ancestor
25866924|NCT00106522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866925|NCT00106522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866926|NCT00106522|Dermatologic Agents|dermatologic agents|mesh-ancestor
24433257|NCT00258050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25866927|NCT00106522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866928|NCT00106522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25866929|NCT00106522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25866930|NCT00106522|Immunologic Factors|immunologic factors|mesh-ancestor
25866931|NCT00106522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25866932|NCT00106522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25866933|NCT00106548|Methotrexate|methotrexate|mesh-list
25866934|NCT00106548|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25866935|NCT00106548|Abortifacient Agents|abortifacient agents|mesh-ancestor
24817508|NCT02084368|Sensory System Agents|sensory system agents|mesh-ancestor
25432749|NCT00680992|Denosumab|denosumab|mesh-list
24817509|NCT02084368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24817511|NCT02084420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24817512|NCT02084420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24817513|NCT02084420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24817514|NCT02084420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817515|NCT02084420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817516|NCT02084433|Anesthetics|anesthetics|mesh-list
24817517|NCT02084433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24896537|NCT04435418|Apixaban|apixaban|mesh-list
24896538|NCT04435418|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24896539|NCT04435418|Antithrombins|antithrombins|mesh-ancestor
24896540|NCT04435418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24896541|NCT04435418|Protease Inhibitors|protease inhibitors|mesh-ancestor
24896542|NCT04435418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896543|NCT04435418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896544|NCT04435418|Anticoagulants|anticoagulants|mesh-ancestor
24896545|NCT04435197|Pembrolizumab|pembrolizumab|mesh-list
24896546|NCT04435197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24896547|NCT04435197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24896548|NCT04435028|Ketotifen|ketotifen|mesh-list
24896549|NCT04435028|Antipruritics|antipruritics|mesh-ancestor
24896550|NCT04435028|Dermatologic Agents|dermatologic agents|mesh-ancestor
24896561|NCT04435210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24896562|NCT04435210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896563|NCT04435210|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24896564|NCT04435210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896566|NCT04435210|Tocolytic Agents|tocolytic agents|mesh-ancestor
24896567|NCT04435210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24896568|NCT04435210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24896569|NCT04434482|Temozolomide|temozolomide|mesh-list
24896570|NCT04434482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24896586|NCT04434378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896587|NCT04434378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896601|NCT04434430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24896602|NCT04434430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24527317|NCT00615875|Naproxen|naproxen|mesh-list
25866936|NCT00106548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25866937|NCT00106548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866938|NCT00106548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25866939|NCT00106548|Antimetabolites|antimetabolites|mesh-ancestor
24686785|NCT04579848|Antimetabolites|antimetabolites|mesh-ancestor
25062673|NCT04231877|Tubulin Modulators|tubulin modulators|mesh-ancestor
24946989|NCT03933605|Anesthetics|anesthetics|mesh-ancestor
25866940|NCT00106548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866941|NCT00106548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866942|NCT00106548|Dermatologic Agents|dermatologic agents|mesh-ancestor
25866943|NCT00106548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896609|NCT04434365|Aspirin|aspirin|mesh-list
24896610|NCT04434365|Clopidogrel|clopidogrel|mesh-list
24896611|NCT04434365|Atorvastatin|atorvastatin|mesh-list
24896612|NCT04434365|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24896613|NCT04434365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24896614|NCT04434365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24896615|NCT04434365|Analgesics|analgesics|mesh-ancestor
24896616|NCT04434365|Sensory System Agents|sensory system agents|mesh-ancestor
24896617|NCT04434365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25866944|NCT00106548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25866945|NCT00106548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25866946|NCT00106548|Immunologic Factors|immunologic factors|mesh-ancestor
25866947|NCT00106548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25866948|NCT00106548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24515857|NCT00599651|Respiratory System Agents|respiratory system agents|mesh-ancestor
25866949|NCT00106561|Irbesartan|irbesartan|mesh-list
25866950|NCT00106561|Spironolactone|spironolactone|mesh-list
25866951|NCT00106561|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25866952|NCT00106561|Hormone Antagonists|hormone antagonists|mesh-ancestor
25866953|NCT00106561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24471839|NCT00397059|Citalopram|citalopram|mesh-list
24515889|NCT00599898|Atosiban|atosiban|mesh-list
24515890|NCT00599898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24515891|NCT00599898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24515899|NCT00599898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24515901|NCT00599911|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25432750|NCT00680992|Immunoglobulins|immunoglobulins|mesh-list
24515902|NCT00599911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24515903|NCT00599911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25866954|NCT00106561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866955|NCT00106561|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24947097|NCT03932526|Apatinib|apatinib|mesh-list
24772398|NCT01833611|Entecavir|entecavir|mesh-list
24947098|NCT03932526|Vinorelbine|vinorelbine|mesh-list
24825223|NCT02127853|Gabapentin|gabapentin|mesh-list
25866956|NCT00106561|Diuretics|diuretics|mesh-ancestor
25866957|NCT00106561|Natriuretic Agents|natriuretic agents|mesh-ancestor
24515904|NCT00599911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515905|NCT00599911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24515906|NCT00599911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515907|NCT00599911|Analgesics|analgesics|mesh-ancestor
24515908|NCT00599911|Sensory System Agents|sensory system agents|mesh-ancestor
24515909|NCT00599911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24515910|NCT00599911|Antidepressive Agents|antidepressive agents|mesh-ancestor
24515911|NCT00599911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24515912|NCT00599911|Dopamine Agents|dopamine agents|mesh-ancestor
24515913|NCT00599937|Tretinoin|tretinoin|mesh-list
25866958|NCT00106561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25866959|NCT00106561|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25866960|NCT00106561|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25866961|NCT00106561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866962|NCT00106587|Paclitaxel|paclitaxel|mesh-list
24896627|NCT04434365|Antipyretics|antipyretics|mesh-ancestor
24896628|NCT04434365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24896629|NCT04434365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24896630|NCT04434365|Antimetabolites|antimetabolites|mesh-ancestor
24896631|NCT04434365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24896632|NCT04434365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24896633|NCT04434365|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24896634|NCT04434365|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24896635|NCT04434365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24896636|NCT04434365|Purinergic Agents|purinergic agents|mesh-ancestor
24473716|NCT00403910|Diuretics|diuretics|mesh-ancestor
25866963|NCT00106587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25866964|NCT00106587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866965|NCT00106587|Tubulin Modulators|tubulin modulators|mesh-ancestor
25866966|NCT00106587|Antimitotic Agents|antimitotic agents|mesh-ancestor
25866967|NCT00106587|Mitosis Modulators|mitosis modulators|mesh-ancestor
25866968|NCT00106587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866969|NCT00106600|Pixantrone|pixantrone|mesh-list
24515936|NCT00600054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24515937|NCT00600054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24515938|NCT00600093|Amantadine|amantadine|mesh-list
24515939|NCT00600093|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24947100|NCT03932526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24947101|NCT03932526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24947102|NCT03932526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947103|NCT03932526|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24947104|NCT03932526|Tubulin Modulators|tubulin modulators|mesh-ancestor
24947105|NCT03932526|Antimitotic Agents|antimitotic agents|mesh-ancestor
24947106|NCT03932526|Mitosis Modulators|mitosis modulators|mesh-ancestor
24947107|NCT03932123|Vancomycin|vancomycin|mesh-list
24947108|NCT03932123|Meropenem|meropenem|mesh-list
24947109|NCT03932123|Tazobactam|tazobactam|mesh-list
24825227|NCT02127853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825228|NCT02127853|Anticonvulsants|anticonvulsants|mesh-ancestor
24825229|NCT02127853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24686995|NCT04433390|Naloxegol|naloxegol|mesh-list
25866970|NCT00106600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25866971|NCT00106600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25866972|NCT00106600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25866973|NCT00106600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25866974|NCT00106600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866975|NCT00106613|Romidepsin|romidepsin|mesh-list
25866976|NCT00106613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25866977|NCT00106613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866978|NCT00106691|Toremifene|toremifene|mesh-list
25866979|NCT00106691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25866980|NCT00106691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25866981|NCT00106691|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25866982|NCT00106691|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25866983|NCT00106691|Hormone Antagonists|hormone antagonists|mesh-ancestor
24901324|NCT04386122|Loxoprofen|loxoprofen|mesh-list
24841920|NCT02219100|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24841921|NCT02219100|Abortifacient Agents|abortifacient agents|mesh-ancestor
25866984|NCT00106691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25866985|NCT00106691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866986|NCT00106691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25866987|NCT00106821|Bromides|bromides|mesh-list
25866988|NCT00106821|Tiotropium Bromide|tiotropium bromide|mesh-list
25866989|NCT00106821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25866990|NCT00106821|Autonomic Agents|autonomic agents|mesh-ancestor
25866991|NCT00106821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25866992|NCT00106821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25866993|NCT00106821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25866994|NCT00106821|Respiratory System Agents|respiratory system agents|mesh-ancestor
24947110|NCT03932123|Piperacillin|piperacillin|mesh-list
24947111|NCT03932123|Cefotaxime|cefotaxime|mesh-list
24947112|NCT03932123|Cefoxitin|cefoxitin|mesh-list
24772474|NCT01833819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24772475|NCT01833819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24772476|NCT01833819|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24772477|NCT01833819|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24953187|NCT03887650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24953188|NCT03887650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24953189|NCT03887650|Respiratory System Agents|respiratory system agents|mesh-ancestor
24953190|NCT03887650|Mydriatics|mydriatics|mesh-ancestor
24953191|NCT03887650|Sympathomimetics|sympathomimetics|mesh-ancestor
24953192|NCT03887650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24825230|NCT02127853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25866995|NCT00106821|Parasympatholytics|parasympatholytics|mesh-ancestor
25866996|NCT00106821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25866997|NCT00106821|Cholinergic Agents|cholinergic agents|mesh-ancestor
25866998|NCT00106821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25866999|NCT00106821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867000|NCT00106821|Anticonvulsants|anticonvulsants|mesh-ancestor
25867001|NCT00106834|Infliximab|infliximab|mesh-list
25867002|NCT00106834|Dermatologic Agents|dermatologic agents|mesh-ancestor
25867003|NCT00106834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25867004|NCT00106834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25867005|NCT00106847|Infliximab|infliximab|mesh-list
25867006|NCT00106847|Dermatologic Agents|dermatologic agents|mesh-ancestor
25867007|NCT00106847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25867008|NCT00106847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25867009|NCT00106886|Folic Acid|folic acid|mesh-list
25867010|NCT00106886|Vitamin B 6|vitamin b 6|mesh-list
25867011|NCT00106886|Pyridoxal|pyridoxal|mesh-list
25867012|NCT00106886|Pyridoxine|pyridoxine|mesh-list
25867013|NCT00106886|Vitamins|vitamins|mesh-ancestor
25867014|NCT00106886|Micronutrients|micronutrients|mesh-ancestor
25867015|NCT00106886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867016|NCT00106886|Hematinics|hematinics|mesh-ancestor
25867017|NCT00106886|Vitamin B Complex|vitamin b complex|mesh-ancestor
25867018|NCT00107003|Lapatinib|lapatinib|mesh-list
25867019|NCT00107003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867020|NCT00107003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25867021|NCT00107003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867022|NCT00107003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867023|NCT00107016|Letrozole|letrozole|mesh-list
24884892|NCT03277066|Diclofenac|diclofenac|mesh-list
24896647|NCT04434248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953193|NCT03887754|Risperidone|risperidone|mesh-list
24953194|NCT03887754|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24953195|NCT03887754|Serotonin Agents|serotonin agents|mesh-ancestor
24953196|NCT03887754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24687277|NCT04108026|Durvalumab|durvalumab|mesh-list
25670483|NCT04381936|Dermatologic Agents|dermatologic agents|mesh-ancestor
25670484|NCT04381936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25670485|NCT04379999|Aspirin|aspirin|mesh-list
25670486|NCT04379999|Atorvastatin|atorvastatin|mesh-list
25670487|NCT04379999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25670488|NCT04379999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25670489|NCT04379999|Analgesics|analgesics|mesh-ancestor
25670490|NCT04379999|Sensory System Agents|sensory system agents|mesh-ancestor
25670491|NCT04379999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25670492|NCT04379999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670493|NCT04379999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25670494|NCT04379999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25670495|NCT04379999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25670496|NCT04379999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25670497|NCT04379999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842058|NCT02219659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25670498|NCT04379999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25867024|NCT00107016|Everolimus|everolimus|mesh-list
25867025|NCT00107016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867026|NCT00107016|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25867027|NCT00107016|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25867028|NCT00107016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867029|NCT00107016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867030|NCT00107016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25867031|NCT00107016|Hormone Antagonists|hormone antagonists|mesh-ancestor
25867032|NCT00107016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24953218|NCT03887858|Adrenergic Agents|adrenergic agents|mesh-ancestor
24953219|NCT03887858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24953220|NCT03887858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953221|NCT03887858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867033|NCT00107016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867034|NCT00107016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25867035|NCT00107016|Immunologic Factors|immunologic factors|mesh-ancestor
25867036|NCT00107081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25867037|NCT00107081|Amoxicillin|amoxicillin|mesh-list
25867038|NCT00107081|Ciprofloxacin|ciprofloxacin|mesh-list
25867039|NCT00107081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25867040|NCT00107081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25867041|NCT00107081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25867042|NCT00107081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867043|NCT00107081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867044|NCT00107081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25062683|NCT04211272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062684|NCT04211272|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25062685|NCT04211272|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25062686|NCT04211272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25062687|NCT04211272|Vasodilator Agents|vasodilator agents|mesh-ancestor
25062688|NCT04211272|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25062689|NCT04211272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25062690|NCT04211272|Urological Agents|urological agents|mesh-ancestor
25062691|NCT04211272|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25062692|NCT04211272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25062693|NCT04211272|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25062694|NCT04211272|Enzyme Activators|enzyme activators|mesh-ancestor
25201669|NCT02726126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867045|NCT00107081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25201670|NCT02726126|Analgesics|analgesics|mesh-ancestor
24896660|NCT04434105|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25867046|NCT00107081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25867047|NCT00107094|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25867048|NCT00107094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25062707|NCT04201964|Tenecteplase|tenecteplase|mesh-list
25062708|NCT04201964|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25062709|NCT04201964|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25062710|NCT04201964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062711|NCT04155203|Calcium, Dietary|calcium, dietary|mesh-list
25062712|NCT04155203|Mupirocin|mupirocin|mesh-list
25062713|NCT04155203|Calcium|calcium|mesh-list
25062714|NCT04155203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25062736|NCT04099355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062737|NCT04099355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25062738|NCT04099355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25062739|NCT04099355|Analgesics|analgesics|mesh-ancestor
25062740|NCT04099355|Sensory System Agents|sensory system agents|mesh-ancestor
25062741|NCT04099355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25062742|NCT04099355|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25670499|NCT04379999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25670500|NCT04379999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25670501|NCT04379999|Antipyretics|antipyretics|mesh-ancestor
25670502|NCT04379999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25670503|NCT04379999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25670504|NCT04379999|Antimetabolites|antimetabolites|mesh-ancestor
25670505|NCT04379999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25670506|NCT04379999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25670507|NCT04369365|Azithromycin|azithromycin|mesh-list
25670508|NCT04369365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25670509|NCT04369365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24539101|NCT00662337|Histamine Antagonists|histamine antagonists|mesh-ancestor
24539103|NCT00662337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24539104|NCT00662337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539105|NCT00662337|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24539106|NCT00662337|Antipruritics|antipruritics|mesh-ancestor
24707357|NCT01495338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24707358|NCT01495338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25062743|NCT04099355|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25062744|NCT04099355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25062745|NCT04099355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062746|NCT04099355|Hormones|hormones|mesh-ancestor
25062769|NCT04072042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825341|NCT02128204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24896692|NCT04433533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24896693|NCT04433533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24896695|NCT04433533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896696|NCT04433533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24473764|NCT00404157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24687894|NCT03618550|Antiviral Agents|antiviral agents|mesh-ancestor
24516047|NCT00600405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24516048|NCT00600405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24884971|NCT03090997|Antioxidants|antioxidants|mesh-ancestor
24896697|NCT04433533|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24896699|NCT04433611|Lidocaine|lidocaine|mesh-list
24896700|NCT04433611|Anesthetics, Local|anesthetics, local|mesh-ancestor
24896701|NCT04433611|Anesthetics|anesthetics|mesh-ancestor
24896702|NCT04433611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24896703|NCT04433611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896704|NCT04433611|Sensory System Agents|sensory system agents|mesh-ancestor
24896705|NCT04433611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24947178|NCT03931889|Vitamin D|vitamin d|mesh-list
24516053|NCT00600405|Narcotics|narcotics|mesh-ancestor
24817542|NCT02084446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24817543|NCT02084446|Antiemetics|antiemetics|mesh-ancestor
24817544|NCT02084446|Autonomic Agents|autonomic agents|mesh-ancestor
24817545|NCT02084446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24817546|NCT02084446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25062821|NCT03912831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062822|NCT03912831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25062823|NCT03912831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25201671|NCT02726126|Sensory System Agents|sensory system agents|mesh-ancestor
25062824|NCT03912831|Alkylating Agents|alkylating agents|mesh-ancestor
25062825|NCT03912831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062826|NCT03912831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25062827|NCT03912831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24825405|NCT02128308|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24516075|NCT00600548|Miltefosine|miltefosine|mesh-list
24516076|NCT00600548|Meglumine Antimoniate|meglumine antimoniate|mesh-list
24516077|NCT00600548|Antifungal Agents|antifungal agents|mesh-ancestor
24516078|NCT00600548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25867049|NCT00107107|Pramlintide|pramlintide|mesh-list
25867050|NCT00107107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25867051|NCT00107107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867052|NCT00107237|Everolimus|everolimus|mesh-list
25867053|NCT00107237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867054|NCT00107237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25867055|NCT00107237|Immunologic Factors|immunologic factors|mesh-ancestor
25867056|NCT00107237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867057|NCT00107263|Zoledronic Acid|zoledronic acid|mesh-list
25867058|NCT00107263|Letrozole|letrozole|mesh-list
25867059|NCT00107263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867060|NCT00107263|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25876616|NCT03257631|Growth Inhibitors|growth inhibitors|mesh-ancestor
24516081|NCT00600548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24516082|NCT00600587|Gemcitabine|gemcitabine|mesh-list
25670510|NCT04329221|Calcitriol|calcitriol|mesh-list
25670511|NCT04329221|Fluorouracil|fluorouracil|mesh-list
25670512|NCT04329221|Calcipotriene|calcipotriene|mesh-list
25670513|NCT04329221|Petrolatum|petrolatum|mesh-list
25670514|NCT04329221|Antimetabolites|antimetabolites|mesh-ancestor
25670515|NCT04329221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670516|NCT04329221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25670517|NCT04329221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670518|NCT04329221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25867061|NCT00107263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25867062|NCT00107263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867063|NCT00107263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867064|NCT00107263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25670519|NCT04329221|Immunologic Factors|immunologic factors|mesh-ancestor
25670520|NCT04329221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670521|NCT04329221|Dermatologic Agents|dermatologic agents|mesh-ancestor
25670522|NCT04329221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25227229|NCT02615873|Levodopa|levodopa|mesh-list
25227230|NCT02615873|Carbidopa|carbidopa|mesh-list
24516083|NCT00600587|Carboplatin|carboplatin|mesh-list
24516084|NCT00600587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24516086|NCT00600587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24516087|NCT00600587|Antimetabolites|antimetabolites|mesh-ancestor
24516088|NCT00600587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062829|NCT03910621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25062830|NCT03910621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062831|NCT03910621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25062832|NCT03910621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25062833|NCT03910621|Antiviral Agents|antiviral agents|mesh-ancestor
25062834|NCT03910621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25062835|NCT03910621|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25062836|NCT03910621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24825415|NCT02128321|Repaglinide|repaglinide|mesh-list
25867065|NCT00107263|Hormone Antagonists|hormone antagonists|mesh-ancestor
25867066|NCT00107263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25867067|NCT00107263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896709|NCT04433611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24896710|NCT04433611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867068|NCT00107263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25867069|NCT00107341|Paclitaxel|paclitaxel|mesh-list
25867070|NCT00107341|Carboplatin|carboplatin|mesh-list
25867071|NCT00107341|Bortezomib|bortezomib|mesh-list
25062837|NCT03910621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825424|NCT02128321|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25867072|NCT00107341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25867073|NCT00107341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867074|NCT00107341|Tubulin Modulators|tubulin modulators|mesh-ancestor
25867075|NCT00107341|Antimitotic Agents|antimitotic agents|mesh-ancestor
25867076|NCT00107341|Mitosis Modulators|mitosis modulators|mesh-ancestor
24516091|NCT00600587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516092|NCT00600587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24516093|NCT00600587|Immunologic Factors|immunologic factors|mesh-ancestor
24516094|NCT00600587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516095|NCT00600587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25201672|NCT02726126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24464674|NCT00365898|Hydromorphone|hydromorphone|mesh-list
24516097|NCT00600600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24516098|NCT00600600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24516099|NCT00600600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24516100|NCT00600600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516101|NCT00600600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516102|NCT00600626|Insulin|insulin|mesh-list
24516104|NCT00600626|Insulin Aspart|insulin aspart|mesh-list
24516105|NCT00600626|Insulin, Long-Acting|insulin, long-acting|mesh-list
24516106|NCT00600626|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24516107|NCT00600626|Biphasic Insulins|biphasic insulins|mesh-list
24516108|NCT00600626|Isophane Insulin, Human|isophane insulin, human|mesh-list
24516109|NCT00600626|Insulin, Isophane|insulin, isophane|mesh-list
24516110|NCT00600626|Isophane insulin, beef|isophane insulin, beef|mesh-list
24516111|NCT00600626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24516112|NCT00600626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516113|NCT00600639|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24516132|NCT00600639|Antiemetics|antiemetics|mesh-ancestor
24516133|NCT00600639|Autonomic Agents|autonomic agents|mesh-ancestor
24516134|NCT00600639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24896715|NCT04433481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896716|NCT04433481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896717|NCT04433481|Anticoagulants|anticoagulants|mesh-ancestor
25670523|NCT04329221|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25670524|NCT04329221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25670525|NCT04329221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25670526|NCT04329221|Vitamins|vitamins|mesh-ancestor
25670527|NCT04329221|Micronutrients|micronutrients|mesh-ancestor
24896718|NCT04433741|Oxytocin|oxytocin|mesh-list
24896720|NCT04433741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25867077|NCT00107341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062849|NCT03866252|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
25062851|NCT03866252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062852|NCT03866252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25867078|NCT00107354|Cytarabine|cytarabine|mesh-list
25867079|NCT00107354|Aldesleukin|aldesleukin|mesh-list
25867080|NCT00107354|Etoposide|etoposide|mesh-list
25867081|NCT00107354|Mitoxantrone|mitoxantrone|mesh-list
25867082|NCT00107354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25867083|NCT00107354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867084|NCT00107354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24473882|NCT00404391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24896735|NCT04433559|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24896736|NCT04433559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24896737|NCT04433559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896738|NCT04433559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896739|NCT04433559|Urological Agents|urological agents|mesh-ancestor
24896741|NCT04433169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24896742|NCT04433169|Keratolytic Agents|keratolytic agents|mesh-ancestor
24896743|NCT04433169|Dermatologic Agents|dermatologic agents|mesh-ancestor
24896744|NCT04433156|Prednisone|prednisone|mesh-list
24896745|NCT04433156|Cyclophosphamide|cyclophosphamide|mesh-list
24896746|NCT04433156|Rituximab|rituximab|mesh-list
24896747|NCT04433156|Bortezomib|bortezomib|mesh-list
24896748|NCT04433156|Epirubicin|epirubicin|mesh-list
24896749|NCT04433156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24896750|NCT04433156|Immunologic Factors|immunologic factors|mesh-ancestor
24896751|NCT04433156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896752|NCT04433156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24473883|NCT00404391|Narcotics|narcotics|mesh-ancestor
24473884|NCT00404391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25867085|NCT00107354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25201673|NCT02726126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25062854|NCT03866252|Serotonin Agents|serotonin agents|mesh-ancestor
25062855|NCT03866252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24947245|NCT03930992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25062856|NCT03866252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062857|NCT03866252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25867086|NCT00107354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867087|NCT00107354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867088|NCT00107354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25867089|NCT00107354|Antimetabolites|antimetabolites|mesh-ancestor
25867090|NCT00107354|Antiviral Agents|antiviral agents|mesh-ancestor
25867091|NCT00107354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25867092|NCT00107354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25867093|NCT00107354|Immunologic Factors|immunologic factors|mesh-ancestor
25867094|NCT00107354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867095|NCT00107354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25867096|NCT00107354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25867097|NCT00107354|Analgesics|analgesics|mesh-ancestor
25867098|NCT00107354|Sensory System Agents|sensory system agents|mesh-ancestor
25867099|NCT00107354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25867100|NCT00107393|Capecitabine|capecitabine|mesh-list
25867101|NCT00107393|Trastuzumab|trastuzumab|mesh-list
25867102|NCT00107393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25867103|NCT00107393|Antimetabolites|antimetabolites|mesh-ancestor
24688908|NCT02578368|Antidotes|antidotes|mesh-ancestor
25867104|NCT00107393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867105|NCT00107393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867106|NCT00107393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25867107|NCT00107419|Pemetrexed|pemetrexed|mesh-list
24896758|NCT04433156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24896759|NCT04433156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24896760|NCT04433156|Glucocorticoids|glucocorticoids|mesh-ancestor
24896761|NCT04433156|Hormones|hormones|mesh-ancestor
24896762|NCT04433156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24896763|NCT04433156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24896764|NCT04433156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24896765|NCT04433156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24896766|NCT04433156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24896767|NCT04433156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896768|NCT04433143|Minocycline|minocycline|mesh-list
25867108|NCT00107419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24896769|NCT04433143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24896770|NCT04433143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24896771|NCT04433078|Doxycycline|doxycycline|mesh-list
24896772|NCT04433078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24896773|NCT04433078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24701241|NCT01457859|Triclosan|triclosan|mesh-list
24896774|NCT04433078|Antimalarials|antimalarials|mesh-ancestor
24896775|NCT04433078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24896776|NCT04433078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24896777|NCT04432714|Prednisone|prednisone|mesh-list
24896778|NCT04432714|Cyclophosphamide|cyclophosphamide|mesh-list
25867109|NCT00107419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867110|NCT00107419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867111|NCT00107419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25867112|NCT00107419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25867113|NCT00107432|Sorafenib|sorafenib|mesh-list
25867114|NCT00107432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867115|NCT00107432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25867116|NCT00107432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867117|NCT00107432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896779|NCT04432714|Rituximab|rituximab|mesh-list
25867118|NCT00107458|Valproic Acid|valproic acid|mesh-list
25867119|NCT00107458|Anticonvulsants|anticonvulsants|mesh-ancestor
25867120|NCT00107458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867121|NCT00107458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867122|NCT00107458|GABA Agents|gaba agents|mesh-ancestor
25867123|NCT00107458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25867124|NCT00107458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867125|NCT00107458|Antimanic Agents|antimanic agents|mesh-ancestor
25867126|NCT00107458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25867127|NCT00107458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25867128|NCT00107458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25867129|NCT00107471|Topotecan|topotecan|mesh-list
25867130|NCT00107471|Lenograstim|lenograstim|mesh-list
25867131|NCT00107471|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25867132|NCT00107471|Immunologic Factors|immunologic factors|mesh-ancestor
25867133|NCT00107471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867134|NCT00107471|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25867135|NCT00107471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24689266|NCT01891747|Growth Substances|growth substances|mesh-ancestor
25062892|NCT03530995|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25062893|NCT03530995|Hormone Antagonists|hormone antagonists|mesh-ancestor
25062894|NCT03530995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25062895|NCT03530995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062896|NCT03530995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24825473|NCT02128451|Sensory System Agents|sensory system agents|mesh-ancestor
24896807|NCT04432714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24896808|NCT04432714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24896809|NCT04432714|Growth Substances|growth substances|mesh-ancestor
24896810|NCT04432714|Growth Inhibitors|growth inhibitors|mesh-ancestor
24896814|NCT04432688|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
24896823|NCT04432688|Adrenergic Agents|adrenergic agents|mesh-ancestor
24896824|NCT04432688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24896825|NCT04432688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896826|NCT04432688|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24896827|NCT04432688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25062897|NCT03530995|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25062898|NCT03530995|Antitubercular Agents|antitubercular agents|mesh-ancestor
25062899|NCT03530995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25062900|NCT03530995|Leprostatic Agents|leprostatic agents|mesh-ancestor
25062901|NCT03530995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25062903|NCT03530995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25062904|NCT03530995|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25062905|NCT03530995|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25062906|NCT03530995|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25062907|NCT03530995|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25062908|NCT03530995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25867136|NCT00107471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867137|NCT00107471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867138|NCT00107471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867139|NCT00107510|Carboplatin|carboplatin|mesh-list
25867140|NCT00107510|Docetaxel|docetaxel|mesh-list
25867141|NCT00107510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867142|NCT00107510|Tubulin Modulators|tubulin modulators|mesh-ancestor
25867143|NCT00107510|Antimitotic Agents|antimitotic agents|mesh-ancestor
25867144|NCT00107510|Mitosis Modulators|mitosis modulators|mesh-ancestor
25867145|NCT00107510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867146|NCT00107523|Cytarabine|cytarabine|mesh-list
25867147|NCT00107523|Idarubicin|idarubicin|mesh-list
25867148|NCT00107523|Pravastatin|pravastatin|mesh-list
25867149|NCT00107523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25867150|NCT00107523|Antimetabolites|antimetabolites|mesh-ancestor
24901971|NCT04379219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25867151|NCT00107523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867152|NCT00107523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867153|NCT00107523|Antiviral Agents|antiviral agents|mesh-ancestor
25867154|NCT00107523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25867155|NCT00107523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24516201|NCT00600977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24516202|NCT00600977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516203|NCT00600977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24516204|NCT00600977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24516205|NCT00600977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516206|NCT00600977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516207|NCT00600990|Vestipitant|vestipitant|mesh-list
24516208|NCT00600990|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24516209|NCT00600990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25062923|NCT03449901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25062924|NCT03449901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25062925|NCT03449901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25062926|NCT03449901|Immunologic Factors|immunologic factors|mesh-ancestor
25062927|NCT03449901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062928|NCT03449901|Tubulin Modulators|tubulin modulators|mesh-ancestor
25062929|NCT03449901|Antimitotic Agents|antimitotic agents|mesh-ancestor
25867156|NCT00107523|Immunologic Factors|immunologic factors|mesh-ancestor
25867157|NCT00107523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867158|NCT00107523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25867159|NCT00107523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25201675|NCT02726126|Anesthetics, General|anesthetics, general|mesh-ancestor
25201676|NCT02726126|Anesthetics|anesthetics|mesh-ancestor
25201677|NCT02726126|Antioxidants|antioxidants|mesh-ancestor
25867160|NCT00107523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25867161|NCT00107523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516211|NCT00600990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516213|NCT00601016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24516214|NCT00601016|Immunologic Factors|immunologic factors|mesh-ancestor
24516215|NCT00601016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516216|NCT00601016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516217|NCT00601016|Interferon Inducers|interferon inducers|mesh-ancestor
24516218|NCT00601042|Lobeline|lobeline|mesh-list
25867162|NCT00107523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25867163|NCT00107523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25867164|NCT00107523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25876617|NCT03257631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24902075|NCT04377867|Abatacept|abatacept|mesh-list
24902099|NCT04377646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902100|NCT04377386|Vitamin D|vitamin d|mesh-list
24902101|NCT04377386|Ergocalciferols|ergocalciferols|mesh-list
24516219|NCT00601042|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24516220|NCT00601042|Autonomic Agents|autonomic agents|mesh-ancestor
24516221|NCT00601042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24516222|NCT00601042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516223|NCT00601042|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24896864|NCT04432558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24641600|NCT01174420|Mitomycins|mitomycins|mesh-list
25062934|NCT03442972|Protective Agents|protective agents|mesh-ancestor
25432751|NCT00680992|Immunoglobulin G|immunoglobulin g|mesh-list
25670528|NCT04329221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25670529|NCT04329221|Emollients|emollients|mesh-ancestor
25670530|NCT04292483|Nitric Oxide|nitric oxide|mesh-list
25670531|NCT04292483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25670532|NCT04292483|Autonomic Agents|autonomic agents|mesh-ancestor
25670533|NCT04292483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25670534|NCT04292483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670535|NCT04292483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25670536|NCT04292483|Respiratory System Agents|respiratory system agents|mesh-ancestor
25670537|NCT04292483|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25670538|NCT04292483|Antioxidants|antioxidants|mesh-ancestor
25670539|NCT04292483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227309|NCT02615574|Interferons|interferons|mesh-list
25227311|NCT02615574|Celecoxib|celecoxib|mesh-list
25062935|NCT03442972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689718|NCT00430040|Carvedilol|carvedilol|mesh-list
25867165|NCT00107523|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25867166|NCT00107601|Insulin|insulin|mesh-list
25867167|NCT00107601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25867168|NCT00107601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867169|NCT00107731|Valproic Acid|valproic acid|mesh-list
25867170|NCT00107731|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25867171|NCT00107731|Antidepressive Agents|antidepressive agents|mesh-ancestor
25867172|NCT00107731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25867173|NCT00107731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25867174|NCT00107731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25867175|NCT00107731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25867176|NCT00107731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867177|NCT00107731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867178|NCT00107731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867179|NCT00107731|Antimanic Agents|antimanic agents|mesh-ancestor
25867180|NCT00107731|Anticonvulsants|anticonvulsants|mesh-ancestor
25201678|NCT02726126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201679|NCT02726126|Protective Agents|protective agents|mesh-ancestor
25201680|NCT02726347|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25201681|NCT02726347|Immunologic Factors|immunologic factors|mesh-ancestor
25201682|NCT02726347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201683|NCT02726035|Naltrexone|naltrexone|mesh-list
25201684|NCT02726035|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25201685|NCT02726035|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24827427|NCT02138994|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24827428|NCT02138994|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
25867181|NCT00107731|GABA Agents|gaba agents|mesh-ancestor
25867182|NCT00107731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25867183|NCT00107770|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25867184|NCT00107770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867185|NCT00107796|Modafinil|modafinil|mesh-list
24902102|NCT04377386|Cholecalciferol|cholecalciferol|mesh-list
24902103|NCT04377386|Vitamins|vitamins|mesh-list
25867186|NCT00107796|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25867187|NCT00107796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867188|NCT00107796|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25867189|NCT00107796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25867190|NCT00107796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25867191|NCT00107796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867192|NCT00107809|Modafinil|modafinil|mesh-list
25867193|NCT00107809|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25867194|NCT00107809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867195|NCT00107809|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25867196|NCT00107809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25867197|NCT00107809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25867198|NCT00107809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516251|NCT00601276|Leuprolide|leuprolide|mesh-list
25867199|NCT00107822|Lidocaine|lidocaine|mesh-list
25867200|NCT00107822|Tetracaine|tetracaine|mesh-list
25867201|NCT00107822|Anesthetics, Local|anesthetics, local|mesh-ancestor
24896905|NCT04432324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896906|NCT04432220|Apixaban|apixaban|mesh-list
24896907|NCT04432220|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24896908|NCT04432220|Antithrombins|antithrombins|mesh-ancestor
24896909|NCT04432220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24896910|NCT04432220|Protease Inhibitors|protease inhibitors|mesh-ancestor
25064090|NCT03463252|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25064091|NCT03463252|Medroxyprogesterone|medroxyprogesterone|mesh-list
25064094|NCT03463252|Hormones|hormones|mesh-ancestor
24896911|NCT04432220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25670540|NCT04292483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25670541|NCT04292483|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25670542|NCT04292483|Vasodilator Agents|vasodilator agents|mesh-ancestor
25670543|NCT04292483|Gasotransmitters|gasotransmitters|mesh-ancestor
25670544|NCT04292483|Protective Agents|protective agents|mesh-ancestor
25670545|NCT04278768|Azacitidine|azacitidine|mesh-list
25670546|NCT04278768|Venetoclax|venetoclax|mesh-list
25670547|NCT04278768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25670548|NCT04278768|Antimetabolites|antimetabolites|mesh-ancestor
25670549|NCT04278768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670550|NCT04278768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043660|NCT01229644|Crenolanib|crenolanib|mesh-list
24896912|NCT04432220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062950|NCT03425292|Nivolumab|nivolumab|mesh-list
25062951|NCT03425292|Ipilimumab|ipilimumab|mesh-list
25062952|NCT03425292|Temozolomide|temozolomide|mesh-list
25062953|NCT03425292|Lomustine|lomustine|mesh-list
25062954|NCT03425292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25062955|NCT03425292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25062956|NCT03425292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25062957|NCT03425292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25062958|NCT03425292|Growth Substances|growth substances|mesh-ancestor
25867202|NCT00107822|Anesthetics|anesthetics|mesh-ancestor
25867203|NCT00107822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25867204|NCT00107822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867205|NCT00107822|Sensory System Agents|sensory system agents|mesh-ancestor
25867206|NCT00107822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25201686|NCT02726035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201687|NCT02726035|Sensory System Agents|sensory system agents|mesh-ancestor
25201688|NCT02726035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25201689|NCT02725736|Nifedipine|nifedipine|mesh-list
25201690|NCT02725736|Atosiban|atosiban|mesh-list
25201691|NCT02725736|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25201692|NCT02725736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25201693|NCT02725736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201694|NCT02725736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25201695|NCT02725736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201696|NCT02725736|Vasodilator Agents|vasodilator agents|mesh-ancestor
25867207|NCT00107822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25867208|NCT00107822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25867209|NCT00107822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25867210|NCT00107822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25867211|NCT00107822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867212|NCT00107835|Lidocaine|lidocaine|mesh-list
25867213|NCT00107835|Tetracaine|tetracaine|mesh-list
25867214|NCT00107835|Anesthetics, Local|anesthetics, local|mesh-ancestor
25867215|NCT00107835|Anesthetics|anesthetics|mesh-ancestor
25867216|NCT00107835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25867217|NCT00107835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516288|NCT00601328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867218|NCT00107835|Sensory System Agents|sensory system agents|mesh-ancestor
24516283|NCT00601315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516284|NCT00601315|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24516285|NCT00601315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24896919|NCT04432259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896920|NCT04432259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24896921|NCT04432259|Glucocorticoids|glucocorticoids|mesh-ancestor
24896923|NCT04432259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24896924|NCT04432259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24896925|NCT04432259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24896926|NCT04432233|Metronidazole|metronidazole|mesh-list
24896927|NCT04432233|Levofloxacin|levofloxacin|mesh-list
24896928|NCT04432233|Ofloxacin|ofloxacin|mesh-list
24896929|NCT04432233|Esomeprazole|esomeprazole|mesh-list
24896930|NCT04432233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24896931|NCT04432233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24896932|NCT04432233|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25062959|NCT03425292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062960|NCT03425292|Growth Inhibitors|growth inhibitors|mesh-ancestor
25062961|NCT03425292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25062962|NCT03425292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062963|NCT03425292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25062964|NCT03425292|Alkylating Agents|alkylating agents|mesh-ancestor
24896933|NCT04432233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24896934|NCT04432233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25867219|NCT00107835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24896941|NCT04432233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24478916|NCT00424944|Vaccines|vaccines|mesh-list
24896942|NCT04432233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24896943|NCT04432233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24896944|NCT04432233|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24896945|NCT04432233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24896947|NCT04432155|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25867220|NCT00107835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24896948|NCT04432155|Anesthetics, General|anesthetics, general|mesh-ancestor
24896949|NCT04432155|Anesthetics|anesthetics|mesh-ancestor
24896950|NCT04432155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24896951|NCT04432155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201697|NCT02725736|Tocolytic Agents|tocolytic agents|mesh-ancestor
25201698|NCT02725736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25867221|NCT00107835|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25867222|NCT00107835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25867223|NCT00107835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25867224|NCT00107835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867226|NCT00107848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25867227|NCT00107848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867228|NCT00107848|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24474034|NCT00404781|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24474035|NCT00404781|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24474036|NCT00404781|Purinergic Agents|purinergic agents|mesh-ancestor
24474037|NCT00404781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25867229|NCT00107848|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25867230|NCT00107848|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25867231|NCT00107848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876618|NCT03257631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24516286|NCT00601328|Calcitriol|calcitriol|mesh-list
24516287|NCT00601328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24896958|NCT04431713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062970|NCT03367988|Analgesics, Opioid|analgesics, opioid|mesh-list
25062971|NCT03367988|Anesthetics|anesthetics|mesh-list
25062972|NCT03367988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25062973|NCT03367988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062974|NCT03367988|Narcotics|narcotics|mesh-ancestor
25062975|NCT03367988|Analgesics|analgesics|mesh-ancestor
25062976|NCT03367988|Sensory System Agents|sensory system agents|mesh-ancestor
25062977|NCT03367988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25062978|NCT03343431|Tenofovir|tenofovir|mesh-list
24516295|NCT00601328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24516296|NCT00601432|Levofloxacin|levofloxacin|mesh-list
24516297|NCT00601432|Ofloxacin|ofloxacin|mesh-list
24516298|NCT00601432|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24516299|NCT00601432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24516300|NCT00601432|Renal Agents|renal agents|mesh-ancestor
24516301|NCT00601432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24516302|NCT00601432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24516303|NCT00601432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25876619|NCT03257631|Leprostatic Agents|leprostatic agents|mesh-ancestor
25876620|NCT03257631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25876621|NCT03257631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25876622|NCT03181867|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25876623|NCT03181867|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25876624|NCT03181867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876625|NCT03164616|Gemcitabine|gemcitabine|mesh-list
25876626|NCT03164616|Cisplatin|cisplatin|mesh-list
25876627|NCT03164616|Carboplatin|carboplatin|mesh-list
25876628|NCT03164616|Pemetrexed|pemetrexed|mesh-list
25201699|NCT02725736|Hormone Antagonists|hormone antagonists|mesh-ancestor
25201700|NCT02725736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25201701|NCT02725918|Pemetrexed|pemetrexed|mesh-list
25201702|NCT02725918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201703|NCT02725918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201704|NCT02725918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201705|NCT02725918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25876629|NCT03164616|Durvalumab|durvalumab|mesh-list
25876630|NCT03164616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24516310|NCT00601510|Imatinib Mesylate|imatinib mesylate|mesh-list
24516311|NCT00601510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516312|NCT00601510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24516313|NCT00601510|Antimetabolites|antimetabolites|mesh-ancestor
24516314|NCT00601510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516315|NCT00601510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24516316|NCT00601510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516317|NCT00601536|Lithium Carbonate|lithium carbonate|mesh-list
24516318|NCT00601536|Antidepressive Agents|antidepressive agents|mesh-ancestor
25062980|NCT03343431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25062981|NCT03343431|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25432752|NCT00680992|Immunologic Factors|immunologic factors|mesh-ancestor
25062982|NCT03343431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25062983|NCT03343431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25062984|NCT03343431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062985|NCT03343431|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25062986|NCT03343431|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25867232|NCT00107874|Misoprostol|misoprostol|mesh-list
25867233|NCT00107874|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25867234|NCT00107874|Abortifacient Agents|abortifacient agents|mesh-ancestor
24817614|NCT02084615|Aspirin|aspirin|mesh-list
24474059|NCT00404794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25867235|NCT00107874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25867236|NCT00107874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867237|NCT00107874|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24817615|NCT02084615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24817617|NCT02084615|Analgesics|analgesics|mesh-ancestor
24817618|NCT02084615|Sensory System Agents|sensory system agents|mesh-ancestor
24719749|NCT01563835|Narcotics|narcotics|mesh-ancestor
24896963|NCT04431349|Clopidogrel|clopidogrel|mesh-list
24896964|NCT04431349|Ticagrelor|ticagrelor|mesh-list
24896965|NCT04431349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24896966|NCT04431349|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24896967|NCT04431349|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24896968|NCT04431349|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24896969|NCT04431349|Purinergic Agents|purinergic agents|mesh-ancestor
24896970|NCT04431349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24474091|NCT00404833|Antitubercular Agents|antitubercular agents|mesh-ancestor
25867238|NCT00107874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25867239|NCT00107874|Oxytocics|oxytocics|mesh-ancestor
25867240|NCT00108004|Pramlintide|pramlintide|mesh-list
24516324|NCT00601536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24516325|NCT00601536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516328|NCT00601562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516329|NCT00601562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24516330|NCT00601562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24902962|NCT04368377|Tirofiban|tirofiban|mesh-list
24818320|NCT02087813|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25201706|NCT02725918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25201707|NCT02725541|Trastuzumab|trastuzumab|mesh-list
25201708|NCT02725541|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25201709|NCT02725541|Maytansine|maytansine|mesh-list
25867241|NCT00108004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25867242|NCT00108004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867243|NCT00108017|Timolol|timolol|mesh-list
25867244|NCT00108017|Dorzolamide|dorzolamide|mesh-list
25867245|NCT00108017|Maleic acid|maleic acid|mesh-list
25867246|NCT00108017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25867247|NCT00108017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24516331|NCT00601562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516332|NCT00601562|Antiviral Agents|antiviral agents|mesh-ancestor
24516333|NCT00601562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24516334|NCT00601562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24516335|NCT00601562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24516336|NCT00601575|Lithium Carbonate|lithium carbonate|mesh-list
24516337|NCT00601575|Antidepressive Agents|antidepressive agents|mesh-ancestor
24516338|NCT00601575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24516339|NCT00601575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516340|NCT00601575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516341|NCT00601575|Antimanic Agents|antimanic agents|mesh-ancestor
24516342|NCT00601575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24529943|NCT00628459|Micronutrients|micronutrients|mesh-list
24896980|NCT04431193|Oxytocin|oxytocin|mesh-list
24896981|NCT04431193|Oxytocics|oxytocics|mesh-ancestor
24896982|NCT04431193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25063011|NCT03237611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825588|NCT02129231|Ezetimibe|ezetimibe|mesh-list
24516343|NCT00601575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24516344|NCT00601575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516345|NCT00601588|Sertraline|sertraline|mesh-list
24516346|NCT00601588|Antidepressive Agents|antidepressive agents|mesh-ancestor
24516347|NCT00601588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24516348|NCT00601588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24516349|NCT00601588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24516350|NCT00601588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24818321|NCT02088008|Valsartan|valsartan|mesh-list
24516351|NCT00601588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516352|NCT00601588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24516358|NCT00601614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516360|NCT00601666|Zolpidem|zolpidem|mesh-list
24516361|NCT00601666|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24516362|NCT00601666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25201710|NCT02725541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25201711|NCT02725541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201712|NCT02725541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25201713|NCT02725541|Tubulin Modulators|tubulin modulators|mesh-ancestor
25201714|NCT02725541|Antimitotic Agents|antimitotic agents|mesh-ancestor
25201715|NCT02725541|Mitosis Modulators|mitosis modulators|mesh-ancestor
25201716|NCT02725541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201717|NCT02725502|Linagliptin|linagliptin|mesh-list
25201718|NCT02725502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25201719|NCT02725502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201720|NCT02725502|Incretins|incretins|mesh-ancestor
25201721|NCT02725502|Hormones|hormones|mesh-ancestor
25867248|NCT00108017|Adrenergic Agents|adrenergic agents|mesh-ancestor
25867249|NCT00108017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25867250|NCT00108017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867251|NCT00108017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867252|NCT00108017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25867253|NCT00108017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25867254|NCT00108017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867255|NCT00108017|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25867256|NCT00108095|Ondansetron|ondansetron|mesh-list
24583174|NCT00873535|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25867257|NCT00108095|Antiemetics|antiemetics|mesh-ancestor
25867258|NCT00108095|Autonomic Agents|autonomic agents|mesh-ancestor
25867259|NCT00108095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25867260|NCT00108095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867261|NCT00108095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25867262|NCT00108095|Antipruritics|antipruritics|mesh-ancestor
25867263|NCT00108095|Dermatologic Agents|dermatologic agents|mesh-ancestor
25867264|NCT00108095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25867265|NCT00108095|Serotonin Agents|serotonin agents|mesh-ancestor
25867266|NCT00108095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25867267|NCT00108095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474110|NCT00404937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25867268|NCT00108095|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25867269|NCT00108095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25867270|NCT00108095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25867271|NCT00108095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25867272|NCT00108095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25867273|NCT00108186|Celecoxib|celecoxib|mesh-list
25867274|NCT00108186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25867275|NCT00108186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25867276|NCT00108186|Analgesics|analgesics|mesh-ancestor
25867277|NCT00108186|Sensory System Agents|sensory system agents|mesh-ancestor
25867278|NCT00108186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25867279|NCT00108186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867280|NCT00108186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25867281|NCT00108186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24516365|NCT00601666|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24516366|NCT00601666|GABA Agonists|gaba agonists|mesh-ancestor
24516367|NCT00601666|GABA Agents|gaba agents|mesh-ancestor
24516368|NCT00601666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24516369|NCT00601666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516370|NCT00601692|Docetaxel|docetaxel|mesh-list
24516371|NCT00601692|Irinotecan|irinotecan|mesh-list
24516372|NCT00601692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516373|NCT00601692|Tubulin Modulators|tubulin modulators|mesh-ancestor
24516374|NCT00601692|Antimitotic Agents|antimitotic agents|mesh-ancestor
24516375|NCT00601692|Mitosis Modulators|mitosis modulators|mesh-ancestor
24516376|NCT00601692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903111|NCT04366739|Dopamine Agents|dopamine agents|mesh-ancestor
24516378|NCT00601692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24516379|NCT00601692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516380|NCT00601874|Pilocarpine|pilocarpine|mesh-list
24516381|NCT00601874|Miotics|miotics|mesh-ancestor
25867282|NCT00108186|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25867283|NCT00108186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24896996|NCT04430777|Coagulants|coagulants|mesh-ancestor
24896997|NCT04430933|Paclitaxel|paclitaxel|mesh-list
24896998|NCT04430933|Docetaxel|docetaxel|mesh-list
24896999|NCT04430933|Carboplatin|carboplatin|mesh-list
24516401|NCT00601887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842442|NCT02221180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842444|NCT02221323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24842445|NCT02221323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842446|NCT02221375|Ciclesonide|ciclesonide|mesh-list
24842447|NCT02221375|Glucocorticoids|glucocorticoids|mesh-ancestor
24842448|NCT02221375|Hormones|hormones|mesh-ancestor
24842449|NCT02221375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24842450|NCT02221375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201722|NCT02725502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25201723|NCT02725502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25201724|NCT02725502|Protease Inhibitors|protease inhibitors|mesh-ancestor
25201725|NCT02725502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201726|NCT02725502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201727|NCT02725398|Scopolamine|scopolamine|mesh-list
25201728|NCT02725398|Bromides|bromides|mesh-list
25201729|NCT02725398|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25201730|NCT02725398|Anticonvulsants|anticonvulsants|mesh-ancestor
25867284|NCT00108186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867285|NCT00108186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867286|NCT00108238|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25867287|NCT00108238|Estradiol|estradiol|mesh-list
25867288|NCT00108238|Progesterone|progesterone|mesh-list
24827454|NCT02139241|Antiemetics|antiemetics|mesh-ancestor
24516402|NCT00601887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516403|NCT00601913|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25867289|NCT00108238|Estrogens|estrogens|mesh-ancestor
25867290|NCT00108238|Hormones|hormones|mesh-ancestor
25867291|NCT00108238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25063015|NCT03237611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25063016|NCT03237611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25867292|NCT00108238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867293|NCT00108238|Progestins|progestins|mesh-ancestor
25867294|NCT00108238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25867295|NCT00108238|Hormone Antagonists|hormone antagonists|mesh-ancestor
25867296|NCT00108238|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25867297|NCT00108238|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25867298|NCT00108238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24516407|NCT00601913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516408|NCT00601978|Levodopa|levodopa|mesh-list
24516409|NCT00601978|Carbidopa|carbidopa|mesh-list
24516410|NCT00601978|Entacapone|entacapone|mesh-list
24516411|NCT00601978|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24516412|NCT00601978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24516413|NCT00601978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24516414|NCT00601978|Dopamine Agents|dopamine agents|mesh-ancestor
24516415|NCT00601978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25867299|NCT00108251|Eplerenone|eplerenone|mesh-list
25867300|NCT00108251|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25867301|NCT00108251|Hormone Antagonists|hormone antagonists|mesh-ancestor
25867302|NCT00108251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24897007|NCT04430933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24897008|NCT04430933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24897009|NCT04430933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24897010|NCT04430998|Chlorhexidine|chlorhexidine|mesh-list
24897011|NCT04430998|Polaprezinc|polaprezinc|mesh-list
24474126|NCT00405080|Antitubercular Agents|antitubercular agents|mesh-ancestor
24897014|NCT04430998|Disinfectants|disinfectants|mesh-ancestor
24897015|NCT04430998|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24897016|NCT04430998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24897017|NCT04430621|Hormones|hormones|mesh-list
24897018|NCT04430621|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24474131|NCT00405080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474132|NCT00405080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903339|NCT04364516|Hemostatics|hemostatics|mesh-ancestor
25670551|NCT04278768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25670552|NCT04268771|Rituximab|rituximab|mesh-list
25670553|NCT04268771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25670554|NCT04268771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670555|NCT04268771|Immunologic Factors|immunologic factors|mesh-ancestor
25670556|NCT04268771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670557|NCT04268771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25670558|NCT04265651|Infigratinib|infigratinib|mesh-list
25670559|NCT04265651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670560|NCT04246619|Pregabalin|pregabalin|mesh-list
24842567|NCT02221999|Letrozole|letrozole|mesh-list
24474133|NCT00405080|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25867303|NCT00108251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867304|NCT00108251|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25867305|NCT00108251|Diuretics|diuretics|mesh-ancestor
25201731|NCT02725398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25201732|NCT02725398|Antiemetics|antiemetics|mesh-ancestor
25201733|NCT02725398|Autonomic Agents|autonomic agents|mesh-ancestor
25201734|NCT02725398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25201740|NCT02725398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25201741|NCT02725398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063017|NCT03237611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063018|NCT03237611|Antipruritics|antipruritics|mesh-ancestor
25063019|NCT03237611|Dermatologic Agents|dermatologic agents|mesh-ancestor
25063020|NCT03237611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25063021|NCT03237611|Serotonin Agents|serotonin agents|mesh-ancestor
25063022|NCT03237611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25063023|NCT03237611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063024|NCT03237611|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25063025|NCT03237611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25063026|NCT03237611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25063027|NCT03237611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25063028|NCT03237611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24691077|NCT01405079|Gefitinib|gefitinib|mesh-list
24897022|NCT04430556|Antidepressive Agents|antidepressive agents|mesh-ancestor
24897024|NCT04430556|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24897025|NCT04430556|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24474134|NCT00405080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24474135|NCT00405080|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24474136|NCT00405080|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24474137|NCT00405080|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24474138|NCT00405080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24474139|NCT00405080|Antiemetics|antiemetics|mesh-ancestor
24474140|NCT00405080|Autonomic Agents|autonomic agents|mesh-ancestor
24516417|NCT00601978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516418|NCT00601978|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24516419|NCT00601978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516420|NCT00601978|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24516421|NCT00601978|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24516422|NCT00601978|Immunologic Factors|immunologic factors|mesh-ancestor
24516423|NCT00601978|Dopamine Agonists|dopamine agonists|mesh-ancestor
24516424|NCT00601991|Aflibercept|aflibercept|mesh-list
24516425|NCT00601991|Endothelial Growth Factors|endothelial growth factors|mesh-list
24516426|NCT00601991|Growth Substances|growth substances|mesh-ancestor
24516427|NCT00601991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516428|NCT00601991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24516429|NCT00601991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24437075|NCT00272610|Vitamin A|vitamin a|mesh-list
24897026|NCT04430556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24897027|NCT04430556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897028|NCT04430556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24897029|NCT04430556|Serotonin Agents|serotonin agents|mesh-ancestor
24897030|NCT04430556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897031|NCT04430361|Dexamethasone|dexamethasone|mesh-list
24897032|NCT04430361|Megestrol|megestrol|mesh-list
24897033|NCT04430361|Megestrol Acetate|megestrol acetate|mesh-list
25201742|NCT02725398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25201743|NCT02725398|Parasympatholytics|parasympatholytics|mesh-ancestor
25201744|NCT02725372|Nitric Oxide|nitric oxide|mesh-list
25201745|NCT02725372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25201746|NCT02725372|Autonomic Agents|autonomic agents|mesh-ancestor
25201747|NCT02725372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25201758|NCT02725372|Protective Agents|protective agents|mesh-ancestor
25201748|NCT02725372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201749|NCT02725372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25670561|NCT04246619|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25670562|NCT04246619|Analgesics|analgesics|mesh-ancestor
25670563|NCT04246619|Sensory System Agents|sensory system agents|mesh-ancestor
25670564|NCT04246619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25670565|NCT04246619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670566|NCT04246619|Anticonvulsants|anticonvulsants|mesh-ancestor
25670567|NCT04246619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25670568|NCT04246619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25670569|NCT04246619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867306|NCT00108251|Natriuretic Agents|natriuretic agents|mesh-ancestor
25867307|NCT00108251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25867308|NCT00108316|Fluoxetine|fluoxetine|mesh-list
25867309|NCT00108316|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25867310|NCT00108316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25867311|NCT00108316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25867312|NCT00108316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443479|NCT00295100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897034|NCT04430361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24474141|NCT00405080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24474142|NCT00405080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474143|NCT00405080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24474144|NCT00405080|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24474145|NCT00405080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24474146|NCT00405119|Esomeprazole|esomeprazole|mesh-list
24474147|NCT00405119|Ranitidine|ranitidine|mesh-list
24474148|NCT00405119|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
24474149|NCT00405119|Loxtidine|loxtidine|mesh-list
24474150|NCT00405119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25867313|NCT00108316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25867314|NCT00108316|Serotonin Agents|serotonin agents|mesh-ancestor
24516435|NCT00602004|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24516436|NCT00602004|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25867315|NCT00108316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867316|NCT00108316|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25867317|NCT00108316|Antidepressive Agents|antidepressive agents|mesh-ancestor
25867318|NCT00108316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25867319|NCT00108316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25867320|NCT00108316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25867321|NCT00108316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867322|NCT00108368|Olanzapine|olanzapine|mesh-list
25867323|NCT00108368|Risperidone|risperidone|mesh-list
25867324|NCT00108368|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25867325|NCT00108368|Serotonin Agents|serotonin agents|mesh-ancestor
24516439|NCT00601159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516440|NCT00601159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24516441|NCT00601159|Antimetabolites|antimetabolites|mesh-ancestor
24516442|NCT00601159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516443|NCT00601159|Antiviral Agents|antiviral agents|mesh-ancestor
24516444|NCT00601159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24516445|NCT00601159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516446|NCT00601159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25867326|NCT00108368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25867327|NCT00108368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867328|NCT00108368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867329|NCT00108368|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24897055|NCT04430166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24897056|NCT04430166|Immunologic Factors|immunologic factors|mesh-ancestor
24897057|NCT04430166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897058|NCT04430062|Anesthetics|anesthetics|mesh-list
24897059|NCT04430062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24897060|NCT04430062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897061|NCT04429867|Hydroxychloroquine|hydroxychloroquine|mesh-list
24897062|NCT04429867|Antimalarials|antimalarials|mesh-ancestor
24474167|NCT00405158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24474168|NCT00405158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516451|NCT00602017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24516452|NCT00602017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24516453|NCT00602017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516454|NCT00602017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25201750|NCT02725372|Respiratory System Agents|respiratory system agents|mesh-ancestor
25201751|NCT02725372|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25201752|NCT02725372|Antioxidants|antioxidants|mesh-ancestor
25201753|NCT02725372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201754|NCT02725372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25201755|NCT02725372|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25201756|NCT02725372|Vasodilator Agents|vasodilator agents|mesh-ancestor
25201757|NCT02725372|Gasotransmitters|gasotransmitters|mesh-ancestor
25867330|NCT00108368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25867331|NCT00108368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25867332|NCT00108368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25867333|NCT00108368|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24691523|NCT01407484|Prednisone|prednisone|mesh-list
24542641|NCT00679653|Verapamil|verapamil|mesh-list
24903580|NCT04362293|Sirolimus|sirolimus|mesh-list
25867334|NCT00108368|Dopamine Agents|dopamine agents|mesh-ancestor
24474194|NCT00405210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24897089|NCT04429282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24897090|NCT04429282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867335|NCT00108368|Antiemetics|antiemetics|mesh-ancestor
24516510|NCT00602186|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24903637|NCT04361825|Durvalumab|durvalumab|mesh-list
24516511|NCT00602186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24516512|NCT00602186|Adrenergic Agents|adrenergic agents|mesh-ancestor
24897121|NCT04429191|Antibodies|antibodies|mesh-list
24530902|NCT00633035|Esomeprazole|esomeprazole|mesh-list
24897133|NCT04429035|Hemostatics|hemostatics|mesh-ancestor
24897134|NCT04429035|Coagulants|coagulants|mesh-ancestor
24897135|NCT04428879|Topotecan|topotecan|mesh-list
24897136|NCT04428879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24897137|NCT04428879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24897138|NCT04428879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474218|NCT00405262|Bupivacaine|bupivacaine|mesh-list
24474219|NCT00405262|Anesthetics, Local|anesthetics, local|mesh-ancestor
24474220|NCT00405262|Anesthetics|anesthetics|mesh-ancestor
24516513|NCT00602186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25867336|NCT00108368|Autonomic Agents|autonomic agents|mesh-ancestor
24516516|NCT00602251|Terbinafine|terbinafine|mesh-list
24516526|NCT00602303|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24516527|NCT00602303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24516528|NCT00602303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516529|NCT00602316|Chelating Agents|chelating agents|mesh-list
24516530|NCT00602316|Sequestering Agents|sequestering agents|mesh-ancestor
25867337|NCT00108368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25867338|NCT00108368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25867339|NCT00108368|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25867340|NCT00108368|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25867341|NCT00108368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25867342|NCT00108394|Pamidronate|pamidronate|mesh-list
25063062|NCT03225417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25063063|NCT03225417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25063064|NCT03225417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063065|NCT03225417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25063066|NCT03225417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25063067|NCT03225417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24474239|NCT00405301|Leprostatic Agents|leprostatic agents|mesh-ancestor
24424018|NCT00227682|Immunologic Factors|immunologic factors|mesh-ancestor
24474240|NCT00405301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24474241|NCT00405301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474242|NCT00405301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867343|NCT00108394|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25867344|NCT00108394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903713|NCT04361461|Azithromycin|azithromycin|mesh-list
25867345|NCT00108420|Prazosin|prazosin|mesh-list
25867346|NCT00108420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25867347|NCT00108420|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25867348|NCT00108420|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25867349|NCT00108420|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25867350|NCT00108420|Adrenergic Agents|adrenergic agents|mesh-ancestor
25867351|NCT00108420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25867352|NCT00108420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867353|NCT00108420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867354|NCT00108446|Lidocaine|lidocaine|mesh-list
24692097|NCT01411176|Menthol|menthol|mesh-list
24897150|NCT04428684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24897152|NCT04428268|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24897153|NCT04428268|Losartan|losartan|mesh-list
24897154|NCT04428268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25201760|NCT02725255|Anthelmintics|anthelmintics|mesh-ancestor
25201761|NCT02725255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25201762|NCT02725255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25201763|NCT02725255|Anticestodal Agents|anticestodal agents|mesh-ancestor
25201764|NCT02725255|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25674489|NCT01772823|Tenofovir|tenofovir|mesh-list
25674490|NCT01772823|Emtricitabine|emtricitabine|mesh-list
25674491|NCT01772823|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25674492|NCT01772823|Antiviral Agents|antiviral agents|mesh-ancestor
25674493|NCT01772823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25674494|NCT01772823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25674495|NCT01772823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25201765|NCT02725255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25201766|NCT02725255|Tubulin Modulators|tubulin modulators|mesh-ancestor
25201767|NCT02725255|Antimitotic Agents|antimitotic agents|mesh-ancestor
25201768|NCT02725255|Mitosis Modulators|mitosis modulators|mesh-ancestor
25867355|NCT00108446|Fentanyl|fentanyl|mesh-list
25867356|NCT00108446|Dextromethorphan|dextromethorphan|mesh-list
25867357|NCT00108446|Naloxone|naloxone|mesh-list
24897155|NCT04428268|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24897156|NCT04428268|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24897157|NCT04428268|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24897167|NCT04428268|Analgesics|analgesics|mesh-ancestor
24897168|NCT04428268|Sensory System Agents|sensory system agents|mesh-ancestor
25867358|NCT00108446|Anesthetics, Local|anesthetics, local|mesh-ancestor
25867359|NCT00108446|Anesthetics|anesthetics|mesh-ancestor
25867360|NCT00108446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24897189|NCT04428632|Berotralstat|berotralstat|mesh-list
24897190|NCT04428632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867361|NCT00108446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063082|NCT03204812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063083|NCT03204812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25063084|NCT03204812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063085|NCT03188172|Dexamethasone|dexamethasone|mesh-list
25063086|NCT03188172|Cyclophosphamide|cyclophosphamide|mesh-list
25063087|NCT03188172|Melphalan|melphalan|mesh-list
25063088|NCT03188172|Lenalidomide|lenalidomide|mesh-list
25063089|NCT03188172|Bortezomib|bortezomib|mesh-list
25063090|NCT03188172|Daratumumab|daratumumab|mesh-list
25063091|NCT03188172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25063092|NCT03188172|Immunologic Factors|immunologic factors|mesh-ancestor
25063093|NCT03188172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201769|NCT02725255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201770|NCT02725255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201780|NCT02725359|Tizanidine|tizanidine|mesh-list
25201781|NCT02725359|Bupivacaine|bupivacaine|mesh-list
25201782|NCT02725359|Anesthetics, Local|anesthetics, local|mesh-ancestor
25201783|NCT02725359|Anesthetics|anesthetics|mesh-ancestor
25201784|NCT02725359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25867362|NCT00108446|Sensory System Agents|sensory system agents|mesh-ancestor
25063094|NCT03188172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24438569|NCT00276198|Vitamin A|vitamin a|mesh-list
25867363|NCT00108446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25867364|NCT00108446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25867365|NCT00108446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25867366|NCT00108446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25867367|NCT00108446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25867368|NCT00108446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867369|NCT00108446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25867370|NCT00108446|Narcotics|narcotics|mesh-ancestor
25867371|NCT00108446|Analgesics|analgesics|mesh-ancestor
25867372|NCT00108446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25867373|NCT00108446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25867374|NCT00108446|Anesthetics, General|anesthetics, general|mesh-ancestor
25867375|NCT00108446|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25867376|NCT00108446|Antitussive Agents|antitussive agents|mesh-ancestor
25867377|NCT00108446|Respiratory System Agents|respiratory system agents|mesh-ancestor
25867378|NCT00108446|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25867379|NCT00108446|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25867380|NCT00108446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25867381|NCT00108498|Mirtazapine|mirtazapine|mesh-list
25867382|NCT00108498|Antidepressive Agents|antidepressive agents|mesh-ancestor
24897195|NCT04427709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867383|NCT00108498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25867384|NCT00108498|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25867385|NCT00108498|Histamine Antagonists|histamine antagonists|mesh-ancestor
25867386|NCT00108498|Histamine Agents|histamine agents|mesh-ancestor
25867387|NCT00108498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25867388|NCT00108498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867389|NCT00108498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867390|NCT00108498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25867391|NCT00108498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25867392|NCT00108498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25867393|NCT00108498|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24583441|NCT00874562|Sirolimus|sirolimus|mesh-list
25063095|NCT03188172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25063096|NCT03188172|Alkylating Agents|alkylating agents|mesh-ancestor
25867394|NCT00108498|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25063097|NCT03188172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063098|NCT03188172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063099|NCT03188172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25063100|NCT03188172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25867395|NCT00108498|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25867396|NCT00108498|Adrenergic Agents|adrenergic agents|mesh-ancestor
25867397|NCT00108498|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25867398|NCT00108498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25867399|NCT00108498|Serotonin Agents|serotonin agents|mesh-ancestor
25867400|NCT00108498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25867401|NCT00108511|Gemfibrozil|gemfibrozil|mesh-list
25867402|NCT00108511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25867403|NCT00108511|Antimetabolites|antimetabolites|mesh-ancestor
25867404|NCT00108511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867405|NCT00108511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25867406|NCT00108511|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25867407|NCT00108511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25867408|NCT00108511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867409|NCT00108537|Bupropion|bupropion|mesh-list
25867410|NCT00108537|Nicotine|nicotine|mesh-list
25867411|NCT00108537|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25867412|NCT00108537|Autonomic Agents|autonomic agents|mesh-ancestor
25867413|NCT00108537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25867414|NCT00108537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867415|NCT00108537|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25867416|NCT00108537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25867417|NCT00108537|Cholinergic Agents|cholinergic agents|mesh-ancestor
25867418|NCT00108537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25867419|NCT00108537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867420|NCT00108537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25201785|NCT02725359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867421|NCT00108537|Antidepressive Agents|antidepressive agents|mesh-ancestor
25867422|NCT00108537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25867423|NCT00108537|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24516561|NCT00602407|Respiratory System Agents|respiratory system agents|mesh-ancestor
24516562|NCT00602407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24516563|NCT00602407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24516564|NCT00602407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516565|NCT00602407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25063102|NCT03188172|Autonomic Agents|autonomic agents|mesh-ancestor
25063103|NCT03188172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25063104|NCT03188172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24516566|NCT00602407|Vasodilator Agents|vasodilator agents|mesh-ancestor
24516567|NCT00602407|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25867424|NCT00108537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25867425|NCT00108537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25867426|NCT00108537|Dopamine Agents|dopamine agents|mesh-ancestor
25867427|NCT00108537|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25867428|NCT00108537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25867429|NCT00108537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867430|NCT00108563|Citalopram|citalopram|mesh-list
25867431|NCT00108563|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25867432|NCT00108563|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24897210|NCT04427618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24897211|NCT04427618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867433|NCT00108563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25867434|NCT00108563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867435|NCT00108563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25867436|NCT00108563|Serotonin Agents|serotonin agents|mesh-ancestor
25867437|NCT00108563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867438|NCT00108563|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25867439|NCT00108563|Antidepressive Agents|antidepressive agents|mesh-ancestor
25867440|NCT00108563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25867441|NCT00108576|Valproic Acid|valproic acid|mesh-list
25867442|NCT00108576|Anticonvulsants|anticonvulsants|mesh-ancestor
25867443|NCT00108576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516576|NCT00602498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516577|NCT00602498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516591|NCT00602511|Growth Substances|growth substances|mesh-ancestor
24516592|NCT00602511|Growth Inhibitors|growth inhibitors|mesh-ancestor
24516593|NCT00602524|Pilocarpine|pilocarpine|mesh-list
24516594|NCT00602524|Miotics|miotics|mesh-ancestor
25043778|NCT01205048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25043779|NCT01205048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25043780|NCT01205048|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25043781|NCT01205048|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24516595|NCT00602524|Autonomic Agents|autonomic agents|mesh-ancestor
25867444|NCT00108576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867445|NCT00108576|GABA Agents|gaba agents|mesh-ancestor
25867446|NCT00108576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25867447|NCT00108576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817622|NCT02084615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24817623|NCT02084615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24817624|NCT02084615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24817625|NCT02084615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817626|NCT02084615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25063105|NCT03188172|Glucocorticoids|glucocorticoids|mesh-ancestor
25063107|NCT03188172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25063108|NCT03188172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25063109|NCT03188172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25063110|NCT03188172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25063111|NCT03188172|Growth Substances|growth substances|mesh-ancestor
25063112|NCT03188172|Growth Inhibitors|growth inhibitors|mesh-ancestor
24817641|NCT02084732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24817642|NCT02084732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24474326|NCT00405574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25867448|NCT00108576|Antimanic Agents|antimanic agents|mesh-ancestor
25867449|NCT00108576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25867450|NCT00108576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25867451|NCT00108576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25867452|NCT00108602|Acetazolamide|acetazolamide|mesh-list
25867453|NCT00108602|Anticonvulsants|anticonvulsants|mesh-ancestor
25867454|NCT00108602|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25867455|NCT00108602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867456|NCT00108602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867457|NCT00108602|Diuretics|diuretics|mesh-ancestor
24817652|NCT02084953|Moxifloxacin|moxifloxacin|mesh-list
24817653|NCT02084953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24817654|NCT02084953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24817655|NCT02084953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24817656|NCT02084953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24817657|NCT02084953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817658|NCT02084953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817659|NCT02084953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24817660|NCT02085005|Capecitabine|capecitabine|mesh-list
24817661|NCT02085005|Oxaliplatin|oxaliplatin|mesh-list
24817662|NCT02085005|Aflibercept|aflibercept|mesh-list
24613764|NCT01020708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24613765|NCT01020708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24613766|NCT01020708|Analgesics|analgesics|mesh-ancestor
24474338|NCT00405717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25867458|NCT00108602|Natriuretic Agents|natriuretic agents|mesh-ancestor
25867459|NCT00108602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474363|NCT00405769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24446522|NCT00305019|Clevudine|clevudine|mesh-list
24446523|NCT00305019|Antiviral Agents|antiviral agents|mesh-ancestor
24516655|NCT00602693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25867460|NCT00108615|Metformin|metformin|mesh-list
25063119|NCT03158805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25063120|NCT03158805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063121|NCT03158805|Incretins|incretins|mesh-ancestor
25063122|NCT03158805|Hormones|hormones|mesh-ancestor
25867461|NCT00108615|Pioglitazone|pioglitazone|mesh-list
25867462|NCT00108615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25867463|NCT00108615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867464|NCT00108667|Levodopa|levodopa|mesh-list
24904252|NCT04357392|Prednisone|prednisone|mesh-list
25201786|NCT02725359|Sensory System Agents|sensory system agents|mesh-ancestor
25670570|NCT04246619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25670571|NCT04246619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25670572|NCT04246619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25670573|NCT04246619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25670574|NCT04246619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25670575|NCT04246619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25670576|NCT04246619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25867465|NCT00108667|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25867466|NCT00108667|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25867468|NCT00108667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24474371|NCT00405808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24474373|NCT00405847|Dexmedetomidine|dexmedetomidine|mesh-list
24474374|NCT00405847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25042558|NCT01418222|Bevacizumab|bevacizumab|mesh-list
25867469|NCT00108667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867470|NCT00108667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867471|NCT00108706|Candesartan|candesartan|mesh-list
25867472|NCT00108706|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24693372|NCT01420094|Analgesics|analgesics|mesh-ancestor
24897309|NCT04426669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24897310|NCT04426669|Antiviral Agents|antiviral agents|mesh-ancestor
24897311|NCT04426669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24897312|NCT04426422|Metformin|metformin|mesh-list
24897313|NCT04426422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24897314|NCT04426422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867473|NCT00108706|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25867474|NCT00108706|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25867475|NCT00108706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867476|NCT00108771|Fentanyl|fentanyl|mesh-list
25867477|NCT00108771|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25867478|NCT00108771|Narcotics|narcotics|mesh-ancestor
25867479|NCT00108771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25867480|NCT00108771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867481|NCT00108771|Analgesics|analgesics|mesh-ancestor
25867482|NCT00108771|Sensory System Agents|sensory system agents|mesh-ancestor
25063148|NCT03029234|Autonomic Agents|autonomic agents|mesh-ancestor
25867483|NCT00108771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25867484|NCT00108771|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25867485|NCT00108771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25867486|NCT00108771|Anesthetics, General|anesthetics, general|mesh-ancestor
25867487|NCT00108771|Anesthetics|anesthetics|mesh-ancestor
25867488|NCT00108797|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
25867489|NCT00108797|Coagulants|coagulants|mesh-ancestor
25867490|NCT00108849|Estradiol|estradiol|mesh-list
25867491|NCT00108849|Estrogens|estrogens|mesh-ancestor
25867492|NCT00108849|Hormones|hormones|mesh-ancestor
25867493|NCT00108849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25867494|NCT00108849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867495|NCT00108875|BIRC5 protein, human|birc5 protein, human|mesh-list
25867496|NCT00108875|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25867497|NCT00108875|Protease Inhibitors|protease inhibitors|mesh-ancestor
25867498|NCT00108875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867499|NCT00108875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201787|NCT02725359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25201788|NCT02725359|Analgesics|analgesics|mesh-ancestor
25201789|NCT02725359|Anticonvulsants|anticonvulsants|mesh-ancestor
25867500|NCT00108979|Citalopram|citalopram|mesh-list
25867501|NCT00108979|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24818453|NCT02088918|Metformin|metformin|mesh-list
25867502|NCT00108979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24516750|NCT00603109|Rimonabant|rimonabant|mesh-list
24516751|NCT00603109|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24897352|NCT04425993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24897353|NCT04425993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24897354|NCT04425993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24897355|NCT04425993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897356|NCT04425993|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24474479|NCT00406146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24474480|NCT00406146|Anthelmintics|anthelmintics|mesh-ancestor
24474481|NCT00406172|Bevacizumab|bevacizumab|mesh-list
24474482|NCT00406172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24474483|NCT00406172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474484|NCT00406172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25670577|NCT04246619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25670578|NCT04246619|Antidepressive Agents|antidepressive agents|mesh-ancestor
25670579|NCT04246619|Dopamine Agents|dopamine agents|mesh-ancestor
25670580|NCT04246359|Interferons|interferons|mesh-list
25670581|NCT04246359|Rituximab|rituximab|mesh-list
25670582|NCT04246359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25670583|NCT04246359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670584|NCT04246359|Immunologic Factors|immunologic factors|mesh-ancestor
25670585|NCT04246359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542976|NCT00681213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24542977|NCT00681213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542978|NCT00681213|Antifungal Agents|antifungal agents|mesh-ancestor
25063150|NCT03029234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063151|NCT03029234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25063152|NCT03029234|Glucocorticoids|glucocorticoids|mesh-ancestor
25063154|NCT03029234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25063155|NCT03029234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25063156|NCT03029234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063158|NCT02949284|Cortisone|cortisone|mesh-list
25063159|NCT02949284|Abiraterone Acetate|abiraterone acetate|mesh-list
25063160|NCT02949284|Hormones|hormones|mesh-list
24897414|NCT04425642|SMOFlipid|smoflipid|mesh-list
25867503|NCT00108979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25867504|NCT00108979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867505|NCT00108979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25867506|NCT00108979|Serotonin Agents|serotonin agents|mesh-ancestor
25867507|NCT00108979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867508|NCT00108979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25867509|NCT00108979|Antidepressive Agents|antidepressive agents|mesh-ancestor
24474490|NCT00406237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24474491|NCT00406237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24825713|NCT02129764|Antimetabolites|antimetabolites|mesh-ancestor
24825715|NCT02129764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867510|NCT00108979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25867511|NCT00108992|Diclofenac|diclofenac|mesh-list
25867512|NCT00108992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25867513|NCT00108992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25867514|NCT00108992|Analgesics|analgesics|mesh-ancestor
25867515|NCT00108992|Sensory System Agents|sensory system agents|mesh-ancestor
25867516|NCT00108992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25867517|NCT00108992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867518|NCT00108992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25867519|NCT00108992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25867520|NCT00108992|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25867521|NCT00108992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867522|NCT00108992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201790|NCT02725359|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24904503|NCT04355273|Heparin|heparin|mesh-list
25867523|NCT00109044|Citalopram|citalopram|mesh-list
25867524|NCT00109044|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25867525|NCT00109044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25867526|NCT00109044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24897429|NCT04425642|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24897430|NCT04425642|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24897431|NCT04425681|Bevacizumab|bevacizumab|mesh-list
24897432|NCT04425681|Osimertinib|osimertinib|mesh-list
24897433|NCT04425681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24897434|NCT04425681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24897435|NCT04425681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24897436|NCT04425681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24897437|NCT04425681|Growth Substances|growth substances|mesh-ancestor
24897438|NCT04425681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897439|NCT04425681|Growth Inhibitors|growth inhibitors|mesh-ancestor
24897440|NCT04425681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24516767|NCT00603317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24516768|NCT00603317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063176|NCT02889159|Imiquimod|imiquimod|mesh-list
25063177|NCT02889159|Histamine|histamine|mesh-list
25063178|NCT02889159|Histamine phosphate|histamine phosphate|mesh-list
25063179|NCT02889159|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25063180|NCT02889159|Immunologic Factors|immunologic factors|mesh-ancestor
25063181|NCT02889159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670586|NCT04246359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25670587|NCT04246359|Antiviral Agents|antiviral agents|mesh-ancestor
25670588|NCT04246359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24825723|NCT02129829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24825724|NCT02129829|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25670589|NCT04196868|Metformin|metformin|mesh-list
25670590|NCT04196868|Methotrexate|methotrexate|mesh-list
25670591|NCT04196868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25670592|NCT04196868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670593|NCT04196868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25670594|NCT04196868|Abortifacient Agents|abortifacient agents|mesh-ancestor
24842830|NCT02224066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25867527|NCT00109044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867528|NCT00109044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25867529|NCT00109044|Serotonin Agents|serotonin agents|mesh-ancestor
24842831|NCT02224066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842832|NCT02224066|Antipyretics|antipyretics|mesh-ancestor
24842833|NCT02224066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24952787|NCT03892148|Diuretics|diuretics|mesh-ancestor
25867530|NCT00109044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867531|NCT00109044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25867532|NCT00109044|Antidepressive Agents|antidepressive agents|mesh-ancestor
24825725|NCT02129829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24825726|NCT02129829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825727|NCT02129829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825728|NCT02129829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24825729|NCT02129829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24582357|NCT00869271|Leucovorin|leucovorin|mesh-list
24825730|NCT02129933|Bevacizumab|bevacizumab|mesh-list
24474520|NCT00406380|Bevacizumab|bevacizumab|mesh-list
24474521|NCT00406380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24474522|NCT00406380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474523|NCT00406380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25867533|NCT00109044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25867534|NCT00109057|Bevacizumab|bevacizumab|mesh-list
25867535|NCT00109057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25867536|NCT00109057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867537|NCT00109057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24897458|NCT04425187|Bevacizumab|bevacizumab|mesh-list
24897460|NCT04425187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24897461|NCT04425187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24897462|NCT04425187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24897463|NCT04425187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24897464|NCT04425187|Growth Substances|growth substances|mesh-ancestor
24897465|NCT04425187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897466|NCT04425187|Growth Inhibitors|growth inhibitors|mesh-ancestor
24897467|NCT04425187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24897468|NCT04425187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855346|NCT02279147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613782|NCT01020734|Immunologic Factors|immunologic factors|mesh-ancestor
24474544|NCT00406471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24474545|NCT00406471|Growth Substances|growth substances|mesh-ancestor
25867538|NCT00109057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25867539|NCT00109057|Growth Substances|growth substances|mesh-ancestor
25201791|NCT02725359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25201792|NCT02725359|Parasympatholytics|parasympatholytics|mesh-ancestor
25201793|NCT02725359|Autonomic Agents|autonomic agents|mesh-ancestor
25201794|NCT02725359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25201795|NCT02725359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25201796|NCT02725359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25867540|NCT00109057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867541|NCT00109057|Growth Inhibitors|growth inhibitors|mesh-ancestor
25867542|NCT00109070|Bevacizumab|bevacizumab|mesh-list
25867543|NCT00109070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25867544|NCT00109070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867545|NCT00109070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25867546|NCT00109070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25867547|NCT00109070|Growth Substances|growth substances|mesh-ancestor
25867548|NCT00109070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063191|NCT02874144|Dermatologic Agents|dermatologic agents|mesh-ancestor
25063192|NCT02874144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25063193|NCT02874144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25063194|NCT02874144|Autonomic Agents|autonomic agents|mesh-ancestor
25063195|NCT02874144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25063196|NCT02874144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063197|NCT02874144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25063198|NCT02874144|Respiratory System Agents|respiratory system agents|mesh-ancestor
25063200|NCT02862171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25670595|NCT04196868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25670596|NCT04196868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25670597|NCT04196868|Antimetabolites|antimetabolites|mesh-ancestor
25670598|NCT04196868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670599|NCT04196868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670600|NCT04196868|Dermatologic Agents|dermatologic agents|mesh-ancestor
25670601|NCT04196868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063201|NCT02862171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25063202|NCT02862171|Antiviral Agents|antiviral agents|mesh-ancestor
25063203|NCT02862171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25867549|NCT00109070|Growth Inhibitors|growth inhibitors|mesh-ancestor
25867550|NCT00109096|Pemetrexed|pemetrexed|mesh-list
25867551|NCT00109096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867552|NCT00109096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867553|NCT00109096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630094|NCT01109498|Dermatologic Agents|dermatologic agents|mesh-ancestor
25867554|NCT00109096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24613783|NCT01020734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817663|NCT02085005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24897494|NCT04425135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063204|NCT02835534|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25063206|NCT02835534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25063207|NCT02835534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25063208|NCT02835534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063209|NCT02722200|Hydrocortisone|hydrocortisone|mesh-list
25063210|NCT02722200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25063212|NCT02620306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25063213|NCT02620306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25063214|NCT02620306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25201797|NCT02725359|Adrenergic Agents|adrenergic agents|mesh-ancestor
24468078|NCT00379717|Cisplatin|cisplatin|mesh-list
25063215|NCT02620306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24897547|NCT04424420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897548|NCT04424563|Aminocaproic Acid|aminocaproic acid|mesh-list
24897549|NCT04424563|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24897550|NCT04424563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24897551|NCT04424563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897552|NCT04424563|Hemostatics|hemostatics|mesh-ancestor
24897553|NCT04424563|Coagulants|coagulants|mesh-ancestor
24897554|NCT04424485|Parathyroid Hormone|parathyroid hormone|mesh-list
24474632|NCT00406978|Glucocorticoids|glucocorticoids|mesh-ancestor
24474633|NCT00406978|Hormones|hormones|mesh-ancestor
24424431|NCT00229385|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24474634|NCT00406978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24474635|NCT00406978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474636|NCT00406978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25867555|NCT00109096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25867556|NCT00109109|Vorinostat|vorinostat|mesh-list
25867557|NCT00109109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25064241|NCT03461718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25064242|NCT03461718|Narcotics|narcotics|mesh-ancestor
24474652|NCT00406978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24897555|NCT04424485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25063260|NCT02477826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063261|NCT02477826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24897573|NCT04423926|Cyclophosphamide|cyclophosphamide|mesh-list
24897574|NCT04423926|Doxorubicin|doxorubicin|mesh-list
24897575|NCT04423926|Vincristine|vincristine|mesh-list
24897583|NCT04423926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897585|NCT04423926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24897586|NCT04423926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24897587|NCT04423926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24897588|NCT04423926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24897589|NCT04423926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24897606|NCT04424017|Immunologic Factors|immunologic factors|mesh-ancestor
24897607|NCT04424017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897608|NCT04424134|Spironolactone|spironolactone|mesh-list
24897609|NCT04424134|Bromhexine|bromhexine|mesh-list
24897610|NCT04424134|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24474679|NCT00407017|Nepafenac|nepafenac|mesh-list
24474680|NCT00407017|Prednisolone acetate|prednisolone acetate|mesh-list
24474681|NCT00407017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24474691|NCT00407017|Analgesics|analgesics|mesh-ancestor
25201798|NCT02725359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25201799|NCT02725359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816566|NCT02077751|Biotin|biotin|mesh-list
24897611|NCT04424134|Hormone Antagonists|hormone antagonists|mesh-ancestor
24897612|NCT04424134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24897613|NCT04424134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897614|NCT04424134|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24897615|NCT04424134|Diuretics|diuretics|mesh-ancestor
24897616|NCT04424134|Natriuretic Agents|natriuretic agents|mesh-ancestor
24842876|NCT02224131|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24842877|NCT02224131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24842878|NCT02224131|Purinergic Agents|purinergic agents|mesh-ancestor
24842879|NCT02224131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24842880|NCT02224170|Dexamethasone|dexamethasone|mesh-list
24842881|NCT02224170|Lidocaine|lidocaine|mesh-list
24842882|NCT02224170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24897617|NCT04424134|Expectorants|expectorants|mesh-ancestor
24897618|NCT04424134|Respiratory System Agents|respiratory system agents|mesh-ancestor
25063262|NCT02477826|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24516795|NCT00603434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24516796|NCT00603759|Celecoxib|celecoxib|mesh-list
24947727|NCT03926559|Analgesics|analgesics|mesh-ancestor
24947728|NCT03926559|Sensory System Agents|sensory system agents|mesh-ancestor
24947729|NCT03926559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24947730|NCT03926377|Clobetasol|clobetasol|mesh-list
24947731|NCT03926377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24947732|NCT03926377|Glucocorticoids|glucocorticoids|mesh-ancestor
24947733|NCT03926377|Hormones|hormones|mesh-ancestor
24773034|NCT01837394|Acetaminophen|acetaminophen|mesh-list
25067429|NCT03443843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897705|NCT04423185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24897706|NCT04423185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897707|NCT04423185|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24474773|NCT00407290|Neostigmine|neostigmine|mesh-list
24474774|NCT00407290|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25867558|NCT00109109|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25867559|NCT00109109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867560|NCT00109109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867561|NCT00109135|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
25867562|NCT00109135|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24516800|NCT00603759|Sensory System Agents|sensory system agents|mesh-ancestor
24516801|NCT00603759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24516802|NCT00603759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533068|NCT00642161|Budesonide|budesonide|mesh-list
24897721|NCT04422678|Imatinib Mesylate|imatinib mesylate|mesh-list
24897722|NCT04422678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24897723|NCT04422678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24897724|NCT04422678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24897725|NCT04422678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897726|NCT04422275|Budesonide|budesonide|mesh-list
25201800|NCT02725489|Durvalumab|durvalumab|mesh-list
25201801|NCT02725489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24897728|NCT04422275|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24897730|NCT04422275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24897731|NCT04422275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897732|NCT04422275|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25067430|NCT03443843|Nasal Decongestants|nasal decongestants|mesh-ancestor
24947749|NCT03926156|Protease Inhibitors|protease inhibitors|mesh-ancestor
24947750|NCT03926156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24947751|NCT03926156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947754|NCT03926000|Sensory System Agents|sensory system agents|mesh-ancestor
24947755|NCT03926000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24947756|NCT03926000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441869|NCT00288652|Reboxetine|reboxetine|mesh-list
24897752|NCT04422392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24817694|NCT02085239|Sensory System Agents|sensory system agents|mesh-ancestor
24817695|NCT02085239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24817696|NCT02085239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24817697|NCT02085239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24817698|NCT02085239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24817699|NCT02085239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25867563|NCT00109135|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25867564|NCT00109135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25876631|NCT03164616|Tremelimumab|tremelimumab|mesh-list
25670602|NCT04196868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25670603|NCT04196868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25670604|NCT04196868|Immunologic Factors|immunologic factors|mesh-ancestor
25670605|NCT04196868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25670606|NCT04196868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25674496|NCT01772823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674497|NCT01772823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474841|NCT00407641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474842|NCT00407680|Valsartan|valsartan|mesh-list
24817702|NCT02085291|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24817703|NCT02085291|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24817704|NCT02085291|Adrenergic Agents|adrenergic agents|mesh-ancestor
24817705|NCT02085291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25063264|NCT02477826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24474866|NCT00407784|Diuretics|diuretics|mesh-ancestor
24474867|NCT00407784|Natriuretic Agents|natriuretic agents|mesh-ancestor
24474868|NCT00407784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25867565|NCT00109135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867566|NCT00109135|Hormones|hormones|mesh-ancestor
25867567|NCT00109135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25867568|NCT00109135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867569|NCT00109148|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
25867570|NCT00109148|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25867571|NCT00109148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25867572|NCT00109148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24474876|NCT00407849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24474877|NCT00407849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474878|NCT00407849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24516815|NCT00603785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25867573|NCT00109148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897773|NCT04422028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24897775|NCT04422184|Diuretics|diuretics|mesh-ancestor
24897776|NCT04422184|Natriuretic Agents|natriuretic agents|mesh-ancestor
24897777|NCT04422184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867574|NCT00109148|Hormones|hormones|mesh-ancestor
25867575|NCT00109148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25867576|NCT00109148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867577|NCT00109161|Antibodies|antibodies|mesh-list
25867578|NCT00109161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24516887|NCT00604409|Antimetabolites|antimetabolites|mesh-ancestor
25867579|NCT00109161|Daclizumab|daclizumab|mesh-list
25867580|NCT00109161|Immunologic Factors|immunologic factors|mesh-ancestor
25867581|NCT00109161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867582|NCT00109161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25867583|NCT00109187|Omalizumab|omalizumab|mesh-list
25867584|NCT00109187|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24516825|NCT00603824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063292|NCT02211131|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25063293|NCT02211131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25063294|NCT02211131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063296|NCT02186847|Paclitaxel|paclitaxel|mesh-list
24825845|NCT02130804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825846|NCT02130804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24825847|NCT02130804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24825851|NCT02130817|Mycophenolic Acid|mycophenolic acid|mesh-list
24516826|NCT00603824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516827|NCT00603824|Anticoagulants|anticoagulants|mesh-ancestor
24516828|NCT00603824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24516829|NCT00603824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24516830|NCT00603824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25867585|NCT00109187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25867586|NCT00109187|Respiratory System Agents|respiratory system agents|mesh-ancestor
25867587|NCT00109200|Omalizumab|omalizumab|mesh-list
24897802|NCT04421911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24897804|NCT04421911|Sensory System Agents|sensory system agents|mesh-ancestor
24897805|NCT04421911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24897806|NCT04421911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897807|NCT04421911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25867588|NCT00109200|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25867589|NCT00109200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25867590|NCT00109200|Respiratory System Agents|respiratory system agents|mesh-ancestor
25867591|NCT00109226|Bevacizumab|bevacizumab|mesh-list
25867592|NCT00109226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25867593|NCT00109226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867594|NCT00109226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25867595|NCT00109226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24516843|NCT00604058|Vaccines|vaccines|mesh-list
24516844|NCT00604058|Immunologic Factors|immunologic factors|mesh-ancestor
25227743|NCT02612272|Hormones|hormones|mesh-ancestor
24516845|NCT00604058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516846|NCT00604084|Ivermectin|ivermectin|mesh-list
24516847|NCT00604084|Permethrin|permethrin|mesh-list
24516848|NCT00604084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24516849|NCT00604084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24516850|NCT00604084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516851|NCT00604084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516852|NCT00604253|Insulin|insulin|mesh-list
24516853|NCT00604253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24516854|NCT00604253|Insulin Detemir|insulin detemir|mesh-list
24516855|NCT00604253|Isophane Insulin, Human|isophane insulin, human|mesh-list
24516856|NCT00604253|Insulin, Isophane|insulin, isophane|mesh-list
25867596|NCT00109226|Growth Substances|growth substances|mesh-ancestor
25867597|NCT00109226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867598|NCT00109226|Growth Inhibitors|growth inhibitors|mesh-ancestor
25867599|NCT00109239|Bevacizumab|bevacizumab|mesh-list
25867600|NCT00109239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25867601|NCT00109239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867602|NCT00109239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25867603|NCT00109239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25867604|NCT00109239|Growth Substances|growth substances|mesh-ancestor
25867605|NCT00109239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867606|NCT00109239|Growth Inhibitors|growth inhibitors|mesh-ancestor
25867607|NCT00109265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25867608|NCT00109265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867609|NCT00109265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24897869|NCT04421105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897870|NCT04421105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24897871|NCT04421105|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24897872|NCT04421105|Serotonin Agents|serotonin agents|mesh-ancestor
24516883|NCT00604396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24516884|NCT00604396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516885|NCT00604409|Capecitabine|capecitabine|mesh-list
24516886|NCT00604409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24516925|NCT00604682|Sensory System Agents|sensory system agents|mesh-ancestor
24516926|NCT00604682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24516927|NCT00604682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516945|NCT00604942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24516946|NCT00604942|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25867610|NCT00109265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063308|NCT02101034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25063309|NCT02101034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516948|NCT00604942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516949|NCT00604942|Antiemetics|antiemetics|mesh-ancestor
24516950|NCT00604942|Autonomic Agents|autonomic agents|mesh-ancestor
24516951|NCT00604942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24516952|NCT00604942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516953|NCT00604942|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24516954|NCT00604942|Dopamine Agents|dopamine agents|mesh-ancestor
24516955|NCT00604942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24516956|NCT00604955|Paromomycin|paromomycin|mesh-list
24516957|NCT00604955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24897913|NCT04420351|Clopidogrel|clopidogrel|mesh-list
24897914|NCT04420351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24897915|NCT04420351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24897916|NCT04420351|Analgesics|analgesics|mesh-ancestor
24897917|NCT04420351|Sensory System Agents|sensory system agents|mesh-ancestor
24897918|NCT04420351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24897919|NCT04420351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897920|NCT04420351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24897921|NCT04420351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24897922|NCT04420351|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24475028|NCT00408551|Antimetabolites|antimetabolites|mesh-ancestor
24897931|NCT04420351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24897932|NCT04420351|Purinergic Agents|purinergic agents|mesh-ancestor
24897933|NCT04420351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24475050|NCT00408655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475051|NCT00408655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24475052|NCT00408655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24475053|NCT00408655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24475054|NCT00408655|Antifungal Agents|antifungal agents|mesh-ancestor
25201802|NCT02725489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201803|NCT02725229|Levobupivacaine|levobupivacaine|mesh-list
25867611|NCT00109265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475055|NCT00408655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24475056|NCT00408655|Immunologic Factors|immunologic factors|mesh-ancestor
24475057|NCT00408655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475060|NCT00408772|Oxaliplatin|oxaliplatin|mesh-list
24475061|NCT00408772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24897968|NCT04419493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897969|NCT04419441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25063313|NCT02097121|Botulinum Toxins|botulinum toxins|mesh-list
24700771|NCT01455103|BMS-936559|bms-936559|mesh-list
24905166|NCT04350671|Lopinavir|lopinavir|mesh-list
24897986|NCT04419259|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
24897987|NCT04419259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897988|NCT04419259|Analgesics|analgesics|mesh-ancestor
24897989|NCT04419259|Sensory System Agents|sensory system agents|mesh-ancestor
24475086|NCT00408798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24897990|NCT04419259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24897991|NCT04419259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897992|NCT04419246|Tranexamic Acid|tranexamic acid|mesh-list
24897993|NCT04419246|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24897994|NCT04419246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24897995|NCT04419246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897996|NCT04419246|Hemostatics|hemostatics|mesh-ancestor
24897997|NCT04419246|Coagulants|coagulants|mesh-ancestor
24897998|NCT04419272|Methylphenidate|methylphenidate|mesh-list
24897999|NCT04419272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24898000|NCT04419272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516990|NCT00605137|Isophane Insulin, Human|isophane insulin, human|mesh-list
24516992|NCT00605137|Isophane insulin, beef|isophane insulin, beef|mesh-list
24898001|NCT04419272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24898002|NCT04419272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24898003|NCT04419272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24898004|NCT04419272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817750|NCT02085577|Acetaminophen|acetaminophen|mesh-list
24817751|NCT02085577|Sufentanil|sufentanil|mesh-list
24817752|NCT02085577|Ketamine|ketamine|mesh-list
24898005|NCT04419272|Dopamine Agents|dopamine agents|mesh-ancestor
24898006|NCT04419272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24898008|NCT04419038|Mitomycin|mitomycin|mesh-list
24898009|NCT04419038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24898010|NCT04419038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867612|NCT00109278|Vaccines|vaccines|mesh-list
25867613|NCT00109278|Immunologic Factors|immunologic factors|mesh-ancestor
25867614|NCT00109278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867615|NCT00109356|AQ4N|aq4n|mesh-list
24898068|NCT04418674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898069|NCT04418674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25867616|NCT00109356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898070|NCT04418674|Narcotics|narcotics|mesh-ancestor
24898071|NCT04418674|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24475172|NCT00409305|Betahistine|betahistine|mesh-list
25867617|NCT00109382|Aspirin|aspirin|mesh-list
24446644|NCT00305513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867618|NCT00109382|Clopidogrel|clopidogrel|mesh-list
24446647|NCT00305513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24818546|NCT02089386|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24818547|NCT02089386|Hormone Antagonists|hormone antagonists|mesh-ancestor
24818548|NCT02089386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24818549|NCT02089386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818555|NCT02089399|Olmesartan|olmesartan|mesh-list
24446649|NCT00305513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24446650|NCT00305539|Adalimumab|adalimumab|mesh-list
24472474|NCT00399256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472475|NCT00399256|Antidotes|antidotes|mesh-ancestor
24472653|NCT00400075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25867619|NCT00109382|Simvastatin|simvastatin|mesh-list
25867620|NCT00109382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24516996|NCT00605371|Anticonvulsants|anticonvulsants|mesh-list
24516997|NCT00605371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25670607|NCT04172701|Cholinergic Agents|cholinergic agents|mesh-list
25670608|NCT04172701|Muscarinic Antagonists|muscarinic antagonists|mesh-list
25670609|NCT04172701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25867621|NCT00109382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25867622|NCT00109382|Analgesics|analgesics|mesh-ancestor
25867623|NCT00109382|Sensory System Agents|sensory system agents|mesh-ancestor
25227777|NCT02612259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25867624|NCT00109382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25867625|NCT00109382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867626|NCT00109382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24898091|NCT04418154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24898092|NCT04418154|Alkylating Agents|alkylating agents|mesh-ancestor
24898093|NCT04418154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24898094|NCT04418154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24898095|NCT04418154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24633818|NCT01131247|Alkylating Agents|alkylating agents|mesh-ancestor
24475239|NCT00409591|Antiviral Agents|antiviral agents|mesh-ancestor
24475240|NCT00409591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24475241|NCT00409591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24475242|NCT00409591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24475243|NCT00409591|Antimetabolites|antimetabolites|mesh-ancestor
24475244|NCT00409591|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24516998|NCT00605371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24898166|NCT04417582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24517062|NCT00605774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517063|NCT00605774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517064|NCT00605774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24898188|NCT04417114|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24898189|NCT04417114|Antimetabolites|antimetabolites|mesh-ancestor
24898190|NCT04417114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898191|NCT04417114|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24898192|NCT04417114|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24898193|NCT04417114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24898195|NCT04417348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898196|NCT04417348|Keratolytic Agents|keratolytic agents|mesh-ancestor
24898197|NCT04417348|Dermatologic Agents|dermatologic agents|mesh-ancestor
24898198|NCT04417543|Memantine|memantine|mesh-list
24898199|NCT04417543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24947767|NCT03925818|Tetracycline|tetracycline|mesh-list
24825888|NCT02130830|Prilocaine|prilocaine|mesh-list
24898200|NCT04417543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24905316|NCT04348786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905317|NCT04348786|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24898201|NCT04417543|Dopamine Agents|dopamine agents|mesh-ancestor
24898202|NCT04417543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24898203|NCT04417543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898204|NCT04417543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898205|NCT04417543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24688017|NCT03522584|Durvalumab|durvalumab|mesh-list
24475323|NCT00409890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475324|NCT00409890|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24475325|NCT00409890|Parasympatholytics|parasympatholytics|mesh-ancestor
24517069|NCT00605774|Respiratory System Agents|respiratory system agents|mesh-ancestor
24517070|NCT00605774|Mydriatics|mydriatics|mesh-ancestor
24517071|NCT00605774|Sympathomimetics|sympathomimetics|mesh-ancestor
24517072|NCT00605774|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24517073|NCT00605787|1-(carboxymethylthio)tetradecane|1-(carboxymethylthio)tetradecane|mesh-list
25201805|NCT02725229|Anesthetics|anesthetics|mesh-ancestor
25201806|NCT02725229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25201807|NCT02725229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201808|NCT02725229|Sensory System Agents|sensory system agents|mesh-ancestor
25201809|NCT02725229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24461402|NCT00352235|KRN 7000|krn 7000|mesh-list
24473588|NCT00403364|Tinidazole|tinidazole|mesh-list
24517074|NCT00605787|Antioxidants|antioxidants|mesh-ancestor
24634170|NCT01132222|Sympathomimetics|sympathomimetics|mesh-ancestor
24517078|NCT00605787|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24517079|NCT00605891|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24517080|NCT00605891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24517081|NCT00605891|Autonomic Agents|autonomic agents|mesh-ancestor
24517082|NCT00605891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25670610|NCT04172701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670611|NCT04172701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670612|NCT04172701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25670613|NCT04154150|Ketamine|ketamine|mesh-list
25670614|NCT04154150|Analgesics|analgesics|mesh-ancestor
25227799|NCT02612233|Dopamine Agents|dopamine agents|mesh-ancestor
24517083|NCT00605891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517084|NCT00605891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24517085|NCT00605891|Respiratory System Agents|respiratory system agents|mesh-ancestor
24517086|NCT00605891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24517087|NCT00605891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24517088|NCT00605891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24517089|NCT00605891|Adrenergic Agents|adrenergic agents|mesh-ancestor
24517090|NCT00605891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24517091|NCT00605891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517092|NCT00605930|Niacinamide|niacinamide|mesh-list
24517094|NCT00605930|Nicotinic Acids|nicotinic acids|mesh-list
24517095|NCT00605930|Vitamin B Complex|vitamin b complex|mesh-ancestor
24517096|NCT00605930|Vitamins|vitamins|mesh-ancestor
24517097|NCT00605930|Micronutrients|micronutrients|mesh-ancestor
24898342|NCT04414995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24898343|NCT04414995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24898344|NCT04414995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24898345|NCT04414995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898347|NCT04414852|Apatinib|apatinib|mesh-list
24898348|NCT04414852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898349|NCT04414852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24898350|NCT04414852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24475416|NCT00410371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24475417|NCT00410371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475418|NCT00410371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24475419|NCT00410371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24475420|NCT00410371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24475421|NCT00410371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25867627|NCT00109382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25867628|NCT00109382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25867629|NCT00109382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25867630|NCT00109382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867631|NCT00109382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25867632|NCT00109382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24905417|NCT04347980|Antiemetics|antiemetics|mesh-ancestor
24905418|NCT04347980|Autonomic Agents|autonomic agents|mesh-ancestor
24905419|NCT04347980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25867633|NCT00109382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867634|NCT00109382|Antipyretics|antipyretics|mesh-ancestor
25867635|NCT00109382|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25867636|NCT00109382|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25867637|NCT00109382|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25867638|NCT00109382|Purinergic Agents|purinergic agents|mesh-ancestor
25867639|NCT00109382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25867640|NCT00109382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25201810|NCT02725242|Budesonide|budesonide|mesh-list
25201811|NCT02725242|Formoterol Fumarate|formoterol fumarate|mesh-list
25201812|NCT02725242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25867641|NCT00109382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25867642|NCT00109382|Antimetabolites|antimetabolites|mesh-ancestor
25867643|NCT00109382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25867644|NCT00109382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25867645|NCT00109395|Midazolam|midazolam|mesh-list
24517132|NCT00606164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517133|NCT00606203|Milnacipran|milnacipran|mesh-list
25063362|NCT01968590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063363|NCT01968590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25063364|NCT01968590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25063365|NCT01938261|Acetaminophen|acetaminophen|mesh-list
24517134|NCT00606203|Levomilnacipran|levomilnacipran|mesh-list
24517135|NCT00606203|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24517136|NCT00606203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24634526|NCT01133873|Dextropropoxyphene|dextropropoxyphene|mesh-list
25867646|NCT00109395|Lorazepam|lorazepam|mesh-list
25867647|NCT00109395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25867648|NCT00109395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25063366|NCT01938261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24898439|NCT04414566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898441|NCT04414566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24898442|NCT04414566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24898443|NCT04414566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24475475|NCT00410592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24475476|NCT00410592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475477|NCT00410631|Cyclophosphamide|cyclophosphamide|mesh-list
24475478|NCT00410631|Melphalan|melphalan|mesh-list
24475479|NCT00410631|Ifosfamide|ifosfamide|mesh-list
24475480|NCT00410631|Dacarbazine|dacarbazine|mesh-list
24475481|NCT00410631|Carboplatin|carboplatin|mesh-list
25086719|NCT03286764|Autonomic Agents|autonomic agents|mesh-ancestor
25867649|NCT00109395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25867650|NCT00109395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898462|NCT04414267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898463|NCT04414267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24898464|NCT04413734|Gemcitabine|gemcitabine|mesh-list
24898465|NCT04413734|Cisplatin|cisplatin|mesh-list
24898466|NCT04413734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898467|NCT04413734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24898468|NCT04413734|Antimetabolites|antimetabolites|mesh-ancestor
24898469|NCT04413734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898470|NCT04413734|Antiviral Agents|antiviral agents|mesh-ancestor
24898471|NCT04413734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24898472|NCT04413734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24898473|NCT04413734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24898474|NCT04413734|Immunologic Factors|immunologic factors|mesh-ancestor
24898475|NCT04413734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898476|NCT04413838|Nivolumab|nivolumab|mesh-list
24898477|NCT04413838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24898487|NCT04413864|Sensory System Agents|sensory system agents|mesh-ancestor
24898488|NCT04413864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24898489|NCT04413864|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24898490|NCT04413864|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24898491|NCT04413864|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24898492|NCT04413864|Adrenergic Agents|adrenergic agents|mesh-ancestor
24898493|NCT04413864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24898494|NCT04413864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898495|NCT04414020|Progesterone|progesterone|mesh-list
25201813|NCT02725242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25201814|NCT02725242|Autonomic Agents|autonomic agents|mesh-ancestor
24898496|NCT04414020|Progestins|progestins|mesh-ancestor
24898497|NCT04414020|Hormones|hormones|mesh-ancestor
25063371|NCT01938261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063372|NCT01938261|Antipyretics|antipyretics|mesh-ancestor
25063382|NCT01828112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25063383|NCT01828112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24634867|NCT01135641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898514|NCT04413292|Protease Inhibitors|protease inhibitors|mesh-ancestor
24898515|NCT04413292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24898516|NCT04413292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898517|NCT04413227|Docetaxel|docetaxel|mesh-list
24898518|NCT04413227|Endostatins|endostatins|mesh-list
24898519|NCT04413227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898520|NCT04413227|Tubulin Modulators|tubulin modulators|mesh-ancestor
24898521|NCT04413227|Antimitotic Agents|antimitotic agents|mesh-ancestor
24898522|NCT04413227|Mitosis Modulators|mitosis modulators|mesh-ancestor
24721413|NCT01573806|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24898556|NCT04412850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24898557|NCT04412850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898558|NCT04412850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24475603|NCT00410943|Analgesics|analgesics|mesh-ancestor
25867651|NCT00109395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25867652|NCT00109395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25867653|NCT00109395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25867654|NCT00109395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24475658|NCT00410995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24475659|NCT00410995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475660|NCT00411034|Hydromorphone|hydromorphone|mesh-list
25063392|NCT01709981|Antimitotic Agents|antimitotic agents|mesh-ancestor
25063393|NCT01709981|Mitosis Modulators|mitosis modulators|mesh-ancestor
25867655|NCT00109395|Anesthetics, General|anesthetics, general|mesh-ancestor
25867656|NCT00109395|Anesthetics|anesthetics|mesh-ancestor
25867657|NCT00109395|GABA Modulators|gaba modulators|mesh-ancestor
24905636|NCT04346147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905637|NCT04346147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24905638|NCT04346147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25064359|NCT03460964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064360|NCT03460860|Tocopherols|tocopherols|mesh-list
24517165|NCT00606333|Tubulin Modulators|tubulin modulators|mesh-ancestor
24517166|NCT00606333|Antimitotic Agents|antimitotic agents|mesh-ancestor
24517167|NCT00606333|Mitosis Modulators|mitosis modulators|mesh-ancestor
24517168|NCT00606333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227839|NCT02611908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25227840|NCT02611921|Ketamine|ketamine|mesh-list
25227841|NCT02611921|Analgesics|analgesics|mesh-ancestor
25867658|NCT00109395|GABA Agents|gaba agents|mesh-ancestor
25867659|NCT00109395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24635272|NCT01138072|Atorvastatin|atorvastatin|mesh-list
24898639|NCT04411524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24898640|NCT04411524|Antimetabolites|antimetabolites|mesh-ancestor
24898641|NCT04411524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898642|NCT04411524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201815|NCT02725242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24898674|NCT04411901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24898692|NCT04411446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24898693|NCT04411446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24898694|NCT04411329|Dexamethasone|dexamethasone|mesh-list
24898695|NCT04411329|Dexmedetomidine|dexmedetomidine|mesh-list
25064361|NCT03460860|Vitamin E|vitamin e|mesh-list
25064362|NCT03460860|Tocotrienols|tocotrienols|mesh-list
25064363|NCT03460860|alpha-Tocopherol|alpha-tocopherol|mesh-list
25064364|NCT03460860|Lycopene|lycopene|mesh-list
24898696|NCT04411329|Bupivacaine|bupivacaine|mesh-list
24898697|NCT04411329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24898698|NCT04411329|Antiemetics|antiemetics|mesh-ancestor
24898699|NCT04411329|Autonomic Agents|autonomic agents|mesh-ancestor
24898724|NCT04411160|Nitric Oxide|nitric oxide|mesh-list
24898725|NCT04411160|Vitamins|vitamins|mesh-ancestor
24898726|NCT04411160|Micronutrients|micronutrients|mesh-ancestor
24898727|NCT04411160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898728|NCT04411160|Antioxidants|antioxidants|mesh-ancestor
24898729|NCT04411160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898730|NCT04411160|Protective Agents|protective agents|mesh-ancestor
24898731|NCT04411160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24533445|NCT00644033|Frovatriptan|frovatriptan|mesh-list
24475772|NCT00411333|Glucocorticoids|glucocorticoids|mesh-ancestor
24475773|NCT00411333|Hormones|hormones|mesh-ancestor
24475779|NCT00411333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475780|NCT00411372|Fluticasone|fluticasone|mesh-list
24475782|NCT00411372|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25063397|NCT01670500|Cisplatin|cisplatin|mesh-list
25063398|NCT01670500|Doxorubicin|doxorubicin|mesh-list
25063399|NCT01670500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25063400|NCT01670500|Immunologic Factors|immunologic factors|mesh-ancestor
24635577|NCT01140399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25063408|NCT01670500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25063409|NCT01670500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25063410|NCT01670500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25063411|NCT01670500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635674|NCT01140620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24855446|NCT02279615|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24898886|NCT04409431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24898887|NCT04409431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898888|NCT04409431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898889|NCT04409431|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24898890|NCT04409431|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24898891|NCT04409431|Autonomic Agents|autonomic agents|mesh-ancestor
24898892|NCT04409431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24517205|NCT00606450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517207|NCT00606515|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24517208|NCT00606515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24517209|NCT00606515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517230|NCT00606775|Protective Agents|protective agents|mesh-ancestor
24517231|NCT00606775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24517232|NCT00606775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24898894|NCT04409431|Respiratory System Agents|respiratory system agents|mesh-ancestor
24898896|NCT04409431|Sympathomimetics|sympathomimetics|mesh-ancestor
24898897|NCT04409431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24898898|NCT04409691|Sirolimus|sirolimus|mesh-list
24898899|NCT04409691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24898900|NCT04409691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24898917|NCT04409223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898918|NCT04409223|Growth Inhibitors|growth inhibitors|mesh-ancestor
24898919|NCT04409223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24898928|NCT04409483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670615|NCT04154150|Sensory System Agents|sensory system agents|mesh-ancestor
25670616|NCT04154150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24898929|NCT04409483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24898930|NCT04409483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24898931|NCT04409483|Antiviral Agents|antiviral agents|mesh-ancestor
24898932|NCT04409483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24898933|NCT04409483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24898936|NCT04409327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24721796|NCT01577095|Rosiglitazone|rosiglitazone|mesh-list
24898937|NCT04408989|Bevacizumab|bevacizumab|mesh-list
24898938|NCT04408989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24898939|NCT04408989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898940|NCT04408989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24905754|NCT04344951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24898941|NCT04408989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24898942|NCT04408989|Growth Substances|growth substances|mesh-ancestor
24898943|NCT04408989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898944|NCT04408989|Growth Inhibitors|growth inhibitors|mesh-ancestor
24898945|NCT04408911|Midazolam|midazolam|mesh-list
24898946|NCT04408911|Lormetazepam|lormetazepam|mesh-list
24898947|NCT04408911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24898948|NCT04408911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24898949|NCT04408911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24898950|NCT04408911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898951|NCT04408911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24898952|NCT04408911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24898981|NCT04408326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898999|NCT04407975|Betamethasone|betamethasone|mesh-list
24899000|NCT04407975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24899004|NCT04407975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899005|NCT04407975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24899006|NCT04407975|Respiratory System Agents|respiratory system agents|mesh-ancestor
24899027|NCT04407312|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24899028|NCT04407312|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24905793|NCT04345198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24475993|NCT00412204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475994|NCT00412204|Anticonvulsants|anticonvulsants|mesh-ancestor
24475995|NCT00412321|Siltuximab|siltuximab|mesh-list
24475996|NCT00412321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24475997|NCT00412334|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24475998|NCT00412334|Interferon-alpha|interferon-alpha|mesh-list
24475999|NCT00412334|Ribavirin|ribavirin|mesh-list
24476000|NCT00412334|Antiviral Agents|antiviral agents|mesh-ancestor
24476004|NCT00412334|Antimetabolites|antimetabolites|mesh-ancestor
25867660|NCT00109395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867661|NCT00109395|Anticonvulsants|anticonvulsants|mesh-ancestor
25867662|NCT00109395|Antiemetics|antiemetics|mesh-ancestor
25867663|NCT00109395|Autonomic Agents|autonomic agents|mesh-ancestor
24476007|NCT00412347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24476008|NCT00412347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476009|NCT00412412|Trastuzumab|trastuzumab|mesh-list
24476010|NCT00412412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24476011|NCT00412412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476012|NCT00412503|Temozolomide|temozolomide|mesh-list
24476013|NCT00412503|Topotecan|topotecan|mesh-list
24476014|NCT00412503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25063425|NCT01453101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476015|NCT00412503|Alkylating Agents|alkylating agents|mesh-ancestor
24476017|NCT00412503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867664|NCT00109395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25201816|NCT02725242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517293|NCT00607152|Antimetabolites|antimetabolites|mesh-ancestor
24517294|NCT00607152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517295|NCT00607152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517296|NCT00607152|Gout Suppressants|gout suppressants|mesh-ancestor
24517297|NCT00607152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24517298|NCT00607152|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24517299|NCT00607152|Antioxidants|antioxidants|mesh-ancestor
24517300|NCT00607152|Protective Agents|protective agents|mesh-ancestor
24636142|NCT01143129|Glucocorticoids|glucocorticoids|mesh-ancestor
25867665|NCT00109395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25867666|NCT00109408|Methotrexate|methotrexate|mesh-list
25867667|NCT00109408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25867668|NCT00109408|Abortifacient Agents|abortifacient agents|mesh-ancestor
25867669|NCT00109408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25867670|NCT00109408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867671|NCT00109408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24476037|NCT00412581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817786|NCT02085590|BCG Vaccine|bcg vaccine|mesh-list
24817787|NCT02085590|Immunologic Factors|immunologic factors|mesh-ancestor
24817788|NCT02085590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817790|NCT02085603|Saracatinib|saracatinib|mesh-list
24899066|NCT04407130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24899067|NCT04407078|Neostigmine|neostigmine|mesh-list
24899068|NCT04407078|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24899069|NCT04407078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517371|NCT00607581|Antiemetics|antiemetics|mesh-ancestor
24517372|NCT00607581|Autonomic Agents|autonomic agents|mesh-ancestor
24517373|NCT00607581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25867672|NCT00109408|Antimetabolites|antimetabolites|mesh-ancestor
25867673|NCT00109408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867674|NCT00109408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867675|NCT00109408|Dermatologic Agents|dermatologic agents|mesh-ancestor
24905859|NCT04344756|Heparin|heparin|mesh-list
25064393|NCT03460808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064394|NCT03460808|Antidotes|antidotes|mesh-ancestor
24826848|NCT02136589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24826849|NCT02136589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24826850|NCT02136589|Analgesics|analgesics|mesh-ancestor
24826851|NCT02136589|Sensory System Agents|sensory system agents|mesh-ancestor
25867676|NCT00109408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867677|NCT00109408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25867678|NCT00109408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25867679|NCT00109408|Immunologic Factors|immunologic factors|mesh-ancestor
25063434|NCT01453101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25867680|NCT00109408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24517510|NCT00608335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24517512|NCT00608361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517513|NCT00608361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24517514|NCT00608361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517515|NCT00608361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517516|NCT00608374|Fludarabine|fludarabine|mesh-list
24517517|NCT00608374|Fludarabine phosphate|fludarabine phosphate|mesh-list
25109192|NCT03126656|Androgens|androgens|mesh-ancestor
25109193|NCT03126656|Hormones|hormones|mesh-ancestor
25109194|NCT03126656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25109195|NCT03126656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109196|NCT03126656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24517518|NCT00608374|Chlorambucil|chlorambucil|mesh-list
24517519|NCT00608374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517520|NCT00608374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25867681|NCT00109408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25867682|NCT00109551|Folic Acid|folic acid|mesh-list
24517555|NCT00608673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24899089|NCT04406779|Hormones|hormones|mesh-list
24899090|NCT04406779|Autoantibodies|autoantibodies|mesh-list
24899091|NCT04406779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24899092|NCT04406779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899093|NCT04406779|Immunologic Factors|immunologic factors|mesh-ancestor
24899094|NCT04406870|Sirolimus|sirolimus|mesh-list
25867683|NCT00109551|Zinc Sulfate|zinc sulfate|mesh-list
25867684|NCT00109551|Hematinics|hematinics|mesh-ancestor
24517651|NCT00609063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24899095|NCT04406870|Propranolol|propranolol|mesh-list
24899096|NCT04406870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24899097|NCT04406870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24899098|NCT04406870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24899099|NCT04406870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24899100|NCT04406870|Antifungal Agents|antifungal agents|mesh-ancestor
24899101|NCT04406870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24899102|NCT04406870|Immunologic Factors|immunologic factors|mesh-ancestor
24899103|NCT04406870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476089|NCT00412919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24476090|NCT00412919|Antimetabolites|antimetabolites|mesh-ancestor
24517652|NCT00609063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25063442|NCT00753532|Tocopherols|tocopherols|mesh-list
24481594|NCT00435760|Anticonvulsants|anticonvulsants|mesh-ancestor
24826862|NCT02136641|Analgesics|analgesics|mesh-ancestor
25063444|NCT00753532|Tocovid|tocovid|mesh-list
24517653|NCT00609063|Antimetabolites|antimetabolites|mesh-ancestor
24517654|NCT00609063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517655|NCT00609063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24517656|NCT00609063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24517657|NCT00609063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867685|NCT00109551|Vitamin B Complex|vitamin b complex|mesh-ancestor
25867686|NCT00109551|Vitamins|vitamins|mesh-ancestor
25227908|NCT02611492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25227909|NCT02611492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25227910|NCT02611492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24636588|NCT01146106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24899110|NCT04406870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24899111|NCT04406870|Vasodilator Agents|vasodilator agents|mesh-ancestor
24899112|NCT04406805|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24899113|NCT04406805|Natriuretic Agents|natriuretic agents|mesh-ancestor
24476095|NCT00412997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476096|NCT00412997|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24476097|NCT00412997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476098|NCT00412997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063448|NCT00753532|Antioxidants|antioxidants|mesh-ancestor
25063449|NCT00753532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063450|NCT00753532|Protective Agents|protective agents|mesh-ancestor
25063452|NCT00003857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25063453|NCT00003857|Hormone Antagonists|hormone antagonists|mesh-ancestor
24818610|NCT02089633|BCT-100|bct-100|mesh-list
24825963|NCT02131246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825964|NCT02131298|Itraconazole|itraconazole|mesh-list
25201817|NCT02725242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25201818|NCT02725242|Respiratory System Agents|respiratory system agents|mesh-ancestor
25201819|NCT02725242|Glucocorticoids|glucocorticoids|mesh-ancestor
25201820|NCT02725242|Hormones|hormones|mesh-ancestor
25201821|NCT02725242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25201822|NCT02725242|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25201823|NCT02725242|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25201824|NCT02725242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24825965|NCT02131298|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
25867687|NCT00109551|Micronutrients|micronutrients|mesh-ancestor
25867688|NCT00109551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867689|NCT00109551|Astringents|astringents|mesh-ancestor
25867690|NCT00109551|Dermatologic Agents|dermatologic agents|mesh-ancestor
24899116|NCT04407000|Antiviral Agents|antiviral agents|mesh-ancestor
24899117|NCT04407000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24899118|NCT04406883|Simvastatin|simvastatin|mesh-list
24899119|NCT04406883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24899120|NCT04406883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24899121|NCT04406883|Antimetabolites|antimetabolites|mesh-ancestor
24899122|NCT04406883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476105|NCT00413023|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24476121|NCT00413127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063475|NCT03468478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24818624|NCT02089854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905902|NCT04344288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905903|NCT04344288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24905904|NCT04344288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905905|NCT04344405|Vitamin D|vitamin d|mesh-list
24905906|NCT04344405|Vitamins|vitamins|mesh-ancestor
24905907|NCT04344405|Micronutrients|micronutrients|mesh-ancestor
24905908|NCT04344405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905909|NCT04344405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24905910|NCT04344379|Azithromycin|azithromycin|mesh-list
24905911|NCT04344379|Hydroxychloroquine|hydroxychloroquine|mesh-list
25064408|NCT03460730|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25064409|NCT03460730|Immunologic Factors|immunologic factors|mesh-ancestor
25064410|NCT03460730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899174|NCT04406051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24899175|NCT04406051|Adrenergic Agents|adrenergic agents|mesh-ancestor
24899176|NCT04406051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24899177|NCT04406051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899178|NCT04406051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899179|NCT04406051|Sympathomimetics|sympathomimetics|mesh-ancestor
24899180|NCT04406051|Autonomic Agents|autonomic agents|mesh-ancestor
24899181|NCT04406051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24899182|NCT04406051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24899183|NCT04405960|Alfacalcidol|alfacalcidol|mesh-list
24899184|NCT04405960|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
25670617|NCT04154150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670618|NCT04154150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25670619|NCT04154150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24899185|NCT04405960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25670620|NCT04154150|Anesthetics, General|anesthetics, general|mesh-ancestor
24899186|NCT04405960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899187|NCT04405960|Vitamins|vitamins|mesh-ancestor
24899188|NCT04405960|Micronutrients|micronutrients|mesh-ancestor
24899189|NCT04405843|Ivermectin|ivermectin|mesh-list
24899190|NCT04405843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24637009|NCT01148316|Fluoxetine|fluoxetine|mesh-list
25867691|NCT00109564|Acetylcholine|acetylcholine|mesh-list
25063476|NCT03468478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063477|NCT03468478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867692|NCT00109564|Nicotinic Agonists|nicotinic agonists|mesh-list
25867693|NCT00109564|Vasodilator Agents|vasodilator agents|mesh-ancestor
24443969|NCT00296387|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24443970|NCT00296387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24443971|NCT00296387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24443972|NCT00296387|Antimetabolites|antimetabolites|mesh-ancestor
25867694|NCT00109564|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24905912|NCT04344379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24905913|NCT04344379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905914|NCT04344379|Antimalarials|antimalarials|mesh-ancestor
24905917|NCT04344379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867695|NCT00109564|Cholinergic Agents|cholinergic agents|mesh-ancestor
25867696|NCT00109564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25867697|NCT00109564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867698|NCT00109564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867699|NCT00109603|Tenofovir|tenofovir|mesh-list
25867700|NCT00109603|Antiviral Agents|antiviral agents|mesh-ancestor
24899231|NCT04405375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24476180|NCT00413387|Respiratory System Agents|respiratory system agents|mesh-ancestor
24476181|NCT00413387|Glucocorticoids|glucocorticoids|mesh-ancestor
24899255|NCT04405193|Antioxidants|antioxidants|mesh-ancestor
24899256|NCT04405193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899257|NCT04405193|Protective Agents|protective agents|mesh-ancestor
24899258|NCT04405193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899259|NCT04405193|Antidotes|antidotes|mesh-ancestor
24899260|NCT04405271|Tenofovir|tenofovir|mesh-list
24899261|NCT04405271|Emtricitabine|emtricitabine|mesh-list
24899262|NCT04405271|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
24899263|NCT04405271|Antiviral Agents|antiviral agents|mesh-ancestor
24899264|NCT04405271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25201825|NCT02725242|Adrenergic Agents|adrenergic agents|mesh-ancestor
24899270|NCT04405271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24899271|NCT04405154|Cisplatin|cisplatin|mesh-list
24637164|NCT01149109|Lomustine|lomustine|mesh-list
24899279|NCT04405011|Antiviral Agents|antiviral agents|mesh-ancestor
25063479|NCT03468465|Solifenacin Succinate|solifenacin succinate|mesh-list
25063480|NCT03468465|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25063481|NCT03468465|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25063482|NCT03468465|Cholinergic Agents|cholinergic agents|mesh-ancestor
25063483|NCT03468465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24899280|NCT04405011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24899281|NCT04405323|Itraconazole|itraconazole|mesh-list
24899282|NCT04405323|Antifungal Agents|antifungal agents|mesh-ancestor
24899283|NCT04405323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24899284|NCT04405323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24899285|NCT04405323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24899286|NCT04405323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899287|NCT04405323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899288|NCT04405323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24899289|NCT04405323|Hormone Antagonists|hormone antagonists|mesh-ancestor
24899290|NCT04405323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24899291|NCT04405323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899292|NCT04405323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24899293|NCT04404946|Phenylephrine|phenylephrine|mesh-list
24899294|NCT04404946|Oxymetazoline|oxymetazoline|mesh-list
24899295|NCT04404946|Norepinephrine|norepinephrine|mesh-list
24476211|NCT00413452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24476212|NCT00413452|Immunologic Factors|immunologic factors|mesh-ancestor
24476213|NCT00413504|PENTA|penta|mesh-list
24476214|NCT00413504|Fondaparinux|fondaparinux|mesh-list
24476215|NCT00413504|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25867701|NCT00109603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25867702|NCT00109603|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25867703|NCT00109603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24517832|NCT00610142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24517833|NCT00610142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517837|NCT00610142|Immunologic Factors|immunologic factors|mesh-ancestor
24517838|NCT00610142|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24517839|NCT00610142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517840|NCT00610142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517841|NCT00610246|Sorafenib|sorafenib|mesh-list
25867704|NCT00109603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906054|NCT04343235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906055|NCT04343235|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24906056|NCT04343235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24906057|NCT04343235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867705|NCT00109603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867706|NCT00109603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25867707|NCT00109603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25867708|NCT00109616|Chlorhexidine|chlorhexidine|mesh-list
24517851|NCT00610324|Dermatologic Agents|dermatologic agents|mesh-ancestor
24517852|NCT00610350|Simendan|simendan|mesh-list
24517853|NCT00610350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24899497|NCT04403282|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25867709|NCT00109616|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25867710|NCT00109616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25867711|NCT00109616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25867712|NCT00109616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25867713|NCT00109616|Disinfectants|disinfectants|mesh-ancestor
24899338|NCT04404686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064424|NCT03460470|Vasodilator Agents|vasodilator agents|mesh-ancestor
25064425|NCT03460470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25064426|NCT03460470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25064427|NCT03460470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899339|NCT04404686|Vasodilator Agents|vasodilator agents|mesh-ancestor
24899349|NCT04404686|Gout Suppressants|gout suppressants|mesh-ancestor
24899350|NCT04404686|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24899351|NCT04404686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899353|NCT04404517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24899354|NCT04404517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24899356|NCT04404491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24899357|NCT04404491|Antimetabolites|antimetabolites|mesh-ancestor
24899358|NCT04404491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899359|NCT04404491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24899360|NCT04404439|Topiramate|topiramate|mesh-list
24899361|NCT04404439|Verapamil|verapamil|mesh-list
24899362|NCT04404439|Paroxetine|paroxetine|mesh-list
24476251|NCT00413712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24476252|NCT00413712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476253|NCT00413712|Analgesics|analgesics|mesh-ancestor
24476254|NCT00413712|Sensory System Agents|sensory system agents|mesh-ancestor
24476255|NCT00413712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24476256|NCT00413712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24476257|NCT00413712|Vasodilator Agents|vasodilator agents|mesh-ancestor
24906100|NCT04342858|Protective Agents|protective agents|mesh-ancestor
24906101|NCT04342858|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24906102|NCT04342858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24906103|NCT04342728|Vitamins|vitamins|mesh-list
24906104|NCT04342728|Ascorbic Acid|ascorbic acid|mesh-list
24906138|NCT04342065|Sensory System Agents|sensory system agents|mesh-ancestor
25063488|NCT03468439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25063489|NCT03468439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25063490|NCT03468439|Disinfectants|disinfectants|mesh-ancestor
25063491|NCT03468439|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25063492|NCT03468439|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25063493|NCT03468348|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25063494|NCT03468348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25063495|NCT03468348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24637423|NCT01150201|Losartan|losartan|mesh-list
25867714|NCT00109616|Dermatologic Agents|dermatologic agents|mesh-ancestor
25876632|NCT03164616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876633|NCT03164616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25876634|NCT03164616|Antimetabolites|antimetabolites|mesh-ancestor
25876635|NCT03164616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876636|NCT03164616|Antiviral Agents|antiviral agents|mesh-ancestor
24906154|NCT04342065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24906221|NCT04341935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24906222|NCT04341935|Protease Inhibitors|protease inhibitors|mesh-ancestor
24476261|NCT00413712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24476262|NCT00413712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476263|NCT00413712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24476264|NCT00413738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
24476265|NCT00413738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24476266|NCT00413751|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25063504|NCT03468348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25063505|NCT03468348|Dopamine Agents|dopamine agents|mesh-ancestor
25063507|NCT03468335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25063508|NCT03468335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25063509|NCT03468335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063510|NCT03468335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063511|NCT03468335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063512|NCT03468296|Aflibercept|aflibercept|mesh-list
25063513|NCT03468296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25063514|NCT03468296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25063515|NCT03468296|Growth Substances|growth substances|mesh-ancestor
25063516|NCT03468296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063517|NCT03468296|Growth Inhibitors|growth inhibitors|mesh-ancestor
25063518|NCT03468296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063520|NCT03468231|Fluorouracil|fluorouracil|mesh-list
25867715|NCT00109746|Chromium|chromium|mesh-list
25867716|NCT00109746|Picolinic acid|picolinic acid|mesh-list
25867717|NCT00109746|Trace Elements|trace elements|mesh-ancestor
25064431|NCT03460405|Immunologic Factors|immunologic factors|mesh-ancestor
25064432|NCT03460405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064433|NCT03460392|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25064434|NCT03460392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25064435|NCT03460275|Osimertinib|osimertinib|mesh-list
25064436|NCT03460275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24818629|NCT02089854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24818630|NCT02089854|Hormone Antagonists|hormone antagonists|mesh-ancestor
24818631|NCT02089854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25867718|NCT00109746|Micronutrients|micronutrients|mesh-ancestor
25867719|NCT00109746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867720|NCT00109746|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25867721|NCT00109746|Chelating Agents|chelating agents|mesh-ancestor
25867722|NCT00109746|Sequestering Agents|sequestering agents|mesh-ancestor
25867723|NCT00109746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899379|NCT04404439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24899380|NCT04404439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24818651|NCT02089932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24818652|NCT02089932|Analgesics|analgesics|mesh-ancestor
24818653|NCT02089932|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24818654|NCT02089932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24906259|NCT04341584|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24906260|NCT04341584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24906280|NCT04341675|Sirolimus|sirolimus|mesh-list
24906281|NCT04341675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24906282|NCT04341675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24899381|NCT04404439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24899382|NCT04404439|Vasodilator Agents|vasodilator agents|mesh-ancestor
25063522|NCT03468231|Sorafenib|sorafenib|mesh-list
25063523|NCT03468231|Antimetabolites|antimetabolites|mesh-ancestor
25063524|NCT03468231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867724|NCT00109785|Idoxuridine|idoxuridine|mesh-list
24518199|NCT05330273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24899385|NCT04404439|Adrenergic Agents|adrenergic agents|mesh-ancestor
24899386|NCT04404361|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
24899387|NCT04404361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24899388|NCT04404361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899389|NCT04404361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899390|NCT04404387|Ascorbic Acid|ascorbic acid|mesh-list
24899391|NCT04404387|Vitamins|vitamins|mesh-ancestor
24899392|NCT04404387|Micronutrients|micronutrients|mesh-ancestor
24899393|NCT04404387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899394|NCT04404387|Antioxidants|antioxidants|mesh-ancestor
24906340|NCT04341181|Trastuzumab|trastuzumab|mesh-list
24906341|NCT04341181|Pertuzumab|pertuzumab|mesh-list
24906342|NCT04341181|Avelumab|avelumab|mesh-list
24906343|NCT04341181|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24906344|NCT04341181|Atezolizumab|atezolizumab|mesh-list
24906345|NCT04341181|Axitinib|axitinib|mesh-list
24481968|NCT00437372|Growth Inhibitors|growth inhibitors|mesh-ancestor
24906381|NCT04341038|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24899395|NCT04404387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899396|NCT04404387|Protective Agents|protective agents|mesh-ancestor
24899397|NCT04404062|Antibodies|antibodies|mesh-list
24899398|NCT04404062|Immunoglobulins|immunoglobulins|mesh-list
24899399|NCT04404062|Immunologic Factors|immunologic factors|mesh-ancestor
24899400|NCT04404062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899401|NCT04404127|Basiliximab|basiliximab|mesh-list
24899402|NCT04404127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24899403|NCT04404127|Immunologic Factors|immunologic factors|mesh-ancestor
24899404|NCT04404127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899405|NCT04403776|Tofacitinib|tofacitinib|mesh-list
24899406|NCT04403776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24899407|NCT04403776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899408|NCT04403776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899409|NCT04403503|Thrombin|thrombin|mesh-list
24899410|NCT04403503|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
24899411|NCT04403503|Hemostatics|hemostatics|mesh-ancestor
24899412|NCT04403503|Coagulants|coagulants|mesh-ancestor
24899420|NCT04403724|Sensory System Agents|sensory system agents|mesh-ancestor
25063538|NCT03468140|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25201826|NCT02725242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25201827|NCT02725242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201829|NCT02725164|Sevoflurane|sevoflurane|mesh-list
25201830|NCT02725164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25201831|NCT02725164|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25201832|NCT02725164|Anesthetics, General|anesthetics, general|mesh-ancestor
25064439|NCT03460275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064440|NCT03460145|Propofol|propofol|mesh-list
24906389|NCT04341155|Antiemetics|antiemetics|mesh-ancestor
24906390|NCT04341155|Autonomic Agents|autonomic agents|mesh-ancestor
24906391|NCT04341155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24906392|NCT04341155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906393|NCT04341155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24906394|NCT04341155|Glucocorticoids|glucocorticoids|mesh-ancestor
24906395|NCT04341155|Hormones|hormones|mesh-ancestor
24906483|NCT04340388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25201833|NCT02725164|Anesthetics|anesthetics|mesh-ancestor
25201834|NCT02725164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24911003|NCT04292314|Siderophores|siderophores|mesh-ancestor
25063539|NCT03468140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25063540|NCT03468140|Immunologic Factors|immunologic factors|mesh-ancestor
25063541|NCT03468140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063542|NCT03468062|Dexmedetomidine|dexmedetomidine|mesh-list
24899434|NCT04403568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24899435|NCT04403568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899437|NCT04403568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24899438|NCT04403568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24899439|NCT04403568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476308|NCT00414128|Mycophenolic Acid|mycophenolic acid|mesh-list
24476309|NCT00414128|Cyclophosphamide|cyclophosphamide|mesh-list
24476310|NCT00414128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24476311|NCT00414128|Immunologic Factors|immunologic factors|mesh-ancestor
24476312|NCT00414128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476313|NCT00414128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24476314|NCT00414128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24476315|NCT00414128|Alkylating Agents|alkylating agents|mesh-ancestor
24476316|NCT00414128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476317|NCT00414128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476318|NCT00414128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24476319|NCT00414128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24476320|NCT00414128|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24899440|NCT04403568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637790|NCT01153191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24817805|NCT02085655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24817806|NCT02085655|Glucocorticoids|glucocorticoids|mesh-ancestor
24817807|NCT02085655|Hormones|hormones|mesh-ancestor
24817808|NCT02085655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24817809|NCT02085655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24817810|NCT02085655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24817811|NCT02085655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24817812|NCT02085655|Antimetabolites|antimetabolites|mesh-ancestor
24817813|NCT02085655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817814|NCT02085655|Antiviral Agents|antiviral agents|mesh-ancestor
24817815|NCT02085655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24817816|NCT02085655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24518253|NCT05329740|Methylprednisolone|methylprednisolone|mesh-list
24518254|NCT05329740|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24518255|NCT05329740|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24518312|NCT05320731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867725|NCT00109785|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25867726|NCT00109785|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25867727|NCT00109785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867728|NCT00109785|Antiviral Agents|antiviral agents|mesh-ancestor
25867729|NCT00109785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24543714|NCT00685100|Glucocorticoids|glucocorticoids|mesh-ancestor
25867730|NCT00109785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25867731|NCT00109785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867732|NCT00109798|Temozolomide|temozolomide|mesh-list
25867733|NCT00109798|Topotecan|topotecan|mesh-list
25867734|NCT00109798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25867735|NCT00109798|Alkylating Agents|alkylating agents|mesh-ancestor
24518314|NCT05310253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24906706|NCT04337918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24906707|NCT04337918|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24906708|NCT04337918|Autonomic Agents|autonomic agents|mesh-ancestor
24906709|NCT04337918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25064441|NCT03460145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25064442|NCT03460145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25064443|NCT03460145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906710|NCT04337918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906711|NCT04337918|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24906712|NCT04337918|Respiratory System Agents|respiratory system agents|mesh-ancestor
24906713|NCT04337918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24906715|NCT04337918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474908|NCT00408148|Rimonabant|rimonabant|mesh-list
24817846|NCT02085902|Anesthetics|anesthetics|mesh-ancestor
24817847|NCT02085902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24817848|NCT02085902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817849|NCT02085902|Sensory System Agents|sensory system agents|mesh-ancestor
25063547|NCT03468062|Analgesics|analgesics|mesh-ancestor
25063548|NCT03468062|Sensory System Agents|sensory system agents|mesh-ancestor
25063549|NCT03468062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25063550|NCT03468062|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24826887|NCT02136771|Vitamin D|vitamin d|mesh-list
24817855|NCT02085967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24817856|NCT02085967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24817857|NCT02085967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24476365|NCT00414336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24518329|NCT05291403|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24518330|NCT05291403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24518331|NCT05291403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817861|NCT02085967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24817862|NCT02085967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24817863|NCT02085967|Anesthetics, General|anesthetics, general|mesh-ancestor
24817864|NCT02085967|Anesthetics|anesthetics|mesh-ancestor
24817865|NCT02085967|GABA Modulators|gaba modulators|mesh-ancestor
24817866|NCT02085967|GABA Agents|gaba agents|mesh-ancestor
24899466|NCT04403334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24899467|NCT04403100|Ritonavir|ritonavir|mesh-list
24899468|NCT04403100|Lopinavir|lopinavir|mesh-list
24899469|NCT04403100|Hydroxychloroquine|hydroxychloroquine|mesh-list
24476368|NCT00414349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24476369|NCT00414349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476370|NCT00414414|Prednisone|prednisone|mesh-list
24476372|NCT00414414|Glucocorticoids|glucocorticoids|mesh-ancestor
24518340|NCT05214807|Chitosan|chitosan|mesh-list
24518342|NCT05214807|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24518343|NCT05214807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24899470|NCT04403100|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24899471|NCT04403100|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24899472|NCT04403100|Protease Inhibitors|protease inhibitors|mesh-ancestor
24899473|NCT04403100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899474|NCT04403100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899475|NCT04403100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24899476|NCT04403100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24899477|NCT04403100|Antiviral Agents|antiviral agents|mesh-ancestor
24899478|NCT04403100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24899479|NCT04403100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24899480|NCT04403100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25432830|NCT00667251|Trastuzumab|trastuzumab|mesh-list
25670621|NCT04154150|Anesthetics|anesthetics|mesh-ancestor
25670622|NCT04154150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25670623|NCT04154150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25670624|NCT04154150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25670625|NCT04154150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24906786|NCT04337606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24906787|NCT04337606|Antimetabolites|antimetabolites|mesh-ancestor
24906788|NCT04337606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899481|NCT04403100|Antimalarials|antimalarials|mesh-ancestor
24899482|NCT04403100|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24899483|NCT04403100|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25063553|NCT03468062|Adrenergic Agents|adrenergic agents|mesh-ancestor
25063554|NCT03468062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25063555|NCT03468062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063556|NCT03468023|Calpastatin|calpastatin|mesh-list
25063557|NCT03468023|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
24638106|NCT01154881|Insulin|insulin|mesh-list
24518349|NCT05214807|Hemostatics|hemostatics|mesh-ancestor
24899492|NCT04403243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24899493|NCT04403282|Eflornithine|eflornithine|mesh-list
24899494|NCT04403282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25064451|NCT03460041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25064452|NCT03460041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064453|NCT03460041|Sensory System Agents|sensory system agents|mesh-ancestor
25064454|NCT03460041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25064455|NCT03460041|Analgesics|analgesics|mesh-ancestor
25064456|NCT03460041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25064457|NCT03460041|Anticonvulsants|anticonvulsants|mesh-ancestor
24826884|NCT02136693|Psyllium|psyllium|mesh-list
24826885|NCT02136693|Cathartics|cathartics|mesh-ancestor
24899498|NCT04403282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24899499|NCT04403282|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
25867736|NCT00109798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867737|NCT00109798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867738|NCT00109798|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25867739|NCT00109798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24476424|NCT00414947|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24476428|NCT00415064|Dexamethasone|dexamethasone|mesh-list
24899508|NCT04403191|Antipruritics|antipruritics|mesh-ancestor
24899509|NCT04403191|Dermatologic Agents|dermatologic agents|mesh-ancestor
24899510|NCT04403191|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24899511|NCT04403191|Serotonin Agents|serotonin agents|mesh-ancestor
24899512|NCT04403191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25201837|NCT02725164|Analgesics|analgesics|mesh-ancestor
25201838|NCT02725164|Sensory System Agents|sensory system agents|mesh-ancestor
24899520|NCT04403321|Tacrolimus|tacrolimus|mesh-list
24476430|NCT00415064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24476432|NCT00415064|Autonomic Agents|autonomic agents|mesh-ancestor
24476433|NCT00415064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24476434|NCT00415064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638217|NCT01155440|Lidocaine|lidocaine|mesh-list
24948109|NCT03923010|Antifungal Agents|antifungal agents|mesh-ancestor
24948110|NCT03923010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24948111|NCT03923010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24948112|NCT03923010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24948113|NCT03923010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24953225|NCT03887416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953226|NCT03887416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24953227|NCT03887416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953234|NCT03887260|Analgesics|analgesics|mesh-ancestor
24953235|NCT03887260|Sensory System Agents|sensory system agents|mesh-ancestor
24953236|NCT03887260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953237|NCT03887260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24953238|NCT03887260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24953239|NCT03887260|Anesthetics, General|anesthetics, general|mesh-ancestor
24953240|NCT03887260|Anesthetics|anesthetics|mesh-ancestor
25063562|NCT03468010|Cisplatin|cisplatin|mesh-list
25063563|NCT03468010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24638393|NCT01156389|Artesunate|artesunate|mesh-list
24476450|NCT00415090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476452|NCT00415090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24518354|NCT05188508|Pembrolizumab|pembrolizumab|mesh-list
24518355|NCT05188508|Temozolomide|temozolomide|mesh-list
24518357|NCT05188508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24518358|NCT05188508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24518359|NCT05188508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24518360|NCT05188508|Alkylating Agents|alkylating agents|mesh-ancestor
24518361|NCT05188508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518362|NCT05188508|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24899557|NCT04402580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24638478|NCT01156883|Mercaptopurine|mercaptopurine|mesh-list
24899572|NCT04402723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24899573|NCT04402723|Immunologic Factors|immunologic factors|mesh-ancestor
24906819|NCT04336904|Favipiravir|favipiravir|mesh-list
24899574|NCT04402723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899575|NCT04402723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24899576|NCT04402723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24518371|NCT05176314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899598|NCT04402359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24899599|NCT04402359|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24899600|NCT04402359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899601|NCT04402359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899602|NCT04402411|Analgesics, Opioid|analgesics, opioid|mesh-list
24899603|NCT04402411|Narcotics|narcotics|mesh-ancestor
24899604|NCT04402411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24899605|NCT04402411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899626|NCT04402047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476500|NCT00415285|Tubulin Modulators|tubulin modulators|mesh-ancestor
24476501|NCT00415285|Antimitotic Agents|antimitotic agents|mesh-ancestor
24476502|NCT00415285|Mitosis Modulators|mitosis modulators|mesh-ancestor
24476503|NCT00415285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906874|NCT04336605|Analgesics|analgesics|mesh-list
24906875|NCT04336605|Sensory System Agents|sensory system agents|mesh-ancestor
24906876|NCT04336605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24906878|NCT04336228|Dexetimide|dexetimide|mesh-list
24906879|NCT04336228|Citalopram|citalopram|mesh-list
24906880|NCT04336228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906881|NCT04336228|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24906883|NCT04336228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24476504|NCT00415285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24476505|NCT00415285|Antimetabolites|antimetabolites|mesh-ancestor
24476506|NCT00415298|Oxaliplatin|oxaliplatin|mesh-list
24476507|NCT00415298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476508|NCT00415311|Lectins|lectins|mesh-list
25867740|NCT00109798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899658|NCT04401852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899659|NCT04401852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24899660|NCT04401852|Tocolytic Agents|tocolytic agents|mesh-ancestor
25063596|NCT03467620|Anticonvulsants|anticonvulsants|mesh-ancestor
25063597|NCT03467438|Polaprezinc|polaprezinc|mesh-list
24899669|NCT04401774|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24899670|NCT04401774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067431|NCT03443843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24899685|NCT04401657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899686|NCT04401137|Topiramate|topiramate|mesh-list
24899687|NCT04401137|Anticonvulsants|anticonvulsants|mesh-ancestor
24899688|NCT04401137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24906907|NCT04335786|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24906908|NCT04335786|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24906909|NCT04335786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906910|NCT04335461|Anesthetics|anesthetics|mesh-list
24906911|NCT04335461|Anesthetics, Local|anesthetics, local|mesh-list
24906912|NCT04335461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24906913|NCT04335461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906914|NCT04335461|Sensory System Agents|sensory system agents|mesh-ancestor
24906915|NCT04335461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24906916|NCT04335526|Cholestyramine Resin|cholestyramine resin|mesh-list
24906917|NCT04335526|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25867741|NCT00109811|Freund's Adjuvant|freund's adjuvant|mesh-list
24906924|NCT04335383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906926|NCT04335123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24906927|NCT04335123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24906928|NCT04335123|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24906931|NCT04335513|Insulin|insulin|mesh-list
24899689|NCT04401137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899690|NCT04401345|Glycopyrrolate|glycopyrrolate|mesh-list
24899691|NCT04401345|Bromides|bromides|mesh-list
24899692|NCT04401345|Anticonvulsants|anticonvulsants|mesh-ancestor
24817867|NCT02085967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24817868|NCT02085967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817869|NCT02085967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24817870|NCT02085967|Antidepressive Agents|antidepressive agents|mesh-ancestor
24817871|NCT02085967|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25432831|NCT00667251|Lapatinib|lapatinib|mesh-list
24817872|NCT02085967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24817873|NCT02085967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24817875|NCT02085967|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24817876|NCT02085967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24899712|NCT04401007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24899713|NCT04401007|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24899714|NCT04401007|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24899715|NCT04401007|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24638974|NCT01159301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906951|NCT04334824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064462|NCT03460041|Tocolytic Agents|tocolytic agents|mesh-ancestor
24899749|NCT04400890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899750|NCT04400890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24899762|NCT04400188|Temozolomide|temozolomide|mesh-list
24639070|NCT01160029|Nateglinide|nateglinide|mesh-list
24826119|NCT02132416|Narcotics|narcotics|mesh-ancestor
24899841|NCT04399434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899843|NCT04399525|Loratadine|loratadine|mesh-list
24899844|NCT04399525|Levocetirizine|levocetirizine|mesh-list
24899845|NCT04399525|Desloratadine|desloratadine|mesh-list
24899846|NCT04399525|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24899848|NCT04399525|Histamine Antagonists|histamine antagonists|mesh-ancestor
24899849|NCT04399525|Histamine Agents|histamine agents|mesh-ancestor
24476724|NCT00416377|Dacarbazine|dacarbazine|mesh-list
24476725|NCT00416377|Vinblastine|vinblastine|mesh-list
24476726|NCT00416377|Procarbazine|procarbazine|mesh-list
24476727|NCT00416377|Chlorambucil|chlorambucil|mesh-list
24476728|NCT00416377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24476729|NCT00416377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476730|NCT00416377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24476731|NCT00416377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24476732|NCT00416377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24518484|NCT04938232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24518485|NCT04938232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24518486|NCT04938232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518495|NCT04908605|Mirtazapine|mirtazapine|mesh-list
24518496|NCT04908605|Antioxidants|antioxidants|mesh-ancestor
25063616|NCT03467178|Gemcitabine|gemcitabine|mesh-list
25063617|NCT03467178|Paclitaxel|paclitaxel|mesh-list
25063618|NCT03467178|Carboplatin|carboplatin|mesh-list
25063619|NCT03467178|Doxorubicin|doxorubicin|mesh-list
25063620|NCT03467178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25063621|NCT03467178|Decitabine|decitabine|mesh-list
24826120|NCT02132416|Analgesics|analgesics|mesh-ancestor
24899905|NCT04399070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24906991|NCT04334629|Ibuprofen|ibuprofen|mesh-list
24906992|NCT04334629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24906993|NCT04334629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24899906|NCT04399070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24899907|NCT04399070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24899908|NCT04399070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24899909|NCT04399070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899910|NCT04399070|Antidepressive Agents|antidepressive agents|mesh-ancestor
24899911|NCT04399070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24899913|NCT04398927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24899914|NCT04399083|Caffeine|caffeine|mesh-list
24899915|NCT04399083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24899916|NCT04399083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899941|NCT04398771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24899943|NCT04398771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899944|NCT04398771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24899945|NCT04398771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24899946|NCT04398771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899947|NCT04398771|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24899948|NCT04398771|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24899949|NCT04398771|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24899950|NCT04398589|Dexmedetomidine|dexmedetomidine|mesh-list
24899951|NCT04398589|Ropivacaine|ropivacaine|mesh-list
24899952|NCT04398589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24899953|NCT04398589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24899954|NCT04398589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899955|NCT04398589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24899956|NCT04398589|Analgesics|analgesics|mesh-ancestor
24899957|NCT04398589|Sensory System Agents|sensory system agents|mesh-ancestor
24899959|NCT04398589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24899983|NCT04398290|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24899984|NCT04398290|Vasodilator Agents|vasodilator agents|mesh-ancestor
24899985|NCT04398290|Gasotransmitters|gasotransmitters|mesh-ancestor
25867742|NCT00109811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25867743|NCT00109811|Immunologic Factors|immunologic factors|mesh-ancestor
25867744|NCT00109811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867745|NCT00109824|Decitabine|decitabine|mesh-list
25867746|NCT00109824|Azacitidine|azacitidine|mesh-list
24518501|NCT04908605|Antidepressive Agents|antidepressive agents|mesh-ancestor
24518502|NCT04908605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24518504|NCT04908605|Histamine Antagonists|histamine antagonists|mesh-ancestor
24518505|NCT04908605|Histamine Agents|histamine agents|mesh-ancestor
24518506|NCT04908605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24899989|NCT04398316|Anesthetics, Local|anesthetics, local|mesh-ancestor
24817892|NCT02085967|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24817893|NCT02085967|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24817894|NCT02085967|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24817895|NCT02085967|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25063628|NCT03467178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25063629|NCT03467178|Antimetabolites|antimetabolites|mesh-ancestor
25063630|NCT03467178|Antiviral Agents|antiviral agents|mesh-ancestor
24817896|NCT02086019|Aspirin|aspirin|mesh-list
24817897|NCT02086019|Ramipril|ramipril|mesh-list
24817898|NCT02086019|Bisoprolol|bisoprolol|mesh-list
24817899|NCT02086019|Heparin|heparin|mesh-list
24817900|NCT02086019|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24817901|NCT02086019|Tinzaparin|tinzaparin|mesh-list
24817902|NCT02086019|Dalteparin|dalteparin|mesh-list
24817903|NCT02086019|Clopidogrel|clopidogrel|mesh-list
24518508|NCT04908605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24900063|NCT04397692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900064|NCT04397692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24900065|NCT04397692|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24900066|NCT04397692|Vasodilator Agents|vasodilator agents|mesh-ancestor
24900067|NCT04397692|Gasotransmitters|gasotransmitters|mesh-ancestor
24900068|NCT04397692|Protective Agents|protective agents|mesh-ancestor
24900069|NCT04397913|Acetaminophen|acetaminophen|mesh-list
24900070|NCT04397913|Ibuprofen|ibuprofen|mesh-list
24900071|NCT04397913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24900092|NCT04397341|Antimetabolites|antimetabolites|mesh-ancestor
24900093|NCT04397341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24900094|NCT04397341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24476824|NCT00416650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476853|NCT00416767|Leucovorin|leucovorin|mesh-list
24900095|NCT04397341|Immunologic Factors|immunologic factors|mesh-ancestor
24900096|NCT04397341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907132|NCT04332536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24900097|NCT04397458|Dexamethasone|dexamethasone|mesh-list
24900098|NCT04397458|Bupivacaine|bupivacaine|mesh-list
24900099|NCT04397458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24900100|NCT04397458|Antiemetics|antiemetics|mesh-ancestor
24900101|NCT04397458|Autonomic Agents|autonomic agents|mesh-ancestor
24817944|NCT02086032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24817945|NCT02086032|Contraceptive Agents|contraceptive agents|mesh-ancestor
24817946|NCT02086032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24817947|NCT02086032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24900190|NCT04396743|Miconazole|miconazole|mesh-list
24900191|NCT04396743|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24900192|NCT04396743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24900193|NCT04396743|Antifungal Agents|antifungal agents|mesh-ancestor
24900194|NCT04396743|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24900195|NCT04396743|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24900196|NCT04396743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24805893|NCT02012569|Hemostatics|hemostatics|mesh-list
24900197|NCT04396743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900198|NCT04396743|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24900199|NCT04396743|Hormone Antagonists|hormone antagonists|mesh-ancestor
24900200|NCT04396743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24900201|NCT04396743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900202|NCT04396743|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24900203|NCT04396743|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24900204|NCT04396977|Histamine|histamine|mesh-list
25670626|NCT04154150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670627|NCT04107051|Nalmefene|nalmefene|mesh-list
25670628|NCT04107051|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24900205|NCT04396977|Histamine Agonists|histamine agonists|mesh-ancestor
24900239|NCT04396223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900240|NCT04396223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24919043|NCT04214626|Methotrexate|methotrexate|mesh-list
25867747|NCT00109824|Valproic Acid|valproic acid|mesh-list
24476987|NCT00416910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24476988|NCT00416910|Analgesics|analgesics|mesh-ancestor
25063637|NCT03467178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25063638|NCT03467178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24476989|NCT00416910|Sensory System Agents|sensory system agents|mesh-ancestor
24476990|NCT00416910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24476991|NCT00416910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24900262|NCT04395768|Vitamins|vitamins|mesh-list
24900263|NCT04395768|Ascorbic Acid|ascorbic acid|mesh-list
24900264|NCT04395768|Vitamin B 12|vitamin b 12|mesh-list
24900265|NCT04395768|Azithromycin|azithromycin|mesh-list
24900266|NCT04395768|Hydroxychloroquine|hydroxychloroquine|mesh-list
24900267|NCT04395768|Micronutrients|micronutrients|mesh-ancestor
24900268|NCT04395768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900269|NCT04395768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24900270|NCT04395768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900271|NCT04395768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24900342|NCT04394975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24900562|NCT04392427|Ivermectin|ivermectin|mesh-list
24900343|NCT04394975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24900344|NCT04394975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24900345|NCT04394975|Growth Substances|growth substances|mesh-ancestor
24900346|NCT04394975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900347|NCT04394975|Growth Inhibitors|growth inhibitors|mesh-ancestor
24900348|NCT04394975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24900349|NCT04394975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817965|NCT02086188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24817966|NCT02086188|Adrenergic Agents|adrenergic agents|mesh-ancestor
24817967|NCT02086188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24817968|NCT02086188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817969|NCT02086188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818000|NCT02086409|Ergocalciferols|ergocalciferols|mesh-list
24900386|NCT04394533|Anesthetics|anesthetics|mesh-ancestor
24900391|NCT04394234|Warfarin|warfarin|mesh-list
24900399|NCT04394442|Antimalarials|antimalarials|mesh-ancestor
24900400|NCT04394442|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24900401|NCT04394442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25063652|NCT03466775|Immunologic Factors|immunologic factors|mesh-ancestor
25063653|NCT03466775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063654|NCT03466775|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25063655|NCT03466775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24900448|NCT04393805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900450|NCT04393792|Povidone|povidone|mesh-list
24900451|NCT04393792|Plasma Substitutes|plasma substitutes|mesh-ancestor
24900452|NCT04393792|Blood Substitutes|blood substitutes|mesh-ancestor
24900453|NCT04393792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24900454|NCT04393792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24900502|NCT04393584|Vitamins|vitamins|mesh-ancestor
24900503|NCT04393584|Micronutrients|micronutrients|mesh-ancestor
24900504|NCT04393220|Bevacizumab|bevacizumab|mesh-list
24900505|NCT04393220|Nivolumab|nivolumab|mesh-list
24900506|NCT04393220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24900507|NCT04393220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24900508|NCT04393220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24907205|NCT04331730|Growth Inhibitors|growth inhibitors|mesh-ancestor
24907206|NCT04331730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24900509|NCT04393220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24900515|NCT04393246|Dapagliflozin|dapagliflozin|mesh-list
24900542|NCT04393025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24900543|NCT04393025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24900544|NCT04393025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900545|NCT04393025|Antipyretics|antipyretics|mesh-ancestor
24900546|NCT04393025|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24900547|NCT04393025|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24900548|NCT04393025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24900549|NCT04393025|Purinergic Agents|purinergic agents|mesh-ancestor
25674498|NCT01772823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24477330|NCT00418288|Glucagon|glucagon|mesh-list
24477331|NCT00418288|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25228112|NCT02609919|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
25228113|NCT02609919|Chelating Agents|chelating agents|mesh-ancestor
25670631|NCT04107051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24843584|NCT02228239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24843585|NCT02228239|Adrenergic Agents|adrenergic agents|mesh-ancestor
24843586|NCT02228239|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24843587|NCT02228239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24843588|NCT02228239|Serotonin Agents|serotonin agents|mesh-ancestor
24843589|NCT02228239|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24843591|NCT02228252|Chelating Agents|chelating agents|mesh-ancestor
24843592|NCT02228252|Sequestering Agents|sequestering agents|mesh-ancestor
24843593|NCT02228252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477332|NCT00418288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24477333|NCT00418288|Hormones|hormones|mesh-ancestor
24477335|NCT00418288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518509|NCT04908605|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25063705|NCT03466567|Gout Suppressants|gout suppressants|mesh-ancestor
25063706|NCT03466567|Renal Agents|renal agents|mesh-ancestor
25063707|NCT03466528|Thiamine|thiamine|mesh-list
25063708|NCT03466528|Vitamin B Complex|vitamin b complex|mesh-list
25201840|NCT02725099|Ticagrelor|ticagrelor|mesh-list
25063709|NCT03466528|Magnesium Sulfate|magnesium sulfate|mesh-list
25063710|NCT03466528|Vitamins|vitamins|mesh-ancestor
25063711|NCT03466528|Micronutrients|micronutrients|mesh-ancestor
25063712|NCT03466528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063713|NCT03466528|Analgesics|analgesics|mesh-ancestor
25063714|NCT03466528|Sensory System Agents|sensory system agents|mesh-ancestor
25063715|NCT03466528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25063716|NCT03466528|Anesthetics|anesthetics|mesh-ancestor
25063720|NCT03466528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25063721|NCT03466528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25063722|NCT03466528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063723|NCT03466528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25063724|NCT03466528|Tocolytic Agents|tocolytic agents|mesh-ancestor
25063725|NCT03466528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25063726|NCT03466502|Vancomycin|vancomycin|mesh-list
25063727|NCT03466502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24640148|NCT01166165|Vitamins|vitamins|mesh-ancestor
24900559|NCT04392973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24900560|NCT04392973|Antiviral Agents|antiviral agents|mesh-ancestor
24900561|NCT04392427|Ribavirin|ribavirin|mesh-list
24518528|NCT04901676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855644|NCT02280486|Incretins|incretins|mesh-ancestor
25063751|NCT03466333|Protease Inhibitors|protease inhibitors|mesh-ancestor
25063752|NCT03466333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25063753|NCT03466320|Cyclophosphamide|cyclophosphamide|mesh-list
24518553|NCT04871412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24518554|NCT04871412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24518555|NCT04871412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24518556|NCT04871412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24518557|NCT04871412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518559|NCT04833140|Estrogens|estrogens|mesh-ancestor
24518560|NCT04833140|Hormones|hormones|mesh-ancestor
25670632|NCT04090567|Olaparib|olaparib|mesh-list
25670633|NCT04090567|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25670634|NCT04090567|Cediranib|cediranib|mesh-list
25670635|NCT04090567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25670636|NCT04090567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670637|NCT04090567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670638|NCT04090567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25670639|NCT04062097|Vitamin K|vitamin k|mesh-list
25670640|NCT04062097|Dabigatran|dabigatran|mesh-list
25670641|NCT04062097|Vitamins|vitamins|mesh-ancestor
25670642|NCT04062097|Micronutrients|micronutrients|mesh-ancestor
25670643|NCT04062097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670644|NCT04062097|Antithrombins|antithrombins|mesh-ancestor
25670645|NCT04062097|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25670646|NCT04062097|Protease Inhibitors|protease inhibitors|mesh-ancestor
25670647|NCT04062097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25670648|NCT04062097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228132|NCT02609646|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25228133|NCT02609646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25228134|NCT02609646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228135|NCT02609646|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25228136|NCT02609581|Immunologic Factors|immunologic factors|mesh-list
25228137|NCT02609581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228138|NCT02609490|Olmesartan|olmesartan|mesh-list
25228139|NCT02609490|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25228140|NCT02609490|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25228145|NCT02609711|Candesartan|candesartan|mesh-list
24518561|NCT04833140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24518562|NCT04833140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518563|NCT04808934|Rivaroxaban|rivaroxaban|mesh-list
24518564|NCT04808934|Apixaban|apixaban|mesh-list
24518565|NCT04808934|Dabigatran|dabigatran|mesh-list
24518566|NCT04808934|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24518567|NCT04808934|Antithrombins|antithrombins|mesh-ancestor
24518569|NCT04808934|Protease Inhibitors|protease inhibitors|mesh-ancestor
24518594|NCT04786275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24518595|NCT04786275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24900575|NCT04392700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063759|NCT03466320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25063760|NCT03466320|Alkylating Agents|alkylating agents|mesh-ancestor
25063761|NCT03466320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826256|NCT02133638|Anesthetics|anesthetics|mesh-ancestor
24826257|NCT02133638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24826258|NCT02133638|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24826259|NCT02133677|Temozolomide|temozolomide|mesh-list
24826260|NCT02133677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24826261|NCT02133677|Alkylating Agents|alkylating agents|mesh-ancestor
24900576|NCT04392700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900577|NCT04392700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24900578|NCT04392700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24900579|NCT04392648|Dexamethasone|dexamethasone|mesh-list
24907319|NCT04331197|Letrozole|letrozole|mesh-list
24818829|NCT02091219|Cholecalciferol|cholecalciferol|mesh-list
24818830|NCT02091219|Calcifediol|calcifediol|mesh-list
24900580|NCT04392648|Cyclophosphamide|cyclophosphamide|mesh-list
24900582|NCT04392648|Pomalidomide|pomalidomide|mesh-list
24900583|NCT04392648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24900584|NCT04392648|Immunologic Factors|immunologic factors|mesh-ancestor
24900585|NCT04392648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201841|NCT02725099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24900586|NCT04392648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24900587|NCT04392648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24900588|NCT04392648|Alkylating Agents|alkylating agents|mesh-ancestor
24900589|NCT04392648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900590|NCT04392648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24900591|NCT04392648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24900592|NCT04392648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24900593|NCT04392648|Antiemetics|antiemetics|mesh-ancestor
24900594|NCT04392648|Autonomic Agents|autonomic agents|mesh-ancestor
24900595|NCT04392648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24900623|NCT04392557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900625|NCT04392713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24900635|NCT04392375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24900637|NCT04391985|Antiviral Agents|antiviral agents|mesh-ancestor
24900638|NCT04391985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24900644|NCT04392063|Melatonin|melatonin|mesh-list
24900645|NCT04392063|Antioxidants|antioxidants|mesh-ancestor
24482673|NCT00440167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482674|NCT00440167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24900646|NCT04392063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900647|NCT04392063|Protective Agents|protective agents|mesh-ancestor
24900648|NCT04392063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670649|NCT04062097|Anticoagulants|anticoagulants|mesh-ancestor
25670650|NCT04062097|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25670651|NCT04062097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25670652|NCT04062097|Hemostatics|hemostatics|mesh-ancestor
25670653|NCT04062097|Coagulants|coagulants|mesh-ancestor
25670654|NCT04007874|Vitamin E|vitamin e|mesh-list
25670655|NCT04007874|Levonorgestrel|levonorgestrel|mesh-list
25670656|NCT04007874|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25670657|NCT04007874|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25670658|NCT04007874|Vitamins|vitamins|mesh-ancestor
25670659|NCT04007874|Micronutrients|micronutrients|mesh-ancestor
25867748|NCT00109824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24843614|NCT02228473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24821290|NCT02104284|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
24447018|NCT00307177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447019|NCT00307203|Bupropion|bupropion|mesh-list
24447020|NCT00307203|Nicotine|nicotine|mesh-list
24447024|NCT00307203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900649|NCT04392063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24900650|NCT04392128|Azithromycin|azithromycin|mesh-list
24900651|NCT04392128|Hydroxychloroquine|hydroxychloroquine|mesh-list
24900669|NCT04392037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24900670|NCT04392037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24900671|NCT04392037|Alkylating Agents|alkylating agents|mesh-ancestor
24900672|NCT04392037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900673|NCT04392037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24900674|NCT04392037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25063762|NCT03466320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063763|NCT03466320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25063764|NCT03466242|Dexmedetomidine|dexmedetomidine|mesh-list
25063765|NCT03466242|Ketamine|ketamine|mesh-list
25063766|NCT03466242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25063767|NCT03466242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25063768|NCT03466242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063769|NCT03466242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24900691|NCT04391998|Anticestodal Agents|anticestodal agents|mesh-ancestor
24900692|NCT04391998|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24900696|NCT04391998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900697|NCT04391998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24900698|NCT04391868|Sildenafil Citrate|sildenafil citrate|mesh-list
24900699|NCT04391868|Citric Acid|citric acid|mesh-list
24900700|NCT04391868|Sodium Citrate|sodium citrate|mesh-list
24900701|NCT04391868|Anticoagulants|anticoagulants|mesh-ancestor
24900713|NCT04391582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24900714|NCT04391582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24900715|NCT04391582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24900725|NCT04391621|Hormones|hormones|mesh-ancestor
24900726|NCT04391621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24640571|NCT01169012|Clofarabine|clofarabine|mesh-list
24826341|NCT02134093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24826342|NCT02134093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826343|NCT02134093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24826344|NCT02134093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24826345|NCT02134093|Anesthetics, General|anesthetics, general|mesh-ancestor
24826346|NCT02134093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24826347|NCT02134093|Analgesics|analgesics|mesh-ancestor
24826348|NCT02134093|Sensory System Agents|sensory system agents|mesh-ancestor
24826349|NCT02134093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24900765|NCT04391478|Protective Agents|protective agents|mesh-ancestor
24900766|NCT04391478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900767|NCT04391361|Atropine|atropine|mesh-list
24900768|NCT04391361|Scopolamine|scopolamine|mesh-list
25063851|NCT03465397|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25063852|NCT03465397|Immunologic Factors|immunologic factors|mesh-ancestor
25063853|NCT03465397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063854|NCT03465345|Metformin|metformin|mesh-list
25063855|NCT03465345|Proanthocyanidin|proanthocyanidin|mesh-list
25063856|NCT03465345|Procyanidin|procyanidin|mesh-list
25063857|NCT03465345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24948288|NCT03920839|Tubulin Modulators|tubulin modulators|mesh-ancestor
24948366|NCT03920475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25063858|NCT03465345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063859|NCT03465345|Antioxidants|antioxidants|mesh-ancestor
24826353|NCT02134093|Adrenergic Agents|adrenergic agents|mesh-ancestor
24900769|NCT04391361|Dexmedetomidine|dexmedetomidine|mesh-list
24900770|NCT04391361|Edaravone|edaravone|mesh-list
25670660|NCT04007874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670661|NCT04007874|Antioxidants|antioxidants|mesh-ancestor
25670662|NCT04007874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670663|NCT04007874|Protective Agents|protective agents|mesh-ancestor
25670664|NCT04007874|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25670665|NCT04007874|Contraceptive Agents|contraceptive agents|mesh-ancestor
25670666|NCT04007874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24900771|NCT04391361|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25432908|NCT00637624|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24843638|NCT02228512|Glucocorticoids|glucocorticoids|mesh-ancestor
24900772|NCT04391361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24900773|NCT04391361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24900774|NCT04391361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900775|NCT04391361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24900776|NCT04391361|Analgesics|analgesics|mesh-ancestor
24900791|NCT04391361|Mydriatics|mydriatics|mesh-ancestor
24900880|NCT04391439|Glucocorticoids|glucocorticoids|mesh-ancestor
24900882|NCT04391439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24900883|NCT04391439|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24900884|NCT04391439|Protective Agents|protective agents|mesh-ancestor
24640875|NCT01170442|Ergocalciferols|ergocalciferols|mesh-list
24900935|NCT04390061|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24900936|NCT04390061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25063866|NCT03465202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25063867|NCT03465202|Antimetabolites|antimetabolites|mesh-ancestor
25063868|NCT03465202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063874|NCT03465085|Calcium heparin|calcium heparin|mesh-list
25063875|NCT03465085|Streptokinase|streptokinase|mesh-list
25063876|NCT03465085|Anticoagulants|anticoagulants|mesh-ancestor
24449755|NCT00316901|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24477730|NCT00419783|Hormone Antagonists|hormone antagonists|mesh-ancestor
24477731|NCT00419783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24518656|NCT04607460|Keratolytic Agents|keratolytic agents|mesh-ancestor
24901400|NCT04385290|Gemtuzumab|gemtuzumab|mesh-list
24818093|NCT02086942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063883|NCT03465059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063884|NCT03465059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900960|NCT04390152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24518657|NCT04607460|Dermatologic Agents|dermatologic agents|mesh-ancestor
24518671|NCT04562090|Urological Agents|urological agents|mesh-ancestor
24900969|NCT04390100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24900970|NCT04390100|Immunologic Factors|immunologic factors|mesh-ancestor
24900971|NCT04390100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900972|NCT04390100|Viscosupplements|viscosupplements|mesh-ancestor
24900973|NCT04390100|Protective Agents|protective agents|mesh-ancestor
24900974|NCT04390100|Hemostatics|hemostatics|mesh-ancestor
24900975|NCT04390100|Coagulants|coagulants|mesh-ancestor
24900981|NCT04389554|Fibrin fragment D|fibrin fragment d|mesh-list
24641069|NCT01171781|Cisplatin|cisplatin|mesh-list
25063908|NCT03464864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25063909|NCT03464734|Paclitaxel|paclitaxel|mesh-list
24826391|NCT02134262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826392|NCT02134262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826393|NCT02134262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24826394|NCT02134288|Everolimus|everolimus|mesh-list
24826395|NCT02134288|Abatacept|abatacept|mesh-list
24826396|NCT02134288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24518686|NCT04524130|Lidocaine|lidocaine|mesh-list
24518687|NCT04524130|Ketamine|ketamine|mesh-list
24518688|NCT04524130|Anesthetics, Local|anesthetics, local|mesh-ancestor
24518689|NCT04524130|Anesthetics|anesthetics|mesh-ancestor
24518690|NCT04524130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24518691|NCT04524130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641169|NCT01172236|Lactoferrin|lactoferrin|mesh-list
24518693|NCT04524130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24518694|NCT04524130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24518695|NCT04524130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25063911|NCT03464734|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25063912|NCT03464734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25063913|NCT03464734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063914|NCT03464734|Tubulin Modulators|tubulin modulators|mesh-ancestor
25063915|NCT03464734|Antimitotic Agents|antimitotic agents|mesh-ancestor
25063916|NCT03464734|Mitosis Modulators|mitosis modulators|mesh-ancestor
25063917|NCT03464734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063918|NCT03464734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25063919|NCT03464682|Atorvastatin|atorvastatin|mesh-list
25063920|NCT03464682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24901021|NCT04389424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24901022|NCT04389424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24901023|NCT04389424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24901024|NCT04389424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24901025|NCT04389424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24901032|NCT04389359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25670667|NCT04007874|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25867749|NCT00109824|Antimetabolites|antimetabolites|mesh-ancestor
25867750|NCT00109824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901033|NCT04389359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24901034|NCT04389359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24901035|NCT04389359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477830|NCT00420498|Adrenergic Agents|adrenergic agents|mesh-ancestor
24518722|NCT04450329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24518723|NCT04450329|Growth Substances|growth substances|mesh-ancestor
24518724|NCT04450329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518725|NCT04450329|Growth Inhibitors|growth inhibitors|mesh-ancestor
24518726|NCT04450329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24518728|NCT04432623|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24518729|NCT04432623|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24518730|NCT04432623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063921|NCT03464682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25063922|NCT03464682|Antimetabolites|antimetabolites|mesh-ancestor
25063923|NCT03464682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063924|NCT03464682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24826418|NCT02134327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24518731|NCT04432623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201842|NCT02725099|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25201843|NCT02725099|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24518732|NCT04432623|Dopamine Agents|dopamine agents|mesh-ancestor
24518733|NCT04432623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24901087|NCT04388774|Anesthetics|anesthetics|mesh-ancestor
24901088|NCT04388774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24901089|NCT04388774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24901090|NCT04388774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24901091|NCT04388774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24641299|NCT01172769|Antifungal Agents|antifungal agents|mesh-ancestor
24901135|NCT04388189|Bupropion|bupropion|mesh-list
24901136|NCT04388189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24901137|NCT04388189|Antidepressive Agents|antidepressive agents|mesh-ancestor
24901138|NCT04388189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24901139|NCT04388189|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24901140|NCT04388189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24477880|NCT00420589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24477881|NCT00420589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477882|NCT00420589|Hormones|hormones|mesh-ancestor
24901141|NCT04388189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24901142|NCT04388189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901143|NCT04388189|Dopamine Agents|dopamine agents|mesh-ancestor
24901144|NCT04388189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25087740|NCT03277079|Ezetimibe|ezetimibe|mesh-list
24901145|NCT04388189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901146|NCT04388189|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24518781|NCT04246437|Carbidopa|carbidopa|mesh-list
24518842|NCT04145076|Tianeptine|tianeptine|mesh-list
24518843|NCT04145076|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24518844|NCT04145076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24518845|NCT04145076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24518846|NCT04145076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518847|NCT04145076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24518848|NCT04145076|Serotonin Agents|serotonin agents|mesh-ancestor
25063932|NCT03464552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25063933|NCT03464552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25063934|NCT03464552|Analgesics|analgesics|mesh-ancestor
25063935|NCT03464552|Sensory System Agents|sensory system agents|mesh-ancestor
25063936|NCT03464552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25063937|NCT03464552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063938|NCT03464552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24901188|NCT04388033|Interleukin-12|interleukin-12|mesh-list
24901189|NCT04388033|Vaccines|vaccines|mesh-list
25063972|NCT03464435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063973|NCT03464435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063974|NCT03464435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25063975|NCT03464435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25063976|NCT03464435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25063977|NCT03464305|Aspirin|aspirin|mesh-list
25063978|NCT03464305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25670668|NCT04007874|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25670669|NCT04007874|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24901195|NCT04388033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908042|NCT04325061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24901196|NCT04388033|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24901197|NCT04388033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24901198|NCT04388033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24901199|NCT04388033|Growth Substances|growth substances|mesh-ancestor
24855770|NCT02280993|Cisplatin|cisplatin|mesh-list
24901220|NCT04387526|Antiviral Agents|antiviral agents|mesh-ancestor
24901221|NCT04387526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24901222|NCT04387500|Axitinib|axitinib|mesh-list
24901223|NCT04387500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24901225|NCT04387500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901232|NCT04387201|Dulaglutide|dulaglutide|mesh-list
24901233|NCT04387201|Vitamins|vitamins|mesh-ancestor
24901234|NCT04387201|Micronutrients|micronutrients|mesh-ancestor
24901235|NCT04387201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901236|NCT04387201|Vitamin B Complex|vitamin b complex|mesh-ancestor
24901237|NCT04387201|Hematinics|hematinics|mesh-ancestor
24901238|NCT04387201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24901239|NCT04386967|Pembrolizumab|pembrolizumab|mesh-list
24730998|NCT01631513|Tapentadol|tapentadol|mesh-list
24901240|NCT04386967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24901241|NCT04386967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24901242|NCT04386876|Ritonavir|ritonavir|mesh-list
24901243|NCT04386876|Lopinavir|lopinavir|mesh-list
24901244|NCT04386876|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24901245|NCT04386876|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24641618|NCT01174524|Gestodene|gestodene|mesh-list
24478030|NCT00421252|Clopidogrel|clopidogrel|mesh-list
24518902|NCT04052490|Keratolytic Agents|keratolytic agents|mesh-ancestor
24518903|NCT04052490|Dermatologic Agents|dermatologic agents|mesh-ancestor
24518904|NCT03992443|Reteplase|reteplase|mesh-list
24518905|NCT03992443|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25867751|NCT00109824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867752|NCT00109824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867753|NCT00109824|Anticonvulsants|anticonvulsants|mesh-ancestor
24518907|NCT03992443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518908|NCT03960554|Denosumab|denosumab|mesh-list
24518909|NCT03960554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24518910|NCT03960554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518911|NCT03950739|Treprostinil|treprostinil|mesh-list
24518912|NCT03950739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24444569|NCT00298506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24518913|NCT03929601|Rituximab|rituximab|mesh-list
24518914|NCT03929601|Abatacept|abatacept|mesh-list
24518915|NCT03929601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24590329|NCT00912145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24519000|NCT03710772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519001|NCT03710772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519002|NCT03710772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24519003|NCT03710772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24519005|NCT03710772|Autonomic Agents|autonomic agents|mesh-ancestor
24519006|NCT03710772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24519007|NCT03710772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24519008|NCT03710772|Glucocorticoids|glucocorticoids|mesh-ancestor
24519009|NCT03710772|Hormones|hormones|mesh-ancestor
24901302|NCT04386499|Vitamin B Complex|vitamin b complex|mesh-ancestor
24901304|NCT04386499|Micronutrients|micronutrients|mesh-ancestor
24901305|NCT04386499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901306|NCT04386499|Antioxidants|antioxidants|mesh-ancestor
24901308|NCT04386499|Protective Agents|protective agents|mesh-ancestor
24901309|NCT04386499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901310|NCT04386499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24901311|NCT04386642|Tranexamic Acid|tranexamic acid|mesh-list
24901312|NCT04386642|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24901313|NCT04386642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24901314|NCT04386642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901315|NCT04386642|Hemostatics|hemostatics|mesh-ancestor
24901316|NCT04386642|Coagulants|coagulants|mesh-ancestor
24901317|NCT04386577|Vitamin D|vitamin d|mesh-list
24901318|NCT04386577|Cholecalciferol|cholecalciferol|mesh-list
24901319|NCT04386577|Vitamins|vitamins|mesh-ancestor
24901320|NCT04386577|Micronutrients|micronutrients|mesh-ancestor
24901321|NCT04386577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901322|NCT04386577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24901360|NCT04385602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24901362|NCT04385602|Sensory System Agents|sensory system agents|mesh-ancestor
25063997|NCT03464058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25063998|NCT03464058|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25063999|NCT03464058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24519052|NCT03690037|Coagulants|coagulants|mesh-ancestor
25867755|NCT00109824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25867756|NCT00109824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867757|NCT00109824|Antimanic Agents|antimanic agents|mesh-ancestor
25228236|NCT02609087|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25228237|NCT02608944|Adenosine|adenosine|mesh-list
25228238|NCT02608944|Regadenoson|regadenoson|mesh-list
25228239|NCT02608944|Analgesics|analgesics|mesh-ancestor
25228240|NCT02608944|Sensory System Agents|sensory system agents|mesh-ancestor
25867758|NCT00109824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25867759|NCT00109824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25867760|NCT00109824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25867761|NCT00109941|Analgesics, Opioid|analgesics, opioid|mesh-list
24519053|NCT03686332|Atezolizumab|atezolizumab|mesh-list
24901363|NCT04385602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24901364|NCT04385602|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24901365|NCT04385602|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24901366|NCT04385602|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24901367|NCT04385602|Adrenergic Agents|adrenergic agents|mesh-ancestor
24901369|NCT04385602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901370|NCT04385836|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
24901371|NCT04385836|Protein C Inhibitor|protein c inhibitor|mesh-list
24818094|NCT02086942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24818095|NCT02086942|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24818096|NCT02086942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24818097|NCT02086942|Antiemetics|antiemetics|mesh-ancestor
24818098|NCT02086942|Autonomic Agents|autonomic agents|mesh-ancestor
24818099|NCT02086942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24818137|NCT02087098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24818138|NCT02087098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818139|NCT02087098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818140|NCT02087098|Urological Agents|urological agents|mesh-ancestor
24818141|NCT02087111|Interferons|interferons|mesh-list
24818143|NCT02087111|Interferon-alpha|interferon-alpha|mesh-list
24818144|NCT02087111|Interferon alpha-2|interferon alpha-2|mesh-list
24901381|NCT04385654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901383|NCT04385563|Trastuzumab|trastuzumab|mesh-list
24901384|NCT04385563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24901385|NCT04385563|Tubulin Modulators|tubulin modulators|mesh-ancestor
25064025|NCT03463642|Vitamin D|vitamin d|mesh-list
25064026|NCT03463642|Cholecalciferol|cholecalciferol|mesh-list
25064027|NCT03463642|Mineral Oil|mineral oil|mesh-list
24948567|NCT03918889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24948568|NCT03918889|Analgesics|analgesics|mesh-ancestor
24948569|NCT03918889|Sensory System Agents|sensory system agents|mesh-ancestor
25867762|NCT00109941|Mitogens|mitogens|mesh-list
24901386|NCT04385563|Antimitotic Agents|antimitotic agents|mesh-ancestor
24901387|NCT04385563|Mitosis Modulators|mitosis modulators|mesh-ancestor
24901388|NCT04385563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901389|NCT04385563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24901390|NCT04385550|Paclitaxel|paclitaxel|mesh-list
24901391|NCT04385550|Docetaxel|docetaxel|mesh-list
24901392|NCT04385550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24901393|NCT04385550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24901394|NCT04385550|Tubulin Modulators|tubulin modulators|mesh-ancestor
24901395|NCT04385550|Antimitotic Agents|antimitotic agents|mesh-ancestor
24901396|NCT04385550|Mitosis Modulators|mitosis modulators|mesh-ancestor
24901397|NCT04385550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901398|NCT04385290|Cytarabine|cytarabine|mesh-list
24901399|NCT04385290|Daunorubicin|daunorubicin|mesh-list
24519083|NCT03441893|Mesalamine|mesalamine|mesh-list
24519084|NCT03441893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24519085|NCT03441893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24519086|NCT03441893|Analgesics|analgesics|mesh-ancestor
24519087|NCT03441893|Sensory System Agents|sensory system agents|mesh-ancestor
24519088|NCT03441893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25867763|NCT00109941|Enkephalin, Methionine|enkephalin, methionine|mesh-list
25867764|NCT00109941|Narcotics|narcotics|mesh-ancestor
25670670|NCT04007874|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25670671|NCT04007874|Estrogens|estrogens|mesh-ancestor
25670672|NCT04007874|Hormones|hormones|mesh-ancestor
25670673|NCT04007874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25670674|NCT04007874|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25670675|NCT04005079|Ofloxacin|ofloxacin|mesh-list
25670676|NCT04005079|Prednisolone|prednisolone|mesh-list
25670677|NCT04005079|Pilocarpine|pilocarpine|mesh-list
25670678|NCT04005079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24843829|NCT02229760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843831|NCT02229760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24843832|NCT02229760|Antiviral Agents|antiviral agents|mesh-ancestor
24843833|NCT02229760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25228259|NCT02608918|BMS-955176|bms-955176|mesh-list
25867765|NCT00109941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24948577|NCT03918889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24948578|NCT03918889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24948579|NCT03918889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24948580|NCT03918889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24948581|NCT03918889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24948582|NCT03918889|Anesthetics, General|anesthetics, general|mesh-ancestor
24948586|NCT03918551|Febuxostat|febuxostat|mesh-list
25064028|NCT03463642|Vitamins|vitamins|mesh-ancestor
25064029|NCT03463642|Micronutrients|micronutrients|mesh-ancestor
24826514|NCT02134886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901554|NCT04383418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24908332|NCT04321616|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24908333|NCT04321616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24908334|NCT04321616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908335|NCT04321616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908336|NCT04321616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24901555|NCT04383418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24901556|NCT04383418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901557|NCT04383418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24901589|NCT04382768|Ibuprofen|ibuprofen|mesh-list
24901590|NCT04382768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24901591|NCT04382768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24901612|NCT04383067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24901613|NCT04383067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24901614|NCT04383067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24901615|NCT04383067|Antiviral Agents|antiviral agents|mesh-ancestor
24901616|NCT04383067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24901618|NCT04382950|Isotretinoin|isotretinoin|mesh-list
24818176|NCT02087215|Trace Elements|trace elements|mesh-ancestor
24818177|NCT02087215|Micronutrients|micronutrients|mesh-ancestor
24818178|NCT02087215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818179|NCT02087332|Torsemide|torsemide|mesh-list
24901648|NCT04382443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901649|NCT04382443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24901651|NCT04382170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24901652|NCT04382170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24901653|NCT04382170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623692|NCT01073189|Vasodilator Agents|vasodilator agents|mesh-ancestor
24623693|NCT01073189|Dopamine Agonists|dopamine agonists|mesh-ancestor
24901654|NCT04382170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24901655|NCT04382170|Analgesics|analgesics|mesh-ancestor
24901656|NCT04382170|Sensory System Agents|sensory system agents|mesh-ancestor
24901657|NCT04382170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24901658|NCT04382170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24901659|NCT04382170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24901660|NCT04382170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24901661|NCT04382170|Adrenergic Agents|adrenergic agents|mesh-ancestor
24901662|NCT04382170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24901663|NCT04382170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901664|NCT04382079|Propolis|propolis|mesh-list
24901665|NCT04382079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24901674|NCT04382209|Meperidine|meperidine|mesh-list
24901736|NCT04382014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24901754|NCT04381234|Sequestering Agents|sequestering agents|mesh-ancestor
24901755|NCT04381234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901756|NCT04381234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24901758|NCT04381104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24901759|NCT04381104|Analgesics|analgesics|mesh-ancestor
24901760|NCT04381104|Sensory System Agents|sensory system agents|mesh-ancestor
24478466|NCT00423007|Bromfenac|bromfenac|mesh-list
24478468|NCT00423007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25670679|NCT04005079|Glucocorticoids|glucocorticoids|mesh-ancestor
25670680|NCT04005079|Hormones|hormones|mesh-ancestor
25670681|NCT04005079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25670682|NCT04005079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670683|NCT04005079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25670684|NCT04005079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670685|NCT04005079|Autonomic Agents|autonomic agents|mesh-ancestor
24519090|NCT03441893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24519091|NCT03441893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24519092|NCT03441893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24519093|NCT03441893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24901765|NCT04380597|Betamethasone Valerate|betamethasone valerate|mesh-list
24908417|NCT04320589|Analgesics|analgesics|mesh-ancestor
24901766|NCT04380597|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24901767|NCT04380597|Betamethasone benzoate|betamethasone benzoate|mesh-list
24901768|NCT04380597|Calcipotriene|calcipotriene|mesh-list
24901769|NCT04380597|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24901770|NCT04380597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24901771|NCT04380597|Glucocorticoids|glucocorticoids|mesh-ancestor
24901772|NCT04380597|Hormones|hormones|mesh-ancestor
24901773|NCT04380597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24901774|NCT04380597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901775|NCT04380597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24901776|NCT04380597|Respiratory System Agents|respiratory system agents|mesh-ancestor
24901777|NCT04380597|Dermatologic Agents|dermatologic agents|mesh-ancestor
24901778|NCT04380818|Ritonavir|ritonavir|mesh-list
24901779|NCT04380818|Lopinavir|lopinavir|mesh-list
24901780|NCT04380818|Azithromycin|azithromycin|mesh-list
25201844|NCT02725099|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24519107|NCT03432949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519108|NCT03432949|Protease Inhibitors|protease inhibitors|mesh-ancestor
24519109|NCT03432949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24519155|NCT03223597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24901782|NCT04380818|Heparin|heparin|mesh-list
25064067|NCT03463317|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25064069|NCT03463317|Purinergic Agents|purinergic agents|mesh-ancestor
25064070|NCT03463317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25064071|NCT03463317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064072|NCT03463317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901783|NCT04380818|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24901784|NCT04380818|Tinzaparin|tinzaparin|mesh-list
24901785|NCT04380818|Dalteparin|dalteparin|mesh-list
24901786|NCT04380818|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24901787|NCT04380818|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24901788|NCT04380818|Protease Inhibitors|protease inhibitors|mesh-ancestor
24901789|NCT04380818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901790|NCT04380818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901791|NCT04380818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24901792|NCT04380818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24901793|NCT04380818|Antiviral Agents|antiviral agents|mesh-ancestor
24901794|NCT04380818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24901795|NCT04380818|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24901796|NCT04380818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24901797|NCT04380818|Anticoagulants|anticoagulants|mesh-ancestor
24901798|NCT04380818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24901799|NCT04380818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24901812|NCT04380857|Glucocorticoids|glucocorticoids|mesh-ancestor
24901813|NCT04380857|Hormones|hormones|mesh-ancestor
24901814|NCT04380857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24855886|NCT02281682|Imiquimod|imiquimod|mesh-list
24901826|NCT04380467|Cholecalciferol|cholecalciferol|mesh-list
24901827|NCT04380467|Vitamins|vitamins|mesh-ancestor
24901828|NCT04380467|Micronutrients|micronutrients|mesh-ancestor
24901829|NCT04380467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901830|NCT04380467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24901831|NCT04380467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24901832|NCT04380220|Protein C|protein c|mesh-list
24901833|NCT04380220|Antithrombins|antithrombins|mesh-list
24901834|NCT04380220|Protein S|protein s|mesh-list
24908503|NCT04319900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24908506|NCT04319900|Antimalarials|antimalarials|mesh-ancestor
24901845|NCT04380220|Immunologic Factors|immunologic factors|mesh-ancestor
24901846|NCT04380220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903028|NCT04367831|Anticoagulants|anticoagulants|mesh-ancestor
24901848|NCT04380376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24901850|NCT04380376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901851|NCT04380376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24901852|NCT04380376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24901853|NCT04380376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24901854|NCT04380376|Immunologic Factors|immunologic factors|mesh-ancestor
24901855|NCT04380376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901856|NCT04380181|Milrinone|milrinone|mesh-list
24901857|NCT04380181|Epinephrine|epinephrine|mesh-list
25867767|NCT00109941|Analgesics|analgesics|mesh-ancestor
25273417|NCT02385448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25273418|NCT02385448|Hormone Antagonists|hormone antagonists|mesh-ancestor
25867768|NCT00109941|Sensory System Agents|sensory system agents|mesh-ancestor
25867769|NCT00109941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24901858|NCT04380181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24901859|NCT04380181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24901860|NCT04380181|Adrenergic Agents|adrenergic agents|mesh-ancestor
24901861|NCT04380181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24901862|NCT04380181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901863|NCT04380181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901864|NCT04380181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24901865|NCT04380181|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25064073|NCT03463317|Anticoagulants|anticoagulants|mesh-ancestor
25064074|NCT03463317|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25064075|NCT03463317|Antithrombins|antithrombins|mesh-ancestor
25064076|NCT03463317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25064077|NCT03463317|Protease Inhibitors|protease inhibitors|mesh-ancestor
24901866|NCT04380181|Autonomic Agents|autonomic agents|mesh-ancestor
24901867|NCT04380181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24908591|NCT04318847|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24908592|NCT04318847|Serotonin Agents|serotonin agents|mesh-ancestor
24908593|NCT04318847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24908595|NCT04318847|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24908649|NCT04318158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24901868|NCT04380181|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24901869|NCT04380181|Respiratory System Agents|respiratory system agents|mesh-ancestor
24901870|NCT04380181|Mydriatics|mydriatics|mesh-ancestor
24901871|NCT04380181|Sympathomimetics|sympathomimetics|mesh-ancestor
24901872|NCT04380181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25201845|NCT02725099|Purinergic Agents|purinergic agents|mesh-ancestor
24901873|NCT04380181|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24901874|NCT04380181|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24901875|NCT04380181|Vasodilator Agents|vasodilator agents|mesh-ancestor
24901887|NCT04380298|Sensory System Agents|sensory system agents|mesh-ancestor
24901888|NCT04380298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24901889|NCT04380298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24901923|NCT04380103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24901924|NCT04380103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24901925|NCT04380103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24818189|NCT02087384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818190|NCT02087462|Vitamins|vitamins|mesh-list
24818191|NCT02087462|Thiamine|thiamine|mesh-list
24818192|NCT02087462|Vitamin B Complex|vitamin b complex|mesh-list
24818193|NCT02087462|Diclofenac|diclofenac|mesh-list
24818194|NCT02087462|Micronutrients|micronutrients|mesh-ancestor
24902667|NCT04371224|Capecitabine|capecitabine|mesh-list
24901967|NCT04379219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24901968|NCT04379219|Abortifacient Agents|abortifacient agents|mesh-ancestor
24901969|NCT04379219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24901970|NCT04379219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642643|NCT01180413|Lercanidipine|lercanidipine|mesh-list
24519245|NCT02668653|Idarubicin|idarubicin|mesh-list
24519246|NCT02668653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24519247|NCT02668653|Antimetabolites|antimetabolites|mesh-ancestor
24519248|NCT02668653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519249|NCT02668653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519250|NCT02668653|Antiviral Agents|antiviral agents|mesh-ancestor
24519251|NCT02668653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24519252|NCT02668653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24519253|NCT02668653|Immunologic Factors|immunologic factors|mesh-ancestor
24902080|NCT04377867|Immunologic Factors|immunologic factors|mesh-ancestor
24902098|NCT04377646|Micronutrients|micronutrients|mesh-ancestor
24902145|NCT04376970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908650|NCT04318158|Adrenergic Agents|adrenergic agents|mesh-ancestor
24902147|NCT04376970|Immunologic Factors|immunologic factors|mesh-ancestor
24902148|NCT04376970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478762|NCT00424281|Fondaparinux|fondaparinux|mesh-list
25670686|NCT04005079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25670687|NCT04005079|Miotics|miotics|mesh-ancestor
25670688|NCT04005079|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25670689|NCT04005079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25670690|NCT04005079|Cholinergic Agents|cholinergic agents|mesh-ancestor
24478763|NCT00424281|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25670691|NCT04005079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25670693|NCT04005079|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25670694|NCT04005079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25670695|NCT04005079|Renal Agents|renal agents|mesh-ancestor
25867770|NCT00109941|Mitosis Modulators|mitosis modulators|mesh-ancestor
25867771|NCT00109941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478764|NCT00424281|Antithrombins|antithrombins|mesh-ancestor
24478766|NCT00424281|Protease Inhibitors|protease inhibitors|mesh-ancestor
24903029|NCT04367831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25670696|NCT04005079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25867772|NCT00109941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25867773|NCT00109954|Cisplatin|cisplatin|mesh-list
24519254|NCT02668653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519255|NCT02668653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24519256|NCT02668653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24519257|NCT02668653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24519258|NCT02668653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902172|NCT04377048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902173|NCT04377048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24902174|NCT04377048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24902175|NCT04376788|Methylene Blue|methylene blue|mesh-list
25064088|NCT03463317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24642779|NCT01181388|Tirofiban|tirofiban|mesh-list
24902245|NCT04376086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24902246|NCT04376086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902300|NCT04375267|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
24902301|NCT04375267|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24902302|NCT04375267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902303|NCT04375267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902304|NCT04375267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24902305|NCT04375267|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24902306|NCT04375202|Colchicine|colchicine|mesh-list
24902307|NCT04375202|Gout Suppressants|gout suppressants|mesh-ancestor
24442969|NCT00293371|Vatalanib|vatalanib|mesh-list
24902308|NCT04375202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24902309|NCT04375202|Tubulin Modulators|tubulin modulators|mesh-ancestor
24519270|NCT02591654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519271|NCT02543255|Prednisone|prednisone|mesh-list
24519272|NCT02543255|Leuprolide|leuprolide|mesh-list
24902338|NCT04374318|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24902339|NCT04374318|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24902340|NCT04374318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24902341|NCT04374318|Adrenergic Agents|adrenergic agents|mesh-ancestor
24902475|NCT04373356|Fluorides, Topical|fluorides, topical|mesh-list
24709487|NCT01505998|Protease Inhibitors|protease inhibitors|mesh-ancestor
24908769|NCT04317001|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24908770|NCT04317001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24908771|NCT04317001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24908772|NCT04317001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908773|NCT04316845|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
24902476|NCT04373356|Cariostatic Agents|cariostatic agents|mesh-ancestor
24902477|NCT04373356|Protective Agents|protective agents|mesh-ancestor
24902478|NCT04373356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902479|NCT04373356|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24902480|NCT04373356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902577|NCT04371874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24902578|NCT04371874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902615|NCT04372082|Antinematodal Agents|antinematodal agents|mesh-ancestor
24902616|NCT04371978|Linagliptin|linagliptin|mesh-list
24902617|NCT04371978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24902664|NCT04371822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902666|NCT04371224|Fluorouracil|fluorouracil|mesh-list
24902670|NCT04371224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902671|NCT04371224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24902672|NCT04371224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24643116|NCT01183676|GABA Agents|gaba agents|mesh-ancestor
24902878|NCT04369222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902927|NCT04368598|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24902928|NCT04368598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24902929|NCT04368598|Antiemetics|antiemetics|mesh-ancestor
25670697|NCT04005079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25670698|NCT04005079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25670699|NCT04005079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25670700|NCT04005079|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25670701|NCT04005079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24902930|NCT04368598|Autonomic Agents|autonomic agents|mesh-ancestor
24902931|NCT04368598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24902932|NCT04368598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902933|NCT04368598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24902934|NCT04368598|Glucocorticoids|glucocorticoids|mesh-ancestor
24902935|NCT04368598|Hormones|hormones|mesh-ancestor
24458347|NCT00337506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24818315|NCT02087813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24818316|NCT02087813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24818317|NCT02087813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24818318|NCT02087813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818319|NCT02087813|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24903027|NCT04367831|Enoxaparin sodium|enoxaparin sodium|mesh-list
24903031|NCT04367831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903033|NCT04367818|Anesthetics, Local|anesthetics, local|mesh-list
24903034|NCT04367818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24903035|NCT04367818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903036|NCT04367818|Sensory System Agents|sensory system agents|mesh-ancestor
24903037|NCT04367818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24903038|NCT04367155|Tranexamic Acid|tranexamic acid|mesh-list
24903039|NCT04367155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24519294|NCT02448381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25064134|NCT03463070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064135|NCT03463070|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25064136|NCT03463070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25064137|NCT03463070|Oxytocics|oxytocics|mesh-ancestor
25064138|NCT03463044|Nangibotide|nangibotide|mesh-list
24519295|NCT02448381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479491|NCT00427089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903092|NCT04366622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903093|NCT04366596|Paclitaxel|paclitaxel|mesh-list
24903094|NCT04366596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24479500|NCT00427128|Fluoxetine|fluoxetine|mesh-list
24903108|NCT04366739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24903109|NCT04366739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24903110|NCT04366739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24903179|NCT04365582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903181|NCT04365582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24903206|NCT04365270|Sequestering Agents|sequestering agents|mesh-ancestor
24908851|NCT04315909|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24908914|NCT04315194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24908915|NCT04315194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24908916|NCT04315194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25064581|NCT03458481|Yimitasvir|yimitasvir|mesh-list
25064582|NCT03458481|Antiviral Agents|antiviral agents|mesh-ancestor
25064583|NCT03458481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25064584|NCT03458468|Tranexamic Acid|tranexamic acid|mesh-list
25064585|NCT03458468|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25064586|NCT03458468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25064587|NCT03458468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064588|NCT03458468|Hemostatics|hemostatics|mesh-ancestor
25064589|NCT03458468|Coagulants|coagulants|mesh-ancestor
24903207|NCT04365270|Hemostatics|hemostatics|mesh-ancestor
24903208|NCT04365270|Coagulants|coagulants|mesh-ancestor
24903209|NCT04365270|Sunscreening Agents|sunscreening agents|mesh-ancestor
24903210|NCT04365270|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24903211|NCT04365270|Protective Agents|protective agents|mesh-ancestor
24903212|NCT04365270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903213|NCT04365270|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24903292|NCT04364945|Adrenergic Agents|adrenergic agents|mesh-ancestor
24903338|NCT04364516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903480|NCT04363762|Antifungal Agents|antifungal agents|mesh-ancestor
24855953|NCT02282059|Sunitinib|sunitinib|mesh-list
24903499|NCT04363203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903533|NCT04362735|Vedolizumab|vedolizumab|mesh-list
24903534|NCT04362735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24903535|NCT04362527|Milrinone|milrinone|mesh-list
24903536|NCT04362527|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24903537|NCT04362527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24903538|NCT04362527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25670702|NCT03999749|Nivolumab|nivolumab|mesh-list
24903539|NCT04362527|Vasodilator Agents|vasodilator agents|mesh-ancestor
24903540|NCT04362527|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24903541|NCT04362527|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24903542|NCT04362527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903543|NCT04362527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903544|NCT04362527|Protective Agents|protective agents|mesh-ancestor
24903545|NCT04362527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903547|NCT04362384|Prednisolone|prednisolone|mesh-list
24903548|NCT04362384|Vitamins|vitamins|mesh-ancestor
25064161|NCT03462836|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25064162|NCT03462836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25064168|NCT03462810|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25064169|NCT03462810|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25064170|NCT03462810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25064171|NCT03462810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064172|NCT03462810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24903549|NCT04362384|Micronutrients|micronutrients|mesh-ancestor
24903550|NCT04362384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903551|NCT04362384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24903552|NCT04362384|Glucocorticoids|glucocorticoids|mesh-ancestor
24903553|NCT04362384|Hormones|hormones|mesh-ancestor
24903554|NCT04362384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24903555|NCT04362384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24903571|NCT04362241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903572|NCT04362241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24479838|NCT00428545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644186|NCT01189695|Ritonavir|ritonavir|mesh-list
25064597|NCT03458416|Cannabidiol|cannabidiol|mesh-list
24827062|NCT02137239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24827063|NCT02137265|Clomiphene|clomiphene|mesh-list
24827064|NCT02137265|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24827065|NCT02137265|Hormone Antagonists|hormone antagonists|mesh-ancestor
24827068|NCT02137265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24903600|NCT04362293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24903617|NCT04362332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903619|NCT04362332|Amebicides|amebicides|mesh-ancestor
24903620|NCT04362332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24903621|NCT04362332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24903622|NCT04362332|Analgesics|analgesics|mesh-ancestor
24903623|NCT04362332|Sensory System Agents|sensory system agents|mesh-ancestor
25867774|NCT00109954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24903634|NCT04362410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24903635|NCT04362410|Immunologic Factors|immunologic factors|mesh-ancestor
25064173|NCT03462810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25064174|NCT03462810|Antiviral Agents|antiviral agents|mesh-ancestor
25064175|NCT03462810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24948800|NCT05402553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24948801|NCT05402553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24948802|NCT05402553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24948803|NCT05402553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24948804|NCT05402319|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24614148|NCT01022645|Copper|copper|mesh-list
24903636|NCT04362410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903685|NCT04361643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903686|NCT04361643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24903687|NCT04361643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24903691|NCT04361513|Triamcinolone|triamcinolone|mesh-list
24903706|NCT04361175|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24903707|NCT04361175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24903764|NCT04361370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903765|NCT04361318|Hydroxychloroquine|hydroxychloroquine|mesh-list
24749433|NCT01093196|Dexamethasone|dexamethasone|mesh-list
24903766|NCT04361318|Nitazoxanide|nitazoxanide|mesh-list
24903767|NCT04361318|Antimalarials|antimalarials|mesh-ancestor
24903768|NCT04361318|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24903769|NCT04361318|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24903770|NCT04361318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903771|NCT04361318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904279|NCT04357002|Coagulants|coagulants|mesh-ancestor
24903772|NCT04361318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903774|NCT04361149|Capsaicin|capsaicin|mesh-list
24903775|NCT04361149|Antipruritics|antipruritics|mesh-ancestor
24903776|NCT04361149|Dermatologic Agents|dermatologic agents|mesh-ancestor
24903777|NCT04361149|Sensory System Agents|sensory system agents|mesh-ancestor
24903778|NCT04361149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25228351|NCT02608242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228352|NCT02608242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24903779|NCT04361149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903780|NCT04361474|Budesonide|budesonide|mesh-list
24903781|NCT04361474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24903800|NCT04361409|Immunologic Factors|immunologic factors|mesh-ancestor
24903801|NCT04361409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903802|NCT04361409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24903803|NCT04361409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24903872|NCT04360655|Immunologic Factors|immunologic factors|mesh-ancestor
24903873|NCT04360655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903875|NCT04360317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24903876|NCT04360317|Tubulin Modulators|tubulin modulators|mesh-ancestor
24903877|NCT04360317|Antimitotic Agents|antimitotic agents|mesh-ancestor
24903878|NCT04360317|Mitosis Modulators|mitosis modulators|mesh-ancestor
24903879|NCT04360317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908924|NCT04315194|Gout Suppressants|gout suppressants|mesh-ancestor
24908925|NCT04315194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24908926|NCT04315194|Antiviral Agents|antiviral agents|mesh-ancestor
25064604|NCT03458260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25064605|NCT03458260|Immunologic Factors|immunologic factors|mesh-ancestor
25064606|NCT03458260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064607|NCT03458260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24903900|NCT04359966|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24903901|NCT04359966|Renal Agents|renal agents|mesh-ancestor
24903902|NCT04359966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24903903|NCT04359966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24903904|NCT04359966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24903905|NCT04359966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24953249|NCT03887130|Paclitaxel|paclitaxel|mesh-list
24953250|NCT03887130|Vinorelbine|vinorelbine|mesh-list
24953251|NCT03887130|Docetaxel|docetaxel|mesh-list
24953252|NCT03887130|Capecitabine|capecitabine|mesh-list
24953253|NCT03887130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24953254|NCT03887130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24953255|NCT03887130|Tubulin Modulators|tubulin modulators|mesh-ancestor
24953256|NCT03887130|Antimitotic Agents|antimitotic agents|mesh-ancestor
24953257|NCT03887130|Mitosis Modulators|mitosis modulators|mesh-ancestor
24953258|NCT03887130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953259|NCT03887130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24953260|NCT03887130|Antimetabolites|antimetabolites|mesh-ancestor
24953261|NCT03887130|Antiviral Agents|antiviral agents|mesh-ancestor
24827079|NCT02137278|Natriuretic Agents|natriuretic agents|mesh-ancestor
24827080|NCT02137278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827081|NCT02137278|Dopamine Agents|dopamine agents|mesh-ancestor
24908928|NCT04315155|Ipilimumab|ipilimumab|mesh-list
24908929|NCT04315155|Belinostat|belinostat|mesh-list
24908930|NCT04315155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24908931|NCT04315155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908932|NCT04315155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24908933|NCT04315155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908934|NCT04315155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24908936|NCT04315116|Loperamide|loperamide|mesh-list
24953262|NCT03887130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24953263|NCT03887130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24953264|NCT03887130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24953265|NCT03887130|Immunologic Factors|immunologic factors|mesh-ancestor
24953266|NCT03887130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953267|NCT03886896|Lidocaine|lidocaine|mesh-list
24953268|NCT03886896|Anesthetics, Local|anesthetics, local|mesh-ancestor
24953269|NCT03886896|Anesthetics|anesthetics|mesh-ancestor
24953270|NCT03886896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24953278|NCT03886896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670703|NCT03999749|Ipilimumab|ipilimumab|mesh-list
25670704|NCT03999749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25670705|NCT03999749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670706|NCT03999749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25670707|NCT03999749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670708|NCT03957304|Dexmedetomidine|dexmedetomidine|mesh-list
25670709|NCT03957304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25228382|NCT02608164|Vitamin D|vitamin d|mesh-list
25228383|NCT02608164|Cholecalciferol|cholecalciferol|mesh-list
24844003|NCT02230735|Adrenergic Agents|adrenergic agents|mesh-ancestor
24953279|NCT03886779|Nepafenac|nepafenac|mesh-list
24953280|NCT03886779|Bromfenac|bromfenac|mesh-list
24953281|NCT03886779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24953282|NCT03886779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24953283|NCT03886779|Analgesics|analgesics|mesh-ancestor
24953284|NCT03886779|Sensory System Agents|sensory system agents|mesh-ancestor
24953285|NCT03886779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953287|NCT03886779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24953288|NCT03886779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24953289|NCT03886948|Mirikizumab|mirikizumab|mesh-list
24644579|NCT01191892|Antimetabolites|antimetabolites|mesh-ancestor
24953297|NCT03886948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24953298|NCT03886948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24644748|NCT01192802|Tubulin Modulators|tubulin modulators|mesh-ancestor
24904066|NCT04359212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24904067|NCT04359212|Protease Inhibitors|protease inhibitors|mesh-ancestor
24904068|NCT04359212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904069|NCT04359316|Azithromycin|azithromycin|mesh-list
25201846|NCT02725099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24499622|NCT00520260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24499623|NCT00520260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24499624|NCT00520260|Analgesics|analgesics|mesh-ancestor
24499625|NCT00520260|Sensory System Agents|sensory system agents|mesh-ancestor
24499626|NCT00520260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24499627|NCT00520260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904070|NCT04359316|Hydroxychloroquine|hydroxychloroquine|mesh-list
24904071|NCT04359316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24904072|NCT04359316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24904073|NCT04359316|Antimalarials|antimalarials|mesh-ancestor
24645106|NCT01195805|Spironolactone|spironolactone|mesh-list
24908946|NCT04314310|Tenoxicam|tenoxicam|mesh-list
25064181|NCT03462446|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25064182|NCT03462446|Antithrombins|antithrombins|mesh-ancestor
25064183|NCT03462446|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25064184|NCT03462446|Protease Inhibitors|protease inhibitors|mesh-ancestor
25064185|NCT03462446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867775|NCT00109993|Methylprednisolone|methylprednisolone|mesh-list
24818402|NCT02088515|Tubulin Modulators|tubulin modulators|mesh-ancestor
24818403|NCT02088515|Antimitotic Agents|antimitotic agents|mesh-ancestor
24818404|NCT02088515|Mitosis Modulators|mitosis modulators|mesh-ancestor
24818405|NCT02088515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818406|NCT02088528|Mitomycins|mitomycins|mesh-list
24818407|NCT02088528|Mitomycin|mitomycin|mesh-list
24818408|NCT02088528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24818409|NCT02088528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24818410|NCT02088528|Alkylating Agents|alkylating agents|mesh-ancestor
24818411|NCT02088528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818412|NCT02088528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24818413|NCT02088528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24818414|NCT02088645|Cholecystokinin|cholecystokinin|mesh-list
24818415|NCT02088645|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24818416|NCT02088645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24818417|NCT02088671|Propofol|propofol|mesh-list
24818418|NCT02088671|Desflurane|desflurane|mesh-list
24818419|NCT02088671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24818420|NCT02088671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24818421|NCT02088671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818422|NCT02088671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24818423|NCT02088671|Anesthetics, General|anesthetics, general|mesh-ancestor
24904184|NCT04358354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24904185|NCT04358354|Immunologic Factors|immunologic factors|mesh-ancestor
24904186|NCT04358354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904187|NCT04358354|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24904188|NCT04358354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24904189|NCT04358354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904190|NCT04358523|Sofosbuvir|sofosbuvir|mesh-list
24904191|NCT04358523|Antiviral Agents|antiviral agents|mesh-ancestor
24904192|NCT04358523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24904193|NCT04358497|Ibuprofen|ibuprofen|mesh-list
25670710|NCT03957304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25670711|NCT03957304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904194|NCT04358497|Polidocanol|polidocanol|mesh-list
25064186|NCT03462446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064187|NCT03462446|Anticoagulants|anticoagulants|mesh-ancestor
25064188|NCT03462446|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25867776|NCT00109993|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25064189|NCT03462446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25064191|NCT03462446|Coagulants|coagulants|mesh-ancestor
25064192|NCT03462368|Anti-Infective Agents|anti-infective agents|mesh-list
25064193|NCT03462368|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25064194|NCT03462329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25064195|NCT03462329|Doxycycline|doxycycline|mesh-list
25064196|NCT03462329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24826688|NCT02135770|Heparin|heparin|mesh-list
24826689|NCT02135770|Calcium heparin|calcium heparin|mesh-list
24645384|NCT01198106|Histamine Agents|histamine agents|mesh-ancestor
24904280|NCT04357002|Oxytocics|oxytocics|mesh-ancestor
24904319|NCT04356677|Ribavirin|ribavirin|mesh-list
24904320|NCT04356677|Antimetabolites|antimetabolites|mesh-ancestor
24904321|NCT04356677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904322|NCT04356677|Antiviral Agents|antiviral agents|mesh-ancestor
25201847|NCT02725099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201848|NCT02725099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201849|NCT02724904|Methotrexate|methotrexate|mesh-list
25201850|NCT02724904|Fludarabine|fludarabine|mesh-list
25201851|NCT02724904|Thiotepa|thiotepa|mesh-list
25201852|NCT02724904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25201853|NCT02724904|Abortifacient Agents|abortifacient agents|mesh-ancestor
24904358|NCT04356222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24904359|NCT04356222|Immunologic Factors|immunologic factors|mesh-ancestor
24904360|NCT04356222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24904361|NCT04356222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24904362|NCT04356222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24904364|NCT04356144|Hemostatics|hemostatics|mesh-ancestor
24904365|NCT04356144|Coagulants|coagulants|mesh-ancestor
24904366|NCT04356118|Methotrexate|methotrexate|mesh-list
24904367|NCT04356118|Endostatins|endostatins|mesh-list
24904368|NCT04356118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24904369|NCT04356118|Abortifacient Agents|abortifacient agents|mesh-ancestor
24904370|NCT04356118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24904371|NCT04356118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904372|NCT04356118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24904373|NCT04356118|Antimetabolites|antimetabolites|mesh-ancestor
24904374|NCT04356118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904375|NCT04356118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904376|NCT04356118|Dermatologic Agents|dermatologic agents|mesh-ancestor
24904377|NCT04356118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904378|NCT04356118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24631932|NCT01121055|Lorazepam|lorazepam|mesh-list
24904379|NCT04356118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24904380|NCT04356118|Immunologic Factors|immunologic factors|mesh-ancestor
24904548|NCT04355026|Antimalarials|antimalarials|mesh-ancestor
24904549|NCT04355026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25064215|NCT03462212|Growth Inhibitors|growth inhibitors|mesh-ancestor
25064216|NCT03462212|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25064217|NCT03462212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904550|NCT04355026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24904551|NCT04355026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24904552|NCT04355026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904553|NCT04355026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904554|NCT04355026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24904555|NCT04355026|Expectorants|expectorants|mesh-ancestor
24904556|NCT04355026|Respiratory System Agents|respiratory system agents|mesh-ancestor
24904557|NCT04355052|Azithromycin|azithromycin|mesh-list
24904632|NCT04354662|Vitamin B Complex|vitamin b complex|mesh-ancestor
24904634|NCT04354662|Micronutrients|micronutrients|mesh-ancestor
24904635|NCT04354441|Hydroxychloroquine|hydroxychloroquine|mesh-list
24904636|NCT04354441|Antimalarials|antimalarials|mesh-ancestor
24904637|NCT04354441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24904638|NCT04354441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24904639|NCT04354441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24904640|NCT04354441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904641|NCT04354441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904642|NCT04354441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24904643|NCT04354545|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24818458|NCT02088944|Dermatologic Agents|dermatologic agents|mesh-ancestor
24818459|NCT02088944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24818460|NCT02088944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24818461|NCT02088970|Riboflavin|riboflavin|mesh-list
24818462|NCT02088970|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24818463|NCT02088970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24818464|NCT02088970|Vitamin B Complex|vitamin b complex|mesh-ancestor
24818465|NCT02088970|Vitamins|vitamins|mesh-ancestor
24544301|NCT00688428|Aspirin|aspirin|mesh-list
24544302|NCT00688428|Esomeprazole|esomeprazole|mesh-list
24544303|NCT00688428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24544304|NCT00688428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24818466|NCT02088970|Micronutrients|micronutrients|mesh-ancestor
24818467|NCT02088970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480563|NCT00431262|Disulfiram|disulfiram|mesh-list
25867777|NCT00109993|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25867778|NCT00109993|Prednisolone|prednisolone|mesh-list
25867779|NCT00109993|Prednisolone acetate|prednisolone acetate|mesh-list
24818471|NCT02088983|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
24905071|NCT04351126|Bromocriptine|bromocriptine|mesh-list
25064240|NCT03461718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904866|NCT04352400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904867|NCT04352400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480790|NCT00432120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480791|NCT00432146|Lugol's solution|lugol's solution|mesh-list
24480793|NCT00432146|Coagulants|coagulants|mesh-ancestor
24904919|NCT04351724|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24904920|NCT04351724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24904921|NCT04351724|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24904922|NCT04351724|Antithrombins|antithrombins|mesh-ancestor
24904923|NCT04351724|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24904924|NCT04351724|Anticoagulants|anticoagulants|mesh-ancestor
24904925|NCT04351724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24904926|NCT04351724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24904927|NCT04351724|Amebicides|amebicides|mesh-ancestor
24904928|NCT04351724|Antimetabolites|antimetabolites|mesh-ancestor
24904929|NCT04351763|Amiodarone|amiodarone|mesh-list
24904930|NCT04351763|Verapamil|verapamil|mesh-list
24904931|NCT04351763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24904932|NCT04351763|Vasodilator Agents|vasodilator agents|mesh-ancestor
24904933|NCT04351763|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24904934|NCT04351763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24519352|NCT01898793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24519353|NCT01898793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24519354|NCT01898793|Antimetabolites|antimetabolites|mesh-ancestor
24519355|NCT01898793|Antiviral Agents|antiviral agents|mesh-ancestor
25064267|NCT03461627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064268|NCT03461627|Glucocorticoids|glucocorticoids|mesh-ancestor
25064269|NCT03461627|Hormones|hormones|mesh-ancestor
24677843|NCT01358435|Insulin|insulin|mesh-list
24818494|NCT02089126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25064277|NCT03461575|Immunologic Factors|immunologic factors|mesh-ancestor
25064278|NCT03461575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064279|NCT03461575|Antifungal Agents|antifungal agents|mesh-ancestor
24614851|NCT01026428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614852|NCT01026467|Carboplatin|carboplatin|mesh-list
24614853|NCT01026467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614854|NCT01026558|Ceftobiprole|ceftobiprole|mesh-list
24614855|NCT01026558|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
24614856|NCT01026558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24614857|NCT01026558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24623607|NCT01072747|Heparin|heparin|mesh-list
24623608|NCT01072747|Calcium heparin|calcium heparin|mesh-list
24623609|NCT01072747|Anticoagulants|anticoagulants|mesh-ancestor
24623610|NCT01072747|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24623611|NCT01072747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24623612|NCT01072747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623613|NCT01072786|Vaccines|vaccines|mesh-list
24623614|NCT01072786|Immunologic Factors|immunologic factors|mesh-ancestor
24623615|NCT01072786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623616|NCT01072812|Phenserine|phenserine|mesh-list
25064283|NCT03461575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25064284|NCT03461328|Magnesium Sulfate|magnesium sulfate|mesh-list
25064285|NCT03461328|Analgesics|analgesics|mesh-ancestor
25064286|NCT03461328|Sensory System Agents|sensory system agents|mesh-ancestor
25670712|NCT03957304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25670713|NCT03957304|Analgesics|analgesics|mesh-ancestor
25670714|NCT03957304|Sensory System Agents|sensory system agents|mesh-ancestor
25670715|NCT03957304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25064287|NCT03461328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24905063|NCT04351581|Protease Inhibitors|protease inhibitors|mesh-ancestor
25670716|NCT03957304|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25670717|NCT03957304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25670718|NCT03957304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25670719|NCT03957304|Adrenergic Agents|adrenergic agents|mesh-ancestor
25670720|NCT03957304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24544323|NCT00688480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544324|NCT00688480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544325|NCT00688480|Gout Suppressants|gout suppressants|mesh-ancestor
24905064|NCT04351581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905065|NCT04351581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905067|NCT04350931|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24905068|NCT04350931|Immunologic Factors|immunologic factors|mesh-ancestor
24909236|NCT04311580|Mitomycins|mitomycins|mesh-list
25201854|NCT02724904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25867780|NCT00109993|Alemtuzumab|alemtuzumab|mesh-list
25867781|NCT00109993|Tacrolimus|tacrolimus|mesh-list
25867782|NCT00109993|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25867783|NCT00109993|Prednisolone phosphate|prednisolone phosphate|mesh-list
24905069|NCT04350931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905070|NCT04351126|Fludrocortisone|fludrocortisone|mesh-list
24905073|NCT04351126|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24905074|NCT04351126|Hormone Antagonists|hormone antagonists|mesh-ancestor
24905075|NCT04351126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24905076|NCT04351126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905077|NCT04351126|Dopamine Agonists|dopamine agonists|mesh-ancestor
24905078|NCT04351126|Dopamine Agents|dopamine agents|mesh-ancestor
24905079|NCT04351126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24905080|NCT04351126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905081|NCT04351126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24905082|NCT04351100|Diacetylrhein|diacetylrhein|mesh-list
24905083|NCT04351100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24905084|NCT04350645|Tranexamic Acid|tranexamic acid|mesh-list
24905085|NCT04350645|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24909268|NCT04310943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24909269|NCT04310943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905086|NCT04350645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24905120|NCT04350580|Immunologic Factors|immunologic factors|mesh-ancestor
24905121|NCT04350580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905122|NCT04350502|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24905123|NCT04350502|Amoxicillin|amoxicillin|mesh-list
24905124|NCT04350502|Clavulanic Acids|clavulanic acids|mesh-list
24905125|NCT04350502|Clavulanic Acid|clavulanic acid|mesh-list
24905126|NCT04350502|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24905127|NCT04350502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905128|NCT04350502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905131|NCT04350684|Interferons|interferons|mesh-list
24905139|NCT04350684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905140|NCT04350684|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24519416|NCT01670877|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24519418|NCT01670877|Hormone Antagonists|hormone antagonists|mesh-ancestor
24519419|NCT01670877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24519420|NCT01670877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905357|NCT04348006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905359|NCT04348006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24905360|NCT04348006|Alkylating Agents|alkylating agents|mesh-ancestor
24905361|NCT04348006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905370|NCT04348006|Hormones|hormones|mesh-ancestor
24905405|NCT04347889|Antimalarials|antimalarials|mesh-ancestor
24905406|NCT04347889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24905407|NCT04347889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24905408|NCT04347889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905409|NCT04347889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905410|NCT04347889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905411|NCT04347889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24728380|NCT01615913|Terbinafine|terbinafine|mesh-list
24905412|NCT04347889|Antioxidants|antioxidants|mesh-ancestor
25201855|NCT02724904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670721|NCT03957304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670722|NCT03924791|Dexamethasone|dexamethasone|mesh-list
25670723|NCT03924791|Methylprednisolone|methylprednisolone|mesh-list
25201856|NCT02724904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25670724|NCT03924791|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25670725|NCT03924791|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25670726|NCT03924791|Prednisolone|prednisolone|mesh-list
25670727|NCT03924791|Prednisolone acetate|prednisolone acetate|mesh-list
25670728|NCT03924791|Lidocaine|lidocaine|mesh-list
25670729|NCT03924791|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25670730|NCT03924791|Prednisolone phosphate|prednisolone phosphate|mesh-list
24544367|NCT00688805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24858020|NCT02294656|Triamcinolone|triamcinolone|mesh-list
24858021|NCT02294656|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25201861|NCT02724904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201862|NCT02724904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25201863|NCT02724904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25201864|NCT02724904|Immunologic Factors|immunologic factors|mesh-ancestor
25201865|NCT02724904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24905413|NCT04347889|Protective Agents|protective agents|mesh-ancestor
24905414|NCT04347980|Hydroxychloroquine|hydroxychloroquine|mesh-list
24905416|NCT04347980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24856482|NCT02284529|Protective Agents|protective agents|mesh-ancestor
24905792|NCT04345198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24906702|NCT04337879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24906703|NCT04337879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906704|NCT04337879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906705|NCT04337918|Nitric Oxide|nitric oxide|mesh-list
24856685|NCT02286258|Edetic Acid|edetic acid|mesh-list
24826964|NCT02136888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24826967|NCT02136979|Sevoflurane|sevoflurane|mesh-list
24907350|NCT04331054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24907351|NCT04331054|Respiratory System Agents|respiratory system agents|mesh-ancestor
24818821|NCT02091063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24818822|NCT02091063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818823|NCT02091180|Mannitol|mannitol|mesh-list
24908720|NCT04316936|Prednisolone acetate|prednisolone acetate|mesh-list
24908721|NCT04316936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24908768|NCT04317001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908848|NCT04315935|Respiratory System Agents|respiratory system agents|mesh-ancestor
24908849|NCT04315935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24908850|NCT04315909|Vitamin E|vitamin e|mesh-list
25064663|NCT03458078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24908972|NCT04314505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24908974|NCT04314193|Methotrexate|methotrexate|mesh-list
24908975|NCT04314193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24908976|NCT04314193|Abortifacient Agents|abortifacient agents|mesh-ancestor
24908977|NCT04314193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24908978|NCT04314193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649225|NCT01219036|Budesonide|budesonide|mesh-list
24909106|NCT04312750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24909148|NCT04312360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24909149|NCT04312360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24909150|NCT04312360|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24909343|NCT04310176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24909344|NCT04310176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24909345|NCT04310176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24909346|NCT04310176|Growth Substances|growth substances|mesh-ancestor
24909605|NCT04306913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909606|NCT04306913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24909608|NCT04306666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24909630|NCT04306731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24909632|NCT04306692|Clomiphene|clomiphene|mesh-list
24909633|NCT04306692|Enclomiphene|enclomiphene|mesh-list
24909634|NCT04306692|Zuclomiphene|zuclomiphene|mesh-list
24909635|NCT04306692|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24909636|NCT04306692|Hormone Antagonists|hormone antagonists|mesh-ancestor
24909637|NCT04306692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24909638|NCT04306692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484326|NCT00447759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24484327|NCT00447759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24484328|NCT00447759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24909437|NCT04308551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24909438|NCT04308551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24909439|NCT04308551|Analgesics|analgesics|mesh-ancestor
24909440|NCT04308551|Sensory System Agents|sensory system agents|mesh-ancestor
24909441|NCT04308551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24909476|NCT04308317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519632|NCT05332028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24909639|NCT04306692|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24818937|NCT02092012|Dexmedetomidine|dexmedetomidine|mesh-list
25670731|NCT03924791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25670732|NCT03924791|Antiemetics|antiemetics|mesh-ancestor
25670733|NCT03924791|Autonomic Agents|autonomic agents|mesh-ancestor
24818938|NCT02092012|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25867784|NCT00109993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25670734|NCT03924791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24818939|NCT02092012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24818940|NCT02092012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818941|NCT02092012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24818943|NCT02092012|Sensory System Agents|sensory system agents|mesh-ancestor
24818954|NCT02092038|Temozolomide|temozolomide|mesh-list
24818955|NCT02092038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24818956|NCT02092038|Alkylating Agents|alkylating agents|mesh-ancestor
24909701|NCT04305743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24909582|NCT04307147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24909702|NCT04305743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24909703|NCT04305743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909704|NCT04305743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24909705|NCT04305743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24909706|NCT04305743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909707|NCT04305743|Cholinergic Agents|cholinergic agents|mesh-ancestor
24909708|NCT04305743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24909709|NCT04305964|Silicon|silicon|mesh-list
24909756|NCT04305457|Protective Agents|protective agents|mesh-ancestor
24909758|NCT04305028|Rivaroxaban|rivaroxaban|mesh-list
24909759|NCT04305028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24909760|NCT04305028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24909761|NCT04305028|Analgesics|analgesics|mesh-ancestor
24909762|NCT04305028|Sensory System Agents|sensory system agents|mesh-ancestor
24909763|NCT04305028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24909764|NCT04305028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909765|NCT04305028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25064704|NCT03457597|GABA Modulators|gaba modulators|mesh-ancestor
24909872|NCT04304261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24909873|NCT04304261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909874|NCT04304261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24909875|NCT04304261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909876|NCT04304248|Paclitaxel|paclitaxel|mesh-list
24909877|NCT04304248|Carboplatin|carboplatin|mesh-list
24909878|NCT04304248|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24909879|NCT04304248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24909886|NCT04304313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909887|NCT04304313|Vasodilator Agents|vasodilator agents|mesh-ancestor
24651898|NCT01234454|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24909925|NCT04303988|Carboplatin|carboplatin|mesh-list
24909926|NCT04303988|Temozolomide|temozolomide|mesh-list
24909927|NCT04303988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24909928|NCT04303988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24909929|NCT04303988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24909961|NCT04303520|Immunologic Factors|immunologic factors|mesh-ancestor
24909962|NCT04303520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909963|NCT04303520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24909964|NCT04303520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24909965|NCT04303520|Alkylating Agents|alkylating agents|mesh-ancestor
24909966|NCT04303520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909968|NCT04303520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24909970|NCT04303377|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24909971|NCT04303377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24651958|NCT01234857|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25064717|NCT03457597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25064739|NCT03457337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774764|NCT01847768|Methacholine Chloride|methacholine chloride|mesh-list
25201866|NCT02724904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25201867|NCT02724904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25201868|NCT02724904|Alkylating Agents|alkylating agents|mesh-ancestor
25201869|NCT02724904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25201871|NCT02725112|Analgesics|analgesics|mesh-ancestor
25201872|NCT02725112|Sensory System Agents|sensory system agents|mesh-ancestor
25201873|NCT02725112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24524413|NCT04954742|Riociguat|riociguat|mesh-list
24827179|NCT02137733|Carvedilol|carvedilol|mesh-list
24910079|NCT04302350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25670735|NCT03924791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670736|NCT03924791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25670737|NCT03924791|Glucocorticoids|glucocorticoids|mesh-ancestor
24652436|NCT01238224|Tadalafil|tadalafil|mesh-list
24910178|NCT04301739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24910179|NCT04301739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910180|NCT04301739|Tubulin Modulators|tubulin modulators|mesh-ancestor
24910181|NCT04301739|Antimitotic Agents|antimitotic agents|mesh-ancestor
24910182|NCT04301739|Mitosis Modulators|mitosis modulators|mesh-ancestor
24910183|NCT04301739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867786|NCT00109993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867787|NCT00109993|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24910444|NCT04297215|Chitosan|chitosan|mesh-list
24910445|NCT04297215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24910446|NCT04297215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24910447|NCT04297215|Antimetabolites|antimetabolites|mesh-ancestor
24910448|NCT04297215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910449|NCT04297215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24485085|NCT00451568|Metformin|metformin|mesh-list
24485086|NCT00451568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24519787|NCT05091866|Progesterone|progesterone|mesh-list
24519788|NCT05091866|Progestins|progestins|mesh-list
24519789|NCT05091866|Hormones|hormones|mesh-ancestor
24910462|NCT04297501|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24910463|NCT04297501|Antiviral Agents|antiviral agents|mesh-ancestor
24910464|NCT04297501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24910465|NCT04297462|Oseltamivir|oseltamivir|mesh-list
24909610|NCT04306653|Betamethasone|betamethasone|mesh-list
24910466|NCT04297462|Antiviral Agents|antiviral agents|mesh-ancestor
24910467|NCT04297462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24910468|NCT04297462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24949483|NCT04669457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953332|NCT03886311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24953333|NCT03886311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953334|NCT03886311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24953335|NCT03886311|Alkylating Agents|alkylating agents|mesh-ancestor
24827228|NCT02137928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24827230|NCT02137928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867788|NCT00109993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867789|NCT00109993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867790|NCT00109993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25867791|NCT00109993|Antiemetics|antiemetics|mesh-ancestor
25867792|NCT00109993|Autonomic Agents|autonomic agents|mesh-ancestor
25867793|NCT00109993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24485125|NCT00451711|Antifungal Agents|antifungal agents|mesh-ancestor
24485126|NCT00451724|Ketamine|ketamine|mesh-list
24485127|NCT00451724|Analgesics|analgesics|mesh-ancestor
24485128|NCT00451724|Sensory System Agents|sensory system agents|mesh-ancestor
24485131|NCT00451724|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24519807|NCT04923620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24519808|NCT04923620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24819020|NCT02092558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24819022|NCT02092597|Linagliptin|linagliptin|mesh-list
24819023|NCT02092597|Gliclazide|gliclazide|mesh-list
24715057|NCT01534169|Dexamethasone|dexamethasone|mesh-list
25065186|NCT03452501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24953355|NCT03885947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24953356|NCT03885947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24953357|NCT03885895|Tranexamic Acid|tranexamic acid|mesh-list
24655400|NCT01256580|Bevacizumab|bevacizumab|mesh-list
24910553|NCT04296695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24910554|NCT04296695|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24910555|NCT04296695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24910556|NCT04296695|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24910557|NCT04296695|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24910558|NCT04296695|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25201874|NCT02725112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910570|NCT04296240|Antimetabolites|antimetabolites|mesh-ancestor
24910571|NCT04296240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064839|NCT03456544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25064840|NCT03456531|Aspirin|aspirin|mesh-list
25064841|NCT03456531|Analgesics|analgesics|mesh-list
25064842|NCT03456531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25064843|NCT03456531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25064844|NCT03456531|Sensory System Agents|sensory system agents|mesh-ancestor
25064845|NCT03456531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25064846|NCT03456531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064847|NCT03456531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25867794|NCT00109993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24827267|NCT02138045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24827268|NCT02138045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827269|NCT02138045|Incretins|incretins|mesh-ancestor
24827270|NCT02138045|Hormones|hormones|mesh-ancestor
25867795|NCT00109993|Glucocorticoids|glucocorticoids|mesh-ancestor
25867796|NCT00109993|Hormones|hormones|mesh-ancestor
25867797|NCT00109993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25867798|NCT00109993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25867799|NCT00109993|Protective Agents|protective agents|mesh-ancestor
25867800|NCT00109993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25867801|NCT00109993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867802|NCT00109993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24910702|NCT04295161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24910703|NCT04294784|Paclitaxel|paclitaxel|mesh-list
24949280|NCT05039073|Nivolumab|nivolumab|mesh-list
24818957|NCT02092038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818958|NCT02092038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24818959|NCT02092142|Vaccines|vaccines|mesh-list
24818960|NCT02092142|Immunologic Factors|immunologic factors|mesh-ancestor
24818961|NCT02092142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910704|NCT04294784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24910705|NCT04294784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24910706|NCT04294784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24910707|NCT04294784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910708|NCT04294784|Tubulin Modulators|tubulin modulators|mesh-ancestor
24658601|NCT01272856|Immunologic Factors|immunologic factors|mesh-ancestor
24910791|NCT04294329|Anesthetics, Local|anesthetics, local|mesh-ancestor
24910793|NCT04294329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24658811|NCT01274195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25065035|NCT03454503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065036|NCT03454217|Oxycodone|oxycodone|mesh-list
25065037|NCT03454217|Tramadol|tramadol|mesh-list
25065038|NCT03454217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25065039|NCT03454217|Narcotics|narcotics|mesh-ancestor
25065040|NCT03454217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25065041|NCT03454217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065042|NCT03454217|Analgesics|analgesics|mesh-ancestor
25065043|NCT03454217|Sensory System Agents|sensory system agents|mesh-ancestor
24827381|NCT02138708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827382|NCT02138708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24827383|NCT02138708|Vasodilator Agents|vasodilator agents|mesh-ancestor
24827388|NCT02138708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615053|NCT01027546|Hemostatics|hemostatics|mesh-ancestor
25065048|NCT03453931|Hormones|hormones|mesh-ancestor
25065049|NCT03453931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25065050|NCT03453931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065051|NCT03453931|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25065052|NCT03453931|Protective Agents|protective agents|mesh-ancestor
24827389|NCT02138708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24827390|NCT02138708|Cholinergic Agents|cholinergic agents|mesh-ancestor
24827391|NCT02138773|Tamsulosin|tamsulosin|mesh-list
25867803|NCT00110006|Prednisone|prednisone|mesh-list
25867804|NCT00110006|Cyclophosphamide|cyclophosphamide|mesh-list
25201875|NCT02725112|Anticonvulsants|anticonvulsants|mesh-ancestor
25065053|NCT03453931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25065054|NCT03453931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065055|NCT03453892|Pembrolizumab|pembrolizumab|mesh-list
25065056|NCT03453892|Nivolumab|nivolumab|mesh-list
25065057|NCT03453892|Ipilimumab|ipilimumab|mesh-list
25065058|NCT03453892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25065059|NCT03453892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065060|NCT03453892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25065061|NCT03453892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659440|NCT01277731|Prednisolone|prednisolone|mesh-list
24911001|NCT04292314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818971|NCT02092363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818972|NCT02092363|Immunologic Factors|immunologic factors|mesh-ancestor
24818973|NCT02092363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818974|NCT02092376|Cholecalciferol|cholecalciferol|mesh-list
24818975|NCT02092376|Vitamin D|vitamin d|mesh-list
24818976|NCT02092376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24818977|NCT02092376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818978|NCT02092376|Vitamins|vitamins|mesh-ancestor
24818979|NCT02092376|Micronutrients|micronutrients|mesh-ancestor
24818980|NCT02092376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25867805|NCT00110006|Rituximab|rituximab|mesh-list
25867806|NCT00110006|Doxorubicin|doxorubicin|mesh-list
25867807|NCT00110006|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25867808|NCT00110006|Vincristine|vincristine|mesh-list
25867809|NCT00110006|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25867810|NCT00110006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24544464|NCT00689156|Mitosis Modulators|mitosis modulators|mesh-ancestor
24544465|NCT00689156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24544466|NCT00689156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24544467|NCT00689156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24544468|NCT00689156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544490|NCT00689169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24911008|NCT04291794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24953370|NCT03885804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24953371|NCT03885804|Analgesics|analgesics|mesh-ancestor
24953372|NCT03885804|Sensory System Agents|sensory system agents|mesh-ancestor
24953373|NCT03885804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24911035|NCT04291755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24911036|NCT04291755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659773|NCT01279694|Glucocorticoids|glucocorticoids|mesh-ancestor
24911201|NCT04290390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24911202|NCT04290390|Leprostatic Agents|leprostatic agents|mesh-ancestor
24911203|NCT04290390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24911204|NCT04290390|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24911205|NCT04290390|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24911206|NCT04290390|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24911207|NCT04290390|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24911208|NCT04290390|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24911209|NCT04290390|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24911210|NCT04290390|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24450154|NCT00317876|Cyclosporine|cyclosporine|mesh-list
24911246|NCT04290169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24911247|NCT04290169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660599|NCT01284725|Azathioprine|azathioprine|mesh-list
25065065|NCT03453840|Antimalarials|antimalarials|mesh-ancestor
25065066|NCT03453840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25065067|NCT03453840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24827418|NCT02138812|Tubulin Modulators|tubulin modulators|mesh-ancestor
24911414|NCT04288349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24911415|NCT04288349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24911416|NCT04288349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24911417|NCT04288349|Adrenergic Agents|adrenergic agents|mesh-ancestor
24911418|NCT04288349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24911421|NCT04288349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24911423|NCT04288349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24911424|NCT04288349|Respiratory System Agents|respiratory system agents|mesh-ancestor
24911425|NCT04288349|Mydriatics|mydriatics|mesh-ancestor
24911426|NCT04288349|Sympathomimetics|sympathomimetics|mesh-ancestor
24911427|NCT04288349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24909679|NCT04306276|Hormone Antagonists|hormone antagonists|mesh-ancestor
25065077|NCT03453723|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25065079|NCT03453723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24660899|NCT01286948|Levonorgestrel|levonorgestrel|mesh-list
25065083|NCT03453632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25065084|NCT03453632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911499|NCT04287361|Anticonvulsants|anticonvulsants|mesh-ancestor
24911500|NCT04287361|GABA Modulators|gaba modulators|mesh-ancestor
24911501|NCT04287361|GABA Agents|gaba agents|mesh-ancestor
24623714|NCT01073371|Anesthetics|anesthetics|mesh-ancestor
24623715|NCT01073371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24623716|NCT01073371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623717|NCT01073371|Sensory System Agents|sensory system agents|mesh-ancestor
25201876|NCT02725112|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24623718|NCT01073371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25670738|NCT03924791|Hormones|hormones|mesh-ancestor
25670739|NCT03924791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25670740|NCT03924791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25670741|NCT03924791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670742|NCT03924791|Anesthetics, Local|anesthetics, local|mesh-ancestor
25670743|NCT03924791|Anesthetics|anesthetics|mesh-ancestor
25670744|NCT03924791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25670745|NCT03924791|Sensory System Agents|sensory system agents|mesh-ancestor
25670746|NCT03924791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25670747|NCT03924791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24623719|NCT01073384|Beclomethasone|beclomethasone|mesh-list
24623720|NCT01073384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24623721|NCT01073384|Glucocorticoids|glucocorticoids|mesh-ancestor
24661033|NCT01287624|Antimitotic Agents|antimitotic agents|mesh-ancestor
25065098|NCT03453541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25065099|NCT03453541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25065100|NCT03453541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065101|NCT03453528|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25065102|NCT03453528|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25065103|NCT03453528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065104|NCT03453346|Ribavirin|ribavirin|mesh-list
25065105|NCT03453346|Sofosbuvir|sofosbuvir|mesh-list
25065106|NCT03453346|Antimetabolites|antimetabolites|mesh-ancestor
25065107|NCT03453346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065122|NCT03453190|Sensory System Agents|sensory system agents|mesh-ancestor
25065123|NCT03453190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25065124|NCT03453190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911550|NCT04286399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911551|NCT04286399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24911552|NCT04286399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24911553|NCT04286399|Protease Inhibitors|protease inhibitors|mesh-ancestor
24911554|NCT04286399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24911555|NCT04286503|Ritonavir|ritonavir|mesh-list
24911556|NCT04286503|Lopinavir|lopinavir|mesh-list
24911557|NCT04286503|Chloroquine|chloroquine|mesh-list
24911558|NCT04286503|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24911559|NCT04286503|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24911560|NCT04286503|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24911562|NCT04286503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24911563|NCT04286503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911564|NCT04286503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24911565|NCT04286503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24911566|NCT04286503|Antiviral Agents|antiviral agents|mesh-ancestor
24911567|NCT04286503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24911568|NCT04286503|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24911569|NCT04286503|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24911584|NCT04286503|Anthelmintics|anthelmintics|mesh-ancestor
24911585|NCT04286035|Bupivacaine|bupivacaine|mesh-list
24911586|NCT04286035|Anesthetics, Local|anesthetics, local|mesh-ancestor
24911587|NCT04286035|Anesthetics|anesthetics|mesh-ancestor
25065156|NCT03452696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25065157|NCT03452696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064706|NCT03457597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25064707|NCT03457597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064708|NCT03457597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24909766|NCT04305028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24909767|NCT04305028|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24717411|NCT01547546|GDC-0084|gdc-0084|mesh-list
25867811|NCT00110006|Immunologic Factors|immunologic factors|mesh-ancestor
25867812|NCT00110006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867813|NCT00110006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25867814|NCT00110006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24911626|NCT04285528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24911627|NCT04285528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911628|NCT04285528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24911629|NCT04285528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24911630|NCT04285528|Anesthetics, General|anesthetics, general|mesh-ancestor
24911632|NCT04285528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24911633|NCT04285528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24911637|NCT04285528|Narcotics|narcotics|mesh-ancestor
25065159|NCT03452657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25065160|NCT03452657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24909790|NCT04304794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909791|NCT04305106|Bevacizumab|bevacizumab|mesh-list
24909792|NCT04305106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24909793|NCT04305106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24909794|NCT04305106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25065161|NCT03452657|Growth Substances|growth substances|mesh-ancestor
25065162|NCT03452657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065163|NCT03452657|Growth Inhibitors|growth inhibitors|mesh-ancestor
25065164|NCT03452657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519937|NCT04413253|Dexamethasone|dexamethasone|mesh-list
24519938|NCT04413253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24519939|NCT04413253|Lifitegrast|lifitegrast|mesh-list
24519940|NCT04413253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24519941|NCT04413253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24519942|NCT04413253|Antiemetics|antiemetics|mesh-ancestor
24519943|NCT04413253|Autonomic Agents|autonomic agents|mesh-ancestor
24519947|NCT04413253|Glucocorticoids|glucocorticoids|mesh-ancestor
24519948|NCT04413253|Hormones|hormones|mesh-ancestor
24519949|NCT04413253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24519950|NCT04413253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24519951|NCT04413253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24911648|NCT04285281|Gabapentin|gabapentin|mesh-list
24911649|NCT04285281|Analgesics|analgesics|mesh-ancestor
24911672|NCT04285268|Bortezomib|bortezomib|mesh-list
24911673|NCT04285268|Venetoclax|venetoclax|mesh-list
24911674|NCT04285268|Antibodies|antibodies|mesh-list
24911693|NCT04284839|Rivaroxaban|rivaroxaban|mesh-list
24911694|NCT04284839|Dabigatran|dabigatran|mesh-list
24519961|NCT04333407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25867815|NCT00110006|Alkylating Agents|alkylating agents|mesh-ancestor
24911721|NCT04284644|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24911723|NCT04284722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24911724|NCT04284722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911725|NCT04284761|Bicalutamide|bicalutamide|mesh-list
24911726|NCT04284761|Androgen Antagonists|androgen antagonists|mesh-ancestor
24911727|NCT04284761|Hormone Antagonists|hormone antagonists|mesh-ancestor
24911728|NCT04284761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24911729|NCT04284761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065190|NCT03452475|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25065192|NCT03452475|Antimalarials|antimalarials|mesh-ancestor
25065193|NCT03452475|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25065194|NCT03452475|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24857293|NCT02290470|Antiemetics|antiemetics|mesh-ancestor
24911739|NCT04284215|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24911740|NCT04284215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24911741|NCT04284215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24911742|NCT04284215|Tubulin Modulators|tubulin modulators|mesh-ancestor
25065198|NCT03452345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25065199|NCT03452345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065200|NCT03452345|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25065201|NCT03452345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25201877|NCT02725112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25201878|NCT02725112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201879|NCT02725112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25201880|NCT02725112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25201881|NCT02725112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25065202|NCT03452345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065207|NCT03452332|Tremelimumab|tremelimumab|mesh-list
25065208|NCT03452332|Immunoglobulins|immunoglobulins|mesh-list
24519980|NCT04333407|Purinergic Agents|purinergic agents|mesh-ancestor
24911750|NCT04284202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911751|NCT04284098|Dexmedetomidine|dexmedetomidine|mesh-list
24911752|NCT04284098|Bupivacaine|bupivacaine|mesh-list
24911753|NCT04284098|Anesthetics, Local|anesthetics, local|mesh-ancestor
24911754|NCT04284098|Anesthetics|anesthetics|mesh-ancestor
25065216|NCT03452332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949997|NCT03095612|Tubulin Modulators|tubulin modulators|mesh-ancestor
24949998|NCT03095612|Antimitotic Agents|antimitotic agents|mesh-ancestor
24949999|NCT03095612|Mitosis Modulators|mitosis modulators|mesh-ancestor
24920690|NCT04199143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867816|NCT00110006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867817|NCT00110006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867818|NCT00110006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25867819|NCT00110006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24950006|NCT03063203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950008|NCT03015896|Lenalidomide|lenalidomide|mesh-list
24950009|NCT03015896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24950010|NCT03015896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950011|NCT03015896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24806797|NCT02018250|Anesthetics|anesthetics|mesh-ancestor
24626395|NCT01087190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24953410|NCT03885388|Methotrexate|methotrexate|mesh-list
24953411|NCT03885388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24953412|NCT03885388|Abortifacient Agents|abortifacient agents|mesh-ancestor
24827527|NCT02140047|Immunologic Factors|immunologic factors|mesh-ancestor
24827528|NCT02140047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827529|NCT02140073|Domperidone|domperidone|mesh-list
25867820|NCT00110006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25867821|NCT00110006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25867822|NCT00110006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25867823|NCT00110006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867824|NCT00110006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24394687|NCT00133887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867825|NCT00110006|Glucocorticoids|glucocorticoids|mesh-ancestor
25867826|NCT00110006|Hormones|hormones|mesh-ancestor
25867827|NCT00110006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25867828|NCT00110006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25867829|NCT00110006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24911755|NCT04284098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24911757|NCT04284098|Sensory System Agents|sensory system agents|mesh-ancestor
25670748|NCT03924791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24911774|NCT04284150|Analgesics|analgesics|mesh-ancestor
24911775|NCT04284150|Sensory System Agents|sensory system agents|mesh-ancestor
24911776|NCT04284150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24911777|NCT04284150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24911778|NCT04284150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24911779|NCT04284150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24911780|NCT04284150|Adrenergic Agents|adrenergic agents|mesh-ancestor
24911781|NCT04284150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24911782|NCT04284150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519981|NCT04333407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24519986|NCT04333407|Anticoagulants|anticoagulants|mesh-ancestor
24519993|NCT04290546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519994|NCT04290546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519996|NCT04286529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24911784|NCT04284150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24911785|NCT04284150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24911786|NCT04284150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24911787|NCT04284150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24911788|NCT04284150|Anesthetics, General|anesthetics, general|mesh-ancestor
24623759|NCT01073527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24623760|NCT01073527|Vasodilator Agents|vasodilator agents|mesh-ancestor
24953421|NCT03885388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24953422|NCT03885388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24953423|NCT03885388|Immunologic Factors|immunologic factors|mesh-ancestor
24953424|NCT03885388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25064711|NCT03457597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25064712|NCT03457597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25064713|NCT03457597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25064714|NCT03457597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25064715|NCT03457597|Sympatholytics|sympatholytics|mesh-ancestor
25064716|NCT03457597|Autonomic Agents|autonomic agents|mesh-ancestor
24909972|NCT04303377|Antimetabolites|antimetabolites|mesh-ancestor
24953425|NCT03885388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24911824|NCT04284007|Protease Inhibitors|protease inhibitors|mesh-ancestor
24911825|NCT04284007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24911826|NCT04284007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911827|NCT04284007|Anesthetics, Local|anesthetics, local|mesh-ancestor
24911829|NCT04284007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24911830|NCT04284007|Sensory System Agents|sensory system agents|mesh-ancestor
24911864|NCT04283435|Estrogens|estrogens|mesh-ancestor
24911865|NCT04283435|Hormones|hormones|mesh-ancestor
24911866|NCT04283435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24911867|NCT04283435|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24911868|NCT04283435|Contraceptive Agents|contraceptive agents|mesh-ancestor
24911869|NCT04283435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24911870|NCT04283435|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24911871|NCT04283435|Vasodilator Agents|vasodilator agents|mesh-ancestor
24911880|NCT04283292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24911881|NCT04283292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911883|NCT04283526|Spartalizumab|spartalizumab|mesh-list
24911884|NCT04283526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25670749|NCT03924791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25670750|NCT03924791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670751|NCT03924791|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25670752|NCT03924791|Protective Agents|protective agents|mesh-ancestor
25670753|NCT03914443|Cisplatin|cisplatin|mesh-list
25670754|NCT03914443|Docetaxel|docetaxel|mesh-list
25670755|NCT03914443|Fluorouracil|fluorouracil|mesh-list
25670756|NCT03914443|Nivolumab|nivolumab|mesh-list
24911895|NCT04283240|Sildenafil Citrate|sildenafil citrate|mesh-list
24911896|NCT04283240|Vasodilator Agents|vasodilator agents|mesh-ancestor
24911897|NCT04283240|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24911898|NCT04283240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24911899|NCT04283240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24911900|NCT04283240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911901|NCT04283240|Urological Agents|urological agents|mesh-ancestor
24911902|NCT04282902|Pirfenidone|pirfenidone|mesh-list
24911903|NCT04282902|Analgesics|analgesics|mesh-ancestor
24911904|NCT04282902|Sensory System Agents|sensory system agents|mesh-ancestor
24911923|NCT04282824|Sequestering Agents|sequestering agents|mesh-ancestor
24911924|NCT04282824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911932|NCT04283058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24911933|NCT04283058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911934|NCT04283058|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24911935|NCT04283058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24911936|NCT04283058|Anesthetics, General|anesthetics, general|mesh-ancestor
24911937|NCT04283058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24911938|NCT04283058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24911939|NCT04283058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24911940|NCT04283058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24911941|NCT04283058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911943|NCT04282941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24912002|NCT04282200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24912003|NCT04282200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24912004|NCT04282200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912006|NCT04282096|Chelating Agents|chelating agents|mesh-ancestor
24912007|NCT04282096|Sequestering Agents|sequestering agents|mesh-ancestor
24912064|NCT04281628|Anesthetics, General|anesthetics, general|mesh-ancestor
24912065|NCT04281628|Anesthetics|anesthetics|mesh-ancestor
24735087|NCT01655628|Cisplatin|cisplatin|mesh-list
24912066|NCT04281628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24912067|NCT04281628|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24912068|NCT04281628|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24912069|NCT04281628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24912070|NCT04281628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912071|NCT04281667|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24912072|NCT04281667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25064718|NCT03457597|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25064719|NCT03457597|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25064720|NCT03457597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25064721|NCT03457597|Adrenergic Agents|adrenergic agents|mesh-ancestor
25064723|NCT03457467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25064724|NCT03457467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25064725|NCT03457467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25064726|NCT03457467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912073|NCT04281680|Octreotide|octreotide|mesh-list
24912074|NCT04281680|Pasireotide|pasireotide|mesh-list
24912075|NCT04281680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24912076|NCT04281680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24912077|NCT04281680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912078|NCT04281680|Hormones|hormones|mesh-ancestor
24912079|NCT04281680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24912080|NCT04281680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065242|NCT03451695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25670757|NCT03914443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670758|NCT03914443|Tubulin Modulators|tubulin modulators|mesh-ancestor
25670759|NCT03914443|Antimitotic Agents|antimitotic agents|mesh-ancestor
25670760|NCT03914443|Mitosis Modulators|mitosis modulators|mesh-ancestor
25670761|NCT03914443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670762|NCT03914443|Antimetabolites|antimetabolites|mesh-ancestor
25065243|NCT03451695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867830|NCT00110006|Tubulin Modulators|tubulin modulators|mesh-ancestor
25065244|NCT03451695|Analgesics|analgesics|mesh-ancestor
25065245|NCT03451695|Sensory System Agents|sensory system agents|mesh-ancestor
25065246|NCT03451695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24912212|NCT04278833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25065248|NCT03451682|Antioxidants|antioxidants|mesh-ancestor
25065249|NCT03451682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065250|NCT03451682|Protective Agents|protective agents|mesh-ancestor
25065251|NCT03451682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912213|NCT04278833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912214|NCT04278833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24912215|NCT04278833|Respiratory System Agents|respiratory system agents|mesh-ancestor
24912216|NCT04278599|Zinc|zinc|mesh-list
24912217|NCT04278599|Trace Elements|trace elements|mesh-ancestor
24912218|NCT04278599|Micronutrients|micronutrients|mesh-ancestor
24912219|NCT04278599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912220|NCT04278937|Azithromycin|azithromycin|mesh-list
24912221|NCT04278937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24912222|NCT04278937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24912223|NCT04278378|Folic Acid|folic acid|mesh-list
24912224|NCT04278378|Riboflavin|riboflavin|mesh-list
24912225|NCT04278378|Hematinics|hematinics|mesh-ancestor
24912226|NCT04278378|Vitamin B Complex|vitamin b complex|mesh-ancestor
24912227|NCT04278378|Vitamins|vitamins|mesh-ancestor
24912228|NCT04278378|Micronutrients|micronutrients|mesh-ancestor
24819173|NCT02093910|Antiemetics|antiemetics|mesh-ancestor
24912253|NCT04278040|Melphalan|melphalan|mesh-list
24912254|NCT04278040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24912301|NCT04277533|Protective Agents|protective agents|mesh-ancestor
24912303|NCT04277143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24910036|NCT04302532|Fertility Agents|fertility agents|mesh-ancestor
24912304|NCT04277143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24912305|NCT04276883|Dexmedetomidine|dexmedetomidine|mesh-list
24912306|NCT04276883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24912307|NCT04276883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24912308|NCT04276883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912309|NCT04276883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24912310|NCT04276883|Analgesics|analgesics|mesh-ancestor
24912311|NCT04276883|Sensory System Agents|sensory system agents|mesh-ancestor
24912312|NCT04276883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24912313|NCT04276883|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24912319|NCT04276688|Interferons|interferons|mesh-list
24664358|NCT01306318|Autonomic Agents|autonomic agents|mesh-ancestor
24912341|NCT04276649|Calcium Carbonate|calcium carbonate|mesh-list
24912342|NCT04276649|Antacids|antacids|mesh-ancestor
24912343|NCT04276649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912391|NCT04276545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910080|NCT04302350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910081|NCT04302350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24910082|NCT04302350|Analgesics|analgesics|mesh-ancestor
24910083|NCT04302350|Sensory System Agents|sensory system agents|mesh-ancestor
25220706|NCT02654730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24910084|NCT04302350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24910085|NCT04302116|Prednisolone|prednisolone|mesh-list
24910086|NCT04302116|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24912392|NCT04276090|Dexamethasone|dexamethasone|mesh-list
24912393|NCT04276090|Floxuridine|floxuridine|mesh-list
24912402|NCT04276090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24912403|NCT04276090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24912404|NCT04276090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912405|NCT04276090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24912406|NCT04276090|Antimetabolites|antimetabolites|mesh-ancestor
24912407|NCT04276090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912409|NCT04276025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24912410|NCT04276025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24912411|NCT04276025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889565|NCT04491773|Tadalafil|tadalafil|mesh-list
24912412|NCT04275960|Selitrectinib|selitrectinib|mesh-list
24912413|NCT04275960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24912414|NCT04275960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912415|NCT04275414|Bevacizumab|bevacizumab|mesh-list
24912416|NCT04275414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24912417|NCT04275414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912418|NCT04275414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24912419|NCT04275414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24519998|NCT04286529|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25867831|NCT00110006|Antimitotic Agents|antimitotic agents|mesh-ancestor
25867832|NCT00110006|Mitosis Modulators|mitosis modulators|mesh-ancestor
25670763|NCT03914443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25670764|NCT03914443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25670765|NCT03914443|Immunologic Factors|immunologic factors|mesh-ancestor
25670766|NCT03914443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519999|NCT04286529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24912450|NCT04275388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912451|NCT04275388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24912452|NCT04275388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24910113|NCT04301908|Antiviral Agents|antiviral agents|mesh-ancestor
24910114|NCT04301908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24910131|NCT04301882|Ribavirin|ribavirin|mesh-list
24912453|NCT04275388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24912454|NCT04275388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24912455|NCT04275388|Immunologic Factors|immunologic factors|mesh-ancestor
24912456|NCT04275388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486967|NCT00460759|Moxifloxacin|moxifloxacin|mesh-list
24520003|NCT04286529|Micronutrients|micronutrients|mesh-ancestor
24520004|NCT04286529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24520005|NCT04235062|Furosemide|furosemide|mesh-list
24520006|NCT04235062|Calcium|calcium|mesh-list
24520007|NCT04235062|Diuretics|diuretics|mesh-list
24520008|NCT04235062|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
24520009|NCT04235062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24520010|NCT04235062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520011|NCT04235062|Natriuretic Agents|natriuretic agents|mesh-ancestor
24520012|NCT04235062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24520013|NCT04235062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912460|NCT04275258|Analgesics, Opioid|analgesics, opioid|mesh-list
24912461|NCT04275258|Narcotics|narcotics|mesh-ancestor
24912462|NCT04275258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24664778|NCT01308632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912482|NCT04275115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24520031|NCT04029116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24520032|NCT04029116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520033|NCT04029116|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24520034|NCT04029116|Hormone Antagonists|hormone antagonists|mesh-ancestor
24520035|NCT04029116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24520036|NCT04029116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520037|NCT04029116|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24912488|NCT04275115|GABA Modulators|gaba modulators|mesh-ancestor
24912489|NCT04275115|GABA Agents|gaba agents|mesh-ancestor
24910142|NCT04301479|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24912490|NCT04275115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24912491|NCT04275115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912493|NCT04275180|Antithrombins|antithrombins|mesh-ancestor
24912494|NCT04275180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24912495|NCT04275180|Protease Inhibitors|protease inhibitors|mesh-ancestor
24912496|NCT04275180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24912497|NCT04275180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912498|NCT04275180|Anticoagulants|anticoagulants|mesh-ancestor
24912499|NCT04275180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24912500|NCT04274933|Capecitabine|capecitabine|mesh-list
24912501|NCT04274933|Venetoclax|venetoclax|mesh-list
24912517|NCT04274907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201882|NCT02725112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24912535|NCT04274803|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24557060|NCT00751153|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24912536|NCT04274803|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24912538|NCT04274270|Endostar protein|endostar protein|mesh-list
24912539|NCT04274270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24912540|NCT04274270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24912541|NCT04274270|Growth Substances|growth substances|mesh-ancestor
24487055|NCT00461344|Mitosis Modulators|mitosis modulators|mesh-ancestor
24487056|NCT00461344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487057|NCT00461344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24487060|NCT00461344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24910184|NCT04301739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24910185|NCT04301739|Immunologic Factors|immunologic factors|mesh-ancestor
25670767|NCT03914443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25670768|NCT03914443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24996732|NCT02470585|Paclitaxel|paclitaxel|mesh-list
25867833|NCT00110006|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25867834|NCT00110032|Etanidazole|etanidazole|mesh-list
24544717|NCT00689845|Antiviral Agents|antiviral agents|mesh-ancestor
24910186|NCT04301739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910187|NCT04301739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24910196|NCT04301583|Procyanidin|procyanidin|mesh-list
24520038|NCT04029116|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24520039|NCT04020185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24520040|NCT04020185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912551|NCT04274413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912577|NCT04273997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24912578|NCT04273997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24912580|NCT04273997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24912581|NCT04273984|Misoprostol|misoprostol|mesh-list
24912582|NCT04273984|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24912583|NCT04273984|Abortifacient Agents|abortifacient agents|mesh-ancestor
24912584|NCT04273984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24912585|NCT04273984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912586|NCT04273984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24912587|NCT04273984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24912588|NCT04273984|Oxytocics|oxytocics|mesh-ancestor
24912601|NCT04273763|Interferons|interferons|mesh-list
24912638|NCT04273529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912639|NCT04273321|Methylprednisolone|methylprednisolone|mesh-list
24912643|NCT04273321|Prednisolone acetate|prednisolone acetate|mesh-list
24912644|NCT04273321|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24912645|NCT04273321|Prednisolone phosphate|prednisolone phosphate|mesh-list
24912646|NCT04273321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25064751|NCT03457233|Hormone Antagonists|hormone antagonists|mesh-ancestor
25064752|NCT03457194|Vaccines|vaccines|mesh-list
24910213|NCT04301726|Tetrabenazine|tetrabenazine|mesh-list
24910214|NCT04301726|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24910215|NCT04301726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24910216|NCT04301726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24910217|NCT04301726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910218|NCT04301726|Adrenergic Agents|adrenergic agents|mesh-ancestor
24910219|NCT04301726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24910221|NCT04301349|Misoprostol|misoprostol|mesh-list
24912647|NCT04273321|Antiemetics|antiemetics|mesh-ancestor
24912648|NCT04273321|Autonomic Agents|autonomic agents|mesh-ancestor
24912649|NCT04273321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24487164|NCT00461825|Antifungal Agents|antifungal agents|mesh-ancestor
24487165|NCT00461825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24487166|NCT00461825|Dermatologic Agents|dermatologic agents|mesh-ancestor
24487167|NCT00461825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24487168|NCT00461825|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24487169|NCT00461825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24912650|NCT04273321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912651|NCT04273321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24912652|NCT04273321|Glucocorticoids|glucocorticoids|mesh-ancestor
24912653|NCT04273321|Hormones|hormones|mesh-ancestor
24912654|NCT04273321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24912655|NCT04273321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24912656|NCT04273321|Protective Agents|protective agents|mesh-ancestor
24912657|NCT04273321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24912658|NCT04273321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912659|NCT04273282|Moxifloxacin|moxifloxacin|mesh-list
24912660|NCT04273282|Dexamethasone|dexamethasone|mesh-list
24912661|NCT04273282|Prednisolone|prednisolone|mesh-list
24912662|NCT04273282|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24912729|NCT04272567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24912730|NCT04272567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912731|NCT04272567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912732|NCT04272567|Sympathomimetics|sympathomimetics|mesh-ancestor
24912733|NCT04272567|Autonomic Agents|autonomic agents|mesh-ancestor
24912734|NCT04272567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24912735|NCT04272567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24912737|NCT04272476|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24519742|NCT05242874|Serotonin Agents|serotonin agents|mesh-ancestor
24519747|NCT05232344|Progesterone|progesterone|mesh-list
25670769|NCT03899103|Mycophenolic Acid|mycophenolic acid|mesh-list
25670770|NCT03899103|Rituximab|rituximab|mesh-list
25670771|NCT03899103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24519748|NCT05232344|Estrogens|estrogens|mesh-ancestor
24519749|NCT05232344|Hormones|hormones|mesh-ancestor
25432909|NCT00637624|Antiviral Agents|antiviral agents|mesh-ancestor
24519750|NCT05232344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24519751|NCT05232344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519752|NCT05232344|Progestins|progestins|mesh-ancestor
24519753|NCT05195034|Dexmedetomidine|dexmedetomidine|mesh-list
24912738|NCT04272476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25201883|NCT02725112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24912739|NCT04272476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24912740|NCT04272476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912741|NCT04272476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24912742|NCT04272476|Serotonin Agents|serotonin agents|mesh-ancestor
24665523|NCT01313143|Adrenergic Agents|adrenergic agents|mesh-ancestor
24912776|NCT04272255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912778|NCT04272255|Parasympatholytics|parasympatholytics|mesh-ancestor
24912779|NCT04272086|Bupivacaine|bupivacaine|mesh-list
24912780|NCT04272086|Anesthetics, Local|anesthetics, local|mesh-ancestor
24912781|NCT04272086|Anesthetics|anesthetics|mesh-ancestor
24912782|NCT04272086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24912783|NCT04272086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912784|NCT04272086|Sensory System Agents|sensory system agents|mesh-ancestor
24912790|NCT04272320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912791|NCT04272320|Sensory System Agents|sensory system agents|mesh-ancestor
24912792|NCT04272320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24912793|NCT04271839|Fluticasone|fluticasone|mesh-list
24912794|NCT04271839|Formoterol Fumarate|formoterol fumarate|mesh-list
24912795|NCT04271839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24912796|NCT04271839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24910291|NCT04301375|Mitosis Modulators|mitosis modulators|mesh-ancestor
24910292|NCT04301375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910293|NCT04301375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24910295|NCT04300686|Antibodies|antibodies|mesh-list
24910296|NCT04300686|Immunoglobulins|immunoglobulins|mesh-list
24910297|NCT04300686|Immunologic Factors|immunologic factors|mesh-ancestor
24910298|NCT04300686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912829|NCT04271007|Mometasone Furoate|mometasone furoate|mesh-list
24912830|NCT04271007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24912877|NCT04270708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24912880|NCT04270708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24912881|NCT04270708|Adrenergic Agents|adrenergic agents|mesh-ancestor
24912882|NCT04270708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24912883|NCT04270708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912884|NCT04270552|Broncho-Vaxom|broncho-vaxom|mesh-list
25053597|NCT00004914|Hematinics|hematinics|mesh-ancestor
24819189|NCT02094053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819190|NCT02094053|Cholinergic Agents|cholinergic agents|mesh-ancestor
24819191|NCT02094053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24819192|NCT02094053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819193|NCT02094053|Nootropic Agents|nootropic agents|mesh-ancestor
24819194|NCT02094066|Tranexamic Acid|tranexamic acid|mesh-list
24819195|NCT02094066|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24487422|NCT00463008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24487423|NCT00463008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25867835|NCT00110032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867836|NCT00110045|Caspofungin|caspofungin|mesh-list
25867837|NCT00110045|Antifungal Agents|antifungal agents|mesh-ancestor
25867838|NCT00110045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25867839|NCT00110045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867840|NCT00110045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867841|NCT00110058|Interferons|interferons|mesh-list
25867842|NCT00110058|Interferon-alpha|interferon-alpha|mesh-list
24819207|NCT02094157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24819208|NCT02094157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24819209|NCT02094157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819210|NCT02094196|Ethanol|ethanol|mesh-list
24819211|NCT02094196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24819212|NCT02094196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24819213|NCT02094196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24910303|NCT04300881|Hormone Antagonists|hormone antagonists|mesh-ancestor
25064766|NCT03456947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25064767|NCT03456947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24819214|NCT02094196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819215|NCT02094222|Glycerol|glycerol|mesh-list
24819216|NCT02094222|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24819217|NCT02094222|Protective Agents|protective agents|mesh-ancestor
24665897|NCT01315795|Lanreotide|lanreotide|mesh-list
24913011|NCT04269187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24913374|NCT04265456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24667372|NCT05455697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25065296|NCT03451487|Antipyretics|antipyretics|mesh-ancestor
24913383|NCT04265612|Laxatives|laxatives|mesh-ancestor
24913385|NCT04265508|Hemostatics|hemostatics|mesh-list
24913386|NCT04265508|Coagulants|coagulants|mesh-ancestor
24913409|NCT04264988|Cariostatic Agents|cariostatic agents|mesh-ancestor
24913423|NCT04264481|Lidocaine|lidocaine|mesh-list
24913424|NCT04264481|Anesthetics, Local|anesthetics, local|mesh-ancestor
24913425|NCT04264481|Anesthetics|anesthetics|mesh-ancestor
24913426|NCT04264481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24913427|NCT04264481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913428|NCT04264481|Sensory System Agents|sensory system agents|mesh-ancestor
25064768|NCT03456947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24910362|NCT04299633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910363|NCT04299633|Chelating Agents|chelating agents|mesh-ancestor
24913429|NCT04264481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24913430|NCT04264481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24913431|NCT04264481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24913432|NCT04264481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24913433|NCT04264481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24913434|NCT04264481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913435|NCT04264624|Erythritol|erythritol|mesh-list
24913436|NCT04264624|Vasodilator Agents|vasodilator agents|mesh-ancestor
24913437|NCT04264078|Fludarabine|fludarabine|mesh-list
24913438|NCT04264078|Cyclophosphamide|cyclophosphamide|mesh-list
24913439|NCT04264078|Melphalan|melphalan|mesh-list
24913440|NCT04264078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913441|NCT04264078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913442|NCT04264078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24913443|NCT04264078|Immunologic Factors|immunologic factors|mesh-ancestor
24913444|NCT04264078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913445|NCT04264078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24913446|NCT04264078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24667692|NCT05323214|Fentanyl|fentanyl|mesh-list
24520107|NCT03897335|Protective Agents|protective agents|mesh-ancestor
24913530|NCT04263844|Anesthetics, General|anesthetics, general|mesh-ancestor
24913531|NCT04263844|Anesthetics|anesthetics|mesh-ancestor
24913532|NCT04263844|GABA Modulators|gaba modulators|mesh-ancestor
24913533|NCT04263844|GABA Agents|gaba agents|mesh-ancestor
24913534|NCT04263519|Tacrolimus|tacrolimus|mesh-list
24913535|NCT04263519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25867843|NCT00110058|Cyclosporine|cyclosporine|mesh-list
25867844|NCT00110058|Mycophenolic Acid|mycophenolic acid|mesh-list
25867845|NCT00110058|Fludarabine|fludarabine|mesh-list
25867846|NCT00110058|Fludarabine phosphate|fludarabine phosphate|mesh-list
25867847|NCT00110058|Imatinib Mesylate|imatinib mesylate|mesh-list
25867848|NCT00110058|Cyclosporins|cyclosporins|mesh-list
25867849|NCT00110058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520122|NCT03879577|Tamoxifen|tamoxifen|mesh-list
24520123|NCT03879577|Docetaxel|docetaxel|mesh-list
24913559|NCT04263402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24913560|NCT04263402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913583|NCT04262999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24913584|NCT04262999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24913585|NCT04262999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24913596|NCT04262635|Antimetabolites|antimetabolites|mesh-ancestor
24913597|NCT04262635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913598|NCT04262635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913599|NCT04262635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24913638|NCT04262765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25409519|NCT03373851|Sensory System Agents|sensory system agents|mesh-ancestor
25867850|NCT00110058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24913639|NCT04262765|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24913640|NCT04262765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24913641|NCT04262765|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24913642|NCT04262765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24913643|NCT04262765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24913644|NCT04262765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24913645|NCT04262765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913646|NCT04262765|Vasodilator Agents|vasodilator agents|mesh-ancestor
25065329|NCT03451318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25065330|NCT03451318|Dermatologic Agents|dermatologic agents|mesh-ancestor
25065331|NCT03451318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24913647|NCT04262765|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24913648|NCT04262765|Protease Inhibitors|protease inhibitors|mesh-ancestor
24913649|NCT04262804|Gemcitabine|gemcitabine|mesh-list
24913650|NCT04262804|Capecitabine|capecitabine|mesh-list
24913651|NCT04262804|Trastuzumab|trastuzumab|mesh-list
24913652|NCT04262804|Vinorelbine|vinorelbine|mesh-list
24913653|NCT04262804|Margetuximab|margetuximab|mesh-list
24913654|NCT04262804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24913655|NCT04262804|Antimetabolites|antimetabolites|mesh-ancestor
24913656|NCT04262804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913657|NCT04262804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913658|NCT04262804|Antiviral Agents|antiviral agents|mesh-ancestor
24913659|NCT04262804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24913660|NCT04262804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24913700|NCT04261907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24913701|NCT04261907|Protease Inhibitors|protease inhibitors|mesh-ancestor
24488245|NCT00467246|Insulin Detemir|insulin detemir|mesh-list
24913702|NCT04261907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24913703|NCT04261907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913704|NCT04261907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24913705|NCT04261907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24913706|NCT04261907|Antiviral Agents|antiviral agents|mesh-ancestor
24913707|NCT04261907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24819339|NCT02094807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24819340|NCT02094807|Analgesics|analgesics|mesh-ancestor
24819341|NCT02094807|Sensory System Agents|sensory system agents|mesh-ancestor
24819342|NCT02094807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24913775|NCT04260828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24913776|NCT04260828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24913778|NCT04260828|Sensory System Agents|sensory system agents|mesh-ancestor
25867851|NCT00110058|Antimetabolites|antimetabolites|mesh-ancestor
24615780|NCT01031875|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24819391|NCT02095132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24819392|NCT02095132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819393|NCT02095132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819394|NCT02095132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24819395|NCT02095132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24520332|NCT02794883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24520333|NCT02794883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520334|NCT02794883|Immunologic Factors|immunologic factors|mesh-ancestor
24827202|NCT02137759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24827203|NCT02137759|Alkylating Agents|alkylating agents|mesh-ancestor
24827205|NCT02137759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910441|NCT04297839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25064807|NCT03456661|Dexmedetomidine|dexmedetomidine|mesh-list
24949394|NCT04814940|Menotropins|menotropins|mesh-list
24520335|NCT02794883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520338|NCT02771249|Pyridoxine|pyridoxine|mesh-list
24819404|NCT02095366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24819405|NCT02095366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819406|NCT02095366|Analgesics|analgesics|mesh-ancestor
25065341|NCT03451227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25065342|NCT03451227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25065343|NCT03451227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819407|NCT02095366|Sensory System Agents|sensory system agents|mesh-ancestor
24819408|NCT02095366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24819409|NCT02095366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24913960|NCT04259073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24913961|NCT04259073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24913962|NCT04259073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24913963|NCT04259073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24913964|NCT04259073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24913966|NCT04258956|Axitinib|axitinib|mesh-list
24913967|NCT04258956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24913968|NCT04258956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914135|NCT04257851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914136|NCT04257851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914137|NCT04257851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24914139|NCT04257851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24914140|NCT04257851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24914141|NCT04257851|Respiratory System Agents|respiratory system agents|mesh-ancestor
25065348|NCT03451227|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25065349|NCT03451227|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25065350|NCT03451227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25065351|NCT03451227|Adrenergic Agents|adrenergic agents|mesh-ancestor
24914142|NCT04257851|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24914143|NCT04257851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24914144|NCT04257851|Vasodilator Agents|vasodilator agents|mesh-ancestor
24914145|NCT04257851|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24914146|NCT04257851|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24914147|NCT04257851|Purinergic Agents|purinergic agents|mesh-ancestor
24914149|NCT04257812|Ceftolozane|ceftolozane|mesh-list
24914150|NCT04257812|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
24914151|NCT04257812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24914152|NCT04257812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24914153|NCT04257812|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24914154|NCT04257812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734491|NCT01652378|Antiemetics|antiemetics|mesh-ancestor
24914156|NCT04257812|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24910469|NCT04297462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914157|NCT04257812|Renal Agents|renal agents|mesh-ancestor
24914215|NCT04257032|Antimetabolites|antimetabolites|mesh-ancestor
24914216|NCT04257032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914217|NCT04257032|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24914218|NCT04257032|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24914219|NCT04257032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24914220|NCT04257032|Antithrombins|antithrombins|mesh-ancestor
25867852|NCT00110058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914409|NCT04255017|Oseltamivir|oseltamivir|mesh-list
24914410|NCT04255017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24914411|NCT04255017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24914412|NCT04255017|Protease Inhibitors|protease inhibitors|mesh-ancestor
24914413|NCT04255017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24914414|NCT04255017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914425|NCT04255121|Epinephrine|epinephrine|mesh-list
24914426|NCT04255121|Racepinephrine|racepinephrine|mesh-list
24914427|NCT04255121|Epinephryl borate|epinephryl borate|mesh-list
24914428|NCT04255121|Anesthetics, Local|anesthetics, local|mesh-ancestor
24914429|NCT04255121|Anesthetics|anesthetics|mesh-ancestor
24914430|NCT04255121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24914431|NCT04255121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914432|NCT04255121|Sensory System Agents|sensory system agents|mesh-ancestor
24914433|NCT04255121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24914434|NCT04255121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24533700|NCT00644800|Dopamine Agents|dopamine agents|mesh-ancestor
24914662|NCT04253353|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24914663|NCT04253353|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24914664|NCT04253353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24914665|NCT04253353|Antimetabolites|antimetabolites|mesh-ancestor
24914734|NCT04252443|Sensory System Agents|sensory system agents|mesh-ancestor
25867853|NCT00110058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24829729|NCT02154217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829730|NCT02154217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829731|NCT02154217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24829732|NCT02154217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24827222|NCT02137928|Carboplatin|carboplatin|mesh-list
24829733|NCT02154217|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24829734|NCT02154217|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24829735|NCT02154230|Calcium|calcium|mesh-list
24829736|NCT02154230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24829737|NCT02154230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829738|NCT02154269|Lenograstim|lenograstim|mesh-list
24829739|NCT02154269|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24829740|NCT02154269|Immunologic Factors|immunologic factors|mesh-ancestor
24829741|NCT02154269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829742|NCT02154334|Mometasone Furoate|mometasone furoate|mesh-list
24829743|NCT02154334|Phenylephrine|phenylephrine|mesh-list
24829744|NCT02154334|Oxymetazoline|oxymetazoline|mesh-list
24829745|NCT02154334|Esketamine|esketamine|mesh-list
25867854|NCT00110058|Immunologic Factors|immunologic factors|mesh-ancestor
24831391|NCT02165046|Autonomic Agents|autonomic agents|mesh-ancestor
24831400|NCT02165046|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24831401|NCT02165046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24831402|NCT02165046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24831403|NCT02165046|Adrenergic Agents|adrenergic agents|mesh-ancestor
24831404|NCT02165046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24831405|NCT02165046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831410|NCT02165098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558724|NCT05435560|Analgesics|analgesics|mesh-ancestor
24831411|NCT02165098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24831412|NCT02165189|Ribavirin|ribavirin|mesh-list
24831413|NCT02165189|Sofosbuvir|sofosbuvir|mesh-list
24831487|NCT02165917|Viscosupplements|viscosupplements|mesh-ancestor
24831526|NCT02166554|Protective Agents|protective agents|mesh-ancestor
24831527|NCT02166593|Atorvastatin|atorvastatin|mesh-list
24831528|NCT02166593|Pravastatin|pravastatin|mesh-list
24831529|NCT02166593|Fenofibrate|fenofibrate|mesh-list
24831530|NCT02166593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24831531|NCT02166593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24831532|NCT02166593|Antimetabolites|antimetabolites|mesh-ancestor
24831559|NCT02166853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24831560|NCT02166853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24831561|NCT02166853|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24831562|NCT02166853|Anesthetics, General|anesthetics, general|mesh-ancestor
24831563|NCT02166853|Anesthetics|anesthetics|mesh-ancestor
24831564|NCT02166853|GABA Modulators|gaba modulators|mesh-ancestor
24831565|NCT02166853|GABA Agents|gaba agents|mesh-ancestor
24831566|NCT02166853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24831572|NCT02166905|Poly ICLC|poly iclc|mesh-list
24831573|NCT02166905|Interferon Inducers|interferon inducers|mesh-ancestor
24831574|NCT02166905|Immunologic Factors|immunologic factors|mesh-ancestor
24831575|NCT02166905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831576|NCT02166905|Laxatives|laxatives|mesh-ancestor
24832102|NCT02170675|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832166|NCT02170805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832168|NCT02170805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832245|NCT02170987|Dabigatran|dabigatran|mesh-list
24832259|NCT02171000|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832260|NCT02171000|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832261|NCT02171000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832262|NCT02171000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832263|NCT02171000|Anticoagulants|anticoagulants|mesh-ancestor
24832264|NCT02171013|Dabigatran|dabigatran|mesh-list
24832265|NCT02171013|Antithrombins|antithrombins|mesh-ancestor
24735718|NCT01658202|Nicotine|nicotine|mesh-list
24833439|NCT02173912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833467|NCT02173990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24833468|NCT02174068|Acetaminophen|acetaminophen|mesh-list
24833469|NCT02174068|Nefopam|nefopam|mesh-list
24833479|NCT02174094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24833480|NCT02174094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24833481|NCT02174094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833482|NCT02174094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24833483|NCT02174094|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24833484|NCT02174094|GABA Agonists|gaba agonists|mesh-ancestor
24833485|NCT02174094|GABA Agents|gaba agents|mesh-ancestor
24833486|NCT02174094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24833487|NCT02174094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833488|NCT02174120|Propofol|propofol|mesh-list
24833523|NCT02174211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24833524|NCT02174250|Rifampin|rifampin|mesh-list
24833525|NCT02174250|Istradefylline|istradefylline|mesh-list
24833526|NCT02174250|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24833527|NCT02174250|Antitubercular Agents|antitubercular agents|mesh-ancestor
24833528|NCT02174250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24833529|NCT02174250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24833530|NCT02174250|Leprostatic Agents|leprostatic agents|mesh-ancestor
24833531|NCT02174250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24833566|NCT02174445|Imatinib Mesylate|imatinib mesylate|mesh-list
24833567|NCT02174445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24833671|NCT02174939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867855|NCT00110058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867856|NCT00110058|Antiviral Agents|antiviral agents|mesh-ancestor
25867857|NCT00110058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25867858|NCT00110058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867859|NCT00110058|Antifungal Agents|antifungal agents|mesh-ancestor
24844350|NCT02232399|Simendan|simendan|mesh-list
25867860|NCT00110058|Dermatologic Agents|dermatologic agents|mesh-ancestor
25867861|NCT00110058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24833786|NCT02175602|Sertraline|sertraline|mesh-list
24833787|NCT02175602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24833788|NCT02175602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24833796|NCT02175602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24833797|NCT02175680|Leronlimab|leronlimab|mesh-list
24833798|NCT02175680|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24833799|NCT02175680|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24833800|NCT02175680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833801|NCT02175680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24833802|NCT02175680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24833803|NCT02175680|Antiviral Agents|antiviral agents|mesh-ancestor
24833883|NCT02176122|Tazobactam|tazobactam|mesh-list
25867862|NCT00110058|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24833884|NCT02176122|Piperacillin|piperacillin|mesh-list
24833885|NCT02176122|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24833886|NCT02176122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24872611|NCT05306899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833941|NCT02176213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833942|NCT02176213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24743637|NCT04704518|Protective Agents|protective agents|mesh-ancestor
24834042|NCT02176720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834043|NCT02176733|Cyclosporine|cyclosporine|mesh-list
24834044|NCT02176733|Cyclosporins|cyclosporins|mesh-list
24834045|NCT02176733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24834153|NCT02177344|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24834154|NCT02177344|Cholinergic Agents|cholinergic agents|mesh-ancestor
24834155|NCT02177344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24834156|NCT02177344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834192|NCT02177409|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24834225|NCT02177448|Telmisartan|telmisartan|mesh-list
24834226|NCT02177448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24834227|NCT02177448|Protease Inhibitors|protease inhibitors|mesh-ancestor
24834228|NCT02177448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867863|NCT00110058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25867864|NCT00110058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25867865|NCT00110058|Antitubercular Agents|antitubercular agents|mesh-ancestor
25867866|NCT00110058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25867867|NCT00110058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25867868|NCT00110071|Iodine|iodine|mesh-list
25867869|NCT00110071|Cadexomer iodine|cadexomer iodine|mesh-list
25867870|NCT00110071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24953344|NCT03885947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867871|NCT00110071|Fludarabine|fludarabine|mesh-list
25867872|NCT00110071|Fludarabine phosphate|fludarabine phosphate|mesh-list
24872685|NCT05271331|Sensory System Agents|sensory system agents|mesh-ancestor
24872686|NCT05271331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834831|NCT02181309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24834832|NCT02181309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24834833|NCT02181309|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24834834|NCT02181309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24835274|NCT02182544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835275|NCT02182544|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25867873|NCT00110071|Tositumomab I-131|tositumomab i-131|mesh-list
25867874|NCT00110071|Antibodies|antibodies|mesh-list
24835278|NCT02182557|Antipruritics|antipruritics|mesh-ancestor
24835279|NCT02182557|Dermatologic Agents|dermatologic agents|mesh-ancestor
24835280|NCT02182557|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24835281|NCT02182557|Histamine Antagonists|histamine antagonists|mesh-ancestor
24835282|NCT02182557|Histamine Agents|histamine agents|mesh-ancestor
24835499|NCT02183025|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24745739|NCT03606980|Antiemetics|antiemetics|mesh-ancestor
24835580|NCT02183103|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24745878|NCT03533712|Folic Acid|folic acid|mesh-list
24835634|NCT02183155|Gout Suppressants|gout suppressants|mesh-ancestor
24835635|NCT02183155|Tocolytic Agents|tocolytic agents|mesh-ancestor
24835669|NCT02183181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835670|NCT02183181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835671|NCT02183194|Paclitaxel|paclitaxel|mesh-list
24836537|NCT02186145|Antifungal Agents|antifungal agents|mesh-ancestor
24836538|NCT02186145|Ionophores|ionophores|mesh-ancestor
25670772|NCT03899103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867875|NCT00110071|Immunoglobulins|immunoglobulins|mesh-list
25867876|NCT00110071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25867877|NCT00110071|Immunologic Factors|immunologic factors|mesh-ancestor
24786217|NCT01918527|Antimetabolites|antimetabolites|mesh-ancestor
25867878|NCT00110071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786218|NCT01918527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786219|NCT01918527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24786224|NCT01918631|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24786225|NCT01918631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24786226|NCT01918631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24786227|NCT01918631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786228|NCT01918631|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24786229|NCT01918631|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24786230|NCT01918709|Valsartan|valsartan|mesh-list
25108246|NCT03133234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108247|NCT03133234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25108248|NCT03133234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25108249|NCT03133234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867879|NCT00110071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867880|NCT00110071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25867881|NCT00110071|Antimetabolites|antimetabolites|mesh-ancestor
25867882|NCT00110071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867883|NCT00110071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25867884|NCT00110071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25867885|NCT00110071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24836550|NCT02186249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24836551|NCT02186249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24836552|NCT02186249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24836553|NCT02186249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867886|NCT00110071|Trace Elements|trace elements|mesh-ancestor
24837333|NCT02191007|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24837334|NCT02191007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24750386|NCT01698164|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24837369|NCT02191124|Histamine Antagonists|histamine antagonists|mesh-ancestor
24837370|NCT02191124|Histamine Agents|histamine agents|mesh-ancestor
24837371|NCT02191124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24837372|NCT02191124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24837373|NCT02191124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24837439|NCT02191293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24837440|NCT02191293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24837441|NCT02191293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24837442|NCT02191293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24837443|NCT02191319|Nevirapine|nevirapine|mesh-list
24837444|NCT02191319|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24837445|NCT02191319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24837446|NCT02191319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750495|NCT01698788|Glucocorticoids|glucocorticoids|mesh-ancestor
24837505|NCT02191670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24837506|NCT02191670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24837507|NCT02191670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837509|NCT02191709|Antitussive Agents|antitussive agents|mesh-ancestor
24837510|NCT02191709|Respiratory System Agents|respiratory system agents|mesh-ancestor
25064810|NCT03456661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25064811|NCT03456661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064813|NCT03456661|Analgesics|analgesics|mesh-ancestor
25064814|NCT03456661|Sensory System Agents|sensory system agents|mesh-ancestor
25867887|NCT00110071|Micronutrients|micronutrients|mesh-ancestor
25867888|NCT00110123|Fotemustine|fotemustine|mesh-list
25867889|NCT00110123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867890|NCT00110162|Hormones|hormones|mesh-list
25867891|NCT00110162|Androgen Antagonists|androgen antagonists|mesh-list
25867892|NCT00110162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24837512|NCT02191709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24837513|NCT02191709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24837514|NCT02191709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837515|NCT02191709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837516|NCT02191748|Triamcinolone|triamcinolone|mesh-list
25867893|NCT00110162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867894|NCT00110162|Hormone Antagonists|hormone antagonists|mesh-ancestor
25867895|NCT00110188|Sirolimus|sirolimus|mesh-list
25867896|NCT00110188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25867897|NCT00110188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25867898|NCT00110188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24837774|NCT02193269|Tetracycline|tetracycline|mesh-list
24837775|NCT02193269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24844372|NCT02232542|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24844373|NCT02232542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24837776|NCT02193269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24837777|NCT02193269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837778|NCT02193269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837845|NCT02194049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837846|NCT02194075|Fluvoxamine|fluvoxamine|mesh-list
24837877|NCT02194166|Tubulin Modulators|tubulin modulators|mesh-ancestor
24837878|NCT02194166|Antimitotic Agents|antimitotic agents|mesh-ancestor
24837879|NCT02194166|Mitosis Modulators|mitosis modulators|mesh-ancestor
24837880|NCT02194166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837881|NCT02194166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24837882|NCT02194179|Nevirapine|nevirapine|mesh-list
24837883|NCT02194179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24837884|NCT02194179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24837885|NCT02194179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837886|NCT02194179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837956|NCT02194374|Cyclophosphamide|cyclophosphamide|mesh-list
24837957|NCT02194374|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24837958|NCT02194374|Rituximab|rituximab|mesh-list
24837959|NCT02194374|Fludarabine|fludarabine|mesh-list
24838056|NCT02194920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24838057|NCT02194920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838058|NCT02195089|Vaccines|vaccines|mesh-list
24838059|NCT02195089|Immunologic Factors|immunologic factors|mesh-ancestor
25867899|NCT00110188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24838295|NCT02197000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24838296|NCT02197026|Hylan|hylan|mesh-list
24838297|NCT02197026|Viscosupplements|viscosupplements|mesh-ancestor
24838298|NCT02197026|Protective Agents|protective agents|mesh-ancestor
24827249|NCT02137993|Autonomic Agents|autonomic agents|mesh-ancestor
24827250|NCT02137993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24827251|NCT02137993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838299|NCT02197026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838340|NCT02197182|Copper|copper|mesh-list
24838341|NCT02197182|Metronidazole|metronidazole|mesh-list
24838342|NCT02197182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24838405|NCT02197676|Guadecitabine|guadecitabine|mesh-list
24838406|NCT02197676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24838407|NCT02197702|Vitamin D|vitamin d|mesh-list
24838409|NCT02197702|Vitamins|vitamins|mesh-ancestor
24838411|NCT02197702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838467|NCT02198170|Ketoconazole|ketoconazole|mesh-list
24838469|NCT02198170|Antifungal Agents|antifungal agents|mesh-ancestor
24838470|NCT02198170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24910542|NCT04296578|Trace Elements|trace elements|mesh-ancestor
24910543|NCT04296578|Micronutrients|micronutrients|mesh-ancestor
25064831|NCT03456648|Anticoagulants|anticoagulants|mesh-ancestor
25064832|NCT03456570|Dydrogesterone|dydrogesterone|mesh-list
25064833|NCT03456570|Progestins|progestins|mesh-ancestor
25064834|NCT03456570|Hormones|hormones|mesh-ancestor
25064835|NCT03456570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25064836|NCT03456570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064837|NCT03456544|Vancomycin|vancomycin|mesh-list
25064838|NCT03456544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24827260|NCT02137993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827261|NCT02137993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24827262|NCT02137993|Serotonin Agents|serotonin agents|mesh-ancestor
25867900|NCT00110188|Antifungal Agents|antifungal agents|mesh-ancestor
25867901|NCT00110188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25867902|NCT00110188|Immunologic Factors|immunologic factors|mesh-ancestor
25867903|NCT00110188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827263|NCT02138019|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24827264|NCT02138019|Hemostatics|hemostatics|mesh-ancestor
24827265|NCT02138019|Coagulants|coagulants|mesh-ancestor
24827266|NCT02138045|Liraglutide|liraglutide|mesh-list
25867904|NCT00110201|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25867905|NCT00110201|Natriuretic Agents|natriuretic agents|mesh-ancestor
24838471|NCT02198170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24838472|NCT02198170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24838473|NCT02198170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25432988|NCT00602459|Fludarabine phosphate|fludarabine phosphate|mesh-list
25670773|NCT03899103|Immunologic Factors|immunologic factors|mesh-ancestor
25670774|NCT03899103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670775|NCT03899103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25867906|NCT00110201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838474|NCT02198170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838490|NCT02198248|Glucocorticoids|glucocorticoids|mesh-list
24838491|NCT02198248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24786326|NCT01919203|Remifentanil|remifentanil|mesh-list
24838534|NCT02198417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24838565|NCT02198482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838566|NCT02198482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24838568|NCT02198482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24786277|NCT01918904|Antitubercular Agents|antitubercular agents|mesh-ancestor
24786278|NCT01918904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24786279|NCT01918904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24786280|NCT01918904|Chelating Agents|chelating agents|mesh-ancestor
24786281|NCT01918904|Sequestering Agents|sequestering agents|mesh-ancestor
24786282|NCT01918917|Dexmedetomidine|dexmedetomidine|mesh-list
24786284|NCT01918917|Levobupivacaine|levobupivacaine|mesh-list
24786285|NCT01918917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24786286|NCT01918917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25867908|NCT00110240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25867909|NCT00110240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867910|NCT00110240|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25867911|NCT00110240|Protease Inhibitors|protease inhibitors|mesh-ancestor
25867912|NCT00110240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867913|NCT00110240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786287|NCT01918917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786288|NCT01918917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24786289|NCT01918917|Analgesics|analgesics|mesh-ancestor
24786290|NCT01918917|Sensory System Agents|sensory system agents|mesh-ancestor
24786291|NCT01918917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24786292|NCT01918917|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24786293|NCT01918917|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24786294|NCT01918917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24786295|NCT01918917|Adrenergic Agents|adrenergic agents|mesh-ancestor
24786296|NCT01918917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24786297|NCT01918917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786298|NCT01918917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24786299|NCT01918917|Narcotics|narcotics|mesh-ancestor
24786300|NCT01918917|Anesthetics, Local|anesthetics, local|mesh-ancestor
25867914|NCT00110253|Lidocaine|lidocaine|mesh-list
24838573|NCT02198482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24838574|NCT02198482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25867915|NCT00110253|Tetracaine|tetracaine|mesh-list
25867916|NCT00110253|Anesthetics, Local|anesthetics, local|mesh-ancestor
25867917|NCT00110253|Anesthetics|anesthetics|mesh-ancestor
25867918|NCT00110253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24910572|NCT04296240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910573|NCT04296240|Autonomic Agents|autonomic agents|mesh-ancestor
25867919|NCT00110253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519829|NCT04907370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519830|NCT04907370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25867920|NCT00110253|Sensory System Agents|sensory system agents|mesh-ancestor
25867921|NCT00110253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25867922|NCT00110253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25867923|NCT00110253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25867924|NCT00110253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25867925|NCT00110253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24838875|NCT02200991|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24838876|NCT02200991|Lixisenatide|lixisenatide|mesh-list
24838877|NCT02200991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24597823|NCT00952029|Levoleucovorin|levoleucovorin|mesh-list
24838878|NCT02200991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838879|NCT02200991|Incretins|incretins|mesh-ancestor
24838880|NCT02200991|Hormones|hormones|mesh-ancestor
24786327|NCT01919203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24838881|NCT02200991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24838882|NCT02200991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25201906|NCT02724761|Epinephrine|epinephrine|mesh-list
25201907|NCT02724761|Racepinephrine|racepinephrine|mesh-list
25201908|NCT02724761|Epinephryl borate|epinephryl borate|mesh-list
25201909|NCT02724761|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25201910|NCT02724761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25201911|NCT02724761|Adrenergic Agents|adrenergic agents|mesh-ancestor
24839311|NCT02203396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24839348|NCT02203461|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24752181|NCT01708850|Rivaroxaban|rivaroxaban|mesh-list
24839380|NCT02203604|Antiviral Agents|antiviral agents|mesh-ancestor
24839381|NCT02203604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24839382|NCT02203643|Dexamethasone|dexamethasone|mesh-list
24839383|NCT02203643|Cyclophosphamide|cyclophosphamide|mesh-list
24839384|NCT02203643|Lenalidomide|lenalidomide|mesh-list
24839385|NCT02203643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24839386|NCT02203643|Immunologic Factors|immunologic factors|mesh-ancestor
24839387|NCT02203643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839388|NCT02203643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24598470|NCT00956202|Vaccines|vaccines|mesh-list
25268744|NCT02414776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24519831|NCT04907370|Antimetabolites|antimetabolites|mesh-ancestor
24839390|NCT02203643|Alkylating Agents|alkylating agents|mesh-ancestor
24839391|NCT02203643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839392|NCT02203643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24839393|NCT02203643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24839426|NCT02203760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24839427|NCT02203760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24839428|NCT02203760|Immunologic Factors|immunologic factors|mesh-ancestor
24839429|NCT02203760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839430|NCT02203799|Immunologic Factors|immunologic factors|mesh-list
24839431|NCT02203799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839432|NCT02204020|Azacitidine|azacitidine|mesh-list
24839433|NCT02204020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24839434|NCT02204020|Antimetabolites|antimetabolites|mesh-ancestor
24839550|NCT02205164|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24839551|NCT02205164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24839552|NCT02205164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839553|NCT02205164|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24839554|NCT02205164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24839590|NCT02205489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24839591|NCT02205489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839592|NCT02205489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24839593|NCT02205489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24839594|NCT02205489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24839595|NCT02205489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24839736|NCT02205931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24839737|NCT02205996|Insulin|insulin|mesh-list
24839738|NCT02205996|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25867926|NCT00110253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867927|NCT00110344|Sorafenib|sorafenib|mesh-list
24839739|NCT02205996|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24752514|NCT01710722|Ephedrine|ephedrine|mesh-list
25064860|NCT03456466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827271|NCT02138045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24827272|NCT02138058|Topiramate|topiramate|mesh-list
25064864|NCT03456401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24839771|NCT02206165|Candesartan|candesartan|mesh-list
24839772|NCT02206165|Candesartan cilexetil|candesartan cilexetil|mesh-list
24839773|NCT02206165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24839774|NCT02206165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24840203|NCT02208583|Prednisone|prednisone|mesh-list
24840204|NCT02208583|Cisplatin|cisplatin|mesh-list
24840205|NCT02208583|Docetaxel|docetaxel|mesh-list
24840206|NCT02208583|Etoposide|etoposide|mesh-list
24840207|NCT02208583|Etoposide phosphate|etoposide phosphate|mesh-list
24840208|NCT02208583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24840306|NCT02209155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786317|NCT01919047|Mirabegron|mirabegron|mesh-list
24786321|NCT01919047|Adrenergic Agents|adrenergic agents|mesh-ancestor
24786322|NCT01919047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24786323|NCT01919047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786324|NCT01919047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786325|NCT01919047|Urological Agents|urological agents|mesh-ancestor
25108363|NCT03132701|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25108364|NCT03132701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25108365|NCT03132701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108366|NCT03132701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25064865|NCT03456401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25064866|NCT03456401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25064867|NCT03456401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064868|NCT03456401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25867928|NCT00110344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867929|NCT00110344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25867930|NCT00110344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24844418|NCT02232607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24844419|NCT02232607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844420|NCT02232672|Choline|choline|mesh-list
24844421|NCT02232672|Lipotropic Agents|lipotropic agents|mesh-ancestor
24844422|NCT02232672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24844423|NCT02232672|Antimetabolites|antimetabolites|mesh-ancestor
25059753|NCT03485456|Tobramycin|tobramycin|mesh-list
25867931|NCT00110344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867932|NCT00110370|Insulin Glargine|insulin glargine|mesh-list
25867933|NCT00110370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25064869|NCT03456401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25064870|NCT03456401|Growth Substances|growth substances|mesh-ancestor
24827284|NCT02138084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24827285|NCT02138084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24827286|NCT02138084|Antiviral Agents|antiviral agents|mesh-ancestor
24827287|NCT02138084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24827288|NCT02138084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24715536|NCT01537055|Dexlansoprazole|dexlansoprazole|mesh-list
25108367|NCT03132701|Tocolytic Agents|tocolytic agents|mesh-ancestor
25108368|NCT03132701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24840413|NCT02210104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24840414|NCT02210104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24840568|NCT02211066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840569|NCT02211066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840570|NCT02211079|Tolbutamide|tolbutamide|mesh-list
24840571|NCT02211079|Midazolam|midazolam|mesh-list
24840572|NCT02211079|Caffeine|caffeine|mesh-list
24840605|NCT02211118|Adrenergic Agents|adrenergic agents|mesh-ancestor
25867934|NCT00110370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867935|NCT00110448|Aspirin|aspirin|mesh-list
25867936|NCT00110448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25867937|NCT00110448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25867938|NCT00110448|Analgesics|analgesics|mesh-ancestor
25867939|NCT00110448|Sensory System Agents|sensory system agents|mesh-ancestor
25867940|NCT00110448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24840697|NCT02211846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840698|NCT02211846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840699|NCT02211846|Urological Agents|urological agents|mesh-ancestor
24840700|NCT02211911|Bisacodyl|bisacodyl|mesh-list
24840701|NCT02211911|Picosulfate sodium|picosulfate sodium|mesh-list
24840702|NCT02211911|Cathartics|cathartics|mesh-ancestor
24840703|NCT02211911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24840704|NCT02211911|Laxatives|laxatives|mesh-ancestor
24840705|NCT02211950|Acarbose|acarbose|mesh-list
24753283|NCT01714427|Antiemetics|antiemetics|mesh-ancestor
25867941|NCT00110448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867942|NCT00110448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25867943|NCT00110448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25867944|NCT00110448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25867945|NCT00110448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25876637|NCT03164616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24840741|NCT02212210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24840743|NCT02212223|Cholecalciferol|cholecalciferol|mesh-list
24840763|NCT02212340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24840764|NCT02212392|Meropenem|meropenem|mesh-list
24840765|NCT02212392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24840771|NCT02212535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24840772|NCT02212535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24840773|NCT02212535|Antiviral Agents|antiviral agents|mesh-ancestor
24840774|NCT02212535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24840775|NCT02212561|Vidarabine|vidarabine|mesh-list
25670776|NCT03899103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25670777|NCT03899103|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25670778|NCT03899103|Antitubercular Agents|antitubercular agents|mesh-ancestor
25670779|NCT03899103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25670780|NCT03899103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25670781|NCT03899103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25670782|NCT03899103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670783|NCT03878472|Oxaliplatin|oxaliplatin|mesh-list
25670784|NCT03878472|Apatinib|apatinib|mesh-list
24840776|NCT02212561|Cytarabine|cytarabine|mesh-list
24840777|NCT02212561|Hydrocortisone|hydrocortisone|mesh-list
24840778|NCT02212561|Methotrexate|methotrexate|mesh-list
25201912|NCT02724761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25409520|NCT03373851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24844441|NCT02232724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24844442|NCT02232724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24844443|NCT02232724|Nootropic Agents|nootropic agents|mesh-ancestor
24844444|NCT02232737|Nicotine|nicotine|mesh-list
24858295|NCT02296073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24844445|NCT02232737|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25201913|NCT02724761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201914|NCT02724761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201915|NCT02724761|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24840787|NCT02212561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840789|NCT02212561|Dermatologic Agents|dermatologic agents|mesh-ancestor
24840790|NCT02212561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867946|NCT00110448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841000|NCT02213614|Antimanic Agents|antimanic agents|mesh-ancestor
24841001|NCT02213614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24841002|NCT02213614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24841003|NCT02213614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841004|NCT02213627|Menotropins|menotropins|mesh-list
25867947|NCT00110448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24841007|NCT02213627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24841008|NCT02213627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841010|NCT02213653|Trace Elements|trace elements|mesh-ancestor
24841011|NCT02213653|Micronutrients|micronutrients|mesh-ancestor
24841012|NCT02213653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841013|NCT02213718|Sufentanil|sufentanil|mesh-list
24841014|NCT02213718|Propofol|propofol|mesh-list
24841015|NCT02213718|Desflurane|desflurane|mesh-list
24841016|NCT02213718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24841017|NCT02213718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24841018|NCT02213718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841019|NCT02213718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24841048|NCT02213757|Estrogens|estrogens|mesh-list
24841049|NCT02213757|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24841050|NCT02213757|Hormones|hormones|mesh-ancestor
24590330|NCT00912145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24841051|NCT02213757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24841052|NCT02213757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841053|NCT02213783|Imipenem|imipenem|mesh-list
24841054|NCT02213783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24841055|NCT02213783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25064887|NCT03455426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841056|NCT02213796|Meropenem|meropenem|mesh-list
24841057|NCT02213796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24841058|NCT02213796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25876638|NCT03164616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841356|NCT02215447|Antimitotic Agents|antimitotic agents|mesh-ancestor
24841357|NCT02215447|Mitosis Modulators|mitosis modulators|mesh-ancestor
24841358|NCT02215447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841360|NCT02215460|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24841361|NCT02215460|Azithromycin|azithromycin|mesh-list
24841362|NCT02215460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24841363|NCT02215460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24841364|NCT02215460|Disinfectants|disinfectants|mesh-ancestor
24841365|NCT02215460|Dermatologic Agents|dermatologic agents|mesh-ancestor
24841366|NCT02215460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25670785|NCT03878472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670786|NCT03878472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25670787|NCT03878472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25670788|NCT03878472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670789|NCT03861871|Fenfluramine|fenfluramine|mesh-list
25670790|NCT03861871|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24841367|NCT02215473|Chlorhexidine|chlorhexidine|mesh-list
25670791|NCT03861871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25670792|NCT03861871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25670793|NCT03861871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670794|NCT03861871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25670795|NCT03861871|Serotonin Agents|serotonin agents|mesh-ancestor
25670796|NCT03861871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670797|NCT03856216|Rituximab|rituximab|mesh-list
25670798|NCT03856216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25670799|NCT03856216|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25670800|NCT03856216|Methotrexate|methotrexate|mesh-list
25670801|NCT03856216|Fludarabine|fludarabine|mesh-list
25670802|NCT03856216|Melphalan|melphalan|mesh-list
25670803|NCT03856216|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25670804|NCT03856216|Mechlorethamine|mechlorethamine|mesh-list
24844457|NCT02232763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24841368|NCT02215473|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24841369|NCT02215473|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24841397|NCT02215720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24841399|NCT02215720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841402|NCT02215733|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24841403|NCT02215733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24841404|NCT02215733|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24841405|NCT02215733|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24841406|NCT02215733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841407|NCT02215733|Natriuretic Agents|natriuretic agents|mesh-ancestor
24841408|NCT02215733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841409|NCT02215733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24841410|NCT02215733|Adrenergic Agents|adrenergic agents|mesh-ancestor
24841411|NCT02215733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24841412|NCT02215798|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24841413|NCT02215798|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25064899|NCT03455322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25064900|NCT03455322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25867948|NCT00110448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24753815|NCT01717950|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24841443|NCT02215993|Ticagrelor|ticagrelor|mesh-list
24841444|NCT02215993|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24841445|NCT02215993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24841446|NCT02215993|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24841447|NCT02215993|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24841448|NCT02215993|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24841449|NCT02215993|Purinergic Agents|purinergic agents|mesh-ancestor
24841925|NCT02219100|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24841926|NCT02219100|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24841958|NCT02219178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24841959|NCT02219178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841960|NCT02219178|Immunologic Factors|immunologic factors|mesh-ancestor
24841961|NCT02219178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24841962|NCT02219178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24841963|NCT02219178|Growth Substances|growth substances|mesh-ancestor
24841964|NCT02219178|Growth Inhibitors|growth inhibitors|mesh-ancestor
24841965|NCT02219191|Puerarin|puerarin|mesh-list
24841966|NCT02219191|Atorvastatin|atorvastatin|mesh-list
24841967|NCT02219191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24754365|NCT01720212|Mirabegron|mirabegron|mesh-list
24842098|NCT02219698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24842099|NCT02219698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24842100|NCT02219698|Analgesics|analgesics|mesh-ancestor
25064918|NCT03455179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25064919|NCT03455179|Dopamine Agents|dopamine agents|mesh-ancestor
25064920|NCT03455179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25064921|NCT03455179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064922|NCT03455179|Adrenergic Agents|adrenergic agents|mesh-ancestor
25064923|NCT03455179|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24827303|NCT02138292|Protective Agents|protective agents|mesh-ancestor
24827304|NCT02138292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827305|NCT02138357|Buprenorphine|buprenorphine|mesh-list
24842137|NCT02219750|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24842138|NCT02219750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24754547|NCT01721382|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24842170|NCT02219867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842172|NCT02219893|Immunologic Factors|immunologic factors|mesh-ancestor
24842173|NCT02219893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842174|NCT02219906|Resveratrol|resveratrol|mesh-list
24842175|NCT02219906|Antioxidants|antioxidants|mesh-ancestor
24842176|NCT02219906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842177|NCT02219906|Protective Agents|protective agents|mesh-ancestor
24842178|NCT02219906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842179|NCT02219906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201916|NCT02724761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24635386|NCT01138852|Sultamicillin|sultamicillin|mesh-list
25108382|NCT03132272|Immunologic Factors|immunologic factors|mesh-ancestor
24842527|NCT02221596|Vitamins|vitamins|mesh-ancestor
24842528|NCT02221596|Micronutrients|micronutrients|mesh-ancestor
25670805|NCT03856216|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25432989|NCT00602459|Lenalidomide|lenalidomide|mesh-list
24842529|NCT02221596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842628|NCT02222428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842629|NCT02222428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24842630|NCT02222428|Respiratory System Agents|respiratory system agents|mesh-ancestor
24842632|NCT02222441|Palbociclib|palbociclib|mesh-list
24842633|NCT02222441|Modafinil|modafinil|mesh-list
25201917|NCT02724761|Autonomic Agents|autonomic agents|mesh-ancestor
25201918|NCT02724761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25201919|NCT02724761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25201920|NCT02724761|Respiratory System Agents|respiratory system agents|mesh-ancestor
25201921|NCT02724761|Mydriatics|mydriatics|mesh-ancestor
25201922|NCT02724761|Sympathomimetics|sympathomimetics|mesh-ancestor
25201923|NCT02724761|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25201924|NCT02724618|Curcumin|curcumin|mesh-list
25201925|NCT02724618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25201926|NCT02724618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25201927|NCT02724618|Analgesics|analgesics|mesh-ancestor
25108423|NCT03132376|Chelating Agents|chelating agents|mesh-ancestor
24842676|NCT02222636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24842677|NCT02222636|Adrenergic Agents|adrenergic agents|mesh-ancestor
24842678|NCT02222636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24842679|NCT02222636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842680|NCT02222636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24842681|NCT02222636|Narcotics|narcotics|mesh-ancestor
24842682|NCT02222636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24755009|NCT01724268|Adrenergic Agents|adrenergic agents|mesh-ancestor
24842714|NCT02222987|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24842715|NCT02222987|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24842716|NCT02222987|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24842717|NCT02222987|Purinergic Agents|purinergic agents|mesh-ancestor
24842718|NCT02222987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24842719|NCT02222987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867949|NCT00110448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590352|NCT00912171|Hormone Antagonists|hormone antagonists|mesh-ancestor
24842720|NCT02222987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842721|NCT02223026|Metformin|metformin|mesh-list
25867950|NCT00110448|Antipyretics|antipyretics|mesh-ancestor
24842724|NCT02223026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842890|NCT02224170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24842891|NCT02224170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24842892|NCT02224170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24842893|NCT02224170|Anesthetics, Local|anesthetics, local|mesh-ancestor
24842894|NCT02224170|Anesthetics|anesthetics|mesh-ancestor
24842895|NCT02224170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25867951|NCT00110474|Acetaminophen|acetaminophen|mesh-list
25867952|NCT00110474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24827482|NCT02139618|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24827483|NCT02139618|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
25867953|NCT00110474|Analgesics|analgesics|mesh-ancestor
25867954|NCT00110474|Sensory System Agents|sensory system agents|mesh-ancestor
25867955|NCT00110474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25867956|NCT00110474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621371|NCT01062048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843138|NCT02225795|Thymoglobulin|thymoglobulin|mesh-list
24843139|NCT02225795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24843140|NCT02225795|Immunologic Factors|immunologic factors|mesh-ancestor
24843141|NCT02225795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843142|NCT02225795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25867957|NCT00110474|Antipyretics|antipyretics|mesh-ancestor
24910710|NCT04294784|Mitosis Modulators|mitosis modulators|mesh-ancestor
25867958|NCT00110578|Aldesleukin|aldesleukin|mesh-list
25201928|NCT02724618|Sensory System Agents|sensory system agents|mesh-ancestor
25201929|NCT02724618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25201930|NCT02724618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201931|NCT02724618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25201932|NCT02724618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25201933|NCT02724618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201934|NCT02724618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201935|NCT02724618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201936|NCT02724332|Sirolimus|sirolimus|mesh-list
25201937|NCT02724332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25201938|NCT02724332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25064952|NCT03455049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25064953|NCT03455049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25867959|NCT00110578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25064954|NCT03455049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25064956|NCT03455049|Sensory System Agents|sensory system agents|mesh-ancestor
25064957|NCT03455049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25064958|NCT03455049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064959|NCT03455049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25064960|NCT03455049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25064961|NCT03455049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24827326|NCT02138383|Antiviral Agents|antiviral agents|mesh-ancestor
25867960|NCT00110578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24843216|NCT02226328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24843217|NCT02226328|Narcotics|narcotics|mesh-ancestor
24843218|NCT02226328|Analgesics|analgesics|mesh-ancestor
24843219|NCT02226328|Sensory System Agents|sensory system agents|mesh-ancestor
24843220|NCT02226328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24843221|NCT02226328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24843222|NCT02226328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24843223|NCT02226328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25867961|NCT00110578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25867962|NCT00110578|Antiviral Agents|antiviral agents|mesh-ancestor
25867963|NCT00110578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25867964|NCT00110591|Leronlimab|leronlimab|mesh-list
25867965|NCT00110591|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25867966|NCT00110591|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25867967|NCT00110591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25867968|NCT00110591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25867969|NCT00110591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25268745|NCT02414581|Ethanol|ethanol|mesh-list
25867970|NCT00110591|Antiviral Agents|antiviral agents|mesh-ancestor
25867971|NCT00110591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25867972|NCT00110604|Folic Acid|folic acid|mesh-list
25064965|NCT03454984|Guadecitabine|guadecitabine|mesh-list
25064966|NCT03454984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25064967|NCT03454945|Doxycycline|doxycycline|mesh-list
25064968|NCT03454945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25064969|NCT03454945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24910761|NCT04294953|Analgesics|analgesics|mesh-ancestor
25867973|NCT00110604|Hematinics|hematinics|mesh-ancestor
25867974|NCT00110604|Vitamin B Complex|vitamin b complex|mesh-ancestor
25867975|NCT00110604|Vitamins|vitamins|mesh-ancestor
24843465|NCT02227797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24755852|NCT01729481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24843671|NCT02228772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24843673|NCT02228772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843674|NCT02228772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843675|NCT02228772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24843676|NCT02228772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24843677|NCT02228772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24843779|NCT02229292|Coagulants|coagulants|mesh-ancestor
24843780|NCT02229422|Obinutuzumab|obinutuzumab|mesh-list
24843781|NCT02229422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24843782|NCT02229422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843783|NCT02229617|Methyltestosterone|methyltestosterone|mesh-list
24843784|NCT02229617|Testosterone|testosterone|mesh-list
25201939|NCT02724332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25201940|NCT02724332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201941|NCT02724332|Antifungal Agents|antifungal agents|mesh-ancestor
24873903|NCT04978038|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24873904|NCT04978038|Immunologic Factors|immunologic factors|mesh-ancestor
24873905|NCT04978038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24873906|NCT04975347|Naloxone|naloxone|mesh-list
24873907|NCT04975347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843787|NCT02229617|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24843789|NCT02229617|Hormones|hormones|mesh-ancestor
25108424|NCT03132376|Sequestering Agents|sequestering agents|mesh-ancestor
25108425|NCT03132376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108426|NCT03132259|Dexmedetomidine|dexmedetomidine|mesh-list
25108427|NCT03132259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25108428|NCT03132259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25108429|NCT03132259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108430|NCT03132259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25108431|NCT03132259|Analgesics|analgesics|mesh-ancestor
24843790|NCT02229617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24843791|NCT02229617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843946|NCT02230176|Sunitinib|sunitinib|mesh-list
24844018|NCT02230800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24844019|NCT02230800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25867976|NCT00110604|Micronutrients|micronutrients|mesh-ancestor
24844020|NCT02230800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844021|NCT02230800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24844022|NCT02230800|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24844023|NCT02230800|Protective Agents|protective agents|mesh-ancestor
24844024|NCT02230800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844025|NCT02230800|Vasodilator Agents|vasodilator agents|mesh-ancestor
24844026|NCT02230800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24844027|NCT02230800|Antioxidants|antioxidants|mesh-ancestor
24844028|NCT02230800|Vitamins|vitamins|mesh-ancestor
24844029|NCT02230800|Micronutrients|micronutrients|mesh-ancestor
24844030|NCT02230930|Hydrocortisone|hydrocortisone|mesh-list
25867977|NCT00110604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844184|NCT02231606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844376|NCT02232542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24844377|NCT02232542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867978|NCT00110630|Nicotine|nicotine|mesh-list
25867979|NCT00110630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24621382|NCT01062087|Anesthetics|anesthetics|mesh-ancestor
25867980|NCT00110630|Autonomic Agents|autonomic agents|mesh-ancestor
25867981|NCT00110630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25867982|NCT00110630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25867983|NCT00110630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25867984|NCT00110630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25867985|NCT00110630|Cholinergic Agents|cholinergic agents|mesh-ancestor
25867986|NCT00110630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25867987|NCT00110630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844379|NCT02232542|Sensory System Agents|sensory system agents|mesh-ancestor
24844380|NCT02232542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25867988|NCT00110669|Prednisone|prednisone|mesh-list
25867989|NCT00110669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25867990|NCT00110669|Glucocorticoids|glucocorticoids|mesh-ancestor
24844381|NCT02232542|Antidepressive Agents|antidepressive agents|mesh-ancestor
24844382|NCT02232542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24844384|NCT02232555|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24844385|NCT02232555|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24844386|NCT02232555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24844387|NCT02232555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24844388|NCT02232555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844389|NCT02232555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24844390|NCT02232555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844391|NCT02232555|Analgesics|analgesics|mesh-ancestor
24844392|NCT02232555|Sensory System Agents|sensory system agents|mesh-ancestor
24844393|NCT02232555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24844394|NCT02232555|Antidepressive Agents|antidepressive agents|mesh-ancestor
24757379|NCT01739556|Antipyretics|antipyretics|mesh-ancestor
24844550|NCT02233218|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24844551|NCT02233218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24844552|NCT02233218|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24844553|NCT02233218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24844554|NCT02233218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844555|NCT02233218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24844556|NCT02233218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844557|NCT02233218|Vasodilator Agents|vasodilator agents|mesh-ancestor
24844558|NCT02233218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24844559|NCT02233218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24844560|NCT02233218|Antimetabolites|antimetabolites|mesh-ancestor
24844564|NCT02233218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24844565|NCT02233218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25867991|NCT00110669|Hormones|hormones|mesh-ancestor
25867992|NCT00110669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24450325|NCT00318760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24844610|NCT02233452|Anesthetics, General|anesthetics, general|mesh-ancestor
24844611|NCT02233452|Anesthetics|anesthetics|mesh-ancestor
24844613|NCT02233452|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24844615|NCT02233452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24844616|NCT02233452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844617|NCT02233452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24844618|NCT02233452|Narcotics|narcotics|mesh-ancestor
24844619|NCT02233452|Antitussive Agents|antitussive agents|mesh-ancestor
24844620|NCT02233452|Respiratory System Agents|respiratory system agents|mesh-ancestor
24844621|NCT02233504|Deferasirox|deferasirox|mesh-list
24844622|NCT02233504|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24844623|NCT02233504|Chelating Agents|chelating agents|mesh-ancestor
24844689|NCT02233881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24844690|NCT02233881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844691|NCT02233881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25867993|NCT00110669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844692|NCT02233881|Respiratory System Agents|respiratory system agents|mesh-ancestor
24844693|NCT02233881|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24844707|NCT02233894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910794|NCT04294329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910795|NCT04294329|Sensory System Agents|sensory system agents|mesh-ancestor
24910796|NCT04294329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24910798|NCT04294056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24910799|NCT04294056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24910801|NCT04294056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25064994|NCT03454789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25064995|NCT03454789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25064996|NCT03454789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25064997|NCT03454789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25064998|NCT03454789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24844708|NCT02233907|Oxitropium|oxitropium|mesh-list
24844709|NCT02233907|Parasympatholytics|parasympatholytics|mesh-ancestor
24844710|NCT02233907|Autonomic Agents|autonomic agents|mesh-ancestor
24844711|NCT02233907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24844712|NCT02233907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844713|NCT02233920|Oxitropium|oxitropium|mesh-list
24844731|NCT02233972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24844732|NCT02233972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844733|NCT02234037|Decitabine|decitabine|mesh-list
24844734|NCT02234037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24844735|NCT02234037|Antimetabolites|antimetabolites|mesh-ancestor
24844736|NCT02234037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844737|NCT02234037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24844738|NCT02234037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24844739|NCT02234050|Trabectedin|trabectedin|mesh-list
24844740|NCT02234050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24844741|NCT02234050|Alkylating Agents|alkylating agents|mesh-ancestor
24844742|NCT02234050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844743|NCT02234050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24844745|NCT02234193|Epinephrine|epinephrine|mesh-list
24844746|NCT02234193|Anesthetics, Local|anesthetics, local|mesh-ancestor
24844747|NCT02234193|Anesthetics|anesthetics|mesh-ancestor
24844748|NCT02234193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24844749|NCT02234193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844750|NCT02234193|Sensory System Agents|sensory system agents|mesh-ancestor
24844751|NCT02234193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24844752|NCT02234193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24844753|NCT02234193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24844803|NCT02234492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24844804|NCT02234492|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24910833|NCT04293549|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24910834|NCT04293549|Mitogens|mitogens|mesh-list
24844805|NCT02234492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24844807|NCT02234544|Cholecalciferol|cholecalciferol|mesh-list
24844808|NCT02234544|Ezetimibe|ezetimibe|mesh-list
24844809|NCT02234544|Vitamins|vitamins|mesh-ancestor
24844810|NCT02234544|Micronutrients|micronutrients|mesh-ancestor
24844811|NCT02234544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844812|NCT02234544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24621376|NCT01062048|Protease Inhibitors|protease inhibitors|mesh-ancestor
24621377|NCT01062048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621378|NCT01062048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621379|NCT01062087|Lidocaine|lidocaine|mesh-list
25867994|NCT00110669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25867995|NCT00110669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25867996|NCT00110682|Imiquimod|imiquimod|mesh-list
25867997|NCT00110682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25867998|NCT00110682|Immunologic Factors|immunologic factors|mesh-ancestor
25867999|NCT00110682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868000|NCT00110682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868001|NCT00110682|Interferon Inducers|interferon inducers|mesh-ancestor
25868002|NCT00110695|Paclitaxel|paclitaxel|mesh-list
25868003|NCT00110695|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25868004|NCT00110695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25868005|NCT00110695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868006|NCT00110695|Tubulin Modulators|tubulin modulators|mesh-ancestor
25868007|NCT00110695|Antimitotic Agents|antimitotic agents|mesh-ancestor
24819091|NCT02093143|Remifentanil|remifentanil|mesh-list
25868008|NCT00110695|Mitosis Modulators|mitosis modulators|mesh-ancestor
25868009|NCT00110695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868010|NCT00110708|Immunoglobulins|immunoglobulins|mesh-list
25868011|NCT00110708|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25868012|NCT00110708|Antibodies|antibodies|mesh-list
25868013|NCT00110708|Immunologic Factors|immunologic factors|mesh-ancestor
25868014|NCT00110708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868015|NCT00110721|Fluorouracil|fluorouracil|mesh-list
24621380|NCT01062087|Bupivacaine|bupivacaine|mesh-list
25868016|NCT00110721|Antimetabolites|antimetabolites|mesh-ancestor
25868017|NCT00110721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868018|NCT00110721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25868019|NCT00110721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868020|NCT00110721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25868021|NCT00110721|Immunologic Factors|immunologic factors|mesh-ancestor
25868022|NCT00110721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827371|NCT02138539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827372|NCT02138539|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24827373|NCT02138552|Octenidine|octenidine|mesh-list
24827374|NCT02138552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24827375|NCT02138552|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24827376|NCT02138708|Adenosine|adenosine|mesh-list
24827377|NCT02138708|Acetylcholine|acetylcholine|mesh-list
24827378|NCT02138708|Analgesics|analgesics|mesh-ancestor
24716294|NCT01540877|Capsaicin|capsaicin|mesh-list
25868023|NCT00110734|Lidocaine|lidocaine|mesh-list
25868024|NCT00110734|Tetracaine|tetracaine|mesh-list
25108465|NCT03132025|Antimetabolites|antimetabolites|mesh-ancestor
25108466|NCT03132025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108467|NCT03132025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108468|NCT03132025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25108469|NCT03132025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25108470|NCT03132051|Triamcinolone|triamcinolone|mesh-list
25108471|NCT03132051|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25108472|NCT03132051|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25108473|NCT03132051|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25108474|NCT03132051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25108475|NCT03132051|Glucocorticoids|glucocorticoids|mesh-ancestor
25108476|NCT03132051|Hormones|hormones|mesh-ancestor
25108477|NCT03132051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25108478|NCT03132051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108479|NCT03132051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25108480|NCT03132051|Immunologic Factors|immunologic factors|mesh-ancestor
25108481|NCT03132051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25108482|NCT03132051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108490|NCT03131700|Bevacizumab|bevacizumab|mesh-list
25108491|NCT03131700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25108492|NCT03131700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108493|NCT03131700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24815212|NCT02068859|Analgesics|analgesics|mesh-ancestor
24611014|NCT01006187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24611015|NCT01006187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24611016|NCT01006187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24611017|NCT01006187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868025|NCT00110734|Anesthetics, Local|anesthetics, local|mesh-ancestor
24844880|NCT02235012|Sensory System Agents|sensory system agents|mesh-ancestor
24844881|NCT02235012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24623350|NCT01071005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24623351|NCT01071005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868026|NCT00110734|Anesthetics|anesthetics|mesh-ancestor
25868027|NCT00110734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24623353|NCT01071057|Naloxone|naloxone|mesh-list
24623354|NCT01071057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24623355|NCT01071057|Narcotics|narcotics|mesh-ancestor
24845106|NCT02236078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24845108|NCT02236169|Norflurane|norflurane|mesh-list
24845109|NCT02236169|Ipratropium|ipratropium|mesh-list
24845110|NCT02236169|Anticonvulsants|anticonvulsants|mesh-ancestor
24845170|NCT02236728|Protective Agents|protective agents|mesh-ancestor
24845171|NCT02236728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845172|NCT02236728|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24845173|NCT02236728|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24845174|NCT02236728|Dopamine Agonists|dopamine agonists|mesh-ancestor
25043904|NCT01188187|Dexamethasone|dexamethasone|mesh-list
24845175|NCT02236728|Dopamine Agents|dopamine agents|mesh-ancestor
24845176|NCT02236728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845177|NCT02236741|Pramipexole|pramipexole|mesh-list
24845179|NCT02236741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845180|NCT02236741|Protective Agents|protective agents|mesh-ancestor
24758109|NCT01743898|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24845206|NCT02236962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845207|NCT02236962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845208|NCT02237027|Tenofovir|tenofovir|mesh-list
24845209|NCT02237027|Emtricitabine|emtricitabine|mesh-list
24845212|NCT02237027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24845213|NCT02237027|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24845214|NCT02237027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24845215|NCT02237027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24845216|NCT02237027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845217|NCT02237027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24845218|NCT02237027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24845219|NCT02237053|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24845220|NCT02237053|Octreotide|octreotide|mesh-list
24845221|NCT02237053|Glucagon|glucagon|mesh-list
24845222|NCT02237053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268746|NCT02414581|Chlorhexidine|chlorhexidine|mesh-list
24845223|NCT02237053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24845224|NCT02237053|Hormones|hormones|mesh-ancestor
24845225|NCT02237053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25868028|NCT00110734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845383|NCT02237755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24845384|NCT02237755|Fertility Agents|fertility agents|mesh-ancestor
24845385|NCT02237755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24845386|NCT02237755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24845387|NCT02237755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24845388|NCT02237768|Dirithromycin|dirithromycin|mesh-list
24845389|NCT02237768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24845390|NCT02237768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24845391|NCT02237807|Dirithromycin|dirithromycin|mesh-list
24845392|NCT02237807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24729218|NCT01620463|Liraglutide|liraglutide|mesh-list
24845393|NCT02237807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24845394|NCT02237820|Dexamethasone|dexamethasone|mesh-list
24845396|NCT02237820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24845397|NCT02237820|Antiemetics|antiemetics|mesh-ancestor
24845398|NCT02237820|Autonomic Agents|autonomic agents|mesh-ancestor
24845399|NCT02237820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845400|NCT02237820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845401|NCT02237820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24845402|NCT02237820|Glucocorticoids|glucocorticoids|mesh-ancestor
24845404|NCT02237820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24758343|NCT01745549|Insulin|insulin|mesh-list
24845537|NCT02238197|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24845538|NCT02238197|Cholinergic Agents|cholinergic agents|mesh-ancestor
24845539|NCT02238197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845540|NCT02238197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845541|NCT02238210|Ipratropium|ipratropium|mesh-list
24845542|NCT02238210|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24845543|NCT02238210|Autonomic Agents|autonomic agents|mesh-ancestor
24845716|NCT02238470|Apixaban|apixaban|mesh-list
24845717|NCT02238470|Anticoagulants|anticoagulants|mesh-list
24845718|NCT02238470|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24845719|NCT02238470|Antithrombins|antithrombins|mesh-ancestor
24845720|NCT02238470|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24845721|NCT02238470|Protease Inhibitors|protease inhibitors|mesh-ancestor
24845874|NCT02239900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24845909|NCT02239952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25868029|NCT00110734|Sensory System Agents|sensory system agents|mesh-ancestor
24827392|NCT02138773|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24845911|NCT02239952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845912|NCT02239952|Growth Inhibitors|growth inhibitors|mesh-ancestor
24845914|NCT02240017|Carboplatin|carboplatin|mesh-list
24845915|NCT02240017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24848885|NCT03298893|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24845945|NCT02240173|Dopamine Agents|dopamine agents|mesh-ancestor
24845946|NCT02240173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845947|NCT02240173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845948|NCT02240173|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25670806|NCT03856216|Antibodies|antibodies|mesh-list
25868030|NCT00110734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845950|NCT02240199|Pregabalin|pregabalin|mesh-list
24845951|NCT02240199|Anesthetics, Local|anesthetics, local|mesh-ancestor
24845952|NCT02240199|Anesthetics|anesthetics|mesh-ancestor
24845953|NCT02240199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24845954|NCT02240199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845955|NCT02240199|Sensory System Agents|sensory system agents|mesh-ancestor
24845956|NCT02240199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845957|NCT02240199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24845958|NCT02240199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24845959|NCT02240199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24846071|NCT02241083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846072|NCT02241083|Sympathomimetics|sympathomimetics|mesh-ancestor
24759161|NCT01749475|Midazolam|midazolam|mesh-list
24846127|NCT02241356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846128|NCT02241356|Sympathomimetics|sympathomimetics|mesh-ancestor
24846129|NCT02241356|Autonomic Agents|autonomic agents|mesh-ancestor
24846210|NCT02242084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846212|NCT02242149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24846213|NCT02242214|Misoprostol|misoprostol|mesh-list
24846214|NCT02242214|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24846215|NCT02242214|Abortifacient Agents|abortifacient agents|mesh-ancestor
24846216|NCT02242214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24846217|NCT02242214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846268|NCT02242266|Tiotropium Bromide|tiotropium bromide|mesh-list
24846269|NCT02242266|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24846270|NCT02242266|Autonomic Agents|autonomic agents|mesh-ancestor
24846271|NCT02242266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24846272|NCT02242266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846273|NCT02242266|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24846274|NCT02242266|Respiratory System Agents|respiratory system agents|mesh-ancestor
24846275|NCT02242266|Parasympatholytics|parasympatholytics|mesh-ancestor
24846276|NCT02242266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24846277|NCT02242266|Cholinergic Agents|cholinergic agents|mesh-ancestor
25201942|NCT02724332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24846278|NCT02242266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24562498|NCT00766805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24846279|NCT02242266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846280|NCT02242279|Tiotropium Bromide|tiotropium bromide|mesh-list
24846281|NCT02242279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24846282|NCT02242279|Autonomic Agents|autonomic agents|mesh-ancestor
24846283|NCT02242279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24846284|NCT02242279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24874402|NCT04767984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24846285|NCT02242279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24846286|NCT02242279|Respiratory System Agents|respiratory system agents|mesh-ancestor
24846287|NCT02242279|Parasympatholytics|parasympatholytics|mesh-ancestor
24846288|NCT02242279|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24846289|NCT02242279|Cholinergic Agents|cholinergic agents|mesh-ancestor
24846290|NCT02242279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24846291|NCT02242279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846292|NCT02242292|Scopolamine|scopolamine|mesh-list
24846293|NCT02242292|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25108496|NCT03131700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847557|NCT02247557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24847624|NCT02248142|Dopamine Agents|dopamine agents|mesh-ancestor
24847625|NCT02248142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24848893|NCT03289351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24848894|NCT03289351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848896|NCT03283488|Megestrol Acetate|megestrol acetate|mesh-list
24848897|NCT03283488|Mirtazapine|mirtazapine|mesh-list
24848898|NCT03283488|Antidepressive Agents|antidepressive agents|mesh-ancestor
24848899|NCT03283488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24848900|NCT03283488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24874467|NCT04740307|Pembrolizumab|pembrolizumab|mesh-list
24848901|NCT03283488|Histamine Antagonists|histamine antagonists|mesh-ancestor
24848902|NCT03283488|Histamine Agents|histamine agents|mesh-ancestor
24848903|NCT03283488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24848904|NCT03283488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848905|NCT03283488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849158|NCT02533232|Minocycline|minocycline|mesh-list
24640261|NCT01167101|Rebamipide|rebamipide|mesh-list
25670807|NCT03856216|Immunoglobulins|immunoglobulins|mesh-list
25229087|NCT02604784|Oxaliplatin|oxaliplatin|mesh-list
24850722|NCT02253901|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24851313|NCT02256423|Ibuprofen|ibuprofen|mesh-list
24851314|NCT02256423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24851315|NCT02256423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24851316|NCT02256423|Analgesics|analgesics|mesh-ancestor
24851317|NCT02256423|Sensory System Agents|sensory system agents|mesh-ancestor
24851513|NCT02256956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24851514|NCT02256956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851515|NCT02256956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868031|NCT00110734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25868032|NCT00110734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25868033|NCT00110734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24874523|NCT04673422|Montelukast|montelukast|mesh-list
24786448|NCT01920022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24786450|NCT01920022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24786451|NCT01920022|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24786452|NCT01920074|Nitroglycerin|nitroglycerin|mesh-list
24786453|NCT01920074|Vasodilator Agents|vasodilator agents|mesh-ancestor
24786454|NCT01920113|Dexmedetomidine|dexmedetomidine|mesh-list
24786455|NCT01920113|Remifentanil|remifentanil|mesh-list
24786456|NCT01920113|Propofol|propofol|mesh-list
24786457|NCT01920113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24786458|NCT01920113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24786459|NCT01920113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786460|NCT01920113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24786461|NCT01920113|Anesthetics, General|anesthetics, general|mesh-ancestor
24459004|NCT00343369|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25201943|NCT02724332|Immunologic Factors|immunologic factors|mesh-ancestor
25868034|NCT00110734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25868035|NCT00110734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868036|NCT00110747|Lidocaine|lidocaine|mesh-list
25868037|NCT00110747|Tetracaine|tetracaine|mesh-list
25868038|NCT00110747|Anesthetics, Local|anesthetics, local|mesh-ancestor
25868039|NCT00110747|Anesthetics|anesthetics|mesh-ancestor
25868040|NCT00110747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25868041|NCT00110747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868042|NCT00110747|Sensory System Agents|sensory system agents|mesh-ancestor
25868043|NCT00110747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25868044|NCT00110747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25868045|NCT00110747|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25868046|NCT00110747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25868047|NCT00110747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25868048|NCT00110747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868049|NCT00110760|Lidocaine|lidocaine|mesh-list
25868050|NCT00110760|Tetracaine|tetracaine|mesh-list
25868051|NCT00110760|Anesthetics, Local|anesthetics, local|mesh-ancestor
24911037|NCT04291755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24911038|NCT04291755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911065|NCT04290819|Caffeine|caffeine|mesh-list
25868052|NCT00110760|Anesthetics|anesthetics|mesh-ancestor
25868053|NCT00110760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25868054|NCT00110760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868055|NCT00110760|Sensory System Agents|sensory system agents|mesh-ancestor
25868056|NCT00110760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25868057|NCT00110760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25868058|NCT00110760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25868059|NCT00110760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25868060|NCT00110760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25868061|NCT00110760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868062|NCT00110773|Lidocaine|lidocaine|mesh-list
25868063|NCT00110773|Tetracaine|tetracaine|mesh-list
25868064|NCT00110773|Anesthetics, Local|anesthetics, local|mesh-ancestor
25868065|NCT00110773|Anesthetics|anesthetics|mesh-ancestor
25868066|NCT00110773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25868067|NCT00110773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459707|NCT00346047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24459708|NCT00346047|Narcotics|narcotics|mesh-ancestor
24537447|NCT00654589|Chelating Agents|chelating agents|mesh-ancestor
25868068|NCT00110773|Sensory System Agents|sensory system agents|mesh-ancestor
25868069|NCT00110773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25868070|NCT00110773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25868071|NCT00110773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25868072|NCT00110773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25868073|NCT00110773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25868074|NCT00110773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868075|NCT00110851|Metformin|metformin|mesh-list
25868076|NCT00110851|Rosiglitazone|rosiglitazone|mesh-list
25868077|NCT00110851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25868078|NCT00110851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868079|NCT00110864|Insulin|insulin|mesh-list
25868080|NCT00110864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25868081|NCT00110864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868082|NCT00110877|Darunavir|darunavir|mesh-list
25868083|NCT00110877|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25868084|NCT00110877|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24911096|NCT04290871|Vasodilator Agents|vasodilator agents|mesh-ancestor
25868085|NCT00110877|Protease Inhibitors|protease inhibitors|mesh-ancestor
25868086|NCT00110877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868087|NCT00110877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868088|NCT00110877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25868089|NCT00110877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25868090|NCT00110877|Antiviral Agents|antiviral agents|mesh-ancestor
25868091|NCT00110877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25868092|NCT00110903|Etanercept|etanercept|mesh-list
25868093|NCT00110903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25868094|NCT00110903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25868095|NCT00110903|Analgesics|analgesics|mesh-ancestor
25868096|NCT00110903|Sensory System Agents|sensory system agents|mesh-ancestor
25868097|NCT00110903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25201944|NCT02724332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868098|NCT00110903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868099|NCT00110903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25868100|NCT00110903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25868101|NCT00110903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25868102|NCT00110903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25868103|NCT00110903|Immunologic Factors|immunologic factors|mesh-ancestor
24815229|NCT02069080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24815231|NCT02069080|Antiviral Agents|antiviral agents|mesh-ancestor
25868104|NCT00110916|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25868105|NCT00110916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25868106|NCT00110929|Cinacalcet|cinacalcet|mesh-list
25868107|NCT00110929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25868108|NCT00110929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868109|NCT00110929|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25868110|NCT00110929|Hormone Antagonists|hormone antagonists|mesh-ancestor
25868111|NCT00110929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25868112|NCT00110955|Darbepoetin alfa|darbepoetin alfa|mesh-list
24953388|NCT03885427|Sensory System Agents|sensory system agents|mesh-ancestor
24911116|NCT04290884|Coagulants|coagulants|mesh-ancestor
24911117|NCT04290793|Cyclophosphamide|cyclophosphamide|mesh-list
24911118|NCT04290793|Trastuzumab|trastuzumab|mesh-list
24911119|NCT04290793|Epirubicin|epirubicin|mesh-list
24911121|NCT04290793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24911122|NCT04290793|Immunologic Factors|immunologic factors|mesh-ancestor
24911123|NCT04290793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868113|NCT00110955|Hematinics|hematinics|mesh-ancestor
25868114|NCT00110981|Etanercept|etanercept|mesh-list
25868115|NCT00110981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25868116|NCT00110981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25868117|NCT00110981|Analgesics|analgesics|mesh-ancestor
25868118|NCT00110981|Sensory System Agents|sensory system agents|mesh-ancestor
25868119|NCT00110981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25868120|NCT00110981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868121|NCT00110981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25868122|NCT00110981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25868123|NCT00110981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25868124|NCT00110981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25868125|NCT00110981|Immunologic Factors|immunologic factors|mesh-ancestor
24459725|NCT00346190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459726|NCT00346229|Doxorubicin|doxorubicin|mesh-list
24459727|NCT00346229|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24459728|NCT00346229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25868126|NCT00111020|Sorafenib|sorafenib|mesh-list
25868127|NCT00111020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868128|NCT00111020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25868129|NCT00111020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868130|NCT00111020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868131|NCT00111046|Ibuprofen|ibuprofen|mesh-list
25868132|NCT00111046|Tramadol|tramadol|mesh-list
24459731|NCT00346229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24459732|NCT00346229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868133|NCT00111046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25868134|NCT00111046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25868135|NCT00111046|Analgesics|analgesics|mesh-ancestor
25868136|NCT00111046|Sensory System Agents|sensory system agents|mesh-ancestor
25868137|NCT00111046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25868138|NCT00111046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868139|NCT00111046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24911248|NCT04290169|Cholinergic Agents|cholinergic agents|mesh-ancestor
24911249|NCT04290169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24911250|NCT04290169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911251|NCT04290169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24911252|NCT04290169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25868140|NCT00111046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25868141|NCT00111046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25868142|NCT00111046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868143|NCT00111046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868144|NCT00111046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25868145|NCT00111046|Narcotics|narcotics|mesh-ancestor
25868146|NCT00111046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25868147|NCT00111072|Dexamethasone|dexamethasone|mesh-list
25868148|NCT00111072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25868149|NCT00111072|Antiemetics|antiemetics|mesh-ancestor
25868150|NCT00111072|Autonomic Agents|autonomic agents|mesh-ancestor
25868151|NCT00111072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25868152|NCT00111072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868153|NCT00111072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25868154|NCT00111072|Glucocorticoids|glucocorticoids|mesh-ancestor
25868155|NCT00111072|Hormones|hormones|mesh-ancestor
25868156|NCT00111072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25868157|NCT00111072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25868158|NCT00111072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868159|NCT00111098|Darbepoetin alfa|darbepoetin alfa|mesh-list
25868160|NCT00111098|Hematinics|hematinics|mesh-ancestor
25868161|NCT00111111|Etanercept|etanercept|mesh-list
25868162|NCT00111111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25868163|NCT00111111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25868164|NCT00111111|Analgesics|analgesics|mesh-ancestor
25868165|NCT00111111|Sensory System Agents|sensory system agents|mesh-ancestor
25868166|NCT00111111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25868167|NCT00111111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911293|NCT04289675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868168|NCT00111111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25868169|NCT00111111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25868170|NCT00111111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25868171|NCT00111111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25868172|NCT00111111|Immunologic Factors|immunologic factors|mesh-ancestor
25868173|NCT00111124|Etanercept|etanercept|mesh-list
24859263|NCT02302547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24859265|NCT02302586|Bupivacaine|bupivacaine|mesh-list
24911294|NCT04289675|Dermatologic Agents|dermatologic agents|mesh-ancestor
24911295|NCT04289675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24911296|NCT04289675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24911297|NCT04289675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24911298|NCT04289675|Analgesics|analgesics|mesh-ancestor
24911299|NCT04289675|Sensory System Agents|sensory system agents|mesh-ancestor
24911300|NCT04289675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24911302|NCT04289675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24874823|NCT04534582|Denosumab|denosumab|mesh-list
25868174|NCT00111124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24859266|NCT02302586|Anesthetics, Local|anesthetics, local|mesh-ancestor
24859268|NCT02302586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24859269|NCT02302586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859270|NCT02302586|Sensory System Agents|sensory system agents|mesh-ancestor
24859271|NCT02302586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24859272|NCT02302586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24859273|NCT02302586|Narcotics|narcotics|mesh-ancestor
24859274|NCT02302586|Analgesics|analgesics|mesh-ancestor
24859275|NCT02302729|Micronutrients|micronutrients|mesh-list
24859276|NCT02302729|Trace Elements|trace elements|mesh-list
24859277|NCT02302729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859278|NCT02302768|Selenium|selenium|mesh-list
24859279|NCT02302768|Antioxidants|antioxidants|mesh-ancestor
25868175|NCT00111124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24859280|NCT02302768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859281|NCT02302768|Protective Agents|protective agents|mesh-ancestor
24859282|NCT02302768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859283|NCT02302768|Trace Elements|trace elements|mesh-ancestor
24911337|NCT04289103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911338|NCT04289467|Fenfluramine|fenfluramine|mesh-list
24859327|NCT02303002|Cholinergic Agents|cholinergic agents|mesh-ancestor
24859328|NCT02303002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24859330|NCT02303002|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24859331|NCT02303002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24859332|NCT02303106|Lamotrigine|lamotrigine|mesh-list
24859333|NCT02303106|Anticonvulsants|anticonvulsants|mesh-ancestor
24859334|NCT02303106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24859335|NCT02303106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24859336|NCT02303106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859337|NCT02303106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24539739|NCT00665340|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24859385|NCT02303418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859387|NCT02303444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859388|NCT02303444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24859389|NCT02303444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859390|NCT02303444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859391|NCT02303483|Niacinamide|niacinamide|mesh-list
24859392|NCT02303483|Niacin|niacin|mesh-list
24859393|NCT02303483|Nicotinic Acids|nicotinic acids|mesh-list
24859394|NCT02303483|Vitamin B Complex|vitamin b complex|mesh-ancestor
24859397|NCT02303483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786463|NCT01920113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24859398|NCT02303483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24859399|NCT02303483|Antimetabolites|antimetabolites|mesh-ancestor
24859566|NCT02304107|Hormone Antagonists|hormone antagonists|mesh-ancestor
24859567|NCT02304107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24859568|NCT02304107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859569|NCT02304198|Udenafil|udenafil|mesh-list
24859570|NCT02304198|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24859571|NCT02304198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24859572|NCT02304198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859573|NCT02304198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859574|NCT02304211|Insulin|insulin|mesh-list
24859575|NCT02304211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24859602|NCT02304289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24859603|NCT02304289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24859604|NCT02304289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24859605|NCT02304289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859606|NCT02304289|Antiviral Agents|antiviral agents|mesh-ancestor
24859607|NCT02304289|Schistosomicides|schistosomicides|mesh-ancestor
24859608|NCT02304289|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24859673|NCT02305160|Poractant alfa|poractant alfa|mesh-list
24859674|NCT02305160|Beractant|beractant|mesh-list
24540109|NCT00666653|Pramipexole|pramipexole|mesh-list
24859699|NCT02305355|Pravastatin|pravastatin|mesh-list
24859700|NCT02305355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24859701|NCT02305355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24859702|NCT02305355|Antimetabolites|antimetabolites|mesh-ancestor
24859703|NCT02305355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859710|NCT02305394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24859711|NCT02305394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859712|NCT02305394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24859713|NCT02305394|Anesthetics, General|anesthetics, general|mesh-ancestor
24859714|NCT02305394|Anesthetics|anesthetics|mesh-ancestor
24859715|NCT02305394|Analgesics|analgesics|mesh-ancestor
24859716|NCT02305394|Sensory System Agents|sensory system agents|mesh-ancestor
24859717|NCT02305394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24859718|NCT02305394|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24859719|NCT02305394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24859720|NCT02305394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25868176|NCT00111124|Analgesics|analgesics|mesh-ancestor
24541054|NCT00670670|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24860783|NCT02312635|Renal Agents|renal agents|mesh-ancestor
24860784|NCT02312635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24860785|NCT02312635|Antitubercular Agents|antitubercular agents|mesh-ancestor
24860786|NCT02312635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24860787|NCT02312635|Antimetabolites|antimetabolites|mesh-ancestor
24860788|NCT02312635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541352|NCT00672360|Micronutrients|micronutrients|mesh-ancestor
24541353|NCT00672360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541356|NCT00672399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25108515|NCT03131973|Flurbiprofen|flurbiprofen|mesh-list
25108516|NCT03131973|Methotrexate|methotrexate|mesh-list
25108517|NCT03131973|Digoxin|digoxin|mesh-list
25108518|NCT03131973|Midazolam|midazolam|mesh-list
25108519|NCT03131973|Caffeine|caffeine|mesh-list
25108520|NCT03131973|Omeprazole|omeprazole|mesh-list
25108541|NCT03131973|Vitamin B Complex|vitamin b complex|mesh-ancestor
25108543|NCT03131973|Micronutrients|micronutrients|mesh-ancestor
25108544|NCT03131973|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25108545|NCT03131973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25108546|NCT03131973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25108547|NCT03131973|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25108548|NCT03131973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25108559|NCT03131973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25108560|NCT03131973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25108561|NCT03131973|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25108562|NCT03131973|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25108563|NCT03131973|Purinergic Agents|purinergic agents|mesh-ancestor
25108564|NCT03131973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25108565|NCT03131973|Respiratory System Agents|respiratory system agents|mesh-ancestor
25108566|NCT03131973|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25108567|NCT03131973|Hormone Antagonists|hormone antagonists|mesh-ancestor
24861377|NCT02317341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24861378|NCT02317341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861379|NCT02317341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24861380|NCT02317341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25868177|NCT00111124|Sensory System Agents|sensory system agents|mesh-ancestor
25868178|NCT00111124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25868179|NCT00111124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868180|NCT00111124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25868181|NCT00111124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25868182|NCT00111124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25868183|NCT00111124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25868184|NCT00111124|Immunologic Factors|immunologic factors|mesh-ancestor
25868185|NCT00111137|Darbepoetin alfa|darbepoetin alfa|mesh-list
25868186|NCT00111137|Hematinics|hematinics|mesh-ancestor
25868187|NCT00111150|Tenofovir|tenofovir|mesh-list
24861478|NCT02318043|Dermatologic Agents|dermatologic agents|mesh-ancestor
24861479|NCT02318043|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24861480|NCT02318043|Glucocorticoids|glucocorticoids|mesh-ancestor
24861481|NCT02318043|Hormones|hormones|mesh-ancestor
24861493|NCT02318056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24861494|NCT02318056|Laxatives|laxatives|mesh-ancestor
24861495|NCT02318056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24861496|NCT02318056|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24861497|NCT02318082|Aldesleukin|aldesleukin|mesh-list
24861498|NCT02318082|Interleukin-2|interleukin-2|mesh-list
24637374|NCT01149980|Dexetimide|dexetimide|mesh-list
24861518|NCT02318225|Abortifacient Agents|abortifacient agents|mesh-ancestor
25065085|NCT03453632|Cholinergic Agents|cholinergic agents|mesh-ancestor
24861607|NCT02319018|Antidotes|antidotes|mesh-ancestor
24861608|NCT02319018|Protective Agents|protective agents|mesh-ancestor
24861609|NCT02319018|Vitamin B Complex|vitamin b complex|mesh-ancestor
24861610|NCT02319018|Vitamins|vitamins|mesh-ancestor
24861611|NCT02319018|Micronutrients|micronutrients|mesh-ancestor
24861612|NCT02319018|Hematinics|hematinics|mesh-ancestor
24861613|NCT02319135|Cytarabine|cytarabine|mesh-list
24861614|NCT02319135|Fludarabine|fludarabine|mesh-list
24861615|NCT02319135|Lenograstim|lenograstim|mesh-list
24861616|NCT02319135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861617|NCT02319135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24861618|NCT02319135|Antimetabolites|antimetabolites|mesh-ancestor
24861619|NCT02319135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861620|NCT02319135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24861621|NCT02319135|Immunologic Factors|immunologic factors|mesh-ancestor
24861622|NCT02319135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861623|NCT02319135|Antiviral Agents|antiviral agents|mesh-ancestor
24861624|NCT02319135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24861658|NCT02319343|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24861659|NCT02319343|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24861660|NCT02319343|Prednisolone|prednisolone|mesh-list
24861661|NCT02319343|Prednisolone acetate|prednisolone acetate|mesh-list
24637394|NCT01149993|Mycophenolic Acid|mycophenolic acid|mesh-list
24861711|NCT02319577|Tubulin Modulators|tubulin modulators|mesh-ancestor
24861712|NCT02319577|Antimitotic Agents|antimitotic agents|mesh-ancestor
24861713|NCT02319577|Mitosis Modulators|mitosis modulators|mesh-ancestor
25868188|NCT00111150|Antiviral Agents|antiviral agents|mesh-ancestor
24875158|NCT04408586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24875159|NCT04408586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875160|NCT04373265|Pembrolizumab|pembrolizumab|mesh-list
24875161|NCT04373265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24875162|NCT04373265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861714|NCT02319577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862026|NCT02322346|Anesthetics, Local|anesthetics, local|mesh-ancestor
24861715|NCT02319577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24861716|NCT02319577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24861718|NCT02319616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24861719|NCT02319616|Glucocorticoids|glucocorticoids|mesh-ancestor
24861720|NCT02319616|Hormones|hormones|mesh-ancestor
24861722|NCT02319616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861723|NCT02319629|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24861724|NCT02319629|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24861725|NCT02319629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24861726|NCT02319707|Oxytocin|oxytocin|mesh-list
24861727|NCT02319707|Oxytocics|oxytocics|mesh-ancestor
24861728|NCT02319707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25868189|NCT00111150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24875186|NCT04345913|Antimitotic Agents|antimitotic agents|mesh-ancestor
24875187|NCT04345913|Mitosis Modulators|mitosis modulators|mesh-ancestor
24875188|NCT04345913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875190|NCT04343248|Nitazoxanide|nitazoxanide|mesh-list
25868190|NCT00111150|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25868191|NCT00111150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25868192|NCT00111150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868193|NCT00111150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861741|NCT02319889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861742|NCT02319915|Tranexamic Acid|tranexamic acid|mesh-list
24861743|NCT02319915|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24861744|NCT02319915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24861745|NCT02319915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861806|NCT02320240|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24861807|NCT02320240|Analgesics|analgesics|mesh-ancestor
24861808|NCT02320240|Sensory System Agents|sensory system agents|mesh-ancestor
24861809|NCT02320240|Dopamine Agents|dopamine agents|mesh-ancestor
24861810|NCT02320240|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24861811|NCT02320240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24861812|NCT02320240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24861813|NCT02320240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24861818|NCT02320357|Clopidogrel|clopidogrel|mesh-list
24861819|NCT02320357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24861944|NCT02321384|Antiviral Agents|antiviral agents|mesh-ancestor
24861945|NCT02321384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24861956|NCT02321397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24861957|NCT02321397|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24861959|NCT02321501|Ceritinib|ceritinib|mesh-list
24541860|NCT00675701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861978|NCT02321761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24861993|NCT02321839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861994|NCT02321852|Mannitol|mannitol|mesh-list
24861995|NCT02321852|Triflusal|triflusal|mesh-list
24861996|NCT02321852|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24862019|NCT02322203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24862020|NCT02322203|Vasodilator Agents|vasodilator agents|mesh-ancestor
24862021|NCT02322203|Vitamin B Complex|vitamin b complex|mesh-ancestor
24862022|NCT02322203|Vitamins|vitamins|mesh-ancestor
24862023|NCT02322203|Micronutrients|micronutrients|mesh-ancestor
24862024|NCT02322203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683744|NCT01393795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24875239|NCT04316702|Analgesics|analgesics|mesh-ancestor
24786526|NCT01920516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24786527|NCT01920516|Immunologic Factors|immunologic factors|mesh-ancestor
24786528|NCT01920516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786529|NCT01920542|Dexmedetomidine|dexmedetomidine|mesh-list
24786530|NCT01920542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24786531|NCT01920542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25065108|NCT03453346|Antiviral Agents|antiviral agents|mesh-ancestor
24786532|NCT01920542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786533|NCT01920542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24786535|NCT01920542|Sensory System Agents|sensory system agents|mesh-ancestor
24786536|NCT01920542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24786537|NCT01920542|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24786538|NCT01920542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24786539|NCT01920542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24786540|NCT01920542|Adrenergic Agents|adrenergic agents|mesh-ancestor
24786541|NCT01920542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24786542|NCT01920542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578771|NCT00851708|Expectorants|expectorants|mesh-ancestor
24862025|NCT02322346|Levobupivacaine|levobupivacaine|mesh-list
25108594|NCT03131882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742326|NCT05275491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25065125|NCT03453190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25065126|NCT03453190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25065127|NCT03453190|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25108597|NCT03131882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25108598|NCT03131882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108599|NCT03131882|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25108600|NCT03131882|Viscosupplements|viscosupplements|mesh-ancestor
25108601|NCT03131882|Protective Agents|protective agents|mesh-ancestor
25108602|NCT03131765|Poly I-C|poly i-c|mesh-list
25108603|NCT03131765|Antiviral Agents|antiviral agents|mesh-ancestor
25108604|NCT03131765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24862070|NCT02322645|Eszopiclone|eszopiclone|mesh-list
24862073|NCT02322645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862077|NCT02322658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862078|NCT02322671|Montelukast|montelukast|mesh-list
24862079|NCT02322671|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24862080|NCT02322671|Respiratory System Agents|respiratory system agents|mesh-ancestor
24862081|NCT02322671|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24862082|NCT02322671|Hormone Antagonists|hormone antagonists|mesh-ancestor
24862083|NCT02322671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24862084|NCT02322671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862085|NCT02322671|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24862086|NCT02322671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24862087|NCT02322671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862089|NCT02322853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24862090|NCT02322853|Hormone Antagonists|hormone antagonists|mesh-ancestor
24813422|NCT02058446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24813423|NCT02058446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813425|NCT02058446|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24542433|NCT00678704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542434|NCT00678704|Urological Agents|urological agents|mesh-ancestor
24542435|NCT00678743|Simvastatin|simvastatin|mesh-list
24542436|NCT00678743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24542437|NCT00678743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24542438|NCT00678743|Antimetabolites|antimetabolites|mesh-ancestor
24542439|NCT00678743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868194|NCT00111150|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25868195|NCT00111150|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25868196|NCT00111163|Artesunate|artesunate|mesh-list
25868197|NCT00111163|Pyrimethamine|pyrimethamine|mesh-list
25868198|NCT00111163|Sulfadoxine|sulfadoxine|mesh-list
25868199|NCT00111163|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25868200|NCT00111163|Amodiaquine|amodiaquine|mesh-list
24863039|NCT03693846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544191|NCT00687700|Adrenergic Agents|adrenergic agents|mesh-ancestor
24544192|NCT00687700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25868201|NCT00111163|Dapsone|dapsone|mesh-list
25868202|NCT00111163|Chlorproguanil|chlorproguanil|mesh-list
24875365|NCT04220008|Antitubercular Agents|antitubercular agents|mesh-ancestor
24864434|NCT04440358|Carboplatin|carboplatin|mesh-list
24864435|NCT04440358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864436|NCT04339140|Zafirlukast|zafirlukast|mesh-list
24864437|NCT04339140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24864438|NCT04339140|Respiratory System Agents|respiratory system agents|mesh-ancestor
24864439|NCT04339140|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24813887|NCT02060786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24813888|NCT02060786|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24866498|NCT04778267|Anesthetics|anesthetics|mesh-ancestor
24813889|NCT02060786|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24813890|NCT02060786|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24813891|NCT02060786|Purinergic Agents|purinergic agents|mesh-ancestor
24813892|NCT02060786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25433065|NCT00588770|Bevacizumab|bevacizumab|mesh-list
25868203|NCT00111163|Antimalarials|antimalarials|mesh-ancestor
25868204|NCT00111163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24421590|NCT00219726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24421753|NCT00220129|Capecitabine|capecitabine|mesh-list
25125716|NCT03067194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24813893|NCT02060786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813894|NCT02060786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813895|NCT02060851|Iron|iron|mesh-list
24813896|NCT02060851|Trace Elements|trace elements|mesh-ancestor
24911592|NCT04286087|Anesthetics|anesthetics|mesh-list
24813897|NCT02060851|Micronutrients|micronutrients|mesh-ancestor
24544356|NCT00688558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24864470|NCT03964207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24864471|NCT03964207|Autonomic Agents|autonomic agents|mesh-ancestor
24864472|NCT03964207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24864473|NCT03964207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864474|NCT03964207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24864475|NCT03964207|Respiratory System Agents|respiratory system agents|mesh-ancestor
24864476|NCT03964207|Parasympatholytics|parasympatholytics|mesh-ancestor
24864477|NCT03964207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24864478|NCT03964207|Cholinergic Agents|cholinergic agents|mesh-ancestor
24633249|NCT01127724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633250|NCT01127724|Hematinics|hematinics|mesh-ancestor
24864479|NCT03964207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24864480|NCT03964207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813939|NCT02061267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24813940|NCT02061267|Antimetabolites|antimetabolites|mesh-ancestor
24813941|NCT02061267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813942|NCT02061267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24813943|NCT02061267|Vasodilator Agents|vasodilator agents|mesh-ancestor
24813944|NCT02061449|Romidepsin|romidepsin|mesh-list
24813945|NCT02061449|Poly ICLC|poly iclc|mesh-list
24813946|NCT02061449|Interferon Inducers|interferon inducers|mesh-ancestor
24813947|NCT02061449|Immunologic Factors|immunologic factors|mesh-ancestor
24813948|NCT02061449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813949|NCT02061449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24813950|NCT02061449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813951|NCT02061475|Lidocaine|lidocaine|mesh-list
24911604|NCT04286152|Mirabegron|mirabegron|mesh-list
25108605|NCT03131765|Interferon Inducers|interferon inducers|mesh-ancestor
24813952|NCT02061475|Anesthetics, Local|anesthetics, local|mesh-ancestor
24813953|NCT02061475|Anesthetics|anesthetics|mesh-ancestor
24813954|NCT02061475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24813955|NCT02061475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813956|NCT02061475|Sensory System Agents|sensory system agents|mesh-ancestor
24813957|NCT02061475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24813958|NCT02061475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24813959|NCT02061475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24813960|NCT02061475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24813961|NCT02061475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24686566|NCT04699383|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
24864563|NCT03368729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864564|NCT03368729|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24864565|NCT03368729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864566|NCT03368729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864567|NCT03344341|Dapagliflozin|dapagliflozin|mesh-list
24864569|NCT03344341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24864570|NCT03344341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814300|NCT02063789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814303|NCT02063802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814304|NCT02063841|Bismuth|bismuth|mesh-list
24814305|NCT02063841|Antacids|antacids|mesh-ancestor
24814306|NCT02063841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814307|NCT02063841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24814342|NCT02064036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814343|NCT02064036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24814344|NCT02064036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24814345|NCT02064036|Androgen Antagonists|androgen antagonists|mesh-ancestor
24814346|NCT02064036|Hormone Antagonists|hormone antagonists|mesh-ancestor
24814347|NCT02064036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24814348|NCT02064049|Sofosbuvir|sofosbuvir|mesh-list
24866493|NCT04778267|Hormones|hormones|mesh-ancestor
24866494|NCT04778267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24866495|NCT04778267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25670808|NCT03856216|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25670809|NCT03856216|Tacrolimus|tacrolimus|mesh-list
25670810|NCT03856216|Lenograstim|lenograstim|mesh-list
25670811|NCT03856216|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24866496|NCT04778267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866497|NCT04778267|Anesthetics, Local|anesthetics, local|mesh-ancestor
24866937|NCT03908307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24866939|NCT03908307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866940|NCT03908307|Protease Inhibitors|protease inhibitors|mesh-ancestor
24866941|NCT03908307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866942|NCT03908307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866944|NCT03878979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24866945|NCT03878979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866946|NCT03878979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25868205|NCT00111163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24610140|NCT00999973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610141|NCT00999973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24610142|NCT00999973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610143|NCT00999986|Cyclophosphamide|cyclophosphamide|mesh-list
24610144|NCT00999986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24547065|NCT00702156|Adrenergic Agents|adrenergic agents|mesh-ancestor
24867036|NCT03739138|Pembrolizumab|pembrolizumab|mesh-list
24867037|NCT03739138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24867038|NCT03739138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24867339|NCT01064245|Mannitol|mannitol|mesh-list
24867340|NCT01064245|Methacholine Chloride|methacholine chloride|mesh-list
24867341|NCT01064245|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25201950|NCT02724358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201951|NCT02724358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25868206|NCT00111163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24867342|NCT01064245|Diuretics|diuretics|mesh-ancestor
24867343|NCT01064245|Natriuretic Agents|natriuretic agents|mesh-ancestor
25065165|NCT03452579|Bevacizumab|bevacizumab|mesh-list
24911675|NCT04285268|Immunoglobulins|immunoglobulins|mesh-list
24911676|NCT04285268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24911677|NCT04285268|Immunologic Factors|immunologic factors|mesh-ancestor
24911690|NCT04285346|GABA Modulators|gaba modulators|mesh-ancestor
24911691|NCT04285346|GABA Agents|gaba agents|mesh-ancestor
25065171|NCT03452579|Growth Substances|growth substances|mesh-ancestor
25065173|NCT03452579|Growth Inhibitors|growth inhibitors|mesh-ancestor
24867344|NCT01064245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867345|NCT01064245|Miotics|miotics|mesh-ancestor
24867346|NCT01064245|Autonomic Agents|autonomic agents|mesh-ancestor
24867347|NCT01064245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24867349|NCT01064245|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
24867350|NCT01064245|Respiratory System Agents|respiratory system agents|mesh-ancestor
24867351|NCT01064245|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24867352|NCT01064245|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24867353|NCT01064245|Cholinergic Agents|cholinergic agents|mesh-ancestor
24547394|NCT00703703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867683|NCT03194165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24867684|NCT03194165|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24867685|NCT03194165|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24867686|NCT03179475|Oxycodone|oxycodone|mesh-list
24814430|NCT02064517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814431|NCT02064530|Dexmedetomidine|dexmedetomidine|mesh-list
24814432|NCT02064530|Bupivacaine|bupivacaine|mesh-list
24814433|NCT02064530|Anesthetics, Local|anesthetics, local|mesh-ancestor
24814434|NCT02064530|Anesthetics|anesthetics|mesh-ancestor
24814435|NCT02064530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24814436|NCT02064530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814437|NCT02064530|Sensory System Agents|sensory system agents|mesh-ancestor
25108607|NCT03131765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814438|NCT02064530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24814439|NCT02064530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24814440|NCT02064530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24814441|NCT02064530|Analgesics|analgesics|mesh-ancestor
24814442|NCT02064530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24814443|NCT02064530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24814444|NCT02064530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24547801|NCT00705796|Methyltestosterone|methyltestosterone|mesh-list
24547802|NCT00705796|Testosterone|testosterone|mesh-list
24867839|NCT05154747|Antiviral Agents|antiviral agents|mesh-ancestor
24867840|NCT05154747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24867841|NCT05154747|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24867842|NCT05154747|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24867843|NCT05154747|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24867844|NCT05154747|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24867845|NCT05154682|Acetaminophen|acetaminophen|mesh-list
24867846|NCT05154682|Naproxen|naproxen|mesh-list
24814575|NCT02065466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24814576|NCT02065466|Alkylating Agents|alkylating agents|mesh-ancestor
24814578|NCT02065492|Calcium Channel Blockers|calcium channel blockers|mesh-list
24814579|NCT02065492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24814580|NCT02065492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814581|NCT02065492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24814582|NCT02065492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24814583|NCT02065492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814584|NCT02065492|Vasodilator Agents|vasodilator agents|mesh-ancestor
24814585|NCT02065609|Trastuzumab|trastuzumab|mesh-list
24814586|NCT02065609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24814587|NCT02065609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24814588|NCT02065739|Itraconazole|itraconazole|mesh-list
24814589|NCT02065739|JNJ-42165279|jnj-42165279|mesh-list
24814590|NCT02065739|Antifungal Agents|antifungal agents|mesh-ancestor
24814591|NCT02065739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24814592|NCT02065739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24814593|NCT02065739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24548513|NCT00709982|Contraceptive Agents|contraceptive agents|mesh-ancestor
24868809|NCT02259517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868207|NCT00111163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201952|NCT02724358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653435|NCT01243827|Carvedilol|carvedilol|mesh-list
24744810|NCT04132232|Carbon Monoxide|carbon monoxide|mesh-list
24744811|NCT04132232|Antimetabolites|antimetabolites|mesh-ancestor
24744812|NCT04132232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744869|NCT04099667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744870|NCT04099667|Cholinergic Agents|cholinergic agents|mesh-ancestor
24744871|NCT04099667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24744876|NCT04096066|Dexamethasone|dexamethasone|mesh-list
25108609|NCT03131622|Keratolytic Agents|keratolytic agents|mesh-ancestor
25108610|NCT03131622|Dermatologic Agents|dermatologic agents|mesh-ancestor
25108611|NCT03131583|Colchicine|colchicine|mesh-list
25108612|NCT03131583|Febuxostat|febuxostat|mesh-list
25108613|NCT03131583|Gout Suppressants|gout suppressants|mesh-ancestor
25108614|NCT03131583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25108615|NCT03131583|Tubulin Modulators|tubulin modulators|mesh-ancestor
25108616|NCT03131583|Antimitotic Agents|antimitotic agents|mesh-ancestor
25108617|NCT03131583|Mitosis Modulators|mitosis modulators|mesh-ancestor
25108618|NCT03131583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108619|NCT03131583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108620|NCT03131336|Fibrin Foam|fibrin foam|mesh-list
24875832|NCT03819465|Pemetrexed|pemetrexed|mesh-list
24875833|NCT03819465|Durvalumab|durvalumab|mesh-list
24875834|NCT03819465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24875835|NCT03819465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24875836|NCT03819465|Tubulin Modulators|tubulin modulators|mesh-ancestor
24875837|NCT03819465|Antimitotic Agents|antimitotic agents|mesh-ancestor
24875838|NCT03819465|Mitosis Modulators|mitosis modulators|mesh-ancestor
25108639|NCT03130933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25108640|NCT03130933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25108641|NCT03131050|Scopolamine|scopolamine|mesh-list
25108642|NCT03131050|Citalopram|citalopram|mesh-list
25108643|NCT03131050|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25108644|NCT03131050|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25108645|NCT03131050|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25108646|NCT03131050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24875876|NCT03816332|Prednisone|prednisone|mesh-list
25108647|NCT03131050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108648|NCT03131050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25108649|NCT03131050|Serotonin Agents|serotonin agents|mesh-ancestor
25108650|NCT03131050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108651|NCT03131050|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25108652|NCT03131050|Antidepressive Agents|antidepressive agents|mesh-ancestor
25108653|NCT03131050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25108654|NCT03131050|Parasympatholytics|parasympatholytics|mesh-ancestor
25201953|NCT02724202|Curcumin|curcumin|mesh-list
25201954|NCT02724202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25201955|NCT02724202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25201956|NCT02724202|Analgesics|analgesics|mesh-ancestor
25201957|NCT02724202|Sensory System Agents|sensory system agents|mesh-ancestor
25201958|NCT02724202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25201959|NCT02724202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25433384|NCT00547196|Immunologic Factors|immunologic factors|mesh-ancestor
25868208|NCT00111163|Antiviral Agents|antiviral agents|mesh-ancestor
25108655|NCT03131050|Autonomic Agents|autonomic agents|mesh-ancestor
25108656|NCT03131050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108657|NCT03131050|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25108658|NCT03131050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25108659|NCT03131050|Cholinergic Agents|cholinergic agents|mesh-ancestor
25108660|NCT03131050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25108662|NCT03131050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25108663|NCT03131050|Mydriatics|mydriatics|mesh-ancestor
25108664|NCT03131063|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25089503|NCT03265002|Psyllium|psyllium|mesh-list
25108665|NCT03131063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24868976|NCT05157542|Durvalumab|durvalumab|mesh-list
25089504|NCT03265002|Calcium polycarbophil|calcium polycarbophil|mesh-list
24868977|NCT05157542|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24868978|NCT05157542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24875887|NCT03816332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458515|NCT00338247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24869263|NCT04278404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24869442|NCT03769376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869444|NCT03645863|Trace Elements|trace elements|mesh-ancestor
24869445|NCT03645863|Micronutrients|micronutrients|mesh-ancestor
24869446|NCT03645863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869447|NCT03564145|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24869448|NCT03564145|Dermatologic Agents|dermatologic agents|mesh-ancestor
24869449|NCT03564119|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24869450|NCT03564119|Dermatologic Agents|dermatologic agents|mesh-ancestor
24869451|NCT03476369|Fentanyl|fentanyl|mesh-list
24869452|NCT03476369|Ticagrelor|ticagrelor|mesh-list
24869453|NCT03476369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24869454|NCT03476369|Narcotics|narcotics|mesh-ancestor
24869939|NCT05070650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24869940|NCT05070650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869942|NCT05070650|Antiviral Agents|antiviral agents|mesh-ancestor
24875911|NCT03813147|Antimetabolites|antimetabolites|mesh-ancestor
24875912|NCT03813147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875913|NCT03813147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24875914|NCT03813147|Dermatologic Agents|dermatologic agents|mesh-ancestor
24875915|NCT03813147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24875916|NCT03813147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25868209|NCT00111163|Schistosomicides|schistosomicides|mesh-ancestor
24870626|NCT04821284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24870805|NCT03691584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870806|NCT03654729|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
24870808|NCT03654729|Anticoagulants|anticoagulants|mesh-ancestor
24870809|NCT03654729|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24870810|NCT03654729|Chelating Agents|chelating agents|mesh-ancestor
24870811|NCT03654729|Sequestering Agents|sequestering agents|mesh-ancestor
24870812|NCT03654729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870813|NCT03654729|Vitamin B Complex|vitamin b complex|mesh-ancestor
24870814|NCT03654729|Vitamins|vitamins|mesh-ancestor
25065205|NCT03452332|Durvalumab|durvalumab|mesh-list
25065210|NCT03452332|Immunoglobulin G|immunoglobulin g|mesh-list
25065211|NCT03452332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25065212|NCT03452332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065213|NCT03452332|Immunologic Factors|immunologic factors|mesh-ancestor
25065214|NCT03452332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065215|NCT03452332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25868210|NCT00111163|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24870815|NCT03654729|Micronutrients|micronutrients|mesh-ancestor
24870816|NCT03654729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870817|NCT03462290|Botulinum Toxins|botulinum toxins|mesh-list
24870818|NCT03462290|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24870822|NCT03462290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870823|NCT03462290|Cholinergic Agents|cholinergic agents|mesh-ancestor
24870824|NCT03462290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24870825|NCT03462290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870826|NCT03462290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24693266|NCT01419340|Donepezil|donepezil|mesh-list
24871068|NCT05163366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871069|NCT05163366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24871070|NCT05163366|Narcotics|narcotics|mesh-ancestor
24871071|NCT05163249|Osimertinib|osimertinib|mesh-list
24871072|NCT05163249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871073|NCT05163249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24871074|NCT05163249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25433537|NCT00479128|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24871156|NCT04658173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871157|NCT04658173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25201961|NCT02724202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25868211|NCT00111163|Anthelmintics|anthelmintics|mesh-ancestor
25868212|NCT00111163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25868213|NCT00111163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868214|NCT00111163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868215|NCT00111163|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25868216|NCT00111163|Renal Agents|renal agents|mesh-ancestor
25868217|NCT00111163|Leprostatic Agents|leprostatic agents|mesh-ancestor
24564527|NCT00776646|Diuretics|diuretics|mesh-ancestor
24871158|NCT04658173|Anesthetics, General|anesthetics, general|mesh-ancestor
24871159|NCT04658173|Anesthetics|anesthetics|mesh-ancestor
25868218|NCT00111163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24871286|NCT04050085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871287|NCT04050085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24871288|NCT04050085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871289|NCT04002362|Triamcinolone|triamcinolone|mesh-list
24871290|NCT04002362|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24871291|NCT04002362|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24871326|NCT03695250|Nivolumab|nivolumab|mesh-list
24871327|NCT03695250|Linrodostat|linrodostat|mesh-list
24871328|NCT03695250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24871364|NCT03205553|Dialysis Solutions|dialysis solutions|mesh-list
24871365|NCT03205553|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24871482|NCT02375555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24871559|NCT05165914|Anesthetics, General|anesthetics, general|mesh-ancestor
24871560|NCT05165914|GABA Modulators|gaba modulators|mesh-ancestor
24871561|NCT05165914|GABA Agents|gaba agents|mesh-ancestor
24871562|NCT05165914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24871563|NCT05165914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871567|NCT05165641|Anesthetics|anesthetics|mesh-list
24871603|NCT05164770|Doxorubicin|doxorubicin|mesh-list
24871604|NCT05164770|Etoposide|etoposide|mesh-list
24871605|NCT05164770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871606|NCT05164770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24871638|NCT05164627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24871639|NCT05164627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24871640|NCT05164627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24871641|NCT05164627|Adrenergic Agents|adrenergic agents|mesh-ancestor
24871642|NCT05164627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24871643|NCT05164627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871644|NCT05164627|Anesthetics|anesthetics|mesh-ancestor
24871645|NCT05164627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24871646|NCT05164627|Anticonvulsants|anticonvulsants|mesh-ancestor
24871678|NCT05145621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871679|NCT05145621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24871681|NCT05145621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871682|NCT05110209|Bevacizumab|bevacizumab|mesh-list
24814869|NCT02067078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24814870|NCT02067078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24814871|NCT02067078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24814903|NCT02067143|Antiviral Agents|antiviral agents|mesh-ancestor
24876327|NCT03597568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25201962|NCT02724202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201964|NCT02724202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201965|NCT02724150|Omeprazole|omeprazole|mesh-list
25201966|NCT02724150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25201967|NCT02724150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25201968|NCT02724150|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25201969|NCT02724150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24876328|NCT03595982|Nifedipine|nifedipine|mesh-list
24876329|NCT03595982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24876330|NCT03595982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24887634|NCT04514029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24876331|NCT03595982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872821|NCT05439798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24872822|NCT05439798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786621|NCT01920984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24786623|NCT01920984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786624|NCT01920984|Growth Inhibitors|growth inhibitors|mesh-ancestor
24786626|NCT01921010|Nicotinic Acids|nicotinic acids|mesh-list
24874315|NCT04830215|Dopamine Agonists|dopamine agonists|mesh-ancestor
24874318|NCT04822350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24874319|NCT04822350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868219|NCT00111189|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25868220|NCT00111189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25868221|NCT00111189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24874398|NCT04774965|Dermatologic Agents|dermatologic agents|mesh-ancestor
24874399|NCT04767984|Calcium, Dietary|calcium, dietary|mesh-list
24874400|NCT04767984|Atorvastatin|atorvastatin|mesh-list
24874401|NCT04767984|Calcium|calcium|mesh-list
24874758|NCT04576104|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24874956|NCT04492033|Irinotecan|irinotecan|mesh-list
24874957|NCT04492033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24874985|NCT04487756|Carboplatin|carboplatin|mesh-list
24874986|NCT04487756|Atezolizumab|atezolizumab|mesh-list
24874987|NCT04487756|Vaccines|vaccines|mesh-list
24874988|NCT04487756|Immunologic Factors|immunologic factors|mesh-ancestor
24874989|NCT04487756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24874990|NCT04487756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868222|NCT00111189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25868223|NCT00111189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24874991|NCT04481204|Leucovorin|leucovorin|mesh-list
24874992|NCT04481204|Gemcitabine|gemcitabine|mesh-list
24876526|NCT03449238|Pembrolizumab|pembrolizumab|mesh-list
24876528|NCT03449238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815333|NCT02069665|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24815334|NCT02069665|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24815335|NCT02069665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24815336|NCT02069665|Adrenergic Agents|adrenergic agents|mesh-ancestor
24815337|NCT02069665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24815338|NCT02069665|Expectorants|expectorants|mesh-ancestor
25108679|NCT03130842|Midazolam|midazolam|mesh-list
25108680|NCT03130842|Alprazolam|alprazolam|mesh-list
24875226|NCT04329325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24875227|NCT04329325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24875228|NCT04329325|Immunologic Factors|immunologic factors|mesh-ancestor
24875229|NCT04329325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24875230|NCT04329325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24875231|NCT04329325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24875731|NCT03896269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875732|NCT03896269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24875733|NCT03896269|Antiviral Agents|antiviral agents|mesh-ancestor
24875734|NCT03896269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24875735|NCT03896269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24875736|NCT03896269|Immunologic Factors|immunologic factors|mesh-ancestor
24815359|NCT02069886|Sequestering Agents|sequestering agents|mesh-ancestor
24815360|NCT02069886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815361|NCT02069977|Aripiprazole|aripiprazole|mesh-list
24815362|NCT02069977|Antidepressive Agents|antidepressive agents|mesh-ancestor
24875753|NCT03878095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875796|NCT03839823|Immunologic Factors|immunologic factors|mesh-ancestor
24875797|NCT03839823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24875798|NCT03839823|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24875799|NCT03839823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24875800|NCT03839823|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24875801|NCT03839823|Hormone Antagonists|hormone antagonists|mesh-ancestor
24875802|NCT03839823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24876048|NCT03761095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24876049|NCT03761095|Alkylating Agents|alkylating agents|mesh-ancestor
24876050|NCT03761095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24876051|NCT03761095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24876052|NCT03745352|Azacitidine|azacitidine|mesh-list
24876053|NCT03745352|Enzyme Inhibitors|enzyme inhibitors|mesh-list
24876054|NCT03745352|Pevonedistat|pevonedistat|mesh-list
24876230|NCT03656068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24876393|NCT03579446|Morphine|morphine|mesh-list
24876594|NCT03345784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24876595|NCT03345784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24876717|NCT03300544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24699125|NCT01445106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24876721|NCT03270020|Denosumab|denosumab|mesh-list
24876722|NCT03270020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25868224|NCT00111189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25868225|NCT00111189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25125850|NCT03066076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24876723|NCT03270020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24876724|NCT03263078|Propofol|propofol|mesh-list
24876725|NCT03263078|Sevoflurane|sevoflurane|mesh-list
24876726|NCT03263078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25108685|NCT03130842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25108686|NCT03130842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25108687|NCT03130842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25108696|NCT03130829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25108697|NCT03130829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25108698|NCT03130829|Anticoagulants|anticoagulants|mesh-ancestor
25108699|NCT03130829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201972|NCT02724098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25108700|NCT03130764|Durvalumab|durvalumab|mesh-list
25108701|NCT03130764|Tremelimumab|tremelimumab|mesh-list
25108702|NCT03130764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25108703|NCT03130764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108704|NCT03130504|Progesterone|progesterone|mesh-list
25108705|NCT03130504|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
25108706|NCT03130504|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
25108707|NCT03130504|Progestins|progestins|mesh-ancestor
25108708|NCT03130504|Hormones|hormones|mesh-ancestor
24851268|NCT02256228|Ropivacaine|ropivacaine|mesh-list
24877060|NCT02974621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24815491|NCT02070510|Warfarin|warfarin|mesh-list
24815492|NCT02070510|Anticoagulants|anticoagulants|mesh-ancestor
24815493|NCT02070510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24815494|NCT02070510|Protease Inhibitors|protease inhibitors|mesh-ancestor
24815495|NCT02070510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815523|NCT02070718|Sensory System Agents|sensory system agents|mesh-ancestor
24815524|NCT02070718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24815525|NCT02070718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24877118|NCT02935205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24815526|NCT02070718|Narcotics|narcotics|mesh-ancestor
24877123|NCT02935205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24877124|NCT02935205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878667|NCT01281176|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24878670|NCT01281176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24879246|NCT04923737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879248|NCT04923737|Analgesics|analgesics|mesh-ancestor
24879614|NCT04622735|Acetaminophen|acetaminophen|mesh-list
24879615|NCT04622735|Nefopam|nefopam|mesh-list
24879616|NCT04622735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24879617|NCT04622735|Analgesics|analgesics|mesh-ancestor
24912082|NCT04281290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24912083|NCT04281290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912084|NCT04281342|Moxifloxacin|moxifloxacin|mesh-list
24879985|NCT04256824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24880650|NCT03526354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24880683|NCT03463993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24880684|NCT03463993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815919|NCT02072720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815920|NCT02072720|Growth Inhibitors|growth inhibitors|mesh-ancestor
24815921|NCT02072746|Zinc|zinc|mesh-list
24815922|NCT02072746|Zinc Sulfate|zinc sulfate|mesh-list
24815923|NCT02072746|Trace Elements|trace elements|mesh-ancestor
24815924|NCT02072746|Micronutrients|micronutrients|mesh-ancestor
24702963|NCT01468740|Prednisone|prednisone|mesh-list
24880771|NCT03391869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201973|NCT02724098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25201974|NCT02724098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24877188|NCT02897648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24877189|NCT02897648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24880781|NCT03344419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25108733|NCT03130452|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25108735|NCT03130452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108736|NCT03130452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25670812|NCT03856216|Immunologic Factors|immunologic factors|mesh-ancestor
25670813|NCT03856216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670814|NCT03856216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108739|NCT03130452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25670815|NCT03856216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24815981|NCT02073149|Trace Elements|trace elements|mesh-ancestor
24815982|NCT02073149|Micronutrients|micronutrients|mesh-ancestor
24815983|NCT02073149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623428|NCT01071369|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24623429|NCT01071369|Anesthetics, Local|anesthetics, local|mesh-ancestor
24882386|NCT00950989|Hematinics|hematinics|mesh-ancestor
24885417|NCT05173090|Sensory System Agents|sensory system agents|mesh-ancestor
24885418|NCT05173090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24981554|NCT02682511|Ifetroban|ifetroban|mesh-list
24885420|NCT05172934|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24464420|NCT00364806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24885499|NCT05171985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24816393|NCT02076815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24816394|NCT02076828|Zinc|zinc|mesh-list
24816395|NCT02076828|Glycine|glycine|mesh-list
24816396|NCT02076828|Trace Elements|trace elements|mesh-ancestor
24816397|NCT02076828|Micronutrients|micronutrients|mesh-ancestor
24816398|NCT02076828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816399|NCT02076828|Glycine Agents|glycine agents|mesh-ancestor
24464450|NCT00364988|Losartan|losartan|mesh-list
24885609|NCT05030272|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24885610|NCT05030272|Autonomic Agents|autonomic agents|mesh-ancestor
24885611|NCT05030272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24885612|NCT05030272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885798|NCT04607928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24885799|NCT04607928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868226|NCT00111189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25868227|NCT00111189|Serotonin Agents|serotonin agents|mesh-ancestor
25868228|NCT00111189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25868229|NCT00111189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886141|NCT02963610|Lenalidomide|lenalidomide|mesh-list
24886142|NCT02963610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24886491|NCT04525495|Sympathomimetics|sympathomimetics|mesh-ancestor
24886492|NCT04525495|Autonomic Agents|autonomic agents|mesh-ancestor
24886558|NCT04525235|Respiratory System Agents|respiratory system agents|mesh-ancestor
24886559|NCT04525235|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24886560|NCT04525235|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24886561|NCT04525235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24886562|NCT04525274|Dexmedetomidine|dexmedetomidine|mesh-list
24886563|NCT04525274|Ketamine|ketamine|mesh-list
24886564|NCT04525274|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24886565|NCT04525274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24465181|NCT00368134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886651|NCT04523844|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24886653|NCT04523844|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24886654|NCT04523844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24886655|NCT04523844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24886656|NCT04523844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24886657|NCT04523844|Adrenergic Agents|adrenergic agents|mesh-ancestor
24886658|NCT04523844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25201975|NCT02724098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25201976|NCT02724098|Analgesics|analgesics|mesh-ancestor
24886659|NCT04523844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886660|NCT04523844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886691|NCT04523623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24886693|NCT04523623|Sensory System Agents|sensory system agents|mesh-ancestor
24886694|NCT04523623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24886695|NCT04523623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886696|NCT04523623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24886697|NCT04523623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24886698|NCT04523623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24886699|NCT04523623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886700|NCT04523623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886701|NCT04523623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24886702|NCT04523623|Narcotics|narcotics|mesh-ancestor
24886703|NCT04523623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24886705|NCT04523662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886706|NCT04523662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24886707|NCT04523662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886708|NCT04523662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886710|NCT04523675|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24886711|NCT04523675|Antiviral Agents|antiviral agents|mesh-ancestor
24886712|NCT04523675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24886713|NCT04523675|Expectorants|expectorants|mesh-ancestor
24886714|NCT04523675|Respiratory System Agents|respiratory system agents|mesh-ancestor
24886751|NCT04523272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24886753|NCT04523272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886754|NCT04523077|Antibodies|antibodies|mesh-list
24886755|NCT04523077|Hormones|hormones|mesh-list
24886756|NCT04523077|Immunologic Factors|immunologic factors|mesh-ancestor
24886757|NCT04523077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886758|NCT04523077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24886762|NCT04522882|Insulin|insulin|mesh-list
24886900|NCT04521400|Interferon beta-1a|interferon beta-1a|mesh-list
24886901|NCT04521400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886902|NCT04521400|Antiviral Agents|antiviral agents|mesh-ancestor
24886903|NCT04521400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24886904|NCT04521400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24886905|NCT04521400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24886906|NCT04521400|Protease Inhibitors|protease inhibitors|mesh-ancestor
24886907|NCT04521400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886908|NCT04521400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886909|NCT04521400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24886910|NCT04521400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24465368|NCT00369239|Dopamine Agents|dopamine agents|mesh-ancestor
24887036|NCT04520880|Immunologic Factors|immunologic factors|mesh-ancestor
24887037|NCT04520880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887038|NCT04520919|Anesthetics|anesthetics|mesh-list
24816615|NCT02077946|Protease Inhibitors|protease inhibitors|mesh-ancestor
24816616|NCT02077946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709396|NCT01505413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887044|NCT04520503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887309|NCT04517526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24887310|NCT04517526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887311|NCT04517526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24887312|NCT04517526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24887313|NCT04517526|Growth Substances|growth substances|mesh-ancestor
24887314|NCT04517526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465612|NCT00370266|Hormones|hormones|mesh-ancestor
24887366|NCT04516850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887367|NCT04516850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887373|NCT04517188|Trace Elements|trace elements|mesh-ancestor
24887374|NCT04517188|Micronutrients|micronutrients|mesh-ancestor
24887375|NCT04517188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887377|NCT04517188|Blood Substitutes|blood substitutes|mesh-ancestor
24887586|NCT04514731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24887587|NCT04514731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887588|NCT04514731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24887590|NCT04514731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24887592|NCT04514796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24887593|NCT04514796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24887594|NCT04514419|Docetaxel|docetaxel|mesh-list
24887595|NCT04514419|Trastuzumab|trastuzumab|mesh-list
24887596|NCT04514419|Pertuzumab|pertuzumab|mesh-list
24887597|NCT04514419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887598|NCT04514419|Tubulin Modulators|tubulin modulators|mesh-ancestor
24887599|NCT04514419|Antimitotic Agents|antimitotic agents|mesh-ancestor
24887600|NCT04514419|Mitosis Modulators|mitosis modulators|mesh-ancestor
24887601|NCT04514419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887602|NCT04514419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24887603|NCT04514588|Caffeine|caffeine|mesh-list
24887751|NCT04513015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887753|NCT04513184|Dexamethasone acetate|dexamethasone acetate|mesh-list
24887754|NCT04513184|BB 1101|bb 1101|mesh-list
24887755|NCT04513184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24887756|NCT04513184|Antiemetics|antiemetics|mesh-ancestor
24887757|NCT04513184|Autonomic Agents|autonomic agents|mesh-ancestor
24887758|NCT04513184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816651|NCT02078089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24816652|NCT02078089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24466017|NCT00371553|Sunitinib|sunitinib|mesh-list
24887994|NCT04509466|Analgesics|analgesics|mesh-ancestor
24887995|NCT04509466|Sensory System Agents|sensory system agents|mesh-ancestor
24888029|NCT04509440|Glucocorticoids|glucocorticoids|mesh-ancestor
25108742|NCT03130426|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24888032|NCT04509440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24877737|NCT02473042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24888047|NCT04509323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888048|NCT04509323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25868230|NCT00111189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24888153|NCT04508686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888155|NCT04508439|Heparin|heparin|mesh-list
24888156|NCT04508439|Enoxaparin|enoxaparin|mesh-list
24888157|NCT04508439|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24888158|NCT04508439|Tinzaparin|tinzaparin|mesh-list
24888159|NCT04508439|Dalteparin|dalteparin|mesh-list
24786662|NCT01921218|Dermatologic Agents|dermatologic agents|mesh-ancestor
24786663|NCT01921218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24786664|NCT01921218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24786665|NCT01921218|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24786666|NCT01921218|Antitubercular Agents|antitubercular agents|mesh-ancestor
24816709|NCT02078336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24816710|NCT02078336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24816711|NCT02078336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24816712|NCT02078336|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24816713|NCT02078336|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24815617|NCT02071342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24815618|NCT02071342|Immunologic Factors|immunologic factors|mesh-ancestor
24815620|NCT02071355|Simeprevir|simeprevir|mesh-list
25868231|NCT00111189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25868232|NCT00111189|Dopamine Agents|dopamine agents|mesh-ancestor
25868233|NCT00111215|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25868234|NCT00111215|Tranexamic Acid|tranexamic acid|mesh-list
24816725|NCT02078440|Hormone Antagonists|hormone antagonists|mesh-ancestor
24816726|NCT02078440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24816727|NCT02078440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816728|NCT02078440|Dopamine Agonists|dopamine agonists|mesh-ancestor
24816729|NCT02078440|Dopamine Agents|dopamine agents|mesh-ancestor
24816730|NCT02078440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24816731|NCT02078440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816732|NCT02078583|Fentanyl|fentanyl|mesh-list
24816733|NCT02078583|Remifentanil|remifentanil|mesh-list
24816734|NCT02078583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24888416|NCT04505657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25108743|NCT03130426|Metformin|metformin|mesh-list
25108748|NCT03130582|Etoposide|etoposide|mesh-list
24888452|NCT04505228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888453|NCT04504877|Cannabidiol|cannabidiol|mesh-list
24888454|NCT04504877|Anticonvulsants|anticonvulsants|mesh-ancestor
24888455|NCT04504851|Rifampin|rifampin|mesh-list
24888456|NCT04504851|Isoniazid|isoniazid|mesh-list
24888457|NCT04504851|Pyrazinamide|pyrazinamide|mesh-list
24888458|NCT04504851|Ethambutol|ethambutol|mesh-list
24888459|NCT04504851|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24888460|NCT04504851|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24888486|NCT04503915|Estrogens|estrogens|mesh-list
24888487|NCT04503915|Hormones|hormones|mesh-ancestor
24888488|NCT04503915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24888489|NCT04503915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888498|NCT04503850|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24888499|NCT04503850|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24888500|NCT04503850|Adrenergic Agents|adrenergic agents|mesh-ancestor
24888501|NCT04503850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24565421|NCT00780325|Celecoxib|celecoxib|mesh-list
24888502|NCT04503850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888504|NCT04503850|Urological Agents|urological agents|mesh-ancestor
24888505|NCT04503850|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24888656|NCT04501809|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24888657|NCT04501809|Abortifacient Agents|abortifacient agents|mesh-ancestor
24888658|NCT04501809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24888659|NCT04501809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24888798|NCT04500561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889064|NCT04498520|Palbociclib|palbociclib|mesh-list
24889065|NCT04498520|Abexinostat|abexinostat|mesh-list
24889066|NCT04498520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24889067|NCT04498520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24889068|NCT04498520|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24889069|NCT04498520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24889095|NCT04498260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889096|NCT04498260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889098|NCT04497831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24889099|NCT04497831|Narcotics|narcotics|mesh-ancestor
24889100|NCT04497831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24889101|NCT04497831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889102|NCT04497831|Analgesics|analgesics|mesh-ancestor
24889103|NCT04497831|Sensory System Agents|sensory system agents|mesh-ancestor
25433538|NCT00479128|Bortezomib|bortezomib|mesh-list
24441600|NCT00287924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24441634|NCT00287950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24441635|NCT00287950|Alkylating Agents|alkylating agents|mesh-ancestor
24441636|NCT00287950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889104|NCT04497831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24889105|NCT04497766|Magnesium Sulfate|magnesium sulfate|mesh-list
24889106|NCT04497766|Analgesics|analgesics|mesh-ancestor
24889107|NCT04497766|Sensory System Agents|sensory system agents|mesh-ancestor
24889108|NCT04497766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24889109|NCT04497766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889110|NCT04497766|Anesthetics|anesthetics|mesh-ancestor
24889111|NCT04497766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24889112|NCT04497766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24889113|NCT04497766|Anticonvulsants|anticonvulsants|mesh-ancestor
24889114|NCT04497766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24877951|NCT02208375|Olaparib|olaparib|mesh-list
25201977|NCT02724098|Sensory System Agents|sensory system agents|mesh-ancestor
25201978|NCT02724098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24877953|NCT02208375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868235|NCT00111215|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24889288|NCT04494828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24889317|NCT04494321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24889318|NCT04494321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24889319|NCT04494321|Autonomic Agents|autonomic agents|mesh-ancestor
24889320|NCT04494321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24889321|NCT04494321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24877987|NCT02181413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24877988|NCT02181413|Protease Inhibitors|protease inhibitors|mesh-ancestor
24877989|NCT02181413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889481|NCT04493073|Mitomycin|mitomycin|mesh-list
24889482|NCT04493073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24889483|NCT04493073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24889484|NCT04493073|Alkylating Agents|alkylating agents|mesh-ancestor
24889485|NCT04493073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623508|NCT01072045|Propranolol|propranolol|mesh-list
24623509|NCT01072045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24889796|NCT04489745|Androgens|androgens|mesh-list
24889797|NCT04489745|Hormones|hormones|mesh-ancestor
24889798|NCT04489745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24889799|NCT04489745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889819|NCT04489459|Polymyxins|polymyxins|mesh-list
24889820|NCT04489459|Polymyxin B|polymyxin b|mesh-list
24889821|NCT04489459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24889822|NCT04489459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24889823|NCT04489459|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24889824|NCT04489459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889825|NCT04489459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712403|NCT01520350|Serotonin Agents|serotonin agents|mesh-ancestor
24889871|NCT04488744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24889872|NCT04488744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889873|NCT04488614|Zoledronic Acid|zoledronic acid|mesh-list
24889874|NCT04488614|Estrogens|estrogens|mesh-list
24889875|NCT04488614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24889876|NCT04488614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889877|NCT04488614|Hormones|hormones|mesh-ancestor
24889878|NCT04488614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24889879|NCT04488926|Palmidrol|palmidrol|mesh-list
24889880|NCT04488926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24890215|NCT04485156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24890216|NCT04485156|Leprostatic Agents|leprostatic agents|mesh-ancestor
24890574|NCT04481815|Lenalidomide|lenalidomide|mesh-list
24890224|NCT04485156|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24890225|NCT04485156|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24890226|NCT04485156|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24890227|NCT04485156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24890228|NCT04485156|Antimetabolites|antimetabolites|mesh-ancestor
24890229|NCT04485156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24467755|NCT00378677|Cyclosporine|cyclosporine|mesh-list
24816828|NCT02079194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833590|NCT02174588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24833591|NCT02174588|GABA Modulators|gaba modulators|mesh-ancestor
24633451|NCT01129414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25670816|NCT03856216|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25670817|NCT03856216|Abortifacient Agents|abortifacient agents|mesh-ancestor
25670818|NCT03856216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25670819|NCT03856216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24816830|NCT02079194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24442101|NCT00290030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24442102|NCT00290030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868236|NCT00111215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24816837|NCT02079194|Antipyretics|antipyretics|mesh-ancestor
24816838|NCT02079220|Capecitabine|capecitabine|mesh-list
24816839|NCT02079220|Oxaliplatin|oxaliplatin|mesh-list
24816840|NCT02079220|Aflibercept|aflibercept|mesh-list
24816841|NCT02079220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24816842|NCT02079220|Antimetabolites|antimetabolites|mesh-ancestor
24890427|NCT04483674|Emtricitabine|emtricitabine|mesh-list
24890428|NCT04483674|Antiviral Agents|antiviral agents|mesh-ancestor
25065276|NCT03451500|Levodopa|levodopa|mesh-list
24890429|NCT04483674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24890430|NCT04483674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24890431|NCT04483674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24890432|NCT04483674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24890433|NCT04483674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890434|NCT04483674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24890435|NCT04483674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24890436|NCT04483492|Caffeine|caffeine|mesh-list
24890437|NCT04483492|Caffeine citrate|caffeine citrate|mesh-list
24890438|NCT04483492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890439|NCT04483492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24890440|NCT04483492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890441|NCT04483492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24890497|NCT04482985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890511|NCT04482712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24890512|NCT04482712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24890526|NCT04482764|Antimanic Agents|antimanic agents|mesh-ancestor
24890527|NCT04482764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24890528|NCT04482764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24890556|NCT04482296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890557|NCT04482296|Dermatologic Agents|dermatologic agents|mesh-ancestor
24890563|NCT04482257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24890564|NCT04481802|Acemannan|acemannan|mesh-list
24890565|NCT04481802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24890566|NCT04481802|Immunologic Factors|immunologic factors|mesh-ancestor
24890567|NCT04481802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890568|NCT04481802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24890569|NCT04481802|Antiviral Agents|antiviral agents|mesh-ancestor
24890570|NCT04481802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24912847|NCT04271189|Hormones|hormones|mesh-ancestor
24890571|NCT04481802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24890572|NCT04481815|Rituximab|rituximab|mesh-list
24890573|NCT04481815|Methotrexate|methotrexate|mesh-list
24890583|NCT04481815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24890817|NCT04479657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24890818|NCT04479657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24890820|NCT04479865|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24890821|NCT04479865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24890966|NCT04477629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24890967|NCT04477629|Immunologic Factors|immunologic factors|mesh-ancestor
24890968|NCT04477629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890969|NCT04477629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24890970|NCT04477629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24890971|NCT04477629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890972|NCT04477629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24890973|NCT04477629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24890974|NCT04477629|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24890975|NCT04477629|Antitubercular Agents|antitubercular agents|mesh-ancestor
24890976|NCT04477629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24890977|NCT04477629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24890978|NCT04477629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24890979|NCT04477629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24890981|NCT04477642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24891017|NCT04477317|Adrenergic Agents|adrenergic agents|mesh-ancestor
24891018|NCT04477317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24891019|NCT04477317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891020|NCT04477317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891021|NCT04477317|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24891022|NCT04477317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25670820|NCT03856216|Antimetabolites|antimetabolites|mesh-ancestor
25670821|NCT03856216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868237|NCT00111215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868238|NCT00111215|Hemostatics|hemostatics|mesh-ancestor
25868239|NCT00111215|Coagulants|coagulants|mesh-ancestor
25868240|NCT00111215|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25868241|NCT00111215|Natriuretic Agents|natriuretic agents|mesh-ancestor
25868242|NCT00111215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868243|NCT00111267|Vitamins|vitamins|mesh-list
25125990|NCT03064984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25125991|NCT03064906|Pancrelipase|pancrelipase|mesh-list
24891023|NCT04477317|Autonomic Agents|autonomic agents|mesh-ancestor
24891024|NCT04477317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891025|NCT04477317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24891026|NCT04477317|Respiratory System Agents|respiratory system agents|mesh-ancestor
24891027|NCT04477317|Mydriatics|mydriatics|mesh-ancestor
24891028|NCT04477317|Sympathomimetics|sympathomimetics|mesh-ancestor
24891029|NCT04477317|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24891030|NCT04477317|Anesthetics, Local|anesthetics, local|mesh-ancestor
24891031|NCT04477317|Anesthetics|anesthetics|mesh-ancestor
24891032|NCT04477317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24891033|NCT04477317|Sensory System Agents|sensory system agents|mesh-ancestor
24891034|NCT04477304|Analgesics, Opioid|analgesics, opioid|mesh-list
24891035|NCT04477304|Narcotics|narcotics|mesh-ancestor
24891036|NCT04477304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24891121|NCT04476069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24891123|NCT04476069|Sensory System Agents|sensory system agents|mesh-ancestor
24891124|NCT04476069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891125|NCT04476069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891127|NCT04476069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24816874|NCT02079337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24891362|NCT04472806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891363|NCT04472806|Growth Inhibitors|growth inhibitors|mesh-ancestor
24891364|NCT04472806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24891365|NCT04472689|Lidocaine|lidocaine|mesh-list
24891375|NCT04472689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24891877|NCT04467125|Anesthetics, Local|anesthetics, local|mesh-ancestor
24819222|NCT02094274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24819223|NCT02094274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25065281|NCT03451500|Dopamine Agents|dopamine agents|mesh-ancestor
24816901|NCT02079558|Carbetocin|carbetocin|mesh-list
24816902|NCT02079558|Oxytocics|oxytocics|mesh-ancestor
24816903|NCT02079558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24816904|NCT02079558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816905|NCT02079701|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24816906|NCT02079701|Immunologic Factors|immunologic factors|mesh-ancestor
24891377|NCT04472481|Ergocalciferols|ergocalciferols|mesh-list
24891378|NCT04472481|Vitamin D|vitamin d|mesh-list
24891379|NCT04472481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24891380|NCT04472481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891404|NCT04471441|Immunologic Factors|immunologic factors|mesh-ancestor
24891405|NCT04471441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891406|NCT04471441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24891540|NCT04470115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891542|NCT04470050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24891543|NCT04470050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24891544|NCT04470050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891581|NCT04469413|Sensory System Agents|sensory system agents|mesh-ancestor
24891582|NCT04469413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891611|NCT04469062|Vedolizumab|vedolizumab|mesh-list
24891612|NCT04469062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24891613|NCT04469062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24891614|NCT04469062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24891615|NCT04469062|Analgesics|analgesics|mesh-ancestor
24891616|NCT04469062|Sensory System Agents|sensory system agents|mesh-ancestor
24891617|NCT04469062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891618|NCT04469062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891619|NCT04469062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24891620|NCT04469062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25670822|NCT03856216|Dermatologic Agents|dermatologic agents|mesh-ancestor
25670823|NCT03856216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25670824|NCT03856216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25670825|NCT03856216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25670826|NCT03856216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25670827|NCT03856216|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25670828|NCT03856216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25670829|NCT03856216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25868246|NCT00111267|Vitamin B 12|vitamin b 12|mesh-list
25868247|NCT00111267|Vitamin B Complex|vitamin b complex|mesh-list
25868248|NCT00111267|Micronutrients|micronutrients|mesh-ancestor
25868249|NCT00111267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868250|NCT00111267|Hematinics|hematinics|mesh-ancestor
25868251|NCT00111280|Etravirine|etravirine|mesh-list
25868252|NCT00111280|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25868253|NCT00111280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25868254|NCT00111280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868255|NCT00111280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868256|NCT00111280|Antiviral Agents|antiviral agents|mesh-ancestor
24891621|NCT04469062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24891622|NCT04468711|Vitamin D|vitamin d|mesh-list
24891623|NCT04468711|Hydrocortisone|hydrocortisone|mesh-list
24891624|NCT04468711|Vitamins|vitamins|mesh-ancestor
24891625|NCT04468711|Micronutrients|micronutrients|mesh-ancestor
24891626|NCT04468711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891627|NCT04468711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24891669|NCT04468542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891671|NCT04468542|Glucocorticoids|glucocorticoids|mesh-ancestor
24891672|NCT04468542|Hormones|hormones|mesh-ancestor
24891673|NCT04468542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24891674|NCT04468542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24891675|NCT04468542|Immunologic Factors|immunologic factors|mesh-ancestor
24891676|NCT04468542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24891677|NCT04468542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714330|NCT01530152|Anesthetics|anesthetics|mesh-ancestor
24891678|NCT04468165|Dimethyl Fumarate|dimethyl fumarate|mesh-list
24891679|NCT04468165|Dermatologic Agents|dermatologic agents|mesh-ancestor
24891680|NCT04468165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24891714|NCT04467892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24891715|NCT04467892|Glucocorticoids|glucocorticoids|mesh-ancestor
24891716|NCT04467892|Hormones|hormones|mesh-ancestor
24891717|NCT04467892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24891803|NCT04467931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24891804|NCT04467931|Adrenergic Agents|adrenergic agents|mesh-ancestor
24891805|NCT04467931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24891806|NCT04467931|Sympatholytics|sympatholytics|mesh-ancestor
24891841|NCT04467931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24891871|NCT04467346|Alkylating Agents|alkylating agents|mesh-ancestor
24891872|NCT04467346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891873|NCT04467346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24891874|NCT04467125|Lidocaine|lidocaine|mesh-list
24891875|NCT04467125|Prilocaine|prilocaine|mesh-list
24891876|NCT04467125|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24891878|NCT04467125|Anesthetics|anesthetics|mesh-ancestor
24892207|NCT04464694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892253|NCT04464629|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24892254|NCT04464629|Prednisolone phosphate|prednisolone phosphate|mesh-list
24878557|NCT01430572|Immunologic Factors|immunologic factors|mesh-ancestor
24878558|NCT01430572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24878559|NCT01425541|Progesterone|progesterone|mesh-list
24878560|NCT01425541|Estradiol|estradiol|mesh-list
24878561|NCT01425541|Estrogens|estrogens|mesh-list
24878570|NCT01410942|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24878571|NCT01410942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24892256|NCT04464629|Glucocorticoids|glucocorticoids|mesh-ancestor
25670830|NCT03856216|Alkylating Agents|alkylating agents|mesh-ancestor
25670831|NCT03856216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25670832|NCT03856216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25670833|NCT03813199|Methotrexate|methotrexate|mesh-list
25670834|NCT03813199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25670835|NCT03813199|Abortifacient Agents|abortifacient agents|mesh-ancestor
25670836|NCT03813199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25670837|NCT03813199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221598|NCT02649478|Dermatologic Agents|dermatologic agents|mesh-ancestor
25670838|NCT03813199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25670839|NCT03813199|Antimetabolites|antimetabolites|mesh-ancestor
25670840|NCT03813199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670841|NCT03813199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670842|NCT03813199|Dermatologic Agents|dermatologic agents|mesh-ancestor
24892258|NCT04464629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24892259|NCT04464629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868257|NCT00111280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25868258|NCT00111306|Epratuzumab|epratuzumab|mesh-list
25868259|NCT00111306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25126024|NCT03064542|Carbimazole|carbimazole|mesh-list
25126025|NCT03064542|Antithyroid Agents|antithyroid agents|mesh-ancestor
25126026|NCT03064542|Hormone Antagonists|hormone antagonists|mesh-ancestor
25048508|NCT00692484|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25126027|NCT03064542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25126028|NCT03064542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868260|NCT00111306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108768|NCT03130348|Antiemetics|antiemetics|mesh-ancestor
25108769|NCT03130348|Autonomic Agents|autonomic agents|mesh-ancestor
25108770|NCT03130348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108771|NCT03130348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108772|NCT03130348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25108773|NCT03130348|Glucocorticoids|glucocorticoids|mesh-ancestor
25108774|NCT03130348|Hormones|hormones|mesh-ancestor
24892260|NCT04464629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24892261|NCT04464629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24892323|NCT04464005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24892324|NCT04464005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892333|NCT04463875|Riboflavin|riboflavin|mesh-list
24892334|NCT04463875|Ubiquinone|ubiquinone|mesh-list
24892335|NCT04463875|Andrographolide|andrographolide|mesh-list
24892336|NCT04463875|Vitamins|vitamins|mesh-ancestor
24892337|NCT04463875|Micronutrients|micronutrients|mesh-ancestor
24892338|NCT04463875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892339|NCT04463875|Vitamin B Complex|vitamin b complex|mesh-ancestor
24892358|NCT04463784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892359|NCT04463784|Antiviral Agents|antiviral agents|mesh-ancestor
24892360|NCT04463784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24892361|NCT04463784|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24892362|NCT04463784|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25201979|NCT02724098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24408673|NCT00179062|Olanzapine|olanzapine|mesh-list
24892363|NCT04463784|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24892364|NCT04463784|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24892365|NCT04463784|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24892366|NCT04463784|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24816942|NCT02080026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24816943|NCT02080026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24816944|NCT02080026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24852983|NCT02265068|Ticagrelor|ticagrelor|mesh-list
24892497|NCT04462250|Analgesics, Opioid|analgesics, opioid|mesh-list
24892498|NCT04462250|Narcotics|narcotics|mesh-ancestor
24892499|NCT04462250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24892500|NCT04462250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892501|NCT04462250|Analgesics|analgesics|mesh-ancestor
24892595|NCT04461353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24469661|NCT00386659|Antimetabolites|antimetabolites|mesh-ancestor
24892647|NCT04460820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24892648|NCT04460820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24892649|NCT04460820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24892651|NCT04460820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24892726|NCT04460079|Lenograstim|lenograstim|mesh-list
24816969|NCT02080078|Vasodilator Agents|vasodilator agents|mesh-ancestor
24816970|NCT02080078|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24816971|NCT02080078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25221621|NCT02649179|Anesthetics|anesthetics|mesh-ancestor
24816972|NCT02080078|Purinergic Agents|purinergic agents|mesh-ancestor
24892743|NCT04459702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892744|NCT04459702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24892745|NCT04459702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24892746|NCT04459702|Antiviral Agents|antiviral agents|mesh-ancestor
24892747|NCT04459702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24892748|NCT04459702|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24892749|NCT04459702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25670843|NCT03813199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25670844|NCT03813199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25670845|NCT03813199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25670846|NCT03813199|Immunologic Factors|immunologic factors|mesh-ancestor
25670847|NCT03813199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25670848|NCT03813199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25670849|NCT03809234|Ondansetron|ondansetron|mesh-list
25670850|NCT03809234|Antiemetics|antiemetics|mesh-ancestor
25670851|NCT03809234|Autonomic Agents|autonomic agents|mesh-ancestor
24955963|NCT03859102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24438239|NCT00275132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438240|NCT00275184|Metoclopramide|metoclopramide|mesh-list
24438241|NCT00275184|Antiemetics|antiemetics|mesh-ancestor
24438242|NCT00275184|Autonomic Agents|autonomic agents|mesh-ancestor
24438243|NCT00275184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24438248|NCT00275184|Dopamine Agents|dopamine agents|mesh-ancestor
24438258|NCT00275197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25868261|NCT00111319|Bortezomib|bortezomib|mesh-list
25868262|NCT00111319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460502|NCT00348504|Sympathomimetics|sympathomimetics|mesh-ancestor
24892750|NCT04459702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24892832|NCT04458636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24892834|NCT04458324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24892835|NCT04458324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24892836|NCT04458324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24892837|NCT04458324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892838|NCT04458324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24892839|NCT04458324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24892840|NCT04458324|Serotonin Agents|serotonin agents|mesh-ancestor
24892876|NCT04457765|Plasma Substitutes|plasma substitutes|mesh-ancestor
24458898|NCT00343096|Antiemetics|antiemetics|mesh-ancestor
24817010|NCT02080182|Respiratory System Agents|respiratory system agents|mesh-ancestor
24817011|NCT02080182|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24817012|NCT02080182|Antioxidants|antioxidants|mesh-ancestor
24893186|NCT04453436|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24893187|NCT04453332|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24893188|NCT04453332|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24893190|NCT04453332|Estradiol|estradiol|mesh-list
24893191|NCT04453332|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24893192|NCT04453332|Progesterone|progesterone|mesh-list
24913165|NCT04268394|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24893193|NCT04453332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24893194|NCT04453332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893195|NCT04453332|Estrogens|estrogens|mesh-ancestor
24893196|NCT04453332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24893197|NCT04453332|Contraceptive Agents|contraceptive agents|mesh-ancestor
24893198|NCT04453332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24893199|NCT04453332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24893200|NCT04453332|Progestins|progestins|mesh-ancestor
24893201|NCT04453189|Lansoprazole|lansoprazole|mesh-list
24893202|NCT04453189|Dexlansoprazole|dexlansoprazole|mesh-list
24893298|NCT04451746|Contraceptive Agents|contraceptive agents|mesh-list
24893299|NCT04451746|Contraceptives, Oral|contraceptives, oral|mesh-list
24893300|NCT04451746|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
24893301|NCT04451746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24893302|NCT04451746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25201980|NCT02724098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25201981|NCT02724098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24893308|NCT04451395|Trace Elements|trace elements|mesh-list
24470329|NCT00389701|Hormones|hormones|mesh-ancestor
24893333|NCT04451239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24893334|NCT04451239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24893335|NCT04451382|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24893336|NCT04451382|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24878794|NCT00828854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24878795|NCT00828854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24878796|NCT00828854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878797|NCT00828854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24878798|NCT00828854|Hormone Antagonists|hormone antagonists|mesh-ancestor
24893337|NCT04451382|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24893338|NCT04451382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24893339|NCT04451382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893340|NCT04451382|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24893341|NCT04451382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24893348|NCT04451174|Hormones|hormones|mesh-ancestor
25409521|NCT03373851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25670852|NCT03809234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25670853|NCT03809234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670854|NCT03809234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25670855|NCT03809234|Antipruritics|antipruritics|mesh-ancestor
25670856|NCT03809234|Dermatologic Agents|dermatologic agents|mesh-ancestor
25670857|NCT03809234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25670858|NCT03809234|Serotonin Agents|serotonin agents|mesh-ancestor
25670859|NCT03809234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25670860|NCT03809234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893349|NCT04451174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24878825|NCT00740805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24878826|NCT00740805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24878827|NCT00740805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24878828|NCT00740805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24893396|NCT04450134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24819277|NCT02094469|Respiratory System Agents|respiratory system agents|mesh-ancestor
24893397|NCT04450134|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24893398|NCT04450134|Histamine Antagonists|histamine antagonists|mesh-ancestor
24893399|NCT04450134|Histamine Agents|histamine agents|mesh-ancestor
24893400|NCT04450134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24893470|NCT04449471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24893471|NCT04449471|Analgesics|analgesics|mesh-ancestor
24893472|NCT04449471|Sensory System Agents|sensory system agents|mesh-ancestor
24786692|NCT01921361|Anesthetics, Local|anesthetics, local|mesh-ancestor
24786693|NCT01921361|Anesthetics|anesthetics|mesh-ancestor
25108775|NCT03130348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25108776|NCT03130348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25108777|NCT03130348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108778|NCT03130348|Protease Inhibitors|protease inhibitors|mesh-ancestor
25108779|NCT03130348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25108780|NCT03130348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108781|NCT03130348|Dermatologic Agents|dermatologic agents|mesh-ancestor
25108782|NCT03130179|Nicotine|nicotine|mesh-list
25108802|NCT03130218|Antiemetics|antiemetics|mesh-ancestor
25108803|NCT03130218|Autonomic Agents|autonomic agents|mesh-ancestor
25108804|NCT03130218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24878869|NCT00494728|Nicotine|nicotine|mesh-list
24423985|NCT00227656|Immunologic Factors|immunologic factors|mesh-ancestor
24424096|NCT00227942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24878870|NCT00494728|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24878871|NCT00494728|Autonomic Agents|autonomic agents|mesh-ancestor
24878872|NCT00494728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24878873|NCT00494728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24878874|NCT00494728|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24878875|NCT00494728|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24878876|NCT00494728|Cholinergic Agents|cholinergic agents|mesh-ancestor
24878877|NCT00494728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25268747|NCT02414581|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24878878|NCT00494728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878879|NCT00494234|Olaparib|olaparib|mesh-list
24878880|NCT00494234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25108846|NCT03129646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25108847|NCT03129646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25108848|NCT03129646|Antifungal Agents|antifungal agents|mesh-ancestor
24893504|NCT04448821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24893505|NCT04448821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893506|NCT04448977|Ocrelizumab|ocrelizumab|mesh-list
24893507|NCT04448977|Immunologic Factors|immunologic factors|mesh-ancestor
24893508|NCT04448977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893509|NCT04448587|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24893510|NCT04448587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24893511|NCT04448587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893512|NCT04448587|Incretins|incretins|mesh-ancestor
24893513|NCT04448587|Hormones|hormones|mesh-ancestor
24893514|NCT04448587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24878930|NCT00268385|Temozolomide|temozolomide|mesh-list
24878931|NCT00268385|Vorinostat|vorinostat|mesh-list
24878932|NCT00268385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24878933|NCT00268385|Alkylating Agents|alkylating agents|mesh-ancestor
24878934|NCT00268385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878935|NCT00268385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201983|NCT02724098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25201984|NCT02724098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201985|NCT02724046|Ciprofloxacin|ciprofloxacin|mesh-list
25201986|NCT02724046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24425256|NCT00232492|Anesthetics|anesthetics|mesh-ancestor
24878936|NCT00268385|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24878937|NCT00268385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613147|NCT01017380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24613148|NCT01017380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613149|NCT01017380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24613150|NCT01017380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25126091|NCT03064243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126092|NCT03063983|Cyclophosphamide|cyclophosphamide|mesh-list
24613151|NCT01017380|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24613152|NCT01017380|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24613153|NCT01017380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613154|NCT01017380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893545|NCT04448379|Afatinib|afatinib|mesh-list
24893546|NCT04448379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24893547|NCT04448379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24893548|NCT04448379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893726|NCT04446715|Bupivacaine|bupivacaine|mesh-list
24893727|NCT04446715|Anesthetics, Local|anesthetics, local|mesh-ancestor
24893728|NCT04446715|Anesthetics|anesthetics|mesh-ancestor
24893729|NCT04446715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24893730|NCT04446715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893731|NCT04446715|Sensory System Agents|sensory system agents|mesh-ancestor
24893732|NCT04446715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24893733|NCT04446715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24893734|NCT04446715|Narcotics|narcotics|mesh-ancestor
24893735|NCT04446715|Analgesics|analgesics|mesh-ancestor
24893736|NCT04446715|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24893742|NCT04446598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24893743|NCT04446598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893744|NCT04446598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893745|NCT04446598|Urological Agents|urological agents|mesh-ancestor
24893746|NCT04446533|Chlorhexidine|chlorhexidine|mesh-list
24893747|NCT04446533|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24893748|NCT04446533|Hydrogen Peroxide|hydrogen peroxide|mesh-list
24893749|NCT04446533|Hyaluronic Acid|hyaluronic acid|mesh-list
24893786|NCT04446403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24893787|NCT04446403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893817|NCT04446234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24893818|NCT04446234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24878970|NCT00045201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24878971|NCT00045201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878972|NCT00045201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24878973|NCT00045201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24817045|NCT02080494|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24817046|NCT02080494|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24817047|NCT02080494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817049|NCT02080494|Coagulants|coagulants|mesh-ancestor
24817050|NCT02080624|Sirolimus|sirolimus|mesh-list
24817051|NCT02080624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24817052|NCT02080624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24817053|NCT02080624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24817054|NCT02080624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24817055|NCT02080624|Antifungal Agents|antifungal agents|mesh-ancestor
24817056|NCT02080624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24817057|NCT02080624|Immunologic Factors|immunologic factors|mesh-ancestor
24817058|NCT02080624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817059|NCT02080715|Tolcapone|tolcapone|mesh-list
24817060|NCT02080715|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24470881|NCT00392340|Vincristine|vincristine|mesh-list
24913447|NCT04264078|Alkylating Agents|alkylating agents|mesh-ancestor
24913448|NCT04264078|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24913449|NCT04264026|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
24913450|NCT04264026|Hallucinogens|hallucinogens|mesh-ancestor
24817092|NCT02080858|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24878996|NCT05174858|Hemostatics|hemostatics|mesh-list
24878997|NCT05174858|Coagulants|coagulants|mesh-ancestor
25201987|NCT02724046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24878998|NCT05174845|Ascorbic Acid|ascorbic acid|mesh-list
24817093|NCT02080858|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24893968|NCT04445571|Pulmonary Surfactants|pulmonary surfactants|mesh-list
24893969|NCT04445571|Respiratory System Agents|respiratory system agents|mesh-ancestor
24894054|NCT04444817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24817096|NCT02080858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24817097|NCT02080858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817098|NCT02080858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817099|NCT02080858|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24817100|NCT02080858|Antithrombins|antithrombins|mesh-ancestor
24817101|NCT02080858|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24817102|NCT02080858|Protease Inhibitors|protease inhibitors|mesh-ancestor
25670861|NCT03809234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25670862|NCT03809234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24817103|NCT02080858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817104|NCT02080858|Anticoagulants|anticoagulants|mesh-ancestor
24894152|NCT04443634|Anesthetics, Local|anesthetics, local|mesh-ancestor
24894210|NCT04443270|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24894211|NCT04443270|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24894212|NCT04443270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24894213|NCT04443270|Antimalarials|antimalarials|mesh-ancestor
24894214|NCT04443270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24894215|NCT04443270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24817154|NCT02081391|Narcotics|narcotics|mesh-ancestor
24894216|NCT04443270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24894217|NCT04443270|Analgesics|analgesics|mesh-ancestor
24894218|NCT04443270|Sensory System Agents|sensory system agents|mesh-ancestor
24894219|NCT04443270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24894220|NCT04443270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894221|NCT04443270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24894222|NCT04443270|Filaricides|filaricides|mesh-ancestor
24894223|NCT04443270|Antinematodal Agents|antinematodal agents|mesh-ancestor
24894224|NCT04443270|Anthelmintics|anthelmintics|mesh-ancestor
24894225|NCT04443322|Durvalumab|durvalumab|mesh-list
24894226|NCT04443322|Lenvatinib|lenvatinib|mesh-list
24894227|NCT04443322|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24894228|NCT04443322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24894229|NCT04443322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894230|NCT04443322|Immunologic Factors|immunologic factors|mesh-ancestor
24894231|NCT04443322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894232|NCT04443322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24894233|NCT04443322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24894250|NCT04443049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24894251|NCT04443049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894252|NCT04443049|Antinematodal Agents|antinematodal agents|mesh-ancestor
24812522|NCT02052934|Vaccines|vaccines|mesh-list
25868264|NCT00111345|Idarubicin|idarubicin|mesh-list
25868265|NCT00111345|Cladribine|cladribine|mesh-list
24894254|NCT04443049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24894255|NCT04443049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24894256|NCT04443049|Tubulin Modulators|tubulin modulators|mesh-ancestor
24894257|NCT04443049|Antimitotic Agents|antimitotic agents|mesh-ancestor
24894258|NCT04443049|Mitosis Modulators|mitosis modulators|mesh-ancestor
24894259|NCT04443166|Hyaluronic Acid|hyaluronic acid|mesh-list
24894260|NCT04443166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24894261|NCT04443166|Immunologic Factors|immunologic factors|mesh-ancestor
24894264|NCT04443166|Protective Agents|protective agents|mesh-ancestor
24894265|NCT04442919|Morphine|morphine|mesh-list
24894266|NCT04442919|Methoxyflurane|methoxyflurane|mesh-list
24894267|NCT04442919|Ticagrelor|ticagrelor|mesh-list
24894268|NCT04442919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24894269|NCT04442919|Narcotics|narcotics|mesh-ancestor
24894270|NCT04442919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25868266|NCT00111345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24894276|NCT04442919|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24894277|NCT04442919|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24894278|NCT04442919|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24894279|NCT04442919|Purinergic Agents|purinergic agents|mesh-ancestor
24894280|NCT04442919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24894281|NCT04442919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894324|NCT04442906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24894325|NCT04442906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24894326|NCT04442906|Adrenergic Agents|adrenergic agents|mesh-ancestor
24894327|NCT04442906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25089718|NCT03263299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24894328|NCT04442906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894329|NCT04442906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24879104|NCT05054868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24879105|NCT05054868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24894330|NCT04442906|Narcotics|narcotics|mesh-ancestor
24894331|NCT04442906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24894332|NCT04442906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24894333|NCT04442906|Anesthetics, General|anesthetics, general|mesh-ancestor
24894341|NCT04442633|Miconazole|miconazole|mesh-list
24879132|NCT05029856|Vaccines|vaccines|mesh-list
24879133|NCT05029856|Immunologic Factors|immunologic factors|mesh-ancestor
24879134|NCT05029856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879135|NCT05016518|Propofol|propofol|mesh-list
25868267|NCT00111345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868268|NCT00111345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25868269|NCT00111345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25868270|NCT00111345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868271|NCT00111345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461223|NCT00351403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25868272|NCT00111345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25868273|NCT00111345|Immunologic Factors|immunologic factors|mesh-ancestor
25868274|NCT00111345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868275|NCT00111371|Levodopa|levodopa|mesh-list
25868276|NCT00111371|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25868277|NCT00111371|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25868278|NCT00111371|Dopamine Agents|dopamine agents|mesh-ancestor
25868279|NCT00111371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25868280|NCT00111371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868281|NCT00111371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894361|NCT04441385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894362|NCT04441385|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24894363|NCT04441385|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24879143|NCT05006599|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24786775|NCT01921790|Bevacizumab|bevacizumab|mesh-list
24786776|NCT01921790|Pegaspargase|pegaspargase|mesh-list
24786786|NCT01921790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24786788|NCT01921790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24786789|NCT01921790|Antimetabolites|antimetabolites|mesh-ancestor
24786790|NCT01921790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786791|NCT01921790|Antiviral Agents|antiviral agents|mesh-ancestor
25108850|NCT03129646|Schistosomicides|schistosomicides|mesh-ancestor
25868282|NCT00111397|Interferons|interferons|mesh-list
25201988|NCT02724046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25201989|NCT02724046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25201990|NCT02724046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25201991|NCT02724046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25201992|NCT02724046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25201993|NCT02724046|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25201994|NCT02724046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25201995|NCT02724293|Pregabalin|pregabalin|mesh-list
25201996|NCT02724293|Analgesics|analgesics|mesh-ancestor
25201997|NCT02724293|Sensory System Agents|sensory system agents|mesh-ancestor
25201998|NCT02724293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25201999|NCT02724293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25202000|NCT02724293|Anticonvulsants|anticonvulsants|mesh-ancestor
25108858|NCT03129594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108860|NCT03129867|Ticagrelor|ticagrelor|mesh-list
25108861|NCT03129867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25108862|NCT03129867|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25108863|NCT03129867|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25108864|NCT03129867|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25108865|NCT03129867|Purinergic Agents|purinergic agents|mesh-ancestor
25108866|NCT03129867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25108867|NCT03129867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108868|NCT03129867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108869|NCT03129698|Apatinib|apatinib|mesh-list
25108870|NCT03129698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108871|NCT03129698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25108872|NCT03129698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24786792|NCT01921790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25108873|NCT03129698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853457|NCT02268370|Dasatinib|dasatinib|mesh-list
24894377|NCT04441398|Nitazoxanide|nitazoxanide|mesh-list
24894378|NCT04441398|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24894379|NCT04441398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24879189|NCT04963530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24879190|NCT04963530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879191|NCT04962893|Vaccines|vaccines|mesh-list
24894601|NCT04438980|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24894602|NCT04438980|Protective Agents|protective agents|mesh-ancestor
24894603|NCT04438980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24894604|NCT04438980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894767|NCT05387941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24894768|NCT05387941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894769|NCT05387941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24894770|NCT05387941|Glucocorticoids|glucocorticoids|mesh-ancestor
24894795|NCT05387616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24894796|NCT05387616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894797|NCT05387603|Capecitabine|capecitabine|mesh-list
24894800|NCT05387603|Antimetabolites|antimetabolites|mesh-ancestor
25670863|NCT03809234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25409522|NCT03373851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25126169|NCT03063541|Aspirin|aspirin|mesh-list
24894801|NCT05387603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894802|NCT05387603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894803|NCT05387603|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24894861|NCT05379855|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24894862|NCT05379855|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25868283|NCT00111397|Interferon-gamma|interferon-gamma|mesh-list
24879279|NCT04920032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894901|NCT05376046|Thrombin|thrombin|mesh-list
24894902|NCT05376046|Hemostatics|hemostatics|mesh-ancestor
24894903|NCT05376046|Coagulants|coagulants|mesh-ancestor
24894904|NCT05375084|Nivolumab|nivolumab|mesh-list
24894905|NCT05375084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24894906|NCT05375084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894984|NCT05301634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25268748|NCT02414581|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24894997|NCT05231382|Leucovorin|leucovorin|mesh-list
24894998|NCT05231382|Fluorouracil|fluorouracil|mesh-list
24894999|NCT05231382|Raltitrexed|raltitrexed|mesh-list
24895000|NCT05231382|Oxaliplatin|oxaliplatin|mesh-list
24895001|NCT05231382|Antimetabolites|antimetabolites|mesh-ancestor
24895002|NCT05231382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879308|NCT04892017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24895003|NCT05231382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24895004|NCT05231382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24895005|NCT05231382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24895370|NCT04427241|Cerebrolysin|cerebrolysin|mesh-list
24895371|NCT04427241|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24895554|NCT03900949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24895555|NCT03895099|Desogestrel|desogestrel|mesh-list
24895556|NCT03895099|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24895557|NCT03895099|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24895558|NCT03895099|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24896334|NCT04437758|Vitamins|vitamins|mesh-ancestor
24896335|NCT04437758|Micronutrients|micronutrients|mesh-ancestor
24896336|NCT04437758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896337|NCT04437758|Antioxidants|antioxidants|mesh-ancestor
24896338|NCT04437758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896339|NCT04437758|Protective Agents|protective agents|mesh-ancestor
24896340|NCT04437693|Hydroxychloroquine|hydroxychloroquine|mesh-list
24896341|NCT04437693|Antimalarials|antimalarials|mesh-ancestor
24473838|NCT00404274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475023|NCT00408551|Irinotecan|irinotecan|mesh-list
24475024|NCT00408551|Calcium|calcium|mesh-list
24815758|NCT02071888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25868284|NCT00111397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815773|NCT02071927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815775|NCT02071966|Ticagrelor|ticagrelor|mesh-list
24815776|NCT02071966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24815805|NCT02072083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24815806|NCT02072083|Adrenergic Agents|adrenergic agents|mesh-ancestor
24815807|NCT02072083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24815809|NCT02072083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24815810|NCT02072083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24475090|NCT00408798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475091|NCT00408798|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24475092|NCT00408798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24475093|NCT00408850|Pioglitazone|pioglitazone|mesh-list
24475094|NCT00408850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24475095|NCT00408850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475096|NCT00408915|Lisuride|lisuride|mesh-list
25868285|NCT00111397|Antiviral Agents|antiviral agents|mesh-ancestor
25868286|NCT00111397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25868287|NCT00111410|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25868288|NCT00111410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24898225|NCT04416334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898590|NCT04412148|Hormones|hormones|mesh-ancestor
24898591|NCT04412148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24898592|NCT04412148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898593|NCT04412148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24898594|NCT04412148|Immunologic Factors|immunologic factors|mesh-ancestor
24898595|NCT04412148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24898596|NCT04412148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898597|NCT04412252|Tofacitinib|tofacitinib|mesh-list
24898598|NCT04412252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25670864|NCT03809234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25876639|NCT03164616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25126199|NCT03063671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25126201|NCT03063671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25126202|NCT03063671|Adrenergic Agents|adrenergic agents|mesh-ancestor
25126208|NCT03063671|Anesthetics|anesthetics|mesh-ancestor
25126219|NCT03063788|Trace Elements|trace elements|mesh-ancestor
25126220|NCT03063788|Micronutrients|micronutrients|mesh-ancestor
25126221|NCT03063788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126222|NCT03063658|Acetaminophen|acetaminophen|mesh-list
25126223|NCT03063658|Ibuprofen|ibuprofen|mesh-list
25126224|NCT03063658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25126225|NCT03063658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25126226|NCT03063658|Analgesics|analgesics|mesh-ancestor
25126227|NCT03063658|Sensory System Agents|sensory system agents|mesh-ancestor
25126228|NCT03063658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24551283|NCT00725036|Insulin|insulin|mesh-list
24898599|NCT04412252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24879460|NCT04752813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24898601|NCT04411875|Amlodipine|amlodipine|mesh-list
24898602|NCT04411875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24898603|NCT04411875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24898604|NCT04411875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24475629|NCT00410982|Rituximab|rituximab|mesh-list
24898675|NCT04411433|Azithromycin|azithromycin|mesh-list
24879420|NCT04788420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24879421|NCT04788420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879422|NCT04780698|Immunoglobulin G|immunoglobulin g|mesh-list
24879423|NCT04780698|Immunologic Factors|immunologic factors|mesh-ancestor
24879424|NCT04780698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879425|NCT04765709|Carboplatin|carboplatin|mesh-list
24879426|NCT04765709|Pemetrexed|pemetrexed|mesh-list
24879427|NCT04765709|Durvalumab|durvalumab|mesh-list
24879428|NCT04765709|Vinorelbine|vinorelbine|mesh-list
24879429|NCT04765709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24879430|NCT04765709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24879431|NCT04765709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24879432|NCT04765709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868289|NCT00111436|Etanercept|etanercept|mesh-list
25868290|NCT00111436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25868291|NCT00111436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25868292|NCT00111436|Analgesics|analgesics|mesh-ancestor
24475939|NCT00412035|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24475948|NCT00412100|Oxycodone|oxycodone|mesh-list
24898983|NCT04408144|Progestins|progestins|mesh-ancestor
24898993|NCT04408443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24898994|NCT04408235|Enoxaparin|enoxaparin|mesh-list
24475962|NCT00412152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24817789|NCT02085590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24817791|NCT02085603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108876|NCT03129347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786816|NCT01921946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24786817|NCT01921946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24786818|NCT01921946|Antimetabolites|antimetabolites|mesh-ancestor
24786819|NCT01921946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395128|NCT00135135|Topotecan|topotecan|mesh-list
24786820|NCT01921946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24879436|NCT04765709|Immunologic Factors|immunologic factors|mesh-ancestor
25670865|NCT03809234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25670866|NCT03804580|Osimertinib|osimertinib|mesh-list
25670867|NCT03804580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670868|NCT03804580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25670869|NCT03804580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25670870|NCT03804580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670871|NCT03781765|Methylphenidate|methylphenidate|mesh-list
25670872|NCT03781765|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25670873|NCT03781765|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25670874|NCT03781765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670875|NCT03781765|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25670876|NCT03781765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25670877|NCT03781765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25670878|NCT03781765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670879|NCT03781765|Dopamine Agents|dopamine agents|mesh-ancestor
24879437|NCT04765709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409523|NCT03373851|Anesthetics, General|anesthetics, general|mesh-ancestor
24879438|NCT04765709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24879439|NCT04765709|Tubulin Modulators|tubulin modulators|mesh-ancestor
24879440|NCT04765709|Antimitotic Agents|antimitotic agents|mesh-ancestor
24879441|NCT04765709|Mitosis Modulators|mitosis modulators|mesh-ancestor
24786821|NCT01921946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24786822|NCT01921946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24786824|NCT01921972|Galantamine|galantamine|mesh-list
24786825|NCT01921972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24786826|NCT01921972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24786827|NCT01921972|Dopamine Agents|dopamine agents|mesh-ancestor
24786828|NCT01921972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24786829|NCT01921972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786830|NCT01921972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786831|NCT01921972|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24786832|NCT01921972|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24786833|NCT01921972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25108877|NCT03129347|Sensory System Agents|sensory system agents|mesh-ancestor
25108878|NCT03129347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108879|NCT03129490|Rivaroxaban|rivaroxaban|mesh-list
25108880|NCT03129490|Apixaban|apixaban|mesh-list
25108881|NCT03129490|Edoxaban|edoxaban|mesh-list
25108882|NCT03129490|Dabigatran|dabigatran|mesh-list
25108883|NCT03129490|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25108884|NCT03129490|Antithrombins|antithrombins|mesh-ancestor
25108885|NCT03129490|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25108886|NCT03129490|Protease Inhibitors|protease inhibitors|mesh-ancestor
25108887|NCT03129490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25108888|NCT03129490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108889|NCT03129490|Anticoagulants|anticoagulants|mesh-ancestor
25108890|NCT03129555|Rivaroxaban|rivaroxaban|mesh-list
25108891|NCT03129555|Apixaban|apixaban|mesh-list
25108892|NCT03129555|Edoxaban|edoxaban|mesh-list
25108893|NCT03129555|Dabigatran|dabigatran|mesh-list
24899206|NCT04405622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24899207|NCT04405622|Antimetabolites|antimetabolites|mesh-ancestor
24899208|NCT04405622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899209|NCT04405622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24899210|NCT04405622|Antiviral Agents|antiviral agents|mesh-ancestor
24899211|NCT04405622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24899212|NCT04405622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899213|NCT04405622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24899214|NCT04405622|Immunologic Factors|immunologic factors|mesh-ancestor
24476149|NCT00413296|Levetiracetam|levetiracetam|mesh-list
24476182|NCT00413387|Hormones|hormones|mesh-ancestor
24476183|NCT00413387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24476184|NCT00413387|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24476185|NCT00413387|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24476186|NCT00413387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24476187|NCT00413387|Adrenergic Agents|adrenergic agents|mesh-ancestor
24476188|NCT00413387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24476189|NCT00413387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476190|NCT00413426|Darifenacin|darifenacin|mesh-list
25868293|NCT00111436|Sensory System Agents|sensory system agents|mesh-ancestor
24879553|NCT04668118|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24879554|NCT04668118|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24879555|NCT04664361|Niacinamide|niacinamide|mesh-list
24879556|NCT04664361|Niacin|niacin|mesh-list
24879557|NCT04664361|Nicotinic Acids|nicotinic acids|mesh-list
24879558|NCT04664361|Vitamin B Complex|vitamin b complex|mesh-ancestor
24879559|NCT04664361|Vitamins|vitamins|mesh-ancestor
24879560|NCT04664361|Micronutrients|micronutrients|mesh-ancestor
24879561|NCT04664361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868294|NCT00111436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24476427|NCT00414947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868295|NCT00111436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868296|NCT00111436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24476475|NCT00415116|Tubulin Modulators|tubulin modulators|mesh-ancestor
24476476|NCT00415116|Antimitotic Agents|antimitotic agents|mesh-ancestor
24476477|NCT00415116|Mitosis Modulators|mitosis modulators|mesh-ancestor
24476478|NCT00415116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476479|NCT00415116|Immunologic Factors|immunologic factors|mesh-ancestor
24476564|NCT00415753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24817880|NCT02085967|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24879618|NCT04622735|Sensory System Agents|sensory system agents|mesh-ancestor
24879619|NCT04622735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24879620|NCT04622735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552254|NCT03734653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24552255|NCT03734653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868297|NCT00111436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24879622|NCT04614545|Phentermine|phentermine|mesh-list
24879623|NCT04614545|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25868298|NCT00111436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25868299|NCT00111436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24817882|NCT02085967|Hormone Antagonists|hormone antagonists|mesh-ancestor
24899870|NCT04399343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24817883|NCT02085967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24913969|NCT04258956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24913970|NCT04258956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817884|NCT02085967|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24817885|NCT02085967|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24817886|NCT02085967|Antitubercular Agents|antitubercular agents|mesh-ancestor
24817887|NCT02085967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24817888|NCT02085967|Leprostatic Agents|leprostatic agents|mesh-ancestor
24817889|NCT02085967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24817890|NCT02085967|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24817891|NCT02085967|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24899693|NCT04401345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24899694|NCT04401345|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24899695|NCT04401345|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24899696|NCT04401345|Cholinergic Agents|cholinergic agents|mesh-ancestor
24899697|NCT04401345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24899698|NCT04401345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899699|NCT04401345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899734|NCT04400916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24853902|NCT02270827|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24899735|NCT04400916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899739|NCT04400890|Cholecalciferol|cholecalciferol|mesh-list
24899740|NCT04400890|Resveratrol|resveratrol|mesh-list
24899741|NCT04400890|Vitamins|vitamins|mesh-ancestor
24899766|NCT04400188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24879643|NCT04594005|Paclitaxel|paclitaxel|mesh-list
24879644|NCT04594005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24879645|NCT04594005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24879646|NCT04594005|Tubulin Modulators|tubulin modulators|mesh-ancestor
24879657|NCT04560660|Midazolam|midazolam|mesh-list
24899782|NCT04400136|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24899783|NCT04400136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24899784|NCT04400136|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24899785|NCT04400136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899786|NCT04400136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899787|NCT04399187|Sodium Hypochlorite|sodium hypochlorite|mesh-list
24899789|NCT04399187|Disinfectants|disinfectants|mesh-ancestor
24899819|NCT04399226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24899820|NCT04399395|Naltrexone|naltrexone|mesh-list
24899821|NCT04399395|Bupropion|bupropion|mesh-list
24879670|NCT04560660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24879671|NCT04560660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879672|NCT04560660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24879673|NCT04560660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24879674|NCT04560660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25202001|NCT02724293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25202002|NCT02724293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25202003|NCT02724293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25202004|NCT02724293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24879680|NCT04551521|Pertuzumab|pertuzumab|mesh-list
24879681|NCT04551521|Atezolizumab|atezolizumab|mesh-list
24879682|NCT04551521|Vemurafenib|vemurafenib|mesh-list
24899822|NCT04399395|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24899823|NCT04399395|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24899824|NCT04399395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899825|NCT04399395|Sensory System Agents|sensory system agents|mesh-ancestor
24899826|NCT04399395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24899827|NCT04399395|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24899828|NCT04399395|Antidepressive Agents|antidepressive agents|mesh-ancestor
25670880|NCT03781765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25670881|NCT03781765|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25670882|NCT03781765|Adrenergic Agents|adrenergic agents|mesh-ancestor
25670883|NCT03781752|Methylphenidate|methylphenidate|mesh-list
24552460|NCT02916862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552461|NCT02916862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25126324|NCT03062800|Thalidomide|thalidomide|mesh-list
25126325|NCT03062800|Carboplatin|carboplatin|mesh-list
25126326|NCT03062800|Pemetrexed|pemetrexed|mesh-list
25126327|NCT03062800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25126328|NCT03062800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126329|NCT03062800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126330|NCT03062800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25126331|NCT03062800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24899829|NCT04399395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24899830|NCT04399395|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24899831|NCT04399395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24899832|NCT04399395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24899833|NCT04399395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879696|NCT04528680|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25868300|NCT00111436|Immunologic Factors|immunologic factors|mesh-ancestor
24899865|NCT04399343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24899866|NCT04399343|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24899868|NCT04399343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24899869|NCT04399343|Adrenergic Agents|adrenergic agents|mesh-ancestor
24899970|NCT04398108|Margetuximab|margetuximab|mesh-list
24899971|NCT04398108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24899972|NCT04398290|Nitric Oxide|nitric oxide|mesh-list
24899973|NCT04398290|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24900021|NCT04397601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24900023|NCT04397601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24900024|NCT04397601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24900025|NCT04397601|Growth Substances|growth substances|mesh-ancestor
24900026|NCT04397601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900027|NCT04397601|Growth Inhibitors|growth inhibitors|mesh-ancestor
25202005|NCT02724293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24817915|NCT02086019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817916|NCT02086019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24817917|NCT02086019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24817918|NCT02086019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24879737|NCT04509596|Antimetabolites|antimetabolites|mesh-ancestor
24815828|NCT02072213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815829|NCT02072213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914158|NCT04257396|Carbon Fiber|carbon fiber|mesh-list
24815830|NCT02072213|Urological Agents|urological agents|mesh-ancestor
24611619|NCT01010139|Codeine|codeine|mesh-list
24817920|NCT02086019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24817921|NCT02086019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24817922|NCT02086019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24817923|NCT02086019|Purinergic Agents|purinergic agents|mesh-ancestor
24817924|NCT02086019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24817925|NCT02086019|Anticoagulants|anticoagulants|mesh-ancestor
24817926|NCT02086019|Protease Inhibitors|protease inhibitors|mesh-ancestor
24817927|NCT02086019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24817928|NCT02086019|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24817929|NCT02086019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25868301|NCT00111449|Etanercept|etanercept|mesh-list
25868302|NCT00111449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25868303|NCT00111449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24900107|NCT04397458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24900108|NCT04397458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24900109|NCT04397458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24900110|NCT04397458|Anesthetics, Local|anesthetics, local|mesh-ancestor
25670884|NCT03781752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25670885|NCT03781752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670886|NCT03781752|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25670887|NCT03781752|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25670888|NCT03781752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25670889|NCT03781752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670890|NCT03781752|Dopamine Agents|dopamine agents|mesh-ancestor
25670891|NCT03781752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25670892|NCT03749629|Psychotropic Drugs|psychotropic drugs|mesh-list
25670893|NCT03718065|Lofexidine|lofexidine|mesh-list
24552650|NCT01487174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552651|NCT01487174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24552652|NCT01487174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24552653|NCT01487174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552654|NCT00732212|Hemostatics|hemostatics|mesh-list
24552655|NCT00732212|Coagulants|coagulants|mesh-ancestor
24552656|NCT00522145|XL647|xl647|mesh-list
24552657|NCT00522145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25126393|NCT03063073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25126394|NCT03063073|Analgesics|analgesics|mesh-ancestor
25126395|NCT03063073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25126396|NCT03063073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24900111|NCT04397458|Anesthetics|anesthetics|mesh-ancestor
24900112|NCT04397458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24900113|NCT04397458|Sensory System Agents|sensory system agents|mesh-ancestor
24900115|NCT04397510|Anticoagulants|anticoagulants|mesh-ancestor
24900116|NCT04397510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24900117|NCT04397510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24900118|NCT04397510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723017|NCT01584206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24900119|NCT04397393|Midazolam|midazolam|mesh-list
24900120|NCT04397393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24815873|NCT02072330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25868304|NCT00111449|Analgesics|analgesics|mesh-ancestor
25868305|NCT00111449|Sensory System Agents|sensory system agents|mesh-ancestor
24786874|NCT01922193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24786875|NCT01922193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786876|NCT01922375|Naftopidil|naftopidil|mesh-list
24786877|NCT01922375|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24786878|NCT01922375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24786879|NCT01922375|Adrenergic Agents|adrenergic agents|mesh-ancestor
24786880|NCT01922375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25202006|NCT02724293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25202007|NCT02724293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25202008|NCT02724293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25007622|NCT03149809|Cholinergic Agents|cholinergic agents|mesh-ancestor
25007623|NCT03149809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24786885|NCT01922375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24786886|NCT01922375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24786887|NCT01922375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24786888|NCT01922427|RNS60|rns60|mesh-list
25268751|NCT02414581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879765|NCT04439799|Methyltestosterone|methyltestosterone|mesh-list
25868306|NCT00111449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25868307|NCT00111449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868308|NCT00111449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24786894|NCT01922427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786895|NCT01922427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24786896|NCT01922427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24786897|NCT01922427|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24786898|NCT01922466|Loxoprofen|loxoprofen|mesh-list
24786899|NCT01922466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24786900|NCT01922466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24786901|NCT01922466|Analgesics|analgesics|mesh-ancestor
24786902|NCT01922466|Sensory System Agents|sensory system agents|mesh-ancestor
24786903|NCT01922466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24786904|NCT01922466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854057|NCT02271542|Propofol|propofol|mesh-list
25108933|NCT03128866|Hemostatics|hemostatics|mesh-ancestor
25108934|NCT03128866|Coagulants|coagulants|mesh-ancestor
25108935|NCT03128736|Esomeprazole|esomeprazole|mesh-list
25108936|NCT03128736|Dexlansoprazole|dexlansoprazole|mesh-list
25108937|NCT03128736|Lansoprazole|lansoprazole|mesh-list
25670894|NCT03718065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25670895|NCT03718065|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25670896|NCT03718065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670897|NCT03718065|Sensory System Agents|sensory system agents|mesh-ancestor
25670898|NCT03718065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25670899|NCT03718065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25670900|NCT03718065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25670901|NCT03718065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25670902|NCT03718065|Adrenergic Agents|adrenergic agents|mesh-ancestor
25670903|NCT03718065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25674499|NCT01772823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25108938|NCT03128736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25108939|NCT03128736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25108940|NCT03128736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25108941|NCT03128736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25108942|NCT03128736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108946|NCT03128515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108947|NCT03128515|Antisickling Agents|antisickling agents|mesh-ancestor
25108948|NCT03128515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25202009|NCT02723968|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25202011|NCT02724163|Cyclophosphamide|cyclophosphamide|mesh-list
25202012|NCT02724163|Busulfan|busulfan|mesh-list
25202013|NCT02724163|Fludarabine|fludarabine|mesh-list
25202014|NCT02724163|Daunorubicin|daunorubicin|mesh-list
25202015|NCT02724163|Mitoxantrone|mitoxantrone|mesh-list
25202016|NCT02724163|Gemtuzumab|gemtuzumab|mesh-list
25202017|NCT02724163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25202018|NCT02724163|Immunologic Factors|immunologic factors|mesh-ancestor
25868309|NCT00111449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25108949|NCT03128515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108950|NCT03128515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25108951|NCT03128528|Empagliflozin|empagliflozin|mesh-list
25108952|NCT03128528|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25108953|NCT03128528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108954|NCT03128528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25108955|NCT03128528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108956|NCT03128242|Oxytocin|oxytocin|mesh-list
25108957|NCT03128242|Oxytocics|oxytocics|mesh-ancestor
25108958|NCT03128242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25108959|NCT03128242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108960|NCT03128216|Bupivacaine|bupivacaine|mesh-list
25108961|NCT03128216|Ropivacaine|ropivacaine|mesh-list
25108962|NCT03128216|Anesthetics, Local|anesthetics, local|mesh-list
25108963|NCT03128216|Anesthetics|anesthetics|mesh-list
25108964|NCT03128216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25108965|NCT03128216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108966|NCT03128216|Sensory System Agents|sensory system agents|mesh-ancestor
25108967|NCT03128216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108968|NCT03128398|Domperidone|domperidone|mesh-list
25108969|NCT03128398|Antiemetics|antiemetics|mesh-ancestor
24817950|NCT02086097|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
24817951|NCT02086097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24817952|NCT02086097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24817953|NCT02086097|Analgesics|analgesics|mesh-ancestor
24817954|NCT02086097|Sensory System Agents|sensory system agents|mesh-ancestor
24817955|NCT02086097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24817956|NCT02086097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817957|NCT02086097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24914436|NCT04255121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24817958|NCT02086097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24817959|NCT02086097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24817960|NCT02086097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817961|NCT02086097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817962|NCT02086188|Mirabegron|mirabegron|mesh-list
24900163|NCT04396990|Glucocorticoids|glucocorticoids|mesh-ancestor
24817963|NCT02086188|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24817964|NCT02086188|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24900164|NCT04396990|Hormones|hormones|mesh-ancestor
24900165|NCT04396990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24900166|NCT04396990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900167|NCT04396990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24900168|NCT04396990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24900169|NCT04396938|Lamotrigine|lamotrigine|mesh-list
24900170|NCT04396938|Anticonvulsants|anticonvulsants|mesh-ancestor
24900171|NCT04396938|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24914486|NCT04254913|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24914487|NCT04254913|Protective Agents|protective agents|mesh-ancestor
25065359|NCT03451110|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
25065360|NCT03451110|Antifungal Agents|antifungal agents|mesh-ancestor
24827652|NCT02140632|Prednisolone|prednisolone|mesh-list
24900172|NCT04396938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24900173|NCT04396938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879845|NCT04369014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879846|NCT04369014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24879847|NCT04369014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24879848|NCT04369014|Anesthetics, General|anesthetics, general|mesh-ancestor
24879849|NCT04360629|Tranexamic Acid|tranexamic acid|mesh-list
24900174|NCT04396938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24900176|NCT04396938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24900177|NCT04396938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24900178|NCT04396938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24900212|NCT04396457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24900213|NCT04396457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24900214|NCT04396457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900215|NCT04396457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900216|NCT04396457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24476964|NCT00416897|Dexamethasone|dexamethasone|mesh-list
24476997|NCT00416923|Immunologic Factors|immunologic factors|mesh-ancestor
24476998|NCT00416923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900280|NCT04395768|Protective Agents|protective agents|mesh-ancestor
24900281|NCT04395768|Vitamin B Complex|vitamin b complex|mesh-ancestor
24900306|NCT04395638|Micronutrients|micronutrients|mesh-ancestor
24900307|NCT04395638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900308|NCT04395638|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25202019|NCT02724163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900332|NCT04395105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24900333|NCT04395105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817981|NCT02086253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817984|NCT02086279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24817985|NCT02086279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818016|NCT02086474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24818017|NCT02086474|Immunologic Factors|immunologic factors|mesh-ancestor
24818018|NCT02086474|Viscosupplements|viscosupplements|mesh-ancestor
24818019|NCT02086474|Protective Agents|protective agents|mesh-ancestor
24818020|NCT02086526|Metformin|metformin|mesh-list
24914547|NCT04254471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914548|NCT04254471|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24914549|NCT04254471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24914550|NCT04254471|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24914551|NCT04254640|Cytarabine|cytarabine|mesh-list
24914552|NCT04254640|Cladribine|cladribine|mesh-list
24914553|NCT04254640|Aclarubicin|aclarubicin|mesh-list
24914554|NCT04254640|Lenograstim|lenograstim|mesh-list
24914555|NCT04254640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24914556|NCT04254640|Antimetabolites|antimetabolites|mesh-ancestor
24914557|NCT04254640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914558|NCT04254640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914559|NCT04254640|Antiviral Agents|antiviral agents|mesh-ancestor
25868310|NCT00111449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24818021|NCT02086526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24818022|NCT02086526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818023|NCT02086656|Bevacizumab|bevacizumab|mesh-list
24818024|NCT02086656|Capecitabine|capecitabine|mesh-list
24818025|NCT02086656|Oxaliplatin|oxaliplatin|mesh-list
24818026|NCT02086656|Irinotecan|irinotecan|mesh-list
24818027|NCT02086656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24818028|NCT02086656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24818029|NCT02086656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24723362|NCT01587066|Anticonvulsants|anticonvulsants|mesh-ancestor
24900350|NCT04394975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900351|NCT04395170|Immunoglobulins|immunoglobulins|mesh-list
24900352|NCT04395170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24900353|NCT04395170|Antibodies|antibodies|mesh-list
24900354|NCT04395170|Immunologic Factors|immunologic factors|mesh-ancestor
24477138|NCT00417443|Clonidine|clonidine|mesh-list
24900387|NCT04394533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24900388|NCT04394533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900389|NCT04394533|Sensory System Agents|sensory system agents|mesh-ancestor
25868311|NCT00111449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25868312|NCT00111449|Immunologic Factors|immunologic factors|mesh-ancestor
24900390|NCT04394533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24900393|NCT04394208|Silymarin|silymarin|mesh-list
24900394|NCT04394208|Antioxidants|antioxidants|mesh-ancestor
24900395|NCT04394208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900396|NCT04394208|Protective Agents|protective agents|mesh-ancestor
24900397|NCT04394208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900398|NCT04394442|Hydroxychloroquine|hydroxychloroquine|mesh-list
24900434|NCT04394143|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25108971|NCT03128398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24900474|NCT04393610|Anesthetics, General|anesthetics, general|mesh-ancestor
24900475|NCT04393610|Anticonvulsants|anticonvulsants|mesh-ancestor
24900510|NCT04393220|Growth Substances|growth substances|mesh-ancestor
24900511|NCT04393220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900512|NCT04393220|Growth Inhibitors|growth inhibitors|mesh-ancestor
24900513|NCT04393220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24900514|NCT04393220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900516|NCT04393246|Ambrisentan|ambrisentan|mesh-list
24900517|NCT04393246|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24900519|NCT04393246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24900520|NCT04393246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900521|NCT04393246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24477292|NCT00418132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24900596|NCT04392648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24900597|NCT04392648|Glucocorticoids|glucocorticoids|mesh-ancestor
24900598|NCT04392648|Hormones|hormones|mesh-ancestor
24900599|NCT04392648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24900600|NCT04392648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24900601|NCT04392648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24900602|NCT04392648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24900603|NCT04392648|Growth Substances|growth substances|mesh-ancestor
24900604|NCT04392648|Growth Inhibitors|growth inhibitors|mesh-ancestor
24900608|NCT04392479|Growth Substances|growth substances|mesh-ancestor
24900609|NCT04392479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900610|NCT04392479|Growth Inhibitors|growth inhibitors|mesh-ancestor
24900611|NCT04392479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24900612|NCT04392557|Metformin|metformin|mesh-list
24819489|NCT02095717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24819490|NCT02095717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819491|NCT02095730|Vitamins|vitamins|mesh-list
24819496|NCT02095730|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24900613|NCT04392557|Pioglitazone|pioglitazone|mesh-list
24900614|NCT04392557|Alogliptin|alogliptin|mesh-list
24900615|NCT04392557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24900616|NCT04392557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900617|NCT04392557|Incretins|incretins|mesh-ancestor
24900618|NCT04392557|Hormones|hormones|mesh-ancestor
24900619|NCT04392557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24900620|NCT04392557|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24900621|NCT04392557|Protease Inhibitors|protease inhibitors|mesh-ancestor
24900662|NCT04392297|Immunologic Factors|immunologic factors|mesh-ancestor
24900663|NCT04392297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900664|NCT04392037|Dexamethasone|dexamethasone|mesh-list
24880044|NCT04155632|Antiviral Agents|antiviral agents|mesh-ancestor
24900710|NCT04391868|Urological Agents|urological agents|mesh-ancestor
24818037|NCT02086656|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24818038|NCT02086656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24818039|NCT02086656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24818040|NCT02086747|Acetaminophen|acetaminophen|mesh-list
24818041|NCT02086747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24818042|NCT02086747|Analgesics|analgesics|mesh-ancestor
24818043|NCT02086747|Sensory System Agents|sensory system agents|mesh-ancestor
24818044|NCT02086747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24818045|NCT02086747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818046|NCT02086747|Antipyretics|antipyretics|mesh-ancestor
24818047|NCT02086825|Rifaximin|rifaximin|mesh-list
24818048|NCT02086825|Lactulose|lactulose|mesh-list
24818049|NCT02086825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24818050|NCT02086825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24818051|NCT02086825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24818052|NCT02086838|Dextrans|dextrans|mesh-list
24900868|NCT04391439|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24900869|NCT04391439|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24900870|NCT04391439|Prednisolone|prednisolone|mesh-list
24900902|NCT04390334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24900903|NCT04390334|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24900904|NCT04390334|Histamine Antagonists|histamine antagonists|mesh-ancestor
24900905|NCT04390334|Histamine Agents|histamine agents|mesh-ancestor
24900906|NCT04390334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24900907|NCT04390334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900908|NCT04390594|Nafamostat|nafamostat|mesh-list
24900909|NCT04390594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24477659|NCT00419601|Anesthetics, General|anesthetics, general|mesh-ancestor
24477697|NCT00419731|Naltrexone|naltrexone|mesh-list
24477698|NCT00419731|Bupropion|bupropion|mesh-list
24477699|NCT00419731|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24477700|NCT00419731|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24477701|NCT00419731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477702|NCT00419731|Sensory System Agents|sensory system agents|mesh-ancestor
25126635|NCT03060798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25126637|NCT03060785|Tenofovir|tenofovir|mesh-list
24477705|NCT00419731|Antidepressive Agents|antidepressive agents|mesh-ancestor
25868313|NCT00111462|Darbepoetin alfa|darbepoetin alfa|mesh-list
24786910|NCT01922596|Anesthetics, Local|anesthetics, local|mesh-ancestor
24786911|NCT01922596|Anesthetics|anesthetics|mesh-ancestor
24786912|NCT01922596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24786913|NCT01922596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786914|NCT01922596|Sensory System Agents|sensory system agents|mesh-ancestor
24786915|NCT01922596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24786916|NCT01922687|Amlodipine|amlodipine|mesh-list
24786917|NCT01922687|Atorvastatin|atorvastatin|mesh-list
24786918|NCT01922687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24786919|NCT01922687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24786920|NCT01922687|Antimetabolites|antimetabolites|mesh-ancestor
24786921|NCT01922687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786922|NCT01922687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25202020|NCT02724163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24786923|NCT01922687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24786924|NCT01922687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24786925|NCT01922687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24786926|NCT01922687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24786927|NCT01922687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24786928|NCT01922687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24786929|NCT01922687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880079|NCT04131829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24786930|NCT01922687|Vasodilator Agents|vasodilator agents|mesh-ancestor
24786931|NCT01922713|Vitamin A|vitamin a|mesh-list
24786932|NCT01922713|Beta Carotene|beta carotene|mesh-list
24786933|NCT01922713|Retinol palmitate|retinol palmitate|mesh-list
24786934|NCT01922713|Vitamins|vitamins|mesh-ancestor
24786935|NCT01922713|Micronutrients|micronutrients|mesh-ancestor
24901473|NCT04384653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901494|NCT04384133|Antioxidants|antioxidants|mesh-ancestor
24901495|NCT04384133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901496|NCT04384133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24901497|NCT04384133|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24901498|NCT04384133|Vasodilator Agents|vasodilator agents|mesh-ancestor
24901499|NCT04384133|Gasotransmitters|gasotransmitters|mesh-ancestor
24901500|NCT04384133|Protective Agents|protective agents|mesh-ancestor
24901504|NCT04383977|Etoposide|etoposide|mesh-list
24901505|NCT04383977|Apatinib|apatinib|mesh-list
25108973|NCT03128398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25868314|NCT00111462|Hematinics|hematinics|mesh-ancestor
24818149|NCT02087111|Antimetabolites|antimetabolites|mesh-ancestor
24818150|NCT02087111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818151|NCT02087111|Immunologic Factors|immunologic factors|mesh-ancestor
24818152|NCT02087111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818153|NCT02087202|Magnesium Sulfate|magnesium sulfate|mesh-list
24818154|NCT02087202|Ketamine|ketamine|mesh-list
24818155|NCT02087202|Analgesics|analgesics|mesh-ancestor
24818156|NCT02087202|Sensory System Agents|sensory system agents|mesh-ancestor
24818157|NCT02087202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24818158|NCT02087202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818159|NCT02087202|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24818160|NCT02087202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24818161|NCT02087202|Anesthetics, General|anesthetics, general|mesh-ancestor
24818162|NCT02087202|Anesthetics|anesthetics|mesh-ancestor
24901702|NCT04382027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901704|NCT04382027|Coagulants|coagulants|mesh-ancestor
24901705|NCT04381884|Ivermectin|ivermectin|mesh-list
24901706|NCT04381884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24901707|NCT04381884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24901708|NCT04381962|Azithromycin|azithromycin|mesh-list
24901709|NCT04381962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24901710|NCT04381962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24901711|NCT04381910|Irinotecan|irinotecan|mesh-list
24901712|NCT04381910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24901713|NCT04381910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24478562|NCT00423514|Antimetabolites|antimetabolites|mesh-ancestor
24901922|NCT04380103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902000|NCT04378972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24902001|NCT04378972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25670904|NCT03718065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902002|NCT04378972|Analgesics|analgesics|mesh-ancestor
25670905|NCT03711188|Nivolumab|nivolumab|mesh-list
24553628|NCT00732420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553630|NCT00732446|Moxifloxacin|moxifloxacin|mesh-list
24553631|NCT00732446|Dexamethasone|dexamethasone|mesh-list
24902003|NCT04378972|Sensory System Agents|sensory system agents|mesh-ancestor
24902004|NCT04378972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24902005|NCT04378972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24902031|NCT04378608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902032|NCT04378608|Antiviral Agents|antiviral agents|mesh-ancestor
24902033|NCT04378608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902034|NCT04378647|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24902035|NCT04378647|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24902036|NCT04378647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24902037|NCT04378647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24725036|NCT01596140|Sirolimus|sirolimus|mesh-list
24902038|NCT04378647|Immunologic Factors|immunologic factors|mesh-ancestor
24902039|NCT04378647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902040|NCT04378231|Amoxicillin|amoxicillin|mesh-list
24902051|NCT04378283|Tetracaine|tetracaine|mesh-list
24902052|NCT04378283|Anesthetics|anesthetics|mesh-list
25065377|NCT03451110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24829142|NCT02150031|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24829143|NCT02150031|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24829144|NCT02150031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25868315|NCT00111540|Exenatide|exenatide|mesh-list
25059926|NCT03484195|Immunologic Factors|immunologic factors|mesh-ancestor
25868316|NCT00111540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24545378|NCT00693212|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24545379|NCT00693212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545380|NCT00693212|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24858315|NCT02296281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24545381|NCT00693212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24545382|NCT00693212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24545383|NCT00693212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545384|NCT00693212|Dopamine Agents|dopamine agents|mesh-ancestor
24545385|NCT00693212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24545386|NCT00693251|Sirolimus|sirolimus|mesh-list
24545387|NCT00693251|Paclitaxel|paclitaxel|mesh-list
24834783|NCT02181023|Cholinergic Agents|cholinergic agents|mesh-ancestor
24545388|NCT00693251|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24545389|NCT00693251|Everolimus|everolimus|mesh-list
24545390|NCT00693251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24545391|NCT00693251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24545392|NCT00693251|Tubulin Modulators|tubulin modulators|mesh-ancestor
24545393|NCT00693251|Antimitotic Agents|antimitotic agents|mesh-ancestor
24447335|NCT00308191|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24447336|NCT00308191|Cholinergic Agents|cholinergic agents|mesh-ancestor
24447337|NCT00308191|Anticonvulsants|anticonvulsants|mesh-ancestor
24447338|NCT00308269|Folic Acid|folic acid|mesh-list
24447339|NCT00308269|Vinca Alkaloids|vinca alkaloids|mesh-list
24447340|NCT00308269|Hematinics|hematinics|mesh-ancestor
25229186|NCT02603965|Micronutrients|micronutrients|mesh-ancestor
24447341|NCT00308269|Vitamin B Complex|vitamin b complex|mesh-ancestor
24447342|NCT00308269|Vitamins|vitamins|mesh-ancestor
25229187|NCT02603965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229188|NCT02603757|Vitamin D|vitamin d|mesh-list
25229189|NCT02603757|Cholecalciferol|cholecalciferol|mesh-list
25229190|NCT02603757|Vitamins|vitamins|mesh-ancestor
25670906|NCT03711188|Ipilimumab|ipilimumab|mesh-list
25670907|NCT03711188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25670908|NCT03711188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670909|NCT03711188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25670910|NCT03711188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229191|NCT02603757|Micronutrients|micronutrients|mesh-ancestor
25229192|NCT02603757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229193|NCT02603757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25409524|NCT03373851|Anesthetics|anesthetics|mesh-ancestor
25868317|NCT00111540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868318|NCT00111540|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25868319|NCT00111540|Incretins|incretins|mesh-ancestor
25868320|NCT00111540|Hormones|hormones|mesh-ancestor
25868321|NCT00111540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25868322|NCT00111566|Eptifibatide|eptifibatide|mesh-list
25868323|NCT00111566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25868324|NCT00111618|Vadimezan|vadimezan|mesh-list
25126717|NCT03059888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126719|NCT03059888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25126720|NCT03059888|Immunologic Factors|immunologic factors|mesh-ancestor
25126721|NCT03059888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229194|NCT02603757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25229195|NCT02603822|Indomethacin|indomethacin|mesh-list
25229196|NCT02603822|Mannitol|mannitol|mesh-list
25229197|NCT02603822|Lactulose|lactulose|mesh-list
25229198|NCT02603822|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25229199|NCT02603822|Diuretics|diuretics|mesh-ancestor
25229200|NCT02603822|Natriuretic Agents|natriuretic agents|mesh-ancestor
25229201|NCT02603822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229202|NCT02603822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25229203|NCT02603822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25229204|NCT02603822|Analgesics|analgesics|mesh-ancestor
25229205|NCT02603822|Sensory System Agents|sensory system agents|mesh-ancestor
25229206|NCT02603822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229207|NCT02603822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25229208|NCT02603822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24844826|NCT02234739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24844827|NCT02234739|Hormone Antagonists|hormone antagonists|mesh-ancestor
24844828|NCT02234739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24844829|NCT02234739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844830|NCT02234739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24844831|NCT02234843|Rivaroxaban|rivaroxaban|mesh-list
24844832|NCT02234843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24844833|NCT02234843|Antithrombins|antithrombins|mesh-ancestor
25059954|NCT03483870|Morphine|morphine|mesh-list
25868325|NCT00111618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868326|NCT00111631|Metformin|metformin|mesh-list
25868327|NCT00111631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24545395|NCT00693251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545396|NCT00693251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24545398|NCT00693251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545399|NCT00693251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24545400|NCT00693251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24545401|NCT00693251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24545402|NCT00693251|Antifungal Agents|antifungal agents|mesh-ancestor
24545403|NCT00693342|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
24545404|NCT00693342|Immunologic Factors|immunologic factors|mesh-ancestor
24545405|NCT00693342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545406|NCT00693355|Butyric Acid|butyric acid|mesh-list
24545407|NCT00693355|Histamine Antagonists|histamine antagonists|mesh-ancestor
24545408|NCT00693355|Histamine Agents|histamine agents|mesh-ancestor
24545409|NCT00693355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24545410|NCT00693355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545411|NCT00693355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545419|NCT00693381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24545420|NCT00693381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545421|NCT00693381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24545422|NCT00693381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24545423|NCT00693381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25868328|NCT00111631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24711676|NCT01516567|Tubulin Modulators|tubulin modulators|mesh-ancestor
24711677|NCT01516567|Antimitotic Agents|antimitotic agents|mesh-ancestor
24711678|NCT01516567|Mitosis Modulators|mitosis modulators|mesh-ancestor
24711679|NCT01516580|Cytarabine|cytarabine|mesh-list
24711680|NCT01516580|Cyclophosphamide|cyclophosphamide|mesh-list
25670911|NCT03684785|Pembrolizumab|pembrolizumab|mesh-list
25670912|NCT03684785|Cemiplimab|cemiplimab|mesh-list
25670913|NCT03684785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25670914|NCT03684785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670915|NCT03682393|Hydrocortisone|hydrocortisone|mesh-list
25670916|NCT03682393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25670917|NCT03654833|Bevacizumab|bevacizumab|mesh-list
25670918|NCT03654833|Pembrolizumab|pembrolizumab|mesh-list
25670919|NCT03654833|Atezolizumab|atezolizumab|mesh-list
25670920|NCT03654833|Niraparib|niraparib|mesh-list
25229213|NCT02603822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229215|NCT02603822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25229216|NCT02603861|Modafinil|modafinil|mesh-list
25229217|NCT02603861|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25229218|NCT02603861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229219|NCT02603861|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25229220|NCT02603861|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24844834|NCT02234843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25069214|NCT03428256|Anesthetics|anesthetics|mesh-list
25868336|NCT00111644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24844843|NCT02234869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24844844|NCT02234869|Antiviral Agents|antiviral agents|mesh-ancestor
25868337|NCT00111644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24813104|NCT02056418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813105|NCT02056418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24813107|NCT02056444|Tranexamic Acid|tranexamic acid|mesh-list
24813108|NCT02056444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24813109|NCT02056444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24813110|NCT02056444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813111|NCT02056444|Hemostatics|hemostatics|mesh-ancestor
24813112|NCT02056444|Coagulants|coagulants|mesh-ancestor
24813113|NCT02056587|Everolimus|everolimus|mesh-list
25868338|NCT00111670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25868339|NCT00111670|Protease Inhibitors|protease inhibitors|mesh-ancestor
24813114|NCT02056587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813115|NCT02056587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24813116|NCT02056587|Immunologic Factors|immunologic factors|mesh-ancestor
24460750|NCT00349401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25868340|NCT00111670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868341|NCT00111670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868342|NCT00111670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25868343|NCT00111670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229221|NCT02603861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25229222|NCT02603861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229224|NCT02603783|Antipruritics|antipruritics|mesh-ancestor
25229225|NCT02603783|Dermatologic Agents|dermatologic agents|mesh-ancestor
25229226|NCT02603783|Sensory System Agents|sensory system agents|mesh-ancestor
25229227|NCT02603783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229228|NCT02603783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229229|NCT02603770|Lovastatin|lovastatin|mesh-list
25229230|NCT02603770|L 647318|l 647318|mesh-list
25229231|NCT02603770|Dihydromevinolin|dihydromevinolin|mesh-list
25229232|NCT02603770|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25229233|NCT02603770|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25229234|NCT02603770|Antimetabolites|antimetabolites|mesh-ancestor
25229235|NCT02603770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229236|NCT02603770|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25229237|NCT02603770|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25229238|NCT02603770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229239|NCT02603991|Levetiracetam|levetiracetam|mesh-list
25229240|NCT02603991|Anticonvulsants|anticonvulsants|mesh-ancestor
25868344|NCT00111748|Thalidomide|thalidomide|mesh-list
25126873|NCT03059238|Parecoxib|parecoxib|mesh-list
25126874|NCT03059238|Oxycodone|oxycodone|mesh-list
25126875|NCT03059238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25126876|NCT03059238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25126877|NCT03059238|Analgesics|analgesics|mesh-ancestor
25126878|NCT03059238|Sensory System Agents|sensory system agents|mesh-ancestor
25126879|NCT03059238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25126880|NCT03059238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126881|NCT03059238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25126882|NCT03059238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25126890|NCT03059134|Mirabegron|mirabegron|mesh-list
25229241|NCT02603991|Nootropic Agents|nootropic agents|mesh-ancestor
25229242|NCT02603705|Oxycodone|oxycodone|mesh-list
25229243|NCT02603705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25229244|NCT02603705|Narcotics|narcotics|mesh-ancestor
24844846|NCT02234869|Immunologic Factors|immunologic factors|mesh-ancestor
24844847|NCT02234869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844848|NCT02234869|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24844849|NCT02234882|Fostemsavir|fostemsavir|mesh-list
24844850|NCT02234882|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24844851|NCT02234882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24844852|NCT02234882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24844853|NCT02234882|Antimetabolites|antimetabolites|mesh-ancestor
24844854|NCT02234882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868345|NCT00111748|Dexamethasone|dexamethasone|mesh-list
25868346|NCT00111748|Bortezomib|bortezomib|mesh-list
24833887|NCT02176122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24833888|NCT02176122|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24844855|NCT02234882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24844856|NCT02234882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24844926|NCT02235324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844935|NCT02235324|Vitamin B Complex|vitamin b complex|mesh-ancestor
24844936|NCT02235324|Vitamins|vitamins|mesh-ancestor
24844937|NCT02235324|Micronutrients|micronutrients|mesh-ancestor
24844938|NCT02235324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24844939|NCT02235324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24844940|NCT02235324|Growth Substances|growth substances|mesh-ancestor
24844941|NCT02235324|Growth Inhibitors|growth inhibitors|mesh-ancestor
24844942|NCT02235337|Riboflavin|riboflavin|mesh-list
25868347|NCT00111748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25868348|NCT00111748|Antiemetics|antiemetics|mesh-ancestor
25868349|NCT00111748|Autonomic Agents|autonomic agents|mesh-ancestor
25868350|NCT00111748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25868351|NCT00111748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868352|NCT00111748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25868353|NCT00111748|Glucocorticoids|glucocorticoids|mesh-ancestor
25868354|NCT00111748|Hormones|hormones|mesh-ancestor
25868355|NCT00111748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25868356|NCT00111748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25868357|NCT00111748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868358|NCT00111748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25868359|NCT00111748|Immunologic Factors|immunologic factors|mesh-ancestor
25868360|NCT00111748|Leprostatic Agents|leprostatic agents|mesh-ancestor
25868361|NCT00111748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24813122|NCT02056665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24813123|NCT02056665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24813124|NCT02056678|Acetaminophen|acetaminophen|mesh-list
24813125|NCT02056678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24813126|NCT02056678|Analgesics|analgesics|mesh-ancestor
24813127|NCT02056678|Sensory System Agents|sensory system agents|mesh-ancestor
25868362|NCT00111748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25868363|NCT00111748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25868364|NCT00111748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25229245|NCT02603705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25670921|NCT03654833|Rucaparib|rucaparib|mesh-list
25670922|NCT03654833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25670923|NCT03654833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670924|NCT03654833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25670925|NCT03654833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25670926|NCT03654833|Growth Substances|growth substances|mesh-ancestor
25670927|NCT03654833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670928|NCT03654833|Growth Inhibitors|growth inhibitors|mesh-ancestor
25670929|NCT03654833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25670930|NCT03654833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229246|NCT02603705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229247|NCT02603705|Analgesics|analgesics|mesh-ancestor
24833889|NCT02176122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126936|NCT03058900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25126937|NCT03058900|Dermatologic Agents|dermatologic agents|mesh-ancestor
25126938|NCT03058900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126939|NCT03058900|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25126940|NCT03058900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25126941|NCT03058900|Immunologic Factors|immunologic factors|mesh-ancestor
25126942|NCT03058900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25126943|NCT03058900|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25126944|NCT03058835|Tenofovir|tenofovir|mesh-list
25126945|NCT03058835|Emtricitabine|emtricitabine|mesh-list
25229248|NCT02603705|Sensory System Agents|sensory system agents|mesh-ancestor
25229249|NCT02603705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229250|NCT02603406|Epoetin Alfa|epoetin alfa|mesh-list
25229251|NCT02603406|Hematinics|hematinics|mesh-ancestor
25229252|NCT02603510|Insulin Lispro|insulin lispro|mesh-list
25229253|NCT02603510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25229254|NCT02603510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229255|NCT02603575|Caspofungin|caspofungin|mesh-list
25229257|NCT02603575|Sulfanilamides|sulfanilamides|mesh-list
25229258|NCT02603575|Methylprednisolone|methylprednisolone|mesh-list
25229259|NCT02603575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25229260|NCT02603575|Antiemetics|antiemetics|mesh-ancestor
25229261|NCT02603575|Autonomic Agents|autonomic agents|mesh-ancestor
25229262|NCT02603575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229263|NCT02603575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229264|NCT02603575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25229265|NCT02603575|Glucocorticoids|glucocorticoids|mesh-ancestor
25273446|NCT02385435|Bupivacaine|bupivacaine|mesh-list
24844947|NCT02235337|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24844948|NCT02235337|Dermatologic Agents|dermatologic agents|mesh-ancestor
24844949|NCT02235389|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25868365|NCT00111748|Growth Substances|growth substances|mesh-ancestor
25868366|NCT00111748|Growth Inhibitors|growth inhibitors|mesh-ancestor
25868367|NCT00111787|Paclitaxel|paclitaxel|mesh-list
25868368|NCT00111787|Lapatinib|lapatinib|mesh-list
24545452|NCT00693433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24545453|NCT00693433|Glucocorticoids|glucocorticoids|mesh-ancestor
24545454|NCT00693433|Hormones|hormones|mesh-ancestor
24545455|NCT00693433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24545456|NCT00693433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24545457|NCT00693433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24545458|NCT00693433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24545459|NCT00693433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24545460|NCT00693433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24545461|NCT00693433|Antifungal Agents|antifungal agents|mesh-ancestor
25868369|NCT00111787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25868370|NCT00111787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868371|NCT00111787|Tubulin Modulators|tubulin modulators|mesh-ancestor
25868372|NCT00111787|Antimitotic Agents|antimitotic agents|mesh-ancestor
25868373|NCT00111787|Mitosis Modulators|mitosis modulators|mesh-ancestor
25868374|NCT00111787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868375|NCT00111787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25868376|NCT00111787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868377|NCT00111852|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
25868378|NCT00111852|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25868379|NCT00111852|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25868380|NCT00111852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813128|NCT02056678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24813129|NCT02056678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813130|NCT02056678|Antipyretics|antipyretics|mesh-ancestor
24813131|NCT02056717|Dexamethasone|dexamethasone|mesh-list
24460774|NCT00349453|Sequestering Agents|sequestering agents|mesh-ancestor
24460775|NCT00349453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460776|NCT00349453|Siderophores|siderophores|mesh-ancestor
24460777|NCT00349492|Cisplatin|cisplatin|mesh-list
24460778|NCT00349492|Irinotecan|irinotecan|mesh-list
25670931|NCT03654833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670932|NCT03646175|Choline|choline|mesh-list
25670933|NCT03646175|Lipotropic Agents|lipotropic agents|mesh-ancestor
25670934|NCT03646175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25670935|NCT03646175|Antimetabolites|antimetabolites|mesh-ancestor
24590353|NCT00912171|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25670936|NCT03646175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670937|NCT03646175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25670938|NCT03646175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25670939|NCT03646175|Nootropic Agents|nootropic agents|mesh-ancestor
25868381|NCT00111891|Niacin|niacin|mesh-list
24460779|NCT00349492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460781|NCT00349492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24460782|NCT00349492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460783|NCT00349492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868382|NCT00111891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25229267|NCT02603575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25229268|NCT02603575|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25229269|NCT02603575|Protective Agents|protective agents|mesh-ancestor
25229270|NCT02603575|Antifungal Agents|antifungal agents|mesh-ancestor
25229271|NCT02603575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25229272|NCT02603575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24844952|NCT02235389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844954|NCT02235402|Bendroflumethiazide|bendroflumethiazide|mesh-list
24757860|NCT01742689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813141|NCT02056717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24813142|NCT02056717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813144|NCT02056730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24813145|NCT02056730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813146|NCT02056743|Fexofenadine|fexofenadine|mesh-list
24813147|NCT02056743|Losartan|losartan|mesh-list
25868383|NCT00111891|Antimetabolites|antimetabolites|mesh-ancestor
25868384|NCT00111891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868385|NCT00111891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25868386|NCT00111891|Vasodilator Agents|vasodilator agents|mesh-ancestor
25868387|NCT00111891|Vitamin B Complex|vitamin b complex|mesh-ancestor
25868388|NCT00111891|Vitamins|vitamins|mesh-ancestor
25868389|NCT00111891|Micronutrients|micronutrients|mesh-ancestor
25868390|NCT00111891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868391|NCT00111904|Paclitaxel|paclitaxel|mesh-list
25868392|NCT00111904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25868393|NCT00111904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868394|NCT00111904|Tubulin Modulators|tubulin modulators|mesh-ancestor
25868395|NCT00111904|Antimitotic Agents|antimitotic agents|mesh-ancestor
25868396|NCT00111904|Mitosis Modulators|mitosis modulators|mesh-ancestor
25868397|NCT00111904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868398|NCT00111943|Tenofovir|tenofovir|mesh-list
25868399|NCT00111943|Antiviral Agents|antiviral agents|mesh-ancestor
25868400|NCT00111943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25868401|NCT00111943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25868402|NCT00111943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25868403|NCT00111943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868404|NCT00111943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868405|NCT00111943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25868406|NCT00111943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25868407|NCT00111956|Etanercept|etanercept|mesh-list
25868408|NCT00111956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25868409|NCT00111956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25868410|NCT00111956|Analgesics|analgesics|mesh-ancestor
24447344|NCT00308269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447345|NCT00308269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447346|NCT00308269|Tubulin Modulators|tubulin modulators|mesh-ancestor
24447347|NCT00308269|Antimitotic Agents|antimitotic agents|mesh-ancestor
24447348|NCT00308269|Mitosis Modulators|mitosis modulators|mesh-ancestor
24447349|NCT00308269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447350|NCT00308321|Prednisolone|prednisolone|mesh-list
24813148|NCT02056743|Midazolam|midazolam|mesh-list
24813149|NCT02056743|Dextromethorphan|dextromethorphan|mesh-list
24813150|NCT02056743|Caffeine|caffeine|mesh-list
25229273|NCT02603575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229274|NCT02603575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25229275|NCT02603445|Idelalisib|idelalisib|mesh-list
25229276|NCT02603445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25229277|NCT02603445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229278|NCT02603445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229279|NCT02603679|Tamoxifen|tamoxifen|mesh-list
25229280|NCT02603679|Paclitaxel|paclitaxel|mesh-list
25229281|NCT02603679|Letrozole|letrozole|mesh-list
25229282|NCT02603679|Palbociclib|palbociclib|mesh-list
25229283|NCT02603679|Anastrozole|anastrozole|mesh-list
25229284|NCT02603679|Exemestane|exemestane|mesh-list
25229285|NCT02603679|Goserelin|goserelin|mesh-list
25229286|NCT02603679|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24844955|NCT02235402|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24844956|NCT02235402|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25229297|NCT02603679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25229298|NCT02603679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229299|NCT02603679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25229300|NCT02603679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25229301|NCT02603679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25108274|NCT03133065|Antiviral Agents|antiviral agents|mesh-list
25229302|NCT02603679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25229303|NCT02603679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25229304|NCT02603497|Peficitinib|peficitinib|mesh-list
25229305|NCT02603497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229306|NCT02603497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229307|NCT02603497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25229308|NCT02603497|Immunologic Factors|immunologic factors|mesh-ancestor
25229309|NCT02603497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273447|NCT02385435|Anesthetics, Local|anesthetics, local|mesh-ancestor
25273448|NCT02385435|Anesthetics|anesthetics|mesh-ancestor
25273449|NCT02385435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25273450|NCT02385435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273451|NCT02385435|Sensory System Agents|sensory system agents|mesh-ancestor
25273452|NCT02385435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25273453|NCT02385435|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25273454|NCT02385435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25273455|NCT02385435|Analgesics|analgesics|mesh-ancestor
25273456|NCT02385435|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25273457|NCT02385435|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25273458|NCT02385435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25273459|NCT02385435|Adrenergic Agents|adrenergic agents|mesh-ancestor
24813151|NCT02056743|Omeprazole|omeprazole|mesh-list
24858318|NCT02296333|Ondansetron|ondansetron|mesh-list
24858319|NCT02296333|Antiemetics|antiemetics|mesh-ancestor
24460797|NCT00349531|Dopamine Agents|dopamine agents|mesh-ancestor
25868411|NCT00111956|Sensory System Agents|sensory system agents|mesh-ancestor
25868412|NCT00111956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25868413|NCT00111956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868414|NCT00111956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25868415|NCT00111956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25868416|NCT00111956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25868417|NCT00111956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25868418|NCT00111956|Immunologic Factors|immunologic factors|mesh-ancestor
25868419|NCT00111995|Darbepoetin alfa|darbepoetin alfa|mesh-list
25868420|NCT00111995|Hematinics|hematinics|mesh-ancestor
25868421|NCT00112008|Darbepoetin alfa|darbepoetin alfa|mesh-list
25868422|NCT00112008|Hematinics|hematinics|mesh-ancestor
25868423|NCT00112021|Pramlintide|pramlintide|mesh-list
25868424|NCT00112021|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
25868425|NCT00112021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25868426|NCT00112021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868427|NCT00112021|Appetite Depressants|appetite depressants|mesh-ancestor
25868428|NCT00112021|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25868429|NCT00112021|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
25868430|NCT00112021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868431|NCT00112034|Methylprednisolone|methylprednisolone|mesh-list
25868432|NCT00112034|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25868433|NCT00112034|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24545513|NCT00693589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24545514|NCT00693589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24545515|NCT00693589|Antimetabolites|antimetabolites|mesh-ancestor
24545516|NCT00693589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545517|NCT00693589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24545518|NCT00693589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24545519|NCT00693589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229310|NCT02603315|Mitogens|mitogens|mesh-list
25229311|NCT02603315|Endothelial Growth Factors|endothelial growth factors|mesh-list
25229312|NCT02603315|Mitosis Modulators|mitosis modulators|mesh-ancestor
25229313|NCT02603315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229314|NCT02603315|Growth Substances|growth substances|mesh-ancestor
25229315|NCT02603315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229316|NCT02603068|Treprostinil|treprostinil|mesh-list
25229317|NCT02603068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25229318|NCT02603159|Capecitabine|capecitabine|mesh-list
25229319|NCT02603159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25229320|NCT02603159|Antimetabolites|antimetabolites|mesh-ancestor
25229321|NCT02603159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229322|NCT02603159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25229323|NCT02603003|Pemetrexed|pemetrexed|mesh-list
25229324|NCT02603003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25229325|NCT02603003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229326|NCT02603003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229327|NCT02603003|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25229328|NCT02603003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25229329|NCT02603081|Ebselen|ebselen|mesh-list
25229330|NCT02603081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25229331|NCT02603081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25229332|NCT02603081|Analgesics|analgesics|mesh-ancestor
25229333|NCT02603081|Sensory System Agents|sensory system agents|mesh-ancestor
25229334|NCT02603081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229335|NCT02603081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229336|NCT02603081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24837517|NCT02191748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24844976|NCT02235428|Autonomic Agents|autonomic agents|mesh-ancestor
24844977|NCT02235428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24844978|NCT02235428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844979|NCT02235428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24844980|NCT02235428|Respiratory System Agents|respiratory system agents|mesh-ancestor
24844981|NCT02235428|Tocolytic Agents|tocolytic agents|mesh-ancestor
24844982|NCT02235428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24844984|NCT02235428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24844985|NCT02235428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24844986|NCT02235428|Adrenergic Agents|adrenergic agents|mesh-ancestor
24545520|NCT00693589|Hematinics|hematinics|mesh-ancestor
24545521|NCT00693589|Vitamin B Complex|vitamin b complex|mesh-ancestor
24545522|NCT00693602|Asparaginase|asparaginase|mesh-list
24545523|NCT00693602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24545524|NCT00693615|Vaccines|vaccines|mesh-list
24545525|NCT00693615|Immunologic Factors|immunologic factors|mesh-ancestor
24545528|NCT00693680|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24545529|NCT00693680|Antidepressive Agents|antidepressive agents|mesh-ancestor
24545530|NCT00693680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24545531|NCT00693680|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24545537|NCT00693680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545540|NCT00693732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24837518|NCT02191748|Glucocorticoids|glucocorticoids|mesh-ancestor
24837519|NCT02191748|Hormones|hormones|mesh-ancestor
24750576|NCT01699490|Valsartan|valsartan|mesh-list
24545541|NCT00693732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25868435|NCT00112034|Prednisolone acetate|prednisolone acetate|mesh-list
25868436|NCT00112034|Methotrexate|methotrexate|mesh-list
25868437|NCT00112034|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25868438|NCT00112034|Prednisolone phosphate|prednisolone phosphate|mesh-list
24858321|NCT02296333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25868439|NCT00112034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25868440|NCT00112034|Abortifacient Agents|abortifacient agents|mesh-ancestor
25868441|NCT00112034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25868442|NCT00112034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868443|NCT00112034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25868445|NCT00112034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554853|NCT00738556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24554854|NCT00738556|Antifungal Agents|antifungal agents|mesh-ancestor
25127223|NCT03057015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24858322|NCT02296333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858323|NCT02296333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24858325|NCT02296333|Dermatologic Agents|dermatologic agents|mesh-ancestor
24858326|NCT02296333|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24858327|NCT02296333|Serotonin Agents|serotonin agents|mesh-ancestor
24858328|NCT02296333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24858329|NCT02296333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858330|NCT02296333|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24858331|NCT02296333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24628121|NCT01096706|Aspirin|aspirin|mesh-list
24858332|NCT02296333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24858333|NCT02296333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24858334|NCT02296333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25868446|NCT00112034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868447|NCT00112034|Dermatologic Agents|dermatologic agents|mesh-ancestor
25868448|NCT00112034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868449|NCT00112034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25868450|NCT00112034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25868451|NCT00112034|Immunologic Factors|immunologic factors|mesh-ancestor
25868452|NCT00112034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25229337|NCT02603081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25229338|NCT02603081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25229339|NCT02603081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25229340|NCT02603081|Antioxidants|antioxidants|mesh-ancestor
25229341|NCT02603081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229342|NCT02603081|Protective Agents|protective agents|mesh-ancestor
25229343|NCT02603081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25229344|NCT02603081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229345|NCT02603081|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25229346|NCT02603276|Red yeast rice|red yeast rice|mesh-list
25229347|NCT02603276|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25229348|NCT02603276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25229349|NCT02603276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25229350|NCT02603276|Antimetabolites|antimetabolites|mesh-ancestor
25868453|NCT00112034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25868454|NCT00112034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25868455|NCT00112034|Antiemetics|antiemetics|mesh-ancestor
25868456|NCT00112034|Autonomic Agents|autonomic agents|mesh-ancestor
25868457|NCT00112034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229351|NCT02603276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229352|NCT02603276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24845004|NCT02235558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24845005|NCT02235558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24845006|NCT02235558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845007|NCT02235558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24845008|NCT02235558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845009|NCT02235558|Vasodilator Agents|vasodilator agents|mesh-ancestor
24845010|NCT02235584|Dexamethasone|dexamethasone|mesh-list
24845011|NCT02235584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24845013|NCT02235584|Autonomic Agents|autonomic agents|mesh-ancestor
24845014|NCT02235584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845015|NCT02235584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670944|NCT03535506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25670945|NCT03535506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670946|NCT03527108|Nivolumab|nivolumab|mesh-list
25670947|NCT03527108|Ramucirumab|ramucirumab|mesh-list
25670948|NCT03527108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25670949|NCT03527108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25670950|NCT03527108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25674500|NCT01773070|Ritonavir|ritonavir|mesh-list
24619911|NCT01054469|Ropivacaine|ropivacaine|mesh-list
25868458|NCT00112034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25868459|NCT00112034|Glucocorticoids|glucocorticoids|mesh-ancestor
25868460|NCT00112034|Hormones|hormones|mesh-ancestor
25868461|NCT00112034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25868462|NCT00112034|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25868463|NCT00112034|Protective Agents|protective agents|mesh-ancestor
25868464|NCT00112034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25868465|NCT00112086|Paclitaxel|paclitaxel|mesh-list
25868466|NCT00112086|Carboplatin|carboplatin|mesh-list
24952989|NCT03889717|Vitamin D|vitamin d|mesh-list
25868467|NCT00112086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25868468|NCT00112086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868469|NCT00112086|Tubulin Modulators|tubulin modulators|mesh-ancestor
25868470|NCT00112086|Antimitotic Agents|antimitotic agents|mesh-ancestor
25229353|NCT02603276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25229354|NCT02602938|Aspirin|aspirin|mesh-list
25229355|NCT02602938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25229356|NCT02602938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25229357|NCT02602938|Analgesics|analgesics|mesh-ancestor
25229358|NCT02602938|Sensory System Agents|sensory system agents|mesh-ancestor
25229359|NCT02602938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229360|NCT02602938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229361|NCT02602938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25229362|NCT02602938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25229363|NCT02602938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25229364|NCT02602938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25229365|NCT02602938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229366|NCT02602938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25229367|NCT02602938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25229368|NCT02602938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229369|NCT02602938|Antipyretics|antipyretics|mesh-ancestor
25229370|NCT02603198|Epinephrine|epinephrine|mesh-list
25229371|NCT02603198|Nordefrin|nordefrin|mesh-list
25229372|NCT02603198|Anesthetics|anesthetics|mesh-list
25229373|NCT02603198|Mepivacaine|mepivacaine|mesh-list
25229374|NCT02603198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25229375|NCT02603198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229376|NCT02603198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25229377|NCT02603198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25229378|NCT02603198|Adrenergic Agents|adrenergic agents|mesh-ancestor
25229379|NCT02603198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25229380|NCT02603198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229381|NCT02603198|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25229382|NCT02603198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25229383|NCT02603198|Autonomic Agents|autonomic agents|mesh-ancestor
25229384|NCT02603198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229385|NCT02603198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25229386|NCT02603198|Respiratory System Agents|respiratory system agents|mesh-ancestor
25868471|NCT00112086|Mitosis Modulators|mitosis modulators|mesh-ancestor
25868472|NCT00112086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868473|NCT00112138|Gabapentin|gabapentin|mesh-list
25868474|NCT00112138|Analgesics|analgesics|mesh-ancestor
24858336|NCT02296398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24858337|NCT02296398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858338|NCT02296411|Glycopyrrolate|glycopyrrolate|mesh-list
24858339|NCT02296411|Bromides|bromides|mesh-list
24858340|NCT02296411|Anticonvulsants|anticonvulsants|mesh-ancestor
24858341|NCT02296411|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24858342|NCT02296411|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24858343|NCT02296411|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24858344|NCT02296411|Cholinergic Agents|cholinergic agents|mesh-ancestor
24858345|NCT02296411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24858346|NCT02296411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868475|NCT00112138|Sensory System Agents|sensory system agents|mesh-ancestor
25868476|NCT00112138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25868477|NCT00112138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868478|NCT00112138|Anticonvulsants|anticonvulsants|mesh-ancestor
25868479|NCT00112138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25868480|NCT00112138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25409525|NCT03371667|Methotrexate|methotrexate|mesh-list
25674501|NCT01773070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24858368|NCT02296671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858370|NCT02296671|Immunologic Factors|immunologic factors|mesh-ancestor
24858371|NCT02296671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858372|NCT02296671|Antidotes|antidotes|mesh-ancestor
24858373|NCT02296671|Protective Agents|protective agents|mesh-ancestor
24858374|NCT02296671|Vitamin B Complex|vitamin b complex|mesh-ancestor
24858376|NCT02296671|Micronutrients|micronutrients|mesh-ancestor
24858377|NCT02296671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24858378|NCT02296671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24858379|NCT02296671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24858380|NCT02296723|Valganciclovir|valganciclovir|mesh-list
24858381|NCT02296723|Antiviral Agents|antiviral agents|mesh-ancestor
25868481|NCT00112138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25868482|NCT00112138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25868483|NCT00112138|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25868484|NCT00112138|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25868485|NCT00112138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25868486|NCT00112138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868487|NCT00112138|Antimanic Agents|antimanic agents|mesh-ancestor
25868488|NCT00112164|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
25868489|NCT00112164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25868490|NCT00112216|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25868491|NCT00112216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25868492|NCT00112216|Immunologic Factors|immunologic factors|mesh-ancestor
25868493|NCT00112216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868494|NCT00112281|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
25868495|NCT00112281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868496|NCT00112281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229387|NCT02603198|Mydriatics|mydriatics|mesh-ancestor
25229388|NCT02603198|Sympathomimetics|sympathomimetics|mesh-ancestor
25229389|NCT02603198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25229390|NCT02603198|Anesthetics, Local|anesthetics, local|mesh-ancestor
25229391|NCT02603198|Sensory System Agents|sensory system agents|mesh-ancestor
25229392|NCT02603055|Vaccines|vaccines|mesh-list
25229393|NCT02603055|Immunologic Factors|immunologic factors|mesh-ancestor
25229394|NCT02603055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229395|NCT02602860|Levetiracetam|levetiracetam|mesh-list
25229396|NCT02602860|Brivaracetam|brivaracetam|mesh-list
24845085|NCT02236026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868497|NCT00112346|Gemcitabine|gemcitabine|mesh-list
25868498|NCT00112346|Cetuximab|cetuximab|mesh-list
25868499|NCT00112346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25868500|NCT00112346|Antimetabolites|antimetabolites|mesh-ancestor
25868501|NCT00112346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868502|NCT00112346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868503|NCT00112346|Antiviral Agents|antiviral agents|mesh-ancestor
25868504|NCT00112346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25868505|NCT00112346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868506|NCT00112346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25868507|NCT00112346|Immunologic Factors|immunologic factors|mesh-ancestor
25868508|NCT00112346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868509|NCT00112346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25868510|NCT00112372|Sirolimus|sirolimus|mesh-list
25868511|NCT00112372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24545598|NCT00693979|Tubulin Modulators|tubulin modulators|mesh-ancestor
24545599|NCT00693979|Antimitotic Agents|antimitotic agents|mesh-ancestor
25868512|NCT00112372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25868513|NCT00112372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25868514|NCT00112372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868515|NCT00112372|Antifungal Agents|antifungal agents|mesh-ancestor
25868516|NCT00112372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25868517|NCT00112372|Immunologic Factors|immunologic factors|mesh-ancestor
25868518|NCT00112372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868519|NCT00112476|Sirolimus|sirolimus|mesh-list
25868520|NCT00112476|Bryostatin 1|bryostatin 1|mesh-list
25868521|NCT00112476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25868522|NCT00112476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24545611|NCT00694005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712117|NCT01518621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24712119|NCT01518621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674502|NCT01773070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25674503|NCT01773070|Protease Inhibitors|protease inhibitors|mesh-ancestor
25674504|NCT01773070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674505|NCT01773070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868527|NCT00112476|Immunologic Factors|immunologic factors|mesh-ancestor
24545613|NCT00694005|Immunologic Factors|immunologic factors|mesh-ancestor
24545614|NCT00694005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545615|NCT00694005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24545616|NCT00694005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24545617|NCT00694005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24545618|NCT00694005|Antifungal Agents|antifungal agents|mesh-ancestor
24545619|NCT00694044|Varenicline|varenicline|mesh-list
24545620|NCT00694044|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24545621|NCT00694044|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24545622|NCT00694044|Cholinergic Agents|cholinergic agents|mesh-ancestor
24545623|NCT00694044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24545624|NCT00694044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545625|NCT00694044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545626|NCT00694148|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25868528|NCT00112476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868529|NCT00112476|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25868530|NCT00112515|Modafinil|modafinil|mesh-list
25868531|NCT00112515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25868532|NCT00112515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868533|NCT00112515|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25868534|NCT00112515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25868535|NCT00112515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25868536|NCT00112515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868537|NCT00112528|Gemcitabine|gemcitabine|mesh-list
25868538|NCT00112528|Bevacizumab|bevacizumab|mesh-list
25229397|NCT02602860|Anticonvulsants|anticonvulsants|mesh-ancestor
24845086|NCT02236026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24845087|NCT02236026|Contraceptive Agents|contraceptive agents|mesh-ancestor
24845132|NCT02236182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25868539|NCT00112528|Oxaliplatin|oxaliplatin|mesh-list
25868540|NCT00112528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25868541|NCT00112528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868542|NCT00112528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25868543|NCT00112528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25868544|NCT00112528|Growth Substances|growth substances|mesh-ancestor
25868545|NCT00112528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868546|NCT00112528|Growth Inhibitors|growth inhibitors|mesh-ancestor
25868547|NCT00112528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24838575|NCT02198482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24845133|NCT02236182|Cholinergic Agents|cholinergic agents|mesh-ancestor
24845134|NCT02236182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845135|NCT02236182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845137|NCT02236260|Anesthetics, Local|anesthetics, local|mesh-ancestor
24845138|NCT02236260|Anesthetics|anesthetics|mesh-ancestor
24845139|NCT02236260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25060068|NCT03483142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060069|NCT03483142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25060070|NCT03483142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25060071|NCT03483142|Oxytocics|oxytocics|mesh-ancestor
25060072|NCT03482960|Xenon|xenon|mesh-list
25868548|NCT00112528|Antimetabolites|antimetabolites|mesh-ancestor
25868549|NCT00112528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868550|NCT00112528|Antiviral Agents|antiviral agents|mesh-ancestor
25868551|NCT00112528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25868552|NCT00112528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876640|NCT03164616|Immunologic Factors|immunologic factors|mesh-ancestor
24845158|NCT02236715|Autonomic Agents|autonomic agents|mesh-ancestor
24545629|NCT00694148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545630|NCT00694148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24545631|NCT00694148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24545632|NCT00694148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545633|NCT00694148|Cholinergic Agents|cholinergic agents|mesh-ancestor
24545634|NCT00694148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24838576|NCT02198482|Analgesics|analgesics|mesh-ancestor
24838577|NCT02198482|Sensory System Agents|sensory system agents|mesh-ancestor
24838581|NCT02198508|Deferasirox|deferasirox|mesh-list
24838681|NCT02199431|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24838682|NCT02199431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24838684|NCT02199431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838685|NCT02199431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24838686|NCT02199431|Hormone Antagonists|hormone antagonists|mesh-ancestor
24838687|NCT02199431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24838688|NCT02199431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545635|NCT00694174|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24545637|NCT00694187|Anticonvulsants|anticonvulsants|mesh-ancestor
25868553|NCT00112528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25868554|NCT00112528|Immunologic Factors|immunologic factors|mesh-ancestor
25868555|NCT00112554|Cytarabine|cytarabine|mesh-list
25868556|NCT00112554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25868557|NCT00112554|Antimetabolites|antimetabolites|mesh-ancestor
25868558|NCT00112554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868559|NCT00112554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868560|NCT00112554|Antiviral Agents|antiviral agents|mesh-ancestor
25868561|NCT00112554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25868562|NCT00112554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25868563|NCT00112554|Immunologic Factors|immunologic factors|mesh-ancestor
25868564|NCT00112554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868565|NCT00112567|Fludarabine|fludarabine|mesh-list
25868566|NCT00112567|Fludarabine phosphate|fludarabine phosphate|mesh-list
25868567|NCT00112567|Thiotepa|thiotepa|mesh-list
25868568|NCT00112567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868569|NCT00112567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25868570|NCT00112567|Antimetabolites|antimetabolites|mesh-ancestor
25868571|NCT00112567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868572|NCT00112567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25229398|NCT02602860|Nootropic Agents|nootropic agents|mesh-ancestor
25229399|NCT02602743|Ketamine|ketamine|mesh-list
25229400|NCT02602743|Remifentanil|remifentanil|mesh-list
25229401|NCT02602743|Propofol|propofol|mesh-list
25229402|NCT02602743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25229403|NCT02602743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25229404|NCT02602743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229405|NCT02602743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25229406|NCT02602743|Anesthetics, General|anesthetics, general|mesh-ancestor
25229407|NCT02602743|Anesthetics|anesthetics|mesh-ancestor
25229408|NCT02602743|Analgesics|analgesics|mesh-ancestor
25229409|NCT02602743|Sensory System Agents|sensory system agents|mesh-ancestor
24838689|NCT02199431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24838690|NCT02199444|Sevelamer|sevelamer|mesh-list
24838691|NCT02199444|Chelating Agents|chelating agents|mesh-ancestor
24838761|NCT02200159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25229410|NCT02602743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229411|NCT02602743|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25229412|NCT02602743|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25229413|NCT02602743|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25229414|NCT02602743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25229415|NCT02602743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229416|NCT02602743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25868573|NCT00112567|Immunologic Factors|immunologic factors|mesh-ancestor
24845155|NCT02236481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24845157|NCT02236715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24845159|NCT02236715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845160|NCT02236715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845161|NCT02236715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24845162|NCT02236715|Respiratory System Agents|respiratory system agents|mesh-ancestor
24845163|NCT02236715|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24845164|NCT02236715|Cholinergic Agents|cholinergic agents|mesh-ancestor
24845165|NCT02236715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845166|NCT02236715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845167|NCT02236728|Pramipexole|pramipexole|mesh-list
24845168|NCT02236728|Antioxidants|antioxidants|mesh-ancestor
25674506|NCT01773070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24845169|NCT02236728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845181|NCT02236741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845182|NCT02236741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24845183|NCT02236741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24845184|NCT02236741|Dopamine Agonists|dopamine agonists|mesh-ancestor
24845185|NCT02236741|Dopamine Agents|dopamine agents|mesh-ancestor
24845186|NCT02236741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845187|NCT02236793|Becaplermin|becaplermin|mesh-list
24845188|NCT02236793|Anticoagulants|anticoagulants|mesh-ancestor
24845189|NCT02236793|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
24845190|NCT02236793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24845191|NCT02236793|Growth Substances|growth substances|mesh-ancestor
25060083|NCT03482544|Pregabalin|pregabalin|mesh-list
25868574|NCT00112567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868575|NCT00112567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25868576|NCT00112567|Alkylating Agents|alkylating agents|mesh-ancestor
25868577|NCT00112567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25868578|NCT00112619|Topotecan|topotecan|mesh-list
25868579|NCT00112619|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25868580|NCT00112619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25868581|NCT00112619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868582|NCT00112619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545642|NCT00694187|GABA Agents|gaba agents|mesh-ancestor
24545643|NCT00694187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24545644|NCT00694187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229417|NCT02602743|Narcotics|narcotics|mesh-ancestor
25229418|NCT02602652|Vaccines|vaccines|mesh-list
25229419|NCT02602652|Immunologic Factors|immunologic factors|mesh-ancestor
25229420|NCT02602652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229421|NCT02602704|Bazedoxifene|bazedoxifene|mesh-list
25229422|NCT02602704|Calcium|calcium|mesh-list
25229423|NCT02602704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25229424|NCT02602704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229425|NCT02602704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25229426|NCT02602704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25229427|NCT02602704|Hormone Antagonists|hormone antagonists|mesh-ancestor
25229428|NCT02602704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25229429|NCT02602704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25229430|NCT02602600|Liraglutide|liraglutide|mesh-list
25229431|NCT02602600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25229432|NCT02602600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229433|NCT02602600|Incretins|incretins|mesh-ancestor
25229434|NCT02602600|Hormones|hormones|mesh-ancestor
25229435|NCT02602600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25229436|NCT02602444|Ticagrelor|ticagrelor|mesh-list
25229437|NCT02602444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25229438|NCT02602444|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25229439|NCT02602444|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25229440|NCT02602444|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25229441|NCT02602444|Purinergic Agents|purinergic agents|mesh-ancestor
25229442|NCT02602444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25229443|NCT02602444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229444|NCT02602444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229445|NCT02602509|Rifampin|rifampin|mesh-list
25229446|NCT02602509|Pyrazinamide|pyrazinamide|mesh-list
24845192|NCT02236793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845193|NCT02236936|Cetuximab|cetuximab|mesh-list
24845232|NCT02237079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24845234|NCT02237079|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24845235|NCT02237079|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24845237|NCT02237079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24845238|NCT02237131|Contraceptive Agents|contraceptive agents|mesh-list
24845239|NCT02237131|Contraceptives, Oral|contraceptives, oral|mesh-list
24845240|NCT02237131|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
24845241|NCT02237131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25060112|NCT03482440|Sensory System Agents|sensory system agents|mesh-ancestor
24545645|NCT00694200|Bevacizumab|bevacizumab|mesh-list
24545646|NCT00694200|Vinorelbine|vinorelbine|mesh-list
24545647|NCT00694200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24858395|NCT02296762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24858396|NCT02296762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858397|NCT02296762|Antifungal Agents|antifungal agents|mesh-ancestor
24858398|NCT02296762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24858401|NCT02296996|Trametinib|trametinib|mesh-list
24858403|NCT02296996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858404|NCT02296996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24858405|NCT02296996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24858406|NCT02296996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858407|NCT02297204|Aflibercept|aflibercept|mesh-list
24858408|NCT02297204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24752248|NCT01709630|Analgesics|analgesics|mesh-ancestor
24858409|NCT02297204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24858410|NCT02297204|Growth Substances|growth substances|mesh-ancestor
24858411|NCT02297204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858412|NCT02297204|Growth Inhibitors|growth inhibitors|mesh-ancestor
24858413|NCT02297204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858414|NCT02297217|Paclitaxel|paclitaxel|mesh-list
24858415|NCT02297217|Carboplatin|carboplatin|mesh-list
24858416|NCT02297217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24858417|NCT02297217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858418|NCT02297217|Tubulin Modulators|tubulin modulators|mesh-ancestor
24858419|NCT02297217|Antimitotic Agents|antimitotic agents|mesh-ancestor
24858420|NCT02297217|Mitosis Modulators|mitosis modulators|mesh-ancestor
24858421|NCT02297217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858422|NCT02297386|Testosterone|testosterone|mesh-list
24858423|NCT02297386|Dihydrotestosterone|dihydrotestosterone|mesh-list
24858424|NCT02297386|Androgens|androgens|mesh-ancestor
24858425|NCT02297386|Hormones|hormones|mesh-ancestor
24858426|NCT02297386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24858427|NCT02297386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858428|NCT02297477|Artesunate|artesunate|mesh-list
24858429|NCT02297477|Atovaquone|atovaquone|mesh-list
24858430|NCT02297477|Proguanil|proguanil|mesh-list
24858431|NCT02297477|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
24858432|NCT02297477|Antimalarials|antimalarials|mesh-ancestor
24858435|NCT02297477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24858436|NCT02297477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858437|NCT02297477|Antiviral Agents|antiviral agents|mesh-ancestor
24858438|NCT02297477|Schistosomicides|schistosomicides|mesh-ancestor
24839775|NCT02206165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24839776|NCT02206165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839777|NCT02206165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24839778|NCT02206165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839779|NCT02206165|Vasodilator Agents|vasodilator agents|mesh-ancestor
24839780|NCT02206165|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24839781|NCT02206165|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24839782|NCT02206178|Acetaminophen|acetaminophen|mesh-list
24839853|NCT02206425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24839854|NCT02206425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24839856|NCT02206425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24839857|NCT02206425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24839858|NCT02206425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24839959|NCT02206789|Methylprednisolone|methylprednisolone|mesh-list
24815133|NCT02068287|Esmolol|esmolol|mesh-list
24858439|NCT02297477|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24858440|NCT02297477|Anthelmintics|anthelmintics|mesh-ancestor
24858441|NCT02297477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24858443|NCT02297477|Antimetabolites|antimetabolites|mesh-ancestor
24858444|NCT02297529|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
24858445|NCT02297529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25229447|NCT02602509|Celecoxib|celecoxib|mesh-list
25229449|NCT02602509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25229450|NCT02602509|Analgesics|analgesics|mesh-ancestor
25229452|NCT02602509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229453|NCT02602509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229454|NCT02602509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25229455|NCT02602509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25229456|NCT02602509|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25229457|NCT02602509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25229458|NCT02602509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273460|NCT02385435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845249|NCT02237261|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24845250|NCT02237261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24845251|NCT02237261|Glucocorticoids|glucocorticoids|mesh-ancestor
24845252|NCT02237261|Hormones|hormones|mesh-ancestor
24447362|NCT00308321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24447363|NCT00308321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447364|NCT00308321|Antiemetics|antiemetics|mesh-ancestor
25274027|NCT02381470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868586|NCT00112632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25868587|NCT00112632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868588|NCT00112632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868589|NCT00112645|Cyclosporine|cyclosporine|mesh-list
24545650|NCT00694200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24545651|NCT00694200|Growth Substances|growth substances|mesh-ancestor
24545652|NCT00694200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545653|NCT00694200|Growth Inhibitors|growth inhibitors|mesh-ancestor
24858451|NCT02297568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858452|NCT02297568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24858453|NCT02297568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24858454|NCT02297594|Ziresovir|ziresovir|mesh-list
24858455|NCT02297594|Antiviral Agents|antiviral agents|mesh-ancestor
24858456|NCT02297594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24858457|NCT02297620|Ipragliflozin|ipragliflozin|mesh-list
24858458|NCT02297620|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24858459|NCT02297620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229459|NCT02602509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229460|NCT02602509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25229461|NCT02602509|Antitubercular Agents|antitubercular agents|mesh-ancestor
25229462|NCT02602509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25229463|NCT02602509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25229464|NCT02602509|Leprostatic Agents|leprostatic agents|mesh-ancestor
25229465|NCT02602509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25229466|NCT02602509|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25229467|NCT02602509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25229468|NCT02602509|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25229469|NCT02602509|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25229470|NCT02602509|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25229471|NCT02602509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25229472|NCT02602470|Metronidazole|metronidazole|mesh-list
25229473|NCT02602470|Azelaic acid|azelaic acid|mesh-list
25229474|NCT02602470|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24786328|NCT01919203|Narcotics|narcotics|mesh-ancestor
25868590|NCT00112645|Methylprednisolone|methylprednisolone|mesh-list
24845277|NCT02237339|Gout Suppressants|gout suppressants|mesh-ancestor
24845278|NCT02237339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24845279|NCT02237339|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24845281|NCT02237339|Protective Agents|protective agents|mesh-ancestor
24858461|NCT02297620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858463|NCT02297763|Antidepressive Agents|antidepressive agents|mesh-ancestor
24858464|NCT02297763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24545654|NCT00694200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24545655|NCT00694200|Tubulin Modulators|tubulin modulators|mesh-ancestor
24545656|NCT00694200|Antimitotic Agents|antimitotic agents|mesh-ancestor
24545657|NCT00694200|Mitosis Modulators|mitosis modulators|mesh-ancestor
24545658|NCT00694200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545659|NCT00694252|Lapatinib|lapatinib|mesh-list
24545660|NCT00694252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24545661|NCT00694252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24545662|NCT00694252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24545663|NCT00694252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229475|NCT02602470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25229476|NCT02602470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25229477|NCT02602470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25229478|NCT02602470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25229479|NCT02602470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25229480|NCT02602470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25229481|NCT02602470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25229482|NCT02602470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25229483|NCT02602470|Adrenergic Agents|adrenergic agents|mesh-ancestor
24753108|NCT01713920|Amlodipine|amlodipine|mesh-list
24840606|NCT02211118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24840607|NCT02211118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840609|NCT02211222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25229484|NCT02602470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25229485|NCT02602470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229486|NCT02602470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229487|NCT02602470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25229488|NCT02602470|Dermatologic Agents|dermatologic agents|mesh-ancestor
25229489|NCT02602483|Ascorbic Acid|ascorbic acid|mesh-list
25229490|NCT02602483|Ibuprofen|ibuprofen|mesh-list
25229491|NCT02602483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25229492|NCT02602483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25229493|NCT02602483|Analgesics|analgesics|mesh-ancestor
25229494|NCT02602483|Sensory System Agents|sensory system agents|mesh-ancestor
25229495|NCT02602483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229496|NCT02602483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229497|NCT02602483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25229498|NCT02602483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25229499|NCT02602483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25229500|NCT02602483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229501|NCT02602483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229502|NCT02602483|Antioxidants|antioxidants|mesh-ancestor
25229503|NCT02602483|Protective Agents|protective agents|mesh-ancestor
24845282|NCT02237339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845302|NCT02237443|Succinylcholine|succinylcholine|mesh-list
24845303|NCT02237443|Anticonvulsants|anticonvulsants|mesh-ancestor
24545664|NCT00694291|Sorafenib|sorafenib|mesh-list
24545665|NCT00694291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868591|NCT00112645|Methotrexate|methotrexate|mesh-list
25868592|NCT00112645|Melphalan|melphalan|mesh-list
25868593|NCT00112645|Busulfan|busulfan|mesh-list
24545679|NCT00694408|Methylprednisolone|methylprednisolone|mesh-list
24545680|NCT00694408|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24545681|NCT00694408|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24840611|NCT02211222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24545682|NCT00694408|Prednisolone|prednisolone|mesh-list
24545683|NCT00694408|Prednisolone acetate|prednisolone acetate|mesh-list
24545684|NCT00694408|Hydrocortisone|hydrocortisone|mesh-list
24858466|NCT02297763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24858467|NCT02297763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24680039|NCT01372761|Growth Inhibitors|growth inhibitors|mesh-ancestor
25868594|NCT00112645|Cyclosporins|cyclosporins|mesh-list
25868595|NCT00112645|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25868596|NCT00112645|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25868597|NCT00112645|Abortifacient Agents|abortifacient agents|mesh-ancestor
25868598|NCT00112645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25868599|NCT00112645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868600|NCT00112645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25868601|NCT00112645|Antimetabolites|antimetabolites|mesh-ancestor
24557151|NCT00751517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557153|NCT00751517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24858468|NCT02297763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858469|NCT02297854|Valganciclovir|valganciclovir|mesh-list
24858470|NCT02297854|Antiviral Agents|antiviral agents|mesh-ancestor
24858477|NCT02297906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858478|NCT02297906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858479|NCT02297906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24858480|NCT02297906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24858481|NCT02297906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24858482|NCT02297906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24858483|NCT02297906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858485|NCT02297945|Antimetabolites|antimetabolites|mesh-ancestor
24858486|NCT02297945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858487|NCT02297945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24858488|NCT02297997|Cetylpyridinium|cetylpyridinium|mesh-list
24858489|NCT02297997|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24858490|NCT02297997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24858491|NCT02298010|Capecitabine|capecitabine|mesh-list
24858492|NCT02298010|Oxaliplatin|oxaliplatin|mesh-list
24858493|NCT02298010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24858494|NCT02298010|Antimetabolites|antimetabolites|mesh-ancestor
24858495|NCT02298010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460959|NCT00350311|Nicotine|nicotine|mesh-list
25868602|NCT00112645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545714|NCT00694629|Antitubercular Agents|antitubercular agents|mesh-ancestor
24545715|NCT00694629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25229504|NCT02602483|Vitamins|vitamins|mesh-ancestor
25229505|NCT02602483|Micronutrients|micronutrients|mesh-ancestor
25229506|NCT02602197|Acetaminophen|acetaminophen|mesh-list
25229507|NCT02602197|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
25229508|NCT02602197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25229509|NCT02602197|Analgesics|analgesics|mesh-ancestor
25229510|NCT02602197|Sensory System Agents|sensory system agents|mesh-ancestor
25229511|NCT02602197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229512|NCT02602197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229513|NCT02602197|Antipyretics|antipyretics|mesh-ancestor
25229514|NCT02602197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25229515|NCT02602197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25229516|NCT02602197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25229517|NCT02602210|Hydrocortisone|hydrocortisone|mesh-list
25229518|NCT02602210|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25229519|NCT02602210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25229520|NCT02602002|Remifentanil|remifentanil|mesh-list
24845306|NCT02237443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24845307|NCT02237443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845308|NCT02237443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545716|NCT00694629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24545717|NCT00694629|Leprostatic Agents|leprostatic agents|mesh-ancestor
24545718|NCT00694629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24545720|NCT00694629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545721|NCT00694629|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24545722|NCT00694629|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24545723|NCT00694629|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24545724|NCT00694629|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24545725|NCT00694629|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25868603|NCT00112645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868604|NCT00112645|Dermatologic Agents|dermatologic agents|mesh-ancestor
25868605|NCT00112645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868606|NCT00112645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25868607|NCT00112645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25868608|NCT00112645|Immunologic Factors|immunologic factors|mesh-ancestor
25868609|NCT00112645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25868610|NCT00112645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24447368|NCT00308321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24447369|NCT00308321|Protective Agents|protective agents|mesh-ancestor
24447371|NCT00308334|Antiemetics|antiemetics|mesh-ancestor
24447372|NCT00308334|Autonomic Agents|autonomic agents|mesh-ancestor
25868611|NCT00112645|Antifungal Agents|antifungal agents|mesh-ancestor
24841006|NCT02213627|Fertility Agents|fertility agents|mesh-ancestor
25868612|NCT00112645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25670951|NCT03527108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670952|NCT03516305|Alprazolam|alprazolam|mesh-list
25670953|NCT03516305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24557591|NCT00753051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557592|NCT00753051|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24557593|NCT00753051|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25127507|NCT03055442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127520|NCT03055091|Sorbitol|sorbitol|mesh-list
25127521|NCT03055091|Cathartics|cathartics|mesh-ancestor
25127522|NCT03055091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25127523|NCT03054948|SMOFlipid|smoflipid|mesh-list
24557594|NCT00753051|Serotonin Agents|serotonin agents|mesh-ancestor
24557595|NCT00753051|GABA Antagonists|gaba antagonists|mesh-ancestor
24557598|NCT00753064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24557600|NCT00753064|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24841009|NCT02213653|Iron|iron|mesh-list
24858521|NCT02298101|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24858522|NCT02298153|Atezolizumab|atezolizumab|mesh-list
24858523|NCT02298153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858524|NCT02298166|Cytarabine|cytarabine|mesh-list
24858525|NCT02298166|Mitoxantrone|mitoxantrone|mesh-list
24858526|NCT02298166|Crenolanib|crenolanib|mesh-list
24858527|NCT02298166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24858528|NCT02298166|Antimetabolites|antimetabolites|mesh-ancestor
24447388|NCT00308360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24447389|NCT00308360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24447390|NCT00308360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24447391|NCT00308360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24447392|NCT00308360|Dopamine Agents|dopamine agents|mesh-ancestor
24447393|NCT00308360|Anticonvulsants|anticonvulsants|mesh-ancestor
24447394|NCT00308360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24447395|NCT00308360|GABA Agents|gaba agents|mesh-ancestor
24447396|NCT00308360|Antimanic Agents|antimanic agents|mesh-ancestor
24545751|NCT00694733|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24545759|NCT00694733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24545760|NCT00694733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545761|NCT00694733|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24545762|NCT00694733|Hormone Antagonists|hormone antagonists|mesh-ancestor
25229521|NCT02602002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25229522|NCT02602002|Narcotics|narcotics|mesh-ancestor
25229523|NCT02602002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25229524|NCT02602002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229525|NCT02602002|Analgesics|analgesics|mesh-ancestor
24845309|NCT02237443|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
24885736|NCT04652206|Gemcitabine|gemcitabine|mesh-list
24545763|NCT00694733|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24545764|NCT00694733|Fertility Agents|fertility agents|mesh-ancestor
24545784|NCT00694863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24545785|NCT00694863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545786|NCT00694915|BCG Vaccine|bcg vaccine|mesh-list
24545787|NCT00694915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24858551|NCT02298218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24858552|NCT02298218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24858553|NCT02298218|Analgesics|analgesics|mesh-ancestor
25868613|NCT00112645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25868614|NCT00112645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25868615|NCT00112645|Antiemetics|antiemetics|mesh-ancestor
25868616|NCT00112645|Autonomic Agents|autonomic agents|mesh-ancestor
25868617|NCT00112645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25868618|NCT00112645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25868619|NCT00112645|Glucocorticoids|glucocorticoids|mesh-ancestor
25868620|NCT00112645|Hormones|hormones|mesh-ancestor
25868621|NCT00112645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25868622|NCT00112645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24545806|NCT00695032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841059|NCT02213848|Calcium|calcium|mesh-list
25868623|NCT00112645|Protective Agents|protective agents|mesh-ancestor
25670954|NCT03516305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25670955|NCT03516305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670956|NCT03516305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25670957|NCT03516305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25670958|NCT03516305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25670959|NCT03516305|GABA Modulators|gaba modulators|mesh-ancestor
25670960|NCT03516305|GABA Agents|gaba agents|mesh-ancestor
25670961|NCT03516305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25670962|NCT03516305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670963|NCT03499483|Tenofovir|tenofovir|mesh-list
25670964|NCT03499483|Emtricitabine|emtricitabine|mesh-list
25868624|NCT00112645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25670965|NCT03499483|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25868626|NCT00112645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25868628|NCT00112658|Gemcitabine|gemcitabine|mesh-list
25868629|NCT00112658|Fluorouracil|fluorouracil|mesh-list
25868630|NCT00112658|Oxaliplatin|oxaliplatin|mesh-list
25229526|NCT02602002|Sensory System Agents|sensory system agents|mesh-ancestor
25229527|NCT02602002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845310|NCT02237443|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24845311|NCT02237443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24845312|NCT02237443|Cholinergic Agents|cholinergic agents|mesh-ancestor
24845313|NCT02237443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845314|NCT02237443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868631|NCT00112658|Irinotecan|irinotecan|mesh-list
25868632|NCT00112658|Calcium|calcium|mesh-list
25868633|NCT00112658|Levoleucovorin|levoleucovorin|mesh-list
25868634|NCT00112658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25868635|NCT00112658|Antimetabolites|antimetabolites|mesh-ancestor
25868636|NCT00112658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868637|NCT00112658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24545837|NCT00695240|Bupivacaine|bupivacaine|mesh-list
24545838|NCT00695240|Anesthetics, Local|anesthetics, local|mesh-ancestor
24545839|NCT00695240|Anesthetics|anesthetics|mesh-ancestor
24545840|NCT00695240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24545841|NCT00695240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545842|NCT00695240|Sensory System Agents|sensory system agents|mesh-ancestor
25868638|NCT00112658|Antiviral Agents|antiviral agents|mesh-ancestor
25868639|NCT00112658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24545843|NCT00695240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24545844|NCT00695331|Misoprostol|misoprostol|mesh-list
24545846|NCT00695331|Oxytocics|oxytocics|mesh-ancestor
24858554|NCT02298218|Sensory System Agents|sensory system agents|mesh-ancestor
24858555|NCT02298218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858556|NCT02298218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858557|NCT02298218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24858558|NCT02298218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24858559|NCT02298218|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24858560|NCT02298218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24858561|NCT02298218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24858562|NCT02298218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858564|NCT02298283|Cyclophosphamide|cyclophosphamide|mesh-list
24858565|NCT02298283|Doxorubicin|doxorubicin|mesh-list
24858566|NCT02298283|Etoposide|etoposide|mesh-list
24858567|NCT02298283|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24858568|NCT02298283|Vincristine|vincristine|mesh-list
24858570|NCT02298283|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24858571|NCT02298283|Procarbazine|procarbazine|mesh-list
24858572|NCT02298283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24858573|NCT02298283|Immunologic Factors|immunologic factors|mesh-ancestor
24858574|NCT02298283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858575|NCT02298283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24858576|NCT02298283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24858577|NCT02298283|Alkylating Agents|alkylating agents|mesh-ancestor
24858578|NCT02298283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858579|NCT02298283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858580|NCT02298283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24858581|NCT02298283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24858582|NCT02298283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24858583|NCT02298283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24858584|NCT02298283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24858585|NCT02298283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24858586|NCT02298283|Glucocorticoids|glucocorticoids|mesh-ancestor
24858587|NCT02298283|Hormones|hormones|mesh-ancestor
25229528|NCT02602301|Oxytocin|oxytocin|mesh-list
25670966|NCT03499483|Antiviral Agents|antiviral agents|mesh-ancestor
25670967|NCT03499483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25670968|NCT03499483|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25868640|NCT00112658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229529|NCT02602301|Oxytocics|oxytocics|mesh-ancestor
25229532|NCT02601989|Tadalafil|tadalafil|mesh-list
25229533|NCT02601989|Vasodilator Agents|vasodilator agents|mesh-ancestor
25229534|NCT02601989|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25229535|NCT02601989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25229536|NCT02601989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229537|NCT02601989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229538|NCT02601989|Urological Agents|urological agents|mesh-ancestor
25229539|NCT02602028|Colchicine|colchicine|mesh-list
24845315|NCT02237495|Dexmedetomidine|dexmedetomidine|mesh-list
24845316|NCT02237495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24845317|NCT02237495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24845318|NCT02237495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845319|NCT02237495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24845320|NCT02237495|Analgesics|analgesics|mesh-ancestor
24845321|NCT02237495|Sensory System Agents|sensory system agents|mesh-ancestor
24845322|NCT02237495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845323|NCT02237495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24845343|NCT02237560|Dermatologic Agents|dermatologic agents|mesh-ancestor
24845344|NCT02237560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24845345|NCT02237560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24845346|NCT02237560|Analgesics|analgesics|mesh-ancestor
24845347|NCT02237560|Sensory System Agents|sensory system agents|mesh-ancestor
24845348|NCT02237560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845349|NCT02237560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274028|NCT02381470|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24858588|NCT02298283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24858589|NCT02298283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24858590|NCT02298283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24858595|NCT02298335|Prednisone|prednisone|mesh-list
24858596|NCT02298335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24858597|NCT02298335|Glucocorticoids|glucocorticoids|mesh-ancestor
24858598|NCT02298335|Hormones|hormones|mesh-ancestor
24858599|NCT02298335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24858600|NCT02298335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461068|NCT00350857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24545847|NCT00695331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24545848|NCT00695331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545849|NCT00695331|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24545850|NCT00695331|Abortifacient Agents|abortifacient agents|mesh-ancestor
24545852|NCT00695331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24545853|NCT00695344|Mycophenolic Acid|mycophenolic acid|mesh-list
24545854|NCT00695344|Everolimus|everolimus|mesh-list
24545858|NCT00695344|Immunologic Factors|immunologic factors|mesh-ancestor
24545859|NCT00695344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545860|NCT00695344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24545861|NCT00695344|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24545862|NCT00695344|Antitubercular Agents|antitubercular agents|mesh-ancestor
24545863|NCT00695344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24545864|NCT00695344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24545865|NCT00695344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868641|NCT00112658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25868642|NCT00112658|Immunologic Factors|immunologic factors|mesh-ancestor
25868643|NCT00112658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868644|NCT00112658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25868645|NCT00112658|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25868646|NCT00112658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25868647|NCT00112658|Antidotes|antidotes|mesh-ancestor
25868648|NCT00112658|Protective Agents|protective agents|mesh-ancestor
25229540|NCT02602028|Gout Suppressants|gout suppressants|mesh-ancestor
25229541|NCT02602028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25229542|NCT02602028|Tubulin Modulators|tubulin modulators|mesh-ancestor
25229543|NCT02602028|Antimitotic Agents|antimitotic agents|mesh-ancestor
25229544|NCT02602028|Mitosis Modulators|mitosis modulators|mesh-ancestor
25229545|NCT02602028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229546|NCT02602028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25229547|NCT02601859|Lithium Carbonate|lithium carbonate|mesh-list
25670969|NCT03499483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25127624|NCT03054220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127626|NCT03054220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127627|NCT03054220|Analgesics|analgesics|mesh-ancestor
25127628|NCT03054220|Sensory System Agents|sensory system agents|mesh-ancestor
25127629|NCT03054220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25127630|NCT03054220|Antidepressive Agents|antidepressive agents|mesh-ancestor
25127631|NCT03054220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25127632|NCT03054220|Dopamine Agents|dopamine agents|mesh-ancestor
25127633|NCT03054220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25127634|NCT03054220|Narcotics|narcotics|mesh-ancestor
25127635|NCT03054220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25229548|NCT02601859|Antidepressive Agents|antidepressive agents|mesh-ancestor
25229549|NCT02601859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25229550|NCT02601859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229551|NCT02601859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229552|NCT02601859|Antimanic Agents|antimanic agents|mesh-ancestor
25229553|NCT02601859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25229554|NCT02601859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25229555|NCT02601859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229556|NCT02601911|Acetaminophen|acetaminophen|mesh-list
25229557|NCT02601911|Ketorolac|ketorolac|mesh-list
25229558|NCT02601911|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25229559|NCT02601911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25229560|NCT02601911|Analgesics|analgesics|mesh-ancestor
24845350|NCT02237560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24845351|NCT02237560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24845352|NCT02237560|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24845353|NCT02237560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24845354|NCT02237560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845355|NCT02237651|Anesthetics|anesthetics|mesh-list
24845356|NCT02237651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24845357|NCT02237651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845358|NCT02237690|Doxorubicin|doxorubicin|mesh-list
24845359|NCT02237690|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24845360|NCT02237690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24845361|NCT02237690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043980|NCT01175785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25043981|NCT01175785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25043982|NCT01175785|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25043983|NCT01175785|Antitubercular Agents|antitubercular agents|mesh-ancestor
25043984|NCT01175785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25043985|NCT01174732|Albuterol|albuterol|mesh-list
25043986|NCT01174732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25043987|NCT01174732|Autonomic Agents|autonomic agents|mesh-ancestor
25043988|NCT01174732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25043989|NCT01174732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043990|NCT01174732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25043991|NCT01174732|Respiratory System Agents|respiratory system agents|mesh-ancestor
25043992|NCT01174732|Tocolytic Agents|tocolytic agents|mesh-ancestor
25043995|NCT01174732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25043996|NCT01174732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25043997|NCT01174732|Adrenergic Agents|adrenergic agents|mesh-ancestor
25868649|NCT00112658|Vitamin B Complex|vitamin b complex|mesh-ancestor
25868650|NCT00112658|Vitamins|vitamins|mesh-ancestor
25868651|NCT00112658|Micronutrients|micronutrients|mesh-ancestor
25868652|NCT00112684|Alvocidib|alvocidib|mesh-list
25868653|NCT00112684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868654|NCT00112684|Growth Inhibitors|growth inhibitors|mesh-ancestor
25868655|NCT00112684|Growth Substances|growth substances|mesh-ancestor
25868656|NCT00112684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670970|NCT03499483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25670971|NCT03499483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670972|NCT03499483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25670973|NCT03499483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25670974|NCT03494530|Edoxaban|edoxaban|mesh-list
25670975|NCT03494530|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25670976|NCT03494530|Antithrombins|antithrombins|mesh-ancestor
25670977|NCT03494530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25670978|NCT03494530|Protease Inhibitors|protease inhibitors|mesh-ancestor
25670979|NCT03494530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25670980|NCT03494530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670981|NCT03494530|Anticoagulants|anticoagulants|mesh-ancestor
25868657|NCT00112684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25868658|NCT00112684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25127671|NCT03053739|Sildenafil Citrate|sildenafil citrate|mesh-list
25868659|NCT00112684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868660|NCT00112697|Cisplatin|cisplatin|mesh-list
25229561|NCT02601911|Sensory System Agents|sensory system agents|mesh-ancestor
25229562|NCT02601911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229563|NCT02601911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229564|NCT02601911|Antipyretics|antipyretics|mesh-ancestor
25229565|NCT02601911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25229566|NCT02601911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25229567|NCT02601911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25229568|NCT02601911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25229569|NCT02601911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229570|NCT02601911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229571|NCT02601963|Minocycline|minocycline|mesh-list
25229572|NCT02601963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25229573|NCT02601963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25229574|NCT02601924|Anesthetics|anesthetics|mesh-list
25229575|NCT02601924|Anesthetics, Local|anesthetics, local|mesh-list
25229576|NCT02601924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25229577|NCT02601924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229578|NCT02601924|Sensory System Agents|sensory system agents|mesh-ancestor
25229579|NCT02601924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229580|NCT02601898|Thioctic Acid|thioctic acid|mesh-list
25229581|NCT02601898|Progesterone|progesterone|mesh-list
25229582|NCT02601898|Progestins|progestins|mesh-ancestor
25229583|NCT02601898|Hormones|hormones|mesh-ancestor
25229584|NCT02601898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25229585|NCT02601898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229586|NCT02601898|Antioxidants|antioxidants|mesh-ancestor
25229587|NCT02601898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229588|NCT02601898|Protective Agents|protective agents|mesh-ancestor
25229589|NCT02601898|Vitamin B Complex|vitamin b complex|mesh-ancestor
25229590|NCT02601898|Vitamins|vitamins|mesh-ancestor
25229591|NCT02601898|Micronutrients|micronutrients|mesh-ancestor
25043998|NCT01174732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25043999|NCT01174732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044000|NCT01173497|Irinotecan|irinotecan|mesh-list
25044001|NCT01173497|Iniparib|iniparib|mesh-list
25868661|NCT00112697|Docetaxel|docetaxel|mesh-list
25868662|NCT00112697|Fluorouracil|fluorouracil|mesh-list
25868663|NCT00112697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868664|NCT00112697|Tubulin Modulators|tubulin modulators|mesh-ancestor
25868665|NCT00112697|Antimitotic Agents|antimitotic agents|mesh-ancestor
25868666|NCT00112697|Mitosis Modulators|mitosis modulators|mesh-ancestor
25044002|NCT01173497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25044003|NCT01173497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25044004|NCT01173497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044005|NCT01173497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044006|NCT01173497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044007|NCT01173497|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25044008|NCT01171313|Carbidopa|carbidopa|mesh-list
25044009|NCT01171313|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25044010|NCT01171313|Levodopa|levodopa|mesh-list
25044011|NCT01171313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25044012|NCT01171313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24845362|NCT02237690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24845363|NCT02237690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24845364|NCT02237690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868667|NCT00112697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868668|NCT00112697|Antimetabolites|antimetabolites|mesh-ancestor
25868669|NCT00112697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25868670|NCT00112697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24545888|NCT00695643|Mesalamine|mesalamine|mesh-list
24712633|NCT01521962|Incretins|incretins|mesh-ancestor
24545889|NCT00695643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24545890|NCT00695643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25868671|NCT00112697|Immunologic Factors|immunologic factors|mesh-ancestor
25868672|NCT00112697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868673|NCT00112710|Gemcitabine|gemcitabine|mesh-list
25868674|NCT00112710|Cisplatin|cisplatin|mesh-list
25868675|NCT00112710|Carboplatin|carboplatin|mesh-list
25868676|NCT00112710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108398|NCT03132233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25108399|NCT03132233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868677|NCT00112710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25868678|NCT00112710|Antimetabolites|antimetabolites|mesh-ancestor
25127772|NCT03053583|Dermatologic Agents|dermatologic agents|mesh-ancestor
25108401|NCT03132142|Capsaicin|capsaicin|mesh-list
25108402|NCT03132142|Menthol|menthol|mesh-list
25868679|NCT00112710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858601|NCT02298335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24858602|NCT02298335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813164|NCT02056743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24813165|NCT02056743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461076|NCT00350948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868680|NCT00112710|Antiviral Agents|antiviral agents|mesh-ancestor
25229592|NCT02601677|Fluoxetine|fluoxetine|mesh-list
25229593|NCT02601677|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25229594|NCT02601677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25229595|NCT02601677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25229596|NCT02601677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229597|NCT02601677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25229598|NCT02601677|Serotonin Agents|serotonin agents|mesh-ancestor
25229599|NCT02601677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229600|NCT02601677|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25229601|NCT02601677|Antidepressive Agents|antidepressive agents|mesh-ancestor
25229602|NCT02601677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25229603|NCT02601677|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25229604|NCT02601677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25229605|NCT02601677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229606|NCT02601703|Tacrolimus|tacrolimus|mesh-list
25229607|NCT02601703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25229608|NCT02601703|Immunologic Factors|immunologic factors|mesh-ancestor
25229609|NCT02601703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229610|NCT02601703|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25229611|NCT02601703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229612|NCT02601703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229613|NCT02601651|Lidocaine|lidocaine|mesh-list
25229614|NCT02601651|Anesthetics, Local|anesthetics, local|mesh-ancestor
24845406|NCT02237820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24845408|NCT02237859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24845409|NCT02237859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24845410|NCT02237924|Endostar protein|endostar protein|mesh-list
24845411|NCT02237924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24845412|NCT02237924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24845413|NCT02237924|Growth Substances|growth substances|mesh-ancestor
24845451|NCT02238106|Respiratory System Agents|respiratory system agents|mesh-ancestor
24845452|NCT02238106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24845453|NCT02238106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24845454|NCT02238106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24845455|NCT02238106|Adrenergic Agents|adrenergic agents|mesh-ancestor
25868681|NCT00112710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24845458|NCT02238119|Formoterol Fumarate|formoterol fumarate|mesh-list
24845459|NCT02238119|Tiotropium Bromide|tiotropium bromide|mesh-list
24845460|NCT02238119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24845461|NCT02238119|Autonomic Agents|autonomic agents|mesh-ancestor
24452672|NCT05457855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24452673|NCT05457855|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24452674|NCT05457855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24452675|NCT05457855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758419|NCT01745666|Epinephrine|epinephrine|mesh-list
25868682|NCT00112710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868683|NCT00112710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25868684|NCT00112710|Immunologic Factors|immunologic factors|mesh-ancestor
25868685|NCT00112710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868686|NCT00112749|Infliximab|infliximab|mesh-list
25670982|NCT03478956|Etrolizumab|etrolizumab|mesh-list
25670983|NCT03478956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25670984|NCT03478956|Immunologic Factors|immunologic factors|mesh-ancestor
25670985|NCT03478956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25670986|NCT03453489|Tryptophan|tryptophan|mesh-list
25868692|NCT00112775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868693|NCT00112775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25868694|NCT00112775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24559489|NCT04757584|Pindolol|pindolol|mesh-list
24559490|NCT04757584|Betaxolol|betaxolol|mesh-list
24559491|NCT04757584|Penbutolol|penbutolol|mesh-list
25868695|NCT00112775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868696|NCT00112853|Etoposide|etoposide|mesh-list
24545926|NCT00695994|Antimitotic Agents|antimitotic agents|mesh-ancestor
24545927|NCT00695994|Mitosis Modulators|mitosis modulators|mesh-ancestor
24545928|NCT00696007|Gemcitabine|gemcitabine|mesh-list
24545929|NCT00696007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24545930|NCT00696007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24545931|NCT00696007|Antimetabolites|antimetabolites|mesh-ancestor
24545932|NCT00696007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545933|NCT00696007|Antiviral Agents|antiviral agents|mesh-ancestor
24545934|NCT00696007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24545935|NCT00696007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229615|NCT02601651|Anesthetics|anesthetics|mesh-ancestor
25229616|NCT02601651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25229617|NCT02601651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229618|NCT02601651|Sensory System Agents|sensory system agents|mesh-ancestor
25229619|NCT02601651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25868697|NCT00112853|Etoposide phosphate|etoposide phosphate|mesh-list
25868698|NCT00112853|Tipifarnib|tipifarnib|mesh-list
25229620|NCT02601651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25229621|NCT02601651|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25229622|NCT02601651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25229623|NCT02601651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25229624|NCT02601651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229625|NCT02601508|Rocuronium|rocuronium|mesh-list
25229626|NCT02601508|Atracurium|atracurium|mesh-list
25229627|NCT02601508|Cisatracurium|cisatracurium|mesh-list
25229628|NCT02601508|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25229629|NCT02601508|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25229630|NCT02601508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25229631|NCT02601508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229632|NCT02601508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229633|NCT02601508|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25229634|NCT02601508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25229635|NCT02601508|Cholinergic Agents|cholinergic agents|mesh-ancestor
25229636|NCT02601508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25229637|NCT02601508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229638|NCT02601365|Molgramostim|molgramostim|mesh-list
25229639|NCT02601365|Sargramostim|sargramostim|mesh-list
25229640|NCT02601365|Immunologic Factors|immunologic factors|mesh-ancestor
25229641|NCT02601365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229642|NCT02601365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24845553|NCT02238262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24845554|NCT02238262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24845555|NCT02238262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24545936|NCT00696007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24545947|NCT00696033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24545948|NCT00696033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24545950|NCT00696033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24545951|NCT00696033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25670988|NCT03453489|Antidepressive Agents|antidepressive agents|mesh-ancestor
25670989|NCT03453489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25670990|NCT03399292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25670991|NCT03399292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25670992|NCT03348930|Tolcapone|tolcapone|mesh-list
25670993|NCT03348930|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25670994|NCT03348930|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24545952|NCT00696033|GABA Modulators|gaba modulators|mesh-ancestor
24559958|NCT03989466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24559960|NCT03989466|Antibodies|antibodies|mesh-list
24559961|NCT03989466|Immunoglobulins|immunoglobulins|mesh-list
24559962|NCT03989466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24559963|NCT03989466|Immunologic Factors|immunologic factors|mesh-ancestor
24559964|NCT03989466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24560075|NCT03617458|Metformin|metformin|mesh-list
25868699|NCT00112853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24560242|NCT03086369|Olaratumab|olaratumab|mesh-list
25127910|NCT03051945|Ketamine|ketamine|mesh-list
24545953|NCT00696033|GABA Agents|gaba agents|mesh-ancestor
24545954|NCT00696033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24545955|NCT00696033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868700|NCT00112853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24545956|NCT00696033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24545957|NCT00696033|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24545958|NCT00696033|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24545959|NCT00696033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24545960|NCT00696033|Anesthetics, General|anesthetics, general|mesh-ancestor
24545961|NCT00696033|Anesthetics|anesthetics|mesh-ancestor
24545962|NCT00696059|Adalimumab|adalimumab|mesh-list
24545963|NCT00696059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24545964|NCT00696059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24545965|NCT00696098|Butyric Acid|butyric acid|mesh-list
24813167|NCT02056743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24842722|NCT02223026|Linagliptin|linagliptin|mesh-list
24842723|NCT02223026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25868701|NCT00112853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25868702|NCT00112853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25868703|NCT00112853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842726|NCT02223026|Hormones|hormones|mesh-ancestor
24813168|NCT02056743|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24813169|NCT02056743|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24813170|NCT02056743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24545983|NCT00696163|Insulin Aspart|insulin aspart|mesh-list
24545984|NCT00696163|Biphasic Insulins|biphasic insulins|mesh-list
24545985|NCT00696163|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24545986|NCT00696163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24545987|NCT00696163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545988|NCT00696202|Levonorgestrel|levonorgestrel|mesh-list
24545989|NCT00696202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24545990|NCT00696202|Contraceptive Agents|contraceptive agents|mesh-ancestor
24545991|NCT00696202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24545992|NCT00696202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546034|NCT00696540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24546035|NCT00696540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24546036|NCT00696540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24546037|NCT00696540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24546038|NCT00696540|Adrenergic Agents|adrenergic agents|mesh-ancestor
25229643|NCT02601287|Botulinum Toxins|botulinum toxins|mesh-list
25229644|NCT02601287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25229645|NCT02601287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25229646|NCT02601287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25229647|NCT02601287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25229648|NCT02601287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229649|NCT02601287|Cholinergic Agents|cholinergic agents|mesh-ancestor
25229650|NCT02601287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25229651|NCT02601287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229652|NCT02601287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25229654|NCT02601157|Aspirin|aspirin|mesh-list
25229655|NCT02601157|Sirolimus|sirolimus|mesh-list
25229656|NCT02601157|Clopidogrel|clopidogrel|mesh-list
25229657|NCT02601157|Ticagrelor|ticagrelor|mesh-list
25229658|NCT02601157|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25229659|NCT02601157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24845556|NCT02238262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845557|NCT02238275|Telmisartan|telmisartan|mesh-list
25670995|NCT03348930|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25670996|NCT03348930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25670997|NCT03348930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25670998|NCT03336216|Leucovorin|leucovorin|mesh-list
25670999|NCT03336216|Gemcitabine|gemcitabine|mesh-list
25671000|NCT03336216|Paclitaxel|paclitaxel|mesh-list
25671001|NCT03336216|Fluorouracil|fluorouracil|mesh-list
25671002|NCT03336216|Oxaliplatin|oxaliplatin|mesh-list
25671003|NCT03336216|Nivolumab|nivolumab|mesh-list
25671004|NCT03336216|Irinotecan|irinotecan|mesh-list
25127928|NCT03051841|Dexamethasone|dexamethasone|mesh-list
24845558|NCT02238275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24845559|NCT02238275|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24845560|NCT02238275|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24845561|NCT02238275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845562|NCT02238288|Acetaminophen|acetaminophen|mesh-list
24842897|NCT02224170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24845563|NCT02238288|Lidocaine|lidocaine|mesh-list
24845564|NCT02238288|Epinephrine|epinephrine|mesh-list
24845565|NCT02238288|Aminocaproic Acid|aminocaproic acid|mesh-list
24845566|NCT02238288|Anesthetics, Local|anesthetics, local|mesh-ancestor
24845567|NCT02238288|Anesthetics|anesthetics|mesh-ancestor
24845568|NCT02238288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24845569|NCT02238288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835442|NCT02182856|Bromides|bromides|mesh-list
24845575|NCT02238288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25868704|NCT00112853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868705|NCT00112879|Ascorbic Acid|ascorbic acid|mesh-list
25868706|NCT00112879|Thalidomide|thalidomide|mesh-list
25868707|NCT00112879|Dexamethasone|dexamethasone|mesh-list
25868708|NCT00112879|Arsenic Trioxide|arsenic trioxide|mesh-list
25868709|NCT00112879|Mitogens|mitogens|mesh-list
25868710|NCT00112879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25868711|NCT00112879|Antiemetics|antiemetics|mesh-ancestor
25868712|NCT00112879|Autonomic Agents|autonomic agents|mesh-ancestor
24813180|NCT02056743|Respiratory System Agents|respiratory system agents|mesh-ancestor
24813181|NCT02056743|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24813182|NCT02056743|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24813183|NCT02056743|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24813184|NCT02056743|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24813185|NCT02056743|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25868713|NCT00112879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25868714|NCT00112879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868715|NCT00112879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25868716|NCT00112879|Glucocorticoids|glucocorticoids|mesh-ancestor
25868717|NCT00112879|Hormones|hormones|mesh-ancestor
25868718|NCT00112879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24546053|NCT00696566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24546055|NCT00696566|Leprostatic Agents|leprostatic agents|mesh-ancestor
25868719|NCT00112879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25868720|NCT00112879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868721|NCT00112879|Mitosis Modulators|mitosis modulators|mesh-ancestor
25868722|NCT00112879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868723|NCT00112879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25868724|NCT00112879|Immunologic Factors|immunologic factors|mesh-ancestor
25868725|NCT00112879|Leprostatic Agents|leprostatic agents|mesh-ancestor
25868726|NCT00112879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25868727|NCT00112879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25868728|NCT00112879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25868729|NCT00112879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25868730|NCT00112879|Growth Substances|growth substances|mesh-ancestor
25868731|NCT00112879|Growth Inhibitors|growth inhibitors|mesh-ancestor
25868732|NCT00112879|Antioxidants|antioxidants|mesh-ancestor
25868733|NCT00112879|Protective Agents|protective agents|mesh-ancestor
25868734|NCT00112879|Vitamins|vitamins|mesh-ancestor
25229660|NCT02601157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25229661|NCT02601157|Analgesics|analgesics|mesh-ancestor
25229662|NCT02601157|Sensory System Agents|sensory system agents|mesh-ancestor
25229663|NCT02601157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229664|NCT02601157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229665|NCT02601157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25229666|NCT02601157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25229667|NCT02601157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25229668|NCT02601157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25229669|NCT02601157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229674|NCT02601157|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24845576|NCT02238288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845577|NCT02238288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24845578|NCT02238288|Analgesics|analgesics|mesh-ancestor
24845579|NCT02238288|Antipyretics|antipyretics|mesh-ancestor
24845580|NCT02238288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24845581|NCT02238288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24845582|NCT02238288|Adrenergic Agents|adrenergic agents|mesh-ancestor
25868735|NCT00112879|Micronutrients|micronutrients|mesh-ancestor
25868736|NCT00112892|Selenium|selenium|mesh-list
25868737|NCT00112892|Irinotecan|irinotecan|mesh-list
25868738|NCT00112892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24845588|NCT02238288|Respiratory System Agents|respiratory system agents|mesh-ancestor
25044013|NCT01171313|Dopamine Agents|dopamine agents|mesh-ancestor
24562635|NCT00767494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868739|NCT00112892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25868740|NCT00112892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868741|NCT00112892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868742|NCT00112892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24546069|NCT00696579|Antiviral Agents|antiviral agents|mesh-ancestor
24546070|NCT00696579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24546071|NCT00696579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24546072|NCT00696579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25868744|NCT00112892|Protective Agents|protective agents|mesh-ancestor
25868745|NCT00112892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868746|NCT00112892|Trace Elements|trace elements|mesh-ancestor
25868747|NCT00112892|Micronutrients|micronutrients|mesh-ancestor
25868748|NCT00112931|Rituximab|rituximab|mesh-list
25868749|NCT00112931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25868750|NCT00112931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858621|NCT02298387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858623|NCT02298530|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24858624|NCT02298530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842912|NCT02224443|Fentanyl|fentanyl|mesh-list
25868751|NCT00112931|Immunologic Factors|immunologic factors|mesh-ancestor
24858640|NCT02298582|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24858641|NCT02298582|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24858642|NCT02298582|Anesthetics, General|anesthetics, general|mesh-ancestor
24858643|NCT02298582|Anesthetics|anesthetics|mesh-ancestor
24858644|NCT02298595|Cetuximab|cetuximab|mesh-list
24858645|NCT02298595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858646|NCT02298595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24858647|NCT02298660|Botulinum Toxins|botulinum toxins|mesh-list
24858648|NCT02298660|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25868752|NCT00112931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868753|NCT00112931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25868754|NCT00112983|Eculizumab|eculizumab|mesh-list
25868755|NCT00112983|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25868756|NCT00112983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25868757|NCT00112983|Immunologic Factors|immunologic factors|mesh-ancestor
25868758|NCT00112983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868759|NCT00112996|Thioctic Acid|thioctic acid|mesh-list
25868760|NCT00112996|Antioxidants|antioxidants|mesh-ancestor
25868761|NCT00112996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868762|NCT00112996|Protective Agents|protective agents|mesh-ancestor
25868763|NCT00112996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868764|NCT00112996|Vitamin B Complex|vitamin b complex|mesh-ancestor
25868765|NCT00112996|Vitamins|vitamins|mesh-ancestor
25868766|NCT00112996|Micronutrients|micronutrients|mesh-ancestor
25229675|NCT02601157|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25229676|NCT02601157|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25229677|NCT02601157|Purinergic Agents|purinergic agents|mesh-ancestor
25229678|NCT02601157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25229679|NCT02601157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25229680|NCT02601157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25229681|NCT02601157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24845594|NCT02238288|Hemostatics|hemostatics|mesh-ancestor
24845595|NCT02238288|Coagulants|coagulants|mesh-ancestor
24845596|NCT02238314|Ritonavir|ritonavir|mesh-list
24845597|NCT02238314|Tipranavir|tipranavir|mesh-list
24845599|NCT02238314|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24845600|NCT02238314|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24845601|NCT02238314|Protease Inhibitors|protease inhibitors|mesh-ancestor
24845602|NCT02238314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24845603|NCT02238314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845604|NCT02238314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24845605|NCT02238314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24845606|NCT02238314|Antiviral Agents|antiviral agents|mesh-ancestor
24858671|NCT02298985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868774|NCT00113074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868776|NCT00113074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25868777|NCT00113074|Cholinergic Agents|cholinergic agents|mesh-ancestor
25868778|NCT00113074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25868779|NCT00113074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868780|NCT00113100|Ethanol|ethanol|mesh-list
25868781|NCT00113100|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24546096|NCT00696722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24546097|NCT00696722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546098|NCT00696722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24546099|NCT00696722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24546100|NCT00696722|Antiviral Agents|antiviral agents|mesh-ancestor
24546101|NCT00696722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25868782|NCT00113100|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25229689|NCT02601235|Pyrilamine|pyrilamine|mesh-list
25229690|NCT02601235|Phenylephrine|phenylephrine|mesh-list
25229691|NCT02601235|Oxymetazoline|oxymetazoline|mesh-list
25229692|NCT02601235|Naphazoline|naphazoline|mesh-list
25229693|NCT02601235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229694|NCT02601235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25229695|NCT02601235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25229696|NCT02601235|Adrenergic Agents|adrenergic agents|mesh-ancestor
25229697|NCT02601235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25868783|NCT00113100|Estradiol|estradiol|mesh-list
25868784|NCT00113100|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25229704|NCT02601235|Respiratory System Agents|respiratory system agents|mesh-ancestor
25229705|NCT02601235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25229706|NCT02601235|Mydriatics|mydriatics|mesh-ancestor
25229707|NCT02601235|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25229708|NCT02601235|Protective Agents|protective agents|mesh-ancestor
25229709|NCT02601235|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25229710|NCT02601235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24845608|NCT02238314|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24845609|NCT02238314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24845610|NCT02238314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24845612|NCT02238340|Morphine|morphine|mesh-list
24845613|NCT02238340|Oxycodone|oxycodone|mesh-list
24845614|NCT02238340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24758587|NCT01746992|Prednisone|prednisone|mesh-list
24858672|NCT02298985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24858673|NCT02298985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24858674|NCT02298985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24858675|NCT02299024|Analgesics, Opioid|analgesics, opioid|mesh-list
24858680|NCT02299024|Sensory System Agents|sensory system agents|mesh-ancestor
25868785|NCT00113100|Estrogens|estrogens|mesh-ancestor
25868786|NCT00113100|Hormones|hormones|mesh-ancestor
25433693|NCT00433511|Immunoglobulins|immunoglobulins|mesh-list
25868787|NCT00113100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24546132|NCT00696956|Mitosis Modulators|mitosis modulators|mesh-ancestor
24546133|NCT00696956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546134|NCT00696969|Amphotericin B|amphotericin b|mesh-list
24546135|NCT00696969|Paromomycin|paromomycin|mesh-list
24546136|NCT00696969|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24546137|NCT00696969|Miltefosine|miltefosine|mesh-list
24546138|NCT00696969|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
24546139|NCT00696969|Deoxycholic Acid|deoxycholic acid|mesh-list
24546140|NCT00696969|Amebicides|amebicides|mesh-ancestor
24546141|NCT00696969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24546142|NCT00696969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24546143|NCT00696969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25229711|NCT02601235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25229712|NCT02601235|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25229713|NCT02601235|Histamine Antagonists|histamine antagonists|mesh-ancestor
25229714|NCT02601235|Histamine Agents|histamine agents|mesh-ancestor
25229715|NCT02601235|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25229716|NCT02601196|Ulipristal acetate|ulipristal acetate|mesh-list
25229717|NCT02601196|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25229718|NCT02601196|Contraceptive Agents|contraceptive agents|mesh-ancestor
25229719|NCT02601196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25229724|NCT02600988|Cholecalciferol|cholecalciferol|mesh-list
25229725|NCT02600988|Vitamins|vitamins|mesh-list
25229726|NCT02600988|Micronutrients|micronutrients|mesh-ancestor
25229727|NCT02600988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229728|NCT02600988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25229729|NCT02600988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25229730|NCT02600793|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
25229731|NCT02600793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25229732|NCT02600793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25868796|NCT00113113|Rubitecan|rubitecan|mesh-list
24845615|NCT02238340|Narcotics|narcotics|mesh-ancestor
24845616|NCT02238340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24845617|NCT02238340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845618|NCT02238340|Analgesics|analgesics|mesh-ancestor
24845619|NCT02238340|Sensory System Agents|sensory system agents|mesh-ancestor
25868797|NCT00113113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868798|NCT00113113|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25868799|NCT00113113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25868800|NCT00113113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868801|NCT00113113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868802|NCT00113165|Lamotrigine|lamotrigine|mesh-list
25868803|NCT00113165|Anticonvulsants|anticonvulsants|mesh-ancestor
25868804|NCT00113165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25868805|NCT00113165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24712953|NCT01523327|Protective Agents|protective agents|mesh-ancestor
25868806|NCT00113165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868807|NCT00113165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24858687|NCT02299063|Analgesics|analgesics|mesh-ancestor
24858688|NCT02299063|Sensory System Agents|sensory system agents|mesh-ancestor
24858689|NCT02299063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858690|NCT02299063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24858691|NCT02299063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24858692|NCT02299063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24858693|NCT02299063|Adrenergic Agents|adrenergic agents|mesh-ancestor
24858694|NCT02299063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24546189|NCT00697034|Dermatologic Agents|dermatologic agents|mesh-ancestor
24546190|NCT00697034|Sensory System Agents|sensory system agents|mesh-ancestor
24546191|NCT00697034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25868812|NCT00113165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25868813|NCT00113165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25868814|NCT00113256|Rubitecan|rubitecan|mesh-list
25229733|NCT02600806|Azithromycin|azithromycin|mesh-list
25229734|NCT02600806|Levofloxacin|levofloxacin|mesh-list
25229735|NCT02600806|Ofloxacin|ofloxacin|mesh-list
25229736|NCT02600806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25229737|NCT02600806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25229738|NCT02600806|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25229739|NCT02600806|Renal Agents|renal agents|mesh-ancestor
25229740|NCT02600806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25229741|NCT02600806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25229742|NCT02600806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229743|NCT02600806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229744|NCT02600806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25229745|NCT02600806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25229746|NCT02600806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25229747|NCT02600780|Allopurinol|allopurinol|mesh-list
25229748|NCT02600780|Febuxostat|febuxostat|mesh-list
24845620|NCT02238340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845621|NCT02238340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24845622|NCT02238340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24845623|NCT02238340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24845624|NCT02238340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24845625|NCT02238340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24845626|NCT02238340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24845627|NCT02238340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845628|NCT02238353|Fluticasone|fluticasone|mesh-list
24845629|NCT02238353|Azelastine|azelastine|mesh-list
24845630|NCT02238353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24845631|NCT02238353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24845632|NCT02238353|Autonomic Agents|autonomic agents|mesh-ancestor
24845633|NCT02238353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845634|NCT02238353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845635|NCT02238353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24845636|NCT02238353|Respiratory System Agents|respiratory system agents|mesh-ancestor
24845637|NCT02238353|Dermatologic Agents|dermatologic agents|mesh-ancestor
24845638|NCT02238353|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25671005|NCT03336216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25868815|NCT00113256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25128282|NCT03048877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229749|NCT02600780|Antimetabolites|antimetabolites|mesh-ancestor
25229750|NCT02600780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229751|NCT02600780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229752|NCT02600780|Gout Suppressants|gout suppressants|mesh-ancestor
25229753|NCT02600780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25229754|NCT02600780|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25229755|NCT02600780|Antioxidants|antioxidants|mesh-ancestor
25229756|NCT02600780|Protective Agents|protective agents|mesh-ancestor
25229757|NCT02600780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229758|NCT02600741|Droperidol|droperidol|mesh-list
25229759|NCT02600741|Haloperidol|haloperidol|mesh-list
25229760|NCT02600741|Pimozide|pimozide|mesh-list
25229761|NCT02600741|Olanzapine|olanzapine|mesh-list
25229762|NCT02600741|Prochlorperazine|prochlorperazine|mesh-list
25229763|NCT02600741|Chlorpromazine|chlorpromazine|mesh-list
25229764|NCT02600741|Trifluoperazine|trifluoperazine|mesh-list
25229765|NCT02600741|Risperidone|risperidone|mesh-list
25229766|NCT02600741|Aripiprazole|aripiprazole|mesh-list
25229767|NCT02600741|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25229768|NCT02600741|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25229769|NCT02600741|Ziprasidone|ziprasidone|mesh-list
25229770|NCT02600741|Clozapine|clozapine|mesh-list
25229771|NCT02600741|Asenapine|asenapine|mesh-list
25229772|NCT02600741|Loxapine|loxapine|mesh-list
25229773|NCT02600741|Iloperidone|iloperidone|mesh-list
25229774|NCT02600741|Perphenazine|perphenazine|mesh-list
25229775|NCT02600741|Fluphenazine|fluphenazine|mesh-list
25229776|NCT02600741|Fluphenazine depot|fluphenazine depot|mesh-list
25229777|NCT02600741|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
25229778|NCT02600741|Thioridazine|thioridazine|mesh-list
25229786|NCT02600741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25229787|NCT02600741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25229788|NCT02600741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25229789|NCT02600741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25229790|NCT02600741|Dopamine Agents|dopamine agents|mesh-ancestor
25229791|NCT02600741|Antiemetics|antiemetics|mesh-ancestor
25229792|NCT02600741|Autonomic Agents|autonomic agents|mesh-ancestor
24845649|NCT02238366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24845650|NCT02238366|Contraceptive Agents|contraceptive agents|mesh-ancestor
24845651|NCT02238366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24845652|NCT02238366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845653|NCT02238366|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24845654|NCT02238366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24845655|NCT02238366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24845657|NCT02238392|Analgesics|analgesics|mesh-ancestor
24845658|NCT02238392|Sensory System Agents|sensory system agents|mesh-ancestor
25868816|NCT00113256|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25868817|NCT00113256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24858702|NCT02299115|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24546211|NCT00697138|Adrenergic Agents|adrenergic agents|mesh-ancestor
24546212|NCT00697138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24546213|NCT00697138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800402|NCT01975441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24546214|NCT00697138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24546216|NCT00697138|Autonomic Agents|autonomic agents|mesh-ancestor
24546217|NCT00697138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24546218|NCT00697138|Dopamine Agents|dopamine agents|mesh-ancestor
24546219|NCT00697138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24546220|NCT00697151|Aspirin|aspirin|mesh-list
24546221|NCT00697151|Warfarin|warfarin|mesh-list
24546266|NCT00697437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868818|NCT00113256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868819|NCT00113256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868820|NCT00113282|Interleukin-2|interleukin-2|mesh-list
25868821|NCT00113282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24546274|NCT00697437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24546276|NCT00697437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24546277|NCT00697450|Insulin Detemir|insulin detemir|mesh-list
25671006|NCT03336216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671007|NCT03336216|Tubulin Modulators|tubulin modulators|mesh-ancestor
24546278|NCT00697450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24546279|NCT00697450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671008|NCT03336216|Antimitotic Agents|antimitotic agents|mesh-ancestor
25671009|NCT03336216|Mitosis Modulators|mitosis modulators|mesh-ancestor
25868825|NCT00113282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858710|NCT02299115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858712|NCT02299115|Autonomic Agents|autonomic agents|mesh-ancestor
24858713|NCT02299115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858714|NCT02299115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24858715|NCT02299115|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24858716|NCT02299115|Protective Agents|protective agents|mesh-ancestor
24858717|NCT02299115|Anticonvulsants|anticonvulsants|mesh-ancestor
24858718|NCT02299115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24858719|NCT02299115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229793|NCT02600741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229794|NCT02600741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25229795|NCT02600741|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25229796|NCT02600741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25229797|NCT02600741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25229798|NCT02600741|Antidepressive Agents|antidepressive agents|mesh-ancestor
25229799|NCT02600741|Dopamine Agonists|dopamine agonists|mesh-ancestor
25222599|NCT02644421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229800|NCT02600741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25229801|NCT02600741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25229802|NCT02600741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24858720|NCT02299115|GABA Agents|gaba agents|mesh-ancestor
24858721|NCT02299115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24858722|NCT02299232|Dexmedetomidine|dexmedetomidine|mesh-list
24858723|NCT02299232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24858724|NCT02299232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24858725|NCT02299232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858726|NCT02299232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24858727|NCT02299232|Analgesics|analgesics|mesh-ancestor
24858728|NCT02299232|Sensory System Agents|sensory system agents|mesh-ancestor
24858729|NCT02299232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858730|NCT02299232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24562882|NCT00768729|Sirolimus|sirolimus|mesh-list
25868826|NCT00113282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868827|NCT00113347|Docetaxel|docetaxel|mesh-list
25868828|NCT00113347|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25868829|NCT00113347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24546289|NCT00697502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24546290|NCT00697502|Antimetabolites|antimetabolites|mesh-ancestor
24858737|NCT02299245|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24858738|NCT02299245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24858739|NCT02299245|Antimetabolites|antimetabolites|mesh-ancestor
24858740|NCT02299245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858741|NCT02299245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24858742|NCT02299245|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24858743|NCT02299245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461231|NCT00351546|Vildagliptin|vildagliptin|mesh-list
24461232|NCT00351546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24461233|NCT00351546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671011|NCT03336216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25671012|NCT03336216|Antimetabolites|antimetabolites|mesh-ancestor
24546296|NCT00697567|Vaccines|vaccines|mesh-list
24546309|NCT00697658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546310|NCT00697658|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24546311|NCT00697658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24546312|NCT00697658|Dopamine Agents|dopamine agents|mesh-ancestor
24546313|NCT00697671|Cyclophosphamide|cyclophosphamide|mesh-list
25868830|NCT00113347|Tubulin Modulators|tubulin modulators|mesh-ancestor
25868831|NCT00113347|Antimitotic Agents|antimitotic agents|mesh-ancestor
25868832|NCT00113347|Mitosis Modulators|mitosis modulators|mesh-ancestor
25868833|NCT00113347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546315|NCT00697671|Interleukin-2|interleukin-2|mesh-list
24546316|NCT00697671|Clofarabine|clofarabine|mesh-list
24546317|NCT00697671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24546318|NCT00697671|Immunologic Factors|immunologic factors|mesh-ancestor
24446713|NCT00305734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446714|NCT00305747|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
25868834|NCT00113347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25229803|NCT02600741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25229804|NCT02600741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25229805|NCT02600741|GABA Antagonists|gaba antagonists|mesh-ancestor
25229806|NCT02600741|GABA Agents|gaba agents|mesh-ancestor
25229807|NCT02600741|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25229808|NCT02600650|Testosterone|testosterone|mesh-list
25229809|NCT02600650|Androgens|androgens|mesh-ancestor
25229810|NCT02600650|Hormones|hormones|mesh-ancestor
25229811|NCT02600650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25229812|NCT02600650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229813|NCT02600585|Vaccines|vaccines|mesh-list
25229814|NCT02600585|Immunologic Factors|immunologic factors|mesh-ancestor
25229815|NCT02600585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868835|NCT00113347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24546319|NCT00697671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546320|NCT00697671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24546321|NCT00697671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24546322|NCT00697671|Alkylating Agents|alkylating agents|mesh-ancestor
24546323|NCT00697671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546324|NCT00697671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24546325|NCT00697671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24546326|NCT00697671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24546327|NCT00697671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24546328|NCT00697671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24546329|NCT00697671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24858747|NCT02299271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24858770|NCT02299440|Sensory System Agents|sensory system agents|mesh-ancestor
24858771|NCT02299440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24461245|NCT00351637|Methadone|methadone|mesh-list
24546330|NCT00697671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25876641|NCT03164616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876642|NCT03164616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25876643|NCT03164616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25876644|NCT03164616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25876645|NCT03093428|Pembrolizumab|pembrolizumab|mesh-list
25876646|NCT03093428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25876647|NCT03093428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876648|NCT03073967|Foscarnet|foscarnet|mesh-list
25876649|NCT03073967|Pritelivir|pritelivir|mesh-list
25876650|NCT03073967|Antiviral Agents|antiviral agents|mesh-ancestor
24429328|NCT00243646|Bicalutamide|bicalutamide|mesh-list
25876651|NCT03073967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25876652|NCT03073967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25876653|NCT03073967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25876654|NCT03073967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876655|NCT03073967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876656|NCT02997228|Leucovorin|leucovorin|mesh-list
25876657|NCT02997228|Bevacizumab|bevacizumab|mesh-list
25876658|NCT02997228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25876659|NCT02997228|Fluorouracil|fluorouracil|mesh-list
25229816|NCT02600455|Abatacept|abatacept|mesh-list
25229817|NCT02600455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25229818|NCT02600455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229819|NCT02600455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25229820|NCT02600455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25229821|NCT02600455|Immunologic Factors|immunologic factors|mesh-ancestor
25229822|NCT02600455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229823|NCT02600455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25229824|NCT02600468|Abatacept|abatacept|mesh-list
25229825|NCT02600468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25108433|NCT03132259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108434|NCT03132259|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25108435|NCT03132259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25108436|NCT03132259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25108437|NCT03132259|Adrenergic Agents|adrenergic agents|mesh-ancestor
25108438|NCT03132259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25108439|NCT03132259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868838|NCT00113503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229826|NCT02600468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229827|NCT02600468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868839|NCT00113503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25044014|NCT01171313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25044015|NCT01171313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044016|NCT01171313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044017|NCT01171313|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25044018|NCT01171313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24546341|NCT00697814|Zuclomiphene|zuclomiphene|mesh-list
24546342|NCT00697814|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24546343|NCT00697814|Hormone Antagonists|hormone antagonists|mesh-ancestor
24546344|NCT00697814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25868840|NCT00113503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868841|NCT00113503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25868842|NCT00113503|Immunologic Factors|immunologic factors|mesh-ancestor
25868843|NCT00113503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868844|NCT00113503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25868845|NCT00113542|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
25868846|NCT00113542|Chelating Agents|chelating agents|mesh-ancestor
25868847|NCT00113542|Sequestering Agents|sequestering agents|mesh-ancestor
25868848|NCT00113542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868849|NCT00113542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868850|NCT00113542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25090257|NCT03259542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25868851|NCT00113542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25868852|NCT00113542|Growth Substances|growth substances|mesh-ancestor
25876660|NCT02997228|Oxaliplatin|oxaliplatin|mesh-list
25671013|NCT03336216|Antiviral Agents|antiviral agents|mesh-ancestor
25671014|NCT03336216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25671015|NCT03336216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25671016|NCT03336216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25868853|NCT00113542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868854|NCT00113542|Growth Inhibitors|growth inhibitors|mesh-ancestor
24563013|NCT00769405|Antidotes|antidotes|mesh-ancestor
24447437|NCT00308477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546345|NCT00697814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546347|NCT00697814|Fertility Agents|fertility agents|mesh-ancestor
24546348|NCT00697814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24546349|NCT00697814|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25108443|NCT03132181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25108444|NCT03132181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108445|NCT03132103|Vitamin D|vitamin d|mesh-list
25108446|NCT03132103|Ergocalciferols|ergocalciferols|mesh-list
25108447|NCT03132103|Cholecalciferol|cholecalciferol|mesh-list
24546350|NCT00697814|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24447483|NCT00308594|Antiemetics|antiemetics|mesh-ancestor
24447484|NCT00308594|Autonomic Agents|autonomic agents|mesh-ancestor
25868855|NCT00113542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447485|NCT00308594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25868856|NCT00113594|Olanzapine|olanzapine|mesh-list
25868857|NCT00113594|Antiemetics|antiemetics|mesh-ancestor
25868858|NCT00113594|Autonomic Agents|autonomic agents|mesh-ancestor
25868859|NCT00113594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229828|NCT02600468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25229829|NCT02600468|Immunologic Factors|immunologic factors|mesh-ancestor
25229830|NCT02600468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229831|NCT02600468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25229832|NCT02600273|Nicotine|nicotine|mesh-list
25229833|NCT02600273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25229834|NCT02600273|Autonomic Agents|autonomic agents|mesh-ancestor
25229835|NCT02600273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229836|NCT02600273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229837|NCT02600273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25229846|NCT02600247|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25229847|NCT02600247|Tramadol|tramadol|mesh-list
25229848|NCT02600247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25044019|NCT01171313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25044020|NCT01171313|Immunologic Factors|immunologic factors|mesh-ancestor
25044021|NCT01171313|Dopamine Agonists|dopamine agonists|mesh-ancestor
25044022|NCT01170650|Doxorubicin|doxorubicin|mesh-list
25044023|NCT01170650|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25044024|NCT01170650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25044025|NCT01170650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044026|NCT01170650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25044027|NCT01170650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25044028|NCT01170650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25108448|NCT03132103|Vitamins|vitamins|mesh-list
25108449|NCT03132103|Micronutrients|micronutrients|mesh-ancestor
25868860|NCT00113594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108450|NCT03132103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108451|NCT03132103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25044029|NCT01170650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868861|NCT00113594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25868862|NCT00113594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25868863|NCT00113594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25868864|NCT00113594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25868865|NCT00113594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25868866|NCT00113594|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25222618|NCT02644252|Antioxidants|antioxidants|mesh-ancestor
25868867|NCT00113594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24461271|NCT00351715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24461272|NCT00351715|Narcotics|narcotics|mesh-ancestor
24461273|NCT00351715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24461274|NCT00351715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858772|NCT02299440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858773|NCT02299440|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24858774|NCT02299440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24858775|NCT02299440|Anesthetics, General|anesthetics, general|mesh-ancestor
24858776|NCT02299440|Anesthetics|anesthetics|mesh-ancestor
24858777|NCT02299440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24858778|NCT02299440|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24858779|NCT02299440|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24858780|NCT02299440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24858781|NCT02299440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858782|NCT02299518|Cytarabine|cytarabine|mesh-list
24858783|NCT02299518|Etoposide|etoposide|mesh-list
24858784|NCT02299518|Mitoxantrone|mitoxantrone|mesh-list
24858785|NCT02299518|Etoposide phosphate|etoposide phosphate|mesh-list
24858789|NCT02299518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24858790|NCT02299518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24858791|NCT02299518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461275|NCT00351715|Analgesics|analgesics|mesh-ancestor
24461276|NCT00351715|Sensory System Agents|sensory system agents|mesh-ancestor
25868872|NCT00113685|Dextrans|dextrans|mesh-list
25868873|NCT00113685|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25868874|NCT00113685|Anticoagulants|anticoagulants|mesh-ancestor
25868875|NCT00113685|Plasma Substitutes|plasma substitutes|mesh-ancestor
24563093|NCT00770042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24858799|NCT02299518|Analgesics|analgesics|mesh-ancestor
25229861|NCT02600247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25108452|NCT03132103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24858800|NCT02299518|Sensory System Agents|sensory system agents|mesh-ancestor
24858801|NCT02299518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858802|NCT02299557|Phenylephrine|phenylephrine|mesh-list
24858803|NCT02299557|Oxymetazoline|oxymetazoline|mesh-list
25229849|NCT02600247|Analgesics|analgesics|mesh-ancestor
25229850|NCT02600247|Sensory System Agents|sensory system agents|mesh-ancestor
25229851|NCT02600247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229852|NCT02600247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229853|NCT02600247|Antipyretics|antipyretics|mesh-ancestor
25229854|NCT02600247|Anticonvulsants|anticonvulsants|mesh-ancestor
25229855|NCT02600247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25229856|NCT02600247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25229857|NCT02600247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229858|NCT02600247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25229859|NCT02600247|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25044030|NCT01168713|Levofloxacin|levofloxacin|mesh-list
25044032|NCT01168713|Solithromycin|solithromycin|mesh-list
25044033|NCT01168713|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25044034|NCT01168713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25044035|NCT01168713|Renal Agents|renal agents|mesh-ancestor
25044036|NCT01168713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25044037|NCT01168713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25044038|NCT01168713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25044045|NCT01168310|Xhance|xhance|mesh-list
24858804|NCT02299557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24858805|NCT02299557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24858806|NCT02299557|Adrenergic Agents|adrenergic agents|mesh-ancestor
24858807|NCT02299557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24858808|NCT02299557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858809|NCT02299557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858810|NCT02299557|Sympathomimetics|sympathomimetics|mesh-ancestor
24858811|NCT02299557|Autonomic Agents|autonomic agents|mesh-ancestor
24858812|NCT02299557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858813|NCT02299557|Nasal Decongestants|nasal decongestants|mesh-ancestor
24858814|NCT02299557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24858815|NCT02299557|Respiratory System Agents|respiratory system agents|mesh-ancestor
24546367|NCT00697892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546369|NCT00697892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24546370|NCT00697892|Antiviral Agents|antiviral agents|mesh-ancestor
24546371|NCT00697892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24546372|NCT00697892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25671017|NCT03336216|Immunologic Factors|immunologic factors|mesh-ancestor
25671018|NCT03336216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671019|NCT03336216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25671020|NCT03336216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25671021|NCT03336216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24858824|NCT02299687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24858825|NCT02299687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858826|NCT02299726|Spironolactone|spironolactone|mesh-list
24858827|NCT02299726|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24858828|NCT02299726|Hormone Antagonists|hormone antagonists|mesh-ancestor
24858829|NCT02299726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24858830|NCT02299726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858831|NCT02299726|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24858832|NCT02299726|Diuretics|diuretics|mesh-ancestor
24858833|NCT02299726|Natriuretic Agents|natriuretic agents|mesh-ancestor
25229860|NCT02600247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25229865|NCT02600247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25229866|NCT02600247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25229867|NCT02600247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25229868|NCT02600247|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25229869|NCT02600247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25229870|NCT02600247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229871|NCT02600247|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25229872|NCT02600247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25229873|NCT02600247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25229874|NCT02600247|Antidepressive Agents|antidepressive agents|mesh-ancestor
25229875|NCT02600247|Dopamine Agents|dopamine agents|mesh-ancestor
24858834|NCT02299765|Gemcitabine|gemcitabine|mesh-list
24858835|NCT02299765|Carboplatin|carboplatin|mesh-list
24858836|NCT02299765|Gefitinib|gefitinib|mesh-list
24858837|NCT02299765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858838|NCT02299765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24858840|NCT02299765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858844|NCT02299765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25868876|NCT00113685|Blood Substitutes|blood substitutes|mesh-ancestor
25868877|NCT00113698|Enalapril|enalapril|mesh-list
25868878|NCT00113698|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25868879|NCT00113698|Protease Inhibitors|protease inhibitors|mesh-ancestor
25868880|NCT00113698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868881|NCT00113698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868882|NCT00113698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25868883|NCT00113737|Fluoxetine|fluoxetine|mesh-list
25868884|NCT00113737|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25868885|NCT00113737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25868886|NCT00113737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25868887|NCT00113737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868888|NCT00113737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25868889|NCT00113737|Serotonin Agents|serotonin agents|mesh-ancestor
25868890|NCT00113737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868891|NCT00113737|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25868892|NCT00113737|Antidepressive Agents|antidepressive agents|mesh-ancestor
25868893|NCT00113737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25868894|NCT00113737|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25868895|NCT00113737|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25868896|NCT00113737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868897|NCT00113802|Epratuzumab|epratuzumab|mesh-list
25868898|NCT00113802|Antibodies|antibodies|mesh-list
25868899|NCT00113802|Immunologic Factors|immunologic factors|mesh-ancestor
25868900|NCT00113802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868901|NCT00113802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25128898|NCT03044171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128899|NCT03044171|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25128900|NCT03044171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25128901|NCT03044184|Tranylcypromine|tranylcypromine|mesh-list
25128902|NCT03044184|Tranexamic Acid|tranexamic acid|mesh-list
25128903|NCT03044184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25868902|NCT00113802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868903|NCT00113815|Topiramate|topiramate|mesh-list
25868904|NCT00113815|Anticonvulsants|anticonvulsants|mesh-ancestor
25868905|NCT00113815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25868906|NCT00113815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868907|NCT00113828|Cyclosporine|cyclosporine|mesh-list
24858909|NCT02300376|Calcium|calcium|mesh-list
24858910|NCT02300376|Pentetic Acid|pentetic acid|mesh-list
24858911|NCT02300376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24858912|NCT02300376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858913|NCT02300376|Anticoagulants|anticoagulants|mesh-ancestor
24858914|NCT02300376|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24858915|NCT02300376|Chelating Agents|chelating agents|mesh-ancestor
24858916|NCT02300376|Sequestering Agents|sequestering agents|mesh-ancestor
25229876|NCT02600260|Enoxaparin|enoxaparin|mesh-list
25229877|NCT02600260|Enoxaparin sodium|enoxaparin sodium|mesh-list
25229878|NCT02600260|Anticoagulants|anticoagulants|mesh-ancestor
25229879|NCT02600260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25229880|NCT02600260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25229881|NCT02600260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273461|NCT02385435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273463|NCT02385396|Inositol|inositol|mesh-list
25273464|NCT02385396|Hematinics|hematinics|mesh-ancestor
25273465|NCT02385396|Vitamin B Complex|vitamin b complex|mesh-ancestor
24845673|NCT02238418|Micronutrients|micronutrients|mesh-ancestor
24845674|NCT02238418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24845675|NCT02238431|Leuprolide|leuprolide|mesh-list
24845676|NCT02238431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24845677|NCT02238431|Fertility Agents|fertility agents|mesh-ancestor
24845678|NCT02238431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24845679|NCT02238431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845680|NCT02238431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24845681|NCT02238431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858917|NCT02300376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858918|NCT02300376|Antidotes|antidotes|mesh-ancestor
24858919|NCT02300376|Protective Agents|protective agents|mesh-ancestor
24858920|NCT02300376|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24858921|NCT02300428|Ferrous fumarate|ferrous fumarate|mesh-list
24858922|NCT02300428|Ferrous gluconate|ferrous gluconate|mesh-list
24858923|NCT02300428|Trace Elements|trace elements|mesh-ancestor
24858924|NCT02300428|Micronutrients|micronutrients|mesh-ancestor
24858925|NCT02300428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858926|NCT02300428|Hematinics|hematinics|mesh-ancestor
24858927|NCT02300623|Lamivudine|lamivudine|mesh-list
24858928|NCT02300623|Stavudine|stavudine|mesh-list
24858929|NCT02300623|Indinavir|indinavir|mesh-list
24858930|NCT02300623|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24858931|NCT02300623|Interleukin-2|interleukin-2|mesh-list
24858932|NCT02300623|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24858933|NCT02300623|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24546395|NCT00697905|Immunologic Factors|immunologic factors|mesh-ancestor
24546396|NCT00697905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858944|NCT02300623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858945|NCT02300623|Antimetabolites|antimetabolites|mesh-ancestor
24858946|NCT02300623|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24813188|NCT02056847|Calcium, Dietary|calcium, dietary|mesh-list
24813189|NCT02056847|Pitavastatin|pitavastatin|mesh-list
24813191|NCT02056847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24813192|NCT02056847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813193|NCT02056847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24813194|NCT02056847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24813195|NCT02056847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24813196|NCT02056847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24813197|NCT02056847|Antimetabolites|antimetabolites|mesh-ancestor
25671022|NCT03336216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25671023|NCT03336216|Antidotes|antidotes|mesh-ancestor
25671024|NCT03336216|Protective Agents|protective agents|mesh-ancestor
25671025|NCT03336216|Vitamin B Complex|vitamin b complex|mesh-ancestor
25671026|NCT03336216|Vitamins|vitamins|mesh-ancestor
25671027|NCT03336216|Micronutrients|micronutrients|mesh-ancestor
25433694|NCT00433511|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25671028|NCT03282240|Vaccines|vaccines|mesh-list
25868908|NCT00113828|Cyclosporins|cyclosporins|mesh-list
24813198|NCT02056847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813199|NCT02056847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813200|NCT02056847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24813201|NCT02056899|Gabapentin|gabapentin|mesh-list
24813202|NCT02056899|Analgesics|analgesics|mesh-ancestor
24813203|NCT02056899|Sensory System Agents|sensory system agents|mesh-ancestor
24813204|NCT02056899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858964|NCT02300688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24858965|NCT02300688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858967|NCT02300701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24858968|NCT02300701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24858969|NCT02300701|Respiratory System Agents|respiratory system agents|mesh-ancestor
24858970|NCT02300740|Niacinamide|niacinamide|mesh-list
24858971|NCT02300740|Niacin|niacin|mesh-list
24858972|NCT02300740|Nicotinic Acids|nicotinic acids|mesh-list
24858973|NCT02300740|Vitamin B Complex|vitamin b complex|mesh-ancestor
24858974|NCT02300740|Vitamins|vitamins|mesh-ancestor
24858975|NCT02300740|Micronutrients|micronutrients|mesh-ancestor
24858976|NCT02300740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858977|NCT02300740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24858978|NCT02300740|Antimetabolites|antimetabolites|mesh-ancestor
24858979|NCT02300740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858980|NCT02300740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24546399|NCT00697944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24546400|NCT00697944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25229882|NCT02599701|Gabapentin|gabapentin|mesh-list
25229883|NCT02599701|Analgesics|analgesics|mesh-ancestor
25229884|NCT02599701|Sensory System Agents|sensory system agents|mesh-ancestor
25229885|NCT02599701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229886|NCT02599701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229887|NCT02599701|Anticonvulsants|anticonvulsants|mesh-ancestor
25229888|NCT02599701|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25229889|NCT02599701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25229890|NCT02599701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24845684|NCT02238444|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24845686|NCT02238444|Dalteparin|dalteparin|mesh-list
24845687|NCT02238444|Dipyridamole|dipyridamole|mesh-list
24845688|NCT02238444|Warfarin|warfarin|mesh-list
24845689|NCT02238444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25060497|NCT03479450|Pulmonary Surfactants|pulmonary surfactants|mesh-list
24546401|NCT00697944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24546402|NCT00697996|Rituximab|rituximab|mesh-list
24546403|NCT00697996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24546404|NCT00697996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24546405|NCT00697996|Immunologic Factors|immunologic factors|mesh-ancestor
24546406|NCT00697996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546407|NCT00697996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24546408|NCT00698126|Insulin|insulin|mesh-list
24546409|NCT00698126|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24546410|NCT00698126|Insulin Aspart|insulin aspart|mesh-list
24546411|NCT00698126|Biphasic Insulins|biphasic insulins|mesh-list
24546412|NCT00698126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24546413|NCT00698126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546422|NCT00698269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24546426|NCT00698334|Ethambutol|ethambutol|mesh-list
24546427|NCT00698334|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24563335|NCT00771199|Fentanyl|fentanyl|mesh-list
24546439|NCT00698334|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24546440|NCT00698334|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24546442|NCT00698425|Sodium Citrate|sodium citrate|mesh-list
24546443|NCT00698425|Anticoagulants|anticoagulants|mesh-ancestor
24858987|NCT02300935|Paclitaxel|paclitaxel|mesh-list
24858988|NCT02300935|Trametinib|trametinib|mesh-list
24858989|NCT02300935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24858990|NCT02300935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858991|NCT02300935|Tubulin Modulators|tubulin modulators|mesh-ancestor
24858992|NCT02300935|Antimitotic Agents|antimitotic agents|mesh-ancestor
24858993|NCT02300935|Mitosis Modulators|mitosis modulators|mesh-ancestor
24858994|NCT02300935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858995|NCT02300935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24858996|NCT02300935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24858997|NCT02300948|Folic Acid|folic acid|mesh-list
24858998|NCT02300948|Vitamin B Complex|vitamin b complex|mesh-list
24858999|NCT02300948|Hematinics|hematinics|mesh-ancestor
24859000|NCT02300948|Vitamins|vitamins|mesh-ancestor
24859001|NCT02300948|Micronutrients|micronutrients|mesh-ancestor
24461482|NCT00352430|Vasodilator Agents|vasodilator agents|mesh-ancestor
24546444|NCT00698425|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24546445|NCT00698425|Chelating Agents|chelating agents|mesh-ancestor
24546446|NCT00698425|Sequestering Agents|sequestering agents|mesh-ancestor
24546487|NCT00698724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24546488|NCT00698724|Protective Agents|protective agents|mesh-ancestor
24546489|NCT00698724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24546493|NCT00698724|Analgesics|analgesics|mesh-ancestor
24546494|NCT00698724|Sensory System Agents|sensory system agents|mesh-ancestor
24546495|NCT00698724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24546496|NCT00698763|Simendan|simendan|mesh-list
24546530|NCT00699023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25229891|NCT02599701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25229892|NCT02599701|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25229893|NCT02599701|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25229894|NCT02599701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25229895|NCT02599701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229896|NCT02599701|Antimanic Agents|antimanic agents|mesh-ancestor
25229897|NCT02599675|Vitamin D|vitamin d|mesh-list
25229898|NCT02599675|Cholecalciferol|cholecalciferol|mesh-list
25229899|NCT02599675|Vitamins|vitamins|mesh-ancestor
25229900|NCT02599675|Micronutrients|micronutrients|mesh-ancestor
25273466|NCT02385396|Vitamins|vitamins|mesh-ancestor
24546551|NCT00699049|Cholinergic Agents|cholinergic agents|mesh-ancestor
24546552|NCT00699049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24546567|NCT00699062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546569|NCT00699114|Ibuprofen|ibuprofen|mesh-list
24546570|NCT00699114|Codeine|codeine|mesh-list
24546571|NCT00699114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24546572|NCT00699114|Analgesics|analgesics|mesh-ancestor
24546573|NCT00699114|Sensory System Agents|sensory system agents|mesh-ancestor
24546574|NCT00699114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24800383|NCT01975363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24800384|NCT01975363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24800386|NCT01975363|Sensory System Agents|sensory system agents|mesh-ancestor
24800397|NCT01975441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24800398|NCT01975441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24800399|NCT01975441|Anthelmintics|anthelmintics|mesh-ancestor
24800400|NCT01975441|Anticestodal Agents|anticestodal agents|mesh-ancestor
24800401|NCT01975441|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24800403|NCT01975441|Tubulin Modulators|tubulin modulators|mesh-ancestor
24800404|NCT01975441|Antimitotic Agents|antimitotic agents|mesh-ancestor
24800405|NCT01975441|Mitosis Modulators|mitosis modulators|mesh-ancestor
24800416|NCT01975454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800417|NCT01975454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800418|NCT01975480|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24800448|NCT01975727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800449|NCT01975727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24800450|NCT01975727|Glucocorticoids|glucocorticoids|mesh-ancestor
24800451|NCT01975727|Hormones|hormones|mesh-ancestor
24800452|NCT01975727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24800453|NCT01975727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24800454|NCT01975727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800455|NCT01975727|Protease Inhibitors|protease inhibitors|mesh-ancestor
24800456|NCT01975727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800457|NCT01975727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800458|NCT01975753|Fentanyl|fentanyl|mesh-list
24800459|NCT01975753|Morphine|morphine|mesh-list
24800460|NCT01975753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24800461|NCT01975753|Narcotics|narcotics|mesh-ancestor
24800462|NCT01975753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24800463|NCT01975753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546575|NCT00699114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546576|NCT00699114|Antipyretics|antipyretics|mesh-ancestor
25671029|NCT03282240|Immunologic Factors|immunologic factors|mesh-ancestor
24546577|NCT00699114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24546616|NCT00699361|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24546617|NCT00699361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24546618|NCT00699361|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24546619|NCT00699361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24546620|NCT00699361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229901|NCT02599675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229902|NCT02599675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25229903|NCT02599675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25229904|NCT02599779|Pembrolizumab|pembrolizumab|mesh-list
25229905|NCT02599779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25229906|NCT02599779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25229907|NCT02599857|Bisoprolol|bisoprolol|mesh-list
24546621|NCT00699387|Benzonidazole|benzonidazole|mesh-list
24546622|NCT00699387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24546623|NCT00699387|Immunologic Factors|immunologic factors|mesh-ancestor
24546624|NCT00699387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546625|NCT00699387|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24546626|NCT00699387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24546627|NCT00699387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24546628|NCT00699387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25868909|NCT00113828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24546672|NCT00699530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24546673|NCT00699530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546674|NCT00699530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546676|NCT00699634|Antiemetics|antiemetics|mesh-ancestor
24546677|NCT00699634|Autonomic Agents|autonomic agents|mesh-ancestor
24546678|NCT00699634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24546679|NCT00699634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546680|NCT00699634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24546681|NCT00699634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24546682|NCT00699634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24546683|NCT00699634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24546684|NCT00699634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24546685|NCT00699686|Insulin Glargine|insulin glargine|mesh-list
24546686|NCT00699686|Insulin Detemir|insulin detemir|mesh-list
24546687|NCT00699686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24546688|NCT00699686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546690|NCT00699764|Immunologic Factors|immunologic factors|mesh-ancestor
24546691|NCT00699764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546692|NCT00699777|Risedronic Acid|risedronic acid|mesh-list
24546693|NCT00699777|Etidronic Acid|etidronic acid|mesh-list
24546694|NCT00699777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24546695|NCT00699777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24546696|NCT00699777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868910|NCT00113828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868911|NCT00113828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25868912|NCT00113828|Immunologic Factors|immunologic factors|mesh-ancestor
25868913|NCT00113828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868914|NCT00113828|Antifungal Agents|antifungal agents|mesh-ancestor
25868915|NCT00113828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25868916|NCT00113828|Dermatologic Agents|dermatologic agents|mesh-ancestor
25868917|NCT00113828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24546770|NCT00700154|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24546771|NCT00700154|Insulin Aspart|insulin aspart|mesh-list
24546772|NCT00700154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24546778|NCT00700284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24546779|NCT00700284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24546780|NCT00700284|Antiviral Agents|antiviral agents|mesh-ancestor
24546781|NCT00700284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24546810|NCT00700492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229908|NCT02599857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25229909|NCT02599857|Sympatholytics|sympatholytics|mesh-ancestor
25229910|NCT02599857|Autonomic Agents|autonomic agents|mesh-ancestor
25229911|NCT02599857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229912|NCT02599857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229913|NCT02599857|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25229914|NCT02599857|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25229915|NCT02599857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25229916|NCT02599857|Adrenergic Agents|adrenergic agents|mesh-ancestor
25229917|NCT02599857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845690|NCT02238444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24845692|NCT02238444|Sensory System Agents|sensory system agents|mesh-ancestor
24845693|NCT02238444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24546811|NCT00700518|Nitroglycerin|nitroglycerin|mesh-list
24546812|NCT00700518|Vasodilator Agents|vasodilator agents|mesh-ancestor
24546813|NCT00700544|Norethandrolone|norethandrolone|mesh-list
24546814|NCT00700544|Anabolic Agents|anabolic agents|mesh-ancestor
24563577|NCT00772499|Hydralazine|hydralazine|mesh-list
24546825|NCT00700583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24546826|NCT00700583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546870|NCT00700921|Antimetabolites|antimetabolites|mesh-ancestor
24546871|NCT00700921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546872|NCT00700921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24546873|NCT00700921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24546874|NCT00700921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24546875|NCT00700947|Metoprolol|metoprolol|mesh-list
24546876|NCT00700947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24546877|NCT00700947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24546878|NCT00700947|Adrenergic Agents|adrenergic agents|mesh-ancestor
24546879|NCT00700947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24590354|NCT00912171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24546880|NCT00700947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868918|NCT00113828|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25868919|NCT00113854|Mannitol|mannitol|mesh-list
25868920|NCT00113854|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25868921|NCT00113854|Diuretics|diuretics|mesh-ancestor
25868922|NCT00113854|Natriuretic Agents|natriuretic agents|mesh-ancestor
25868923|NCT00113854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868924|NCT00113906|Melatonin|melatonin|mesh-list
24546881|NCT00700947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546882|NCT00700947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24546883|NCT00700947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24546884|NCT00700947|Sympatholytics|sympatholytics|mesh-ancestor
24546885|NCT00700947|Autonomic Agents|autonomic agents|mesh-ancestor
24546911|NCT00701233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800466|NCT01975753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24546930|NCT00701285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546931|NCT00701285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24546932|NCT00701285|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24546933|NCT00701285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868925|NCT00113906|Antioxidants|antioxidants|mesh-ancestor
25868926|NCT00113906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868927|NCT00113906|Protective Agents|protective agents|mesh-ancestor
25868928|NCT00113906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868929|NCT00113906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25868930|NCT00113945|Cinacalcet|cinacalcet|mesh-list
25868931|NCT00113945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25868932|NCT00113945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868933|NCT00113945|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25868934|NCT00113945|Hormone Antagonists|hormone antagonists|mesh-ancestor
24958699|NCT03830385|Carboplatin|carboplatin|mesh-list
25868935|NCT00113945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25868936|NCT00113958|Cinacalcet|cinacalcet|mesh-list
25868937|NCT00113958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25868938|NCT00113958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868939|NCT00113958|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25868940|NCT00113958|Hormone Antagonists|hormone antagonists|mesh-ancestor
25876661|NCT02997228|Atezolizumab|atezolizumab|mesh-list
24546942|NCT00701298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24546943|NCT00701298|Immunologic Factors|immunologic factors|mesh-ancestor
24546944|NCT00701298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546945|NCT00701298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25229918|NCT02599857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229919|NCT02599792|Ivacaftor|ivacaftor|mesh-list
25229920|NCT02599792|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25229921|NCT02599792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25229922|NCT02599792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229923|NCT02599532|Apixaban|apixaban|mesh-list
25229924|NCT02599532|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25229925|NCT02599532|Antithrombins|antithrombins|mesh-ancestor
24845694|NCT02238444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845695|NCT02238444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24845696|NCT02238444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24845697|NCT02238444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24845698|NCT02238444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24845699|NCT02238444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845700|NCT02238444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24845701|NCT02238444|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24845702|NCT02238444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24845703|NCT02238444|Antipyretics|antipyretics|mesh-ancestor
24845704|NCT02238444|Anticoagulants|anticoagulants|mesh-ancestor
25060529|NCT03479086|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24546946|NCT00701298|Antimetabolites|antimetabolites|mesh-ancestor
24800486|NCT01975961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800487|NCT01975961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24800488|NCT01975961|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24800489|NCT01975961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800490|NCT01975961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24800491|NCT01975961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24800492|NCT01975961|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24800493|NCT01976078|Midazolam|midazolam|mesh-list
24800494|NCT01976078|Esomeprazole|esomeprazole|mesh-list
24800495|NCT01976078|Ranitidine|ranitidine|mesh-list
24800496|NCT01976078|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
24800497|NCT01976078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24800498|NCT01976078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24800499|NCT01976078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24800500|NCT01976078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800501|NCT01976078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24800502|NCT01976078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24800503|NCT01976078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24800504|NCT01976078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24550989|NCT00723502|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24550990|NCT00723502|Renal Agents|renal agents|mesh-ancestor
24550991|NCT00723502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24550992|NCT00723502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24550993|NCT00723502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550995|NCT00723515|Listerine|listerine|mesh-list
24800507|NCT01976078|GABA Modulators|gaba modulators|mesh-ancestor
24800508|NCT01976078|GABA Agents|gaba agents|mesh-ancestor
24800509|NCT01976078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24800510|NCT01976078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800511|NCT01976078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24800512|NCT01976078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24800513|NCT01976078|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24800514|NCT01976078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24551026|NCT00723658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24551027|NCT00723658|Antiemetics|antiemetics|mesh-ancestor
24551028|NCT00723658|Autonomic Agents|autonomic agents|mesh-ancestor
24547002|NCT00701857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547003|NCT00701857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547004|NCT00701857|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24547005|NCT00701857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25671030|NCT03282240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129455|NCT03040830|Hormones|hormones|mesh-ancestor
24547006|NCT00701909|Ketamine|ketamine|mesh-list
24547007|NCT00701909|Morphine|morphine|mesh-list
24547008|NCT00701909|Analgesics|analgesics|mesh-ancestor
24547038|NCT00702091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547039|NCT00702091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24547040|NCT00702117|Flecainide|flecainide|mesh-list
24547041|NCT00702117|Procainamide|procainamide|mesh-list
25229926|NCT02599532|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24547042|NCT00702117|Ajmaline|ajmaline|mesh-list
24547043|NCT00702117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25229927|NCT02599532|Protease Inhibitors|protease inhibitors|mesh-ancestor
25229928|NCT02599532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229929|NCT02599532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229930|NCT02599532|Anticoagulants|anticoagulants|mesh-ancestor
25229931|NCT02599571|Nicotine|nicotine|mesh-list
25229932|NCT02599571|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25229933|NCT02599571|Autonomic Agents|autonomic agents|mesh-ancestor
25229934|NCT02599571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229935|NCT02599571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229936|NCT02599571|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25229937|NCT02599571|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24845705|NCT02238444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24845706|NCT02238444|Vasodilator Agents|vasodilator agents|mesh-ancestor
24845707|NCT02238457|Losartan|losartan|mesh-list
24845708|NCT02238457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24845709|NCT02238457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24845710|NCT02238457|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24845711|NCT02238457|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25060542|NCT03478709|Sympathomimetics|sympathomimetics|mesh-ancestor
24547044|NCT00702117|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24547045|NCT00702117|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24547046|NCT00702117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24547066|NCT00702156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24547067|NCT00702156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547120|NCT00702481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24547121|NCT00702572|Paclitaxel|paclitaxel|mesh-list
24547122|NCT00702572|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24547123|NCT00702572|Bevacizumab|bevacizumab|mesh-list
25222689|NCT02643563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24547124|NCT00702572|Carboplatin|carboplatin|mesh-list
24547125|NCT00702572|Vorinostat|vorinostat|mesh-list
24547126|NCT00702572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24547127|NCT00702572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547128|NCT00702572|Tubulin Modulators|tubulin modulators|mesh-ancestor
24547129|NCT00702572|Antimitotic Agents|antimitotic agents|mesh-ancestor
24547130|NCT00702572|Mitosis Modulators|mitosis modulators|mesh-ancestor
24547131|NCT00702572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547132|NCT00702572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24547133|NCT00702572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24547134|NCT00702572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24800515|NCT01976078|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24800516|NCT01976078|Histamine Antagonists|histamine antagonists|mesh-ancestor
24800517|NCT01976078|Histamine Agents|histamine agents|mesh-ancestor
24800518|NCT01976143|Etirinotecan pegol|etirinotecan pegol|mesh-list
24800519|NCT01976143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800520|NCT01976143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24800521|NCT01976143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24800522|NCT01976143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800523|NCT01976143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547163|NCT00702767|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24547164|NCT00702767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24446738|NCT00305812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446739|NCT00305812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24446740|NCT00305812|Glucocorticoids|glucocorticoids|mesh-ancestor
24446741|NCT00305812|Hormones|hormones|mesh-ancestor
24446742|NCT00305812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25868941|NCT00113958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25868942|NCT00113971|Epratuzumab|epratuzumab|mesh-list
25868943|NCT00113971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25868944|NCT00113971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547166|NCT00702793|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24547167|NCT00702793|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24547168|NCT00702793|Cholinergic Agents|cholinergic agents|mesh-ancestor
24547169|NCT00702793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25409526|NCT03371667|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24547170|NCT00702793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868945|NCT00113984|Metronidazole|metronidazole|mesh-list
25868947|NCT00113984|Sargramostim|sargramostim|mesh-list
24547171|NCT00702793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547173|NCT00702819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24547174|NCT00702819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547175|NCT00702819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24547176|NCT00702819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24547177|NCT00702819|Growth Substances|growth substances|mesh-ancestor
24547178|NCT00702819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868948|NCT00113984|Immunologic Factors|immunologic factors|mesh-ancestor
25229938|NCT02599571|Cholinergic Agents|cholinergic agents|mesh-ancestor
25229939|NCT02599571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25229940|NCT02599571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229941|NCT02599623|Anesthetics|anesthetics|mesh-list
25229942|NCT02599623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25229943|NCT02599623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229944|NCT02599493|Rifampin|rifampin|mesh-list
25229945|NCT02599493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24845712|NCT02238457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845714|NCT02238470|Rivaroxaban|rivaroxaban|mesh-list
24714019|NCT01528800|Vitamins|vitamins|mesh-ancestor
25868949|NCT00113984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868950|NCT00113984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868951|NCT00113984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25868952|NCT00113984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24800527|NCT01976182|Immunologic Factors|immunologic factors|mesh-ancestor
24800528|NCT01976182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800529|NCT01976182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25222695|NCT02643563|Adrenergic Agents|adrenergic agents|mesh-ancestor
25222696|NCT02643563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24800530|NCT01976182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24800531|NCT01976182|Alkylating Agents|alkylating agents|mesh-ancestor
24800532|NCT01976182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800533|NCT01976182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800534|NCT01976182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24800535|NCT01976182|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24800536|NCT01976182|Abortifacient Agents|abortifacient agents|mesh-ancestor
24800537|NCT01976182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24800538|NCT01976182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24800539|NCT01976182|Antimetabolites|antimetabolites|mesh-ancestor
24551150|NCT00724113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24551152|NCT00724113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25868953|NCT00113984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868954|NCT00113984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25868955|NCT00113984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25868956|NCT00113984|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25868957|NCT00113984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25868958|NCT00114010|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25868959|NCT00114010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25868960|NCT00114010|Immunologic Factors|immunologic factors|mesh-ancestor
25868961|NCT00114010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868962|NCT00114010|Antacids|antacids|mesh-ancestor
25868963|NCT00114010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868964|NCT00114010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25868965|NCT00114023|Imiquimod|imiquimod|mesh-list
25868966|NCT00114023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24547224|NCT00703079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24547225|NCT00703079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547228|NCT00703144|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24547229|NCT00703144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24547230|NCT00703144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24547250|NCT00703196|Hematinics|hematinics|mesh-ancestor
24547251|NCT00703196|Vitamin B Complex|vitamin b complex|mesh-ancestor
24547253|NCT00703196|Micronutrients|micronutrients|mesh-ancestor
24547254|NCT00703196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868967|NCT00114023|Immunologic Factors|immunologic factors|mesh-ancestor
24547267|NCT00703300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24547269|NCT00703300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547270|NCT00703300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547271|NCT00703313|Moxifloxacin|moxifloxacin|mesh-list
24547272|NCT00703313|Levofloxacin|levofloxacin|mesh-list
24547273|NCT00703313|Ofloxacin|ofloxacin|mesh-list
25868968|NCT00114023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547274|NCT00703313|Gatifloxacin|gatifloxacin|mesh-list
25868969|NCT00114023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868970|NCT00114023|Interferon Inducers|interferon inducers|mesh-ancestor
25868971|NCT00114153|Carboplatin|carboplatin|mesh-list
25868972|NCT00114153|Capecitabine|capecitabine|mesh-list
25868973|NCT00114153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868974|NCT00114153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25868975|NCT00114153|Antimetabolites|antimetabolites|mesh-ancestor
25868976|NCT00114153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25868977|NCT00114179|Gemcitabine|gemcitabine|mesh-list
25868978|NCT00114179|Bevacizumab|bevacizumab|mesh-list
25868979|NCT00114179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25868980|NCT00114179|Capecitabine|capecitabine|mesh-list
25868981|NCT00114179|Antibodies|antibodies|mesh-list
25229946|NCT02599493|Antitubercular Agents|antitubercular agents|mesh-ancestor
25229947|NCT02599493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25229948|NCT02599493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25229949|NCT02599493|Leprostatic Agents|leprostatic agents|mesh-ancestor
24845715|NCT02238470|Dabigatran|dabigatran|mesh-list
24845739|NCT02238639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845740|NCT02238639|Hemostatics|hemostatics|mesh-ancestor
24845741|NCT02238639|Coagulants|coagulants|mesh-ancestor
24845742|NCT02238704|Calcium, Dietary|calcium, dietary|mesh-list
24845744|NCT02238704|Folic Acid|folic acid|mesh-list
24845745|NCT02238704|Vitamin B Complex|vitamin b complex|mesh-list
24845746|NCT02238704|Calcium|calcium|mesh-list
24845747|NCT02238704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24845748|NCT02238704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845749|NCT02238704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24845750|NCT02238704|Trace Elements|trace elements|mesh-ancestor
24845751|NCT02238704|Micronutrients|micronutrients|mesh-ancestor
24845752|NCT02238704|Hematinics|hematinics|mesh-ancestor
24845753|NCT02238704|Vitamins|vitamins|mesh-ancestor
24845754|NCT02238717|Pregabalin|pregabalin|mesh-list
24845755|NCT02238717|PF-06372865|pf-06372865|mesh-list
25868982|NCT00114179|Immunoglobulins|immunoglobulins|mesh-list
25868983|NCT00114179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25868984|NCT00114179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25868985|NCT00114179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24547275|NCT00703313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24547276|NCT00703313|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24547277|NCT00703313|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24547278|NCT00703313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24800584|NCT01976611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24800585|NCT01976611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800586|NCT01976611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24800587|NCT01976611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24800588|NCT01976676|Folic Acid|folic acid|mesh-list
24800589|NCT01976676|Hematinics|hematinics|mesh-ancestor
24800590|NCT01976676|Vitamin B Complex|vitamin b complex|mesh-ancestor
24800591|NCT01976676|Vitamins|vitamins|mesh-ancestor
24800592|NCT01976676|Micronutrients|micronutrients|mesh-ancestor
24547350|NCT00703586|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24547351|NCT00703586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547352|NCT00703586|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24800593|NCT01976676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800594|NCT01976780|Artesunate|artesunate|mesh-list
24800595|NCT01976780|Lumefantrine|lumefantrine|mesh-list
24800596|NCT01976780|Artemether|artemether|mesh-list
24800597|NCT01976780|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24800599|NCT01976780|Antimalarials|antimalarials|mesh-ancestor
24800600|NCT01976780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24800601|NCT01976780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24800602|NCT01976780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24800603|NCT01976780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800604|NCT01976780|Antiviral Agents|antiviral agents|mesh-ancestor
24800605|NCT01976780|Schistosomicides|schistosomicides|mesh-ancestor
24800606|NCT01976780|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25868986|NCT00114179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25868987|NCT00114179|Growth Substances|growth substances|mesh-ancestor
24547470|NCT00704223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24547471|NCT00704223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547473|NCT00704249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24547474|NCT00704249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24547475|NCT00704249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229950|NCT02599493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25868988|NCT00114179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25868989|NCT00114179|Growth Inhibitors|growth inhibitors|mesh-ancestor
25868990|NCT00114179|Immunologic Factors|immunologic factors|mesh-ancestor
25229951|NCT02599493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229952|NCT02599493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229953|NCT02599493|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25229954|NCT02599493|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25229955|NCT02599493|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25229956|NCT02599493|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25229957|NCT02599493|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25229958|NCT02599493|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25229959|NCT02599311|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25229960|NCT02599311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25229961|NCT02599311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25229962|NCT02599311|Cholinergic Agents|cholinergic agents|mesh-ancestor
25229963|NCT02599311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845778|NCT02238860|Antiviral Agents|antiviral agents|mesh-ancestor
24845779|NCT02238860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24845780|NCT02238860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24845781|NCT02238860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25868991|NCT00114179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25868992|NCT00114179|Antimetabolites|antimetabolites|mesh-ancestor
24547517|NCT00704366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547519|NCT00704392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547533|NCT00704509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800608|NCT01976923|Bevacizumab|bevacizumab|mesh-list
24800609|NCT01976923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24800610|NCT01976923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800611|NCT01976923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24800612|NCT01976923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24800613|NCT01976923|Growth Substances|growth substances|mesh-ancestor
24551434|NCT00726687|Capecitabine|capecitabine|mesh-list
25868993|NCT00114179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547543|NCT00704574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24547546|NCT00704600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24547547|NCT00704600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24547548|NCT00704600|Protease Inhibitors|protease inhibitors|mesh-ancestor
24547549|NCT00704600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547550|NCT00704600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547551|NCT00704600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24547552|NCT00704600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24547553|NCT00704600|Antiviral Agents|antiviral agents|mesh-ancestor
24547554|NCT00704600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24547555|NCT00704639|Carboplatin|carboplatin|mesh-list
24547556|NCT00704639|Cetuximab|cetuximab|mesh-list
24547557|NCT00704639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547558|NCT00704639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24547559|NCT00704665|Methocarbamol|methocarbamol|mesh-list
24547560|NCT00704665|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24547561|NCT00704665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547562|NCT00704665|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25868994|NCT00114179|Antiviral Agents|antiviral agents|mesh-ancestor
25868995|NCT00114179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25868996|NCT00114179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25868997|NCT00114179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25868998|NCT00114192|Thalidomide|thalidomide|mesh-list
25868999|NCT00114192|Docetaxel|docetaxel|mesh-list
25869000|NCT00114192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547595|NCT00704756|Interferon-alpha|interferon-alpha|mesh-list
24547596|NCT00704756|Antimetabolites|antimetabolites|mesh-ancestor
24547598|NCT00704756|Antiviral Agents|antiviral agents|mesh-ancestor
25869001|NCT00114192|Tubulin Modulators|tubulin modulators|mesh-ancestor
25869002|NCT00114192|Antimitotic Agents|antimitotic agents|mesh-ancestor
25869003|NCT00114192|Mitosis Modulators|mitosis modulators|mesh-ancestor
25869004|NCT00114192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564868|NCT00778063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24547615|NCT00704899|Analgesics|analgesics|mesh-ancestor
25869005|NCT00114192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24547636|NCT00704951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24547637|NCT00704951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24547638|NCT00704951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25869006|NCT00114192|Immunologic Factors|immunologic factors|mesh-ancestor
24547641|NCT00704951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547642|NCT00704951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24547700|NCT00705315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25229964|NCT02599311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129786|NCT03038282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129787|NCT03038282|Antioxidants|antioxidants|mesh-ancestor
25129788|NCT03038282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129789|NCT03038282|Protective Agents|protective agents|mesh-ancestor
25129790|NCT03038217|Capecitabine|capecitabine|mesh-list
25129791|NCT03038217|Oxaliplatin|oxaliplatin|mesh-list
25129792|NCT03038217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24628343|NCT01098344|Immunologic Factors|immunologic factors|mesh-ancestor
25129794|NCT03038217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129815|NCT03038334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25129816|NCT03038334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859284|NCT02302768|Micronutrients|micronutrients|mesh-ancestor
25229965|NCT02599311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229966|NCT02599311|Urological Agents|urological agents|mesh-ancestor
25229967|NCT02599480|Mirabegron|mirabegron|mesh-list
25229968|NCT02599480|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25229969|NCT02599480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25229970|NCT02599480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25229971|NCT02599480|Adrenergic Agents|adrenergic agents|mesh-ancestor
24845785|NCT02238860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24845786|NCT02239107|Acetylcysteine|acetylcysteine|mesh-list
24845787|NCT02239107|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24845788|NCT02239107|Antiviral Agents|antiviral agents|mesh-ancestor
24845789|NCT02239107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446764|NCT00305825|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24547701|NCT00705315|Growth Substances|growth substances|mesh-ancestor
24547706|NCT00705315|Mitosis Modulators|mitosis modulators|mesh-ancestor
25222720|NCT02643823|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24547707|NCT00705315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547708|NCT00705315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24547709|NCT00705315|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24547710|NCT00705315|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24547711|NCT00705315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547712|NCT00705354|Bacitracin|bacitracin|mesh-list
24547713|NCT00705354|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24547714|NCT00705354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24547715|NCT00705354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24547716|NCT00705419|Tenofovir|tenofovir|mesh-list
24547717|NCT00705419|Emtricitabine|emtricitabine|mesh-list
24547718|NCT00705419|Maleic acid|maleic acid|mesh-list
24547719|NCT00705419|Antiviral Agents|antiviral agents|mesh-ancestor
24547720|NCT00705419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24547721|NCT00705419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24800616|NCT01976936|Lovastatin|lovastatin|mesh-list
24800617|NCT01976936|L 647318|l 647318|mesh-list
24800629|NCT01977118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800631|NCT01977209|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24800632|NCT01977209|Contraceptive Agents|contraceptive agents|mesh-ancestor
25869007|NCT00114192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869008|NCT00114192|Leprostatic Agents|leprostatic agents|mesh-ancestor
25869009|NCT00114192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25869010|NCT00114192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25869011|NCT00114192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25869012|NCT00114192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25869013|NCT00114192|Growth Substances|growth substances|mesh-ancestor
24547733|NCT00705471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24800646|NCT01977300|Serotonin Agents|serotonin agents|mesh-ancestor
24800647|NCT01977300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24547736|NCT00705510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24547737|NCT00705510|Cyclosporins|cyclosporins|mesh-list
24547738|NCT00705510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25869014|NCT00114192|Growth Inhibitors|growth inhibitors|mesh-ancestor
25229972|NCT02599480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25229973|NCT02599480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671031|NCT03263429|Irinotecan|irinotecan|mesh-list
25671032|NCT03263429|Panitumumab|panitumumab|mesh-list
25671033|NCT03263429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25671034|NCT03263429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25671035|NCT03263429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25671036|NCT03263429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671037|NCT03263429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671038|NCT03263429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25671039|NCT03260868|Insulin|insulin|mesh-list
25671040|NCT03260868|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25671041|NCT03260868|Insulin Glargine|insulin glargine|mesh-list
25409527|NCT03371667|Abortifacient Agents|abortifacient agents|mesh-ancestor
25671042|NCT03260868|Insulin Lispro|insulin lispro|mesh-list
25869015|NCT00114205|Docetaxel|docetaxel|mesh-list
25129913|NCT03038009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129914|NCT03037606|Rabeprazole|rabeprazole|mesh-list
25129915|NCT03037606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25129920|NCT03037593|Vitamin D|vitamin d|mesh-list
25229974|NCT02599480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229975|NCT02599480|Urological Agents|urological agents|mesh-ancestor
25229976|NCT02599337|Sorafenib|sorafenib|mesh-list
25229977|NCT02599337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25229978|NCT02599337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25229979|NCT02599337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24845791|NCT02239107|Respiratory System Agents|respiratory system agents|mesh-ancestor
24845792|NCT02239107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24845793|NCT02239107|Antioxidants|antioxidants|mesh-ancestor
25869016|NCT00114205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25869017|NCT00114205|Tubulin Modulators|tubulin modulators|mesh-ancestor
25869018|NCT00114205|Antimitotic Agents|antimitotic agents|mesh-ancestor
25869019|NCT00114205|Mitosis Modulators|mitosis modulators|mesh-ancestor
25869020|NCT00114205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869021|NCT00114257|Decitabine|decitabine|mesh-list
25869022|NCT00114257|Romidepsin|romidepsin|mesh-list
25869023|NCT00114257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24547746|NCT00705510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24547747|NCT00705510|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24547748|NCT00705510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24547749|NCT00705549|Gemcitabine|gemcitabine|mesh-list
25869024|NCT00114257|Antimetabolites|antimetabolites|mesh-ancestor
25869025|NCT00114257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869026|NCT00114257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25869027|NCT00114257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25869028|NCT00114257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24800757|NCT01978405|Micronutrients|micronutrients|mesh-ancestor
25869029|NCT00114270|Zoledronic Acid|zoledronic acid|mesh-list
25869030|NCT00114270|Letrozole|letrozole|mesh-list
25869031|NCT00114270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25869032|NCT00114270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25869033|NCT00114270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25869034|NCT00114270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25869035|NCT00114270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714538|NCT01531192|Nystatin|nystatin|mesh-list
24547810|NCT00705796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24547811|NCT00705796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547812|NCT00705796|Anabolic Agents|anabolic agents|mesh-ancestor
24547813|NCT00705822|Prednisone|prednisone|mesh-list
24547814|NCT00705822|Hydrocortisone|hydrocortisone|mesh-list
25869036|NCT00114270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24547815|NCT00705822|Docetaxel|docetaxel|mesh-list
25229980|NCT02599337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229981|NCT02599168|Dexmedetomidine|dexmedetomidine|mesh-list
25229982|NCT02599168|Propofol|propofol|mesh-list
25229983|NCT02599168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25229984|NCT02599168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25229985|NCT02599168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229986|NCT02599168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25229987|NCT02599168|Anesthetics, General|anesthetics, general|mesh-ancestor
25229988|NCT02599168|Anesthetics|anesthetics|mesh-ancestor
25671043|NCT03260868|Insulin Aspart|insulin aspart|mesh-list
25671044|NCT03260868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25671045|NCT03260868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671046|NCT03244020|Aspirin|aspirin|mesh-list
25671047|NCT03244020|Enoxaparin|enoxaparin|mesh-list
25671048|NCT03244020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25671049|NCT03244020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25671050|NCT03244020|Analgesics|analgesics|mesh-ancestor
25671051|NCT03244020|Sensory System Agents|sensory system agents|mesh-ancestor
25671052|NCT03244020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25869037|NCT00114270|Hormone Antagonists|hormone antagonists|mesh-ancestor
25129977|NCT03037073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25129978|NCT03037073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25129979|NCT03037073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845796|NCT02239107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845798|NCT02239276|Stiripentol|stiripentol|mesh-list
24886583|NCT04525326|Bevacizumab|bevacizumab|mesh-list
24547816|NCT00705822|Estramustine|estramustine|mesh-list
24547817|NCT00705822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547818|NCT00705822|Tubulin Modulators|tubulin modulators|mesh-ancestor
24547819|NCT00705822|Antimitotic Agents|antimitotic agents|mesh-ancestor
24547820|NCT00705822|Mitosis Modulators|mitosis modulators|mesh-ancestor
24447545|NCT00308841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24447546|NCT00308841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447547|NCT00308880|Tranexamic Acid|tranexamic acid|mesh-list
24447548|NCT00308880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24447549|NCT00308880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24447550|NCT00308880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447551|NCT00308880|Hemostatics|hemostatics|mesh-ancestor
24447552|NCT00308880|Coagulants|coagulants|mesh-ancestor
25869038|NCT00114270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24565636|NCT00781521|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24800763|NCT01978418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24800764|NCT01978418|Respiratory System Agents|respiratory system agents|mesh-ancestor
24800765|NCT01978418|Tocolytic Agents|tocolytic agents|mesh-ancestor
24547912|NCT00706680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24547913|NCT00706680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090595|NCT03256071|Decitabine|decitabine|mesh-list
24547914|NCT00706680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24547915|NCT00706680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547916|NCT00706680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547917|NCT00706680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547918|NCT00706680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24547919|NCT00706680|Immunologic Factors|immunologic factors|mesh-ancestor
24547928|NCT00706680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24547929|NCT00706680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24547930|NCT00706680|Protective Agents|protective agents|mesh-ancestor
24547931|NCT00706862|Lactoferrin|lactoferrin|mesh-list
24547932|NCT00706862|Talactoferrin alfa|talactoferrin alfa|mesh-list
24714624|NCT01531647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25671053|NCT03244020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671054|NCT03244020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25671055|NCT03244020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25671056|NCT03244020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25671057|NCT03244020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25671058|NCT03244020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671059|NCT03244020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25671060|NCT03244020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25671061|NCT03244020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25671062|NCT03244020|Antipyretics|antipyretics|mesh-ancestor
25671063|NCT03244020|Anticoagulants|anticoagulants|mesh-ancestor
25671064|NCT03211286|Tranexamic Acid|tranexamic acid|mesh-list
25671065|NCT03211286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25671066|NCT03211286|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25229989|NCT02599168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25229990|NCT02599168|Analgesics|analgesics|mesh-ancestor
25229991|NCT02599168|Sensory System Agents|sensory system agents|mesh-ancestor
25229992|NCT02599168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229993|NCT02599168|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25229994|NCT02599168|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25229995|NCT02599168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25229996|NCT02599168|Adrenergic Agents|adrenergic agents|mesh-ancestor
25229997|NCT02599168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25229998|NCT02599168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229999|NCT02599077|Dienogest|dienogest|mesh-list
25230000|NCT02599077|Levonorgestrel|levonorgestrel|mesh-list
25230001|NCT02599077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25230002|NCT02599077|Contraceptive Agents|contraceptive agents|mesh-ancestor
25230003|NCT02599077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24845804|NCT02239445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845805|NCT02239445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25869039|NCT00114270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547933|NCT00706862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547934|NCT00706862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24547935|NCT00706888|Vitamin B 6|vitamin b 6|mesh-list
24547936|NCT00706888|Pyridoxal|pyridoxal|mesh-list
24547937|NCT00706888|Pyridoxine|pyridoxine|mesh-list
24547938|NCT00706888|Vitamins|vitamins|mesh-ancestor
24547939|NCT00706888|Micronutrients|micronutrients|mesh-ancestor
24547940|NCT00706888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869040|NCT00114270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25869041|NCT00114283|Lapatinib|lapatinib|mesh-list
25869042|NCT00114283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25869043|NCT00114283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25869044|NCT00114283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25869045|NCT00114283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869046|NCT00114361|Ribavirin|ribavirin|mesh-list
25869047|NCT00114361|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25869048|NCT00114361|Antimetabolites|antimetabolites|mesh-ancestor
25869049|NCT00114361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869050|NCT00114361|Antiviral Agents|antiviral agents|mesh-ancestor
25869051|NCT00114361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25869052|NCT00114374|Citalopram|citalopram|mesh-list
25869053|NCT00114374|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25869054|NCT00114374|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24800778|NCT01978431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24800779|NCT01978431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24800780|NCT01978431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869055|NCT00114374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24548008|NCT00707135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24548009|NCT00707135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24548010|NCT00707135|Antifungal Agents|antifungal agents|mesh-ancestor
24548011|NCT00707135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24548012|NCT00707135|Immunologic Factors|immunologic factors|mesh-ancestor
24548013|NCT00707135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548014|NCT00707187|Tadalafil|tadalafil|mesh-list
24800802|NCT01978457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24548029|NCT00707278|Antimetabolites|antimetabolites|mesh-ancestor
24548030|NCT00707278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548031|NCT00707278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24548033|NCT00707330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24548034|NCT00707330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24800794|NCT01978457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24800795|NCT01978457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230004|NCT02599077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230005|NCT02599077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25230006|NCT02599077|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24861509|NCT02318121|Oxytocin|oxytocin|mesh-list
25230007|NCT02599077|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25230008|NCT02599077|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25230009|NCT02599077|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25230010|NCT02599077|Hormone Antagonists|hormone antagonists|mesh-ancestor
24845806|NCT02239445|Analgesics|analgesics|mesh-ancestor
24845807|NCT02239445|Sensory System Agents|sensory system agents|mesh-ancestor
24845808|NCT02239445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845809|NCT02239445|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24845810|NCT02239445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24845811|NCT02239445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24845812|NCT02239445|Adrenergic Agents|adrenergic agents|mesh-ancestor
24845813|NCT02239445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845814|NCT02239445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845815|NCT02239458|Saxagliptin|saxagliptin|mesh-list
24800796|NCT01978457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800797|NCT01978457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24800798|NCT01978457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24800799|NCT01978457|Vasodilator Agents|vasodilator agents|mesh-ancestor
24551987|NCT04318210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25869056|NCT00114374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869057|NCT00114374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25869058|NCT00114374|Serotonin Agents|serotonin agents|mesh-ancestor
25869059|NCT00114374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869060|NCT00114374|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25869061|NCT00114374|Antidepressive Agents|antidepressive agents|mesh-ancestor
25869062|NCT00114374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25869063|NCT00114387|Tocopherols|tocopherols|mesh-list
25869064|NCT00114387|Vitamin E|vitamin e|mesh-list
25869065|NCT00114387|Tocotrienols|tocotrienols|mesh-list
25869066|NCT00114387|alpha-Tocopherol|alpha-tocopherol|mesh-list
25869067|NCT00114387|Antioxidants|antioxidants|mesh-ancestor
25869068|NCT00114387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869069|NCT00114387|Protective Agents|protective agents|mesh-ancestor
25869070|NCT00114387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869071|NCT00114387|Vitamins|vitamins|mesh-ancestor
25869072|NCT00114387|Micronutrients|micronutrients|mesh-ancestor
25869073|NCT00114400|Vitamins|vitamins|mesh-list
25869074|NCT00114400|Folic Acid|folic acid|mesh-list
25869075|NCT00114400|Vitamin B 12|vitamin b 12|mesh-list
24548097|NCT00707551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24566149|NCT00784498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25869076|NCT00114400|Hydroxocobalamin|hydroxocobalamin|mesh-list
24447568|NCT00308971|Protective Agents|protective agents|mesh-ancestor
24447569|NCT00308971|Vitamin B Complex|vitamin b complex|mesh-ancestor
24447570|NCT00309049|Epothilones|epothilones|mesh-list
24447571|NCT00309049|Tubulin Modulators|tubulin modulators|mesh-ancestor
24447572|NCT00309049|Antimitotic Agents|antimitotic agents|mesh-ancestor
24447573|NCT00309049|Mitosis Modulators|mitosis modulators|mesh-ancestor
24447574|NCT00309049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447575|NCT00309049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447577|NCT00309088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24447578|NCT00309088|Immunologic Factors|immunologic factors|mesh-ancestor
24447579|NCT00309088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447580|NCT00309088|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24800800|NCT01978457|Anesthetics, Local|anesthetics, local|mesh-ancestor
24800801|NCT01978457|Anesthetics|anesthetics|mesh-ancestor
24801078|NCT01980745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24800805|NCT01978457|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24800806|NCT01978457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24800820|NCT01978665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24800821|NCT01978665|Glucocorticoids|glucocorticoids|mesh-ancestor
24800822|NCT01978665|Hormones|hormones|mesh-ancestor
25230011|NCT02599077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25230012|NCT02599077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25230013|NCT02599077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230014|NCT02598830|Vitamin D|vitamin d|mesh-list
25230015|NCT02598830|Cholecalciferol|cholecalciferol|mesh-list
25230016|NCT02598830|Vitamins|vitamins|mesh-ancestor
25230017|NCT02598830|Micronutrients|micronutrients|mesh-ancestor
25230018|NCT02598830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230019|NCT02598830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25230020|NCT02598830|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24845816|NCT02239458|Incretins|incretins|mesh-ancestor
24845818|NCT02239458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24845819|NCT02239458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845820|NCT02239458|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24845821|NCT02239458|Protease Inhibitors|protease inhibitors|mesh-ancestor
24476461|NCT00415103|Autonomic Agents|autonomic agents|mesh-ancestor
24845847|NCT02239614|Immunologic Factors|immunologic factors|mesh-ancestor
24845848|NCT02239614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845849|NCT02239614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24845850|NCT02239614|Antacids|antacids|mesh-ancestor
24800823|NCT01978665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25869077|NCT00114400|Vitamin B 6|vitamin b 6|mesh-list
25869078|NCT00114400|Pyridoxal|pyridoxal|mesh-list
25869079|NCT00114400|Pyridoxine|pyridoxine|mesh-list
25869080|NCT00114400|Vitamin B Complex|vitamin b complex|mesh-list
25130244|NCT03035253|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25130245|NCT03035253|Immunologic Factors|immunologic factors|mesh-ancestor
25130246|NCT03035253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130247|NCT03035084|Vitamin D|vitamin d|mesh-list
25130248|NCT03035084|Ergocalciferols|ergocalciferols|mesh-list
25130249|NCT03035084|Cholecalciferol|cholecalciferol|mesh-list
24800824|NCT01978665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800825|NCT01978665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24800826|NCT01978665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800827|NCT01978678|Budesonide|budesonide|mesh-list
24800828|NCT01978678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24800829|NCT01978678|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24447581|NCT00309088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25869081|NCT00114400|Micronutrients|micronutrients|mesh-ancestor
25869082|NCT00114400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869083|NCT00114400|Hematinics|hematinics|mesh-ancestor
25869084|NCT00114439|Lithium Carbonate|lithium carbonate|mesh-list
24861730|NCT02319772|Galidesivir|galidesivir|mesh-list
24861820|NCT02320357|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25869085|NCT00114439|Antidepressive Agents|antidepressive agents|mesh-ancestor
25869086|NCT00114439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25869087|NCT00114439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548125|NCT00707785|Vitamin A|vitamin a|mesh-list
24548126|NCT00707785|Vitamins|vitamins|mesh-ancestor
24548127|NCT00707785|Micronutrients|micronutrients|mesh-ancestor
24548128|NCT00707785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800830|NCT01978678|Autonomic Agents|autonomic agents|mesh-ancestor
24800831|NCT01978678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24800832|NCT01978678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800852|NCT01978782|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24800853|NCT01978782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800878|NCT01978873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800879|NCT01978873|Anabolic Agents|anabolic agents|mesh-ancestor
24800880|NCT01979341|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24800881|NCT01979341|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24800882|NCT01979341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800883|NCT01979341|Luteolytic Agents|luteolytic agents|mesh-ancestor
24800884|NCT01979341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24548129|NCT00707798|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25869088|NCT00114439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869089|NCT00114439|Antimanic Agents|antimanic agents|mesh-ancestor
25869090|NCT00114439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25869091|NCT00114439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25869092|NCT00114439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869093|NCT00114478|Epinephrine|epinephrine|mesh-list
25869094|NCT00114478|Albuterol|albuterol|mesh-list
25869095|NCT00114478|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25869096|NCT00114478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25869097|NCT00114478|Adrenergic Agents|adrenergic agents|mesh-ancestor
25230067|NCT02598596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24548174|NCT00707941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548175|NCT00707941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548176|NCT00708149|Lansoprazole|lansoprazole|mesh-list
24548177|NCT00708149|Dexlansoprazole|dexlansoprazole|mesh-list
24548178|NCT00708149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24548180|NCT00708149|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24548181|NCT00708149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230021|NCT02599090|Temozolomide|temozolomide|mesh-list
25230022|NCT02599090|Sorafenib|sorafenib|mesh-list
25230023|NCT02599090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25230024|NCT02599090|Alkylating Agents|alkylating agents|mesh-ancestor
25230025|NCT02599090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230026|NCT02599090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230027|NCT02599090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25230028|NCT02599090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230029|NCT02598778|Chlorhexidine|chlorhexidine|mesh-list
25230030|NCT02598778|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25230031|NCT02598778|Listerine|listerine|mesh-list
24845851|NCT02239614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845852|NCT02239614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25671067|NCT03211286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25671068|NCT03211286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671069|NCT03211286|Hemostatics|hemostatics|mesh-ancestor
25671070|NCT03211286|Coagulants|coagulants|mesh-ancestor
25671071|NCT03162510|Paclitaxel|paclitaxel|mesh-list
25671072|NCT03162510|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25869098|NCT00114478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25130342|NCT03034382|Analgesics|analgesics|mesh-ancestor
25130343|NCT03034382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25130344|NCT03034382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25130345|NCT03034382|Adrenergic Agents|adrenergic agents|mesh-ancestor
25130346|NCT03034382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25130347|NCT03034382|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25130348|NCT03034382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25130349|NCT03034382|Autonomic Agents|autonomic agents|mesh-ancestor
25130350|NCT03034382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25130351|NCT03034382|Respiratory System Agents|respiratory system agents|mesh-ancestor
25130352|NCT03034382|Mydriatics|mydriatics|mesh-ancestor
25130355|NCT03034304|Ifosfamide|ifosfamide|mesh-list
24845853|NCT02239731|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24845854|NCT02239731|Doxycycline|doxycycline|mesh-list
24845855|NCT02239731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24512273|NCT00573950|Cilostazol|cilostazol|mesh-list
25869099|NCT00114478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869100|NCT00114478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869101|NCT00114478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25869102|NCT00114478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25869103|NCT00114478|Autonomic Agents|autonomic agents|mesh-ancestor
24800885|NCT01979341|Contraceptive Agents|contraceptive agents|mesh-ancestor
24800886|NCT01979341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24800887|NCT01979341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25869104|NCT00114478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25869105|NCT00114478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25869106|NCT00114478|Respiratory System Agents|respiratory system agents|mesh-ancestor
25869107|NCT00114478|Mydriatics|mydriatics|mesh-ancestor
25869108|NCT00114478|Sympathomimetics|sympathomimetics|mesh-ancestor
25869109|NCT00114478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25869110|NCT00114478|Tocolytic Agents|tocolytic agents|mesh-ancestor
25869111|NCT00114478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25869112|NCT00114478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25869113|NCT00114491|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25869114|NCT00114491|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24548187|NCT00708240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548188|NCT00708240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24548190|NCT00708240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548191|NCT00708240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24548192|NCT00708240|Antidepressive Agents|antidepressive agents|mesh-ancestor
24800918|NCT01979653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24800919|NCT01979653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24800920|NCT01979653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800921|NCT01979653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24800922|NCT01979653|Analgesics|analgesics|mesh-ancestor
24800923|NCT01979653|Sensory System Agents|sensory system agents|mesh-ancestor
24800924|NCT01979653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24800925|NCT01979653|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24800926|NCT01979653|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24800927|NCT01979653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24800928|NCT01979653|Adrenergic Agents|adrenergic agents|mesh-ancestor
24800929|NCT01979653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24800930|NCT01979653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800931|NCT01979653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24800932|NCT01979653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24800933|NCT01979653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24800934|NCT01979653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24800935|NCT01979653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24800936|NCT01979653|Anesthetics, General|anesthetics, general|mesh-ancestor
24800937|NCT01979653|Anesthetics|anesthetics|mesh-ancestor
24800952|NCT01979679|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24800953|NCT01979679|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24800956|NCT01979679|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25671073|NCT03162510|Oxaliplatin|oxaliplatin|mesh-list
25671074|NCT03162510|Tegafur|tegafur|mesh-list
25671075|NCT03162510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25671076|NCT03162510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671077|NCT03162510|Tubulin Modulators|tubulin modulators|mesh-ancestor
25671078|NCT03162510|Antimitotic Agents|antimitotic agents|mesh-ancestor
25671079|NCT03162510|Mitosis Modulators|mitosis modulators|mesh-ancestor
25671080|NCT03162510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671081|NCT03162510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25671082|NCT03162510|Antimetabolites|antimetabolites|mesh-ancestor
25671083|NCT03162497|Azithromycin|azithromycin|mesh-list
25869115|NCT00114491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24595151|NCT00936988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24595153|NCT00937027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24595154|NCT00937027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595155|NCT00937027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869116|NCT00114491|Antimetabolites|antimetabolites|mesh-ancestor
25869117|NCT00114491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230032|NCT02598778|Fluorides|fluorides|mesh-list
25230033|NCT02598778|Sodium Fluoride|sodium fluoride|mesh-list
25230034|NCT02598778|Cariostatic Agents|cariostatic agents|mesh-ancestor
25230035|NCT02598778|Protective Agents|protective agents|mesh-ancestor
25230036|NCT02598778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230037|NCT02598778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25230038|NCT02598778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24845860|NCT02239835|Saquinavir|saquinavir|mesh-list
24845861|NCT02239835|Tipranavir|tipranavir|mesh-list
24845862|NCT02239835|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24845863|NCT02239835|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24845864|NCT02239835|Protease Inhibitors|protease inhibitors|mesh-ancestor
24845865|NCT02239835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605987|NCT00988507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24845876|NCT02239900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25869118|NCT00114491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24548196|NCT00708266|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24548197|NCT00708266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24595175|NCT00937092|Dopamine Agents|dopamine agents|mesh-ancestor
24595176|NCT00937092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24548199|NCT00708318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24548200|NCT00708318|Narcotics|narcotics|mesh-ancestor
24548201|NCT00708318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24548202|NCT00708318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548203|NCT00708318|Analgesics|analgesics|mesh-ancestor
24548204|NCT00708318|Sensory System Agents|sensory system agents|mesh-ancestor
24548205|NCT00708318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24548206|NCT00708318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24548207|NCT00708318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24548208|NCT00708318|Anesthetics, General|anesthetics, general|mesh-ancestor
24548209|NCT00708318|Anesthetics|anesthetics|mesh-ancestor
24548210|NCT00708344|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24548212|NCT00708344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24548213|NCT00708344|Diuretics|diuretics|mesh-ancestor
24548214|NCT00708344|Natriuretic Agents|natriuretic agents|mesh-ancestor
24548215|NCT00708344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108577|NCT03131973|Analgesics|analgesics|mesh-ancestor
24862092|NCT02322853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548216|NCT00708344|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24548217|NCT00708344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25869119|NCT00114491|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25869120|NCT00114491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715115|NCT01534585|Mitogens|mitogens|mesh-list
24548228|NCT00708396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548229|NCT00708396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24548230|NCT00708396|Serotonin Agents|serotonin agents|mesh-ancestor
24548231|NCT00708396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548232|NCT00708396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24548233|NCT00708396|Antidepressive Agents|antidepressive agents|mesh-ancestor
24548234|NCT00708396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24548235|NCT00708539|Progesterone|progesterone|mesh-list
24548236|NCT00708539|Progestins|progestins|mesh-ancestor
24548237|NCT00708539|Hormones|hormones|mesh-ancestor
25869121|NCT00114556|Zoledronic Acid|zoledronic acid|mesh-list
25869122|NCT00114556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24595182|NCT00937131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595183|NCT00937131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24622275|NCT01066429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24622276|NCT01066429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24622277|NCT01066429|Protease Inhibitors|protease inhibitors|mesh-ancestor
24622278|NCT01066429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622279|NCT01066429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622280|NCT01066468|Imatinib Mesylate|imatinib mesylate|mesh-list
25230040|NCT02598778|Dermatologic Agents|dermatologic agents|mesh-ancestor
25230042|NCT02598856|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25230043|NCT02598856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230044|NCT02598856|Sensory System Agents|sensory system agents|mesh-ancestor
25130515|NCT03033316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130516|NCT03033316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130517|NCT03033316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25130518|NCT03033316|Glucocorticoids|glucocorticoids|mesh-ancestor
25130519|NCT03033316|Hormones|hormones|mesh-ancestor
25130520|NCT03033316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25130521|NCT03033316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25130522|NCT03033316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25130523|NCT03032848|Estrogens|estrogens|mesh-list
25130524|NCT03032848|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24459692|NCT00345800|Anesthetics|anesthetics|mesh-ancestor
24459693|NCT00345800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25130525|NCT03032848|Hormones|hormones|mesh-ancestor
25130526|NCT03032848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25130527|NCT03032848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130547|NCT03032666|Sofosbuvir|sofosbuvir|mesh-list
25230045|NCT02598856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25230046|NCT02598869|Triamcinolone|triamcinolone|mesh-list
25230047|NCT02598869|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25230048|NCT02598869|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25230049|NCT02598869|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24845877|NCT02239900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845879|NCT02239913|Phentermine|phentermine|mesh-list
24800991|NCT01980316|Heparin|heparin|mesh-list
24800992|NCT01980316|Calcium heparin|calcium heparin|mesh-list
24800993|NCT01980316|Argatroban|argatroban|mesh-list
24800994|NCT01980316|Anticoagulants|anticoagulants|mesh-ancestor
24800995|NCT01980316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24552428|NCT03164447|Antiviral Agents|antiviral agents|mesh-ancestor
25869123|NCT00114556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869124|NCT00114569|Lorazepam|lorazepam|mesh-list
25869125|NCT00114569|Anticonvulsants|anticonvulsants|mesh-ancestor
25869126|NCT00114569|Antiemetics|antiemetics|mesh-ancestor
25869127|NCT00114569|Autonomic Agents|autonomic agents|mesh-ancestor
25869128|NCT00114569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25869129|NCT00114569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869130|NCT00114569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25869131|NCT00114569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25869132|NCT00114569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25869133|NCT00114569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25869134|NCT00114569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25869135|NCT00114569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24548266|NCT00708591|Hormone Antagonists|hormone antagonists|mesh-ancestor
24801006|NCT01980329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801007|NCT01980329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24801008|NCT01980329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24801009|NCT01980329|Antiviral Agents|antiviral agents|mesh-ancestor
24801010|NCT01980329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24801011|NCT01980329|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24801013|NCT01980407|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
24801014|NCT01980407|Oxaliplatin|oxaliplatin|mesh-list
24801015|NCT01980407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24801016|NCT01980407|Antidotes|antidotes|mesh-ancestor
24801017|NCT01980407|Protective Agents|protective agents|mesh-ancestor
24801018|NCT01980407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869136|NCT00114569|GABA Modulators|gaba modulators|mesh-ancestor
25869137|NCT00114569|GABA Agents|gaba agents|mesh-ancestor
25671084|NCT03162497|Doxycycline|doxycycline|mesh-list
25671085|NCT03162497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25671086|NCT03162497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25671087|NCT03162497|Antimalarials|antimalarials|mesh-ancestor
25671088|NCT03162497|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25671089|NCT03162497|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25671090|NCT03161756|Denosumab|denosumab|mesh-list
25671091|NCT03161756|Nivolumab|nivolumab|mesh-list
25671092|NCT03161756|Ipilimumab|ipilimumab|mesh-list
25671093|NCT03161756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25671094|NCT03161756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671095|NCT03161756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25671096|NCT03161756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671097|NCT03161756|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25671098|NCT03161756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671099|NCT03157037|Immunoglobulins|immunoglobulins|mesh-list
25869138|NCT00114569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25869139|NCT00114569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671100|NCT03157037|Immunoglobulin G|immunoglobulin g|mesh-list
25130593|NCT03032458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25130594|NCT03032458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25130595|NCT03032458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25130596|NCT03032458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25130597|NCT03032458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25130599|NCT03032458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25130600|NCT03032367|Bedaquiline|bedaquiline|mesh-list
25130601|NCT03032367|Antitubercular Agents|antitubercular agents|mesh-ancestor
25869140|NCT00114686|Valproic Acid|valproic acid|mesh-list
24548270|NCT00708656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24548271|NCT00708656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24548272|NCT00708656|Analgesics|analgesics|mesh-ancestor
24548273|NCT00708656|Sensory System Agents|sensory system agents|mesh-ancestor
25869141|NCT00114686|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25869142|NCT00114686|Antidepressive Agents|antidepressive agents|mesh-ancestor
25869143|NCT00114686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25869144|NCT00114686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25869145|NCT00114686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25869146|NCT00114686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25869147|NCT00114686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869148|NCT00114686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25869149|NCT00114686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869150|NCT00114686|Antimanic Agents|antimanic agents|mesh-ancestor
25869151|NCT00114686|Anticonvulsants|anticonvulsants|mesh-ancestor
25869152|NCT00114686|GABA Agents|gaba agents|mesh-ancestor
25869153|NCT00114686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25869154|NCT00114764|Lenograstim|lenograstim|mesh-list
24801020|NCT01980407|Vitamins|vitamins|mesh-ancestor
24801021|NCT01980407|Micronutrients|micronutrients|mesh-ancestor
25869155|NCT00114764|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25869156|NCT00114764|Immunologic Factors|immunologic factors|mesh-ancestor
25869157|NCT00114764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230068|NCT02598791|Glucagon|glucagon|mesh-list
25869158|NCT00114803|Calcitonin|calcitonin|mesh-list
25869159|NCT00114803|Salmon calcitonin|salmon calcitonin|mesh-list
25869160|NCT00114803|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
25869161|NCT00114803|Katacalcin|katacalcin|mesh-list
25869162|NCT00114803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25869163|NCT00114803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869164|NCT00114803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25869165|NCT00114803|Vasodilator Agents|vasodilator agents|mesh-ancestor
25869166|NCT00114816|Docetaxel|docetaxel|mesh-list
25869167|NCT00114816|Capecitabine|capecitabine|mesh-list
25230050|NCT02598869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25230051|NCT02598869|Glucocorticoids|glucocorticoids|mesh-ancestor
25230052|NCT02598869|Hormones|hormones|mesh-ancestor
25273467|NCT02385396|Micronutrients|micronutrients|mesh-ancestor
24845880|NCT02239913|Cocaine|cocaine|mesh-list
24845881|NCT02239913|Anticonvulsants|anticonvulsants|mesh-ancestor
24845882|NCT02239913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24845883|NCT02239913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845884|NCT02239913|Anesthetics, Local|anesthetics, local|mesh-ancestor
24845885|NCT02239913|Anesthetics|anesthetics|mesh-ancestor
24845886|NCT02239913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24845919|NCT02240017|Antiviral Agents|antiviral agents|mesh-ancestor
24845920|NCT02240017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24845921|NCT02240017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24845922|NCT02240017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24845923|NCT02240017|Immunologic Factors|immunologic factors|mesh-ancestor
25869168|NCT00114816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24801029|NCT01980472|Mitosis Modulators|mitosis modulators|mesh-ancestor
24801030|NCT01980472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801031|NCT01980472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25671101|NCT03157037|Immunologic Factors|immunologic factors|mesh-ancestor
25671102|NCT03157037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671103|NCT03127007|Atezolizumab|atezolizumab|mesh-list
25671104|NCT03127007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671105|NCT03058757|Mitomycins|mitomycins|mesh-list
25671106|NCT03058757|Mitomycin|mitomycin|mesh-list
25671107|NCT03058757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25671108|NCT03058757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671109|NCT03058757|Alkylating Agents|alkylating agents|mesh-ancestor
24801032|NCT01980472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24801033|NCT01980472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24801034|NCT01980472|Growth Substances|growth substances|mesh-ancestor
24801035|NCT01980472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801036|NCT01980472|Growth Inhibitors|growth inhibitors|mesh-ancestor
24801038|NCT01980498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24801039|NCT01980498|Narcotics|narcotics|mesh-ancestor
24801040|NCT01980498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24801041|NCT01980498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801042|NCT01980498|Analgesics|analgesics|mesh-ancestor
24801043|NCT01980498|Sensory System Agents|sensory system agents|mesh-ancestor
24801044|NCT01980498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24801045|NCT01980498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24801046|NCT01980498|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24801047|NCT01980498|Anesthetics, General|anesthetics, general|mesh-ancestor
24801048|NCT01980498|Anesthetics|anesthetics|mesh-ancestor
24801049|NCT01980550|Nicotine|nicotine|mesh-list
24801050|NCT01980550|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24801051|NCT01980550|Autonomic Agents|autonomic agents|mesh-ancestor
24801052|NCT01980550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24801053|NCT01980550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801054|NCT01980550|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25869169|NCT00114816|Tubulin Modulators|tubulin modulators|mesh-ancestor
25869170|NCT00114816|Antimitotic Agents|antimitotic agents|mesh-ancestor
24801056|NCT01980550|Cholinergic Agents|cholinergic agents|mesh-ancestor
24801057|NCT01980550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24801058|NCT01980550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801059|NCT01980615|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24801060|NCT01980615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24801061|NCT01980615|Respiratory System Agents|respiratory system agents|mesh-ancestor
24801063|NCT01980667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24801064|NCT01980680|Estradiol|estradiol|mesh-list
24801065|NCT01980680|Progesterone|progesterone|mesh-list
24801066|NCT01980680|Estrogens|estrogens|mesh-ancestor
24801067|NCT01980680|Hormones|hormones|mesh-ancestor
24801068|NCT01980680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24801069|NCT01980680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801070|NCT01980680|Progestins|progestins|mesh-ancestor
24801071|NCT01980745|Chloroquine|chloroquine|mesh-list
24801072|NCT01980745|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24801073|NCT01980745|Amebicides|amebicides|mesh-ancestor
24801074|NCT01980745|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24801075|NCT01980745|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24801076|NCT01980745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24801077|NCT01980745|Antimalarials|antimalarials|mesh-ancestor
25230053|NCT02598869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25230054|NCT02598869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230055|NCT02598869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25230056|NCT02598869|Immunologic Factors|immunologic factors|mesh-ancestor
25230057|NCT02598869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230058|NCT02598869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230059|NCT02598596|Azathioprine|azathioprine|mesh-list
25230060|NCT02598596|Antimetabolites|antimetabolites|mesh-ancestor
25230061|NCT02598596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230062|NCT02598596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24845926|NCT02240043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24845927|NCT02240043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845928|NCT02240160|Nabiximols|nabiximols|mesh-list
24845929|NCT02240160|Analgesics|analgesics|mesh-ancestor
24845930|NCT02240160|Sensory System Agents|sensory system agents|mesh-ancestor
24845931|NCT02240160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845932|NCT02240160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845933|NCT02240173|Haloperidol|haloperidol|mesh-list
24845934|NCT02240173|Haloperidol decanoate|haloperidol decanoate|mesh-list
24845935|NCT02240173|Antiemetics|antiemetics|mesh-ancestor
24801079|NCT01980745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24801080|NCT01980745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24801081|NCT01980745|Analgesics|analgesics|mesh-ancestor
24801082|NCT01980745|Sensory System Agents|sensory system agents|mesh-ancestor
24801083|NCT01980745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24801084|NCT01980745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801085|NCT01980745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24801086|NCT01980745|Filaricides|filaricides|mesh-ancestor
24801087|NCT01980745|Antinematodal Agents|antinematodal agents|mesh-ancestor
24801089|NCT01980810|Paclitaxel|paclitaxel|mesh-list
24548340|NCT00709163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548341|NCT00709189|Folic Acid|folic acid|mesh-list
24548342|NCT00709189|Norgestimate|norgestimate|mesh-list
24548343|NCT00709189|Estradiol|estradiol|mesh-list
24548344|NCT00709189|Estrogens|estrogens|mesh-ancestor
24548346|NCT00709189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24548347|NCT00709189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869171|NCT00114816|Mitosis Modulators|mitosis modulators|mesh-ancestor
24544515|NCT00689208|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25869172|NCT00114816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869173|NCT00114816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25869174|NCT00114816|Antimetabolites|antimetabolites|mesh-ancestor
25869175|NCT00114868|Vitamins|vitamins|mesh-list
25869176|NCT00114868|Vitamin A|vitamin a|mesh-list
25869177|NCT00114868|Retinol palmitate|retinol palmitate|mesh-list
24548349|NCT00709189|Contraceptive Agents|contraceptive agents|mesh-ancestor
24548350|NCT00709189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24548351|NCT00709189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24548353|NCT00709189|Vitamin B Complex|vitamin b complex|mesh-ancestor
24548354|NCT00709189|Vitamins|vitamins|mesh-ancestor
24548355|NCT00709189|Micronutrients|micronutrients|mesh-ancestor
24548356|NCT00709189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24548357|NCT00709189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25869178|NCT00114868|Micronutrients|micronutrients|mesh-ancestor
25869179|NCT00114868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869180|NCT00114868|Antioxidants|antioxidants|mesh-ancestor
25869181|NCT00114868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869182|NCT00114868|Protective Agents|protective agents|mesh-ancestor
24567301|NCT00790439|Anticoagulants|anticoagulants|mesh-ancestor
24447624|NCT00309218|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24447625|NCT00309218|Protective Agents|protective agents|mesh-ancestor
25869183|NCT00114868|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25869184|NCT00114868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25869185|NCT00114933|Ritonavir|ritonavir|mesh-list
25869186|NCT00114933|Lopinavir|lopinavir|mesh-list
25869187|NCT00114933|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25869188|NCT00114933|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25869189|NCT00114933|Protease Inhibitors|protease inhibitors|mesh-ancestor
25869190|NCT00114933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548359|NCT00709215|Pentostatin|pentostatin|mesh-list
24548360|NCT00709215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230063|NCT02598596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230064|NCT02598596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25230065|NCT02598596|Immunologic Factors|immunologic factors|mesh-ancestor
25230066|NCT02598596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230069|NCT02598791|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24546648|NCT00699478|Vitamins|vitamins|mesh-ancestor
24866793|NCT04818177|Immunoglobulins|immunoglobulins|mesh-list
24866794|NCT04818177|Antibodies|antibodies|mesh-list
24866795|NCT04818177|gamma-Globulins|gamma-globulins|mesh-list
24866796|NCT04818177|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24866797|NCT04818177|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24866798|NCT04818177|Immunologic Factors|immunologic factors|mesh-ancestor
24845938|NCT02240173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845971|NCT02240212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24845972|NCT02240212|Tubulin Modulators|tubulin modulators|mesh-ancestor
24845973|NCT02240212|Antimitotic Agents|antimitotic agents|mesh-ancestor
24845974|NCT02240212|Mitosis Modulators|mitosis modulators|mesh-ancestor
24845975|NCT02240212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845976|NCT02240238|Gemcitabine|gemcitabine|mesh-list
24548361|NCT00709215|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
24548362|NCT00709215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25869191|NCT00114933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869192|NCT00114933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25869193|NCT00114933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25869194|NCT00114933|Antiviral Agents|antiviral agents|mesh-ancestor
24801093|NCT01980810|Tubulin Modulators|tubulin modulators|mesh-ancestor
24801094|NCT01980810|Antimitotic Agents|antimitotic agents|mesh-ancestor
24801095|NCT01980810|Mitosis Modulators|mitosis modulators|mesh-ancestor
24801096|NCT01980810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801123|NCT01981278|Tapentadol|tapentadol|mesh-list
24801133|NCT01981278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24801134|NCT01981278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801135|NCT01981278|Adrenergic Agents|adrenergic agents|mesh-ancestor
24801136|NCT01981278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24801138|NCT01981291|Mepivacaine|mepivacaine|mesh-list
24801139|NCT01981291|Anesthetics, Local|anesthetics, local|mesh-list
24801140|NCT01981291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24801141|NCT01981291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801142|NCT01981291|Sensory System Agents|sensory system agents|mesh-ancestor
25130813|NCT03030937|Irinotecan|irinotecan|mesh-list
24801143|NCT01981291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24801144|NCT01981330|Hyaluronic Acid|hyaluronic acid|mesh-list
24801146|NCT01981330|Immunologic Factors|immunologic factors|mesh-ancestor
24801147|NCT01981330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801148|NCT01981330|Viscosupplements|viscosupplements|mesh-ancestor
24801149|NCT01981330|Protective Agents|protective agents|mesh-ancestor
24801150|NCT01981369|Dexmedetomidine|dexmedetomidine|mesh-list
24801151|NCT01981369|Propofol|propofol|mesh-list
24801152|NCT01981369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25869195|NCT00114933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24801153|NCT01981369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25869196|NCT00114933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24866799|NCT04818177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814365|NCT02064140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869197|NCT00114933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25869198|NCT00114946|Bevacizumab|bevacizumab|mesh-list
25869199|NCT00114946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25869200|NCT00114946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25869201|NCT00114946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25869202|NCT00114946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25869203|NCT00114946|Growth Substances|growth substances|mesh-ancestor
25869204|NCT00114946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869205|NCT00114946|Growth Inhibitors|growth inhibitors|mesh-ancestor
25869206|NCT00115011|Citalopram|citalopram|mesh-list
25869207|NCT00115011|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25869208|NCT00115011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25869209|NCT00115011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25869210|NCT00115011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869211|NCT00115011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25869212|NCT00115011|Serotonin Agents|serotonin agents|mesh-ancestor
24801154|NCT01981369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801155|NCT01981369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24801156|NCT01981369|Anesthetics, General|anesthetics, general|mesh-ancestor
24801157|NCT01981369|Anesthetics|anesthetics|mesh-ancestor
25230075|NCT02598635|Cholecalciferol|cholecalciferol|mesh-list
25230076|NCT02598635|Vitamin D|vitamin d|mesh-list
25230077|NCT02598635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25230078|NCT02598635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230079|NCT02598635|Vitamins|vitamins|mesh-ancestor
25230080|NCT02598635|Micronutrients|micronutrients|mesh-ancestor
25230081|NCT02598635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24845977|NCT02240238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24845978|NCT02240238|Antimetabolites|antimetabolites|mesh-ancestor
24845979|NCT02240238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845980|NCT02240238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24845981|NCT02240238|Antiviral Agents|antiviral agents|mesh-ancestor
24845982|NCT02240238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24845983|NCT02240238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886998|NCT04521140|Glucocorticoids|glucocorticoids|mesh-ancestor
24801158|NCT01981369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24801159|NCT01981369|Analgesics|analgesics|mesh-ancestor
25869213|NCT00115011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869214|NCT00115011|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25869215|NCT00115011|Antidepressive Agents|antidepressive agents|mesh-ancestor
25869216|NCT00115011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24548461|NCT00709644|Norgestimate|norgestimate|mesh-list
24548462|NCT00709644|Estradiol|estradiol|mesh-list
24548463|NCT00709644|Estrogens|estrogens|mesh-ancestor
25869217|NCT00115024|Estradiol|estradiol|mesh-list
24548464|NCT00709644|Hormones|hormones|mesh-ancestor
24567646|NCT00791856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24548489|NCT00709683|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24548491|NCT00709683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548492|NCT00709839|Hydrocortisone|hydrocortisone|mesh-list
24548493|NCT00709839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24548494|NCT00709917|Repaglinide|repaglinide|mesh-list
24548495|NCT00709917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24548496|NCT00709917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548497|NCT00709969|Lumefantrine|lumefantrine|mesh-list
24548498|NCT00709969|Artemether|artemether|mesh-list
25869218|NCT00115024|Estrogens|estrogens|mesh-ancestor
24548524|NCT00710086|Hydromorphone|hydromorphone|mesh-list
24548525|NCT00710086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24548526|NCT00710086|Narcotics|narcotics|mesh-ancestor
24548527|NCT00710086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25433695|NCT00433511|Immunoglobulin G|immunoglobulin g|mesh-list
25130876|NCT03030703|Micronutrients|micronutrients|mesh-ancestor
25130878|NCT03030469|Analgesics, Opioid|analgesics, opioid|mesh-list
24548528|NCT00710086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548529|NCT00710086|Analgesics|analgesics|mesh-ancestor
24548530|NCT00710086|Sensory System Agents|sensory system agents|mesh-ancestor
24548531|NCT00710086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24548532|NCT00710099|Sildenafil Citrate|sildenafil citrate|mesh-list
24548533|NCT00710099|Vasodilator Agents|vasodilator agents|mesh-ancestor
24801160|NCT01981369|Sensory System Agents|sensory system agents|mesh-ancestor
24801161|NCT01981369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24801162|NCT01981369|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24801168|NCT01981447|Lacosamide|lacosamide|mesh-list
24801174|NCT01981460|Methylene Blue|methylene blue|mesh-list
24801175|NCT01981460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24801176|NCT01981460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801177|NCT01981499|Cetirizine|cetirizine|mesh-list
24801178|NCT01981499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24548534|NCT00710099|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24548535|NCT00710099|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24548536|NCT00710099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548537|NCT00710099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548539|NCT00710125|Doxorubicin|doxorubicin|mesh-list
24548540|NCT00710125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24548541|NCT00710125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24548542|NCT00710125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24548543|NCT00710125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24548544|NCT00710125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548562|NCT00710216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24548563|NCT00710229|Bevacizumab|bevacizumab|mesh-list
24548574|NCT00710268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24548575|NCT00710268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24548613|NCT00710619|Coagulants|coagulants|mesh-ancestor
25230085|NCT02598687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230086|NCT02598687|Tubulin Modulators|tubulin modulators|mesh-ancestor
25230087|NCT02598687|Antimitotic Agents|antimitotic agents|mesh-ancestor
25230088|NCT02598687|Mitosis Modulators|mitosis modulators|mesh-ancestor
25230089|NCT02598687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230090|NCT02598453|Ibandronic Acid|ibandronic acid|mesh-list
24548821|NCT00712374|Sulfadoxine|sulfadoxine|mesh-list
25230092|NCT02598453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845984|NCT02240238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24867847|NCT05154682|Oxycodone|oxycodone|mesh-list
24845985|NCT02240238|Immunologic Factors|immunologic factors|mesh-ancestor
25044061|NCT01168310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044063|NCT01167166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044064|NCT01167166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24816608|NCT02077946|Liraglutide|liraglutide|mesh-list
25869219|NCT00115024|Hormones|hormones|mesh-ancestor
25869220|NCT00115024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25869221|NCT00115024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869222|NCT00115089|Beclomethasone|beclomethasone|mesh-list
25869223|NCT00115089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25869224|NCT00115089|Glucocorticoids|glucocorticoids|mesh-ancestor
25869225|NCT00115089|Hormones|hormones|mesh-ancestor
25869226|NCT00115089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25869227|NCT00115089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869228|NCT00115089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25869229|NCT00115089|Respiratory System Agents|respiratory system agents|mesh-ancestor
25869230|NCT00115102|Fentanyl|fentanyl|mesh-list
25869231|NCT00115102|Ketamine|ketamine|mesh-list
24548629|NCT00710788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548630|NCT00710788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24548632|NCT00710788|Sequestering Agents|sequestering agents|mesh-ancestor
24548633|NCT00710827|Testosterone undecanoate|testosterone undecanoate|mesh-list
24548634|NCT00710827|Androgens|androgens|mesh-ancestor
24548635|NCT00710827|Hormones|hormones|mesh-ancestor
24548660|NCT00711204|Nootropic Agents|nootropic agents|mesh-ancestor
24548661|NCT00711256|Sunscreening Agents|sunscreening agents|mesh-list
24548662|NCT00711256|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24548663|NCT00711256|Protective Agents|protective agents|mesh-ancestor
24548664|NCT00711256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548665|NCT00711256|Dermatologic Agents|dermatologic agents|mesh-ancestor
24548666|NCT00711295|Vaccines|vaccines|mesh-list
24548667|NCT00711295|Immunologic Factors|immunologic factors|mesh-ancestor
25671110|NCT03058757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25433925|NCT00338377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25130914|NCT03031262|Antiviral Agents|antiviral agents|mesh-ancestor
25130915|NCT03031262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25130916|NCT03031262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25130917|NCT03031262|Immunologic Factors|immunologic factors|mesh-ancestor
25130918|NCT03031262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130920|NCT03030131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25130922|NCT03030287|Paclitaxel|paclitaxel|mesh-list
25130928|NCT03030287|Mitosis Modulators|mitosis modulators|mesh-ancestor
25130929|NCT03030287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130930|NCT03030287|Immunologic Factors|immunologic factors|mesh-ancestor
25130931|NCT03030287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130932|NCT03030300|Metformin|metformin|mesh-list
24548668|NCT00711295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548669|NCT00711308|Vitamin K|vitamin k|mesh-list
24548670|NCT00711308|Tinzaparin|tinzaparin|mesh-list
24548671|NCT00711308|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24548672|NCT00711308|Dalteparin|dalteparin|mesh-list
24548673|NCT00711308|Acenocoumarol|acenocoumarol|mesh-list
24548674|NCT00711308|Vitamins|vitamins|mesh-ancestor
24548675|NCT00711308|Micronutrients|micronutrients|mesh-ancestor
24548676|NCT00711308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869232|NCT00115102|Esketamine|esketamine|mesh-list
25869233|NCT00115102|Analgesics|analgesics|mesh-ancestor
25869234|NCT00115102|Sensory System Agents|sensory system agents|mesh-ancestor
25869235|NCT00115102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25869236|NCT00115102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869237|NCT00115102|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25869238|NCT00115102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25869239|NCT00115102|Anesthetics, General|anesthetics, general|mesh-ancestor
25869240|NCT00115102|Anesthetics|anesthetics|mesh-ancestor
25869241|NCT00115102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24867848|NCT05154682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24868817|NCT02209545|Pyridoxine|pyridoxine|mesh-list
24868818|NCT02209545|Vitamin B 6|vitamin b 6|mesh-list
25869242|NCT00115102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25869243|NCT00115102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25869244|NCT00115102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25869245|NCT00115102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869246|NCT00115102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25869247|NCT00115102|Narcotics|narcotics|mesh-ancestor
25869248|NCT00115102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25230096|NCT02598466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230097|NCT02598466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25230098|NCT02598466|Immunologic Factors|immunologic factors|mesh-ancestor
25044065|NCT01167166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044066|NCT01167166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044068|NCT01166412|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24845986|NCT02240238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869249|NCT00115102|Antidepressive Agents|antidepressive agents|mesh-ancestor
25060663|NCT03478020|Contraceptive Agents|contraceptive agents|mesh-list
25869250|NCT00115102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25869251|NCT00115115|Dopamine|dopamine|mesh-list
25869252|NCT00115115|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25869253|NCT00115115|Sympathomimetics|sympathomimetics|mesh-ancestor
25671111|NCT03058757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25671112|NCT03058757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25671113|NCT02996760|Mitogens|mitogens|mesh-list
25671114|NCT02996760|Mitosis Modulators|mitosis modulators|mesh-ancestor
25671115|NCT02996760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671116|NCT02991651|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25671117|NCT02991651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671118|NCT02991651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25671119|NCT02991651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25671120|NCT02991651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671121|NCT02987946|Nadroparin|nadroparin|mesh-list
25671122|NCT02987946|Anticoagulants|anticoagulants|mesh-ancestor
25671123|NCT02987946|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25671124|NCT02987946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25869254|NCT00115115|Autonomic Agents|autonomic agents|mesh-ancestor
25869255|NCT00115115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25869267|NCT00115154|Immunologic Factors|immunologic factors|mesh-ancestor
25869268|NCT00115154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869269|NCT00115154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25869270|NCT00115154|Interferon Inducers|interferon inducers|mesh-ancestor
25869271|NCT00115167|Darbepoetin alfa|darbepoetin alfa|mesh-list
25869272|NCT00115167|Hematinics|hematinics|mesh-ancestor
25876662|NCT02997228|Endothelial Growth Factors|endothelial growth factors|mesh-list
25876663|NCT02997228|Antibodies|antibodies|mesh-list
25274029|NCT02381470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24868819|NCT02209545|Misoprostol|misoprostol|mesh-list
24548716|NCT00711841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24548717|NCT00711841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24548718|NCT00711841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24548719|NCT00711841|Protease Inhibitors|protease inhibitors|mesh-ancestor
24801185|NCT01981499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801187|NCT01981525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24801188|NCT01981525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548720|NCT00711841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548721|NCT00711841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548722|NCT00711854|Rifampin|rifampin|mesh-list
24548723|NCT00711854|Linezolid|linezolid|mesh-list
24548724|NCT00711854|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25876664|NCT02997228|Immunoglobulins|immunoglobulins|mesh-list
25876665|NCT02997228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25876666|NCT02997228|Immunoglobulin G|immunoglobulin g|mesh-list
24548736|NCT00711854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25230099|NCT02598466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230100|NCT02598466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25230101|NCT02598427|Trastuzumab|trastuzumab|mesh-list
25230102|NCT02598427|Pertuzumab|pertuzumab|mesh-list
25230103|NCT02598427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25230104|NCT02598427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230105|NCT02598414|Fluorophosphate|fluorophosphate|mesh-list
25230106|NCT02598414|Cariostatic Agents|cariostatic agents|mesh-ancestor
25230107|NCT02598414|Protective Agents|protective agents|mesh-ancestor
25230108|NCT02598414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230109|NCT02598440|Alendronate|alendronate|mesh-list
24845988|NCT02240433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24845989|NCT02240433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24845990|NCT02240433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24875890|NCT03816332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875891|NCT03816332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24845991|NCT02240433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671125|NCT02987946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671126|NCT02969083|Gemcitabine|gemcitabine|mesh-list
25671127|NCT02969083|Cisplatin|cisplatin|mesh-list
24548766|NCT00711919|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24548767|NCT00711919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24548768|NCT00711919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24548769|NCT00711919|Antimetabolites|antimetabolites|mesh-ancestor
24548771|NCT00711919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548810|NCT00712205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548811|NCT00712205|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24548812|NCT00712205|Vitamins|vitamins|mesh-ancestor
24548813|NCT00712205|Micronutrients|micronutrients|mesh-ancestor
24548814|NCT00712205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24548815|NCT00712257|Heparin|heparin|mesh-list
24548816|NCT00712257|Anticoagulants|anticoagulants|mesh-ancestor
25230110|NCT02598440|Ibandronic Acid|ibandronic acid|mesh-list
25230111|NCT02598440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25230112|NCT02598440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230113|NCT02598310|Paclitaxel|paclitaxel|mesh-list
25230114|NCT02598310|Trastuzumab|trastuzumab|mesh-list
25230115|NCT02598310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25230116|NCT02598310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230117|NCT02598310|Tubulin Modulators|tubulin modulators|mesh-ancestor
25230118|NCT02598310|Antimitotic Agents|antimitotic agents|mesh-ancestor
25230119|NCT02598310|Mitosis Modulators|mitosis modulators|mesh-ancestor
25230120|NCT02598310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230121|NCT02598310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25230123|NCT02598362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25230124|NCT02598362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25230125|NCT02598362|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25230126|NCT02598362|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25230127|NCT02598362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24875917|NCT03813147|Immunologic Factors|immunologic factors|mesh-ancestor
24875918|NCT03813147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25230128|NCT02598362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230129|NCT02598362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230130|NCT02598362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25230131|NCT02598362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25273468|NCT02385396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273469|NCT02385266|Cycloserine|cycloserine|mesh-list
25273470|NCT02385266|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25273471|NCT02385266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24548817|NCT00712257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24548818|NCT00712257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24548819|NCT00712257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548820|NCT00712374|Pyrimethamine|pyrimethamine|mesh-list
24548828|NCT00712374|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24548829|NCT00712374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548830|NCT00712374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548831|NCT00712374|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24548833|NCT00712400|Latanoprost|latanoprost|mesh-list
24548834|NCT00712400|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24548835|NCT00712400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24548836|NCT00712439|Gabapentin|gabapentin|mesh-list
25869273|NCT00115219|Etanercept|etanercept|mesh-list
25869274|NCT00115219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25869275|NCT00115219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25869276|NCT00115219|Analgesics|analgesics|mesh-ancestor
25869277|NCT00115219|Sensory System Agents|sensory system agents|mesh-ancestor
25869278|NCT00115219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25869279|NCT00115219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869280|NCT00115219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24548857|NCT00712452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24548858|NCT00712452|Alkylating Agents|alkylating agents|mesh-ancestor
24548859|NCT00712452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801200|NCT01981746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24801201|NCT01981746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801202|NCT01981746|Sensory System Agents|sensory system agents|mesh-ancestor
24568447|NCT00796029|Serotonin Agents|serotonin agents|mesh-ancestor
25869283|NCT00115219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25869284|NCT00115219|Immunologic Factors|immunologic factors|mesh-ancestor
25869285|NCT00115245|Adefovir|adefovir|mesh-list
25869286|NCT00115245|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25869287|NCT00115245|Telbivudine|telbivudine|mesh-list
25869288|NCT00115245|Antiviral Agents|antiviral agents|mesh-ancestor
25869289|NCT00115245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25869290|NCT00115245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25869291|NCT00115245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24548862|NCT00712452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24548863|NCT00712452|Tubulin Modulators|tubulin modulators|mesh-ancestor
24548864|NCT00712452|Antimitotic Agents|antimitotic agents|mesh-ancestor
24548865|NCT00712452|Mitosis Modulators|mitosis modulators|mesh-ancestor
24548867|NCT00712465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25869292|NCT00115245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25869293|NCT00115245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870627|NCT04821284|Antidotes|antidotes|mesh-ancestor
24870628|NCT04821284|Protective Agents|protective agents|mesh-ancestor
25869294|NCT00115310|Capsaicin|capsaicin|mesh-list
25230132|NCT02598102|Diclofenac|diclofenac|mesh-list
25230133|NCT02598102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25230134|NCT02598102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25230135|NCT02598102|Analgesics|analgesics|mesh-ancestor
25230136|NCT02598102|Sensory System Agents|sensory system agents|mesh-ancestor
25230137|NCT02598102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25230138|NCT02598102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230139|NCT02598102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25230140|NCT02598102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25869295|NCT00115310|Antipruritics|antipruritics|mesh-ancestor
25869296|NCT00115310|Dermatologic Agents|dermatologic agents|mesh-ancestor
25869297|NCT00115310|Sensory System Agents|sensory system agents|mesh-ancestor
25869298|NCT00115310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25869299|NCT00115310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869300|NCT00115362|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25869301|NCT00115362|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25869302|NCT00115362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25869303|NCT00115362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25869304|NCT00115362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869305|NCT00115362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25869306|NCT00115362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869307|NCT00115362|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25869308|NCT00115362|Antidepressive Agents|antidepressive agents|mesh-ancestor
25869309|NCT00115362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25869310|NCT00115375|Clopidogrel|clopidogrel|mesh-list
25869311|NCT00115375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25869312|NCT00115375|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25869313|NCT00115375|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25869314|NCT00115375|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25869315|NCT00115375|Purinergic Agents|purinergic agents|mesh-ancestor
25869316|NCT00115375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25869317|NCT00115375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869318|NCT00115375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548891|NCT00712504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548892|NCT00712504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24548893|NCT00712504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24548894|NCT00712504|Growth Substances|growth substances|mesh-ancestor
24548895|NCT00712504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548896|NCT00712504|Growth Inhibitors|growth inhibitors|mesh-ancestor
24548897|NCT00712504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24548898|NCT00712504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25869319|NCT00115414|Cyclophosphamide|cyclophosphamide|mesh-list
25869320|NCT00115414|Docetaxel|docetaxel|mesh-list
25869321|NCT00115414|Doxorubicin|doxorubicin|mesh-list
25869322|NCT00115414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25869323|NCT00115414|Immunologic Factors|immunologic factors|mesh-ancestor
25869324|NCT00115414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869325|NCT00115414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25869326|NCT00115414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25869327|NCT00115414|Alkylating Agents|alkylating agents|mesh-ancestor
24548903|NCT00712517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548904|NCT00712517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24548905|NCT00712517|Anesthetics, General|anesthetics, general|mesh-ancestor
24548906|NCT00712517|Anesthetics|anesthetics|mesh-ancestor
24548907|NCT00712517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25230141|NCT02598102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25230142|NCT02598102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230143|NCT02598102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230144|NCT02597998|BI 409306|bi 409306|mesh-list
25230145|NCT02597998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25230146|NCT02597998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230147|NCT02597998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230148|NCT02598063|Lamivudine|lamivudine|mesh-list
25230149|NCT02598063|Adefovir|adefovir|mesh-list
25230150|NCT02598063|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25230151|NCT02598063|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25230152|NCT02598063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25869328|NCT00115414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869329|NCT00115414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25869330|NCT00115414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25869331|NCT00115414|Tubulin Modulators|tubulin modulators|mesh-ancestor
25869332|NCT00115414|Antimitotic Agents|antimitotic agents|mesh-ancestor
25869333|NCT00115414|Mitosis Modulators|mitosis modulators|mesh-ancestor
25869334|NCT00115414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25869335|NCT00115414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25869336|NCT00115414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25869337|NCT00115414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24801205|NCT01981811|Antidepressive Agents|antidepressive agents|mesh-ancestor
24801206|NCT01981811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24801207|NCT01981811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24801208|NCT01981811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24801209|NCT01981811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24801210|NCT01981811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801211|NCT01981811|Dopamine Agonists|dopamine agonists|mesh-ancestor
24801212|NCT01981811|Dopamine Agents|dopamine agents|mesh-ancestor
24801213|NCT01981811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24801214|NCT01981811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801215|NCT01981811|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24801216|NCT01981811|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24801217|NCT01981811|Serotonin Agents|serotonin agents|mesh-ancestor
24801218|NCT01981811|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24801219|NCT01981811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24801223|NCT01981889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25869338|NCT00115479|Benzocaine|benzocaine|mesh-list
24548968|NCT00712686|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24548969|NCT00712686|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24548970|NCT00712738|Nifedipine|nifedipine|mesh-list
24548971|NCT00712738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24548972|NCT00712738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24548973|NCT00712738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548974|NCT00712738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25869339|NCT00115479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869340|NCT00115479|Anesthetics, Local|anesthetics, local|mesh-ancestor
24570525|NCT00805116|Vitamins|vitamins|mesh-ancestor
24548975|NCT00712738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548976|NCT00712738|Vasodilator Agents|vasodilator agents|mesh-ancestor
24548977|NCT00712738|Tocolytic Agents|tocolytic agents|mesh-ancestor
24548978|NCT00712738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24548979|NCT00712764|Adenosine|adenosine|mesh-list
24801234|NCT01981941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801235|NCT01981941|Anticonvulsants|anticonvulsants|mesh-ancestor
24801236|NCT01981941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24801237|NCT01981941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24801238|NCT01981941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24801239|NCT01981941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25869341|NCT00115479|Anesthetics|anesthetics|mesh-ancestor
24548992|NCT00712777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24548993|NCT00712777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24548994|NCT00712777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24548995|NCT00712777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24548996|NCT00712777|Adrenergic Agents|adrenergic agents|mesh-ancestor
24548997|NCT00712777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24548998|NCT00712777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548999|NCT00712777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549013|NCT00712894|Nitroglycerin|nitroglycerin|mesh-list
24549014|NCT00712894|Vasodilator Agents|vasodilator agents|mesh-ancestor
24549015|NCT00712894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24549016|NCT00712894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24549017|NCT00712894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24549018|NCT00712894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230153|NCT02598063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25230154|NCT02598063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230155|NCT02598063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846011|NCT02240602|Narcotics|narcotics|mesh-ancestor
24549019|NCT00712894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24549020|NCT00712894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549021|NCT00712894|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24549022|NCT00712907|Ascorbic Acid|ascorbic acid|mesh-list
24549023|NCT00712907|Vitamins|vitamins|mesh-ancestor
24549024|NCT00712907|Micronutrients|micronutrients|mesh-ancestor
24549025|NCT00712907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549026|NCT00712907|Antioxidants|antioxidants|mesh-ancestor
24549027|NCT00712907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549028|NCT00712907|Protective Agents|protective agents|mesh-ancestor
24549029|NCT00712933|Belimumab|belimumab|mesh-list
24549030|NCT00712933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24549033|NCT00713011|Nifedipine|nifedipine|mesh-list
24549052|NCT00713193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24549053|NCT00713193|Glucocorticoids|glucocorticoids|mesh-ancestor
24568893|NCT00798070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549066|NCT00713193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24549069|NCT00713271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24549070|NCT00713271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24549071|NCT00713271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24549072|NCT00713271|Adrenergic Agents|adrenergic agents|mesh-ancestor
25869342|NCT00115479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25869343|NCT00115479|Sensory System Agents|sensory system agents|mesh-ancestor
25869344|NCT00115479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25869345|NCT00115492|Fluticasone|fluticasone|mesh-list
25869346|NCT00115492|Xhance|xhance|mesh-list
25869347|NCT00115492|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25869348|NCT00115492|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25869349|NCT00115492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25869350|NCT00115492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24405946|NCT00168870|Gemcitabine|gemcitabine|mesh-list
25869351|NCT00115492|Autonomic Agents|autonomic agents|mesh-ancestor
25869352|NCT00115492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25869353|NCT00115492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869354|NCT00115492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25869355|NCT00115492|Respiratory System Agents|respiratory system agents|mesh-ancestor
25869356|NCT00115492|Dermatologic Agents|dermatologic agents|mesh-ancestor
25869357|NCT00115492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25869358|NCT00115492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25869359|NCT00115492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25869360|NCT00115492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25869361|NCT00115492|Adrenergic Agents|adrenergic agents|mesh-ancestor
25434387|NCT00160173|Estrogens|estrogens|mesh-ancestor
25869362|NCT00115492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25869363|NCT00115492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131433|NCT03025880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131434|NCT03025880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25131440|NCT03025958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25131441|NCT03025958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25869364|NCT00115492|Glucocorticoids|glucocorticoids|mesh-ancestor
25869365|NCT00115492|Hormones|hormones|mesh-ancestor
25869366|NCT00115492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25869367|NCT00115492|Sympathomimetics|sympathomimetics|mesh-ancestor
24569083|NCT00798980|Contraceptive Agents|contraceptive agents|mesh-ancestor
25869368|NCT00115518|Cetuximab|cetuximab|mesh-list
25869369|NCT00115518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25869370|NCT00115518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25869371|NCT00115531|Vaccines|vaccines|mesh-list
25869372|NCT00115531|Immunologic Factors|immunologic factors|mesh-ancestor
25869373|NCT00115531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869374|NCT00115544|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
25869375|NCT00115544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25869376|NCT00115544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869377|NCT00115570|Insulin|insulin|mesh-list
25230156|NCT02598063|Antiviral Agents|antiviral agents|mesh-ancestor
25230157|NCT02598063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25230158|NCT02598063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25230159|NCT02598063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25230160|NCT02598011|Flucytosine|flucytosine|mesh-list
25230161|NCT02598011|Antifungal Agents|antifungal agents|mesh-ancestor
25230162|NCT02598011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24549103|NCT00713440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24549104|NCT00713440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549105|NCT00713440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24569219|NCT00799448|Insulin, Isophane|insulin, isophane|mesh-list
24549116|NCT00713440|Antipyretics|antipyretics|mesh-ancestor
24549117|NCT00713557|Tirofiban|tirofiban|mesh-list
24549118|NCT00713557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24549119|NCT00713557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25869378|NCT00115570|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25869379|NCT00115570|Insulin Glargine|insulin glargine|mesh-list
25869380|NCT00115570|Insulin Lispro|insulin lispro|mesh-list
25869381|NCT00115570|Insulin glulisine|insulin glulisine|mesh-list
25869382|NCT00115570|Insulin, Isophane|insulin, isophane|mesh-list
25869383|NCT00115570|Isophane Insulin, Human|isophane insulin, human|mesh-list
25869384|NCT00115570|Isophane insulin, beef|isophane insulin, beef|mesh-list
25869385|NCT00115570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25869386|NCT00115570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869387|NCT00115583|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
25869388|NCT00115583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25869389|NCT00115583|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25869390|NCT00115583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869391|NCT00115609|Tenofovir|tenofovir|mesh-list
25869392|NCT00115609|Emtricitabine|emtricitabine|mesh-list
25869393|NCT00115609|Efavirenz|efavirenz|mesh-list
25869394|NCT00115609|Antiviral Agents|antiviral agents|mesh-ancestor
25869395|NCT00115609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25869396|NCT00115609|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25869397|NCT00115609|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25869398|NCT00115609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25869399|NCT00115609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869400|NCT00115609|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25869401|NCT00115609|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25869402|NCT00115609|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25869403|NCT00115609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25869404|NCT00115609|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25869405|NCT00115609|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25869406|NCT00115609|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24569409|NCT00800462|Cholinergic Agents|cholinergic agents|mesh-ancestor
24814904|NCT02067143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24814937|NCT02067416|Tubulin Modulators|tubulin modulators|mesh-ancestor
24814938|NCT02067416|Antimitotic Agents|antimitotic agents|mesh-ancestor
24871877|NCT04078906|SMOFlipid|smoflipid|mesh-list
24553647|NCT00732446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25671128|NCT02969083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671129|NCT02969083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25671130|NCT02969083|Antimetabolites|antimetabolites|mesh-ancestor
25671131|NCT02969083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671132|NCT02969083|Antiviral Agents|antiviral agents|mesh-ancestor
25131535|NCT03025295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24549176|NCT00713739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549177|NCT00713739|Vasodilator Agents|vasodilator agents|mesh-ancestor
24549178|NCT00713739|Tocolytic Agents|tocolytic agents|mesh-ancestor
24549179|NCT00713739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24549180|NCT00713739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24549181|NCT00713739|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24549182|NCT00713739|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24549183|NCT00713739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24549184|NCT00713739|Adrenergic Agents|adrenergic agents|mesh-ancestor
25869407|NCT00115609|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25869408|NCT00115622|Fluticasone|fluticasone|mesh-list
25869409|NCT00115622|Xhance|xhance|mesh-list
25869410|NCT00115622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25869411|NCT00115622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25230163|NCT02598011|Antimetabolites|antimetabolites|mesh-ancestor
25230164|NCT02598011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230165|NCT02597868|Capecitabine|capecitabine|mesh-list
25230166|NCT02597868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25230167|NCT02597868|Antimetabolites|antimetabolites|mesh-ancestor
25273472|NCT02385266|Renal Agents|renal agents|mesh-ancestor
24846080|NCT02241096|Anesthetics, Local|anesthetics, local|mesh-ancestor
25869412|NCT00115622|Autonomic Agents|autonomic agents|mesh-ancestor
25869413|NCT00115622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25869414|NCT00115622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869415|NCT00115622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25869416|NCT00115622|Respiratory System Agents|respiratory system agents|mesh-ancestor
25869417|NCT00115622|Dermatologic Agents|dermatologic agents|mesh-ancestor
24549185|NCT00713739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24549186|NCT00713739|Urological Agents|urological agents|mesh-ancestor
24549188|NCT00713765|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24595483|NCT00938821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24595484|NCT00938821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24595485|NCT00938821|Narcotics|narcotics|mesh-ancestor
24595486|NCT00938821|Analgesics|analgesics|mesh-ancestor
24595488|NCT00938899|Antiviral Agents|antiviral agents|mesh-ancestor
24595489|NCT00938899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24595490|NCT00938899|Protease Inhibitors|protease inhibitors|mesh-ancestor
24595491|NCT00938899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595492|NCT00938899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869418|NCT00115622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24549189|NCT00713765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549190|NCT00713765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549191|NCT00713765|Cholinergic Agents|cholinergic agents|mesh-ancestor
24549192|NCT00713765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24549193|NCT00713765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549194|NCT00713765|Nootropic Agents|nootropic agents|mesh-ancestor
24549195|NCT00713921|Fesoterodine|fesoterodine|mesh-list
24549196|NCT00713921|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25869419|NCT00115635|Gemcitabine|gemcitabine|mesh-list
25869420|NCT00115635|Docetaxel|docetaxel|mesh-list
25869421|NCT00115635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24406703|NCT00171041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25869422|NCT00115635|Antimetabolites|antimetabolites|mesh-ancestor
25869423|NCT00115635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869424|NCT00115635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25869425|NCT00115635|Antiviral Agents|antiviral agents|mesh-ancestor
25869426|NCT00115635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25869427|NCT00115635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25869428|NCT00115635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25869429|NCT00115635|Immunologic Factors|immunologic factors|mesh-ancestor
24622281|NCT01066468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622282|NCT01066468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24622283|NCT01066468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622284|NCT01066468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622285|NCT01066494|Cytarabine|cytarabine|mesh-list
24622286|NCT01066494|Amonafide|amonafide|mesh-list
24622287|NCT01066494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24622288|NCT01066494|Antimetabolites|antimetabolites|mesh-ancestor
24622289|NCT01066494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622290|NCT01066494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622293|NCT01066494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24622294|NCT01066494|Immunologic Factors|immunologic factors|mesh-ancestor
25671133|NCT02969083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25671134|NCT02969083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622295|NCT01066494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622296|NCT01066494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622297|NCT01066559|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
24622298|NCT01066559|Vasodilator Agents|vasodilator agents|mesh-ancestor
24622299|NCT01066559|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25869430|NCT00115635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230168|NCT02597868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230169|NCT02597868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230170|NCT02597829|Certolizumab Pegol|certolizumab pegol|mesh-list
25230171|NCT02597829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25230172|NCT02597829|Immunologic Factors|immunologic factors|mesh-ancestor
25230173|NCT02597829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230174|NCT02597829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25230175|NCT02597699|Lidocaine|lidocaine|mesh-list
25230176|NCT02597699|Sufentanil|sufentanil|mesh-list
24846040|NCT02240719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24846041|NCT02240719|Alkylating Agents|alkylating agents|mesh-ancestor
24846042|NCT02240719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476639|NCT00415935|Antimetabolites|antimetabolites|mesh-ancestor
24846069|NCT02241083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24846070|NCT02241083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846075|NCT02241083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24846076|NCT02241083|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24846077|NCT02241083|Dopamine Agents|dopamine agents|mesh-ancestor
24846078|NCT02241083|Protective Agents|protective agents|mesh-ancestor
24846079|NCT02241096|Lidocaine|lidocaine|mesh-list
25869431|NCT00115635|Tubulin Modulators|tubulin modulators|mesh-ancestor
25869432|NCT00115635|Antimitotic Agents|antimitotic agents|mesh-ancestor
25869433|NCT00115635|Mitosis Modulators|mitosis modulators|mesh-ancestor
25869434|NCT00115648|Zidovudine|zidovudine|mesh-list
24622309|NCT01066572|Protective Agents|protective agents|mesh-ancestor
24622310|NCT01066572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869435|NCT00115648|Nevirapine|nevirapine|mesh-list
25869436|NCT00115648|Antimetabolites|antimetabolites|mesh-ancestor
25869437|NCT00115648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869438|NCT00115648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24873136|NCT05391971|Sensory System Agents|sensory system agents|mesh-ancestor
24873203|NCT05320380|Cytarabine|cytarabine|mesh-list
24873204|NCT05320380|Prednisolone|prednisolone|mesh-list
24873205|NCT05320380|Hydrocortisone|hydrocortisone|mesh-list
25869439|NCT00115648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25869440|NCT00115648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25869441|NCT00115648|Antiviral Agents|antiviral agents|mesh-ancestor
25869442|NCT00115648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25869443|NCT00115648|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25869444|NCT00115648|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24549261|NCT00714103|Vasodilator Agents|vasodilator agents|mesh-ancestor
24549262|NCT00714103|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24549263|NCT00714103|Purinergic Agonists|purinergic agonists|mesh-ancestor
24549264|NCT00714103|Purinergic Agents|purinergic agents|mesh-ancestor
24549265|NCT00714103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24549266|NCT00714103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549267|NCT00714181|Hydroxychloroquine|hydroxychloroquine|mesh-list
24549268|NCT00714181|Temozolomide|temozolomide|mesh-list
24549296|NCT00714480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549297|NCT00714480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25869445|NCT00115648|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24549298|NCT00714519|Castor Oil|castor oil|mesh-list
24549299|NCT00714519|Cathartics|cathartics|mesh-ancestor
24549300|NCT00714519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24549301|NCT00714558|Fentanyl|fentanyl|mesh-list
24549302|NCT00714558|Naltrexone|naltrexone|mesh-list
25869446|NCT00115648|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25869447|NCT00115661|Rosiglitazone|rosiglitazone|mesh-list
25230177|NCT02597699|Remifentanil|remifentanil|mesh-list
25230179|NCT02597699|Anesthetics, Local|anesthetics, local|mesh-ancestor
25230180|NCT02597699|Anesthetics|anesthetics|mesh-ancestor
25230181|NCT02597699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25230182|NCT02597699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230183|NCT02597699|Sensory System Agents|sensory system agents|mesh-ancestor
25230184|NCT02597699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25230185|NCT02597699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25230186|NCT02597699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25230187|NCT02597699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25230188|NCT02597699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25869448|NCT00115661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25230190|NCT02597699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25230191|NCT02597699|Narcotics|narcotics|mesh-ancestor
25230192|NCT02597699|Analgesics|analgesics|mesh-ancestor
25230193|NCT02597699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24874310|NCT04830215|Brexpiprazole|brexpiprazole|mesh-list
25230194|NCT02597699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25230195|NCT02597699|Anesthetics, General|anesthetics, general|mesh-ancestor
25230196|NCT02597556|Albendazole|albendazole|mesh-list
24846087|NCT02241096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24846088|NCT02241096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24846089|NCT02241096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24846101|NCT02241161|Protective Agents|protective agents|mesh-ancestor
24846090|NCT02241096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606220|NCT00989625|Naproxen|naproxen|mesh-list
24846091|NCT02241148|Acetaminophen|acetaminophen|mesh-list
24846093|NCT02241148|Analgesics|analgesics|mesh-ancestor
24846094|NCT02241148|Sensory System Agents|sensory system agents|mesh-ancestor
24846095|NCT02241148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24846096|NCT02241148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869449|NCT00115661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869450|NCT00115687|Nicotine|nicotine|mesh-list
25869451|NCT00115687|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25869452|NCT00115687|Autonomic Agents|autonomic agents|mesh-ancestor
25869453|NCT00115687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24622321|NCT01066650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553844|NCT00733031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24549331|NCT00714623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869454|NCT00115687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549332|NCT00714649|Cetuximab|cetuximab|mesh-list
24549333|NCT00714649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24549334|NCT00714649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549335|NCT00714740|Acetazolamide|acetazolamide|mesh-list
24549336|NCT00714740|Anticonvulsants|anticonvulsants|mesh-ancestor
24549337|NCT00714740|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24549338|NCT00714740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549339|NCT00714740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549340|NCT00714740|Diuretics|diuretics|mesh-ancestor
24549341|NCT00714740|Natriuretic Agents|natriuretic agents|mesh-ancestor
24549342|NCT00714740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549343|NCT00714779|Fluoxetine|fluoxetine|mesh-list
25869455|NCT00115687|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25869456|NCT00115687|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25869457|NCT00115687|Cholinergic Agents|cholinergic agents|mesh-ancestor
25869458|NCT00115687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25869459|NCT00115687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549350|NCT00714779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549351|NCT00714779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24549352|NCT00714779|Antidepressive Agents|antidepressive agents|mesh-ancestor
25090930|NCT03252496|Ephedrine|ephedrine|mesh-list
24874311|NCT04830215|Serotonin Agents|serotonin agents|mesh-ancestor
24549353|NCT00714779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24549354|NCT00714779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24549355|NCT00714779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25671135|NCT02969083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25671136|NCT02969083|Immunologic Factors|immunologic factors|mesh-ancestor
25671137|NCT02969083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671138|NCT02866383|Nivolumab|nivolumab|mesh-list
25671139|NCT02866383|Ipilimumab|ipilimumab|mesh-list
25671140|NCT02866383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25671141|NCT02866383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549356|NCT00714779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230199|NCT02597556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25230200|NCT02597556|Anticestodal Agents|anticestodal agents|mesh-ancestor
25230201|NCT02597556|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25230202|NCT02597556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25230203|NCT02597556|Tubulin Modulators|tubulin modulators|mesh-ancestor
25230204|NCT02597556|Antimitotic Agents|antimitotic agents|mesh-ancestor
25230205|NCT02597556|Mitosis Modulators|mitosis modulators|mesh-ancestor
25230206|NCT02597556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230207|NCT02597556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230208|NCT02597387|Mitoxantrone|mitoxantrone|mesh-list
25230209|NCT02597387|Analgesics|analgesics|mesh-ancestor
25230210|NCT02597387|Sensory System Agents|sensory system agents|mesh-ancestor
25230211|NCT02597387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25230212|NCT02597387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230213|NCT02597387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230214|NCT02597387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24846097|NCT02241148|Antipyretics|antipyretics|mesh-ancestor
24846098|NCT02241161|Bacteriocins|bacteriocins|mesh-list
24846099|NCT02241161|Antioxidants|antioxidants|mesh-list
24846100|NCT02241161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846102|NCT02241161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846103|NCT02241161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24846104|NCT02241161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25869460|NCT00115700|Prednisolone|prednisolone|mesh-list
25869461|NCT00115700|Cyclophosphamide|cyclophosphamide|mesh-list
25869463|NCT00115700|Vincristine|vincristine|mesh-list
25869464|NCT00115700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25869465|NCT00115700|Immunologic Factors|immunologic factors|mesh-ancestor
25869466|NCT00115700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869467|NCT00115700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24549363|NCT00714857|Sensory System Agents|sensory system agents|mesh-ancestor
24549364|NCT00714857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24549365|NCT00714857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24549366|NCT00714857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24549367|NCT00714857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24549368|NCT00714857|Adrenergic Agents|adrenergic agents|mesh-ancestor
24549369|NCT00714857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24549370|NCT00714857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549372|NCT00714883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24549373|NCT00714883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24549374|NCT00714883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24447721|NCT00309491|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24447738|NCT00309530|Fluorouracil|fluorouracil|mesh-list
24622325|NCT01066663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24622326|NCT01066663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24622327|NCT01066663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24553962|NCT00733564|Lidocaine|lidocaine|mesh-list
24447739|NCT00309530|Antimetabolites|antimetabolites|mesh-ancestor
24447740|NCT00309530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447741|NCT00309530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24447742|NCT00309530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447743|NCT00309530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24447744|NCT00309530|Immunologic Factors|immunologic factors|mesh-ancestor
24447745|NCT00309530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447746|NCT00309530|Antiviral Agents|antiviral agents|mesh-ancestor
24447747|NCT00309530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24447748|NCT00309543|Leucovorin|leucovorin|mesh-list
24447749|NCT00309543|Fluorouracil|fluorouracil|mesh-list
25869468|NCT00115700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25869469|NCT00115700|Alkylating Agents|alkylating agents|mesh-ancestor
25869470|NCT00115700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549434|NCT00715273|Niacinamide|niacinamide|mesh-list
24549435|NCT00715273|Nicotinic Acids|nicotinic acids|mesh-list
24549436|NCT00715273|Atorvastatin|atorvastatin|mesh-list
25869471|NCT00115700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25869472|NCT00115700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25869473|NCT00115700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25869474|NCT00115700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25869475|NCT00115700|Tubulin Modulators|tubulin modulators|mesh-ancestor
25230215|NCT02597387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25230216|NCT02597387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230217|NCT02597387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869476|NCT00115700|Antimitotic Agents|antimitotic agents|mesh-ancestor
25230220|NCT02597400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230221|NCT02597361|Irbesartan|irbesartan|mesh-list
25230222|NCT02597361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24874993|NCT04481204|Paclitaxel|paclitaxel|mesh-list
25869477|NCT00115700|Mitosis Modulators|mitosis modulators|mesh-ancestor
25869478|NCT00115700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25869479|NCT00115700|Glucocorticoids|glucocorticoids|mesh-ancestor
25869480|NCT00115700|Hormones|hormones|mesh-ancestor
25869481|NCT00115700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25869482|NCT00115700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24801271|NCT01982461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24801272|NCT01982461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25869483|NCT00115726|Furosemide|furosemide|mesh-list
25869484|NCT00115726|Diuretics|diuretics|mesh-ancestor
25869485|NCT00115726|Natriuretic Agents|natriuretic agents|mesh-ancestor
25869486|NCT00115726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869487|NCT00115726|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25869488|NCT00115726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25869489|NCT00115726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869490|NCT00115752|Valdecoxib|valdecoxib|mesh-list
25869491|NCT00115752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
25869492|NCT00115752|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25869493|NCT00115752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25869494|NCT00115752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869495|NCT00115752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25869496|NCT00115752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25869497|NCT00115752|Analgesics|analgesics|mesh-ancestor
25869498|NCT00115752|Sensory System Agents|sensory system agents|mesh-ancestor
24549482|NCT00715637|Daunorubicin|daunorubicin|mesh-list
24549483|NCT00715637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24549484|NCT00715637|Antimetabolites|antimetabolites|mesh-ancestor
24549485|NCT00715637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801278|NCT01982578|Genistein|genistein|mesh-list
24801285|NCT01982578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801286|NCT01982578|Phytoestrogens|phytoestrogens|mesh-ancestor
24801287|NCT01982578|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24801288|NCT01982578|Estrogens|estrogens|mesh-ancestor
24801289|NCT01982578|Hormones|hormones|mesh-ancestor
24801290|NCT01982578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25230223|NCT02597361|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25230224|NCT02597361|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25230225|NCT02597361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230226|NCT02597283|Sirolimus|sirolimus|mesh-list
25230227|NCT02597283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25230228|NCT02597283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25230229|NCT02597283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24846113|NCT02241278|Sensory System Agents|sensory system agents|mesh-ancestor
24846114|NCT02241278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24846115|NCT02241278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846147|NCT02241460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846148|NCT02241460|Sensory System Agents|sensory system agents|mesh-ancestor
24846149|NCT02241460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24846150|NCT02241460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25060793|NCT03476564|Protective Agents|protective agents|mesh-ancestor
24801291|NCT01982734|Curcumin|curcumin|mesh-list
24801292|NCT01982734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24554094|NCT00734279|Leuprolide|leuprolide|mesh-list
24554095|NCT00734279|Ganirelix|ganirelix|mesh-list
24554096|NCT00734279|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24554097|NCT00734279|Fertility Agents|fertility agents|mesh-ancestor
24554098|NCT00734279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24554101|NCT00734279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25869499|NCT00115752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25869500|NCT00115752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869501|NCT00115752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25869502|NCT00115752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25869503|NCT00115817|Atorvastatin|atorvastatin|mesh-list
25869504|NCT00115817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25869505|NCT00115817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25869506|NCT00115817|Antimetabolites|antimetabolites|mesh-ancestor
25869507|NCT00115817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549493|NCT00715637|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24573199|NCT00818415|Naproxen|naproxen|mesh-list
24549494|NCT00715637|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24549495|NCT00715637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549496|NCT00715663|Insulin Aspart|insulin aspart|mesh-list
25869508|NCT00115817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25869509|NCT00115817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25869510|NCT00115817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25869511|NCT00115830|Atorvastatin|atorvastatin|mesh-list
25869512|NCT00115830|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25869513|NCT00115830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25869514|NCT00115830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25869515|NCT00115830|Antimetabolites|antimetabolites|mesh-ancestor
25869516|NCT00115830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869517|NCT00115830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25869518|NCT00115830|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25869519|NCT00115830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25869520|NCT00115908|Ribavirin|ribavirin|mesh-list
25869521|NCT00115908|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25869522|NCT00115908|Antimetabolites|antimetabolites|mesh-ancestor
25869523|NCT00115908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869524|NCT00115908|Antiviral Agents|antiviral agents|mesh-ancestor
24549509|NCT00715702|Antiviral Agents|antiviral agents|mesh-ancestor
25869525|NCT00115908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25869526|NCT00115921|Antimalarials|antimalarials|mesh-list
25869527|NCT00115921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25869528|NCT00115921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25869529|NCT00115921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25869530|NCT00115947|Terlipressin|terlipressin|mesh-list
25869531|NCT00115947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25869532|NCT00115947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25869533|NCT00115973|Insulin Aspart|insulin aspart|mesh-list
25869534|NCT00115973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25869535|NCT00115973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869536|NCT00116064|Lorazepam|lorazepam|mesh-list
25869537|NCT00116064|Paraldehyde|paraldehyde|mesh-list
25869538|NCT00116064|Anticonvulsants|anticonvulsants|mesh-ancestor
25869539|NCT00116064|Antiemetics|antiemetics|mesh-ancestor
25869540|NCT00116064|Autonomic Agents|autonomic agents|mesh-ancestor
25230230|NCT02597283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230231|NCT02597283|Antifungal Agents|antifungal agents|mesh-ancestor
25230232|NCT02597283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25230233|NCT02597283|Immunologic Factors|immunologic factors|mesh-ancestor
25230234|NCT02597283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230235|NCT02597231|Melatonin|melatonin|mesh-list
25230236|NCT02597231|Antioxidants|antioxidants|mesh-ancestor
25230237|NCT02597231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230238|NCT02597231|Protective Agents|protective agents|mesh-ancestor
24846151|NCT02241460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24846152|NCT02241460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24846218|NCT02242214|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24846154|NCT02241460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846155|NCT02241499|Fluorouracil|fluorouracil|mesh-list
24846156|NCT02241499|Oxaliplatin|oxaliplatin|mesh-list
24846157|NCT02241499|Antimetabolites|antimetabolites|mesh-ancestor
24846158|NCT02241499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846159|NCT02241499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24846160|NCT02241499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24846161|NCT02241499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24846162|NCT02241499|Immunologic Factors|immunologic factors|mesh-ancestor
24476755|NCT00416429|Interferons|interferons|mesh-list
24846194|NCT02241876|Expectorants|expectorants|mesh-ancestor
24846195|NCT02241876|Respiratory System Agents|respiratory system agents|mesh-ancestor
24846196|NCT02241876|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24846197|NCT02241876|Antioxidants|antioxidants|mesh-ancestor
24846198|NCT02241876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846199|NCT02241876|Protective Agents|protective agents|mesh-ancestor
24846200|NCT02241876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846201|NCT02241876|Antidotes|antidotes|mesh-ancestor
25869541|NCT00116064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25869542|NCT00116064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549525|NCT00715780|Biphasic Insulins|biphasic insulins|mesh-list
24549526|NCT00715780|Isophane Insulin, Human|isophane insulin, human|mesh-list
24801300|NCT01982734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24801301|NCT01982734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409528|NCT03371667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25869543|NCT00116064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25869544|NCT00116064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25869545|NCT00116064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25131959|NCT03022240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25131960|NCT03022240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25131961|NCT03022240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25131962|NCT03022201|Domperidone|domperidone|mesh-list
25131963|NCT03022201|Antiemetics|antiemetics|mesh-ancestor
25131964|NCT03022201|Autonomic Agents|autonomic agents|mesh-ancestor
25131965|NCT03022201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25131966|NCT03022201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131967|NCT03022201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25131988|NCT03022500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25131989|NCT03022500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131990|NCT03021772|Dexamethasone|dexamethasone|mesh-list
25131991|NCT03021772|Neostigmine|neostigmine|mesh-list
25131992|NCT03021772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25131993|NCT03021772|Antiemetics|antiemetics|mesh-ancestor
24801302|NCT01982734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801303|NCT01982760|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24801304|NCT01982760|Hemostatics|hemostatics|mesh-ancestor
24801305|NCT01982760|Coagulants|coagulants|mesh-ancestor
24801306|NCT01982760|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24801307|NCT01982760|Natriuretic Agents|natriuretic agents|mesh-ancestor
24801308|NCT01982760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801309|NCT01982799|Acetaminophen|acetaminophen|mesh-list
24801310|NCT01982799|Ibuprofen|ibuprofen|mesh-list
24801311|NCT01982799|Naproxen|naproxen|mesh-list
24801312|NCT01982799|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
24801313|NCT01982799|Hydrocodone|hydrocodone|mesh-list
24801314|NCT01982799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24801315|NCT01982799|Analgesics|analgesics|mesh-ancestor
24801316|NCT01982799|Sensory System Agents|sensory system agents|mesh-ancestor
24801317|NCT01982799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24570721|NCT00806247|Tapentadol|tapentadol|mesh-list
24549537|NCT00715858|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24549538|NCT00715858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24549539|NCT00715858|Antitubercular Agents|antitubercular agents|mesh-ancestor
24549540|NCT00715858|Leprostatic Agents|leprostatic agents|mesh-ancestor
24549541|NCT00715858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24549542|NCT00715858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549543|NCT00715858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230239|NCT02597231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230240|NCT02597231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25230241|NCT02597309|Canagliflozin|canagliflozin|mesh-list
25230242|NCT02597309|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25230243|NCT02597309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230244|NCT02597309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25230245|NCT02597309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230246|NCT02597114|Insulin|insulin|mesh-list
25230247|NCT02597114|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25230248|NCT02597114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25230249|NCT02597114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230250|NCT02597257|Lidocaine|lidocaine|mesh-list
25230251|NCT02597257|Anesthetics, Local|anesthetics, local|mesh-ancestor
25230252|NCT02597257|Anesthetics|anesthetics|mesh-ancestor
25230253|NCT02597257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25230254|NCT02597257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230255|NCT02597257|Sensory System Agents|sensory system agents|mesh-ancestor
25230256|NCT02597257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25671142|NCT02866383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25671143|NCT02866383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671144|NCT02865473|Pilocarpine|pilocarpine|mesh-list
25671145|NCT02865473|Miotics|miotics|mesh-ancestor
25671146|NCT02865473|Autonomic Agents|autonomic agents|mesh-ancestor
25671147|NCT02865473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25671148|NCT02865473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671149|NCT02865473|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25671150|NCT02865473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25671151|NCT02865473|Cholinergic Agents|cholinergic agents|mesh-ancestor
25671152|NCT02865473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25671153|NCT02865473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671154|NCT02850419|Doxorubicin|doxorubicin|mesh-list
25671155|NCT02850419|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25671156|NCT02850419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25230257|NCT02597257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24573234|NCT00818675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230258|NCT02597257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25230259|NCT02597257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24846203|NCT02241941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24846204|NCT02241941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24846205|NCT02242032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24846219|NCT02242214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24846220|NCT02242214|Oxytocics|oxytocics|mesh-ancestor
24846221|NCT02242227|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24846222|NCT02242227|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24846223|NCT02242227|Autonomic Agents|autonomic agents|mesh-ancestor
24846224|NCT02242227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24846225|NCT02242227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869546|NCT00116064|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25869547|NCT00116064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25869548|NCT00116064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25869549|NCT00116064|GABA Modulators|gaba modulators|mesh-ancestor
25869550|NCT00116064|GABA Agents|gaba agents|mesh-ancestor
25869551|NCT00116064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25869552|NCT00116064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869553|NCT00116103|Tacrolimus|tacrolimus|mesh-list
24549544|NCT00715858|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24549545|NCT00715858|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24549546|NCT00715858|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24549547|NCT00715858|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24549548|NCT00715858|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24549561|NCT00715975|Halobetasol|halobetasol|mesh-list
24549562|NCT00715975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24549563|NCT00715975|Glucocorticoids|glucocorticoids|mesh-ancestor
24549564|NCT00715975|Hormones|hormones|mesh-ancestor
24549565|NCT00715975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24549566|NCT00715975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549567|NCT00715975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24549569|NCT00716001|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24549570|NCT00716001|Antiviral Agents|antiviral agents|mesh-ancestor
24549571|NCT00716001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24549572|NCT00716001|Expectorants|expectorants|mesh-ancestor
24549573|NCT00716001|Respiratory System Agents|respiratory system agents|mesh-ancestor
24549574|NCT00716001|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24549581|NCT00716170|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
24549583|NCT00716170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24549584|NCT00716170|Hormones|hormones|mesh-ancestor
24549585|NCT00716170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24549586|NCT00716170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549587|NCT00716170|Incretins|incretins|mesh-ancestor
25869554|NCT00116103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25869555|NCT00116103|Immunologic Factors|immunologic factors|mesh-ancestor
24801322|NCT01982799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24801323|NCT01982799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24801324|NCT01982799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24801325|NCT01982799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230260|NCT02597257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25230261|NCT02597257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230262|NCT02597140|Lidocaine|lidocaine|mesh-list
25230263|NCT02597140|Propofol|propofol|mesh-list
25230264|NCT02597140|Anesthetics, Local|anesthetics, local|mesh-ancestor
25230265|NCT02597140|Anesthetics|anesthetics|mesh-ancestor
25230266|NCT02597140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25230267|NCT02597140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471748|NCT00396734|Modafinil|modafinil|mesh-list
25230268|NCT02597140|Sensory System Agents|sensory system agents|mesh-ancestor
25230269|NCT02597140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25230270|NCT02597140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25434388|NCT00160173|Hormones|hormones|mesh-ancestor
25671157|NCT02850419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671158|NCT02850419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25671159|NCT02850419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25671160|NCT02850419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25671161|NCT02850419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671162|NCT02847624|Tolvaptan|tolvaptan|mesh-list
25671163|NCT02847624|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25671164|NCT02847624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671165|NCT02847624|Natriuretic Agents|natriuretic agents|mesh-ancestor
24801327|NCT01982799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25869556|NCT00116103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869557|NCT00116103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25869558|NCT00116103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25869559|NCT00116103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869560|NCT00116181|Etanercept|etanercept|mesh-list
25869561|NCT00116181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25869562|NCT00116181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25869563|NCT00116181|Analgesics|analgesics|mesh-ancestor
25869564|NCT00116181|Sensory System Agents|sensory system agents|mesh-ancestor
24549604|NCT00716248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549605|NCT00716248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24549607|NCT00716248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549608|NCT00716248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549609|NCT00716248|Dermatologic Agents|dermatologic agents|mesh-ancestor
24549610|NCT00716248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549611|NCT00716248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25869565|NCT00116181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25869566|NCT00116181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869567|NCT00116181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25869568|NCT00116181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25869569|NCT00116181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25869570|NCT00116181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25869571|NCT00116181|Immunologic Factors|immunologic factors|mesh-ancestor
25869572|NCT00116259|Aripiprazole|aripiprazole|mesh-list
25869573|NCT00116259|Antidepressive Agents|antidepressive agents|mesh-ancestor
25869574|NCT00116259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25869575|NCT00116259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25869576|NCT00116259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25869577|NCT00116259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25869578|NCT00116259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869579|NCT00116259|Dopamine Agonists|dopamine agonists|mesh-ancestor
24549612|NCT00716248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24549613|NCT00716248|Immunologic Factors|immunologic factors|mesh-ancestor
24549614|NCT00716248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24549615|NCT00716248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24549616|NCT00716248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24549617|NCT00716248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24549618|NCT00716248|Analgesics|analgesics|mesh-ancestor
24549619|NCT00716248|Sensory System Agents|sensory system agents|mesh-ancestor
24549620|NCT00716248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24549621|NCT00716248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25869580|NCT00116259|Dopamine Agents|dopamine agents|mesh-ancestor
25869581|NCT00116259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25869582|NCT00116259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869583|NCT00116259|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25869584|NCT00116259|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25869585|NCT00116259|Serotonin Agents|serotonin agents|mesh-ancestor
25230272|NCT02597140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25230273|NCT02597140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25230274|NCT02597140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230275|NCT02597140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25230276|NCT02597140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25230277|NCT02597140|Anesthetics, General|anesthetics, general|mesh-ancestor
25230278|NCT02597166|Sofosbuvir|sofosbuvir|mesh-list
24846233|NCT02242227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434463|NCT00101101|Cyclophosphamide|cyclophosphamide|mesh-list
25869588|NCT00116259|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25869589|NCT00116259|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25869590|NCT00116324|Montelukast|montelukast|mesh-list
25869591|NCT00116324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25869592|NCT00116324|Respiratory System Agents|respiratory system agents|mesh-ancestor
25869593|NCT00116324|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25869594|NCT00116324|Hormone Antagonists|hormone antagonists|mesh-ancestor
25869595|NCT00116324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25869596|NCT00116324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869597|NCT00116324|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24801343|NCT01982929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801345|NCT01982929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24801346|NCT01982929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24801347|NCT01982929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24801348|NCT01982929|Adrenergic Agents|adrenergic agents|mesh-ancestor
25869598|NCT00116324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25869599|NCT00116324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869600|NCT00116350|Misoprostol|misoprostol|mesh-list
25869601|NCT00116350|Oxytocin|oxytocin|mesh-list
24549626|NCT00716391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549627|NCT00716391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24549628|NCT00716469|Talaporfin|talaporfin|mesh-list
25869602|NCT00116350|Oxytocics|oxytocics|mesh-ancestor
24447751|NCT00309543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571152|NCT00808314|Dipyridamole|dipyridamole|mesh-list
25869603|NCT00116350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25869604|NCT00116350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869605|NCT00116350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25230279|NCT02597166|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25230280|NCT02597166|Ledipasvir|ledipasvir|mesh-list
25230281|NCT02597166|Antiviral Agents|antiviral agents|mesh-ancestor
25230282|NCT02597166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25230283|NCT02597153|Mitoxantrone|mitoxantrone|mesh-list
25230284|NCT02597153|Analgesics|analgesics|mesh-ancestor
25230285|NCT02597153|Sensory System Agents|sensory system agents|mesh-ancestor
25230286|NCT02597153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25230287|NCT02597153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230288|NCT02597153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230289|NCT02597153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25230290|NCT02597153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25230291|NCT02597153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230292|NCT02597153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230293|NCT02596984|Caspofungin|caspofungin|mesh-list
25671166|NCT02847624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671167|NCT02841371|Edetic Acid|edetic acid|mesh-list
25671168|NCT02841371|Pentetic Acid|pentetic acid|mesh-list
25671169|NCT02841371|Antidotes|antidotes|mesh-ancestor
25671170|NCT02841371|Protective Agents|protective agents|mesh-ancestor
25671171|NCT02841371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671172|NCT02841371|Chelating Agents|chelating agents|mesh-ancestor
25671173|NCT02841371|Sequestering Agents|sequestering agents|mesh-ancestor
25671174|NCT02841371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869612|NCT00116389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869613|NCT00116389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25869614|NCT00116389|Antiviral Agents|antiviral agents|mesh-ancestor
25869615|NCT00116389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25869616|NCT00116389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25869617|NCT00116389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25869618|NCT00116389|Immunologic Factors|immunologic factors|mesh-ancestor
25869619|NCT00116389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869620|NCT00116402|Fluticasone|fluticasone|mesh-list
25869621|NCT00116402|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25869622|NCT00116402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25869623|NCT00116402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25869624|NCT00116402|Autonomic Agents|autonomic agents|mesh-ancestor
24801351|NCT01982929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25869625|NCT00116402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25869626|NCT00116402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869627|NCT00116402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25108713|NCT03130634|Silymarin|silymarin|mesh-list
25869628|NCT00116402|Respiratory System Agents|respiratory system agents|mesh-ancestor
25869629|NCT00116402|Dermatologic Agents|dermatologic agents|mesh-ancestor
25869630|NCT00116402|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25869631|NCT00116402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25869632|NCT00116402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25869633|NCT00116402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24549652|NCT00716547|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24549653|NCT00716547|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24549654|NCT00716547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549655|NCT00716547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549656|NCT00716573|Everolimus|everolimus|mesh-list
24549657|NCT00716573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549658|NCT00716573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24549659|NCT00716573|Immunologic Factors|immunologic factors|mesh-ancestor
24549660|NCT00716573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549661|NCT00716612|Ubiquinone|ubiquinone|mesh-list
24549662|NCT00716612|Coenzyme Q10|coenzyme q10|mesh-list
24549663|NCT00716612|Micronutrients|micronutrients|mesh-ancestor
25230300|NCT02597322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25230301|NCT02597322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230302|NCT02597322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230303|NCT02597036|Zansecimab|zansecimab|mesh-list
25230304|NCT02597036|Paclitaxel|paclitaxel|mesh-list
25230305|NCT02597036|Ramucirumab|ramucirumab|mesh-list
25230306|NCT02597036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25230307|NCT02597036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230308|NCT02597036|Tubulin Modulators|tubulin modulators|mesh-ancestor
25230309|NCT02597036|Antimitotic Agents|antimitotic agents|mesh-ancestor
25230310|NCT02597036|Mitosis Modulators|mitosis modulators|mesh-ancestor
25230311|NCT02597036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230312|NCT02597036|Antiviral Agents|antiviral agents|mesh-ancestor
25869634|NCT00116402|Adrenergic Agents|adrenergic agents|mesh-ancestor
25869637|NCT00116454|Ethiodized Oil|ethiodized oil|mesh-list
25869638|NCT00116454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25869639|NCT00116467|Vaccines|vaccines|mesh-list
24549690|NCT00716924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549692|NCT00716950|Losartan|losartan|mesh-list
24549697|NCT00716950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549710|NCT00717210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869640|NCT00116467|Immunologic Factors|immunologic factors|mesh-ancestor
25869641|NCT00116467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869642|NCT00116480|Misoprostol|misoprostol|mesh-list
25869643|NCT00116480|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24549728|NCT00717379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24549729|NCT00717379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549730|NCT00717379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24549731|NCT00717379|Immunologic Factors|immunologic factors|mesh-ancestor
25869644|NCT00116480|Abortifacient Agents|abortifacient agents|mesh-ancestor
24549753|NCT00717470|Hormones|hormones|mesh-ancestor
24549754|NCT00717470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24549755|NCT00717470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549756|NCT00717470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24549757|NCT00717470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549758|NCT00717470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24549759|NCT00717470|Immunologic Factors|immunologic factors|mesh-ancestor
25869645|NCT00116480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25869646|NCT00116480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869647|NCT00116480|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25869648|NCT00116480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25869649|NCT00116480|Oxytocics|oxytocics|mesh-ancestor
25869650|NCT00116493|Folic Acid|folic acid|mesh-list
24447770|NCT00309556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447771|NCT00309556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24549766|NCT00717470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24549767|NCT00717470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24549768|NCT00717470|Antiemetics|antiemetics|mesh-ancestor
24549769|NCT00717470|Autonomic Agents|autonomic agents|mesh-ancestor
24549770|NCT00717470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24549771|NCT00717470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24549772|NCT00717470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24671062|NCT01323465|Rifampin|rifampin|mesh-list
24447782|NCT00309569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24447783|NCT00309569|Immunologic Factors|immunologic factors|mesh-ancestor
24447784|NCT00309569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447785|NCT00309569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24447786|NCT00309569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24447787|NCT00309569|Alkylating Agents|alkylating agents|mesh-ancestor
24447788|NCT00309569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230316|NCT02596880|Antimetabolites|antimetabolites|mesh-ancestor
25230317|NCT02596880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230318|NCT02596880|Antiviral Agents|antiviral agents|mesh-ancestor
25230319|NCT02596880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25230320|NCT02596828|Sirolimus|sirolimus|mesh-list
25671176|NCT02841371|Anticoagulants|anticoagulants|mesh-ancestor
25671177|NCT02841371|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24549789|NCT00717561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549792|NCT00717561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24549793|NCT00717561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549794|NCT00717561|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24549796|NCT00717561|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24549797|NCT00717561|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25869651|NCT00116493|Mebendazole|mebendazole|mesh-list
25869652|NCT00116493|Piperazine|piperazine|mesh-list
25869653|NCT00116493|Piperazine citrate|piperazine citrate|mesh-list
25869654|NCT00116493|DMP 777|dmp 777|mesh-list
25869655|NCT00116493|Hematinics|hematinics|mesh-ancestor
25869656|NCT00116493|Vitamin B Complex|vitamin b complex|mesh-ancestor
25869657|NCT00116493|Vitamins|vitamins|mesh-ancestor
25869658|NCT00116493|Micronutrients|micronutrients|mesh-ancestor
25869659|NCT00116493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869660|NCT00116493|Antinematodal Agents|antinematodal agents|mesh-ancestor
25869661|NCT00116493|Anthelmintics|anthelmintics|mesh-ancestor
25869662|NCT00116493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25869663|NCT00116493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25869664|NCT00116493|Tubulin Modulators|tubulin modulators|mesh-ancestor
25869665|NCT00116493|Antimitotic Agents|antimitotic agents|mesh-ancestor
25869666|NCT00116493|Mitosis Modulators|mitosis modulators|mesh-ancestor
25869667|NCT00116493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869668|NCT00116493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230321|NCT02596828|Irinotecan|irinotecan|mesh-list
25230322|NCT02596828|Temozolomide|temozolomide|mesh-list
25230323|NCT02596828|Dasatinib|dasatinib|mesh-list
25230324|NCT02596828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25230325|NCT02596828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25230326|NCT02596828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230327|NCT02596828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230328|NCT02596828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230329|NCT02596828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25230330|NCT02596828|Alkylating Agents|alkylating agents|mesh-ancestor
25230331|NCT02596828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25230332|NCT02596828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25230333|NCT02596828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25230334|NCT02596828|Antifungal Agents|antifungal agents|mesh-ancestor
25230335|NCT02596828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25230336|NCT02596828|Immunologic Factors|immunologic factors|mesh-ancestor
25230337|NCT02596828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846245|NCT02242240|Adrenergic Agents|adrenergic agents|mesh-ancestor
24846246|NCT02242240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24846247|NCT02242240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869669|NCT00116493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24447796|NCT00309569|Dermatologic Agents|dermatologic agents|mesh-ancestor
25869670|NCT00116506|Bevacizumab|bevacizumab|mesh-list
25869671|NCT00116506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25869672|NCT00116506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25869673|NCT00116506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25869674|NCT00116506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25869675|NCT00116506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25869676|NCT00116506|Growth Substances|growth substances|mesh-ancestor
25869677|NCT00116506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869678|NCT00116506|Growth Inhibitors|growth inhibitors|mesh-ancestor
25869679|NCT00116506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25869680|NCT00116506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574219|NCT00824200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24574220|NCT00824200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574222|NCT00824200|Urological Agents|urological agents|mesh-ancestor
25869681|NCT00116506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869682|NCT00116532|Citalopram|citalopram|mesh-list
25869683|NCT00116532|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25869684|NCT00116532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25869685|NCT00116532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25869686|NCT00116532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869687|NCT00116532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25869688|NCT00116532|Serotonin Agents|serotonin agents|mesh-ancestor
24877426|NCT02692339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24877430|NCT02692339|Hormones|hormones|mesh-ancestor
25869689|NCT00116532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869690|NCT00116532|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25869691|NCT00116532|Antidepressive Agents|antidepressive agents|mesh-ancestor
25869692|NCT00116532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25869693|NCT00116545|Troglitazone|troglitazone|mesh-list
25869694|NCT00116545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24801377|NCT01983371|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24801378|NCT01983371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24801379|NCT01983384|Anesthetics|anesthetics|mesh-list
24801380|NCT01983384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24801381|NCT01983384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801382|NCT01983449|Dexamethasone|dexamethasone|mesh-list
25869695|NCT00116545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869696|NCT00116623|Indomethacin|indomethacin|mesh-list
25869697|NCT00116623|Magnesium Sulfate|magnesium sulfate|mesh-list
25869698|NCT00116623|Analgesics|analgesics|mesh-ancestor
25869699|NCT00116623|Sensory System Agents|sensory system agents|mesh-ancestor
24572050|NCT00812825|Prednisolone|prednisolone|mesh-list
24549858|NCT00717808|Tranilast|tranilast|mesh-list
24549859|NCT00717808|Anthranilic acid|anthranilic acid|mesh-list
24549860|NCT00717808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24549861|NCT00717808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24549862|NCT00717808|Analgesics|analgesics|mesh-ancestor
24549863|NCT00717808|Sensory System Agents|sensory system agents|mesh-ancestor
24549864|NCT00717808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24549865|NCT00717808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549866|NCT00717808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24549867|NCT00717808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25869700|NCT00116623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25869701|NCT00116623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869702|NCT00116623|Anesthetics|anesthetics|mesh-ancestor
25869703|NCT00116623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25869704|NCT00116623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24549873|NCT00717808|Histamine Antagonists|histamine antagonists|mesh-ancestor
24549875|NCT00717808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25230338|NCT02596828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25230339|NCT02596776|Deuterium Oxide|deuterium oxide|mesh-list
25230340|NCT02596776|Propranolol|propranolol|mesh-list
25230341|NCT02596776|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25230342|NCT02596776|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25230343|NCT02596776|Adrenergic Agents|adrenergic agents|mesh-ancestor
25230344|NCT02596776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25230345|NCT02596776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230346|NCT02596776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230347|NCT02596776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24846248|NCT02242240|Parasympatholytics|parasympatholytics|mesh-ancestor
24846249|NCT02242240|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24846250|NCT02242240|Cholinergic Agents|cholinergic agents|mesh-ancestor
24846251|NCT02242253|Tiotropium Bromide|tiotropium bromide|mesh-list
24846252|NCT02242253|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24846253|NCT02242253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24846254|NCT02242253|Autonomic Agents|autonomic agents|mesh-ancestor
24846255|NCT02242253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24846256|NCT02242253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846257|NCT02242253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24846258|NCT02242253|Respiratory System Agents|respiratory system agents|mesh-ancestor
25434464|NCT00101101|Doxorubicin|doxorubicin|mesh-list
25671178|NCT02822625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25671179|NCT02822625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25671180|NCT02822625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671181|NCT02783859|Amoxicillin|amoxicillin|mesh-list
24549876|NCT00717808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24549877|NCT00717808|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24549878|NCT00717808|Anticonvulsants|anticonvulsants|mesh-ancestor
24549880|NCT00717821|Darbepoetin alfa|darbepoetin alfa|mesh-list
24549881|NCT00717821|Hematinics|hematinics|mesh-ancestor
24801383|NCT01983449|Dexamethasone acetate|dexamethasone acetate|mesh-list
24801384|NCT01983449|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24801385|NCT01983449|BB 1101|bb 1101|mesh-list
24801386|NCT01983449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24801387|NCT01983449|Antiemetics|antiemetics|mesh-ancestor
24801388|NCT01983449|Autonomic Agents|autonomic agents|mesh-ancestor
24801389|NCT01983449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24549882|NCT00717834|Formaldehyde|formaldehyde|mesh-list
24549883|NCT00717834|Disinfectants|disinfectants|mesh-ancestor
24549884|NCT00717834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24549885|NCT00717925|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
24549886|NCT00717925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24549887|NCT00717925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549927|NCT00717990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24549928|NCT00717990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549944|NCT00718289|Dialysis Solutions|dialysis solutions|mesh-list
25869705|NCT00116623|Anticonvulsants|anticonvulsants|mesh-ancestor
24549945|NCT00718289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24549947|NCT00718354|Carboplatin|carboplatin|mesh-list
25869706|NCT00116623|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24549948|NCT00718354|Fluorouracil|fluorouracil|mesh-list
24549949|NCT00718354|Capecitabine|capecitabine|mesh-list
25869707|NCT00116623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25869708|NCT00116623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869709|NCT00116623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24549950|NCT00718354|Oxaliplatin|oxaliplatin|mesh-list
24549951|NCT00718354|Epirubicin|epirubicin|mesh-list
24549952|NCT00718354|Enoxaparin|enoxaparin|mesh-list
24549954|NCT00718354|Antimetabolites|antimetabolites|mesh-ancestor
24549983|NCT00718406|Adrenergic Agents|adrenergic agents|mesh-ancestor
24549984|NCT00718406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25869710|NCT00116623|Tocolytic Agents|tocolytic agents|mesh-ancestor
25869711|NCT00116623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25869712|NCT00116623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25869713|NCT00116623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25869714|NCT00116623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25869715|NCT00116623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24549985|NCT00718406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549986|NCT00718471|Heparin|heparin|mesh-list
24549987|NCT00718471|Enoxaparin|enoxaparin|mesh-list
24549988|NCT00718471|Calcium heparin|calcium heparin|mesh-list
24549989|NCT00718471|Anticoagulants|anticoagulants|mesh-ancestor
24549990|NCT00718471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24549991|NCT00718471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25230348|NCT02596776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25230349|NCT02596776|Vasodilator Agents|vasodilator agents|mesh-ancestor
25230350|NCT02596776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230351|NCT02596776|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25230352|NCT02596776|Protective Agents|protective agents|mesh-ancestor
25230353|NCT02596763|Baclofen|baclofen|mesh-list
25230354|NCT02596763|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25230355|NCT02596763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230356|NCT02596763|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25230357|NCT02596763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25230358|NCT02596763|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25230359|NCT02596763|GABA Agonists|gaba agonists|mesh-ancestor
24846307|NCT02242318|Valsartan|valsartan|mesh-list
24846308|NCT02242318|Telmisartan|telmisartan|mesh-list
24846309|NCT02242318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24846310|NCT02242318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24846311|NCT02242318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24846312|NCT02242318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846313|NCT02242331|Telmisartan|telmisartan|mesh-list
24846314|NCT02242331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24846315|NCT02242331|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24846316|NCT02242331|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24549992|NCT00718471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549993|NCT00718484|Doxorubicin|doxorubicin|mesh-list
24549994|NCT00718484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24549995|NCT00718484|Isophosphamide mustard|isophosphamide mustard|mesh-list
24549996|NCT00718484|Ifosfamide|ifosfamide|mesh-list
24549997|NCT00718484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24549998|NCT00718484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24574680|NCT00826839|Fertility Agents|fertility agents|mesh-ancestor
24574681|NCT00826839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24574682|NCT00826839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549999|NCT00718484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24550000|NCT00718484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25869716|NCT00116623|Gout Suppressants|gout suppressants|mesh-ancestor
25869717|NCT00116623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25869718|NCT00116623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25869719|NCT00116701|Darbepoetin alfa|darbepoetin alfa|mesh-list
25869720|NCT00116701|Hematinics|hematinics|mesh-ancestor
25869721|NCT00116727|Etanercept|etanercept|mesh-list
24550010|NCT00718536|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24550012|NCT00718536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550013|NCT00718536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550015|NCT00718601|Motesanib diphosphate|motesanib diphosphate|mesh-list
24550016|NCT00718601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550017|NCT00718601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550018|NCT00718601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24550020|NCT00718705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24550021|NCT00718705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24550022|NCT00718757|Dexamethasone|dexamethasone|mesh-list
24550023|NCT00718757|Irinotecan|irinotecan|mesh-list
24550024|NCT00718757|Vincristine|vincristine|mesh-list
25869722|NCT00116727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25869723|NCT00116727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25869724|NCT00116727|Analgesics|analgesics|mesh-ancestor
25869725|NCT00116727|Sensory System Agents|sensory system agents|mesh-ancestor
24550051|NCT00718796|L 647318|l 647318|mesh-list
24550052|NCT00718796|Dihydromevinolin|dihydromevinolin|mesh-list
24550053|NCT00718796|Anticholesteremic Agents|anticholesteremic agents|mesh-list
25869726|NCT00116727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24887996|NCT04509466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25869727|NCT00116727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869728|NCT00116727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25869729|NCT00116727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25869730|NCT00116727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25230360|NCT02596763|GABA Agents|gaba agents|mesh-ancestor
25230361|NCT02596763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25230362|NCT02596763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846317|NCT02242331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846318|NCT02242344|Telmisartan|telmisartan|mesh-list
24846319|NCT02242344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24846320|NCT02242344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24846321|NCT02242344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25044069|NCT01166412|Contraceptive Agents|contraceptive agents|mesh-ancestor
25044070|NCT01166412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25044071|NCT01166412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044072|NCT01166412|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25000417|NCT05404919|gamma-Globulins|gamma-globulins|mesh-list
25000418|NCT05404919|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25671182|NCT02783859|Clavulanic Acids|clavulanic acids|mesh-list
25671183|NCT02783859|Clavulanic Acid|clavulanic acid|mesh-list
25671184|NCT02783859|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25671185|NCT02783859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25671186|NCT02783859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25671187|NCT02783859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25671188|NCT02783859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671189|NCT02783859|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25674507|NCT01773070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25674508|NCT01773070|Antiviral Agents|antiviral agents|mesh-ancestor
25132637|NCT03017729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24953067|NCT03888846|Colchicine|colchicine|mesh-list
25869731|NCT00116727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25869732|NCT00116727|Immunologic Factors|immunologic factors|mesh-ancestor
25869733|NCT00116870|Lovastatin|lovastatin|mesh-list
25869734|NCT00116870|L 647318|l 647318|mesh-list
25869735|NCT00116870|Dihydromevinolin|dihydromevinolin|mesh-list
25869736|NCT00116870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25869737|NCT00116870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25869738|NCT00116870|Antimetabolites|antimetabolites|mesh-ancestor
24550056|NCT00718796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550057|NCT00718796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24550058|NCT00718796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24550059|NCT00718796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550060|NCT00718796|Vitamins|vitamins|mesh-ancestor
24550073|NCT00718952|Vasodilator Agents|vasodilator agents|mesh-ancestor
24550074|NCT00718952|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24550075|NCT00718952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24550076|NCT00718952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550077|NCT00718952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550078|NCT00718952|Urological Agents|urological agents|mesh-ancestor
24550079|NCT00719056|Ciprofloxacin|ciprofloxacin|mesh-list
24550080|NCT00719056|Lactams|lactams|mesh-list
24550081|NCT00719056|Cephalosporins|cephalosporins|mesh-list
24550082|NCT00719056|Teicoplanin|teicoplanin|mesh-list
24550083|NCT00719056|beta-Lactams|beta-lactams|mesh-list
24550117|NCT00719121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25869739|NCT00116870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869740|NCT00116870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25869741|NCT00116870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25869742|NCT00116870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876667|NCT02997228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447797|NCT00309569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24447798|NCT00309569|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25230373|NCT02596555|Dabigatran|dabigatran|mesh-list
25230374|NCT02596555|Antithrombins|antithrombins|mesh-ancestor
25230375|NCT02596555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25230376|NCT02596555|Protease Inhibitors|protease inhibitors|mesh-ancestor
25230377|NCT02596555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230378|NCT02596555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230379|NCT02596555|Anticoagulants|anticoagulants|mesh-ancestor
25230380|NCT02596373|Mitoxantrone|mitoxantrone|mesh-list
25230381|NCT02596373|Analgesics|analgesics|mesh-ancestor
25230382|NCT02596373|Sensory System Agents|sensory system agents|mesh-ancestor
25230383|NCT02596373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25230384|NCT02596373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230385|NCT02596373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230386|NCT02596373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25230387|NCT02596373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25230388|NCT02596373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230389|NCT02596373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230390|NCT02596282|Anesthetics|anesthetics|mesh-list
25000419|NCT05404919|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25000420|NCT05404919|Antiviral Agents|antiviral agents|mesh-ancestor
25000424|NCT05404919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044073|NCT01166412|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25044074|NCT01166412|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25044075|NCT01160601|Paclitaxel|paclitaxel|mesh-list
25044076|NCT01160601|Carboplatin|carboplatin|mesh-list
25044077|NCT01160601|Bavituximab|bavituximab|mesh-list
25671190|NCT02652169|Amikacin|amikacin|mesh-list
25671191|NCT02652169|Teicoplanin|teicoplanin|mesh-list
25671192|NCT02652169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25671193|NCT02652169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25671194|NCT02620865|Calcium, Dietary|calcium, dietary|mesh-list
25671195|NCT02620865|Leucovorin|leucovorin|mesh-list
24846322|NCT02242344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876668|NCT02997228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24447800|NCT00309569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24447801|NCT00309569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24550154|NCT00719420|Metronidazole|metronidazole|mesh-list
24550155|NCT00719420|Clarithromycin|clarithromycin|mesh-list
24550156|NCT00719420|Omeprazole|omeprazole|mesh-list
24550157|NCT00719420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24550158|NCT00719420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24550159|NCT00719420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24550160|NCT00719420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24550201|NCT00719602|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24550202|NCT00719602|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24550203|NCT00719693|Calcium, Dietary|calcium, dietary|mesh-list
24550204|NCT00719693|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24550205|NCT00719693|Fenofibric acid|fenofibric acid|mesh-list
24550207|NCT00719693|Calcium|calcium|mesh-list
24550208|NCT00719693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24550209|NCT00719693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550210|NCT00719693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24550211|NCT00719693|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24550212|NCT00719693|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25869743|NCT00116896|Cisplatin|cisplatin|mesh-list
24550226|NCT00719758|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24447802|NCT00309569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24447804|NCT00309621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447805|NCT00309621|Dermatologic Agents|dermatologic agents|mesh-ancestor
24447806|NCT00309634|Vaccines|vaccines|mesh-list
24447807|NCT00309634|Immunologic Factors|immunologic factors|mesh-ancestor
24447808|NCT00309634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447810|NCT00309660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24447811|NCT00309660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550244|NCT00719797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230391|NCT02596282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25230392|NCT02596282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273473|NCT02385266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25273474|NCT02385266|Antitubercular Agents|antitubercular agents|mesh-ancestor
25273475|NCT02385266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25273476|NCT02385266|Antimetabolites|antimetabolites|mesh-ancestor
25273477|NCT02385266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273478|NCT02385305|Anesthetics|anesthetics|mesh-list
25273479|NCT02385305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25273480|NCT02385305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273481|NCT02385058|Mebendazole|mebendazole|mesh-list
25273482|NCT02385058|Piperazine|piperazine|mesh-list
25273483|NCT02385058|Piperazine citrate|piperazine citrate|mesh-list
25273484|NCT02385058|DMP 777|dmp 777|mesh-list
25273485|NCT02385058|Antinematodal Agents|antinematodal agents|mesh-ancestor
25273486|NCT02385058|Anthelmintics|anthelmintics|mesh-ancestor
25273487|NCT02385058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25273488|NCT02385058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25273489|NCT02385058|Tubulin Modulators|tubulin modulators|mesh-ancestor
25273490|NCT02385058|Antimitotic Agents|antimitotic agents|mesh-ancestor
24550245|NCT00719797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24550246|NCT00719797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24550247|NCT00719797|Immunologic Factors|immunologic factors|mesh-ancestor
24550273|NCT00720018|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24550275|NCT00720018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24550276|NCT00720018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550277|NCT00720018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550278|NCT00720135|Rituximab|rituximab|mesh-list
25434465|NCT00101101|Vincristine|vincristine|mesh-list
25869744|NCT00116896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25869745|NCT00116922|Metformin|metformin|mesh-list
25869746|NCT00116922|Rosiglitazone|rosiglitazone|mesh-list
25869747|NCT00116922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25869748|NCT00116922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869749|NCT00116935|Imatinib Mesylate|imatinib mesylate|mesh-list
25869752|NCT00116935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25869753|NCT00116935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869754|NCT00116948|Cimetidine|cimetidine|mesh-list
25869755|NCT00116948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25869756|NCT00116948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25869757|NCT00116948|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25869758|NCT00116948|Histamine Antagonists|histamine antagonists|mesh-ancestor
25869759|NCT00116948|Histamine Agents|histamine agents|mesh-ancestor
25869760|NCT00116948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25869761|NCT00116948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869762|NCT00116948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550364|NCT00720421|GABA Modulators|gaba modulators|mesh-ancestor
24550365|NCT00720421|GABA Agents|gaba agents|mesh-ancestor
24801406|NCT01983462|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24801407|NCT01983462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24801408|NCT01983462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550366|NCT00720421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24550367|NCT00720421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550368|NCT00720447|Cytarabine|cytarabine|mesh-list
24550370|NCT00720447|Melphalan|melphalan|mesh-list
24550371|NCT00720447|Alemtuzumab|alemtuzumab|mesh-list
24550372|NCT00720447|Carmustine|carmustine|mesh-list
24550373|NCT00720447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25869763|NCT00116948|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25869764|NCT00116948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24550396|NCT00720512|Levoleucovorin|levoleucovorin|mesh-list
24550397|NCT00720512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25869765|NCT00116948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25869766|NCT00116961|Dexamethasone|dexamethasone|mesh-list
25869767|NCT00116961|Bortezomib|bortezomib|mesh-list
25869768|NCT00116961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24550445|NCT00720577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550446|NCT00720577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25230393|NCT02596334|Lamivudine|lamivudine|mesh-list
25230394|NCT02596334|Abacavir|abacavir|mesh-list
25230395|NCT02596334|Dolutegravir|dolutegravir|mesh-list
25230396|NCT02596334|Triumeq|triumeq|mesh-list
25230397|NCT02596334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25230398|NCT02596334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25230399|NCT02596334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230400|NCT02596334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230401|NCT02596334|Antiviral Agents|antiviral agents|mesh-ancestor
25230402|NCT02596334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25869769|NCT00116961|Antiemetics|antiemetics|mesh-ancestor
24550447|NCT00720577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550448|NCT00720577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24550449|NCT00720577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24550450|NCT00720577|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25869770|NCT00116961|Autonomic Agents|autonomic agents|mesh-ancestor
24801422|NCT01983501|Tucatinib|tucatinib|mesh-list
24801423|NCT01983501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24801424|NCT01983501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555600|NCT00742287|Proanthocyanidin|proanthocyanidin|mesh-list
25869793|NCT00117013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25869794|NCT00117013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25869813|NCT00117065|Hematinics|hematinics|mesh-ancestor
25869814|NCT00117078|Darbepoetin alfa|darbepoetin alfa|mesh-list
25869815|NCT00117078|Hematinics|hematinics|mesh-ancestor
25230443|NCT02595918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230445|NCT02595840|Afatinib|afatinib|mesh-list
25230446|NCT02595840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230447|NCT02595840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230448|NCT02595840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889060|NCT04498286|Antibodies|antibodies|mesh-list
24889833|NCT04489147|Metformin|metformin|mesh-list
25869828|NCT00117182|Ipratropium|ipratropium|mesh-list
25869829|NCT00117182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25869830|NCT00117182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25869831|NCT00117182|Autonomic Agents|autonomic agents|mesh-ancestor
25869832|NCT00117182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25869833|NCT00117182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869834|NCT00117182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25869835|NCT00117182|Respiratory System Agents|respiratory system agents|mesh-ancestor
25869836|NCT00117182|Glucocorticoids|glucocorticoids|mesh-ancestor
25869837|NCT00117182|Hormones|hormones|mesh-ancestor
25869838|NCT00117182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25869839|NCT00117182|Anticonvulsants|anticonvulsants|mesh-ancestor
25869840|NCT00117182|Tocolytic Agents|tocolytic agents|mesh-ancestor
25869841|NCT00117182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25869842|NCT00117182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25869843|NCT00117182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25869844|NCT00117182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25869845|NCT00117182|Adrenergic Agents|adrenergic agents|mesh-ancestor
24573787|NCT00822081|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25869846|NCT00117182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25869847|NCT00117182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869848|NCT00117182|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25869849|NCT00117182|Diuretics|diuretics|mesh-ancestor
25869850|NCT00117182|Natriuretic Agents|natriuretic agents|mesh-ancestor
25869858|NCT00117234|Darbepoetin alfa|darbepoetin alfa|mesh-list
25869859|NCT00117234|Hematinics|hematinics|mesh-ancestor
25869860|NCT00117247|Darbepoetin alfa|darbepoetin alfa|mesh-list
25133386|NCT03013075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25133387|NCT03013075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133389|NCT03013075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25133390|NCT03013075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25133391|NCT03013075|Narcotics|narcotics|mesh-ancestor
25133392|NCT03013075|Analgesics|analgesics|mesh-ancestor
25133393|NCT03013127|Pembrolizumab|pembrolizumab|mesh-list
25223380|NCT02640300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24836490|NCT02186106|Vitamin D|vitamin d|mesh-list
25133394|NCT03013127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25133395|NCT03013127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25133396|NCT03013101|Antibodies|antibodies|mesh-list
25133397|NCT03013101|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25133398|NCT03013101|Immunologic Factors|immunologic factors|mesh-ancestor
25133399|NCT03013101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133400|NCT03013114|Bortezomib|bortezomib|mesh-list
25133401|NCT03013114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962043|NCT03803007|Glenzocimab|glenzocimab|mesh-list
24575443|NCT00831636|Cytarabine|cytarabine|mesh-list
25869861|NCT00117247|Hematinics|hematinics|mesh-ancestor
25869862|NCT00117260|Levonorgestrel|levonorgestrel|mesh-list
25869863|NCT00117260|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24575444|NCT00831636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24575483|NCT00832039|Sodium Selenite|sodium selenite|mesh-list
24575484|NCT00832039|Trace Elements|trace elements|mesh-ancestor
24575711|NCT00833404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24575712|NCT00833404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575713|NCT00833404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24575714|NCT00833404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25230454|NCT02595606|Immunologic Factors|immunologic factors|mesh-ancestor
25230455|NCT02595606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230456|NCT02595606|Viscosupplements|viscosupplements|mesh-ancestor
25230457|NCT02595606|Protective Agents|protective agents|mesh-ancestor
25230458|NCT02595554|Paclitaxel|paclitaxel|mesh-list
25230459|NCT02595554|Cisplatin|cisplatin|mesh-list
25230460|NCT02595554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25230461|NCT02595554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230462|NCT02595554|Tubulin Modulators|tubulin modulators|mesh-ancestor
25230463|NCT02595554|Antimitotic Agents|antimitotic agents|mesh-ancestor
25230464|NCT02595554|Mitosis Modulators|mitosis modulators|mesh-ancestor
25230465|NCT02595554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230467|NCT02595346|Antimalarials|antimalarials|mesh-ancestor
25230468|NCT02595346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25230469|NCT02595346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25230470|NCT02595346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25230471|NCT02595346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230472|NCT02595346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671197|NCT02620865|Gemcitabine|gemcitabine|mesh-list
25671198|NCT02620865|Aldesleukin|aldesleukin|mesh-list
25671199|NCT02620865|Paclitaxel|paclitaxel|mesh-list
25671200|NCT02620865|Camptothecin|camptothecin|mesh-list
25671201|NCT02620865|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25671202|NCT02620865|Fluorouracil|fluorouracil|mesh-list
25671203|NCT02620865|Oxaliplatin|oxaliplatin|mesh-list
25671204|NCT02620865|Irinotecan|irinotecan|mesh-list
25671205|NCT02620865|Interleukin-2|interleukin-2|mesh-list
25671206|NCT02620865|Antibodies|antibodies|mesh-list
25671207|NCT02620865|Immunoglobulins|immunoglobulins|mesh-list
25671208|NCT02620865|Sargramostim|sargramostim|mesh-list
25671209|NCT02620865|Calcium|calcium|mesh-list
25671210|NCT02620865|Levoleucovorin|levoleucovorin|mesh-list
25671211|NCT02620865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25671212|NCT02620865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671213|NCT02620865|Tubulin Modulators|tubulin modulators|mesh-ancestor
25671214|NCT02620865|Antimitotic Agents|antimitotic agents|mesh-ancestor
25671215|NCT02620865|Mitosis Modulators|mitosis modulators|mesh-ancestor
25671216|NCT02620865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671217|NCT02620865|Immunologic Factors|immunologic factors|mesh-ancestor
25671218|NCT02620865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671219|NCT02620865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25671220|NCT02620865|Antimetabolites|antimetabolites|mesh-ancestor
25671221|NCT02620865|Antiviral Agents|antiviral agents|mesh-ancestor
25671222|NCT02620865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25671223|NCT02620865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25671224|NCT02620865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25671225|NCT02620865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25671226|NCT02620865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25230501|NCT02595476|Anesthetics|anesthetics|mesh-ancestor
25230502|NCT02595476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25230503|NCT02595476|Narcotics|narcotics|mesh-ancestor
25230504|NCT02595476|Analgesics|analgesics|mesh-ancestor
25230505|NCT02595476|Sensory System Agents|sensory system agents|mesh-ancestor
25230506|NCT02595476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25230508|NCT02595541|Sildenafil Citrate|sildenafil citrate|mesh-list
25230512|NCT02595541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230513|NCT02595541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25409529|NCT03371667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671227|NCT02620865|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25671228|NCT02620865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25671229|NCT02620865|Antidotes|antidotes|mesh-ancestor
24846375|NCT02242474|Golimumab|golimumab|mesh-list
24846376|NCT02242474|Infliximab|infliximab|mesh-list
24846377|NCT02242474|Certolizumab Pegol|certolizumab pegol|mesh-list
25869873|NCT00117260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25869874|NCT00117260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25230514|NCT02595541|Urological Agents|urological agents|mesh-ancestor
25230515|NCT02595541|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25230516|NCT02595541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25230517|NCT02595541|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25230518|NCT02595541|Protective Agents|protective agents|mesh-ancestor
25230519|NCT02595541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230520|NCT02595268|Pitavastatin|pitavastatin|mesh-list
25230521|NCT02595268|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25230522|NCT02595268|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25230523|NCT02595268|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25230524|NCT02595268|Antimetabolites|antimetabolites|mesh-ancestor
25230525|NCT02595268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230526|NCT02595268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230530|NCT02595190|Tramadol|tramadol|mesh-list
25230531|NCT02595190|Analgesics|analgesics|mesh-ancestor
25230532|NCT02595190|Sensory System Agents|sensory system agents|mesh-ancestor
25230533|NCT02595190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24815670|NCT02071537|Antiviral Agents|antiviral agents|mesh-ancestor
25230534|NCT02595190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230535|NCT02595190|Anticonvulsants|anticonvulsants|mesh-ancestor
25230536|NCT02595190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25230537|NCT02595190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25230538|NCT02595190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25230539|NCT02595190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25230540|NCT02595190|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25230541|NCT02595190|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25230542|NCT02595190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25671230|NCT02620865|Protective Agents|protective agents|mesh-ancestor
25671231|NCT02620865|Vitamin B Complex|vitamin b complex|mesh-ancestor
25671232|NCT02620865|Vitamins|vitamins|mesh-ancestor
25671233|NCT02620865|Micronutrients|micronutrients|mesh-ancestor
25671234|NCT02620865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25671235|NCT02620865|Analgesics|analgesics|mesh-ancestor
25671236|NCT02620865|Sensory System Agents|sensory system agents|mesh-ancestor
25671237|NCT02620865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25671238|NCT02620865|Hematinics|hematinics|mesh-ancestor
25671239|NCT02620865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25869875|NCT00117260|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25869876|NCT00117260|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25869877|NCT00117260|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25869878|NCT00117273|Levonorgestrel|levonorgestrel|mesh-list
25869879|NCT00117273|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25869880|NCT00117273|Estradiol|estradiol|mesh-list
25869881|NCT00117273|Estrogens|estrogens|mesh-ancestor
25869882|NCT00117273|Hormones|hormones|mesh-ancestor
25869883|NCT00117273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25869884|NCT00117273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230548|NCT02595138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25230549|NCT02595138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230550|NCT02595242|Prednisone|prednisone|mesh-list
25230551|NCT02595242|Cyclophosphamide|cyclophosphamide|mesh-list
25230552|NCT02595242|Vincristine|vincristine|mesh-list
25230553|NCT02595242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25230554|NCT02595242|Immunologic Factors|immunologic factors|mesh-ancestor
25230555|NCT02595242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230556|NCT02595242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25230557|NCT02595242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25230558|NCT02595242|Alkylating Agents|alkylating agents|mesh-ancestor
25230559|NCT02595242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044081|NCT01160601|Antimitotic Agents|antimitotic agents|mesh-ancestor
25044082|NCT01160601|Mitosis Modulators|mitosis modulators|mesh-ancestor
25044083|NCT01160601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044090|NCT01159249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230560|NCT02595242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230561|NCT02595242|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25230562|NCT02595242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25230563|NCT02595242|Glucocorticoids|glucocorticoids|mesh-ancestor
25230564|NCT02595242|Hormones|hormones|mesh-ancestor
25230565|NCT02595242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25230566|NCT02595242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25230567|NCT02595242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25230568|NCT02595242|Tubulin Modulators|tubulin modulators|mesh-ancestor
25230569|NCT02595242|Antimitotic Agents|antimitotic agents|mesh-ancestor
25230570|NCT02595242|Mitosis Modulators|mitosis modulators|mesh-ancestor
25230571|NCT02595034|Clindamycin|clindamycin|mesh-list
25230572|NCT02595034|Clindamycin palmitate|clindamycin palmitate|mesh-list
25230573|NCT02595034|Clindamycin phosphate|clindamycin phosphate|mesh-list
25230574|NCT02595034|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25230575|NCT02595034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25230576|NCT02595034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25230577|NCT02595034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25230578|NCT02595034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230579|NCT02595034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230580|NCT02595034|Dermatologic Agents|dermatologic agents|mesh-ancestor
25230581|NCT02594579|Vitamin D|vitamin d|mesh-list
25230582|NCT02594579|Cholecalciferol|cholecalciferol|mesh-list
25230583|NCT02594579|Vitamins|vitamins|mesh-ancestor
25230584|NCT02594579|Micronutrients|micronutrients|mesh-ancestor
25230585|NCT02594579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230586|NCT02594579|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25230587|NCT02594579|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25230588|NCT02594761|Trastuzumab|trastuzumab|mesh-list
25230589|NCT02594761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25230590|NCT02594761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230591|NCT02594800|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25230592|NCT02594800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25230593|NCT02594800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25230594|NCT02594800|Antimetabolites|antimetabolites|mesh-ancestor
25044091|NCT01159249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044093|NCT01156753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25044094|NCT01156753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044096|NCT01156415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25044097|NCT01156415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25044107|NCT01143064|Hormones|hormones|mesh-ancestor
25044108|NCT01143064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25869885|NCT00117273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25671243|NCT02585375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25671244|NCT02566395|Cyclophosphamide|cyclophosphamide|mesh-list
25869886|NCT00117273|Contraceptive Agents|contraceptive agents|mesh-ancestor
25869887|NCT00117273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25869888|NCT00117273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25869889|NCT00117273|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25869890|NCT00117273|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25869891|NCT00117273|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25869892|NCT00117299|Vatalanib|vatalanib|mesh-list
25869893|NCT00117299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25869894|NCT00117299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230610|NCT02594358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25230611|NCT02594358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230612|NCT02594358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230613|NCT02594358|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25230614|NCT02594358|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25230615|NCT02594358|Purinergic Agents|purinergic agents|mesh-ancestor
25230616|NCT02594358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25273492|NCT02385058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273493|NCT02385058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25273494|NCT02385058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273496|NCT02385227|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25273497|NCT02385227|Autonomic Agents|autonomic agents|mesh-ancestor
25273498|NCT02385227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25273499|NCT02385227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273500|NCT02385227|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25273501|NCT02385227|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25273502|NCT02385227|Cholinergic Agents|cholinergic agents|mesh-ancestor
25273503|NCT02385227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25273504|NCT02385227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273505|NCT02385188|Acetaminophen|acetaminophen|mesh-list
25273506|NCT02385188|Imiquimod|imiquimod|mesh-list
25273507|NCT02385188|Lidocaine|lidocaine|mesh-list
24846383|NCT02242474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24801530|NCT01984008|Citric Acid|citric acid|mesh-list
25230617|NCT02594423|Bevacizumab|bevacizumab|mesh-list
25230618|NCT02594423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25230619|NCT02594423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230620|NCT02594423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25230621|NCT02594423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25230622|NCT02594423|Growth Substances|growth substances|mesh-ancestor
25230623|NCT02594423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230624|NCT02594423|Growth Inhibitors|growth inhibitors|mesh-ancestor
25230625|NCT02594293|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25230626|NCT02594293|Antiviral Agents|antiviral agents|mesh-ancestor
25230652|NCT02594241|Prednisolone acetate|prednisolone acetate|mesh-list
25061117|NCT03473613|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24801532|NCT01984008|Anticoagulants|anticoagulants|mesh-ancestor
24801533|NCT01984008|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24801534|NCT01984008|Chelating Agents|chelating agents|mesh-ancestor
24801535|NCT01984008|Sequestering Agents|sequestering agents|mesh-ancestor
25869895|NCT00117299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869896|NCT00117351|Bortezomib|bortezomib|mesh-list
24878698|NCT01139970|Temozolomide|temozolomide|mesh-list
24892751|NCT04459702|Antimalarials|antimalarials|mesh-ancestor
24892752|NCT04459702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24892753|NCT04459702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24892754|NCT04459702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24715400|NCT01536223|Antimetabolites|antimetabolites|mesh-ancestor
24454275|NCT04207086|Pembrolizumab|pembrolizumab|mesh-list
25869897|NCT00117351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25869898|NCT00117364|Sacchachitin|sacchachitin|mesh-list
25869899|NCT00117364|Antioxidants|antioxidants|mesh-ancestor
25869900|NCT00117364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869901|NCT00117364|Protective Agents|protective agents|mesh-ancestor
25869902|NCT00117364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846401|NCT02242513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24454308|NCT04109482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24454309|NCT04109482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24801557|NCT01984086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801559|NCT01984086|Respiratory System Agents|respiratory system agents|mesh-ancestor
24801560|NCT01984086|Tocolytic Agents|tocolytic agents|mesh-ancestor
24574940|NCT00828763|Antiviral Agents|antiviral agents|mesh-ancestor
24801571|NCT01984099|Vitamin B Complex|vitamin b complex|mesh-list
24801572|NCT01984099|Methotrexate|methotrexate|mesh-list
24801573|NCT01984099|Vitamins|vitamins|mesh-ancestor
24801574|NCT01984099|Micronutrients|micronutrients|mesh-ancestor
24801575|NCT01984099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801576|NCT01984099|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24801577|NCT01984099|Abortifacient Agents|abortifacient agents|mesh-ancestor
25869903|NCT00117377|Pimecrolimus|pimecrolimus|mesh-list
25230670|NCT02594449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25230671|NCT02594033|Insulin Aspart|insulin aspart|mesh-list
25230672|NCT02594033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25230673|NCT02594033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230674|NCT02593942|Remifentanil|remifentanil|mesh-list
25230675|NCT02593942|Propofol|propofol|mesh-list
25230676|NCT02593942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25230677|NCT02593942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25230678|NCT02593942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230679|NCT02593942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25230680|NCT02593942|Anesthetics, General|anesthetics, general|mesh-ancestor
25230681|NCT02593942|Anesthetics|anesthetics|mesh-ancestor
25230682|NCT02593942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25230683|NCT02593942|Narcotics|narcotics|mesh-ancestor
25230684|NCT02593942|Analgesics|analgesics|mesh-ancestor
25230685|NCT02593942|Sensory System Agents|sensory system agents|mesh-ancestor
25869904|NCT00117377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25869905|NCT00117377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25869906|NCT00117377|Analgesics|analgesics|mesh-ancestor
25869907|NCT00117377|Sensory System Agents|sensory system agents|mesh-ancestor
25869908|NCT00117377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25869909|NCT00117377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869910|NCT00117377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25869911|NCT00117377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25869912|NCT00117377|Dermatologic Agents|dermatologic agents|mesh-ancestor
25869913|NCT00117377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25869914|NCT00117377|Immunologic Factors|immunologic factors|mesh-ancestor
25869915|NCT00117377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25869916|NCT00117377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25134217|NCT03007303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25134218|NCT03007303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134219|NCT03007303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134220|NCT03007303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25230688|NCT02594072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25230689|NCT02594072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230690|NCT02593968|Interferons|interferons|mesh-list
25230691|NCT02593968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25230692|NCT02593968|Antiviral Agents|antiviral agents|mesh-ancestor
25230693|NCT02593968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25230694|NCT02593747|Loratadine|loratadine|mesh-list
25230695|NCT02593747|Antipruritics|antipruritics|mesh-ancestor
25230696|NCT02593747|Dermatologic Agents|dermatologic agents|mesh-ancestor
24846402|NCT02242513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24846403|NCT02242513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846405|NCT02242591|Anesthetics, Local|anesthetics, local|mesh-ancestor
24846406|NCT02242591|Anesthetics|anesthetics|mesh-ancestor
24461578|NCT00352742|Growth Substances|growth substances|mesh-ancestor
25230697|NCT02593747|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25230698|NCT02593747|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25230699|NCT02593747|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25230700|NCT02593747|Histamine Antagonists|histamine antagonists|mesh-ancestor
25230701|NCT02593747|Histamine Agents|histamine agents|mesh-ancestor
25230702|NCT02593747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25230703|NCT02593747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230704|NCT02593747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230705|NCT02593734|Olanzapine|olanzapine|mesh-list
25230706|NCT02593734|Risperidone|risperidone|mesh-list
25230707|NCT02593734|Fluoxetine|fluoxetine|mesh-list
25230708|NCT02593734|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25230709|NCT02593734|Serotonin Agents|serotonin agents|mesh-ancestor
25230710|NCT02593734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25230711|NCT02593734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230712|NCT02593734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230713|NCT02593734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25230714|NCT02593734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25230715|NCT02593734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25230716|NCT02593734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25230717|NCT02593734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25230718|NCT02593734|Dopamine Agents|dopamine agents|mesh-ancestor
25230720|NCT02593734|Autonomic Agents|autonomic agents|mesh-ancestor
25230721|NCT02593734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25230722|NCT02593734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25230723|NCT02593734|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25230724|NCT02593734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25671256|NCT02556099|Antisickling Agents|antisickling agents|mesh-ancestor
25671257|NCT02556099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25671258|NCT02556099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671259|NCT02556099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25671260|NCT02516813|Cisplatin|cisplatin|mesh-list
25671261|NCT02516813|Peposertib|peposertib|mesh-list
25671262|NCT02516813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671263|NCT02516813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25671264|NCT02516813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25671265|NCT02516813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671266|NCT02498392|JNJ-42165279|jnj-42165279|mesh-list
25671267|NCT02498392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230741|NCT02593695|Fluoxetine|fluoxetine|mesh-list
25230742|NCT02593695|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25230743|NCT02593695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25230744|NCT02593695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25230745|NCT02593695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230746|NCT02593695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25230747|NCT02593695|Serotonin Agents|serotonin agents|mesh-ancestor
25230748|NCT02593695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230749|NCT02593695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25230750|NCT02593695|Antidepressive Agents|antidepressive agents|mesh-ancestor
25230751|NCT02593695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25230752|NCT02593695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25273508|NCT02385188|Petrolatum|petrolatum|mesh-list
24846408|NCT02242591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846416|NCT02242656|Analgesics|analgesics|mesh-ancestor
24846417|NCT02242656|Sensory System Agents|sensory system agents|mesh-ancestor
24846418|NCT02242656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24846419|NCT02242656|Antidiarrheals|antidiarrheals|mesh-ancestor
24846420|NCT02242656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24846421|NCT02242656|Antitussive Agents|antitussive agents|mesh-ancestor
24846422|NCT02242656|Respiratory System Agents|respiratory system agents|mesh-ancestor
24846423|NCT02242695|Clotrimazole|clotrimazole|mesh-list
24846424|NCT02242695|Dequalinium|dequalinium|mesh-list
24846425|NCT02242695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25869925|NCT00117403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869926|NCT00117403|Protective Agents|protective agents|mesh-ancestor
25869927|NCT00117403|Vitamin B Complex|vitamin b complex|mesh-ancestor
25869928|NCT00117442|Paclitaxel|paclitaxel|mesh-list
25869929|NCT00117442|Carboplatin|carboplatin|mesh-list
25869930|NCT00117442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25869931|NCT00117442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25869932|NCT00117442|Tubulin Modulators|tubulin modulators|mesh-ancestor
25108806|NCT03130218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25108807|NCT03130218|Parasympatholytics|parasympatholytics|mesh-ancestor
25108808|NCT03130153|Aspirin|aspirin|mesh-list
25108809|NCT03130153|Salicylic Acid|salicylic acid|mesh-list
25108810|NCT03130153|Salicylates|salicylates|mesh-list
25108811|NCT03130153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25108812|NCT03130153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25869933|NCT00117442|Antimitotic Agents|antimitotic agents|mesh-ancestor
25869934|NCT00117442|Mitosis Modulators|mitosis modulators|mesh-ancestor
25876670|NCT02997228|Growth Substances|growth substances|mesh-ancestor
25230762|NCT02593721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25230763|NCT02593721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25230764|NCT02593721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25230765|NCT02593721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230768|NCT02593526|Dialysis Solutions|dialysis solutions|mesh-list
25230769|NCT02593526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25230770|NCT02593526|Diuretics|diuretics|mesh-ancestor
25230771|NCT02593526|Natriuretic Agents|natriuretic agents|mesh-ancestor
25230772|NCT02593526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869936|NCT00117455|Lenograstim|lenograstim|mesh-list
25869937|NCT00117455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25869938|NCT00117455|Immunologic Factors|immunologic factors|mesh-ancestor
25869939|NCT00117455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869940|NCT00117468|Progesterone|progesterone|mesh-list
25869941|NCT00117468|Progestins|progestins|mesh-ancestor
25869942|NCT00117468|Hormones|hormones|mesh-ancestor
25869943|NCT00117468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25869944|NCT00117468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869945|NCT00117494|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24846426|NCT02242695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24846427|NCT02242695|Antifungal Agents|antifungal agents|mesh-ancestor
24846428|NCT02242695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24846429|NCT02242695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25869946|NCT00117494|Pravastatin|pravastatin|mesh-list
25869947|NCT00117494|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25869948|NCT00117494|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25869949|NCT00117494|Antimetabolites|antimetabolites|mesh-ancestor
25869950|NCT00117494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869951|NCT00117494|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25869952|NCT00117494|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25869953|NCT00117494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25869954|NCT00117520|Caffeine|caffeine|mesh-list
25869955|NCT00117520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25869956|NCT00117520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869957|NCT00117520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25869958|NCT00117520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25869959|NCT00117520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869960|NCT00117520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25869961|NCT00117520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25869962|NCT00117520|Purinergic Agents|purinergic agents|mesh-ancestor
25869963|NCT00117520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25869964|NCT00117533|Ribavirin|ribavirin|mesh-list
25869965|NCT00117533|Interferon alpha-2|interferon alpha-2|mesh-list
25869966|NCT00117533|Antimetabolites|antimetabolites|mesh-ancestor
25434466|NCT00101101|Interleukin-2|interleukin-2|mesh-list
25230794|NCT02593643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25044121|NCT01138163|Bavituximab|bavituximab|mesh-list
25044122|NCT01138163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044123|NCT01138163|Tubulin Modulators|tubulin modulators|mesh-ancestor
25044124|NCT01138163|Antimitotic Agents|antimitotic agents|mesh-ancestor
25044125|NCT01138163|Mitosis Modulators|mitosis modulators|mesh-ancestor
25044126|NCT01138163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869967|NCT00117533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869968|NCT00117533|Antiviral Agents|antiviral agents|mesh-ancestor
25869969|NCT00117533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25869970|NCT00117533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25869971|NCT00117546|Methyldopa|methyldopa|mesh-list
25869972|NCT00117546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25869973|NCT00117546|Sympatholytics|sympatholytics|mesh-ancestor
25869974|NCT00117546|Autonomic Agents|autonomic agents|mesh-ancestor
25869975|NCT00117546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24878974|NCT00045201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25230795|NCT02593643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25230796|NCT02593643|GABA Modulators|gaba modulators|mesh-ancestor
25230797|NCT02593643|GABA Agents|gaba agents|mesh-ancestor
25230798|NCT02593669|Dexamethasone|dexamethasone|mesh-list
25230799|NCT02593669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25230800|NCT02593669|Antiemetics|antiemetics|mesh-ancestor
25230801|NCT02593669|Autonomic Agents|autonomic agents|mesh-ancestor
25230802|NCT02593669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25230803|NCT02593669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230804|NCT02593669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25230805|NCT02593669|Glucocorticoids|glucocorticoids|mesh-ancestor
25044130|NCT01137968|Motesanib diphosphate|motesanib diphosphate|mesh-list
25044131|NCT01137968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25070785|NCT03415906|Valsartan|valsartan|mesh-list
25869976|NCT00117546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273509|NCT02385188|Anesthetics, Local|anesthetics, local|mesh-ancestor
25273510|NCT02385188|Anesthetics|anesthetics|mesh-ancestor
25273511|NCT02385188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25869977|NCT00117546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24801623|NCT01984567|Vitamin E|vitamin e|mesh-list
24801624|NCT01984567|Thioctic Acid|thioctic acid|mesh-list
25869978|NCT00117546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25869979|NCT00117546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25869980|NCT00117546|Adrenergic Agents|adrenergic agents|mesh-ancestor
25869981|NCT00117546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25869982|NCT00117546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25869983|NCT00117611|Omalizumab|omalizumab|mesh-list
25869984|NCT00117611|Antibodies|antibodies|mesh-list
25869985|NCT00117611|Immunologic Factors|immunologic factors|mesh-ancestor
25869986|NCT00117611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869987|NCT00117611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25869988|NCT00117611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25869989|NCT00117611|Respiratory System Agents|respiratory system agents|mesh-ancestor
25869990|NCT00117624|Darbepoetin alfa|darbepoetin alfa|mesh-list
25869991|NCT00117624|Hematinics|hematinics|mesh-ancestor
25869992|NCT00117663|Hormones|hormones|mesh-list
25869993|NCT00117663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25869994|NCT00117663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25869995|NCT00117689|Mycophenolic Acid|mycophenolic acid|mesh-list
25869996|NCT00117689|Tacrolimus|tacrolimus|mesh-list
25230823|NCT02593383|Clindamycin phosphate|clindamycin phosphate|mesh-list
25230824|NCT02593383|Adapalene|adapalene|mesh-list
25230825|NCT02593383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25230826|NCT02593383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25230827|NCT02593383|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25230828|NCT02593383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230829|NCT02593383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230830|NCT02593383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25230831|NCT02593383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25230832|NCT02593383|Analgesics|analgesics|mesh-ancestor
25230833|NCT02593383|Sensory System Agents|sensory system agents|mesh-ancestor
25230834|NCT02593383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25230845|NCT02593409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24817105|NCT02081027|Riluzole|riluzole|mesh-list
25409530|NCT03371667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25671274|NCT02478775|Hormone Antagonists|hormone antagonists|mesh-ancestor
25671275|NCT02478775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25671276|NCT02437071|Pembrolizumab|pembrolizumab|mesh-list
24836654|NCT02186782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671277|NCT02437071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25671278|NCT02437071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671279|NCT02422641|Methotrexate|methotrexate|mesh-list
25671280|NCT02422641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25671281|NCT02422641|Abortifacient Agents|abortifacient agents|mesh-ancestor
25671282|NCT02422641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25671283|NCT02422641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671284|NCT02422641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25671285|NCT02422641|Antimetabolites|antimetabolites|mesh-ancestor
25671286|NCT02422641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671287|NCT02422641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671288|NCT02422641|Dermatologic Agents|dermatologic agents|mesh-ancestor
25134885|NCT03004339|Calcipotriene|calcipotriene|mesh-list
25134887|NCT03004339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25134888|NCT03004339|Glucocorticoids|glucocorticoids|mesh-ancestor
25870014|NCT00117702|Immunologic Factors|immunologic factors|mesh-ancestor
25870015|NCT00117702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870016|NCT00117702|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25870017|NCT00117702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870018|NCT00117702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870019|NCT00117702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870020|NCT00117728|Nevirapine|nevirapine|mesh-list
25870021|NCT00117728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25870022|NCT00117728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25671289|NCT02422641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25671290|NCT02422641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25671291|NCT02422641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25671292|NCT02422641|Immunologic Factors|immunologic factors|mesh-ancestor
25671293|NCT02422641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25671294|NCT02422641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25671295|NCT02394132|Imiquimod|imiquimod|mesh-list
25671296|NCT02394132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25671297|NCT02394132|Immunologic Factors|immunologic factors|mesh-ancestor
25671298|NCT02394132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671299|NCT02394132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671300|NCT02394132|Interferon Inducers|interferon inducers|mesh-ancestor
25671301|NCT02392871|Trametinib|trametinib|mesh-list
25671302|NCT02392871|Dabrafenib|dabrafenib|mesh-list
25671303|NCT02392871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671304|NCT02392871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25671305|NCT02392871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25671306|NCT02392871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671307|NCT02382575|Rituximab|rituximab|mesh-list
25671308|NCT02382575|Tacrolimus|tacrolimus|mesh-list
25671309|NCT02382575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
25671310|NCT02382575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25671311|NCT02382575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870041|NCT00117767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870042|NCT00117780|Insulin|insulin|mesh-list
25870043|NCT00117780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25870044|NCT00117780|Insulin Aspart|insulin aspart|mesh-list
25870045|NCT00117780|Insulin Detemir|insulin detemir|mesh-list
25870046|NCT00117780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25870047|NCT00117780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870048|NCT00117832|Azelastine|azelastine|mesh-list
25870049|NCT00117832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25870050|NCT00117832|Autonomic Agents|autonomic agents|mesh-ancestor
25230877|NCT02593370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25230878|NCT02593370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230879|NCT02593370|Sensory System Agents|sensory system agents|mesh-ancestor
25230880|NCT02593370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25230881|NCT02593370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25230882|NCT02593370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25230883|NCT02593370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25230884|NCT02593370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25230885|NCT02593370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230886|NCT02593370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25870067|NCT00117897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870069|NCT00117936|Mitosis Modulators|mitosis modulators|mesh-ancestor
24622335|NCT01066676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25870070|NCT00117936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230893|NCT02593370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25230894|NCT02593370|Respiratory System Agents|respiratory system agents|mesh-ancestor
25230895|NCT02593370|Mydriatics|mydriatics|mesh-ancestor
25230896|NCT02593370|Sympathomimetics|sympathomimetics|mesh-ancestor
25230897|NCT02593370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25230898|NCT02593370|Chelating Agents|chelating agents|mesh-ancestor
25230899|NCT02593370|Sequestering Agents|sequestering agents|mesh-ancestor
25230900|NCT02593019|Adavosertib|adavosertib|mesh-list
25230901|NCT02593019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25230902|NCT02593019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230903|NCT02593162|Ribavirin|ribavirin|mesh-list
25230904|NCT02593162|Antimetabolites|antimetabolites|mesh-ancestor
25230905|NCT02593162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230906|NCT02593162|Antiviral Agents|antiviral agents|mesh-ancestor
25230907|NCT02593162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25230908|NCT02592980|Warfarin|warfarin|mesh-list
25230909|NCT02592980|Anticoagulants|anticoagulants|mesh-ancestor
25230910|NCT02593201|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25230911|NCT02593201|Cefazolin|cefazolin|mesh-list
25230912|NCT02593201|Ceftazidime|ceftazidime|mesh-list
25230913|NCT02593201|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25230914|NCT02593201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25230915|NCT02593201|Antitubercular Agents|antitubercular agents|mesh-ancestor
25230916|NCT02592941|Deflazacort|deflazacort|mesh-list
25230917|NCT02592941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25230918|NCT02592941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25870071|NCT00117975|Galiximab|galiximab|mesh-list
25870072|NCT00117975|Rituximab|rituximab|mesh-list
25870073|NCT00117975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25870074|NCT00117975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870075|NCT00117975|Immunologic Factors|immunologic factors|mesh-ancestor
25870076|NCT00117975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870077|NCT00117975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25870078|NCT00117975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25870079|NCT00118014|Sertraline|sertraline|mesh-list
25870080|NCT00118014|Antidepressive Agents|antidepressive agents|mesh-ancestor
25870081|NCT00118014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25870082|NCT00118014|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25870090|NCT00118027|Sulfadoxine|sulfadoxine|mesh-list
25870091|NCT00118027|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25870092|NCT00118027|Antimalarials|antimalarials|mesh-ancestor
24846450|NCT02242799|Amodiaquine|amodiaquine|mesh-list
24846451|NCT02242799|Dolutegravir|dolutegravir|mesh-list
24461894|NCT00354302|Alendronate|alendronate|mesh-list
25044184|NCT01130142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25044185|NCT01130142|Immunologic Factors|immunologic factors|mesh-ancestor
25044186|NCT01130142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044187|NCT01129674|Olanzapine|olanzapine|mesh-list
25044188|NCT01129674|Risperidone|risperidone|mesh-list
25044189|NCT01129674|Aripiprazole|aripiprazole|mesh-list
25044190|NCT01129674|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25044191|NCT01129674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25044192|NCT01129674|Serotonin Agents|serotonin agents|mesh-ancestor
25870093|NCT00118027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25870094|NCT00118027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25870095|NCT00118027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25230950|NCT02592772|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25230952|NCT02592772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25230953|NCT02592772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230954|NCT02592772|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25230955|NCT02592772|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25230956|NCT02592772|Cholinergic Agents|cholinergic agents|mesh-ancestor
25230957|NCT02592772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25230958|NCT02592772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25230960|NCT02592772|Dermatologic Agents|dermatologic agents|mesh-ancestor
25230961|NCT02592915|Clonidine|clonidine|mesh-list
25230962|NCT02592915|Anesthetics|anesthetics|mesh-list
25230963|NCT02592915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25230964|NCT02592915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25230965|NCT02592915|Analgesics|analgesics|mesh-ancestor
25230966|NCT02592915|Sensory System Agents|sensory system agents|mesh-ancestor
25230967|NCT02592915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25230968|NCT02592915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25230969|NCT02592915|Sympatholytics|sympatholytics|mesh-ancestor
25230970|NCT02592915|Autonomic Agents|autonomic agents|mesh-ancestor
25230971|NCT02592915|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25230972|NCT02592915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25230973|NCT02592915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25230974|NCT02592915|Adrenergic Agents|adrenergic agents|mesh-ancestor
25230975|NCT02592915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25230976|NCT02592915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273515|NCT02385188|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25273516|NCT02385188|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25273517|NCT02385188|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25273518|NCT02385188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25044198|NCT01129674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25044199|NCT01129674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25044200|NCT01129674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25044201|NCT01129674|Dopamine Agents|dopamine agents|mesh-ancestor
25044203|NCT01129674|Autonomic Agents|autonomic agents|mesh-ancestor
25870096|NCT00118027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25870097|NCT00118027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870098|NCT00118027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870099|NCT00118027|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25231014|NCT02592694|Protease Inhibitors|protease inhibitors|mesh-ancestor
25231015|NCT02592694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25231017|NCT02592694|Anticoagulants|anticoagulants|mesh-ancestor
25231018|NCT02592694|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25231019|NCT02592694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25231020|NCT02592694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25231021|NCT02592226|Anesthetics|anesthetics|mesh-list
25231022|NCT02592226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25231023|NCT02592226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231024|NCT02592395|Folfirinox|folfirinox|mesh-list
25231025|NCT02592395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231026|NCT02592278|Listerine|listerine|mesh-list
25231027|NCT02592278|Fluorides|fluorides|mesh-list
25231028|NCT02592278|Fluorides, Topical|fluorides, topical|mesh-list
25231029|NCT02592278|Sodium Fluoride|sodium fluoride|mesh-list
25231030|NCT02592278|Cariostatic Agents|cariostatic agents|mesh-ancestor
25231031|NCT02592278|Protective Agents|protective agents|mesh-ancestor
25231032|NCT02592278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231033|NCT02592278|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25231034|NCT02592278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25231035|NCT02592083|Tamoxifen|tamoxifen|mesh-list
25231036|NCT02592083|Goserelin|goserelin|mesh-list
25231037|NCT02592083|Palbociclib|palbociclib|mesh-list
25870112|NCT00118105|Capecitabine|capecitabine|mesh-list
25870113|NCT00118105|Oxaliplatin|oxaliplatin|mesh-list
25870114|NCT00118105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25870115|NCT00118105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870116|NCT00118105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25870117|NCT00118105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25870118|NCT00118105|Growth Substances|growth substances|mesh-ancestor
25870119|NCT00118105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231038|NCT02592083|Exemestane|exemestane|mesh-list
25231039|NCT02592083|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25231040|NCT02592083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25231041|NCT02592083|Hormone Antagonists|hormone antagonists|mesh-ancestor
25231042|NCT02592083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25231043|NCT02592083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231044|NCT02592083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25231045|NCT02592083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231046|NCT02592083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25231047|NCT02592083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25231048|NCT02592083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25231049|NCT02592083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25231050|NCT02592083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25231051|NCT02592083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231052|NCT02592083|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25671315|NCT02382575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25870120|NCT00118105|Growth Inhibitors|growth inhibitors|mesh-ancestor
25231059|NCT02592122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231060|NCT02592122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25231061|NCT02592122|Respiratory System Agents|respiratory system agents|mesh-ancestor
25231062|NCT02592122|Tocolytic Agents|tocolytic agents|mesh-ancestor
25870121|NCT00118105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25055543|NCT03520062|Incretins|incretins|mesh-ancestor
25091548|NCT03248648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091549|NCT03248648|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25870122|NCT00118105|Antimetabolites|antimetabolites|mesh-ancestor
25870123|NCT00118105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870124|NCT00118170|Sorafenib|sorafenib|mesh-list
25870125|NCT00118170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870126|NCT00118170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25870127|NCT00118170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870128|NCT00118170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870129|NCT00118183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25870130|NCT00118183|Cetuximab|cetuximab|mesh-list
25870131|NCT00118183|Docetaxel|docetaxel|mesh-list
25870132|NCT00118183|Bortezomib|bortezomib|mesh-list
25870133|NCT00118183|Antibodies|antibodies|mesh-list
25870134|NCT00118183|Immunoglobulins|immunoglobulins|mesh-list
25870135|NCT00118183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25870136|NCT00118183|Immunologic Factors|immunologic factors|mesh-ancestor
25870137|NCT00118183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870138|NCT00118183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231063|NCT02592122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25231064|NCT02592122|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25231065|NCT02592122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25231066|NCT02592122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25231067|NCT02592122|Adrenergic Agents|adrenergic agents|mesh-ancestor
25231068|NCT02592122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25231069|NCT02592122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231070|NCT02592096|Carbamide Peroxide|carbamide peroxide|mesh-list
25231071|NCT02592096|Pazufloxacin|pazufloxacin|mesh-list
25231072|NCT02592096|Fluoroquinolones|fluoroquinolones|mesh-list
25231073|NCT02592096|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25231074|NCT02592096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25231075|NCT02592096|Antitubercular Agents|antitubercular agents|mesh-ancestor
25231076|NCT02592096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25231077|NCT02592096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25231078|NCT02592096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25231079|NCT02592096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25231080|NCT02592096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231081|NCT02592096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231082|NCT02592096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25231083|NCT02592057|Sofosbuvir|sofosbuvir|mesh-list
25231084|NCT02592057|Antiviral Agents|antiviral agents|mesh-ancestor
25231085|NCT02592057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25231086|NCT02591914|Bevacizumab|bevacizumab|mesh-list
24846469|NCT02242812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24846470|NCT02242812|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24889992|NCT04487392|Hormones|hormones|mesh-ancestor
25870139|NCT00118183|Tubulin Modulators|tubulin modulators|mesh-ancestor
25870140|NCT00118183|Antimitotic Agents|antimitotic agents|mesh-ancestor
25870141|NCT00118183|Mitosis Modulators|mitosis modulators|mesh-ancestor
25870142|NCT00118183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870143|NCT00118196|Azacitidine|azacitidine|mesh-list
25870144|NCT00118196|Arsenic Trioxide|arsenic trioxide|mesh-list
25870145|NCT00118196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25870146|NCT00118196|Antimetabolites|antimetabolites|mesh-ancestor
24447917|NCT00309881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24447944|NCT00309894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447945|NCT00309894|Antifungal Agents|antifungal agents|mesh-ancestor
25870147|NCT00118196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447964|NCT00309920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870148|NCT00118196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870149|NCT00118196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870164|NCT00118235|Cisplatin|cisplatin|mesh-list
25870165|NCT00118235|Irinotecan|irinotecan|mesh-list
25870166|NCT00118235|Antibodies|antibodies|mesh-list
25870167|NCT00118235|Immunoglobulins|immunoglobulins|mesh-list
25870168|NCT00118235|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25870169|NCT00118235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870170|NCT00118235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25870171|NCT00118235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25870172|NCT00118235|Growth Substances|growth substances|mesh-ancestor
24836733|NCT02187133|Immunologic Factors|immunologic factors|mesh-ancestor
24836735|NCT02187133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25870173|NCT00118235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899169|NCT04406025|Anesthetics|anesthetics|mesh-list
24879562|NCT04664361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24879563|NCT04664361|Antimetabolites|antimetabolites|mesh-ancestor
25870174|NCT00118235|Growth Inhibitors|growth inhibitors|mesh-ancestor
25870175|NCT00118235|Immunologic Factors|immunologic factors|mesh-ancestor
25870176|NCT00118235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25870177|NCT00118235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25870178|NCT00118235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25231087|NCT02591914|Ranibizumab|ranibizumab|mesh-list
25231088|NCT02591914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25231089|NCT02591914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231090|NCT02591914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24846471|NCT02242812|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24846472|NCT02242812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846473|NCT02242812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24846476|NCT02242812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24846477|NCT02242812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846478|NCT02242812|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24462121|NCT00354991|Losartan|losartan|mesh-list
25870179|NCT00118235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870180|NCT00118261|Leucovorin|leucovorin|mesh-list
25870181|NCT00118261|Bevacizumab|bevacizumab|mesh-list
25870182|NCT00118261|Fluorouracil|fluorouracil|mesh-list
25870183|NCT00118261|Oxaliplatin|oxaliplatin|mesh-list
25870184|NCT00118261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25870185|NCT00118261|Calcium|calcium|mesh-list
25870186|NCT00118261|Levoleucovorin|levoleucovorin|mesh-list
25870187|NCT00118261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25870188|NCT00118261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870189|NCT00118261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25870190|NCT00118261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25870191|NCT00118261|Growth Substances|growth substances|mesh-ancestor
25870192|NCT00118261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870193|NCT00118261|Growth Inhibitors|growth inhibitors|mesh-ancestor
25870194|NCT00118261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25870195|NCT00118261|Antimetabolites|antimetabolites|mesh-ancestor
25409531|NCT03371667|Antimetabolites|antimetabolites|mesh-ancestor
25671316|NCT02382575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25231093|NCT02591914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231094|NCT02591914|Growth Inhibitors|growth inhibitors|mesh-ancestor
25231095|NCT02591927|Insulin|insulin|mesh-list
25231096|NCT02591927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25231097|NCT02591927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231098|NCT02591615|Paclitaxel|paclitaxel|mesh-list
25231099|NCT02591615|Carboplatin|carboplatin|mesh-list
25231100|NCT02591615|Pembrolizumab|pembrolizumab|mesh-list
25231101|NCT02591615|Pemetrexed|pemetrexed|mesh-list
25231102|NCT02591615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25231103|NCT02591615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231104|NCT02591615|Tubulin Modulators|tubulin modulators|mesh-ancestor
25870214|NCT00118313|Freund's Adjuvant|freund's adjuvant|mesh-list
25870215|NCT00118313|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
25870216|NCT00118313|Immunologic Factors|immunologic factors|mesh-ancestor
25870217|NCT00118313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870218|NCT00118313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870219|NCT00118313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25870220|NCT00118313|Interferon Inducers|interferon inducers|mesh-ancestor
25870221|NCT00118313|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25870222|NCT00118313|Protective Agents|protective agents|mesh-ancestor
25870223|NCT00118313|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25870224|NCT00118313|Antioxidants|antioxidants|mesh-ancestor
25870225|NCT00118313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870226|NCT00118326|Lenograstim|lenograstim|mesh-list
25061506|NCT03470532|Epinephrine|epinephrine|mesh-list
25674509|NCT01773070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25674510|NCT01773070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25674511|NCT01773070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25674512|NCT01773109|Irinotecan|irinotecan|mesh-list
25674513|NCT01773109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
25674514|NCT01773109|Etirinotecan pegol|etirinotecan pegol|mesh-list
25674515|NCT01773109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25674516|NCT01773109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25231107|NCT02591615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231108|NCT02591615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25231109|NCT02591615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25231110|NCT02591615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25231111|NCT02591615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25231112|NCT02591888|Bupivacaine|bupivacaine|mesh-list
25231113|NCT02591888|Anesthetics, Local|anesthetics, local|mesh-ancestor
25231114|NCT02591888|Anesthetics|anesthetics|mesh-ancestor
25231115|NCT02591888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25231116|NCT02591888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231117|NCT02591888|Sensory System Agents|sensory system agents|mesh-ancestor
25231118|NCT02591888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25231119|NCT02591771|Epinephrine|epinephrine|mesh-list
25231120|NCT02591771|Racepinephrine|racepinephrine|mesh-list
25231121|NCT02591771|Epinephryl borate|epinephryl borate|mesh-list
25231122|NCT02591771|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25231123|NCT02591771|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25231124|NCT02591771|Adrenergic Agents|adrenergic agents|mesh-ancestor
25231125|NCT02591771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25231126|NCT02591771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231127|NCT02591771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870237|NCT00118638|Darbepoetin alfa|darbepoetin alfa|mesh-list
25870238|NCT00118638|Hematinics|hematinics|mesh-ancestor
25870239|NCT00118690|Fluticasone|fluticasone|mesh-list
25870240|NCT00118690|Xhance|xhance|mesh-list
25870241|NCT00118690|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25870242|NCT00118690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25870243|NCT00118690|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25870244|NCT00118690|Autonomic Agents|autonomic agents|mesh-ancestor
25870245|NCT00118690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25870246|NCT00118690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879697|NCT04528680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24846479|NCT02242812|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24846480|NCT02242812|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24846481|NCT02242812|Adrenergic Agents|adrenergic agents|mesh-ancestor
24846482|NCT02242812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24846483|NCT02242825|Telmisartan|telmisartan|mesh-list
24846484|NCT02242825|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
25870247|NCT00118690|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25870248|NCT00118690|Respiratory System Agents|respiratory system agents|mesh-ancestor
25870249|NCT00118690|Dermatologic Agents|dermatologic agents|mesh-ancestor
25870250|NCT00118690|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25870251|NCT00118690|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25870252|NCT00118690|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25870253|NCT00118690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25870254|NCT00118690|Adrenergic Agents|adrenergic agents|mesh-ancestor
25870255|NCT00118690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25870256|NCT00118690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870266|NCT00118794|Dapsone|dapsone|mesh-list
25870267|NCT00118794|Chlorproguanil|chlorproguanil|mesh-list
25870268|NCT00118794|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25870269|NCT00118794|Antimalarials|antimalarials|mesh-ancestor
25870270|NCT00118794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25870271|NCT00118794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25870272|NCT00118794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25870273|NCT00118794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25870274|NCT00118794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870275|NCT00118794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870276|NCT00118794|Leprostatic Agents|leprostatic agents|mesh-ancestor
25870277|NCT00118794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25870278|NCT00118807|Artesunate|artesunate|mesh-list
25870279|NCT00118807|Chloroquine|chloroquine|mesh-list
25870280|NCT00118807|Pyrimethamine|pyrimethamine|mesh-list
25231138|NCT02591836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25231139|NCT02591836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25231140|NCT02591836|Antimetabolites|antimetabolites|mesh-ancestor
25231141|NCT02591836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231142|NCT02591836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25231143|NCT02591836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25231144|NCT02591836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25231145|NCT02591849|Glucagon|glucagon|mesh-list
25231146|NCT02591849|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25231147|NCT02591849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25231148|NCT02591849|Hormones|hormones|mesh-ancestor
25231149|NCT02591849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25231150|NCT02591849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231151|NCT02591849|Incretins|incretins|mesh-ancestor
25231152|NCT02591667|Bevacizumab|bevacizumab|mesh-list
25870294|NCT00118807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25870295|NCT00118807|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25870296|NCT00118807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25071068|NCT03413150|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24722913|NCT01583439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25671317|NCT02382575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671318|NCT02239874|Vitamin D|vitamin d|mesh-list
25671319|NCT02239874|Ergocalciferols|ergocalciferols|mesh-list
25671320|NCT02239874|Cholecalciferol|cholecalciferol|mesh-list
25671321|NCT02239874|Vitamins|vitamins|mesh-list
25671322|NCT02239874|Micronutrients|micronutrients|mesh-ancestor
25671323|NCT02239874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671324|NCT02239874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25870301|NCT00118820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25876671|NCT02997228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876672|NCT02997228|Growth Inhibitors|growth inhibitors|mesh-ancestor
25876673|NCT02997228|Immunologic Factors|immunologic factors|mesh-ancestor
25876674|NCT02997228|Antimetabolites|antimetabolites|mesh-ancestor
25876675|NCT02997228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876676|NCT02997228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25876677|NCT02997228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25876678|NCT02997228|Antidotes|antidotes|mesh-ancestor
25876679|NCT02997228|Protective Agents|protective agents|mesh-ancestor
25876680|NCT02997228|Vitamin B Complex|vitamin b complex|mesh-ancestor
25876681|NCT02997228|Vitamins|vitamins|mesh-ancestor
25876682|NCT02997228|Micronutrients|micronutrients|mesh-ancestor
25876683|NCT02962414|Everolimus|everolimus|mesh-list
25876684|NCT02962414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876685|NCT02962414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25876686|NCT02962414|Immunologic Factors|immunologic factors|mesh-ancestor
25876687|NCT02962414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876688|NCT02960555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25876689|NCT02960555|Immunologic Factors|immunologic factors|mesh-ancestor
25876690|NCT02960555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876691|NCT02960022|Prednisone|prednisone|mesh-list
25876692|NCT02960022|Abiraterone Acetate|abiraterone acetate|mesh-list
25273534|NCT02385136|Alkylating Agents|alkylating agents|mesh-ancestor
25273535|NCT02385136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273536|NCT02385136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25273537|NCT02385071|Simeprevir|simeprevir|mesh-list
25273538|NCT02385071|Antiviral Agents|antiviral agents|mesh-ancestor
25273539|NCT02385071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25273540|NCT02385071|Protease Inhibitors|protease inhibitors|mesh-ancestor
25273541|NCT02385071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273542|NCT02385071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622354|NCT01066689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622355|NCT01066728|Theophylline|theophylline|mesh-list
24622356|NCT01066728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24622392|NCT01066832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24622393|NCT01066832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622394|NCT01066832|Tubulin Modulators|tubulin modulators|mesh-ancestor
24622395|NCT01066832|Antimitotic Agents|antimitotic agents|mesh-ancestor
24622396|NCT01066832|Mitosis Modulators|mitosis modulators|mesh-ancestor
24622397|NCT01066832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870307|NCT00118950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25870308|NCT00118950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870309|NCT00118963|Metformin|metformin|mesh-list
25870310|NCT00118963|Insulin Aspart|insulin aspart|mesh-list
25870311|NCT00118963|Repaglinide|repaglinide|mesh-list
25870312|NCT00118963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25870313|NCT00118963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870314|NCT00118976|Lisinopril|lisinopril|mesh-list
25870315|NCT00118976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25870316|NCT00118976|Protease Inhibitors|protease inhibitors|mesh-ancestor
25870317|NCT00118976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870318|NCT00118976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870319|NCT00118976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24622399|NCT01066845|Vasodilator Agents|vasodilator agents|mesh-ancestor
24622400|NCT01066845|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24622401|NCT01066845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24622402|NCT01066845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870320|NCT00118976|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25870321|NCT00118976|Protective Agents|protective agents|mesh-ancestor
25870322|NCT00118976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870323|NCT00119002|Dexamethasone|dexamethasone|mesh-list
25870324|NCT00119002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25870325|NCT00119002|Antiemetics|antiemetics|mesh-ancestor
25231196|NCT02591173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231197|NCT02590874|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25870335|NCT00119119|Tocopherols|tocopherols|mesh-list
25870336|NCT00119119|Vitamin E|vitamin e|mesh-list
25870337|NCT00119119|Tocotrienols|tocotrienols|mesh-list
25870338|NCT00119119|alpha-Tocopherol|alpha-tocopherol|mesh-list
25870339|NCT00119119|Antioxidants|antioxidants|mesh-ancestor
25870340|NCT00119119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870341|NCT00119119|Protective Agents|protective agents|mesh-ancestor
25870342|NCT00119119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870343|NCT00119119|Vitamins|vitamins|mesh-ancestor
25870344|NCT00119119|Micronutrients|micronutrients|mesh-ancestor
25870345|NCT00119132|Artesunate|artesunate|mesh-list
25870346|NCT00119132|Pyrimethamine|pyrimethamine|mesh-list
25870347|NCT00119132|Sulfadoxine|sulfadoxine|mesh-list
25870348|NCT00119132|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25870349|NCT00119132|Amodiaquine|amodiaquine|mesh-list
24577958|NCT00846430|Analgesics|analgesics|mesh-ancestor
25870350|NCT00119132|Antimalarials|antimalarials|mesh-ancestor
25870351|NCT00119132|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25870352|NCT00119132|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25870353|NCT00119132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25870354|NCT00119132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870355|NCT00119132|Antiviral Agents|antiviral agents|mesh-ancestor
25870356|NCT00119132|Schistosomicides|schistosomicides|mesh-ancestor
25870357|NCT00119132|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25870358|NCT00119132|Anthelmintics|anthelmintics|mesh-ancestor
24900310|NCT04395417|Hyaluronic Acid|hyaluronic acid|mesh-list
25870359|NCT00119132|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25671325|NCT02239874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25671326|NCT02236910|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
25671327|NCT02236910|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25870360|NCT00119132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25671328|NCT02236910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846496|NCT02242838|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24846497|NCT02242838|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24846498|NCT02242838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846499|NCT02242851|Telmisartan|telmisartan|mesh-list
24846500|NCT02242851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24846501|NCT02242851|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25870363|NCT00119132|Renal Agents|renal agents|mesh-ancestor
25870364|NCT00119145|Artesunate|artesunate|mesh-list
25870365|NCT00119145|Amodiaquine|amodiaquine|mesh-list
25044204|NCT01129674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25044205|NCT01129674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25044206|NCT01129674|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25044207|NCT01129674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25044208|NCT01129674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25870366|NCT00119145|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25870367|NCT00119145|Antimalarials|antimalarials|mesh-ancestor
24558964|NCT05382338|Lomustine|lomustine|mesh-list
24447973|NCT00309920|Mitosis Modulators|mitosis modulators|mesh-ancestor
24447974|NCT00309920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24447975|NCT00309920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24447976|NCT00309920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25870368|NCT00119145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24447997|NCT00310011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24447998|NCT00310011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447999|NCT00310011|Tubulin Modulators|tubulin modulators|mesh-ancestor
25231212|NCT02591017|Chitosan|chitosan|mesh-list
25231213|NCT02591017|Analgesics|analgesics|mesh-ancestor
25231214|NCT02591017|Sensory System Agents|sensory system agents|mesh-ancestor
25231215|NCT02591017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25231216|NCT02591017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231217|NCT02591017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25231218|NCT02591017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25231219|NCT02591017|Anesthetics, General|anesthetics, general|mesh-ancestor
25231220|NCT02591017|Anesthetics|anesthetics|mesh-ancestor
25231221|NCT02591017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25231236|NCT02591095|Navitoclax|navitoclax|mesh-list
25231222|NCT02591017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25231223|NCT02591017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25231224|NCT02591017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25231225|NCT02591017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231226|NCT02591017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25231227|NCT02591017|Narcotics|narcotics|mesh-ancestor
25231228|NCT02591017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25231229|NCT02591017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25231230|NCT02591017|Antimetabolites|antimetabolites|mesh-ancestor
25231231|NCT02591017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25231232|NCT02591017|Chelating Agents|chelating agents|mesh-ancestor
25231233|NCT02591017|Sequestering Agents|sequestering agents|mesh-ancestor
25044209|NCT01129674|Antidepressive Agents|antidepressive agents|mesh-ancestor
25044210|NCT01129674|Dopamine Agonists|dopamine agonists|mesh-ancestor
25044211|NCT01129674|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25044212|NCT01129674|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25044213|NCT01129674|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25044214|NCT01129674|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25044215|NCT01129648|Allopurinol|allopurinol|mesh-list
25044216|NCT01129648|Antimetabolites|antimetabolites|mesh-ancestor
25061639|NCT03469323|Succinylcholine|succinylcholine|mesh-list
25870369|NCT00119145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25870387|NCT00119210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24622425|NCT01066962|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24622426|NCT01066962|Protease Inhibitors|protease inhibitors|mesh-ancestor
24622427|NCT01066962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622428|NCT01066962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622429|NCT01066962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24622430|NCT01066962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24578334|NCT00848679|Lidocaine|lidocaine|mesh-list
24818054|NCT02086838|Hematinics|hematinics|mesh-list
25231234|NCT02591017|Hemostatics|hemostatics|mesh-ancestor
25231235|NCT02591017|Coagulants|coagulants|mesh-ancestor
25231237|NCT02591095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231238|NCT02591004|Nifedipine|nifedipine|mesh-list
25231239|NCT02591004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25231240|NCT02591004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25231241|NCT02591004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231242|NCT02591004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25044217|NCT01129648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044218|NCT01129648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044219|NCT01129648|Gout Suppressants|gout suppressants|mesh-ancestor
25044220|NCT01129648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25044221|NCT01129648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25044223|NCT01129648|Protective Agents|protective agents|mesh-ancestor
25000548|NCT04225988|Tacrolimus|tacrolimus|mesh-list
25044224|NCT01129648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044254|NCT01124552|Botulinum Toxins|botulinum toxins|mesh-list
24452752|NCT05453045|Anthelmintics|anthelmintics|mesh-ancestor
24452753|NCT05453045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25870388|NCT00119210|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25870389|NCT00119210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25870390|NCT00119210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25870391|NCT00119210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231265|NCT02590705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25108974|NCT03128398|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25108975|NCT03128398|Dopamine Agents|dopamine agents|mesh-ancestor
25108976|NCT03128398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25108977|NCT03128398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108978|NCT03128346|Aspirin|aspirin|mesh-list
25108979|NCT03128346|Acetaminophen|acetaminophen|mesh-list
25108980|NCT03128346|Fentanyl|fentanyl|mesh-list
25108981|NCT03128346|Hydromorphone|hydromorphone|mesh-list
25108982|NCT03128346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25108983|NCT03128346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25109000|NCT03128346|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25109001|NCT03128346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25870392|NCT00119210|Dopamine Agents|dopamine agents|mesh-ancestor
25870393|NCT00119210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25870394|NCT00119210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870395|NCT00119210|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25870396|NCT00119210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25870397|NCT00119210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870398|NCT00119236|Irinotecan|irinotecan|mesh-list
25870399|NCT00119236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25870400|NCT00119236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25870401|NCT00119236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25061667|NCT03469271|Vitamins|vitamins|mesh-ancestor
25870402|NCT00119236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870403|NCT00119236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870404|NCT00119249|Sorafenib|sorafenib|mesh-list
25870405|NCT00119249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870406|NCT00119249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25870407|NCT00119249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409610|NCT03366298|Epinephryl borate|epinephryl borate|mesh-list
24478343|NCT00422435|Paclitaxel|paclitaxel|mesh-list
24452777|NCT05449327|Rivaroxaban|rivaroxaban|mesh-list
24452778|NCT05449327|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24452779|NCT05449327|Antithrombins|antithrombins|mesh-ancestor
24452780|NCT05449327|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24452781|NCT05449327|Protease Inhibitors|protease inhibitors|mesh-ancestor
24452782|NCT05449327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24846502|NCT02242851|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24846503|NCT02242851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846504|NCT02242864|Telmisartan|telmisartan|mesh-list
24452783|NCT05449327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452784|NCT05449327|Anticoagulants|anticoagulants|mesh-ancestor
25061680|NCT03469167|Autonomic Agents|autonomic agents|mesh-ancestor
25231278|NCT02590601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25231279|NCT02590601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870414|NCT00119301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25870415|NCT00119301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870416|NCT00119301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25870417|NCT00119301|Abortifacient Agents|abortifacient agents|mesh-ancestor
25136588|NCT02990286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25136589|NCT02990286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25136590|NCT02990286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136591|NCT02990286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136593|NCT02990312|Maraviroc|maraviroc|mesh-list
25136594|NCT02990312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25136595|NCT02990312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25136596|NCT02990312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25136597|NCT02990312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136598|NCT02990312|Antifungal Agents|antifungal agents|mesh-ancestor
25136599|NCT02990312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25136600|NCT02990312|Immunologic Factors|immunologic factors|mesh-ancestor
25231280|NCT02590601|Dopamine Agonists|dopamine agonists|mesh-ancestor
25231281|NCT02590601|Dopamine Agents|dopamine agents|mesh-ancestor
25231282|NCT02590601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25231283|NCT02590601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231284|NCT02590627|Lumefantrine|lumefantrine|mesh-list
25231285|NCT02590627|Artemether|artemether|mesh-list
25231286|NCT02590627|Piperaquine|piperaquine|mesh-list
25231287|NCT02590627|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25231288|NCT02590627|Artenimol|artenimol|mesh-list
25231289|NCT02590627|Antimalarials|antimalarials|mesh-ancestor
25231290|NCT02590627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25231291|NCT02590627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25231292|NCT02590627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25231293|NCT02590614|Vitamin D|vitamin d|mesh-list
25231294|NCT02590614|Vitamins|vitamins|mesh-ancestor
25231295|NCT02590614|Micronutrients|micronutrients|mesh-ancestor
25231296|NCT02590614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231297|NCT02590614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25231298|NCT02590510|Methotrexate|methotrexate|mesh-list
25231299|NCT02590510|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25231300|NCT02590510|Abortifacient Agents|abortifacient agents|mesh-ancestor
25231301|NCT02590510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25231302|NCT02590510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231303|NCT02590510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25231304|NCT02590510|Antimetabolites|antimetabolites|mesh-ancestor
25231305|NCT02590510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231306|NCT02590510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231307|NCT02590510|Dermatologic Agents|dermatologic agents|mesh-ancestor
25231308|NCT02590510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25231309|NCT02590510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25231310|NCT02590510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25231311|NCT02590510|Immunologic Factors|immunologic factors|mesh-ancestor
25231312|NCT02590510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25231313|NCT02590510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25231314|NCT02590263|Temozolomide|temozolomide|mesh-list
25870418|NCT00119301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24953829|NCT03881111|Pembrolizumab|pembrolizumab|mesh-list
25671329|NCT02118584|Etrolizumab|etrolizumab|mesh-list
25671330|NCT02118584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25671331|NCT02118584|Immunologic Factors|immunologic factors|mesh-ancestor
25671332|NCT02118584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671333|NCT02115997|Prednisone|prednisone|mesh-list
25671334|NCT02115997|Methylprednisolone|methylprednisolone|mesh-list
25671335|NCT02115997|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25671336|NCT02115997|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25671337|NCT02115997|Prednisolone|prednisolone|mesh-list
25671338|NCT02115997|Prednisolone acetate|prednisolone acetate|mesh-list
25671339|NCT02115997|Rituximab|rituximab|mesh-list
25671340|NCT02115997|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25671341|NCT02115997|Prednisolone phosphate|prednisolone phosphate|mesh-list
25671342|NCT02115997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25434774|NCT00006721|Mitosis Modulators|mitosis modulators|mesh-ancestor
25870419|NCT00119301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25870420|NCT00119301|Antimetabolites|antimetabolites|mesh-ancestor
25870421|NCT00119301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870422|NCT00119301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870423|NCT00119301|Dermatologic Agents|dermatologic agents|mesh-ancestor
25870424|NCT00119301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870425|NCT00119301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25870426|NCT00119301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25870427|NCT00119301|Immunologic Factors|immunologic factors|mesh-ancestor
25231323|NCT02590224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231324|NCT02590133|Fluorouracil|fluorouracil|mesh-list
25231325|NCT02590133|Endostar protein|endostar protein|mesh-list
25231326|NCT02590133|Endostatins|endostatins|mesh-list
25231327|NCT02590133|Nedaplatin|nedaplatin|mesh-list
25231328|NCT02590133|Antimetabolites|antimetabolites|mesh-ancestor
25231329|NCT02590133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231330|NCT02590133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25231331|NCT02590133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231332|NCT02590133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25231333|NCT02590133|Immunologic Factors|immunologic factors|mesh-ancestor
25231334|NCT02590133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231335|NCT02590133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25231336|NCT02590133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25231337|NCT02590133|Growth Substances|growth substances|mesh-ancestor
25231338|NCT02590133|Growth Inhibitors|growth inhibitors|mesh-ancestor
25231339|NCT02590250|Botulinum Toxins|botulinum toxins|mesh-list
25231340|NCT02590250|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25231341|NCT02590250|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25231342|NCT02590250|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25231343|NCT02590250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24614486|NCT01024491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25671349|NCT02115997|Hormones|hormones|mesh-ancestor
25870494|NCT00119496|Theophylline|theophylline|mesh-list
24801699|NCT01985087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24801700|NCT01985087|Alkylating Agents|alkylating agents|mesh-ancestor
25870535|NCT00119652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870543|NCT00119652|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25870544|NCT00119652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25870545|NCT00119652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870546|NCT00119691|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24903098|NCT04366596|Mitosis Modulators|mitosis modulators|mesh-ancestor
25870547|NCT00119691|Natriuretic Agents|natriuretic agents|mesh-ancestor
25870548|NCT00119691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870549|NCT00119704|Botulinum Toxins|botulinum toxins|mesh-list
25870550|NCT00119704|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25870551|NCT00119704|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24903099|NCT04366596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903100|NCT04366739|Chlorpromazine|chlorpromazine|mesh-list
24903101|NCT04366739|Antiemetics|antiemetics|mesh-ancestor
24903102|NCT04366739|Autonomic Agents|autonomic agents|mesh-ancestor
24903103|NCT04366739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24903104|NCT04366739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880855|NCT03270176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25870552|NCT00119704|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25870553|NCT00119704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25870554|NCT00119704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560182|NCT03321513|Bevacizumab|bevacizumab|mesh-list
24560183|NCT03321513|Aflibercept|aflibercept|mesh-list
24560184|NCT03321513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24560185|NCT03321513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24560186|NCT03321513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25231428|NCT02589288|Ropivacaine|ropivacaine|mesh-list
25870555|NCT00119704|Cholinergic Agents|cholinergic agents|mesh-ancestor
25870556|NCT00119704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25231413|NCT02589652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671353|NCT02115997|Autonomic Agents|autonomic agents|mesh-ancestor
25671354|NCT02115997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25671355|NCT02115997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25671356|NCT02115997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25671357|NCT02115997|Protective Agents|protective agents|mesh-ancestor
25671358|NCT01746238|Bevacizumab|bevacizumab|mesh-list
25671359|NCT01746238|Doxorubicin|doxorubicin|mesh-list
25671360|NCT01746238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24582172|NCT00868465|Artenimol|artenimol|mesh-list
25870620|NCT00120081|Antacids|antacids|mesh-ancestor
25870621|NCT00120081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870622|NCT00120081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25870623|NCT00120120|Lenalidomide|lenalidomide|mesh-list
25231460|NCT02588755|Tegafur|tegafur|mesh-list
24903749|NCT04361305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25231461|NCT02588755|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25231462|NCT02588755|Estrogens|estrogens|mesh-ancestor
25231463|NCT02588755|Hormones|hormones|mesh-ancestor
25231464|NCT02588755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25231465|NCT02588755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231466|NCT02588755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25231467|NCT02588755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870624|NCT00120120|Immunologic Factors|immunologic factors|mesh-ancestor
25870625|NCT00120120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870626|NCT00120120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25870627|NCT00120120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25870628|NCT00120120|Growth Substances|growth substances|mesh-ancestor
25870629|NCT00120120|Growth Inhibitors|growth inhibitors|mesh-ancestor
25870630|NCT00120120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870631|NCT00120133|Atorvastatin|atorvastatin|mesh-list
25870632|NCT00120133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25870633|NCT00120133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25870634|NCT00120133|Antimetabolites|antimetabolites|mesh-ancestor
24722683|NCT01581944|Goserelin|goserelin|mesh-list
25671367|NCT01746238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25671368|NCT01746238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25671369|NCT01746238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25671370|NCT01746238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25671371|NCT01746238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671372|NCT01648205|Ranolazine|ranolazine|mesh-list
25671373|NCT01648205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25671374|NCT01648205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25671375|NCT01648205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671376|NCT01642901|Zoledronic Acid|zoledronic acid|mesh-list
25671377|NCT01642901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25671378|NCT01642901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671379|NCT01641055|Caseins|caseins|mesh-list
25671380|NCT01641055|Chelating Agents|chelating agents|mesh-ancestor
25671381|NCT01641055|Sequestering Agents|sequestering agents|mesh-ancestor
25231473|NCT02588937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25231474|NCT02588534|Etanercept|etanercept|mesh-list
25231475|NCT02588534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25231476|NCT02588534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25231477|NCT02588534|Analgesics|analgesics|mesh-ancestor
25231478|NCT02588534|Sensory System Agents|sensory system agents|mesh-ancestor
25231479|NCT02588534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25231480|NCT02588534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231481|NCT02588534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25231482|NCT02588534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25231483|NCT02588534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25044263|NCT01124552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25044264|NCT01124552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25044265|NCT01122784|Vaccines|vaccines|mesh-list
25044266|NCT01122784|Immunologic Factors|immunologic factors|mesh-ancestor
25044267|NCT01122784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044268|NCT01120470|Prednisone|prednisone|mesh-list
25044269|NCT01120470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25044270|NCT01120470|Glucocorticoids|glucocorticoids|mesh-ancestor
25044271|NCT01120470|Hormones|hormones|mesh-ancestor
25044272|NCT01120470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25044273|NCT01120470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044274|NCT01120470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25044275|NCT01120470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870656|NCT00120185|Sensory System Agents|sensory system agents|mesh-ancestor
25870657|NCT00120185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25870658|NCT00120185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870659|NCT00120198|Rituximab|rituximab|mesh-list
25870660|NCT00120198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25870661|NCT00120198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25870662|NCT00120198|Immunologic Factors|immunologic factors|mesh-ancestor
25870663|NCT00120198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870664|NCT00120198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25870665|NCT00120237|Misoprostol|misoprostol|mesh-list
25870666|NCT00120237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25870667|NCT00120237|Abortifacient Agents|abortifacient agents|mesh-ancestor
25870668|NCT00120237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25870669|NCT00120237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870670|NCT00120237|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24726869|NCT01606462|Oxytocin|oxytocin|mesh-list
25870671|NCT00120237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25870672|NCT00120237|Oxytocics|oxytocics|mesh-ancestor
25870673|NCT00120302|Pimecrolimus|pimecrolimus|mesh-list
25870674|NCT00120302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25870675|NCT00120302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25870676|NCT00120302|Analgesics|analgesics|mesh-ancestor
25870677|NCT00120302|Sensory System Agents|sensory system agents|mesh-ancestor
25870678|NCT00120302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25870679|NCT00120302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870680|NCT00120302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25870681|NCT00120302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25044278|NCT01117584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25044279|NCT01117584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044280|NCT01117584|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25044281|NCT01117584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044283|NCT01116141|Methotrexate|methotrexate|mesh-list
25044284|NCT01116141|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25044285|NCT01116141|Abortifacient Agents|abortifacient agents|mesh-ancestor
25044286|NCT01116141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24801790|NCT01985750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24561401|NCT00760032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24561403|NCT00760032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870687|NCT00120302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561472|NCT00760864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448087|NCT00310154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448088|NCT00310154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24448089|NCT00310154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448090|NCT00310206|Vaccines|vaccines|mesh-list
24448091|NCT00310206|Immunologic Factors|immunologic factors|mesh-ancestor
24448092|NCT00310206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044288|NCT01116141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25870688|NCT00120315|Esomeprazole|esomeprazole|mesh-list
25870689|NCT00120315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25870690|NCT00120315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25870691|NCT00120315|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25870692|NCT00120315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870693|NCT00120315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870694|NCT00120341|Analgesics|analgesics|mesh-list
25870695|NCT00120341|Sensory System Agents|sensory system agents|mesh-ancestor
25870696|NCT00120341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25870697|NCT00120341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870698|NCT00120354|Lamivudine|lamivudine|mesh-list
25870699|NCT00120354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25870700|NCT00120354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25870701|NCT00120354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870702|NCT00120354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870703|NCT00120354|Antiviral Agents|antiviral agents|mesh-ancestor
25870704|NCT00120354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25870705|NCT00120354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25870706|NCT00120354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24723201|NCT01585870|Sorafenib|sorafenib|mesh-list
25870707|NCT00120367|Tenofovir|tenofovir|mesh-list
25870708|NCT00120367|Emtricitabine|emtricitabine|mesh-list
25870709|NCT00120367|Enfuvirtide|enfuvirtide|mesh-list
25870710|NCT00120367|Antiviral Agents|antiviral agents|mesh-ancestor
25870711|NCT00120367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25870712|NCT00120367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24596020|NCT00941174|Antidotes|antidotes|mesh-ancestor
24801797|NCT01985789|Diphenhydramine|diphenhydramine|mesh-list
24801798|NCT01985789|Promethazine|promethazine|mesh-list
25071337|NCT03411252|Mirabegron|mirabegron|mesh-list
25409612|NCT03366298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25671382|NCT01641055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671383|NCT01420874|Leucovorin|leucovorin|mesh-list
25671384|NCT01420874|Fluorouracil|fluorouracil|mesh-list
25671385|NCT01420874|Oxaliplatin|oxaliplatin|mesh-list
25671386|NCT01420874|Antimetabolites|antimetabolites|mesh-ancestor
25870713|NCT00120367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24846566|NCT02243098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846567|NCT02243124|Dexamethasone|dexamethasone|mesh-list
25870732|NCT00120432|Phenylephrine|phenylephrine|mesh-list
25870733|NCT00120432|Oxymetazoline|oxymetazoline|mesh-list
25870734|NCT00120432|Tropicamide|tropicamide|mesh-list
25870735|NCT00120432|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25870736|NCT00120432|Mydriatics|mydriatics|mesh-ancestor
25409613|NCT03366298|Adrenergic Agents|adrenergic agents|mesh-ancestor
25870737|NCT00120432|Autonomic Agents|autonomic agents|mesh-ancestor
24846578|NCT02243124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478299|NCT00422240|Adapalene|adapalene|mesh-list
25870751|NCT00120432|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24953147|NCT03888144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25870752|NCT00120432|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25870753|NCT00120432|Cholinergic Agents|cholinergic agents|mesh-ancestor
25231531|NCT02588417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25231532|NCT02588417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25231533|NCT02588417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231534|NCT02588417|Anesthetics, Local|anesthetics, local|mesh-ancestor
25231536|NCT02588417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25231537|NCT02588417|Sensory System Agents|sensory system agents|mesh-ancestor
25231538|NCT02588404|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25231539|NCT02588404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25231540|NCT02588404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231541|NCT02588404|Luteolytic Agents|luteolytic agents|mesh-ancestor
25231542|NCT02588404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25231543|NCT02588404|Contraceptive Agents|contraceptive agents|mesh-ancestor
25231544|NCT02588404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25231545|NCT02588404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231546|NCT02588404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25231547|NCT02588287|Tenofovir|tenofovir|mesh-list
24846585|NCT02243137|Sensory System Agents|sensory system agents|mesh-ancestor
24846586|NCT02243137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24846587|NCT02243137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846588|NCT02243137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24448151|NCT00310518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24448152|NCT00310518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24448153|NCT00310518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904165|NCT04358341|Antimetabolites|antimetabolites|mesh-ancestor
24448154|NCT00310518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448155|NCT00310518|Antiviral Agents|antiviral agents|mesh-ancestor
24448156|NCT00310531|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
24801811|NCT01985789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24801812|NCT01985789|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24448157|NCT00310531|Estradiol|estradiol|mesh-list
24448158|NCT00310531|Estrogens|estrogens|mesh-ancestor
24448159|NCT00310531|Hormones|hormones|mesh-ancestor
24448160|NCT00310531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24448161|NCT00310531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876698|NCT02960022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24448162|NCT00310531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25876699|NCT02960022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876700|NCT02960022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25231558|NCT02588235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24846589|NCT02243137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24846590|NCT02243137|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24846591|NCT02243137|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24846592|NCT02243137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846593|NCT02243137|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24628889|NCT01101789|Triclosan|triclosan|mesh-list
24904198|NCT04358497|Sensory System Agents|sensory system agents|mesh-ancestor
24904199|NCT04358497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24904200|NCT04358497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904201|NCT04358497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24881297|NCT02696564|Losartan|losartan|mesh-list
25870777|NCT00120510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25044291|NCT01116141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231559|NCT02588235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25231560|NCT02588235|Antimetabolites|antimetabolites|mesh-ancestor
25231561|NCT02588235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231562|NCT02588235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25434777|NCT00006436|Rituximab|rituximab|mesh-list
25671387|NCT01420874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671388|NCT01420874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25870778|NCT00120510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25231579|NCT02588196|Protease Inhibitors|protease inhibitors|mesh-ancestor
25231585|NCT02588131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231586|NCT02588118|Propofol|propofol|mesh-list
25231587|NCT02588118|Cisatracurium|cisatracurium|mesh-list
25231588|NCT02588118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24904202|NCT04358497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25231589|NCT02588118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25231590|NCT02588118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231591|NCT02588118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25231592|NCT02588118|Anesthetics, General|anesthetics, general|mesh-ancestor
25231593|NCT02588118|Anesthetics|anesthetics|mesh-ancestor
25231594|NCT02588118|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25231595|NCT02588118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25231596|NCT02588118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25231597|NCT02587845|Tranexamic Acid|tranexamic acid|mesh-list
25044294|NCT01116141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25044295|NCT01116141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25044296|NCT01116141|Immunologic Factors|immunologic factors|mesh-ancestor
25044297|NCT01116141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25044298|NCT01116141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25044299|NCT01116141|Hematinics|hematinics|mesh-ancestor
25044300|NCT01116141|Vitamin B Complex|vitamin b complex|mesh-ancestor
25044301|NCT01116141|Vitamins|vitamins|mesh-ancestor
25870779|NCT00120510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870780|NCT00120510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870781|NCT00120510|Antiviral Agents|antiviral agents|mesh-ancestor
25870782|NCT00120510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25870783|NCT00120510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25870784|NCT00120510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25870785|NCT00120510|Antimetabolites|antimetabolites|mesh-ancestor
24801817|NCT01985789|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25870786|NCT00120510|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25434778|NCT00006436|Doxorubicin|doxorubicin|mesh-list
25671389|NCT01420874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671390|NCT01420874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25671391|NCT01420874|Immunologic Factors|immunologic factors|mesh-ancestor
24589342|NCT00906880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24589391|NCT00907166|Immunologic Factors|immunologic factors|mesh-ancestor
25870792|NCT00120536|Vildagliptin|vildagliptin|mesh-list
25870793|NCT00120536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25870794|NCT00120536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870795|NCT00120536|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25870796|NCT00120536|Protease Inhibitors|protease inhibitors|mesh-ancestor
25138078|NCT02980965|Letrozole|letrozole|mesh-list
25138079|NCT02980965|Epirubicin|epirubicin|mesh-list
25138080|NCT02980965|Leuprolide|leuprolide|mesh-list
25138081|NCT02980965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25138082|NCT02980965|Immunologic Factors|immunologic factors|mesh-ancestor
25138083|NCT02980965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966570|NCT03766997|Hormones|hormones|mesh-ancestor
25870797|NCT00120536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589392|NCT00907166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589393|NCT00907179|Pemetrexed|pemetrexed|mesh-list
24589436|NCT00907452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870798|NCT00120536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870799|NCT00120601|Naltrexone|naltrexone|mesh-list
25870800|NCT00120601|Acamprosate|acamprosate|mesh-list
24448163|NCT00310531|Hormone Antagonists|hormone antagonists|mesh-ancestor
24448164|NCT00310531|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24448165|NCT00310531|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24448166|NCT00310531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24448168|NCT00310583|Analgesics|analgesics|mesh-ancestor
24448169|NCT00310583|Sensory System Agents|sensory system agents|mesh-ancestor
24448170|NCT00310583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24448171|NCT00310583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448172|NCT00310583|Anticonvulsants|anticonvulsants|mesh-ancestor
24448173|NCT00310583|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24448174|NCT00310583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24448175|NCT00310583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671392|NCT01420874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671393|NCT01420874|Antidotes|antidotes|mesh-ancestor
25671394|NCT01420874|Protective Agents|protective agents|mesh-ancestor
25671395|NCT01420874|Vitamin B Complex|vitamin b complex|mesh-ancestor
25671396|NCT01420874|Vitamins|vitamins|mesh-ancestor
25671397|NCT01420874|Micronutrients|micronutrients|mesh-ancestor
25671398|NCT01312922|Dexetimide|dexetimide|mesh-list
25671399|NCT01312922|Pipamperone|pipamperone|mesh-list
25671400|NCT01312922|Citalopram|citalopram|mesh-list
25671401|NCT01312922|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25671402|NCT01312922|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25671403|NCT01312922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25671404|NCT01312922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671405|NCT01312922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25671406|NCT01312922|Serotonin Agents|serotonin agents|mesh-ancestor
25671407|NCT01312922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671408|NCT01312922|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25671409|NCT01312922|Antidepressive Agents|antidepressive agents|mesh-ancestor
25671410|NCT01312922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25671411|NCT01312922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25671412|NCT01312922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25671413|NCT01312922|Parasympatholytics|parasympatholytics|mesh-ancestor
25671414|NCT01312922|Autonomic Agents|autonomic agents|mesh-ancestor
25671415|NCT01312922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25671416|NCT01312922|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25044318|NCT01114308|Analgesics|analgesics|mesh-ancestor
25044319|NCT01114308|Sensory System Agents|sensory system agents|mesh-ancestor
25044320|NCT01114308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25044321|NCT01114308|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25044322|NCT01113957|Doxorubicin|doxorubicin|mesh-list
25044323|NCT01113957|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24801834|NCT01985841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24562446|NCT00766441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24562447|NCT00766441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24562448|NCT00766441|Protease Inhibitors|protease inhibitors|mesh-ancestor
24562449|NCT00766441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562451|NCT00766480|Fluorouracil|fluorouracil|mesh-list
25870808|NCT00120640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25870809|NCT00120640|Hormone Antagonists|hormone antagonists|mesh-ancestor
25870810|NCT00120640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25870811|NCT00120640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870812|NCT00120640|Progestins|progestins|mesh-ancestor
25870814|NCT00120653|Metoclopramide|metoclopramide|mesh-list
25870815|NCT00120653|Antiemetics|antiemetics|mesh-ancestor
25870816|NCT00120653|Autonomic Agents|autonomic agents|mesh-ancestor
25870817|NCT00120653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25870818|NCT00120653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870819|NCT00120653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25870820|NCT00120653|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25870821|NCT00120653|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25870822|NCT00120653|Dopamine Agents|dopamine agents|mesh-ancestor
24448202|NCT00310765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870823|NCT00120653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25870824|NCT00120653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870825|NCT00120679|Epoetin Alfa|epoetin alfa|mesh-list
25870826|NCT00120679|Darbepoetin alfa|darbepoetin alfa|mesh-list
25870827|NCT00120679|Hematinics|hematinics|mesh-ancestor
25870828|NCT00120692|Epoetin Alfa|epoetin alfa|mesh-list
25870829|NCT00120692|Darbepoetin alfa|darbepoetin alfa|mesh-list
25870830|NCT00120692|Hematinics|hematinics|mesh-ancestor
24505110|NCT00539877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231612|NCT02587871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231614|NCT02587455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25231615|NCT02587455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231616|NCT02587533|Dopamine|dopamine|mesh-list
25231617|NCT02587533|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25231618|NCT02587533|Sympathomimetics|sympathomimetics|mesh-ancestor
25231619|NCT02587533|Autonomic Agents|autonomic agents|mesh-ancestor
25231620|NCT02587533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25870856|NCT00120744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25870857|NCT00120744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870858|NCT00120744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25870859|NCT00120744|Antipruritics|antipruritics|mesh-ancestor
25870860|NCT00120744|Dermatologic Agents|dermatologic agents|mesh-ancestor
25870861|NCT00120744|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25870862|NCT00120744|Serotonin Agents|serotonin agents|mesh-ancestor
25870863|NCT00120744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25870864|NCT00120744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870865|NCT00120744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25870866|NCT00120744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25870867|NCT00120744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25870868|NCT00120744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24801844|NCT01985841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24801845|NCT01985841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24904480|NCT04355416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24904482|NCT04355416|Sensory System Agents|sensory system agents|mesh-ancestor
24904570|NCT04355052|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24904572|NCT04354961|Carboplatin|carboplatin|mesh-list
24904573|NCT04354961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24904574|NCT04354961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904575|NCT04354961|Tubulin Modulators|tubulin modulators|mesh-ancestor
24801846|NCT01985841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24801847|NCT01985841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24801848|NCT01985841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870869|NCT00120744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25870870|NCT00120757|Alendronate|alendronate|mesh-list
25870871|NCT00120757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25870872|NCT00120757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231633|NCT02587312|Cholinergic Agents|cholinergic agents|mesh-ancestor
25231634|NCT02587312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25231635|NCT02587312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231636|NCT02587416|Atorvastatin|atorvastatin|mesh-list
25231637|NCT02587416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25231638|NCT02587416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25231639|NCT02587416|Antimetabolites|antimetabolites|mesh-ancestor
25231640|NCT02587416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231641|NCT02587416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25231642|NCT02587416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25231643|NCT02587416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25231644|NCT02587390|Simvastatin|simvastatin|mesh-list
25231645|NCT02587390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25870873|NCT00120770|Anti-Infective Agents|anti-infective agents|mesh-list
25870874|NCT00120783|Ritonavir|ritonavir|mesh-list
25870875|NCT00120783|Indinavir|indinavir|mesh-list
25870876|NCT00120783|Lamivudine|lamivudine|mesh-list
25870877|NCT00120783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25870878|NCT00120783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25870879|NCT00120783|Protease Inhibitors|protease inhibitors|mesh-ancestor
25870880|NCT00120783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24585438|NCT00885625|Immunologic Factors|immunologic factors|mesh-ancestor
24505111|NCT00539890|Insulin|insulin|mesh-list
25870881|NCT00120783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870882|NCT00120783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25870883|NCT00120783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24801849|NCT01985854|Propofol|propofol|mesh-list
24801850|NCT01985854|Desflurane|desflurane|mesh-list
25870884|NCT00120783|Antiviral Agents|antiviral agents|mesh-ancestor
25870885|NCT00120783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25870886|NCT00120783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25109060|NCT03127631|Protease Inhibitors|protease inhibitors|mesh-ancestor
25109061|NCT03127137|Triamcinolone|triamcinolone|mesh-list
25109062|NCT03127137|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24816044|NCT02073773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816045|NCT02073773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25870887|NCT00120783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25870888|NCT00120783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25870889|NCT00120783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25231647|NCT02587390|Antimetabolites|antimetabolites|mesh-ancestor
25231648|NCT02587390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231649|NCT02587390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25231650|NCT02587390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25870890|NCT00120796|Lamivudine|lamivudine|mesh-list
25870891|NCT00120796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24801871|NCT01986049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24801872|NCT01986049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562936|NCT00769054|Ropivacaine|ropivacaine|mesh-list
25870892|NCT00120796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25671417|NCT01312922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25671418|NCT01312922|Cholinergic Agents|cholinergic agents|mesh-ancestor
25671419|NCT01312922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25671420|NCT01312922|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25671421|NCT01312922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25671422|NCT01312922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25870893|NCT00120796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870894|NCT00120796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870895|NCT00120796|Antiviral Agents|antiviral agents|mesh-ancestor
25870896|NCT00120796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25870897|NCT00120796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25870898|NCT00120796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25870899|NCT00120809|Pyrimethamine|pyrimethamine|mesh-list
25870900|NCT00120809|Sulfadoxine|sulfadoxine|mesh-list
25870901|NCT00120809|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25870902|NCT00120809|Antimalarials|antimalarials|mesh-ancestor
25870903|NCT00120809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25870904|NCT00120809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25870905|NCT00120809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25870906|NCT00120809|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25870907|NCT00120809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25870919|NCT00120835|Antiviral Agents|antiviral agents|mesh-ancestor
24801931|NCT01986426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24801932|NCT01986426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24801934|NCT01986465|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25870968|NCT00121017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25870970|NCT00121017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448291|NCT00311051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24448292|NCT00311051|Respiratory System Agents|respiratory system agents|mesh-ancestor
25870971|NCT00121017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801943|NCT01986465|Autonomic Agents|autonomic agents|mesh-ancestor
24905043|NCT04351256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24905167|NCT04350671|Interferon-beta|interferon-beta|mesh-list
24905168|NCT04350671|Interferon beta-1a|interferon beta-1a|mesh-list
24905169|NCT04350671|Hydroxychloroquine|hydroxychloroquine|mesh-list
24801944|NCT01986465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24801945|NCT01986465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801946|NCT01986465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24801947|NCT01986465|Glucocorticoids|glucocorticoids|mesh-ancestor
24801949|NCT01986465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25870972|NCT00121017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25870973|NCT00121017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25870974|NCT00121017|Antiviral Agents|antiviral agents|mesh-ancestor
25870975|NCT00121017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25870976|NCT00121017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25870977|NCT00121017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25870978|NCT00121017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25870979|NCT00121017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24801951|NCT01986465|Protective Agents|protective agents|mesh-ancestor
24801952|NCT01986465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24801953|NCT01986465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24801955|NCT01986556|Gout Suppressants|gout suppressants|mesh-ancestor
24801956|NCT01986556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24801957|NCT01986556|Uricosuric Agents|uricosuric agents|mesh-ancestor
25876701|NCT02960022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25231697|NCT02587052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25231698|NCT02587052|Immunologic Factors|immunologic factors|mesh-ancestor
25231699|NCT02587052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846635|NCT02243358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24846636|NCT02243358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044324|NCT01113957|Temozolomide|temozolomide|mesh-list
24629068|NCT01103115|Vitamin D|vitamin d|mesh-list
24452964|NCT05378113|Anesthetics|anesthetics|mesh-ancestor
24452965|NCT05378113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24452966|NCT05378113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452967|NCT05378113|Sensory System Agents|sensory system agents|mesh-ancestor
24452968|NCT05378113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24452969|NCT05378113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24452970|NCT05378113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24452971|NCT05378113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24905170|NCT04350671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905182|NCT04350671|Antimalarials|antimalarials|mesh-ancestor
24905183|NCT04350671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24905184|NCT04350671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24905185|NCT04350671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24905212|NCT04350281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24452972|NCT05378113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24452973|NCT05378113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452974|NCT05378113|Antiemetics|antiemetics|mesh-ancestor
24452975|NCT05378113|Autonomic Agents|autonomic agents|mesh-ancestor
24452976|NCT05378113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25870988|NCT00121043|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25870989|NCT00121043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25870990|NCT00121056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25870991|NCT00121056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25870992|NCT00121069|Citalopram|citalopram|mesh-list
25870993|NCT00121069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25870994|NCT00121069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25870995|NCT00121069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25231700|NCT02587052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25231701|NCT02587052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25231702|NCT02587052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231703|NCT02587130|Ketamine|ketamine|mesh-list
25231705|NCT02587130|Sensory System Agents|sensory system agents|mesh-ancestor
25231706|NCT02587130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24623659|NCT01073059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25231714|NCT02587130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25231715|NCT02587130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25231716|NCT02587130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231718|NCT02587195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25231719|NCT02587195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25231720|NCT02587195|Analgesics|analgesics|mesh-ancestor
25231721|NCT02587195|Sensory System Agents|sensory system agents|mesh-ancestor
25231722|NCT02587195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25231723|NCT02587195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231724|NCT02587195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25231725|NCT02587195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25231726|NCT02587195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25231727|NCT02587195|Immunologic Factors|immunologic factors|mesh-ancestor
25870996|NCT00121069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25870997|NCT00121069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25870998|NCT00121069|Serotonin Agents|serotonin agents|mesh-ancestor
25871017|NCT00121147|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25871018|NCT00121147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24623656|NCT01073059|Ertapenem|ertapenem|mesh-list
24623657|NCT01073059|Valproic Acid|valproic acid|mesh-list
24623658|NCT01073059|Anticonvulsants|anticonvulsants|mesh-ancestor
25231735|NCT02587169|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25231736|NCT02587169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25231737|NCT02587169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231738|NCT02587169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25231739|NCT02587169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25231740|NCT02587169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25231741|NCT02587169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231742|NCT02586987|Durvalumab|durvalumab|mesh-list
25231743|NCT02586987|Tremelimumab|tremelimumab|mesh-list
25231744|NCT02586987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25231745|NCT02586987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231746|NCT02586961|Betamethasone|betamethasone|mesh-list
25231747|NCT02586961|Betamethasone Valerate|betamethasone valerate|mesh-list
25231749|NCT02586961|Betamethasone benzoate|betamethasone benzoate|mesh-list
25231750|NCT02586961|Epinephrine|epinephrine|mesh-list
25231751|NCT02586961|Racepinephrine|racepinephrine|mesh-list
25231752|NCT02586961|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25231753|NCT02586961|Epinephryl borate|epinephryl borate|mesh-list
25231754|NCT02586961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25231755|NCT02586961|Glucocorticoids|glucocorticoids|mesh-ancestor
25871019|NCT00121147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25871020|NCT00121147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25871021|NCT00121147|Adrenergic Agents|adrenergic agents|mesh-ancestor
25871022|NCT00121147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25871023|NCT00121147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871024|NCT00121147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871025|NCT00121264|Sorafenib|sorafenib|mesh-list
25871026|NCT00121264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25871027|NCT00121264|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25871028|NCT00121264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876780|NCT02794571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25231765|NCT02586961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231766|NCT02586961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25231767|NCT02586961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25231769|NCT02586961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25231770|NCT02586961|Mydriatics|mydriatics|mesh-ancestor
25231771|NCT02586961|Sympathomimetics|sympathomimetics|mesh-ancestor
25231772|NCT02586961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25231773|NCT02586753|Paclitaxel|paclitaxel|mesh-list
25231774|NCT02586753|Cisplatin|cisplatin|mesh-list
25231775|NCT02586753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25231776|NCT02586753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231777|NCT02586753|Tubulin Modulators|tubulin modulators|mesh-ancestor
25231778|NCT02586753|Antimitotic Agents|antimitotic agents|mesh-ancestor
25231779|NCT02586753|Mitosis Modulators|mitosis modulators|mesh-ancestor
25231780|NCT02586753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231785|NCT02586649|Autonomic Agents|autonomic agents|mesh-ancestor
25231786|NCT02586649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25231787|NCT02586649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231788|NCT02586649|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25871029|NCT00121264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871030|NCT00121277|Capecitabine|capecitabine|mesh-list
25871031|NCT00121277|Vorinostat|vorinostat|mesh-list
25871032|NCT00121277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25871033|NCT00121277|Antimetabolites|antimetabolites|mesh-ancestor
25871034|NCT00121277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871035|NCT00121277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671430|NCT01091831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25671431|NCT01091831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25671432|NCT01091831|Alkylating Agents|alkylating agents|mesh-ancestor
25671433|NCT01091831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671434|NCT01091831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671435|NCT01091831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25231798|NCT02586636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231800|NCT02586636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25231801|NCT02586636|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25231802|NCT02586636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25231803|NCT02586636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231804|NCT02586311|Amlodipine|amlodipine|mesh-list
25231805|NCT02586311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25231806|NCT02586311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25231807|NCT02586311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25231808|NCT02586311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231809|NCT02586311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25231810|NCT02586311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231811|NCT02586311|Vasodilator Agents|vasodilator agents|mesh-ancestor
25231812|NCT02586402|Epoetin Alfa|epoetin alfa|mesh-list
25231813|NCT02586402|Hematinics|hematinics|mesh-ancestor
25231814|NCT02586259|Budesonide|budesonide|mesh-list
25231817|NCT02586259|Autonomic Agents|autonomic agents|mesh-ancestor
25231818|NCT02586259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25231819|NCT02586259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231820|NCT02586259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25231821|NCT02586259|Respiratory System Agents|respiratory system agents|mesh-ancestor
25231822|NCT02586259|Glucocorticoids|glucocorticoids|mesh-ancestor
25231823|NCT02586259|Hormones|hormones|mesh-ancestor
25231824|NCT02586259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25231825|NCT02586441|Bromides|bromides|mesh-list
25231826|NCT02586441|Propofol|propofol|mesh-list
25231827|NCT02586441|Rocuronium|rocuronium|mesh-list
25231828|NCT02586441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25231829|NCT02586441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25231830|NCT02586441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231831|NCT02586441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25231832|NCT02586441|Anesthetics, General|anesthetics, general|mesh-ancestor
25231833|NCT02586441|Anesthetics|anesthetics|mesh-ancestor
25231834|NCT02586441|Anticonvulsants|anticonvulsants|mesh-ancestor
25231835|NCT02586441|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25231836|NCT02586441|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25231837|NCT02586441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25231841|NCT02586454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24846661|NCT02243436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24846662|NCT02243436|Glucocorticoids|glucocorticoids|mesh-ancestor
24846664|NCT02243436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25871036|NCT00121277|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25871037|NCT00121277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871038|NCT00121303|Cytarabine|cytarabine|mesh-list
24846665|NCT02243436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24846666|NCT02243436|Protective Agents|protective agents|mesh-ancestor
24846667|NCT02243436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24846668|NCT02243553|Vitamin K|vitamin k|mesh-list
25871039|NCT00121303|Daunorubicin|daunorubicin|mesh-list
25871040|NCT00121303|Gemtuzumab|gemtuzumab|mesh-list
25871041|NCT00121303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25871042|NCT00121303|Antimetabolites|antimetabolites|mesh-ancestor
25871043|NCT00121303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871044|NCT00121303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25871045|NCT00121303|Antiviral Agents|antiviral agents|mesh-ancestor
25871046|NCT00121303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25231867|NCT02586181|Cholecalciferol|cholecalciferol|mesh-list
25231868|NCT02586181|Vitamins|vitamins|mesh-list
25231869|NCT02586181|Folic Acid|folic acid|mesh-list
25231870|NCT02586181|Calcium|calcium|mesh-list
25231871|NCT02586181|Micronutrients|micronutrients|mesh-ancestor
25231872|NCT02586181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231873|NCT02586181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25231874|NCT02586181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25231875|NCT02586181|Vitamin B Complex|vitamin b complex|mesh-ancestor
25231876|NCT02586181|Hematinics|hematinics|mesh-ancestor
25231877|NCT02586129|Metformin|metformin|mesh-list
25231878|NCT02586129|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24846670|NCT02243553|Tipranavir|tipranavir|mesh-list
24846678|NCT02243553|Vitamins|vitamins|mesh-ancestor
24846679|NCT02243553|Micronutrients|micronutrients|mesh-ancestor
24846680|NCT02243553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846681|NCT02243553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24846682|NCT02243553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24478713|NCT00424151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25871050|NCT00121303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25871051|NCT00121303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25871052|NCT00121303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25871053|NCT00121303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871054|NCT00121303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25871055|NCT00121316|Pimecrolimus|pimecrolimus|mesh-list
25871056|NCT00121316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25231882|NCT02586129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25231883|NCT02586129|Antimetabolites|antimetabolites|mesh-ancestor
25231884|NCT02586129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231885|NCT02586129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25231886|NCT02586129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25231887|NCT02586129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25231888|NCT02586051|Obinutuzumab|obinutuzumab|mesh-list
25231889|NCT02586051|Immunoglobulins|immunoglobulins|mesh-list
25231890|NCT02586051|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25231891|NCT02586051|Antibodies|antibodies|mesh-list
25231892|NCT02586051|gamma-Globulins|gamma-globulins|mesh-list
25231893|NCT02586051|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25231894|NCT02586051|Immunologic Factors|immunologic factors|mesh-ancestor
25671436|NCT01091831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25231902|NCT02586142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24905402|NCT04347889|Vitamins|vitamins|mesh-ancestor
24905403|NCT04347889|Micronutrients|micronutrients|mesh-ancestor
24905444|NCT04347720|Acetaminophen|acetaminophen|mesh-list
25231903|NCT02586142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231904|NCT02586142|Cholinergic Agents|cholinergic agents|mesh-ancestor
25231905|NCT02586142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25231906|NCT02586142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231908|NCT02586142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25231909|NCT02585973|Cisplatin|cisplatin|mesh-list
25231911|NCT02585973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231912|NCT02585973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25231913|NCT02585973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231914|NCT02585947|Tenofovir|tenofovir|mesh-list
25231915|NCT02585947|Antiviral Agents|antiviral agents|mesh-ancestor
25231916|NCT02585947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25231917|NCT02585947|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25231918|NCT02585947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25231919|NCT02585947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25231920|NCT02585947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231921|NCT02585947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25231922|NCT02585947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25231923|NCT02585882|Fluorides|fluorides|mesh-list
25231924|NCT02585882|Cariostatic Agents|cariostatic agents|mesh-ancestor
25231925|NCT02585882|Protective Agents|protective agents|mesh-ancestor
25231926|NCT02585882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273556|NCT02384915|Sensory System Agents|sensory system agents|mesh-ancestor
25273557|NCT02384915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25273558|NCT02384954|Rituximab|rituximab|mesh-list
25273559|NCT02384954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25273560|NCT02384954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25273561|NCT02384954|Immunologic Factors|immunologic factors|mesh-ancestor
25273562|NCT02384954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273563|NCT02384954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25273564|NCT02384967|Darunavir|darunavir|mesh-list
25273565|NCT02384967|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25273566|NCT02384967|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25273567|NCT02384967|Protease Inhibitors|protease inhibitors|mesh-ancestor
25273568|NCT02384967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273569|NCT02384967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273570|NCT02384967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25273571|NCT02384967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25273572|NCT02384967|Antiviral Agents|antiviral agents|mesh-ancestor
25273573|NCT02384967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25273574|NCT02384876|Ephedrine|ephedrine|mesh-list
25273575|NCT02384876|Pseudoephedrine|pseudoephedrine|mesh-list
25273576|NCT02384876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25231927|NCT02585648|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25231928|NCT02585648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25231929|NCT02585674|Insulin Glargine|insulin glargine|mesh-list
25231930|NCT02585674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25231931|NCT02585674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231932|NCT02585804|Dapagliflozin|dapagliflozin|mesh-list
25231933|NCT02585804|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25231934|NCT02585804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231935|NCT02585804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25231936|NCT02585804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231937|NCT02585791|Glycerol|glycerol|mesh-list
25231938|NCT02585791|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25231939|NCT02585791|Protective Agents|protective agents|mesh-ancestor
25231940|NCT02585791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231941|NCT02585765|Pioglitazone|pioglitazone|mesh-list
25231942|NCT02585765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25231943|NCT02585765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231944|NCT02586610|Pembrolizumab|pembrolizumab|mesh-list
25231945|NCT02586610|Capecitabine|capecitabine|mesh-list
25231946|NCT02586610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25231947|NCT02586610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231948|NCT02586610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25231949|NCT02586610|Antimetabolites|antimetabolites|mesh-ancestor
25231950|NCT02586610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231951|NCT02585531|Dexamethasone|dexamethasone|mesh-list
24801977|NCT01986608|Lacosamide|lacosamide|mesh-list
24801978|NCT01986608|Anticonvulsants|anticonvulsants|mesh-ancestor
24801979|NCT01986608|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24801980|NCT01986608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24801981|NCT01986608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24801983|NCT01986660|Ibuprofen|ibuprofen|mesh-list
25871069|NCT00121316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871070|NCT00121329|Lidocaine|lidocaine|mesh-list
24622435|NCT01066962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24564022|NCT00774813|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24564023|NCT00774813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24564024|NCT00774813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25231952|NCT02585531|Epinephrine|epinephrine|mesh-list
25231953|NCT02585531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25231954|NCT02585531|Antiemetics|antiemetics|mesh-ancestor
25231955|NCT02585531|Autonomic Agents|autonomic agents|mesh-ancestor
25231956|NCT02585531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25231957|NCT02585531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231958|NCT02585531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25871084|NCT00121381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25871085|NCT00121381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24452988|NCT05371964|Imetelstat|imetelstat|mesh-list
24846692|NCT02243553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24846693|NCT02243553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846694|NCT02243553|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25062178|NCT05234697|Analgesics|analgesics|mesh-ancestor
24448378|NCT00311636|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25871086|NCT00121381|Analgesics|analgesics|mesh-ancestor
25871087|NCT00121381|Sensory System Agents|sensory system agents|mesh-ancestor
25871088|NCT00121381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25231960|NCT02585531|Hormones|hormones|mesh-ancestor
25231961|NCT02585531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25231962|NCT02585531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25231963|NCT02585531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231964|NCT02585531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25231965|NCT02585531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25231966|NCT02585531|Adrenergic Agents|adrenergic agents|mesh-ancestor
25231967|NCT02585531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25231968|NCT02585531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231969|NCT02585531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25231970|NCT02585531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25231971|NCT02585531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25231972|NCT02585531|Respiratory System Agents|respiratory system agents|mesh-ancestor
25231973|NCT02585531|Mydriatics|mydriatics|mesh-ancestor
25231974|NCT02585531|Sympathomimetics|sympathomimetics|mesh-ancestor
25231975|NCT02585531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25231976|NCT02585570|Phenylephrine|phenylephrine|mesh-list
25231977|NCT02585570|Oxymetazoline|oxymetazoline|mesh-list
25231978|NCT02585570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25231979|NCT02585570|Mydriatics|mydriatics|mesh-ancestor
25231980|NCT02585570|Autonomic Agents|autonomic agents|mesh-ancestor
25231981|NCT02585570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25044326|NCT01113957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25044327|NCT01113957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044328|NCT01113957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25044329|NCT01113957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25044331|NCT01113957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044332|NCT01113957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25044333|NCT01113957|Alkylating Agents|alkylating agents|mesh-ancestor
25044334|NCT01113957|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25044335|NCT01113593|Formoterol Fumarate|formoterol fumarate|mesh-list
24622446|NCT01067053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24564082|NCT00775073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24564083|NCT00775073|Growth Substances|growth substances|mesh-ancestor
24564084|NCT00775073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564085|NCT00775073|Growth Inhibitors|growth inhibitors|mesh-ancestor
24564088|NCT00775086|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24622452|NCT01067053|Growth Inhibitors|growth inhibitors|mesh-ancestor
24622453|NCT01067053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25871092|NCT00121381|Dermatologic Agents|dermatologic agents|mesh-ancestor
25871093|NCT00121381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25871094|NCT00121381|Immunologic Factors|immunologic factors|mesh-ancestor
25871095|NCT00121381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25871096|NCT00121381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871097|NCT00121381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871098|NCT00121394|Chlorhexidine|chlorhexidine|mesh-list
25871099|NCT00121394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25434779|NCT00006436|Etoposide|etoposide|mesh-list
25871103|NCT00121407|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24598282|NCT00955045|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
24598283|NCT00955045|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24598284|NCT00955045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25871104|NCT00121407|Dermatologic Agents|dermatologic agents|mesh-ancestor
25871105|NCT00121420|Motexafin gadolinium|motexafin gadolinium|mesh-list
25871106|NCT00121420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25871107|NCT00121420|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25871108|NCT00121420|Dermatologic Agents|dermatologic agents|mesh-ancestor
25871109|NCT00121446|Enoxaparin|enoxaparin|mesh-list
25871110|NCT00121446|Tenecteplase|tenecteplase|mesh-list
25871111|NCT00121446|Clopidogrel|clopidogrel|mesh-list
25871112|NCT00121446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24454971|NCT03122262|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25871113|NCT00121446|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25871114|NCT00121446|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25871115|NCT00121446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25871116|NCT00121446|Purinergic Agents|purinergic agents|mesh-ancestor
24622472|NCT01067222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25231982|NCT02585570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25231983|NCT02585570|Sympathomimetics|sympathomimetics|mesh-ancestor
25231984|NCT02585570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25231985|NCT02585570|Nasal Decongestants|nasal decongestants|mesh-ancestor
25231986|NCT02585570|Respiratory System Agents|respiratory system agents|mesh-ancestor
25231987|NCT02585570|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25231988|NCT02585570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25231989|NCT02585570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25231990|NCT02585570|Adrenergic Agents|adrenergic agents|mesh-ancestor
25231991|NCT02585570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25044336|NCT01113593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25671438|NCT01091831|Autonomic Agents|autonomic agents|mesh-ancestor
25671439|NCT01091831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25671440|NCT01091831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25671441|NCT01091831|Glucocorticoids|glucocorticoids|mesh-ancestor
25671442|NCT01091831|Hormones|hormones|mesh-ancestor
25671443|NCT01091831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25671444|NCT01091831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25671445|NCT01091831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25671446|NCT01091831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25671447|NCT01091831|Growth Substances|growth substances|mesh-ancestor
25671448|NCT01091831|Growth Inhibitors|growth inhibitors|mesh-ancestor
25671449|NCT00915681|Silybin|silybin|mesh-list
25671450|NCT00915681|Protective Agents|protective agents|mesh-ancestor
25671451|NCT00915681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671452|NCT00915681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25044337|NCT01113593|Autonomic Agents|autonomic agents|mesh-ancestor
25044338|NCT01113593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25044339|NCT01113593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044340|NCT01113593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25044341|NCT01113593|Respiratory System Agents|respiratory system agents|mesh-ancestor
25044342|NCT01113593|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25044343|NCT01113593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25044344|NCT01113593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25044345|NCT01113593|Adrenergic Agents|adrenergic agents|mesh-ancestor
25044346|NCT01113593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25044347|NCT01113593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564248|NCT00775697|Hormone Antagonists|hormone antagonists|mesh-ancestor
25871117|NCT00121446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25871118|NCT00121446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871119|NCT00121446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871120|NCT00121446|Anticoagulants|anticoagulants|mesh-ancestor
25871121|NCT00121446|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25231992|NCT02585570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626484|NCT01087580|Prednisone|prednisone|mesh-list
25231993|NCT02585570|Protective Agents|protective agents|mesh-ancestor
25231994|NCT02585479|Oxaliplatin|oxaliplatin|mesh-list
25231995|NCT02585479|Ethiodized Oil|ethiodized oil|mesh-list
25231996|NCT02585479|Pirarubicin|pirarubicin|mesh-list
25231997|NCT02585479|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
25231998|NCT02585479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25231999|NCT02585479|Hemostatics|hemostatics|mesh-ancestor
25232000|NCT02585479|Coagulants|coagulants|mesh-ancestor
25232001|NCT02585440|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
25232002|NCT02585440|Antiviral Agents|antiviral agents|mesh-ancestor
25232003|NCT02585440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25232004|NCT02585440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25232005|NCT02585440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25232006|NCT02585180|Silver Sulfadiazine|silver sulfadiazine|mesh-list
25044349|NCT01111955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25044350|NCT01111955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044351|NCT01111773|Lidocaine|lidocaine|mesh-list
25044352|NCT01111773|Tetracaine|tetracaine|mesh-list
25044353|NCT01111773|Anesthetics, Local|anesthetics, local|mesh-ancestor
25044354|NCT01111773|Anesthetics|anesthetics|mesh-ancestor
25671453|NCT00915681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671454|NCT00773695|Paclitaxel|paclitaxel|mesh-list
25671455|NCT00773695|Docetaxel|docetaxel|mesh-list
25671456|NCT00773695|Cyclophosphamide|cyclophosphamide|mesh-list
25671457|NCT00773695|Bevacizumab|bevacizumab|mesh-list
25671458|NCT00773695|Fluorouracil|fluorouracil|mesh-list
25671459|NCT00773695|Epirubicin|epirubicin|mesh-list
25671460|NCT00773695|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25671461|NCT00773695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25671462|NCT00773695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671463|NCT00773695|Tubulin Modulators|tubulin modulators|mesh-ancestor
25871122|NCT00121446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25871123|NCT00121459|Psyllium|psyllium|mesh-list
25871124|NCT00121459|Calcium polycarbophil|calcium polycarbophil|mesh-list
25871125|NCT00121459|Cathartics|cathartics|mesh-ancestor
25871126|NCT00121459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25871127|NCT00121459|Antidiarrheals|antidiarrheals|mesh-ancestor
25871128|NCT00121498|Lidocaine|lidocaine|mesh-list
25871129|NCT00121498|Anesthetics, Local|anesthetics, local|mesh-list
25871130|NCT00121498|Anesthetics|anesthetics|mesh-list
25871132|NCT00121498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871133|NCT00121498|Sensory System Agents|sensory system agents|mesh-ancestor
25871134|NCT00121498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25871135|NCT00121498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25871136|NCT00121498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25232007|NCT02585180|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25232008|NCT02585180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25232009|NCT02585258|Prednisolone|prednisolone|mesh-list
25232010|NCT02585258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25232011|NCT02585258|Glucocorticoids|glucocorticoids|mesh-ancestor
25232012|NCT02585258|Hormones|hormones|mesh-ancestor
25232013|NCT02585258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25232014|NCT02585258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232015|NCT02585258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25232016|NCT02585258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232017|NCT02585401|Aflibercept|aflibercept|mesh-list
25232018|NCT02585401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25232019|NCT02585401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25232020|NCT02585401|Growth Substances|growth substances|mesh-ancestor
25232021|NCT02585401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232022|NCT02585401|Growth Inhibitors|growth inhibitors|mesh-ancestor
25232023|NCT02585401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232024|NCT02585388|Letrozole|letrozole|mesh-list
25232025|NCT02585388|Vinorelbine|vinorelbine|mesh-list
25232026|NCT02585388|Anastrozole|anastrozole|mesh-list
25232027|NCT02585388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232028|NCT02585388|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24452992|NCT05371964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25671464|NCT00773695|Antimitotic Agents|antimitotic agents|mesh-ancestor
25671465|NCT00773695|Mitosis Modulators|mitosis modulators|mesh-ancestor
25871137|NCT00121498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25871138|NCT00121498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412651|NCT00191711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25871139|NCT00121498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273577|NCT02384876|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25671472|NCT00773695|Alkylating Agents|alkylating agents|mesh-ancestor
25232036|NCT02585388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25232038|NCT02585388|Antimitotic Agents|antimitotic agents|mesh-ancestor
25232039|NCT02585388|Mitosis Modulators|mitosis modulators|mesh-ancestor
25232040|NCT02585388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25232041|NCT02585141|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25232042|NCT02585141|Clindamycin|clindamycin|mesh-list
25232043|NCT02585141|Clindamycin palmitate|clindamycin palmitate|mesh-list
25232044|NCT02585141|Clindamycin phosphate|clindamycin phosphate|mesh-list
25232045|NCT02585141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24846710|NCT02243553|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24846711|NCT02243553|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25871174|NCT00121524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25871175|NCT00121524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25871176|NCT00121524|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25871177|NCT00121524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25871178|NCT00121524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871179|NCT00121524|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25871206|NCT00121563|Leprostatic Agents|leprostatic agents|mesh-ancestor
25232055|NCT02585011|Sensory System Agents|sensory system agents|mesh-ancestor
25232056|NCT02585011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25232057|NCT02585011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25232058|NCT02585011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25232059|NCT02585011|Adrenergic Agents|adrenergic agents|mesh-ancestor
25232060|NCT02585011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25232061|NCT02585011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232062|NCT02585011|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25232063|NCT02585011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25232064|NCT02585011|Autonomic Agents|autonomic agents|mesh-ancestor
25232065|NCT02585011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25232066|NCT02585011|Respiratory System Agents|respiratory system agents|mesh-ancestor
25232068|NCT02585011|Sympathomimetics|sympathomimetics|mesh-ancestor
25232069|NCT02585011|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25232070|NCT02584881|Analgesics, Opioid|analgesics, opioid|mesh-list
24882071|NCT02827526|Ketamine|ketamine|mesh-list
25232071|NCT02584881|Narcotics|narcotics|mesh-ancestor
25232072|NCT02584881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25232073|NCT02584881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232074|NCT02584881|Analgesics|analgesics|mesh-ancestor
25232075|NCT02584881|Sensory System Agents|sensory system agents|mesh-ancestor
25232076|NCT02584881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25232077|NCT02584816|Vaccines|vaccines|mesh-list
25232078|NCT02584816|Immunologic Factors|immunologic factors|mesh-ancestor
25871207|NCT00121563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25871208|NCT00121563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25871209|NCT00121563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25871210|NCT00121563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25871211|NCT00121563|Growth Substances|growth substances|mesh-ancestor
25871212|NCT00121563|Growth Inhibitors|growth inhibitors|mesh-ancestor
25871213|NCT00121563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25871214|NCT00121563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25871215|NCT00121563|Anticonvulsants|anticonvulsants|mesh-ancestor
25871216|NCT00121563|Antiemetics|antiemetics|mesh-ancestor
25871217|NCT00121563|Autonomic Agents|autonomic agents|mesh-ancestor
25871218|NCT00121563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25871219|NCT00121563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24448470|NCT00311961|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24802018|NCT01986777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24802019|NCT01986777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24448506|NCT00312013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871220|NCT00121563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25871227|NCT00121563|Anesthetics, General|anesthetics, general|mesh-ancestor
25871228|NCT00121563|Anesthetics|anesthetics|mesh-ancestor
25871229|NCT00121563|GABA Modulators|gaba modulators|mesh-ancestor
25871230|NCT00121563|GABA Agents|gaba agents|mesh-ancestor
25871231|NCT00121563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25871232|NCT00121602|Darbepoetin alfa|darbepoetin alfa|mesh-list
25871233|NCT00121602|Hematinics|hematinics|mesh-ancestor
25871234|NCT00121615|Etanercept|etanercept|mesh-list
25871235|NCT00121615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25871236|NCT00121615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25871237|NCT00121615|Analgesics|analgesics|mesh-ancestor
24588314|NCT00902031|Sennosides|sennosides|mesh-list
25871238|NCT00121615|Sensory System Agents|sensory system agents|mesh-ancestor
25871239|NCT00121615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25871240|NCT00121615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232094|NCT02584751|Antioxidants|antioxidants|mesh-ancestor
25232079|NCT02584816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232080|NCT02584751|Nitric Oxide|nitric oxide|mesh-list
25232081|NCT02584751|Omeprazole|omeprazole|mesh-list
25232082|NCT02584751|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25232083|NCT02584751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25232084|NCT02584751|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25232085|NCT02584751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232086|NCT02584751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871241|NCT00121615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25871242|NCT00121615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25871243|NCT00121615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25871244|NCT00121615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25871245|NCT00121615|Immunologic Factors|immunologic factors|mesh-ancestor
25871246|NCT00121628|Motesanib diphosphate|motesanib diphosphate|mesh-list
25871247|NCT00121628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25871248|NCT00121628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448661|NCT00312546|Anticonvulsants|anticonvulsants|mesh-ancestor
25871256|NCT00121784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25871257|NCT00121784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25871258|NCT00121784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25871259|NCT00121784|Antitubercular Agents|antitubercular agents|mesh-ancestor
25871260|NCT00121784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25871261|NCT00121784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25871262|NCT00121784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871263|NCT00121784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871264|NCT00121797|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25871265|NCT00121797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25871266|NCT00121875|Hormones|hormones|mesh-list
25871267|NCT00121875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25871268|NCT00121875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871269|NCT00121888|Paroxetine|paroxetine|mesh-list
25871270|NCT00121888|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25871271|NCT00121888|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25871272|NCT00121888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25871273|NCT00121888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871274|NCT00121888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25871275|NCT00121888|Serotonin Agents|serotonin agents|mesh-ancestor
25871276|NCT00121888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871277|NCT00121888|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25871278|NCT00121888|Antidepressive Agents|antidepressive agents|mesh-ancestor
25232088|NCT02584751|Autonomic Agents|autonomic agents|mesh-ancestor
25232089|NCT02584751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25232090|NCT02584751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232091|NCT02584751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25232092|NCT02584751|Respiratory System Agents|respiratory system agents|mesh-ancestor
25232093|NCT02584751|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24455055|NCT02955602|Seladelpar|seladelpar|mesh-list
24455056|NCT02955602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24455057|NCT02955602|Antimetabolites|antimetabolites|mesh-ancestor
25871279|NCT00121888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25871280|NCT00121888|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25871281|NCT00121888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25871282|NCT00121888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24802023|NCT01986777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24802025|NCT01986894|Thalidomide|thalidomide|mesh-list
24802026|NCT01986894|Pomalidomide|pomalidomide|mesh-list
24802027|NCT01986894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24802028|NCT01986894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24802029|NCT01986894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24802030|NCT01986894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24802031|NCT01986894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565046|NCT00778596|Hormones|hormones|mesh-ancestor
25871283|NCT00121914|Ethanol|ethanol|mesh-list
25871295|NCT00121966|Rosiglitazone|rosiglitazone|mesh-list
25871296|NCT00121966|Isophane Insulin, Human|isophane insulin, human|mesh-list
25871297|NCT00121966|Insulin, Isophane|insulin, isophane|mesh-list
25871298|NCT00121966|Isophane insulin, beef|isophane insulin, beef|mesh-list
25871299|NCT00121966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25871300|NCT00121966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871301|NCT00121979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
25871302|NCT00121979|Racivir|racivir|mesh-list
25871303|NCT00121979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25871304|NCT00121979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871305|NCT00121979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871306|NCT00121979|Antiviral Agents|antiviral agents|mesh-ancestor
25871307|NCT00121979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25871308|NCT00122018|Acetylcysteine|acetylcysteine|mesh-list
25871309|NCT00122018|Fenoldopam|fenoldopam|mesh-list
25871310|NCT00122018|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24802038|NCT01986894|Growth Substances|growth substances|mesh-ancestor
24802039|NCT01986894|Growth Inhibitors|growth inhibitors|mesh-ancestor
24802040|NCT01986894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24802041|NCT01986894|Leprostatic Agents|leprostatic agents|mesh-ancestor
24802042|NCT01986998|Methylprednisolone|methylprednisolone|mesh-list
24802043|NCT01986998|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24802044|NCT01986998|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24802045|NCT01986998|Prednisolone|prednisolone|mesh-list
24802046|NCT01986998|Prednisolone acetate|prednisolone acetate|mesh-list
24802047|NCT01986998|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24802048|NCT01986998|Prednisolone phosphate|prednisolone phosphate|mesh-list
24565211|NCT00779233|Zidovudine|zidovudine|mesh-list
24448697|NCT00312650|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24448699|NCT00312650|Antimetabolites|antimetabolites|mesh-ancestor
25871311|NCT00122018|Antiviral Agents|antiviral agents|mesh-ancestor
25871312|NCT00122018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25871313|NCT00122018|Expectorants|expectorants|mesh-ancestor
25871314|NCT00122018|Respiratory System Agents|respiratory system agents|mesh-ancestor
25871315|NCT00122018|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25871316|NCT00122018|Antioxidants|antioxidants|mesh-ancestor
25871317|NCT00122018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25434780|NCT00006436|Vincristine|vincristine|mesh-list
25871318|NCT00122018|Protective Agents|protective agents|mesh-ancestor
25871329|NCT00122044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25871330|NCT00122044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25871331|NCT00122044|Cholinergic Agents|cholinergic agents|mesh-ancestor
25871332|NCT00122044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24588773|NCT00904202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25871333|NCT00122044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871334|NCT00122044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871335|NCT00122057|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25871336|NCT00122057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25876702|NCT02960022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876703|NCT02960022|Hormone Antagonists|hormone antagonists|mesh-ancestor
25876704|NCT02960022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25876705|NCT02952092|Darbepoetin alfa|darbepoetin alfa|mesh-list
25876706|NCT02952092|Hematinics|hematinics|mesh-ancestor
25876707|NCT02927301|Atezolizumab|atezolizumab|mesh-list
25876708|NCT02927301|Antibodies|antibodies|mesh-list
25876709|NCT02927301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25876710|NCT02927301|Immunologic Factors|immunologic factors|mesh-ancestor
25876711|NCT02927301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802064|NCT01987076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24802065|NCT01987076|Glucocorticoids|glucocorticoids|mesh-ancestor
25232111|NCT02584738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25232112|NCT02584738|Glucocorticoids|glucocorticoids|mesh-ancestor
25232113|NCT02584738|Hormones|hormones|mesh-ancestor
25232114|NCT02584738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25232115|NCT02584738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25671474|NCT00773695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25224147|NCT02634489|Tamsulosin|tamsulosin|mesh-list
25876712|NCT02927301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232116|NCT02584738|Protective Agents|protective agents|mesh-ancestor
25876713|NCT02884206|Valsartan|valsartan|mesh-list
25871345|NCT00122096|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25062312|NCT04928183|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24946622|NCT03936426|Copper|copper|mesh-list
25062313|NCT04928183|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25062314|NCT04928183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25062315|NCT04928183|Adrenergic Agents|adrenergic agents|mesh-ancestor
25062316|NCT04928183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25062318|NCT04928183|Protective Agents|protective agents|mesh-ancestor
24455086|NCT02876107|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24455088|NCT02876107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24455090|NCT02876107|Immunoglobulins|immunoglobulins|mesh-list
24455091|NCT02876107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24455092|NCT02876107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24455093|NCT02876107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24455094|NCT02876107|Tubulin Modulators|tubulin modulators|mesh-ancestor
24455095|NCT02876107|Antimitotic Agents|antimitotic agents|mesh-ancestor
25232118|NCT02584738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232119|NCT02584738|Anticonvulsants|anticonvulsants|mesh-ancestor
25232120|NCT02584738|Analgesics|analgesics|mesh-ancestor
25232121|NCT02584738|Sensory System Agents|sensory system agents|mesh-ancestor
25232122|NCT02584738|Anesthetics|anesthetics|mesh-ancestor
25232123|NCT02584738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25232124|NCT02584738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25232125|NCT02584738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25232126|NCT02584738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25232127|NCT02584738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232128|NCT02584738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25232129|NCT02584738|Tocolytic Agents|tocolytic agents|mesh-ancestor
25232130|NCT02584738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25232131|NCT02584738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25232132|NCT02584738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25232133|NCT02584738|Respiratory System Agents|respiratory system agents|mesh-ancestor
25232134|NCT02584738|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25671475|NCT00773695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25671476|NCT00773695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25671477|NCT00773695|Growth Substances|growth substances|mesh-ancestor
25671478|NCT00773695|Growth Inhibitors|growth inhibitors|mesh-ancestor
25671479|NCT00773695|Antimetabolites|antimetabolites|mesh-ancestor
25671480|NCT00773695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25671481|NCT00773695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25671482|NCT00773695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25671483|NCT00773695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25671484|NCT00773695|Hormone Antagonists|hormone antagonists|mesh-ancestor
25671485|NCT00773695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25671486|NCT00773695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25139209|NCT02972866|Respiratory System Agents|respiratory system agents|mesh-ancestor
25139211|NCT02972866|Hormones|hormones|mesh-ancestor
25139212|NCT02972866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25139213|NCT02972723|Metformin|metformin|mesh-list
25139214|NCT02972723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25139215|NCT02972723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139216|NCT02972762|Propofol|propofol|mesh-list
25139222|NCT02972762|Anesthetics|anesthetics|mesh-ancestor
25232135|NCT02584738|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25232136|NCT02584738|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25232137|NCT02584738|Adrenergic Agents|adrenergic agents|mesh-ancestor
25232138|NCT02584738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25232139|NCT02584738|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25232140|NCT02584738|Cholinergic Agents|cholinergic agents|mesh-ancestor
25232141|NCT02584647|Sirolimus|sirolimus|mesh-list
25232142|NCT02584647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25232143|NCT02584647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25232144|NCT02584647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25232145|NCT02584647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232146|NCT02584647|Antifungal Agents|antifungal agents|mesh-ancestor
24455096|NCT02876107|Mitosis Modulators|mitosis modulators|mesh-ancestor
24455097|NCT02876107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455098|NCT02876107|Immunologic Factors|immunologic factors|mesh-ancestor
24802066|NCT01987076|Hormones|hormones|mesh-ancestor
24802067|NCT01987076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24802068|NCT01987076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802069|NCT01987076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24802070|NCT01987076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24802071|NCT01987128|Ropivacaine|ropivacaine|mesh-list
24455099|NCT02876107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455100|NCT02850016|Romidepsin|romidepsin|mesh-list
24455101|NCT02850016|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
24455102|NCT02850016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24455103|NCT02850016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24455104|NCT02850016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871346|NCT00122096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25871347|NCT00122096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871348|NCT00122096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871349|NCT00122096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25871350|NCT00122096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25871351|NCT00122096|Analgesics|analgesics|mesh-ancestor
25871352|NCT00122096|Sensory System Agents|sensory system agents|mesh-ancestor
25871353|NCT00122096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25871354|NCT00122096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871355|NCT00122096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25871356|NCT00122096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25871357|NCT00122226|Ritonavir|ritonavir|mesh-list
25871358|NCT00122226|Lopinavir|lopinavir|mesh-list
25871359|NCT00122226|Lamivudine|lamivudine|mesh-list
25871360|NCT00122226|Zidovudine|zidovudine|mesh-list
25871361|NCT00122226|Nevirapine|nevirapine|mesh-list
25871362|NCT00122226|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25871363|NCT00122226|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24802072|NCT01987128|Anesthetics, Local|anesthetics, local|mesh-ancestor
24802073|NCT01987128|Anesthetics|anesthetics|mesh-ancestor
24802074|NCT01987128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25671487|NCT00773695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25671488|NCT00773695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25671489|NCT00700596|Salvinorin A|salvinorin a|mesh-list
25671490|NCT00700596|Hallucinogens|hallucinogens|mesh-ancestor
25671491|NCT00700596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671492|NCT00700596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25671493|NCT00145158|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25671494|NCT00145158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25671495|NCT00145158|Immunologic Factors|immunologic factors|mesh-ancestor
25671496|NCT00145158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671497|NCT01732809|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25671498|NCT01732809|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25871369|NCT00122226|Antiviral Agents|antiviral agents|mesh-ancestor
25871370|NCT00122226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25871371|NCT00122226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25871372|NCT00122226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25871373|NCT00122226|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25871374|NCT00122226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25232147|NCT02584647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25232148|NCT02584647|Immunologic Factors|immunologic factors|mesh-ancestor
25232149|NCT02584647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232150|NCT02584582|Liraglutide|liraglutide|mesh-list
25232151|NCT02584582|Exenatide|exenatide|mesh-list
25232152|NCT02584582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24479365|NCT00426582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25871375|NCT00122226|Antimetabolites|antimetabolites|mesh-ancestor
25871376|NCT00122226|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25871377|NCT00122226|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25871378|NCT00122291|Capecitabine|capecitabine|mesh-list
25871379|NCT00122291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25871380|NCT00122291|Antimetabolites|antimetabolites|mesh-ancestor
25871381|NCT00122291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871382|NCT00122291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25871383|NCT00122304|Eculizumab|eculizumab|mesh-list
25871384|NCT00122304|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25871385|NCT00122304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25871386|NCT00122304|Immunologic Factors|immunologic factors|mesh-ancestor
25871387|NCT00122304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871388|NCT00122330|Eculizumab|eculizumab|mesh-list
24882267|NCT01962792|Antiemetics|antiemetics|mesh-ancestor
25871389|NCT00122330|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25871390|NCT00122330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25871391|NCT00122330|Immunologic Factors|immunologic factors|mesh-ancestor
25871392|NCT00122330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871393|NCT00122343|Sirolimus|sirolimus|mesh-list
25871394|NCT00122343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25671499|NCT01732809|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25671500|NCT01732809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25671501|NCT01732809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671502|NCT01732809|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25671506|NCT01732809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25671507|NCT01732822|Clopidogrel|clopidogrel|mesh-list
25671508|NCT01732822|Ticagrelor|ticagrelor|mesh-list
25671509|NCT01732822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24863748|NCT03490058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24863750|NCT03490058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863751|NCT03490058|Antiviral Agents|antiviral agents|mesh-ancestor
24863752|NCT03490058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24863753|NCT03490058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24863754|NCT03490058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24863755|NCT03451825|Avelumab|avelumab|mesh-list
24863756|NCT03451825|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24863757|NCT03451825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24609395|NCT00996424|Expectorants|expectorants|mesh-ancestor
24863758|NCT03451825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863759|NCT03451825|Immunologic Factors|immunologic factors|mesh-ancestor
24863760|NCT03451825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863761|NCT03439046|Letrozole|letrozole|mesh-list
24863762|NCT03439046|Fulvestrant|fulvestrant|mesh-list
24863772|NCT03439046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25046470|NCT00843687|Risperidone|risperidone|mesh-list
25871395|NCT00122343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25871396|NCT00122343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25871397|NCT00122343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24802084|NCT01987167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24565742|NCT00782197|Protective Agents|protective agents|mesh-ancestor
25871398|NCT00122343|Antifungal Agents|antifungal agents|mesh-ancestor
25871399|NCT00122343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25871400|NCT00122343|Immunologic Factors|immunologic factors|mesh-ancestor
25871401|NCT00122343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871402|NCT00122356|Alendronate|alendronate|mesh-list
25871403|NCT00122356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25871404|NCT00122356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871405|NCT00122434|Tiotropium Bromide|tiotropium bromide|mesh-list
25871406|NCT00122434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25871407|NCT00122434|Autonomic Agents|autonomic agents|mesh-ancestor
25871408|NCT00122434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25871409|NCT00122434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871410|NCT00122434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25232153|NCT02584582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232154|NCT02584582|Incretins|incretins|mesh-ancestor
25232155|NCT02584582|Hormones|hormones|mesh-ancestor
25232156|NCT02584582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25232157|NCT02584582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25232158|NCT02584543|Vaccines|vaccines|mesh-list
25232159|NCT02584543|Immunologic Factors|immunologic factors|mesh-ancestor
25232160|NCT02584543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232161|NCT02584465|Tamoxifen|tamoxifen|mesh-list
25232162|NCT02584465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25232163|NCT02584465|Hormone Antagonists|hormone antagonists|mesh-ancestor
24413457|NCT00193921|Antiviral Agents|antiviral agents|mesh-ancestor
25409614|NCT03366298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25671510|NCT01732822|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25671511|NCT01732822|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25671512|NCT01732822|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25671513|NCT01732822|Purinergic Agents|purinergic agents|mesh-ancestor
25671514|NCT01732822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25671515|NCT01732822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671516|NCT01732822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671517|NCT01733121|Tetrabenazine|tetrabenazine|mesh-list
25671518|NCT01733121|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25671519|NCT01733121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25671520|NCT01733121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25671521|NCT01733121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671522|NCT01733121|Adrenergic Agents|adrenergic agents|mesh-ancestor
25671523|NCT01733121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25671524|NCT01733121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871416|NCT00122434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871417|NCT00122473|Imatinib Mesylate|imatinib mesylate|mesh-list
25871418|NCT00122473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25871419|NCT00122473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25871420|NCT00122473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871421|NCT00122473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871422|NCT00122486|Tenofovir|tenofovir|mesh-list
25871423|NCT00122486|Antiviral Agents|antiviral agents|mesh-ancestor
24802085|NCT01987167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802086|NCT01987297|Cytarabine|cytarabine|mesh-list
24802087|NCT01987297|Daunorubicin|daunorubicin|mesh-list
25871424|NCT00122486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25871425|NCT00122486|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24448911|NCT00313534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24448912|NCT00313534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24448913|NCT00313534|Analgesics|analgesics|mesh-ancestor
24448914|NCT00313534|Sensory System Agents|sensory system agents|mesh-ancestor
24448915|NCT00313534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24448916|NCT00313534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24448917|NCT00313534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24448918|NCT00313547|Amlodipine|amlodipine|mesh-list
24448919|NCT00313547|Quinapril|quinapril|mesh-list
24448920|NCT00313547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25871426|NCT00122486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25871427|NCT00122486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871428|NCT00122486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871429|NCT00122486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25871430|NCT00122486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25871431|NCT00122499|Tadalafil|tadalafil|mesh-list
25871432|NCT00122499|Vasodilator Agents|vasodilator agents|mesh-ancestor
25871433|NCT00122499|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25871434|NCT00122499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25871435|NCT00122499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232167|NCT02584465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232168|NCT02584465|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25232169|NCT02584465|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25671525|NCT01733316|Cysteamine|cysteamine|mesh-list
25232170|NCT02584465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25671526|NCT01733316|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
25871440|NCT00122512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25871441|NCT00122512|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25871442|NCT00122512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25871443|NCT00122512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871444|NCT00122512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871445|NCT00122512|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25871446|NCT00122512|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25871447|NCT00122538|Lamivudine|lamivudine|mesh-list
25871448|NCT00122538|Efavirenz|efavirenz|mesh-list
25044355|NCT01111773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25072010|NCT03404414|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25871449|NCT00122538|Didanosine|didanosine|mesh-list
25871450|NCT00122538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25871451|NCT00122538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25871452|NCT00122538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871453|NCT00122538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871454|NCT00122538|Antiviral Agents|antiviral agents|mesh-ancestor
25871455|NCT00122538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25232171|NCT02584400|Imidazole|imidazole|mesh-list
25232172|NCT02584400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25434781|NCT00006436|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25671531|NCT01733329|Abortifacient Agents|abortifacient agents|mesh-ancestor
25671532|NCT01733329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25671533|NCT01733329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671534|NCT01733329|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25671535|NCT01733329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25671536|NCT01733329|Oxytocics|oxytocics|mesh-ancestor
25232175|NCT02584335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25232176|NCT02584335|Anesthetics, Local|anesthetics, local|mesh-ancestor
25232177|NCT02584335|Anesthetics|anesthetics|mesh-ancestor
25232178|NCT02584335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25232179|NCT02584335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232180|NCT02584335|Sensory System Agents|sensory system agents|mesh-ancestor
25232181|NCT02584335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25232182|NCT02584335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25232183|NCT02584335|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25232184|NCT02584335|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25232185|NCT02584335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25871456|NCT00122538|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25871457|NCT00122538|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25871458|NCT00122538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25871459|NCT00122538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25871460|NCT00122538|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25871461|NCT00122538|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25871462|NCT00122538|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25871463|NCT00122538|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25871464|NCT00122538|Antimetabolites|antimetabolites|mesh-ancestor
25871465|NCT00122551|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25871466|NCT00122551|Antiviral Agents|antiviral agents|mesh-ancestor
25871467|NCT00122551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25871468|NCT00122577|Ritonavir|ritonavir|mesh-list
25871469|NCT00122577|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25871470|NCT00122577|Tenofovir|tenofovir|mesh-list
25871471|NCT00122577|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25871472|NCT00122577|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25871473|NCT00122577|Protease Inhibitors|protease inhibitors|mesh-ancestor
25871474|NCT00122577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871475|NCT00122577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871476|NCT00122577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25871477|NCT00122577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25871478|NCT00122577|Antiviral Agents|antiviral agents|mesh-ancestor
25871479|NCT00122577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25871480|NCT00122577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25871481|NCT00122577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25871482|NCT00122577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25871483|NCT00122577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25871484|NCT00122590|Ritonavir|ritonavir|mesh-list
25871485|NCT00122590|Lopinavir|lopinavir|mesh-list
25871486|NCT00122590|Nelfinavir|nelfinavir|mesh-list
25871487|NCT00122590|Indinavir|indinavir|mesh-list
25871488|NCT00122590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25871489|NCT00122590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25871490|NCT00122590|Protease Inhibitors|protease inhibitors|mesh-ancestor
25871491|NCT00122590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871492|NCT00122590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871493|NCT00122590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25871494|NCT00122590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25871495|NCT00122590|Antiviral Agents|antiviral agents|mesh-ancestor
24448957|NCT00313625|Immunologic Factors|immunologic factors|mesh-ancestor
24448958|NCT00313625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24448959|NCT00313625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25671537|NCT01733329|Hematinics|hematinics|mesh-ancestor
25671538|NCT01733329|Vitamin B Complex|vitamin b complex|mesh-ancestor
25671539|NCT01733329|Vitamins|vitamins|mesh-ancestor
25671540|NCT01733329|Micronutrients|micronutrients|mesh-ancestor
25671541|NCT01733472|Remifentanil|remifentanil|mesh-list
25671542|NCT01733472|Propofol|propofol|mesh-list
25671543|NCT01733472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25671544|NCT01733472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25671545|NCT01733472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232189|NCT02584075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25232190|NCT02584075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232191|NCT02584075|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25232192|NCT02584075|Incretins|incretins|mesh-ancestor
25232193|NCT02584075|Hormones|hormones|mesh-ancestor
25232194|NCT02584075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25871497|NCT00122590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25871498|NCT00122590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25871499|NCT00122603|Saquinavir|saquinavir|mesh-list
25871500|NCT00122603|Fosamprenavir|fosamprenavir|mesh-list
25871501|NCT00122603|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25871502|NCT00122603|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25871503|NCT00122603|Protease Inhibitors|protease inhibitors|mesh-ancestor
25871504|NCT00122603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871505|NCT00122603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871506|NCT00122603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25871507|NCT00122603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25871508|NCT00122603|Antiviral Agents|antiviral agents|mesh-ancestor
25871509|NCT00122603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25871510|NCT00122603|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25871511|NCT00122603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25871512|NCT00122616|Ribavirin|ribavirin|mesh-list
25871513|NCT00122616|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25871514|NCT00122616|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25871515|NCT00122616|Antimetabolites|antimetabolites|mesh-ancestor
25871516|NCT00122616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871517|NCT00122616|Antiviral Agents|antiviral agents|mesh-ancestor
25871518|NCT00122616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25871519|NCT00122629|Interferons|interferons|mesh-list
25871520|NCT00122629|Ribavirin|ribavirin|mesh-list
25871521|NCT00122629|Interferon-alpha|interferon-alpha|mesh-list
25871522|NCT00122629|Interferon alpha-2|interferon alpha-2|mesh-list
25871523|NCT00122629|Amantadine|amantadine|mesh-list
25871524|NCT00122629|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25871525|NCT00122629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25871526|NCT00122629|Antiviral Agents|antiviral agents|mesh-ancestor
25671546|NCT01733472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25671547|NCT01733472|Anesthetics, General|anesthetics, general|mesh-ancestor
25671548|NCT01733472|Anesthetics|anesthetics|mesh-ancestor
25671549|NCT01733472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25671550|NCT01733472|Narcotics|narcotics|mesh-ancestor
25671551|NCT01733472|Analgesics|analgesics|mesh-ancestor
25671552|NCT01733472|Sensory System Agents|sensory system agents|mesh-ancestor
25871527|NCT00122629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25671553|NCT01733472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25671554|NCT01733680|Amiloride|amiloride|mesh-list
25671555|NCT01733680|Diuretics|diuretics|mesh-ancestor
25232195|NCT02584231|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25232196|NCT02584231|Hemostatics|hemostatics|mesh-ancestor
25232197|NCT02584231|Coagulants|coagulants|mesh-ancestor
25232198|NCT02584231|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25871533|NCT00122629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25871534|NCT00122629|Dopamine Agents|dopamine agents|mesh-ancestor
25871535|NCT00122629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25871536|NCT00122629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25871537|NCT00122629|Analgesics|analgesics|mesh-ancestor
25871538|NCT00122629|Sensory System Agents|sensory system agents|mesh-ancestor
25871539|NCT00122629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25871540|NCT00122655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
25871541|NCT00122655|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
25871542|NCT00122655|Protease Inhibitors|protease inhibitors|mesh-list
25871543|NCT00122655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25871544|NCT00122655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871545|NCT00122655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871546|NCT00122655|Antiviral Agents|antiviral agents|mesh-ancestor
25871547|NCT00122655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24802114|NCT01987323|Latanoprost|latanoprost|mesh-list
24802115|NCT01987323|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24802116|NCT01987323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24802117|NCT01987375|Cetuximab|cetuximab|mesh-list
25092482|NCT03241472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566277|NCT00784940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25871548|NCT00122655|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25871549|NCT00122655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25871550|NCT00122655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25871551|NCT00122668|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
25871552|NCT00122668|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
25871553|NCT00122668|Protease Inhibitors|protease inhibitors|mesh-list
24448999|NCT00313885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24449000|NCT00313885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449001|NCT00313885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24449002|NCT00313885|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24449003|NCT00313885|Serotonin Agents|serotonin agents|mesh-ancestor
24449023|NCT00313937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449024|NCT00313950|Vaccines|vaccines|mesh-list
24449025|NCT00313950|Immunologic Factors|immunologic factors|mesh-ancestor
24449026|NCT00313950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449027|NCT00313963|Magnesium Sulfate|magnesium sulfate|mesh-list
24449028|NCT00313963|Analgesics|analgesics|mesh-ancestor
24449029|NCT00313963|Sensory System Agents|sensory system agents|mesh-ancestor
24802118|NCT01987375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24802119|NCT01987375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25871554|NCT00122668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25871555|NCT00122668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871556|NCT00122668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871557|NCT00122668|Antiviral Agents|antiviral agents|mesh-ancestor
25871558|NCT00122668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25871559|NCT00122668|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25871560|NCT00122668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25871561|NCT00122668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25871562|NCT00122694|Carbon Monoxide|carbon monoxide|mesh-list
25871563|NCT00122694|Antimetabolites|antimetabolites|mesh-ancestor
25871564|NCT00122694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871565|NCT00122694|Gasotransmitters|gasotransmitters|mesh-ancestor
25871566|NCT00122694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25871567|NCT00122694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871568|NCT00122720|Darbepoetin alfa|darbepoetin alfa|mesh-list
25871569|NCT00122720|Hematinics|hematinics|mesh-ancestor
25273579|NCT02384876|Sympathomimetics|sympathomimetics|mesh-ancestor
25273580|NCT02384876|Autonomic Agents|autonomic agents|mesh-ancestor
25273581|NCT02384876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25871573|NCT00122733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25062384|NCT04862650|Tubulin Modulators|tubulin modulators|mesh-ancestor
25871574|NCT00122733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871575|NCT00122733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25871576|NCT00122733|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25871577|NCT00122733|Dopamine Agents|dopamine agents|mesh-ancestor
25871578|NCT00122733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25871579|NCT00122733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871580|NCT00122746|Cisplatin|cisplatin|mesh-list
25871581|NCT00122746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25871582|NCT00122759|Ketamine|ketamine|mesh-list
25871583|NCT00122759|Analgesics|analgesics|mesh-ancestor
25871584|NCT00122759|Sensory System Agents|sensory system agents|mesh-ancestor
25871585|NCT00122759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25871586|NCT00122759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871587|NCT00122759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25871588|NCT00122759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25871589|NCT00122759|Anesthetics, General|anesthetics, general|mesh-ancestor
25871590|NCT00122759|Anesthetics|anesthetics|mesh-ancestor
25871591|NCT00122759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25871592|NCT00122759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25871593|NCT00122759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25871594|NCT00122759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25871595|NCT00122759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871596|NCT00122772|Cisplatin|cisplatin|mesh-list
25871597|NCT00122772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25871598|NCT00122785|Dexamethasone|dexamethasone|mesh-list
25871599|NCT00122785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25871600|NCT00122785|Antiemetics|antiemetics|mesh-ancestor
25871601|NCT00122785|Autonomic Agents|autonomic agents|mesh-ancestor
25871602|NCT00122785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25871603|NCT00122785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871604|NCT00122785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25871605|NCT00122785|Glucocorticoids|glucocorticoids|mesh-ancestor
25871606|NCT00122785|Hormones|hormones|mesh-ancestor
25871607|NCT00122785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25871608|NCT00122785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25871609|NCT00122785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25871610|NCT00122811|Perindopril|perindopril|mesh-list
25232201|NCT02584153|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25232202|NCT02584153|Hemostatics|hemostatics|mesh-ancestor
25232203|NCT02584153|Coagulants|coagulants|mesh-ancestor
25232204|NCT02584010|Silicon|silicon|mesh-list
25232205|NCT02584010|Trace Elements|trace elements|mesh-ancestor
25671556|NCT01733680|Natriuretic Agents|natriuretic agents|mesh-ancestor
25671557|NCT01733680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232206|NCT02584010|Micronutrients|micronutrients|mesh-ancestor
25871613|NCT00122811|Protease Inhibitors|protease inhibitors|mesh-ancestor
25871614|NCT00122811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871615|NCT00122811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871616|NCT00122811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25871617|NCT00122811|Diuretics|diuretics|mesh-ancestor
25871618|NCT00122811|Natriuretic Agents|natriuretic agents|mesh-ancestor
25871619|NCT00122811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871620|NCT00122811|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25871621|NCT00122811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25871622|NCT00122824|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25871623|NCT00122824|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25871624|NCT00122824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25871625|NCT00122824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25871626|NCT00122824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871627|NCT00122824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25871628|NCT00122824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871629|NCT00122824|Analgesics|analgesics|mesh-ancestor
25871630|NCT00122824|Sensory System Agents|sensory system agents|mesh-ancestor
25871631|NCT00122824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25871632|NCT00122824|Antidepressive Agents|antidepressive agents|mesh-ancestor
25871633|NCT00122824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25871634|NCT00122824|Dopamine Agents|dopamine agents|mesh-ancestor
24802129|NCT01987570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802131|NCT01987739|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25871635|NCT00122837|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25232214|NCT02583828|Letrozole|letrozole|mesh-list
25232215|NCT02583828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25232216|NCT02583828|Immunologic Factors|immunologic factors|mesh-ancestor
24449346|NCT00315042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25871650|NCT00122850|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25871651|NCT00122850|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25871652|NCT00122850|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25871653|NCT00122850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25871654|NCT00122850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25871655|NCT00122850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871656|NCT00122850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25871657|NCT00122850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591296|NCT00915811|Busulfan|busulfan|mesh-list
24802140|NCT01987804|Oxytocin|oxytocin|mesh-list
24802141|NCT01987804|Oxytocics|oxytocics|mesh-ancestor
24566795|NCT00787969|Antifungal Agents|antifungal agents|mesh-ancestor
25232217|NCT02583828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232218|NCT02583828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25232219|NCT02583828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25232220|NCT02583828|Alkylating Agents|alkylating agents|mesh-ancestor
25232221|NCT02583828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871666|NCT00122863|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25871668|NCT00122863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25871669|NCT00122863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871670|NCT00122863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25871671|NCT00122863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871672|NCT00122863|Analgesics|analgesics|mesh-ancestor
25871673|NCT00122863|Sensory System Agents|sensory system agents|mesh-ancestor
25871674|NCT00122863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25871675|NCT00122863|Antidepressive Agents|antidepressive agents|mesh-ancestor
25871676|NCT00122863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24591382|NCT00916123|Prednisone|prednisone|mesh-list
25871677|NCT00122863|Dopamine Agents|dopamine agents|mesh-ancestor
25871678|NCT00122876|Talaporfin|talaporfin|mesh-list
25871679|NCT00122876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25871680|NCT00122876|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25871681|NCT00122876|Dermatologic Agents|dermatologic agents|mesh-ancestor
25871682|NCT00122889|Allicin|allicin|mesh-list
24449409|NCT00315523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449412|NCT00315536|Remifentanil|remifentanil|mesh-list
24449413|NCT00315536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25232222|NCT02583828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232223|NCT02583828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25232224|NCT02583828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25232225|NCT02583828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25232226|NCT02583828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232227|NCT02583828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25232228|NCT02583828|Hormone Antagonists|hormone antagonists|mesh-ancestor
24846772|NCT02243800|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24479518|NCT00427167|Antacids|antacids|mesh-ancestor
24946797|NCT03935347|Alkylating Agents|alkylating agents|mesh-ancestor
24802148|NCT01988077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802149|NCT01988116|Calcitriol|calcitriol|mesh-list
24802150|NCT01988116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24802151|NCT01988116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802152|NCT01988116|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24449414|NCT00315536|Narcotics|narcotics|mesh-ancestor
24449415|NCT00315536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24449416|NCT00315536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449417|NCT00315536|Analgesics|analgesics|mesh-ancestor
24449418|NCT00315536|Sensory System Agents|sensory system agents|mesh-ancestor
25871683|NCT00122889|Allyl sulfide|allyl sulfide|mesh-list
24455168|NCT02544750|Anticonvulsants|anticonvulsants|mesh-ancestor
25671558|NCT01733680|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
25871684|NCT00122889|Antioxidants|antioxidants|mesh-ancestor
25871690|NCT00122889|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25139573|NCT02970409|Heparin|heparin|mesh-list
24455174|NCT02448771|Bazedoxifene|bazedoxifene|mesh-list
25871691|NCT00122889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871692|NCT00122889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25871693|NCT00122889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25871694|NCT00122889|Antimetabolites|antimetabolites|mesh-ancestor
25871695|NCT00122889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25871696|NCT00122889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25871697|NCT00122889|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25871698|NCT00122941|Micronutrients|micronutrients|mesh-list
25871699|NCT00122941|Trace Elements|trace elements|mesh-list
25871700|NCT00122941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871701|NCT00123149|Epoetin Alfa|epoetin alfa|mesh-list
24802163|NCT01988298|Sensory System Agents|sensory system agents|mesh-ancestor
25871702|NCT00123149|Hematinics|hematinics|mesh-ancestor
25871703|NCT00123175|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25871704|NCT00123175|Medroxyprogesterone|medroxyprogesterone|mesh-list
25871705|NCT00123175|Progestins|progestins|mesh-list
25871706|NCT00123175|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25871707|NCT00123175|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25232229|NCT02583828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25232230|NCT02583893|Cytarabine|cytarabine|mesh-list
25232231|NCT02583893|Sirolimus|sirolimus|mesh-list
25232232|NCT02583893|Etoposide|etoposide|mesh-list
25232233|NCT02583893|Mitoxantrone|mitoxantrone|mesh-list
25232234|NCT02583893|Etoposide phosphate|etoposide phosphate|mesh-list
25232235|NCT02583893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25232236|NCT02583893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232237|NCT02583893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25232238|NCT02583893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25232239|NCT02583893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25062394|NCT04807972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232240|NCT02583893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232241|NCT02583893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25232242|NCT02583893|Antimetabolites|antimetabolites|mesh-ancestor
25232243|NCT02583893|Antiviral Agents|antiviral agents|mesh-ancestor
25232244|NCT02583893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25232245|NCT02583893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25232246|NCT02583893|Immunologic Factors|immunologic factors|mesh-ancestor
25232247|NCT02583893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232248|NCT02583893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25232249|NCT02583893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25062409|NCT04742777|Sirolimus|sirolimus|mesh-list
25062410|NCT04742777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25062411|NCT04742777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25062412|NCT04742777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25062413|NCT04742777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24846782|NCT02243826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24846783|NCT02243839|Fibrinolytic Agents|fibrinolytic agents|mesh-list
24846784|NCT02243839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24846785|NCT02243839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846786|NCT02243852|Hormones|hormones|mesh-list
25671560|NCT01733680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25671561|NCT01733680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671562|NCT01733680|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
25671563|NCT01733680|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25671564|NCT01733732|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25671565|NCT01733732|Lubricant Eye Drops|lubricant eye drops|mesh-list
25671566|NCT01733732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25671567|NCT01733745|Vitamins|vitamins|mesh-list
25671568|NCT01733745|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25671569|NCT01733745|Micronutrients|micronutrients|mesh-ancestor
25232251|NCT02583893|Analgesics|analgesics|mesh-ancestor
25232252|NCT02583893|Sensory System Agents|sensory system agents|mesh-ancestor
25232268|NCT02583698|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25232269|NCT02583698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25232270|NCT02583594|Loratadine|loratadine|mesh-list
25232271|NCT02583594|Acyclovir|acyclovir|mesh-list
25871715|NCT00123175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25871716|NCT00123175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25871717|NCT00123175|Hormones|hormones|mesh-ancestor
25871718|NCT00123175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25871719|NCT00123201|Dronabinol|dronabinol|mesh-list
25871720|NCT00123201|Hallucinogens|hallucinogens|mesh-ancestor
25871721|NCT00123201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871722|NCT00123201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24455204|NCT02329080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455205|NCT02329080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24455206|NCT02329080|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24455207|NCT02329080|Abortifacient Agents|abortifacient agents|mesh-ancestor
24455208|NCT02329080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24591720|NCT00918320|Topotecan|topotecan|mesh-list
24802186|NCT01988506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871723|NCT00123201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25871724|NCT00123201|Analgesics|analgesics|mesh-ancestor
25871725|NCT00123201|Sensory System Agents|sensory system agents|mesh-ancestor
25871726|NCT00123201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25871727|NCT00123201|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24449451|NCT00315679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25871728|NCT00123201|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24591771|NCT00918554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25871729|NCT00123201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25871730|NCT00123201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871731|NCT00123201|Hormones|hormones|mesh-ancestor
25871732|NCT00123201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25232274|NCT02583594|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
25232275|NCT02583594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25232276|NCT02583594|Antiemetics|antiemetics|mesh-ancestor
25232277|NCT02583594|Autonomic Agents|autonomic agents|mesh-ancestor
25232278|NCT02583594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25232279|NCT02583594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232280|NCT02583594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25232281|NCT02583594|Glucocorticoids|glucocorticoids|mesh-ancestor
25232282|NCT02583594|Hormones|hormones|mesh-ancestor
25232283|NCT02583594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25232284|NCT02583594|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25232285|NCT02583594|Protective Agents|protective agents|mesh-ancestor
25232286|NCT02583594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232287|NCT02583594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24802204|NCT01988610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24802205|NCT01988610|Contraceptive Agents|contraceptive agents|mesh-ancestor
24802206|NCT01988610|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24802207|NCT01988610|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24592011|NCT00920088|Anesthetics|anesthetics|mesh-ancestor
25232288|NCT02583594|Antiviral Agents|antiviral agents|mesh-ancestor
25232289|NCT02583594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25232290|NCT02583594|Antipruritics|antipruritics|mesh-ancestor
25232291|NCT02583594|Dermatologic Agents|dermatologic agents|mesh-ancestor
25232292|NCT02583594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25232293|NCT02583594|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25232294|NCT02583594|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25232295|NCT02583594|Histamine Antagonists|histamine antagonists|mesh-ancestor
25232296|NCT02583594|Histamine Agents|histamine agents|mesh-ancestor
25232297|NCT02583594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25232298|NCT02583594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671573|NCT01733758|rGLP-1 protein|rglp-1 protein|mesh-list
25671574|NCT01733758|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24802209|NCT01988610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24802210|NCT01988610|Luteolytic Agents|luteolytic agents|mesh-ancestor
24802211|NCT01988610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25871752|NCT00123305|Plasminogen|plasminogen|mesh-list
24393159|NCT00128934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24393160|NCT00128934|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24393161|NCT00128934|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24393162|NCT00128934|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24393163|NCT00128934|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24393164|NCT00128947|Mycophenolic Acid|mycophenolic acid|mesh-list
24393165|NCT00128947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24393166|NCT00128947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393167|NCT00128947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24393168|NCT00128947|Antitubercular Agents|antitubercular agents|mesh-ancestor
24393169|NCT00128947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24393170|NCT00128947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24393171|NCT00128947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24802212|NCT01988610|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24802214|NCT01988649|Oxytocics|oxytocics|mesh-ancestor
24802215|NCT01988649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24802216|NCT01988649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802217|NCT01988831|Propranolol|propranolol|mesh-list
24567460|NCT00791271|Decitabine|decitabine|mesh-list
25232300|NCT02583633|Nitroglycerin|nitroglycerin|mesh-list
25232301|NCT02583633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25232302|NCT02583633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25232303|NCT02583633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232304|NCT02583633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25232305|NCT02583633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232306|NCT02583633|Vasodilator Agents|vasodilator agents|mesh-ancestor
25232307|NCT02583633|Tocolytic Agents|tocolytic agents|mesh-ancestor
25232308|NCT02583633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25232309|NCT02583568|Bevacizumab|bevacizumab|mesh-list
25232310|NCT02583568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25062446|NCT04659928|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25671575|NCT01733758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25671576|NCT01733758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671577|NCT01733758|Incretins|incretins|mesh-ancestor
25671578|NCT01733758|Hormones|hormones|mesh-ancestor
25671579|NCT01733758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25671580|NCT01733953|Atorvastatin|atorvastatin|mesh-list
25671581|NCT01733953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25871753|NCT00123305|Fibrinolysin|fibrinolysin|mesh-list
25871754|NCT00123305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25871755|NCT00123305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25871756|NCT00123305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871757|NCT00123318|Cisplatin|cisplatin|mesh-list
25871758|NCT00123318|Fluorouracil|fluorouracil|mesh-list
25871759|NCT00123318|Epirubicin|epirubicin|mesh-list
25871760|NCT00123318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25871761|NCT00123318|Antimetabolites|antimetabolites|mesh-ancestor
24393237|NCT00129181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871767|NCT00123318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24567554|NCT00791531|Antimetabolites|antimetabolites|mesh-ancestor
25093013|NCT03237533|Ionophores|ionophores|mesh-ancestor
24393283|NCT00129363|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24393284|NCT00129506|Methotrexate|methotrexate|mesh-list
24393285|NCT00129506|Misoprostol|misoprostol|mesh-list
24393286|NCT00129506|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25232313|NCT02583568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25232314|NCT02583568|Growth Substances|growth substances|mesh-ancestor
25232315|NCT02583568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232316|NCT02583568|Growth Inhibitors|growth inhibitors|mesh-ancestor
25232317|NCT02583451|Lemborexant|lemborexant|mesh-list
25232319|NCT02583451|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25232320|NCT02583451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25671582|NCT01733953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25671583|NCT01733953|Antimetabolites|antimetabolites|mesh-ancestor
25671584|NCT01733953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671585|NCT01733953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25671586|NCT01733953|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25671587|NCT01733953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232321|NCT02583451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232322|NCT02583451|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25671588|NCT01734161|Dexamethasone|dexamethasone|mesh-list
25871768|NCT00123318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25871769|NCT00123318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25871770|NCT00123318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871771|NCT00123331|Cyclosporine|cyclosporine|mesh-list
25871772|NCT00123331|Sirolimus|sirolimus|mesh-list
25871773|NCT00123331|Cyclosporins|cyclosporins|mesh-list
24802241|NCT01989000|Antiviral Agents|antiviral agents|mesh-ancestor
24802242|NCT01989000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24802243|NCT01989000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24802244|NCT01989000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24802245|NCT01989000|Immunologic Factors|immunologic factors|mesh-ancestor
24567610|NCT00791739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24393404|NCT00129922|Alkylating Agents|alkylating agents|mesh-ancestor
24393405|NCT00129922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24393513|NCT00130195|Dermatologic Agents|dermatologic agents|mesh-ancestor
24393514|NCT00130195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232324|NCT02583451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25232325|NCT02583451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232326|NCT02583464|Tenofovir|tenofovir|mesh-list
25232327|NCT02583464|Emtricitabine|emtricitabine|mesh-list
25232328|NCT02583464|Antiviral Agents|antiviral agents|mesh-ancestor
25232329|NCT02583464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25232330|NCT02583464|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25232331|NCT02583464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25671595|NCT01734161|Glucocorticoids|glucocorticoids|mesh-ancestor
25671596|NCT01734161|Hormones|hormones|mesh-ancestor
25671597|NCT01734161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25871779|NCT00123331|Antifungal Agents|antifungal agents|mesh-ancestor
25871780|NCT00123331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25871781|NCT00123331|Dermatologic Agents|dermatologic agents|mesh-ancestor
25871782|NCT00123331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25871783|NCT00123331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24393560|NCT00130351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24393561|NCT00130351|Respiratory System Agents|respiratory system agents|mesh-ancestor
24393562|NCT00130351|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24393563|NCT00130351|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24451968|NCT00325546|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24451970|NCT00325546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451971|NCT00325546|Hormones|hormones|mesh-ancestor
24393580|NCT00130364|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24393581|NCT00130364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24393582|NCT00130364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393583|NCT00130390|Nitazoxanide|nitazoxanide|mesh-list
24393584|NCT00130390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24393585|NCT00130390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24393586|NCT00130403|Risedronic Acid|risedronic acid|mesh-list
24393587|NCT00130403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24393588|NCT00130403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24393589|NCT00130403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393590|NCT00130403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25232332|NCT02583464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232333|NCT02583464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232334|NCT02583464|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25232335|NCT02583464|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25232336|NCT02583438|Saxagliptin|saxagliptin|mesh-list
25232337|NCT02583438|Incretins|incretins|mesh-ancestor
25232338|NCT02583438|Hormones|hormones|mesh-ancestor
25671603|NCT01734395|Galantamine|galantamine|mesh-list
25671604|NCT01734395|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25671605|NCT01734395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871787|NCT00123370|Modafinil|modafinil|mesh-list
25871788|NCT00123370|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25273582|NCT02384876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25871789|NCT00123370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871790|NCT00123370|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25871791|NCT00123370|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25871792|NCT00123370|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25871793|NCT00123370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871794|NCT00123383|Modafinil|modafinil|mesh-list
25871795|NCT00123383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25871796|NCT00123383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871797|NCT00123383|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25871798|NCT00123383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25871799|NCT00123383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25871800|NCT00123383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871801|NCT00123461|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
25871802|NCT00123461|Vitamins|vitamins|mesh-ancestor
25871803|NCT00123461|Micronutrients|micronutrients|mesh-ancestor
25871804|NCT00123461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871805|NCT00123461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25871806|NCT00123539|Estrogens|estrogens|mesh-list
25871807|NCT00123539|Hormones|hormones|mesh-ancestor
24393656|NCT00130572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24859015|NCT02301091|Alkylating Agents|alkylating agents|mesh-ancestor
24393657|NCT00130572|Dermatologic Agents|dermatologic agents|mesh-ancestor
24393658|NCT00130572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24393659|NCT00130572|Immunologic Factors|immunologic factors|mesh-ancestor
24393660|NCT00130572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24393661|NCT00130572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24393662|NCT00130572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393664|NCT00130585|Vitamin B Complex|vitamin b complex|mesh-list
24393665|NCT00130585|Hematinics|hematinics|mesh-ancestor
24393666|NCT00130585|Vitamins|vitamins|mesh-ancestor
24393667|NCT00130585|Micronutrients|micronutrients|mesh-ancestor
24393668|NCT00130585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452033|NCT00325793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24802255|NCT01989052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24567885|NCT00793377|Tamoxifen|tamoxifen|mesh-list
24393740|NCT00130884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393741|NCT00130897|Sunitinib|sunitinib|mesh-list
24393742|NCT00130897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393743|NCT00130897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25671606|NCT01734395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671607|NCT01734395|Cholinergic Agents|cholinergic agents|mesh-ancestor
25671608|NCT01734395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25876783|NCT02794571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25876784|NCT02778685|Pembrolizumab|pembrolizumab|mesh-list
25876785|NCT02778685|Letrozole|letrozole|mesh-list
25876786|NCT02778685|Fulvestrant|fulvestrant|mesh-list
25876787|NCT02778685|Palbociclib|palbociclib|mesh-list
25876788|NCT02778685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25876789|NCT02778685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876790|NCT02778685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25232347|NCT02583685|Interferon-alpha|interferon-alpha|mesh-list
25232349|NCT02583685|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25232350|NCT02583685|Simeprevir|simeprevir|mesh-list
25232351|NCT02583685|Antiviral Agents|antiviral agents|mesh-ancestor
25671609|NCT01734395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871810|NCT00123552|Artesunate|artesunate|mesh-list
25871811|NCT00123552|Lumefantrine|lumefantrine|mesh-list
25871812|NCT00123552|Pyrimethamine|pyrimethamine|mesh-list
25871813|NCT00123552|Artemether|artemether|mesh-list
25871814|NCT00123552|Sulfadoxine|sulfadoxine|mesh-list
25871815|NCT00123552|Amodiaquine|amodiaquine|mesh-list
25232360|NCT02583516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24846791|NCT02244021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25871820|NCT00123552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25871821|NCT00123552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25871823|NCT00123552|Schistosomicides|schistosomicides|mesh-ancestor
25871824|NCT00123552|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25871825|NCT00123552|Anthelmintics|anthelmintics|mesh-ancestor
25871826|NCT00123552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25871827|NCT00123552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871831|NCT00123578|Pentobarbital|pentobarbital|mesh-list
24455249|NCT02244125|Growth Inhibitors|growth inhibitors|mesh-ancestor
24394123|NCT00132210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24394124|NCT00132210|Antiviral Agents|antiviral agents|mesh-ancestor
24596630|NCT00944502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596631|NCT00944515|Azithromycin|azithromycin|mesh-list
25871832|NCT00123578|Lorazepam|lorazepam|mesh-list
25871833|NCT00123578|Anticonvulsants|anticonvulsants|mesh-ancestor
25871834|NCT00123578|Antiemetics|antiemetics|mesh-ancestor
25871835|NCT00123578|Autonomic Agents|autonomic agents|mesh-ancestor
25871836|NCT00123578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25232381|NCT02582996|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25232382|NCT02582996|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25232383|NCT02582996|Purinergic Agents|purinergic agents|mesh-ancestor
25232384|NCT02582996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25871837|NCT00123578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871838|NCT00123578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25871839|NCT00123578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25871840|NCT00123578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25871841|NCT00123578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25871842|NCT00123578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25871843|NCT00123578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25871844|NCT00123578|GABA Modulators|gaba modulators|mesh-ancestor
25871845|NCT00123578|GABA Agents|gaba agents|mesh-ancestor
25871846|NCT00123578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25871847|NCT00123578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871848|NCT00123578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25871849|NCT00123656|Fluticasone|fluticasone|mesh-list
25871850|NCT00123656|Esomeprazole|esomeprazole|mesh-list
24596640|NCT00944541|Antiviral Agents|antiviral agents|mesh-ancestor
24394125|NCT00132210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24394127|NCT00132236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24394128|NCT00132236|Autonomic Agents|autonomic agents|mesh-ancestor
25871851|NCT00123656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25871852|NCT00123656|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25871853|NCT00123656|Autonomic Agents|autonomic agents|mesh-ancestor
25232385|NCT02582996|Antiemetics|antiemetics|mesh-ancestor
25232386|NCT02582996|Autonomic Agents|autonomic agents|mesh-ancestor
25232387|NCT02582996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25232388|NCT02582996|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25671610|NCT01734395|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25671611|NCT01734395|Autonomic Agents|autonomic agents|mesh-ancestor
25671612|NCT01734395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25671613|NCT01734395|Nootropic Agents|nootropic agents|mesh-ancestor
25671614|NCT01734525|Anidulafungin|anidulafungin|mesh-list
25671615|NCT01734525|Antifungal Agents|antifungal agents|mesh-ancestor
25671616|NCT01734525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25671617|NCT01734551|Clonidine|clonidine|mesh-list
25671618|NCT01734551|Morphine|morphine|mesh-list
25232392|NCT02582996|Dopamine Agonists|dopamine agonists|mesh-ancestor
25232394|NCT02583217|Remifentanil|remifentanil|mesh-list
25232395|NCT02583217|Propofol|propofol|mesh-list
25232396|NCT02583217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25232397|NCT02583217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25232398|NCT02583217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232399|NCT02583217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25232400|NCT02583217|Anesthetics, General|anesthetics, general|mesh-ancestor
25232401|NCT02583217|Anesthetics|anesthetics|mesh-ancestor
25232402|NCT02583217|Analgesics|analgesics|mesh-ancestor
25232403|NCT02583217|Sensory System Agents|sensory system agents|mesh-ancestor
25232404|NCT02583217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25232405|NCT02583217|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25232406|NCT02583217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25232407|NCT02583217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25232408|NCT02583217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25232409|NCT02583217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232410|NCT02583217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25232411|NCT02583217|Narcotics|narcotics|mesh-ancestor
25232412|NCT02583243|Buprenorphine|buprenorphine|mesh-list
25232413|NCT02583243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25871860|NCT00123656|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25871861|NCT00123656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24596641|NCT00944541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24596642|NCT00944541|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24596644|NCT00944606|Vitamins|vitamins|mesh-ancestor
24596645|NCT00944606|Micronutrients|micronutrients|mesh-ancestor
24593654|NCT00930475|Everolimus|everolimus|mesh-list
25871862|NCT00123656|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25871863|NCT00123656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24452173|NCT00326300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24452174|NCT00326300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24452205|NCT00326391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24463006|NCT00358319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24463007|NCT00358319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24452219|NCT00326404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25671619|NCT01734551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25671620|NCT01734551|Narcotics|narcotics|mesh-ancestor
25671621|NCT01734551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25671622|NCT01734551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671623|NCT01734551|Analgesics|analgesics|mesh-ancestor
25671624|NCT01734551|Sensory System Agents|sensory system agents|mesh-ancestor
25671625|NCT01734551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25671626|NCT01734551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25671627|NCT01734551|Sympatholytics|sympatholytics|mesh-ancestor
25671628|NCT01734551|Autonomic Agents|autonomic agents|mesh-ancestor
24866904|NCT03951025|Melatonin|melatonin|mesh-list
24866905|NCT03951025|Antioxidants|antioxidants|mesh-ancestor
25139865|NCT02968160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139866|NCT02968160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25139867|NCT02968160|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25139868|NCT02968160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866936|NCT03908307|Hormones|hormones|mesh-ancestor
24866947|NCT03878979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452220|NCT00326404|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24452221|NCT00326404|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24452222|NCT00326404|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24452223|NCT00326404|Progestins|progestins|mesh-ancestor
24452225|NCT00326456|Carboplatin|carboplatin|mesh-list
24802266|NCT01989091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24802267|NCT01989091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802269|NCT01989312|Epinephrine|epinephrine|mesh-list
24802270|NCT01989312|Midazolam|midazolam|mesh-list
24802271|NCT01989312|Levobupivacaine|levobupivacaine|mesh-list
24802272|NCT01989312|Anesthetics, Local|anesthetics, local|mesh-ancestor
24802273|NCT01989312|Anesthetics|anesthetics|mesh-ancestor
24568623|NCT00796692|Heparin|heparin|mesh-list
25232414|NCT02583243|Narcotics|narcotics|mesh-ancestor
25232415|NCT02583243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25232416|NCT02583243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232417|NCT02583243|Analgesics|analgesics|mesh-ancestor
25232418|NCT02583243|Sensory System Agents|sensory system agents|mesh-ancestor
25232419|NCT02583243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25671632|NCT01734551|Adrenergic Agents|adrenergic agents|mesh-ancestor
25671633|NCT01734551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25671634|NCT01734551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671635|NCT01734772|Dabigatran|dabigatran|mesh-list
25671636|NCT01734772|Ticagrelor|ticagrelor|mesh-list
25671637|NCT01734772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25671638|NCT01734772|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25671639|NCT01734772|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25671640|NCT01734772|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25671641|NCT01734772|Purinergic Agents|purinergic agents|mesh-ancestor
25671642|NCT01734772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25671643|NCT01734772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671644|NCT01734772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671645|NCT01734772|Antithrombins|antithrombins|mesh-ancestor
25671646|NCT01734772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25671647|NCT01734772|Protease Inhibitors|protease inhibitors|mesh-ancestor
25139881|NCT02968082|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25139882|NCT02968082|Cholinergic Agents|cholinergic agents|mesh-ancestor
25139883|NCT02968082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25139884|NCT02968082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139885|NCT02968082|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25871866|NCT00123669|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
24802280|NCT01989312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24802281|NCT01989312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24452262|NCT00326768|Natriuretic Agents|natriuretic agents|mesh-ancestor
24452263|NCT00326768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452264|NCT00326768|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24452265|NCT00326768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24452266|NCT00326807|Naltrexone|naltrexone|mesh-list
24452267|NCT00326807|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24452268|NCT00326807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24452269|NCT00326807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452270|NCT00326807|Sensory System Agents|sensory system agents|mesh-ancestor
24452271|NCT00326807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24463122|NCT00358930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24463123|NCT00358930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24463124|NCT00358930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463125|NCT00358930|Antiviral Agents|antiviral agents|mesh-ancestor
24463126|NCT00358969|Guanfacine|guanfacine|mesh-list
24463127|NCT00358969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24463128|NCT00358969|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24463129|NCT00358969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25671648|NCT01734772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25671649|NCT01734772|Anticoagulants|anticoagulants|mesh-ancestor
25671650|NCT01734785|Empagliflozin|empagliflozin|mesh-list
25671651|NCT01734785|Linagliptin|linagliptin|mesh-list
25671652|NCT01734785|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25671653|NCT01734785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671654|NCT01734785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25671655|NCT01734785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671656|NCT01734785|Incretins|incretins|mesh-ancestor
25671657|NCT01734785|Hormones|hormones|mesh-ancestor
25671658|NCT01734785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25671659|NCT01734785|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25671660|NCT01734785|Protease Inhibitors|protease inhibitors|mesh-ancestor
25671661|NCT01734785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25671662|NCT01734850|Busulfan|busulfan|mesh-list
25871867|NCT00123669|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
25871868|NCT00123669|Progestins|progestins|mesh-ancestor
25871869|NCT00123669|Hormones|hormones|mesh-ancestor
25871870|NCT00123669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25871871|NCT00123669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871872|NCT00123669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25871873|NCT00123669|Hormone Antagonists|hormone antagonists|mesh-ancestor
25876791|NCT02778685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25876792|NCT02778685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876793|NCT02778685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802300|NCT01989312|Respiratory System Agents|respiratory system agents|mesh-ancestor
24802301|NCT01989312|Mydriatics|mydriatics|mesh-ancestor
24802302|NCT01989312|Sympathomimetics|sympathomimetics|mesh-ancestor
24802303|NCT01989312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24802304|NCT01989416|Chlorhexidine|chlorhexidine|mesh-list
24568808|NCT00797693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25671663|NCT01734850|Alkylating Agents|alkylating agents|mesh-ancestor
25671664|NCT01734850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671665|NCT01734850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25871883|NCT00123825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24463246|NCT00359658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24463247|NCT00359658|Dermatologic Agents|dermatologic agents|mesh-ancestor
24463248|NCT00359658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24463249|NCT00359658|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24463250|NCT00359658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24463251|NCT00359658|Glucocorticoids|glucocorticoids|mesh-ancestor
25871885|NCT00123825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802308|NCT01989416|Disinfectants|disinfectants|mesh-ancestor
24802309|NCT01989416|Dermatologic Agents|dermatologic agents|mesh-ancestor
24802310|NCT01989507|Nicotine|nicotine|mesh-list
24802311|NCT01989507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24802312|NCT01989507|Autonomic Agents|autonomic agents|mesh-ancestor
24802313|NCT01989507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24802314|NCT01989507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802315|NCT01989507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24802316|NCT01989507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24802317|NCT01989507|Cholinergic Agents|cholinergic agents|mesh-ancestor
24802318|NCT01989507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24802319|NCT01989507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802320|NCT01989559|Vaccines|vaccines|mesh-list
24802321|NCT01989559|Immunologic Factors|immunologic factors|mesh-ancestor
24802322|NCT01989559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802330|NCT01989611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802331|NCT01989611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24802332|NCT01989611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24802333|NCT01989663|Tenofovir|tenofovir|mesh-list
24802334|NCT01989663|Antiviral Agents|antiviral agents|mesh-ancestor
24802335|NCT01989663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24568869|NCT00797810|Antiviral Agents|antiviral agents|mesh-ancestor
24802336|NCT01989663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24802337|NCT01989663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24802338|NCT01989663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232430|NCT02583308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24802339|NCT01989663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232431|NCT02583308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25232432|NCT02583282|Doxycycline|doxycycline|mesh-list
25232433|NCT02583282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25671666|NCT01734850|Immunologic Factors|immunologic factors|mesh-ancestor
25671667|NCT01734850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671668|NCT01734850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25232434|NCT02583282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25232435|NCT02583282|Antimalarials|antimalarials|mesh-ancestor
25671669|NCT01734850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25871886|NCT00123851|Capecitabine|capecitabine|mesh-list
25871887|NCT00123851|Oxaliplatin|oxaliplatin|mesh-list
25871888|NCT00123851|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25871889|NCT00123851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25871890|NCT00123851|Antimetabolites|antimetabolites|mesh-ancestor
25871891|NCT00123851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871892|NCT00123851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25871893|NCT00123851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24846807|NCT02244112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846808|NCT02244112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24846809|NCT02244112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24846810|NCT02244112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24846811|NCT02244112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24846812|NCT02244112|Anesthetics, General|anesthetics, general|mesh-ancestor
25062550|NCT04370301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24802340|NCT01989663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24463272|NCT00359723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24660700|NCT01285375|Analgesics|analgesics|mesh-ancestor
25232437|NCT02583282|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25232439|NCT02583022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25232440|NCT02583022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25232441|NCT02583022|Analgesics|analgesics|mesh-ancestor
25232442|NCT02583022|Sensory System Agents|sensory system agents|mesh-ancestor
25232443|NCT02583022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25232444|NCT02583022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232445|NCT02583022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25232446|NCT02583022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25232447|NCT02583022|Dermatologic Agents|dermatologic agents|mesh-ancestor
25232448|NCT02583022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25232449|NCT02583022|Immunologic Factors|immunologic factors|mesh-ancestor
25232450|NCT02583022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25232451|NCT02583022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232452|NCT02583022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232453|NCT02582892|Vitamin D|vitamin d|mesh-list
25232454|NCT02582892|Vitamins|vitamins|mesh-ancestor
25232455|NCT02582892|Micronutrients|micronutrients|mesh-ancestor
25232456|NCT02582892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232457|NCT02582892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25076979|NCT03369015|Sympathomimetics|sympathomimetics|mesh-ancestor
25671670|NCT01734850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25674517|NCT01773109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674518|NCT01773109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25674519|NCT01773109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25674520|NCT01773122|Dapsone|dapsone|mesh-list
24802395|NCT01989897|Histamine Agonists|histamine agonists|mesh-ancestor
25674521|NCT01773122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25871901|NCT00123890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232469|NCT02582736|Antipsychotic Agents|antipsychotic agents|mesh-list
25232470|NCT02582736|Clozapine|clozapine|mesh-list
25232471|NCT02582736|Loxapine|loxapine|mesh-list
25232472|NCT02582736|Perphenazine|perphenazine|mesh-list
25232473|NCT02582736|Fluphenazine|fluphenazine|mesh-list
25232474|NCT02582736|Thioridazine|thioridazine|mesh-list
25232475|NCT02582736|Flupenthixol|flupenthixol|mesh-list
25232476|NCT02582736|Clopenthixol|clopenthixol|mesh-list
25232477|NCT02582736|Chlorprothixene|chlorprothixene|mesh-list
25232478|NCT02582736|Fluspirilene|fluspirilene|mesh-list
25232479|NCT02582736|Thiothixene|thiothixene|mesh-list
25232480|NCT02582736|Mesoridazine|mesoridazine|mesh-list
25232481|NCT02582736|Chlormezanone|chlormezanone|mesh-list
24463358|NCT00360191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24463371|NCT00360386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077057|NCT03368352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463373|NCT00360438|Gout Suppressants|gout suppressants|mesh-ancestor
24802428|NCT01990079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24463375|NCT00360464|Azithromycin|azithromycin|mesh-list
24463376|NCT00360464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24463377|NCT00360464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24463378|NCT00360594|Acamprosate|acamprosate|mesh-list
25671673|NCT01734889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671674|NCT01734902|Scopolamine|scopolamine|mesh-list
25671675|NCT01734902|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25671676|NCT01734902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25671677|NCT01734902|Antiemetics|antiemetics|mesh-ancestor
25871912|NCT00123903|Autonomic Agents|autonomic agents|mesh-ancestor
25871913|NCT00123903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25671683|NCT01734902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25871919|NCT00123903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25871920|NCT00123903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25871921|NCT00123903|Antioxidants|antioxidants|mesh-ancestor
25871922|NCT00123903|Protective Agents|protective agents|mesh-ancestor
25140074|NCT02966847|Anesthetics|anesthetics|mesh-list
25046667|NCT00838279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25046668|NCT00838279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046676|NCT00838136|Lamotrigine|lamotrigine|mesh-list
24463503|NCT00361244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24463504|NCT00361244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24463505|NCT00361244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463506|NCT00361244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463507|NCT00361244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24463508|NCT00361244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24463509|NCT00361244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24463510|NCT00361244|Growth Substances|growth substances|mesh-ancestor
24463511|NCT00361244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463512|NCT00361244|Growth Inhibitors|growth inhibitors|mesh-ancestor
24463513|NCT00361244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24463514|NCT00361309|Sunitinib|sunitinib|mesh-list
24463515|NCT00361309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463516|NCT00361309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25871923|NCT00123903|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25871924|NCT00123903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24463529|NCT00361322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24802439|NCT01990079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24802440|NCT01990079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24463530|NCT00361322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24463531|NCT00361322|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24463532|NCT00361322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25871925|NCT00123903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25871926|NCT00123903|Vasodilator Agents|vasodilator agents|mesh-ancestor
25871927|NCT00123903|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25232486|NCT02582736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232487|NCT02582736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232488|NCT02582736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25232489|NCT02582736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25274034|NCT02381470|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24463533|NCT00361322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463534|NCT00361322|Antifungal Agents|antifungal agents|mesh-ancestor
24463535|NCT00361322|Keratolytic Agents|keratolytic agents|mesh-ancestor
24463536|NCT00361322|Dermatologic Agents|dermatologic agents|mesh-ancestor
24463537|NCT00361322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24463538|NCT00361322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25671684|NCT01734902|Cholinergic Agents|cholinergic agents|mesh-ancestor
25671685|NCT01734902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25671686|NCT01734902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671687|NCT01734902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25671688|NCT01734902|Parasympatholytics|parasympatholytics|mesh-ancestor
25671689|NCT01735279|Mineral Oil|mineral oil|mesh-list
25671690|NCT01735279|Emollients|emollients|mesh-ancestor
25671691|NCT01735279|Dermatologic Agents|dermatologic agents|mesh-ancestor
25671692|NCT01735396|Abiraterone Acetate|abiraterone acetate|mesh-list
25671693|NCT01735396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671694|NCT01735396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25671695|NCT01735396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674522|NCT01773122|Antimalarials|antimalarials|mesh-ancestor
25871928|NCT00123903|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25871929|NCT00123903|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25871934|NCT00123916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25871935|NCT00123916|Immunologic Factors|immunologic factors|mesh-ancestor
25871936|NCT00123916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871937|NCT00123916|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25871938|NCT00123916|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25871939|NCT00123916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25871940|NCT00123916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25871941|NCT00123929|Docetaxel|docetaxel|mesh-list
24463666|NCT00361790|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24463667|NCT00361790|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24463668|NCT00361790|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24463698|NCT00361894|Anticoagulants|anticoagulants|mesh-ancestor
24463699|NCT00361894|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24463700|NCT00361894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25871947|NCT00123929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463714|NCT00361933|Antiviral Agents|antiviral agents|mesh-ancestor
24463715|NCT00361933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24463716|NCT00361959|Fluticasone|fluticasone|mesh-list
24463717|NCT00361959|Xhance|xhance|mesh-list
24463718|NCT00361959|Bromides|bromides|mesh-list
24463719|NCT00361959|Tiotropium Bromide|tiotropium bromide|mesh-list
25232490|NCT02582736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25232491|NCT02582736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24463721|NCT00361959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25671704|NCT01735630|Vitamin B Complex|vitamin b complex|mesh-ancestor
25671705|NCT01735630|Vitamins|vitamins|mesh-ancestor
25671706|NCT01735630|Micronutrients|micronutrients|mesh-ancestor
25671707|NCT01735630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671708|NCT01736085|Nicotine|nicotine|mesh-list
25671709|NCT01736085|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25671710|NCT01736085|Autonomic Agents|autonomic agents|mesh-ancestor
25671711|NCT01736085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25671712|NCT01736085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463722|NCT00361959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24463723|NCT00361959|Autonomic Agents|autonomic agents|mesh-ancestor
24463724|NCT00361959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25871948|NCT00123929|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25871949|NCT00123929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25671717|NCT01736085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232494|NCT02582736|Autonomic Agents|autonomic agents|mesh-ancestor
24626546|NCT01087749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671720|NCT01736176|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25871953|NCT00124059|Antidepressive Agents|antidepressive agents|mesh-ancestor
25871954|NCT00124059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25871955|NCT00124059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25871956|NCT00124059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25871957|NCT00124059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25871958|NCT00124059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25871959|NCT00124098|Darbepoetin alfa|darbepoetin alfa|mesh-list
24599973|NCT02940522|Hormones|hormones|mesh-ancestor
25671723|NCT01736176|Dopamine Agents|dopamine agents|mesh-ancestor
25671724|NCT01736176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25671725|NCT01736176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671726|NCT01736176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671727|NCT01736176|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25671728|NCT01736176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25671729|NCT01736176|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25671730|NCT01736176|Immunologic Factors|immunologic factors|mesh-ancestor
25671731|NCT01736176|Dopamine Agonists|dopamine agonists|mesh-ancestor
25671732|NCT01736189|Adalimumab|adalimumab|mesh-list
25671733|NCT01736189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24463996|NCT00362934|Fenofibrate|fenofibrate|mesh-list
24463997|NCT00362934|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24463998|NCT00362934|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25871991|NCT00124150|Sensory System Agents|sensory system agents|mesh-ancestor
25871992|NCT00124150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25871993|NCT00124150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463999|NCT00362934|Antimetabolites|antimetabolites|mesh-ancestor
24464000|NCT00362934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464004|NCT00362947|Parnaparin|parnaparin|mesh-list
24464019|NCT00362973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464020|NCT00362986|Sunscreening Agents|sunscreening agents|mesh-list
24464021|NCT00362986|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24464022|NCT00362986|Protective Agents|protective agents|mesh-ancestor
24464023|NCT00362986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464024|NCT00362986|Dermatologic Agents|dermatologic agents|mesh-ancestor
24464025|NCT00363025|Daunorubicin|daunorubicin|mesh-list
25871994|NCT00124150|Anesthetics|anesthetics|mesh-ancestor
25871995|NCT00124150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24464040|NCT00363090|Immunologic Factors|immunologic factors|mesh-ancestor
24464041|NCT00363090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464042|NCT00363090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25871996|NCT00124150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25274035|NCT02381158|Beclomethasone|beclomethasone|mesh-list
24802544|NCT01990807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24802545|NCT01990807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24802546|NCT01990807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24802547|NCT01990807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24802548|NCT01990807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24802549|NCT01990807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802550|NCT01990872|Vitamin D|vitamin d|mesh-list
24802551|NCT01990872|Cholecalciferol|cholecalciferol|mesh-list
25232505|NCT02582736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25232506|NCT02582736|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25232507|NCT02582736|GABA Antagonists|gaba antagonists|mesh-ancestor
25232508|NCT02582736|GABA Agents|gaba agents|mesh-ancestor
25671734|NCT01736189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25671735|NCT01736215|Epoetin Alfa|epoetin alfa|mesh-list
25671736|NCT01736215|Hematinics|hematinics|mesh-ancestor
25671737|NCT01736254|Gemfibrozil|gemfibrozil|mesh-list
25671738|NCT01736254|Evacetrapib|evacetrapib|mesh-list
25671739|NCT01736254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25871997|NCT00124150|Anticonvulsants|anticonvulsants|mesh-ancestor
25871998|NCT00124150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25871999|NCT00124150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25872000|NCT00124150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876794|NCT02778685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24464144|NCT00363519|Hormones|hormones|mesh-ancestor
24464145|NCT00363519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24464146|NCT00363519|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24863091|NCT03261830|Clindamycin|clindamycin|mesh-list
24454552|NCT03878524|Vitamins|vitamins|mesh-list
24452642|NCT05457894|Immunologic Factors|immunologic factors|mesh-ancestor
24452643|NCT05457894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872008|NCT00124241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25671740|NCT01736254|Antimetabolites|antimetabolites|mesh-ancestor
25671741|NCT01736254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671742|NCT01736254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25671743|NCT01736254|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25671744|NCT01736254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25671745|NCT01736254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25671746|NCT01736254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25872009|NCT00124241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671752|NCT01736358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25671753|NCT01736358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872013|NCT00124241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25872014|NCT00124267|Quinine|quinine|mesh-list
25872015|NCT00124267|Antimalarials|antimalarials|mesh-ancestor
25872016|NCT00124267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25872017|NCT00124267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25872018|NCT00124267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25872022|NCT00124267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25872023|NCT00124267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24452739|NCT05455944|Sensory System Agents|sensory system agents|mesh-ancestor
24464298|NCT00364091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24464300|NCT00364143|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24464301|NCT00364143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24464302|NCT00364143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464303|NCT00364143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872024|NCT00124267|Analgesics|analgesics|mesh-ancestor
24464306|NCT00364195|Histamine Antagonists|histamine antagonists|mesh-ancestor
24464307|NCT00364195|Histamine Agents|histamine agents|mesh-ancestor
24464308|NCT00364195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25872025|NCT00124267|Sensory System Agents|sensory system agents|mesh-ancestor
24464321|NCT00364273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464322|NCT00364273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24464323|NCT00364273|Respiratory System Agents|respiratory system agents|mesh-ancestor
24464324|NCT00364273|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25872026|NCT00124280|Everolimus|everolimus|mesh-list
25872027|NCT00124280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872028|NCT00124280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24464325|NCT00364273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24464326|NCT00364273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24464327|NCT00364273|Adrenergic Agents|adrenergic agents|mesh-ancestor
24464328|NCT00364273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25671755|NCT01736358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25671756|NCT01736358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25671757|NCT01736358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25671758|NCT01736358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671759|NCT01736475|Factor VIII|factor viii|mesh-list
25671760|NCT01736475|BAX 855|bax 855|mesh-list
25671761|NCT01736475|Coagulants|coagulants|mesh-ancestor
25671762|NCT01736527|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25872029|NCT00124280|Immunologic Factors|immunologic factors|mesh-ancestor
25872038|NCT00124306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25872039|NCT00124306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872040|NCT00124306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25872041|NCT00124306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25872042|NCT00124306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25872043|NCT00124306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671763|NCT01736527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25671764|NCT01736579|Immunoglobulins|immunoglobulins|mesh-list
25671766|NCT01736579|gamma-Globulins|gamma-globulins|mesh-list
25671767|NCT01736579|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25671768|NCT01736579|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25671769|NCT01736579|Immunologic Factors|immunologic factors|mesh-ancestor
25671770|NCT01736579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671771|NCT01736696|Tofacitinib|tofacitinib|mesh-list
25671772|NCT01736696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25671773|NCT01736696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464419|NCT00364806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671774|NCT01736696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464520|NCT00365287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24464521|NCT00365287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25872048|NCT00124332|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24464546|NCT00365313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464548|NCT00365313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24464549|NCT00365313|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24464551|NCT00365339|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24464552|NCT00365339|Tenofovir|tenofovir|mesh-list
24464553|NCT00365339|Aripiprazole|aripiprazole|mesh-list
24464554|NCT00365339|Famotidine|famotidine|mesh-list
24464555|NCT00365339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24464556|NCT00365339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24464557|NCT00365339|Protease Inhibitors|protease inhibitors|mesh-ancestor
24464558|NCT00365339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872049|NCT00124332|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24464619|NCT00365612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24464620|NCT00365612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872050|NCT00124332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24464643|NCT00365742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464644|NCT00365742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24464645|NCT00365742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24464646|NCT00365742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464647|NCT00365755|Cyclophosphamide|cyclophosphamide|mesh-list
24464648|NCT00365755|Melphalan|melphalan|mesh-list
24464649|NCT00365755|Carboplatin|carboplatin|mesh-list
25872051|NCT00124332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464659|NCT00365755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24464660|NCT00365755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24802577|NCT01991054|Cholecalciferol|cholecalciferol|mesh-list
24464745|NCT00366470|Vitamins|vitamins|mesh-ancestor
24464746|NCT00366470|Micronutrients|micronutrients|mesh-ancestor
24464765|NCT00366652|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24464766|NCT00366652|Adrenergic Agents|adrenergic agents|mesh-ancestor
24464767|NCT00366691|Loteprednol Etabonate|loteprednol etabonate|mesh-list
24464768|NCT00366691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24464769|NCT00366730|Nitazoxanide|nitazoxanide|mesh-list
24464770|NCT00366730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25872052|NCT00124332|Hormones|hormones|mesh-ancestor
25872053|NCT00124332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25872054|NCT00124332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872055|NCT00124358|Buprenorphine|buprenorphine|mesh-list
25872056|NCT00124358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25077436|NCT03364764|Sirolimus|sirolimus|mesh-list
25232542|NCT02582372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25232543|NCT02582372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25232544|NCT02582372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25232545|NCT02582372|Analgesics|analgesics|mesh-ancestor
25232546|NCT02582372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25232547|NCT02582372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25872057|NCT00124358|Narcotics|narcotics|mesh-ancestor
24464809|NCT00366938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464810|NCT00366938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24464811|NCT00366938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24464812|NCT00366938|Analgesics|analgesics|mesh-ancestor
24464813|NCT00366938|Sensory System Agents|sensory system agents|mesh-ancestor
24464814|NCT00366938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24464815|NCT00366938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464816|NCT00366938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24464817|NCT00366938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24464819|NCT00367068|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24464820|NCT00367068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464821|NCT00367068|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24464822|NCT00367068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24464823|NCT00367068|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25872058|NCT00124358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25872059|NCT00124358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872060|NCT00124358|Analgesics|analgesics|mesh-ancestor
24802579|NCT01991054|Micronutrients|micronutrients|mesh-ancestor
24802580|NCT01991054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802581|NCT01991054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25671775|NCT01736852|Oxytocin|oxytocin|mesh-list
25671776|NCT01736852|Oxytocics|oxytocics|mesh-ancestor
25671777|NCT01736852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25671778|NCT01736852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671779|NCT01736865|Cholecalciferol|cholecalciferol|mesh-list
25671780|NCT01736865|Vitamin D|vitamin d|mesh-list
25671781|NCT01736865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25671782|NCT01736865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872061|NCT00124358|Sensory System Agents|sensory system agents|mesh-ancestor
25872062|NCT00124358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25872063|NCT00124358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25232556|NCT02582372|Anesthetics, General|anesthetics, general|mesh-ancestor
25232557|NCT02582437|Analgesics, Opioid|analgesics, opioid|mesh-list
25232558|NCT02582437|Narcotics|narcotics|mesh-ancestor
25232559|NCT02582437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25232560|NCT02582437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464855|NCT00367120|Azithromycin|azithromycin|mesh-list
24464856|NCT00367120|Clavulanic Acid|clavulanic acid|mesh-list
24464857|NCT00367120|Clavulanic Acids|clavulanic acids|mesh-list
24464858|NCT00367120|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24464877|NCT00367185|Growth Inhibitors|growth inhibitors|mesh-ancestor
24464878|NCT00367185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24464880|NCT00367211|Omeprazole|omeprazole|mesh-list
25671783|NCT01736865|Vitamins|vitamins|mesh-ancestor
25671784|NCT01736865|Micronutrients|micronutrients|mesh-ancestor
25671785|NCT01736865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25671786|NCT01736917|Dexamethasone|dexamethasone|mesh-list
25671787|NCT01736917|Fosaprepitant|fosaprepitant|mesh-list
25671788|NCT01736917|Aprepitant|aprepitant|mesh-list
25671789|NCT01736917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25671790|NCT01736917|Antiemetics|antiemetics|mesh-ancestor
25671791|NCT01736917|Autonomic Agents|autonomic agents|mesh-ancestor
25671792|NCT01736917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25671793|NCT01736917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671794|NCT01736917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24954589|NCT03874832|Analgesics|analgesics|mesh-ancestor
25671795|NCT01736917|Glucocorticoids|glucocorticoids|mesh-ancestor
25671796|NCT01736917|Hormones|hormones|mesh-ancestor
25671797|NCT01736917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25671798|NCT01736917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25671799|NCT01736917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671800|NCT01736917|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25671801|NCT01736917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25671802|NCT01736917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671803|NCT01736943|Doxorubicin|doxorubicin|mesh-list
25671804|NCT01736943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25671805|NCT01736943|Bortezomib|bortezomib|mesh-list
25671806|NCT01736943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25671807|NCT01736943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25674523|NCT01773122|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25872089|NCT00124527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872090|NCT00124527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872091|NCT00124527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25872092|NCT00124527|Alkylating Agents|alkylating agents|mesh-ancestor
25232580|NCT02582307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25232581|NCT02582307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232582|NCT02582307|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25232583|NCT02582307|Parasympatholytics|parasympatholytics|mesh-ancestor
25232584|NCT02582476|Bumetanide|bumetanide|mesh-list
25044357|NCT01111773|Sensory System Agents|sensory system agents|mesh-ancestor
25044358|NCT01111773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25044359|NCT01111773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25044360|NCT01111773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25044361|NCT01111773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25044362|NCT01111773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25062668|NCT04231877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25872103|NCT00124566|Mitoxantrone|mitoxantrone|mesh-list
25872104|NCT00124566|Irofulven|irofulven|mesh-list
25872105|NCT00124566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25872106|NCT00124566|Glucocorticoids|glucocorticoids|mesh-ancestor
25872107|NCT00124566|Hormones|hormones|mesh-ancestor
25872108|NCT00124566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25872109|NCT00124566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872110|NCT00124566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25872111|NCT00124566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872112|NCT00124566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25872113|NCT00124566|Antimetabolites|antimetabolites|mesh-ancestor
24465154|NCT00368030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24465155|NCT00368030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25872114|NCT00124566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671808|NCT01736943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25671809|NCT01736943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25671810|NCT01736943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25671811|NCT01736943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671812|NCT01737268|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25671813|NCT01737268|Antidepressive Agents|antidepressive agents|mesh-ancestor
25671814|NCT01737268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25671815|NCT01737268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25872115|NCT00124566|Analgesics|analgesics|mesh-ancestor
25872116|NCT00124566|Sensory System Agents|sensory system agents|mesh-ancestor
24465245|NCT00368342|Erythromycin Estolate|erythromycin estolate|mesh-list
24465246|NCT00368342|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24465247|NCT00368342|Erythromycin stearate|erythromycin stearate|mesh-list
24465248|NCT00368342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24465249|NCT00368342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24465250|NCT00368342|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25232585|NCT02582476|Diuretics|diuretics|mesh-ancestor
25232586|NCT02582476|Natriuretic Agents|natriuretic agents|mesh-ancestor
25077491|NCT03364218|Antidotes|antidotes|mesh-ancestor
25232587|NCT02582476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232588|NCT02582476|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25232589|NCT02582476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25232590|NCT02582476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232591|NCT02582190|Colchicine|colchicine|mesh-list
25232592|NCT02582190|Gout Suppressants|gout suppressants|mesh-ancestor
25232593|NCT02582190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25044369|NCT01110889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25044370|NCT01110889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25044371|NCT01110889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802660|NCT01991327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802661|NCT01991327|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24465298|NCT00368862|Citalopram|citalopram|mesh-list
24465299|NCT00368862|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25671816|NCT01737268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25671817|NCT01737268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25671818|NCT01737268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671819|NCT01737593|Acetaminophen|acetaminophen|mesh-list
25671820|NCT01737593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25671821|NCT01737593|Analgesics|analgesics|mesh-ancestor
25671822|NCT01737593|Sensory System Agents|sensory system agents|mesh-ancestor
25671823|NCT01737593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25671824|NCT01737593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872142|NCT00124644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24802666|NCT01991379|Imatinib Mesylate|imatinib mesylate|mesh-list
24802667|NCT01991379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24802668|NCT01991379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25872143|NCT00124644|Immunologic Factors|immunologic factors|mesh-ancestor
24802669|NCT01991379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24802670|NCT01991379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232594|NCT02582190|Tubulin Modulators|tubulin modulators|mesh-ancestor
25232595|NCT02582190|Antimitotic Agents|antimitotic agents|mesh-ancestor
25232596|NCT02582190|Mitosis Modulators|mitosis modulators|mesh-ancestor
25232598|NCT02582190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232599|NCT02582177|Ketoconazole|ketoconazole|mesh-list
25232600|NCT02582177|Clotrimazole|clotrimazole|mesh-list
25232601|NCT02582177|Miconazole|miconazole|mesh-list
25232602|NCT02582177|Dexamethasone|dexamethasone|mesh-list
25232603|NCT02582177|Dexamethasone acetate|dexamethasone acetate|mesh-list
25232604|NCT02582177|Betamethasone|betamethasone|mesh-list
25044373|NCT01110746|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25044374|NCT01110746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25044375|NCT01110746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044376|NCT01107496|Viloxazine|viloxazine|mesh-list
24846858|NCT02244216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24846859|NCT02244216|Respiratory System Agents|respiratory system agents|mesh-ancestor
24846860|NCT02244216|Sympathomimetics|sympathomimetics|mesh-ancestor
24846861|NCT02244216|Tocolytic Agents|tocolytic agents|mesh-ancestor
24846862|NCT02244216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24846863|NCT02244216|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24846864|NCT02244216|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24846865|NCT02244216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24846866|NCT02244216|Adrenergic Agents|adrenergic agents|mesh-ancestor
24802671|NCT01991561|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24802672|NCT01991561|Vaccines|vaccines|mesh-list
24802673|NCT01991561|Immunologic Factors|immunologic factors|mesh-ancestor
24802674|NCT01991561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802675|NCT01991561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24802699|NCT01991834|Cefazolin|cefazolin|mesh-list
24802700|NCT01991834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24802701|NCT01991834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24802702|NCT01991873|Leucovorin|leucovorin|mesh-list
24802703|NCT01991873|Folic Acid|folic acid|mesh-list
24802704|NCT01991873|Fluorouracil|fluorouracil|mesh-list
24802705|NCT01991873|Oxaliplatin|oxaliplatin|mesh-list
24802706|NCT01991873|Panitumumab|panitumumab|mesh-list
24802707|NCT01991873|Levoleucovorin|levoleucovorin|mesh-list
25077522|NCT03364075|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24802708|NCT01991873|Antimetabolites|antimetabolites|mesh-ancestor
25671825|NCT01737593|Antipyretics|antipyretics|mesh-ancestor
24802709|NCT01991873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802710|NCT01991873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25671826|NCT01737710|Vaccines|vaccines|mesh-list
25671827|NCT01737710|Immunologic Factors|immunologic factors|mesh-ancestor
25671828|NCT01737710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671829|NCT01737840|Pantoprazole|pantoprazole|mesh-list
25671830|NCT01737840|Ranitidine|ranitidine|mesh-list
25671831|NCT01737840|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
25671832|NCT01737840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24465347|NCT00369044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465348|NCT00369096|Bemiparin|bemiparin|mesh-list
24465349|NCT00369096|Anticoagulants|anticoagulants|mesh-ancestor
24465351|NCT00369148|Mitiglinide|mitiglinide|mesh-list
24465352|NCT00369148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24465353|NCT00369148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465354|NCT00369174|Rosiglitazone|rosiglitazone|mesh-list
24465355|NCT00369174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24465356|NCT00369174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465362|NCT00369239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465363|NCT00369239|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24465364|NCT00369239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24465365|NCT00369239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24465366|NCT00369239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24465367|NCT00369239|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24465369|NCT00369252|Nimotuzumab|nimotuzumab|mesh-list
25872149|NCT00124683|Autonomic Agents|autonomic agents|mesh-ancestor
25872150|NCT00124683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25872151|NCT00124683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232605|NCT02582177|Betamethasone Valerate|betamethasone valerate|mesh-list
25232606|NCT02582177|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25232607|NCT02582177|Betamethasone benzoate|betamethasone benzoate|mesh-list
25232608|NCT02582177|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25232609|NCT02582177|BB 1101|bb 1101|mesh-list
25232610|NCT02582177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25232611|NCT02582177|Antiemetics|antiemetics|mesh-ancestor
25232612|NCT02582177|Autonomic Agents|autonomic agents|mesh-ancestor
25232613|NCT02582177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25232614|NCT02582177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232615|NCT02582177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25232616|NCT02582177|Glucocorticoids|glucocorticoids|mesh-ancestor
25232617|NCT02582177|Hormones|hormones|mesh-ancestor
25077523|NCT03364075|Serotonin Agents|serotonin agents|mesh-ancestor
25872152|NCT00124683|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25232618|NCT02582177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25232619|NCT02582177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25232620|NCT02582177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232621|NCT02582177|Protease Inhibitors|protease inhibitors|mesh-ancestor
25232622|NCT02582177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24465405|NCT00369434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24863599|NCT04194554|Leuprolide|leuprolide|mesh-list
24465412|NCT00369538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24465413|NCT00369538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25671833|NCT01737840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25671834|NCT01737840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25671835|NCT01737840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25671836|NCT01737840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671837|NCT01737840|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25671838|NCT01737840|Histamine Antagonists|histamine antagonists|mesh-ancestor
25671839|NCT01737840|Histamine Agents|histamine agents|mesh-ancestor
25671840|NCT01737840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24465414|NCT00369538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24465415|NCT00369538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140647|NCT02962830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25140648|NCT02962830|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25872156|NCT00124683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872157|NCT00124683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25872158|NCT00124683|Antidepressive Agents|antidepressive agents|mesh-ancestor
24873453|NCT05222828|Sensory System Agents|sensory system agents|mesh-ancestor
24873454|NCT05222828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24465417|NCT00369538|Natriuretic Agents|natriuretic agents|mesh-ancestor
24802721|NCT01991873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24465418|NCT00369538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465419|NCT00369538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24465420|NCT00369538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24465421|NCT00369551|Paclitaxel|paclitaxel|mesh-list
24465431|NCT00369551|Antimitotic Agents|antimitotic agents|mesh-ancestor
24465451|NCT00369603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24465452|NCT00369694|Terlipressin|terlipressin|mesh-list
24465454|NCT00369694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24465455|NCT00369733|Darbepoetin alfa|darbepoetin alfa|mesh-list
24465456|NCT00369733|Hematinics|hematinics|mesh-ancestor
24465457|NCT00369772|Darbepoetin alfa|darbepoetin alfa|mesh-list
24465458|NCT00369772|Hematinics|hematinics|mesh-ancestor
24465459|NCT00369798|Rolipram|rolipram|mesh-list
24465460|NCT00369798|Antidepressive Agents|antidepressive agents|mesh-ancestor
24465503|NCT00369889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24465504|NCT00369889|Growth Substances|growth substances|mesh-ancestor
24465505|NCT00369889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232623|NCT02582177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232624|NCT02582177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25232625|NCT02582177|Respiratory System Agents|respiratory system agents|mesh-ancestor
25232626|NCT02582177|Antifungal Agents|antifungal agents|mesh-ancestor
25232627|NCT02582177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25232628|NCT02582177|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25232629|NCT02582177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25232630|NCT02582177|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25232631|NCT02582177|Hormone Antagonists|hormone antagonists|mesh-ancestor
25232632|NCT02582177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25232633|NCT02582177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25232634|NCT02582177|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25232635|NCT02582203|Vancomycin|vancomycin|mesh-list
24465512|NCT00369954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465513|NCT00369954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24465515|NCT00369954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802752|NCT01992198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802753|NCT01992198|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24802754|NCT01992198|Renal Agents|renal agents|mesh-ancestor
24802755|NCT01992211|Metformin|metformin|mesh-list
24802756|NCT01992211|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25671843|NCT01737879|Hematinics|hematinics|mesh-ancestor
25671844|NCT01737931|Diphenhydramine|diphenhydramine|mesh-list
25671845|NCT01737931|Promethazine|promethazine|mesh-list
25671846|NCT01737931|Dexamethasone|dexamethasone|mesh-list
25671847|NCT01737931|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25671848|NCT01737931|Histamine Antagonists|histamine antagonists|mesh-list
25671849|NCT01737931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25671850|NCT01737931|Antiemetics|antiemetics|mesh-ancestor
25671851|NCT01737931|Autonomic Agents|autonomic agents|mesh-ancestor
25872159|NCT00124683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25872160|NCT00124683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25872161|NCT00124683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25872162|NCT00124683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25872163|NCT00124683|Dopamine Agents|dopamine agents|mesh-ancestor
25140701|NCT02962518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25140703|NCT02962336|Amlodipine|amlodipine|mesh-list
25140704|NCT02962336|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25140705|NCT02962336|Olmesartan|olmesartan|mesh-list
25140706|NCT02962336|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25872164|NCT00124683|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24802757|NCT01992211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24802758|NCT01992211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802759|NCT01992211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24802760|NCT01992211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24802761|NCT01992211|Antimetabolites|antimetabolites|mesh-ancestor
24573514|NCT00820482|Fertility Agents|fertility agents|mesh-ancestor
24802842|NCT01992653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24802843|NCT01992653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24802844|NCT01992653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24802845|NCT01992653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24802846|NCT01992653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24802848|NCT01992653|Hormones|hormones|mesh-ancestor
24802849|NCT01992653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24597302|NCT00948402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24597304|NCT00948480|Immunologic Factors|immunologic factors|mesh-ancestor
25872165|NCT00124683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24622508|NCT01067365|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24622509|NCT01067365|Hormone Antagonists|hormone antagonists|mesh-ancestor
24622510|NCT01067365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24622511|NCT01067365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802889|NCT01993134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24802890|NCT01993134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24802891|NCT01993173|Vaccines|vaccines|mesh-list
24802892|NCT01993173|Immunologic Factors|immunologic factors|mesh-ancestor
24802893|NCT01993173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802894|NCT01993212|Enclomiphene|enclomiphene|mesh-list
24802895|NCT01993212|Testosterone|testosterone|mesh-list
24802896|NCT01993212|Androgens|androgens|mesh-ancestor
25077543|NCT03363867|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25872166|NCT00124683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872167|NCT00124696|Cocaethylene|cocaethylene|mesh-list
24802898|NCT01993212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24802899|NCT01993212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802900|NCT01993212|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24802901|NCT01993212|Hormone Antagonists|hormone antagonists|mesh-ancestor
24802902|NCT01993212|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24802918|NCT01993225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25232636|NCT02582203|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
25232637|NCT02582203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25232638|NCT02582203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25232639|NCT02582099|Gentamicins|gentamicins|mesh-list
25232640|NCT02582099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25232641|NCT02582099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25232642|NCT02582099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24846867|NCT02244216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24846868|NCT02244216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846870|NCT02244229|Finasteride|finasteride|mesh-list
24846871|NCT02244229|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24846872|NCT02244229|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24846873|NCT02244229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24846874|NCT02244229|Adrenergic Agents|adrenergic agents|mesh-ancestor
24846875|NCT02244229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25671852|NCT01737931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25671853|NCT01737931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671854|NCT01737931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25671855|NCT01737931|Glucocorticoids|glucocorticoids|mesh-ancestor
25671856|NCT01737931|Hormones|hormones|mesh-ancestor
25671857|NCT01737931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25671858|NCT01737931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25671859|NCT01737931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25140735|NCT02962323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25140736|NCT02962323|Antimetabolites|antimetabolites|mesh-ancestor
25140737|NCT02962323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140738|NCT02962323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25140739|NCT02962323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25140740|NCT02962323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25671860|NCT01737931|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24874966|NCT04491032|Anesthetics|anesthetics|mesh-list
24846876|NCT02244229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846877|NCT02244229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846878|NCT02244229|Urological Agents|urological agents|mesh-ancestor
24846879|NCT02244229|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24846880|NCT02244229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24802920|NCT01993251|Melatonin|melatonin|mesh-list
24802921|NCT01993251|Antioxidants|antioxidants|mesh-ancestor
24802922|NCT01993251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802923|NCT01993251|Protective Agents|protective agents|mesh-ancestor
24802925|NCT01993251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24802927|NCT01993290|Anesthetics, Local|anesthetics, local|mesh-ancestor
24802928|NCT01993290|Anesthetics|anesthetics|mesh-ancestor
24802967|NCT01993472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24802968|NCT01993537|Vitamin D|vitamin d|mesh-list
24802969|NCT01993537|Vitamins|vitamins|mesh-ancestor
24802970|NCT01993537|Micronutrients|micronutrients|mesh-ancestor
24802971|NCT01993537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802972|NCT01993537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24802973|NCT01993589|Acetaminophen|acetaminophen|mesh-list
24802974|NCT01993589|Analgesics|analgesics|mesh-list
24802975|NCT01993589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24802976|NCT01993589|Sensory System Agents|sensory system agents|mesh-ancestor
24802977|NCT01993589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24802978|NCT01993589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465803|NCT00370747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465804|NCT00370747|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24465805|NCT00370747|Protective Agents|protective agents|mesh-ancestor
24802979|NCT01993589|Antipyretics|antipyretics|mesh-ancestor
24802980|NCT01993680|Fludrocortisone|fludrocortisone|mesh-list
24802982|NCT01993680|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
24802983|NCT01993680|Anticonvulsants|anticonvulsants|mesh-ancestor
24802984|NCT01993680|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24802985|NCT01993680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24802986|NCT01993680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802987|NCT01993680|Cholinergic Agents|cholinergic agents|mesh-ancestor
24802988|NCT01993680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24802989|NCT01993680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802990|NCT01993680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24802991|NCT01993771|Anesthetics|anesthetics|mesh-list
24802992|NCT01993771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24802993|NCT01993771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232643|NCT02582099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232644|NCT02582099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232645|NCT02581969|Factor VIII|factor viii|mesh-list
25232646|NCT02581969|Coagulants|coagulants|mesh-ancestor
25232648|NCT02581982|Pembrolizumab|pembrolizumab|mesh-list
25232649|NCT02581982|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25232650|NCT02581982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25232651|NCT02581982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232652|NCT02581982|Tubulin Modulators|tubulin modulators|mesh-ancestor
25232653|NCT02581982|Antimitotic Agents|antimitotic agents|mesh-ancestor
25232654|NCT02581982|Mitosis Modulators|mitosis modulators|mesh-ancestor
25232655|NCT02581982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232656|NCT02581982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25232657|NCT02581826|Silodosin|silodosin|mesh-list
25232658|NCT02581826|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25232659|NCT02581826|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25232660|NCT02581826|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25671861|NCT01737931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25671862|NCT01737931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25671863|NCT01737931|Anesthetics, Local|anesthetics, local|mesh-ancestor
25671864|NCT01737931|Anesthetics|anesthetics|mesh-ancestor
25671865|NCT01737931|Sensory System Agents|sensory system agents|mesh-ancestor
25671866|NCT01737931|Histamine Agents|histamine agents|mesh-ancestor
25671867|NCT01737931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25674524|NCT01773122|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25872174|NCT00124696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872175|NCT00124722|Bromides|bromides|mesh-list
25872176|NCT00124722|Rocuronium|rocuronium|mesh-list
25872177|NCT00124722|Anticonvulsants|anticonvulsants|mesh-ancestor
25872178|NCT00124722|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24802994|NCT01993784|Nimotuzumab|nimotuzumab|mesh-list
24802995|NCT01993784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24802997|NCT01993810|Paclitaxel|paclitaxel|mesh-list
24802998|NCT01993810|Etoposide|etoposide|mesh-list
24802999|NCT01993810|Podophyllotoxin|podophyllotoxin|mesh-list
24803000|NCT01993810|Cisplatin|cisplatin|mesh-list
24803001|NCT01993810|Carboplatin|carboplatin|mesh-list
24803002|NCT01993810|Pemetrexed|pemetrexed|mesh-list
24803003|NCT01993810|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24803004|NCT01993810|Etoposide phosphate|etoposide phosphate|mesh-list
24803005|NCT01993810|Durvalumab|durvalumab|mesh-list
24803006|NCT01993810|Immunoglobulins|immunoglobulins|mesh-list
24803007|NCT01993810|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24803026|NCT01993979|Cisplatin|cisplatin|mesh-list
24465815|NCT00370760|Antiemetics|antiemetics|mesh-ancestor
24465816|NCT00370760|Autonomic Agents|autonomic agents|mesh-ancestor
24465817|NCT00370760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24465818|NCT00370760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465819|NCT00370760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24465820|NCT00370760|Glucocorticoids|glucocorticoids|mesh-ancestor
24465821|NCT00370760|Hormones|hormones|mesh-ancestor
24803056|NCT01994096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803057|NCT01994265|Warfarin|warfarin|mesh-list
24803058|NCT01994265|Dabigatran|dabigatran|mesh-list
24803059|NCT01994265|Anticoagulants|anticoagulants|mesh-ancestor
24803060|NCT01994265|Antithrombins|antithrombins|mesh-ancestor
24803061|NCT01994265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24803062|NCT01994265|Protease Inhibitors|protease inhibitors|mesh-ancestor
24803063|NCT01994265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24803064|NCT01994265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803065|NCT01994330|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24465822|NCT00370760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24465823|NCT00370760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24465824|NCT00370760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232661|NCT02581826|Adrenergic Agents|adrenergic agents|mesh-ancestor
25232662|NCT02581826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25232663|NCT02581826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232664|NCT02581826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671871|NCT01737931|Dermatologic Agents|dermatologic agents|mesh-ancestor
25671872|NCT01737944|Methotrexate|methotrexate|mesh-list
25671873|NCT01737944|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25671874|NCT01737944|Abortifacient Agents|abortifacient agents|mesh-ancestor
25671875|NCT01737944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25671876|NCT01737944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671877|NCT01737944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25232665|NCT02581826|Urological Agents|urological agents|mesh-ancestor
25232667|NCT02581761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25140816|NCT02961842|Anesthetics, Local|anesthetics, local|mesh-ancestor
24875577|NCT04021108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24875649|NCT03977194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24875650|NCT03977194|Tubulin Modulators|tubulin modulators|mesh-ancestor
25232668|NCT02581761|Abortifacient Agents|abortifacient agents|mesh-ancestor
25232669|NCT02581761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25232670|NCT02581761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232671|NCT02581761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25232672|NCT02581761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25232673|NCT02581761|Oxytocics|oxytocics|mesh-ancestor
25232674|NCT02581696|Irsogladine|irsogladine|mesh-list
25232675|NCT02581696|Lafutidine|lafutidine|mesh-list
25232676|NCT02581696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232677|NCT02581696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25232678|NCT02581696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25232679|NCT02581696|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25872179|NCT00124722|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24846901|NCT02244255|Urological Agents|urological agents|mesh-ancestor
24846903|NCT02244268|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24846904|NCT02244268|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24846905|NCT02244268|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24846906|NCT02244268|Adrenergic Agents|adrenergic agents|mesh-ancestor
25872180|NCT00124722|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25872181|NCT00124722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25872182|NCT00124722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872183|NCT00124787|Dimenhydrinate|dimenhydrinate|mesh-list
24846907|NCT02244268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24846908|NCT02244268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846909|NCT02244268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465825|NCT00370760|Anticoagulants|anticoagulants|mesh-ancestor
24465826|NCT00370760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24465827|NCT00370760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24465858|NCT00370825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24465881|NCT00371007|Protease Inhibitors|protease inhibitors|mesh-ancestor
24465882|NCT00371007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733410|NCT01645800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24465883|NCT00371007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465885|NCT00371020|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24465886|NCT00371020|Tinzaparin|tinzaparin|mesh-list
24465887|NCT00371020|Dalteparin|dalteparin|mesh-list
24465888|NCT00371020|Anticoagulants|anticoagulants|mesh-ancestor
24465889|NCT00371020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24465890|NCT00371020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24465891|NCT00371020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671879|NCT01737944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671880|NCT01737944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671881|NCT01737944|Dermatologic Agents|dermatologic agents|mesh-ancestor
25671882|NCT01737944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25671883|NCT01737944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25671884|NCT01737944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25671885|NCT01737944|Immunologic Factors|immunologic factors|mesh-ancestor
25671886|NCT01737944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25671887|NCT01737944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25872184|NCT00124787|Antiemetics|antiemetics|mesh-ancestor
25872185|NCT00124787|Autonomic Agents|autonomic agents|mesh-ancestor
25872186|NCT00124787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25872187|NCT00124787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872188|NCT00124787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25872189|NCT00124787|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25872190|NCT00124787|Histamine Antagonists|histamine antagonists|mesh-ancestor
25872191|NCT00124787|Histamine Agents|histamine agents|mesh-ancestor
25232683|NCT02581696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872193|NCT00124787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077601|NCT03363659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25077602|NCT03363659|Trace Elements|trace elements|mesh-ancestor
25232684|NCT02581696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232685|NCT02581696|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25232686|NCT02581696|Protective Agents|protective agents|mesh-ancestor
25232687|NCT02581696|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25232688|NCT02581683|Magnesium Sulfate|magnesium sulfate|mesh-list
25232689|NCT02581683|Ropivacaine|ropivacaine|mesh-list
25232690|NCT02581683|Anesthetics, Local|anesthetics, local|mesh-ancestor
25232691|NCT02581683|Anesthetics|anesthetics|mesh-ancestor
25232692|NCT02581683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25232693|NCT02581683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232694|NCT02581683|Sensory System Agents|sensory system agents|mesh-ancestor
25232695|NCT02581683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25232696|NCT02581683|Analgesics|analgesics|mesh-ancestor
25232697|NCT02581683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25232698|NCT02581683|Anticonvulsants|anticonvulsants|mesh-ancestor
25232699|NCT02581683|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25232700|NCT02581683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25232701|NCT02581683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232702|NCT02581683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25232703|NCT02581683|Tocolytic Agents|tocolytic agents|mesh-ancestor
25232704|NCT02581683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25232705|NCT02581553|Allopurinol|allopurinol|mesh-list
24846910|NCT02244268|Urological Agents|urological agents|mesh-ancestor
24846911|NCT02244281|Tamsulosin|tamsulosin|mesh-list
24846912|NCT02244281|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24846913|NCT02244281|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24846914|NCT02244281|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24846915|NCT02244281|Adrenergic Agents|adrenergic agents|mesh-ancestor
24846916|NCT02244281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24846917|NCT02244281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846918|NCT02244281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846919|NCT02244281|Urological Agents|urological agents|mesh-ancestor
24846920|NCT02244294|Tamsulosin|tamsulosin|mesh-list
25872195|NCT00124813|Idarubicin|idarubicin|mesh-list
25872196|NCT00124813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25872197|NCT00124813|Immunologic Factors|immunologic factors|mesh-ancestor
25872198|NCT00124813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872199|NCT00124813|Leprostatic Agents|leprostatic agents|mesh-ancestor
24465905|NCT00371033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24465906|NCT00371072|Mitomycins|mitomycins|mesh-list
25671888|NCT01738191|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25671889|NCT01738191|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25671890|NCT01738191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25671891|NCT01738191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25671892|NCT01738191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671893|NCT01738191|Adrenergic Agents|adrenergic agents|mesh-ancestor
25671894|NCT01738191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24465910|NCT00371072|Alkylating Agents|alkylating agents|mesh-ancestor
24465911|NCT00371072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232706|NCT02581553|Lesinurad|lesinurad|mesh-list
25232707|NCT02581553|Antimetabolites|antimetabolites|mesh-ancestor
25232708|NCT02581553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232709|NCT02581553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232710|NCT02581553|Gout Suppressants|gout suppressants|mesh-ancestor
25232711|NCT02581553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25232712|NCT02581553|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25232713|NCT02581553|Antioxidants|antioxidants|mesh-ancestor
25232714|NCT02581553|Protective Agents|protective agents|mesh-ancestor
25232715|NCT02581553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232716|NCT02581553|Uricosuric Agents|uricosuric agents|mesh-ancestor
25232718|NCT02581566|Dexmedetomidine|dexmedetomidine|mesh-list
25232719|NCT02581566|Bupivacaine|bupivacaine|mesh-list
25232720|NCT02581566|Anesthetics, Local|anesthetics, local|mesh-ancestor
25232721|NCT02581566|Anesthetics|anesthetics|mesh-ancestor
25232722|NCT02581566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25232723|NCT02581566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232724|NCT02581566|Sensory System Agents|sensory system agents|mesh-ancestor
25232725|NCT02581566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25232726|NCT02581566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25232727|NCT02581566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25232728|NCT02581566|Analgesics|analgesics|mesh-ancestor
25232729|NCT02581566|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25232730|NCT02581566|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25232731|NCT02581566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25232732|NCT02581566|Adrenergic Agents|adrenergic agents|mesh-ancestor
25232733|NCT02581566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25232734|NCT02581566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232735|NCT02581371|Cerebrolysin|cerebrolysin|mesh-list
25232736|NCT02581371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25232737|NCT02581371|Protective Agents|protective agents|mesh-ancestor
25232738|NCT02581371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232739|NCT02581371|Nootropic Agents|nootropic agents|mesh-ancestor
25232740|NCT02581501|Gemcitabine|gemcitabine|mesh-list
25872200|NCT00124813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24846931|NCT02244307|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
24846932|NCT02244307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25872201|NCT00124813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25872202|NCT00124813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25872203|NCT00124813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25872204|NCT00124813|Growth Substances|growth substances|mesh-ancestor
25872205|NCT00124813|Growth Inhibitors|growth inhibitors|mesh-ancestor
25872206|NCT00124813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872207|NCT00124813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25072491|NCT03401372|Hormones|hormones|mesh-ancestor
24465912|NCT00371072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24803066|NCT01994330|Hemostatics|hemostatics|mesh-ancestor
24803067|NCT01994330|Coagulants|coagulants|mesh-ancestor
24803068|NCT01994330|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24803069|NCT01994330|Natriuretic Agents|natriuretic agents|mesh-ancestor
24803070|NCT01994330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803071|NCT01994356|Contraceptive Agents|contraceptive agents|mesh-list
24803099|NCT01994642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671895|NCT01738191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671896|NCT01738503|Buprenorphine|buprenorphine|mesh-list
25671897|NCT01738503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25671898|NCT01738503|Narcotics|narcotics|mesh-ancestor
24803100|NCT01994642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25671899|NCT01738503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25671900|NCT01738503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140953|NCT02960880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25140954|NCT02960880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140955|NCT02960880|Anticoagulants|anticoagulants|mesh-ancestor
25140956|NCT02960906|Nivolumab|nivolumab|mesh-list
25140957|NCT02960906|Ipilimumab|ipilimumab|mesh-list
25140958|NCT02960906|Sunitinib|sunitinib|mesh-list
25140959|NCT02960906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25140960|NCT02960906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25140961|NCT02960906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25140963|NCT02960906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24803101|NCT01994642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24803102|NCT01994642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24803103|NCT01994642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24803104|NCT01994642|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24803105|NCT01994642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24803106|NCT01994668|Lorazepam|lorazepam|mesh-list
24803107|NCT01994668|Anticonvulsants|anticonvulsants|mesh-ancestor
24803108|NCT01994668|Antiemetics|antiemetics|mesh-ancestor
24803109|NCT01994668|Autonomic Agents|autonomic agents|mesh-ancestor
24803110|NCT01994668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803111|NCT01994668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803112|NCT01994668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24803113|NCT01994668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24803114|NCT01994668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24803147|NCT01994824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803149|NCT01994941|Clopidogrel|clopidogrel|mesh-list
24803150|NCT01994941|Ticagrelor|ticagrelor|mesh-list
24803151|NCT01994941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24803152|NCT01994941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24803153|NCT01994941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24803154|NCT01994941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24803155|NCT01994941|Purinergic Agents|purinergic agents|mesh-ancestor
25232741|NCT02581501|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25232742|NCT02581501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25232743|NCT02581501|Antimetabolites|antimetabolites|mesh-ancestor
25232744|NCT02581501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232745|NCT02581501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232746|NCT02581501|Antiviral Agents|antiviral agents|mesh-ancestor
25232747|NCT02581501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25232748|NCT02581501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232749|NCT02581501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25232750|NCT02581501|Immunologic Factors|immunologic factors|mesh-ancestor
25232751|NCT02581501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232752|NCT02581462|Trastuzumab|trastuzumab|mesh-list
25232753|NCT02581462|Pertuzumab|pertuzumab|mesh-list
25232754|NCT02581462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25232755|NCT02581462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232756|NCT02581631|Nivolumab|nivolumab|mesh-list
25232757|NCT02581631|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25232758|NCT02581631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25232759|NCT02581631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24846934|NCT02244307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846935|NCT02244320|Tamsulosin|tamsulosin|mesh-list
24846936|NCT02244320|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24846937|NCT02244320|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24846938|NCT02244320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24846939|NCT02244320|Adrenergic Agents|adrenergic agents|mesh-ancestor
24846940|NCT02244320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24846941|NCT02244320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846942|NCT02244320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846943|NCT02244320|Urological Agents|urological agents|mesh-ancestor
24607170|NCT05123092|Analgesics|analgesics|mesh-ancestor
24846944|NCT02244437|Acetaminophen|acetaminophen|mesh-list
24846945|NCT02244437|Ibuprofen|ibuprofen|mesh-list
25876795|NCT02778685|Hormone Antagonists|hormone antagonists|mesh-ancestor
25671901|NCT01738503|Analgesics|analgesics|mesh-ancestor
25671902|NCT01738503|Sensory System Agents|sensory system agents|mesh-ancestor
25671903|NCT01738503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25671904|NCT01738503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25671905|NCT01738594|Romidepsin|romidepsin|mesh-list
25671906|NCT01738594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25671907|NCT01738594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671908|NCT01738646|Bevacizumab|bevacizumab|mesh-list
25671909|NCT01738646|Vorinostat|vorinostat|mesh-list
25671910|NCT01738646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25671911|NCT01738646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24803157|NCT01994941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574138|NCT00823875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24465990|NCT00371501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24465991|NCT00371501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597613|NCT00950261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622549|NCT01067443|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
24622550|NCT01067443|Amebicides|amebicides|mesh-ancestor
24622551|NCT01067443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24622552|NCT01067443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24622553|NCT01067443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24622557|NCT01067443|Schistosomicides|schistosomicides|mesh-ancestor
24622569|NCT01067534|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24622570|NCT01067534|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24622571|NCT01067534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24622572|NCT01067534|Adrenergic Agents|adrenergic agents|mesh-ancestor
24622573|NCT01067534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24622574|NCT01067534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622575|NCT01067547|Iron|iron|mesh-list
24622576|NCT01067547|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25232760|NCT02581631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25232761|NCT02581631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232762|NCT02581423|Capecitabine|capecitabine|mesh-list
25232763|NCT02581423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25232764|NCT02581423|Antimetabolites|antimetabolites|mesh-ancestor
25232765|NCT02581423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232766|NCT02581423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232767|NCT02581124|Lapatinib|lapatinib|mesh-list
25232768|NCT02581124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232769|NCT02581124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25232770|NCT02581124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232771|NCT02581124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232772|NCT02581176|Apixaban|apixaban|mesh-list
25232773|NCT02581176|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25232775|NCT02581176|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25232777|NCT02581176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232778|NCT02581176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232779|NCT02581176|Anticoagulants|anticoagulants|mesh-ancestor
25671912|NCT01738646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25671913|NCT01738646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25671914|NCT01738646|Growth Substances|growth substances|mesh-ancestor
25671915|NCT01738646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671916|NCT01738646|Growth Inhibitors|growth inhibitors|mesh-ancestor
25671917|NCT01738646|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25671918|NCT01738646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674525|NCT01773122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24846946|NCT02244437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24622577|NCT01067547|Trace Elements|trace elements|mesh-ancestor
24465993|NCT00371501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24465994|NCT00371501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24465995|NCT00371501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24465996|NCT00371501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465997|NCT00371501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24803173|NCT01995006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24803174|NCT01995006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24803176|NCT01995006|Sensory System Agents|sensory system agents|mesh-ancestor
24803177|NCT01995006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803178|NCT01995006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803179|NCT01995006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24803180|NCT01995006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24803181|NCT01995006|Gout Suppressants|gout suppressants|mesh-ancestor
24803214|NCT01995058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24803215|NCT01995058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803218|NCT01995058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24803219|NCT01995058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24803220|NCT01995058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803221|NCT01995058|Hormone Antagonists|hormone antagonists|mesh-ancestor
24803222|NCT01995058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24803224|NCT01995084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24803225|NCT01995084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803226|NCT01995188|Bevacizumab|bevacizumab|mesh-list
24803227|NCT01995188|Carboplatin|carboplatin|mesh-list
24803228|NCT01995188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24803229|NCT01995188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232790|NCT02580968|Flunarizine|flunarizine|mesh-list
25232791|NCT02580968|Anticonvulsants|anticonvulsants|mesh-ancestor
25232792|NCT02580968|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25232793|NCT02580968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25232794|NCT02580968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671919|NCT01738646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671920|NCT01738672|Nitrous Oxide|nitrous oxide|mesh-list
25671921|NCT01738672|Entonox|entonox|mesh-list
25671922|NCT01738672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25671923|NCT01738672|Anesthetics, General|anesthetics, general|mesh-ancestor
25671924|NCT01738672|Anesthetics|anesthetics|mesh-ancestor
25671925|NCT01738672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25671926|NCT01738672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671927|NCT01738672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25671928|NCT01738672|Analgesics|analgesics|mesh-ancestor
25671929|NCT01738672|Sensory System Agents|sensory system agents|mesh-ancestor
25671930|NCT01738672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25671931|NCT01738672|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25141101|NCT02959749|Tubulin Modulators|tubulin modulators|mesh-ancestor
25141102|NCT02959749|Antimitotic Agents|antimitotic agents|mesh-ancestor
25141103|NCT02959749|Mitosis Modulators|mitosis modulators|mesh-ancestor
25141127|NCT02959606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25141128|NCT02959606|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25141129|NCT02959606|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25141139|NCT02959476|Ropivacaine|ropivacaine|mesh-list
25232795|NCT02580968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25232796|NCT02580968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232797|NCT02580968|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25232798|NCT02580968|Histamine Antagonists|histamine antagonists|mesh-ancestor
25232799|NCT02580968|Histamine Agents|histamine agents|mesh-ancestor
25232800|NCT02580968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25232801|NCT02580968|Vasodilator Agents|vasodilator agents|mesh-ancestor
25232802|NCT02581046|Dexamethasone|dexamethasone|mesh-list
24846947|NCT02244437|Analgesics|analgesics|mesh-ancestor
24846948|NCT02244437|Sensory System Agents|sensory system agents|mesh-ancestor
24846949|NCT02244437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24846950|NCT02244437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846951|NCT02244437|Antipyretics|antipyretics|mesh-ancestor
24846952|NCT02244437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25872208|NCT00124813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25077699|NCT03362814|Lactams|lactams|mesh-list
25077700|NCT03362814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24846953|NCT02244437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24846954|NCT02244437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25872209|NCT00124813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24803230|NCT01995188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24803231|NCT01995188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24803232|NCT01995188|Growth Substances|growth substances|mesh-ancestor
24803233|NCT01995188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803234|NCT01995188|Growth Inhibitors|growth inhibitors|mesh-ancestor
24803251|NCT01995331|Cyclosporine|cyclosporine|mesh-list
24803252|NCT01995331|Cyclophosphamide|cyclophosphamide|mesh-list
24803253|NCT01995331|Cyclosporins|cyclosporins|mesh-list
24466003|NCT00371501|Antimetabolites|antimetabolites|mesh-ancestor
24466004|NCT00371501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25095604|NCT03217942|Mitogens|mitogens|mesh-list
24466005|NCT00371501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24466006|NCT00371527|Ipratropium|ipratropium|mesh-list
24466007|NCT00371527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24466008|NCT00371527|Autonomic Agents|autonomic agents|mesh-ancestor
24466009|NCT00371527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24466010|NCT00371527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803299|NCT01995370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24803300|NCT01995370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24803301|NCT01995370|Antipyretics|antipyretics|mesh-ancestor
24803302|NCT01995370|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24803303|NCT01995370|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24803304|NCT01995370|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24803305|NCT01995370|Purinergic Agents|purinergic agents|mesh-ancestor
24803307|NCT01995370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24803308|NCT01995370|Autonomic Agents|autonomic agents|mesh-ancestor
24803309|NCT01995370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24803310|NCT01995370|Respiratory System Agents|respiratory system agents|mesh-ancestor
24803311|NCT01995370|Vasodilator Agents|vasodilator agents|mesh-ancestor
24803312|NCT01995370|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24803313|NCT01995370|Protective Agents|protective agents|mesh-ancestor
24803314|NCT01995370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25671932|NCT01738971|Progestins|progestins|mesh-list
25671933|NCT01738971|Hormones|hormones|mesh-ancestor
25671934|NCT01738971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25671935|NCT01738971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671936|NCT01739335|Mifepristone|mifepristone|mesh-list
25671937|NCT01739335|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25671938|NCT01739335|Abortifacient Agents|abortifacient agents|mesh-ancestor
25671939|NCT01739335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25872210|NCT00124813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872211|NCT00124813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872212|NCT00124826|Insulin|insulin|mesh-list
25872213|NCT00124826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25872214|NCT00124826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872215|NCT00124839|Naltrexone|naltrexone|mesh-list
24803317|NCT01995695|Vaccines|vaccines|mesh-list
24803318|NCT01995695|Immunologic Factors|immunologic factors|mesh-ancestor
24803321|NCT01995734|Hormones|hormones|mesh-ancestor
24803322|NCT01995734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24466011|NCT00371527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24466037|NCT00371592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24466039|NCT00371696|Diclofenac|diclofenac|mesh-list
24466040|NCT00371696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24466041|NCT00371696|Analgesics|analgesics|mesh-ancestor
24466042|NCT00371696|Sensory System Agents|sensory system agents|mesh-ancestor
25232803|NCT02581046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25232804|NCT02581046|Antiemetics|antiemetics|mesh-ancestor
25232805|NCT02581046|Autonomic Agents|autonomic agents|mesh-ancestor
25232806|NCT02581046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25232807|NCT02581046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232808|NCT02581046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25232809|NCT02581046|Glucocorticoids|glucocorticoids|mesh-ancestor
25232810|NCT02581046|Hormones|hormones|mesh-ancestor
25232811|NCT02581046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25232812|NCT02581046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25232813|NCT02581046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232814|NCT02580773|Tinzaparin|tinzaparin|mesh-list
25872216|NCT00124839|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25872217|NCT00124839|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25872218|NCT00124839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466043|NCT00371696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24466044|NCT00371696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466045|NCT00371696|Antipyretics|antipyretics|mesh-ancestor
24466046|NCT00371696|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24803404|NCT01996306|Antidotes|antidotes|mesh-ancestor
24803406|NCT01996306|Vitamin B Complex|vitamin b complex|mesh-ancestor
24803408|NCT01996306|Micronutrients|micronutrients|mesh-ancestor
24803410|NCT01996358|Succinylcholine|succinylcholine|mesh-list
24803411|NCT01996358|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24803412|NCT01996358|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24803413|NCT01996358|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24803414|NCT01996358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803415|NCT01996358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803416|NCT01996358|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
24803417|NCT01996384|Lidocaine|lidocaine|mesh-list
24803418|NCT01996384|Anesthetics, Local|anesthetics, local|mesh-ancestor
24803419|NCT01996384|Anesthetics|anesthetics|mesh-ancestor
24803420|NCT01996384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24803421|NCT01996384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803431|NCT01996423|Vitamins|vitamins|mesh-ancestor
24803432|NCT01996423|Micronutrients|micronutrients|mesh-ancestor
24803433|NCT01996423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803434|NCT01996423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24803435|NCT01996423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24803436|NCT01996462|Dexetimide|dexetimide|mesh-list
24803437|NCT01996462|Citalopram|citalopram|mesh-list
24803438|NCT01996462|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24803444|NCT01996462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803445|NCT01996462|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24803446|NCT01996462|Antidepressive Agents|antidepressive agents|mesh-ancestor
24803447|NCT01996462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24803448|NCT01996462|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24803449|NCT01996462|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24803450|NCT01996462|Parasympatholytics|parasympatholytics|mesh-ancestor
24803451|NCT01996462|Autonomic Agents|autonomic agents|mesh-ancestor
24803452|NCT01996462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803453|NCT01996462|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24803454|NCT01996462|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24803455|NCT01996462|Cholinergic Agents|cholinergic agents|mesh-ancestor
24803456|NCT01996475|Dexetimide|dexetimide|mesh-list
24803457|NCT01996475|Citalopram|citalopram|mesh-list
24803458|NCT01996475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24803502|NCT01996501|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25872219|NCT00124839|Sensory System Agents|sensory system agents|mesh-ancestor
25872220|NCT00124839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25872221|NCT00124930|Olanzapine|olanzapine|mesh-list
25872222|NCT00124930|Antiemetics|antiemetics|mesh-ancestor
24803587|NCT01997203|Micronutrients|micronutrients|mesh-ancestor
24803588|NCT01997203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803589|NCT01997203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24803590|NCT01997203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24803591|NCT01997203|Antiviral Agents|antiviral agents|mesh-ancestor
24803592|NCT01997203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24803593|NCT01997203|Antimetabolites|antimetabolites|mesh-ancestor
24803594|NCT01997203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232815|NCT02580773|Anticoagulants|anticoagulants|mesh-ancestor
25232816|NCT02580773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25232817|NCT02580773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25232818|NCT02580773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232819|NCT02580604|Calcium|calcium|mesh-list
25232820|NCT02580604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25232821|NCT02580604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232822|NCT02580734|Melatonin|melatonin|mesh-list
25232823|NCT02580734|Antioxidants|antioxidants|mesh-ancestor
25154448|NCT05471479|Charcoal|charcoal|mesh-list
25154449|NCT05471479|Antidotes|antidotes|mesh-ancestor
24453164|NCT05238831|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24453165|NCT05238831|Bevacizumab|bevacizumab|mesh-list
24803616|NCT01997580|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24803617|NCT01997580|Antidepressive Agents|antidepressive agents|mesh-ancestor
24803618|NCT01997580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24803619|NCT01997593|Ropivacaine|ropivacaine|mesh-list
24803620|NCT01997593|Anesthetics, Local|anesthetics, local|mesh-ancestor
24803621|NCT01997593|Anesthetics|anesthetics|mesh-ancestor
24803622|NCT01997593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24803623|NCT01997593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803624|NCT01997593|Sensory System Agents|sensory system agents|mesh-ancestor
24622648|NCT01067898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622649|NCT01067898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24622650|NCT01067898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24622652|NCT01067898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622653|NCT01067898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24622654|NCT01067950|Pancrelipase|pancrelipase|mesh-list
24622655|NCT01067950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24622656|NCT01067989|Zoledronic Acid|zoledronic acid|mesh-list
24622657|NCT01067989|Pamidronate|pamidronate|mesh-list
25671940|NCT01739335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671941|NCT01739335|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25671942|NCT01739335|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25671943|NCT01739335|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25671944|NCT01739335|Contraceptive Agents|contraceptive agents|mesh-ancestor
25671945|NCT01739335|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25671946|NCT01739335|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24803655|NCT01997762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24803656|NCT01997775|Metformin|metformin|mesh-list
24803657|NCT01997775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24878328|NCT01915810|Autonomic Agents|autonomic agents|mesh-ancestor
24878329|NCT01915810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24878330|NCT01915810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24878331|NCT01915810|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24878332|NCT01915810|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24878333|NCT01915810|Cholinergic Agents|cholinergic agents|mesh-ancestor
24878334|NCT01915810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25141212|NCT02959060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25141214|NCT02958917|Analgesics|analgesics|mesh-ancestor
25141215|NCT02958917|Sensory System Agents|sensory system agents|mesh-ancestor
24803658|NCT01997775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803659|NCT01997788|Morphine|morphine|mesh-list
24803660|NCT01997788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24803661|NCT01997788|Narcotics|narcotics|mesh-ancestor
24803664|NCT01997788|Analgesics|analgesics|mesh-ancestor
24803672|NCT01997801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24803673|NCT01997801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24803674|NCT01997801|Anesthetics, General|anesthetics, general|mesh-ancestor
24803675|NCT01997801|Anesthetics|anesthetics|mesh-ancestor
24803676|NCT01997801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24803677|NCT01997801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24574691|NCT00826852|Mitosis Modulators|mitosis modulators|mesh-ancestor
24574692|NCT00826852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803688|NCT01997944|Interferon alpha-2|interferon alpha-2|mesh-list
24803689|NCT01997944|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24803690|NCT01997944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24803691|NCT01997944|Antiviral Agents|antiviral agents|mesh-ancestor
24803692|NCT01997944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24803693|NCT01997944|Immunologic Factors|immunologic factors|mesh-ancestor
24803694|NCT01997944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803695|NCT01997983|Botulinum Toxins|botulinum toxins|mesh-list
24803696|NCT01997983|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24803697|NCT01997983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25232824|NCT02580734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232825|NCT02580734|Protective Agents|protective agents|mesh-ancestor
25232826|NCT02580734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232827|NCT02580734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25232828|NCT02580344|Ibuprofen|ibuprofen|mesh-list
25232829|NCT02580344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25232830|NCT02580344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24846961|NCT02244489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24846963|NCT02244489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846964|NCT02244489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24896740|NCT04433169|Tretinoin|tretinoin|mesh-list
24803698|NCT01997983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803699|NCT01997983|Cholinergic Agents|cholinergic agents|mesh-ancestor
24803700|NCT01997983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24803701|NCT01997983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803703|NCT01998113|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24803704|NCT01998113|Metformin|metformin|mesh-list
25671948|NCT01739335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25671949|NCT01739335|Luteolytic Agents|luteolytic agents|mesh-ancestor
25671950|NCT01739335|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25671951|NCT01739335|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25671952|NCT01739361|Acetaminophen|acetaminophen|mesh-list
25671953|NCT01739361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25671954|NCT01739361|Analgesics|analgesics|mesh-ancestor
25671955|NCT01739361|Sensory System Agents|sensory system agents|mesh-ancestor
25671956|NCT01739361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25671957|NCT01739361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671958|NCT01739361|Antipyretics|antipyretics|mesh-ancestor
25671959|NCT01739400|Macitentan|macitentan|mesh-list
25671960|NCT01739400|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
24803706|NCT01998113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24803707|NCT01998113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803708|NCT01998126|Nivolumab|nivolumab|mesh-list
24803709|NCT01998126|Ipilimumab|ipilimumab|mesh-list
24803710|NCT01998126|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25077785|NCT03362073|Ketamine|ketamine|mesh-list
25077786|NCT03362073|Analgesics|analgesics|mesh-ancestor
25077787|NCT03362073|Sensory System Agents|sensory system agents|mesh-ancestor
24803780|NCT01998503|Antiemetics|antiemetics|mesh-ancestor
24466100|NCT00371995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24466101|NCT00371995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24466102|NCT00371995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24466103|NCT00371995|Antifungal Agents|antifungal agents|mesh-ancestor
24466104|NCT00371995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466105|NCT00372008|Testosterone|testosterone|mesh-list
24466106|NCT00372008|Androgens|androgens|mesh-ancestor
24466107|NCT00372008|Hormones|hormones|mesh-ancestor
25872226|NCT00124930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24453521|NCT04942340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24453522|NCT04942340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24453523|NCT04942340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24803782|NCT01998503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803845|NCT01998763|Vitamins|vitamins|mesh-ancestor
24803846|NCT01998763|Micronutrients|micronutrients|mesh-ancestor
24803847|NCT01998763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803848|NCT01998763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24803852|NCT01998776|Abortifacient Agents|abortifacient agents|mesh-ancestor
24803853|NCT01998776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24803854|NCT01998776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803855|NCT01998776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24803856|NCT01998776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25872227|NCT00124930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25872228|NCT00124930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25872229|NCT00124930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25872230|NCT00124930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25872231|NCT00124930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25872232|NCT00124930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25872233|NCT00124930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25872234|NCT00124930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859610|NCT02304354|Rituximab|rituximab|mesh-list
24803857|NCT01998776|Oxytocics|oxytocics|mesh-ancestor
24803858|NCT01998789|Everolimus|everolimus|mesh-list
24803859|NCT01998789|Tacrolimus|tacrolimus|mesh-list
24803860|NCT01998789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24803861|NCT01998789|Immunologic Factors|immunologic factors|mesh-ancestor
25232831|NCT02580344|Analgesics|analgesics|mesh-ancestor
25232832|NCT02580344|Sensory System Agents|sensory system agents|mesh-ancestor
25232833|NCT02580344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25232834|NCT02580344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232835|NCT02580344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25232836|NCT02580344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25232837|NCT02580344|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25232838|NCT02580344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232839|NCT02580344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232840|NCT02580448|Seviteronel|seviteronel|mesh-list
25232841|NCT02580448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232842|NCT02580448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24846965|NCT02244489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25671961|NCT01739400|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25671962|NCT01739400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095980|NCT03214731|Artesunate|artesunate|mesh-list
25671963|NCT01739400|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25671964|NCT01739595|Enclomiphene|enclomiphene|mesh-list
25671965|NCT01739595|Clomiphene|clomiphene|mesh-list
25671966|NCT01739595|Zuclomiphene|zuclomiphene|mesh-list
24878699|NCT01139970|Veliparib|veliparib|mesh-list
25872237|NCT00124956|Doxorubicin|doxorubicin|mesh-list
25141303|NCT02958566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141305|NCT02958566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25141306|NCT02958566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25141307|NCT02958566|Anesthetics, General|anesthetics, general|mesh-ancestor
25141308|NCT02958566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25141309|NCT02958566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25141310|NCT02958566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25141311|NCT02958566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25141313|NCT02958566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25141314|NCT02958566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25141315|NCT02958566|Antipyretics|antipyretics|mesh-ancestor
24846966|NCT02244489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24846968|NCT02244502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25062853|NCT03866252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24803862|NCT01998789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803863|NCT01998789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24598418|NCT00956098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598419|NCT00956098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24598420|NCT00956098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24598421|NCT00956098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598422|NCT00956098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598424|NCT00956111|Immunologic Factors|immunologic factors|mesh-ancestor
24598425|NCT00956111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622673|NCT01067989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24622674|NCT01067989|Abortifacient Agents|abortifacient agents|mesh-ancestor
24622675|NCT01067989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24622676|NCT01067989|Dermatologic Agents|dermatologic agents|mesh-ancestor
24622677|NCT01067989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622678|NCT01067989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24622679|NCT01067989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24622680|NCT01067989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24622681|NCT01067989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24622682|NCT01067989|Analgesics|analgesics|mesh-ancestor
24803897|NCT01999413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24803900|NCT01999413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24803903|NCT01999413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24803904|NCT01999413|Immunologic Factors|immunologic factors|mesh-ancestor
24574954|NCT00828789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24453524|NCT04942340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24453525|NCT04942340|Adrenergic Agents|adrenergic agents|mesh-ancestor
24453538|NCT04941144|Immunologic Factors|immunologic factors|mesh-ancestor
24466108|NCT00372008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24466109|NCT00372008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466111|NCT00372086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24466155|NCT00372294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466156|NCT00372294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24466157|NCT00372294|Glucocorticoids|glucocorticoids|mesh-ancestor
24466159|NCT00372294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24466160|NCT00372294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24466161|NCT00372294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466162|NCT00372294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24466163|NCT00372294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25671967|NCT01739595|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25671968|NCT01739595|Hormone Antagonists|hormone antagonists|mesh-ancestor
25671969|NCT01739595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25671970|NCT01739595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671971|NCT01739595|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25096074|NCT03214003|Cisplatin|cisplatin|mesh-list
25671972|NCT01739595|Fertility Agents|fertility agents|mesh-ancestor
25671973|NCT01739595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25671974|NCT01739595|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25671975|NCT01739595|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25671976|NCT01739699|Acetaminophen|acetaminophen|mesh-list
25671977|NCT01739699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25671978|NCT01739699|Analgesics|analgesics|mesh-ancestor
25671979|NCT01739699|Sensory System Agents|sensory system agents|mesh-ancestor
25671980|NCT01739699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803908|NCT01999413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24803909|NCT01999413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24803910|NCT01999647|Ropivacaine|ropivacaine|mesh-list
24803911|NCT01999647|Anesthetics, Local|anesthetics, local|mesh-list
24803912|NCT01999647|Anesthetics|anesthetics|mesh-list
24803913|NCT01999647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24803914|NCT01999647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232843|NCT02580448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232844|NCT02580448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273586|NCT02384876|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25273587|NCT02384876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25273588|NCT02384876|Respiratory System Agents|respiratory system agents|mesh-ancestor
25273589|NCT02384876|Nasal Decongestants|nasal decongestants|mesh-ancestor
25273590|NCT02384837|Sirolimus|sirolimus|mesh-list
25273591|NCT02384837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24803915|NCT01999647|Sensory System Agents|sensory system agents|mesh-ancestor
24803916|NCT01999647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803917|NCT01999673|Docetaxel|docetaxel|mesh-list
24803918|NCT01999673|Bavituximab|bavituximab|mesh-list
24803919|NCT01999673|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24803920|NCT01999673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24803921|NCT01999673|Tubulin Modulators|tubulin modulators|mesh-ancestor
24803922|NCT01999673|Antimitotic Agents|antimitotic agents|mesh-ancestor
24803923|NCT01999673|Mitosis Modulators|mitosis modulators|mesh-ancestor
25671981|NCT01739699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671982|NCT01739699|Antipyretics|antipyretics|mesh-ancestor
25671983|NCT01739764|Vemurafenib|vemurafenib|mesh-list
25671984|NCT01739764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25671985|NCT01739764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25671986|NCT01739764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25671987|NCT01739764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671988|NCT01739790|Acetylcysteine|acetylcysteine|mesh-list
25872240|NCT00124956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25872241|NCT00124956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25872242|NCT00124956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872243|NCT00124956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872244|NCT00124969|Amlodipine|amlodipine|mesh-list
25872245|NCT00124969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25872246|NCT00124969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25872247|NCT00124969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24803938|NCT01999829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803939|NCT01999829|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24803941|NCT01999829|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24803942|NCT01999829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232845|NCT02580331|Metformin|metformin|mesh-list
25232846|NCT02580331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25232847|NCT02580331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232848|NCT02580474|Asunaprevir|asunaprevir|mesh-list
25232849|NCT02580474|Protease Inhibitors|protease inhibitors|mesh-ancestor
25232850|NCT02580474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232851|NCT02580474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232852|NCT02580695|Hyaluronic Acid|hyaluronic acid|mesh-list
25232853|NCT02580695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25232854|NCT02580695|Immunologic Factors|immunologic factors|mesh-ancestor
25232855|NCT02580695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232856|NCT02580695|Viscosupplements|viscosupplements|mesh-ancestor
25232857|NCT02580695|Protective Agents|protective agents|mesh-ancestor
25232858|NCT02580227|Tranexamic Acid|tranexamic acid|mesh-list
25232859|NCT02580227|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25232860|NCT02580227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25232861|NCT02580227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232862|NCT02580227|Hemostatics|hemostatics|mesh-ancestor
25232863|NCT02580227|Coagulants|coagulants|mesh-ancestor
25872248|NCT00124969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872249|NCT00124969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25872250|NCT00124969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232864|NCT02580006|Epoetin Alfa|epoetin alfa|mesh-list
25232865|NCT02580006|Hematinics|hematinics|mesh-ancestor
25232866|NCT02580149|Clopidogrel|clopidogrel|mesh-list
25232867|NCT02580149|Ticagrelor|ticagrelor|mesh-list
25232868|NCT02580149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25232869|NCT02580149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25232870|NCT02580149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25232871|NCT02580149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25232872|NCT02580149|Purinergic Agents|purinergic agents|mesh-ancestor
25232873|NCT02580149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24803943|NCT01999829|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24803945|NCT01999829|Purinergic Agents|purinergic agents|mesh-ancestor
24803946|NCT01999829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24803948|NCT01999842|Immunologic Factors|immunologic factors|mesh-ancestor
24803949|NCT01999842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803950|NCT01999907|Vitamin D|vitamin d|mesh-list
24803951|NCT01999907|Ergocalciferols|ergocalciferols|mesh-list
24803952|NCT01999907|Cholecalciferol|cholecalciferol|mesh-list
24803953|NCT01999907|Vitamins|vitamins|mesh-list
24803954|NCT01999907|Micronutrients|micronutrients|mesh-ancestor
24803955|NCT01999907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803956|NCT01999907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24803957|NCT01999907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24803958|NCT01999933|Cisplatin|cisplatin|mesh-list
24803959|NCT01999933|Docetaxel|docetaxel|mesh-list
24803960|NCT01999933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24803961|NCT01999933|Tubulin Modulators|tubulin modulators|mesh-ancestor
24803962|NCT01999933|Antimitotic Agents|antimitotic agents|mesh-ancestor
24803963|NCT01999933|Mitosis Modulators|mitosis modulators|mesh-ancestor
24803965|NCT02000102|Aflibercept|aflibercept|mesh-list
24466249|NCT00372736|Docetaxel|docetaxel|mesh-list
24466250|NCT00372736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466251|NCT00372736|Tubulin Modulators|tubulin modulators|mesh-ancestor
24466252|NCT00372736|Antimitotic Agents|antimitotic agents|mesh-ancestor
25872251|NCT00124969|Vasodilator Agents|vasodilator agents|mesh-ancestor
25872252|NCT00124995|Terbutaline|terbutaline|mesh-list
25872253|NCT00124995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25872254|NCT00124995|Autonomic Agents|autonomic agents|mesh-ancestor
24466256|NCT00372762|Bumetanide|bumetanide|mesh-list
24466259|NCT00372762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415561|NCT00199979|Nevirapine|nevirapine|mesh-list
24466260|NCT00372762|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24466261|NCT00372762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25409691|NCT03358563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25872255|NCT00124995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24466262|NCT00372762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466264|NCT00372788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466265|NCT00372788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466266|NCT00372788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466267|NCT00372788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24803991|NCT02000206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803992|NCT02000206|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24803993|NCT02000206|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24803994|NCT02000206|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24803995|NCT02000206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24803996|NCT02000206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803997|NCT02000206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24803998|NCT02000206|Narcotics|narcotics|mesh-ancestor
24803999|NCT02000336|Prednisolone|prednisolone|mesh-list
24804000|NCT02000336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24804001|NCT02000336|Glucocorticoids|glucocorticoids|mesh-ancestor
24804006|NCT02000336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466352|NCT00373204|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24466353|NCT00373204|Dermatologic Agents|dermatologic agents|mesh-ancestor
24804016|NCT02000388|Sensory System Agents|sensory system agents|mesh-ancestor
24804017|NCT02000388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804018|NCT02000388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804019|NCT02000388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24804020|NCT02000388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24804021|NCT02000388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24804022|NCT02000388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24804023|NCT02000388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804024|NCT02000401|Ketorolac|ketorolac|mesh-list
24804025|NCT02000401|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24804026|NCT02000401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24804027|NCT02000401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24804028|NCT02000401|Analgesics|analgesics|mesh-ancestor
24804029|NCT02000401|Sensory System Agents|sensory system agents|mesh-ancestor
24804030|NCT02000401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804031|NCT02000401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846980|NCT02244515|Sensory System Agents|sensory system agents|mesh-ancestor
25872258|NCT00124995|Respiratory System Agents|respiratory system agents|mesh-ancestor
25872259|NCT00124995|Sympathomimetics|sympathomimetics|mesh-ancestor
24883790|NCT04770012|Aspirin|aspirin|mesh-list
25872260|NCT00124995|Tocolytic Agents|tocolytic agents|mesh-ancestor
25872261|NCT00124995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25872262|NCT00124995|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25044407|NCT01106807|Sensory System Agents|sensory system agents|mesh-ancestor
25044408|NCT01106807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25044409|NCT01106807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044410|NCT01106807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25062887|NCT03530995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062888|NCT03530995|Antifungal Agents|antifungal agents|mesh-ancestor
25062889|NCT03530995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24804032|NCT02000401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24804033|NCT02000401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24804034|NCT02000401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24804075|NCT02000947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804076|NCT02000947|Immunologic Factors|immunologic factors|mesh-ancestor
24804077|NCT02000947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804078|NCT02001012|Chloroquine|chloroquine|mesh-list
24804079|NCT02001012|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24804080|NCT02001012|Lumefantrine|lumefantrine|mesh-list
24804081|NCT02001012|Artemether|artemether|mesh-list
24804082|NCT02001012|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24804083|NCT02001012|Amebicides|amebicides|mesh-ancestor
24804084|NCT02001012|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24804085|NCT02001012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24804086|NCT02001012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25671989|NCT01739790|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25671990|NCT01739790|Antiviral Agents|antiviral agents|mesh-ancestor
25671991|NCT01739790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25671992|NCT01739790|Expectorants|expectorants|mesh-ancestor
25671993|NCT01739790|Respiratory System Agents|respiratory system agents|mesh-ancestor
25671994|NCT01739790|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24880060|NCT04145518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880061|NCT04145518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24880103|NCT04100135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24880104|NCT04100135|Purinergic Agents|purinergic agents|mesh-ancestor
25046981|NCT00834743|Metformin|metformin|mesh-list
24804087|NCT02001012|Antimalarials|antimalarials|mesh-ancestor
24804088|NCT02001012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24804089|NCT02001012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24804090|NCT02001012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24804091|NCT02001012|Analgesics|analgesics|mesh-ancestor
24804092|NCT02001012|Sensory System Agents|sensory system agents|mesh-ancestor
24804093|NCT02001012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804094|NCT02001012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804095|NCT02001012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24804096|NCT02001012|Filaricides|filaricides|mesh-ancestor
24804097|NCT02001012|Antinematodal Agents|antinematodal agents|mesh-ancestor
24804098|NCT02001012|Anthelmintics|anthelmintics|mesh-ancestor
24804099|NCT02001103|Memantine|memantine|mesh-list
24804100|NCT02001103|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24804101|NCT02001103|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25872263|NCT00124995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24466375|NCT00373373|Sorafenib|sorafenib|mesh-list
24466376|NCT00373373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466377|NCT00373373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24466378|NCT00373373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466379|NCT00373373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804112|NCT02001168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804113|NCT02001168|Tubulin Modulators|tubulin modulators|mesh-ancestor
24804114|NCT02001168|Antimitotic Agents|antimitotic agents|mesh-ancestor
24804115|NCT02001168|Mitosis Modulators|mitosis modulators|mesh-ancestor
24804116|NCT02001168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804117|NCT02001168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232874|NCT02580149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232875|NCT02580149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232876|NCT02579642|Ketamine|ketamine|mesh-list
25232877|NCT02579642|Analgesics|analgesics|mesh-ancestor
25232878|NCT02579642|Sensory System Agents|sensory system agents|mesh-ancestor
25232879|NCT02579642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25232880|NCT02579642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232881|NCT02579642|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25232882|NCT02579642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25232883|NCT02579642|Anesthetics, General|anesthetics, general|mesh-ancestor
25232884|NCT02579642|Anesthetics|anesthetics|mesh-ancestor
25232885|NCT02579642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25232886|NCT02579642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25232887|NCT02579642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25232888|NCT02579642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25273592|NCT02384837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25044411|NCT01106807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25044412|NCT01105624|Azithromycin|azithromycin|mesh-list
25044413|NCT01105624|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25044414|NCT01105624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25044415|NCT01105624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25044416|NCT01105624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25044418|NCT01102660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25044419|NCT01102660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25044420|NCT01102660|Analgesics|analgesics|mesh-ancestor
25044421|NCT01102660|Sensory System Agents|sensory system agents|mesh-ancestor
25044422|NCT01102660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25044423|NCT01102660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044424|NCT01102660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24804118|NCT02001168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24804119|NCT02001168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24804120|NCT02001168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24804121|NCT02001168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24804122|NCT02001168|Growth Substances|growth substances|mesh-ancestor
24804123|NCT02001168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804124|NCT02001168|Growth Inhibitors|growth inhibitors|mesh-ancestor
25671995|NCT01739790|Antioxidants|antioxidants|mesh-ancestor
25671996|NCT01739790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25671997|NCT01739790|Protective Agents|protective agents|mesh-ancestor
25671998|NCT01739790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25671999|NCT01739790|Antidotes|antidotes|mesh-ancestor
25672000|NCT01739933|Dexmedetomidine|dexmedetomidine|mesh-list
25672001|NCT01739933|Propofol|propofol|mesh-list
25141424|NCT02957864|Antiviral Agents|antiviral agents|mesh-ancestor
25141425|NCT02957864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25141426|NCT02957864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24760094|NCT01756417|Metformin|metformin|mesh-list
24804125|NCT02001207|Hydrocortisone|hydrocortisone|mesh-list
24804126|NCT02001207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24804135|NCT02001259|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24804136|NCT02001259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24804139|NCT02001272|Paclitaxel|paclitaxel|mesh-list
24598653|NCT00957177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24804141|NCT02001272|Carboplatin|carboplatin|mesh-list
24804142|NCT02001272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24804143|NCT02001272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804144|NCT02001272|Tubulin Modulators|tubulin modulators|mesh-ancestor
24804145|NCT02001272|Antimitotic Agents|antimitotic agents|mesh-ancestor
24804146|NCT02001272|Mitosis Modulators|mitosis modulators|mesh-ancestor
24804147|NCT02001272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804148|NCT02001285|Remifentanil|remifentanil|mesh-list
24804149|NCT02001285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24804150|NCT02001285|Narcotics|narcotics|mesh-ancestor
24804151|NCT02001285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24804152|NCT02001285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804153|NCT02001285|Analgesics|analgesics|mesh-ancestor
24804154|NCT02001285|Sensory System Agents|sensory system agents|mesh-ancestor
24804155|NCT02001285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804156|NCT02001298|Nitroprusside|nitroprusside|mesh-list
24804158|NCT02001298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24804159|NCT02001298|Narcotics|narcotics|mesh-ancestor
24804160|NCT02001298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24804161|NCT02001298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804162|NCT02001298|Analgesics|analgesics|mesh-ancestor
24804163|NCT02001298|Sensory System Agents|sensory system agents|mesh-ancestor
24804164|NCT02001298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24598724|NCT00957411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24598725|NCT00957554|Amlodipine|amlodipine|mesh-list
24598726|NCT00957554|Irbesartan|irbesartan|mesh-list
24598727|NCT00957554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24598728|NCT00957554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24598744|NCT00957879|Ergocalciferols|ergocalciferols|mesh-list
24598745|NCT00957879|Vitamin D|vitamin d|mesh-list
25872264|NCT00124995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24466432|NCT00373542|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24466433|NCT00373542|Dopamine Agonists|dopamine agonists|mesh-ancestor
25232889|NCT02579642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232890|NCT02579902|Vitamin D|vitamin d|mesh-list
25232891|NCT02579902|Cholecalciferol|cholecalciferol|mesh-list
25232892|NCT02579902|Vitamins|vitamins|mesh-ancestor
25232893|NCT02579902|Micronutrients|micronutrients|mesh-ancestor
25232894|NCT02579902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232895|NCT02579902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25232896|NCT02579902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25232897|NCT02579590|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25232898|NCT02579590|Medroxyprogesterone|medroxyprogesterone|mesh-list
25232899|NCT02579590|Desogestrel|desogestrel|mesh-list
25232900|NCT02579590|Etonogestrel|etonogestrel|mesh-list
25232901|NCT02579590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25232902|NCT02579590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25044425|NCT01102660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25044426|NCT01102660|Gout Suppressants|gout suppressants|mesh-ancestor
25044427|NCT01102660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25044428|NCT01102660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044429|NCT01102660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044430|NCT01101594|Doxorubicin|doxorubicin|mesh-list
25044431|NCT01101594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25072628|NCT03400267|Antipyretics|antipyretics|mesh-ancestor
25672002|NCT01739933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25672003|NCT01739933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25672004|NCT01739933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672005|NCT01739933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25672006|NCT01739933|Anesthetics, General|anesthetics, general|mesh-ancestor
25672007|NCT01739933|Anesthetics|anesthetics|mesh-ancestor
25872265|NCT00124995|Adrenergic Agents|adrenergic agents|mesh-ancestor
25872266|NCT00124995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24804178|NCT02001363|Incretins|incretins|mesh-ancestor
24804179|NCT02001363|Hormones|hormones|mesh-ancestor
24804195|NCT02001506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24804236|NCT02001818|Interferon-alpha|interferon-alpha|mesh-list
24804237|NCT02001818|Interferon alpha-2|interferon alpha-2|mesh-list
24804238|NCT02001818|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24804239|NCT02001818|Imatinib Mesylate|imatinib mesylate|mesh-list
24804240|NCT02001818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804241|NCT02001818|Antiviral Agents|antiviral agents|mesh-ancestor
24804242|NCT02001818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24804243|NCT02001818|Immunologic Factors|immunologic factors|mesh-ancestor
24804244|NCT02001818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804245|NCT02001818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24804246|NCT02001818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24804247|NCT02001818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804248|NCT02001857|Hemostatics|hemostatics|mesh-list
24804249|NCT02001857|Coagulants|coagulants|mesh-ancestor
24804250|NCT02001883|Policosanol|policosanol|mesh-list
24804251|NCT02001883|Atorvastatin|atorvastatin|mesh-list
24804262|NCT02001896|Gemcitabine|gemcitabine|mesh-list
24804263|NCT02001896|Carboplatin|carboplatin|mesh-list
24804264|NCT02001896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24804265|NCT02001896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804266|NCT02001896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24804267|NCT02001896|Antimetabolites|antimetabolites|mesh-ancestor
24804268|NCT02001896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804269|NCT02001896|Antiviral Agents|antiviral agents|mesh-ancestor
24804270|NCT02001896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24804271|NCT02001896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232903|NCT02579590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25232904|NCT02579590|Contraceptive Agents|contraceptive agents|mesh-ancestor
25232905|NCT02579590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25232906|NCT02579590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232907|NCT02579590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25232908|NCT02579590|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25232909|NCT02579590|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25232910|NCT02579590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25232911|NCT02579590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232912|NCT02579590|Progestins|progestins|mesh-ancestor
25232914|NCT02579590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25232915|NCT02579564|Gemcitabine|gemcitabine|mesh-list
25232916|NCT02579564|Paclitaxel|paclitaxel|mesh-list
25232917|NCT02579564|Vinorelbine|vinorelbine|mesh-list
25232918|NCT02579564|Pemetrexed|pemetrexed|mesh-list
25232919|NCT02579564|Endostar protein|endostar protein|mesh-list
25232920|NCT02579564|Endostatins|endostatins|mesh-list
25232921|NCT02579564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25232922|NCT02579564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232923|NCT02579564|Tubulin Modulators|tubulin modulators|mesh-ancestor
24804272|NCT02001896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24804273|NCT02001896|Immunologic Factors|immunologic factors|mesh-ancestor
24804274|NCT02001896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804291|NCT02001935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804292|NCT02001935|Vasodilator Agents|vasodilator agents|mesh-ancestor
25672008|NCT01739933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24804293|NCT02001935|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24804294|NCT02001935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24804295|NCT02001935|Purinergic Agents|purinergic agents|mesh-ancestor
25141574|NCT02956538|Thalidomide|thalidomide|mesh-list
25141575|NCT02956538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25141576|NCT02956538|Immunologic Factors|immunologic factors|mesh-ancestor
25141577|NCT02956538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466437|NCT00373542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466438|NCT00373568|Miltefosine|miltefosine|mesh-list
24466439|NCT00373568|Antifungal Agents|antifungal agents|mesh-ancestor
24466440|NCT00373568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24466441|NCT00373568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804296|NCT02001935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24804297|NCT02001948|Morphine|morphine|mesh-list
24804298|NCT02001948|Bupivacaine|bupivacaine|mesh-list
24804299|NCT02001948|Anesthetics, Local|anesthetics, local|mesh-ancestor
24662799|NCT01296997|Calcium|calcium|mesh-list
24804300|NCT02001948|Anesthetics|anesthetics|mesh-ancestor
24804301|NCT02001948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24804316|NCT02002000|Cholecalciferol|cholecalciferol|mesh-list
24804317|NCT02002000|Vitamins|vitamins|mesh-ancestor
24804318|NCT02002000|Micronutrients|micronutrients|mesh-ancestor
24804319|NCT02002000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804320|NCT02002000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24804322|NCT02002039|Epoetin Alfa|epoetin alfa|mesh-list
24466462|NCT00373594|Rituximab|rituximab|mesh-list
24804344|NCT02002078|Protective Agents|protective agents|mesh-ancestor
24804345|NCT02002078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24804346|NCT02002078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804348|NCT02002156|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24804349|NCT02002156|BCG Vaccine|bcg vaccine|mesh-list
24804350|NCT02002156|Immunologic Factors|immunologic factors|mesh-ancestor
24804351|NCT02002156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804352|NCT02002156|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24804353|NCT02002195|Leucovorin|leucovorin|mesh-list
24804354|NCT02002195|Fluorouracil|fluorouracil|mesh-list
24804355|NCT02002195|Capecitabine|capecitabine|mesh-list
24804356|NCT02002195|Oxaliplatin|oxaliplatin|mesh-list
24804357|NCT02002195|Antimetabolites|antimetabolites|mesh-ancestor
24804358|NCT02002195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804359|NCT02002195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24804360|NCT02002195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804361|NCT02002195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24804362|NCT02002195|Immunologic Factors|immunologic factors|mesh-ancestor
24804363|NCT02002195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804365|NCT02002195|Protective Agents|protective agents|mesh-ancestor
24804366|NCT02002195|Vitamin B Complex|vitamin b complex|mesh-ancestor
24804367|NCT02002195|Vitamins|vitamins|mesh-ancestor
24804368|NCT02002195|Micronutrients|micronutrients|mesh-ancestor
24804369|NCT02002247|Selenium|selenium|mesh-list
24804370|NCT02002247|Selenious Acid|selenious acid|mesh-list
24804371|NCT02002247|Sodium Selenite|sodium selenite|mesh-list
24804372|NCT02002247|Antioxidants|antioxidants|mesh-ancestor
24804373|NCT02002247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804374|NCT02002247|Protective Agents|protective agents|mesh-ancestor
24804375|NCT02002247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804376|NCT02002247|Trace Elements|trace elements|mesh-ancestor
24804386|NCT02002260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24804387|NCT02002260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804388|NCT02002260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24804389|NCT02002260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25077920|NCT03360760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24804390|NCT02002260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24804391|NCT02002260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24804392|NCT02002260|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24804393|NCT02002286|Triptolide|triptolide|mesh-list
24804394|NCT02002286|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
24599013|NCT05351021|Metformin|metformin|mesh-list
24662931|NCT01297764|Vorinostat|vorinostat|mesh-list
24599014|NCT05351021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25232924|NCT02579564|Antimitotic Agents|antimitotic agents|mesh-ancestor
25232925|NCT02579564|Mitosis Modulators|mitosis modulators|mesh-ancestor
24804422|NCT02002390|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25672009|NCT01739933|Analgesics|analgesics|mesh-ancestor
25672010|NCT01739933|Sensory System Agents|sensory system agents|mesh-ancestor
25672011|NCT01739933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25674526|NCT01773122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24804423|NCT02002390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804425|NCT02002390|Immunologic Factors|immunologic factors|mesh-ancestor
24804426|NCT02002390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804427|NCT02002403|Danazol|danazol|mesh-list
24804432|NCT02002442|Chlorhexidine|chlorhexidine|mesh-list
24804433|NCT02002442|Cetylpyridinium|cetylpyridinium|mesh-list
24804465|NCT02002663|Ropivacaine|ropivacaine|mesh-list
24804466|NCT02002663|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24804467|NCT02002663|Prednisolone phosphate|prednisolone phosphate|mesh-list
24804468|NCT02002663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24804469|NCT02002663|Narcotics|narcotics|mesh-ancestor
24804470|NCT02002663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24804471|NCT02002663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872267|NCT00124995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872268|NCT00125008|Vaccines|vaccines|mesh-list
25872269|NCT00125008|Immunologic Factors|immunologic factors|mesh-ancestor
25872270|NCT00125008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077923|NCT03360760|Abortifacient Agents|abortifacient agents|mesh-ancestor
25872271|NCT00125021|Capecitabine|capecitabine|mesh-list
25872272|NCT00125021|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25077938|NCT03360734|Necitumumab|necitumumab|mesh-list
25077939|NCT03360734|Antibodies|antibodies|mesh-list
25077940|NCT03360734|Immunologic Factors|immunologic factors|mesh-ancestor
25077943|NCT03360734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25077944|NCT03360682|Tenofovir|tenofovir|mesh-list
25077945|NCT03360682|Lamivudine|lamivudine|mesh-list
25077946|NCT03360682|Emtricitabine|emtricitabine|mesh-list
24804496|NCT02002715|Glucocorticoids|glucocorticoids|mesh-ancestor
24804497|NCT02002715|Hormones|hormones|mesh-ancestor
24466450|NCT00373581|Sensory System Agents|sensory system agents|mesh-ancestor
24804500|NCT02002741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24804501|NCT02002741|Analgesics|analgesics|mesh-ancestor
24804502|NCT02002741|Sensory System Agents|sensory system agents|mesh-ancestor
24804503|NCT02002741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804504|NCT02002741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804505|NCT02002741|Antipyretics|antipyretics|mesh-ancestor
24804506|NCT02002754|Bambuterol|bambuterol|mesh-list
24804507|NCT02002754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24804508|NCT02002754|Autonomic Agents|autonomic agents|mesh-ancestor
24804516|NCT02002806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24804517|NCT02002806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804519|NCT02002858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24804520|NCT02002858|Autonomic Agents|autonomic agents|mesh-ancestor
24804521|NCT02002858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804522|NCT02002858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804523|NCT02002858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24804524|NCT02002858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24804525|NCT02002858|Cholinergic Agents|cholinergic agents|mesh-ancestor
24804526|NCT02002858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24804527|NCT02002858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804528|NCT02002923|Botulinum Toxins|botulinum toxins|mesh-list
24804529|NCT02002923|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24804530|NCT02002923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24804531|NCT02002923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804532|NCT02002923|Cholinergic Agents|cholinergic agents|mesh-ancestor
25232926|NCT02579564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232927|NCT02579564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25232928|NCT02579564|Antimetabolites|antimetabolites|mesh-ancestor
25232929|NCT02579564|Antiviral Agents|antiviral agents|mesh-ancestor
25872273|NCT00125021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25077947|NCT03360682|Abacavir|abacavir|mesh-list
25077948|NCT03360682|Dolutegravir|dolutegravir|mesh-list
25154450|NCT05471479|Protective Agents|protective agents|mesh-ancestor
25154451|NCT05471479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154453|NCT05471453|Vitamin E|vitamin e|mesh-list
25154454|NCT05471453|Tocopherols|tocopherols|mesh-list
25154455|NCT05471453|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25154456|NCT05471453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25154457|NCT05471453|Immunologic Factors|immunologic factors|mesh-ancestor
25062936|NCT03440216|Meropenem|meropenem|mesh-list
24804533|NCT02002923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24804534|NCT02002923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872274|NCT00125021|Antimetabolites|antimetabolites|mesh-ancestor
25141731|NCT02955927|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25141732|NCT02955927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25141733|NCT02955927|Cholinergic Agents|cholinergic agents|mesh-ancestor
25141734|NCT02955927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25090383|NCT03258385|Vitamin B 12|vitamin b 12|mesh-list
24456737|NCT00332072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24456738|NCT00332072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24477355|NCT00418353|Glucocorticoids|glucocorticoids|mesh-ancestor
24477356|NCT00418353|Hormones|hormones|mesh-ancestor
24804535|NCT02002962|Botulinum Toxins|botulinum toxins|mesh-list
24804536|NCT02002962|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24445021|NCT00300040|Analgesics|analgesics|mesh-ancestor
24804549|NCT02003001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804551|NCT02003001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24804552|NCT02003001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804555|NCT02003209|Trastuzumab|trastuzumab|mesh-list
24804556|NCT02003209|Pertuzumab|pertuzumab|mesh-list
24804557|NCT02003209|Goserelin|goserelin|mesh-list
24804558|NCT02003209|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
24804559|NCT02003209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24804575|NCT02003209|Hormone Antagonists|hormone antagonists|mesh-ancestor
24804576|NCT02003209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24804577|NCT02003313|Vaccines|vaccines|mesh-list
24804578|NCT02003313|Immunologic Factors|immunologic factors|mesh-ancestor
24804579|NCT02003313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804580|NCT02003456|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24804581|NCT02003456|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24804583|NCT02003495|Vaccines|vaccines|mesh-list
24804591|NCT02003664|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24804594|NCT02003664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24466513|NCT00373672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466514|NCT00373776|Miltefosine|miltefosine|mesh-list
24466515|NCT00373776|Antifungal Agents|antifungal agents|mesh-ancestor
24466530|NCT00373789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804595|NCT02003664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804596|NCT02003677|Insulin|insulin|mesh-list
24804597|NCT02003677|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25672013|NCT01739933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25672014|NCT01739933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25672015|NCT01739933|Adrenergic Agents|adrenergic agents|mesh-ancestor
25672016|NCT01739933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25672017|NCT01739933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672018|NCT01740089|Ribavirin|ribavirin|mesh-list
25672019|NCT01740089|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25672020|NCT01740089|Antimetabolites|antimetabolites|mesh-ancestor
25672021|NCT01740089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672022|NCT01740089|Antiviral Agents|antiviral agents|mesh-ancestor
25672023|NCT01740089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25672024|NCT01740206|Methylphenidate|methylphenidate|mesh-list
25672025|NCT01740206|Amphetamine|amphetamine|mesh-list
25672026|NCT01740206|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25672027|NCT01740206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672028|NCT01740206|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25672029|NCT01740206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25672030|NCT01740206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25141781|NCT02954692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141782|NCT02954822|Glimepiride|glimepiride|mesh-list
25141783|NCT02954822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25141784|NCT02954822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25141785|NCT02954822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804598|NCT02003677|Insulin Aspart|insulin aspart|mesh-list
24804599|NCT02003677|Insulin, Long-Acting|insulin, long-acting|mesh-list
24804600|NCT02003677|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24804601|NCT02003677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24804602|NCT02003677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804603|NCT02003768|Propofol|propofol|mesh-list
25232930|NCT02579564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25232931|NCT02579564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232932|NCT02579564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25232933|NCT02579564|Immunologic Factors|immunologic factors|mesh-ancestor
25232934|NCT02579564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232935|NCT02579564|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25232936|NCT02579564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25232937|NCT02579564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25232938|NCT02579564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25232939|NCT02579564|Growth Substances|growth substances|mesh-ancestor
25232940|NCT02579564|Growth Inhibitors|growth inhibitors|mesh-ancestor
25232941|NCT02579707|Ivosidenib|ivosidenib|mesh-list
25232942|NCT02579707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25154458|NCT05471453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154459|NCT05471453|Antioxidants|antioxidants|mesh-ancestor
25154460|NCT05471453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154461|NCT05471453|Protective Agents|protective agents|mesh-ancestor
25154462|NCT05471453|Vitamins|vitamins|mesh-ancestor
25154463|NCT05471453|Micronutrients|micronutrients|mesh-ancestor
25154464|NCT05471427|Docetaxel|docetaxel|mesh-list
25154466|NCT05471427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804604|NCT02003768|Desflurane|desflurane|mesh-list
24599306|NCT04770493|Lamotrigine|lamotrigine|mesh-list
24599307|NCT04770493|Anticonvulsants|anticonvulsants|mesh-ancestor
24599308|NCT04770493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24599309|NCT04770493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24599310|NCT04770493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599311|NCT04770493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24599318|NCT04768686|Pembrolizumab|pembrolizumab|mesh-list
24804680|NCT02004314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24804681|NCT02004314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24804682|NCT02004314|Antimalarials|antimalarials|mesh-ancestor
24804683|NCT02004314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24804684|NCT02004418|Choline|choline|mesh-list
24804687|NCT02004418|Antimetabolites|antimetabolites|mesh-ancestor
24804694|NCT02004574|Betamethasone Valerate|betamethasone valerate|mesh-list
24804695|NCT02004574|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24804696|NCT02004574|Betamethasone benzoate|betamethasone benzoate|mesh-list
24804697|NCT02004574|Calcipotriene|calcipotriene|mesh-list
24864226|NCT05146713|Disinfectants|disinfectants|mesh-ancestor
24804739|NCT02004860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804740|NCT02004860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24804741|NCT02004860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24804742|NCT02004860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804743|NCT02004860|Antifungal Agents|antifungal agents|mesh-ancestor
24804744|NCT02004860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24466531|NCT00373802|Phenylephrine|phenylephrine|mesh-list
24466532|NCT00373802|Oxymetazoline|oxymetazoline|mesh-list
24466533|NCT00373802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24466534|NCT00373802|Mydriatics|mydriatics|mesh-ancestor
24466535|NCT00373802|Autonomic Agents|autonomic agents|mesh-ancestor
24466730|NCT00374764|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24466538|NCT00373802|Sympathomimetics|sympathomimetics|mesh-ancestor
24466539|NCT00373802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24466540|NCT00373802|Nasal Decongestants|nasal decongestants|mesh-ancestor
24466541|NCT00373802|Respiratory System Agents|respiratory system agents|mesh-ancestor
24466542|NCT00373802|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24466543|NCT00373802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25672031|NCT01740206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672032|NCT01740206|Dopamine Agents|dopamine agents|mesh-ancestor
25672033|NCT01740206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25672034|NCT01740206|Sympathomimetics|sympathomimetics|mesh-ancestor
25672035|NCT01740206|Autonomic Agents|autonomic agents|mesh-ancestor
25872275|NCT00125021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466615|NCT00374205|Schistosomicides|schistosomicides|mesh-ancestor
25409692|NCT03358472|Cisplatin|cisplatin|mesh-list
25047095|NCT00834197|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25047096|NCT00834197|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25047097|NCT00834197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25047098|NCT00834197|Adrenergic Agents|adrenergic agents|mesh-ancestor
25047101|NCT00834197|Serotonin Agents|serotonin agents|mesh-ancestor
24466616|NCT00374205|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24466617|NCT00374205|Anthelmintics|anthelmintics|mesh-ancestor
24466619|NCT00374348|Antidepressive Agents|antidepressive agents|mesh-ancestor
24466620|NCT00374348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24804768|NCT02005107|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24804769|NCT02005107|Antidepressive Agents|antidepressive agents|mesh-ancestor
24804770|NCT02005107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24804772|NCT02005120|Endostatins|endostatins|mesh-list
24804773|NCT02005120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24804774|NCT02005120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232943|NCT02579707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25232944|NCT02579707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232945|NCT02579681|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25232946|NCT02579681|Dermatologic Agents|dermatologic agents|mesh-ancestor
25232947|NCT02579681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25232948|NCT02579681|Immunologic Factors|immunologic factors|mesh-ancestor
25232949|NCT02579681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232950|NCT02579733|Azathioprine|azathioprine|mesh-list
25154468|NCT05471427|Antimitotic Agents|antimitotic agents|mesh-ancestor
25154469|NCT05471427|Mitosis Modulators|mitosis modulators|mesh-ancestor
25154470|NCT05471427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804775|NCT02005120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24804776|NCT02005120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24804777|NCT02005120|Growth Substances|growth substances|mesh-ancestor
24804778|NCT02005120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804779|NCT02005120|Growth Inhibitors|growth inhibitors|mesh-ancestor
24804781|NCT02005289|Immunologic Factors|immunologic factors|mesh-ancestor
24804782|NCT02005289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804783|NCT02005289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24804784|NCT02005289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24804785|NCT02005289|Growth Substances|growth substances|mesh-ancestor
24804786|NCT02005289|Growth Inhibitors|growth inhibitors|mesh-ancestor
24804824|NCT02005419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24576062|NCT00836485|Histamine Agents|histamine agents|mesh-ancestor
24576063|NCT00836485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576064|NCT00836485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872276|NCT00125021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24576066|NCT00836485|Dermatologic Agents|dermatologic agents|mesh-ancestor
24576067|NCT00836537|Benazepril|benazepril|mesh-list
24576068|NCT00836537|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24466621|NCT00374348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24466622|NCT00374348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24466623|NCT00374348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24466624|NCT00374348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466625|NCT00374348|Dopamine Agonists|dopamine agonists|mesh-ancestor
24466626|NCT00374348|Dopamine Agents|dopamine agents|mesh-ancestor
24466627|NCT00374348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24466628|NCT00374348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466629|NCT00374348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24804850|NCT02005575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24804851|NCT02005575|Sensory System Agents|sensory system agents|mesh-ancestor
24804852|NCT02005588|Iron|iron|mesh-list
24804853|NCT02005588|Ferrous fumarate|ferrous fumarate|mesh-list
24804854|NCT02005588|Iron Chelating Agents|iron chelating agents|mesh-list
24804855|NCT02005588|Trace Elements|trace elements|mesh-ancestor
24804856|NCT02005588|Micronutrients|micronutrients|mesh-ancestor
24804899|NCT02005757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24804900|NCT02005757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804901|NCT02005757|Antimalarials|antimalarials|mesh-ancestor
24804902|NCT02005757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24804903|NCT02005757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24804904|NCT02005757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24804909|NCT02005770|Sevoflurane|sevoflurane|mesh-list
24804910|NCT02005770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25672036|NCT01740206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25672037|NCT01740206|Adrenergic Agents|adrenergic agents|mesh-ancestor
25672038|NCT01740206|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25672039|NCT01740258|Bevacizumab|bevacizumab|mesh-list
25672040|NCT01740258|Temozolomide|temozolomide|mesh-list
25872277|NCT00125021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24477662|NCT00419653|Olanzapine|olanzapine|mesh-list
25872283|NCT00125060|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25872284|NCT00125060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25872285|NCT00125060|Antimetabolites|antimetabolites|mesh-ancestor
25872286|NCT00125060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672041|NCT01740258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25872287|NCT00125060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25872288|NCT00125060|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25672042|NCT01740258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672043|NCT01740258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25872289|NCT00125060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466717|NCT00374686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24466718|NCT00374699|Bortezomib|bortezomib|mesh-list
24466719|NCT00374699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466720|NCT00374764|Risperidone|risperidone|mesh-list
24466721|NCT00374764|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24466722|NCT00374764|Serotonin Agents|serotonin agents|mesh-ancestor
24804916|NCT02005770|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24804917|NCT02005770|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25077989|NCT03360123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25077990|NCT03360123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077991|NCT03360045|Tranexamic Acid|tranexamic acid|mesh-list
25077992|NCT03360045|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
25077993|NCT03360045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25077994|NCT03360045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24804918|NCT02005783|Cyclophosphamide|cyclophosphamide|mesh-list
24804919|NCT02005783|Docetaxel|docetaxel|mesh-list
25232951|NCT02579733|Antimetabolites|antimetabolites|mesh-ancestor
25232952|NCT02579733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232953|NCT02579733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25232954|NCT02579733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25232955|NCT02579733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25232956|NCT02579733|Immunologic Factors|immunologic factors|mesh-ancestor
25232957|NCT02579733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154475|NCT05471063|Amphotericin B|amphotericin b|mesh-list
25154476|NCT05471063|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24846990|NCT02244528|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24846991|NCT02244528|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24846992|NCT02244528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24846993|NCT02244528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846994|NCT02244528|Urological Agents|urological agents|mesh-ancestor
24846996|NCT02244567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846997|NCT02244567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24846998|NCT02244632|Bevacizumab|bevacizumab|mesh-list
24846999|NCT02244632|Fluorouracil|fluorouracil|mesh-list
24847000|NCT02244632|Oxaliplatin|oxaliplatin|mesh-list
24804920|NCT02005783|Epirubicin|epirubicin|mesh-list
24599474|NCT04492956|Ecopipam|ecopipam|mesh-list
25077995|NCT03360045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077996|NCT03360045|Hemostatics|hemostatics|mesh-ancestor
25077997|NCT03360045|Coagulants|coagulants|mesh-ancestor
24883938|NCT04408508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24804976|NCT02006355|Anesthetics, Local|anesthetics, local|mesh-ancestor
24804977|NCT02006355|Anesthetics|anesthetics|mesh-ancestor
24804978|NCT02006355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24804979|NCT02006355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804980|NCT02006355|Sensory System Agents|sensory system agents|mesh-ancestor
24804981|NCT02006355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804982|NCT02006485|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24804983|NCT02006485|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25672044|NCT01740258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25672045|NCT01740258|Growth Substances|growth substances|mesh-ancestor
25672046|NCT01740258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672047|NCT01740258|Growth Inhibitors|growth inhibitors|mesh-ancestor
25672048|NCT01740258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25672049|NCT01740258|Alkylating Agents|alkylating agents|mesh-ancestor
24466728|NCT00374764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24466729|NCT00374764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24466731|NCT00374764|Dopamine Agents|dopamine agents|mesh-ancestor
24466733|NCT00374777|Zolpidem|zolpidem|mesh-list
24466734|NCT00374777|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24466735|NCT00374777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24466736|NCT00374777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24466737|NCT00374777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466738|NCT00374777|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24466739|NCT00374777|GABA Agonists|gaba agonists|mesh-ancestor
24466740|NCT00374777|GABA Agents|gaba agents|mesh-ancestor
24466741|NCT00374777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24466742|NCT00374777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466743|NCT00374777|Anticonvulsants|anticonvulsants|mesh-ancestor
24466744|NCT00374777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25232958|NCT02579733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25232959|NCT02579473|Rotigotine|rotigotine|mesh-list
25232960|NCT02579473|Dopamine Agonists|dopamine agonists|mesh-ancestor
25232961|NCT02579473|Dopamine Agents|dopamine agents|mesh-ancestor
25232962|NCT02579473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25232963|NCT02579473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25232964|NCT02579473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232965|NCT02579434|Midazolam|midazolam|mesh-list
25232966|NCT02579434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25232967|NCT02579434|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25232968|NCT02579434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25232969|NCT02579434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25232970|NCT02579434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25232971|NCT02579434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25232972|NCT02579434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25232973|NCT02579434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25232974|NCT02579434|Anesthetics, General|anesthetics, general|mesh-ancestor
25232975|NCT02579434|Anesthetics|anesthetics|mesh-ancestor
25232976|NCT02579434|GABA Modulators|gaba modulators|mesh-ancestor
25232977|NCT02579434|GABA Agents|gaba agents|mesh-ancestor
24847005|NCT02244632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24847006|NCT02244632|Growth Substances|growth substances|mesh-ancestor
24847007|NCT02244632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847008|NCT02244632|Growth Inhibitors|growth inhibitors|mesh-ancestor
24847009|NCT02244632|Antimetabolites|antimetabolites|mesh-ancestor
24631807|NCT01120314|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25872290|NCT00125151|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25872291|NCT00125151|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24804991|NCT02006498|Antioxidants|antioxidants|mesh-ancestor
24804992|NCT02006498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804993|NCT02006498|Protective Agents|protective agents|mesh-ancestor
24804994|NCT02006498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804995|NCT02006589|Candesartan|candesartan|mesh-list
24804996|NCT02006589|Candesartan cilexetil|candesartan cilexetil|mesh-list
24804997|NCT02006589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24804998|NCT02006589|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24804999|NCT02006589|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24576304|NCT00837941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24576307|NCT00837941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25672050|NCT01740258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672051|NCT01740323|Curcumin|curcumin|mesh-list
25672052|NCT01740323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25872292|NCT00125151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25872293|NCT00125151|Immunologic Factors|immunologic factors|mesh-ancestor
24805015|NCT02006849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805017|NCT02006914|Picolinic acid|picolinic acid|mesh-list
24805018|NCT02006914|Trace Elements|trace elements|mesh-ancestor
24805019|NCT02006914|Micronutrients|micronutrients|mesh-ancestor
24805020|NCT02006914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805021|NCT02006914|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24805022|NCT02006914|Chelating Agents|chelating agents|mesh-ancestor
24805023|NCT02006914|Sequestering Agents|sequestering agents|mesh-ancestor
24805024|NCT02006914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576419|NCT00838370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24576420|NCT00838370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24576421|NCT00838370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25872296|NCT00125203|Botulinum Toxins|botulinum toxins|mesh-list
25872297|NCT00125203|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25872298|NCT00125203|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25872299|NCT00125203|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25872300|NCT00125203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25872301|NCT00125203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872302|NCT00125203|Cholinergic Agents|cholinergic agents|mesh-ancestor
25872303|NCT00125203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25872304|NCT00125203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872305|NCT00125203|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25872306|NCT00125203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24466957|NCT00375687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466958|NCT00375765|Dutasteride|dutasteride|mesh-list
24466959|NCT00375765|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24466960|NCT00375765|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25872307|NCT00125203|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25872308|NCT00125229|Mannitol|mannitol|mesh-list
25872309|NCT00125229|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25872310|NCT00125229|Diuretics|diuretics|mesh-ancestor
25872311|NCT00125229|Natriuretic Agents|natriuretic agents|mesh-ancestor
25872312|NCT00125229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872313|NCT00125255|Lidocaine|lidocaine|mesh-list
24466967|NCT00375778|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24466968|NCT00375778|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24466969|NCT00375778|Dopamine Agents|dopamine agents|mesh-ancestor
24466970|NCT00375778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24466971|NCT00375778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466993|NCT00375895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24466994|NCT00375895|Immunologic Factors|immunologic factors|mesh-ancestor
24466995|NCT00375895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466996|NCT00375895|Antifungal Agents|antifungal agents|mesh-ancestor
24805038|NCT02007005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466999|NCT00375895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24467000|NCT00375895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25872314|NCT00125255|Tetracaine|tetracaine|mesh-list
25872315|NCT00125255|Anesthetics, Local|anesthetics, local|mesh-ancestor
25872316|NCT00125255|Anesthetics|anesthetics|mesh-ancestor
25872317|NCT00125255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25872318|NCT00125255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467056|NCT00376077|gamma-Globulins|gamma-globulins|mesh-list
24467057|NCT00376077|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24467058|NCT00376077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24467060|NCT00376077|Autonomic Agents|autonomic agents|mesh-ancestor
25233002|NCT02579161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25233003|NCT02579161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25233004|NCT02579161|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25872319|NCT00125255|Sensory System Agents|sensory system agents|mesh-ancestor
25872320|NCT00125255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25233010|NCT02579161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24805041|NCT02007005|Antiviral Agents|antiviral agents|mesh-ancestor
24805042|NCT02007005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24805044|NCT02007148|Capecitabine|capecitabine|mesh-list
24805045|NCT02007148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24805046|NCT02007148|Tubulin Modulators|tubulin modulators|mesh-ancestor
24805047|NCT02007148|Antimitotic Agents|antimitotic agents|mesh-ancestor
24805048|NCT02007148|Mitosis Modulators|mitosis modulators|mesh-ancestor
24805049|NCT02007148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805050|NCT02007148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24576641|NCT00839501|Acetazolamide|acetazolamide|mesh-list
24467067|NCT00376077|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24467068|NCT00376077|Protective Agents|protective agents|mesh-ancestor
24467069|NCT00376077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24467070|NCT00376077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467071|NCT00376077|Immunologic Factors|immunologic factors|mesh-ancestor
24467072|NCT00376103|Temozolomide|temozolomide|mesh-list
24467073|NCT00376103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24467099|NCT00376181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467114|NCT00376311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24467115|NCT00376311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467116|NCT00376311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24467117|NCT00376311|Vasodilator Agents|vasodilator agents|mesh-ancestor
24467119|NCT00376324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24467184|NCT00376480|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24467185|NCT00376480|Protective Agents|protective agents|mesh-ancestor
24467186|NCT00376480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24467187|NCT00376480|Alkylating Agents|alkylating agents|mesh-ancestor
24467188|NCT00376480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24467189|NCT00376493|Metronidazole|metronidazole|mesh-list
24467190|NCT00376493|Doxycycline|doxycycline|mesh-list
24467191|NCT00376493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24467192|NCT00376493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24467193|NCT00376493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24467250|NCT00376740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467252|NCT00376766|Anticonvulsants|anticonvulsants|mesh-ancestor
24467253|NCT00376766|Nootropic Agents|nootropic agents|mesh-ancestor
24467255|NCT00376792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467256|NCT00376792|Tubulin Modulators|tubulin modulators|mesh-ancestor
24467257|NCT00376792|Antimitotic Agents|antimitotic agents|mesh-ancestor
24467258|NCT00376792|Mitosis Modulators|mitosis modulators|mesh-ancestor
25078060|NCT03359655|Oxytocics|oxytocics|mesh-ancestor
25872322|NCT00125255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25872323|NCT00125255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25872324|NCT00125255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25872325|NCT00125255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872326|NCT00125294|Methadone|methadone|mesh-list
25872327|NCT00125294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25872328|NCT00125294|Narcotics|narcotics|mesh-ancestor
25872329|NCT00125294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25672053|NCT01740323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25672054|NCT01740323|Analgesics|analgesics|mesh-ancestor
25672055|NCT01740323|Sensory System Agents|sensory system agents|mesh-ancestor
25672056|NCT01740323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25872330|NCT00125294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872331|NCT00125294|Analgesics|analgesics|mesh-ancestor
25233011|NCT02578914|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25233012|NCT02578914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24467273|NCT00376831|Anesthetics|anesthetics|mesh-ancestor
24467274|NCT00376831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24467308|NCT00377000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078061|NCT03359655|Anticonvulsants|anticonvulsants|mesh-ancestor
24805088|NCT02007408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805089|NCT02007408|Sensory System Agents|sensory system agents|mesh-ancestor
24805090|NCT02007408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24805091|NCT02007408|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24576802|NCT00840580|Ofloxacin|ofloxacin|mesh-list
24467312|NCT00377052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24467313|NCT00377052|Antimetabolites|antimetabolites|mesh-ancestor
24467314|NCT00377052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467315|NCT00377052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467316|NCT00377052|Antiviral Agents|antiviral agents|mesh-ancestor
24467317|NCT00377052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24467318|NCT00377052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467319|NCT00377052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24467320|NCT00377052|Immunologic Factors|immunologic factors|mesh-ancestor
24467321|NCT00377052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467322|NCT00377065|Raltegravir Potassium|raltegravir potassium|mesh-list
24467323|NCT00377065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24467324|NCT00377065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24467369|NCT00377325|Antifungal Agents|antifungal agents|mesh-ancestor
24467370|NCT00377325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25872333|NCT00125294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25872334|NCT00125294|Antitussive Agents|antitussive agents|mesh-ancestor
25872335|NCT00125294|Respiratory System Agents|respiratory system agents|mesh-ancestor
25872336|NCT00125307|Tacrolimus|tacrolimus|mesh-list
24805117|NCT02007798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24805118|NCT02007798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24805119|NCT02007798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805120|NCT02007798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24805122|NCT02007798|Sensory System Agents|sensory system agents|mesh-ancestor
24805123|NCT02007798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24805124|NCT02007798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24805125|NCT02007798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24805126|NCT02007798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24576873|NCT00840801|Vaccines|vaccines|mesh-list
25872337|NCT00125307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24467376|NCT00377390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24467377|NCT00377390|Respiratory System Agents|respiratory system agents|mesh-ancestor
24467379|NCT00377442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24467382|NCT00377442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467384|NCT00377442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24467385|NCT00377442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467386|NCT00377468|Dronabinol|dronabinol|mesh-list
24467387|NCT00377468|Hallucinogens|hallucinogens|mesh-ancestor
25097281|NCT03205033|Melatonin|melatonin|mesh-list
24467388|NCT00377468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813933|NCT02061267|Niacin|niacin|mesh-list
24805139|NCT02007837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24805140|NCT02007837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24805141|NCT02007837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805142|NCT02007837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24805143|NCT02007837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25672058|NCT01740323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25672059|NCT01740323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25672060|NCT01740323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672061|NCT01740323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672062|NCT01740323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872338|NCT00125307|Immunologic Factors|immunologic factors|mesh-ancestor
25872339|NCT00125307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233022|NCT02578953|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25233023|NCT02578953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25233024|NCT02578953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233025|NCT02578953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233026|NCT02578953|Hormone Antagonists|hormone antagonists|mesh-ancestor
25233027|NCT02578953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25233028|NCT02578953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233029|NCT02578849|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25233030|NCT02578849|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25233031|NCT02578849|Immunologic Factors|immunologic factors|mesh-ancestor
24816305|NCT02076230|Alkylating Agents|alkylating agents|mesh-ancestor
24816306|NCT02076230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672064|NCT01740362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25672065|NCT01740362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672066|NCT01740362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876729|NCT02834013|Nivolumab|nivolumab|mesh-list
25876730|NCT02834013|Ipilimumab|ipilimumab|mesh-list
24805162|NCT02007928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805163|NCT02007928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663704|NCT01303471|Remifentanil|remifentanil|mesh-list
24805164|NCT02007928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24805165|NCT02007928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24805166|NCT02007928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24805167|NCT02007928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24805169|NCT02007928|Dopamine Agents|dopamine agents|mesh-ancestor
24805170|NCT02007928|Antiemetics|antiemetics|mesh-ancestor
24805171|NCT02007928|Autonomic Agents|autonomic agents|mesh-ancestor
25672069|NCT01740388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25672070|NCT01740388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25672071|NCT01740388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25672072|NCT01740388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672073|NCT01740388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672074|NCT01740388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672075|NCT01740401|Cyclophosphamide|cyclophosphamide|mesh-list
25672076|NCT01740401|Ipilimumab|ipilimumab|mesh-list
25672077|NCT01740401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25672078|NCT01740401|Immunologic Factors|immunologic factors|mesh-ancestor
25672079|NCT01740401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599837|NCT03581240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599842|NCT03559192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24599844|NCT03549715|Tremelimumab|tremelimumab|mesh-list
24599845|NCT03549715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24577275|NCT00842686|Antimetabolites|antimetabolites|mesh-ancestor
24577277|NCT00842894|Insulin|insulin|mesh-list
24467771|NCT00378690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467772|NCT00378690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24467773|NCT00378690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25233038|NCT02578849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233039|NCT02578823|Antipyretics|antipyretics|mesh-list
25233040|NCT02578823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233041|NCT02578719|Bupivacaine|bupivacaine|mesh-list
25233042|NCT02578719|Anesthetics, Local|anesthetics, local|mesh-ancestor
25233043|NCT02578719|Anesthetics|anesthetics|mesh-ancestor
25233044|NCT02578719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25233045|NCT02578719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233046|NCT02578719|Sensory System Agents|sensory system agents|mesh-ancestor
25233047|NCT02578719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25233048|NCT02578641|Gemcitabine|gemcitabine|mesh-list
25233049|NCT02578641|Carboplatin|carboplatin|mesh-list
25672080|NCT01740401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25672081|NCT01740401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25672082|NCT01740401|Alkylating Agents|alkylating agents|mesh-ancestor
25672083|NCT01740401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672084|NCT01740401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672085|NCT01740401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25672086|NCT01740401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24467778|NCT00378716|Levoleucovorin|levoleucovorin|mesh-list
25872358|NCT00125411|Mitosis Modulators|mitosis modulators|mesh-ancestor
24467818|NCT00378833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467820|NCT00378833|Vasodilator Agents|vasodilator agents|mesh-ancestor
24467821|NCT00378833|Vitamin B Complex|vitamin b complex|mesh-ancestor
24577336|NCT00843154|Candesartan|candesartan|mesh-list
24467832|NCT00378911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467833|NCT00378911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24467834|NCT00378911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24467835|NCT00378911|Growth Substances|growth substances|mesh-ancestor
24467836|NCT00378911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467837|NCT00378911|Growth Inhibitors|growth inhibitors|mesh-ancestor
24467838|NCT00378911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24467839|NCT00378911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467840|NCT00378911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467841|NCT00378937|Acetaminophen|acetaminophen|mesh-list
24467842|NCT00378937|Morphine|morphine|mesh-list
24467843|NCT00378937|Oxycodone|oxycodone|mesh-list
25872359|NCT00125411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872360|NCT00125424|Midazolam|midazolam|mesh-list
25078113|NCT03359070|Hormone Antagonists|hormone antagonists|mesh-ancestor
25078119|NCT03359057|Folic Acid|folic acid|mesh-list
24467844|NCT00378937|Codeine|codeine|mesh-list
24467845|NCT00378937|Dextropropoxyphene|dextropropoxyphene|mesh-list
24467847|NCT00378937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24467848|NCT00378937|Narcotics|narcotics|mesh-ancestor
24467849|NCT00378937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24467851|NCT00378937|Analgesics|analgesics|mesh-ancestor
24467863|NCT00379015|Trastuzumab|trastuzumab|mesh-list
24467864|NCT00379015|Epirubicin|epirubicin|mesh-list
24467865|NCT00379015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24467866|NCT00379015|Immunologic Factors|immunologic factors|mesh-ancestor
24467867|NCT00379015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467902|NCT00379028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24467948|NCT00379249|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25872361|NCT00125424|Fospropofol|fospropofol|mesh-list
24467975|NCT00379431|Methylprednisolone|methylprednisolone|mesh-list
24467976|NCT00379431|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24467977|NCT00379431|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24467978|NCT00379431|Prednisolone|prednisolone|mesh-list
24467979|NCT00379431|Prednisolone acetate|prednisolone acetate|mesh-list
24599852|NCT03449758|Hydroxychloroquine|hydroxychloroquine|mesh-list
24599853|NCT03449758|Chloroquine|chloroquine|mesh-list
24599854|NCT03449758|Sulfasalazine|sulfasalazine|mesh-list
24599855|NCT03449758|Methotrexate|methotrexate|mesh-list
24805182|NCT02007928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24805183|NCT02008006|Cytarabine|cytarabine|mesh-list
24805184|NCT02008006|Etoposide|etoposide|mesh-list
24467980|NCT00379431|Rituximab|rituximab|mesh-list
24467981|NCT00379431|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24467982|NCT00379431|Prednisolone phosphate|prednisolone phosphate|mesh-list
25233050|NCT02578641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467983|NCT00379431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24467984|NCT00379431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467985|NCT00379431|Immunologic Factors|immunologic factors|mesh-ancestor
25233051|NCT02578641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25233052|NCT02578641|Antimetabolites|antimetabolites|mesh-ancestor
25233053|NCT02578641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233054|NCT02578641|Antiviral Agents|antiviral agents|mesh-ancestor
25233055|NCT02578641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25233056|NCT02578641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233057|NCT02578641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24847041|NCT02244762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24847042|NCT02244762|Antitussive Agents|antitussive agents|mesh-ancestor
24847043|NCT02244762|Respiratory System Agents|respiratory system agents|mesh-ancestor
24847044|NCT02244827|Levonadifloxacin|levonadifloxacin|mesh-list
25872362|NCT00125424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25872363|NCT00125424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25872364|NCT00125424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25872365|NCT00125424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847046|NCT02244827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24847047|NCT02244866|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24467986|NCT00379431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872366|NCT00125424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24467988|NCT00379431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25872367|NCT00125424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25872368|NCT00125424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25872369|NCT00125424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25872370|NCT00125424|Anesthetics, General|anesthetics, general|mesh-ancestor
25872371|NCT00125424|Anesthetics|anesthetics|mesh-ancestor
24954670|NCT03873298|Nitric Oxide|nitric oxide|mesh-list
25872372|NCT00125424|GABA Modulators|gaba modulators|mesh-ancestor
25872373|NCT00125424|GABA Agents|gaba agents|mesh-ancestor
25872374|NCT00125424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24468008|NCT00379457|Vinorelbine|vinorelbine|mesh-list
24468009|NCT00379457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24468010|NCT00379457|Immunologic Factors|immunologic factors|mesh-ancestor
24468011|NCT00379457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468012|NCT00379457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24468013|NCT00379457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24468014|NCT00379457|Alkylating Agents|alkylating agents|mesh-ancestor
24468054|NCT00379626|Hormones|hormones|mesh-list
24468055|NCT00379626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24468056|NCT00379626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468057|NCT00379665|Cisplatin|cisplatin|mesh-list
24468058|NCT00379665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468059|NCT00379691|Phenylephrine|phenylephrine|mesh-list
24468060|NCT00379691|Oxymetazoline|oxymetazoline|mesh-list
24468061|NCT00379691|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24468062|NCT00379691|Mydriatics|mydriatics|mesh-ancestor
24468063|NCT00379691|Autonomic Agents|autonomic agents|mesh-ancestor
24468064|NCT00379691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24468065|NCT00379691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468066|NCT00379691|Sympathomimetics|sympathomimetics|mesh-ancestor
24468126|NCT00379977|Immunologic Factors|immunologic factors|mesh-ancestor
24468127|NCT00379977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468128|NCT00380120|Warfarin|warfarin|mesh-list
24468129|NCT00380120|Anticoagulants|anticoagulants|mesh-ancestor
24468130|NCT00380133|Prednisolone|prednisolone|mesh-list
24468131|NCT00380133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24468132|NCT00380133|Glucocorticoids|glucocorticoids|mesh-ancestor
24468133|NCT00380133|Hormones|hormones|mesh-ancestor
24805190|NCT02008006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24805194|NCT02008006|Antimetabolites|antimetabolites|mesh-ancestor
24468135|NCT00380133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233058|NCT02578641|Immunologic Factors|immunologic factors|mesh-ancestor
25233059|NCT02578641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273593|NCT02384837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25273594|NCT02384837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25273595|NCT02384837|Antifungal Agents|antifungal agents|mesh-ancestor
25273596|NCT02384837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25273597|NCT02384837|Immunologic Factors|immunologic factors|mesh-ancestor
25273598|NCT02384837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273599|NCT02384889|Eflornithine|eflornithine|mesh-list
25273600|NCT02384889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24847048|NCT02244866|Hormones|hormones|mesh-ancestor
25672087|NCT01740401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25672088|NCT01740414|Ibudilast|ibudilast|mesh-list
25672089|NCT01740414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24847049|NCT02244866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24847052|NCT02244879|Antioxidants|antioxidants|mesh-ancestor
24847060|NCT02245022|Efavirenz|efavirenz|mesh-list
25672090|NCT01740414|Autonomic Agents|autonomic agents|mesh-ancestor
25672091|NCT01740414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25672092|NCT01740414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672093|NCT01740414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25672094|NCT01740414|Respiratory System Agents|respiratory system agents|mesh-ancestor
25672095|NCT01740414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25672096|NCT01740414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872375|NCT00125424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872376|NCT00125437|Spironolactone|spironolactone|mesh-list
25872377|NCT00125437|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24468137|NCT00380133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468138|NCT00380146|Pyrimethamine|pyrimethamine|mesh-list
24468139|NCT00380146|Sulfadoxine|sulfadoxine|mesh-list
24468140|NCT00380146|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24468141|NCT00380146|Antimalarials|antimalarials|mesh-ancestor
24468142|NCT00380146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24468143|NCT00380146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24468144|NCT00380146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24468145|NCT00380146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24468146|NCT00380146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24468182|NCT00380354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468183|NCT00380380|Vildagliptin|vildagliptin|mesh-list
24468257|NCT00380770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24468274|NCT00380913|Antiemetics|antiemetics|mesh-ancestor
24468275|NCT00380913|Autonomic Agents|autonomic agents|mesh-ancestor
24468276|NCT00380913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24468277|NCT00380913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468278|NCT00380913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24468279|NCT00380913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24468280|NCT00380913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24468281|NCT00380913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24468282|NCT00380913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24468283|NCT00380939|Atorvastatin|atorvastatin|mesh-list
24468284|NCT00380939|Pravastatin|pravastatin|mesh-list
24468285|NCT00380939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24468286|NCT00380939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24468287|NCT00380939|Antimetabolites|antimetabolites|mesh-ancestor
24468288|NCT00380939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468289|NCT00380939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24468290|NCT00380939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24468291|NCT00380939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24468293|NCT00380965|Antiemetics|antiemetics|mesh-ancestor
24468294|NCT00380965|Autonomic Agents|autonomic agents|mesh-ancestor
24805235|NCT02008162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805236|NCT02008162|Anticonvulsants|anticonvulsants|mesh-ancestor
24805237|NCT02008162|Tocolytic Agents|tocolytic agents|mesh-ancestor
24805238|NCT02008162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24805239|NCT02008162|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24805240|NCT02008162|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24805241|NCT02008162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24805242|NCT02008162|Adrenergic Agents|adrenergic agents|mesh-ancestor
24805243|NCT02008201|Vitamin D|vitamin d|mesh-list
24805244|NCT02008201|Vitamins|vitamins|mesh-ancestor
24805245|NCT02008201|Micronutrients|micronutrients|mesh-ancestor
24805246|NCT02008201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805247|NCT02008201|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24577700|NCT00845598|Xhance|xhance|mesh-list
24468317|NCT00381030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468318|NCT00381030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24468319|NCT00381030|Antioxidants|antioxidants|mesh-ancestor
24468320|NCT00381030|Protective Agents|protective agents|mesh-ancestor
24468349|NCT00381173|Cyclophosphamide|cyclophosphamide|mesh-list
24468352|NCT00381173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468353|NCT00381173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25233060|NCT02578602|Edetic Acid|edetic acid|mesh-list
25233061|NCT02578602|Pentetic Acid|pentetic acid|mesh-list
25233062|NCT02578602|Antidotes|antidotes|mesh-ancestor
25233063|NCT02578602|Protective Agents|protective agents|mesh-ancestor
25233064|NCT02578602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233065|NCT02578602|Chelating Agents|chelating agents|mesh-ancestor
25233066|NCT02578602|Sequestering Agents|sequestering agents|mesh-ancestor
25273601|NCT02384889|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24847056|NCT02244879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24847057|NCT02244879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24847059|NCT02245022|Lamivudine|lamivudine|mesh-list
24847062|NCT02245022|Antiviral Agents|antiviral agents|mesh-ancestor
24847063|NCT02245022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24847064|NCT02245022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24468460|NCT00381589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24468461|NCT00381589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468463|NCT00381654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468464|NCT00381654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24468465|NCT00381654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24468466|NCT00381654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468467|NCT00381732|Tadalafil|tadalafil|mesh-list
24468468|NCT00381732|Vasodilator Agents|vasodilator agents|mesh-ancestor
24468469|NCT00381732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25233067|NCT02578602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233068|NCT02578602|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25233069|NCT02578602|Anticoagulants|anticoagulants|mesh-ancestor
25233070|NCT02578602|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25233071|NCT02578550|Tenofovir|tenofovir|mesh-list
25233072|NCT02578550|Emtricitabine|emtricitabine|mesh-list
25233073|NCT02578550|Darunavir|darunavir|mesh-list
25233074|NCT02578550|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25233075|NCT02578550|Cobicistat|cobicistat|mesh-list
25233076|NCT02578550|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25233077|NCT02578550|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
25233078|NCT02578550|Antiviral Agents|antiviral agents|mesh-ancestor
25872383|NCT00125437|Natriuretic Agents|natriuretic agents|mesh-ancestor
25872384|NCT00125463|Candesartan|candesartan|mesh-list
25872385|NCT00125463|Candesartan cilexetil|candesartan cilexetil|mesh-list
25233082|NCT02578550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233083|NCT02578550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233084|NCT02578550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25233085|NCT02578550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25233086|NCT02578550|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25233087|NCT02578550|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25233088|NCT02578550|Protease Inhibitors|protease inhibitors|mesh-ancestor
25233089|NCT02578550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25233090|NCT02578550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25233091|NCT02578251|Acetaminophen|acetaminophen|mesh-list
24847066|NCT02245022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24847067|NCT02245022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847068|NCT02245022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24847069|NCT02245022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24847070|NCT02245022|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24847071|NCT02245022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25872388|NCT00125463|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24805265|NCT02008422|Endostatins|endostatins|mesh-list
24805266|NCT02008422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468682|NCT00382668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468683|NCT00382668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24468684|NCT00382668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24468685|NCT00382668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468686|NCT00382681|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25872389|NCT00125463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872390|NCT00125489|Chloroquine|chloroquine|mesh-list
25872391|NCT00125489|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
25872392|NCT00125489|Pyrimethamine|pyrimethamine|mesh-list
25872393|NCT00125489|Sulfadoxine|sulfadoxine|mesh-list
25872394|NCT00125489|Amebicides|amebicides|mesh-ancestor
25047267|NCT00829712|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
25047269|NCT00829712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468687|NCT00382694|Fludarabine|fludarabine|mesh-list
25872395|NCT00125489|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25872396|NCT00125489|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24468795|NCT00383474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468797|NCT00383487|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
24468798|NCT00383487|Naproxen|naproxen|mesh-list
24468799|NCT00383487|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
24468800|NCT00383487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24468801|NCT00383487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24468802|NCT00383487|Analgesics|analgesics|mesh-ancestor
25872397|NCT00125489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24468837|NCT00383682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468839|NCT00383682|Sensory System Agents|sensory system agents|mesh-ancestor
24468840|NCT00383682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24468841|NCT00383682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24468842|NCT00383682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24468843|NCT00383682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24468844|NCT00383682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24469051|NCT00384436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24469052|NCT00384436|Antidepressive Agents|antidepressive agents|mesh-ancestor
25872398|NCT00125489|Antimalarials|antimalarials|mesh-ancestor
24469069|NCT00384540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24469070|NCT00384540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469071|NCT00384540|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24469072|NCT00384540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24469073|NCT00384540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24469074|NCT00384540|Adrenergic Agents|adrenergic agents|mesh-ancestor
24469075|NCT00384540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24469076|NCT00384540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469077|NCT00384540|Protective Agents|protective agents|mesh-ancestor
25097664|NCT03202446|Chitosan|chitosan|mesh-list
24469130|NCT00384618|Micronutrients|micronutrients|mesh-ancestor
24469131|NCT00384618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469132|NCT00384618|Antioxidants|antioxidants|mesh-ancestor
24469135|NCT00384618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24469136|NCT00384618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24469137|NCT00384618|Antimetabolites|antimetabolites|mesh-ancestor
24469138|NCT00384618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24469139|NCT00384618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24469140|NCT00384618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469141|NCT00384631|Bevacizumab|bevacizumab|mesh-list
24469142|NCT00384631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24469143|NCT00384631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469144|NCT00384631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24469145|NCT00384631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24469146|NCT00384631|Growth Substances|growth substances|mesh-ancestor
24469147|NCT00384631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233092|NCT02578251|Meperidine|meperidine|mesh-list
25233093|NCT02578251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25233094|NCT02578251|Analgesics|analgesics|mesh-ancestor
25233095|NCT02578251|Sensory System Agents|sensory system agents|mesh-ancestor
25233096|NCT02578251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25233097|NCT02578251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233098|NCT02578251|Antipyretics|antipyretics|mesh-ancestor
25233099|NCT02578251|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25233100|NCT02578251|Narcotics|narcotics|mesh-ancestor
24847072|NCT02245022|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25672097|NCT01740414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672098|NCT01740414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25672099|NCT01740414|Vasodilator Agents|vasodilator agents|mesh-ancestor
25672100|NCT01740713|Deferiprone|deferiprone|mesh-list
25672101|NCT01740713|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25672102|NCT01740713|Chelating Agents|chelating agents|mesh-ancestor
25672103|NCT01740713|Sequestering Agents|sequestering agents|mesh-ancestor
25672104|NCT01740713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672106|NCT01740726|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24882035|NCT02979977|Cetuximab|cetuximab|mesh-list
24847073|NCT02245022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24847074|NCT02245022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24469221|NCT00384917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24469222|NCT00384917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469223|NCT00384917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24469224|NCT00384969|Sorafenib|sorafenib|mesh-list
24469226|NCT00384969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469227|NCT00384969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24469228|NCT00384969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469229|NCT00384969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469230|NCT00384969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24469231|NCT00384969|Immunologic Factors|immunologic factors|mesh-ancestor
24469232|NCT00384969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469233|NCT00385021|Leucovorin|leucovorin|mesh-list
24469234|NCT00385021|Fluorouracil|fluorouracil|mesh-list
24469235|NCT00385021|Oxaliplatin|oxaliplatin|mesh-list
24469236|NCT00385021|Bevacizumab|bevacizumab|mesh-list
24469237|NCT00385021|Antimetabolites|antimetabolites|mesh-ancestor
24469238|NCT00385021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469239|NCT00385021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24469272|NCT00385307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469273|NCT00385359|Albuterol|albuterol|mesh-list
24469274|NCT00385359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24469275|NCT00385359|Autonomic Agents|autonomic agents|mesh-ancestor
24469276|NCT00385359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24469277|NCT00385359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469287|NCT00385359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469289|NCT00385385|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24469290|NCT00385385|Antitubercular Agents|antitubercular agents|mesh-ancestor
24469291|NCT00385385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24469292|NCT00385385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24469293|NCT00385385|Leprostatic Agents|leprostatic agents|mesh-ancestor
24469294|NCT00385398|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24469296|NCT00385398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469297|NCT00385398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24469298|NCT00385398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469332|NCT00385437|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24469334|NCT00385450|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24469335|NCT00385450|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24469336|NCT00385450|Protease Inhibitors|protease inhibitors|mesh-ancestor
24469337|NCT00385450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469338|NCT00385450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469339|NCT00385450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24469340|NCT00385450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24469342|NCT00385450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24469344|NCT00385463|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24469345|NCT00385463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24469346|NCT00385463|Respiratory System Agents|respiratory system agents|mesh-ancestor
24469347|NCT00385463|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24469348|NCT00385463|Hormone Antagonists|hormone antagonists|mesh-ancestor
24469349|NCT00385463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24469350|NCT00385463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469351|NCT00385463|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24469352|NCT00385463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24469437|NCT00385853|Vatalanib|vatalanib|mesh-list
24469438|NCT00385853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24469439|NCT00385853|Alkylating Agents|alkylating agents|mesh-ancestor
24469440|NCT00385853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469441|NCT00385853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469442|NCT00385853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24469443|NCT00385853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233101|NCT02578251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25233102|NCT02578251|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25233103|NCT02578277|BMS-955176|bms-955176|mesh-list
25233104|NCT02578277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25233105|NCT02578277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25672107|NCT01740726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24469460|NCT00385957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469462|NCT00385957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24469463|NCT00385957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24469464|NCT00385957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24469466|NCT00385970|polysaccharide-K|polysaccharide-k|mesh-list
24469467|NCT00385970|Tegafur|tegafur|mesh-list
24469469|NCT00385970|Levoleucovorin|levoleucovorin|mesh-list
24469478|NCT00385970|Antimetabolites|antimetabolites|mesh-ancestor
24469479|NCT00385970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469516|NCT00386191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24736860|NCT01665404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872404|NCT00125489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24864927|NCT05148026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24469551|NCT00386282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24469569|NCT00386373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469571|NCT00386399|Mitomycin|mitomycin|mesh-list
24469572|NCT00386399|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24469573|NCT00386399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469574|NCT00386399|Alkylating Agents|alkylating agents|mesh-ancestor
24469575|NCT00386399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469576|NCT00386399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24469577|NCT00386399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872405|NCT00125489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469584|NCT00386503|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24469585|NCT00386503|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24469593|NCT00386516|Antimetabolites|antimetabolites|mesh-ancestor
24469633|NCT00386581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469634|NCT00386646|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24469635|NCT00386646|Laxatives|laxatives|mesh-ancestor
24469636|NCT00386646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24469637|NCT00386659|Ritonavir|ritonavir|mesh-list
24469638|NCT00386659|Lopinavir|lopinavir|mesh-list
24469639|NCT00386659|Tenofovir|tenofovir|mesh-list
24469640|NCT00386659|Abacavir|abacavir|mesh-list
24469641|NCT00386659|Efavirenz|efavirenz|mesh-list
24469642|NCT00386659|Dideoxynucleosides|dideoxynucleosides|mesh-list
24469643|NCT00386659|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25872406|NCT00125489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24469644|NCT00386659|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24469645|NCT00386659|Protease Inhibitors|protease inhibitors|mesh-ancestor
24469646|NCT00386659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469647|NCT00386659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233106|NCT02578277|Antiviral Agents|antiviral agents|mesh-ancestor
25672108|NCT01740726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25672109|NCT01740726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672110|NCT01740726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25672111|NCT01740726|Serotonin Agents|serotonin agents|mesh-ancestor
25672112|NCT01740726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233107|NCT02578277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25233108|NCT02578537|Clopidogrel|clopidogrel|mesh-list
25233109|NCT02578537|Ticagrelor|ticagrelor|mesh-list
25409693|NCT03358472|Carboplatin|carboplatin|mesh-list
25672113|NCT01740726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25872407|NCT00125489|Filaricides|filaricides|mesh-ancestor
24469720|NCT00386841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24469721|NCT00386841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25872408|NCT00125489|Antinematodal Agents|antinematodal agents|mesh-ancestor
24469798|NCT00387374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25872409|NCT00125489|Anthelmintics|anthelmintics|mesh-ancestor
25872410|NCT00125489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25872411|NCT00125489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872412|NCT00125489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872413|NCT00125489|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25872414|NCT00125489|Renal Agents|renal agents|mesh-ancestor
25872415|NCT00125541|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25872416|NCT00125541|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25872417|NCT00125541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25872418|NCT00125541|Immunologic Factors|immunologic factors|mesh-ancestor
25872419|NCT00125541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872420|NCT00125554|Metyrapone|metyrapone|mesh-list
25872421|NCT00125554|Antimetabolites|antimetabolites|mesh-ancestor
25872422|NCT00125554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469885|NCT00387699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469887|NCT00387738|Histamine Agonists|histamine agonists|mesh-ancestor
24469888|NCT00387738|Histamine Agents|histamine agents|mesh-ancestor
24469889|NCT00387738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24469890|NCT00387738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469891|NCT00387738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469892|NCT00387777|Buprenorphine|buprenorphine|mesh-list
24469893|NCT00387777|Analgesics|analgesics|mesh-list
25872423|NCT00125554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469904|NCT00387868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24469905|NCT00387868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25872424|NCT00125567|Levodopa|levodopa|mesh-list
24805313|NCT02008786|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24805314|NCT02008786|Antimetabolites|antimetabolites|mesh-ancestor
24805315|NCT02008786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805316|NCT02008786|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24578348|NCT00848692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469958|NCT00388128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469959|NCT00388128|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25872425|NCT00125567|Carbidopa|carbidopa|mesh-list
25872426|NCT00125567|Entacapone|entacapone|mesh-list
25872427|NCT00125567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25233116|NCT02578537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469965|NCT00388167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24469966|NCT00388167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469967|NCT00388167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469968|NCT00388193|Rituximab|rituximab|mesh-list
24469969|NCT00388193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24469970|NCT00388193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469971|NCT00388193|Immunologic Factors|immunologic factors|mesh-ancestor
25872432|NCT00125567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872433|NCT00125567|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24469983|NCT00388258|Alvimopan|alvimopan|mesh-list
24469984|NCT00388258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24469985|NCT00388271|Alfuzosin|alfuzosin|mesh-list
24805317|NCT02008786|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24805318|NCT02008786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24805319|NCT02008786|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24805320|NCT02008786|Protease Inhibitors|protease inhibitors|mesh-ancestor
24805321|NCT02008786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24805322|NCT02008968|Allopurinol|allopurinol|mesh-list
24469986|NCT00388271|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24469987|NCT00388271|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24469988|NCT00388271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24469989|NCT00388271|Adrenergic Agents|adrenergic agents|mesh-ancestor
24469990|NCT00388271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24469996|NCT00388388|Losartan|losartan|mesh-list
24470018|NCT00388479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24470019|NCT00388557|Ketoconazole|ketoconazole|mesh-list
24470020|NCT00388557|Antifungal Agents|antifungal agents|mesh-ancestor
24470021|NCT00388557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24470022|NCT00388557|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24470023|NCT00388557|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24470024|NCT00388557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24470025|NCT00388557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470026|NCT00388557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24470027|NCT00388557|Hormone Antagonists|hormone antagonists|mesh-ancestor
24470028|NCT00388557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24470029|NCT00388557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470030|NCT00388557|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24470032|NCT00388635|Melphalan|melphalan|mesh-list
24470033|NCT00388635|Bortezomib|bortezomib|mesh-list
24470056|NCT00388700|Leucovorin|leucovorin|mesh-list
24470057|NCT00388700|Bevacizumab|bevacizumab|mesh-list
24470058|NCT00388700|Fluorouracil|fluorouracil|mesh-list
24470059|NCT00388700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24470060|NCT00388700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872434|NCT00125567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24470061|NCT00388700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24419627|NCT00213122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24470097|NCT00388739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24470098|NCT00388739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470099|NCT00388778|Doxycycline|doxycycline|mesh-list
24470100|NCT00388778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24805326|NCT02008968|Gout Suppressants|gout suppressants|mesh-ancestor
24805327|NCT02008968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24805328|NCT02008968|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24805329|NCT02008968|Antioxidants|antioxidants|mesh-ancestor
24805330|NCT02008968|Protective Agents|protective agents|mesh-ancestor
24805331|NCT02008968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805332|NCT02008981|Aspirin|aspirin|mesh-list
24805333|NCT02008981|Turmeric extract|turmeric extract|mesh-list
24470118|NCT00388882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24470119|NCT00388882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470120|NCT00388882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24470121|NCT00388882|Respiratory System Agents|respiratory system agents|mesh-ancestor
24470122|NCT00388882|Parasympatholytics|parasympatholytics|mesh-ancestor
24470123|NCT00388882|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24470124|NCT00388882|Cholinergic Agents|cholinergic agents|mesh-ancestor
24470125|NCT00388882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24470126|NCT00388882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872435|NCT00125567|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25872436|NCT00125645|Irbesartan|irbesartan|mesh-list
25872437|NCT00125645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25872438|NCT00125645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24470128|NCT00388882|Tocolytic Agents|tocolytic agents|mesh-ancestor
24470129|NCT00388882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24470131|NCT00388882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25872439|NCT00125645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24470133|NCT00388882|Adrenergic Agents|adrenergic agents|mesh-ancestor
24470148|NCT00389025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24470149|NCT00389025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24470151|NCT00389025|Sensory System Agents|sensory system agents|mesh-ancestor
24470152|NCT00389025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24470153|NCT00389025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470154|NCT00389025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24470155|NCT00389025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24470156|NCT00389025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24470157|NCT00389025|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24470158|NCT00389025|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24470159|NCT00389025|Histamine Antagonists|histamine antagonists|mesh-ancestor
24470160|NCT00389025|Histamine Agents|histamine agents|mesh-ancestor
24470233|NCT00389285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24470234|NCT00389285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470235|NCT00389311|Nonoxynol|nonoxynol|mesh-list
25672118|NCT01740726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672119|NCT01740791|Velpatasvir|velpatasvir|mesh-list
25872440|NCT00125645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872441|NCT00125671|Warfarin|warfarin|mesh-list
25872442|NCT00125671|Anticoagulants|anticoagulants|mesh-ancestor
25872443|NCT00125684|Morphine|morphine|mesh-list
25233132|NCT02578511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233134|NCT02578043|Clindamycin palmitate|clindamycin palmitate|mesh-list
25233135|NCT02578043|Clindamycin phosphate|clindamycin phosphate|mesh-list
25233136|NCT02578043|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25872445|NCT00125684|Narcotics|narcotics|mesh-ancestor
25872446|NCT00125684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24847080|NCT02245126|Anesthetics, Local|anesthetics, local|mesh-ancestor
24847082|NCT02245126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24847083|NCT02245126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847084|NCT02245126|Sensory System Agents|sensory system agents|mesh-ancestor
24847085|NCT02245126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24470241|NCT00389311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24470242|NCT00389311|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24470243|NCT00389376|Silymarin|silymarin|mesh-list
24470244|NCT00389376|Antioxidants|antioxidants|mesh-ancestor
24470246|NCT00389376|Protective Agents|protective agents|mesh-ancestor
24470268|NCT00389415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470269|NCT00389428|Cytarabine|cytarabine|mesh-list
24954795|NCT03872011|Vitamins|vitamins|mesh-list
24470270|NCT00389428|Daunorubicin|daunorubicin|mesh-list
24470271|NCT00389428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25872447|NCT00125684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872448|NCT00125684|Analgesics|analgesics|mesh-ancestor
25233137|NCT02578043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25233138|NCT02578043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25233139|NCT02578043|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25233140|NCT02578043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233141|NCT02578043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233142|NCT02578043|Dermatologic Agents|dermatologic agents|mesh-ancestor
25233143|NCT02578108|Lidocaine|lidocaine|mesh-list
25233144|NCT02578108|Anesthetics, Local|anesthetics, local|mesh-list
25233145|NCT02578108|Anesthetics|anesthetics|mesh-list
25672120|NCT01740791|Antiviral Agents|antiviral agents|mesh-ancestor
25672121|NCT01740791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25672122|NCT01740817|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25672123|NCT01740817|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25672124|NCT01740817|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25672125|NCT01740817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25672126|NCT01741259|Meperidine|meperidine|mesh-list
25672127|NCT01741259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25872449|NCT00125684|Sensory System Agents|sensory system agents|mesh-ancestor
25872450|NCT00125684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25872451|NCT00125736|Rabeprazole|rabeprazole|mesh-list
25872452|NCT00125736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25233148|NCT02578108|Sensory System Agents|sensory system agents|mesh-ancestor
25233149|NCT02578108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25233150|NCT02578108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25233151|NCT02578108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25233152|NCT02578108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25233153|NCT02578108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25233154|NCT02578108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233155|NCT02577965|Everolimus|everolimus|mesh-list
25872453|NCT00125736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25872454|NCT00125736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25233156|NCT02577965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25233157|NCT02577965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25233158|NCT02577965|Immunologic Factors|immunologic factors|mesh-ancestor
25233159|NCT02577965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233160|NCT02578121|Dexamethasone|dexamethasone|mesh-list
25233161|NCT02578121|Pomalidomide|pomalidomide|mesh-list
25233162|NCT02578121|Ixazomib|ixazomib|mesh-list
25233163|NCT02578121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25233164|NCT02578121|Antiemetics|antiemetics|mesh-ancestor
25872455|NCT00125736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872456|NCT00125736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470305|NCT00389584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24470306|NCT00389584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470307|NCT00389584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470309|NCT00389636|Anticoagulants|anticoagulants|mesh-ancestor
24470310|NCT00389636|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
24470311|NCT00389636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24470312|NCT00389636|Growth Substances|growth substances|mesh-ancestor
24470313|NCT00389636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470314|NCT00389688|Pemetrexed|pemetrexed|mesh-list
24470315|NCT00389688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470316|NCT00389688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24470317|NCT00389688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470318|NCT00389688|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24470319|NCT00389688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24470320|NCT00389701|Dexamethasone|dexamethasone|mesh-list
24470321|NCT00389701|Bortezomib|bortezomib|mesh-list
25872457|NCT00125801|Hydromorphone|hydromorphone|mesh-list
25872458|NCT00125801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25872459|NCT00125801|Narcotics|narcotics|mesh-ancestor
24470323|NCT00389701|Antiemetics|antiemetics|mesh-ancestor
24470324|NCT00389701|Autonomic Agents|autonomic agents|mesh-ancestor
24470325|NCT00389701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24470326|NCT00389701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470327|NCT00389701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24470328|NCT00389701|Glucocorticoids|glucocorticoids|mesh-ancestor
24470330|NCT00389701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24470331|NCT00389701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24470332|NCT00389701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470333|NCT00389766|Topotecan|topotecan|mesh-list
25872460|NCT00125801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24470449|NCT00390195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470451|NCT00390208|Ranibizumab|ranibizumab|mesh-list
24470452|NCT00390208|Verteporfin|verteporfin|mesh-list
24470453|NCT00390208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24470454|NCT00390208|Antiemetics|antiemetics|mesh-ancestor
24470455|NCT00390208|Autonomic Agents|autonomic agents|mesh-ancestor
24470456|NCT00390208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24470457|NCT00390208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470458|NCT00390208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24470459|NCT00390208|Glucocorticoids|glucocorticoids|mesh-ancestor
24470460|NCT00390208|Hormones|hormones|mesh-ancestor
24470462|NCT00390208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24470466|NCT00390208|Growth Substances|growth substances|mesh-ancestor
24470467|NCT00390208|Growth Inhibitors|growth inhibitors|mesh-ancestor
24470468|NCT00390208|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24470469|NCT00390208|Dermatologic Agents|dermatologic agents|mesh-ancestor
24470470|NCT00390247|Thalidomide|thalidomide|mesh-list
24470471|NCT00390247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24470472|NCT00390247|Immunologic Factors|immunologic factors|mesh-ancestor
24470473|NCT00390247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872463|NCT00125801|Sensory System Agents|sensory system agents|mesh-ancestor
24470479|NCT00390247|Growth Substances|growth substances|mesh-ancestor
24470480|NCT00390247|Growth Inhibitors|growth inhibitors|mesh-ancestor
24470481|NCT00390247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470482|NCT00390260|Acetaminophen|acetaminophen|mesh-list
24470483|NCT00390260|Rofecoxib|rofecoxib|mesh-list
24470484|NCT00390260|Hydrocodone|hydrocodone|mesh-list
25872464|NCT00125801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24470509|NCT00390312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24470510|NCT00390312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470512|NCT00390312|Sensory System Agents|sensory system agents|mesh-ancestor
24470513|NCT00390312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24470514|NCT00390390|Lansoprazole|lansoprazole|mesh-list
24470515|NCT00390390|Dexlansoprazole|dexlansoprazole|mesh-list
24470516|NCT00390390|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25872465|NCT00125814|Interferons|interferons|mesh-list
24470517|NCT00390390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24470518|NCT00390390|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24470519|NCT00390390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24805340|NCT02008981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24805341|NCT02008981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24805342|NCT02008981|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24805343|NCT02008981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24805345|NCT02008981|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24805347|NCT02008981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24805348|NCT02008981|Antipyretics|antipyretics|mesh-ancestor
24805349|NCT02008981|Antioxidants|antioxidants|mesh-ancestor
24805350|NCT02008981|Protective Agents|protective agents|mesh-ancestor
24470522|NCT00390403|Temozolomide|temozolomide|mesh-list
24470523|NCT00390403|Retinol acetate|retinol acetate|mesh-list
24470524|NCT00390403|Gossypol acetic acid|gossypol acetic acid|mesh-list
24470525|NCT00390403|Gossypol|gossypol|mesh-list
24470526|NCT00390403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24954871|NCT03871478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24470597|NCT00390793|Alkylating Agents|alkylating agents|mesh-ancestor
24470598|NCT00390793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470599|NCT00390793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470600|NCT00390793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24470601|NCT00390793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24470638|NCT00390871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24470639|NCT00390871|Anesthetics, General|anesthetics, general|mesh-ancestor
24470640|NCT00390871|Anesthetics|anesthetics|mesh-ancestor
24470641|NCT00390871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24470642|NCT00390871|Analgesics|analgesics|mesh-ancestor
25409694|NCT03358472|Pembrolizumab|pembrolizumab|mesh-list
25872466|NCT00125814|Interferon-alpha|interferon-alpha|mesh-list
25872467|NCT00125814|Interferon alpha-2|interferon alpha-2|mesh-list
25872468|NCT00125814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872469|NCT00125814|Antiviral Agents|antiviral agents|mesh-ancestor
25872470|NCT00125814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25872471|NCT00125814|Immunologic Factors|immunologic factors|mesh-ancestor
25872472|NCT00125814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872473|NCT00125827|Clofarabine|clofarabine|mesh-list
25233171|NCT02578121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25233173|NCT02578121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25233174|NCT02578121|Immunologic Factors|immunologic factors|mesh-ancestor
25233175|NCT02578121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25233176|NCT02578121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25233177|NCT02578121|Growth Substances|growth substances|mesh-ancestor
25233178|NCT02578121|Growth Inhibitors|growth inhibitors|mesh-ancestor
25233179|NCT02578121|Protease Inhibitors|protease inhibitors|mesh-ancestor
25233180|NCT02578121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233181|NCT02578121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233182|NCT02577848|Liraglutide|liraglutide|mesh-list
24470657|NCT00390897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24470686|NCT00391014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24470687|NCT00391014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24470703|NCT00391144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24470704|NCT00391144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24470705|NCT00391144|Growth Substances|growth substances|mesh-ancestor
24470706|NCT00391144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470707|NCT00391144|Growth Inhibitors|growth inhibitors|mesh-ancestor
24470708|NCT00391144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24470709|NCT00391144|Glucocorticoids|glucocorticoids|mesh-ancestor
24470710|NCT00391144|Hormones|hormones|mesh-ancestor
24470711|NCT00391144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24470712|NCT00391157|Dexamethasone|dexamethasone|mesh-list
24470713|NCT00391157|Bortezomib|bortezomib|mesh-list
24805351|NCT02009007|Phenylephrine|phenylephrine|mesh-list
24805352|NCT02009007|Dopamine|dopamine|mesh-list
24805353|NCT02009007|Oxymetazoline|oxymetazoline|mesh-list
24805354|NCT02009007|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24805355|NCT02009007|Mydriatics|mydriatics|mesh-ancestor
24805356|NCT02009007|Autonomic Agents|autonomic agents|mesh-ancestor
24805357|NCT02009007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24805358|NCT02009007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805359|NCT02009007|Sympathomimetics|sympathomimetics|mesh-ancestor
24805360|NCT02009007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24805361|NCT02009007|Nasal Decongestants|nasal decongestants|mesh-ancestor
24805362|NCT02009007|Respiratory System Agents|respiratory system agents|mesh-ancestor
24805363|NCT02009007|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24805364|NCT02009007|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24805365|NCT02009007|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24805366|NCT02009007|Adrenergic Agents|adrenergic agents|mesh-ancestor
24805367|NCT02009007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24805368|NCT02009007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805369|NCT02009007|Protective Agents|protective agents|mesh-ancestor
24805370|NCT02009007|Dopamine Agents|dopamine agents|mesh-ancestor
24470717|NCT00391157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24470718|NCT00391157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470719|NCT00391157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24470720|NCT00391157|Glucocorticoids|glucocorticoids|mesh-ancestor
24470721|NCT00391157|Hormones|hormones|mesh-ancestor
24470723|NCT00391157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24470725|NCT00391248|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24470726|NCT00391248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470727|NCT00391248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25233192|NCT02577809|Anesthetics, Local|anesthetics, local|mesh-ancestor
25233193|NCT02577809|Anesthetics|anesthetics|mesh-ancestor
24847086|NCT02245126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24847087|NCT02245126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24847088|NCT02245126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24847089|NCT02245126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24470768|NCT00391638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24470769|NCT00391638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24805371|NCT02009098|Cefuroxime|cefuroxime|mesh-list
24805372|NCT02009098|Cefuroxime axetil|cefuroxime axetil|mesh-list
24805373|NCT02009098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24805374|NCT02009098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24805376|NCT02009189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24805377|NCT02009189|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24805378|NCT02009189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24805379|NCT02009202|Picosulfate sodium|picosulfate sodium|mesh-list
24805380|NCT02009202|Cathartics|cathartics|mesh-ancestor
24805381|NCT02009202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24805382|NCT02009215|Piperaquine|piperaquine|mesh-list
24805383|NCT02009215|Artenimol|artenimol|mesh-list
24805384|NCT02009215|Antimalarials|antimalarials|mesh-ancestor
24805385|NCT02009215|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24805386|NCT02009215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24805387|NCT02009215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24805388|NCT02009280|Anesthetics|anesthetics|mesh-list
24470770|NCT00391651|Nitrofurantoin|nitrofurantoin|mesh-list
24470771|NCT00391651|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24470772|NCT00391651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24470773|NCT00391651|Renal Agents|renal agents|mesh-ancestor
24470774|NCT00391651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24470775|NCT00391690|Zoledronic Acid|zoledronic acid|mesh-list
24470776|NCT00391690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24470777|NCT00391690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470778|NCT00391885|Anesthetics|anesthetics|mesh-list
24470779|NCT00391885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24470781|NCT00391911|Acetylcysteine|acetylcysteine|mesh-list
24470806|NCT00392028|Ertapenem|ertapenem|mesh-list
25233194|NCT02577809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25233195|NCT02577809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672128|NCT01741259|Narcotics|narcotics|mesh-ancestor
25233196|NCT02577809|Sensory System Agents|sensory system agents|mesh-ancestor
25233197|NCT02577809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25672129|NCT01741259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25143222|NCT02944201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24883307|NCT03991403|Paclitaxel|paclitaxel|mesh-list
25233198|NCT02577809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25233199|NCT02577809|Narcotics|narcotics|mesh-ancestor
25233200|NCT02577809|Analgesics|analgesics|mesh-ancestor
25233201|NCT02577809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25233202|NCT02577809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25233203|NCT02577809|Anesthetics, General|anesthetics, general|mesh-ancestor
25233204|NCT02577809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25233205|NCT02577809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25233206|NCT02577809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25233207|NCT02577809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25233208|NCT02577809|Gout Suppressants|gout suppressants|mesh-ancestor
25233209|NCT02577809|Tocolytic Agents|tocolytic agents|mesh-ancestor
25233210|NCT02577809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25233211|NCT02577809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25872474|NCT00125827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25233212|NCT02577809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233213|NCT02577809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233214|NCT02577783|Dexamethasone|dexamethasone|mesh-list
25233215|NCT02577783|Dexamethasone acetate|dexamethasone acetate|mesh-list
25872475|NCT00125827|Antimetabolites|antimetabolites|mesh-ancestor
25872476|NCT00125827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063182|NCT02889159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063183|NCT02889159|Interferon Inducers|interferon inducers|mesh-ancestor
25872477|NCT00125827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470833|NCT00392106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24470834|NCT00392106|Vasodilator Agents|vasodilator agents|mesh-ancestor
24470893|NCT00392340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24470895|NCT00392418|Trace Elements|trace elements|mesh-list
24470896|NCT00392418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470897|NCT00392431|Amiodarone|amiodarone|mesh-list
24470898|NCT00392431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24470899|NCT00392431|Vasodilator Agents|vasodilator agents|mesh-ancestor
24470900|NCT00392431|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24470950|NCT00392652|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
24470951|NCT00392652|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24470952|NCT00392652|Protective Agents|protective agents|mesh-ancestor
24470953|NCT00392652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470954|NCT00392652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470956|NCT00392691|Melphalan|melphalan|mesh-list
24470972|NCT00392717|Atorvastatin|atorvastatin|mesh-list
24470973|NCT00392717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24470974|NCT00392717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24470975|NCT00392717|Antimetabolites|antimetabolites|mesh-ancestor
24470976|NCT00392717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470977|NCT00392717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24470978|NCT00392717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24470979|NCT00392717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24471006|NCT00392886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24471048|NCT00393107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24471049|NCT00393107|Alkylating Agents|alkylating agents|mesh-ancestor
24471050|NCT00393107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471051|NCT00393107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24471052|NCT00393107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24471053|NCT00393107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24471099|NCT00393328|Aripiprazole|aripiprazole|mesh-list
24471106|NCT00393328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24471107|NCT00393328|Antiviral Agents|antiviral agents|mesh-ancestor
24471108|NCT00393328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25672130|NCT01741259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672131|NCT01741259|Analgesics|analgesics|mesh-ancestor
25672132|NCT01741259|Sensory System Agents|sensory system agents|mesh-ancestor
25672133|NCT01741259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25672134|NCT01741259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25672135|NCT01741454|Tamsulosin|tamsulosin|mesh-list
25672136|NCT01741454|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25672137|NCT01741454|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24471109|NCT00393328|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24471110|NCT00393328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24471130|NCT00393393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471133|NCT00393445|Incretins|incretins|mesh-ancestor
24471134|NCT00393445|Hormones|hormones|mesh-ancestor
24471136|NCT00393445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471148|NCT00393471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24471149|NCT00393471|Immunologic Factors|immunologic factors|mesh-ancestor
24471150|NCT00393497|Bevacizumab|bevacizumab|mesh-list
24471151|NCT00393497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24471152|NCT00393497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24471153|NCT00393497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24471154|NCT00393497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25872478|NCT00125840|Clofarabine|clofarabine|mesh-list
24471155|NCT00393497|Growth Substances|growth substances|mesh-ancestor
24471156|NCT00393497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471157|NCT00393497|Growth Inhibitors|growth inhibitors|mesh-ancestor
25233216|NCT02577783|Doxorubicin|doxorubicin|mesh-list
25233217|NCT02577783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25233218|NCT02577783|BB 1101|bb 1101|mesh-list
25233219|NCT02577783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25233220|NCT02577783|Antiemetics|antiemetics|mesh-ancestor
25233221|NCT02577783|Autonomic Agents|autonomic agents|mesh-ancestor
25233222|NCT02577783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25233223|NCT02577783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233225|NCT02577783|Glucocorticoids|glucocorticoids|mesh-ancestor
25233226|NCT02577783|Hormones|hormones|mesh-ancestor
24453170|NCT05238831|Atezolizumab|atezolizumab|mesh-list
24453171|NCT05238831|Letrozole|letrozole|mesh-list
24471158|NCT00393562|Methylphenidate|methylphenidate|mesh-list
24471160|NCT00393562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24805396|NCT02009280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24805397|NCT02009280|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24805398|NCT02009306|Fentanyl|fentanyl|mesh-list
25872479|NCT00125840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25872480|NCT00125840|Antimetabolites|antimetabolites|mesh-ancestor
25872481|NCT00125840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578986|NCT00852787|Digoxin|digoxin|mesh-list
24471161|NCT00393562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471162|NCT00393562|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24471163|NCT00393562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24471164|NCT00393562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24471165|NCT00393562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471166|NCT00393562|Dopamine Agents|dopamine agents|mesh-ancestor
24471167|NCT00393562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24471168|NCT00393562|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24471169|NCT00393562|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24471170|NCT00393562|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24471171|NCT00393614|Levetiracetam|levetiracetam|mesh-list
24471172|NCT00393614|Anticonvulsants|anticonvulsants|mesh-ancestor
24471173|NCT00393614|Nootropic Agents|nootropic agents|mesh-ancestor
24471174|NCT00393679|Artesunate|artesunate|mesh-list
24471175|NCT00393679|Lumefantrine|lumefantrine|mesh-list
24471176|NCT00393679|Artemether|artemether|mesh-list
24471197|NCT00393731|Misoprostol|misoprostol|mesh-list
24471198|NCT00393731|Oxytocin|oxytocin|mesh-list
24471199|NCT00393731|Oxytocics|oxytocics|mesh-ancestor
24471200|NCT00393731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24471201|NCT00393731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471202|NCT00393731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24471203|NCT00393731|Abortifacient Agents|abortifacient agents|mesh-ancestor
24471204|NCT00393731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24471205|NCT00393731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24471267|NCT00394368|Autonomic Agents|autonomic agents|mesh-ancestor
24471268|NCT00394368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25872482|NCT00125840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872483|NCT00125892|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25872484|NCT00125892|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25872485|NCT00125892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25872486|NCT00125892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25872487|NCT00125892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872488|NCT00125892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25872489|NCT00125892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872490|NCT00125892|Analgesics|analgesics|mesh-ancestor
24471321|NCT00394485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24471322|NCT00394485|Adrenergic Agents|adrenergic agents|mesh-ancestor
24471324|NCT00394498|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24471325|NCT00394498|Immunologic Factors|immunologic factors|mesh-ancestor
25233227|NCT02577783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25233228|NCT02577783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25233229|NCT02577783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25233230|NCT02577783|Protease Inhibitors|protease inhibitors|mesh-ancestor
25233231|NCT02577783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233232|NCT02577783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233233|NCT02577783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25233234|NCT02577783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25233235|NCT02577783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25233236|NCT02577575|Oxytocin|oxytocin|mesh-list
25233237|NCT02577575|Oxytocics|oxytocics|mesh-ancestor
25233238|NCT02577575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24453172|NCT05238831|Olaparib|olaparib|mesh-list
24453173|NCT05238831|Fulvestrant|fulvestrant|mesh-list
24453174|NCT05238831|Palbociclib|palbociclib|mesh-list
25872491|NCT00125892|Sensory System Agents|sensory system agents|mesh-ancestor
25872492|NCT00125892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25872493|NCT00125892|Antidepressive Agents|antidepressive agents|mesh-ancestor
25872494|NCT00125892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25872495|NCT00125892|Dopamine Agents|dopamine agents|mesh-ancestor
25872496|NCT00125905|Bupropion|bupropion|mesh-list
25872497|NCT00125905|Nicotine|nicotine|mesh-list
24453175|NCT05238831|Anastrozole|anastrozole|mesh-list
24453176|NCT05238831|Pertuzumab|pertuzumab|mesh-list
24453182|NCT05238831|Immunoglobulins|immunoglobulins|mesh-list
24453183|NCT05238831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24453184|NCT05238831|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24453185|NCT05238831|Immunoglobulin G|immunoglobulin g|mesh-list
24453186|NCT05238831|Immunoconjugates|immunoconjugates|mesh-list
24453187|NCT05238831|Entrectinib|entrectinib|mesh-list
24453188|NCT05238831|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
25872498|NCT00125905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24847090|NCT02245126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847091|NCT02245165|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
24847092|NCT02245165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872499|NCT00125905|Autonomic Agents|autonomic agents|mesh-ancestor
25154477|NCT05471063|Flucytosine|flucytosine|mesh-list
25872500|NCT00125905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24471326|NCT00394498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805409|NCT02009306|Anesthetics, General|anesthetics, general|mesh-ancestor
24805410|NCT02009306|Anesthetics|anesthetics|mesh-ancestor
24805411|NCT02009306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24805412|NCT02009306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24805413|NCT02009306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24805414|NCT02009306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24805415|NCT02009306|GABA Modulators|gaba modulators|mesh-ancestor
24805416|NCT02009306|GABA Agents|gaba agents|mesh-ancestor
24805417|NCT02009306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24805418|NCT02009306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805419|NCT02009410|Pancrelipase|pancrelipase|mesh-list
24471419|NCT00395239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24471429|NCT00395252|Gemcitabine|gemcitabine|mesh-list
24471430|NCT00395252|Cetuximab|cetuximab|mesh-list
24471431|NCT00395252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24471432|NCT00395252|Antimetabolites|antimetabolites|mesh-ancestor
24471469|NCT00395434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24471470|NCT00395434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24471472|NCT00395434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471473|NCT00395434|Growth Inhibitors|growth inhibitors|mesh-ancestor
24471474|NCT00395434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24471475|NCT00395434|Tubulin Modulators|tubulin modulators|mesh-ancestor
24471476|NCT00395434|Antimitotic Agents|antimitotic agents|mesh-ancestor
25872501|NCT00125905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471501|NCT00395655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24471502|NCT00395655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471503|NCT00395655|GABA Agents|gaba agents|mesh-ancestor
24471504|NCT00395655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24471505|NCT00395655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471506|NCT00395655|Antimanic Agents|antimanic agents|mesh-ancestor
24471507|NCT00395655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25233266|NCT02577497|Glucocorticoids|glucocorticoids|mesh-ancestor
24471508|NCT00395655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24471509|NCT00395655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24471510|NCT00395655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24471511|NCT00395655|Vasodilator Agents|vasodilator agents|mesh-ancestor
24471512|NCT00395681|Propofol|propofol|mesh-list
24805428|NCT02009449|Leucovorin|leucovorin|mesh-list
24805430|NCT02009449|Paclitaxel|paclitaxel|mesh-list
24805449|NCT02009449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24805450|NCT02009449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233239|NCT02577575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233240|NCT02577614|Coagulants|coagulants|mesh-list
25233241|NCT02577614|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
25233242|NCT02577458|Everolimus|everolimus|mesh-list
25233243|NCT02577458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25233244|NCT02577458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25233245|NCT02577458|Immunologic Factors|immunologic factors|mesh-ancestor
25233246|NCT02577458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233247|NCT02577341|Docetaxel|docetaxel|mesh-list
25233248|NCT02577341|Nimotuzumab|nimotuzumab|mesh-list
25233249|NCT02577341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25233250|NCT02577341|Tubulin Modulators|tubulin modulators|mesh-ancestor
25233251|NCT02577341|Antimitotic Agents|antimitotic agents|mesh-ancestor
25233252|NCT02577341|Mitosis Modulators|mitosis modulators|mesh-ancestor
25233253|NCT02577341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233254|NCT02577341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25233255|NCT02577497|Fluticasone|fluticasone|mesh-list
25233256|NCT02577497|Beclomethasone|beclomethasone|mesh-list
25872502|NCT00125905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25872503|NCT00125905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25044432|NCT01101594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044433|NCT01101594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25000767|NCT03490513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25000768|NCT03490513|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25000769|NCT03490513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25000770|NCT03490513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25000771|NCT03490513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000772|NCT03490513|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25000773|NCT03490513|Hormone Antagonists|hormone antagonists|mesh-ancestor
25044434|NCT01101594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25044435|NCT01101594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044436|NCT01101594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044437|NCT01098435|ALKS-33|alks-33|mesh-list
25044438|NCT01098435|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25044439|NCT01098435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044440|NCT01098435|Sensory System Agents|sensory system agents|mesh-ancestor
25044441|NCT01098435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25044442|NCT01097018|Capecitabine|capecitabine|mesh-list
25044443|NCT01097018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25044444|NCT01097018|Antimetabolites|antimetabolites|mesh-ancestor
25044445|NCT01097018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044446|NCT01097018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044447|NCT01096862|Peficitinib|peficitinib|mesh-list
25044448|NCT01096862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044449|NCT01096862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044452|NCT01096862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805451|NCT02009449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24805452|NCT02009449|Immunologic Factors|immunologic factors|mesh-ancestor
24805453|NCT02009449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805454|NCT02009449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24805455|NCT02009449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24805456|NCT02009449|Antidotes|antidotes|mesh-ancestor
25872504|NCT00125905|Cholinergic Agents|cholinergic agents|mesh-ancestor
25233257|NCT02577497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25233258|NCT02577497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25233259|NCT02577497|Autonomic Agents|autonomic agents|mesh-ancestor
25233260|NCT02577497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25233261|NCT02577497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233262|NCT02577497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25233263|NCT02577497|Respiratory System Agents|respiratory system agents|mesh-ancestor
25233264|NCT02577497|Dermatologic Agents|dermatologic agents|mesh-ancestor
25233265|NCT02577497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25233268|NCT02577497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25233269|NCT02577393|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
25233270|NCT02577393|Antioxidants|antioxidants|mesh-ancestor
25233271|NCT02577393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233272|NCT02577393|Protective Agents|protective agents|mesh-ancestor
25233273|NCT02577393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233274|NCT02577393|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25233275|NCT02577393|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25233276|NCT02577393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25233277|NCT02577393|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25233279|NCT02577770|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25233280|NCT02577770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233281|NCT02577770|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25233284|NCT02577770|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25233285|NCT02577770|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25233286|NCT02577770|Purinergic Agents|purinergic agents|mesh-ancestor
25233287|NCT02577770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25233288|NCT02577432|Fentanyl|fentanyl|mesh-list
25154478|NCT05471063|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
25154479|NCT05471063|Antifungal Agents|antifungal agents|mesh-ancestor
25154480|NCT05471063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25154481|NCT05471063|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25154482|NCT05471063|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25154483|NCT05471063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25154484|NCT05471063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471513|NCT00395681|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24471514|NCT00395681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24471515|NCT00395681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471516|NCT00395681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24471519|NCT00395707|Ranibizumab|ranibizumab|mesh-list
24471520|NCT00395707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24471521|NCT00395707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24471522|NCT00395707|Growth Substances|growth substances|mesh-ancestor
24471523|NCT00395707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471524|NCT00395707|Growth Inhibitors|growth inhibitors|mesh-ancestor
24471525|NCT00395707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24471526|NCT00395720|Vaccines|vaccines|mesh-list
24471527|NCT00395720|Immunologic Factors|immunologic factors|mesh-ancestor
24471528|NCT00395720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872505|NCT00125905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25409695|NCT03358472|Fluorouracil|fluorouracil|mesh-list
25672138|NCT01741454|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25672139|NCT01741454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25872506|NCT00125905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872507|NCT00125905|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25872508|NCT00125905|Antidepressive Agents|antidepressive agents|mesh-ancestor
25872509|NCT00125905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25872510|NCT00125905|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24471590|NCT00396058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471592|NCT00396058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24471593|NCT00396058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25872512|NCT00125905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24471633|NCT00396344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24471634|NCT00396396|Acetylcysteine|acetylcysteine|mesh-list
24471635|NCT00396396|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25233289|NCT02577432|Bupivacaine|bupivacaine|mesh-list
25233290|NCT02577432|Anesthetics, Local|anesthetics, local|mesh-ancestor
25233291|NCT02577432|Anesthetics|anesthetics|mesh-ancestor
25233292|NCT02577432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25233293|NCT02577432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233294|NCT02577432|Sensory System Agents|sensory system agents|mesh-ancestor
25233295|NCT02577432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25233296|NCT02577432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25233297|NCT02577432|Narcotics|narcotics|mesh-ancestor
25233298|NCT02577432|Analgesics|analgesics|mesh-ancestor
25233299|NCT02577432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25154486|NCT05471063|Hormone Antagonists|hormone antagonists|mesh-ancestor
24471636|NCT00396396|Antiviral Agents|antiviral agents|mesh-ancestor
24471637|NCT00396396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25872513|NCT00125905|Dopamine Agents|dopamine agents|mesh-ancestor
24471639|NCT00396396|Respiratory System Agents|respiratory system agents|mesh-ancestor
24471640|NCT00396396|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24471641|NCT00396396|Antioxidants|antioxidants|mesh-ancestor
24471642|NCT00396396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471643|NCT00396396|Protective Agents|protective agents|mesh-ancestor
24471644|NCT00396396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471645|NCT00396396|Antidotes|antidotes|mesh-ancestor
24805468|NCT02009488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471711|NCT00396669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24471712|NCT00396669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471713|NCT00396669|Dopamine Agents|dopamine agents|mesh-ancestor
24471714|NCT00396669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24471715|NCT00396669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471716|NCT00396669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24471717|NCT00396669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24471718|NCT00396669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24471719|NCT00396682|Cyclophosphamide|cyclophosphamide|mesh-list
25872514|NCT00125905|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25872515|NCT00125905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25872516|NCT00125905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872517|NCT00125918|Tadalafil|tadalafil|mesh-list
25872518|NCT00125918|Vasodilator Agents|vasodilator agents|mesh-ancestor
25872519|NCT00125918|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25872520|NCT00125918|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25872521|NCT00125918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24471724|NCT00396682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24471772|NCT00396747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471773|NCT00396747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24471774|NCT00396747|Dermatologic Agents|dermatologic agents|mesh-ancestor
24471775|NCT00396747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24471776|NCT00396747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24471777|NCT00396747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24471778|NCT00396747|Immunologic Factors|immunologic factors|mesh-ancestor
24471779|NCT00396747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24471795|NCT00396760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24471796|NCT00396760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471797|NCT00396760|Hemostatics|hemostatics|mesh-ancestor
24805472|NCT02009514|Hemodialysis Solutions|hemodialysis solutions|mesh-list
24471807|NCT00396786|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24471808|NCT00396786|Protease Inhibitors|protease inhibitors|mesh-ancestor
24471809|NCT00396786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233300|NCT02577432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25233301|NCT02577432|Anesthetics, General|anesthetics, general|mesh-ancestor
25154489|NCT05471063|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25154490|NCT05471063|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25872522|NCT00125918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872523|NCT00125918|Urological Agents|urological agents|mesh-ancestor
25872524|NCT00125983|Ritonavir|ritonavir|mesh-list
25872525|NCT00125983|Lopinavir|lopinavir|mesh-list
25872526|NCT00125983|Norinyl|norinyl|mesh-list
25872527|NCT00125983|Ortho Evra|ortho evra|mesh-list
25872528|NCT00125983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25872529|NCT00125983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25872530|NCT00125983|Protease Inhibitors|protease inhibitors|mesh-ancestor
24955016|NCT03869281|Pancrelipase|pancrelipase|mesh-list
25154491|NCT05471063|Amebicides|amebicides|mesh-ancestor
25154492|NCT05471063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25154493|NCT05471063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25154494|NCT05471063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25154495|NCT05471063|Antimetabolites|antimetabolites|mesh-ancestor
25154496|NCT05471063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24471810|NCT00396786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471811|NCT00396786|Anticoagulants|anticoagulants|mesh-ancestor
24471812|NCT00396786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24471813|NCT00396786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24471814|NCT00396799|Bazedoxifene|bazedoxifene|mesh-list
24471815|NCT00396799|Estrogens|estrogens|mesh-list
24471816|NCT00396799|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24471817|NCT00396799|Hormones|hormones|mesh-ancestor
24471818|NCT00396799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24471819|NCT00396799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471820|NCT00396799|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24471821|NCT00396799|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24471822|NCT00396799|Hormone Antagonists|hormone antagonists|mesh-ancestor
24471832|NCT00396929|Mitosis Modulators|mitosis modulators|mesh-ancestor
24471833|NCT00396929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471834|NCT00396968|Plerixafor|plerixafor|mesh-list
24471835|NCT00396968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24471836|NCT00396968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24471837|NCT00396968|Antiviral Agents|antiviral agents|mesh-ancestor
25672140|NCT01741454|Adrenergic Agents|adrenergic agents|mesh-ancestor
25672141|NCT01741454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25672142|NCT01741454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672143|NCT01741454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805478|NCT02009540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24579405|NCT00854841|Dasatinib|dasatinib|mesh-list
24471864|NCT00397176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25872531|NCT00125983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233302|NCT02577250|Ketamine|ketamine|mesh-list
25233303|NCT02577250|Analgesics|analgesics|mesh-ancestor
25233304|NCT02577250|Sensory System Agents|sensory system agents|mesh-ancestor
25233307|NCT02577250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25233308|NCT02577250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25233309|NCT02577250|Anesthetics, General|anesthetics, general|mesh-ancestor
25233310|NCT02577250|Anesthetics|anesthetics|mesh-ancestor
25233311|NCT02577250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25154499|NCT05471063|Protective Agents|protective agents|mesh-ancestor
25154500|NCT05471063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25154501|NCT05471050|Danazol|danazol|mesh-list
25154502|NCT05471050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25154503|NCT05471050|Hormone Antagonists|hormone antagonists|mesh-ancestor
25154504|NCT05471050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25154505|NCT05471050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947739|NCT03926182|Aflutinib|aflutinib|mesh-list
25872532|NCT00125983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448856|NCT00313391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24448857|NCT00313391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448858|NCT00313391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448859|NCT00313391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24448860|NCT00313391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25872533|NCT00125983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25872534|NCT00125983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25872535|NCT00125983|Antiviral Agents|antiviral agents|mesh-ancestor
25872536|NCT00125983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25872537|NCT00125983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24471905|NCT00397384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471906|NCT00397423|Lenograstim|lenograstim|mesh-list
25099732|NCT03187795|Oxybutynin|oxybutynin|mesh-list
24471907|NCT00397423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24471908|NCT00397423|Immunologic Factors|immunologic factors|mesh-ancestor
24471909|NCT00397423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471910|NCT00397475|Cholecalciferol|cholecalciferol|mesh-list
24471911|NCT00397475|Vitamin D|vitamin d|mesh-list
24471912|NCT00397475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24471913|NCT00397475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471914|NCT00397475|Vitamins|vitamins|mesh-ancestor
24471915|NCT00397475|Micronutrients|micronutrients|mesh-ancestor
24471916|NCT00397475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24471917|NCT00397501|Sodium thiosulfate|sodium thiosulfate|mesh-list
24471918|NCT00397501|Carboplatin|carboplatin|mesh-list
24471919|NCT00397501|Methotrexate|methotrexate|mesh-list
24471920|NCT00397501|Trastuzumab|trastuzumab|mesh-list
24471921|NCT00397501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24471922|NCT00397501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24471923|NCT00397501|Abortifacient Agents|abortifacient agents|mesh-ancestor
24471924|NCT00397501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24471925|NCT00397501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872538|NCT00125983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25872539|NCT00125983|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25872540|NCT00125983|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25872541|NCT00125983|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24955050|NCT03869073|Evolocumab|evolocumab|mesh-list
24471981|NCT00397709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471982|NCT00397709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24471983|NCT00397709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24471984|NCT00397709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24471985|NCT00397709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24471986|NCT00397709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24471987|NCT00397709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24471988|NCT00397709|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24471989|NCT00397709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24472061|NCT00397826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24472064|NCT00397917|Hematinics|hematinics|mesh-ancestor
24472065|NCT00397917|Vitamin B Complex|vitamin b complex|mesh-ancestor
24472066|NCT00397917|Vitamins|vitamins|mesh-ancestor
24472067|NCT00397917|Micronutrients|micronutrients|mesh-ancestor
24472068|NCT00397917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472069|NCT00397956|Ertapenem|ertapenem|mesh-list
24805508|NCT02009748|Vitamins|vitamins|mesh-ancestor
24805509|NCT02009748|Micronutrients|micronutrients|mesh-ancestor
24472085|NCT00398034|Hormones|hormones|mesh-ancestor
24472086|NCT00398034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24472087|NCT00398034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472088|NCT00398099|Ertapenem|ertapenem|mesh-list
24472090|NCT00398099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25872542|NCT00125983|Contraceptive Agents|contraceptive agents|mesh-ancestor
25872543|NCT00125983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25872544|NCT00125983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872545|NCT00125983|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25872546|NCT00125983|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25872547|NCT00125996|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25872548|NCT00125996|Hematinics|hematinics|mesh-ancestor
25872549|NCT00126009|Amisulpride|amisulpride|mesh-list
25872550|NCT00126009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25872551|NCT00126009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25154516|NCT05470972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154517|NCT05470881|Atropine|atropine|mesh-list
25872553|NCT00126009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872554|NCT00126009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25872555|NCT00126009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25872556|NCT00126009|Dopamine Agents|dopamine agents|mesh-ancestor
25872557|NCT00126009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25872558|NCT00126009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872559|NCT00126009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25872560|NCT00126009|Antidepressive Agents|antidepressive agents|mesh-ancestor
25872561|NCT00126022|Tedisamil|tedisamil|mesh-list
25872562|NCT00126022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25872563|NCT00126022|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25872564|NCT00126022|Protective Agents|protective agents|mesh-ancestor
25872565|NCT00126022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872566|NCT00126048|Atorvastatin|atorvastatin|mesh-list
25872567|NCT00126048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25872568|NCT00126048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24472091|NCT00398229|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24472092|NCT00398229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24472093|NCT00398229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472094|NCT00398281|Dutasteride|dutasteride|mesh-list
24472095|NCT00398281|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24472096|NCT00398281|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24472097|NCT00398281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24472098|NCT00398281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472099|NCT00398281|Hormone Antagonists|hormone antagonists|mesh-ancestor
24955079|NCT03868072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24955080|NCT03868072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472127|NCT00398450|Interferons|interferons|mesh-list
24472128|NCT00398450|Interferon-alpha|interferon-alpha|mesh-list
24472129|NCT00398450|Interferon alpha-2|interferon alpha-2|mesh-list
24472130|NCT00398450|Azacitidine|azacitidine|mesh-list
24472131|NCT00398450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472132|NCT00398450|Antiviral Agents|antiviral agents|mesh-ancestor
24472133|NCT00398450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24472134|NCT00398450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24472135|NCT00398450|Antimetabolites|antimetabolites|mesh-ancestor
24472136|NCT00398450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472137|NCT00398450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24472138|NCT00398450|Immunologic Factors|immunologic factors|mesh-ancestor
24472139|NCT00398450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472140|NCT00398463|polysaccharide-K|polysaccharide-k|mesh-list
24472141|NCT00398463|Tirofiban|tirofiban|mesh-list
24472142|NCT00398463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24472143|NCT00398463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24472163|NCT00398489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24472164|NCT00398489|Immunologic Factors|immunologic factors|mesh-ancestor
25233332|NCT02576964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25233333|NCT02576964|Antiviral Agents|antiviral agents|mesh-ancestor
25233335|NCT02576782|Dexamethasone|dexamethasone|mesh-list
25233336|NCT02576782|Dexamethasone acetate|dexamethasone acetate|mesh-list
25233337|NCT02576782|Bupivacaine|bupivacaine|mesh-list
25233338|NCT02576782|BB 1101|bb 1101|mesh-list
25233339|NCT02576782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25233341|NCT02576782|Autonomic Agents|autonomic agents|mesh-ancestor
25233342|NCT02576782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25233343|NCT02576782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233344|NCT02576782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25233345|NCT02576782|Glucocorticoids|glucocorticoids|mesh-ancestor
25233346|NCT02576782|Hormones|hormones|mesh-ancestor
24955081|NCT03868124|Travoprost|travoprost|mesh-list
25233347|NCT02576782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25233348|NCT02576782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25233349|NCT02576782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25233350|NCT02576782|Protease Inhibitors|protease inhibitors|mesh-ancestor
25872569|NCT00126048|Antimetabolites|antimetabolites|mesh-ancestor
25872570|NCT00126048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872571|NCT00126048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25872572|NCT00126048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25872573|NCT00126048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872574|NCT00126061|Tedisamil|tedisamil|mesh-list
25872575|NCT00126061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25872576|NCT00126061|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25872577|NCT00126061|Protective Agents|protective agents|mesh-ancestor
24472165|NCT00398489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472166|NCT00398489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24472167|NCT00398489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24472168|NCT00398489|Alkylating Agents|alkylating agents|mesh-ancestor
24472169|NCT00398489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472170|NCT00398489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472171|NCT00398489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24472172|NCT00398489|Tubulin Modulators|tubulin modulators|mesh-ancestor
24472173|NCT00398489|Antimitotic Agents|antimitotic agents|mesh-ancestor
24472175|NCT00398489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24472176|NCT00398489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24472177|NCT00398489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24472178|NCT00398489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24472179|NCT00398489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24472180|NCT00398489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24600185|NCT02008292|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25099915|NCT03186742|Diuretics|diuretics|mesh-ancestor
24600186|NCT02008292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600187|NCT02008292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600188|NCT02008292|Cholinergic Agents|cholinergic agents|mesh-ancestor
24600189|NCT02008292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24600190|NCT02008292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600192|NCT02008292|Autonomic Agents|autonomic agents|mesh-ancestor
24472242|NCT00398580|Testosterone enanthate|testosterone enanthate|mesh-list
24472243|NCT00398580|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24472244|NCT00398580|Dutasteride|dutasteride|mesh-list
24472245|NCT00398580|Androgens|androgens|mesh-ancestor
24472246|NCT00398580|Hormones|hormones|mesh-ancestor
24472247|NCT00398580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24472248|NCT00398580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472249|NCT00398580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24472250|NCT00398580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472251|NCT00398580|Anabolic Agents|anabolic agents|mesh-ancestor
24472252|NCT00398580|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24472253|NCT00398580|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24472254|NCT00398580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24472255|NCT00398580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472256|NCT00398580|Hormone Antagonists|hormone antagonists|mesh-ancestor
24472257|NCT00398658|Clindamycin|clindamycin|mesh-list
24472275|NCT00398684|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24472276|NCT00398684|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24472277|NCT00398697|Gemcitabine|gemcitabine|mesh-list
24473195|NCT00402376|Adrenergic Agents|adrenergic agents|mesh-ancestor
24472279|NCT00398697|Antimetabolites|antimetabolites|mesh-ancestor
24472280|NCT00398697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472281|NCT00398697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472282|NCT00398697|Antiviral Agents|antiviral agents|mesh-ancestor
24472283|NCT00398697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24472284|NCT00398697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24472285|NCT00398697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24472286|NCT00398697|Immunologic Factors|immunologic factors|mesh-ancestor
25233351|NCT02576782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233352|NCT02576782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063295|NCT02186847|Metformin|metformin|mesh-list
25872579|NCT00126074|Tedisamil|tedisamil|mesh-list
25872580|NCT00126074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25872581|NCT00126074|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25872582|NCT00126074|Protective Agents|protective agents|mesh-ancestor
24472367|NCT00399022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25872583|NCT00126074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472368|NCT00399022|Antidepressive Agents|antidepressive agents|mesh-ancestor
24472369|NCT00399022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24472370|NCT00399022|Dopamine Agents|dopamine agents|mesh-ancestor
24472371|NCT00399048|Hydromorphone|hydromorphone|mesh-list
24472372|NCT00399048|Oxycodone|oxycodone|mesh-list
24472373|NCT00399048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24472374|NCT00399048|Narcotics|narcotics|mesh-ancestor
24472375|NCT00399048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24472376|NCT00399048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472377|NCT00399048|Analgesics|analgesics|mesh-ancestor
24472378|NCT00399048|Sensory System Agents|sensory system agents|mesh-ancestor
24472379|NCT00399048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24472380|NCT00399061|Cyclosporine|cyclosporine|mesh-list
24472381|NCT00399061|Cyclosporins|cyclosporins|mesh-list
24472382|NCT00399061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24472383|NCT00399061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472384|NCT00399061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24472385|NCT00399061|Immunologic Factors|immunologic factors|mesh-ancestor
24472386|NCT00399061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472387|NCT00399061|Antifungal Agents|antifungal agents|mesh-ancestor
24472388|NCT00399061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24472402|NCT00399074|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24472403|NCT00399074|Renal Agents|renal agents|mesh-ancestor
24472415|NCT00399087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472416|NCT00399087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25233362|NCT02577094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233363|NCT02577094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25233364|NCT02577094|Immunologic Factors|immunologic factors|mesh-ancestor
25233365|NCT02577094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872584|NCT00126087|Dopamine|dopamine|mesh-list
25872585|NCT00126087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25872586|NCT00126087|Sympathomimetics|sympathomimetics|mesh-ancestor
25872587|NCT00126087|Autonomic Agents|autonomic agents|mesh-ancestor
25872588|NCT00126087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25872589|NCT00126087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872590|NCT00126087|Dopamine Agents|dopamine agents|mesh-ancestor
25872591|NCT00126087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25872592|NCT00126087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063297|NCT02186847|Carboplatin|carboplatin|mesh-list
24472503|NCT00399399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24472504|NCT00399399|Immunologic Factors|immunologic factors|mesh-ancestor
24472505|NCT00399399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422196|NCT00221611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24472506|NCT00399399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24472507|NCT00399399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24472508|NCT00399399|Alkylating Agents|alkylating agents|mesh-ancestor
24472509|NCT00399399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472510|NCT00399399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472511|NCT00399399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24472512|NCT00399399|Antimetabolites|antimetabolites|mesh-ancestor
24472513|NCT00399399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24472514|NCT00399425|Heparin|heparin|mesh-list
24472515|NCT00399425|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24472516|NCT00399425|Tinzaparin|tinzaparin|mesh-list
24472517|NCT00399425|Dalteparin|dalteparin|mesh-list
24472518|NCT00399425|Bemiparin|bemiparin|mesh-list
24805528|NCT02010411|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24805529|NCT02010411|Protease Inhibitors|protease inhibitors|mesh-ancestor
24805530|NCT02010411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24805531|NCT02010411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805532|NCT02010437|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
24805540|NCT02010762|Micronutrients|micronutrients|mesh-ancestor
24805541|NCT02010762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805542|NCT02010762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24805543|NCT02010788|Botulinum Toxins|botulinum toxins|mesh-list
24805544|NCT02010788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24805545|NCT02010788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24472519|NCT00399425|Anticoagulants|anticoagulants|mesh-ancestor
24472520|NCT00399425|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25233375|NCT02577068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25233376|NCT02577068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233377|NCT02577068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25233378|NCT02577068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25233379|NCT02577068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24805547|NCT02010788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24805548|NCT02010788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805549|NCT02010788|Cholinergic Agents|cholinergic agents|mesh-ancestor
24805550|NCT02010788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24805551|NCT02010788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805552|NCT02010788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24805553|NCT02010788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24805554|NCT02010827|Glucagon|glucagon|mesh-list
24805555|NCT02010827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24805556|NCT02010827|Hormones|hormones|mesh-ancestor
24805557|NCT02010827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24805558|NCT02010827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805559|NCT02010905|Losartan|losartan|mesh-list
24545300|NCT00693004|Cholinergic Agents|cholinergic agents|mesh-ancestor
24472710|NCT00400335|Anabolic Agents|anabolic agents|mesh-ancestor
24472711|NCT00400335|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24472712|NCT00400335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24805567|NCT02010944|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24805568|NCT02010944|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24805569|NCT02010944|Cholinergic Agents|cholinergic agents|mesh-ancestor
24805570|NCT02010944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24805571|NCT02010944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872594|NCT00126100|Lenograstim|lenograstim|mesh-list
25872595|NCT00126100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25872596|NCT00126100|Immunologic Factors|immunologic factors|mesh-ancestor
25872597|NCT00126100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872598|NCT00126139|Abciximab|abciximab|mesh-list
25872599|NCT00126139|Anticoagulants|anticoagulants|mesh-ancestor
25872600|NCT00126139|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25872601|NCT00126204|Doxycycline|doxycycline|mesh-list
25872602|NCT00126204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25872603|NCT00126204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25872604|NCT00126204|Antimalarials|antimalarials|mesh-ancestor
24472879|NCT00400855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25872609|NCT00126230|Tubulin Modulators|tubulin modulators|mesh-ancestor
25872610|NCT00126230|Antimitotic Agents|antimitotic agents|mesh-ancestor
25872611|NCT00126230|Mitosis Modulators|mitosis modulators|mesh-ancestor
24472880|NCT00400855|Respiratory System Agents|respiratory system agents|mesh-ancestor
24472881|NCT00400855|Dermatologic Agents|dermatologic agents|mesh-ancestor
24472882|NCT00400855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24472883|NCT00400998|Fluticasone|fluticasone|mesh-list
24472885|NCT00400998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24472886|NCT00400998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24472887|NCT00400998|Autonomic Agents|autonomic agents|mesh-ancestor
24472888|NCT00400998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24472889|NCT00400998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473193|NCT00402376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25233383|NCT02577159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25872612|NCT00126230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233384|NCT02577159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872613|NCT00126243|Rituximab|rituximab|mesh-list
25872614|NCT00126243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25872615|NCT00126243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872616|NCT00126243|Immunologic Factors|immunologic factors|mesh-ancestor
25872617|NCT00126243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805581|NCT02010957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805582|NCT02010957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24805583|NCT02010957|Anesthetics, General|anesthetics, general|mesh-ancestor
24805584|NCT02010957|Anesthetics|anesthetics|mesh-ancestor
24805585|NCT02010970|Itraconazole|itraconazole|mesh-list
24805586|NCT02010970|Diltiazem|diltiazem|mesh-list
24805587|NCT02010970|Calcium Channel Blockers|calcium channel blockers|mesh-list
24805588|NCT02010970|Midazolam|midazolam|mesh-list
24472900|NCT00401115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24472901|NCT00401115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24472902|NCT00401115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24472903|NCT00401115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472904|NCT00401115|Antifungal Agents|antifungal agents|mesh-ancestor
24472905|NCT00401115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24472908|NCT00401128|Gemcitabine|gemcitabine|mesh-list
24472930|NCT00401167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24472931|NCT00401180|Docetaxel|docetaxel|mesh-list
24472932|NCT00401180|Temozolomide|temozolomide|mesh-list
24472933|NCT00401180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472934|NCT00401180|Tubulin Modulators|tubulin modulators|mesh-ancestor
25872619|NCT00126256|Leucovorin|leucovorin|mesh-list
25872620|NCT00126256|Fluorouracil|fluorouracil|mesh-list
25872621|NCT00126256|Oxaliplatin|oxaliplatin|mesh-list
25872622|NCT00126256|Irinotecan|irinotecan|mesh-list
25872623|NCT00126256|Antimetabolites|antimetabolites|mesh-ancestor
25872624|NCT00126256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872625|NCT00126256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25872626|NCT00126256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872627|NCT00126256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25872628|NCT00126256|Immunologic Factors|immunologic factors|mesh-ancestor
25872629|NCT00126256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872630|NCT00126256|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25872631|NCT00126256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25872632|NCT00126256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872633|NCT00126256|Antidotes|antidotes|mesh-ancestor
25872634|NCT00126256|Protective Agents|protective agents|mesh-ancestor
25872635|NCT00126256|Vitamin B Complex|vitamin b complex|mesh-ancestor
25872636|NCT00126256|Vitamins|vitamins|mesh-ancestor
25872637|NCT00126256|Micronutrients|micronutrients|mesh-ancestor
24805597|NCT02010970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24805598|NCT02010970|Anesthetics, General|anesthetics, general|mesh-ancestor
24805600|NCT02010970|GABA Modulators|gaba modulators|mesh-ancestor
25872638|NCT00126269|Gemcitabine|gemcitabine|mesh-list
25872639|NCT00126269|Cisplatin|cisplatin|mesh-list
24444358|NCT00297661|Paclitaxel|paclitaxel|mesh-list
24444359|NCT00297661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24472994|NCT00401440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24472995|NCT00401440|Oxytocics|oxytocics|mesh-ancestor
24472996|NCT00401479|Solabegron|solabegron|mesh-list
24472997|NCT00401479|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24472998|NCT00401479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24472999|NCT00401479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24473000|NCT00401479|Adrenergic Agents|adrenergic agents|mesh-ancestor
24473001|NCT00401479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24473002|NCT00401479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473003|NCT00401479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872641|NCT00126269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24444408|NCT00297804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444409|NCT00297817|Vaccines|vaccines|mesh-list
24444411|NCT00297817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444412|NCT00297947|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24444413|NCT00297947|Antidepressive Agents|antidepressive agents|mesh-ancestor
24444414|NCT00297947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24444478|NCT00298181|polysaccharide-K|polysaccharide-k|mesh-list
24444479|NCT00298181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24473194|NCT00402376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24805608|NCT02010970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24805609|NCT02010970|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24580391|NCT00861523|Antiemetics|antiemetics|mesh-ancestor
24444480|NCT00298181|Immunologic Factors|immunologic factors|mesh-ancestor
24444481|NCT00298181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444482|NCT00298181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24444483|NCT00298181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24444484|NCT00298181|Antiviral Agents|antiviral agents|mesh-ancestor
25872642|NCT00126269|Antimetabolites|antimetabolites|mesh-ancestor
25872643|NCT00126269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444485|NCT00298181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24444486|NCT00298181|Interferon Inducers|interferon inducers|mesh-ancestor
24444487|NCT00298181|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24444488|NCT00298181|Protective Agents|protective agents|mesh-ancestor
24444490|NCT00298194|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24444532|NCT00298350|Antiviral Agents|antiviral agents|mesh-ancestor
24444533|NCT00298350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25872644|NCT00126269|Antiviral Agents|antiviral agents|mesh-ancestor
24473067|NCT00401674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473068|NCT00401674|Tubulin Modulators|tubulin modulators|mesh-ancestor
24473069|NCT00401674|Antimitotic Agents|antimitotic agents|mesh-ancestor
24473070|NCT00401674|Mitosis Modulators|mitosis modulators|mesh-ancestor
24473071|NCT00401674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473074|NCT00401765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473075|NCT00401765|Tubulin Modulators|tubulin modulators|mesh-ancestor
25872645|NCT00126269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25872646|NCT00126269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872647|NCT00126269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25872648|NCT00126269|Immunologic Factors|immunologic factors|mesh-ancestor
25144326|NCT02937181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24473076|NCT00401765|Antimitotic Agents|antimitotic agents|mesh-ancestor
24473077|NCT00401765|Mitosis Modulators|mitosis modulators|mesh-ancestor
24473078|NCT00401765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473079|NCT00401804|Dexamethasone|dexamethasone|mesh-list
24473137|NCT00402142|Immunologic Factors|immunologic factors|mesh-ancestor
25872649|NCT00126269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473179|NCT00402350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24473180|NCT00402350|Narcotics|narcotics|mesh-ancestor
24473181|NCT00402350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24473182|NCT00402350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473183|NCT00402350|Analgesics|analgesics|mesh-ancestor
24473184|NCT00402350|Sensory System Agents|sensory system agents|mesh-ancestor
24473185|NCT00402350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24473186|NCT00402350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24473187|NCT00402350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25233399|NCT02576808|Loratadine|loratadine|mesh-list
25233400|NCT02576808|Antipruritics|antipruritics|mesh-ancestor
25233401|NCT02576808|Dermatologic Agents|dermatologic agents|mesh-ancestor
25233402|NCT02576808|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25233403|NCT02576808|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25233404|NCT02576808|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25233405|NCT02576808|Histamine Antagonists|histamine antagonists|mesh-ancestor
25233406|NCT02576808|Histamine Agents|histamine agents|mesh-ancestor
24847103|NCT02245191|Sympathomimetics|sympathomimetics|mesh-ancestor
24847104|NCT02245191|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24847105|NCT02245191|Nasal Decongestants|nasal decongestants|mesh-ancestor
24847106|NCT02245191|Respiratory System Agents|respiratory system agents|mesh-ancestor
24847107|NCT02245191|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24473192|NCT00402376|Pravastatin|pravastatin|mesh-list
24738945|NCT01678404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738946|NCT01678404|Immunologic Factors|immunologic factors|mesh-ancestor
24473197|NCT00402376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444676|NCT00298870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24444677|NCT00298870|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24444678|NCT00298870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24444679|NCT00298870|Antimetabolites|antimetabolites|mesh-ancestor
24444680|NCT00298870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444681|NCT00298870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24444682|NCT00298883|Mycophenolic Acid|mycophenolic acid|mesh-list
24444683|NCT00298883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24444684|NCT00298883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24444685|NCT00298883|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24444686|NCT00298883|Antitubercular Agents|antitubercular agents|mesh-ancestor
24444687|NCT00298883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24444688|NCT00298883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24444689|NCT00298883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444690|NCT00298883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444692|NCT00298909|Niacinamide|niacinamide|mesh-list
24444693|NCT00298909|Nicotinic Acids|nicotinic acids|mesh-list
24444694|NCT00298909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24444695|NCT00298909|Antimetabolites|antimetabolites|mesh-ancestor
24444696|NCT00298909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444697|NCT00298909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24444698|NCT00298909|Vasodilator Agents|vasodilator agents|mesh-ancestor
24444699|NCT00298909|Vitamin B Complex|vitamin b complex|mesh-ancestor
24444700|NCT00298909|Vitamins|vitamins|mesh-ancestor
24444701|NCT00298909|Micronutrients|micronutrients|mesh-ancestor
24473209|NCT00402376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24473210|NCT00402376|Antimetabolites|antimetabolites|mesh-ancestor
24473211|NCT00402376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24473212|NCT00402376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24473213|NCT00402376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473214|NCT00402376|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24473244|NCT00402454|Antitubercular Agents|antitubercular agents|mesh-ancestor
24473250|NCT00402454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473252|NCT00402454|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24473273|NCT00402480|Hydroxyurea|hydroxyurea|mesh-list
24473274|NCT00402480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473275|NCT00402480|Antisickling Agents|antisickling agents|mesh-ancestor
24473276|NCT00402480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473277|NCT00402480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672144|NCT01741454|Urological Agents|urological agents|mesh-ancestor
25672145|NCT01741454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24473278|NCT00402480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24473282|NCT00402493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24473283|NCT00402493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24473284|NCT00402493|Analgesics|analgesics|mesh-ancestor
24473285|NCT00402493|Sensory System Agents|sensory system agents|mesh-ancestor
24473286|NCT00402493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24473287|NCT00402493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473288|NCT00402493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24473289|NCT00402493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24473290|NCT00402493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24473291|NCT00402493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233407|NCT02576808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25233408|NCT02576808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233409|NCT02576808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273604|NCT02384889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25273605|NCT02384889|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
24847108|NCT02245191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24847109|NCT02245191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24473359|NCT00402558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24473361|NCT00402558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24473362|NCT00402571|Acetaminophen|acetaminophen|mesh-list
24473363|NCT00402571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24473364|NCT00402571|Analgesics|analgesics|mesh-ancestor
24473365|NCT00402571|Sensory System Agents|sensory system agents|mesh-ancestor
24473366|NCT00402571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24473376|NCT00402610|Pyrazinamide|pyrazinamide|mesh-list
24473377|NCT00402610|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24473378|NCT00402610|Antitubercular Agents|antitubercular agents|mesh-ancestor
24473379|NCT00402610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24473380|NCT00402610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24473381|NCT00402610|Leprostatic Agents|leprostatic agents|mesh-ancestor
24473382|NCT00402610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24473383|NCT00402610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473384|NCT00402610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444789|NCT00299091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473408|NCT00402636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473410|NCT00402662|Imatinib Mesylate|imatinib mesylate|mesh-list
24473411|NCT00402662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473412|NCT00402662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24473413|NCT00402662|Immunologic Factors|immunologic factors|mesh-ancestor
24473414|NCT00402662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473415|NCT00402662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24473416|NCT00402662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473417|NCT00402662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473418|NCT00402766|Dexamethasone|dexamethasone|mesh-list
24473419|NCT00402766|Cisplatin|cisplatin|mesh-list
24473420|NCT00402766|Pemetrexed|pemetrexed|mesh-list
24473421|NCT00402766|Imatinib Mesylate|imatinib mesylate|mesh-list
24739059|NCT01679041|Cyclophosphamide|cyclophosphamide|mesh-list
24739078|NCT01679093|Droperidol|droperidol|mesh-list
25872650|NCT00126282|Cycloserine|cycloserine|mesh-list
25872651|NCT00126282|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25872652|NCT00126282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25872653|NCT00126282|Renal Agents|renal agents|mesh-ancestor
25872654|NCT00126282|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24473422|NCT00402766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473423|NCT00402766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24473425|NCT00402766|Autonomic Agents|autonomic agents|mesh-ancestor
24473426|NCT00402766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24473427|NCT00402766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473428|NCT00402766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24473429|NCT00402766|Glucocorticoids|glucocorticoids|mesh-ancestor
24473430|NCT00402766|Hormones|hormones|mesh-ancestor
24473431|NCT00402766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24473432|NCT00402766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24473433|NCT00402766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473434|NCT00402766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473519|NCT00403156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473520|NCT00403156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25233410|NCT02576626|Glycopyrrolate|glycopyrrolate|mesh-list
25233411|NCT02576626|Albuterol|albuterol|mesh-list
25233412|NCT02576626|Ipratropium|ipratropium|mesh-list
24444800|NCT00299208|Quinine|quinine|mesh-list
24473571|NCT00403325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24473572|NCT00403325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24473573|NCT00403325|Growth Substances|growth substances|mesh-ancestor
24581208|NCT00864734|Metformin|metformin|mesh-list
24473597|NCT00403364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24473598|NCT00403364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24473599|NCT00403364|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24473600|NCT00403364|Alkylating Agents|alkylating agents|mesh-ancestor
24473601|NCT00403364|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
24473602|NCT00403364|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24473603|NCT00403364|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24473604|NCT00403429|Capecitabine|capecitabine|mesh-list
24473605|NCT00403429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24473606|NCT00403429|Antimetabolites|antimetabolites|mesh-ancestor
24473607|NCT00403429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473608|NCT00403429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872655|NCT00126282|Antitubercular Agents|antitubercular agents|mesh-ancestor
24473637|NCT00403650|Iloprost|iloprost|mesh-list
24473638|NCT00403650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24473639|NCT00403650|Vasodilator Agents|vasodilator agents|mesh-ancestor
24473640|NCT00403663|Fentanyl|fentanyl|mesh-list
24473641|NCT00403663|Morphine|morphine|mesh-list
24473642|NCT00403663|Bupivacaine|bupivacaine|mesh-list
25872656|NCT00126282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24473671|NCT00403780|Sensory System Agents|sensory system agents|mesh-ancestor
24473672|NCT00403780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25872657|NCT00126282|Antimetabolites|antimetabolites|mesh-ancestor
25233413|NCT02576626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25233414|NCT02576626|Autonomic Agents|autonomic agents|mesh-ancestor
25233415|NCT02576626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25233416|NCT02576626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233417|NCT02576626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25233418|NCT02576626|Respiratory System Agents|respiratory system agents|mesh-ancestor
25233419|NCT02576626|Tocolytic Agents|tocolytic agents|mesh-ancestor
25233420|NCT02576626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25872658|NCT00126282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473702|NCT00403819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24473704|NCT00403858|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24473705|NCT00403858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24473706|NCT00403858|Laxatives|laxatives|mesh-ancestor
24805749|NCT02012036|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24581456|NCT00865215|Propranolol|propranolol|mesh-list
25872659|NCT00126308|Mannitol|mannitol|mesh-list
25872660|NCT00126308|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25872661|NCT00126308|Diuretics|diuretics|mesh-ancestor
24473730|NCT00403962|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24473731|NCT00403962|Antidepressive Agents|antidepressive agents|mesh-ancestor
24473732|NCT00403962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24473733|NCT00403962|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25233429|NCT02576626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24445435|NCT00301587|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25672146|NCT01741454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25672147|NCT01741454|Cholinergic Agents|cholinergic agents|mesh-ancestor
25672148|NCT01741532|Deferiprone|deferiprone|mesh-list
25672149|NCT01741532|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25672150|NCT01741532|Chelating Agents|chelating agents|mesh-ancestor
25672151|NCT01741532|Sequestering Agents|sequestering agents|mesh-ancestor
25672152|NCT01741532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672153|NCT01741545|Interferons|interferons|mesh-list
24445437|NCT00301587|Estrogens|estrogens|mesh-ancestor
24445438|NCT00301587|Hormones|hormones|mesh-ancestor
24445439|NCT00301587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24445440|NCT00301587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445441|NCT00301587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24445442|NCT00301587|Contraceptive Agents|contraceptive agents|mesh-ancestor
24445443|NCT00301587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24805759|NCT02012049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24805760|NCT02012049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24805761|NCT02012049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24805762|NCT02012049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24805763|NCT02012049|Dopamine Agents|dopamine agents|mesh-ancestor
24805765|NCT02012062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24805766|NCT02012062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24805768|NCT02012075|Carvedilol|carvedilol|mesh-list
24805769|NCT02012075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24445444|NCT00301587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24445445|NCT00301587|Hematinics|hematinics|mesh-ancestor
24445446|NCT00301587|Vitamin B Complex|vitamin b complex|mesh-ancestor
24445447|NCT00301587|Vitamins|vitamins|mesh-ancestor
24445537|NCT00301795|Oblimersen|oblimersen|mesh-list
24445538|NCT00301795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24445539|NCT00301795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445614|NCT00301925|Immunologic Factors|immunologic factors|mesh-ancestor
24445615|NCT00301925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445616|NCT00301925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24445617|NCT00301925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24445618|NCT00301925|Alkylating Agents|alkylating agents|mesh-ancestor
25233430|NCT02576626|Cholinergic Agents|cholinergic agents|mesh-ancestor
25233431|NCT02576665|Flucytosine|flucytosine|mesh-list
25233432|NCT02576665|Antifungal Agents|antifungal agents|mesh-ancestor
25233433|NCT02576665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25233434|NCT02576665|Antimetabolites|antimetabolites|mesh-ancestor
25233435|NCT02576665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233436|NCT02576600|Remifentanil|remifentanil|mesh-list
25233437|NCT02576600|Propofol|propofol|mesh-list
25233438|NCT02576600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25233439|NCT02576600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25233440|NCT02576600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233441|NCT02576600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25233442|NCT02576600|Anesthetics, General|anesthetics, general|mesh-ancestor
24445619|NCT00301925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445620|NCT00301925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445621|NCT00301925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24445623|NCT00301925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24445624|NCT00301925|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24445625|NCT00301925|Abortifacient Agents|abortifacient agents|mesh-ancestor
24445626|NCT00301925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24445627|NCT00301925|Dermatologic Agents|dermatologic agents|mesh-ancestor
24445628|NCT00301925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445629|NCT00301925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24445630|NCT00301925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24445631|NCT00301925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24445632|NCT00301925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24445633|NCT00301925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24445679|NCT00302224|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24473752|NCT00404053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25872662|NCT00126308|Natriuretic Agents|natriuretic agents|mesh-ancestor
25872663|NCT00126308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872664|NCT00126321|Cladribine|cladribine|mesh-list
24445842|NCT00302705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24445844|NCT00302705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545595|NCT00693979|Paclitaxel|paclitaxel|mesh-list
24805791|NCT02012088|Rituximab|rituximab|mesh-list
24455198|NCT02329080|Ifosfamide|ifosfamide|mesh-list
24455199|NCT02329080|Thiotepa|thiotepa|mesh-list
24455200|NCT02329080|Carmustine|carmustine|mesh-list
24445870|NCT00302822|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24473783|NCT00404183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24473784|NCT00404183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24473785|NCT00404183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24473786|NCT00404196|Calcipotriene|calcipotriene|mesh-list
24473787|NCT00404196|Dermatologic Agents|dermatologic agents|mesh-ancestor
24473788|NCT00404222|Acetaminophen|acetaminophen|mesh-list
24473789|NCT00404222|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
24473800|NCT00404222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24455201|NCT02329080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24955268|NCT03866447|Vitamin D|vitamin d|mesh-list
25872665|NCT00126321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473801|NCT00404222|Antitussive Agents|antitussive agents|mesh-ancestor
24473812|NCT00404261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24805795|NCT02012088|Immunologic Factors|immunologic factors|mesh-ancestor
24805796|NCT02012088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805797|NCT02012088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24805798|NCT02012088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24805799|NCT02012088|Alkylating Agents|alkylating agents|mesh-ancestor
24805800|NCT02012088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805801|NCT02012088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24805802|NCT02012088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24805803|NCT02012088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24581860|NCT00866554|Tamoxifen|tamoxifen|mesh-list
24473817|NCT00404261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24473818|NCT00404261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25872666|NCT00126321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25872667|NCT00126321|Immunologic Factors|immunologic factors|mesh-ancestor
25872668|NCT00126321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872669|NCT00126347|Folic Acid|folic acid|mesh-list
25872670|NCT00126347|Betaine|betaine|mesh-list
25872671|NCT00126347|Hematinics|hematinics|mesh-ancestor
24473858|NCT00404378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24473859|NCT00404378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233452|NCT02576444|Olaparib|olaparib|mesh-list
25233453|NCT02576444|Adavosertib|adavosertib|mesh-list
25233454|NCT02576444|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25233455|NCT02576444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233456|NCT02576444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233457|NCT02576444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25233458|NCT02576353|Fentanyl|fentanyl|mesh-list
24884596|NCT00271817|Micronutrients|micronutrients|mesh-ancestor
24445997|NCT00303524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24445998|NCT00303524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445999|NCT00303537|Metformin|metformin|mesh-list
24446000|NCT00303537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24805820|NCT02012140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24805821|NCT02012140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24473864|NCT00404378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473865|NCT00404378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24473866|NCT00404378|Antiemetics|antiemetics|mesh-ancestor
25233459|NCT02576353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25233460|NCT02576353|Narcotics|narcotics|mesh-ancestor
25233461|NCT02576353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25233462|NCT02576353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233463|NCT02576353|Analgesics|analgesics|mesh-ancestor
25672154|NCT01741545|Ribavirin|ribavirin|mesh-list
25672155|NCT01741545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672156|NCT01741545|Antiviral Agents|antiviral agents|mesh-ancestor
25233464|NCT02576353|Sensory System Agents|sensory system agents|mesh-ancestor
25672157|NCT01741545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25672158|NCT01741545|Antimetabolites|antimetabolites|mesh-ancestor
25672159|NCT01741545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674527|NCT01773122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144863|NCT02934061|Anticonvulsants|anticonvulsants|mesh-ancestor
25233465|NCT02576353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25233466|NCT02576353|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25233467|NCT02576353|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24955295|NCT03865888|Tacrolimus|tacrolimus|mesh-list
24955296|NCT03865888|Cyclosporins|cyclosporins|mesh-list
25233468|NCT02576353|Anesthetics, General|anesthetics, general|mesh-ancestor
25233469|NCT02576353|Anesthetics|anesthetics|mesh-ancestor
25233470|NCT02576340|Octylonium|octylonium|mesh-list
25233471|NCT02576340|Bromides|bromides|mesh-list
25233472|NCT02576340|Anticonvulsants|anticonvulsants|mesh-ancestor
25273606|NCT02384889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063385|NCT01733888|Hydrogen Peroxide|hydrogen peroxide|mesh-list
24473867|NCT00404378|Autonomic Agents|autonomic agents|mesh-ancestor
24473868|NCT00404378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24473869|NCT00404378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24473870|NCT00404378|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24473871|NCT00404378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24473872|NCT00404391|Acetaminophen|acetaminophen|mesh-list
24473873|NCT00404391|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
24473874|NCT00404391|Hydrocodone|hydrocodone|mesh-list
24473875|NCT00404391|Oxycodone|oxycodone|mesh-list
24473876|NCT00404391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24473877|NCT00404391|Analgesics|analgesics|mesh-ancestor
24473888|NCT00404391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24473889|NCT00404391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24473891|NCT00404404|Bevacizumab|bevacizumab|mesh-list
24805824|NCT02012140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805825|NCT02012140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473893|NCT00404404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24473894|NCT00404404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473895|NCT00404404|Tubulin Modulators|tubulin modulators|mesh-ancestor
24473896|NCT00404404|Antimitotic Agents|antimitotic agents|mesh-ancestor
24473897|NCT00404404|Mitosis Modulators|mitosis modulators|mesh-ancestor
24446019|NCT00303615|Anastrozole|anastrozole|mesh-list
24446020|NCT00303615|Fluoxymesterone|fluoxymesterone|mesh-list
24446021|NCT00303615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24446022|NCT00303615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446023|NCT00303615|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24446124|NCT00303810|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24446125|NCT00303810|Abortifacient Agents|abortifacient agents|mesh-ancestor
24446126|NCT00303810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24446127|NCT00303810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24446129|NCT00303810|Dermatologic Agents|dermatologic agents|mesh-ancestor
24446130|NCT00303810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446131|NCT00303810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24739720|NCT01683656|Vitamins|vitamins|mesh-ancestor
24446135|NCT00303810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24446136|NCT00303810|Tubulin Modulators|tubulin modulators|mesh-ancestor
24446138|NCT00303810|Mitosis Modulators|mitosis modulators|mesh-ancestor
25233473|NCT02576340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25233474|NCT02576340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25233475|NCT02576340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233476|NCT02576340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25233477|NCT02576340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233478|NCT02576340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25233479|NCT02576340|Parasympatholytics|parasympatholytics|mesh-ancestor
24473917|NCT00404456|Antioxidants|antioxidants|mesh-ancestor
25872672|NCT00126347|Vitamin B Complex|vitamin b complex|mesh-ancestor
24473931|NCT00404482|Dermatologic Agents|dermatologic agents|mesh-ancestor
25233481|NCT02576340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24473959|NCT00404534|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24473960|NCT00404534|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24473961|NCT00404573|Cariprazine|cariprazine|mesh-list
24473962|NCT00404573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24473963|NCT00404573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24473964|NCT00404573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24473965|NCT00404573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672160|NCT01741792|Blinatumomab|blinatumomab|mesh-list
25672161|NCT01741792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672162|NCT01742117|Clopidogrel|clopidogrel|mesh-list
25672163|NCT01742117|Ticagrelor|ticagrelor|mesh-list
25672164|NCT01742117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24473969|NCT00404586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24473970|NCT00404586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24473971|NCT00404586|Autonomic Agents|autonomic agents|mesh-ancestor
24473972|NCT00404586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24473973|NCT00404586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473974|NCT00404586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24473975|NCT00404586|Respiratory System Agents|respiratory system agents|mesh-ancestor
25872673|NCT00126347|Vitamins|vitamins|mesh-ancestor
25872674|NCT00126347|Micronutrients|micronutrients|mesh-ancestor
25872675|NCT00126347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872676|NCT00126347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25872677|NCT00126347|Lipotropic Agents|lipotropic agents|mesh-ancestor
25872678|NCT00126347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25872679|NCT00126347|Antimetabolites|antimetabolites|mesh-ancestor
25872680|NCT00126347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805851|NCT02012309|Immunologic Factors|immunologic factors|mesh-ancestor
24805852|NCT02012309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805853|NCT02012322|Ubiquinone|ubiquinone|mesh-list
24805854|NCT02012322|Coenzyme Q10|coenzyme q10|mesh-list
24805855|NCT02012322|Micronutrients|micronutrients|mesh-ancestor
24805856|NCT02012322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805857|NCT02012322|Vitamins|vitamins|mesh-ancestor
24739884|NCT01684865|Rituximab|rituximab|mesh-list
25872681|NCT00126347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24781143|NCT01888250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25872682|NCT00126360|Anastrozole|anastrozole|mesh-list
25872683|NCT00126360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25872684|NCT00126360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25233484|NCT02576340|Cholinergic Agents|cholinergic agents|mesh-ancestor
25233485|NCT02576340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25233486|NCT02576314|Sofosbuvir|sofosbuvir|mesh-list
25233487|NCT02576314|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
24473993|NCT00404703|Growth Substances|growth substances|mesh-ancestor
25872685|NCT00126360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25872686|NCT00126360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25872687|NCT00126360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600623|NCT00959582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24600624|NCT00959582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600625|NCT00959595|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24600626|NCT00959595|Anesthetics, Local|anesthetics, local|mesh-ancestor
24600627|NCT00959595|Anesthetics|anesthetics|mesh-ancestor
24474009|NCT00404716|Protective Agents|protective agents|mesh-ancestor
24474010|NCT00404716|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24474011|NCT00404716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24474012|NCT00404716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24865790|NCT04940572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25233488|NCT02576314|Ledipasvir|ledipasvir|mesh-list
25233489|NCT02576314|Antiviral Agents|antiviral agents|mesh-ancestor
25233490|NCT02576314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25233491|NCT02576301|Cytarabine|cytarabine|mesh-list
25233492|NCT02576301|Combretastatin|combretastatin|mesh-list
25233493|NCT02576301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25233494|NCT02576301|Antimetabolites|antimetabolites|mesh-ancestor
25233495|NCT02576301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233496|NCT02576301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25233497|NCT02576301|Antiviral Agents|antiviral agents|mesh-ancestor
25672165|NCT01742117|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25672166|NCT01742117|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25672167|NCT01742117|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25672168|NCT01742117|Purinergic Agents|purinergic agents|mesh-ancestor
25672169|NCT01742117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25672170|NCT01742117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672171|NCT01742117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674528|NCT01773122|Leprostatic Agents|leprostatic agents|mesh-ancestor
25872688|NCT00126360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872689|NCT00126360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24600632|NCT00959595|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24600634|NCT00959621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25233498|NCT02576301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25233499|NCT02576301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25233501|NCT02576301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233502|NCT02576301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25233503|NCT02576301|Tubulin Modulators|tubulin modulators|mesh-ancestor
25233504|NCT02576301|Antimitotic Agents|antimitotic agents|mesh-ancestor
25233505|NCT02576301|Mitosis Modulators|mitosis modulators|mesh-ancestor
25233506|NCT02576288|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25233507|NCT02576288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25233508|NCT02576288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233509|NCT02576288|Incretins|incretins|mesh-ancestor
25233511|NCT02576288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25233512|NCT02576288|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25233513|NCT02576288|Protease Inhibitors|protease inhibitors|mesh-ancestor
25233514|NCT02576288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446291|NCT00304317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24446292|NCT00304317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24446293|NCT00304317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872690|NCT00126360|Hormone Antagonists|hormone antagonists|mesh-ancestor
25872691|NCT00126360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24423815|NCT00226954|Zoledronic Acid|zoledronic acid|mesh-list
25872692|NCT00126360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872693|NCT00126373|Bupropion|bupropion|mesh-list
25872694|NCT00126373|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24446336|NCT00304473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872695|NCT00126373|Antidepressive Agents|antidepressive agents|mesh-ancestor
24600639|NCT00959621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600640|NCT00959621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24600641|NCT00959621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24600642|NCT00959621|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24600643|NCT00959621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24600644|NCT00959621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474056|NCT00404794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24474057|NCT00404794|Immunologic Factors|immunologic factors|mesh-ancestor
25872696|NCT00126373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25872697|NCT00126373|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25872698|NCT00126373|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24600647|NCT00959621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600648|NCT00959621|Antipyretics|antipyretics|mesh-ancestor
24600649|NCT00959686|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24600650|NCT00959686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24600651|NCT00959686|Alkylating Agents|alkylating agents|mesh-ancestor
24600653|NCT00959686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24805860|NCT02012335|Sensory System Agents|sensory system agents|mesh-ancestor
24474071|NCT00404794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25233515|NCT02576288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233516|NCT02576275|Rituximab|rituximab|mesh-list
25233517|NCT02576275|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24446346|NCT00304499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805864|NCT02012335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24805865|NCT02012335|Anesthetics, General|anesthetics, general|mesh-ancestor
24805867|NCT02012335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24805868|NCT02012335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24805869|NCT02012335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24446357|NCT00304551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446358|NCT00304551|Antiviral Agents|antiviral agents|mesh-ancestor
25872699|NCT00126373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25872700|NCT00126373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872701|NCT00126373|Dopamine Agents|dopamine agents|mesh-ancestor
24474113|NCT00404937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24474114|NCT00404937|Glucocorticoids|glucocorticoids|mesh-ancestor
24474115|NCT00404937|Hormones|hormones|mesh-ancestor
24474116|NCT00404937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24474117|NCT00404937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474118|NCT00404937|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25872702|NCT00126373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25872703|NCT00126373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872704|NCT00126373|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25872705|NCT00126373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25872706|NCT00126373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872707|NCT00126386|Zoledronic Acid|zoledronic acid|mesh-list
24805870|NCT02012335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24805871|NCT02012335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805873|NCT02012387|Vaccines|vaccines|mesh-list
24805874|NCT02012387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25233518|NCT02576275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25233519|NCT02576275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25233520|NCT02576275|Immunologic Factors|immunologic factors|mesh-ancestor
25233521|NCT02576275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872708|NCT00126386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25872709|NCT00126386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872710|NCT00126399|Doxycycline|doxycycline|mesh-list
25872711|NCT00126399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25872712|NCT00126399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25872713|NCT00126399|Antimalarials|antimalarials|mesh-ancestor
25872714|NCT00126399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25872715|NCT00126399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25872716|NCT00126412|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
25872717|NCT00126412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872718|NCT00126412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872719|NCT00126412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805878|NCT02012387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24805879|NCT02012387|Respiratory System Agents|respiratory system agents|mesh-ancestor
24805881|NCT02012465|Insulin Glargine|insulin glargine|mesh-list
24805882|NCT02012465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24393249|NCT00129233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24805883|NCT02012465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805884|NCT02012517|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24446363|NCT00304616|Risperidone|risperidone|mesh-list
25872720|NCT00126412|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25872721|NCT00126451|Vorinostat|vorinostat|mesh-list
25233522|NCT02576275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25233523|NCT02576275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25233524|NCT02576275|Alkylating Agents|alkylating agents|mesh-ancestor
25233525|NCT02576275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233526|NCT02576223|Ropivacaine|ropivacaine|mesh-list
25233527|NCT02576223|Anesthetics, Local|anesthetics, local|mesh-ancestor
25233528|NCT02576223|Anesthetics|anesthetics|mesh-ancestor
25233529|NCT02576223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25233530|NCT02576223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872722|NCT00126451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872723|NCT00126451|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25872724|NCT00126451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872725|NCT00126451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872726|NCT00126464|Tamoxifen|tamoxifen|mesh-list
25872727|NCT00126464|Fulvestrant|fulvestrant|mesh-list
25872728|NCT00126464|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25872729|NCT00126464|Hormone Antagonists|hormone antagonists|mesh-ancestor
25872730|NCT00126464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25872731|NCT00126464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872732|NCT00126464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25872733|NCT00126464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872734|NCT00126464|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25872735|NCT00126464|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25872736|NCT00126464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24805885|NCT02012517|Cefazolin|cefazolin|mesh-list
24805886|NCT02012517|Cephalexin|cephalexin|mesh-list
24805887|NCT02012517|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25233531|NCT02576223|Sensory System Agents|sensory system agents|mesh-ancestor
25233532|NCT02576223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25233533|NCT02576366|Rifampin|rifampin|mesh-list
25233534|NCT02576366|Voriconazole|voriconazole|mesh-list
25233535|NCT02576366|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24847150|NCT02245295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805888|NCT02012517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24805889|NCT02012517|Antitubercular Agents|antitubercular agents|mesh-ancestor
24805890|NCT02012556|Tesamorelin|tesamorelin|mesh-list
24805891|NCT02012556|Growth Substances|growth substances|mesh-ancestor
24805892|NCT02012556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872737|NCT00126464|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25872738|NCT00126516|Angiotensin II|angiotensin ii|mesh-list
25872739|NCT00126516|Giapreza|giapreza|mesh-list
25872740|NCT00126516|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25872741|NCT00126516|Angiotensinogen|angiotensinogen|mesh-list
25872742|NCT00126516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25872743|NCT00126516|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
25872744|NCT00126516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872745|NCT00126516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25101436|NCT03174821|Insulin|insulin|mesh-list
25872746|NCT00126516|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25872747|NCT00126516|Protease Inhibitors|protease inhibitors|mesh-ancestor
25872748|NCT00126542|Bevacizumab|bevacizumab|mesh-list
24474153|NCT00405119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474154|NCT00405119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474155|NCT00405119|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24474156|NCT00405119|Histamine Antagonists|histamine antagonists|mesh-ancestor
24474157|NCT00405119|Histamine Agents|histamine agents|mesh-ancestor
24474158|NCT00405119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24474159|NCT00405119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474160|NCT00405158|Acetaminophen|acetaminophen|mesh-list
24474161|NCT00405158|Antipyretics|antipyretics|mesh-list
24446398|NCT00304629|Autonomic Agents|autonomic agents|mesh-ancestor
25872749|NCT00126542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25872750|NCT00126542|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25872751|NCT00126542|Antibodies|antibodies|mesh-list
25872752|NCT00126542|Immunoglobulins|immunoglobulins|mesh-list
25872753|NCT00126542|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25872754|NCT00126542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446401|NCT00304642|Dapivirine|dapivirine|mesh-list
25233536|NCT02576366|Antitubercular Agents|antitubercular agents|mesh-ancestor
25233537|NCT02576366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25233538|NCT02576366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25233539|NCT02576366|Leprostatic Agents|leprostatic agents|mesh-ancestor
25233540|NCT02576366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25233541|NCT02576366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233542|NCT02576366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233543|NCT02576366|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24805920|NCT02012920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24805921|NCT02012920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805922|NCT02012933|Amifampridine|amifampridine|mesh-list
24805923|NCT02012933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24805924|NCT02012933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24805925|NCT02012933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805926|NCT02012933|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24805927|NCT02012933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24805928|NCT02012933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805929|NCT02012946|Simendan|simendan|mesh-list
24805930|NCT02012946|Dobutamine|dobutamine|mesh-list
24805931|NCT02012946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24474186|NCT00405210|Docetaxel|docetaxel|mesh-list
24474191|NCT00405210|Mitosis Modulators|mitosis modulators|mesh-ancestor
24474192|NCT00405210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474193|NCT00405210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24474200|NCT00405236|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24474201|NCT00405236|Respiratory System Agents|respiratory system agents|mesh-ancestor
24474202|NCT00405236|Parasympatholytics|parasympatholytics|mesh-ancestor
24474203|NCT00405236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24474204|NCT00405236|Cholinergic Agents|cholinergic agents|mesh-ancestor
24474205|NCT00405236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24474206|NCT00405236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872755|NCT00126542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24446414|NCT00304655|Dopamine Agents|dopamine agents|mesh-ancestor
24446415|NCT00304655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24781187|NCT01888445|Darbepoetin alfa|darbepoetin alfa|mesh-list
24955432|NCT03865147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24955434|NCT03865147|Mydriatics|mydriatics|mesh-ancestor
24955436|NCT03865147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24446416|NCT00304655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446417|NCT00304655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25872756|NCT00126542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24805932|NCT02012946|Vasodilator Agents|vasodilator agents|mesh-ancestor
24582922|NCT00872625|Fluorouracil|fluorouracil|mesh-list
24474227|NCT00405262|Analgesics|analgesics|mesh-ancestor
24474228|NCT00405262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24474229|NCT00405262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24474230|NCT00405262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24474231|NCT00405262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474232|NCT00405262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474233|NCT00405301|Rifampin|rifampin|mesh-list
24474234|NCT00405301|Pyrazinamide|pyrazinamide|mesh-list
24474235|NCT00405301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24474236|NCT00405301|Antitubercular Agents|antitubercular agents|mesh-ancestor
25233544|NCT02576366|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25233545|NCT02576366|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25233546|NCT02576366|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25233547|NCT02576366|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25233548|NCT02576366|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25233549|NCT02576366|Antifungal Agents|antifungal agents|mesh-ancestor
25233550|NCT02576366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25872757|NCT00126542|Growth Substances|growth substances|mesh-ancestor
25872758|NCT00126542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872759|NCT00126542|Growth Inhibitors|growth inhibitors|mesh-ancestor
24474244|NCT00405301|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24474245|NCT00405301|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24474246|NCT00405301|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24474247|NCT00405301|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24474248|NCT00405301|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24474249|NCT00405340|Rituximab|rituximab|mesh-list
24474250|NCT00405340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24474251|NCT00405340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474252|NCT00405340|Immunologic Factors|immunologic factors|mesh-ancestor
24474253|NCT00405340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474270|NCT00405405|Growth Inhibitors|growth inhibitors|mesh-ancestor
24474271|NCT00405405|Tubulin Modulators|tubulin modulators|mesh-ancestor
24474272|NCT00405405|Antimitotic Agents|antimitotic agents|mesh-ancestor
24474273|NCT00405405|Mitosis Modulators|mitosis modulators|mesh-ancestor
24474274|NCT00405405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474275|NCT00405405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24474278|NCT00405418|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24474279|NCT00405418|Insulin Glargine|insulin glargine|mesh-list
24474280|NCT00405418|Insulin Detemir|insulin detemir|mesh-list
24474281|NCT00405418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24805935|NCT02012946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24805936|NCT02012946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805937|NCT02012946|Protective Agents|protective agents|mesh-ancestor
25872760|NCT00126542|Immunologic Factors|immunologic factors|mesh-ancestor
25872761|NCT00126542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25872762|NCT00126542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872763|NCT00126542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872764|NCT00126607|Trastuzumab|trastuzumab|mesh-list
25872765|NCT00126607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24474287|NCT00405444|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24474288|NCT00405444|Narcotics|narcotics|mesh-ancestor
24474289|NCT00405444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24474290|NCT00405444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474291|NCT00405444|Analgesics|analgesics|mesh-ancestor
25872766|NCT00126607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872767|NCT00126620|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25872768|NCT00126620|Sorafenib|sorafenib|mesh-list
25872769|NCT00126620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872770|NCT00126620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25872771|NCT00126620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872772|NCT00126620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872773|NCT00126633|Gemcitabine|gemcitabine|mesh-list
25872774|NCT00126633|Bevacizumab|bevacizumab|mesh-list
25872775|NCT00126633|Cisplatin|cisplatin|mesh-list
24955462|NCT03864783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24805955|NCT02013089|Gefitinib|gefitinib|mesh-list
25872780|NCT00126633|Growth Substances|growth substances|mesh-ancestor
25233551|NCT02576366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25233552|NCT02576366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25233553|NCT02576366|Hormone Antagonists|hormone antagonists|mesh-ancestor
25233554|NCT02576366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25872781|NCT00126633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872782|NCT00126633|Growth Inhibitors|growth inhibitors|mesh-ancestor
25872783|NCT00126633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25872784|NCT00126633|Antimetabolites|antimetabolites|mesh-ancestor
24474292|NCT00405444|Sensory System Agents|sensory system agents|mesh-ancestor
24474293|NCT00405444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24474294|NCT00405444|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24474295|NCT00405444|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24474296|NCT00405444|Anesthetics, General|anesthetics, general|mesh-ancestor
24474297|NCT00405444|Anesthetics|anesthetics|mesh-ancestor
24474298|NCT00405457|Cyclosporine|cyclosporine|mesh-list
24474299|NCT00405457|Cyclosporins|cyclosporins|mesh-list
24446487|NCT00304850|Anesthetics, General|anesthetics, general|mesh-ancestor
25872785|NCT00126633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805956|NCT02013089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24805957|NCT02013089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24805958|NCT02013089|Immunologic Factors|immunologic factors|mesh-ancestor
25872786|NCT00126633|Antiviral Agents|antiviral agents|mesh-ancestor
25233555|NCT02576366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233556|NCT02576366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25233557|NCT02576327|Dexamethasone|dexamethasone|mesh-list
25233558|NCT02576327|Dexamethasone acetate|dexamethasone acetate|mesh-list
25233559|NCT02576327|Aprepitant|aprepitant|mesh-list
25233560|NCT02576327|Tropisetron|tropisetron|mesh-list
25233561|NCT02576327|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25233562|NCT02576327|BB 1101|bb 1101|mesh-list
25233563|NCT02576327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25233564|NCT02576327|Antiemetics|antiemetics|mesh-ancestor
25233565|NCT02576327|Autonomic Agents|autonomic agents|mesh-ancestor
25233566|NCT02576327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25063454|NCT00003857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25063461|NCT03468595|Listerine|listerine|mesh-list
25872787|NCT00126633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25872788|NCT00126633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872789|NCT00126633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25872790|NCT00126633|Immunologic Factors|immunologic factors|mesh-ancestor
24446490|NCT00304850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25872791|NCT00126646|Antibodies|antibodies|mesh-list
25872792|NCT00126646|Immunoconjugates|immunoconjugates|mesh-list
25872793|NCT00126646|Immunotoxins|immunotoxins|mesh-list
25872794|NCT00126646|Immunologic Factors|immunologic factors|mesh-ancestor
25872795|NCT00126646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872796|NCT00126698|Ciprofloxacin|ciprofloxacin|mesh-list
25872797|NCT00126698|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25872798|NCT00126698|Trimethoprim|trimethoprim|mesh-list
25872799|NCT00126698|Sulfamethoxazole|sulfamethoxazole|mesh-list
25872800|NCT00126698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25872801|NCT00126698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25872802|NCT00126698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25872803|NCT00126698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25872804|NCT00126698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872805|NCT00126698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872806|NCT00126698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872807|NCT00126698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25872808|NCT00126698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24446491|NCT00304850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24446492|NCT00304850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24446493|NCT00304850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233569|NCT02576327|Glucocorticoids|glucocorticoids|mesh-ancestor
25233570|NCT02576327|Hormones|hormones|mesh-ancestor
25233571|NCT02576327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25233572|NCT02576327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25233573|NCT02576327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25233574|NCT02576327|Protease Inhibitors|protease inhibitors|mesh-ancestor
25233575|NCT02576327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233576|NCT02576327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233577|NCT02576327|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25233578|NCT02576327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25000812|NCT03081858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25000813|NCT03081858|Tubulin Modulators|tubulin modulators|mesh-ancestor
25000814|NCT03081858|Antimitotic Agents|antimitotic agents|mesh-ancestor
25000815|NCT03081858|Mitosis Modulators|mitosis modulators|mesh-ancestor
25000817|NCT03053362|Vortioxetine|vortioxetine|mesh-list
25044453|NCT01094262|Oxycodone|oxycodone|mesh-list
24446496|NCT00304980|Pyrimethamine|pyrimethamine|mesh-list
24805959|NCT02013089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805960|NCT02013089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24805961|NCT02013089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618212|NCT01047202|Vaccines|vaccines|mesh-list
24955510|NCT03864588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955511|NCT03864588|Sensory System Agents|sensory system agents|mesh-ancestor
25872809|NCT00126698|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25872810|NCT00126698|Renal Agents|renal agents|mesh-ancestor
25872811|NCT00126698|Antimalarials|antimalarials|mesh-ancestor
25872812|NCT00126698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25872813|NCT00126698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25872814|NCT00126698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25872815|NCT00126698|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25872816|NCT00126698|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25872817|NCT00126763|Fentanyl|fentanyl|mesh-list
25872818|NCT00126763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25872819|NCT00126763|Narcotics|narcotics|mesh-ancestor
25872820|NCT00126763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25872821|NCT00126763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872822|NCT00126763|Analgesics|analgesics|mesh-ancestor
25872823|NCT00126763|Sensory System Agents|sensory system agents|mesh-ancestor
25872824|NCT00126763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25872825|NCT00126763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25872826|NCT00126763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25233579|NCT02576327|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25233580|NCT02576327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25233581|NCT02576327|Serotonin Agents|serotonin agents|mesh-ancestor
25233582|NCT02576015|Lidocaine|lidocaine|mesh-list
25233583|NCT02576015|Ropivacaine|ropivacaine|mesh-list
25233584|NCT02576015|Anesthetics, Local|anesthetics, local|mesh-ancestor
25233585|NCT02576015|Anesthetics|anesthetics|mesh-ancestor
25233586|NCT02576015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25233587|NCT02576015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233588|NCT02576015|Sensory System Agents|sensory system agents|mesh-ancestor
25233589|NCT02576015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25233590|NCT02576015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25233591|NCT02576015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25872827|NCT00126763|Anesthetics, General|anesthetics, general|mesh-ancestor
25872828|NCT00126763|Anesthetics|anesthetics|mesh-ancestor
25872829|NCT00126789|Fentanyl|fentanyl|mesh-list
25872830|NCT00126789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25872831|NCT00126789|Narcotics|narcotics|mesh-ancestor
25872832|NCT00126789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24474375|NCT00405847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24474376|NCT00405847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474377|NCT00405847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24474378|NCT00405847|Analgesics|analgesics|mesh-ancestor
24474379|NCT00405847|Sensory System Agents|sensory system agents|mesh-ancestor
24740721|NCT01689987|Antiemetics|antiemetics|mesh-ancestor
25872833|NCT00126789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872834|NCT00126789|Analgesics|analgesics|mesh-ancestor
25872835|NCT00126789|Sensory System Agents|sensory system agents|mesh-ancestor
25872836|NCT00126789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25872837|NCT00126789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25872838|NCT00126789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25872839|NCT00126789|Anesthetics, General|anesthetics, general|mesh-ancestor
25872841|NCT00126880|Lamivudine|lamivudine|mesh-list
25872842|NCT00126880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25872843|NCT00126880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25872844|NCT00126880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872845|NCT00126880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872846|NCT00126880|Antiviral Agents|antiviral agents|mesh-ancestor
24805962|NCT02013089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805963|NCT02013089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24805964|NCT02013089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24805965|NCT02013089|Growth Substances|growth substances|mesh-ancestor
24805966|NCT02013089|Growth Inhibitors|growth inhibitors|mesh-ancestor
24805967|NCT02013102|Decitabine|decitabine|mesh-list
24805968|NCT02013102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24805969|NCT02013102|Antimetabolites|antimetabolites|mesh-ancestor
24805970|NCT02013102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583266|NCT00873834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25872847|NCT00126880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25233592|NCT02576015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25233593|NCT02576015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24446528|NCT00305201|Antimetabolites|antimetabolites|mesh-ancestor
24446529|NCT00305201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474380|NCT00405847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24546086|NCT00696631|Dronedarone|dronedarone|mesh-list
25872848|NCT00126880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25872849|NCT00126880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25872850|NCT00126906|Pyrimethamine|pyrimethamine|mesh-list
24474414|NCT00405977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24474415|NCT00405977|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24474416|NCT00405977|Anticonvulsants|anticonvulsants|mesh-ancestor
24474417|NCT00405977|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24474418|NCT00405977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24474419|NCT00405977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740777|NCT01690286|Ketoconazole|ketoconazole|mesh-list
25872851|NCT00126906|Sulfadoxine|sulfadoxine|mesh-list
25872852|NCT00126906|Antimalarials|antimalarials|mesh-ancestor
25872853|NCT00126906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25872854|NCT00126906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25872855|NCT00126906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24474420|NCT00405977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24474421|NCT00405977|Tocolytic Agents|tocolytic agents|mesh-ancestor
24955529|NCT03864575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24955531|NCT03864185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24955532|NCT03864185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474422|NCT00405977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24474423|NCT00406003|Paroxetine|paroxetine|mesh-list
24805973|NCT02013115|Budesonide|budesonide|mesh-list
24805974|NCT02013115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24805975|NCT02013115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24805976|NCT02013115|Autonomic Agents|autonomic agents|mesh-ancestor
24805977|NCT02013115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24474429|NCT00406003|Serotonin Agents|serotonin agents|mesh-ancestor
24474430|NCT00406003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474431|NCT00406003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24474432|NCT00406003|Antidepressive Agents|antidepressive agents|mesh-ancestor
25872856|NCT00126906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25872857|NCT00126906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872858|NCT00126906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872859|NCT00126906|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25872860|NCT00126906|Renal Agents|renal agents|mesh-ancestor
25233594|NCT02576015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233595|NCT02576080|Imatinib Mesylate|imatinib mesylate|mesh-list
25233596|NCT02576080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25233597|NCT02576080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25233598|NCT02576080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233599|NCT02576080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233600|NCT02576119|Moxifloxacin|moxifloxacin|mesh-list
25233601|NCT02576119|BMS-955176|bms-955176|mesh-list
25233602|NCT02576119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25872861|NCT00126971|Dapsone|dapsone|mesh-list
25872862|NCT00126971|Chlorproguanil|chlorproguanil|mesh-list
25872863|NCT00126971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25872864|NCT00126971|Antimalarials|antimalarials|mesh-ancestor
25872865|NCT00126971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24506144|NCT00544219|Prednisone|prednisone|mesh-list
25872866|NCT00126971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25872867|NCT00126971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25872868|NCT00126971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872869|NCT00126971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955533|NCT03864185|Immunologic Factors|immunologic factors|mesh-ancestor
24955534|NCT03864185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955535|NCT03864185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24955536|NCT03864172|Calcium, Dietary|calcium, dietary|mesh-list
25872870|NCT00126971|Leprostatic Agents|leprostatic agents|mesh-ancestor
25872871|NCT00126971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24474436|NCT00406003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474437|NCT00406042|Prednisolone|prednisolone|mesh-list
24474438|NCT00406042|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24474439|NCT00406042|Methylprednisolone|methylprednisolone|mesh-list
25872872|NCT00127010|Vaccines|vaccines|mesh-list
25872873|NCT00127010|Immunologic Factors|immunologic factors|mesh-ancestor
25872874|NCT00127010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872875|NCT00127023|Vaccines|vaccines|mesh-list
25872876|NCT00127023|Immunologic Factors|immunologic factors|mesh-ancestor
25872877|NCT00127023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872878|NCT00127049|Gemcitabine|gemcitabine|mesh-list
25872879|NCT00127049|Cisplatin|cisplatin|mesh-list
25872880|NCT00127049|Ifosfamide|ifosfamide|mesh-list
25872881|NCT00127049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872882|NCT00127049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24393487|NCT00130195|Vincristine|vincristine|mesh-list
24393493|NCT00130195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24393494|NCT00130195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24393495|NCT00130195|Alkylating Agents|alkylating agents|mesh-ancestor
24393496|NCT00130195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393497|NCT00130195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393498|NCT00130195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24393499|NCT00130195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24393502|NCT00130195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24393503|NCT00130195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24393504|NCT00130195|Glucocorticoids|glucocorticoids|mesh-ancestor
24393505|NCT00130195|Hormones|hormones|mesh-ancestor
24393509|NCT00130195|Abortifacient Agents|abortifacient agents|mesh-ancestor
25233606|NCT02576119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25154527|NCT05470881|Parasympatholytics|parasympatholytics|mesh-ancestor
25154528|NCT05470881|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24474459|NCT00406094|Respiratory System Agents|respiratory system agents|mesh-ancestor
25872883|NCT00127049|Antimetabolites|antimetabolites|mesh-ancestor
25872884|NCT00127049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872885|NCT00127049|Antiviral Agents|antiviral agents|mesh-ancestor
25872886|NCT00127049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24474476|NCT00406146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474477|NCT00406146|Antiviral Agents|antiviral agents|mesh-ancestor
24446603|NCT00305422|Dopamine Agents|dopamine agents|mesh-ancestor
24446604|NCT00305422|Antidepressive Agents|antidepressive agents|mesh-ancestor
24806002|NCT02013232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24806003|NCT02013232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25872887|NCT00127049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872888|NCT00127049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24446606|NCT00305461|Glucocorticoids|glucocorticoids|mesh-ancestor
25233608|NCT02576119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25233609|NCT02576119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25233610|NCT02576119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25233611|NCT02576119|Antiviral Agents|antiviral agents|mesh-ancestor
25233613|NCT02575924|Cholinergic Agents|cholinergic agents|mesh-ancestor
25233614|NCT02575924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25233615|NCT02575924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233616|NCT02575924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233617|NCT02575859|Cisplatin|cisplatin|mesh-list
25233618|NCT02575859|Mitomycins|mitomycins|mesh-list
25233619|NCT02575859|Mitomycin|mitomycin|mesh-list
25154543|NCT05470816|Tranexamic Acid|tranexamic acid|mesh-list
25154544|NCT05470816|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25674529|NCT01773122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25674530|NCT01773473|Insulin|insulin|mesh-list
25674531|NCT01773473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25674532|NCT01773473|Insulin Lispro|insulin lispro|mesh-list
25674533|NCT01773473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25674534|NCT01773473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674535|NCT01773889|Interferon alpha-2|interferon alpha-2|mesh-list
25674536|NCT01773889|Denileukin diftitox|denileukin diftitox|mesh-list
25674537|NCT01773889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25674538|NCT01773889|Antiviral Agents|antiviral agents|mesh-ancestor
25154548|NCT05470816|Coagulants|coagulants|mesh-ancestor
25044468|NCT01092065|Levodopa|levodopa|mesh-list
25154550|NCT05470764|Perindopril|perindopril|mesh-list
25154551|NCT05470764|Indapamide|indapamide|mesh-list
25154552|NCT05470764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25872889|NCT00127049|Immunologic Factors|immunologic factors|mesh-ancestor
25872890|NCT00127049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872891|NCT00127049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25872892|NCT00127049|Alkylating Agents|alkylating agents|mesh-ancestor
25872893|NCT00127075|Estradiol|estradiol|mesh-list
25872894|NCT00127075|Estrogens|estrogens|mesh-ancestor
25872895|NCT00127075|Hormones|hormones|mesh-ancestor
25872896|NCT00127075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25233620|NCT02575859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25233621|NCT02575859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25233622|NCT02575859|Alkylating Agents|alkylating agents|mesh-ancestor
25233623|NCT02575859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233624|NCT02575859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25233625|NCT02575859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233626|NCT02575885|Nicotine|nicotine|mesh-list
25233627|NCT02575885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25233628|NCT02575885|Autonomic Agents|autonomic agents|mesh-ancestor
25233629|NCT02575885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25233630|NCT02575885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233631|NCT02575885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25233632|NCT02575885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25233633|NCT02575885|Cholinergic Agents|cholinergic agents|mesh-ancestor
25233634|NCT02575885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25233635|NCT02575885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233636|NCT02575768|Adenosine|adenosine|mesh-list
25233637|NCT02575768|Analgesics|analgesics|mesh-ancestor
25233638|NCT02575768|Sensory System Agents|sensory system agents|mesh-ancestor
25233639|NCT02575768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25233640|NCT02575768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872897|NCT00127075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866237|NCT02568449|Nintedanib|nintedanib|mesh-list
24474503|NCT00406289|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24474504|NCT00406289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24474505|NCT00406289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474507|NCT00406302|Oxaliplatin|oxaliplatin|mesh-list
24474508|NCT00406302|Cetuximab|cetuximab|mesh-list
24474509|NCT00406302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474510|NCT00406302|Tubulin Modulators|tubulin modulators|mesh-ancestor
24474511|NCT00406302|Antimitotic Agents|antimitotic agents|mesh-ancestor
24474512|NCT00406302|Mitosis Modulators|mitosis modulators|mesh-ancestor
24474513|NCT00406302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474514|NCT00406302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25872898|NCT00127088|Docetaxel|docetaxel|mesh-list
25233644|NCT02575768|Purinergic Agonists|purinergic agonists|mesh-ancestor
25233645|NCT02575768|Purinergic Agents|purinergic agents|mesh-ancestor
25233646|NCT02575768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25233647|NCT02575768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233648|NCT02575755|Azithromycin|azithromycin|mesh-list
25233649|NCT02575755|Pyrimethamine|pyrimethamine|mesh-list
25233650|NCT02575755|Piperaquine|piperaquine|mesh-list
25233651|NCT02575755|Sulfadoxine|sulfadoxine|mesh-list
25154560|NCT05470764|Protease Inhibitors|protease inhibitors|mesh-ancestor
25154561|NCT05470764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25154562|NCT05470764|Diuretics|diuretics|mesh-ancestor
25154563|NCT05470764|Natriuretic Agents|natriuretic agents|mesh-ancestor
25154564|NCT05470764|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25154569|NCT05470647|Interleukin-4|interleukin-4|mesh-list
25154570|NCT05470647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25063528|NCT03468231|Immunologic Factors|immunologic factors|mesh-ancestor
24474538|NCT00406432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24474539|NCT00406432|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25674539|NCT01773889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25674540|NCT01773954|Aflibercept|aflibercept|mesh-list
25872899|NCT00127088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474546|NCT00406471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474548|NCT00406471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806016|NCT02013232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24806019|NCT02013258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24806020|NCT02013258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806021|NCT02013271|Paclitaxel|paclitaxel|mesh-list
24806022|NCT02013271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24806023|NCT02013271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806024|NCT02013271|Tubulin Modulators|tubulin modulators|mesh-ancestor
24806025|NCT02013271|Antimitotic Agents|antimitotic agents|mesh-ancestor
24806026|NCT02013271|Mitosis Modulators|mitosis modulators|mesh-ancestor
24806027|NCT02013271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806028|NCT02013362|Folic Acid|folic acid|mesh-list
24806029|NCT02013362|Vitamin B 12|vitamin b 12|mesh-list
24806030|NCT02013362|Hydroxocobalamin|hydroxocobalamin|mesh-list
24806031|NCT02013362|Vitamins|vitamins|mesh-ancestor
24806032|NCT02013362|Micronutrients|micronutrients|mesh-ancestor
25872900|NCT00127088|Tubulin Modulators|tubulin modulators|mesh-ancestor
25872901|NCT00127088|Antimitotic Agents|antimitotic agents|mesh-ancestor
25872902|NCT00127088|Mitosis Modulators|mitosis modulators|mesh-ancestor
25233652|NCT02575755|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25233653|NCT02575755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25233654|NCT02575755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25233655|NCT02575755|Antimalarials|antimalarials|mesh-ancestor
25233656|NCT02575755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25233657|NCT02575755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25233658|NCT02575755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25233659|NCT02575755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233660|NCT02575755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233661|NCT02575755|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25233662|NCT02575755|Renal Agents|renal agents|mesh-ancestor
25233663|NCT02575729|Betamethasone|betamethasone|mesh-list
25233664|NCT02575729|Glucocorticoids|glucocorticoids|mesh-list
25233665|NCT02575729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25233666|NCT02575729|Hormones|hormones|mesh-ancestor
25233667|NCT02575729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25233668|NCT02575729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233669|NCT02575729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25233670|NCT02575729|Respiratory System Agents|respiratory system agents|mesh-ancestor
25233671|NCT02575677|Oxycodone|oxycodone|mesh-list
25872903|NCT00127088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872904|NCT00127114|Amantadine|amantadine|mesh-list
25872905|NCT00127114|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24474550|NCT00406497|Glucocorticoids|glucocorticoids|mesh-ancestor
24474551|NCT00406497|Hormones|hormones|mesh-ancestor
24474552|NCT00406497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24474553|NCT00406497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474554|NCT00406575|Methocarbamol|methocarbamol|mesh-list
24474555|NCT00406575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24474556|NCT00406575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474557|NCT00406575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24474558|NCT00406575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24474559|NCT00406601|Sorafenib|sorafenib|mesh-list
24474560|NCT00406601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424355|NCT00228982|Vancomycin|vancomycin|mesh-list
24474561|NCT00406601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25872906|NCT00127114|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25872907|NCT00127114|Antiviral Agents|antiviral agents|mesh-ancestor
25872908|NCT00127114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25872909|NCT00127114|Dopamine Agents|dopamine agents|mesh-ancestor
25872910|NCT00127114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25872911|NCT00127114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872912|NCT00127114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872913|NCT00127114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25872914|NCT00127114|Analgesics|analgesics|mesh-ancestor
25872915|NCT00127114|Sensory System Agents|sensory system agents|mesh-ancestor
25872916|NCT00127114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25876731|NCT02834013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25876732|NCT02834013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145709|NCT02927886|Botulinum Toxins|botulinum toxins|mesh-list
25872917|NCT00127140|Vorinostat|vorinostat|mesh-list
25872918|NCT00127140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872919|NCT00127140|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24806043|NCT02013427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24806044|NCT02013427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24806046|NCT02013427|Sensory System Agents|sensory system agents|mesh-ancestor
24806047|NCT02013427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24806048|NCT02013427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806049|NCT02013427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24806050|NCT02013427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24806051|NCT02013427|Gout Suppressants|gout suppressants|mesh-ancestor
24474583|NCT00406796|Ranibizumab|ranibizumab|mesh-list
24474584|NCT00406796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24474585|NCT00406796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24741110|NCT01691937|Narcotics|narcotics|mesh-ancestor
25872920|NCT00127140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25872921|NCT00127140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233672|NCT02575677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25233673|NCT02575677|Narcotics|narcotics|mesh-ancestor
25233674|NCT02575677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25233675|NCT02575677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233676|NCT02575677|Analgesics|analgesics|mesh-ancestor
25233677|NCT02575677|Sensory System Agents|sensory system agents|mesh-ancestor
25233678|NCT02575677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25233679|NCT02575443|Rocuronium|rocuronium|mesh-list
25233680|NCT02575443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25233681|NCT02575443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25233682|NCT02575443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25233684|NCT02575443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233685|NCT02575534|Procainamide|procainamide|mesh-list
25233686|NCT02575534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25233687|NCT02575534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25233688|NCT02575534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25872922|NCT00127153|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25872923|NCT00127153|Immunologic Factors|immunologic factors|mesh-ancestor
24474586|NCT00406796|Growth Substances|growth substances|mesh-ancestor
24474587|NCT00406796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474609|NCT00406887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24474610|NCT00406887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474611|NCT00406913|Mupirocin|mupirocin|mesh-list
24474612|NCT00406913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24474613|NCT00406913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24474614|NCT00406913|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25872924|NCT00127153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872925|NCT00127257|Diazepam|diazepam|mesh-list
25872926|NCT00127257|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25872927|NCT00127257|Anticonvulsants|anticonvulsants|mesh-ancestor
25872928|NCT00127257|Antiemetics|antiemetics|mesh-ancestor
25872929|NCT00127257|Autonomic Agents|autonomic agents|mesh-ancestor
25872930|NCT00127257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25872931|NCT00127257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474637|NCT00406978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474638|NCT00406978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24474639|NCT00406978|Alkylating Agents|alkylating agents|mesh-ancestor
24474640|NCT00406978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474641|NCT00406978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24474642|NCT00406978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25233689|NCT02575534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25233690|NCT02575534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233691|NCT02575521|Dexmedetomidine|dexmedetomidine|mesh-list
25233692|NCT02575521|Propofol|propofol|mesh-list
25233693|NCT02575521|Sevoflurane|sevoflurane|mesh-list
25233694|NCT02575521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25674541|NCT01773954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25674542|NCT01773954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25674543|NCT01773954|Growth Substances|growth substances|mesh-ancestor
25674544|NCT01773954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674545|NCT01773954|Growth Inhibitors|growth inhibitors|mesh-ancestor
25674546|NCT01773954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25674547|NCT01773993|Pregabalin|pregabalin|mesh-list
25674548|NCT01773993|Analgesics|analgesics|mesh-ancestor
25674549|NCT01773993|Sensory System Agents|sensory system agents|mesh-ancestor
25674550|NCT01773993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24847165|NCT02245438|Norethindrone Acetate|norethindrone acetate|mesh-list
24847167|NCT02245438|Estradiol|estradiol|mesh-list
24847168|NCT02245438|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25872932|NCT00127257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24474643|NCT00406978|Immunologic Factors|immunologic factors|mesh-ancestor
24474644|NCT00406978|Leprostatic Agents|leprostatic agents|mesh-ancestor
24474645|NCT00406978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24806060|NCT02013453|Tubulin Modulators|tubulin modulators|mesh-ancestor
24806061|NCT02013453|Antimitotic Agents|antimitotic agents|mesh-ancestor
24806062|NCT02013453|Mitosis Modulators|mitosis modulators|mesh-ancestor
24806063|NCT02013453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806064|NCT02013453|Antimetabolites|antimetabolites|mesh-ancestor
24806065|NCT02013453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24806066|NCT02013453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24474646|NCT00406978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24474647|NCT00406978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24474648|NCT00406978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25872933|NCT00127257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25233698|NCT02575521|Anesthetics, General|anesthetics, general|mesh-ancestor
25233699|NCT02575521|Anesthetics|anesthetics|mesh-ancestor
25233700|NCT02575521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25233701|NCT02575521|Analgesics|analgesics|mesh-ancestor
25233702|NCT02575521|Sensory System Agents|sensory system agents|mesh-ancestor
25233703|NCT02575521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25233704|NCT02575521|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25233705|NCT02575521|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25233706|NCT02575521|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25233707|NCT02575521|Adrenergic Agents|adrenergic agents|mesh-ancestor
25233708|NCT02575521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25233709|NCT02575521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233710|NCT02575521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25233711|NCT02575521|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25233712|NCT02575638|Camptothecin|camptothecin|mesh-list
25233713|NCT02575638|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25233714|NCT02575638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25233715|NCT02575638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25233716|NCT02575638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25233717|NCT02575638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233718|NCT02575638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233720|NCT02575547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25233721|NCT02575547|Tubulin Modulators|tubulin modulators|mesh-ancestor
25233722|NCT02575547|Antimitotic Agents|antimitotic agents|mesh-ancestor
25233723|NCT02575547|Mitosis Modulators|mitosis modulators|mesh-ancestor
25233724|NCT02575547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872934|NCT00127257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25872935|NCT00127257|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25872936|NCT00127257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25872937|NCT00127257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25872938|NCT00127257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25872939|NCT00127257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25872940|NCT00127257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25872941|NCT00127257|Anesthetics, General|anesthetics, general|mesh-ancestor
25872942|NCT00127257|Anesthetics|anesthetics|mesh-ancestor
25872943|NCT00127257|GABA Modulators|gaba modulators|mesh-ancestor
25872944|NCT00127257|GABA Agents|gaba agents|mesh-ancestor
25872945|NCT00127257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24474673|NCT00406991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24474674|NCT00406991|Purinergic Agents|purinergic agents|mesh-ancestor
24474675|NCT00406991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24474677|NCT00407017|Gatifloxacin|gatifloxacin|mesh-list
24474678|NCT00407017|Ketorolac|ketorolac|mesh-list
25233729|NCT02575664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233730|NCT02575664|Analgesics|analgesics|mesh-ancestor
25233731|NCT02575664|Sensory System Agents|sensory system agents|mesh-ancestor
25233732|NCT02575664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25233733|NCT02575664|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25233734|NCT02575495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25233735|NCT02575495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25233736|NCT02575495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25233737|NCT02575495|Antitubercular Agents|antitubercular agents|mesh-ancestor
25233738|NCT02575508|Fluorouracil|fluorouracil|mesh-list
25233739|NCT02575508|Oxaliplatin|oxaliplatin|mesh-list
25233741|NCT02575508|Camptothecin|camptothecin|mesh-list
25233742|NCT02575508|Infigratinib|infigratinib|mesh-list
25233743|NCT02575508|Antimetabolites|antimetabolites|mesh-ancestor
25233744|NCT02575508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233745|NCT02575508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25233746|NCT02575508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25233747|NCT02575508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25073254|NCT03396250|Anesthetics, Local|anesthetics, local|mesh-ancestor
25672172|NCT01742208|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25672173|NCT01742208|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25672174|NCT01742208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672175|NCT01742208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25672176|NCT01742208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672177|NCT01742286|Ceritinib|ceritinib|mesh-list
25233749|NCT02575508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233750|NCT02575508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25233751|NCT02575508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25233752|NCT02575508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233753|NCT02575508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25233754|NCT02575248|Dienogest|dienogest|mesh-list
25233755|NCT02575248|Clomiphene|clomiphene|mesh-list
25233756|NCT02575248|Enclomiphene|enclomiphene|mesh-list
25233757|NCT02575248|Zuclomiphene|zuclomiphene|mesh-list
25233758|NCT02575248|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25233759|NCT02575248|Hormone Antagonists|hormone antagonists|mesh-ancestor
25233760|NCT02575248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25233761|NCT02575248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233762|NCT02575248|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25233764|NCT02575248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25233765|NCT02575248|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25233766|NCT02575248|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25233767|NCT02575248|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25233768|NCT02575248|Contraceptive Agents|contraceptive agents|mesh-ancestor
25233770|NCT02575248|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25233771|NCT02575248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25233772|NCT02575248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25233773|NCT02575248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25233774|NCT02575248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25233776|NCT02575183|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25233777|NCT02575183|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25233778|NCT02575183|Cholinergic Agents|cholinergic agents|mesh-ancestor
25233779|NCT02575183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25233780|NCT02575183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233781|NCT02575183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233782|NCT02575170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25233783|NCT02575235|Cetylpyridinium|cetylpyridinium|mesh-list
25233784|NCT02575235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25233785|NCT02575235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25233786|NCT02575222|Nivolumab|nivolumab|mesh-list
24847181|NCT02245438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24847182|NCT02245438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847183|NCT02245438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24847185|NCT02245438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25273607|NCT02384889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273608|NCT02384655|Fenugreek seed meal|fenugreek seed meal|mesh-list
25273609|NCT02384655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25273610|NCT02384655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273611|NCT02384746|Fulvestrant|fulvestrant|mesh-list
25872959|NCT00127335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872960|NCT00127335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25872961|NCT00127335|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25872962|NCT00127335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063561|NCT03468010|Paclitaxel|paclitaxel|mesh-list
25872963|NCT00127387|Etanercept|etanercept|mesh-list
25872964|NCT00127387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25872965|NCT00127387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25872966|NCT00127387|Analgesics|analgesics|mesh-ancestor
25872967|NCT00127387|Sensory System Agents|sensory system agents|mesh-ancestor
24866352|NCT05153304|Ipilimumab|ipilimumab|mesh-list
24905737|NCT04345406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905738|NCT04345406|Antimalarials|antimalarials|mesh-ancestor
24905739|NCT04345406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24481424|NCT00434447|Zoledronic Acid|zoledronic acid|mesh-list
25672178|NCT01742286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672179|NCT01742286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25672180|NCT01742286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672181|NCT01742286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672182|NCT01742832|Citalopram|citalopram|mesh-list
25672183|NCT01742832|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
25672184|NCT01742832|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25672185|NCT01742832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25672186|NCT01742832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25872971|NCT00127387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25872972|NCT00127387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25872973|NCT00127387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25872974|NCT00127387|Immunologic Factors|immunologic factors|mesh-ancestor
24905775|NCT04345146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905776|NCT04345146|Growth Inhibitors|growth inhibitors|mesh-ancestor
24905778|NCT04345276|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24905813|NCT04344483|Epinephryl borate|epinephryl borate|mesh-list
24905814|NCT04344483|Anesthetics, Local|anesthetics, local|mesh-ancestor
24905815|NCT04344483|Anesthetics|anesthetics|mesh-ancestor
24905816|NCT04344483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24955707|NCT03862404|Mydriatics|mydriatics|mesh-ancestor
24905817|NCT04344483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905818|NCT04344483|Sensory System Agents|sensory system agents|mesh-ancestor
25233787|NCT02575222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25233788|NCT02575222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25233789|NCT02575222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25233790|NCT02575222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233791|NCT02574962|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25233793|NCT02574962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25233794|NCT02574962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273613|NCT02384746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25273614|NCT02384746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25273615|NCT02384746|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25273616|NCT02384746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25273617|NCT02384746|Hormone Antagonists|hormone antagonists|mesh-ancestor
24453260|NCT05198960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24453261|NCT05198960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24453262|NCT05198960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24453263|NCT05198960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24453264|NCT05198960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24453265|NCT05198960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24453266|NCT05198960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24847186|NCT02245438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24847187|NCT02245438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24847188|NCT02245438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24847189|NCT02245438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24847190|NCT02245438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24847191|NCT02245451|Ritonavir|ritonavir|mesh-list
24847192|NCT02245451|Tipranavir|tipranavir|mesh-list
24481512|NCT00435292|Naproxen|naproxen|mesh-list
24905874|NCT04344782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905875|NCT04344782|Growth Inhibitors|growth inhibitors|mesh-ancestor
24905876|NCT04344730|Dexamethasone|dexamethasone|mesh-list
24905877|NCT04344730|Dexamethasone acetate|dexamethasone acetate|mesh-list
24905878|NCT04344730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24905879|NCT04344730|Antiemetics|antiemetics|mesh-ancestor
24905880|NCT04344730|Autonomic Agents|autonomic agents|mesh-ancestor
24616569|NCT01038063|Artemether|artemether|mesh-list
24905881|NCT04344730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24905882|NCT04344730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905883|NCT04344730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24905884|NCT04344730|Glucocorticoids|glucocorticoids|mesh-ancestor
24905885|NCT04344730|Hormones|hormones|mesh-ancestor
24905886|NCT04344730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24905887|NCT04344730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24905888|NCT04344730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905889|NCT04344236|Chlorhexidine|chlorhexidine|mesh-list
24905890|NCT04344236|Povidone-Iodine|povidone-iodine|mesh-list
24905891|NCT04344236|Povidone|povidone|mesh-list
24741217|NCT01692808|Vitamin D|vitamin d|mesh-list
24741220|NCT01692808|Vitamins|vitamins|mesh-list
25872976|NCT00127478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25872977|NCT00127478|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
24787055|NCT01923454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787056|NCT01923454|Diuretics|diuretics|mesh-ancestor
25872978|NCT00127478|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25145974|NCT02924987|Aflibercept|aflibercept|mesh-list
24787057|NCT01923454|Natriuretic Agents|natriuretic agents|mesh-ancestor
25233796|NCT02575092|Enalapril|enalapril|mesh-list
25233797|NCT02575092|Enalaprilat|enalaprilat|mesh-list
25233798|NCT02575092|Maleic acid|maleic acid|mesh-list
25233799|NCT02575092|Hematinics|hematinics|mesh-ancestor
25233800|NCT02575092|Vitamin B Complex|vitamin b complex|mesh-ancestor
25233801|NCT02575092|Vitamins|vitamins|mesh-ancestor
25233802|NCT02575092|Micronutrients|micronutrients|mesh-ancestor
25233803|NCT02575092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233804|NCT02575092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233805|NCT02575092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233806|NCT02575092|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25233807|NCT02575092|Protease Inhibitors|protease inhibitors|mesh-ancestor
25233808|NCT02575092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25233809|NCT02575001|Hydrocortisone|hydrocortisone|mesh-list
25233810|NCT02575001|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25233812|NCT02575001|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25233813|NCT02575001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25233814|NCT02574819|Methylnaltrexone|methylnaltrexone|mesh-list
25233815|NCT02574819|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25233816|NCT02574819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233817|NCT02574819|Sensory System Agents|sensory system agents|mesh-ancestor
25872979|NCT00127478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393805|NCT00131027|Hormones|hormones|mesh-ancestor
25872980|NCT00127504|Azithromycin|azithromycin|mesh-list
25872981|NCT00127504|Rifampin|rifampin|mesh-list
25872982|NCT00127504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25872983|NCT00127504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25872984|NCT00127504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24787083|NCT01923623|Ropivacaine|ropivacaine|mesh-list
24787084|NCT01923623|Anesthetics, Local|anesthetics, local|mesh-ancestor
24787085|NCT01923623|Anesthetics|anesthetics|mesh-ancestor
24787086|NCT01923623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24787087|NCT01923623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109109|NCT03127124|Oxaliplatin|oxaliplatin|mesh-list
25109110|NCT03127124|Calcium|calcium|mesh-list
25109111|NCT03127124|Levoleucovorin|levoleucovorin|mesh-list
25109112|NCT03127124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25109113|NCT03127124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109114|NCT03127124|Antimetabolites|antimetabolites|mesh-ancestor
25109115|NCT03127124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109116|NCT03127124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25109117|NCT03127124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109118|NCT03127124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25109119|NCT03127124|Immunologic Factors|immunologic factors|mesh-ancestor
25109120|NCT03127124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25109121|NCT03127124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25109122|NCT03127124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25109123|NCT03127124|Growth Substances|growth substances|mesh-ancestor
25109124|NCT03127124|Growth Inhibitors|growth inhibitors|mesh-ancestor
25109125|NCT03127124|Antidotes|antidotes|mesh-ancestor
25109126|NCT03127124|Protective Agents|protective agents|mesh-ancestor
25109127|NCT03127124|Vitamin B Complex|vitamin b complex|mesh-ancestor
25109128|NCT03127124|Vitamins|vitamins|mesh-ancestor
24626559|NCT01087840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24393816|NCT00131027|Antimetabolites|antimetabolites|mesh-ancestor
25109129|NCT03127124|Micronutrients|micronutrients|mesh-ancestor
25109130|NCT03127046|Aceclofenac|aceclofenac|mesh-list
25109131|NCT03127046|Diclofenac|diclofenac|mesh-list
25109132|NCT03127046|Esomeprazole|esomeprazole|mesh-list
25109133|NCT03127046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25109134|NCT03127046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25109135|NCT03127046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25109136|NCT03127046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906118|NCT04342650|Antimalarials|antimalarials|mesh-ancestor
24906119|NCT04342650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24906120|NCT04342650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25674551|NCT01773993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674552|NCT01773993|Anticonvulsants|anticonvulsants|mesh-ancestor
25674553|NCT01773993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25674554|NCT01773993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25674555|NCT01773993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674556|NCT01773993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25674557|NCT01773993|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25674558|NCT01773993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24906123|NCT04342650|Sensory System Agents|sensory system agents|mesh-ancestor
24906124|NCT04342650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24906125|NCT04342650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906126|NCT04342650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24906127|NCT04342650|Filaricides|filaricides|mesh-ancestor
24906128|NCT04342650|Antinematodal Agents|antinematodal agents|mesh-ancestor
25233819|NCT02574975|Budesonide|budesonide|mesh-list
25233820|NCT02574975|Adenosine|adenosine|mesh-list
25233821|NCT02574975|Formoterol Fumarate|formoterol fumarate|mesh-list
25233822|NCT02574975|Methacholine Chloride|methacholine chloride|mesh-list
25233823|NCT02574975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24906129|NCT04342650|Anthelmintics|anthelmintics|mesh-ancestor
24906130|NCT04342819|Empagliflozin|empagliflozin|mesh-list
24906131|NCT04342819|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
24906132|NCT04342819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906137|NCT04342065|Analgesics|analgesics|mesh-ancestor
24906156|NCT04342065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906157|NCT04342156|Hydroxychloroquine|hydroxychloroquine|mesh-list
24906158|NCT04342156|Antimalarials|antimalarials|mesh-ancestor
24906159|NCT04342156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24906160|NCT04342156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24906161|NCT04342156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24906162|NCT04342156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906163|NCT04342156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906164|NCT04342156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24906165|NCT04342221|Hydroxychloroquine|hydroxychloroquine|mesh-list
24906166|NCT04342221|Antimalarials|antimalarials|mesh-ancestor
24906167|NCT04342221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24906168|NCT04342221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24906169|NCT04342221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24741400|NCT01693822|Axitinib|axitinib|mesh-list
25872985|NCT00127504|Antitubercular Agents|antitubercular agents|mesh-ancestor
25872986|NCT00127504|Leprostatic Agents|leprostatic agents|mesh-ancestor
24906170|NCT04342221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906171|NCT04342221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906172|NCT04342221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24906174|NCT04342247|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24906175|NCT04342247|Testosterone|testosterone|mesh-list
24906176|NCT04342247|Testosterone undecanoate|testosterone undecanoate|mesh-list
24906177|NCT04342247|Testosterone enanthate|testosterone enanthate|mesh-list
24906178|NCT04342247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24906179|NCT04342247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24906180|NCT04342247|Anabolic Agents|anabolic agents|mesh-ancestor
24906181|NCT04342247|Hormones|hormones|mesh-ancestor
24906182|NCT04342247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24906183|NCT04342247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906184|NCT04342247|Androgens|androgens|mesh-ancestor
24906185|NCT04342351|Valsartan|valsartan|mesh-list
24906186|NCT04342351|Perindopril|perindopril|mesh-list
24955729|NCT03862287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906187|NCT04342351|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24906188|NCT04342351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24866478|NCT04884893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25872987|NCT00127504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25872988|NCT00127504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24818669|NCT02090153|Leucovorin|leucovorin|mesh-list
24818670|NCT02090153|Tegafur|tegafur|mesh-list
24818671|NCT02090153|Antidotes|antidotes|mesh-ancestor
24818672|NCT02090153|Protective Agents|protective agents|mesh-ancestor
24818673|NCT02090153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818674|NCT02090153|Vitamin B Complex|vitamin b complex|mesh-ancestor
24818675|NCT02090153|Vitamins|vitamins|mesh-ancestor
24818676|NCT02090153|Micronutrients|micronutrients|mesh-ancestor
24818677|NCT02090153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24818678|NCT02090153|Antimetabolites|antimetabolites|mesh-ancestor
24818679|NCT02090153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818680|NCT02090153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24818681|NCT02090244|Teriparatide|teriparatide|mesh-list
24818682|NCT02090244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24818683|NCT02090244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818684|NCT02090244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24818685|NCT02090296|Hydroxyurea|hydroxyurea|mesh-list
24818686|NCT02090296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24906261|NCT04341428|Lansoprazole|lansoprazole|mesh-list
24906262|NCT04341428|Dexlansoprazole|dexlansoprazole|mesh-list
24906263|NCT04341428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24906264|NCT04341428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24906265|NCT04341428|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24906266|NCT04341428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906267|NCT04341428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906268|NCT04341571|Metformin|metformin|mesh-list
24906269|NCT04341571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24906270|NCT04341571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906271|NCT04341493|Hydroxychloroquine|hydroxychloroquine|mesh-list
24906272|NCT04341493|Nitazoxanide|nitazoxanide|mesh-list
24906273|NCT04341493|Antimalarials|antimalarials|mesh-ancestor
24906274|NCT04341493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24906275|NCT04341493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24906276|NCT04341493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24906277|NCT04341493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906310|NCT04341727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24955731|NCT03862053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24955732|NCT03862079|Tazobactam|tazobactam|mesh-list
24955733|NCT03862079|Piperacillin|piperacillin|mesh-list
24955734|NCT03862079|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24955736|NCT03862079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24955753|NCT03862144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24955754|NCT03862144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955755|NCT03861598|Carvedilol|carvedilol|mesh-list
24955756|NCT03861598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24955757|NCT03861598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24955758|NCT03861598|Adrenergic Agents|adrenergic agents|mesh-ancestor
24955759|NCT03861598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25872989|NCT00127504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25872990|NCT00127504|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25872991|NCT00127504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24906311|NCT04341727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24906362|NCT04341038|Prednisolone|prednisolone|mesh-list
24906363|NCT04341038|Prednisolone acetate|prednisolone acetate|mesh-list
24906364|NCT04341038|Tacrolimus|tacrolimus|mesh-list
25872992|NCT00127504|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25872993|NCT00127504|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25872994|NCT00127504|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24906365|NCT04341038|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24906366|NCT04341038|Prednisolone phosphate|prednisolone phosphate|mesh-list
24906367|NCT04341038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24906368|NCT04341038|Immunologic Factors|immunologic factors|mesh-ancestor
24906369|NCT04341038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906370|NCT04341038|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24906371|NCT04341038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866607|NCT05258721|Protective Agents|protective agents|mesh-ancestor
24906432|NCT04340778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906433|NCT04340778|Oxytocics|oxytocics|mesh-ancestor
24906434|NCT04340778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24906435|NCT04340778|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24906437|NCT04340908|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24906438|NCT04340908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906439|NCT04340908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24906440|NCT04340908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906441|NCT04340258|Pembrolizumab|pembrolizumab|mesh-list
24906442|NCT04340258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24906443|NCT04340258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24906444|NCT04340401|Capecitabine|capecitabine|mesh-list
24906451|NCT04340349|Bromhexine|bromhexine|mesh-list
24906454|NCT04340349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24906455|NCT04340349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24906456|NCT04340349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906457|NCT04340349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906458|NCT04340349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25047767|NCT00765700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047769|NCT00765323|Somatostatin|somatostatin|mesh-list
25047770|NCT00765323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25047771|NCT00765323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25047772|NCT00765323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25047773|NCT00765323|Hormones|hormones|mesh-ancestor
25047776|NCT00764634|Vaccines|vaccines|mesh-list
24906459|NCT04340349|Expectorants|expectorants|mesh-ancestor
24906460|NCT04340349|Respiratory System Agents|respiratory system agents|mesh-ancestor
24906461|NCT04340128|Meglumine Antimoniate|meglumine antimoniate|mesh-list
24906462|NCT04340128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24906463|NCT04340128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24393862|NCT00131053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24393863|NCT00131053|Abortifacient Agents|abortifacient agents|mesh-ancestor
24393864|NCT00131053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24393865|NCT00131053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24393866|NCT00131053|Antimetabolites|antimetabolites|mesh-ancestor
24955764|NCT03861598|Protective Agents|protective agents|mesh-ancestor
24906464|NCT04340128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24906466|NCT04340388|Lamivudine|lamivudine|mesh-list
24906467|NCT04340388|Zidovudine|zidovudine|mesh-list
24906471|NCT04340388|Cobicistat|cobicistat|mesh-list
24906472|NCT04340388|Rilpivirine|rilpivirine|mesh-list
24906473|NCT04340388|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24906474|NCT04340388|Antiviral Agents|antiviral agents|mesh-ancestor
24906475|NCT04340388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24906476|NCT04340388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24741559|NCT05288153|Metformin|metformin|mesh-list
25872995|NCT00127504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25872996|NCT00127569|Rituximab|rituximab|mesh-list
25872997|NCT00127569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24906516|NCT04339816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24906517|NCT04339816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24906518|NCT04339816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906519|NCT04339816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906520|NCT04339816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24906521|NCT04339868|Terlipressin|terlipressin|mesh-list
24906522|NCT04339868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24906523|NCT04339868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25872998|NCT00127569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24906524|NCT04339712|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24906525|NCT04339712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24906527|NCT04339361|Dinoprostone|dinoprostone|mesh-list
24906528|NCT04339361|Anesthetics, Local|anesthetics, local|mesh-ancestor
24861814|NCT02320240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24861815|NCT02320240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24393887|NCT00131183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24393888|NCT00131183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393889|NCT00131235|Azithromycin|azithromycin|mesh-list
24393890|NCT00131235|Pyrimethamine|pyrimethamine|mesh-list
24906529|NCT04339361|Anesthetics|anesthetics|mesh-ancestor
24906530|NCT04339361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24906561|NCT04339348|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24906563|NCT04339348|Anesthetics, Local|anesthetics, local|mesh-ancestor
24906564|NCT04339348|Anesthetics|anesthetics|mesh-ancestor
24906565|NCT04339348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24787091|NCT01923649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787092|NCT01923818|Aspirin|aspirin|mesh-list
24787093|NCT01923818|Rivaroxaban|rivaroxaban|mesh-list
24787094|NCT01923818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24787095|NCT01923818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24741594|NCT05291195|Eusol|eusol|mesh-list
25872999|NCT00127569|Immunologic Factors|immunologic factors|mesh-ancestor
25672187|NCT01742832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672188|NCT01742832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25672189|NCT01742832|Serotonin Agents|serotonin agents|mesh-ancestor
25672190|NCT01742832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672191|NCT01742832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25672192|NCT01742832|Antidepressive Agents|antidepressive agents|mesh-ancestor
25672193|NCT01742832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25873000|NCT00127569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873001|NCT00127569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25873002|NCT00127595|Gemcitabine|gemcitabine|mesh-list
25233834|NCT02574975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25233835|NCT02574975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25233836|NCT02574975|Adrenergic Agents|adrenergic agents|mesh-ancestor
25233837|NCT02574975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25233838|NCT02574975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233839|NCT02574975|Analgesics|analgesics|mesh-ancestor
25233840|NCT02574975|Sensory System Agents|sensory system agents|mesh-ancestor
25233841|NCT02574975|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24906566|NCT04339348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906567|NCT04339348|Sensory System Agents|sensory system agents|mesh-ancestor
24906568|NCT04339348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24906571|NCT04339348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24906572|NCT04339348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24482081|NCT00437853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818703|NCT02090348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24482108|NCT00437957|Antimanic Agents|antimanic agents|mesh-ancestor
24482143|NCT00438048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24482144|NCT00438048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482150|NCT00438087|Methylprednisolone|methylprednisolone|mesh-list
24955774|NCT03861403|Cyclophosphamide|cyclophosphamide|mesh-list
24955775|NCT03861403|Avelumab|avelumab|mesh-list
24955776|NCT03861403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24955777|NCT03861403|Immunologic Factors|immunologic factors|mesh-ancestor
24955778|NCT03861403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955779|NCT03861403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24955780|NCT03861403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24906656|NCT04338373|Respiratory System Agents|respiratory system agents|mesh-ancestor
24906657|NCT04338373|Mydriatics|mydriatics|mesh-ancestor
24906658|NCT04338373|Parasympatholytics|parasympatholytics|mesh-ancestor
24906659|NCT04338373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24906660|NCT04338373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24906661|NCT04338373|Cholinergic Agents|cholinergic agents|mesh-ancestor
24906662|NCT04338373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25109137|NCT03127046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109138|NCT03127046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25109139|NCT03127046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25109140|NCT03127046|Analgesics|analgesics|mesh-ancestor
24866751|NCT04990804|Analgesics|analgesics|mesh-list
24906663|NCT04338373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906665|NCT04338191|Fluorouracil|fluorouracil|mesh-list
24906666|NCT04338191|Oxaliplatin|oxaliplatin|mesh-list
24906667|NCT04338191|Irinotecan|irinotecan|mesh-list
24906668|NCT04338191|Levoleucovorin|levoleucovorin|mesh-list
24906669|NCT04338191|Antimetabolites|antimetabolites|mesh-ancestor
24906670|NCT04338191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906671|NCT04338191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24906672|NCT04338191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24906673|NCT04338191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24906674|NCT04338191|Immunologic Factors|immunologic factors|mesh-ancestor
24906675|NCT04338191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906676|NCT04338191|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24906677|NCT04338191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24906678|NCT04338191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906679|NCT04338191|Antidotes|antidotes|mesh-ancestor
24906680|NCT04338191|Protective Agents|protective agents|mesh-ancestor
24906681|NCT04338191|Vitamin B Complex|vitamin b complex|mesh-ancestor
25233842|NCT02574975|Vasodilator Agents|vasodilator agents|mesh-ancestor
25233843|NCT02574975|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25233844|NCT02574975|Purinergic Agonists|purinergic agonists|mesh-ancestor
25233845|NCT02574975|Purinergic Agents|purinergic agents|mesh-ancestor
25233846|NCT02574975|Miotics|miotics|mesh-ancestor
25873003|NCT00127595|Oxaliplatin|oxaliplatin|mesh-list
25873004|NCT00127595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25873005|NCT00127595|Antimetabolites|antimetabolites|mesh-ancestor
25873006|NCT00127595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873007|NCT00127595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873008|NCT00127595|Antiviral Agents|antiviral agents|mesh-ancestor
24906682|NCT04338191|Vitamins|vitamins|mesh-ancestor
24906683|NCT04338191|Micronutrients|micronutrients|mesh-ancestor
24906684|NCT04338438|Apatinib|apatinib|mesh-list
24906685|NCT04338438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873009|NCT00127595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24906692|NCT04338126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906693|NCT04338126|Hemostatics|hemostatics|mesh-ancestor
24906694|NCT04338126|Coagulants|coagulants|mesh-ancestor
24906695|NCT04337879|Oxaliplatin|oxaliplatin|mesh-list
24906696|NCT04337879|Irinotecan|irinotecan|mesh-list
24906729|NCT04337814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24906730|NCT04337814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24906731|NCT04337814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24906732|NCT04337814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906733|NCT04337814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906734|NCT04337814|Anesthetics, Local|anesthetics, local|mesh-ancestor
24906735|NCT04337814|Anesthetics|anesthetics|mesh-ancestor
24906736|NCT04337814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24393891|NCT00131235|Sulfadoxine|sulfadoxine|mesh-list
24393898|NCT00131235|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24906737|NCT04337814|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24906738|NCT04337593|Pegaspargase|pegaspargase|mesh-list
24906739|NCT04337593|Basiliximab|basiliximab|mesh-list
24906740|NCT04337593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24906741|NCT04337593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24906742|NCT04337593|Immunologic Factors|immunologic factors|mesh-ancestor
24906743|NCT04337593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906744|NCT04337632|Paclitaxel|paclitaxel|mesh-list
24906745|NCT04337632|Carboplatin|carboplatin|mesh-list
24906746|NCT04337632|Doxorubicin|doxorubicin|mesh-list
24906747|NCT04337632|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24906748|NCT04337632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24482216|NCT00438152|Antiviral Agents|antiviral agents|mesh-ancestor
24906809|NCT04336891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24866816|NCT04754386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906841|NCT04337099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906842|NCT04337099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24906843|NCT04337099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906844|NCT04337099|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24906845|NCT04337099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24906847|NCT04336566|Antioxidants|antioxidants|mesh-ancestor
24906848|NCT04336566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906849|NCT04336566|Protective Agents|protective agents|mesh-ancestor
24906850|NCT04336566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906851|NCT04336566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24729796|NCT01624025|Docetaxel|docetaxel|mesh-list
24906852|NCT04336332|Azithromycin|azithromycin|mesh-list
24906853|NCT04336332|Hydroxychloroquine|hydroxychloroquine|mesh-list
25233847|NCT02574975|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25233848|NCT02574975|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
25233849|NCT02574975|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25233850|NCT02574975|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25233851|NCT02574975|Cholinergic Agents|cholinergic agents|mesh-ancestor
25233852|NCT02574533|Pembrolizumab|pembrolizumab|mesh-list
25233853|NCT02574533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25233854|NCT02574533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25233855|NCT02574533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25233856|NCT02574533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873010|NCT00127595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24393925|NCT00131300|Viscosupplements|viscosupplements|mesh-ancestor
25233857|NCT02574741|Aripiprazole|aripiprazole|mesh-list
25233858|NCT02574741|Antidepressive Agents|antidepressive agents|mesh-ancestor
24906854|NCT04336332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24906855|NCT04336332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24906856|NCT04336332|Antimalarials|antimalarials|mesh-ancestor
24906857|NCT04336332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24906858|NCT04336332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25873011|NCT00127595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25873012|NCT00127595|Immunologic Factors|immunologic factors|mesh-ancestor
24818754|NCT02090673|Hormones|hormones|mesh-ancestor
24818755|NCT02090673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24818756|NCT02090738|Amoxicillin|amoxicillin|mesh-list
24818757|NCT02090738|Clarithromycin|clarithromycin|mesh-list
24818758|NCT02090738|Acetazolamide|acetazolamide|mesh-list
24818759|NCT02090738|Esomeprazole|esomeprazole|mesh-list
24955814|NCT03860831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24818816|NCT02090933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24818817|NCT02090933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818818|NCT02091063|Ricolinostat|ricolinostat|mesh-list
24818819|NCT02091063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24907110|NCT04333095|Anesthetics|anesthetics|mesh-ancestor
24907111|NCT04333095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24907112|NCT04333095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907113|NCT04333095|Sensory System Agents|sensory system agents|mesh-ancestor
24907114|NCT04333095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24907115|NCT04333004|Pembrolizumab|pembrolizumab|mesh-list
25873014|NCT00127686|Dextromethorphan|dextromethorphan|mesh-list
25873015|NCT00127686|Antitussive Agents|antitussive agents|mesh-ancestor
25873016|NCT00127686|Respiratory System Agents|respiratory system agents|mesh-ancestor
24955815|NCT03860831|Anesthetics, General|anesthetics, general|mesh-ancestor
24955816|NCT03860831|Anesthetics|anesthetics|mesh-ancestor
24907116|NCT04333004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24907117|NCT04333004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24907118|NCT04332627|Neostigmine|neostigmine|mesh-list
24907119|NCT04332627|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24907120|NCT04332627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24482466|NCT00439166|Doxycycline|doxycycline|mesh-list
25233859|NCT02574741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24482503|NCT00439283|Dermatologic Agents|dermatologic agents|mesh-ancestor
24482504|NCT00439283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24482505|NCT00439283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24482506|NCT00439283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24482507|NCT00439283|Immunologic Factors|immunologic factors|mesh-ancestor
24482508|NCT00439283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24787101|NCT01923818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24787102|NCT01923818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25873017|NCT00127686|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24787122|NCT01923831|Glucocorticoids|glucocorticoids|mesh-ancestor
24787124|NCT01923831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24787125|NCT01923831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25873018|NCT00127686|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25873019|NCT00127686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25873020|NCT00127686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873021|NCT00127686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873022|NCT00127764|Dexamethasone|dexamethasone|mesh-list
25873023|NCT00127764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25873024|NCT00127764|Antiemetics|antiemetics|mesh-ancestor
25873025|NCT00127764|Autonomic Agents|autonomic agents|mesh-ancestor
25873026|NCT00127764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24856593|NCT02285738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24907182|NCT04331834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24907183|NCT04331834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24907184|NCT04331834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907185|NCT04331834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907186|NCT04331834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24907190|NCT04331743|Mitoxantrone|mitoxantrone|mesh-list
24907191|NCT04331743|Analgesics|analgesics|mesh-ancestor
24907192|NCT04331743|Sensory System Agents|sensory system agents|mesh-ancestor
24907193|NCT04331743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24907194|NCT04331743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907195|NCT04331743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24482518|NCT00439361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25109149|NCT03126877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25109150|NCT03126877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109151|NCT03126877|Alkylating Agents|alkylating agents|mesh-ancestor
25109152|NCT03126877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109153|NCT03126877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25109154|NCT03126877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225119|NCT02629042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25225120|NCT02629042|Glucocorticoids|glucocorticoids|mesh-ancestor
25225121|NCT02629042|Hormones|hormones|mesh-ancestor
25273282|NCT02386475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25109155|NCT03126864|Vidarabine|vidarabine|mesh-list
25109156|NCT03126864|Cyclophosphamide|cyclophosphamide|mesh-list
25109157|NCT03126864|Fludarabine|fludarabine|mesh-list
24406568|NCT00170781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24741882|NCT05291793|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25873027|NCT00127764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873028|NCT00127764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25873029|NCT00127764|Glucocorticoids|glucocorticoids|mesh-ancestor
25873030|NCT00127764|Hormones|hormones|mesh-ancestor
25233865|NCT02574741|Dopamine Agents|dopamine agents|mesh-ancestor
25233866|NCT02574741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25233867|NCT02574741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873031|NCT00127764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25873032|NCT00127764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25873033|NCT00127764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623679|NCT01073111|Antifungal Agents|antifungal agents|mesh-ancestor
24907263|NCT04331418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873034|NCT00127777|Amantadine|amantadine|mesh-list
25873035|NCT00127777|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25873036|NCT00127777|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25873037|NCT00127777|Antiviral Agents|antiviral agents|mesh-ancestor
25873038|NCT00127777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25873039|NCT00127777|Dopamine Agents|dopamine agents|mesh-ancestor
24907289|NCT04331470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24907290|NCT04331470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24818824|NCT02091180|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24818826|NCT02091180|Natriuretic Agents|natriuretic agents|mesh-ancestor
24818827|NCT02091180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818828|NCT02091219|Vitamin D|vitamin d|mesh-list
24818852|NCT02091310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24818853|NCT02091310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24818854|NCT02091310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24818855|NCT02091310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24818856|NCT02091310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818857|NCT02091310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24818858|NCT02091336|Metformin|metformin|mesh-list
24818859|NCT02091336|Glyburide|glyburide|mesh-list
24818860|NCT02091336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25233868|NCT02574741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25233869|NCT02574741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25233870|NCT02574741|Serotonin Agents|serotonin agents|mesh-ancestor
25233871|NCT02574741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25233872|NCT02574741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25233873|NCT02574741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25233874|NCT02574741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25233875|NCT02574663|Leucovorin|leucovorin|mesh-list
25233876|NCT02574663|Folic Acid|folic acid|mesh-list
25873040|NCT00127777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25873041|NCT00127777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063639|NCT03467022|Ascorbic Acid|ascorbic acid|mesh-list
24818861|NCT02091336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818862|NCT02091388|Risperidone|risperidone|mesh-list
25873042|NCT00127777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146613|NCT02920489|Anesthetics, Local|anesthetics, local|mesh-ancestor
25146614|NCT02920489|Anesthetics|anesthetics|mesh-ancestor
25146615|NCT02920489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24859553|NCT02304094|Hormones|hormones|mesh-ancestor
25146616|NCT02920489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818863|NCT02091388|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24818864|NCT02091388|Serotonin Agents|serotonin agents|mesh-ancestor
24818865|NCT02091388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24907460|NCT04330300|Natriuretic Agents|natriuretic agents|mesh-ancestor
24907461|NCT04330300|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24907462|NCT04330300|Protease Inhibitors|protease inhibitors|mesh-ancestor
24907463|NCT04330300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907465|NCT04330300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24907466|NCT04330300|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24907467|NCT04330300|Protective Agents|protective agents|mesh-ancestor
24907468|NCT04330300|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
24907469|NCT04330547|Analgesics|analgesics|mesh-list
24907470|NCT04330547|Sensory System Agents|sensory system agents|mesh-ancestor
24907471|NCT04330547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24907472|NCT04330547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907473|NCT04330586|Ciclesonide|ciclesonide|mesh-list
24907474|NCT04330586|Glucocorticoids|glucocorticoids|mesh-ancestor
24907475|NCT04330586|Hormones|hormones|mesh-ancestor
24393970|NCT00131430|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24393972|NCT00131430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24907678|NCT04328636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24907679|NCT04328636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24907680|NCT04328636|Anticonvulsants|anticonvulsants|mesh-ancestor
24907681|NCT04328636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24907682|NCT04328636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24907683|NCT04328636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907684|NCT04328636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24907685|NCT04328636|Tocolytic Agents|tocolytic agents|mesh-ancestor
24907686|NCT04328636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24907687|NCT04328753|Chlorhexidine|chlorhexidine|mesh-list
24907688|NCT04328753|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24907689|NCT04328753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24907690|NCT04328753|Disinfectants|disinfectants|mesh-ancestor
24907691|NCT04328493|Chloroquine|chloroquine|mesh-list
24907692|NCT04328493|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24907718|NCT04328285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24907719|NCT04328285|Antiviral Agents|antiviral agents|mesh-ancestor
24907720|NCT04328285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24907721|NCT04328285|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24907722|NCT04328285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24907723|NCT04328285|Antimalarials|antimalarials|mesh-ancestor
24907724|NCT04328285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24907725|NCT04328285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24907726|NCT04328285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24907735|NCT04328272|Azithromycin|azithromycin|mesh-list
24907736|NCT04328272|Hydroxychloroquine|hydroxychloroquine|mesh-list
24907737|NCT04328272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24907738|NCT04328272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24907739|NCT04328272|Antimalarials|antimalarials|mesh-ancestor
24907781|NCT04327726|Adrenergic Agents|adrenergic agents|mesh-ancestor
24907782|NCT04327726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24907783|NCT04327726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907784|NCT04327245|Tagatose|tagatose|mesh-list
24907785|NCT04327245|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24482971|NCT00441207|Micronutrients|micronutrients|mesh-ancestor
24907814|NCT04327427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25233877|NCT02574663|Gemcitabine|gemcitabine|mesh-list
25233878|NCT02574663|Paclitaxel|paclitaxel|mesh-list
25233879|NCT02574663|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25873043|NCT00127777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24847195|NCT02245451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24847196|NCT02245451|Protease Inhibitors|protease inhibitors|mesh-ancestor
24847197|NCT02245451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672194|NCT01742832|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25672195|NCT01742832|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25672196|NCT01742897|Fentanyl|fentanyl|mesh-list
25672197|NCT01742897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25672198|NCT01742897|Narcotics|narcotics|mesh-ancestor
25672199|NCT01742897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25672200|NCT01742897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873044|NCT00127777|Analgesics|analgesics|mesh-ancestor
25146702|NCT02919501|Antidepressive Agents|antidepressive agents|mesh-ancestor
25146703|NCT02919501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25146704|NCT02919501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25672201|NCT01742897|Analgesics|analgesics|mesh-ancestor
25146705|NCT02919501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25146721|NCT02919462|Cisplatin|cisplatin|mesh-list
24847198|NCT02245451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847199|NCT02245451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24847200|NCT02245451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24847201|NCT02245451|Antiviral Agents|antiviral agents|mesh-ancestor
24847202|NCT02245451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24847203|NCT02245451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24955885|NCT03860220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847204|NCT02245451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24955886|NCT03860220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24907815|NCT04327427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907817|NCT04327453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24907818|NCT04327453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24907819|NCT04327453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24907820|NCT04327453|Antitubercular Agents|antitubercular agents|mesh-ancestor
24907821|NCT04327232|Spironolactone|spironolactone|mesh-list
24907822|NCT04327232|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24907823|NCT04327232|Hormone Antagonists|hormone antagonists|mesh-ancestor
24907824|NCT04327232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24907825|NCT04327232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907827|NCT04327232|Diuretics|diuretics|mesh-ancestor
24907828|NCT04327232|Natriuretic Agents|natriuretic agents|mesh-ancestor
24907829|NCT04326920|Sargramostim|sargramostim|mesh-list
24907830|NCT04326920|Immunologic Factors|immunologic factors|mesh-ancestor
24907831|NCT04326920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907832|NCT04327011|Flucytosine|flucytosine|mesh-list
24907833|NCT04327011|Antifungal Agents|antifungal agents|mesh-ancestor
24787152|NCT01923857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24787153|NCT01923857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24787154|NCT01923870|Enclomiphene|enclomiphene|mesh-list
24787155|NCT01923870|Clomiphene|clomiphene|mesh-list
24787156|NCT01923870|Zuclomiphene|zuclomiphene|mesh-list
24787157|NCT01923870|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24787158|NCT01923870|Hormone Antagonists|hormone antagonists|mesh-ancestor
24787159|NCT01923870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24787160|NCT01923870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856859|NCT02287246|Anesthetics, Local|anesthetics, local|mesh-ancestor
24907883|NCT04326868|Antimitotic Agents|antimitotic agents|mesh-ancestor
24907884|NCT04326868|Mitosis Modulators|mitosis modulators|mesh-ancestor
24867276|NCT02478788|Sympathomimetics|sympathomimetics|mesh-ancestor
24907940|NCT04326166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24907941|NCT04326166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907942|NCT04325984|Dexamethasone|dexamethasone|mesh-list
24907943|NCT04325984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24907944|NCT04325984|Antiemetics|antiemetics|mesh-ancestor
24907945|NCT04325984|Autonomic Agents|autonomic agents|mesh-ancestor
24907946|NCT04325984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24907947|NCT04325984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907948|NCT04325984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24907949|NCT04325984|Glucocorticoids|glucocorticoids|mesh-ancestor
24907950|NCT04325984|Hormones|hormones|mesh-ancestor
24483089|NCT00441740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907986|NCT04325698|Carboplatin|carboplatin|mesh-list
24730952|NCT01631409|Aspirin|aspirin|mesh-list
24907987|NCT04325698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24907988|NCT04325698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24483123|NCT00441961|Methotrexate|methotrexate|mesh-list
24908015|NCT04325425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233880|NCT02574663|Bevacizumab|bevacizumab|mesh-list
25233881|NCT02574663|Fluorouracil|fluorouracil|mesh-list
25233882|NCT02574663|Oxaliplatin|oxaliplatin|mesh-list
25233883|NCT02574663|Levoleucovorin|levoleucovorin|mesh-list
25233884|NCT02574663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25233885|NCT02574663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25233886|NCT02574663|Tubulin Modulators|tubulin modulators|mesh-ancestor
25233887|NCT02574663|Antimitotic Agents|antimitotic agents|mesh-ancestor
25672202|NCT01742897|Sensory System Agents|sensory system agents|mesh-ancestor
25672203|NCT01742897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25672204|NCT01742897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25672205|NCT01742897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25672206|NCT01742897|Anesthetics, General|anesthetics, general|mesh-ancestor
24908020|NCT04325113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24908021|NCT04325113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908075|NCT04324307|Oxaliplatin|oxaliplatin|mesh-list
24908076|NCT04324307|Irinotecan|irinotecan|mesh-list
24908077|NCT04324307|Folfirinox|folfirinox|mesh-list
24908078|NCT04324307|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24908079|NCT04324307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908080|NCT04324307|Tubulin Modulators|tubulin modulators|mesh-ancestor
24908081|NCT04324307|Antimitotic Agents|antimitotic agents|mesh-ancestor
24908082|NCT04324307|Mitosis Modulators|mitosis modulators|mesh-ancestor
24908083|NCT04324307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908084|NCT04324307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24908085|NCT04324307|Antimetabolites|antimetabolites|mesh-ancestor
24908202|NCT04322760|Anesthetics, Local|anesthetics, local|mesh-ancestor
24908203|NCT04322760|Anesthetics|anesthetics|mesh-ancestor
24908204|NCT04322760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24908205|NCT04322760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908206|NCT04322760|Sensory System Agents|sensory system agents|mesh-ancestor
25873045|NCT00127777|Sensory System Agents|sensory system agents|mesh-ancestor
25873046|NCT00127777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24908207|NCT04322760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24908208|NCT04322760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24407039|NCT00171743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24407040|NCT00171756|Atenolol|atenolol|mesh-list
24742360|NCT05273242|Infliximab|infliximab|mesh-list
24742361|NCT05273242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24742362|NCT05273242|Dermatologic Agents|dermatologic agents|mesh-ancestor
24908209|NCT04322760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24908349|NCT04321837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908350|NCT04321837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24623681|NCT01073150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24908400|NCT04320706|Oxytocin|oxytocin|mesh-list
24908483|NCT04320173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24908484|NCT04320173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24908512|NCT04319471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908515|NCT04319588|Anesthetics, Local|anesthetics, local|mesh-list
24908516|NCT04319588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25233893|NCT02574663|Growth Substances|growth substances|mesh-ancestor
25233894|NCT02574663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233895|NCT02574663|Growth Inhibitors|growth inhibitors|mesh-ancestor
25233896|NCT02574663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25233897|NCT02574663|Antimetabolites|antimetabolites|mesh-ancestor
25233898|NCT02574663|Antiviral Agents|antiviral agents|mesh-ancestor
25233899|NCT02574663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25233900|NCT02574663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25233901|NCT02574663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25233902|NCT02574663|Immunologic Factors|immunologic factors|mesh-ancestor
25233903|NCT02574663|Antidotes|antidotes|mesh-ancestor
25233904|NCT02574663|Protective Agents|protective agents|mesh-ancestor
24847211|NCT02245451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24633700|NCT01130805|Capecitabine|capecitabine|mesh-list
24482556|NCT00439543|Iloprost|iloprost|mesh-list
24908529|NCT04319484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908530|NCT04319484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908555|NCT04319549|Analgesics|analgesics|mesh-ancestor
24908556|NCT04319549|Sensory System Agents|sensory system agents|mesh-ancestor
24908557|NCT04319549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24908608|NCT04318730|Apatinib|apatinib|mesh-list
24908609|NCT04318730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908610|NCT04318730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25873047|NCT00127829|Gefitinib|gefitinib|mesh-list
24908657|NCT04318158|Anesthetics, General|anesthetics, general|mesh-ancestor
24908658|NCT04318223|Palbociclib|palbociclib|mesh-list
24908829|NCT04316039|Alkylating Agents|alkylating agents|mesh-ancestor
24908830|NCT04316039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908832|NCT04315935|Fentanyl|fentanyl|mesh-list
24908833|NCT04315935|Butorphanol|butorphanol|mesh-list
24394053|NCT00131963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24908834|NCT04315935|Propofol|propofol|mesh-list
24908835|NCT04315935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24483753|NCT00444834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24908857|NCT04315909|Protective Agents|protective agents|mesh-ancestor
24908858|NCT04315909|Hemostatics|hemostatics|mesh-ancestor
24908859|NCT04315909|Coagulants|coagulants|mesh-ancestor
24908860|NCT04315584|Deoxyglucose|deoxyglucose|mesh-list
24908861|NCT04315584|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24483854|NCT00445497|Ciprofloxacin|ciprofloxacin|mesh-list
25233905|NCT02574663|Vitamin B Complex|vitamin b complex|mesh-ancestor
25233906|NCT02574663|Vitamins|vitamins|mesh-ancestor
25233907|NCT02574663|Micronutrients|micronutrients|mesh-ancestor
25233908|NCT02574663|Hematinics|hematinics|mesh-ancestor
25233909|NCT02574468|Dexamethasone|dexamethasone|mesh-list
25233910|NCT02574468|Dexamethasone acetate|dexamethasone acetate|mesh-list
25233911|NCT02574468|BB 1101|bb 1101|mesh-list
25233912|NCT02574468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25233913|NCT02574468|Antiemetics|antiemetics|mesh-ancestor
25233914|NCT02574468|Autonomic Agents|autonomic agents|mesh-ancestor
25233915|NCT02574468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25233916|NCT02574468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233917|NCT02574468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25233918|NCT02574468|Glucocorticoids|glucocorticoids|mesh-ancestor
25233919|NCT02574468|Hormones|hormones|mesh-ancestor
25233920|NCT02574468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25233921|NCT02574468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25233922|NCT02574468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25233923|NCT02574468|Protease Inhibitors|protease inhibitors|mesh-ancestor
25873048|NCT00127829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873049|NCT00127829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25873050|NCT00127829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672207|NCT01742897|Anesthetics|anesthetics|mesh-ancestor
25672208|NCT01743001|Macitentan|macitentan|mesh-list
25672209|NCT01743001|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25672210|NCT01743001|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25233941|NCT02574754|Anticoagulants|anticoagulants|mesh-ancestor
25233942|NCT02574715|Levonorgestrel|levonorgestrel|mesh-list
25233943|NCT02574715|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25233944|NCT02574715|Contraceptive Agents|contraceptive agents|mesh-ancestor
25233945|NCT02574715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25233946|NCT02574715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233947|NCT02574715|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25233948|NCT02574715|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25233949|NCT02574715|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25233950|NCT02574403|Eculizumab|eculizumab|mesh-list
25233951|NCT02574403|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25233952|NCT02574403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25233953|NCT02574403|Immunologic Factors|immunologic factors|mesh-ancestor
25233954|NCT02574403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233955|NCT02574221|Fluorides|fluorides|mesh-list
25233956|NCT02574221|Tin Fluorides|tin fluorides|mesh-list
25233957|NCT02574221|Cariostatic Agents|cariostatic agents|mesh-ancestor
25233958|NCT02574221|Protective Agents|protective agents|mesh-ancestor
25233959|NCT02574221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233960|NCT02574338|Alprostadil|alprostadil|mesh-list
25233961|NCT02574338|Misoprostol|misoprostol|mesh-list
25233962|NCT02574338|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25873061|NCT00127868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25873062|NCT00127868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873063|NCT00127868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25873064|NCT00127868|Hormone Antagonists|hormone antagonists|mesh-ancestor
25873065|NCT00127868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24483857|NCT00445497|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24908989|NCT04314193|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24908990|NCT04314193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24908991|NCT04314193|Glucocorticoids|glucocorticoids|mesh-ancestor
24787175|NCT01923935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24787176|NCT01923935|Immunologic Factors|immunologic factors|mesh-ancestor
24787177|NCT01923935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787179|NCT01923948|Analgesics|analgesics|mesh-ancestor
24787181|NCT01923948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24787182|NCT01923948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787183|NCT01923948|Anticonvulsants|anticonvulsants|mesh-ancestor
24787184|NCT01923948|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24909086|NCT04313036|Defibrotide|defibrotide|mesh-list
24909090|NCT04313036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24909091|NCT04312841|Acetic Acid|acetic acid|mesh-list
24909139|NCT04312243|Vasodilator Agents|vasodilator agents|mesh-ancestor
24909140|NCT04312243|Gasotransmitters|gasotransmitters|mesh-ancestor
24909141|NCT04312243|Protective Agents|protective agents|mesh-ancestor
24909143|NCT04312438|Chelating Agents|chelating agents|mesh-ancestor
25233963|NCT02574338|Abortifacient Agents|abortifacient agents|mesh-ancestor
25233964|NCT02574338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25233965|NCT02574338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233966|NCT02574338|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25233967|NCT02574338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25233968|NCT02574338|Oxytocics|oxytocics|mesh-ancestor
25233969|NCT02574338|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25233970|NCT02574338|Vasodilator Agents|vasodilator agents|mesh-ancestor
25233971|NCT02574338|Urological Agents|urological agents|mesh-ancestor
25233972|NCT02574156|Insulin|insulin|mesh-list
25233973|NCT02574156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25233974|NCT02574156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233975|NCT02574130|Amikacin|amikacin|mesh-list
25233976|NCT02574130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25233977|NCT02574130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25233978|NCT02573935|Clarithromycin|clarithromycin|mesh-list
25233979|NCT02573935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25233980|NCT02573935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25233981|NCT02573935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25233982|NCT02573935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24955903|NCT03860077|Nicotine|nicotine|mesh-list
24955904|NCT03860077|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24955905|NCT03860077|Autonomic Agents|autonomic agents|mesh-ancestor
24885205|NCT01481272|Leucovorin|leucovorin|mesh-list
25873066|NCT00127868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873067|NCT00127868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25873068|NCT00127868|Antioxidants|antioxidants|mesh-ancestor
25873069|NCT00127868|Protective Agents|protective agents|mesh-ancestor
25233983|NCT02573935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25233984|NCT02573935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25233985|NCT02573935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25233986|NCT02573909|Oxycodone|oxycodone|mesh-list
25044500|NCT01086748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25044502|NCT01086748|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25044503|NCT01086748|Dopamine Agents|dopamine agents|mesh-ancestor
25044504|NCT01086267|Cetuximab|cetuximab|mesh-list
25044505|NCT01086267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25044506|NCT01086267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044507|NCT01084330|Docetaxel|docetaxel|mesh-list
25044508|NCT01084330|Irinotecan|irinotecan|mesh-list
25044509|NCT01084330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044510|NCT01084330|Tubulin Modulators|tubulin modulators|mesh-ancestor
25044511|NCT01084330|Antimitotic Agents|antimitotic agents|mesh-ancestor
25044512|NCT01084330|Mitosis Modulators|mitosis modulators|mesh-ancestor
25044513|NCT01084330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044514|NCT01084330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25044515|NCT01084330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25873070|NCT00127868|Trace Elements|trace elements|mesh-ancestor
25873071|NCT00127868|Micronutrients|micronutrients|mesh-ancestor
25873072|NCT00127868|Dermatologic Agents|dermatologic agents|mesh-ancestor
25873073|NCT00127881|Zanolimumab|zanolimumab|mesh-list
25047884|NCT00755287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25047885|NCT00755287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047886|NCT00755287|Incretins|incretins|mesh-ancestor
25047888|NCT00755287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25044516|NCT01084330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044517|NCT01084161|Morphine|morphine|mesh-list
25044518|NCT01084161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25044519|NCT01084161|Narcotics|narcotics|mesh-ancestor
25044520|NCT01084161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25044521|NCT01084161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044522|NCT01084161|Analgesics|analgesics|mesh-ancestor
25044523|NCT01084161|Sensory System Agents|sensory system agents|mesh-ancestor
25044524|NCT01084161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25044525|NCT01083615|Prednisone|prednisone|mesh-list
24909144|NCT04312438|Sequestering Agents|sequestering agents|mesh-ancestor
24909173|NCT04312282|Hormone Antagonists|hormone antagonists|mesh-ancestor
24909174|NCT04312282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24909175|NCT04312282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909176|NCT04312282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24909177|NCT04312282|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24909178|NCT04312282|Antitubercular Agents|antitubercular agents|mesh-ancestor
24909179|NCT04312282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24909180|NCT04312282|Leprostatic Agents|leprostatic agents|mesh-ancestor
24909181|NCT04312282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24909182|NCT04312282|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24909183|NCT04312282|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24909184|NCT04312282|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24909185|NCT04312282|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24909186|NCT04312282|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24909187|NCT04312282|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24484008|NCT00446173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24484044|NCT00446329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24484045|NCT00446368|Everolimus|everolimus|mesh-list
24867528|NCT04170998|Metformin|metformin|mesh-list
25233987|NCT02573909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25233988|NCT02573909|Narcotics|narcotics|mesh-ancestor
25233989|NCT02573909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25233990|NCT02573909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25233991|NCT02573909|Analgesics|analgesics|mesh-ancestor
25233992|NCT02573909|Sensory System Agents|sensory system agents|mesh-ancestor
25233993|NCT02573909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25233994|NCT02573922|Oxycodone|oxycodone|mesh-list
25233995|NCT02573922|Naloxone|naloxone|mesh-list
25233996|NCT02573922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25233997|NCT02573922|Narcotics|narcotics|mesh-ancestor
25233998|NCT02573922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25233999|NCT02573922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234000|NCT02573922|Analgesics|analgesics|mesh-ancestor
25234001|NCT02573922|Sensory System Agents|sensory system agents|mesh-ancestor
25234002|NCT02573922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234003|NCT02573922|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25234004|NCT02573987|Lidocaine|lidocaine|mesh-list
25234005|NCT02573987|Nitrous Oxide|nitrous oxide|mesh-list
25234006|NCT02573987|Anesthetics, Local|anesthetics, local|mesh-ancestor
25234007|NCT02573987|Anesthetics|anesthetics|mesh-ancestor
25234008|NCT02573987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25234009|NCT02573987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234010|NCT02573987|Sensory System Agents|sensory system agents|mesh-ancestor
25234011|NCT02573987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25044526|NCT01083615|Docetaxel|docetaxel|mesh-list
25044527|NCT01083615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044528|NCT01083615|Tubulin Modulators|tubulin modulators|mesh-ancestor
25044529|NCT01083615|Antimitotic Agents|antimitotic agents|mesh-ancestor
25044530|NCT01083615|Mitosis Modulators|mitosis modulators|mesh-ancestor
25044531|NCT01083615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044532|NCT01083615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25044533|NCT01083615|Glucocorticoids|glucocorticoids|mesh-ancestor
25044534|NCT01083615|Hormones|hormones|mesh-ancestor
25409697|NCT03358472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672211|NCT01743001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672212|NCT01743001|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25672213|NCT01743027|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25672214|NCT01743027|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25147313|NCT02914158|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25147314|NCT02914158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25044535|NCT01083615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25044536|NCT01083615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847218|NCT02245464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154573|NCT05470647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24909337|NCT04310228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24909339|NCT04310176|Fluorouracil|fluorouracil|mesh-list
24909340|NCT04310176|Capecitabine|capecitabine|mesh-list
24909341|NCT04310176|Valproic Acid|valproic acid|mesh-list
24484106|NCT00446576|Epoetin Alfa|epoetin alfa|mesh-list
24818908|NCT02091817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24732370|NCT01638988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24909357|NCT04310176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24909358|NCT04310176|Antimanic Agents|antimanic agents|mesh-ancestor
24909359|NCT04310176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24909360|NCT04310176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24909361|NCT04310176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24909420|NCT04309240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909421|NCT04309240|Anticoagulants|anticoagulants|mesh-ancestor
24909422|NCT04308954|Flumazenil|flumazenil|mesh-list
24909423|NCT04308954|Antidotes|antidotes|mesh-ancestor
24909424|NCT04308954|Protective Agents|protective agents|mesh-ancestor
24909425|NCT04308954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909426|NCT04308954|GABA Modulators|gaba modulators|mesh-ancestor
24484171|NCT00446901|Selenium|selenium|mesh-list
24909459|NCT04308525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24909460|NCT04308525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909461|NCT04308525|Analgesics|analgesics|mesh-ancestor
25873074|NCT00127881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24909464|NCT04308317|Tetrandrine|tetrandrine|mesh-list
24909465|NCT04308317|Antimalarials|antimalarials|mesh-ancestor
24909466|NCT04308317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24909467|NCT04308317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24909468|NCT04308317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24909469|NCT04308317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24909470|NCT04308317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24867564|NCT03842696|Cyclosporine|cyclosporine|mesh-list
24818950|NCT02092012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818951|NCT02092012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25234012|NCT02573987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25234013|NCT02573987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25234014|NCT02573987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25234015|NCT02573987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25234016|NCT02573987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234017|NCT02573987|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25234018|NCT02573987|Anesthetics, General|anesthetics, general|mesh-ancestor
25234019|NCT02573987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25234020|NCT02573987|Analgesics|analgesics|mesh-ancestor
25234021|NCT02573714|Ketamine|ketamine|mesh-list
25234022|NCT02573714|Analgesics|analgesics|mesh-ancestor
25234023|NCT02573714|Sensory System Agents|sensory system agents|mesh-ancestor
25234024|NCT02573714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234025|NCT02573714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154575|NCT05470595|Atezolizumab|atezolizumab|mesh-list
25154576|NCT05470595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25154577|NCT05470582|Vaccines|vaccines|mesh-list
25154578|NCT05470582|Immunologic Factors|immunologic factors|mesh-ancestor
25154579|NCT05470582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154580|NCT05470530|Dexamethasone|dexamethasone|mesh-list
25154581|NCT05470530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25154582|NCT05470530|Antiemetics|antiemetics|mesh-ancestor
25154583|NCT05470530|Autonomic Agents|autonomic agents|mesh-ancestor
25154584|NCT05470530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25672215|NCT01743027|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25672216|NCT01743027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25672217|NCT01743027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25154585|NCT05470530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672218|NCT01743027|Analgesics|analgesics|mesh-ancestor
25672219|NCT01743027|Sensory System Agents|sensory system agents|mesh-ancestor
25672220|NCT01743027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25147496|NCT02912793|Sequestering Agents|sequestering agents|mesh-ancestor
25147497|NCT02912793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147498|NCT02912663|Magnesium Sulfate|magnesium sulfate|mesh-list
25147499|NCT02912663|Verapamil|verapamil|mesh-list
25147500|NCT02912663|Analgesics|analgesics|mesh-ancestor
25147501|NCT02912663|Sensory System Agents|sensory system agents|mesh-ancestor
25147515|NCT02912637|Xenon|xenon|mesh-list
25154586|NCT05470530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25154587|NCT05470530|Glucocorticoids|glucocorticoids|mesh-ancestor
25154588|NCT05470530|Hormones|hormones|mesh-ancestor
25154589|NCT05470530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25154590|NCT05470530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24955971|NCT03859102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24955972|NCT03859102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24955973|NCT03859102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24885252|NCT01300143|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24909777|NCT04305028|Protease Inhibitors|protease inhibitors|mesh-ancestor
24909941|NCT04303819|Incretins|incretins|mesh-ancestor
24909950|NCT04303767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909951|NCT04304014|Sulfalene|sulfalene|mesh-list
24909952|NCT04304014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24909953|NCT04304014|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24909954|NCT04304014|Renal Agents|renal agents|mesh-ancestor
24909955|NCT04304014|Antimalarials|antimalarials|mesh-ancestor
24909956|NCT04304014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24910087|NCT04302116|Methylprednisolone|methylprednisolone|mesh-list
24910125|NCT04301895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24910162|NCT04301661|Lamivudine|lamivudine|mesh-list
24484798|NCT00450086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24484799|NCT00450086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24484800|NCT00450086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24484801|NCT00450086|Analgesics|analgesics|mesh-ancestor
24910280|NCT04300959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24910281|NCT04300959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24910282|NCT04300959|Immunologic Factors|immunologic factors|mesh-ancestor
24910283|NCT04300959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847271|NCT02245789|Analgesics|analgesics|mesh-ancestor
24819007|NCT02092506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24819008|NCT02092532|Aflibercept|aflibercept|mesh-list
24819009|NCT02092532|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24819010|NCT02092532|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24819011|NCT02092532|Growth Substances|growth substances|mesh-ancestor
24819012|NCT02092532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819013|NCT02092532|Growth Inhibitors|growth inhibitors|mesh-ancestor
24819014|NCT02092532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25234026|NCT02573714|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25234027|NCT02573714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25234028|NCT02573714|Anesthetics, General|anesthetics, general|mesh-ancestor
25234029|NCT02573714|Anesthetics|anesthetics|mesh-ancestor
25234030|NCT02573714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25234031|NCT02573714|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25234032|NCT02573714|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25234033|NCT02573714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25234034|NCT02573714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955974|NCT03859102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24955975|NCT03859102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24955976|NCT03859102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24955977|NCT03859102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955978|NCT03859102|Antimanic Agents|antimanic agents|mesh-ancestor
24955979|NCT03859102|Antipruritics|antipruritics|mesh-ancestor
25234035|NCT02573701|Risperidone|risperidone|mesh-list
25234036|NCT02573701|Antipsychotic Agents|antipsychotic agents|mesh-list
25234037|NCT02573701|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25234038|NCT02573701|Serotonin Agents|serotonin agents|mesh-ancestor
25234039|NCT02573701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25234040|NCT02573701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672221|NCT01743027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672222|NCT01743027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25672223|NCT01743027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25672224|NCT01743027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25672225|NCT01743027|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25672226|NCT01743027|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25672227|NCT01743027|Histamine Antagonists|histamine antagonists|mesh-ancestor
24847223|NCT02245477|Growth Substances|growth substances|mesh-ancestor
24847224|NCT02245477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847226|NCT02245490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24847227|NCT02245490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24847228|NCT02245490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25234046|NCT02573701|Dopamine Agents|dopamine agents|mesh-ancestor
25234047|NCT02573831|Oxycodone|oxycodone|mesh-list
25234048|NCT02573831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25234049|NCT02573831|Narcotics|narcotics|mesh-ancestor
25234050|NCT02573831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25234051|NCT02573831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234052|NCT02573831|Analgesics|analgesics|mesh-ancestor
25234053|NCT02573831|Sensory System Agents|sensory system agents|mesh-ancestor
25234054|NCT02573831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234055|NCT02573610|Levofloxacin|levofloxacin|mesh-list
25234056|NCT02573610|Ofloxacin|ofloxacin|mesh-list
25234057|NCT02573610|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25234058|NCT02573610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25234059|NCT02573610|Renal Agents|renal agents|mesh-ancestor
25234060|NCT02573610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25234061|NCT02573610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25234062|NCT02573610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25234063|NCT02573610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234064|NCT02573610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234066|NCT02573610|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25234067|NCT02573610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25234068|NCT02573597|Sufentanil|sufentanil|mesh-list
25234069|NCT02573597|Bupivacaine|bupivacaine|mesh-list
25234070|NCT02573597|Anesthetics, Local|anesthetics, local|mesh-ancestor
25234071|NCT02573597|Anesthetics|anesthetics|mesh-ancestor
25234072|NCT02573597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25234073|NCT02573597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234074|NCT02573597|Sensory System Agents|sensory system agents|mesh-ancestor
25234075|NCT02573597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234076|NCT02573597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25234077|NCT02573597|Narcotics|narcotics|mesh-ancestor
25234078|NCT02573597|Analgesics|analgesics|mesh-ancestor
25234079|NCT02573597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25234080|NCT02573597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25234081|NCT02573597|Anesthetics, General|anesthetics, general|mesh-ancestor
25234082|NCT02573519|Acetylcholine|acetylcholine|mesh-list
25234083|NCT02573519|Donepezil|donepezil|mesh-list
25234084|NCT02573519|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
25234085|NCT02573519|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25234086|NCT02573519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234087|NCT02573519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847230|NCT02245490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24394198|NCT00132548|Schistosomicides|schistosomicides|mesh-ancestor
24394199|NCT00132548|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24847231|NCT02245490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847232|NCT02245490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847233|NCT02245490|Urological Agents|urological agents|mesh-ancestor
24847234|NCT02245503|Tamsulosin|tamsulosin|mesh-list
24847235|NCT02245503|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24847236|NCT02245503|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24847237|NCT02245503|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24847238|NCT02245503|Adrenergic Agents|adrenergic agents|mesh-ancestor
24453356|NCT05126836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24819015|NCT02092558|Nitrofurantoin|nitrofurantoin|mesh-list
24819016|NCT02092558|Cephalosporins|cephalosporins|mesh-list
24819017|NCT02092558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24819018|NCT02092558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24819019|NCT02092558|Renal Agents|renal agents|mesh-ancestor
24910310|NCT04300452|Carbetocin|carbetocin|mesh-list
24910311|NCT04300452|Ergonovine|ergonovine|mesh-list
24910312|NCT04300452|Oxytocics|oxytocics|mesh-ancestor
24910313|NCT04300452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24910314|NCT04300452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910315|NCT04300374|Anesthetics|anesthetics|mesh-list
24910316|NCT04300374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24910317|NCT04300374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910318|NCT04300751|Analgesics, Opioid|analgesics, opioid|mesh-list
24910319|NCT04300751|Narcotics|narcotics|mesh-ancestor
24484917|NCT00450762|Gemcitabine|gemcitabine|mesh-list
24484995|NCT00451074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484996|NCT00451074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484997|NCT00451100|Glycopyrrolate|glycopyrrolate|mesh-list
24484998|NCT00451100|Neostigmine|neostigmine|mesh-list
24484999|NCT00451100|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24485000|NCT00451100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485001|NCT00451100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485002|NCT00451100|Cholinergic Agents|cholinergic agents|mesh-ancestor
24485037|NCT00451139|Analgesics|analgesics|mesh-ancestor
25234088|NCT02573519|Cholinergic Agents|cholinergic agents|mesh-ancestor
25234089|NCT02573519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25234090|NCT02573519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234091|NCT02573519|Nootropic Agents|nootropic agents|mesh-ancestor
25234092|NCT02573519|Vasodilator Agents|vasodilator agents|mesh-ancestor
25234093|NCT02573519|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25234094|NCT02573727|Terlipressin|terlipressin|mesh-list
25234095|NCT02573727|Epinephrine|epinephrine|mesh-list
25234096|NCT02573727|Racepinephrine|racepinephrine|mesh-list
25234097|NCT02573727|Norepinephrine|norepinephrine|mesh-list
25234098|NCT02573727|Epinephryl borate|epinephryl borate|mesh-list
25234099|NCT02573727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25234100|NCT02573727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25234101|NCT02573727|Adrenergic Agents|adrenergic agents|mesh-ancestor
25234102|NCT02573727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25234103|NCT02573727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672228|NCT01743027|Histamine Agents|histamine agents|mesh-ancestor
25672229|NCT01743027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25672230|NCT01743027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672231|NCT01743131|Abatacept|abatacept|mesh-list
25672232|NCT01743131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25672233|NCT01743131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672234|NCT01743131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24453357|NCT05126836|Vasodilator Agents|vasodilator agents|mesh-ancestor
24453358|NCT05126836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24453359|NCT05126836|Protective Agents|protective agents|mesh-ancestor
24453360|NCT05126836|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24453361|NCT05126836|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24453362|NCT05126836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25873075|NCT00127881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24819033|NCT02092597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819035|NCT02092701|Vitamin D|vitamin d|mesh-list
24819036|NCT02092701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24819037|NCT02092701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819038|NCT02092701|Vitamins|vitamins|mesh-ancestor
24819039|NCT02092701|Micronutrients|micronutrients|mesh-ancestor
24819040|NCT02092701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25109241|NCT03126422|Analgesics|analgesics|mesh-ancestor
25109242|NCT03126422|Sensory System Agents|sensory system agents|mesh-ancestor
25109243|NCT03126422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25109244|NCT03126422|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25109245|NCT03126422|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25109246|NCT03126422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24910562|NCT04296214|Antimetabolites|antimetabolites|mesh-ancestor
24910563|NCT04296214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910564|NCT04296214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910565|NCT04296214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24910566|NCT04296240|Capecitabine|capecitabine|mesh-list
24910567|NCT04296240|Oxaliplatin|oxaliplatin|mesh-list
24910568|NCT04296240|Antiemetics|antiemetics|mesh-list
24910611|NCT04295993|Norepinephrine|norepinephrine|mesh-list
24910612|NCT04295993|Methylene Blue|methylene blue|mesh-list
24910613|NCT04295993|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24910614|NCT04295993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24910615|NCT04295993|Adrenergic Agents|adrenergic agents|mesh-ancestor
24910616|NCT04295993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24910617|NCT04295993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234116|NCT02573558|Propofol|propofol|mesh-list
25234117|NCT02573558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25234118|NCT02573558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25234119|NCT02573558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234120|NCT02573558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25234121|NCT02573558|Anesthetics, General|anesthetics, general|mesh-ancestor
25234122|NCT02573558|Anesthetics|anesthetics|mesh-ancestor
25234123|NCT02573558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25234124|NCT02573558|Analgesics|analgesics|mesh-ancestor
25873076|NCT00127907|Vasopressins|vasopressins|mesh-list
25873077|NCT00127907|Arginine Vasopressin|arginine vasopressin|mesh-list
25873078|NCT00127907|Epinephrine|epinephrine|mesh-list
25873079|NCT00127907|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25234125|NCT02573558|Sensory System Agents|sensory system agents|mesh-ancestor
25234126|NCT02573558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25672235|NCT01743131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25672236|NCT01743131|Immunologic Factors|immunologic factors|mesh-ancestor
25873080|NCT00127907|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25873081|NCT00127907|Adrenergic Agents|adrenergic agents|mesh-ancestor
25873082|NCT00127907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25234130|NCT02573558|Adrenergic Agents|adrenergic agents|mesh-ancestor
25234131|NCT02573558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25234132|NCT02573558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234133|NCT02573363|Cytarabine|cytarabine|mesh-list
25234134|NCT02573363|Mitoxantrone|mitoxantrone|mesh-list
25234135|NCT02573363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25234136|NCT02573363|Antimetabolites|antimetabolites|mesh-ancestor
25273621|NCT02384746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24910619|NCT04295993|Sympathomimetics|sympathomimetics|mesh-ancestor
24910620|NCT04295993|Autonomic Agents|autonomic agents|mesh-ancestor
24910621|NCT04295993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24910622|NCT04295993|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25873083|NCT00127907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873084|NCT00127907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873085|NCT00127907|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24485294|NCT00452556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485295|NCT00452556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25109249|NCT03126422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485403|NCT00452894|Cholinergic Agents|cholinergic agents|mesh-ancestor
24485404|NCT00452894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24485405|NCT00452894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485406|NCT00452894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485407|NCT00452907|Artesunate|artesunate|mesh-list
24819109|NCT02093299|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24819110|NCT02093299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24819111|NCT02093299|Purinergic Agents|purinergic agents|mesh-ancestor
25873086|NCT00127907|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24819112|NCT02093299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24911228|NCT04290013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24911229|NCT04290013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24911230|NCT04290013|Contraceptive Agents|contraceptive agents|mesh-ancestor
24911231|NCT04290013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24911265|NCT04290026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24911266|NCT04290026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911267|NCT04290026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24911268|NCT04290026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24911269|NCT04290026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24911270|NCT04290026|Dopamine Agents|dopamine agents|mesh-ancestor
24911271|NCT04290026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25109251|NCT03126461|Ipilimumab|ipilimumab|mesh-list
25873087|NCT00127907|Autonomic Agents|autonomic agents|mesh-ancestor
24911320|NCT04289792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24911321|NCT04289792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24911393|NCT04288700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24911394|NCT04288700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24911395|NCT04288700|Adrenergic Agents|adrenergic agents|mesh-ancestor
24911396|NCT04288700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24867690|NCT03179475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24623744|NCT01073527|Autonomic Agents|autonomic agents|mesh-ancestor
24623745|NCT01073527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24623746|NCT01073527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623747|NCT01073527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25109257|NCT03126188|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25109258|NCT03126188|Antidepressive Agents|antidepressive agents|mesh-ancestor
25109259|NCT03126188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25109260|NCT03126188|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25234137|NCT02573363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234138|NCT02573363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873088|NCT00127907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25873089|NCT00127907|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25873090|NCT00127907|Respiratory System Agents|respiratory system agents|mesh-ancestor
25873091|NCT00127907|Mydriatics|mydriatics|mesh-ancestor
25873092|NCT00127907|Sympathomimetics|sympathomimetics|mesh-ancestor
25873093|NCT00127907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25873094|NCT00127907|Hemostatics|hemostatics|mesh-ancestor
25873095|NCT00127907|Coagulants|coagulants|mesh-ancestor
25873096|NCT00127907|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25234147|NCT02573363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25234148|NCT02573363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24911964|NCT04283110|Anesthetics|anesthetics|mesh-ancestor
24911965|NCT04283110|GABA Modulators|gaba modulators|mesh-ancestor
24911966|NCT04283110|GABA Agents|gaba agents|mesh-ancestor
24911967|NCT04283110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24911968|NCT04283110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911969|NCT04282785|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24911970|NCT04282785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24911971|NCT04282746|Ketamine|ketamine|mesh-list
24911972|NCT04282746|Analgesics|analgesics|mesh-ancestor
24911973|NCT04282746|Sensory System Agents|sensory system agents|mesh-ancestor
24911974|NCT04282746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24911975|NCT04282746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486537|NCT00458328|Z 338|z 338|mesh-list
24912009|NCT04281862|Prednisolone|prednisolone|mesh-list
24912010|NCT04281862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24912011|NCT04281862|Glucocorticoids|glucocorticoids|mesh-ancestor
24912012|NCT04281862|Hormones|hormones|mesh-ancestor
24912013|NCT04281862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24486687|NCT00459420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486688|NCT00459420|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24486689|NCT00459420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24912161|NCT04279106|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24912162|NCT04279106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24912164|NCT04279106|Dermatologic Agents|dermatologic agents|mesh-ancestor
24912165|NCT04278950|Povidone-Iodine|povidone-iodine|mesh-list
24912166|NCT04278950|Povidone|povidone|mesh-list
24912167|NCT04278950|Plasma Substitutes|plasma substitutes|mesh-ancestor
24912168|NCT04278950|Blood Substitutes|blood substitutes|mesh-ancestor
24912169|NCT04278950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24912170|NCT04278950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446480|NCT00304850|Ketamine|ketamine|mesh-list
24787206|NCT01924013|Vitamins|vitamins|mesh-ancestor
24787207|NCT01924013|Micronutrients|micronutrients|mesh-ancestor
24787208|NCT01924013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787209|NCT01924013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24787210|NCT01924013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24912278|NCT04277702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24912279|NCT04277702|Respiratory System Agents|respiratory system agents|mesh-ancestor
24912280|NCT04277702|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24912281|NCT04277702|Hormone Antagonists|hormone antagonists|mesh-ancestor
24912282|NCT04277702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24912283|NCT04277702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912284|NCT04277702|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24956013|NCT03858465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24462884|NCT00357773|Azithromycin|azithromycin|mesh-list
24462885|NCT00357773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24912285|NCT04277702|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24912286|NCT04277702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234149|NCT02573363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273618|NCT02384746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25273619|NCT02384746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273620|NCT02384746|Protease Inhibitors|protease inhibitors|mesh-ancestor
25048078|NCT00743925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048079|NCT00743925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25048080|NCT00743925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25048081|NCT00743925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25097493|NCT03203668|Antimetabolites|antimetabolites|mesh-ancestor
25148067|NCT05312645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25148087|NCT05312398|Cetuximab|cetuximab|mesh-list
25148088|NCT05312398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25148089|NCT05312398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25148090|NCT05312398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25148091|NCT05312398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148092|NCT05312398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148093|NCT05312398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25148095|NCT05312372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25148096|NCT05312372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24766084|NCT01792557|Phenol|phenol|mesh-list
25148114|NCT05312242|Hematinics|hematinics|mesh-ancestor
25063873|NCT03465085|Heparin|heparin|mesh-list
24912314|NCT04276883|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24912315|NCT04276883|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24912316|NCT04276883|Adrenergic Agents|adrenergic agents|mesh-ancestor
24912317|NCT04276883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24912318|NCT04276883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912320|NCT04276688|Ritonavir|ritonavir|mesh-list
24912321|NCT04276688|Ribavirin|ribavirin|mesh-list
24912322|NCT04276688|Lopinavir|lopinavir|mesh-list
24912323|NCT04276688|Interferon-beta|interferon-beta|mesh-list
24912324|NCT04276688|Interferon beta-1b|interferon beta-1b|mesh-list
24743262|NCT04921527|Paclitaxel|paclitaxel|mesh-list
24912397|NCT04276090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24912398|NCT04276090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912399|NCT04276090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24912400|NCT04276090|Glucocorticoids|glucocorticoids|mesh-ancestor
24462887|NCT00357825|Reboxetine|reboxetine|mesh-list
24912618|NCT04273581|Growth Inhibitors|growth inhibitors|mesh-ancestor
24487123|NCT00461747|Dexamethasone|dexamethasone|mesh-list
24487170|NCT00461825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487171|NCT00461825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24487172|NCT00461825|Antitubercular Agents|antitubercular agents|mesh-ancestor
24912679|NCT04273282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24912680|NCT04273282|Protective Agents|protective agents|mesh-ancestor
24912681|NCT04273282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24912682|NCT04273282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24912683|NCT04273282|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24912684|NCT04273282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24912685|NCT04273282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24912686|NCT04273282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912687|NCT04273256|Inositol|inositol|mesh-list
24912688|NCT04273256|Vitamin B Complex|vitamin b complex|mesh-ancestor
24912689|NCT04273256|Vitamins|vitamins|mesh-ancestor
24912690|NCT04273256|Micronutrients|micronutrients|mesh-ancestor
24912691|NCT04273256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912919|NCT04270344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912920|NCT04270344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25672237|NCT01743131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672238|NCT01743131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25672239|NCT01743521|Ribavirin|ribavirin|mesh-list
25672240|NCT01743521|Antimetabolites|antimetabolites|mesh-ancestor
25672241|NCT01743521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672242|NCT01743521|Antiviral Agents|antiviral agents|mesh-ancestor
25672243|NCT01743521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25672244|NCT01743560|Everolimus|everolimus|mesh-list
25672245|NCT01743560|Exemestane|exemestane|mesh-list
25672246|NCT01743560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672247|NCT01743560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25672248|NCT01743560|Immunologic Factors|immunologic factors|mesh-ancestor
25672249|NCT01743560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672250|NCT01743560|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25672251|NCT01743560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25672252|NCT01743560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672253|NCT01743560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672254|NCT01743560|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24956040|NCT03858270|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25672255|NCT01743560|Hormone Antagonists|hormone antagonists|mesh-ancestor
24956045|NCT03858270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24956046|NCT03858270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24956048|NCT03858062|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24956049|NCT03858062|Pancrelipase|pancrelipase|mesh-list
24956084|NCT03857763|Paclitaxel|paclitaxel|mesh-list
25234165|NCT02573064|Tigecycline|tigecycline|mesh-list
25234166|NCT02573064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25234167|NCT02573064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24847268|NCT02245789|Anesthetics, General|anesthetics, general|mesh-ancestor
24847269|NCT02245789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24847270|NCT02245789|Narcotics|narcotics|mesh-ancestor
24847272|NCT02245789|Sensory System Agents|sensory system agents|mesh-ancestor
24634149|NCT01132222|Ibuprofen|ibuprofen|mesh-list
24912921|NCT04270344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24487453|NCT00463112|Antidepressive Agents|antidepressive agents|mesh-ancestor
24487454|NCT00463112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24487455|NCT00463112|Appetite Depressants|appetite depressants|mesh-ancestor
24912955|NCT04269863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24912956|NCT04269863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24858033|NCT02294656|Hormones|hormones|mesh-ancestor
24912957|NCT04269863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24912958|NCT04269863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24912959|NCT04269863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912960|NCT04269863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24912961|NCT04269863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24912962|NCT04269863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24912964|NCT04269928|Epinephrine|epinephrine|mesh-list
24912965|NCT04269928|Racepinephrine|racepinephrine|mesh-list
24912994|NCT04269460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912995|NCT04269460|Sensory System Agents|sensory system agents|mesh-ancestor
24912996|NCT04269460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24912997|NCT04269187|Theophylline|theophylline|mesh-list
24912998|NCT04269187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24912999|NCT04269187|Autonomic Agents|autonomic agents|mesh-ancestor
24913236|NCT04267614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913237|NCT04267614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24913238|NCT04267614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24913239|NCT04267614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24913240|NCT04267614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24913241|NCT04267614|Immunologic Factors|immunologic factors|mesh-ancestor
24913242|NCT04267497|Amphotericin B|amphotericin b|mesh-list
24913243|NCT04267497|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24913244|NCT04267497|Amebicides|amebicides|mesh-ancestor
24913245|NCT04267497|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24913246|NCT04267497|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24913247|NCT04267497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24487795|NCT00465192|Estradiol|estradiol|mesh-list
24913280|NCT04267250|Contraceptive Agents|contraceptive agents|mesh-ancestor
24913281|NCT04267250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24913282|NCT04267250|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24913283|NCT04267250|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24487840|NCT00465257|Artesunate|artesunate|mesh-list
24913915|NCT04259606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24913917|NCT04259476|Analgesics|analgesics|mesh-ancestor
24913918|NCT04259476|Sensory System Agents|sensory system agents|mesh-ancestor
24913919|NCT04259476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24913920|NCT04259476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913921|NCT04259476|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24913922|NCT04259476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24914012|NCT04258475|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24914013|NCT04258475|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24914014|NCT04258475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24914015|NCT04258475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914016|NCT04258644|Paclitaxel|paclitaxel|mesh-list
24914017|NCT04258644|Apatinib|apatinib|mesh-list
24914019|NCT04258644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148358|NCT05148195|Levoleucovorin|levoleucovorin|mesh-list
25148359|NCT05148195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148360|NCT05148195|Tubulin Modulators|tubulin modulators|mesh-ancestor
25148361|NCT05148195|Antimitotic Agents|antimitotic agents|mesh-ancestor
25148362|NCT05148195|Mitosis Modulators|mitosis modulators|mesh-ancestor
24914074|NCT04258241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24914077|NCT04258423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25234168|NCT02573064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25234169|NCT02573064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234170|NCT02573064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234176|NCT02573220|Calcium|calcium|mesh-list
25234177|NCT02573220|Levoleucovorin|levoleucovorin|mesh-list
25234178|NCT02573220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25273623|NCT02384343|Dexmedetomidine|dexmedetomidine|mesh-list
25873097|NCT00127907|Natriuretic Agents|natriuretic agents|mesh-ancestor
24847294|NCT02246023|Anesthetics, General|anesthetics, general|mesh-ancestor
24847295|NCT02246023|Anesthetics|anesthetics|mesh-ancestor
24847296|NCT02246049|Leucovorin|leucovorin|mesh-list
24847297|NCT02246049|Bevacizumab|bevacizumab|mesh-list
25873098|NCT00127920|Bevacizumab|bevacizumab|mesh-list
25873099|NCT00127920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25063895|NCT03464968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24914078|NCT04258423|Immunologic Factors|immunologic factors|mesh-ancestor
24914079|NCT04258423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914080|NCT04258423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24914081|NCT04258423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24914103|NCT04258098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24914104|NCT04258098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914109|NCT04258007|Neostigmine|neostigmine|mesh-list
24914110|NCT04258007|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24914111|NCT04258007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24914112|NCT04258007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914113|NCT04258007|Cholinergic Agents|cholinergic agents|mesh-ancestor
24914114|NCT04258007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24914115|NCT04258007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914116|NCT04258007|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24914119|NCT04257838|Meropenem|meropenem|mesh-list
24787220|NCT01924078|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24787221|NCT01924078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24787222|NCT01924078|Antimetabolites|antimetabolites|mesh-ancestor
25672256|NCT01743560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25672257|NCT01743677|Moxifloxacin|moxifloxacin|mesh-list
25672258|NCT01743677|Tofacitinib|tofacitinib|mesh-list
25672259|NCT01743677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25672260|NCT01743677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25672261|NCT01743677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25672262|NCT01743677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25672263|NCT01743677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672264|NCT01743677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672265|NCT01743677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672266|NCT01743677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25672267|NCT01743729|Lifitegrast|lifitegrast|mesh-list
25873100|NCT00127920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787223|NCT01924078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873101|NCT00127920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25873102|NCT00127920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25873103|NCT00127920|Growth Substances|growth substances|mesh-ancestor
25873104|NCT00127920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048155|NCT00734435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25048157|NCT00734292|Xhance|xhance|mesh-list
25048158|NCT00734292|Formoterol Fumarate|formoterol fumarate|mesh-list
25048159|NCT00734292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25048161|NCT00734292|Autonomic Agents|autonomic agents|mesh-ancestor
24787224|NCT01924078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787225|NCT01924078|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24787226|NCT01924078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787227|NCT01924078|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24787228|NCT01924078|Hormone Antagonists|hormone antagonists|mesh-ancestor
24787229|NCT01924078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24787230|NCT01924078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787231|NCT01924091|Dapivirine|dapivirine|mesh-list
25234179|NCT02573220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234180|NCT02573220|Antimetabolites|antimetabolites|mesh-ancestor
25234181|NCT02573220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234182|NCT02573220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25234183|NCT02573220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25234184|NCT02573220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25234185|NCT02573220|Immunologic Factors|immunologic factors|mesh-ancestor
25234186|NCT02573220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25234187|NCT02573220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25234188|NCT02573220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234189|NCT02573220|Antidotes|antidotes|mesh-ancestor
25234190|NCT02573220|Protective Agents|protective agents|mesh-ancestor
25234191|NCT02573220|Vitamin B Complex|vitamin b complex|mesh-ancestor
25234192|NCT02573220|Vitamins|vitamins|mesh-ancestor
25234193|NCT02573220|Micronutrients|micronutrients|mesh-ancestor
25234195|NCT02573220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25234196|NCT02573038|Aflibercept|aflibercept|mesh-list
25234197|NCT02573038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25234198|NCT02573038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25234199|NCT02573038|Growth Substances|growth substances|mesh-ancestor
25873105|NCT00127920|Growth Inhibitors|growth inhibitors|mesh-ancestor
25873106|NCT00127959|Tenofovir|tenofovir|mesh-list
25873107|NCT00127959|Zidovudine|zidovudine|mesh-list
24787232|NCT01924091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24914260|NCT04256525|Sensory System Agents|sensory system agents|mesh-ancestor
24488884|NCT00470483|Paroxetine|paroxetine|mesh-list
24914323|NCT04255771|Gemcitabine|gemcitabine|mesh-list
24914324|NCT04255771|Cisplatin|cisplatin|mesh-list
24914325|NCT04255771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914326|NCT04255771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24743649|NCT04696380|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24743650|NCT04696380|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24743651|NCT04696380|Cholinergic Agents|cholinergic agents|mesh-ancestor
24743652|NCT04696380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24956129|NCT03856853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24956130|NCT03856853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24956131|NCT03856853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24956132|NCT03856866|Hydroxychloroquine|hydroxychloroquine|mesh-list
24885456|NCT05172518|Antimetabolites|antimetabolites|mesh-ancestor
24743653|NCT04696380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109278|NCT03126123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109279|NCT03126084|Acetaminophen|acetaminophen|mesh-list
25109280|NCT03126084|Tramadol|tramadol|mesh-list
25109295|NCT03125980|Capecitabine|capecitabine|mesh-list
24858300|NCT02296203|Irinotecan|irinotecan|mesh-list
25672268|NCT01743729|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25672269|NCT01743729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25672270|NCT01743859|Lenalidomide|lenalidomide|mesh-list
25672271|NCT01743859|Azacitidine|azacitidine|mesh-list
25672272|NCT01743859|Immunologic Factors|immunologic factors|mesh-ancestor
25672273|NCT01743859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672274|NCT01743859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25672275|NCT01743859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24914370|NCT04255498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24914371|NCT04255498|Luteolytic Agents|luteolytic agents|mesh-ancestor
25672276|NCT01743859|Growth Substances|growth substances|mesh-ancestor
25873108|NCT00127959|Emtricitabine|emtricitabine|mesh-list
25873109|NCT00127959|Efavirenz|efavirenz|mesh-list
25148550|NCT04943757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148551|NCT04943757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25148552|NCT04932083|Fentanyl|fentanyl|mesh-list
25148553|NCT04932083|Midazolam|midazolam|mesh-list
25148554|NCT04932083|Nalbuphine|nalbuphine|mesh-list
25148555|NCT04932083|Bupivacaine|bupivacaine|mesh-list
24914372|NCT04255498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24914373|NCT04255498|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24914374|NCT04255368|Choline|choline|mesh-list
24914422|NCT04254835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24914423|NCT04254835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24914424|NCT04255121|Lidocaine|lidocaine|mesh-list
24914460|NCT04254822|Protective Agents|protective agents|mesh-ancestor
24914461|NCT04254822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24914462|NCT04254822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24489057|NCT00471341|Analgesics|analgesics|mesh-ancestor
24914498|NCT04254744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24914499|NCT04254744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914537|NCT04254380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24914538|NCT04254380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914539|NCT04254471|Carboplatin|carboplatin|mesh-list
24914540|NCT04254471|Etoposide|etoposide|mesh-list
24914571|NCT04254042|Captopril|captopril|mesh-list
24819467|NCT02095665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24914572|NCT04254042|Calcium|calcium|mesh-list
24914573|NCT04254042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24914574|NCT04254042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914575|NCT04254042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24914576|NCT04254042|Protease Inhibitors|protease inhibitors|mesh-ancestor
24914577|NCT04254042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24914578|NCT04254042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914579|NCT04254042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24914580|NCT04254081|Lidocaine|lidocaine|mesh-list
24914581|NCT04254081|Buprenorphine|buprenorphine|mesh-list
24914582|NCT04254081|Anesthetics, Local|anesthetics, local|mesh-ancestor
24914583|NCT04254081|Anesthetics|anesthetics|mesh-ancestor
24914584|NCT04254081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24489176|NCT00471640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24819492|NCT02095730|Riboflavin|riboflavin|mesh-list
24819493|NCT02095730|Vitamin B Complex|vitamin b complex|mesh-list
25234200|NCT02573038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234201|NCT02573038|Growth Inhibitors|growth inhibitors|mesh-ancestor
25234202|NCT02573038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25234203|NCT02573051|Isosorbide|isosorbide|mesh-list
25234204|NCT02573051|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25873110|NCT00127959|Antiviral Agents|antiviral agents|mesh-ancestor
25234205|NCT02573051|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25234206|NCT02573051|Misoprostol|misoprostol|mesh-list
25234207|NCT02573051|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25234208|NCT02573051|Abortifacient Agents|abortifacient agents|mesh-ancestor
25234209|NCT02573051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25234210|NCT02573051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234211|NCT02573051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24819494|NCT02095730|Micronutrients|micronutrients|mesh-ancestor
24819495|NCT02095730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914607|NCT04253678|Antidepressive Agents|antidepressive agents|mesh-ancestor
24914633|NCT04253873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24914640|NCT04253132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24914641|NCT04253132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24914642|NCT04253132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24914643|NCT04253132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24914644|NCT04253132|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24914645|NCT04253132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24914646|NCT04253132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914776|NCT04252521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24489423|NCT00473174|Ramipril|ramipril|mesh-list
24914817|NCT04251962|Anesthetics, General|anesthetics, general|mesh-ancestor
24914819|NCT04251871|Ritonavir|ritonavir|mesh-list
25672277|NCT01743859|Growth Inhibitors|growth inhibitors|mesh-ancestor
25672278|NCT01743859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672279|NCT01743859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25672280|NCT01743859|Antimetabolites|antimetabolites|mesh-ancestor
25672281|NCT01743859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672282|NCT01743859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25148664|NCT04823845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25148665|NCT04823845|Dermatologic Agents|dermatologic agents|mesh-ancestor
25148666|NCT04819399|Catumaxomab|catumaxomab|mesh-list
25148667|NCT04819399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25148668|NCT04802616|Broncho-Vaxom|broncho-vaxom|mesh-list
25148669|NCT04802616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25148670|NCT04802616|Immunologic Factors|immunologic factors|mesh-ancestor
25148671|NCT04802616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148673|NCT04790045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148674|NCT04772274|Ustekinumab|ustekinumab|mesh-list
25148675|NCT04772274|Dermatologic Agents|dermatologic agents|mesh-ancestor
25148676|NCT04758975|Rituximab|rituximab|mesh-list
25148677|NCT04758975|Venetoclax|venetoclax|mesh-list
25148678|NCT04758975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24914820|NCT04251871|Lopinavir|lopinavir|mesh-list
24914821|NCT04251871|Interferon-alpha|interferon-alpha|mesh-list
24914851|NCT04251832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914852|NCT04251832|Antitubercular Agents|antitubercular agents|mesh-ancestor
24914853|NCT04251832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24914854|NCT04251832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24914855|NCT04251832|Chelating Agents|chelating agents|mesh-ancestor
24914856|NCT04251832|Sequestering Agents|sequestering agents|mesh-ancestor
24914857|NCT04251247|Fibrin fragment D|fibrin fragment d|mesh-list
24743737|NCT04648241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873111|NCT00127959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25873112|NCT00127959|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25873113|NCT00127959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25873114|NCT00127959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25873115|NCT00127959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914858|NCT04251247|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24914859|NCT04251247|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24914860|NCT04251247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914861|NCT04251247|Hemostatics|hemostatics|mesh-ancestor
24956210|NCT03856242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24956211|NCT03856242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816402|NCT02076841|Interferons|interferons|mesh-list
24914862|NCT04251247|Coagulants|coagulants|mesh-ancestor
24914864|NCT04251169|Pembrolizumab|pembrolizumab|mesh-list
24914865|NCT04251169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24914866|NCT04251169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914892|NCT05253508|Lidocaine|lidocaine|mesh-list
24914893|NCT05253508|Anesthetics, Local|anesthetics, local|mesh-ancestor
24914894|NCT05253508|Anesthetics|anesthetics|mesh-ancestor
24914895|NCT05253508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24914896|NCT05253508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914907|NCT05253118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914908|NCT05253118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24914909|NCT05253118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24914910|NCT05253066|Docetaxel|docetaxel|mesh-list
24914911|NCT05253066|Epirubicin|epirubicin|mesh-list
24914912|NCT05253066|Exemestane|exemestane|mesh-list
25234212|NCT02573051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25234213|NCT02573051|Oxytocics|oxytocics|mesh-ancestor
25234214|NCT02573051|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25234215|NCT02573051|Diuretics|diuretics|mesh-ancestor
25234216|NCT02573051|Natriuretic Agents|natriuretic agents|mesh-ancestor
25234217|NCT02573051|Vasodilator Agents|vasodilator agents|mesh-ancestor
25234218|NCT02573051|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25672283|NCT01743976|Donepezil|donepezil|mesh-list
25672284|NCT01743976|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25672285|NCT01743976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672286|NCT01743976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672287|NCT01743976|Cholinergic Agents|cholinergic agents|mesh-ancestor
25672288|NCT01743976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25672289|NCT01743976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672290|NCT01743976|Nootropic Agents|nootropic agents|mesh-ancestor
25672291|NCT01744197|Lidocaine|lidocaine|mesh-list
25672292|NCT01744197|Tetracaine|tetracaine|mesh-list
25672293|NCT01744197|Anesthetics, Local|anesthetics, local|mesh-ancestor
25672294|NCT01744197|Anesthetics|anesthetics|mesh-ancestor
25672295|NCT01744197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25672296|NCT01744197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234219|NCT02573051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234220|NCT02573025|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24914943|NCT05253014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914944|NCT05253014|Antipyretics|antipyretics|mesh-ancestor
24914945|NCT05252715|Vaccines|vaccines|mesh-list
24914946|NCT05252715|Immunologic Factors|immunologic factors|mesh-ancestor
24914957|NCT05252546|Loperamide|loperamide|mesh-list
24914958|NCT05252546|Antidiarrheals|antidiarrheals|mesh-list
24914959|NCT05252546|Bentonite|bentonite|mesh-list
24914960|NCT05252546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24819581|NCT02096068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24819582|NCT02096068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914973|NCT05252325|Hyaluronic Acid|hyaluronic acid|mesh-list
24914974|NCT05252325|Anesthetics, Local|anesthetics, local|mesh-ancestor
24914976|NCT05252325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24489703|NCT00474916|KRN 5500|krn 5500|mesh-list
24915003|NCT05251766|Mitosis Modulators|mitosis modulators|mesh-ancestor
24915010|NCT05251662|Growth Substances|growth substances|mesh-ancestor
24915011|NCT05251662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915012|NCT05251662|Growth Inhibitors|growth inhibitors|mesh-ancestor
24915020|NCT05251610|Propranolol|propranolol|mesh-list
24915022|NCT05251610|Oxytocics|oxytocics|mesh-ancestor
24915023|NCT05251610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25234265|NCT02572583|Antiviral Agents|antiviral agents|mesh-ancestor
24915049|NCT04962503|Dermatologic Agents|dermatologic agents|mesh-ancestor
25109304|NCT03126097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25109305|NCT03126097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25109306|NCT03126097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25109307|NCT03126097|Contraceptive Agents|contraceptive agents|mesh-ancestor
25109308|NCT03126097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25109309|NCT03126097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109310|NCT03126097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25109312|NCT03126097|Hormones|hormones|mesh-ancestor
25109313|NCT03126097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25109314|NCT03126097|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24626640|NCT01088022|Serotonin Agents|serotonin agents|mesh-ancestor
25078274|NCT03357822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25078275|NCT03357822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25078276|NCT03357822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25109315|NCT03126097|Hormone Antagonists|hormone antagonists|mesh-ancestor
25109316|NCT03126097|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25109317|NCT03126097|Diuretics|diuretics|mesh-ancestor
25234221|NCT02573025|Interferon-alpha|interferon-alpha|mesh-list
25234222|NCT02573025|Interferon alpha-2|interferon alpha-2|mesh-list
25234223|NCT02573025|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
25234224|NCT02573025|Antiviral Agents|antiviral agents|mesh-ancestor
25234225|NCT02573025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25234226|NCT02573025|Immunologic Factors|immunologic factors|mesh-ancestor
25234227|NCT02573025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234228|NCT02573025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25234229|NCT02572986|Permethrin|permethrin|mesh-list
25873116|NCT00127959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25873117|NCT00127959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25109318|NCT03126097|Natriuretic Agents|natriuretic agents|mesh-ancestor
25109319|NCT03126071|Bevacizumab|bevacizumab|mesh-list
25109320|NCT03126071|Oxaliplatin|oxaliplatin|mesh-list
25109321|NCT03126071|Irinotecan|irinotecan|mesh-list
25672297|NCT01744197|Sensory System Agents|sensory system agents|mesh-ancestor
25672298|NCT01744197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25672299|NCT01744197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25672300|NCT01744197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25672301|NCT01744197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25873118|NCT00127959|Antimetabolites|antimetabolites|mesh-ancestor
25873119|NCT00127959|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25873120|NCT00127959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25873121|NCT00127959|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25109322|NCT03126071|Raltitrexed|raltitrexed|mesh-list
24616069|NCT01033760|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24616070|NCT01033760|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24616071|NCT01033760|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24616072|NCT01033877|Vaccines|vaccines|mesh-list
24868011|NCT04144023|Vaccines|vaccines|mesh-list
24915380|NCT03196180|Interferon Inducers|interferon inducers|mesh-ancestor
24915381|NCT03187210|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24915382|NCT03187210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24915383|NCT03187210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915385|NCT03075423|Ipilimumab|ipilimumab|mesh-list
24915386|NCT03075423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24915418|NCT02631941|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24868052|NCT03994172|Cinacalcet|cinacalcet|mesh-list
24915579|NCT04250506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915581|NCT04250519|Sodium Hypochlorite|sodium hypochlorite|mesh-list
24915583|NCT04250519|Disinfectants|disinfectants|mesh-ancestor
24915584|NCT04250519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24915585|NCT04250246|Nivolumab|nivolumab|mesh-list
24915586|NCT04250246|Ipilimumab|ipilimumab|mesh-list
24915587|NCT04250246|Guadecitabine|guadecitabine|mesh-list
24915588|NCT04250246|Azacitidine|azacitidine|mesh-list
24915589|NCT04250246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24915590|NCT04250246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915591|NCT04250246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24915593|NCT04250246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24915623|NCT04250116|Protease Inhibitors|protease inhibitors|mesh-ancestor
24819666|NCT02096601|Levodopa|levodopa|mesh-list
24819667|NCT02096601|Carbidopa|carbidopa|mesh-list
24819668|NCT02096601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24441615|NCT00287937|Paclitaxel|paclitaxel|mesh-list
24915837|NCT04247633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915838|NCT04247633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24915840|NCT04247633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234230|NCT02572986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234231|NCT02572986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234232|NCT02572960|Vitamin D|vitamin d|mesh-list
25234233|NCT02572960|Cholecalciferol|cholecalciferol|mesh-list
25234234|NCT02572960|Valsartan|valsartan|mesh-list
25234235|NCT02572960|Vitamins|vitamins|mesh-ancestor
25234236|NCT02572960|Micronutrients|micronutrients|mesh-ancestor
25234237|NCT02572960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234238|NCT02572960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25234239|NCT02572960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25234240|NCT02572960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25234241|NCT02572960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25234242|NCT02572960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25234243|NCT02572960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234244|NCT02572947|Dolutegravir|dolutegravir|mesh-list
25672302|NCT01744197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25672303|NCT01744197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672304|NCT01744353|Oxaliplatin|oxaliplatin|mesh-list
25672305|NCT01744353|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25672306|NCT01744353|Paclitaxel|paclitaxel|mesh-list
25672307|NCT01744353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672308|NCT01744353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672309|NCT01744353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25873122|NCT00127959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25873123|NCT00127959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24915842|NCT04247646|Antioxidants|antioxidants|mesh-ancestor
24915843|NCT04247646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915844|NCT04247646|Protective Agents|protective agents|mesh-ancestor
24915845|NCT04247646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915846|NCT04247646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24915847|NCT04247815|Methotrexate|methotrexate|mesh-list
24915848|NCT04247815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25234245|NCT02572947|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25234246|NCT02572947|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25234247|NCT02572947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234248|NCT02572947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234249|NCT02572947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25234250|NCT02572947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25234251|NCT02572947|Antiviral Agents|antiviral agents|mesh-ancestor
25234252|NCT02572947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25234253|NCT02572505|Tenofovir|tenofovir|mesh-list
25234254|NCT02572505|Emtricitabine|emtricitabine|mesh-list
25234255|NCT02572505|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25234256|NCT02572505|Antiviral Agents|antiviral agents|mesh-ancestor
25234257|NCT02572505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25234258|NCT02572505|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25234259|NCT02572505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25234260|NCT02572505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234261|NCT02572505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234262|NCT02572505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25234263|NCT02572505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25234264|NCT02572583|Oseltamivir|oseltamivir|mesh-list
25234269|NCT02572687|Durvalumab|durvalumab|mesh-list
25234270|NCT02572687|Ramucirumab|ramucirumab|mesh-list
25234271|NCT02572687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25234272|NCT02572687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25234273|NCT02572596|Cyclophosphamide|cyclophosphamide|mesh-list
25234274|NCT02572596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25234275|NCT02572596|Immunologic Factors|immunologic factors|mesh-ancestor
25234276|NCT02572596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234277|NCT02572596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24954071|NCT03879590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24915849|NCT04247815|Abortifacient Agents|abortifacient agents|mesh-ancestor
24490590|NCT00479076|Aflibercept|aflibercept|mesh-list
24916014|NCT04245787|Cariostatic Agents|cariostatic agents|mesh-ancestor
24916015|NCT04245787|Protective Agents|protective agents|mesh-ancestor
25672310|NCT01744353|Tubulin Modulators|tubulin modulators|mesh-ancestor
25672311|NCT01744353|Antimitotic Agents|antimitotic agents|mesh-ancestor
25672312|NCT01744353|Mitosis Modulators|mitosis modulators|mesh-ancestor
25672313|NCT01744496|Rotigotine|rotigotine|mesh-list
25672314|NCT01744496|Dopamine Agonists|dopamine agonists|mesh-ancestor
25672315|NCT01744496|Dopamine Agents|dopamine agents|mesh-ancestor
25672316|NCT01744496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25672317|NCT01744496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873124|NCT00127959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25873125|NCT00127972|Lamivudine|lamivudine|mesh-list
25873126|NCT00127972|Efavirenz|efavirenz|mesh-list
25873127|NCT00127972|Nevirapine|nevirapine|mesh-list
25873128|NCT00127972|Stavudine|stavudine|mesh-list
25873129|NCT00127972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25873130|NCT00127972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25873131|NCT00127972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25149187|NCT03777904|Micronutrients|micronutrients|mesh-ancestor
25149188|NCT03777904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149189|NCT03766581|Aspirin|aspirin|mesh-list
25149190|NCT03766581|Clopidogrel|clopidogrel|mesh-list
24916016|NCT04245787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916017|NCT04245774|Bupivacaine|bupivacaine|mesh-list
24916018|NCT04245774|Levobupivacaine|levobupivacaine|mesh-list
24916020|NCT04245774|Anesthetics|anesthetics|mesh-ancestor
24916065|NCT04245046|Amlodipine|amlodipine|mesh-list
24916066|NCT04245046|Candesartan|candesartan|mesh-list
24916067|NCT04245046|Atorvastatin|atorvastatin|mesh-list
24916097|NCT04244695|Antiemetics|antiemetics|mesh-ancestor
24916098|NCT04244695|Autonomic Agents|autonomic agents|mesh-ancestor
24916099|NCT04244695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24916100|NCT04244695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819684|NCT02096614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819685|NCT02096614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24819686|NCT02096614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24819687|NCT02096913|Ibuprofen|ibuprofen|mesh-list
24819688|NCT02096913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24819689|NCT02096913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24819690|NCT02096913|Analgesics|analgesics|mesh-ancestor
24819691|NCT02096913|Sensory System Agents|sensory system agents|mesh-ancestor
25234278|NCT02572596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25234279|NCT02572596|Alkylating Agents|alkylating agents|mesh-ancestor
25234280|NCT02572596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234281|NCT02572596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24956348|NCT03855371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234282|NCT02572596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25234283|NCT02572492|Dexamethasone|dexamethasone|mesh-list
25234284|NCT02572492|Dexamethasone acetate|dexamethasone acetate|mesh-list
25234285|NCT02572492|Melphalan|melphalan|mesh-list
25234286|NCT02572492|BB 1101|bb 1101|mesh-list
25234287|NCT02572492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25234288|NCT02572492|Antiemetics|antiemetics|mesh-ancestor
25873132|NCT00127972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744179|NCT04484350|Sympathomimetics|sympathomimetics|mesh-ancestor
24916214|NCT04243434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916216|NCT04243434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24916217|NCT04243434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24916218|NCT04243434|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24916219|NCT04243434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24916220|NCT04243434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916221|NCT04243434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24916222|NCT04243434|Glucocorticoids|glucocorticoids|mesh-ancestor
24916223|NCT04243434|Hormones|hormones|mesh-ancestor
24916224|NCT04243434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24916225|NCT04243434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24916226|NCT04243434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24916227|NCT04243434|Tubulin Modulators|tubulin modulators|mesh-ancestor
24787296|NCT01924325|Sensory System Agents|sensory system agents|mesh-ancestor
25234332|NCT02572375|Sympathomimetics|sympathomimetics|mesh-ancestor
24787297|NCT01924325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24787298|NCT01924325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916257|NCT04242914|Analgesics|analgesics|mesh-ancestor
24916258|NCT04242914|Sensory System Agents|sensory system agents|mesh-ancestor
24916259|NCT04242914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24916260|NCT04242914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916261|NCT04242914|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24916262|NCT04242914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24916263|NCT04242914|Anesthetics, General|anesthetics, general|mesh-ancestor
24819753|NCT02097147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24819754|NCT02097147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24819755|NCT02097147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819757|NCT02097147|Serotonin Agents|serotonin agents|mesh-ancestor
24819758|NCT02097147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819759|NCT02097147|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24819760|NCT02097147|Antidepressive Agents|antidepressive agents|mesh-ancestor
24819761|NCT02097147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24819762|NCT02097147|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24819763|NCT02097147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25672318|NCT01744496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672319|NCT01744574|Progesterone|progesterone|mesh-list
25672320|NCT01744574|Progestins|progestins|mesh-ancestor
25672321|NCT01744574|Hormones|hormones|mesh-ancestor
25149333|NCT02859415|Plicamycin|plicamycin|mesh-list
25149334|NCT02859415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25149335|NCT02859415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149336|NCT02859415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25149337|NCT02859415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25149338|NCT02859415|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25149339|NCT02859415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25149340|NCT02859415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496778|NCT00506701|Urological Agents|urological agents|mesh-ancestor
25149341|NCT02859415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25149342|NCT02842866|Vaccines|vaccines|mesh-list
24819764|NCT02097147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819765|NCT02097147|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25234289|NCT02572492|Autonomic Agents|autonomic agents|mesh-ancestor
25234290|NCT02572492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234291|NCT02572492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234292|NCT02572492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25234293|NCT02572492|Glucocorticoids|glucocorticoids|mesh-ancestor
25234294|NCT02572492|Hormones|hormones|mesh-ancestor
25234295|NCT02572492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25234296|NCT02572492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25234297|NCT02572492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25234298|NCT02572492|Protease Inhibitors|protease inhibitors|mesh-ancestor
24491025|NCT00480870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916308|NCT04242212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24916309|NCT04242212|Oxytocics|oxytocics|mesh-ancestor
24916310|NCT04242368|Fluticasone|fluticasone|mesh-list
24491085|NCT00481182|Ritonavir|ritonavir|mesh-list
24916346|NCT04241731|Raltitrexed|raltitrexed|mesh-list
24916347|NCT04241731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24916348|NCT04241731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24916349|NCT04241731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24916350|NCT04241731|Antimetabolites|antimetabolites|mesh-ancestor
24916351|NCT04241731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916352|NCT04241731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24916376|NCT04241523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916378|NCT04241380|Anticoagulants|anticoagulants|mesh-list
24916379|NCT04241380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24916380|NCT04241380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24916381|NCT04241380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24916384|NCT04241211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24916385|NCT04241211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916386|NCT04241458|Midazolam|midazolam|mesh-list
24916387|NCT04241458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24916388|NCT04241458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24916389|NCT04241458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24916390|NCT04241458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916391|NCT04241458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24916392|NCT04241458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24916393|NCT04241458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25672322|NCT01744574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25672323|NCT01744574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672324|NCT01744704|Mitogens|mitogens|mesh-list
25672325|NCT01744704|Mitosis Modulators|mitosis modulators|mesh-ancestor
25672326|NCT01744704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672327|NCT01744730|Clindamycin|clindamycin|mesh-list
25672328|NCT01744730|Clindamycin palmitate|clindamycin palmitate|mesh-list
25672329|NCT01744730|Clindamycin phosphate|clindamycin phosphate|mesh-list
25672330|NCT01744730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25672331|NCT01744730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25672332|NCT01744730|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25672333|NCT01744730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672334|NCT01744730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672335|NCT01744782|Cysteamine|cysteamine|mesh-list
25672336|NCT01744782|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
25149429|NCT05467670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25149430|NCT05467553|Tenofovir|tenofovir|mesh-list
25149431|NCT05467553|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25149432|NCT05467553|Antiviral Agents|antiviral agents|mesh-ancestor
25149433|NCT05467553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25149434|NCT05467553|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25873133|NCT00127972|Antiviral Agents|antiviral agents|mesh-ancestor
24916394|NCT04241458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24916395|NCT04241458|Anesthetics, General|anesthetics, general|mesh-ancestor
24916396|NCT04241458|Anesthetics|anesthetics|mesh-ancestor
24916397|NCT04241458|GABA Modulators|gaba modulators|mesh-ancestor
24916398|NCT04241458|GABA Agents|gaba agents|mesh-ancestor
24916399|NCT04241458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25109339|NCT03125772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25109340|NCT03125772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109341|NCT03125772|Tubulin Modulators|tubulin modulators|mesh-ancestor
24916444|NCT04240756|Adrenergic Agents|adrenergic agents|mesh-ancestor
24916445|NCT04240756|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25234333|NCT02572375|Autonomic Agents|autonomic agents|mesh-ancestor
24916482|NCT04240496|GABA Agents|gaba agents|mesh-ancestor
24916483|NCT04240535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24916484|NCT04240535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24819773|NCT02097173|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24819774|NCT02097173|Abortifacient Agents|abortifacient agents|mesh-ancestor
24819811|NCT02097329|Histamine Agents|histamine agents|mesh-ancestor
24819812|NCT02097329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24916496|NCT04239794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24916497|NCT04239794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916498|NCT04239794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24916499|NCT04239794|Anesthetics, General|anesthetics, general|mesh-ancestor
24916500|NCT04239794|Anesthetics|anesthetics|mesh-ancestor
24916501|NCT04239794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24916502|NCT04239794|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24916503|NCT04239833|Gefitinib|gefitinib|mesh-list
24916504|NCT04239833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491320|NCT00482079|Incretins|incretins|mesh-ancestor
24916568|NCT04238936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24916569|NCT04238936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24916570|NCT04238988|Paclitaxel|paclitaxel|mesh-list
24916571|NCT04238988|Carboplatin|carboplatin|mesh-list
24916572|NCT04238988|Pembrolizumab|pembrolizumab|mesh-list
24916573|NCT04238988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25234299|NCT02572492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234300|NCT02572492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234301|NCT02572492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25234302|NCT02572492|Alkylating Agents|alkylating agents|mesh-ancestor
25234303|NCT02572492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25234304|NCT02572492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25234305|NCT02572492|Immunologic Factors|immunologic factors|mesh-ancestor
25234306|NCT02572336|Plasminogen|plasminogen|mesh-list
25672337|NCT01744782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672338|NCT01744821|Vitamin D|vitamin d|mesh-list
25672339|NCT01744821|Cholecalciferol|cholecalciferol|mesh-list
25672340|NCT01744821|Vitamins|vitamins|mesh-ancestor
25672341|NCT01744821|Micronutrients|micronutrients|mesh-ancestor
25672342|NCT01744821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672343|NCT01744821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25672344|NCT01744821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25672345|NCT01745055|Methotrexate|methotrexate|mesh-list
25672346|NCT01745055|Tofacitinib|tofacitinib|mesh-list
25672347|NCT01745055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25873134|NCT00127972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25873135|NCT00127972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25873136|NCT00127972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25873137|NCT00127972|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25873138|NCT00127972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25873139|NCT00127972|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25873140|NCT00127972|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25873141|NCT00127972|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25149499|NCT05467189|Immunologic Factors|immunologic factors|mesh-ancestor
25149500|NCT05467189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149501|NCT05467189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25149502|NCT05467189|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25048302|NCT00713518|Ranibizumab|ranibizumab|mesh-list
25048303|NCT00713518|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25048304|NCT00713518|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25048305|NCT00713518|Growth Substances|growth substances|mesh-ancestor
25048306|NCT00713518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048309|NCT00713401|Esmolol|esmolol|mesh-list
24916574|NCT04238988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24916575|NCT04238988|Tubulin Modulators|tubulin modulators|mesh-ancestor
24916576|NCT04238988|Antimitotic Agents|antimitotic agents|mesh-ancestor
24916577|NCT04238988|Mitosis Modulators|mitosis modulators|mesh-ancestor
24916578|NCT04238988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916579|NCT04238988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24916589|NCT04239170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24916590|NCT04239170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916591|NCT04239170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24491448|NCT00482521|Growth Inhibitors|growth inhibitors|mesh-ancestor
24491449|NCT00482521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873142|NCT00127972|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24916657|NCT04238208|Capsaicin|capsaicin|mesh-list
24916658|NCT04238208|Anesthetics, Local|anesthetics, local|mesh-ancestor
24916659|NCT04238208|Anesthetics|anesthetics|mesh-ancestor
24916691|NCT04238195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24916694|NCT04238195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24916695|NCT04238195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916696|NCT04238195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917048|NCT04234607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917050|NCT04234516|Buprenorphine|buprenorphine|mesh-list
24616264|NCT01035450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24616265|NCT01035450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24819858|NCT02097407|Anesthetics|anesthetics|mesh-ancestor
24819859|NCT02097407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24819860|NCT02097407|Analgesics|analgesics|mesh-ancestor
24819861|NCT02097407|Sensory System Agents|sensory system agents|mesh-ancestor
24819862|NCT02097407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234307|NCT02572336|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25234308|NCT02572336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25234309|NCT02572336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25234310|NCT02572336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234311|NCT02572375|Phenylpropanolamine|phenylpropanolamine|mesh-list
25234313|NCT02572375|Guaifenesin|guaifenesin|mesh-list
25234314|NCT02572375|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
25234315|NCT02572375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25234316|NCT02572375|Narcotics|narcotics|mesh-ancestor
25234317|NCT02572375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25234318|NCT02572375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234319|NCT02572375|Analgesics|analgesics|mesh-ancestor
25234320|NCT02572375|Sensory System Agents|sensory system agents|mesh-ancestor
25234321|NCT02572375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25672348|NCT01745055|Abortifacient Agents|abortifacient agents|mesh-ancestor
25672349|NCT01745055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25672350|NCT01745055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672351|NCT01745055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25672352|NCT01745055|Antimetabolites|antimetabolites|mesh-ancestor
25672353|NCT01745055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672354|NCT01745055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672355|NCT01745055|Dermatologic Agents|dermatologic agents|mesh-ancestor
25672356|NCT01745055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672357|NCT01745055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25672358|NCT01745055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25873143|NCT00127972|Antimetabolites|antimetabolites|mesh-ancestor
25873144|NCT00127985|Prednisolone|prednisolone|mesh-list
25873145|NCT00127985|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25873146|NCT00127985|Methylprednisolone|methylprednisolone|mesh-list
25873147|NCT00127985|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25873148|NCT00127985|Prednisolone acetate|prednisolone acetate|mesh-list
25873149|NCT00127985|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24767479|NCT01801046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508701|NCT00556465|Antiviral Agents|antiviral agents|mesh-ancestor
24508702|NCT00556465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24508703|NCT00556465|Expectorants|expectorants|mesh-ancestor
25149660|NCT05466279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25149661|NCT05466279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25149662|NCT05466279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149663|NCT05466279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25149664|NCT05466279|Anesthetics, General|anesthetics, general|mesh-ancestor
25149666|NCT05466279|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25149667|NCT05466279|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25149668|NCT05466279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25149669|NCT05466279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25149670|NCT05466279|GABA Modulators|gaba modulators|mesh-ancestor
25149671|NCT05466279|GABA Agents|gaba agents|mesh-ancestor
25234322|NCT02572375|Antitussive Agents|antitussive agents|mesh-ancestor
25234323|NCT02572375|Respiratory System Agents|respiratory system agents|mesh-ancestor
25234324|NCT02572375|Expectorants|expectorants|mesh-ancestor
25234325|NCT02572375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25234326|NCT02572375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25234327|NCT02572375|Adrenergic Agents|adrenergic agents|mesh-ancestor
25234328|NCT02572375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25873150|NCT00127985|Prednisolone phosphate|prednisolone phosphate|mesh-list
24847321|NCT02246049|Vitamin B Complex|vitamin b complex|mesh-ancestor
24847323|NCT02246049|Micronutrients|micronutrients|mesh-ancestor
24847324|NCT02246127|Everolimus|everolimus|mesh-list
24847325|NCT02246127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24847326|NCT02246127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24847327|NCT02246127|Immunologic Factors|immunologic factors|mesh-ancestor
25064016|NCT03463733|Temozolomide|temozolomide|mesh-list
24819863|NCT02097407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24819864|NCT02097407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24917080|NCT04233996|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24917081|NCT04233996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819879|NCT02097459|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24819880|NCT02097459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24819881|NCT02097459|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24819882|NCT02097459|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24819883|NCT02097459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819884|NCT02097459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819885|NCT02097511|Metoprolol|metoprolol|mesh-list
24819886|NCT02097511|Sarpogrelate|sarpogrelate|mesh-list
24819887|NCT02097511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24819888|NCT02097511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24819889|NCT02097511|Sympatholytics|sympatholytics|mesh-ancestor
24819890|NCT02097511|Autonomic Agents|autonomic agents|mesh-ancestor
24492259|NCT00485810|Olanzapine|olanzapine|mesh-list
24917438|NCT04230070|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24917439|NCT04230070|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24917471|NCT04229212|Cimetidine|cimetidine|mesh-list
24917472|NCT04229212|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24917473|NCT04229212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24917474|NCT04229212|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24917475|NCT04229212|Histamine Antagonists|histamine antagonists|mesh-ancestor
24917476|NCT04229212|Histamine Agents|histamine agents|mesh-ancestor
24917477|NCT04229212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24917478|NCT04229212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917479|NCT04229212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917480|NCT04229212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24917481|NCT04229212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24917482|NCT04229212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672359|NCT01745055|Immunologic Factors|immunologic factors|mesh-ancestor
25672360|NCT01745055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25672361|NCT01745055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25672362|NCT01745055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25672363|NCT01745094|Solifenacin Succinate|solifenacin succinate|mesh-list
25672364|NCT01745094|Mirabegron|mirabegron|mesh-list
25672365|NCT01745094|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25672366|NCT01745094|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25672367|NCT01745094|Cholinergic Agents|cholinergic agents|mesh-ancestor
25672368|NCT01745094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25672369|NCT01745094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672370|NCT01745094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672371|NCT01745094|Urological Agents|urological agents|mesh-ancestor
25672372|NCT01745094|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24917483|NCT04229264|Apixaban|apixaban|mesh-list
25149725|NCT05465733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149727|NCT05465733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25149739|NCT05465304|Azithromycin|azithromycin|mesh-list
25149740|NCT05465304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25149741|NCT05465304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25149742|NCT05464836|Venetoclax|venetoclax|mesh-list
25149743|NCT05464836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508713|NCT00556608|Hylan|hylan|mesh-list
24917484|NCT04229264|Clopidogrel|clopidogrel|mesh-list
24492326|NCT00485888|Serotonin Agents|serotonin agents|mesh-ancestor
25873151|NCT00127985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25873152|NCT00127985|Glucocorticoids|glucocorticoids|mesh-ancestor
25873153|NCT00127985|Hormones|hormones|mesh-ancestor
25234329|NCT02572375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234330|NCT02572375|Appetite Depressants|appetite depressants|mesh-ancestor
25234331|NCT02572375|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25234334|NCT02572375|Nasal Decongestants|nasal decongestants|mesh-ancestor
25234335|NCT02572375|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25234336|NCT02572089|Naloxone|naloxone|mesh-list
25234337|NCT02572089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25234338|NCT02572089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234339|NCT02572089|Sensory System Agents|sensory system agents|mesh-ancestor
25234340|NCT02572089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234341|NCT02571842|Prednisolone|prednisolone|mesh-list
25234342|NCT02571842|Rituximab|rituximab|mesh-list
24956515|NCT03853785|Dermatologic Agents|dermatologic agents|mesh-ancestor
25234343|NCT02571842|Enalapril|enalapril|mesh-list
24847334|NCT02246179|Anesthetics, Local|anesthetics, local|mesh-ancestor
24975849|NCT02824575|Paclitaxel|paclitaxel|mesh-list
24917516|NCT04229602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24917517|NCT04229602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917518|NCT04229602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24917519|NCT04229602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917520|NCT04229602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24917521|NCT04229602|Antidepressive Agents|antidepressive agents|mesh-ancestor
24917522|NCT04229602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24492410|NCT00486174|Methylene Blue|methylene blue|mesh-list
24917596|NCT04227990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917598|NCT04227886|Irinotecan|irinotecan|mesh-list
24917599|NCT04227886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24868297|NCT05157243|Nitazoxanide|nitazoxanide|mesh-list
24917952|NCT04224649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24918009|NCT04224441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24918010|NCT04224441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918011|NCT04224441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24918012|NCT04224441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24918013|NCT04224441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24918014|NCT04224441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24819939|NCT02097953|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24819940|NCT02097953|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24616318|NCT01035983|Frovatriptan|frovatriptan|mesh-list
24819973|NCT02098330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24579557|NCT00856063|Adrenergic Agents|adrenergic agents|mesh-ancestor
24579558|NCT00856063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24579559|NCT00856063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579561|NCT00856089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24579562|NCT00856089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24579563|NCT00856271|Losartan|losartan|mesh-list
24579564|NCT00856271|Olmesartan|olmesartan|mesh-list
24579565|NCT00856271|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24579566|NCT00856271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24579567|NCT00856271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24579568|NCT00856271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24579569|NCT00856271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25109363|NCT03125746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409698|NCT03358472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25672373|NCT01745094|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25672374|NCT01745094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25672375|NCT01745094|Adrenergic Agents|adrenergic agents|mesh-ancestor
25672376|NCT01745133|Calcitriol|calcitriol|mesh-list
25672377|NCT01745133|Clobetasol|clobetasol|mesh-list
25672378|NCT01745133|Calcipotriene|calcipotriene|mesh-list
25672379|NCT01745133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25672380|NCT01745133|Glucocorticoids|glucocorticoids|mesh-ancestor
25672381|NCT01745133|Hormones|hormones|mesh-ancestor
25674559|NCT01773993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25109368|NCT03125746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109370|NCT03125616|Immunologic Factors|immunologic factors|mesh-ancestor
25109371|NCT03125616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109372|NCT03125486|Belimumab|belimumab|mesh-list
25109373|NCT03125486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25109374|NCT03125486|Immunologic Factors|immunologic factors|mesh-ancestor
25109375|NCT03125486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109376|NCT03125473|Vaccines|vaccines|mesh-list
25109377|NCT03125473|Immunologic Factors|immunologic factors|mesh-ancestor
25109378|NCT03125473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109379|NCT03125187|Heparin|heparin|mesh-list
25109380|NCT03125187|Calcium heparin|calcium heparin|mesh-list
25109381|NCT03125187|Anticoagulants|anticoagulants|mesh-ancestor
25109382|NCT03125187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25109383|NCT03125187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25234344|NCT02571842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25234345|NCT02571842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25234346|NCT02571842|Immunologic Factors|immunologic factors|mesh-ancestor
25234347|NCT02571842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234348|NCT02571842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25234349|NCT02571842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24847335|NCT02246179|Anesthetics|anesthetics|mesh-ancestor
24847336|NCT02246179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25154610|NCT05470465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25044537|NCT01083615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25044538|NCT01082549|Gemcitabine|gemcitabine|mesh-list
25044539|NCT01082549|Carboplatin|carboplatin|mesh-list
24956582|NCT03853200|Disinfectants|disinfectants|mesh-ancestor
25672382|NCT01745133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25672383|NCT01745133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672384|NCT01745133|Dermatologic Agents|dermatologic agents|mesh-ancestor
25672385|NCT01745133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25672386|NCT01745133|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25672387|NCT01745133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25672388|NCT01745133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672389|NCT01745133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25672390|NCT01745133|Vitamins|vitamins|mesh-ancestor
25150030|NCT05356104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25150031|NCT05356104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25150033|NCT05356104|Hormones|hormones|mesh-ancestor
25150034|NCT05356104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25048395|NCT00708292|Bortezomib|bortezomib|mesh-list
24708844|NCT01503242|Antibodies|antibodies|mesh-list
25234350|NCT02571842|Glucocorticoids|glucocorticoids|mesh-ancestor
25234351|NCT02571842|Hormones|hormones|mesh-ancestor
25234352|NCT02571842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25234353|NCT02571842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24956606|NCT03852914|Hyaluronic Acid|hyaluronic acid|mesh-list
25234354|NCT02571842|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25234355|NCT02571842|Protease Inhibitors|protease inhibitors|mesh-ancestor
25234356|NCT02571842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234357|NCT02571842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234358|NCT02571842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25234359|NCT02571959|Amoxicillin|amoxicillin|mesh-list
25234360|NCT02571959|Clavulanic Acids|clavulanic acids|mesh-list
25234361|NCT02571959|Clavulanic Acid|clavulanic acid|mesh-list
25234362|NCT02571959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25234363|NCT02571959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25234364|NCT02571959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234365|NCT02571959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234366|NCT02571959|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25234367|NCT02571712|Timolol|timolol|mesh-list
25234368|NCT02571712|Bimatoprost|bimatoprost|mesh-list
25234369|NCT02571712|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25234370|NCT02571712|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25234371|NCT02571712|Adrenergic Agents|adrenergic agents|mesh-ancestor
25234372|NCT02571712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25234373|NCT02571712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234374|NCT02571712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956630|NCT03852797|Oxytocics|oxytocics|mesh-ancestor
25078323|NCT03357718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25078324|NCT03357718|Anesthetics, General|anesthetics, general|mesh-ancestor
25234380|NCT02571881|Narcotics|narcotics|mesh-ancestor
25234381|NCT02571881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25234382|NCT02571881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234383|NCT02571881|Analgesics|analgesics|mesh-ancestor
25234384|NCT02571881|Sensory System Agents|sensory system agents|mesh-ancestor
25234385|NCT02571881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234386|NCT02571881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25273624|NCT02384343|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25409699|NCT03358472|Antimetabolites|antimetabolites|mesh-ancestor
25672391|NCT01745133|Micronutrients|micronutrients|mesh-ancestor
25672392|NCT01745133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25672393|NCT01745367|Paclitaxel|paclitaxel|mesh-list
25672394|NCT01745367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25672395|NCT01745367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672396|NCT01745367|Tubulin Modulators|tubulin modulators|mesh-ancestor
25672397|NCT01745367|Antimitotic Agents|antimitotic agents|mesh-ancestor
25672398|NCT01745367|Mitosis Modulators|mitosis modulators|mesh-ancestor
25672399|NCT01745367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672400|NCT01745380|Phenylephrine|phenylephrine|mesh-list
25672401|NCT01745380|Oxymetazoline|oxymetazoline|mesh-list
25672402|NCT01745380|Tetracaine|tetracaine|mesh-list
25672403|NCT01745380|Anesthetics, Local|anesthetics, local|mesh-ancestor
25672404|NCT01745380|Anesthetics|anesthetics|mesh-ancestor
25672405|NCT01745380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24997302|NCT05207644|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24997303|NCT05207644|Abortifacient Agents|abortifacient agents|mesh-ancestor
24997304|NCT05207644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24997305|NCT05207644|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24997306|NCT05207644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24997307|NCT05207644|Oxytocics|oxytocics|mesh-ancestor
25273625|NCT02384343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25109385|NCT03125213|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24819974|NCT02098330|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24918029|NCT04224103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24918031|NCT04224103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24918032|NCT04224103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918033|NCT04224103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24918034|NCT04224103|Respiratory System Agents|respiratory system agents|mesh-ancestor
24918035|NCT04224103|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24956641|NCT03852628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24956642|NCT03852628|Analgesics|analgesics|mesh-ancestor
24956643|NCT03852303|Ivermectin|ivermectin|mesh-list
24956644|NCT03852303|Anticonvulsants|anticonvulsants|mesh-list
24956645|NCT03852303|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24956646|NCT03852303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24918036|NCT04224103|Antioxidants|antioxidants|mesh-ancestor
24918037|NCT04224103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918038|NCT04224103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24918039|NCT04224103|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24918040|NCT04224103|Vasodilator Agents|vasodilator agents|mesh-ancestor
24918041|NCT04224103|Gasotransmitters|gasotransmitters|mesh-ancestor
24918042|NCT04224103|Protective Agents|protective agents|mesh-ancestor
24918043|NCT04224116|Tranexamic Acid|tranexamic acid|mesh-list
24918044|NCT04224116|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24918045|NCT04224116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24918046|NCT04224116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918047|NCT04224116|Hemostatics|hemostatics|mesh-ancestor
24918048|NCT04224116|Coagulants|coagulants|mesh-ancestor
24744615|NCT04224558|Anesthetics|anesthetics|mesh-ancestor
25876733|NCT02834013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24548569|NCT00710229|Growth Substances|growth substances|mesh-ancestor
25109394|NCT03124680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24918283|NCT04221321|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24918284|NCT04221321|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24918285|NCT04221321|Antimetabolites|antimetabolites|mesh-ancestor
24918286|NCT04221321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672406|NCT01745380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672407|NCT01745380|Sensory System Agents|sensory system agents|mesh-ancestor
25672408|NCT01745380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25672409|NCT01745380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25672410|NCT01745380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25672411|NCT01745380|Adrenergic Agents|adrenergic agents|mesh-ancestor
25672412|NCT01745380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25672413|NCT01745380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672414|NCT01745380|Sympathomimetics|sympathomimetics|mesh-ancestor
25672415|NCT01745380|Autonomic Agents|autonomic agents|mesh-ancestor
25672416|NCT01745380|Nasal Decongestants|nasal decongestants|mesh-ancestor
25672417|NCT01745380|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25672418|NCT01745380|Respiratory System Agents|respiratory system agents|mesh-ancestor
25672419|NCT01745380|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25876734|NCT02834013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876735|NCT02824523|Aspirin|aspirin|mesh-list
25150186|NCT05314569|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25150199|NCT05314569|Narcotics|narcotics|mesh-ancestor
24463021|NCT00358358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24956666|NCT03852407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24956667|NCT03852407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25234387|NCT02571608|Metformin|metformin|mesh-list
25234388|NCT02571608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25234389|NCT02571608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234390|NCT02571283|Epinephrine|epinephrine|mesh-list
25234391|NCT02571283|Bupivacaine|bupivacaine|mesh-list
25234392|NCT02571283|Anesthetics, Local|anesthetics, local|mesh-ancestor
25234393|NCT02571283|Anesthetics|anesthetics|mesh-ancestor
25234394|NCT02571283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25234395|NCT02571283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234396|NCT02571283|Sensory System Agents|sensory system agents|mesh-ancestor
25234397|NCT02571283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234398|NCT02571283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234399|NCT02571283|Autonomic Agents|autonomic agents|mesh-ancestor
25234400|NCT02571283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25234401|NCT02571283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24956668|NCT03852563|Petrolatum|petrolatum|mesh-list
24956669|NCT03852563|Emollients|emollients|mesh-ancestor
24956670|NCT03852563|Dermatologic Agents|dermatologic agents|mesh-ancestor
24956671|NCT03852251|Capecitabine|capecitabine|mesh-list
24956672|NCT03852251|Oxaliplatin|oxaliplatin|mesh-list
24956674|NCT03852251|Antimetabolites|antimetabolites|mesh-ancestor
25672420|NCT01745380|Mydriatics|mydriatics|mesh-ancestor
25672421|NCT01745380|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25672422|NCT01745380|Protective Agents|protective agents|mesh-ancestor
25672423|NCT01745822|Tenofovir|tenofovir|mesh-list
25672424|NCT01745822|Antiviral Agents|antiviral agents|mesh-ancestor
25672425|NCT01745822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25672426|NCT01745822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25672427|NCT01745822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25672428|NCT01745822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672429|NCT01745822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672430|NCT01745822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24508985|NCT00557934|Protective Agents|protective agents|mesh-ancestor
24509009|NCT00558077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24509010|NCT00558077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509011|NCT00558077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24509012|NCT00558077|Hormone Antagonists|hormone antagonists|mesh-ancestor
25154611|NCT05470465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154612|NCT05470465|Analgesics|analgesics|mesh-ancestor
25154613|NCT05470465|Sensory System Agents|sensory system agents|mesh-ancestor
25044541|NCT01082549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24918287|NCT04221321|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24918369|NCT04220476|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25234402|NCT02571283|Adrenergic Agents|adrenergic agents|mesh-ancestor
25234403|NCT02571283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25234404|NCT02571283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25234405|NCT02571283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25234409|NCT02571283|Sympathomimetics|sympathomimetics|mesh-ancestor
25234410|NCT02571283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25234411|NCT02571517|Methylprednisolone|methylprednisolone|mesh-list
25234412|NCT02571517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25234413|NCT02571517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25234414|NCT02571517|Prednisolone|prednisolone|mesh-list
25234415|NCT02571517|Prednisolone acetate|prednisolone acetate|mesh-list
25234416|NCT02571517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25234417|NCT02571517|Prednisolone phosphate|prednisolone phosphate|mesh-list
25234418|NCT02571517|Glucocorticoids|glucocorticoids|mesh-list
25234419|NCT02571517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25234420|NCT02571517|Antiemetics|antiemetics|mesh-ancestor
25234421|NCT02571517|Autonomic Agents|autonomic agents|mesh-ancestor
25234422|NCT02571517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234423|NCT02571517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234424|NCT02571517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25274036|NCT02381158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24956742|NCT03851731|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24956743|NCT03851731|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24956744|NCT03851731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956745|NCT03851731|Sensory System Agents|sensory system agents|mesh-ancestor
24956746|NCT03851731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234426|NCT02571517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25234427|NCT02571517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25234428|NCT02571517|Protective Agents|protective agents|mesh-ancestor
25234429|NCT02571517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25234430|NCT02571517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25234431|NCT02571556|Dexamethasone|dexamethasone|mesh-list
25234432|NCT02571556|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25234433|NCT02571556|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25234434|NCT02571556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25234435|NCT02571556|Antiemetics|antiemetics|mesh-ancestor
25234436|NCT02571556|Autonomic Agents|autonomic agents|mesh-ancestor
25234437|NCT02571556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234438|NCT02571556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044542|NCT01082549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25044543|NCT01082549|Antimetabolites|antimetabolites|mesh-ancestor
25044544|NCT01082549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044545|NCT01082549|Antiviral Agents|antiviral agents|mesh-ancestor
25672431|NCT01745822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25672432|NCT01746043|Minocycline|minocycline|mesh-list
25672433|NCT01746043|Modafinil|modafinil|mesh-list
25672434|NCT01746043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25672435|NCT01746043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25672436|NCT01746043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25672437|NCT01746043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225509|NCT02626845|Rituximab|rituximab|mesh-list
25672438|NCT01746043|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25672439|NCT01746043|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25672440|NCT01746043|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25150454|NCT05242081|Antidepressive Agents|antidepressive agents|mesh-ancestor
25150455|NCT05242081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25150459|NCT05238207|Psyllium|psyllium|mesh-list
25044546|NCT01082549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25044547|NCT01082549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044548|NCT01082549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25044549|NCT01082549|Immunologic Factors|immunologic factors|mesh-ancestor
25044550|NCT01082549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044551|NCT01082549|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25044553|NCT01082068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044554|NCT01082068|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24918370|NCT04220476|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24918371|NCT04220476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918372|NCT04220476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918373|NCT04220476|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24918374|NCT04220476|Hormone Antagonists|hormone antagonists|mesh-ancestor
24918375|NCT04220476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24918376|NCT04220476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918377|NCT04220476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24918412|NCT04219995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918413|NCT04219995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24918414|NCT04219995|Glucocorticoids|glucocorticoids|mesh-ancestor
24918416|NCT04219995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24918417|NCT04219995|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24918418|NCT04219995|Protective Agents|protective agents|mesh-ancestor
24918419|NCT04219995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24918420|NCT04219995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24918450|NCT04219579|Antithrombins|antithrombins|mesh-list
24918451|NCT04219579|Antithrombin III|antithrombin iii|mesh-list
24918454|NCT04219579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498268|NCT00513864|Narcotics|narcotics|mesh-ancestor
24918457|NCT04219553|Anti-Infective Agents|anti-infective agents|mesh-list
24918458|NCT04219553|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24918459|NCT04219124|Dapagliflozin|dapagliflozin|mesh-list
24918460|NCT04219124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
24918461|NCT04219124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918462|NCT04219124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24918463|NCT04219124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918464|NCT04219358|Imiquimod|imiquimod|mesh-list
24918465|NCT04219358|Sunscreening Agents|sunscreening agents|mesh-list
24918466|NCT04219358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24918467|NCT04219358|Immunologic Factors|immunologic factors|mesh-ancestor
25274037|NCT02381158|Glucocorticoids|glucocorticoids|mesh-ancestor
24956766|NCT03851341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24956767|NCT03851341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24956768|NCT03851341|Protease Inhibitors|protease inhibitors|mesh-ancestor
24956771|NCT03851172|Ketorolac|ketorolac|mesh-list
24918468|NCT04219358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918570|NCT04218552|Telmisartan|telmisartan|mesh-list
24918571|NCT04218552|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24918572|NCT04218552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24918795|NCT04216771|Cytarabine|cytarabine|mesh-list
24918796|NCT04216771|Idarubicin|idarubicin|mesh-list
24918797|NCT04216771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24918798|NCT04216771|Antimetabolites|antimetabolites|mesh-ancestor
25234439|NCT02571556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25234440|NCT02571556|Glucocorticoids|glucocorticoids|mesh-ancestor
25234441|NCT02571556|Hormones|hormones|mesh-ancestor
25234442|NCT02571556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25234443|NCT02571556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25234444|NCT02571556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25234445|NCT02571556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25234446|NCT02571426|Propofol|propofol|mesh-list
25234447|NCT02571426|Sevoflurane|sevoflurane|mesh-list
25234448|NCT02571426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25234449|NCT02571426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25234450|NCT02571426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234451|NCT02571426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25044555|NCT01082068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25044556|NCT01082068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672441|NCT01746043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672442|NCT01746095|Vancomycin|vancomycin|mesh-list
25672443|NCT01746095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25150558|NCT05171075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25150559|NCT05171075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150576|NCT05157867|Trypsin Inhibitors|trypsin inhibitors|mesh-list
25150577|NCT05157867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25150578|NCT05157867|Protease Inhibitors|protease inhibitors|mesh-ancestor
25150579|NCT05157867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591975|NCT00919880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24591976|NCT00919880|Carboplatin|carboplatin|mesh-list
24591977|NCT00919880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24591978|NCT00919880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591979|NCT00919880|Tubulin Modulators|tubulin modulators|mesh-ancestor
24591980|NCT00919880|Antimitotic Agents|antimitotic agents|mesh-ancestor
24591981|NCT00919880|Mitosis Modulators|mitosis modulators|mesh-ancestor
25044557|NCT01082068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044559|NCT01082068|Hormone Antagonists|hormone antagonists|mesh-ancestor
25044560|NCT01082068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25044561|NCT01082068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044562|NCT01081782|Ceralifimod|ceralifimod|mesh-list
24956823|NCT03850769|Mitosis Modulators|mitosis modulators|mesh-ancestor
24956824|NCT03850769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956825|NCT03850561|Ubiquinone|ubiquinone|mesh-list
24956826|NCT03850561|Coenzyme Q10|coenzyme q10|mesh-list
24956827|NCT03850561|Micronutrients|micronutrients|mesh-ancestor
25873154|NCT00127985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25044563|NCT01081782|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25044564|NCT01081782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918799|NCT04216771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918800|NCT04216771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24918801|NCT04216771|Antiviral Agents|antiviral agents|mesh-ancestor
24918802|NCT04216771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24918803|NCT04216771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24918804|NCT04216771|Immunologic Factors|immunologic factors|mesh-ancestor
25873155|NCT00127985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873156|NCT00127985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25873157|NCT00127985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873158|NCT00127985|Antiemetics|antiemetics|mesh-ancestor
25873159|NCT00127985|Autonomic Agents|autonomic agents|mesh-ancestor
25873160|NCT00127985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25873161|NCT00127985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25873162|NCT00127985|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25873163|NCT00127985|Protective Agents|protective agents|mesh-ancestor
25873164|NCT00127998|Artesunate|artesunate|mesh-list
25873165|NCT00127998|Chloroquine|chloroquine|mesh-list
25873166|NCT00127998|Lumefantrine|lumefantrine|mesh-list
25873167|NCT00127998|Pyrimethamine|pyrimethamine|mesh-list
25873168|NCT00127998|Artemether|artemether|mesh-list
24918949|NCT04215445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918950|NCT04215445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24918951|NCT04215445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918953|NCT04215432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24918954|NCT04215237|Atorvastatin|atorvastatin|mesh-list
24918955|NCT04215237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24918956|NCT04215237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24918957|NCT04215237|Antimetabolites|antimetabolites|mesh-ancestor
24918958|NCT04215237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493904|NCT00492934|Menotropins|menotropins|mesh-list
24919097|NCT04214145|Norepinephrine|norepinephrine|mesh-list
24919098|NCT04214145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24919099|NCT04214145|Mydriatics|mydriatics|mesh-ancestor
24919100|NCT04214145|Autonomic Agents|autonomic agents|mesh-ancestor
25672444|NCT01746095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25672445|NCT01746225|Paclitaxel|paclitaxel|mesh-list
25672446|NCT01746225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25672447|NCT01746225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672448|NCT01746225|Tubulin Modulators|tubulin modulators|mesh-ancestor
25672449|NCT01746225|Antimitotic Agents|antimitotic agents|mesh-ancestor
25672450|NCT01746225|Mitosis Modulators|mitosis modulators|mesh-ancestor
25672451|NCT01746225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672452|NCT01746264|Vitamin D|vitamin d|mesh-list
25672453|NCT01746264|Cholecalciferol|cholecalciferol|mesh-list
25672454|NCT01746264|Vitamins|vitamins|mesh-ancestor
25672455|NCT01746264|Micronutrients|micronutrients|mesh-ancestor
25672456|NCT01746264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672457|NCT01746264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25873169|NCT00127998|Sulfadoxine|sulfadoxine|mesh-list
25150694|NCT05104229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25150695|NCT05104229|Analgesics|analgesics|mesh-ancestor
25150696|NCT05104229|Sensory System Agents|sensory system agents|mesh-ancestor
24509019|NCT00558090|Morphine|morphine|mesh-list
24919101|NCT04214145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24956846|NCT03850587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24956865|NCT03849833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24919102|NCT04214145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919136|NCT04213924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919137|NCT04213924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24919139|NCT04213924|Analgesics|analgesics|mesh-ancestor
24919140|NCT04213924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24919141|NCT04213924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24919142|NCT04213924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24919143|NCT04213924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24919144|NCT04213937|Paclitaxel|paclitaxel|mesh-list
24919192|NCT04213833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24919193|NCT04213833|Adrenergic Agents|adrenergic agents|mesh-ancestor
24919194|NCT04213833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24919196|NCT04213781|Propofol|propofol|mesh-list
24919197|NCT04213781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24919198|NCT04213781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25234452|NCT02571426|Anesthetics, General|anesthetics, general|mesh-ancestor
25234453|NCT02571426|Anesthetics|anesthetics|mesh-ancestor
25234454|NCT02571426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25234455|NCT02571426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25234456|NCT02571361|Acetaminophen|acetaminophen|mesh-list
25234457|NCT02571361|Ibuprofen|ibuprofen|mesh-list
25234458|NCT02571361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25234459|NCT02571361|Analgesics|analgesics|mesh-ancestor
25234460|NCT02571361|Sensory System Agents|sensory system agents|mesh-ancestor
25234461|NCT02571361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234462|NCT02571361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234463|NCT02571361|Antipyretics|antipyretics|mesh-ancestor
25044565|NCT01081782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25044566|NCT01081782|Immunologic Factors|immunologic factors|mesh-ancestor
25044567|NCT01081782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154614|NCT05470465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25154615|NCT05470465|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25154616|NCT05470465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25064068|NCT03463317|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24919199|NCT04213781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919200|NCT04213781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24919201|NCT04213781|Anesthetics, General|anesthetics, general|mesh-ancestor
24919202|NCT04213781|Anesthetics|anesthetics|mesh-ancestor
24919203|NCT04213781|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24919204|NCT04213781|Narcotics|narcotics|mesh-ancestor
24494263|NCT00494598|Anesthetics|anesthetics|mesh-ancestor
24494265|NCT00494611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24619705|NCT01053403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24619781|NCT01053689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24920256|NCT04204044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25109402|NCT03124524|Estrogens|estrogens|mesh-ancestor
25109404|NCT03124524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25109405|NCT03124524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109406|NCT03124524|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25109407|NCT03124524|Contraceptive Agents|contraceptive agents|mesh-ancestor
25109408|NCT03124524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25109409|NCT03124524|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25109410|NCT03124524|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25109411|NCT03124524|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25109412|NCT03124524|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25109413|NCT03124524|Hormone Antagonists|hormone antagonists|mesh-ancestor
25109414|NCT03124524|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25109416|NCT03124524|Natriuretic Agents|natriuretic agents|mesh-ancestor
25109417|NCT03124524|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25109418|NCT03124524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25109419|NCT03124524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109420|NCT03124420|Amoxicillin|amoxicillin|mesh-list
25109421|NCT03124420|Clarithromycin|clarithromycin|mesh-list
25109422|NCT03124420|Lansoprazole|lansoprazole|mesh-list
25109423|NCT03124420|Dexlansoprazole|dexlansoprazole|mesh-list
25672458|NCT01746264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25672459|NCT01746420|Becaplermin|becaplermin|mesh-list
25672460|NCT01746420|Anticoagulants|anticoagulants|mesh-ancestor
25672461|NCT01746420|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
25150808|NCT05047952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25150809|NCT05047952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150810|NCT05047952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25150811|NCT05047952|Serotonin Agents|serotonin agents|mesh-ancestor
25150812|NCT05047952|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25150813|NCT05047952|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25150814|NCT05047952|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25150815|NCT05047952|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25150816|NCT05044637|Primaquine|primaquine|mesh-list
25150817|NCT05044637|Antimalarials|antimalarials|mesh-ancestor
25150818|NCT05044637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25150819|NCT05044637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25150820|NCT05044637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25150821|NCT05039593|Chlorhexidine|chlorhexidine|mesh-list
25109424|NCT03124420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25109425|NCT03124420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25109426|NCT03124420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25109427|NCT03124420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25109428|NCT03124420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109429|NCT03124420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25109430|NCT03124420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25109434|NCT03124082|Lidocaine|lidocaine|mesh-list
24920498|NCT04202224|Sensory System Agents|sensory system agents|mesh-ancestor
24920534|NCT04201990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24920535|NCT04201990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920537|NCT04201678|Anesthetics|anesthetics|mesh-list
24920748|NCT04198129|Antitubercular Agents|antitubercular agents|mesh-ancestor
24920749|NCT04198129|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24920750|NCT04198129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920751|NCT04198129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920752|NCT04198129|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24920753|NCT04198233|Diazepam|diazepam|mesh-list
24920754|NCT04198233|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24920755|NCT04198233|Anticonvulsants|anticonvulsants|mesh-ancestor
24920756|NCT04198233|Antiemetics|antiemetics|mesh-ancestor
24920757|NCT04198233|Autonomic Agents|autonomic agents|mesh-ancestor
24920758|NCT04198233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24920878|NCT04196998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24920879|NCT04196998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920880|NCT04196998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234464|NCT02571361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25234465|NCT02571361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25234466|NCT02571361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25234467|NCT02571361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25234468|NCT02571361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234469|NCT02571361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234470|NCT02571543|Ibuprofen|ibuprofen|mesh-list
25154618|NCT05470465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154619|NCT05470465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25154620|NCT05470465|Serotonin Agents|serotonin agents|mesh-ancestor
24920881|NCT04196998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24920882|NCT04196998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24920883|NCT04196621|Lubricant Eye Drops|lubricant eye drops|mesh-list
24920884|NCT04196621|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24920885|NCT04196621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24920886|NCT04196452|Ipilimumab|ipilimumab|mesh-list
24920887|NCT04196452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24920888|NCT04196452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24920889|NCT04196452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25672462|NCT01746420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25672463|NCT01746420|Growth Substances|growth substances|mesh-ancestor
25672464|NCT01746420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672465|NCT01746511|Glycerol|glycerol|mesh-list
25672466|NCT01746511|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25672467|NCT01746511|Protective Agents|protective agents|mesh-ancestor
25672468|NCT01746511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672469|NCT01746732|Moxifloxacin|moxifloxacin|mesh-list
25672470|NCT01746732|Evacetrapib|evacetrapib|mesh-list
25672471|NCT01746732|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25672472|NCT01746732|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25672473|NCT01746732|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25672474|NCT01746732|Antimetabolites|antimetabolites|mesh-ancestor
25672475|NCT01746732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150926|NCT04959825|Melatonin|melatonin|mesh-list
25150927|NCT04959825|Antioxidants|antioxidants|mesh-ancestor
25150928|NCT04959825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150929|NCT04959825|Protective Agents|protective agents|mesh-ancestor
25150930|NCT04959825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25150931|NCT04959825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25150932|NCT04953910|Decitabine|decitabine|mesh-list
25150933|NCT04953910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24920989|NCT04195243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24920990|NCT04195243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920991|NCT04195100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24920992|NCT04195100|Pilocarpine|pilocarpine|mesh-list
24920993|NCT04195100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24920994|NCT04195100|Miotics|miotics|mesh-ancestor
24920995|NCT04195100|Autonomic Agents|autonomic agents|mesh-ancestor
24920996|NCT04195100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24920997|NCT04195100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921053|NCT04194905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921054|NCT04194905|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24921055|NCT04194905|Contraceptive Agents|contraceptive agents|mesh-ancestor
24921056|NCT04194905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24921057|NCT04194905|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24921060|NCT04194905|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24921062|NCT04194658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921063|NCT04194658|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24921064|NCT04194658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24921065|NCT04194658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24745017|NCT04038502|Carboplatin|carboplatin|mesh-list
24745018|NCT04038502|Olaparib|olaparib|mesh-list
24745019|NCT04038502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745020|NCT04038502|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24745021|NCT04038502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24868436|NCT04774250|Zonisamide|zonisamide|mesh-list
24921073|NCT04194684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921075|NCT04194684|Antimitotic Agents|antimitotic agents|mesh-ancestor
24921076|NCT04194684|Mitosis Modulators|mitosis modulators|mesh-ancestor
24921144|NCT04193930|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24921145|NCT04193930|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24921146|NCT04193930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921147|NCT04193930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921148|NCT04193930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24921149|NCT04193930|Hormone Antagonists|hormone antagonists|mesh-ancestor
24921150|NCT04193930|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24921151|NCT04193930|Fertility Agents|fertility agents|mesh-ancestor
24921180|NCT04193852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921181|NCT04193852|Androgens|androgens|mesh-ancestor
24921182|NCT04193852|Anabolic Agents|anabolic agents|mesh-ancestor
24921183|NCT04193631|Cannabidiol|cannabidiol|mesh-list
24921184|NCT04193631|Anticonvulsants|anticonvulsants|mesh-ancestor
24921185|NCT04193592|Pirfenidone|pirfenidone|mesh-list
24921186|NCT04193592|Analgesics|analgesics|mesh-ancestor
24921187|NCT04193592|Sensory System Agents|sensory system agents|mesh-ancestor
24921188|NCT04193592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24921189|NCT04193592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921193|NCT04193592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24921205|NCT04193553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921206|NCT04193319|Fluconazole|fluconazole|mesh-list
24921207|NCT04193319|Antifungal Agents|antifungal agents|mesh-ancestor
24588520|NCT00902954|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24921208|NCT04193319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24921209|NCT04193319|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24921271|NCT04192916|Antithrombins|antithrombins|mesh-ancestor
24921272|NCT04192916|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25234471|NCT02571543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25274038|NCT02381158|Hormones|hormones|mesh-ancestor
25234472|NCT02571543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25234473|NCT02571543|Analgesics|analgesics|mesh-ancestor
25234474|NCT02571543|Sensory System Agents|sensory system agents|mesh-ancestor
25154621|NCT05470465|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25672476|NCT01746732|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25672477|NCT01746732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25672478|NCT01746732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25672479|NCT01746732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25672480|NCT01746732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25672481|NCT01746732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672482|NCT01746732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672483|NCT01746732|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25672484|NCT01746732|Contraceptive Agents|contraceptive agents|mesh-ancestor
24499520|NCT00519870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24499753|NCT00520949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24499754|NCT00520949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24535277|NCT00648921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24768466|NCT01808469|Antibodies|antibodies|mesh-list
25151054|NCT04910100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25151055|NCT04908371|Lidocaine|lidocaine|mesh-list
25154623|NCT05470465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25154624|NCT05470465|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25154625|NCT05470465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25154626|NCT05470465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921273|NCT04192916|Protease Inhibitors|protease inhibitors|mesh-ancestor
24921274|NCT04192916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921275|NCT04192916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921344|NCT04192656|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24921345|NCT04192656|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24921346|NCT04192656|Prednisolone|prednisolone|mesh-list
24921347|NCT04192656|Prednisolone acetate|prednisolone acetate|mesh-list
24921348|NCT04192656|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24921349|NCT04192656|Prednisolone phosphate|prednisolone phosphate|mesh-list
24921350|NCT04192656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24921351|NCT04192656|Antiemetics|antiemetics|mesh-ancestor
24921352|NCT04192656|Autonomic Agents|autonomic agents|mesh-ancestor
24921353|NCT04192656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24496682|NCT00506168|Capecitabine|capecitabine|mesh-list
24924001|NCT04164459|Latanoprost|latanoprost|mesh-list
25873170|NCT00127998|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24497055|NCT00507858|Hormones|hormones|mesh-ancestor
24921689|NCT04188184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24921690|NCT04188184|Autonomic Agents|autonomic agents|mesh-ancestor
24921691|NCT04188184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24921692|NCT04188184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24921693|NCT04188184|Respiratory System Agents|respiratory system agents|mesh-ancestor
24921695|NCT04188184|Sympathomimetics|sympathomimetics|mesh-ancestor
24921696|NCT04188184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24921697|NCT04188184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24921698|NCT04188184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24921832|NCT04186559|Vasodilator Agents|vasodilator agents|mesh-ancestor
24921833|NCT04186559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24921834|NCT04186559|Antioxidants|antioxidants|mesh-ancestor
24921835|NCT04186897|Salicylic Acid|salicylic acid|mesh-list
24921836|NCT04186897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24921837|NCT04186897|Antifungal Agents|antifungal agents|mesh-ancestor
24787403|NCT01925027|Sirolimus|sirolimus|mesh-list
24787404|NCT01925027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24787405|NCT01925027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24787406|NCT01925027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24787407|NCT01925027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787420|NCT01925092|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24922112|NCT04183491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922113|NCT04183491|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24922115|NCT04183361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24922116|NCT04183192|Reslizumab|reslizumab|mesh-list
24922117|NCT04183192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24922118|NCT04183192|Respiratory System Agents|respiratory system agents|mesh-ancestor
24922119|NCT04183322|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24922120|NCT04183322|Immunologic Factors|immunologic factors|mesh-ancestor
24922121|NCT04183322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922122|NCT04183387|Simvastatin|simvastatin|mesh-list
24922123|NCT04183387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24922124|NCT04183387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25234475|NCT02571543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234476|NCT02571543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234477|NCT02571543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25234478|NCT02571543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25234479|NCT02571543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25234480|NCT02571543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234481|NCT02571543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672485|NCT01746732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25672486|NCT01746732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672487|NCT01746732|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25672488|NCT01746732|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25672489|NCT01746732|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25672490|NCT01746901|Naltrexone|naltrexone|mesh-list
25672491|NCT01746901|Oxycodone|oxycodone|mesh-list
25151131|NCT04885686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151132|NCT04885686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25151133|NCT04885686|Glucocorticoids|glucocorticoids|mesh-ancestor
25151136|NCT04885686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25234482|NCT02571205|Testosterone|testosterone|mesh-list
24922125|NCT04183387|Antimetabolites|antimetabolites|mesh-ancestor
24957056|NCT03847922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957057|NCT03847922|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24957058|NCT03847922|Anesthetics, General|anesthetics, general|mesh-ancestor
24957059|NCT03847922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24957060|NCT03847922|Analgesics|analgesics|mesh-ancestor
24922126|NCT04183387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623962|NCT01074073|Adrenergic Agents|adrenergic agents|mesh-ancestor
24497634|NCT00510939|Bortezomib|bortezomib|mesh-list
24922196|NCT04182737|Immunologic Factors|immunologic factors|mesh-ancestor
24497714|NCT00511576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497715|NCT00511576|Tubulin Modulators|tubulin modulators|mesh-ancestor
24497716|NCT00511576|Antimitotic Agents|antimitotic agents|mesh-ancestor
25109455|NCT03124082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25109456|NCT03124082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25109457|NCT03124082|Narcotics|narcotics|mesh-ancestor
25109458|NCT03124082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25873171|NCT00127998|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25873172|NCT00127998|Amodiaquine|amodiaquine|mesh-list
24924002|NCT04164459|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25873173|NCT00127998|Mefloquine|mefloquine|mesh-list
25873174|NCT00127998|Antimalarials|antimalarials|mesh-ancestor
24922327|NCT04181749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24922328|NCT04181385|Bromocriptine|bromocriptine|mesh-list
24922329|NCT04181385|Olanzapine|olanzapine|mesh-list
24922330|NCT04181385|Antiemetics|antiemetics|mesh-ancestor
24922331|NCT04181385|Autonomic Agents|autonomic agents|mesh-ancestor
24922332|NCT04181385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24922333|NCT04181385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922334|NCT04181385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24922335|NCT04181385|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24922336|NCT04181385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24497812|NCT00511966|Rabeprazole|rabeprazole|mesh-list
24497880|NCT00512291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814555|NCT02065414|Chlorhexidine|chlorhexidine|mesh-list
25873175|NCT00127998|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25873176|NCT00127998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24922468|NCT04179604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24922469|NCT04179604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922470|NCT04179604|Protective Agents|protective agents|mesh-ancestor
24922471|NCT04179604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922472|NCT04179500|Moxifloxacin|moxifloxacin|mesh-list
24922473|NCT04179500|Pyrazinamide|pyrazinamide|mesh-list
24922474|NCT04179500|Bedaquiline|bedaquiline|mesh-list
25234483|NCT02571205|Androgens|androgens|mesh-ancestor
25234484|NCT02571205|Hormones|hormones|mesh-ancestor
25234485|NCT02571205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24624368|NCT01075880|Interferon beta-1a|interferon beta-1a|mesh-list
25064089|NCT03463317|Antipyretics|antipyretics|mesh-ancestor
24922475|NCT04179500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25109480|NCT03123770|Antimitotic Agents|antimitotic agents|mesh-ancestor
24922511|NCT04179071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25672492|NCT01746901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25672493|NCT01746901|Narcotics|narcotics|mesh-ancestor
25672494|NCT01746901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25672495|NCT01746901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672496|NCT01746901|Analgesics|analgesics|mesh-ancestor
25672497|NCT01746901|Sensory System Agents|sensory system agents|mesh-ancestor
25672498|NCT01746901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25672499|NCT01746901|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24922512|NCT04179071|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24498015|NCT00513032|Methylene Blue|methylene blue|mesh-list
24498039|NCT00513149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24498040|NCT00513149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25873177|NCT00127998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24997362|NCT05131828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997363|NCT05131828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24997364|NCT05101551|Gemcitabine|gemcitabine|mesh-list
24997366|NCT05101551|Talazoparib|talazoparib|mesh-list
24997367|NCT05101551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24498041|NCT00513149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24498042|NCT00513149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24922618|NCT04178200|Lidocaine|lidocaine|mesh-list
24922619|NCT04178200|Bupivacaine|bupivacaine|mesh-list
24922620|NCT04178200|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24922621|NCT04178200|Anesthetics, Local|anesthetics, local|mesh-ancestor
24922622|NCT04178200|Anesthetics|anesthetics|mesh-ancestor
24922623|NCT04178200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24922624|NCT04178200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498156|NCT00513383|Antimitotic Agents|antimitotic agents|mesh-ancestor
24498157|NCT00513383|Mitosis Modulators|mitosis modulators|mesh-ancestor
25234486|NCT02571205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234487|NCT02571296|Progesterone|progesterone|mesh-list
25234488|NCT02571296|Progestins|progestins|mesh-ancestor
25234489|NCT02571296|Hormones|hormones|mesh-ancestor
25234490|NCT02571296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25234491|NCT02571296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234492|NCT02571192|Volixibat|volixibat|mesh-list
25234493|NCT02571192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25234494|NCT02571400|Analgesics, Opioid|analgesics, opioid|mesh-list
25234495|NCT02571400|Analgesics|analgesics|mesh-list
25234496|NCT02571400|Narcotics|narcotics|mesh-ancestor
25234497|NCT02571400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25234498|NCT02571400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234499|NCT02571400|Sensory System Agents|sensory system agents|mesh-ancestor
25234500|NCT02571400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234501|NCT02571491|Ketamine|ketamine|mesh-list
25234502|NCT02571491|Morphine|morphine|mesh-list
25234503|NCT02571491|Remifentanil|remifentanil|mesh-list
25234504|NCT02571491|Analgesics|analgesics|mesh-ancestor
24957096|NCT03847558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24957098|NCT03847558|Androgens|androgens|mesh-ancestor
24957099|NCT03847363|Anesthetics|anesthetics|mesh-list
25234505|NCT02571491|Sensory System Agents|sensory system agents|mesh-ancestor
25234506|NCT02571491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234507|NCT02571491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234508|NCT02571491|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25234509|NCT02571491|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25234510|NCT02571491|Anesthetics, General|anesthetics, general|mesh-ancestor
25234511|NCT02571491|Anesthetics|anesthetics|mesh-ancestor
25234512|NCT02571491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25234513|NCT02571491|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24902247|NCT04376216|Prednisone|prednisone|mesh-list
24498169|NCT00513396|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24498171|NCT00513396|Antimetabolites|antimetabolites|mesh-ancestor
24498172|NCT00513396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498173|NCT00513396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25873178|NCT00127998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873179|NCT00127998|Antiviral Agents|antiviral agents|mesh-ancestor
25672500|NCT01746901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25672501|NCT01746940|Cocaine|cocaine|mesh-list
25672502|NCT01746940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25672503|NCT01746940|Anesthetics, Local|anesthetics, local|mesh-ancestor
25672504|NCT01746940|Anesthetics|anesthetics|mesh-ancestor
25672505|NCT01746940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25672506|NCT01746940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672507|NCT01746940|Sensory System Agents|sensory system agents|mesh-ancestor
25873180|NCT00127998|Schistosomicides|schistosomicides|mesh-ancestor
25873181|NCT00127998|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24976995|NCT04691856|Analgesics|analgesics|mesh-ancestor
25873182|NCT00127998|Anthelmintics|anthelmintics|mesh-ancestor
25873183|NCT00127998|Amebicides|amebicides|mesh-ancestor
25873184|NCT00127998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25873185|NCT00127998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25873186|NCT00127998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25873187|NCT00127998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873188|NCT00127998|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25151392|NCT04696042|Lanreotide|lanreotide|mesh-list
25151393|NCT04696042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25151394|NCT04693169|Choline|choline|mesh-list
25151395|NCT04693169|Lipotropic Agents|lipotropic agents|mesh-ancestor
25151396|NCT04693169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25151397|NCT04693169|Antimetabolites|antimetabolites|mesh-ancestor
25151398|NCT04693169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25151399|NCT04693169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25151400|NCT04693169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25151401|NCT04693169|Nootropic Agents|nootropic agents|mesh-ancestor
25151402|NCT04691817|Atezolizumab|atezolizumab|mesh-list
25151404|NCT04672382|Morphine|morphine|mesh-list
25873189|NCT00127998|Renal Agents|renal agents|mesh-ancestor
25873190|NCT00128037|Cisplatin|cisplatin|mesh-list
24498269|NCT00513864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24498270|NCT00513864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498302|NCT00513955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24498303|NCT00513955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24498304|NCT00513955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498305|NCT00513955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24498306|NCT00513955|Tubulin Modulators|tubulin modulators|mesh-ancestor
24498307|NCT00513955|Antimitotic Agents|antimitotic agents|mesh-ancestor
24498308|NCT00513955|Mitosis Modulators|mitosis modulators|mesh-ancestor
24498309|NCT00513955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24498310|NCT00513955|Glucocorticoids|glucocorticoids|mesh-ancestor
24886233|NCT02432378|Celecoxib|celecoxib|mesh-list
24463080|NCT00358566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463081|NCT00358566|Antiviral Agents|antiviral agents|mesh-ancestor
24463082|NCT00358566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24463083|NCT00358566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24463084|NCT00358566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24463085|NCT00358566|Immunologic Factors|immunologic factors|mesh-ancestor
24463086|NCT00358566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463087|NCT00358618|Propofol|propofol|mesh-list
24922790|NCT04177095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922791|NCT04177095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24922792|NCT04177095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922793|NCT04177095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24922794|NCT04177095|Immunologic Factors|immunologic factors|mesh-ancestor
24922795|NCT04177095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24922796|NCT04177095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24922797|NCT04177095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24922833|NCT04176367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873191|NCT00128037|Mitomycins|mitomycins|mesh-list
25873192|NCT00128037|Mitomycin|mitomycin|mesh-list
24922834|NCT04176367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922903|NCT04174937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24922905|NCT04175067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922906|NCT04175067|Protective Agents|protective agents|mesh-ancestor
24922907|NCT04175067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624132|NCT01074892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24500415|NCT00524186|Leucovorin|leucovorin|mesh-list
24624133|NCT01074892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922927|NCT04174872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922928|NCT04174872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24498563|NCT00515281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24498564|NCT00515281|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24923166|NCT04172064|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24923167|NCT04172064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24923168|NCT04172064|Adrenergic Agents|adrenergic agents|mesh-ancestor
24923169|NCT04172064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24923170|NCT04172064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923171|NCT04172064|Protective Agents|protective agents|mesh-ancestor
25672508|NCT01746940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25672509|NCT01746940|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25672510|NCT01746940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25672511|NCT01746940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25672512|NCT01746940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25672513|NCT01746940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672514|NCT01746940|Dopamine Agents|dopamine agents|mesh-ancestor
25672515|NCT01746940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25672516|NCT01746979|Gemcitabine|gemcitabine|mesh-list
25672517|NCT01746979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25873193|NCT00128037|Vindesine|vindesine|mesh-list
25873194|NCT00128037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25151585|NCT04575844|Liraglutide|liraglutide|mesh-list
25151586|NCT04575844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25151587|NCT04575844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151588|NCT04575844|Incretins|incretins|mesh-ancestor
25151589|NCT04575844|Hormones|hormones|mesh-ancestor
25151590|NCT04575844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25151593|NCT04562441|Avelumab|avelumab|mesh-list
25151597|NCT04562441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25151598|NCT04562441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25151599|NCT04562441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25151601|NCT04554888|Histamine|histamine|mesh-list
25151602|NCT04554888|Histamine Agonists|histamine agonists|mesh-ancestor
24787426|NCT01925092|Hormone Antagonists|hormone antagonists|mesh-ancestor
24787427|NCT01925092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25234514|NCT02571491|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25234515|NCT02571491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25234516|NCT02571491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234517|NCT02571491|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25234518|NCT02571491|Narcotics|narcotics|mesh-ancestor
25234519|NCT02571166|Valacyclovir|valacyclovir|mesh-list
24463093|NCT00358618|Anesthetics|anesthetics|mesh-ancestor
24847339|NCT02246179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24847340|NCT02246179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24787428|NCT01925092|Luteolytic Agents|luteolytic agents|mesh-ancestor
24787429|NCT01925092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24787430|NCT01925092|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24787433|NCT01925287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25109482|NCT03123770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25109483|NCT03123770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25109484|NCT03123770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25109485|NCT03123770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499196|NCT00518232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24499198|NCT00518245|Anticoagulants|anticoagulants|mesh-ancestor
24923623|NCT04168619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24923624|NCT04168619|Abortifacient Agents|abortifacient agents|mesh-ancestor
24923625|NCT04168619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24923626|NCT04168619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923627|NCT04168619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24923628|NCT04168619|Antimetabolites|antimetabolites|mesh-ancestor
24923629|NCT04168619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923630|NCT04168619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923631|NCT04168619|Dermatologic Agents|dermatologic agents|mesh-ancestor
24923632|NCT04168619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24923633|NCT04168619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24499208|NCT00518271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499258|NCT00518466|Adrenergic Agents|adrenergic agents|mesh-ancestor
24923785|NCT04167007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24923787|NCT04167007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923840|NCT04166578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923848|NCT04166565|Dexamethasone|dexamethasone|mesh-list
24923849|NCT04166565|Cyclophosphamide|cyclophosphamide|mesh-list
24923852|NCT04166565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24923853|NCT04166565|Immunologic Factors|immunologic factors|mesh-ancestor
25109486|NCT03123692|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
24923854|NCT04166565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923855|NCT04166565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24923856|NCT04166565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24923857|NCT04166565|Alkylating Agents|alkylating agents|mesh-ancestor
24923858|NCT04166565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923859|NCT04166565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25409776|NCT03349450|Alkylating Agents|alkylating agents|mesh-ancestor
25672518|NCT01746979|Antimetabolites|antimetabolites|mesh-ancestor
25672519|NCT01746979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672520|NCT01746979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672521|NCT01746979|Antiviral Agents|antiviral agents|mesh-ancestor
25672522|NCT01746979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25672523|NCT01746979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672524|NCT01746979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25672525|NCT01746979|Immunologic Factors|immunologic factors|mesh-ancestor
25672526|NCT01746979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672527|NCT01747330|Pancreatin|pancreatin|mesh-list
25672528|NCT01747330|Pancrelipase|pancrelipase|mesh-list
25672529|NCT01747330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25151774|NCT04484610|Narcotics|narcotics|mesh-ancestor
25151775|NCT04484610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25151776|NCT04484610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151777|NCT04484610|Analgesics|analgesics|mesh-ancestor
25151778|NCT04484610|Sensory System Agents|sensory system agents|mesh-ancestor
25151779|NCT04484610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25151780|NCT04462627|Antibodies|antibodies|mesh-list
25151816|NCT04428333|Fluorouracil|fluorouracil|mesh-list
25151817|NCT04428333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25151841|NCT04397484|Lidocaine|lidocaine|mesh-list
25151842|NCT04397484|Epinephrine|epinephrine|mesh-list
25151843|NCT04397484|Racepinephrine|racepinephrine|mesh-list
24923860|NCT04166565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24923861|NCT04166565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24923862|NCT04166565|Antiemetics|antiemetics|mesh-ancestor
24923863|NCT04166565|Autonomic Agents|autonomic agents|mesh-ancestor
24923864|NCT04166565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24923865|NCT04166565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24923866|NCT04166565|Glucocorticoids|glucocorticoids|mesh-ancestor
24923868|NCT04166565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24923869|NCT04166565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24923870|NCT04166006|Interleukin-2|interleukin-2|mesh-list
24923871|NCT04166006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923872|NCT04166006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24923873|NCT04166006|Analgesics|analgesics|mesh-ancestor
24923874|NCT04166006|Sensory System Agents|sensory system agents|mesh-ancestor
24923875|NCT04166006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24923876|NCT04166006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24747699|NCT03164889|Entecavir|entecavir|mesh-list
24923877|NCT04166253|Vitamin D|vitamin d|mesh-list
24624183|NCT01075022|Micronutrients|micronutrients|mesh-ancestor
24624184|NCT01075022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624185|NCT01075022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24624186|NCT01075022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24624203|NCT01075126|GABA Agents|gaba agents|mesh-ancestor
24624204|NCT01075126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24624205|NCT01075308|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
24624206|NCT01075308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24624210|NCT01075425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624211|NCT01075425|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24624212|NCT01075425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234520|NCT02571166|Antiviral Agents|antiviral agents|mesh-ancestor
25234521|NCT02571166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25234522|NCT02571179|Fentanyl|fentanyl|mesh-list
24847344|NCT02246179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847345|NCT02246179|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24847346|NCT02246179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24847347|NCT02246179|Adrenergic Agents|adrenergic agents|mesh-ancestor
24847348|NCT02246179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24847349|NCT02246179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24624213|NCT01075425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624214|NCT01075438|Vaccines|vaccines|mesh-list
24624215|NCT01075438|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24624216|NCT01075438|Immunologic Factors|immunologic factors|mesh-ancestor
24624217|NCT01075438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923911|NCT04165850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24923912|NCT04165850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24923913|NCT04165850|Analgesics|analgesics|mesh-ancestor
24923914|NCT04165850|Sensory System Agents|sensory system agents|mesh-ancestor
24923915|NCT04165850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25873195|NCT00128037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25873196|NCT00128037|Alkylating Agents|alkylating agents|mesh-ancestor
25672530|NCT01747499|Azacitidine|azacitidine|mesh-list
24839251|NCT02203175|Propofol|propofol|mesh-list
25672531|NCT01747499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25672532|NCT01747499|Antimetabolites|antimetabolites|mesh-ancestor
25672533|NCT01747499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672534|NCT01747499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672535|NCT01747499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672536|NCT01747551|Leucovorin|leucovorin|mesh-list
25672537|NCT01747551|Fluorouracil|fluorouracil|mesh-list
25672538|NCT01747551|Oxaliplatin|oxaliplatin|mesh-list
25672539|NCT01747551|Aflibercept|aflibercept|mesh-list
25672540|NCT01747551|Antimetabolites|antimetabolites|mesh-ancestor
25672541|NCT01747551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25151957|NCT04312503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25151958|NCT04312503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25151959|NCT04312503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25151960|NCT04312503|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25151964|NCT04310995|Nicorandil|nicorandil|mesh-list
24500307|NCT00523692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25152032|NCT04273776|Zolpidem|zolpidem|mesh-list
25873197|NCT00128037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873198|NCT00128037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25873199|NCT00128037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25873200|NCT00128037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24957106|NCT03847246|Entecavir|entecavir|mesh-list
24923916|NCT04165850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923917|NCT04165850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24923918|NCT04165850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24923919|NCT04165850|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24923920|NCT04165850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24923921|NCT04165850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24923922|NCT04165850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923923|NCT04165850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24923924|NCT04165850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24923953|NCT04165629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24923954|NCT04165629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24923955|NCT04165629|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24923956|NCT04165629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24923957|NCT04165629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923958|NCT04165629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24923959|NCT04165629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24923960|NCT04165629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24923962|NCT04165629|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24923963|NCT04165629|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24923964|NCT04165629|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25234523|NCT02571179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25234524|NCT02571179|Narcotics|narcotics|mesh-ancestor
25234525|NCT02571179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25234526|NCT02571179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234527|NCT02571179|Analgesics|analgesics|mesh-ancestor
25234528|NCT02571179|Sensory System Agents|sensory system agents|mesh-ancestor
25234529|NCT02571179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234530|NCT02571179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25234531|NCT02571179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25234532|NCT02571179|Anesthetics, General|anesthetics, general|mesh-ancestor
24923965|NCT04165629|Purinergic Agents|purinergic agents|mesh-ancestor
24923966|NCT04165629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24923967|NCT04165174|Apatinib|apatinib|mesh-list
24923983|NCT04164615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923984|NCT04164615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923985|NCT04164524|Gentamicins|gentamicins|mesh-list
24923986|NCT04164524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24923987|NCT04164524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24923988|NCT04164524|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24923989|NCT04164524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24923990|NCT04164524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923991|NCT04164797|Endostar protein|endostar protein|mesh-list
24923992|NCT04164797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24923993|NCT04164797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24923994|NCT04164797|Growth Substances|growth substances|mesh-ancestor
24923995|NCT04164797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923996|NCT04164797|Growth Inhibitors|growth inhibitors|mesh-ancestor
24923997|NCT04164797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923998|NCT04164745|Pembrolizumab|pembrolizumab|mesh-list
25672542|NCT01747551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25672543|NCT01747551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672544|NCT01747551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25672545|NCT01747551|Immunologic Factors|immunologic factors|mesh-ancestor
25672546|NCT01747551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672547|NCT01747551|Antidotes|antidotes|mesh-ancestor
25672548|NCT01747551|Protective Agents|protective agents|mesh-ancestor
25672549|NCT01747551|Vitamin B Complex|vitamin b complex|mesh-ancestor
25672550|NCT01747551|Vitamins|vitamins|mesh-ancestor
25672551|NCT01747551|Micronutrients|micronutrients|mesh-ancestor
25873202|NCT00128037|Antimitotic Agents|antimitotic agents|mesh-ancestor
25152247|NCT04168502|Gemtuzumab|gemtuzumab|mesh-list
25152248|NCT04168502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25152249|NCT04168502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25152250|NCT04167085|Doxycycline|doxycycline|mesh-list
25152251|NCT04167085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25152252|NCT04167085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24923999|NCT04164745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24745676|NCT03651102|Growth Inhibitors|growth inhibitors|mesh-ancestor
25873203|NCT00128037|Mitosis Modulators|mitosis modulators|mesh-ancestor
25873204|NCT00128154|Chromium|chromium|mesh-list
25873205|NCT00128154|Picolinic acid|picolinic acid|mesh-list
25873206|NCT00128154|Trace Elements|trace elements|mesh-ancestor
24924000|NCT04164745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924005|NCT04164719|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24924006|NCT04164719|Antidepressive Agents|antidepressive agents|mesh-ancestor
24924007|NCT04164719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24924008|NCT04164719|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24924009|NCT04164719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924010|NCT04164719|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24924011|NCT04164719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24924012|NCT04164719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24924013|NCT04164719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24924014|NCT04164693|Heparin|heparin|mesh-list
24924015|NCT04164693|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24924016|NCT04164693|Tinzaparin|tinzaparin|mesh-list
24924017|NCT04164693|Dalteparin|dalteparin|mesh-list
24924018|NCT04164693|Warfarin|warfarin|mesh-list
24924019|NCT04164693|Anticoagulants|anticoagulants|mesh-ancestor
24924020|NCT04164693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24924021|NCT04164693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24924022|NCT04164693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924023|NCT04164238|Paclitaxel|paclitaxel|mesh-list
24924024|NCT04164238|Carboplatin|carboplatin|mesh-list
24924025|NCT04164238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24924026|NCT04164238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924027|NCT04164238|Tubulin Modulators|tubulin modulators|mesh-ancestor
24924028|NCT04164238|Antimitotic Agents|antimitotic agents|mesh-ancestor
24924029|NCT04164238|Mitosis Modulators|mitosis modulators|mesh-ancestor
24924030|NCT04164238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234533|NCT02571179|Anesthetics|anesthetics|mesh-ancestor
25234534|NCT02570893|Paclitaxel|paclitaxel|mesh-list
25234535|NCT02570893|Carboplatin|carboplatin|mesh-list
25234536|NCT02570893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25064133|NCT03463070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24924031|NCT04164355|Tadalafil|tadalafil|mesh-list
24924032|NCT04164355|Vasodilator Agents|vasodilator agents|mesh-ancestor
24924033|NCT04164355|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24924034|NCT04164355|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24924035|NCT04164355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24868828|NCT02209545|Oxytocics|oxytocics|mesh-ancestor
24924076|NCT04163536|Hormones|hormones|mesh-ancestor
24500416|NCT00524186|Fluorouracil|fluorouracil|mesh-list
24924077|NCT04163536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24924078|NCT04163536|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24924079|NCT04163536|Protective Agents|protective agents|mesh-ancestor
24924080|NCT04163536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24924081|NCT04163536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672552|NCT01747551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25672553|NCT01747551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25672554|NCT01747551|Growth Substances|growth substances|mesh-ancestor
25672555|NCT01747551|Growth Inhibitors|growth inhibitors|mesh-ancestor
25672556|NCT01747629|Albuterol|albuterol|mesh-list
25672557|NCT01747629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25672558|NCT01747629|Autonomic Agents|autonomic agents|mesh-ancestor
25672559|NCT01747629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25672560|NCT01747629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672561|NCT01747629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25672562|NCT01747629|Respiratory System Agents|respiratory system agents|mesh-ancestor
25672563|NCT01747629|Tocolytic Agents|tocolytic agents|mesh-ancestor
25672564|NCT01747629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25672565|NCT01747629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25672566|NCT01747629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25672567|NCT01747629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25672568|NCT01747629|Adrenergic Agents|adrenergic agents|mesh-ancestor
24924082|NCT04163523|Zanubrutinib|zanubrutinib|mesh-list
24924083|NCT04163523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924084|NCT04163523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24924085|NCT04163523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924086|NCT04163523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924087|NCT04163419|Tanezumab|tanezumab|mesh-list
24924088|NCT04163419|Analgesics|analgesics|mesh-ancestor
24924089|NCT04163419|Sensory System Agents|sensory system agents|mesh-ancestor
24499701|NCT00520650|Aripiprazole|aripiprazole|mesh-list
24924174|NCT04162028|Analgesics|analgesics|mesh-ancestor
24924175|NCT04162028|Sensory System Agents|sensory system agents|mesh-ancestor
24924176|NCT04162028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24924216|NCT04161664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924217|NCT04161664|Tubulin Modulators|tubulin modulators|mesh-ancestor
25873207|NCT00128154|Micronutrients|micronutrients|mesh-ancestor
24499914|NCT00521521|Tubulin Modulators|tubulin modulators|mesh-ancestor
24924277|NCT04161274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24500005|NCT00522132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24500006|NCT00522132|Antiviral Agents|antiviral agents|mesh-ancestor
24500007|NCT00522132|Schistosomicides|schistosomicides|mesh-ancestor
24500008|NCT00522132|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25873208|NCT00128154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924469|NCT04159870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24924470|NCT04159870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24924471|NCT04159870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24924472|NCT04159870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24500192|NCT00523185|Autonomic Agents|autonomic agents|mesh-ancestor
24928039|NCT04126993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24500193|NCT00523185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24500194|NCT00523185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500220|NCT00523289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24500226|NCT00523354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24500227|NCT00523354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24500228|NCT00523380|Doxorubicin|doxorubicin|mesh-list
24500229|NCT00523380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24500230|NCT00523380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24500231|NCT00523380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24500244|NCT00523406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24500246|NCT00523432|Sirolimus|sirolimus|mesh-list
24500247|NCT00523432|Topotecan|topotecan|mesh-list
24500248|NCT00523432|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24500249|NCT00523432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24500250|NCT00523432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24500251|NCT00523432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500252|NCT00523432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25234537|NCT02570893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25234538|NCT02570893|Tubulin Modulators|tubulin modulators|mesh-ancestor
25234539|NCT02570893|Antimitotic Agents|antimitotic agents|mesh-ancestor
25234540|NCT02570893|Mitosis Modulators|mitosis modulators|mesh-ancestor
24839286|NCT02203253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25234541|NCT02570893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234542|NCT02570971|Mannitol|mannitol|mesh-list
25873209|NCT00128154|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24500253|NCT00523432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24500254|NCT00523432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24500255|NCT00523432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25873210|NCT00128154|Chelating Agents|chelating agents|mesh-ancestor
24924644|NCT04158102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24924645|NCT04158167|Oxytocin|oxytocin|mesh-list
24924646|NCT04158167|Oxytocics|oxytocics|mesh-ancestor
24924647|NCT04158167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24924648|NCT04158167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924649|NCT04158050|Omalizumab|omalizumab|mesh-list
24924650|NCT04158050|Antibodies|antibodies|mesh-list
24924651|NCT04158050|Immunologic Factors|immunologic factors|mesh-ancestor
24924652|NCT04158050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924653|NCT04158050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24924654|NCT04158050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24924655|NCT04158050|Respiratory System Agents|respiratory system agents|mesh-ancestor
24924656|NCT04158388|Tryptophan|tryptophan|mesh-list
24924657|NCT04158388|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24500419|NCT00524186|Calcium|calcium|mesh-list
24500420|NCT00524186|Levoleucovorin|levoleucovorin|mesh-list
24500421|NCT00524186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24500422|NCT00524186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500423|NCT00524186|Antimetabolites|antimetabolites|mesh-ancestor
25674560|NCT01773993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25674561|NCT01774149|Diazepam|diazepam|mesh-list
24509195|NCT00559312|Respiratory System Agents|respiratory system agents|mesh-ancestor
24623489|NCT01071772|Insulin|insulin|mesh-list
24816373|NCT02076685|Isoniazid|isoniazid|mesh-list
24816374|NCT02076685|Antitubercular Agents|antitubercular agents|mesh-ancestor
24493289|NCT00490308|Estrogens|estrogens|mesh-ancestor
24884898|NCT03277066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884899|NCT03277066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24884900|NCT03277066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24884901|NCT03277066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24463987|NCT00362921|Carmustine|carmustine|mesh-list
25152489|NCT04026880|Hormones|hormones|mesh-ancestor
25873211|NCT00128154|Sequestering Agents|sequestering agents|mesh-ancestor
25873212|NCT00128154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925170|NCT04153084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24925172|NCT04152655|Coenzyme Q10|coenzyme q10|mesh-list
24925173|NCT04152655|Idebenone|idebenone|mesh-list
24925174|NCT04152655|Micronutrients|micronutrients|mesh-ancestor
24925175|NCT04152655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925176|NCT04152655|Vitamins|vitamins|mesh-ancestor
24925177|NCT04152655|Antioxidants|antioxidants|mesh-ancestor
24500847|NCT00525967|Analgesics|analgesics|mesh-ancestor
24787486|NCT01925547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24787487|NCT01925547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24787488|NCT01925547|Analgesics|analgesics|mesh-ancestor
24787489|NCT01925547|Sensory System Agents|sensory system agents|mesh-ancestor
24787490|NCT01925547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24787491|NCT01925547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787492|NCT01925547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24787493|NCT01925547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24787494|NCT01925547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787495|NCT01925547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925719|NCT04148846|Analgesics|analgesics|mesh-ancestor
24925720|NCT04148846|Sensory System Agents|sensory system agents|mesh-ancestor
24925721|NCT04148846|Anticonvulsants|anticonvulsants|mesh-ancestor
24925722|NCT04148846|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24925723|NCT04148846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24925724|NCT04148846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24925725|NCT04148846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24410456|NCT00185419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24410457|NCT00185419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873213|NCT00128232|Octreotide|octreotide|mesh-list
24925768|NCT04148183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925769|NCT04147572|Tiotropium Bromide|tiotropium bromide|mesh-list
24925770|NCT04147572|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24925771|NCT04147572|Autonomic Agents|autonomic agents|mesh-ancestor
24925772|NCT04147572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25109492|NCT03123679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109493|NCT03123744|Palbociclib|palbociclib|mesh-list
25109494|NCT03123744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109495|NCT03123744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25109496|NCT03123744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25109497|NCT03123744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234543|NCT02570971|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25234544|NCT02570971|Diuretics|diuretics|mesh-ancestor
25234545|NCT02570971|Natriuretic Agents|natriuretic agents|mesh-ancestor
25672569|NCT01747629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25672570|NCT01747629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672571|NCT01747850|Ethanol|ethanol|mesh-list
25672572|NCT01747850|Nabiximols|nabiximols|mesh-list
25672573|NCT01747850|Dronabinol|dronabinol|mesh-list
25672574|NCT01747850|Cannabidiol|cannabidiol|mesh-list
25672575|NCT01747850|Peppermint oil|peppermint oil|mesh-list
25672576|NCT01747850|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25672577|NCT01747850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25672578|NCT01747850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25672579|NCT01747850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672580|NCT01747850|Anticonvulsants|anticonvulsants|mesh-ancestor
25873214|NCT00128232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25873215|NCT00128232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25873216|NCT00128232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873217|NCT00128245|Pimecrolimus|pimecrolimus|mesh-list
25873218|NCT00128245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25873219|NCT00128245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25873220|NCT00128245|Analgesics|analgesics|mesh-ancestor
25152679|NCT03878589|Oxytocics|oxytocics|mesh-ancestor
25152680|NCT03878589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25152681|NCT03878589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25152710|NCT03831932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25152711|NCT03831932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25152712|NCT03831932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25152713|NCT03813875|Fentanyl|fentanyl|mesh-list
25152714|NCT03813875|Midazolam|midazolam|mesh-list
25152715|NCT03813875|Alfentanil|alfentanil|mesh-list
25152716|NCT03813875|Propofol|propofol|mesh-list
25152717|NCT03813875|Sevoflurane|sevoflurane|mesh-list
25152718|NCT03813875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25109498|NCT03123718|Methotrexate|methotrexate|mesh-list
25109499|NCT03123718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25109500|NCT03123718|Abortifacient Agents|abortifacient agents|mesh-ancestor
25109501|NCT03123718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25109502|NCT03123718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873221|NCT00128245|Sensory System Agents|sensory system agents|mesh-ancestor
24925775|NCT04147572|Respiratory System Agents|respiratory system agents|mesh-ancestor
24925776|NCT04147572|Parasympatholytics|parasympatholytics|mesh-ancestor
25873222|NCT00128245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24624349|NCT01075802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24624350|NCT01075802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624351|NCT01075802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24624352|NCT01075802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624355|NCT01075802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24624357|NCT01075828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24624358|NCT01075828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624359|NCT01075841|Cetuximab|cetuximab|mesh-list
24624360|NCT01075841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24624361|NCT01075841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746023|NCT03456700|Sirolimus|sirolimus|mesh-list
25873223|NCT00128245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873224|NCT00128245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25873225|NCT00128245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25873226|NCT00128245|Dermatologic Agents|dermatologic agents|mesh-ancestor
24463188|NCT00359190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463189|NCT00359190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24463190|NCT00359190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24463191|NCT00359190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463192|NCT00359229|Zolpidem|zolpidem|mesh-list
25873227|NCT00128245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25873228|NCT00128245|Immunologic Factors|immunologic factors|mesh-ancestor
25873229|NCT00128245|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25873230|NCT00128245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24624362|NCT01075854|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24624363|NCT01075854|Hormones|hormones|mesh-ancestor
24624364|NCT01075854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24624365|NCT01075854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624366|NCT01075880|Interferons|interferons|mesh-list
24624367|NCT01075880|Interferon-beta|interferon-beta|mesh-list
24624370|NCT01075880|Antiviral Agents|antiviral agents|mesh-ancestor
24624371|NCT01075880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24624372|NCT01075880|Immunologic Factors|immunologic factors|mesh-ancestor
24624373|NCT01075880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624374|NCT01075880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24624375|NCT01075906|Colchicine|colchicine|mesh-list
24624376|NCT01075906|Gout Suppressants|gout suppressants|mesh-ancestor
24624377|NCT01075906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24624378|NCT01075906|Tubulin Modulators|tubulin modulators|mesh-ancestor
24624379|NCT01075906|Antimitotic Agents|antimitotic agents|mesh-ancestor
24624380|NCT01075906|Mitosis Modulators|mitosis modulators|mesh-ancestor
25672581|NCT01747850|Analgesics|analgesics|mesh-ancestor
25672582|NCT01747850|Sensory System Agents|sensory system agents|mesh-ancestor
25672583|NCT01747850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25672584|NCT01747850|Hallucinogens|hallucinogens|mesh-ancestor
25672585|NCT01747850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25672586|NCT01747850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25672587|NCT01747850|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25672588|NCT01747850|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25672589|NCT01747850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25672590|NCT01747850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672591|NCT01747850|Hormones|hormones|mesh-ancestor
25152822|NCT03786081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25152823|NCT03786081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25152824|NCT03786081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25152864|NCT03760575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25152881|NCT03748810|Metformin|metformin|mesh-list
25152882|NCT03748810|Dapagliflozin|dapagliflozin|mesh-list
25152883|NCT03748810|Empagliflozin|empagliflozin|mesh-list
25152884|NCT03748810|Glimepiride|glimepiride|mesh-list
25152886|NCT03748810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25152951|NCT03646058|Buprenorphine|buprenorphine|mesh-list
25152952|NCT03646058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25152953|NCT03646058|Narcotics|narcotics|mesh-ancestor
25152954|NCT03646058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25152955|NCT03646058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234546|NCT02570971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234547|NCT02571140|Teriparatide|teriparatide|mesh-list
25234548|NCT02571140|Parathyroid Hormone|parathyroid hormone|mesh-list
25234549|NCT02571140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25234550|NCT02571140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234551|NCT02571140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25234552|NCT02570841|Capsaicin|capsaicin|mesh-list
25234553|NCT02570841|Antipruritics|antipruritics|mesh-ancestor
25234554|NCT02570841|Dermatologic Agents|dermatologic agents|mesh-ancestor
25234555|NCT02570841|Sensory System Agents|sensory system agents|mesh-ancestor
25234556|NCT02570841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24847355|NCT02246179|Sympathomimetics|sympathomimetics|mesh-ancestor
24957123|NCT03847272|Hormones|hormones|mesh-ancestor
24847356|NCT02246179|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24847357|NCT02246179|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24624381|NCT01075906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926219|NCT04143685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24926220|NCT04143685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926221|NCT04143685|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24926223|NCT04143685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24926224|NCT04143685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24926225|NCT04143854|Botulinum Toxins|botulinum toxins|mesh-list
24926373|NCT04142762|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24926374|NCT04142762|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24926376|NCT04142749|Antiviral Agents|antiviral agents|mesh-ancestor
24926532|NCT04140513|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24926533|NCT04140513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926534|NCT04140513|Antimetabolites|antimetabolites|mesh-ancestor
24926535|NCT04140513|Antiviral Agents|antiviral agents|mesh-ancestor
24926536|NCT04140513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24926537|NCT04140461|Amphotericin B|amphotericin b|mesh-list
24926574|NCT04140006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24624403|NCT01076140|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24926752|NCT04138888|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25672592|NCT01747850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25672593|NCT01747850|Antiemetics|antiemetics|mesh-ancestor
25672594|NCT01747850|Autonomic Agents|autonomic agents|mesh-ancestor
25672595|NCT01747850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25672596|NCT01747850|Parasympatholytics|parasympatholytics|mesh-ancestor
25672597|NCT01747915|Pregabalin|pregabalin|mesh-list
25672598|NCT01747915|Analgesics|analgesics|mesh-ancestor
25672599|NCT01747915|Sensory System Agents|sensory system agents|mesh-ancestor
25672600|NCT01747915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25672601|NCT01747915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672602|NCT01747915|Anticonvulsants|anticonvulsants|mesh-ancestor
25672603|NCT01747915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25672604|NCT01747915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25672605|NCT01747915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672606|NCT01747915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25672607|NCT01747915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25672608|NCT01747915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24997629|NCT04550546|Ionophores|ionophores|mesh-ancestor
24997630|NCT04550546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24997631|NCT04550546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997632|NCT04546828|Gemcitabine|gemcitabine|mesh-list
24997633|NCT04546828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24997634|NCT04546828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25152997|NCT03583333|Linezolid|linezolid|mesh-list
24926753|NCT04138888|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24926756|NCT04138836|Esomeprazole|esomeprazole|mesh-list
24926757|NCT04138836|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24926826|NCT04138472|Anesthetics, General|anesthetics, general|mesh-ancestor
24926827|NCT04138264|Analgesics, Opioid|analgesics, opioid|mesh-list
24926828|NCT04138264|Narcotics|narcotics|mesh-ancestor
24926829|NCT04138264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24926830|NCT04138264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926831|NCT04138264|Analgesics|analgesics|mesh-ancestor
24926881|NCT04137640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926882|NCT04137640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24926883|NCT04137640|Tubulin Modulators|tubulin modulators|mesh-ancestor
24926884|NCT04137640|Antimitotic Agents|antimitotic agents|mesh-ancestor
24926885|NCT04137640|Mitosis Modulators|mitosis modulators|mesh-ancestor
24926886|NCT04137640|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24926887|NCT04137640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24926888|NCT04137640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24926889|NCT04137640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24926890|NCT04137640|Hormone Antagonists|hormone antagonists|mesh-ancestor
24926891|NCT04137640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24926892|NCT04137640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25873231|NCT00128245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873232|NCT00128271|Bavituximab|bavituximab|mesh-list
24926911|NCT04137653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24926912|NCT04137653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787498|NCT01925638|Antifungal Agents|antifungal agents|mesh-ancestor
24787499|NCT01925638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25234557|NCT02570841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234559|NCT02570789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25234560|NCT02570789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25234561|NCT02570789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25234562|NCT02570789|Growth Substances|growth substances|mesh-ancestor
25234563|NCT02570789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234564|NCT02570789|Growth Inhibitors|growth inhibitors|mesh-ancestor
25234565|NCT02570789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25234566|NCT02570789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24847358|NCT02246244|Citalopram|citalopram|mesh-list
24847359|NCT02246244|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24634937|NCT01136031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24634960|NCT01136252|Adalimumab|adalimumab|mesh-list
24483552|NCT00443963|Histamine Agents|histamine agents|mesh-ancestor
24787500|NCT01925638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24415207|NCT00199095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24787501|NCT01925638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24787502|NCT01925638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787503|NCT01925638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672609|NCT01747915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25672610|NCT01747915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25672611|NCT01748045|Nitric Oxide|nitric oxide|mesh-list
25672612|NCT01748045|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25672613|NCT01748045|Autonomic Agents|autonomic agents|mesh-ancestor
25672614|NCT01748045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25672615|NCT01748045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672616|NCT01748045|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25672617|NCT01748045|Respiratory System Agents|respiratory system agents|mesh-ancestor
25672618|NCT01748045|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25873233|NCT00128271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25873234|NCT00128271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873235|NCT00128297|Pamidronate|pamidronate|mesh-list
25873236|NCT00128297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25873237|NCT00128297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873238|NCT00128310|Gemcitabine|gemcitabine|mesh-list
25153098|NCT03502668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623046|NCT01069874|Vitamins|vitamins|mesh-ancestor
25153099|NCT03502668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25153100|NCT03502668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25153144|NCT03465787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25153145|NCT03465787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153146|NCT03465787|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25153147|NCT03465787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25153148|NCT03465787|Serotonin Agents|serotonin agents|mesh-ancestor
25153149|NCT03465787|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25153150|NCT03465787|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25153151|NCT03465787|Dopamine Agents|dopamine agents|mesh-ancestor
25153152|NCT03436992|Resveratrol|resveratrol|mesh-list
25153153|NCT03436992|Antioxidants|antioxidants|mesh-list
25153154|NCT03436992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153155|NCT03436992|Protective Agents|protective agents|mesh-ancestor
25153160|NCT03429946|Spironolactone|spironolactone|mesh-list
24787504|NCT01925638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24503144|NCT03126331|Nivolumab|nivolumab|mesh-list
24927357|NCT04134637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24927359|NCT04133571|Anesthetics, Local|anesthetics, local|mesh-ancestor
24927360|NCT04133571|Anesthetics|anesthetics|mesh-ancestor
24927361|NCT04133571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24927362|NCT04133571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927363|NCT04133571|Sensory System Agents|sensory system agents|mesh-ancestor
24927364|NCT04133571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24927365|NCT04133571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24503237|NCT02503839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24927657|NCT04131231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24927659|NCT04131231|Sensory System Agents|sensory system agents|mesh-ancestor
24927660|NCT04131231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24927661|NCT04131231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24927664|NCT04131231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24927666|NCT04131322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24927667|NCT04131322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24927668|NCT04131322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24927669|NCT04131335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24927670|NCT04131335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24927671|NCT04130698|Nicotine|nicotine|mesh-list
24927672|NCT04130698|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24927965|NCT04127721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24927967|NCT04127396|Lenvatinib|lenvatinib|mesh-list
24927968|NCT04127396|Chlorotrianisene|chlorotrianisene|mesh-list
24927969|NCT04127396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873239|NCT00128310|Vinorelbine|vinorelbine|mesh-list
24886338|NCT04527133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886355|NCT04526951|Aspirin|aspirin|mesh-list
24927970|NCT04127396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24927971|NCT04127396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927972|NCT04127396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927973|NCT04127396|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24927974|NCT04127396|Estrogens|estrogens|mesh-ancestor
24624640|NCT01077466|Immunologic Factors|immunologic factors|mesh-ancestor
24928036|NCT04126993|Apatinib|apatinib|mesh-list
24928037|NCT04126993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24928038|NCT04126993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25234575|NCT02570581|Alprazolam|alprazolam|mesh-list
25234576|NCT02570581|Zopiclone|zopiclone|mesh-list
25672619|NCT01748045|Antioxidants|antioxidants|mesh-ancestor
25672620|NCT01748045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672621|NCT01748045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25672622|NCT01748045|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25672623|NCT01748045|Vasodilator Agents|vasodilator agents|mesh-ancestor
25672624|NCT01748045|Gasotransmitters|gasotransmitters|mesh-ancestor
25672625|NCT01748045|Protective Agents|protective agents|mesh-ancestor
25672626|NCT01748240|Azacitidine|azacitidine|mesh-list
25672627|NCT01748240|Vorinostat|vorinostat|mesh-list
25672628|NCT01748240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25672629|NCT01748240|Antimetabolites|antimetabolites|mesh-ancestor
25672630|NCT01748240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672631|NCT01748240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672632|NCT01748240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672633|NCT01748240|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25672634|NCT01748292|Ranibizumab|ranibizumab|mesh-list
25234577|NCT02570581|Oxazepam|oxazepam|mesh-list
25672635|NCT01748292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25153255|NCT03370783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25153256|NCT03370783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25153257|NCT03370783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25153258|NCT03370783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153259|NCT03358693|Infliximab|infliximab|mesh-list
24935569|NCT04048889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935570|NCT04048889|Sensory System Agents|sensory system agents|mesh-ancestor
25234578|NCT02570581|Donepezil|donepezil|mesh-list
25234579|NCT02570581|Clopidogrel|clopidogrel|mesh-list
25234580|NCT02570581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25234581|NCT02570581|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25873240|NCT00128310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25873241|NCT00128310|Antimetabolites|antimetabolites|mesh-ancestor
25873242|NCT00128310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873243|NCT00128310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873244|NCT00128310|Antiviral Agents|antiviral agents|mesh-ancestor
25873245|NCT00128310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25873246|NCT00128310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24929372|NCT04113668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24929373|NCT04113668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929374|NCT04113668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24929375|NCT04113668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24929376|NCT04113668|Analgesics|analgesics|mesh-ancestor
24929377|NCT04113668|Sensory System Agents|sensory system agents|mesh-ancestor
24929378|NCT04113668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24929379|NCT04113668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929380|NCT04113668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24929381|NCT04113668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24957185|NCT03846765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24929402|NCT04113226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24929403|NCT04113226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929404|NCT04113226|Immunologic Factors|immunologic factors|mesh-ancestor
24929434|NCT04112550|Acetaminophen|acetaminophen|mesh-list
24929435|NCT04112550|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
24929436|NCT04112550|Oxycodone|oxycodone|mesh-list
24929437|NCT04112550|Methadone|methadone|mesh-list
24929438|NCT04112550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24929439|NCT04112550|Analgesics|analgesics|mesh-ancestor
25234582|NCT02570581|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25234583|NCT02570581|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25234584|NCT02570581|Purinergic Agents|purinergic agents|mesh-ancestor
25234585|NCT02570581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25234586|NCT02570581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234587|NCT02570581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234588|NCT02570581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25234589|NCT02570581|Analgesics|analgesics|mesh-ancestor
25234590|NCT02570581|Sensory System Agents|sensory system agents|mesh-ancestor
24847370|NCT02246595|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24847371|NCT02246595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24847372|NCT02246595|Immunologic Factors|immunologic factors|mesh-ancestor
24929440|NCT04112550|Sensory System Agents|sensory system agents|mesh-ancestor
24957219|NCT03846284|Magnesium Sulfate|magnesium sulfate|mesh-list
24410837|NCT00187070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746321|NCT05437783|Azithromycin|azithromycin|mesh-list
24746322|NCT05437783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24746323|NCT05437783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24746324|NCT05437718|Ropivacaine|ropivacaine|mesh-list
24746325|NCT05437718|Anesthetics, Local|anesthetics, local|mesh-ancestor
24929447|NCT04112550|Antitussive Agents|antitussive agents|mesh-ancestor
25672636|NCT01748292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25672637|NCT01748292|Growth Substances|growth substances|mesh-ancestor
25672638|NCT01748292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672639|NCT01748292|Growth Inhibitors|growth inhibitors|mesh-ancestor
25672640|NCT01748292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672641|NCT01748643|Glycopyrrolate|glycopyrrolate|mesh-list
25672642|NCT01748643|Rocuronium|rocuronium|mesh-list
25672643|NCT01748643|Neostigmine|neostigmine|mesh-list
25672644|NCT01748643|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25672645|NCT01748643|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25672646|NCT01748643|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25153330|NCT03250832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25153331|NCT03250832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25153332|NCT03250832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25153333|NCT03250832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25102910|NCT03165591|Vaccines|vaccines|mesh-list
25153334|NCT03250832|Growth Substances|growth substances|mesh-ancestor
25153335|NCT03250832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153336|NCT03250832|Growth Inhibitors|growth inhibitors|mesh-ancestor
25153337|NCT03245021|Rituximab|rituximab|mesh-list
25153338|NCT03245021|Nivolumab|nivolumab|mesh-list
25153339|NCT03245021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25153340|NCT03245021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25153341|NCT03245021|Immunologic Factors|immunologic factors|mesh-ancestor
25153342|NCT03245021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153343|NCT03245021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25153344|NCT03245021|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25153345|NCT03245021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153346|NCT03244176|Avelumab|avelumab|mesh-list
25153347|NCT03244176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25153348|NCT03244176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25153355|NCT03194867|Cemiplimab|cemiplimab|mesh-list
25153356|NCT03194867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25153357|NCT03194867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929448|NCT04112550|Respiratory System Agents|respiratory system agents|mesh-ancestor
24929449|NCT04112550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24929508|NCT04111328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24929509|NCT04111328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24929510|NCT04111328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929511|NCT04111328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24929512|NCT04111328|Analgesics|analgesics|mesh-ancestor
24929513|NCT04111328|Sensory System Agents|sensory system agents|mesh-ancestor
24929514|NCT04111328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24929515|NCT04111328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24929516|NCT04111328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24929517|NCT04111328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24929554|NCT04111848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24929555|NCT04111848|Anesthetics, General|anesthetics, general|mesh-ancestor
24929557|NCT04111848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24929592|NCT04110834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929594|NCT04110834|Hormone Antagonists|hormone antagonists|mesh-ancestor
25225676|NCT02625103|Serotonin Agents|serotonin agents|mesh-ancestor
24929595|NCT04110834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24929596|NCT04110834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929597|NCT04110834|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24957254|NCT03845699|Fentanyl|fentanyl|mesh-list
24929705|NCT04110288|Paclitaxel|paclitaxel|mesh-list
24929706|NCT04110288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24929707|NCT04110288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929719|NCT04110340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929720|NCT04110340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672647|NCT01748643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25672648|NCT01748643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672649|NCT01748643|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25672650|NCT01748643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672651|NCT01748643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672652|NCT01748643|Cholinergic Agents|cholinergic agents|mesh-ancestor
25672653|NCT01748643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25672654|NCT01748643|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25672655|NCT01748643|Autonomic Agents|autonomic agents|mesh-ancestor
25672656|NCT01748643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25672657|NCT01748643|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25672658|NCT01748643|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25672659|NCT01748799|Ethanol|ethanol|mesh-list
25672660|NCT01748799|Nabiximols|nabiximols|mesh-list
25672661|NCT01748799|Dronabinol|dronabinol|mesh-list
25672662|NCT01748799|Cannabidiol|cannabidiol|mesh-list
25672663|NCT01748799|Peppermint oil|peppermint oil|mesh-list
25672664|NCT01748799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25672665|NCT01748799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25672666|NCT01748799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25672667|NCT01748799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672668|NCT01748799|Anticonvulsants|anticonvulsants|mesh-ancestor
25672669|NCT01748799|Analgesics|analgesics|mesh-ancestor
25672670|NCT01748799|Sensory System Agents|sensory system agents|mesh-ancestor
25153402|NCT03126591|Olaratumab|olaratumab|mesh-list
24770030|NCT01817439|Amiodarone|amiodarone|mesh-list
24509283|NCT00559546|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24509284|NCT00559546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509285|NCT00559676|Leucovorin|leucovorin|mesh-list
24929721|NCT04110340|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24929722|NCT04110340|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24929723|NCT04110340|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24929724|NCT04110275|Plasminogen|plasminogen|mesh-list
24929725|NCT04110275|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24929726|NCT04110275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24929727|NCT04110275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24929728|NCT04110275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109525|NCT03123484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787540|NCT01925755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234591|NCT02570581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234592|NCT02570581|Antipyretics|antipyretics|mesh-ancestor
25234593|NCT02570581|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25234594|NCT02570581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234595|NCT02570581|Cholinergic Agents|cholinergic agents|mesh-ancestor
25234596|NCT02570581|Nootropic Agents|nootropic agents|mesh-ancestor
25234597|NCT02570581|Diuretics|diuretics|mesh-ancestor
25234598|NCT02570581|Natriuretic Agents|natriuretic agents|mesh-ancestor
24957267|NCT03845777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25873247|NCT00128310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25873248|NCT00128310|Immunologic Factors|immunologic factors|mesh-ancestor
24930567|NCT04100330|Immunologic Factors|immunologic factors|mesh-ancestor
25873249|NCT00128310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873250|NCT00128310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25873251|NCT00128310|Tubulin Modulators|tubulin modulators|mesh-ancestor
25873252|NCT00128310|Antimitotic Agents|antimitotic agents|mesh-ancestor
24787542|NCT01925755|Anticoagulants|anticoagulants|mesh-ancestor
25109527|NCT03123289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109528|NCT03123289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25672671|NCT01748799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25672672|NCT01748799|Hallucinogens|hallucinogens|mesh-ancestor
25672673|NCT01748799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25672674|NCT01748799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25672675|NCT01748799|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25672676|NCT01748799|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25672677|NCT01748799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25672678|NCT01748799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672679|NCT01748799|Hormones|hormones|mesh-ancestor
25672680|NCT01748799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25672681|NCT01748799|Antiemetics|antiemetics|mesh-ancestor
25873253|NCT00128310|Mitosis Modulators|mitosis modulators|mesh-ancestor
25109529|NCT03123445|Gemcitabine|gemcitabine|mesh-list
25109530|NCT03123445|Endostar protein|endostar protein|mesh-list
25109531|NCT03123445|Endostatins|endostatins|mesh-list
25109532|NCT03123445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873254|NCT00128323|Nystatin|nystatin|mesh-list
25873255|NCT00128323|Gentian Violet|gentian violet|mesh-list
25873256|NCT00128323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25873257|NCT00128323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25873258|NCT00128323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25873259|NCT00128323|Antifungal Agents|antifungal agents|mesh-ancestor
25873260|NCT00128323|Ionophores|ionophores|mesh-ancestor
25873261|NCT00128323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25873262|NCT00128323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873263|NCT00128323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25153549|NCT02863328|Empagliflozin|empagliflozin|mesh-list
25153550|NCT02863328|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25153551|NCT02863328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153552|NCT02863328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25153553|NCT02863328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153554|NCT02849080|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25153555|NCT02849080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25153556|NCT02849080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957300|NCT03845348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24957301|NCT03845322|Curcumin|curcumin|mesh-list
24957302|NCT03845322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25109533|NCT03123445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25109534|NCT03123445|Antimetabolites|antimetabolites|mesh-ancestor
25109535|NCT03123445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109536|NCT03123445|Antiviral Agents|antiviral agents|mesh-ancestor
25109537|NCT03123445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24746443|NCT05436522|Propofol|propofol|mesh-list
24746444|NCT05436522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24746445|NCT05436522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24929812|NCT04108468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24929813|NCT04108468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25234599|NCT02570581|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25234600|NCT02570581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25234601|NCT02570581|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25234602|NCT02570581|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25234603|NCT02570581|Dopamine Agents|dopamine agents|mesh-ancestor
25234604|NCT02570581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25234605|NCT02570581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25234606|NCT02570581|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25234607|NCT02570581|Protease Inhibitors|protease inhibitors|mesh-ancestor
25234608|NCT02570581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25234609|NCT02570581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25234610|NCT02570581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25234611|NCT02570581|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24957317|NCT03845179|Incretins|incretins|mesh-ancestor
24957318|NCT03845179|Hormones|hormones|mesh-ancestor
24957319|NCT03845179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24957320|NCT03845179|Protease Inhibitors|protease inhibitors|mesh-ancestor
24957349|NCT03844841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24957351|NCT03844984|Lidocaine|lidocaine|mesh-list
24575285|NCT00830505|Fluticasone|fluticasone|mesh-list
25234612|NCT02570581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25234613|NCT02570581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25234614|NCT02570581|GABA Modulators|gaba modulators|mesh-ancestor
25234615|NCT02570581|GABA Agents|gaba agents|mesh-ancestor
25234616|NCT02570191|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25234617|NCT02570191|Antiviral Agents|antiviral agents|mesh-ancestor
25234618|NCT02570191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25234619|NCT02570230|Ketamine|ketamine|mesh-list
25234620|NCT02570230|Analgesics|analgesics|mesh-ancestor
25234621|NCT02570230|Sensory System Agents|sensory system agents|mesh-ancestor
25234622|NCT02570230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234623|NCT02570230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929822|NCT04108637|Penicillins|penicillins|mesh-list
24929964|NCT04106752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24929965|NCT04106752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929966|NCT04106752|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24929967|NCT04106752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24930084|NCT04106297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24930085|NCT04105920|Hyaluronic Acid|hyaluronic acid|mesh-list
24930086|NCT04105920|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24930087|NCT04105920|Immunologic Factors|immunologic factors|mesh-ancestor
24860943|NCT02314182|Bevacizumab|bevacizumab|mesh-list
25672682|NCT01748799|Autonomic Agents|autonomic agents|mesh-ancestor
25672683|NCT01748799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25672684|NCT01748799|Parasympatholytics|parasympatholytics|mesh-ancestor
25672685|NCT01748825|Adavosertib|adavosertib|mesh-list
25672686|NCT01748825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672687|NCT01748825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672688|NCT01748942|Dexamethasone|dexamethasone|mesh-list
25672689|NCT01748942|Dexamethasone acetate|dexamethasone acetate|mesh-list
25672690|NCT01748942|Ichthammol|ichthammol|mesh-list
25672691|NCT01748942|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25153677|NCT02569645|Antimetabolites|antimetabolites|mesh-ancestor
25153678|NCT02569645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153679|NCT02569645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25153680|NCT02569645|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25153681|NCT02569645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25153682|NCT02521753|Metformin|metformin|mesh-list
25153683|NCT02521753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25153684|NCT02521753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153685|NCT02503774|Durvalumab|durvalumab|mesh-list
24624944|NCT01079455|Bupivacaine|bupivacaine|mesh-list
25234624|NCT02570230|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25234625|NCT02570230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25234626|NCT02570230|Anesthetics, General|anesthetics, general|mesh-ancestor
25234627|NCT02570230|Anesthetics|anesthetics|mesh-ancestor
25234628|NCT02570230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25234629|NCT02570230|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25234630|NCT02570230|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25234631|NCT02570230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25234632|NCT02570230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234633|NCT02570334|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25234634|NCT02570334|Antiviral Agents|antiviral agents|mesh-ancestor
25234635|NCT02570334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25234636|NCT02570243|Heparin|heparin|mesh-list
25234637|NCT02570243|Calcium heparin|calcium heparin|mesh-list
25234638|NCT02570243|Anticoagulants|anticoagulants|mesh-ancestor
25234639|NCT02570243|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25234640|NCT02570243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25234641|NCT02570243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234642|NCT02570347|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25234643|NCT02570347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25234644|NCT02570347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25234645|NCT02570347|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25873265|NCT00128414|Gout Suppressants|gout suppressants|mesh-ancestor
24930089|NCT04105920|Viscosupplements|viscosupplements|mesh-ancestor
24930090|NCT04105920|Protective Agents|protective agents|mesh-ancestor
24930091|NCT04105764|Bromides|bromides|mesh-list
24930228|NCT04103684|Protective Agents|protective agents|mesh-ancestor
24624829|NCT01078961|Bortezomib|bortezomib|mesh-list
24624830|NCT01078961|Sorafenib|sorafenib|mesh-list
24624831|NCT01078961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24631221|NCT01116583|Gabapentin|gabapentin|mesh-list
24631371|NCT01117220|Ziprasidone|ziprasidone|mesh-list
24624832|NCT01078961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24624833|NCT01078961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24624834|NCT01078961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624835|NCT01079013|Treosulfan|treosulfan|mesh-list
24624836|NCT01079013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24624837|NCT01079013|Alkylating Agents|alkylating agents|mesh-ancestor
24624838|NCT01079013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624839|NCT01079013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624840|NCT01079052|Famotidine|famotidine|mesh-list
24624841|NCT01079052|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24624842|NCT01079052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24624843|NCT01079052|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24624844|NCT01079052|Histamine Antagonists|histamine antagonists|mesh-ancestor
25672692|NCT01748942|BB 1101|bb 1101|mesh-list
25672693|NCT01748942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25672694|NCT01748942|Antiemetics|antiemetics|mesh-ancestor
25672695|NCT01748942|Autonomic Agents|autonomic agents|mesh-ancestor
25672696|NCT01748942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25672697|NCT01748942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672698|NCT01748942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25672699|NCT01748942|Glucocorticoids|glucocorticoids|mesh-ancestor
25672700|NCT01748942|Hormones|hormones|mesh-ancestor
25672701|NCT01748942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25873266|NCT00128414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25873267|NCT00128414|Tubulin Modulators|tubulin modulators|mesh-ancestor
25873268|NCT00128414|Antimitotic Agents|antimitotic agents|mesh-ancestor
25873269|NCT00128414|Mitosis Modulators|mitosis modulators|mesh-ancestor
25873270|NCT00128414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873271|NCT00128414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873272|NCT00128427|Colchicine|colchicine|mesh-list
25873273|NCT00128427|Gout Suppressants|gout suppressants|mesh-ancestor
25873274|NCT00128427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25153928|NCT02071862|Paclitaxel|paclitaxel|mesh-list
25153929|NCT02071862|Docetaxel|docetaxel|mesh-list
24997818|NCT04326439|Antiviral Agents|antiviral agents|mesh-ancestor
25153947|NCT02021474|Phenol|phenol|mesh-list
24624845|NCT01079052|Histamine Agents|histamine agents|mesh-ancestor
24624846|NCT01079052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24624847|NCT01079052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506303|NCT00544596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24506350|NCT00544791|Protective Agents|protective agents|mesh-ancestor
24930267|NCT04102878|Anesthetics, Local|anesthetics, local|mesh-list
24930268|NCT04102878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24930269|NCT04102878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930270|NCT04102878|Sensory System Agents|sensory system agents|mesh-ancestor
24930271|NCT04102878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24930272|NCT04102670|Hyaluronic Acid|hyaluronic acid|mesh-list
24930523|NCT04101019|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24930524|NCT04101019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24930527|NCT04100759|Sildenafil Citrate|sildenafil citrate|mesh-list
24930562|NCT04100330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930563|NCT04100330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24930565|NCT04100330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24930566|NCT04100330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24930598|NCT04100083|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24930688|NCT04098653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24930689|NCT04098653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24930690|NCT04098653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24930691|NCT04098653|Antimetabolites|antimetabolites|mesh-ancestor
24930727|NCT04097847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930729|NCT04097847|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24930730|NCT04097847|Protective Agents|protective agents|mesh-ancestor
25234646|NCT02570347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234647|NCT02570347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234648|NCT02569866|Cephalexin|cephalexin|mesh-list
25234649|NCT02569866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25234650|NCT02569866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25234651|NCT02570035|Mirabegron|mirabegron|mesh-list
25234652|NCT02570035|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25234653|NCT02570035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25234654|NCT02570035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25234655|NCT02570035|Adrenergic Agents|adrenergic agents|mesh-ancestor
25234656|NCT02570035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25234657|NCT02570035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930731|NCT04097847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930732|NCT04097847|Vasodilator Agents|vasodilator agents|mesh-ancestor
24930733|NCT04097847|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24930734|NCT04097847|Antioxidants|antioxidants|mesh-ancestor
24930735|NCT04097847|Vitamins|vitamins|mesh-ancestor
24787553|NCT01925859|Autonomic Agents|autonomic agents|mesh-ancestor
24787554|NCT01925859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24787555|NCT01925859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787556|NCT01925859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24787557|NCT01925859|Glucocorticoids|glucocorticoids|mesh-ancestor
24787558|NCT01925859|Hormones|hormones|mesh-ancestor
24787559|NCT01925859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24787560|NCT01925859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24787561|NCT01925859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787562|NCT01925859|Protease Inhibitors|protease inhibitors|mesh-ancestor
24787563|NCT01925859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787564|NCT01925859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672702|NCT01748942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25672703|NCT01748942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672704|NCT01748942|Protease Inhibitors|protease inhibitors|mesh-ancestor
25672705|NCT01748942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672706|NCT01748942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672707|NCT01748942|Dermatologic Agents|dermatologic agents|mesh-ancestor
25672708|NCT01748955|Bupropion|bupropion|mesh-list
25873276|NCT00128427|Antimitotic Agents|antimitotic agents|mesh-ancestor
25154070|NCT01651403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25154071|NCT01651403|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25154072|NCT01651403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25154073|NCT01651403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25154075|NCT01651403|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24787566|NCT01925898|Ketamine|ketamine|mesh-list
24787567|NCT01925898|Analgesics|analgesics|mesh-ancestor
24787568|NCT01925898|Sensory System Agents|sensory system agents|mesh-ancestor
24787569|NCT01925898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24787571|NCT01925898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24787572|NCT01925898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24787573|NCT01925898|Anesthetics, General|anesthetics, general|mesh-ancestor
24787574|NCT01925898|Anesthetics|anesthetics|mesh-ancestor
24787575|NCT01925898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24787576|NCT01925898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24787577|NCT01925898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24787578|NCT01925898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24930736|NCT04097847|Micronutrients|micronutrients|mesh-ancestor
24930737|NCT04097847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24930793|NCT04097288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24930794|NCT04097288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24930795|NCT04097288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930796|NCT04097288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24930797|NCT04097288|Serotonin Agents|serotonin agents|mesh-ancestor
24930798|NCT04097288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930799|NCT04097288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24930800|NCT04097288|Antidepressive Agents|antidepressive agents|mesh-ancestor
24930801|NCT04097288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24930802|NCT04097288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24930839|NCT04096742|Keratolytic Agents|keratolytic agents|mesh-ancestor
24930840|NCT04096742|Dermatologic Agents|dermatologic agents|mesh-ancestor
24624938|NCT01079364|Insulin Aspart|insulin aspart|mesh-list
24624939|NCT01079364|Insulin glulisine|insulin glulisine|mesh-list
24624940|NCT01079364|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24624941|NCT01079364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24624942|NCT01079364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624943|NCT01079455|Corticosterone|corticosterone|mesh-list
25109569|NCT03123016|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25109570|NCT03123016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234658|NCT02570035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234659|NCT02570035|Urological Agents|urological agents|mesh-ancestor
25273626|NCT02384343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273627|NCT02384343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25273628|NCT02384343|Analgesics|analgesics|mesh-ancestor
25273629|NCT02384343|Sensory System Agents|sensory system agents|mesh-ancestor
25273630|NCT02384343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25273631|NCT02384343|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25044586|NCT01076764|Antithrombins|antithrombins|mesh-ancestor
25044587|NCT01076764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25044588|NCT01076764|Protease Inhibitors|protease inhibitors|mesh-ancestor
25044589|NCT01076764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044590|NCT01074294|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
25044591|NCT01074294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044592|NCT01072981|Gemcitabine|gemcitabine|mesh-list
25044593|NCT01072981|Fluorouracil|fluorouracil|mesh-list
25044594|NCT01072981|Pancrelipase|pancrelipase|mesh-list
25044595|NCT01072981|Immunologic Factors|immunologic factors|mesh-list
25044596|NCT01072981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25109571|NCT03123016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109572|NCT03123107|Ascorbic Acid|ascorbic acid|mesh-list
24931075|NCT04093713|Nordefrin|nordefrin|mesh-list
24931076|NCT04093713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24931077|NCT04093648|Cyclophosphamide|cyclophosphamide|mesh-list
24931078|NCT04093648|Fludarabine|fludarabine|mesh-list
25672709|NCT01748955|Paroxetine|paroxetine|mesh-list
25672710|NCT01748955|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25672711|NCT01748955|Antidepressive Agents|antidepressive agents|mesh-ancestor
25672712|NCT01748955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25672713|NCT01748955|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25672714|NCT01748955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25672715|NCT01748955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24931148|NCT04092595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24931149|NCT04092595|Antimetabolites|antimetabolites|mesh-ancestor
24931150|NCT04092595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931151|NCT04092595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24931152|NCT04092595|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24931153|NCT04092595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24931154|NCT04092387|Nicotine|nicotine|mesh-list
24931155|NCT04092387|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24931156|NCT04092387|Autonomic Agents|autonomic agents|mesh-ancestor
24931157|NCT04092387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24931158|NCT04092387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931159|NCT04092387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24931663|NCT04086108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931664|NCT04086108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931665|NCT04086290|Androgens|androgens|mesh-list
24931666|NCT04086290|Hormones|hormones|mesh-ancestor
24931667|NCT04086290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24931668|NCT04086290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507974|NCT00553683|Poly ICLC|poly iclc|mesh-list
24931706|NCT04085913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931805|NCT04085094|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25873277|NCT00128427|Mitosis Modulators|mitosis modulators|mesh-ancestor
24931891|NCT04084912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24931975|NCT04083105|Anesthetics, General|anesthetics, general|mesh-ancestor
24931977|NCT04083105|GABA Modulators|gaba modulators|mesh-ancestor
24931978|NCT04083105|GABA Agents|gaba agents|mesh-ancestor
24931979|NCT04083105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24931980|NCT04083105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234660|NCT02569970|Fluoxetine|fluoxetine|mesh-list
25234661|NCT02569970|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25234662|NCT02569970|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25234663|NCT02569970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25234664|NCT02569970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672716|NCT01748955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672717|NCT01748955|Dopamine Agents|dopamine agents|mesh-ancestor
25672718|NCT01748955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25672719|NCT01748955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672720|NCT01748955|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25672721|NCT01748955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25672722|NCT01748955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672723|NCT01748955|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25672724|NCT01748955|Serotonin Agents|serotonin agents|mesh-ancestor
25672725|NCT01748994|Pioglitazone|pioglitazone|mesh-list
25672726|NCT01748994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25672727|NCT01748994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674562|NCT01774149|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25674563|NCT01774149|Anticonvulsants|anticonvulsants|mesh-ancestor
25674564|NCT01774149|Antiemetics|antiemetics|mesh-ancestor
25674565|NCT01774149|Autonomic Agents|autonomic agents|mesh-ancestor
25154387|NCT00606294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25154388|NCT00606294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24620586|NCT01057758|Antimetabolites|antimetabolites|mesh-ancestor
24884935|NCT03193333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24935753|NCT04047849|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25234665|NCT02569970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25234666|NCT02569970|Serotonin Agents|serotonin agents|mesh-ancestor
25234667|NCT02569970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234668|NCT02569970|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25234669|NCT02569970|Antidepressive Agents|antidepressive agents|mesh-ancestor
25234670|NCT02569970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25044597|NCT01072981|Antimetabolites|antimetabolites|mesh-ancestor
25044598|NCT01072981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044599|NCT01072981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044600|NCT01072981|Antiviral Agents|antiviral agents|mesh-ancestor
25044601|NCT01072981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25000951|NCT05462535|Losartan|losartan|mesh-list
25044602|NCT01072981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044603|NCT01072981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25044604|NCT01072981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064197|NCT03462329|Antimalarials|antimalarials|mesh-ancestor
24931981|NCT04083105|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24931982|NCT04083105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24931983|NCT04083105|Analgesics|analgesics|mesh-ancestor
25078405|NCT03356769|Anticonvulsants|anticonvulsants|mesh-list
25078406|NCT03356769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24931984|NCT04083105|Sensory System Agents|sensory system agents|mesh-ancestor
24931985|NCT04083105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24931986|NCT04083209|Analgesics, Opioid|analgesics, opioid|mesh-list
24931987|NCT04083209|Narcotics|narcotics|mesh-ancestor
24931988|NCT04083209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24931989|NCT04083209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931990|NCT04083209|Analgesics|analgesics|mesh-ancestor
24931992|NCT04083209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24931993|NCT04083066|Cytarabine|cytarabine|mesh-list
24931994|NCT04083066|Dexamethasone|dexamethasone|mesh-list
24931995|NCT04083066|Rituximab|rituximab|mesh-list
24931996|NCT04083066|Methotrexate|methotrexate|mesh-list
24931997|NCT04083066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24931998|NCT04083066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931999|NCT04083066|Immunologic Factors|immunologic factors|mesh-ancestor
24508303|NCT00555022|Bromides|bromides|mesh-list
24932195|NCT04082559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24932196|NCT04082559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24932197|NCT04082559|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24932198|NCT04082559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24932199|NCT04082559|Immunologic Factors|immunologic factors|mesh-ancestor
24932200|NCT04082559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932201|NCT04082286|Antibodies|antibodies|mesh-list
24932202|NCT04082286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24932203|NCT04082286|Immunologic Factors|immunologic factors|mesh-ancestor
24932204|NCT04082286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932205|NCT04082260|Alemtuzumab|alemtuzumab|mesh-list
24932206|NCT04082260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24932207|NCT04082260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24932208|NCT04081909|Fentanyl|fentanyl|mesh-list
25672728|NCT01749215|Topiramate|topiramate|mesh-list
25672729|NCT01749215|Anticonvulsants|anticonvulsants|mesh-ancestor
25672730|NCT01749215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25672731|NCT01749215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672732|NCT01749293|Cyclophosphamide|cyclophosphamide|mesh-list
25672733|NCT01749293|Busulfan|busulfan|mesh-list
25672734|NCT01749293|Fludarabine|fludarabine|mesh-list
25672735|NCT01749293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25672736|NCT01749293|Immunologic Factors|immunologic factors|mesh-ancestor
25672737|NCT01749293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672738|NCT01749293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25672739|NCT01749293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25672740|NCT01749293|Alkylating Agents|alkylating agents|mesh-ancestor
24997881|NCT04233047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24997882|NCT04233047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24997883|NCT04233047|Antiviral Agents|antiviral agents|mesh-ancestor
24997884|NCT04233047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24997885|NCT04233047|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24997886|NCT04233047|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24997887|NCT04233047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997897|NCT04188730|Lofexidine|lofexidine|mesh-list
24997898|NCT04188730|Clonidine|clonidine|mesh-list
24997899|NCT04188730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24997900|NCT04188730|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24997901|NCT04188730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502504|NCT05013892|Dopamine Agents|dopamine agents|mesh-ancestor
24932209|NCT04081909|Dexmedetomidine|dexmedetomidine|mesh-list
24932210|NCT04081909|Ketamine|ketamine|mesh-list
24932211|NCT04081909|Remifentanil|remifentanil|mesh-list
24787579|NCT01925898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787580|NCT01925898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24787581|NCT01925898|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24787582|NCT01925898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24746996|NCT02333292|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24746997|NCT02333292|Protease Inhibitors|protease inhibitors|mesh-ancestor
24746998|NCT02333292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24746999|NCT02333292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24747000|NCT02333292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24747001|NCT02333292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24787595|NCT01925911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24787596|NCT01925911|Anesthetics, General|anesthetics, general|mesh-ancestor
24787598|NCT01925911|GABA Modulators|gaba modulators|mesh-ancestor
24787599|NCT01925911|GABA Agents|gaba agents|mesh-ancestor
24787600|NCT01925911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24787601|NCT01925911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787602|NCT01925937|Ubiquinone|ubiquinone|mesh-list
24787603|NCT01925937|Coenzyme Q10|coenzyme q10|mesh-list
24787604|NCT01925937|Atorvastatin|atorvastatin|mesh-list
24787605|NCT01925937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25234671|NCT02569970|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25234672|NCT02569970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25234673|NCT02569970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234674|NCT02569905|Flurbiprofen|flurbiprofen|mesh-list
25234675|NCT02569905|Parecoxib|parecoxib|mesh-list
25234676|NCT02569905|Analgesics|analgesics|mesh-ancestor
25234677|NCT02569905|Sensory System Agents|sensory system agents|mesh-ancestor
25234678|NCT02569905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234679|NCT02569905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234680|NCT02569905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25044608|NCT01071902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25044609|NCT01071902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25044610|NCT01071902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25044611|NCT01071902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25044612|NCT01071902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044613|NCT01071902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044614|NCT01071902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904459|NCT04355637|Budesonide|budesonide|mesh-list
24787606|NCT01925937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24787607|NCT01925937|Antimetabolites|antimetabolites|mesh-ancestor
24787608|NCT01925937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109583|NCT03122782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25109584|NCT03122782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109585|NCT03122782|Hemostatics|hemostatics|mesh-ancestor
25109586|NCT03122782|Coagulants|coagulants|mesh-ancestor
25109587|NCT03122561|Acetaminophen|acetaminophen|mesh-list
25109608|NCT03122613|Curcumin|curcumin|mesh-list
25672741|NCT01749293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672742|NCT01749293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672743|NCT01749293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25672744|NCT01749410|Botulinum Toxins|botulinum toxins|mesh-list
25672745|NCT01749410|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25672746|NCT01749410|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25672747|NCT01749410|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25672748|NCT01749410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25672749|NCT01749410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672750|NCT01749410|Cholinergic Agents|cholinergic agents|mesh-ancestor
25672751|NCT01749410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25672752|NCT01749410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997999|NCT04038255|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24998000|NCT04038255|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24998001|NCT04038255|Cholinergic Agents|cholinergic agents|mesh-ancestor
24998003|NCT04038255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998004|NCT04010539|Azithromycin|azithromycin|mesh-list
24998005|NCT04010539|Ceftriaxone|ceftriaxone|mesh-list
24998006|NCT04010539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24998007|NCT04010539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24998019|NCT03944512|Pravastatin|pravastatin|mesh-list
24463262|NCT00359697|Mannitol|mannitol|mesh-list
25109609|NCT03122613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25109610|NCT03122613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25109611|NCT03122613|Analgesics|analgesics|mesh-ancestor
25109612|NCT03122613|Sensory System Agents|sensory system agents|mesh-ancestor
25109613|NCT03122613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25109614|NCT03122613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109615|NCT03122613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25109616|NCT03122613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25109617|NCT03122613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109618|NCT03122613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25109619|NCT03122613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109620|NCT03122756|Dexamethasone|dexamethasone|mesh-list
25109621|NCT03122756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25109622|NCT03122756|Antiemetics|antiemetics|mesh-ancestor
25109623|NCT03122756|Autonomic Agents|autonomic agents|mesh-ancestor
25109624|NCT03122756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24932386|NCT04080310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24932387|NCT04080869|Vitamin A|vitamin a|mesh-list
24932388|NCT04080869|Tretinoin|tretinoin|mesh-list
24932389|NCT04080869|Retinol palmitate|retinol palmitate|mesh-list
24932390|NCT04080869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873278|NCT00128427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932437|NCT04079725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932438|NCT04079725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24932441|NCT04079413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24932442|NCT04079413|Insulin Aspart|insulin aspart|mesh-list
24932443|NCT04079413|Insulin, Long-Acting|insulin, long-acting|mesh-list
24932444|NCT04079413|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24957557|NCT03843879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24957558|NCT03843879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957559|NCT03843879|Sensory System Agents|sensory system agents|mesh-ancestor
24957560|NCT03843879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24957561|NCT03843879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24957563|NCT03843879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24932445|NCT04079413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25234681|NCT02569905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25234682|NCT02569905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25234683|NCT02569905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25234684|NCT02569905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25234685|NCT02569905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234686|NCT02569905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234687|NCT02569905|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25234688|NCT02569814|Amlodipine|amlodipine|mesh-list
25234689|NCT02569814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25234690|NCT02569814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25234691|NCT02569814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24932446|NCT04079413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932447|NCT04079426|Dimercaprol|dimercaprol|mesh-list
24932448|NCT04079426|Chelating Agents|chelating agents|mesh-ancestor
25672753|NCT01749410|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25672754|NCT01749410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25672755|NCT01749501|Rocuronium|rocuronium|mesh-list
25672756|NCT01749501|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25672757|NCT01749501|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25672758|NCT01749501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25672759|NCT01749501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25672760|NCT01749501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672761|NCT01749605|Ciprofloxacin|ciprofloxacin|mesh-list
25672762|NCT01749605|Nitrofurantoin|nitrofurantoin|mesh-list
25672763|NCT01749605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24998079|NCT03841565|Dermatologic Agents|dermatologic agents|mesh-ancestor
24998080|NCT03780608|Durvalumab|durvalumab|mesh-list
24998081|NCT03780608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24998082|NCT03780608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998083|NCT03722849|Adenosine|adenosine|mesh-list
24998084|NCT03722849|Capsaicin|capsaicin|mesh-list
24998085|NCT03722849|Antipruritics|antipruritics|mesh-ancestor
24998086|NCT03722849|Dermatologic Agents|dermatologic agents|mesh-ancestor
24978284|NCT04939636|Cholecalciferol|cholecalciferol|mesh-list
24795390|NCT02807454|Daratumumab|daratumumab|mesh-list
24932477|NCT04079374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24932479|NCT04079374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24932480|NCT04079374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24932481|NCT04079374|Immunologic Factors|immunologic factors|mesh-ancestor
24932490|NCT04079088|(T,G)-A-L|(t,g)-a-l|mesh-list
25234751|NCT02569073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24625174|NCT01080729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24625175|NCT01080729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625176|NCT01080742|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24625178|NCT01080742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24625179|NCT01080742|Diuretics|diuretics|mesh-ancestor
24625180|NCT01080742|Natriuretic Agents|natriuretic agents|mesh-ancestor
24625181|NCT01080742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783465|NCT01902160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783466|NCT01902160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24475223|NCT00409461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24625182|NCT01080742|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24625183|NCT01080742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24625184|NCT01080742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625185|NCT01080742|Sympatholytics|sympatholytics|mesh-ancestor
24625186|NCT01080742|Autonomic Agents|autonomic agents|mesh-ancestor
24625187|NCT01080742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24625188|NCT01080742|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24625189|NCT01080742|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24625190|NCT01080742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24625191|NCT01080742|Adrenergic Agents|adrenergic agents|mesh-ancestor
24625192|NCT01080742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24814667|NCT02065947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24932772|NCT04077255|Antimitotic Agents|antimitotic agents|mesh-ancestor
24932773|NCT04077255|Mitosis Modulators|mitosis modulators|mesh-ancestor
24932774|NCT04077255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932775|NCT04077255|Immunologic Factors|immunologic factors|mesh-ancestor
24932776|NCT04077255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932778|NCT04077125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24932779|NCT04077125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24932780|NCT04077125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24932808|NCT04076826|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24932809|NCT04076826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24932810|NCT04076826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24932811|NCT04076826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24932812|NCT04076826|GABA Modulators|gaba modulators|mesh-ancestor
24932813|NCT04076826|GABA Agents|gaba agents|mesh-ancestor
24932814|NCT04076527|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24932815|NCT04076527|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24932816|NCT04076527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24932817|NCT04076371|Olanzapine|olanzapine|mesh-list
24932818|NCT04076371|Risperidone|risperidone|mesh-list
24932819|NCT04076371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24932820|NCT04076371|Ziprasidone|ziprasidone|mesh-list
24932821|NCT04076371|Sertraline|sertraline|mesh-list
24757239|NCT01738724|Hormones|hormones|mesh-ancestor
24932822|NCT04076371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25672764|NCT01749605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25672765|NCT01749605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25672766|NCT01749605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25672767|NCT01749605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672768|NCT01749605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672769|NCT01749605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672770|NCT01749605|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25672771|NCT01749605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25672772|NCT01749605|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25672773|NCT01749605|Renal Agents|renal agents|mesh-ancestor
24982231|NCT03445858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24982233|NCT03445858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24982234|NCT03445858|Antimetabolites|antimetabolites|mesh-ancestor
24982235|NCT03445858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982236|NCT03445858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24982316|NCT03117309|Nivolumab|nivolumab|mesh-list
24932823|NCT04076371|Serotonin Agents|serotonin agents|mesh-ancestor
25873279|NCT00128427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873280|NCT00128440|Tiotropium Bromide|tiotropium bromide|mesh-list
24932829|NCT04076371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24932866|NCT04075955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24932867|NCT04075955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24932868|NCT04075955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24932869|NCT04075955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24509231|NCT00559455|Leucovorin|leucovorin|mesh-list
24625272|NCT01081431|Growth Inhibitors|growth inhibitors|mesh-ancestor
24625273|NCT01081431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24625275|NCT01081535|Fentanyl|fentanyl|mesh-list
24625276|NCT01081535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24625277|NCT01081535|Narcotics|narcotics|mesh-ancestor
24625278|NCT01081535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25234692|NCT02569814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25234693|NCT02569814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625352|NCT01081847|Immunologic Factors|immunologic factors|mesh-ancestor
25154659|NCT05470270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25154660|NCT05470270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154661|NCT05470270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25154662|NCT05470244|Analgesics|analgesics|mesh-list
24933021|NCT04074564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24933022|NCT04074564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24933023|NCT04074564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625279|NCT01081535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509443|NCT00560300|Chelating Agents|chelating agents|mesh-ancestor
24933057|NCT04074213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24933059|NCT04074213|GABA Antagonists|gaba antagonists|mesh-ancestor
24933060|NCT04074213|GABA Agents|gaba agents|mesh-ancestor
24933061|NCT04073953|Primaquine|primaquine|mesh-list
24933062|NCT04073953|Antimalarials|antimalarials|mesh-ancestor
24933063|NCT04073953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24933064|NCT04073953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25234694|NCT02569814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25234695|NCT02569814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234696|NCT02569814|Vasodilator Agents|vasodilator agents|mesh-ancestor
24957713|NCT03842423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25234697|NCT02569814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25234698|NCT02569814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25234699|NCT02569814|Antimetabolites|antimetabolites|mesh-ancestor
25234700|NCT02569814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25234701|NCT02569814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25234702|NCT02569814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234703|NCT02569515|Epoetin Alfa|epoetin alfa|mesh-list
25234704|NCT02569515|Hematinics|hematinics|mesh-ancestor
25234705|NCT02569463|Aldesleukin|aldesleukin|mesh-list
25672774|NCT01749904|Timolol|timolol|mesh-list
25672775|NCT01749904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25672776|NCT01749904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25672777|NCT01749904|Adrenergic Agents|adrenergic agents|mesh-ancestor
25672778|NCT01749904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25672779|NCT01749904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672780|NCT01749904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672781|NCT01749904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25672782|NCT01749904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25873281|NCT00128440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25873282|NCT00128440|Autonomic Agents|autonomic agents|mesh-ancestor
25873283|NCT00128440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25873284|NCT00128440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873285|NCT00128440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25873286|NCT00128440|Respiratory System Agents|respiratory system agents|mesh-ancestor
25873287|NCT00128440|Parasympatholytics|parasympatholytics|mesh-ancestor
25234718|NCT02569502|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25234719|NCT02569502|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25154686|NCT05469984|Gentamicins|gentamicins|mesh-list
24625283|NCT01081535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24625284|NCT01081535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24625286|NCT01081535|Anesthetics|anesthetics|mesh-ancestor
24933166|NCT04073134|Antimetabolites|antimetabolites|mesh-ancestor
24933167|NCT04073134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933168|NCT04073134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24933170|NCT04074122|Isoproterenol|isoproterenol|mesh-list
24933171|NCT04074122|Epinephrine|epinephrine|mesh-list
24933172|NCT04074122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24933173|NCT04074122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24933174|NCT04074122|Adrenergic Agents|adrenergic agents|mesh-ancestor
24509585|NCT00561093|Vasodilator Agents|vasodilator agents|mesh-ancestor
24933263|NCT04072263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873288|NCT00128440|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25873289|NCT00128440|Cholinergic Agents|cholinergic agents|mesh-ancestor
25873290|NCT00128440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24933349|NCT04071639|Antidepressive Agents|antidepressive agents|mesh-ancestor
24933350|NCT04071639|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24933351|NCT04071639|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24933352|NCT04071639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24933353|NCT04071639|Antiemetics|antiemetics|mesh-ancestor
24933354|NCT04071639|Autonomic Agents|autonomic agents|mesh-ancestor
24933355|NCT04071639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24933356|NCT04071639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25234720|NCT02569502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234721|NCT02569502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25234722|NCT02569502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25234723|NCT02569502|Antiviral Agents|antiviral agents|mesh-ancestor
25234724|NCT02569502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25234725|NCT02569554|Rabeprazole|rabeprazole|mesh-list
25234726|NCT02569554|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25234727|NCT02569554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25234728|NCT02569554|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25234729|NCT02569554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234730|NCT02569554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234731|NCT02569346|Triumeq|triumeq|mesh-list
25234732|NCT02569346|Lamivudine|lamivudine|mesh-list
25234733|NCT02569346|Abacavir|abacavir|mesh-list
25234734|NCT02569346|Dolutegravir|dolutegravir|mesh-list
25234735|NCT02569346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25234736|NCT02569346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25234737|NCT02569346|Antiviral Agents|antiviral agents|mesh-ancestor
25234738|NCT02569346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25873291|NCT00128440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873292|NCT00128453|Colchicine|colchicine|mesh-list
25873293|NCT00128453|Gout Suppressants|gout suppressants|mesh-ancestor
25873294|NCT00128453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25873295|NCT00128453|Tubulin Modulators|tubulin modulators|mesh-ancestor
24446850|NCT00306267|Epoetin Alfa|epoetin alfa|mesh-list
25873296|NCT00128453|Antimitotic Agents|antimitotic agents|mesh-ancestor
25873297|NCT00128453|Mitosis Modulators|mitosis modulators|mesh-ancestor
24998191|NCT03442556|Carboplatin|carboplatin|mesh-list
24998192|NCT03442556|Docetaxel|docetaxel|mesh-list
24998193|NCT03442556|Rucaparib|rucaparib|mesh-list
24998194|NCT03442556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998195|NCT03442556|Tubulin Modulators|tubulin modulators|mesh-ancestor
24998196|NCT03442556|Antimitotic Agents|antimitotic agents|mesh-ancestor
24998197|NCT03442556|Mitosis Modulators|mitosis modulators|mesh-ancestor
24998198|NCT03442556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998199|NCT03442556|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24998200|NCT03442556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998201|NCT03434028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
24998202|NCT03430531|Lidocaine|lidocaine|mesh-list
24998203|NCT03430531|Anesthetics, Local|anesthetics, local|mesh-ancestor
24933357|NCT04071639|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24933389|NCT04071262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24933390|NCT04071262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933391|NCT04071262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933392|NCT04071262|Hormone Antagonists|hormone antagonists|mesh-ancestor
24957768|NCT03841747|Paclitaxel|paclitaxel|mesh-list
24933393|NCT04071262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24933394|NCT04071353|Interferons|interferons|mesh-list
24933395|NCT04071353|Ribavirin|ribavirin|mesh-list
24933396|NCT04071353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24933397|NCT04071353|Antiviral Agents|antiviral agents|mesh-ancestor
24933398|NCT04071353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24933399|NCT04071353|Antimetabolites|antimetabolites|mesh-ancestor
24747211|NCT01555541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621406|NCT01062152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24621407|NCT01062152|Growth Substances|growth substances|mesh-ancestor
24621408|NCT01062152|Growth Inhibitors|growth inhibitors|mesh-ancestor
24621409|NCT01062152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24621410|NCT01062191|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24621411|NCT01062191|Laxatives|laxatives|mesh-ancestor
24621412|NCT01062191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24621413|NCT01062204|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24621414|NCT01062204|Laxatives|laxatives|mesh-ancestor
24621415|NCT01062204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24621417|NCT01062282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24621418|NCT01062282|Vasodilator Agents|vasodilator agents|mesh-ancestor
24621419|NCT01062360|Aspirin|aspirin|mesh-list
24621420|NCT01062360|Pseudoephedrine|pseudoephedrine|mesh-list
24621421|NCT01062360|Ephedrine|ephedrine|mesh-list
24621422|NCT01062360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24621423|NCT01062360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24621424|NCT01062360|Analgesics|analgesics|mesh-ancestor
25234739|NCT02569346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25234740|NCT02569346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25234741|NCT02569346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234742|NCT02569346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234743|NCT02569346|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25234744|NCT02569346|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25234745|NCT02569307|Minocycline|minocycline|mesh-list
25234746|NCT02569307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25234747|NCT02569307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25234748|NCT02569073|Dronabinol|dronabinol|mesh-list
25234749|NCT02569073|Hallucinogens|hallucinogens|mesh-ancestor
25234750|NCT02569073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234752|NCT02569073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25234753|NCT02569073|Analgesics|analgesics|mesh-ancestor
25234754|NCT02569073|Sensory System Agents|sensory system agents|mesh-ancestor
25672783|NCT01749930|Timolol|timolol|mesh-list
25672784|NCT01749930|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25672785|NCT01749930|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25672786|NCT01749930|Adrenergic Agents|adrenergic agents|mesh-ancestor
25672787|NCT01749930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25672788|NCT01749930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672789|NCT01749930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672790|NCT01749930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25672791|NCT01749930|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25672792|NCT01749956|Leucovorin|leucovorin|mesh-list
25672793|NCT01749956|Fluorouracil|fluorouracil|mesh-list
25672794|NCT01749956|Oxaliplatin|oxaliplatin|mesh-list
25672795|NCT01749956|Aflibercept|aflibercept|mesh-list
25672796|NCT01749956|Antimetabolites|antimetabolites|mesh-ancestor
25674566|NCT01774149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25004585|NCT02786329|Sensory System Agents|sensory system agents|mesh-ancestor
25004586|NCT02786329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25004587|NCT02786329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25004588|NCT02786329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25004589|NCT02786329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25004590|NCT02786329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25004591|NCT02786329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004592|NCT02786329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25004593|NCT02786329|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25004594|NCT02786329|Anesthetics, General|anesthetics, general|mesh-ancestor
25004595|NCT02731352|Apatinib|apatinib|mesh-list
25004596|NCT02731352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24933638|NCT04068948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24933639|NCT04068948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24933640|NCT04068948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933641|NCT04068948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24933642|NCT04068948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24933643|NCT04068948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24933678|NCT04068506|Gabapentin|gabapentin|mesh-list
24933679|NCT04068506|Analgesics|analgesics|mesh-ancestor
24933680|NCT04068506|Sensory System Agents|sensory system agents|mesh-ancestor
24933681|NCT04068506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234757|NCT02569073|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25234758|NCT02569073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25234759|NCT02569073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234760|NCT02569073|Hormones|hormones|mesh-ancestor
25234761|NCT02569073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25234762|NCT02569320|Dexamethasone|dexamethasone|mesh-list
25234763|NCT02569320|Dexamethasone acetate|dexamethasone acetate|mesh-list
25234764|NCT02569320|Pomalidomide|pomalidomide|mesh-list
25234765|NCT02569320|Ichthammol|ichthammol|mesh-list
25234766|NCT02569320|BB 1101|bb 1101|mesh-list
25234767|NCT02569320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25234768|NCT02569320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25234769|NCT02569320|Antiemetics|antiemetics|mesh-ancestor
25234770|NCT02569320|Autonomic Agents|autonomic agents|mesh-ancestor
25234771|NCT02569320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234772|NCT02569320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234773|NCT02569320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25234774|NCT02569320|Glucocorticoids|glucocorticoids|mesh-ancestor
25234775|NCT02569320|Hormones|hormones|mesh-ancestor
24418087|NCT00208546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25234776|NCT02569320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24625351|NCT01081847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25672797|NCT01749956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852540|NCT02262715|Oseltamivir|oseltamivir|mesh-list
24847447|NCT02247128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847448|NCT02247128|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24847449|NCT02247128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24847450|NCT02247128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24847451|NCT02247128|Antipyretics|antipyretics|mesh-ancestor
24847452|NCT02247128|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24847453|NCT02247128|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24847454|NCT02247128|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25873298|NCT00128453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873299|NCT00128453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873300|NCT00128466|Gentamicins|gentamicins|mesh-list
25873301|NCT00128466|Streptomycin|streptomycin|mesh-list
24847461|NCT02247141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847462|NCT02247154|Immunoglobulins|immunoglobulins|mesh-list
24847463|NCT02247154|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24847464|NCT02247154|Antibodies|antibodies|mesh-list
24847465|NCT02247154|Immunologic Factors|immunologic factors|mesh-ancestor
24847466|NCT02247154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847467|NCT02247258|Azathioprine|azathioprine|mesh-list
24847468|NCT02247258|Antimetabolites|antimetabolites|mesh-ancestor
24847469|NCT02247258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948808|NCT05402189|Fentanyl|fentanyl|mesh-list
24933682|NCT04068506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933683|NCT04068506|Anticonvulsants|anticonvulsants|mesh-ancestor
24933684|NCT04068506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24933685|NCT04068506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24933686|NCT04068506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24933718|NCT04067817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24933719|NCT04067817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933720|NCT04067817|Sympathomimetics|sympathomimetics|mesh-ancestor
24933721|NCT04067817|Nasal Decongestants|nasal decongestants|mesh-ancestor
24933722|NCT04067817|Respiratory System Agents|respiratory system agents|mesh-ancestor
25234777|NCT02569320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25234778|NCT02569320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25234779|NCT02569320|Protease Inhibitors|protease inhibitors|mesh-ancestor
25234780|NCT02569320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234781|NCT02569320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234782|NCT02569320|Immunologic Factors|immunologic factors|mesh-ancestor
25234783|NCT02569320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25234784|NCT02569320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25234785|NCT02569320|Growth Substances|growth substances|mesh-ancestor
25234786|NCT02569320|Growth Inhibitors|growth inhibitors|mesh-ancestor
25234787|NCT02569320|Dermatologic Agents|dermatologic agents|mesh-ancestor
25234788|NCT02569125|Everolimus|everolimus|mesh-list
25234789|NCT02569125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25234790|NCT02569125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25234791|NCT02569125|Immunologic Factors|immunologic factors|mesh-ancestor
25234792|NCT02569125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234793|NCT02568995|Ketorolac|ketorolac|mesh-list
25234797|NCT02568995|Epinephryl borate|epinephryl borate|mesh-list
25234798|NCT02568995|Anesthetics, Local|anesthetics, local|mesh-ancestor
25234799|NCT02568995|Anesthetics|anesthetics|mesh-ancestor
25234800|NCT02568995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25234801|NCT02568995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234802|NCT02568995|Sensory System Agents|sensory system agents|mesh-ancestor
25234803|NCT02568995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234804|NCT02568995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25234805|NCT02568995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25234806|NCT02568995|Analgesics|analgesics|mesh-ancestor
25078420|NCT03356769|Antipyretics|antipyretics|mesh-ancestor
24847470|NCT02247258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24847471|NCT02247258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24847472|NCT02247258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24847473|NCT02247258|Immunologic Factors|immunologic factors|mesh-ancestor
24847474|NCT02247258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847475|NCT02247258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24847476|NCT02247310|Interferons|interferons|mesh-list
24847477|NCT02247310|Interferon-beta|interferon-beta|mesh-list
24933938|NCT04065906|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24933939|NCT04065906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933940|NCT04065906|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24933941|NCT04065906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25672798|NCT01749956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24933943|NCT04065906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625354|NCT01081847|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24625356|NCT01081847|Natriuretic Agents|natriuretic agents|mesh-ancestor
24625358|NCT01081938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24625359|NCT01081938|Insulin Glargine|insulin glargine|mesh-list
24625360|NCT01081938|Insulin glulisine|insulin glulisine|mesh-list
24625361|NCT01081938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24625362|NCT01081938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625363|NCT01081964|Levofloxacin|levofloxacin|mesh-list
24625364|NCT01081964|Ofloxacin|ofloxacin|mesh-list
24934089|NCT04063904|Oxytocics|oxytocics|mesh-ancestor
24934090|NCT04063904|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24934092|NCT04063904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24934133|NCT04063540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24934134|NCT04063540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934135|NCT04063540|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24934136|NCT04063540|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24934584|NCT04060381|Dopamine|dopamine|mesh-list
24934585|NCT04060381|Epinephrine|epinephrine|mesh-list
24934586|NCT04060381|Norepinephrine|norepinephrine|mesh-list
24934587|NCT04060381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24934588|NCT04060381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24934589|NCT04060381|Analgesics|analgesics|mesh-ancestor
24934590|NCT04060381|Sensory System Agents|sensory system agents|mesh-ancestor
24934591|NCT04060381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24934592|NCT04060381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511226|NCT00567866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24934874|NCT04057300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934875|NCT04057300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24934876|NCT04057300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24934877|NCT04057300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24934878|NCT04057300|Antipyretics|antipyretics|mesh-ancestor
24934879|NCT04057300|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24934880|NCT04057300|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24934881|NCT04057300|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24934882|NCT04057300|Purinergic Agents|purinergic agents|mesh-ancestor
24934883|NCT04057300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24934884|NCT04057326|Pancreatin|pancreatin|mesh-list
24934885|NCT04057326|Pancrelipase|pancrelipase|mesh-list
24934886|NCT04057326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24934887|NCT04057482|Dequalinium|dequalinium|mesh-list
24934888|NCT04057482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25234810|NCT02568995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234811|NCT02568995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234812|NCT02568995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25234813|NCT02568995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25234814|NCT02568995|Adrenergic Agents|adrenergic agents|mesh-ancestor
25234815|NCT02568995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24847478|NCT02247310|Interferon beta-1b|interferon beta-1b|mesh-list
24847479|NCT02247310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24847480|NCT02247310|Antiviral Agents|antiviral agents|mesh-ancestor
24847481|NCT02247310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24847482|NCT02247310|Immunologic Factors|immunologic factors|mesh-ancestor
24847501|NCT02247414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24847502|NCT02247414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934975|NCT04056702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24511342|NCT00568347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24935013|NCT04056169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935014|NCT04056169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24935015|NCT04056169|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24636256|NCT01144195|Panitumumab|panitumumab|mesh-list
24625440|NCT01082237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625441|NCT01082237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24625443|NCT01082237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625444|NCT01082237|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25672799|NCT01749956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542708|NCT00679835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24625445|NCT01082237|Antidepressive Agents|antidepressive agents|mesh-ancestor
24625446|NCT01082237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24625447|NCT01082250|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
24625448|NCT01082250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24625449|NCT01082250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24625450|NCT01082250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24625451|NCT01082250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935101|NCT04054830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935102|NCT04054830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935104|NCT04054531|Carboplatin|carboplatin|mesh-list
24935110|NCT04054531|Mitosis Modulators|mitosis modulators|mesh-ancestor
24511535|NCT00569400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935147|NCT04054206|Ibudilast|ibudilast|mesh-list
24935148|NCT04054206|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24935183|NCT04054063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935184|NCT04054063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24935185|NCT04054063|Anesthetics, General|anesthetics, general|mesh-ancestor
24935186|NCT04054063|Anesthetics|anesthetics|mesh-ancestor
24511724|NCT00570479|Anecortave|anecortave|mesh-list
24668772|NCT04609514|Nicotine|nicotine|mesh-list
24668773|NCT04609514|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24456335|NCT00330941|Anesthetics, Local|anesthetics, local|mesh-ancestor
24456336|NCT00330941|Anesthetics|anesthetics|mesh-ancestor
24456337|NCT00330941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24456338|NCT00330941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004611|NCT02726659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004612|NCT02726659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004614|NCT02654132|Dexamethasone acetate|dexamethasone acetate|mesh-list
25004624|NCT02654132|Glucocorticoids|glucocorticoids|mesh-ancestor
25004626|NCT02654132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25004627|NCT02654132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25004628|NCT02654132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25004629|NCT02654132|Protease Inhibitors|protease inhibitors|mesh-ancestor
25004630|NCT02654132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004631|NCT02654132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004632|NCT02654132|Immunologic Factors|immunologic factors|mesh-ancestor
25234816|NCT02568995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25004633|NCT02654132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25004634|NCT02654132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25004635|NCT02654132|Growth Substances|growth substances|mesh-ancestor
25004636|NCT02654132|Growth Inhibitors|growth inhibitors|mesh-ancestor
25004637|NCT02646475|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
25004638|NCT02646475|Angiotensin II|angiotensin ii|mesh-list
25004639|NCT02646475|Angiotensinogen|angiotensinogen|mesh-list
25004640|NCT02646475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25004641|NCT02646475|Vasodilator Agents|vasodilator agents|mesh-ancestor
25004642|NCT02646475|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25004643|NCT02646475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25004644|NCT02646475|Protease Inhibitors|protease inhibitors|mesh-ancestor
25004645|NCT02646475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004646|NCT02646475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004653|NCT02602314|Imatinib Mesylate|imatinib mesylate|mesh-list
25004654|NCT02602314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873302|NCT00128466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25873303|NCT00128466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25873304|NCT00128466|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25873305|NCT00128466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25873306|NCT00128466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004655|NCT02602314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25004656|NCT02602314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004657|NCT02602314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004659|NCT02600923|Palbociclib|palbociclib|mesh-list
25004660|NCT02600923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24958095|NCT03836703|Iron|iron|mesh-list
25004661|NCT02600923|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24621436|NCT01062360|Antipyretics|antipyretics|mesh-ancestor
24668960|NCT04406857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24668961|NCT04406857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512341|NCT00574366|Everolimus|everolimus|mesh-list
24747662|NCT00095784|Decitabine|decitabine|mesh-list
25234827|NCT02568943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234828|NCT02568943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234829|NCT02568839|Docetaxel|docetaxel|mesh-list
25672800|NCT01749956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24456475|NCT00331240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24456477|NCT00331240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25004678|NCT02484664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24456478|NCT00331240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456479|NCT00331240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456480|NCT00331240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24669616|NCT03777982|Hormone Antagonists|hormone antagonists|mesh-ancestor
24669617|NCT03777982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24669650|NCT03772314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24669651|NCT03772314|Dopamine Agents|dopamine agents|mesh-ancestor
24669652|NCT03772314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24669653|NCT03772314|Adrenergic Agents|adrenergic agents|mesh-ancestor
25873307|NCT00128479|Mifepristone|mifepristone|mesh-list
24618703|NCT01049464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24537743|NCT00656110|Prednisolone|prednisolone|mesh-list
24669654|NCT03772314|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24669655|NCT03772314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24669656|NCT03772314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24456485|NCT00331305|Antidepressive Agents|antidepressive agents|mesh-ancestor
24513059|NCT00578435|Busulfan|busulfan|mesh-list
25234837|NCT02568839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25234838|NCT02568800|Cefepime|cefepime|mesh-list
25234839|NCT02568800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25234840|NCT02568800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25234841|NCT02568709|Oxytocin|oxytocin|mesh-list
25064299|NCT03461302|Coal Tar|coal tar|mesh-list
24454304|NCT04109482|Cyclophosphamide|cyclophosphamide|mesh-list
24787706|NCT01926652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24787707|NCT01926652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24787708|NCT01926652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787709|NCT01926652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24787710|NCT01926652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787711|NCT01926652|Vasodilator Agents|vasodilator agents|mesh-ancestor
25873308|NCT00128479|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25873309|NCT00128479|Abortifacient Agents|abortifacient agents|mesh-ancestor
25873310|NCT00128479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25873311|NCT00128479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873312|NCT00128479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25873313|NCT00128479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25873314|NCT00128479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25873315|NCT00128479|Contraceptive Agents|contraceptive agents|mesh-ancestor
25873316|NCT00128479|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25873317|NCT00128479|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25873318|NCT00128479|Hormone Antagonists|hormone antagonists|mesh-ancestor
25873319|NCT00128479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25004679|NCT02484664|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25004680|NCT02484664|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25004681|NCT02484664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004691|NCT02428647|Trace Elements|trace elements|mesh-ancestor
25234842|NCT02568709|Oxytocics|oxytocics|mesh-ancestor
25234843|NCT02568709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25225833|NCT02624479|Chelating Agents|chelating agents|mesh-ancestor
25234844|NCT02568709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234846|NCT02568735|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
25234847|NCT02568735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24784339|NCT01907529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784340|NCT01907529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784341|NCT01907529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24784342|NCT01907529|Tubulin Modulators|tubulin modulators|mesh-ancestor
24784343|NCT01907529|Antimitotic Agents|antimitotic agents|mesh-ancestor
25234848|NCT02568735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25234849|NCT02568735|Analgesics|analgesics|mesh-ancestor
25234850|NCT02568735|Sensory System Agents|sensory system agents|mesh-ancestor
25234851|NCT02568735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234852|NCT02568735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234853|NCT02568735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25234854|NCT02568735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25234855|NCT02568735|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24847539|NCT02247518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24847540|NCT02247518|Adrenergic Agents|adrenergic agents|mesh-ancestor
24847541|NCT02247518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24847542|NCT02247518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847543|NCT02247544|Trabectedin|trabectedin|mesh-list
24847544|NCT02247544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24847545|NCT02247544|Alkylating Agents|alkylating agents|mesh-ancestor
24847546|NCT02247544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847547|NCT02247544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24847548|NCT02247557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24847549|NCT02247557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25004692|NCT02428647|Micronutrients|micronutrients|mesh-ancestor
25004693|NCT02428647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004694|NCT02371889|Topiramate|topiramate|mesh-list
25004695|NCT02371889|Anticonvulsants|anticonvulsants|mesh-ancestor
25004696|NCT02371889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25004713|NCT02034422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004714|NCT01988883|Propranolol|propranolol|mesh-list
25004724|NCT01988883|Vasodilator Agents|vasodilator agents|mesh-ancestor
25004725|NCT01988883|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25004726|NCT01988883|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25004727|NCT01988883|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25004728|NCT01988883|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25004729|NCT01945775|Talazoparib|talazoparib|mesh-list
24670268|NCT03117049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24456550|NCT00331695|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
24670414|NCT02663622|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24670416|NCT02655016|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24670417|NCT02655016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24670418|NCT02655016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24670419|NCT02655016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25234856|NCT02568735|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25234857|NCT02568735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234858|NCT02568735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234859|NCT02568618|Analgesics|analgesics|mesh-list
25234860|NCT02568618|Sensory System Agents|sensory system agents|mesh-ancestor
25234861|NCT02568618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234862|NCT02568618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234863|NCT02568488|Metformin|metformin|mesh-list
25234864|NCT02568488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25234865|NCT02568488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234866|NCT02568241|Interferons|interferons|mesh-list
25234867|NCT02568241|Interferon-alpha|interferon-alpha|mesh-list
25234868|NCT02568241|Interferon alpha-2|interferon alpha-2|mesh-list
25234869|NCT02568241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25234870|NCT02568241|Antiviral Agents|antiviral agents|mesh-ancestor
25234871|NCT02568241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25672801|NCT01749956|Immunologic Factors|immunologic factors|mesh-ancestor
24946420|NCT03939923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234872|NCT02568241|Immunologic Factors|immunologic factors|mesh-ancestor
25234873|NCT02568241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234874|NCT02568280|Insulin|insulin|mesh-list
25234875|NCT02568280|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24847552|NCT02247557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847553|NCT02247557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24847554|NCT02247557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24847555|NCT02247557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847556|NCT02247557|Cholinergic Agents|cholinergic agents|mesh-ancestor
24847563|NCT02247596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004754|NCT01858922|Antiemetics|antiemetics|mesh-ancestor
25064317|NCT03461081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25064318|NCT03461081|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25064319|NCT03461081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25064320|NCT03461081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24454351|NCT04034485|Evolocumab|evolocumab|mesh-list
24454352|NCT04034485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24454353|NCT04034485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24454354|NCT04034485|Antimetabolites|antimetabolites|mesh-ancestor
24454355|NCT04034485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456577|NCT00331747|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25873320|NCT00128479|Luteolytic Agents|luteolytic agents|mesh-ancestor
25234879|NCT02568280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25234880|NCT02568280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234881|NCT02568176|Midazolam|midazolam|mesh-list
25234882|NCT02568176|Bupropion|bupropion|mesh-list
25234883|NCT02568176|Esketamine|esketamine|mesh-list
25234884|NCT02568176|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25234885|NCT02568176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25234886|NCT02568176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25234887|NCT02568176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234888|NCT02568176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25234889|NCT02568176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25234890|NCT02568176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25234891|NCT02568176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24847564|NCT02247596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24847566|NCT02247648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24847567|NCT02247648|Narcotics|narcotics|mesh-ancestor
24847568|NCT02247648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24847569|NCT02247648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847570|NCT02247648|Analgesics|analgesics|mesh-ancestor
25074171|NCT03390387|Hormones|hormones|mesh-ancestor
24847571|NCT02247648|Sensory System Agents|sensory system agents|mesh-ancestor
24847572|NCT02247648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24847573|NCT02247687|Raltegravir Potassium|raltegravir potassium|mesh-list
24847574|NCT02247687|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
24635583|NCT01140399|Protective Agents|protective agents|mesh-ancestor
24635584|NCT01140412|Ritonavir|ritonavir|mesh-list
24635585|NCT01140412|Fosamprenavir|fosamprenavir|mesh-list
24635586|NCT01140412|Maraviroc|maraviroc|mesh-list
25873321|NCT00128479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25873322|NCT00128479|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24456579|NCT00331747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456580|NCT00331747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24456581|NCT00331747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24456582|NCT00331786|Aspirin|aspirin|mesh-list
24456583|NCT00331786|Nitroaspirin|nitroaspirin|mesh-list
25672802|NCT01749956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672803|NCT01749956|Antidotes|antidotes|mesh-ancestor
25672804|NCT01749956|Protective Agents|protective agents|mesh-ancestor
25672805|NCT01749956|Vitamin B Complex|vitamin b complex|mesh-ancestor
24456584|NCT00331786|Nitric Oxide|nitric oxide|mesh-list
25672806|NCT01749956|Vitamins|vitamins|mesh-ancestor
25873323|NCT00128505|Mifepristone|mifepristone|mesh-list
25873324|NCT00128505|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25873325|NCT00128505|Abortifacient Agents|abortifacient agents|mesh-ancestor
25873326|NCT00128505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25873327|NCT00128505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873328|NCT00128505|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24885002|NCT02969928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885003|NCT02969928|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24509440|NCT00560300|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24509488|NCT00560495|Growth Substances|growth substances|mesh-ancestor
24509489|NCT00560495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509490|NCT00560495|Growth Inhibitors|growth inhibitors|mesh-ancestor
24509491|NCT00560495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509492|NCT00560495|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24509494|NCT00560547|Hematinics|hematinics|mesh-ancestor
24456585|NCT00331786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24670669|NCT02150967|Infigratinib|infigratinib|mesh-list
24670670|NCT02150967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25234902|NCT02568176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25234903|NCT02568176|Dopamine Agents|dopamine agents|mesh-ancestor
25234904|NCT02568176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25234905|NCT02568176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25234906|NCT02568176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234907|NCT02568319|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25234908|NCT02568319|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25234909|NCT02568319|Autonomic Agents|autonomic agents|mesh-ancestor
25234910|NCT02568319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234911|NCT02568319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234912|NCT02568319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25234914|NCT02568319|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25234915|NCT02568319|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25234916|NCT02568319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25873329|NCT00128505|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24670755|NCT01998971|Respiratory System Agents|respiratory system agents|mesh-ancestor
25873330|NCT00128505|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24670756|NCT01998971|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24670757|NCT01998971|Hormone Antagonists|hormone antagonists|mesh-ancestor
24670758|NCT01998971|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24514191|NCT00588913|Zoledronic Acid|zoledronic acid|mesh-list
24456589|NCT00331786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24456590|NCT00331786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456591|NCT00331786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24456592|NCT00331786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24456593|NCT00331786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24456594|NCT00331786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24670771|NCT01998971|Dermatologic Agents|dermatologic agents|mesh-ancestor
24514262|NCT00589316|Mycophenolic Acid|mycophenolic acid|mesh-list
24514263|NCT00589316|Cadexomer iodine|cadexomer iodine|mesh-list
24514264|NCT00589316|Cyclophosphamide|cyclophosphamide|mesh-list
25234917|NCT02568319|Adrenergic Agents|adrenergic agents|mesh-ancestor
25234918|NCT02568319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25234919|NCT02568319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672807|NCT01749956|Micronutrients|micronutrients|mesh-ancestor
25672808|NCT01749956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25672809|NCT01749956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25672810|NCT01749956|Growth Substances|growth substances|mesh-ancestor
25672811|NCT01749956|Growth Inhibitors|growth inhibitors|mesh-ancestor
25672812|NCT01749982|Choline|choline|mesh-list
25672813|NCT01749982|Betaine|betaine|mesh-list
25672814|NCT01749982|Lipotropic Agents|lipotropic agents|mesh-ancestor
25672815|NCT01749982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25672816|NCT01749982|Antimetabolites|antimetabolites|mesh-ancestor
25273632|NCT02384343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25672817|NCT01749982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873331|NCT00128505|Contraceptive Agents|contraceptive agents|mesh-ancestor
25873332|NCT00128505|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25873333|NCT00128505|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25873334|NCT00128505|Hormone Antagonists|hormone antagonists|mesh-ancestor
25873335|NCT00128505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25873336|NCT00128505|Luteolytic Agents|luteolytic agents|mesh-ancestor
25873337|NCT00128505|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25873338|NCT00128505|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25873339|NCT00128518|Perindopril|perindopril|mesh-list
25873340|NCT00128518|Indapamide|indapamide|mesh-list
25873341|NCT00128518|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25873342|NCT00128518|Protease Inhibitors|protease inhibitors|mesh-ancestor
25873343|NCT00128518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24949369|NCT04916392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949370|NCT04916392|Sensory System Agents|sensory system agents|mesh-ancestor
24949421|NCT04778982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24949422|NCT04778982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24949518|NCT04603911|Bupivacaine|bupivacaine|mesh-list
24949519|NCT04603911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24949520|NCT04603911|Antiemetics|antiemetics|mesh-ancestor
24949521|NCT04603911|Autonomic Agents|autonomic agents|mesh-ancestor
25273633|NCT02384343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25273634|NCT02384343|Adrenergic Agents|adrenergic agents|mesh-ancestor
25273635|NCT02384343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25273636|NCT02384343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273637|NCT02384499|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25273638|NCT02384499|Hemostatics|hemostatics|mesh-ancestor
25273639|NCT02384499|Coagulants|coagulants|mesh-ancestor
25273640|NCT02384512|Rasagiline|rasagiline|mesh-list
25273641|NCT02384512|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25273642|NCT02384512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273643|NCT02384512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873344|NCT00128518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873345|NCT00128518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25873346|NCT00128518|Diuretics|diuretics|mesh-ancestor
25873347|NCT00128518|Natriuretic Agents|natriuretic agents|mesh-ancestor
25873348|NCT00128518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873349|NCT00128518|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24514266|NCT00589316|Fludarabine phosphate|fludarabine phosphate|mesh-list
24514267|NCT00589316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24456607|NCT00331786|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24514269|NCT00589316|Antibodies|antibodies|mesh-list
24958605|NCT03831126|Hormones|hormones|mesh-ancestor
25004731|NCT01945775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004745|NCT01858922|Immunologic Factors|immunologic factors|mesh-ancestor
25004746|NCT01858922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004747|NCT01858922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25004748|NCT01858922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25004749|NCT01858922|Alkylating Agents|alkylating agents|mesh-ancestor
25004750|NCT01858922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004751|NCT01858922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25004752|NCT01858922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25004753|NCT01858922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25004755|NCT01858922|Autonomic Agents|autonomic agents|mesh-ancestor
25004756|NCT01858922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25004757|NCT01858922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25004758|NCT01858922|Glucocorticoids|glucocorticoids|mesh-ancestor
25004759|NCT01858922|Hormones|hormones|mesh-ancestor
25004760|NCT01858922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25004761|NCT01858922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25004762|NCT01858922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004763|NCT01858922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25004764|NCT01858922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25004765|NCT01858922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24618708|NCT01049542|Astressin|astressin|mesh-list
25004766|NCT01858922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25004767|NCT01858922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25004769|NCT01858922|Antiviral Agents|antiviral agents|mesh-ancestor
25004770|NCT01858922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25004771|NCT01858922|Tubulin Modulators|tubulin modulators|mesh-ancestor
25004772|NCT01858922|Antimitotic Agents|antimitotic agents|mesh-ancestor
25004773|NCT01858922|Mitosis Modulators|mitosis modulators|mesh-ancestor
25004774|NCT01781637|Omalizumab|omalizumab|mesh-list
25004775|NCT01781637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25672818|NCT01749982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25672819|NCT01749982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25672820|NCT01749982|Nootropic Agents|nootropic agents|mesh-ancestor
25672821|NCT01750086|Denosumab|denosumab|mesh-list
25672822|NCT01750086|Alendronate|alendronate|mesh-list
25672823|NCT01750086|Teriparatide|teriparatide|mesh-list
25672824|NCT01750086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25672825|NCT01750086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672826|NCT01750086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25672827|NCT01750268|Topiramate|topiramate|mesh-list
24949635|NCT04006288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24949636|NCT04006288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24949637|NCT04006288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24949638|NCT04006288|Antipyretics|antipyretics|mesh-ancestor
24949639|NCT04006288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25004776|NCT01781637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25004777|NCT01781637|Respiratory System Agents|respiratory system agents|mesh-ancestor
25004778|NCT01773278|Antioxidants|antioxidants|mesh-list
25004779|NCT01773278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004780|NCT01773278|Protective Agents|protective agents|mesh-ancestor
25004781|NCT01773278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004782|NCT01670539|Triamcinolone|triamcinolone|mesh-list
25004783|NCT01670539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25004784|NCT01670539|Glucocorticoids|glucocorticoids|mesh-ancestor
25004786|NCT01670539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25004787|NCT01670539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787747|NCT01927029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787748|NCT01927224|Nifurtimox|nifurtimox|mesh-list
24787753|NCT01927263|Infliximab|infliximab|mesh-list
25234920|NCT02567955|Vaccines|vaccines|mesh-list
25234921|NCT02567955|Immunologic Factors|immunologic factors|mesh-ancestor
25234922|NCT02567955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234923|NCT02567942|Propofol|propofol|mesh-list
25234924|NCT02567942|Sevoflurane|sevoflurane|mesh-list
25234925|NCT02567942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25234926|NCT02567942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25234927|NCT02567942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234928|NCT02567942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25873350|NCT00128518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24484304|NCT00447577|Glucocorticoids|glucocorticoids|mesh-ancestor
25873351|NCT00128531|Leuprolide|leuprolide|mesh-list
25873352|NCT00128531|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25873353|NCT00128531|Fertility Agents|fertility agents|mesh-ancestor
24847589|NCT02247986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24847590|NCT02247986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24847591|NCT02247986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847592|NCT02247986|Dopamine Agents|dopamine agents|mesh-ancestor
24847593|NCT02247986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24847594|NCT02248012|Everolimus|everolimus|mesh-list
24847595|NCT02248012|Temozolomide|temozolomide|mesh-list
24847596|NCT02248012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24847597|NCT02248012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24847598|NCT02248012|Immunologic Factors|immunologic factors|mesh-ancestor
24847599|NCT02248012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24670929|NCT01078662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24670930|NCT01078662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24670933|NCT00680901|Lapatinib|lapatinib|mesh-list
24670934|NCT00680901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24670935|NCT00680901|Antimetabolites|antimetabolites|mesh-ancestor
24670936|NCT00680901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455522|NCT00327678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672828|NCT01750268|Anticonvulsants|anticonvulsants|mesh-ancestor
25672829|NCT01750268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25672830|NCT01750268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672831|NCT01750294|Chlorthalidone|chlorthalidone|mesh-list
25672832|NCT01750294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25672833|NCT01750294|Diuretics|diuretics|mesh-ancestor
25672834|NCT01750294|Natriuretic Agents|natriuretic agents|mesh-ancestor
25672835|NCT01750294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672836|NCT01750294|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25672837|NCT01750294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25873354|NCT00128531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25873355|NCT00128531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873356|NCT00128531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24950168|NCT02348203|Hormone Antagonists|hormone antagonists|mesh-ancestor
24950169|NCT02348203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24950247|NCT01883297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24950249|NCT01883297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24950250|NCT01883297|Antiviral Agents|antiviral agents|mesh-ancestor
24950251|NCT01883297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24950252|NCT01864109|Cyclophosphamide|cyclophosphamide|mesh-list
24950253|NCT01864109|Temozolomide|temozolomide|mesh-list
24455524|NCT00327678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24455525|NCT00327678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24455526|NCT00327678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455528|NCT00327691|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24455529|NCT00327691|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24455530|NCT00327691|Antimetabolites|antimetabolites|mesh-ancestor
24455531|NCT00327691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455532|NCT00327691|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24455533|NCT00327691|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24455534|NCT00327691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24455535|NCT00327730|Eperisone|eperisone|mesh-list
24455536|NCT00327730|Anticonvulsants|anticonvulsants|mesh-ancestor
25234929|NCT02567942|Anesthetics, General|anesthetics, general|mesh-ancestor
25234930|NCT02567942|Anesthetics|anesthetics|mesh-ancestor
25234931|NCT02567942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25234932|NCT02567942|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25234933|NCT02568423|Mirikizumab|mirikizumab|mesh-list
25234934|NCT02568423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25234935|NCT02568423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25234936|NCT02568423|Analgesics|analgesics|mesh-ancestor
25234937|NCT02568423|Sensory System Agents|sensory system agents|mesh-ancestor
25234938|NCT02568423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25234939|NCT02568423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234940|NCT02568423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25234941|NCT02568423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25234942|NCT02568423|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25234943|NCT02568423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25234944|NCT02568111|Interferons|interferons|mesh-list
25234945|NCT02568111|Interferon-beta|interferon-beta|mesh-list
24847606|NCT02248129|Telmisartan|telmisartan|mesh-list
24847607|NCT02248129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24847608|NCT02248129|Diuretics|diuretics|mesh-ancestor
24455537|NCT00327730|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24455538|NCT00327730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24455539|NCT00327730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455540|NCT00327730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24455541|NCT00327730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455542|NCT00327730|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24455543|NCT00327730|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24455544|NCT00327730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24455545|NCT00327730|Parasympatholytics|parasympatholytics|mesh-ancestor
24455546|NCT00327730|Autonomic Agents|autonomic agents|mesh-ancestor
24455547|NCT00327730|Vasodilator Agents|vasodilator agents|mesh-ancestor
24455548|NCT00327756|Ubiquinone|ubiquinone|mesh-list
24514698|NCT00592332|Alprazolam|alprazolam|mesh-list
24455577|NCT00327834|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24455616|NCT00328120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24455617|NCT00328120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455618|NCT00328211|Bile Acids and Salts|bile acids and salts|mesh-list
24455619|NCT00328211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24455620|NCT00328302|Candesartan|candesartan|mesh-list
24455621|NCT00328302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24455622|NCT00328302|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24455623|NCT00328302|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24455624|NCT00328302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455625|NCT00328367|Aripiprazole|aripiprazole|mesh-list
25234952|NCT02568111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672838|NCT01750294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672839|NCT01750398|Methyltestosterone|methyltestosterone|mesh-list
25672840|NCT01750398|Leuprolide|leuprolide|mesh-list
25672841|NCT01750398|Goserelin|goserelin|mesh-list
25672842|NCT01750398|Testosterone|testosterone|mesh-list
25672843|NCT01750398|Testosterone undecanoate|testosterone undecanoate|mesh-list
25672844|NCT01750398|Testosterone enanthate|testosterone enanthate|mesh-list
25672845|NCT01750398|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25672846|NCT01750398|Androgens|androgens|mesh-ancestor
24950487|NCT03915561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25234954|NCT02568111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24847613|NCT02248129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154688|NCT05469984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25044615|NCT01071850|Metformin|metformin|mesh-list
25044616|NCT01071850|Ipragliflozin|ipragliflozin|mesh-list
25044617|NCT01071850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25044618|NCT01071850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044619|NCT01071850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24847614|NCT02248129|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24847615|NCT02248129|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24847616|NCT02248142|Pramipexole|pramipexole|mesh-list
24847617|NCT02248142|Antioxidants|antioxidants|mesh-ancestor
24847618|NCT02248142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847627|NCT02248155|Antioxidants|antioxidants|mesh-ancestor
24847628|NCT02248155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847629|NCT02248155|Protective Agents|protective agents|mesh-ancestor
24847630|NCT02248155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847631|NCT02248155|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24455801|NCT00329069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24455802|NCT00329069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24455803|NCT00329069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24455804|NCT00329095|Bimatoprost|bimatoprost|mesh-list
24455806|NCT00329095|Antihypertensive Agents|antihypertensive agents|mesh-list
24455807|NCT00329095|Latanoprost|latanoprost|mesh-list
24455815|NCT00329134|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24455817|NCT00329134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24455818|NCT00329134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24455819|NCT00329134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24455822|NCT00329147|Paroxetine|paroxetine|mesh-list
24455823|NCT00329147|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24455824|NCT00329147|Desipramine|desipramine|mesh-list
24455825|NCT00329147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24455826|NCT00329147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24455827|NCT00329147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24455828|NCT00329147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455851|NCT00329186|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24455852|NCT00329186|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24474682|NCT00407017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24455853|NCT00329186|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25234955|NCT02568111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25234956|NCT02568111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25234957|NCT02568111|Adrenergic Agents|adrenergic agents|mesh-ancestor
25234958|NCT02568111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25234959|NCT02568111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234960|NCT02568111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25234961|NCT02567981|Vitamin A|vitamin a|mesh-list
25234962|NCT02567981|Micronutrients|micronutrients|mesh-list
25234963|NCT02567981|Trace Elements|trace elements|mesh-list
25234970|NCT02568033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25234971|NCT02568033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25234972|NCT02568033|Tubulin Modulators|tubulin modulators|mesh-ancestor
25234973|NCT02568033|Antimitotic Agents|antimitotic agents|mesh-ancestor
25234974|NCT02568033|Mitosis Modulators|mitosis modulators|mesh-ancestor
25234975|NCT02568033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25234976|NCT02568033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25234977|NCT02568033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25234978|NCT02568033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25234980|NCT02567916|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24635670|NCT01140620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873357|NCT00128531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873358|NCT00128544|Telbivudine|telbivudine|mesh-list
25873359|NCT00128544|Antiviral Agents|antiviral agents|mesh-ancestor
25873360|NCT00128544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25672847|NCT01750398|Hormones|hormones|mesh-ancestor
25873361|NCT00128544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25873362|NCT00128544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25873363|NCT00128544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873364|NCT00128557|Vitamin A|vitamin a|mesh-list
25873365|NCT00128557|Vitamins|vitamins|mesh-ancestor
25873366|NCT00128557|Micronutrients|micronutrients|mesh-ancestor
24966075|NCT03771677|Interferon-alpha|interferon-alpha|mesh-list
24966076|NCT03771677|Interferon alpha-2|interferon alpha-2|mesh-list
24966077|NCT03771677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950880|NCT03910556|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24950881|NCT03910556|Anesthetics, General|anesthetics, general|mesh-ancestor
24950882|NCT03910556|Anesthetics|anesthetics|mesh-ancestor
24950883|NCT03910543|Tofacitinib|tofacitinib|mesh-list
25873367|NCT00128557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064398|NCT03460782|Ipilimumab|ipilimumab|mesh-list
24455854|NCT00329186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24455855|NCT00329186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24455856|NCT00329186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839628|NCT02205502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25057267|NCT03506516|Ethanol|ethanol|mesh-list
24455857|NCT00329186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24455858|NCT00329186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455859|NCT00329186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24455860|NCT00329186|Antidepressive Agents|antidepressive agents|mesh-ancestor
24455861|NCT00329186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24455862|NCT00329225|Rosiglitazone|rosiglitazone|mesh-list
24455863|NCT00329225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24455864|NCT00329225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455986|NCT00329472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455987|NCT00329498|Ascorbic Acid|ascorbic acid|mesh-list
24456116|NCT00330135|Protective Agents|protective agents|mesh-ancestor
24456118|NCT00330148|Nifurtimox|nifurtimox|mesh-list
24456119|NCT00330148|Melarsoprol|melarsoprol|mesh-list
24456120|NCT00330148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24456121|NCT00330148|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24456122|NCT00330148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24456123|NCT00330148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24456124|NCT00330148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24515241|NCT00596050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25234981|NCT02567916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25234982|NCT02567916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234983|NCT02567916|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25234984|NCT02567916|Anesthetics, General|anesthetics, general|mesh-ancestor
25234985|NCT02567916|Anesthetics|anesthetics|mesh-ancestor
25234986|NCT02567929|Propofol|propofol|mesh-list
25234987|NCT02567929|Sevoflurane|sevoflurane|mesh-list
25234988|NCT02567929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25234989|NCT02567929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25234990|NCT02567929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25234991|NCT02567929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25234992|NCT02567929|Anesthetics, General|anesthetics, general|mesh-ancestor
25234993|NCT02567929|Anesthetics|anesthetics|mesh-ancestor
25234996|NCT02567851|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25234997|NCT02567851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25234998|NCT02567851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25235000|NCT02567838|Anesthetics, Local|anesthetics, local|mesh-ancestor
25672848|NCT01750398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25672849|NCT01750398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672850|NCT01750398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25672851|NCT01750398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672852|NCT01750398|Anabolic Agents|anabolic agents|mesh-ancestor
25672853|NCT01750398|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25672854|NCT01750398|Fertility Agents|fertility agents|mesh-ancestor
25672855|NCT01750398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25672856|NCT01750697|Rituximab|rituximab|mesh-list
25672857|NCT01750697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25672858|NCT01750697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672859|NCT01750697|Immunologic Factors|immunologic factors|mesh-ancestor
25672860|NCT01750697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873368|NCT00128596|Arsenic Trioxide|arsenic trioxide|mesh-list
25873369|NCT00128596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25235004|NCT02567838|Sensory System Agents|sensory system agents|mesh-ancestor
25235005|NCT02567838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25235006|NCT02567838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25235007|NCT02567838|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25235008|NCT02567838|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25235009|NCT02567838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25235010|NCT02567838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235011|NCT02567773|Itraconazole|itraconazole|mesh-list
25235012|NCT02567773|GSK2881078|gsk2881078|mesh-list
25235013|NCT02567773|Antifungal Agents|antifungal agents|mesh-ancestor
25235014|NCT02567773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25235015|NCT02567773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25235016|NCT02567773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25235017|NCT02567773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235018|NCT02567773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235019|NCT02567773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25235020|NCT02567773|Hormone Antagonists|hormone antagonists|mesh-ancestor
25235021|NCT02567773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25235022|NCT02567773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235023|NCT02567773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25235024|NCT02567773|Anabolic Agents|anabolic agents|mesh-ancestor
25235025|NCT02567773|Hormones|hormones|mesh-ancestor
25235026|NCT02567487|Levobupivacaine|levobupivacaine|mesh-list
25235027|NCT02567487|Anesthetics, Local|anesthetics, local|mesh-ancestor
25235028|NCT02567487|Anesthetics|anesthetics|mesh-ancestor
25235029|NCT02567487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25154690|NCT05469984|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25154692|NCT05469984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635715|NCT01140932|Protective Agents|protective agents|mesh-ancestor
24635717|NCT01140971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24635718|NCT01140971|Abortifacient Agents|abortifacient agents|mesh-ancestor
24635719|NCT01140971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25064416|NCT03460678|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25873370|NCT00128622|Denileukin diftitox|denileukin diftitox|mesh-list
25873371|NCT00128622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873372|NCT00128635|Antibodies|antibodies|mesh-list
25873373|NCT00128635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25873374|NCT00128635|Immunologic Factors|immunologic factors|mesh-ancestor
25873375|NCT00128635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873376|NCT00128700|Temozolomide|temozolomide|mesh-list
25873377|NCT00128700|Vatalanib|vatalanib|mesh-list
25235035|NCT02567383|Tubulin Modulators|tubulin modulators|mesh-ancestor
25235036|NCT02567383|Antimitotic Agents|antimitotic agents|mesh-ancestor
25235037|NCT02567383|Mitosis Modulators|mitosis modulators|mesh-ancestor
25235038|NCT02567383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235039|NCT02567786|Plasma-lyte 148|plasma-lyte 148|mesh-list
25235040|NCT02567786|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25235041|NCT02567786|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25235042|NCT02567461|Aspirin|aspirin|mesh-list
25235043|NCT02567461|Edoxaban|edoxaban|mesh-list
25235044|NCT02567461|Clopidogrel|clopidogrel|mesh-list
24959029|NCT03827876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25235045|NCT02567461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25235046|NCT02567461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24453458|NCT05008224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24453459|NCT05008224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24453460|NCT05008224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24453461|NCT05008224|Tubulin Modulators|tubulin modulators|mesh-ancestor
24453462|NCT05008224|Antimitotic Agents|antimitotic agents|mesh-ancestor
24621469|NCT01062516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004875|NCT01019356|Acarbose|acarbose|mesh-list
25004876|NCT01019356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25672862|NCT01750840|Cimetidine|cimetidine|mesh-list
25672863|NCT01750840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25672864|NCT01750840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25672865|NCT01750840|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25873382|NCT00128700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25873383|NCT00128700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25873384|NCT00128739|Budesonide|budesonide|mesh-list
25873385|NCT00128739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25873386|NCT00128739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25873387|NCT00128739|Autonomic Agents|autonomic agents|mesh-ancestor
25873388|NCT00128739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25061167|NCT03473314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061168|NCT03473314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25061169|NCT03473314|Respiratory System Agents|respiratory system agents|mesh-ancestor
25004877|NCT01019356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004878|NCT01019356|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25004879|NCT01019356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004880|NCT01019356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004881|NCT05202730|Anesthetics|anesthetics|mesh-list
25004882|NCT05202730|Anesthetics, Local|anesthetics, local|mesh-list
25004883|NCT05202730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25004884|NCT05202730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004885|NCT05202730|Sensory System Agents|sensory system agents|mesh-ancestor
25004886|NCT05202730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24959113|NCT03827278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25004888|NCT05202665|Fluorides, Topical|fluorides, topical|mesh-list
25004889|NCT05202665|Cariostatic Agents|cariostatic agents|mesh-ancestor
25004890|NCT05202665|Protective Agents|protective agents|mesh-ancestor
25004891|NCT05202665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004892|NCT05202496|Calcitriol|calcitriol|mesh-list
25004893|NCT05202496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25004894|NCT05202496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004895|NCT05202496|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25004896|NCT05202496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25004897|NCT05202496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004899|NCT05202496|Vitamins|vitamins|mesh-ancestor
24621474|NCT01062633|Erythritol|erythritol|mesh-list
25004918|NCT05202275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25004919|NCT05202275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25004920|NCT05202275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873389|NCT00128739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517549|NCT00608673|Hormones|hormones|mesh-ancestor
24466280|NCT00372801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466282|NCT00372827|Brinzolamide|brinzolamide|mesh-list
24466283|NCT00372827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24466284|NCT00372827|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24466285|NCT00372827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466286|NCT00372827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466287|NCT00372853|Tremelimumab|tremelimumab|mesh-list
24466288|NCT00372853|Ipilimumab|ipilimumab|mesh-list
24466289|NCT00372853|Sunitinib|sunitinib|mesh-list
24466290|NCT00372853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25235047|NCT02567461|Analgesics|analgesics|mesh-ancestor
25235048|NCT02567461|Sensory System Agents|sensory system agents|mesh-ancestor
25235049|NCT02567461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25235050|NCT02567461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235051|NCT02567461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25235052|NCT02567461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25235053|NCT02567461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25235054|NCT02567461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25235055|NCT02567461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064430|NCT03460405|Vaccines|vaccines|mesh-list
24466291|NCT00372853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24466292|NCT00372853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24466592|NCT00374075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24466594|NCT00374101|Pantoprazole|pantoprazole|mesh-list
24517944|NCT00610792|Bortezomib|bortezomib|mesh-list
24467174|NCT00376480|Immunologic Factors|immunologic factors|mesh-ancestor
24467207|NCT00376519|Alkylating Agents|alkylating agents|mesh-ancestor
24467208|NCT00376519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467209|NCT00376519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467210|NCT00376519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24467213|NCT00376519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672866|NCT01750840|Histamine Antagonists|histamine antagonists|mesh-ancestor
25672867|NCT01750840|Histamine Agents|histamine agents|mesh-ancestor
25672868|NCT01750840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25672869|NCT01750840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672870|NCT01750840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672871|NCT01750840|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25672872|NCT01750840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25672873|NCT01750840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672874|NCT01750918|Fluorouracil|fluorouracil|mesh-list
24824387|NCT02123069|Cholinergic Agents|cholinergic agents|mesh-ancestor
25062056|NCT05345691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25062057|NCT05345691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772554|NCT01834235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24772555|NCT01834235|Antimetabolites|antimetabolites|mesh-ancestor
24772556|NCT01834235|Antiviral Agents|antiviral agents|mesh-ancestor
24772557|NCT01834235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24772558|NCT01834235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772559|NCT01834235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24467214|NCT00376519|Antifungal Agents|antifungal agents|mesh-ancestor
24467215|NCT00376519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25873390|NCT00128739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25873391|NCT00128739|Respiratory System Agents|respiratory system agents|mesh-ancestor
25873392|NCT00128739|Glucocorticoids|glucocorticoids|mesh-ancestor
25873393|NCT00128739|Hormones|hormones|mesh-ancestor
25873394|NCT00128739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24456908|NCT00332618|Glycerol|glycerol|mesh-list
24456909|NCT00332618|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24456910|NCT00332618|Protective Agents|protective agents|mesh-ancestor
24456911|NCT00332618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456912|NCT00332631|Acetylcysteine|acetylcysteine|mesh-list
24456913|NCT00332631|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25873395|NCT00128752|Beta Carotene|beta carotene|mesh-list
24468301|NCT00380965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24468302|NCT00381017|Interferons|interferons|mesh-list
24468303|NCT00381017|Interferon-alpha|interferon-alpha|mesh-list
24468427|NCT00381537|Anticonvulsants|anticonvulsants|mesh-ancestor
24468428|NCT00381537|Antimanic Agents|antimanic agents|mesh-ancestor
24468429|NCT00381537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24468430|NCT00381537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24468824|NCT00383539|Immunologic Factors|immunologic factors|mesh-ancestor
25873396|NCT00128752|Carotenoids|carotenoids|mesh-list
24468852|NCT00383695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468853|NCT00383695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24468856|NCT00383799|Amiodarone|amiodarone|mesh-list
24468857|NCT00383799|Procainamide|procainamide|mesh-list
24518432|NCT05059626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24469057|NCT00384475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24469058|NCT00384475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469059|NCT00384475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24469060|NCT00384527|Vancomycin|vancomycin|mesh-list
24469061|NCT00384527|Nitazoxanide|nitazoxanide|mesh-list
25873397|NCT00128752|Antioxidants|antioxidants|mesh-ancestor
25873398|NCT00128752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873399|NCT00128752|Protective Agents|protective agents|mesh-ancestor
24469262|NCT00385125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25235056|NCT02567461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25235057|NCT02567461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25235058|NCT02567461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235059|NCT02567461|Antipyretics|antipyretics|mesh-ancestor
25235060|NCT02567461|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25235061|NCT02567461|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25235062|NCT02567461|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25873400|NCT00128752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469263|NCT00385125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24469264|NCT00385125|Alkylating Agents|alkylating agents|mesh-ancestor
24469265|NCT00385125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469267|NCT00385307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24469268|NCT00385307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24469269|NCT00385307|Adrenergic Agents|adrenergic agents|mesh-ancestor
24469270|NCT00385307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24469271|NCT00385307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873401|NCT00128752|Provitamins|provitamins|mesh-ancestor
25873402|NCT00128752|Vitamins|vitamins|mesh-ancestor
25873403|NCT00128752|Micronutrients|micronutrients|mesh-ancestor
25672875|NCT01750918|Panitumumab|panitumumab|mesh-list
25672876|NCT01750918|Trametinib|trametinib|mesh-list
25672877|NCT01750918|Dabrafenib|dabrafenib|mesh-list
25672878|NCT01750918|Antimetabolites|antimetabolites|mesh-ancestor
25672879|NCT01750918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672880|NCT01750918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25672881|NCT01750918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672882|NCT01750918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25672883|NCT01750918|Immunologic Factors|immunologic factors|mesh-ancestor
25672884|NCT01750918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065733|NCT05283161|Dronabinol|dronabinol|mesh-list
25065734|NCT05283161|Cannabidiol|cannabidiol|mesh-list
25065735|NCT05283161|Anticonvulsants|anticonvulsants|mesh-ancestor
25065736|NCT05283161|Hallucinogens|hallucinogens|mesh-ancestor
24776244|NCT01857284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24626177|NCT01085851|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24626178|NCT01085851|Histamine Antagonists|histamine antagonists|mesh-ancestor
24953453|NCT03884972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24953454|NCT03884972|Alkylating Agents|alkylating agents|mesh-ancestor
24953455|NCT03884972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469412|NCT00385645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24469413|NCT00385645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25873404|NCT00128778|Doxorubicin|doxorubicin|mesh-list
25873405|NCT00128778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25873406|NCT00128778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25873407|NCT00128778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873408|NCT00128778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25873409|NCT00128778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25873410|NCT00128778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469684|NCT00386763|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24469685|NCT00386763|Antimalarials|antimalarials|mesh-ancestor
24469686|NCT00386763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24469687|NCT00386763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24469688|NCT00386763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24469689|NCT00386802|Antifungal Agents|antifungal agents|mesh-list
24469690|NCT00386802|Clotrimazole|clotrimazole|mesh-list
24469792|NCT00387374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24469810|NCT00387400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24469812|NCT00387400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469813|NCT00387413|Niacinamide|niacinamide|mesh-list
24469814|NCT00387413|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24469902|NCT00387868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470130|NCT00388882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24470132|NCT00388882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25873411|NCT00128778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470245|NCT00389376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470247|NCT00389376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470248|NCT00389402|Ritonavir|ritonavir|mesh-list
24470249|NCT00389402|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24470250|NCT00389402|Saquinavir|saquinavir|mesh-list
24470251|NCT00389402|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24470252|NCT00389402|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24470253|NCT00389402|Protease Inhibitors|protease inhibitors|mesh-ancestor
24470254|NCT00389402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24470255|NCT00389402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470256|NCT00389402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24470257|NCT00389402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24470258|NCT00389402|Antiviral Agents|antiviral agents|mesh-ancestor
24470259|NCT00389402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24470260|NCT00389402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24470261|NCT00389402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24470262|NCT00389415|Vildagliptin|vildagliptin|mesh-list
24470436|NCT00390156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24959241|NCT03825861|Folfirinox|folfirinox|mesh-list
24470437|NCT00390156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24470438|NCT00390156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24470439|NCT00390156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24470440|NCT00390156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24470441|NCT00390156|Growth Substances|growth substances|mesh-ancestor
24518841|NCT04145076|Citalopram|citalopram|mesh-list
24518878|NCT04094961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25235063|NCT02567461|Purinergic Agents|purinergic agents|mesh-ancestor
25235064|NCT02567461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25235065|NCT02567461|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25235066|NCT02567461|Antithrombins|antithrombins|mesh-ancestor
25672885|NCT01750918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25672886|NCT01750918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25672887|NCT01750918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672888|NCT01750931|Meloxicam|meloxicam|mesh-list
25672889|NCT01750931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25672890|NCT01750931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25672891|NCT01750931|Analgesics|analgesics|mesh-ancestor
25672892|NCT01750931|Sensory System Agents|sensory system agents|mesh-ancestor
25672893|NCT01750931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24509933|NCT00562835|Thiamine|thiamine|mesh-list
24906714|NCT04337918|Antioxidants|antioxidants|mesh-ancestor
24470958|NCT00392691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24471062|NCT00393198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24471063|NCT00393198|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24471064|NCT00393198|Abortifacient Agents|abortifacient agents|mesh-ancestor
24471065|NCT00393198|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24471066|NCT00393198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25873412|NCT00128791|Nitroprusside|nitroprusside|mesh-list
24471100|NCT00393328|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24471409|NCT00395213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471410|NCT00395213|Sympathomimetics|sympathomimetics|mesh-ancestor
24471411|NCT00395213|Autonomic Agents|autonomic agents|mesh-ancestor
24519111|NCT03421288|Leucovorin|leucovorin|mesh-list
24471699|NCT00396578|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24471700|NCT00396578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24471701|NCT00396578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787885|NCT01928069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24787886|NCT01928069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787887|NCT01928069|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24787888|NCT01928069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24787889|NCT01928069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787890|NCT01928134|Calcium Carbonate|calcium carbonate|mesh-list
24787891|NCT01928134|Calcium|calcium|mesh-list
24787892|NCT01928134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24787893|NCT01928134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787894|NCT01928134|Antacids|antacids|mesh-ancestor
24787895|NCT01928134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787896|NCT01928134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24787897|NCT01928160|Carboplatin|carboplatin|mesh-list
24787898|NCT01928160|Pemetrexed|pemetrexed|mesh-list
24787899|NCT01928160|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24787900|NCT01928160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787901|NCT01928160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481245|NCT00433927|Leucovorin|leucovorin|mesh-list
24787903|NCT01928160|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24787904|NCT01928160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24787905|NCT01928160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24787906|NCT01928316|Mizolastine|mizolastine|mesh-list
24787907|NCT01928316|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24787908|NCT01928316|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24787909|NCT01928316|Histamine Antagonists|histamine antagonists|mesh-ancestor
24787910|NCT01928316|Histamine Agents|histamine agents|mesh-ancestor
24787915|NCT01928407|Darunavir|darunavir|mesh-list
24471880|NCT00397241|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24471881|NCT00397241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24471882|NCT00397241|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25004925|NCT05202275|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25004926|NCT05201560|Fentanyl|fentanyl|mesh-list
25004941|NCT05201560|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25109626|NCT03122756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25109627|NCT03122756|Glucocorticoids|glucocorticoids|mesh-ancestor
25109628|NCT03122756|Hormones|hormones|mesh-ancestor
25109629|NCT03122756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25109630|NCT03122756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25109631|NCT03122756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25235067|NCT02567461|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25235068|NCT02567461|Protease Inhibitors|protease inhibitors|mesh-ancestor
25235069|NCT02567461|Anticoagulants|anticoagulants|mesh-ancestor
25235070|NCT02567396|Talazoparib|talazoparib|mesh-list
25235071|NCT02567396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25235072|NCT02567396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235073|NCT02567396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235074|NCT02567396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25235075|NCT02567799|Paclitaxel|paclitaxel|mesh-list
25235076|NCT02567799|Carboplatin|carboplatin|mesh-list
25235077|NCT02567799|Genistein|genistein|mesh-list
25873413|NCT00128791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25873414|NCT00128791|Vasodilator Agents|vasodilator agents|mesh-ancestor
25873415|NCT00128791|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25873416|NCT00128791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873417|NCT00128804|Beta Carotene|beta carotene|mesh-list
25873418|NCT00128804|Carotenoids|carotenoids|mesh-list
24453481|NCT04998669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24453482|NCT04998669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873419|NCT00128804|Antioxidants|antioxidants|mesh-ancestor
25064444|NCT03460145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25109633|NCT03122678|Vitamins|vitamins|mesh-ancestor
25109634|NCT03122678|Micronutrients|micronutrients|mesh-ancestor
25109635|NCT03122678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109636|NCT03122678|Vitamin B Complex|vitamin b complex|mesh-ancestor
25109637|NCT03122665|Nefopam|nefopam|mesh-list
25109638|NCT03122665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25109640|NCT03122665|Sensory System Agents|sensory system agents|mesh-ancestor
25109641|NCT03122665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25109642|NCT03122665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472595|NCT00399685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24472596|NCT00399685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24472598|NCT00399698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24472599|NCT00399698|Serotonin Agents|serotonin agents|mesh-ancestor
24472600|NCT00399698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24473435|NCT00402766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24473436|NCT00402766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24475657|NCT00410995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24475873|NCT00411879|Adrenergic Agents|adrenergic agents|mesh-ancestor
24475874|NCT00411879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24475875|NCT00411879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475876|NCT00411879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475877|NCT00411879|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24475878|NCT00411879|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24475879|NCT00411879|Autonomic Agents|autonomic agents|mesh-ancestor
24475880|NCT00411879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25873420|NCT00128804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873421|NCT00128804|Protective Agents|protective agents|mesh-ancestor
25235079|NCT02567799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25235081|NCT02567799|Antimitotic Agents|antimitotic agents|mesh-ancestor
25235082|NCT02567799|Mitosis Modulators|mitosis modulators|mesh-ancestor
25235083|NCT02567799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235084|NCT02567799|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25235085|NCT02567799|Protective Agents|protective agents|mesh-ancestor
25235086|NCT02567799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235087|NCT02567799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25235088|NCT02567799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235089|NCT02567799|Phytoestrogens|phytoestrogens|mesh-ancestor
25235090|NCT02567799|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24476949|NCT00416858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477085|NCT00417157|Hormone Antagonists|hormone antagonists|mesh-ancestor
24477086|NCT00417157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24477087|NCT00417157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477088|NCT00417157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24477089|NCT00417183|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24477091|NCT00417183|Luteolytic Agents|luteolytic agents|mesh-ancestor
24477092|NCT00417183|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24477093|NCT00417183|Contraceptive Agents|contraceptive agents|mesh-ancestor
24477094|NCT00417183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24477095|NCT00417183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477096|NCT00417183|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24477097|NCT00417183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24477214|NCT00417833|Growth Substances|growth substances|mesh-ancestor
24477215|NCT00417833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477216|NCT00417833|Growth Inhibitors|growth inhibitors|mesh-ancestor
24477217|NCT00417872|Metronidazole|metronidazole|mesh-list
24477571|NCT00419146|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
24477690|NCT00419692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24477691|NCT00419692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477692|NCT00419692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477693|NCT00419718|Insulin|insulin|mesh-list
24477694|NCT00419718|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24477695|NCT00419718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24477988|NCT00421109|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24477989|NCT00421109|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24456985|NCT00332852|Hormone Antagonists|hormone antagonists|mesh-ancestor
24456986|NCT00332852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24456987|NCT00332852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478370|NCT00422578|Tadalafil|tadalafil|mesh-list
25071049|NCT03413371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24457026|NCT00333008|Prednisone|prednisone|mesh-list
25873422|NCT00128804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873423|NCT00128804|Provitamins|provitamins|mesh-ancestor
25873424|NCT00128804|Vitamins|vitamins|mesh-ancestor
25873425|NCT00128804|Micronutrients|micronutrients|mesh-ancestor
24478746|NCT00424203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478747|NCT00424229|Lenalidomide|lenalidomide|mesh-list
24478748|NCT00424229|Immunologic Factors|immunologic factors|mesh-ancestor
24478749|NCT00424229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478750|NCT00424229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24748917|NCT01996267|Antimetabolites|antimetabolites|mesh-ancestor
24479141|NCT00425724|Methylprednisolone|methylprednisolone|mesh-list
25004942|NCT05201352|Trifluridine|trifluridine|mesh-list
25235094|NCT02567331|Capecitabine|capecitabine|mesh-list
25235095|NCT02567331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25235096|NCT02567331|Antimetabolites|antimetabolites|mesh-ancestor
25235097|NCT02567331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24453493|NCT04982796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24479148|NCT00425724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25873426|NCT00128843|Anastrozole|anastrozole|mesh-list
25873427|NCT00128843|Exemestane|exemestane|mesh-list
25873428|NCT00128843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25873429|NCT00128843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479206|NCT00425997|Natriuretic Agents|natriuretic agents|mesh-ancestor
24457085|NCT00333086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24457086|NCT00333086|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24520318|NCT02795858|Lanreotide|lanreotide|mesh-list
24479227|NCT00426023|Antifungal Agents|antifungal agents|mesh-ancestor
25873430|NCT00128843|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24479250|NCT00426101|Autonomic Agents|autonomic agents|mesh-ancestor
24520361|NCT02771249|Vitamins|vitamins|mesh-ancestor
24479354|NCT00426530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479355|NCT00426530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24479356|NCT00426530|Immunologic Factors|immunologic factors|mesh-ancestor
24479357|NCT00426530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873431|NCT00128843|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24748949|NCT01913951|Azacitidine|azacitidine|mesh-list
24479594|NCT00427388|Protective Agents|protective agents|mesh-ancestor
24479595|NCT00427388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24479596|NCT00427388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479597|NCT00427414|Daunorubicin|daunorubicin|mesh-list
24479598|NCT00427414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479599|NCT00427414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25873432|NCT00128843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25873433|NCT00128843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873434|NCT00128843|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24479788|NCT00428428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24479789|NCT00428428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24479790|NCT00428428|Adrenergic Agents|adrenergic agents|mesh-ancestor
24479791|NCT00428428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24479792|NCT00428428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479793|NCT00428428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479794|NCT00428428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25873435|NCT00128843|Hormone Antagonists|hormone antagonists|mesh-ancestor
24480007|NCT00429520|Hyaluronic Acid|hyaluronic acid|mesh-list
24480008|NCT00429520|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24480009|NCT00429520|Immunologic Factors|immunologic factors|mesh-ancestor
24480010|NCT00429520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480011|NCT00429520|Viscosupplements|viscosupplements|mesh-ancestor
24520713|NCT05334004|Ritonavir|ritonavir|mesh-list
25873436|NCT00128843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25873437|NCT00128843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873438|NCT00128856|Gemcitabine|gemcitabine|mesh-list
25873439|NCT00128856|Paclitaxel|paclitaxel|mesh-list
24480145|NCT00429936|Protective Agents|protective agents|mesh-ancestor
24480146|NCT00429936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480242|NCT00430118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24480243|NCT00430118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24480244|NCT00430118|Antiviral Agents|antiviral agents|mesh-ancestor
24480245|NCT00430118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25235098|NCT02567331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25235099|NCT02567032|Oxytocin|oxytocin|mesh-list
25235100|NCT02567032|Oxytocics|oxytocics|mesh-ancestor
25235101|NCT02567032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25672894|NCT01750931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873440|NCT00128856|Doxorubicin|doxorubicin|mesh-list
24480328|NCT00430586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480329|NCT00430586|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24480330|NCT00430586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24480331|NCT00430586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480332|NCT00430586|Cholinergic Agents|cholinergic agents|mesh-ancestor
24480333|NCT00430586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24480335|NCT00430651|Docetaxel|docetaxel|mesh-list
24480336|NCT00430651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480337|NCT00430651|Tubulin Modulators|tubulin modulators|mesh-ancestor
25873451|NCT00128856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25873452|NCT00128856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24480393|NCT00430924|Natriuretic Agents|natriuretic agents|mesh-ancestor
24480394|NCT00430924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24480395|NCT00430963|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24480474|NCT00431119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24480475|NCT00431119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24480476|NCT00431119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480477|NCT00431119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480635|NCT00431522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480714|NCT00431704|Mitosis Modulators|mitosis modulators|mesh-ancestor
24480715|NCT00431704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457164|NCT00333281|Tadalafil|tadalafil|mesh-list
24457165|NCT00333281|Vasodilator Agents|vasodilator agents|mesh-ancestor
25873453|NCT00128856|Immunologic Factors|immunologic factors|mesh-ancestor
25235104|NCT02567149|Antiviral Agents|antiviral agents|mesh-ancestor
25235105|NCT02567149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25235106|NCT02567149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235107|NCT02567149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235108|NCT02567253|Cisplatin|cisplatin|mesh-list
25235109|NCT02567253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25235110|NCT02567279|Denosumab|denosumab|mesh-list
25235111|NCT02567279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25235112|NCT02567279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235113|NCT02567175|Domperidone|domperidone|mesh-list
25235114|NCT02567175|Antiemetics|antiemetics|mesh-ancestor
25235115|NCT02567175|Autonomic Agents|autonomic agents|mesh-ancestor
25235116|NCT02567175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25273645|NCT02384512|Protective Agents|protective agents|mesh-ancestor
24949117|NCT05255666|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24949118|NCT05255666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24847656|NCT02248207|Pramipexole|pramipexole|mesh-list
24847657|NCT02248207|Antioxidants|antioxidants|mesh-ancestor
24847658|NCT02248207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847659|NCT02248207|Protective Agents|protective agents|mesh-ancestor
25235117|NCT02567175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235118|NCT02567175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24635794|NCT01141192|Vitamin D|vitamin d|mesh-list
24481193|NCT00433719|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
24481243|NCT00433823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25235120|NCT02567175|Dopamine Agents|dopamine agents|mesh-ancestor
25235121|NCT02567175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25235122|NCT02567175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235123|NCT02567240|Carbon Monoxide|carbon monoxide|mesh-list
25235124|NCT02567240|Antimetabolites|antimetabolites|mesh-ancestor
25235125|NCT02567240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235126|NCT02567240|Gasotransmitters|gasotransmitters|mesh-ancestor
25235127|NCT02567240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25235128|NCT02567240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235129|NCT02566967|Tofacitinib|tofacitinib|mesh-list
25235130|NCT02566967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25235131|NCT02566967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235132|NCT02566967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235133|NCT02567214|Glycopyrrolate|glycopyrrolate|mesh-list
25235134|NCT02567214|Tiotropium Bromide|tiotropium bromide|mesh-list
25235135|NCT02567214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25235136|NCT02567214|Autonomic Agents|autonomic agents|mesh-ancestor
25235137|NCT02567214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25235138|NCT02567214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235139|NCT02567214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25235140|NCT02567214|Respiratory System Agents|respiratory system agents|mesh-ancestor
25235141|NCT02567214|Parasympatholytics|parasympatholytics|mesh-ancestor
25235142|NCT02567214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25873457|NCT00128856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24481251|NCT00433927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24481252|NCT00433927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873458|NCT00128895|Azathioprine|azathioprine|mesh-list
25873459|NCT00128895|Antimetabolites|antimetabolites|mesh-ancestor
25873460|NCT00128895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873461|NCT00128895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24810833|NCT02042690|Glucocorticoids|glucocorticoids|mesh-ancestor
24810834|NCT02042690|Hormones|hormones|mesh-ancestor
24810836|NCT02042690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25074598|NCT03387111|Cyclophosphamide|cyclophosphamide|mesh-list
25074599|NCT03387111|Bevacizumab|bevacizumab|mesh-list
25074600|NCT03387111|Fluorouracil|fluorouracil|mesh-list
25873462|NCT00128895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25226000|NCT02623673|Growth Inhibitors|growth inhibitors|mesh-ancestor
25873463|NCT00128895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25873464|NCT00128895|Immunologic Factors|immunologic factors|mesh-ancestor
24481392|NCT00434239|Immunologic Factors|immunologic factors|mesh-ancestor
24481393|NCT00434239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481394|NCT00434239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24787917|NCT01928407|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24787919|NCT01928407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481395|NCT00434239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24521289|NCT04898894|Vidarabine|vidarabine|mesh-list
25873465|NCT00128895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873466|NCT00128895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25873467|NCT00128908|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25873468|NCT00128908|Antiviral Agents|antiviral agents|mesh-ancestor
25873469|NCT00128908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25876736|NCT02824523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25876737|NCT02824523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25876738|NCT02824523|Analgesics|analgesics|mesh-ancestor
25876739|NCT02824523|Sensory System Agents|sensory system agents|mesh-ancestor
25876740|NCT02824523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25876741|NCT02824523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876742|NCT02824523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25876743|NCT02824523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25876744|NCT02824523|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25235143|NCT02567214|Cholinergic Agents|cholinergic agents|mesh-ancestor
25235144|NCT02567214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25235145|NCT02567214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235146|NCT02567214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24959697|NCT03823248|Hematinics|hematinics|mesh-ancestor
25235147|NCT02567214|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25235148|NCT02566824|Methylphenidate|methylphenidate|mesh-list
25235149|NCT02566824|Amphetamine|amphetamine|mesh-list
25235150|NCT02566824|Adderall|adderall|mesh-list
25235151|NCT02566824|Dextroamphetamine|dextroamphetamine|mesh-list
25235152|NCT02566824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25235153|NCT02566824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235154|NCT02566824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25235155|NCT02566824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25235156|NCT02566824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25235157|NCT02566824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235158|NCT02566824|Dopamine Agents|dopamine agents|mesh-ancestor
25235159|NCT02566824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25876745|NCT02824523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25876746|NCT02824523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876747|NCT02824523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24635818|NCT01141296|Fenofibrate|fenofibrate|mesh-list
25876748|NCT02824523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25876749|NCT02824523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876750|NCT02824523|Antipyretics|antipyretics|mesh-ancestor
25876751|NCT02823366|Fenofibrate|fenofibrate|mesh-list
25876752|NCT02823366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25876753|NCT02823366|Antimetabolites|antimetabolites|mesh-ancestor
25876754|NCT02823366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876755|NCT02823366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25876756|NCT02794571|Paclitaxel|paclitaxel|mesh-list
24457222|NCT00333476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24457223|NCT00333476|Growth Substances|growth substances|mesh-ancestor
25672895|NCT01750931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25672896|NCT01750931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25672897|NCT01750931|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25672898|NCT01750931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25672899|NCT01750931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672900|NCT01750931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672901|NCT01751087|Vitamins|vitamins|mesh-list
25672902|NCT01751087|Vitamin B 12|vitamin b 12|mesh-list
25672903|NCT01751087|Misoprostol|misoprostol|mesh-list
25672904|NCT01751087|Mifepristone|mifepristone|mesh-list
25672905|NCT01751087|Micronutrients|micronutrients|mesh-ancestor
24954308|NCT03877692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24954309|NCT03877692|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24954310|NCT03877692|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24954311|NCT03877679|Triamcinolone|triamcinolone|mesh-list
24779954|NCT01880216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24954313|NCT03877679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24954314|NCT03877679|Glucocorticoids|glucocorticoids|mesh-ancestor
24954315|NCT03877679|Hormones|hormones|mesh-ancestor
24954316|NCT03877679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25075081|NCT03383393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075083|NCT03383393|Vasodilator Agents|vasodilator agents|mesh-ancestor
25873470|NCT05562518|Estrogens|estrogens|mesh-list
25873471|NCT05562518|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24481726|NCT00436709|Antimitotic Agents|antimitotic agents|mesh-ancestor
24481727|NCT00436709|Mitosis Modulators|mitosis modulators|mesh-ancestor
24481728|NCT00436709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873472|NCT05562518|Hormones|hormones|mesh-ancestor
25873473|NCT05562518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25873474|NCT05562518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873475|NCT05562518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25873476|NCT05562518|Immunologic Factors|immunologic factors|mesh-ancestor
25873477|NCT05562492|Insulin|insulin|mesh-list
24482488|NCT00439192|Cholinergic Agents|cholinergic agents|mesh-ancestor
24482489|NCT00439192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24482490|NCT00439192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482491|NCT00439192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482492|NCT00439192|Urological Agents|urological agents|mesh-ancestor
24482493|NCT00439283|Methotrexate|methotrexate|mesh-list
24482494|NCT00439283|Infliximab|infliximab|mesh-list
24521850|NCT04460248|Rituximab|rituximab|mesh-list
24482577|NCT00439751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24482578|NCT00439751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24482580|NCT00439829|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24482581|NCT00439829|Fertility Agents|fertility agents|mesh-ancestor
24457285|NCT00333918|Bromfenac|bromfenac|mesh-list
24457286|NCT00333918|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24457287|NCT00333918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24457288|NCT00333918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24457289|NCT00333918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24457290|NCT00333918|Analgesics|analgesics|mesh-ancestor
24457291|NCT00333918|Sensory System Agents|sensory system agents|mesh-ancestor
25873478|NCT05562492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25873479|NCT05562492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873480|NCT05562466|Budesonide|budesonide|mesh-list
25873481|NCT05562466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25873482|NCT05562466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25873483|NCT05562466|Autonomic Agents|autonomic agents|mesh-ancestor
25235160|NCT02566824|Sympathomimetics|sympathomimetics|mesh-ancestor
25235161|NCT02566824|Autonomic Agents|autonomic agents|mesh-ancestor
25235162|NCT02566824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25235163|NCT02566824|Adrenergic Agents|adrenergic agents|mesh-ancestor
25235164|NCT02566824|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25235165|NCT02566928|Chlorhexidine|chlorhexidine|mesh-list
25235166|NCT02566928|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25235167|NCT02566928|Bacitracin|bacitracin|mesh-list
25235168|NCT02566928|Mupirocin|mupirocin|mesh-list
25235169|NCT02566928|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25235170|NCT02566928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25235171|NCT02566928|Disinfectants|disinfectants|mesh-ancestor
25235172|NCT02566928|Dermatologic Agents|dermatologic agents|mesh-ancestor
25235174|NCT02566928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25235175|NCT02566928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235176|NCT02566928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235177|NCT02566707|Lamivudine|lamivudine|mesh-list
25672906|NCT01751087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672907|NCT01751087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25672908|NCT01751087|Abortifacient Agents|abortifacient agents|mesh-ancestor
25672909|NCT01751087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25672910|NCT01751087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25672911|NCT01751087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25672912|NCT01751087|Oxytocics|oxytocics|mesh-ancestor
25672913|NCT01751087|Vitamin B Complex|vitamin b complex|mesh-ancestor
25672914|NCT01751087|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25672915|NCT01751087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25873484|NCT05562466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25672916|NCT01751087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24482786|NCT00440622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24482787|NCT00440622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24521965|NCT04388683|Nitric Oxide|nitric oxide|mesh-list
24483023|NCT00441506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24483024|NCT00441506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483025|NCT00441519|Aspirin|aspirin|mesh-list
24457305|NCT00333944|Antidotes|antidotes|mesh-ancestor
24405924|NCT00168779|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24959877|NCT03821714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815913|NCT02072720|Bevacizumab|bevacizumab|mesh-list
24959878|NCT03821714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24959880|NCT03821714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24457306|NCT00333944|Protective Agents|protective agents|mesh-ancestor
24457307|NCT00333944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457308|NCT00333944|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
24457309|NCT00333944|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
24457310|NCT00333944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457311|NCT00333944|Cholinergic Agents|cholinergic agents|mesh-ancestor
25873491|NCT05562375|Tolonium Chloride|tolonium chloride|mesh-list
25873492|NCT05562375|Hemostatics|hemostatics|mesh-ancestor
25235178|NCT02566707|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25235179|NCT02566707|Dolutegravir|dolutegravir|mesh-list
25235180|NCT02566707|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25235181|NCT02566707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25235182|NCT02566707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235183|NCT02566707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235184|NCT02566707|Antiviral Agents|antiviral agents|mesh-ancestor
25235185|NCT02566707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25235186|NCT02566707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25235187|NCT02566707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25235188|NCT02566707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25235189|NCT02566707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25235190|NCT02566707|Protease Inhibitors|protease inhibitors|mesh-ancestor
25235191|NCT02566707|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25235192|NCT02566707|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24959881|NCT03821480|Fluconazole|fluconazole|mesh-list
25235199|NCT02566720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25235200|NCT02566720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235201|NCT02566720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907373|NCT04330820|Venetoclax|venetoclax|mesh-list
25672917|NCT01751087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24483083|NCT00441740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24483084|NCT00441740|Antimetabolites|antimetabolites|mesh-ancestor
25672918|NCT01751087|Contraceptive Agents|contraceptive agents|mesh-ancestor
25672919|NCT01751087|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24460713|NCT00349284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998610|NCT02448329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483085|NCT00441740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483086|NCT00441740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24457326|NCT00334022|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24457327|NCT00334022|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24457345|NCT00334048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24457346|NCT00334048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457347|NCT00334048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483214|NCT00442325|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24457351|NCT00334126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24457354|NCT00334126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24457355|NCT00334126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457356|NCT00334126|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24457357|NCT00334126|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24457358|NCT00334126|Serotonin Agents|serotonin agents|mesh-ancestor
24457359|NCT00334126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24618820|NCT01049815|Sequestering Agents|sequestering agents|mesh-ancestor
24618821|NCT01049841|Sirolimus|sirolimus|mesh-list
24618822|NCT01049841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24618823|NCT01049841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24618824|NCT01049841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24618825|NCT01049841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24483322|NCT00442780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483323|NCT00442793|Epoetin Alfa|epoetin alfa|mesh-list
24483386|NCT00443170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24483388|NCT00443222|Infliximab|infliximab|mesh-list
24483389|NCT00443222|Dermatologic Agents|dermatologic agents|mesh-ancestor
24483390|NCT00443222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24483391|NCT00443222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24457365|NCT00334139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24522350|NCT03940196|Paclitaxel|paclitaxel|mesh-list
24483490|NCT00443794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24483491|NCT00443794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24483492|NCT00443794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873493|NCT05562375|Coagulants|coagulants|mesh-ancestor
25873494|NCT05562375|Heparin Antagonists|heparin antagonists|mesh-ancestor
24483521|NCT00443937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24483522|NCT00443937|Immunologic Factors|immunologic factors|mesh-ancestor
24483523|NCT00443937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522383|NCT03893175|Acetaminophen|acetaminophen|mesh-list
24483558|NCT00444015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24483559|NCT00444015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483560|NCT00444015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483561|NCT00444041|Bevacizumab|bevacizumab|mesh-list
24483562|NCT00444041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24483563|NCT00444041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24483564|NCT00444041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25235202|NCT02566720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25235203|NCT02566720|Analgesics|analgesics|mesh-ancestor
25235204|NCT02566720|Sensory System Agents|sensory system agents|mesh-ancestor
25235205|NCT02566720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24847696|NCT02248259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24847697|NCT02248259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635930|NCT01141894|Adrenergic Agents|adrenergic agents|mesh-ancestor
24847698|NCT02248259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24847699|NCT02248259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24847700|NCT02248415|Anesthetics|anesthetics|mesh-list
24847701|NCT02248415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24847702|NCT02248415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847703|NCT02248428|Thalidomide|thalidomide|mesh-list
24847704|NCT02248428|Clarithromycin|clarithromycin|mesh-list
24847705|NCT02248428|Dexamethasone|dexamethasone|mesh-list
24847706|NCT02248428|Cyclophosphamide|cyclophosphamide|mesh-list
24847707|NCT02248428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24847708|NCT02248428|Immunologic Factors|immunologic factors|mesh-ancestor
24847709|NCT02248428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847710|NCT02248428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25672920|NCT01751087|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25672921|NCT01751087|Hormone Antagonists|hormone antagonists|mesh-ancestor
25672922|NCT01751087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25048720|NCT00673478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25048721|NCT00673478|Respiratory System Agents|respiratory system agents|mesh-ancestor
25048722|NCT00673478|Parasympatholytics|parasympatholytics|mesh-ancestor
24999060|NCT05312762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24999062|NCT05312762|Sequestering Agents|sequestering agents|mesh-ancestor
24999063|NCT05312762|Hemostatics|hemostatics|mesh-ancestor
24999064|NCT05312762|Coagulants|coagulants|mesh-ancestor
24999065|NCT05312762|Laxatives|laxatives|mesh-ancestor
24839992|NCT02206815|Clopidogrel|clopidogrel|mesh-list
24840031|NCT02206932|Simeprevir|simeprevir|mesh-list
24999168|NCT05083312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24840073|NCT02207387|Rasagiline|rasagiline|mesh-list
25064496|NCT03459417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24457400|NCT00334347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457401|NCT00334347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457403|NCT00334347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24457404|NCT00334347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457405|NCT00334347|Antimanic Agents|antimanic agents|mesh-ancestor
24457406|NCT00334347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24457407|NCT00334347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24457408|NCT00334347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25873495|NCT05562375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873496|NCT05562349|Clavulanic Acids|clavulanic acids|mesh-list
24484154|NCT00446836|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
24484155|NCT00446836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24457423|NCT00334360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749318|NCT01190787|Bortezomib|bortezomib|mesh-list
24457427|NCT00334360|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24457428|NCT00334360|Serotonin Agents|serotonin agents|mesh-ancestor
24457429|NCT00334386|Torsemide|torsemide|mesh-list
24457430|NCT00334386|Diuretics|diuretics|mesh-list
24457431|NCT00334386|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
24457432|NCT00334386|Natriuretic Agents|natriuretic agents|mesh-ancestor
24457433|NCT00334386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457434|NCT00334386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24457435|NCT00334386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457436|NCT00334386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24457437|NCT00334399|Miglitol|miglitol|mesh-list
24457438|NCT00334399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457439|NCT00334399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457440|NCT00334399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24457441|NCT00334399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235206|NCT02566733|Remifentanil|remifentanil|mesh-list
25235207|NCT02566733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25235208|NCT02566733|Narcotics|narcotics|mesh-ancestor
25235209|NCT02566733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25235210|NCT02566733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235211|NCT02566733|Analgesics|analgesics|mesh-ancestor
25235212|NCT02566733|Sensory System Agents|sensory system agents|mesh-ancestor
25235213|NCT02566733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25273646|NCT02384512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273647|NCT02384135|Fibrin fragment D|fibrin fragment d|mesh-list
25273648|NCT02384135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25273649|NCT02384135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25273650|NCT02384135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273651|NCT02384135|Hemostatics|hemostatics|mesh-ancestor
25273652|NCT02384135|Coagulants|coagulants|mesh-ancestor
25273653|NCT02384122|Octreotide|octreotide|mesh-list
25273654|NCT02384122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24847711|NCT02248428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24847713|NCT02248428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847714|NCT02248428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24847715|NCT02248428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24847716|NCT02248428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25672923|NCT01751087|Luteolytic Agents|luteolytic agents|mesh-ancestor
25672924|NCT01751087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25672925|NCT01751087|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25672926|NCT01751113|Fluticasone|fluticasone|mesh-list
25672928|NCT01751113|Bromides|bromides|mesh-list
25672929|NCT01751113|Tiotropium Bromide|tiotropium bromide|mesh-list
25672930|NCT01751113|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25672931|NCT01751113|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25672932|NCT01751113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25672933|NCT01751113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24798408|NCT01963546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24798409|NCT01963546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798410|NCT01963546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25048794|NCT00668772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24847717|NCT02248428|Antiemetics|antiemetics|mesh-ancestor
24847718|NCT02248428|Autonomic Agents|autonomic agents|mesh-ancestor
24847719|NCT02248428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24847720|NCT02248428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24847721|NCT02248428|Glucocorticoids|glucocorticoids|mesh-ancestor
24847722|NCT02248428|Hormones|hormones|mesh-ancestor
24457445|NCT00334412|Antifungal Agents|antifungal agents|mesh-ancestor
24457446|NCT00334412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24457447|NCT00334412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457448|NCT00334412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457476|NCT00334490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24457477|NCT00334490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457478|NCT00334490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457479|NCT00334490|Urological Agents|urological agents|mesh-ancestor
24457481|NCT00334503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24749355|NCT01166113|Growth Substances|growth substances|mesh-ancestor
24749356|NCT01166113|Growth Inhibitors|growth inhibitors|mesh-ancestor
24749358|NCT01160107|Melphalan|melphalan|mesh-list
24749359|NCT01160107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24486879|NCT00460382|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24486881|NCT00460447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24486882|NCT00460447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486883|NCT00460473|Dexmedetomidine|dexmedetomidine|mesh-list
24486884|NCT00460473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24486885|NCT00460473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24523086|NCT02821507|Antifungal Agents|antifungal agents|mesh-ancestor
24487541|NCT00463736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487542|NCT00463736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24487543|NCT00463736|Tocolytic Agents|tocolytic agents|mesh-ancestor
24487544|NCT00463736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24487545|NCT00463762|Sulbactam|sulbactam|mesh-list
24487546|NCT00463762|Cefoperazone|cefoperazone|mesh-list
24487547|NCT00463762|Sulperazone|sulperazone|mesh-list
24487548|NCT00463762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24487549|NCT00463762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24523160|NCT02451358|Vaccines|vaccines|mesh-list
24487828|NCT00465244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24487829|NCT00465244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487831|NCT00465244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24487832|NCT00465244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25235214|NCT02566356|Oxytocin|oxytocin|mesh-list
25235215|NCT02566356|Oxytocics|oxytocics|mesh-ancestor
25235216|NCT02566356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25235217|NCT02566356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235218|NCT02566252|Cromolyn Sodium|cromolyn sodium|mesh-list
25235219|NCT02566252|Albuterol|albuterol|mesh-list
25235220|NCT02566252|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
25235221|NCT02566252|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25235222|NCT02566252|Autonomic Agents|autonomic agents|mesh-ancestor
25235223|NCT02566252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25235224|NCT02566252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235225|NCT02566252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25235226|NCT02566252|Respiratory System Agents|respiratory system agents|mesh-ancestor
25235227|NCT02566252|Tocolytic Agents|tocolytic agents|mesh-ancestor
25078580|NCT03355300|Anticonvulsants|anticonvulsants|mesh-ancestor
25078581|NCT03355248|Acetaminophen|acetaminophen|mesh-list
25672934|NCT01751113|Autonomic Agents|autonomic agents|mesh-ancestor
25672935|NCT01751113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25672936|NCT01751113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672937|NCT01751113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25672938|NCT01751113|Respiratory System Agents|respiratory system agents|mesh-ancestor
25672939|NCT01751113|Dermatologic Agents|dermatologic agents|mesh-ancestor
25672940|NCT01751113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25672941|NCT01751113|Parasympatholytics|parasympatholytics|mesh-ancestor
24635918|NCT01141894|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24635929|NCT01141894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24635931|NCT01141894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24635932|NCT01141894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635933|NCT01141894|Protective Agents|protective agents|mesh-ancestor
24635934|NCT01141894|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24635935|NCT01141894|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24635936|NCT01141894|Plasma Substitutes|plasma substitutes|mesh-ancestor
24635937|NCT01141894|Blood Substitutes|blood substitutes|mesh-ancestor
24635939|NCT01141972|Vitamins|vitamins|mesh-ancestor
24487833|NCT00465244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24487834|NCT00465244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24487835|NCT00465244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24487836|NCT00465244|GABA Modulators|gaba modulators|mesh-ancestor
24487837|NCT00465244|GABA Agents|gaba agents|mesh-ancestor
24487838|NCT00465244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24487873|NCT00465439|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24487875|NCT00465439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24487876|NCT00465439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487877|NCT00465439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24523245|NCT02336750|Aprepitant|aprepitant|mesh-list
24488652|NCT00469664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24488653|NCT00469664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488654|NCT00469664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488655|NCT00469690|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24488656|NCT00469690|Bromfenac|bromfenac|mesh-list
24488657|NCT00469690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24488658|NCT00469690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24488659|NCT00469690|Analgesics|analgesics|mesh-ancestor
24488660|NCT00469690|Sensory System Agents|sensory system agents|mesh-ancestor
24523290|NCT02178709|Leucovorin|leucovorin|mesh-list
24523363|NCT01721746|Alkylating Agents|alkylating agents|mesh-ancestor
24523364|NCT01716312|Omalizumab|omalizumab|mesh-list
25235229|NCT02566252|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25235230|NCT02566252|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25235231|NCT02566252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25235232|NCT02566252|Adrenergic Agents|adrenergic agents|mesh-ancestor
25235233|NCT02566252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25235234|NCT02566252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235235|NCT02566252|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
25235236|NCT02566252|Immunologic Factors|immunologic factors|mesh-ancestor
25235237|NCT02566252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25235238|NCT02565979|Resveratrol|resveratrol|mesh-list
25235239|NCT02565979|Antioxidants|antioxidants|mesh-ancestor
25235240|NCT02565979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235241|NCT02565979|Protective Agents|protective agents|mesh-ancestor
25235242|NCT02565979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235243|NCT02565979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235244|NCT02565979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25235245|NCT02565953|Paclitaxel|paclitaxel|mesh-list
25672942|NCT01751113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25672943|NCT01751113|Cholinergic Agents|cholinergic agents|mesh-ancestor
25672944|NCT01751113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25235246|NCT02565953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25235247|NCT02565953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24798487|NCT01963832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24798488|NCT01963832|Antidepressive Agents|antidepressive agents|mesh-ancestor
24798489|NCT01963832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24999896|NCT02884219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24999897|NCT02884219|Analgesics|analgesics|mesh-ancestor
24999898|NCT02884219|Sensory System Agents|sensory system agents|mesh-ancestor
24999899|NCT02884219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24999900|NCT02884219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999901|NCT02884219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24999902|NCT02884219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25235248|NCT02565953|Tubulin Modulators|tubulin modulators|mesh-ancestor
25235249|NCT02565953|Antimitotic Agents|antimitotic agents|mesh-ancestor
25235250|NCT02565953|Mitosis Modulators|mitosis modulators|mesh-ancestor
25235251|NCT02565953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235252|NCT02566187|Atorvastatin|atorvastatin|mesh-list
25235253|NCT02566187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24489855|NCT00475618|Fluorides, Topical|fluorides, topical|mesh-list
24489856|NCT00475618|Cariostatic Agents|cariostatic agents|mesh-ancestor
24489857|NCT00475618|Protective Agents|protective agents|mesh-ancestor
24489858|NCT00475618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489929|NCT00475956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24489957|NCT00476034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25004979|NCT05200663|Hormone Antagonists|hormone antagonists|mesh-ancestor
25004980|NCT05200663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25004981|NCT05200663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25004982|NCT05200663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25004983|NCT05200663|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25004984|NCT05200663|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25004985|NCT05200663|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25004986|NCT05200663|Antioxidants|antioxidants|mesh-ancestor
25004987|NCT05200663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004988|NCT05200663|Protective Agents|protective agents|mesh-ancestor
25004989|NCT05198531|Gemcitabine|gemcitabine|mesh-list
25004990|NCT05198531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749504|NCT00945009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24749505|NCT00945009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24749506|NCT00945009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749507|NCT00945009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24749508|NCT00945009|Tubulin Modulators|tubulin modulators|mesh-ancestor
25873497|NCT05562349|Clavulanic Acid|clavulanic acid|mesh-list
25004991|NCT05198531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25004992|NCT05198531|Antimetabolites|antimetabolites|mesh-ancestor
25004993|NCT05198531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004994|NCT05198531|Antiviral Agents|antiviral agents|mesh-ancestor
25873498|NCT05562349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25873499|NCT05562349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25873500|NCT05562349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235254|NCT02566187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25235255|NCT02566187|Antimetabolites|antimetabolites|mesh-ancestor
24960082|NCT03819348|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25235256|NCT02566187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235257|NCT02566187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25235258|NCT02566187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25235259|NCT02566187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235260|NCT02565992|Pembrolizumab|pembrolizumab|mesh-list
25235261|NCT02565992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25005014|NCT05180214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24870446|NCT05161403|Viscosupplements|viscosupplements|mesh-ancestor
24749543|NCT00866918|Methotrexate|methotrexate|mesh-list
24749544|NCT00866918|Mercaptopurine|mercaptopurine|mesh-list
24749545|NCT00866918|Mitoxantrone|mitoxantrone|mesh-list
24749546|NCT00866918|Idarubicin|idarubicin|mesh-list
25672945|NCT01751113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672946|NCT01751113|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25672947|NCT01751113|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25672948|NCT01751113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25672949|NCT01751113|Adrenergic Agents|adrenergic agents|mesh-ancestor
25672950|NCT01751113|Anticonvulsants|anticonvulsants|mesh-ancestor
25672951|NCT01751113|Glucocorticoids|glucocorticoids|mesh-ancestor
25672952|NCT01751113|Hormones|hormones|mesh-ancestor
25672953|NCT01751113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25672954|NCT01751113|Sympathomimetics|sympathomimetics|mesh-ancestor
25876757|NCT02794571|Etoposide|etoposide|mesh-list
25048863|NCT00662506|Antimetabolites|antimetabolites|mesh-ancestor
25048895|NCT00658372|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24944862|NCT03956823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24938225|NCT04020653|Artemether|artemether|mesh-list
24938226|NCT04020653|Artemisinins|artemisinins|mesh-list
24938227|NCT04020653|Artemisinin|artemisinin|mesh-list
24841657|NCT02217267|Sensory System Agents|sensory system agents|mesh-ancestor
25000604|NCT04147351|Bevacizumab|bevacizumab|mesh-list
24490319|NCT00477737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24490320|NCT00477737|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24490321|NCT00477763|Cyclosporine|cyclosporine|mesh-list
24490322|NCT00477763|Cyclosporins|cyclosporins|mesh-list
24490323|NCT00477763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490324|NCT00477763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490325|NCT00477763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24490326|NCT00477763|Immunologic Factors|immunologic factors|mesh-ancestor
24523643|NCT05341193|Antiviral Agents|antiviral agents|mesh-ancestor
24490577|NCT00478985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490578|NCT00478985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24490579|NCT00478985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490580|NCT00478985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446932|NCT00306696|Spironolactone|spironolactone|mesh-list
24446933|NCT00306696|Furosemide|furosemide|mesh-list
24490614|NCT00479193|Bacitracin|bacitracin|mesh-list
24490615|NCT00479193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24490616|NCT00479193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24490617|NCT00479193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24490618|NCT00479206|Artesunate|artesunate|mesh-list
24870510|NCT05063851|Memantine|memantine|mesh-list
24490874|NCT00480363|Hormones|hormones|mesh-ancestor
24490875|NCT00480363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24490876|NCT00480363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25235262|NCT02565992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25235263|NCT02566096|Morphine|morphine|mesh-list
25235264|NCT02566096|Bupivacaine|bupivacaine|mesh-list
25235265|NCT02566096|Anesthetics, Local|anesthetics, local|mesh-list
25235266|NCT02566096|Anesthetics|anesthetics|mesh-list
25235267|NCT02566096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25235268|NCT02566096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235269|NCT02566096|Sensory System Agents|sensory system agents|mesh-ancestor
25235270|NCT02566096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25235271|NCT02566096|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25235272|NCT02566096|Narcotics|narcotics|mesh-ancestor
25235273|NCT02566096|Analgesics|analgesics|mesh-ancestor
25235274|NCT02566226|Morphine|morphine|mesh-list
25235275|NCT02566226|Bupivacaine|bupivacaine|mesh-list
25235276|NCT02566226|Anesthetics, Local|anesthetics, local|mesh-ancestor
25235277|NCT02566226|Anesthetics|anesthetics|mesh-ancestor
25235278|NCT02566226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24635961|NCT01142245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044620|NCT01071850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044622|NCT01071239|Busulfan|busulfan|mesh-list
25044623|NCT01071239|Fludarabine|fludarabine|mesh-list
25044624|NCT01071239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25044625|NCT01071239|Immunologic Factors|immunologic factors|mesh-ancestor
25044626|NCT01071239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490877|NCT00480363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490878|NCT00480363|Immunologic Factors|immunologic factors|mesh-ancestor
24490879|NCT00480363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24490880|NCT00480363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24490881|NCT00480363|Growth Substances|growth substances|mesh-ancestor
24490882|NCT00480363|Growth Inhibitors|growth inhibitors|mesh-ancestor
24490884|NCT00480376|Ofloxacin|ofloxacin|mesh-list
24490885|NCT00480376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25876758|NCT02794571|Bevacizumab|bevacizumab|mesh-list
25672955|NCT01751178|Ethanol|ethanol|mesh-list
25672956|NCT01751178|Chlorhexidine|chlorhexidine|mesh-list
25672957|NCT01751178|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25672958|NCT01751178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25672959|NCT01751178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25672960|NCT01751178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25672961|NCT01751178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672962|NCT01751178|Disinfectants|disinfectants|mesh-ancestor
24490912|NCT00480558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490913|NCT00480571|Perphenazine|perphenazine|mesh-list
25876759|NCT02794571|Cisplatin|cisplatin|mesh-list
25876760|NCT02794571|Carboplatin|carboplatin|mesh-list
25001098|NCT05461261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25001099|NCT05461261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25001100|NCT05461261|Glucocorticoids|glucocorticoids|mesh-ancestor
25001101|NCT05461261|Hormones|hormones|mesh-ancestor
25001102|NCT05461261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25001108|NCT05461261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25001109|NCT05461261|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24490914|NCT00480571|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
24490915|NCT00480571|GABA Agents|gaba agents|mesh-ancestor
24490916|NCT00480571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24490917|NCT00480571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490918|NCT00480571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490919|NCT00480571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24491014|NCT00480844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24491015|NCT00480844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491016|NCT00480844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491017|NCT00480844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24491020|NCT00480844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24491021|NCT00480844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24492286|NCT00485823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24492320|NCT00485888|Citalopram|citalopram|mesh-list
24492321|NCT00485888|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24492351|NCT00485901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24492352|NCT00485940|Prucalopride|prucalopride|mesh-list
24492353|NCT00485940|Laxatives|laxatives|mesh-ancestor
24492354|NCT00485940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24492355|NCT00485940|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24492356|NCT00485940|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24492357|NCT00485940|Serotonin Agents|serotonin agents|mesh-ancestor
24492358|NCT00485940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492359|NCT00485940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492360|NCT00485940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492361|NCT00485979|Docetaxel|docetaxel|mesh-list
24492923|NCT00488605|Protective Agents|protective agents|mesh-ancestor
24492924|NCT00488605|Vitamin B Complex|vitamin b complex|mesh-ancestor
24492925|NCT00488605|Vitamins|vitamins|mesh-ancestor
24492926|NCT00488605|Micronutrients|micronutrients|mesh-ancestor
24492983|NCT00488813|Cephalosporins|cephalosporins|mesh-list
24492984|NCT00488813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24492985|NCT00488813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24492986|NCT00488891|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24492987|NCT00488891|Antipsychotic Agents|antipsychotic agents|mesh-list
24492988|NCT00488891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24492989|NCT00488891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24493025|NCT00489099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493026|NCT00489138|Ertapenem|ertapenem|mesh-list
25876761|NCT02794571|Pembrolizumab|pembrolizumab|mesh-list
24493061|NCT00489372|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
24493062|NCT00489372|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24493063|NCT00489372|Protective Agents|protective agents|mesh-ancestor
25235279|NCT02566226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235280|NCT02566226|Sensory System Agents|sensory system agents|mesh-ancestor
25235281|NCT02566226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25235282|NCT02566226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25235283|NCT02566226|Narcotics|narcotics|mesh-ancestor
25235284|NCT02566226|Analgesics|analgesics|mesh-ancestor
25235285|NCT02565888|Ritonavir|ritonavir|mesh-list
25235286|NCT02565888|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25672963|NCT01751178|Dermatologic Agents|dermatologic agents|mesh-ancestor
25672964|NCT01751386|Baclofen|baclofen|mesh-list
25672965|NCT01751386|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25672966|NCT01751386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672967|NCT01751386|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25672968|NCT01751386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25672969|NCT01751386|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25672970|NCT01751386|GABA Agonists|gaba agonists|mesh-ancestor
25672971|NCT01751386|GABA Agents|gaba agents|mesh-ancestor
25235287|NCT02565888|Cobicistat|cobicistat|mesh-list
25235288|NCT02565888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24493327|NCT00490412|Micronutrients|micronutrients|mesh-ancestor
25672972|NCT01751386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25876762|NCT02794571|Capecitabine|capecitabine|mesh-list
25876763|NCT02794571|Pemetrexed|pemetrexed|mesh-list
25049057|NCT00641732|Protease Inhibitors|protease inhibitors|mesh-ancestor
25049065|NCT00640484|Respiratory System Agents|respiratory system agents|mesh-ancestor
25049066|NCT00640484|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25049067|NCT00640484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25049068|NCT00640484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25049069|NCT00640484|Adrenergic Agents|adrenergic agents|mesh-ancestor
25049070|NCT00640484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25049071|NCT00640484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798558|NCT01964157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24798559|NCT01964157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842924|NCT02224443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24493328|NCT00490412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493329|NCT00490412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24493330|NCT00490464|Nicardipine|nicardipine|mesh-list
24493331|NCT00490464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24493332|NCT00490464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24493333|NCT00490464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24493334|NCT00490464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493361|NCT00490685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493362|NCT00490685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493363|NCT00490711|Gemcitabine|gemcitabine|mesh-list
24493364|NCT00490711|Paclitaxel|paclitaxel|mesh-list
24493554|NCT00491426|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24493556|NCT00491426|Ampicillin|ampicillin|mesh-list
24493557|NCT00491426|Caspofungin|caspofungin|mesh-list
24787991|NCT01928888|Histamine Agents|histamine agents|mesh-ancestor
24787994|NCT01928888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787995|NCT01928888|Antacids|antacids|mesh-ancestor
24787997|NCT01928901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24787998|NCT01928901|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24787999|NCT01928901|Antifungal Agents|antifungal agents|mesh-ancestor
24788000|NCT01928914|Moxifloxacin|moxifloxacin|mesh-list
24788001|NCT01928914|Tafenoquine|tafenoquine|mesh-list
24788002|NCT01928914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24788003|NCT01928914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24788004|NCT01928914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24788005|NCT01928914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24788006|NCT01928914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788007|NCT01928914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788008|NCT01928914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25235289|NCT02565888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25235290|NCT02565888|Protease Inhibitors|protease inhibitors|mesh-ancestor
25235291|NCT02565888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235292|NCT02565888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235293|NCT02565888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25235294|NCT02565888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25235295|NCT02565888|Antiviral Agents|antiviral agents|mesh-ancestor
25235296|NCT02565888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24788009|NCT01928914|Antimalarials|antimalarials|mesh-ancestor
24788010|NCT01928914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24788011|NCT01928914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24788012|NCT01929070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24788013|NCT01929070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24788014|NCT01929070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24788015|NCT01929070|Antimetabolites|antimetabolites|mesh-ancestor
24788016|NCT01929070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788017|NCT01929070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24493558|NCT00491426|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24493559|NCT00491426|Anidulafungin|anidulafungin|mesh-list
24493601|NCT00491634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24493602|NCT00491712|Triamcinolone|triamcinolone|mesh-list
25672973|NCT01751386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672974|NCT01751451|Abiraterone Acetate|abiraterone acetate|mesh-list
25672975|NCT01751451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25672976|NCT01751451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25672977|NCT01751451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672978|NCT01751451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25672979|NCT01751451|Hormone Antagonists|hormone antagonists|mesh-ancestor
25672980|NCT01751451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25672981|NCT01751451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672982|NCT01751451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25672983|NCT01751568|Raltegravir Potassium|raltegravir potassium|mesh-list
25049243|NCT00626106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049244|NCT00626106|Immunologic Factors|immunologic factors|mesh-ancestor
25049246|NCT00625833|Antidepressive Agents|antidepressive agents|mesh-ancestor
25049247|NCT00625833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25049248|NCT00625833|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25049249|NCT00625833|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24843943|NCT02230163|Antibodies|antibodies|mesh-list
25002504|NCT04604782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493603|NCT00491712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24493827|NCT00492518|Expectorants|expectorants|mesh-ancestor
25005018|NCT05170893|Micronutrients|micronutrients|mesh-ancestor
25005019|NCT05170893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005023|NCT05074121|Antiviral Agents|antiviral agents|mesh-ancestor
25005024|NCT05074121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25005025|NCT05074121|Expectorants|expectorants|mesh-ancestor
24960231|NCT03818919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25005026|NCT05074121|Respiratory System Agents|respiratory system agents|mesh-ancestor
25005027|NCT05074121|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25005028|NCT05074121|Antioxidants|antioxidants|mesh-ancestor
25005029|NCT05074121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005030|NCT05074121|Protective Agents|protective agents|mesh-ancestor
25005031|NCT05074121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005032|NCT05074121|Antidotes|antidotes|mesh-ancestor
25005033|NCT05069012|Morphine|morphine|mesh-list
25005034|NCT05069012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25005035|NCT05069012|Narcotics|narcotics|mesh-ancestor
25005036|NCT05069012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25005037|NCT05069012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005038|NCT05069012|Analgesics|analgesics|mesh-ancestor
25005039|NCT05069012|Sensory System Agents|sensory system agents|mesh-ancestor
25005040|NCT05069012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25005041|NCT05049343|Ketamine|ketamine|mesh-list
25005042|NCT05049343|Analgesics|analgesics|mesh-ancestor
25005043|NCT05049343|Sensory System Agents|sensory system agents|mesh-ancestor
25005044|NCT05049343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24493828|NCT00492518|Respiratory System Agents|respiratory system agents|mesh-ancestor
24493829|NCT00492518|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24493899|NCT00492830|Immunologic Factors|immunologic factors|mesh-ancestor
24493900|NCT00492830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493936|NCT00493116|Glucocorticoids|glucocorticoids|mesh-ancestor
24623317|NCT01070862|Alkylating Agents|alkylating agents|mesh-ancestor
24495164|NCT00498901|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24495480|NCT00500422|Antimetabolites|antimetabolites|mesh-ancestor
24495570|NCT00501137|Vaccines|vaccines|mesh-list
24495571|NCT00501137|Immunologic Factors|immunologic factors|mesh-ancestor
24495572|NCT00501137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495573|NCT00501150|Linezolid|linezolid|mesh-list
24495574|NCT00501150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24495575|NCT00501150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25876764|NCT02794571|Atezolizumab|atezolizumab|mesh-list
24495772|NCT00501878|Protective Agents|protective agents|mesh-ancestor
24495774|NCT00501904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24495775|NCT00501904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495776|NCT00501917|Darbepoetin alfa|darbepoetin alfa|mesh-list
24495777|NCT00501917|Hematinics|hematinics|mesh-ancestor
25235297|NCT02565888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25235298|NCT02565888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25235299|NCT02565719|Interferons|interferons|mesh-list
24457585|NCT00334685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24457586|NCT00334685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24496154|NCT00503594|Cytarabine|cytarabine|mesh-list
24496155|NCT00503594|Methotrexate|methotrexate|mesh-list
24496156|NCT00503594|Vincristine|vincristine|mesh-list
24496157|NCT00503594|Temozolomide|temozolomide|mesh-list
24496158|NCT00503594|Procarbazine|procarbazine|mesh-list
24496192|NCT00503620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24496193|NCT00503620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496194|NCT00503620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25672984|NCT01751568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25672985|NCT01751568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25672986|NCT01751568|Antiviral Agents|antiviral agents|mesh-ancestor
25672987|NCT01751568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25672988|NCT01751568|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25672989|NCT01751568|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25672990|NCT01751568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25672991|NCT01751568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496195|NCT00503620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25672992|NCT01751646|Vitamin D|vitamin d|mesh-list
25003144|NCT03959085|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25003145|NCT03959085|Levoleucovorin|levoleucovorin|mesh-list
25003146|NCT03959085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25003147|NCT03959085|Immunologic Factors|immunologic factors|mesh-ancestor
25003148|NCT03959085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25003149|NCT03959085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25003150|NCT03959085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25003151|NCT03959085|Alkylating Agents|alkylating agents|mesh-ancestor
25003152|NCT03959085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25003153|NCT03959085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25003154|NCT03959085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25003155|NCT03959085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25003157|NCT03959085|Autonomic Agents|autonomic agents|mesh-ancestor
24462092|NCT00354900|Aprotinin|aprotinin|mesh-list
25873501|NCT05562349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496258|NCT00504062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24496260|NCT00504101|Melphalan|melphalan|mesh-list
24749837|NCT01694134|Antiemetics|antiemetics|mesh-ancestor
24496261|NCT00504101|Arsenic Trioxide|arsenic trioxide|mesh-list
24496262|NCT00504101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496263|NCT00504101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24496264|NCT00504101|Alkylating Agents|alkylating agents|mesh-ancestor
24496265|NCT00504101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496266|NCT00504101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24496267|NCT00504101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24496268|NCT00504101|Immunologic Factors|immunologic factors|mesh-ancestor
24496373|NCT00504413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24496374|NCT00504413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24496375|NCT00504413|Dopamine Agents|dopamine agents|mesh-ancestor
24496376|NCT00504413|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24496377|NCT00504413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24496378|NCT00504413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496379|NCT00504413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24496381|NCT00504413|Analgesics|analgesics|mesh-ancestor
24496382|NCT00504413|Sensory System Agents|sensory system agents|mesh-ancestor
24496383|NCT00504413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24496384|NCT00504413|Antitussive Agents|antitussive agents|mesh-ancestor
25235300|NCT02565719|Tenofovir|tenofovir|mesh-list
25235301|NCT02565719|Interferon-alpha|interferon-alpha|mesh-list
25235302|NCT02565719|Interferon alpha-2|interferon alpha-2|mesh-list
25235303|NCT02565719|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25235304|NCT02565719|REP 2139|rep 2139|mesh-list
25235305|NCT02565719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25235306|NCT02565719|Antiviral Agents|antiviral agents|mesh-ancestor
25235307|NCT02565719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25235308|NCT02565719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25235309|NCT02565719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25873502|NCT05562349|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25873503|NCT05562297|Gemcitabine|gemcitabine|mesh-list
24496557|NCT00505492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24496559|NCT00505492|Tubulin Modulators|tubulin modulators|mesh-ancestor
24496560|NCT00505492|Antimitotic Agents|antimitotic agents|mesh-ancestor
24496561|NCT00505492|Mitosis Modulators|mitosis modulators|mesh-ancestor
24496562|NCT00505492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457590|NCT00334685|Adrenergic Agents|adrenergic agents|mesh-ancestor
24457591|NCT00334685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24457592|NCT00334698|Cetirizine|cetirizine|mesh-list
24457593|NCT00334698|Pseudoephedrine|pseudoephedrine|mesh-list
24457594|NCT00334698|Ephedrine|ephedrine|mesh-list
24457595|NCT00334698|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24496563|NCT00505505|Insulin|insulin|mesh-list
25672993|NCT01751646|Ergocalciferols|ergocalciferols|mesh-list
25672994|NCT01751646|Cholecalciferol|cholecalciferol|mesh-list
25672995|NCT01751646|Vitamins|vitamins|mesh-list
25672996|NCT01751646|Micronutrients|micronutrients|mesh-ancestor
25672997|NCT01751646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25672998|NCT01751646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25672999|NCT01751646|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25673000|NCT01751724|Caffeine|caffeine|mesh-list
25673001|NCT01751724|Caffeine citrate|caffeine citrate|mesh-list
25673002|NCT01751724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673003|NCT01751724|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25673004|NCT01751724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673005|NCT01751724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25673006|NCT01751724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998339|NCT03110484|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24998340|NCT03110484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998341|NCT03110484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998342|NCT03110484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998343|NCT03110484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24499195|NCT00518232|Dopamine Agents|dopamine agents|mesh-ancestor
25003305|NCT03830866|Carboplatin|carboplatin|mesh-list
25003307|NCT03830866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25003308|NCT03830866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24496564|NCT00505505|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24496565|NCT00505505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24496566|NCT00505505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496567|NCT00505531|Diphenhydramine|diphenhydramine|mesh-list
24496568|NCT00505531|Tramadol|tramadol|mesh-list
24496569|NCT00505531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24496570|NCT00505531|Narcotics|narcotics|mesh-ancestor
24496717|NCT00506298|Diflunisal|diflunisal|mesh-list
24496718|NCT00506298|Bezafibrate|bezafibrate|mesh-list
24496719|NCT00506298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24496720|NCT00506298|Antimetabolites|antimetabolites|mesh-ancestor
24496812|NCT00506935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496815|NCT00506961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24496816|NCT00506961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24496817|NCT00506961|Antimetabolites|antimetabolites|mesh-ancestor
24496818|NCT00506961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873504|NCT05562297|Paclitaxel|paclitaxel|mesh-list
24496904|NCT00507195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24496905|NCT00507195|GABA Modulators|gaba modulators|mesh-ancestor
24496906|NCT00507195|GABA Agents|gaba agents|mesh-ancestor
24496908|NCT00507195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496975|NCT00507637|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24496976|NCT00507637|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24496977|NCT00507637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24496978|NCT00507637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496979|NCT00507637|Cholinergic Agents|cholinergic agents|mesh-ancestor
24496980|NCT00507637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24496981|NCT00507637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235310|NCT02565719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235311|NCT02565719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235312|NCT02565719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25235313|NCT02565719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25235314|NCT02565719|Immunologic Factors|immunologic factors|mesh-ancestor
25235315|NCT02565719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235316|NCT02565680|Prednisone|prednisone|mesh-list
25235317|NCT02565680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25235318|NCT02565680|Glucocorticoids|glucocorticoids|mesh-ancestor
25235319|NCT02565680|Hormones|hormones|mesh-ancestor
25154711|NCT05469880|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25154712|NCT05469880|Dermatologic Agents|dermatologic agents|mesh-ancestor
25154713|NCT05469750|Capecitabine|capecitabine|mesh-list
25154714|NCT05469750|Letrozole|letrozole|mesh-list
25154715|NCT05469750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25154716|NCT05469750|Antimetabolites|antimetabolites|mesh-ancestor
25154717|NCT05469750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154718|NCT05469750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25154719|NCT05469750|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25078625|NCT03355027|Atorvastatin|atorvastatin|mesh-list
25154720|NCT05469750|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25154721|NCT05469750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25154722|NCT05469750|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25154723|NCT05469750|Hormone Antagonists|hormone antagonists|mesh-ancestor
25154724|NCT05469750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25154725|NCT05469750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154738|NCT05469659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154739|NCT05469659|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25409928|NCT03337698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25673007|NCT01751724|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25673008|NCT01751724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25673009|NCT01751724|Purinergic Agents|purinergic agents|mesh-ancestor
25673010|NCT01751724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25673011|NCT01751802|Ecopipam|ecopipam|mesh-list
25673012|NCT01751802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25673013|NCT01751802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25673014|NCT01751802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25673015|NCT01751802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049360|NCT00613002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25049362|NCT00612820|Fluticasone|fluticasone|mesh-list
25049364|NCT00612820|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
25049365|NCT00612820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25049366|NCT00612820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25049367|NCT00612820|Autonomic Agents|autonomic agents|mesh-ancestor
25049368|NCT00612820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25049369|NCT00612820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154740|NCT05469659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154741|NCT05469529|Dexmedetomidine|dexmedetomidine|mesh-list
25154742|NCT05469529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25064580|NCT03458481|Sofosbuvir|sofosbuvir|mesh-list
25235320|NCT02565680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25235321|NCT02565680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235322|NCT02565680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25235323|NCT02565680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25235324|NCT02565862|Metformin|metformin|mesh-list
25235325|NCT02565862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25235326|NCT02565862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235327|NCT02565836|Thrombin|thrombin|mesh-list
25235328|NCT02565836|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
25235329|NCT02565836|Hemostatics|hemostatics|mesh-ancestor
25235330|NCT02565836|Coagulants|coagulants|mesh-ancestor
25235331|NCT02565641|Gemcitabine|gemcitabine|mesh-list
25235332|NCT02565641|Capecitabine|capecitabine|mesh-list
25235333|NCT02565641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25235334|NCT02565641|Antimetabolites|antimetabolites|mesh-ancestor
25235335|NCT02565641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235336|NCT02565641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25235337|NCT02565641|Antiviral Agents|antiviral agents|mesh-ancestor
25235338|NCT02565641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25235339|NCT02565641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235340|NCT02565641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25235341|NCT02565641|Immunologic Factors|immunologic factors|mesh-ancestor
25235342|NCT02565641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235343|NCT02565693|Aspirin|aspirin|mesh-list
25235344|NCT02565693|Carbaspirin calcium|carbaspirin calcium|mesh-list
25235345|NCT02565693|Dipyridamole|dipyridamole|mesh-list
25235346|NCT02565693|Apixaban|apixaban|mesh-list
25235347|NCT02565693|Clopidogrel|clopidogrel|mesh-list
25235348|NCT02565693|Calcium|calcium|mesh-list
25235349|NCT02565693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25235350|NCT02565693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235351|NCT02565693|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25235352|NCT02565693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25235353|NCT02565693|Analgesics|analgesics|mesh-ancestor
25235354|NCT02565693|Sensory System Agents|sensory system agents|mesh-ancestor
24704261|NCT01477385|Fluorides|fluorides|mesh-list
25235355|NCT02565693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25235356|NCT02565693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25235357|NCT02565693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25235358|NCT02565693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25154747|NCT05469529|Sensory System Agents|sensory system agents|mesh-ancestor
25154748|NCT05469529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25154749|NCT05469529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25154750|NCT05469529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25154751|NCT05469529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25154752|NCT05469529|Adrenergic Agents|adrenergic agents|mesh-ancestor
25154753|NCT05469529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25154754|NCT05469529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154755|NCT05469412|Midazolam|midazolam|mesh-list
25154756|NCT05469412|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25154757|NCT05469412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25673016|NCT01751802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25673017|NCT01751802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25673018|NCT01751802|Dopamine Agents|dopamine agents|mesh-ancestor
25673019|NCT01751802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25673020|NCT01751802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673021|NCT01751867|Decitabine|decitabine|mesh-list
25673022|NCT01751867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25673023|NCT01751867|Antimetabolites|antimetabolites|mesh-ancestor
25673024|NCT01751867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673025|NCT01751867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25049480|NCT00602602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049481|NCT00602602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25003917|NCT02923128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25003918|NCT02923128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25003920|NCT02923128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25873505|NCT05562297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24847761|NCT02248506|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24847762|NCT02248506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24847763|NCT02248506|Antifungal Agents|antifungal agents|mesh-ancestor
24847764|NCT02248506|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24960496|NCT03816020|Niacin|niacin|mesh-list
24960560|NCT03815838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847765|NCT02248506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24847784|NCT05354479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635971|NCT01142258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635972|NCT01142258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24635973|NCT01142258|Serotonin Agents|serotonin agents|mesh-ancestor
24497088|NCT00507975|Autonomic Agents|autonomic agents|mesh-ancestor
24497089|NCT00507975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24497090|NCT00507975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497091|NCT00507975|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24497092|NCT00507975|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24497093|NCT00507975|Cholinergic Agents|cholinergic agents|mesh-ancestor
24497094|NCT00507975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24524545|NCT04739592|Micronutrients|micronutrients|mesh-ancestor
24524546|NCT04739592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497307|NCT00509405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497308|NCT00509405|Expectorants|expectorants|mesh-ancestor
24497309|NCT00509405|Respiratory System Agents|respiratory system agents|mesh-ancestor
24497311|NCT00509431|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24497312|NCT00509431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25235359|NCT02565693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25235360|NCT02565693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235361|NCT02565693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25235362|NCT02565693|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25235363|NCT02565693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235364|NCT02565693|Antipyretics|antipyretics|mesh-ancestor
25235365|NCT02565693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25235366|NCT02565693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25235367|NCT02565693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25235368|NCT02565693|Purinergic Agents|purinergic agents|mesh-ancestor
25235369|NCT02565693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25235370|NCT02565693|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25235371|NCT02565693|Antithrombins|antithrombins|mesh-ancestor
25235372|NCT02565693|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25235373|NCT02565693|Protease Inhibitors|protease inhibitors|mesh-ancestor
25235374|NCT02565693|Anticoagulants|anticoagulants|mesh-ancestor
25235375|NCT02565693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25235376|NCT02565693|Vasodilator Agents|vasodilator agents|mesh-ancestor
25235377|NCT02565602|Vitamin D|vitamin d|mesh-list
25235378|NCT02565602|Cholecalciferol|cholecalciferol|mesh-list
25235379|NCT02565602|Vitamins|vitamins|mesh-ancestor
25235380|NCT02565602|Micronutrients|micronutrients|mesh-ancestor
25235381|NCT02565602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235382|NCT02565602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25235383|NCT02565602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25235384|NCT02565368|Metformin|metformin|mesh-list
25235385|NCT02565368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25235386|NCT02565368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235387|NCT02565212|Montelukast|montelukast|mesh-list
25235388|NCT02565212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25673026|NCT01751867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25673027|NCT01752413|Ferrous gluconate|ferrous gluconate|mesh-list
25673028|NCT01752413|Hematinics|hematinics|mesh-ancestor
25673029|NCT01752426|Deuterium Oxide|deuterium oxide|mesh-list
25673030|NCT01752426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673031|NCT01752426|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25673032|NCT01752426|Protective Agents|protective agents|mesh-ancestor
25673033|NCT01752426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873506|NCT05562297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24635975|NCT01142258|Antidepressive Agents|antidepressive agents|mesh-ancestor
25873507|NCT05562297|Tubulin Modulators|tubulin modulators|mesh-ancestor
24847792|NCT05354076|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24847793|NCT05354076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24847794|NCT05354076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24847795|NCT05354076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24847796|NCT05354076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24847797|NCT05354076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24847798|NCT05354076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847800|NCT05353816|Anticoagulants|anticoagulants|mesh-ancestor
24847801|NCT05353816|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24847802|NCT05353816|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24847803|NCT05353816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847804|NCT05353673|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24847805|NCT05353673|Danazol|danazol|mesh-list
24847806|NCT05353673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24949210|NCT05158998|Propofol|propofol|mesh-list
24497313|NCT00509431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24497314|NCT00509431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497315|NCT00509431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497316|NCT00509431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24497317|NCT00509431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24497318|NCT00509431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24497319|NCT00509431|Antifungal Agents|antifungal agents|mesh-ancestor
24497320|NCT00509431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24497321|NCT00509431|Immunologic Factors|immunologic factors|mesh-ancestor
24497322|NCT00509431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497323|NCT00509470|Amlodipine|amlodipine|mesh-list
24497324|NCT00509470|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24497325|NCT00509470|Telmisartan|telmisartan|mesh-list
24497326|NCT00509470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24497327|NCT00509470|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24497413|NCT00509990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497414|NCT00510003|Pimecrolimus|pimecrolimus|mesh-list
25235389|NCT02565212|Respiratory System Agents|respiratory system agents|mesh-ancestor
25235390|NCT02565212|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25235391|NCT02565212|Hormone Antagonists|hormone antagonists|mesh-ancestor
25235392|NCT02565212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25235393|NCT02565212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235394|NCT02565212|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25235395|NCT02565212|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25235396|NCT02565212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235397|NCT02565303|Ropivacaine|ropivacaine|mesh-list
25235398|NCT02565303|Anesthetics, Local|anesthetics, local|mesh-ancestor
25235399|NCT02565303|Anesthetics|anesthetics|mesh-ancestor
25235400|NCT02565303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25235401|NCT02565303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235402|NCT02565303|Sensory System Agents|sensory system agents|mesh-ancestor
25235403|NCT02565303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25235404|NCT02565316|Sertraline|sertraline|mesh-list
25235405|NCT02565316|Antidepressive Agents|antidepressive agents|mesh-ancestor
25235406|NCT02565316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25235407|NCT02565316|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25235408|NCT02565316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25235409|NCT02565316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25235410|NCT02565316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235411|NCT02565316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25235412|NCT02565316|Serotonin Agents|serotonin agents|mesh-ancestor
25235413|NCT02565316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235414|NCT02565173|Timolol|timolol|mesh-list
25235415|NCT02565173|Adenosine|adenosine|mesh-list
25673034|NCT01752712|Oxytocin|oxytocin|mesh-list
25873508|NCT05562297|Antimitotic Agents|antimitotic agents|mesh-ancestor
25873509|NCT05562297|Mitosis Modulators|mitosis modulators|mesh-ancestor
25873510|NCT05562297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873511|NCT05562297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25873512|NCT05562297|Antimetabolites|antimetabolites|mesh-ancestor
25873513|NCT05562297|Antiviral Agents|antiviral agents|mesh-ancestor
25873514|NCT05562297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24497840|NCT00512070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497841|NCT00512070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24497843|NCT00512070|Autonomic Agents|autonomic agents|mesh-ancestor
24749973|NCT01695174|Rifaximin|rifaximin|mesh-list
24497992|NCT00512980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497993|NCT00512980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497994|NCT00512980|Antiviral Agents|antiviral agents|mesh-ancestor
24497995|NCT00512980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24497996|NCT00512980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497997|NCT00512980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24497998|NCT00512980|Immunologic Factors|immunologic factors|mesh-ancestor
24498034|NCT00513110|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24498035|NCT00513110|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24498105|NCT00513188|Micronutrients|micronutrients|mesh-ancestor
24498795|NCT00516399|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24498796|NCT00516399|Plasma Substitutes|plasma substitutes|mesh-ancestor
24498797|NCT00516399|Blood Substitutes|blood substitutes|mesh-ancestor
24498798|NCT00516399|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24498799|NCT00516399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24498800|NCT00516399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24524658|NCT04549207|Denosumab|denosumab|mesh-list
24498983|NCT00517114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24498984|NCT00517114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24498985|NCT00517114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24498986|NCT00517114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498987|NCT00517114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498988|NCT00517179|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
25235416|NCT02565173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25235417|NCT02565173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25235418|NCT02565173|Adrenergic Agents|adrenergic agents|mesh-ancestor
25235419|NCT02565173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25235420|NCT02565173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235421|NCT02565173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235422|NCT02565173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25235423|NCT02565173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25235424|NCT02565173|Analgesics|analgesics|mesh-ancestor
25235425|NCT02565173|Sensory System Agents|sensory system agents|mesh-ancestor
25235426|NCT02565173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25235427|NCT02565173|Vasodilator Agents|vasodilator agents|mesh-ancestor
25235428|NCT02565173|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25235429|NCT02565173|Purinergic Agonists|purinergic agonists|mesh-ancestor
25235430|NCT02565173|Purinergic Agents|purinergic agents|mesh-ancestor
24847809|NCT05353673|Hormones|hormones|mesh-ancestor
24484720|NCT00449657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24847814|NCT05353673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673035|NCT01752712|Oxytocics|oxytocics|mesh-ancestor
25673036|NCT01752712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25673037|NCT01752712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673038|NCT01752842|Fenofibrate|fenofibrate|mesh-list
25873516|NCT05562297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25873517|NCT05562297|Immunologic Factors|immunologic factors|mesh-ancestor
25673039|NCT01752842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25673040|NCT01752842|Antimetabolites|antimetabolites|mesh-ancestor
25873518|NCT05562297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498989|NCT00517179|Vasodilator Agents|vasodilator agents|mesh-ancestor
24498990|NCT00517179|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24499052|NCT00517504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24499229|NCT00518375|Sirolimus|sirolimus|mesh-list
24499230|NCT00518375|Cyclosporins|cyclosporins|mesh-list
24499231|NCT00518375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499232|NCT00518375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499233|NCT00518375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24499234|NCT00518375|Immunologic Factors|immunologic factors|mesh-ancestor
24499235|NCT00518375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499236|NCT00518375|Antifungal Agents|antifungal agents|mesh-ancestor
24499237|NCT00518375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24499238|NCT00518375|Dermatologic Agents|dermatologic agents|mesh-ancestor
24499239|NCT00518375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24499240|NCT00518375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24499241|NCT00518375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24499242|NCT00518375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24499460|NCT00519480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499461|NCT00519519|Omeprazole|omeprazole|mesh-list
24499462|NCT00519519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24499463|NCT00519519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24499464|NCT00519519|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24889664|NCT04490967|Silybin|silybin|mesh-list
24499465|NCT00519519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25005102|NCT04856176|Sargramostim|sargramostim|mesh-list
24499466|NCT00519519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499468|NCT00519675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24499469|NCT00519675|Dermatologic Agents|dermatologic agents|mesh-ancestor
24499470|NCT00519688|Thalidomide|thalidomide|mesh-list
24499471|NCT00519688|Tegafur|tegafur|mesh-list
24499472|NCT00519688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24499473|NCT00519688|Immunologic Factors|immunologic factors|mesh-ancestor
24499474|NCT00519688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499475|NCT00519688|Leprostatic Agents|leprostatic agents|mesh-ancestor
24499577|NCT00520091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24499578|NCT00520091|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24499579|NCT00520091|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24499581|NCT00520104|Analgesics|analgesics|mesh-ancestor
24499582|NCT00520104|Sensory System Agents|sensory system agents|mesh-ancestor
24499631|NCT00520260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499662|NCT00520442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499663|NCT00520442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499664|NCT00520442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24499665|NCT00520442|Narcotics|narcotics|mesh-ancestor
24499666|NCT00520442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24499667|NCT00520442|Antitussive Agents|antitussive agents|mesh-ancestor
24499668|NCT00520442|Respiratory System Agents|respiratory system agents|mesh-ancestor
24499669|NCT00520455|Levonorgestrel|levonorgestrel|mesh-list
24499670|NCT00520455|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25235431|NCT02564861|DS-1971a|ds-1971a|mesh-list
25235432|NCT02564861|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25235433|NCT02564861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25235434|NCT02564861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25235435|NCT02564861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273655|NCT02384122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25273656|NCT02384122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25273657|NCT02383901|Methotrexate|methotrexate|mesh-list
25273658|NCT02383901|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25273659|NCT02383901|Abortifacient Agents|abortifacient agents|mesh-ancestor
25273660|NCT02383901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25673041|NCT01752842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673042|NCT01752842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25873520|NCT05562089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25873521|NCT05562089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873522|NCT05562089|Tubulin Modulators|tubulin modulators|mesh-ancestor
25873523|NCT05562089|Antimitotic Agents|antimitotic agents|mesh-ancestor
25873524|NCT05562089|Mitosis Modulators|mitosis modulators|mesh-ancestor
24499671|NCT00520455|Contraceptive Agents|contraceptive agents|mesh-ancestor
24499672|NCT00520455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24499673|NCT00520455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499674|NCT00520455|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24499675|NCT00520455|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24499676|NCT00520455|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24499677|NCT00520507|Olanzapine|olanzapine|mesh-list
24499678|NCT00520507|Antiemetics|antiemetics|mesh-ancestor
24499679|NCT00520507|Autonomic Agents|autonomic agents|mesh-ancestor
24499680|NCT00520507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24500132|NCT00522821|Antibodies|antibodies|mesh-list
24500133|NCT00522821|gamma-Globulins|gamma-globulins|mesh-list
24500134|NCT00522821|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24500135|NCT00522821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24500136|NCT00522821|Immunologic Factors|immunologic factors|mesh-ancestor
24750123|NCT01696617|Dopamine Agents|dopamine agents|mesh-ancestor
24500137|NCT00522821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500139|NCT00522886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25873525|NCT05562089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500339|NCT00523913|Rosiglitazone|rosiglitazone|mesh-list
24500340|NCT00523913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24500341|NCT00523913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500342|NCT00523926|Bedaquiline|bedaquiline|mesh-list
24500343|NCT00523926|Antitubercular Agents|antitubercular agents|mesh-ancestor
24500345|NCT00523926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24500347|NCT00523952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24500348|NCT00523952|Immunologic Factors|immunologic factors|mesh-ancestor
24500349|NCT00523952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873526|NCT05562063|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25873527|NCT05562063|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25873528|NCT05562063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873529|NCT05562063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25873530|NCT05562063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873531|NCT05561972|Hyaluronic Acid|hyaluronic acid|mesh-list
25873532|NCT05561972|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25873533|NCT05561972|Immunologic Factors|immunologic factors|mesh-ancestor
25873534|NCT05561972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873535|NCT05561972|Viscosupplements|viscosupplements|mesh-ancestor
25235436|NCT02564536|Decitabine|decitabine|mesh-list
25235437|NCT02564536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25235438|NCT02564536|Antimetabolites|antimetabolites|mesh-ancestor
25235439|NCT02564536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235440|NCT02564536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25235441|NCT02564536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235442|NCT02564315|Nicotine|nicotine|mesh-list
24960690|NCT03814707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25235443|NCT02564315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25235444|NCT02564315|Autonomic Agents|autonomic agents|mesh-ancestor
25235445|NCT02564315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25235446|NCT02564315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235447|NCT02564315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25235448|NCT02564315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25235449|NCT02564315|Cholinergic Agents|cholinergic agents|mesh-ancestor
25235450|NCT02564315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25235451|NCT02564315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235452|NCT02564237|Vaccines|vaccines|mesh-list
24457632|NCT00334789|Vitamins|vitamins|mesh-ancestor
24457633|NCT00334789|Micronutrients|micronutrients|mesh-ancestor
24457634|NCT00334789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394494|NCT00133367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24500684|NCT00525473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24500685|NCT00525473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673043|NCT01752855|Adalimumab|adalimumab|mesh-list
25673044|NCT01752855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25673045|NCT01752855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25673046|NCT01752933|Guadecitabine|guadecitabine|mesh-list
25673047|NCT01752933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673048|NCT01753115|Ciprofloxacin|ciprofloxacin|mesh-list
25673049|NCT01753115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25673050|NCT01753115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25673051|NCT01753115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25673052|NCT01753115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24501048|NCT00526409|Glucocorticoids|glucocorticoids|mesh-ancestor
24501049|NCT00526409|Hormones|hormones|mesh-ancestor
24501050|NCT00526409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24501051|NCT00526409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24501452|NCT00528658|Analgesics|analgesics|mesh-ancestor
24501453|NCT00528658|Sensory System Agents|sensory system agents|mesh-ancestor
24501454|NCT00528658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24501478|NCT00528723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501480|NCT00528814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24501481|NCT00528814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24501482|NCT00528814|Disinfectants|disinfectants|mesh-ancestor
24501483|NCT00528827|Nicardipine|nicardipine|mesh-list
24501484|NCT00528827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24457635|NCT00334789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457636|NCT00334789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24457637|NCT00334789|Keratolytic Agents|keratolytic agents|mesh-ancestor
24501485|NCT00528827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24501486|NCT00528827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24501487|NCT00528827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501489|NCT00528827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501490|NCT00528827|Vasodilator Agents|vasodilator agents|mesh-ancestor
24501491|NCT00528892|Raltegravir Potassium|raltegravir potassium|mesh-list
24501492|NCT00528892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24501493|NCT00528892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24501494|NCT00528892|Antiviral Agents|antiviral agents|mesh-ancestor
25235459|NCT02564107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501497|NCT00528892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24501498|NCT00528892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501499|NCT00528892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501500|NCT00528918|Insulin glulisine|insulin glulisine|mesh-list
24501601|NCT00529750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501602|NCT00529750|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24501603|NCT00529750|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24501604|NCT00529750|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24501605|NCT00529750|Adrenergic Agents|adrenergic agents|mesh-ancestor
24501606|NCT00529750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24501607|NCT00529841|Hydrocortisone|hydrocortisone|mesh-list
24501608|NCT00529841|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24501609|NCT00529841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24501610|NCT00529867|Lumefantrine|lumefantrine|mesh-list
24501611|NCT00529867|Artemether|artemether|mesh-list
24501612|NCT00529867|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24501613|NCT00529867|Antimalarials|antimalarials|mesh-ancestor
24501614|NCT00529867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24501615|NCT00529867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24501616|NCT00529867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24501617|NCT00529880|Cytarabine|cytarabine|mesh-list
24501618|NCT00529880|Fludarabine|fludarabine|mesh-list
24501619|NCT00529880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501620|NCT00529880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24501621|NCT00529880|Antimetabolites|antimetabolites|mesh-ancestor
24501622|NCT00529880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501623|NCT00529880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24501624|NCT00529880|Immunologic Factors|immunologic factors|mesh-ancestor
24501625|NCT00529880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501626|NCT00529880|Antiviral Agents|antiviral agents|mesh-ancestor
24501627|NCT00529880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24501629|NCT00530101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24501630|NCT00530101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501631|NCT00530101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25409929|NCT03337698|Protease Inhibitors|protease inhibitors|mesh-ancestor
25673055|NCT01753115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105841|NCT04850495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105842|NCT04850495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25105843|NCT04850495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25105844|NCT04850495|Alkylating Agents|alkylating agents|mesh-ancestor
25105846|NCT04850495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774479|NCT01845701|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24774481|NCT01845701|Artenimol|artenimol|mesh-list
24774482|NCT01845701|Antimalarials|antimalarials|mesh-ancestor
24774483|NCT01845701|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24774484|NCT01845701|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24774485|NCT01845701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24774486|NCT01845701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501632|NCT00530101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24501634|NCT00530101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501635|NCT00530127|Deferiprone|deferiprone|mesh-list
24501636|NCT00530127|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24501638|NCT00530127|Sequestering Agents|sequestering agents|mesh-ancestor
24501699|NCT00530517|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24501701|NCT00530517|Serotonin Agents|serotonin agents|mesh-ancestor
25873538|NCT05561959|Vasodilator Agents|vasodilator agents|mesh-ancestor
24501864|NCT00531349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25873539|NCT05561764|Imipenem|imipenem|mesh-list
24960825|NCT03813927|Micronutrients|micronutrients|mesh-ancestor
24889894|NCT04488926|Hormones|hormones|mesh-ancestor
24502688|NCT04642378|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24788019|NCT01929070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788020|NCT01929096|Edaravone|edaravone|mesh-list
25235461|NCT02564146|Paclitaxel|paclitaxel|mesh-list
25235462|NCT02564146|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25235463|NCT02564146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25235464|NCT02564146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25235465|NCT02564146|Tubulin Modulators|tubulin modulators|mesh-ancestor
25235466|NCT02564146|Antimitotic Agents|antimitotic agents|mesh-ancestor
25235467|NCT02564146|Mitosis Modulators|mitosis modulators|mesh-ancestor
25273661|NCT02383901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873540|NCT05561764|Relebactam|relebactam|mesh-list
25873541|NCT05561764|Cilastatin|cilastatin|mesh-list
25873542|NCT05561764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25064665|NCT03458078|Anesthetics|anesthetics|mesh-ancestor
24788021|NCT01929096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24788022|NCT01929096|Antioxidants|antioxidants|mesh-ancestor
24788023|NCT01929096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788024|NCT01929096|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25005068|NCT05028673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25005069|NCT05028673|Immunologic Factors|immunologic factors|mesh-ancestor
25005070|NCT05028673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005071|NCT05028673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005072|NCT05028673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25005073|NCT04996368|Tranexamic Acid|tranexamic acid|mesh-list
25005074|NCT04996368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25005075|NCT04996368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25005076|NCT04996368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005077|NCT04996368|Hemostatics|hemostatics|mesh-ancestor
25005078|NCT04996368|Coagulants|coagulants|mesh-ancestor
25005079|NCT04941755|Famotidine|famotidine|mesh-list
25005080|NCT04941755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25005081|NCT04941755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24788036|NCT01929213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25005082|NCT04941755|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25005083|NCT04941755|Histamine Antagonists|histamine antagonists|mesh-ancestor
25005084|NCT04941755|Histamine Agents|histamine agents|mesh-ancestor
25005085|NCT04941755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24871317|NCT03765632|Busulfan|busulfan|mesh-list
25673056|NCT01753115|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25673057|NCT01753115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25673058|NCT01753297|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25673059|NCT01753297|Luteolytic Agents|luteolytic agents|mesh-ancestor
25673060|NCT01753297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25673061|NCT01753297|Contraceptive Agents|contraceptive agents|mesh-ancestor
25673062|NCT01753297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25673063|NCT01753297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673064|NCT01753297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25673065|NCT01753297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25673066|NCT01753297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673067|NCT01753310|Botulinum Toxins|botulinum toxins|mesh-list
24982521|NCT02441686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24982522|NCT02441686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24982523|NCT02441686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24982524|NCT02441686|Immunologic Factors|immunologic factors|mesh-ancestor
24982525|NCT02441686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24982526|NCT02441686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24982527|NCT02441686|Growth Substances|growth substances|mesh-ancestor
24502741|NCT04497168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24502742|NCT04497168|Serotonin Agents|serotonin agents|mesh-ancestor
24502743|NCT04497168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502744|NCT04497168|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24502745|NCT04497168|Antidepressive Agents|antidepressive agents|mesh-ancestor
24502746|NCT04497168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24502748|NCT04480502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24502749|NCT04480502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24457638|NCT00334789|Dermatologic Agents|dermatologic agents|mesh-ancestor
24457639|NCT00334789|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24457640|NCT00334789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457641|NCT00334854|Doxorubicin|doxorubicin|mesh-list
24457642|NCT00334854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24502750|NCT04480502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24502751|NCT04480502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505565|NCT00541463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505567|NCT00541463|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24505568|NCT00541463|Protease Inhibitors|protease inhibitors|mesh-ancestor
24505569|NCT00541463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505570|NCT00541463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24505571|NCT00541463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24505572|NCT00541463|Antiviral Agents|antiviral agents|mesh-ancestor
24505573|NCT00541463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24505574|NCT00541489|Naproxen|naproxen|mesh-list
24505575|NCT00541489|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
24505576|NCT00541489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24457650|NCT00334854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24457651|NCT00334854|Alkylating Agents|alkylating agents|mesh-ancestor
24457652|NCT00334867|Cyclophosphamide|cyclophosphamide|mesh-list
24457653|NCT00334867|Ifosfamide|ifosfamide|mesh-list
24457654|NCT00334867|Doxorubicin|doxorubicin|mesh-list
24457655|NCT00334867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24457656|NCT00334867|Etoposide|etoposide|mesh-list
24457657|NCT00334867|Vincristine|vincristine|mesh-list
24505577|NCT00541489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24505578|NCT00541489|Analgesics|analgesics|mesh-ancestor
24505580|NCT00541489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25873543|NCT05561764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25873544|NCT05561764|Protease Inhibitors|protease inhibitors|mesh-ancestor
25873545|NCT05561764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25873546|NCT05561764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235468|NCT02564146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235469|NCT02564146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25235470|NCT02564146|Antimetabolites|antimetabolites|mesh-ancestor
25873547|NCT05561764|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25873548|NCT05561751|Propranolol|propranolol|mesh-list
25873549|NCT05561751|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25873550|NCT05561751|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25673068|NCT01753310|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25673069|NCT01753310|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25673070|NCT01753310|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25673071|NCT01753310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25673072|NCT01753310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673073|NCT01753310|Cholinergic Agents|cholinergic agents|mesh-ancestor
25673074|NCT01753310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25673075|NCT01753310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673076|NCT01753310|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25673077|NCT01753310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25873551|NCT05561751|Adrenergic Agents|adrenergic agents|mesh-ancestor
24505616|NCT00541567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24505651|NCT00541814|Dermatologic Agents|dermatologic agents|mesh-ancestor
24505652|NCT00541814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24505653|NCT00541814|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24505654|NCT00541840|Sorafenib|sorafenib|mesh-list
24505655|NCT00541840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505656|NCT00541840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24505657|NCT00541840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525448|NCT03333408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505809|NCT00542568|Hematinics|hematinics|mesh-ancestor
24505810|NCT00542607|Levocetirizine|levocetirizine|mesh-list
24505811|NCT00542607|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24960956|NCT03813069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960957|NCT03813056|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24960958|NCT03813056|Lubricant Eye Drops|lubricant eye drops|mesh-list
24960959|NCT03813056|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24960960|NCT03812965|Botulinum Toxins|botulinum toxins|mesh-list
24457658|NCT00334867|Topotecan|topotecan|mesh-list
25873553|NCT05561751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873554|NCT05561751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873555|NCT05561751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25873556|NCT05561751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25873557|NCT05561751|Vasodilator Agents|vasodilator agents|mesh-ancestor
24505814|NCT00542607|Histamine Agents|histamine agents|mesh-ancestor
24505815|NCT00542607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24505816|NCT00542607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505817|NCT00542607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505818|NCT00542711|Curcumin|curcumin|mesh-list
24505819|NCT00542711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24505820|NCT00542711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24505821|NCT00542711|Analgesics|analgesics|mesh-ancestor
24505822|NCT00542711|Sensory System Agents|sensory system agents|mesh-ancestor
24525482|NCT03289741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505911|NCT00543179|Lanreotide|lanreotide|mesh-list
24505912|NCT00543179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506047|NCT00543933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24506048|NCT00543933|Autonomic Agents|autonomic agents|mesh-ancestor
24506049|NCT00543933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24506050|NCT00543933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506051|NCT00543933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24506052|NCT00543933|Respiratory System Agents|respiratory system agents|mesh-ancestor
24506053|NCT00543933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24506055|NCT00543933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506059|NCT00543933|Gasotransmitters|gasotransmitters|mesh-ancestor
24506060|NCT00543933|Protective Agents|protective agents|mesh-ancestor
24864222|NCT05146713|Propolis|propolis|mesh-list
24394984|NCT00134875|Naloxone|naloxone|mesh-list
24457671|NCT00334867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25235471|NCT02564146|Antiviral Agents|antiviral agents|mesh-ancestor
25235480|NCT02564003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24457672|NCT00334867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24457673|NCT00334867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457674|NCT00334867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24457675|NCT00334867|Tubulin Modulators|tubulin modulators|mesh-ancestor
24457676|NCT00334867|Antimitotic Agents|antimitotic agents|mesh-ancestor
24457677|NCT00334867|Mitosis Modulators|mitosis modulators|mesh-ancestor
24457678|NCT00334867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24506910|NCT00547508|Tadalafil|tadalafil|mesh-list
24506911|NCT00547508|Vasodilator Agents|vasodilator agents|mesh-ancestor
24525716|NCT02856594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24507049|NCT00548483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24507050|NCT00548483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507051|NCT00548483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24750460|NCT01698645|Sensory System Agents|sensory system agents|mesh-ancestor
25873558|NCT05561738|Niacinamide|niacinamide|mesh-list
25873559|NCT05561738|Niacin|niacin|mesh-list
24507111|NCT00548704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25873560|NCT05561738|Nicotinic Acids|nicotinic acids|mesh-list
24507169|NCT00549107|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24507229|NCT00549289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25673078|NCT01753336|Botulinum Toxins|botulinum toxins|mesh-list
25673079|NCT01753336|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24507231|NCT00549289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24507232|NCT00549289|Immunologic Factors|immunologic factors|mesh-ancestor
24507233|NCT00549289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507281|NCT00549588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507283|NCT00549614|Acipimox|acipimox|mesh-list
24507284|NCT00549614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24507285|NCT00549614|Antimetabolites|antimetabolites|mesh-ancestor
24507286|NCT00549614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525755|NCT02792413|Denosumab|denosumab|mesh-list
24507496|NCT00550927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25873561|NCT05561738|Vitamin B Complex|vitamin b complex|mesh-ancestor
24507655|NCT00551252|Antimetabolites|antimetabolites|mesh-ancestor
25005103|NCT04856176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24788073|NCT01929278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24788074|NCT01929278|Keratolytic Agents|keratolytic agents|mesh-ancestor
24788076|NCT01929330|Dutasteride|dutasteride|mesh-list
24788105|NCT01929512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788106|NCT01929512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25109654|NCT03122769|Metformin|metformin|mesh-list
25109655|NCT03122769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25109656|NCT03122769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109657|NCT03122353|Calcitriol|calcitriol|mesh-list
25109658|NCT03122353|Betamethasone|betamethasone|mesh-list
25109659|NCT03122353|Betamethasone Valerate|betamethasone valerate|mesh-list
24750555|NCT01699412|Clobetasol|clobetasol|mesh-list
25109661|NCT03122353|Betamethasone benzoate|betamethasone benzoate|mesh-list
25109662|NCT03122353|Calcipotriene|calcipotriene|mesh-list
25109663|NCT03122353|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25109664|NCT03122353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25109665|NCT03122353|Glucocorticoids|glucocorticoids|mesh-ancestor
25109666|NCT03122353|Hormones|hormones|mesh-ancestor
24507761|NCT00551889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24457696|NCT00334906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457697|NCT00334906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24457698|NCT00334906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24507904|NCT00553137|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25235481|NCT02564003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235482|NCT02564003|Analgesics|analgesics|mesh-ancestor
25873562|NCT05561738|Vitamins|vitamins|mesh-ancestor
25873563|NCT05561738|Micronutrients|micronutrients|mesh-ancestor
25873564|NCT05561738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873565|NCT05561738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24507905|NCT00553137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24507906|NCT00553137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507907|NCT00553137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507908|NCT00553137|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24507909|NCT00553137|Hormone Antagonists|hormone antagonists|mesh-ancestor
24507910|NCT00553137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24507911|NCT00553137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507912|NCT00553137|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25873566|NCT05561738|Antimetabolites|antimetabolites|mesh-ancestor
25873567|NCT05561738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873568|NCT05561738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24508558|NCT00556127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508559|NCT00556127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508560|NCT00556127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24508589|NCT00556192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24508591|NCT00556192|Immunologic Factors|immunologic factors|mesh-ancestor
24508592|NCT00556192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508593|NCT00556192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24508594|NCT00556205|Bevacizumab|bevacizumab|mesh-list
24508595|NCT00556205|Sunitinib|sunitinib|mesh-list
24508596|NCT00556205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24508597|NCT00556205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508598|NCT00556205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24508599|NCT00556205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24508600|NCT00556205|Growth Substances|growth substances|mesh-ancestor
24508601|NCT00556205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508602|NCT00556205|Growth Inhibitors|growth inhibitors|mesh-ancestor
24508603|NCT00556205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24508604|NCT00556205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394207|NCT00132561|Pyrimethamine|pyrimethamine|mesh-list
24795968|NCT01947062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24795969|NCT01947062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24795970|NCT01947062|Alkylating Agents|alkylating agents|mesh-ancestor
24795971|NCT01947062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795972|NCT01947062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795973|NCT01947062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24508640|NCT00556348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24508641|NCT00556348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508642|NCT00556348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24508643|NCT00556348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24508729|NCT00556621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508730|NCT00556634|Efavirenz|efavirenz|mesh-list
24508731|NCT00556634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24508733|NCT00556634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508956|NCT00557921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24508957|NCT00557921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25235487|NCT02563951|Autonomic Agents|autonomic agents|mesh-ancestor
25235488|NCT02563951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25235489|NCT02563951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235490|NCT02563951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25235491|NCT02563951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25235492|NCT02563951|Serotonin Agents|serotonin agents|mesh-ancestor
25235493|NCT02563951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25235494|NCT02563951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235499|NCT02563782|Mycophenolic Acid|mycophenolic acid|mesh-list
25235500|NCT02563782|Tacrolimus|tacrolimus|mesh-list
24508960|NCT00557921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508962|NCT00557921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24508963|NCT00557921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508965|NCT00557921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24508966|NCT00557921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24509051|NCT00558181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24509052|NCT00558181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25235503|NCT02563782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235505|NCT02563782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235506|NCT02563782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235507|NCT02563782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25235508|NCT02563782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25235509|NCT02563782|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25235510|NCT02563782|Antitubercular Agents|antitubercular agents|mesh-ancestor
25235511|NCT02563782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25235512|NCT02563782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25235513|NCT02563795|Fentanyl|fentanyl|mesh-list
24847853|NCT05353192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24509073|NCT00558298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24509074|NCT00558298|Dopamine Agents|dopamine agents|mesh-ancestor
24509076|NCT00558337|Carbidopa|carbidopa|mesh-list
24509158|NCT00559052|Pancreatin|pancreatin|mesh-list
24509159|NCT00559052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24509160|NCT00559091|Ribavirin|ribavirin|mesh-list
24509161|NCT00559091|Antimetabolites|antimetabolites|mesh-ancestor
24509162|NCT00559091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509163|NCT00559091|Antiviral Agents|antiviral agents|mesh-ancestor
24509164|NCT00559091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24509165|NCT00559169|Verapamil|verapamil|mesh-list
24509166|NCT00559169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24509167|NCT00559169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24509168|NCT00559169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24509169|NCT00559169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509170|NCT00559169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24509171|NCT00559169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509172|NCT00559169|Vasodilator Agents|vasodilator agents|mesh-ancestor
24750679|NCT01700010|Paclitaxel|paclitaxel|mesh-list
25673080|NCT01753336|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25673081|NCT01753336|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25673082|NCT01753336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25673083|NCT01753336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673084|NCT01753336|Cholinergic Agents|cholinergic agents|mesh-ancestor
25673085|NCT01753336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25673086|NCT01753336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984570|NCT04386616|Antiviral Agents|antiviral agents|mesh-ancestor
25106936|NCT03143452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106937|NCT03143452|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25106939|NCT03143465|Salmon calcitonin|salmon calcitonin|mesh-list
25106940|NCT03143465|Sildenafil Citrate|sildenafil citrate|mesh-list
25873569|NCT05561738|Vasodilator Agents|vasodilator agents|mesh-ancestor
24509179|NCT00559195|Epoetin Alfa|epoetin alfa|mesh-list
24509180|NCT00559195|Hematinics|hematinics|mesh-ancestor
24509206|NCT00559312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24509207|NCT00559312|Sympathomimetics|sympathomimetics|mesh-ancestor
24509208|NCT00559338|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24509209|NCT00559338|Natriuretic Agents|natriuretic agents|mesh-ancestor
24509210|NCT00559338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509212|NCT00559351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509213|NCT00559351|Antimetabolites|antimetabolites|mesh-ancestor
24509214|NCT00559351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509215|NCT00559351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24509216|NCT00559351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24509217|NCT00559351|Immunologic Factors|immunologic factors|mesh-ancestor
24509218|NCT00559351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526077|NCT01845441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24457709|NCT00334932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457710|NCT00334932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24457711|NCT00334932|Alkylating Agents|alkylating agents|mesh-ancestor
25235518|NCT02563795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235519|NCT02563795|Sensory System Agents|sensory system agents|mesh-ancestor
25235520|NCT02563795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25235522|NCT02563795|Narcotics|narcotics|mesh-ancestor
25235523|NCT02563795|Analgesics|analgesics|mesh-ancestor
25235524|NCT02563795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25235525|NCT02563795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24509515|NCT00560599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24526143|NCT01059071|Etoposide|etoposide|mesh-list
24509716|NCT00561756|Immunologic Factors|immunologic factors|mesh-ancestor
24509717|NCT00561756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509718|NCT00561886|Formoterol Fumarate|formoterol fumarate|mesh-list
24509719|NCT00561886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24509720|NCT00561886|Autonomic Agents|autonomic agents|mesh-ancestor
24509782|NCT00562068|Hormones|hormones|mesh-ancestor
24509783|NCT00562068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24509784|NCT00562068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24509785|NCT00562068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24509786|NCT00562133|Insulin|insulin|mesh-list
24509787|NCT00562133|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24509788|NCT00562133|Insulin glulisine|insulin glulisine|mesh-list
25873570|NCT05561725|Dexamethasone|dexamethasone|mesh-list
24509819|NCT00562198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24509820|NCT00562198|Immunologic Factors|immunologic factors|mesh-ancestor
24509821|NCT00562198|Dopamine Agonists|dopamine agonists|mesh-ancestor
24509825|NCT00562224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24509826|NCT00562224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509827|NCT00562250|Dapagliflozin|dapagliflozin|mesh-list
24509828|NCT00562250|Glimepiride|glimepiride|mesh-list
24509829|NCT00562250|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24509830|NCT00562250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509866|NCT00562289|Protease Inhibitors|protease inhibitors|mesh-ancestor
24509867|NCT00562289|Anticoagulants|anticoagulants|mesh-ancestor
24509868|NCT00562289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24457713|NCT00334932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24509869|NCT00562289|Vasodilator Agents|vasodilator agents|mesh-ancestor
24509870|NCT00562406|Ranibizumab|ranibizumab|mesh-list
25673087|NCT01753336|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25673088|NCT01753336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25673089|NCT01753362|Liraglutide|liraglutide|mesh-list
25673090|NCT01753362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25673091|NCT01753362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673092|NCT01753362|Incretins|incretins|mesh-ancestor
25673093|NCT01753362|Hormones|hormones|mesh-ancestor
25673094|NCT01753362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25673095|NCT01753401|Prednisone|prednisone|mesh-list
24985981|NCT02422368|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24985982|NCT02422368|Prednisolone phosphate|prednisolone phosphate|mesh-list
24985983|NCT02422368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24985984|NCT02422368|Antiemetics|antiemetics|mesh-ancestor
24509871|NCT00562406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25235526|NCT02563795|Anesthetics, General|anesthetics, general|mesh-ancestor
25235527|NCT02563847|Erythritol|erythritol|mesh-list
25235528|NCT02563847|Tryptophan|tryptophan|mesh-list
25235529|NCT02563847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25235530|NCT02563847|Antidepressive Agents|antidepressive agents|mesh-ancestor
25235531|NCT02563847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25235532|NCT02563847|Vasodilator Agents|vasodilator agents|mesh-ancestor
25235533|NCT02563769|Clavulanic Acids|clavulanic acids|mesh-list
25235534|NCT02563769|Clavulanic Acid|clavulanic acid|mesh-list
25235535|NCT02563769|Cocaine|cocaine|mesh-list
25235536|NCT02563769|Anesthetics, Local|anesthetics, local|mesh-ancestor
25235537|NCT02563769|Anesthetics|anesthetics|mesh-ancestor
24510139|NCT00563589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24510140|NCT00563589|Antimetabolites|antimetabolites|mesh-ancestor
24510141|NCT00563589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510142|NCT00563589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873571|NCT05561725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24510178|NCT00563758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510179|NCT00563758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510207|NCT00563875|Sensory System Agents|sensory system agents|mesh-ancestor
24510208|NCT00563875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24510209|NCT00563875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510210|NCT00563875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24510212|NCT00563875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24788109|NCT01929512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788110|NCT01929512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25226425|NCT02620605|Cabergoline|cabergoline|mesh-list
24512445|NCT00575224|Interferons|interferons|mesh-list
25005132|NCT04782687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25005133|NCT04782687|Glucocorticoids|glucocorticoids|mesh-ancestor
25005134|NCT04782687|Hormones|hormones|mesh-ancestor
25005135|NCT04782687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25005136|NCT04782687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25005137|NCT04782687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005138|NCT04782687|Immunologic Factors|immunologic factors|mesh-ancestor
25005139|NCT04782687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25005140|NCT04782687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25005141|NCT04782687|Growth Substances|growth substances|mesh-ancestor
25005142|NCT04782687|Growth Inhibitors|growth inhibitors|mesh-ancestor
25005143|NCT04742673|Guanfacine|guanfacine|mesh-list
25005144|NCT04742673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25005145|NCT04742673|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25005146|NCT04742673|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24814908|NCT02067182|Dabigatran|dabigatran|mesh-list
24510576|NCT00565019|Triamcinolone|triamcinolone|mesh-list
24510577|NCT00565019|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24510578|NCT00565019|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24510579|NCT00565019|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24510580|NCT00565019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24510581|NCT00565019|Glucocorticoids|glucocorticoids|mesh-ancestor
24510582|NCT00565019|Hormones|hormones|mesh-ancestor
24510583|NCT00565019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24510584|NCT00565019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510585|NCT00565019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24510586|NCT00565019|Immunologic Factors|immunologic factors|mesh-ancestor
24510587|NCT00565019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24511575|NCT00569712|Glucocorticoids|glucocorticoids|mesh-ancestor
24511648|NCT00569985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24511649|NCT00569985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24511979|NCT00571870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25235538|NCT02563769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25235539|NCT02563769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636224|NCT01144000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24636225|NCT01144065|Hydrocortisone|hydrocortisone|mesh-list
24636226|NCT01144065|Testosterone|testosterone|mesh-list
24636229|NCT01144065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24511980|NCT00571870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673096|NCT01753401|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25673097|NCT01753401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25673098|NCT01753401|Glucocorticoids|glucocorticoids|mesh-ancestor
25673099|NCT01753401|Hormones|hormones|mesh-ancestor
24796443|NCT01950000|Narcotics|narcotics|mesh-ancestor
24796444|NCT01950000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24631124|NCT01116180|Candesartan|candesartan|mesh-list
24796445|NCT01950000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986733|NCT05188118|Nivolumab|nivolumab|mesh-list
24511981|NCT00571870|Hormone Antagonists|hormone antagonists|mesh-ancestor
24512079|NCT00572650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512081|NCT00572663|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24512085|NCT00572663|Respiratory System Agents|respiratory system agents|mesh-ancestor
24512124|NCT00573001|Zidovudine|zidovudine|mesh-list
24512125|NCT00573001|Emtricitabine|emtricitabine|mesh-list
24512126|NCT00573001|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24512198|NCT00573599|Prochlorperazine|prochlorperazine|mesh-list
24457725|NCT00335088|Moxifloxacin|moxifloxacin|mesh-list
24457726|NCT00335088|Povidone-Iodine|povidone-iodine|mesh-list
24457727|NCT00335088|Povidone|povidone|mesh-list
24512199|NCT00573599|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24512200|NCT00573599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24512201|NCT00573599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24512202|NCT00573599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512203|NCT00573599|Anesthetics, Local|anesthetics, local|mesh-ancestor
24512437|NCT00574964|Carmustine|carmustine|mesh-list
24512447|NCT00575224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512448|NCT00575224|Antiviral Agents|antiviral agents|mesh-ancestor
24512449|NCT00575224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24512450|NCT00575224|Antimetabolites|antimetabolites|mesh-ancestor
24512451|NCT00575224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512452|NCT00575302|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24512453|NCT00575302|Hormones|hormones|mesh-ancestor
24512454|NCT00575302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24512455|NCT00575302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512456|NCT00575341|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24512457|NCT00575341|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24512501|NCT00575419|Antiviral Agents|antiviral agents|mesh-ancestor
24512537|NCT00575549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24512538|NCT00575549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512539|NCT00575549|Protective Agents|protective agents|mesh-ancestor
24512540|NCT00575601|Simvastatin|simvastatin|mesh-list
24512604|NCT00575861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24512636|NCT00575952|Mitosis Modulators|mitosis modulators|mesh-ancestor
24512637|NCT00575952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513002|NCT00578097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513003|NCT00578097|Cholinergic Agents|cholinergic agents|mesh-ancestor
24513004|NCT00578097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24513005|NCT00578097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513006|NCT00578097|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24513007|NCT00578097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24513008|NCT00578149|Paclitaxel|paclitaxel|mesh-list
24513009|NCT00578149|Bevacizumab|bevacizumab|mesh-list
24961249|NCT03809650|Macitentan|macitentan|mesh-list
24513010|NCT00578149|Carboplatin|carboplatin|mesh-list
24513208|NCT00579969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513209|NCT00579969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513211|NCT00579969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24513212|NCT00579969|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24513213|NCT00579969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24513214|NCT00579995|Acetylcysteine|acetylcysteine|mesh-list
24513215|NCT00579995|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24513216|NCT00579995|Antiviral Agents|antiviral agents|mesh-ancestor
24513217|NCT00579995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24513218|NCT00579995|Expectorants|expectorants|mesh-ancestor
25235540|NCT02563769|Sensory System Agents|sensory system agents|mesh-ancestor
25235541|NCT02563769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25235542|NCT02563769|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25235543|NCT02563769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25235544|NCT02563769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25673100|NCT01753401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25673101|NCT01753401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673102|NCT01753401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25673103|NCT01753401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673104|NCT01753557|Interferon alpha-2|interferon alpha-2|mesh-list
25873572|NCT05561725|Antiemetics|antiemetics|mesh-ancestor
25873573|NCT05561725|Autonomic Agents|autonomic agents|mesh-ancestor
25873574|NCT05561725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25873575|NCT05561725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873576|NCT05561725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25873577|NCT05561725|Glucocorticoids|glucocorticoids|mesh-ancestor
25873578|NCT05561725|Hormones|hormones|mesh-ancestor
25873579|NCT05561725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24513467|NCT00581789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24513468|NCT00581789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513894|NCT00586118|Propofol|propofol|mesh-list
24513895|NCT00586118|Sevoflurane|sevoflurane|mesh-list
24513896|NCT00586118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24394215|NCT00132561|Schistosomicides|schistosomicides|mesh-ancestor
24513952|NCT00586443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24513953|NCT00586443|Growth Substances|growth substances|mesh-ancestor
24513954|NCT00586443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513955|NCT00586443|Growth Inhibitors|growth inhibitors|mesh-ancestor
24513956|NCT00586443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24513957|NCT00586443|Immunologic Factors|immunologic factors|mesh-ancestor
24513958|NCT00586560|Cyclophosphamide|cyclophosphamide|mesh-list
25235545|NCT02563769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25235546|NCT02563769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235547|NCT02563769|Dopamine Agents|dopamine agents|mesh-ancestor
25235548|NCT02563769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25235549|NCT02563769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25235550|NCT02563769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25235551|NCT02563769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235552|NCT02563769|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25235553|NCT02563704|Artesunate|artesunate|mesh-list
25235554|NCT02563704|Quinine|quinine|mesh-list
25235555|NCT02563704|Antimalarials|antimalarials|mesh-ancestor
25235556|NCT02563704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25235557|NCT02563704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25235558|NCT02563704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25235559|NCT02563704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25235560|NCT02563704|Antiviral Agents|antiviral agents|mesh-ancestor
25235561|NCT02563704|Schistosomicides|schistosomicides|mesh-ancestor
25235562|NCT02563704|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25064735|NCT03457337|Gefitinib|gefitinib|mesh-list
24513959|NCT00586560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24513960|NCT00586560|Immunologic Factors|immunologic factors|mesh-ancestor
24513961|NCT00586560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513964|NCT00586560|Alkylating Agents|alkylating agents|mesh-ancestor
24513991|NCT00586976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513992|NCT00586976|Sensory System Agents|sensory system agents|mesh-ancestor
24513993|NCT00586976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24513994|NCT00587015|Immunotoxin HA22|immunotoxin ha22|mesh-list
25005185|NCT04467723|Pirfenidone|pirfenidone|mesh-list
24788176|NCT01929941|Mitosis Modulators|mitosis modulators|mesh-ancestor
24513995|NCT00587015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751012|NCT01701518|Hormones|hormones|mesh-ancestor
24513997|NCT00587119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24513998|NCT00587119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24513999|NCT00587119|Autonomic Agents|autonomic agents|mesh-ancestor
24514000|NCT00587119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25673105|NCT01753557|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25673106|NCT01753557|Antiviral Agents|antiviral agents|mesh-ancestor
25673107|NCT01753557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25673108|NCT01753557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673109|NCT01753570|Interferon-beta|interferon-beta|mesh-list
25673110|NCT01753570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673111|NCT01753570|Antiviral Agents|antiviral agents|mesh-ancestor
25673112|NCT01753570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25673113|NCT01753570|Immunologic Factors|immunologic factors|mesh-ancestor
24514001|NCT00587119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514002|NCT00587119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24514003|NCT00587119|Respiratory System Agents|respiratory system agents|mesh-ancestor
24514009|NCT00587145|Tubulin Modulators|tubulin modulators|mesh-ancestor
24514010|NCT00587145|Antimitotic Agents|antimitotic agents|mesh-ancestor
24514011|NCT00587145|Mitosis Modulators|mitosis modulators|mesh-ancestor
24514012|NCT00587145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514014|NCT00587249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24514015|NCT00587249|Immunologic Factors|immunologic factors|mesh-ancestor
24514016|NCT00587249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406383|NCT00169988|Dopamine Agents|dopamine agents|mesh-ancestor
24514043|NCT00587470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24514044|NCT00587470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24514045|NCT00587470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514048|NCT00587496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24514049|NCT00587496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24514050|NCT00587496|Analgesics|analgesics|mesh-ancestor
24514051|NCT00587496|Sensory System Agents|sensory system agents|mesh-ancestor
24514052|NCT00587496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24514053|NCT00587496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514054|NCT00587496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24514055|NCT00587496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24396259|NCT00138229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514102|NCT00587873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514103|NCT00587873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24457756|NCT00335166|Protective Agents|protective agents|mesh-ancestor
24514125|NCT00588003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24514126|NCT00588003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514127|NCT00588016|Itraconazole|itraconazole|mesh-list
24514128|NCT00588016|Antifungal Agents|antifungal agents|mesh-ancestor
24514129|NCT00588016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25873580|NCT05561725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25873581|NCT05561725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873582|NCT05561673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25235563|NCT02563704|Anthelmintics|anthelmintics|mesh-ancestor
25235564|NCT02563704|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24840676|NCT02211729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235565|NCT02563704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235566|NCT02563704|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25235567|NCT02563704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25235568|NCT02563704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25235569|NCT02563704|Analgesics|analgesics|mesh-ancestor
25235570|NCT02563704|Sensory System Agents|sensory system agents|mesh-ancestor
25235571|NCT02563821|Clonidine|clonidine|mesh-list
25235572|NCT02563821|Sufentanil|sufentanil|mesh-list
25235573|NCT02563821|Levobupivacaine|levobupivacaine|mesh-list
25235574|NCT02563821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25235575|NCT02563821|Narcotics|narcotics|mesh-ancestor
25873583|NCT05561673|Vaccines|vaccines|mesh-list
25873584|NCT05561673|Immunologic Factors|immunologic factors|mesh-ancestor
25873585|NCT05561673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873586|NCT05561673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24453549|NCT04935177|Immunoglobulins|immunoglobulins|mesh-list
24514172|NCT00588835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514173|NCT00588835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24514174|NCT00588835|Glucocorticoids|glucocorticoids|mesh-ancestor
24514175|NCT00588835|Hormones|hormones|mesh-ancestor
24514176|NCT00588835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24514177|NCT00588835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24514178|NCT00588835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514179|NCT00588835|Antipruritics|antipruritics|mesh-ancestor
24514180|NCT00588835|Dermatologic Agents|dermatologic agents|mesh-ancestor
24514181|NCT00588835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24457750|NCT00335114|Dermatologic Agents|dermatologic agents|mesh-ancestor
24457751|NCT00335114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24457752|NCT00335114|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24457753|NCT00335166|Pramipexole|pramipexole|mesh-list
24514182|NCT00588835|Serotonin Agents|serotonin agents|mesh-ancestor
24514183|NCT00588835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24514184|NCT00588835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514185|NCT00588835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24514186|NCT00588835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24514187|NCT00588835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25005186|NCT04467723|Atezolizumab|atezolizumab|mesh-list
24514203|NCT00588926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24987194|NCT03470675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987195|NCT03470675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24987196|NCT03470675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24861791|NCT02320240|Paroxetine|paroxetine|mesh-list
24987215|NCT03467360|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24787587|NCT01925911|Midazolam|midazolam|mesh-list
24987217|NCT03467360|Natriuretic Agents|natriuretic agents|mesh-ancestor
24775229|NCT01851005|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24987218|NCT03467360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514204|NCT00588926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514224|NCT00589186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24514225|NCT00589186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514226|NCT00589186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24514227|NCT00589186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24514228|NCT00589186|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24961376|NCT03809143|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24514229|NCT00589186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24514230|NCT00589186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24514231|NCT00589186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514232|NCT00589238|Paclitaxel|paclitaxel|mesh-list
24514233|NCT00589238|Cyclophosphamide|cyclophosphamide|mesh-list
24514275|NCT00589316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24514276|NCT00589316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24514277|NCT00589316|Alkylating Agents|alkylating agents|mesh-ancestor
24514278|NCT00589316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514279|NCT00589316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514280|NCT00589316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24514281|NCT00589316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24514282|NCT00589316|Antimetabolites|antimetabolites|mesh-ancestor
24514283|NCT00589316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24457755|NCT00335166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457757|NCT00335166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514312|NCT00589862|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24514563|NCT00591604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24514564|NCT00591617|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
24514565|NCT00591617|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25235576|NCT02563821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25235577|NCT02563821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235578|NCT02563821|Analgesics|analgesics|mesh-ancestor
25235579|NCT02563821|Sensory System Agents|sensory system agents|mesh-ancestor
25235580|NCT02563821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25235581|NCT02563821|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25235582|NCT02563821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24453551|NCT04935177|gamma-Globulins|gamma-globulins|mesh-list
24453552|NCT04935177|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24453553|NCT04935177|Eculizumab|eculizumab|mesh-list
24453554|NCT04935177|Immunologic Factors|immunologic factors|mesh-ancestor
24514567|NCT00591617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24514568|NCT00591617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514569|NCT00591617|Analgesics|analgesics|mesh-ancestor
24514570|NCT00591617|Sensory System Agents|sensory system agents|mesh-ancestor
24514571|NCT00591617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24514572|NCT00591617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24514573|NCT00591643|Epinephrine|epinephrine|mesh-list
24514574|NCT00591643|Racepinephrine|racepinephrine|mesh-list
24514575|NCT00591643|Epinephryl borate|epinephryl borate|mesh-list
24514576|NCT00591643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24514577|NCT00591643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24514578|NCT00591643|Adrenergic Agents|adrenergic agents|mesh-ancestor
25005187|NCT04467723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005188|NCT04467723|Analgesics|analgesics|mesh-ancestor
25005189|NCT04467723|Sensory System Agents|sensory system agents|mesh-ancestor
24961428|NCT03808805|Antipruritics|antipruritics|mesh-ancestor
25005190|NCT04467723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25005191|NCT04467723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673114|NCT01753570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673115|NCT01753739|Bepotastine besilate|bepotastine besilate|mesh-list
25673116|NCT01753739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25673117|NCT01753856|Vitamin D|vitamin d|mesh-list
25673118|NCT01753856|Denosumab|denosumab|mesh-list
25673119|NCT01753856|Teriparatide|teriparatide|mesh-list
25673120|NCT01753856|Tetracycline|tetracycline|mesh-list
25673121|NCT01753856|Demeclocycline|demeclocycline|mesh-list
25673122|NCT01753856|Calcium|calcium|mesh-list
25673123|NCT01753856|Vitamins|vitamins|mesh-ancestor
25673124|NCT01753856|Micronutrients|micronutrients|mesh-ancestor
24622100|NCT01065649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24622101|NCT01065649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622104|NCT01065662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25005192|NCT04467723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24514579|NCT00591643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24514580|NCT00591643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514581|NCT00591643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514582|NCT00591643|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24514585|NCT00591643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24514586|NCT00591643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24514732|NCT00592566|Natriuretic Agents|natriuretic agents|mesh-ancestor
24526937|NCT00613769|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24526938|NCT00613769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24526939|NCT00613782|Methyltestosterone|methyltestosterone|mesh-list
25873587|NCT05561673|Antacids|antacids|mesh-ancestor
24515005|NCT00593853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24516915|NCT00604591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517001|NCT00605371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517002|NCT00605371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24517003|NCT00605371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24961444|NCT03808142|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24961445|NCT03808142|Immunologic Factors|immunologic factors|mesh-ancestor
24517004|NCT00605371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24517005|NCT00605371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24517006|NCT00605371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24517008|NCT00605397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24517009|NCT00605397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517012|NCT00605410|Anticonvulsants|anticonvulsants|mesh-ancestor
24517013|NCT00605410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24517014|NCT00605410|Autonomic Agents|autonomic agents|mesh-ancestor
24517015|NCT00605410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24517016|NCT00605410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788183|NCT01929941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24788184|NCT01929941|Immunologic Factors|immunologic factors|mesh-ancestor
25235583|NCT02563821|Anesthetics, General|anesthetics, general|mesh-ancestor
25235584|NCT02563821|Anesthetics|anesthetics|mesh-ancestor
25235585|NCT02563821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25235586|NCT02563821|Sympatholytics|sympatholytics|mesh-ancestor
25235587|NCT02563821|Autonomic Agents|autonomic agents|mesh-ancestor
24453555|NCT04935177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847883|NCT05353101|Loteprednol Etabonate|loteprednol etabonate|mesh-list
24847884|NCT05353101|Cyclosporine|cyclosporine|mesh-list
24847886|NCT05353101|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24847887|NCT05353101|Cyclosporins|cyclosporins|mesh-list
24847888|NCT05353101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24847889|NCT05353101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847890|NCT05353101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24847891|NCT05353101|Immunologic Factors|immunologic factors|mesh-ancestor
24847892|NCT05353101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636322|NCT01144728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24636323|NCT01144728|Immunologic Factors|immunologic factors|mesh-ancestor
24636325|NCT01144754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24636326|NCT01144754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24961524|NCT03807297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24961525|NCT03807297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961526|NCT03807297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961527|NCT03807297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24961528|NCT03807297|Anesthetics, General|anesthetics, general|mesh-ancestor
24961529|NCT03807297|Anesthetics|anesthetics|mesh-ancestor
24961530|NCT03807297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24961531|NCT03807297|Analgesics|analgesics|mesh-ancestor
24961532|NCT03807297|Sensory System Agents|sensory system agents|mesh-ancestor
24636327|NCT01144754|Immunologic Factors|immunologic factors|mesh-ancestor
25673125|NCT01753856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673126|NCT01753856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25673127|NCT01753856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25673128|NCT01753856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25673129|NCT01753856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24788185|NCT01929941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788186|NCT01930019|Thiopental|thiopental|mesh-list
24788187|NCT01930019|Etomidate|etomidate|mesh-list
24788188|NCT01930019|Anesthetics|anesthetics|mesh-ancestor
24788189|NCT01930019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24788190|NCT01930019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788191|NCT01930019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24788195|NCT01930019|GABA Modulators|gaba modulators|mesh-ancestor
24788196|NCT01930019|GABA Agents|gaba agents|mesh-ancestor
24788197|NCT01930019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24788198|NCT01930019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517017|NCT00605410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24517116|NCT00606099|Telbivudine|telbivudine|mesh-list
24517261|NCT00606983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517262|NCT00606983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517263|NCT00606983|Urological Agents|urological agents|mesh-ancestor
24517264|NCT00607035|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24517265|NCT00607035|Olmesartan|olmesartan|mesh-list
24517329|NCT00607503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24517330|NCT00607503|Respiratory System Agents|respiratory system agents|mesh-ancestor
24517331|NCT00607503|Sympathomimetics|sympathomimetics|mesh-ancestor
24517332|NCT00607503|Tocolytic Agents|tocolytic agents|mesh-ancestor
24517333|NCT00607503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24517334|NCT00607503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24517335|NCT00607503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24517336|NCT00607503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24517337|NCT00607503|Adrenergic Agents|adrenergic agents|mesh-ancestor
24517529|NCT00608595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24517530|NCT00608595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24517532|NCT00608595|Sensory System Agents|sensory system agents|mesh-ancestor
24517577|NCT00608712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24517578|NCT00608712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24396741|NCT00139841|Alkylating Agents|alkylating agents|mesh-ancestor
25235591|NCT02563821|Adrenergic Agents|adrenergic agents|mesh-ancestor
25235592|NCT02563821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25235593|NCT02563821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235594|NCT02563821|Anesthetics, Local|anesthetics, local|mesh-ancestor
25235596|NCT02563405|Nifedipine|nifedipine|mesh-list
25235597|NCT02563405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25235598|NCT02563405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25235599|NCT02563405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235600|NCT02563405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25235601|NCT02563405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235602|NCT02563405|Vasodilator Agents|vasodilator agents|mesh-ancestor
25235603|NCT02563405|Tocolytic Agents|tocolytic agents|mesh-ancestor
25235604|NCT02563405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25235605|NCT02563405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25673130|NCT01753856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25673131|NCT01753856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25673132|NCT01753856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673133|NCT01754259|Ranolazine|ranolazine|mesh-list
25673134|NCT01754259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25673135|NCT01754259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25673136|NCT01754259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673137|NCT01754376|Aldesleukin|aldesleukin|mesh-list
25673138|NCT01754376|Interleukin-2|interleukin-2|mesh-list
24518659|NCT04592991|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
24518660|NCT04592991|Chelating Agents|chelating agents|mesh-ancestor
24518661|NCT04592991|Sequestering Agents|sequestering agents|mesh-ancestor
25235606|NCT02563405|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25235607|NCT02563405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25235608|NCT02563405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25235609|NCT02563405|Adrenergic Agents|adrenergic agents|mesh-ancestor
25235610|NCT02563405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25235611|NCT02563340|Rituximab|rituximab|mesh-list
25235612|NCT02563340|Bortezomib|bortezomib|mesh-list
25235613|NCT02563340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25235614|NCT02563340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25235615|NCT02563340|Immunologic Factors|immunologic factors|mesh-ancestor
25235616|NCT02563340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235617|NCT02563340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25235618|NCT02563353|Teriparatide|teriparatide|mesh-list
25235619|NCT02563353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25235620|NCT02563353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235621|NCT02563353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25235622|NCT02563288|Dexmedetomidine|dexmedetomidine|mesh-list
25235623|NCT02563288|Esmolol|esmolol|mesh-list
25235624|NCT02563288|Adrenergic Agents|adrenergic agents|mesh-list
25235625|NCT02563288|Adrenergic Agonists|adrenergic agonists|mesh-list
25235626|NCT02563288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-list
25235627|NCT02563288|Adrenergic Antagonists|adrenergic antagonists|mesh-list
25235628|NCT02563288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25873591|NCT05561660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25873592|NCT05561660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24847893|NCT05353101|Antifungal Agents|antifungal agents|mesh-ancestor
24484896|NCT00450645|Heparin|heparin|mesh-list
25074700|NCT03386630|Dsuvia|dsuvia|mesh-list
25873593|NCT05561660|Analgesics|analgesics|mesh-ancestor
25873594|NCT05561660|Sensory System Agents|sensory system agents|mesh-ancestor
25873595|NCT05561660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25235634|NCT02563288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25235635|NCT02563288|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25235636|NCT02563288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25235637|NCT02563288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235638|NCT02563288|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25235639|NCT02563288|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25235640|NCT02563327|Pyridoxine|pyridoxine|mesh-list
25235641|NCT02563327|Vitamin B 6|vitamin b 6|mesh-list
25235642|NCT02563327|Moxifloxacin|moxifloxacin|mesh-list
25235643|NCT02563327|Rifampin|rifampin|mesh-list
25235644|NCT02563327|Isoniazid|isoniazid|mesh-list
25235645|NCT02563327|Pyrazinamide|pyrazinamide|mesh-list
25235646|NCT02563327|Ethambutol|ethambutol|mesh-list
25235648|NCT02563327|Vitamins|vitamins|mesh-ancestor
25235649|NCT02563327|Micronutrients|micronutrients|mesh-ancestor
25235650|NCT02563327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235651|NCT02563327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25235652|NCT02563327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25235653|NCT02563327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25235654|NCT02563327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25235655|NCT02563327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235656|NCT02563327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235657|NCT02563327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25235658|NCT02563327|Vitamin B Complex|vitamin b complex|mesh-ancestor
25235659|NCT02563327|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25235660|NCT02563327|Antitubercular Agents|antitubercular agents|mesh-ancestor
25235661|NCT02563327|Leprostatic Agents|leprostatic agents|mesh-ancestor
25235662|NCT02563327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25235663|NCT02563327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25235664|NCT02563327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25235665|NCT02563327|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24636475|NCT01145703|Cholecalciferol|cholecalciferol|mesh-list
24636476|NCT01145703|Vitamins|vitamins|mesh-list
24636477|NCT01145703|Micronutrients|micronutrients|mesh-ancestor
25673139|NCT01754376|Vemurafenib|vemurafenib|mesh-list
25673140|NCT01754376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673141|NCT01754376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25673142|NCT01754376|Analgesics|analgesics|mesh-ancestor
25673143|NCT01754376|Sensory System Agents|sensory system agents|mesh-ancestor
25673144|NCT01754376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25673145|NCT01754376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636478|NCT01145703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873596|NCT05561660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518662|NCT04592991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518664|NCT04562090|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24518868|NCT04094961|Dexamethasone|dexamethasone|mesh-list
24518869|NCT04094961|Dexamethasone acetate|dexamethasone acetate|mesh-list
24518870|NCT04094961|Pomalidomide|pomalidomide|mesh-list
24518873|NCT04094961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24518874|NCT04094961|Antiemetics|antiemetics|mesh-ancestor
24518937|NCT03889756|Anesthetics|anesthetics|mesh-ancestor
24518938|NCT03889756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24518939|NCT03889756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24961733|NCT03806049|Carboplatin|carboplatin|mesh-list
24961734|NCT03806049|Niraparib|niraparib|mesh-list
24961735|NCT03806049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24518940|NCT03889756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24518941|NCT03889756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24518942|NCT03889756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518943|NCT03889756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24518944|NCT03889756|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24518945|NCT03889756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24518946|NCT03889756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24518976|NCT03773445|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24518977|NCT03773445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24518978|NCT03773445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24518979|NCT03710772|Cytarabine|cytarabine|mesh-list
25235666|NCT02563327|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25235667|NCT02563327|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25235668|NCT02563327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25235669|NCT02563327|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25235670|NCT02563327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25235671|NCT02563327|Antimetabolites|antimetabolites|mesh-ancestor
25235672|NCT02563327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25235673|NCT02563054|Fluorouracil|fluorouracil|mesh-list
25235674|NCT02563054|Capecitabine|capecitabine|mesh-list
25235675|NCT02563054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25235676|NCT02563054|Antimetabolites|antimetabolites|mesh-ancestor
25235677|NCT02563054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961762|NCT03805568|Dexmedetomidine|dexmedetomidine|mesh-list
24961763|NCT03805568|Remifentanil|remifentanil|mesh-list
24961764|NCT03805568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24961765|NCT03805568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961766|NCT03805568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961767|NCT03805568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24961768|NCT03805568|Analgesics|analgesics|mesh-ancestor
24961769|NCT03805568|Sensory System Agents|sensory system agents|mesh-ancestor
25235678|NCT02563054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25235679|NCT02563054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25235680|NCT02563054|Immunologic Factors|immunologic factors|mesh-ancestor
25235681|NCT02563054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235682|NCT02563041|Heparin|heparin|mesh-list
25235683|NCT02563041|Calcium heparin|calcium heparin|mesh-list
25235684|NCT02563041|Anticoagulants|anticoagulants|mesh-ancestor
25235685|NCT02563041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235686|NCT02563041|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25235687|NCT02563041|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25235688|NCT02562950|Midazolam|midazolam|mesh-list
25673146|NCT01754376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25873597|NCT05561660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25873598|NCT05561660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25873599|NCT05561660|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25873600|NCT05561660|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25873601|NCT05561660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873602|NCT05561660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25873603|NCT05561660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25873604|NCT05561660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25873605|NCT05561660|Antipyretics|antipyretics|mesh-ancestor
25873606|NCT05561543|Peppermint oil|peppermint oil|mesh-list
25873607|NCT05561543|Antiemetics|antiemetics|mesh-ancestor
25873608|NCT05561543|Autonomic Agents|autonomic agents|mesh-ancestor
25873609|NCT05561543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25873610|NCT05561543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993071|NCT01358201|Antimetabolites|antimetabolites|mesh-ancestor
24993072|NCT01358201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993073|NCT01358201|Dermatologic Agents|dermatologic agents|mesh-ancestor
24993074|NCT01358201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24993075|NCT01358201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24993076|NCT01358201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24993077|NCT01358201|Immunologic Factors|immunologic factors|mesh-ancestor
24993078|NCT01358201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24814377|NCT02064374|Metformin|metformin|mesh-list
25235689|NCT02562950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25235690|NCT02562950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25235691|NCT02562950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25873611|NCT05561543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25873612|NCT05561543|Parasympatholytics|parasympatholytics|mesh-ancestor
25873613|NCT05561387|Dexamethasone|dexamethasone|mesh-list
25873614|NCT05561387|Dexamethasone acetate|dexamethasone acetate|mesh-list
24847925|NCT05340452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24847926|NCT05340452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24847927|NCT05340452|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24847928|NCT05340452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24847929|NCT05340452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847930|NCT05340452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25873615|NCT05561387|Lenalidomide|lenalidomide|mesh-list
25873616|NCT05561387|Bortezomib|bortezomib|mesh-list
25873617|NCT05561387|Daratumumab|daratumumab|mesh-list
25154758|NCT05469412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25044685|NCT01064518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25044686|NCT01064518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044687|NCT01064518|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25044688|NCT01064518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25044689|NCT01060579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25044691|NCT01060579|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25044692|NCT01057667|Ribavirin|ribavirin|mesh-list
25044693|NCT01057667|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25044694|NCT01057667|Antimetabolites|antimetabolites|mesh-ancestor
24518980|NCT03710772|Dexamethasone|dexamethasone|mesh-list
24518981|NCT03710772|Dexamethasone acetate|dexamethasone acetate|mesh-list
24519151|NCT03245892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961817|NCT03804931|Prednisone|prednisone|mesh-list
24519179|NCT03112603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519181|NCT03112603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24519182|NCT03112603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24519183|NCT03112603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25873618|NCT05561387|Ichthammol|ichthammol|mesh-list
24519184|NCT03112603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24519185|NCT03112603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24519186|NCT03112603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24519187|NCT03112603|Antitubercular Agents|antitubercular agents|mesh-ancestor
24519188|NCT03112603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24519189|NCT03112603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24519190|NCT03112603|Antifungal Agents|antifungal agents|mesh-ancestor
25673147|NCT01754376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25673148|NCT01754376|Antiviral Agents|antiviral agents|mesh-ancestor
25673149|NCT01754376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25673150|NCT01754376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25673151|NCT01754376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25673152|NCT01754376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673153|NCT01754389|Sirolimus|sirolimus|mesh-list
25673154|NCT01754389|Methotrexate|methotrexate|mesh-list
25673155|NCT01754389|Bortezomib|bortezomib|mesh-list
25673156|NCT01754389|Tacrolimus|tacrolimus|mesh-list
25673157|NCT01754389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25673158|NCT01754389|Abortifacient Agents|abortifacient agents|mesh-ancestor
25673159|NCT01754389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25673160|NCT01754389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873619|NCT05561387|BB 1101|bb 1101|mesh-list
25873620|NCT05561387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24994082|NCT04930744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994083|NCT04930744|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24994084|NCT04930744|Antitubercular Agents|antitubercular agents|mesh-ancestor
24994085|NCT04930744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24994086|NCT04930744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24994087|NCT04930744|Leprostatic Agents|leprostatic agents|mesh-ancestor
24785885|NCT01917032|Dermatologic Agents|dermatologic agents|mesh-ancestor
24785886|NCT01917045|Sufentanil|sufentanil|mesh-list
24785887|NCT01917045|Morphine|morphine|mesh-list
25235692|NCT02562950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235693|NCT02562950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25235694|NCT02562950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25235703|NCT02562742|Ribavirin|ribavirin|mesh-list
25235704|NCT02562742|Antimetabolites|antimetabolites|mesh-ancestor
25235705|NCT02562742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235706|NCT02562742|Antiviral Agents|antiviral agents|mesh-ancestor
25235707|NCT02562742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25273662|NCT02383901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25273663|NCT02383901|Antimetabolites|antimetabolites|mesh-ancestor
25273664|NCT02383901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273665|NCT02383901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25273666|NCT02383901|Dermatologic Agents|dermatologic agents|mesh-ancestor
25273667|NCT02383901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273668|NCT02383901|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25273669|NCT02383901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25273670|NCT02383901|Immunologic Factors|immunologic factors|mesh-ancestor
25273671|NCT02383901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25273672|NCT02383901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25273673|NCT02383823|Estradiol|estradiol|mesh-list
25273674|NCT02383823|Estrogens|estrogens|mesh-list
25273675|NCT02383823|Hormones|hormones|mesh-ancestor
25044695|NCT01057667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044696|NCT01057667|Antiviral Agents|antiviral agents|mesh-ancestor
25044697|NCT01057667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25044698|NCT01057147|Rebamipide|rebamipide|mesh-list
25044699|NCT01057147|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25044700|NCT01057147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25044701|NCT01057147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25044702|NCT01057147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25044703|NCT01057147|Antioxidants|antioxidants|mesh-ancestor
25044704|NCT01057147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044705|NCT01057147|Protective Agents|protective agents|mesh-ancestor
25044706|NCT01057147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044707|NCT01057147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044708|NCT01056393|Ibalizumab|ibalizumab|mesh-list
25044709|NCT01056393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25044710|NCT01056393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25873621|NCT05561387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25873622|NCT05561387|Antiemetics|antiemetics|mesh-ancestor
25873623|NCT05561387|Autonomic Agents|autonomic agents|mesh-ancestor
25873624|NCT05561387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25873625|NCT05561387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873626|NCT05561387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25873627|NCT05561387|Glucocorticoids|glucocorticoids|mesh-ancestor
25873628|NCT05561387|Hormones|hormones|mesh-ancestor
24519191|NCT03112603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24519311|NCT02224144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519629|NCT05332028|Sensory System Agents|sensory system agents|mesh-ancestor
24519697|NCT05315024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519698|NCT05315024|Interferon Inducers|interferon inducers|mesh-ancestor
24457787|NCT00335205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519944|NCT04413253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25673161|NCT01754389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25673162|NCT01754389|Antimetabolites|antimetabolites|mesh-ancestor
25673163|NCT01754389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673164|NCT01754389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673165|NCT01754389|Dermatologic Agents|dermatologic agents|mesh-ancestor
25673166|NCT01754389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25673167|NCT01754389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25673168|NCT01754389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25673169|NCT01754389|Immunologic Factors|immunologic factors|mesh-ancestor
25873629|NCT05561387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24519945|NCT04413253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519946|NCT04413253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24994702|NCT03347617|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24994703|NCT03347617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24994705|NCT03315741|Analgesics|analgesics|mesh-ancestor
24994706|NCT03315741|Sensory System Agents|sensory system agents|mesh-ancestor
24994707|NCT03315741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24994710|NCT03315741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24519982|NCT04333407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24519983|NCT04333407|Antithrombins|antithrombins|mesh-ancestor
24519984|NCT04333407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24519985|NCT04333407|Protease Inhibitors|protease inhibitors|mesh-ancestor
25235708|NCT02562690|Thrombin|thrombin|mesh-list
25235709|NCT02562690|Hemostatics|hemostatics|mesh-ancestor
25235710|NCT02562690|Coagulants|coagulants|mesh-ancestor
25235730|NCT02562625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25235732|NCT02562664|Metformin|metformin|mesh-list
25235733|NCT02562664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25235734|NCT02562664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873630|NCT05561387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25873631|NCT05561387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873632|NCT05561387|Protease Inhibitors|protease inhibitors|mesh-ancestor
24787858|NCT01928043|Curcumin|curcumin|mesh-list
25154759|NCT05469412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154760|NCT05469412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25154761|NCT05469412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25154762|NCT05469412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25154763|NCT05469412|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25154764|NCT05469412|Anesthetics, General|anesthetics, general|mesh-ancestor
25154765|NCT05469412|Anesthetics|anesthetics|mesh-ancestor
25154766|NCT05469412|GABA Modulators|gaba modulators|mesh-ancestor
25154767|NCT05469412|GABA Agents|gaba agents|mesh-ancestor
25154768|NCT05469412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25154769|NCT05469412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154770|NCT05469386|Methylphenidate|methylphenidate|mesh-list
25154771|NCT05469386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25154772|NCT05469386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154773|NCT05469386|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25154774|NCT05469386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25154775|NCT05469386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25154776|NCT05469386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154777|NCT05469386|Dopamine Agents|dopamine agents|mesh-ancestor
25154778|NCT05469386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25078737|NCT03353948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25235764|NCT02562144|Anesthetics|anesthetics|mesh-ancestor
25235765|NCT02562144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25235766|NCT02562144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235767|NCT02562144|Sensory System Agents|sensory system agents|mesh-ancestor
25235768|NCT02562144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25235769|NCT02562144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25235770|NCT02562144|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25235771|NCT02562144|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25235772|NCT02562144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25235773|NCT02562144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154783|NCT05469204|Digoxin|digoxin|mesh-list
25673170|NCT01754389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25673171|NCT01754389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25673172|NCT01754389|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25673173|NCT01754389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25673174|NCT01754389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25673175|NCT01754389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25673176|NCT01754389|Antifungal Agents|antifungal agents|mesh-ancestor
25673177|NCT01754402|Dexamethasone|dexamethasone|mesh-list
25673178|NCT01754402|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24960609|NCT03815344|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25409930|NCT03337698|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25673179|NCT01754402|Pomalidomide|pomalidomide|mesh-list
25873633|NCT05561387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25873634|NCT05561387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847934|NCT05339399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24847935|NCT05339399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847936|NCT05338983|Anesthetics|anesthetics|mesh-list
24847937|NCT05338983|Mepivacaine|mepivacaine|mesh-list
24847938|NCT05338983|Anesthetics, Local|anesthetics, local|mesh-list
24636545|NCT01146028|Analgesics|analgesics|mesh-ancestor
24891038|NCT04477304|Analgesics|analgesics|mesh-ancestor
24949476|NCT04669457|Sensory System Agents|sensory system agents|mesh-ancestor
24949477|NCT04669457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24949478|NCT04669457|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24949479|NCT04669457|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24949480|NCT04669457|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24949481|NCT04669457|Adrenergic Agents|adrenergic agents|mesh-ancestor
25235774|NCT02562300|Misoprostol|misoprostol|mesh-list
25235775|NCT02562300|Oxytocin|oxytocin|mesh-list
25235776|NCT02562300|Oxytocics|oxytocics|mesh-ancestor
25235777|NCT02562300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25235778|NCT02562300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235779|NCT02562300|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25235780|NCT02562300|Abortifacient Agents|abortifacient agents|mesh-ancestor
25235781|NCT02562300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25235782|NCT02562300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25235784|NCT02562118|Lenvatinib|lenvatinib|mesh-list
25235785|NCT02562118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25235786|NCT02562118|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25235787|NCT02562118|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25235788|NCT02562118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235789|NCT02562118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235790|NCT02562118|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25235791|NCT02562118|Hormone Antagonists|hormone antagonists|mesh-ancestor
25235792|NCT02562118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25235793|NCT02562118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044718|NCT01055444|Anesthetics, Local|anesthetics, local|mesh-ancestor
25235802|NCT02562287|Risperidone|risperidone|mesh-list
25235803|NCT02562287|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25235804|NCT02562287|Clozapine|clozapine|mesh-list
25235805|NCT02562287|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25235806|NCT02562287|Serotonin Agents|serotonin agents|mesh-ancestor
25673180|NCT01754402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25673181|NCT01754402|Antiemetics|antiemetics|mesh-ancestor
25673182|NCT01754402|Autonomic Agents|autonomic agents|mesh-ancestor
25673183|NCT01754402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25673184|NCT01754402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673185|NCT01754402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25673186|NCT01754402|Glucocorticoids|glucocorticoids|mesh-ancestor
25673187|NCT01754402|Hormones|hormones|mesh-ancestor
25673188|NCT01754402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25673189|NCT01754402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25673190|NCT01754402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520707|NCT05334043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520709|NCT05334043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24520710|NCT05334043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520711|NCT05334043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24520740|NCT05333731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521285|NCT04907279|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24521318|NCT04876937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25235812|NCT02562287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25235813|NCT02562287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25235814|NCT02562287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25235815|NCT02562287|Dopamine Agents|dopamine agents|mesh-ancestor
25235816|NCT02562287|Antiemetics|antiemetics|mesh-ancestor
25235817|NCT02562287|Autonomic Agents|autonomic agents|mesh-ancestor
25235818|NCT02562287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25235819|NCT02562287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25235820|NCT02562287|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25235821|NCT02562287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25235822|NCT02562287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25235823|NCT02562287|Antidepressive Agents|antidepressive agents|mesh-ancestor
25235824|NCT02562287|GABA Antagonists|gaba antagonists|mesh-ancestor
25235825|NCT02562287|GABA Agents|gaba agents|mesh-ancestor
25235826|NCT02562053|Fluoxetine|fluoxetine|mesh-list
25235827|NCT02562053|Contraceptive Agents|contraceptive agents|mesh-list
25235828|NCT02562053|Contraceptives, Oral|contraceptives, oral|mesh-list
25044719|NCT01055444|Anesthetics|anesthetics|mesh-ancestor
25235830|NCT02562053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25235831|NCT02562053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235832|NCT02562053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25235833|NCT02562053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25235834|NCT02562053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25673191|NCT01754402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25673192|NCT01754402|Alkylating Agents|alkylating agents|mesh-ancestor
25235835|NCT02562053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235836|NCT02562053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25235837|NCT02562053|Serotonin Agents|serotonin agents|mesh-ancestor
25235838|NCT02562053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25235839|NCT02562053|Antidepressive Agents|antidepressive agents|mesh-ancestor
25235840|NCT02562053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25235841|NCT02562053|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25235842|NCT02562053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25235843|NCT02562053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235844|NCT02562053|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25235845|NCT02562313|Insulin Lispro|insulin lispro|mesh-list
25235846|NCT02562313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25235847|NCT02562313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235848|NCT02561936|Rilpivirine|rilpivirine|mesh-list
25235849|NCT02561936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25235850|NCT02561936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25235851|NCT02561936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235852|NCT02561936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235853|NCT02561936|Antiviral Agents|antiviral agents|mesh-ancestor
25235854|NCT02561936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25235855|NCT02561936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25235856|NCT02561936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25235857|NCT02561923|Rivaroxaban|rivaroxaban|mesh-list
25235858|NCT02561923|Tranexamic Acid|tranexamic acid|mesh-list
25235859|NCT02561923|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25235860|NCT02561923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25235861|NCT02561923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235862|NCT02561923|Hemostatics|hemostatics|mesh-ancestor
25235863|NCT02561923|Coagulants|coagulants|mesh-ancestor
25235865|NCT02561923|Antithrombins|antithrombins|mesh-ancestor
25235866|NCT02561923|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25235867|NCT02561923|Protease Inhibitors|protease inhibitors|mesh-ancestor
25873635|NCT05561387|Immunologic Factors|immunologic factors|mesh-ancestor
25873636|NCT05561387|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25873637|NCT05561387|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25873638|NCT05561387|Growth Substances|growth substances|mesh-ancestor
25873639|NCT05561387|Growth Inhibitors|growth inhibitors|mesh-ancestor
25673193|NCT01754402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673194|NCT01754402|Immunologic Factors|immunologic factors|mesh-ancestor
25873640|NCT05561387|Dermatologic Agents|dermatologic agents|mesh-ancestor
25873641|NCT05561361|Spironolactone|spironolactone|mesh-list
25673195|NCT01754402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25673196|NCT01754402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25873642|NCT05561361|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25873643|NCT05561361|Hormone Antagonists|hormone antagonists|mesh-ancestor
25873644|NCT05561361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25873645|NCT05561361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873646|NCT05561361|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25873648|NCT05561361|Natriuretic Agents|natriuretic agents|mesh-ancestor
25873649|NCT05561309|Ropivacaine|ropivacaine|mesh-list
25873650|NCT05561309|Anesthetics, Local|anesthetics, local|mesh-ancestor
25873651|NCT05561309|Anesthetics|anesthetics|mesh-ancestor
25873652|NCT05561309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25873653|NCT05561309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873654|NCT05561309|Sensory System Agents|sensory system agents|mesh-ancestor
24847973|NCT05298696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24847974|NCT05298696|Autonomic Agents|autonomic agents|mesh-ancestor
24847975|NCT05298696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24457793|NCT00335231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24521804|NCT04500158|Anesthetics|anesthetics|mesh-ancestor
24521805|NCT04500158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24521838|NCT04480125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24521840|NCT04472143|Granisetron|granisetron|mesh-list
24521841|NCT04472143|Antiemetics|antiemetics|mesh-ancestor
24521842|NCT04472143|Autonomic Agents|autonomic agents|mesh-ancestor
25235868|NCT02561923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235869|NCT02561923|Anticoagulants|anticoagulants|mesh-ancestor
25235870|NCT02561884|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25235871|NCT02561884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25235872|NCT02561884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25235873|NCT02561884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25235874|NCT02561884|Antimetabolites|antimetabolites|mesh-ancestor
25235875|NCT02561884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235876|NCT02561884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25235877|NCT02561884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25235878|NCT02561884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235879|NCT02561884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25235880|NCT02561884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25235881|NCT02561884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25235882|NCT02561845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25235883|NCT02561845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25235884|NCT02561845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25235885|NCT02561845|Antimetabolites|antimetabolites|mesh-ancestor
25235886|NCT02561845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235887|NCT02561845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25235888|NCT02561845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25235889|NCT02561845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235890|NCT02561767|Mycophenolic Acid|mycophenolic acid|mesh-list
25235891|NCT02561767|Tacrolimus|tacrolimus|mesh-list
25235892|NCT02561767|Basiliximab|basiliximab|mesh-list
25235893|NCT02561767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25235894|NCT02561767|Immunologic Factors|immunologic factors|mesh-ancestor
25235895|NCT02561767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235896|NCT02561767|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25235897|NCT02561767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235898|NCT02561767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235899|NCT02561767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24847976|NCT05298696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847977|NCT05298696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25673197|NCT01754402|Growth Substances|growth substances|mesh-ancestor
25673198|NCT01754402|Growth Inhibitors|growth inhibitors|mesh-ancestor
25673199|NCT01754480|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25673200|NCT01754480|Hemostatics|hemostatics|mesh-ancestor
25673201|NCT01754480|Coagulants|coagulants|mesh-ancestor
25673202|NCT01754493|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25673203|NCT01754493|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25673204|NCT01754493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24847984|NCT05298696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24847985|NCT05298696|Protective Agents|protective agents|mesh-ancestor
24847986|NCT05298696|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24847987|NCT05298696|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24847988|NCT05298696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24847990|NCT05289323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24847991|NCT05289323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235900|NCT02561767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25235901|NCT02561767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25235902|NCT02561767|Antitubercular Agents|antitubercular agents|mesh-ancestor
25235903|NCT02561767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25235904|NCT02561767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25235905|NCT02561494|Nefopam|nefopam|mesh-list
25235906|NCT02561494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25235907|NCT02561494|Analgesics|analgesics|mesh-ancestor
25235908|NCT02561494|Sensory System Agents|sensory system agents|mesh-ancestor
25235909|NCT02561494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25235910|NCT02561494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235911|NCT02561520|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25235912|NCT02561520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25235913|NCT02561468|Nefopam|nefopam|mesh-list
25235914|NCT02561468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25235915|NCT02561468|Analgesics|analgesics|mesh-ancestor
25235916|NCT02561468|Sensory System Agents|sensory system agents|mesh-ancestor
25235917|NCT02561468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25235918|NCT02561468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235919|NCT02561117|Metronidazole|metronidazole|mesh-list
25235920|NCT02561117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25235921|NCT02561117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25235922|NCT02561117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25235923|NCT02561117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25235924|NCT02561169|Oseltamivir|oseltamivir|mesh-list
25235925|NCT02561169|Calcium Carbonate|calcium carbonate|mesh-list
25235926|NCT02561169|Antiviral Agents|antiviral agents|mesh-ancestor
25235927|NCT02561169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25235928|NCT02561169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235929|NCT02561169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235930|NCT02561169|Antacids|antacids|mesh-ancestor
25235931|NCT02561169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25235932|NCT02561039|Ibandronic Acid|ibandronic acid|mesh-list
25235933|NCT02561039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25235934|NCT02561039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235935|NCT02561013|Monensin|monensin|mesh-list
25673205|NCT01754493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25673206|NCT01754493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673207|NCT01754493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25235936|NCT02561013|Antifungal Agents|antifungal agents|mesh-ancestor
25235937|NCT02561013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25873659|NCT05561257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873660|NCT05561257|Antioxidants|antioxidants|mesh-ancestor
25873661|NCT05561257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873662|NCT05561257|Protective Agents|protective agents|mesh-ancestor
25873663|NCT05561231|Pyrithione zinc|pyrithione zinc|mesh-list
25873664|NCT05561231|Keratolytic Agents|keratolytic agents|mesh-ancestor
25873665|NCT05561231|Dermatologic Agents|dermatologic agents|mesh-ancestor
25873666|NCT05561205|Methylphenidate|methylphenidate|mesh-list
25873667|NCT05561205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25873668|NCT05561205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873669|NCT05561205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25873670|NCT05561205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24848015|NCT05248633|Lenalidomide|lenalidomide|mesh-list
24848016|NCT05248633|Bortezomib|bortezomib|mesh-list
24636781|NCT01147289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24522148|NCT04207177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24457794|NCT00335231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24457795|NCT00335231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457796|NCT00335231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464060|NCT00363090|Mitosis Modulators|mitosis modulators|mesh-ancestor
24457797|NCT00335231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522149|NCT04207177|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24522150|NCT04207177|Antitubercular Agents|antitubercular agents|mesh-ancestor
25235942|NCT02561013|Uncoupling Agents|uncoupling agents|mesh-ancestor
25235943|NCT02561013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235944|NCT02561013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235945|NCT02561013|Ionophores|ionophores|mesh-ancestor
25235946|NCT02561013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25235947|NCT02561013|Sodium Ionophores|sodium ionophores|mesh-ancestor
25235948|NCT02560974|Capecitabine|capecitabine|mesh-list
25235949|NCT02560974|Oxaliplatin|oxaliplatin|mesh-list
25235950|NCT02560974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25235951|NCT02560974|Antimetabolites|antimetabolites|mesh-ancestor
25235952|NCT02560974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235953|NCT02560974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25235954|NCT02560935|Hydroxyurea|hydroxyurea|mesh-list
25235955|NCT02560935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25235956|NCT02560935|Antisickling Agents|antisickling agents|mesh-ancestor
25235957|NCT02560935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25235958|NCT02560935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235959|NCT02560935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25273676|NCT02383823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25273677|NCT02383823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273678|NCT02383888|BI 425809|bi 425809|mesh-list
25273679|NCT02383888|Nootropic Agents|nootropic agents|mesh-ancestor
25273680|NCT02383927|Tipifarnib|tipifarnib|mesh-list
25273681|NCT02383927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962332|NCT03800290|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25673208|NCT01754493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673209|NCT01754493|Analgesics|analgesics|mesh-ancestor
25673210|NCT01754493|Sensory System Agents|sensory system agents|mesh-ancestor
25673211|NCT01754493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25673212|NCT01754493|Antidepressive Agents|antidepressive agents|mesh-ancestor
25154789|NCT05469204|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25154790|NCT05469204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25154791|NCT05469204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25154792|NCT05469204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25154793|NCT05469204|Anesthetics, General|anesthetics, general|mesh-ancestor
25154794|NCT05469204|Anesthetics|anesthetics|mesh-ancestor
25154795|NCT05469204|GABA Modulators|gaba modulators|mesh-ancestor
25154796|NCT05469204|GABA Agents|gaba agents|mesh-ancestor
25154797|NCT05469204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24522151|NCT04207177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24522152|NCT04207177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25235960|NCT02560909|Vaccines|vaccines|mesh-list
25235961|NCT02560909|Immunologic Factors|immunologic factors|mesh-ancestor
24962404|NCT03799120|Tamsulosin|tamsulosin|mesh-list
25235962|NCT02560909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235963|NCT02560870|Chlorhexidine|chlorhexidine|mesh-list
25235964|NCT02560870|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25235965|NCT02560870|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25235966|NCT02560870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25235967|NCT02560870|Disinfectants|disinfectants|mesh-ancestor
25235968|NCT02560870|Dermatologic Agents|dermatologic agents|mesh-ancestor
25235969|NCT02560766|Gabapentin|gabapentin|mesh-list
25235970|NCT02560766|Analgesics|analgesics|mesh-ancestor
25235971|NCT02560766|Sensory System Agents|sensory system agents|mesh-ancestor
25235972|NCT02560766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25235973|NCT02560766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235974|NCT02560766|Anticonvulsants|anticonvulsants|mesh-ancestor
25235975|NCT02560766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25235976|NCT02560766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25235977|NCT02560766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25235978|NCT02560766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25235979|NCT02560766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25235980|NCT02560766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25235981|NCT02560766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25235982|NCT02560766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235983|NCT02560766|Antimanic Agents|antimanic agents|mesh-ancestor
25235984|NCT02560688|Clopidogrel|clopidogrel|mesh-list
25235985|NCT02560688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25235986|NCT02560688|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25235987|NCT02560688|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25235988|NCT02560688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25235989|NCT02560688|Purinergic Agents|purinergic agents|mesh-ancestor
25235990|NCT02560688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24962461|NCT03798392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962462|NCT03798314|Nivolumab|nivolumab|mesh-list
24962463|NCT03798314|Pomalidomide|pomalidomide|mesh-list
24962464|NCT03798314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24962465|NCT03798314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962466|NCT03798314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24962467|NCT03798314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235991|NCT02560688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25235992|NCT02560688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25235993|NCT02560649|Tenofovir|tenofovir|mesh-list
25235994|NCT02560649|Lamivudine|lamivudine|mesh-list
25235995|NCT02560649|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25673213|NCT01754493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25673214|NCT01754493|Dopamine Agents|dopamine agents|mesh-ancestor
25673215|NCT01754623|Gemcitabine|gemcitabine|mesh-list
25673216|NCT01754623|Fluorouracil|fluorouracil|mesh-list
25673217|NCT01754623|Capecitabine|capecitabine|mesh-list
25236000|NCT02560649|Antiviral Agents|antiviral agents|mesh-ancestor
25236001|NCT02560649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25236002|NCT02560649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25236003|NCT02560649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25236004|NCT02560649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25236005|NCT02560649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236006|NCT02560649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25236007|NCT02560649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25236008|NCT02560649|Immunologic Factors|immunologic factors|mesh-ancestor
25236009|NCT02560649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236010|NCT02560636|Pembrolizumab|pembrolizumab|mesh-list
25236011|NCT02560636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25236012|NCT02560636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236013|NCT02560519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25236014|NCT02560376|Exenatide|exenatide|mesh-list
25236015|NCT02560376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25236016|NCT02560376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236017|NCT02560376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25236018|NCT02560376|Incretins|incretins|mesh-ancestor
25236019|NCT02560376|Hormones|hormones|mesh-ancestor
25236020|NCT02560376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25236021|NCT02560220|Mitomycins|mitomycins|mesh-list
25236022|NCT02560220|Mitomycin|mitomycin|mesh-list
25236023|NCT02560220|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25236024|NCT02560220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236025|NCT02560220|Alkylating Agents|alkylating agents|mesh-ancestor
25236055|NCT02559921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236029|NCT02560207|Cefotaxime|cefotaxime|mesh-list
24962527|NCT03799913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848027|NCT05248633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24848028|NCT05248633|Immunologic Factors|immunologic factors|mesh-ancestor
24848029|NCT05248633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24848030|NCT05248633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24848031|NCT05248633|Growth Substances|growth substances|mesh-ancestor
24848032|NCT05248633|Growth Inhibitors|growth inhibitors|mesh-ancestor
24841100|NCT02213913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24862330|NCT02324452|Fluorouracil|fluorouracil|mesh-list
24485491|NCT00453232|Etoposide|etoposide|mesh-list
24522254|NCT04081831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522255|NCT04081831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24522256|NCT04081831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24522500|NCT03673956|Levofloxacin|levofloxacin|mesh-list
24522501|NCT03673956|Ofloxacin|ofloxacin|mesh-list
24522502|NCT03673956|Tobramycin|tobramycin|mesh-list
24788199|NCT01930201|Anesthetics|anesthetics|mesh-list
24788200|NCT01930201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24788201|NCT01930201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580442|NCT00861861|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24580587|NCT00862394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580589|NCT00862420|Clopidogrel|clopidogrel|mesh-list
24580590|NCT00862420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24580591|NCT00862420|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24962556|NCT03797729|Tirofiban|tirofiban|mesh-list
24580592|NCT00862420|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24580593|NCT00862420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25236030|NCT02560207|Cefoxitin|cefoxitin|mesh-list
25236031|NCT02560207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25236032|NCT02560207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25236033|NCT02560155|Chlorhexidine|chlorhexidine|mesh-list
25236034|NCT02560155|Mupirocin|mupirocin|mesh-list
25236035|NCT02560155|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25236036|NCT02560155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25236037|NCT02560155|Disinfectants|disinfectants|mesh-ancestor
25236038|NCT02560155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25236039|NCT02560155|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25236040|NCT02560155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25236041|NCT02560155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236042|NCT02559973|Buprenorphine|buprenorphine|mesh-list
25236043|NCT02559973|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25236044|NCT02559973|Naloxone|naloxone|mesh-list
25236045|NCT02559973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25236046|NCT02559973|Narcotics|narcotics|mesh-ancestor
25236047|NCT02559973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25236048|NCT02559973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236049|NCT02559973|Analgesics|analgesics|mesh-ancestor
25236050|NCT02559973|Sensory System Agents|sensory system agents|mesh-ancestor
25236051|NCT02559973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25236052|NCT02559973|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25236053|NCT02559921|Vaccines|vaccines|mesh-list
25236054|NCT02559921|Immunologic Factors|immunologic factors|mesh-ancestor
25673218|NCT01754623|Docetaxel|docetaxel|mesh-list
25673219|NCT01754623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25673220|NCT01754623|Antimetabolites|antimetabolites|mesh-ancestor
25673221|NCT01754623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673222|NCT01754623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673223|NCT01754623|Antiviral Agents|antiviral agents|mesh-ancestor
25673224|NCT01754623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25673225|NCT01754623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25673226|NCT01754623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25673227|NCT01754623|Immunologic Factors|immunologic factors|mesh-ancestor
24522928|NCT03044613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523118|NCT02584309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25005215|NCT04368559|Rezafungin|rezafungin|mesh-list
25005216|NCT04368559|Trimethoprim|trimethoprim|mesh-list
25005217|NCT04368559|Sulfamethoxazole|sulfamethoxazole|mesh-list
25005218|NCT04368559|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25005219|NCT04368559|Antifungal Agents|antifungal agents|mesh-ancestor
25005220|NCT04368559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25005221|NCT04368559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25005222|NCT04368559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25005223|NCT04368559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25005224|NCT04368559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005225|NCT04368559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24523194|NCT02389036|Colistin|colistin|mesh-list
24523195|NCT02389036|Nystatin|nystatin|mesh-list
24523196|NCT02389036|Cefotaxime|cefotaxime|mesh-list
24523197|NCT02389036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24523198|NCT02389036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24523199|NCT02389036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24523200|NCT02389036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24523264|NCT02336750|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24523280|NCT02268175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24523312|NCT02066220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523314|NCT02066220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24523316|NCT02066220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236059|NCT02559908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236060|NCT02559908|Viscosupplements|viscosupplements|mesh-ancestor
25236061|NCT02559908|Protective Agents|protective agents|mesh-ancestor
25236062|NCT02559791|Reslizumab|reslizumab|mesh-list
25236063|NCT02559791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25673229|NCT01754623|Tubulin Modulators|tubulin modulators|mesh-ancestor
25673230|NCT01754623|Antimitotic Agents|antimitotic agents|mesh-ancestor
25673231|NCT01754623|Mitosis Modulators|mitosis modulators|mesh-ancestor
25673232|NCT01754909|Enalapril|enalapril|mesh-list
25673233|NCT01754909|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25673234|NCT01754909|Protease Inhibitors|protease inhibitors|mesh-ancestor
25236064|NCT02559791|Respiratory System Agents|respiratory system agents|mesh-ancestor
25236073|NCT02559674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25236075|NCT02559674|Antiviral Agents|antiviral agents|mesh-ancestor
25236076|NCT02559674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25236077|NCT02559674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24523317|NCT02066220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24523318|NCT02066220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24523319|NCT02066220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24523320|NCT02066220|Tubulin Modulators|tubulin modulators|mesh-ancestor
24523321|NCT02066220|Antimitotic Agents|antimitotic agents|mesh-ancestor
24523322|NCT02066220|Mitosis Modulators|mitosis modulators|mesh-ancestor
24523326|NCT01855867|Emtricitabine|emtricitabine|mesh-list
24523327|NCT01855867|Antiviral Agents|antiviral agents|mesh-ancestor
24523426|NCT00887536|Growth Inhibitors|growth inhibitors|mesh-ancestor
24523494|NCT05342532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24523495|NCT05342532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24523496|NCT05342532|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24523582|NCT05341817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24523584|NCT05341817|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25236079|NCT02559674|Immunologic Factors|immunologic factors|mesh-ancestor
25236080|NCT02559674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236081|NCT02559648|Denosumab|denosumab|mesh-list
25236082|NCT02559648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25236083|NCT02559648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236084|NCT02559440|Mometasone Furoate|mometasone furoate|mesh-list
25236085|NCT02559440|Phenylephrine|phenylephrine|mesh-list
25236086|NCT02559440|Oxymetazoline|oxymetazoline|mesh-list
25236087|NCT02559440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25236088|NCT02559440|Dermatologic Agents|dermatologic agents|mesh-ancestor
25236089|NCT02559440|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25236090|NCT02559440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25236091|NCT02559440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25236092|NCT02559440|Adrenergic Agents|adrenergic agents|mesh-ancestor
25236093|NCT02559440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25236094|NCT02559440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236095|NCT02559440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236096|NCT02559440|Sympathomimetics|sympathomimetics|mesh-ancestor
25236097|NCT02559440|Autonomic Agents|autonomic agents|mesh-ancestor
25236098|NCT02559440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25236099|NCT02559440|Nasal Decongestants|nasal decongestants|mesh-ancestor
25236100|NCT02559440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25236101|NCT02559440|Respiratory System Agents|respiratory system agents|mesh-ancestor
25236102|NCT02559440|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25236103|NCT02559440|Mydriatics|mydriatics|mesh-ancestor
25236104|NCT02559440|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25236105|NCT02559440|Protective Agents|protective agents|mesh-ancestor
25236106|NCT02559388|Montelukast|montelukast|mesh-list
25236107|NCT02559388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25236119|NCT02559297|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25236120|NCT02559297|Anesthetics, General|anesthetics, general|mesh-ancestor
25236121|NCT02559297|Anesthetics|anesthetics|mesh-ancestor
25236122|NCT02559297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25236123|NCT02559297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236124|NCT02559232|Anticoagulants|anticoagulants|mesh-list
25236125|NCT02559154|Thalidomide|thalidomide|mesh-list
25236126|NCT02559154|Dexamethasone|dexamethasone|mesh-list
25236127|NCT02559154|Cyclophosphamide|cyclophosphamide|mesh-list
25236128|NCT02559154|Doxorubicin|doxorubicin|mesh-list
25236129|NCT02559154|Bortezomib|bortezomib|mesh-list
25236130|NCT02559154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25236131|NCT02559154|Immunologic Factors|immunologic factors|mesh-ancestor
25236132|NCT02559154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236133|NCT02559154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25236169|NCT02559141|Norepinephrine|norepinephrine|mesh-list
25236134|NCT02559154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25236135|NCT02559154|Alkylating Agents|alkylating agents|mesh-ancestor
25236136|NCT02559154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236137|NCT02559154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236138|NCT02559154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25236139|NCT02559154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25236140|NCT02559154|Antiemetics|antiemetics|mesh-ancestor
25236141|NCT02559154|Autonomic Agents|autonomic agents|mesh-ancestor
24848079|NCT05197062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848080|NCT05197062|Sensory System Agents|sensory system agents|mesh-ancestor
25873675|NCT05561179|Hyaluronic Acid|hyaluronic acid|mesh-list
25873676|NCT05561179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25108497|NCT03131700|Growth Inhibitors|growth inhibitors|mesh-ancestor
24523587|NCT05341817|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24523588|NCT05341817|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24523589|NCT05341817|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24523590|NCT05341817|Contraceptive Agents|contraceptive agents|mesh-ancestor
24523595|NCT05341817|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24523596|NCT05341583|Ensartinib|ensartinib|mesh-list
24523597|NCT05341583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24523598|NCT05341583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24872423|NCT05386810|Vaccines|vaccines|mesh-list
24523830|NCT05339802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24523831|NCT05339802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523832|NCT05339646|Ritonavir|ritonavir|mesh-list
24523833|NCT05339646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24523834|NCT05339646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24523835|NCT05339646|Protease Inhibitors|protease inhibitors|mesh-ancestor
24523836|NCT05339646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24523837|NCT05339646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523838|NCT05339646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24523839|NCT05339646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25236144|NCT02559154|Glucocorticoids|glucocorticoids|mesh-ancestor
25236145|NCT02559154|Hormones|hormones|mesh-ancestor
25236146|NCT02559154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25236147|NCT02559154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25236148|NCT02559154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25236149|NCT02559154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25236150|NCT02559154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25236151|NCT02559154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25236152|NCT02559154|Leprostatic Agents|leprostatic agents|mesh-ancestor
25236153|NCT02559154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25236154|NCT02559154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25236155|NCT02559154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25236156|NCT02559154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25236157|NCT02559154|Growth Substances|growth substances|mesh-ancestor
25236158|NCT02559154|Growth Inhibitors|growth inhibitors|mesh-ancestor
25236159|NCT02559167|Cannabidiol|cannabidiol|mesh-list
25236160|NCT02559167|Anticonvulsants|anticonvulsants|mesh-ancestor
25236161|NCT02559180|Aflibercept|aflibercept|mesh-list
25236162|NCT02559180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25236163|NCT02559180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25236164|NCT02559180|Growth Substances|growth substances|mesh-ancestor
25236165|NCT02559180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236166|NCT02559180|Growth Inhibitors|growth inhibitors|mesh-ancestor
25236167|NCT02559180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673236|NCT01754909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673237|NCT01754909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25673238|NCT01755026|Cefazolin|cefazolin|mesh-list
25673239|NCT01755026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25673240|NCT01755026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25673241|NCT01755091|Dronabinol|dronabinol|mesh-list
25673242|NCT01755091|Hallucinogens|hallucinogens|mesh-ancestor
25873677|NCT05561179|Immunologic Factors|immunologic factors|mesh-ancestor
25873678|NCT05561179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873679|NCT05561179|Viscosupplements|viscosupplements|mesh-ancestor
25873680|NCT05561179|Protective Agents|protective agents|mesh-ancestor
25873681|NCT05561062|Atorvastatin|atorvastatin|mesh-list
25873682|NCT05561062|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25873683|NCT05561062|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24523922|NCT05338502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523923|NCT05338502|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24528094|NCT00619697|Metformin|metformin|mesh-list
24524038|NCT05322031|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24524040|NCT05319093|Ozanimod|ozanimod|mesh-list
24524041|NCT05319093|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24524097|NCT05279833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524098|NCT05279833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524099|NCT05279833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25236170|NCT02559141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25236171|NCT02559141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25236172|NCT02559141|Adrenergic Agents|adrenergic agents|mesh-ancestor
25236173|NCT02559141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25236174|NCT02559141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236175|NCT02559141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236176|NCT02559141|Sympathomimetics|sympathomimetics|mesh-ancestor
25236177|NCT02559141|Autonomic Agents|autonomic agents|mesh-ancestor
25236178|NCT02559141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25236179|NCT02559141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25236180|NCT02559141|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25236181|NCT02559141|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25236182|NCT02559141|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25236183|NCT02559141|Protective Agents|protective agents|mesh-ancestor
24788853|NCT01934166|Nalmefene|nalmefene|mesh-list
25873684|NCT05561062|Antimetabolites|antimetabolites|mesh-ancestor
25873685|NCT05561062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873686|NCT05561062|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25236184|NCT02559102|Dexmedetomidine|dexmedetomidine|mesh-list
25236185|NCT02559102|Anesthetics|anesthetics|mesh-list
25236186|NCT02559102|Sevoflurane|sevoflurane|mesh-list
25236187|NCT02559102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25236188|NCT02559102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673243|NCT01755091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673244|NCT01755091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25673245|NCT01755091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25673246|NCT01755091|Analgesics|analgesics|mesh-ancestor
25673247|NCT01755091|Sensory System Agents|sensory system agents|mesh-ancestor
25673248|NCT01755091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25673249|NCT01755091|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25673250|NCT01755091|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25673251|NCT01755091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25873687|NCT05561062|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25873688|NCT05561062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25873689|NCT05561049|Thalidomide|thalidomide|mesh-list
25873690|NCT05561049|Dexamethasone|dexamethasone|mesh-list
25873691|NCT05561049|Bortezomib|bortezomib|mesh-list
25873692|NCT05561049|Daratumumab|daratumumab|mesh-list
25873693|NCT05561049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25873694|NCT05561049|Antiemetics|antiemetics|mesh-ancestor
24814493|NCT02064777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815356|NCT02069886|Deferasirox|deferasirox|mesh-list
24868577|NCT04206761|Bromides|bromides|mesh-list
24706152|NCT01488838|Cisplatin|cisplatin|mesh-list
24868578|NCT04206761|Anticonvulsants|anticonvulsants|mesh-ancestor
25236189|NCT02559102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25236190|NCT02559102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25236191|NCT02559102|Analgesics|analgesics|mesh-ancestor
25236192|NCT02559102|Sensory System Agents|sensory system agents|mesh-ancestor
25236193|NCT02559102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25236194|NCT02559102|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25236195|NCT02559102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25236196|NCT02559102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25236197|NCT02559102|Adrenergic Agents|adrenergic agents|mesh-ancestor
25236198|NCT02559102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25236199|NCT02559102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236201|NCT02559102|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25236202|NCT02559102|Anesthetics, General|anesthetics, general|mesh-ancestor
25236203|NCT02558972|Droxidopa|droxidopa|mesh-list
25236204|NCT02558972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25236205|NCT02558972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25236206|NCT02558933|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
25236207|NCT02558933|Antioxidants|antioxidants|mesh-ancestor
25236208|NCT02558933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236209|NCT02558933|Protective Agents|protective agents|mesh-ancestor
25236210|NCT02558933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236211|NCT02558933|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25236212|NCT02558933|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25236213|NCT02558933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236214|NCT02558933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25236215|NCT02558959|Capecitabine|capecitabine|mesh-list
25236216|NCT02558959|Irinotecan|irinotecan|mesh-list
25236217|NCT02558959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25236218|NCT02558959|Antimetabolites|antimetabolites|mesh-ancestor
25236219|NCT02558959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236220|NCT02558959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236221|NCT02558959|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25236222|NCT02558959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25236223|NCT02558959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25236224|NCT02558868|Oxaliplatin|oxaliplatin|mesh-list
25236225|NCT02558868|Irinotecan|irinotecan|mesh-list
25236226|NCT02558868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485830|NCT00455234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25873695|NCT05561049|Autonomic Agents|autonomic agents|mesh-ancestor
25873696|NCT05561049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24485926|NCT00455442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24848150|NCT05059977|gamma-Globulins|gamma-globulins|mesh-list
24848151|NCT05059977|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24848152|NCT05059977|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24848153|NCT05059977|Immunologic Factors|immunologic factors|mesh-ancestor
24848154|NCT05059977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236227|NCT02558868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25236228|NCT02558868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25236229|NCT02558868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25236230|NCT02558868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236231|NCT02558816|Obinutuzumab|obinutuzumab|mesh-list
25236233|NCT02558816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25236234|NCT02558816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236235|NCT02558751|Vaccines|vaccines|mesh-list
25236236|NCT02558751|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25236237|NCT02558751|Immunologic Factors|immunologic factors|mesh-ancestor
25236238|NCT02558751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236239|NCT02558595|Niacinamide|niacinamide|mesh-list
25236240|NCT02558595|Niacin|niacin|mesh-list
25236241|NCT02558595|Nicotinic Acids|nicotinic acids|mesh-list
25236242|NCT02558595|Vitamins|vitamins|mesh-ancestor
25236243|NCT02558595|Micronutrients|micronutrients|mesh-ancestor
25236244|NCT02558595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236245|NCT02558595|Vitamin B Complex|vitamin b complex|mesh-ancestor
25236246|NCT02558595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25236247|NCT02558595|Antimetabolites|antimetabolites|mesh-ancestor
25409931|NCT03337698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25673252|NCT01755091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673253|NCT01755091|Hormones|hormones|mesh-ancestor
25673254|NCT01755091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25673255|NCT01755156|Metformin|metformin|mesh-list
25108668|NCT03131037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24872904|NCT05439408|Dasatinib|dasatinib|mesh-list
24872978|NCT05438706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397944|NCT00143130|Pregabalin|pregabalin|mesh-list
25236248|NCT02558595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236249|NCT02558595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25236250|NCT02558595|Vasodilator Agents|vasodilator agents|mesh-ancestor
25236251|NCT02558569|Levobupivacaine|levobupivacaine|mesh-list
25236252|NCT02558569|Anesthetics, Local|anesthetics, local|mesh-ancestor
25236253|NCT02558569|Anesthetics|anesthetics|mesh-ancestor
25236254|NCT02558569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25236255|NCT02558569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236256|NCT02558569|Sensory System Agents|sensory system agents|mesh-ancestor
25236257|NCT02558569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25236258|NCT02558517|Prednisone|prednisone|mesh-list
25236259|NCT02558517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25236260|NCT02558517|Glucocorticoids|glucocorticoids|mesh-ancestor
25236261|NCT02558517|Hormones|hormones|mesh-ancestor
25236262|NCT02558517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25236263|NCT02558517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236264|NCT02558517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25236265|NCT02558517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24848167|NCT05000736|Fulvestrant|fulvestrant|mesh-list
24848168|NCT05000736|Palbociclib|palbociclib|mesh-list
24848169|NCT05000736|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24848170|NCT05000736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24848171|NCT05000736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637419|NCT01150162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044724|NCT01055444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25044725|NCT01055444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25044726|NCT01055444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25044727|NCT01055444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25044728|NCT01055444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044729|NCT01055106|Metronidazole|metronidazole|mesh-list
25044730|NCT01055106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25044731|NCT01055106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25044732|NCT01055106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25044733|NCT01055106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25044734|NCT01055015|Morphine|morphine|mesh-list
25044735|NCT01055015|Oxycodone|oxycodone|mesh-list
25044736|NCT01055015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24524142|NCT05236985|Oxytocin|oxytocin|mesh-list
24524143|NCT05236985|Oxytocics|oxytocics|mesh-ancestor
24524247|NCT05091905|Anesthetics, Local|anesthetics, local|mesh-list
25236266|NCT02558452|Tacrolimus|tacrolimus|mesh-list
25236267|NCT02558452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25236268|NCT02558452|Immunologic Factors|immunologic factors|mesh-ancestor
25236269|NCT02558452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236270|NCT02558452|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25236271|NCT02558452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25236272|NCT02558452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236273|NCT02558387|Nintedanib|nintedanib|mesh-list
25236274|NCT02558387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673256|NCT01755156|Insulin Glargine|insulin glargine|mesh-list
25673257|NCT01755156|Glimepiride|glimepiride|mesh-list
25673258|NCT01755156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25673259|NCT01755156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673260|NCT01755156|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25673261|NCT01755156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25673262|NCT01755156|Immunologic Factors|immunologic factors|mesh-ancestor
25673263|NCT01755169|Ketamine|ketamine|mesh-list
25673264|NCT01755169|Analgesics|analgesics|mesh-ancestor
25673265|NCT01755169|Sensory System Agents|sensory system agents|mesh-ancestor
25673266|NCT01755169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25673267|NCT01755169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236282|NCT02558283|Anesthetics|anesthetics|mesh-ancestor
25236283|NCT02558283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25236284|NCT02558283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236285|NCT02558283|Sensory System Agents|sensory system agents|mesh-ancestor
25236286|NCT02558283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25236287|NCT02558283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25236288|NCT02558283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25236289|NCT02558283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25236290|NCT02558283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25236291|NCT02558283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236292|NCT02558270|Dapagliflozin|dapagliflozin|mesh-list
25236293|NCT02558270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25236294|NCT02558270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236295|NCT02558270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25236296|NCT02558270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044737|NCT01055015|Narcotics|narcotics|mesh-ancestor
25044738|NCT01055015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25044739|NCT01055015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044740|NCT01055015|Analgesics|analgesics|mesh-ancestor
25044741|NCT01055015|Sensory System Agents|sensory system agents|mesh-ancestor
25044742|NCT01055015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25044743|NCT01051414|Asunaprevir|asunaprevir|mesh-list
25044744|NCT01051414|Protease Inhibitors|protease inhibitors|mesh-ancestor
25044745|NCT01051414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044746|NCT01051414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524248|NCT05091905|Anesthetics|anesthetics|mesh-list
24524249|NCT05091905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24524250|NCT05091905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457818|NCT00335270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24524251|NCT05091905|Sensory System Agents|sensory system agents|mesh-ancestor
24524252|NCT05091905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25673268|NCT01755169|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25673269|NCT01755169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25673270|NCT01755169|Anesthetics, General|anesthetics, general|mesh-ancestor
25673271|NCT01755169|Anesthetics|anesthetics|mesh-ancestor
25673272|NCT01755169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25673273|NCT01755169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25673274|NCT01755169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24877297|NCT02856451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24877298|NCT02856451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456958|NCT00332774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24456960|NCT00332774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456961|NCT00332787|Fluoxetine|fluoxetine|mesh-list
24456962|NCT00332787|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24477399|NCT00418496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24877387|NCT02756013|Paclitaxel|paclitaxel|mesh-list
24524253|NCT05074823|Ketamine|ketamine|mesh-list
24524254|NCT05074823|Analgesics|analgesics|mesh-ancestor
24524255|NCT05074823|Sensory System Agents|sensory system agents|mesh-ancestor
24524256|NCT05074823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24524289|NCT05050500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236297|NCT02558218|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
25236298|NCT02558218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25236299|NCT02558218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25236300|NCT02558218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25236301|NCT02558218|Glucocorticoids|glucocorticoids|mesh-ancestor
25236302|NCT02558218|Hormones|hormones|mesh-ancestor
25236303|NCT02558218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25236304|NCT02558218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236305|NCT02558218|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25236306|NCT02558218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25236307|NCT02558361|Apremilast|apremilast|mesh-list
25236308|NCT02558361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25236309|NCT02558361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25236310|NCT02558361|Analgesics|analgesics|mesh-ancestor
25236311|NCT02558361|Sensory System Agents|sensory system agents|mesh-ancestor
25236312|NCT02558361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25236313|NCT02558361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236314|NCT02558361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25236315|NCT02558361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25236316|NCT02558361|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25236317|NCT02558361|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25236318|NCT02558361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25236319|NCT02558361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236320|NCT02558153|Paclitaxel|paclitaxel|mesh-list
25236321|NCT02558153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25236322|NCT02558153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236323|NCT02558153|Tubulin Modulators|tubulin modulators|mesh-ancestor
25236324|NCT02558153|Antimitotic Agents|antimitotic agents|mesh-ancestor
25236325|NCT02558153|Mitosis Modulators|mitosis modulators|mesh-ancestor
25236326|NCT02558153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154798|NCT05469204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154799|NCT05469204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25154801|NCT05469204|Sensory System Agents|sensory system agents|mesh-ancestor
25154802|NCT05469204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25154803|NCT05469204|Antipyretics|antipyretics|mesh-ancestor
25154804|NCT05469204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25154805|NCT05469204|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24524456|NCT04914741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24524457|NCT04914741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24524458|NCT04914741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24524459|NCT04914741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24524460|NCT04914741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25673275|NCT01755169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25673276|NCT01755169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674567|NCT01774149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674568|NCT01774149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25674569|NCT01774149|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25674570|NCT01774149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25674571|NCT01774149|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25674572|NCT01774149|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25674573|NCT01774149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25674574|NCT01774149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25674575|NCT01774149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24878678|NCT01258933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24878679|NCT01160211|Trastuzumab|trastuzumab|mesh-list
24878680|NCT01160211|Lapatinib|lapatinib|mesh-list
24878681|NCT01160211|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24879054|NCT05089370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24880027|NCT04219735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24880028|NCT04178460|Niraparib|niraparib|mesh-list
24524461|NCT04914741|Tubulin Modulators|tubulin modulators|mesh-ancestor
24524462|NCT04914741|Antimitotic Agents|antimitotic agents|mesh-ancestor
24524463|NCT04914741|Mitosis Modulators|mitosis modulators|mesh-ancestor
24524464|NCT04914741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24524541|NCT04739592|Vitamin D|vitamin d|mesh-list
24524542|NCT04739592|Cholecalciferol|cholecalciferol|mesh-list
24457822|NCT00335309|Amoxicillin|amoxicillin|mesh-list
24457823|NCT00335309|Clavulanic Acid|clavulanic acid|mesh-list
24457824|NCT00335309|Clavulanic Acids|clavulanic acids|mesh-list
24457825|NCT00335309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24457826|NCT00335309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24457827|NCT00335309|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24524543|NCT04739592|Alendronate|alendronate|mesh-list
24524559|NCT04703075|Antitubercular Agents|antitubercular agents|mesh-ancestor
24524560|NCT04703075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24524561|NCT04703075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24865455|NCT02863770|Pancrelipase|pancrelipase|mesh-list
24524562|NCT04703075|Leprostatic Agents|leprostatic agents|mesh-ancestor
24524563|NCT04703075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25236327|NCT02558088|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25236328|NCT02558088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25236329|NCT02558088|Autonomic Agents|autonomic agents|mesh-ancestor
25236330|NCT02558088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25236331|NCT02558088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236332|NCT02558088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25236333|NCT02558088|Respiratory System Agents|respiratory system agents|mesh-ancestor
25236334|NCT02558088|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25236335|NCT02558088|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25236336|NCT02558088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25236337|NCT02558088|Adrenergic Agents|adrenergic agents|mesh-ancestor
25236338|NCT02558088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25236339|NCT02558088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236340|NCT02558114|Ribavirin|ribavirin|mesh-list
25236341|NCT02558114|Antimetabolites|antimetabolites|mesh-ancestor
25236342|NCT02558114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236343|NCT02558114|Antiviral Agents|antiviral agents|mesh-ancestor
25236344|NCT02558114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25154817|NCT05469165|Cyproheptadine|cyproheptadine|mesh-list
25154818|NCT05469165|Antipruritics|antipruritics|mesh-ancestor
25154819|NCT05469165|Dermatologic Agents|dermatologic agents|mesh-ancestor
25154820|NCT05469165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25154821|NCT05469165|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25044747|NCT01046422|Metformin|metformin|mesh-list
24848173|NCT05000736|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24848174|NCT05000736|Hormone Antagonists|hormone antagonists|mesh-ancestor
24848175|NCT05000736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24848176|NCT05000736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848177|NCT05000736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24848178|NCT05000736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24848179|NCT05000736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236351|NCT02558023|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25236352|NCT02558023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25236353|NCT02558023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236354|NCT02558023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25236355|NCT02558023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236356|NCT02558023|Vasodilator Agents|vasodilator agents|mesh-ancestor
24963344|NCT03791827|Antimetabolites|antimetabolites|mesh-ancestor
25673277|NCT01755234|Propofol|propofol|mesh-list
25673278|NCT01755234|Sevoflurane|sevoflurane|mesh-list
25673279|NCT01755234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25673280|NCT01755234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25673281|NCT01755234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673282|NCT01755234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25673283|NCT01755234|Anesthetics, General|anesthetics, general|mesh-ancestor
25673284|NCT01755234|Anesthetics|anesthetics|mesh-ancestor
25673285|NCT01755234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24704696|NCT01479751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24882615|NCT05168059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24882616|NCT05168059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24882617|NCT05168059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885407|NCT05173246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885408|NCT05173246|Tubulin Modulators|tubulin modulators|mesh-ancestor
24885409|NCT05173246|Antimitotic Agents|antimitotic agents|mesh-ancestor
24885410|NCT05173246|Mitosis Modulators|mitosis modulators|mesh-ancestor
25108740|NCT03130452|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24885411|NCT05173246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885412|NCT05173090|Ropivacaine|ropivacaine|mesh-list
24885413|NCT05173090|Anesthetics, Local|anesthetics, local|mesh-ancestor
25236357|NCT02558023|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25236358|NCT02558023|Serotonin Agents|serotonin agents|mesh-ancestor
25236359|NCT02558023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25236360|NCT02558023|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25236361|NCT02558023|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25236362|NCT02558023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25236363|NCT02558023|Adrenergic Agents|adrenergic agents|mesh-ancestor
25236364|NCT02557932|Bismuth|bismuth|mesh-list
25236365|NCT02557932|Antacids|antacids|mesh-ancestor
25236366|NCT02557932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236367|NCT02557932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25236368|NCT02557984|Naltrexone|naltrexone|mesh-list
25236369|NCT02557984|Amisulpride|amisulpride|mesh-list
25236370|NCT02557984|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25236371|NCT02557984|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25236372|NCT02557984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236373|NCT02557984|Sensory System Agents|sensory system agents|mesh-ancestor
25236374|NCT02557984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25236375|NCT02557984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25236376|NCT02557984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25236377|NCT02557984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25236378|NCT02557984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25236379|NCT02557984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25236380|NCT02557984|Dopamine Agents|dopamine agents|mesh-ancestor
25236381|NCT02557984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25236382|NCT02557984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236383|NCT02557984|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25236384|NCT02557984|Antidepressive Agents|antidepressive agents|mesh-ancestor
25236385|NCT02557971|Botulinum Toxins|botulinum toxins|mesh-list
24848217|NCT04876066|Analgesics|analgesics|mesh-ancestor
24848218|NCT04876066|Sensory System Agents|sensory system agents|mesh-ancestor
24963411|NCT03790839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24848219|NCT04876066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24524564|NCT04703075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24524567|NCT04703075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24524568|NCT04703075|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25673287|NCT01755416|Insulin|insulin|mesh-list
25673288|NCT01755416|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25673289|NCT01755416|Liraglutide|liraglutide|mesh-list
25673290|NCT01755416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25673291|NCT01755416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673292|NCT01755416|Incretins|incretins|mesh-ancestor
25673293|NCT01755416|Hormones|hormones|mesh-ancestor
25673294|NCT01755416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25673295|NCT01755546|Buprenorphine|buprenorphine|mesh-list
25673296|NCT01755546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25673297|NCT01755546|Narcotics|narcotics|mesh-ancestor
25673298|NCT01755546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25673299|NCT01755546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673300|NCT01755546|Analgesics|analgesics|mesh-ancestor
25673301|NCT01755546|Sensory System Agents|sensory system agents|mesh-ancestor
25673302|NCT01755546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25673303|NCT01755546|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25673304|NCT01755637|Albendazole|albendazole|mesh-list
24524569|NCT04703075|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24524570|NCT04703075|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24524571|NCT04703075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24524574|NCT04701476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24524575|NCT04701476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24524577|NCT04688658|Axitinib|axitinib|mesh-list
24524647|NCT04639986|Immunologic Factors|immunologic factors|mesh-ancestor
24524680|NCT04532463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24524682|NCT04532463|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24524683|NCT04532463|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24524684|NCT04532463|Amebicides|amebicides|mesh-ancestor
24524685|NCT04532463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24524686|NCT04532463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24524687|NCT04532463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24524688|NCT04532463|Antimetabolites|antimetabolites|mesh-ancestor
24457828|NCT00335309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457829|NCT00335309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457830|NCT00335348|Dexamethasone|dexamethasone|mesh-list
25236386|NCT02557971|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25236387|NCT02557971|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25236388|NCT02557971|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25236389|NCT02557971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25236390|NCT02557971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236391|NCT02557971|Cholinergic Agents|cholinergic agents|mesh-ancestor
25236392|NCT02557971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25236393|NCT02557971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236394|NCT02557971|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25236395|NCT02557971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25236396|NCT02557867|Dexmedetomidine|dexmedetomidine|mesh-list
25236397|NCT02557867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25236398|NCT02557867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25236399|NCT02557867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236400|NCT02557867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25236401|NCT02557867|Analgesics|analgesics|mesh-ancestor
25236402|NCT02557867|Sensory System Agents|sensory system agents|mesh-ancestor
25236403|NCT02557867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25236404|NCT02557867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24626921|NCT01089309|Spironolactone|spironolactone|mesh-list
25236405|NCT02557867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25236406|NCT02557867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24848231|NCT04866706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24848232|NCT04866706|Immunologic Factors|immunologic factors|mesh-ancestor
24848233|NCT04866706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848234|NCT04866706|Viscosupplements|viscosupplements|mesh-ancestor
24848235|NCT04866706|Protective Agents|protective agents|mesh-ancestor
24848236|NCT04856007|Metformin|metformin|mesh-list
24848237|NCT04856007|Dapagliflozin|dapagliflozin|mesh-list
24848238|NCT04856007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25673305|NCT01755637|Anthelmintics|anthelmintics|mesh-ancestor
25673306|NCT01755637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25673307|NCT01755637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25673308|NCT01755637|Anticestodal Agents|anticestodal agents|mesh-ancestor
25673309|NCT01755637|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25673310|NCT01755637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25673311|NCT01755637|Tubulin Modulators|tubulin modulators|mesh-ancestor
25673312|NCT01755637|Antimitotic Agents|antimitotic agents|mesh-ancestor
25673313|NCT01755637|Mitosis Modulators|mitosis modulators|mesh-ancestor
24963516|NCT03790371|Oxytocics|oxytocics|mesh-ancestor
25236411|NCT02557737|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25236412|NCT02557737|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25236413|NCT02557737|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25236414|NCT02557737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25236415|NCT02557737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236416|NCT02557737|Cholinergic Agents|cholinergic agents|mesh-ancestor
25236417|NCT02557737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25236418|NCT02557737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236419|NCT02557737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25236420|NCT02557737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25236421|NCT02557789|Lefamulin|lefamulin|mesh-list
25236422|NCT02557789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25236423|NCT02557789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25236424|NCT02557581|Terbutaline|terbutaline|mesh-list
25236425|NCT02557581|Clenbuterol|clenbuterol|mesh-list
25236426|NCT02557581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25236427|NCT02557581|Autonomic Agents|autonomic agents|mesh-ancestor
25236428|NCT02557581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25236429|NCT02557581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236430|NCT02557581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25236431|NCT02557581|Respiratory System Agents|respiratory system agents|mesh-ancestor
25236432|NCT02557581|Sympathomimetics|sympathomimetics|mesh-ancestor
25236433|NCT02557581|Tocolytic Agents|tocolytic agents|mesh-ancestor
25236434|NCT02557581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25236435|NCT02557581|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25236436|NCT02557581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25236437|NCT02557581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25236438|NCT02557581|Adrenergic Agents|adrenergic agents|mesh-ancestor
25236439|NCT02557581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25236440|NCT02557581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236441|NCT02557958|Azithromycin|azithromycin|mesh-list
25236442|NCT02557958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25673314|NCT01755637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673315|NCT01755637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673316|NCT01755702|Acetaminophen|acetaminophen|mesh-list
25673317|NCT01755702|Ibuprofen|ibuprofen|mesh-list
24889741|NCT04490421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889742|NCT04490421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24889744|NCT04490031|Analgesics|analgesics|mesh-ancestor
24889745|NCT04490031|Sensory System Agents|sensory system agents|mesh-ancestor
24889746|NCT04490031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24890562|NCT04482257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848261|NCT04759339|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24848262|NCT04736979|Amoxicillin|amoxicillin|mesh-list
24848263|NCT04736979|Clavulanic Acid|clavulanic acid|mesh-list
24848264|NCT04736979|Clavulanic Acids|clavulanic acids|mesh-list
24848265|NCT04736979|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24848266|NCT04736979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24848267|NCT04736979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24848268|NCT04736979|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24848269|NCT04736979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24963544|NCT03790384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24848270|NCT04736979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848271|NCT04710030|Valacyclovir|valacyclovir|mesh-list
24524734|NCT04480918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24524735|NCT04480918|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24524736|NCT04480918|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24524737|NCT04480918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24524758|NCT04446962|Growth Substances|growth substances|mesh-ancestor
24524759|NCT04446962|Growth Inhibitors|growth inhibitors|mesh-ancestor
24524760|NCT04446962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24524761|NCT04403698|Alendronate|alendronate|mesh-list
24528425|NCT00621101|Sirolimus|sirolimus|mesh-list
24524890|NCT04243122|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24524891|NCT04243122|Protease Inhibitors|protease inhibitors|mesh-ancestor
24524892|NCT04243122|Anticoagulants|anticoagulants|mesh-ancestor
24524894|NCT04234217|Niacinamide|niacinamide|mesh-list
24524895|NCT04234217|Nicotinic Acids|nicotinic acids|mesh-list
24524896|NCT04234217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24524897|NCT04234217|Antimetabolites|antimetabolites|mesh-ancestor
24524898|NCT04234217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524924|NCT04200417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236443|NCT02557958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25236444|NCT02557854|Doxorubicin|doxorubicin|mesh-list
25236445|NCT02557854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25236446|NCT02557854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25236447|NCT02557854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236448|NCT02557854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25236449|NCT02557854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25236450|NCT02557854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25236451|NCT02557854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236452|NCT02557451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
25236453|NCT02557451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25236454|NCT02557451|Growth Substances|growth substances|mesh-ancestor
25236455|NCT02557451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236456|NCT02557451|Growth Inhibitors|growth inhibitors|mesh-ancestor
25236457|NCT02557451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236458|NCT02557594|Tenofovir|tenofovir|mesh-list
25236459|NCT02557594|Antiviral Agents|antiviral agents|mesh-ancestor
25236460|NCT02557594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25236461|NCT02557594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25236462|NCT02557594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25236463|NCT02557594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25673318|NCT01755702|Caffeine|caffeine|mesh-list
25673319|NCT01755702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25673320|NCT01755702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25673321|NCT01755702|Analgesics|analgesics|mesh-ancestor
25673322|NCT01755702|Sensory System Agents|sensory system agents|mesh-ancestor
25673323|NCT01755702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25673324|NCT01755702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673325|NCT01755702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25673326|NCT01755702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25673327|NCT01755702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25236466|NCT02557594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24848275|NCT04704050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24848283|NCT04697576|Pembrolizumab|pembrolizumab|mesh-list
24848284|NCT04697576|Nivolumab|nivolumab|mesh-list
24848285|NCT04697576|Ipilimumab|ipilimumab|mesh-list
24848286|NCT04697576|Vaccines|vaccines|mesh-list
24848287|NCT04697576|Immunologic Factors|immunologic factors|mesh-ancestor
24848288|NCT04697576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848289|NCT04697576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24848290|NCT04697576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24848291|NCT04697576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24486181|NCT00456794|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
25065000|NCT03454724|Sirolimus|sirolimus|mesh-list
24524925|NCT04200417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24580602|NCT00862420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621501|NCT01062906|Anesthetics, Local|anesthetics, local|mesh-ancestor
24621502|NCT01062906|Anesthetics|anesthetics|mesh-ancestor
24751899|NCT01707199|Artesunate|artesunate|mesh-list
24621503|NCT01062906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24621504|NCT01062906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621505|NCT01062906|Sensory System Agents|sensory system agents|mesh-ancestor
24621506|NCT01062906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24621507|NCT01062906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24621508|NCT01062906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24621509|NCT01062906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24621510|NCT01062906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24872564|NCT05313659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24621519|NCT01062932|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24621520|NCT01062932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25005227|NCT04368559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25005228|NCT04368559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005229|NCT04368559|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25005230|NCT04368559|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25005231|NCT04368559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25236467|NCT02557542|Polidocanol|polidocanol|mesh-list
25236468|NCT02557542|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
25236469|NCT02557542|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25236470|NCT02557542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25236471|NCT02557490|Oxaliplatin|oxaliplatin|mesh-list
25236472|NCT02557490|Raltitrexed|raltitrexed|mesh-list
25236473|NCT02557490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236474|NCT02557490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25236475|NCT02557490|Antimetabolites|antimetabolites|mesh-ancestor
25236476|NCT02557490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236477|NCT02557490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25236478|NCT02557490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25236479|NCT02557503|Fluorouracil|fluorouracil|mesh-list
25236480|NCT02557503|Oxaliplatin|oxaliplatin|mesh-list
25236481|NCT02557503|Antimetabolites|antimetabolites|mesh-ancestor
25236482|NCT02557503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236483|NCT02557503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25236484|NCT02557503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236485|NCT02557503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25236486|NCT02557503|Immunologic Factors|immunologic factors|mesh-ancestor
25236487|NCT02557503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236488|NCT02557386|Levobupivacaine|levobupivacaine|mesh-list
25236489|NCT02557386|Anesthetics, Local|anesthetics, local|mesh-ancestor
25236490|NCT02557386|Anesthetics|anesthetics|mesh-ancestor
25673328|NCT01755702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25673329|NCT01755702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673330|NCT01755702|Antipyretics|antipyretics|mesh-ancestor
25005237|NCT04368559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25005238|NCT04368559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25005250|NCT04364048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25005251|NCT04364048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25005252|NCT04364048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005253|NCT04364048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25005254|NCT04364048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25236491|NCT02557386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25236492|NCT02557386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236493|NCT02557386|Sensory System Agents|sensory system agents|mesh-ancestor
25236494|NCT02557386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25236495|NCT02557373|Vitamins|vitamins|mesh-list
25236496|NCT02557373|Vitamin A|vitamin a|mesh-list
25236497|NCT02557373|Retinol palmitate|retinol palmitate|mesh-list
25236498|NCT02557373|Micronutrients|micronutrients|mesh-ancestor
25236499|NCT02557373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236500|NCT02557373|Antioxidants|antioxidants|mesh-ancestor
25236501|NCT02557373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236502|NCT02557373|Protective Agents|protective agents|mesh-ancestor
25236503|NCT02557373|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25236504|NCT02557373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236505|NCT02557269|Mometasone Furoate|mometasone furoate|mesh-list
25236506|NCT02557269|Azelastine|azelastine|mesh-list
25236507|NCT02557269|Prednisolone|prednisolone|mesh-list
25236508|NCT02557269|Xylometazoline|xylometazoline|mesh-list
25236509|NCT02557269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25673331|NCT01755702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25673332|NCT01755702|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25673333|NCT01755702|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25673334|NCT01755702|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25673335|NCT01755702|Purinergic Agents|purinergic agents|mesh-ancestor
25673336|NCT01755702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25673337|NCT01755949|Colchicine|colchicine|mesh-list
25236515|NCT02557269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236517|NCT02557269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25236518|NCT02557269|Dermatologic Agents|dermatologic agents|mesh-ancestor
25236519|NCT02557269|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25236520|NCT02557269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25236521|NCT02557269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24486230|NCT00456898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25236522|NCT02557269|Respiratory System Agents|respiratory system agents|mesh-ancestor
25236523|NCT02557269|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25236524|NCT02557269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25236525|NCT02557269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236526|NCT02557269|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25236527|NCT02557269|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25236528|NCT02557269|Histamine Antagonists|histamine antagonists|mesh-ancestor
25236529|NCT02557269|Histamine Agents|histamine agents|mesh-ancestor
25236530|NCT02557269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25236531|NCT02557269|Nasal Decongestants|nasal decongestants|mesh-ancestor
25236532|NCT02557269|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25236542|NCT02557087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25236543|NCT02557087|Antiemetics|antiemetics|mesh-ancestor
25236544|NCT02557087|Autonomic Agents|autonomic agents|mesh-ancestor
25236545|NCT02557087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25236546|NCT02557087|Mydriatics|mydriatics|mesh-ancestor
25236547|NCT02557087|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25236548|NCT02557087|Cholinergic Agents|cholinergic agents|mesh-ancestor
25236549|NCT02557087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25236550|NCT02557087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236551|NCT02557087|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25236552|NCT02556931|Mycophenolic Acid|mycophenolic acid|mesh-list
25236553|NCT02556931|Cyclophosphamide|cyclophosphamide|mesh-list
25236554|NCT02556931|Fludarabine|fludarabine|mesh-list
25236555|NCT02556931|Tacrolimus|tacrolimus|mesh-list
25236556|NCT02556931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25236557|NCT02556931|Immunologic Factors|immunologic factors|mesh-ancestor
25236558|NCT02556931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236559|NCT02556931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25236560|NCT02556931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25673338|NCT01755949|Gout Suppressants|gout suppressants|mesh-ancestor
25673339|NCT01755949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25673340|NCT01755949|Tubulin Modulators|tubulin modulators|mesh-ancestor
25236561|NCT02556931|Alkylating Agents|alkylating agents|mesh-ancestor
25236562|NCT02556931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044751|NCT01044381|Antifungal Agents|antifungal agents|mesh-ancestor
25154824|NCT05469165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25154825|NCT05469165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154826|NCT05469165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154827|NCT05469165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25154828|NCT05469165|Serotonin Agents|serotonin agents|mesh-ancestor
25154829|NCT05469165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25154838|NCT05469113|Repaglinide|repaglinide|mesh-list
25005255|NCT04364048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25005256|NCT04364048|Immunologic Factors|immunologic factors|mesh-ancestor
24963866|NCT03787992|Gefitinib|gefitinib|mesh-list
25005257|NCT04364048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005258|NCT04344444|Azithromycin|azithromycin|mesh-list
25236563|NCT02556931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236564|NCT02556931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25236565|NCT02556931|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25236566|NCT02556931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25236567|NCT02556931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25236568|NCT02556931|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25236569|NCT02556931|Antitubercular Agents|antitubercular agents|mesh-ancestor
25236578|NCT02556905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236579|NCT02556905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25236580|NCT02556905|Glucocorticoids|glucocorticoids|mesh-ancestor
25236581|NCT02556905|Hormones|hormones|mesh-ancestor
25236582|NCT02556905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25236583|NCT02556905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25236584|NCT02556905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236585|NCT02556905|Immunologic Factors|immunologic factors|mesh-ancestor
25236586|NCT02556905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25236587|NCT02556905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25236588|NCT02556905|Growth Substances|growth substances|mesh-ancestor
25236589|NCT02556905|Growth Inhibitors|growth inhibitors|mesh-ancestor
25236590|NCT02556970|Acetaminophen|acetaminophen|mesh-list
25236591|NCT02556970|Diclofenac|diclofenac|mesh-list
25236592|NCT02556970|Levobupivacaine|levobupivacaine|mesh-list
25236593|NCT02556970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25236594|NCT02556970|Analgesics|analgesics|mesh-ancestor
25236595|NCT02556970|Sensory System Agents|sensory system agents|mesh-ancestor
25236596|NCT02556970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25236669|NCT02556411|Estrogens|estrogens|mesh-ancestor
25154840|NCT05469113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154841|NCT05469061|Cisplatin|cisplatin|mesh-list
25154842|NCT05469061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25154843|NCT05469035|Heparin|heparin|mesh-list
25154844|NCT05469035|Calcium heparin|calcium heparin|mesh-list
25154845|NCT05469035|Anticoagulants|anticoagulants|mesh-ancestor
25673341|NCT01755949|Antimitotic Agents|antimitotic agents|mesh-ancestor
25673342|NCT01755949|Mitosis Modulators|mitosis modulators|mesh-ancestor
25673343|NCT01755949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673344|NCT01755949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673345|NCT01756079|Ribavirin|ribavirin|mesh-list
25673346|NCT01756079|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25673347|NCT01756079|Antimetabolites|antimetabolites|mesh-ancestor
25674576|NCT01774149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24902607|NCT04372082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24614487|NCT01024491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902760|NCT04370782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24902761|NCT04370782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24902762|NCT04370782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902763|NCT04370782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902783|NCT04370431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154846|NCT05469035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25154847|NCT05469035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25154848|NCT05469035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154850|NCT05469022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25154851|NCT05469022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25154852|NCT05469022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154863|NCT05468879|Glimepiride|glimepiride|mesh-list
25154864|NCT05468879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25154865|NCT05468879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25154866|NCT05468879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154867|NCT05468879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25005259|NCT04344444|Hydroxychloroquine|hydroxychloroquine|mesh-list
25005260|NCT04344444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25005261|NCT04344444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25005262|NCT04344444|Antimalarials|antimalarials|mesh-ancestor
25005263|NCT04344444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25005264|NCT04344444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25005265|NCT04344444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25005266|NCT04344444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005267|NCT04344444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25005268|NCT04324606|Acetaminophen|acetaminophen|mesh-list
25005269|NCT04324606|Vaccines|vaccines|mesh-list
25005270|NCT04324606|Immunologic Factors|immunologic factors|mesh-ancestor
25005272|NCT04324606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24525054|NCT04032626|Growth Substances|growth substances|mesh-ancestor
24525055|NCT04032626|Growth Inhibitors|growth inhibitors|mesh-ancestor
24525056|NCT04032626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236599|NCT02556970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25236610|NCT02556879|Immunologic Factors|immunologic factors|mesh-ancestor
25236611|NCT02556879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236612|NCT02556879|Hematinics|hematinics|mesh-ancestor
25236613|NCT02556866|Prednisone|prednisone|mesh-list
25236614|NCT02556866|Rituximab|rituximab|mesh-list
25236615|NCT02556866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25236616|NCT02556866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236617|NCT02556866|Immunologic Factors|immunologic factors|mesh-ancestor
25236618|NCT02556866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236619|NCT02556866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25236620|NCT02556866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25236621|NCT02556866|Glucocorticoids|glucocorticoids|mesh-ancestor
25236622|NCT02556866|Hormones|hormones|mesh-ancestor
25236623|NCT02556866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25236624|NCT02556866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25236625|NCT02556723|Aflibercept|aflibercept|mesh-list
25236626|NCT02556723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25154875|NCT05468840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25154877|NCT05468840|Anesthetics|anesthetics|mesh-ancestor
25154878|NCT05468840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25154879|NCT05468840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25154880|NCT05468840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25154881|NCT05468840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25154882|NCT05468840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044752|NCT01044381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24525135|NCT03927989|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24525136|NCT03927989|Cholinergic Agents|cholinergic agents|mesh-ancestor
24525137|NCT03927989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24525138|NCT03927989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673348|NCT01756079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673349|NCT01756079|Antiviral Agents|antiviral agents|mesh-ancestor
25673350|NCT01756079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25673351|NCT01756157|Complement C1s|complement c1s|mesh-list
25673352|NCT01756157|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25673353|NCT01756157|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
25673354|NCT01756157|Immunologic Factors|immunologic factors|mesh-ancestor
25673355|NCT01756157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236641|NCT02556814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236642|NCT02556814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25236643|NCT02556814|Glucocorticoids|glucocorticoids|mesh-ancestor
25236644|NCT02556814|Hormones|hormones|mesh-ancestor
25236645|NCT02556814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25236646|NCT02556814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25236647|NCT02556814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24537697|NCT00655837|Immunologic Factors|immunologic factors|mesh-ancestor
25236649|NCT02556814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236650|NCT02556814|Protective Agents|protective agents|mesh-ancestor
25236651|NCT02556840|Insulin|insulin|mesh-list
25236652|NCT02556840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25236653|NCT02556840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236654|NCT02556593|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25873699|NCT05561049|Glucocorticoids|glucocorticoids|mesh-ancestor
24848307|NCT04659369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637770|NCT01152931|Antiviral Agents|antiviral agents|mesh-ancestor
25873700|NCT05561049|Hormones|hormones|mesh-ancestor
24525143|NCT03893617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24525144|NCT03893617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525145|NCT03893617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525146|NCT03893617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24525147|NCT03893617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24525148|NCT03893617|Vasodilator Agents|vasodilator agents|mesh-ancestor
24525149|NCT03879135|Factor VIII|factor viii|mesh-list
24525150|NCT03879135|Coagulants|coagulants|mesh-ancestor
25236655|NCT02556593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236656|NCT02556593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25236657|NCT02556593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25236658|NCT02556593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236659|NCT02556411|Levonorgestrel|levonorgestrel|mesh-list
25236660|NCT02556411|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25236661|NCT02556411|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25236662|NCT02556411|Contraceptive Agents|contraceptive agents|mesh-ancestor
25236663|NCT02556411|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25236664|NCT02556411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236665|NCT02556411|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25236666|NCT02556411|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25236667|NCT02556411|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25236668|NCT02556411|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25236670|NCT02556411|Hormones|hormones|mesh-ancestor
25674577|NCT01774149|Anesthetics, General|anesthetics, general|mesh-ancestor
25674578|NCT01774149|Anesthetics|anesthetics|mesh-ancestor
25674579|NCT01774149|GABA Modulators|gaba modulators|mesh-ancestor
25873701|NCT05561049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25873702|NCT05561049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25873703|NCT05561049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873704|NCT05561049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25873705|NCT05561049|Immunologic Factors|immunologic factors|mesh-ancestor
25873706|NCT05561049|Leprostatic Agents|leprostatic agents|mesh-ancestor
25873707|NCT05561049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25236677|NCT02556463|Immunologic Factors|immunologic factors|mesh-ancestor
25236678|NCT02556463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236679|NCT02556437|Immunoglobulins|immunoglobulins|mesh-list
25236680|NCT02556437|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25236681|NCT02556437|Antibodies|antibodies|mesh-list
25236682|NCT02556437|Immunologic Factors|immunologic factors|mesh-ancestor
24525287|NCT03709758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24525288|NCT03709758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24525289|NCT03709758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24525290|NCT03709758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525430|NCT03364686|Vitamin B Complex|vitamin b complex|mesh-ancestor
24525432|NCT03364686|Micronutrients|micronutrients|mesh-ancestor
24525433|NCT03364686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525453|NCT03326856|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24525454|NCT03326856|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24525455|NCT03326856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24525468|NCT03326791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525469|NCT03326791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24525470|NCT03326791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24525471|NCT03326791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24525506|NCT03255915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525507|NCT03255915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24525508|NCT03255915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24525509|NCT03208231|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24525510|NCT03208231|Antiviral Agents|antiviral agents|mesh-ancestor
24525511|NCT03208231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24525512|NCT03195374|Analgesics, Opioid|analgesics, opioid|mesh-list
25227024|NCT02617121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24525514|NCT03195374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24525515|NCT03195374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525516|NCT03195374|Analgesics|analgesics|mesh-ancestor
24525517|NCT03195374|Sensory System Agents|sensory system agents|mesh-ancestor
24752035|NCT01707849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752036|NCT01707940|Ketoconazole|ketoconazole|mesh-list
24752037|NCT01707940|Antifungal Agents|antifungal agents|mesh-ancestor
24752041|NCT01707940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25873708|NCT05561049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25873709|NCT05561049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25873710|NCT05561049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25873711|NCT05561049|Growth Substances|growth substances|mesh-ancestor
25873712|NCT05561049|Growth Inhibitors|growth inhibitors|mesh-ancestor
25873713|NCT05561036|Doxorubicin|doxorubicin|mesh-list
25873714|NCT05561036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25236683|NCT02556437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236684|NCT02556320|Anticonvulsants|anticonvulsants|mesh-list
25873715|NCT05561036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525557|NCT03133221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525558|NCT03133221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525559|NCT03133221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525597|NCT03015974|Prednisone|prednisone|mesh-list
24525598|NCT03015974|Prednisolone|prednisolone|mesh-list
24525599|NCT03015974|Deflazacort|deflazacort|mesh-list
24525600|NCT03015974|Cyclophosphamide|cyclophosphamide|mesh-list
24525601|NCT03015974|Dipyridamole|dipyridamole|mesh-list
24525602|NCT03015974|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24525603|NCT03015974|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24525604|NCT03015974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24525605|NCT03015974|Immunologic Factors|immunologic factors|mesh-ancestor
24525631|NCT03013504|Epirubicin|epirubicin|mesh-list
24525638|NCT03013504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525675|NCT02927938|Cytarabine|cytarabine|mesh-list
25673356|NCT01756157|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24957172|NCT03846765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525676|NCT02927938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24525710|NCT02856594|Sensory System Agents|sensory system agents|mesh-ancestor
24525711|NCT02856594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24525712|NCT02856594|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24525713|NCT02856594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24525714|NCT02856594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24525778|NCT02757872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525779|NCT02757872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24525780|NCT02757872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24525781|NCT02746796|Capecitabine|capecitabine|mesh-list
24525783|NCT02746796|Oxaliplatin|oxaliplatin|mesh-list
24525784|NCT02746796|Nivolumab|nivolumab|mesh-list
24525785|NCT02746796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24525786|NCT02746796|Antimetabolites|antimetabolites|mesh-ancestor
24528694|NCT00622349|Isophosphamide mustard|isophosphamide mustard|mesh-list
24525889|NCT02519777|Antiviral Agents|antiviral agents|mesh-ancestor
25236698|NCT02556268|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25236699|NCT02556268|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25236700|NCT02556268|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25236701|NCT02556268|Triumeq|triumeq|mesh-list
25236702|NCT02556268|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
25236703|NCT02556268|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
25236704|NCT02556268|Riociguat|riociguat|mesh-list
24848308|NCT04659369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24848309|NCT04659369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848310|NCT04644237|Trastuzumab|trastuzumab|mesh-list
24848311|NCT04644237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24848312|NCT04644237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24848313|NCT04578535|Immunoglobulins|immunoglobulins|mesh-list
24848314|NCT04578535|Immunologic Factors|immunologic factors|mesh-ancestor
25873716|NCT05561036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24525893|NCT02519777|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24525894|NCT02519777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525903|NCT02441491|Cyclophosphamide|cyclophosphamide|mesh-list
24525904|NCT02441491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24525905|NCT02441491|Immunologic Factors|immunologic factors|mesh-ancestor
24525906|NCT02441491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788246|NCT01930552|Fluorouracil|fluorouracil|mesh-list
24788247|NCT01930552|Irinotecan|irinotecan|mesh-list
24788248|NCT01930552|Aflibercept|aflibercept|mesh-list
25005281|NCT04320940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005282|NCT04320940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25005283|NCT04320940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25005284|NCT04320940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25005285|NCT04320940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005286|NCT04320940|GABA Modulators|gaba modulators|mesh-ancestor
25005287|NCT04320940|GABA Agents|gaba agents|mesh-ancestor
25005288|NCT04320940|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25005289|NCT04320940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25005290|NCT04320940|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25005291|NCT04295577|Niraparib|niraparib|mesh-list
25005292|NCT04295577|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25005293|NCT04295577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25005315|NCT04232423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25005317|NCT04196010|Cytarabine|cytarabine|mesh-list
25005318|NCT04196010|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
25005319|NCT04196010|Mitoxantrone|mitoxantrone|mesh-list
25005320|NCT04196010|Cladribine|cladribine|mesh-list
25673357|NCT01756157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25673358|NCT01756209|Acetaminophen|acetaminophen|mesh-list
25673359|NCT01756209|Ibuprofen|ibuprofen|mesh-list
25673360|NCT01756209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25673361|NCT01756209|Analgesics|analgesics|mesh-ancestor
25673362|NCT01756209|Sensory System Agents|sensory system agents|mesh-ancestor
25005322|NCT04196010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25005323|NCT04196010|Antimetabolites|antimetabolites|mesh-ancestor
25005324|NCT04196010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005325|NCT04196010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005326|NCT04196010|Antiviral Agents|antiviral agents|mesh-ancestor
25005327|NCT04196010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25236705|NCT02556268|Protease Inhibitors|protease inhibitors|mesh-list
25236706|NCT02556268|Antiviral Agents|antiviral agents|mesh-ancestor
25236708|NCT02556268|Enzyme Activators|enzyme activators|mesh-ancestor
25236709|NCT02556268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236710|NCT02556268|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25236711|NCT02556268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25236712|NCT02556268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25236713|NCT02556268|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25236714|NCT02556268|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25236715|NCT02556229|Aflibercept|aflibercept|mesh-list
25236716|NCT02556229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25236717|NCT02556229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25236718|NCT02556229|Growth Substances|growth substances|mesh-ancestor
25236719|NCT02556229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779194|NCT01874574|Hylan|hylan|mesh-list
25005328|NCT04196010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25005329|NCT04196010|Immunologic Factors|immunologic factors|mesh-ancestor
25005330|NCT04196010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005331|NCT04196010|Analgesics|analgesics|mesh-ancestor
25005332|NCT04196010|Sensory System Agents|sensory system agents|mesh-ancestor
24526808|NCT00613457|Dexamethasone|dexamethasone|mesh-list
24526023|NCT02051933|Cholinergic Agents|cholinergic agents|mesh-ancestor
24526024|NCT02051933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24526025|NCT02051933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526026|NCT02051933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24526027|NCT02051933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24526028|NCT01999569|Letrozole|letrozole|mesh-list
24526029|NCT01999569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873717|NCT05561036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25873718|NCT05561036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24526184|NCT00782288|Digitoxin|digitoxin|mesh-list
24526185|NCT00782288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24526186|NCT00782288|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24526187|NCT00782288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24526188|NCT00782288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526189|NCT00782288|Protective Agents|protective agents|mesh-ancestor
24964344|NCT03783728|Isoniazid|isoniazid|mesh-list
24526190|NCT00782288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526191|NCT00771654|Phentermine|phentermine|mesh-list
24526192|NCT00771654|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25236720|NCT02556229|Growth Inhibitors|growth inhibitors|mesh-ancestor
25236721|NCT02556229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236722|NCT02556008|Cannabidiol|cannabidiol|mesh-list
25236723|NCT02556008|Anticonvulsants|anticonvulsants|mesh-ancestor
25236724|NCT02556060|Lamotrigine|lamotrigine|mesh-list
25236725|NCT02556060|Anticonvulsants|anticonvulsants|mesh-ancestor
25236726|NCT02556060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25236727|NCT02556060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25236728|NCT02556060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236729|NCT02556060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24526193|NCT00771654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526194|NCT00771654|Appetite Depressants|appetite depressants|mesh-ancestor
24526195|NCT00771654|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24526196|NCT00771654|Sympathomimetics|sympathomimetics|mesh-ancestor
24526197|NCT00771654|Autonomic Agents|autonomic agents|mesh-ancestor
24526198|NCT00771654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25673363|NCT01756209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24526199|NCT00771654|Adrenergic Agents|adrenergic agents|mesh-ancestor
25873719|NCT05561036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873720|NCT05561010|Bupivacaine|bupivacaine|mesh-list
25873721|NCT05561010|Anesthetics, Local|anesthetics, local|mesh-ancestor
25873722|NCT05561010|Anesthetics|anesthetics|mesh-ancestor
25873723|NCT05561010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25873724|NCT05561010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873725|NCT05561010|Sensory System Agents|sensory system agents|mesh-ancestor
24526209|NCT00765310|Micronutrients|micronutrients|mesh-ancestor
24526220|NCT00621751|Antimanic Agents|antimanic agents|mesh-ancestor
24526221|NCT00621751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24526222|NCT00621751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24526223|NCT00621751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526224|NCT00621751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24526225|NCT00621751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24526226|NCT00621751|Analgesics|analgesics|mesh-ancestor
24526227|NCT00621751|Sensory System Agents|sensory system agents|mesh-ancestor
24526304|NCT00248703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526307|NCT00195091|Sequestering Agents|sequestering agents|mesh-ancestor
24526308|NCT00195091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526309|NCT00195091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24526310|NCT00195091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24526311|NCT00195091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24526312|NCT00195091|Growth Substances|growth substances|mesh-ancestor
24526313|NCT00195091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526314|NCT00195091|Growth Inhibitors|growth inhibitors|mesh-ancestor
24526330|NCT00611169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526331|NCT00611169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24526332|NCT00611195|Remifentanil|remifentanil|mesh-list
24526333|NCT00611195|Propofol|propofol|mesh-list
24788321|NCT01930786|Botulinum Toxins|botulinum toxins|mesh-list
24788322|NCT01930786|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25873726|NCT05561010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25873727|NCT05560945|Listerine|listerine|mesh-list
25873728|NCT05560945|Fluorides|fluorides|mesh-list
24788323|NCT01930786|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24788324|NCT01930786|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24788325|NCT01930786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24788326|NCT01930786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788327|NCT01930786|Cholinergic Agents|cholinergic agents|mesh-ancestor
24788328|NCT01930786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24788329|NCT01930786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788330|NCT01930786|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24788331|NCT01930786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24788332|NCT01930812|Listerine|listerine|mesh-list
24788333|NCT01930812|Fluorides|fluorides|mesh-list
24788334|NCT01930812|Sodium Fluoride|sodium fluoride|mesh-list
24788335|NCT01930812|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
24526708|NCT00612794|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24526709|NCT00612794|Incretins|incretins|mesh-ancestor
24526710|NCT00612794|Hormones|hormones|mesh-ancestor
24526785|NCT00613223|Etoposide|etoposide|mesh-list
24526786|NCT00613223|Etoposide phosphate|etoposide phosphate|mesh-list
24526787|NCT00613223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24526788|NCT00613223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236730|NCT02556060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236731|NCT02556060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25236732|NCT02556060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25236733|NCT02556060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25236734|NCT02556060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25236735|NCT02556060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25673364|NCT01756209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873729|NCT05560945|Sodium Fluoride|sodium fluoride|mesh-list
24526807|NCT00613457|Cytarabine|cytarabine|mesh-list
24526872|NCT00613496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236737|NCT02556086|Antiviral Agents|antiviral agents|mesh-ancestor
25236738|NCT02556086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25236739|NCT02555943|Ritonavir|ritonavir|mesh-list
25236740|NCT02555943|Tenofovir|tenofovir|mesh-list
25236741|NCT02555943|Sofosbuvir|sofosbuvir|mesh-list
25236742|NCT02555943|Entecavir|entecavir|mesh-list
25236743|NCT02555943|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25236744|NCT02555943|Ledipasvir|ledipasvir|mesh-list
25236745|NCT02555943|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25236746|NCT02555943|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25236747|NCT02555943|Protease Inhibitors|protease inhibitors|mesh-ancestor
25236748|NCT02555943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25236749|NCT02555943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236750|NCT02555943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25236751|NCT02555943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25236752|NCT02555943|Antiviral Agents|antiviral agents|mesh-ancestor
25236753|NCT02555943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25236754|NCT02555943|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24859045|NCT02301286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25236865|NCT02555358|Docetaxel|docetaxel|mesh-list
24526873|NCT00613561|Fludarabine|fludarabine|mesh-list
24526874|NCT00613561|Busulfan|busulfan|mesh-list
24526924|NCT00613769|Cefuroxime axetil|cefuroxime axetil|mesh-list
24526925|NCT00613769|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24526926|NCT00613769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24526927|NCT00613769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24526928|NCT00613769|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24526929|NCT00613769|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24526930|NCT00613769|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24526931|NCT00613769|Renal Agents|renal agents|mesh-ancestor
24526932|NCT00613769|Antimalarials|antimalarials|mesh-ancestor
24526933|NCT00613769|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25236755|NCT02555943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25236756|NCT02555943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25236757|NCT02555943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25236758|NCT02555813|Gemcitabine|gemcitabine|mesh-list
25673365|NCT01756209|Antipyretics|antipyretics|mesh-ancestor
25673366|NCT01756209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25236760|NCT02555813|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25236761|NCT02555813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25236762|NCT02555813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236763|NCT02555813|Tubulin Modulators|tubulin modulators|mesh-ancestor
25236764|NCT02555813|Antimitotic Agents|antimitotic agents|mesh-ancestor
25236765|NCT02555813|Mitosis Modulators|mitosis modulators|mesh-ancestor
25236766|NCT02555813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236767|NCT02555813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25236768|NCT02555813|Antimetabolites|antimetabolites|mesh-ancestor
25236769|NCT02555813|Antiviral Agents|antiviral agents|mesh-ancestor
25236770|NCT02555813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25236771|NCT02555813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25236772|NCT02555813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25236773|NCT02555813|Immunologic Factors|immunologic factors|mesh-ancestor
25236774|NCT02555813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236776|NCT02555800|Bevacizumab|bevacizumab|mesh-list
25236777|NCT02555800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25236778|NCT02555800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236779|NCT02555800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25236780|NCT02555800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25236781|NCT02555800|Growth Substances|growth substances|mesh-ancestor
25236782|NCT02555800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236783|NCT02555800|Growth Inhibitors|growth inhibitors|mesh-ancestor
25236784|NCT02555800|Antiviral Agents|antiviral agents|mesh-ancestor
25873730|NCT05560945|Cariostatic Agents|cariostatic agents|mesh-ancestor
25873731|NCT05560945|Protective Agents|protective agents|mesh-ancestor
25873732|NCT05560945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873733|NCT05560945|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25873734|NCT05560945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25873735|NCT05560919|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
25873736|NCT05560919|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
24526934|NCT00613769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24526997|NCT00614159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24527070|NCT00614757|Protective Agents|protective agents|mesh-ancestor
24527071|NCT00614757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527073|NCT00614809|Gefitinib|gefitinib|mesh-list
24527074|NCT00614809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527075|NCT00614809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24527076|NCT00614809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527077|NCT00614809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527078|NCT00614835|Gemcitabine|gemcitabine|mesh-list
24527079|NCT00614835|Docetaxel|docetaxel|mesh-list
24527080|NCT00614835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24527081|NCT00614835|Antimetabolites|antimetabolites|mesh-ancestor
24527082|NCT00614835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527083|NCT00614835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527084|NCT00614835|Antiviral Agents|antiviral agents|mesh-ancestor
24527085|NCT00614835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24527086|NCT00614835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527087|NCT00614835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24527088|NCT00614835|Immunologic Factors|immunologic factors|mesh-ancestor
24527116|NCT00615134|Antiviral Agents|antiviral agents|mesh-ancestor
25236785|NCT02555800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25236786|NCT02555800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25236787|NCT02555800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236788|NCT02555852|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
25236789|NCT02555852|Esomeprazole|esomeprazole|mesh-list
25236790|NCT02555852|Omeprazole|omeprazole|mesh-list
25236791|NCT02555852|Rabeprazole|rabeprazole|mesh-list
25236792|NCT02555852|Pantoprazole|pantoprazole|mesh-list
25236793|NCT02555852|Lansoprazole|lansoprazole|mesh-list
25236794|NCT02555852|Famotidine|famotidine|mesh-list
25236795|NCT02555852|Ranitidine|ranitidine|mesh-list
25236796|NCT02555852|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
25236797|NCT02555852|Cimetidine|cimetidine|mesh-list
25236798|NCT02555852|Nizatidine|nizatidine|mesh-list
25236799|NCT02555852|Lafutidine|lafutidine|mesh-list
25236800|NCT02555852|Roxatidine acetate|roxatidine acetate|mesh-list
25236801|NCT02555852|Bismuth|bismuth|mesh-list
25236802|NCT02555852|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25873737|NCT05560919|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25873738|NCT05560919|Protective Agents|protective agents|mesh-ancestor
25873739|NCT05560919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873740|NCT05560919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25873741|NCT05560919|Antioxidants|antioxidants|mesh-ancestor
25873742|NCT05560919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959143|NCT03826875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24959144|NCT03826589|Avelumab|avelumab|mesh-list
24959145|NCT03826589|Axitinib|axitinib|mesh-list
24959146|NCT03826589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24959147|NCT03826589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24888213|NCT04508166|Dexmedetomidine|dexmedetomidine|mesh-list
24959209|NCT03826524|Mydriatics|mydriatics|mesh-ancestor
24959210|NCT03826524|Sympathomimetics|sympathomimetics|mesh-ancestor
24959211|NCT03826524|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24511414|NCT00568672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24959273|NCT03825809|Narcotics|narcotics|mesh-ancestor
24959274|NCT03825809|Antitussive Agents|antitussive agents|mesh-ancestor
24959275|NCT03825809|Respiratory System Agents|respiratory system agents|mesh-ancestor
24959276|NCT03825809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24959277|NCT03825809|Antiemetics|antiemetics|mesh-ancestor
25236803|NCT02555852|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
25236804|NCT02555852|Histamine|histamine|mesh-list
25236805|NCT02555852|Histamine phosphate|histamine phosphate|mesh-list
24964604|NCT03781687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25873743|NCT05560919|Vitamins|vitamins|mesh-ancestor
25873744|NCT05560919|Micronutrients|micronutrients|mesh-ancestor
25044820|NCT01035502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25044821|NCT01035502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25044822|NCT01035502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044823|NCT01035502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044824|NCT01033292|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25044826|NCT01033292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044827|NCT01033292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044828|NCT01033292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527117|NCT00615134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24527118|NCT00615147|Fibrin fragment D|fibrin fragment d|mesh-list
24527119|NCT00615147|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24527120|NCT00615147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24527204|NCT00615446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24527205|NCT00615446|Growth Substances|growth substances|mesh-ancestor
24527206|NCT00615446|Growth Inhibitors|growth inhibitors|mesh-ancestor
24527207|NCT00615446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25873745|NCT05560919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24527271|NCT00615797|Immunoglobulins|immunoglobulins|mesh-list
24527272|NCT00615797|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24527273|NCT00615797|Antibodies|antibodies|mesh-list
24527274|NCT00615797|gamma-Globulins|gamma-globulins|mesh-list
24527275|NCT00615797|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24527276|NCT00615797|Immunologic Factors|immunologic factors|mesh-ancestor
24527277|NCT00615797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527334|NCT00616005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527408|NCT00616460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527409|NCT00616460|Anticoagulants|anticoagulants|mesh-ancestor
24527410|NCT00616499|Gefitinib|gefitinib|mesh-list
25673367|NCT01756209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25673368|NCT01756209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25673369|NCT01756209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25673370|NCT01756209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25673371|NCT01756209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673372|NCT01756456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25673373|NCT01756456|Mitogens|mitogens|mesh-list
25673374|NCT01756456|Mitosis Modulators|mitosis modulators|mesh-ancestor
25673375|NCT01756456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673376|NCT01756833|Doxycycline|doxycycline|mesh-list
25673377|NCT01756833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25673378|NCT01756833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25673379|NCT01756833|Antimalarials|antimalarials|mesh-ancestor
25673380|NCT01756833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25673381|NCT01756833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25673382|NCT01756885|Varenicline|varenicline|mesh-list
25673383|NCT01756885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25673384|NCT01756885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25873746|NCT05560282|Fenfluramine|fenfluramine|mesh-list
24527411|NCT00616499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527412|NCT00616499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24527413|NCT00616499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527414|NCT00616499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527416|NCT00616538|Xhance|xhance|mesh-list
24527417|NCT00616538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24527418|NCT00616538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24527419|NCT00616538|Autonomic Agents|autonomic agents|mesh-ancestor
24527488|NCT00616863|Oxcarbazepine|oxcarbazepine|mesh-list
24527489|NCT00616863|Anticonvulsants|anticonvulsants|mesh-ancestor
24527490|NCT00616863|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24872930|NCT05439213|Mydriatics|mydriatics|mesh-ancestor
24527523|NCT00616993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527524|NCT00617045|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24527525|NCT00617045|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24527605|NCT00617656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24527606|NCT00617656|Antimetabolites|antimetabolites|mesh-ancestor
25236806|NCT02555852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236807|NCT02555852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25236808|NCT02555852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25236809|NCT02555852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25236810|NCT02555852|Antacids|antacids|mesh-ancestor
25236811|NCT02555852|Histamine Antagonists|histamine antagonists|mesh-ancestor
25236812|NCT02555852|Histamine Agents|histamine agents|mesh-ancestor
25236813|NCT02555852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25236814|NCT02555852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236815|NCT02555852|Histamine Agonists|histamine agonists|mesh-ancestor
25236816|NCT02555852|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25236817|NCT02555852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25236818|NCT02555852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25273704|NCT02384187|Gabapentin|gabapentin|mesh-list
25273705|NCT02384187|Analgesics|analgesics|mesh-ancestor
25044830|NCT01033123|Iniparib|iniparib|mesh-list
25044831|NCT01033123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044832|NCT01033123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044833|NCT01033123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044834|NCT01030432|Ribavirin|ribavirin|mesh-list
25044835|NCT01030432|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25044836|NCT01030432|Interferon-alpha|interferon-alpha|mesh-list
25044837|NCT01030432|Asunaprevir|asunaprevir|mesh-list
25044838|NCT01030432|Antimetabolites|antimetabolites|mesh-ancestor
24841810|NCT02218047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044839|NCT01030432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044840|NCT01030432|Antiviral Agents|antiviral agents|mesh-ancestor
25044841|NCT01030432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25044842|NCT01030432|Immunologic Factors|immunologic factors|mesh-ancestor
25044843|NCT01030432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044844|NCT01030432|Protease Inhibitors|protease inhibitors|mesh-ancestor
25044845|NCT01030432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044846|NCT01029873|Cisplatin|cisplatin|mesh-list
25044847|NCT01029873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044848|NCT01027013|Rebamipide|rebamipide|mesh-list
25044849|NCT01027013|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25044850|NCT01027013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25044851|NCT01027013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25873747|NCT05560282|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24486368|NCT00457652|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24527607|NCT00617656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527608|NCT00617656|Antiviral Agents|antiviral agents|mesh-ancestor
24527609|NCT00617656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24527610|NCT00617656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527611|NCT00617656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24527670|NCT00618046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24527671|NCT00618046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24527672|NCT00618046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964715|NCT03781115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24527673|NCT00618046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25673385|NCT01756885|Cholinergic Agents|cholinergic agents|mesh-ancestor
24527674|NCT00618046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25873748|NCT05560282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25873749|NCT05560282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25873750|NCT05560282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960196|NCT03818932|Antiemetics|antiemetics|mesh-ancestor
24960197|NCT03818932|Autonomic Agents|autonomic agents|mesh-ancestor
24960198|NCT03818932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24960199|NCT03818932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24527677|NCT00618059|Autonomic Agents|autonomic agents|mesh-ancestor
24527678|NCT00618059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25236819|NCT02555696|Paclitaxel|paclitaxel|mesh-list
25236820|NCT02555696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25236821|NCT02555696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236822|NCT02555696|Tubulin Modulators|tubulin modulators|mesh-ancestor
25236823|NCT02555696|Antimitotic Agents|antimitotic agents|mesh-ancestor
25236824|NCT02555696|Mitosis Modulators|mitosis modulators|mesh-ancestor
25236825|NCT02555696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236826|NCT02555644|Cetuximab|cetuximab|mesh-list
25236827|NCT02555644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236828|NCT02555644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25236829|NCT02555761|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25236830|NCT02555761|Alcaftadine|alcaftadine|mesh-list
25236842|NCT02555748|Growth Substances|growth substances|mesh-ancestor
25236843|NCT02555748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236844|NCT02555748|Growth Inhibitors|growth inhibitors|mesh-ancestor
25236845|NCT02555748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25236846|NCT02555748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25236847|NCT02555748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154913|NCT05468645|Hemay005|hemay005|mesh-list
25154914|NCT05468645|Dermatologic Agents|dermatologic agents|mesh-ancestor
25154915|NCT05468645|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25154916|NCT05468645|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25154917|NCT05468645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457850|NCT00335413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457851|NCT00335413|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24527679|NCT00618059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527680|NCT00618059|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24527681|NCT00618059|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25078956|NCT03352076|Danazol|danazol|mesh-list
24527682|NCT00618059|Cholinergic Agents|cholinergic agents|mesh-ancestor
24527683|NCT00618059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24527684|NCT00618059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527685|NCT00618111|Granisetron|granisetron|mesh-list
24527686|NCT00618111|Antiemetics|antiemetics|mesh-ancestor
24527687|NCT00618111|Autonomic Agents|autonomic agents|mesh-ancestor
24527688|NCT00618111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25236848|NCT02555605|Dexmedetomidine|dexmedetomidine|mesh-list
25236849|NCT02555605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25236850|NCT02555605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25236851|NCT02555605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236852|NCT02555605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25236853|NCT02555605|Analgesics|analgesics|mesh-ancestor
25236854|NCT02555605|Sensory System Agents|sensory system agents|mesh-ancestor
25236855|NCT02555605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25236856|NCT02555605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25236857|NCT02555605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25236858|NCT02555605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25236859|NCT02555605|Adrenergic Agents|adrenergic agents|mesh-ancestor
25236860|NCT02555605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25236867|NCT02555358|Oxaliplatin|oxaliplatin|mesh-list
25236868|NCT02555358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236869|NCT02555358|Tubulin Modulators|tubulin modulators|mesh-ancestor
25236870|NCT02555358|Antimitotic Agents|antimitotic agents|mesh-ancestor
25236871|NCT02555358|Mitosis Modulators|mitosis modulators|mesh-ancestor
25236872|NCT02555358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236873|NCT02555358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25236874|NCT02555358|Antimetabolites|antimetabolites|mesh-ancestor
25154926|NCT05468606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873751|NCT05560282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25873752|NCT05560282|Serotonin Agents|serotonin agents|mesh-ancestor
25873753|NCT05560282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527838|NCT00618423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527840|NCT00618501|Cytarabine|cytarabine|mesh-list
24527841|NCT00618501|Prednisolone|prednisolone|mesh-list
24527842|NCT00618501|Hydrocortisone|hydrocortisone|mesh-list
25673386|NCT01756885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25673387|NCT01756885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673388|NCT01756885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673389|NCT01757275|Esomeprazole|esomeprazole|mesh-list
24960556|NCT03815838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24960754|NCT03814226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527843|NCT00618501|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24527844|NCT00618501|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24527845|NCT00618501|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24527846|NCT00618501|Methotrexate|methotrexate|mesh-list
24527847|NCT00618501|Etoposide|etoposide|mesh-list
24527848|NCT00618501|Vincristine|vincristine|mesh-list
24527849|NCT00618501|Imatinib Mesylate|imatinib mesylate|mesh-list
24527850|NCT00618501|Daunorubicin|daunorubicin|mesh-list
24527851|NCT00618501|Levoleucovorin|levoleucovorin|mesh-list
24527852|NCT00618501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527853|NCT00618501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25873754|NCT05558137|Mivacurium|mivacurium|mesh-list
25873755|NCT05558137|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25873756|NCT05558137|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25873757|NCT05558137|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24528013|NCT00619216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24528014|NCT00619216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528015|NCT00619216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24528016|NCT00619216|Antitubercular Agents|antitubercular agents|mesh-ancestor
24528017|NCT00619216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24528018|NCT00619216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24528019|NCT00619216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528020|NCT00619216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528048|NCT00619346|Pafuramidine|pafuramidine|mesh-list
24528049|NCT00619346|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24528050|NCT00619346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24528051|NCT00619346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24528052|NCT00619346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24528053|NCT00619372|Muromonab-CD3|muromonab-cd3|mesh-list
24528054|NCT00619372|Immunologic Factors|immunologic factors|mesh-ancestor
24528055|NCT00619372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528165|NCT00620178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24528166|NCT00620178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24528167|NCT00620178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24528168|NCT00620178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25236875|NCT02555423|Anesthetics|anesthetics|mesh-list
25236876|NCT02555423|Levobupivacaine|levobupivacaine|mesh-list
25236877|NCT02555423|Anesthetics, Local|anesthetics, local|mesh-list
25236878|NCT02555423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25236879|NCT02555423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964877|NCT03779789|Fluvoxamine|fluvoxamine|mesh-list
25236880|NCT02555423|Sensory System Agents|sensory system agents|mesh-ancestor
25236881|NCT02555423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25236882|NCT02555059|Ciprofloxacin|ciprofloxacin|mesh-list
25236883|NCT02555059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25236884|NCT02555059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25236885|NCT02555059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25236886|NCT02555059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25236887|NCT02555059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457858|NCT00335439|Analgesics|analgesics|mesh-ancestor
24399549|NCT00148070|Erythromycin|erythromycin|mesh-list
24528211|NCT00620438|Lumefantrine|lumefantrine|mesh-list
24528214|NCT00620438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24528215|NCT00620438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24528216|NCT00620438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528217|NCT00620438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528219|NCT00620438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24528220|NCT00620438|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24528221|NCT00620438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24528222|NCT00620438|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25673390|NCT01757275|Cimetidine|cimetidine|mesh-list
25673391|NCT01757275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25673392|NCT01757275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25673393|NCT01757275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25673394|NCT01757275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25673395|NCT01757275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873758|NCT05558137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25873759|NCT05558137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528228|NCT00620438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24528229|NCT00620438|Antitubercular Agents|antitubercular agents|mesh-ancestor
24528230|NCT00620438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24528231|NCT00620438|Leprostatic Agents|leprostatic agents|mesh-ancestor
24528242|NCT00620477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873760|NCT05556356|Acetaminophen|acetaminophen|mesh-list
24528274|NCT00620620|GABA Agents|gaba agents|mesh-ancestor
24528275|NCT00620620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24528276|NCT00620620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528279|NCT00620646|Clopidogrel|clopidogrel|mesh-list
24528280|NCT00620646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24528281|NCT00620646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24528282|NCT00620646|Analgesics|analgesics|mesh-ancestor
24528283|NCT00620646|Sensory System Agents|sensory system agents|mesh-ancestor
24528284|NCT00620646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24528285|NCT00620646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528286|NCT00620646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24528287|NCT00620646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24752667|NCT01711515|Cisplatin|cisplatin|mesh-list
25873761|NCT05556356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25873762|NCT05556356|Analgesics|analgesics|mesh-ancestor
25873763|NCT05556356|Sensory System Agents|sensory system agents|mesh-ancestor
25236888|NCT02555059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236889|NCT02555059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236890|NCT02555059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25236891|NCT02555059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25236900|NCT02555150|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25236901|NCT02555150|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25873764|NCT05556356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24528288|NCT00620646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24528289|NCT00620646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24528290|NCT00620646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528345|NCT00620802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528346|NCT00620802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528347|NCT00620867|Ibuprofen|ibuprofen|mesh-list
24528348|NCT00620867|Celecoxib|celecoxib|mesh-list
24528377|NCT00620971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24528378|NCT00620971|Growth Substances|growth substances|mesh-ancestor
24528379|NCT00620971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673396|NCT01757275|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25673397|NCT01757275|Histamine Antagonists|histamine antagonists|mesh-ancestor
25673398|NCT01757275|Histamine Agents|histamine agents|mesh-ancestor
25673399|NCT01757275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25673400|NCT01757275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673401|NCT01757275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25873765|NCT05556356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873766|NCT05556356|Antipyretics|antipyretics|mesh-ancestor
25873767|NCT05555706|Paclitaxel|paclitaxel|mesh-list
25873768|NCT05555706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25873769|NCT05555706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873770|NCT05555706|Tubulin Modulators|tubulin modulators|mesh-ancestor
25873771|NCT05555706|Antimitotic Agents|antimitotic agents|mesh-ancestor
25873772|NCT05555706|Mitosis Modulators|mitosis modulators|mesh-ancestor
25873773|NCT05555706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236904|NCT02555150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25236905|NCT02555150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25236906|NCT02555150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236907|NCT02555150|Dopamine Agents|dopamine agents|mesh-ancestor
25236908|NCT02555150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25236909|NCT02555046|Anesthetics|anesthetics|mesh-list
25236910|NCT02555046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25236911|NCT02555046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236912|NCT02554942|Epoetin Alfa|epoetin alfa|mesh-list
25236913|NCT02554942|Hematinics|hematinics|mesh-ancestor
25236914|NCT02555007|Vinorelbine|vinorelbine|mesh-list
25236915|NCT02555007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25236916|NCT02555007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236917|NCT02555007|Tubulin Modulators|tubulin modulators|mesh-ancestor
25236918|NCT02555007|Antimitotic Agents|antimitotic agents|mesh-ancestor
25236919|NCT02555007|Mitosis Modulators|mitosis modulators|mesh-ancestor
25236920|NCT02555007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236921|NCT02554955|Mycophenolic Acid|mycophenolic acid|mesh-list
25236923|NCT02554955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25236924|NCT02554955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236925|NCT02554955|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25236926|NCT02554955|Antitubercular Agents|antitubercular agents|mesh-ancestor
25236927|NCT02554955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25236928|NCT02554955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25236929|NCT02554955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25236930|NCT02554955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236931|NCT02554955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24848362|NCT04553003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24848363|NCT04553003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848364|NCT04553003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24848365|NCT04553003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065166|NCT03452579|Nivolumab|nivolumab|mesh-list
24528380|NCT00620971|Growth Inhibitors|growth inhibitors|mesh-ancestor
24528381|NCT00620971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24528382|NCT00620971|Antimetabolites|antimetabolites|mesh-ancestor
24528383|NCT00620971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528384|NCT00620971|Antiviral Agents|antiviral agents|mesh-ancestor
24752683|NCT01711528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24752685|NCT01711528|Hormones|hormones|mesh-ancestor
25873774|NCT05554419|Cytarabine|cytarabine|mesh-list
25873775|NCT05554419|Azacitidine|azacitidine|mesh-list
25873776|NCT05554419|Daunorubicin|daunorubicin|mesh-list
24528385|NCT00620971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24528386|NCT00620971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25236932|NCT02554955|Immunologic Factors|immunologic factors|mesh-ancestor
25236933|NCT02554955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236935|NCT02554864|Ropivacaine|ropivacaine|mesh-list
25236936|NCT02554864|Anesthetics, Local|anesthetics, local|mesh-ancestor
25236937|NCT02554864|Anesthetics|anesthetics|mesh-ancestor
25236938|NCT02554864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25236939|NCT02554864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236940|NCT02554864|Sensory System Agents|sensory system agents|mesh-ancestor
25236941|NCT02554864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25236942|NCT02554864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25236943|NCT02554864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25236944|NCT02554864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25236945|NCT02554864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25236946|NCT02554864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236947|NCT02554851|Mitogens|mitogens|mesh-list
25236948|NCT02554851|Mitosis Modulators|mitosis modulators|mesh-ancestor
25273706|NCT02384187|Sensory System Agents|sensory system agents|mesh-ancestor
25273707|NCT02384187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25273708|NCT02384187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273709|NCT02384187|Anticonvulsants|anticonvulsants|mesh-ancestor
25273710|NCT02384187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25273714|NCT02384187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25273715|NCT02384187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25273716|NCT02384187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24457861|NCT00335439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528394|NCT00620997|Anesthetics, Local|anesthetics, local|mesh-ancestor
24528395|NCT00620997|Anesthetics|anesthetics|mesh-ancestor
24752699|NCT01711567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25236949|NCT02554851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236953|NCT02554734|Levodopa|levodopa|mesh-list
25236954|NCT02554734|Carbidopa|carbidopa|mesh-list
25236955|NCT02554734|Entacapone|entacapone|mesh-list
25236956|NCT02554734|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25236957|NCT02554734|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25236958|NCT02554734|Dopamine Agents|dopamine agents|mesh-ancestor
25236959|NCT02554734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25236960|NCT02554734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236961|NCT02554734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236962|NCT02554734|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25236963|NCT02554734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25236964|NCT02554734|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25236966|NCT02554695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25236967|NCT02554695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236968|NCT02554357|Bupivacaine|bupivacaine|mesh-list
25236969|NCT02554357|Anesthetics, Local|anesthetics, local|mesh-ancestor
25236970|NCT02554357|Anesthetics|anesthetics|mesh-ancestor
24790974|NCT05409157|Bisacodyl|bisacodyl|mesh-list
25873777|NCT05554419|Venetoclax|venetoclax|mesh-list
25873778|NCT05554419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25873779|NCT05554419|Antimetabolites|antimetabolites|mesh-ancestor
25873780|NCT05554419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873781|NCT05554419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873782|NCT05554419|Antiviral Agents|antiviral agents|mesh-ancestor
25873783|NCT05554419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25873784|NCT05554419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25873785|NCT05554419|Immunologic Factors|immunologic factors|mesh-ancestor
25873786|NCT05554419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873787|NCT05554419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528396|NCT00620997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24528459|NCT00621283|Hormones|hormones|mesh-ancestor
24528460|NCT00621283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24528461|NCT00621283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528463|NCT00621361|Cediranib|cediranib|mesh-list
24528464|NCT00621361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528465|NCT00621361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24528466|NCT00621361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24528467|NCT00621361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24528468|NCT00621361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25236973|NCT02554357|Sensory System Agents|sensory system agents|mesh-ancestor
25236974|NCT02554357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25236975|NCT02554175|Propofol|propofol|mesh-list
25236976|NCT02554175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25236977|NCT02554175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25236978|NCT02554175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236979|NCT02554175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25236980|NCT02554175|Anesthetics, General|anesthetics, general|mesh-ancestor
25236981|NCT02554175|Anesthetics|anesthetics|mesh-ancestor
25236982|NCT02554344|Curcumin|curcumin|mesh-list
25236983|NCT02554344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25236984|NCT02554344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25236985|NCT02554344|Analgesics|analgesics|mesh-ancestor
25236986|NCT02554344|Sensory System Agents|sensory system agents|mesh-ancestor
25236987|NCT02554344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25236988|NCT02554344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236989|NCT02554344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25236990|NCT02554344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25236991|NCT02554344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236992|NCT02554344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273370|NCT02385617|Octreotide|octreotide|mesh-list
25236993|NCT02554344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25236994|NCT02554123|Vitamin E|vitamin e|mesh-list
25873788|NCT05554419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24848400|NCT04509336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24848401|NCT04458311|Abiraterone Acetate|abiraterone acetate|mesh-list
24848402|NCT04458311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24848409|NCT04458311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24848423|NCT04422795|Anesthetics, Local|anesthetics, local|mesh-ancestor
24848425|NCT04422795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24848426|NCT04422795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848427|NCT04422795|Sensory System Agents|sensory system agents|mesh-ancestor
25065187|NCT03452475|Lumefantrine|lumefantrine|mesh-list
24528470|NCT00621361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24528471|NCT00621387|Ofloxacin|ofloxacin|mesh-list
24528472|NCT00621387|Roxithromycin|roxithromycin|mesh-list
24528473|NCT00621387|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24528474|NCT00621387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24528475|NCT00621387|Renal Agents|renal agents|mesh-ancestor
24528476|NCT00621387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24528477|NCT00621387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24528478|NCT00621387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24528479|NCT00621387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528480|NCT00621387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528481|NCT00621387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25236995|NCT02554123|Petrolatum|petrolatum|mesh-list
25236996|NCT02554123|Vitamins|vitamins|mesh-ancestor
25236997|NCT02554123|Micronutrients|micronutrients|mesh-ancestor
25236998|NCT02554123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25236999|NCT02554123|Antioxidants|antioxidants|mesh-ancestor
25237000|NCT02554123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237001|NCT02554123|Protective Agents|protective agents|mesh-ancestor
25237002|NCT02554123|Emollients|emollients|mesh-ancestor
25237003|NCT02554123|Dermatologic Agents|dermatologic agents|mesh-ancestor
25237004|NCT02554045|Tadalafil|tadalafil|mesh-list
25237005|NCT02554045|Vasodilator Agents|vasodilator agents|mesh-ancestor
25237006|NCT02554045|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25237007|NCT02554045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25237008|NCT02554045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237009|NCT02554045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237010|NCT02554045|Urological Agents|urological agents|mesh-ancestor
25273718|NCT02384187|Antimanic Agents|antimanic agents|mesh-ancestor
25273720|NCT02383771|Ticagrelor|ticagrelor|mesh-list
25273721|NCT02383771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25273722|NCT02383771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25273723|NCT02383771|Analgesics|analgesics|mesh-ancestor
25273724|NCT02383771|Sensory System Agents|sensory system agents|mesh-ancestor
25273725|NCT02383771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25873789|NCT05554419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24962933|NCT03794440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962934|NCT03794440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24962935|NCT03794440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24962936|NCT03794440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963055|NCT03792776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24963056|NCT03792776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25273726|NCT02383771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273727|NCT02383771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25273728|NCT02383771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25273729|NCT02383771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25273730|NCT02383771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25273731|NCT02383771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273732|NCT02383771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25273733|NCT02383771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24848428|NCT04422795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24848429|NCT04368533|Fluorides|fluorides|mesh-list
24848430|NCT04368533|Cariostatic Agents|cariostatic agents|mesh-ancestor
24848431|NCT04368533|Protective Agents|protective agents|mesh-ancestor
25154927|NCT05468606|Interferon Inducers|interferon inducers|mesh-ancestor
24848432|NCT04368533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848433|NCT04280562|Acetaminophen|acetaminophen|mesh-list
24848434|NCT04280562|Analgesics|analgesics|mesh-list
24848435|NCT04280562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24848436|NCT04280562|Sensory System Agents|sensory system agents|mesh-ancestor
24848437|NCT04280562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24848438|NCT04280562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848439|NCT04280562|Antipyretics|antipyretics|mesh-ancestor
24848440|NCT04270682|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
24848441|NCT04270682|Cathartics|cathartics|mesh-ancestor
24859047|NCT02301286|Antipyretics|antipyretics|mesh-ancestor
24848442|NCT04270682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24848443|NCT04199728|Liraglutide|liraglutide|mesh-list
24848444|NCT04199728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24619192|NCT01051284|Gemcitabine|gemcitabine|mesh-list
25873790|NCT05554419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25873791|NCT05554406|Cytarabine|cytarabine|mesh-list
25237011|NCT02553824|Topiramate|topiramate|mesh-list
25237012|NCT02553824|Phentermine|phentermine|mesh-list
25237013|NCT02553824|Anticonvulsants|anticonvulsants|mesh-ancestor
25237014|NCT02553824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25237015|NCT02553824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237016|NCT02553824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25237017|NCT02553824|Appetite Depressants|appetite depressants|mesh-ancestor
25237018|NCT02553824|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25237019|NCT02553824|Sympathomimetics|sympathomimetics|mesh-ancestor
25237020|NCT02553824|Autonomic Agents|autonomic agents|mesh-ancestor
25237021|NCT02553824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25237022|NCT02553824|Adrenergic Agents|adrenergic agents|mesh-ancestor
25237023|NCT02553824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25237024|NCT02553824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237025|NCT02553551|Vitamins|vitamins|mesh-list
25673402|NCT01757275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25673403|NCT01757288|Paclitaxel|paclitaxel|mesh-list
25673404|NCT01757288|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25673405|NCT01757288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25673406|NCT01757288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673407|NCT01757288|Tubulin Modulators|tubulin modulators|mesh-ancestor
25673408|NCT01757288|Antimitotic Agents|antimitotic agents|mesh-ancestor
25673409|NCT01757288|Mitosis Modulators|mitosis modulators|mesh-ancestor
25237026|NCT02553551|Ascorbic Acid|ascorbic acid|mesh-list
25237027|NCT02553551|Micronutrients|micronutrients|mesh-ancestor
25873792|NCT05554406|Azacitidine|azacitidine|mesh-list
25873793|NCT05554406|Daunorubicin|daunorubicin|mesh-list
25873794|NCT05554406|Venetoclax|venetoclax|mesh-list
25873795|NCT05554406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25873796|NCT05554406|Antimetabolites|antimetabolites|mesh-ancestor
25873797|NCT05554406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873798|NCT05554406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873799|NCT05554406|Antiviral Agents|antiviral agents|mesh-ancestor
25873800|NCT05554406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25873801|NCT05554406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25873802|NCT05554406|Immunologic Factors|immunologic factors|mesh-ancestor
25873803|NCT05554406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873804|NCT05554406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078827|NCT03353363|Anesthetics, Local|anesthetics, local|mesh-ancestor
25078828|NCT03353363|Anesthetics|anesthetics|mesh-ancestor
25078829|NCT03353363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25237028|NCT02553551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237029|NCT02553551|Antioxidants|antioxidants|mesh-ancestor
25237030|NCT02553551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237032|NCT02553707|Ibandronic Acid|ibandronic acid|mesh-list
25237033|NCT02553707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25237034|NCT02553707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237036|NCT02553603|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
25237037|NCT02553603|Tesamorelin|tesamorelin|mesh-list
25237038|NCT02553603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25237039|NCT02553603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237040|NCT02553603|Growth Substances|growth substances|mesh-ancestor
25237041|NCT02553226|Oxytocin|oxytocin|mesh-list
25237042|NCT02553226|Oxytocics|oxytocics|mesh-ancestor
25273734|NCT02383771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24848451|NCT04167813|Autonomic Agents|autonomic agents|mesh-ancestor
24848452|NCT04167813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24848453|NCT04167813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486925|NCT00460642|Cetrorelix|cetrorelix|mesh-list
24528483|NCT00621387|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25237043|NCT02553226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25237044|NCT02553226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237045|NCT02553083|Amoxicillin|amoxicillin|mesh-list
25237046|NCT02553083|Doxycycline|doxycycline|mesh-list
25237047|NCT02553083|Esomeprazole|esomeprazole|mesh-list
25237048|NCT02553083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25237049|NCT02553083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25237050|NCT02553083|Antimalarials|antimalarials|mesh-ancestor
25237051|NCT02553083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25673410|NCT01757288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673411|NCT01757561|Propofol|propofol|mesh-list
25673412|NCT01757561|Sevoflurane|sevoflurane|mesh-list
25673413|NCT01757561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25673414|NCT01757561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25673415|NCT01757561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673416|NCT01757561|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25673417|NCT01757561|Anesthetics, General|anesthetics, general|mesh-ancestor
25673418|NCT01757561|Anesthetics|anesthetics|mesh-ancestor
25673419|NCT01757561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25673420|NCT01757561|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25673421|NCT01757691|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25237052|NCT02553083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25237061|NCT02553018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25237062|NCT02553018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237063|NCT02553018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25237064|NCT02553018|Antimetabolites|antimetabolites|mesh-ancestor
25237065|NCT02553018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237066|NCT02553018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25237067|NCT02553018|Dermatologic Agents|dermatologic agents|mesh-ancestor
25237068|NCT02553018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237069|NCT02553018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25237070|NCT02553018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25237071|NCT02553018|Immunologic Factors|immunologic factors|mesh-ancestor
25237072|NCT02553018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25237073|NCT02553018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25237074|NCT02552745|Parecoxib|parecoxib|mesh-list
25237075|NCT02552745|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25873805|NCT05554406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24848482|NCT04042727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848483|NCT04042727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24848484|NCT04042727|Analgesics|analgesics|mesh-ancestor
24848485|NCT04042727|Sensory System Agents|sensory system agents|mesh-ancestor
24848486|NCT04042727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25237083|NCT02552745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25237084|NCT02552745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237085|NCT02552745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25237086|NCT02552745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25237088|NCT02553044|Cholecalciferol|cholecalciferol|mesh-list
25237089|NCT02553044|Vitamins|vitamins|mesh-ancestor
25237090|NCT02553044|Micronutrients|micronutrients|mesh-ancestor
25237091|NCT02553044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237092|NCT02553044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25673422|NCT01757691|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25673423|NCT01757691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673424|NCT01757691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25673425|NCT01757691|Immunologic Factors|immunologic factors|mesh-ancestor
25673426|NCT01757691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673427|NCT01758432|Apixaban|apixaban|mesh-list
25873806|NCT05554406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25873807|NCT05554406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25873808|NCT05554393|Cytarabine|cytarabine|mesh-list
25873809|NCT05554393|Azacitidine|azacitidine|mesh-list
25873810|NCT05554393|Daunorubicin|daunorubicin|mesh-list
25873811|NCT05554393|Venetoclax|venetoclax|mesh-list
25873812|NCT05554393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25873813|NCT05554393|Antimetabolites|antimetabolites|mesh-ancestor
25873814|NCT05554393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237118|NCT02552459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25237119|NCT02552459|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25237120|NCT02552459|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25237121|NCT02552459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25237122|NCT02552459|Adrenergic Agents|adrenergic agents|mesh-ancestor
25237123|NCT02552459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25237124|NCT02552459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237125|NCT02552459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25237126|NCT02552459|Narcotics|narcotics|mesh-ancestor
25237127|NCT02552459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25237128|NCT02552459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25237129|NCT02552459|Anesthetics, General|anesthetics, general|mesh-ancestor
25237130|NCT02552459|Anesthetics|anesthetics|mesh-ancestor
25237131|NCT02552342|Methylprednisolone|methylprednisolone|mesh-list
25237132|NCT02552342|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25237133|NCT02552342|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25873815|NCT05554393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25237134|NCT02552342|Prednisolone|prednisolone|mesh-list
25237135|NCT02552342|Prednisolone acetate|prednisolone acetate|mesh-list
25237136|NCT02552342|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25237137|NCT02552342|Prednisolone phosphate|prednisolone phosphate|mesh-list
25237138|NCT02552342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25237139|NCT02552342|Antiemetics|antiemetics|mesh-ancestor
25673428|NCT01758432|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25237140|NCT02552342|Autonomic Agents|autonomic agents|mesh-ancestor
25237141|NCT02552342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25873816|NCT05554393|Antiviral Agents|antiviral agents|mesh-ancestor
25873817|NCT05554393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25873818|NCT05554393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25873819|NCT05554393|Immunologic Factors|immunologic factors|mesh-ancestor
25873820|NCT05554393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873821|NCT05554393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25873822|NCT05554393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25873823|NCT05554393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25873825|NCT05554367|Palbociclib|palbociclib|mesh-list
25873826|NCT05554367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873827|NCT05554367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25075909|NCT03377335|Metformin|metformin|mesh-list
24608880|NCT00994253|Diuretics|diuretics|mesh-ancestor
24848505|NCT04014387|Suvorexant|suvorexant|mesh-list
24848506|NCT04014387|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24453728|NCT04803422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529735|NCT00627666|Vitamin B Complex|vitamin b complex|mesh-ancestor
25873828|NCT05554367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950007|NCT03015896|Nivolumab|nivolumab|mesh-list
25237154|NCT02552537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25237155|NCT02552537|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25237156|NCT02552537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237157|NCT02552537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237158|NCT02552537|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25237159|NCT02552537|Diuretics|diuretics|mesh-ancestor
25237160|NCT02552537|Natriuretic Agents|natriuretic agents|mesh-ancestor
25237161|NCT02552537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237162|NCT02552589|Fluorides|fluorides|mesh-list
25237163|NCT02552589|Fluorophosphate|fluorophosphate|mesh-list
25237164|NCT02552589|Cariostatic Agents|cariostatic agents|mesh-ancestor
25237165|NCT02552589|Protective Agents|protective agents|mesh-ancestor
25237166|NCT02552589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273735|NCT02383771|Antipyretics|antipyretics|mesh-ancestor
25273736|NCT02383771|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25273737|NCT02383771|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25273738|NCT02383771|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25273739|NCT02383771|Purinergic Agents|purinergic agents|mesh-ancestor
25273740|NCT02383771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25273741|NCT02383563|Metformin|metformin|mesh-list
25273742|NCT02383563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25273743|NCT02383563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273744|NCT02383121|Midodrine|midodrine|mesh-list
25273745|NCT02383121|Sympathomimetics|sympathomimetics|mesh-ancestor
25273746|NCT02383121|Autonomic Agents|autonomic agents|mesh-ancestor
25273747|NCT02383121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25273748|NCT02383121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273749|NCT02383121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25673429|NCT01758432|Antithrombins|antithrombins|mesh-ancestor
25673430|NCT01758432|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25873829|NCT05554367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873830|NCT05554354|Fulvestrant|fulvestrant|mesh-list
25873831|NCT05554354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25873832|NCT05554354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873833|NCT05554354|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25273751|NCT02383121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25273752|NCT02383121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25273753|NCT02383121|Adrenergic Agents|adrenergic agents|mesh-ancestor
25273754|NCT02383121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25273755|NCT02383121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273756|NCT02383212|Paclitaxel|paclitaxel|mesh-list
25273757|NCT02383212|Docetaxel|docetaxel|mesh-list
25273758|NCT02383212|Cyclophosphamide|cyclophosphamide|mesh-list
25273759|NCT02383212|Carboplatin|carboplatin|mesh-list
25273760|NCT02383212|Pemetrexed|pemetrexed|mesh-list
25273761|NCT02383212|Cemiplimab|cemiplimab|mesh-list
25273762|NCT02383212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24528484|NCT00621400|Dexamethasone|dexamethasone|mesh-list
24528485|NCT00621400|Lenalidomide|lenalidomide|mesh-list
24528486|NCT00621400|Melphalan|melphalan|mesh-list
24528487|NCT00621400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24528488|NCT00621400|Antiemetics|antiemetics|mesh-ancestor
24528561|NCT00621647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24528562|NCT00621647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24528563|NCT00621647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24528564|NCT00621647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528565|NCT00621673|Factor VIII|factor viii|mesh-list
24528566|NCT00621673|Coagulants|coagulants|mesh-ancestor
24528567|NCT00621699|Ezetimibe|ezetimibe|mesh-list
24528568|NCT00621699|Tacrolimus|tacrolimus|mesh-list
24528569|NCT00621699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24528570|NCT00621699|Immunologic Factors|immunologic factors|mesh-ancestor
24528571|NCT00621699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528572|NCT00621699|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24528573|NCT00621699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528574|NCT00621699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528575|NCT00621699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24528576|NCT00621699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25873834|NCT05554354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25873835|NCT05554354|Hormone Antagonists|hormone antagonists|mesh-ancestor
25873836|NCT05554354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25873837|NCT05554354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873838|NCT05554341|Paclitaxel|paclitaxel|mesh-list
25873839|NCT05554341|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25873840|NCT05554341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24965588|NCT03775902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24965589|NCT03775902|Immunologic Factors|immunologic factors|mesh-ancestor
25873841|NCT05554341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873842|NCT05554341|Tubulin Modulators|tubulin modulators|mesh-ancestor
25873843|NCT05554341|Antimitotic Agents|antimitotic agents|mesh-ancestor
25873844|NCT05554341|Mitosis Modulators|mitosis modulators|mesh-ancestor
25873845|NCT05554341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873846|NCT05554328|Olaparib|olaparib|mesh-list
25873847|NCT05554328|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25873848|NCT05554328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25873849|NCT05554328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873850|NCT05554328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873851|NCT05553392|Petrolatum|petrolatum|mesh-list
24528577|NCT00621699|Antimetabolites|antimetabolites|mesh-ancestor
24528578|NCT00621699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24528579|NCT00621725|Cediranib|cediranib|mesh-list
24528580|NCT00621725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528581|NCT00621725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24528582|NCT00621725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237167|NCT02551861|Ribavirin|ribavirin|mesh-list
25237168|NCT02551861|Sofosbuvir|sofosbuvir|mesh-list
25237169|NCT02551861|Antimetabolites|antimetabolites|mesh-ancestor
25237170|NCT02551861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237171|NCT02551861|Antiviral Agents|antiviral agents|mesh-ancestor
25237172|NCT02551861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25237173|NCT02551848|Botulinum Toxins|botulinum toxins|mesh-list
25237174|NCT02551848|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25237175|NCT02551848|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25237176|NCT02551848|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24528583|NCT00621725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528584|NCT00621790|Fenoldopam|fenoldopam|mesh-list
24528585|NCT00621790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24528586|NCT00621790|Vasodilator Agents|vasodilator agents|mesh-ancestor
24965621|NCT03775746|Ticagrelor|ticagrelor|mesh-list
24528587|NCT00621790|Dopamine Agonists|dopamine agonists|mesh-ancestor
24528588|NCT00621790|Dopamine Agents|dopamine agents|mesh-ancestor
24528589|NCT00621790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24529843|NCT00627991|Valsartan|valsartan|mesh-list
25873852|NCT05553392|Emollients|emollients|mesh-ancestor
25873853|NCT05553392|Dermatologic Agents|dermatologic agents|mesh-ancestor
25873854|NCT05552144|Listerine|listerine|mesh-list
25873855|NCT05552144|Sodium Fluoride|sodium fluoride|mesh-list
25873856|NCT05552144|Cariostatic Agents|cariostatic agents|mesh-ancestor
25873857|NCT05552144|Protective Agents|protective agents|mesh-ancestor
25873858|NCT05552144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873859|NCT05552144|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25873860|NCT05552144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24528664|NCT00622141|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24528665|NCT00622206|Ritonavir|ritonavir|mesh-list
24528666|NCT00622206|Saquinavir|saquinavir|mesh-list
24528667|NCT00622206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24528668|NCT00622206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24528669|NCT00622206|Protease Inhibitors|protease inhibitors|mesh-ancestor
24457863|NCT00335439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24457864|NCT00335439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24399843|NCT00148746|Hormones|hormones|mesh-ancestor
24788336|NCT01930812|Cariostatic Agents|cariostatic agents|mesh-ancestor
24788337|NCT01930812|Protective Agents|protective agents|mesh-ancestor
24788338|NCT01930812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788339|NCT01930812|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24788340|NCT01930812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24788341|NCT01930812|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24788342|NCT01930812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788344|NCT01930864|Irinotecan|irinotecan|mesh-list
24788345|NCT01930864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24529737|NCT00627666|Micronutrients|micronutrients|mesh-ancestor
24788347|NCT01930864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24788348|NCT01930864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25237178|NCT02551848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25237179|NCT02551848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237180|NCT02551848|Cholinergic Agents|cholinergic agents|mesh-ancestor
25237181|NCT02551848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25237182|NCT02551848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237183|NCT02551848|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25237184|NCT02551848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25237185|NCT02551549|Rezafungin|rezafungin|mesh-list
25873861|NCT05550337|Trifarotene|trifarotene|mesh-list
24788350|NCT01930864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788351|NCT01930864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24788353|NCT01930877|Anesthetics, Local|anesthetics, local|mesh-ancestor
24788354|NCT01930877|Anesthetics|anesthetics|mesh-ancestor
24788355|NCT01930877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24788356|NCT01930877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788357|NCT01930877|Sensory System Agents|sensory system agents|mesh-ancestor
24788364|NCT01930916|Anticoagulants|anticoagulants|mesh-list
25005372|NCT04178993|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25005373|NCT04178993|Methylphenidate|methylphenidate|mesh-list
25005374|NCT04178993|Methamphetamine|methamphetamine|mesh-list
25005375|NCT04178993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25005376|NCT04178993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005377|NCT04178993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25005378|NCT04178993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25005379|NCT04178993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25005380|NCT04178993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005381|NCT04178993|Dopamine Agents|dopamine agents|mesh-ancestor
25005382|NCT04178993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25237186|NCT02551549|Antifungal Agents|antifungal agents|mesh-ancestor
25237187|NCT02551549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25237188|NCT02551523|Dolutegravir|dolutegravir|mesh-list
25237189|NCT02551523|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25237190|NCT02551523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25237191|NCT02551523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25237192|NCT02551523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25673431|NCT01758432|Protease Inhibitors|protease inhibitors|mesh-ancestor
25673432|NCT01758432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25673433|NCT01758432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673434|NCT01758432|Anticoagulants|anticoagulants|mesh-ancestor
25673435|NCT01758523|Dutasteride|dutasteride|mesh-list
25673436|NCT01758523|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25673437|NCT01758523|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25237195|NCT02551523|Antiviral Agents|antiviral agents|mesh-ancestor
25237196|NCT02551523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25237197|NCT02551536|Fexofenadine|fexofenadine|mesh-list
25065232|NCT03451734|Metformin|metformin|mesh-list
25873862|NCT05550337|Dermatologic Agents|dermatologic agents|mesh-ancestor
25873863|NCT05549895|Dexamethasone|dexamethasone|mesh-list
25873864|NCT05549895|Bupivacaine|bupivacaine|mesh-list
25873865|NCT05549895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25873866|NCT05549895|Antiemetics|antiemetics|mesh-ancestor
25873867|NCT05549895|Autonomic Agents|autonomic agents|mesh-ancestor
25873868|NCT05549895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25873869|NCT05549895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873870|NCT05549895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25873871|NCT05549895|Glucocorticoids|glucocorticoids|mesh-ancestor
25873872|NCT05549895|Hormones|hormones|mesh-ancestor
25873873|NCT05549895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25005383|NCT04178993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25005385|NCT04178993|Sensory System Agents|sensory system agents|mesh-ancestor
25005386|NCT04178993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25873874|NCT05549895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25873875|NCT05549895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873876|NCT05549895|Anesthetics, Local|anesthetics, local|mesh-ancestor
25873877|NCT05549895|Anesthetics|anesthetics|mesh-ancestor
25873878|NCT05549895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25873879|NCT05549895|Sensory System Agents|sensory system agents|mesh-ancestor
25873880|NCT05546567|Niacinamide|niacinamide|mesh-list
25873881|NCT05546567|Niacin|niacin|mesh-list
25873882|NCT05546567|Nicotinic Acids|nicotinic acids|mesh-list
25237198|NCT02551536|Montelukast|montelukast|mesh-list
25237199|NCT02551536|Levocetirizine|levocetirizine|mesh-list
25237200|NCT02551536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25237201|NCT02551536|Respiratory System Agents|respiratory system agents|mesh-ancestor
25237202|NCT02551536|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25237203|NCT02551536|Hormone Antagonists|hormone antagonists|mesh-ancestor
25237204|NCT02551536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25237205|NCT02551536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237206|NCT02551536|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25237207|NCT02551536|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25873883|NCT05546567|Vitamin B Complex|vitamin b complex|mesh-ancestor
25873884|NCT05546567|Vitamins|vitamins|mesh-ancestor
25873885|NCT05546567|Micronutrients|micronutrients|mesh-ancestor
25873886|NCT05546567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873887|NCT05546567|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25873888|NCT05546567|Antimetabolites|antimetabolites|mesh-ancestor
25873889|NCT05546567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873890|NCT05546567|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25873891|NCT05546567|Vasodilator Agents|vasodilator agents|mesh-ancestor
25873892|NCT05544110|Paroxetine|paroxetine|mesh-list
25873893|NCT05544110|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25873894|NCT05544110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25873895|NCT05544110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24528670|NCT00622206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528671|NCT00622206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528672|NCT00622206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24528673|NCT00622206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24528674|NCT00622206|Antiviral Agents|antiviral agents|mesh-ancestor
24528675|NCT00622206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25873896|NCT05544110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873897|NCT05544110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25873898|NCT05544110|Serotonin Agents|serotonin agents|mesh-ancestor
25873899|NCT05544110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873900|NCT05544110|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25673438|NCT01758523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25673439|NCT01758523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673440|NCT01758523|Hormone Antagonists|hormone antagonists|mesh-ancestor
25673441|NCT01758523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25673442|NCT01758523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673443|NCT01758588|Interferons|interferons|mesh-list
25873903|NCT05544110|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25873904|NCT05544110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25873906|NCT05543109|Fentanyl|fentanyl|mesh-list
25873907|NCT05543109|Narcotics|narcotics|mesh-list
25005471|NCT03979885|Autonomic Agents|autonomic agents|mesh-ancestor
25873908|NCT05543109|Propofol|propofol|mesh-list
25873909|NCT05543109|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
24528676|NCT00622206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25873910|NCT05543109|Ropivacaine|ropivacaine|mesh-list
25237210|NCT02551536|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25237212|NCT02551536|Histamine Antagonists|histamine antagonists|mesh-ancestor
25237213|NCT02551536|Histamine Agents|histamine agents|mesh-ancestor
25237214|NCT02551536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25237215|NCT02551796|Levofloxacin|levofloxacin|mesh-list
25075981|NCT03376854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528716|NCT00622375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528717|NCT00622375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24528718|NCT00622375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24528719|NCT00622414|Aflibercept|aflibercept|mesh-list
24528720|NCT00622414|Endothelial Growth Factors|endothelial growth factors|mesh-list
24528721|NCT00622414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24528722|NCT00622414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24528723|NCT00622414|Growth Substances|growth substances|mesh-ancestor
24528724|NCT00622414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528725|NCT00622414|Growth Inhibitors|growth inhibitors|mesh-ancestor
24528760|NCT00622648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24528761|NCT00622648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528763|NCT00622674|Bortezomib|bortezomib|mesh-list
24528764|NCT00622674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24528765|NCT00622674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528766|NCT00622687|Iloprost|iloprost|mesh-list
24528767|NCT00622687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24528768|NCT00622687|Vasodilator Agents|vasodilator agents|mesh-ancestor
24528769|NCT00622752|Nicotine|nicotine|mesh-list
24528770|NCT00622752|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24528771|NCT00622752|Autonomic Agents|autonomic agents|mesh-ancestor
24528772|NCT00622752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24528773|NCT00622752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528774|NCT00622752|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24528789|NCT00622817|Autonomic Agents|autonomic agents|mesh-ancestor
24528790|NCT00622817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24528791|NCT00622817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24528792|NCT00622817|Respiratory System Agents|respiratory system agents|mesh-ancestor
24528793|NCT00622817|Mydriatics|mydriatics|mesh-ancestor
24528794|NCT00622817|Sympathomimetics|sympathomimetics|mesh-ancestor
24528795|NCT00622817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24528796|NCT00622817|Nasal Decongestants|nasal decongestants|mesh-ancestor
24528856|NCT00623155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24528858|NCT00623168|Ribavirin|ribavirin|mesh-list
24528859|NCT00623168|Antimetabolites|antimetabolites|mesh-ancestor
24528860|NCT00623168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528864|NCT00623207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24528865|NCT00623207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24528866|NCT00623207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24528867|NCT00623207|Autonomic Agents|autonomic agents|mesh-ancestor
24528868|NCT00623207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24528869|NCT00623207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528870|NCT00623207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24528871|NCT00623207|Respiratory System Agents|respiratory system agents|mesh-ancestor
24528872|NCT00623207|Mydriatics|mydriatics|mesh-ancestor
24528873|NCT00623207|Parasympatholytics|parasympatholytics|mesh-ancestor
24457867|NCT00335465|Insulin Glargine|insulin glargine|mesh-list
24457868|NCT00335465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24457869|NCT00335465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457870|NCT00335543|Gemcitabine|gemcitabine|mesh-list
24528874|NCT00623207|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24528876|NCT00623207|Cholinergic Agents|cholinergic agents|mesh-ancestor
24528877|NCT00623207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24528878|NCT00623207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530000|NCT00628706|Hormones|hormones|mesh-ancestor
25873911|NCT05543109|Anesthetics|anesthetics|mesh-list
25237217|NCT02551796|Tobramycin|tobramycin|mesh-list
25237218|NCT02551796|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
25237219|NCT02551796|Dexamethasone|dexamethasone|mesh-list
25237220|NCT02551796|Dexamethasone acetate|dexamethasone acetate|mesh-list
25237221|NCT02551796|BB 1101|bb 1101|mesh-list
24528923|NCT00623376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24528926|NCT00623402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528927|NCT00623402|Antiviral Agents|antiviral agents|mesh-ancestor
24528928|NCT00623402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24528929|NCT00623402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24528930|NCT00623402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528931|NCT00623402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528932|NCT00623415|Flupirtine|flupirtine|mesh-list
24528933|NCT00623415|Analgesics|analgesics|mesh-ancestor
24528934|NCT00623415|Sensory System Agents|sensory system agents|mesh-ancestor
24529125|NCT00624676|Analgesics|analgesics|mesh-ancestor
24529126|NCT00624676|Sensory System Agents|sensory system agents|mesh-ancestor
24529127|NCT00624676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24529133|NCT00624676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529135|NCT00624702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529136|NCT00624702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529137|NCT00624741|Pergolide|pergolide|mesh-list
24529138|NCT00624741|Dopamine Agonists|dopamine agonists|mesh-ancestor
24529139|NCT00624741|Dopamine Agents|dopamine agents|mesh-ancestor
24529140|NCT00624741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24529169|NCT00624871|Micronutrients|micronutrients|mesh-ancestor
25873912|NCT05543109|Sevoflurane|sevoflurane|mesh-list
25873913|NCT05543109|Anesthetics, Local|anesthetics, local|mesh-list
25873914|NCT05543109|Rocuronium|rocuronium|mesh-list
25873915|NCT05543109|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25873916|NCT05543109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25873917|NCT05543109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873918|NCT05543109|Anesthetics, General|anesthetics, general|mesh-ancestor
24529170|NCT00624871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394229|NCT00132600|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24529200|NCT00625014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24529201|NCT00625014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24529202|NCT00625014|Dopamine Agents|dopamine agents|mesh-ancestor
24529203|NCT00625014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24529204|NCT00625014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529205|NCT00625014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24529206|NCT00625079|Sildenafil Citrate|sildenafil citrate|mesh-list
24529207|NCT00625079|Vasodilator Agents|vasodilator agents|mesh-ancestor
24529208|NCT00625079|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24529209|NCT00625079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24529210|NCT00625079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529211|NCT00625079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529234|NCT00625170|Antiemetics|antiemetics|mesh-ancestor
24529235|NCT00625170|Autonomic Agents|autonomic agents|mesh-ancestor
24529236|NCT00625170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24529278|NCT00625274|Esomeprazole|esomeprazole|mesh-list
24529279|NCT00625274|Pantoprazole|pantoprazole|mesh-list
24529280|NCT00625274|Lansoprazole|lansoprazole|mesh-list
24529281|NCT00625274|Dexlansoprazole|dexlansoprazole|mesh-list
24529282|NCT00625274|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24529283|NCT00625274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24530140|NCT00629226|Bortezomib|bortezomib|mesh-list
24529420|NCT00625898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24529421|NCT00625898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25237223|NCT02551796|Dipivefrin|dipivefrin|mesh-list
25237224|NCT02551796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25237225|NCT02551796|Antiemetics|antiemetics|mesh-ancestor
25237226|NCT02551796|Autonomic Agents|autonomic agents|mesh-ancestor
25237227|NCT02551796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24873592|NCT05129748|Chelating Agents|chelating agents|mesh-ancestor
24457874|NCT00335543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457875|NCT00335543|Antiviral Agents|antiviral agents|mesh-ancestor
24529427|NCT00625911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24529428|NCT00625911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529429|NCT00625911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24529430|NCT00625911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24529431|NCT00625911|Anesthetics, General|anesthetics, general|mesh-ancestor
24529433|NCT00625911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24788388|NCT01931137|Insulin|insulin|mesh-list
24529434|NCT00625911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24791461|NCT04411940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24791462|NCT04411940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24791463|NCT04411940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25873919|NCT05543109|Sensory System Agents|sensory system agents|mesh-ancestor
24529476|NCT00626158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24529477|NCT00626158|Immunologic Factors|immunologic factors|mesh-ancestor
24529478|NCT00626158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529480|NCT00626223|Hematinics|hematinics|mesh-ancestor
24529481|NCT00626223|Vitamin B Complex|vitamin b complex|mesh-ancestor
24529482|NCT00626223|Vitamins|vitamins|mesh-ancestor
24529483|NCT00626223|Micronutrients|micronutrients|mesh-ancestor
24529484|NCT00626223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529485|NCT00626262|Esomeprazole|esomeprazole|mesh-list
24529527|NCT00626600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24752933|NCT01712828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24752934|NCT01712828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25873920|NCT05543109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25873921|NCT05543109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25873922|NCT05543109|Analgesics|analgesics|mesh-ancestor
25873923|NCT05543109|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24529528|NCT00626613|Risperidone|risperidone|mesh-list
24529529|NCT00626613|Galantamine|galantamine|mesh-list
24529530|NCT00626613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24529531|NCT00626613|Serotonin Agents|serotonin agents|mesh-ancestor
24529532|NCT00626613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24529533|NCT00626613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529618|NCT00626990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529619|NCT00626990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24529621|NCT00627003|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24529622|NCT00627003|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24529623|NCT00627003|Dopamine Agonists|dopamine agonists|mesh-ancestor
24529654|NCT00627354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529656|NCT00627354|Antimitotic Agents|antimitotic agents|mesh-ancestor
24529657|NCT00627354|Mitosis Modulators|mitosis modulators|mesh-ancestor
24529658|NCT00627354|Analgesics|analgesics|mesh-ancestor
25237228|NCT02551796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237229|NCT02551796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25237230|NCT02551796|Glucocorticoids|glucocorticoids|mesh-ancestor
25237231|NCT02551796|Hormones|hormones|mesh-ancestor
25237232|NCT02551796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24529659|NCT00627354|Sensory System Agents|sensory system agents|mesh-ancestor
25873924|NCT05543109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24529732|NCT00627666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24529734|NCT00627666|Protective Agents|protective agents|mesh-ancestor
24457878|NCT00335543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24457879|NCT00335543|Immunologic Factors|immunologic factors|mesh-ancestor
24529738|NCT00627666|Alkylating Agents|alkylating agents|mesh-ancestor
24529739|NCT00627666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24529742|NCT00627692|Laxatives|laxatives|mesh-ancestor
24529743|NCT00627692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25873925|NCT05543109|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24529784|NCT00627809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24529785|NCT00627809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529787|NCT00627835|Sorafenib|sorafenib|mesh-list
24529788|NCT00627835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24529789|NCT00627835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24529809|NCT00627887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24529810|NCT00627887|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24529812|NCT00627900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24529813|NCT00627900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24529814|NCT00627900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24529815|NCT00627900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673444|NCT01758588|Interferon-alpha|interferon-alpha|mesh-list
25673445|NCT01758588|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25673446|NCT01758588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673447|NCT01758588|Antiviral Agents|antiviral agents|mesh-ancestor
25673448|NCT01758588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25673449|NCT01758588|Immunologic Factors|immunologic factors|mesh-ancestor
25674580|NCT01774149|GABA Agents|gaba agents|mesh-ancestor
25873926|NCT05543109|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24965999|NCT03772223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24529816|NCT00627900|Antifungal Agents|antifungal agents|mesh-ancestor
24529817|NCT00627900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24529818|NCT00627900|Immunologic Factors|immunologic factors|mesh-ancestor
24529819|NCT00627900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529820|NCT00627913|Anesthetics|anesthetics|mesh-list
24529821|NCT00627913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25005426|NCT04107727|Cytarabine|cytarabine|mesh-list
24788389|NCT01931137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24788390|NCT01931137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788393|NCT01931189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24788394|NCT01931189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24788395|NCT01931215|Clonidine|clonidine|mesh-list
24788396|NCT01931215|Morphine|morphine|mesh-list
25005427|NCT04107727|Idarubicin|idarubicin|mesh-list
25005428|NCT04107727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25005429|NCT04107727|Antimetabolites|antimetabolites|mesh-ancestor
25873927|NCT05543109|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24842545|NCT02221635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25873928|NCT05543109|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25873929|NCT05538910|Mecamylamine|mecamylamine|mesh-list
25005434|NCT04107727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25005435|NCT04107727|Immunologic Factors|immunologic factors|mesh-ancestor
25005436|NCT04107727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005446|NCT04107077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005447|NCT04107077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25005449|NCT04065074|FX006|fx006|mesh-list
25005450|NCT04065074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25005451|NCT04065074|Glucocorticoids|glucocorticoids|mesh-ancestor
25005452|NCT04065074|Hormones|hormones|mesh-ancestor
25005453|NCT04065074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25237233|NCT02551796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25237234|NCT02551796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25237235|NCT02551796|Protease Inhibitors|protease inhibitors|mesh-ancestor
25237236|NCT02551796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237237|NCT02551796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237238|NCT02551796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25237239|NCT02551796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25873930|NCT05538910|Nicotine|nicotine|mesh-list
25873931|NCT05538910|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25873932|NCT05538910|Autonomic Agents|autonomic agents|mesh-ancestor
25873933|NCT05538910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25005454|NCT04065074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005455|NCT04065074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25005456|NCT04065074|Immunologic Factors|immunologic factors|mesh-ancestor
24753032|NCT01713387|Gemcitabine|gemcitabine|mesh-list
25873934|NCT05538910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005464|NCT03997097|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25005465|NCT03997097|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25005466|NCT03997097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25005467|NCT03997097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005468|NCT03997097|Urological Agents|urological agents|mesh-ancestor
25005469|NCT03979885|Nicotine|nicotine|mesh-list
25005470|NCT03979885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25005475|NCT03979885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25005476|NCT03979885|Cholinergic Agents|cholinergic agents|mesh-ancestor
25005477|NCT03979885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25005478|NCT03979885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109667|NCT03122353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25109668|NCT03122353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109669|NCT03122353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25109670|NCT03122353|Respiratory System Agents|respiratory system agents|mesh-ancestor
25109671|NCT03122353|Dermatologic Agents|dermatologic agents|mesh-ancestor
25109672|NCT03122353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25109673|NCT03122353|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25109674|NCT03122353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25673450|NCT01758588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673451|NCT01758731|Cetuximab|cetuximab|mesh-list
25673452|NCT01758731|Olaparib|olaparib|mesh-list
25673453|NCT01758731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25079224|NCT03349346|Immunologic Factors|immunologic factors|mesh-ancestor
25079225|NCT03349346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079226|NCT03349346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24965196|NCT03778281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25079227|NCT03349346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25079228|NCT03349346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25079229|NCT03349346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25109678|NCT03122353|Micronutrients|micronutrients|mesh-ancestor
24529822|NCT00627913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529824|NCT00627952|Manidipine|manidipine|mesh-list
24529825|NCT00627952|Delapril|delapril|mesh-list
24529863|NCT00628121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24529864|NCT00628160|Terlipressin|terlipressin|mesh-list
24529865|NCT00628160|Dopamine|dopamine|mesh-list
24529866|NCT00628160|Norepinephrine|norepinephrine|mesh-list
24529867|NCT00628160|Adrenergic Agents|adrenergic agents|mesh-list
24529868|NCT00628160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24529869|NCT00628160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24529870|NCT00628160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25237240|NCT02551796|Renal Agents|renal agents|mesh-ancestor
25237241|NCT02551796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24530255|NCT00629616|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25237242|NCT02551796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25237243|NCT02551796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25237244|NCT02551796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25237245|NCT02551796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25237246|NCT02551796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25237247|NCT02551796|Immunologic Factors|immunologic factors|mesh-ancestor
25237248|NCT02551796|Viscosupplements|viscosupplements|mesh-ancestor
25237249|NCT02551796|Protective Agents|protective agents|mesh-ancestor
25237250|NCT02551796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24529890|NCT00628225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24529891|NCT00628225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529949|NCT00628550|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24529950|NCT00628550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24529951|NCT00628550|Adrenergic Agents|adrenergic agents|mesh-ancestor
24529952|NCT00628550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24529953|NCT00628550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529954|NCT00628550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873935|NCT05538910|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24529967|NCT00628550|Natriuretic Agents|natriuretic agents|mesh-ancestor
24529968|NCT00628576|Heparin|heparin|mesh-list
24529969|NCT00628576|Calcium heparin|calcium heparin|mesh-list
24529970|NCT00628576|Tinzaparin|tinzaparin|mesh-list
24529971|NCT00628576|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24529973|NCT00628576|Anticoagulants|anticoagulants|mesh-ancestor
24529974|NCT00628576|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24529975|NCT00628576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24529976|NCT00628576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529977|NCT00628667|Esomeprazole|esomeprazole|mesh-list
24529978|NCT00628667|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24529979|NCT00628667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24529980|NCT00628667|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24529981|NCT00628667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400479|NCT00150657|Gemcitabine|gemcitabine|mesh-list
24530019|NCT00628732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24530020|NCT00628732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24530021|NCT00628732|Alkylating Agents|alkylating agents|mesh-ancestor
24530022|NCT00628732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530023|NCT00628732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530024|NCT00628732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24530531|NCT00630903|Dermatologic Agents|dermatologic agents|mesh-ancestor
24530061|NCT00628914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464538|NCT00365313|Sensory System Agents|sensory system agents|mesh-ancestor
24464539|NCT00365313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24530064|NCT00628914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673454|NCT01758731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673455|NCT01758731|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25673456|NCT01758731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25673457|NCT01758731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673458|NCT01759277|Anesthetics|anesthetics|mesh-list
25673459|NCT01759277|Anesthetics, Local|anesthetics, local|mesh-list
25673460|NCT01759277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24530129|NCT00629200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24530130|NCT00629200|Schistosomicides|schistosomicides|mesh-ancestor
24530131|NCT00629200|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24530132|NCT00629200|Anthelmintics|anthelmintics|mesh-ancestor
25005479|NCT03970200|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24530134|NCT00629213|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24530135|NCT00629213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530136|NCT00629213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530137|NCT00629213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24530138|NCT00629213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530139|NCT00629226|Cetuximab|cetuximab|mesh-list
24530175|NCT00629278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24530177|NCT00629278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24530178|NCT00629278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24530179|NCT00629278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24530180|NCT00629278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24530503|NCT00630695|Hormones|hormones|mesh-ancestor
24530250|NCT00629616|Fulvestrant|fulvestrant|mesh-list
24530251|NCT00629616|Anastrozole|anastrozole|mesh-list
25237251|NCT02551796|Adrenergic Agents|adrenergic agents|mesh-ancestor
25237252|NCT02551796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24530252|NCT00629616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24530253|NCT00629616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530254|NCT00629616|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24530256|NCT00629616|Hormone Antagonists|hormone antagonists|mesh-ancestor
24530257|NCT00629616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24530258|NCT00629616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530283|NCT00629681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530284|NCT00629681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24530285|NCT00629681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24530286|NCT00629681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24530287|NCT00629681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24530290|NCT00629720|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24530291|NCT00629720|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24530367|NCT00630019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530368|NCT00630019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530369|NCT00630019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24530370|NCT00630019|Contraceptive Agents|contraceptive agents|mesh-ancestor
24530371|NCT00630019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24530372|NCT00630019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530373|NCT00630019|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24530452|NCT00630383|Histamine Agonists|histamine agonists|mesh-ancestor
24530453|NCT00630383|Histamine Agents|histamine agents|mesh-ancestor
24530454|NCT00630383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24530455|NCT00630383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530456|NCT00630383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530457|NCT00630435|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24530458|NCT00630435|Estrogens|estrogens|mesh-ancestor
24530460|NCT00630435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24530626|NCT00631514|Antipyretics|antipyretics|mesh-ancestor
24530500|NCT00630695|Lanreotide|lanreotide|mesh-list
24530501|NCT00630695|Somatostatin|somatostatin|mesh-list
25873936|NCT05538910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24530527|NCT00630890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530528|NCT00630890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530529|NCT00630903|Methoxsalen|methoxsalen|mesh-list
24530530|NCT00630903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24530534|NCT00630929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24530535|NCT00630929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24530536|NCT00630929|Analgesics|analgesics|mesh-ancestor
24530537|NCT00630929|Sensory System Agents|sensory system agents|mesh-ancestor
24530538|NCT00630929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24530539|NCT00630929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530540|NCT00630929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24530541|NCT00630929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24788459|NCT01931501|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24788460|NCT01931501|Hormone Antagonists|hormone antagonists|mesh-ancestor
25409932|NCT03337698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24761244|NCT01761916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24761245|NCT01761916|Sympatholytics|sympatholytics|mesh-ancestor
24761246|NCT01761916|Autonomic Agents|autonomic agents|mesh-ancestor
24620106|NCT01055418|Protective Agents|protective agents|mesh-ancestor
24620108|NCT01055431|Trace Elements|trace elements|mesh-ancestor
24620109|NCT01055431|Micronutrients|micronutrients|mesh-ancestor
24788461|NCT01931501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24788462|NCT01931501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788463|NCT01931501|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24788464|NCT01931501|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24788465|NCT01931501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788467|NCT01931514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24788468|NCT01931514|Respiratory System Agents|respiratory system agents|mesh-ancestor
24788469|NCT01931514|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24788470|NCT01931514|Hormone Antagonists|hormone antagonists|mesh-ancestor
24788491|NCT01931657|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24788492|NCT01931657|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24788493|NCT01931657|Contraceptive Agents|contraceptive agents|mesh-ancestor
24788494|NCT01931657|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24788495|NCT01931657|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25237253|NCT02551796|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25237254|NCT02551796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24788496|NCT01931657|Hormone Antagonists|hormone antagonists|mesh-ancestor
24788497|NCT01931657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24788498|NCT01931657|Luteolytic Agents|luteolytic agents|mesh-ancestor
24788499|NCT01931657|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24788500|NCT01931657|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24966361|NCT03768882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24966362|NCT03768882|Analgesics|analgesics|mesh-ancestor
24966363|NCT03768882|Sensory System Agents|sensory system agents|mesh-ancestor
24780374|NCT01884272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24966390|NCT03768609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24966391|NCT03768609|Dermatologic Agents|dermatologic agents|mesh-ancestor
24966392|NCT03768609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24966393|NCT03768609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24966394|NCT03768557|Minocycline|minocycline|mesh-list
24966395|NCT03768557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24966396|NCT03768557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24966397|NCT03768531|Nivolumab|nivolumab|mesh-list
24966398|NCT03768531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24966399|NCT03768531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24966400|NCT03768531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24788502|NCT01931683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24530542|NCT00630929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25873937|NCT05538910|Cholinergic Agents|cholinergic agents|mesh-ancestor
24530619|NCT00631514|Ibuprofen|ibuprofen|mesh-list
24530620|NCT00631514|Piroxicam|piroxicam|mesh-list
24530624|NCT00631514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24530658|NCT00631592|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24530659|NCT00631592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530660|NCT00631592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530661|NCT00631592|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25005480|NCT03970200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25005481|NCT03951961|Midostaurin|midostaurin|mesh-list
25005482|NCT03951961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005483|NCT03951961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25005484|NCT03951961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25005485|NCT03951961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005486|NCT03947216|Pimavanserin|pimavanserin|mesh-list
25005487|NCT03947216|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25005488|NCT03947216|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25005489|NCT03947216|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25005490|NCT03947216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25005491|NCT03947216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25005492|NCT03947216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673461|NCT01759277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673462|NCT01759277|Sensory System Agents|sensory system agents|mesh-ancestor
25673463|NCT01759277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25673464|NCT01759407|Epinephrine|epinephrine|mesh-list
25673465|NCT01759407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25673466|NCT01759407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25673467|NCT01759407|Adrenergic Agents|adrenergic agents|mesh-ancestor
25005495|NCT03947216|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25005497|NCT03947216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25005498|NCT03947216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005507|NCT03939520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25005508|NCT03939520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530741|NCT00632216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24530754|NCT00632268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530755|NCT00632268|Antidotes|antidotes|mesh-ancestor
24530756|NCT00632268|Protective Agents|protective agents|mesh-ancestor
24530757|NCT00632268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530758|NCT00632268|Vitamin B Complex|vitamin b complex|mesh-ancestor
24530759|NCT00632268|Vitamins|vitamins|mesh-ancestor
24530760|NCT00632268|Micronutrients|micronutrients|mesh-ancestor
24530761|NCT00632268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24530762|NCT00632268|Immunologic Factors|immunologic factors|mesh-ancestor
24530763|NCT00632333|Fluorouracil|fluorouracil|mesh-list
24530764|NCT00632333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530765|NCT00632333|Antimetabolites|antimetabolites|mesh-ancestor
24530766|NCT00632333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530767|NCT00632333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24530768|NCT00632333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24530769|NCT00632333|Immunologic Factors|immunologic factors|mesh-ancestor
24530770|NCT00632333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530775|NCT00632385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530776|NCT00632385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530777|NCT00632476|Ascorbic Acid|ascorbic acid|mesh-list
24530779|NCT00632476|Micronutrients|micronutrients|mesh-ancestor
24530780|NCT00632476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530781|NCT00632476|Antioxidants|antioxidants|mesh-ancestor
24530805|NCT00632580|Anesthetics, Local|anesthetics, local|mesh-ancestor
25873938|NCT05538910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25873939|NCT05538910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237255|NCT02551276|Albuterol|albuterol|mesh-list
25237256|NCT02551276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25237257|NCT02551276|Autonomic Agents|autonomic agents|mesh-ancestor
25237258|NCT02551276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25237259|NCT02551276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530839|NCT00632645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25237323|NCT02551107|Protective Agents|protective agents|mesh-ancestor
24530840|NCT00632645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530841|NCT00632645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24530842|NCT00632645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24530879|NCT00632762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530908|NCT00633035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530910|NCT00633035|Histamine Antagonists|histamine antagonists|mesh-ancestor
24530911|NCT00633035|Histamine Agents|histamine agents|mesh-ancestor
24530912|NCT00633035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24530913|NCT00633035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530914|NCT00633269|Olaparib|olaparib|mesh-list
24530964|NCT00633412|Esomeprazole|esomeprazole|mesh-list
24464722|NCT00366262|Naproxen|naproxen|mesh-list
24530993|NCT00633438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24457895|NCT00335621|Tiotropium Bromide|tiotropium bromide|mesh-list
24457896|NCT00335621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24457897|NCT00335621|Autonomic Agents|autonomic agents|mesh-ancestor
24457898|NCT00335621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24530996|NCT00633490|Apatinib|apatinib|mesh-list
24531240|NCT00634634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24531241|NCT00634634|Hormone Antagonists|hormone antagonists|mesh-ancestor
24531242|NCT00634634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24531243|NCT00634634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531278|NCT00634790|GABA Agents|gaba agents|mesh-ancestor
24531279|NCT00634790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24531280|NCT00634790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531315|NCT00634998|Protective Agents|protective agents|mesh-ancestor
24531316|NCT00635037|Bupivacaine|bupivacaine|mesh-list
24531317|NCT00635037|Anesthetics, Local|anesthetics, local|mesh-ancestor
24531318|NCT00635037|Anesthetics|anesthetics|mesh-ancestor
24531319|NCT00635037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24531352|NCT00635284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24531545|NCT00636311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531547|NCT00636311|Antiviral Agents|antiviral agents|mesh-ancestor
24531548|NCT00636311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24531549|NCT00636311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24531550|NCT00636311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24531551|NCT00636311|Immunologic Factors|immunologic factors|mesh-ancestor
24531552|NCT00636311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531582|NCT00636493|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
24531675|NCT00636909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24531676|NCT00636909|Alkylating Agents|alkylating agents|mesh-ancestor
24531677|NCT00636909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531678|NCT00636909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531679|NCT00636909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24531680|NCT00636909|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24531681|NCT00636909|Abortifacient Agents|abortifacient agents|mesh-ancestor
24531751|NCT00637078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24531842|NCT00637442|Cholinergic Agents|cholinergic agents|mesh-ancestor
24531843|NCT00637442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25873940|NCT05538910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24531915|NCT00637585|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24531916|NCT00637585|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24531917|NCT00637585|Histamine Antagonists|histamine antagonists|mesh-ancestor
24531918|NCT00637585|Histamine Agents|histamine agents|mesh-ancestor
24531919|NCT00637585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24531920|NCT00637585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531921|NCT00637585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237260|NCT02551276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25043787|NCT01204749|Paclitaxel|paclitaxel|mesh-list
25237261|NCT02551276|Respiratory System Agents|respiratory system agents|mesh-ancestor
25237262|NCT02551276|Tocolytic Agents|tocolytic agents|mesh-ancestor
25237263|NCT02551276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25237264|NCT02551276|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25237265|NCT02551276|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24531923|NCT00637611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24531924|NCT00637611|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24532032|NCT00637884|Histamine Antagonists|histamine antagonists|mesh-ancestor
24532034|NCT00637884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24532035|NCT00637884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532036|NCT00637884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532039|NCT00637897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24532040|NCT00637897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24532041|NCT00637897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24532042|NCT00637897|Tubulin Modulators|tubulin modulators|mesh-ancestor
24532043|NCT00637897|Antimitotic Agents|antimitotic agents|mesh-ancestor
24532044|NCT00637897|Mitosis Modulators|mitosis modulators|mesh-ancestor
24532045|NCT00637897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532047|NCT00637910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24532048|NCT00637910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24532049|NCT00637910|Tubulin Modulators|tubulin modulators|mesh-ancestor
24532050|NCT00637910|Antimitotic Agents|antimitotic agents|mesh-ancestor
24532051|NCT00637910|Mitosis Modulators|mitosis modulators|mesh-ancestor
24966458|NCT03767920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966459|NCT03767920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24532052|NCT00637910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005509|NCT03939520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24788508|NCT01931683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24788510|NCT01931787|Antioxidants|antioxidants|mesh-ancestor
24788511|NCT01931787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788512|NCT01931787|Protective Agents|protective agents|mesh-ancestor
24646055|NCT01201642|Prednisolone|prednisolone|mesh-list
24788513|NCT01931787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788514|NCT01931787|Vitamin B Complex|vitamin b complex|mesh-ancestor
24788515|NCT01931787|Vitamins|vitamins|mesh-ancestor
24788516|NCT01931787|Micronutrients|micronutrients|mesh-ancestor
24788517|NCT01931982|Liraglutide|liraglutide|mesh-list
24788518|NCT01931982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24762599|NCT01768780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788519|NCT01931982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788520|NCT01931982|Incretins|incretins|mesh-ancestor
24788521|NCT01931982|Hormones|hormones|mesh-ancestor
24457905|NCT00335621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24457906|NCT00335621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237266|NCT02551276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25237267|NCT02551276|Adrenergic Agents|adrenergic agents|mesh-ancestor
25237268|NCT02551276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25237269|NCT02551276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237270|NCT02551367|Letrozole|letrozole|mesh-list
25237271|NCT02551367|Clomiphene|clomiphene|mesh-list
25237272|NCT02551367|Enclomiphene|enclomiphene|mesh-list
25237273|NCT02551367|Zuclomiphene|zuclomiphene|mesh-list
25237274|NCT02551367|Hormones|hormones|mesh-list
25237275|NCT02551367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532204|NCT00638560|Antioxidants|antioxidants|mesh-list
24532205|NCT00638560|Micronutrients|micronutrients|mesh-ancestor
24532206|NCT00638560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532207|NCT00638560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532208|NCT00638560|Protective Agents|protective agents|mesh-ancestor
24532209|NCT00638612|Valacyclovir|valacyclovir|mesh-list
24532210|NCT00638612|Antiviral Agents|antiviral agents|mesh-ancestor
24532211|NCT00638612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24532212|NCT00638638|Abciximab|abciximab|mesh-list
24532305|NCT00639249|SA 4503|sa 4503|mesh-list
24532306|NCT00639249|Nootropic Agents|nootropic agents|mesh-ancestor
24532307|NCT00639262|Temozolomide|temozolomide|mesh-list
24532308|NCT00639262|Sorafenib|sorafenib|mesh-list
24753401|NCT01715168|Doxorubicin|doxorubicin|mesh-list
25873941|NCT05538910|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
25873942|NCT05538910|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25873943|NCT05538910|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24966481|NCT03767569|Folic Acid|folic acid|mesh-list
25873944|NCT05536349|Valacyclovir|valacyclovir|mesh-list
25873945|NCT05536349|Venetoclax|venetoclax|mesh-list
25873946|NCT05536349|Obinutuzumab|obinutuzumab|mesh-list
24532309|NCT00639262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24532572|NCT00640471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24532574|NCT00640549|Atorvastatin|atorvastatin|mesh-list
25005510|NCT03939520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25005511|NCT03939520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25005512|NCT03939520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25005513|NCT03920306|Silver Nitrate|silver nitrate|mesh-list
25005514|NCT03920306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25005515|NCT03920306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25005516|NCT03906708|Carbon Monoxide|carbon monoxide|mesh-list
25005517|NCT03906708|Antimetabolites|antimetabolites|mesh-ancestor
24532578|NCT00640549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532579|NCT00640549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24532580|NCT00640549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24532987|NCT00641927|Antimanic Agents|antimanic agents|mesh-ancestor
24532988|NCT00641927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24533055|NCT00642135|Nasal Decongestants|nasal decongestants|mesh-ancestor
24533056|NCT00642135|Respiratory System Agents|respiratory system agents|mesh-ancestor
24533057|NCT00642135|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24533058|NCT00642135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24533059|NCT00642135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24457929|NCT00335686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533155|NCT00642499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24533156|NCT00642499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24533157|NCT00642499|Analgesics|analgesics|mesh-ancestor
24533158|NCT00642499|Sensory System Agents|sensory system agents|mesh-ancestor
24533159|NCT00642499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24533160|NCT00642499|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24533161|NCT00642499|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24533162|NCT00642499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24533225|NCT00642577|Vitamins|vitamins|mesh-ancestor
25873947|NCT05536349|Allopurinol|allopurinol|mesh-list
25873948|NCT05536349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873949|NCT05536349|Antimetabolites|antimetabolites|mesh-ancestor
25873950|NCT05536349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873951|NCT05536349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25673470|NCT01759407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873952|NCT05536349|Gout Suppressants|gout suppressants|mesh-ancestor
25873953|NCT05536349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25873954|NCT05536349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25873955|NCT05536349|Antioxidants|antioxidants|mesh-ancestor
25873956|NCT05536349|Protective Agents|protective agents|mesh-ancestor
25873957|NCT05536349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873958|NCT05536349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25873959|NCT05536349|Antiviral Agents|antiviral agents|mesh-ancestor
25873960|NCT05536349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25873962|NCT05533164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25873963|NCT05533164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873964|NCT05533164|Immunologic Factors|immunologic factors|mesh-ancestor
25873965|NCT05533164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873966|NCT05533164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25873967|NCT05528848|Fentanyl|fentanyl|mesh-list
25873968|NCT05528848|Carfentanil|carfentanil|mesh-list
25873969|NCT05528848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25873970|NCT05528848|Narcotics|narcotics|mesh-ancestor
25873971|NCT05528848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25873972|NCT05528848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25873973|NCT05528848|Analgesics|analgesics|mesh-ancestor
25873974|NCT05528848|Sensory System Agents|sensory system agents|mesh-ancestor
25237280|NCT02551367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25237281|NCT02551367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237282|NCT02551367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25237283|NCT02551367|Hormone Antagonists|hormone antagonists|mesh-ancestor
25237284|NCT02551367|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25237285|NCT02551367|Fertility Agents|fertility agents|mesh-ancestor
25237286|NCT02551367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25237287|NCT02551367|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25237288|NCT02551367|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25873975|NCT05528848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24531602|NCT00636766|Metformin|metformin|mesh-list
25873976|NCT05528848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25873977|NCT05528848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25873978|NCT05528848|Anesthetics, General|anesthetics, general|mesh-ancestor
25873979|NCT05528848|Anesthetics|anesthetics|mesh-ancestor
25005537|NCT03847519|Pembrolizumab|pembrolizumab|mesh-list
25005538|NCT03847519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25005539|NCT03847519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005542|NCT03793010|Glucocorticoids|glucocorticoids|mesh-ancestor
25005544|NCT03793010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25005545|NCT03793010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966541|NCT03767296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24966542|NCT03767218|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24966544|NCT03767218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24966545|NCT03767218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966546|NCT03767075|Atezolizumab|atezolizumab|mesh-list
24966547|NCT03767075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24966548|NCT03767036|Ketorolac|ketorolac|mesh-list
25005546|NCT03793010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25237289|NCT02551042|Factor VIII|factor viii|mesh-list
25237290|NCT02551042|Coagulants|coagulants|mesh-ancestor
25237291|NCT02551029|Capsaicin|capsaicin|mesh-list
25237292|NCT02551029|Antipruritics|antipruritics|mesh-ancestor
25237293|NCT02551029|Dermatologic Agents|dermatologic agents|mesh-ancestor
25237294|NCT02551029|Sensory System Agents|sensory system agents|mesh-ancestor
25237295|NCT02551029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25237296|NCT02551029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237297|NCT02550977|Gestodene|gestodene|mesh-list
24402032|NCT00154687|Paclitaxel|paclitaxel|mesh-list
25873980|NCT05522673|Rolipram|rolipram|mesh-list
25873981|NCT05522673|Antidepressive Agents|antidepressive agents|mesh-ancestor
25873982|NCT05522673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25873983|NCT05522673|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25873984|NCT05522673|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25873985|NCT05522673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25873986|NCT05522673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873987|NCT05519917|Afatinib|afatinib|mesh-list
25873988|NCT05519917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873989|NCT05519917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25873990|NCT05519917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25873991|NCT05519917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25873992|NCT05517278|Anti-Infective Agents|anti-infective agents|mesh-list
24753553|NCT01715922|Antimetabolites|antimetabolites|mesh-ancestor
25873993|NCT05517278|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25873994|NCT05516628|Bevacizumab|bevacizumab|mesh-list
25873995|NCT05516628|Atezolizumab|atezolizumab|mesh-list
25237299|NCT02550977|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25237300|NCT02550977|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25237301|NCT02550977|Contraceptive Agents|contraceptive agents|mesh-ancestor
25237302|NCT02550977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25237303|NCT02550977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237304|NCT02550977|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25237305|NCT02550977|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25237306|NCT02550977|Progestins|progestins|mesh-ancestor
25873997|NCT05516628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25873998|NCT05516628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25873999|NCT05516628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25874000|NCT05516628|Growth Substances|growth substances|mesh-ancestor
25874001|NCT05516628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874002|NCT05516628|Growth Inhibitors|growth inhibitors|mesh-ancestor
25874003|NCT05514444|Pembrolizumab|pembrolizumab|mesh-list
25874004|NCT05514444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24457991|NCT00336154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24457992|NCT00336154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24457993|NCT00336154|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24457994|NCT00336154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457995|NCT00336154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874005|NCT05514444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874006|NCT05513586|Immunoglobulins|immunoglobulins|mesh-list
24457997|NCT00336167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24457998|NCT00336167|Antimetabolites|antimetabolites|mesh-ancestor
24457999|NCT00336167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458000|NCT00336167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24458001|NCT00336206|Alemtuzumab|alemtuzumab|mesh-list
24458002|NCT00336206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25227642|NCT02613026|Antimitotic Agents|antimitotic agents|mesh-ancestor
24458003|NCT00336206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25237308|NCT02550977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25237309|NCT02551107|Nitric Oxide|nitric oxide|mesh-list
25874007|NCT05513586|Immunologic Factors|immunologic factors|mesh-ancestor
25874008|NCT05513586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449808|NCT00317070|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24449809|NCT00317070|Protective Agents|protective agents|mesh-ancestor
25874010|NCT05497336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25874011|NCT05497336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874012|NCT05473520|Doxycycline|doxycycline|mesh-list
25874013|NCT05473520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24532273|NCT00638859|Telithromycin|telithromycin|mesh-list
25237316|NCT02551107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25237317|NCT02551107|Antioxidants|antioxidants|mesh-ancestor
25237318|NCT02551107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237319|NCT02551107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25237320|NCT02551107|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25237321|NCT02551107|Vasodilator Agents|vasodilator agents|mesh-ancestor
25237322|NCT02551107|Gasotransmitters|gasotransmitters|mesh-ancestor
25874014|NCT05473520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25874015|NCT05473520|Antimalarials|antimalarials|mesh-ancestor
24458067|NCT00336414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24458068|NCT00336414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24458069|NCT00336414|Alkylating Agents|alkylating agents|mesh-ancestor
24458070|NCT00336414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487147|NCT00461747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24458071|NCT00336414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458072|NCT00336414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24458073|NCT00336414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24458074|NCT00336414|Glucocorticoids|glucocorticoids|mesh-ancestor
24532429|NCT00639938|Nevirapine|nevirapine|mesh-list
25874016|NCT05473520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25874017|NCT05473520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25874018|NCT05470491|Maraviroc|maraviroc|mesh-list
25874019|NCT05470491|Plerixafor|plerixafor|mesh-list
25874020|NCT05470491|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25874021|NCT05470491|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24458100|NCT00336531|Hormone Antagonists|hormone antagonists|mesh-ancestor
24458101|NCT00336531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24458102|NCT00336531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458103|NCT00336531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24458104|NCT00336648|Gemcitabine|gemcitabine|mesh-list
24458105|NCT00336648|Bevacizumab|bevacizumab|mesh-list
24458106|NCT00336648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24458107|NCT00336648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458108|NCT00336648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25874022|NCT05470491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874023|NCT05470491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24458115|NCT00336648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237324|NCT02551133|Dexamethasone|dexamethasone|mesh-list
25237325|NCT02551133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25237326|NCT02551133|Antiemetics|antiemetics|mesh-ancestor
25237327|NCT02551133|Autonomic Agents|autonomic agents|mesh-ancestor
25237328|NCT02551133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25237329|NCT02551133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237330|NCT02551133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25237331|NCT02551133|Glucocorticoids|glucocorticoids|mesh-ancestor
25237332|NCT02551133|Hormones|hormones|mesh-ancestor
25237333|NCT02551133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25874024|NCT05470491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25874025|NCT05470491|Antiviral Agents|antiviral agents|mesh-ancestor
25874026|NCT05470491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25079134|NCT03350191|Hormones|hormones|mesh-ancestor
25079180|NCT03349658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25079181|NCT03349658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458151|NCT00336791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24458152|NCT00336791|Alkylating Agents|alkylating agents|mesh-ancestor
24753719|NCT01717222|Anesthetics|anesthetics|mesh-ancestor
24753722|NCT01717222|Sensory System Agents|sensory system agents|mesh-ancestor
25874027|NCT05470491|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25874028|NCT05468619|Valacyclovir|valacyclovir|mesh-list
25874029|NCT05468619|Antiviral Agents|antiviral agents|mesh-ancestor
25874030|NCT05468619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25874031|NCT05442515|Cyclophosphamide|cyclophosphamide|mesh-list
25874032|NCT05442515|Fludarabine|fludarabine|mesh-list
25237334|NCT02551133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25237335|NCT02551133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25237336|NCT02550912|Vitamin D|vitamin d|mesh-list
25237337|NCT02550912|Ergocalciferols|ergocalciferols|mesh-list
25237338|NCT02550912|Cholecalciferol|cholecalciferol|mesh-list
25237339|NCT02550912|Vitamins|vitamins|mesh-list
25237340|NCT02550912|Micronutrients|micronutrients|mesh-ancestor
25237341|NCT02550912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237342|NCT02550912|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25237343|NCT02550912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25874033|NCT05442515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25874034|NCT05442515|Immunologic Factors|immunologic factors|mesh-ancestor
25874035|NCT05442515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874036|NCT05442515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25874037|NCT05442515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25874038|NCT05442515|Alkylating Agents|alkylating agents|mesh-ancestor
25874039|NCT05442515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874040|NCT05442515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874041|NCT05442515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25874042|NCT05439616|Cariprazine|cariprazine|mesh-list
25874043|NCT05439616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25874044|NCT05439616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25874045|NCT05439616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25874046|NCT05439616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753747|NCT01717404|Mexiletine|mexiletine|mesh-list
25874047|NCT05439616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25874048|NCT05436418|Sirolimus|sirolimus|mesh-list
25874049|NCT05436418|Cyclophosphamide|cyclophosphamide|mesh-list
24458178|NCT00336921|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24458179|NCT00336921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24458180|NCT00336921|Adrenergic Agents|adrenergic agents|mesh-ancestor
25874050|NCT05436418|Melphalan|melphalan|mesh-list
25874051|NCT05436418|Fludarabine|fludarabine|mesh-list
25874052|NCT05436418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25874053|NCT05436418|Immunologic Factors|immunologic factors|mesh-ancestor
25874054|NCT05436418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874055|NCT05436418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25874056|NCT05436418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25874057|NCT05436418|Alkylating Agents|alkylating agents|mesh-ancestor
25874058|NCT05436418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887445|NCT04516174|Ropivacaine|ropivacaine|mesh-list
24887525|NCT04515732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24887526|NCT04515732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24763471|NCT01773837|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24763472|NCT01773837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24763473|NCT01773837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24763474|NCT01773837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763476|NCT01773837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24966097|NCT03771768|Immunologic Factors|immunologic factors|mesh-ancestor
25874059|NCT05436418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874060|NCT05436418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25874061|NCT05436418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25874062|NCT05436418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25874063|NCT05436418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25874064|NCT05436418|Antifungal Agents|antifungal agents|mesh-ancestor
25874065|NCT05419050|Denosumab|denosumab|mesh-list
25874066|NCT05419050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25874067|NCT05419050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874068|NCT05417425|Lidocaine|lidocaine|mesh-list
25874069|NCT05417425|Protective Agents|protective agents|mesh-list
25237344|NCT02550782|Dexmedetomidine|dexmedetomidine|mesh-list
25237345|NCT02550782|Bupivacaine|bupivacaine|mesh-list
25237346|NCT02550782|Anesthetics, Local|anesthetics, local|mesh-ancestor
25237347|NCT02550782|Anesthetics|anesthetics|mesh-ancestor
25237348|NCT02550782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25273380|NCT02385539|Levobupivacaine|levobupivacaine|mesh-list
25237349|NCT02550782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237350|NCT02550782|Sensory System Agents|sensory system agents|mesh-ancestor
25237351|NCT02550782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25237352|NCT02550782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25237353|NCT02550782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25237354|NCT02550782|Analgesics|analgesics|mesh-ancestor
24966620|NCT03766867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25237355|NCT02550782|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24458190|NCT00336960|Celecoxib|celecoxib|mesh-list
24458191|NCT00336960|Fluorouracil|fluorouracil|mesh-list
24458192|NCT00336960|Antimetabolites|antimetabolites|mesh-ancestor
25874070|NCT05417425|Anesthetics, Local|anesthetics, local|mesh-ancestor
25874071|NCT05417425|Anesthetics|anesthetics|mesh-ancestor
24533033|NCT00642122|Budesonide|budesonide|mesh-list
25874072|NCT05417425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25874073|NCT05417425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874074|NCT05417425|Sensory System Agents|sensory system agents|mesh-ancestor
25874075|NCT05417425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25874076|NCT05417425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25874077|NCT05417425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25874078|NCT05417425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25874079|NCT05417425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25874080|NCT05417425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005578|NCT03501940|Cariostatic Agents|cariostatic agents|mesh-ancestor
25874081|NCT05413304|Temozolomide|temozolomide|mesh-list
25874082|NCT05413304|Dialysis Solutions|dialysis solutions|mesh-list
25874083|NCT05413304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25874084|NCT05413304|Alkylating Agents|alkylating agents|mesh-ancestor
25874085|NCT05413304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874086|NCT05413304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874087|NCT05413304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25673471|NCT01759407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25673472|NCT01759407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25673473|NCT01759407|Autonomic Agents|autonomic agents|mesh-ancestor
25673474|NCT01759407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25673475|NCT01759407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25673476|NCT01759407|Respiratory System Agents|respiratory system agents|mesh-ancestor
25673477|NCT01759407|Mydriatics|mydriatics|mesh-ancestor
25673478|NCT01759407|Sympathomimetics|sympathomimetics|mesh-ancestor
25673479|NCT01759407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25673480|NCT01759420|Ondansetron|ondansetron|mesh-list
25673481|NCT01759420|Antiemetics|antiemetics|mesh-ancestor
25673482|NCT01759420|Autonomic Agents|autonomic agents|mesh-ancestor
25673483|NCT01759420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25874089|NCT05413161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25874090|NCT05413161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25874091|NCT05413161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24788555|NCT01932203|Respiratory System Agents|respiratory system agents|mesh-ancestor
24788556|NCT01932203|Vasodilator Agents|vasodilator agents|mesh-ancestor
24788557|NCT01932203|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24788558|NCT01932203|Protective Agents|protective agents|mesh-ancestor
24788559|NCT01932203|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24788560|NCT01932203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24788561|NCT01932229|Afatinib|afatinib|mesh-list
24788562|NCT01932229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24788563|NCT01932229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24788564|NCT01932229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788565|NCT01932229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788566|NCT01932268|Rifampin|rifampin|mesh-list
24788567|NCT01932268|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24788568|NCT01932268|Antitubercular Agents|antitubercular agents|mesh-ancestor
24788569|NCT01932268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24788570|NCT01932268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24788571|NCT01932268|Leprostatic Agents|leprostatic agents|mesh-ancestor
24788574|NCT01932268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788575|NCT01932268|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25874092|NCT05413161|Respiratory System Agents|respiratory system agents|mesh-ancestor
25874093|NCT05413161|Immunologic Factors|immunologic factors|mesh-ancestor
25874094|NCT05413161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874095|NCT05411081|Atezolizumab|atezolizumab|mesh-list
25874096|NCT05411081|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25874097|NCT05411081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874098|NCT05411081|Immunologic Factors|immunologic factors|mesh-ancestor
25874099|NCT05411081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874100|NCT05393817|Caffeine|caffeine|mesh-list
25874101|NCT05393817|Caffeine citrate|caffeine citrate|mesh-list
25874102|NCT05393817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874103|NCT05393817|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25874104|NCT05393817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874105|NCT05393817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25874106|NCT05393817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874107|NCT05393817|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25874108|NCT05393817|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25874109|NCT05393817|Purinergic Agents|purinergic agents|mesh-ancestor
25005552|NCT03781219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005553|NCT03728556|Antibodies|antibodies|mesh-list
25005554|NCT03728556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25005555|NCT03728556|Immunologic Factors|immunologic factors|mesh-ancestor
24966668|NCT03766594|Micronutrients|micronutrients|mesh-ancestor
25005556|NCT03728556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005560|NCT03596905|Plecanatide|plecanatide|mesh-list
25005561|NCT03596905|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25005562|NCT03596905|Enzyme Activators|enzyme activators|mesh-ancestor
25005563|NCT03596905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005570|NCT03529942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005571|NCT03529942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25005572|NCT03529942|Immunologic Factors|immunologic factors|mesh-ancestor
25005573|NCT03503370|Chlorhexidine|chlorhexidine|mesh-list
25005574|NCT03503370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25005575|NCT03503370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24753863|NCT01718236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24753864|NCT01718236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753865|NCT01718236|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24753866|NCT01718236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25005577|NCT03501940|Fluorides|fluorides|mesh-list
25874110|NCT05393817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25874111|NCT05389423|Prednisone|prednisone|mesh-list
25874112|NCT05389423|Cyclophosphamide|cyclophosphamide|mesh-list
25874113|NCT05389423|Rituximab|rituximab|mesh-list
25874114|NCT05389423|Doxorubicin|doxorubicin|mesh-list
25874115|NCT05389423|Etoposide|etoposide|mesh-list
25874116|NCT05389423|Vincristine|vincristine|mesh-list
25874117|NCT05389423|Pomalidomide|pomalidomide|mesh-list
24533190|NCT00642512|Hormones|hormones|mesh-ancestor
25874118|NCT05389423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25874119|NCT05389423|Immunologic Factors|immunologic factors|mesh-ancestor
24701601|NCT01459640|Immunologic Factors|immunologic factors|mesh-ancestor
25237356|NCT02550782|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25237357|NCT02550782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25237358|NCT02550782|Adrenergic Agents|adrenergic agents|mesh-ancestor
25237359|NCT02550782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25237360|NCT02550782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237361|NCT02550756|Capsaicin|capsaicin|mesh-list
25237362|NCT02550756|Antipruritics|antipruritics|mesh-ancestor
25237363|NCT02550756|Dermatologic Agents|dermatologic agents|mesh-ancestor
24701607|NCT01459809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24701608|NCT01459809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487219|NCT00462111|Tocolytic Agents|tocolytic agents|mesh-ancestor
24701609|NCT01459809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24701610|NCT01459809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24613271|NCT01017939|Abiraterone Acetate|abiraterone acetate|mesh-list
24613272|NCT01017939|Theophylline|theophylline|mesh-list
24613273|NCT01017939|Dextromethorphan|dextromethorphan|mesh-list
24613274|NCT01017939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24613275|NCT01017939|Glucocorticoids|glucocorticoids|mesh-ancestor
24613276|NCT01017939|Hormones|hormones|mesh-ancestor
24613277|NCT01017939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24613278|NCT01017939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613279|NCT01017939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24613280|NCT01017939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613281|NCT01017939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24613282|NCT01017939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613283|NCT01017939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613284|NCT01017939|Hormone Antagonists|hormone antagonists|mesh-ancestor
24613285|NCT01017939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24613287|NCT01017939|Respiratory System Agents|respiratory system agents|mesh-ancestor
25874120|NCT05389423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613298|NCT01017939|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24613299|NCT01017939|Purinergic Agents|purinergic agents|mesh-ancestor
24613300|NCT01018160|Rabeprazole|rabeprazole|mesh-list
24613301|NCT01018160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24613302|NCT01018160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24613303|NCT01018160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24613304|NCT01018160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613305|NCT01018160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613306|NCT01018225|Darifenacin|darifenacin|mesh-list
24613307|NCT01018225|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24613308|NCT01018225|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24613309|NCT01018225|Cholinergic Agents|cholinergic agents|mesh-ancestor
24613310|NCT01018225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24613311|NCT01018225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701649|NCT01460069|Hormones|hormones|mesh-ancestor
24701683|NCT01460355|Cholinergic Agents|cholinergic agents|mesh-ancestor
24701684|NCT01460355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24701685|NCT01460355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753927|NCT01718340|Metformin|metformin|mesh-list
24701686|NCT01460355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24701687|NCT01460355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24701801|NCT01461031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24701802|NCT01461031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701804|NCT01461174|Modafinil|modafinil|mesh-list
24701805|NCT01461174|Donepezil|donepezil|mesh-list
24701806|NCT01461174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24701807|NCT01461174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25005579|NCT03501940|Protective Agents|protective agents|mesh-ancestor
24701808|NCT01461174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701809|NCT01461174|Cholinergic Agents|cholinergic agents|mesh-ancestor
24701810|NCT01461174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24701811|NCT01461174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237364|NCT02550756|Sensory System Agents|sensory system agents|mesh-ancestor
25237369|NCT02550665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701854|NCT01461876|Antiviral Agents|antiviral agents|mesh-ancestor
24701855|NCT01461876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24701856|NCT01462006|Sirolimus|sirolimus|mesh-list
24701857|NCT01462006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24701858|NCT01462006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24701859|NCT01462006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24701860|NCT01462006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701861|NCT01462006|Antifungal Agents|antifungal agents|mesh-ancestor
24701862|NCT01462006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24701863|NCT01462006|Immunologic Factors|immunologic factors|mesh-ancestor
24701864|NCT01462006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701865|NCT01462058|Vitamin D|vitamin d|mesh-list
24701866|NCT01462058|Cholecalciferol|cholecalciferol|mesh-list
24701867|NCT01462058|Vitamins|vitamins|mesh-ancestor
24966176|NCT03770416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24701868|NCT01462058|Micronutrients|micronutrients|mesh-ancestor
24701882|NCT01462422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24701883|NCT01462422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701884|NCT01462422|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24701885|NCT01462422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24701886|NCT01462422|Oxytocics|oxytocics|mesh-ancestor
24701887|NCT01462474|Cisplatin|cisplatin|mesh-list
24701888|NCT01462474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701889|NCT01462487|Zanamivir|zanamivir|mesh-list
24701890|NCT01462487|Antiviral Agents|antiviral agents|mesh-ancestor
24701891|NCT01462487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24701892|NCT01462487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701893|NCT01462487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701894|NCT01462500|Miltefosine|miltefosine|mesh-list
24701895|NCT01462500|Antifungal Agents|antifungal agents|mesh-ancestor
24701896|NCT01462500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24701897|NCT01462500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701898|NCT01462500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24701899|NCT01462500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24701900|NCT01462617|Nemiralisib|nemiralisib|mesh-list
24701901|NCT01462617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24701902|NCT01462617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701903|NCT01462617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701907|NCT01462669|Ezogabine|ezogabine|mesh-list
24701960|NCT01463150|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24701961|NCT01463150|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24613351|NCT01018446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613352|NCT01018446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24613388|NCT01018823|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24867388|NCT00585195|Leprostatic Agents|leprostatic agents|mesh-ancestor
24702129|NCT01464112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24702130|NCT01464112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702131|NCT01464112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25237368|NCT02550665|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25237370|NCT02550665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702134|NCT01464112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24702136|NCT01464112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24702137|NCT01464125|Azithromycin|azithromycin|mesh-list
24702138|NCT01464125|Fosmidomycin|fosmidomycin|mesh-list
24702139|NCT01464125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24702140|NCT01464125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24702177|NCT01464476|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24702178|NCT01464476|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24702179|NCT01464476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24702180|NCT01464476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702181|NCT01464476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24702182|NCT01464476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702183|NCT01464489|Atropine|atropine|mesh-list
24702184|NCT01464489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24702185|NCT01464489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24702186|NCT01464489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24702187|NCT01464489|Autonomic Agents|autonomic agents|mesh-ancestor
24702188|NCT01464489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24487851|NCT00465283|Donepezil|donepezil|mesh-list
24702189|NCT01464489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702190|NCT01464489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24702191|NCT01464489|Respiratory System Agents|respiratory system agents|mesh-ancestor
24702192|NCT01464489|Mydriatics|mydriatics|mesh-ancestor
24702193|NCT01464489|Parasympatholytics|parasympatholytics|mesh-ancestor
24702194|NCT01464489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24702195|NCT01464489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24702196|NCT01464489|Cholinergic Agents|cholinergic agents|mesh-ancestor
24702197|NCT01464489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24702198|NCT01464489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874121|NCT05389423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24702268|NCT01464944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24702269|NCT01464944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24702270|NCT01464944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24754073|NCT01718912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24702271|NCT01464944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24702272|NCT01464944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673484|NCT01759420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765127|NCT01786070|Respiratory System Agents|respiratory system agents|mesh-ancestor
24765128|NCT01786070|Glucocorticoids|glucocorticoids|mesh-ancestor
24404002|NCT00162383|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24765129|NCT01786070|Hormones|hormones|mesh-ancestor
24765130|NCT01786070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24765131|NCT01786200|Aspirin|aspirin|mesh-list
24765132|NCT01786200|Ibuprofen|ibuprofen|mesh-list
24765134|NCT01786200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24702273|NCT01464944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24702274|NCT01464944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24702275|NCT01464944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702277|NCT01464983|Aspirin|aspirin|mesh-list
24702278|NCT01464983|Ibuprofen|ibuprofen|mesh-list
24702279|NCT01464983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25005580|NCT03501940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702280|NCT01464983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24702281|NCT01464983|Analgesics|analgesics|mesh-ancestor
24702282|NCT01464983|Sensory System Agents|sensory system agents|mesh-ancestor
24702283|NCT01464983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24702284|NCT01464983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702330|NCT01465113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24702331|NCT01465113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24702332|NCT01465113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24702333|NCT01465113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24702334|NCT01465113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24754107|NCT01719133|Histamine|histamine|mesh-list
24702336|NCT01465113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702338|NCT01465152|Repaglinide|repaglinide|mesh-list
24702339|NCT01465152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25237371|NCT02550665|Cholinergic Agents|cholinergic agents|mesh-ancestor
25237372|NCT02550665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25237373|NCT02550665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237374|NCT02550665|Nootropic Agents|nootropic agents|mesh-ancestor
24702379|NCT01465503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702380|NCT01465568|Denosumab|denosumab|mesh-list
24702381|NCT01465568|Diphosphonates|diphosphonates|mesh-list
24702382|NCT01465568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24702383|NCT01465568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702565|NCT01466517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702566|NCT01466517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702567|NCT01466530|Misoprostol|misoprostol|mesh-list
24702568|NCT01466530|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24702569|NCT01466530|Abortifacient Agents|abortifacient agents|mesh-ancestor
24702570|NCT01466530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24644183|NCT01189656|Vaccines|vaccines|mesh-list
24702571|NCT01466530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702573|NCT01466530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24702574|NCT01466530|Oxytocics|oxytocics|mesh-ancestor
24702575|NCT01466543|Udenafil|udenafil|mesh-list
24702576|NCT01466543|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24754143|NCT01719302|Gemcitabine|gemcitabine|mesh-list
24702579|NCT01466543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702581|NCT01466608|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24702582|NCT01466608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24702583|NCT01466608|Antimetabolites|antimetabolites|mesh-ancestor
24702584|NCT01466608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702585|NCT01466608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24702586|NCT01466608|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24702587|NCT01466608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702588|NCT01466712|Beclomethasone|beclomethasone|mesh-list
24702589|NCT01466712|Formoterol Fumarate|formoterol fumarate|mesh-list
24702590|NCT01466712|Tiotropium Bromide|tiotropium bromide|mesh-list
24966898|NCT03764280|Insulin|insulin|mesh-list
24966899|NCT03764280|Insulin, Short-Acting|insulin, short-acting|mesh-list
24702614|NCT01466829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24702616|NCT01466855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24702617|NCT01466855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25673485|NCT01759420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25673486|NCT01759420|Antipruritics|antipruritics|mesh-ancestor
25673487|NCT01759420|Dermatologic Agents|dermatologic agents|mesh-ancestor
25673488|NCT01759420|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25673489|NCT01759420|Serotonin Agents|serotonin agents|mesh-ancestor
25673490|NCT01759420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25673491|NCT01759420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673492|NCT01759420|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25080238|NCT03340779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25080239|NCT03340779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25080240|NCT03340779|Adrenergic Agents|adrenergic agents|mesh-ancestor
25080241|NCT03340779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24902459|NCT04373967|Liraglutide|liraglutide|mesh-list
24765243|NCT01787123|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24765244|NCT01787123|Protective Agents|protective agents|mesh-ancestor
24702618|NCT01466855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702619|NCT01466855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788576|NCT01932268|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24788577|NCT01932268|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24788578|NCT01932268|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24788579|NCT01932268|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25005581|NCT03349775|Metformin|metformin|mesh-list
25005588|NCT03216187|Pregabalin|pregabalin|mesh-list
25005602|NCT03207815|Prednisone|prednisone|mesh-list
25005603|NCT03207815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25005604|NCT03207815|Glucocorticoids|glucocorticoids|mesh-ancestor
25005605|NCT03207815|Hormones|hormones|mesh-ancestor
25005606|NCT03207815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25005607|NCT03207815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005608|NCT03207815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25005609|NCT03207815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005610|NCT03159936|Tofacitinib|tofacitinib|mesh-list
25005611|NCT03159936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005612|NCT03159936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25005613|NCT03159936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25005614|NCT03156816|Colchicine|colchicine|mesh-list
25237375|NCT02550483|Beta Carotene|beta carotene|mesh-list
25237376|NCT02550483|Lycopene|lycopene|mesh-list
25237377|NCT02550483|Carotenoids|carotenoids|mesh-list
25005623|NCT03141983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25005624|NCT03019640|Cytarabine|cytarabine|mesh-list
25005625|NCT03019640|Rituximab|rituximab|mesh-list
25005626|NCT03019640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25005639|NCT03019640|Immunologic Factors|immunologic factors|mesh-ancestor
25005641|NCT03019640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005642|NCT03019640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25005643|NCT03019640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24788581|NCT01932320|Ketoconazole|ketoconazole|mesh-list
25005644|NCT03019640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25005645|NCT03019640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25005646|NCT03019640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25005647|NCT03019640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005648|NCT03019640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25005649|NCT03019640|Antimetabolites|antimetabolites|mesh-ancestor
25005650|NCT03019640|Antiviral Agents|antiviral agents|mesh-ancestor
24702626|NCT01466959|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25874122|NCT05389423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25874123|NCT05389423|Alkylating Agents|alkylating agents|mesh-ancestor
25237378|NCT02550483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25237379|NCT02550483|Antioxidants|antioxidants|mesh-ancestor
25237380|NCT02550483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237381|NCT02550483|Protective Agents|protective agents|mesh-ancestor
25237382|NCT02550483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237383|NCT02550483|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25237384|NCT02550483|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25237385|NCT02550483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25237386|NCT02550483|Provitamins|provitamins|mesh-ancestor
25237387|NCT02550483|Vitamins|vitamins|mesh-ancestor
25237388|NCT02550483|Micronutrients|micronutrients|mesh-ancestor
24702731|NCT01467401|Insulin Aspart|insulin aspart|mesh-list
24702732|NCT01467401|Biphasic Insulins|biphasic insulins|mesh-list
24702733|NCT01467401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24702751|NCT01467518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237389|NCT02550717|Aspirin|aspirin|mesh-list
25673493|NCT01759420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25673494|NCT01759420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25673495|NCT01759420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25673496|NCT01759420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25673497|NCT01759602|Complement C1s|complement c1s|mesh-list
25673498|NCT01759602|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25673499|NCT01759602|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
25673500|NCT01759602|Immunologic Factors|immunologic factors|mesh-ancestor
25237390|NCT02550717|Anticoagulants|anticoagulants|mesh-list
25237391|NCT02550717|Clopidogrel|clopidogrel|mesh-list
25237392|NCT02550717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25237393|NCT02550717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25237395|NCT02550717|Sensory System Agents|sensory system agents|mesh-ancestor
25237396|NCT02550717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24702759|NCT01467531|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24702760|NCT01467531|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24702761|NCT01467531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702762|NCT01467531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702763|NCT01467531|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24702826|NCT01468025|Sensory System Agents|sensory system agents|mesh-ancestor
24702827|NCT01468025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24702828|NCT01468025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702829|NCT01468025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24702830|NCT01468025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24702831|NCT01468025|Gout Suppressants|gout suppressants|mesh-ancestor
24702832|NCT01468025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24702833|NCT01468025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702834|NCT01468025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702836|NCT01468038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25874124|NCT05389423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874125|NCT05389423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874126|NCT05389423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24702837|NCT01468038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24702838|NCT01468038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24702839|NCT01468038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702840|NCT01468038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24702841|NCT01468038|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24702842|NCT01468038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24702873|NCT01468272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24702874|NCT01468272|Respiratory System Agents|respiratory system agents|mesh-ancestor
24702875|NCT01468272|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24702876|NCT01468272|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24702877|NCT01468272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24702878|NCT01468272|Adrenergic Agents|adrenergic agents|mesh-ancestor
24702879|NCT01468272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24702880|NCT01468272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702881|NCT01468272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24702882|NCT01468272|Glucocorticoids|glucocorticoids|mesh-ancestor
24702883|NCT01468272|Hormones|hormones|mesh-ancestor
24702884|NCT01468272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24702885|NCT01468285|Betahistine|betahistine|mesh-list
24702886|NCT01468285|Vasodilator Agents|vasodilator agents|mesh-ancestor
24702913|NCT01468441|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24702915|NCT01468441|Hormone Antagonists|hormone antagonists|mesh-ancestor
24702916|NCT01468441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24702917|NCT01468480|Calcium, Dietary|calcium, dietary|mesh-list
24702918|NCT01468480|Calcium|calcium|mesh-list
24702919|NCT01468480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24702920|NCT01468480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702921|NCT01468480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24702922|NCT01468519|Insulin|insulin|mesh-list
24702923|NCT01468519|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24702924|NCT01468519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24702925|NCT01468519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702926|NCT01468545|Iloprost|iloprost|mesh-list
24627179|NCT01090895|Antioxidants|antioxidants|mesh-ancestor
24702927|NCT01468545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24702928|NCT01468545|Vasodilator Agents|vasodilator agents|mesh-ancestor
24754295|NCT01719952|Carbetocin|carbetocin|mesh-list
24702929|NCT01468571|Spironolactone|spironolactone|mesh-list
24702930|NCT01468571|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24702931|NCT01468571|Hormone Antagonists|hormone antagonists|mesh-ancestor
24702932|NCT01468571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24702933|NCT01468571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703002|NCT01469156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24703003|NCT01469156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24703004|NCT01469156|Growth Substances|growth substances|mesh-ancestor
24703005|NCT01469156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673501|NCT01759602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887739|NCT04513379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703006|NCT01469156|Growth Inhibitors|growth inhibitors|mesh-ancestor
24703007|NCT01469156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703008|NCT01469169|Iloprost|iloprost|mesh-list
24703039|NCT01469416|Antimetabolites|antimetabolites|mesh-ancestor
24703040|NCT01469416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24703041|NCT01469416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24703050|NCT01469468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703051|NCT01469481|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
24703084|NCT01469572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24703085|NCT01469598|Gemcitabine|gemcitabine|mesh-list
24703123|NCT01469884|Everolimus|everolimus|mesh-list
24703124|NCT01469884|Tacrolimus|tacrolimus|mesh-list
24703157|NCT01470040|Sensory System Agents|sensory system agents|mesh-ancestor
24703158|NCT01470040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24703161|NCT01470040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24703163|NCT01470040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24703164|NCT01470040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703165|NCT01470040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24966986|NCT03763734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24966987|NCT03763734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966988|NCT03763734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24966989|NCT03763734|Glucocorticoids|glucocorticoids|mesh-ancestor
24966990|NCT03763734|Hormones|hormones|mesh-ancestor
24703229|NCT01470339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703230|NCT01470339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24703231|NCT01470339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703233|NCT01470339|Sensory System Agents|sensory system agents|mesh-ancestor
24703234|NCT01470339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24703235|NCT01470339|Antidepressive Agents|antidepressive agents|mesh-ancestor
24703236|NCT01470339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24703237|NCT01470339|Dopamine Agents|dopamine agents|mesh-ancestor
24703238|NCT01470352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24703239|NCT01470352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24703240|NCT01470352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24703241|NCT01470352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24703242|NCT01470352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703243|NCT01470352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25874127|NCT05389423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24703275|NCT01470755|Albuterol|albuterol|mesh-list
24703276|NCT01470755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24703277|NCT01470755|Autonomic Agents|autonomic agents|mesh-ancestor
24703278|NCT01470755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24703279|NCT01470755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703280|NCT01470755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24703282|NCT01470755|Tocolytic Agents|tocolytic agents|mesh-ancestor
24703283|NCT01470755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24703284|NCT01470755|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24703285|NCT01470755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24703325|NCT01471067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24703359|NCT01471158|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24703360|NCT01471184|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24703361|NCT01471184|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25237397|NCT02550717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237407|NCT02550717|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25237408|NCT02550717|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25237409|NCT02550717|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25237410|NCT02550717|Purinergic Agents|purinergic agents|mesh-ancestor
25237411|NCT02550717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25237412|NCT02550444|Clonidine|clonidine|mesh-list
24703511|NCT01472016|Tubulin Modulators|tubulin modulators|mesh-ancestor
24703512|NCT01472016|Antimitotic Agents|antimitotic agents|mesh-ancestor
24703513|NCT01472016|Mitosis Modulators|mitosis modulators|mesh-ancestor
24703514|NCT01472016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703515|NCT01472016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25005652|NCT03019640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24703546|NCT01472263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703548|NCT01472263|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24703549|NCT01472263|Protective Agents|protective agents|mesh-ancestor
25673502|NCT01759602|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25874128|NCT05389423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25874129|NCT05389423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25874130|NCT05389423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25874131|NCT05389423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874132|NCT05389423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25874133|NCT05389423|Glucocorticoids|glucocorticoids|mesh-ancestor
24703550|NCT01472263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703551|NCT01472263|Vasodilator Agents|vasodilator agents|mesh-ancestor
24703552|NCT01472263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24703591|NCT01472666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703593|NCT01472731|Immunologic Factors|immunologic factors|mesh-ancestor
24703594|NCT01472731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703595|NCT01472770|Gemcitabine|gemcitabine|mesh-list
24703596|NCT01472770|Capecitabine|capecitabine|mesh-list
24703597|NCT01472770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24703598|NCT01472770|Antimetabolites|antimetabolites|mesh-ancestor
24703599|NCT01472770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703600|NCT01472770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703601|NCT01472770|Antiviral Agents|antiviral agents|mesh-ancestor
25227884|NCT02611804|Analgesics|analgesics|mesh-ancestor
24703602|NCT01472770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24703603|NCT01472770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703604|NCT01472770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24703605|NCT01472770|Immunologic Factors|immunologic factors|mesh-ancestor
24703606|NCT01472770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703607|NCT01472783|Veliparib|veliparib|mesh-list
24703723|NCT01473316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24703725|NCT01473316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24703796|NCT01474330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24703797|NCT01474330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24703798|NCT01474330|Growth Substances|growth substances|mesh-ancestor
24703799|NCT01474330|Growth Inhibitors|growth inhibitors|mesh-ancestor
24703800|NCT01474330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703802|NCT01474382|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24703803|NCT01474382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24703804|NCT01474382|Adrenergic Agents|adrenergic agents|mesh-ancestor
24703805|NCT01474382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24703806|NCT01474382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703834|NCT01474642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703835|NCT01474642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24703836|NCT01474642|Antimetabolites|antimetabolites|mesh-ancestor
24786431|NCT01919918|Purinergic Agonists|purinergic agonists|mesh-ancestor
24703837|NCT01474642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703838|NCT01474902|Enoxaparin|enoxaparin|mesh-list
24703839|NCT01474902|Anticoagulants|anticoagulants|mesh-ancestor
24703840|NCT01474902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24703841|NCT01474902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25237413|NCT02550444|Analgesics|analgesics|mesh-ancestor
25237414|NCT02550444|Sensory System Agents|sensory system agents|mesh-ancestor
25237415|NCT02550444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25237416|NCT02550444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237417|NCT02550444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25237418|NCT02550444|Sympatholytics|sympatholytics|mesh-ancestor
25237419|NCT02550444|Autonomic Agents|autonomic agents|mesh-ancestor
25237420|NCT02550444|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25237421|NCT02550444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24703854|NCT01475019|Appetite Depressants|appetite depressants|mesh-ancestor
24703856|NCT01475032|Formoterol Fumarate|formoterol fumarate|mesh-list
24703857|NCT01475032|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24703877|NCT01475227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703879|NCT01475227|Dermatologic Agents|dermatologic agents|mesh-ancestor
24703881|NCT01475266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703883|NCT01475279|Anticoagulants|anticoagulants|mesh-ancestor
24703884|NCT01475318|Letrozole|letrozole|mesh-list
24703885|NCT01475318|Misoprostol|misoprostol|mesh-list
24703886|NCT01475318|Mifepristone|mifepristone|mesh-list
25673503|NCT01759602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25673504|NCT01759862|Aminophylline|aminophylline|mesh-list
25673505|NCT01759862|Theophylline|theophylline|mesh-list
25673506|NCT01759862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25673507|NCT01759862|Autonomic Agents|autonomic agents|mesh-ancestor
24703887|NCT01475318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703888|NCT01475318|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24703889|NCT01475318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24703890|NCT01475318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25673508|NCT01759862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24703891|NCT01475318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703892|NCT01475318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24703893|NCT01475318|Hormone Antagonists|hormone antagonists|mesh-ancestor
24703894|NCT01475318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24703895|NCT01475318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703896|NCT01475318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24703897|NCT01475318|Abortifacient Agents|abortifacient agents|mesh-ancestor
24703898|NCT01475318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24703899|NCT01475318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24703900|NCT01475318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24703901|NCT01475318|Oxytocics|oxytocics|mesh-ancestor
24703902|NCT01475318|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24703903|NCT01475318|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24703904|NCT01475318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24703905|NCT01475318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24703906|NCT01475318|Contraceptive Agents|contraceptive agents|mesh-ancestor
24703907|NCT01475318|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24703908|NCT01475318|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24703909|NCT01475318|Luteolytic Agents|luteolytic agents|mesh-ancestor
24489666|NCT00474721|Antitussive Agents|antitussive agents|mesh-ancestor
24703910|NCT01475318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24703911|NCT01475318|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24703912|NCT01475552|Aspirin|aspirin|mesh-list
24703944|NCT01475578|Vasodilator Agents|vasodilator agents|mesh-ancestor
24703945|NCT01475578|Nootropic Agents|nootropic agents|mesh-ancestor
24703946|NCT01475578|Dopamine Agonists|dopamine agonists|mesh-ancestor
24703947|NCT01475578|Dopamine Agents|dopamine agents|mesh-ancestor
24703948|NCT01475617|Calcium, Dietary|calcium, dietary|mesh-list
25874134|NCT05389423|Hormones|hormones|mesh-ancestor
25874135|NCT05389423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25874136|NCT05389423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25237422|NCT02550444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25237423|NCT02550444|Adrenergic Agents|adrenergic agents|mesh-ancestor
25237424|NCT02550444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25237425|NCT02550444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237426|NCT02550314|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25237427|NCT02550314|Hemostatics|hemostatics|mesh-ancestor
25237428|NCT02550314|Coagulants|coagulants|mesh-ancestor
25237429|NCT02550119|Dexamethasone|dexamethasone|mesh-list
25237430|NCT02550119|Dexamethasone acetate|dexamethasone acetate|mesh-list
25874137|NCT05389423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25874138|NCT05389423|Tubulin Modulators|tubulin modulators|mesh-ancestor
24703951|NCT01475617|Calcium|calcium|mesh-list
24703952|NCT01475617|Vitamins|vitamins|mesh-ancestor
24703953|NCT01475617|Micronutrients|micronutrients|mesh-ancestor
24703954|NCT01475617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703955|NCT01475617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24704033|NCT01476215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704068|NCT01476410|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24704069|NCT01476410|Immunologic Factors|immunologic factors|mesh-ancestor
24704070|NCT01476410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704071|NCT01476410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24704072|NCT01476410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472695|NCT00400322|Valganciclovir|valganciclovir|mesh-list
24704073|NCT01476410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24704074|NCT01476410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24704075|NCT01476410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704076|NCT01476410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754512|NCT01721031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754513|NCT01721031|Analgesics|analgesics|mesh-ancestor
25874139|NCT05389423|Antimitotic Agents|antimitotic agents|mesh-ancestor
24875510|NCT04108897|Doxycycline|doxycycline|mesh-list
25874140|NCT05389423|Mitosis Modulators|mitosis modulators|mesh-ancestor
25237431|NCT02550119|Aprepitant|aprepitant|mesh-list
25237432|NCT02550119|Dolasetron|dolasetron|mesh-list
25237433|NCT02550119|Ichthammol|ichthammol|mesh-list
25237434|NCT02550119|BB 1101|bb 1101|mesh-list
25237435|NCT02550119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25237436|NCT02550119|Antiemetics|antiemetics|mesh-ancestor
25237437|NCT02550119|Autonomic Agents|autonomic agents|mesh-ancestor
25237438|NCT02550119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25237439|NCT02550119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237440|NCT02550119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25237441|NCT02550119|Glucocorticoids|glucocorticoids|mesh-ancestor
25237442|NCT02550119|Hormones|hormones|mesh-ancestor
25237443|NCT02550119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24765681|NCT01789892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25874141|NCT05389423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25237444|NCT02550119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24704172|NCT01477021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25874142|NCT05389423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24704211|NCT01477190|Sensory System Agents|sensory system agents|mesh-ancestor
24704236|NCT01477242|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24704237|NCT01477242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24704238|NCT01477242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24704239|NCT01477242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24704240|NCT01477242|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24704241|NCT01477268|Sertraline|sertraline|mesh-list
24704242|NCT01477268|Antidepressive Agents|antidepressive agents|mesh-list
24704243|NCT01477268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24704244|NCT01477268|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24704245|NCT01477268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24754532|NCT01721291|Albuterol|albuterol|mesh-list
25237445|NCT02550119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25237446|NCT02550119|Protease Inhibitors|protease inhibitors|mesh-ancestor
25237447|NCT02550119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237448|NCT02550119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237449|NCT02550119|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25237450|NCT02550119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25237451|NCT02550119|Dermatologic Agents|dermatologic agents|mesh-ancestor
25237452|NCT02550119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24465544|NCT00370019|Hormones|hormones|mesh-ancestor
25237453|NCT02550119|Serotonin Agents|serotonin agents|mesh-ancestor
25237454|NCT02550067|Copper|copper|mesh-list
25237455|NCT02550067|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25237456|NCT02550067|Levonorgestrel|levonorgestrel|mesh-list
25237457|NCT02550067|Medroxyprogesterone|medroxyprogesterone|mesh-list
25237458|NCT02550067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25237459|NCT02550067|Contraceptive Agents|contraceptive agents|mesh-ancestor
25237460|NCT02550067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24704249|NCT01477268|Serotonin Agents|serotonin agents|mesh-ancestor
24704250|NCT01477268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704252|NCT01477294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24704253|NCT01477294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704254|NCT01477294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24704255|NCT01477294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704256|NCT01477294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704257|NCT01477294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24704258|NCT01477294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24704357|NCT01477931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24704358|NCT01477931|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24704359|NCT01477931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24704360|NCT01477931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24704361|NCT01477931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704362|NCT01477931|Dopamine Agents|dopamine agents|mesh-ancestor
24704364|NCT01477931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704365|NCT01477931|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24704386|NCT01478022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24704387|NCT01478022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704388|NCT01478022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704389|NCT01478022|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24704391|NCT01478022|Natriuretic Agents|natriuretic agents|mesh-ancestor
24704392|NCT01478022|Vasodilator Agents|vasodilator agents|mesh-ancestor
24704393|NCT01478022|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24704403|NCT01478074|Fludarabine|fludarabine|mesh-list
24704404|NCT01478074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24704405|NCT01478074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24704406|NCT01478074|Antimetabolites|antimetabolites|mesh-ancestor
24704407|NCT01478074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704408|NCT01478074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24704409|NCT01478074|Immunologic Factors|immunologic factors|mesh-ancestor
24704410|NCT01478074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704411|NCT01478074|Antiviral Agents|antiviral agents|mesh-ancestor
24704412|NCT01478074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24704413|NCT01478165|Palonosetron|palonosetron|mesh-list
24704414|NCT01478165|Anesthetics|anesthetics|mesh-list
24704415|NCT01478165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24704504|NCT01478568|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25673509|NCT01759862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237461|NCT02550067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237462|NCT02550067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25237463|NCT02550067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25237464|NCT02550067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25237465|NCT02550067|Trace Elements|trace elements|mesh-ancestor
25237466|NCT02550067|Micronutrients|micronutrients|mesh-ancestor
25237467|NCT02550067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25237468|NCT02550067|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25237469|NCT02550067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24848682|NCT03670966|Fludarabine phosphate|fludarabine phosphate|mesh-list
24848683|NCT03670966|Tacrolimus|tacrolimus|mesh-list
24848684|NCT03670966|Antibodies|antibodies|mesh-list
24848685|NCT03670966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24848686|NCT03670966|Lenograstim|lenograstim|mesh-list
24639326|NCT01161108|Melatonin|melatonin|mesh-list
24848692|NCT03670966|Alkylating Agents|alkylating agents|mesh-ancestor
24848693|NCT03670966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848694|NCT03670966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24848695|NCT03670966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24848696|NCT03670966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24848697|NCT03670966|Antimetabolites|antimetabolites|mesh-ancestor
24848698|NCT03670966|Antiviral Agents|antiviral agents|mesh-ancestor
24848699|NCT03670966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24704520|NCT01478607|Antipruritics|antipruritics|mesh-ancestor
24788644|NCT01932541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24788645|NCT01932541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788646|NCT01932541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24788647|NCT01932541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24788649|NCT01932541|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24788650|NCT01932541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24788651|NCT01932541|Dopamine Agents|dopamine agents|mesh-ancestor
24788652|NCT01932554|Ibuprofen|ibuprofen|mesh-list
24788653|NCT01932554|Fentanyl|fentanyl|mesh-list
24788654|NCT01932554|Morphine|morphine|mesh-list
24788655|NCT01932554|Hydromorphone|hydromorphone|mesh-list
24788656|NCT01932554|Narcotics|narcotics|mesh-list
24788657|NCT01932554|Abciximab|abciximab|mesh-list
24788658|NCT01932554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24788659|NCT01932554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24788660|NCT01932554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788661|NCT01932554|Analgesics|analgesics|mesh-ancestor
24788662|NCT01932554|Sensory System Agents|sensory system agents|mesh-ancestor
24788663|NCT01932554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24788664|NCT01932554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24788665|NCT01932554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24788666|NCT01932554|Anesthetics, General|anesthetics, general|mesh-ancestor
24788667|NCT01932554|Anesthetics|anesthetics|mesh-ancestor
24788668|NCT01932554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24581035|NCT00864305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24581036|NCT00864305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25237470|NCT02550067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25273763|NCT02383212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25273764|NCT02383212|Tubulin Modulators|tubulin modulators|mesh-ancestor
25273765|NCT02383212|Antimitotic Agents|antimitotic agents|mesh-ancestor
25673510|NCT01759862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25273766|NCT02383212|Mitosis Modulators|mitosis modulators|mesh-ancestor
25673511|NCT01759862|Respiratory System Agents|respiratory system agents|mesh-ancestor
24766177|NCT01793077|Leuprolide|leuprolide|mesh-list
25273767|NCT02383212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273768|NCT02383212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25273769|NCT02383212|Immunologic Factors|immunologic factors|mesh-ancestor
25273770|NCT02383212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273771|NCT02383212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25273772|NCT02383212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25273773|NCT02383212|Alkylating Agents|alkylating agents|mesh-ancestor
25273774|NCT02383212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25273775|NCT02383212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273776|NCT02383212|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25273777|NCT02383212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25273778|NCT02383212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25273779|NCT02383238|Dapagliflozin|dapagliflozin|mesh-list
25273780|NCT02383238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25273781|NCT02383238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273782|NCT02383238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25273783|NCT02383238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273784|NCT02383030|Fulvestrant|fulvestrant|mesh-list
24867919|NCT05005897|Hematinics|hematinics|mesh-ancestor
24704521|NCT01478607|Dermatologic Agents|dermatologic agents|mesh-ancestor
25874143|NCT05389423|Growth Substances|growth substances|mesh-ancestor
24613555|NCT01019655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24613556|NCT01019655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25005653|NCT03019640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25005654|NCT03019640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24754624|NCT01722110|Indomethacin|indomethacin|mesh-list
25005658|NCT03019640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25005659|NCT03019640|Alkylating Agents|alkylating agents|mesh-ancestor
25005660|NCT03019640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25005661|NCT03019640|Keratolytic Agents|keratolytic agents|mesh-ancestor
25005662|NCT03019640|Dermatologic Agents|dermatologic agents|mesh-ancestor
25005663|NCT03019640|Tubulin Modulators|tubulin modulators|mesh-ancestor
25005664|NCT03019640|Antimitotic Agents|antimitotic agents|mesh-ancestor
25005665|NCT03019640|Mitosis Modulators|mitosis modulators|mesh-ancestor
25005666|NCT02991937|Tazobactam|tazobactam|mesh-list
25005667|NCT02991937|Piperacillin|piperacillin|mesh-list
25005668|NCT02991937|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25005669|NCT02991937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25005670|NCT02991937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25005671|NCT02991937|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25005672|NCT02991937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25005673|NCT02991937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005674|NCT02968563|Obinutuzumab|obinutuzumab|mesh-list
25005675|NCT02968563|Idelalisib|idelalisib|mesh-list
24875718|NCT03905603|Hormones|hormones|mesh-ancestor
25874144|NCT05389423|Growth Inhibitors|growth inhibitors|mesh-ancestor
25237471|NCT02550262|Fentanyl|fentanyl|mesh-list
25237472|NCT02550262|Bupivacaine|bupivacaine|mesh-list
25237473|NCT02550262|Anesthetics, Local|anesthetics, local|mesh-ancestor
25237474|NCT02550262|Anesthetics|anesthetics|mesh-ancestor
25237475|NCT02550262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25237476|NCT02550262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237477|NCT02550262|Sensory System Agents|sensory system agents|mesh-ancestor
25154936|NCT05468489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25154937|NCT05468489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25154938|NCT05468489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25154939|NCT05468489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25154940|NCT05468489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005682|NCT02931890|Carboplatin|carboplatin|mesh-list
25005683|NCT02931890|Capecitabine|capecitabine|mesh-list
25005684|NCT02931890|Oxaliplatin|oxaliplatin|mesh-list
25005685|NCT02931890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25005686|NCT02931890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005687|NCT02931890|Tubulin Modulators|tubulin modulators|mesh-ancestor
24613557|NCT01019655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613558|NCT01019668|Verteporfin|verteporfin|mesh-list
24613559|NCT01019668|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24613560|NCT01019668|Dermatologic Agents|dermatologic agents|mesh-ancestor
24613561|NCT01019746|Propofol|propofol|mesh-list
24613562|NCT01019746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24613563|NCT01019746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24613564|NCT01019746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613565|NCT01019746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24613566|NCT01019746|Anesthetics, General|anesthetics, general|mesh-ancestor
25673512|NCT01759862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24613567|NCT01019746|Anesthetics|anesthetics|mesh-ancestor
24613568|NCT01019772|Vaccines|vaccines|mesh-list
24613569|NCT01019772|Immunologic Factors|immunologic factors|mesh-ancestor
24613570|NCT01019772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613571|NCT01019785|Ergocalciferols|ergocalciferols|mesh-list
24613572|NCT01019785|Vitamin D|vitamin d|mesh-list
25874145|NCT05388669|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
24704568|NCT01478737|Protease Inhibitors|protease inhibitors|mesh-ancestor
24704569|NCT01478737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704570|NCT01478737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704572|NCT01478997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24704573|NCT01478997|Analgesics|analgesics|mesh-ancestor
24704574|NCT01478997|Sensory System Agents|sensory system agents|mesh-ancestor
24704575|NCT01478997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24704576|NCT01478997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704577|NCT01478997|Antipyretics|antipyretics|mesh-ancestor
24704810|NCT01480531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24704811|NCT01480531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704813|NCT01480609|Anticonvulsants|anticonvulsants|mesh-ancestor
24704814|NCT01480609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24704815|NCT01480609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704817|NCT01480687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25237480|NCT02550262|Narcotics|narcotics|mesh-ancestor
25237481|NCT02550262|Analgesics|analgesics|mesh-ancestor
25237482|NCT02550262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25237483|NCT02550262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25237484|NCT02550262|Anesthetics, General|anesthetics, general|mesh-ancestor
25237485|NCT02550418|Budesonide|budesonide|mesh-list
25237486|NCT02550418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25237487|NCT02550418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25237488|NCT02550418|Autonomic Agents|autonomic agents|mesh-ancestor
25237489|NCT02550418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25237490|NCT02550418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237491|NCT02550418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25237492|NCT02550418|Respiratory System Agents|respiratory system agents|mesh-ancestor
25237493|NCT02550418|Glucocorticoids|glucocorticoids|mesh-ancestor
25237494|NCT02550418|Hormones|hormones|mesh-ancestor
25154941|NCT05468450|Polidocanol|polidocanol|mesh-list
25154942|NCT05468450|Sclerosing Solutions|sclerosing solutions|mesh-list
24848714|NCT03637972|Cholinergic Agents|cholinergic agents|mesh-ancestor
24848715|NCT03637972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24848716|NCT03637972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065459|NCT05322265|Mydriatics|mydriatics|mesh-ancestor
24704818|NCT01480687|Antimetabolites|antimetabolites|mesh-ancestor
24704819|NCT01480687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704820|NCT01480687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24704856|NCT01480765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24704857|NCT01480765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25874146|NCT05388669|Lazertinib|lazertinib|mesh-list
24704932|NCT01481194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24704968|NCT01481454|Immunologic Factors|immunologic factors|mesh-ancestor
25005688|NCT02931890|Antimitotic Agents|antimitotic agents|mesh-ancestor
25005689|NCT02931890|Mitosis Modulators|mitosis modulators|mesh-ancestor
24704969|NCT01481454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704970|NCT01481519|Povidone-Iodine|povidone-iodine|mesh-list
24704971|NCT01481519|Dexamethasone|dexamethasone|mesh-list
24704972|NCT01481519|Dexamethasone acetate|dexamethasone acetate|mesh-list
24704974|NCT01481519|Lubricant Eye Drops|lubricant eye drops|mesh-list
24705039|NCT01481831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705041|NCT01481844|Metronidazole|metronidazole|mesh-list
24705042|NCT01481844|Clarithromycin|clarithromycin|mesh-list
24705043|NCT01481844|Tetracycline|tetracycline|mesh-list
24705044|NCT01481844|Tinidazole|tinidazole|mesh-list
24705045|NCT01481844|Lansoprazole|lansoprazole|mesh-list
24705046|NCT01481844|Dexlansoprazole|dexlansoprazole|mesh-list
24705081|NCT01481883|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24705082|NCT01481883|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24705159|NCT01482442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705160|NCT01482468|Palonosetron|palonosetron|mesh-list
24705161|NCT01482468|Antiemetics|antiemetics|mesh-ancestor
24705162|NCT01482468|Autonomic Agents|autonomic agents|mesh-ancestor
24705163|NCT01482468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24705164|NCT01482468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705166|NCT01482468|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24705167|NCT01482468|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24705169|NCT01482468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25874147|NCT05388669|Antibodies, Bispecific|antibodies, bispecific|mesh-list
24705215|NCT01482897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25874148|NCT05388669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24705319|NCT01484171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24705320|NCT01484171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24705321|NCT01484171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237495|NCT02550418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25237496|NCT02550080|Dapsone|dapsone|mesh-list
25237497|NCT02550080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25237498|NCT02550080|Antimalarials|antimalarials|mesh-ancestor
25237499|NCT02550080|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25237500|NCT02550080|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25237501|NCT02550080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25237502|NCT02550080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237503|NCT02550080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848747|NCT03561870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487908|NCT00465543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24705322|NCT01484171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705324|NCT01484184|Buspirone|buspirone|mesh-list
24705325|NCT01484184|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24705326|NCT01484184|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24705327|NCT01484184|Dopamine Agents|dopamine agents|mesh-ancestor
24705328|NCT01484184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25237504|NCT02550080|Leprostatic Agents|leprostatic agents|mesh-ancestor
25237505|NCT02550080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25237506|NCT02550249|Nivolumab|nivolumab|mesh-list
25237507|NCT02550249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25237508|NCT02550249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25237509|NCT02550249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25874149|NCT05388669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874150|NCT05388669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874151|NCT05388669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25874152|NCT05388669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874153|NCT05388669|Immunologic Factors|immunologic factors|mesh-ancestor
25874154|NCT05388669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874155|NCT05371054|Prednisone|prednisone|mesh-list
25874156|NCT05371054|Venetoclax|venetoclax|mesh-list
25874157|NCT05371054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25874158|NCT05371054|Glucocorticoids|glucocorticoids|mesh-ancestor
25874159|NCT05371054|Hormones|hormones|mesh-ancestor
25237517|NCT02550028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237518|NCT02550028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25237519|NCT02550028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25237520|NCT02550028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25237521|NCT02550028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237522|NCT02550028|GABA Modulators|gaba modulators|mesh-ancestor
25237524|NCT02550028|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25237525|NCT02550028|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25237526|NCT02550028|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25237527|NCT02550327|Gemcitabine|gemcitabine|mesh-list
25237528|NCT02550327|Paclitaxel|paclitaxel|mesh-list
25237529|NCT02550327|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25237530|NCT02550327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25237531|NCT02550327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25237532|NCT02550327|Tubulin Modulators|tubulin modulators|mesh-ancestor
25237533|NCT02550327|Antimitotic Agents|antimitotic agents|mesh-ancestor
25237534|NCT02550327|Mitosis Modulators|mitosis modulators|mesh-ancestor
25237535|NCT02550327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581053|NCT00864318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24581054|NCT00864318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581055|NCT00864318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24581056|NCT00864318|Alkylating Agents|alkylating agents|mesh-ancestor
24621540|NCT01062958|Micronutrients|micronutrients|mesh-ancestor
24621541|NCT01062958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754803|NCT01722968|Paclitaxel|paclitaxel|mesh-list
25874160|NCT05371054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25874161|NCT05371054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874162|NCT05371054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25874163|NCT05371054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874164|NCT05368558|Cariprazine|cariprazine|mesh-list
25874165|NCT05368558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25874166|NCT05368558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25874167|NCT05368558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25874168|NCT05368558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874169|NCT05368558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25874170|NCT05366166|Cisplatin|cisplatin|mesh-list
25874171|NCT05366166|Pembrolizumab|pembrolizumab|mesh-list
25874172|NCT05366166|Olaparib|olaparib|mesh-list
25237536|NCT02550327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25237537|NCT02550327|Antimetabolites|antimetabolites|mesh-ancestor
25237538|NCT02550327|Antiviral Agents|antiviral agents|mesh-ancestor
25237539|NCT02550327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25237540|NCT02550327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237541|NCT02550327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25237542|NCT02550327|Immunologic Factors|immunologic factors|mesh-ancestor
25237543|NCT02550327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237544|NCT02550327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25237545|NCT02549846|Atorvastatin|atorvastatin|mesh-list
25005693|NCT02915783|Everolimus|everolimus|mesh-list
24621543|NCT01062958|Vitamin B Complex|vitamin b complex|mesh-ancestor
24621544|NCT01063010|Bevacizumab|bevacizumab|mesh-list
25273395|NCT02385474|Fluorides|fluorides|mesh-list
24621545|NCT01063010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24621546|NCT01063010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24621547|NCT01063010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24868112|NCT03643965|Hormones|hormones|mesh-ancestor
24705494|NCT01485445|Fluticasone|fluticasone|mesh-list
24705495|NCT01485445|Xhance|xhance|mesh-list
24705510|NCT01485562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24705693|NCT01486381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24705755|NCT01486602|Paclitaxel|paclitaxel|mesh-list
24705890|NCT01487369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24705896|NCT01487395|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24705897|NCT01487395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874173|NCT05366166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874174|NCT05366166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25874175|NCT05366166|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25874176|NCT05366166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705898|NCT01487395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705900|NCT01487395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24705901|NCT01487395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705902|NCT01487395|Nootropic Agents|nootropic agents|mesh-ancestor
25237546|NCT02549846|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25237547|NCT02549846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25237548|NCT02549846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25237549|NCT02549846|Antimetabolites|antimetabolites|mesh-ancestor
25237550|NCT02549846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237551|NCT02549846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25237552|NCT02549846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25237553|NCT02549846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237554|NCT02549924|Resveratrol|resveratrol|mesh-list
25237555|NCT02549924|Antioxidants|antioxidants|mesh-ancestor
25237556|NCT02549924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237557|NCT02549924|Protective Agents|protective agents|mesh-ancestor
25237558|NCT02549924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237559|NCT02549924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237560|NCT02549924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25237562|NCT02549742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25237563|NCT02549742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25237564|NCT02549963|Rivaroxaban|rivaroxaban|mesh-list
24848778|NCT03497169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24848779|NCT03497156|Lercanidipine|lercanidipine|mesh-list
24621549|NCT01063010|Growth Substances|growth substances|mesh-ancestor
24848791|NCT03497143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24848792|NCT03497143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953436|NCT03884881|Meropenem|meropenem|mesh-list
24705903|NCT01487408|Insulin Aspart|insulin aspart|mesh-list
24705904|NCT01487408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24705905|NCT01487408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705906|NCT01487421|Insulin|insulin|mesh-list
24705907|NCT01487421|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24705908|NCT01487421|Insulin Aspart|insulin aspart|mesh-list
24705909|NCT01487421|Insulin Detemir|insulin detemir|mesh-list
25005690|NCT02931890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005691|NCT02931890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25005692|NCT02931890|Antimetabolites|antimetabolites|mesh-ancestor
25005694|NCT02915783|Lenvatinib|lenvatinib|mesh-list
25005695|NCT02915783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005696|NCT02915783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25005697|NCT02915783|Immunologic Factors|immunologic factors|mesh-ancestor
25005698|NCT02915783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005699|NCT02915783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25005700|NCT02915783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25005701|NCT02915783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005702|NCT02913482|Risdiplam|risdiplam|mesh-list
25005703|NCT02913482|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25237565|NCT02549963|Anticoagulants|anticoagulants|mesh-list
25237566|NCT02549963|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25237567|NCT02549963|Antithrombins|antithrombins|mesh-ancestor
25237568|NCT02549963|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25237569|NCT02549963|Protease Inhibitors|protease inhibitors|mesh-ancestor
25237570|NCT02549963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237571|NCT02549963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874177|NCT05366166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874178|NCT05364944|Octreotide|octreotide|mesh-list
25874179|NCT05364944|Lanreotide|lanreotide|mesh-list
25237572|NCT02550002|Aflibercept|aflibercept|mesh-list
25237573|NCT02550002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25237574|NCT02550002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25237575|NCT02550002|Growth Substances|growth substances|mesh-ancestor
25237576|NCT02550002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237577|NCT02550002|Growth Inhibitors|growth inhibitors|mesh-ancestor
25237578|NCT02550002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24848793|NCT03497143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24848794|NCT03497143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24848795|NCT03497143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24848796|NCT03497143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24848797|NCT03497143|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24848798|NCT03479684|Warfarin|warfarin|mesh-list
24848799|NCT03479684|Anticoagulants|anticoagulants|mesh-ancestor
24848800|NCT03466151|Sirolimus|sirolimus|mesh-list
24848801|NCT03466151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24848802|NCT03466151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24848803|NCT03466151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24848804|NCT03466151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706102|NCT01488552|Antimetabolites|antimetabolites|mesh-ancestor
24706103|NCT01488552|Antiviral Agents|antiviral agents|mesh-ancestor
24706104|NCT01488552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24706105|NCT01488552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706106|NCT01488552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24706107|NCT01488552|Immunologic Factors|immunologic factors|mesh-ancestor
24706108|NCT01488552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706109|NCT01488552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24706111|NCT01488565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24706112|NCT01488565|Antimetabolites|antimetabolites|mesh-ancestor
24707000|NCT01493453|Cyclophosphamide|cyclophosphamide|mesh-list
24707001|NCT01493453|Fludarabine|fludarabine|mesh-list
24613752|NCT01020708|Mesalamine|mesalamine|mesh-list
24613753|NCT01020708|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24613754|NCT01020708|Antiviral Agents|antiviral agents|mesh-ancestor
24613755|NCT01020708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25874180|NCT05364944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24613810|NCT01020864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24613811|NCT01020864|Tubulin Modulators|tubulin modulators|mesh-ancestor
24613812|NCT01020864|Antimitotic Agents|antimitotic agents|mesh-ancestor
24613813|NCT01020864|Mitosis Modulators|mitosis modulators|mesh-ancestor
24449939|NCT00317408|Tubulin Modulators|tubulin modulators|mesh-ancestor
24707044|NCT01493791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24707045|NCT01493791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707046|NCT01493791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24707048|NCT01493843|Bevacizumab|bevacizumab|mesh-list
24707049|NCT01493843|Carboplatin|carboplatin|mesh-list
24707050|NCT01493843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24707051|NCT01493843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24707052|NCT01493843|Tubulin Modulators|tubulin modulators|mesh-ancestor
24707053|NCT01493843|Antimitotic Agents|antimitotic agents|mesh-ancestor
24707054|NCT01493843|Mitosis Modulators|mitosis modulators|mesh-ancestor
24707055|NCT01493843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707056|NCT01493843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24707057|NCT01493843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24707058|NCT01493843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24707059|NCT01493843|Growth Substances|growth substances|mesh-ancestor
24707092|NCT01494090|Antimetabolites|antimetabolites|mesh-ancestor
24707136|NCT01494311|Sensory System Agents|sensory system agents|mesh-ancestor
24707137|NCT01494311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24707138|NCT01494311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25237600|NCT02549690|Testosterone|testosterone|mesh-list
25237601|NCT02549690|Androgens|androgens|mesh-ancestor
25237602|NCT02549690|Hormones|hormones|mesh-ancestor
25237603|NCT02549690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24639588|NCT01162941|Hormones|hormones|mesh-ancestor
24797641|NCT01956981|Anesthetics|anesthetics|mesh-ancestor
24639608|NCT01162967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24707139|NCT01494311|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24707140|NCT01494311|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24707141|NCT01494311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24707279|NCT01495104|Anticonvulsants|anticonvulsants|mesh-ancestor
24707280|NCT01495104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707281|NCT01495104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707282|NCT01495104|GABA Agents|gaba agents|mesh-ancestor
24707287|NCT01495104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24707288|NCT01495104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24707290|NCT01495117|Chlorhexidine|chlorhexidine|mesh-list
24707490|NCT01496196|Tranexamic Acid|tranexamic acid|mesh-list
24707491|NCT01496196|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24707492|NCT01496196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24644655|NCT01192243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874182|NCT05364944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24707526|NCT01496326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24707527|NCT01496326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24707528|NCT01496326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707529|NCT01496326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707530|NCT01496417|Abatacept|abatacept|mesh-list
24707531|NCT01496417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24707532|NCT01496417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707533|NCT01496417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24707570|NCT01496690|Anticonvulsants|anticonvulsants|mesh-ancestor
24707571|NCT01496690|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25874183|NCT05361824|Acetaminophen|acetaminophen|mesh-list
24707605|NCT01496911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707606|NCT01496911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707608|NCT01496911|Dermatologic Agents|dermatologic agents|mesh-ancestor
24707609|NCT01496989|Interleukin-12|interleukin-12|mesh-list
24707610|NCT01496989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24707644|NCT01497093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24707645|NCT01497093|Glucocorticoids|glucocorticoids|mesh-ancestor
24707646|NCT01497093|Hormones|hormones|mesh-ancestor
24707647|NCT01497093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24707648|NCT01497093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24755000|NCT01724268|Hormones|hormones|mesh-ancestor
25874184|NCT05361824|Ketorolac|ketorolac|mesh-list
25874185|NCT05361824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25237604|NCT02549690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237605|NCT02549768|Dexmedetomidine|dexmedetomidine|mesh-list
25237606|NCT02549768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25237607|NCT02549768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24466366|NCT00373282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24466367|NCT00373282|Glucocorticoids|glucocorticoids|mesh-ancestor
24466368|NCT00373282|Hormones|hormones|mesh-ancestor
24466369|NCT00373282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24466370|NCT00373282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874186|NCT05361824|Analgesics|analgesics|mesh-ancestor
25237608|NCT02549768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237609|NCT02549768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25237610|NCT02549768|Analgesics|analgesics|mesh-ancestor
25237611|NCT02549768|Sensory System Agents|sensory system agents|mesh-ancestor
24848843|NCT03391466|Immunologic Factors|immunologic factors|mesh-ancestor
25237612|NCT02549768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25237613|NCT02549768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25237614|NCT02549768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25237615|NCT02549768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25237616|NCT02549768|Adrenergic Agents|adrenergic agents|mesh-ancestor
25237617|NCT02549768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25237618|NCT02549768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237619|NCT02549677|Cyclophosphamide|cyclophosphamide|mesh-list
25237620|NCT02549677|Docetaxel|docetaxel|mesh-list
25237621|NCT02549677|Epirubicin|epirubicin|mesh-list
25237622|NCT02549677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24767250|NCT01799460|Antifungal Agents|antifungal agents|mesh-ancestor
25237623|NCT02549677|Immunologic Factors|immunologic factors|mesh-ancestor
25237624|NCT02549677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237625|NCT02549677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25237626|NCT02549677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25237627|NCT02549677|Alkylating Agents|alkylating agents|mesh-ancestor
25237628|NCT02549677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237629|NCT02549677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25237630|NCT02549677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25237631|NCT02549677|Tubulin Modulators|tubulin modulators|mesh-ancestor
25237632|NCT02549677|Antimitotic Agents|antimitotic agents|mesh-ancestor
25237633|NCT02549677|Mitosis Modulators|mitosis modulators|mesh-ancestor
25237634|NCT02549677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25237635|NCT02549677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25237636|NCT02549677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25237637|NCT02549677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237638|NCT02549651|Durvalumab|durvalumab|mesh-list
25237639|NCT02549651|Tremelimumab|tremelimumab|mesh-list
25237640|NCT02549651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25237641|NCT02549651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25237642|NCT02549261|Etoposide|etoposide|mesh-list
25237643|NCT02549261|Nimotuzumab|nimotuzumab|mesh-list
25237644|NCT02549261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25237645|NCT02549261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25237646|NCT02549261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25237647|NCT02549261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25237648|NCT02549261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237649|NCT02549261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237650|NCT02549261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25237651|NCT02549326|Vitamin D|vitamin d|mesh-list
25237652|NCT02549326|Cholecalciferol|cholecalciferol|mesh-list
24848862|NCT03360721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24707653|NCT01497093|Growth Substances|growth substances|mesh-ancestor
24707654|NCT01497093|Growth Inhibitors|growth inhibitors|mesh-ancestor
25874187|NCT05361824|Sensory System Agents|sensory system agents|mesh-ancestor
24707695|NCT01497431|Selenium|selenium|mesh-list
24707872|NCT01498562|Gefitinib|gefitinib|mesh-list
24707873|NCT01498562|Nimotuzumab|nimotuzumab|mesh-list
24707874|NCT01498562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874188|NCT05361824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25874189|NCT05361824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874190|NCT05361824|Antipyretics|antipyretics|mesh-ancestor
25874191|NCT05361824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25874192|NCT05361824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24707875|NCT01498562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24707876|NCT01498562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707877|NCT01498562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707878|NCT01498562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24621548|NCT01063010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25673513|NCT01759862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25673514|NCT01759862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673515|NCT01759862|Vasodilator Agents|vasodilator agents|mesh-ancestor
25673516|NCT01759862|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25673517|NCT01759862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25673518|NCT01759862|Purinergic Agents|purinergic agents|mesh-ancestor
25673519|NCT01759862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24621550|NCT01063010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621551|NCT01063010|Growth Inhibitors|growth inhibitors|mesh-ancestor
24621552|NCT01063023|Moxifloxacin|moxifloxacin|mesh-list
25673520|NCT01759862|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25673521|NCT01759862|Protective Agents|protective agents|mesh-ancestor
25874193|NCT05361824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25874196|NCT05361824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888546|NCT04502771|Antifungal Agents|antifungal agents|mesh-list
24888547|NCT04502771|Clotrimazole|clotrimazole|mesh-list
24888548|NCT04502771|Miconazole|miconazole|mesh-list
24621553|NCT01063023|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24621554|NCT01063023|Asunaprevir|asunaprevir|mesh-list
24621555|NCT01063023|Protease Inhibitors|protease inhibitors|mesh-ancestor
24621556|NCT01063023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621557|NCT01063023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621558|NCT01063023|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24621559|NCT01063023|Contraceptive Agents|contraceptive agents|mesh-ancestor
24707913|NCT01498809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707914|NCT01498835|Sunitinib|sunitinib|mesh-list
24707915|NCT01498835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24707916|NCT01498835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24707917|NCT01498835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24707918|NCT01498835|Growth Substances|growth substances|mesh-ancestor
24707950|NCT01498913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24707951|NCT01498913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707953|NCT01498926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24708125|NCT01500018|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24708126|NCT01500018|Appetite Depressants|appetite depressants|mesh-ancestor
24708127|NCT01500018|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24708128|NCT01500018|Sympathomimetics|sympathomimetics|mesh-ancestor
24708129|NCT01500018|Autonomic Agents|autonomic agents|mesh-ancestor
24708130|NCT01500018|Adrenergic Agents|adrenergic agents|mesh-ancestor
24708131|NCT01500070|Everolimus|everolimus|mesh-list
24708132|NCT01500070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708133|NCT01500070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24708134|NCT01500070|Immunologic Factors|immunologic factors|mesh-ancestor
24708135|NCT01500070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708136|NCT01500161|Cytarabine|cytarabine|mesh-list
25237653|NCT02549326|Vitamins|vitamins|mesh-ancestor
25237654|NCT02549326|Micronutrients|micronutrients|mesh-ancestor
25237655|NCT02549326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237656|NCT02549326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25237657|NCT02549326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25237658|NCT02549469|Naproxen|naproxen|mesh-list
25237659|NCT02549469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25237660|NCT02549469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25237661|NCT02549469|Analgesics|analgesics|mesh-ancestor
25237662|NCT02549469|Sensory System Agents|sensory system agents|mesh-ancestor
25237663|NCT02549469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24848863|NCT03360721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24848864|NCT03360721|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24848865|NCT03360721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24848866|NCT03360721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848867|NCT03360721|Hormone Antagonists|hormone antagonists|mesh-ancestor
24848868|NCT03360721|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24848869|NCT03350815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24848870|NCT03350815|Immunologic Factors|immunologic factors|mesh-ancestor
24848871|NCT03350815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848872|NCT03347331|Befiradol|befiradol|mesh-list
24848873|NCT03347331|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24848874|NCT03347331|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24848875|NCT03347331|Serotonin Agents|serotonin agents|mesh-ancestor
24848876|NCT03347331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24848877|NCT03347331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848878|NCT03347331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848879|NCT03319745|Pembrolizumab|pembrolizumab|mesh-list
25673522|NCT01760304|Budesonide|budesonide|mesh-list
25673523|NCT01760304|Formoterol Fumarate|formoterol fumarate|mesh-list
25673524|NCT01760304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25673525|NCT01760304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25673526|NCT01760304|Autonomic Agents|autonomic agents|mesh-ancestor
25874198|NCT05357989|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25874199|NCT05357989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874200|NCT05357989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874201|NCT05357989|Cholinergic Agents|cholinergic agents|mesh-ancestor
25237668|NCT02549469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25237669|NCT02549469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237670|NCT02549469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237672|NCT02549391|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25237673|NCT02549391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237674|NCT02549391|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25237675|NCT02549391|Hormone Antagonists|hormone antagonists|mesh-ancestor
25237676|NCT02549391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25237677|NCT02549430|Letrozole|letrozole|mesh-list
25237678|NCT02549430|Fulvestrant|fulvestrant|mesh-list
25237679|NCT02549430|Palbociclib|palbociclib|mesh-list
25237680|NCT02549430|Anastrozole|anastrozole|mesh-list
25237681|NCT02549430|Exemestane|exemestane|mesh-list
25237682|NCT02549430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25237683|NCT02549430|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25237684|NCT02549430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25237685|NCT02549430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237686|NCT02549430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237687|NCT02549430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25237688|NCT02549430|Hormone Antagonists|hormone antagonists|mesh-ancestor
25237689|NCT02549430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25228127|NCT02609646|Linezolid|linezolid|mesh-list
25237690|NCT02549430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237691|NCT02549430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25237692|NCT02549430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25237693|NCT02549430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25237694|NCT02549105|Lidocaine|lidocaine|mesh-list
25237695|NCT02549105|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25237696|NCT02549105|Anesthetics, Local|anesthetics, local|mesh-ancestor
25237697|NCT02549105|Anesthetics|anesthetics|mesh-ancestor
25237698|NCT02549105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25237699|NCT02549105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237700|NCT02549105|Sensory System Agents|sensory system agents|mesh-ancestor
25237701|NCT02549105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25237702|NCT02549105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25237703|NCT02549105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24848926|NCT03283488|Appetite Stimulants|appetite stimulants|mesh-ancestor
24848927|NCT03283488|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24848928|NCT03282916|Valacyclovir|valacyclovir|mesh-list
24848929|NCT03282916|Antiviral Agents|antiviral agents|mesh-ancestor
24848930|NCT03282916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24848931|NCT03257163|Pembrolizumab|pembrolizumab|mesh-list
24488137|NCT00466791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044863|NCT01025648|Adrenergic Agents|adrenergic agents|mesh-ancestor
25044864|NCT01025648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25044865|NCT01025648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044866|NCT01025648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044867|NCT01025648|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25044868|NCT01025648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25044869|NCT01025648|Autonomic Agents|autonomic agents|mesh-ancestor
25044873|NCT01025648|Mydriatics|mydriatics|mesh-ancestor
25154944|NCT05468372|Amphotericin B|amphotericin b|mesh-list
25154945|NCT05468372|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25154946|NCT05468372|Posaconazole|posaconazole|mesh-list
25154947|NCT05468372|Amebicides|amebicides|mesh-ancestor
24708137|NCT01500161|Fludarabine|fludarabine|mesh-list
24708138|NCT01500161|Etoposide|etoposide|mesh-list
24708139|NCT01500161|Melphalan|melphalan|mesh-list
24708140|NCT01500161|Busulfan|busulfan|mesh-list
24708141|NCT01500161|Carmustine|carmustine|mesh-list
24708142|NCT01500161|Clofarabine|clofarabine|mesh-list
24708143|NCT01500161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708144|NCT01500161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24708145|NCT01500161|Antimetabolites|antimetabolites|mesh-ancestor
25237711|NCT02548923|Dexmedetomidine|dexmedetomidine|mesh-list
24466872|NCT00375375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24767717|NCT01802814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24767718|NCT01802814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767719|NCT01802892|Plerixafor|plerixafor|mesh-list
24466873|NCT00375388|Metformin|metformin|mesh-list
25237712|NCT02548923|Propofol|propofol|mesh-list
25237713|NCT02548923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25237714|NCT02548923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25237715|NCT02548923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237716|NCT02548923|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25237717|NCT02548923|Anesthetics, General|anesthetics, general|mesh-ancestor
25237718|NCT02548923|Anesthetics|anesthetics|mesh-ancestor
25237719|NCT02548923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25237720|NCT02548923|Analgesics|analgesics|mesh-ancestor
25237721|NCT02548923|Sensory System Agents|sensory system agents|mesh-ancestor
25237722|NCT02548923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25237723|NCT02548923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25237724|NCT02548923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25237725|NCT02548923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25237726|NCT02548923|Adrenergic Agents|adrenergic agents|mesh-ancestor
25237727|NCT02548923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25154949|NCT05468372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25154950|NCT05468372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25154951|NCT05468372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25154952|NCT05468372|Antifungal Agents|antifungal agents|mesh-ancestor
25154953|NCT05468372|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25154954|NCT05468372|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25154955|NCT05468372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25154956|NCT05468372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25154957|NCT05468372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154958|NCT05468372|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25154959|NCT05468372|Hormone Antagonists|hormone antagonists|mesh-ancestor
25154960|NCT05468372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25154961|NCT05468372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466874|NCT00375388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25237737|NCT02549118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25237738|NCT02549118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25237739|NCT02549118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25237740|NCT02549118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25237741|NCT02549118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25237742|NCT02549118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25237743|NCT02549118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25237744|NCT02549118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237745|NCT02549118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237746|NCT02548975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
25237747|NCT02548975|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25237748|NCT02548975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25237749|NCT02548975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25237750|NCT02548975|Antimetabolites|antimetabolites|mesh-ancestor
25237751|NCT02548975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237752|NCT02548975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237753|NCT02548975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25237754|NCT02548975|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25237755|NCT02548975|Adrenergic Agents|adrenergic agents|mesh-ancestor
25237756|NCT02548975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25237757|NCT02548975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237759|NCT02549066|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25237760|NCT02549066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25237761|NCT02549066|Vasodilator Agents|vasodilator agents|mesh-ancestor
25237762|NCT02549066|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25237763|NCT02549066|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25237764|NCT02549066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25154993|NCT05468294|Nivolumab|nivolumab|mesh-list
25154994|NCT05468294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25154995|NCT05468294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25154996|NCT05468294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25154997|NCT05468294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154998|NCT05468242|Bevacizumab|bevacizumab|mesh-list
25154999|NCT05468242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25155000|NCT05468242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673527|NCT01760304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25673528|NCT01760304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673529|NCT01760304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25155005|NCT05468242|Growth Inhibitors|growth inhibitors|mesh-ancestor
25155006|NCT05468203|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
24708157|NCT01500161|Alkylating Agents|alkylating agents|mesh-ancestor
24708158|NCT01500161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24708159|NCT01500408|Interferons|interferons|mesh-list
24708160|NCT01500408|Interferon-beta|interferon-beta|mesh-list
24708161|NCT01500408|Interferon beta-1a|interferon beta-1a|mesh-list
24708162|NCT01500408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708163|NCT01500408|Antiviral Agents|antiviral agents|mesh-ancestor
24708164|NCT01500408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24708165|NCT01500408|Immunologic Factors|immunologic factors|mesh-ancestor
24708166|NCT01500408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708167|NCT01500408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24708168|NCT01500473|Desogestrel|desogestrel|mesh-list
24613912|NCT01021579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24708333|NCT01501123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25237765|NCT02549066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237766|NCT02549066|Protective Agents|protective agents|mesh-ancestor
25237767|NCT02549066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237768|NCT02548936|Simvastatin|simvastatin|mesh-list
25237769|NCT02548936|Ezetimibe|ezetimibe|mesh-list
25237770|NCT02548936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25237771|NCT02548936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25237772|NCT02548936|Antimetabolites|antimetabolites|mesh-ancestor
25237773|NCT02548936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237774|NCT02548936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25237775|NCT02548936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25237776|NCT02548936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237777|NCT02548832|Magnesium Oxide|magnesium oxide|mesh-list
25237778|NCT02548832|Bezafibrate|bezafibrate|mesh-list
25237779|NCT02548832|Antacids|antacids|mesh-ancestor
25237780|NCT02548832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237781|NCT02548832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25237782|NCT02548832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25237783|NCT02548832|Antimetabolites|antimetabolites|mesh-ancestor
25237784|NCT02548832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25237785|NCT02548806|Clonidine|clonidine|mesh-list
25237786|NCT02548806|Analgesics|analgesics|mesh-ancestor
25237787|NCT02548806|Sensory System Agents|sensory system agents|mesh-ancestor
25237788|NCT02548806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24848968|NCT03170882|Pomalidomide|pomalidomide|mesh-list
24848969|NCT03170882|Ixazomib|ixazomib|mesh-list
24848990|NCT03165994|Carboplatin|carboplatin|mesh-list
24848991|NCT03165994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24848992|NCT03165994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25237789|NCT02548806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237790|NCT02548806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25237791|NCT02548806|Sympatholytics|sympatholytics|mesh-ancestor
25237792|NCT02548806|Autonomic Agents|autonomic agents|mesh-ancestor
25237793|NCT02548806|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25237794|NCT02548806|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25237795|NCT02548806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25237796|NCT02548806|Adrenergic Agents|adrenergic agents|mesh-ancestor
25237797|NCT02548806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25237798|NCT02548806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237799|NCT02548741|Metformin|metformin|mesh-list
25237800|NCT02548741|Calcium Carbonate|calcium carbonate|mesh-list
25237801|NCT02548741|Calcium|calcium|mesh-list
25237802|NCT02548741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25673530|NCT01760304|Respiratory System Agents|respiratory system agents|mesh-ancestor
25673531|NCT01760304|Glucocorticoids|glucocorticoids|mesh-ancestor
25237803|NCT02548741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237804|NCT02548741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25237805|NCT02548741|Antacids|antacids|mesh-ancestor
25237815|NCT02548468|Vidarabine|vidarabine|mesh-list
25237816|NCT02548468|Mycophenolic Acid|mycophenolic acid|mesh-list
25237817|NCT02548468|Cyclophosphamide|cyclophosphamide|mesh-list
25237818|NCT02548468|Fludarabine|fludarabine|mesh-list
25237819|NCT02548468|Fludarabine phosphate|fludarabine phosphate|mesh-list
25237821|NCT02548468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25237822|NCT02548468|Immunologic Factors|immunologic factors|mesh-ancestor
25237823|NCT02548468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237824|NCT02548468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25237825|NCT02548468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25237826|NCT02548468|Alkylating Agents|alkylating agents|mesh-ancestor
25237827|NCT02548468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237828|NCT02548468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25237829|NCT02548468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25237830|NCT02548468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25237831|NCT02548468|Antimetabolites|antimetabolites|mesh-ancestor
25237832|NCT02548468|Antiviral Agents|antiviral agents|mesh-ancestor
25237833|NCT02548468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25237834|NCT02548468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24849000|NCT03126435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849001|NCT03126435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24849002|NCT03126435|Antiviral Agents|antiviral agents|mesh-ancestor
24849007|NCT03126435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998409|NCT02960646|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24849008|NCT03074318|Avelumab|avelumab|mesh-list
24849009|NCT03074318|Trabectedin|trabectedin|mesh-list
24849010|NCT03074318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24708334|NCT01501123|Anesthetics, General|anesthetics, general|mesh-ancestor
24708335|NCT01501123|Anesthetics|anesthetics|mesh-ancestor
24628092|NCT01096511|Contraceptive Agents|contraceptive agents|mesh-ancestor
24708336|NCT01501123|GABA Modulators|gaba modulators|mesh-ancestor
24708370|NCT01501136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24708371|NCT01501136|Protease Inhibitors|protease inhibitors|mesh-ancestor
24708372|NCT01501136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708373|NCT01501136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708374|NCT01501136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24708375|NCT01501136|Antimetabolites|antimetabolites|mesh-ancestor
24708376|NCT01501136|Antiviral Agents|antiviral agents|mesh-ancestor
25237835|NCT02548468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237836|NCT02548468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25237837|NCT02548468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25237838|NCT02548468|Antitubercular Agents|antitubercular agents|mesh-ancestor
25237839|NCT02548468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25237840|NCT02548611|Clopidogrel|clopidogrel|mesh-list
25237841|NCT02548611|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25237842|NCT02548611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25237843|NCT02548611|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25237844|NCT02548611|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25237845|NCT02548611|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25237846|NCT02548611|Purinergic Agents|purinergic agents|mesh-ancestor
25237847|NCT02548611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25237848|NCT02548611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237849|NCT02548611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237850|NCT02548533|Lidocaine|lidocaine|mesh-list
25237852|NCT02548533|Prilocaine|prilocaine|mesh-list
25237853|NCT02548533|Carticaine|carticaine|mesh-list
25237854|NCT02548533|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25237855|NCT02548533|Anesthetics, Local|anesthetics, local|mesh-ancestor
25237856|NCT02548533|Anesthetics|anesthetics|mesh-ancestor
25237857|NCT02548533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25237858|NCT02548533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237859|NCT02548533|Sensory System Agents|sensory system agents|mesh-ancestor
25237860|NCT02548533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25237861|NCT02548533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25237862|NCT02548533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25237863|NCT02548533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25237864|NCT02548533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25273785|NCT02383030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24849011|NCT03074318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24849012|NCT03074318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24849013|NCT03074318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24849014|NCT03074318|Alkylating Agents|alkylating agents|mesh-ancestor
24849015|NCT03074318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849016|NCT03074318|Immunologic Factors|immunologic factors|mesh-ancestor
24849017|NCT03074318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849018|NCT03043924|Cyproterone Acetate|cyproterone acetate|mesh-list
24849019|NCT03043924|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24849020|NCT03043924|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24849021|NCT03043924|Levonorgestrel|levonorgestrel|mesh-list
24849022|NCT03043924|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24849024|NCT03043924|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24849025|NCT03043924|Cyproterone|cyproterone|mesh-list
24849026|NCT03043924|Estrogens|estrogens|mesh-ancestor
24849027|NCT03043924|Hormones|hormones|mesh-ancestor
24849028|NCT03043924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24849029|NCT03043924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849039|NCT03043924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24849040|NCT03043924|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24849043|NCT03041740|Anticonvulsants|anticonvulsants|mesh-ancestor
24849044|NCT03041740|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24849045|NCT02991456|Ondansetron|ondansetron|mesh-list
24849046|NCT02991456|Rolapitant|rolapitant|mesh-list
24849047|NCT02991456|Antiemetics|antiemetics|mesh-ancestor
24849048|NCT02991456|Autonomic Agents|autonomic agents|mesh-ancestor
24849049|NCT02991456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24849050|NCT02991456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849051|NCT02991456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25237865|NCT02548533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237866|NCT02548533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25237867|NCT02548533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25237868|NCT02548533|Adrenergic Agents|adrenergic agents|mesh-ancestor
25237869|NCT02548533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25237870|NCT02548533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25237872|NCT02548533|Autonomic Agents|autonomic agents|mesh-ancestor
25237873|NCT02548533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25237874|NCT02548533|Respiratory System Agents|respiratory system agents|mesh-ancestor
25237876|NCT02548533|Sympathomimetics|sympathomimetics|mesh-ancestor
25237877|NCT02548533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25673532|NCT01760304|Hormones|hormones|mesh-ancestor
25673533|NCT01760304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25273790|NCT02383030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25273791|NCT02383030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273792|NCT02382757|Insulin|insulin|mesh-list
25273793|NCT02382757|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25273794|NCT02382757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25273795|NCT02382757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273796|NCT02382653|Piroxicam|piroxicam|mesh-list
25273797|NCT02382653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25273798|NCT02382653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25273799|NCT02382653|Analgesics|analgesics|mesh-ancestor
25273800|NCT02382653|Sensory System Agents|sensory system agents|mesh-ancestor
25273801|NCT02382653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25273802|NCT02382653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273803|NCT02382653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25273804|NCT02382653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25273805|NCT02382653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25273806|NCT02382653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273807|NCT02382653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273808|NCT02382679|Vitamins|vitamins|mesh-list
25273809|NCT02382679|Micronutrients|micronutrients|mesh-ancestor
25273810|NCT02382679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273811|NCT02382666|Rolapitant|rolapitant|mesh-list
24488372|NCT00468234|Autonomic Agents|autonomic agents|mesh-ancestor
24849056|NCT02991456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24849057|NCT02991456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849058|NCT02991456|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24849059|NCT02991456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24849060|NCT02991456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24849061|NCT02991456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24849062|NCT02991456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24849063|NCT02991456|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25237881|NCT02548494|Insulin|insulin|mesh-list
25237882|NCT02548494|Insulin Glargine|insulin glargine|mesh-list
24849064|NCT02983578|Durvalumab|durvalumab|mesh-list
25237883|NCT02548494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25237884|NCT02548494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237885|NCT02548403|Simethicone|simethicone|mesh-list
25237886|NCT02548403|Antifoaming Agents|antifoaming agents|mesh-ancestor
25673534|NCT01760304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25673535|NCT01760304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25673536|NCT01760304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25237898|NCT02548117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25237899|NCT02548117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237920|NCT02548286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25237921|NCT02548286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25237922|NCT02548286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25079277|NCT03349008|Entecavir|entecavir|mesh-list
24488412|NCT00468364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25874202|NCT05357989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25065807|NCT05198362|Metoprolol|metoprolol|mesh-list
24708377|NCT01501136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25237923|NCT02548286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237924|NCT02548286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25673537|NCT01760304|Adrenergic Agents|adrenergic agents|mesh-ancestor
25673538|NCT01760304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25673539|NCT01760304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673540|NCT01760785|Valproic Acid|valproic acid|mesh-list
25673541|NCT01760785|Anticonvulsants|anticonvulsants|mesh-ancestor
25673542|NCT01760785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874203|NCT05357989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874204|NCT05352672|Pembrolizumab|pembrolizumab|mesh-list
25874205|NCT05352672|Cemiplimab|cemiplimab|mesh-list
25874206|NCT05352672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25874207|NCT05352672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874208|NCT05350774|Methylprednisolone|methylprednisolone|mesh-list
25874209|NCT05350774|Immunoglobulins|immunoglobulins|mesh-list
24768726|NCT01810393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24768727|NCT01810393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768728|NCT01810458|Acetaminophen|acetaminophen|mesh-list
24768729|NCT01810458|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
24768730|NCT01810458|Lidocaine|lidocaine|mesh-list
24768731|NCT01810458|Fentanyl|fentanyl|mesh-list
24889091|NCT04498260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24889093|NCT04498260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24889094|NCT04498260|Immunologic Factors|immunologic factors|mesh-ancestor
24843800|NCT02229721|Oxytocin|oxytocin|mesh-list
25874212|NCT05350774|gamma-Globulins|gamma-globulins|mesh-list
25874213|NCT05350774|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25874214|NCT05350774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24889129|NCT04497012|Iron|iron|mesh-list
24513019|NCT00578149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24513020|NCT00578149|Growth Substances|growth substances|mesh-ancestor
24768732|NCT01810458|Midazolam|midazolam|mesh-list
25237925|NCT02548286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237926|NCT02548286|Vasodilator Agents|vasodilator agents|mesh-ancestor
25237927|NCT02548286|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25237928|NCT02548286|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25237929|NCT02548052|Betamethasone|betamethasone|mesh-list
25237930|NCT02548052|Betamethasone Valerate|betamethasone valerate|mesh-list
25237931|NCT02548052|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25237932|NCT02548052|Betamethasone benzoate|betamethasone benzoate|mesh-list
25237933|NCT02548052|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25237934|NCT02548052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25237935|NCT02548052|Glucocorticoids|glucocorticoids|mesh-ancestor
25237936|NCT02548052|Hormones|hormones|mesh-ancestor
25237937|NCT02548052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25237938|NCT02548052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237939|NCT02548052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25237940|NCT02548052|Respiratory System Agents|respiratory system agents|mesh-ancestor
25237941|NCT02547597|Atenolol|atenolol|mesh-list
25237942|NCT02547597|Carvedilol|carvedilol|mesh-list
25237943|NCT02547597|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25237944|NCT02547597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25237945|NCT02547597|Adrenergic Agents|adrenergic agents|mesh-ancestor
25237946|NCT02547597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25237947|NCT02547597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237948|NCT02547597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237949|NCT02547597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25237950|NCT02547597|Antioxidants|antioxidants|mesh-ancestor
25237951|NCT02547597|Protective Agents|protective agents|mesh-ancestor
25237952|NCT02547597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25237953|NCT02547597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25237954|NCT02547597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25237955|NCT02547597|Vasodilator Agents|vasodilator agents|mesh-ancestor
25237956|NCT02547597|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25673543|NCT01760785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673544|NCT01760785|GABA Agents|gaba agents|mesh-ancestor
25673545|NCT01760785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25673546|NCT01760785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673547|NCT01760785|Antimanic Agents|antimanic agents|mesh-ancestor
25673548|NCT01760785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25673549|NCT01760785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25673550|NCT01760785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25673551|NCT01761292|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
25673552|NCT01761292|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25673553|NCT01761292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25673554|NCT01761292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673555|NCT01761747|Ponatinib|ponatinib|mesh-list
25673556|NCT01761747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673557|NCT01761747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25673558|NCT01761747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25673559|NCT01761747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673560|NCT01762059|Pancrelipase|pancrelipase|mesh-list
25673561|NCT01762059|Pancreatin|pancreatin|mesh-list
25673562|NCT01762059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24966732|NCT03765827|Micronutrients|micronutrients|mesh-ancestor
24966733|NCT03765827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966734|NCT03765827|Antioxidants|antioxidants|mesh-ancestor
25080670|NCT03336632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25080671|NCT03336632|Dermatologic Agents|dermatologic agents|mesh-ancestor
25237957|NCT02547597|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25874215|NCT05350774|Antiemetics|antiemetics|mesh-ancestor
24849068|NCT02983578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24849069|NCT02983578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24849070|NCT02983578|Immunologic Factors|immunologic factors|mesh-ancestor
24849071|NCT02983578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849072|NCT02940548|Amlodipine|amlodipine|mesh-list
24849073|NCT02940548|Nifedipine|nifedipine|mesh-list
24849074|NCT02940548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24849075|NCT02940548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24849076|NCT02940548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24849077|NCT02940548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849078|NCT02940548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24849087|NCT02915016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24849088|NCT02871401|Valganciclovir|valganciclovir|mesh-list
24849089|NCT02871401|Antiviral Agents|antiviral agents|mesh-ancestor
24849090|NCT02871401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24849091|NCT02801656|Vancomycin|vancomycin|mesh-list
24849092|NCT02801656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24849093|NCT02801656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24609604|NCT00997477|Hormones|hormones|mesh-ancestor
24849094|NCT02689453|Alemtuzumab|alemtuzumab|mesh-list
24849095|NCT02689453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24849096|NCT02689453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25237958|NCT02547597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25237959|NCT02547597|Sympatholytics|sympatholytics|mesh-ancestor
25237960|NCT02547597|Autonomic Agents|autonomic agents|mesh-ancestor
25237961|NCT02547597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25237962|NCT02547597|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25237970|NCT02547870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25237971|NCT02547870|Antiviral Agents|antiviral agents|mesh-ancestor
25237972|NCT02547870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25237973|NCT02547870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25237974|NCT02547870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25237975|NCT02547896|Diclofenac|diclofenac|mesh-list
25237976|NCT02547896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25237977|NCT02547896|Codeine|codeine|mesh-list
25237978|NCT02547896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25237979|NCT02547896|Analgesics|analgesics|mesh-ancestor
25237980|NCT02547896|Sensory System Agents|sensory system agents|mesh-ancestor
25237981|NCT02547896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25237982|NCT02547896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25237983|NCT02547896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25237984|NCT02547896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25673563|NCT01762501|Amlodipine|amlodipine|mesh-list
25673564|NCT01762501|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25673565|NCT01762501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25673566|NCT01762501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25673567|NCT01762501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25673568|NCT01762501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673569|NCT01762501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25874216|NCT05350774|Autonomic Agents|autonomic agents|mesh-ancestor
25874217|NCT05350774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25237985|NCT02547896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25237986|NCT02547896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25237987|NCT02547896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874218|NCT05350774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874219|NCT05350774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25874220|NCT05350774|Glucocorticoids|glucocorticoids|mesh-ancestor
25874221|NCT05350774|Hormones|hormones|mesh-ancestor
25874222|NCT05350774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25874223|NCT05350774|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25874224|NCT05350774|Protective Agents|protective agents|mesh-ancestor
25237990|NCT02547896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25237992|NCT02547896|Respiratory System Agents|respiratory system agents|mesh-ancestor
25237993|NCT02547844|Tenofovir|tenofovir|mesh-list
25237994|NCT02547844|Efavirenz|efavirenz|mesh-list
25237995|NCT02547844|Emtricitabine|emtricitabine|mesh-list
24849105|NCT02684162|Guadecitabine|guadecitabine|mesh-list
24849106|NCT02684162|Azacitidine|azacitidine|mesh-list
24849107|NCT02684162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24849108|NCT02684162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24849109|NCT02684162|Antimetabolites|antimetabolites|mesh-ancestor
24849110|NCT02684162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849111|NCT02684162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849112|NCT02621398|Paclitaxel|paclitaxel|mesh-list
24849113|NCT02621398|Carboplatin|carboplatin|mesh-list
24849114|NCT02621398|Pembrolizumab|pembrolizumab|mesh-list
24849115|NCT02621398|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25155031|NCT05468073|Analgesics|analgesics|mesh-ancestor
24849116|NCT02621398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24849117|NCT02621398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065880|NCT04984889|Protein C|protein c|mesh-list
24708378|NCT01501136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24708379|NCT01501136|Immunologic Factors|immunologic factors|mesh-ancestor
25109681|NCT03122197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708417|NCT01501214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24708418|NCT01501253|Amlodipine|amlodipine|mesh-list
24708419|NCT01501253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24708420|NCT01501253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24708421|NCT01501253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24708422|NCT01501253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708423|NCT01501253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25874225|NCT05350774|Immunologic Factors|immunologic factors|mesh-ancestor
24708455|NCT01501396|Megestrol Acetate|megestrol acetate|mesh-list
24708456|NCT01501396|Mirtazapine|mirtazapine|mesh-list
24708457|NCT01501396|Antidepressive Agents|antidepressive agents|mesh-ancestor
24708458|NCT01501396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24708503|NCT01501448|Estradiol|estradiol|mesh-list
24708504|NCT01501448|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24708539|NCT01501591|Dermatologic Agents|dermatologic agents|mesh-ancestor
24613973|NCT01021865|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
24613974|NCT01021865|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24614010|NCT01022021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614011|NCT01022021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25874226|NCT05345678|Durvalumab|durvalumab|mesh-list
24708647|NCT01501890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24644996|NCT01194778|Hemostatics|hemostatics|mesh-ancestor
24708649|NCT01501890|Progestins|progestins|mesh-ancestor
24708722|NCT01502280|Ascorbic Acid|ascorbic acid|mesh-list
24708723|NCT01502280|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24708724|NCT01502280|Antioxidants|antioxidants|mesh-ancestor
25874227|NCT05345678|Tremelimumab|tremelimumab|mesh-list
24708790|NCT01502943|Atorvastatin|atorvastatin|mesh-list
25237996|NCT02547844|Antiviral Agents|antiviral agents|mesh-ancestor
25237997|NCT02547844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25237998|NCT02547844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25237999|NCT02547844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25238000|NCT02547844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238001|NCT02547844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238002|NCT02547844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25238003|NCT02547844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25238004|NCT02547844|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25238005|NCT02547844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25238006|NCT02547844|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25238007|NCT02547844|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25238008|NCT02547844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25238009|NCT02547844|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25238010|NCT02547519|Insulin|insulin|mesh-list
25238011|NCT02547519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25238012|NCT02547519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238013|NCT02547350|Pirarubicin|pirarubicin|mesh-list
25238014|NCT02547350|Epirubicin|epirubicin|mesh-list
25238015|NCT02547350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25238016|NCT02547350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25238024|NCT02547402|Pravastatin|pravastatin|mesh-list
25238025|NCT02547402|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
25238026|NCT02547402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25238027|NCT02547402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25238031|NCT02547402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25238032|NCT02547402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238033|NCT02547402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25238034|NCT02547480|Irinotecan|irinotecan|mesh-list
25238035|NCT02547480|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25238036|NCT02547480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25238037|NCT02547480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238038|NCT02547480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238039|NCT02547480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25238040|NCT02547025|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25238041|NCT02547025|Amoxicillin|amoxicillin|mesh-list
25238042|NCT02547025|Clarithromycin|clarithromycin|mesh-list
25238043|NCT02547025|Levofloxacin|levofloxacin|mesh-list
25238044|NCT02547025|Ofloxacin|ofloxacin|mesh-list
25238045|NCT02547025|Tetracycline|tetracycline|mesh-list
25238046|NCT02547025|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25238047|NCT02547025|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
25238048|NCT02547025|Rabeprazole|rabeprazole|mesh-list
25673570|NCT01762501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673571|NCT01762501|Vasodilator Agents|vasodilator agents|mesh-ancestor
25673572|NCT01762501|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25673573|NCT01762501|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25673574|NCT01762800|Fluticasone|fluticasone|mesh-list
25238049|NCT02547025|Bismuth|bismuth|mesh-list
25238050|NCT02547025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25238051|NCT02547025|Antitubercular Agents|antitubercular agents|mesh-ancestor
25238052|NCT02547025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25238053|NCT02547025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25673575|NCT01762800|Xhance|xhance|mesh-list
25673576|NCT01762800|Bromides|bromides|mesh-list
25673577|NCT01762800|Tiotropium Bromide|tiotropium bromide|mesh-list
25673578|NCT01762800|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25674581|NCT01774149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25238054|NCT02547025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044926|NCT01019187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044927|NCT01018875|Donepezil|donepezil|mesh-list
25155007|NCT05468203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25155008|NCT05468203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25155009|NCT05468203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155010|NCT05468164|Omeprazole|omeprazole|mesh-list
25155011|NCT05468164|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25155012|NCT05468164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25155013|NCT05468164|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25155014|NCT05468164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25155015|NCT05468164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25155019|NCT05468099|Chlorhexidine|chlorhexidine|mesh-list
25155020|NCT05468099|Povidone-Iodine|povidone-iodine|mesh-list
25155021|NCT05468099|Povidone|povidone|mesh-list
25155022|NCT05468099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25155023|NCT05468099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25155024|NCT05468099|Disinfectants|disinfectants|mesh-ancestor
25155025|NCT05468099|Plasma Substitutes|plasma substitutes|mesh-ancestor
25155026|NCT05468099|Blood Substitutes|blood substitutes|mesh-ancestor
25155027|NCT05468073|Aldesleukin|aldesleukin|mesh-list
25155028|NCT05468073|Interleukin-2|interleukin-2|mesh-list
25155029|NCT05468073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25155030|NCT05468073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25155032|NCT05468073|Sensory System Agents|sensory system agents|mesh-ancestor
25155033|NCT05468073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25155034|NCT05468073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155035|NCT05468073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25155039|NCT05468047|Ketamine|ketamine|mesh-list
25238055|NCT02547025|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25238056|NCT02547025|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25238057|NCT02547025|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25238058|NCT02547025|Renal Agents|renal agents|mesh-ancestor
25238059|NCT02547025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25238060|NCT02547025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25238061|NCT02547025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25238062|NCT02547025|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25238063|NCT02547025|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25238064|NCT02547025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25238065|NCT02547025|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25238066|NCT02547025|Antacids|antacids|mesh-ancestor
25238067|NCT02547155|Anesthetics|anesthetics|mesh-list
25238083|NCT02547116|Antitubercular Agents|antitubercular agents|mesh-ancestor
25238084|NCT02547116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25238085|NCT02547116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25238086|NCT02547116|Leprostatic Agents|leprostatic agents|mesh-ancestor
25238087|NCT02547116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25238088|NCT02547116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238089|NCT02547116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238090|NCT02547116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25238091|NCT02547116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25238092|NCT02547116|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25155042|NCT05468047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25155043|NCT05468047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155044|NCT05468047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25155045|NCT05468047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25155046|NCT05468047|Anesthetics, General|anesthetics, general|mesh-ancestor
25155047|NCT05468047|Anesthetics|anesthetics|mesh-ancestor
25155048|NCT05468047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25155049|NCT05468047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25155050|NCT05468047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24806804|NCT02018263|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25155051|NCT05468047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25673579|NCT01762800|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25673580|NCT01762800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25673581|NCT01762800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25155071|NCT05467852|Dydrogesterone|dydrogesterone|mesh-list
25155072|NCT05467852|Progestins|progestins|mesh-ancestor
25155073|NCT05467852|Hormones|hormones|mesh-ancestor
25155075|NCT05467852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238093|NCT02547116|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25238094|NCT02547116|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25238095|NCT02547116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25238096|NCT02546843|Rocuronium|rocuronium|mesh-list
25238097|NCT02546843|Atracurium|atracurium|mesh-list
25238098|NCT02546843|Cisatracurium|cisatracurium|mesh-list
25238099|NCT02546843|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25238100|NCT02546843|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25238101|NCT02546843|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25238102|NCT02546843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25238103|NCT02546843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238104|NCT02546843|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25238105|NCT02546843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25238106|NCT02546843|Cholinergic Agents|cholinergic agents|mesh-ancestor
25238107|NCT02546843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25238108|NCT02546843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238110|NCT02546791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25238111|NCT02546791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25238112|NCT02546791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238113|NCT02546791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238114|NCT02546804|Chlorhexidine|chlorhexidine|mesh-list
25238115|NCT02546804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25238116|NCT02546804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25238117|NCT02546804|Disinfectants|disinfectants|mesh-ancestor
25238118|NCT02546648|Tranexamic Acid|tranexamic acid|mesh-list
25238119|NCT02546648|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25238120|NCT02546648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25238121|NCT02546648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25238122|NCT02546648|Antimetabolites|antimetabolites|mesh-ancestor
25238123|NCT02546648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238124|NCT02546648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25238125|NCT02546648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25238126|NCT02546648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238127|NCT02546648|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25238128|NCT02546648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25238129|NCT02546648|Hemostatics|hemostatics|mesh-ancestor
25238130|NCT02546648|Coagulants|coagulants|mesh-ancestor
25238131|NCT02546531|Gemcitabine|gemcitabine|mesh-list
25238132|NCT02546531|Pembrolizumab|pembrolizumab|mesh-list
25874228|NCT05345678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24849166|NCT02506959|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
24849167|NCT02506959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24849168|NCT02506959|Antimetabolites|antimetabolites|mesh-ancestor
24849169|NCT02506959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849170|NCT02506959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24849171|NCT02506959|Antiviral Agents|antiviral agents|mesh-ancestor
24849172|NCT02506959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24849173|NCT02506959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708791|NCT01502943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708792|NCT01502943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24708793|NCT01502943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24708794|NCT01502943|Analgesics|analgesics|mesh-ancestor
24708795|NCT01502943|Sensory System Agents|sensory system agents|mesh-ancestor
24708796|NCT01502943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24708797|NCT01502943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24708798|NCT01502943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24708799|NCT01502943|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24708800|NCT01502943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24708801|NCT01502943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708802|NCT01502943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24708803|NCT01502943|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24708805|NCT01502943|Antipyretics|antipyretics|mesh-ancestor
24708806|NCT01502943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24708807|NCT01502943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24708808|NCT01502943|Antimetabolites|antimetabolites|mesh-ancestor
25874229|NCT05345678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25238133|NCT02546531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25238134|NCT02546531|Antimetabolites|antimetabolites|mesh-ancestor
25238135|NCT02546531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238136|NCT02546531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25238137|NCT02546531|Antiviral Agents|antiviral agents|mesh-ancestor
25238138|NCT02546531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25238139|NCT02546531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238140|NCT02546531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25238141|NCT02546531|Immunologic Factors|immunologic factors|mesh-ancestor
25238142|NCT02546531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238143|NCT02546531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25273812|NCT02382666|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25273813|NCT02382666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25273814|NCT02382666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273815|NCT02382666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275633|NCT02370745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25275634|NCT02370758|Valganciclovir|valganciclovir|mesh-list
25275635|NCT02370758|Ganciclovir|ganciclovir|mesh-list
25275636|NCT02370758|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25275637|NCT02370758|Antiviral Agents|antiviral agents|mesh-ancestor
25275638|NCT02370758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25275639|NCT02370758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24849179|NCT02506959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24849180|NCT02506959|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24708834|NCT01503216|Ergocalciferols|ergocalciferols|mesh-list
24708835|NCT01503216|Vitamins|vitamins|mesh-ancestor
24708836|NCT01503216|Micronutrients|micronutrients|mesh-ancestor
24708837|NCT01503216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708838|NCT01503216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24708839|NCT01503216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25109682|NCT03122197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24868551|NCT04325659|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24708840|NCT01503242|Cyclosporine|cyclosporine|mesh-list
24708841|NCT01503242|Mycophenolic Acid|mycophenolic acid|mesh-list
24708842|NCT01503242|Fludarabine|fludarabine|mesh-list
24708843|NCT01503242|Fludarabine phosphate|fludarabine phosphate|mesh-list
24807048|NCT02019459|Nicotine|nicotine|mesh-list
24708845|NCT01503242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24708846|NCT01503242|Cyclosporins|cyclosporins|mesh-list
24708847|NCT01503242|Immunologic Factors|immunologic factors|mesh-ancestor
24708848|NCT01503242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708849|NCT01503242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708850|NCT01503242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24708851|NCT01503242|Antimetabolites|antimetabolites|mesh-ancestor
24708852|NCT01503242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708853|NCT01503242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24708854|NCT01503242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708855|NCT01503242|Antifungal Agents|antifungal agents|mesh-ancestor
24708856|NCT01503242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24708857|NCT01503242|Dermatologic Agents|dermatologic agents|mesh-ancestor
24708858|NCT01503242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24708890|NCT01503385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708891|NCT01503398|Olanzapine|olanzapine|mesh-list
24708892|NCT01503398|Antiemetics|antiemetics|mesh-ancestor
24708893|NCT01503398|Autonomic Agents|autonomic agents|mesh-ancestor
24708894|NCT01503398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24708895|NCT01503398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708896|NCT01503398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24614035|NCT01022138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614036|NCT01022138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24614037|NCT01022138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24708934|NCT01503437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24708935|NCT01503437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24708936|NCT01503437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673582|NCT01762800|Autonomic Agents|autonomic agents|mesh-ancestor
25238145|NCT02546440|Dermatologic Agents|dermatologic agents|mesh-ancestor
25238146|NCT02546440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25238147|NCT02546440|Immunologic Factors|immunologic factors|mesh-ancestor
25238148|NCT02546440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238150|NCT02546401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25238151|NCT02546401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238152|NCT02546141|Caseins|caseins|mesh-list
25238153|NCT02546141|Chelating Agents|chelating agents|mesh-ancestor
25238154|NCT02546141|Sequestering Agents|sequestering agents|mesh-ancestor
25275640|NCT02370758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874230|NCT05323435|Vaccines|vaccines|mesh-list
25238155|NCT02546141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238157|NCT02546349|Tiotropium Bromide|tiotropium bromide|mesh-list
25238158|NCT02546349|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25238159|NCT02546349|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25238160|NCT02546349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25238161|NCT02546349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25238162|NCT02546349|Autonomic Agents|autonomic agents|mesh-ancestor
25238163|NCT02546349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25238164|NCT02546349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238165|NCT02546349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25238166|NCT02546349|Respiratory System Agents|respiratory system agents|mesh-ancestor
25238167|NCT02546349|Dermatologic Agents|dermatologic agents|mesh-ancestor
25238168|NCT02546349|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25238169|NCT02546349|Parasympatholytics|parasympatholytics|mesh-ancestor
25238172|NCT02546349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25238173|NCT02546349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238174|NCT02546349|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25238175|NCT02546349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25238176|NCT02546349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25238177|NCT02546349|Adrenergic Agents|adrenergic agents|mesh-ancestor
25238178|NCT02546349|Glucocorticoids|glucocorticoids|mesh-ancestor
25238179|NCT02546349|Hormones|hormones|mesh-ancestor
25238180|NCT02546349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25238181|NCT02546349|Sympathomimetics|sympathomimetics|mesh-ancestor
25238182|NCT02546154|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25238183|NCT02546154|Hematinics|hematinics|mesh-ancestor
25238184|NCT02546297|Budesonide|budesonide|mesh-list
25238185|NCT02546297|Bromides|bromides|mesh-list
25238186|NCT02546297|Formoterol Fumarate|formoterol fumarate|mesh-list
25238187|NCT02546297|Tiotropium Bromide|tiotropium bromide|mesh-list
25238188|NCT02546297|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25238189|NCT02546297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25238190|NCT02546297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25238191|NCT02546297|Autonomic Agents|autonomic agents|mesh-ancestor
24708975|NCT01503658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24708976|NCT01503658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24708977|NCT01503658|Analgesics|analgesics|mesh-ancestor
24708981|NCT01503658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24708982|NCT01503658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24709016|NCT01503788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709017|NCT01503788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24709018|NCT01503788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24709019|NCT01503788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24709020|NCT01503788|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24709021|NCT01503788|Anesthetics, General|anesthetics, general|mesh-ancestor
24755287|NCT01725607|Adrenergic Agents|adrenergic agents|mesh-ancestor
25874231|NCT05323435|Immunologic Factors|immunologic factors|mesh-ancestor
24709055|NCT01503905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24709056|NCT01503905|Tubulin Modulators|tubulin modulators|mesh-ancestor
24709057|NCT01503905|Antimitotic Agents|antimitotic agents|mesh-ancestor
25673583|NCT01762800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24709094|NCT01504074|Hormones|hormones|mesh-ancestor
24709095|NCT01504074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24709096|NCT01504074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621560|NCT01063023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24621561|NCT01063023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621562|NCT01063023|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24621563|NCT01063023|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24621564|NCT01063023|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24621565|NCT01063023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25238192|NCT02546297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25238193|NCT02546297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238194|NCT02546297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25238195|NCT02546297|Respiratory System Agents|respiratory system agents|mesh-ancestor
25238196|NCT02546297|Glucocorticoids|glucocorticoids|mesh-ancestor
25238197|NCT02546297|Hormones|hormones|mesh-ancestor
25238198|NCT02546297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24849194|NCT02296229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621566|NCT01063023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24709097|NCT01504074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709098|NCT01504074|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24709099|NCT01504074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25238199|NCT02546297|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25238200|NCT02546297|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25238201|NCT02546297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25238202|NCT02546297|Adrenergic Agents|adrenergic agents|mesh-ancestor
25238203|NCT02546297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25238204|NCT02546297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238205|NCT02546297|Parasympatholytics|parasympatholytics|mesh-ancestor
25238206|NCT02546297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25238207|NCT02546297|Cholinergic Agents|cholinergic agents|mesh-ancestor
25238208|NCT02546297|Anticonvulsants|anticonvulsants|mesh-ancestor
25238209|NCT02546050|Metformin|metformin|mesh-list
25238210|NCT02546050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25238211|NCT02546050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238212|NCT02546024|Antidepressive Agents|antidepressive agents|mesh-list
25238213|NCT02546024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25238214|NCT02545751|Thymalfasin|thymalfasin|mesh-list
24710270|NCT01509300|Tacrolimus|tacrolimus|mesh-list
25238229|NCT02545712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25238231|NCT02545712|Anesthetics|anesthetics|mesh-ancestor
25238232|NCT02545712|Sensory System Agents|sensory system agents|mesh-ancestor
24849197|NCT02185417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24849198|NCT02185417|Diuretics|diuretics|mesh-ancestor
24849199|NCT02185417|Natriuretic Agents|natriuretic agents|mesh-ancestor
24849200|NCT02185417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849201|NCT02185417|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24849202|NCT02185417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24849203|NCT02185417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849204|NCT02176148|Fluocinonide|fluocinonide|mesh-list
24849205|NCT02176148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24849206|NCT02176148|Glucocorticoids|glucocorticoids|mesh-ancestor
24849207|NCT02176148|Hormones|hormones|mesh-ancestor
25409933|NCT03337009|Naloxone|naloxone|mesh-list
24769749|NCT01815723|Dimethyl Fumarate|dimethyl fumarate|mesh-list
24769750|NCT01815723|Dermatologic Agents|dermatologic agents|mesh-ancestor
24769751|NCT01815723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24782393|NCT01895829|Hematinics|hematinics|mesh-ancestor
25874233|NCT05319587|Cytarabine|cytarabine|mesh-list
24769752|NCT01815723|Immunologic Factors|immunologic factors|mesh-ancestor
24769753|NCT01815723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769754|NCT01815892|Furosemide|furosemide|mesh-list
24769755|NCT01815892|Diuretics|diuretics|mesh-ancestor
24769756|NCT01815892|Natriuretic Agents|natriuretic agents|mesh-ancestor
24849208|NCT02176148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24849209|NCT02176148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849210|NCT02176148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24709101|NCT01504074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24709102|NCT01504074|Adrenergic Agents|adrenergic agents|mesh-ancestor
25238233|NCT02545712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25238234|NCT02545777|Diclofenac|diclofenac|mesh-list
25238235|NCT02545777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25238236|NCT02545777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25238237|NCT02545777|Analgesics|analgesics|mesh-ancestor
25238238|NCT02545777|Sensory System Agents|sensory system agents|mesh-ancestor
25238239|NCT02545777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25238240|NCT02545777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238241|NCT02545777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25238242|NCT02545777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25238243|NCT02545777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25874234|NCT05319587|Annamycin|annamycin|mesh-list
25238244|NCT02545777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238245|NCT02545777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238246|NCT02545972|Tacrolimus|tacrolimus|mesh-list
25238247|NCT02545972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25238248|NCT02545972|Immunologic Factors|immunologic factors|mesh-ancestor
25238249|NCT02545972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238250|NCT02545972|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25238251|NCT02545972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238252|NCT02545972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238253|NCT02545959|Methylprednisolone|methylprednisolone|mesh-list
25238254|NCT02545959|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25238255|NCT02545959|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25238256|NCT02545959|Prednisolone|prednisolone|mesh-list
25238257|NCT02545959|Prednisolone acetate|prednisolone acetate|mesh-list
25238258|NCT02545959|Rituximab|rituximab|mesh-list
25238259|NCT02545959|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25238260|NCT02545959|Prednisolone phosphate|prednisolone phosphate|mesh-list
25238261|NCT02545959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25238262|NCT02545959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25238263|NCT02545959|Immunologic Factors|immunologic factors|mesh-ancestor
25238264|NCT02545959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238265|NCT02545959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25238266|NCT02545959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25238267|NCT02545959|Antiemetics|antiemetics|mesh-ancestor
25673584|NCT01762800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673585|NCT01762800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25673586|NCT01762800|Respiratory System Agents|respiratory system agents|mesh-ancestor
25673587|NCT01762800|Dermatologic Agents|dermatologic agents|mesh-ancestor
25673588|NCT01762800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25673589|NCT01762800|Parasympatholytics|parasympatholytics|mesh-ancestor
25673590|NCT01762800|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25673591|NCT01762800|Cholinergic Agents|cholinergic agents|mesh-ancestor
25673592|NCT01762800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25673593|NCT01762800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874235|NCT05319587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25874236|NCT05319587|Antimetabolites|antimetabolites|mesh-ancestor
25874237|NCT05319587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874238|NCT05319587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874239|NCT05319587|Antiviral Agents|antiviral agents|mesh-ancestor
25874240|NCT05319587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25874241|NCT05319587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25874242|NCT05319587|Immunologic Factors|immunologic factors|mesh-ancestor
25874243|NCT05319587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709103|NCT01504074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24709104|NCT01504074|Sympatholytics|sympatholytics|mesh-ancestor
24709105|NCT01504074|Autonomic Agents|autonomic agents|mesh-ancestor
25238268|NCT02545959|Autonomic Agents|autonomic agents|mesh-ancestor
25238269|NCT02545959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25238270|NCT02545959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25238271|NCT02545959|Glucocorticoids|glucocorticoids|mesh-ancestor
25238272|NCT02545959|Hormones|hormones|mesh-ancestor
25238273|NCT02545959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25238274|NCT02545959|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25238275|NCT02545959|Protective Agents|protective agents|mesh-ancestor
25238276|NCT02545959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25238277|NCT02545634|Sulfalene|sulfalene|mesh-list
25238278|NCT02545634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25238279|NCT02545634|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25238280|NCT02545634|Renal Agents|renal agents|mesh-ancestor
25238281|NCT02545634|Antimalarials|antimalarials|mesh-ancestor
25238282|NCT02545634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25238283|NCT02545634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25238284|NCT02545738|Liraglutide|liraglutide|mesh-list
25238285|NCT02545738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25238286|NCT02545738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238287|NCT02545738|Incretins|incretins|mesh-ancestor
25238288|NCT02545738|Hormones|hormones|mesh-ancestor
25238289|NCT02545738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25238290|NCT02545465|Riociguat|riociguat|mesh-list
25238291|NCT02545465|Enzyme Activators|enzyme activators|mesh-ancestor
25238294|NCT02545426|Calcium|calcium|mesh-list
25238295|NCT02545426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25238296|NCT02545426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238297|NCT02545426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25238298|NCT02545530|Clonidine|clonidine|mesh-list
25238299|NCT02545530|Analgesics|analgesics|mesh-ancestor
25238300|NCT02545530|Sensory System Agents|sensory system agents|mesh-ancestor
25238301|NCT02545530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25238302|NCT02545530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238303|NCT02545530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24849268|NCT01659606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709107|NCT01504126|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24709108|NCT01504126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24709109|NCT01504126|Adrenergic Agents|adrenergic agents|mesh-ancestor
24709110|NCT01504126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24709111|NCT01504126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709143|NCT01504178|Emetics|emetics|mesh-ancestor
24709144|NCT01504178|Autonomic Agents|autonomic agents|mesh-ancestor
24709145|NCT01504178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24709146|NCT01504178|Dopamine Agonists|dopamine agonists|mesh-ancestor
24709147|NCT01504256|Leucovorin|leucovorin|mesh-list
24709150|NCT01504256|Oxaliplatin|oxaliplatin|mesh-list
24709151|NCT01504256|Catumaxomab|catumaxomab|mesh-list
24709152|NCT01504256|Antibodies, Bispecific|antibodies, bispecific|mesh-list
24709154|NCT01504256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24709155|NCT01504256|Tubulin Modulators|tubulin modulators|mesh-ancestor
24709156|NCT01504256|Antimitotic Agents|antimitotic agents|mesh-ancestor
24709157|NCT01504256|Mitosis Modulators|mitosis modulators|mesh-ancestor
24709193|NCT01504347|Immunologic Factors|immunologic factors|mesh-ancestor
24709194|NCT01504347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709195|NCT01504386|Ropivacaine|ropivacaine|mesh-list
24709196|NCT01504386|Anesthetics, Local|anesthetics, local|mesh-ancestor
24709197|NCT01504386|Anesthetics|anesthetics|mesh-ancestor
24709198|NCT01504386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25874258|NCT05305885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24619557|NCT01052987|Tranilast|tranilast|mesh-list
24709226|NCT01504581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24709227|NCT01504620|Insulin|insulin|mesh-list
24709228|NCT01504620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24709229|NCT01504620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709230|NCT01504646|Lyprinol|lyprinol|mesh-list
24709231|NCT01504646|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24614061|NCT01022164|Hemostatics|hemostatics|mesh-ancestor
24709233|NCT01504646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24709310|NCT01505088|Prednisolone phosphate|prednisolone phosphate|mesh-list
24709311|NCT01505088|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24709312|NCT01505088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24709313|NCT01505088|Antiemetics|antiemetics|mesh-ancestor
24709314|NCT01505088|Autonomic Agents|autonomic agents|mesh-ancestor
24709315|NCT01505088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24709316|NCT01505088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709345|NCT01505127|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24709346|NCT01505218|Propofol|propofol|mesh-list
24709347|NCT01505218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24709348|NCT01505218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24709349|NCT01505218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238304|NCT02545530|Sympatholytics|sympatholytics|mesh-ancestor
25238305|NCT02545530|Autonomic Agents|autonomic agents|mesh-ancestor
25238306|NCT02545530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25238307|NCT02545530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25238308|NCT02545530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25238309|NCT02545530|Adrenergic Agents|adrenergic agents|mesh-ancestor
25238310|NCT02545530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25238311|NCT02545530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238312|NCT02545452|Anastrozole|anastrozole|mesh-list
25238313|NCT02545452|Levonorgestrel|levonorgestrel|mesh-list
24849269|NCT01659606|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24849270|NCT01659606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849271|NCT01659606|Antifungal Agents|antifungal agents|mesh-ancestor
24849272|NCT01659606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24849273|NCT01659606|Dermatologic Agents|dermatologic agents|mesh-ancestor
24849274|NCT01659606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24849275|NCT01659606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24849276|NCT01659606|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24849277|NCT01659606|Antitubercular Agents|antitubercular agents|mesh-ancestor
24849278|NCT01659606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24849279|NCT01659606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25066200|NCT04119453|Apatinib|apatinib|mesh-list
24709350|NCT01505218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24709351|NCT01505218|Anesthetics, General|anesthetics, general|mesh-ancestor
24709352|NCT01505218|Anesthetics|anesthetics|mesh-ancestor
24709353|NCT01505231|Vasopressins|vasopressins|mesh-list
24709354|NCT01505231|Arginine Vasopressin|arginine vasopressin|mesh-list
24709355|NCT01505231|Norepinephrine|norepinephrine|mesh-list
24709356|NCT01505231|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24709357|NCT01505231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24709358|NCT01505231|Adrenergic Agents|adrenergic agents|mesh-ancestor
24709359|NCT01505231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24709360|NCT01505231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709392|NCT01505413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24709404|NCT01505426|Metformin|metformin|mesh-list
24709407|NCT01505426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709408|NCT01505426|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24709443|NCT01505777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868698|NCT03474640|Antibodies|antibodies|mesh-list
24709476|NCT01505946|Coagulants|coagulants|mesh-ancestor
24709477|NCT01505998|Amlodipine|amlodipine|mesh-list
24709478|NCT01505998|Benazepril|benazepril|mesh-list
24709479|NCT01505998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24709480|NCT01505998|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24709481|NCT01505998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24709482|NCT01505998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709506|NCT01506024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24709507|NCT01506024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709508|NCT01506024|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24709509|NCT01506024|Autonomic Agents|autonomic agents|mesh-ancestor
24709510|NCT01506024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24709511|NCT01506024|Nootropic Agents|nootropic agents|mesh-ancestor
24709512|NCT01506037|Desloratadine|desloratadine|mesh-list
24709513|NCT01506037|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24709514|NCT01506037|Cholinergic Agents|cholinergic agents|mesh-ancestor
24709515|NCT01506037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24876847|NCT03199053|Protease Inhibitors|protease inhibitors|mesh-ancestor
24709525|NCT01506050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24709526|NCT01506050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709527|NCT01506050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709528|NCT01506050|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24709529|NCT01506050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24709530|NCT01506050|Histamine Antagonists|histamine antagonists|mesh-ancestor
24709565|NCT01506167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24709566|NCT01506167|Growth Substances|growth substances|mesh-ancestor
24709567|NCT01506167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709568|NCT01506167|Growth Inhibitors|growth inhibitors|mesh-ancestor
24709569|NCT01506167|Antimetabolites|antimetabolites|mesh-ancestor
24709570|NCT01506167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238314|NCT02545452|Nonoxynol|nonoxynol|mesh-list
25238315|NCT02545452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25238316|NCT02545452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25238317|NCT02545452|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25238318|NCT02545452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25238319|NCT02545452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238320|NCT02545452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238321|NCT02545452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25238322|NCT02545452|Hormone Antagonists|hormone antagonists|mesh-ancestor
25238323|NCT02545452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25238324|NCT02545452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238325|NCT02545452|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24709596|NCT01506388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24709597|NCT01506388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709598|NCT01506388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24709604|NCT01506414|Immunologic Factors|immunologic factors|mesh-ancestor
24709605|NCT01506414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709606|NCT01506414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24709608|NCT01506505|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24709609|NCT01506505|Lisinopril|lisinopril|mesh-list
24709610|NCT01506505|Simvastatin|simvastatin|mesh-list
24621567|NCT01063023|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24621568|NCT01063023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24621580|NCT01063140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788669|NCT01932554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24788670|NCT01932554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24788671|NCT01932554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24788672|NCT01932554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24788673|NCT01932554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788674|NCT01932554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788675|NCT01932554|Anticoagulants|anticoagulants|mesh-ancestor
24788676|NCT01932554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24788677|NCT01932580|Docetaxel|docetaxel|mesh-list
24788678|NCT01932580|Fluorouracil|fluorouracil|mesh-list
24788679|NCT01932580|Oxaliplatin|oxaliplatin|mesh-list
24788680|NCT01932580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24788681|NCT01932580|Tubulin Modulators|tubulin modulators|mesh-ancestor
24788682|NCT01932580|Antimitotic Agents|antimitotic agents|mesh-ancestor
24788683|NCT01932580|Mitosis Modulators|mitosis modulators|mesh-ancestor
24788684|NCT01932580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755519|NCT01726920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24755521|NCT01726920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25238333|NCT02545452|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25874264|NCT05303532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005766|NCT02764489|Thrombin|thrombin|mesh-list
25005767|NCT02764489|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
25005768|NCT02764489|Coagulants|coagulants|mesh-list
25005769|NCT02764489|Hemostatics|hemostatics|mesh-ancestor
25005770|NCT02756845|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25005771|NCT02756845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25005772|NCT02756845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109684|NCT03122197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25109685|NCT03122197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109686|NCT03122197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25109687|NCT03122197|Hormone Antagonists|hormone antagonists|mesh-ancestor
24755550|NCT01727401|PENTA|penta|mesh-list
24709648|NCT01506557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24709649|NCT01506557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709651|NCT01506557|Micronutrients|micronutrients|mesh-ancestor
24709652|NCT01506557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24709653|NCT01506570|Vaccines|vaccines|mesh-list
24709654|NCT01506570|Immunologic Factors|immunologic factors|mesh-ancestor
24709655|NCT01506570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709656|NCT01506622|Fentanyl|fentanyl|mesh-list
24709657|NCT01506622|Propofol|propofol|mesh-list
24709658|NCT01506622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24709659|NCT01506622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25238334|NCT02545231|Pitavastatin|pitavastatin|mesh-list
25238335|NCT02545231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25238336|NCT02545231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25238337|NCT02545231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25238338|NCT02545231|Antimetabolites|antimetabolites|mesh-ancestor
25238339|NCT02545231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238340|NCT02545231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238341|NCT02545231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25238342|NCT02545244|Chlorhexidine|chlorhexidine|mesh-list
25155080|NCT05467826|Antimetabolites|antimetabolites|mesh-ancestor
24709661|NCT01506622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25673594|NCT01762800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25673595|NCT01762800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25673596|NCT01762800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25673597|NCT01762800|Adrenergic Agents|adrenergic agents|mesh-ancestor
25874266|NCT05303064|Antiemetics|antiemetics|mesh-ancestor
25874267|NCT05303064|Autonomic Agents|autonomic agents|mesh-ancestor
25874268|NCT05303064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24709779|NCT01506921|Anesthetics, General|anesthetics, general|mesh-ancestor
24709781|NCT01506921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24709782|NCT01506921|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24709783|NCT01506921|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24709784|NCT01506921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24709785|NCT01506921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709786|NCT01506921|Antidepressive Agents|antidepressive agents|mesh-ancestor
24709787|NCT01506921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24709788|NCT01507064|Sorafenib|sorafenib|mesh-list
24709789|NCT01507064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25238343|NCT02545244|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25238344|NCT02545244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25238345|NCT02545244|Disinfectants|disinfectants|mesh-ancestor
25238346|NCT02545010|Paclitaxel|paclitaxel|mesh-list
25238347|NCT02545010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25238348|NCT02545010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25238349|NCT02545010|Tubulin Modulators|tubulin modulators|mesh-ancestor
25238350|NCT02545010|Antimitotic Agents|antimitotic agents|mesh-ancestor
25238351|NCT02545010|Mitosis Modulators|mitosis modulators|mesh-ancestor
25238352|NCT02545010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238353|NCT02544919|SMOFlipid|smoflipid|mesh-list
25238354|NCT02544919|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25238355|NCT02544919|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25238356|NCT02544919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25238357|NCT02544906|Propofol|propofol|mesh-list
25238358|NCT02544906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25238359|NCT02544906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25238360|NCT02544906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238361|NCT02544906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25238362|NCT02544906|Anesthetics, General|anesthetics, general|mesh-ancestor
25238363|NCT02544906|Anesthetics|anesthetics|mesh-ancestor
25238364|NCT02544880|Tadalafil|tadalafil|mesh-list
25238365|NCT02544880|Vaccines|vaccines|mesh-list
25238366|NCT02544880|Immunologic Factors|immunologic factors|mesh-ancestor
25238367|NCT02544880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238368|NCT02544880|Vasodilator Agents|vasodilator agents|mesh-ancestor
25066249|NCT04019873|Lamivudine|lamivudine|mesh-list
24709790|NCT01507064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24709791|NCT01507064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709822|NCT01507272|Incretins|incretins|mesh-ancestor
24709823|NCT01507272|Hormones|hormones|mesh-ancestor
24709824|NCT01507272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24709825|NCT01507285|Liraglutide|liraglutide|mesh-list
24709826|NCT01507285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24709827|NCT01507285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709828|NCT01507285|Incretins|incretins|mesh-ancestor
24709872|NCT01507428|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24709949|NCT01507701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24709950|NCT01507701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709951|NCT01507727|Tolvaptan|tolvaptan|mesh-list
24709952|NCT01507727|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24709953|NCT01507727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709954|NCT01507727|Natriuretic Agents|natriuretic agents|mesh-ancestor
24709955|NCT01507727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709956|NCT01507740|Bevacizumab|bevacizumab|mesh-list
24709957|NCT01507740|Sorafenib|sorafenib|mesh-list
24709958|NCT01507740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24709959|NCT01507740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24709960|NCT01507740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24709961|NCT01507740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24709962|NCT01507740|Growth Substances|growth substances|mesh-ancestor
24709963|NCT01507740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709964|NCT01507740|Growth Inhibitors|growth inhibitors|mesh-ancestor
24645122|NCT01196013|Clofarabine|clofarabine|mesh-list
25238369|NCT02544880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25238370|NCT02544880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25238371|NCT02544880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238372|NCT02544880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238373|NCT02544880|Urological Agents|urological agents|mesh-ancestor
25238374|NCT02544893|Dexmedetomidine|dexmedetomidine|mesh-list
25238375|NCT02544893|Bupivacaine|bupivacaine|mesh-list
25238376|NCT02544893|Anesthetics, Local|anesthetics, local|mesh-ancestor
25238377|NCT02544893|Anesthetics|anesthetics|mesh-ancestor
25238378|NCT02544893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24710271|NCT01509300|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25238379|NCT02544893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238380|NCT02544893|Sensory System Agents|sensory system agents|mesh-ancestor
25238381|NCT02544893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25238382|NCT02544893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25238383|NCT02544893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25238384|NCT02544893|Analgesics|analgesics|mesh-ancestor
25238385|NCT02544893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25238386|NCT02544893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25874269|NCT05303064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709991|NCT01507922|Autonomic Agents|autonomic agents|mesh-ancestor
24709992|NCT01507922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24709993|NCT01507922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709994|NCT01507974|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24709995|NCT01507974|Amoxicillin|amoxicillin|mesh-list
25874270|NCT05303064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24710007|NCT01507974|Renal Agents|renal agents|mesh-ancestor
24710008|NCT01507974|Antimalarials|antimalarials|mesh-ancestor
24710009|NCT01507974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24710010|NCT01507974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24710011|NCT01507974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24710012|NCT01507974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25409934|NCT03337009|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25874271|NCT05303064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25874272|NCT05303064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25874273|NCT05303064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25874274|NCT05303064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25874275|NCT05303064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24816892|NCT02079506|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24816893|NCT02079506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816894|NCT02079506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24816895|NCT02079506|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24710013|NCT01507974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710014|NCT01507974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24614158|NCT01022645|Micronutrients|micronutrients|mesh-ancestor
24614159|NCT01022658|Insulin|insulin|mesh-list
24614160|NCT01022658|Insulin Detemir|insulin detemir|mesh-list
24614161|NCT01022658|Insulin Aspart|insulin aspart|mesh-list
24614162|NCT01022658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24614163|NCT01022658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614164|NCT01022671|Belotecan|belotecan|mesh-list
24614165|NCT01022671|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24614166|NCT01022671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24614167|NCT01022671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24614168|NCT01022671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614169|NCT01022671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614170|NCT01022736|Gabapentin|gabapentin|mesh-list
24614171|NCT01022736|Analgesics|analgesics|mesh-ancestor
24710020|NCT01508000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24710022|NCT01508000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24710023|NCT01508000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25238387|NCT02544893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25238388|NCT02544893|Adrenergic Agents|adrenergic agents|mesh-ancestor
25238389|NCT02544893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25238390|NCT02544893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238391|NCT02545153|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25238392|NCT02545153|Aprotinin|aprotinin|mesh-list
25238393|NCT02545153|Hemostatics|hemostatics|mesh-ancestor
25238394|NCT02545153|Coagulants|coagulants|mesh-ancestor
25238395|NCT02545153|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25238396|NCT02545153|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25238397|NCT02545153|Protease Inhibitors|protease inhibitors|mesh-ancestor
25238398|NCT02545153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238399|NCT02545153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238400|NCT02544932|Warfarin|warfarin|mesh-list
25238401|NCT02544932|Dabigatran|dabigatran|mesh-list
25238402|NCT02544932|Anticoagulants|anticoagulants|mesh-ancestor
25238403|NCT02544932|Antithrombins|antithrombins|mesh-ancestor
25238404|NCT02544932|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25238405|NCT02544932|Protease Inhibitors|protease inhibitors|mesh-ancestor
25238406|NCT02544932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238407|NCT02544932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849348|NCT00559936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489086|NCT00471406|Dermatologic Agents|dermatologic agents|mesh-ancestor
24849371|NCT00454753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24849372|NCT00454753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045000|NCT01007721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24710024|NCT01508000|Growth Substances|growth substances|mesh-ancestor
24710025|NCT01508000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710026|NCT01508000|Growth Inhibitors|growth inhibitors|mesh-ancestor
24710029|NCT01508104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24710030|NCT01508104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24710031|NCT01508104|Immunologic Factors|immunologic factors|mesh-ancestor
24710057|NCT01508195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24710067|NCT01508221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710068|NCT01508221|Protective Agents|protective agents|mesh-ancestor
24710069|NCT01508221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24710070|NCT01508221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24710071|NCT01508221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24710072|NCT01508221|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24710073|NCT01508221|Vasodilator Agents|vasodilator agents|mesh-ancestor
24710074|NCT01508221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24710076|NCT01508260|Diuretics|diuretics|mesh-ancestor
24710077|NCT01508260|Natriuretic Agents|natriuretic agents|mesh-ancestor
24469425|NCT00385710|Valproic Acid|valproic acid|mesh-list
25673598|NCT01762800|Anticonvulsants|anticonvulsants|mesh-ancestor
25673599|NCT01762800|Glucocorticoids|glucocorticoids|mesh-ancestor
25673600|NCT01762800|Hormones|hormones|mesh-ancestor
25673601|NCT01762800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25673602|NCT01762800|Sympathomimetics|sympathomimetics|mesh-ancestor
25673603|NCT01762904|Ethanol|ethanol|mesh-list
25673604|NCT01762904|Chlorhexidine|chlorhexidine|mesh-list
24710080|NCT01508260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24710112|NCT01508468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710113|NCT01508468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24710114|NCT01508468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24710115|NCT01508468|Natriuretic Agents|natriuretic agents|mesh-ancestor
24710116|NCT01508468|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24710117|NCT01508468|Adrenergic Agents|adrenergic agents|mesh-ancestor
24710118|NCT01508468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24710119|NCT01508468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238408|NCT02544828|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25238409|NCT02544828|Hematinics|hematinics|mesh-ancestor
25238410|NCT02544854|Propofol|propofol|mesh-list
25238411|NCT02544854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25238412|NCT02544854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25238413|NCT02544854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238414|NCT02544854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25238415|NCT02544854|Anesthetics, General|anesthetics, general|mesh-ancestor
25238416|NCT02544854|Anesthetics|anesthetics|mesh-ancestor
25238417|NCT02545114|Tolvaptan|tolvaptan|mesh-list
25238418|NCT02545114|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25238419|NCT02545114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238420|NCT02545114|Natriuretic Agents|natriuretic agents|mesh-ancestor
25238421|NCT02545114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273816|NCT02382380|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
25045002|NCT01007721|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25045003|NCT01007721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045004|NCT01007292|Rituximab|rituximab|mesh-list
25045005|NCT01007292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25045006|NCT01007292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045007|NCT01007292|Immunologic Factors|immunologic factors|mesh-ancestor
25045008|NCT01007292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045009|NCT01007292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25045010|NCT01007097|Glimepiride|glimepiride|mesh-list
25045011|NCT01007097|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25045012|NCT01007097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25045013|NCT01007097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045014|NCT01007097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25045015|NCT01007097|Immunologic Factors|immunologic factors|mesh-ancestor
25045016|NCT01005108|Gabapentin|gabapentin|mesh-list
25045017|NCT01005108|Analgesics|analgesics|mesh-ancestor
25045018|NCT01005108|Sensory System Agents|sensory system agents|mesh-ancestor
25045019|NCT01005108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045020|NCT01005108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849373|NCT00454753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849376|NCT00436254|Immunologic Factors|immunologic factors|mesh-ancestor
24710120|NCT01508468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24755715|NCT01728480|Cisplatin|cisplatin|mesh-list
24710121|NCT01508468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24710122|NCT01508468|Protease Inhibitors|protease inhibitors|mesh-ancestor
24710123|NCT01508468|Hormone Antagonists|hormone antagonists|mesh-ancestor
24710124|NCT01508468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25874276|NCT05303064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24710153|NCT01508637|Adrenergic Agents|adrenergic agents|mesh-ancestor
24710154|NCT01508637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24710155|NCT01508637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710156|NCT01508637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710157|NCT01508637|Urological Agents|urological agents|mesh-ancestor
24710158|NCT01508663|Everolimus|everolimus|mesh-list
24710159|NCT01508663|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24710160|NCT01508663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24710161|NCT01508663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25238422|NCT02544776|Amlodipine|amlodipine|mesh-list
25238423|NCT02544776|Clomiphene|clomiphene|mesh-list
25238424|NCT02544776|Enclomiphene|enclomiphene|mesh-list
25673605|NCT01762904|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25238428|NCT02544776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25238429|NCT02544776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25238430|NCT02544776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25238431|NCT02544776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238432|NCT02544776|Vasodilator Agents|vasodilator agents|mesh-ancestor
25238433|NCT02544776|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25238434|NCT02544776|Hormone Antagonists|hormone antagonists|mesh-ancestor
25238435|NCT02544776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25238436|NCT02544776|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25238437|NCT02544776|Fertility Agents|fertility agents|mesh-ancestor
25238438|NCT02544776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25238439|NCT02544776|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25238440|NCT02544776|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25238441|NCT02544659|Pamidronate|pamidronate|mesh-list
25238442|NCT02544659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25238443|NCT02544659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238444|NCT02544698|Vaccines|vaccines|mesh-list
25238445|NCT02544698|Immunologic Factors|immunologic factors|mesh-ancestor
25238446|NCT02544698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238447|NCT02544789|Clofarabine|clofarabine|mesh-list
25238448|NCT02544789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25238449|NCT02544789|Antimetabolites|antimetabolites|mesh-ancestor
25874277|NCT05303064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25874278|NCT05303064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874279|NCT05303064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25874280|NCT05303064|Serotonin Agents|serotonin agents|mesh-ancestor
25874281|NCT05292339|Triamcinolone|triamcinolone|mesh-list
25874282|NCT05292339|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25874283|NCT05292339|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25874284|NCT05292339|Ketorolac|ketorolac|mesh-list
25874285|NCT05292339|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25874286|NCT05292339|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25874287|NCT05292339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25874288|NCT05292339|Glucocorticoids|glucocorticoids|mesh-ancestor
25155081|NCT05467826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238450|NCT02544789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238452|NCT02544737|Apatinib|apatinib|mesh-list
25238453|NCT02544737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25238454|NCT02544737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25238455|NCT02544737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238456|NCT02544737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238457|NCT02544724|Interleukin-12|interleukin-12|mesh-list
25238458|NCT02544724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25238459|NCT02544724|Immunologic Factors|immunologic factors|mesh-ancestor
25238460|NCT02544724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238461|NCT02544724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25238462|NCT02544724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25238463|NCT02544724|Growth Substances|growth substances|mesh-ancestor
25238464|NCT02544724|Growth Inhibitors|growth inhibitors|mesh-ancestor
25238465|NCT02544724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25238466|NCT02544529|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25238467|NCT02544529|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25238468|NCT02544529|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25238469|NCT02544529|Echothiophate Iodide|echothiophate iodide|mesh-list
25238470|NCT02544529|Laxatives|laxatives|mesh-ancestor
25238471|NCT02544529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25238472|NCT02544529|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25238473|NCT02544529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238474|NCT02544529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673606|NCT01762904|Triclosan|triclosan|mesh-list
25673607|NCT01762904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
25673608|NCT01762904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25673609|NCT01762904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25673610|NCT01762904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673611|NCT01762904|Disinfectants|disinfectants|mesh-ancestor
25238477|NCT02544529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238478|NCT02544529|Miotics|miotics|mesh-ancestor
25238479|NCT02544529|Autonomic Agents|autonomic agents|mesh-ancestor
25273817|NCT02382380|Chelating Agents|chelating agents|mesh-ancestor
24469607|NCT00386529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24469749|NCT00386984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24469750|NCT00386984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849377|NCT00436254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228626|NCT02607202|Paclitaxel|paclitaxel|mesh-list
24849378|NCT00436254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24849379|NCT00358163|Paclitaxel|paclitaxel|mesh-list
25238480|NCT02544529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25238481|NCT02544529|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25238482|NCT02544425|Dexamethasone|dexamethasone|mesh-list
25238483|NCT02544425|Etoposide|etoposide|mesh-list
25238484|NCT02544425|Melphalan|melphalan|mesh-list
25238485|NCT02544425|Busulfan|busulfan|mesh-list
25238486|NCT02544425|Ifosfamide|ifosfamide|mesh-list
25238487|NCT02544425|Asparaginase|asparaginase|mesh-list
25238488|NCT02544425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25238489|NCT02544425|Antiemetics|antiemetics|mesh-ancestor
25238490|NCT02544425|Autonomic Agents|autonomic agents|mesh-ancestor
25238491|NCT02544425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25238492|NCT02544425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238493|NCT02544425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25238494|NCT02544425|Glucocorticoids|glucocorticoids|mesh-ancestor
25238495|NCT02544425|Hormones|hormones|mesh-ancestor
25238496|NCT02544425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25238497|NCT02544425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25238498|NCT02544425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25238499|NCT02544425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25238500|NCT02544425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25238501|NCT02544425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25238502|NCT02544425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238503|NCT02544425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238504|NCT02544425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25238505|NCT02544425|Alkylating Agents|alkylating agents|mesh-ancestor
25238506|NCT02544425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25238507|NCT02544425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25238508|NCT02544425|Immunologic Factors|immunologic factors|mesh-ancestor
25238509|NCT02544282|Acetaminophen|acetaminophen|mesh-list
25238510|NCT02544282|Sufentanil|sufentanil|mesh-list
25238511|NCT02544282|Tramadol|tramadol|mesh-list
25238512|NCT02544282|Pirinitramide|pirinitramide|mesh-list
25238513|NCT02544282|Propofol|propofol|mesh-list
25238514|NCT02544282|Sevoflurane|sevoflurane|mesh-list
25673612|NCT01762904|Dermatologic Agents|dermatologic agents|mesh-ancestor
25673613|NCT01762904|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25673614|NCT01762904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25673615|NCT01762904|Antimetabolites|antimetabolites|mesh-ancestor
25238515|NCT02544282|Levobupivacaine|levobupivacaine|mesh-list
25238516|NCT02544282|Atracurium|atracurium|mesh-list
25874289|NCT05292339|Hormones|hormones|mesh-ancestor
25874290|NCT05292339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25874291|NCT05292339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874292|NCT05292339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25874293|NCT05292339|Immunologic Factors|immunologic factors|mesh-ancestor
25874294|NCT05292339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874295|NCT05292339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874296|NCT05292339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25874297|NCT05292339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25874298|NCT05292339|Analgesics|analgesics|mesh-ancestor
25874299|NCT05292339|Sensory System Agents|sensory system agents|mesh-ancestor
25874300|NCT05292339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24849394|NCT02248571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24849395|NCT02248571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24849396|NCT02248571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25238521|NCT02544282|Anesthetics, General|anesthetics, general|mesh-ancestor
25238522|NCT02544282|Anesthetics|anesthetics|mesh-ancestor
25238523|NCT02544282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25238524|NCT02544282|Analgesics|analgesics|mesh-ancestor
25238525|NCT02544282|Sensory System Agents|sensory system agents|mesh-ancestor
25238526|NCT02544282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25238527|NCT02544282|Antipyretics|antipyretics|mesh-ancestor
25238528|NCT02544282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25238529|NCT02544282|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25238530|NCT02544282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25238531|NCT02544282|Narcotics|narcotics|mesh-ancestor
25238532|NCT02544282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25238533|NCT02544282|Anesthetics, Local|anesthetics, local|mesh-ancestor
25238534|NCT02544282|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25238535|NCT02544282|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25238536|NCT02544282|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25238537|NCT02544282|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25238538|NCT02544282|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25238539|NCT02544282|Cholinergic Agents|cholinergic agents|mesh-ancestor
25238540|NCT02544282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25238541|NCT02544282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238542|NCT02544308|Dexamethasone|dexamethasone|mesh-list
25238543|NCT02544308|Lenalidomide|lenalidomide|mesh-list
25238544|NCT02544308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25238545|NCT02544308|Antiemetics|antiemetics|mesh-ancestor
25238546|NCT02544308|Autonomic Agents|autonomic agents|mesh-ancestor
25238547|NCT02544308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25238548|NCT02544308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238549|NCT02544308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25238550|NCT02544308|Glucocorticoids|glucocorticoids|mesh-ancestor
25238551|NCT02544308|Hormones|hormones|mesh-ancestor
25238552|NCT02544308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25238553|NCT02544308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25238554|NCT02544308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25238555|NCT02544308|Immunologic Factors|immunologic factors|mesh-ancestor
25238556|NCT02544308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25238557|NCT02544308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25238558|NCT02544308|Growth Substances|growth substances|mesh-ancestor
25238559|NCT02544308|Growth Inhibitors|growth inhibitors|mesh-ancestor
25238560|NCT02544191|Goserelin|goserelin|mesh-list
25673616|NCT01762904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673617|NCT01762904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25673618|NCT01762943|Leuprolide|leuprolide|mesh-list
25238561|NCT02544191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25238562|NCT02544191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005777|NCT02586675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25005779|NCT02586675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25005780|NCT02586675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005787|NCT02560805|Losartan|losartan|mesh-list
25005813|NCT02560805|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25005814|NCT02560805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25005815|NCT02560805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25005816|NCT02560805|Vasodilator Agents|vasodilator agents|mesh-ancestor
25005817|NCT02560805|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25005820|NCT02485418|Propofol|propofol|mesh-list
25005821|NCT02485418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25005822|NCT02485418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25005823|NCT02485418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005824|NCT02485418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25005825|NCT02485418|Anesthetics, General|anesthetics, general|mesh-ancestor
25005826|NCT02485418|Anesthetics|anesthetics|mesh-ancestor
25005832|NCT02274571|Estrogens|estrogens|mesh-list
25005833|NCT02274571|Hormones|hormones|mesh-ancestor
25005834|NCT02274571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25005835|NCT02274571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005836|NCT02162420|Cyclophosphamide|cyclophosphamide|mesh-list
25005837|NCT02162420|Fludarabine|fludarabine|mesh-list
25005838|NCT02162420|Alemtuzumab|alemtuzumab|mesh-list
25005839|NCT02162420|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25005840|NCT02162420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25005841|NCT02162420|Immunologic Factors|immunologic factors|mesh-ancestor
25005842|NCT02162420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788719|NCT01933022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005843|NCT02162420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25005844|NCT02162420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24710249|NCT01509209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24710250|NCT01509209|Autonomic Agents|autonomic agents|mesh-ancestor
25238563|NCT02544165|Caffeine|caffeine|mesh-list
25238564|NCT02544165|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25238565|NCT02544165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238566|NCT02544165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25238567|NCT02544165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238568|NCT02544165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238569|NCT02544165|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25238570|NCT02544165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24470139|NCT00388986|Glyburide|glyburide|mesh-list
24710251|NCT01509209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24710252|NCT01509209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24710253|NCT01509209|Respiratory System Agents|respiratory system agents|mesh-ancestor
24710265|NCT01509261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771441|NCT01827280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039925|NCT03594058|Adrenergic Agents|adrenergic agents|mesh-ancestor
24771442|NCT01827280|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24710267|NCT01509300|Cyclophosphamide|cyclophosphamide|mesh-list
24710268|NCT01509300|Rituximab|rituximab|mesh-list
24710269|NCT01509300|Fludarabine|fludarabine|mesh-list
24710272|NCT01509300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24710273|NCT01509300|Immunologic Factors|immunologic factors|mesh-ancestor
24710298|NCT01509391|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
24710299|NCT01509391|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24710300|NCT01509391|Immunologic Factors|immunologic factors|mesh-ancestor
24710612|NCT01511237|Nevirapine|nevirapine|mesh-list
24710302|NCT01509469|Caseins|caseins|mesh-list
24710303|NCT01509469|Chelating Agents|chelating agents|mesh-ancestor
24710304|NCT01509469|Sequestering Agents|sequestering agents|mesh-ancestor
24710305|NCT01509469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710306|NCT01509521|Phenylephrine|phenylephrine|mesh-list
24710307|NCT01509521|Oxymetazoline|oxymetazoline|mesh-list
24710308|NCT01509521|Ephedrine|ephedrine|mesh-list
24710309|NCT01509521|Pseudoephedrine|pseudoephedrine|mesh-list
24710313|NCT01509521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24710314|NCT01509521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710315|NCT01509521|Sympathomimetics|sympathomimetics|mesh-ancestor
24710316|NCT01509521|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24710317|NCT01509521|Nasal Decongestants|nasal decongestants|mesh-ancestor
24710318|NCT01509521|Respiratory System Agents|respiratory system agents|mesh-ancestor
24710319|NCT01509521|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24710386|NCT01510093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710387|NCT01510132|Timolol|timolol|mesh-list
24710388|NCT01510132|Travoprost|travoprost|mesh-list
24710389|NCT01510132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25874301|NCT05292339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24614209|NCT01022918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24614210|NCT01022918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24614211|NCT01022918|Growth Substances|growth substances|mesh-ancestor
24614212|NCT01022918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614213|NCT01022918|Growth Inhibitors|growth inhibitors|mesh-ancestor
25238571|NCT02544165|Purinergic Agents|purinergic agents|mesh-ancestor
25238572|NCT02544165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25238573|NCT02544243|Gemcitabine|gemcitabine|mesh-list
25238574|NCT02544243|Vinorelbine|vinorelbine|mesh-list
25238575|NCT02544243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25238576|NCT02544243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25238577|NCT02544243|Antimetabolites|antimetabolites|mesh-ancestor
25238578|NCT02544243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238579|NCT02544243|Antiviral Agents|antiviral agents|mesh-ancestor
25238580|NCT02544243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25238581|NCT02544243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238582|NCT02544243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25238583|NCT02544243|Immunologic Factors|immunologic factors|mesh-ancestor
25238584|NCT02544243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238585|NCT02544243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25238586|NCT02544243|Tubulin Modulators|tubulin modulators|mesh-ancestor
25238587|NCT02544243|Antimitotic Agents|antimitotic agents|mesh-ancestor
24849447|NCT02248753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24849448|NCT02248753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24849449|NCT02248753|Sympatholytics|sympatholytics|mesh-ancestor
24849450|NCT02248753|Autonomic Agents|autonomic agents|mesh-ancestor
24849451|NCT02248753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24849452|NCT02248753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849453|NCT02248753|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24849454|NCT02248753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24951382|NCT03904849|Cannabidiol|cannabidiol|mesh-list
24614214|NCT01022918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24614215|NCT01022918|Alkylating Agents|alkylating agents|mesh-ancestor
24614216|NCT01022918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614218|NCT01022983|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24614219|NCT01022983|Vasodilator Agents|vasodilator agents|mesh-ancestor
24614220|NCT01022983|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24614221|NCT01022983|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24614222|NCT01022983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25005845|NCT02162420|Alkylating Agents|alkylating agents|mesh-ancestor
25673619|NCT01762943|Estradiol|estradiol|mesh-list
25673620|NCT01762943|Progesterone|progesterone|mesh-list
25673621|NCT01762943|Estrogens|estrogens|mesh-ancestor
25673622|NCT01762943|Hormones|hormones|mesh-ancestor
24614223|NCT01022983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614224|NCT01022983|Protective Agents|protective agents|mesh-ancestor
24614225|NCT01022983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614226|NCT01023087|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24710466|NCT01510613|Immunologic Factors|immunologic factors|mesh-ancestor
24710492|NCT01510860|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24710500|NCT01510990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24710501|NCT01510990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24710502|NCT01510990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710503|NCT01511003|Tacrolimus|tacrolimus|mesh-list
24710504|NCT01511003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24710505|NCT01511003|Immunologic Factors|immunologic factors|mesh-ancestor
24710506|NCT01511003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710507|NCT01511003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24710508|NCT01511003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24710509|NCT01511003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710510|NCT01511029|Moxifloxacin|moxifloxacin|mesh-list
24710511|NCT01511029|Pramipexole|pramipexole|mesh-list
24710512|NCT01511029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24710513|NCT01511029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24710514|NCT01511029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25874302|NCT05292339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25874303|NCT05289908|Folic Acid|folic acid|mesh-list
25874304|NCT05289908|Vitamin B 12|vitamin b 12|mesh-list
25874305|NCT05289908|Hydroxocobalamin|hydroxocobalamin|mesh-list
25874306|NCT05289908|Dexamethasone|dexamethasone|mesh-list
25874307|NCT05289908|Pemetrexed|pemetrexed|mesh-list
25238588|NCT02544243|Mitosis Modulators|mitosis modulators|mesh-ancestor
25238589|NCT02544269|Bupivacaine|bupivacaine|mesh-list
25238590|NCT02544269|Ropivacaine|ropivacaine|mesh-list
25238591|NCT02544269|Anesthetics, Local|anesthetics, local|mesh-ancestor
25238592|NCT02544269|Anesthetics|anesthetics|mesh-ancestor
25238593|NCT02544269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25238594|NCT02544269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238595|NCT02544269|Sensory System Agents|sensory system agents|mesh-ancestor
25238596|NCT02544269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25238597|NCT02544061|Interleukin-12|interleukin-12|mesh-list
25238598|NCT02544061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25238599|NCT02544061|Immunologic Factors|immunologic factors|mesh-ancestor
25238600|NCT02544061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238601|NCT02544061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25238602|NCT02544061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25238603|NCT02544061|Growth Substances|growth substances|mesh-ancestor
25874308|NCT05289908|Vitamins|vitamins|mesh-ancestor
25874309|NCT05289908|Micronutrients|micronutrients|mesh-ancestor
25874310|NCT05289908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874311|NCT05289908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25874312|NCT05289908|Antiemetics|antiemetics|mesh-ancestor
25874313|NCT05289908|Autonomic Agents|autonomic agents|mesh-ancestor
24710515|NCT01511029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24710553|NCT01511146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24710554|NCT01511146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24710555|NCT01511146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24710556|NCT01511146|Immunologic Factors|immunologic factors|mesh-ancestor
24710570|NCT01511172|Liraglutide|liraglutide|mesh-list
24710571|NCT01511172|Glimepiride|glimepiride|mesh-list
24710572|NCT01511172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24470695|NCT00391105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470696|NCT00391105|Analgesics|analgesics|mesh-ancestor
24470697|NCT00391105|Sensory System Agents|sensory system agents|mesh-ancestor
24470698|NCT00391105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24470699|NCT00391144|Triamcinolone|triamcinolone|mesh-list
24470700|NCT00391144|Bevacizumab|bevacizumab|mesh-list
24470701|NCT00391144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24470702|NCT00391144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470743|NCT00391417|Estradiol|estradiol|mesh-list
24470744|NCT00391417|Estrogens|estrogens|mesh-ancestor
24710573|NCT01511172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710574|NCT01511172|Incretins|incretins|mesh-ancestor
24710575|NCT01511172|Hormones|hormones|mesh-ancestor
24710576|NCT01511172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24710577|NCT01511172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24710578|NCT01511172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24710579|NCT01511172|Immunologic Factors|immunologic factors|mesh-ancestor
24710580|NCT01511185|Liraglutide|liraglutide|mesh-list
24710581|NCT01511185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24710582|NCT01511185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874314|NCT05289908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24771715|NCT01829178|Cisplatin|cisplatin|mesh-list
24771716|NCT01829178|Docetaxel|docetaxel|mesh-list
24710583|NCT01511185|Incretins|incretins|mesh-ancestor
24710584|NCT01511185|Hormones|hormones|mesh-ancestor
24710585|NCT01511185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24710586|NCT01511198|Metformin|metformin|mesh-list
24710587|NCT01511198|Liraglutide|liraglutide|mesh-list
24710600|NCT01511211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24710602|NCT01511211|Hormones|hormones|mesh-ancestor
24710713|NCT01511692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710605|NCT01511211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24710606|NCT01511211|Anesthetics, Local|anesthetics, local|mesh-ancestor
24710607|NCT01511211|Anesthetics|anesthetics|mesh-ancestor
24710608|NCT01511211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24710609|NCT01511211|Sensory System Agents|sensory system agents|mesh-ancestor
24710610|NCT01511237|Lamivudine|lamivudine|mesh-list
24710611|NCT01511237|Zidovudine|zidovudine|mesh-list
24710615|NCT01511237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24710616|NCT01511237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710617|NCT01511237|Antiviral Agents|antiviral agents|mesh-ancestor
25238604|NCT02544061|Growth Inhibitors|growth inhibitors|mesh-ancestor
25238605|NCT02544061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25238606|NCT02543879|Azacitidine|azacitidine|mesh-list
25238607|NCT02543879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25238608|NCT02543879|Antimetabolites|antimetabolites|mesh-ancestor
25238609|NCT02543879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238610|NCT02543879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25238611|NCT02543879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238612|NCT05226923|Meropenem|meropenem|mesh-list
25874315|NCT05289908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24614259|NCT01023243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614260|NCT01023243|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24614261|NCT01023243|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24614263|NCT01023243|Antipyretics|antipyretics|mesh-ancestor
24614264|NCT01023334|Lidocaine|lidocaine|mesh-list
24614265|NCT01023334|Anesthetics|anesthetics|mesh-list
24710695|NCT01511562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24619651|NCT01053338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24619652|NCT01053338|Analgesics|analgesics|mesh-ancestor
24619653|NCT01053338|Sensory System Agents|sensory system agents|mesh-ancestor
24619654|NCT01053338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24710696|NCT01511562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710697|NCT01511562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25874316|NCT05289908|Glucocorticoids|glucocorticoids|mesh-ancestor
25874317|NCT05289908|Hormones|hormones|mesh-ancestor
25874318|NCT05289908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25874319|NCT05289908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25874320|NCT05289908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25238613|NCT05226923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24628496|NCT01099436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25238614|NCT05226923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25238615|NCT05226832|Triamcinolone|triamcinolone|mesh-list
25238616|NCT05226832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25238617|NCT05226832|Glucocorticoids|glucocorticoids|mesh-ancestor
25238618|NCT05226832|Hormones|hormones|mesh-ancestor
25238619|NCT05226832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25238620|NCT05226832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238623|NCT05226728|Pembrolizumab|pembrolizumab|mesh-list
25238624|NCT05226728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25238625|NCT05226728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641315|NCT01172912|Etoposide|etoposide|mesh-list
24454035|NCT04520217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24454036|NCT04520217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24454038|NCT04507412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24454039|NCT04507412|Antiemetics|antiemetics|mesh-ancestor
24454040|NCT04507412|Autonomic Agents|autonomic agents|mesh-ancestor
24849493|NCT02248844|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24849494|NCT02248844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24849495|NCT02248844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849496|NCT02248844|Cholinergic Agents|cholinergic agents|mesh-ancestor
25874321|NCT05289908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874322|NCT05289908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673623|NCT01762943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24877790|NCT02417103|Hormones|hormones|mesh-ancestor
24710712|NCT01511692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25273821|NCT02382263|Paclitaxel|paclitaxel|mesh-list
24771936|NCT01830517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24771937|NCT01830517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771938|NCT01830517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24891608|NCT04469114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273822|NCT02382263|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25273823|NCT02382263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25273824|NCT02382263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25273825|NCT02382263|Tubulin Modulators|tubulin modulators|mesh-ancestor
25273826|NCT02382263|Antimitotic Agents|antimitotic agents|mesh-ancestor
25273827|NCT02382263|Mitosis Modulators|mitosis modulators|mesh-ancestor
25273828|NCT02382263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273829|NCT02382263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25273830|NCT02382263|Antimetabolites|antimetabolites|mesh-ancestor
25273831|NCT02382263|Antiviral Agents|antiviral agents|mesh-ancestor
25273832|NCT02382263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25273833|NCT02382263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849497|NCT02248844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25045021|NCT01005108|Anticonvulsants|anticonvulsants|mesh-ancestor
25045022|NCT01005108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25045023|NCT01005108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25045024|NCT01005108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25045025|NCT01005108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24849498|NCT02248844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849499|NCT02248844|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24849500|NCT02248844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24849501|NCT02248870|Dexamethasone|dexamethasone|mesh-list
24849502|NCT02248870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24849503|NCT02248870|Antiemetics|antiemetics|mesh-ancestor
24641352|NCT01173003|Misoprostol|misoprostol|mesh-list
24454041|NCT04507412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24454042|NCT04507412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24454043|NCT04507412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24454044|NCT04507412|Glucocorticoids|glucocorticoids|mesh-ancestor
24454045|NCT04507412|Hormones|hormones|mesh-ancestor
24710728|NCT01511705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24710729|NCT01511705|Serotonin Agents|serotonin agents|mesh-ancestor
24710730|NCT01511705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24710731|NCT01511705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710732|NCT01511705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24710733|NCT01511705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24710734|NCT01511705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24710735|NCT01511705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24710736|NCT01511705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24710737|NCT01511718|Ondansetron|ondansetron|mesh-list
24710738|NCT01511718|Antiemetics|antiemetics|mesh-ancestor
24710739|NCT01511718|Autonomic Agents|autonomic agents|mesh-ancestor
24710740|NCT01511718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24710741|NCT01511718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710742|NCT01511718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24710743|NCT01511718|Antipruritics|antipruritics|mesh-ancestor
24710744|NCT01511718|Dermatologic Agents|dermatologic agents|mesh-ancestor
24710745|NCT01511718|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24710746|NCT01511718|Serotonin Agents|serotonin agents|mesh-ancestor
24710747|NCT01511718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24710748|NCT01511718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710749|NCT01511718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24710750|NCT01511718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24710756|NCT01511731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24710757|NCT01511731|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24710758|NCT01511731|Histamine Antagonists|histamine antagonists|mesh-ancestor
24710759|NCT01511731|Histamine Agents|histamine agents|mesh-ancestor
24710760|NCT01511731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24710761|NCT01511731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710762|NCT01511731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710763|NCT01511757|Fluconazole|fluconazole|mesh-list
24710764|NCT01511757|Antifungal Agents|antifungal agents|mesh-ancestor
24710765|NCT01511757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24710766|NCT01511757|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25673624|NCT01762943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673625|NCT01762943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25673626|NCT01762943|Progestins|progestins|mesh-ancestor
25673627|NCT01762943|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25673628|NCT01762943|Fertility Agents|fertility agents|mesh-ancestor
25238638|NCT05225974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238641|NCT05225974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25238642|NCT05225844|Apatinib|apatinib|mesh-list
25238643|NCT05225844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25238644|NCT05225844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25238645|NCT05225844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238646|NCT05225844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238647|NCT05225831|Cyclophosphamide|cyclophosphamide|mesh-list
25238648|NCT05225831|Fludarabine|fludarabine|mesh-list
25238649|NCT05225831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25238650|NCT05225831|Immunologic Factors|immunologic factors|mesh-ancestor
25238651|NCT05225831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24454046|NCT04507412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24454047|NCT04507412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24454048|NCT04507412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24454049|NCT04485195|Procainamide|procainamide|mesh-list
24454050|NCT04485195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24454051|NCT04485195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24489596|NCT00474136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25874323|NCT05289908|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24849504|NCT02248870|Autonomic Agents|autonomic agents|mesh-ancestor
24710769|NCT01511757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710770|NCT01511757|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24710771|NCT01511757|Hormone Antagonists|hormone antagonists|mesh-ancestor
24710772|NCT01511757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24710773|NCT01511757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710774|NCT01511757|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24710775|NCT01511757|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24710776|NCT01511770|Fluconazole|fluconazole|mesh-list
24710777|NCT01511770|Antifungal Agents|antifungal agents|mesh-ancestor
24710778|NCT01511770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24710794|NCT01511822|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
24710795|NCT01511822|Estradiol|estradiol|mesh-list
24710796|NCT01511822|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24710813|NCT01511822|Diuretics|diuretics|mesh-ancestor
24710814|NCT01511822|Natriuretic Agents|natriuretic agents|mesh-ancestor
24756082|NCT01731158|Sunitinib|sunitinib|mesh-list
24756083|NCT01731158|Everolimus|everolimus|mesh-list
24710815|NCT01511835|Folic Acid|folic acid|mesh-list
24710816|NCT01511835|Vitamin B Complex|vitamin b complex|mesh-list
24710817|NCT01511835|Inositol|inositol|mesh-list
24710818|NCT01511835|Hematinics|hematinics|mesh-ancestor
24710819|NCT01511835|Vitamins|vitamins|mesh-ancestor
24710820|NCT01511835|Micronutrients|micronutrients|mesh-ancestor
24710821|NCT01511835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710822|NCT01511848|Deferasirox|deferasirox|mesh-list
24614271|NCT01023334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24614272|NCT01023334|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24614273|NCT01023334|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24614274|NCT01023334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24614275|NCT01023334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614277|NCT01023347|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24614278|NCT01023347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24614279|NCT01023347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614280|NCT01023347|Tubulin Modulators|tubulin modulators|mesh-ancestor
24614281|NCT01023347|Antimitotic Agents|antimitotic agents|mesh-ancestor
24614282|NCT01023347|Mitosis Modulators|mitosis modulators|mesh-ancestor
25410391|NCT03321981|Tubulin Modulators|tubulin modulators|mesh-ancestor
24772790|NCT01835691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783350|NCT01901276|Omeprazole|omeprazole|mesh-list
24891737|NCT04467931|Candesartan|candesartan|mesh-list
24891738|NCT04467931|Candesartan cilexetil|candesartan cilexetil|mesh-list
24891739|NCT04467931|Ramipril|ramipril|mesh-list
24614283|NCT01023347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614284|NCT01023360|Esomeprazole|esomeprazole|mesh-list
24614285|NCT01023360|Rabeprazole|rabeprazole|mesh-list
24614286|NCT01023360|Pantoprazole|pantoprazole|mesh-list
25238652|NCT05225831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25238653|NCT05225831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25238654|NCT05225831|Alkylating Agents|alkylating agents|mesh-ancestor
25238655|NCT05225831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238656|NCT05225831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25238657|NCT05225831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25238658|NCT05225766|Bupivacaine|bupivacaine|mesh-list
25238659|NCT05225766|Anesthetics, Local|anesthetics, local|mesh-ancestor
25238660|NCT05225766|Anesthetics|anesthetics|mesh-ancestor
25238661|NCT05225766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25238662|NCT05225766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238663|NCT05225766|Sensory System Agents|sensory system agents|mesh-ancestor
25238664|NCT05225766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25238665|NCT05225753|Chrysarobin|chrysarobin|mesh-list
25238666|NCT05225753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25238667|NCT05225753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25238668|NCT05225753|Analgesics|analgesics|mesh-ancestor
24849506|NCT02248870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849507|NCT02248870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24849508|NCT02248870|Glucocorticoids|glucocorticoids|mesh-ancestor
24849510|NCT02248870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24849512|NCT02248870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24849514|NCT02248883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24849515|NCT02248883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25874324|NCT05289908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25874325|NCT05289908|Hematinics|hematinics|mesh-ancestor
25066512|NCT03019588|Paclitaxel|paclitaxel|mesh-list
24614287|NCT01023360|Clopidogrel|clopidogrel|mesh-list
24614288|NCT01023360|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24614289|NCT01023360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24614290|NCT01023360|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24614291|NCT01023360|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24614317|NCT01023425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614319|NCT01023464|Emollients|emollients|mesh-list
24471331|NCT00394537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24471332|NCT00394537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471333|NCT00394537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471334|NCT00394537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24471335|NCT00394537|Sympathomimetics|sympathomimetics|mesh-ancestor
24471336|NCT00394537|Autonomic Agents|autonomic agents|mesh-ancestor
24471340|NCT00394628|Temozolomide|temozolomide|mesh-list
24614320|NCT01023464|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25673629|NCT01762943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25673630|NCT01762943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673631|NCT01762982|Benzalkonium Compounds|benzalkonium compounds|mesh-list
25673632|NCT01762982|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25673633|NCT01762982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25673634|NCT01763164|Dacarbazine|dacarbazine|mesh-list
25874326|NCT05289908|Vitamin B Complex|vitamin b complex|mesh-ancestor
25410392|NCT03321981|Antimitotic Agents|antimitotic agents|mesh-ancestor
25874327|NCT05286827|Olaparib|olaparib|mesh-list
25874328|NCT05286827|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25874329|NCT05286827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874330|NCT05286827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874331|NCT05286827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874332|NCT05286814|Leucovorin|leucovorin|mesh-list
25874333|NCT05286814|Gemcitabine|gemcitabine|mesh-list
25874334|NCT05286814|Dexamethasone|dexamethasone|mesh-list
25874335|NCT05286814|Fluorouracil|fluorouracil|mesh-list
25874336|NCT05286814|Oxaliplatin|oxaliplatin|mesh-list
25874337|NCT05286814|Irinotecan|irinotecan|mesh-list
25874338|NCT05286814|Floxuridine|floxuridine|mesh-list
25874339|NCT05286814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25874340|NCT05286814|Antiemetics|antiemetics|mesh-ancestor
25238694|NCT05162131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25238695|NCT05162131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238696|NCT05162131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238697|NCT05157412|Doxycycline|doxycycline|mesh-list
25238698|NCT05157412|Prednisolone|prednisolone|mesh-list
24489746|NCT00475189|Norinyl|norinyl|mesh-list
24489747|NCT00475189|Mestranol|mestranol|mesh-list
25155102|NCT05466305|Trace Elements|trace elements|mesh-ancestor
25155103|NCT05466305|Micronutrients|micronutrients|mesh-ancestor
25155104|NCT05466305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155105|NCT05464940|Caffeine|caffeine|mesh-list
25155106|NCT05464940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25077063|NCT03368274|Glucocorticoids|glucocorticoids|mesh-ancestor
24811653|NCT02047539|Antipyretics|antipyretics|mesh-ancestor
24811655|NCT02047552|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24811656|NCT02047552|Oxandrolone|oxandrolone|mesh-list
24811657|NCT02047552|Trace Elements|trace elements|mesh-ancestor
24811658|NCT02047552|Micronutrients|micronutrients|mesh-ancestor
24811659|NCT02047552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811660|NCT02047552|Hematinics|hematinics|mesh-ancestor
25238699|NCT05157412|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25238700|NCT05157412|Methylprednisolone|methylprednisolone|mesh-list
25238701|NCT05157412|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25238702|NCT05157412|Prednisolone acetate|prednisolone acetate|mesh-list
25238703|NCT05157412|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25238704|NCT05157412|Prednisolone phosphate|prednisolone phosphate|mesh-list
25238705|NCT05157412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25238706|NCT05157412|Glucocorticoids|glucocorticoids|mesh-ancestor
25238707|NCT05157412|Hormones|hormones|mesh-ancestor
25238708|NCT05157412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25238709|NCT05157412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849571|NCT02249130|Lamivudine|lamivudine|mesh-list
25238727|NCT05155436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25673635|NCT01763164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25673636|NCT01763164|Alkylating Agents|alkylating agents|mesh-ancestor
25874341|NCT05286814|Autonomic Agents|autonomic agents|mesh-ancestor
25874342|NCT05286814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25874343|NCT05286814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874344|NCT05286814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25874345|NCT05286814|Glucocorticoids|glucocorticoids|mesh-ancestor
25874346|NCT05286814|Hormones|hormones|mesh-ancestor
25874347|NCT05286814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24892265|NCT04464629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24773229|NCT01838473|Respiratory System Agents|respiratory system agents|mesh-ancestor
24773230|NCT01838538|Paclitaxel|paclitaxel|mesh-list
24773231|NCT01838538|Bevacizumab|bevacizumab|mesh-list
24773232|NCT01838538|Carboplatin|carboplatin|mesh-list
25238728|NCT05155436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238729|NCT05155436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25238730|NCT05155436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238731|NCT05155436|Vasodilator Agents|vasodilator agents|mesh-ancestor
25238732|NCT05155436|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25238733|NCT05155436|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24711050|NCT01513070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24711051|NCT01513070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711065|NCT01513070|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25238751|NCT05139212|Dexmedetomidine|dexmedetomidine|mesh-list
25238752|NCT05139212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25238753|NCT05139212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25238754|NCT05139212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238755|NCT05139212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25238756|NCT05139212|Analgesics|analgesics|mesh-ancestor
25238757|NCT05139212|Sensory System Agents|sensory system agents|mesh-ancestor
25238758|NCT05139212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25238759|NCT05139212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25238760|NCT05139212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25238761|NCT05139212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25238762|NCT05139212|Adrenergic Agents|adrenergic agents|mesh-ancestor
25238763|NCT05139212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25238764|NCT05139212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849558|NCT02249039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849559|NCT02249039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24849561|NCT02249039|Autonomic Agents|autonomic agents|mesh-ancestor
24849562|NCT02249039|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24711066|NCT01513083|Trastuzumab|trastuzumab|mesh-list
24711067|NCT01513083|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24711093|NCT01513525|Liraglutide|liraglutide|mesh-list
24711094|NCT01513525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25673637|NCT01763164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673638|NCT01763164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673639|NCT01763346|Metformin|metformin|mesh-list
25673640|NCT01763346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25673641|NCT01763346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673642|NCT01763606|Aspirin|aspirin|mesh-list
25673643|NCT01763606|Enoxaparin|enoxaparin|mesh-list
25673644|NCT01763606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25673645|NCT01763606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25673646|NCT01763606|Analgesics|analgesics|mesh-ancestor
25673647|NCT01763606|Sensory System Agents|sensory system agents|mesh-ancestor
25673648|NCT01763606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25673649|NCT01763606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673650|NCT01763606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24849569|NCT02249078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24849570|NCT02249130|Ritonavir|ritonavir|mesh-list
24849580|NCT02249130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788805|NCT01933945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788806|NCT01933945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788808|NCT01933971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24788809|NCT01933971|Immunologic Factors|immunologic factors|mesh-ancestor
24788810|NCT01933971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788811|NCT01933997|Pyridoxine|pyridoxine|mesh-list
24788812|NCT01933997|Metadoxine|metadoxine|mesh-list
24788813|NCT01933997|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24788814|NCT01933997|Vitamin B Complex|vitamin b complex|mesh-ancestor
24788815|NCT01933997|Vitamins|vitamins|mesh-ancestor
24788816|NCT01933997|Micronutrients|micronutrients|mesh-ancestor
24471846|NCT00397059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471847|NCT00397059|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24471848|NCT00397059|Antidepressive Agents|antidepressive agents|mesh-ancestor
24788817|NCT01933997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788818|NCT01934023|Varenicline|varenicline|mesh-list
24788819|NCT01934023|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24788820|NCT01934023|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24788821|NCT01934023|Cholinergic Agents|cholinergic agents|mesh-ancestor
24788822|NCT01934023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24788823|NCT01934023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788824|NCT01934023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788825|NCT01934049|Anesthetics|anesthetics|mesh-list
24711097|NCT01513525|Hormones|hormones|mesh-ancestor
24711098|NCT01513525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24711099|NCT01513564|Morphine|morphine|mesh-list
24711100|NCT01513564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24711101|NCT01513564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711102|NCT01513564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25238811|NCT04861298|Quercetin|quercetin|mesh-list
25238812|NCT04861298|Antioxidants|antioxidants|mesh-ancestor
25238813|NCT04861298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238814|NCT04861298|Protective Agents|protective agents|mesh-ancestor
25238815|NCT04861298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005853|NCT01822652|Fludarabine phosphate|fludarabine phosphate|mesh-list
25005854|NCT01822652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25005855|NCT01822652|Immunologic Factors|immunologic factors|mesh-ancestor
25005856|NCT01822652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005857|NCT01822652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25005858|NCT01822652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25005859|NCT01822652|Alkylating Agents|alkylating agents|mesh-ancestor
24756281|NCT01732068|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25874348|NCT05286814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24471934|NCT00397501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25874349|NCT05286814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874350|NCT05286814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25874351|NCT05286814|Antimetabolites|antimetabolites|mesh-ancestor
25874352|NCT05286814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874353|NCT05286814|Antiviral Agents|antiviral agents|mesh-ancestor
25874354|NCT05286814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25874355|NCT05286814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874356|NCT05286814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25874357|NCT05286814|Immunologic Factors|immunologic factors|mesh-ancestor
25273839|NCT02382354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25273840|NCT02382354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25273841|NCT02382354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273842|NCT02382354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25273843|NCT02382354|Anesthetics, General|anesthetics, general|mesh-ancestor
25273844|NCT02382354|Anesthetics|anesthetics|mesh-ancestor
25273845|NCT02382354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25273846|NCT02382354|Narcotics|narcotics|mesh-ancestor
25273847|NCT02382354|Analgesics|analgesics|mesh-ancestor
25273848|NCT02382354|Sensory System Agents|sensory system agents|mesh-ancestor
25273849|NCT02382354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25273850|NCT02382328|Thioctic Acid|thioctic acid|mesh-list
25273851|NCT02382328|Antioxidants|antioxidants|mesh-ancestor
25273852|NCT02382328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273853|NCT02382328|Protective Agents|protective agents|mesh-ancestor
25273854|NCT02382328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273855|NCT02382328|Vitamin B Complex|vitamin b complex|mesh-ancestor
25273856|NCT02382328|Vitamins|vitamins|mesh-ancestor
25273857|NCT02382328|Micronutrients|micronutrients|mesh-ancestor
25273858|NCT02382198|Glycopyrrolate|glycopyrrolate|mesh-list
25273859|NCT02382198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25273860|NCT02382198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25273861|NCT02382198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25273862|NCT02382198|Cholinergic Agents|cholinergic agents|mesh-ancestor
25273863|NCT02382198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25273864|NCT02382198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273865|NCT02382198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273866|NCT02382523|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25273867|NCT02382523|Hormones|hormones|mesh-ancestor
25273868|NCT02382523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25273869|NCT02382523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273870|NCT02382432|Meperidine|meperidine|mesh-list
25273871|NCT02382432|Dexmedetomidine|dexmedetomidine|mesh-list
24849632|NCT02249442|Protease Inhibitors|protease inhibitors|mesh-ancestor
24849633|NCT02249442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849634|NCT02249442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628588|NCT01100060|Amebicides|amebicides|mesh-ancestor
24471942|NCT00397501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24471943|NCT00397501|Chelating Agents|chelating agents|mesh-ancestor
24711439|NCT01515228|Immunologic Factors|immunologic factors|mesh-ancestor
25874358|NCT05286814|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24849635|NCT02249442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24849636|NCT02249442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24849637|NCT02249442|Antiviral Agents|antiviral agents|mesh-ancestor
25874359|NCT05286814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24711228|NCT01514123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874360|NCT05286814|Antidotes|antidotes|mesh-ancestor
25874361|NCT05286814|Protective Agents|protective agents|mesh-ancestor
25874362|NCT05286814|Vitamin B Complex|vitamin b complex|mesh-ancestor
25874363|NCT05286814|Vitamins|vitamins|mesh-ancestor
25874364|NCT05286814|Micronutrients|micronutrients|mesh-ancestor
25874365|NCT05285813|Acetaminophen|acetaminophen|mesh-list
25874366|NCT05285813|Diphenhydramine|diphenhydramine|mesh-list
25874367|NCT05285813|Promethazine|promethazine|mesh-list
25874368|NCT05285813|Dexamethasone|dexamethasone|mesh-list
25874369|NCT05285813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25874370|NCT05285813|Antiemetics|antiemetics|mesh-ancestor
25874371|NCT05285813|Autonomic Agents|autonomic agents|mesh-ancestor
24711232|NCT01514175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24711234|NCT01514175|Analgesics|analgesics|mesh-ancestor
24711235|NCT01514175|Sensory System Agents|sensory system agents|mesh-ancestor
25874372|NCT05285813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24711265|NCT01514227|Antipyretics|antipyretics|mesh-ancestor
24711266|NCT01514266|Curcumin|curcumin|mesh-list
24711267|NCT01514266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24711268|NCT01514266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24711269|NCT01514266|Analgesics|analgesics|mesh-ancestor
24711270|NCT01514266|Sensory System Agents|sensory system agents|mesh-ancestor
24711271|NCT01514266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24711272|NCT01514266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711273|NCT01514266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24711274|NCT01514266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24711275|NCT01514266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24711276|NCT01514266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874373|NCT05285813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874374|NCT05285813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25874375|NCT05285813|Glucocorticoids|glucocorticoids|mesh-ancestor
25874376|NCT05285813|Hormones|hormones|mesh-ancestor
24711309|NCT01514695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24711310|NCT01514695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24711311|NCT01514695|GABA Modulators|gaba modulators|mesh-ancestor
24711312|NCT01514695|GABA Agents|gaba agents|mesh-ancestor
24711313|NCT01514695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24711314|NCT01514695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711315|NCT01514721|Timolol|timolol|mesh-list
25238846|NCT04844918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25238847|NCT04840628|Respiratory System Agents|respiratory system agents|mesh-list
25238848|NCT04812366|Prednisone|prednisone|mesh-list
25238849|NCT04812366|Docetaxel|docetaxel|mesh-list
25238850|NCT04812366|Atezolizumab|atezolizumab|mesh-list
25238851|NCT04812366|Abiraterone Acetate|abiraterone acetate|mesh-list
25238852|NCT04812366|Niraparib|niraparib|mesh-list
25238853|NCT04812366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25238854|NCT04812366|Tubulin Modulators|tubulin modulators|mesh-ancestor
25238855|NCT04812366|Antimitotic Agents|antimitotic agents|mesh-ancestor
25238856|NCT04812366|Mitosis Modulators|mitosis modulators|mesh-ancestor
25238857|NCT04812366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849638|NCT02249442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24849639|NCT02249442|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24849640|NCT02249442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24849641|NCT02249481|Bupivacaine|bupivacaine|mesh-list
24951720|NCT03901768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25066709|NCT02099175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066710|NCT02099175|Tubulin Modulators|tubulin modulators|mesh-ancestor
25066711|NCT02099175|Antimitotic Agents|antimitotic agents|mesh-ancestor
25066712|NCT02099175|Mitosis Modulators|mitosis modulators|mesh-ancestor
25066713|NCT02099175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066714|NCT02099175|Antimetabolites|antimetabolites|mesh-ancestor
25066715|NCT02099175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25066716|NCT02099175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25066717|NCT02099175|Immunologic Factors|immunologic factors|mesh-ancestor
24829165|NCT02150122|Micronutrients|micronutrients|mesh-ancestor
24917588|NCT04227990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497535|NCT00510393|Everolimus|everolimus|mesh-list
24711318|NCT01514721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24711341|NCT01514825|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24711342|NCT01514825|Protease Inhibitors|protease inhibitors|mesh-ancestor
24711343|NCT01514825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711344|NCT01514825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711345|NCT01514825|Anticoagulants|anticoagulants|mesh-ancestor
24711346|NCT01514838|Acarbose|acarbose|mesh-list
24711347|NCT01514838|Ipragliflozin|ipragliflozin|mesh-list
24711438|NCT01515228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24711474|NCT01515579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24711475|NCT01515579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711477|NCT01515579|Hormones|hormones|mesh-ancestor
24711505|NCT01515813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24711506|NCT01515813|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24711507|NCT01515813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24711508|NCT01515813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410393|NCT03321981|Mitosis Modulators|mitosis modulators|mesh-ancestor
24711510|NCT01515813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24711511|NCT01515813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24711512|NCT01515813|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24711513|NCT01515813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24711592|NCT01516060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25238858|NCT04812366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25238859|NCT04812366|Glucocorticoids|glucocorticoids|mesh-ancestor
25238860|NCT04812366|Hormones|hormones|mesh-ancestor
25238861|NCT04812366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25238862|NCT04812366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238863|NCT04812366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25238867|NCT04812366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25238868|NCT04812366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25238870|NCT04740996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25238871|NCT04740996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25238876|NCT04731779|Cannabidiol|cannabidiol|mesh-list
25238877|NCT04731779|Anticonvulsants|anticonvulsants|mesh-ancestor
25238878|NCT04721626|Chlorhexidine|chlorhexidine|mesh-list
25238879|NCT04721626|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25238880|NCT04721626|Povidone-Iodine|povidone-iodine|mesh-list
25238881|NCT04721626|Tetracycline|tetracycline|mesh-list
25874377|NCT05285813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25874378|NCT05285813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25874379|NCT05285813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874380|NCT05285813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25874381|NCT05285813|Analgesics|analgesics|mesh-ancestor
25874382|NCT05285813|Sensory System Agents|sensory system agents|mesh-ancestor
24849642|NCT02249481|Anesthetics, Local|anesthetics, local|mesh-ancestor
24849643|NCT02249481|Anesthetics|anesthetics|mesh-ancestor
24849644|NCT02249481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24849645|NCT02249481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849646|NCT02249481|Sensory System Agents|sensory system agents|mesh-ancestor
24849647|NCT02249481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24849648|NCT02249546|Amoxicillin|amoxicillin|mesh-list
24849649|NCT02249546|Clarithromycin|clarithromycin|mesh-list
24849650|NCT02249546|Acetylcysteine|acetylcysteine|mesh-list
24849651|NCT02249546|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25874383|NCT05285813|Antipyretics|antipyretics|mesh-ancestor
24965387|NCT03777761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24490248|NCT00477126|Antiviral Agents|antiviral agents|mesh-ancestor
25045026|NCT01005108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25045027|NCT01005108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25045028|NCT01005108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24711593|NCT01516060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711594|NCT01516060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711595|NCT01516060|Antiviral Agents|antiviral agents|mesh-ancestor
24711596|NCT01516060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24711597|NCT01516060|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24711598|NCT01516060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24711599|NCT01516060|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24711600|NCT01516060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24711601|NCT01516060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24711602|NCT01516060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24711603|NCT01516138|Insulin|insulin|mesh-list
25238882|NCT04721626|Doxycycline|doxycycline|mesh-list
25238883|NCT04721626|Povidone|povidone|mesh-list
25238884|NCT04721626|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25238885|NCT04721626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25238886|NCT04721626|Disinfectants|disinfectants|mesh-ancestor
25673651|NCT01763606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25673652|NCT01763606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25673653|NCT01763606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25673654|NCT01763606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673655|NCT01763606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25673656|NCT01763606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25673657|NCT01763606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874384|NCT05285813|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24892449|NCT04462588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25238887|NCT04721626|Dermatologic Agents|dermatologic agents|mesh-ancestor
25238888|NCT04721626|Plasma Substitutes|plasma substitutes|mesh-ancestor
25238889|NCT04721626|Blood Substitutes|blood substitutes|mesh-ancestor
25238890|NCT04721626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25238891|NCT04721626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25238892|NCT04721626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238893|NCT04721626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238894|NCT04721626|Antimalarials|antimalarials|mesh-ancestor
25238895|NCT04721626|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25238896|NCT04721626|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25238902|NCT04649203|Vitamins|vitamins|mesh-ancestor
25238903|NCT04649203|Micronutrients|micronutrients|mesh-ancestor
25238904|NCT04649203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238905|NCT04649203|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25238906|NCT04649203|Dermatologic Agents|dermatologic agents|mesh-ancestor
25238907|NCT04649203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25238908|NCT04649203|Antimetabolites|antimetabolites|mesh-ancestor
25238909|NCT04649203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238910|NCT04649203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25238911|NCT04649203|Vasodilator Agents|vasodilator agents|mesh-ancestor
25238912|NCT04638465|Cisplatin|cisplatin|mesh-list
25238913|NCT04638465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25238914|NCT04634162|Cangrelor|cangrelor|mesh-list
25238915|NCT04634162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25045029|NCT01005108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045031|NCT01004081|Exemestane|exemestane|mesh-list
25045032|NCT01004081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045033|NCT01004081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25045034|NCT01004081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25045035|NCT01004081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045036|NCT01004081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25155107|NCT05464940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155108|NCT05464940|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25155109|NCT05464940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25155110|NCT05464940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25155111|NCT05464940|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25155112|NCT05464940|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25155113|NCT05464940|Purinergic Agents|purinergic agents|mesh-ancestor
25155114|NCT05464940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24711604|NCT01516138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24711605|NCT01516138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711606|NCT01516255|Liraglutide|liraglutide|mesh-list
24711607|NCT01516255|Moxifloxacin|moxifloxacin|mesh-list
24711608|NCT01516255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24711609|NCT01516255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24711672|NCT01516567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24711673|NCT01516567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24711674|NCT01516567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711675|NCT01516567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24711831|NCT01517321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711907|NCT01517555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24711909|NCT01517568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24711984|NCT01517932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712016|NCT01518166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712017|NCT01518166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24712018|NCT01518166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24712019|NCT01518166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24712020|NCT01518166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24712021|NCT01518166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712022|NCT01518166|Incretins|incretins|mesh-ancestor
24712023|NCT01518166|Hormones|hormones|mesh-ancestor
24712024|NCT01518166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24712025|NCT01518166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24712026|NCT01518166|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24712027|NCT01518166|Protective Agents|protective agents|mesh-ancestor
24712028|NCT01518166|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24712064|NCT01518413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25238930|NCT04633148|Alkylating Agents|alkylating agents|mesh-ancestor
25673658|NCT01763606|Antipyretics|antipyretics|mesh-ancestor
25673659|NCT01763606|Anticoagulants|anticoagulants|mesh-ancestor
25238931|NCT04633148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25155115|NCT05464693|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25155116|NCT05464693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25155118|NCT05461131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25155119|NCT05461131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25155130|NCT05455424|Niraparib|niraparib|mesh-list
25155131|NCT05455424|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25155132|NCT05455424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25155133|NCT05455424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25155134|NCT05455424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472333|NCT00398892|Vitamin B Complex|vitamin b complex|mesh-ancestor
24472335|NCT00398892|Micronutrients|micronutrients|mesh-ancestor
24472336|NCT00398905|Enoxaparin|enoxaparin|mesh-list
24472337|NCT00398905|Rivaroxaban|rivaroxaban|mesh-list
24472338|NCT00398905|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24472339|NCT00398905|Antithrombins|antithrombins|mesh-ancestor
25066771|NCT00493896|Enoxaparin|enoxaparin|mesh-list
24498321|NCT00513981|Leucovorin|leucovorin|mesh-list
24712066|NCT01518413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238932|NCT04633148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25238933|NCT04633148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25238934|NCT04627753|Rituximab|rituximab|mesh-list
25238935|NCT04627753|Lenalidomide|lenalidomide|mesh-list
25238936|NCT04627753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25238937|NCT04627753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25238938|NCT04627753|Immunologic Factors|immunologic factors|mesh-ancestor
25238939|NCT04627753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238940|NCT04627753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25238941|NCT04627753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25238942|NCT04627753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25238943|NCT04627753|Growth Substances|growth substances|mesh-ancestor
25238944|NCT04627753|Growth Inhibitors|growth inhibitors|mesh-ancestor
25238945|NCT04599504|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25238959|NCT04565925|Sildenafil Citrate|sildenafil citrate|mesh-list
25238960|NCT04565925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238961|NCT04565925|Vasodilator Agents|vasodilator agents|mesh-ancestor
25238962|NCT04565925|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25238963|NCT04565925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25238964|NCT04565925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25238965|NCT04565925|Urological Agents|urological agents|mesh-ancestor
25238966|NCT04545515|Ivacaftor|ivacaftor|mesh-list
25238967|NCT04545515|Elexacaftor|elexacaftor|mesh-list
24472340|NCT00398905|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25155155|NCT05451329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25155156|NCT05451329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25066809|NCT03450317|Aspirin|aspirin|mesh-list
24712067|NCT01518413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712068|NCT01518413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24712069|NCT01518413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24712070|NCT01518465|Dexamethasone|dexamethasone|mesh-list
24712071|NCT01518465|Lenalidomide|lenalidomide|mesh-list
24712072|NCT01518465|Dalteparin|dalteparin|mesh-list
24712073|NCT01518465|Tinzaparin|tinzaparin|mesh-list
24712107|NCT01518608|Narcotics|narcotics|mesh-ancestor
24712108|NCT01518608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24712109|NCT01518608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712110|NCT01518608|Analgesics|analgesics|mesh-ancestor
24712111|NCT01518608|Sensory System Agents|sensory system agents|mesh-ancestor
24712112|NCT01518608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24712113|NCT01518608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24712210|NCT01519128|Antiviral Agents|antiviral agents|mesh-ancestor
24712211|NCT01519128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24712246|NCT01519310|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24712247|NCT01519310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24712248|NCT01519336|Ritonavir|ritonavir|mesh-list
24712321|NCT01519856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24712322|NCT01519856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24712323|NCT01519856|Dopamine Agonists|dopamine agonists|mesh-ancestor
24712324|NCT01519856|Dopamine Agents|dopamine agents|mesh-ancestor
24712325|NCT01519856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24712326|NCT01519856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712348|NCT01520077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712350|NCT01520103|Everolimus|everolimus|mesh-list
24712351|NCT01520103|Vinorelbine|vinorelbine|mesh-list
24712352|NCT01520103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24712353|NCT01520103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24712354|NCT01520103|Immunologic Factors|immunologic factors|mesh-ancestor
24712356|NCT01520103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24788830|NCT01934088|Propofol|propofol|mesh-list
24788831|NCT01934088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25238968|NCT04545515|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25238969|NCT04545515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25238970|NCT04545515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238971|NCT04515615|Oxaliplatin|oxaliplatin|mesh-list
25238972|NCT04515615|Tegafur|tegafur|mesh-list
25238973|NCT04515615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25238974|NCT04515615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25238975|NCT04515615|Antimetabolites|antimetabolites|mesh-ancestor
25238976|NCT04515615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25238977|NCT04489628|Vitamin D|vitamin d|mesh-list
25238978|NCT04489628|Cholecalciferol|cholecalciferol|mesh-list
25238979|NCT04489628|Vitamins|vitamins|mesh-ancestor
25238980|NCT04489628|Micronutrients|micronutrients|mesh-ancestor
25238981|NCT04489628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25238982|NCT04489628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25238983|NCT04489628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25238984|NCT04483414|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
24849652|NCT02249546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24849653|NCT02249546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24849654|NCT02249546|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24849655|NCT02249546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849656|NCT02249546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849657|NCT02249546|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24849658|NCT02249546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24849659|NCT02249546|Antiviral Agents|antiviral agents|mesh-ancestor
24849661|NCT02249546|Respiratory System Agents|respiratory system agents|mesh-ancestor
24849662|NCT02249546|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24849663|NCT02249546|Antioxidants|antioxidants|mesh-ancestor
24849664|NCT02249546|Protective Agents|protective agents|mesh-ancestor
24849665|NCT02249546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849666|NCT02249546|Antidotes|antidotes|mesh-ancestor
24849667|NCT02249663|Fluticasone|fluticasone|mesh-list
24849669|NCT02249663|Azelastine|azelastine|mesh-list
24849670|NCT02249663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24849671|NCT02249663|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25874385|NCT05285813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24788849|NCT01934088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788851|NCT01934127|Immunologic Factors|immunologic factors|mesh-ancestor
24581204|NCT00864643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788852|NCT01934127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788854|NCT01934166|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24788855|NCT01934166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788856|NCT01934166|Sensory System Agents|sensory system agents|mesh-ancestor
24788857|NCT01934166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24788858|NCT01934361|Carboplatin|carboplatin|mesh-list
24788859|NCT01934361|Lomustine|lomustine|mesh-list
24788860|NCT01934361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24788861|NCT01934361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24712357|NCT01520103|Tubulin Modulators|tubulin modulators|mesh-ancestor
24712359|NCT01520103|Mitosis Modulators|mitosis modulators|mesh-ancestor
24712360|NCT01520103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712361|NCT01520116|Timolol|timolol|mesh-list
24712362|NCT01520116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24712363|NCT01520116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24712364|NCT01520116|Adrenergic Agents|adrenergic agents|mesh-ancestor
25005870|NCT01821690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005871|NCT01821690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25005872|NCT01821690|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25005873|NCT01821690|Serotonin Agents|serotonin agents|mesh-ancestor
25874386|NCT05285813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25238985|NCT04483414|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25238986|NCT04483414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874387|NCT05285813|Anesthetics, Local|anesthetics, local|mesh-ancestor
25874388|NCT05285813|Anesthetics|anesthetics|mesh-ancestor
25874389|NCT05285813|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25874390|NCT05285813|Histamine Antagonists|histamine antagonists|mesh-ancestor
25874391|NCT05285813|Histamine Agents|histamine agents|mesh-ancestor
25874392|NCT05285813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25874393|NCT05285813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239007|NCT04390581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25239008|NCT04390581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239022|NCT04366115|Dexamethasone acetate|dexamethasone acetate|mesh-list
25239023|NCT04366115|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25239024|NCT04366115|BB 1101|bb 1101|mesh-list
25239025|NCT04366115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25239026|NCT04366115|Antiemetics|antiemetics|mesh-ancestor
25239027|NCT04366115|Autonomic Agents|autonomic agents|mesh-ancestor
25239028|NCT04366115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239029|NCT04366115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239030|NCT04366115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25239031|NCT04366115|Glucocorticoids|glucocorticoids|mesh-ancestor
25239032|NCT04366115|Hormones|hormones|mesh-ancestor
25239033|NCT04366115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25239034|NCT04366115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25239035|NCT04366115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25239036|NCT04366115|Protease Inhibitors|protease inhibitors|mesh-ancestor
24472496|NCT00399334|Antipsychotic Agents|antipsychotic agents|mesh-list
25005896|NCT01502085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25005897|NCT01502085|Glucocorticoids|glucocorticoids|mesh-ancestor
25005898|NCT01502085|Hormones|hormones|mesh-ancestor
25005899|NCT01502085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25005900|NCT01502085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25005901|NCT01502085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24712365|NCT01520116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24712366|NCT01520116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712367|NCT01520116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712368|NCT01520116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24712369|NCT01520116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24712371|NCT01520181|beta-Lactams|beta-lactams|mesh-list
25239037|NCT04366115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25239038|NCT04366115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239042|NCT04292470|Amitriptyline|amitriptyline|mesh-list
25239043|NCT04292470|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25239044|NCT04292470|Antidepressive Agents|antidepressive agents|mesh-ancestor
25239045|NCT04292470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24712372|NCT01520181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24712373|NCT01520181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24712374|NCT01520285|Felodipine|felodipine|mesh-list
24712375|NCT01520285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24712376|NCT01520285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25874398|NCT05284552|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24712411|NCT01520389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25874399|NCT05284552|Dalteparin|dalteparin|mesh-list
25874400|NCT05284552|Anticoagulants|anticoagulants|mesh-ancestor
25874401|NCT05284552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25874402|NCT05284552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25874403|NCT05284552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874404|NCT05274269|Ivacaftor|ivacaftor|mesh-list
25874405|NCT05274269|Elexacaftor|elexacaftor|mesh-list
25874406|NCT05274269|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24712449|NCT01520467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712451|NCT01520584|Micronutrients|micronutrients|mesh-ancestor
24712452|NCT01520584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712485|NCT01520818|Insulin, Long-Acting|insulin, long-acting|mesh-list
24712486|NCT01520818|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24712487|NCT01520818|Biphasic Insulins|biphasic insulins|mesh-list
24712488|NCT01520818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24712489|NCT01520818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712490|NCT01520831|Insulin|insulin|mesh-list
25874407|NCT05274269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24712492|NCT01520831|Insulin Aspart|insulin aspart|mesh-list
24712493|NCT01520831|Insulin, Long-Acting|insulin, long-acting|mesh-list
24712494|NCT01520831|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24712495|NCT01520831|Biphasic Insulins|biphasic insulins|mesh-list
24712523|NCT01521299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24712524|NCT01521312|Saxagliptin|saxagliptin|mesh-list
24712525|NCT01521312|Incretins|incretins|mesh-ancestor
24712527|NCT01521312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24712528|NCT01521312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712529|NCT01521312|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24712530|NCT01521312|Protease Inhibitors|protease inhibitors|mesh-ancestor
24712531|NCT01521312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24712532|NCT01521312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712533|NCT01521312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24712534|NCT01521325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24712535|NCT01521325|Immunologic Factors|immunologic factors|mesh-ancestor
24712536|NCT01521325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712537|NCT01521377|Moxifloxacin|moxifloxacin|mesh-list
25874408|NCT05274269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712870|NCT01523054|Metoprolol|metoprolol|mesh-list
24614519|NCT01024543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614520|NCT01024543|Sympathomimetics|sympathomimetics|mesh-ancestor
24614521|NCT01024543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24614522|NCT01024543|Nasal Decongestants|nasal decongestants|mesh-ancestor
24614523|NCT01024543|Respiratory System Agents|respiratory system agents|mesh-ancestor
24614536|NCT01024647|Immunologic Factors|immunologic factors|mesh-ancestor
24614537|NCT01024647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614538|NCT01024647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24614540|NCT01024660|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24614541|NCT01024660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24614542|NCT01024660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614543|NCT01024660|Cholinergic Agents|cholinergic agents|mesh-ancestor
24614544|NCT01024660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24614545|NCT01024660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239046|NCT04292470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25239047|NCT04292470|Analgesics|analgesics|mesh-ancestor
25239048|NCT04292470|Sensory System Agents|sensory system agents|mesh-ancestor
25239049|NCT04292470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239050|NCT04292470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239051|NCT04292470|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25239052|NCT04292470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25239053|NCT04292470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24849698|NCT02249702|Immunologic Factors|immunologic factors|mesh-ancestor
24614546|NCT01024660|Nootropic Agents|nootropic agents|mesh-ancestor
24614547|NCT01024712|Paclitaxel|paclitaxel|mesh-list
25874409|NCT05274243|Phenol|phenol|mesh-list
24712632|NCT01521962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712763|NCT01522768|Afatinib|afatinib|mesh-list
24712764|NCT01522768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24712765|NCT01522768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24712766|NCT01522768|Tubulin Modulators|tubulin modulators|mesh-ancestor
24712767|NCT01522768|Antimitotic Agents|antimitotic agents|mesh-ancestor
24712768|NCT01522768|Mitosis Modulators|mitosis modulators|mesh-ancestor
24712769|NCT01522768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712782|NCT01522846|Anticoagulants|anticoagulants|mesh-ancestor
24712783|NCT01522846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24712784|NCT01522846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24712785|NCT01522846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712786|NCT01522872|Dexamethasone|dexamethasone|mesh-list
24712787|NCT01522872|Dexamethasone acetate|dexamethasone acetate|mesh-list
24712788|NCT01522872|Bortezomib|bortezomib|mesh-list
24712789|NCT01522872|Pomalidomide|pomalidomide|mesh-list
24712790|NCT01522872|Phosphoramide Mustards|phosphoramide mustards|mesh-list
24712842|NCT01523002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24712843|NCT01523002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24712844|NCT01523002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24712846|NCT01523002|Schistosomicides|schistosomicides|mesh-ancestor
24712847|NCT01523002|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24712848|NCT01523002|Anthelmintics|anthelmintics|mesh-ancestor
24712849|NCT01523015|Docetaxel|docetaxel|mesh-list
24712850|NCT01523015|Fluorouracil|fluorouracil|mesh-list
24712851|NCT01523015|Oxaliplatin|oxaliplatin|mesh-list
24712852|NCT01523015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24712853|NCT01523015|Tubulin Modulators|tubulin modulators|mesh-ancestor
24712855|NCT01523015|Mitosis Modulators|mitosis modulators|mesh-ancestor
24712856|NCT01523015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874410|NCT05274243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24712860|NCT01523015|Immunologic Factors|immunologic factors|mesh-ancestor
24712861|NCT01523015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712863|NCT01523041|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24645510|NCT01198496|Losartan|losartan|mesh-list
24712865|NCT01523041|Insulin, Long-Acting|insulin, long-acting|mesh-list
24712866|NCT01523041|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24712867|NCT01523041|Biphasic Insulins|biphasic insulins|mesh-list
24712868|NCT01523041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24712869|NCT01523041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712871|NCT01523054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25239054|NCT04292470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239055|NCT04292470|Adrenergic Agents|adrenergic agents|mesh-ancestor
25239056|NCT04292470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25239057|NCT04209790|Temozolomide|temozolomide|mesh-list
25239058|NCT04209790|Benzolamide|benzolamide|mesh-list
25239059|NCT04209790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25239060|NCT04209790|Alkylating Agents|alkylating agents|mesh-ancestor
25239061|NCT04209790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239062|NCT04209790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25239063|NCT04209790|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25239064|NCT04209790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24712874|NCT01523054|Autonomic Agents|autonomic agents|mesh-ancestor
24712875|NCT01523054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24472633|NCT00399867|Antimetabolites|antimetabolites|mesh-ancestor
24814220|NCT02063360|Etravirine|etravirine|mesh-list
24814221|NCT02063360|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24814222|NCT02063360|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25874411|NCT05274243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25874412|NCT05274243|Disinfectants|disinfectants|mesh-ancestor
25874413|NCT05274243|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
24712876|NCT01523054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712877|NCT01523054|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24712878|NCT01523054|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24712879|NCT01523054|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24712880|NCT01523054|Adrenergic Agents|adrenergic agents|mesh-ancestor
24712881|NCT01523054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24712882|NCT01523054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712883|NCT01523067|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
24614590|NCT01025128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614591|NCT01025128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24614592|NCT01025245|Remifentanil|remifentanil|mesh-list
24614593|NCT01025245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24614594|NCT01025245|Narcotics|narcotics|mesh-ancestor
24614595|NCT01025245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24614596|NCT01025245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614597|NCT01025245|Analgesics|analgesics|mesh-ancestor
24614598|NCT01025245|Sensory System Agents|sensory system agents|mesh-ancestor
24614599|NCT01025245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24614600|NCT01025349|Bevacizumab|bevacizumab|mesh-list
24614602|NCT01025349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24614603|NCT01025349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614604|NCT01025349|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24614605|NCT01025349|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24614606|NCT01025349|Growth Substances|growth substances|mesh-ancestor
24614633|NCT01025544|Vaccines|vaccines|mesh-list
24713076|NCT01524081|Cefuroxime axetil|cefuroxime axetil|mesh-list
24713077|NCT01524081|Fluconazole|fluconazole|mesh-list
24713114|NCT01524237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24713115|NCT01524237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713151|NCT01524432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24713152|NCT01524432|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24713153|NCT01524432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24713154|NCT01524432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24713182|NCT01524575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713183|NCT01524575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673660|NCT01763645|Paclitaxel|paclitaxel|mesh-list
24777423|NCT01863888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24777424|NCT01863888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24777425|NCT01863888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24777426|NCT01863888|Immunologic Factors|immunologic factors|mesh-ancestor
24777427|NCT01863888|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24777428|NCT01863888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24777429|NCT01863888|Antimetabolites|antimetabolites|mesh-ancestor
24777430|NCT01863888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777431|NCT01863888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24777432|NCT01863914|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24777433|NCT01863914|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24777434|NCT01863914|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24777495|NCT01864551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24777528|NCT01864681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777532|NCT01864798|Denosumab|denosumab|mesh-list
24777533|NCT01864798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24713184|NCT01524575|Antiviral Agents|antiviral agents|mesh-ancestor
24713185|NCT01524575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24788862|NCT01934361|Alkylating Agents|alkylating agents|mesh-ancestor
25874414|NCT05274243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24814223|NCT02063360|Protease Inhibitors|protease inhibitors|mesh-ancestor
24814224|NCT02063360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24814225|NCT02063360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814226|NCT02063360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24814228|NCT02063360|Antiviral Agents|antiviral agents|mesh-ancestor
24788863|NCT01934361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788865|NCT01934569|Midazolam|midazolam|mesh-list
24788866|NCT01934569|Caffeine|caffeine|mesh-list
24788867|NCT01934569|Omeprazole|omeprazole|mesh-list
24788868|NCT01934569|Pravastatin|pravastatin|mesh-list
24788869|NCT01934569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24788870|NCT01934569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24788871|NCT01934569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24788872|NCT01934569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788873|NCT01934569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24788874|NCT01934569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24788875|NCT01934569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24788876|NCT01934569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24788877|NCT01934569|Anesthetics, General|anesthetics, general|mesh-ancestor
24788878|NCT01934569|Anesthetics|anesthetics|mesh-ancestor
25239066|NCT04183790|Elexacaftor|elexacaftor|mesh-list
25239067|NCT04183790|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25239068|NCT04183790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25239069|NCT04183790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239070|NCT04179396|Rucaparib|rucaparib|mesh-list
25239071|NCT04179396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24713189|NCT01524575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713190|NCT01524601|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24713191|NCT01524601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25673661|NCT01763645|Bevacizumab|bevacizumab|mesh-list
25673662|NCT01763645|Carboplatin|carboplatin|mesh-list
25673663|NCT01763645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25673664|NCT01763645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673665|NCT01763645|Tubulin Modulators|tubulin modulators|mesh-ancestor
25673666|NCT01763645|Antimitotic Agents|antimitotic agents|mesh-ancestor
25673667|NCT01763645|Mitosis Modulators|mitosis modulators|mesh-ancestor
25673668|NCT01763645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673669|NCT01763645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25673670|NCT01763645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25673671|NCT01763645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25673672|NCT01763645|Growth Substances|growth substances|mesh-ancestor
25673673|NCT01763645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673674|NCT01763645|Growth Inhibitors|growth inhibitors|mesh-ancestor
25673675|NCT01763827|Ezetimibe|ezetimibe|mesh-list
25673676|NCT01763827|Evolocumab|evolocumab|mesh-list
25673677|NCT01763827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25673678|NCT01763827|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25673679|NCT01763827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24713192|NCT01524601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24713193|NCT01524601|Antimetabolites|antimetabolites|mesh-ancestor
24713194|NCT01524601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713195|NCT01524601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24713223|NCT01524731|Autonomic Agents|autonomic agents|mesh-ancestor
24713224|NCT01524731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24713225|NCT01524731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713226|NCT01524731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24713230|NCT01524731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24713231|NCT01524731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24713232|NCT01524731|Protease Inhibitors|protease inhibitors|mesh-ancestor
24713233|NCT01524731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874415|NCT05265065|Vaccines|vaccines|mesh-list
25874416|NCT05265065|Immunologic Factors|immunologic factors|mesh-ancestor
24713358|NCT01525771|Docetaxel|docetaxel|mesh-list
24713359|NCT01525771|Capecitabine|capecitabine|mesh-list
24472727|NCT00400374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472728|NCT00400374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24472729|NCT00400374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25874417|NCT05265065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472775|NCT00400491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472776|NCT00400491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24472777|NCT00400491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24713361|NCT01525771|Tubulin Modulators|tubulin modulators|mesh-ancestor
24713362|NCT01525771|Antimitotic Agents|antimitotic agents|mesh-ancestor
24713363|NCT01525771|Mitosis Modulators|mitosis modulators|mesh-ancestor
24713364|NCT01525771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713365|NCT01525771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24713366|NCT01525771|Antimetabolites|antimetabolites|mesh-ancestor
24713368|NCT01525823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24713369|NCT01525823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713402|NCT01526005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713403|NCT01526005|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24713404|NCT01526005|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24713405|NCT01526005|Cholinergic Agents|cholinergic agents|mesh-ancestor
24756748|NCT01735370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24421479|NCT00219258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421480|NCT00219271|Zoledronic Acid|zoledronic acid|mesh-list
25874418|NCT05257460|Insulin|insulin|mesh-list
24713895|NCT01527903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24713443|NCT01526122|Sensory System Agents|sensory system agents|mesh-ancestor
24713444|NCT01526122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24713445|NCT01526122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713446|NCT01526122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24713447|NCT01526122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24713448|NCT01526122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24713449|NCT01526122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24713450|NCT01526122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713451|NCT01526122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24713452|NCT01526122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24713453|NCT01526122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24713454|NCT01526122|Antipyretics|antipyretics|mesh-ancestor
24713455|NCT01526122|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24713456|NCT01526122|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24713457|NCT01526122|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25239072|NCT04179396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25239073|NCT04179396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814524|NCT02065063|Trametinib|trametinib|mesh-list
24814525|NCT02065063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24713490|NCT01526278|Alendronate|alendronate|mesh-list
24713541|NCT01526499|Cyclophosphamide|cyclophosphamide|mesh-list
24713543|NCT01526499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24713544|NCT01526499|Immunologic Factors|immunologic factors|mesh-ancestor
24713545|NCT01526499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713581|NCT01526525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24713582|NCT01526525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24713583|NCT01526564|Acetylcarnitine|acetylcarnitine|mesh-list
25673680|NCT01763827|Antimetabolites|antimetabolites|mesh-ancestor
25673681|NCT01763827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874419|NCT05257460|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25874420|NCT05257460|Insulin Lispro|insulin lispro|mesh-list
25874421|NCT05257460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24713585|NCT01526564|Vitamins|vitamins|mesh-ancestor
24713586|NCT01526564|Micronutrients|micronutrients|mesh-ancestor
24614664|NCT01025765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24614665|NCT01025765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614703|NCT01025934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24614704|NCT01025934|Growth Substances|growth substances|mesh-ancestor
24713794|NCT01527539|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24713795|NCT01527539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24713796|NCT01527539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713797|NCT01527552|Insulin Aspart|insulin aspart|mesh-list
24713798|NCT01527552|Biphasic Insulins|biphasic insulins|mesh-list
24713799|NCT01527552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24713800|NCT01527552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713801|NCT01527565|Insulin Aspart|insulin aspart|mesh-list
24713802|NCT01527565|Biphasic Insulins|biphasic insulins|mesh-list
24713803|NCT01527565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24713804|NCT01527565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713805|NCT01527591|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24713806|NCT01527591|Immunologic Factors|immunologic factors|mesh-ancestor
24713839|NCT01527734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713840|NCT01527747|Saxagliptin|saxagliptin|mesh-list
24713841|NCT01527747|Incretins|incretins|mesh-ancestor
24713843|NCT01527747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24614730|NCT01026116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24614731|NCT01026116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24614760|NCT01026285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614761|NCT01026285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24614762|NCT01026285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24614763|NCT01026285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24614764|NCT01026285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24614765|NCT01026285|Dopamine Agents|dopamine agents|mesh-ancestor
24614766|NCT01026311|Ubiquinone|ubiquinone|mesh-list
24713886|NCT01527903|Midazolam|midazolam|mesh-list
24713887|NCT01527903|Propofol|propofol|mesh-list
24713888|NCT01527903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24713889|NCT01527903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24713890|NCT01527903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713891|NCT01527903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24713892|NCT01527903|Anesthetics, General|anesthetics, general|mesh-ancestor
24713893|NCT01527903|Anesthetics|anesthetics|mesh-ancestor
24713894|NCT01527903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24713896|NCT01527903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24713932|NCT01528163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713933|NCT01528163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24713934|NCT01528163|Antimetabolites|antimetabolites|mesh-ancestor
24713935|NCT01528163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713971|NCT01528540|Pregabalin|pregabalin|mesh-list
24713972|NCT01528540|Antioxidants|antioxidants|mesh-list
24713973|NCT01528540|Analgesics|analgesics|mesh-ancestor
24814526|NCT02065063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24814883|NCT02067078|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24472781|NCT00400556|Lenograstim|lenograstim|mesh-list
24713974|NCT01528540|Sensory System Agents|sensory system agents|mesh-ancestor
24714005|NCT01528644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714006|NCT01528644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24714008|NCT01528644|Micronutrients|micronutrients|mesh-ancestor
24714009|NCT01528644|Hematinics|hematinics|mesh-ancestor
24714010|NCT01528722|Bupivacaine|bupivacaine|mesh-list
24714011|NCT01528722|Anesthetics, Local|anesthetics, local|mesh-ancestor
24714012|NCT01528722|Anesthetics|anesthetics|mesh-ancestor
24714013|NCT01528722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25239074|NCT04179396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25239075|NCT04140214|Carbocysteine|carbocysteine|mesh-list
25239076|NCT04140214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24714014|NCT01528722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714015|NCT01528722|Sensory System Agents|sensory system agents|mesh-ancestor
24714016|NCT01528722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24714017|NCT01528800|Vitamin K|vitamin k|mesh-list
25005932|NCT01178814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005933|NCT01178814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25005934|NCT01178814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25005935|NCT01178814|Growth Substances|growth substances|mesh-ancestor
25005937|NCT01178814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005938|NCT01125176|Thalidomide|thalidomide|mesh-list
25005940|NCT01125176|Lenalidomide|lenalidomide|mesh-list
25005941|NCT01125176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25005942|NCT01125176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005943|NCT01125176|Immunologic Factors|immunologic factors|mesh-ancestor
25005945|NCT01125176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25005946|NCT01125176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25005947|NCT01125176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25005948|NCT01125176|Growth Substances|growth substances|mesh-ancestor
25005949|NCT01125176|Growth Inhibitors|growth inhibitors|mesh-ancestor
25005950|NCT01125176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24714176|NCT01529242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24714177|NCT01529242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714178|NCT01529242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24714179|NCT01529242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472790|NCT00400595|Mupirocin|mupirocin|mesh-list
24714180|NCT01529242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24714181|NCT01529242|Respiratory System Agents|respiratory system agents|mesh-ancestor
24714182|NCT01529242|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24714183|NCT01529242|Cholinergic Agents|cholinergic agents|mesh-ancestor
24714184|NCT01529242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24714185|NCT01529242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714186|NCT01529242|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24714187|NCT01529242|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24714188|NCT01529242|Histamine Antagonists|histamine antagonists|mesh-ancestor
24714189|NCT01529242|Histamine Agents|histamine agents|mesh-ancestor
24714190|NCT01529255|Telbivudine|telbivudine|mesh-list
24714191|NCT01529255|Antiviral Agents|antiviral agents|mesh-ancestor
24714205|NCT01529320|Prednisolone|prednisolone|mesh-list
24714206|NCT01529320|Prednisolone acetate|prednisolone acetate|mesh-list
24714207|NCT01529320|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
24714208|NCT01529320|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24714209|NCT01529320|Prednisolone phosphate|prednisolone phosphate|mesh-list
24714210|NCT01529320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24714211|NCT01529320|Antiemetics|antiemetics|mesh-ancestor
24714212|NCT01529320|Autonomic Agents|autonomic agents|mesh-ancestor
24714213|NCT01529320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24714214|NCT01529320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619728|NCT01053559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619729|NCT01053559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24788944|NCT01934816|Incretins|incretins|mesh-ancestor
25874422|NCT05257460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874423|NCT05246514|Trastuzumab|trastuzumab|mesh-list
25874424|NCT05246514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24714231|NCT01529476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24714232|NCT01529476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24714233|NCT01529476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24714234|NCT01529476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714235|NCT01529476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24714236|NCT01529476|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24714237|NCT01529476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24714239|NCT01529528|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24714240|NCT01529528|Protease Inhibitors|protease inhibitors|mesh-ancestor
24714241|NCT01529528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25239077|NCT04140214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25239078|NCT04140214|Expectorants|expectorants|mesh-ancestor
25239079|NCT04140214|Respiratory System Agents|respiratory system agents|mesh-ancestor
25273872|NCT02382432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25273873|NCT02382432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25273874|NCT02382432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714242|NCT01529528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714243|NCT01529528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24714244|NCT01529528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714245|NCT01529541|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24714247|NCT01529541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24714273|NCT01529710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24757050|NCT01737359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25874425|NCT05246514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24714274|NCT01529788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25874426|NCT05234307|Nivolumab|nivolumab|mesh-list
25874427|NCT05234307|Adenosine|adenosine|mesh-list
24778419|NCT01870648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24778420|NCT01870648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24778421|NCT01870648|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24778422|NCT01870674|Prucalopride|prucalopride|mesh-list
24778423|NCT01870674|YH12852|yh12852|mesh-list
24797353|NCT01955187|Protective Agents|protective agents|mesh-ancestor
25081753|NCT03327454|Immunologic Factors|immunologic factors|mesh-ancestor
25081754|NCT03327389|Dexmedetomidine|dexmedetomidine|mesh-list
25081755|NCT03327389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25081756|NCT03327389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25081757|NCT03327389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714275|NCT01529788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24714276|NCT01529788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24714277|NCT01529788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24714278|NCT01529788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714279|NCT01529788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24714280|NCT01529788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24714281|NCT01529788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714282|NCT01529788|Cholinergic Agents|cholinergic agents|mesh-ancestor
24714283|NCT01529788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24714402|NCT01530490|Dopamine Agents|dopamine agents|mesh-ancestor
24714403|NCT01530490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24714404|NCT01530490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714405|NCT01530490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714406|NCT01530490|Plasma Substitutes|plasma substitutes|mesh-ancestor
24714407|NCT01530490|Blood Substitutes|blood substitutes|mesh-ancestor
24714409|NCT01530503|Mitomycins|mitomycins|mesh-list
24714448|NCT01530607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714484|NCT01530763|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24714485|NCT01530763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24714486|NCT01530763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714513|NCT01531114|Ticagrelor|ticagrelor|mesh-list
24870181|NCT03527186|Dopamine Agents|dopamine agents|mesh-ancestor
24714514|NCT01531114|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24714515|NCT01531114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24714516|NCT01531114|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24714517|NCT01531114|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24714518|NCT01531114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24714519|NCT01531114|Purinergic Agents|purinergic agents|mesh-ancestor
24714520|NCT01531114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24714521|NCT01531114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714522|NCT01531114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714523|NCT01531140|Bisacodyl|bisacodyl|mesh-list
24714524|NCT01531140|Senna Extract|senna extract|mesh-list
24714525|NCT01531140|Sennosides|sennosides|mesh-list
24714604|NCT01531595|Oxaliplatin|oxaliplatin|mesh-list
24714605|NCT01531595|Irinotecan|irinotecan|mesh-list
24714606|NCT01531595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24714607|NCT01531595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24714608|NCT01531595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24714609|NCT01531595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24714610|NCT01531595|Growth Substances|growth substances|mesh-ancestor
24714611|NCT01531595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501009|NCT00526396|Cisplatin|cisplatin|mesh-list
24714612|NCT01531595|Growth Inhibitors|growth inhibitors|mesh-ancestor
24714613|NCT01531595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24714614|NCT01531595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24714615|NCT01531595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24714616|NCT01531595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714617|NCT01531647|Ritonavir|ritonavir|mesh-list
25874428|NCT05234307|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-list
25239080|NCT04115774|Diphosphonates|diphosphonates|mesh-list
25239081|NCT04115774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25673682|NCT01763827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25673683|NCT01763827|Immunologic Factors|immunologic factors|mesh-ancestor
25673684|NCT01763827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673685|NCT01763866|Atorvastatin|atorvastatin|mesh-list
25673686|NCT01763866|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25673687|NCT01763866|Simvastatin|simvastatin|mesh-list
25673688|NCT01763866|Ezetimibe|ezetimibe|mesh-list
25673689|NCT01763866|Evolocumab|evolocumab|mesh-list
25673690|NCT01763866|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25673691|NCT01763866|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25673692|NCT01763866|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25673693|NCT01763866|Antimetabolites|antimetabolites|mesh-ancestor
24714689|NCT01531855|Insulin, Short-Acting|insulin, short-acting|mesh-list
24714690|NCT01531855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24714691|NCT01531855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714692|NCT01531920|Ethanol|ethanol|mesh-list
24714693|NCT01531920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24714694|NCT01531920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714709|NCT01532115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24714710|NCT01532115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714711|NCT01532115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24714712|NCT01532115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24714713|NCT01532115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24472836|NCT00400738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472837|NCT00400738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24472838|NCT00400738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24472839|NCT00400738|Antiviral Agents|antiviral agents|mesh-ancestor
24714714|NCT01532115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714715|NCT01532115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24714716|NCT01532115|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24714717|NCT01532115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25005967|NCT00790829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24714718|NCT01532115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24714719|NCT01532154|4-Aminopyridine|4-aminopyridine|mesh-list
24714720|NCT01532154|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24714721|NCT01532154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24714722|NCT01532154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714723|NCT01532232|Varenicline|varenicline|mesh-list
25239085|NCT04034004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239086|NCT04034004|Sensory System Agents|sensory system agents|mesh-ancestor
25239087|NCT04034004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239088|NCT04015115|Analgesics, Opioid|analgesics, opioid|mesh-list
25239089|NCT04015115|Narcotics|narcotics|mesh-ancestor
25239090|NCT04015115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25239091|NCT04015115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239092|NCT04015115|Analgesics|analgesics|mesh-ancestor
24788945|NCT01934816|Hormones|hormones|mesh-ancestor
25239093|NCT04015115|Sensory System Agents|sensory system agents|mesh-ancestor
25239094|NCT04015115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239095|NCT04012138|Insulin|insulin|mesh-list
25239096|NCT04012138|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25239097|NCT04012138|Insulin Aspart|insulin aspart|mesh-list
25239098|NCT04012138|Albuterol|albuterol|mesh-list
25239099|NCT04012138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25239100|NCT04012138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239101|NCT04012138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25239102|NCT04012138|Autonomic Agents|autonomic agents|mesh-ancestor
25239103|NCT04012138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239104|NCT04012138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25239105|NCT04012138|Respiratory System Agents|respiratory system agents|mesh-ancestor
24714731|NCT01532297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24714732|NCT01532336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24714733|NCT01532466|Rocuronium|rocuronium|mesh-list
24714734|NCT01532466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24757208|NCT01738451|Dabrafenib|dabrafenib|mesh-list
25874429|NCT05234307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25874430|NCT05234307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874431|NCT05234307|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25874432|NCT05234307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628687|NCT01100619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24628688|NCT01100619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628689|NCT01100736|Bosentan|bosentan|mesh-list
24628690|NCT01100736|Sitaxsentan|sitaxsentan|mesh-list
24628691|NCT01100736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24628692|NCT01100736|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24815718|NCT02071641|Sunitinib|sunitinib|mesh-list
25874433|NCT05234307|Analgesics|analgesics|mesh-ancestor
25874434|NCT05234307|Sensory System Agents|sensory system agents|mesh-ancestor
25874435|NCT05234307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25874436|NCT05234307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874437|NCT05234307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24879177|NCT04969861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24714738|NCT01532466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714740|NCT01532518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24714741|NCT01532518|Autonomic Agents|autonomic agents|mesh-ancestor
24714742|NCT01532518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24714743|NCT01532518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714744|NCT01532518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24714745|NCT01532518|Respiratory System Agents|respiratory system agents|mesh-ancestor
24714746|NCT01532544|Heparin|heparin|mesh-list
24714747|NCT01532544|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24714764|NCT01532804|Bevacizumab|bevacizumab|mesh-list
24714765|NCT01532804|Oxaliplatin|oxaliplatin|mesh-list
24714766|NCT01532804|Raltitrexed|raltitrexed|mesh-list
24714767|NCT01532804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24714768|NCT01532804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24714769|NCT01532804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24714770|NCT01532804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25874438|NCT05234307|Vasodilator Agents|vasodilator agents|mesh-ancestor
25874439|NCT05234307|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25874440|NCT05234307|Purinergic Agonists|purinergic agonists|mesh-ancestor
25874441|NCT05234307|Purinergic Agents|purinergic agents|mesh-ancestor
25239107|NCT04012138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25239108|NCT04012138|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25239109|NCT04012138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25239110|NCT04012138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25239111|NCT04012138|Adrenergic Agents|adrenergic agents|mesh-ancestor
25239112|NCT04012138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25239113|NCT04012138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239114|NCT03955861|Adalimumab|adalimumab|mesh-list
25239115|NCT03955861|Etanercept|etanercept|mesh-list
25239116|NCT03955861|Golimumab|golimumab|mesh-list
25239117|NCT03955861|Certolizumab Pegol|certolizumab pegol|mesh-list
25239118|NCT03955861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25239119|NCT03955861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25239120|NCT03955861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25874442|NCT05234307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24714772|NCT01532804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714773|NCT01532804|Growth Inhibitors|growth inhibitors|mesh-ancestor
24714774|NCT01532804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24714775|NCT01532804|Antimetabolites|antimetabolites|mesh-ancestor
24714776|NCT01532804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714777|NCT01532804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24714778|NCT01532804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24714790|NCT01532856|Immunologic Factors|immunologic factors|mesh-ancestor
24714791|NCT01532856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714792|NCT01532856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24614780|NCT01026337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614782|NCT01026350|Immunologic Factors|immunologic factors|mesh-ancestor
24614783|NCT01026350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614786|NCT01026363|Cholecalciferol|cholecalciferol|mesh-list
24614787|NCT01026363|Calcitriol|calcitriol|mesh-list
24614788|NCT01026363|Vitamins|vitamins|mesh-list
24614789|NCT01026363|Micronutrients|micronutrients|mesh-ancestor
24757253|NCT01738815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874443|NCT05234307|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25874444|NCT05234307|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25874445|NCT05234112|Acetic Acid|acetic acid|mesh-list
25874446|NCT05234112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25239125|NCT03955861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239127|NCT03955861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25239128|NCT03955861|Immunologic Factors|immunologic factors|mesh-ancestor
25239129|NCT03955861|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25874447|NCT05234112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24614790|NCT01026363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614791|NCT01026363|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24614792|NCT01026363|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24714826|NCT01532960|Immunologic Factors|immunologic factors|mesh-ancestor
24714827|NCT01532960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714829|NCT01533090|Cathartics|cathartics|mesh-ancestor
24714830|NCT01533090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24714831|NCT01533090|Laxatives|laxatives|mesh-ancestor
24714832|NCT01533129|Testosterone|testosterone|mesh-list
24714863|NCT01533155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25005968|NCT00790829|Cholinergic Agents|cholinergic agents|mesh-ancestor
24788928|NCT01934777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788930|NCT01934777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788931|NCT01934777|Protective Agents|protective agents|mesh-ancestor
24788932|NCT01934777|Lipotropic Agents|lipotropic agents|mesh-ancestor
24788933|NCT01934777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24788934|NCT01934777|Antimetabolites|antimetabolites|mesh-ancestor
24788935|NCT01934777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24788936|NCT01934777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24788937|NCT01934777|Nootropic Agents|nootropic agents|mesh-ancestor
24788938|NCT01934816|Liraglutide|liraglutide|mesh-list
24788939|NCT01934816|Exenatide|exenatide|mesh-list
24788940|NCT01934816|Glucagon|glucagon|mesh-list
24788941|NCT01934816|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24788942|NCT01934816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24788943|NCT01934816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788957|NCT01934933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24788958|NCT01934933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24788959|NCT01934933|Analgesics|analgesics|mesh-ancestor
24788960|NCT01934933|Sensory System Agents|sensory system agents|mesh-ancestor
24788961|NCT01934933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24714864|NCT01533155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24714865|NCT01533155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24714867|NCT01533220|Naphazoline|naphazoline|mesh-list
24714868|NCT01533220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714869|NCT01533220|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24714870|NCT01533220|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24714871|NCT01533220|Adrenergic Agents|adrenergic agents|mesh-ancestor
24714872|NCT01533220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24714873|NCT01533220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005969|NCT00790829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25005970|NCT00790829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005971|NCT00070564|Paclitaxel|paclitaxel|mesh-list
25005972|NCT00070564|Cyclophosphamide|cyclophosphamide|mesh-list
25874448|NCT05232084|Fentanyl|fentanyl|mesh-list
25874449|NCT05232084|Bupivacaine|bupivacaine|mesh-list
24780131|NCT01881971|Calcium|calcium|mesh-list
25239130|NCT03912298|Analgesics, Opioid|analgesics, opioid|mesh-list
25239131|NCT03912298|Narcotics|narcotics|mesh-ancestor
25239132|NCT03912298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25239133|NCT03912298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239134|NCT03912298|Analgesics|analgesics|mesh-ancestor
25239135|NCT03912298|Sensory System Agents|sensory system agents|mesh-ancestor
25239136|NCT03912298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239137|NCT02543697|Epinephrine|epinephrine|mesh-list
25874450|NCT05232084|Anesthetics, Local|anesthetics, local|mesh-ancestor
25874451|NCT05232084|Anesthetics|anesthetics|mesh-ancestor
25874452|NCT05232084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25874453|NCT05232084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874454|NCT05232084|Sensory System Agents|sensory system agents|mesh-ancestor
25874455|NCT05232084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25005974|NCT00070564|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25005975|NCT00070564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25005976|NCT00070564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005977|NCT00070564|Tubulin Modulators|tubulin modulators|mesh-ancestor
25005978|NCT00070564|Antimitotic Agents|antimitotic agents|mesh-ancestor
25005979|NCT00070564|Mitosis Modulators|mitosis modulators|mesh-ancestor
25874456|NCT05232084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24714902|NCT01533272|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24714904|NCT01533324|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
24714905|NCT01533324|Antidotes|antidotes|mesh-ancestor
24714906|NCT01533324|Protective Agents|protective agents|mesh-ancestor
24714907|NCT01533324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714908|NCT01533324|Vitamin B Complex|vitamin b complex|mesh-ancestor
24714909|NCT01533324|Vitamins|vitamins|mesh-ancestor
24714910|NCT01533324|Micronutrients|micronutrients|mesh-ancestor
24714911|NCT01533376|Timolol|timolol|mesh-list
24714915|NCT01533376|Adrenergic Agents|adrenergic agents|mesh-ancestor
24714916|NCT01533376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24714917|NCT01533376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714918|NCT01533376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874457|NCT05232084|Narcotics|narcotics|mesh-ancestor
25874458|NCT05232084|Analgesics|analgesics|mesh-ancestor
24472991|NCT00401440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24714919|NCT01533376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24714920|NCT01533376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24714921|NCT01533376|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25874459|NCT05232084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24714951|NCT01533545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714952|NCT01533545|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24714953|NCT01533545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24714955|NCT01533545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24714956|NCT01533545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24714957|NCT01533545|Respiratory System Agents|respiratory system agents|mesh-ancestor
24714958|NCT01533545|Mydriatics|mydriatics|mesh-ancestor
25239138|NCT02543697|Racepinephrine|racepinephrine|mesh-list
25239139|NCT02543697|Epinephryl borate|epinephryl borate|mesh-list
25239140|NCT02543697|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25239141|NCT02543697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25239142|NCT02543697|Adrenergic Agents|adrenergic agents|mesh-ancestor
25239143|NCT02543697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25239144|NCT02543697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239145|NCT02543697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849724|NCT02249897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849725|NCT02249897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24714959|NCT01533545|Sympathomimetics|sympathomimetics|mesh-ancestor
24714960|NCT01533545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24714961|NCT01533545|Anesthetics, Local|anesthetics, local|mesh-ancestor
24714962|NCT01533545|Anesthetics|anesthetics|mesh-ancestor
24714963|NCT01533545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24714964|NCT01533545|Sensory System Agents|sensory system agents|mesh-ancestor
24714965|NCT01533558|Caspofungin|caspofungin|mesh-list
24714966|NCT01533558|Antifungal Agents|antifungal agents|mesh-ancestor
24714967|NCT01533558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24715001|NCT01533740|Growth Substances|growth substances|mesh-ancestor
24715036|NCT01533870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24715037|NCT01533870|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24715038|NCT01533870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715039|NCT01533870|Sensory System Agents|sensory system agents|mesh-ancestor
24715040|NCT01533870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24715042|NCT01534026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25874460|NCT05232084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24780504|NCT01884623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24780505|NCT01884623|Immunologic Factors|immunologic factors|mesh-ancestor
24715043|NCT01534026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24715044|NCT01534026|Analgesics|analgesics|mesh-ancestor
24715045|NCT01534026|Sensory System Agents|sensory system agents|mesh-ancestor
24715046|NCT01534026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24715047|NCT01534026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715048|NCT01534026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24715049|NCT01534026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24715050|NCT01534026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24715076|NCT01534312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24715077|NCT01534312|Analgesics|analgesics|mesh-ancestor
24715078|NCT01534312|Sensory System Agents|sensory system agents|mesh-ancestor
24715079|NCT01534312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24715080|NCT01534312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715081|NCT01534312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24715082|NCT01534312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24715083|NCT01534442|Atropine|atropine|mesh-list
24715084|NCT01534442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24715085|NCT01534442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24715086|NCT01534442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24715087|NCT01534442|Autonomic Agents|autonomic agents|mesh-ancestor
24715088|NCT01534442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24715089|NCT01534442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715090|NCT01534442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24715091|NCT01534442|Respiratory System Agents|respiratory system agents|mesh-ancestor
24444361|NCT00297661|Tubulin Modulators|tubulin modulators|mesh-ancestor
24444362|NCT00297661|Antimitotic Agents|antimitotic agents|mesh-ancestor
24444363|NCT00297661|Mitosis Modulators|mitosis modulators|mesh-ancestor
24628733|NCT01101152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24628734|NCT01101204|Metformin|metformin|mesh-list
24628735|NCT01101204|Simvastatin|simvastatin|mesh-list
24628736|NCT01101204|Fenofibrate|fenofibrate|mesh-list
24628737|NCT01101204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24628738|NCT01101204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628739|NCT01101204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24715092|NCT01534442|Mydriatics|mydriatics|mesh-ancestor
25874461|NCT05232084|Anesthetics, General|anesthetics, general|mesh-ancestor
24715093|NCT01534442|Parasympatholytics|parasympatholytics|mesh-ancestor
24715094|NCT01534442|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24614825|NCT01026415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24614826|NCT01026415|Leprostatic Agents|leprostatic agents|mesh-ancestor
25239146|NCT02543697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25239147|NCT02543697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25239148|NCT02543697|Autonomic Agents|autonomic agents|mesh-ancestor
25239149|NCT02543697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239150|NCT02543697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25045093|NCT01001091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045095|NCT01001091|Glucocorticoids|glucocorticoids|mesh-ancestor
24614827|NCT01026415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24614828|NCT01026415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24614829|NCT01026415|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24614830|NCT01026415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24715107|NCT01534494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24715108|NCT01534546|Capecitabine|capecitabine|mesh-list
24715109|NCT01534546|Oxaliplatin|oxaliplatin|mesh-list
24715110|NCT01534546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24715111|NCT01534546|Antimetabolites|antimetabolites|mesh-ancestor
24715112|NCT01534546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715113|NCT01534546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715114|NCT01534585|Paclitaxel|paclitaxel|mesh-list
24715146|NCT01534754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24715147|NCT01534806|Ketorolac|ketorolac|mesh-list
24715148|NCT01534806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24715149|NCT01534806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24715153|NCT01534806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715154|NCT01534806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24715155|NCT01534806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24715156|NCT01534806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24715157|NCT01534806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715191|NCT01535027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24715192|NCT01535027|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24715193|NCT01535027|Hormone Antagonists|hormone antagonists|mesh-ancestor
25673694|NCT01763866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874462|NCT05221320|Hydroxychloroquine|hydroxychloroquine|mesh-list
25404133|NCT03682978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715194|NCT01535027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24715225|NCT01535157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24715227|NCT01535157|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24645708|NCT01199432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24715228|NCT01535157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24444369|NCT00297661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24715229|NCT01535157|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24715230|NCT01535157|Protective Agents|protective agents|mesh-ancestor
24715232|NCT01535170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24715233|NCT01535183|Irinotecan|irinotecan|mesh-list
24715234|NCT01535183|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24715235|NCT01535183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24715355|NCT01536028|Biphasic Insulins|biphasic insulins|mesh-list
24645714|NCT01199432|Antimetabolites|antimetabolites|mesh-ancestor
24715356|NCT01536028|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24715357|NCT01536028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24715438|NCT01536314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715439|NCT01536314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715440|NCT01536314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24715441|NCT01536314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24614831|NCT01026415|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24614832|NCT01026415|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24614833|NCT01026415|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24614834|NCT01026415|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24715463|NCT01536600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715464|NCT01536613|Insulin Aspart|insulin aspart|mesh-list
24715465|NCT01536613|Biphasic Insulins|biphasic insulins|mesh-list
24715466|NCT01536613|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24715499|NCT01536691|Antipruritics|antipruritics|mesh-ancestor
24715500|NCT01536691|Dermatologic Agents|dermatologic agents|mesh-ancestor
24548026|NCT00707278|Capecitabine|capecitabine|mesh-list
24715504|NCT01536691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715506|NCT01536691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24715507|NCT01536691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24715535|NCT01537055|Lansoprazole|lansoprazole|mesh-list
24757512|NCT01740518|Ascorbic Acid|ascorbic acid|mesh-list
24757513|NCT01740518|Antioxidants|antioxidants|mesh-ancestor
25874463|NCT05221320|Antimalarials|antimalarials|mesh-ancestor
24788970|NCT01934933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24788971|NCT01934933|Immunologic Factors|immunologic factors|mesh-ancestor
24788972|NCT01935063|Lidocaine|lidocaine|mesh-list
24788973|NCT01935063|Anesthetics, Local|anesthetics, local|mesh-ancestor
24788974|NCT01935063|Anesthetics|anesthetics|mesh-ancestor
24788975|NCT01935063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24788976|NCT01935063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788977|NCT01935063|Sensory System Agents|sensory system agents|mesh-ancestor
24788978|NCT01935063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24788979|NCT01935063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24788980|NCT01935063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24788981|NCT01935063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24788982|NCT01935063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24757529|NCT01740921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25045121|NCT00993382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25045123|NCT00993382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25045124|NCT00993382|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24444475|NCT00298168|Interferon Inducers|interferon inducers|mesh-ancestor
25045125|NCT00993382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25874464|NCT05221320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25874465|NCT05221320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25874466|NCT05221320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25874467|NCT05221320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874468|NCT05221320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874469|NCT05221320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24788983|NCT01935063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788985|NCT01935089|Interferon-alpha|interferon-alpha|mesh-list
24788986|NCT01935089|Interferon alpha-2|interferon alpha-2|mesh-list
24788987|NCT01935089|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24788988|NCT01935089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24788989|NCT01935089|Antiviral Agents|antiviral agents|mesh-ancestor
24788990|NCT01935089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24788991|NCT01935089|Immunologic Factors|immunologic factors|mesh-ancestor
24715546|NCT01537055|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24715547|NCT01537055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24715548|NCT01537055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24715549|NCT01537055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24715550|NCT01537055|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25239190|NCT02543671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239191|NCT02543671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25239192|NCT02543671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25006028|NCT05206448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25006029|NCT05206448|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24715588|NCT01537250|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24715589|NCT01537250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24715590|NCT01537354|Poractant alfa|poractant alfa|mesh-list
24628783|NCT01101412|Antimalarials|antimalarials|mesh-ancestor
24628784|NCT01101412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24628785|NCT01101412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24628786|NCT01101412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24628787|NCT01101412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874470|NCT05216250|Botulinum Toxins|botulinum toxins|mesh-list
24715592|NCT01537354|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
24715593|NCT01537354|Respiratory System Agents|respiratory system agents|mesh-ancestor
24715595|NCT01537380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24715626|NCT01537744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715627|NCT01537744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715628|NCT01537744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757611|NCT01741324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757612|NCT01741324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24757613|NCT01741324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24715633|NCT01537770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24715634|NCT01537770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715635|NCT01537770|Sensory System Agents|sensory system agents|mesh-ancestor
24715636|NCT01537770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24715637|NCT01537770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24715638|NCT01537770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24715639|NCT01537770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24715640|NCT01537770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25239193|NCT02543645|Atezolizumab|atezolizumab|mesh-list
25239194|NCT02543645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25239195|NCT02543411|Lidocaine|lidocaine|mesh-list
25239196|NCT02543411|Anesthetics, Local|anesthetics, local|mesh-ancestor
25239197|NCT02543411|Anesthetics|anesthetics|mesh-ancestor
25239198|NCT02543411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25239199|NCT02543411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239200|NCT02543411|Sensory System Agents|sensory system agents|mesh-ancestor
25239201|NCT02543411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239202|NCT02543411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25239203|NCT02543411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25155189|NCT05444556|Antimetabolites|antimetabolites|mesh-ancestor
24952016|NCT03899285|Citalopram|citalopram|mesh-list
25874471|NCT05216250|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24715673|NCT01537861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24715675|NCT01537861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24715676|NCT01537861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24715677|NCT01537861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24614859|NCT01026584|Antidepressive Agents|antidepressive agents|mesh-ancestor
24614860|NCT01026584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24614861|NCT01026584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24614862|NCT01026584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24473261|NCT00402467|Enoxaparin|enoxaparin|mesh-list
24473352|NCT00402558|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24473353|NCT00402558|Alkylating Agents|alkylating agents|mesh-ancestor
24473354|NCT00402558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24473355|NCT00402558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24666810|NCT01321034|Antimetabolites|antimetabolites|mesh-ancestor
24667083|NCT01322139|Analgesics|analgesics|mesh-ancestor
24628788|NCT01101412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628790|NCT01101412|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24628791|NCT01101412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24628793|NCT01101412|Anticoagulants|anticoagulants|mesh-ancestor
24628794|NCT01101412|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24628797|NCT01101412|Antidotes|antidotes|mesh-ancestor
24781546|NCT01890538|Antiemetics|antiemetics|mesh-ancestor
24614863|NCT01026584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24614864|NCT01026584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614894|NCT01026714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614895|NCT01026714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24614896|NCT01026714|Hormone Antagonists|hormone antagonists|mesh-ancestor
24474686|NCT00407017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874472|NCT05216250|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24614897|NCT01026714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24614898|NCT01026714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614899|NCT01026714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24614900|NCT01026714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25140887|NCT02961803|Biotin|biotin|mesh-list
24614905|NCT01026714|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24614906|NCT01026714|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24614907|NCT01026714|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24614908|NCT01026714|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24715703|NCT01538316|Quercetin|quercetin|mesh-list
24715704|NCT01538316|Antioxidants|antioxidants|mesh-ancestor
24715705|NCT01538316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715736|NCT01538394|Varenicline|varenicline|mesh-list
24715737|NCT01538394|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24715738|NCT01538394|Autonomic Agents|autonomic agents|mesh-ancestor
24715739|NCT01538394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24715740|NCT01538394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715741|NCT01538394|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24715742|NCT01538394|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24715743|NCT01538394|Cholinergic Agents|cholinergic agents|mesh-ancestor
24715744|NCT01538394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24715745|NCT01538394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715746|NCT01538446|Clopidogrel|clopidogrel|mesh-list
24715747|NCT01538446|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25874473|NCT05216250|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25874474|NCT05216250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24715748|NCT01538446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24645768|NCT01199757|Fluticasone|fluticasone|mesh-list
24715790|NCT01538537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715791|NCT01538537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25239204|NCT02543411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25239205|NCT02543411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25239206|NCT02543411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239207|NCT02543606|Esomeprazole|esomeprazole|mesh-list
25239208|NCT02543606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25239209|NCT02543606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25239210|NCT02543606|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25239211|NCT02543606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25155190|NCT05444556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25155191|NCT05444556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25155194|NCT05444556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25155195|NCT05444556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25155196|NCT05444556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25155197|NCT05444556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25155198|NCT05444556|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25155199|NCT05444556|Protective Agents|protective agents|mesh-ancestor
24715792|NCT01538537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874475|NCT05216250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614925|NCT01026740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24614926|NCT01026740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24614927|NCT01026961|Acetaminophen|acetaminophen|mesh-list
24614928|NCT01026961|Dimethindene|dimethindene|mesh-list
24614929|NCT01026961|Phenylephrine|phenylephrine|mesh-list
24614930|NCT01026961|Oxymetazoline|oxymetazoline|mesh-list
24614931|NCT01026961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24614932|NCT01026961|Analgesics|analgesics|mesh-ancestor
24614933|NCT01026961|Sensory System Agents|sensory system agents|mesh-ancestor
24614934|NCT01026961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24614935|NCT01026961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614936|NCT01026961|Antipyretics|antipyretics|mesh-ancestor
24614937|NCT01026961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614938|NCT01026961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24614939|NCT01026961|Mydriatics|mydriatics|mesh-ancestor
24614940|NCT01026961|Autonomic Agents|autonomic agents|mesh-ancestor
25673695|NCT01763866|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24614941|NCT01026961|Sympathomimetics|sympathomimetics|mesh-ancestor
24614942|NCT01026961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24614943|NCT01026961|Nasal Decongestants|nasal decongestants|mesh-ancestor
25874476|NCT05216250|Cholinergic Agents|cholinergic agents|mesh-ancestor
24815884|NCT02072408|Aflibercept|aflibercept|mesh-list
25874477|NCT05216250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25874478|NCT05216250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874479|NCT05216250|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25874480|NCT05216250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25874481|NCT05209152|Azacitidine|azacitidine|mesh-list
25874482|NCT05209152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25874483|NCT05209152|Antimetabolites|antimetabolites|mesh-ancestor
24715837|NCT01538693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24715839|NCT01538693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715840|NCT01538693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24715841|NCT01538693|Antidepressive Agents|antidepressive agents|mesh-ancestor
24715842|NCT01538693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24715843|NCT01538693|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24715844|NCT01538693|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24715845|NCT01538693|Parasympatholytics|parasympatholytics|mesh-ancestor
24715846|NCT01538693|Autonomic Agents|autonomic agents|mesh-ancestor
24715847|NCT01538693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24715848|NCT01538693|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24715849|NCT01538693|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24460057|NCT00347204|Ketorolac|ketorolac|mesh-list
24715850|NCT01538693|Cholinergic Agents|cholinergic agents|mesh-ancestor
24715851|NCT01538693|Antipruritics|antipruritics|mesh-ancestor
24715852|NCT01538693|Dermatologic Agents|dermatologic agents|mesh-ancestor
24715854|NCT01538693|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24715855|NCT01538693|Histamine Antagonists|histamine antagonists|mesh-ancestor
24715856|NCT01538693|Histamine Agents|histamine agents|mesh-ancestor
24715857|NCT01538693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24715858|NCT01538693|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24715884|NCT01538875|Adrenergic Agents|adrenergic agents|mesh-ancestor
24715885|NCT01538875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25239212|NCT02543606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239213|NCT02543385|Ketamine|ketamine|mesh-list
25239214|NCT02543385|Esketamine|esketamine|mesh-list
25239215|NCT02543385|Analgesics|analgesics|mesh-ancestor
25239216|NCT02543385|Sensory System Agents|sensory system agents|mesh-ancestor
25239217|NCT02543385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239218|NCT02543385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239219|NCT02543385|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25239220|NCT02543385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25239221|NCT02543385|Anesthetics, General|anesthetics, general|mesh-ancestor
25239222|NCT02543385|Anesthetics|anesthetics|mesh-ancestor
24816476|NCT02077257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816477|NCT02077309|Linagliptin|linagliptin|mesh-list
24816478|NCT02077309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24816479|NCT02077309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816480|NCT02077309|Incretins|incretins|mesh-ancestor
24816481|NCT02077309|Hormones|hormones|mesh-ancestor
24816482|NCT02077309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24816483|NCT02077309|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24716058|NCT01539655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716059|NCT01539655|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24716060|NCT01539655|Histamine Antagonists|histamine antagonists|mesh-ancestor
24716062|NCT01539655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24716063|NCT01539655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716064|NCT01539681|Sorafenib|sorafenib|mesh-list
24716065|NCT01539681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24716066|NCT01539681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24716067|NCT01539681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716068|NCT01539681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716069|NCT01539707|Solifenacin Succinate|solifenacin succinate|mesh-list
24716070|NCT01539707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24716071|NCT01539707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24716072|NCT01539707|Cholinergic Agents|cholinergic agents|mesh-ancestor
24716106|NCT01539733|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24716107|NCT01539798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24716109|NCT01539902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24716110|NCT01539902|Immunologic Factors|immunologic factors|mesh-ancestor
24716111|NCT01539902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716112|NCT01539902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24716144|NCT01540110|Alkylating Agents|alkylating agents|mesh-ancestor
25239223|NCT02543385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25404134|NCT03682536|Epoetin Alfa|epoetin alfa|mesh-list
24784088|NCT01905904|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24784089|NCT01905904|Anesthetics, General|anesthetics, general|mesh-ancestor
24784090|NCT01905904|Anesthetics|anesthetics|mesh-ancestor
24827332|NCT02138383|Hormones|hormones|mesh-ancestor
24784130|NCT01906411|Autonomic Agents|autonomic agents|mesh-ancestor
25239224|NCT02543385|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25239225|NCT02543385|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25239226|NCT02543385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25239227|NCT02543385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239228|NCT02543385|Antidepressive Agents|antidepressive agents|mesh-ancestor
25239229|NCT02543385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25239230|NCT02543034|Petrolatum|petrolatum|mesh-list
25239231|NCT02543034|Emollients|emollients|mesh-ancestor
24615027|NCT01027494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24716219|NCT01540721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24716220|NCT01540721|Analgesics|analgesics|mesh-ancestor
24716221|NCT01540721|Sensory System Agents|sensory system agents|mesh-ancestor
24716222|NCT01540721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24716223|NCT01540721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716224|NCT01540721|Antipyretics|antipyretics|mesh-ancestor
24716225|NCT01540734|Acetaminophen|acetaminophen|mesh-list
24716226|NCT01540734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24716227|NCT01540734|Analgesics|analgesics|mesh-ancestor
24716228|NCT01540734|Sensory System Agents|sensory system agents|mesh-ancestor
25874484|NCT05209152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716263|NCT01540812|Glucocorticoids|glucocorticoids|mesh-ancestor
24716264|NCT01540812|Hormones|hormones|mesh-ancestor
24716265|NCT01540812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24716266|NCT01540812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24716267|NCT01540812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24716268|NCT01540812|Protease Inhibitors|protease inhibitors|mesh-ancestor
24716269|NCT01540812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716270|NCT01540812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788992|NCT01935089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788993|NCT01935115|Ketamine|ketamine|mesh-list
24788994|NCT01935115|Propofol|propofol|mesh-list
24788995|NCT01935115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24619878|NCT01054105|Iloprost|iloprost|mesh-list
25006034|NCT05206175|Methamphetamine|methamphetamine|mesh-list
25006035|NCT05206175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25006036|NCT05206175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006037|NCT05206175|Sympathomimetics|sympathomimetics|mesh-ancestor
25006038|NCT05206175|Autonomic Agents|autonomic agents|mesh-ancestor
25006039|NCT05206175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25006040|NCT05206175|Dopamine Agents|dopamine agents|mesh-ancestor
25006041|NCT05206175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25006042|NCT05206175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006043|NCT05206175|Adrenergic Agents|adrenergic agents|mesh-ancestor
25006044|NCT05206175|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25239232|NCT02543034|Dermatologic Agents|dermatologic agents|mesh-ancestor
25006056|NCT05205837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25239242|NCT02543086|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25239243|NCT02543086|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25239244|NCT02543086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25239245|NCT02543229|Ranibizumab|ranibizumab|mesh-list
25239246|NCT02543229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25239247|NCT02543229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25239248|NCT02543229|Growth Substances|growth substances|mesh-ancestor
25239249|NCT02543229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239250|NCT02543229|Growth Inhibitors|growth inhibitors|mesh-ancestor
25239251|NCT02543229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25239252|NCT02543060|Fluorides|fluorides|mesh-list
25239253|NCT02543060|Tin Fluorides|tin fluorides|mesh-list
25239254|NCT02543060|Cariostatic Agents|cariostatic agents|mesh-ancestor
25006076|NCT05205720|Ropivacaine|ropivacaine|mesh-list
25006077|NCT05205720|Anesthetics, Local|anesthetics, local|mesh-ancestor
25006078|NCT05205720|Anesthetics|anesthetics|mesh-ancestor
25006079|NCT05205720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25006080|NCT05205720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006081|NCT05205720|Sensory System Agents|sensory system agents|mesh-ancestor
25006082|NCT05205720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25006084|NCT05205603|Infliximab|infliximab|mesh-list
25006085|NCT05205603|Vedolizumab|vedolizumab|mesh-list
25673696|NCT01763866|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25673697|NCT01763866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25673698|NCT01763866|Immunologic Factors|immunologic factors|mesh-ancestor
24785572|NCT01915134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25006086|NCT05205603|Dermatologic Agents|dermatologic agents|mesh-ancestor
24788999|NCT01935115|Anesthetics, General|anesthetics, general|mesh-ancestor
25006087|NCT05205603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25006088|NCT05205603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25006089|NCT05205603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25006090|NCT05205603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24716309|NCT01541072|Lenograstim|lenograstim|mesh-list
24716310|NCT01541072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24716311|NCT01541072|Immunologic Factors|immunologic factors|mesh-ancestor
24716312|NCT01541072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716313|NCT01541085|Ritonavir|ritonavir|mesh-list
24716314|NCT01541085|Darunavir|darunavir|mesh-list
24716315|NCT01541085|Efavirenz|efavirenz|mesh-list
24473679|NCT00403780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24550453|NCT00720590|Lopinavir|lopinavir|mesh-list
24550455|NCT00720590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24550456|NCT00720590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24550457|NCT00720590|Protease Inhibitors|protease inhibitors|mesh-ancestor
24550458|NCT00720590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24670931|NCT00680901|Capecitabine|capecitabine|mesh-list
24716316|NCT01541085|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24716317|NCT01541085|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24716318|NCT01541085|Protease Inhibitors|protease inhibitors|mesh-ancestor
24716393|NCT01541332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716394|NCT01541332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24716395|NCT01541332|Glucocorticoids|glucocorticoids|mesh-ancestor
24716396|NCT01541332|Hormones|hormones|mesh-ancestor
24716397|NCT01541332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24716398|NCT01541332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24716399|NCT01541332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874485|NCT05209152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24615067|NCT01027611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24615068|NCT01027611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615069|NCT01027689|Alprazolam|alprazolam|mesh-list
25239255|NCT02543060|Protective Agents|protective agents|mesh-ancestor
25239256|NCT02543060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503107|NCT03283566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24716486|NCT01541943|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24716487|NCT01541943|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24716489|NCT01541956|Vildagliptin|vildagliptin|mesh-list
24716490|NCT01541956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24716491|NCT01541956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716504|NCT01542099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24716505|NCT01542099|Narcotics|narcotics|mesh-ancestor
24716537|NCT01542190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716539|NCT01542242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24716540|NCT01542242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716541|NCT01542242|Incretins|incretins|mesh-ancestor
24716542|NCT01542242|Hormones|hormones|mesh-ancestor
24716543|NCT01542242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24757882|NCT01742702|Adrenergic Agents|adrenergic agents|mesh-ancestor
24757885|NCT01742702|Vasodilator Agents|vasodilator agents|mesh-ancestor
25874486|NCT05209152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25239266|NCT02543073|Glucocorticoids|glucocorticoids|mesh-list
25239267|NCT02543073|Hormones|hormones|mesh-ancestor
25239268|NCT02543073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25239269|NCT02543073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239270|NCT02542930|Thymalfasin|thymalfasin|mesh-list
25239271|NCT02542930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25239272|NCT02542930|Immunologic Factors|immunologic factors|mesh-ancestor
25239273|NCT02542930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239274|NCT02542852|Ritonavir|ritonavir|mesh-list
25239275|NCT02542852|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25239276|NCT02542852|Dolutegravir|dolutegravir|mesh-list
25239277|NCT02542852|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25239278|NCT02542852|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24716653|NCT01542918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716655|NCT01542918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24716656|NCT01542918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24716658|NCT01542918|Growth Inhibitors|growth inhibitors|mesh-ancestor
24716659|NCT01543035|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24615102|NCT01027923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24615103|NCT01027923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25874487|NCT05201248|Prednisone|prednisone|mesh-list
24615104|NCT01027923|Immunologic Factors|immunologic factors|mesh-ancestor
25404135|NCT03682536|Luspatercept|luspatercept|mesh-list
24786446|NCT01920022|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24786447|NCT01920022|Hormone Antagonists|hormone antagonists|mesh-ancestor
24786476|NCT01920191|Interferon Inducers|interferon inducers|mesh-ancestor
24786477|NCT01920191|Immunologic Factors|immunologic factors|mesh-ancestor
24615105|NCT01027923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615106|NCT01027923|Analgesics|analgesics|mesh-ancestor
24615107|NCT01027923|Sensory System Agents|sensory system agents|mesh-ancestor
24615108|NCT01027923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24615109|NCT01027923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24716676|NCT01543165|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24716677|NCT01543165|Morphine|morphine|mesh-list
24716678|NCT01543165|Analgesics|analgesics|mesh-list
24716679|NCT01543165|Nefopam|nefopam|mesh-list
24716680|NCT01543165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24716681|NCT01543165|Narcotics|narcotics|mesh-ancestor
24716682|NCT01543165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24716683|NCT01543165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716716|NCT01543399|Tibolone|tibolone|mesh-list
25239279|NCT02542852|Protease Inhibitors|protease inhibitors|mesh-ancestor
25239280|NCT02542852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25239284|NCT02542852|Antiviral Agents|antiviral agents|mesh-ancestor
25239285|NCT02542852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25239286|NCT02542852|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25239287|NCT02542852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25239288|NCT02542852|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24849756|NCT02250209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24849757|NCT02250300|Ixazomib|ixazomib|mesh-list
24849758|NCT02250300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24499067|NCT00517582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24473757|NCT00404053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24473758|NCT00404053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473759|NCT00404053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473760|NCT00404131|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24716717|NCT01543399|Androgen Antagonists|androgen antagonists|mesh-ancestor
24716718|NCT01543399|Hormone Antagonists|hormone antagonists|mesh-ancestor
24716719|NCT01543399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24716720|NCT01543399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673699|NCT01763866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673700|NCT01763905|Ezetimibe|ezetimibe|mesh-list
25673701|NCT01763905|Evolocumab|evolocumab|mesh-list
25673702|NCT01763905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25673703|NCT01763905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25673704|NCT01763905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25673705|NCT01763905|Antimetabolites|antimetabolites|mesh-ancestor
25673706|NCT01763905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673707|NCT01763905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25673708|NCT01763905|Immunologic Factors|immunologic factors|mesh-ancestor
25673709|NCT01763905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674582|NCT01774149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674583|NCT01774305|Dexmedetomidine|dexmedetomidine|mesh-list
25674584|NCT01774305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25674585|NCT01774305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25006095|NCT05205603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25006097|NCT05205577|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25006098|NCT05205577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25006099|NCT05205577|Trace Elements|trace elements|mesh-ancestor
25006100|NCT05205577|Micronutrients|micronutrients|mesh-ancestor
25006101|NCT05205577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006102|NCT05205525|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25006103|NCT05205525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25006104|NCT05205525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25006105|NCT05205525|Antitubercular Agents|antitubercular agents|mesh-ancestor
25109688|NCT03122197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25109703|NCT03121963|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25109705|NCT03121963|Gabapentin|gabapentin|mesh-list
25109706|NCT03121963|Hydrocodone|hydrocodone|mesh-list
25109707|NCT03121963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25109710|NCT03121963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25109711|NCT03121963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109713|NCT03121963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25109714|NCT03121963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25109715|NCT03121963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24870938|NCT01588431|Cetuximab|cetuximab|mesh-list
24716721|NCT01543399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24716749|NCT01543737|Hyaluronic Acid|hyaluronic acid|mesh-list
24716750|NCT01543737|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24716751|NCT01543737|Immunologic Factors|immunologic factors|mesh-ancestor
24880368|NCT03827889|Fluorides|fluorides|mesh-list
25239289|NCT02542852|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25874488|NCT05201248|Cyclophosphamide|cyclophosphamide|mesh-list
24473861|NCT00404378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24473862|NCT00404378|Hormone Antagonists|hormone antagonists|mesh-ancestor
24817295|NCT02082405|Antiemetics|antiemetics|mesh-ancestor
24817296|NCT02082405|Autonomic Agents|autonomic agents|mesh-ancestor
24817297|NCT02082405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24817298|NCT02082405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24817299|NCT02082405|Glucocorticoids|glucocorticoids|mesh-ancestor
24817300|NCT02082405|Hormones|hormones|mesh-ancestor
24817301|NCT02082405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24817302|NCT02082405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24817303|NCT02082418|Caseins|caseins|mesh-list
25239290|NCT02542748|Norepinephrine|norepinephrine|mesh-list
25239291|NCT02542748|Ephedrine|ephedrine|mesh-list
25239292|NCT02542748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25239293|NCT02542748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25239294|NCT02542748|Adrenergic Agents|adrenergic agents|mesh-ancestor
25239295|NCT02542748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25239296|NCT02542748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239297|NCT02542748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239298|NCT02542748|Sympathomimetics|sympathomimetics|mesh-ancestor
25239299|NCT02542748|Autonomic Agents|autonomic agents|mesh-ancestor
25239300|NCT02542748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239301|NCT02542748|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25239302|NCT02542748|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25239303|NCT02542839|Botulinum Toxins|botulinum toxins|mesh-list
25067035|NCT03447873|Lamivudine|lamivudine|mesh-list
24716797|NCT01543945|Protease Inhibitors|protease inhibitors|mesh-ancestor
24716798|NCT01543945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716799|NCT01543945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673710|NCT01763918|Evolocumab|evolocumab|mesh-list
25673711|NCT01763918|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25673712|NCT01763918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25673713|NCT01763918|Antimetabolites|antimetabolites|mesh-ancestor
25674586|NCT01774305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716827|NCT01544140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24716840|NCT01544192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716841|NCT01544192|Protective Agents|protective agents|mesh-ancestor
24716842|NCT01544192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817304|NCT02082418|Chelating Agents|chelating agents|mesh-ancestor
24817309|NCT02082496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817310|NCT02082496|Incretins|incretins|mesh-ancestor
24817312|NCT02082496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24613398|NCT01018836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716844|NCT01544192|Micronutrients|micronutrients|mesh-ancestor
24716845|NCT01544283|Triamcinolone|triamcinolone|mesh-list
24716846|NCT01544283|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24716847|NCT01544283|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24716884|NCT01544504|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24716922|NCT01544634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24716960|NCT01544829|Autonomic Agents|autonomic agents|mesh-ancestor
24716961|NCT01544829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24716962|NCT01544829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716963|NCT01544829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24716964|NCT01544829|Respiratory System Agents|respiratory system agents|mesh-ancestor
24716965|NCT01544829|Vasodilator Agents|vasodilator agents|mesh-ancestor
24716966|NCT01544842|Triamcinolone|triamcinolone|mesh-list
24716967|NCT01544842|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24716968|NCT01544842|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24717006|NCT01544959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717007|NCT01544959|Analgesics|analgesics|mesh-ancestor
24717008|NCT01544959|Sensory System Agents|sensory system agents|mesh-ancestor
24717009|NCT01544959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24717010|NCT01544959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25874489|NCT05201248|Rituximab|rituximab|mesh-list
24717037|NCT01545024|Hormones|hormones|mesh-ancestor
24717038|NCT01545024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24717039|NCT01545024|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24717040|NCT01545024|Protease Inhibitors|protease inhibitors|mesh-ancestor
24717041|NCT01545024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717042|NCT01545024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717043|NCT01545271|Xenon|xenon|mesh-list
24717044|NCT01545271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24717045|NCT01545271|Anesthetics, General|anesthetics, general|mesh-ancestor
24717046|NCT01545271|Anesthetics|anesthetics|mesh-ancestor
24717050|NCT01545284|Keratolytic Agents|keratolytic agents|mesh-ancestor
24717051|NCT01545284|Dermatologic Agents|dermatologic agents|mesh-ancestor
25239304|NCT02542839|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25239305|NCT02542839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25239306|NCT02542839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239307|NCT02542839|Cholinergic Agents|cholinergic agents|mesh-ancestor
25239308|NCT02542839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25239309|NCT02542839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239310|NCT02542592|Methylprednisolone|methylprednisolone|mesh-list
25239311|NCT02542592|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25239312|NCT02542592|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25239313|NCT02542592|Prednisolone|prednisolone|mesh-list
25874490|NCT05201248|Doxorubicin|doxorubicin|mesh-list
25874491|NCT05201248|Vincristine|vincristine|mesh-list
24717052|NCT01545297|Dexmedetomidine|dexmedetomidine|mesh-list
24717053|NCT01545297|Remifentanil|remifentanil|mesh-list
24717054|NCT01545297|Propofol|propofol|mesh-list
25874492|NCT05201248|Lenalidomide|lenalidomide|mesh-list
24717077|NCT01545427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717078|NCT01545440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24717079|NCT01545440|Immunologic Factors|immunologic factors|mesh-ancestor
24717080|NCT01545440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717081|NCT01545479|Captopril|captopril|mesh-list
24717082|NCT01545479|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24717194|NCT01546389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24717195|NCT01546389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24717196|NCT01546389|Antimalarials|antimalarials|mesh-ancestor
24717197|NCT01546389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24717198|NCT01546558|Metformin|metformin|mesh-list
24717199|NCT01546558|Ranolazine|ranolazine|mesh-list
24717200|NCT01546558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24550502|NCT00720811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24550503|NCT00720824|Anesthetics|anesthetics|mesh-list
25874493|NCT05201248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24717201|NCT01546558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717202|NCT01546558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24717203|NCT01546558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24789137|NCT01935674|Ritonavir|ritonavir|mesh-list
24789138|NCT01935674|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24717387|NCT01547416|Analgesics|analgesics|mesh-ancestor
24789148|NCT01935674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24789149|NCT01935674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24789150|NCT01935674|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24789151|NCT01935674|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24789152|NCT01935674|Antimetabolites|antimetabolites|mesh-ancestor
24789153|NCT01935674|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24789154|NCT01935674|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24789155|NCT01935713|Nicotine|nicotine|mesh-list
24789156|NCT01935713|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24789157|NCT01935713|Autonomic Agents|autonomic agents|mesh-ancestor
24789158|NCT01935713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24789159|NCT01935713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789160|NCT01935713|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24789161|NCT01935713|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24789162|NCT01935713|Cholinergic Agents|cholinergic agents|mesh-ancestor
24789163|NCT01935713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24717288|NCT01547143|Antiemetics|antiemetics|mesh-ancestor
24717289|NCT01547143|Autonomic Agents|autonomic agents|mesh-ancestor
24717294|NCT01547143|Hormones|hormones|mesh-ancestor
25006124|NCT05204979|Misoprostol|misoprostol|mesh-list
24871124|NCT04820179|Atezolizumab|atezolizumab|mesh-list
24445992|NCT00303433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445993|NCT00303433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445994|NCT00303433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24717325|NCT01547221|Hormone Antagonists|hormone antagonists|mesh-ancestor
24717326|NCT01547221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24717327|NCT01547221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717328|NCT01547221|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24717329|NCT01547221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24717347|NCT01547312|Ribavirin|ribavirin|mesh-list
24717383|NCT01547416|Sensory System Agents|sensory system agents|mesh-ancestor
24717384|NCT01547416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24717385|NCT01547416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24717386|NCT01547416|Narcotics|narcotics|mesh-ancestor
25239314|NCT02542592|Prednisolone acetate|prednisolone acetate|mesh-list
25239315|NCT02542592|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25239316|NCT02542592|Prednisolone phosphate|prednisolone phosphate|mesh-list
25239317|NCT02542592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24849759|NCT02250300|Protease Inhibitors|protease inhibitors|mesh-ancestor
24849760|NCT02250300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642421|NCT01179269|Antimitotic Agents|antimitotic agents|mesh-ancestor
25673714|NCT01763918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673715|NCT01763918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25673716|NCT01763931|Digoxin|digoxin|mesh-list
25673717|NCT01763931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25673718|NCT01763931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24717392|NCT01547455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24717393|NCT01547455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24717394|NCT01547455|Antimetabolites|antimetabolites|mesh-ancestor
24717395|NCT01547455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717462|NCT01548144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24717463|NCT01548144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24717464|NCT01548144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24717465|NCT01548157|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24717466|NCT01548157|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24717467|NCT01548157|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24717468|NCT01548157|Antimetabolites|antimetabolites|mesh-ancestor
24717469|NCT01548157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717470|NCT01548157|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24717471|NCT01548157|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24717472|NCT01548157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717473|NCT01548170|Ketoconazole|ketoconazole|mesh-list
24717474|NCT01548170|Sunitinib|sunitinib|mesh-list
24717475|NCT01548170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24615123|NCT01028079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615125|NCT01028079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24615126|NCT01028079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615127|NCT01028079|Antipyretics|antipyretics|mesh-ancestor
24615128|NCT01028092|Cyclosporine|cyclosporine|mesh-list
24615129|NCT01028092|Everolimus|everolimus|mesh-list
24615130|NCT01028092|Interleukin-2|interleukin-2|mesh-list
24615131|NCT01028092|Cyclosporins|cyclosporins|mesh-list
24615132|NCT01028092|Thymoglobulin|thymoglobulin|mesh-list
24615133|NCT01028092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717501|NCT01548209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24717502|NCT01548209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24717532|NCT01548326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24717535|NCT01548482|Trebananib|trebananib|mesh-list
24717536|NCT01548482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24717537|NCT01548482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24717538|NCT01548482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24717539|NCT01548482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24717540|NCT01548482|Antifungal Agents|antifungal agents|mesh-ancestor
25239318|NCT02542592|Antiemetics|antiemetics|mesh-ancestor
25239319|NCT02542592|Autonomic Agents|autonomic agents|mesh-ancestor
25239320|NCT02542592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239321|NCT02542592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239322|NCT02542592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25239323|NCT02542592|Glucocorticoids|glucocorticoids|mesh-ancestor
25239324|NCT02542592|Hormones|hormones|mesh-ancestor
25239325|NCT02542592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25239326|NCT02542592|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25239327|NCT02542592|Protective Agents|protective agents|mesh-ancestor
25239328|NCT02542592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25239329|NCT02542592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25239330|NCT02542813|Oxytocin|oxytocin|mesh-list
25239331|NCT02542813|Oxytocics|oxytocics|mesh-ancestor
25239332|NCT02542813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25239333|NCT02542813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273875|NCT02382432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24717541|NCT01548482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24717542|NCT01548482|Immunologic Factors|immunologic factors|mesh-ancestor
24717543|NCT01548482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717544|NCT01548482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24717545|NCT01548482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24717546|NCT01548482|Growth Substances|growth substances|mesh-ancestor
24717547|NCT01548482|Growth Inhibitors|growth inhibitors|mesh-ancestor
24717548|NCT01548521|Oxytocin|oxytocin|mesh-list
24717549|NCT01548521|Oxytocics|oxytocics|mesh-ancestor
24717585|NCT01548807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473951|NCT00404534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24473952|NCT00404534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24473953|NCT00404534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24473954|NCT00404534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24717586|NCT01548807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24476232|NCT00413608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874495|NCT05201248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790501|NCT01943136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790502|NCT01943188|Cyclophosphamide|cyclophosphamide|mesh-list
24790503|NCT01943188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24790504|NCT01943188|Immunologic Factors|immunologic factors|mesh-ancestor
24790505|NCT01943188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790506|NCT01943188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24790507|NCT01943188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24790508|NCT01943188|Alkylating Agents|alkylating agents|mesh-ancestor
24790509|NCT01943188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874496|NCT05201248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25874497|NCT05201248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25239334|NCT02542241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25239335|NCT02542254|Albuterol|albuterol|mesh-list
25239336|NCT02542254|Ipratropium|ipratropium|mesh-list
25239337|NCT02542254|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25239338|NCT02542254|Autonomic Agents|autonomic agents|mesh-ancestor
25239339|NCT02542254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239340|NCT02542254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239341|NCT02542254|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25239342|NCT02542254|Respiratory System Agents|respiratory system agents|mesh-ancestor
25239343|NCT02542254|Tocolytic Agents|tocolytic agents|mesh-ancestor
25239344|NCT02542254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25239345|NCT02542254|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25239346|NCT02542254|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25239347|NCT02542254|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25239348|NCT02542254|Adrenergic Agents|adrenergic agents|mesh-ancestor
25239349|NCT02542254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25239350|NCT02542254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239351|NCT02542254|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25239352|NCT02542254|Cholinergic Agents|cholinergic agents|mesh-ancestor
25239353|NCT02542137|Thymalfasin|thymalfasin|mesh-list
24473955|NCT00404534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24473956|NCT00404534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817836|NCT02085824|Antithrombins|antithrombins|mesh-ancestor
24817837|NCT02085824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24817838|NCT02085824|Protease Inhibitors|protease inhibitors|mesh-ancestor
24817839|NCT02085824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817840|NCT02085824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817841|NCT02085824|Anticoagulants|anticoagulants|mesh-ancestor
24817842|NCT02085824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24817843|NCT02085824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24613972|NCT01021865|Incretins|incretins|mesh-ancestor
25874498|NCT05201248|Alkylating Agents|alkylating agents|mesh-ancestor
25874499|NCT05201248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874500|NCT05201248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673719|NCT01763931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25673720|NCT01763931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673721|NCT01763931|Protective Agents|protective agents|mesh-ancestor
25673722|NCT01763931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673723|NCT01763996|Febuxostat|febuxostat|mesh-list
25673724|NCT01763996|Gout Suppressants|gout suppressants|mesh-ancestor
25673725|NCT01763996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25673726|NCT01764022|Paclitaxel|paclitaxel|mesh-list
25673727|NCT01764022|Trastuzumab|trastuzumab|mesh-list
25673728|NCT01764022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25673729|NCT01764022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673730|NCT01764022|Tubulin Modulators|tubulin modulators|mesh-ancestor
25673731|NCT01764022|Antimitotic Agents|antimitotic agents|mesh-ancestor
25673732|NCT01764022|Mitosis Modulators|mitosis modulators|mesh-ancestor
25673733|NCT01764022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673734|NCT01764022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25874501|NCT05201248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24717622|NCT01548950|Sildenafil Citrate|sildenafil citrate|mesh-list
24717623|NCT01548950|Vasodilator Agents|vasodilator agents|mesh-ancestor
24717624|NCT01548950|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24717625|NCT01548950|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24717626|NCT01548950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717627|NCT01548950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717628|NCT01548950|Urological Agents|urological agents|mesh-ancestor
24717629|NCT01548950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24717630|NCT01548950|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24717631|NCT01549093|Gemcitabine|gemcitabine|mesh-list
24717632|NCT01549093|Carboplatin|carboplatin|mesh-list
24717633|NCT01549093|Endostar protein|endostar protein|mesh-list
24717634|NCT01549093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25239354|NCT02542137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25239355|NCT02542137|Immunologic Factors|immunologic factors|mesh-ancestor
24440830|NCT00284947|Autonomic Agents|autonomic agents|mesh-ancestor
25239356|NCT02542137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239357|NCT02542124|Interleukin-12|interleukin-12|mesh-list
25239358|NCT02542124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25239359|NCT02542124|Immunologic Factors|immunologic factors|mesh-ancestor
25239360|NCT02542124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239361|NCT02542124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25239362|NCT02542124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25239363|NCT02542124|Growth Substances|growth substances|mesh-ancestor
25239364|NCT02542124|Growth Inhibitors|growth inhibitors|mesh-ancestor
25239365|NCT02542124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25239366|NCT02542111|Gemcitabine|gemcitabine|mesh-list
25239367|NCT02542111|Dexamethasone|dexamethasone|mesh-list
25239369|NCT02542111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25239370|NCT02542111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25239371|NCT02542111|Antiemetics|antiemetics|mesh-ancestor
25239372|NCT02542111|Autonomic Agents|autonomic agents|mesh-ancestor
25239373|NCT02542111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25067109|NCT03446937|Dexamethasone acetate|dexamethasone acetate|mesh-list
25239379|NCT02542111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25239380|NCT02542111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24717673|NCT01549418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24717675|NCT01549418|Analgesics|analgesics|mesh-ancestor
24717676|NCT01549418|Sensory System Agents|sensory system agents|mesh-ancestor
24717677|NCT01549418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24717678|NCT01549418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717704|NCT01549496|Amlodipine|amlodipine|mesh-list
24717705|NCT01549496|Diltiazem|diltiazem|mesh-list
24717706|NCT01549496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24717707|NCT01549496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24717708|NCT01549496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24717709|NCT01549496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717710|NCT01549496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24717711|NCT01549496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717712|NCT01549496|Vasodilator Agents|vasodilator agents|mesh-ancestor
24717713|NCT01549548|Ponatinib|ponatinib|mesh-list
24717714|NCT01549548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24717715|NCT01549548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24550549|NCT00721201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24550550|NCT00721201|Contraceptive Agents|contraceptive agents|mesh-ancestor
24550551|NCT00721201|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25673735|NCT01764464|Gabapentin|gabapentin|mesh-list
24583561|NCT00875173|Trace Elements|trace elements|mesh-ancestor
24583562|NCT00875173|Micronutrients|micronutrients|mesh-ancestor
24583563|NCT00875238|Doxorubicin|doxorubicin|mesh-list
24583564|NCT00875238|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24583565|NCT00875238|Trastuzumab|trastuzumab|mesh-list
24583566|NCT00875238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24583567|NCT00875238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583568|NCT00875238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24717716|NCT01549548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717717|NCT01549548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717718|NCT01549574|Crizotinib|crizotinib|mesh-list
24717719|NCT01549574|Esomeprazole|esomeprazole|mesh-list
24789164|NCT01935713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717754|NCT01549743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24717755|NCT01549743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24717756|NCT01549743|Analgesics|analgesics|mesh-ancestor
24717757|NCT01549743|Sensory System Agents|sensory system agents|mesh-ancestor
24717758|NCT01549743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24717759|NCT01549743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717760|NCT01549743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24717761|NCT01549743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24717762|NCT01549743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24717763|NCT01549743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24717797|NCT01550055|Irinotecan|irinotecan|mesh-list
24717798|NCT01550055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24717799|NCT01550055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24717800|NCT01550055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717801|NCT01550055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717830|NCT01550302|Bupivacaine|bupivacaine|mesh-list
24717831|NCT01550302|Anesthetics, Local|anesthetics, local|mesh-ancestor
24717832|NCT01550302|Anesthetics|anesthetics|mesh-ancestor
24717833|NCT01550302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24550552|NCT00721201|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24550553|NCT00721201|Hormone Antagonists|hormone antagonists|mesh-ancestor
25874502|NCT05201248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25874503|NCT05201248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25874504|NCT05201248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25874505|NCT05201248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25874506|NCT05201248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24818212|NCT02087475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24717834|NCT01550302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717835|NCT01550302|Sensory System Agents|sensory system agents|mesh-ancestor
24717857|NCT01550419|Antimetabolites|antimetabolites|mesh-ancestor
24717858|NCT01550419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874507|NCT05201248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24717887|NCT01550458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24717888|NCT01550458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717889|NCT01550458|Vasodilator Agents|vasodilator agents|mesh-ancestor
25239383|NCT02542111|Antiviral Agents|antiviral agents|mesh-ancestor
25239384|NCT02542111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25239385|NCT02542111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25239386|NCT02542111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25239387|NCT02542111|Immunologic Factors|immunologic factors|mesh-ancestor
25239388|NCT02542007|Sirolimus|sirolimus|mesh-list
25874508|NCT05201248|Glucocorticoids|glucocorticoids|mesh-ancestor
25874509|NCT05201248|Hormones|hormones|mesh-ancestor
25874510|NCT05201248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25874511|NCT05201248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25874512|NCT05201248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25874513|NCT05201248|Tubulin Modulators|tubulin modulators|mesh-ancestor
24717891|NCT01550458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24717892|NCT01550458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24818213|NCT02087475|Immunologic Factors|immunologic factors|mesh-ancestor
24818214|NCT02087475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818215|NCT02087475|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24818216|NCT02087475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25673736|NCT01764464|Analgesics|analgesics|mesh-ancestor
25673737|NCT01764464|Sensory System Agents|sensory system agents|mesh-ancestor
25673738|NCT01764464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25673739|NCT01764464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673740|NCT01764464|Anticonvulsants|anticonvulsants|mesh-ancestor
25673741|NCT01764464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25673742|NCT01764464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25673743|NCT01764464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24791441|NCT04411953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24791544|NCT03970694|Capecitabine|capecitabine|mesh-list
24791545|NCT03970694|Oxaliplatin|oxaliplatin|mesh-list
24803554|NCT01997099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24791546|NCT03970694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24791547|NCT03970694|Antimetabolites|antimetabolites|mesh-ancestor
24791548|NCT03970694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791549|NCT03970694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791550|NCT03962062|Moxidectin|moxidectin|mesh-list
24791551|NCT03962062|Anthelmintics|anthelmintics|mesh-ancestor
24924521|NCT04159246|Sofosbuvir|sofosbuvir|mesh-list
24791636|NCT03714880|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24791637|NCT03714880|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24584549|NCT00880841|Narcotics|narcotics|mesh-ancestor
24584550|NCT00880841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24584551|NCT00880841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584552|NCT00880841|Analgesics|analgesics|mesh-ancestor
24584553|NCT00880841|Sensory System Agents|sensory system agents|mesh-ancestor
24717893|NCT01550640|Remifentanil|remifentanil|mesh-list
24717894|NCT01550640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24717895|NCT01550640|Narcotics|narcotics|mesh-ancestor
24717896|NCT01550640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24717897|NCT01550640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717898|NCT01550640|Analgesics|analgesics|mesh-ancestor
24717899|NCT01550640|Sensory System Agents|sensory system agents|mesh-ancestor
24717900|NCT01550640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24717901|NCT01550653|Liraglutide|liraglutide|mesh-list
24717902|NCT01550653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24717903|NCT01550653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717904|NCT01550653|Incretins|incretins|mesh-ancestor
24717905|NCT01550653|Hormones|hormones|mesh-ancestor
24717936|NCT01551069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24717937|NCT01551069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24717938|NCT01551069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24717939|NCT01551069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717940|NCT01551069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717941|NCT01551069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24717943|NCT01551147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24717944|NCT01551147|Respiratory System Agents|respiratory system agents|mesh-ancestor
24717945|NCT01551147|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24717946|NCT01551147|Hormone Antagonists|hormone antagonists|mesh-ancestor
24717947|NCT01551147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24450346|NCT00318825|Anesthetics|anesthetics|mesh-ancestor
24717976|NCT01551329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24717977|NCT01551329|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24717978|NCT01551329|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24717979|NCT01551329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24717980|NCT01551329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717981|NCT01551368|Nimodipine|nimodipine|mesh-list
24717982|NCT01551368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24717983|NCT01551368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24717984|NCT01551368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24717985|NCT01551368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717986|NCT01551368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24717987|NCT01551368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717988|NCT01551368|Vasodilator Agents|vasodilator agents|mesh-ancestor
25673744|NCT01764464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25673745|NCT01764464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25673746|NCT01764464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25673747|NCT01764464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25673748|NCT01764464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673749|NCT01764464|Antimanic Agents|antimanic agents|mesh-ancestor
25673750|NCT01764607|Sirolimus|sirolimus|mesh-list
25673751|NCT01764607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25673752|NCT01764607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25673753|NCT01764607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25673754|NCT01764607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673755|NCT01764607|Antifungal Agents|antifungal agents|mesh-ancestor
25673756|NCT01764607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25673757|NCT01764607|Immunologic Factors|immunologic factors|mesh-ancestor
25673758|NCT01764607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673759|NCT01764685|Topiramate|topiramate|mesh-list
25673760|NCT01764685|Anticonvulsants|anticonvulsants|mesh-ancestor
25673761|NCT01764685|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24792335|NCT05320406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24792337|NCT05312892|Antihypertensive Agents|antihypertensive agents|mesh-list
24792338|NCT05312892|Moxonidine|moxonidine|mesh-list
24585269|NCT00884676|Sunitinib|sunitinib|mesh-list
24792339|NCT05312892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24792340|NCT05312892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24792341|NCT05312892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924781|NCT04156425|Calcium|calcium|mesh-list
24717989|NCT01551394|Gentamicins|gentamicins|mesh-list
24717990|NCT01551394|Meropenem|meropenem|mesh-list
24718021|NCT01551485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718022|NCT01551511|Dronabinol|dronabinol|mesh-list
24718023|NCT01551511|Hallucinogens|hallucinogens|mesh-ancestor
24718024|NCT01551511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550603|NCT00721344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24550604|NCT00721344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718025|NCT01551511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25874514|NCT05201248|Antimitotic Agents|antimitotic agents|mesh-ancestor
25874515|NCT05201248|Mitosis Modulators|mitosis modulators|mesh-ancestor
25874516|NCT05201248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25874517|NCT05201248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25874518|NCT05201248|Growth Substances|growth substances|mesh-ancestor
25239389|NCT02542007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25239390|NCT02542007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25239391|NCT02542007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25239392|NCT02542007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25239393|NCT02542007|Antifungal Agents|antifungal agents|mesh-ancestor
25239394|NCT02542007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25239395|NCT02542007|Immunologic Factors|immunologic factors|mesh-ancestor
25239396|NCT02542007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239397|NCT02542098|Hydrocodone|hydrocodone|mesh-list
24718027|NCT01551511|Analgesics|analgesics|mesh-ancestor
24718028|NCT01551511|Sensory System Agents|sensory system agents|mesh-ancestor
24718029|NCT01551511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24718030|NCT01551511|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24718031|NCT01551511|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24718032|NCT01551511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24718033|NCT01551511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718034|NCT01551511|Hormones|hormones|mesh-ancestor
25874519|NCT05201248|Growth Inhibitors|growth inhibitors|mesh-ancestor
24718054|NCT01551641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24718055|NCT01551641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24718056|NCT01551641|Growth Substances|growth substances|mesh-ancestor
24718057|NCT01551641|Growth Inhibitors|growth inhibitors|mesh-ancestor
24718058|NCT01551641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718059|NCT01551667|Antibodies|antibodies|mesh-list
24718060|NCT01551667|Immunologic Factors|immunologic factors|mesh-ancestor
24718061|NCT01551667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718062|NCT01551680|Iniparib|iniparib|mesh-list
24550605|NCT00721344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550606|NCT00721344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718063|NCT01551680|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24718064|NCT01551680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718065|NCT01551680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718066|NCT01551680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718067|NCT01551719|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24718068|NCT01551719|Vancomycin|vancomycin|mesh-list
24718069|NCT01551719|Linezolid|linezolid|mesh-list
24718070|NCT01551719|Daptomycin|daptomycin|mesh-list
24718071|NCT01551719|Penicillins|penicillins|mesh-list
24718072|NCT01551719|Tigecycline|tigecycline|mesh-list
24718073|NCT01551719|Cephalosporins|cephalosporins|mesh-list
24718074|NCT01551719|Teicoplanin|teicoplanin|mesh-list
24718075|NCT01551719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24718076|NCT01551719|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24718077|NCT01551719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718088|NCT01551810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673762|NCT01764685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673763|NCT01764841|Ciprofloxacin|ciprofloxacin|mesh-list
25673764|NCT01764841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25673765|NCT01764841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25673766|NCT01764841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25673767|NCT01764841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25673768|NCT01764841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25673769|NCT01764841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874520|NCT05201144|Sildenafil Citrate|sildenafil citrate|mesh-list
24718105|NCT01552005|Protease Inhibitors|protease inhibitors|mesh-ancestor
24718106|NCT01552005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718107|NCT01552005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718108|NCT01552005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24718109|NCT01552018|Saxagliptin|saxagliptin|mesh-list
24718110|NCT01552018|Incretins|incretins|mesh-ancestor
24718111|NCT01552018|Hormones|hormones|mesh-ancestor
24718112|NCT01552018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24718113|NCT01552018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718114|NCT01552018|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24718148|NCT01552187|Colchicine|colchicine|mesh-list
24718149|NCT01552187|Gout Suppressants|gout suppressants|mesh-ancestor
24718150|NCT01552187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24718151|NCT01552187|Tubulin Modulators|tubulin modulators|mesh-ancestor
24718152|NCT01552187|Antimitotic Agents|antimitotic agents|mesh-ancestor
24718153|NCT01552187|Mitosis Modulators|mitosis modulators|mesh-ancestor
25239398|NCT02542098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25239399|NCT02542098|Narcotics|narcotics|mesh-ancestor
25239400|NCT02542098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25239401|NCT02542098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239402|NCT02542098|Analgesics|analgesics|mesh-ancestor
24718229|NCT01552980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718230|NCT01552993|Acetaminophen|acetaminophen|mesh-list
24718231|NCT01552993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24718232|NCT01552993|Analgesics|analgesics|mesh-ancestor
24718233|NCT01552993|Sensory System Agents|sensory system agents|mesh-ancestor
24818510|NCT02089178|Sensory System Agents|sensory system agents|mesh-ancestor
24474092|NCT00404833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24474097|NCT00404833|Glucocorticoids|glucocorticoids|mesh-ancestor
24437220|NCT00273026|Xhance|xhance|mesh-list
24446340|NCT00304499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24718234|NCT01552993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24718235|NCT01552993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718236|NCT01552993|Antipyretics|antipyretics|mesh-ancestor
24718237|NCT01553006|Cefditoren|cefditoren|mesh-list
24718238|NCT01553006|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
24718239|NCT01553006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24718240|NCT01553006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24718241|NCT01553019|Gemcitabine|gemcitabine|mesh-list
24718242|NCT01553019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24718243|NCT01553019|Antimetabolites|antimetabolites|mesh-ancestor
24718244|NCT01553019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718245|NCT01553019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718246|NCT01553019|Antiviral Agents|antiviral agents|mesh-ancestor
24718247|NCT01553019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25874521|NCT05201144|Vasodilator Agents|vasodilator agents|mesh-ancestor
24718275|NCT01553357|Growth Inhibitors|growth inhibitors|mesh-ancestor
24718276|NCT01553435|Dextromethorphan|dextromethorphan|mesh-list
24718293|NCT01553721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718294|NCT01553721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718296|NCT01553773|Estrogens|estrogens|mesh-ancestor
24718297|NCT01553773|Hormones|hormones|mesh-ancestor
24718365|NCT01554345|Protective Agents|protective agents|mesh-ancestor
24615167|NCT01028261|Growth Inhibitors|growth inhibitors|mesh-ancestor
24615168|NCT01028261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24615169|NCT01028287|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24615170|NCT01028287|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
24615173|NCT01028287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24615174|NCT01028287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615205|NCT01028339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615207|NCT01028404|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24615208|NCT01028404|Insulin Aspart|insulin aspart|mesh-list
24615209|NCT01028404|Insulin, Long-Acting|insulin, long-acting|mesh-list
25673770|NCT01764841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24615210|NCT01028404|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24615211|NCT01028404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24615212|NCT01028404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874522|NCT05201144|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24967988|NCT03755466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25874523|NCT05201144|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25874524|NCT05201144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874525|NCT05201144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874526|NCT05201144|Urological Agents|urological agents|mesh-ancestor
25874527|NCT05185947|Paclitaxel|paclitaxel|mesh-list
25874528|NCT05185947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25239403|NCT02542098|Sensory System Agents|sensory system agents|mesh-ancestor
25239404|NCT02542098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239405|NCT02542098|Antitussive Agents|antitussive agents|mesh-ancestor
25239406|NCT02542098|Respiratory System Agents|respiratory system agents|mesh-ancestor
25239407|NCT02541734|Exenatide|exenatide|mesh-list
25239408|NCT02541734|Polygeline|polygeline|mesh-list
25239409|NCT02541734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25239410|NCT02541734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239411|NCT02541734|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25874529|NCT05185947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874530|NCT05185947|Tubulin Modulators|tubulin modulators|mesh-ancestor
24718383|NCT01554631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718384|NCT01554657|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24718385|NCT01554657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24718387|NCT01554657|Antitubercular Agents|antitubercular agents|mesh-ancestor
24718389|NCT01554813|Immunologic Factors|immunologic factors|mesh-ancestor
24718390|NCT01554813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718391|NCT01554826|Vaccines|vaccines|mesh-list
25239412|NCT02541734|Incretins|incretins|mesh-ancestor
24718392|NCT01554826|Immunologic Factors|immunologic factors|mesh-ancestor
25239413|NCT02541734|Hormones|hormones|mesh-ancestor
25239414|NCT02541734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25239415|NCT02541734|Plasma Substitutes|plasma substitutes|mesh-ancestor
25239416|NCT02541734|Blood Substitutes|blood substitutes|mesh-ancestor
25239417|NCT02541786|Rabeprazole|rabeprazole|mesh-list
25239418|NCT02541786|Dexlansoprazole|dexlansoprazole|mesh-list
25239419|NCT02541786|Lansoprazole|lansoprazole|mesh-list
25239420|NCT02541786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25239421|NCT02541786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25874531|NCT05185947|Antimitotic Agents|antimitotic agents|mesh-ancestor
25874532|NCT05185947|Mitosis Modulators|mitosis modulators|mesh-ancestor
25239422|NCT02541786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25239423|NCT02541786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25239424|NCT02541786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239425|NCT02541760|Mometasone Furoate|mometasone furoate|mesh-list
25239426|NCT02541760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25239427|NCT02541760|Dermatologic Agents|dermatologic agents|mesh-ancestor
25239430|NCT02541643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25239431|NCT02541708|Folic Acid|folic acid|mesh-list
24849776|NCT02250599|Paclitaxel|paclitaxel|mesh-list
24849777|NCT02250599|Bevacizumab|bevacizumab|mesh-list
24849778|NCT02250599|Carboplatin|carboplatin|mesh-list
24849779|NCT02250599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25067120|NCT03446937|Hormones|hormones|mesh-ancestor
24718393|NCT01554826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789167|NCT01935778|Oxaliplatin|oxaliplatin|mesh-list
24789168|NCT01935778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789169|NCT01935778|Tubulin Modulators|tubulin modulators|mesh-ancestor
24789170|NCT01935778|Antimitotic Agents|antimitotic agents|mesh-ancestor
24789171|NCT01935778|Mitosis Modulators|mitosis modulators|mesh-ancestor
24789172|NCT01935778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789173|NCT01935778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24789174|NCT01935778|Antimetabolites|antimetabolites|mesh-ancestor
24789175|NCT01935804|Metformin|metformin|mesh-list
24718398|NCT01554852|Melphalan|melphalan|mesh-list
24718399|NCT01554852|Lenalidomide|lenalidomide|mesh-list
25673771|NCT01764841|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25673772|NCT01764841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25673773|NCT01765179|Methyltestosterone|methyltestosterone|mesh-list
25673774|NCT01765179|Testosterone|testosterone|mesh-list
24718400|NCT01554852|Bortezomib|bortezomib|mesh-list
24718401|NCT01554852|Vorinostat|vorinostat|mesh-list
24718402|NCT01554852|BB 1101|bb 1101|mesh-list
25673775|NCT01765179|Testosterone undecanoate|testosterone undecanoate|mesh-list
25673776|NCT01765179|Testosterone enanthate|testosterone enanthate|mesh-list
25673777|NCT01765179|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24718403|NCT01554852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24718437|NCT01554930|Antiemetics|antiemetics|mesh-ancestor
24718438|NCT01554930|Autonomic Agents|autonomic agents|mesh-ancestor
24718439|NCT01554930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24718440|NCT01554930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718441|NCT01554930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24718442|NCT01554930|Glucocorticoids|glucocorticoids|mesh-ancestor
24718443|NCT01554930|Hormones|hormones|mesh-ancestor
24718444|NCT01554930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24718468|NCT01555008|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24718469|NCT01555008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718470|NCT01555008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24718471|NCT01555008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718472|NCT01555060|Ferrous gluconate|ferrous gluconate|mesh-list
24718473|NCT01555060|Hematinics|hematinics|mesh-ancestor
24718474|NCT01555099|Budesonide|budesonide|mesh-list
24718475|NCT01555099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24718476|NCT01555099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24718477|NCT01555099|Autonomic Agents|autonomic agents|mesh-ancestor
24718478|NCT01555099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24718479|NCT01555099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718480|NCT01555099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24718481|NCT01555099|Respiratory System Agents|respiratory system agents|mesh-ancestor
24718482|NCT01555099|Glucocorticoids|glucocorticoids|mesh-ancestor
24718483|NCT01555099|Hormones|hormones|mesh-ancestor
24718484|NCT01555099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25006159|NCT05204641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25006160|NCT05204641|Dopamine Agents|dopamine agents|mesh-ancestor
25006161|NCT05204641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24718485|NCT01555112|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
24718486|NCT01555112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24718487|NCT01555112|Immunologic Factors|immunologic factors|mesh-ancestor
24718488|NCT01555112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718489|NCT01555112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718490|NCT01555112|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24718563|NCT01555658|Anticoagulants|anticoagulants|mesh-ancestor
24718564|NCT01555658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25239432|NCT02541708|Hematinics|hematinics|mesh-ancestor
24718582|NCT01555710|Alkylating Agents|alkylating agents|mesh-ancestor
24718583|NCT01555788|Pancrelipase|pancrelipase|mesh-list
25239433|NCT02541708|Vitamin B Complex|vitamin b complex|mesh-ancestor
25239434|NCT02541708|Vitamins|vitamins|mesh-ancestor
25239435|NCT02541708|Micronutrients|micronutrients|mesh-ancestor
25239436|NCT02541708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239437|NCT02541526|Mirtazapine|mirtazapine|mesh-list
25239438|NCT02541526|Antidepressive Agents|antidepressive agents|mesh-ancestor
25239439|NCT02541526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24550642|NCT00721526|GABA Modulators|gaba modulators|mesh-ancestor
24550643|NCT00721526|GABA Agents|gaba agents|mesh-ancestor
24818768|NCT02090738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24818769|NCT02090738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24818770|NCT02090738|Anticonvulsants|anticonvulsants|mesh-ancestor
24818771|NCT02090738|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24818772|NCT02090738|Diuretics|diuretics|mesh-ancestor
24818773|NCT02090738|Natriuretic Agents|natriuretic agents|mesh-ancestor
25239440|NCT02541526|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25239441|NCT02541526|Histamine Antagonists|histamine antagonists|mesh-ancestor
24849780|NCT02250599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24849781|NCT02250599|Tubulin Modulators|tubulin modulators|mesh-ancestor
24849782|NCT02250599|Antimitotic Agents|antimitotic agents|mesh-ancestor
24849783|NCT02250599|Mitosis Modulators|mitosis modulators|mesh-ancestor
24849784|NCT02250599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718612|NCT01555918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24718613|NCT01555970|Acetylcysteine|acetylcysteine|mesh-list
24718614|NCT01555970|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24718615|NCT01555970|Antiviral Agents|antiviral agents|mesh-ancestor
24718616|NCT01555970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24718617|NCT01555970|Expectorants|expectorants|mesh-ancestor
24718618|NCT01555970|Respiratory System Agents|respiratory system agents|mesh-ancestor
24718619|NCT01555970|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24718620|NCT01555970|Antioxidants|antioxidants|mesh-ancestor
25876765|NCT02794571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24718655|NCT01556321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24718656|NCT01556334|Azithromycin|azithromycin|mesh-list
24718657|NCT01556334|Erythromycin|erythromycin|mesh-list
24718691|NCT01556542|Antimitotic Agents|antimitotic agents|mesh-ancestor
24718692|NCT01556542|Mitosis Modulators|mitosis modulators|mesh-ancestor
24718693|NCT01556542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718694|NCT01556646|Tolvaptan|tolvaptan|mesh-list
24718695|NCT01556646|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25874533|NCT05185947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718728|NCT01556737|Phytoestrogens|phytoestrogens|mesh-ancestor
24718905|NCT01557816|Analgesics|analgesics|mesh-ancestor
24718906|NCT01557816|Sensory System Agents|sensory system agents|mesh-ancestor
24718907|NCT01557816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24718908|NCT01557816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718909|NCT01557816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24718910|NCT01557816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24718911|NCT01557816|Gout Suppressants|gout suppressants|mesh-ancestor
24718912|NCT01557816|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24718913|NCT01557816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718914|NCT01557816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718915|NCT01557829|Silicon|silicon|mesh-list
24818774|NCT02090738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818775|NCT02090790|Dexamethasone|dexamethasone|mesh-list
24718916|NCT01557829|Trace Elements|trace elements|mesh-ancestor
24718917|NCT01557829|Micronutrients|micronutrients|mesh-ancestor
24719009|NCT01558622|Narcotics|narcotics|mesh-ancestor
24719010|NCT01558622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24719011|NCT01558622|Analgesics|analgesics|mesh-ancestor
24719012|NCT01558622|Sensory System Agents|sensory system agents|mesh-ancestor
24719013|NCT01558622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24719014|NCT01558622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24719015|NCT01558622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24719057|NCT01558934|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24719084|NCT01559025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24719085|NCT01559025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789187|NCT01935817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24789188|NCT01935817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789190|NCT01935830|Efavirenz|efavirenz|mesh-list
24789191|NCT01935830|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24789192|NCT01935830|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24789193|NCT01935830|Protease Inhibitors|protease inhibitors|mesh-ancestor
24789194|NCT01935830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24789195|NCT01935830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789196|NCT01935830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24789197|NCT01935830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24789198|NCT01935830|Antiviral Agents|antiviral agents|mesh-ancestor
24789199|NCT01935830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24789200|NCT01935830|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24789201|NCT01935830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24789215|NCT01935882|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24789216|NCT01935882|Antimalarials|antimalarials|mesh-ancestor
24789217|NCT01935882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25239442|NCT02541526|Histamine Agents|histamine agents|mesh-ancestor
25239443|NCT02541526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25239444|NCT02541526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239445|NCT02541526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239446|NCT02541526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24849785|NCT02250599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24849787|NCT02250599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24818777|NCT02090790|BB 1101|bb 1101|mesh-list
24849788|NCT02250599|Growth Substances|growth substances|mesh-ancestor
24849789|NCT02250599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849790|NCT02250599|Growth Inhibitors|growth inhibitors|mesh-ancestor
24849791|NCT02250664|Nicotine|nicotine|mesh-list
25067132|NCT03446872|Leucovorin|leucovorin|mesh-list
24789218|NCT01935882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24881067|NCT03101475|Tremelimumab|tremelimumab|mesh-list
25006163|NCT05204641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006164|NCT05204641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25006165|NCT05204641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25006166|NCT05204641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25006167|NCT05204641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25006169|NCT05204628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006170|NCT05204628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25006171|NCT05204628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25006172|NCT05204628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006173|NCT05204524|Temozolomide|temozolomide|mesh-list
25006174|NCT05204524|Epirubicin|epirubicin|mesh-list
25006175|NCT05204524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25874534|NCT05161468|Triamcinolone|triamcinolone|mesh-list
25874535|NCT05161468|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25006177|NCT05204524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006178|NCT05204524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006179|NCT05204524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25006180|NCT05204524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25006181|NCT05204524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25006182|NCT05204524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25006183|NCT05204329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25006184|NCT05204329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25006186|NCT05204173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25006187|NCT05204173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006188|NCT05204173|Tubulin Modulators|tubulin modulators|mesh-ancestor
25006189|NCT05204173|Antimitotic Agents|antimitotic agents|mesh-ancestor
25006190|NCT05204173|Mitosis Modulators|mitosis modulators|mesh-ancestor
25006192|NCT05204121|Elsulfavirine|elsulfavirine|mesh-list
25006193|NCT05204121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25006194|NCT05204121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25006195|NCT05204121|Antiviral Agents|antiviral agents|mesh-ancestor
25006196|NCT05204121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24871778|NCT04527289|Amantadine|amantadine|mesh-list
24719088|NCT01559051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719089|NCT01559142|Azathioprine|azathioprine|mesh-list
24719090|NCT01559142|Infliximab|infliximab|mesh-list
24719091|NCT01559142|Dermatologic Agents|dermatologic agents|mesh-ancestor
25239447|NCT02541526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25239448|NCT02541526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25239449|NCT02541526|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25239450|NCT02541526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25239451|NCT02541526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25239452|NCT02541526|Adrenergic Agents|adrenergic agents|mesh-ancestor
25239453|NCT02541526|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24550650|NCT00721552|Prednisolone|prednisolone|mesh-list
25874536|NCT05161468|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25874537|NCT05161468|Lidocaine|lidocaine|mesh-list
25874538|NCT05161468|Acid citrate dextrose|acid citrate dextrose|mesh-list
24646066|NCT01201694|Analgesics|analgesics|mesh-ancestor
24719097|NCT01559142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719098|NCT01559142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24719099|NCT01559142|Immunologic Factors|immunologic factors|mesh-ancestor
24719100|NCT01559142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719101|NCT01559272|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24719102|NCT01559272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24719120|NCT01559285|Sensory System Agents|sensory system agents|mesh-ancestor
24719121|NCT01559285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24719124|NCT01559298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24719125|NCT01559298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24719126|NCT01559298|Analgesics|analgesics|mesh-ancestor
24719127|NCT01559298|Sensory System Agents|sensory system agents|mesh-ancestor
24719128|NCT01559298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24719129|NCT01559298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719130|NCT01559298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24719131|NCT01559298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24719132|NCT01559298|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24719133|NCT01559298|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24719134|NCT01559298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719135|NCT01559298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24719136|NCT01559298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24719137|NCT01559298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24719138|NCT01559298|Antipyretics|antipyretics|mesh-ancestor
24719139|NCT01559298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24719140|NCT01559298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24719141|NCT01559298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24719142|NCT01559298|Purinergic Agents|purinergic agents|mesh-ancestor
24719143|NCT01559298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24719144|NCT01559480|Desogestrel|desogestrel|mesh-list
24819638|NCT02096315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25874539|NCT05161468|Glucocorticoids|glucocorticoids|mesh-list
24719145|NCT01559480|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24719146|NCT01559480|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24719147|NCT01559480|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24719148|NCT01559480|Contraceptive Agents|contraceptive agents|mesh-ancestor
24971163|NCT03728101|Anticoagulants|anticoagulants|mesh-ancestor
24971164|NCT03727867|Mitogens|mitogens|mesh-list
24971165|NCT03727867|Mitosis Modulators|mitosis modulators|mesh-ancestor
24971166|NCT03727867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719149|NCT01559480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24719151|NCT01559480|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24719152|NCT01559480|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24719259|NCT01560117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24719260|NCT01560221|Buprenorphine|buprenorphine|mesh-list
24719295|NCT01560442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24719296|NCT01560442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719298|NCT01560442|Sensory System Agents|sensory system agents|mesh-ancestor
24719330|NCT01560689|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24719447|NCT01561391|Factor VIII|factor viii|mesh-list
24719448|NCT01561391|Coagulants|coagulants|mesh-ancestor
24758922|NCT01748487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874540|NCT05161468|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25874541|NCT05161468|Anesthetics, Local|anesthetics, local|mesh-ancestor
24719454|NCT01561456|Docetaxel|docetaxel|mesh-list
25239454|NCT02541526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25239455|NCT02541526|Serotonin Agents|serotonin agents|mesh-ancestor
25239456|NCT02541526|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24506473|NCT00545480|Ibandronic Acid|ibandronic acid|mesh-list
24719455|NCT01561456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874542|NCT05161468|Anesthetics|anesthetics|mesh-ancestor
24719475|NCT01561508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719476|NCT01561508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719477|NCT01561586|Cisplatin|cisplatin|mesh-list
24719478|NCT01561586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719479|NCT01561742|Minocycline|minocycline|mesh-list
24719480|NCT01561742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25874543|NCT05161468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24719481|NCT01561742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24719482|NCT01561781|Digoxin|digoxin|mesh-list
24719483|NCT01561781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24719484|NCT01561781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25874544|NCT05161468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874545|NCT05161468|Sensory System Agents|sensory system agents|mesh-ancestor
25874546|NCT05161468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25874547|NCT05161468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25673778|NCT01765179|Androgens|androgens|mesh-ancestor
25673779|NCT01765179|Hormones|hormones|mesh-ancestor
25673780|NCT01765179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25673781|NCT01765179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673782|NCT01765179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25673783|NCT01765179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673784|NCT01765179|Anabolic Agents|anabolic agents|mesh-ancestor
25673785|NCT01765192|Montelukast|montelukast|mesh-list
25673786|NCT01765192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25673787|NCT01765192|Respiratory System Agents|respiratory system agents|mesh-ancestor
25673788|NCT01765192|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25673789|NCT01765192|Hormone Antagonists|hormone antagonists|mesh-ancestor
25673790|NCT01765192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24719495|NCT01561794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719496|NCT01561794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719497|NCT01561794|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24719498|NCT01561794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24719500|NCT01561911|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24719501|NCT01561911|Immunologic Factors|immunologic factors|mesh-ancestor
25006198|NCT05204069|Mydriatics|mydriatics|mesh-ancestor
24719502|NCT01561911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719503|NCT01561937|Warfarin|warfarin|mesh-list
24719504|NCT01561937|Anticoagulants|anticoagulants|mesh-ancestor
24719505|NCT01561950|Clopidogrel|clopidogrel|mesh-list
24719506|NCT01561950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24719507|NCT01561950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24719508|NCT01561950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24719509|NCT01561950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24719545|NCT01562405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719546|NCT01562405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24719547|NCT01562405|Glucocorticoids|glucocorticoids|mesh-ancestor
24719548|NCT01562405|Hormones|hormones|mesh-ancestor
25874551|NCT05161468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719576|NCT01562561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719578|NCT01562626|Antifungal Agents|antifungal agents|mesh-ancestor
24719579|NCT01562626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24719580|NCT01562626|Antimetabolites|antimetabolites|mesh-ancestor
24719581|NCT01562626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719582|NCT01562691|Petrolatum|petrolatum|mesh-list
24719583|NCT01562691|Emollients|emollients|mesh-ancestor
25239457|NCT02541552|Ropivacaine|ropivacaine|mesh-list
25239458|NCT02541552|Anesthetics, Local|anesthetics, local|mesh-ancestor
25239459|NCT02541552|Anesthetics|anesthetics|mesh-ancestor
25239460|NCT02541552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25239461|NCT02541552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239462|NCT02541552|Sensory System Agents|sensory system agents|mesh-ancestor
25239463|NCT02541552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239464|NCT02541500|Minocycline|minocycline|mesh-list
25239465|NCT02541500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25239466|NCT02541500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25239467|NCT02541396|Ketamine|ketamine|mesh-list
25067156|NCT03446625|Resveratrol|resveratrol|mesh-list
24719584|NCT01562691|Dermatologic Agents|dermatologic agents|mesh-ancestor
24719585|NCT01562704|Acetaminophen|acetaminophen|mesh-list
24719586|NCT01562704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24719587|NCT01562704|Analgesics|analgesics|mesh-ancestor
24719588|NCT01562704|Sensory System Agents|sensory system agents|mesh-ancestor
24719589|NCT01562704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24719590|NCT01562704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719591|NCT01562704|Antipyretics|antipyretics|mesh-ancestor
24719598|NCT01562717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719616|NCT01562808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24719617|NCT01562808|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24719618|NCT01562808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24719619|NCT01562808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24719620|NCT01562808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719621|NCT01562808|Dopamine Agonists|dopamine agonists|mesh-ancestor
24719622|NCT01562808|Dopamine Agents|dopamine agents|mesh-ancestor
24719623|NCT01562808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24719624|NCT01562808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719625|NCT01562808|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24719626|NCT01562808|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24719658|NCT01562990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25874552|NCT05161468|Anticoagulants|anticoagulants|mesh-ancestor
24719659|NCT01562990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24719660|NCT01562990|Antimetabolites|antimetabolites|mesh-ancestor
25874553|NCT05161468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25874554|NCT05161468|Hormones|hormones|mesh-ancestor
25876766|NCT02794571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24971968|NCT03721380|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24971969|NCT03721380|Narcotics|narcotics|mesh-ancestor
24971970|NCT03721380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24971971|NCT03721380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971972|NCT03721380|Analgesics|analgesics|mesh-ancestor
24971973|NCT03721380|Sensory System Agents|sensory system agents|mesh-ancestor
24971974|NCT03721380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24972007|NCT03720873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972009|NCT03720756|Nickel|nickel|mesh-list
24719661|NCT01562990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719662|NCT01562990|Antiviral Agents|antiviral agents|mesh-ancestor
24719663|NCT01562990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24719664|NCT01562990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24719665|NCT01562990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24719666|NCT01562990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24615290|NCT01028638|Growth Inhibitors|growth inhibitors|mesh-ancestor
24719667|NCT01563068|Calcipotriene|calcipotriene|mesh-list
24719668|NCT01563068|Dermatologic Agents|dermatologic agents|mesh-ancestor
24719669|NCT01563120|Metformin|metformin|mesh-list
24719670|NCT01563120|Glyburide|glyburide|mesh-list
25874555|NCT05161468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24719700|NCT01563328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24719701|NCT01563328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24789225|NCT01935973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24789226|NCT01935973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24789227|NCT01935973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550679|NCT00721747|Cyclophosphamide|cyclophosphamide|mesh-list
24789229|NCT01936012|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24789230|NCT01936012|Protease Inhibitors|protease inhibitors|mesh-ancestor
24789231|NCT01936012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24789232|NCT01936012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789233|NCT01936012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24789234|NCT01936012|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24789235|NCT01936012|Protective Agents|protective agents|mesh-ancestor
24789236|NCT01936012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789237|NCT01936025|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24789238|NCT01936025|Dextromethorphan|dextromethorphan|mesh-list
25006222|NCT05204056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25006223|NCT05204056|Adrenergic Agents|adrenergic agents|mesh-ancestor
25006224|NCT05204056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25006225|NCT05204056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239492|NCT02541383|Antiemetics|antiemetics|mesh-ancestor
25239468|NCT02541396|Oxycodone|oxycodone|mesh-list
25239469|NCT02541396|Analgesics|analgesics|mesh-ancestor
25239470|NCT02541396|Sensory System Agents|sensory system agents|mesh-ancestor
25239471|NCT02541396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239472|NCT02541396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239473|NCT02541396|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25239474|NCT02541396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25239475|NCT02541396|Anesthetics, General|anesthetics, general|mesh-ancestor
25239476|NCT02541396|Anesthetics|anesthetics|mesh-ancestor
25239477|NCT02541396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25874556|NCT05161468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25874557|NCT05161468|Immunologic Factors|immunologic factors|mesh-ancestor
25874558|NCT05161468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874559|NCT05150340|Immunoglobulins|immunoglobulins|mesh-list
25874560|NCT05150340|Immunologic Factors|immunologic factors|mesh-ancestor
25876767|NCT02794571|Tubulin Modulators|tubulin modulators|mesh-ancestor
25006236|NCT05204056|Hemostatics|hemostatics|mesh-ancestor
25006237|NCT05204056|Coagulants|coagulants|mesh-ancestor
25006238|NCT05203913|Paclitaxel|paclitaxel|mesh-list
25006239|NCT05203913|Nivolumab|nivolumab|mesh-list
24720056|NCT01566253|Ketoprofen|ketoprofen|mesh-list
25006240|NCT05203913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25673791|NCT01765192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673792|NCT01765192|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25673793|NCT01765192|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25673794|NCT01765192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673795|NCT01765270|Saxagliptin|saxagliptin|mesh-list
25673796|NCT01765270|Incretins|incretins|mesh-ancestor
25673797|NCT01765270|Hormones|hormones|mesh-ancestor
25673798|NCT01765270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25006241|NCT05203913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006242|NCT05203913|Tubulin Modulators|tubulin modulators|mesh-ancestor
25006243|NCT05203913|Antimitotic Agents|antimitotic agents|mesh-ancestor
24759769|NCT01754805|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24972863|NCT03714594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24972864|NCT03714594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973037|NCT03712735|Bupivacaine|bupivacaine|mesh-list
24973038|NCT03712735|Anesthetics, Local|anesthetics, local|mesh-ancestor
24973039|NCT03712735|Anesthetics|anesthetics|mesh-ancestor
24973040|NCT03712735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24973041|NCT03712735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973042|NCT03712735|Sensory System Agents|sensory system agents|mesh-ancestor
24973043|NCT03712735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24759770|NCT01754805|Abortifacient Agents|abortifacient agents|mesh-ancestor
24759771|NCT01754805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24759772|NCT01754805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006244|NCT05203913|Mitosis Modulators|mitosis modulators|mesh-ancestor
25006245|NCT05203913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719702|NCT01563328|Antiviral Agents|antiviral agents|mesh-ancestor
24719703|NCT01563328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24719704|NCT01563367|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
24719705|NCT01563367|Hematinics|hematinics|mesh-ancestor
24719706|NCT01563601|Carboplatin|carboplatin|mesh-list
24719707|NCT01563601|Etoposide|etoposide|mesh-list
24719708|NCT01563601|Etoposide phosphate|etoposide phosphate|mesh-list
24719709|NCT01563601|Obatoclax|obatoclax|mesh-list
24719710|NCT01563601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719711|NCT01563601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24719712|NCT01563601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24719713|NCT01563601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24719714|NCT01563601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24719715|NCT01563601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719716|NCT01563614|Cytarabine|cytarabine|mesh-list
24719746|NCT01563835|Sensory System Agents|sensory system agents|mesh-ancestor
24719747|NCT01563835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24719750|NCT01563835|Analgesics|analgesics|mesh-ancestor
24719751|NCT01563835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24719752|NCT01563835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24719753|NCT01563835|Anesthetics, General|anesthetics, general|mesh-ancestor
24719754|NCT01563835|Anticoagulants|anticoagulants|mesh-ancestor
24719755|NCT01563835|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24719761|NCT01563939|Narcotics|narcotics|mesh-ancestor
24719762|NCT01563939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24719763|NCT01563939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719764|NCT01563939|Analgesics|analgesics|mesh-ancestor
24719795|NCT01564108|Growth Inhibitors|growth inhibitors|mesh-ancestor
24719796|NCT01564108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719799|NCT01564199|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24719800|NCT01564199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24719801|NCT01564199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24719802|NCT01564199|Autonomic Agents|autonomic agents|mesh-ancestor
24719803|NCT01564199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24719804|NCT01564199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719805|NCT01564199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24719806|NCT01564199|Respiratory System Agents|respiratory system agents|mesh-ancestor
24719807|NCT01564199|Dermatologic Agents|dermatologic agents|mesh-ancestor
24719808|NCT01564199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24719809|NCT01564199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24719810|NCT01564199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24719845|NCT01564303|Antidotes|antidotes|mesh-ancestor
24719846|NCT01564303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25673799|NCT01765270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673800|NCT01765270|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25673801|NCT01765270|Protease Inhibitors|protease inhibitors|mesh-ancestor
25673802|NCT01765270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25673803|NCT01765270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673804|NCT01765270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25673805|NCT01765543|Rifampin|rifampin|mesh-list
25673806|NCT01765543|Vemurafenib|vemurafenib|mesh-list
25673807|NCT01765543|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25673808|NCT01765543|Antitubercular Agents|antitubercular agents|mesh-ancestor
25673809|NCT01765543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25673810|NCT01765543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25673811|NCT01765543|Leprostatic Agents|leprostatic agents|mesh-ancestor
24719847|NCT01564303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404136|NCT03682536|Hematinics|hematinics|mesh-ancestor
24794599|NCT04905979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794600|NCT04905979|Adrenergic Agents|adrenergic agents|mesh-ancestor
24794601|NCT04905979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24794602|NCT04905979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973606|NCT03708458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24973607|NCT03708458|Gout Suppressants|gout suppressants|mesh-ancestor
24973608|NCT03708458|Tocolytic Agents|tocolytic agents|mesh-ancestor
24973609|NCT03708458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24973610|NCT03708458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25239478|NCT02541396|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25239479|NCT02541396|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24719848|NCT01564329|Endostar protein|endostar protein|mesh-list
24719849|NCT01564329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24719850|NCT01564329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24719882|NCT01564680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24719883|NCT01564680|Analgesics|analgesics|mesh-ancestor
24719884|NCT01564680|Sensory System Agents|sensory system agents|mesh-ancestor
24615357|NCT01029002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24581712|NCT00865891|Tocolytic Agents|tocolytic agents|mesh-ancestor
24581713|NCT00865891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24581715|NCT00865917|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24581716|NCT00865917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24581717|NCT00865917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24581718|NCT00865917|Sympatholytics|sympatholytics|mesh-ancestor
24581719|NCT00865917|Autonomic Agents|autonomic agents|mesh-ancestor
24581720|NCT00865917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24581721|NCT00865917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581722|NCT00865917|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24581723|NCT00865917|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24581724|NCT00865917|Adrenergic Agents|adrenergic agents|mesh-ancestor
24581725|NCT00865917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581726|NCT00865917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621581|NCT01063179|Thalidomide|thalidomide|mesh-list
24621582|NCT01063179|Prednisone|prednisone|mesh-list
24621583|NCT01063179|Bortezomib|bortezomib|mesh-list
24621584|NCT01063179|Melphalan|melphalan|mesh-list
24621585|NCT01063179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24621586|NCT01063179|Glucocorticoids|glucocorticoids|mesh-ancestor
25673812|NCT01765543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25673813|NCT01765543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25673814|NCT01765543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673815|NCT01765543|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25673816|NCT01765543|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25673817|NCT01765543|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25673818|NCT01765543|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25673819|NCT01765543|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25673820|NCT01765543|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25673821|NCT01765543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673822|NCT01765543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25673823|NCT01765569|Vemurafenib|vemurafenib|mesh-list
25673824|NCT01765569|Digoxin|digoxin|mesh-list
25673825|NCT01765569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25673826|NCT01765569|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25673827|NCT01765569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973816|NCT03706703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973817|NCT03706703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24719971|NCT01565278|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24646122|NCT01202097|Autonomic Agents|autonomic agents|mesh-ancestor
24719972|NCT01565278|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24719973|NCT01565278|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24719974|NCT01565278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24719975|NCT01565512|Bupivacaine|bupivacaine|mesh-list
25006246|NCT05203913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25006247|NCT05203913|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25006248|NCT05203744|Tafenoquine|tafenoquine|mesh-list
25006249|NCT05203744|Antimalarials|antimalarials|mesh-ancestor
25006250|NCT05203744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25006251|NCT05203744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25006252|NCT05203744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25006254|NCT05203588|Denosumab|denosumab|mesh-list
25006255|NCT05203588|Calcium|calcium|mesh-list
25006256|NCT05203588|Vitamins|vitamins|mesh-ancestor
25006257|NCT05203588|Micronutrients|micronutrients|mesh-ancestor
25006258|NCT05203588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006259|NCT05203588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25006260|NCT05203588|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25006261|NCT05203432|Atropine|atropine|mesh-list
25006262|NCT05203432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25006263|NCT05203432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25239480|NCT02541396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25239481|NCT02541396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239482|NCT02541396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25239483|NCT02541396|Narcotics|narcotics|mesh-ancestor
25239484|NCT02541383|Thalidomide|thalidomide|mesh-list
25239485|NCT02541383|Dexamethasone|dexamethasone|mesh-list
25239486|NCT02541383|Dexamethasone acetate|dexamethasone acetate|mesh-list
25239487|NCT02541383|Bortezomib|bortezomib|mesh-list
25239488|NCT02541383|Daratumumab|daratumumab|mesh-list
25239489|NCT02541383|BB 1101|bb 1101|mesh-list
25239490|NCT02541383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25239491|NCT02541383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25006268|NCT05203432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25006269|NCT05203432|Respiratory System Agents|respiratory system agents|mesh-ancestor
25006270|NCT05203432|Mydriatics|mydriatics|mesh-ancestor
25006271|NCT05203432|Parasympatholytics|parasympatholytics|mesh-ancestor
25006272|NCT05203432|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25006273|NCT05203432|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25006274|NCT05203432|Cholinergic Agents|cholinergic agents|mesh-ancestor
24720014|NCT01565733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720015|NCT01565746|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
24720016|NCT01565746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720018|NCT01565759|Antidepressive Agents|antidepressive agents|mesh-ancestor
24720019|NCT01565759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24720020|NCT01565759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720021|NCT01565759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720022|NCT01565759|Antimanic Agents|antimanic agents|mesh-ancestor
24720058|NCT01566253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24720059|NCT01566253|Narcotics|narcotics|mesh-ancestor
24720128|NCT01566565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720130|NCT01566565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24720131|NCT01566565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24720132|NCT01566565|Purinergic Agents|purinergic agents|mesh-ancestor
24720159|NCT01566669|Analgesics|analgesics|mesh-ancestor
25874561|NCT05150340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874562|NCT05149131|Leuprolide|leuprolide|mesh-list
25874563|NCT05149131|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25874564|NCT05149131|Fertility Agents|fertility agents|mesh-ancestor
25874565|NCT05149131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25874566|NCT05149131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874567|NCT05149131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24720160|NCT01566669|Sensory System Agents|sensory system agents|mesh-ancestor
24720161|NCT01566669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24720162|NCT01566669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720163|NCT01566669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24720165|NCT01566734|Cefazolin|cefazolin|mesh-list
24720166|NCT01566734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25673828|NCT01765569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720167|NCT01566734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24720168|NCT01566760|Fesoterodine|fesoterodine|mesh-list
24720403|NCT01568281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24974571|NCT04394481|Antiemetics|antiemetics|mesh-ancestor
24720404|NCT01568281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239494|NCT02541383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239495|NCT02541383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239496|NCT02541383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25239497|NCT02541383|Glucocorticoids|glucocorticoids|mesh-ancestor
25239498|NCT02541383|Hormones|hormones|mesh-ancestor
25239499|NCT02541383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25239500|NCT02541383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24720406|NCT01568281|Hormone Antagonists|hormone antagonists|mesh-ancestor
24720407|NCT01568281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24720408|NCT01568281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720410|NCT01568294|Immunologic Factors|immunologic factors|mesh-ancestor
25874568|NCT05149131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720519|NCT01569035|Warfarin|warfarin|mesh-list
24615386|NCT01029288|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24615387|NCT01029288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615388|NCT01029418|Sorafenib|sorafenib|mesh-list
24615389|NCT01029418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079560|NCT03346837|Itraconazole|itraconazole|mesh-list
24759819|NCT01754961|Cholecalciferol|cholecalciferol|mesh-list
24759820|NCT01754961|Vitamins|vitamins|mesh-list
24759821|NCT01754961|Micronutrients|micronutrients|mesh-ancestor
24615390|NCT01029418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25874569|NCT05148234|Decitabine|decitabine|mesh-list
25874570|NCT05148234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25874571|NCT05148234|Antimetabolites|antimetabolites|mesh-ancestor
25874572|NCT05148234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720693|NCT01569984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720694|NCT01569984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24720695|NCT01569984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24720696|NCT01569984|Growth Substances|growth substances|mesh-ancestor
24759847|NCT01755117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25874573|NCT05148234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720697|NCT01569984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239501|NCT02541383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25239502|NCT02541383|Protease Inhibitors|protease inhibitors|mesh-ancestor
25239503|NCT02541383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273876|NCT02382432|Analgesics|analgesics|mesh-ancestor
24720736|NCT01570569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24720737|NCT01570569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24720766|NCT01570569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24720769|NCT01570582|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24720770|NCT01570582|Carboplatin|carboplatin|mesh-list
24720771|NCT01570582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24720772|NCT01570582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673829|NCT01765569|Protective Agents|protective agents|mesh-ancestor
25673830|NCT01765569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673831|NCT01765569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673832|NCT01765569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25673833|NCT01765582|Leucovorin|leucovorin|mesh-list
25673834|NCT01765582|Folic Acid|folic acid|mesh-list
25673835|NCT01765582|Bevacizumab|bevacizumab|mesh-list
25673836|NCT01765582|Fluorouracil|fluorouracil|mesh-list
25673837|NCT01765582|Capecitabine|capecitabine|mesh-list
25673838|NCT01765582|Oxaliplatin|oxaliplatin|mesh-list
25874574|NCT05148234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874575|NCT05137717|Maribavir|maribavir|mesh-list
25874576|NCT05137717|Antiviral Agents|antiviral agents|mesh-ancestor
24720774|NCT01570582|Antimitotic Agents|antimitotic agents|mesh-ancestor
24720775|NCT01570582|Mitosis Modulators|mitosis modulators|mesh-ancestor
24720776|NCT01570582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720814|NCT01570790|Mitosis Modulators|mitosis modulators|mesh-ancestor
24720844|NCT01570985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24720845|NCT01570985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720847|NCT01570985|Immunologic Factors|immunologic factors|mesh-ancestor
24720848|NCT01570985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720849|NCT01570985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720851|NCT01571024|Fluorouracil|fluorouracil|mesh-list
24720852|NCT01571024|Oxaliplatin|oxaliplatin|mesh-list
24759873|NCT01755299|Purinergic Agents|purinergic agents|mesh-ancestor
24759874|NCT01755299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24759875|NCT01755338|Methylprednisolone|methylprednisolone|mesh-list
24759876|NCT01755338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25874577|NCT05137717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25874578|NCT05137054|Dexamethasone|dexamethasone|mesh-list
25874579|NCT05137054|Lenalidomide|lenalidomide|mesh-list
24474386|NCT00405847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474387|NCT00405860|Mycophenolic Acid|mycophenolic acid|mesh-list
24474388|NCT00405860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24474389|NCT00405860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874580|NCT05137054|Bortezomib|bortezomib|mesh-list
24720853|NCT01571024|Antimetabolites|antimetabolites|mesh-ancestor
24720854|NCT01571024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646236|NCT01202513|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24720855|NCT01571024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24720856|NCT01571024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720857|NCT01571024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24720858|NCT01571024|Immunologic Factors|immunologic factors|mesh-ancestor
24720896|NCT01571206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24720897|NCT01571219|Infliximab|infliximab|mesh-list
24721017|NCT01571908|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24721018|NCT01571908|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24721025|NCT01571921|Tocopherols|tocopherols|mesh-list
24721026|NCT01571921|Antioxidants|antioxidants|mesh-ancestor
24721027|NCT01571921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721054|NCT01572025|Immunologic Factors|immunologic factors|mesh-ancestor
24721055|NCT01572025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721056|NCT01572090|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24721057|NCT01572090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721059|NCT01572116|Epinephrine|epinephrine|mesh-list
24721060|NCT01572116|Racepinephrine|racepinephrine|mesh-list
24721061|NCT01572116|Sufentanil|sufentanil|mesh-list
24721062|NCT01572116|Epinephryl borate|epinephryl borate|mesh-list
24721063|NCT01572116|Anesthetics, Local|anesthetics, local|mesh-ancestor
24721064|NCT01572116|Anesthetics|anesthetics|mesh-ancestor
24721065|NCT01572116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24721066|NCT01572116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721067|NCT01572116|Sensory System Agents|sensory system agents|mesh-ancestor
25239504|NCT02541383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239505|NCT02541383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25239506|NCT02541383|Immunologic Factors|immunologic factors|mesh-ancestor
25239507|NCT02541383|Leprostatic Agents|leprostatic agents|mesh-ancestor
25239508|NCT02541383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25239509|NCT02541383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25239510|NCT02541383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24446530|NCT00305201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24759878|NCT01755338|Prednisolone|prednisolone|mesh-list
24759925|NCT01755494|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24759926|NCT01755494|Protease Inhibitors|protease inhibitors|mesh-ancestor
25239511|NCT02541383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25239512|NCT02541383|Growth Substances|growth substances|mesh-ancestor
25239513|NCT02541383|Growth Inhibitors|growth inhibitors|mesh-ancestor
25239514|NCT02541331|Broncho-Vaxom|broncho-vaxom|mesh-list
24491099|NCT00481182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25404137|NCT03682068|Gemcitabine|gemcitabine|mesh-list
25673839|NCT01765582|Irinotecan|irinotecan|mesh-list
25874581|NCT05137054|Daratumumab|daratumumab|mesh-list
25874582|NCT05137054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25874583|NCT05137054|Antiemetics|antiemetics|mesh-ancestor
25874584|NCT05137054|Autonomic Agents|autonomic agents|mesh-ancestor
25874585|NCT05137054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24621595|NCT01063179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24621596|NCT01063179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24621597|NCT01063179|Immunologic Factors|immunologic factors|mesh-ancestor
25006276|NCT05203432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006277|NCT05203354|Acitretin|acitretin|mesh-list
25006278|NCT05203354|Keratolytic Agents|keratolytic agents|mesh-ancestor
25006279|NCT05203354|Dermatologic Agents|dermatologic agents|mesh-ancestor
25006280|NCT05203055|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25006281|NCT05203055|Interferon-alpha|interferon-alpha|mesh-list
25006282|NCT05203055|Antiviral Agents|antiviral agents|mesh-ancestor
25006283|NCT05203055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25006284|NCT05203055|Immunologic Factors|immunologic factors|mesh-ancestor
25006285|NCT05203055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006286|NCT05202821|Fluorides|fluorides|mesh-list
25006298|NCT05198388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109717|NCT03121963|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25109719|NCT03121963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109720|NCT03121963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25109721|NCT03121963|Narcotics|narcotics|mesh-ancestor
24759958|NCT01755559|Antimalarials|antimalarials|mesh-ancestor
25079567|NCT03346837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759959|NCT01755559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24965553|NCT03775876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109722|NCT03121963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25109723|NCT03121963|Anticonvulsants|anticonvulsants|mesh-ancestor
25109724|NCT03121963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25109726|NCT03121963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25109727|NCT03121963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25109728|NCT03121963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25109729|NCT03121963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25109730|NCT03121963|Antimanic Agents|antimanic agents|mesh-ancestor
25109731|NCT03121963|Antitussive Agents|antitussive agents|mesh-ancestor
25109732|NCT03121963|Respiratory System Agents|respiratory system agents|mesh-ancestor
25109733|NCT03122132|Ritonavir|ritonavir|mesh-list
25109746|NCT03122002|Clopidogrel|clopidogrel|mesh-list
25109747|NCT03122002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25109748|NCT03122002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25109749|NCT03122002|Analgesics|analgesics|mesh-ancestor
25109750|NCT03122002|Sensory System Agents|sensory system agents|mesh-ancestor
25109751|NCT03122002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25109752|NCT03122002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109753|NCT03122002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25109754|NCT03122002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25109755|NCT03122002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25239515|NCT02541331|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25239516|NCT02541331|Immunologic Factors|immunologic factors|mesh-ancestor
25239517|NCT02541331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239518|NCT02541084|Aflibercept|aflibercept|mesh-list
25239519|NCT02541084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25239520|NCT02541084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25239521|NCT02541084|Growth Substances|growth substances|mesh-ancestor
25239522|NCT02541084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239523|NCT02541084|Growth Inhibitors|growth inhibitors|mesh-ancestor
25239524|NCT02541084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25239525|NCT02541071|Clonidine|clonidine|mesh-list
25874586|NCT05137054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897771|NCT04422028|Progestins|progestins|mesh-ancestor
25874587|NCT05137054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25874588|NCT05137054|Glucocorticoids|glucocorticoids|mesh-ancestor
25874589|NCT05137054|Hormones|hormones|mesh-ancestor
25109757|NCT03122002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109758|NCT03122002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25874590|NCT05137054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25874591|NCT05137054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25874592|NCT05137054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874593|NCT05137054|Immunologic Factors|immunologic factors|mesh-ancestor
25874594|NCT05137054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25874595|NCT05137054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25874596|NCT05137054|Growth Substances|growth substances|mesh-ancestor
25109762|NCT03122002|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24721158|NCT01572350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721113|NCT01572259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24721116|NCT01572285|Dexamethasone acetate|dexamethasone acetate|mesh-list
24721118|NCT01572285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24721149|NCT01572350|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24721150|NCT01572350|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24721151|NCT01572350|Bevacizumab|bevacizumab|mesh-list
24721152|NCT01572350|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25874597|NCT05137054|Growth Inhibitors|growth inhibitors|mesh-ancestor
25239526|NCT02541071|Yohimbine|yohimbine|mesh-list
25239527|NCT02541071|Analgesics|analgesics|mesh-ancestor
25239528|NCT02541071|Sensory System Agents|sensory system agents|mesh-ancestor
25239529|NCT02541071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239530|NCT02541071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239531|NCT02541071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25239532|NCT02541071|Sympatholytics|sympatholytics|mesh-ancestor
25239533|NCT02541071|Autonomic Agents|autonomic agents|mesh-ancestor
25239534|NCT02541071|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25239535|NCT02541071|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24759979|NCT01755663|Sympatholytics|sympatholytics|mesh-ancestor
24760016|NCT01755871|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24760017|NCT01755871|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24760018|NCT01755871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760019|NCT01755871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24760020|NCT01755871|Immunologic Factors|immunologic factors|mesh-ancestor
25239536|NCT02541071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25239537|NCT02541071|Adrenergic Agents|adrenergic agents|mesh-ancestor
25239538|NCT02541071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25239539|NCT02541071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239540|NCT02541071|Mydriatics|mydriatics|mesh-ancestor
24849830|NCT02250820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24849832|NCT02250820|Sensory System Agents|sensory system agents|mesh-ancestor
24849833|NCT02250820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24849834|NCT02250820|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24849835|NCT02250820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24849836|NCT02250820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24849837|NCT02250820|Adrenergic Agents|adrenergic agents|mesh-ancestor
24849838|NCT02250820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24849839|NCT02250820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849840|NCT02250820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25874598|NCT05130463|Empagliflozin|empagliflozin|mesh-list
25874599|NCT05130463|Linagliptin|linagliptin|mesh-list
25874600|NCT05130463|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25874601|NCT05130463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721153|NCT01572350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24721154|NCT01572350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24721155|NCT01572350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24721156|NCT01572350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24721157|NCT01572350|Growth Substances|growth substances|mesh-ancestor
24721196|NCT01572558|Ciprofloxacin|ciprofloxacin|mesh-list
24721197|NCT01572558|Meropenem|meropenem|mesh-list
24721198|NCT01572558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24721199|NCT01572558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24721235|NCT01572623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721236|NCT01572623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24721237|NCT01572623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24721238|NCT01572623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24721239|NCT01572623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24450467|NCT00319267|Bosentan|bosentan|mesh-list
24721269|NCT01572857|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25874602|NCT05130463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25874603|NCT05130463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874604|NCT05130463|Incretins|incretins|mesh-ancestor
25874605|NCT05130463|Hormones|hormones|mesh-ancestor
25874606|NCT05130463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25876768|NCT02794571|Antimitotic Agents|antimitotic agents|mesh-ancestor
24721271|NCT01572857|Immunologic Factors|immunologic factors|mesh-ancestor
24721272|NCT01572857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721273|NCT01572961|Aspirin|aspirin|mesh-list
24721274|NCT01572961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25239541|NCT02541071|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25239542|NCT02541071|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25239543|NCT02541071|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25239544|NCT02541071|Urological Agents|urological agents|mesh-ancestor
25239545|NCT02541045|Metadoxine|metadoxine|mesh-list
25239546|NCT02541045|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25239547|NCT02541227|Cerebrolysin|cerebrolysin|mesh-list
25239548|NCT02541227|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25239549|NCT02541227|Protective Agents|protective agents|mesh-ancestor
25239550|NCT02541227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239551|NCT02541227|Nootropic Agents|nootropic agents|mesh-ancestor
25239552|NCT02541032|Minocycline|minocycline|mesh-list
25239553|NCT02541032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25239554|NCT02541032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25239555|NCT02541019|Ondansetron|ondansetron|mesh-list
25239556|NCT02541019|Palonosetron|palonosetron|mesh-list
25239557|NCT02541019|Antiemetics|antiemetics|mesh-ancestor
25239558|NCT02541019|Autonomic Agents|autonomic agents|mesh-ancestor
25239559|NCT02541019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239560|NCT02541019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239561|NCT02541019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25239562|NCT02541019|Antipruritics|antipruritics|mesh-ancestor
24849843|NCT02250833|Amlodipine|amlodipine|mesh-list
24849844|NCT02250833|Telmisartan|telmisartan|mesh-list
24849845|NCT02250833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24849846|NCT02250833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24849847|NCT02250833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24849848|NCT02250833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849849|NCT02250833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24721275|NCT01572961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24721276|NCT01572961|Analgesics|analgesics|mesh-ancestor
24721277|NCT01572961|Sensory System Agents|sensory system agents|mesh-ancestor
24721280|NCT01572961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24721320|NCT01573377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24721321|NCT01573377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721322|NCT01573377|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24721323|NCT01573377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24721324|NCT01573377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24721325|NCT01573377|Contraceptive Agents|contraceptive agents|mesh-ancestor
24721326|NCT01573377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24721327|NCT01573377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24721360|NCT01573663|Dipropizine|dipropizine|mesh-list
24721362|NCT01573663|Expectorants|expectorants|mesh-ancestor
24789331|NCT01936350|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24789332|NCT01936350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24615512|NCT01030081|Vasodilator Agents|vasodilator agents|mesh-ancestor
24615514|NCT01030081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24615515|NCT01030094|Topiramate|topiramate|mesh-list
24615516|NCT01030094|Carbamazepine|carbamazepine|mesh-list
24615517|NCT01030094|Valproic Acid|valproic acid|mesh-list
24721414|NCT01573806|Incretins|incretins|mesh-ancestor
24721415|NCT01573806|Hormones|hormones|mesh-ancestor
25239578|NCT02541006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24721421|NCT01573975|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24721422|NCT01573975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24721423|NCT01573975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006301|NCT05180032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25006302|NCT05180032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006303|NCT05172050|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25006304|NCT05172050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25006305|NCT05172050|Hormone Antagonists|hormone antagonists|mesh-ancestor
25006306|NCT05172050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25006307|NCT05172050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874607|NCT05130463|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25874608|NCT05130463|Protease Inhibitors|protease inhibitors|mesh-ancestor
25874609|NCT05130463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874610|NCT05123599|Tenofovir|tenofovir|mesh-list
25874611|NCT05123599|Antiviral Agents|antiviral agents|mesh-ancestor
25874612|NCT05123599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25874613|NCT05123599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25874614|NCT05123599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25239563|NCT02541019|Dermatologic Agents|dermatologic agents|mesh-ancestor
25239564|NCT02541019|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25239565|NCT02541019|Serotonin Agents|serotonin agents|mesh-ancestor
25239566|NCT02541019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25239567|NCT02541019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239568|NCT02541019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25239569|NCT02541019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25239570|NCT02541019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24849850|NCT02250833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671450|NCT01325935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25155208|NCT05444556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24849852|NCT02250833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24849853|NCT02250833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24849854|NCT02250859|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25874621|NCT05120349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25239571|NCT02541019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25239572|NCT02541019|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25239573|NCT02541019|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25239574|NCT02540928|N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine|mesh-list
25239575|NCT02540928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25239576|NCT02540928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239577|NCT02541006|Tiotropium Bromide|tiotropium bromide|mesh-list
25239581|NCT02541006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239583|NCT02541006|Respiratory System Agents|respiratory system agents|mesh-ancestor
25239584|NCT02541006|Parasympatholytics|parasympatholytics|mesh-ancestor
25239585|NCT02541006|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25239586|NCT02541006|Cholinergic Agents|cholinergic agents|mesh-ancestor
25239587|NCT02541006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25239588|NCT02541006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239589|NCT02540876|Ilorasertib|ilorasertib|mesh-list
25239590|NCT02540876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25239591|NCT02540876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25239592|NCT02540876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25239593|NCT02540876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239594|NCT02540824|Apatinib|apatinib|mesh-list
25239595|NCT02540824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25239596|NCT02540824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25239597|NCT02540824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25239598|NCT02540824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273877|NCT02382432|Sensory System Agents|sensory system agents|mesh-ancestor
25273878|NCT02382432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25404138|NCT03682068|Cisplatin|cisplatin|mesh-list
25673842|NCT01765582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673843|NCT01765582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25673844|NCT01765582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25673845|NCT01765582|Growth Substances|growth substances|mesh-ancestor
25273880|NCT02382432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25273882|NCT02382432|Adrenergic Agents|adrenergic agents|mesh-ancestor
25273883|NCT02382432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25273884|NCT02382432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273885|NCT02382432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25273886|NCT02382432|Narcotics|narcotics|mesh-ancestor
25273887|NCT02382432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25273888|NCT02382146|Dexamethasone|dexamethasone|mesh-list
25273889|NCT02382146|Dexamethasone acetate|dexamethasone acetate|mesh-list
25273890|NCT02382146|Ondansetron|ondansetron|mesh-list
25273891|NCT02382146|BB 1101|bb 1101|mesh-list
25273892|NCT02382146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24474667|NCT00406991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24474669|NCT00406991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474670|NCT00406991|Antipyretics|antipyretics|mesh-ancestor
24474671|NCT00406991|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24474672|NCT00406991|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24474702|NCT00407056|Glucocorticoids|glucocorticoids|mesh-ancestor
24474703|NCT00407056|Hormones|hormones|mesh-ancestor
24474704|NCT00407056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25273893|NCT02382146|Antiemetics|antiemetics|mesh-ancestor
25273894|NCT02382146|Autonomic Agents|autonomic agents|mesh-ancestor
25273895|NCT02382146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25273896|NCT02382146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874622|NCT05120349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25067284|NCT03444649|Antimetabolites|antimetabolites|mesh-ancestor
25006314|NCT05167370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006315|NCT05156879|Aspirin|aspirin|mesh-list
25006316|NCT05156879|Drospirenone|drospirenone|mesh-list
25006317|NCT05156879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25006318|NCT05156879|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
25006319|NCT05156879|Estradiol|estradiol|mesh-list
25006320|NCT05156879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25006321|NCT05156879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25006322|NCT05156879|Analgesics|analgesics|mesh-ancestor
25006323|NCT05156879|Sensory System Agents|sensory system agents|mesh-ancestor
25006324|NCT05156879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25006325|NCT05156879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006326|NCT05156879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25239603|NCT02540837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239604|NCT02540837|Sensory System Agents|sensory system agents|mesh-ancestor
25239605|NCT02540837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239606|NCT02540785|Levofloxacin|levofloxacin|mesh-list
25239608|NCT02540785|Tobramycin|tobramycin|mesh-list
25239609|NCT02540785|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
25239610|NCT02540785|Dexamethasone|dexamethasone|mesh-list
25239611|NCT02540785|Dexamethasone acetate|dexamethasone acetate|mesh-list
25239612|NCT02540785|BB 1101|bb 1101|mesh-list
25239613|NCT02540785|Hyaluronic Acid|hyaluronic acid|mesh-list
25239614|NCT02540785|Dipivefrin|dipivefrin|mesh-list
25239615|NCT02540785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25239616|NCT02540785|Antiemetics|antiemetics|mesh-ancestor
24812001|NCT02049229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24812002|NCT02049229|Immunologic Factors|immunologic factors|mesh-ancestor
24812003|NCT02049229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812004|NCT02049255|Bupivacaine|bupivacaine|mesh-list
25067300|NCT03444636|Anesthetics|anesthetics|mesh-ancestor
25874623|NCT05120349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721574|NCT01575639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24721576|NCT01575652|Perindopril|perindopril|mesh-list
24721577|NCT01575652|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24721578|NCT01575652|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25874624|NCT05109234|Brivaracetam|brivaracetam|mesh-list
25874625|NCT05109234|Anticonvulsants|anticonvulsants|mesh-ancestor
25874626|NCT05102409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25874627|NCT05102409|Lifitegrast|lifitegrast|mesh-list
25874628|NCT05102409|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25874629|NCT05092958|Avelumab|avelumab|mesh-list
25874630|NCT05092958|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25874631|NCT05092958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25874632|NCT05092958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874633|NCT05092958|Immunologic Factors|immunologic factors|mesh-ancestor
25087160|NCT03281941|Antipruritics|antipruritics|mesh-ancestor
25087161|NCT03281941|Dermatologic Agents|dermatologic agents|mesh-ancestor
24822723|NCT02112981|Sirolimus|sirolimus|mesh-list
25087330|NCT03280004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25087331|NCT03280004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087332|NCT03280004|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24721579|NCT01575652|Protease Inhibitors|protease inhibitors|mesh-ancestor
24721613|NCT01575795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721614|NCT01575795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874634|NCT05092958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874635|NCT05084989|Vaccines|vaccines|mesh-list
25239618|NCT02540785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239619|NCT02540785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239621|NCT02540785|Glucocorticoids|glucocorticoids|mesh-ancestor
25239622|NCT02540785|Hormones|hormones|mesh-ancestor
25239623|NCT02540785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25239624|NCT02540785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25239625|NCT02540785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874636|NCT05084989|Immunologic Factors|immunologic factors|mesh-ancestor
25239626|NCT02540785|Protease Inhibitors|protease inhibitors|mesh-ancestor
25239627|NCT02540785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25239628|NCT02540785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239629|NCT02540785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25239630|NCT02540785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25404139|NCT03682068|Carboplatin|carboplatin|mesh-list
25673846|NCT01765582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673847|NCT01765582|Growth Inhibitors|growth inhibitors|mesh-ancestor
25673848|NCT01765582|Antimetabolites|antimetabolites|mesh-ancestor
25673849|NCT01765582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673850|NCT01765582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25673851|NCT01765582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25673852|NCT01765582|Immunologic Factors|immunologic factors|mesh-ancestor
25673853|NCT01765582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25673854|NCT01765582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25673855|NCT01765582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25673856|NCT01765582|Antidotes|antidotes|mesh-ancestor
25673857|NCT01765582|Protective Agents|protective agents|mesh-ancestor
25673858|NCT01765582|Vitamin B Complex|vitamin b complex|mesh-ancestor
25673859|NCT01765582|Vitamins|vitamins|mesh-ancestor
25673860|NCT01765582|Micronutrients|micronutrients|mesh-ancestor
25673861|NCT01765582|Hematinics|hematinics|mesh-ancestor
25874637|NCT05084989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874638|NCT05077904|Alprazolam|alprazolam|mesh-list
25874639|NCT05077904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25874640|NCT05077904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25874641|NCT05077904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874642|NCT05077904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25874643|NCT05077904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25874644|NCT05077904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25874645|NCT05077904|GABA Modulators|gaba modulators|mesh-ancestor
25874646|NCT05077904|GABA Agents|gaba agents|mesh-ancestor
25874647|NCT05077904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25874648|NCT05077904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874649|NCT05076617|Alprazolam|alprazolam|mesh-list
24721704|NCT01576458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24721706|NCT01576627|Zinc Oxide|zinc oxide|mesh-list
24721707|NCT01576627|Trace Elements|trace elements|mesh-ancestor
24721741|NCT01576692|Antiviral Agents|antiviral agents|mesh-ancestor
24721742|NCT01576692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24721743|NCT01576731|Tenofovir|tenofovir|mesh-list
24721744|NCT01576731|Emtricitabine|emtricitabine|mesh-list
24721745|NCT01576731|Lopinavir|lopinavir|mesh-list
24721746|NCT01576731|Raltegravir Potassium|raltegravir potassium|mesh-list
25239631|NCT02540785|Renal Agents|renal agents|mesh-ancestor
25239632|NCT02540785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25239633|NCT02540785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25239634|NCT02540785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25239635|NCT02540785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25239636|NCT02540785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25239637|NCT02540785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25239638|NCT02540785|Immunologic Factors|immunologic factors|mesh-ancestor
25239639|NCT02540785|Viscosupplements|viscosupplements|mesh-ancestor
25239640|NCT02540785|Protective Agents|protective agents|mesh-ancestor
25239641|NCT02540785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25239642|NCT02540785|Adrenergic Agents|adrenergic agents|mesh-ancestor
25239643|NCT02540785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25239644|NCT02540785|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25239645|NCT02540785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25239646|NCT02540720|Dexamethasone|dexamethasone|mesh-list
25239647|NCT02540720|gamma-Globulins|gamma-globulins|mesh-list
25239648|NCT02540720|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25239649|NCT02540720|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25239650|NCT02540720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25239651|NCT02540720|Antiemetics|antiemetics|mesh-ancestor
25239652|NCT02540720|Autonomic Agents|autonomic agents|mesh-ancestor
25239653|NCT02540720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239654|NCT02540720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239655|NCT02540720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25239656|NCT02540720|Glucocorticoids|glucocorticoids|mesh-ancestor
25239657|NCT02540720|Hormones|hormones|mesh-ancestor
25239658|NCT02540720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24760165|NCT01756521|Moxifloxacin|moxifloxacin|mesh-list
24812012|NCT02049268|Ethanol|ethanol|mesh-list
24812013|NCT02049268|Nicotine|nicotine|mesh-list
24812014|NCT02049268|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24812015|NCT02049268|Autonomic Agents|autonomic agents|mesh-ancestor
24812016|NCT02049268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24721747|NCT01576731|Antiviral Agents|antiviral agents|mesh-ancestor
25673863|NCT01765764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25673864|NCT01765764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25673865|NCT01765803|Thioridazine|thioridazine|mesh-list
25673866|NCT01765803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25673867|NCT01765803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24721748|NCT01576731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24721749|NCT01576731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24615534|NCT01030094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24721911|NCT01577914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24721913|NCT01577914|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24721914|NCT01577914|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24721915|NCT01577940|Ropivacaine|ropivacaine|mesh-list
24721946|NCT01578161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24721947|NCT01578161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721948|NCT01578161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24721950|NCT01578161|Sensory System Agents|sensory system agents|mesh-ancestor
24721951|NCT01578161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24721952|NCT01578161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24721953|NCT01578161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24721954|NCT01578161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24722040|NCT01578343|Glucocorticoids|glucocorticoids|mesh-ancestor
24722041|NCT01578343|Hormones|hormones|mesh-ancestor
25874651|NCT05076617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24722067|NCT01578434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722068|NCT01578434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24722069|NCT01578434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24722070|NCT01578434|Antacids|antacids|mesh-ancestor
24722071|NCT01578434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722072|NCT01578434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24722073|NCT01578447|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24722074|NCT01578447|Medroxyprogesterone|medroxyprogesterone|mesh-list
24406626|NCT00170924|Valsartan|valsartan|mesh-list
25239659|NCT02540720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25239660|NCT02540720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25239661|NCT02540720|Immunologic Factors|immunologic factors|mesh-ancestor
25239662|NCT02540642|Vitamin B 12|vitamin b 12|mesh-list
25239663|NCT02540642|Vitamins|vitamins|mesh-ancestor
25239664|NCT02540642|Micronutrients|micronutrients|mesh-ancestor
25239665|NCT02540642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239666|NCT02540642|Vitamin B Complex|vitamin b complex|mesh-ancestor
25239667|NCT02540486|Insulin Glargine|insulin glargine|mesh-list
25239668|NCT02540486|Insulin, Long-Acting|insulin, long-acting|mesh-list
25239669|NCT02540486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25239670|NCT02540486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239671|NCT02540707|Solifenacin Succinate|solifenacin succinate|mesh-list
25239672|NCT02540707|Mirabegron|mirabegron|mesh-list
25239673|NCT02540707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25239674|NCT02540707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25239675|NCT02540707|Cholinergic Agents|cholinergic agents|mesh-ancestor
25239676|NCT02540707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25874652|NCT05076617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874653|NCT05076617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25874654|NCT05076617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25874655|NCT05076617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25045127|NCT00992732|Ganciclovir|ganciclovir|mesh-list
25404140|NCT03682068|Durvalumab|durvalumab|mesh-list
25874656|NCT05076617|GABA Modulators|gaba modulators|mesh-ancestor
25874657|NCT05076617|GABA Agents|gaba agents|mesh-ancestor
25874658|NCT05076617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25874659|NCT05076617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874660|NCT05070364|Interferons|interferons|mesh-list
25874661|NCT05070364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874662|NCT05070364|Antiviral Agents|antiviral agents|mesh-ancestor
25087765|NCT03276858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25087766|NCT03276858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25087767|NCT03276858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25045128|NCT00992732|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25045129|NCT00992732|Arginine butyrate|arginine butyrate|mesh-list
25045130|NCT00992732|Antiviral Agents|antiviral agents|mesh-ancestor
25045131|NCT00992732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25045132|NCT00992732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25045133|NCT00992732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045134|NCT00992732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045135|NCT00992732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045136|NCT00992563|Ranibizumab|ranibizumab|mesh-list
25239677|NCT02540707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239678|NCT02540707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239679|NCT02540707|Urological Agents|urological agents|mesh-ancestor
25239680|NCT02540707|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25239681|NCT02540707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25239682|NCT02540707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25239683|NCT02540707|Adrenergic Agents|adrenergic agents|mesh-ancestor
25239684|NCT02540460|Delpazolid|delpazolid|mesh-list
25239685|NCT02540460|Oxazolidinones|oxazolidinones|mesh-list
25239686|NCT02540460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25239687|NCT02540460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25239688|NCT02540460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25239689|NCT02540460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25239690|NCT02540460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239691|NCT02540512|Acetaminophen|acetaminophen|mesh-list
25239692|NCT02540512|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25239693|NCT02540512|Hydrocodone|hydrocodone|mesh-list
25239694|NCT02540512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25239695|NCT02540512|Analgesics|analgesics|mesh-ancestor
25239696|NCT02540512|Sensory System Agents|sensory system agents|mesh-ancestor
25239697|NCT02540512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239698|NCT02540512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239699|NCT02540512|Antipyretics|antipyretics|mesh-ancestor
25239700|NCT02540512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25239701|NCT02540512|Narcotics|narcotics|mesh-ancestor
25239702|NCT02540512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25239703|NCT02540512|Antitussive Agents|antitussive agents|mesh-ancestor
25239704|NCT02540512|Respiratory System Agents|respiratory system agents|mesh-ancestor
25239705|NCT02540512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25239706|NCT02540512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25239707|NCT02540512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25239708|NCT02540239|Simethicone|simethicone|mesh-list
25239709|NCT02540239|Antifoaming Agents|antifoaming agents|mesh-ancestor
25239710|NCT02540239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239711|NCT02540239|Emollients|emollients|mesh-ancestor
25239712|NCT02540239|Dermatologic Agents|dermatologic agents|mesh-ancestor
25239713|NCT02540395|Mycophenolic Acid|mycophenolic acid|mesh-list
25239714|NCT02540395|Prednisolone|prednisolone|mesh-list
25239715|NCT02540395|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25239716|NCT02540395|Methylprednisolone|methylprednisolone|mesh-list
25045142|NCT00992563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045143|NCT00991172|Fasinumab|fasinumab|mesh-list
25045144|NCT00991172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25045145|NCT00991172|Analgesics|analgesics|mesh-ancestor
25045146|NCT00991172|Sensory System Agents|sensory system agents|mesh-ancestor
25045147|NCT00991172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045148|NCT00991172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045149|NCT00991068|Lidocaine|lidocaine|mesh-list
25045150|NCT00991068|Tetracaine|tetracaine|mesh-list
25045151|NCT00991068|Anesthetics, Local|anesthetics, local|mesh-ancestor
25874663|NCT05070364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25874664|NCT05070260|Glenzocimab|glenzocimab|mesh-list
25874665|NCT05070260|Anticoagulants|anticoagulants|mesh-ancestor
25874666|NCT05065411|Everolimus|everolimus|mesh-list
25874667|NCT05065411|Fulvestrant|fulvestrant|mesh-list
25874668|NCT05065411|Exemestane|exemestane|mesh-list
25874669|NCT05065411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404141|NCT03682068|Tremelimumab|tremelimumab|mesh-list
25673868|NCT01765803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25673869|NCT01765803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673870|NCT01765803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25673871|NCT01765803|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25673872|NCT01765803|Dopamine Agents|dopamine agents|mesh-ancestor
25673873|NCT01765803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25673874|NCT01765803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874670|NCT05065411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25874671|NCT05065411|Immunologic Factors|immunologic factors|mesh-ancestor
25874672|NCT05065411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874673|NCT05065411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25874674|NCT05065411|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25874675|NCT05065411|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25874676|NCT05065411|Hormone Antagonists|hormone antagonists|mesh-ancestor
25874677|NCT05065411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25874678|NCT05065411|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25067386|NCT03443960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24722075|NCT01578447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24722076|NCT01578447|Contraceptive Agents|contraceptive agents|mesh-ancestor
24722077|NCT01578447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24722078|NCT01578447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722079|NCT01578447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24722080|NCT01578447|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24722081|NCT01578447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25239717|NCT02540395|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25239718|NCT02540395|Prednisolone acetate|prednisolone acetate|mesh-list
25239719|NCT02540395|Tacrolimus|tacrolimus|mesh-list
25239720|NCT02540395|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25239721|NCT02540395|Prednisolone phosphate|prednisolone phosphate|mesh-list
25239722|NCT02540395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25239723|NCT02540395|Immunologic Factors|immunologic factors|mesh-ancestor
25239724|NCT02540395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239725|NCT02540395|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25239726|NCT02540395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25239727|NCT02540395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239728|NCT02540395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25239729|NCT02540395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25239730|NCT02540395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25239731|NCT02540395|Antitubercular Agents|antitubercular agents|mesh-ancestor
25239732|NCT02540395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25239733|NCT02540395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25239734|NCT02540395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25239735|NCT02540395|Glucocorticoids|glucocorticoids|mesh-ancestor
25239736|NCT02540395|Hormones|hormones|mesh-ancestor
25239737|NCT02540395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25239738|NCT02540395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25239739|NCT02540395|Antiemetics|antiemetics|mesh-ancestor
25239740|NCT02540395|Autonomic Agents|autonomic agents|mesh-ancestor
25239741|NCT02540395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239742|NCT02540395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25239743|NCT02540395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25239744|NCT02540395|Protective Agents|protective agents|mesh-ancestor
25239746|NCT02540369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25239747|NCT02540369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25239748|NCT02540369|Growth Substances|growth substances|mesh-ancestor
25239749|NCT02540369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874679|NCT05065411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24444164|NCT00296803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444165|NCT00296803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155209|NCT05444556|Adrenergic Agents|adrenergic agents|mesh-ancestor
25155210|NCT05444556|Antimalarials|antimalarials|mesh-ancestor
25155211|NCT05444556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25155212|NCT05444556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25155213|NCT05444556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25155214|NCT05444556|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25155215|NCT05444556|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25079609|NCT03346629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25079610|NCT03346629|Abortifacient Agents|abortifacient agents|mesh-ancestor
25079615|NCT03346629|Oxytocics|oxytocics|mesh-ancestor
25155216|NCT05444556|Cholinergic Agents|cholinergic agents|mesh-ancestor
25155217|NCT05444556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25155218|NCT05444556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25155219|NCT05444556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24722082|NCT01578447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24722118|NCT01578603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722119|NCT01578603|Chelating Agents|chelating agents|mesh-ancestor
24789346|NCT01936532|Hormones|hormones|mesh-ancestor
25127055|NCT03058471|Methotrexate|methotrexate|mesh-list
24722121|NCT01578603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722123|NCT01578629|Vitamin E|vitamin e|mesh-list
24722124|NCT01578629|Tocopherols|tocopherols|mesh-list
25088050|NCT03274102|Vaccines|vaccines|mesh-list
25088051|NCT03274102|Immunologic Factors|immunologic factors|mesh-ancestor
25088053|NCT03274024|Mitomycins|mitomycins|mesh-list
24722125|NCT01578629|Tocotrienols|tocotrienols|mesh-list
24722126|NCT01578629|Vitamins|vitamins|mesh-ancestor
24722127|NCT01578629|Micronutrients|micronutrients|mesh-ancestor
24722128|NCT01578629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722129|NCT01578629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24722130|NCT01578629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24722131|NCT01578629|Analgesics|analgesics|mesh-ancestor
24722132|NCT01578629|Sensory System Agents|sensory system agents|mesh-ancestor
24722133|NCT01578629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25079638|NCT03346525|Penicillin G Procaine|penicillin g procaine|mesh-list
25079639|NCT03346525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25079640|NCT03346525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25079641|NCT03346317|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24722134|NCT01578629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24722135|NCT01578629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24722136|NCT01578629|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24722137|NCT01578629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24722138|NCT01578629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615603|NCT01030692|Rivastigmine|rivastigmine|mesh-list
24615604|NCT01030692|Huperzine A|huperzine a|mesh-list
24615605|NCT01030692|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24615606|NCT01030692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615607|NCT01030692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615608|NCT01030692|Cholinergic Agents|cholinergic agents|mesh-ancestor
24615609|NCT01030692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24615610|NCT01030692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615611|NCT01030692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25874680|NCT05065411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760421|NCT01758029|Testosterone undecanoate|testosterone undecanoate|mesh-list
24760422|NCT01758029|Testosterone enanthate|testosterone enanthate|mesh-list
24760423|NCT01758029|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24760424|NCT01758029|Androgens|androgens|mesh-ancestor
24760425|NCT01758029|Hormones|hormones|mesh-ancestor
24760433|NCT01758094|Hormones|hormones|mesh-ancestor
24394821|NCT00134368|Etanercept|etanercept|mesh-list
25874681|NCT05065411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239750|NCT02540369|Growth Inhibitors|growth inhibitors|mesh-ancestor
25239751|NCT02540369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25239752|NCT02540070|Ketorolac|ketorolac|mesh-list
25239753|NCT02540070|Epinephrine|epinephrine|mesh-list
25239754|NCT02540070|Dexmedetomidine|dexmedetomidine|mesh-list
25239755|NCT02540070|Morphine|morphine|mesh-list
25239756|NCT02540070|Ropivacaine|ropivacaine|mesh-list
25239757|NCT02540070|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25239758|NCT02540070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25239759|NCT02540070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239760|NCT02540070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25239761|NCT02540070|Analgesics|analgesics|mesh-ancestor
25239762|NCT02540070|Sensory System Agents|sensory system agents|mesh-ancestor
25239763|NCT02540070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239764|NCT02540070|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25155220|NCT05444556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25155221|NCT05444556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25874682|NCT05058651|Cisplatin|cisplatin|mesh-list
25874683|NCT05058651|Carboplatin|carboplatin|mesh-list
25874684|NCT05058651|Etoposide|etoposide|mesh-list
24615638|NCT01030900|Immunologic Factors|immunologic factors|mesh-ancestor
24615639|NCT01030900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509511|NCT00560599|Disinfectants|disinfectants|mesh-ancestor
24722152|NCT01578668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24722153|NCT01578720|Aflibercept|aflibercept|mesh-list
24722154|NCT01578720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24722155|NCT01578720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24722156|NCT01578720|Growth Substances|growth substances|mesh-ancestor
24722157|NCT01578720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722158|NCT01578720|Growth Inhibitors|growth inhibitors|mesh-ancestor
24881526|NCT02101853|BB 1101|bb 1101|mesh-list
24722195|NCT01579058|Bisoprolol|bisoprolol|mesh-list
24722196|NCT01579058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24722197|NCT01579058|Sympatholytics|sympatholytics|mesh-ancestor
25673875|NCT01766024|Interferons|interferons|mesh-list
25673876|NCT01766024|Interferon-beta|interferon-beta|mesh-list
24722198|NCT01579058|Autonomic Agents|autonomic agents|mesh-ancestor
24722199|NCT01579058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25410468|NCT03318900|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25874685|NCT05058651|Etoposide phosphate|etoposide phosphate|mesh-list
25088371|NCT04877821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25088372|NCT04877821|Alkylating Agents|alkylating agents|mesh-ancestor
25088373|NCT04877821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24402760|NCT00158457|Efavirenz|efavirenz|mesh-list
24722200|NCT01579058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722201|NCT01579058|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24722202|NCT01579058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24722203|NCT01579058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24722204|NCT01579058|Adrenergic Agents|adrenergic agents|mesh-ancestor
24722205|NCT01579058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24722206|NCT01579058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722207|NCT01579110|Levamisole|levamisole|mesh-list
24722208|NCT01579110|Prednisone|prednisone|mesh-list
24722209|NCT01579110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24722211|NCT01579110|Hormones|hormones|mesh-ancestor
25239789|NCT02539979|Analgesics|analgesics|mesh-ancestor
24722212|NCT01579110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24722213|NCT01579110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722214|NCT01579110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24722215|NCT01579110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006327|NCT05156879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25006328|NCT05156879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24872633|NCT05298670|Metformin|metformin|mesh-list
24722216|NCT01579110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24722217|NCT01579110|Immunologic Factors|immunologic factors|mesh-ancestor
24722280|NCT01579461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722281|NCT01579461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722282|NCT01579461|Urological Agents|urological agents|mesh-ancestor
25239765|NCT02540070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25239766|NCT02540070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25239767|NCT02540070|Adrenergic Agents|adrenergic agents|mesh-ancestor
25239768|NCT02540070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25239769|NCT02540070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239770|NCT02540070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25239771|NCT02540070|Narcotics|narcotics|mesh-ancestor
25239772|NCT02540070|Anesthetics, Local|anesthetics, local|mesh-ancestor
25239773|NCT02540070|Anesthetics|anesthetics|mesh-ancestor
25239774|NCT02540070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25239775|NCT02540070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24444173|NCT00296894|Adalimumab|adalimumab|mesh-list
24444174|NCT00296894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24444175|NCT00296894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24444176|NCT00296933|Citalopram|citalopram|mesh-list
24444177|NCT00296933|Bupropion|bupropion|mesh-list
24444178|NCT00296933|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24444179|NCT00296933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24444180|NCT00296933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24491691|NCT00483626|Urological Agents|urological agents|mesh-ancestor
24474880|NCT00407849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474881|NCT00407849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474882|NCT00407862|Losartan|losartan|mesh-list
24474883|NCT00407862|Telmisartan|telmisartan|mesh-list
24474884|NCT00407862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24474885|NCT00407862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24444211|NCT00296972|Ribavirin|ribavirin|mesh-list
24722283|NCT01579500|Botulinum Toxins|botulinum toxins|mesh-list
24722284|NCT01579500|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24722285|NCT01579500|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24722286|NCT01579500|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24722287|NCT01579500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25874686|NCT05058651|Atezolizumab|atezolizumab|mesh-list
24722347|NCT01579786|Acetaminophen|acetaminophen|mesh-list
24722348|NCT01579786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24722349|NCT01579786|Analgesics|analgesics|mesh-ancestor
24722350|NCT01579786|Sensory System Agents|sensory system agents|mesh-ancestor
24722351|NCT01579786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24722352|NCT01579786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722353|NCT01579786|Antipyretics|antipyretics|mesh-ancestor
24722354|NCT01579838|Eculizumab|eculizumab|mesh-list
24722355|NCT01579838|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24722356|NCT01579838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24722357|NCT01579838|Immunologic Factors|immunologic factors|mesh-ancestor
25673877|NCT01766024|Interferon beta-1a|interferon beta-1a|mesh-list
25673878|NCT01766024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673879|NCT01766024|Antiviral Agents|antiviral agents|mesh-ancestor
25673880|NCT01766024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25673881|NCT01766024|Immunologic Factors|immunologic factors|mesh-ancestor
24722378|NCT01579890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722379|NCT01579903|Factor VIII|factor viii|mesh-list
24722384|NCT01579929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24722385|NCT01579929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25239776|NCT02540070|Autonomic Agents|autonomic agents|mesh-ancestor
25239777|NCT02540070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25239778|NCT02540070|Respiratory System Agents|respiratory system agents|mesh-ancestor
25239779|NCT02540070|Mydriatics|mydriatics|mesh-ancestor
25239780|NCT02540070|Sympathomimetics|sympathomimetics|mesh-ancestor
25239781|NCT02540070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25239782|NCT02540070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25239783|NCT02540070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25239784|NCT02540070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25239785|NCT02540070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25239786|NCT02540070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25239787|NCT02539979|Acetaminophen|acetaminophen|mesh-list
25239788|NCT02539979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25239790|NCT02539979|Sensory System Agents|sensory system agents|mesh-ancestor
25239791|NCT02539979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24760521|NCT01758367|Decitabine|decitabine|mesh-list
24474916|NCT00408148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474917|NCT00408174|Balsalazide|balsalazide|mesh-list
24474918|NCT00408174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24474919|NCT00408174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24474920|NCT00408174|Analgesics|analgesics|mesh-ancestor
24474921|NCT00408174|Sensory System Agents|sensory system agents|mesh-ancestor
25874687|NCT05058651|Podophyllotoxin|podophyllotoxin|mesh-list
25874688|NCT05058651|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25874689|NCT05058651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874690|NCT05058651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24760525|NCT01758367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25239792|NCT02539979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239793|NCT02539979|Antipyretics|antipyretics|mesh-ancestor
25239794|NCT02539966|Sirolimus|sirolimus|mesh-list
25239795|NCT02539966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25239796|NCT02539966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25239797|NCT02539966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25239798|NCT02539966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25239799|NCT02539966|Antifungal Agents|antifungal agents|mesh-ancestor
25239800|NCT02539966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25239801|NCT02539966|Immunologic Factors|immunologic factors|mesh-ancestor
24849870|NCT02251015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24849871|NCT02251015|Antifungal Agents|antifungal agents|mesh-ancestor
24849872|NCT02251015|Keratolytic Agents|keratolytic agents|mesh-ancestor
24849873|NCT02251015|Dermatologic Agents|dermatologic agents|mesh-ancestor
25874691|NCT05058651|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25874692|NCT05058651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25874693|NCT05058651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874694|NCT05058651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491752|NCT00483834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874695|NCT05058651|Immunologic Factors|immunologic factors|mesh-ancestor
25874696|NCT05058651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874697|NCT05058651|Keratolytic Agents|keratolytic agents|mesh-ancestor
25874698|NCT05058651|Dermatologic Agents|dermatologic agents|mesh-ancestor
24722386|NCT01579929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722399|NCT01580007|Micronutrients|micronutrients|mesh-ancestor
24722400|NCT01580007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24722401|NCT01580007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24722402|NCT01580033|Vaccines|vaccines|mesh-list
24722403|NCT01580033|Immunologic Factors|immunologic factors|mesh-ancestor
24722404|NCT01580033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722406|NCT01580163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25874699|NCT05058651|Tubulin Modulators|tubulin modulators|mesh-ancestor
24722431|NCT01580371|CKD-581|ckd-581|mesh-list
24554867|NCT00738595|Nicotine|nicotine|mesh-list
24722432|NCT01580371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615663|NCT01031030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24615664|NCT01031030|Antimetabolites|antimetabolites|mesh-ancestor
24615665|NCT01031030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24615666|NCT01031030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24615667|NCT01031030|Abortifacient Agents|abortifacient agents|mesh-ancestor
24615668|NCT01031030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24615669|NCT01031030|Dermatologic Agents|dermatologic agents|mesh-ancestor
24615670|NCT01031030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615671|NCT01031030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24615672|NCT01031030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24760527|NCT01758380|Metformin|metformin|mesh-list
25874700|NCT05058651|Antimitotic Agents|antimitotic agents|mesh-ancestor
25091090|NCT03251170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091091|NCT03251170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25091092|NCT03251170|Narcotics|narcotics|mesh-ancestor
24615673|NCT01031030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24615700|NCT01031355|Estrogens|estrogens|mesh-ancestor
24615701|NCT01031355|Hormones|hormones|mesh-ancestor
24615702|NCT01031355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24615703|NCT01031355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24615704|NCT01031355|Contraceptive Agents|contraceptive agents|mesh-ancestor
24615705|NCT01031355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24615706|NCT01031355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24615707|NCT01031355|Vitamin B Complex|vitamin b complex|mesh-ancestor
24615708|NCT01031355|Vitamins|vitamins|mesh-ancestor
24615709|NCT01031355|Micronutrients|micronutrients|mesh-ancestor
24615710|NCT01031368|Cytarabine|cytarabine|mesh-list
24615711|NCT01031368|Clofarabine|clofarabine|mesh-list
24722499|NCT01580943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24647274|NCT01207310|Nicotine|nicotine|mesh-list
24722501|NCT01580943|Dermatologic Agents|dermatologic agents|mesh-ancestor
25239802|NCT02539966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239803|NCT02540018|Paclitaxel|paclitaxel|mesh-list
25239804|NCT02540018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25239805|NCT02540018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25239806|NCT02540018|Tubulin Modulators|tubulin modulators|mesh-ancestor
25239807|NCT02540018|Antimitotic Agents|antimitotic agents|mesh-ancestor
25239808|NCT02540018|Mitosis Modulators|mitosis modulators|mesh-ancestor
25239809|NCT02540018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239810|NCT02539940|Paclitaxel|paclitaxel|mesh-list
25239811|NCT02539940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25239812|NCT02539940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25239813|NCT02539940|Tubulin Modulators|tubulin modulators|mesh-ancestor
25239814|NCT02539940|Antimitotic Agents|antimitotic agents|mesh-ancestor
25239815|NCT02539940|Mitosis Modulators|mitosis modulators|mesh-ancestor
25239816|NCT02539940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239817|NCT02539849|Adalimumab|adalimumab|mesh-list
25239818|NCT02539849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25239819|NCT02539849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25239820|NCT02539810|Antihypertensive Agents|antihypertensive agents|mesh-list
25874701|NCT05058651|Mitosis Modulators|mitosis modulators|mesh-ancestor
25874702|NCT05055128|Lansoprazole|lansoprazole|mesh-list
24760551|NCT01758627|Icodextrin|icodextrin|mesh-list
24760591|NCT01758835|Calpastatin|calpastatin|mesh-list
24722502|NCT01581073|Darbepoetin alfa|darbepoetin alfa|mesh-list
24722503|NCT01581073|Hematinics|hematinics|mesh-ancestor
24722504|NCT01581151|Dexamethasone|dexamethasone|mesh-list
24722505|NCT01581151|Ranibizumab|ranibizumab|mesh-list
24722506|NCT01581151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24722507|NCT01581151|Antiemetics|antiemetics|mesh-ancestor
24722508|NCT01581151|Autonomic Agents|autonomic agents|mesh-ancestor
24722509|NCT01581151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24722510|NCT01581151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722511|NCT01581151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24722512|NCT01581151|Glucocorticoids|glucocorticoids|mesh-ancestor
24722513|NCT01581151|Hormones|hormones|mesh-ancestor
24722514|NCT01581151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24722515|NCT01581151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24722516|NCT01581151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006330|NCT05156879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239825|NCT02539706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239826|NCT02539706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239827|NCT02539745|Vitamin D|vitamin d|mesh-list
25239828|NCT02539745|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
25239829|NCT02539745|Vitamins|vitamins|mesh-ancestor
25239830|NCT02539745|Micronutrients|micronutrients|mesh-ancestor
25239831|NCT02539745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239832|NCT02539745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25239833|NCT02539641|Hormones|hormones|mesh-list
25673882|NCT01766024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673883|NCT01766024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25673884|NCT01766050|Abatacept|abatacept|mesh-list
25239834|NCT02539641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25239835|NCT02539641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673885|NCT01766050|Losartan|losartan|mesh-list
25673886|NCT01766050|Midazolam|midazolam|mesh-list
25673887|NCT01766050|Dextromethorphan|dextromethorphan|mesh-list
25673888|NCT01766050|Caffeine|caffeine|mesh-list
25673889|NCT01766050|Omeprazole|omeprazole|mesh-list
25673890|NCT01766050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25092114|NCT03244553|Prucalopride|prucalopride|mesh-list
25239836|NCT02539628|Ropivacaine|ropivacaine|mesh-list
25239837|NCT02539628|Anesthetics, Local|anesthetics, local|mesh-ancestor
25239838|NCT02539628|Anesthetics|anesthetics|mesh-ancestor
25239839|NCT02539628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25239840|NCT02539628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239841|NCT02539628|Sensory System Agents|sensory system agents|mesh-ancestor
25239842|NCT02539628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239844|NCT02539316|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25874703|NCT05055128|Dexlansoprazole|dexlansoprazole|mesh-list
24760593|NCT01758835|Protease Inhibitors|protease inhibitors|mesh-ancestor
24760628|NCT01759108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874704|NCT05055128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25874705|NCT05055128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25874706|NCT05055128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25874707|NCT05055128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24789347|NCT01936532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24789348|NCT01936532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24789349|NCT01936532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789351|NCT01936532|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24789352|NCT01936532|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24789353|NCT01936532|Growth Substances|growth substances|mesh-ancestor
24789354|NCT01936532|Growth Inhibitors|growth inhibitors|mesh-ancestor
24789355|NCT01936532|Protease Inhibitors|protease inhibitors|mesh-ancestor
25006331|NCT05156879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25006332|NCT05156879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25006333|NCT05156879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25006334|NCT05156879|Antipyretics|antipyretics|mesh-ancestor
25006335|NCT05156879|Estrogens|estrogens|mesh-ancestor
25006336|NCT05156879|Hormones|hormones|mesh-ancestor
25006337|NCT05156879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25006338|NCT05156879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25006339|NCT05156879|Contraceptive Agents|contraceptive agents|mesh-ancestor
25006340|NCT05156879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25006341|NCT05156879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25006342|NCT05156879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25006343|NCT05156879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25006344|NCT05156879|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25006345|NCT05156879|Hormone Antagonists|hormone antagonists|mesh-ancestor
25006346|NCT05156879|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25006347|NCT05156879|Diuretics|diuretics|mesh-ancestor
25006348|NCT05156879|Natriuretic Agents|natriuretic agents|mesh-ancestor
25006349|NCT05136560|Dexamethasone|dexamethasone|mesh-list
25006350|NCT05136560|Dexamethasone acetate|dexamethasone acetate|mesh-list
25006351|NCT05136560|BB 1101|bb 1101|mesh-list
25006352|NCT05136560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25006353|NCT05136560|Antiemetics|antiemetics|mesh-ancestor
25874708|NCT05055128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006356|NCT05136560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006357|NCT05136560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25006358|NCT05136560|Glucocorticoids|glucocorticoids|mesh-ancestor
25874709|NCT05049057|Erenumab|erenumab|mesh-list
24760661|NCT01759524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24395570|NCT00136396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24395571|NCT00136396|Immunologic Factors|immunologic factors|mesh-ancestor
24395572|NCT00136396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006359|NCT05136560|Hormones|hormones|mesh-ancestor
25006360|NCT05136560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25006361|NCT05136560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25006362|NCT05136560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006363|NCT05136560|Protease Inhibitors|protease inhibitors|mesh-ancestor
25006364|NCT05136560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25006365|NCT05136560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239846|NCT02539316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25239847|NCT02539199|Misoprostol|misoprostol|mesh-list
25239848|NCT02539199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25239849|NCT02539199|Abortifacient Agents|abortifacient agents|mesh-ancestor
25239850|NCT02539199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25239851|NCT02539199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239852|NCT02539199|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24444223|NCT00297011|Hormones|hormones|mesh-ancestor
25673891|NCT01766050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25673892|NCT01766050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25092547|NCT03241706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25092550|NCT03241381|Micronutrients|micronutrients|mesh-ancestor
25874710|NCT05049057|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25874711|NCT05049057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760662|NCT01759524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24760663|NCT01759524|Adrenergic Agents|adrenergic agents|mesh-ancestor
24760664|NCT01759524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24760665|NCT01759576|Canagliflozin|canagliflozin|mesh-list
24760666|NCT01759576|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24760667|NCT01759576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760668|NCT01759576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24760669|NCT01759576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760670|NCT01759589|Remifentanil|remifentanil|mesh-list
24760672|NCT01759589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
24760684|NCT01759589|Sensory System Agents|sensory system agents|mesh-ancestor
24760685|NCT01759589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24760686|NCT01759706|Dexamethasone|dexamethasone|mesh-list
24760687|NCT01759706|Sufentanil|sufentanil|mesh-list
24760688|NCT01759706|Diazepam|diazepam|mesh-list
25874712|NCT05049057|Analgesics|analgesics|mesh-ancestor
25874713|NCT05049057|Sensory System Agents|sensory system agents|mesh-ancestor
25874714|NCT05049057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25874715|NCT05049057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874716|NCT05027945|Mycophenolic Acid|mycophenolic acid|mesh-list
25874717|NCT05027945|Sirolimus|sirolimus|mesh-list
25874718|NCT05027945|Cyclophosphamide|cyclophosphamide|mesh-list
25874719|NCT05027945|Busulfan|busulfan|mesh-list
25874720|NCT05027945|Fludarabine|fludarabine|mesh-list
25006366|NCT05125523|Sirolimus|sirolimus|mesh-list
25006367|NCT05125523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25006368|NCT05125523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25006369|NCT05125523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25006370|NCT05125523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006371|NCT05125523|Antifungal Agents|antifungal agents|mesh-ancestor
25006372|NCT05125523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25006373|NCT05125523|Immunologic Factors|immunologic factors|mesh-ancestor
24722663|NCT01581879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24722665|NCT01581879|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24722730|NCT01582425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24722731|NCT01582425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722732|NCT01582425|Analgesics|analgesics|mesh-ancestor
24722733|NCT01582425|Sensory System Agents|sensory system agents|mesh-ancestor
24722734|NCT01582425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24722735|NCT01582425|Antitussive Agents|antitussive agents|mesh-ancestor
24722736|NCT01582425|Respiratory System Agents|respiratory system agents|mesh-ancestor
24722737|NCT01582425|Antifungal Agents|antifungal agents|mesh-ancestor
24722738|NCT01582425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24722739|NCT01582438|Sildenafil Citrate|sildenafil citrate|mesh-list
24722740|NCT01582438|Citric Acid|citric acid|mesh-list
24722741|NCT01582438|Sodium Citrate|sodium citrate|mesh-list
24722742|NCT01582438|Anticoagulants|anticoagulants|mesh-ancestor
24722743|NCT01582438|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24722744|NCT01582438|Chelating Agents|chelating agents|mesh-ancestor
24760689|NCT01759706|Ondansetron|ondansetron|mesh-list
25239854|NCT02539199|Oxytocics|oxytocics|mesh-ancestor
25273897|NCT02382146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25273898|NCT02382146|Glucocorticoids|glucocorticoids|mesh-ancestor
25273899|NCT02382146|Hormones|hormones|mesh-ancestor
25273900|NCT02382146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25273901|NCT02382146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25273902|NCT02382146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25273903|NCT02382146|Protease Inhibitors|protease inhibitors|mesh-ancestor
25273904|NCT02382146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273905|NCT02382146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673893|NCT01766050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673894|NCT01766050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25273906|NCT02382146|Antipruritics|antipruritics|mesh-ancestor
25273907|NCT02382146|Dermatologic Agents|dermatologic agents|mesh-ancestor
25273908|NCT02382146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25673895|NCT01766050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25673896|NCT01766050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25673897|NCT01766050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25673898|NCT01766050|Anesthetics, General|anesthetics, general|mesh-ancestor
25673899|NCT01766050|Anesthetics|anesthetics|mesh-ancestor
25673900|NCT01766050|GABA Modulators|gaba modulators|mesh-ancestor
25673901|NCT01766050|GABA Agents|gaba agents|mesh-ancestor
25673902|NCT01766050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25273909|NCT02382146|Serotonin Agents|serotonin agents|mesh-ancestor
25273910|NCT02382146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25273911|NCT02382146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25273912|NCT02382146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25273913|NCT02382146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25273914|NCT02382146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25273915|NCT02382146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25273916|NCT02381964|Coenzyme Q10|coenzyme q10|mesh-list
25273917|NCT02381964|Vitamins|vitamins|mesh-ancestor
25273918|NCT02381964|Micronutrients|micronutrients|mesh-ancestor
25273919|NCT02381964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491813|NCT00484068|Enalapril|enalapril|mesh-list
24444225|NCT00297011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079720|NCT03346083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444241|NCT00297076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24444242|NCT00297128|Capecitabine|capecitabine|mesh-list
24444243|NCT00297128|Cetuximab|cetuximab|mesh-list
24444244|NCT00297128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24444245|NCT00297128|Antimetabolites|antimetabolites|mesh-ancestor
24444246|NCT00297128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444247|NCT00297128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24444248|NCT00297128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24444249|NCT00297141|Capecitabine|capecitabine|mesh-list
24444250|NCT00297141|Oxaliplatin|oxaliplatin|mesh-list
24444251|NCT00297141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24444252|NCT00297141|Antimetabolites|antimetabolites|mesh-ancestor
24444253|NCT00297141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444254|NCT00297141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874721|NCT05027945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25874722|NCT05027945|Immunologic Factors|immunologic factors|mesh-ancestor
25874723|NCT05027945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874724|NCT05027945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25874725|NCT05027945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24722745|NCT01582438|Sequestering Agents|sequestering agents|mesh-ancestor
24722774|NCT01582568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24722776|NCT01582607|Bupivacaine|bupivacaine|mesh-list
24722777|NCT01582607|Ropivacaine|ropivacaine|mesh-list
24615744|NCT01031667|Probucol|probucol|mesh-list
24615745|NCT01031667|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24615746|NCT01031667|Autonomic Agents|autonomic agents|mesh-ancestor
24615747|NCT01031667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24647366|NCT01208454|Keratolytic Agents|keratolytic agents|mesh-ancestor
24615748|NCT01031667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615749|NCT01031667|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24615750|NCT01031667|Respiratory System Agents|respiratory system agents|mesh-ancestor
24615751|NCT01031667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24615752|NCT01031667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24615753|NCT01031667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615754|NCT01031667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24615755|NCT01031667|Vasodilator Agents|vasodilator agents|mesh-ancestor
24615756|NCT01031667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24615757|NCT01031667|Protective Agents|protective agents|mesh-ancestor
24722917|NCT01583439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24722918|NCT01583439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24722919|NCT01583439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25874726|NCT05027945|Alkylating Agents|alkylating agents|mesh-ancestor
24722953|NCT01583660|Analgesics|analgesics|mesh-ancestor
24722954|NCT01583660|Sensory System Agents|sensory system agents|mesh-ancestor
24722955|NCT01583660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24724252|NCT01592019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24722956|NCT01583660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239855|NCT02539394|Methylprednisolone|methylprednisolone|mesh-list
25239856|NCT02539394|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25239857|NCT02539394|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25239858|NCT02539394|Prednisolone|prednisolone|mesh-list
25239859|NCT02539394|Prednisolone acetate|prednisolone acetate|mesh-list
25239860|NCT02539394|Hemostatics|hemostatics|mesh-list
25239861|NCT02539394|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25239862|NCT02539394|Prednisolone phosphate|prednisolone phosphate|mesh-list
25239863|NCT02539394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25239864|NCT02539394|Antiemetics|antiemetics|mesh-ancestor
25239865|NCT02539394|Autonomic Agents|autonomic agents|mesh-ancestor
25239866|NCT02539394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239867|NCT02539394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239868|NCT02539394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25239869|NCT02539394|Glucocorticoids|glucocorticoids|mesh-ancestor
25239870|NCT02539394|Hormones|hormones|mesh-ancestor
24896279|NCT04438421|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25093190|NCT03236740|Hormones|hormones|mesh-ancestor
25239871|NCT02539394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25239872|NCT02539394|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25239873|NCT02539394|Protective Agents|protective agents|mesh-ancestor
25239874|NCT02539394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25239875|NCT02539394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25239876|NCT02539394|Coagulants|coagulants|mesh-ancestor
25239877|NCT02538926|Prednisone|prednisone|mesh-list
25239878|NCT02538926|Cortisone|cortisone|mesh-list
25239879|NCT02538926|Cyclophosphamide|cyclophosphamide|mesh-list
24722958|NCT01583660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24722959|NCT01583660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24722989|NCT01583972|Antioxidants|antioxidants|mesh-ancestor
25079676|NCT03346226|Sensory System Agents|sensory system agents|mesh-ancestor
24475188|NCT00409318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24722990|NCT01583972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722991|NCT01583972|Protective Agents|protective agents|mesh-ancestor
24722992|NCT01583972|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24722993|NCT01583972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24722995|NCT01584050|Hematinics|hematinics|mesh-ancestor
24722996|NCT01584050|Vitamin B Complex|vitamin b complex|mesh-ancestor
24722997|NCT01584050|Vitamins|vitamins|mesh-ancestor
24722998|NCT01584050|Micronutrients|micronutrients|mesh-ancestor
24722999|NCT01584050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723000|NCT01584076|Donepezil|donepezil|mesh-list
24723001|NCT01584076|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24556698|NCT00749138|Tamoxifen|tamoxifen|mesh-list
24723002|NCT01584076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396034|NCT00137709|Lamotrigine|lamotrigine|mesh-list
25874727|NCT05027945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874728|NCT05027945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874729|NCT05027945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25239880|NCT02538926|Rituximab|rituximab|mesh-list
25239881|NCT02538926|Doxorubicin|doxorubicin|mesh-list
25239882|NCT02538926|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25239883|NCT02538926|Etoposide|etoposide|mesh-list
25239884|NCT02538926|Vincristine|vincristine|mesh-list
25239885|NCT02538926|Etoposide phosphate|etoposide phosphate|mesh-list
25239886|NCT02538926|Imatinib Mesylate|imatinib mesylate|mesh-list
25239887|NCT02538926|Asparaginase|asparaginase|mesh-list
25239888|NCT02538926|Podophyllotoxin|podophyllotoxin|mesh-list
25239889|NCT02538926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25239890|NCT02538926|Antibodies|antibodies|mesh-list
25239891|NCT02538926|Immunoglobulins|immunoglobulins|mesh-list
25239892|NCT02538926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25239893|NCT02538926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25239894|NCT02538926|Immunologic Factors|immunologic factors|mesh-ancestor
25239895|NCT02538926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239896|NCT02538926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25239897|NCT02538926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25239898|NCT02538926|Alkylating Agents|alkylating agents|mesh-ancestor
25239899|NCT02538926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239900|NCT02538926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25239901|NCT02538926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25239902|NCT02538926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25239903|NCT02538926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25239904|NCT02538926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25239905|NCT02538926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24425025|NCT00231647|Topiramate|topiramate|mesh-list
24760715|NCT01759706|Narcotics|narcotics|mesh-ancestor
24760716|NCT01759706|Analgesics|analgesics|mesh-ancestor
25239906|NCT02538926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25239907|NCT02538926|Glucocorticoids|glucocorticoids|mesh-ancestor
25239908|NCT02538926|Hormones|hormones|mesh-ancestor
25045153|NCT00991068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25045154|NCT00991068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045156|NCT00991068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045157|NCT00991068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25045158|NCT00991068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25045159|NCT00991068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25045160|NCT00991068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25045161|NCT00991068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045162|NCT00990912|Carboplatin|carboplatin|mesh-list
25045163|NCT00990912|Irinotecan|irinotecan|mesh-list
25673903|NCT01766050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045164|NCT00990912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045165|NCT00990912|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25874730|NCT05027945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25874731|NCT05027945|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25874732|NCT05027945|Antitubercular Agents|antitubercular agents|mesh-ancestor
25874733|NCT05027945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25045166|NCT00990912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25045167|NCT00990912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045168|NCT00990912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045169|NCT00990327|Adenosine|adenosine|mesh-list
25045170|NCT00990327|Analgesics|analgesics|mesh-ancestor
25045171|NCT00990327|Sensory System Agents|sensory system agents|mesh-ancestor
25045172|NCT00990327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045173|NCT00990327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874734|NCT05027945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25874735|NCT05027945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874736|NCT05027945|Antifungal Agents|antifungal agents|mesh-ancestor
25874737|NCT05020236|Dexamethasone|dexamethasone|mesh-list
25874738|NCT05020236|Daratumumab|daratumumab|mesh-list
25874739|NCT05020236|Pomalidomide|pomalidomide|mesh-list
24723174|NCT01585623|GABA Agents|gaba agents|mesh-ancestor
25874740|NCT05020236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25874741|NCT05020236|Antiemetics|antiemetics|mesh-ancestor
25874742|NCT05020236|Autonomic Agents|autonomic agents|mesh-ancestor
25874743|NCT05020236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239909|NCT02538926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25239910|NCT02538926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25239911|NCT02538926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25239912|NCT02538926|Tubulin Modulators|tubulin modulators|mesh-ancestor
25239913|NCT02538926|Antimitotic Agents|antimitotic agents|mesh-ancestor
25239914|NCT02538926|Mitosis Modulators|mitosis modulators|mesh-ancestor
25239915|NCT02538926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25239916|NCT02538926|Keratolytic Agents|keratolytic agents|mesh-ancestor
25239917|NCT02538926|Dermatologic Agents|dermatologic agents|mesh-ancestor
25239918|NCT02538939|Sodium thiosulfate|sodium thiosulfate|mesh-list
25239919|NCT02538939|Antidotes|antidotes|mesh-ancestor
25239920|NCT02538939|Protective Agents|protective agents|mesh-ancestor
25239921|NCT02538939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239922|NCT02538939|Antioxidants|antioxidants|mesh-ancestor
25239923|NCT02538939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760717|NCT01759706|Sensory System Agents|sensory system agents|mesh-ancestor
25239924|NCT02538939|Antitubercular Agents|antitubercular agents|mesh-ancestor
25239925|NCT02538939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25239926|NCT02538939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25239927|NCT02538939|Chelating Agents|chelating agents|mesh-ancestor
25239928|NCT02538939|Sequestering Agents|sequestering agents|mesh-ancestor
25239929|NCT02538718|Ritodrine|ritodrine|mesh-list
25239930|NCT02538718|Sympathomimetics|sympathomimetics|mesh-ancestor
25239931|NCT02538718|Autonomic Agents|autonomic agents|mesh-ancestor
25239932|NCT02538718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239933|NCT02538718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239934|NCT02538718|Tocolytic Agents|tocolytic agents|mesh-ancestor
25239935|NCT02538718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25239936|NCT02538718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25239937|NCT02538718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25239938|NCT02538718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25239939|NCT02538718|Adrenergic Agents|adrenergic agents|mesh-ancestor
25239940|NCT02538718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24444328|NCT00297505|Citalopram|citalopram|mesh-list
24444329|NCT00297505|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24444330|NCT00297505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24444331|NCT00297505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24724348|NCT01592253|Antifungal Agents|antifungal agents|mesh-ancestor
24849892|NCT02251041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24760774|NCT01759875|Antimetabolites|antimetabolites|mesh-ancestor
24723003|NCT01584076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723004|NCT01584076|Cholinergic Agents|cholinergic agents|mesh-ancestor
24647451|NCT01208935|Nicotine|nicotine|mesh-list
25673904|NCT01766050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25673905|NCT01766050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24723005|NCT01584076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24723036|NCT01584362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25673906|NCT01766050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25673907|NCT01766050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25673908|NCT01766050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25673909|NCT01766050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25673910|NCT01766050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25673911|NCT01766050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25093596|NCT03233880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25093597|NCT03233880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25093598|NCT03233815|Propofol|propofol|mesh-list
24896329|NCT04437836|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24896343|NCT04437693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24723037|NCT01584362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24723038|NCT01584362|Antinematodal Agents|antinematodal agents|mesh-ancestor
24723044|NCT01584492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24723045|NCT01584492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723046|NCT01584492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24723047|NCT01584492|Respiratory System Agents|respiratory system agents|mesh-ancestor
24723048|NCT01584492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24723079|NCT01584726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24723080|NCT01584726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723081|NCT01584726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24723082|NCT01584726|Tocolytic Agents|tocolytic agents|mesh-ancestor
24723083|NCT01584726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24723084|NCT01584778|Eosinophil Cationic Protein|eosinophil cationic protein|mesh-list
24723085|NCT01584778|Immunologic Factors|immunologic factors|mesh-ancestor
25239957|NCT02538367|Prucalopride|prucalopride|mesh-list
25239959|NCT02538367|Laxatives|laxatives|mesh-ancestor
25239960|NCT02538367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25239961|NCT02538367|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
25155240|NCT05438979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25155241|NCT05438979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067642|NCT03441412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24510478|NCT00564655|Anesthetics, Local|anesthetics, local|mesh-ancestor
24723089|NCT01584791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24723117|NCT01584934|Anesthetics|anesthetics|mesh-ancestor
24723118|NCT01584934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24723119|NCT01584934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723120|NCT01584947|Bupivacaine|bupivacaine|mesh-list
24723121|NCT01584947|Anesthetics, Local|anesthetics, local|mesh-ancestor
24723122|NCT01584947|Anesthetics|anesthetics|mesh-ancestor
24723123|NCT01584947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25874744|NCT05020236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723124|NCT01584947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723125|NCT01584947|Sensory System Agents|sensory system agents|mesh-ancestor
24760825|NCT01760148|Interferon alpha-2|interferon alpha-2|mesh-list
24723126|NCT01584947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24723127|NCT01585051|Vitamin D|vitamin d|mesh-list
24723128|NCT01585051|Vitamins|vitamins|mesh-ancestor
24723129|NCT01585051|Micronutrients|micronutrients|mesh-ancestor
24723130|NCT01585051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723131|NCT01585051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24510551|NCT00564824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24723132|NCT01585350|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
24723133|NCT01585350|Freund's Adjuvant|freund's adjuvant|mesh-list
24723134|NCT01585350|Poly ICLC|poly iclc|mesh-list
24723135|NCT01585350|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24723136|NCT01585350|Immunologic Factors|immunologic factors|mesh-ancestor
24723163|NCT01585623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24723164|NCT01585623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24723165|NCT01585623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24723166|NCT01585623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723167|NCT01585623|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24723168|NCT01585623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24723169|NCT01585623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24723170|NCT01585623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24723171|NCT01585623|Anesthetics, General|anesthetics, general|mesh-ancestor
24723172|NCT01585623|Anesthetics|anesthetics|mesh-ancestor
24723173|NCT01585623|GABA Modulators|gaba modulators|mesh-ancestor
25239964|NCT02538367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25239965|NCT02538367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239966|NCT02538367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25239967|NCT02538393|Sorafenib|sorafenib|mesh-list
25239968|NCT02538393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25239969|NCT02538393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25239970|NCT02538393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25410937|NCT03284463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25673912|NCT01766050|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25673913|NCT01766050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25673914|NCT01766050|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25673915|NCT01766050|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25673916|NCT01766050|Purinergic Agents|purinergic agents|mesh-ancestor
25673917|NCT01766050|Antitussive Agents|antitussive agents|mesh-ancestor
25239971|NCT02538393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25239972|NCT02538224|Doxycycline|doxycycline|mesh-list
25239973|NCT02538224|Ketoprofen|ketoprofen|mesh-list
25239974|NCT02538224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25239975|NCT02538224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25239976|NCT02538224|Antimalarials|antimalarials|mesh-ancestor
25239977|NCT02538224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24849893|NCT02251041|Hematinics|hematinics|mesh-ancestor
24849894|NCT02251041|Vitamins|vitamins|mesh-ancestor
24849895|NCT02251041|Micronutrients|micronutrients|mesh-ancestor
24849896|NCT02251041|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24849897|NCT02251041|Protease Inhibitors|protease inhibitors|mesh-ancestor
24849898|NCT02251041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849899|NCT02251041|Anticoagulants|anticoagulants|mesh-ancestor
24849900|NCT02251041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24849901|NCT02251041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24849902|NCT02251041|Vasodilator Agents|vasodilator agents|mesh-ancestor
24723181|NCT01585623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24723182|NCT01585623|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24723183|NCT01585623|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24723184|NCT01585623|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24723220|NCT01586117|Amifostine|amifostine|mesh-list
24723221|NCT01586117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24723222|NCT01586117|Protective Agents|protective agents|mesh-ancestor
24723223|NCT01586117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723224|NCT01586143|Acetaminophen|acetaminophen|mesh-list
24789451|NCT01937234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789452|NCT01937234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24789453|NCT01937234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24789454|NCT01937234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24789455|NCT01937234|Dopamine Agents|dopamine agents|mesh-ancestor
24789456|NCT01937234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24789457|NCT01937234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789458|NCT01937325|Ivacaftor|ivacaftor|mesh-list
24789459|NCT01937325|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24789460|NCT01937325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24789461|NCT01937325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874745|NCT05020236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25874746|NCT05020236|Glucocorticoids|glucocorticoids|mesh-ancestor
25874747|NCT05020236|Hormones|hormones|mesh-ancestor
25874748|NCT05020236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24789462|NCT01937338|AZD7624|azd7624|mesh-list
24789463|NCT01937338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24789464|NCT01937338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24789465|NCT01937338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789466|NCT01937442|Thalidomide|thalidomide|mesh-list
24789467|NCT01937442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24789468|NCT01937442|Immunologic Factors|immunologic factors|mesh-ancestor
24789474|NCT01937442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25006394|NCT05123365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006395|NCT05123365|Antidotes|antidotes|mesh-ancestor
25239991|NCT02538211|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25239992|NCT02538211|Immunologic Factors|immunologic factors|mesh-ancestor
25239993|NCT02538211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475871|NCT00411879|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25006415|NCT05083910|Misoprostol|misoprostol|mesh-list
24723299|NCT01586494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24723300|NCT01586494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723302|NCT01586494|Sensory System Agents|sensory system agents|mesh-ancestor
24723303|NCT01586494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24723304|NCT01586507|Tramadol|tramadol|mesh-list
24723305|NCT01586507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24723306|NCT01586507|Narcotics|narcotics|mesh-ancestor
24723307|NCT01586507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24723308|NCT01586507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723309|NCT01586507|Analgesics|analgesics|mesh-ancestor
24723310|NCT01586507|Sensory System Agents|sensory system agents|mesh-ancestor
24816086|NCT02074150|Cholinergic Agents|cholinergic agents|mesh-ancestor
24723390|NCT01587261|Ascorbic Acid|ascorbic acid|mesh-list
24723391|NCT01587261|Vitamins|vitamins|mesh-ancestor
25673918|NCT01766050|Respiratory System Agents|respiratory system agents|mesh-ancestor
25673919|NCT01766050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24723479|NCT01587508|Sensory System Agents|sensory system agents|mesh-ancestor
24723480|NCT01587508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24723481|NCT01587508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723482|NCT01587508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24723483|NCT01587508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24723484|NCT01587508|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24723485|NCT01587508|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24723493|NCT01587508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24723494|NCT01587508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24723495|NCT01587508|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24723496|NCT01587508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24723497|NCT01587508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24723498|NCT01587508|Adrenergic Agents|adrenergic agents|mesh-ancestor
24723499|NCT01587508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24647706|NCT01210287|Antiviral Agents|antiviral agents|mesh-ancestor
24723500|NCT01587586|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25239994|NCT02538302|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25239995|NCT02538302|Oxybutynin|oxybutynin|mesh-list
25239996|NCT02538302|Parasympatholytics|parasympatholytics|mesh-ancestor
25239997|NCT02538302|Autonomic Agents|autonomic agents|mesh-ancestor
25239998|NCT02538302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25239999|NCT02538302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240000|NCT02538302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25240001|NCT02538302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25240002|NCT02538302|Cholinergic Agents|cholinergic agents|mesh-ancestor
25240003|NCT02538302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25240006|NCT02538302|Hemostatics|hemostatics|mesh-ancestor
25240007|NCT02538302|Coagulants|coagulants|mesh-ancestor
25240008|NCT02538302|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25240009|NCT02538302|Natriuretic Agents|natriuretic agents|mesh-ancestor
24444388|NCT00297739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24444389|NCT00297739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24444390|NCT00297739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24444391|NCT00297739|Dopamine Agents|dopamine agents|mesh-ancestor
24444392|NCT00297752|Silver Sulfadiazine|silver sulfadiazine|mesh-list
24444393|NCT00297752|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24444394|NCT00297752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24444395|NCT00297765|Tacrolimus|tacrolimus|mesh-list
24444430|NCT00297960|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24444431|NCT00297960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24723501|NCT01587586|Antiviral Agents|antiviral agents|mesh-ancestor
24723502|NCT01587586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24723504|NCT01587625|Oxytocics|oxytocics|mesh-ancestor
24723505|NCT01587625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24723506|NCT01587625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723507|NCT01587638|Metoprolol|metoprolol|mesh-list
24723508|NCT01587638|Atenolol|atenolol|mesh-list
24723509|NCT01587638|Carvedilol|carvedilol|mesh-list
24723510|NCT01587638|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-list
24723513|NCT01587638|Sympatholytics|sympatholytics|mesh-ancestor
24723530|NCT01587729|Antidepressive Agents|antidepressive agents|mesh-list
24723532|NCT01587729|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
24723533|NCT01587729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24760970|NCT01760642|Anesthetics|anesthetics|mesh-ancestor
24723534|NCT01587729|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24723535|NCT01587729|Serotonin Agents|serotonin agents|mesh-ancestor
24723536|NCT01587729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24723537|NCT01587729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723538|NCT01587729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723539|NCT01587729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24723540|NCT01587729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24723541|NCT01587768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24723542|NCT01587768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24723543|NCT01587807|Dimercaprol|dimercaprol|mesh-list
24723544|NCT01587807|Chelating Agents|chelating agents|mesh-ancestor
24723545|NCT01587807|Sequestering Agents|sequestering agents|mesh-ancestor
24723546|NCT01587807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723547|NCT01587820|Cisplatin|cisplatin|mesh-list
24723548|NCT01587820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789497|NCT01937611|Sensory System Agents|sensory system agents|mesh-ancestor
24723629|NCT01588639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24723630|NCT01588639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24723631|NCT01588639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723632|NCT01588704|Bevacizumab|bevacizumab|mesh-list
24723671|NCT01588782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24723672|NCT01588782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25093994|NCT03230058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25874749|NCT05020236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25874750|NCT05020236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874751|NCT05020236|Immunologic Factors|immunologic factors|mesh-ancestor
25874752|NCT05020236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25874753|NCT05020236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25874754|NCT05020236|Growth Substances|growth substances|mesh-ancestor
25874755|NCT05020236|Growth Inhibitors|growth inhibitors|mesh-ancestor
25874756|NCT05009069|Fluorouracil|fluorouracil|mesh-list
24723673|NCT01588782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723674|NCT01588782|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24723675|NCT01588782|Hormone Antagonists|hormone antagonists|mesh-ancestor
24723676|NCT01588782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24723677|NCT01588782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723706|NCT01588847|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24723707|NCT01588847|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24723771|NCT01589068|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24723772|NCT01589068|Autonomic Agents|autonomic agents|mesh-ancestor
24723773|NCT01589068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24723774|NCT01589068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006439|NCT05079841|Oxytocics|oxytocics|mesh-ancestor
25006440|NCT05079841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25006441|NCT05079841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240010|NCT02538432|Gemcitabine|gemcitabine|mesh-list
25240011|NCT02538432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25240012|NCT02538432|Antimetabolites|antimetabolites|mesh-ancestor
25240013|NCT02538432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240014|NCT02538432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25240017|NCT02538432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240018|NCT02538432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25240019|NCT02538432|Immunologic Factors|immunologic factors|mesh-ancestor
25240020|NCT02538432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444432|NCT00297960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24444442|NCT00298012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24444443|NCT00298012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444444|NCT00298012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24444446|NCT00298012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444447|NCT00298012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24444448|NCT00298012|Dermatologic Agents|dermatologic agents|mesh-ancestor
24444449|NCT00298012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25006447|NCT05055999|Atezolizumab|atezolizumab|mesh-list
25006448|NCT05055999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24723775|NCT01589068|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24723807|NCT01589159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24723866|NCT01589471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24723892|NCT01589562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24723893|NCT01589562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24723894|NCT01589562|Appetite Stimulants|appetite stimulants|mesh-ancestor
24723895|NCT01589562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24723896|NCT01589614|Erythromycin|erythromycin|mesh-list
24723897|NCT01589614|Erythromycin Estolate|erythromycin estolate|mesh-list
24723898|NCT01589614|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24723899|NCT01589614|Erythromycin stearate|erythromycin stearate|mesh-list
24723900|NCT01589614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24723901|NCT01589614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24723902|NCT01589614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24723903|NCT01589614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24723904|NCT01589614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24723905|NCT01589614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723906|NCT01589640|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24723907|NCT01589640|Lubricant Eye Drops|lubricant eye drops|mesh-list
24723908|NCT01589640|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24723909|NCT01589744|Hemostatics|hemostatics|mesh-list
25673920|NCT01766050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25673921|NCT01766050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25673922|NCT01766050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25673923|NCT01766050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25673924|NCT01766050|Immunologic Factors|immunologic factors|mesh-ancestor
25673925|NCT01766050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25673926|NCT01766076|Atorvastatin|atorvastatin|mesh-list
25673927|NCT01766076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25094138|NCT03228667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094139|NCT03228667|Immunologic Factors|immunologic factors|mesh-ancestor
25094168|NCT03228862|Ergocalciferols|ergocalciferols|mesh-list
25094170|NCT03228862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25094171|NCT03228862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094172|NCT03228862|Vitamins|vitamins|mesh-ancestor
25094173|NCT03228862|Micronutrients|micronutrients|mesh-ancestor
24723945|NCT01590173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723946|NCT01590199|Everolimus|everolimus|mesh-list
24723947|NCT01590199|Pasireotide|pasireotide|mesh-list
24723948|NCT01590199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24723949|NCT01590199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24723950|NCT01590199|Immunologic Factors|immunologic factors|mesh-ancestor
24723951|NCT01590199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723994|NCT01590537|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24724219|NCT01591889|Alkylating Agents|alkylating agents|mesh-ancestor
24647826|NCT01210976|Protective Agents|protective agents|mesh-ancestor
25874757|NCT05009069|Capecitabine|capecitabine|mesh-list
24724248|NCT01592019|Sensory System Agents|sensory system agents|mesh-ancestor
24724249|NCT01592019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24724250|NCT01592019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724251|NCT01592019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24724349|NCT01592253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24724350|NCT01592253|Immunologic Factors|immunologic factors|mesh-ancestor
24724351|NCT01592253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724353|NCT01592279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24724354|NCT01592279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240021|NCT02538237|Ibuprofen|ibuprofen|mesh-list
25240022|NCT02538237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25240023|NCT02538237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25240024|NCT02538237|Analgesics|analgesics|mesh-ancestor
25240025|NCT02538237|Sensory System Agents|sensory system agents|mesh-ancestor
25240026|NCT02538237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25240027|NCT02538237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444450|NCT00298012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25874758|NCT05009069|Atezolizumab|atezolizumab|mesh-list
25874759|NCT05009069|Antimetabolites|antimetabolites|mesh-ancestor
25874760|NCT05009069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874761|NCT05009069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24444451|NCT00298012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24724355|NCT01592279|Incretins|incretins|mesh-ancestor
24724356|NCT01592279|Hormones|hormones|mesh-ancestor
24724357|NCT01592279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24724358|NCT01592305|Ritonavir|ritonavir|mesh-list
24724359|NCT01592305|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24724360|NCT01592305|Tenofovir|tenofovir|mesh-list
24724362|NCT01592305|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24724363|NCT01592305|Protease Inhibitors|protease inhibitors|mesh-ancestor
24724364|NCT01592305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724365|NCT01592305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724366|NCT01592305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24724367|NCT01592305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25006449|NCT05055947|Atezolizumab|atezolizumab|mesh-list
24789498|NCT01937611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24789499|NCT01937611|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24789500|NCT01937611|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25006464|NCT05023837|Pembrolizumab|pembrolizumab|mesh-list
25006465|NCT05023837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25006466|NCT05023837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006467|NCT05003076|Methamphetamine|methamphetamine|mesh-list
25006468|NCT05003076|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25006469|NCT05003076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006483|NCT04984330|Antiemetics|antiemetics|mesh-ancestor
25006484|NCT04984330|Autonomic Agents|autonomic agents|mesh-ancestor
25006485|NCT04984330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24789517|NCT01937650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24789518|NCT01937650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24398178|NCT00143702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25673928|NCT01766076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25673929|NCT01766076|Antimetabolites|antimetabolites|mesh-ancestor
25673930|NCT01766076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673931|NCT01766076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25673932|NCT01766076|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25673933|NCT01766076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478864|NCT00424801|Serotonin Agents|serotonin agents|mesh-ancestor
25094433|NCT03226340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24398179|NCT00143702|Vitamin B Complex|vitamin b complex|mesh-ancestor
24615855|NCT01032148|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24615856|NCT01032148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615857|NCT01032148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615858|NCT01032187|Amphotericin B|amphotericin b|mesh-list
24615859|NCT01032187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24615860|NCT01032187|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
24615861|NCT01032187|Meglumine Antimoniate|meglumine antimoniate|mesh-list
24615862|NCT01032187|Deoxycholic Acid|deoxycholic acid|mesh-list
24615863|NCT01032187|Amebicides|amebicides|mesh-ancestor
24615864|NCT01032187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24615865|NCT01032187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24615866|NCT01032187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24615867|NCT01032187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24615868|NCT01032187|Antifungal Agents|antifungal agents|mesh-ancestor
24615869|NCT01032187|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24615870|NCT01032187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24615871|NCT01032213|Magnesium Sulfate|magnesium sulfate|mesh-list
24615872|NCT01032213|Analgesics|analgesics|mesh-ancestor
24450560|NCT00319566|Estrogens|estrogens|mesh-ancestor
24724394|NCT01592526|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24724395|NCT01592526|Cholinergic Agents|cholinergic agents|mesh-ancestor
24724396|NCT01592526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24724397|NCT01592526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724398|NCT01592630|Ropivacaine|ropivacaine|mesh-list
24724399|NCT01592630|Anesthetics, Local|anesthetics, local|mesh-ancestor
24724400|NCT01592630|Anesthetics|anesthetics|mesh-ancestor
24724401|NCT01592630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25874762|NCT05009069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24849930|NCT02251132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849931|NCT02251132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954666|NCT03873974|Immunoglobulin G|immunoglobulin g|mesh-list
24849932|NCT02251132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24724402|NCT01592630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724403|NCT01592630|Sensory System Agents|sensory system agents|mesh-ancestor
24615891|NCT01032434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24724449|NCT01593137|Glimepiride|glimepiride|mesh-list
24724450|NCT01593137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24724451|NCT01593137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724452|NCT01593137|Incretins|incretins|mesh-ancestor
24552015|NCT04254627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24552016|NCT04254627|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24761199|NCT01761552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761200|NCT01761552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24761201|NCT01761552|Respiratory System Agents|respiratory system agents|mesh-ancestor
24761202|NCT01761552|Mydriatics|mydriatics|mesh-ancestor
24724453|NCT01593137|Hormones|hormones|mesh-ancestor
24724454|NCT01593137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24724455|NCT01593137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24724456|NCT01593137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24724457|NCT01593137|Immunologic Factors|immunologic factors|mesh-ancestor
25240043|NCT02538172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25240044|NCT02538003|Delpazolid|delpazolid|mesh-list
25240045|NCT02538003|Oxazolidinones|oxazolidinones|mesh-list
25240046|NCT02538003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25240047|NCT02538003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25240048|NCT02538003|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25240049|NCT02538003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240050|NCT02538003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240051|NCT02538146|Acetylcarnitine|acetylcarnitine|mesh-list
25240052|NCT02538146|Vitamin B Complex|vitamin b complex|mesh-ancestor
25240053|NCT02538146|Vitamins|vitamins|mesh-ancestor
25240054|NCT02538146|Micronutrients|micronutrients|mesh-ancestor
25240055|NCT02538146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240056|NCT02538146|Nootropic Agents|nootropic agents|mesh-ancestor
25240057|NCT02537964|Chlorhexidine|chlorhexidine|mesh-list
25240058|NCT02537964|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25240059|NCT02537964|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25240060|NCT02537964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25240061|NCT02537964|Disinfectants|disinfectants|mesh-ancestor
25240062|NCT02537964|Dermatologic Agents|dermatologic agents|mesh-ancestor
25673935|NCT01766219|Antioxidants|antioxidants|mesh-ancestor
25673936|NCT01766219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240063|NCT02538081|Risperidone|risperidone|mesh-list
25240064|NCT02538081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25240065|NCT02538081|Serotonin Agents|serotonin agents|mesh-ancestor
25240066|NCT02538081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25240067|NCT02538081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240068|NCT02538081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240069|NCT02538081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25240070|NCT02538081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25240071|NCT02538081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25240072|NCT02538081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25240073|NCT02538081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25240074|NCT02538081|Dopamine Agents|dopamine agents|mesh-ancestor
24444456|NCT00298025|Menotropins|menotropins|mesh-list
24444457|NCT00298025|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24444458|NCT00298025|Hormones|hormones|mesh-list
25067751|NCT03440034|Pioglitazone|pioglitazone|mesh-list
24724490|NCT01593293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24724491|NCT01593306|Paclitaxel|paclitaxel|mesh-list
24724492|NCT01593306|Cisplatin|cisplatin|mesh-list
24724537|NCT01593410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24724538|NCT01593410|Glucocorticoids|glucocorticoids|mesh-ancestor
24724539|NCT01593410|Hormones|hormones|mesh-ancestor
24724540|NCT01593410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24724541|NCT01593410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24724542|NCT01593410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24724573|NCT01593566|Anesthetics|anesthetics|mesh-ancestor
24724576|NCT01593566|Sensory System Agents|sensory system agents|mesh-ancestor
24724584|NCT01593605|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24724585|NCT01593644|Adenosine|adenosine|mesh-list
24724586|NCT01593644|Dipyridamole|dipyridamole|mesh-list
24724587|NCT01593644|Analgesics|analgesics|mesh-ancestor
24724588|NCT01593644|Sensory System Agents|sensory system agents|mesh-ancestor
24724620|NCT01593826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24615892|NCT01032434|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24615893|NCT01032434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24615894|NCT01032434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24615895|NCT01032434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615896|NCT01032434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24615897|NCT01032434|Serotonin Agents|serotonin agents|mesh-ancestor
24615898|NCT01032434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615899|NCT01032486|Rasagiline|rasagiline|mesh-list
24724641|NCT01593930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724643|NCT01593995|Mitosis Modulators|mitosis modulators|mesh-ancestor
24724644|NCT01593995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724645|NCT01594047|Ketamine|ketamine|mesh-list
24724646|NCT01594047|Methadone|methadone|mesh-list
24724647|NCT01594047|Analgesics|analgesics|mesh-ancestor
24724648|NCT01594047|Sensory System Agents|sensory system agents|mesh-ancestor
24724649|NCT01594047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24724650|NCT01594047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724651|NCT01594047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24724652|NCT01594047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25874763|NCT05009069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25240075|NCT02537860|Fentanyl|fentanyl|mesh-list
25240076|NCT02537860|Bupivacaine|bupivacaine|mesh-list
25240077|NCT02537860|Anesthetics, Local|anesthetics, local|mesh-ancestor
25240078|NCT02537860|Anesthetics|anesthetics|mesh-ancestor
25240079|NCT02537860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25240080|NCT02537860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240081|NCT02537860|Sensory System Agents|sensory system agents|mesh-ancestor
25240082|NCT02537860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25240083|NCT02537860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25240084|NCT02537860|Narcotics|narcotics|mesh-ancestor
25240085|NCT02537860|Analgesics|analgesics|mesh-ancestor
25240086|NCT02537860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25240087|NCT02537860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25240088|NCT02537860|Anesthetics, General|anesthetics, general|mesh-ancestor
25240089|NCT02537847|Ertapenem|ertapenem|mesh-list
25240090|NCT02537847|Fluoroquinolones|fluoroquinolones|mesh-list
24444463|NCT00298025|Hormone Antagonists|hormone antagonists|mesh-ancestor
24444464|NCT00298025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24849934|NCT02251132|Antiviral Agents|antiviral agents|mesh-ancestor
24849935|NCT02251132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24849936|NCT02251132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24444498|NCT00298285|Anticoagulants|anticoagulants|mesh-ancestor
24444499|NCT00298285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25874764|NCT05009069|Immunologic Factors|immunologic factors|mesh-ancestor
24444500|NCT00298285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24444501|NCT00298285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874765|NCT05009069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724662|NCT01594047|Antitussive Agents|antitussive agents|mesh-ancestor
24724690|NCT01594177|Immunologic Factors|immunologic factors|mesh-ancestor
24724691|NCT01594177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724692|NCT01594177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24724693|NCT01594177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24724694|NCT01594177|Alkylating Agents|alkylating agents|mesh-ancestor
24724695|NCT01594177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24620119|NCT01055470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24761314|NCT01762202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24761315|NCT01762202|Immunologic Factors|immunologic factors|mesh-ancestor
24761316|NCT01762202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761317|NCT01762202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24761318|NCT01762202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24761319|NCT01762202|Alkylating Agents|alkylating agents|mesh-ancestor
24761320|NCT01762202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899002|NCT04407975|Hormones|hormones|mesh-ancestor
25874766|NCT05007821|Linezolid|linezolid|mesh-list
25874767|NCT05007821|Bedaquiline|bedaquiline|mesh-list
25874768|NCT05007821|Diarylquinolines|diarylquinolines|mesh-list
24724696|NCT01594177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24647890|NCT01211314|Enalapril|enalapril|mesh-list
24724697|NCT01594177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24724698|NCT01594177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24724699|NCT01594177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24724700|NCT01594177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724701|NCT01594177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24724703|NCT01594229|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25240091|NCT02537847|Sitafloxacin|sitafloxacin|mesh-list
25240092|NCT02537847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25240093|NCT02537847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25240094|NCT02537847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25240095|NCT02537847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240096|NCT02537847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240097|NCT02537847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25240098|NCT02537847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25240099|NCT02537847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25240100|NCT02537925|Celecoxib|celecoxib|mesh-list
25240101|NCT02537925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
25240102|NCT02537925|Nedaplatin|nedaplatin|mesh-list
25240103|NCT02537925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25240104|NCT02537925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25240105|NCT02537925|Analgesics|analgesics|mesh-ancestor
25240106|NCT02537925|Sensory System Agents|sensory system agents|mesh-ancestor
25240107|NCT02537925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25240108|NCT02537925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240109|NCT02537925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25240110|NCT02537925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25240111|NCT02537925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25240112|NCT02537925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444507|NCT00298324|Glucocorticoids|glucocorticoids|mesh-ancestor
24444508|NCT00298324|Hormones|hormones|mesh-ancestor
25874769|NCT05007821|Clofazimine|clofazimine|mesh-list
24724704|NCT01594229|Venetoclax|venetoclax|mesh-list
24724705|NCT01594229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24724706|NCT01594229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24724707|NCT01594229|Immunologic Factors|immunologic factors|mesh-ancestor
24724708|NCT01594229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724709|NCT01594229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24724778|NCT01594671|Hemostatics|hemostatics|mesh-ancestor
24789561|NCT01937767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24789562|NCT01937767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24789563|NCT01937767|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24789564|NCT01937767|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24789565|NCT01937767|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24789566|NCT01937767|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24789567|NCT01937767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24789568|NCT01937806|Tenofovir|tenofovir|mesh-list
24789569|NCT01937806|Antiviral Agents|antiviral agents|mesh-ancestor
24789570|NCT01937806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24789571|NCT01937806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24789572|NCT01937806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24789573|NCT01937806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874770|NCT05007821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25874771|NCT05007821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24789574|NCT01937806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789576|NCT01937806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24789577|NCT01937832|Ertapenem|ertapenem|mesh-list
24789578|NCT01937832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24789579|NCT01937832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24789580|NCT01938092|Diazepam|diazepam|mesh-list
24789581|NCT01938092|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24789582|NCT01938092|Anticonvulsants|anticonvulsants|mesh-ancestor
24789583|NCT01938092|Antiemetics|antiemetics|mesh-ancestor
24724710|NCT01594229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25006513|NCT04917029|Dexmedetomidine|dexmedetomidine|mesh-list
25240113|NCT02537925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240114|NCT02537925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25240115|NCT02537834|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
25240116|NCT02537834|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25240117|NCT02537834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240118|NCT02537834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25240119|NCT02537834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761337|NCT01762306|Vitamin B Complex|vitamin b complex|mesh-ancestor
24761338|NCT01762306|Vitamins|vitamins|mesh-ancestor
25240127|NCT02537691|Theophylline|theophylline|mesh-list
24492055|NCT00485108|Ketorolac|ketorolac|mesh-list
24998410|NCT02960646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25006515|NCT04917029|Anesthetics, Local|anesthetics, local|mesh-ancestor
25006516|NCT04917029|Anesthetics|anesthetics|mesh-ancestor
25006517|NCT04917029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25006518|NCT04917029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006519|NCT04917029|Sensory System Agents|sensory system agents|mesh-ancestor
25006520|NCT04917029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25006521|NCT04917029|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25006522|NCT04917029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25006523|NCT04917029|Analgesics|analgesics|mesh-ancestor
25006524|NCT04917029|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25006525|NCT04917029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25006526|NCT04917029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25006527|NCT04917029|Adrenergic Agents|adrenergic agents|mesh-ancestor
25006528|NCT04917029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25006529|NCT04917029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724775|NCT01594671|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24724776|NCT01594671|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24724777|NCT01594671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724803|NCT01594866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24724860|NCT01595152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761339|NCT01762306|Micronutrients|micronutrients|mesh-ancestor
24724861|NCT01595152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724863|NCT01595334|Cetrorelix|cetrorelix|mesh-list
24724864|NCT01595334|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24724865|NCT01595334|Fertility Agents|fertility agents|mesh-ancestor
24724866|NCT01595334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24724867|NCT01595334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724868|NCT01595334|Hormone Antagonists|hormone antagonists|mesh-ancestor
24724869|NCT01595334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24724870|NCT01595399|Atropine|atropine|mesh-list
24724871|NCT01595399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24724872|NCT01595399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24724873|NCT01595399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24724874|NCT01595399|Autonomic Agents|autonomic agents|mesh-ancestor
24724875|NCT01595399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24724876|NCT01595399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724877|NCT01595399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24724878|NCT01595399|Respiratory System Agents|respiratory system agents|mesh-ancestor
25240128|NCT02537691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25240129|NCT02537691|Autonomic Agents|autonomic agents|mesh-ancestor
25240130|NCT02537691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25240131|NCT02537691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240132|NCT02537691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25240133|NCT02537691|Respiratory System Agents|respiratory system agents|mesh-ancestor
25673937|NCT01766219|Protective Agents|protective agents|mesh-ancestor
25874772|NCT05007821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25874773|NCT05007821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874774|NCT05007821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874775|NCT05007821|Antitubercular Agents|antitubercular agents|mesh-ancestor
25874776|NCT05007821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25874777|NCT05007821|Leprostatic Agents|leprostatic agents|mesh-ancestor
25240134|NCT02537691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25240135|NCT02537691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240136|NCT02537691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240137|NCT02537691|Vasodilator Agents|vasodilator agents|mesh-ancestor
25240138|NCT02537691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25240139|NCT02537691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25240140|NCT02537691|Purinergic Agents|purinergic agents|mesh-ancestor
24444509|NCT00298324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25874778|NCT05002465|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25874779|NCT05002465|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25874780|NCT05002465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874781|NCT05001828|Azacitidine|azacitidine|mesh-list
25874782|NCT05001828|Venetoclax|venetoclax|mesh-list
25874783|NCT05001828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25874784|NCT05001828|Antimetabolites|antimetabolites|mesh-ancestor
25874785|NCT05001828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444510|NCT00298324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724879|NCT01595399|Mydriatics|mydriatics|mesh-ancestor
24724880|NCT01595399|Parasympatholytics|parasympatholytics|mesh-ancestor
24724881|NCT01595399|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24724882|NCT01595399|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24615903|NCT01032486|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24724883|NCT01595399|Cholinergic Agents|cholinergic agents|mesh-ancestor
24724884|NCT01595399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24724885|NCT01595399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724886|NCT01595425|Esomeprazole|esomeprazole|mesh-list
24615921|NCT01032798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24789584|NCT01938092|Autonomic Agents|autonomic agents|mesh-ancestor
24615923|NCT01032798|Sensory System Agents|sensory system agents|mesh-ancestor
24615924|NCT01032798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24615925|NCT01033058|Atorvastatin|atorvastatin|mesh-list
24615926|NCT01033058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24615927|NCT01033058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24615928|NCT01033058|Antimetabolites|antimetabolites|mesh-ancestor
24615929|NCT01033058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615930|NCT01033058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25240141|NCT02537691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25240142|NCT02537457|Rivaroxaban|rivaroxaban|mesh-list
25240143|NCT02537457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25240144|NCT02537457|Antithrombins|antithrombins|mesh-ancestor
25240145|NCT02537457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25240146|NCT02537457|Protease Inhibitors|protease inhibitors|mesh-ancestor
25240147|NCT02537457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240148|NCT02537457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240149|NCT02537457|Anticoagulants|anticoagulants|mesh-ancestor
25240150|NCT02537353|Epinephrine|epinephrine|mesh-list
25240151|NCT02537353|Racepinephrine|racepinephrine|mesh-list
25240152|NCT02537353|Epinephryl borate|epinephryl borate|mesh-list
25240153|NCT02537353|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25240154|NCT02537353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25240155|NCT02537353|Adrenergic Agents|adrenergic agents|mesh-ancestor
25240156|NCT02537353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25240157|NCT02537353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240158|NCT02537353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240159|NCT02537353|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24444511|NCT00298324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24444512|NCT00298324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477788|NCT00420082|Cetirizine|cetirizine|mesh-list
25673938|NCT01766219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673939|NCT01766219|Vitamin B Complex|vitamin b complex|mesh-ancestor
25673940|NCT01766219|Vitamins|vitamins|mesh-ancestor
25673941|NCT01766219|Micronutrients|micronutrients|mesh-ancestor
25673942|NCT01766310|Folic Acid|folic acid|mesh-list
25673943|NCT01766310|Hematinics|hematinics|mesh-ancestor
25673944|NCT01766310|Vitamin B Complex|vitamin b complex|mesh-ancestor
25673945|NCT01766310|Vitamins|vitamins|mesh-ancestor
25673946|NCT01766310|Micronutrients|micronutrients|mesh-ancestor
25673947|NCT01766310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673948|NCT01766336|Inositol|inositol|mesh-list
25874786|NCT05001828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772148|NCT01831947|Growth Substances|growth substances|mesh-ancestor
24772149|NCT01831947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772150|NCT01831947|Growth Inhibitors|growth inhibitors|mesh-ancestor
24772151|NCT01831947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772152|NCT01832051|Trastuzumab|trastuzumab|mesh-list
25095445|NCT03219008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24480897|NCT00432588|Dinoprostone|dinoprostone|mesh-list
25874787|NCT05001828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25095477|NCT03218709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761394|NCT01762540|Glucocorticoids|glucocorticoids|mesh-list
24849976|NCT02251171|Protease Inhibitors|protease inhibitors|mesh-ancestor
24849977|NCT02251171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849978|NCT02251171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849979|NCT02251171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24615931|NCT01033058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24615932|NCT01033058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615933|NCT01033084|Sertraline|sertraline|mesh-list
24615934|NCT01033084|Antidepressive Agents|antidepressive agents|mesh-ancestor
24615935|NCT01033084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24615936|NCT01033084|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24615937|NCT01033084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24724957|NCT01595828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24724958|NCT01595828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24724959|NCT01595828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24724960|NCT01595828|Antimetabolites|antimetabolites|mesh-ancestor
25240160|NCT02537353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25240161|NCT02537353|Autonomic Agents|autonomic agents|mesh-ancestor
25240162|NCT02537353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25240163|NCT02537353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25240164|NCT02537353|Respiratory System Agents|respiratory system agents|mesh-ancestor
25240165|NCT02537353|Mydriatics|mydriatics|mesh-ancestor
25240166|NCT02537353|Sympathomimetics|sympathomimetics|mesh-ancestor
25240167|NCT02537353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25240168|NCT02537470|Remogliflozin etabonate|remogliflozin etabonate|mesh-list
25240169|NCT02537470|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25240170|NCT02537470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240171|NCT02537470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25240172|NCT02537470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240173|NCT02537561|Gemcitabine|gemcitabine|mesh-list
25240174|NCT02537561|Cisplatin|cisplatin|mesh-list
25240175|NCT02537561|Talazoparib|talazoparib|mesh-list
24761398|NCT01762540|Hormones|hormones|mesh-ancestor
25240176|NCT02537561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25240177|NCT02537561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25240178|NCT02537561|Antimetabolites|antimetabolites|mesh-ancestor
25240179|NCT02537561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240180|NCT02537561|Antiviral Agents|antiviral agents|mesh-ancestor
25240181|NCT02537561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25240182|NCT02537561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240183|NCT02537561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25240184|NCT02537561|Immunologic Factors|immunologic factors|mesh-ancestor
25240185|NCT02537561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240186|NCT02537561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24725392|NCT01597531|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25874788|NCT04995263|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
24444570|NCT00298506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24444571|NCT00298506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25874789|NCT04995263|Caffeine|caffeine|mesh-list
25874790|NCT04995263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25874791|NCT04995263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874792|NCT04995263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25067854|NCT03438240|Sympathomimetics|sympathomimetics|mesh-list
25673949|NCT01766336|Vitamin B Complex|vitamin b complex|mesh-ancestor
25673950|NCT01766336|Vitamins|vitamins|mesh-ancestor
25673951|NCT01766336|Micronutrients|micronutrients|mesh-ancestor
25673952|NCT01766336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673953|NCT01766440|Calcitriol|calcitriol|mesh-list
25673954|NCT01766440|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25673955|NCT01766440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673956|NCT01766440|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25673957|NCT01766440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24724961|NCT01595828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724962|NCT01595828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724963|NCT01595828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24724964|NCT01595867|Naltrexone|naltrexone|mesh-list
24724965|NCT01595867|Morphine|morphine|mesh-list
24724966|NCT01595867|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24724967|NCT01595867|Narcotics|narcotics|mesh-ancestor
24724968|NCT01595867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24724969|NCT01595867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724970|NCT01595867|Analgesics|analgesics|mesh-ancestor
24724975|NCT01595880|Metformin|metformin|mesh-list
24725065|NCT01596166|Autonomic Agents|autonomic agents|mesh-ancestor
24725066|NCT01596166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25874793|NCT04995263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725102|NCT01596413|Serotonin Agents|serotonin agents|mesh-ancestor
24725103|NCT01596413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24725104|NCT01596413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725147|NCT01596647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24725148|NCT01596647|Anesthetics, General|anesthetics, general|mesh-ancestor
25240187|NCT02537600|Vemurafenib|vemurafenib|mesh-list
25240188|NCT02537600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25240189|NCT02537600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25240190|NCT02537600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240191|NCT02537600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240192|NCT02537379|Ribavirin|ribavirin|mesh-list
25240193|NCT02537379|Antimetabolites|antimetabolites|mesh-ancestor
25240194|NCT02537379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240195|NCT02537379|Antiviral Agents|antiviral agents|mesh-ancestor
25240196|NCT02537379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25240197|NCT02537366|Dexmedetomidine|dexmedetomidine|mesh-list
25240198|NCT02537366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25240199|NCT02537366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25240200|NCT02537366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240201|NCT02537366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25240202|NCT02537366|Analgesics|analgesics|mesh-ancestor
25240203|NCT02537366|Sensory System Agents|sensory system agents|mesh-ancestor
25240204|NCT02537366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25240205|NCT02537366|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25240206|NCT02537366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25240207|NCT02537366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25240208|NCT02537366|Adrenergic Agents|adrenergic agents|mesh-ancestor
25240209|NCT02537366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25240210|NCT02537366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240211|NCT02537392|Folic Acid|folic acid|mesh-list
24849983|NCT02251171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24849984|NCT02251171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24849985|NCT02251171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24849986|NCT02251171|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24849987|NCT02251171|Antitubercular Agents|antitubercular agents|mesh-ancestor
24849990|NCT02251184|Lansoprazole|lansoprazole|mesh-list
24849991|NCT02251184|Dexlansoprazole|dexlansoprazole|mesh-list
24849992|NCT02251184|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
24849993|NCT02251184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24725149|NCT01596647|Anesthetics|anesthetics|mesh-ancestor
25874794|NCT04995263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874795|NCT04995263|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25874796|NCT04995263|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25874797|NCT04995263|Purinergic Agents|purinergic agents|mesh-ancestor
25874798|NCT04995263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25874799|NCT04995263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25874800|NCT04994509|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25874801|NCT04994509|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25874802|NCT04994509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25874803|NCT04994509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25874804|NCT04994509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874805|NCT04994509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874806|NCT04994509|Antiviral Agents|antiviral agents|mesh-ancestor
25874807|NCT04994509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25874808|NCT04994509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25874809|NCT04994509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25874810|NCT04973605|Dexamethasone|dexamethasone|mesh-list
25874811|NCT04973605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25874812|NCT04973605|Antiemetics|antiemetics|mesh-ancestor
25874813|NCT04973605|Autonomic Agents|autonomic agents|mesh-ancestor
25876769|NCT02794571|Mitosis Modulators|mitosis modulators|mesh-ancestor
25874814|NCT04973605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25874815|NCT04973605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874816|NCT04973605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25874817|NCT04973605|Glucocorticoids|glucocorticoids|mesh-ancestor
25874818|NCT04973605|Hormones|hormones|mesh-ancestor
25874819|NCT04973605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25874820|NCT04973605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25874821|NCT04973605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24725180|NCT01596673|Narcotics|narcotics|mesh-ancestor
24725181|NCT01596673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24725182|NCT01596673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725183|NCT01596673|Analgesics|analgesics|mesh-ancestor
25240212|NCT02537392|Vitamin B Complex|vitamin b complex|mesh-list
25240213|NCT02537392|Vitamins|vitamins|mesh-ancestor
25240214|NCT02537392|Micronutrients|micronutrients|mesh-ancestor
25240215|NCT02537392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240216|NCT02537392|Hematinics|hematinics|mesh-ancestor
25273920|NCT02382068|Dexamethasone|dexamethasone|mesh-list
25273921|NCT02382068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25273922|NCT02382068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25273923|NCT02382068|Antiemetics|antiemetics|mesh-ancestor
25273924|NCT02382068|Autonomic Agents|autonomic agents|mesh-ancestor
25273925|NCT02382068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25273926|NCT02382068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273927|NCT02382068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25273928|NCT02382068|Glucocorticoids|glucocorticoids|mesh-ancestor
25273929|NCT02382068|Hormones|hormones|mesh-ancestor
25273930|NCT02382068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25273931|NCT02382068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24725187|NCT01596673|Respiratory System Agents|respiratory system agents|mesh-ancestor
24725189|NCT01596686|Cathartics|cathartics|mesh-ancestor
24725190|NCT01596686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24725191|NCT01596738|Tranexamic Acid|tranexamic acid|mesh-list
24725192|NCT01596738|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24725193|NCT01596738|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24725228|NCT01596777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24725229|NCT01596777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24725230|NCT01596803|Ascorbic Acid|ascorbic acid|mesh-list
24725231|NCT01596803|Vitamin E|vitamin e|mesh-list
24725232|NCT01596803|alpha-Tocopherol|alpha-tocopherol|mesh-list
24725233|NCT01596803|Tocopherols|tocopherols|mesh-list
24725234|NCT01596803|Antioxidants|antioxidants|mesh-list
25240217|NCT02537249|Dexmedetomidine|dexmedetomidine|mesh-list
25240218|NCT02537249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25240219|NCT02537249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25240220|NCT02537249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240221|NCT02537249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25240222|NCT02537249|Analgesics|analgesics|mesh-ancestor
25240223|NCT02537249|Sensory System Agents|sensory system agents|mesh-ancestor
25240224|NCT02537249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25240225|NCT02537249|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25240226|NCT02537249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25240227|NCT02537249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25240228|NCT02537249|Adrenergic Agents|adrenergic agents|mesh-ancestor
25240229|NCT02537249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25240230|NCT02537249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240231|NCT02537210|Mesalamine|mesalamine|mesh-list
25240232|NCT02537210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25240233|NCT02537210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25240234|NCT02537210|Analgesics|analgesics|mesh-ancestor
25240235|NCT02537210|Sensory System Agents|sensory system agents|mesh-ancestor
25240236|NCT02537210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25240237|NCT02537210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240238|NCT02537210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25240239|NCT02537210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25240240|NCT02537158|Sorafenib|sorafenib|mesh-list
25240241|NCT02537158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25240242|NCT02537158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25240243|NCT02537158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240244|NCT02537158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674587|NCT01774305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25411858|NCT03224507|Lenalidomide|lenalidomide|mesh-list
25674588|NCT01774305|Analgesics|analgesics|mesh-ancestor
25674589|NCT01774305|Sensory System Agents|sensory system agents|mesh-ancestor
25674590|NCT01774305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25674591|NCT01774305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25096158|NCT03213743|Dexmedetomidine|dexmedetomidine|mesh-list
25096159|NCT03213743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25096160|NCT03213743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24482319|NCT00438737|Leucovorin|leucovorin|mesh-list
25096196|NCT03213392|Anesthetics|anesthetics|mesh-list
25874822|NCT04955366|Abatacept|abatacept|mesh-list
24849994|NCT02251184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24849995|NCT02251184|Analgesics|analgesics|mesh-ancestor
24849996|NCT02251184|Sensory System Agents|sensory system agents|mesh-ancestor
24953504|NCT03884530|Antipyretics|antipyretics|mesh-ancestor
24725268|NCT01596907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725830|NCT01599962|Hormone Antagonists|hormone antagonists|mesh-ancestor
24725269|NCT01596907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24725271|NCT01596907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615959|NCT01033149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615960|NCT01033149|Protective Agents|protective agents|mesh-ancestor
24615961|NCT01033149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615988|NCT01033370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615990|NCT01033396|Terfenadine|terfenadine|mesh-list
24615991|NCT01033396|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24615992|NCT01033396|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24615993|NCT01033396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24615994|NCT01033396|Histamine Antagonists|histamine antagonists|mesh-ancestor
24615995|NCT01033396|Histamine Agents|histamine agents|mesh-ancestor
24615996|NCT01033396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24615997|NCT01033396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615998|NCT01033396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615999|NCT01033409|Vaccines|vaccines|mesh-list
24616000|NCT01033409|Immunologic Factors|immunologic factors|mesh-ancestor
24789585|NCT01938092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24789586|NCT01938092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789587|NCT01938092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24789588|NCT01938092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24789589|NCT01938092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24789590|NCT01938092|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24789591|NCT01938092|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24789592|NCT01938092|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24789593|NCT01938092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25874823|NCT04955366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24725350|NCT01597310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24725351|NCT01597310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24725352|NCT01597310|Dopamine Agonists|dopamine agonists|mesh-ancestor
24725353|NCT01597310|Dopamine Agents|dopamine agents|mesh-ancestor
24725354|NCT01597310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24725355|NCT01597336|Plasminogen|plasminogen|mesh-list
24725356|NCT01597336|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24725357|NCT01597336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24725359|NCT01597336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725360|NCT01597427|Clonidine|clonidine|mesh-list
24725361|NCT01597427|Analgesics|analgesics|mesh-ancestor
25874824|NCT04955366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725390|NCT01597531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725391|NCT01597531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725393|NCT01597531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24725394|NCT01597609|Sibutramine|sibutramine|mesh-list
24725395|NCT01597609|Antidepressive Agents|antidepressive agents|mesh-ancestor
24725396|NCT01597609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24725397|NCT01597609|Appetite Depressants|appetite depressants|mesh-ancestor
24725398|NCT01597609|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24725399|NCT01597648|Maraviroc|maraviroc|mesh-list
24725400|NCT01597648|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25240245|NCT02537223|Cisplatin|cisplatin|mesh-list
25240246|NCT02537223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25240247|NCT02537171|Apatinib|apatinib|mesh-list
25240248|NCT02537171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25240249|NCT02537171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25240250|NCT02537171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240251|NCT02537171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240252|NCT02537288|Moxifloxacin|moxifloxacin|mesh-list
25240253|NCT02537288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25240254|NCT02537288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25673958|NCT01766440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673959|NCT01766440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25673960|NCT01766440|Vitamins|vitamins|mesh-ancestor
25673961|NCT01766440|Micronutrients|micronutrients|mesh-ancestor
25096578|NCT03210766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25096579|NCT03210766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24423416|NCT00225862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240255|NCT02537288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24849997|NCT02251184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24849998|NCT02251184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849999|NCT02251184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25874825|NCT04955366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874826|NCT04955366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25874827|NCT04955366|Immunologic Factors|immunologic factors|mesh-ancestor
25874828|NCT04955366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953515|NCT03884127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953516|NCT03884127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24953517|NCT03884127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24953518|NCT03884127|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24725401|NCT01597648|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24725402|NCT01597648|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24725403|NCT01597648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725404|NCT01597648|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24725419|NCT01597661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725420|NCT01597661|Dopamine Agents|dopamine agents|mesh-ancestor
24725421|NCT01597661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24400003|NCT00149240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25006543|NCT04892420|Dexamethasone|dexamethasone|mesh-list
24725423|NCT01597661|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24725424|NCT01597661|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24725425|NCT01597661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725434|NCT01597713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725436|NCT01597726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24725437|NCT01597726|Abortifacient Agents|abortifacient agents|mesh-ancestor
24725438|NCT01597726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24725439|NCT01597726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725440|NCT01597726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24725441|NCT01597726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24725442|NCT01597726|Oxytocics|oxytocics|mesh-ancestor
24725444|NCT01597765|Vitamin E|vitamin e|mesh-list
24725445|NCT01597765|Tocopherols|tocopherols|mesh-list
24725446|NCT01597765|Tocotrienols|tocotrienols|mesh-list
24725447|NCT01597765|alpha-Tocopherol|alpha-tocopherol|mesh-list
24725448|NCT01597765|Acetylcysteine|acetylcysteine|mesh-list
24725449|NCT01597765|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24725450|NCT01597765|Deferiprone|deferiprone|mesh-list
24725451|NCT01597765|Micronutrients|micronutrients|mesh-ancestor
24725452|NCT01597765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725454|NCT01597765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24725491|NCT01597934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24725492|NCT01597934|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24725493|NCT01597934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24616027|NCT01033526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616028|NCT01033526|Antipyretics|antipyretics|mesh-ancestor
25240256|NCT02537288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25240257|NCT02537288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240258|NCT02537288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240259|NCT02537288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25240260|NCT02537080|Nimodipine|nimodipine|mesh-list
25240261|NCT02537080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25240262|NCT02537080|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25240263|NCT02537080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25240264|NCT02537080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240265|NCT02537080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25240266|NCT02537080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673962|NCT01766440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25673963|NCT01766466|Ticagrelor|ticagrelor|mesh-list
25673964|NCT01766466|Cangrelor|cangrelor|mesh-list
25673965|NCT01766466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25673966|NCT01766466|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25673967|NCT01766466|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25673968|NCT01766466|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25128471|NCT03046953|Avelumab|avelumab|mesh-list
25673969|NCT01766466|Purinergic Agents|purinergic agents|mesh-ancestor
25673970|NCT01766466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25673971|NCT01766466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097068|NCT03207477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097069|NCT03207139|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25097070|NCT03207139|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25097071|NCT03207139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240267|NCT02537080|Vasodilator Agents|vasodilator agents|mesh-ancestor
25240268|NCT02537405|Rivaroxaban|rivaroxaban|mesh-list
25240269|NCT02537405|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25240270|NCT02537405|Antithrombins|antithrombins|mesh-ancestor
25240271|NCT02537405|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25240272|NCT02537405|Protease Inhibitors|protease inhibitors|mesh-ancestor
25240273|NCT02537405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273932|NCT02382094|Bicalutamide|bicalutamide|mesh-list
25874829|NCT04955366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25874830|NCT04952519|Amantadine|amantadine|mesh-list
25874831|NCT04952519|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25874832|NCT04952519|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25874833|NCT04952519|Antiviral Agents|antiviral agents|mesh-ancestor
25874834|NCT04952519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25874835|NCT04952519|Dopamine Agents|dopamine agents|mesh-ancestor
25874836|NCT04952519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25874837|NCT04952519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874838|NCT04952519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874839|NCT04952519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25874840|NCT04952519|Analgesics|analgesics|mesh-ancestor
25874841|NCT04952519|Sensory System Agents|sensory system agents|mesh-ancestor
25874842|NCT04952519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25874843|NCT04938466|Hormones|hormones|mesh-list
24726255|NCT01602588|Antimalarials|antimalarials|mesh-ancestor
25874844|NCT04938466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25874845|NCT04938466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616029|NCT01033656|Methotrexate|methotrexate|mesh-list
24616030|NCT01033656|Azathioprine|azathioprine|mesh-list
24616031|NCT01033656|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24616032|NCT01033656|Leflunomide|leflunomide|mesh-list
24616033|NCT01033656|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24616034|NCT01033656|Abortifacient Agents|abortifacient agents|mesh-ancestor
24616035|NCT01033656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24616036|NCT01033656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616037|NCT01033656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24616038|NCT01033656|Antimetabolites|antimetabolites|mesh-ancestor
24616039|NCT01033656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616040|NCT01033656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616041|NCT01033656|Dermatologic Agents|dermatologic agents|mesh-ancestor
25240274|NCT02537405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240275|NCT02537405|Anticoagulants|anticoagulants|mesh-ancestor
25240276|NCT02537054|Aflibercept|aflibercept|mesh-list
25240277|NCT02537054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25240278|NCT02537054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25240279|NCT02537054|Growth Substances|growth substances|mesh-ancestor
25240280|NCT02537054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240281|NCT02537054|Growth Inhibitors|growth inhibitors|mesh-ancestor
25240282|NCT02537054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25240283|NCT02536989|Omeprazole|omeprazole|mesh-list
25240284|NCT02536989|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25240285|NCT02536989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25240286|NCT02536989|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25240287|NCT02536989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240288|NCT02536989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240289|NCT02536859|Insulin|insulin|mesh-list
25240290|NCT02536859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25240291|NCT02536859|Insulin Glargine|insulin glargine|mesh-list
25240292|NCT02536859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25240293|NCT02536859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240294|NCT02536937|Eliglustat|eliglustat|mesh-list
25240295|NCT02536937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240296|NCT02536937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240297|NCT02536807|Hyaluronic Acid|hyaluronic acid|mesh-list
25673972|NCT01766466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25673973|NCT01766713|Ezetimibe|ezetimibe|mesh-list
25673974|NCT01766713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25673975|NCT01766713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25673976|NCT01766713|Antimetabolites|antimetabolites|mesh-ancestor
25673977|NCT01766713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673978|NCT01766713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25673979|NCT01766778|Metformin|metformin|mesh-list
25673980|NCT01766778|Vildagliptin|vildagliptin|mesh-list
25240298|NCT02536807|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25240299|NCT02536807|Immunologic Factors|immunologic factors|mesh-ancestor
25240300|NCT02536807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240301|NCT02536807|Viscosupplements|viscosupplements|mesh-ancestor
25240302|NCT02536807|Protective Agents|protective agents|mesh-ancestor
25240303|NCT02536690|Midazolam|midazolam|mesh-list
25240304|NCT02536690|Remifentanil|remifentanil|mesh-list
25874846|NCT04937062|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25874847|NCT04937062|Glycerol|glycerol|mesh-list
25874848|NCT04937062|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25874849|NCT04937062|Protective Agents|protective agents|mesh-ancestor
24616042|NCT01033656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616043|NCT01033656|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24616044|NCT01033656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24616045|NCT01033656|Immunologic Factors|immunologic factors|mesh-ancestor
24725524|NCT01598012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725526|NCT01598012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24725527|NCT01598012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24725528|NCT01598012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725529|NCT01598012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725530|NCT01598051|Rivaroxaban|rivaroxaban|mesh-list
24725531|NCT01598051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24725532|NCT01598051|Antithrombins|antithrombins|mesh-ancestor
24725533|NCT01598051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24725534|NCT01598051|Protease Inhibitors|protease inhibitors|mesh-ancestor
24400262|NCT00150215|Serotonin Agents|serotonin agents|mesh-ancestor
24725550|NCT01598259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725553|NCT01598337|Tirofiban|tirofiban|mesh-list
24725554|NCT01598337|Clopidogrel|clopidogrel|mesh-list
24725555|NCT01598337|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24725556|NCT01598337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24725557|NCT01598337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24725638|NCT01598584|Adrenergic Agents|adrenergic agents|mesh-ancestor
24725639|NCT01598584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24725680|NCT01598948|Mipomersen|mipomersen|mesh-list
24725718|NCT01599117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24725719|NCT01599117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24725720|NCT01599117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725721|NCT01599117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725722|NCT01599130|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24725723|NCT01599130|Entecavir|entecavir|mesh-list
24725724|NCT01599130|Antiviral Agents|antiviral agents|mesh-ancestor
24725725|NCT01599130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24725726|NCT01599273|Triamcinolone|triamcinolone|mesh-list
24725727|NCT01599273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24725728|NCT01599273|Glucocorticoids|glucocorticoids|mesh-ancestor
24725729|NCT01599273|Hormones|hormones|mesh-ancestor
25874850|NCT04937062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616088|NCT01033955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24616089|NCT01033955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24616091|NCT01033981|Sunitinib|sunitinib|mesh-list
24616092|NCT01033981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616093|NCT01033981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24616094|NCT01033981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24616095|NCT01033981|Growth Substances|growth substances|mesh-ancestor
25006545|NCT04892420|Dexmedetomidine|dexmedetomidine|mesh-list
25006546|NCT04892420|Bupivacaine|bupivacaine|mesh-list
25240305|NCT02536690|Propofol|propofol|mesh-list
25240306|NCT02536690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25240307|NCT02536690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25240308|NCT02536690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240309|NCT02536690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25240310|NCT02536690|Anesthetics, General|anesthetics, general|mesh-ancestor
25240311|NCT02536690|Anesthetics|anesthetics|mesh-ancestor
25240312|NCT02536690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25240313|NCT02536690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25240314|NCT02536690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25240315|NCT02536690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25240316|NCT02536690|GABA Modulators|gaba modulators|mesh-ancestor
25240317|NCT02536690|GABA Agents|gaba agents|mesh-ancestor
25874851|NCT04937062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25240318|NCT02536690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25273933|NCT02382094|Androgen Antagonists|androgen antagonists|mesh-ancestor
25874852|NCT04936542|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25874853|NCT04936542|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25673981|NCT01766778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25673982|NCT01766778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897265|NCT04426552|Dexmedetomidine|dexmedetomidine|mesh-list
24897267|NCT04426552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24897268|NCT04426552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24897269|NCT04426552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098083|NCT03199820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25098084|NCT03199820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098085|NCT03199339|Midazolam|midazolam|mesh-list
25874854|NCT04936542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25874855|NCT04936542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874856|NCT04936542|Cholinergic Agents|cholinergic agents|mesh-ancestor
25874857|NCT04936542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25874858|NCT04936542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874859|NCT04935359|Gemcitabine|gemcitabine|mesh-list
25874860|NCT04935359|Paclitaxel|paclitaxel|mesh-list
25874861|NCT04935359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25874862|NCT04935359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616096|NCT01033981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616097|NCT01033981|Growth Inhibitors|growth inhibitors|mesh-ancestor
24616098|NCT01033981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24616134|NCT01034124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24725829|NCT01599962|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24725831|NCT01599962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24725832|NCT01599975|Methylphenidate|methylphenidate|mesh-list
24725833|NCT01599975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24725834|NCT01599975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725835|NCT01599975|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24725836|NCT01599975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24725837|NCT01599975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24725838|NCT01599975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725877|NCT01600274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24725878|NCT01600274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24616137|NCT01034124|Coagulants|coagulants|mesh-ancestor
24616138|NCT01034189|Paclitaxel|paclitaxel|mesh-list
24616139|NCT01034189|Cetuximab|cetuximab|mesh-list
24616140|NCT01034189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24616141|NCT01034189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616142|NCT01034189|Tubulin Modulators|tubulin modulators|mesh-ancestor
24616143|NCT01034189|Antimitotic Agents|antimitotic agents|mesh-ancestor
24616144|NCT01034189|Mitosis Modulators|mitosis modulators|mesh-ancestor
25240319|NCT02536690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240320|NCT02536690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25240321|NCT02536690|Narcotics|narcotics|mesh-ancestor
25240322|NCT02536690|Analgesics|analgesics|mesh-ancestor
25240323|NCT02536690|Sensory System Agents|sensory system agents|mesh-ancestor
25240324|NCT02536690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25240325|NCT02536911|Eliglustat|eliglustat|mesh-list
25240326|NCT02536911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240327|NCT02536911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240328|NCT02536742|Fulvestrant|fulvestrant|mesh-list
25240329|NCT02536742|Palbociclib|palbociclib|mesh-list
25240330|NCT02536742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25240331|NCT02536742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25240332|NCT02536742|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25240333|NCT02536742|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25240334|NCT02536742|Hormone Antagonists|hormone antagonists|mesh-ancestor
25673983|NCT01766778|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25673984|NCT01766778|Protease Inhibitors|protease inhibitors|mesh-ancestor
25673985|NCT01766778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25673986|NCT01766778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673987|NCT01767103|Deferiprone|deferiprone|mesh-list
25673988|NCT01767103|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25673989|NCT01767103|Chelating Agents|chelating agents|mesh-ancestor
25673990|NCT01767103|Sequestering Agents|sequestering agents|mesh-ancestor
25673991|NCT01767103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673992|NCT01767116|Ribavirin|ribavirin|mesh-list
25673993|NCT01767116|Antimetabolites|antimetabolites|mesh-ancestor
25673994|NCT01767116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25673995|NCT01767116|Antiviral Agents|antiviral agents|mesh-ancestor
25673996|NCT01767116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25673997|NCT01767155|Doxorubicin|doxorubicin|mesh-list
25673998|NCT01767155|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25673999|NCT01767155|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25674000|NCT01767155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25240335|NCT02536742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25240336|NCT02536742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240338|NCT02536742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240339|NCT02536742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240340|NCT02536872|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25240341|NCT02536872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25874863|NCT04935359|Tubulin Modulators|tubulin modulators|mesh-ancestor
25874864|NCT04935359|Antimitotic Agents|antimitotic agents|mesh-ancestor
25874865|NCT04935359|Mitosis Modulators|mitosis modulators|mesh-ancestor
25874866|NCT04935359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874867|NCT04935359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25874868|NCT04935359|Antimetabolites|antimetabolites|mesh-ancestor
25874869|NCT04935359|Antiviral Agents|antiviral agents|mesh-ancestor
25874870|NCT04935359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25874871|NCT04935359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874872|NCT04935359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25874873|NCT04935359|Immunologic Factors|immunologic factors|mesh-ancestor
24725881|NCT01600274|Hormone Antagonists|hormone antagonists|mesh-ancestor
24725882|NCT01600274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24725883|NCT01600274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789599|NCT01938092|GABA Agents|gaba agents|mesh-ancestor
24725884|NCT01600274|Androgens|androgens|mesh-ancestor
24725885|NCT01600274|Anabolic Agents|anabolic agents|mesh-ancestor
24725886|NCT01600365|Ganciclovir|ganciclovir|mesh-list
24725887|NCT01600365|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
24725888|NCT01600365|Lubricant Eye Drops|lubricant eye drops|mesh-list
24725889|NCT01600365|Antiviral Agents|antiviral agents|mesh-ancestor
24725917|NCT01600456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24725918|NCT01600456|Serotonin Agents|serotonin agents|mesh-ancestor
24725919|NCT01600456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725921|NCT01600573|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24725922|NCT01600573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24725923|NCT01600573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725924|NCT01600573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725925|NCT01600573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24725926|NCT01600599|Tranexamic Acid|tranexamic acid|mesh-list
24725927|NCT01600599|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24725928|NCT01600599|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24725929|NCT01600599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725930|NCT01600599|Hemostatics|hemostatics|mesh-ancestor
24725931|NCT01600599|Coagulants|coagulants|mesh-ancestor
24725932|NCT01600612|Oxytocin|oxytocin|mesh-list
24725933|NCT01600612|Carbetocin|carbetocin|mesh-list
24725934|NCT01600612|Oxytocics|oxytocics|mesh-ancestor
24725935|NCT01600612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24725961|NCT01600807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24725962|NCT01600963|Bedaquiline|bedaquiline|mesh-list
24725963|NCT01600963|Diarylquinolines|diarylquinolines|mesh-list
24725964|NCT01600963|Antitubercular Agents|antitubercular agents|mesh-ancestor
24725965|NCT01600963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24725977|NCT01601002|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24725978|NCT01601002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24725979|NCT01601002|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24725980|NCT01601002|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24725981|NCT01601002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24725982|NCT01601002|Adrenergic Agents|adrenergic agents|mesh-ancestor
24726016|NCT01601184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726017|NCT01601184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24726018|NCT01601314|Magnesium Sulfate|magnesium sulfate|mesh-list
24726019|NCT01601314|Analgesics|analgesics|mesh-ancestor
24726020|NCT01601314|Sensory System Agents|sensory system agents|mesh-ancestor
24726021|NCT01601314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24726022|NCT01601314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726057|NCT01601509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726058|NCT01601561|Insulin|insulin|mesh-list
24616231|NCT01035190|Respiratory System Agents|respiratory system agents|mesh-ancestor
25240342|NCT02536495|Docetaxel|docetaxel|mesh-list
25240343|NCT02536495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25240344|NCT02536495|Tubulin Modulators|tubulin modulators|mesh-ancestor
25240345|NCT02536495|Antimitotic Agents|antimitotic agents|mesh-ancestor
25240346|NCT02536495|Mitosis Modulators|mitosis modulators|mesh-ancestor
25240347|NCT02536495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240348|NCT02536417|Melatonin|melatonin|mesh-list
25240349|NCT02536417|Antioxidants|antioxidants|mesh-ancestor
25240350|NCT02536417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240351|NCT02536417|Protective Agents|protective agents|mesh-ancestor
25240352|NCT02536417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240353|NCT02536417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25240354|NCT02536209|Oxycodone|oxycodone|mesh-list
25874874|NCT04935359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874875|NCT04933539|Dexamethasone|dexamethasone|mesh-list
25874876|NCT04933539|Daratumumab|daratumumab|mesh-list
25874877|NCT04933539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25874878|NCT04933539|Antiemetics|antiemetics|mesh-ancestor
25874879|NCT04933539|Autonomic Agents|autonomic agents|mesh-ancestor
25874880|NCT04933539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25874881|NCT04933539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874882|NCT04933539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25874883|NCT04933539|Glucocorticoids|glucocorticoids|mesh-ancestor
24850004|NCT02251184|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24850005|NCT02251184|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24850006|NCT02251184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850007|NCT02251184|Antipyretics|antipyretics|mesh-ancestor
24850008|NCT02251184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24850009|NCT02251184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24850010|NCT02251184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24850011|NCT02251184|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24850012|NCT02251184|Vasodilator Agents|vasodilator agents|mesh-ancestor
24850013|NCT02251223|Ritonavir|ritonavir|mesh-list
24850014|NCT02251223|Tipranavir|tipranavir|mesh-list
24761765|NCT01764451|Simvastatin|simvastatin|mesh-list
24761766|NCT01764451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24850015|NCT02251223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24953131|NCT03888157|Liraglutide|liraglutide|mesh-list
25006548|NCT04892420|Antiemetics|antiemetics|mesh-ancestor
24881996|NCT00006455|Autonomic Agents|autonomic agents|mesh-ancestor
24726221|NCT01602302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24726222|NCT01602302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24726223|NCT01602302|Analgesics|analgesics|mesh-ancestor
24726224|NCT01602302|Sensory System Agents|sensory system agents|mesh-ancestor
24726250|NCT01602523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24726251|NCT01602523|Adrenergic Agents|adrenergic agents|mesh-ancestor
24726252|NCT01602523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24726253|NCT01602523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726257|NCT01602588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24726258|NCT01602588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24726259|NCT01602588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24726261|NCT01602588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24726304|NCT01602822|Protease Inhibitors|protease inhibitors|mesh-ancestor
24726305|NCT01602822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24726306|NCT01602822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726308|NCT01602822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24726309|NCT01602822|Antiviral Agents|antiviral agents|mesh-ancestor
24726310|NCT01602822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25006549|NCT04892420|Autonomic Agents|autonomic agents|mesh-ancestor
24789601|NCT01938092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789602|NCT01938105|Nimotuzumab|nimotuzumab|mesh-list
24726311|NCT01602822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24726312|NCT01602822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25240355|NCT02536209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25240356|NCT02536209|Narcotics|narcotics|mesh-ancestor
25240357|NCT02536209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25240358|NCT02536209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240359|NCT02536209|Analgesics|analgesics|mesh-ancestor
25240360|NCT02536209|Sensory System Agents|sensory system agents|mesh-ancestor
24761767|NCT01764451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25240361|NCT02536209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25240362|NCT02536430|Ketorolac|ketorolac|mesh-list
25240363|NCT02536430|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25240364|NCT02536430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25240365|NCT02536430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25240366|NCT02536430|Analgesics|analgesics|mesh-ancestor
25240367|NCT02536430|Sensory System Agents|sensory system agents|mesh-ancestor
25240368|NCT02536430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25240369|NCT02536430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240370|NCT02536430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25240371|NCT02536430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25240372|NCT02536430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25874884|NCT04933539|Hormones|hormones|mesh-ancestor
25240373|NCT02536430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240374|NCT02536430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240375|NCT02536352|Vitamins|vitamins|mesh-list
25240376|NCT02536352|Fluorides|fluorides|mesh-list
25240377|NCT02536352|Micronutrients|micronutrients|mesh-ancestor
24850016|NCT02251223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24850017|NCT02251223|Protease Inhibitors|protease inhibitors|mesh-ancestor
24850018|NCT02251223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874885|NCT04933539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25874886|NCT04933539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25874887|NCT04933539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874888|NCT04933227|Capecitabine|capecitabine|mesh-list
25874889|NCT04933227|Oxaliplatin|oxaliplatin|mesh-list
25874890|NCT04933227|Atezolizumab|atezolizumab|mesh-list
25874891|NCT04933227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24492509|NCT00486564|Nifurtimox|nifurtimox|mesh-list
24444610|NCT00298636|Analgesics|analgesics|mesh-ancestor
24444611|NCT00298636|Sensory System Agents|sensory system agents|mesh-ancestor
24444612|NCT00298636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24444613|NCT00298636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874892|NCT04933227|Antimetabolites|antimetabolites|mesh-ancestor
25874893|NCT04933227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550672|NCT00721552|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24479173|NCT00425841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874894|NCT04933227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874895|NCT04922333|Risedronic Acid|risedronic acid|mesh-list
25874896|NCT04922333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25874897|NCT04922333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25874898|NCT04922333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726313|NCT01602822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24726314|NCT01602822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24726315|NCT01602861|Spironolactone|spironolactone|mesh-list
24726316|NCT01602861|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24726317|NCT01602861|Hormone Antagonists|hormone antagonists|mesh-ancestor
24616241|NCT01035281|Autonomic Agents|autonomic agents|mesh-ancestor
24616242|NCT01035281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24616243|NCT01035281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616244|NCT01035281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24616245|NCT01035281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24616246|NCT01035281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24726360|NCT01602913|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24726361|NCT01602913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24726362|NCT01602913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24726363|NCT01602913|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24726364|NCT01602913|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24726365|NCT01602913|Antimetabolites|antimetabolites|mesh-ancestor
24726366|NCT01602913|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24726367|NCT01602913|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24726368|NCT01602939|Cladribine|cladribine|mesh-list
24726369|NCT01602939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24726370|NCT01602939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24726378|NCT01603030|Prednisolone acetate|prednisolone acetate|mesh-list
24450620|NCT00319865|Antiemetics|antiemetics|mesh-ancestor
24726413|NCT01603134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726415|NCT01603134|Gout Suppressants|gout suppressants|mesh-ancestor
24726416|NCT01603134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24726453|NCT01603212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240378|NCT02536352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240379|NCT02536352|Cariostatic Agents|cariostatic agents|mesh-ancestor
25240380|NCT02536352|Protective Agents|protective agents|mesh-ancestor
25240381|NCT02535988|Thymalfasin|thymalfasin|mesh-list
25240382|NCT02535988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25240383|NCT02535988|Immunologic Factors|immunologic factors|mesh-ancestor
25240384|NCT02535988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240385|NCT02535910|Vitamin D|vitamin d|mesh-list
25240386|NCT02535910|Cholecalciferol|cholecalciferol|mesh-list
25240387|NCT02535910|Calcifediol|calcifediol|mesh-list
25240388|NCT02535910|Vitamins|vitamins|mesh-ancestor
25240389|NCT02535910|Micronutrients|micronutrients|mesh-ancestor
25240390|NCT02535910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240391|NCT02535910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25240392|NCT02535910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25240393|NCT02535975|Metformin|metformin|mesh-list
25240394|NCT02535975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25240395|NCT02535975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240397|NCT02536014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25240398|NCT02536014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25240399|NCT02536014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240400|NCT02536014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24850019|NCT02251223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850020|NCT02251223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24850021|NCT02251223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24850022|NCT02251223|Antiviral Agents|antiviral agents|mesh-ancestor
24850023|NCT02251223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24850024|NCT02251223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24726454|NCT01603212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726456|NCT01603251|Lumefantrine|lumefantrine|mesh-list
24726457|NCT01603251|Artemether|artemether|mesh-list
24726488|NCT01603498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24726489|NCT01603498|Glucocorticoids|glucocorticoids|mesh-ancestor
24726491|NCT01603498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24726492|NCT01603498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24726493|NCT01603498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24726494|NCT01603498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24726495|NCT01603498|Protective Agents|protective agents|mesh-ancestor
24726497|NCT01603511|Antidotes|antidotes|mesh-ancestor
24726498|NCT01603511|Protective Agents|protective agents|mesh-ancestor
24726499|NCT01603511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726500|NCT01603654|Ascorbic Acid|ascorbic acid|mesh-list
24726501|NCT01603654|Picosulfate sodium|picosulfate sodium|mesh-list
24726530|NCT01604031|Lenalidomide|lenalidomide|mesh-list
24726531|NCT01604031|Immunologic Factors|immunologic factors|mesh-ancestor
24726532|NCT01604031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726533|NCT01604031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24726534|NCT01604031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24726535|NCT01604031|Growth Substances|growth substances|mesh-ancestor
24726536|NCT01604031|Growth Inhibitors|growth inhibitors|mesh-ancestor
24726537|NCT01604031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24726538|NCT01604057|Teriparatide|teriparatide|mesh-list
24726539|NCT01604057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24401552|NCT00153192|Hormones|hormones|mesh-ancestor
24726541|NCT01604057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25006550|NCT04892420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25006551|NCT04892420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006552|NCT04892420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24726544|NCT01604135|Vitamin B Complex|vitamin b complex|mesh-ancestor
24726545|NCT01604135|Vitamins|vitamins|mesh-ancestor
24726546|NCT01604135|Micronutrients|micronutrients|mesh-ancestor
24726547|NCT01604135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726580|NCT01604330|GABA Agents|gaba agents|mesh-ancestor
24726581|NCT01604330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24726582|NCT01604330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726583|NCT01604382|Remifentanil|remifentanil|mesh-list
24726584|NCT01604382|Bupivacaine|bupivacaine|mesh-list
24726585|NCT01604382|Anesthetics|anesthetics|mesh-list
24726586|NCT01604382|Propofol|propofol|mesh-list
24726587|NCT01604382|Anesthetics, Local|anesthetics, local|mesh-ancestor
24726588|NCT01604382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24726589|NCT01604382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726590|NCT01604382|Sensory System Agents|sensory system agents|mesh-ancestor
24726591|NCT01604382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24726627|NCT01604863|Etoposide|etoposide|mesh-list
24726628|NCT01604863|Docetaxel|docetaxel|mesh-list
24726629|NCT01604863|Carboplatin|carboplatin|mesh-list
24726630|NCT01604863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24726631|NCT01604863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24726632|NCT01604863|Tubulin Modulators|tubulin modulators|mesh-ancestor
24726633|NCT01604863|Antimitotic Agents|antimitotic agents|mesh-ancestor
24726634|NCT01604863|Mitosis Modulators|mitosis modulators|mesh-ancestor
25874899|NCT04922333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24616292|NCT01035593|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
24726669|NCT01605240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24726670|NCT01605240|Analgesics|analgesics|mesh-ancestor
24726671|NCT01605240|Sensory System Agents|sensory system agents|mesh-ancestor
25240401|NCT02536014|Analgesics|analgesics|mesh-ancestor
25240402|NCT02536014|Sensory System Agents|sensory system agents|mesh-ancestor
25240403|NCT02536014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25240404|NCT02536014|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25240405|NCT02536014|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25874900|NCT04922333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874901|NCT04922333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24720118|NCT01566565|Theophylline|theophylline|mesh-list
24897306|NCT04426669|Sensory System Agents|sensory system agents|mesh-ancestor
24897307|NCT04426669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24897308|NCT04426669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24516695|NCT00602849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24516696|NCT00602849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24516697|NCT00602849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24516698|NCT00602849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516699|NCT00602849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24516700|NCT00602849|Serotonin Agents|serotonin agents|mesh-ancestor
25874902|NCT04915755|Niraparib|niraparib|mesh-list
25874903|NCT04915755|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25098985|NCT03194204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25098986|NCT03194204|Antioxidants|antioxidants|mesh-ancestor
25098987|NCT03194204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098988|NCT03194204|Protective Agents|protective agents|mesh-ancestor
25098989|NCT03194204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098990|NCT03194204|Immunologic Factors|immunologic factors|mesh-ancestor
25874904|NCT04915755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761898|NCT01765088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874905|NCT04915755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874906|NCT04915755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874907|NCT04915183|Atorvastatin|atorvastatin|mesh-list
25874908|NCT04915183|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25874909|NCT04915183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24726701|NCT01605279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726702|NCT01605279|Protective Agents|protective agents|mesh-ancestor
24726703|NCT01605318|Irinotecan|irinotecan|mesh-list
24726704|NCT01605318|Labetuzumab|labetuzumab|mesh-list
24726705|NCT01605318|Immunoconjugates|immunoconjugates|mesh-list
24726706|NCT01605318|Immunologic Factors|immunologic factors|mesh-ancestor
24726707|NCT01605318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726708|NCT01605318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24726709|NCT01605318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24726710|NCT01605318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24726742|NCT01605487|Cyproheptadine|cyproheptadine|mesh-list
24726743|NCT01605487|Antipruritics|antipruritics|mesh-ancestor
24726744|NCT01605487|Dermatologic Agents|dermatologic agents|mesh-ancestor
24726745|NCT01605487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24726746|NCT01605487|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24726747|NCT01605487|Histamine Antagonists|histamine antagonists|mesh-ancestor
24726748|NCT01605487|Histamine Agents|histamine agents|mesh-ancestor
24726749|NCT01605487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24726750|NCT01605487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24874316|NCT04830215|Dopamine Agents|dopamine agents|mesh-ancestor
24726793|NCT01605929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25240407|NCT02536014|Adrenergic Agents|adrenergic agents|mesh-ancestor
25240408|NCT02536014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25240409|NCT02536014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240410|NCT02535767|Primaquine|primaquine|mesh-list
25240411|NCT02535767|Antimalarials|antimalarials|mesh-ancestor
25240412|NCT02535767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25240413|NCT02535767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25411859|NCT03224507|Daratumumab|daratumumab|mesh-list
25674001|NCT01767155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25674002|NCT01767155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25674003|NCT01767155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674004|NCT01767155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674005|NCT01767285|Etonogestrel|etonogestrel|mesh-list
25674006|NCT01767285|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25674007|NCT01767285|Contraceptive Agents|contraceptive agents|mesh-ancestor
25674008|NCT01767285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25674009|NCT01767285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674010|NCT01767285|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25674011|NCT01767506|Azithromycin|azithromycin|mesh-list
25674012|NCT01767506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25674013|NCT01767506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25674014|NCT01767519|Solifenacin Succinate|solifenacin succinate|mesh-list
25674015|NCT01767519|Botulinum Toxins|botulinum toxins|mesh-list
25674016|NCT01767519|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25674017|NCT01767519|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25674018|NCT01767519|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25099036|NCT03193944|Vitamin D|vitamin d|mesh-list
25240414|NCT02535767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25240415|NCT02535689|Tofacitinib|tofacitinib|mesh-list
25240416|NCT02535689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25240417|NCT02535689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240418|NCT02535689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761959|NCT01765556|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24761960|NCT01765556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24761961|NCT01765556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761962|NCT01765556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761963|NCT01765556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24761964|NCT01765556|Hormone Antagonists|hormone antagonists|mesh-ancestor
24761965|NCT01765556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24817802|NCT02085655|Autonomic Agents|autonomic agents|mesh-ancestor
25273934|NCT02382094|Hormone Antagonists|hormone antagonists|mesh-ancestor
24727954|NCT01613755|Metformin|metformin|mesh-list
25273935|NCT02382094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25273936|NCT02382094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874910|NCT04915183|Antimetabolites|antimetabolites|mesh-ancestor
25874911|NCT04915183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874912|NCT04915183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25874913|NCT04915183|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25874914|NCT04915183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874915|NCT04910568|Dexamethasone|dexamethasone|mesh-list
25874916|NCT04910568|Daratumumab|daratumumab|mesh-list
25874917|NCT04910568|Pomalidomide|pomalidomide|mesh-list
25874918|NCT04910568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25874919|NCT04910568|Antiemetics|antiemetics|mesh-ancestor
25874920|NCT04910568|Autonomic Agents|autonomic agents|mesh-ancestor
25874921|NCT04910568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24624028|NCT01074411|Bortezomib|bortezomib|mesh-list
25874922|NCT04910568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726828|NCT01606072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726829|NCT01606111|Cerebrolysin|cerebrolysin|mesh-list
24648234|NCT01213238|Bevacizumab|bevacizumab|mesh-list
24726830|NCT01606111|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24726831|NCT01606111|Protective Agents|protective agents|mesh-ancestor
24726832|NCT01606111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726833|NCT01606111|Nootropic Agents|nootropic agents|mesh-ancestor
25874923|NCT04910568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24726868|NCT01606436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24726870|NCT01606462|Oxytocics|oxytocics|mesh-ancestor
24726871|NCT01606462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24726872|NCT01606462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726873|NCT01606527|Ibuprofen|ibuprofen|mesh-list
24726874|NCT01606527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24450626|NCT00319865|Hormones|hormones|mesh-ancestor
24726903|NCT01606722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726904|NCT01606722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24726905|NCT01606722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24726906|NCT01606722|Antiviral Agents|antiviral agents|mesh-ancestor
24726907|NCT01606722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24726908|NCT01606722|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24726909|NCT01606722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24616316|NCT01035853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24616317|NCT01035853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24616319|NCT01035983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24726967|NCT01607086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24726968|NCT01607086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24726969|NCT01607086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24726971|NCT01607125|Antidepressive Agents|antidepressive agents|mesh-ancestor
24726972|NCT01607125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24726973|NCT01607125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24726974|NCT01607125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24726975|NCT01607125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24726976|NCT01607125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726977|NCT01607125|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24726978|NCT01607125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24726979|NCT01607125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25240466|NCT02535273|Adrenergic Agents|adrenergic agents|mesh-ancestor
24726982|NCT01607125|Serotonin Agents|serotonin agents|mesh-ancestor
25411860|NCT03224507|BB 1101|bb 1101|mesh-list
25874924|NCT04910568|Glucocorticoids|glucocorticoids|mesh-ancestor
25874925|NCT04910568|Hormones|hormones|mesh-ancestor
24726983|NCT01607125|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24727013|NCT01607580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24727014|NCT01607580|Hormones|hormones|mesh-ancestor
24727015|NCT01607580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25240430|NCT02535351|Sunitinib|sunitinib|mesh-list
25240431|NCT02535351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25240432|NCT02535351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25240433|NCT02535351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25240434|NCT02535351|Growth Substances|growth substances|mesh-ancestor
25240435|NCT02535351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240436|NCT02535351|Growth Inhibitors|growth inhibitors|mesh-ancestor
25240437|NCT02535351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25240438|NCT02535351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240439|NCT02535351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240440|NCT02535299|Metformin|metformin|mesh-list
25240441|NCT02535299|Liraglutide|liraglutide|mesh-list
25240442|NCT02535299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25240443|NCT02535299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25874926|NCT04910568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25874927|NCT04910568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25874928|NCT04910568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874929|NCT04910568|Immunologic Factors|immunologic factors|mesh-ancestor
24761973|NCT01765608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25874930|NCT04910568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25874931|NCT04910568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25874932|NCT04910568|Growth Substances|growth substances|mesh-ancestor
25068049|NCT03436836|Lidocaine|lidocaine|mesh-list
24727016|NCT01607580|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24727017|NCT01607580|Protective Agents|protective agents|mesh-ancestor
24727018|NCT01607580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24727019|NCT01607580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727020|NCT01607671|Timolol|timolol|mesh-list
24727021|NCT01607671|Maleic acid|maleic acid|mesh-list
24727022|NCT01607671|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24727023|NCT01607671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24727024|NCT01607671|Adrenergic Agents|adrenergic agents|mesh-ancestor
25874933|NCT04910568|Growth Inhibitors|growth inhibitors|mesh-ancestor
25874934|NCT04906395|Tamoxifen|tamoxifen|mesh-list
24402514|NCT00157547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25006553|NCT04892420|Glucocorticoids|glucocorticoids|mesh-ancestor
24727025|NCT01607671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24727026|NCT01607671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727051|NCT01607762|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24727052|NCT01607762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24727053|NCT01607762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24727054|NCT01607762|Antidepressive Agents|antidepressive agents|mesh-ancestor
24727055|NCT01607762|Dopamine Agonists|dopamine agonists|mesh-ancestor
24727056|NCT01607762|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24727057|NCT01607762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24727058|NCT01607762|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24727059|NCT01607762|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24727060|NCT01607879|Androgens|androgens|mesh-list
24727061|NCT01607879|Hormones|hormones|mesh-ancestor
24727062|NCT01607879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24727063|NCT01607879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727064|NCT01607918|Amoxicillin|amoxicillin|mesh-list
24882132|NCT02735707|Losartan|losartan|mesh-list
24727075|NCT01607918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761993|NCT01765790|Antibodies|antibodies|mesh-list
24762004|NCT01765829|Aripiprazole|aripiprazole|mesh-list
24727076|NCT01607918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24402515|NCT00157547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25874935|NCT04906395|Letrozole|letrozole|mesh-list
25874936|NCT04906395|Anastrozole|anastrozole|mesh-list
25874937|NCT04906395|Exemestane|exemestane|mesh-list
25874938|NCT04906395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874939|NCT04906395|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24727796|NCT01612871|Letrozole|letrozole|mesh-list
25874940|NCT04906395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25874941|NCT04906395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874942|NCT04906395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727077|NCT01607918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24727114|NCT01608139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25874943|NCT04906395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25874944|NCT04906395|Hormone Antagonists|hormone antagonists|mesh-ancestor
24727115|NCT01608139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24727116|NCT01608139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727147|NCT01608269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727149|NCT01608269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24727151|NCT01608269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24727153|NCT01608334|Sufentanil|sufentanil|mesh-list
25240444|NCT02535299|Incretins|incretins|mesh-ancestor
25240445|NCT02535299|Hormones|hormones|mesh-ancestor
25240446|NCT02535299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25240447|NCT02535273|Lidocaine|lidocaine|mesh-list
25240448|NCT02535273|Dexmedetomidine|dexmedetomidine|mesh-list
25240449|NCT02535273|Anesthetics, Local|anesthetics, local|mesh-ancestor
25240450|NCT02535273|Anesthetics|anesthetics|mesh-ancestor
25240451|NCT02535273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24727955|NCT01613755|Dipyridamole|dipyridamole|mesh-list
25240452|NCT02535273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240453|NCT02535273|Sensory System Agents|sensory system agents|mesh-ancestor
25240454|NCT02535273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24727159|NCT01608334|Sensory System Agents|sensory system agents|mesh-ancestor
24727188|NCT01608373|Sensory System Agents|sensory system agents|mesh-ancestor
24727189|NCT01608373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24727190|NCT01608373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24727191|NCT01608373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24727192|NCT01608373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24727193|NCT01608373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24727194|NCT01608373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727196|NCT01608412|Tacrolimus|tacrolimus|mesh-list
24762005|NCT01765829|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24762040|NCT01765829|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24762041|NCT01765829|GABA Antagonists|gaba antagonists|mesh-ancestor
24727197|NCT01608412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24727198|NCT01608412|Immunologic Factors|immunologic factors|mesh-ancestor
24727199|NCT01608412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727200|NCT01608412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24727201|NCT01608412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24727202|NCT01608412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727203|NCT01608412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727204|NCT01608464|Cisplatin|cisplatin|mesh-list
24727205|NCT01608464|Docetaxel|docetaxel|mesh-list
24616342|NCT01036399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24616343|NCT01036399|Growth Substances|growth substances|mesh-ancestor
24616344|NCT01036399|Growth Inhibitors|growth inhibitors|mesh-ancestor
24402744|NCT00158405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24616345|NCT01036399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616347|NCT01036412|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24616348|NCT01036412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24616349|NCT01036412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24616383|NCT01036854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616384|NCT01036854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24789611|NCT01938144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789612|NCT01938144|Antipyretics|antipyretics|mesh-ancestor
24789613|NCT01938144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24789614|NCT01938144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24789615|NCT01938144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24789616|NCT01938144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24582014|NCT00867126|Pioglitazone|pioglitazone|mesh-list
25240455|NCT02535273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25240456|NCT02535273|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25240457|NCT02535273|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25240458|NCT02535273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25240459|NCT02535273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240460|NCT02535273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25240461|NCT02535273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25240462|NCT02535273|Analgesics|analgesics|mesh-ancestor
25240463|NCT02535273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25240464|NCT02535273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25240465|NCT02535273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25240471|NCT02535156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25874945|NCT04906395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24444637|NCT00298675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24444638|NCT00298675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25874946|NCT04906395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850048|NCT02251483|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25099590|NCT03189069|Protease Inhibitors|protease inhibitors|mesh-ancestor
24850050|NCT02251483|Immunologic Factors|immunologic factors|mesh-ancestor
24850051|NCT02251483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850052|NCT02251509|Metoprolol|metoprolol|mesh-list
24644469|NCT01191203|Copper|copper|mesh-list
25874947|NCT04906395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25874948|NCT04906395|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24789617|NCT01938144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24582086|NCT00867867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616386|NCT01036854|Dermatologic Agents|dermatologic agents|mesh-ancestor
24616387|NCT01036854|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24616388|NCT01036854|Serotonin Agents|serotonin agents|mesh-ancestor
24616389|NCT01036854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24616390|NCT01036854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616391|NCT01036854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24616392|NCT01036854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25874949|NCT04906395|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24727267|NCT01608750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727268|NCT01608841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24727340|NCT01609166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727341|NCT01609166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762073|NCT01765881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24727342|NCT01609166|Gout Suppressants|gout suppressants|mesh-ancestor
24727343|NCT01609166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24727344|NCT01609166|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24727345|NCT01609166|Antioxidants|antioxidants|mesh-ancestor
24727346|NCT01609166|Protective Agents|protective agents|mesh-ancestor
25874950|NCT04906395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24727364|NCT01609387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727365|NCT01609387|Vitamins|vitamins|mesh-ancestor
24727366|NCT01609387|Micronutrients|micronutrients|mesh-ancestor
24727367|NCT01609413|Calcium Carbonate|calcium carbonate|mesh-list
24727368|NCT01609413|Antacids|antacids|mesh-ancestor
24727369|NCT01609413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727370|NCT01609413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24727371|NCT01609439|Vitamin D|vitamin d|mesh-list
24727372|NCT01609439|Vitamins|vitamins|mesh-ancestor
24727373|NCT01609439|Micronutrients|micronutrients|mesh-ancestor
24727374|NCT01609439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727375|NCT01609439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24727376|NCT01609491|Phenylephrine|phenylephrine|mesh-list
24727377|NCT01609491|Oxymetazoline|oxymetazoline|mesh-list
24727378|NCT01609491|Norepinephrine|norepinephrine|mesh-list
25874951|NCT04895436|Venetoclax|venetoclax|mesh-list
25874952|NCT04895436|Obinutuzumab|obinutuzumab|mesh-list
25874953|NCT04895436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874954|NCT04895436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25874955|NCT04891289|Gemcitabine|gemcitabine|mesh-list
25240472|NCT02535156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240473|NCT02535156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240474|NCT02535156|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25240475|NCT02535156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25240476|NCT02535156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25240477|NCT02535156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25240478|NCT02535156|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25240479|NCT02535156|Dopamine Agents|dopamine agents|mesh-ancestor
25240480|NCT05299203|Verapamil|verapamil|mesh-list
25240481|NCT05299203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25240482|NCT05299203|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25240483|NCT05299203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25240484|NCT05299203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850056|NCT02251509|Sympatholytics|sympatholytics|mesh-ancestor
24403015|NCT00159081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24727379|NCT01609491|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24727380|NCT01609491|Mydriatics|mydriatics|mesh-ancestor
24727381|NCT01609491|Autonomic Agents|autonomic agents|mesh-ancestor
24727382|NCT01609491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24727383|NCT01609491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727384|NCT01609491|Sympathomimetics|sympathomimetics|mesh-ancestor
25006555|NCT04892420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25006556|NCT04892420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25674019|NCT01767519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25006557|NCT04892420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006558|NCT04892420|Anesthetics, Local|anesthetics, local|mesh-ancestor
25006559|NCT04892420|Anesthetics|anesthetics|mesh-ancestor
25006562|NCT04892420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25006563|NCT04892420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25006565|NCT04892420|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25006566|NCT04892420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25006567|NCT04892420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25006568|NCT04892420|Adrenergic Agents|adrenergic agents|mesh-ancestor
25006569|NCT04892420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24727385|NCT01609491|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24727386|NCT01609491|Nasal Decongestants|nasal decongestants|mesh-ancestor
24727387|NCT01609491|Respiratory System Agents|respiratory system agents|mesh-ancestor
24727388|NCT01609491|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25874956|NCT04891289|Dexamethasone|dexamethasone|mesh-list
24727424|NCT01609855|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25240485|NCT05299203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25240486|NCT05299203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240487|NCT05299203|Vasodilator Agents|vasodilator agents|mesh-ancestor
25240488|NCT05299164|Gemcitabine|gemcitabine|mesh-list
25240489|NCT05299164|Rituximab|rituximab|mesh-list
25240490|NCT05299164|Vinorelbine|vinorelbine|mesh-list
25240491|NCT05299164|Mitoxantrone|mitoxantrone|mesh-list
25240492|NCT05299164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25240493|NCT05299164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874957|NCT04891289|Oxaliplatin|oxaliplatin|mesh-list
25240494|NCT05299164|Immunologic Factors|immunologic factors|mesh-ancestor
25240495|NCT05299164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240496|NCT05299164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25240497|NCT05299164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25240498|NCT05299164|Antimetabolites|antimetabolites|mesh-ancestor
25240499|NCT05299164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240500|NCT05299164|Antiviral Agents|antiviral agents|mesh-ancestor
25240501|NCT05299164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24850062|NCT02251509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25874958|NCT04891289|Floxuridine|floxuridine|mesh-list
25874959|NCT04891289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25874960|NCT04891289|Antiemetics|antiemetics|mesh-ancestor
25068100|NCT03436303|Hormones|hormones|mesh-ancestor
24727425|NCT01609855|Anticonvulsants|anticonvulsants|mesh-ancestor
24727426|NCT01609855|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24727427|NCT01609855|Antiemetics|antiemetics|mesh-ancestor
24727428|NCT01609855|Autonomic Agents|autonomic agents|mesh-ancestor
24515308|NCT00596206|Leflunomide|leflunomide|mesh-list
24727461|NCT01609907|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25874961|NCT04891289|Autonomic Agents|autonomic agents|mesh-ancestor
24727462|NCT01609907|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24727463|NCT01609959|Valsartan|valsartan|mesh-list
24727464|NCT01609959|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
24727465|NCT01609959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24727466|NCT01609959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24727467|NCT01609959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24727468|NCT01609959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616420|NCT01037101|Antitubercular Agents|antitubercular agents|mesh-ancestor
24616421|NCT01037101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24616422|NCT01037101|Antimetabolites|antimetabolites|mesh-ancestor
24616423|NCT01037101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616424|NCT01037140|Vitamin D|vitamin d|mesh-list
24616425|NCT01037140|Cholecalciferol|cholecalciferol|mesh-list
24616438|NCT01037335|Analgesics|analgesics|mesh-ancestor
24616439|NCT01037335|Sensory System Agents|sensory system agents|mesh-ancestor
25874962|NCT04891289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24727502|NCT01610778|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24727503|NCT01610778|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24727504|NCT01610778|Dermatologic Agents|dermatologic agents|mesh-ancestor
24727506|NCT01610869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727507|NCT01610869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24727508|NCT01610869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24727549|NCT01610947|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24727550|NCT01610999|Plerixafor|plerixafor|mesh-list
24727551|NCT01610999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24727552|NCT01610999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24727553|NCT01610999|Antiviral Agents|antiviral agents|mesh-ancestor
24727554|NCT01610999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24727555|NCT01611038|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
25240502|NCT05299164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240503|NCT05299164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25240504|NCT05299164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25874963|NCT04891289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099778|NCT03187457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25099779|NCT03187457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25099780|NCT03187457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25099781|NCT03187457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25099782|NCT03187093|Vortioxetine|vortioxetine|mesh-list
25099783|NCT03187093|Citalopram|citalopram|mesh-list
25099784|NCT03187093|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25099785|NCT03187093|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25240505|NCT05299164|Tubulin Modulators|tubulin modulators|mesh-ancestor
25240506|NCT05299164|Antimitotic Agents|antimitotic agents|mesh-ancestor
25240507|NCT05299164|Mitosis Modulators|mitosis modulators|mesh-ancestor
25240508|NCT05299164|Analgesics|analgesics|mesh-ancestor
25240509|NCT05299164|Sensory System Agents|sensory system agents|mesh-ancestor
25240510|NCT05299164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25240511|NCT05299164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25240512|NCT05299164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25874964|NCT04891289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25874965|NCT04891289|Glucocorticoids|glucocorticoids|mesh-ancestor
25874966|NCT04891289|Hormones|hormones|mesh-ancestor
25874967|NCT04891289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25874968|NCT04891289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24727556|NCT01611038|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24727557|NCT01611038|Protective Agents|protective agents|mesh-ancestor
24727558|NCT01611038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727559|NCT01611038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727561|NCT01611077|Candesartan|candesartan|mesh-list
24727594|NCT01611324|Mydriatics|mydriatics|mesh-ancestor
24727595|NCT01611324|Sympathomimetics|sympathomimetics|mesh-ancestor
24727596|NCT01611324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24727597|NCT01611324|Anesthetics, Local|anesthetics, local|mesh-ancestor
24727598|NCT01611324|Anesthetics|anesthetics|mesh-ancestor
24727599|NCT01611324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24727600|NCT01611324|Sensory System Agents|sensory system agents|mesh-ancestor
24727601|NCT01611363|Ipragliflozin|ipragliflozin|mesh-list
24727667|NCT01612065|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24727668|NCT01612065|Abortifacient Agents|abortifacient agents|mesh-ancestor
24762286|NCT01767428|Analgesics|analgesics|mesh-ancestor
25874969|NCT04891289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727669|NCT01612065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24727670|NCT01612065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727671|NCT01612065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24727672|NCT01612065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24727673|NCT01612065|Oxytocics|oxytocics|mesh-ancestor
24727674|NCT01612078|Droxidopa|droxidopa|mesh-list
24727675|NCT01612078|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24727677|NCT01612247|Aspirin|aspirin|mesh-list
24727678|NCT01612247|Cyclophosphamide|cyclophosphamide|mesh-list
24727679|NCT01612247|Methotrexate|methotrexate|mesh-list
24727680|NCT01612247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24727712|NCT01612273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24727714|NCT01612273|Sensory System Agents|sensory system agents|mesh-ancestor
24727715|NCT01612273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24727762|NCT01612468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24727764|NCT01612507|Cephalosporins|cephalosporins|mesh-list
24616469|NCT01037491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24616470|NCT01037491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24616471|NCT01037491|Analgesics|analgesics|mesh-ancestor
24727803|NCT01612871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727805|NCT01612871|Hormone Antagonists|hormone antagonists|mesh-ancestor
24727806|NCT01612871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24762346|NCT01767714|Lenograstim|lenograstim|mesh-list
24479678|NCT00428025|Diclofenac|diclofenac|mesh-list
24492791|NCT00487994|Atorvastatin|atorvastatin|mesh-list
25674020|NCT01767519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674021|NCT01767519|Cholinergic Agents|cholinergic agents|mesh-ancestor
25674022|NCT01767519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25674023|NCT01767519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674024|NCT01767519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25674025|NCT01767519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25674026|NCT01767519|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25674027|NCT01767519|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24850091|NCT02251769|Ritonavir|ritonavir|mesh-list
25674028|NCT01767519|Urological Agents|urological agents|mesh-ancestor
25674029|NCT01767701|Raltegravir Potassium|raltegravir potassium|mesh-list
25674030|NCT01767701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25674031|NCT01767701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25099887|NCT03186755|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25099888|NCT03186755|Hyaluronic Acid|hyaluronic acid|mesh-list
25099889|NCT03186755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25099890|NCT03186755|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24850092|NCT02251769|Tipranavir|tipranavir|mesh-list
24850093|NCT02251769|Clarithromycin|clarithromycin|mesh-list
24850094|NCT02251769|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24850095|NCT02251769|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25874970|NCT04891289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25874971|NCT04891289|Antimetabolites|antimetabolites|mesh-ancestor
25874972|NCT04891289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874973|NCT04891289|Antiviral Agents|antiviral agents|mesh-ancestor
25874974|NCT04891289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25874975|NCT04891289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874976|NCT04891289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25874977|NCT04891289|Immunologic Factors|immunologic factors|mesh-ancestor
25874978|NCT04890093|Vincristine|vincristine|mesh-list
25874979|NCT04890093|Temozolomide|temozolomide|mesh-list
24727807|NCT01612871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727808|NCT01612871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24727809|NCT01612871|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25874980|NCT04890093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24727843|NCT01613040|Contraceptive Agents|contraceptive agents|mesh-ancestor
24727844|NCT01613040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24404000|NCT00162383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874981|NCT04890093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874982|NCT04890093|Tubulin Modulators|tubulin modulators|mesh-ancestor
25874983|NCT04890093|Antimitotic Agents|antimitotic agents|mesh-ancestor
24727956|NCT01613755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25240541|NCT05298761|Narcotics|narcotics|mesh-ancestor
25240542|NCT05298761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25240543|NCT05298761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240544|NCT05298761|Analgesics|analgesics|mesh-ancestor
25240545|NCT05298761|Sensory System Agents|sensory system agents|mesh-ancestor
25240546|NCT05298761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25240547|NCT05298761|Anesthetics, Local|anesthetics, local|mesh-ancestor
25240548|NCT05298761|Anesthetics|anesthetics|mesh-ancestor
25240549|NCT05298761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25240550|NCT05298761|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25240551|NCT05298761|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25240552|NCT05298761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25240553|NCT05298761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240554|NCT05298683|Acetaminophen|acetaminophen|mesh-list
25240555|NCT05298683|Diphenhydramine|diphenhydramine|mesh-list
25240556|NCT05298683|Promethazine|promethazine|mesh-list
25240557|NCT05298683|Dexamethasone|dexamethasone|mesh-list
25240558|NCT05298683|Pomalidomide|pomalidomide|mesh-list
25240559|NCT05298683|Ranitidine|ranitidine|mesh-list
24492859|NCT00488384|Acitretin|acitretin|mesh-list
24850111|NCT02251795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25874984|NCT04890093|Mitosis Modulators|mitosis modulators|mesh-ancestor
25874985|NCT04890093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874986|NCT04890093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25874987|NCT04890093|Alkylating Agents|alkylating agents|mesh-ancestor
25874988|NCT04887805|Pembrolizumab|pembrolizumab|mesh-list
25874989|NCT04887805|Lenvatinib|lenvatinib|mesh-list
25874990|NCT04887805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25874991|NCT04887805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25874992|NCT04887805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24404145|NCT00162643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24727845|NCT01613040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727877|NCT01613092|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24727878|NCT01613092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25109765|NCT03122002|Purinergic Agents|purinergic agents|mesh-ancestor
24727879|NCT01613092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674032|NCT01767701|Antiviral Agents|antiviral agents|mesh-ancestor
25674033|NCT01767701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25674034|NCT01767701|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25674035|NCT01767701|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25674036|NCT01767701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674037|NCT01767701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674038|NCT01767792|Bevacizumab|bevacizumab|mesh-list
25674039|NCT01767792|Endothelial Growth Factors|endothelial growth factors|mesh-list
25674040|NCT01767792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25674041|NCT01767792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727880|NCT01613092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24727882|NCT01613105|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24727883|NCT01613105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24727884|NCT01613105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727885|NCT01613105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24727886|NCT01613105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727887|NCT01613170|Estrogens|estrogens|mesh-list
24727921|NCT01613482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727922|NCT01613495|Octreotide|octreotide|mesh-list
24727923|NCT01613495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24727924|NCT01613495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24727925|NCT01613495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727926|NCT01613534|Sucralfate|sucralfate|mesh-list
24727927|NCT01613534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24727928|NCT01613534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24727929|NCT01613547|Amoxicillin|amoxicillin|mesh-list
24727930|NCT01613547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24727952|NCT01613729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24727953|NCT01613729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24727957|NCT01613755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727958|NCT01613755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24727959|NCT01613755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24727960|NCT01613755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727961|NCT01613755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25240560|NCT05298683|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
25240561|NCT05298683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25240562|NCT05298683|Antiemetics|antiemetics|mesh-ancestor
25240563|NCT05298683|Autonomic Agents|autonomic agents|mesh-ancestor
25240564|NCT05298683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25240565|NCT05298683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240566|NCT05298683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25240567|NCT05298683|Glucocorticoids|glucocorticoids|mesh-ancestor
25240568|NCT05298683|Hormones|hormones|mesh-ancestor
25240569|NCT05298683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25240570|NCT05298683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24850117|NCT02251795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24850118|NCT02251795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24850119|NCT02251795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25874993|NCT04887805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25874994|NCT04887805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25874995|NCT04854499|Cisplatin|cisplatin|mesh-list
25874996|NCT04854499|Carboplatin|carboplatin|mesh-list
24727962|NCT01613755|Vasodilator Agents|vasodilator agents|mesh-ancestor
24727963|NCT01613794|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25874997|NCT04854499|Docetaxel|docetaxel|mesh-list
24727964|NCT01613794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24727966|NCT01613794|Antimetabolites|antimetabolites|mesh-ancestor
24727974|NCT01613807|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
24727976|NCT01613807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24727977|NCT01613807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727978|NCT01613820|Scopolamine|scopolamine|mesh-list
24727980|NCT01613820|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25874998|NCT04854499|Pembrolizumab|pembrolizumab|mesh-list
24728001|NCT01613820|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24728002|NCT01613820|Parasympatholytics|parasympatholytics|mesh-ancestor
24728003|NCT01613846|Sorafenib|sorafenib|mesh-list
24728004|NCT01613846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24728005|NCT01613846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24728006|NCT01613846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762439|NCT01768299|Oxytocics|oxytocics|mesh-ancestor
24728007|NCT01613846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728008|NCT01613924|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24728009|NCT01613924|Dermatologic Agents|dermatologic agents|mesh-ancestor
24728010|NCT01613963|Cyclosporine|cyclosporine|mesh-list
24728011|NCT01613963|Mycophenolic Acid|mycophenolic acid|mesh-list
25874999|NCT04854499|Magrolimab|magrolimab|mesh-list
25875000|NCT04854499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875001|NCT04854499|Tubulin Modulators|tubulin modulators|mesh-ancestor
25875002|NCT04854499|Antimitotic Agents|antimitotic agents|mesh-ancestor
25875003|NCT04854499|Mitosis Modulators|mitosis modulators|mesh-ancestor
25875004|NCT04854499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875005|NCT04854499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25875006|NCT04844606|Mirikizumab|mirikizumab|mesh-list
25875007|NCT04844606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25875008|NCT04844606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25875009|NCT04844606|Analgesics|analgesics|mesh-ancestor
25875010|NCT04844606|Sensory System Agents|sensory system agents|mesh-ancestor
25875011|NCT04844606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25875012|NCT04844606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240571|NCT05298683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25240572|NCT05298683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25240573|NCT05298683|Analgesics|analgesics|mesh-ancestor
25240574|NCT05298683|Sensory System Agents|sensory system agents|mesh-ancestor
25240575|NCT05298683|Antipyretics|antipyretics|mesh-ancestor
25240578|NCT05298683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25240580|NCT05298683|Growth Inhibitors|growth inhibitors|mesh-ancestor
25240581|NCT05298683|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25240582|NCT05298683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25240583|NCT05298683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25240584|NCT05298683|Anesthetics, Local|anesthetics, local|mesh-ancestor
25240585|NCT05298683|Anesthetics|anesthetics|mesh-ancestor
25240586|NCT05298683|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25240587|NCT05298683|Histamine Antagonists|histamine antagonists|mesh-ancestor
24762495|NCT01768377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24762521|NCT01768455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24762522|NCT01768455|Immunologic Factors|immunologic factors|mesh-ancestor
24762523|NCT01768481|Atorvastatin|atorvastatin|mesh-list
24762524|NCT01768481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25240588|NCT05298683|Histamine Agents|histamine agents|mesh-ancestor
25240589|NCT05298683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24728014|NCT01613963|Etanercept|etanercept|mesh-list
24728015|NCT01613963|Methotrexate|methotrexate|mesh-list
24728016|NCT01613963|Azathioprine|azathioprine|mesh-list
24728017|NCT01613963|Infliximab|infliximab|mesh-list
24728018|NCT01613963|Cyclosporins|cyclosporins|mesh-list
24728019|NCT01613963|Immunosuppressive Agents|immunosuppressive agents|mesh-list
24728020|NCT01613963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24728021|NCT01613963|Immunologic Factors|immunologic factors|mesh-ancestor
24728022|NCT01613963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728023|NCT01613963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24728024|NCT01613963|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24728025|NCT01613963|Abortifacient Agents|abortifacient agents|mesh-ancestor
24728026|NCT01613963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24728027|NCT01613963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24728028|NCT01613963|Antimetabolites|antimetabolites|mesh-ancestor
24728029|NCT01613963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728030|NCT01613963|Dermatologic Agents|dermatologic agents|mesh-ancestor
24728031|NCT01613963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728032|NCT01613963|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24728033|NCT01613963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24728034|NCT01613963|Antifungal Agents|antifungal agents|mesh-ancestor
25875013|NCT04844606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24728167|NCT01614405|Tenofovir|tenofovir|mesh-list
24728178|NCT01614405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25875014|NCT04844606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24728211|NCT01614938|Antimitotic Agents|antimitotic agents|mesh-ancestor
24728212|NCT01614938|Mitosis Modulators|mitosis modulators|mesh-ancestor
24728213|NCT01614938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728214|NCT01614938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24728215|NCT01614964|Lumefantrine|lumefantrine|mesh-list
24728216|NCT01614964|Artemether|artemether|mesh-list
24728217|NCT01614964|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24728218|NCT01614964|Antimalarials|antimalarials|mesh-ancestor
24728219|NCT01614964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24728220|NCT01614964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24728221|NCT01614964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24728222|NCT01615016|Pulmonary Surfactants|pulmonary surfactants|mesh-list
24728254|NCT01615185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24728255|NCT01615185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24762568|NCT01768663|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25875015|NCT04844606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25875016|NCT04844606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24728256|NCT01615185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24728257|NCT01615185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728258|NCT01615185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24728259|NCT01615185|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24728260|NCT01615185|Dopamine Agents|dopamine agents|mesh-ancestor
24728298|NCT01615354|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24728299|NCT01615354|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
24728300|NCT01615354|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24728328|NCT01615601|Ritonavir|ritonavir|mesh-list
24728329|NCT01615601|Darunavir|darunavir|mesh-list
24728330|NCT01615601|Etravirine|etravirine|mesh-list
24728331|NCT01615601|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24728429|NCT01616069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728335|NCT01615601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728336|NCT01615601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728337|NCT01615601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25240590|NCT05298683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240591|NCT05298683|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25240592|NCT05298683|Antipruritics|antipruritics|mesh-ancestor
25240593|NCT05298683|Dermatologic Agents|dermatologic agents|mesh-ancestor
25875017|NCT04835506|Infliximab|infliximab|mesh-list
24620159|NCT01055743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24620160|NCT01055743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24620161|NCT01055743|Immunologic Factors|immunologic factors|mesh-ancestor
24620162|NCT01055743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620164|NCT01055756|Pseudoephedrine|pseudoephedrine|mesh-list
24620165|NCT01055756|Ephedrine|ephedrine|mesh-list
24620166|NCT01055756|Antipruritics|antipruritics|mesh-ancestor
24620167|NCT01055756|Dermatologic Agents|dermatologic agents|mesh-ancestor
24620168|NCT01055756|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25875018|NCT04835506|Dermatologic Agents|dermatologic agents|mesh-ancestor
24479879|NCT00428727|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25240594|NCT05298683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25240596|NCT05298462|Antibodies|antibodies|mesh-list
25240597|NCT05298462|Immunologic Factors|immunologic factors|mesh-ancestor
25240598|NCT05298462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728338|NCT01615601|Antiviral Agents|antiviral agents|mesh-ancestor
24728339|NCT01615601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24728340|NCT01615601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24728341|NCT01615601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24728342|NCT01615601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24728343|NCT01615601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24728344|NCT01615614|Rilpivirine|rilpivirine|mesh-list
24728345|NCT01615614|Rifabutin|rifabutin|mesh-list
24728346|NCT01615614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24728347|NCT01615614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24728348|NCT01615614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728389|NCT01615913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24728390|NCT01615913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728742|NCT01617824|Protease Inhibitors|protease inhibitors|mesh-ancestor
24728428|NCT01616069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25875019|NCT04835506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25875020|NCT04835506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25875021|NCT04832854|Gemcitabine|gemcitabine|mesh-list
25875022|NCT04832854|Paclitaxel|paclitaxel|mesh-list
24728430|NCT01616069|Protective Agents|protective agents|mesh-ancestor
24728431|NCT01616108|Bupivacaine|bupivacaine|mesh-list
24728432|NCT01616108|Anesthetics, Local|anesthetics, local|mesh-ancestor
24728433|NCT01616108|Anesthetics|anesthetics|mesh-ancestor
24728434|NCT01616108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24728435|NCT01616108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728436|NCT01616108|Sensory System Agents|sensory system agents|mesh-ancestor
24728437|NCT01616108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24728466|NCT01616407|Methylphenidate|methylphenidate|mesh-list
24728467|NCT01616407|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
24728468|NCT01616407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24728469|NCT01616407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240599|NCT05298449|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25240600|NCT05298449|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25240601|NCT05298449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25240602|NCT05298449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25240603|NCT05298449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728470|NCT01616407|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24728580|NCT01617135|Immunologic Factors|immunologic factors|mesh-ancestor
24728615|NCT01617226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24728617|NCT01617226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728618|NCT01617226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24728619|NCT01617226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728620|NCT01617226|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24728621|NCT01617317|Immunoglobulins|immunoglobulins|mesh-list
24728638|NCT01617356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24728639|NCT01617356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728641|NCT01617538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25875023|NCT04832854|Cisplatin|cisplatin|mesh-list
24613767|NCT01020708|Sensory System Agents|sensory system agents|mesh-ancestor
24613768|NCT01020708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24613769|NCT01020708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24516780|NCT00603343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516781|NCT00603343|Urological Agents|urological agents|mesh-ancestor
24516782|NCT00603356|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24516783|NCT00603356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24728642|NCT01617538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24728643|NCT01617538|Antimetabolites|antimetabolites|mesh-ancestor
24728644|NCT01617538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728645|NCT01617538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24728646|NCT01617538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24728647|NCT01617538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728648|NCT01617551|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
24728649|NCT01617551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728651|NCT01617564|Bupivacaine|bupivacaine|mesh-list
24728740|NCT01617824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24728741|NCT01617824|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24762689|NCT01769118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24762690|NCT01769118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728743|NCT01617824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728744|NCT01617824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728746|NCT01617928|Carboplatin|carboplatin|mesh-list
24728748|NCT01617928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24728749|NCT01617928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24728750|NCT01617928|Tubulin Modulators|tubulin modulators|mesh-ancestor
24728751|NCT01617928|Antimitotic Agents|antimitotic agents|mesh-ancestor
24728782|NCT01618188|Insulin Aspart|insulin aspart|mesh-list
24728783|NCT01618188|Insulin, Long-Acting|insulin, long-acting|mesh-list
24728784|NCT01618188|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24728785|NCT01618188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24728786|NCT01618188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728787|NCT01618253|Sorafenib|sorafenib|mesh-list
24728788|NCT01618253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24728789|NCT01618253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24728790|NCT01618253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728791|NCT01618253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728792|NCT01618370|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
24728793|NCT01618370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24728818|NCT01618474|Tubulin Modulators|tubulin modulators|mesh-ancestor
24728819|NCT01618474|Antimitotic Agents|antimitotic agents|mesh-ancestor
24728838|NCT01618591|Rifaximin|rifaximin|mesh-list
24728839|NCT01618591|Loperamide|loperamide|mesh-list
24728840|NCT01618591|Antidiarrheals|antidiarrheals|mesh-list
24728841|NCT01618591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24728842|NCT01618591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24728843|NCT01618591|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24728844|NCT01618591|Renal Agents|renal agents|mesh-ancestor
24728845|NCT01618591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25109767|NCT03122041|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24621607|NCT01063192|Fluorouracil|fluorouracil|mesh-list
24621608|NCT01063192|Oxaliplatin|oxaliplatin|mesh-list
24621609|NCT01063192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25006570|NCT04892420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006571|NCT04892420|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25006572|NCT04892420|Anticonvulsants|anticonvulsants|mesh-ancestor
25006573|NCT04892420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25006574|NCT04892420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25006575|NCT04892420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25006576|NCT04892420|Tocolytic Agents|tocolytic agents|mesh-ancestor
25006577|NCT04892420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25240604|NCT05298449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25240605|NCT05298449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25875024|NCT04832854|Carboplatin|carboplatin|mesh-list
25875025|NCT04832854|Pemetrexed|pemetrexed|mesh-list
25674042|NCT01767792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25674043|NCT01767792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25674044|NCT01767792|Growth Substances|growth substances|mesh-ancestor
25674045|NCT01767792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674046|NCT01767792|Growth Inhibitors|growth inhibitors|mesh-ancestor
25674047|NCT01767909|Insulin|insulin|mesh-list
25674048|NCT01767909|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25674049|NCT01767909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25674050|NCT01767909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100830|NCT03179839|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24426921|NCT00236821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24426922|NCT00236834|Levofloxacin|levofloxacin|mesh-list
25100832|NCT03179813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25100833|NCT03179735|Cetylpyridinium|cetylpyridinium|mesh-list
24628230|NCT01097382|GABA Agonists|gaba agonists|mesh-ancestor
25875026|NCT04832854|Atezolizumab|atezolizumab|mesh-list
25006578|NCT04876677|Beclomethasone|beclomethasone|mesh-list
25006579|NCT04876677|Glycopyrrolate|glycopyrrolate|mesh-list
25006580|NCT04876677|Formoterol Fumarate|formoterol fumarate|mesh-list
25006581|NCT04876677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25006582|NCT04876677|Autonomic Agents|autonomic agents|mesh-ancestor
25006583|NCT04876677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25006584|NCT04876677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006585|NCT04876677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25006586|NCT04876677|Respiratory System Agents|respiratory system agents|mesh-ancestor
25006587|NCT04876677|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25006588|NCT04876677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25006593|NCT04876677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25006594|NCT04876677|Glucocorticoids|glucocorticoids|mesh-ancestor
25006596|NCT04876677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25006597|NCT04876677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25006598|NCT04876677|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25006599|NCT04876677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25006600|NCT04876677|Cholinergic Agents|cholinergic agents|mesh-ancestor
25006601|NCT04874194|Venetoclax|venetoclax|mesh-list
25006602|NCT04874194|Homoharringtonine|homoharringtonine|mesh-list
25006603|NCT04874194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006604|NCT04874194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25006605|NCT04874194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25006606|NCT04874194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25006607|NCT04874194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006608|NCT04845919|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25006609|NCT04845919|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25006621|NCT04843579|Hormones|hormones|mesh-ancestor
25006631|NCT04843579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25006632|NCT04843579|Immunologic Factors|immunologic factors|mesh-ancestor
25006633|NCT04843579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25006634|NCT04843579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25240606|NCT05298449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240607|NCT05298449|Cholinergic Agents|cholinergic agents|mesh-ancestor
25240608|NCT05298449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25240609|NCT05298202|Capsaicin|capsaicin|mesh-list
25240610|NCT05298202|Antipruritics|antipruritics|mesh-ancestor
25240611|NCT05298202|Dermatologic Agents|dermatologic agents|mesh-ancestor
25240612|NCT05298202|Sensory System Agents|sensory system agents|mesh-ancestor
25240613|NCT05298202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25240614|NCT05298202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240615|NCT05298176|Carboplatin|carboplatin|mesh-list
25240616|NCT05298176|Pemetrexed|pemetrexed|mesh-list
25240617|NCT05298176|Afatinib|afatinib|mesh-list
25240618|NCT05298176|Osimertinib|osimertinib|mesh-list
25240619|NCT05298176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25240620|NCT05298176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240621|NCT05298176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875027|NCT04832854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25875028|NCT04832854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875029|NCT04832854|Tubulin Modulators|tubulin modulators|mesh-ancestor
25875030|NCT04832854|Antimitotic Agents|antimitotic agents|mesh-ancestor
25875031|NCT04832854|Mitosis Modulators|mitosis modulators|mesh-ancestor
25875032|NCT04832854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875033|NCT04832854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24922937|NCT04174339|Apatinib|apatinib|mesh-list
25006635|NCT04843579|Growth Substances|growth substances|mesh-ancestor
24621610|NCT01063192|Antimetabolites|antimetabolites|mesh-ancestor
25006636|NCT04843579|Growth Inhibitors|growth inhibitors|mesh-ancestor
25006637|NCT04821375|Bazedoxifene|bazedoxifene|mesh-list
25674051|NCT01767987|Ranolazine|ranolazine|mesh-list
25674052|NCT01767987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25674053|NCT01767987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25674054|NCT01767987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674055|NCT01768286|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25674056|NCT01768286|Ledipasvir|ledipasvir|mesh-list
25674057|NCT01768286|Antiviral Agents|antiviral agents|mesh-ancestor
25100861|NCT03179280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25100863|NCT03178994|Ketoconazole|ketoconazole|mesh-list
24728846|NCT01618591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24728847|NCT01618591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616564|NCT01038037|Antimitotic Agents|antimitotic agents|mesh-ancestor
24616565|NCT01038037|Mitosis Modulators|mitosis modulators|mesh-ancestor
24616566|NCT01038037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616567|NCT01038037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24616570|NCT01038063|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24616571|NCT01038063|Antimalarials|antimalarials|mesh-ancestor
24616572|NCT01038063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24616573|NCT01038063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24616574|NCT01038063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24616575|NCT01038089|Resveratrol|resveratrol|mesh-list
24616576|NCT01038089|Antioxidants|antioxidants|mesh-ancestor
24616577|NCT01038089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616578|NCT01038089|Protective Agents|protective agents|mesh-ancestor
24616579|NCT01038089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616580|NCT01038089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407110|NCT00171886|Octreotide|octreotide|mesh-list
25875034|NCT04832854|Antimetabolites|antimetabolites|mesh-ancestor
25079916|NCT03344042|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25079917|NCT03344042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25079918|NCT03344042|Anesthetics, General|anesthetics, general|mesh-ancestor
25079920|NCT03344029|Vaccines|vaccines|mesh-list
25079921|NCT03344029|Immunologic Factors|immunologic factors|mesh-ancestor
25079923|NCT03344003|Factor VIII|factor viii|mesh-list
25875035|NCT04832854|Antiviral Agents|antiviral agents|mesh-ancestor
24616605|NCT01038349|Abortifacient Agents|abortifacient agents|mesh-ancestor
24616606|NCT01038349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24616607|NCT01038349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616608|NCT01038349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24616609|NCT01038349|Antimetabolites|antimetabolites|mesh-ancestor
24616610|NCT01038349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616611|NCT01038349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616612|NCT01038349|Dermatologic Agents|dermatologic agents|mesh-ancestor
24616613|NCT01038349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616614|NCT01038349|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24616615|NCT01038349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24728867|NCT01618760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240622|NCT05298176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25240623|NCT05298176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25240624|NCT05298176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25240625|NCT05298163|Calcitriol|calcitriol|mesh-list
25240626|NCT05298163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25240627|NCT05298163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240628|NCT05298163|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25240629|NCT05298163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25240630|NCT05298163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240631|NCT05298163|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25240632|NCT05298163|Vitamins|vitamins|mesh-ancestor
25240633|NCT05298163|Micronutrients|micronutrients|mesh-ancestor
25240649|NCT05298020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240634|NCT05298163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25875036|NCT04832854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25875037|NCT04832854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762889|NCT01770080|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24762890|NCT01770080|Antiemetics|antiemetics|mesh-ancestor
24762891|NCT01770080|Autonomic Agents|autonomic agents|mesh-ancestor
24762892|NCT01770080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24762893|NCT01770080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875038|NCT04832854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25875039|NCT04832854|Immunologic Factors|immunologic factors|mesh-ancestor
25875040|NCT04832854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875041|NCT04832854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24850228|NCT02252367|Vasodilator Agents|vasodilator agents|mesh-ancestor
24850229|NCT02252367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25130511|NCT03033316|Dexamethasone|dexamethasone|mesh-list
24850230|NCT02252367|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24728868|NCT01618760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728898|NCT01618825|Lamotrigine|lamotrigine|mesh-list
24728899|NCT01618825|Anticonvulsants|anticonvulsants|mesh-list
25411861|NCT03224507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25674058|NCT01768286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25674059|NCT01768520|Celecoxib|celecoxib|mesh-list
25674060|NCT01768520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25101003|NCT03178526|Lovastatin|lovastatin|mesh-list
24728900|NCT01618825|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24728901|NCT01618825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24728902|NCT01618825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728903|NCT01618825|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24728904|NCT01618825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728905|NCT01618825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24728906|NCT01618825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24728907|NCT01618825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25875042|NCT04832854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24728908|NCT01618825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24728909|NCT01618825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24728910|NCT01618877|Levetiracetam|levetiracetam|mesh-list
24728911|NCT01618877|Anticonvulsants|anticonvulsants|mesh-ancestor
24728912|NCT01618877|Nootropic Agents|nootropic agents|mesh-ancestor
24728947|NCT01619072|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24517011|NCT00605410|Ipratropium|ipratropium|mesh-list
24728948|NCT01619072|Abortifacient Agents|abortifacient agents|mesh-ancestor
24728949|NCT01619072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24762963|NCT01770301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762970|NCT01770444|Cytarabine|cytarabine|mesh-list
24728950|NCT01619072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728975|NCT01619150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24728976|NCT01619150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728978|NCT01619163|Prednisolone|prednisolone|mesh-list
24728979|NCT01619163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24728980|NCT01619163|Glucocorticoids|glucocorticoids|mesh-ancestor
24728982|NCT01619163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24728983|NCT01619163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728984|NCT01619163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24728985|NCT01619163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006638|NCT04821375|Estrogens|estrogens|mesh-list
24728986|NCT01619176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
24728987|NCT01619176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24728988|NCT01619176|Methotrexate|methotrexate|mesh-list
24728989|NCT01619176|Leflunomide|leflunomide|mesh-list
24728990|NCT01619176|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24729069|NCT01619683|Clomiphene|clomiphene|mesh-list
24729070|NCT01619683|Zuclomiphene|zuclomiphene|mesh-list
24729071|NCT01619683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24729072|NCT01619683|Hormone Antagonists|hormone antagonists|mesh-ancestor
25240635|NCT05298020|Gemcitabine|gemcitabine|mesh-list
25240636|NCT05298020|Paclitaxel|paclitaxel|mesh-list
25240637|NCT05298020|Endostar protein|endostar protein|mesh-list
25240638|NCT05298020|Endostatins|endostatins|mesh-list
25240639|NCT05298020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25240640|NCT05298020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25240641|NCT05298020|Tubulin Modulators|tubulin modulators|mesh-ancestor
25240642|NCT05298020|Antimitotic Agents|antimitotic agents|mesh-ancestor
25240643|NCT05298020|Mitosis Modulators|mitosis modulators|mesh-ancestor
25240644|NCT05298020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240645|NCT05298020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25240646|NCT05298020|Antimetabolites|antimetabolites|mesh-ancestor
25240647|NCT05298020|Antiviral Agents|antiviral agents|mesh-ancestor
25240648|NCT05298020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24850231|NCT02252367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850232|NCT02252367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850233|NCT02252367|Urological Agents|urological agents|mesh-ancestor
25875043|NCT04775953|Vancomycin|vancomycin|mesh-list
25875044|NCT04775953|Cefazolin|cefazolin|mesh-list
24729073|NCT01619683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24729074|NCT01619683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729075|NCT01619683|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24729076|NCT01619683|Fertility Agents|fertility agents|mesh-ancestor
24729077|NCT01619683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24729078|NCT01619683|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24729080|NCT01619761|Mycophenolic Acid|mycophenolic acid|mesh-list
24729118|NCT01619813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24729119|NCT01619813|Tubulin Modulators|tubulin modulators|mesh-ancestor
24729120|NCT01619813|Antimitotic Agents|antimitotic agents|mesh-ancestor
24729121|NCT01619813|Mitosis Modulators|mitosis modulators|mesh-ancestor
24729122|NCT01619813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729123|NCT01619813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25674061|NCT01768520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25674062|NCT01768520|Analgesics|analgesics|mesh-ancestor
24729124|NCT01619813|Glucocorticoids|glucocorticoids|mesh-ancestor
24729175|NCT01620307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24729177|NCT01620307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24729178|NCT01620307|Immunologic Factors|immunologic factors|mesh-ancestor
24729179|NCT01620307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729226|NCT01620476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729227|NCT01620476|Incretins|incretins|mesh-ancestor
24729228|NCT01620476|Hormones|hormones|mesh-ancestor
24729229|NCT01620476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24729230|NCT01620684|Metyrapone|metyrapone|mesh-list
25875045|NCT04775953|Daptomycin|daptomycin|mesh-list
24729261|NCT01620814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729263|NCT01620814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24729264|NCT01620814|Oxytocics|oxytocics|mesh-ancestor
24729265|NCT01620840|Lacosamide|lacosamide|mesh-list
24729266|NCT01620840|Anticonvulsants|anticonvulsants|mesh-ancestor
24729267|NCT01620840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24729268|NCT01620840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24729269|NCT01620840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24729270|NCT01620840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729271|NCT01620944|Ritonavir|ritonavir|mesh-list
24729272|NCT01620944|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24729273|NCT01620944|Tenofovir|tenofovir|mesh-list
24729364|NCT01621308|Insulin|insulin|mesh-list
24407693|NCT00175032|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24517499|NCT00608231|Analgesics|analgesics|mesh-ancestor
24729376|NCT01621321|Antifungal Agents|antifungal agents|mesh-ancestor
24729377|NCT01621321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24729378|NCT01621321|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24729379|NCT01621321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24729380|NCT01621321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729381|NCT01621321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729382|NCT01621321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24729383|NCT01621321|Hormone Antagonists|hormone antagonists|mesh-ancestor
24729384|NCT01621321|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24729386|NCT01621373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24729387|NCT01621373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24729388|NCT01621373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240651|NCT05298020|Immunologic Factors|immunologic factors|mesh-ancestor
25240652|NCT05298020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240653|NCT05298020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25240654|NCT05298020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25240655|NCT05298020|Growth Substances|growth substances|mesh-ancestor
25240656|NCT05298020|Growth Inhibitors|growth inhibitors|mesh-ancestor
24729389|NCT01621373|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24729390|NCT01621373|Anesthetics, General|anesthetics, general|mesh-ancestor
24729391|NCT01621373|Anesthetics|anesthetics|mesh-ancestor
24729392|NCT01621386|Prednisone|prednisone|mesh-list
24763089|NCT01771406|Nebivolol|nebivolol|mesh-list
24729393|NCT01621386|Montelukast|montelukast|mesh-list
24729394|NCT01621386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24729395|NCT01621386|Glucocorticoids|glucocorticoids|mesh-ancestor
24729396|NCT01621386|Hormones|hormones|mesh-ancestor
24729397|NCT01621386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24729452|NCT01621698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24729453|NCT01621698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24729455|NCT01621698|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24729456|NCT01621698|Narcotics|narcotics|mesh-ancestor
24729457|NCT01621698|Analgesics|analgesics|mesh-ancestor
24616668|NCT01038570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616669|NCT01038583|Aspirin|aspirin|mesh-list
24616670|NCT01038583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24616671|NCT01038583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24616672|NCT01038583|Analgesics|analgesics|mesh-ancestor
24616673|NCT01038583|Sensory System Agents|sensory system agents|mesh-ancestor
24616674|NCT01038583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24407803|NCT00175591|Bupivacaine|bupivacaine|mesh-list
25875046|NCT04775953|Dalbavancin|dalbavancin|mesh-list
25875047|NCT04775953|Oxacillin|oxacillin|mesh-list
25875048|NCT04775953|Nafcillin|nafcillin|mesh-list
25875049|NCT04775953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24729475|NCT01621750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729476|NCT01621763|Clopidogrel|clopidogrel|mesh-list
24729477|NCT01621763|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25875050|NCT04775953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25875051|NCT04759586|Prednisone|prednisone|mesh-list
25875052|NCT04759586|Prednisolone|prednisolone|mesh-list
24897862|NCT04421079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897863|NCT04421079|Protective Agents|protective agents|mesh-ancestor
24897864|NCT04421079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897865|NCT04421079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24897866|NCT04421079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24897867|NCT04421105|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
24897875|NCT04421105|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25875053|NCT04759586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25875054|NCT04759586|Methylprednisolone|methylprednisolone|mesh-list
25875055|NCT04759586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25875056|NCT04759586|Prednisolone acetate|prednisolone acetate|mesh-list
25875057|NCT04759586|Hydrocortisone|hydrocortisone|mesh-list
25875058|NCT04759586|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25875059|NCT04759586|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25875060|NCT04759586|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24850281|NCT02252523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25875061|NCT04759586|Cortisone|cortisone|mesh-list
25875062|NCT04759586|Cyclophosphamide|cyclophosphamide|mesh-list
25875063|NCT04759586|Rituximab|rituximab|mesh-list
24729523|NCT01622283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729555|NCT01622361|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24729556|NCT01622361|Hormone Antagonists|hormone antagonists|mesh-ancestor
24649180|NCT01218737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006639|NCT04821375|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25006640|NCT04821375|Hormones|hormones|mesh-ancestor
24729557|NCT01622361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24729558|NCT01622361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24729559|NCT01622361|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25875064|NCT04759586|Doxorubicin|doxorubicin|mesh-list
25875065|NCT04759586|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25875066|NCT04759586|Nivolumab|nivolumab|mesh-list
25875067|NCT04759586|Etoposide|etoposide|mesh-list
25875068|NCT04759586|Vincristine|vincristine|mesh-list
25875069|NCT04759586|Etoposide phosphate|etoposide phosphate|mesh-list
24729560|NCT01622361|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24729561|NCT01622361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24729643|NCT01622933|Interferons|interferons|mesh-list
24729644|NCT01622933|Interferon-alpha|interferon-alpha|mesh-list
24729645|NCT01622933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24729646|NCT01622933|Antiviral Agents|antiviral agents|mesh-ancestor
24729647|NCT01622933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24729648|NCT01622933|Immunologic Factors|immunologic factors|mesh-ancestor
24729649|NCT01622933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729650|NCT01622946|Tranexamic Acid|tranexamic acid|mesh-list
24729651|NCT01622946|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24729680|NCT01623102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24729682|NCT01623206|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24729684|NCT01623206|Coagulants|coagulants|mesh-ancestor
24729685|NCT01623206|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24729686|NCT01623206|Natriuretic Agents|natriuretic agents|mesh-ancestor
24729687|NCT01623206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729688|NCT01623284|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24729689|NCT01623284|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24427559|NCT00238368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875070|NCT04759586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25875071|NCT04759586|Antibodies|antibodies|mesh-list
25875072|NCT04759586|Immunoglobulins|immunoglobulins|mesh-list
24729690|NCT01623284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729691|NCT01623336|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24729692|NCT01623336|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24729693|NCT01623336|Interferon-alpha|interferon-alpha|mesh-list
24729694|NCT01623336|Antiviral Agents|antiviral agents|mesh-ancestor
24729695|NCT01623336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24729696|NCT01623336|Immunologic Factors|immunologic factors|mesh-ancestor
24729697|NCT01623336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729699|NCT01623349|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25674063|NCT01768520|Sensory System Agents|sensory system agents|mesh-ancestor
25674064|NCT01768520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25674065|NCT01768520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674066|NCT01768520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25674067|NCT01768520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25674068|NCT01768520|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25674069|NCT01768520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25674070|NCT01768520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875073|NCT04759586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25875074|NCT04759586|Lenograstim|lenograstim|mesh-list
25101327|NCT03175666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25101328|NCT03175666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25101329|NCT03175666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24729700|NCT01623349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875075|NCT04759586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24729766|NCT01623778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24729772|NCT01623817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24729773|NCT01623817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24729774|NCT01623908|Zoledronic Acid|zoledronic acid|mesh-list
24729775|NCT01623908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24729776|NCT01623908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763220|NCT01772290|Itraconazole|itraconazole|mesh-list
24729818|NCT01624064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25006641|NCT04821375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24621678|NCT01063439|Busulfan|busulfan|mesh-list
24789618|NCT01938144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789619|NCT01938183|Metronidazole|metronidazole|mesh-list
25875076|NCT04759586|Prednisolone phosphate|prednisolone phosphate|mesh-list
25875077|NCT04759586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25006642|NCT04821375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006643|NCT04821375|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25006644|NCT04821375|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25006645|NCT04821375|Hormone Antagonists|hormone antagonists|mesh-ancestor
25006646|NCT04821375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25006647|NCT04808505|Miglustat|miglustat|mesh-list
25006648|NCT04808505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25006649|NCT04808505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006650|NCT04808505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25006651|NCT04808505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25006652|NCT04808505|Antiviral Agents|antiviral agents|mesh-ancestor
25006653|NCT04808505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25006654|NCT04808505|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25006655|NCT04808505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25006656|NCT04808505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240665|NCT05297929|Irbesartan|irbesartan|mesh-list
25240666|NCT05297929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25240667|NCT05297929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25240668|NCT05297929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24729936|NCT01624675|Dopamine Agents|dopamine agents|mesh-ancestor
24729944|NCT01624766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24729945|NCT01624766|Immunologic Factors|immunologic factors|mesh-ancestor
24729946|NCT01624766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729947|NCT01624766|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24729948|NCT01624766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24729950|NCT01624805|Methylprednisolone|methylprednisolone|mesh-list
24729951|NCT01624805|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24729952|NCT01624805|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24616732|NCT01039025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24729985|NCT01624857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24729986|NCT01624857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24729987|NCT01624857|Antimetabolites|antimetabolites|mesh-ancestor
24729988|NCT01624857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729989|NCT01624857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24729990|NCT01624857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24729991|NCT01624857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729992|NCT01625026|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
24729993|NCT01625026|Cathartics|cathartics|mesh-ancestor
24729994|NCT01625026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24729995|NCT01625156|Sirolimus|sirolimus|mesh-list
24730029|NCT01625351|Antifungal Agents|antifungal agents|mesh-ancestor
24730030|NCT01625351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24730031|NCT01625351|Alkylating Agents|alkylating agents|mesh-ancestor
24730032|NCT01625351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24616766|NCT01039103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616767|NCT01039103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24616768|NCT01039103|Glucocorticoids|glucocorticoids|mesh-ancestor
25674071|NCT01768520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674072|NCT01768559|Insulin|insulin|mesh-list
25674073|NCT01768559|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25674074|NCT01768559|Metformin|metformin|mesh-list
25674075|NCT01768559|Insulin Glargine|insulin glargine|mesh-list
25674076|NCT01768559|Insulin glulisine|insulin glulisine|mesh-list
25674077|NCT01768559|Lixisenatide|lixisenatide|mesh-list
24616769|NCT01039103|Hormones|hormones|mesh-ancestor
24616770|NCT01039103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24616771|NCT01039103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24616772|NCT01039103|Protective Agents|protective agents|mesh-ancestor
24730191|NCT01627041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24730194|NCT01627041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409073|NCT00180843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24730211|NCT01627106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24730212|NCT01627106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24730213|NCT01627106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24730214|NCT01627106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24730215|NCT01627106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24730216|NCT01627106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24730285|NCT01627236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25240669|NCT05297929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240670|NCT05297669|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
25240671|NCT05297669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25240672|NCT05297669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25875078|NCT04759586|Immunologic Factors|immunologic factors|mesh-ancestor
25875079|NCT04759586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444721|NCT00298974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24730286|NCT01627236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730288|NCT01627262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24730289|NCT01627262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24730291|NCT01627262|Sensory System Agents|sensory system agents|mesh-ancestor
24730292|NCT01627262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24730293|NCT01627262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730319|NCT01627353|Analgesics|analgesics|mesh-ancestor
24730320|NCT01627353|Anticonvulsants|anticonvulsants|mesh-ancestor
24730321|NCT01627353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24730322|NCT01627353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24730323|NCT01627353|Tocolytic Agents|tocolytic agents|mesh-ancestor
24730324|NCT01627353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24730325|NCT01627379|Panitumumab|panitumumab|mesh-list
24730326|NCT01627379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730327|NCT01627379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24616801|NCT01039194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24730403|NCT01627834|Dopamine Agents|dopamine agents|mesh-ancestor
24730404|NCT01627834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24730451|NCT01628055|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24730452|NCT01628055|Immunoglobulin G|immunoglobulin g|mesh-list
24730453|NCT01628055|Immunologic Factors|immunologic factors|mesh-ancestor
24730454|NCT01628055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730456|NCT01628211|Folic Acid|folic acid|mesh-list
24730457|NCT01628211|Fluorouracil|fluorouracil|mesh-list
24730458|NCT01628211|Oxaliplatin|oxaliplatin|mesh-list
24730459|NCT01628211|Levoleucovorin|levoleucovorin|mesh-list
24730460|NCT01628211|Antimetabolites|antimetabolites|mesh-ancestor
24730499|NCT01628471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24730534|NCT01628731|Furosemide|furosemide|mesh-list
24730541|NCT01628731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730564|NCT01628952|Cholinergic Agents|cholinergic agents|mesh-ancestor
24730565|NCT01628952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24730566|NCT01628952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730568|NCT01629082|Clofarabine|clofarabine|mesh-list
24730569|NCT01629082|Immunologic Factors|immunologic factors|mesh-ancestor
24730570|NCT01629082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730571|NCT01629082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24730572|NCT01629082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24730573|NCT01629082|Growth Substances|growth substances|mesh-ancestor
24730574|NCT01629082|Growth Inhibitors|growth inhibitors|mesh-ancestor
24730575|NCT01629082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730576|NCT01629082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24730577|NCT01629082|Antimetabolites|antimetabolites|mesh-ancestor
24730631|NCT01629394|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24763495|NCT01774396|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24763496|NCT01774396|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24763497|NCT01774396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24763498|NCT01774396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900711|NCT04391582|Sulfadiazine|sulfadiazine|mesh-list
25875080|NCT04759586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24730632|NCT01629394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25412409|NCT03197935|Doxorubicin|doxorubicin|mesh-list
25101512|NCT03174236|Penicillin G Benzathine|penicillin g benzathine|mesh-list
25101513|NCT03174236|Penicillin G Procaine|penicillin g procaine|mesh-list
25101514|NCT03174236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25101515|NCT03174236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25101516|NCT03174236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25101517|NCT03174236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25101551|NCT03174041|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25101553|NCT03174041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25101554|NCT03174041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25101555|NCT03174041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25101556|NCT03174041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101557|NCT03174041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25101558|NCT03174041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25101578|NCT03174041|Hormone Antagonists|hormone antagonists|mesh-ancestor
25101579|NCT03174041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25101580|NCT03174041|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25101581|NCT03173898|Anesthetics|anesthetics|mesh-list
24730633|NCT01629394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730634|NCT01629394|Cholinergic Agents|cholinergic agents|mesh-ancestor
24730635|NCT01629394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24730636|NCT01629394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730668|NCT01629511|Immunologic Factors|immunologic factors|mesh-ancestor
24730669|NCT01629511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730670|NCT01629511|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24730671|NCT01629511|Abortifacient Agents|abortifacient agents|mesh-ancestor
24730672|NCT01629511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24730673|NCT01629511|Dermatologic Agents|dermatologic agents|mesh-ancestor
25240673|NCT05297669|Analgesics|analgesics|mesh-ancestor
25240674|NCT05297669|Sensory System Agents|sensory system agents|mesh-ancestor
25240675|NCT05297669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24730674|NCT01629511|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24730675|NCT01629511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24730676|NCT01629511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24730677|NCT01629511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24730678|NCT01629511|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24394610|NCT00133731|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24730708|NCT01629758|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24730709|NCT01629758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730758|NCT01630187|Oxytocin|oxytocin|mesh-list
24730759|NCT01630187|Oxytocics|oxytocics|mesh-ancestor
24730760|NCT01630187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24730761|NCT01630187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730762|NCT01630226|Cisplatin|cisplatin|mesh-list
24789666|NCT01938300|Tocolytic Agents|tocolytic agents|mesh-ancestor
24789667|NCT01938300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24789668|NCT01938417|Tobramycin|tobramycin|mesh-list
24789669|NCT01938417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24882693|NCT05111912|Liraglutide|liraglutide|mesh-list
24730841|NCT01630733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730842|NCT01630733|Tubulin Modulators|tubulin modulators|mesh-ancestor
24730843|NCT01630733|Antimitotic Agents|antimitotic agents|mesh-ancestor
24730844|NCT01630733|Mitosis Modulators|mitosis modulators|mesh-ancestor
24730845|NCT01630733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519142|NCT03245892|Paclitaxel|paclitaxel|mesh-list
24730847|NCT01630902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25674078|NCT01768559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25674079|NCT01768559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674080|NCT01768572|Hydroxychloroquine|hydroxychloroquine|mesh-list
25674081|NCT01768572|Sulfasalazine|sulfasalazine|mesh-list
25674082|NCT01768572|Methotrexate|methotrexate|mesh-list
25674083|NCT01768572|Leflunomide|leflunomide|mesh-list
25674084|NCT01768572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25674085|NCT01768572|Abortifacient Agents|abortifacient agents|mesh-ancestor
25674086|NCT01768572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25674087|NCT01768572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674088|NCT01768572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25674089|NCT01768572|Antimetabolites|antimetabolites|mesh-ancestor
25674090|NCT01768572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674091|NCT01768572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25674092|NCT01768572|Dermatologic Agents|dermatologic agents|mesh-ancestor
25674093|NCT01768572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674094|NCT01768572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25674095|NCT01768572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25101663|NCT03173508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101664|NCT03173508|Diuretics|diuretics|mesh-ancestor
24730848|NCT01630902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24730853|NCT01630902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730854|NCT01630902|Vasodilator Agents|vasodilator agents|mesh-ancestor
24730855|NCT01630915|Clopidogrel|clopidogrel|mesh-list
24730856|NCT01630915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24730857|NCT01630915|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24394783|NCT00134186|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24730888|NCT01631136|Antiviral Agents|antiviral agents|mesh-ancestor
24730890|NCT01631136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24730891|NCT01631136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24730892|NCT01631136|Immunologic Factors|immunologic factors|mesh-ancestor
24730893|NCT01631136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730894|NCT01631136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25875081|NCT04759586|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24730932|NCT01631383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24730933|NCT01631383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24730934|NCT01631383|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24730935|NCT01631383|Dopamine Agents|dopamine agents|mesh-ancestor
24730936|NCT01631383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24730937|NCT01631383|Adrenergic Agents|adrenergic agents|mesh-ancestor
24730938|NCT01631383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24730939|NCT01631383|Analgesics|analgesics|mesh-ancestor
24730940|NCT01631383|Sensory System Agents|sensory system agents|mesh-ancestor
24730941|NCT01631383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25240676|NCT05297669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240677|NCT05297669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25240678|NCT05297669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24730945|NCT01631396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730976|NCT01631409|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24730978|NCT01631409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24730979|NCT01631409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24730981|NCT01631409|Autonomic Agents|autonomic agents|mesh-ancestor
24730982|NCT01631409|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24730983|NCT01631409|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24730984|NCT01631409|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24730985|NCT01631409|Adrenergic Agents|adrenergic agents|mesh-ancestor
24730986|NCT01631409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24730987|NCT01631409|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24730988|NCT01631409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24731038|NCT01631669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731039|NCT01631669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24731040|NCT01631669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24731041|NCT01631669|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24731042|NCT01631669|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24731043|NCT01631669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394963|NCT00134745|Estradiol|estradiol|mesh-list
24731082|NCT01632007|Protease Inhibitors|protease inhibitors|mesh-ancestor
24731114|NCT01632514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731116|NCT01632514|Micronutrients|micronutrients|mesh-ancestor
24731120|NCT01632540|Glucocorticoids|glucocorticoids|mesh-ancestor
24731202|NCT01633203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24731204|NCT01633203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731205|NCT01633203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24763542|NCT01774487|Protective Agents|protective agents|mesh-ancestor
24763543|NCT01774487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763544|NCT01774487|Vasodilator Agents|vasodilator agents|mesh-ancestor
24763545|NCT01774487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24763546|NCT01774487|Antioxidants|antioxidants|mesh-ancestor
24763547|NCT01774565|Insulin|insulin|mesh-list
24763548|NCT01774565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24620264|NCT01056224|Remifentanil|remifentanil|mesh-list
24620265|NCT01056224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24620268|NCT01056224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620269|NCT01056224|Analgesics|analgesics|mesh-ancestor
24620270|NCT01056224|Sensory System Agents|sensory system agents|mesh-ancestor
24731206|NCT01633203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24731207|NCT01633203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24731208|NCT01633203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731209|NCT01633294|Gentamicins|gentamicins|mesh-list
24731210|NCT01633294|Ampicillin|ampicillin|mesh-list
24731242|NCT01633645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25674096|NCT01768572|Immunologic Factors|immunologic factors|mesh-ancestor
25674097|NCT01768572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24731243|NCT01633645|Antimetabolites|antimetabolites|mesh-ancestor
25875082|NCT04759586|Alkylating Agents|alkylating agents|mesh-ancestor
25875083|NCT04759586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875084|NCT04759586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875085|NCT04759586|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25875086|NCT04759586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25875087|NCT04759586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25875088|NCT04759586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25875089|NCT04759586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875090|NCT04759586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24850319|NCT02252627|Adrenergic Agents|adrenergic agents|mesh-ancestor
25875091|NCT04759586|Glucocorticoids|glucocorticoids|mesh-ancestor
25875092|NCT04759586|Hormones|hormones|mesh-ancestor
25875093|NCT04759586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25875094|NCT04759586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25875095|NCT04759586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24616852|NCT01039545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24616853|NCT01039545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24616854|NCT01039545|Analgesics|analgesics|mesh-ancestor
24616855|NCT01039545|Sensory System Agents|sensory system agents|mesh-ancestor
24616856|NCT01039545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24616857|NCT01039545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616859|NCT01039545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24616860|NCT01039545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24616861|NCT01039545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24455339|NCT01785459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24616889|NCT01039610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24616890|NCT01039610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616891|NCT01039610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616892|NCT01039610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616893|NCT01039610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24731244|NCT01633645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731246|NCT01633645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24731385|NCT01634412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24731386|NCT01634412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24616949|NCT01040091|Emtricitabine|emtricitabine|mesh-list
24616951|NCT01040091|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24616952|NCT01040091|Antiviral Agents|antiviral agents|mesh-ancestor
24616953|NCT01040091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24616954|NCT01040091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24616955|NCT01040091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24731418|NCT01634594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24731419|NCT01634594|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24731420|NCT01634594|Anesthetics, General|anesthetics, general|mesh-ancestor
24731421|NCT01634594|Anesthetics|anesthetics|mesh-ancestor
24731422|NCT01634594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24731423|NCT01634594|Narcotics|narcotics|mesh-ancestor
24731424|NCT01634594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24731425|NCT01634594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25240687|NCT05297422|Ketamine|ketamine|mesh-list
25240688|NCT05297422|Ropivacaine|ropivacaine|mesh-list
25240689|NCT05297422|Analgesics|analgesics|mesh-ancestor
25240690|NCT05297422|Sensory System Agents|sensory system agents|mesh-ancestor
24850320|NCT02252627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24850321|NCT02252627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850322|NCT02252627|Protective Agents|protective agents|mesh-ancestor
24850323|NCT02252627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24850325|NCT02252692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24850326|NCT02252692|Protease Inhibitors|protease inhibitors|mesh-ancestor
24850327|NCT02252692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850328|NCT02252692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731426|NCT01634594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24731427|NCT01634594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24731428|NCT01634594|Vasodilator Agents|vasodilator agents|mesh-ancestor
24731429|NCT01634685|Capecitabine|capecitabine|mesh-list
24731430|NCT01634685|Bavituximab|bavituximab|mesh-list
24731464|NCT01634893|Hydroxychloroquine|hydroxychloroquine|mesh-list
24731465|NCT01634893|Sorafenib|sorafenib|mesh-list
24731466|NCT01634893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731467|NCT01634893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24731468|NCT01634893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24519806|NCT04923620|Cetuximab|cetuximab|mesh-list
24395456|NCT00135967|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24731494|NCT01634958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24731496|NCT01634958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731497|NCT01634958|Antacids|antacids|mesh-ancestor
24731498|NCT01634958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731499|NCT01634958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24731500|NCT01635088|Mometasone Furoate|mometasone furoate|mesh-list
24731501|NCT01635088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24731502|NCT01635088|Dermatologic Agents|dermatologic agents|mesh-ancestor
24731503|NCT01635088|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24731504|NCT01635114|Resveratrol|resveratrol|mesh-list
24731505|NCT01635114|Antioxidants|antioxidants|mesh-ancestor
24731506|NCT01635114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731508|NCT01635114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731509|NCT01635114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731510|NCT01635114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24731512|NCT01635205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24731513|NCT01635205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731515|NCT01635296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24731553|NCT01635530|Ceftriaxone|ceftriaxone|mesh-list
24731554|NCT01635530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24731555|NCT01635530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24731556|NCT01635530|Antimalarials|antimalarials|mesh-ancestor
24731557|NCT01635530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24731558|NCT01635530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24731559|NCT01635608|Acetaminophen|acetaminophen|mesh-list
24731560|NCT01635608|Amoxicillin|amoxicillin|mesh-list
24731562|NCT01635608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24731563|NCT01635608|Analgesics|analgesics|mesh-ancestor
24731564|NCT01635608|Sensory System Agents|sensory system agents|mesh-ancestor
24731565|NCT01635608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24395548|NCT00136383|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24731586|NCT01635686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24731587|NCT01635686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25240691|NCT05297422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25240692|NCT05297422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240693|NCT05297422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25240694|NCT05297422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25240695|NCT05297422|Anesthetics, General|anesthetics, general|mesh-ancestor
25240696|NCT05297422|Anesthetics|anesthetics|mesh-ancestor
25240697|NCT05297422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25240698|NCT05297422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25240699|NCT05297422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24850329|NCT02252692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24850330|NCT02252731|Warfarin|warfarin|mesh-list
24850331|NCT02252731|Anticoagulants|anticoagulants|mesh-ancestor
24731588|NCT01635686|Immunologic Factors|immunologic factors|mesh-ancestor
24731589|NCT01635751|Pregabalin|pregabalin|mesh-list
24731590|NCT01635751|Analgesics|analgesics|mesh-ancestor
24731591|NCT01635751|Sensory System Agents|sensory system agents|mesh-ancestor
24731592|NCT01635751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24731593|NCT01635751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731594|NCT01635751|Anticonvulsants|anticonvulsants|mesh-ancestor
24731595|NCT01635751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24763690|NCT01775839|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24731596|NCT01635751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24731597|NCT01635751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731598|NCT01635751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24731599|NCT01635751|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24731600|NCT01635751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24731601|NCT01635751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24731602|NCT01635751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24731603|NCT01635777|Miltefosine|miltefosine|mesh-list
24731604|NCT01635777|Antifungal Agents|antifungal agents|mesh-ancestor
24616968|NCT01040195|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24616969|NCT01040195|Abortifacient Agents|abortifacient agents|mesh-ancestor
24731609|NCT01635790|Bevacizumab|bevacizumab|mesh-list
24731610|NCT01635790|Ranibizumab|ranibizumab|mesh-list
24731611|NCT01635790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24731647|NCT01635829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24731648|NCT01635829|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24731649|NCT01635946|Isavuconazole|isavuconazole|mesh-list
24731650|NCT01635946|Atorvastatin|atorvastatin|mesh-list
24731651|NCT01635946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24731684|NCT01636037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731685|NCT01636037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731686|NCT01636037|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24731721|NCT01636245|Vaccines|vaccines|mesh-list
24731726|NCT01636271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395706|NCT00136656|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24731758|NCT01636336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731760|NCT01636336|Hormones|hormones|mesh-ancestor
24731761|NCT01636336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24731763|NCT01636401|Anticonvulsants|anticonvulsants|mesh-ancestor
24731764|NCT01636505|Cetrorelix|cetrorelix|mesh-list
24731765|NCT01636505|Buserelin|buserelin|mesh-list
24731857|NCT01636869|Anesthetics, Local|anesthetics, local|mesh-ancestor
24731858|NCT01636869|Anesthetics|anesthetics|mesh-ancestor
24731859|NCT01636869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24731860|NCT01636869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455384|NCT01539447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731896|NCT01636999|Anesthetics|anesthetics|mesh-ancestor
24731897|NCT01636999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24731898|NCT01636999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520236|NCT03486314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520237|NCT03486314|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24520238|NCT03486314|Antitubercular Agents|antitubercular agents|mesh-ancestor
24731937|NCT01637233|Protease Inhibitors|protease inhibitors|mesh-list
24731938|NCT01637233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24731939|NCT01637233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731940|NCT01637233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731941|NCT01637233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24731975|NCT01637259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24731976|NCT01637259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24731977|NCT01637259|Antimetabolites|antimetabolites|mesh-ancestor
24731978|NCT01637259|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24520316|NCT02795858|Octreotide|octreotide|mesh-list
24731979|NCT01637259|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24731980|NCT01637259|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25240700|NCT05297422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25240701|NCT05297422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875096|NCT04759586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24444731|NCT00299013|Glucocorticoids|glucocorticoids|mesh-ancestor
24444732|NCT00299013|Hormones|hormones|mesh-ancestor
24444733|NCT00299013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24444734|NCT00299013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731981|NCT01637376|Temoporfin|temoporfin|mesh-list
24731982|NCT01637376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731983|NCT01637376|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24732027|NCT01637558|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24732028|NCT01637558|Protease Inhibitors|protease inhibitors|mesh-ancestor
24732029|NCT01637558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732030|NCT01637558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732068|NCT01637636|Hormone Antagonists|hormone antagonists|mesh-ancestor
25006703|NCT04716699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732069|NCT01637636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24732070|NCT01637636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732071|NCT01637636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24732073|NCT01637675|Sildenafil Citrate|sildenafil citrate|mesh-list
24732075|NCT01637675|Sodium Citrate|sodium citrate|mesh-list
24732076|NCT01637675|Anticoagulants|anticoagulants|mesh-ancestor
24732077|NCT01637675|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24732078|NCT01637675|Chelating Agents|chelating agents|mesh-ancestor
24732079|NCT01637675|Sequestering Agents|sequestering agents|mesh-ancestor
24732080|NCT01637675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732081|NCT01637675|Vasodilator Agents|vasodilator agents|mesh-ancestor
24732082|NCT01637675|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24732083|NCT01637675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24732084|NCT01637675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732085|NCT01637675|Urological Agents|urological agents|mesh-ancestor
24732086|NCT01637675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24732087|NCT01637675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24617031|NCT01040338|Cholinergic Agents|cholinergic agents|mesh-ancestor
24617032|NCT01040338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24617033|NCT01040338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617035|NCT01040429|Analgesics|analgesics|mesh-ancestor
24480537|NCT00431236|Serotonin Agents|serotonin agents|mesh-ancestor
24480546|NCT00431249|Cilostazol|cilostazol|mesh-list
24480552|NCT00431249|Respiratory System Agents|respiratory system agents|mesh-ancestor
24617036|NCT01040429|Sensory System Agents|sensory system agents|mesh-ancestor
24617037|NCT01040429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24617038|NCT01040429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617039|NCT01040429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24617040|NCT01040429|Sympatholytics|sympatholytics|mesh-ancestor
24732228|NCT01638377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24732230|NCT01638403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24732231|NCT01638403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732232|NCT01638403|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24732233|NCT01638403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24732234|NCT01638403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24732235|NCT01638403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732236|NCT01638442|Tosedostat|tosedostat|mesh-list
24732237|NCT01638442|Glycine|glycine|mesh-list
24732238|NCT01638442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732239|NCT01638442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240702|NCT05297422|Anesthetics, Local|anesthetics, local|mesh-ancestor
25240703|NCT05297292|Ranibizumab|ranibizumab|mesh-list
25240704|NCT05297292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25240705|NCT05297292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25240706|NCT05297292|Growth Substances|growth substances|mesh-ancestor
25240707|NCT05297292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444738|NCT00299013|Autonomic Agents|autonomic agents|mesh-ancestor
25875097|NCT04759586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25875098|NCT04759586|Tubulin Modulators|tubulin modulators|mesh-ancestor
24444750|NCT00299039|Acetaminophen|acetaminophen|mesh-list
24444751|NCT00299039|Ibuprofen|ibuprofen|mesh-list
24444752|NCT00299039|Codeine|codeine|mesh-list
24444753|NCT00299039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24444754|NCT00299039|Analgesics|analgesics|mesh-ancestor
24444755|NCT00299039|Sensory System Agents|sensory system agents|mesh-ancestor
24444756|NCT00299039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24444781|NCT00299065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444784|NCT00299065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25875099|NCT04759586|Antimitotic Agents|antimitotic agents|mesh-ancestor
24850415|NCT02252926|Analgesics|analgesics|mesh-ancestor
24850439|NCT02253004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24850440|NCT02253004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646468|NCT01204086|Serotonin Agents|serotonin agents|mesh-ancestor
24850464|NCT02253095|Tubulin Modulators|tubulin modulators|mesh-ancestor
24850465|NCT02253095|Antimitotic Agents|antimitotic agents|mesh-ancestor
24850466|NCT02253095|Mitosis Modulators|mitosis modulators|mesh-ancestor
24850467|NCT02253095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732240|NCT01638442|Glycine Agents|glycine agents|mesh-ancestor
24732241|NCT01638442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24732242|NCT01638442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24876095|NCT03730649|Sulforaphane|sulforaphane|mesh-list
24732244|NCT01638624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24732245|NCT01638624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24732246|NCT01638624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732348|NCT01638962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24732349|NCT01638962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732350|NCT01638962|Antipyretics|antipyretics|mesh-ancestor
24732351|NCT01638962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25273944|NCT02382029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273946|NCT02381899|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25273947|NCT02381899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25273948|NCT02381899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25273949|NCT02381899|Immunologic Factors|immunologic factors|mesh-ancestor
25273950|NCT02381899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273951|NCT02381899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25273952|NCT02381899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25273953|NCT02381899|Alkylating Agents|alkylating agents|mesh-ancestor
25273954|NCT02381899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273955|NCT02381600|Vitamin D|vitamin d|mesh-list
25273956|NCT02381600|Vitamins|vitamins|mesh-ancestor
25273957|NCT02381600|Micronutrients|micronutrients|mesh-ancestor
25273958|NCT02381600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273959|NCT02381600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25273961|NCT02381717|Bupivacaine|bupivacaine|mesh-list
25102174|NCT03169751|Purinergic Agents|purinergic agents|mesh-ancestor
25102175|NCT03169751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25102177|NCT03169764|Cyclophosphamide|cyclophosphamide|mesh-list
25102178|NCT03169764|Bevacizumab|bevacizumab|mesh-list
25102179|NCT03169764|Fluorouracil|fluorouracil|mesh-list
25102181|NCT03169764|Nivolumab|nivolumab|mesh-list
25273962|NCT02381717|Anesthetics, Local|anesthetics, local|mesh-ancestor
25273963|NCT02381717|Anesthetics|anesthetics|mesh-ancestor
25273964|NCT02381717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25273965|NCT02381717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273966|NCT02381717|Sensory System Agents|sensory system agents|mesh-ancestor
25273967|NCT02381717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24850468|NCT02253095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850469|NCT02253095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850471|NCT02253108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850472|NCT02253108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24850473|NCT02253108|Immunologic Factors|immunologic factors|mesh-ancestor
24763840|NCT01777503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24850474|NCT02253108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850519|NCT02253420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24850520|NCT02253420|Leprostatic Agents|leprostatic agents|mesh-ancestor
24850521|NCT02253420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24850522|NCT02253420|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24850523|NCT02253420|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24850524|NCT02253420|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24732352|NCT01638962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24732353|NCT01638962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24732354|NCT01638962|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24732355|NCT01638962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732382|NCT01639027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732383|NCT01639027|Parasympatholytics|parasympatholytics|mesh-ancestor
24732384|NCT01639027|Autonomic Agents|autonomic agents|mesh-ancestor
24732385|NCT01639027|Vasodilator Agents|vasodilator agents|mesh-ancestor
24732386|NCT01639066|Tenofovir|tenofovir|mesh-list
24732387|NCT01639066|Entecavir|entecavir|mesh-list
24732388|NCT01639066|Antiviral Agents|antiviral agents|mesh-ancestor
24732389|NCT01639066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24732390|NCT01639066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24732394|NCT01639066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24732395|NCT01639066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24732396|NCT01639092|Tenofovir|tenofovir|mesh-list
24732397|NCT01639092|Entecavir|entecavir|mesh-list
24732398|NCT01639092|Antiviral Agents|antiviral agents|mesh-ancestor
24732399|NCT01639092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24732400|NCT01639092|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24763904|NCT01778101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24732401|NCT01639092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24732402|NCT01639092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732403|NCT01639092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732404|NCT01639092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24732405|NCT01639092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24732442|NCT01639456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732443|NCT01639456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24732444|NCT01639456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24732445|NCT01639456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24732446|NCT01639456|Antiviral Agents|antiviral agents|mesh-ancestor
24617121|NCT01041092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24617123|NCT01041092|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24617124|NCT01041092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25006704|NCT04708145|Aflibercept|aflibercept|mesh-list
24789680|NCT01938456|Antimitotic Agents|antimitotic agents|mesh-ancestor
24789681|NCT01938456|Mitosis Modulators|mitosis modulators|mesh-ancestor
24789682|NCT01938456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240710|NCT05297123|Tretinoin|tretinoin|mesh-list
25240711|NCT05297123|Arsenic Trioxide|arsenic trioxide|mesh-list
25240712|NCT05297123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25240713|NCT05297123|Keratolytic Agents|keratolytic agents|mesh-ancestor
25240722|NCT05264168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25240723|NCT05264168|Antithrombins|antithrombins|mesh-ancestor
25240724|NCT05264168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25412410|NCT03197935|Atezolizumab|atezolizumab|mesh-list
25674098|NCT01768572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25674099|NCT01768572|Antimalarials|antimalarials|mesh-ancestor
25674100|NCT01768572|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25674101|NCT01768572|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25674102|NCT01768572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25102270|NCT03169790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102271|NCT03169790|Tubulin Modulators|tubulin modulators|mesh-ancestor
24481825|NCT00436839|Hormones|hormones|mesh-ancestor
25875100|NCT04759586|Mitosis Modulators|mitosis modulators|mesh-ancestor
24763905|NCT01778101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763907|NCT01778114|Vitamin D|vitamin d|mesh-list
25875101|NCT04759586|Antiemetics|antiemetics|mesh-ancestor
25875102|NCT04759586|Autonomic Agents|autonomic agents|mesh-ancestor
25875103|NCT04759586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25875104|NCT04759586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25875105|NCT04759586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25875106|NCT04759586|Protective Agents|protective agents|mesh-ancestor
25875107|NCT04751370|Nivolumab|nivolumab|mesh-list
25875108|NCT04751370|Ipilimumab|ipilimumab|mesh-list
25875109|NCT04751370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24789683|NCT01938456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24789684|NCT01938456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617125|NCT01041092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24732470|NCT01639521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24732471|NCT01639521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24732472|NCT01639521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24732473|NCT01639521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24732474|NCT01639521|Tubulin Modulators|tubulin modulators|mesh-ancestor
24732475|NCT01639521|Antimitotic Agents|antimitotic agents|mesh-ancestor
24732476|NCT01639521|Mitosis Modulators|mitosis modulators|mesh-ancestor
24732478|NCT01639547|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24732479|NCT01639547|Antimetabolites|antimetabolites|mesh-ancestor
24732480|NCT01639547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732481|NCT01639547|Antiviral Agents|antiviral agents|mesh-ancestor
24732482|NCT01639547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24732483|NCT01639573|Alemtuzumab|alemtuzumab|mesh-list
24732484|NCT01639573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24732509|NCT01639898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24732511|NCT01639898|Autonomic Agents|autonomic agents|mesh-ancestor
24732512|NCT01639898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24732513|NCT01639898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732514|NCT01639898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24732515|NCT01639898|Glucocorticoids|glucocorticoids|mesh-ancestor
24732516|NCT01639898|Hormones|hormones|mesh-ancestor
25875110|NCT04751370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875111|NCT04751370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25875112|NCT04751370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875113|NCT04745910|Rasburicase|rasburicase|mesh-list
24480761|NCT00432055|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25875114|NCT04745910|Uric Acid|uric acid|mesh-list
24732517|NCT01639898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24732518|NCT01639898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24732519|NCT01639898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732520|NCT01639898|Protease Inhibitors|protease inhibitors|mesh-ancestor
24732521|NCT01639898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732522|NCT01639898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732523|NCT01639898|Immunologic Factors|immunologic factors|mesh-ancestor
24732524|NCT01639898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25068319|NCT03434613|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25240729|NCT05256797|Rivaroxaban|rivaroxaban|mesh-list
25240730|NCT05256797|Apixaban|apixaban|mesh-list
25240731|NCT05256797|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24732531|NCT01640002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24732532|NCT01640002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24520879|NCT05258747|Olaparib|olaparib|mesh-list
24732535|NCT01640002|Cholinergic Agents|cholinergic agents|mesh-ancestor
24396600|NCT00139373|Donepezil|donepezil|mesh-list
24732564|NCT01640405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25006705|NCT04708145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25006706|NCT04708145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25006707|NCT04708145|Growth Substances|growth substances|mesh-ancestor
24413033|NCT00193011|Antimitotic Agents|antimitotic agents|mesh-ancestor
24413034|NCT00193011|Mitosis Modulators|mitosis modulators|mesh-ancestor
25875115|NCT04745910|Gout Suppressants|gout suppressants|mesh-ancestor
25875116|NCT04745910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25875117|NCT04745910|Antioxidants|antioxidants|mesh-ancestor
25006708|NCT04708145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674103|NCT01768572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25674104|NCT01768572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25674105|NCT01768572|Analgesics|analgesics|mesh-ancestor
25674106|NCT01768572|Sensory System Agents|sensory system agents|mesh-ancestor
25674107|NCT01768572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25006709|NCT04708145|Growth Inhibitors|growth inhibitors|mesh-ancestor
25006710|NCT04708145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006712|NCT04688177|Carbon Monoxide|carbon monoxide|mesh-list
25006713|NCT04688177|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25006714|NCT04688177|Autonomic Agents|autonomic agents|mesh-ancestor
25006715|NCT04688177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25006716|NCT04688177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006717|NCT04688177|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25006718|NCT04688177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25006719|NCT04688177|Cholinergic Agents|cholinergic agents|mesh-ancestor
25006720|NCT04688177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24732565|NCT01640405|Growth Substances|growth substances|mesh-ancestor
24732566|NCT01640405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732567|NCT01640405|Growth Inhibitors|growth inhibitors|mesh-ancestor
24732570|NCT01640444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24732571|NCT01640444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732572|NCT01640444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24732573|NCT01640444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24732574|NCT01640444|Growth Substances|growth substances|mesh-ancestor
24732575|NCT01640444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732576|NCT01640444|Growth Inhibitors|growth inhibitors|mesh-ancestor
24732577|NCT01640496|Vitamin D|vitamin d|mesh-list
24732578|NCT01640496|Cholecalciferol|cholecalciferol|mesh-list
24732610|NCT01640574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24732612|NCT01640574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24732613|NCT01640574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24732614|NCT01640574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24732615|NCT01640574|Analgesics|analgesics|mesh-ancestor
24732617|NCT01640574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24732618|NCT01640574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732619|NCT01640574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24732620|NCT01640574|Filaricides|filaricides|mesh-ancestor
24732621|NCT01640574|Antinematodal Agents|antinematodal agents|mesh-ancestor
24732622|NCT01640574|Anthelmintics|anthelmintics|mesh-ancestor
25240732|NCT05256797|Antithrombins|antithrombins|mesh-ancestor
25240733|NCT05256797|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25240734|NCT05256797|Protease Inhibitors|protease inhibitors|mesh-ancestor
25240735|NCT05256797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240736|NCT05256797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240737|NCT05256797|Anticoagulants|anticoagulants|mesh-ancestor
24732658|NCT01640691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732660|NCT01640743|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24732661|NCT01640743|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24732662|NCT01640743|Prednisolone|prednisolone|mesh-list
24732663|NCT01640743|Prednisolone acetate|prednisolone acetate|mesh-list
24732664|NCT01640743|Everolimus|everolimus|mesh-list
24732714|NCT01640990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24732715|NCT01640990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396773|NCT00139880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24732734|NCT01641224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24732735|NCT01641224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732737|NCT01641224|Autonomic Agents|autonomic agents|mesh-ancestor
24732740|NCT01641250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24732742|NCT01641250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732743|NCT01641250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732744|NCT01641250|Antiviral Agents|antiviral agents|mesh-ancestor
24732745|NCT01641250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24732746|NCT01641250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24732747|NCT01641250|Immunologic Factors|immunologic factors|mesh-ancestor
24732748|NCT01641250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732750|NCT01641289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24732752|NCT01641289|Sensory System Agents|sensory system agents|mesh-ancestor
24732753|NCT01641289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24732754|NCT01641289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732755|NCT01641289|Antipyretics|antipyretics|mesh-ancestor
24732756|NCT01641315|Immunoglobulins|immunoglobulins|mesh-list
24732757|NCT01641315|Immunologic Factors|immunologic factors|mesh-ancestor
24732758|NCT01641315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732759|NCT01641341|Nitazoxanide|nitazoxanide|mesh-list
24732760|NCT01641341|Pancrelipase|pancrelipase|mesh-list
24732761|NCT01641341|Pancreatin|pancreatin|mesh-list
24732762|NCT01641341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25875118|NCT04745910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875119|NCT04745910|Protective Agents|protective agents|mesh-ancestor
24900298|NCT04395612|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25875120|NCT04745910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240746|NCT05214664|Anesthetics|anesthetics|mesh-list
25240747|NCT05214664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25240748|NCT05214664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240749|NCT05132179|Sodium Hypochlorite|sodium hypochlorite|mesh-list
25240750|NCT05132179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25240751|NCT05132179|Disinfectants|disinfectants|mesh-ancestor
25240752|NCT05132179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24764007|NCT01778842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764009|NCT01779089|Minocycline|minocycline|mesh-list
25240753|NCT05110300|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25875122|NCT04734730|Cortisone|cortisone|mesh-list
25875123|NCT04734730|Leuprolide|leuprolide|mesh-list
25875124|NCT04734730|Goserelin|goserelin|mesh-list
25875125|NCT04734730|Abiraterone Acetate|abiraterone acetate|mesh-list
25875126|NCT04734730|Bicalutamide|bicalutamide|mesh-list
25875127|NCT04734730|Talazoparib|talazoparib|mesh-list
25875128|NCT04734730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25875129|NCT04734730|Glucocorticoids|glucocorticoids|mesh-ancestor
25875130|NCT04734730|Hormones|hormones|mesh-ancestor
25875131|NCT04734730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24732763|NCT01641341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24732764|NCT01641341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24732765|NCT01641406|Cyclophosphamide|cyclophosphamide|mesh-list
24732767|NCT01641406|Docetaxel|docetaxel|mesh-list
24732768|NCT01641406|Capecitabine|capecitabine|mesh-list
24617192|NCT01041508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24617216|NCT01041690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617217|NCT01041690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24617218|NCT01041690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24617221|NCT01041690|Growth Inhibitors|growth inhibitors|mesh-ancestor
24617223|NCT01041729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24617224|NCT01041729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24732777|NCT01641406|Alkylating Agents|alkylating agents|mesh-ancestor
24617225|NCT01041729|Antimetabolites|antimetabolites|mesh-ancestor
25875132|NCT04734730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732792|NCT01641406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24732823|NCT01641510|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24732824|NCT01641510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24732825|NCT01641510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24732826|NCT01641510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24732827|NCT01641510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24732828|NCT01641510|Purinergic Agents|purinergic agents|mesh-ancestor
24732829|NCT01641510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25240754|NCT05110300|Luteolytic Agents|luteolytic agents|mesh-ancestor
25240755|NCT05110300|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25240756|NCT05110300|Contraceptive Agents|contraceptive agents|mesh-ancestor
25240757|NCT05110300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25240758|NCT05110300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240759|NCT05110300|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25240760|NCT05110300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25240761|NCT05110300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25240763|NCT05096884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24850634|NCT02253836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24647306|NCT01207921|Lenalidomide|lenalidomide|mesh-list
24481074|NCT00433225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25068343|NCT03434275|Meloxicam|meloxicam|mesh-list
24732830|NCT01641510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732831|NCT01641510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732832|NCT01641523|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
24732833|NCT01641523|Vasodilator Agents|vasodilator agents|mesh-ancestor
24732834|NCT01641523|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24396957|NCT00140478|Mifepristone|mifepristone|mesh-list
25674108|NCT01768572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25674109|NCT01768572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25674110|NCT01768637|Aspirin|aspirin|mesh-list
25674111|NCT01768637|Clopidogrel|clopidogrel|mesh-list
25674112|NCT01768637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25674113|NCT01768637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25674114|NCT01768637|Analgesics|analgesics|mesh-ancestor
25674115|NCT01768637|Sensory System Agents|sensory system agents|mesh-ancestor
25674116|NCT01768637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25102619|NCT03167216|Cromolyn Sodium|cromolyn sodium|mesh-list
25102620|NCT03167216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24428628|NCT00240812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24732867|NCT01641783|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24732868|NCT01641783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24732869|NCT01641783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732870|NCT01641783|Tubulin Modulators|tubulin modulators|mesh-ancestor
24732871|NCT01641783|Antimitotic Agents|antimitotic agents|mesh-ancestor
24732872|NCT01641783|Mitosis Modulators|mitosis modulators|mesh-ancestor
24732873|NCT01641783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732874|NCT01641796|Paromomycin|paromomycin|mesh-list
24732875|NCT01641796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24732876|NCT01641796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24732877|NCT01641796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24732878|NCT01641796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24732879|NCT01642030|Buprenorphine|buprenorphine|mesh-list
24413591|NCT00194597|Sildenafil Citrate|sildenafil citrate|mesh-list
24413593|NCT00194597|Vasodilator Agents|vasodilator agents|mesh-ancestor
24481075|NCT00433225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24481076|NCT00433225|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24481077|NCT00433225|Protective Agents|protective agents|mesh-ancestor
24481125|NCT00433433|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24481126|NCT00433433|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24481146|NCT00433459|Hormones|hormones|mesh-ancestor
24481147|NCT00433459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24732911|NCT01642134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732913|NCT01642134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24732914|NCT01642134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732915|NCT01642134|Antipyretics|antipyretics|mesh-ancestor
24732916|NCT01642134|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24732917|NCT01642134|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24732918|NCT01642134|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24732919|NCT01642134|Purinergic Agents|purinergic agents|mesh-ancestor
24732920|NCT01642134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24732949|NCT01642472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24732950|NCT01642472|Contraceptive Agents|contraceptive agents|mesh-ancestor
24732951|NCT01642472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24732952|NCT01642472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732953|NCT01642472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24732955|NCT01642524|Anticoagulants|anticoagulants|mesh-ancestor
24732956|NCT01642524|Plasma Substitutes|plasma substitutes|mesh-ancestor
24732957|NCT01642524|Blood Substitutes|blood substitutes|mesh-ancestor
24732959|NCT01642667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24732960|NCT01642667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25240764|NCT05096884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25240765|NCT05096884|Sympatholytics|sympatholytics|mesh-ancestor
25240766|NCT05096884|Autonomic Agents|autonomic agents|mesh-ancestor
25240767|NCT05096884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25240768|NCT05096884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764045|NCT01779258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764046|NCT01779258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24764047|NCT01779271|Loxoprofen|loxoprofen|mesh-list
24764048|NCT01779271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24764049|NCT01779271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24764050|NCT01779271|Analgesics|analgesics|mesh-ancestor
24764051|NCT01779271|Sensory System Agents|sensory system agents|mesh-ancestor
24764052|NCT01779271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24764053|NCT01779271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764054|NCT01779271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24764055|NCT01779271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24764056|NCT01779284|Timolol|timolol|mesh-list
25240769|NCT05096884|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25240770|NCT05096884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25240771|NCT05096884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25240772|NCT05096884|Adrenergic Agents|adrenergic agents|mesh-ancestor
25240773|NCT05096884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25240774|NCT05096884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240775|NCT05068232|Carboplatin|carboplatin|mesh-list
25240776|NCT05068232|Etoposide|etoposide|mesh-list
25240777|NCT05068232|Durvalumab|durvalumab|mesh-list
25240778|NCT05068232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25674117|NCT01768637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674118|NCT01768637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25674119|NCT01768637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25241768|NCT05299593|Adrenergic Agents|adrenergic agents|mesh-ancestor
25241769|NCT05299593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25241770|NCT05299593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241771|NCT05299593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241772|NCT05299593|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25241773|NCT05299593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25241775|NCT05299580|Dabrafenib|dabrafenib|mesh-list
25241776|NCT05299580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25241777|NCT05299580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25241778|NCT05299580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240779|NCT05068232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24732961|NCT01642667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732962|NCT01642745|Mannitol|mannitol|mesh-list
24732963|NCT01642745|Methacholine Chloride|methacholine chloride|mesh-list
24732964|NCT01642745|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24732965|NCT01642745|Diuretics|diuretics|mesh-ancestor
24397127|NCT00140868|GABA Agents|gaba agents|mesh-ancestor
24617242|NCT01041872|Sensory System Agents|sensory system agents|mesh-ancestor
24617243|NCT01041872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24617244|NCT01041872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24617245|NCT01041872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24617246|NCT01041872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24617247|NCT01041872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24733314|NCT01645085|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24617248|NCT01041872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617249|NCT01041872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24617250|NCT01041872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24617251|NCT01041872|Anesthetics, General|anesthetics, general|mesh-ancestor
24617252|NCT01041963|Losartan|losartan|mesh-list
24617253|NCT01041963|Enalapril|enalapril|mesh-list
24617254|NCT01041963|Enalaprilat|enalaprilat|mesh-list
24617255|NCT01041963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24617256|NCT01041963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24733041|NCT01642979|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25875133|NCT04734730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24733045|NCT01643031|Clopidogrel|clopidogrel|mesh-list
24733046|NCT01643031|Ticagrelor|ticagrelor|mesh-list
24733047|NCT01643031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24397201|NCT00141063|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24733076|NCT01643135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24733077|NCT01643135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24733078|NCT01643135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24733079|NCT01643135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733080|NCT01643187|Vitamins|vitamins|mesh-list
24733091|NCT01643252|Dermatologic Agents|dermatologic agents|mesh-ancestor
24733092|NCT01643265|Caseins|caseins|mesh-list
24397243|NCT00141193|Celecoxib|celecoxib|mesh-list
24733119|NCT01643434|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24733120|NCT01643434|Hormone Antagonists|hormone antagonists|mesh-ancestor
24733121|NCT01643434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24733122|NCT01643434|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24733123|NCT01643434|Diuretics|diuretics|mesh-ancestor
24733124|NCT01643434|Natriuretic Agents|natriuretic agents|mesh-ancestor
24733125|NCT01643447|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
24733126|NCT01643447|Urinastatin|urinastatin|mesh-list
24733127|NCT01643447|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24733128|NCT01643447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24733129|NCT01643447|Protease Inhibitors|protease inhibitors|mesh-ancestor
24733130|NCT01643447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733131|NCT01643447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733132|NCT01643447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24733133|NCT01643499|Leucovorin|leucovorin|mesh-list
24733134|NCT01643499|Fluorouracil|fluorouracil|mesh-list
25674120|NCT01768637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25674121|NCT01768637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25674122|NCT01768637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674123|NCT01768637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25674124|NCT01768637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25674125|NCT01768637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674126|NCT01768637|Antipyretics|antipyretics|mesh-ancestor
25674127|NCT01768637|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25674128|NCT01768637|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25674129|NCT01768637|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24733135|NCT01643499|Oxaliplatin|oxaliplatin|mesh-list
24395610|NCT00136474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395612|NCT00136487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25241798|NCT05277480|Apatinib|apatinib|mesh-list
25241799|NCT05277480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25241800|NCT05277480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25241801|NCT05277480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25241802|NCT05277480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241803|NCT05277285|Sodium thiosulfate|sodium thiosulfate|mesh-list
25241814|NCT05259943|Psilocybin|psilocybin|mesh-list
24733136|NCT01643499|Irinotecan|irinotecan|mesh-list
24733137|NCT01643499|Calcium|calcium|mesh-list
24733138|NCT01643499|Levoleucovorin|levoleucovorin|mesh-list
24733180|NCT01643759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24733216|NCT01644071|Cholinergic Agents|cholinergic agents|mesh-ancestor
24649608|NCT01220622|Nimodipine|nimodipine|mesh-list
24733217|NCT01644071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24733218|NCT01644071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733219|NCT01644071|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24397364|NCT00141401|Sensory System Agents|sensory system agents|mesh-ancestor
24733249|NCT01644253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617273|NCT01042028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25240780|NCT05068232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25240781|NCT05068232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24850647|NCT02253849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24617274|NCT01042028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617275|NCT01042028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24617276|NCT01042028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24617277|NCT01042028|Immunologic Factors|immunologic factors|mesh-ancestor
24617278|NCT01042028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617280|NCT01042041|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24617281|NCT01042041|Sorafenib|sorafenib|mesh-list
24617282|NCT01042041|Mitomycins|mitomycins|mesh-list
24617283|NCT01042041|Mitomycin|mitomycin|mesh-list
24617284|NCT01042041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617285|NCT01042041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24617286|NCT01042041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24733308|NCT01644864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24733309|NCT01644955|Carboplatin|carboplatin|mesh-list
24733310|NCT01644955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733311|NCT01644994|Cisplatin|cisplatin|mesh-list
24733312|NCT01644994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733313|NCT01645085|Mannitol|mannitol|mesh-list
24733315|NCT01645085|Diuretics|diuretics|mesh-ancestor
24733316|NCT01645085|Natriuretic Agents|natriuretic agents|mesh-ancestor
24733317|NCT01645085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733318|NCT01645124|Hydroxyurea|hydroxyurea|mesh-list
24733319|NCT01645124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733320|NCT01645124|Antisickling Agents|antisickling agents|mesh-ancestor
24733321|NCT01645124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733322|NCT01645124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733323|NCT01645124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24733324|NCT01645228|Calcium|calcium|mesh-list
24733325|NCT01645228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24733326|NCT01645228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733327|NCT01645241|Ganirelix|ganirelix|mesh-list
24733328|NCT01645241|Hormone Antagonists|hormone antagonists|mesh-ancestor
24733329|NCT01645241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24764171|NCT01779843|Cytarabine|cytarabine|mesh-list
24733330|NCT01645241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733331|NCT01645254|Antimalarials|antimalarials|mesh-list
24733372|NCT01645449|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24733373|NCT01645449|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24733374|NCT01645449|Antimetabolites|antimetabolites|mesh-ancestor
24733475|NCT01646437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25412411|NCT03197935|Antibodies|antibodies|mesh-list
25674130|NCT01768637|Purinergic Agents|purinergic agents|mesh-ancestor
25674131|NCT01768637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25674132|NCT01768858|Adalimumab|adalimumab|mesh-list
25674133|NCT01768858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25674134|NCT01768858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25674135|NCT01769170|Cidofovir|cidofovir|mesh-list
25674136|NCT01769170|Brincidofovir|brincidofovir|mesh-list
25674137|NCT01769170|Antiviral Agents|antiviral agents|mesh-ancestor
25674138|NCT01769170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25674139|NCT01769170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674140|NCT01769170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733478|NCT01646437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24733479|NCT01646515|Udenafil|udenafil|mesh-list
25875134|NCT04734730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24414970|NCT00199017|Dexamethasone|dexamethasone|mesh-list
25875135|NCT04734730|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24733480|NCT01646515|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24733481|NCT01646515|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25240782|NCT05068232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240783|NCT05068232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240784|NCT05068232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24850648|NCT02253849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24850649|NCT02253849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24850650|NCT02253849|Anticonvulsants|anticonvulsants|mesh-ancestor
24850651|NCT02253849|Antimanic Agents|antimanic agents|mesh-ancestor
24850652|NCT02253849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24850653|NCT02253849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24850654|NCT02253849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850655|NCT02253849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24850656|NCT02253849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24850657|NCT02253849|Analgesics|analgesics|mesh-ancestor
24850658|NCT02253849|Sensory System Agents|sensory system agents|mesh-ancestor
24850659|NCT02253849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24850660|NCT02253849|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24850661|NCT02253849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24830880|NCT02161965|Warfarin|warfarin|mesh-list
24733482|NCT01646515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733483|NCT01646515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733484|NCT01646554|Oxaliplatin|oxaliplatin|mesh-list
24733485|NCT01646554|Aflibercept|aflibercept|mesh-list
24733486|NCT01646554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733487|NCT01646554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24733488|NCT01646554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24733489|NCT01646554|Growth Substances|growth substances|mesh-ancestor
24733490|NCT01646554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397638|NCT00142129|Bortezomib|bortezomib|mesh-list
24733522|NCT01646619|Tocolytic Agents|tocolytic agents|mesh-ancestor
24733523|NCT01646619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24733524|NCT01646684|Pasireotide|pasireotide|mesh-list
24733525|NCT01646684|Hormones|hormones|mesh-ancestor
24733526|NCT01646684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24733527|NCT01646684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733528|NCT01646736|Cyclophosphamide|cyclophosphamide|mesh-list
24733529|NCT01646736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24733530|NCT01646736|Immunologic Factors|immunologic factors|mesh-ancestor
24733531|NCT01646736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733532|NCT01646736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24733560|NCT01646853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733561|NCT01646853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24733562|NCT01646853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24733563|NCT01646853|Immunologic Factors|immunologic factors|mesh-ancestor
24617362|NCT01042704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25875136|NCT04734730|Fertility Agents|fertility agents|mesh-ancestor
24617366|NCT01042704|Immunologic Factors|immunologic factors|mesh-ancestor
24733624|NCT01647646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24733625|NCT01647646|Autonomic Agents|autonomic agents|mesh-ancestor
24733626|NCT01647646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24733627|NCT01647646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733628|NCT01647646|Glucocorticoids|glucocorticoids|mesh-ancestor
24733629|NCT01647646|Hormones|hormones|mesh-ancestor
24733630|NCT01647646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24733631|NCT01647646|Sympathomimetics|sympathomimetics|mesh-ancestor
24733632|NCT01647659|Trametinib|trametinib|mesh-list
24734707|NCT01653236|Ribavirin|ribavirin|mesh-list
24733662|NCT01647828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733663|NCT01647828|Tubulin Modulators|tubulin modulators|mesh-ancestor
24733664|NCT01647828|Antimitotic Agents|antimitotic agents|mesh-ancestor
24733665|NCT01647828|Mitosis Modulators|mitosis modulators|mesh-ancestor
24415360|NCT00199316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25240785|NCT05040334|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25240786|NCT05040334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25240787|NCT04920149|Mesalamine|mesalamine|mesh-list
24960950|NCT03813043|GABA Modulators|gaba modulators|mesh-ancestor
25240788|NCT04920149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25240789|NCT04920149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25240790|NCT04920149|Analgesics|analgesics|mesh-ancestor
25240791|NCT04920149|Sensory System Agents|sensory system agents|mesh-ancestor
25240792|NCT04920149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25240793|NCT04920149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240794|NCT04920149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25240795|NCT04920149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25240796|NCT04910022|Lomustine|lomustine|mesh-list
25240797|NCT04910022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25240798|NCT04910022|Alkylating Agents|alkylating agents|mesh-ancestor
25240799|NCT04910022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875137|NCT04734730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25875138|NCT04734730|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25875139|NCT04734730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875140|NCT04734730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617409|NCT01042873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617412|NCT01042951|Immunologic Factors|immunologic factors|mesh-ancestor
24617413|NCT01042951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875141|NCT04734730|Hormone Antagonists|hormone antagonists|mesh-ancestor
25875142|NCT04734730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25875143|NCT04734730|Androgen Antagonists|androgen antagonists|mesh-ancestor
25875144|NCT04734730|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25875145|NCT04729322|Metronidazole|metronidazole|mesh-list
25875146|NCT04729322|Vancomycin|vancomycin|mesh-list
25875147|NCT04729322|Neomycin|neomycin|mesh-list
24617414|NCT01043172|Gemcitabine|gemcitabine|mesh-list
24617415|NCT01043172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24617416|NCT01043172|Antimetabolites|antimetabolites|mesh-ancestor
25875148|NCT04729322|Pembrolizumab|pembrolizumab|mesh-list
25875149|NCT04729322|Nivolumab|nivolumab|mesh-list
25875150|NCT04729322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25875151|NCT04729322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875152|NCT04729322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25875153|NCT04729322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875154|NCT04729322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25875155|NCT04729322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25875156|NCT04729322|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25875157|NCT04729322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25875158|NCT04729322|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24415704|NCT00200525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415706|NCT00200538|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25875159|NCT04729322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240800|NCT04910022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25240801|NCT04756804|Ethanol|ethanol|mesh-list
25240802|NCT04756804|Chlorhexidine|chlorhexidine|mesh-list
25240803|NCT04756804|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25240804|NCT04756804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25240805|NCT04756804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25240806|NCT04756804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25240807|NCT04756804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240808|NCT04756804|Disinfectants|disinfectants|mesh-ancestor
25875160|NCT04718181|Omeprazole|omeprazole|mesh-list
25875161|NCT04718181|Risdiplam|risdiplam|mesh-list
25875162|NCT04718181|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24733890|NCT01649284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733892|NCT01649336|Antimitotic Agents|antimitotic agents|mesh-list
24733893|NCT01649336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24733894|NCT01649336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733895|NCT01649336|Tubulin Modulators|tubulin modulators|mesh-ancestor
24733896|NCT01649336|Mitosis Modulators|mitosis modulators|mesh-ancestor
24733897|NCT01649336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733898|NCT01649466|Insulin|insulin|mesh-list
24733920|NCT01649570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24733921|NCT01649570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733922|NCT01649622|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24733923|NCT01649622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24733924|NCT01649622|Alkylating Agents|alkylating agents|mesh-ancestor
24733925|NCT01649622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733926|NCT01649622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733928|NCT01649635|Prednisone|prednisone|mesh-list
24733929|NCT01649635|Lenograstim|lenograstim|mesh-list
24733930|NCT01649635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24733931|NCT01649635|Glucocorticoids|glucocorticoids|mesh-ancestor
24733932|NCT01649635|Hormones|hormones|mesh-ancestor
24733933|NCT01649635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24398137|NCT00143624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24764389|NCT01781052|Iloprost|iloprost|mesh-list
24733967|NCT01649895|Renal Agents|renal agents|mesh-ancestor
24733968|NCT01649895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24733969|NCT01649895|Antitubercular Agents|antitubercular agents|mesh-ancestor
24733970|NCT01649895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24733971|NCT01649895|Antimetabolites|antimetabolites|mesh-ancestor
24734005|NCT01650181|Thioctic Acid|thioctic acid|mesh-list
24734006|NCT01650181|Metformin|metformin|mesh-list
24734007|NCT01650181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24734008|NCT01650181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734010|NCT01650181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734011|NCT01650181|Protective Agents|protective agents|mesh-ancestor
24734013|NCT01650181|Micronutrients|micronutrients|mesh-ancestor
24734051|NCT01650428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24734052|NCT01650428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24734053|NCT01650428|Immunologic Factors|immunologic factors|mesh-ancestor
25240809|NCT04756804|Dermatologic Agents|dermatologic agents|mesh-ancestor
25240810|NCT04735068|Hydroxychloroquine|hydroxychloroquine|mesh-list
25240811|NCT04735068|Antimalarials|antimalarials|mesh-ancestor
25240812|NCT04735068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24850680|NCT02253862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24850681|NCT02253862|Urological Agents|urological agents|mesh-ancestor
24850685|NCT02253875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24850686|NCT02253875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24734085|NCT01650506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734086|NCT01650506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24734087|NCT01650506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24734088|NCT01650506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734089|NCT01650506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734090|NCT01650597|JNJ-42165279|jnj-42165279|mesh-list
24734091|NCT01650597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734092|NCT01650597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734093|NCT01650649|Lofexidine|lofexidine|mesh-list
24734095|NCT01650649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24734096|NCT01650649|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24734118|NCT01650662|Dermatologic Agents|dermatologic agents|mesh-ancestor
24734119|NCT01650662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24734120|NCT01650662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25875163|NCT04718181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25006732|NCT04685590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109770|NCT03122041|Incretins|incretins|mesh-ancestor
25109771|NCT03122041|Hormones|hormones|mesh-ancestor
25109772|NCT03122041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25109773|NCT03122041|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25109774|NCT03122041|Protease Inhibitors|protease inhibitors|mesh-ancestor
25109775|NCT03122041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416108|NCT00202020|Aspirin|aspirin|mesh-list
25240813|NCT04735068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25240814|NCT04735068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25240815|NCT04735068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240816|NCT04735068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240817|NCT04735068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25240824|NCT04667078|Cangrelor|cangrelor|mesh-list
25240825|NCT04667078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25240826|NCT04667078|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25273968|NCT02381717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24850687|NCT02253875|Protease Inhibitors|protease inhibitors|mesh-ancestor
24672449|NCT01332279|Everolimus|everolimus|mesh-list
25109776|NCT03122041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109777|NCT03121846|Apatinib|apatinib|mesh-list
24883124|NCT04452383|Ketamine|ketamine|mesh-list
24734144|NCT01650740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24734145|NCT01650740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24734146|NCT01650740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617474|NCT01043419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24617475|NCT01043419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617476|NCT01043445|Glycerol|glycerol|mesh-list
24617477|NCT01043445|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24617478|NCT01043445|Protective Agents|protective agents|mesh-ancestor
24617479|NCT01043445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617480|NCT01043484|Bevacizumab|bevacizumab|mesh-list
24617481|NCT01043484|Capecitabine|capecitabine|mesh-list
24617482|NCT01043484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24617483|NCT01043484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617484|NCT01043484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24617485|NCT01043484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25241899|NCT05178628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25241900|NCT05178628|Tubulin Modulators|tubulin modulators|mesh-ancestor
25241901|NCT05178628|Antimitotic Agents|antimitotic agents|mesh-ancestor
25241902|NCT05178628|Mitosis Modulators|mitosis modulators|mesh-ancestor
25241903|NCT05178628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241904|NCT05178628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25241905|NCT05178628|Antimetabolites|antimetabolites|mesh-ancestor
25241906|NCT05178628|Antiviral Agents|antiviral agents|mesh-ancestor
24617486|NCT01043484|Growth Substances|growth substances|mesh-ancestor
24617487|NCT01043484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617488|NCT01043484|Growth Inhibitors|growth inhibitors|mesh-ancestor
24617489|NCT01043484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24617490|NCT01043484|Antimetabolites|antimetabolites|mesh-ancestor
24617491|NCT01043484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734179|NCT01650883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24734180|NCT01650883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25875164|NCT04718181|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25875165|NCT04718181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875166|NCT04718181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875167|NCT04718181|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25875168|NCT04718181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25875169|NCT04718181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734257|NCT01651390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24734258|NCT01651390|Tubulin Modulators|tubulin modulators|mesh-ancestor
24734259|NCT01651390|Antimitotic Agents|antimitotic agents|mesh-ancestor
24734260|NCT01651390|Mitosis Modulators|mitosis modulators|mesh-ancestor
24734261|NCT01651390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734262|NCT01651390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24734263|NCT01651390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24734264|NCT01651390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24734265|NCT01651390|Antifungal Agents|antifungal agents|mesh-ancestor
24734298|NCT01651481|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24734300|NCT01651481|Histamine Antagonists|histamine antagonists|mesh-ancestor
24734301|NCT01651481|Histamine Agents|histamine agents|mesh-ancestor
24734302|NCT01651481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25240827|NCT04667078|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25240828|NCT04667078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25240829|NCT04667078|Purinergic Agents|purinergic agents|mesh-ancestor
25240830|NCT04667078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25240831|NCT04667078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240832|NCT04667078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240833|NCT04655157|Nivolumab|nivolumab|mesh-list
25240834|NCT04655157|Ipilimumab|ipilimumab|mesh-list
25240835|NCT04655157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25240836|NCT04655157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850688|NCT02253875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850689|NCT02253875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850690|NCT02253875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24850691|NCT02253875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24850692|NCT02253875|Antiviral Agents|antiviral agents|mesh-ancestor
24850693|NCT02253875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24734303|NCT01651520|Flumazenil|flumazenil|mesh-list
24734304|NCT01651520|Antidotes|antidotes|mesh-ancestor
24734305|NCT01651520|Protective Agents|protective agents|mesh-ancestor
24734306|NCT01651520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734333|NCT01651728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734334|NCT01651923|Heparin|heparin|mesh-list
24734335|NCT01651923|Calcium heparin|calcium heparin|mesh-list
24734336|NCT01651923|Anticoagulants|anticoagulants|mesh-ancestor
24734337|NCT01651923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24734338|NCT01651923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24734339|NCT01651923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734340|NCT01651962|Fentanyl|fentanyl|mesh-list
24734341|NCT01651962|Terbutaline|terbutaline|mesh-list
24734342|NCT01651962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24734343|NCT01651962|Narcotics|narcotics|mesh-ancestor
25674141|NCT01769209|Cytarabine|cytarabine|mesh-list
25674142|NCT01769209|Dexamethasone|dexamethasone|mesh-list
25674143|NCT01769209|Doxorubicin|doxorubicin|mesh-list
25674144|NCT01769209|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25674145|NCT01769209|Methotrexate|methotrexate|mesh-list
25674146|NCT01769209|Vincristine|vincristine|mesh-list
25674147|NCT01769209|Bortezomib|bortezomib|mesh-list
25674148|NCT01769209|Asparaginase|asparaginase|mesh-list
25674149|NCT01769209|Pegaspargase|pegaspargase|mesh-list
25674150|NCT01769209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24851446|NCT02256813|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24851447|NCT02256813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851448|NCT02256813|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24851449|NCT02256813|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24851450|NCT02256813|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24851451|NCT02256813|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24851452|NCT02256813|Purinergic Agents|purinergic agents|mesh-ancestor
24851453|NCT02256813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24734344|NCT01651962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24734345|NCT01651962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734393|NCT01652014|Antitubercular Agents|antitubercular agents|mesh-ancestor
24734394|NCT01652014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24734395|NCT01652014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24734397|NCT01652118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24734398|NCT01652118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24734399|NCT01652118|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24734400|NCT01652118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398659|NCT00145236|Nebivolol|nebivolol|mesh-list
24734428|NCT01652196|Protective Agents|protective agents|mesh-ancestor
24734429|NCT01652196|Vitamin B Complex|vitamin b complex|mesh-ancestor
24734430|NCT01652196|Vitamins|vitamins|mesh-ancestor
24734431|NCT01652196|Micronutrients|micronutrients|mesh-ancestor
24734432|NCT01652196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24734433|NCT01652196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24734434|NCT01652196|Growth Substances|growth substances|mesh-ancestor
24734435|NCT01652196|Growth Inhibitors|growth inhibitors|mesh-ancestor
24734436|NCT01652196|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24734437|NCT01652313|Rasagiline|rasagiline|mesh-list
24734438|NCT01652313|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24734439|NCT01652313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734440|NCT01652313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734441|NCT01652313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24734442|NCT01652313|Protective Agents|protective agents|mesh-ancestor
24734443|NCT01652313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734444|NCT01652326|Diazepam|diazepam|mesh-list
24734445|NCT01652326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24734446|NCT01652326|Anticonvulsants|anticonvulsants|mesh-ancestor
24734447|NCT01652326|Antiemetics|antiemetics|mesh-ancestor
24734448|NCT01652326|Autonomic Agents|autonomic agents|mesh-ancestor
24734486|NCT01652378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24398746|NCT00145522|Tibolone|tibolone|mesh-list
24617531|NCT01043666|Mirabegron|mirabegron|mesh-list
24617532|NCT01043666|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24617533|NCT01043666|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24617534|NCT01043666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24734527|NCT01652534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24734528|NCT01652534|Dopamine Agents|dopamine agents|mesh-ancestor
24734529|NCT01652534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24734530|NCT01652534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734531|NCT01652534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734532|NCT01652534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24398823|NCT00145873|Natriuretic Agents|natriuretic agents|mesh-ancestor
24734566|NCT01652586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24734567|NCT01652586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24734568|NCT01652586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24734569|NCT01652586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24734570|NCT01652586|Anesthetics, General|anesthetics, general|mesh-ancestor
24734571|NCT01652586|Anesthetics|anesthetics|mesh-ancestor
24734572|NCT01652586|GABA Modulators|gaba modulators|mesh-ancestor
25240837|NCT04655157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25240838|NCT04655157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273969|NCT02381717|Narcotics|narcotics|mesh-ancestor
25273970|NCT02381717|Analgesics|analgesics|mesh-ancestor
25273971|NCT02381730|Aflibercept|aflibercept|mesh-list
25273972|NCT02381730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25674151|NCT01769209|Antiemetics|antiemetics|mesh-ancestor
25674152|NCT01769209|Autonomic Agents|autonomic agents|mesh-ancestor
25674153|NCT01769209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25674154|NCT01769209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674155|NCT01769209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25674156|NCT01769209|Glucocorticoids|glucocorticoids|mesh-ancestor
25674157|NCT01769209|Hormones|hormones|mesh-ancestor
25674158|NCT01769209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25674159|NCT01769209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24850694|NCT02253875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24850695|NCT02253875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24850696|NCT02253875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24850697|NCT02253875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24850698|NCT02253875|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24850699|NCT02253888|Ritonavir|ritonavir|mesh-list
24850700|NCT02253888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24850701|NCT02253888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24850702|NCT02253888|Protease Inhibitors|protease inhibitors|mesh-ancestor
24850703|NCT02253888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734573|NCT01652586|GABA Agents|gaba agents|mesh-ancestor
24734574|NCT01652586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24734575|NCT01652586|Narcotics|narcotics|mesh-ancestor
24734610|NCT01652794|Immunologic Factors|immunologic factors|mesh-ancestor
24734611|NCT01652794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734612|NCT01652820|Gemcitabine|gemcitabine|mesh-list
24734700|NCT01653171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734702|NCT01653171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734703|NCT01653171|Antidotes|antidotes|mesh-ancestor
24734704|NCT01653171|Antifoaming Agents|antifoaming agents|mesh-ancestor
24734705|NCT01653171|Emollients|emollients|mesh-ancestor
24734706|NCT01653171|Dermatologic Agents|dermatologic agents|mesh-ancestor
24734708|NCT01653236|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24734709|NCT01653236|Antimetabolites|antimetabolites|mesh-ancestor
24734710|NCT01653236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734711|NCT01653236|Antiviral Agents|antiviral agents|mesh-ancestor
24734747|NCT01653470|Antidotes|antidotes|mesh-ancestor
24734748|NCT01653470|Protective Agents|protective agents|mesh-ancestor
24523325|NCT01855867|Tenofovir|tenofovir|mesh-list
24734782|NCT01653717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734783|NCT01653717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24734784|NCT01653717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24734828|NCT01654146|Tubulin Modulators|tubulin modulators|mesh-ancestor
24734829|NCT01654146|Antimitotic Agents|antimitotic agents|mesh-ancestor
24734830|NCT01654146|Mitosis Modulators|mitosis modulators|mesh-ancestor
24734831|NCT01654146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734832|NCT01654185|Letrozole|letrozole|mesh-list
24734833|NCT01654185|Exemestane|exemestane|mesh-list
24734834|NCT01654185|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24734835|NCT01654185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24734836|NCT01654185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24734859|NCT01654367|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24734860|NCT01654367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734861|NCT01654367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24734862|NCT01654367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734863|NCT01654367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734864|NCT01654367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24734865|NCT01654367|Hormone Antagonists|hormone antagonists|mesh-ancestor
24734866|NCT01654367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24617536|NCT01043666|Adrenergic Agents|adrenergic agents|mesh-ancestor
24736518|NCT01662700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24735080|NCT01655524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735082|NCT01655524|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24735083|NCT01655524|Purinergic Agents|purinergic agents|mesh-ancestor
24850704|NCT02253888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850705|NCT02253888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24850706|NCT02253888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24850707|NCT02253888|Antiviral Agents|antiviral agents|mesh-ancestor
24850708|NCT02253888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24850709|NCT02253888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24850755|NCT02253940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850757|NCT02253940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24735084|NCT01655524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24399375|NCT00147615|Diuretics|diuretics|mesh-ancestor
24617557|NCT01043744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24617558|NCT01043952|Remifentanil|remifentanil|mesh-list
24617559|NCT01043952|Propofol|propofol|mesh-list
24617560|NCT01043952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24617561|NCT01043952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24617562|NCT01043952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617563|NCT01043952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24735123|NCT01655706|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24735124|NCT01655706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24399457|NCT00147862|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24735157|NCT01655810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241985|NCT05072262|Analgesics|analgesics|mesh-ancestor
25241986|NCT05072262|Sensory System Agents|sensory system agents|mesh-ancestor
25241987|NCT05072262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25241988|NCT05070754|Cantharidin|cantharidin|mesh-list
25241989|NCT05070754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25241991|NCT05061017|Cyclophosphamide|cyclophosphamide|mesh-list
24735158|NCT01655810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24735159|NCT01655862|Botulinum Toxins|botulinum toxins|mesh-list
24735160|NCT01655862|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24735161|NCT01655862|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24735162|NCT01655862|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24735163|NCT01655862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24735164|NCT01655862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735165|NCT01655862|Cholinergic Agents|cholinergic agents|mesh-ancestor
24735166|NCT01655862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24735167|NCT01655862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735265|NCT01656057|Antipyretics|antipyretics|mesh-ancestor
24735266|NCT01656057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24764656|NCT01783106|Budesonide|budesonide|mesh-list
24735267|NCT01656057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24735268|NCT01656057|Antimetabolites|antimetabolites|mesh-ancestor
24735269|NCT01656057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735270|NCT01656057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24735271|NCT01656057|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24735364|NCT01656642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24735365|NCT01656642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735366|NCT01656642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735498|NCT01657331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735500|NCT01657331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24735502|NCT01657396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24735544|NCT01657487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24735545|NCT01657487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735546|NCT01657487|Glucocorticoids|glucocorticoids|mesh-ancestor
24735547|NCT01657487|Hormones|hormones|mesh-ancestor
24735645|NCT01657929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850760|NCT02253940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24764657|NCT01783106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24764688|NCT01783197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764689|NCT01783197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764690|NCT01783197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24764691|NCT01783197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24764695|NCT01783379|Micafungin|micafungin|mesh-list
24850761|NCT02253940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24735647|NCT01657929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735648|NCT01657929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24735649|NCT01657955|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24735650|NCT01657955|Chlorambucil|chlorambucil|mesh-list
24735651|NCT01657955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24735652|NCT01657955|Alkylating Agents|alkylating agents|mesh-ancestor
24735653|NCT01657955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735654|NCT01657955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24735657|NCT01657513|Infliximab|infliximab|mesh-list
24735658|NCT01657513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24735659|NCT01657513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24735690|NCT01658033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24735691|NCT01658033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24735692|NCT01658033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24735693|NCT01658033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24735694|NCT01658033|Growth Substances|growth substances|mesh-ancestor
24735695|NCT01658033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735696|NCT01658033|Growth Inhibitors|growth inhibitors|mesh-ancestor
24735697|NCT01658033|Antidotes|antidotes|mesh-ancestor
24735698|NCT01658033|Protective Agents|protective agents|mesh-ancestor
24735699|NCT01658033|Vitamin B Complex|vitamin b complex|mesh-ancestor
24735700|NCT01658033|Vitamins|vitamins|mesh-ancestor
24735701|NCT01658033|Micronutrients|micronutrients|mesh-ancestor
24735743|NCT01658319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735744|NCT01658319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25674160|NCT01769209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25674161|NCT01769209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25674162|NCT01769209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25674163|NCT01769209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25674164|NCT01769209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274053|NCT02381145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735745|NCT01658319|Immunologic Factors|immunologic factors|mesh-ancestor
24735746|NCT01658319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735747|NCT01658358|Doxorubicin|doxorubicin|mesh-list
24735780|NCT01658527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735783|NCT01658553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24735784|NCT01658553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24735785|NCT01658553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735786|NCT01658553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400190|NCT00150046|Everolimus|everolimus|mesh-list
24735816|NCT01658878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735817|NCT01658878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24735818|NCT01658878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735820|NCT01658891|Formoterol Fumarate|formoterol fumarate|mesh-list
24735821|NCT01658891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24735822|NCT01658891|Autonomic Agents|autonomic agents|mesh-ancestor
24735823|NCT01658891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24735824|NCT01658891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735825|NCT01658891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24617659|NCT01044719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24617660|NCT01044719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24617661|NCT01044810|Efavirenz|efavirenz|mesh-list
24617662|NCT01044810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24617663|NCT01044810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24617664|NCT01044810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617693|NCT01045018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24617694|NCT01045018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25875170|NCT04708782|Treprostinil|treprostinil|mesh-list
24617695|NCT01045083|Methylphenidate|methylphenidate|mesh-list
24617696|NCT01045083|Citalopram|citalopram|mesh-list
24617697|NCT01045083|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24617730|NCT01045304|Gemcitabine|gemcitabine|mesh-list
25240862|NCT04585477|Durvalumab|durvalumab|mesh-list
25240863|NCT04585477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25240864|NCT04585477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25240865|NCT04578613|Rituximab|rituximab|mesh-list
25240866|NCT04578613|Chlorambucil|chlorambucil|mesh-list
24850771|NCT02253953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24850772|NCT02253953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24850773|NCT02253953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24850774|NCT02253966|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24850775|NCT02253966|Methylprednisolone|methylprednisolone|mesh-list
24850776|NCT02253966|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25068422|NCT03433378|Tretinoin|tretinoin|mesh-list
24617731|NCT01045304|Carboplatin|carboplatin|mesh-list
24617732|NCT01045304|Iniparib|iniparib|mesh-list
24617733|NCT01045304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617734|NCT01045304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24617735|NCT01045304|Antimetabolites|antimetabolites|mesh-ancestor
24617736|NCT01045304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617737|NCT01045304|Antiviral Agents|antiviral agents|mesh-ancestor
24617738|NCT01045304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24617739|NCT01045304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764724|NCT01783756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24735902|NCT01659242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24735903|NCT01659242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24735904|NCT01659242|Analgesics|analgesics|mesh-ancestor
24735905|NCT01659242|Sensory System Agents|sensory system agents|mesh-ancestor
24735959|NCT01659359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24735960|NCT01659359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24735961|NCT01659359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24400390|NCT00150449|Pregabalin|pregabalin|mesh-list
24617742|NCT01045304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617743|NCT01045304|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24617745|NCT01045369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24617746|NCT01045369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24617747|NCT01045369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617748|NCT01045369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617749|NCT01045369|Antiviral Agents|antiviral agents|mesh-ancestor
24617750|NCT01045369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24617751|NCT01045434|Omeprazole|omeprazole|mesh-list
24617752|NCT01045434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25674165|NCT01769209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617753|NCT01045434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25674166|NCT01769209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25242033|NCT05037812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24617754|NCT01045434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24617755|NCT01045434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617756|NCT01045434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617757|NCT01045538|Capecitabine|capecitabine|mesh-list
24420877|NCT00217048|Urological Agents|urological agents|mesh-ancestor
24617758|NCT01045538|Vorinostat|vorinostat|mesh-list
25674167|NCT01769209|Abortifacient Agents|abortifacient agents|mesh-ancestor
25674168|NCT01769209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25674169|NCT01769209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25674170|NCT01769209|Antimetabolites|antimetabolites|mesh-ancestor
25674171|NCT01769209|Dermatologic Agents|dermatologic agents|mesh-ancestor
25674172|NCT01769209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24617759|NCT01045538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617760|NCT01045538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24736012|NCT01659684|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24736014|NCT01659684|gamma-Globulins|gamma-globulins|mesh-list
24650773|NCT01227876|Glucocorticoids|glucocorticoids|mesh-ancestor
24736048|NCT01659892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24736049|NCT01659892|Respiratory System Agents|respiratory system agents|mesh-ancestor
24736050|NCT01659892|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24736051|NCT01659892|Hormone Antagonists|hormone antagonists|mesh-ancestor
24736182|NCT01660620|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24789800|NCT01939327|Lenalidomide|lenalidomide|mesh-list
24789801|NCT01939327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24764825|NCT01784380|Metformin|metformin|mesh-list
24789802|NCT01939327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25240867|NCT04578613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25240868|NCT04578613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25240869|NCT04578613|Immunologic Factors|immunologic factors|mesh-ancestor
25240870|NCT04578613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240871|NCT04578613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25240872|NCT04578613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25240873|NCT04578613|Alkylating Agents|alkylating agents|mesh-ancestor
24850777|NCT02253966|Prednisolone|prednisolone|mesh-list
24850778|NCT02253966|Prednisolone acetate|prednisolone acetate|mesh-list
24850779|NCT02253966|Lidocaine|lidocaine|mesh-list
24850780|NCT02253966|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24850781|NCT02253966|Prednisolone phosphate|prednisolone phosphate|mesh-list
24850782|NCT02253966|Anesthetics, Local|anesthetics, local|mesh-ancestor
24850783|NCT02253966|Anesthetics|anesthetics|mesh-ancestor
25068427|NCT03433352|Propylthiouracil|propylthiouracil|mesh-list
25006754|NCT04668365|Epirubicin|epirubicin|mesh-list
25006755|NCT04668365|Zanubrutinib|zanubrutinib|mesh-list
25006756|NCT04668365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25006757|NCT04668365|Immunologic Factors|immunologic factors|mesh-ancestor
25006758|NCT04668365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006759|NCT04668365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25006760|NCT04668365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25006761|NCT04668365|Alkylating Agents|alkylating agents|mesh-ancestor
25006762|NCT04668365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006763|NCT04668365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006764|NCT04668365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25006765|NCT04668365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25006766|NCT04668365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25006767|NCT04668365|Glucocorticoids|glucocorticoids|mesh-ancestor
25006768|NCT04668365|Hormones|hormones|mesh-ancestor
25006769|NCT04668365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25006770|NCT04668365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25006771|NCT04668365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25006772|NCT04668365|Tubulin Modulators|tubulin modulators|mesh-ancestor
25006773|NCT04668365|Antimitotic Agents|antimitotic agents|mesh-ancestor
25006774|NCT04668365|Mitosis Modulators|mitosis modulators|mesh-ancestor
24764842|NCT01784445|Ceftazidime|ceftazidime|mesh-list
25080168|NCT03341390|Sensory System Agents|sensory system agents|mesh-ancestor
25006775|NCT04668365|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24736084|NCT01659931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24736085|NCT01659931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24736086|NCT01659931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736088|NCT01659944|Eliglustat|eliglustat|mesh-list
24736089|NCT01659944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25674173|NCT01769209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25413364|NCT03136146|Mitosis Modulators|mitosis modulators|mesh-ancestor
24736176|NCT01660620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24736177|NCT01660620|Sympatholytics|sympatholytics|mesh-ancestor
24736178|NCT01660620|Autonomic Agents|autonomic agents|mesh-ancestor
24736179|NCT01660620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24736180|NCT01660620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736181|NCT01660620|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24736183|NCT01660620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24736184|NCT01660620|Adrenergic Agents|adrenergic agents|mesh-ancestor
24736185|NCT01660620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24400671|NCT00151073|Alkylating Agents|alkylating agents|mesh-ancestor
24736210|NCT01660854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24736211|NCT01660854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24736212|NCT01660854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24736213|NCT01660854|Antimetabolites|antimetabolites|mesh-ancestor
24736214|NCT01660854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736216|NCT01660867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24736217|NCT01660867|Antiemetics|antiemetics|mesh-ancestor
24736218|NCT01660867|Autonomic Agents|autonomic agents|mesh-ancestor
25080179|NCT03341390|Antipyretics|antipyretics|mesh-ancestor
24736219|NCT01660867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24736220|NCT01660867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240874|NCT04578613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240876|NCT04576546|Vitamin B Complex|vitamin b complex|mesh-ancestor
25240878|NCT04576546|Micronutrients|micronutrients|mesh-ancestor
25240879|NCT04576546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240880|NCT04566653|Calcium|calcium|mesh-list
25240881|NCT04566653|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
24850784|NCT02253966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24850785|NCT02253966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850786|NCT02253966|Sensory System Agents|sensory system agents|mesh-ancestor
24850787|NCT02253966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24850788|NCT02253966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24850789|NCT02253966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25068438|NCT03433235|Edoxaban|edoxaban|mesh-list
24736221|NCT01660867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24736222|NCT01660867|Glucocorticoids|glucocorticoids|mesh-ancestor
24736223|NCT01660867|Hormones|hormones|mesh-ancestor
24736224|NCT01660867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24736225|NCT01660867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24736226|NCT01660867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24736227|NCT01660919|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24736228|NCT01660919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24736229|NCT01660919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24736230|NCT01660919|Antimetabolites|antimetabolites|mesh-ancestor
24736231|NCT01660919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736232|NCT01660919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24400712|NCT00151203|Antiemetics|antiemetics|mesh-ancestor
24421691|NCT00219908|Analgesics|analgesics|mesh-ancestor
24421692|NCT00219908|Sensory System Agents|sensory system agents|mesh-ancestor
24421693|NCT00219908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24421694|NCT00219908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736305|NCT01661322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24736306|NCT01661322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24736307|NCT01661322|Antipyretics|antipyretics|mesh-ancestor
24736308|NCT01661322|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24736309|NCT01661322|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24736310|NCT01661322|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24736311|NCT01661322|Purinergic Agents|purinergic agents|mesh-ancestor
24736312|NCT01661322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24736341|NCT01661335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24736342|NCT01661335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24736343|NCT01661335|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24736345|NCT01661439|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24736473|NCT01662466|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24736474|NCT01662466|Androgens|androgens|mesh-ancestor
24736475|NCT01662466|Hormones|hormones|mesh-ancestor
24736476|NCT01662466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24736477|NCT01662466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736478|NCT01662466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24736479|NCT01662466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24736480|NCT01662466|Anabolic Agents|anabolic agents|mesh-ancestor
24400981|NCT00151827|Losartan|losartan|mesh-list
24736510|NCT01662687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24399699|NCT00148447|Citalopram|citalopram|mesh-list
24736511|NCT01662687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24736513|NCT01662687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24736514|NCT01662687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736515|NCT01662700|Artesunate|artesunate|mesh-list
24736516|NCT01662700|Chloroquine|chloroquine|mesh-list
24736517|NCT01662700|Antimalarials|antimalarials|mesh-ancestor
24736519|NCT01662700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24736520|NCT01662700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24736521|NCT01662700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24736522|NCT01662700|Antiviral Agents|antiviral agents|mesh-ancestor
24736523|NCT01662700|Schistosomicides|schistosomicides|mesh-ancestor
24736524|NCT01662700|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24736525|NCT01662700|Anthelmintics|anthelmintics|mesh-ancestor
24736526|NCT01662700|Amebicides|amebicides|mesh-ancestor
24736527|NCT01662700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24736528|NCT01662804|Interleukin-2|interleukin-2|mesh-list
24617822|NCT01045889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24877395|NCT02718404|Analgesics|analgesics|mesh-list
24617823|NCT01045889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24650850|NCT01228240|Metformin|metformin|mesh-list
25240882|NCT04566653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25240883|NCT04566653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240884|NCT04566653|Chelating Agents|chelating agents|mesh-ancestor
25240885|NCT04566653|Sequestering Agents|sequestering agents|mesh-ancestor
25240886|NCT04566653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240887|NCT04551677|Vaccines|vaccines|mesh-list
25240888|NCT04551677|Immunologic Factors|immunologic factors|mesh-ancestor
24850791|NCT02253966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24850792|NCT02253966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850793|NCT02253966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24850794|NCT02253966|Antiemetics|antiemetics|mesh-ancestor
24812175|NCT02050074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24812176|NCT02050152|Nitrous Oxide|nitrous oxide|mesh-list
24850804|NCT02254005|Maytansine|maytansine|mesh-list
24850805|NCT02254005|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
25875171|NCT04708782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25875172|NCT04671667|Cisplatin|cisplatin|mesh-list
25068446|NCT03433222|Coal Tar|coal tar|mesh-list
24617832|NCT01045889|Hormones|hormones|mesh-ancestor
24736562|NCT01662921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525279|NCT03709758|Antimetabolites|antimetabolites|mesh-ancestor
24736563|NCT01663038|Aspirin|aspirin|mesh-list
24736564|NCT01663038|Clopidogrel|clopidogrel|mesh-list
24401047|NCT00152035|Amphetamine|amphetamine|mesh-list
24736596|NCT01663077|GABA Agents|gaba agents|mesh-ancestor
24736597|NCT01663090|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24736598|NCT01663090|Hematinics|hematinics|mesh-ancestor
24736599|NCT01663090|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24736600|NCT01663090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24736602|NCT01663168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24736603|NCT01663168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24736604|NCT01663168|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24736605|NCT01663168|Antitubercular Agents|antitubercular agents|mesh-ancestor
24736618|NCT01663662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736619|NCT01663753|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24736620|NCT01663753|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24736621|NCT01663753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736693|NCT01664650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736695|NCT01664650|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24736696|NCT01664650|Estrogens|estrogens|mesh-ancestor
24736697|NCT01664650|Hormones|hormones|mesh-ancestor
24736698|NCT01664650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24736699|NCT01664676|Liraglutide|liraglutide|mesh-list
24736700|NCT01664676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24617873|NCT01045928|Growth Substances|growth substances|mesh-ancestor
24617874|NCT01045928|Growth Inhibitors|growth inhibitors|mesh-ancestor
24736813|NCT01665235|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24736814|NCT01665235|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24736815|NCT01665235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24737082|NCT01666678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737084|NCT01666678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24737085|NCT01666678|Gout Suppressants|gout suppressants|mesh-ancestor
24737086|NCT01666678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24737087|NCT01666678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575050|NCT00829192|Afamelanotide|afamelanotide|mesh-list
24737088|NCT01666678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875173|NCT04671667|Carboplatin|carboplatin|mesh-list
24737089|NCT01666678|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25242102|NCT04974996|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
25242103|NCT04974996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24737090|NCT01666678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24737091|NCT01666678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24737092|NCT01666678|Anesthetics, Local|anesthetics, local|mesh-ancestor
24737131|NCT01667094|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
24737132|NCT01667094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24765000|NCT01785589|Sensory System Agents|sensory system agents|mesh-ancestor
24765001|NCT01785589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24765029|NCT01785693|Sensory System Agents|sensory system agents|mesh-ancestor
25240889|NCT04551677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240891|NCT04530058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25240892|NCT04530058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875174|NCT04671667|Pembrolizumab|pembrolizumab|mesh-list
25875175|NCT04671667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737173|NCT01667315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737174|NCT01667445|Morphine|morphine|mesh-list
24737175|NCT01667445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24737212|NCT01667575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24737213|NCT01667575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737214|NCT01667575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24737252|NCT01667718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24737284|NCT01668056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24737285|NCT01668056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737287|NCT01668069|Antiemetics|antiemetics|mesh-ancestor
24737288|NCT01668069|Autonomic Agents|autonomic agents|mesh-ancestor
24737289|NCT01668069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737290|NCT01668069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737291|NCT01668069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24737465|NCT01669044|Sensory System Agents|sensory system agents|mesh-ancestor
24765030|NCT01785693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737466|NCT01669044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737503|NCT01669239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24737504|NCT01669239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24737505|NCT01669239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737541|NCT01669369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24737568|NCT01669707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24737569|NCT01669707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24737570|NCT01669707|Growth Substances|growth substances|mesh-ancestor
24737571|NCT01669707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737572|NCT01669707|Growth Inhibitors|growth inhibitors|mesh-ancestor
24737573|NCT01669707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737580|NCT01669824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737581|NCT01669824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24737582|NCT01669824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24737583|NCT01669824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24737584|NCT01669824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25068456|NCT03433196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737626|NCT01670071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737627|NCT01670071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737667|NCT01670084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24737704|NCT01670162|Growth Substances|growth substances|mesh-ancestor
24737705|NCT01670162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737706|NCT01670162|Growth Inhibitors|growth inhibitors|mesh-ancestor
24737737|NCT01670318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737739|NCT01670318|Micronutrients|micronutrients|mesh-ancestor
24883401|NCT03852888|Methotrexate|methotrexate|mesh-list
24737927|NCT01671787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737928|NCT01671787|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24737929|NCT01671787|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24737930|NCT01671800|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
24737931|NCT01671800|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24737932|NCT01671800|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24737933|NCT01671800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24737934|NCT01671800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737967|NCT01671982|Antiviral Agents|antiviral agents|mesh-ancestor
25674174|NCT01769209|Immunologic Factors|immunologic factors|mesh-ancestor
25674175|NCT01769209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24737968|NCT01671982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25674176|NCT01769209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25674177|NCT01769209|Antiviral Agents|antiviral agents|mesh-ancestor
25674178|NCT01769209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24400752|NCT00151242|Keratolytic Agents|keratolytic agents|mesh-ancestor
25242140|NCT04955158|Adrenergic Agents|adrenergic agents|mesh-ancestor
25242141|NCT04955158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24737969|NCT01671982|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24737970|NCT01671982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24737971|NCT01671982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737972|NCT01671982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737973|NCT01671982|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24737974|NCT01671982|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24737975|NCT01672047|Vitamin D|vitamin d|mesh-list
24737976|NCT01672047|Ergocalciferols|ergocalciferols|mesh-list
24737977|NCT01672047|Vitamins|vitamins|mesh-ancestor
24402530|NCT00157651|Warfarin|warfarin|mesh-list
24738014|NCT01672346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24738015|NCT01672346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738016|NCT01672346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24738101|NCT01673087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738102|NCT01673087|Antimetabolites|antimetabolites|mesh-ancestor
24738103|NCT01673087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738104|NCT01673087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24738105|NCT01673204|Calcitriol|calcitriol|mesh-list
24738106|NCT01673204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24738107|NCT01673204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738108|NCT01673204|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24738109|NCT01673204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24738110|NCT01673204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738111|NCT01673204|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25240916|NCT04498832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875176|NCT04671667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25875177|NCT04668157|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25875178|NCT04668157|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24493676|NCT00491946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25006811|NCT04629378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24738143|NCT01673399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24738144|NCT01673399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738145|NCT01673399|Tocolytic Agents|tocolytic agents|mesh-ancestor
24738146|NCT01673399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24738147|NCT01673542|Lidocaine|lidocaine|mesh-list
24738148|NCT01673542|Prilocaine|prilocaine|mesh-list
24738149|NCT01673542|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24738150|NCT01673542|Anesthetics, Local|anesthetics, local|mesh-ancestor
24738151|NCT01673542|Anesthetics|anesthetics|mesh-ancestor
24738152|NCT01673542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24738153|NCT01673542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738154|NCT01673542|Sensory System Agents|sensory system agents|mesh-ancestor
24738155|NCT01673542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24738156|NCT01673542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24738157|NCT01673542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24738158|NCT01673542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24738159|NCT01673542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24738160|NCT01673542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738161|NCT01673542|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24738162|NCT01673724|Pramipexole|pramipexole|mesh-list
24738163|NCT01673724|Bromocriptine|bromocriptine|mesh-list
24738164|NCT01673724|Antioxidants|antioxidants|mesh-ancestor
24738165|NCT01673724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738166|NCT01673724|Protective Agents|protective agents|mesh-ancestor
24738167|NCT01673724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240917|NCT04487925|Hormones|hormones|mesh-list
25240918|NCT04487925|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25240919|NCT04487925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25240920|NCT04487925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240921|NCT04451837|Dapagliflozin|dapagliflozin|mesh-list
25240922|NCT04451837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25240923|NCT04451837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240924|NCT04451837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25240925|NCT04451837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240926|NCT04430036|Gemcitabine|gemcitabine|mesh-list
25240927|NCT04430036|Cisplatin|cisplatin|mesh-list
25133004|NCT03016091|Pembrolizumab|pembrolizumab|mesh-list
25674179|NCT01769209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25674180|NCT01769209|Tubulin Modulators|tubulin modulators|mesh-ancestor
25674181|NCT01769209|Antimitotic Agents|antimitotic agents|mesh-ancestor
24790160|NCT01941134|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25007172|NCT04074785|Bevacizumab|bevacizumab|mesh-list
25007173|NCT04074785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25007174|NCT04074785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007186|NCT04069585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25007187|NCT04069585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25007188|NCT04069585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25007189|NCT04069585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24775666|NCT01854203|Gemcitabine|gemcitabine|mesh-list
25240928|NCT04430036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25240929|NCT04430036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25240930|NCT04430036|Antimetabolites|antimetabolites|mesh-ancestor
25240931|NCT04430036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240932|NCT04430036|Antiviral Agents|antiviral agents|mesh-ancestor
25240933|NCT04430036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25240934|NCT04430036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240935|NCT04430036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25240936|NCT04430036|Immunologic Factors|immunologic factors|mesh-ancestor
24955495|NCT03864250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24444823|NCT00299234|Adrenergic Agents|adrenergic agents|mesh-ancestor
24444824|NCT00299234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25875179|NCT04668157|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25875180|NCT04668157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738168|NCT01673724|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24738169|NCT01673724|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24738170|NCT01673724|Dopamine Agonists|dopamine agonists|mesh-ancestor
24738171|NCT01673724|Dopamine Agents|dopamine agents|mesh-ancestor
24738240|NCT01674257|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24738241|NCT01674257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24738242|NCT01674270|Bicalutamide|bicalutamide|mesh-list
24738243|NCT01674270|Androgen Antagonists|androgen antagonists|mesh-ancestor
24738245|NCT01674270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25875181|NCT04666610|Brivaracetam|brivaracetam|mesh-list
24738281|NCT01674556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24738283|NCT01674556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738284|NCT01674556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738285|NCT01674556|Antiviral Agents|antiviral agents|mesh-ancestor
24738286|NCT01674556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24738287|NCT01674556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24738321|NCT01674777|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24738322|NCT01674777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738323|NCT01674777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24738324|NCT01674777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738326|NCT01674842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738363|NCT01675024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738426|NCT01675362|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25875182|NCT04666610|Anticonvulsants|anticonvulsants|mesh-ancestor
24738427|NCT01675362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738428|NCT01675362|Protective Agents|protective agents|mesh-ancestor
24738429|NCT01675362|Trace Elements|trace elements|mesh-ancestor
24738430|NCT01675362|Micronutrients|micronutrients|mesh-ancestor
24738431|NCT01675362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24738432|NCT01675362|Vasodilator Agents|vasodilator agents|mesh-ancestor
24738434|NCT01675466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24738435|NCT01675466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738436|NCT01675518|ASP7991|asp7991|mesh-list
24738437|NCT01675518|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24617949|NCT01046214|Dopamine Agents|dopamine agents|mesh-ancestor
24617950|NCT01046214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24617951|NCT01046214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738443|NCT01675557|Cholecalciferol|cholecalciferol|mesh-list
24738444|NCT01675557|Vitamins|vitamins|mesh-list
24738445|NCT01675557|Micronutrients|micronutrients|mesh-ancestor
25674182|NCT01769209|Mitosis Modulators|mitosis modulators|mesh-ancestor
25674183|NCT01769222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25674184|NCT01769222|Ipilimumab|ipilimumab|mesh-list
25674185|NCT01769222|Antibodies|antibodies|mesh-list
25674186|NCT01769222|Immunoglobulins|immunoglobulins|mesh-list
25674187|NCT01769222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25674188|NCT01769222|Immunologic Factors|immunologic factors|mesh-ancestor
25674189|NCT01769222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674190|NCT01769222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25674191|NCT01769222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24765483|NCT01788774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24738446|NCT01675557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738447|NCT01675557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24738448|NCT01675557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24738449|NCT01675648|Lofexidine|lofexidine|mesh-list
24738450|NCT01675648|Clonidine|clonidine|mesh-list
24738451|NCT01675648|Diazepam|diazepam|mesh-list
24738452|NCT01675648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24738453|NCT01675648|Anticonvulsants|anticonvulsants|mesh-ancestor
24738454|NCT01675648|Antiemetics|antiemetics|mesh-ancestor
24738455|NCT01675648|Autonomic Agents|autonomic agents|mesh-ancestor
25240937|NCT04430036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25240938|NCT04401982|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25240939|NCT04401982|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25240940|NCT04397406|Fentanyl|fentanyl|mesh-list
25240941|NCT04397406|Dexmedetomidine|dexmedetomidine|mesh-list
25240942|NCT04397406|Levobupivacaine|levobupivacaine|mesh-list
25240943|NCT04397406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25240944|NCT04397406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25240945|NCT04397406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875183|NCT04657302|Obinutuzumab|obinutuzumab|mesh-list
25875184|NCT04657302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25875185|NCT04657302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875186|NCT04650854|Rozanolixizumab|rozanolixizumab|mesh-list
24850882|NCT02254174|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24850883|NCT02254174|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24850885|NCT02254174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24850886|NCT02254174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850887|NCT02254174|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24493729|NCT00492219|Cimetidine|cimetidine|mesh-list
24850919|NCT02254226|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24850921|NCT02254226|Adrenergic Agents|adrenergic agents|mesh-ancestor
25068497|NCT03432975|Povidone-Iodine|povidone-iodine|mesh-list
24738456|NCT01675648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24403025|NCT00159081|Dopamine Agents|dopamine agents|mesh-ancestor
24738527|NCT01675973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24738528|NCT01675973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24738529|NCT01675973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738558|NCT01675999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738609|NCT01676363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24738640|NCT01676558|Rituximab|rituximab|mesh-list
24738641|NCT01676558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24738642|NCT01676558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738643|NCT01676558|Immunologic Factors|immunologic factors|mesh-ancestor
24738644|NCT01676558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738645|NCT01676558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24738646|NCT01676571|Vortioxetine|vortioxetine|mesh-list
24738647|NCT01676571|Antidepressive Agents|antidepressive agents|mesh-ancestor
24738648|NCT01676571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24738649|NCT01676571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24738650|NCT01676571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24738651|NCT01676571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24738652|NCT01676571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738653|NCT01676571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24738721|NCT01677039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24738755|NCT01677260|Metformin|metformin|mesh-list
24738756|NCT01677260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24738757|NCT01677260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738758|NCT01677273|Caseins|caseins|mesh-list
24738759|NCT01677273|Chelating Agents|chelating agents|mesh-ancestor
24738760|NCT01677273|Sequestering Agents|sequestering agents|mesh-ancestor
24738761|NCT01677273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738762|NCT01677351|Clonidine|clonidine|mesh-list
24738800|NCT01677468|Hemostatics|hemostatics|mesh-ancestor
24877786|NCT02417103|Liraglutide|liraglutide|mesh-list
24738801|NCT01677468|Coagulants|coagulants|mesh-ancestor
24738803|NCT01677546|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24617955|NCT01046227|Vaccines|vaccines|mesh-list
24617956|NCT01046227|Immunologic Factors|immunologic factors|mesh-ancestor
24617957|NCT01046227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617958|NCT01046240|Palonosetron|palonosetron|mesh-list
24738871|NCT01677949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24738872|NCT01677949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24738937|NCT01678365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24738938|NCT01678365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24738939|NCT01678365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25875187|NCT04650854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25875188|NCT04650854|Immunologic Factors|immunologic factors|mesh-ancestor
24400990|NCT00151827|Diuretics|diuretics|mesh-ancestor
24440959|NCT00285415|Carboplatin|carboplatin|mesh-list
24401090|NCT00152178|Fluorouracil|fluorouracil|mesh-list
24401091|NCT00152178|Methotrexate|methotrexate|mesh-list
24738940|NCT01678365|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24738941|NCT01678365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24738942|NCT01678365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240946|NCT04397406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25240947|NCT04397406|Analgesics|analgesics|mesh-ancestor
25240948|NCT04397406|Sensory System Agents|sensory system agents|mesh-ancestor
25240949|NCT04397406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25240950|NCT04397406|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25240951|NCT04397406|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25240952|NCT04397406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25240953|NCT04397406|Adrenergic Agents|adrenergic agents|mesh-ancestor
25240954|NCT04397406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25240955|NCT04397406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240956|NCT04397406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25240957|NCT04397406|Narcotics|narcotics|mesh-ancestor
25240958|NCT04397406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25240959|NCT04397406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24850923|NCT02254226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850924|NCT02254239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24738944|NCT01678404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24739013|NCT01678690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24739014|NCT01678690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24739015|NCT01678690|Immunologic Factors|immunologic factors|mesh-ancestor
24739016|NCT01678690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739017|NCT01678703|Misoprostol|misoprostol|mesh-list
24739018|NCT01678703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24739019|NCT01678703|Abortifacient Agents|abortifacient agents|mesh-ancestor
24739020|NCT01678703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24403636|NCT00161122|Vaccines|vaccines|mesh-list
24739149|NCT01679561|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24739150|NCT01679561|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24739225|NCT01679964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24739226|NCT01679964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24739227|NCT01679964|Antiviral Agents|antiviral agents|mesh-ancestor
24739228|NCT01679964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24739229|NCT01679964|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24739230|NCT01679964|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24739231|NCT01679964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24739232|NCT01679964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739234|NCT01680042|Anticonvulsants|anticonvulsants|mesh-ancestor
24739235|NCT01680042|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24739236|NCT01680042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24739237|NCT01680042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24739238|NCT01680042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739239|NCT01680042|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24739240|NCT01680042|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24739271|NCT01680146|Chelating Agents|chelating agents|mesh-ancestor
24739272|NCT01680146|Sequestering Agents|sequestering agents|mesh-ancestor
24789861|NCT01939483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24789862|NCT01939509|Atenolol|atenolol|mesh-list
24789863|NCT01939509|Bisoprolol|bisoprolol|mesh-list
24789864|NCT01939509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24789865|NCT01939509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24618003|NCT01046461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618004|NCT01046461|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24618005|NCT01046461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24618006|NCT01046461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618007|NCT01046461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24618008|NCT01046461|Serotonin Agents|serotonin agents|mesh-ancestor
24618009|NCT01046487|Cyclophosphamide|cyclophosphamide|mesh-list
24618010|NCT01046487|Imatinib Mesylate|imatinib mesylate|mesh-list
24618011|NCT01046487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24618012|NCT01046487|Immunologic Factors|immunologic factors|mesh-ancestor
25674192|NCT01769222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674193|NCT01769339|Miconazole|miconazole|mesh-list
25674194|NCT01769339|Hydrocortisone|hydrocortisone|mesh-list
25674195|NCT01769339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25674196|NCT01769339|Antifungal Agents|antifungal agents|mesh-ancestor
25875189|NCT04650854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875190|NCT04639843|Doxorubicin|doxorubicin|mesh-list
25875191|NCT04639843|Romidepsin|romidepsin|mesh-list
25875192|NCT04639843|Azacitidine|azacitidine|mesh-list
25875193|NCT04639843|Cc-486|cc-486|mesh-list
25875194|NCT04639843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25875195|NCT04639843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875196|NCT04639843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24618047|NCT01046578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24618049|NCT01046630|Ketamine|ketamine|mesh-list
24618050|NCT01046630|Analgesics|analgesics|mesh-ancestor
24618051|NCT01046630|Sensory System Agents|sensory system agents|mesh-ancestor
24618052|NCT01046630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24403945|NCT00162214|Dasatinib|dasatinib|mesh-list
24739336|NCT01680536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24739337|NCT01680536|Antiviral Agents|antiviral agents|mesh-ancestor
24739338|NCT01680536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24739339|NCT01680536|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24739341|NCT01680679|Immunologic Factors|immunologic factors|mesh-ancestor
24739342|NCT01680679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739343|NCT01680718|Vasopressins|vasopressins|mesh-list
24739344|NCT01680718|Arginine Vasopressin|arginine vasopressin|mesh-list
24739345|NCT01680718|Oxytocin|oxytocin|mesh-list
24739346|NCT01680718|Oxytocics|oxytocics|mesh-ancestor
24739347|NCT01680718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24739348|NCT01680718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739349|NCT01680718|Hemostatics|hemostatics|mesh-ancestor
25006820|NCT04616183|Immunoglobulins|immunoglobulins|mesh-list
25006821|NCT04616183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25240960|NCT04397406|Anesthetics, General|anesthetics, general|mesh-ancestor
25240961|NCT04397406|Anesthetics|anesthetics|mesh-ancestor
25240962|NCT04397406|Anesthetics, Local|anesthetics, local|mesh-ancestor
25240963|NCT04392921|Amiodarone|amiodarone|mesh-list
25240964|NCT04392921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24765715|NCT01790022|Antiemetics|antiemetics|mesh-ancestor
24739550|NCT01682408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739551|NCT01682421|Dexamethasone|dexamethasone|mesh-list
24739552|NCT01682421|Dexamethasone acetate|dexamethasone acetate|mesh-list
24739553|NCT01682421|BB 1101|bb 1101|mesh-list
24739554|NCT01682421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739555|NCT01682421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739556|NCT01682421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24739557|NCT01682421|Antiemetics|antiemetics|mesh-ancestor
24739558|NCT01682421|Autonomic Agents|autonomic agents|mesh-ancestor
24739559|NCT01682421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24739560|NCT01682421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24739561|NCT01682421|Glucocorticoids|glucocorticoids|mesh-ancestor
24739563|NCT01682421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24739597|NCT01682733|Botulinum Toxins|botulinum toxins|mesh-list
24739598|NCT01682733|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24739599|NCT01682733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24739600|NCT01682733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739635|NCT01683032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24618055|NCT01046630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24618056|NCT01046630|Anesthetics, General|anesthetics, general|mesh-ancestor
24739647|NCT01683162|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24739648|NCT01683175|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24739649|NCT01683175|Vinorelbine|vinorelbine|mesh-list
24739651|NCT01683175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739752|NCT01683760|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24739753|NCT01683786|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24739754|NCT01683786|Antiviral Agents|antiviral agents|mesh-ancestor
24739789|NCT01684111|Nintedanib|nintedanib|mesh-list
24739790|NCT01684111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24739791|NCT01684111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875197|NCT04639843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24739792|NCT01684111|Tubulin Modulators|tubulin modulators|mesh-ancestor
24739793|NCT01684111|Antimitotic Agents|antimitotic agents|mesh-ancestor
24739794|NCT01684111|Mitosis Modulators|mitosis modulators|mesh-ancestor
24739829|NCT01684449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24739830|NCT01684449|Antifungal Agents|antifungal agents|mesh-ancestor
24739832|NCT01684657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25674197|NCT01769339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25674198|NCT01769339|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25674199|NCT01769339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25674200|NCT01769339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24739935|NCT01685125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045188|NCT00987272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045189|NCT00987272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045190|NCT00987272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25045191|NCT00987272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25045192|NCT00987272|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24739936|NCT01685125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24739937|NCT01685125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24739938|NCT01685125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240965|NCT04392921|Vasodilator Agents|vasodilator agents|mesh-ancestor
25240966|NCT04392921|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25240967|NCT04392921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25240968|NCT04392921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25240969|NCT04392921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25240970|NCT04392921|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24740065|NCT01686217|Peficitinib|peficitinib|mesh-list
24740066|NCT01686217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24740067|NCT01686217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740068|NCT01686217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24740069|NCT01686217|Immunologic Factors|immunologic factors|mesh-ancestor
24740070|NCT01686217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740071|NCT01686217|Vitamin B Complex|vitamin b complex|mesh-ancestor
24740072|NCT01686217|Vitamins|vitamins|mesh-ancestor
24740073|NCT01686217|Micronutrients|micronutrients|mesh-ancestor
24740074|NCT01686256|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
24740075|NCT01686256|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24740076|NCT01686256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740077|NCT01686321|Rituximab|rituximab|mesh-list
24740114|NCT01686386|Alkylating Agents|alkylating agents|mesh-ancestor
24740115|NCT01686386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740149|NCT01686607|Anidulafungin|anidulafungin|mesh-list
24740150|NCT01686607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24740151|NCT01686607|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24740152|NCT01686607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24740153|NCT01686607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24740154|NCT01686607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740155|NCT01686607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24740376|NCT01688089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740377|NCT01688089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740378|NCT01688089|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24740380|NCT01688089|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24740381|NCT01688154|Proanthocyanidin|proanthocyanidin|mesh-list
24740382|NCT01688154|Procyanidin|procyanidin|mesh-list
24740383|NCT01688154|Antioxidants|antioxidants|mesh-ancestor
24740384|NCT01688154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740418|NCT01688401|Alkylating Agents|alkylating agents|mesh-ancestor
24740419|NCT01688401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740420|NCT01688401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24740421|NCT01688401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24651317|NCT01230983|Mitosis Modulators|mitosis modulators|mesh-ancestor
24740422|NCT01688401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24740423|NCT01688401|Immunologic Factors|immunologic factors|mesh-ancestor
24740424|NCT01688401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740431|NCT01688518|Tetracaine|tetracaine|mesh-list
24740432|NCT01688518|Anesthetics, Local|anesthetics, local|mesh-ancestor
24740496|NCT01688648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24740497|NCT01688648|Analgesics|analgesics|mesh-ancestor
24740498|NCT01688648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24740533|NCT01688947|Pregabalin|pregabalin|mesh-list
25240971|NCT04392921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25240972|NCT04392921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25240973|NCT04392921|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25240974|NCT04392921|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25240975|NCT04392921|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25240976|NCT04342585|Progesterone|progesterone|mesh-list
25240977|NCT04342585|Progestins|progestins|mesh-ancestor
25240978|NCT04342585|Hormones|hormones|mesh-ancestor
24953539|NCT03883919|Vitamins|vitamins|mesh-ancestor
25674201|NCT01769339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674202|NCT01769339|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25674203|NCT01769339|Hormone Antagonists|hormone antagonists|mesh-ancestor
25674204|NCT01769339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25155322|NCT05417113|Bupivacaine|bupivacaine|mesh-list
25155323|NCT05417113|Anesthetics, Local|anesthetics, local|mesh-ancestor
25155324|NCT05417113|Anesthetics|anesthetics|mesh-ancestor
25155325|NCT05417113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24406789|NCT00171288|Ezetimibe|ezetimibe|mesh-list
24740534|NCT01688947|Analgesics|analgesics|mesh-ancestor
24740535|NCT01688947|Sensory System Agents|sensory system agents|mesh-ancestor
24740536|NCT01688947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24883520|NCT05238727|Carticaine|carticaine|mesh-list
24740542|NCT01688947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24740543|NCT01688947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24740544|NCT01688947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24740545|NCT01688947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24740546|NCT01688947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24740547|NCT01688960|Aflibercept|aflibercept|mesh-list
24740548|NCT01688960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24405203|NCT00165815|Donepezil|donepezil|mesh-list
24740655|NCT01689597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740656|NCT01689623|Simeprevir|simeprevir|mesh-list
24740657|NCT01689623|Atorvastatin|atorvastatin|mesh-list
24740658|NCT01689623|Simvastatin|simvastatin|mesh-list
24740659|NCT01689623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24740660|NCT01689623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24740661|NCT01689623|Antimetabolites|antimetabolites|mesh-ancestor
24740662|NCT01689623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740663|NCT01689623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24740664|NCT01689623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24740665|NCT01689623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24740666|NCT01689623|Antiviral Agents|antiviral agents|mesh-ancestor
24741046|NCT01691456|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24741047|NCT01691456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741049|NCT01691469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24741050|NCT01691469|Respiratory System Agents|respiratory system agents|mesh-ancestor
24741051|NCT01691469|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24741052|NCT01691469|Hormone Antagonists|hormone antagonists|mesh-ancestor
24741334|NCT01693419|Antiviral Agents|antiviral agents|mesh-ancestor
24741335|NCT01693419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24741336|NCT01693419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24741337|NCT01693419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24741338|NCT01693419|Immunologic Factors|immunologic factors|mesh-ancestor
24741339|NCT01693419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741340|NCT01693419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24741341|NCT01693432|Docetaxel|docetaxel|mesh-list
24741342|NCT01693432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24741343|NCT01693432|Tubulin Modulators|tubulin modulators|mesh-ancestor
24741344|NCT01693432|Antimitotic Agents|antimitotic agents|mesh-ancestor
24741345|NCT01693432|Mitosis Modulators|mitosis modulators|mesh-ancestor
24765925|NCT01791400|Autonomic Agents|autonomic agents|mesh-ancestor
24741346|NCT01693432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875198|NCT04639843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875199|NCT04639843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875200|NCT04639843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25875201|NCT04639843|Antimetabolites|antimetabolites|mesh-ancestor
25875202|NCT04635683|Lenalidomide|lenalidomide|mesh-list
25240982|NCT04240626|Scopolamine|scopolamine|mesh-list
25240983|NCT04240626|Oxycodone|oxycodone|mesh-list
25240984|NCT04240626|Gabapentin|gabapentin|mesh-list
25240985|NCT04240626|Hydromorphone|hydromorphone|mesh-list
25240986|NCT04240626|Hydrocodone|hydrocodone|mesh-list
25240987|NCT04240626|Bupivacaine|bupivacaine|mesh-list
25240988|NCT04240626|Cyclobenzaprine|cyclobenzaprine|mesh-list
25875203|NCT04635683|Immunologic Factors|immunologic factors|mesh-ancestor
25875204|NCT04635683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741361|NCT01693640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741362|NCT01693640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24741363|NCT01693640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24741364|NCT01693640|Immunologic Factors|immunologic factors|mesh-ancestor
24741365|NCT01693640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741366|NCT01693640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24741368|NCT01693679|Adefovir|adefovir|mesh-list
25674205|NCT01769339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674206|NCT01769339|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25674207|NCT01769339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25674208|NCT01769352|Prednisolone acetate|prednisolone acetate|mesh-list
24741369|NCT01693679|Telbivudine|telbivudine|mesh-list
24741370|NCT01693679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25875205|NCT04635683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24651670|NCT01233167|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24441223|NCT00286481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25674209|NCT01769352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25674210|NCT01769365|Amoxicillin|amoxicillin|mesh-list
24441224|NCT00286481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441232|NCT00286611|Amifostine|amifostine|mesh-list
24441233|NCT00286611|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24441234|NCT00286611|Protective Agents|protective agents|mesh-ancestor
24407344|NCT00174317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407345|NCT00174330|Amlodipine|amlodipine|mesh-list
24741371|NCT01693679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24765982|NCT01791868|GABA Agents|gaba agents|mesh-ancestor
24741372|NCT01693679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24741373|NCT01693679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741374|NCT01693679|Antiviral Agents|antiviral agents|mesh-ancestor
24741375|NCT01693679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24741376|NCT01693679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24741377|NCT01693679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24741378|NCT01693718|Fluorouracil|fluorouracil|mesh-list
24741379|NCT01693718|Hydroxyurea|hydroxyurea|mesh-list
24741380|NCT01693718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24741381|NCT01693718|Antimetabolites|antimetabolites|mesh-ancestor
24741382|NCT01693718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741481|NCT05288660|Immunologic Factors|immunologic factors|mesh-ancestor
24406414|NCT00170209|Rifampin|rifampin|mesh-list
24618267|NCT01047566|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24618268|NCT01047566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24618269|NCT01047566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742077|NCT05293704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24742078|NCT05293704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24618342|NCT01047982|Inositol|inositol|mesh-list
24618343|NCT01047982|Hematinics|hematinics|mesh-ancestor
24742150|NCT05293132|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24742151|NCT05293132|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25240989|NCT04240626|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25240990|NCT04240626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25240991|NCT04240626|Analgesics|analgesics|mesh-ancestor
25240992|NCT04240626|Sensory System Agents|sensory system agents|mesh-ancestor
25240993|NCT04240626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24493876|NCT00492700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24742152|NCT05293132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742154|NCT05293132|Micronutrients|micronutrients|mesh-ancestor
25875206|NCT04635683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25875207|NCT04635683|Growth Substances|growth substances|mesh-ancestor
25875208|NCT04635683|Growth Inhibitors|growth inhibitors|mesh-ancestor
25875209|NCT04635683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875210|NCT04628767|Gemcitabine|gemcitabine|mesh-list
24742155|NCT05293119|Mometasone Furoate|mometasone furoate|mesh-list
24742156|NCT05293119|Tofacitinib|tofacitinib|mesh-list
24742157|NCT05293119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24742158|NCT05293119|Dermatologic Agents|dermatologic agents|mesh-ancestor
24742159|NCT05293119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24742160|NCT05293119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24742198|NCT05296369|Micronutrients|micronutrients|mesh-ancestor
24742199|NCT05296369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742200|NCT05296317|Cyclophosphamide|cyclophosphamide|mesh-list
24742213|NCT05296317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24742214|NCT05296317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24742215|NCT05296317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24742216|NCT05296317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24742217|NCT05296005|Leucovorin|leucovorin|mesh-list
24742218|NCT05296005|Docetaxel|docetaxel|mesh-list
24742219|NCT05296005|Fluorouracil|fluorouracil|mesh-list
24742220|NCT05296005|Capecitabine|capecitabine|mesh-list
24742221|NCT05296005|Oxaliplatin|oxaliplatin|mesh-list
24742222|NCT05296005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24742223|NCT05296005|Tubulin Modulators|tubulin modulators|mesh-ancestor
24742224|NCT05296005|Antimitotic Agents|antimitotic agents|mesh-ancestor
25674211|NCT01769365|Metronidazole|metronidazole|mesh-list
25674212|NCT01769365|Clarithromycin|clarithromycin|mesh-list
25674213|NCT01769365|Pantoprazole|pantoprazole|mesh-list
25674214|NCT01769365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25674215|NCT01769365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25674216|NCT01769365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25674217|NCT01769365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25674218|NCT01769365|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25674219|NCT01769365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875211|NCT04628767|Cisplatin|cisplatin|mesh-list
24742225|NCT05296005|Mitosis Modulators|mitosis modulators|mesh-ancestor
24742226|NCT05296005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618344|NCT01047982|Vitamin B Complex|vitamin b complex|mesh-ancestor
24742227|NCT05296005|Antimetabolites|antimetabolites|mesh-ancestor
24742228|NCT05296005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24742229|NCT05296005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24742240|NCT05295836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742242|NCT05295537|Hematinics|hematinics|mesh-ancestor
24742243|NCT05295355|Bromides|bromides|mesh-list
24742244|NCT05295355|Tiotropium Bromide|tiotropium bromide|mesh-list
24742245|NCT05295355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24742246|NCT05295355|Autonomic Agents|autonomic agents|mesh-ancestor
24742396|NCT05269095|Anesthetics|anesthetics|mesh-list
24742397|NCT05269095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24742398|NCT05269095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742399|NCT05267938|Lidocaine|lidocaine|mesh-list
24742400|NCT05267938|Epinephrine|epinephrine|mesh-list
24742401|NCT05267938|Anesthetics, Local|anesthetics, local|mesh-list
24742408|NCT05267938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24742409|NCT05267938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24742410|NCT05267938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24742411|NCT05267938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742412|NCT05267938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24742413|NCT05267938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24742414|NCT05267938|Adrenergic Agents|adrenergic agents|mesh-ancestor
24742445|NCT05266248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24742446|NCT05266248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875212|NCT04628767|Doxorubicin|doxorubicin|mesh-list
24742447|NCT05266248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24742448|NCT05266248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24742451|NCT05266248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24742452|NCT05266248|Purinergic Agents|purinergic agents|mesh-ancestor
24742453|NCT05266248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24742455|NCT05264896|Docetaxel|docetaxel|mesh-list
24742456|NCT05264896|Oxaliplatin|oxaliplatin|mesh-list
24742457|NCT05264896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24742458|NCT05264896|Tubulin Modulators|tubulin modulators|mesh-ancestor
24742459|NCT05264896|Antimitotic Agents|antimitotic agents|mesh-ancestor
24742460|NCT05264896|Mitosis Modulators|mitosis modulators|mesh-ancestor
24742461|NCT05264896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742462|NCT05264896|Antidotes|antidotes|mesh-ancestor
24742463|NCT05264896|Protective Agents|protective agents|mesh-ancestor
24742464|NCT05264896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742465|NCT05264896|Vitamin B Complex|vitamin b complex|mesh-ancestor
24742490|NCT05262686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24742491|NCT05262686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742493|NCT05262686|Immunologic Factors|immunologic factors|mesh-ancestor
24742494|NCT05262686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24742596|NCT05219799|Vasodilator Agents|vasodilator agents|mesh-ancestor
24742658|NCT05203705|Anticoagulants|anticoagulants|mesh-ancestor
24742659|NCT05203705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24742660|NCT05203705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24742661|NCT05203705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742663|NCT05202561|Immunologic Factors|immunologic factors|mesh-ancestor
24742664|NCT05202561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742687|NCT05192629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24618346|NCT01047982|Micronutrients|micronutrients|mesh-ancestor
24407273|NCT00174174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24742688|NCT05192629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742689|NCT05192629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24742690|NCT05192629|Analgesics|analgesics|mesh-ancestor
24742691|NCT05192629|Sensory System Agents|sensory system agents|mesh-ancestor
24742692|NCT05192629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24742693|NCT05192629|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24742694|NCT05192629|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24742695|NCT05192629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24742696|NCT05192629|Adrenergic Agents|adrenergic agents|mesh-ancestor
24742697|NCT05192629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24742698|NCT05192629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742699|NCT05192629|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25241002|NCT04240626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25241003|NCT04240626|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24742869|NCT05146778|Narcotics|narcotics|mesh-ancestor
24742870|NCT05146778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25875213|NCT04628767|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24618396|NCT01048138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24789866|NCT01939509|Sympatholytics|sympatholytics|mesh-ancestor
24789867|NCT01939509|Autonomic Agents|autonomic agents|mesh-ancestor
24789868|NCT01939509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24789869|NCT01939509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743057|NCT05022901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24743058|NCT05022901|Immunologic Factors|immunologic factors|mesh-ancestor
24743068|NCT05013567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24743069|NCT05013567|Analgesics|analgesics|mesh-ancestor
24743070|NCT05013567|Sensory System Agents|sensory system agents|mesh-ancestor
24743071|NCT05013567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24743072|NCT05013567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006844|NCT04606069|Regadenoson|regadenoson|mesh-list
24744067|NCT04521920|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25241006|NCT04240626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241007|NCT04240626|Antimanic Agents|antimanic agents|mesh-ancestor
25241008|NCT04240626|Anesthetics, Local|anesthetics, local|mesh-ancestor
25241009|NCT04240626|Anesthetics|anesthetics|mesh-ancestor
25241010|NCT04240626|Antiemetics|antiemetics|mesh-ancestor
25241011|NCT04240626|Autonomic Agents|autonomic agents|mesh-ancestor
25241012|NCT04240626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25241013|NCT04240626|Antitussive Agents|antitussive agents|mesh-ancestor
25241014|NCT04240626|Respiratory System Agents|respiratory system agents|mesh-ancestor
25241015|NCT04240626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25241016|NCT04240626|Mydriatics|mydriatics|mesh-ancestor
24955571|NCT03863977|Anesthetics, Local|anesthetics, local|mesh-ancestor
24743161|NCT04975802|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24743162|NCT04975802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743163|NCT04975802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24743164|NCT04975802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24743165|NCT04975802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743166|NCT04975802|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24743632|NCT04704518|Hyaluronic Acid|hyaluronic acid|mesh-list
24743174|NCT04973930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24743175|NCT04973930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743206|NCT04964700|Natalizumab|natalizumab|mesh-list
24743208|NCT04964700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743209|NCT04952779|Insulin|insulin|mesh-list
24743210|NCT04952779|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24743211|NCT04952779|Liraglutide|liraglutide|mesh-list
24743212|NCT04952779|Insulin, Long-Acting|insulin, long-acting|mesh-list
24743213|NCT04952779|Xultophy|xultophy|mesh-list
24743214|NCT04952779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24743215|NCT04952779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743216|NCT04952779|Incretins|incretins|mesh-ancestor
24743217|NCT04952779|Hormones|hormones|mesh-ancestor
24743218|NCT04952779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24743219|NCT04950868|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24743220|NCT04950868|Antidepressive Agents|antidepressive agents|mesh-ancestor
24407834|NCT00175682|Prazosin|prazosin|mesh-list
24743258|NCT04926181|Androgens|androgens|mesh-list
24743259|NCT04926181|Hormones|hormones|mesh-ancestor
24743312|NCT04897802|Exenatide|exenatide|mesh-list
24743313|NCT04897802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24743321|NCT04887948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674220|NCT01769365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674221|NCT01769365|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25674222|NCT01769365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25674223|NCT01769365|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25674224|NCT01769365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24743322|NCT04883749|Acalabrutinib|acalabrutinib|mesh-list
24743323|NCT04883749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24743324|NCT04882332|Vitamin B 12|vitamin b 12|mesh-list
24743325|NCT04882332|Hydroxocobalamin|hydroxocobalamin|mesh-list
24743326|NCT04882332|Vitamins|vitamins|mesh-ancestor
24743327|NCT04882332|Micronutrients|micronutrients|mesh-ancestor
24743328|NCT04882332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743329|NCT04882332|Vitamin B Complex|vitamin b complex|mesh-ancestor
24743330|NCT04882332|Hematinics|hematinics|mesh-ancestor
24743331|NCT04882202|Acetaminophen|acetaminophen|mesh-list
24743332|NCT04882202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24743333|NCT04882202|Analgesics|analgesics|mesh-ancestor
24743334|NCT04882202|Sensory System Agents|sensory system agents|mesh-ancestor
24743363|NCT04869605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24743364|NCT04869605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25241019|NCT04240626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25241020|NCT04240626|Parasympatholytics|parasympatholytics|mesh-ancestor
25241021|NCT04240626|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25241022|NCT04240626|Antidepressive Agents|antidepressive agents|mesh-ancestor
25241023|NCT04240626|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24652090|NCT01236040|Vaccines|vaccines|mesh-list
24743411|NCT04835584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743431|NCT04815967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24743432|NCT04815967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24743433|NCT04811404|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
24743434|NCT04811404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25080335|NCT03340168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743435|NCT04811404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24743436|NCT04800107|Curcumin|curcumin|mesh-list
24743437|NCT04800107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24743438|NCT04800107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24743439|NCT04800107|Analgesics|analgesics|mesh-ancestor
24743440|NCT04800107|Sensory System Agents|sensory system agents|mesh-ancestor
24743451|NCT04793867|Anesthetics|anesthetics|mesh-ancestor
24427813|NCT00239057|Mycophenolic Acid|mycophenolic acid|mesh-list
24743464|NCT04781647|Antiviral Agents|antiviral agents|mesh-ancestor
24743465|NCT04781647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24743466|NCT04781647|Immunologic Factors|immunologic factors|mesh-ancestor
24743467|NCT04781647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743468|NCT04777539|Natalizumab|natalizumab|mesh-list
24743469|NCT04777539|Immunologic Factors|immunologic factors|mesh-ancestor
24743480|NCT04767503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24743481|NCT04767503|Anesthetics, General|anesthetics, general|mesh-ancestor
24743482|NCT04767503|Anesthetics|anesthetics|mesh-ancestor
24743483|NCT04767503|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24743484|NCT04763564|Liraglutide|liraglutide|mesh-list
24743485|NCT04763564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24743486|NCT04763564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743487|NCT04763564|Incretins|incretins|mesh-ancestor
24743489|NCT04763564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24743523|NCT04760496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743524|NCT04753216|Bevacizumab|bevacizumab|mesh-list
24743526|NCT04753216|Irinotecan|irinotecan|mesh-list
24743529|NCT04753216|Immunoglobulins|immunoglobulins|mesh-list
24743530|NCT04753216|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24743531|NCT04753216|Immunoglobulin G|immunoglobulin g|mesh-list
24743532|NCT04753216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24743533|NCT04753216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24743534|NCT04753216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24743535|NCT04753216|Growth Substances|growth substances|mesh-ancestor
24743536|NCT04753216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533186|NCT00642512|Analgesics|analgesics|mesh-ancestor
24743538|NCT04753216|Immunologic Factors|immunologic factors|mesh-ancestor
24743539|NCT04753216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24743540|NCT04753216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24408141|NCT00176670|Anesthetics|anesthetics|mesh-ancestor
24743563|NCT04750967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24743564|NCT04750967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743565|NCT04750967|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24743571|NCT04750967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24743573|NCT04750967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24743610|NCT04730947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24743611|NCT04730947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743615|NCT04716712|Azithromycin|azithromycin|mesh-list
24743616|NCT04716712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24743617|NCT04716712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24743618|NCT04707794|Sevoflurane|sevoflurane|mesh-list
24743619|NCT04707794|Desflurane|desflurane|mesh-list
24743620|NCT04707794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24743621|NCT04707794|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24743622|NCT04707794|Anesthetics, General|anesthetics, general|mesh-ancestor
24418554|NCT00209755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24418555|NCT00209781|Pyrimethamine|pyrimethamine|mesh-list
24743623|NCT04707794|Anesthetics|anesthetics|mesh-ancestor
24743624|NCT04707794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24743625|NCT04707794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743626|NCT04707235|Hydroxyurea|hydroxyurea|mesh-list
24743627|NCT04707235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24743628|NCT04707235|Antisickling Agents|antisickling agents|mesh-ancestor
24743629|NCT04707235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24743630|NCT04707235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743631|NCT04707235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25241043|NCT04126824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241044|NCT04126824|Sensory System Agents|sensory system agents|mesh-ancestor
25241045|NCT04126824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25241046|NCT04126824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25241047|NCT04126824|Glucocorticoids|glucocorticoids|mesh-ancestor
25241048|NCT04126824|Hormones|hormones|mesh-ancestor
25241049|NCT04126824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24744013|NCT04540133|Autonomic Agents|autonomic agents|mesh-ancestor
24744014|NCT04540133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24744015|NCT04540133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744016|NCT04540133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24744020|NCT04540133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24744021|NCT04540133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652778|NCT01240096|Serotonin Agents|serotonin agents|mesh-ancestor
24744061|NCT04521920|Narcotics|narcotics|mesh-ancestor
24744062|NCT04521920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24744063|NCT04521920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744064|NCT04521920|Analgesics|analgesics|mesh-ancestor
24744065|NCT04521920|Sensory System Agents|sensory system agents|mesh-ancestor
24744066|NCT04521920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24766802|NCT01796808|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25241052|NCT04115956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25241053|NCT04115956|Antiemetics|antiemetics|mesh-ancestor
25241054|NCT04115956|Autonomic Agents|autonomic agents|mesh-ancestor
25241055|NCT04115956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25241056|NCT04115956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241057|NCT04115956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25241058|NCT04115956|Glucocorticoids|glucocorticoids|mesh-ancestor
25241059|NCT04115956|Hormones|hormones|mesh-ancestor
25241060|NCT04115956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25241061|NCT04115956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25241062|NCT04115956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25241063|NCT04115956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25241064|NCT04115956|Alkylating Agents|alkylating agents|mesh-ancestor
25241065|NCT04115956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241066|NCT04115956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25241067|NCT04115956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25241068|NCT04115956|Immunologic Factors|immunologic factors|mesh-ancestor
25241069|NCT04109222|Vaccines|vaccines|mesh-list
25241070|NCT04109222|Immunologic Factors|immunologic factors|mesh-ancestor
25241071|NCT04109222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409695|NCT00182715|Antidotes|antidotes|mesh-ancestor
24744408|NCT04291079|Antibodies|antibodies|mesh-list
24429417|NCT00243880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24429418|NCT00243880|Antimetabolites|antimetabolites|mesh-ancestor
24744481|NCT04264637|Respiratory System Agents|respiratory system agents|mesh-ancestor
24744482|NCT04264637|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24744483|NCT04264637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24744484|NCT04264637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789881|NCT01939561|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24789882|NCT01939561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24789883|NCT01939561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744523|NCT04238546|Sirolimus|sirolimus|mesh-list
24429647|NCT00244556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24744702|NCT04183205|Sertraline|sertraline|mesh-list
24744703|NCT04183205|Antidepressive Agents|antidepressive agents|mesh-ancestor
24744704|NCT04183205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24744705|NCT04183205|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24744706|NCT04183205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24744707|NCT04183205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25413439|NCT03131908|Pembrolizumab|pembrolizumab|mesh-list
25674225|NCT01769365|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25674226|NCT01769378|Glimepiride|glimepiride|mesh-list
24421180|NCT00218075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24421181|NCT00218075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421182|NCT00218075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007307|NCT03797560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25007308|NCT03797560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25007309|NCT03797560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25007310|NCT03740919|Insulin|insulin|mesh-list
25007311|NCT03740919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25007312|NCT03740919|Insulin Glargine|insulin glargine|mesh-list
25007313|NCT03740919|Insulin Lispro|insulin lispro|mesh-list
25007314|NCT03740919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25007315|NCT03740919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007316|NCT03737565|Tryptophan|tryptophan|mesh-list
24744754|NCT04157881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744756|NCT04157881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24744757|NCT04157881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24744758|NCT04157881|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24744759|NCT04151563|Docetaxel|docetaxel|mesh-list
24744760|NCT04151563|Nivolumab|nivolumab|mesh-list
24744761|NCT04151563|Ipilimumab|ipilimumab|mesh-list
24744762|NCT04151563|Ramucirumab|ramucirumab|mesh-list
24744763|NCT04151563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24744764|NCT04151563|Tubulin Modulators|tubulin modulators|mesh-ancestor
24744765|NCT04151563|Antimitotic Agents|antimitotic agents|mesh-ancestor
24744766|NCT04151563|Mitosis Modulators|mitosis modulators|mesh-ancestor
24744767|NCT04151563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744768|NCT04151563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24744769|NCT04151563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24744770|NCT04150900|Pembrolizumab|pembrolizumab|mesh-list
24744771|NCT04150900|Bavituximab|bavituximab|mesh-list
24744772|NCT04150900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24744773|NCT04150900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24744774|NCT04143711|Paclitaxel|paclitaxel|mesh-list
24744775|NCT04143711|Nivolumab|nivolumab|mesh-list
24744822|NCT04129060|Cholinergic Antagonists|cholinergic antagonists|mesh-list
24744823|NCT04129060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24744824|NCT04129060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744825|NCT04129060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494030|NCT00493428|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24850965|NCT02254668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850966|NCT02254668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24850967|NCT02254668|Immunologic Factors|immunologic factors|mesh-ancestor
24850968|NCT02254668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744860|NCT04114890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744861|NCT04114890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24744862|NCT04114890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24744863|NCT04099667|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
24744864|NCT04099667|Botulinum Toxins|botulinum toxins|mesh-list
24744865|NCT04099667|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24744866|NCT04099667|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24744867|NCT04099667|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24744868|NCT04099667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24744910|NCT04084548|Anesthetics, General|anesthetics, general|mesh-ancestor
24744911|NCT04084548|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24744912|NCT04084548|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24744913|NCT04084548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24618502|NCT01048580|Antimetabolites|antimetabolites|mesh-ancestor
24745147|NCT03930615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24745148|NCT03930615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24745149|NCT03930615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745186|NCT03926091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674227|NCT01769378|Dulaglutide|dulaglutide|mesh-list
25674228|NCT01769378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25674229|NCT01769378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25674230|NCT01769378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674231|NCT01769378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25674232|NCT01769378|Immunologic Factors|immunologic factors|mesh-ancestor
25674233|NCT01769391|Paclitaxel|paclitaxel|mesh-list
25674234|NCT01769391|Carboplatin|carboplatin|mesh-list
25674235|NCT01769391|Necitumumab|necitumumab|mesh-list
25674236|NCT01769391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25674237|NCT01769391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25674238|NCT01769391|Tubulin Modulators|tubulin modulators|mesh-ancestor
25674239|NCT01769391|Antimitotic Agents|antimitotic agents|mesh-ancestor
25674240|NCT01769391|Mitosis Modulators|mitosis modulators|mesh-ancestor
25875214|NCT04628767|Methotrexate|methotrexate|mesh-list
25875215|NCT04628767|Durvalumab|durvalumab|mesh-list
24422670|NCT00223418|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24422673|NCT00223509|Anticonvulsants|anticonvulsants|mesh-ancestor
24422674|NCT00223509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24422808|NCT00223691|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24745187|NCT03926091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745222|NCT03893448|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24745223|NCT03893448|Immunologic Factors|immunologic factors|mesh-ancestor
24745224|NCT03893448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745225|NCT03889314|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24745226|NCT03889314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24557991|NCT00755066|Xhance|xhance|mesh-list
24745227|NCT03889314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24745229|NCT03889314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850971|NCT02254668|Antitubercular Agents|antitubercular agents|mesh-ancestor
24850972|NCT02254668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24850973|NCT02254668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24850974|NCT02254668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850975|NCT02254668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850976|NCT02254720|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24850977|NCT02254759|Midazolam|midazolam|mesh-list
24850978|NCT02254759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24745230|NCT03889314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24745411|NCT03785106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24745412|NCT03785106|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24745413|NCT03785106|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24745414|NCT03785106|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24789884|NCT01939561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24789885|NCT01939561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789886|NCT01939561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24789887|NCT01939561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24789888|NCT01939561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24789889|NCT01939561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24789890|NCT01939561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24789891|NCT01939574|Bevacizumab|bevacizumab|mesh-list
24789892|NCT01939574|Temozolomide|temozolomide|mesh-list
25006861|NCT04603846|Immunologic Factors|immunologic factors|mesh-ancestor
25006862|NCT04603846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006863|NCT04603742|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25006864|NCT04603742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25006873|NCT04578106|Trastuzumab|trastuzumab|mesh-list
25006874|NCT04578106|Pertuzumab|pertuzumab|mesh-list
25006875|NCT04578106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25006876|NCT04578106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006877|NCT04568902|Histamine Antagonists|histamine antagonists|mesh-list
25006878|NCT04568902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25006879|NCT04568902|Histamine Agents|histamine agents|mesh-ancestor
25006918|NCT04518501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006919|NCT04518046|Nivolumab|nivolumab|mesh-list
25006920|NCT04518046|Ipilimumab|ipilimumab|mesh-list
25006921|NCT04518046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24745415|NCT03785106|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24745416|NCT03785106|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24745417|NCT03785106|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24745477|NCT03760835|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24745478|NCT03760835|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24767056|NCT01798537|Vancomycin|vancomycin|mesh-list
24745479|NCT03760835|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24745481|NCT03760835|Glucocorticoids|glucocorticoids|mesh-list
24745482|NCT03760835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24850981|NCT02254759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850983|NCT02254759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24850984|NCT02254759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24850985|NCT02254759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24850986|NCT02254759|Anesthetics, General|anesthetics, general|mesh-ancestor
24850987|NCT02254759|Anesthetics|anesthetics|mesh-ancestor
24850988|NCT02254759|GABA Modulators|gaba modulators|mesh-ancestor
24850989|NCT02254759|GABA Agents|gaba agents|mesh-ancestor
24648649|NCT01216111|Antimetabolites|antimetabolites|mesh-ancestor
24745483|NCT03760835|Antiemetics|antiemetics|mesh-ancestor
24745492|NCT03759496|Durvalumab|durvalumab|mesh-list
25674241|NCT01769391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674242|NCT01769391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25674243|NCT01769404|Insulin Glargine|insulin glargine|mesh-list
25674244|NCT01769404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24424841|NCT00230997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424842|NCT00230997|Cholinergic Agents|cholinergic agents|mesh-ancestor
24745493|NCT03759496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24745494|NCT03759496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006922|NCT04518046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745495|NCT03759184|Obinutuzumab|obinutuzumab|mesh-list
24409981|NCT00183989|Rituximab|rituximab|mesh-list
24789947|NCT01939743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25080394|NCT03339544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24745528|NCT03727880|Pembrolizumab|pembrolizumab|mesh-list
24745529|NCT03727880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24745541|NCT03715829|PF-06700841|pf-06700841|mesh-list
24745542|NCT03715829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24745543|NCT03715829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24745544|NCT03715829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745545|NCT03712254|Fosphenytoin|fosphenytoin|mesh-list
24745546|NCT03712254|Anticonvulsants|anticonvulsants|mesh-ancestor
24745577|NCT03693677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24745579|NCT03693677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745580|NCT03693677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24745581|NCT03693677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25241099|NCT04095689|Docetaxel|docetaxel|mesh-list
25241100|NCT04095689|Pembrolizumab|pembrolizumab|mesh-list
25241101|NCT04095689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25241102|NCT04095689|Tubulin Modulators|tubulin modulators|mesh-ancestor
25241103|NCT04095689|Antimitotic Agents|antimitotic agents|mesh-ancestor
25241104|NCT04095689|Mitosis Modulators|mitosis modulators|mesh-ancestor
25241105|NCT04095689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241106|NCT04095689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25241107|NCT04082572|Pembrolizumab|pembrolizumab|mesh-list
25241108|NCT04082572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25241109|NCT04082572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25241110|NCT04069312|Azithromycin|azithromycin|mesh-list
25241111|NCT04069312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25241112|NCT04069312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24767236|NCT01799460|Tacrolimus|tacrolimus|mesh-list
25241113|NCT04046939|Pramipexole|pramipexole|mesh-list
24745840|NCT03573115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745841|NCT03573115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24745842|NCT03573115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24745843|NCT03569475|Milnacipran|milnacipran|mesh-list
24745872|NCT03546556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24746022|NCT03460210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618563|NCT01048983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24410553|NCT00185952|Nifedipine|nifedipine|mesh-list
24746415|NCT05436678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24767283|NCT01799863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24746416|NCT05436678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746417|NCT05436678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24746419|NCT05436678|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24746420|NCT05436678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24746421|NCT05436678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24746422|NCT05436678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746423|NCT05436678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24746424|NCT05436678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24746425|NCT05436678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24746426|NCT05436678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24746427|NCT05436678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746428|NCT05436678|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24746429|NCT05436678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25241114|NCT04046939|Antioxidants|antioxidants|mesh-ancestor
25241115|NCT04046939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241116|NCT04046939|Protective Agents|protective agents|mesh-ancestor
25241119|NCT04046939|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25241120|NCT04046939|Dopamine Agonists|dopamine agonists|mesh-ancestor
25241121|NCT04046939|Dopamine Agents|dopamine agents|mesh-ancestor
25241122|NCT04046939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25241123|NCT04038086|Insulin|insulin|mesh-list
25241124|NCT04038086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25875216|NCT04628767|Vinblastine|vinblastine|mesh-list
25875217|NCT04628767|Lenograstim|lenograstim|mesh-list
25875218|NCT04628767|Immunoglobulins|immunoglobulins|mesh-list
25875219|NCT04628767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25674245|NCT01769404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674246|NCT01769456|Tenofovir|tenofovir|mesh-list
25875220|NCT04628767|Immunoglobulin G|immunoglobulin g|mesh-list
25875221|NCT04628767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25875222|NCT04628767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25875223|NCT04628767|Antimetabolites|antimetabolites|mesh-ancestor
25875224|NCT04628767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431147|NCT00250562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006950|NCT04462965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25006951|NCT04462965|Alkylating Agents|alkylating agents|mesh-ancestor
25006952|NCT04462965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006953|NCT04462965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006954|NCT04423744|Moxifloxacin|moxifloxacin|mesh-list
25006955|NCT04423744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25006956|NCT04423744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25006957|NCT04423744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25006958|NCT04423744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25006959|NCT04423744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25006960|NCT04423744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006961|NCT04423744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767375|NCT01800422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24558372|NCT00756873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558373|NCT00756873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24558374|NCT00756873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24746551|NCT05145764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25241125|NCT04038086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875225|NCT04628767|Antiviral Agents|antiviral agents|mesh-ancestor
25875226|NCT04628767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25875227|NCT04628767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25875228|NCT04628767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25875229|NCT04628767|Immunologic Factors|immunologic factors|mesh-ancestor
25875230|NCT04628767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25875231|NCT04628767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24746825|NCT03424122|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24746826|NCT03424122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24746827|NCT03424122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746828|NCT03424122|Immunologic Factors|immunologic factors|mesh-ancestor
24746829|NCT03424122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746830|NCT03424122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24746831|NCT03424122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24746832|NCT03424122|Alkylating Agents|alkylating agents|mesh-ancestor
24746833|NCT03424122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746872|NCT03029780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618631|NCT01049347|Adrenergic Agents|adrenergic agents|mesh-ancestor
24746874|NCT02968940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24746875|NCT02968940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431462|NCT00251784|Urological Agents|urological agents|mesh-ancestor
24746991|NCT02333292|Grazoprevir|grazoprevir|mesh-list
24746992|NCT02333292|Ledipasvir|ledipasvir|mesh-list
24746993|NCT02333292|Velpatasvir|velpatasvir|mesh-list
24747031|NCT02203773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25241138|NCT04033263|Fluorides|fluorides|mesh-list
24747815|NCT03083197|Doxycycline|doxycycline|mesh-list
24747816|NCT03083197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24747817|NCT03083197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24747818|NCT03083197|Antimalarials|antimalarials|mesh-ancestor
24747819|NCT03083197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24747820|NCT03083197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24747884|NCT03054363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24747885|NCT03054363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24747886|NCT03054363|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24747887|NCT03054363|Hormone Antagonists|hormone antagonists|mesh-ancestor
24749021|NCT01863186|Analgesics|analgesics|mesh-ancestor
24747888|NCT03054363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24747889|NCT03054363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24747890|NCT03054363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24747891|NCT03054181|Immunoglobulins|immunoglobulins|mesh-list
24747892|NCT03054181|Immunologic Factors|immunologic factors|mesh-ancestor
24747893|NCT03054181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621717|NCT01063569|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24621718|NCT01063569|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24621719|NCT01063569|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24621720|NCT01063569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24621721|NCT01063621|Apomorphine|apomorphine|mesh-list
24621722|NCT01063621|Emetics|emetics|mesh-ancestor
25413440|NCT03131908|GSK2636771|gsk2636771|mesh-list
24427108|NCT00237445|Telithromycin|telithromycin|mesh-list
24427109|NCT00237445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24427110|NCT00237445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24427111|NCT00237471|Insulin|insulin|mesh-list
24427117|NCT00237484|Interferon alpha-2|interferon alpha-2|mesh-list
24427118|NCT00237484|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24621723|NCT01063621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241140|NCT04033263|Protective Agents|protective agents|mesh-ancestor
25241141|NCT04033263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241142|NCT04032990|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
25241143|NCT04032990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25241144|NCT04032990|Immunologic Factors|immunologic factors|mesh-ancestor
25241145|NCT04032990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241146|NCT04013854|Nivolumab|nivolumab|mesh-list
25241147|NCT04013854|Ipilimumab|ipilimumab|mesh-list
25006992|NCT04386811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25006993|NCT04386811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006994|NCT04386811|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25006995|NCT04386811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25006996|NCT04386811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006997|NCT04386811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25006999|NCT04386811|Micronutrients|micronutrients|mesh-ancestor
25007000|NCT04386811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24748100|NCT02943785|Anticoagulants|anticoagulants|mesh-ancestor
24748105|NCT02908334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24748106|NCT02908334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24748189|NCT02810743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24748190|NCT02810743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24748191|NCT02810743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748192|NCT02810743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748193|NCT02792114|Cyclophosphamide|cyclophosphamide|mesh-list
24748194|NCT02792114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24748195|NCT02792114|Immunologic Factors|immunologic factors|mesh-ancestor
24748196|NCT02792114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748197|NCT02792114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24748198|NCT02792114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24748199|NCT02792114|Alkylating Agents|alkylating agents|mesh-ancestor
24748200|NCT02792114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748201|NCT02792114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748202|NCT02792114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24748203|NCT02787551|Metformin|metformin|mesh-list
24748327|NCT02688712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24748328|NCT02688712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748329|NCT02688712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24748330|NCT02688712|Immunologic Factors|immunologic factors|mesh-ancestor
24748331|NCT02688712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748367|NCT02678572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748368|NCT02678572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24748369|NCT02678572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25241148|NCT04013854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25241149|NCT04013854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25241150|NCT04013854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25241151|NCT04013854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748396|NCT02623998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748397|NCT02623998|Incretins|incretins|mesh-ancestor
24748454|NCT02584829|Antiviral Agents|antiviral agents|mesh-ancestor
24748455|NCT02584829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24748456|NCT02584829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24748457|NCT02584829|Immunologic Factors|immunologic factors|mesh-ancestor
24748458|NCT02584829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748459|NCT02559856|Rivaroxaban|rivaroxaban|mesh-list
24748487|NCT02499367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24748570|NCT02368301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24748571|NCT02368301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24748572|NCT02368301|Growth Substances|growth substances|mesh-ancestor
24748573|NCT02368301|Growth Inhibitors|growth inhibitors|mesh-ancestor
25674247|NCT01769456|Emtricitabine|emtricitabine|mesh-list
25674248|NCT01769456|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25674249|NCT01769456|Antiviral Agents|antiviral agents|mesh-ancestor
25674250|NCT01769456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25674251|NCT01769456|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24748600|NCT02363998|Analgesics|analgesics|mesh-ancestor
24748601|NCT02363998|Sympatholytics|sympatholytics|mesh-ancestor
24748602|NCT02363998|Autonomic Agents|autonomic agents|mesh-ancestor
24748603|NCT02355379|Capecitabine|capecitabine|mesh-list
24748604|NCT02355379|Fluorouracil|fluorouracil|mesh-list
24748605|NCT02355379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24748606|NCT02355379|Antimetabolites|antimetabolites|mesh-ancestor
24748607|NCT02355379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748608|NCT02355379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748609|NCT02355379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24748610|NCT02355379|Immunologic Factors|immunologic factors|mesh-ancestor
24748611|NCT02355379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748613|NCT02325466|Ticagrelor|ticagrelor|mesh-list
24748614|NCT02325466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24748615|NCT02325466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24748616|NCT02325466|Analgesics|analgesics|mesh-ancestor
24767601|NCT01802502|Rifampin|rifampin|mesh-list
24904909|NCT04351724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24748617|NCT02325466|Sensory System Agents|sensory system agents|mesh-ancestor
24748618|NCT02325466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24748706|NCT02212015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24748707|NCT02212015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748708|NCT02212015|Tubulin Modulators|tubulin modulators|mesh-ancestor
24748709|NCT02212015|Antimitotic Agents|antimitotic agents|mesh-ancestor
24748710|NCT02212015|Mitosis Modulators|mitosis modulators|mesh-ancestor
24748711|NCT02212015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748712|NCT02204241|Dexamethasone|dexamethasone|mesh-list
24748713|NCT02204241|Cyclophosphamide|cyclophosphamide|mesh-list
24748714|NCT02204241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24748868|NCT02040857|Exemestane|exemestane|mesh-list
24398579|NCT00144911|Xhance|xhance|mesh-list
24748869|NCT02040857|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24748896|NCT01997463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24748897|NCT01997463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241166|NCT03932162|Insulin|insulin|mesh-list
25241167|NCT03932162|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25241168|NCT03932162|Mitogens|mitogens|mesh-list
25241169|NCT03932162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25241170|NCT03932162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241171|NCT03932162|Mitosis Modulators|mitosis modulators|mesh-ancestor
25241172|NCT03932162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241173|NCT03912259|Emollients|emollients|mesh-list
25241174|NCT03912259|Dermatologic Agents|dermatologic agents|mesh-ancestor
25241175|NCT03890367|Vaccines|vaccines|mesh-list
25241176|NCT03890367|Immunologic Factors|immunologic factors|mesh-ancestor
25241177|NCT03890367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241178|NCT03799744|Durvalumab|durvalumab|mesh-list
25241179|NCT03799744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25241180|NCT03799744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25241181|NCT03760679|Chlorhexidine|chlorhexidine|mesh-list
25241182|NCT03760679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25241183|NCT03760679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25241184|NCT03760679|Disinfectants|disinfectants|mesh-ancestor
25241185|NCT03715946|Nivolumab|nivolumab|mesh-list
25241186|NCT03715946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25241187|NCT03715946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25241188|NCT03715946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24749008|NCT01863186|Lofexidine|lofexidine|mesh-list
24749009|NCT01863186|Clonidine|clonidine|mesh-list
24749010|NCT01863186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24749011|NCT01863186|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24749012|NCT01863186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749013|NCT01863186|Sensory System Agents|sensory system agents|mesh-ancestor
25007025|NCT04349371|Chloroquine|chloroquine|mesh-list
25007026|NCT04349371|Amebicides|amebicides|mesh-ancestor
24749014|NCT01863186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24749015|NCT01863186|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24749016|NCT01863186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24749018|NCT01863186|Adrenergic Agents|adrenergic agents|mesh-ancestor
24749019|NCT01863186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24749020|NCT01863186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749022|NCT01863186|Sympatholytics|sympatholytics|mesh-ancestor
24749023|NCT01863186|Autonomic Agents|autonomic agents|mesh-ancestor
24749024|NCT01857115|Dexamethasone|dexamethasone|mesh-list
24749025|NCT01857115|Cyclophosphamide|cyclophosphamide|mesh-list
24749026|NCT01857115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24749063|NCT01828840|Sensory System Agents|sensory system agents|mesh-ancestor
25241189|NCT03715946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875232|NCT04628767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25875233|NCT04628767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25242440|NCT04414761|Cetrorelix|cetrorelix|mesh-list
25242441|NCT04414761|Progesterone|progesterone|mesh-list
25242442|NCT04414761|Dydrogesterone|dydrogesterone|mesh-list
25875234|NCT04628767|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24749064|NCT01828840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24749065|NCT01828840|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24749100|NCT01741103|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24620410|NCT01056926|Autonomic Agents|autonomic agents|mesh-ancestor
24620411|NCT01056926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24620412|NCT01056926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620413|NCT01056926|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24620414|NCT01056926|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24620415|NCT01056926|Cholinergic Agents|cholinergic agents|mesh-ancestor
24749102|NCT01741103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273973|NCT02381730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25273974|NCT02381730|Growth Substances|growth substances|mesh-ancestor
25273975|NCT02381730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273976|NCT02381730|Growth Inhibitors|growth inhibitors|mesh-ancestor
25273977|NCT02381730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25273978|NCT02381548|Belinostat|belinostat|mesh-list
25273979|NCT02381548|Adavosertib|adavosertib|mesh-list
25273980|NCT02381548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273981|NCT02381548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273982|NCT02381548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749229|NCT01414777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749231|NCT01414777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24749232|NCT01414777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24749266|NCT01380938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749267|NCT01374516|Vaccines|vaccines|mesh-list
24749268|NCT01374516|Immunologic Factors|immunologic factors|mesh-ancestor
24749269|NCT01374516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749270|NCT01373281|Vaccines|vaccines|mesh-list
24749271|NCT01373281|Immunologic Factors|immunologic factors|mesh-ancestor
24749497|NCT00945009|Cactinomycin|cactinomycin|mesh-list
24749498|NCT00945009|Doxorubicin|doxorubicin|mesh-list
24749499|NCT00945009|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24749500|NCT00945009|Vincristine|vincristine|mesh-list
24749501|NCT00945009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24749502|NCT00945009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749503|NCT00945009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24413839|NCT00195416|Analgesics|analgesics|mesh-ancestor
24749611|NCT00576836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24749612|NCT00576836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618877|NCT01050036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618878|NCT01050036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24618879|NCT01050036|Immunologic Factors|immunologic factors|mesh-ancestor
24618880|NCT01050036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618881|NCT01050036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24618882|NCT01050036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618883|NCT01050036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24618884|NCT01050088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24618886|NCT01050114|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24433312|NCT00258115|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
24749950|NCT01695070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24749952|NCT01695109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25241190|NCT03653832|Clonidine|clonidine|mesh-list
25241191|NCT03653832|Dexmedetomidine|dexmedetomidine|mesh-list
25241192|NCT03653832|Propofol|propofol|mesh-list
25241193|NCT03653832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25241194|NCT03653832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25241195|NCT03653832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241196|NCT03653832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25241197|NCT03653832|Anesthetics, General|anesthetics, general|mesh-ancestor
25241198|NCT03653832|Anesthetics|anesthetics|mesh-ancestor
25241199|NCT03653832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25241200|NCT03653832|Analgesics|analgesics|mesh-ancestor
25241201|NCT03653832|Sensory System Agents|sensory system agents|mesh-ancestor
25241202|NCT03653832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24655583|NCT01257360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25674252|NCT01769456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25674253|NCT01769456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674254|NCT01769456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674255|NCT01769456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24749963|NCT01695122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749964|NCT01695122|Antimanic Agents|antimanic agents|mesh-ancestor
24749966|NCT01695122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24750289|NCT01697410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24750291|NCT01697436|Antimetabolites|antimetabolites|mesh-ancestor
24750292|NCT01697436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750293|NCT01697436|Antiviral Agents|antiviral agents|mesh-ancestor
24750294|NCT01697436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24750295|NCT01697605|Infigratinib|infigratinib|mesh-list
24750296|NCT01697605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24750297|NCT01697618|Insulin|insulin|mesh-list
24750298|NCT01697618|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24750299|NCT01697618|Insulin Aspart|insulin aspart|mesh-list
24750300|NCT01697618|Biphasic Insulins|biphasic insulins|mesh-list
24655684|NCT01257672|Ondansetron|ondansetron|mesh-list
24414730|NCT00198536|Ecabet|ecabet|mesh-list
24414741|NCT00198562|Losartan|losartan|mesh-list
24750323|NCT01697670|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24750324|NCT01697670|Dermatologic Agents|dermatologic agents|mesh-ancestor
24750325|NCT01697722|Beclomethasone|beclomethasone|mesh-list
24750326|NCT01697722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24750327|NCT01697722|Glucocorticoids|glucocorticoids|mesh-ancestor
24750328|NCT01697722|Hormones|hormones|mesh-ancestor
24750329|NCT01697722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24750330|NCT01697722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750331|NCT01697722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24750332|NCT01697722|Respiratory System Agents|respiratory system agents|mesh-ancestor
24750333|NCT01697735|Atorvastatin|atorvastatin|mesh-list
24750348|NCT01697787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24750349|NCT01697787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24540461|NCT00668044|Ciprofloxacin|ciprofloxacin|mesh-list
24750350|NCT01697787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24750351|NCT01697787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24750352|NCT01697787|Antiviral Agents|antiviral agents|mesh-ancestor
24414767|NCT00198614|Metoprolol|metoprolol|mesh-list
24750384|NCT01698138|Cholinergic Agents|cholinergic agents|mesh-ancestor
24750385|NCT01698138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24750387|NCT01698164|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24750389|NCT01698164|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24750390|NCT01698164|Progesterone|progesterone|mesh-list
24750391|NCT01698164|Estrogens|estrogens|mesh-ancestor
24750392|NCT01698164|Hormones|hormones|mesh-ancestor
24414811|NCT00198718|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24750439|NCT01698593|Sensory System Agents|sensory system agents|mesh-ancestor
24750440|NCT01698593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25241203|NCT03653832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25241204|NCT03653832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25241205|NCT03653832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25241206|NCT03653832|Adrenergic Agents|adrenergic agents|mesh-ancestor
25241207|NCT03653832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25241208|NCT03653832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241209|NCT03653832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25241210|NCT03653832|Sympatholytics|sympatholytics|mesh-ancestor
25241211|NCT03653832|Autonomic Agents|autonomic agents|mesh-ancestor
25241212|NCT03612960|Nicotine|nicotine|mesh-list
25241213|NCT03612960|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24750452|NCT01698593|Sympathomimetics|sympathomimetics|mesh-ancestor
24750453|NCT01698593|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24750519|NCT01699126|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24750536|NCT01699347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24750537|NCT01699360|Cyclosporine|cyclosporine|mesh-list
24750538|NCT01699360|Sirolimus|sirolimus|mesh-list
24750539|NCT01699360|Tacrolimus|tacrolimus|mesh-list
24750540|NCT01699360|Cyclosporins|cyclosporins|mesh-list
24750541|NCT01699360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24750542|NCT01699360|Immunologic Factors|immunologic factors|mesh-ancestor
24767844|NCT01803659|Vitamin A|vitamin a|mesh-list
24750543|NCT01699360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750544|NCT01699360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24750545|NCT01699360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750546|NCT01699360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750585|NCT01699490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24619014|NCT01050478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24619015|NCT01050478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241214|NCT03612960|Autonomic Agents|autonomic agents|mesh-ancestor
25241215|NCT03612960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25241216|NCT03612960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241217|NCT03612960|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25241218|NCT03612960|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25674256|NCT01769456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24460270|NCT00347971|Rituximab|rituximab|mesh-list
24460271|NCT00347971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24460272|NCT00347971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460273|NCT00347971|Immunologic Factors|immunologic factors|mesh-ancestor
24460274|NCT00347971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460275|NCT00347971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25241219|NCT03612960|Cholinergic Agents|cholinergic agents|mesh-ancestor
25241220|NCT03612960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25241221|NCT03612960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750642|NCT01699828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24750643|NCT01699828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24750644|NCT01699828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541033|NCT00670566|Irbesartan|irbesartan|mesh-list
24750896|NCT01701076|Dexamethasone|dexamethasone|mesh-list
24750897|NCT01701076|Lenalidomide|lenalidomide|mesh-list
24750898|NCT01701076|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24750899|NCT01701076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24750900|NCT01701076|Antiemetics|antiemetics|mesh-ancestor
24750901|NCT01701076|Autonomic Agents|autonomic agents|mesh-ancestor
24750905|NCT01701076|Glucocorticoids|glucocorticoids|mesh-ancestor
24750906|NCT01701076|Hormones|hormones|mesh-ancestor
24750907|NCT01701076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24750908|NCT01701076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24750909|NCT01701076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767946|NCT01804400|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24767947|NCT01804400|Hormone Antagonists|hormone antagonists|mesh-ancestor
24767949|NCT01804400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750910|NCT01701076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750911|NCT01701076|Immunologic Factors|immunologic factors|mesh-ancestor
24750912|NCT01701076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24750913|NCT01701076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24750914|NCT01701076|Growth Substances|growth substances|mesh-ancestor
24750915|NCT01701076|Growth Inhibitors|growth inhibitors|mesh-ancestor
24750916|NCT01701076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24751123|NCT01702181|Immunologic Factors|immunologic factors|mesh-ancestor
24751124|NCT01702181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751160|NCT01702610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751161|NCT01702610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751162|NCT01702623|Oxcarbazepine|oxcarbazepine|mesh-list
24751199|NCT01702701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24751239|NCT01702857|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24751240|NCT01702857|Vaccines|vaccines|mesh-list
24751241|NCT01702857|Aluminum sulfate|aluminum sulfate|mesh-list
24751281|NCT01703234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619058|NCT01050608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24619059|NCT01050608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24619060|NCT01050608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24619061|NCT01050608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619063|NCT01050621|Vitamins|vitamins|mesh-ancestor
24619064|NCT01050621|Micronutrients|micronutrients|mesh-ancestor
24619065|NCT01050621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619066|NCT01050621|Antioxidants|antioxidants|mesh-ancestor
25241246|NCT03607422|Upadacitinib|upadacitinib|mesh-list
25241247|NCT03607422|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25241248|NCT03607422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25241249|NCT03607422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25241250|NCT03607422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241251|NCT03607422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25241252|NCT03600805|Prednisone|prednisone|mesh-list
25241253|NCT03600805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25241254|NCT03600805|Glucocorticoids|glucocorticoids|mesh-ancestor
24619067|NCT01050621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619070|NCT01050699|Midazolam|midazolam|mesh-list
24619071|NCT01050699|Dexmedetomidine|dexmedetomidine|mesh-list
24619072|NCT01050699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24619073|NCT01050699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24768023|NCT01805258|Nevirapine|nevirapine|mesh-list
25674257|NCT01769469|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25674258|NCT01769469|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25674259|NCT01769469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25674260|NCT01769469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674261|NCT01769469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415783|NCT00200655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24751376|NCT01703910|Paclitaxel|paclitaxel|mesh-list
24751377|NCT01703910|Etoposide|etoposide|mesh-list
24751378|NCT01703910|Vinorelbine|vinorelbine|mesh-list
24751379|NCT01703910|Docetaxel|docetaxel|mesh-list
24751380|NCT01703910|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24751382|NCT01703910|Doxorubicin|doxorubicin|mesh-list
24751383|NCT01703910|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24751384|NCT01703910|Fluorouracil|fluorouracil|mesh-list
24751421|NCT01704027|Androgens|androgens|mesh-list
24751422|NCT01704027|Hormones|hormones|mesh-ancestor
24751423|NCT01704027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24751424|NCT01704027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751550|NCT01704716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24415993|NCT00201708|Docetaxel|docetaxel|mesh-list
24751579|NCT01704794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751581|NCT01704872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751582|NCT01704898|Efavirenz|efavirenz|mesh-list
24751583|NCT01704898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24751584|NCT01704898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24751585|NCT01704898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24751586|NCT01704898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751587|NCT01704898|Antiviral Agents|antiviral agents|mesh-ancestor
24751588|NCT01704898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24751589|NCT01704898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24434311|NCT00262054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460310|NCT00348101|Vasodilator Agents|vasodilator agents|mesh-ancestor
24751591|NCT01704898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24751592|NCT01704898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24751593|NCT01704898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24751594|NCT01704898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24751597|NCT01705002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24751598|NCT01705002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24416034|NCT00201786|Pentostatin|pentostatin|mesh-list
24751611|NCT01705158|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24619088|NCT01050699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24619089|NCT01050699|Anesthetics, General|anesthetics, general|mesh-ancestor
24619091|NCT01050699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24619092|NCT01050699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24619093|NCT01050699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24619094|NCT01050699|GABA Modulators|gaba modulators|mesh-ancestor
24619095|NCT01050699|GABA Agents|gaba agents|mesh-ancestor
24619096|NCT01050712|Carbon Monoxide|carbon monoxide|mesh-list
24619097|NCT01050712|Antimetabolites|antimetabolites|mesh-ancestor
24619098|NCT01050712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619099|NCT01050712|Gasotransmitters|gasotransmitters|mesh-ancestor
24619100|NCT01050712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24619101|NCT01050712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619102|NCT01050777|Paromomycin|paromomycin|mesh-list
24619103|NCT01050777|Meglumine Antimoniate|meglumine antimoniate|mesh-list
24619104|NCT01050777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24619105|NCT01050777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24619106|NCT01050777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24619107|NCT01050777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24619108|NCT01050842|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
24619109|NCT01050842|Bicalutamide|bicalutamide|mesh-list
25241255|NCT03600805|Hormones|hormones|mesh-ancestor
25241256|NCT03600805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25241257|NCT03600805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241258|NCT03600805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25241259|NCT03600805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25241260|NCT03547427|Acetaminophen|acetaminophen|mesh-list
25241261|NCT03547427|Insulin|insulin|mesh-list
24619110|NCT01050842|Androgen Antagonists|androgen antagonists|mesh-ancestor
24619111|NCT01050842|Hormone Antagonists|hormone antagonists|mesh-ancestor
24619112|NCT01050842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24416079|NCT00201981|Antioxidants|antioxidants|mesh-ancestor
24751639|NCT01705249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24751640|NCT01705249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751641|NCT01705249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24751642|NCT01705249|Contraceptive Agents|contraceptive agents|mesh-ancestor
24751643|NCT01705249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24751644|NCT01705249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24751680|NCT01705392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24751681|NCT01705392|Vasodilator Agents|vasodilator agents|mesh-ancestor
24768097|NCT01805726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24436787|NCT00271401|Heparin|heparin|mesh-list
24751683|NCT01705392|Alkylating Agents|alkylating agents|mesh-ancestor
24416168|NCT00202189|Hormones|hormones|mesh-ancestor
24751743|NCT01705938|Dolcanatide|dolcanatide|mesh-list
24751744|NCT01705938|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
24751745|NCT01705938|Enzyme Activators|enzyme activators|mesh-ancestor
25875235|NCT04628767|Abortifacient Agents|abortifacient agents|mesh-ancestor
24751751|NCT01705951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24751752|NCT01705951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751754|NCT01705951|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24751755|NCT01705951|Cholinergic Agents|cholinergic agents|mesh-ancestor
24751756|NCT01705951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24751757|NCT01705951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751758|NCT01706055|Interferons|interferons|mesh-list
24751759|NCT01706055|Interferon-beta|interferon-beta|mesh-list
24751760|NCT01706055|Interferon beta-1b|interferon beta-1b|mesh-list
24751761|NCT01706055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751762|NCT01706055|Antiviral Agents|antiviral agents|mesh-ancestor
24751763|NCT01706055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24751764|NCT01706055|Immunologic Factors|immunologic factors|mesh-ancestor
24751765|NCT01706055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751766|NCT01706055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24751767|NCT01706120|Paclitaxel|paclitaxel|mesh-list
24751768|NCT01706120|Bevacizumab|bevacizumab|mesh-list
24434580|NCT00262886|Fludarabine|fludarabine|mesh-list
24434581|NCT00262886|Fludarabine phosphate|fludarabine phosphate|mesh-list
24434582|NCT00262886|Tacrolimus|tacrolimus|mesh-list
24434583|NCT00262886|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24751769|NCT01706120|Carboplatin|carboplatin|mesh-list
24751770|NCT01706120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24751771|NCT01706120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789983|NCT01939912|Vasodilator Agents|vasodilator agents|mesh-ancestor
24789984|NCT01939912|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24789985|NCT01939912|Purinergic Agonists|purinergic agonists|mesh-ancestor
24789986|NCT01939912|Purinergic Agents|purinergic agents|mesh-ancestor
24789987|NCT01939912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24789988|NCT01939912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789989|NCT01939990|Nebivolol|nebivolol|mesh-list
24789990|NCT01939990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24789991|NCT01939990|Vasodilator Agents|vasodilator agents|mesh-ancestor
24789992|NCT01939990|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24789993|NCT01939990|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24789994|NCT01939990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24789995|NCT01939990|Adrenergic Agents|adrenergic agents|mesh-ancestor
24559154|NCT05249569|Bavituximab|bavituximab|mesh-list
24789996|NCT01939990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24789997|NCT01939990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789998|NCT01939990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241262|NCT03547427|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25241263|NCT03547427|Pramlintide|pramlintide|mesh-list
25241264|NCT03547427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25241265|NCT03547427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241266|NCT03547427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25241267|NCT03547427|Analgesics|analgesics|mesh-ancestor
25241268|NCT03547427|Sensory System Agents|sensory system agents|mesh-ancestor
24790002|NCT01940081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790004|NCT01940172|Conatumumab|conatumumab|mesh-list
24790005|NCT01940172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24751803|NCT01706354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24751804|NCT01706367|Vaccines|vaccines|mesh-list
24751805|NCT01706367|Immunologic Factors|immunologic factors|mesh-ancestor
24751806|NCT01706367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751807|NCT01706471|Mycophenolic Acid|mycophenolic acid|mesh-list
24751808|NCT01706471|Everolimus|everolimus|mesh-list
24751809|NCT01706471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751810|NCT01706471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24751811|NCT01706471|Immunologic Factors|immunologic factors|mesh-ancestor
24751812|NCT01706471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751813|NCT01706471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24751814|NCT01706471|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24751815|NCT01706471|Antitubercular Agents|antitubercular agents|mesh-ancestor
24751816|NCT01706471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25007033|NCT04332211|Ephedrine|ephedrine|mesh-list
24768184|NCT01806311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24768185|NCT01806311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768191|NCT01806324|Losartan|losartan|mesh-list
25007034|NCT04332211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24437123|NCT00272740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25007035|NCT04332211|Autonomic Agents|autonomic agents|mesh-ancestor
24751960|NCT01707407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24751961|NCT01707407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24751962|NCT01707407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24751963|NCT01707407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24751964|NCT01707407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751965|NCT01707407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24751966|NCT01707407|Hormone Antagonists|hormone antagonists|mesh-ancestor
24751967|NCT01707407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24751989|NCT01707407|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24751990|NCT01707407|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25875236|NCT04628767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24619121|NCT01050933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619122|NCT01050933|Gasotransmitters|gasotransmitters|mesh-ancestor
24619123|NCT01050933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24619124|NCT01050933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619125|NCT01050985|Sirolimus|sirolimus|mesh-list
24619126|NCT01050985|Capecitabine|capecitabine|mesh-list
24619127|NCT01050985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24619128|NCT01050985|Antimetabolites|antimetabolites|mesh-ancestor
24619129|NCT01050985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25875237|NCT04628767|Dermatologic Agents|dermatologic agents|mesh-ancestor
25875238|NCT04628767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25875239|NCT04628767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25875240|NCT04628767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25875241|NCT04628767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25875242|NCT04628767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25875243|NCT04628767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25875244|NCT04628767|Tubulin Modulators|tubulin modulators|mesh-ancestor
25875245|NCT04628767|Antimitotic Agents|antimitotic agents|mesh-ancestor
25875246|NCT04628767|Mitosis Modulators|mitosis modulators|mesh-ancestor
24619136|NCT01050985|Immunologic Factors|immunologic factors|mesh-ancestor
24619137|NCT01050985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619138|NCT01051011|Metformin|metformin|mesh-list
24619139|NCT01051011|Insulin Glargine|insulin glargine|mesh-list
25241269|NCT03547427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25241270|NCT03547427|Antipyretics|antipyretics|mesh-ancestor
25241271|NCT03489525|Antibodies|antibodies|mesh-list
25241272|NCT03489525|Immunoglobulins|immunoglobulins|mesh-list
25241273|NCT03489525|Immunoconjugates|immunoconjugates|mesh-list
25241274|NCT03489525|Immunologic Factors|immunologic factors|mesh-ancestor
25241275|NCT03489525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241276|NCT03459092|Botulinum Toxins|botulinum toxins|mesh-list
24752025|NCT01707823|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24752026|NCT01707823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752027|NCT01707823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24752028|NCT01707823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24752029|NCT01707823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752030|NCT01707823|Antipyretics|antipyretics|mesh-ancestor
24752031|NCT01707849|Everolimus|everolimus|mesh-list
24752032|NCT01707849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24752033|NCT01707849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24752034|NCT01707849|Immunologic Factors|immunologic factors|mesh-ancestor
24752125|NCT01708616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24752126|NCT01708616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752128|NCT01708616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24752135|NCT01708642|Racepinephrine|racepinephrine|mesh-list
24752136|NCT01708642|Epinephryl borate|epinephryl borate|mesh-list
24416675|NCT00203736|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24752168|NCT01708798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24752169|NCT01708798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752170|NCT01708798|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24752172|NCT01708798|Natriuretic Agents|natriuretic agents|mesh-ancestor
24752173|NCT01708798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24752174|NCT01708837|Propofol|propofol|mesh-list
24752175|NCT01708837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24752176|NCT01708837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24752177|NCT01708837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752178|NCT01708837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24752179|NCT01708837|Anesthetics, General|anesthetics, general|mesh-ancestor
24752240|NCT01709370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674262|NCT01769469|Antiviral Agents|antiviral agents|mesh-ancestor
25875247|NCT04621149|Lactoferrin|lactoferrin|mesh-list
25674615|NCT01774604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752244|NCT01709370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24752377|NCT01710072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24752378|NCT01710072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24752379|NCT01710072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24752380|NCT01710072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752381|NCT01710072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24752382|NCT01710072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24752383|NCT01710072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752385|NCT01710163|Aripiprazole|aripiprazole|mesh-list
24752386|NCT01710163|Antidepressive Agents|antidepressive agents|mesh-ancestor
24752387|NCT01710163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24752388|NCT01710163|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24752389|NCT01710163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24752484|NCT01710592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241277|NCT03459092|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25241278|NCT03459092|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25241279|NCT03459092|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25241280|NCT03459092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24752485|NCT01710592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24752486|NCT01710592|Antimetabolites|antimetabolites|mesh-ancestor
24752487|NCT01710592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24752488|NCT01710592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24752489|NCT01710592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24752490|NCT01710592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752491|NCT01710631|Eszopiclone|eszopiclone|mesh-list
24752492|NCT01710631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24752493|NCT01710631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24752494|NCT01710631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752495|NCT01710670|Ethanol|ethanol|mesh-list
24752496|NCT01710670|Brivaracetam|brivaracetam|mesh-list
24752497|NCT01710670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24752498|NCT01710670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24752499|NCT01710670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24752500|NCT01710670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752501|NCT01710670|Anticonvulsants|anticonvulsants|mesh-ancestor
24752502|NCT01710696|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24752503|NCT01710696|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24752537|NCT01710748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24752538|NCT01710748|Immunologic Factors|immunologic factors|mesh-ancestor
24752539|NCT01710748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752540|NCT01710761|Caffeine|caffeine|mesh-list
24752541|NCT01710761|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25080620|NCT03336840|Metformin|metformin|mesh-list
25080621|NCT03336840|Promethazine|promethazine|mesh-list
25080622|NCT03336840|Diphenhydramine|diphenhydramine|mesh-list
25080634|NCT03336840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24768307|NCT01807325|Pancrelipase|pancrelipase|mesh-list
24753286|NCT01714427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753287|NCT01714427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24753288|NCT01714427|Glucocorticoids|glucocorticoids|mesh-ancestor
24753289|NCT01714427|Hormones|hormones|mesh-ancestor
24753290|NCT01714427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24753990|NCT01718626|Antimitotic Agents|antimitotic agents|mesh-ancestor
24753991|NCT01718626|Mitosis Modulators|mitosis modulators|mesh-ancestor
25241281|NCT03459092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241282|NCT03459092|Cholinergic Agents|cholinergic agents|mesh-ancestor
25241283|NCT03459092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25241284|NCT03459092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241285|NCT03459092|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25241286|NCT03459092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25241287|NCT03434119|Insulin|insulin|mesh-list
25241288|NCT03434119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25241289|NCT03434119|Insulin Glargine|insulin glargine|mesh-list
25241290|NCT03434119|Lixisenatide|lixisenatide|mesh-list
25241291|NCT03434119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25241292|NCT03434119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241293|NCT03397966|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24754030|NCT01718834|Immunologic Factors|immunologic factors|mesh-ancestor
24754031|NCT01718834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754032|NCT01718873|Leucovorin|leucovorin|mesh-list
24754033|NCT01718873|Folic Acid|folic acid|mesh-list
24754071|NCT01718912|Antifungal Agents|antifungal agents|mesh-ancestor
24754072|NCT01718912|Ionophores|ionophores|mesh-ancestor
24418725|NCT00209937|Gaboxadol|gaboxadol|mesh-list
24544413|NCT00688948|Alfuzosin|alfuzosin|mesh-list
24438710|NCT00276679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438711|NCT00276679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438713|NCT00276692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24790441|NCT01942551|Tadalafil|tadalafil|mesh-list
24754193|NCT01719614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24754194|NCT01719614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768322|NCT01807377|GABA Agents|gaba agents|mesh-ancestor
24754195|NCT01719614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24754196|NCT01719614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24754197|NCT01719614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24754208|NCT01719627|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24754209|NCT01719627|Antiviral Agents|antiviral agents|mesh-ancestor
24418856|NCT00210379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24754246|NCT01719835|Vincristine|vincristine|mesh-list
24619423|NCT01052363|Growth Substances|growth substances|mesh-ancestor
24619425|NCT01052363|Growth Inhibitors|growth inhibitors|mesh-ancestor
24619426|NCT01052389|Haloperidol|haloperidol|mesh-list
24619427|NCT01052389|Olanzapine|olanzapine|mesh-list
24619428|NCT01052389|Aripiprazole|aripiprazole|mesh-list
24619429|NCT01052389|Haloperidol decanoate|haloperidol decanoate|mesh-list
24619430|NCT01052389|Antiemetics|antiemetics|mesh-ancestor
24619431|NCT01052389|Autonomic Agents|autonomic agents|mesh-ancestor
25007061|NCT04284657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790008|NCT01940224|Morphine|morphine|mesh-list
24790009|NCT01940224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24790010|NCT01940224|Narcotics|narcotics|mesh-ancestor
25007062|NCT04284657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25007063|NCT04284657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25007064|NCT04284657|Antimetabolites|antimetabolites|mesh-ancestor
25007065|NCT04284657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25007066|NCT04284657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25007067|NCT04284657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25007068|NCT04226352|Dextromethorphan|dextromethorphan|mesh-list
25007069|NCT04226352|Antitussive Agents|antitussive agents|mesh-ancestor
25007070|NCT04226352|Respiratory System Agents|respiratory system agents|mesh-ancestor
25007071|NCT04226352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25007072|NCT04226352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25007073|NCT04226352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24559382|NCT04984759|Tafenoquine|tafenoquine|mesh-list
25007074|NCT04226352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007075|NCT04226352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007076|NCT04222816|Lithium Carbonate|lithium carbonate|mesh-list
25007077|NCT04222816|Antidepressive Agents|antidepressive agents|mesh-ancestor
25007078|NCT04222816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25007079|NCT04222816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876796|NCT02778685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25007080|NCT04222816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007081|NCT04222816|Antimanic Agents|antimanic agents|mesh-ancestor
25007082|NCT04222816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24884022|NCT03571633|Mitosis Modulators|mitosis modulators|mesh-ancestor
25007093|NCT04179968|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25007094|NCT04179968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007095|NCT04161248|Gemcitabine|gemcitabine|mesh-list
25241294|NCT03397966|Natriuretic Agents|natriuretic agents|mesh-ancestor
25241295|NCT03397966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241296|NCT03278626|Paclitaxel|paclitaxel|mesh-list
25241297|NCT03278626|Carboplatin|carboplatin|mesh-list
25241298|NCT03278626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25241299|NCT03278626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25241300|NCT03278626|Tubulin Modulators|tubulin modulators|mesh-ancestor
25241301|NCT03278626|Antimitotic Agents|antimitotic agents|mesh-ancestor
25007096|NCT04161248|Dexamethasone|dexamethasone|mesh-list
25007097|NCT04161248|Rituximab|rituximab|mesh-list
25007098|NCT04161248|Venetoclax|venetoclax|mesh-list
25007099|NCT04161248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25007100|NCT04161248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007101|NCT04161248|Immunologic Factors|immunologic factors|mesh-ancestor
25007102|NCT04161248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007103|NCT04161248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25007104|NCT04161248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25674616|NCT01774786|Cisplatin|cisplatin|mesh-list
25674617|NCT01774786|Fluorouracil|fluorouracil|mesh-list
25674618|NCT01774786|Capecitabine|capecitabine|mesh-list
25674619|NCT01774786|Trastuzumab|trastuzumab|mesh-list
25674620|NCT01774786|Pertuzumab|pertuzumab|mesh-list
25674621|NCT01774786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438865|NCT00276835|Aldesleukin|aldesleukin|mesh-list
25007105|NCT04161248|Antiemetics|antiemetics|mesh-ancestor
25007106|NCT04161248|Autonomic Agents|autonomic agents|mesh-ancestor
25007120|NCT04160910|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
25007121|NCT04160910|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25007122|NCT04160910|Antidepressive Agents|antidepressive agents|mesh-ancestor
25007123|NCT04160910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25007130|NCT04149145|Niraparib|niraparib|mesh-list
25007131|NCT04149145|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25007132|NCT04149145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24619432|NCT01052389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24619433|NCT01052389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660206|NCT01282073|Immunologic Factors|immunologic factors|mesh-ancestor
24619436|NCT01052389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24619437|NCT01052389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24619438|NCT01052389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24619439|NCT01052389|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24619440|NCT01052389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24754346|NCT01720095|Niacin|niacin|mesh-list
24754347|NCT01720095|Nicotinic Acids|nicotinic acids|mesh-list
24754348|NCT01720095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24754349|NCT01720095|Antimetabolites|antimetabolites|mesh-ancestor
24419060|NCT00210912|Topiramate|topiramate|mesh-list
24754579|NCT01721525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24754580|NCT01721525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24754581|NCT01721616|Azithromycin|azithromycin|mesh-list
25241302|NCT03278626|Mitosis Modulators|mitosis modulators|mesh-ancestor
25241303|NCT03278626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241304|NCT03259165|Diuretics|diuretics|mesh-list
25241305|NCT03259165|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
25241306|NCT03259165|Natriuretic Agents|natriuretic agents|mesh-ancestor
25241307|NCT03259165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241308|NCT03259165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25241309|NCT03259165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241310|NCT03211858|Insulin|insulin|mesh-list
25241311|NCT03211858|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25241312|NCT03211858|Insulin Glargine|insulin glargine|mesh-list
25241313|NCT03211858|Insulin Aspart|insulin aspart|mesh-list
25241314|NCT03211858|Insulin, Long-Acting|insulin, long-acting|mesh-list
25241315|NCT03211858|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24851102|NCT02255370|Sensory System Agents|sensory system agents|mesh-ancestor
25155265|NCT05431595|Valproic Acid|valproic acid|mesh-list
24851103|NCT02255370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24754582|NCT01721616|Cefazolin|cefazolin|mesh-list
24754583|NCT01721616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24754584|NCT01721616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24754585|NCT01721655|Spironolactone|spironolactone|mesh-list
24754586|NCT01721655|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24754587|NCT01721655|Hormone Antagonists|hormone antagonists|mesh-ancestor
24754708|NCT01722409|Adrenergic Agents|adrenergic agents|mesh-ancestor
24754709|NCT01722409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24754710|NCT01722409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754711|NCT01722409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24754712|NCT01722409|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24754713|NCT01722409|Anesthetics, General|anesthetics, general|mesh-ancestor
24754714|NCT01722409|Anesthetics|anesthetics|mesh-ancestor
24754716|NCT01722448|Lipotropic Agents|lipotropic agents|mesh-ancestor
24754717|NCT01722448|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24754718|NCT01722448|Antimetabolites|antimetabolites|mesh-ancestor
24754719|NCT01722448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754720|NCT01722448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24754721|NCT01722448|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24754722|NCT01722448|Nootropic Agents|nootropic agents|mesh-ancestor
24754797|NCT01722942|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24754872|NCT01723501|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24754873|NCT01723501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24754874|NCT01723501|Disinfectants|disinfectants|mesh-ancestor
24754875|NCT01723527|Buprenorphine|buprenorphine|mesh-list
24754877|NCT01723527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24754878|NCT01723527|Narcotics|narcotics|mesh-ancestor
24754879|NCT01723527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24754880|NCT01723527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754881|NCT01723527|Analgesics|analgesics|mesh-ancestor
24754919|NCT01723800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24754920|NCT01723800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674622|NCT01774786|Antimetabolites|antimetabolites|mesh-ancestor
25007494|NCT03498014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24439363|NCT00278382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439366|NCT00278408|Rituximab|rituximab|mesh-list
24439367|NCT00278408|Doxorubicin|doxorubicin|mesh-list
24439368|NCT00278408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24439394|NCT00278421|Cyclophosphamide|cyclophosphamide|mesh-list
24754921|NCT01723800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24754922|NCT01723800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24754923|NCT01723852|Vitamin D|vitamin d|mesh-list
24754924|NCT01723852|Ergocalciferols|ergocalciferols|mesh-list
24754925|NCT01723852|Cholecalciferol|cholecalciferol|mesh-list
24754926|NCT01723852|Vitamins|vitamins|mesh-list
24754927|NCT01723852|Micronutrients|micronutrients|mesh-ancestor
24754928|NCT01723852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754929|NCT01723852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24754930|NCT01723852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24754931|NCT01724086|Interferons|interferons|mesh-list
24754932|NCT01724086|Ritonavir|ritonavir|mesh-list
24754933|NCT01724086|Ribavirin|ribavirin|mesh-list
24754934|NCT01724086|Interferon-alpha|interferon-alpha|mesh-list
24754935|NCT01724086|Interferon alpha-2|interferon alpha-2|mesh-list
24619508|NCT01052792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619509|NCT01052792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24619510|NCT01052792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24619511|NCT01052792|Gout Suppressants|gout suppressants|mesh-ancestor
24619512|NCT01052792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24619513|NCT01052792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24619600|NCT01053065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24619514|NCT01052792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619515|NCT01052870|Finasteride|finasteride|mesh-list
24619516|NCT01052870|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24619517|NCT01052870|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24619518|NCT01052870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24619519|NCT01052870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619520|NCT01052870|Hormone Antagonists|hormone antagonists|mesh-ancestor
24619521|NCT01052870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24619522|NCT01052870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754954|NCT01724138|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24754957|NCT01724138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754959|NCT01724190|Cholecalciferol|cholecalciferol|mesh-list
24754960|NCT01724190|Vitamins|vitamins|mesh-ancestor
24754961|NCT01724190|Micronutrients|micronutrients|mesh-ancestor
25241316|NCT03211858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25241317|NCT03211858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241318|NCT03113968|Ketamine|ketamine|mesh-list
25241319|NCT03113968|Analgesics|analgesics|mesh-ancestor
25241320|NCT03113968|Sensory System Agents|sensory system agents|mesh-ancestor
24754962|NCT01724190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754963|NCT01724190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24754964|NCT01724190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24754965|NCT01724229|Antifungal Agents|antifungal agents|mesh-list
24754966|NCT01724229|Clotrimazole|clotrimazole|mesh-list
24754967|NCT01724229|Miconazole|miconazole|mesh-list
24754968|NCT01724229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24754969|NCT01724229|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24755062|NCT01724450|Adrenergic Agents|adrenergic agents|mesh-ancestor
24755063|NCT01724450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24755064|NCT01724450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755065|NCT01724450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661094|NCT01287780|Gentamicins|gentamicins|mesh-list
24755066|NCT01724450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24755067|NCT01724450|Antioxidants|antioxidants|mesh-ancestor
25045876|NCT00902928|Enoxaparin|enoxaparin|mesh-list
24755068|NCT01724450|Protective Agents|protective agents|mesh-ancestor
24755069|NCT01724450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24755070|NCT01724450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24755071|NCT01724450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25674623|NCT01774786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674624|NCT01774786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25674625|NCT01774786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25674626|NCT01774786|Immunologic Factors|immunologic factors|mesh-ancestor
25674627|NCT01774786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674628|NCT01774786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24755072|NCT01724450|Vasodilator Agents|vasodilator agents|mesh-ancestor
24755073|NCT01724450|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24755074|NCT01724450|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24755108|NCT01724788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755110|NCT01724814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24755111|NCT01724814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755112|NCT01724892|Loteprednol Etabonate|loteprednol etabonate|mesh-list
24755113|NCT01724892|Dexamethasone|dexamethasone|mesh-list
24755114|NCT01724892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24755115|NCT01724892|Antiemetics|antiemetics|mesh-ancestor
24755180|NCT01725048|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24755181|NCT01725048|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24755185|NCT01725087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24755186|NCT01725087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755187|NCT01725087|Analgesics|analgesics|mesh-ancestor
24755188|NCT01725087|Sensory System Agents|sensory system agents|mesh-ancestor
24419966|NCT00214682|Vitamins|vitamins|mesh-ancestor
24755222|NCT01725230|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24755224|NCT01725230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24755225|NCT01725230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24755226|NCT01725230|Antimetabolites|antimetabolites|mesh-ancestor
24755285|NCT01725607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24755286|NCT01725607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24420055|NCT00215046|Methotrexate|methotrexate|mesh-list
24619588|NCT01053039|Morphine|morphine|mesh-list
24619589|NCT01053039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24619590|NCT01053039|Narcotics|narcotics|mesh-ancestor
24619591|NCT01053039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24619592|NCT01053039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619593|NCT01053039|Analgesics|analgesics|mesh-ancestor
24619594|NCT01053039|Sensory System Agents|sensory system agents|mesh-ancestor
24619595|NCT01053039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24619596|NCT01053065|Atorvastatin|atorvastatin|mesh-list
24619597|NCT01053065|Cholestyramine Resin|cholestyramine resin|mesh-list
24619598|NCT01053065|Gamma-sitosterol|gamma-sitosterol|mesh-list
24619599|NCT01053065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24619604|NCT01053065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24755346|NCT01726075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24755348|NCT01726088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24755349|NCT01726088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241321|NCT03113968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25241322|NCT03113968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241323|NCT03113968|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25241324|NCT03113968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25876797|NCT02778685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851106|NCT02255370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24851107|NCT02255370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755350|NCT01726088|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24755351|NCT01726088|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24755352|NCT01726088|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24755353|NCT01726088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755354|NCT01726192|Ropivacaine|ropivacaine|mesh-list
24755355|NCT01726192|Anesthetics, Local|anesthetics, local|mesh-ancestor
24755356|NCT01726192|Anesthetics|anesthetics|mesh-ancestor
24755357|NCT01726192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24755358|NCT01726192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755359|NCT01726192|Sensory System Agents|sensory system agents|mesh-ancestor
24755392|NCT01726400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755393|NCT01726400|Immunologic Factors|immunologic factors|mesh-ancestor
24661437|NCT01289496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24755394|NCT01726400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755395|NCT01726465|Acetylcysteine|acetylcysteine|mesh-list
24755396|NCT01726465|Methylprednisolone|methylprednisolone|mesh-list
24755397|NCT01726465|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24755398|NCT01726465|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24755644|NCT01727869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755645|NCT01727973|Doxycycline|doxycycline|mesh-list
24755646|NCT01727973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24755647|NCT01727973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24755648|NCT01727973|Antimalarials|antimalarials|mesh-ancestor
24757008|NCT01737177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24755800|NCT01729195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25279142|NCT02346188|Dermatologic Agents|dermatologic agents|mesh-ancestor
24755801|NCT01729195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24755802|NCT01729195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24755803|NCT01729195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24755804|NCT01729195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24755805|NCT01729195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755806|NCT01729195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755807|NCT01729195|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24755808|NCT01729195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24755811|NCT01729260|Piperazine citrate|piperazine citrate|mesh-list
24755812|NCT01729260|DMP 777|dmp 777|mesh-list
25241325|NCT03113968|Anesthetics, General|anesthetics, general|mesh-ancestor
25241326|NCT03113968|Anesthetics|anesthetics|mesh-ancestor
25241327|NCT03113968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25241328|NCT03113968|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25241329|NCT03113968|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25241330|NCT03113968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25241331|NCT03113968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241332|NCT03093480|Factor VIII|factor viii|mesh-list
25241333|NCT03093480|Coagulants|coagulants|mesh-ancestor
25241334|NCT03092323|Pembrolizumab|pembrolizumab|mesh-list
25241335|NCT03092323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25241336|NCT03092323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25241337|NCT03077438|Vaccines|vaccines|mesh-list
25241338|NCT03077438|Immunologic Factors|immunologic factors|mesh-ancestor
25241339|NCT03077438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241340|NCT03045653|Tamoxifen|tamoxifen|mesh-list
25241341|NCT03045653|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25241342|NCT03045653|Hormone Antagonists|hormone antagonists|mesh-ancestor
25241343|NCT03045653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25876798|NCT02778685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24755813|NCT01729260|Antinematodal Agents|antinematodal agents|mesh-ancestor
24755814|NCT01729260|Anthelmintics|anthelmintics|mesh-ancestor
24755815|NCT01729260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24755816|NCT01729260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24755817|NCT01729260|Tubulin Modulators|tubulin modulators|mesh-ancestor
24755818|NCT01729260|Antimitotic Agents|antimitotic agents|mesh-ancestor
24755819|NCT01729260|Mitosis Modulators|mitosis modulators|mesh-ancestor
24755820|NCT01729260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755821|NCT01729260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755822|NCT01729260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24755823|NCT01729468|Aspirin|aspirin|mesh-list
24755824|NCT01729468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24755825|NCT01729468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24755945|NCT01730326|Acetaminophen|acetaminophen|mesh-list
24755946|NCT01730326|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
24755947|NCT01730326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24755948|NCT01730326|Analgesics|analgesics|mesh-ancestor
24755949|NCT01730326|Sensory System Agents|sensory system agents|mesh-ancestor
24755950|NCT01730326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24768758|NCT01810458|GABA Modulators|gaba modulators|mesh-ancestor
24755951|NCT01730326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756078|NCT01731132|Trace Elements|trace elements|mesh-ancestor
24756079|NCT01731132|Micronutrients|micronutrients|mesh-ancestor
24756080|NCT01731158|Interferon alpha-2|interferon alpha-2|mesh-list
24756081|NCT01731158|Bevacizumab|bevacizumab|mesh-list
25241344|NCT03045653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241345|NCT03045653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25241346|NCT03045653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25241347|NCT03045653|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25241348|NCT03045653|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25241349|NCT03045653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25241350|NCT02991365|Insulin|insulin|mesh-list
25241351|NCT02991365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25241352|NCT02991365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241353|NCT02890069|Everolimus|everolimus|mesh-list
25241354|NCT02890069|Panobinostat|panobinostat|mesh-list
25241355|NCT02890069|Spartalizumab|spartalizumab|mesh-list
25241356|NCT02890069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25241357|NCT02890069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25241358|NCT02890069|Immunologic Factors|immunologic factors|mesh-ancestor
25241359|NCT02890069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241360|NCT02890069|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25241361|NCT02890069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25241362|NCT02890069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241363|NCT02890069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24756104|NCT01731184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24756105|NCT01731184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24756229|NCT01731756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24756230|NCT01731756|Analgesics|analgesics|mesh-ancestor
24662057|NCT01292174|Ibalizumab|ibalizumab|mesh-list
24756231|NCT01731756|Sensory System Agents|sensory system agents|mesh-ancestor
24756319|NCT01732276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24756320|NCT01732276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24756321|NCT01732276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756322|NCT01732276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756342|NCT01732380|Raltitrexed|raltitrexed|mesh-list
24756343|NCT01732380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24756344|NCT01732380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24756345|NCT01732380|Antimetabolites|antimetabolites|mesh-ancestor
24756346|NCT01732380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756347|NCT01732380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24756348|NCT01732380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756349|NCT01732393|Quercetin|quercetin|mesh-list
24756350|NCT01732393|Antioxidants|antioxidants|mesh-ancestor
24756351|NCT01732393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756352|NCT01732393|Protective Agents|protective agents|mesh-ancestor
24756353|NCT01732393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546782|NCT00700297|Colchicine|colchicine|mesh-list
24756355|NCT01732666|Nefopam|nefopam|mesh-list
24756356|NCT01732666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24756357|NCT01732666|Narcotics|narcotics|mesh-ancestor
24756358|NCT01732666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24756667|NCT01735019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24756668|NCT01735058|Hyaluronic Acid|hyaluronic acid|mesh-list
24756672|NCT01735058|Viscosupplements|viscosupplements|mesh-ancestor
24756673|NCT01735058|Protective Agents|protective agents|mesh-ancestor
24756674|NCT01735071|Bevacizumab|bevacizumab|mesh-list
24756675|NCT01735071|Carboplatin|carboplatin|mesh-list
24756676|NCT01735071|Trabectedin|trabectedin|mesh-list
24756677|NCT01735071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24756678|NCT01735071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24756679|NCT01735071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24756743|NCT01735370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24756744|NCT01735370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756745|NCT01735370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25241369|NCT02864407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25241370|NCT02864407|Autonomic Agents|autonomic agents|mesh-ancestor
25241371|NCT02864407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25273986|NCT02381249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25876799|NCT02778685|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25273987|NCT02381249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24756746|NCT01735370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24756747|NCT01735370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24437256|NCT00273247|Interferons|interferons|mesh-list
25876800|NCT02778685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25876801|NCT02736422|Xenon|xenon|mesh-list
25080664|NCT03336632|Alkylating Agents|alkylating agents|mesh-ancestor
24756801|NCT01735825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24756802|NCT01735825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24756803|NCT01735825|Tubulin Modulators|tubulin modulators|mesh-ancestor
24756804|NCT01735825|Antimitotic Agents|antimitotic agents|mesh-ancestor
25242570|NCT04360070|Anesthetics|anesthetics|mesh-ancestor
24756867|NCT01736150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756869|NCT01736163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24756870|NCT01736163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547296|NCT00703352|Eplerenone|eplerenone|mesh-list
24756872|NCT01736371|Sevoflurane|sevoflurane|mesh-list
24756873|NCT01736371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24756874|NCT01736371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24756898|NCT01736449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24756900|NCT01736449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756901|NCT01736449|Growth Inhibitors|growth inhibitors|mesh-ancestor
24756902|NCT01736488|Atenolol|atenolol|mesh-list
24756905|NCT01736488|Sympatholytics|sympatholytics|mesh-ancestor
24756987|NCT01737073|Analgesics, Opioid|analgesics, opioid|mesh-list
24756988|NCT01737073|Narcotics|narcotics|mesh-ancestor
24756989|NCT01737073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24756990|NCT01737073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756991|NCT01737073|Analgesics|analgesics|mesh-ancestor
24756992|NCT01737073|Sensory System Agents|sensory system agents|mesh-ancestor
24756993|NCT01737073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24756994|NCT01737086|Zinc Sulfate|zinc sulfate|mesh-list
24756996|NCT01737086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756997|NCT01737086|Dermatologic Agents|dermatologic agents|mesh-ancestor
24756998|NCT01737112|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
24756999|NCT01737112|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24757000|NCT01737112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757001|NCT01737177|Rituximab|rituximab|mesh-list
24757002|NCT01737177|Lenalidomide|lenalidomide|mesh-list
24757003|NCT01737177|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24757004|NCT01737177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24757005|NCT01737177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24757006|NCT01737177|Immunologic Factors|immunologic factors|mesh-ancestor
24757007|NCT01737177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241373|NCT02864407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25241374|NCT02864407|Respiratory System Agents|respiratory system agents|mesh-ancestor
25241375|NCT02864407|Parasympatholytics|parasympatholytics|mesh-ancestor
25241376|NCT02864407|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25241377|NCT02864407|Cholinergic Agents|cholinergic agents|mesh-ancestor
25241378|NCT02864407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25273988|NCT02381314|Ipilimumab|ipilimumab|mesh-list
25273989|NCT02381314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25273990|NCT02381314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25273991|NCT02381314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25241398|NCT02846532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25241399|NCT02846532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25241400|NCT02846532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25241401|NCT02846532|Antipyretics|antipyretics|mesh-ancestor
25241404|NCT02688933|Insulin|insulin|mesh-list
25241405|NCT02688933|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25241406|NCT02688933|Insulin Glargine|insulin glargine|mesh-list
25241407|NCT02688933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25241408|NCT02688933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241409|NCT02550197|Vaccines|vaccines|mesh-list
25241410|NCT02550197|Immunologic Factors|immunologic factors|mesh-ancestor
25241411|NCT02550197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241412|NCT02492165|Vaccines|vaccines|mesh-list
25241413|NCT02492165|Immunologic Factors|immunologic factors|mesh-ancestor
25241414|NCT02492165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241415|NCT02476006|Atorvastatin|atorvastatin|mesh-list
25241416|NCT02476006|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25241417|NCT02476006|Simvastatin|simvastatin|mesh-list
25241418|NCT02476006|Ezetimibe|ezetimibe|mesh-list
25241419|NCT02476006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25241420|NCT02476006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25241421|NCT02476006|Antimetabolites|antimetabolites|mesh-ancestor
25241422|NCT02476006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241423|NCT02476006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25241424|NCT02476006|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25241425|NCT02476006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25241426|NCT02332590|Adalimumab|adalimumab|mesh-list
25241427|NCT02332590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25241428|NCT02332590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24575603|NCT00832689|Irinotecan|irinotecan|mesh-list
25241429|NCT02289209|Pembrolizumab|pembrolizumab|mesh-list
25241430|NCT02289209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25241431|NCT02289209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25674629|NCT01774851|Paclitaxel|paclitaxel|mesh-list
24442004|NCT00289419|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25241432|NCT02256865|Ketoconazole|ketoconazole|mesh-list
25241433|NCT02256865|Hydrocortisone|hydrocortisone|mesh-list
24790113|NCT01940965|Lixisenatide|lixisenatide|mesh-list
24790115|NCT01940965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24790116|NCT01940965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790117|NCT01940978|Cyproheptadine|cyproheptadine|mesh-list
24790118|NCT01940978|Methylphenidate|methylphenidate|mesh-list
24790119|NCT01940978|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24790120|NCT01940978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241434|NCT02256865|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25241435|NCT02256865|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25241436|NCT02256865|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25241437|NCT02256865|Methyltestosterone|methyltestosterone|mesh-list
25241438|NCT02256865|Testosterone|testosterone|mesh-list
25241439|NCT02256865|Testosterone undecanoate|testosterone undecanoate|mesh-list
25241440|NCT02256865|Testosterone enanthate|testosterone enanthate|mesh-list
25241441|NCT02256865|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25241442|NCT02256865|Androgens|androgens|mesh-ancestor
25241443|NCT02256865|Hormones|hormones|mesh-ancestor
25241444|NCT02256865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25241445|NCT02256865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241446|NCT02256865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25241447|NCT02256865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25241448|NCT02256865|Anabolic Agents|anabolic agents|mesh-ancestor
25241449|NCT02256865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25241450|NCT02256865|Antifungal Agents|antifungal agents|mesh-ancestor
25241451|NCT02256865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25241452|NCT02256865|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25241453|NCT02256865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25241454|NCT02256865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25241455|NCT02256865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241456|NCT02256865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25241457|NCT02256865|Hormone Antagonists|hormone antagonists|mesh-ancestor
25241458|NCT02256865|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25241459|NCT02255656|Alemtuzumab|alemtuzumab|mesh-list
24851171|NCT02255812|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24851172|NCT02255812|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24851173|NCT02255812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24851174|NCT02255812|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24851175|NCT02255812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851176|NCT02255812|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24851177|NCT02255812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851178|NCT02255812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24851179|NCT02255812|Analgesics|analgesics|mesh-ancestor
24851180|NCT02255812|Sensory System Agents|sensory system agents|mesh-ancestor
25078271|NCT03357822|Entecavir|entecavir|mesh-list
24851181|NCT02255812|Anticoagulants|anticoagulants|mesh-ancestor
24851182|NCT02255812|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24851183|NCT02255812|Chelating Agents|chelating agents|mesh-ancestor
24851184|NCT02255812|Sequestering Agents|sequestering agents|mesh-ancestor
25876802|NCT02736422|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24790121|NCT01940978|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24619717|NCT01053442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619718|NCT01053481|Vitamin D|vitamin d|mesh-list
24619719|NCT01053481|Vitamins|vitamins|mesh-ancestor
24619720|NCT01053481|Micronutrients|micronutrients|mesh-ancestor
24619721|NCT01053481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619722|NCT01053481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24619723|NCT01053520|Navitoclax|navitoclax|mesh-list
24619724|NCT01053520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24619725|NCT01053559|Certolizumab Pegol|certolizumab pegol|mesh-list
24662649|NCT01295892|Hormones|hormones|mesh-ancestor
24757104|NCT01737918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24757105|NCT01737918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757106|NCT01737918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757107|NCT01737918|Urological Agents|urological agents|mesh-ancestor
24757108|NCT01738035|Budesonide|budesonide|mesh-list
24757109|NCT01738035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24757110|NCT01738035|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24757111|NCT01738035|Autonomic Agents|autonomic agents|mesh-ancestor
24757112|NCT01738035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24757113|NCT01738035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757114|NCT01738035|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25674630|NCT01774851|Trastuzumab|trastuzumab|mesh-list
24757115|NCT01738035|Respiratory System Agents|respiratory system agents|mesh-ancestor
24442204|NCT00290485|Imatinib Mesylate|imatinib mesylate|mesh-list
24442205|NCT00290485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442206|NCT00290485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24442207|NCT00290485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757116|NCT01738035|Glucocorticoids|glucocorticoids|mesh-ancestor
24757117|NCT01738035|Hormones|hormones|mesh-ancestor
24757118|NCT01738035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24757467|NCT01739985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24757468|NCT01739985|Dopamine Agents|dopamine agents|mesh-ancestor
24757470|NCT01740245|Chlorhexidine|chlorhexidine|mesh-list
24757471|NCT01740245|Polihexanide|polihexanide|mesh-list
24757472|NCT01740245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24757473|NCT01740245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24757474|NCT01740245|Disinfectants|disinfectants|mesh-ancestor
24757475|NCT01740245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24757476|NCT01740245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422324|NCT00222079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24422325|NCT00222079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24757844|NCT01742676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757845|NCT01742676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757847|NCT01742689|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24757848|NCT01742689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24757849|NCT01742689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24757851|NCT01742689|Sensory System Agents|sensory system agents|mesh-ancestor
25241460|NCT02255656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25241461|NCT02255656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25241462|NCT01900444|Vaccines|vaccines|mesh-list
25241463|NCT01900444|Immunologic Factors|immunologic factors|mesh-ancestor
25241464|NCT01900444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241465|NCT01751126|Cyclosporine|cyclosporine|mesh-list
25241466|NCT01751126|Cyclosporins|cyclosporins|mesh-list
25241467|NCT01751126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25241468|NCT01751126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241469|NCT01751126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25241470|NCT01751126|Immunologic Factors|immunologic factors|mesh-ancestor
25241471|NCT01751126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274006|NCT02381184|Hormone Antagonists|hormone antagonists|mesh-ancestor
25274007|NCT02381184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25274008|NCT02381184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274009|NCT02381184|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25274010|NCT02381184|Fertility Agents|fertility agents|mesh-ancestor
25274011|NCT02381184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25274012|NCT02381184|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25274013|NCT02381184|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25274014|NCT02381470|Amoxicillin|amoxicillin|mesh-list
25274015|NCT02381470|Rifampin|rifampin|mesh-list
25274016|NCT02381470|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25274017|NCT02381470|Clavulanic Acids|clavulanic acids|mesh-list
25274018|NCT02381470|Clavulanic Acid|clavulanic acid|mesh-list
25274019|NCT02381470|Cefadroxil|cefadroxil|mesh-list
25274020|NCT02381470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24769262|NCT01813552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25274021|NCT02381470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25274022|NCT02381470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25274023|NCT02381470|Antitubercular Agents|antitubercular agents|mesh-ancestor
25274024|NCT02381470|Leprostatic Agents|leprostatic agents|mesh-ancestor
25241506|NCT00859781|Antifungal Agents|antifungal agents|mesh-ancestor
25241507|NCT00859781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25241508|NCT00859781|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25241509|NCT00859781|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25241510|NCT00859781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25241511|NCT00859781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241512|NCT00859781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25241513|NCT00859781|Hormone Antagonists|hormone antagonists|mesh-ancestor
25241514|NCT00859781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25241515|NCT00859781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241516|NCT00859781|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25241518|NCT00727090|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25279143|NCT02346188|Sunscreening Agents|sunscreening agents|mesh-ancestor
25674631|NCT01774851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25674632|NCT01774851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25674633|NCT01774851|Tubulin Modulators|tubulin modulators|mesh-ancestor
25674634|NCT01774851|Antimitotic Agents|antimitotic agents|mesh-ancestor
24442667|NCT00291980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442668|NCT00292071|Caspofungin|caspofungin|mesh-list
24442669|NCT00292071|Antifungal Agents|antifungal agents|mesh-ancestor
25241519|NCT00727090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241520|NCT00727090|Natriuretic Agents|natriuretic agents|mesh-ancestor
25876803|NCT02736422|Anesthetics, General|anesthetics, general|mesh-ancestor
25876804|NCT02736422|Anesthetics|anesthetics|mesh-ancestor
25876805|NCT02736422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25876806|NCT02736422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876807|NCT02599363|Paclitaxel|paclitaxel|mesh-list
25876808|NCT02599363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25876809|NCT02599363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24769282|NCT01813617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24769283|NCT01813617|Glucocorticoids|glucocorticoids|mesh-ancestor
24769284|NCT01813617|Hormones|hormones|mesh-ancestor
24769286|NCT01813617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876810|NCT02599363|Tubulin Modulators|tubulin modulators|mesh-ancestor
25876811|NCT02599363|Antimitotic Agents|antimitotic agents|mesh-ancestor
25876812|NCT02599363|Mitosis Modulators|mitosis modulators|mesh-ancestor
25876813|NCT02599363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876814|NCT02580838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25876815|NCT02580838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25876816|NCT02580838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25876817|NCT02580838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25241521|NCT00727090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241538|NCT05301530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769384|NCT01814059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769385|NCT01814085|Citalopram|citalopram|mesh-list
24769386|NCT01814085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25241539|NCT05301530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25241540|NCT05301361|Methylphenidate|methylphenidate|mesh-list
25241541|NCT05301361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25241542|NCT05301361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241543|NCT05301361|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25241544|NCT05301361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25241545|NCT05301361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25241546|NCT05301361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241547|NCT05301361|Dopamine Agents|dopamine agents|mesh-ancestor
25241548|NCT05301361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25241549|NCT05301205|Gabapentin|gabapentin|mesh-list
25241550|NCT05301205|Analgesics|analgesics|mesh-ancestor
25241551|NCT05301205|Sensory System Agents|sensory system agents|mesh-ancestor
25241552|NCT05301205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25241553|NCT05301205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241554|NCT05301205|Anticonvulsants|anticonvulsants|mesh-ancestor
25241555|NCT05301205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25241556|NCT05301205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25241557|NCT05301205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25241558|NCT05301205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25241559|NCT05301205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25241560|NCT05301205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25241561|NCT05301205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25241562|NCT05301205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241563|NCT05301205|Antimanic Agents|antimanic agents|mesh-ancestor
25241564|NCT05301023|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24444843|NCT00299351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24444845|NCT00299364|Tibolone|tibolone|mesh-list
25674635|NCT01774851|Mitosis Modulators|mitosis modulators|mesh-ancestor
25674636|NCT01774851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674637|NCT01774851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25674638|NCT01774903|Fentanyl|fentanyl|mesh-list
25674639|NCT01774903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25674640|NCT01774903|Narcotics|narcotics|mesh-ancestor
25674641|NCT01774903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25674642|NCT01774903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674643|NCT01774903|Analgesics|analgesics|mesh-ancestor
25674644|NCT01774903|Sensory System Agents|sensory system agents|mesh-ancestor
25674645|NCT01774903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25674646|NCT01774903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25674647|NCT01774903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25674648|NCT01774903|Anesthetics, General|anesthetics, general|mesh-ancestor
25674649|NCT01774903|Anesthetics|anesthetics|mesh-ancestor
25674650|NCT01774929|Fentanyl|fentanyl|mesh-list
25876818|NCT02580838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876819|NCT02580838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25674651|NCT01774929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25876820|NCT02580838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25876821|NCT02580838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25155267|NCT05431595|Chlorpromazine|chlorpromazine|mesh-list
24560497|NCT02476279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876822|NCT02580838|Cholinergic Agents|cholinergic agents|mesh-ancestor
25876823|NCT02580838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25876824|NCT02537613|Obinutuzumab|obinutuzumab|mesh-list
25876825|NCT02537613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25876826|NCT02537613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24851305|NCT02256319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851306|NCT02256319|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24851307|NCT02256319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24851308|NCT02256319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24851309|NCT02256319|Adrenergic Agents|adrenergic agents|mesh-ancestor
24851310|NCT02256319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24851311|NCT02256319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851312|NCT02256319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25241570|NCT05301010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25241571|NCT05301010|Tubulin Modulators|tubulin modulators|mesh-ancestor
25241572|NCT05301010|Antimitotic Agents|antimitotic agents|mesh-ancestor
25241573|NCT05301010|Mitosis Modulators|mitosis modulators|mesh-ancestor
25241574|NCT05301010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241575|NCT05301010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25241577|NCT05300958|Siderophores|siderophores|mesh-ancestor
25241578|NCT05300958|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25241579|NCT05300958|Chelating Agents|chelating agents|mesh-ancestor
25241580|NCT05300958|Sequestering Agents|sequestering agents|mesh-ancestor
25241581|NCT05300958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241582|NCT05300932|Cyclophosphamide|cyclophosphamide|mesh-list
25241583|NCT05300932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25241584|NCT05300932|Immunologic Factors|immunologic factors|mesh-ancestor
25241585|NCT05300932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241586|NCT05300932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25241587|NCT05300932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25241588|NCT05300932|Alkylating Agents|alkylating agents|mesh-ancestor
25241589|NCT05300932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241590|NCT05300932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25241591|NCT05300932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25241592|NCT05300854|Anesthetics|anesthetics|mesh-list
25241593|NCT05300854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25241594|NCT05300854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966757|NCT03765554|PF-06700841|pf-06700841|mesh-list
25876827|NCT02500121|Pembrolizumab|pembrolizumab|mesh-list
25876828|NCT02500121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24851343|NCT02256709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24851358|NCT02256722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24851359|NCT02256722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851360|NCT02256722|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24851361|NCT02256722|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24851362|NCT02256722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24851363|NCT02256722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24851364|NCT02256722|Vasodilator Agents|vasodilator agents|mesh-ancestor
24851365|NCT02256722|Sympatholytics|sympatholytics|mesh-ancestor
24757924|NCT01742988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24757926|NCT01743014|Clopidogrel|clopidogrel|mesh-list
24757927|NCT01743014|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24757928|NCT01743014|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24757929|NCT01743014|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24757930|NCT01743014|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24757931|NCT01743014|Purinergic Agents|purinergic agents|mesh-ancestor
25241610|NCT05300555|Rivaroxaban|rivaroxaban|mesh-list
25241611|NCT05300555|Anticoagulants|anticoagulants|mesh-ancestor
25674652|NCT01774929|Narcotics|narcotics|mesh-ancestor
25674653|NCT01774929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25674654|NCT01774929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674655|NCT01774929|Analgesics|analgesics|mesh-ancestor
25674656|NCT01774929|Sensory System Agents|sensory system agents|mesh-ancestor
25674657|NCT01774929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25692340|NCT01998919|Gemcitabine|gemcitabine|mesh-list
25876829|NCT02500121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876830|NCT02465060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25876831|NCT02465060|Nivolumab|nivolumab|mesh-list
25876832|NCT02465060|Trastuzumab|trastuzumab|mesh-list
25876833|NCT02465060|Pertuzumab|pertuzumab|mesh-list
25876834|NCT02465060|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24884881|NCT03316586|Nivolumab|nivolumab|mesh-list
24790525|NCT01943409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25241612|NCT05300555|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25241613|NCT05300555|Antithrombins|antithrombins|mesh-ancestor
25241614|NCT05300555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25241615|NCT05300555|Protease Inhibitors|protease inhibitors|mesh-ancestor
25241616|NCT05300555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25241617|NCT05300555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241618|NCT05300490|Prednisolone|prednisolone|mesh-list
25241619|NCT05300490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25241620|NCT05300490|Glucocorticoids|glucocorticoids|mesh-ancestor
25241621|NCT05300490|Hormones|hormones|mesh-ancestor
25241622|NCT05300490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25241623|NCT05300490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241624|NCT05300490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25241625|NCT05300490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25241626|NCT05300477|Acetazolamide|acetazolamide|mesh-list
25241627|NCT05300477|Epoetin Alfa|epoetin alfa|mesh-list
25241628|NCT05300477|Hematinics|hematinics|mesh-ancestor
25241629|NCT05300477|Anticonvulsants|anticonvulsants|mesh-ancestor
25241630|NCT05300477|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24769472|NCT01814423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24769473|NCT01814423|Antimalarials|antimalarials|mesh-ancestor
24769474|NCT01814423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24769477|NCT01814423|Analgesics|analgesics|mesh-ancestor
25241631|NCT05300477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876835|NCT02465060|Sunitinib|sunitinib|mesh-list
25876836|NCT02465060|Dasatinib|dasatinib|mesh-list
25876837|NCT02465060|Palbociclib|palbociclib|mesh-list
25876838|NCT02465060|Trametinib|trametinib|mesh-list
25876839|NCT02465060|Osimertinib|osimertinib|mesh-list
25876840|NCT02465060|Afatinib|afatinib|mesh-list
25876841|NCT02465060|Dabrafenib|dabrafenib|mesh-list
25069040|NCT03429738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757978|NCT01743157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24757979|NCT01743157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24758165|NCT01744184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24758166|NCT01744184|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24758167|NCT01744236|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24758168|NCT01744236|Liraglutide|liraglutide|mesh-list
24758170|NCT01744236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24769506|NCT01814475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769507|NCT01814475|Antiviral Agents|antiviral agents|mesh-ancestor
24769508|NCT01814475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24769509|NCT01814475|Alkylating Agents|alkylating agents|mesh-ancestor
24769510|NCT01814475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24758171|NCT01744236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758172|NCT01744236|Incretins|incretins|mesh-ancestor
24758173|NCT01744236|Hormones|hormones|mesh-ancestor
24758174|NCT01744236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24758175|NCT01744236|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24758176|NCT01744236|Protease Inhibitors|protease inhibitors|mesh-ancestor
24758177|NCT01744236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758178|NCT01744236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758205|NCT01744314|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24758206|NCT01744314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758207|NCT01744314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758208|NCT01744314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24758209|NCT01744314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24758210|NCT01744314|Analgesics|analgesics|mesh-ancestor
24758211|NCT01744314|Sensory System Agents|sensory system agents|mesh-ancestor
24758212|NCT01744314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24758213|NCT01744314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674658|NCT01774929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25674659|NCT01774929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25674660|NCT01774929|Anesthetics, General|anesthetics, general|mesh-ancestor
25674661|NCT01774929|Anesthetics|anesthetics|mesh-ancestor
25674662|NCT01774968|Insulin|insulin|mesh-list
25674663|NCT01774968|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25674664|NCT01774968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25674665|NCT01774968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674666|NCT01775124|Ranibizumab|ranibizumab|mesh-list
24437057|NCT00272584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24443027|NCT00293475|Abortifacient Agents|abortifacient agents|mesh-ancestor
24758353|NCT01745562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24758354|NCT01745562|GABA Modulators|gaba modulators|mesh-ancestor
24758355|NCT01745562|GABA Agents|gaba agents|mesh-ancestor
25241632|NCT05300477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241633|NCT05300477|Diuretics|diuretics|mesh-ancestor
24769554|NCT01814618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25241640|NCT05300386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241641|NCT05300386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25241642|NCT05300386|Serotonin Agents|serotonin agents|mesh-ancestor
25241643|NCT05300386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241644|NCT05300386|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25241645|NCT05300386|Antidepressive Agents|antidepressive agents|mesh-ancestor
25241646|NCT05300386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25241647|NCT05300373|Adenosine|adenosine|mesh-list
25241648|NCT05300373|Analgesics|analgesics|mesh-ancestor
25241649|NCT05300373|Sensory System Agents|sensory system agents|mesh-ancestor
25241650|NCT05300373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25241651|NCT05300373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241652|NCT05300373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25876842|NCT02465060|Crizotinib|crizotinib|mesh-list
25876843|NCT02465060|Maytansine|maytansine|mesh-list
24851374|NCT02256735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24851375|NCT02256735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24851376|NCT02256735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24851377|NCT02256735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851378|NCT02256735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758356|NCT01745562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24758357|NCT01745562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758358|NCT01745575|Alprazolam|alprazolam|mesh-list
24758359|NCT01745575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24758498|NCT01746563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24758499|NCT01746563|Growth Substances|growth substances|mesh-ancestor
24758500|NCT01746563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758501|NCT01746563|Growth Inhibitors|growth inhibitors|mesh-ancestor
24758502|NCT01746563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758537|NCT01746680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24758538|NCT01746680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24758539|NCT01746680|Immunologic Factors|immunologic factors|mesh-ancestor
24758540|NCT01746680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24758541|NCT01746680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24758542|NCT01746680|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24423265|NCT00225238|Esomeprazole|esomeprazole|mesh-list
24758648|NCT01747148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24758649|NCT01747161|Botulinum Toxins|botulinum toxins|mesh-list
24758650|NCT01747161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24758651|NCT01747161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24758652|NCT01747161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758653|NCT01747161|Cholinergic Agents|cholinergic agents|mesh-ancestor
24758654|NCT01747161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24758655|NCT01747161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758657|NCT01747174|Nitroprusside|nitroprusside|mesh-list
24758658|NCT01747174|Analgesics|analgesics|mesh-ancestor
24758659|NCT01747174|Sensory System Agents|sensory system agents|mesh-ancestor
24758660|NCT01747174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24758661|NCT01747174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758662|NCT01747174|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25241658|NCT05300373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241659|NCT05300360|Adenosine|adenosine|mesh-list
25241660|NCT05300360|Analgesics|analgesics|mesh-ancestor
25241661|NCT05300360|Sensory System Agents|sensory system agents|mesh-ancestor
25241662|NCT05300360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25241663|NCT05300360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241664|NCT05300360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25241665|NCT05300360|Vasodilator Agents|vasodilator agents|mesh-ancestor
25241666|NCT05300360|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25674667|NCT01775124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25674668|NCT01775124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25674669|NCT01775124|Growth Substances|growth substances|mesh-ancestor
25674670|NCT01775124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674671|NCT01775124|Growth Inhibitors|growth inhibitors|mesh-ancestor
25674672|NCT01775124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25674673|NCT01775189|Naltrexone|naltrexone|mesh-list
25876844|NCT02465060|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
24437750|NCT00274417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25876845|NCT02465060|GSK2636771|gsk2636771|mesh-list
25876846|NCT02465060|Antibodies|antibodies|mesh-list
25876847|NCT02465060|Immunoglobulins|immunoglobulins|mesh-list
24438767|NCT00276731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25876848|NCT02465060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25876849|NCT02465060|Immunoglobulin G|immunoglobulin g|mesh-list
25241667|NCT05300360|Purinergic Agonists|purinergic agonists|mesh-ancestor
25241668|NCT05300360|Purinergic Agents|purinergic agents|mesh-ancestor
25241669|NCT05300360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25241670|NCT05300360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241671|NCT05300347|Adenosine|adenosine|mesh-list
25241672|NCT05300347|Analgesics|analgesics|mesh-ancestor
25241673|NCT05300347|Sensory System Agents|sensory system agents|mesh-ancestor
24423397|NCT00225849|Analgesics|analgesics|mesh-ancestor
24758677|NCT01747252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758679|NCT01747252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758728|NCT01747590|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24758729|NCT01747590|GABA Agonists|gaba agonists|mesh-ancestor
24758730|NCT01747590|GABA Agents|gaba agents|mesh-ancestor
24758731|NCT01747590|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24758732|NCT01747590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24758733|NCT01747590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24758734|NCT01747590|GABA Modulators|gaba modulators|mesh-ancestor
24758735|NCT01747616|Acetylcysteine|acetylcysteine|mesh-list
25241674|NCT05300347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25241675|NCT05300347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241676|NCT05300347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25241677|NCT05300347|Vasodilator Agents|vasodilator agents|mesh-ancestor
25241678|NCT05300347|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25241679|NCT05300347|Purinergic Agonists|purinergic agonists|mesh-ancestor
25241680|NCT05300347|Purinergic Agents|purinergic agents|mesh-ancestor
25241681|NCT05300347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24769785|NCT01816191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24769786|NCT01816191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24769817|NCT01816334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25241688|NCT05300334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25241689|NCT05300334|Vasodilator Agents|vasodilator agents|mesh-ancestor
25241690|NCT05300334|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25241691|NCT05300334|Purinergic Agonists|purinergic agonists|mesh-ancestor
25241692|NCT05300334|Purinergic Agents|purinergic agents|mesh-ancestor
25241693|NCT05300334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25241694|NCT05300334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241695|NCT05300282|Gemcitabine|gemcitabine|mesh-list
25241696|NCT05300282|Atezolizumab|atezolizumab|mesh-list
25241697|NCT05300282|Vinorelbine|vinorelbine|mesh-list
25241698|NCT05300282|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25241699|NCT05300282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25241700|NCT05300282|Antimetabolites|antimetabolites|mesh-ancestor
25241701|NCT05300282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241702|NCT05300282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25241703|NCT05300282|Antiviral Agents|antiviral agents|mesh-ancestor
25241704|NCT05300282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24851380|NCT02256735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851382|NCT02256735|Autonomic Agents|autonomic agents|mesh-ancestor
24851383|NCT02256735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851384|NCT02256735|Sympathomimetics|sympathomimetics|mesh-ancestor
24851385|NCT02256735|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24851386|NCT02256735|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24851387|NCT02256735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24851388|NCT02256735|Adrenergic Agents|adrenergic agents|mesh-ancestor
24851389|NCT02256735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25674674|NCT01775189|Oxycodone|oxycodone|mesh-list
25674675|NCT01775189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25674676|NCT01775189|Narcotics|narcotics|mesh-ancestor
25674677|NCT01775189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25674678|NCT01775189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674679|NCT01775189|Analgesics|analgesics|mesh-ancestor
24851391|NCT02256748|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25674680|NCT01775189|Sensory System Agents|sensory system agents|mesh-ancestor
25674681|NCT01775189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25674682|NCT01775189|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25674683|NCT01775189|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25674684|NCT01775501|Leucovorin|leucovorin|mesh-list
25674685|NCT01775501|Fluorouracil|fluorouracil|mesh-list
25674686|NCT01775501|Oxaliplatin|oxaliplatin|mesh-list
25080784|NCT03335527|Analgesics|analgesics|mesh-ancestor
24851392|NCT02256748|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24851393|NCT02256748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24851394|NCT02256748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851395|NCT02256748|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24851396|NCT02256748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24851397|NCT02256748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24851398|NCT02256748|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24758736|NCT01747616|Chitosan|chitosan|mesh-list
24758737|NCT01747616|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24758746|NCT01747616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758781|NCT01747720|Micronutrients|micronutrients|mesh-ancestor
24758782|NCT01747720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758783|NCT01747720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24758784|NCT01747720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24758785|NCT01747746|Enoxaparin|enoxaparin|mesh-list
24758786|NCT01747746|Warfarin|warfarin|mesh-list
24758787|NCT01747746|Rivaroxaban|rivaroxaban|mesh-list
24758788|NCT01747746|Anticoagulants|anticoagulants|mesh-ancestor
24758789|NCT01747746|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24758790|NCT01747746|Antithrombins|antithrombins|mesh-ancestor
25241705|NCT05300282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25241706|NCT05300282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25241707|NCT05300282|Immunologic Factors|immunologic factors|mesh-ancestor
25241708|NCT05300282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769845|NCT01816555|Vitamins|vitamins|mesh-ancestor
24769846|NCT01816555|Micronutrients|micronutrients|mesh-ancestor
25241709|NCT05300282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25241710|NCT05300282|Tubulin Modulators|tubulin modulators|mesh-ancestor
25241711|NCT05300282|Antimitotic Agents|antimitotic agents|mesh-ancestor
25241712|NCT05300282|Mitosis Modulators|mitosis modulators|mesh-ancestor
25241713|NCT05300282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25241714|NCT05300282|Alkylating Agents|alkylating agents|mesh-ancestor
25241721|NCT05300191|Dialysis Solutions|dialysis solutions|mesh-list
25241722|NCT05300191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24851400|NCT02256748|Anesthetics|anesthetics|mesh-ancestor
25155268|NCT05431595|Haloperidol decanoate|haloperidol decanoate|mesh-list
25876850|NCT02465060|Immunoconjugates|immunoconjugates|mesh-list
25876851|NCT02465060|Adavosertib|adavosertib|mesh-list
25876852|NCT02465060|Immunologic Factors|immunologic factors|mesh-ancestor
25876853|NCT02465060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460371|NCT00348296|Antibodies|antibodies|mesh-list
24769951|NCT01817257|Enoxaparin|enoxaparin|mesh-list
25241741|NCT05300035|Antibodies|antibodies|mesh-list
25241742|NCT05300035|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25241743|NCT05300035|Immunologic Factors|immunologic factors|mesh-ancestor
25241744|NCT05300035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241745|NCT05300009|Methotrexate|methotrexate|mesh-list
25241746|NCT05300009|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25241747|NCT05300009|Abortifacient Agents|abortifacient agents|mesh-ancestor
25241748|NCT05300009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25069156|NCT03428529|Fluorouracil|fluorouracil|mesh-list
25876854|NCT02465060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876855|NCT02465060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25876856|NCT02465060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876857|NCT02465060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25876858|NCT02465060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25876859|NCT02465060|Growth Substances|growth substances|mesh-ancestor
25876860|NCT02465060|Growth Inhibitors|growth inhibitors|mesh-ancestor
25876861|NCT02465060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25876862|NCT02465060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876863|NCT02465060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24450857|NCT00320723|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24966855|NCT03764540|Glucocorticoids|glucocorticoids|mesh-ancestor
24450858|NCT00320723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24450859|NCT00320723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450860|NCT00320736|Galantamine|galantamine|mesh-list
24450861|NCT00320736|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24450862|NCT00320736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450863|NCT00320736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876864|NCT02465060|Tubulin Modulators|tubulin modulators|mesh-ancestor
25876865|NCT02465060|Antimitotic Agents|antimitotic agents|mesh-ancestor
25876866|NCT02465060|Mitosis Modulators|mitosis modulators|mesh-ancestor
25876867|NCT02437370|Gemcitabine|gemcitabine|mesh-list
25876868|NCT02437370|Docetaxel|docetaxel|mesh-list
25876869|NCT02437370|Pembrolizumab|pembrolizumab|mesh-list
25876870|NCT02437370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25275462|NCT02372318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25876871|NCT02437370|Antimetabolites|antimetabolites|mesh-ancestor
25876872|NCT02437370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876873|NCT02437370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876874|NCT02437370|Antiviral Agents|antiviral agents|mesh-ancestor
25876875|NCT02437370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25876876|NCT02437370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876877|NCT02437370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25876878|NCT02437370|Immunologic Factors|immunologic factors|mesh-ancestor
25876879|NCT02437370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876880|NCT02437370|Tubulin Modulators|tubulin modulators|mesh-ancestor
25876881|NCT02437370|Antimitotic Agents|antimitotic agents|mesh-ancestor
25876882|NCT02437370|Mitosis Modulators|mitosis modulators|mesh-ancestor
25241749|NCT05300009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241750|NCT05300009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24449131|NCT00314509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449132|NCT00314509|Glucocorticoids|glucocorticoids|mesh-ancestor
25876883|NCT02437370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25876884|NCT02415309|Melatonin|melatonin|mesh-list
25876885|NCT02415309|Antioxidants|antioxidants|mesh-ancestor
25876886|NCT02415309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876887|NCT02415309|Protective Agents|protective agents|mesh-ancestor
25876888|NCT02415309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876889|NCT02415309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25876890|NCT02258451|Everolimus|everolimus|mesh-list
25876891|NCT02258451|Exemestane|exemestane|mesh-list
25876892|NCT02258451|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25876893|NCT02258451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876894|NCT02258451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25876895|NCT02258451|Immunologic Factors|immunologic factors|mesh-ancestor
25876896|NCT02258451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876897|NCT02258451|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25876898|NCT02258451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24831109|NCT02163174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268766|NCT02414490|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25268767|NCT02414490|Immunologic Factors|immunologic factors|mesh-ancestor
25268768|NCT02414490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268769|NCT02414685|Paclitaxel|paclitaxel|mesh-list
25268770|NCT02414685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25268771|NCT02414685|Cisplatin|cisplatin|mesh-list
25268772|NCT02414685|Ifosfamide|ifosfamide|mesh-list
25268773|NCT02414685|Isophosphamide mustard|isophosphamide mustard|mesh-list
25268774|NCT02414685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25268775|NCT02414685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25268776|NCT02414685|Tubulin Modulators|tubulin modulators|mesh-ancestor
25268777|NCT02414685|Antimitotic Agents|antimitotic agents|mesh-ancestor
25268778|NCT02414685|Mitosis Modulators|mitosis modulators|mesh-ancestor
25241751|NCT05300009|Antimetabolites|antimetabolites|mesh-ancestor
25268779|NCT02414685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268780|NCT02414685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25268781|NCT02414685|Alkylating Agents|alkylating agents|mesh-ancestor
25876899|NCT02258451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876900|NCT02258451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876901|NCT02258451|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25876902|NCT02258451|Hormone Antagonists|hormone antagonists|mesh-ancestor
25876903|NCT02258451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25876904|NCT02242942|Venetoclax|venetoclax|mesh-list
25876905|NCT02242942|Obinutuzumab|obinutuzumab|mesh-list
25876906|NCT02242942|Chlorambucil|chlorambucil|mesh-list
25876907|NCT02242942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876908|NCT02242942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25876909|NCT02242942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24465655|NCT00370422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465657|NCT00370422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25876910|NCT02242942|Alkylating Agents|alkylating agents|mesh-ancestor
25876911|NCT02242942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620522|NCT01057342|Paclitaxel|paclitaxel|mesh-list
24620569|NCT01057615|Protective Agents|protective agents|mesh-ancestor
25876912|NCT02194738|Gemcitabine|gemcitabine|mesh-list
25876913|NCT02194738|Paclitaxel|paclitaxel|mesh-list
25876914|NCT02194738|Cisplatin|cisplatin|mesh-list
25674687|NCT01775501|Sorafenib|sorafenib|mesh-list
25674688|NCT01775501|Antimetabolites|antimetabolites|mesh-ancestor
25674689|NCT01775501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674690|NCT01775501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25876915|NCT02194738|Carboplatin|carboplatin|mesh-list
25876916|NCT02194738|Pembrolizumab|pembrolizumab|mesh-list
25876918|NCT02194738|Pemetrexed|pemetrexed|mesh-list
25876919|NCT02194738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25876920|NCT02194738|Crizotinib|crizotinib|mesh-list
24460792|NCT00349531|Protective Agents|protective agents|mesh-ancestor
24460793|NCT00349531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460794|NCT00349531|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24460795|NCT00349531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24460796|NCT00349531|Dopamine Agonists|dopamine agonists|mesh-ancestor
24460798|NCT00349531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24460799|NCT00349557|Bevacizumab|bevacizumab|mesh-list
24460801|NCT00349557|Bicalutamide|bicalutamide|mesh-list
25876921|NCT02194738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25876922|NCT02194738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25268793|NCT02414451|Propranolol|propranolol|mesh-list
25268794|NCT02414451|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25268795|NCT02414451|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25268796|NCT02414451|Adrenergic Agents|adrenergic agents|mesh-ancestor
25268797|NCT02414451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25268798|NCT02414451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268799|NCT02414451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268800|NCT02414451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25268801|NCT02414451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25268802|NCT02414451|Vasodilator Agents|vasodilator agents|mesh-ancestor
25268804|NCT02414425|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25268805|NCT02414425|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25268806|NCT02414425|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25268807|NCT02414425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25268808|NCT02414425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268809|NCT02414425|Cholinergic Agents|cholinergic agents|mesh-ancestor
24831119|NCT02163291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24831120|NCT02163291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24831121|NCT02163291|Tubulin Modulators|tubulin modulators|mesh-ancestor
24831122|NCT02163291|Antimitotic Agents|antimitotic agents|mesh-ancestor
24831123|NCT02163291|Mitosis Modulators|mitosis modulators|mesh-ancestor
24831125|NCT02163330|Acetazolamide|acetazolamide|mesh-list
25876923|NCT02194738|Tubulin Modulators|tubulin modulators|mesh-ancestor
24770113|NCT01817985|Velpatasvir|velpatasvir|mesh-list
25876924|NCT02194738|Antimitotic Agents|antimitotic agents|mesh-ancestor
25876925|NCT02194738|Mitosis Modulators|mitosis modulators|mesh-ancestor
25876926|NCT02194738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876927|NCT02194738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25876928|NCT02194738|Antimetabolites|antimetabolites|mesh-ancestor
25876929|NCT02194738|Antiviral Agents|antiviral agents|mesh-ancestor
25876930|NCT02194738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25876931|NCT02194738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876932|NCT02194738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24696637|NCT01430520|Citalopram|citalopram|mesh-list
25876933|NCT02194738|Immunologic Factors|immunologic factors|mesh-ancestor
24831135|NCT02163616|Abortifacient Agents|abortifacient agents|mesh-ancestor
24831136|NCT02163616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24831137|NCT02163616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831138|NCT02163616|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24831139|NCT02163616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24831141|NCT02163655|Furosemide|furosemide|mesh-list
25268810|NCT02414425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25268811|NCT02414425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268812|NCT02414425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25268813|NCT02414425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275458|NCT02372292|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25275459|NCT02372292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25275460|NCT02372292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275461|NCT02372318|Nalmefene|nalmefene|mesh-list
25674691|NCT01775501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25674692|NCT01775501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25674693|NCT01775501|Immunologic Factors|immunologic factors|mesh-ancestor
25674694|NCT01775501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674695|NCT01775501|Antidotes|antidotes|mesh-ancestor
25674696|NCT01775501|Protective Agents|protective agents|mesh-ancestor
25674697|NCT01775501|Vitamin B Complex|vitamin b complex|mesh-ancestor
25674698|NCT01775501|Vitamins|vitamins|mesh-ancestor
25674699|NCT01775501|Micronutrients|micronutrients|mesh-ancestor
25674700|NCT01775501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25674701|NCT01775501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876934|NCT02194738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876935|NCT02194738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25876937|NCT02194738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25876938|NCT02194738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25876939|NCT02194738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25876940|NCT02158091|Cyclophosphamide|cyclophosphamide|mesh-list
25876941|NCT02158091|Rituximab|rituximab|mesh-list
25876942|NCT02158091|Fludarabine|fludarabine|mesh-list
25136874|NCT02988063|Polidocanol|polidocanol|mesh-list
25876943|NCT02158091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25876944|NCT02158091|Immunologic Factors|immunologic factors|mesh-ancestor
25876945|NCT02158091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876946|NCT02158091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25876947|NCT02158091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25876948|NCT02158091|Alkylating Agents|alkylating agents|mesh-ancestor
25876949|NCT02158091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876950|NCT02158091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876951|NCT02158091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25876952|NCT02158091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25876953|NCT02141438|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25268814|NCT02414464|Calcium, Dietary|calcium, dietary|mesh-list
25268815|NCT02414464|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25268816|NCT02414464|Calcium|calcium|mesh-list
25268817|NCT02414464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25268818|NCT02414464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268819|NCT02414464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25268821|NCT02414464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25268822|NCT02414399|Azithromycin|azithromycin|mesh-list
25876954|NCT02141438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876955|NCT02086175|Rituximab|rituximab|mesh-list
25876956|NCT02086175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25876957|NCT02086175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876958|NCT02086175|Immunologic Factors|immunologic factors|mesh-ancestor
25876959|NCT02086175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876960|NCT02086175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24831153|NCT02163720|Doxorubicin|doxorubicin|mesh-list
24831154|NCT02163720|Trabectedin|trabectedin|mesh-list
24831155|NCT02163720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24831156|NCT02163720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876961|NCT02065154|Cyclophosphamide|cyclophosphamide|mesh-list
25876962|NCT02065154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25876963|NCT02065154|Immunologic Factors|immunologic factors|mesh-ancestor
25876964|NCT02065154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876965|NCT02065154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25876966|NCT02065154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24770252|NCT01819220|Diuretics|diuretics|mesh-ancestor
24770253|NCT01819220|Natriuretic Agents|natriuretic agents|mesh-ancestor
24770254|NCT01819220|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24770255|NCT01819259|Nicotine|nicotine|mesh-list
24770256|NCT01819259|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24770266|NCT01819285|Hormones|hormones|mesh-ancestor
24770274|NCT01819402|Pioglitazone|pioglitazone|mesh-list
25876967|NCT02065154|Alkylating Agents|alkylating agents|mesh-ancestor
24696820|NCT01431326|Adrenergic Agents|adrenergic agents|mesh-ancestor
25876968|NCT02065154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876969|NCT02065154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876970|NCT02065154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25876971|NCT02005471|Rituximab|rituximab|mesh-list
25876972|NCT02005471|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25876973|NCT02005471|Venetoclax|venetoclax|mesh-list
25876974|NCT02005471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25876975|NCT02005471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876976|NCT02005471|Immunologic Factors|immunologic factors|mesh-ancestor
24831159|NCT02163720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24831160|NCT02163720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831161|NCT02163720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24831162|NCT02163720|Alkylating Agents|alkylating agents|mesh-ancestor
24831163|NCT02163954|Clopidogrel|clopidogrel|mesh-list
24831164|NCT02163954|Ticagrelor|ticagrelor|mesh-list
24733222|NCT01644071|Serotonin Agents|serotonin agents|mesh-ancestor
25876977|NCT02005471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25876978|NCT02005471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25876979|NCT02005471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25876980|NCT02005471|Alkylating Agents|alkylating agents|mesh-ancestor
25279144|NCT02346188|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25876984|NCT01990911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268824|NCT02414399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25268825|NCT02414256|Anesthetics|anesthetics|mesh-list
25268826|NCT02414256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25268827|NCT02414256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268828|NCT02414373|Bupivacaine|bupivacaine|mesh-list
25268829|NCT02414373|Ropivacaine|ropivacaine|mesh-list
24770306|NCT01819649|Antioxidants|antioxidants|mesh-ancestor
25268830|NCT02414373|Anesthetics, Local|anesthetics, local|mesh-ancestor
25268831|NCT02414373|Anesthetics|anesthetics|mesh-ancestor
25268832|NCT02414373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25268833|NCT02414373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268834|NCT02414373|Sensory System Agents|sensory system agents|mesh-ancestor
25876985|NCT01828099|Cisplatin|cisplatin|mesh-list
25876986|NCT01828099|Carboplatin|carboplatin|mesh-list
25876987|NCT01828099|Pemetrexed|pemetrexed|mesh-list
25876988|NCT01828099|Ceritinib|ceritinib|mesh-list
25876989|NCT01828099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25876990|NCT01828099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25876991|NCT01828099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25876992|NCT01828099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25876993|NCT01828099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25876994|NCT01828099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25876995|NCT01803594|Nicotinic Acids|nicotinic acids|mesh-list
25876996|NCT01803594|Niacin|niacin|mesh-list
25876997|NCT01803594|Niacinamide|niacinamide|mesh-list
24831181|NCT02163980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24831182|NCT02163980|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24831183|NCT02163980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24831184|NCT02163980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24831185|NCT02163980|Adrenergic Agents|adrenergic agents|mesh-ancestor
24617310|NCT01042561|Vitamin D|vitamin d|mesh-list
25876998|NCT01803594|Vitamin B Complex|vitamin b complex|mesh-ancestor
25876999|NCT01803594|Vitamins|vitamins|mesh-ancestor
25877000|NCT01803594|Micronutrients|micronutrients|mesh-ancestor
25877001|NCT01803594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25877002|NCT01803594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25877003|NCT01803594|Antimetabolites|antimetabolites|mesh-ancestor
25877004|NCT01803594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25877005|NCT01803594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25877006|NCT01803594|Vasodilator Agents|vasodilator agents|mesh-ancestor
25877007|NCT01731236|Aspirin|aspirin|mesh-list
25877008|NCT01731236|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25877009|NCT01731236|Vancomycin|vancomycin|mesh-list
25877010|NCT01731236|Ciprofloxacin|ciprofloxacin|mesh-list
25877011|NCT01731236|Neomycin|neomycin|mesh-list
25877012|NCT01731236|Choline|choline|mesh-list
25877013|NCT01731236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25877014|NCT01731236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25877015|NCT01731236|Analgesics|analgesics|mesh-ancestor
24831186|NCT02163980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24831187|NCT02163980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831188|NCT02163980|Anesthetics, Local|anesthetics, local|mesh-ancestor
24831189|NCT02163980|Anesthetics|anesthetics|mesh-ancestor
24831190|NCT02164006|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24831191|NCT02164006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24831192|NCT02164006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24831193|NCT02164006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25877016|NCT01731236|Sensory System Agents|sensory system agents|mesh-ancestor
25877017|NCT01731236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25877018|NCT01731236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25877019|NCT01731236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25877020|NCT01731236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24770570|NCT01821170|Dopamine Agents|dopamine agents|mesh-ancestor
25877021|NCT01731236|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25268835|NCT02414373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25877022|NCT01731236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25268836|NCT02414165|Flucytosine|flucytosine|mesh-list
25268837|NCT02414165|Bevacizumab|bevacizumab|mesh-list
25877023|NCT01731236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25877024|NCT01731236|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25268838|NCT02414165|Temozolomide|temozolomide|mesh-list
25268839|NCT02414165|Lomustine|lomustine|mesh-list
24770471|NCT01820767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770472|NCT01820767|Vitamins|vitamins|mesh-ancestor
24770473|NCT01820767|Micronutrients|micronutrients|mesh-ancestor
24770474|NCT01820767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24770475|NCT01820793|Cefoxitin|cefoxitin|mesh-list
24770476|NCT01820793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24770477|NCT01820793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25268840|NCT02414165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25268841|NCT02414165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25268842|NCT02414165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25877025|NCT01731236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25877026|NCT01731236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24831197|NCT02164032|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24831198|NCT02164032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24831199|NCT02164032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831200|NCT02164045|Fostemsavir|fostemsavir|mesh-list
24831201|NCT02164045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24831202|NCT02164045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24831203|NCT02164045|Antiviral Agents|antiviral agents|mesh-ancestor
24831204|NCT02164045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24733345|NCT01645384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25877027|NCT01731236|Antipyretics|antipyretics|mesh-ancestor
25877028|NCT01731236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25877029|NCT01731236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25877030|NCT01731236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25877031|NCT01731236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25877032|NCT01731236|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24831205|NCT02164045|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24770513|NCT01820897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24770515|NCT01820962|Anticoagulants|anticoagulants|mesh-ancestor
24770516|NCT01820962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770517|NCT01820962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24770518|NCT01820962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24831206|NCT02164045|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24831207|NCT02164045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831208|NCT02164097|Heparin|heparin|mesh-list
24831209|NCT02164097|Anticoagulants|anticoagulants|mesh-ancestor
24831210|NCT02164097|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24831211|NCT02164097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24831212|NCT02164097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25877033|NCT01731236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25877034|NCT01731236|Lipotropic Agents|lipotropic agents|mesh-ancestor
25877035|NCT01731236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24831215|NCT02164110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831216|NCT02164214|Etanercept|etanercept|mesh-list
24831217|NCT02164214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25877036|NCT01731236|Antimetabolites|antimetabolites|mesh-ancestor
25877037|NCT01731236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25877038|NCT01731236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25877039|NCT01731236|Nootropic Agents|nootropic agents|mesh-ancestor
25877040|NCT01731236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25877041|NCT01726452|Leucovorin|leucovorin|mesh-list
25268843|NCT02414165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25268844|NCT02414165|Growth Substances|growth substances|mesh-ancestor
25268845|NCT02414165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770560|NCT01821066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24770561|NCT01821066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770562|NCT01821066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770563|NCT01821170|Methylphenidate|methylphenidate|mesh-list
24770564|NCT01821170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24770565|NCT01821170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770566|NCT01821170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24770567|NCT01821170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25268846|NCT02414165|Growth Inhibitors|growth inhibitors|mesh-ancestor
25268847|NCT02414165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25268848|NCT02414165|Alkylating Agents|alkylating agents|mesh-ancestor
25268849|NCT02414165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268850|NCT02414165|Antifungal Agents|antifungal agents|mesh-ancestor
25674702|NCT01775787|Menthol|menthol|mesh-list
25674703|NCT01775787|Nicotine|nicotine|mesh-list
25674704|NCT01775787|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25674705|NCT01775787|Autonomic Agents|autonomic agents|mesh-ancestor
25268851|NCT02414165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25268852|NCT02414165|Antimetabolites|antimetabolites|mesh-ancestor
25268853|NCT02414009|Leucovorin|leucovorin|mesh-list
25268854|NCT02414009|Fluorouracil|fluorouracil|mesh-list
25268855|NCT02414009|Capecitabine|capecitabine|mesh-list
25268856|NCT02414009|Irinotecan|irinotecan|mesh-list
25877042|NCT01726452|Paclitaxel|paclitaxel|mesh-list
25877043|NCT01726452|Docetaxel|docetaxel|mesh-list
25877044|NCT01726452|Cisplatin|cisplatin|mesh-list
25877045|NCT01726452|Carboplatin|carboplatin|mesh-list
25877046|NCT01726452|Fluorouracil|fluorouracil|mesh-list
25877047|NCT01726452|Capecitabine|capecitabine|mesh-list
25877048|NCT01726452|Oxaliplatin|oxaliplatin|mesh-list
25877049|NCT01726452|Epirubicin|epirubicin|mesh-list
25877050|NCT01726452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25877051|NCT01726452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25877052|NCT01726452|Tubulin Modulators|tubulin modulators|mesh-ancestor
25877053|NCT01726452|Antimitotic Agents|antimitotic agents|mesh-ancestor
25877054|NCT01726452|Mitosis Modulators|mitosis modulators|mesh-ancestor
25877055|NCT01726452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25877056|NCT01726452|Antimetabolites|antimetabolites|mesh-ancestor
25877057|NCT01726452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25877058|NCT01726452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25877059|NCT01726452|Immunologic Factors|immunologic factors|mesh-ancestor
24449147|NCT00314613|Risperidone|risperidone|mesh-list
25877060|NCT01726452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25877061|NCT01726452|Antidotes|antidotes|mesh-ancestor
25877062|NCT01726452|Protective Agents|protective agents|mesh-ancestor
25877063|NCT01726452|Vitamin B Complex|vitamin b complex|mesh-ancestor
25877064|NCT01726452|Vitamins|vitamins|mesh-ancestor
24770640|NCT01821573|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24770641|NCT01821573|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24770642|NCT01821573|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24770643|NCT01821573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24770644|NCT01821573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770645|NCT01821573|Cholinergic Agents|cholinergic agents|mesh-ancestor
24770646|NCT01821573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24770647|NCT01821573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770648|NCT01821573|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24770649|NCT01821573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24770684|NCT01821703|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25877065|NCT01726452|Micronutrients|micronutrients|mesh-ancestor
24831255|NCT02164552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831256|NCT02164552|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24831257|NCT02164552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25877066|NCT01726452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25877067|NCT01726452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25877068|NCT01726452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25877069|NCT01726452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25877070|NCT01593254|Imatinib Mesylate|imatinib mesylate|mesh-list
25877071|NCT01593254|Dasatinib|dasatinib|mesh-list
25877072|NCT01593254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25877073|NCT01593254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25877074|NCT01593254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25877075|NCT01593254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25877076|NCT01574274|Pegaspargase|pegaspargase|mesh-list
25877077|NCT01574274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25877078|NCT01436968|Valacyclovir|valacyclovir|mesh-list
25877079|NCT01436968|Antiviral Agents|antiviral agents|mesh-ancestor
24966872|NCT03764527|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24966873|NCT03764527|Anthelmintics|anthelmintics|mesh-ancestor
24966874|NCT03764488|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
24966875|NCT03764488|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24966876|NCT03764488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966877|NCT03764462|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25080832|NCT03335293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080833|NCT03335293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080834|NCT03335293|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25877080|NCT01436968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25877081|NCT01409161|Vitamins|vitamins|mesh-list
25877082|NCT01409161|Vitamin A|vitamin a|mesh-list
25877083|NCT01409161|Tretinoin|tretinoin|mesh-list
25877084|NCT01409161|Retinol palmitate|retinol palmitate|mesh-list
25877085|NCT01409161|Arsenic Trioxide|arsenic trioxide|mesh-list
25877086|NCT01409161|Gemtuzumab|gemtuzumab|mesh-list
25877087|NCT01409161|Calicheamicins|calicheamicins|mesh-list
25877088|NCT01409161|Micronutrients|micronutrients|mesh-ancestor
25877089|NCT01409161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25877090|NCT01409161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25877092|NCT01409161|Dermatologic Agents|dermatologic agents|mesh-ancestor
25877093|NCT01409161|Antioxidants|antioxidants|mesh-ancestor
25877094|NCT01409161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25877095|NCT01409161|Protective Agents|protective agents|mesh-ancestor
25268857|NCT02414009|Temozolomide|temozolomide|mesh-list
25268858|NCT02414009|Antimetabolites|antimetabolites|mesh-ancestor
25268859|NCT02414009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268860|NCT02414009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25268861|NCT02414009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25080841|NCT03335293|Sympathomimetics|sympathomimetics|mesh-ancestor
25080842|NCT03335293|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25080843|NCT03335241|Doxorubicin|doxorubicin|mesh-list
25080844|NCT03335241|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25268862|NCT02414009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25268863|NCT02414009|Immunologic Factors|immunologic factors|mesh-ancestor
25268864|NCT02414009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268865|NCT02414009|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25877096|NCT01409161|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24456883|NCT00332553|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24456884|NCT00332553|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25877097|NCT01409161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25877098|NCT01409161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25877099|NCT01335399|Dexamethasone|dexamethasone|mesh-list
25877100|NCT01335399|Dexamethasone acetate|dexamethasone acetate|mesh-list
25877101|NCT01335399|Lenalidomide|lenalidomide|mesh-list
25877102|NCT01335399|Elotuzumab|elotuzumab|mesh-list
25877103|NCT01335399|BB 1101|bb 1101|mesh-list
25877104|NCT01335399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25877105|NCT01335399|Antiemetics|antiemetics|mesh-ancestor
25877106|NCT01335399|Autonomic Agents|autonomic agents|mesh-ancestor
25877107|NCT01335399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25877108|NCT01335399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25877109|NCT01335399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25877110|NCT01335399|Glucocorticoids|glucocorticoids|mesh-ancestor
25080883|NCT03335098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25080884|NCT03335098|Growth Substances|growth substances|mesh-ancestor
25080885|NCT03335098|Growth Inhibitors|growth inhibitors|mesh-ancestor
25080887|NCT03335085|Oxytocics|oxytocics|mesh-ancestor
25080888|NCT03335085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25080889|NCT03335085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561875|NCT00763373|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25877111|NCT01335399|Hormones|hormones|mesh-ancestor
25877112|NCT01335399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25877113|NCT01335399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25877114|NCT01335399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25877115|NCT01335399|Protease Inhibitors|protease inhibitors|mesh-ancestor
25877116|NCT01335399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25877117|NCT01335399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25877118|NCT01335399|Immunologic Factors|immunologic factors|mesh-ancestor
25877119|NCT01335399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25877120|NCT01335399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25877121|NCT01335399|Growth Substances|growth substances|mesh-ancestor
25877122|NCT01335399|Growth Inhibitors|growth inhibitors|mesh-ancestor
25268870|NCT02414009|Vitamin B Complex|vitamin b complex|mesh-ancestor
25268871|NCT02414009|Vitamins|vitamins|mesh-ancestor
25268872|NCT02414009|Micronutrients|micronutrients|mesh-ancestor
25268873|NCT02414009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25268874|NCT02414009|Alkylating Agents|alkylating agents|mesh-ancestor
25268875|NCT02413853|Leucovorin|leucovorin|mesh-list
25268876|NCT02413853|Bevacizumab|bevacizumab|mesh-list
25268877|NCT02413853|Fluorouracil|fluorouracil|mesh-list
25268878|NCT02413853|Oxaliplatin|oxaliplatin|mesh-list
25268879|NCT02413853|Calcium|calcium|mesh-list
25877123|NCT01036087|Paclitaxel|paclitaxel|mesh-list
25877124|NCT01036087|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25877125|NCT01036087|Cyclophosphamide|cyclophosphamide|mesh-list
24449154|NCT00314613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24449155|NCT00314613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24449156|NCT00314613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24449157|NCT00314613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24449158|NCT00314613|Dopamine Agents|dopamine agents|mesh-ancestor
24449159|NCT00314626|Lamivudine|lamivudine|mesh-list
24449160|NCT00314626|Efavirenz|efavirenz|mesh-list
24449161|NCT00314626|Abacavir|abacavir|mesh-list
25877126|NCT01036087|Carboplatin|carboplatin|mesh-list
25877127|NCT01036087|Fluorouracil|fluorouracil|mesh-list
24449162|NCT00314626|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24831278|NCT02164578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24561876|NCT00763373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24561877|NCT00763373|Antitubercular Agents|antitubercular agents|mesh-ancestor
24561878|NCT00763438|Sertindole|sertindole|mesh-list
24620591|NCT01057849|Olanzapine|olanzapine|mesh-list
24831279|NCT02164578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25877128|NCT01036087|Epirubicin|epirubicin|mesh-list
25877129|NCT01036087|Panitumumab|panitumumab|mesh-list
25877130|NCT01036087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25877131|NCT01036087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25877132|NCT01036087|Tubulin Modulators|tubulin modulators|mesh-ancestor
25877133|NCT01036087|Antimitotic Agents|antimitotic agents|mesh-ancestor
25877134|NCT01036087|Mitosis Modulators|mitosis modulators|mesh-ancestor
25877135|NCT01036087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25877136|NCT01036087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25268880|NCT02413853|Levoleucovorin|levoleucovorin|mesh-list
25268881|NCT02413853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25268882|NCT02413853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25268883|NCT02413853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25268884|NCT02413853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25268885|NCT02413853|Growth Substances|growth substances|mesh-ancestor
25268886|NCT02413853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268887|NCT02413853|Growth Inhibitors|growth inhibitors|mesh-ancestor
25268888|NCT02413853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25268889|NCT02413853|Antimetabolites|antimetabolites|mesh-ancestor
25268890|NCT02413853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268891|NCT02413853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25268892|NCT02413853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25268893|NCT02413853|Immunologic Factors|immunologic factors|mesh-ancestor
25268894|NCT02413853|Antidotes|antidotes|mesh-ancestor
25268895|NCT02413853|Protective Agents|protective agents|mesh-ancestor
25268896|NCT02413853|Vitamin B Complex|vitamin b complex|mesh-ancestor
25877137|NCT01036087|Immunologic Factors|immunologic factors|mesh-ancestor
25877138|NCT01036087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620603|NCT01057849|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24620604|NCT01057849|Dopamine Agents|dopamine agents|mesh-ancestor
25877139|NCT01036087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25877140|NCT01036087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25877141|NCT01036087|Alkylating Agents|alkylating agents|mesh-ancestor
25877142|NCT01036087|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25050789|NCT00468039|Metformin|metformin|mesh-list
25877143|NCT01036087|Antimetabolites|antimetabolites|mesh-ancestor
24831284|NCT02164578|Protease Inhibitors|protease inhibitors|mesh-ancestor
24831285|NCT02164578|Anticoagulants|anticoagulants|mesh-ancestor
24831286|NCT02164604|Ranibizumab|ranibizumab|mesh-list
25877144|NCT01036087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25877145|NCT01036087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25877146|NCT01036087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25877147|NCT01036087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25877148|NCT01036087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25877149|NCT01036087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25877150|NCT00608023|Tesamorelin|tesamorelin|mesh-list
24831292|NCT02164604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24831293|NCT02164734|Remifentanil|remifentanil|mesh-list
24831294|NCT02164734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24831295|NCT02164734|Narcotics|narcotics|mesh-ancestor
24831296|NCT02164734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25877151|NCT00608023|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
25877152|NCT00608023|Growth Substances|growth substances|mesh-ancestor
25877153|NCT00608023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25877154|NCT00608023|Hormones|hormones|mesh-ancestor
24770741|NCT01822080|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24770748|NCT01822210|Botulinum Toxins|botulinum toxins|mesh-list
24770775|NCT01822405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080903|NCT03335007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24770776|NCT01822405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24770777|NCT01822405|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24770778|NCT01822405|Protective Agents|protective agents|mesh-ancestor
24770779|NCT01822405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25877155|NCT00608023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25877156|NCT00601003|Nifurtimox|nifurtimox|mesh-list
25877157|NCT00601003|Cyclophosphamide|cyclophosphamide|mesh-list
25877158|NCT00601003|Topotecan|topotecan|mesh-list
25877159|NCT00601003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25877160|NCT00601003|Immunologic Factors|immunologic factors|mesh-ancestor
24461393|NCT00352196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24461398|NCT00352196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24461399|NCT00352196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24461400|NCT00352196|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25877161|NCT00601003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25877162|NCT00601003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25877163|NCT00601003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25877164|NCT00601003|Alkylating Agents|alkylating agents|mesh-ancestor
25877165|NCT00601003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25877166|NCT00601003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25877167|NCT00601003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25877168|NCT00601003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25268897|NCT02413853|Vitamins|vitamins|mesh-ancestor
25137291|NCT02985658|Cisplatin|cisplatin|mesh-list
25268898|NCT02413853|Micronutrients|micronutrients|mesh-ancestor
25268899|NCT02413658|Phenytoin|phenytoin|mesh-list
25268900|NCT02413658|Anticonvulsants|anticonvulsants|mesh-ancestor
25268901|NCT02413658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25268902|NCT02413658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25268903|NCT02413658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25268904|NCT02413658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268905|NCT02413658|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25268906|NCT02413658|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25268907|NCT02413268|Nitroglycerin|nitroglycerin|mesh-list
25268908|NCT02413268|Vasodilator Agents|vasodilator agents|mesh-ancestor
25268909|NCT02413281|Buprenorphine|buprenorphine|mesh-list
24770827|NCT01822639|Amlodipine|amlodipine|mesh-list
25268910|NCT02413281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25268911|NCT02413281|Narcotics|narcotics|mesh-ancestor
25877169|NCT00601003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25877170|NCT00601003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25877171|NCT00601003|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25877172|NCT00601003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25877173|NCT00601003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25877174|NCT00601003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24697201|NCT01433627|Hirudins|hirudins|mesh-list
24449174|NCT00314626|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24449175|NCT00314626|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24449177|NCT00314639|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24449178|NCT00314639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449187|NCT00314652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449188|NCT00314652|Analgesics|analgesics|mesh-ancestor
24449189|NCT00314652|Sensory System Agents|sensory system agents|mesh-ancestor
24449190|NCT00314652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24449191|NCT00314652|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24449192|NCT00314665|Thalidomide|thalidomide|mesh-list
24831311|NCT02164773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24831312|NCT02164773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831313|NCT02164773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24831314|NCT02164773|Tocolytic Agents|tocolytic agents|mesh-ancestor
24463948|NCT00362804|Adrenergic Agents|adrenergic agents|mesh-ancestor
25268912|NCT02413281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25268913|NCT02413281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268914|NCT02413281|Analgesics|analgesics|mesh-ancestor
25268915|NCT02413281|Sensory System Agents|sensory system agents|mesh-ancestor
25268916|NCT02413281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25268917|NCT02413281|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25268918|NCT02413515|Nifedipine|nifedipine|mesh-list
25268919|NCT02413515|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25080907|NCT03335007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674706|NCT01775787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25674707|NCT01775787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674708|NCT01775787|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25674709|NCT01775787|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25674710|NCT01775787|Cholinergic Agents|cholinergic agents|mesh-ancestor
25674711|NCT01775787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25674712|NCT01775787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007872|NCT02582775|Tacrolimus|tacrolimus|mesh-list
25080908|NCT03335007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25080909|NCT03335007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24770924|NCT01823133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770925|NCT01823133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24770926|NCT01823133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24770927|NCT01823133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770928|NCT01823159|Ezogabine|ezogabine|mesh-list
24770929|NCT01823159|Anticonvulsants|anticonvulsants|mesh-ancestor
25275463|NCT02372318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770935|NCT01823185|Clopidogrel|clopidogrel|mesh-list
24770936|NCT01823185|Ticagrelor|ticagrelor|mesh-list
24770937|NCT01823185|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24770938|NCT01823185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24770939|NCT01823185|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24770940|NCT01823185|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25268922|NCT02413515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25268923|NCT02413515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268924|NCT02413515|Vasodilator Agents|vasodilator agents|mesh-ancestor
25268925|NCT02413515|Tocolytic Agents|tocolytic agents|mesh-ancestor
25268926|NCT02413515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25268927|NCT02413554|Rivastigmine|rivastigmine|mesh-list
25268928|NCT02413554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25268929|NCT02413554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25268930|NCT02413554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770966|NCT01823770|Dopamine Agonists|dopamine agonists|mesh-ancestor
24770967|NCT01823770|Dopamine Agents|dopamine agents|mesh-ancestor
24770968|NCT01823770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24770969|NCT01823770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770971|NCT01823809|Adenosine|adenosine|mesh-list
24770972|NCT01823809|Analgesics|analgesics|mesh-ancestor
24770973|NCT01823809|Sensory System Agents|sensory system agents|mesh-ancestor
24770976|NCT01823809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25674713|NCT01775787|Antipruritics|antipruritics|mesh-ancestor
25674714|NCT01775787|Dermatologic Agents|dermatologic agents|mesh-ancestor
25674715|NCT01775865|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
24550745|NCT00722098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24550746|NCT00722098|Alkylating Agents|alkylating agents|mesh-ancestor
24550747|NCT00722098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550748|NCT00722098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550749|NCT00722098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24550751|NCT00722150|Antimalarials|antimalarials|mesh-ancestor
24550847|NCT00722852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102623|NCT03167216|Histamine Antagonists|histamine antagonists|mesh-ancestor
24697343|NCT01434173|Cefuroxime|cefuroxime|mesh-list
24771007|NCT01824199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24831417|NCT02165189|Antiviral Agents|antiviral agents|mesh-ancestor
24831418|NCT02165189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24831419|NCT02165189|Protease Inhibitors|protease inhibitors|mesh-ancestor
24831420|NCT02165189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24831421|NCT02165215|Etrolizumab|etrolizumab|mesh-list
24831422|NCT02165215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24831423|NCT02165215|Immunologic Factors|immunologic factors|mesh-ancestor
25268931|NCT02413554|Cholinergic Agents|cholinergic agents|mesh-ancestor
25268932|NCT02413554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25268933|NCT02413554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268934|NCT02413554|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25268935|NCT02413554|Protective Agents|protective agents|mesh-ancestor
25268936|NCT02413541|Polymyxins|polymyxins|mesh-list
25268937|NCT02413541|Polymyxin B|polymyxin b|mesh-list
25268938|NCT02413541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24771045|NCT01824420|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24771046|NCT01824420|Oxybutynin|oxybutynin|mesh-list
24771047|NCT01824420|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25674716|NCT01775865|Sodium Salicylate|sodium salicylate|mesh-list
25674717|NCT01775865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25674718|NCT01775865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25674719|NCT01775865|Analgesics|analgesics|mesh-ancestor
25674720|NCT01775865|Sensory System Agents|sensory system agents|mesh-ancestor
25674721|NCT01775865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25674722|NCT01775865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674723|NCT01775865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24551194|NCT00724386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24551195|NCT00724386|Tubulin Modulators|tubulin modulators|mesh-ancestor
24551196|NCT00724386|Antimitotic Agents|antimitotic agents|mesh-ancestor
24551197|NCT00724386|Mitosis Modulators|mitosis modulators|mesh-ancestor
24551226|NCT00724620|Antiviral Agents|antiviral agents|mesh-ancestor
24551227|NCT00724620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24790807|NCT01945450|Ampicillin|ampicillin|mesh-list
24771048|NCT01824420|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24771049|NCT01824420|Cholinergic Agents|cholinergic agents|mesh-ancestor
24771050|NCT01824420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24771051|NCT01824420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771052|NCT01824420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771053|NCT01824420|Urological Agents|urological agents|mesh-ancestor
24771054|NCT01824420|Parasympatholytics|parasympatholytics|mesh-ancestor
24771055|NCT01824420|Autonomic Agents|autonomic agents|mesh-ancestor
24831424|NCT02165215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831425|NCT02165332|Moxifloxacin|moxifloxacin|mesh-list
24589354|NCT00907036|Antimetabolites|antimetabolites|mesh-ancestor
24831426|NCT02165332|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24831427|NCT02165332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24831438|NCT02165332|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24831439|NCT02165332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24831440|NCT02165332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24831441|NCT02165449|Ketamine|ketamine|mesh-list
24831442|NCT02165449|Analgesics|analgesics|mesh-ancestor
24831459|NCT02165566|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24831486|NCT02165917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831490|NCT02165930|Oxycodone|oxycodone|mesh-list
24831491|NCT02165930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24831492|NCT02165930|Narcotics|narcotics|mesh-ancestor
24831493|NCT02165930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24831494|NCT02165930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771082|NCT01824524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771083|NCT01824524|Analgesics|analgesics|mesh-ancestor
24831495|NCT02165930|Analgesics|analgesics|mesh-ancestor
24831496|NCT02165930|Sensory System Agents|sensory system agents|mesh-ancestor
24831497|NCT02165930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24831498|NCT02165930|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24831499|NCT02165930|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24589427|NCT00907452|Thalidomide|thalidomide|mesh-list
24831500|NCT02166229|Valproic Acid|valproic acid|mesh-list
24831501|NCT02166229|Anticonvulsants|anticonvulsants|mesh-ancestor
24831502|NCT02166229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279145|NCT02346188|Protective Agents|protective agents|mesh-ancestor
25674724|NCT01775865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25674725|NCT01775865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25674726|NCT01775865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674727|NCT01775865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674728|NCT01776008|Anastrozole|anastrozole|mesh-list
25674729|NCT01776008|Goserelin|goserelin|mesh-list
25674730|NCT01776008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25674731|NCT01776008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25674732|NCT01776008|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25674733|NCT01776008|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24831555|NCT02166853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24831556|NCT02166853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24831557|NCT02166853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831558|NCT02166853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24831577|NCT02166905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24831578|NCT02166905|Antiviral Agents|antiviral agents|mesh-ancestor
24831579|NCT02166905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24831580|NCT02166944|Tamoxifen|tamoxifen|mesh-list
24831581|NCT02166944|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24831582|NCT02166944|Hormone Antagonists|hormone antagonists|mesh-ancestor
24831583|NCT02166944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24831584|NCT02166944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268939|NCT02413541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25268940|NCT02413086|Chitosan|chitosan|mesh-list
25268941|NCT02413086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25268942|NCT02413086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25268943|NCT02413086|Antimetabolites|antimetabolites|mesh-ancestor
25268944|NCT02413086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25268945|NCT02413086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25268946|NCT02413086|Chelating Agents|chelating agents|mesh-ancestor
25268947|NCT02413086|Sequestering Agents|sequestering agents|mesh-ancestor
25268948|NCT02413086|Hemostatics|hemostatics|mesh-ancestor
25268949|NCT02413086|Coagulants|coagulants|mesh-ancestor
25268953|NCT02412930|Tramadol|tramadol|mesh-list
24562261|NCT00765167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562262|NCT00765167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25268954|NCT02412930|Bupivacaine|bupivacaine|mesh-list
25268955|NCT02412930|Anesthetics, Local|anesthetics, local|mesh-ancestor
24941146|NCT03994692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24941147|NCT03994692|Anesthetics, General|anesthetics, general|mesh-ancestor
24714802|NCT01532856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24831601|NCT02167178|Plasma Substitutes|plasma substitutes|mesh-ancestor
24831602|NCT02167178|Blood Substitutes|blood substitutes|mesh-ancestor
24831603|NCT02167321|Leucovorin|leucovorin|mesh-list
24831604|NCT02167321|Fluorouracil|fluorouracil|mesh-list
24831605|NCT02167321|Oxaliplatin|oxaliplatin|mesh-list
24831606|NCT02167321|Antimetabolites|antimetabolites|mesh-ancestor
24831611|NCT02167321|Immunologic Factors|immunologic factors|mesh-ancestor
24831612|NCT02167321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831613|NCT02167321|Antidotes|antidotes|mesh-ancestor
24831614|NCT02167321|Protective Agents|protective agents|mesh-ancestor
24831615|NCT02167321|Vitamin B Complex|vitamin b complex|mesh-ancestor
24771175|NCT01825044|Cyclosporins|cyclosporins|mesh-list
24771176|NCT01825044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771177|NCT01825044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771187|NCT01825083|Analgesics|analgesics|mesh-ancestor
24831617|NCT02167321|Micronutrients|micronutrients|mesh-ancestor
24831618|NCT02167425|Methadone|methadone|mesh-list
24831619|NCT02167425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24831621|NCT02167425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24831622|NCT02167425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831623|NCT02167425|Analgesics|analgesics|mesh-ancestor
24831624|NCT02167425|Sensory System Agents|sensory system agents|mesh-ancestor
24831625|NCT02167425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24831626|NCT02167425|Antitussive Agents|antitussive agents|mesh-ancestor
24831628|NCT02167464|Coal Tar|coal tar|mesh-list
24831657|NCT02167698|Prednisolone|prednisolone|mesh-list
24831658|NCT02167698|Prednisolone acetate|prednisolone acetate|mesh-list
24831659|NCT02167698|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24831660|NCT02167698|Prednisolone phosphate|prednisolone phosphate|mesh-list
24831661|NCT02167698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24831662|NCT02167698|Antiemetics|antiemetics|mesh-ancestor
24831663|NCT02167698|Autonomic Agents|autonomic agents|mesh-ancestor
25007942|NCT02420821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007943|NCT02420821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25007944|NCT02420821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25007945|NCT02420821|Growth Substances|growth substances|mesh-ancestor
25007946|NCT02420821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007947|NCT02420821|Growth Inhibitors|growth inhibitors|mesh-ancestor
24831664|NCT02167698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24831665|NCT02167698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268956|NCT02412930|Anesthetics|anesthetics|mesh-ancestor
25268957|NCT02412930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25268958|NCT02412930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268959|NCT02412930|Sensory System Agents|sensory system agents|mesh-ancestor
25268960|NCT02412930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25268961|NCT02412930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25268962|NCT02412930|Narcotics|narcotics|mesh-ancestor
25268965|NCT02413021|Deferasirox|deferasirox|mesh-list
25268966|NCT02413021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25268967|NCT02413021|Antimetabolites|antimetabolites|mesh-ancestor
25268968|NCT02413021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422656|NCT00223418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24697515|NCT01435252|Cetuximab|cetuximab|mesh-list
24831671|NCT02167698|Protective Agents|protective agents|mesh-ancestor
24831672|NCT02167698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24831673|NCT02167698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24831674|NCT02167854|Trastuzumab|trastuzumab|mesh-list
24831675|NCT02167854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24831676|NCT02167854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24831677|NCT02167958|Cyclophosphamide|cyclophosphamide|mesh-list
24831678|NCT02167958|Fludarabine|fludarabine|mesh-list
24831679|NCT02167958|Tacrolimus|tacrolimus|mesh-list
24831680|NCT02167958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24831681|NCT02167958|Immunologic Factors|immunologic factors|mesh-ancestor
24831682|NCT02167958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734690|NCT01653119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674734|NCT01776008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674735|NCT01776008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674736|NCT01776008|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25674737|NCT01776008|Hormone Antagonists|hormone antagonists|mesh-ancestor
25674738|NCT01776008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25674739|NCT01776008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674740|NCT01776424|Aspirin|aspirin|mesh-list
25674741|NCT01776424|Pantoprazole|pantoprazole|mesh-list
24551830|NCT04956627|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25674742|NCT01776424|Rivaroxaban|rivaroxaban|mesh-list
25674743|NCT01776424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24831684|NCT02167958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24831685|NCT02167958|Alkylating Agents|alkylating agents|mesh-ancestor
24831686|NCT02167958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831687|NCT02167958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24831688|NCT02167958|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24831689|NCT02167958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24831690|NCT02167958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25268969|NCT02413021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25268970|NCT02413021|Antiviral Agents|antiviral agents|mesh-ancestor
25268971|NCT02413021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25268972|NCT02413021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25268973|NCT02413021|Immunologic Factors|immunologic factors|mesh-ancestor
25268974|NCT02413021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268975|NCT02413021|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25268976|NCT02413021|Chelating Agents|chelating agents|mesh-ancestor
25268977|NCT02413021|Sequestering Agents|sequestering agents|mesh-ancestor
25268978|NCT02412917|Valacyclovir|valacyclovir|mesh-list
24771315|NCT01825993|Morphine|morphine|mesh-list
24771316|NCT01825993|Bupivacaine|bupivacaine|mesh-list
24771318|NCT01825993|Anesthetics|anesthetics|mesh-ancestor
24831691|NCT02168010|Neurotropin|neurotropin|mesh-list
24831692|NCT02168010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24831707|NCT02168127|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24831712|NCT02168127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24831713|NCT02168205|Pomalidomide|pomalidomide|mesh-list
24831714|NCT02168205|Caffeine|caffeine|mesh-list
25674744|NCT01776424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25674745|NCT01776424|Analgesics|analgesics|mesh-ancestor
25674746|NCT01776424|Sensory System Agents|sensory system agents|mesh-ancestor
25674747|NCT01776424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25674748|NCT01776424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674749|NCT01776424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25674750|NCT01776424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25674751|NCT01776424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24552158|NCT04130204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24583553|NCT00875147|Growth Substances|growth substances|mesh-ancestor
24583554|NCT00875147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583555|NCT00875147|Growth Inhibitors|growth inhibitors|mesh-ancestor
25109824|NCT03121521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109825|NCT03121521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25109826|NCT03121664|Itraconazole|itraconazole|mesh-list
25109827|NCT03121664|Antifungal Agents|antifungal agents|mesh-ancestor
24831715|NCT02168205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24831716|NCT02168205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831717|NCT02168205|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24831718|NCT02168205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24831719|NCT02168205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771379|NCT01826916|Sensory System Agents|sensory system agents|mesh-ancestor
24771380|NCT01826916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24771381|NCT01826916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771382|NCT01826916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24771383|NCT01826916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24771384|NCT01826916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24771385|NCT01826916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24771386|NCT01827007|Polygeline|polygeline|mesh-list
24771387|NCT01827007|Plasma Substitutes|plasma substitutes|mesh-ancestor
24831720|NCT02168205|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24831721|NCT02168205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24831722|NCT02168205|Purinergic Agents|purinergic agents|mesh-ancestor
24831723|NCT02168205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24831724|NCT02168205|Immunologic Factors|immunologic factors|mesh-ancestor
24831725|NCT02168205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24831726|NCT02168205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24831727|NCT02168205|Growth Substances|growth substances|mesh-ancestor
24831728|NCT02168205|Growth Inhibitors|growth inhibitors|mesh-ancestor
24831729|NCT02168205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24831730|NCT02168426|Hyaluronic Acid|hyaluronic acid|mesh-list
24831731|NCT02168426|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24831732|NCT02168426|Immunologic Factors|immunologic factors|mesh-ancestor
24449196|NCT00314665|Leprostatic Agents|leprostatic agents|mesh-ancestor
24449197|NCT00314665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24449198|NCT00314665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24449199|NCT00314665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24449200|NCT00314665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24562562|NCT00766909|Antifungal Agents|antifungal agents|mesh-ancestor
24562563|NCT00766909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24562566|NCT00767091|Rivastigmine|rivastigmine|mesh-list
24771462|NCT01827293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24771463|NCT01827293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771465|NCT01827293|Dermatologic Agents|dermatologic agents|mesh-ancestor
24449201|NCT00314665|Growth Substances|growth substances|mesh-ancestor
24449216|NCT00314704|Norepinephrine|norepinephrine|mesh-list
24449217|NCT00314704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25268979|NCT02412917|Antiviral Agents|antiviral agents|mesh-ancestor
25268980|NCT02412917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25268981|NCT02412904|Menotropins|menotropins|mesh-list
25268982|NCT02412904|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25268983|NCT02412904|Fertility Agents|fertility agents|mesh-ancestor
25268984|NCT02412904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25674752|NCT01776424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25674753|NCT01776424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674754|NCT01776424|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25674755|NCT01776424|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25674756|NCT01776424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674757|NCT01776424|Antipyretics|antipyretics|mesh-ancestor
25674758|NCT01776424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25674759|NCT01776424|Antithrombins|antithrombins|mesh-ancestor
24790906|NCT05410314|Vitamins|vitamins|mesh-ancestor
24790907|NCT05410314|Micronutrients|micronutrients|mesh-ancestor
24790908|NCT05410314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268985|NCT02412904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25268986|NCT02412813|Cobalt|cobalt|mesh-list
25268987|NCT02412813|Trace Elements|trace elements|mesh-ancestor
25268988|NCT02412813|Micronutrients|micronutrients|mesh-ancestor
25268989|NCT02412813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941173|NCT03994211|Leprostatic Agents|leprostatic agents|mesh-ancestor
24449218|NCT00314704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24449219|NCT00314704|Adrenergic Agents|adrenergic agents|mesh-ancestor
25674760|NCT01776424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25674761|NCT01776424|Protease Inhibitors|protease inhibitors|mesh-ancestor
25674762|NCT01776424|Anticoagulants|anticoagulants|mesh-ancestor
25674763|NCT01776424|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25674764|NCT01776424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25674765|NCT01776424|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25674766|NCT01777139|Ezogabine|ezogabine|mesh-list
25674767|NCT01777139|Anticonvulsants|anticonvulsants|mesh-ancestor
25674768|NCT01777139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25674769|NCT01777139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553112|NCT00729573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553114|NCT00729573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24553115|NCT00729599|Cetylpyridinium|cetylpyridinium|mesh-list
24553116|NCT00729599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24553117|NCT00729599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24553118|NCT00729638|Lenalidomide|lenalidomide|mesh-list
24553119|NCT00729638|Everolimus|everolimus|mesh-list
24553120|NCT00729638|Immunologic Factors|immunologic factors|mesh-ancestor
25008065|NCT02113878|Cisplatin|cisplatin|mesh-list
24553149|NCT00729768|Immunologic Factors|immunologic factors|mesh-ancestor
24553150|NCT00729768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553151|NCT00729768|Antifungal Agents|antifungal agents|mesh-ancestor
24553152|NCT00729768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24697578|NCT01435707|Triamcinolone|triamcinolone|mesh-list
24831778|NCT02168881|Oxytocics|oxytocics|mesh-ancestor
24831781|NCT02168907|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24831782|NCT02168907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24831783|NCT02168907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24831784|NCT02168907|Immunologic Factors|immunologic factors|mesh-ancestor
25268991|NCT02412683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25268992|NCT02412566|SMOFlipid|smoflipid|mesh-list
25268993|NCT02412566|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25268994|NCT02412566|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25268995|NCT02412566|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25268996|NCT02412475|Cytarabine|cytarabine|mesh-list
25268997|NCT02412475|Fludarabine|fludarabine|mesh-list
25268998|NCT02412475|Sorafenib|sorafenib|mesh-list
25268999|NCT02412475|Decitabine|decitabine|mesh-list
25269000|NCT02412475|Vorinostat|vorinostat|mesh-list
25269001|NCT02412475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25269002|NCT02412475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25269003|NCT02412475|Antimetabolites|antimetabolites|mesh-ancestor
25269004|NCT02412475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269005|NCT02412475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25269044|NCT02412059|Prednisolone|prednisolone|mesh-list
25080964|NCT03334487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24831785|NCT02168907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831786|NCT02168907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24831787|NCT02168907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24831788|NCT02168907|Alkylating Agents|alkylating agents|mesh-ancestor
24831789|NCT02168907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584499|NCT00880672|Dutasteride|dutasteride|mesh-list
24831791|NCT02168907|Protective Agents|protective agents|mesh-ancestor
25674770|NCT01777152|Prednisone|prednisone|mesh-list
25674771|NCT01777152|Cyclophosphamide|cyclophosphamide|mesh-list
25674772|NCT01777152|Doxorubicin|doxorubicin|mesh-list
25674773|NCT01777152|Vincristine|vincristine|mesh-list
25674774|NCT01777152|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25674775|NCT01777152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25674776|NCT01777152|Immunologic Factors|immunologic factors|mesh-ancestor
25674777|NCT01777152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674778|NCT01777152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25674779|NCT01777152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25674780|NCT01777152|Alkylating Agents|alkylating agents|mesh-ancestor
25674781|NCT01777152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674782|NCT01777152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24553312|NCT00730288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553313|NCT00730366|Chloroquine|chloroquine|mesh-list
24553314|NCT00730366|Pyrimethamine|pyrimethamine|mesh-list
24553315|NCT00730366|Sulfadoxine|sulfadoxine|mesh-list
24553316|NCT00730366|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24553317|NCT00730366|Amebicides|amebicides|mesh-ancestor
24553318|NCT00730366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24553319|NCT00730366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24553320|NCT00730366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24553321|NCT00730366|Antimalarials|antimalarials|mesh-ancestor
24553322|NCT00730366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24831792|NCT02168907|Vitamin B Complex|vitamin b complex|mesh-ancestor
24831793|NCT02168907|Vitamins|vitamins|mesh-ancestor
24831794|NCT02168907|Micronutrients|micronutrients|mesh-ancestor
24831795|NCT02168959|Bupivacaine|bupivacaine|mesh-list
24831796|NCT02168959|Anesthetics, Local|anesthetics, local|mesh-ancestor
24831797|NCT02168959|Anesthetics|anesthetics|mesh-ancestor
24831798|NCT02168959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24831799|NCT02168959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771571|NCT01827878|Protective Agents|protective agents|mesh-ancestor
24771572|NCT01828125|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24771573|NCT01828125|Glucagon|glucagon|mesh-list
24771574|NCT01828125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24771575|NCT01828125|Hormones|hormones|mesh-ancestor
24771576|NCT01828125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24771577|NCT01828125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771578|NCT01828203|Minocycline|minocycline|mesh-list
24771579|NCT01828203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24771580|NCT01828203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24771581|NCT01828294|Immunoglobulins|immunoglobulins|mesh-list
24771582|NCT01828294|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24771584|NCT01828294|Immunologic Factors|immunologic factors|mesh-ancestor
24771585|NCT01828294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771586|NCT01828346|Azacitidine|azacitidine|mesh-list
24562689|NCT00767715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24771587|NCT01828346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24771610|NCT01828385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24771611|NCT01828385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24771612|NCT01828385|Anticonvulsants|anticonvulsants|mesh-ancestor
24771613|NCT01828385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25269006|NCT02412475|Immunologic Factors|immunologic factors|mesh-ancestor
25269007|NCT02412475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269008|NCT02412475|Antiviral Agents|antiviral agents|mesh-ancestor
25269009|NCT02412475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25269010|NCT02412475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25269011|NCT02412475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25269012|NCT02412475|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25269013|NCT02412449|Glycine|glycine|mesh-list
25269014|NCT02412449|Glycine Agents|glycine agents|mesh-ancestor
25674783|NCT01777152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25674784|NCT01777152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25674785|NCT01777152|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25674786|NCT01777152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25674787|NCT01777152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674788|NCT01777152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25674789|NCT01777152|Glucocorticoids|glucocorticoids|mesh-ancestor
25674790|NCT01777152|Hormones|hormones|mesh-ancestor
25674791|NCT01777152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25674792|NCT01777152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25269015|NCT02412449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25279163|NCT02346110|Dexamethasone|dexamethasone|mesh-list
25269016|NCT02412449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269017|NCT02412449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275464|NCT02372318|Sensory System Agents|sensory system agents|mesh-ancestor
25275465|NCT02372318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275466|NCT02372357|Posaconazole|posaconazole|mesh-list
25275467|NCT02372357|Antifungal Agents|antifungal agents|mesh-ancestor
25275468|NCT02372357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25275469|NCT02372357|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25275470|NCT02372357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25275471|NCT02372357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25275472|NCT02372357|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25275473|NCT02372357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24831800|NCT02168959|Sensory System Agents|sensory system agents|mesh-ancestor
24831801|NCT02168959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24589815|NCT00909129|Interferon-alpha|interferon-alpha|mesh-list
24831802|NCT02169063|Listerine|listerine|mesh-list
24831803|NCT02169063|Fluorides|fluorides|mesh-list
24831804|NCT02169063|Sodium Fluoride|sodium fluoride|mesh-list
24831805|NCT02169063|Cariostatic Agents|cariostatic agents|mesh-ancestor
24831806|NCT02169063|Protective Agents|protective agents|mesh-ancestor
24831807|NCT02169063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831808|NCT02169063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24831809|NCT02169063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24831810|NCT02169154|Diclofenac|diclofenac|mesh-list
24831811|NCT02169154|Menthol|menthol|mesh-list
24831830|NCT02169544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831831|NCT02169544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24831832|NCT02169544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24831833|NCT02169544|Immunologic Factors|immunologic factors|mesh-ancestor
24831834|NCT02169544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831835|NCT02169544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24831837|NCT02169570|Vitamin D|vitamin d|mesh-list
24831838|NCT02169570|Ergocalciferols|ergocalciferols|mesh-list
24831839|NCT02169570|Cholecalciferol|cholecalciferol|mesh-list
24831840|NCT02169570|Vitamins|vitamins|mesh-list
24831841|NCT02169570|Calcium|calcium|mesh-list
24831842|NCT02169570|Micronutrients|micronutrients|mesh-ancestor
24831843|NCT02169570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831844|NCT02169570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24831845|NCT02169570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24831846|NCT02169583|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24831847|NCT02169596|Ticagrelor|ticagrelor|mesh-list
24831848|NCT02169596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24967066|NCT03763084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24771699|NCT01828879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24771700|NCT01828879|Immunologic Factors|immunologic factors|mesh-ancestor
24771701|NCT01828879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771702|NCT01828879|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24771703|NCT01828879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771704|NCT01828879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771705|NCT01828892|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24831849|NCT02169596|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24831850|NCT02169596|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24831851|NCT02169596|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24831852|NCT02169596|Purinergic Agents|purinergic agents|mesh-ancestor
24831853|NCT02169596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24831854|NCT02169596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831855|NCT02169596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831857|NCT02169609|Dinutuximab|dinutuximab|mesh-list
24771747|NCT01829529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24771748|NCT01829529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24771749|NCT01829659|Ticagrelor|ticagrelor|mesh-list
24771751|NCT01829659|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24771752|NCT01829659|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24771753|NCT01829659|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24771754|NCT01829659|Purinergic Agents|purinergic agents|mesh-ancestor
24771755|NCT01829659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24771756|NCT01829659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771757|NCT01829659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771758|NCT01829685|Entecavir|entecavir|mesh-list
24771759|NCT01829685|Adefovir|adefovir|mesh-list
24831858|NCT02169609|Isotretinoin|isotretinoin|mesh-list
24831859|NCT02169609|Sargramostim|sargramostim|mesh-list
24831860|NCT02169609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24831862|NCT02169609|Analgesics|analgesics|mesh-ancestor
24831889|NCT02169713|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24697685|NCT01436513|Hormones|hormones|mesh-ancestor
25269018|NCT02412423|Cyclophosphamide|cyclophosphamide|mesh-list
25269019|NCT02412423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25269020|NCT02412423|Immunologic Factors|immunologic factors|mesh-ancestor
25269021|NCT02412423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269022|NCT02412423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25275474|NCT02372357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466140|NCT00372229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24715343|NCT01536002|Propofol|propofol|mesh-list
24831904|NCT02169843|Dexmedetomidine|dexmedetomidine|mesh-list
24831905|NCT02169843|Sevoflurane|sevoflurane|mesh-list
24831906|NCT02169843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24831907|NCT02169843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24831908|NCT02169843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831947|NCT02169856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24831948|NCT02169856|Analgesics|analgesics|mesh-ancestor
24831949|NCT02169856|Sensory System Agents|sensory system agents|mesh-ancestor
24831950|NCT02169856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24831951|NCT02169856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25269023|NCT02412423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25269024|NCT02412423|Alkylating Agents|alkylating agents|mesh-ancestor
25269025|NCT02412423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269026|NCT02412423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25269027|NCT02412423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25269028|NCT02412345|Alprostadil|alprostadil|mesh-list
25269029|NCT02412345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25269030|NCT02412345|Vasodilator Agents|vasodilator agents|mesh-ancestor
25269031|NCT02412345|Urological Agents|urological agents|mesh-ancestor
25269032|NCT02412267|Carboplatin|carboplatin|mesh-list
24831952|NCT02169856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24831953|NCT02169856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24831954|NCT02169856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24831955|NCT02169856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24831956|NCT02169856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24831957|NCT02169856|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24831958|NCT02169856|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24831959|NCT02169856|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24831960|NCT02169856|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24831976|NCT02169882|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24831977|NCT02169882|Antitubercular Agents|antitubercular agents|mesh-ancestor
24831978|NCT02169882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24831979|NCT02169882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24831980|NCT02169882|Leprostatic Agents|leprostatic agents|mesh-ancestor
24831981|NCT02169882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24831982|NCT02169882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24831983|NCT02169882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697787|NCT01437293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24831995|NCT02170038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24831997|NCT02170038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25269033|NCT02412267|Etoposide|etoposide|mesh-list
25269034|NCT02412267|Ifosfamide|ifosfamide|mesh-list
25269035|NCT02412267|Ofatumumab|ofatumumab|mesh-list
25269036|NCT02412267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25269037|NCT02412267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25269038|NCT02412267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25269039|NCT02412267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24554734|NCT00737867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24554754|NCT00737971|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24554755|NCT00737971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24554756|NCT00737971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24554757|NCT00737971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24554758|NCT00737971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24554764|NCT00737971|Hormones|hormones|mesh-ancestor
25269040|NCT02412267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25269041|NCT02412267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269042|NCT02412267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25269043|NCT02412267|Alkylating Agents|alkylating agents|mesh-ancestor
25269048|NCT02412059|Prednisolone acetate|prednisolone acetate|mesh-list
25269049|NCT02412059|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25269050|NCT02412059|Prednisolone phosphate|prednisolone phosphate|mesh-list
24466276|NCT00372801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24466277|NCT00372801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24466278|NCT00372801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24831998|NCT02170038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831999|NCT02170038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24832000|NCT02170038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24832001|NCT02170038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24832002|NCT02170038|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24832003|NCT02170038|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24832004|NCT02170038|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
24832005|NCT02170038|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24832006|NCT02170038|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24832007|NCT02170116|Dabigatran|dabigatran|mesh-list
24832008|NCT02170116|Antithrombins|antithrombins|mesh-ancestor
24832009|NCT02170116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832010|NCT02170116|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832011|NCT02170116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832012|NCT02170116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832013|NCT02170116|Anticoagulants|anticoagulants|mesh-ancestor
24590040|NCT00910416|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24832015|NCT02170246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24832016|NCT02170246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24832017|NCT02170246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24832018|NCT02170246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832019|NCT02170324|Exenatide|exenatide|mesh-list
24832020|NCT02170324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24832021|NCT02170324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832022|NCT02170324|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24832024|NCT02170324|Hormones|hormones|mesh-ancestor
24832025|NCT02170324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24832040|NCT02170415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24832041|NCT02170415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24832042|NCT02170415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24832043|NCT02170415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24832044|NCT02170571|Dabigatran|dabigatran|mesh-list
24832045|NCT02170571|Antithrombins|antithrombins|mesh-ancestor
24832046|NCT02170571|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25269051|NCT02412059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25269052|NCT02412059|Glucocorticoids|glucocorticoids|mesh-ancestor
25674793|NCT01777152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25674794|NCT01777152|Tubulin Modulators|tubulin modulators|mesh-ancestor
25674795|NCT01777152|Antimitotic Agents|antimitotic agents|mesh-ancestor
25674796|NCT01777152|Mitosis Modulators|mitosis modulators|mesh-ancestor
25674797|NCT01777152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25674798|NCT01777191|Ixekizumab|ixekizumab|mesh-list
25674799|NCT01777191|Dermatologic Agents|dermatologic agents|mesh-ancestor
25692341|NCT01998919|Cisplatin|cisplatin|mesh-list
25692342|NCT01998919|Carboplatin|carboplatin|mesh-list
24555274|NCT00740922|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
24555276|NCT00740922|Growth Substances|growth substances|mesh-ancestor
25269053|NCT02412059|Hormones|hormones|mesh-ancestor
25269054|NCT02412059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25269055|NCT02412059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269056|NCT02412059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25269057|NCT02412059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25269058|NCT02412059|Antiemetics|antiemetics|mesh-ancestor
25269059|NCT02412059|Autonomic Agents|autonomic agents|mesh-ancestor
24832048|NCT02170571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832049|NCT02170571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832051|NCT02170584|Dabigatran|dabigatran|mesh-list
24832052|NCT02170584|Antithrombins|antithrombins|mesh-ancestor
24832053|NCT02170584|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832054|NCT02170584|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832055|NCT02170584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832056|NCT02170584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832057|NCT02170584|Anticoagulants|anticoagulants|mesh-ancestor
24832058|NCT02170597|Dabigatran|dabigatran|mesh-list
24832059|NCT02170597|Antithrombins|antithrombins|mesh-ancestor
24832060|NCT02170597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832061|NCT02170597|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832062|NCT02170597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832063|NCT02170597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832065|NCT02170610|Pantoprazole|pantoprazole|mesh-list
24832066|NCT02170610|Dabigatran|dabigatran|mesh-list
24832067|NCT02170610|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24832068|NCT02170610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24771988|NCT01830829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771989|NCT01830829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771990|NCT01830829|Urological Agents|urological agents|mesh-ancestor
24771991|NCT01830829|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24771992|NCT01830829|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24771993|NCT01830829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771994|NCT01830829|Hormone Antagonists|hormone antagonists|mesh-ancestor
24771995|NCT01830829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24771997|NCT01830868|Anticonvulsants|anticonvulsants|mesh-ancestor
24771998|NCT01830868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24771999|NCT01830868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24832072|NCT02170610|Antithrombins|antithrombins|mesh-ancestor
24832075|NCT02170610|Anticoagulants|anticoagulants|mesh-ancestor
24832076|NCT02170623|Pantoprazole|pantoprazole|mesh-list
24832077|NCT02170623|Dabigatran|dabigatran|mesh-list
24832078|NCT02170623|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24832079|NCT02170623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24832080|NCT02170623|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24832081|NCT02170623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832082|NCT02170623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832083|NCT02170623|Antithrombins|antithrombins|mesh-ancestor
24832084|NCT02170623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832085|NCT02170623|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832086|NCT02170623|Anticoagulants|anticoagulants|mesh-ancestor
25269060|NCT02412059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25269061|NCT02412059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25269062|NCT02412059|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25269063|NCT02412059|Protective Agents|protective agents|mesh-ancestor
25269064|NCT02412150|Dexmedetomidine|dexmedetomidine|mesh-list
25269065|NCT02412150|Remifentanil|remifentanil|mesh-list
25269066|NCT02412150|Desflurane|desflurane|mesh-list
25269067|NCT02412150|Anesthetics|anesthetics|mesh-list
25674800|NCT01777217|Solifenacin Succinate|solifenacin succinate|mesh-list
25674801|NCT01777217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25692713|NCT02004093|Immunologic Factors|immunologic factors|mesh-ancestor
24555694|NCT00742807|Anesthetics|anesthetics|mesh-ancestor
24555699|NCT00742820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008195|NCT01042522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008197|NCT01042522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25008198|NCT01042522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25269068|NCT02412150|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
24772045|NCT01831193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772046|NCT01831323|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24772049|NCT01831323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24772055|NCT01831323|Analgesics|analgesics|mesh-ancestor
24483289|NCT00442637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832193|NCT02170896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24832194|NCT02170896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24832195|NCT02170896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24832196|NCT02170896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25269069|NCT02412150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25269070|NCT02412150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25269071|NCT02412150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269072|NCT02412150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24483290|NCT00442676|Celecoxib|celecoxib|mesh-list
25269073|NCT02412150|Analgesics|analgesics|mesh-ancestor
25269074|NCT02412150|Sensory System Agents|sensory system agents|mesh-ancestor
25269075|NCT02412150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25269076|NCT02412150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25269077|NCT02412150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25269078|NCT02412150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25269079|NCT02412150|Adrenergic Agents|adrenergic agents|mesh-ancestor
25269080|NCT02412150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24466386|NCT00373451|Abciximab|abciximab|mesh-list
24832197|NCT02170896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832198|NCT02170896|Antithrombins|antithrombins|mesh-ancestor
24832202|NCT02170909|Dabigatran|dabigatran|mesh-list
24832203|NCT02170909|Antithrombins|antithrombins|mesh-ancestor
24832204|NCT02170909|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832205|NCT02170909|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832206|NCT02170909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24697992|NCT01438320|Protective Agents|protective agents|mesh-ancestor
25279164|NCT02346110|Epinephrine|epinephrine|mesh-list
25674802|NCT01777217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25674803|NCT01777217|Cholinergic Agents|cholinergic agents|mesh-ancestor
25674804|NCT01777217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25674805|NCT01777217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674806|NCT01777217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791114|NCT05273567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24791115|NCT05273567|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24791116|NCT05273567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24851639|NCT02257671|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24851642|NCT02257671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24851643|NCT02257697|Mizoribine|mizoribine|mesh-list
24851644|NCT02257697|Cyclophosphamide|cyclophosphamide|mesh-list
24791117|NCT05273567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24791118|NCT05273567|Adrenergic Agents|adrenergic agents|mesh-ancestor
24791119|NCT05273567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24816410|NCT02076841|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24889256|NCT04494659|Rifampin|rifampin|mesh-list
24555814|NCT00743834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24555815|NCT00743834|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24832218|NCT02170935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832219|NCT02170935|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832220|NCT02170935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832221|NCT02170935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832222|NCT02170935|Anticoagulants|anticoagulants|mesh-ancestor
24832223|NCT02170948|Dexmedetomidine|dexmedetomidine|mesh-list
24832224|NCT02170948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24832225|NCT02170948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24772081|NCT01831505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24772082|NCT01831505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772083|NCT01831505|Immunologic Factors|immunologic factors|mesh-ancestor
24772108|NCT01831622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832226|NCT02170948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832227|NCT02170948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24832228|NCT02170948|Analgesics|analgesics|mesh-ancestor
24832229|NCT02170948|Sensory System Agents|sensory system agents|mesh-ancestor
24832230|NCT02170948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24832231|NCT02170948|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24832232|NCT02170948|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24832233|NCT02170948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24832234|NCT02170948|Adrenergic Agents|adrenergic agents|mesh-ancestor
24832235|NCT02170948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24832236|NCT02170948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832237|NCT02170974|Dabigatran|dabigatran|mesh-list
24832238|NCT02170974|Antithrombins|antithrombins|mesh-ancestor
24832270|NCT02171013|Anticoagulants|anticoagulants|mesh-ancestor
24620607|NCT01057849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24620608|NCT01057849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24620609|NCT01057849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24620610|NCT01057849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24620611|NCT01057849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24620612|NCT01057849|Antidepressive Agents|antidepressive agents|mesh-ancestor
24620613|NCT01057849|Dopamine Agonists|dopamine agonists|mesh-ancestor
24620614|NCT01057849|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25674807|NCT01777217|Urological Agents|urological agents|mesh-ancestor
25674808|NCT01777269|Tamsulosin|tamsulosin|mesh-list
25674809|NCT01777269|Dutasteride|dutasteride|mesh-list
25674810|NCT01777269|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25674811|NCT01777269|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25674812|NCT01777269|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25674813|NCT01777269|Adrenergic Agents|adrenergic agents|mesh-ancestor
25674814|NCT01777269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25674815|NCT01777269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674816|NCT01777269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674817|NCT01777269|Urological Agents|urological agents|mesh-ancestor
25674818|NCT01777269|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25674819|NCT01777269|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25674820|NCT01777269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674821|NCT01777269|Hormone Antagonists|hormone antagonists|mesh-ancestor
25692343|NCT01998919|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25242933|NCT05358977|Hemostatics|hemostatics|mesh-ancestor
25242934|NCT05358977|Coagulants|coagulants|mesh-ancestor
25269082|NCT02412150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25269083|NCT02412150|Narcotics|narcotics|mesh-ancestor
25269084|NCT02412150|Anesthetics, General|anesthetics, general|mesh-ancestor
25269085|NCT02412189|Norepinephrine|norepinephrine|mesh-list
25269086|NCT02412189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25269087|NCT02412189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25269088|NCT02412189|Adrenergic Agents|adrenergic agents|mesh-ancestor
24620619|NCT01057875|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24620620|NCT01057875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620621|NCT01057875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24651966|NCT01234857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24832275|NCT02171026|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832276|NCT02171026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832277|NCT02171026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832278|NCT02171026|Anticoagulants|anticoagulants|mesh-ancestor
24832279|NCT02171026|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24832280|NCT02171026|Vasodilator Agents|vasodilator agents|mesh-ancestor
24832281|NCT02171026|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24832282|NCT02171026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24832283|NCT02171026|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24832284|NCT02171026|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24832285|NCT02171026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24832286|NCT02171026|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24832287|NCT02171026|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24832288|NCT02171026|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24967079|NCT03762967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24967080|NCT03762967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967081|NCT03762928|Efavirenz|efavirenz|mesh-list
24967082|NCT03762928|Midazolam|midazolam|mesh-list
24967083|NCT03762928|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25269089|NCT02412189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25269090|NCT02412189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269091|NCT02412189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269092|NCT02412189|Sympathomimetics|sympathomimetics|mesh-ancestor
25269093|NCT02412189|Autonomic Agents|autonomic agents|mesh-ancestor
25269094|NCT02412189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25269095|NCT02412189|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25269096|NCT02411942|Adapalene|adapalene|mesh-list
25269097|NCT02411942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25269098|NCT02411942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25269099|NCT02411942|Analgesics|analgesics|mesh-ancestor
25269100|NCT02411942|Sensory System Agents|sensory system agents|mesh-ancestor
25674822|NCT01777269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25674823|NCT01777282|Biguanides|biguanides|mesh-list
24556667|NCT00748787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24556718|NCT00749359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791192|NCT05049707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24791194|NCT05049707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24791195|NCT05043870|Infliximab|infliximab|mesh-list
24791196|NCT05043870|Immunosuppressive Agents|immunosuppressive agents|mesh-list
24791197|NCT05043870|Dermatologic Agents|dermatologic agents|mesh-ancestor
24780263|NCT01883167|Verinurad|verinurad|mesh-list
25008319|NCT00344487|Ritonavir|ritonavir|mesh-list
25008320|NCT00344487|Lopinavir|lopinavir|mesh-list
25008321|NCT00344487|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25269101|NCT02411942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25269102|NCT02411942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269103|NCT02411942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25269104|NCT02411942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25269105|NCT02411942|Dermatologic Agents|dermatologic agents|mesh-ancestor
25269106|NCT02411955|Nicotinic Acids|nicotinic acids|mesh-list
24466390|NCT00373451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466391|NCT00373451|Antithrombins|antithrombins|mesh-ancestor
24517924|NCT00610584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517925|NCT00610610|Paroxetine|paroxetine|mesh-list
24517926|NCT00610610|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24517927|NCT00610610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24517928|NCT00610610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24517929|NCT00610610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517930|NCT00610610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24517931|NCT00610610|Serotonin Agents|serotonin agents|mesh-ancestor
24423076|NCT00224588|Ketamine|ketamine|mesh-list
24590362|NCT00912275|Vinorelbine|vinorelbine|mesh-list
25674824|NCT01777282|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
25674825|NCT01777282|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
25674826|NCT01777282|rGLP-1 protein|rglp-1 protein|mesh-list
25674827|NCT01777282|Incretins|incretins|mesh-ancestor
25674828|NCT01777282|Hormones|hormones|mesh-ancestor
25674829|NCT01777282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25674830|NCT01777282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674831|NCT01777282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25674832|NCT01777282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674833|NCT01777282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674834|NCT01777334|Tiotropium Bromide|tiotropium bromide|mesh-list
25674835|NCT01777334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25674836|NCT01777334|Autonomic Agents|autonomic agents|mesh-ancestor
25674837|NCT01777334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25674838|NCT01777334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674839|NCT01777334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25674840|NCT01777334|Respiratory System Agents|respiratory system agents|mesh-ancestor
25674841|NCT01777334|Parasympatholytics|parasympatholytics|mesh-ancestor
24556847|NCT00749918|Vitamins|vitamins|mesh-ancestor
24620637|NCT01058057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24620638|NCT01058057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620639|NCT01058109|Calcium, Dietary|calcium, dietary|mesh-list
24620640|NCT01058109|Calcium|calcium|mesh-list
24620641|NCT01058109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24620644|NCT01058174|Fluconazole|fluconazole|mesh-list
24832328|NCT02171208|Immunologic Factors|immunologic factors|mesh-ancestor
24832329|NCT02171208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832331|NCT02171221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24832332|NCT02171221|Antimetabolites|antimetabolites|mesh-ancestor
24832333|NCT02171221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832334|NCT02171221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24832335|NCT02171299|Ropivacaine|ropivacaine|mesh-list
24832336|NCT02171299|Anesthetics, Local|anesthetics, local|mesh-list
24832337|NCT02171299|Anesthetics|anesthetics|mesh-list
24832338|NCT02171299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25269107|NCT02411955|Tazarotene|tazarotene|mesh-list
25269108|NCT02411955|Dermatologic Agents|dermatologic agents|mesh-ancestor
25269109|NCT02411955|Keratolytic Agents|keratolytic agents|mesh-ancestor
25269110|NCT02411955|Vitamin B Complex|vitamin b complex|mesh-ancestor
25269111|NCT02411955|Vitamins|vitamins|mesh-ancestor
24620661|NCT01058174|Amebicides|amebicides|mesh-ancestor
24620662|NCT01058174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24620663|NCT01058174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24620664|NCT01058174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24620665|NCT01058252|Indomethacin|indomethacin|mesh-list
24620666|NCT01058252|Letrozole|letrozole|mesh-list
24620667|NCT01058252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24620668|NCT01058252|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25269112|NCT02411955|Micronutrients|micronutrients|mesh-ancestor
25269113|NCT02411955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269114|NCT02412085|Golimumab|golimumab|mesh-list
25269115|NCT02412085|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25269116|NCT02412085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25269117|NCT02412085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25269118|NCT02412085|Immunologic Factors|immunologic factors|mesh-ancestor
25269119|NCT02412085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269120|NCT02412033|Misoprostol|misoprostol|mesh-list
25269121|NCT02412033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25269122|NCT02412033|Abortifacient Agents|abortifacient agents|mesh-ancestor
25269123|NCT02412033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25269124|NCT02412033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269125|NCT02412033|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25269126|NCT02412033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25269127|NCT02412033|Oxytocics|oxytocics|mesh-ancestor
25269128|NCT02411994|Artesunate|artesunate|mesh-list
25269129|NCT02411994|Lumefantrine|lumefantrine|mesh-list
25269130|NCT02411994|Artemether|artemether|mesh-list
24941286|NCT03992586|Autonomic Agents|autonomic agents|mesh-ancestor
24941287|NCT03992586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24941288|NCT03992586|Dopamine Agents|dopamine agents|mesh-ancestor
24941289|NCT03992586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24941291|NCT03992586|Adrenergic Agents|adrenergic agents|mesh-ancestor
25674842|NCT01777334|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25674843|NCT01777334|Cholinergic Agents|cholinergic agents|mesh-ancestor
24558046|NCT00755170|Growth Substances|growth substances|mesh-ancestor
24832355|NCT02171338|Penicillin G|penicillin g|mesh-list
24832356|NCT02171338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24772169|NCT01832285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24772170|NCT01832285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24772171|NCT01832285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772172|NCT01832285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24772173|NCT01832285|Serotonin Agents|serotonin agents|mesh-ancestor
24772174|NCT01832285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24772175|NCT01832285|Antidepressive Agents|antidepressive agents|mesh-ancestor
24772176|NCT01832285|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24772177|NCT01832285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24772178|NCT01832285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423163|NCT00224822|Dopamine Agonists|dopamine agonists|mesh-ancestor
24772179|NCT01832285|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25269131|NCT02411994|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25269132|NCT02411994|Pyronaridine|pyronaridine|mesh-list
25269133|NCT02411994|Antimalarials|antimalarials|mesh-ancestor
25269134|NCT02411994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25269135|NCT02411994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25269136|NCT02411994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25269137|NCT02411994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25269138|NCT02411994|Antiviral Agents|antiviral agents|mesh-ancestor
25269139|NCT02411994|Schistosomicides|schistosomicides|mesh-ancestor
25269140|NCT02411994|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25269141|NCT02411994|Anthelmintics|anthelmintics|mesh-ancestor
25269142|NCT02411877|Clotrimazole|clotrimazole|mesh-list
25269143|NCT02411877|Miconazole|miconazole|mesh-list
25269144|NCT02411877|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25269145|NCT02411877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25269146|NCT02411877|Antifungal Agents|antifungal agents|mesh-ancestor
24466593|NCT00374101|Omeprazole|omeprazole|mesh-list
24941296|NCT03992755|Treprostinil|treprostinil|mesh-list
24941298|NCT03992170|Daratumumab|daratumumab|mesh-list
24772183|NCT01832311|Analgesics|analgesics|mesh-ancestor
25269147|NCT02411877|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25674844|NCT01777334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25674845|NCT01777334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674846|NCT01777412|Bevacizumab|bevacizumab|mesh-list
25674847|NCT01777412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25674848|NCT01777412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25674849|NCT01777412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25674850|NCT01777412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25674851|NCT01777412|Growth Substances|growth substances|mesh-ancestor
25674852|NCT01777412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584144|NCT00878670|Dermatologic Agents|dermatologic agents|mesh-ancestor
24584145|NCT00878748|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24584146|NCT00878748|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24584147|NCT00878748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24584148|NCT00878748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25269148|NCT02411877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25269149|NCT02411877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25269150|NCT02411877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269151|NCT02411877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25269152|NCT02411877|Hormone Antagonists|hormone antagonists|mesh-ancestor
25269153|NCT02411877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25269154|NCT02411877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269155|NCT02411877|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25269156|NCT02411877|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25269157|NCT02411903|Clopidogrel|clopidogrel|mesh-list
25269158|NCT02411903|Atorvastatin|atorvastatin|mesh-list
25269159|NCT02411903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25269160|NCT02411903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25269161|NCT02411903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25269162|NCT02411903|Antimetabolites|antimetabolites|mesh-ancestor
25269163|NCT02411903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269164|NCT02411903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25269165|NCT02411903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25269166|NCT02411903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772217|NCT01832350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24967100|NCT03762928|Antiviral Agents|antiviral agents|mesh-ancestor
24832364|NCT02171338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449239|NCT00314743|Glucocorticoids|glucocorticoids|mesh-ancestor
24449240|NCT00314743|Hormones|hormones|mesh-ancestor
24449241|NCT00314743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24449242|NCT00314743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24449244|NCT00314743|Antipruritics|antipruritics|mesh-ancestor
24449245|NCT00314743|Dermatologic Agents|dermatologic agents|mesh-ancestor
24449246|NCT00314743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24832400|NCT02171468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269167|NCT02411903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25269168|NCT02411903|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25269169|NCT02411903|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25269170|NCT02411903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25269171|NCT02411903|Purinergic Agents|purinergic agents|mesh-ancestor
25269172|NCT02411903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25269173|NCT02411903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269174|NCT02411786|Molgramostim|molgramostim|mesh-list
25269175|NCT02411786|Sargramostim|sargramostim|mesh-list
25269176|NCT02411786|Immunologic Factors|immunologic factors|mesh-ancestor
24772252|NCT01832571|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24772253|NCT01832623|Vitamin D|vitamin d|mesh-list
24772254|NCT01832623|Vitamins|vitamins|mesh-ancestor
24772255|NCT01832623|Micronutrients|micronutrients|mesh-ancestor
25279165|NCT02346110|Racepinephrine|racepinephrine|mesh-list
25674853|NCT01777412|Growth Inhibitors|growth inhibitors|mesh-ancestor
25674854|NCT01777542|Insulin|insulin|mesh-list
25674855|NCT01777542|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25674856|NCT01777542|Mitogens|mitogens|mesh-list
25674857|NCT01777542|Mecasermin|mecasermin|mesh-list
25674858|NCT01777542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24559184|NCT05222438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24559185|NCT05222438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24559266|NCT05122221|Fludarabine|fludarabine|mesh-list
24559267|NCT05122221|Interleukin-2|interleukin-2|mesh-list
24559289|NCT05117554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24559290|NCT05117554|Anesthetics, General|anesthetics, general|mesh-ancestor
24772256|NCT01832623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772257|NCT01832623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25269177|NCT02411786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269178|NCT02411786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25269179|NCT02411825|Metformin|metformin|mesh-list
25269180|NCT02411825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25269181|NCT02411825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269182|NCT02411695|Brexpiprazole|brexpiprazole|mesh-list
25269183|NCT02411695|Serotonin Agents|serotonin agents|mesh-ancestor
25269184|NCT02411695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25269185|NCT02411695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269186|NCT02411695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269187|NCT02411695|Dopamine Agonists|dopamine agonists|mesh-ancestor
25269190|NCT02411604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25269191|NCT02411604|Immunologic Factors|immunologic factors|mesh-ancestor
25269192|NCT02411604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269193|NCT02411604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25269194|NCT02411604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466884|NCT00375466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24464434|NCT00364871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464435|NCT00364871|Sensory System Agents|sensory system agents|mesh-ancestor
25269195|NCT02411604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269196|NCT02411149|Epinephrine|epinephrine|mesh-list
25269197|NCT02411149|Racepinephrine|racepinephrine|mesh-list
25269198|NCT02411149|Morphine|morphine|mesh-list
25674859|NCT01777542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674860|NCT01777542|Mitosis Modulators|mitosis modulators|mesh-ancestor
25674861|NCT01777542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674862|NCT01777542|Growth Substances|growth substances|mesh-ancestor
25674863|NCT01777581|Milnacipran|milnacipran|mesh-list
25674864|NCT01777581|Levomilnacipran|levomilnacipran|mesh-list
25674865|NCT01777581|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25674866|NCT01777581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25008464|NCT05207735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008466|NCT05207683|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
25008467|NCT05207683|Immunologic Factors|immunologic factors|mesh-ancestor
25008468|NCT05207683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008469|NCT05207514|Ethanol|ethanol|mesh-list
25008470|NCT05207514|Cyclophosphamide|cyclophosphamide|mesh-list
24559447|NCT04767061|Nebivolol|nebivolol|mesh-list
24559448|NCT04767061|Bisoprolol|bisoprolol|mesh-list
24559449|NCT04767061|Labetalol|labetalol|mesh-list
24559450|NCT04767061|Pindolol|pindolol|mesh-list
24559451|NCT04767061|Betaxolol|betaxolol|mesh-list
24559452|NCT04767061|Penbutolol|penbutolol|mesh-list
25269199|NCT02411149|Ropivacaine|ropivacaine|mesh-list
25269200|NCT02411149|Epinephryl borate|epinephryl borate|mesh-list
25269201|NCT02411149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25269202|NCT02411149|Narcotics|narcotics|mesh-ancestor
25269203|NCT02411149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25269204|NCT02411149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269205|NCT02411149|Analgesics|analgesics|mesh-ancestor
25269206|NCT02411149|Sensory System Agents|sensory system agents|mesh-ancestor
25269207|NCT02411149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25269208|NCT02411149|Anesthetics, Local|anesthetics, local|mesh-ancestor
25269209|NCT02411149|Anesthetics|anesthetics|mesh-ancestor
25269210|NCT02411149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25269211|NCT02411149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25269212|NCT02411149|Adrenergic Agents|adrenergic agents|mesh-ancestor
25269213|NCT02411149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24941357|NCT03991845|Levocetirizine|levocetirizine|mesh-list
24941358|NCT03991845|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24941359|NCT03991845|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24941360|NCT03991845|Histamine Antagonists|histamine antagonists|mesh-ancestor
24941361|NCT03991845|Histamine Agents|histamine agents|mesh-ancestor
24941362|NCT03991845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24518007|NCT00611039|Protease Inhibitors|protease inhibitors|mesh-ancestor
24772329|NCT01832987|Renal Agents|renal agents|mesh-ancestor
24518008|NCT00611039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24518009|NCT00611039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941363|NCT03991845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674867|NCT01777581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25674868|NCT01777581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674869|NCT01777581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25674870|NCT01777581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674871|NCT01777581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25674872|NCT01777581|Analgesics|analgesics|mesh-ancestor
25674873|NCT01777581|Sensory System Agents|sensory system agents|mesh-ancestor
25674874|NCT01777581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25674875|NCT01777581|Antidepressive Agents|antidepressive agents|mesh-ancestor
25674876|NCT01777581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25674877|NCT01777620|Botulinum Toxins|botulinum toxins|mesh-list
24559900|NCT04128748|Immunologic Factors|immunologic factors|mesh-ancestor
24559901|NCT04128748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24559902|NCT04128748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24559903|NCT04128748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24559904|NCT04128748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24559933|NCT04007809|Glucagon|glucagon|mesh-list
24559934|NCT04007809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24559935|NCT04007809|Hormones|hormones|mesh-ancestor
24559972|NCT03916419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24559973|NCT03916419|Tubulin Modulators|tubulin modulators|mesh-ancestor
24560000|NCT03873883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25269214|NCT02411149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269215|NCT02411149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25269216|NCT02411149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25269217|NCT02411149|Autonomic Agents|autonomic agents|mesh-ancestor
25269218|NCT02411149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25269219|NCT02411149|Respiratory System Agents|respiratory system agents|mesh-ancestor
25269220|NCT02411149|Mydriatics|mydriatics|mesh-ancestor
25269221|NCT02411149|Sympathomimetics|sympathomimetics|mesh-ancestor
25269222|NCT02411149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25269223|NCT02411526|Risperidone|risperidone|mesh-list
25269224|NCT02411526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25269225|NCT02411526|Serotonin Agents|serotonin agents|mesh-ancestor
25269226|NCT02411526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25269227|NCT02411526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269228|NCT02411526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269229|NCT02411526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25269230|NCT02411526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25269231|NCT02411526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25269232|NCT02411526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25674878|NCT01777620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25674879|NCT01777620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25674880|NCT01777620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25674881|NCT01777620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25674882|NCT01777620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674883|NCT01777620|Cholinergic Agents|cholinergic agents|mesh-ancestor
25674884|NCT01777620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25674885|NCT01777620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674886|NCT01777620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25674887|NCT01777620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25674888|NCT01777763|Posaconazole|posaconazole|mesh-list
25674889|NCT01777763|Antifungal Agents|antifungal agents|mesh-ancestor
25674890|NCT01777763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25674891|NCT01777763|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25674892|NCT01777763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25674893|NCT01777763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25674894|NCT01777763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25008503|NCT05187208|Niraparib|niraparib|mesh-list
25008504|NCT05187208|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25008505|NCT05187208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25008506|NCT05187208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008507|NCT05187208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008508|NCT05186467|Magnesium Sulfate|magnesium sulfate|mesh-list
25008509|NCT05186467|Analgesics|analgesics|mesh-ancestor
25008513|NCT05186467|Anesthetics|anesthetics|mesh-ancestor
24832419|NCT02171507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25269233|NCT02411526|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25269234|NCT02411526|Dopamine Agents|dopamine agents|mesh-ancestor
25269235|NCT02411630|Tenofovir|tenofovir|mesh-list
25269236|NCT02411630|Emtricitabine|emtricitabine|mesh-list
25269237|NCT02411630|Antiviral Agents|antiviral agents|mesh-ancestor
25269238|NCT02411630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25269239|NCT02411630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25269240|NCT02411630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24467128|NCT00376337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24467129|NCT00376337|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24467130|NCT00376337|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25081087|NCT03333018|Bromides|bromides|mesh-list
24467131|NCT00376337|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24467132|NCT00376337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467133|NCT00376337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269241|NCT02411630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25269242|NCT02411630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269243|NCT02411630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25269244|NCT02411630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25269245|NCT02411318|Ethanol|ethanol|mesh-list
25269246|NCT02411318|Caffeine|caffeine|mesh-list
25269247|NCT02411318|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25269248|NCT02411318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269249|NCT02411318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25269250|NCT02411318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772424|NCT01833715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24772425|NCT01833715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269251|NCT02411318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269252|NCT02411318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25269253|NCT02411318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25269254|NCT02411318|Purinergic Agents|purinergic agents|mesh-ancestor
25269255|NCT02411318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25269256|NCT02411318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25269257|NCT02411318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25674895|NCT01777763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25674896|NCT01777763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674897|NCT01777763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674898|NCT01777763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25674899|NCT01777763|Hormone Antagonists|hormone antagonists|mesh-ancestor
25674900|NCT01777763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25279166|NCT02346110|Bupivacaine|bupivacaine|mesh-list
24553714|NCT00732576|Coagulants|coagulants|mesh-ancestor
24553715|NCT00732576|Vitamins|vitamins|mesh-ancestor
24553716|NCT00732576|Micronutrients|micronutrients|mesh-ancestor
25269258|NCT02411318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25269259|NCT02411175|Ethanol|ethanol|mesh-list
25269260|NCT02411175|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25269261|NCT02411175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25269262|NCT02411175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24467136|NCT00376337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24467137|NCT00376337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467138|NCT00376337|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25674901|NCT01777763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674902|NCT01777945|Docetaxel|docetaxel|mesh-list
25674903|NCT01777945|Capecitabine|capecitabine|mesh-list
25674904|NCT01777945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941396|NCT03991559|Immunoglobulins|immunoglobulins|mesh-list
24772444|NCT01833767|Interleukin-2|interleukin-2|mesh-list
25269263|NCT02411175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269264|NCT02411331|Ethanol|ethanol|mesh-list
25269265|NCT02411331|Enoxaparin|enoxaparin|mesh-list
25269266|NCT02411331|Anticoagulants|anticoagulants|mesh-ancestor
25269267|NCT02411331|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25269268|NCT02411331|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25269269|NCT02411331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269270|NCT02411331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25674905|NCT01777945|Tubulin Modulators|tubulin modulators|mesh-ancestor
25674906|NCT01777945|Antimitotic Agents|antimitotic agents|mesh-ancestor
25674907|NCT01777945|Mitosis Modulators|mitosis modulators|mesh-ancestor
25674908|NCT01777945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269271|NCT02411331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25269272|NCT02411331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25269273|NCT02411331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269274|NCT02411344|Pertuzumab|pertuzumab|mesh-list
24560771|NCT01451515|Etoposide|etoposide|mesh-list
24560772|NCT01451515|Vincristine|vincristine|mesh-list
25674909|NCT01777945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25674910|NCT01777945|Antimetabolites|antimetabolites|mesh-ancestor
24560773|NCT01451515|Daunorubicin|daunorubicin|mesh-list
24560780|NCT01451515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25275648|NCT02370550|Calcium|calcium|mesh-list
25269275|NCT02411344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25269276|NCT02411344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25269277|NCT02410863|Trametinib|trametinib|mesh-list
25269278|NCT02410863|Dabrafenib|dabrafenib|mesh-list
25269279|NCT02410863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25269280|NCT02410863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25269281|NCT02410863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25269282|NCT02410863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269283|NCT02410980|Tretinoin|tretinoin|mesh-list
25269284|NCT02410980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25269285|NCT02410980|Keratolytic Agents|keratolytic agents|mesh-ancestor
25045496|NCT00945802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25045497|NCT00945802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25045498|NCT00945802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045499|NCT00945802|Protease Inhibitors|protease inhibitors|mesh-ancestor
25045500|NCT00945802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045501|NCT00945802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045502|NCT00945802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25045503|NCT00945802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25045504|NCT00945802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25045505|NCT00945802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25045506|NCT00945802|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25045507|NCT00945802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25045508|NCT00945763|Ibuprofen|ibuprofen|mesh-list
25045509|NCT00945763|Meloxicam|meloxicam|mesh-list
25045510|NCT00945763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25045511|NCT00945763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25045512|NCT00945763|Analgesics|analgesics|mesh-ancestor
25045513|NCT00945763|Sensory System Agents|sensory system agents|mesh-ancestor
25045514|NCT00945763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045515|NCT00945763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045516|NCT00945763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25045517|NCT00945763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25045518|NCT00945763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25045519|NCT00945763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045520|NCT00945763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045521|NCT00945763|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25045522|NCT00945646|Dexamethasone|dexamethasone|mesh-list
25045523|NCT00945646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24832423|NCT02171507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832425|NCT02171507|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832426|NCT02171507|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832427|NCT02171507|Anticoagulants|anticoagulants|mesh-ancestor
25269286|NCT02410980|Dermatologic Agents|dermatologic agents|mesh-ancestor
25269287|NCT02410759|Carbetocin|carbetocin|mesh-list
25269289|NCT02410759|Oxytocics|oxytocics|mesh-ancestor
25269290|NCT02410759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25269291|NCT02410759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269292|NCT02410694|Thalidomide|thalidomide|mesh-list
25269293|NCT02410694|Dexamethasone|dexamethasone|mesh-list
25269294|NCT02410694|Ixazomib|ixazomib|mesh-list
25269295|NCT02410694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24772547|NCT01834235|Paclitaxel|paclitaxel|mesh-list
25674911|NCT01777997|Tenofovir|tenofovir|mesh-list
25674912|NCT01777997|Emtricitabine|emtricitabine|mesh-list
25674913|NCT01777997|Rilpivirine|rilpivirine|mesh-list
25674914|NCT01777997|Antiviral Agents|antiviral agents|mesh-ancestor
24591032|NCT00914693|Estrogens|estrogens|mesh-ancestor
25674915|NCT01777997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25674916|NCT01777997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24561262|NCT00759200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24561263|NCT00759200|Immunologic Factors|immunologic factors|mesh-ancestor
25674917|NCT01777997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25674918|NCT01777997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674919|NCT01777997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674920|NCT01777997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24561264|NCT00759200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561265|NCT00759226|Leucovorin|leucovorin|mesh-list
24561266|NCT00759226|Folic Acid|folic acid|mesh-list
24561267|NCT00759226|Gemcitabine|gemcitabine|mesh-list
25243014|NCT05357820|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25243015|NCT05357820|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25269296|NCT02410694|Antiemetics|antiemetics|mesh-ancestor
25269297|NCT02410694|Autonomic Agents|autonomic agents|mesh-ancestor
25269298|NCT02410694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25269299|NCT02410694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269300|NCT02410694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25269301|NCT02410694|Glucocorticoids|glucocorticoids|mesh-ancestor
25269302|NCT02410694|Hormones|hormones|mesh-ancestor
25269303|NCT02410694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25269304|NCT02410694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25269306|NCT02410694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25269307|NCT02410694|Immunologic Factors|immunologic factors|mesh-ancestor
25269308|NCT02410694|Leprostatic Agents|leprostatic agents|mesh-ancestor
25269309|NCT02410694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25269310|NCT02410694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25269311|NCT02410694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25269312|NCT02410694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25269313|NCT02410694|Growth Substances|growth substances|mesh-ancestor
25269314|NCT02410694|Growth Inhibitors|growth inhibitors|mesh-ancestor
25269315|NCT02410694|Protease Inhibitors|protease inhibitors|mesh-ancestor
25269316|NCT02410694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25269317|NCT02410694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269318|NCT02410746|Ibuprofen|ibuprofen|mesh-list
25269319|NCT02410746|Morphine|morphine|mesh-list
24832428|NCT02171520|Dabigatran|dabigatran|mesh-list
24832429|NCT02171520|Antithrombins|antithrombins|mesh-ancestor
24464568|NCT00365339|Antidepressive Agents|antidepressive agents|mesh-ancestor
24698571|NCT01441947|Fulvestrant|fulvestrant|mesh-list
24449301|NCT00314977|Immunologic Factors|immunologic factors|mesh-ancestor
24449302|NCT00314977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449303|NCT00314977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24449304|NCT00314977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24449305|NCT00314977|Alkylating Agents|alkylating agents|mesh-ancestor
24449306|NCT00314977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449307|NCT00314977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449308|NCT00314977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24449309|NCT00314977|Tubulin Modulators|tubulin modulators|mesh-ancestor
24449310|NCT00314977|Antimitotic Agents|antimitotic agents|mesh-ancestor
24449311|NCT00314977|Mitosis Modulators|mitosis modulators|mesh-ancestor
25674921|NCT01777997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25674922|NCT01778010|Cocaine|cocaine|mesh-list
25674923|NCT01778010|Modafinil|modafinil|mesh-list
25674924|NCT01778010|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25674925|NCT01778010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674926|NCT01778010|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25674927|NCT01778010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25674928|NCT01778010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25674929|NCT01778010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561404|NCT00760032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561405|NCT00760032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24561410|NCT00760045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24561411|NCT00760045|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24561412|NCT00760045|Immunologic Factors|immunologic factors|mesh-ancestor
24772694|NCT01835067|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24772695|NCT01835067|Plasminogen|plasminogen|mesh-list
25269320|NCT02410746|Levobupivacaine|levobupivacaine|mesh-list
25269321|NCT02410746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25269322|NCT02410746|Narcotics|narcotics|mesh-ancestor
25269323|NCT02410746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25269324|NCT02410746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772696|NCT01835067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24967146|NCT03762538|Anesthetics|anesthetics|mesh-ancestor
25279167|NCT02346110|Epinephryl borate|epinephryl borate|mesh-list
25674930|NCT01778010|Anesthetics, Local|anesthetics, local|mesh-ancestor
25674931|NCT01778010|Anesthetics|anesthetics|mesh-ancestor
25674932|NCT01778010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25674933|NCT01778010|Sensory System Agents|sensory system agents|mesh-ancestor
25674934|NCT01778010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25674935|NCT01778010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24561634|NCT00761722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24561635|NCT00761722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24561636|NCT00761852|Ruboxistaurin|ruboxistaurin|mesh-list
25269328|NCT02410746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25269329|NCT02410746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25269330|NCT02410746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25269331|NCT02410746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25269332|NCT02410746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25269333|NCT02410746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25269334|NCT02410746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269335|NCT02410746|Anesthetics, Local|anesthetics, local|mesh-ancestor
25269336|NCT02410746|Anesthetics|anesthetics|mesh-ancestor
25275475|NCT02372357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275477|NCT02372357|Hormone Antagonists|hormone antagonists|mesh-ancestor
25275478|NCT02372357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25275479|NCT02372357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832464|NCT02171546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24832465|NCT02171546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772817|NCT01836016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25674936|NCT01778010|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25674937|NCT01778010|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25674938|NCT01778010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24562054|NCT00764413|Prednisolone|prednisolone|mesh-list
24832484|NCT02171559|Anticoagulants|anticoagulants|mesh-ancestor
24832485|NCT02171559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24832486|NCT02171559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24832487|NCT02171559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832488|NCT02171559|Antithrombins|antithrombins|mesh-ancestor
24832489|NCT02171559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24449319|NCT00314990|Hydroxocobalamin|hydroxocobalamin|mesh-list
24449321|NCT00314990|Vitamin B Complex|vitamin b complex|mesh-ancestor
24449323|NCT00314990|Micronutrients|micronutrients|mesh-ancestor
24449324|NCT00314990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449325|NCT00315003|Azithromycin|azithromycin|mesh-list
24449326|NCT00315003|Telithromycin|telithromycin|mesh-list
24449327|NCT00315003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24449328|NCT00315003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24449330|NCT00315016|Fosinopril|fosinopril|mesh-list
24832490|NCT02171559|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832491|NCT02171559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832492|NCT02171572|Dabigatran|dabigatran|mesh-list
24832493|NCT02171572|Antithrombins|antithrombins|mesh-ancestor
24832494|NCT02171572|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832495|NCT02171572|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832496|NCT02171572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737094|NCT01666678|Antiemetics|antiemetics|mesh-ancestor
24449331|NCT00315016|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24449332|NCT00315016|Hormone Antagonists|hormone antagonists|mesh-ancestor
24449333|NCT00315016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24449356|NCT00315081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269341|NCT02410590|Neostigmine|neostigmine|mesh-list
25269342|NCT02410590|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25269343|NCT02410590|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25269344|NCT02410590|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25269345|NCT02410590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25269346|NCT02410590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269347|NCT02410590|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25269348|NCT02410590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25269349|NCT02410590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25269350|NCT02410590|Autonomic Agents|autonomic agents|mesh-ancestor
25269351|NCT02410590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25269352|NCT02410590|Respiratory System Agents|respiratory system agents|mesh-ancestor
25269353|NCT02410590|Mydriatics|mydriatics|mesh-ancestor
25269354|NCT02410590|Parasympatholytics|parasympatholytics|mesh-ancestor
25269355|NCT02410590|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25269356|NCT02410590|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25269357|NCT02410590|Cholinergic Agents|cholinergic agents|mesh-ancestor
25269358|NCT02410590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25269359|NCT02410590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449358|NCT00315185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24449359|NCT00315185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25674939|NCT01778010|Dopamine Agents|dopamine agents|mesh-ancestor
25674940|NCT01778010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25674941|NCT01778049|Empagliflozin|empagliflozin|mesh-list
25674942|NCT01778049|Linagliptin|linagliptin|mesh-list
25674943|NCT01778049|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25674944|NCT01778049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25674945|NCT01778049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25674946|NCT01778049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449360|NCT00315211|Docetaxel|docetaxel|mesh-list
24449361|NCT00315211|Topotecan|topotecan|mesh-list
24449362|NCT00315211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449363|NCT00315211|Tubulin Modulators|tubulin modulators|mesh-ancestor
24449370|NCT00315276|Modafinil|modafinil|mesh-list
25269360|NCT02410590|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25269361|NCT02410590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25269362|NCT02410590|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25269363|NCT02410590|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
25269364|NCT02410720|Picosulfate sodium|picosulfate sodium|mesh-list
25269365|NCT02410720|Cathartics|cathartics|mesh-ancestor
25269366|NCT02410720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25269367|NCT02410655|Oxytocin|oxytocin|mesh-list
25269368|NCT02410655|Oxytocics|oxytocics|mesh-ancestor
25269369|NCT02410655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25269370|NCT02410655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269371|NCT02410499|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25269372|NCT02410499|Immunologic Factors|immunologic factors|mesh-ancestor
25269373|NCT02410499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269374|NCT02410460|Lidocaine|lidocaine|mesh-list
25269375|NCT02410460|Clonidine|clonidine|mesh-list
25269376|NCT02410460|Midazolam|midazolam|mesh-list
25269377|NCT02410460|Glycopyrrolate|glycopyrrolate|mesh-list
25269378|NCT02410460|Scopolamine|scopolamine|mesh-list
24563069|NCT00769873|Anticoagulants|anticoagulants|mesh-ancestor
24563070|NCT00769873|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24563071|NCT00769873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24563072|NCT00769873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563073|NCT00769990|Genistein|genistein|mesh-list
24563074|NCT00769990|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24563075|NCT00769990|Protective Agents|protective agents|mesh-ancestor
25008584|NCT05047939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25008585|NCT05047939|Anesthetics, General|anesthetics, general|mesh-ancestor
25008586|NCT05047939|Anesthetics|anesthetics|mesh-ancestor
24781256|NCT01888744|Ganirelix|ganirelix|mesh-list
25008598|NCT04947059|Gemcitabine|gemcitabine|mesh-list
25008599|NCT04947059|Epirubicin|epirubicin|mesh-list
25008600|NCT04947059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24832504|NCT02171585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832505|NCT02171585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832506|NCT02171585|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24832507|NCT02171585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24832508|NCT02171585|Antithrombins|antithrombins|mesh-ancestor
24832509|NCT02171585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24737234|NCT01667718|Ofloxacin|ofloxacin|mesh-list
24698835|NCT01443104|Sirolimus|sirolimus|mesh-list
24832510|NCT02171585|Protease Inhibitors|protease inhibitors|mesh-ancestor
25269379|NCT02410460|Ketamine|ketamine|mesh-list
25269380|NCT02410460|Ondansetron|ondansetron|mesh-list
25269381|NCT02410460|Metoclopramide|metoclopramide|mesh-list
25269382|NCT02410460|Bupivacaine|bupivacaine|mesh-list
25269383|NCT02410460|Propofol|propofol|mesh-list
25269384|NCT02410460|Sevoflurane|sevoflurane|mesh-list
25269385|NCT02410460|Desflurane|desflurane|mesh-list
25269386|NCT02410460|Famotidine|famotidine|mesh-list
25269387|NCT02410460|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25674947|NCT01778049|Incretins|incretins|mesh-ancestor
25674948|NCT01778049|Hormones|hormones|mesh-ancestor
25674949|NCT01778049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25674950|NCT01778049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25674951|NCT01778049|Protease Inhibitors|protease inhibitors|mesh-ancestor
25674952|NCT01778049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674953|NCT01778465|Salicylic Acid|salicylic acid|mesh-list
25674954|NCT01778465|Salicylates|salicylates|mesh-list
25674955|NCT01778465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25674956|NCT01778465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25674957|NCT01778465|Analgesics|analgesics|mesh-ancestor
25674958|NCT01778465|Sensory System Agents|sensory system agents|mesh-ancestor
25674959|NCT01778465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25674960|NCT01778465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269388|NCT02410460|Anesthetics, Local|anesthetics, local|mesh-ancestor
25269389|NCT02410460|Anesthetics|anesthetics|mesh-ancestor
25008628|NCT04908475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25008629|NCT04908475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25008630|NCT04908475|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25008631|NCT04908475|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25008632|NCT04908475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25269390|NCT02410460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25269391|NCT02410460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269392|NCT02410460|Sensory System Agents|sensory system agents|mesh-ancestor
25269393|NCT02410460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25269394|NCT02410460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25275480|NCT02372149|Immunoglobulins|immunoglobulins|mesh-list
24832518|NCT02171598|Purinergic Agents|purinergic agents|mesh-ancestor
24832519|NCT02171598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24832520|NCT02171598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832521|NCT02171598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832522|NCT02171598|Antithrombins|antithrombins|mesh-ancestor
24484065|NCT00446420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24832553|NCT02171637|Afatinib|afatinib|mesh-list
25674961|NCT01778465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25674962|NCT01778465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25674963|NCT01778465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25674964|NCT01778465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674965|NCT01778465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832556|NCT02171637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832557|NCT02171637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269395|NCT02410460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25269396|NCT02410460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25269412|NCT02410460|GABA Agents|gaba agents|mesh-ancestor
24832558|NCT02171650|Afatinib|afatinib|mesh-list
24832559|NCT02171650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24832560|NCT02171650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24832561|NCT02171650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832562|NCT02171650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832581|NCT02171689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832582|NCT02171702|Afatinib|afatinib|mesh-list
24832583|NCT02171702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24832584|NCT02171702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24484083|NCT00446472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24832585|NCT02171702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832586|NCT02171702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832587|NCT02171715|Afatinib|afatinib|mesh-list
24832588|NCT02171715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24590688|NCT00913588|Fluoxetine|fluoxetine|mesh-list
24832592|NCT02171728|Afatinib|afatinib|mesh-list
24832593|NCT02171728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24832594|NCT02171728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24449410|NCT00315523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449429|NCT00315549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25269397|NCT02410460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25269398|NCT02410460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269399|NCT02410460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25269400|NCT02410460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24467850|NCT00378937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467852|NCT00378937|Sensory System Agents|sensory system agents|mesh-ancestor
24467853|NCT00378937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24467854|NCT00378937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24467855|NCT00378937|Antipyretics|antipyretics|mesh-ancestor
24467856|NCT00378937|Antitussive Agents|antitussive agents|mesh-ancestor
24467857|NCT00378937|Respiratory System Agents|respiratory system agents|mesh-ancestor
24699054|NCT01444612|PENTA|penta|mesh-list
25081133|NCT03332719|Antimetabolites|antimetabolites|mesh-ancestor
24832656|NCT02171910|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24832657|NCT02171910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269401|NCT02410460|Anesthetics, General|anesthetics, general|mesh-ancestor
25269402|NCT02410460|Analgesics|analgesics|mesh-ancestor
25269403|NCT02410460|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24773126|NCT01837628|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25269404|NCT02410460|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25269405|NCT02410460|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25269406|NCT02410460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25269407|NCT02410460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25269408|NCT02410460|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25269409|NCT02410460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25269410|NCT02410460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25269411|NCT02410460|GABA Modulators|gaba modulators|mesh-ancestor
24467915|NCT00379041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24467916|NCT00379041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467917|NCT00379041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467918|NCT00379041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24467925|NCT00379041|Tubulin Modulators|tubulin modulators|mesh-ancestor
24467926|NCT00379041|Antimitotic Agents|antimitotic agents|mesh-ancestor
24467927|NCT00379041|Mitosis Modulators|mitosis modulators|mesh-ancestor
24467928|NCT00379041|Alkylating Agents|alkylating agents|mesh-ancestor
24467929|NCT00379041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24467931|NCT00379067|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24467950|NCT00379262|Fluorouracil|fluorouracil|mesh-list
24467951|NCT00379262|Capecitabine|capecitabine|mesh-list
24467952|NCT00379262|Antimetabolites|antimetabolites|mesh-ancestor
25269413|NCT02410460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25269414|NCT02410460|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25269415|NCT02410460|Antiemetics|antiemetics|mesh-ancestor
25269416|NCT02410460|Autonomic Agents|autonomic agents|mesh-ancestor
25269417|NCT02410460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25269418|NCT02410460|Antipruritics|antipruritics|mesh-ancestor
25269419|NCT02410460|Dermatologic Agents|dermatologic agents|mesh-ancestor
25269420|NCT02410460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25269421|NCT02410460|Serotonin Agents|serotonin agents|mesh-ancestor
25269422|NCT02410460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25269423|NCT02410460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25269424|NCT02410460|Sympatholytics|sympatholytics|mesh-ancestor
25269425|NCT02410460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25269426|NCT02410460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25269427|NCT02410460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25269428|NCT02410460|Adrenergic Agents|adrenergic agents|mesh-ancestor
25269429|NCT02410460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25269433|NCT02410460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25269434|NCT02410460|Cholinergic Agents|cholinergic agents|mesh-ancestor
25269435|NCT02410460|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25269436|NCT02410460|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25269437|NCT02410460|Histamine Antagonists|histamine antagonists|mesh-ancestor
25269439|NCT02410460|Mydriatics|mydriatics|mesh-ancestor
24445132|NCT00300508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25269440|NCT02410460|Parasympatholytics|parasympatholytics|mesh-ancestor
25269441|NCT02410226|Anesthetics|anesthetics|mesh-list
25269442|NCT02410226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25269443|NCT02410226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269444|NCT02410031|Cyproterone Acetate|cyproterone acetate|mesh-list
25269445|NCT02410031|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24467953|NCT00379262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467954|NCT00379262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24467955|NCT00379262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467956|NCT00379262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24467957|NCT00379262|Immunologic Factors|immunologic factors|mesh-ancestor
24832670|NCT02171988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832671|NCT02171988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24832672|NCT02171988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24832673|NCT02171988|Vasodilator Agents|vasodilator agents|mesh-ancestor
24832674|NCT02171988|Sympatholytics|sympatholytics|mesh-ancestor
24699207|NCT01445418|Carboplatin|carboplatin|mesh-list
24465099|NCT00367913|Rifampin|rifampin|mesh-list
24465100|NCT00367913|Ethambutol|ethambutol|mesh-list
24699248|NCT01445639|Adrenergic Agents|adrenergic agents|mesh-ancestor
25674966|NCT01778465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25269446|NCT02410031|Cyproterone|cyproterone|mesh-list
25269447|NCT02410031|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
24563947|NCT00774501|Anesthetics|anesthetics|mesh-list
24563948|NCT00774501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24563949|NCT00774501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563950|NCT00774527|Cyclophosphamide|cyclophosphamide|mesh-list
24563985|NCT00774644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24891763|NCT04467931|Trandolapril|trandolapril|mesh-list
25269448|NCT02410031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25269449|NCT02410031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25269450|NCT02410031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24467959|NCT00379405|Ritonavir|ritonavir|mesh-list
24467960|NCT00379405|Saquinavir|saquinavir|mesh-list
24467961|NCT00379405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24467962|NCT00379405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24467963|NCT00379405|Protease Inhibitors|protease inhibitors|mesh-ancestor
24467964|NCT00379405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467973|NCT00379418|Anticoagulants|anticoagulants|mesh-ancestor
24564607|NCT00776841|Cholic Acids|cholic acids|mesh-list
25269451|NCT02410031|Contraceptive Agents|contraceptive agents|mesh-ancestor
25269452|NCT02410031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25269453|NCT02410031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269454|NCT02410031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25269455|NCT02410031|Estrogens|estrogens|mesh-ancestor
25269456|NCT02410031|Hormones|hormones|mesh-ancestor
25269457|NCT02410031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25269458|NCT02410031|Androgen Antagonists|androgen antagonists|mesh-ancestor
25269459|NCT02410031|Hormone Antagonists|hormone antagonists|mesh-ancestor
25269460|NCT02410031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25269461|NCT02410031|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25269462|NCT02410096|Methacholine Chloride|methacholine chloride|mesh-list
25269463|NCT02410096|Miotics|miotics|mesh-ancestor
25269464|NCT02410096|Autonomic Agents|autonomic agents|mesh-ancestor
25269465|NCT02410096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25269466|NCT02410096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269467|NCT02410096|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25269468|NCT02410096|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
25269469|NCT02410096|Respiratory System Agents|respiratory system agents|mesh-ancestor
25269470|NCT02410096|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25269471|NCT02410096|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25269472|NCT02410096|Cholinergic Agents|cholinergic agents|mesh-ancestor
25269473|NCT02410096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25269474|NCT02410096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269475|NCT02410317|Morphine|morphine|mesh-list
25269476|NCT02410317|Ropivacaine|ropivacaine|mesh-list
25269477|NCT02410317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25269478|NCT02410317|Narcotics|narcotics|mesh-ancestor
25269479|NCT02410317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24773343|NCT01839149|Oxytocics|oxytocics|mesh-ancestor
25269480|NCT02410317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269481|NCT02410317|Analgesics|analgesics|mesh-ancestor
25269482|NCT02410317|Sensory System Agents|sensory system agents|mesh-ancestor
25269483|NCT02410317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25269484|NCT02410317|Anesthetics, Local|anesthetics, local|mesh-ancestor
25269485|NCT02410317|Anesthetics|anesthetics|mesh-ancestor
25674967|NCT01778465|Antifungal Agents|antifungal agents|mesh-ancestor
25674968|NCT01778465|Keratolytic Agents|keratolytic agents|mesh-ancestor
25674969|NCT01778465|Dermatologic Agents|dermatologic agents|mesh-ancestor
25674970|NCT01778634|Azithromycin|azithromycin|mesh-list
25674971|NCT01778634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25269486|NCT02410083|Aspirin|aspirin|mesh-list
25674972|NCT01778634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25674973|NCT01778985|Estrogens|estrogens|mesh-list
25674974|NCT01778985|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25674975|NCT01778985|Hormones|hormones|mesh-ancestor
25674976|NCT01778985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25674977|NCT01778985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674978|NCT01779167|Thalidomide|thalidomide|mesh-list
25674979|NCT01779167|Rituximab|rituximab|mesh-list
25674980|NCT01779167|Lenalidomide|lenalidomide|mesh-list
25674981|NCT01779167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25674982|NCT01779167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25674983|NCT01779167|Immunologic Factors|immunologic factors|mesh-ancestor
25674984|NCT01779167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243145|NCT05356169|Venetoclax|venetoclax|mesh-list
25269487|NCT02410083|Clopidogrel|clopidogrel|mesh-list
24468269|NCT00380887|Estrogens|estrogens|mesh-ancestor
25269493|NCT02410083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269494|NCT02410083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25269495|NCT02410083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25269496|NCT02410083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25269497|NCT02410083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24941648|NCT03989089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24832718|NCT02172131|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24832719|NCT02172131|Autonomic Agents|autonomic agents|mesh-ancestor
24773422|NCT01839552|Anesthetics, General|anesthetics, general|mesh-ancestor
24832731|NCT02172144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832732|NCT02172144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24832733|NCT02172144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832734|NCT02172144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24449487|NCT00315835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24449488|NCT00315848|Buprenorphine|buprenorphine|mesh-list
25269498|NCT02410083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468256|NCT00380770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24468258|NCT00380770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24468259|NCT00380770|Antimetabolites|antimetabolites|mesh-ancestor
24468261|NCT00380822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25674985|NCT01779167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24564055|NCT00774982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24564056|NCT00774982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24564102|NCT00775125|Darunavir|darunavir|mesh-list
24564103|NCT00775125|Fosamprenavir|fosamprenavir|mesh-list
24468262|NCT00380822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468263|NCT00380822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24468264|NCT00380822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941655|NCT03989037|Mitosis Modulators|mitosis modulators|mesh-ancestor
24449489|NCT00315848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24449490|NCT00315848|Narcotics|narcotics|mesh-ancestor
24449491|NCT00315848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24449492|NCT00315848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449493|NCT00315848|Analgesics|analgesics|mesh-ancestor
24449499|NCT00315861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612965|NCT01016054|Antimetabolites|antimetabolites|mesh-ancestor
25269503|NCT02410083|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25269504|NCT02410083|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25269505|NCT02410083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25269506|NCT02410083|Purinergic Agents|purinergic agents|mesh-ancestor
25269507|NCT02410083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25269508|NCT02410005|Calcitriol|calcitriol|mesh-list
25269509|NCT02410005|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
25269510|NCT02410005|Losartan|losartan|mesh-list
25269511|NCT02410005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25269513|NCT02410005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25674986|NCT01779167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25674987|NCT01779167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25674988|NCT01779167|Growth Substances|growth substances|mesh-ancestor
25674989|NCT01779167|Growth Inhibitors|growth inhibitors|mesh-ancestor
25674990|NCT01779167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25674991|NCT01779167|Leprostatic Agents|leprostatic agents|mesh-ancestor
25674992|NCT01779167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24468266|NCT00380835|Amrubicin|amrubicin|mesh-list
24468267|NCT00380835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24564176|NCT00775372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24564180|NCT00775489|Hormones|hormones|mesh-ancestor
24564181|NCT00775489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24564182|NCT00775489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564183|NCT00775489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24564184|NCT00775489|Respiratory System Agents|respiratory system agents|mesh-ancestor
24832749|NCT02172170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24832750|NCT02172170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832751|NCT02172196|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24832752|NCT02172196|Empagliflozin|empagliflozin|mesh-list
24832753|NCT02172196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24773489|NCT01839929|Tacrolimus|tacrolimus|mesh-list
25674993|NCT01779167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25674994|NCT01779375|Metformin|metformin|mesh-list
25674995|NCT01779375|Insulin Glargine|insulin glargine|mesh-list
25674996|NCT01779375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25674997|NCT01779375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25674998|NCT01779700|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25674999|NCT01779700|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25675000|NCT01779700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243179|NCT05355610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25243180|NCT05355610|Antiemetics|antiemetics|mesh-ancestor
24449512|NCT00315874|Sensory System Agents|sensory system agents|mesh-ancestor
24449513|NCT00315874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24449514|NCT00315874|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25269514|NCT02410005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25269515|NCT02410005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468268|NCT00380887|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24468270|NCT00380887|Hormones|hormones|mesh-ancestor
24468305|NCT00381017|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24468306|NCT00381017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468307|NCT00381017|Antiviral Agents|antiviral agents|mesh-ancestor
24941669|NCT03989024|Hormones|hormones|mesh-ancestor
24565704|NCT00782041|Leucovorin|leucovorin|mesh-list
25675001|NCT01779700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25675002|NCT01779700|Immunologic Factors|immunologic factors|mesh-ancestor
24449552|NCT00315926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449553|NCT00315926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25269516|NCT02410005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25269517|NCT02410005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269518|NCT02410005|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25269519|NCT02410005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25269520|NCT02410005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25269521|NCT02410005|Vitamins|vitamins|mesh-ancestor
24468308|NCT00381017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24468309|NCT00381017|Immunologic Factors|immunologic factors|mesh-ancestor
24468310|NCT00381017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468311|NCT00381030|Carvedilol|carvedilol|mesh-list
24449554|NCT00315965|Nitric Oxide|nitric oxide|mesh-list
24832805|NCT02172274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832806|NCT02172287|Tiotropium Bromide|tiotropium bromide|mesh-list
24832807|NCT02172287|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24832808|NCT02172287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24832809|NCT02172287|Autonomic Agents|autonomic agents|mesh-ancestor
24832810|NCT02172287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24832811|NCT02172287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773714|NCT01841424|Sensory System Agents|sensory system agents|mesh-ancestor
24699780|NCT01448993|Azithromycin|azithromycin|mesh-list
25675004|NCT01779869|Regadenoson|regadenoson|mesh-list
25675005|NCT01779869|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25675006|NCT01779869|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24564370|NCT00776113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564371|NCT00776113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24564372|NCT00776113|Antioxidants|antioxidants|mesh-ancestor
24564373|NCT00776113|Protective Agents|protective agents|mesh-ancestor
25269522|NCT02410005|Micronutrients|micronutrients|mesh-ancestor
25269523|NCT02410005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25269524|NCT02410135|Mirabegron|mirabegron|mesh-list
24967299|NCT03760809|Dexmedetomidine|dexmedetomidine|mesh-list
25269525|NCT02410135|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25269526|NCT02410135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25269527|NCT02410135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25269528|NCT02410135|Adrenergic Agents|adrenergic agents|mesh-ancestor
25269529|NCT02410135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25269530|NCT02410135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786079|NCT01917877|Antiemetics|antiemetics|mesh-ancestor
24456920|NCT00332631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456921|NCT00332631|Protective Agents|protective agents|mesh-ancestor
24941686|NCT03988530|Mydriatics|mydriatics|mesh-ancestor
24832817|NCT02172287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24832818|NCT02172287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081223|NCT03332316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24832819|NCT02172287|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24832820|NCT02172287|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24832821|NCT02172287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24832822|NCT02172287|Adrenergic Agents|adrenergic agents|mesh-ancestor
25675007|NCT01779869|Purinergic Agonists|purinergic agonists|mesh-ancestor
25675008|NCT01779869|Purinergic Agents|purinergic agents|mesh-ancestor
25675009|NCT01779869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25675010|NCT01779869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269531|NCT02410135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269532|NCT02410135|Urological Agents|urological agents|mesh-ancestor
25269534|NCT02409849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25269535|NCT02409849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25269536|NCT02409849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25269537|NCT02409823|Antipsychotic Agents|antipsychotic agents|mesh-list
25269538|NCT02409823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25269539|NCT02409823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25269540|NCT02409823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269541|NCT02409823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25269542|NCT02409862|Oxytocin|oxytocin|mesh-list
25269543|NCT02409862|Oxytocics|oxytocics|mesh-ancestor
24468423|NCT00381511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24468424|NCT00381511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468425|NCT00381537|Carbamazepine|carbamazepine|mesh-list
24468426|NCT00381537|Phenobarbital|phenobarbital|mesh-list
24423573|NCT00226356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24468783|NCT00383396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24468784|NCT00383396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468785|NCT00383396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24468786|NCT00383396|Immunologic Factors|immunologic factors|mesh-ancestor
24468858|NCT00383799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24468859|NCT00383799|Vasodilator Agents|vasodilator agents|mesh-ancestor
24468860|NCT00383799|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24468861|NCT00383799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24468862|NCT00383799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269544|NCT02409862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25269545|NCT02409862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269546|NCT02409641|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25269547|NCT02409641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25269548|NCT02409498|Bupivacaine|bupivacaine|mesh-list
25269549|NCT02409498|Anesthetics, Local|anesthetics, local|mesh-ancestor
25269550|NCT02409498|Anesthetics|anesthetics|mesh-ancestor
24620735|NCT01058824|Lincomycin|lincomycin|mesh-list
25269551|NCT02409498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25269552|NCT02409498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269553|NCT02409498|Sensory System Agents|sensory system agents|mesh-ancestor
25269554|NCT02409498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24564820|NCT00778011|Antipruritics|antipruritics|mesh-ancestor
24564821|NCT00778011|Dermatologic Agents|dermatologic agents|mesh-ancestor
24564822|NCT00778011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24564823|NCT00778011|Serotonin Agents|serotonin agents|mesh-ancestor
24564824|NCT00778011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24564825|NCT00778011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564826|NCT00778011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24564827|NCT00778011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24564828|NCT00778011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24564829|NCT00778011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25243271|NCT05354986|Povidone|povidone|mesh-list
25269555|NCT02409537|Resveratrol|resveratrol|mesh-list
25269556|NCT02409537|Antioxidants|antioxidants|mesh-ancestor
25269557|NCT02409537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269558|NCT02409537|Protective Agents|protective agents|mesh-ancestor
25269559|NCT02409537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269560|NCT02409537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25269561|NCT02409537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25269562|NCT02409407|Alprostadil|alprostadil|mesh-list
25269563|NCT02409407|Misoprostol|misoprostol|mesh-list
25269564|NCT02409407|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25269565|NCT02409407|Abortifacient Agents|abortifacient agents|mesh-ancestor
25269566|NCT02409407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25269567|NCT02409407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269568|NCT02409407|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25269569|NCT02409407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25269570|NCT02409407|Oxytocics|oxytocics|mesh-ancestor
25269571|NCT02409407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25269572|NCT02409407|Vasodilator Agents|vasodilator agents|mesh-ancestor
25269573|NCT02409407|Urological Agents|urological agents|mesh-ancestor
25269574|NCT02409563|Budesonide|budesonide|mesh-list
25269575|NCT02409563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25269576|NCT02409563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25269577|NCT02409563|Autonomic Agents|autonomic agents|mesh-ancestor
25269578|NCT02409563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24456924|NCT00332735|Bupivacaine|bupivacaine|mesh-list
24465680|NCT00370539|Growth Inhibitors|growth inhibitors|mesh-ancestor
25675011|NCT01779869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675012|NCT01780324|Lidocaine|lidocaine|mesh-list
25675013|NCT01780324|Anesthetics, Local|anesthetics, local|mesh-ancestor
25675014|NCT01780324|Anesthetics|anesthetics|mesh-ancestor
25675015|NCT01780324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25675016|NCT01780324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675017|NCT01780324|Sensory System Agents|sensory system agents|mesh-ancestor
25675018|NCT01780324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25675019|NCT01780324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25675020|NCT01780324|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25675021|NCT01780324|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25269587|NCT02409433|Anticonvulsants|anticonvulsants|mesh-ancestor
24832843|NCT02172326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24832844|NCT02172326|Cholinergic Agents|cholinergic agents|mesh-ancestor
24832847|NCT02172339|Tiotropium Bromide|tiotropium bromide|mesh-list
24451933|NCT00325325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24451934|NCT00325325|Immunologic Factors|immunologic factors|mesh-ancestor
24451935|NCT00325325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451936|NCT00325325|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24451937|NCT00325325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451938|NCT00325325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451939|NCT00325325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451940|NCT00325351|Carboplatin|carboplatin|mesh-list
24451941|NCT00325351|Sagopilone|sagopilone|mesh-list
25675025|NCT01780337|Oxytocics|oxytocics|mesh-ancestor
25675026|NCT01780337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25675027|NCT01780337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675028|NCT01780389|Milnacipran|milnacipran|mesh-list
25269602|NCT02409004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25269603|NCT02409004|Antitubercular Agents|antitubercular agents|mesh-ancestor
25269604|NCT02409004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24468929|NCT00383929|Candesartan|candesartan|mesh-list
24468930|NCT00383929|Candesartan cilexetil|candesartan cilexetil|mesh-list
24468931|NCT00383929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24468932|NCT00383929|Diuretics|diuretics|mesh-ancestor
24468933|NCT00383929|Natriuretic Agents|natriuretic agents|mesh-ancestor
24468934|NCT00383929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774099|NCT01843868|Prednisolone|prednisolone|mesh-list
24832874|NCT02172378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24832875|NCT02172378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832876|NCT02172378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24832877|NCT02172378|Respiratory System Agents|respiratory system agents|mesh-ancestor
25675033|NCT01780389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675034|NCT01780389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25675035|NCT01780389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675036|NCT01780389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25675037|NCT01780389|Analgesics|analgesics|mesh-ancestor
25675038|NCT01780389|Sensory System Agents|sensory system agents|mesh-ancestor
25675039|NCT01780389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25675040|NCT01780389|Antidepressive Agents|antidepressive agents|mesh-ancestor
25675041|NCT01780389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25675043|NCT01780454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25269606|NCT02409004|Leprostatic Agents|leprostatic agents|mesh-ancestor
25269607|NCT02409004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25269608|NCT02409004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25269609|NCT02409004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565468|NCT00780728|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24565470|NCT00780728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832884|NCT02172391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24590968|NCT00914498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24832885|NCT02172391|Autonomic Agents|autonomic agents|mesh-ancestor
24832886|NCT02172391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24832889|NCT02172391|Respiratory System Agents|respiratory system agents|mesh-ancestor
24832890|NCT02172391|Parasympatholytics|parasympatholytics|mesh-ancestor
24565473|NCT00780754|Dutasteride|dutasteride|mesh-list
24565474|NCT00780754|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24565475|NCT00780754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24565476|NCT00780754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565477|NCT00780754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565478|NCT00780754|Hormone Antagonists|hormone antagonists|mesh-ancestor
24565479|NCT00780754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24484467|NCT00448552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24469062|NCT00384527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24469063|NCT00384527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24469064|NCT00384527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24469066|NCT00384540|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24469067|NCT00384540|Sympathomimetics|sympathomimetics|mesh-ancestor
24469068|NCT00384540|Autonomic Agents|autonomic agents|mesh-ancestor
24469096|NCT00384566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24484535|NCT00449059|Nitroglycerin|nitroglycerin|mesh-list
24484536|NCT00449059|Vasodilator Agents|vasodilator agents|mesh-ancestor
24774306|NCT01845064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24832917|NCT02172417|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24832918|NCT02172417|Cholinergic Agents|cholinergic agents|mesh-ancestor
25675044|NCT01780454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675045|NCT01780454|Immunologic Factors|immunologic factors|mesh-ancestor
25675046|NCT01780454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675047|NCT01780454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24469100|NCT00384566|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24469101|NCT00384566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24469102|NCT00384566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24469103|NCT00384566|Vasodilator Agents|vasodilator agents|mesh-ancestor
24774309|NCT01845090|Calcium|calcium|mesh-list
24469104|NCT00384566|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24832928|NCT02172417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832929|NCT02172430|Tiotropium Bromide|tiotropium bromide|mesh-list
24832930|NCT02172430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24832931|NCT02172430|Autonomic Agents|autonomic agents|mesh-ancestor
24832932|NCT02172430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740849|NCT01690403|Leprostatic Agents|leprostatic agents|mesh-ancestor
25675048|NCT01780506|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25675049|NCT01780506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25675050|NCT01780506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25675051|NCT01780506|Antiviral Agents|antiviral agents|mesh-ancestor
25675052|NCT01780506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675053|NCT01780662|Gemcitabine|gemcitabine|mesh-list
25675054|NCT01780662|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25675061|NCT01780662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675062|NCT01780662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25675064|NCT01780662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675065|NCT01780662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675066|NCT01780662|Antiviral Agents|antiviral agents|mesh-ancestor
25675067|NCT01780662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675069|NCT01780662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25675078|NCT01780831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675079|NCT01780935|Ranibizumab|ranibizumab|mesh-list
25269660|NCT02409147|Hormones|hormones|mesh-ancestor
25269661|NCT02409147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25269662|NCT02409147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269663|NCT02409147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25269664|NCT02409147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25269665|NCT02409147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25269666|NCT02409147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25269667|NCT02409147|Analgesics|analgesics|mesh-ancestor
25269668|NCT02409147|Sensory System Agents|sensory system agents|mesh-ancestor
24833058|NCT02172547|Cholinergic Agents|cholinergic agents|mesh-ancestor
24833059|NCT02172547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24774619|NCT01846962|Fluticasone|fluticasone|mesh-list
25675087|NCT01780974|Antioxidants|antioxidants|mesh-ancestor
25675088|NCT01780974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675089|NCT01780974|Protective Agents|protective agents|mesh-ancestor
25675090|NCT01780974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675091|NCT01780974|Vitamin B Complex|vitamin b complex|mesh-ancestor
25675092|NCT01780974|Vitamins|vitamins|mesh-ancestor
25675093|NCT01780974|Micronutrients|micronutrients|mesh-ancestor
25675094|NCT01780987|Heparin|heparin|mesh-list
25675095|NCT01780987|Calcium heparin|calcium heparin|mesh-list
25675096|NCT01780987|Warfarin|warfarin|mesh-list
25675097|NCT01780987|Apixaban|apixaban|mesh-list
25675098|NCT01780987|Anticoagulants|anticoagulants|mesh-ancestor
24833109|NCT02172729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24833110|NCT02172729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269669|NCT02409147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25269670|NCT02409147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25269671|NCT02409147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25269672|NCT02409147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25269673|NCT02409147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269674|NCT02409147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25269675|NCT02409147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25269676|NCT02409147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24833112|NCT02172768|Antifungal Agents|antifungal agents|mesh-ancestor
24833113|NCT02172768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24833114|NCT02172781|Tiotropium Bromide|tiotropium bromide|mesh-list
24833115|NCT02172781|Ipratropium|ipratropium|mesh-list
24833116|NCT02172781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25675099|NCT01780987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25675100|NCT01780987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25675101|NCT01780987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675102|NCT01780987|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25675103|NCT01780987|Antithrombins|antithrombins|mesh-ancestor
24452196|NCT00326378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675109|NCT01781169|Micronutrients|micronutrients|mesh-ancestor
25675110|NCT01781169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008819|NCT04249258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25008820|NCT04249258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574869|NCT00828087|Trace Elements|trace elements|mesh-ancestor
24833232|NCT02173288|Diuretics|diuretics|mesh-ancestor
24833233|NCT02173288|Natriuretic Agents|natriuretic agents|mesh-ancestor
24833246|NCT02173288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24833247|NCT02173288|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24833248|NCT02173288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24833249|NCT02173288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25269692|NCT02409186|Antimitotic Agents|antimitotic agents|mesh-ancestor
25269693|NCT02409186|Mitosis Modulators|mitosis modulators|mesh-ancestor
24952542|NCT03893526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24952543|NCT03893435|Valsartan|valsartan|mesh-list
25067506|NCT03443492|Antimetabolites|antimetabolites|mesh-ancestor
25067507|NCT03443492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067508|NCT03443492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25067509|NCT03443492|Antiviral Agents|antiviral agents|mesh-ancestor
24952615|NCT03892928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24920855|NCT04197050|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24920856|NCT04197050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25269694|NCT02409186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269695|NCT02409186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25269696|NCT02408978|Naproxen|naproxen|mesh-list
25269697|NCT02408978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25269698|NCT02408978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25269699|NCT02408978|Analgesics|analgesics|mesh-ancestor
25269700|NCT02408978|Sensory System Agents|sensory system agents|mesh-ancestor
25269701|NCT02408978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25269702|NCT02408978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469578|NCT00386412|Valganciclovir|valganciclovir|mesh-list
24469579|NCT00386412|Antiviral Agents|antiviral agents|mesh-ancestor
24469580|NCT00386412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24469581|NCT00386503|Artesunate|artesunate|mesh-list
24469582|NCT00386503|Amodiaquine|amodiaquine|mesh-list
24833250|NCT02173288|Adrenergic Agents|adrenergic agents|mesh-ancestor
24833251|NCT02173288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24833252|NCT02173418|Ropivacaine|ropivacaine|mesh-list
24833253|NCT02173418|Anesthetics, Local|anesthetics, local|mesh-ancestor
24833254|NCT02173418|Anesthetics|anesthetics|mesh-ancestor
24634176|NCT01132235|Analgesics|analgesics|mesh-ancestor
24833263|NCT02173457|Hormones|hormones|mesh-ancestor
24742548|NCT05236608|Nivolumab|nivolumab|mesh-list
25675111|NCT01781169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25675112|NCT01781234|Insulin|insulin|mesh-list
25279169|NCT02346110|Antiemetics|antiemetics|mesh-ancestor
25675113|NCT01781234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25675114|NCT01781234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675115|NCT01781403|Capecitabine|capecitabine|mesh-list
25675116|NCT01781403|Temozolomide|temozolomide|mesh-list
25675117|NCT01781403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25675118|NCT01781403|Antimetabolites|antimetabolites|mesh-ancestor
25692344|NCT01998919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675121|NCT01781403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25675123|NCT01781468|Modafinil|modafinil|mesh-list
25675124|NCT01781468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25675125|NCT01781468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833277|NCT02173639|Protease Inhibitors|protease inhibitors|mesh-ancestor
25675128|NCT01781468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25675129|NCT01781468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675131|NCT01781611|Dipyridamole|dipyridamole|mesh-list
25243712|NCT05246943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24469618|NCT00386555|Crenolanib|crenolanib|mesh-list
24469619|NCT00386555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469620|NCT00386555|Tubulin Modulators|tubulin modulators|mesh-ancestor
24469621|NCT00386555|Antimitotic Agents|antimitotic agents|mesh-ancestor
24469622|NCT00386555|Mitosis Modulators|mitosis modulators|mesh-ancestor
24469682|NCT00386763|Lumefantrine|lumefantrine|mesh-list
24833337|NCT02173730|Pantoprazole|pantoprazole|mesh-list
24833338|NCT02173730|Dabigatran|dabigatran|mesh-list
24833339|NCT02173730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24833340|NCT02173730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24833341|NCT02173730|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24771910|NCT01830491|Aspirin|aspirin|mesh-list
24833342|NCT02173730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24833343|NCT02173730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833344|NCT02173730|Antithrombins|antithrombins|mesh-ancestor
24833345|NCT02173730|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24833346|NCT02173730|Protease Inhibitors|protease inhibitors|mesh-ancestor
24833347|NCT02173730|Anticoagulants|anticoagulants|mesh-ancestor
24833348|NCT02173756|Morphine|morphine|mesh-list
24833349|NCT02173756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24452232|NCT00326456|Mitosis Modulators|mitosis modulators|mesh-ancestor
24452233|NCT00326456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452234|NCT00326456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24452244|NCT00326586|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
24452246|NCT00326586|Hormone Antagonists|hormone antagonists|mesh-ancestor
25279170|NCT02346110|Autonomic Agents|autonomic agents|mesh-ancestor
25675132|NCT01781611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25675133|NCT01781611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25675134|NCT01781611|Analgesics|analgesics|mesh-ancestor
25675135|NCT01781611|Sensory System Agents|sensory system agents|mesh-ancestor
25675136|NCT01781611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25675137|NCT01781611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675138|NCT01781611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25675139|NCT01781611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25675140|NCT01781611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25675141|NCT01781611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25675142|NCT01781611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675143|NCT01781611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25675144|NCT01781611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25269715|NCT02408679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269716|NCT02408679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25269717|NCT02408705|Acetaminophen|acetaminophen|mesh-list
25269718|NCT02408705|Liraglutide|liraglutide|mesh-list
25269719|NCT02408705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25269720|NCT02408705|Analgesics|analgesics|mesh-ancestor
25269721|NCT02408705|Sensory System Agents|sensory system agents|mesh-ancestor
24469692|NCT00386802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24469693|NCT00386802|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24469694|NCT00386802|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24957836|NCT03840122|Sensory System Agents|sensory system agents|mesh-ancestor
24452300|NCT00327093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24452301|NCT00327093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24452304|NCT00327093|Growth Substances|growth substances|mesh-ancestor
24452305|NCT00327093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452306|NCT00327093|Growth Inhibitors|growth inhibitors|mesh-ancestor
24833422|NCT02173886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24833423|NCT02173886|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24833424|NCT02173886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24833425|NCT02173886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25675145|NCT01781611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675146|NCT01781611|Antipyretics|antipyretics|mesh-ancestor
25675147|NCT01781611|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25675148|NCT01781611|Vasodilator Agents|vasodilator agents|mesh-ancestor
25675150|NCT01781806|Emtricitabine|emtricitabine|mesh-list
25675151|NCT01781806|Antiviral Agents|antiviral agents|mesh-ancestor
25675152|NCT01781806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675153|NCT01781806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25675154|NCT01781806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25243798|NCT05219435|Ipilimumab|ipilimumab|mesh-list
25243799|NCT05219435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25243800|NCT05219435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25243801|NCT05219435|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25243802|NCT05219435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243803|NCT05213208|Propofol|propofol|mesh-list
25243804|NCT05213208|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25243805|NCT05213208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25243806|NCT05213208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243807|NCT05213208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25243808|NCT05213208|Anesthetics, General|anesthetics, general|mesh-ancestor
25243809|NCT05213208|Anesthetics|anesthetics|mesh-ancestor
24445703|NCT00302341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445704|NCT00302341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24445706|NCT00302341|Renal Agents|renal agents|mesh-ancestor
24833426|NCT02173886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833427|NCT02173886|Dopamine Agents|dopamine agents|mesh-ancestor
24833437|NCT02173912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24833438|NCT02173912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24833440|NCT02173912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24833441|NCT02173912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833442|NCT02173912|Vasodilator Agents|vasodilator agents|mesh-ancestor
24833443|NCT02173912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24833444|NCT02173912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24833446|NCT02173951|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24833447|NCT02173951|Chelating Agents|chelating agents|mesh-ancestor
24833448|NCT02173951|Sequestering Agents|sequestering agents|mesh-ancestor
24833449|NCT02173951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833452|NCT02173964|Anticonvulsants|anticonvulsants|mesh-ancestor
24833453|NCT02173964|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24833454|NCT02173964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24833455|NCT02173964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833456|NCT02173964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24833457|NCT02173964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833458|NCT02173964|Parasympatholytics|parasympatholytics|mesh-ancestor
24833459|NCT02173964|Autonomic Agents|autonomic agents|mesh-ancestor
24833460|NCT02173964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24833461|NCT02173990|Aflibercept|aflibercept|mesh-list
24833462|NCT02173990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24833463|NCT02173990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24833489|NCT02174120|Etomidate|etomidate|mesh-list
24833508|NCT02174172|Growth Substances|growth substances|mesh-ancestor
24833509|NCT02174172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833510|NCT02174172|Growth Inhibitors|growth inhibitors|mesh-ancestor
24833511|NCT02174172|Antiviral Agents|antiviral agents|mesh-ancestor
24833561|NCT02174328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269722|NCT02408705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25269723|NCT02408705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269724|NCT02408705|Antipyretics|antipyretics|mesh-ancestor
25269725|NCT02408705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25269726|NCT02408705|Incretins|incretins|mesh-ancestor
25067608|NCT03441841|Sensory System Agents|sensory system agents|mesh-ancestor
24469695|NCT00386802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24469696|NCT00386802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469697|NCT00386802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469698|NCT00386802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25675155|NCT01781806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675156|NCT01781806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675157|NCT01781806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25675158|NCT01781806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25675159|NCT01781975|Imatinib Mesylate|imatinib mesylate|mesh-list
25675160|NCT01781975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675161|NCT01781975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25675162|NCT01781975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675163|NCT01781975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675164|NCT01782131|Voriconazole|voriconazole|mesh-list
25675165|NCT01782131|Posaconazole|posaconazole|mesh-list
25675166|NCT01782131|Antifungal Agents|antifungal agents|mesh-ancestor
25675167|NCT01782131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675168|NCT01782131|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25675169|NCT01782131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25070991|NCT03414164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445754|NCT00302419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25243833|NCT05183139|Dexamethasone|dexamethasone|mesh-list
25243834|NCT05183139|Lenalidomide|lenalidomide|mesh-list
25243835|NCT05183139|Pomalidomide|pomalidomide|mesh-list
25243836|NCT05183139|Ixazomib|ixazomib|mesh-list
24469699|NCT00386802|Hormone Antagonists|hormone antagonists|mesh-ancestor
24469700|NCT00386802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24469701|NCT00386802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833562|NCT02174328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24833563|NCT02174328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24833565|NCT02174328|Antipyretics|antipyretics|mesh-ancestor
24833568|NCT02174445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24833569|NCT02174445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24833570|NCT02174445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833572|NCT02174575|Desflurane|desflurane|mesh-list
24833573|NCT02174575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24833574|NCT02174575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24833575|NCT02174575|Anesthetics, General|anesthetics, general|mesh-ancestor
24833576|NCT02174575|Anesthetics|anesthetics|mesh-ancestor
24833577|NCT02174575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24833578|NCT02174575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634984|NCT01136317|Omeprazole|omeprazole|mesh-list
24833629|NCT02174757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24833630|NCT02174757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24833633|NCT02174887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24833634|NCT02174887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24833635|NCT02174887|Tubulin Modulators|tubulin modulators|mesh-ancestor
24833636|NCT02174887|Antimitotic Agents|antimitotic agents|mesh-ancestor
24833646|NCT02174887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833647|NCT02174900|Lumefantrine|lumefantrine|mesh-list
24833648|NCT02174900|Artemether|artemether|mesh-list
24833649|NCT02174900|Primaquine|primaquine|mesh-list
24833650|NCT02174900|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24833651|NCT02174900|Antimalarials|antimalarials|mesh-ancestor
24833652|NCT02174900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24833653|NCT02174900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24833654|NCT02174900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24833655|NCT02174939|Cilostazol|cilostazol|mesh-list
24833656|NCT02174939|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24833657|NCT02174939|Autonomic Agents|autonomic agents|mesh-ancestor
24833658|NCT02174939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24833659|NCT02174939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833660|NCT02174939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24833661|NCT02174939|Respiratory System Agents|respiratory system agents|mesh-ancestor
24833662|NCT02174939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24833663|NCT02174939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24833707|NCT02175355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25675173|NCT01782131|Hormone Antagonists|hormone antagonists|mesh-ancestor
25675174|NCT01782131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25675175|NCT01782131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675176|NCT01782131|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25675177|NCT01782131|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25675178|NCT01782131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25675179|NCT01782131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25675180|NCT01782222|Rotigotine|rotigotine|mesh-list
25675181|NCT01782222|Dopamine Agonists|dopamine agonists|mesh-ancestor
24445801|NCT00302627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24445802|NCT00302640|Nitazoxanide|nitazoxanide|mesh-list
24445803|NCT00302640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24445804|NCT00302640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24445805|NCT00302653|Rasburicase|rasburicase|mesh-list
24445806|NCT00302653|Gout Suppressants|gout suppressants|mesh-ancestor
24445807|NCT00302653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24445808|NCT00302666|Dienogest|dienogest|mesh-list
24445809|NCT00302666|Nandrolone|nandrolone|mesh-list
24833708|NCT02175355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24833710|NCT02175381|Carboplatin|carboplatin|mesh-list
24833711|NCT02175381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24833712|NCT02175381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24833713|NCT02175381|Antimetabolites|antimetabolites|mesh-ancestor
24635041|NCT01136590|Tranexamic Acid|tranexamic acid|mesh-list
25269727|NCT02408705|Hormones|hormones|mesh-ancestor
25269728|NCT02408705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25269729|NCT02408744|Pirfenidone|pirfenidone|mesh-list
25269730|NCT02408744|Analgesics|analgesics|mesh-ancestor
25269731|NCT02408744|Sensory System Agents|sensory system agents|mesh-ancestor
25269732|NCT02408744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24600076|NCT02711137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600077|NCT02711137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24600295|NCT01264679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24600296|NCT01155388|Ferrous fumarate|ferrous fumarate|mesh-list
24600297|NCT01155388|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25269733|NCT02408744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269734|NCT02408744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24833741|NCT02175394|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
24600300|NCT01155388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24833743|NCT02175394|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24833745|NCT02175407|Antifungal Agents|antifungal agents|mesh-ancestor
24833746|NCT02175407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24833747|NCT02175407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24496428|NCT00504816|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24833748|NCT02175407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24833749|NCT02175407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24833750|NCT02175407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833751|NCT02175407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24833752|NCT02175407|Hormone Antagonists|hormone antagonists|mesh-ancestor
24833753|NCT02175407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24833754|NCT02175407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833755|NCT02175407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24833756|NCT02175420|BCG Vaccine|bcg vaccine|mesh-list
24833757|NCT02175420|Immunologic Factors|immunologic factors|mesh-ancestor
24468187|NCT00380380|Protease Inhibitors|protease inhibitors|mesh-ancestor
24468188|NCT00380380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24468189|NCT00380380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468190|NCT00380406|Leuprolide|leuprolide|mesh-list
25675182|NCT01782222|Dopamine Agents|dopamine agents|mesh-ancestor
25675183|NCT01782222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25675184|NCT01782222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675185|NCT01782222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675186|NCT01782495|Ritonavir|ritonavir|mesh-list
25675187|NCT01782495|Ribavirin|ribavirin|mesh-list
25675188|NCT01782495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25675189|NCT01782495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25675190|NCT01782495|Protease Inhibitors|protease inhibitors|mesh-ancestor
25675191|NCT01782495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675192|NCT01782495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675193|NCT01782495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25675194|NCT01782495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25675195|NCT01782495|Antiviral Agents|antiviral agents|mesh-ancestor
25675196|NCT01782495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675198|NCT01782495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25675200|NCT01782690|Gemcitabine|gemcitabine|mesh-list
25675201|NCT01782690|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25675202|NCT01782690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25675203|NCT01782690|Antimetabolites|antimetabolites|mesh-ancestor
25675204|NCT01782690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675205|NCT01782690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675206|NCT01782690|Antiviral Agents|antiviral agents|mesh-ancestor
24468191|NCT00380406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24468192|NCT00380406|Fertility Agents|fertility agents|mesh-ancestor
24833758|NCT02175420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833760|NCT02175446|Bevacizumab|bevacizumab|mesh-list
24833761|NCT02175446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24834006|NCT02176499|Telmisartan|telmisartan|mesh-list
24833762|NCT02175446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25067665|NCT03441373|Histamine Agonists|histamine agonists|mesh-ancestor
24833835|NCT02175901|Diuretics|diuretics|mesh-ancestor
24833836|NCT02175901|Natriuretic Agents|natriuretic agents|mesh-ancestor
24833837|NCT02175901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833838|NCT02175901|Expectorants|expectorants|mesh-ancestor
24833839|NCT02175901|Respiratory System Agents|respiratory system agents|mesh-ancestor
24833840|NCT02175914|Erythromycin|erythromycin|mesh-list
25269735|NCT02408744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25269736|NCT02408744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25269737|NCT02408744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25269738|NCT02408744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25269740|NCT02408939|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25269741|NCT02408939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25269742|NCT02408926|Vaccines|vaccines|mesh-list
25269743|NCT02408926|Immunologic Factors|immunologic factors|mesh-ancestor
25269744|NCT02408926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469707|NCT00386815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050880|NCT00464061|Volinanserin|volinanserin|mesh-list
24542920|NCT00680940|Paclitaxel|paclitaxel|mesh-list
24863172|NCT02934529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24833841|NCT02175914|Erythromycin Estolate|erythromycin estolate|mesh-list
24833842|NCT02175914|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24833843|NCT02175914|Erythromycin stearate|erythromycin stearate|mesh-list
24833844|NCT02175914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24833845|NCT02175914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24833846|NCT02175914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24833847|NCT02175914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24833848|NCT02175914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635208|NCT01137708|Estrogens|estrogens|mesh-ancestor
24833873|NCT02175927|Respiratory System Agents|respiratory system agents|mesh-ancestor
24833875|NCT02176044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24833876|NCT02176044|Vasodilator Agents|vasodilator agents|mesh-ancestor
24833877|NCT02176044|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24833878|NCT02176044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833879|NCT02176057|Azithromycin|azithromycin|mesh-list
24833880|NCT02176057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24833928|NCT02176200|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24833930|NCT02176200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24833931|NCT02176200|Adrenergic Agents|adrenergic agents|mesh-ancestor
24833932|NCT02176200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24833934|NCT02176200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24833943|NCT02176213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24833944|NCT02176213|Alkylating Agents|alkylating agents|mesh-ancestor
24833945|NCT02176213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833946|NCT02176213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24833947|NCT02176213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24833948|NCT02176213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24566660|NCT00787111|Serotonin Agents|serotonin agents|mesh-ancestor
24566661|NCT00787111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566662|NCT00787111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24566663|NCT00787111|Antidepressive Agents|antidepressive agents|mesh-ancestor
24566664|NCT00787111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24566665|NCT00787111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24566666|NCT00787111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24557017|NCT00751049|Timolol|timolol|mesh-list
24566667|NCT00787111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24833949|NCT02176213|Antiemetics|antiemetics|mesh-ancestor
24833950|NCT02176213|Autonomic Agents|autonomic agents|mesh-ancestor
24833951|NCT02176213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24833952|NCT02176213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24833953|NCT02176213|Glucocorticoids|glucocorticoids|mesh-ancestor
24833954|NCT02176213|Hormones|hormones|mesh-ancestor
24833955|NCT02176213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24833956|NCT02176213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24833984|NCT02176304|Glucocorticoids|glucocorticoids|mesh-ancestor
24833985|NCT02176304|Hormones|hormones|mesh-ancestor
24833986|NCT02176304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24833987|NCT02176304|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24635301|NCT01138137|Antioxidants|antioxidants|mesh-ancestor
24834003|NCT02176460|Mitosis Modulators|mitosis modulators|mesh-ancestor
24834004|NCT02176460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834005|NCT02176460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24834008|NCT02176499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24834010|NCT02176499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834012|NCT02176512|Telmisartan|telmisartan|mesh-list
24834013|NCT02176512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24834014|NCT02176512|Diuretics|diuretics|mesh-ancestor
24834015|NCT02176512|Natriuretic Agents|natriuretic agents|mesh-ancestor
24834016|NCT02176512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834017|NCT02176512|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24834018|NCT02176512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24834019|NCT02176512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834020|NCT02176512|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24834021|NCT02176512|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24621941|NCT01064986|Hydrocortisone|hydrocortisone|mesh-list
24834022|NCT02176564|Bronchodilator Agents|bronchodilator agents|mesh-list
24469708|NCT00386815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24469779|NCT00387322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469781|NCT00387322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469783|NCT00387322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24469784|NCT00387322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24469785|NCT00387374|Paclitaxel|paclitaxel|mesh-list
24834023|NCT02176564|Autonomic Agents|autonomic agents|mesh-ancestor
24834024|NCT02176564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834025|NCT02176564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834026|NCT02176564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24834027|NCT02176564|Respiratory System Agents|respiratory system agents|mesh-ancestor
24834029|NCT02176681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24834030|NCT02176681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834031|NCT02176681|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24834032|NCT02176681|Protease Inhibitors|protease inhibitors|mesh-ancestor
24834033|NCT02176681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24834034|NCT02176681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675207|NCT01782690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675208|NCT01782690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675209|NCT01782690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25675210|NCT01782690|Immunologic Factors|immunologic factors|mesh-ancestor
25675211|NCT01782690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675212|NCT01782690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25675213|NCT01782742|Bexarotene|bexarotene|mesh-list
25675214|NCT01782742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675215|NCT01782859|Prednisone|prednisone|mesh-list
25675216|NCT01782859|Hydrocortisone|hydrocortisone|mesh-list
25244007|NCT05097976|Methylprednisolone|methylprednisolone|mesh-list
25244008|NCT05097976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25244009|NCT05097976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25244010|NCT05097976|Prednisolone|prednisolone|mesh-list
25244011|NCT05097976|Prednisolone acetate|prednisolone acetate|mesh-list
25244012|NCT05097976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25244013|NCT05097976|Prednisolone phosphate|prednisolone phosphate|mesh-list
25244036|NCT05076110|Acetaminophen|acetaminophen|mesh-list
25244037|NCT05076110|Ibuprofen|ibuprofen|mesh-list
25244038|NCT05076110|Oxycodone|oxycodone|mesh-list
25244039|NCT05076110|Gabapentin|gabapentin|mesh-list
25244040|NCT05076110|Methocarbamol|methocarbamol|mesh-list
25244041|NCT05076110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24834036|NCT02176720|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
24834037|NCT02176720|Cariostatic Agents|cariostatic agents|mesh-ancestor
24834049|NCT02176733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834050|NCT02176733|Antifungal Agents|antifungal agents|mesh-ancestor
24834051|NCT02176733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24834052|NCT02176733|Dermatologic Agents|dermatologic agents|mesh-ancestor
24834053|NCT02176733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24834054|NCT02176733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24834055|NCT02176759|Citric Acid|citric acid|mesh-list
24834056|NCT02176759|Sodium Citrate|sodium citrate|mesh-list
24834057|NCT02176759|Anticoagulants|anticoagulants|mesh-ancestor
24834058|NCT02176759|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24834059|NCT02176759|Chelating Agents|chelating agents|mesh-ancestor
24834060|NCT02176759|Sequestering Agents|sequestering agents|mesh-ancestor
24834061|NCT02176759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834112|NCT02177305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24834113|NCT02177305|Autonomic Agents|autonomic agents|mesh-ancestor
24834114|NCT02177305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834115|NCT02177305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834116|NCT02177305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24834117|NCT02177305|Respiratory System Agents|respiratory system agents|mesh-ancestor
24834118|NCT02177305|Parasympatholytics|parasympatholytics|mesh-ancestor
24834119|NCT02177305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24834120|NCT02177305|Cholinergic Agents|cholinergic agents|mesh-ancestor
24834121|NCT02177305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24834126|NCT02177318|Autonomic Agents|autonomic agents|mesh-ancestor
24834127|NCT02177318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834128|NCT02177318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834129|NCT02177318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24834130|NCT02177318|Respiratory System Agents|respiratory system agents|mesh-ancestor
24834131|NCT02177318|Parasympatholytics|parasympatholytics|mesh-ancestor
24834132|NCT02177318|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24834133|NCT02177318|Cholinergic Agents|cholinergic agents|mesh-ancestor
24834134|NCT02177318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24834135|NCT02177318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834136|NCT02177318|Anticonvulsants|anticonvulsants|mesh-ancestor
24834137|NCT02177331|Lacidipine|lacidipine|mesh-list
24834138|NCT02177331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24834139|NCT02177331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24921260|NCT04193059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24921261|NCT04193059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24921262|NCT04193059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24921263|NCT04193059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24921264|NCT04193059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24921265|NCT04193059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921266|NCT04192916|Rivaroxaban|rivaroxaban|mesh-list
24834140|NCT02177331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25675217|NCT01782859|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25675218|NCT01782859|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25675219|NCT01782859|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25675220|NCT01782859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25675221|NCT01782859|Glucocorticoids|glucocorticoids|mesh-ancestor
25675222|NCT01782859|Hormones|hormones|mesh-ancestor
25675223|NCT01782859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25675224|NCT01782859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675225|NCT01782859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25675226|NCT01782859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675227|NCT01782872|Ropivacaine|ropivacaine|mesh-list
25269751|NCT02408562|Becaplermin|becaplermin|mesh-list
25269752|NCT02408562|Anticoagulants|anticoagulants|mesh-ancestor
24566790|NCT00787969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557084|NCT00751205|Antiemetics|antiemetics|mesh-ancestor
25269753|NCT02408562|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
25269754|NCT02408562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25269755|NCT02408562|Growth Substances|growth substances|mesh-ancestor
24469787|NCT00387374|Carboplatin|carboplatin|mesh-list
24469788|NCT00387374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24469789|NCT00387374|Antibodies|antibodies|mesh-list
24469790|NCT00387374|Immunoglobulins|immunoglobulins|mesh-list
24834150|NCT02177344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834151|NCT02177344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24834152|NCT02177344|Respiratory System Agents|respiratory system agents|mesh-ancestor
24834157|NCT02177357|Pramipexole|pramipexole|mesh-list
24834158|NCT02177357|Antioxidants|antioxidants|mesh-ancestor
24834159|NCT02177357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834160|NCT02177357|Protective Agents|protective agents|mesh-ancestor
24834161|NCT02177357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834162|NCT02177357|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24834163|NCT02177357|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24834164|NCT02177357|Dopamine Agonists|dopamine agonists|mesh-ancestor
24834165|NCT02177357|Dopamine Agents|dopamine agents|mesh-ancestor
24834166|NCT02177357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24834167|NCT02177370|Fenoterol|fenoterol|mesh-list
24834168|NCT02177370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24834169|NCT02177370|Autonomic Agents|autonomic agents|mesh-ancestor
24834170|NCT02177370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24921286|NCT04192617|Abortifacient Agents|abortifacient agents|mesh-ancestor
24834171|NCT02177370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834172|NCT02177370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24834173|NCT02177370|Respiratory System Agents|respiratory system agents|mesh-ancestor
24834174|NCT02177370|Sympathomimetics|sympathomimetics|mesh-ancestor
24592468|NCT00921830|Ibuprofen|ibuprofen|mesh-list
24834196|NCT02177409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834197|NCT02177409|Vasodilator Agents|vasodilator agents|mesh-ancestor
24834198|NCT02177409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24834199|NCT02177409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24834200|NCT02177422|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24834201|NCT02177422|Telmisartan|telmisartan|mesh-list
24834202|NCT02177422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24834203|NCT02177422|Diuretics|diuretics|mesh-ancestor
24834204|NCT02177422|Natriuretic Agents|natriuretic agents|mesh-ancestor
24834205|NCT02177422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834206|NCT02177422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24834210|NCT02177422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24834211|NCT02177435|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24834212|NCT02177435|Telmisartan|telmisartan|mesh-list
24834213|NCT02177435|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
24834214|NCT02177435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24834215|NCT02177435|Diuretics|diuretics|mesh-ancestor
24834216|NCT02177435|Natriuretic Agents|natriuretic agents|mesh-ancestor
24834217|NCT02177435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834218|NCT02177435|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24834219|NCT02177435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24834220|NCT02177435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834221|NCT02177435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24834222|NCT02177435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24834243|NCT02177461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834244|NCT02177461|Sympatholytics|sympatholytics|mesh-ancestor
24921326|NCT04192292|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24834245|NCT02177461|Autonomic Agents|autonomic agents|mesh-ancestor
24834246|NCT02177461|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24834247|NCT02177461|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24834248|NCT02177461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24834249|NCT02177461|Adrenergic Agents|adrenergic agents|mesh-ancestor
24834250|NCT02177461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24834251|NCT02177461|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24834252|NCT02177461|Protease Inhibitors|protease inhibitors|mesh-ancestor
24834253|NCT02177461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24834254|NCT02177487|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25269756|NCT02408562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269757|NCT02408393|Ropivacaine|ropivacaine|mesh-list
25269758|NCT02408393|Anesthetics, Local|anesthetics, local|mesh-ancestor
25675228|NCT01782872|Anesthetics, Local|anesthetics, local|mesh-ancestor
25675229|NCT01782872|Anesthetics|anesthetics|mesh-ancestor
25269759|NCT02408393|Anesthetics|anesthetics|mesh-ancestor
24834260|NCT02177487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834261|NCT02177487|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24834262|NCT02177487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24834263|NCT02177487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834266|NCT02177500|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24834268|NCT02177500|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
24834285|NCT02177539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834286|NCT02177539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834287|NCT02177539|Sympathomimetics|sympathomimetics|mesh-ancestor
24834312|NCT02177552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24834313|NCT02177552|Antimetabolites|antimetabolites|mesh-ancestor
24834314|NCT02177552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24834315|NCT02177552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24834316|NCT02177552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24834317|NCT02177552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592606|NCT00923234|Growth Substances|growth substances|mesh-ancestor
24834323|NCT02177643|Diacetylrhein|diacetylrhein|mesh-list
24834324|NCT02177643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24834325|NCT02177734|Vaccines|vaccines|mesh-list
24834326|NCT02177734|Immunologic Factors|immunologic factors|mesh-ancestor
24834327|NCT02177734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834328|NCT02177760|Sirolimus|sirolimus|mesh-list
24834329|NCT02177760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24834330|NCT02177760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24834331|NCT02177760|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24834332|NCT02177760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24834348|NCT02177955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24834349|NCT02177955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24834490|NCT02179034|Dermatologic Agents|dermatologic agents|mesh-ancestor
24834350|NCT02177955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24834351|NCT02177955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834352|NCT02177955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25269760|NCT02408393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25269761|NCT02408393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269762|NCT02408393|Sensory System Agents|sensory system agents|mesh-ancestor
25269763|NCT02408393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25269764|NCT02408354|Glycerol|glycerol|mesh-list
25269765|NCT02408354|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25269766|NCT02408354|Protective Agents|protective agents|mesh-ancestor
25269767|NCT02408354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834358|NCT02177955|GABA Modulators|gaba modulators|mesh-ancestor
24834359|NCT02177955|GABA Agents|gaba agents|mesh-ancestor
24834360|NCT02177955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24834361|NCT02177955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834362|NCT02177955|Anticonvulsants|anticonvulsants|mesh-ancestor
24834365|NCT02177955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834366|NCT02177955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24834367|NCT02177955|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25067721|NCT03440359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25067722|NCT03440359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25067723|NCT03440359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25067724|NCT03440359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067725|NCT03440359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25067726|NCT03440359|Hormone Antagonists|hormone antagonists|mesh-ancestor
24834368|NCT02177955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24834422|NCT02178449|Autonomic Agents|autonomic agents|mesh-ancestor
24834423|NCT02178449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834424|NCT02178449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834425|NCT02178449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24834426|NCT02178449|Glucocorticoids|glucocorticoids|mesh-ancestor
24834427|NCT02178449|Hormones|hormones|mesh-ancestor
24834428|NCT02178449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24834429|NCT02178449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24834430|NCT02178449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24834431|NCT02178449|Anesthetics, Local|anesthetics, local|mesh-ancestor
25244098|NCT05059535|Antipyretics|antipyretics|mesh-ancestor
25244099|NCT05053087|Ropivacaine|ropivacaine|mesh-list
25244100|NCT05053087|Anesthetics, Local|anesthetics, local|mesh-ancestor
25244101|NCT05053087|Anesthetics|anesthetics|mesh-ancestor
25244102|NCT05053087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25244103|NCT05053087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244104|NCT05053087|Sensory System Agents|sensory system agents|mesh-ancestor
25244105|NCT05053087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834432|NCT02178449|Anesthetics|anesthetics|mesh-ancestor
24834433|NCT02178449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24834434|NCT02178449|Sensory System Agents|sensory system agents|mesh-ancestor
24834435|NCT02178449|Protease Inhibitors|protease inhibitors|mesh-ancestor
24834436|NCT02178449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24834437|NCT02178449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834438|NCT02178488|Cholecalciferol|cholecalciferol|mesh-list
24834439|NCT02178488|Vitamin D|vitamin d|mesh-list
24834570|NCT02179775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24834440|NCT02178488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24834441|NCT02178488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834442|NCT02178488|Vitamins|vitamins|mesh-ancestor
24834464|NCT02178761|Chromium|chromium|mesh-list
24834465|NCT02178761|Everolimus|everolimus|mesh-list
24834466|NCT02178761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24834467|NCT02178761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24834468|NCT02178761|Immunologic Factors|immunologic factors|mesh-ancestor
24834469|NCT02178761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834470|NCT02178761|Trace Elements|trace elements|mesh-ancestor
24834471|NCT02178761|Micronutrients|micronutrients|mesh-ancestor
24834472|NCT02178813|Minocycline|minocycline|mesh-list
24834473|NCT02178813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24834474|NCT02178813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24834475|NCT02179008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24834476|NCT02179008|Latanoprost|latanoprost|mesh-list
24834477|NCT02179008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24834478|NCT02179034|Menthol|menthol|mesh-list
24834479|NCT02179034|Nicotine|nicotine|mesh-list
24834480|NCT02179034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24834481|NCT02179034|Autonomic Agents|autonomic agents|mesh-ancestor
24834482|NCT02179034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834483|NCT02179034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834484|NCT02179034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24834485|NCT02179034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24834486|NCT02179034|Cholinergic Agents|cholinergic agents|mesh-ancestor
24834487|NCT02179034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24834488|NCT02179034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834489|NCT02179034|Antipruritics|antipruritics|mesh-ancestor
24834492|NCT02179099|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24834493|NCT02179099|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24469820|NCT00387413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469821|NCT00387413|Analgesics|analgesics|mesh-ancestor
24469822|NCT00387413|Sensory System Agents|sensory system agents|mesh-ancestor
24469823|NCT00387413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24469824|NCT00387413|Antidepressive Agents|antidepressive agents|mesh-ancestor
24469825|NCT00387413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24469826|NCT00387413|Dopamine Agents|dopamine agents|mesh-ancestor
24469827|NCT00387413|Vitamin B Complex|vitamin b complex|mesh-ancestor
24469829|NCT00387413|Micronutrients|micronutrients|mesh-ancestor
24834498|NCT02179099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834499|NCT02179099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24834500|NCT02179099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834502|NCT02179255|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24834523|NCT02179294|Remifentanil|remifentanil|mesh-list
24834524|NCT02179294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24834525|NCT02179294|Narcotics|narcotics|mesh-ancestor
24834526|NCT02179294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24834527|NCT02179294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834528|NCT02179294|Analgesics|analgesics|mesh-ancestor
25675230|NCT01782872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25675231|NCT01782872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675232|NCT01782872|Sensory System Agents|sensory system agents|mesh-ancestor
25675233|NCT01782872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25675234|NCT01782885|Acetaminophen|acetaminophen|mesh-list
25675235|NCT01782885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25675236|NCT01782885|Analgesics|analgesics|mesh-ancestor
25675237|NCT01782885|Sensory System Agents|sensory system agents|mesh-ancestor
25244170|NCT04944888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25244171|NCT04944888|Eliglustat|eliglustat|mesh-list
25244172|NCT04944888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244173|NCT04944888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244174|NCT04944888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24834529|NCT02179294|Sensory System Agents|sensory system agents|mesh-ancestor
24834530|NCT02179294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834531|NCT02179294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24834532|NCT02179528|Etoposide|etoposide|mesh-list
24834533|NCT02179528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24834535|NCT02179528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24834536|NCT02179528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24834537|NCT02179528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24834538|NCT02179528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834539|NCT02179567|Bevacizumab|bevacizumab|mesh-list
24834540|NCT02179567|Docetaxel|docetaxel|mesh-list
25675238|NCT01782885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25675239|NCT01782885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675240|NCT01782885|Antipyretics|antipyretics|mesh-ancestor
25675241|NCT01782898|Esmolol|esmolol|mesh-list
25675242|NCT01782898|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24834541|NCT02179567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24834542|NCT02179567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24834543|NCT02179567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24834544|NCT02179567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24834545|NCT02179567|Growth Substances|growth substances|mesh-ancestor
24834546|NCT02179567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834547|NCT02179567|Growth Inhibitors|growth inhibitors|mesh-ancestor
24834548|NCT02179567|Tubulin Modulators|tubulin modulators|mesh-ancestor
24834549|NCT02179567|Antimitotic Agents|antimitotic agents|mesh-ancestor
24834550|NCT02179567|Mitosis Modulators|mitosis modulators|mesh-ancestor
24834551|NCT02179567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834552|NCT02179645|Celecoxib|celecoxib|mesh-list
24834567|NCT02179658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24834568|NCT02179658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24834569|NCT02179775|Propranolol|propranolol|mesh-list
24834571|NCT02179775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24834572|NCT02179775|Adrenergic Agents|adrenergic agents|mesh-ancestor
24834573|NCT02179775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24861352|NCT02317198|Purinergic Agents|purinergic agents|mesh-ancestor
24834574|NCT02179775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834575|NCT02179775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834576|NCT02179775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24834577|NCT02179775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24834578|NCT02179775|Vasodilator Agents|vasodilator agents|mesh-ancestor
24834579|NCT02179814|Diphenhydramine|diphenhydramine|mesh-list
24834580|NCT02179814|Promethazine|promethazine|mesh-list
24834581|NCT02179814|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25269769|NCT02408185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25269770|NCT02408185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25269771|NCT02408302|Midazolam|midazolam|mesh-list
25269772|NCT02408302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25269773|NCT02408302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25269774|NCT02408302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25269775|NCT02408302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269776|NCT02408302|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25269777|NCT02408302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25269778|NCT02408302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25269779|NCT02408302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25269780|NCT02408302|Anesthetics, General|anesthetics, general|mesh-ancestor
24470043|NCT00388635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834598|NCT02179814|Antipruritics|antipruritics|mesh-ancestor
24452313|NCT00327119|Panitumumab|panitumumab|mesh-list
24452314|NCT00327119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24834599|NCT02179814|Dermatologic Agents|dermatologic agents|mesh-ancestor
24834600|NCT02179931|Flupenthixol|flupenthixol|mesh-list
24834601|NCT02179931|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
24834602|NCT02179931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24834603|NCT02179931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24834604|NCT02179931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25675243|NCT01782898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25675244|NCT01782898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25675245|NCT01782898|Adrenergic Agents|adrenergic agents|mesh-ancestor
25675246|NCT01782898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25675247|NCT01782898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244213|NCT04922944|Immunologic Factors|immunologic factors|mesh-ancestor
25244214|NCT04922944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851935|NCT02259855|Ritonavir|ritonavir|mesh-list
24834605|NCT02179931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834606|NCT02179931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24636036|NCT01142505|Mannitol|mannitol|mesh-list
24452317|NCT00327132|Clarithromycin|clarithromycin|mesh-list
24452318|NCT00327132|Omeprazole|omeprazole|mesh-list
24452319|NCT00327132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24452320|NCT00327132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24834633|NCT02180087|Sensory System Agents|sensory system agents|mesh-ancestor
24834634|NCT02180087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834635|NCT02180087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834636|NCT02180087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24834637|NCT02180087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25067797|NCT03439358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24921477|NCT04191278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921478|NCT04191278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522732|NCT03366844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24522733|NCT03366844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522734|NCT03365752|Anesthetics|anesthetics|mesh-list
24522735|NCT03365752|Mepivacaine|mepivacaine|mesh-list
24522736|NCT03365752|Chloroprocaine|chloroprocaine|mesh-list
24522737|NCT03365752|Anesthetics, General|anesthetics, general|mesh-list
24834638|NCT02180087|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24834639|NCT02180087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24834640|NCT02180087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834641|NCT02180204|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24834642|NCT02180204|Tenecteplase|tenecteplase|mesh-list
24834643|NCT02180204|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24834644|NCT02180204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24834645|NCT02180204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834646|NCT02180321|Tranexamic Acid|tranexamic acid|mesh-list
24834647|NCT02180321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24834648|NCT02180321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24834649|NCT02180321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834650|NCT02180321|Hemostatics|hemostatics|mesh-ancestor
24834651|NCT02180321|Coagulants|coagulants|mesh-ancestor
24834652|NCT02180334|Acetaminophen|acetaminophen|mesh-list
24834653|NCT02180334|Linagliptin|linagliptin|mesh-list
24834654|NCT02180334|Mosapride|mosapride|mesh-list
24452321|NCT00327132|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24452322|NCT00327132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24452323|NCT00327132|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24452324|NCT00327132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24452325|NCT00327132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452326|NCT00327132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24834661|NCT02180334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834663|NCT02180334|Incretins|incretins|mesh-ancestor
24834664|NCT02180334|Hormones|hormones|mesh-ancestor
24834665|NCT02180334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24834666|NCT02180334|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24834667|NCT02180334|Protease Inhibitors|protease inhibitors|mesh-ancestor
24834668|NCT02180334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921514|NCT04190160|Xultophy|xultophy|mesh-list
24834669|NCT02180334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24834670|NCT02180334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24834671|NCT02180334|Serotonin Agents|serotonin agents|mesh-ancestor
24834672|NCT02180334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25269781|NCT02408302|Anesthetics|anesthetics|mesh-ancestor
25269782|NCT02408302|GABA Modulators|gaba modulators|mesh-ancestor
25269783|NCT02408302|GABA Agents|gaba agents|mesh-ancestor
25269784|NCT02408302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24501637|NCT00530127|Chelating Agents|chelating agents|mesh-ancestor
24834673|NCT02180425|Adapalene|adapalene|mesh-list
24834674|NCT02180425|Tretinoin|tretinoin|mesh-list
24834675|NCT02180425|Isotretinoin|isotretinoin|mesh-list
24834676|NCT02180425|Dermatologic Agents|dermatologic agents|mesh-ancestor
25675248|NCT01782898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675249|NCT01782963|Dexamethasone|dexamethasone|mesh-list
25675250|NCT01782963|Lenalidomide|lenalidomide|mesh-list
25675251|NCT01782963|Bortezomib|bortezomib|mesh-list
25675252|NCT01782963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25675253|NCT01782963|Antiemetics|antiemetics|mesh-ancestor
24834677|NCT02180425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24834678|NCT02180425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24834680|NCT02180425|Sensory System Agents|sensory system agents|mesh-ancestor
24834681|NCT02180425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24468948|NCT00384020|Paroxetine|paroxetine|mesh-list
24834682|NCT02180425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834683|NCT02180425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24834684|NCT02180425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24834685|NCT02180425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24834686|NCT02180425|Keratolytic Agents|keratolytic agents|mesh-ancestor
24834687|NCT02180503|Linagliptin|linagliptin|mesh-list
24834688|NCT02180503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24834689|NCT02180503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834690|NCT02180503|Incretins|incretins|mesh-ancestor
24834691|NCT02180503|Hormones|hormones|mesh-ancestor
24834692|NCT02180503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24834693|NCT02180503|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24834694|NCT02180503|Protease Inhibitors|protease inhibitors|mesh-ancestor
24834695|NCT02180503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24834696|NCT02180503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834698|NCT02180516|Etodolac|etodolac|mesh-list
24834699|NCT02180516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
24834700|NCT02180516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24834701|NCT02180516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24834702|NCT02180516|Analgesics|analgesics|mesh-ancestor
24834703|NCT02180516|Sensory System Agents|sensory system agents|mesh-ancestor
24834704|NCT02180516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834705|NCT02180516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834706|NCT02180516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24834707|NCT02180516|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24834708|NCT02180516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24834709|NCT02180516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24834726|NCT02180737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24834727|NCT02180737|Analgesics|analgesics|mesh-ancestor
24921533|NCT04189744|Artenimol|artenimol|mesh-list
24834728|NCT02180737|Sensory System Agents|sensory system agents|mesh-ancestor
24834729|NCT02180737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834730|NCT02180737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24834731|NCT02180737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24834732|NCT02180737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24834733|NCT02180737|Adrenergic Agents|adrenergic agents|mesh-ancestor
24834734|NCT02180737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24834735|NCT02180737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834736|NCT02180789|Tamsulosin|tamsulosin|mesh-list
24834737|NCT02180789|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24834742|NCT02180789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834743|NCT02180789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834744|NCT02180789|Urological Agents|urological agents|mesh-ancestor
24834795|NCT02181205|Sensory System Agents|sensory system agents|mesh-ancestor
24834796|NCT02181205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834797|NCT02181218|Gemcitabine|gemcitabine|mesh-list
24834798|NCT02181218|Dexamethasone|dexamethasone|mesh-list
24834799|NCT02181218|Dexamethasone acetate|dexamethasone acetate|mesh-list
24834800|NCT02181218|Oxaliplatin|oxaliplatin|mesh-list
24834801|NCT02181218|Romidepsin|romidepsin|mesh-list
24834802|NCT02181218|BB 1101|bb 1101|mesh-list
24834803|NCT02181218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24834804|NCT02181218|Antiemetics|antiemetics|mesh-ancestor
24834805|NCT02181218|Autonomic Agents|autonomic agents|mesh-ancestor
24834806|NCT02181218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834807|NCT02181218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269785|NCT02408302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269786|NCT02408328|Caffeine|caffeine|mesh-list
24470045|NCT00388635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24470046|NCT00388635|Immunologic Factors|immunologic factors|mesh-ancestor
24470389|NCT00390026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24470390|NCT00390026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24470391|NCT00390026|Growth Substances|growth substances|mesh-ancestor
24834808|NCT02181218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24834809|NCT02181218|Glucocorticoids|glucocorticoids|mesh-ancestor
24834811|NCT02181218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24834812|NCT02181218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24834813|NCT02181218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244266|NCT04873063|Glucocorticoids|glucocorticoids|mesh-ancestor
25244267|NCT04873063|Hormones|hormones|mesh-ancestor
25244268|NCT04873063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25244269|NCT04873063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244270|NCT04873063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24834814|NCT02181218|Protease Inhibitors|protease inhibitors|mesh-ancestor
25067827|NCT03438708|Axitinib|axitinib|mesh-list
24834815|NCT02181218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24834816|NCT02181218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834817|NCT02181218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24834818|NCT02181218|Antimetabolites|antimetabolites|mesh-ancestor
24834839|NCT02181322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24834840|NCT02181322|Analgesics|analgesics|mesh-ancestor
24834841|NCT02181322|Sensory System Agents|sensory system agents|mesh-ancestor
24834842|NCT02181322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834843|NCT02181322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863673|NCT03954938|Cocaine|cocaine|mesh-list
24834844|NCT02181322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24834850|NCT02181335|Budesonide|budesonide|mesh-list
24834855|NCT02181335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834856|NCT02181335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24834857|NCT02181335|Respiratory System Agents|respiratory system agents|mesh-ancestor
24834858|NCT02181335|Glucocorticoids|glucocorticoids|mesh-ancestor
24834859|NCT02181335|Hormones|hormones|mesh-ancestor
24834860|NCT02181335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24834861|NCT02181348|Vitamin E|vitamin e|mesh-list
24834862|NCT02181348|Vitamins|vitamins|mesh-ancestor
24834863|NCT02181348|Micronutrients|micronutrients|mesh-ancestor
24834864|NCT02181348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834865|NCT02181348|Antioxidants|antioxidants|mesh-ancestor
24834866|NCT02181348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834867|NCT02181348|Protective Agents|protective agents|mesh-ancestor
24834868|NCT02181361|Aspirin|aspirin|mesh-list
24834869|NCT02181361|Hirudins|hirudins|mesh-list
24834870|NCT02181361|Warfarin|warfarin|mesh-list
24834871|NCT02181361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24834872|NCT02181361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24834886|NCT02181361|Anticoagulants|anticoagulants|mesh-ancestor
24834887|NCT02181361|Antithrombins|antithrombins|mesh-ancestor
24834888|NCT02181361|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24834889|NCT02181361|Protease Inhibitors|protease inhibitors|mesh-ancestor
24834891|NCT02181478|Mycophenolic Acid|mycophenolic acid|mesh-list
24834892|NCT02181478|Cyclophosphamide|cyclophosphamide|mesh-list
24834894|NCT02181478|Fludarabine phosphate|fludarabine phosphate|mesh-list
24834895|NCT02181478|Cyclosporins|cyclosporins|mesh-list
24834896|NCT02181478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24834897|NCT02181478|Immunologic Factors|immunologic factors|mesh-ancestor
24834898|NCT02181478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834899|NCT02181478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24834900|NCT02181478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24834901|NCT02181478|Alkylating Agents|alkylating agents|mesh-ancestor
24834902|NCT02181478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834903|NCT02181478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24834904|NCT02181478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24834905|NCT02181478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24834906|NCT02181478|Antimetabolites|antimetabolites|mesh-ancestor
24834907|NCT02181478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24834908|NCT02181478|Antifungal Agents|antifungal agents|mesh-ancestor
24834909|NCT02181478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25269787|NCT02408328|Caffeine citrate|caffeine citrate|mesh-list
25269788|NCT02408328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269789|NCT02408328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25269790|NCT02408328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470392|NCT00390026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470394|NCT00390026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24470395|NCT00390026|Dermatologic Agents|dermatologic agents|mesh-ancestor
25675254|NCT01782963|Autonomic Agents|autonomic agents|mesh-ancestor
25675255|NCT01782963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25675256|NCT01782963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675257|NCT01782963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25675258|NCT01782963|Glucocorticoids|glucocorticoids|mesh-ancestor
24834910|NCT02181478|Dermatologic Agents|dermatologic agents|mesh-ancestor
25675259|NCT01782963|Hormones|hormones|mesh-ancestor
25244325|NCT04836429|Dermatologic Agents|dermatologic agents|mesh-ancestor
25244326|NCT04836429|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25244328|NCT04828083|Anesthetics, Local|anesthetics, local|mesh-ancestor
25244329|NCT04828083|Anesthetics|anesthetics|mesh-ancestor
25244330|NCT04828083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25244331|NCT04828083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244332|NCT04828083|Sensory System Agents|sensory system agents|mesh-ancestor
25155348|NCT05411237|Mitosis Modulators|mitosis modulators|mesh-ancestor
24958594|NCT03831464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24834911|NCT02181478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24834912|NCT02181478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24834913|NCT02181478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24834914|NCT02181478|Antitubercular Agents|antitubercular agents|mesh-ancestor
24834937|NCT02181920|Analgesics|analgesics|mesh-ancestor
24834938|NCT02181920|Sensory System Agents|sensory system agents|mesh-ancestor
24834939|NCT02181920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834940|NCT02181920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834941|NCT02181920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24834942|NCT02181920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24834943|NCT02181920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24834944|NCT02181920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24834945|NCT02181920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834946|NCT02181920|Antipyretics|antipyretics|mesh-ancestor
24834947|NCT02181933|Lamivudine|lamivudine|mesh-list
24834948|NCT02181933|Zidovudine|zidovudine|mesh-list
24834949|NCT02181933|Nevirapine|nevirapine|mesh-list
24834950|NCT02181933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24834966|NCT02181946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24834977|NCT02181946|Antiviral Agents|antiviral agents|mesh-ancestor
24834978|NCT02181946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24834979|NCT02181946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24834980|NCT02181946|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24834981|NCT02181946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25675266|NCT01782963|Growth Substances|growth substances|mesh-ancestor
25675267|NCT01782963|Growth Inhibitors|growth inhibitors|mesh-ancestor
25675268|NCT01783054|Gemcitabine|gemcitabine|mesh-list
25675269|NCT01783054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25675270|NCT01783054|Antimetabolites|antimetabolites|mesh-ancestor
25675271|NCT01783054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675272|NCT01783054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675273|NCT01783054|Antiviral Agents|antiviral agents|mesh-ancestor
25675274|NCT01783054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675275|NCT01783054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675276|NCT01783054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24654900|NCT01251991|Antidiarrheals|antidiarrheals|mesh-ancestor
24445845|NCT00302705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24445846|NCT00302705|Protease Inhibitors|protease inhibitors|mesh-ancestor
24445847|NCT00302705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498063|NCT00513188|Leucovorin|leucovorin|mesh-list
25244371|NCT04767841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244398|NCT04754945|Dexamethasone|dexamethasone|mesh-list
25244399|NCT04754945|Dexamethasone acetate|dexamethasone acetate|mesh-list
25244400|NCT04754945|Cyclophosphamide|cyclophosphamide|mesh-list
25244401|NCT04754945|Bortezomib|bortezomib|mesh-list
25244402|NCT04754945|Ichthammol|ichthammol|mesh-list
25244403|NCT04754945|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25244404|NCT04754945|BB 1101|bb 1101|mesh-list
25244405|NCT04754945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25244406|NCT04754945|Immunologic Factors|immunologic factors|mesh-ancestor
25244407|NCT04754945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244408|NCT04754945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24622778|NCT01068392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835043|NCT02182141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835004|NCT02182011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835006|NCT02182024|Antithrombins|antithrombins|mesh-ancestor
25269791|NCT02408328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25269792|NCT02408328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25269793|NCT02408328|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24470398|NCT00390039|Narcotics|narcotics|mesh-ancestor
24470399|NCT00390039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24470400|NCT00390039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470401|NCT00390039|Analgesics|analgesics|mesh-ancestor
24835007|NCT02182024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25675284|NCT01783236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675285|NCT01783236|Antipyretics|antipyretics|mesh-ancestor
25675286|NCT01783444|Capecitabine|capecitabine|mesh-list
25675287|NCT01783444|Everolimus|everolimus|mesh-list
25675288|NCT01783444|Exemestane|exemestane|mesh-list
25675289|NCT01783444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25675290|NCT01783444|Antimetabolites|antimetabolites|mesh-ancestor
25675291|NCT01783444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675292|NCT01783444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675293|NCT01783444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25675294|NCT01783444|Immunologic Factors|immunologic factors|mesh-ancestor
25675295|NCT01783444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675296|NCT01783444|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25675297|NCT01783444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25675298|NCT01783444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675299|NCT01783444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25675300|NCT01783444|Hormone Antagonists|hormone antagonists|mesh-ancestor
25675301|NCT01783444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25675302|NCT01783470|Mirabegron|mirabegron|mesh-list
25675303|NCT01783470|Adrenergic Agents|adrenergic agents|mesh-list
24835009|NCT02182024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469355|NCT00385463|Autonomic Agents|autonomic agents|mesh-ancestor
24835010|NCT02182024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835011|NCT02182024|Anticoagulants|anticoagulants|mesh-ancestor
24835022|NCT02182076|Nintedanib|nintedanib|mesh-list
24835024|NCT02182076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24835025|NCT02182076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835026|NCT02182076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835027|NCT02182102|Pemetrexed|pemetrexed|mesh-list
24835028|NCT02182102|Nintedanib|nintedanib|mesh-list
24835029|NCT02182102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24835030|NCT02182102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835031|NCT02182102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835032|NCT02182102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24835033|NCT02182102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24835034|NCT02182102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24835035|NCT02182128|Nintedanib|nintedanib|mesh-list
24835036|NCT02182128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24835037|NCT02182128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24835038|NCT02182128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835039|NCT02182128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835040|NCT02182141|Nintedanib|nintedanib|mesh-list
24835041|NCT02182141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24835042|NCT02182141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24835044|NCT02182141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835045|NCT02182154|Nintedanib|nintedanib|mesh-list
24835046|NCT02182154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675304|NCT01783470|Adrenergic Agonists|adrenergic agonists|mesh-list
25675305|NCT01783470|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25675306|NCT01783470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25675307|NCT01783470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25675308|NCT01783470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675309|NCT01783470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675310|NCT01783470|Urological Agents|urological agents|mesh-ancestor
25692345|NCT01998919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25692346|NCT01998919|Antimetabolites|antimetabolites|mesh-ancestor
24470403|NCT00390039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24470404|NCT00390065|Nitric Oxide|nitric oxide|mesh-list
24470405|NCT00390065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24470435|NCT00390156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835057|NCT02182167|Antioxidants|antioxidants|mesh-ancestor
24835059|NCT02182167|Protective Agents|protective agents|mesh-ancestor
24835066|NCT02182193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835068|NCT02182206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24835069|NCT02182206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24835070|NCT02182206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835071|NCT02182206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835073|NCT02182219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24835074|NCT02182219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24835075|NCT02182219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24953510|NCT03884127|Orlistat|orlistat|mesh-list
24452353|NCT00327197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24835083|NCT02182232|Antimitotic Agents|antimitotic agents|mesh-ancestor
24637252|NCT01149408|Antimetabolites|antimetabolites|mesh-ancestor
25269802|NCT02408289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269804|NCT02408289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25269805|NCT02408289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24470443|NCT00390156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24470444|NCT00390156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24863902|NCT02966548|Nivolumab|nivolumab|mesh-list
24470446|NCT00390195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470447|NCT00390195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24470448|NCT00390195|Immunologic Factors|immunologic factors|mesh-ancestor
24470520|NCT00390390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470521|NCT00390403|Acetic Acid|acetic acid|mesh-list
24470544|NCT00390520|Vildagliptin|vildagliptin|mesh-list
24470545|NCT00390520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24470546|NCT00390520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835115|NCT02182336|Dextromethorphan|dextromethorphan|mesh-list
24921779|NCT04187456|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24835116|NCT02182336|Caffeine|caffeine|mesh-list
24835117|NCT02182336|Omeprazole|omeprazole|mesh-list
24835118|NCT02182336|Warfarin|warfarin|mesh-list
24835119|NCT02182336|Vitamins|vitamins|mesh-ancestor
24835120|NCT02182336|Micronutrients|micronutrients|mesh-ancestor
24835121|NCT02182336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835122|NCT02182336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24835123|NCT02182336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24835124|NCT02182336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25675311|NCT01783548|Beclomethasone|beclomethasone|mesh-list
25675312|NCT01783548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25675313|NCT01783548|Glucocorticoids|glucocorticoids|mesh-ancestor
25675314|NCT01783548|Hormones|hormones|mesh-ancestor
25675315|NCT01783548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25675316|NCT01783548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675317|NCT01783548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25675318|NCT01783548|Respiratory System Agents|respiratory system agents|mesh-ancestor
25675319|NCT01783561|Caffeine|caffeine|mesh-list
25675320|NCT01783561|Caffeine citrate|caffeine citrate|mesh-list
25675321|NCT01783561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675322|NCT01783561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25675323|NCT01783561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675324|NCT01783561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25675325|NCT01783561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675326|NCT01783561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25675327|NCT01783561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25675328|NCT01783561|Purinergic Agents|purinergic agents|mesh-ancestor
25675329|NCT01783561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25675330|NCT01783574|Methyltestosterone|methyltestosterone|mesh-list
25675332|NCT01783574|Testosterone undecanoate|testosterone undecanoate|mesh-list
25675333|NCT01783574|Testosterone enanthate|testosterone enanthate|mesh-list
25675334|NCT01783574|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25675335|NCT01783574|Androgens|androgens|mesh-ancestor
25675336|NCT01783574|Hormones|hormones|mesh-ancestor
25675337|NCT01783574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25675338|NCT01783574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675339|NCT01783574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25675340|NCT01783574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675341|NCT01783574|Anabolic Agents|anabolic agents|mesh-ancestor
24445866|NCT00302822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24445867|NCT00302822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24445868|NCT00302822|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24835125|NCT02182336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24835126|NCT02182336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24835127|NCT02182336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24835128|NCT02182336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24835129|NCT02182336|Anesthetics, General|anesthetics, general|mesh-ancestor
24835130|NCT02182336|Anesthetics|anesthetics|mesh-ancestor
24835131|NCT02182336|GABA Modulators|gaba modulators|mesh-ancestor
24835132|NCT02182336|GABA Agents|gaba agents|mesh-ancestor
24835133|NCT02182336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25269807|NCT02408419|Anesthetics, Local|anesthetics, local|mesh-ancestor
25269808|NCT02408419|Anesthetics|anesthetics|mesh-ancestor
25269809|NCT02408419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24921898|NCT04185649|Capecitabine|capecitabine|mesh-list
25269810|NCT02408419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269811|NCT02408419|Sensory System Agents|sensory system agents|mesh-ancestor
25269812|NCT02408419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25269813|NCT02408172|Metoprolol|metoprolol|mesh-list
25269814|NCT02408172|Amlodipine|amlodipine|mesh-list
25269815|NCT02408172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25269816|NCT02408172|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24813787|NCT02060396|Aspirin|aspirin|mesh-list
25269817|NCT02408172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25275490|NCT02371941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518877|NCT04094961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470565|NCT00390624|Respiratory System Agents|respiratory system agents|mesh-ancestor
24470566|NCT00390676|Carboplatin|carboplatin|mesh-list
24470568|NCT00390676|Capecitabine|capecitabine|mesh-list
24470569|NCT00390676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470570|NCT00390676|Tubulin Modulators|tubulin modulators|mesh-ancestor
24470571|NCT00390676|Antimitotic Agents|antimitotic agents|mesh-ancestor
24470572|NCT00390676|Mitosis Modulators|mitosis modulators|mesh-ancestor
24470573|NCT00390676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470609|NCT00390793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24470610|NCT00390793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24470611|NCT00390793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25675342|NCT01783678|Sofosbuvir|sofosbuvir|mesh-list
25675343|NCT01783678|Antiviral Agents|antiviral agents|mesh-ancestor
25675344|NCT01783678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675345|NCT01783821|Budesonide|budesonide|mesh-list
25675346|NCT01783821|Formoterol Fumarate|formoterol fumarate|mesh-list
25675347|NCT01783821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24470780|NCT00391885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675356|NCT01783821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24852051|NCT02260050|Histamine Agents|histamine agents|mesh-ancestor
24835162|NCT02182375|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24835163|NCT02182375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835164|NCT02182375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835165|NCT02182401|Tolbutamide|tolbutamide|mesh-list
24835166|NCT02182401|Midazolam|midazolam|mesh-list
24835167|NCT02182401|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24835168|NCT02182401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24835169|NCT02182401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24835170|NCT02182401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835171|NCT02182401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24835172|NCT02182401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24835173|NCT02182401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24835176|NCT02182401|Anesthetics|anesthetics|mesh-ancestor
24835178|NCT02182401|GABA Agents|gaba agents|mesh-ancestor
24835179|NCT02182401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24835180|NCT02182401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835181|NCT02182401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24835182|NCT02182453|Empagliflozin|empagliflozin|mesh-list
24835183|NCT02182453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24835184|NCT02182453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835185|NCT02182453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24835186|NCT02182453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835187|NCT02182479|Fenoterol|fenoterol|mesh-list
24835188|NCT02182479|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
24835189|NCT02182479|Ipratropium|ipratropium|mesh-list
24835190|NCT02182479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25269835|NCT02408146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25269836|NCT02408146|Narcotics|narcotics|mesh-ancestor
25269837|NCT02408146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25269838|NCT02408146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269839|NCT02408146|Analgesics|analgesics|mesh-ancestor
25269840|NCT02408146|Sensory System Agents|sensory system agents|mesh-ancestor
25269841|NCT02408146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25269842|NCT02408146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25269843|NCT02408146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25269844|NCT02408146|Anesthetics, General|anesthetics, general|mesh-ancestor
25269845|NCT02408146|Anesthetics|anesthetics|mesh-ancestor
25269846|NCT02408146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470783|NCT00391911|Antiviral Agents|antiviral agents|mesh-ancestor
24470784|NCT00391911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24506629|NCT00546286|Dorzolamide|dorzolamide|mesh-list
24835191|NCT02182479|Autonomic Agents|autonomic agents|mesh-ancestor
24835192|NCT02182479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835195|NCT02182479|Respiratory System Agents|respiratory system agents|mesh-ancestor
24835196|NCT02182479|Sympathomimetics|sympathomimetics|mesh-ancestor
24835197|NCT02182479|Tocolytic Agents|tocolytic agents|mesh-ancestor
24835198|NCT02182479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24835199|NCT02182479|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24835200|NCT02182479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24835201|NCT02182479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24835207|NCT02182505|Fenoterol|fenoterol|mesh-list
24835216|NCT02182505|Sympathomimetics|sympathomimetics|mesh-ancestor
24835217|NCT02182505|Tocolytic Agents|tocolytic agents|mesh-ancestor
24835218|NCT02182505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24835219|NCT02182505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24835220|NCT02182505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24835221|NCT02182505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24835222|NCT02182505|Adrenergic Agents|adrenergic agents|mesh-ancestor
25675357|NCT01783821|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25675358|NCT01783821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25675359|NCT01783821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25675360|NCT01783821|Adrenergic Agents|adrenergic agents|mesh-ancestor
25675361|NCT01783821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25675362|NCT01783821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244663|NCT04545762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24637975|NCT01154426|Antimetabolites|antimetabolites|mesh-ancestor
24922030|NCT04183881|Brodalumab|brodalumab|mesh-list
24835261|NCT02182531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835262|NCT02182531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24835263|NCT02182531|Histamine Antagonists|histamine antagonists|mesh-ancestor
24835264|NCT02182531|Histamine Agents|histamine agents|mesh-ancestor
24835265|NCT02182544|Ketotifen|ketotifen|mesh-list
24835266|NCT02182544|Epinastine|epinastine|mesh-list
24835267|NCT02182544|Antipruritics|antipruritics|mesh-ancestor
24835268|NCT02182544|Dermatologic Agents|dermatologic agents|mesh-ancestor
24835269|NCT02182544|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24835270|NCT02182544|Histamine Antagonists|histamine antagonists|mesh-ancestor
24835271|NCT02182544|Histamine Agents|histamine agents|mesh-ancestor
24835272|NCT02182544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24835273|NCT02182544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835276|NCT02182557|Ketotifen|ketotifen|mesh-list
24835286|NCT02182557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24835287|NCT02182570|Epinastine|epinastine|mesh-list
24835338|NCT02182700|Ipratropium|ipratropium|mesh-list
24835339|NCT02182700|Anticonvulsants|anticonvulsants|mesh-ancestor
24835340|NCT02182700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24835341|NCT02182700|Autonomic Agents|autonomic agents|mesh-ancestor
24835342|NCT02182700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835343|NCT02182700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269847|NCT02408146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25269848|NCT02408146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25269849|NCT02408146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25269850|NCT02408146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24470786|NCT00391911|Respiratory System Agents|respiratory system agents|mesh-ancestor
24470787|NCT00391911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24470798|NCT00391950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24470799|NCT00391950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470801|NCT00392002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24470802|NCT00392002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24470803|NCT00392002|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24470804|NCT00392002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24470870|NCT00392275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25675363|NCT01783847|Prednisolone|prednisolone|mesh-list
25675364|NCT01783847|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25675365|NCT01783847|Methylprednisolone|methylprednisolone|mesh-list
25675366|NCT01783847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25675367|NCT01783847|Prednisolone acetate|prednisolone acetate|mesh-list
25675368|NCT01783847|Epoetin Alfa|epoetin alfa|mesh-list
25675369|NCT01783847|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25675370|NCT01783847|Prednisolone phosphate|prednisolone phosphate|mesh-list
25675371|NCT01783847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24835344|NCT02182700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25675372|NCT01783847|Glucocorticoids|glucocorticoids|mesh-ancestor
24813853|NCT02060656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25244671|NCT04541680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244672|NCT04539223|Evolocumab|evolocumab|mesh-list
24835345|NCT02182700|Respiratory System Agents|respiratory system agents|mesh-ancestor
24835346|NCT02182700|Tocolytic Agents|tocolytic agents|mesh-ancestor
24835347|NCT02182700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25067976|NCT03437473|Cholinergic Agents|cholinergic agents|mesh-list
24835348|NCT02182700|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24835349|NCT02182700|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24835350|NCT02182700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24835351|NCT02182700|Adrenergic Agents|adrenergic agents|mesh-ancestor
24835352|NCT02182700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24835353|NCT02182700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835366|NCT02182713|Tocolytic Agents|tocolytic agents|mesh-ancestor
24835367|NCT02182713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24835368|NCT02182713|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24835369|NCT02182713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24835370|NCT02182713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24835371|NCT02182713|Adrenergic Agents|adrenergic agents|mesh-ancestor
24835372|NCT02182713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24835373|NCT02182713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835374|NCT02182713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24835375|NCT02182713|Cholinergic Agents|cholinergic agents|mesh-ancestor
24835377|NCT02182739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24835378|NCT02182739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24835379|NCT02182739|Analgesics|analgesics|mesh-ancestor
24835380|NCT02182739|Sensory System Agents|sensory system agents|mesh-ancestor
24835382|NCT02182739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638234|NCT01155505|Lenalidomide|lenalidomide|mesh-list
24835399|NCT02182752|Analgesics|analgesics|mesh-ancestor
24835400|NCT02182765|Nevirapine|nevirapine|mesh-list
24835401|NCT02182765|Abacavir|abacavir|mesh-list
24835402|NCT02182765|Amprenavir|amprenavir|mesh-list
24835419|NCT02182778|Gemcitabine|gemcitabine|mesh-list
24835420|NCT02182778|Cisplatin|cisplatin|mesh-list
24835421|NCT02182778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24835422|NCT02182778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24835423|NCT02182778|Antimetabolites|antimetabolites|mesh-ancestor
25269851|NCT02408146|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25269852|NCT02408146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25269853|NCT02408146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25269854|NCT02408146|Antiemetics|antiemetics|mesh-ancestor
25269855|NCT02408146|Autonomic Agents|autonomic agents|mesh-ancestor
25269856|NCT02408146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25269857|NCT02408146|Antipruritics|antipruritics|mesh-ancestor
25269858|NCT02408146|Dermatologic Agents|dermatologic agents|mesh-ancestor
25675374|NCT01783847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25675375|NCT01783847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675376|NCT01783847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25675377|NCT01783847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675378|NCT01783847|Antiemetics|antiemetics|mesh-ancestor
25675379|NCT01783847|Autonomic Agents|autonomic agents|mesh-ancestor
25675380|NCT01783847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25244719|NCT04502095|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25244721|NCT04502095|Clindamycin|clindamycin|mesh-list
25244722|NCT04502095|Ertapenem|ertapenem|mesh-list
25244723|NCT04502095|Sulfamethoxazole|sulfamethoxazole|mesh-list
25244724|NCT04502095|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25244725|NCT04502095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25244726|NCT04502095|Renal Agents|renal agents|mesh-ancestor
25269859|NCT02408146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25269860|NCT02408146|Serotonin Agents|serotonin agents|mesh-ancestor
24470871|NCT00392275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24470872|NCT00392275|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24470874|NCT00392314|Deoxyglucose|deoxyglucose|mesh-list
24835437|NCT02182791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24835438|NCT02182791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24835459|NCT02182856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835460|NCT02182856|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24835461|NCT02182856|Cholinergic Agents|cholinergic agents|mesh-ancestor
24835484|NCT02183012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24835485|NCT02183012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24835486|NCT02183012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24835487|NCT02183012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835488|NCT02183012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835490|NCT02183025|Mefenamic Acid|mefenamic acid|mesh-list
24835491|NCT02183025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24835492|NCT02183025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24835493|NCT02183025|Analgesics|analgesics|mesh-ancestor
24835494|NCT02183025|Sensory System Agents|sensory system agents|mesh-ancestor
24835495|NCT02183025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835496|NCT02183025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835500|NCT02183025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24835501|NCT02183025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835502|NCT02183025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835503|NCT02183038|Naproxen|naproxen|mesh-list
24835504|NCT02183038|Meloxicam|meloxicam|mesh-list
24835505|NCT02183038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24835506|NCT02183038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24835507|NCT02183038|Analgesics|analgesics|mesh-ancestor
24835508|NCT02183038|Sensory System Agents|sensory system agents|mesh-ancestor
24835509|NCT02183038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835510|NCT02183038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835511|NCT02183038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24835517|NCT02183038|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24835518|NCT02183051|Ibuprofen|ibuprofen|mesh-list
25269861|NCT02408146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25269862|NCT02408146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25269863|NCT02408146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25269864|NCT02408146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25269865|NCT02408146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25269866|NCT02407899|Vitamin D|vitamin d|mesh-list
24470878|NCT00392314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24470879|NCT00392340|Doxorubicin|doxorubicin|mesh-list
24470880|NCT00392340|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24470908|NCT00392431|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24470909|NCT00392431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24835519|NCT02183051|Meloxicam|meloxicam|mesh-list
24835520|NCT02183051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24835521|NCT02183051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25675381|NCT01783847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25675382|NCT01783847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25675383|NCT01783847|Protective Agents|protective agents|mesh-ancestor
25675384|NCT01783847|Hematinics|hematinics|mesh-ancestor
25675385|NCT01783860|Azithromycin|azithromycin|mesh-list
25675386|NCT01783860|Doxycycline|doxycycline|mesh-list
25675387|NCT01783860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25675388|NCT01783860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675389|NCT01783860|Antimalarials|antimalarials|mesh-ancestor
25675390|NCT01783860|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25675391|NCT01783860|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25675392|NCT01783886|Aflibercept|aflibercept|mesh-list
25068004|NCT03437200|Nivolumab|nivolumab|mesh-list
24722223|NCT01579149|Plerixafor|plerixafor|mesh-list
24470334|NCT00389766|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24470335|NCT00389766|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24470336|NCT00389766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24470344|NCT00389909|Doxapram|doxapram|mesh-list
25675393|NCT01783886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25675394|NCT01783886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25675395|NCT01783886|Growth Substances|growth substances|mesh-ancestor
25675396|NCT01783886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675397|NCT01783886|Growth Inhibitors|growth inhibitors|mesh-ancestor
25675398|NCT01783886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675399|NCT01783912|Nicotine|nicotine|mesh-list
25244802|NCT04453137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25244803|NCT04453137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25244804|NCT04436926|Analgesics, Opioid|analgesics, opioid|mesh-list
25675400|NCT01783912|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25675401|NCT01783912|Autonomic Agents|autonomic agents|mesh-ancestor
25675402|NCT01783912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25675403|NCT01783912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675404|NCT01783912|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25675405|NCT01783912|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25675406|NCT01783912|Cholinergic Agents|cholinergic agents|mesh-ancestor
25675407|NCT01783912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25675408|NCT01783912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675409|NCT01783938|Nivolumab|nivolumab|mesh-list
25244805|NCT04436926|Narcotics|narcotics|mesh-ancestor
25244806|NCT04436926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24835599|NCT02183129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24638519|NCT01156909|Rituximab|rituximab|mesh-list
24835618|NCT02183142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24835623|NCT02183142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835625|NCT02183155|Meloxicam|meloxicam|mesh-list
24835639|NCT02183155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835640|NCT02183155|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24835641|NCT02183168|Indomethacin|indomethacin|mesh-list
24835642|NCT02183168|Meloxicam|meloxicam|mesh-list
24835643|NCT02183168|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24835644|NCT02183168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24835645|NCT02183168|Analgesics|analgesics|mesh-ancestor
24835646|NCT02183168|Sensory System Agents|sensory system agents|mesh-ancestor
24835647|NCT02183168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835648|NCT02183168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835649|NCT02183168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24835650|NCT02183168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24835651|NCT02183168|Gout Suppressants|gout suppressants|mesh-ancestor
24835652|NCT02183168|Tocolytic Agents|tocolytic agents|mesh-ancestor
24835653|NCT02183168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24835654|NCT02183168|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24835655|NCT02183168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835656|NCT02183168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835658|NCT02183181|Meloxicam|meloxicam|mesh-list
24835700|NCT02183272|Sensory System Agents|sensory system agents|mesh-ancestor
24835701|NCT02183272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835702|NCT02183272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835703|NCT02183272|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24835704|NCT02183272|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24835718|NCT02183298|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24835719|NCT02183298|Protease Inhibitors|protease inhibitors|mesh-ancestor
24835720|NCT02183298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835740|NCT02183324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835741|NCT02183324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835742|NCT02183337|Pioglitazone|pioglitazone|mesh-list
24835743|NCT02183337|Linagliptin|linagliptin|mesh-list
24835744|NCT02183337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24835745|NCT02183337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835746|NCT02183337|Incretins|incretins|mesh-ancestor
24835747|NCT02183337|Hormones|hormones|mesh-ancestor
24835748|NCT02183337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25675410|NCT01783938|Ipilimumab|ipilimumab|mesh-list
25675411|NCT01783938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25675412|NCT01783938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675413|NCT01783938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25675414|NCT01783938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675415|NCT01783990|Hydroxyurea|hydroxyurea|mesh-list
25675416|NCT01783990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24835749|NCT02183337|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24835804|NCT02183402|Incretins|incretins|mesh-ancestor
24835805|NCT02183402|Hormones|hormones|mesh-ancestor
24746171|NCT03251924|Nivolumab|nivolumab|mesh-list
24746172|NCT03251924|Ipilimumab|ipilimumab|mesh-list
25675421|NCT01784029|Vitamin D|vitamin d|mesh-list
25675422|NCT01784029|Cholecalciferol|cholecalciferol|mesh-list
25675423|NCT01784029|Vitamins|vitamins|mesh-ancestor
25675424|NCT01784029|Micronutrients|micronutrients|mesh-ancestor
25675425|NCT01784029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675426|NCT01784029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25675427|NCT01784029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25675429|NCT01784211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25675430|NCT01784211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675431|NCT01784419|Ivacaftor|ivacaftor|mesh-list
25675432|NCT01784419|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25675433|NCT01784419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25269879|NCT02407899|Incretins|incretins|mesh-ancestor
25269880|NCT02407899|Hormones|hormones|mesh-ancestor
25269881|NCT02407899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25269882|NCT02407899|Protease Inhibitors|protease inhibitors|mesh-ancestor
24470963|NCT00392691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24470965|NCT00392691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835853|NCT02183467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24835854|NCT02183467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24835855|NCT02183467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835856|NCT02183467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835857|NCT02183467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24835858|NCT02183467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835859|NCT02183467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24835860|NCT02183467|Incretins|incretins|mesh-ancestor
24835861|NCT02183467|Hormones|hormones|mesh-ancestor
24835862|NCT02183467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24835863|NCT02183467|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24835864|NCT02183467|Protease Inhibitors|protease inhibitors|mesh-ancestor
24835865|NCT02183480|Linagliptin|linagliptin|mesh-list
24835866|NCT02183480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24835867|NCT02183480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835869|NCT02183480|Hormones|hormones|mesh-ancestor
24835870|NCT02183480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24835871|NCT02183480|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24835872|NCT02183480|Protease Inhibitors|protease inhibitors|mesh-ancestor
24835873|NCT02183480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835919|NCT02183584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835920|NCT02183584|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24835921|NCT02183584|Antitubercular Agents|antitubercular agents|mesh-ancestor
24835922|NCT02183584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24835940|NCT02183610|Protease Inhibitors|protease inhibitors|mesh-ancestor
24639019|NCT01159548|Antiemetics|antiemetics|mesh-ancestor
24835947|NCT02183623|Antimetabolites|antimetabolites|mesh-ancestor
24835948|NCT02183623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835949|NCT02183623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24835950|NCT02183623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24835951|NCT02183623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835952|NCT02183623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24835953|NCT02183623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835955|NCT02183623|Hormones|hormones|mesh-ancestor
24835963|NCT02183636|Incretins|incretins|mesh-ancestor
24835964|NCT02183636|Hormones|hormones|mesh-ancestor
24835965|NCT02183636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24835966|NCT02183636|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24835967|NCT02183636|Protease Inhibitors|protease inhibitors|mesh-ancestor
24835968|NCT02183636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25269883|NCT02407899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25269884|NCT02407899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269885|NCT02408042|Rituximab|rituximab|mesh-list
25269886|NCT02408042|Pembrolizumab|pembrolizumab|mesh-list
25269887|NCT02408042|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25269888|NCT02408042|Carboplatin|carboplatin|mesh-list
25675435|NCT01784523|Hydroxychloroquine|hydroxychloroquine|mesh-list
25675436|NCT01784523|Antimalarials|antimalarials|mesh-ancestor
25675437|NCT01784523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24852194|NCT02261077|Mydriatics|mydriatics|mesh-ancestor
24852195|NCT02261077|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24852196|NCT02261077|Cholinergic Agents|cholinergic agents|mesh-ancestor
24852197|NCT02261077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24864997|NCT04989322|Carboplatin|carboplatin|mesh-list
24859057|NCT02301494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25269889|NCT02408042|Etoposide|etoposide|mesh-list
25269890|NCT02408042|Ifosfamide|ifosfamide|mesh-list
25269891|NCT02408042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25269892|NCT02408042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25269893|NCT02408042|Immunologic Factors|immunologic factors|mesh-ancestor
24470967|NCT00392691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24471018|NCT00392912|Testosterone undecanoate|testosterone undecanoate|mesh-list
24471019|NCT00392912|Testosterone enanthate|testosterone enanthate|mesh-list
24471020|NCT00392912|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24471021|NCT00392912|Androgens|androgens|mesh-ancestor
24471022|NCT00392912|Hormones|hormones|mesh-ancestor
24471023|NCT00392912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24746453|NCT05432518|Palbociclib|palbociclib|mesh-list
24835969|NCT02183636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835970|NCT02183649|Carbetapentane|carbetapentane|mesh-list
24835971|NCT02183649|Antitussive Agents|antitussive agents|mesh-ancestor
24835972|NCT02183649|Respiratory System Agents|respiratory system agents|mesh-ancestor
24835973|NCT02183688|Acetaminophen|acetaminophen|mesh-list
24835974|NCT02183688|Caffeine|caffeine|mesh-list
24835975|NCT02183688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24835976|NCT02183688|Analgesics|analgesics|mesh-ancestor
24835992|NCT02183701|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24835993|NCT02183701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24835994|NCT02183701|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24835995|NCT02183701|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24836004|NCT02183779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24836005|NCT02183779|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24836006|NCT02183779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24836007|NCT02183779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594591|NCT00934713|Montelukast|montelukast|mesh-list
24836008|NCT02183779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836009|NCT02183779|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24836010|NCT02183779|Hormone Antagonists|hormone antagonists|mesh-ancestor
24836011|NCT02183779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24836012|NCT02183779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836013|NCT02183779|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24836016|NCT02183805|Carboplatin|carboplatin|mesh-list
24836023|NCT02183805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24836024|NCT02183805|Alkylating Agents|alkylating agents|mesh-ancestor
24836025|NCT02183805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836026|NCT02183805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24836027|NCT02183805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25675438|NCT01784523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25675439|NCT01784523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675440|NCT01784523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675441|NCT01784523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675442|NCT01784523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25675443|NCT01784614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25269894|NCT02408042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269895|NCT02408042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25269896|NCT02408042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25269897|NCT02408042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25269898|NCT02408042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25269899|NCT02408042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25269900|NCT02408042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471024|NCT00392912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836037|NCT02183948|Oxytocin|oxytocin|mesh-list
24836084|NCT02184091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24836085|NCT02184091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836086|NCT02184091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836087|NCT02184091|Antiviral Agents|antiviral agents|mesh-ancestor
24836088|NCT02184091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24836089|NCT02184091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24836090|NCT02184091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24836091|NCT02184091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24836092|NCT02184091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24836094|NCT02184104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24836095|NCT02184104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836096|NCT02184104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24836097|NCT02184104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639322|NCT01161069|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25269901|NCT02408042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25269902|NCT02408042|Alkylating Agents|alkylating agents|mesh-ancestor
25269903|NCT02408003|Simendan|simendan|mesh-list
25269904|NCT02408003|Milrinone|milrinone|mesh-list
24471025|NCT00392912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24471026|NCT00392912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24471027|NCT00392912|Anabolic Agents|anabolic agents|mesh-ancestor
24471054|NCT00393198|Misoprostol|misoprostol|mesh-list
24471055|NCT00393198|Levonorgestrel|levonorgestrel|mesh-list
24471056|NCT00393198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24567163|NCT00789763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567164|NCT00789763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24922509|NCT04179071|Famotidine|famotidine|mesh-list
24471281|NCT00394368|Hormones|hormones|mesh-ancestor
24836098|NCT02184104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836099|NCT02184104|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24836100|NCT02184104|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24836101|NCT02184104|Purinergic Agents|purinergic agents|mesh-ancestor
24836102|NCT02184104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24836103|NCT02184117|Adenosine|adenosine|mesh-list
24836104|NCT02184117|Analgesics|analgesics|mesh-ancestor
24836110|NCT02184117|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24836111|NCT02184117|Purinergic Agonists|purinergic agonists|mesh-ancestor
24836112|NCT02184117|Purinergic Agents|purinergic agents|mesh-ancestor
24836113|NCT02184117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24746727|NCT04058743|Cobalt|cobalt|mesh-list
24922560|NCT04178876|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24452378|NCT00327327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452379|NCT00327353|Formoterol Fumarate|formoterol fumarate|mesh-list
24452380|NCT00327353|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24452381|NCT00327353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24452382|NCT00327353|Autonomic Agents|autonomic agents|mesh-ancestor
25675458|NCT01784861|Immunologic Factors|immunologic factors|mesh-ancestor
25675459|NCT01784861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675460|NCT01784965|Liraglutide|liraglutide|mesh-list
25675461|NCT01784965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25675462|NCT01784965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675463|NCT01784965|Incretins|incretins|mesh-ancestor
25675464|NCT01784965|Hormones|hormones|mesh-ancestor
25675465|NCT01784965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25675466|NCT01785095|Hormones|hormones|mesh-list
25675467|NCT01785095|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25675468|NCT01785095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25675469|NCT01785095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675470|NCT01785160|Raltegravir Potassium|raltegravir potassium|mesh-list
25675471|NCT01785160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25675472|NCT01785160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25675473|NCT01785160|Antiviral Agents|antiviral agents|mesh-ancestor
24471061|NCT00393198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24836122|NCT02184247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24836124|NCT02184247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836125|NCT02184247|Vasodilator Agents|vasodilator agents|mesh-ancestor
24836132|NCT02184260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24836134|NCT02184260|Sensory System Agents|sensory system agents|mesh-ancestor
24836135|NCT02184260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24639565|NCT01162902|Candesartan|candesartan|mesh-list
25139656|NCT02969733|Anesthetics, Local|anesthetics, local|mesh-ancestor
24836141|NCT02184273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24836142|NCT02184273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24836144|NCT02184273|Sensory System Agents|sensory system agents|mesh-ancestor
24836145|NCT02184273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24836146|NCT02184273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836147|NCT02184273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24836148|NCT02184273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24836150|NCT02184286|Nevirapine|nevirapine|mesh-list
24836151|NCT02184286|Saquinavir|saquinavir|mesh-list
24836152|NCT02184286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24836153|NCT02184286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24836154|NCT02184286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836155|NCT02184286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836156|NCT02184286|Antiviral Agents|antiviral agents|mesh-ancestor
24836157|NCT02184286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24836158|NCT02184286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24836176|NCT02184299|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24836177|NCT02184299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24836179|NCT02184299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836180|NCT02184299|Antiviral Agents|antiviral agents|mesh-ancestor
24836181|NCT02184299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24836182|NCT02184299|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24836183|NCT02184299|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24836184|NCT02184299|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24836185|NCT02184299|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24836186|NCT02184312|Nevirapine|nevirapine|mesh-list
24836187|NCT02184312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24836188|NCT02184312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24836189|NCT02184312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25269910|NCT02408003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269911|NCT02408003|Protective Agents|protective agents|mesh-ancestor
25675474|NCT01785160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675475|NCT01785160|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25675476|NCT01785160|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25675477|NCT01785160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836234|NCT02184559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24836236|NCT02184637|Artemether|artemether|mesh-list
24836237|NCT02184637|Piperaquine|piperaquine|mesh-list
24836238|NCT02184637|Artenimol|artenimol|mesh-list
24836239|NCT02184637|Tafenoquine|tafenoquine|mesh-list
24836240|NCT02184637|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24836254|NCT02184819|Vasodilator Agents|vasodilator agents|mesh-ancestor
24836255|NCT02184819|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24836256|NCT02184819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24836257|NCT02184819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836261|NCT02184832|Tryptophan|tryptophan|mesh-list
24836262|NCT02184832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24836263|NCT02184832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836264|NCT02184832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24836265|NCT02184832|Antidepressive Agents|antidepressive agents|mesh-ancestor
24836266|NCT02184832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25269922|NCT02407821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25269923|NCT02407821|Antidepressive Agents|antidepressive agents|mesh-ancestor
25269924|NCT02407821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24836267|NCT02184858|Lisinopril|lisinopril|mesh-list
24836268|NCT02184858|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24836283|NCT02184910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836284|NCT02184975|Hemostatics|hemostatics|mesh-list
25269925|NCT02407912|Cisplatin|cisplatin|mesh-list
25269926|NCT02407912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25269927|NCT02407834|Sodium Hypochlorite|sodium hypochlorite|mesh-list
25269928|NCT02407834|Eusol|eusol|mesh-list
25269929|NCT02407834|Disinfectants|disinfectants|mesh-ancestor
24865450|NCT02891954|Canagliflozin|canagliflozin|mesh-list
25269930|NCT02407834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25269931|NCT02407782|Ivermectin|ivermectin|mesh-list
25269932|NCT02407782|Permethrin|permethrin|mesh-list
24423930|NCT00227448|Sympathomimetics|sympathomimetics|mesh-ancestor
24941964|NCT03985735|Anesthetics|anesthetics|mesh-list
24836285|NCT02184975|Coagulants|coagulants|mesh-ancestor
24836286|NCT02185066|Metformin|metformin|mesh-list
24836287|NCT02185066|Atorvastatin|atorvastatin|mesh-list
24836288|NCT02185066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24836289|NCT02185066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640177|NCT01166542|Paclitaxel|paclitaxel|mesh-list
24836412|NCT02185716|Sensory System Agents|sensory system agents|mesh-ancestor
24836413|NCT02185716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24836415|NCT02185768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24836416|NCT02185768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24836417|NCT02185768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24836418|NCT02185768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24836419|NCT02185768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836420|NCT02185768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836428|NCT02185859|Magnesium Sulfate|magnesium sulfate|mesh-list
24836429|NCT02185859|Anesthetics, Local|anesthetics, local|mesh-ancestor
25675483|NCT01785186|Pyrazinamide|pyrazinamide|mesh-list
25675484|NCT01785186|Ethambutol|ethambutol|mesh-list
25675485|NCT01785186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25675486|NCT01785186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675487|NCT01785186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25675488|NCT01785186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25675489|NCT01785186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675490|NCT01785186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836752|NCT02187276|Cholinergic Agents|cholinergic agents|mesh-ancestor
25245177|NCT04239092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25269944|NCT02407600|Autonomic Agents|autonomic agents|mesh-ancestor
25675491|NCT01785186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675492|NCT01785186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675493|NCT01785186|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25675494|NCT01785186|Antitubercular Agents|antitubercular agents|mesh-ancestor
25675495|NCT01785186|Leprostatic Agents|leprostatic agents|mesh-ancestor
25269945|NCT02407600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25269946|NCT02407600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269947|NCT02407600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25269948|NCT02407600|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25269949|NCT02407600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24471380|NCT00395031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24471381|NCT00395031|Serotonin Agents|serotonin agents|mesh-ancestor
24471382|NCT00395031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24471383|NCT00395031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471384|NCT00395031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471385|NCT00395031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24471386|NCT00395031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24471387|NCT00395031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24471388|NCT00395031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24471389|NCT00395031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24471390|NCT00395031|Dopamine Agents|dopamine agents|mesh-ancestor
24471392|NCT00395070|Dacarbazine|dacarbazine|mesh-list
24471393|NCT00395070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24471394|NCT00395070|Alkylating Agents|alkylating agents|mesh-ancestor
24471395|NCT00395070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471396|NCT00395070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24471397|NCT00395174|Hemagglutinins|hemagglutinins|mesh-list
24471398|NCT00395174|Agglutinins|agglutinins|mesh-ancestor
24471399|NCT00395174|Immunologic Factors|immunologic factors|mesh-ancestor
24471400|NCT00395174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471401|NCT00395213|Norepinephrine|norepinephrine|mesh-list
24471402|NCT00395213|Serotonin|serotonin|mesh-list
24471403|NCT00395213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
24471404|NCT00395213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24471405|NCT00395213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24471406|NCT00395213|Adrenergic Agents|adrenergic agents|mesh-ancestor
24471407|NCT00395213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25046599|NCT00840099|Clavulanic Acid|clavulanic acid|mesh-list
24865669|NCT05151393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24865670|NCT05151393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25269950|NCT02407600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269951|NCT02407626|Propofol|propofol|mesh-list
25269952|NCT02407626|Sevoflurane|sevoflurane|mesh-list
25269953|NCT02407626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25269954|NCT02407626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25269955|NCT02407626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269956|NCT02407626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25269957|NCT02407626|Anesthetics, General|anesthetics, general|mesh-ancestor
25269958|NCT02407626|Anesthetics|anesthetics|mesh-ancestor
25269959|NCT02407626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25269960|NCT02407626|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25269961|NCT02407392|Acetic Acid|acetic acid|mesh-list
25269962|NCT02407392|Retinol acetate|retinol acetate|mesh-list
25269963|NCT02407392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25269964|NCT02407392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25269965|NCT02407392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25269966|NCT02407392|Immunologic Factors|immunologic factors|mesh-ancestor
25675496|NCT01785186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25675497|NCT01785186|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25675498|NCT01785186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25675499|NCT01785186|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25675500|NCT01785186|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25675501|NCT01785186|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24852313|NCT02261896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25269969|NCT02407392|Protective Agents|protective agents|mesh-ancestor
25269973|NCT02407366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25269974|NCT02407366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25269975|NCT02407366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25269976|NCT02407366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25269977|NCT02407366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24471413|NCT00395213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24471414|NCT00395213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24471445|NCT00395369|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24471446|NCT00395369|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24471447|NCT00395369|Protease Inhibitors|protease inhibitors|mesh-ancestor
24471448|NCT00395369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24471449|NCT00395369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471936|NCT00397501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24640841|NCT01170338|Varenicline|varenicline|mesh-list
24836446|NCT02185898|Menthol|menthol|mesh-list
24836447|NCT02185898|Nicotine|nicotine|mesh-list
24836448|NCT02185898|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24836449|NCT02185898|Autonomic Agents|autonomic agents|mesh-ancestor
24836450|NCT02185898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24747873|NCT03056014|Antioxidants|antioxidants|mesh-ancestor
25675502|NCT01785186|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25675503|NCT01785186|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25675504|NCT01785186|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25675505|NCT01785186|Antimetabolites|antimetabolites|mesh-ancestor
25675506|NCT01785186|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25675507|NCT01785186|Vitamin B Complex|vitamin b complex|mesh-ancestor
25675508|NCT01785186|Vitamins|vitamins|mesh-ancestor
25675509|NCT01785186|Micronutrients|micronutrients|mesh-ancestor
25675510|NCT01785472|Olmesartan|olmesartan|mesh-list
25675511|NCT01785472|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25692347|NCT01998919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836468|NCT02185924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24836469|NCT02185924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836470|NCT02185924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836471|NCT02185924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24836472|NCT02185924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24836473|NCT02185924|Analgesics|analgesics|mesh-ancestor
24836474|NCT02185924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24836475|NCT02185924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24836476|NCT02185963|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24747939|NCT03012815|Valproic Acid|valproic acid|mesh-list
24836477|NCT02185963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25269989|NCT02407548|Micronutrients|micronutrients|mesh-ancestor
25269990|NCT02407548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25269991|NCT02407548|Antioxidants|antioxidants|mesh-ancestor
25269992|NCT02407548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601730|NCT00965796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24836633|NCT02186769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675513|NCT01785472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25675514|NCT01785472|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25270021|NCT02407314|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25270022|NCT02407314|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25270023|NCT02407314|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25270024|NCT02407314|Purinergic Agents|purinergic agents|mesh-ancestor
25270025|NCT02407314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25270026|NCT02407080|Interferons|interferons|mesh-list
25270027|NCT02407080|Interferon-alpha|interferon-alpha|mesh-list
25270028|NCT02407080|Interferon alpha-2|interferon alpha-2|mesh-list
25270029|NCT02407080|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25675515|NCT01785472|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25675516|NCT01785472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675517|NCT01785615|Atorvastatin|atorvastatin|mesh-list
24836762|NCT02187367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836763|NCT02187367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24836764|NCT02187367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24836765|NCT02187367|Alkylating Agents|alkylating agents|mesh-ancestor
24836766|NCT02187367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836767|NCT02187367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24836768|NCT02187367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24836769|NCT02187419|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
24836770|NCT02187419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25270038|NCT02406950|Incretins|incretins|mesh-ancestor
24473443|NCT00402792|Analgesics|analgesics|mesh-ancestor
24473444|NCT00402792|Sensory System Agents|sensory system agents|mesh-ancestor
24475316|NCT00409890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24475317|NCT00409890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836787|NCT02187484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836788|NCT02187497|Telmisartan|telmisartan|mesh-list
24836789|NCT02187497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24836790|NCT02187497|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24836791|NCT02187497|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24836792|NCT02187497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836793|NCT02187523|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24836794|NCT02187523|Telmisartan|telmisartan|mesh-list
24836795|NCT02187523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24836796|NCT02187523|Diuretics|diuretics|mesh-ancestor
24618804|NCT01049711|Epoetin Alfa|epoetin alfa|mesh-list
25675518|NCT01785615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24643142|NCT01183910|Calcium|calcium|mesh-list
25270043|NCT02406950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25270044|NCT02406950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270045|NCT02406911|Ticagrelor|ticagrelor|mesh-list
25270046|NCT02406911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25270047|NCT02406911|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25270048|NCT02406911|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25270049|NCT02406911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25270050|NCT02406911|Purinergic Agents|purinergic agents|mesh-ancestor
25270051|NCT02406911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25675524|NCT01785615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675525|NCT01785810|Maraviroc|maraviroc|mesh-list
25675526|NCT01785810|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25675527|NCT01785810|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25675528|NCT01785810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675529|NCT01785810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25675530|NCT01785810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25675531|NCT01785810|Antiviral Agents|antiviral agents|mesh-ancestor
25675532|NCT01785810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675533|NCT01785810|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25675534|NCT01786109|Dronabinol|dronabinol|mesh-list
25675535|NCT01786109|Hallucinogens|hallucinogens|mesh-ancestor
25675536|NCT01786109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675537|NCT01786109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25675538|NCT01786109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25270056|NCT02406872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25270057|NCT02406872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270058|NCT02406872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25270059|NCT02406872|Anesthetics, General|anesthetics, general|mesh-ancestor
24475650|NCT00410995|Analgesics|analgesics|mesh-ancestor
24643468|NCT01185808|Vitamin D|vitamin d|mesh-list
24836942|NCT02188225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836943|NCT02188225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24836944|NCT02188225|Serotonin Agents|serotonin agents|mesh-ancestor
24836945|NCT02188225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836946|NCT02188225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24836947|NCT02188225|Antidepressive Agents|antidepressive agents|mesh-ancestor
24836948|NCT02188225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24836949|NCT02188225|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24836950|NCT02188225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24836951|NCT02188225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595701|NCT00940303|Leucovorin|leucovorin|mesh-list
24836974|NCT02188368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24836975|NCT02188368|Alkylating Agents|alkylating agents|mesh-ancestor
25675541|NCT01786109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25675542|NCT01786109|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25675543|NCT01786109|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25675544|NCT01786109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25675545|NCT01786109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675546|NCT01786109|Hormones|hormones|mesh-ancestor
25675547|NCT01786109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24567947|NCT00793663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25245553|NCT03898986|Immunologic Factors|immunologic factors|mesh-ancestor
25245554|NCT03898986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245556|NCT03891264|Anticonvulsants|anticonvulsants|mesh-ancestor
24589709|NCT00908713|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24589710|NCT00908713|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24589755|NCT00908869|Interferon-alpha|interferon-alpha|mesh-list
24589756|NCT00908869|Interferon alpha-2|interferon alpha-2|mesh-list
24589757|NCT00908869|Cyclophosphamide|cyclophosphamide|mesh-list
24589758|NCT00908869|Vinorelbine|vinorelbine|mesh-list
24589759|NCT00908869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24837036|NCT02188511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24837037|NCT02188511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24837038|NCT02188511|Cholinergic Agents|cholinergic agents|mesh-ancestor
24837039|NCT02188511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24837040|NCT02188511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837041|NCT02188537|Nelfinavir|nelfinavir|mesh-list
24837042|NCT02188537|Dexamethasone|dexamethasone|mesh-list
24837043|NCT02188537|Bortezomib|bortezomib|mesh-list
24837044|NCT02188537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25270062|NCT02406781|Cyclophosphamide|cyclophosphamide|mesh-list
24837045|NCT02188537|Antiemetics|antiemetics|mesh-ancestor
25270063|NCT02406781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25270064|NCT02406781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270065|NCT02406781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24475653|NCT00410995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475654|NCT00410995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24475655|NCT00410995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24475656|NCT00410995|Gout Suppressants|gout suppressants|mesh-ancestor
24725455|NCT01597765|Expectorants|expectorants|mesh-ancestor
24837046|NCT02188537|Autonomic Agents|autonomic agents|mesh-ancestor
25675550|NCT01786161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675551|NCT01786174|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25675552|NCT01786174|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25675553|NCT01786174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675554|NCT01786174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25675555|NCT01786174|Immunologic Factors|immunologic factors|mesh-ancestor
25675556|NCT01786174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675557|NCT01786239|Risperidone|risperidone|mesh-list
25675558|NCT01786239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25675559|NCT01786239|Serotonin Agents|serotonin agents|mesh-ancestor
25675560|NCT01786239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25675561|NCT01786239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675562|NCT01786239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675563|NCT01786239|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25675564|NCT01786239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25675565|NCT01786239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25675566|NCT01786239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25675567|NCT01786239|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25675568|NCT01786239|Dopamine Agents|dopamine agents|mesh-ancestor
25675569|NCT01786252|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25675570|NCT01786252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25270067|NCT02406781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270068|NCT02406781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25270069|NCT02406781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24837097|NCT02188888|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24837098|NCT02188888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24837099|NCT02188888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24837100|NCT02188888|Adrenergic Agents|adrenergic agents|mesh-ancestor
24837101|NCT02188888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24837102|NCT02188888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837103|NCT02188888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837104|NCT02188953|Calcium, Dietary|calcium, dietary|mesh-list
24837105|NCT02188953|Calcium Carbonate|calcium carbonate|mesh-list
24837106|NCT02188953|Calcium|calcium|mesh-list
24837107|NCT02188953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24837108|NCT02188953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837109|NCT02188953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24837111|NCT02188953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837113|NCT02189304|Budesonide|budesonide|mesh-list
24837114|NCT02189304|Glycopyrrolate|glycopyrrolate|mesh-list
24837115|NCT02189304|Formoterol Fumarate|formoterol fumarate|mesh-list
24643971|NCT01188148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675583|NCT01786551|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25675584|NCT01786551|Diuretics|diuretics|mesh-ancestor
25675585|NCT01786551|Natriuretic Agents|natriuretic agents|mesh-ancestor
25675586|NCT01786551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25675587|NCT01786603|Rasagiline|rasagiline|mesh-list
25675588|NCT01786603|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25675589|NCT01786603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675590|NCT01786603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675591|NCT01786603|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25675592|NCT01786603|Protective Agents|protective agents|mesh-ancestor
25675593|NCT01786603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675594|NCT01786668|Tofacitinib|tofacitinib|mesh-list
24837188|NCT02189655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24837189|NCT02189681|Anesthetics|anesthetics|mesh-list
24618947|NCT01050348|Calcium|calcium|mesh-list
24644209|NCT01189773|Ibuprofen|ibuprofen|mesh-list
24837190|NCT02189681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25675602|NCT01786902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25675603|NCT01786902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675604|NCT01786967|Fesoterodine|fesoterodine|mesh-list
25675605|NCT01786967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25675606|NCT01786967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25675607|NCT01786967|Cholinergic Agents|cholinergic agents|mesh-ancestor
25675608|NCT01786967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25692350|NCT01998919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837194|NCT02189694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24837196|NCT02189720|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24837197|NCT02189720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24837198|NCT02189720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837199|NCT02189720|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24837202|NCT02189772|Metadoxine|metadoxine|mesh-list
24837353|NCT02191124|Mirtazapine|mirtazapine|mesh-list
24837233|NCT02190526|Amitriptyline|amitriptyline|mesh-list
24473052|NCT00401635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473054|NCT00401648|Anticonvulsants|anticonvulsants|mesh-ancestor
24473055|NCT00401661|Alfuzosin|alfuzosin|mesh-list
25270075|NCT02406508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270076|NCT02406508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25270077|NCT02406508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473056|NCT00401661|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24473057|NCT00401661|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24473058|NCT00401661|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24473059|NCT00401661|Adrenergic Agents|adrenergic agents|mesh-ancestor
24473060|NCT00401661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24473061|NCT00401661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473062|NCT00401661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837294|NCT02190760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24837295|NCT02190760|Sensory System Agents|sensory system agents|mesh-ancestor
24837297|NCT02190838|Dacarbazine|dacarbazine|mesh-list
24837298|NCT02190838|Melatonin|melatonin|mesh-list
24837299|NCT02190838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24837300|NCT02190838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837301|NCT02190838|Antioxidants|antioxidants|mesh-ancestor
24837302|NCT02190838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837303|NCT02190838|Protective Agents|protective agents|mesh-ancestor
24837304|NCT02190838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24837305|NCT02190838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24837308|NCT02190994|Prednisone|prednisone|mesh-list
24837344|NCT02191059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473097|NCT00401804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837345|NCT02191059|Tubulin Modulators|tubulin modulators|mesh-ancestor
25675609|NCT01786967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675610|NCT01786967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675611|NCT01786967|Urological Agents|urological agents|mesh-ancestor
25675612|NCT01787006|Cisplatin|cisplatin|mesh-list
25675613|NCT01787006|Fluorouracil|fluorouracil|mesh-list
24473098|NCT00401856|Eplerenone|eplerenone|mesh-list
25245717|NCT03770455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25245724|NCT03762915|Minocycline|minocycline|mesh-list
25245725|NCT03762915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25245726|NCT03762915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25245729|NCT03746275|Aspirin|aspirin|mesh-list
25245730|NCT03746275|Rivaroxaban|rivaroxaban|mesh-list
25245731|NCT03746275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25245732|NCT03746275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25245733|NCT03746275|Analgesics|analgesics|mesh-ancestor
24473099|NCT00401856|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24473100|NCT00401856|Hormone Antagonists|hormone antagonists|mesh-ancestor
24473101|NCT00401856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24837346|NCT02191059|Antimitotic Agents|antimitotic agents|mesh-ancestor
24837347|NCT02191059|Mitosis Modulators|mitosis modulators|mesh-ancestor
24837348|NCT02191059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837349|NCT02191072|Omalizumab|omalizumab|mesh-list
24837350|NCT02191072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24837351|NCT02191072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24837352|NCT02191072|Respiratory System Agents|respiratory system agents|mesh-ancestor
24837354|NCT02191124|Paroxetine|paroxetine|mesh-list
24837355|NCT02191124|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24837356|NCT02191124|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24837389|NCT02191189|Nevirapine|nevirapine|mesh-list
24837390|NCT02191189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24837391|NCT02191189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24837392|NCT02191189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837393|NCT02191189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837410|NCT02191215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837411|NCT02191215|Antiviral Agents|antiviral agents|mesh-ancestor
24837436|NCT02191293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837437|NCT02191293|Antiviral Agents|antiviral agents|mesh-ancestor
24837438|NCT02191293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24837447|NCT02191319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837449|NCT02191319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24837450|NCT02191319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24837451|NCT02191319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24837452|NCT02191319|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24837453|NCT02191319|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24837454|NCT02191332|Nevirapine|nevirapine|mesh-list
24837455|NCT02191332|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24837456|NCT02191332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24837457|NCT02191332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837458|NCT02191332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837459|NCT02191332|Antiviral Agents|antiviral agents|mesh-ancestor
24837460|NCT02191332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25270078|NCT02406508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270079|NCT02406508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25270080|NCT02406508|Alkylating Agents|alkylating agents|mesh-ancestor
24837463|NCT02191332|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24837464|NCT02191332|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24837466|NCT02191371|Desflurane|desflurane|mesh-list
24837467|NCT02191371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24837468|NCT02191371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24837469|NCT02191371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837470|NCT02191371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24473154|NCT00402207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24473155|NCT00402207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24473156|NCT00402207|Autonomic Agents|autonomic agents|mesh-ancestor
24473157|NCT00402207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24473158|NCT00402207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675614|NCT01787006|Cetuximab|cetuximab|mesh-list
25675615|NCT01787006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675616|NCT01787006|Antimetabolites|antimetabolites|mesh-ancestor
25675617|NCT01787006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675618|NCT01787006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25675619|NCT01787006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25675620|NCT01787006|Immunologic Factors|immunologic factors|mesh-ancestor
25675621|NCT01787006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245743|NCT03746275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25245744|NCT03746275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25245745|NCT03746275|Antipyretics|antipyretics|mesh-ancestor
25245746|NCT03746275|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24473159|NCT00402207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24473160|NCT00402207|Respiratory System Agents|respiratory system agents|mesh-ancestor
24473161|NCT00402207|Dermatologic Agents|dermatologic agents|mesh-ancestor
24473162|NCT00402207|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24473163|NCT00402207|Glucocorticoids|glucocorticoids|mesh-ancestor
24837529|NCT02191839|Protein C Inhibitor|protein c inhibitor|mesh-list
24837530|NCT02191839|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24837531|NCT02191839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24837532|NCT02191839|Protease Inhibitors|protease inhibitors|mesh-ancestor
24837533|NCT02191839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837534|NCT02191839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837535|NCT02191891|Afatinib|afatinib|mesh-list
24837536|NCT02191891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24837584|NCT02192203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837585|NCT02192203|Antipruritics|antipruritics|mesh-ancestor
24837586|NCT02192203|Dermatologic Agents|dermatologic agents|mesh-ancestor
24837587|NCT02192229|Vitamin D|vitamin d|mesh-list
24837588|NCT02192229|Cholecalciferol|cholecalciferol|mesh-list
24837589|NCT02192229|Vitamins|vitamins|mesh-ancestor
24837590|NCT02192229|Micronutrients|micronutrients|mesh-ancestor
24837591|NCT02192229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837592|NCT02192229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24837593|NCT02192229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24837594|NCT02192320|Dexamethasone|dexamethasone|mesh-list
24837595|NCT02192320|Atorvastatin|atorvastatin|mesh-list
24837596|NCT02192320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24837622|NCT02192411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24596444|NCT00943566|Analgesics|analgesics|mesh-ancestor
24837699|NCT02192723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24837700|NCT02192723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24866567|NCT05259098|Anesthetics|anesthetics|mesh-ancestor
24837701|NCT02192723|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25270081|NCT02406508|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25270082|NCT02406508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25270083|NCT02406508|Immunologic Factors|immunologic factors|mesh-ancestor
25270084|NCT02406508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270085|NCT02406690|Leuprolide|leuprolide|mesh-list
25270086|NCT02406690|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25270087|NCT02406690|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25270088|NCT02406690|Estradiol|estradiol|mesh-list
25270089|NCT02406690|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25270090|NCT02406690|Progesterone|progesterone|mesh-list
25270091|NCT02406690|Estrogens|estrogens|mesh-ancestor
25270092|NCT02406690|Hormones|hormones|mesh-ancestor
24837704|NCT02192723|Antidepressive Agents|antidepressive agents|mesh-ancestor
24837711|NCT02192827|Dexamethasone acetate|dexamethasone acetate|mesh-list
24837712|NCT02192827|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24837714|NCT02192827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24837715|NCT02192827|Antiemetics|antiemetics|mesh-ancestor
24837716|NCT02192827|Autonomic Agents|autonomic agents|mesh-ancestor
25675622|NCT01787006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25675623|NCT01787032|Ketoconazole|ketoconazole|mesh-list
25675624|NCT01787032|Voriconazole|voriconazole|mesh-list
25675625|NCT01787032|Antifungal Agents|antifungal agents|mesh-ancestor
25675626|NCT01787032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675627|NCT01787032|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25675628|NCT01787032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25675629|NCT01787032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675630|NCT01787032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675631|NCT01787032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24837717|NCT02192827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25245783|NCT03723564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24837718|NCT02192827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837721|NCT02192827|Hormones|hormones|mesh-ancestor
24837789|NCT02193308|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24837790|NCT02193308|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24473222|NCT00402415|Antifungal Agents|antifungal agents|mesh-ancestor
24473223|NCT00402415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24473224|NCT00402415|Immunologic Factors|immunologic factors|mesh-ancestor
24473226|NCT00402415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24837844|NCT02194049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837847|NCT02194075|Methylphenidate|methylphenidate|mesh-list
24473292|NCT00402493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473293|NCT00402493|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24473294|NCT00402493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24473295|NCT00402493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24473296|NCT00402493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24473297|NCT00402493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24473298|NCT00402493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24473299|NCT00402493|Adrenergic Agents|adrenergic agents|mesh-ancestor
24473300|NCT00402493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24473302|NCT00402506|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
24473303|NCT00402506|Vitamin B Complex|vitamin b complex|mesh-ancestor
24837888|NCT02194179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24837889|NCT02194179|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24473326|NCT00402558|Aldesleukin|aldesleukin|mesh-list
24473327|NCT00402558|Methotrexate|methotrexate|mesh-list
24837920|NCT02194218|Antiviral Agents|antiviral agents|mesh-ancestor
24444767|NCT00299039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24444768|NCT00299039|Antitussive Agents|antitussive agents|mesh-ancestor
24444769|NCT00299039|Respiratory System Agents|respiratory system agents|mesh-ancestor
24444770|NCT00299065|Zileuton|zileuton|mesh-list
24444771|NCT00299065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24444772|NCT00299065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24444773|NCT00299065|Analgesics|analgesics|mesh-ancestor
24837968|NCT02194374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270093|NCT02406690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25270094|NCT02406690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270095|NCT02406690|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24837970|NCT02194374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24838010|NCT02194686|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24838011|NCT02194686|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24838012|NCT02194686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24838013|NCT02194764|Naltrexone|naltrexone|mesh-list
24838014|NCT02194764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24838015|NCT02194764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24838016|NCT02194764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838017|NCT02194764|Sensory System Agents|sensory system agents|mesh-ancestor
24838018|NCT02194764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838019|NCT02194829|Gemcitabine|gemcitabine|mesh-list
24838020|NCT02194829|Paclitaxel|paclitaxel|mesh-list
24838021|NCT02194829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24838022|NCT02194829|Adavosertib|adavosertib|mesh-list
24473389|NCT00402610|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24473390|NCT00402610|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24473391|NCT00402610|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25675632|NCT01787032|Hormone Antagonists|hormone antagonists|mesh-ancestor
25675633|NCT01787032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25675634|NCT01787032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473392|NCT00402610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24473393|NCT00402610|Antimetabolites|antimetabolites|mesh-ancestor
24473394|NCT00402610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24473397|NCT00402623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838049|NCT02194894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24838050|NCT02194894|Analgesics|analgesics|mesh-ancestor
24838051|NCT02194894|Sensory System Agents|sensory system agents|mesh-ancestor
24838052|NCT02194894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838053|NCT02194894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838054|NCT02194894|Antipyretics|antipyretics|mesh-ancestor
24838055|NCT02194920|Parathyroid Hormone|parathyroid hormone|mesh-list
24838070|NCT02195115|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24838071|NCT02195115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24838072|NCT02195115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24838073|NCT02195115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838075|NCT02195115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24444786|NCT00299091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24444787|NCT00299091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24444788|NCT00299091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24838091|NCT02195180|Antidotes|antidotes|mesh-ancestor
24838092|NCT02195180|Protective Agents|protective agents|mesh-ancestor
24838093|NCT02195180|Vitamin B Complex|vitamin b complex|mesh-ancestor
24838094|NCT02195180|Vitamins|vitamins|mesh-ancestor
24838095|NCT02195180|Micronutrients|micronutrients|mesh-ancestor
24838096|NCT02195271|Melatonin|melatonin|mesh-list
24838097|NCT02195271|Antioxidants|antioxidants|mesh-ancestor
24751109|NCT01702103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24644887|NCT01193595|Bevacizumab|bevacizumab|mesh-list
24838120|NCT02195375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25270096|NCT02406690|Contraceptive Agents|contraceptive agents|mesh-ancestor
25270097|NCT02406690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25270098|NCT02406690|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25270099|NCT02406690|Progestins|progestins|mesh-ancestor
25270100|NCT02406690|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25270101|NCT02406690|Fertility Agents|fertility agents|mesh-ancestor
24838121|NCT02195375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838123|NCT02195375|Respiratory System Agents|respiratory system agents|mesh-ancestor
24473454|NCT00402792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24838165|NCT02195635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24838166|NCT02195661|Melatonin|melatonin|mesh-list
24838172|NCT02195661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24838173|NCT02195661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24838174|NCT02195791|Pioglitazone|pioglitazone|mesh-list
24838175|NCT02195791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24838176|NCT02195791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838177|NCT02195804|Ranitidine|ranitidine|mesh-list
24838178|NCT02195804|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
24838179|NCT02195804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24838180|NCT02195804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24838181|NCT02195804|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24838182|NCT02195804|Histamine Antagonists|histamine antagonists|mesh-ancestor
24672207|NCT01330615|Lidocaine|lidocaine|mesh-list
24838183|NCT02195804|Histamine Agents|histamine agents|mesh-ancestor
24838184|NCT02195804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24838185|NCT02195804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838186|NCT02195804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838187|NCT02195817|Nalmefene|nalmefene|mesh-list
24838188|NCT02195817|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24838189|NCT02195817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838190|NCT02195817|Sensory System Agents|sensory system agents|mesh-ancestor
24838191|NCT02195817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838192|NCT02195908|Antiemetics|antiemetics|mesh-list
24838193|NCT02195908|Autonomic Agents|autonomic agents|mesh-ancestor
24838194|NCT02195908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838195|NCT02195908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473462|NCT00402974|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24473463|NCT00402974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24473464|NCT00402974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473465|NCT00402974|Hemostatics|hemostatics|mesh-ancestor
24473466|NCT00402974|Coagulants|coagulants|mesh-ancestor
24838238|NCT02196207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838240|NCT02196285|Immunologic Factors|immunologic factors|mesh-ancestor
24838241|NCT02196285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838242|NCT02196441|Bupivacaine|bupivacaine|mesh-list
24838243|NCT02196441|Anesthetics, Local|anesthetics, local|mesh-list
24838244|NCT02196441|Tetracaine|tetracaine|mesh-list
24838245|NCT02196441|Anesthetics|anesthetics|mesh-list
24838258|NCT02196662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838259|NCT02196662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838260|NCT02196662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24838261|NCT02196662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24838262|NCT02196740|Metronidazole|metronidazole|mesh-list
24838263|NCT02196740|Ciprofloxacin|ciprofloxacin|mesh-list
24838264|NCT02196740|Clindamycin|clindamycin|mesh-list
24838265|NCT02196740|Clindamycin palmitate|clindamycin palmitate|mesh-list
24473481|NCT00403026|Bevacizumab|bevacizumab|mesh-list
24473482|NCT00403026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24473483|NCT00403026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473484|NCT00403026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24473485|NCT00403026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24473486|NCT00403026|Growth Substances|growth substances|mesh-ancestor
24473487|NCT00403026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473488|NCT00403026|Growth Inhibitors|growth inhibitors|mesh-ancestor
24473489|NCT00403039|Ranibizumab|ranibizumab|mesh-list
24473490|NCT00403039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24838272|NCT02196740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24838273|NCT02196740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24838274|NCT02196740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24838275|NCT02196740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838276|NCT02196740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24838277|NCT02196740|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24838278|NCT02196740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24838279|NCT02196740|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24838280|NCT02196740|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25270102|NCT02406690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25270103|NCT02406690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270104|NCT02406703|Mepivacaine|mepivacaine|mesh-list
24838283|NCT02196805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24838284|NCT02196805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24838285|NCT02196805|Antimetabolites|antimetabolites|mesh-ancestor
24838287|NCT02196805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24473495|NCT00403039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473496|NCT00403052|1018 oligonucleotide|1018 oligonucleotide|mesh-list
24473497|NCT00403052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24473498|NCT00403052|Immunologic Factors|immunologic factors|mesh-ancestor
24838374|NCT02197403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838375|NCT02197403|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24473501|NCT00403065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24473502|NCT00403065|Antiemetics|antiemetics|mesh-ancestor
24838402|NCT02197637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838403|NCT02197650|Asparaginase|asparaginase|mesh-list
24838453|NCT02198001|Clavulanic Acid|clavulanic acid|mesh-list
24838454|NCT02198001|Clavulanic Acids|clavulanic acids|mesh-list
24838455|NCT02198001|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24838456|NCT02198001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24838457|NCT02198001|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24838458|NCT02198001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24838459|NCT02198001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838460|NCT02198027|Bupivacaine|bupivacaine|mesh-list
24838461|NCT02198027|Anesthetics, Local|anesthetics, local|mesh-ancestor
24838462|NCT02198027|Anesthetics|anesthetics|mesh-ancestor
24838463|NCT02198027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24838464|NCT02198027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838465|NCT02198027|Sensory System Agents|sensory system agents|mesh-ancestor
24838466|NCT02198027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838498|NCT02198248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24838499|NCT02198248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24838503|NCT02198300|Clopidogrel|clopidogrel|mesh-list
24838520|NCT02198378|Sensory System Agents|sensory system agents|mesh-ancestor
24838521|NCT02198378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838522|NCT02198378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24838523|NCT02198378|Antipyretics|antipyretics|mesh-ancestor
25270105|NCT02406703|Chloroprocaine|chloroprocaine|mesh-list
25270106|NCT02406703|Anesthetics, Local|anesthetics, local|mesh-ancestor
25270107|NCT02406703|Anesthetics|anesthetics|mesh-ancestor
25270108|NCT02406703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25270109|NCT02406703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270110|NCT02406703|Sensory System Agents|sensory system agents|mesh-ancestor
25270111|NCT02406703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24476659|NCT00416039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24476660|NCT00416039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838524|NCT02198378|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24672997|NCT01334671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24672998|NCT01334671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673039|NCT01334905|Urological Agents|urological agents|mesh-ancestor
24673076|NCT01335126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24673077|NCT01335139|Immunologic Factors|immunologic factors|mesh-list
24673078|NCT01335139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838525|NCT02198378|Anesthetics|anesthetics|mesh-ancestor
24838526|NCT02198404|Propofol|propofol|mesh-list
24838527|NCT02198404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24838586|NCT02198508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838587|NCT02198547|Magnesium Sulfate|magnesium sulfate|mesh-list
24838588|NCT02198547|Ropivacaine|ropivacaine|mesh-list
24838589|NCT02198547|Anesthetics, Local|anesthetics, local|mesh-ancestor
24473523|NCT00403182|Letrozole|letrozole|mesh-list
24473524|NCT00403182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473525|NCT00403182|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24473526|NCT00403182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24473527|NCT00403182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473528|NCT00403182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473529|NCT00403182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24473530|NCT00403182|Hormone Antagonists|hormone antagonists|mesh-ancestor
24444799|NCT00299208|Artesunate|artesunate|mesh-list
24838637|NCT02198924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24838638|NCT02198924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444801|NCT00299208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24444802|NCT00299208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24444803|NCT00299208|Antimalarials|antimalarials|mesh-ancestor
24444804|NCT00299208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24444805|NCT00299208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24444806|NCT00299208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24444807|NCT00299208|Antiviral Agents|antiviral agents|mesh-ancestor
24444808|NCT00299208|Schistosomicides|schistosomicides|mesh-ancestor
24444809|NCT00299208|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24444810|NCT00299208|Anthelmintics|anthelmintics|mesh-ancestor
24838671|NCT02199418|Cisplatin|cisplatin|mesh-list
24838672|NCT02199418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24444821|NCT00299234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24838772|NCT02200172|Antioxidants|antioxidants|mesh-ancestor
25270126|NCT02406300|Anesthetics|anesthetics|mesh-ancestor
24838773|NCT02200172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838774|NCT02200172|Protective Agents|protective agents|mesh-ancestor
24838775|NCT02200172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838776|NCT02200172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24838777|NCT02200185|Morphine|morphine|mesh-list
24838778|NCT02200185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24838779|NCT02200185|Narcotics|narcotics|mesh-ancestor
24838780|NCT02200185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24838781|NCT02200185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838782|NCT02200185|Analgesics|analgesics|mesh-ancestor
24838783|NCT02200185|Sensory System Agents|sensory system agents|mesh-ancestor
24838784|NCT02200185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838785|NCT02200237|Aluminum phosphate|aluminum phosphate|mesh-list
25270112|NCT02406521|Sorafenib|sorafenib|mesh-list
24673087|NCT01335321|Immunologic Factors|immunologic factors|mesh-ancestor
25270113|NCT02406521|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25270114|NCT02406521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270115|NCT02406521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25270116|NCT02406521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25270117|NCT02406521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270118|NCT02406287|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25270119|NCT02406287|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24476690|NCT00416169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476691|NCT00416169|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24476693|NCT00416169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24476694|NCT00416169|Nootropic Agents|nootropic agents|mesh-ancestor
24838786|NCT02200237|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24838787|NCT02200237|Immunologic Factors|immunologic factors|mesh-ancestor
24838788|NCT02200237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838789|NCT02200237|Antacids|antacids|mesh-ancestor
24838790|NCT02200237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838791|NCT02200237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24838792|NCT02200315|Anti-Infective Agents|anti-infective agents|mesh-list
24838827|NCT02200575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24838828|NCT02200575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838830|NCT02200640|Telmisartan|telmisartan|mesh-list
24838831|NCT02200640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24838832|NCT02200640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24838833|NCT02200640|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24838836|NCT02200653|Losartan|losartan|mesh-list
24838844|NCT02200718|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24840056|NCT02207348|Incretins|incretins|mesh-ancestor
24838951|NCT02201238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24838953|NCT02201238|Sensory System Agents|sensory system agents|mesh-ancestor
24838954|NCT02201238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838955|NCT02201238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838956|NCT02201238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24838957|NCT02201238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24838958|NCT02201238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24839011|NCT02201563|Minocycline|minocycline|mesh-list
24839012|NCT02201563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24839013|NCT02201563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24839014|NCT02201576|Bortezomib|bortezomib|mesh-list
24473609|NCT00403442|Bevacizumab|bevacizumab|mesh-list
24473610|NCT00403442|Verteporfin|verteporfin|mesh-list
24473611|NCT00403442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24473612|NCT00403442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473613|NCT00403442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24473614|NCT00403442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25068411|NCT03433586|Antipyretics|antipyretics|mesh-ancestor
24473615|NCT00403442|Growth Substances|growth substances|mesh-ancestor
24473616|NCT00403442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473617|NCT00403442|Growth Inhibitors|growth inhibitors|mesh-ancestor
24473618|NCT00403442|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24473619|NCT00403442|Dermatologic Agents|dermatologic agents|mesh-ancestor
24473620|NCT00403533|Atorvastatin|atorvastatin|mesh-list
24839047|NCT02201667|Antipyretics|antipyretics|mesh-ancestor
24839048|NCT02201667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24839050|NCT02201667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24839084|NCT02202005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24839085|NCT02202005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24839086|NCT02202005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24839087|NCT02202005|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24839088|NCT02202005|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24839089|NCT02202070|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24839090|NCT02202070|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24839091|NCT02202070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24839092|NCT02202070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24839093|NCT02202070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270124|NCT02406300|Desflurane|desflurane|mesh-list
25270125|NCT02406300|Anesthetics, Local|anesthetics, local|mesh-ancestor
24958064|NCT03838029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24645291|NCT01197170|Everolimus|everolimus|mesh-list
24473673|NCT00403780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839165|NCT02202512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24839166|NCT02202512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839167|NCT02202512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24839168|NCT02202512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24839169|NCT02202512|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24839170|NCT02202512|Histamine Antagonists|histamine antagonists|mesh-ancestor
24839171|NCT02202512|Histamine Agents|histamine agents|mesh-ancestor
24839172|NCT02202512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24839173|NCT02202512|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24839174|NCT02202512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24839175|NCT02202525|Telmisartan|telmisartan|mesh-list
24839176|NCT02202525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24839177|NCT02202525|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24839178|NCT02202525|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24839179|NCT02202525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839180|NCT02202564|Ganciclovir|ganciclovir|mesh-list
24839181|NCT02202564|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
24839182|NCT02202564|Antiviral Agents|antiviral agents|mesh-ancestor
24839183|NCT02202564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24839184|NCT02202564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24839185|NCT02202564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24839186|NCT02202564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473689|NCT00403806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24473690|NCT00403806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473692|NCT00403806|Glucocorticoids|glucocorticoids|mesh-ancestor
24473693|NCT00403806|Hormones|hormones|mesh-ancestor
24473694|NCT00403806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24473695|NCT00403806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24839208|NCT02202707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24839209|NCT02202707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24839210|NCT02202707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24839211|NCT02202707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24839212|NCT02202707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839213|NCT02202707|Antimanic Agents|antimanic agents|mesh-ancestor
24839280|NCT02203253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24839318|NCT02203422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270129|NCT02406300|Sensory System Agents|sensory system agents|mesh-ancestor
25270130|NCT02406300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25270131|NCT02406300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25270132|NCT02406300|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25270133|NCT02406300|Anesthetics, General|anesthetics, general|mesh-ancestor
25270134|NCT02406183|Ipilimumab|ipilimumab|mesh-list
25270135|NCT02406183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25270136|NCT02406183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270137|NCT02406183|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24839319|NCT02203422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24839320|NCT02203422|Immunologic Factors|immunologic factors|mesh-ancestor
24839321|NCT02203422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839322|NCT02203422|Antifungal Agents|antifungal agents|mesh-ancestor
25675635|NCT01787032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24839323|NCT02203422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673830|NCT01340547|Ifosfamide|ifosfamide|mesh-list
24839324|NCT02203422|Dermatologic Agents|dermatologic agents|mesh-ancestor
24839325|NCT02203422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24839326|NCT02203422|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24839327|NCT02203461|Ritonavir|ritonavir|mesh-list
24839328|NCT02203461|Lopinavir|lopinavir|mesh-list
24839329|NCT02203461|Darunavir|darunavir|mesh-list
24839330|NCT02203461|Tenofovir|tenofovir|mesh-list
24839331|NCT02203461|Emtricitabine|emtricitabine|mesh-list
24839332|NCT02203461|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24839333|NCT02203461|Cobicistat|cobicistat|mesh-list
24839334|NCT02203461|Elvitegravir|elvitegravir|mesh-list
24839335|NCT02203461|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24839337|NCT02203461|Protease Inhibitors|protease inhibitors|mesh-ancestor
24839373|NCT02203604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839374|NCT02203604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24839375|NCT02203604|Analgesics|analgesics|mesh-ancestor
24839376|NCT02203604|Sensory System Agents|sensory system agents|mesh-ancestor
24839377|NCT02203604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24839378|NCT02203604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24839379|NCT02203604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24839542|NCT02205151|Vasodilator Agents|vasodilator agents|mesh-ancestor
24839611|NCT02205489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24839612|NCT02205489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24839613|NCT02205489|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24839614|NCT02205489|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24839615|NCT02205489|Histamine Antagonists|histamine antagonists|mesh-ancestor
24839650|NCT02205580|Dsuvia|dsuvia|mesh-list
24839668|NCT02205775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24839669|NCT02205775|Ezetimibe|ezetimibe|mesh-list
24839670|NCT02205775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24839671|NCT02205775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24839672|NCT02205775|Antimetabolites|antimetabolites|mesh-ancestor
24839673|NCT02205775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839674|NCT02205775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24839675|NCT02205775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24839676|NCT02205775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24839677|NCT02205879|Pregabalin|pregabalin|mesh-list
24839678|NCT02205879|Analgesics|analgesics|mesh-ancestor
24839728|NCT02205931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24839729|NCT02205931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24839809|NCT02206204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24839810|NCT02206204|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24839811|NCT02206204|Contraceptive Agents|contraceptive agents|mesh-ancestor
24839812|NCT02206204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24839813|NCT02206204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839814|NCT02206204|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24839877|NCT02206490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839878|NCT02206490|Sensory System Agents|sensory system agents|mesh-ancestor
24839879|NCT02206490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24839880|NCT02206490|Antitussive Agents|antitussive agents|mesh-ancestor
24839881|NCT02206490|Respiratory System Agents|respiratory system agents|mesh-ancestor
24839882|NCT02206490|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24839883|NCT02206490|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24839884|NCT02206490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24839891|NCT02206503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270138|NCT02406183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270139|NCT02406144|Dexamethasone|dexamethasone|mesh-list
25270140|NCT02406144|Lenalidomide|lenalidomide|mesh-list
25270141|NCT02406144|Ixazomib|ixazomib|mesh-list
24519395|NCT01724866|Mitosis Modulators|mitosis modulators|mesh-ancestor
24519396|NCT01711021|Amphetamine|amphetamine|mesh-list
24519397|NCT01711021|Dextroamphetamine|dextroamphetamine|mesh-list
25675636|NCT01787097|Formoterol Fumarate|formoterol fumarate|mesh-list
24590646|NCT00913419|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24839917|NCT02206555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24839918|NCT02206555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24839919|NCT02206555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839920|NCT02206555|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24839940|NCT02206737|Nicotine|nicotine|mesh-list
24839941|NCT02206737|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24839942|NCT02206737|Autonomic Agents|autonomic agents|mesh-ancestor
24839943|NCT02206737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24839944|NCT02206737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839945|NCT02206737|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24839946|NCT02206737|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24839948|NCT02206737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24839949|NCT02206737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839950|NCT02206763|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24839951|NCT02206763|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
24839993|NCT02206815|Ticagrelor|ticagrelor|mesh-list
24839994|NCT02206815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24839995|NCT02206815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24839996|NCT02206815|Analgesics|analgesics|mesh-ancestor
24645658|NCT01199276|Anesthetics|anesthetics|mesh-ancestor
24840044|NCT02207335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24840045|NCT02207335|Antimetabolites|antimetabolites|mesh-ancestor
24840046|NCT02207335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840047|NCT02207335|Antiviral Agents|antiviral agents|mesh-ancestor
24840048|NCT02207335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24840049|NCT02207335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840050|NCT02207335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24840051|NCT02207335|Immunologic Factors|immunologic factors|mesh-ancestor
24840052|NCT02207335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840054|NCT02207348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24840055|NCT02207348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840057|NCT02207348|Hormones|hormones|mesh-ancestor
24840058|NCT02207348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24840059|NCT02207361|Paclitaxel|paclitaxel|mesh-list
24840060|NCT02207361|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25270142|NCT02406144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25270143|NCT02406144|Antiemetics|antiemetics|mesh-ancestor
25270144|NCT02406144|Autonomic Agents|autonomic agents|mesh-ancestor
25270145|NCT02406144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25270146|NCT02406144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270147|NCT02406144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25270148|NCT02406144|Glucocorticoids|glucocorticoids|mesh-ancestor
25270149|NCT02406144|Hormones|hormones|mesh-ancestor
25270150|NCT02406144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24610703|NCT01004497|Mitosis Modulators|mitosis modulators|mesh-ancestor
25270151|NCT02406144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25270152|NCT02406144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270153|NCT02406144|Immunologic Factors|immunologic factors|mesh-ancestor
25270154|NCT02406144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25270155|NCT02406144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25270156|NCT02406144|Growth Substances|growth substances|mesh-ancestor
24476812|NCT00416533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24840061|NCT02207361|Carboplatin|carboplatin|mesh-list
24840062|NCT02207361|Epirubicin|epirubicin|mesh-list
24840096|NCT02207452|Autonomic Agents|autonomic agents|mesh-ancestor
24840097|NCT02207452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24840098|NCT02207452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840099|NCT02207452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24840100|NCT02207452|Respiratory System Agents|respiratory system agents|mesh-ancestor
24840101|NCT02207452|Tocolytic Agents|tocolytic agents|mesh-ancestor
24840102|NCT02207452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24840103|NCT02207452|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24840104|NCT02207452|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24840105|NCT02207452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24840108|NCT02207452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840109|NCT02207452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24840139|NCT02207920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840140|NCT02207959|Proflavine|proflavine|mesh-list
24840141|NCT02207959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24840142|NCT02207959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24840143|NCT02208128|Bevacizumab|bevacizumab|mesh-list
24840144|NCT02208128|Sunitinib|sunitinib|mesh-list
24840145|NCT02208128|Everolimus|everolimus|mesh-list
24840146|NCT02208128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24840147|NCT02208128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24840148|NCT02208128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24840149|NCT02208128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24840150|NCT02208128|Growth Substances|growth substances|mesh-ancestor
24840151|NCT02208128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840152|NCT02208128|Growth Inhibitors|growth inhibitors|mesh-ancestor
24840170|NCT02208245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24840172|NCT02208427|Rifapentine|rifapentine|mesh-list
24840173|NCT02208427|Antitubercular Agents|antitubercular agents|mesh-ancestor
24840174|NCT02208427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24840175|NCT02208427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24840176|NCT02208427|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24840177|NCT02208427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24840178|NCT02208427|Antimetabolites|antimetabolites|mesh-ancestor
24840179|NCT02208427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599481|NCT04492956|Dopamine Agents|dopamine agents|mesh-ancestor
24840228|NCT02208596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840229|NCT02208596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24840230|NCT02208596|Anesthetics, General|anesthetics, general|mesh-ancestor
24840231|NCT02208596|Anesthetics|anesthetics|mesh-ancestor
24840232|NCT02208596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24840233|NCT02208596|Narcotics|narcotics|mesh-ancestor
24840269|NCT02208882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24840270|NCT02208882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840272|NCT02208882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24840273|NCT02208882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24840274|NCT02208882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25270157|NCT02406144|Growth Inhibitors|growth inhibitors|mesh-ancestor
25270158|NCT02406144|Protease Inhibitors|protease inhibitors|mesh-ancestor
25270159|NCT02406144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25270160|NCT02406144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476814|NCT00416585|Dermatologic Agents|dermatologic agents|mesh-ancestor
24967067|NCT03763084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24967068|NCT03763084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24840317|NCT02209350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840318|NCT02209350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24840319|NCT02209350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25675637|NCT01787097|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25675638|NCT01787097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25675639|NCT01787097|Autonomic Agents|autonomic agents|mesh-ancestor
25675640|NCT01787097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25675641|NCT01787097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840320|NCT02209350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24840321|NCT02209350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25279171|NCT02346110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24590716|NCT00913666|Interferon beta-1a|interferon beta-1a|mesh-list
24590722|NCT00913666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24590723|NCT00913718|Fluoxetine|fluoxetine|mesh-list
24590744|NCT00913783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590745|NCT00913783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24590746|NCT00913783|Serotonin Agents|serotonin agents|mesh-ancestor
24852494|NCT02262624|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24852495|NCT02262624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840322|NCT02209350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840323|NCT02209350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24840324|NCT02209350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24840325|NCT02209350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840326|NCT02209350|Antipyretics|antipyretics|mesh-ancestor
24840327|NCT02209350|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24840328|NCT02209350|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24840329|NCT02209350|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24840330|NCT02209350|Purinergic Agents|purinergic agents|mesh-ancestor
24840331|NCT02209350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24840332|NCT02209428|Temozolomide|temozolomide|mesh-list
24840333|NCT02209428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24840334|NCT02209428|Alkylating Agents|alkylating agents|mesh-ancestor
24840335|NCT02209428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840336|NCT02209428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24840337|NCT02209441|Sorafenib|sorafenib|mesh-list
24599712|NCT03973177|Hormones|hormones|mesh-ancestor
24446210|NCT00304018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24446211|NCT00304018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24446212|NCT00304018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24446213|NCT00304018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840354|NCT02209649|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24840355|NCT02209649|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24840356|NCT02209649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840357|NCT02209649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24840358|NCT02209649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24840359|NCT02209649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24840360|NCT02209649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840361|NCT02209701|Porfiromycin|porfiromycin|mesh-list
24840362|NCT02209701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24840363|NCT02209701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24840364|NCT02209740|Tenofovir|tenofovir|mesh-list
24840365|NCT02209740|Antiviral Agents|antiviral agents|mesh-ancestor
24840366|NCT02209740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24840406|NCT02209987|Immunologic Factors|immunologic factors|mesh-ancestor
24840440|NCT02210156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840442|NCT02210169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24840443|NCT02210169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25270162|NCT02406170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25270163|NCT02406170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270165|NCT02406170|Antimitotic Agents|antimitotic agents|mesh-ancestor
25270166|NCT02406170|Mitosis Modulators|mitosis modulators|mesh-ancestor
25270167|NCT02406170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270168|NCT02406014|Diclofenac|diclofenac|mesh-list
25270169|NCT02406014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25270170|NCT02406014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25270171|NCT02406014|Analgesics|analgesics|mesh-ancestor
24840446|NCT02210182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24840447|NCT02210182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24840448|NCT02210182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24840449|NCT02210182|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24840450|NCT02210260|Heroin|heroin|mesh-list
24840451|NCT02210260|Bupivacaine|bupivacaine|mesh-list
24840452|NCT02210260|Anesthetics, Local|anesthetics, local|mesh-list
24840453|NCT02210260|Anesthetics|anesthetics|mesh-list
24840454|NCT02210260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24840455|NCT02210260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675642|NCT01787097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25675643|NCT01787097|Respiratory System Agents|respiratory system agents|mesh-ancestor
25675644|NCT01787097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25675645|NCT01787097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25675646|NCT01787097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25675647|NCT01787097|Adrenergic Agents|adrenergic agents|mesh-ancestor
25675648|NCT01787097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25675649|NCT01787097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840456|NCT02210260|Sensory System Agents|sensory system agents|mesh-ancestor
24840457|NCT02210260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24840465|NCT02210325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24840466|NCT02210364|Capecitabine|capecitabine|mesh-list
24840467|NCT02210364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24840468|NCT02210364|Antimetabolites|antimetabolites|mesh-ancestor
24840469|NCT02210364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840470|NCT02210364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599891|NCT03284502|Cetuximab|cetuximab|mesh-list
24840471|NCT02210598|Oxytocin|oxytocin|mesh-list
24840472|NCT02210598|Oxytocics|oxytocics|mesh-ancestor
24840475|NCT02210663|Veliparib|veliparib|mesh-list
24840484|NCT02210702|Norethindrone Acetate|norethindrone acetate|mesh-list
24840486|NCT02210702|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24840487|NCT02210702|Estrogens|estrogens|mesh-ancestor
24840488|NCT02210702|Hormones|hormones|mesh-ancestor
24840489|NCT02210702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24840490|NCT02210702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646063|NCT01201694|Curcumin|curcumin|mesh-list
24840549|NCT02210858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24840550|NCT02210884|Vitamin D|vitamin d|mesh-list
24840551|NCT02210884|Ergocalciferols|ergocalciferols|mesh-list
24840552|NCT02210884|Cholecalciferol|cholecalciferol|mesh-list
24840553|NCT02210884|Vitamins|vitamins|mesh-list
24840554|NCT02210884|Micronutrients|micronutrients|mesh-ancestor
24840555|NCT02210884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840556|NCT02210884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24840558|NCT02210949|Epoetin Alfa|epoetin alfa|mesh-list
24840602|NCT02211118|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24840603|NCT02211118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24840604|NCT02211118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24840678|NCT02211729|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24840706|NCT02211950|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24840707|NCT02211950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840708|NCT02211950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840724|NCT02212210|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24840725|NCT02212210|Prednisolone|prednisolone|mesh-list
24840726|NCT02212210|Prednisolone acetate|prednisolone acetate|mesh-list
24840727|NCT02212210|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24840728|NCT02212210|Prednisolone phosphate|prednisolone phosphate|mesh-list
24840729|NCT02212210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24840730|NCT02212210|Antiemetics|antiemetics|mesh-ancestor
24840731|NCT02212210|Autonomic Agents|autonomic agents|mesh-ancestor
24473997|NCT00404716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24840754|NCT02212340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24840755|NCT02212340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840756|NCT02212340|Analgesics|analgesics|mesh-ancestor
24840757|NCT02212340|Sensory System Agents|sensory system agents|mesh-ancestor
24840758|NCT02212340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24840759|NCT02212340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24840760|NCT02212340|Anesthetics, General|anesthetics, general|mesh-ancestor
24840761|NCT02212340|Anesthetics|anesthetics|mesh-ancestor
24868216|NCT02318329|Bemarituzumab|bemarituzumab|mesh-list
24840762|NCT02212340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24840802|NCT02212613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840803|NCT02212613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840804|NCT02212613|Dopamine Agonists|dopamine agonists|mesh-ancestor
24840807|NCT02212639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24840808|NCT02212639|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24840809|NCT02212639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25270172|NCT02406014|Sensory System Agents|sensory system agents|mesh-ancestor
24967071|NCT03763045|Sildenafil Citrate|sildenafil citrate|mesh-list
24967072|NCT03763045|Vasodilator Agents|vasodilator agents|mesh-ancestor
24967074|NCT03763045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24476863|NCT00416767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24840810|NCT02212639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840813|NCT02212652|Vitamin D|vitamin d|mesh-list
24840844|NCT02212795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24840845|NCT02212795|Renal Agents|renal agents|mesh-ancestor
24840846|NCT02212795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24840847|NCT02212795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24840848|NCT02212795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24840849|NCT02212795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840850|NCT02212795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840851|NCT02212795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24840854|NCT02212795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24840855|NCT02212808|Anti-Infective Agents|anti-infective agents|mesh-list
24840856|NCT02212808|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24840906|NCT02213159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24840907|NCT02213159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24840908|NCT02213159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840909|NCT02213159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24840911|NCT02213159|Sensory System Agents|sensory system agents|mesh-ancestor
24840912|NCT02213159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24840913|NCT02213159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24840914|NCT02213159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24840915|NCT02213159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24840916|NCT02213159|Adrenergic Agents|adrenergic agents|mesh-ancestor
24840917|NCT02213159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24840918|NCT02213159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840919|NCT02213159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24840921|NCT02213211|Lumefantrine|lumefantrine|mesh-list
24840922|NCT02213211|Artemether|artemether|mesh-list
24840948|NCT02213302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24840949|NCT02213302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840973|NCT02213328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840974|NCT02213328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24840975|NCT02213328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24840977|NCT02213419|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24840978|NCT02213419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24840979|NCT02213419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24840980|NCT02213419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841020|NCT02213718|Anesthetics, General|anesthetics, general|mesh-ancestor
24841033|NCT02213744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24841034|NCT02213744|Antimetabolites|antimetabolites|mesh-ancestor
24841035|NCT02213744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841036|NCT02213744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841037|NCT02213744|Antiviral Agents|antiviral agents|mesh-ancestor
24841038|NCT02213744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24841039|NCT02213744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25270173|NCT02406014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25270174|NCT02406014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270175|NCT02406014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25270176|NCT02406014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25270177|NCT02406014|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24476866|NCT00416767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24841040|NCT02213744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24841041|NCT02213744|Immunologic Factors|immunologic factors|mesh-ancestor
24841042|NCT02213744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841043|NCT02213744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24841044|NCT02213744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24841045|NCT02213744|Tubulin Modulators|tubulin modulators|mesh-ancestor
24841046|NCT02213744|Antimitotic Agents|antimitotic agents|mesh-ancestor
24841047|NCT02213744|Mitosis Modulators|mitosis modulators|mesh-ancestor
24841066|NCT02213887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841067|NCT02213887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675650|NCT01787188|Meloxicam|meloxicam|mesh-list
25675651|NCT01787188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25675652|NCT01787188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25675653|NCT01787188|Analgesics|analgesics|mesh-ancestor
25675654|NCT01787188|Sensory System Agents|sensory system agents|mesh-ancestor
24591002|NCT00914654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24591003|NCT00914654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591004|NCT00914654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24852510|NCT02262637|Natriuretic Agents|natriuretic agents|mesh-ancestor
24960327|NCT03818048|Propofol|propofol|mesh-list
24852511|NCT02262637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841069|NCT02213913|Cyclophosphamide|cyclophosphamide|mesh-list
24841071|NCT02213913|Doxorubicin|doxorubicin|mesh-list
24841072|NCT02213913|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24841074|NCT02213913|Vincristine|vincristine|mesh-list
24841075|NCT02213913|Lenalidomide|lenalidomide|mesh-list
24841076|NCT02213913|Etoposide phosphate|etoposide phosphate|mesh-list
24841077|NCT02213913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24841078|NCT02213913|Immunologic Factors|immunologic factors|mesh-ancestor
24841079|NCT02213913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841110|NCT02214004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841111|NCT02214004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841112|NCT02214004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24841113|NCT02214004|Hormone Antagonists|hormone antagonists|mesh-ancestor
24841114|NCT02214004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24841115|NCT02214004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841116|NCT02214095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24841117|NCT02214368|Propofol|propofol|mesh-list
24841118|NCT02214368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24841119|NCT02214368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24841120|NCT02214368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841121|NCT02214368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24841122|NCT02214368|Anesthetics, General|anesthetics, general|mesh-ancestor
24841123|NCT02214368|Anesthetics|anesthetics|mesh-ancestor
24841124|NCT02214381|Paclitaxel|paclitaxel|mesh-list
24841125|NCT02214381|Cyclophosphamide|cyclophosphamide|mesh-list
24841126|NCT02214381|Doxorubicin|doxorubicin|mesh-list
24841127|NCT02214381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24841128|NCT02214381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841129|NCT02214381|Tubulin Modulators|tubulin modulators|mesh-ancestor
24841140|NCT02214381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24841141|NCT02214381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24841142|NCT02214381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24841149|NCT02214433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841150|NCT02214433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841151|NCT02214498|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24841152|NCT02214498|Enalapril|enalapril|mesh-list
24841153|NCT02214498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24841154|NCT02214498|Diuretics|diuretics|mesh-ancestor
24841155|NCT02214498|Natriuretic Agents|natriuretic agents|mesh-ancestor
24841156|NCT02214498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841157|NCT02214498|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24841158|NCT02214498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24646558|NCT01204307|Cisplatin|cisplatin|mesh-list
24841178|NCT02214602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841179|NCT02214680|Timolol|timolol|mesh-list
24841180|NCT02214680|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24841181|NCT02214680|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
24841182|NCT02214680|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24841183|NCT02214680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25270179|NCT02406014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270180|NCT02405910|Gemcitabine|gemcitabine|mesh-list
25270181|NCT02405910|Paclitaxel|paclitaxel|mesh-list
25270182|NCT02405910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25270183|NCT02405910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270184|NCT02405910|Tubulin Modulators|tubulin modulators|mesh-ancestor
25675655|NCT01787188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25675656|NCT01787188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675657|NCT01787188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25675658|NCT01787188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24548418|NCT00709436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25675659|NCT01787188|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25675660|NCT01787188|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25675661|NCT01787188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675662|NCT01787188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841186|NCT02214680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591083|NCT00914901|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24591084|NCT00914901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24591085|NCT00914901|Autonomic Agents|autonomic agents|mesh-ancestor
24591086|NCT00914901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24568642|NCT00796835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24568643|NCT00796835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568644|NCT00796835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24568645|NCT00796835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24512830|NCT00577057|Fluorouracil|fluorouracil|mesh-list
24568659|NCT00796887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24841217|NCT02214966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841218|NCT02214966|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24841219|NCT02214966|Protease Inhibitors|protease inhibitors|mesh-ancestor
24841220|NCT02214966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841221|NCT02214979|Telmisartan|telmisartan|mesh-list
24841222|NCT02214979|Ramipril|ramipril|mesh-list
24841223|NCT02214979|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24841224|NCT02214979|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24841225|NCT02214979|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24841226|NCT02214979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841227|NCT02214979|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24841228|NCT02214979|Protease Inhibitors|protease inhibitors|mesh-ancestor
24841234|NCT02214992|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24841235|NCT02214992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841236|NCT02214992|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24841237|NCT02214992|Protease Inhibitors|protease inhibitors|mesh-ancestor
24841238|NCT02214992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841239|NCT02215005|Telmisartan|telmisartan|mesh-list
24841240|NCT02215005|Ramipril|ramipril|mesh-list
24841241|NCT02215005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24841242|NCT02215005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24841243|NCT02215005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25068490|NCT03433001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24841244|NCT02215005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841245|NCT02215005|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24841246|NCT02215005|Protease Inhibitors|protease inhibitors|mesh-ancestor
24841247|NCT02215005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841248|NCT02215018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24841249|NCT02215044|Gemcitabine|gemcitabine|mesh-list
24841250|NCT02215044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24841393|NCT02215720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24841394|NCT02215720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24841395|NCT02215720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24841396|NCT02215720|Antifungal Agents|antifungal agents|mesh-ancestor
24841398|NCT02215720|Immunologic Factors|immunologic factors|mesh-ancestor
24841414|NCT02215798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24841415|NCT02215798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24841416|NCT02215798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841417|NCT02215798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24841418|NCT02215798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841420|NCT02215798|Sensory System Agents|sensory system agents|mesh-ancestor
24841421|NCT02215798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24841422|NCT02215798|Antidepressive Agents|antidepressive agents|mesh-ancestor
24841423|NCT02215798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24841424|NCT02215798|Dopamine Agents|dopamine agents|mesh-ancestor
24841425|NCT02215863|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24841458|NCT02216045|Antiviral Agents|antiviral agents|mesh-ancestor
24841459|NCT02216045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24841460|NCT02216045|Immunologic Factors|immunologic factors|mesh-ancestor
24841461|NCT02216045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841463|NCT02216058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25675663|NCT01787240|Citalopram|citalopram|mesh-list
25675664|NCT01787240|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25675665|NCT01787240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25675666|NCT01787240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25675667|NCT01787240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675668|NCT01787240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25675669|NCT01787240|Serotonin Agents|serotonin agents|mesh-ancestor
25675670|NCT01787240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675671|NCT01787240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24852518|NCT02262650|Purinergic Agents|purinergic agents|mesh-ancestor
24852519|NCT02262650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24568716|NCT00797160|Propofol|propofol|mesh-list
24841464|NCT02216058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24841465|NCT02216058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24841466|NCT02216058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841467|NCT02216058|Antifungal Agents|antifungal agents|mesh-ancestor
24841468|NCT02216058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25270185|NCT02405910|Antimitotic Agents|antimitotic agents|mesh-ancestor
25270186|NCT02405910|Mitosis Modulators|mitosis modulators|mesh-ancestor
25270187|NCT02405910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270188|NCT02405910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25270189|NCT02405910|Antimetabolites|antimetabolites|mesh-ancestor
24476870|NCT00416767|Protective Agents|protective agents|mesh-ancestor
24476871|NCT00416767|Vitamin B Complex|vitamin b complex|mesh-ancestor
24841469|NCT02216058|Immunologic Factors|immunologic factors|mesh-ancestor
24841470|NCT02216058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841472|NCT02216149|Tegafur|tegafur|mesh-list
24841473|NCT02216149|Oxaliplatin|oxaliplatin|mesh-list
24841474|NCT02216149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24841478|NCT02216227|Iodine|iodine|mesh-list
24841516|NCT02216331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24841517|NCT02216331|Leprostatic Agents|leprostatic agents|mesh-ancestor
24678300|NCT01360788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24841566|NCT02216617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841568|NCT02216617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841569|NCT02216656|Cinacalcet|cinacalcet|mesh-list
24841570|NCT02216656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24841571|NCT02216656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841572|NCT02216656|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24841573|NCT02216656|Hormone Antagonists|hormone antagonists|mesh-ancestor
24841574|NCT02216656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24841575|NCT02216669|Imidazole|imidazole|mesh-list
24841576|NCT02216669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841577|NCT02216669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841578|NCT02216747|Prednisone|prednisone|mesh-list
24841579|NCT02216747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24841580|NCT02216747|Glucocorticoids|glucocorticoids|mesh-ancestor
24841581|NCT02216747|Hormones|hormones|mesh-ancestor
24841582|NCT02216747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24841601|NCT02216799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841602|NCT02216877|Magnesium Hydroxide|magnesium hydroxide|mesh-list
24841603|NCT02216877|Antacids|antacids|mesh-ancestor
24841604|NCT02216877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841605|NCT02216877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24841606|NCT02216994|Mineral Oil|mineral oil|mesh-list
24841607|NCT02216994|Lactulose|lactulose|mesh-list
24841608|NCT02216994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24841609|NCT02216994|Emollients|emollients|mesh-ancestor
24841610|NCT02216994|Dermatologic Agents|dermatologic agents|mesh-ancestor
24841613|NCT02217007|Calcium|calcium|mesh-list
24841616|NCT02217007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24841617|NCT02217007|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24841618|NCT02217020|Oxaliplatin|oxaliplatin|mesh-list
24841619|NCT02217020|Irinotecan|irinotecan|mesh-list
24841620|NCT02217020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841621|NCT02217020|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24841622|NCT02217020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24841680|NCT02217514|Anesthetics, General|anesthetics, general|mesh-ancestor
24841682|NCT02217514|GABA Modulators|gaba modulators|mesh-ancestor
24841683|NCT02217514|GABA Agents|gaba agents|mesh-ancestor
24841684|NCT02217514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24841685|NCT02217514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841686|NCT02217553|Cholecalciferol|cholecalciferol|mesh-list
24841687|NCT02217553|Vitamin D|vitamin d|mesh-list
25675672|NCT01787240|Antidepressive Agents|antidepressive agents|mesh-ancestor
25675673|NCT01787240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24841688|NCT02217553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24841689|NCT02217553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675674|NCT01787279|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24841745|NCT02217787|PF-06372865|pf-06372865|mesh-list
24841746|NCT02217787|GABA Modulators|gaba modulators|mesh-ancestor
24841747|NCT02217787|GABA Agents|gaba agents|mesh-ancestor
24841748|NCT02217787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24841749|NCT02217787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841750|NCT02217787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841751|NCT02217826|Octreotide|octreotide|mesh-list
24841752|NCT02217826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24841753|NCT02217826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24841754|NCT02217826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841755|NCT02217839|Octreotide|octreotide|mesh-list
24841756|NCT02217839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24841757|NCT02217839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25270193|NCT02405910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25270194|NCT02405910|Immunologic Factors|immunologic factors|mesh-ancestor
25270195|NCT02405910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270196|NCT02406066|Oxazepam|oxazepam|mesh-list
25270197|NCT02406066|Metyrapone|metyrapone|mesh-list
24476877|NCT00416819|Methotrexate|methotrexate|mesh-list
24476878|NCT00416819|Etoposide|etoposide|mesh-list
24476879|NCT00416819|Temozolomide|temozolomide|mesh-list
24476880|NCT00416819|Etoposide phosphate|etoposide phosphate|mesh-list
24476881|NCT00416819|Levoleucovorin|levoleucovorin|mesh-list
24841786|NCT02217956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24841787|NCT02217956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24841788|NCT02217956|Growth Substances|growth substances|mesh-ancestor
24841789|NCT02217956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841790|NCT02217956|Growth Inhibitors|growth inhibitors|mesh-ancestor
24841791|NCT02218021|Oxycodone|oxycodone|mesh-list
25675678|NCT01787331|Antifungal Agents|antifungal agents|mesh-ancestor
25675679|NCT01787331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24841792|NCT02218021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24841837|NCT02218398|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24841838|NCT02218398|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24841840|NCT02218398|Adrenergic Agents|adrenergic agents|mesh-ancestor
24841841|NCT02218398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24841842|NCT02218398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841854|NCT02218645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24619434|NCT01052389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24619435|NCT01052389|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24841863|NCT02218671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841865|NCT02218684|Lacidipine|lacidipine|mesh-list
24841866|NCT02218684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24841867|NCT02218684|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24841868|NCT02218684|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24841869|NCT02218684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841870|NCT02218684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24841871|NCT02218684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24841872|NCT02218684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24841873|NCT02218684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841874|NCT02218697|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24841875|NCT02218697|Immunologic Factors|immunologic factors|mesh-ancestor
24841876|NCT02218697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841877|NCT02218762|Fluticasone|fluticasone|mesh-list
24841878|NCT02218762|Xhance|xhance|mesh-list
24841879|NCT02218762|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24841880|NCT02218762|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24841881|NCT02218762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24841882|NCT02218762|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24841887|NCT02218762|Respiratory System Agents|respiratory system agents|mesh-ancestor
24841888|NCT02218762|Dermatologic Agents|dermatologic agents|mesh-ancestor
24754294|NCT01719952|Oxytocin|oxytocin|mesh-list
24841889|NCT02218762|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24841890|NCT02218762|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24841891|NCT02218762|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24841892|NCT02218762|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25140333|NCT02965196|Hormones|hormones|mesh-ancestor
24841893|NCT02218762|Adrenergic Agents|adrenergic agents|mesh-ancestor
24841894|NCT02218762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24841895|NCT02218762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841897|NCT02218762|Hormones|hormones|mesh-ancestor
25241752|NCT05300009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841898|NCT02218762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24841899|NCT02218762|Sympathomimetics|sympathomimetics|mesh-ancestor
24841900|NCT02218775|Aticaprant|aticaprant|mesh-list
24841901|NCT02218775|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24841902|NCT02218775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841903|NCT02218775|Sensory System Agents|sensory system agents|mesh-ancestor
24841904|NCT02218775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24841905|NCT02218814|Bupivacaine|bupivacaine|mesh-list
25270198|NCT02406066|Antimetabolites|antimetabolites|mesh-ancestor
25270199|NCT02406066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270200|NCT02406066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25270201|NCT02406066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24476882|NCT00416819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24476883|NCT00416819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476884|NCT00416819|Immunologic Factors|immunologic factors|mesh-ancestor
24476885|NCT00416819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476886|NCT00416819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24841906|NCT02218814|Anesthetics, Local|anesthetics, local|mesh-ancestor
24841908|NCT02218814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24841909|NCT02218814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841910|NCT02218814|Sensory System Agents|sensory system agents|mesh-ancestor
24841911|NCT02218814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24841912|NCT02218827|Loteprednol Etabonate|loteprednol etabonate|mesh-list
24841913|NCT02218827|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24841914|NCT02218879|Dimethyl Fumarate|dimethyl fumarate|mesh-list
24568870|NCT00797810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24568871|NCT00797810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24568873|NCT00797810|Antimitotic Agents|antimitotic agents|mesh-ancestor
24568874|NCT00797810|Mitosis Modulators|mitosis modulators|mesh-ancestor
24568875|NCT00797836|Interferons|interferons|mesh-list
24568889|NCT00798070|Docetaxel|docetaxel|mesh-list
24568935|NCT00798083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24568936|NCT00798083|Adrenergic Agents|adrenergic agents|mesh-ancestor
24568937|NCT00798148|Carboplatin|carboplatin|mesh-list
24568939|NCT00798148|Melphalan|melphalan|mesh-list
24568940|NCT00798148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24568952|NCT00798213|Gemtuzumab|gemtuzumab|mesh-list
24841915|NCT02218879|Dermatologic Agents|dermatologic agents|mesh-ancestor
25270202|NCT02406066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25270203|NCT02406066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270204|NCT02406066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25270205|NCT02406066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25270206|NCT02406066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24476887|NCT00416819|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24476889|NCT00416819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24476890|NCT00416819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24476891|NCT00416819|Antimetabolites|antimetabolites|mesh-ancestor
24842034|NCT02219490|Antiviral Agents|antiviral agents|mesh-ancestor
24842035|NCT02219490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24842036|NCT02219646|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24842039|NCT02219646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24842040|NCT02219646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842041|NCT02219646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842042|NCT02219646|Urological Agents|urological agents|mesh-ancestor
24842043|NCT02219659|Fentanyl|fentanyl|mesh-list
24842044|NCT02219659|Midazolam|midazolam|mesh-list
25675680|NCT01787331|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25675681|NCT01787331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25675682|NCT01787331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675683|NCT01787331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675684|NCT01787331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25675685|NCT01787331|Hormone Antagonists|hormone antagonists|mesh-ancestor
25675686|NCT01787331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25675687|NCT01787331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675688|NCT01787331|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25675689|NCT01787916|Liraglutide|liraglutide|mesh-list
25675690|NCT01787916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25675691|NCT01787916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675692|NCT01787916|Incretins|incretins|mesh-ancestor
25675693|NCT01787916|Hormones|hormones|mesh-ancestor
25675694|NCT01787916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25675695|NCT01788215|Doxycycline|doxycycline|mesh-list
24568994|NCT00798395|Serotonin Agents|serotonin agents|mesh-ancestor
24568995|NCT00798395|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24568996|NCT00798460|Lamivudine|lamivudine|mesh-list
24568997|NCT00798460|Adefovir|adefovir|mesh-list
24568998|NCT00798460|Clevudine|clevudine|mesh-list
24568999|NCT00798460|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24889092|NCT04498260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569004|NCT00798460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24569017|NCT00798525|Anticoagulants|anticoagulants|mesh-ancestor
24569018|NCT00798525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24569019|NCT00798525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24569020|NCT00798525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24569021|NCT00798616|Methylprednisolone|methylprednisolone|mesh-list
24569029|NCT00798616|Antiemetics|antiemetics|mesh-ancestor
24842045|NCT02219659|Propofol|propofol|mesh-list
24842051|NCT02219659|Anesthetics|anesthetics|mesh-ancestor
24842064|NCT02219659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842067|NCT02219672|Tenofovir|tenofovir|mesh-list
24842068|NCT02219672|Lamivudine|lamivudine|mesh-list
24842069|NCT02219672|Raltegravir Potassium|raltegravir potassium|mesh-list
24842070|NCT02219672|Triptolide|triptolide|mesh-list
24842071|NCT02219672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24842072|NCT02219672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24842073|NCT02219672|Protease Inhibitors|protease inhibitors|mesh-ancestor
24842074|NCT02219672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842075|NCT02219672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842076|NCT02219672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24842077|NCT02219672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24842078|NCT02219672|Antiviral Agents|antiviral agents|mesh-ancestor
24842079|NCT02219672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24842080|NCT02219672|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24842081|NCT02219672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24842082|NCT02219672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24842083|NCT02219672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24842084|NCT02219672|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24842085|NCT02219672|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24842086|NCT02219672|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
24842087|NCT02219672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842088|NCT02219672|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24842089|NCT02219672|Contraceptive Agents|contraceptive agents|mesh-ancestor
24842090|NCT02219672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24842091|NCT02219672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24842092|NCT02219672|Immunologic Factors|immunologic factors|mesh-ancestor
24842094|NCT02219672|Alkylating Agents|alkylating agents|mesh-ancestor
24842113|NCT02219737|Etoposide|etoposide|mesh-list
24842114|NCT02219737|Etoposide phosphate|etoposide phosphate|mesh-list
24842115|NCT02219737|Ifosfamide|ifosfamide|mesh-list
24842131|NCT02219737|Alkylating Agents|alkylating agents|mesh-ancestor
24842132|NCT02219737|Keratolytic Agents|keratolytic agents|mesh-ancestor
24842133|NCT02219737|Dermatologic Agents|dermatologic agents|mesh-ancestor
24842134|NCT02219737|Tubulin Modulators|tubulin modulators|mesh-ancestor
24842135|NCT02219737|Antimitotic Agents|antimitotic agents|mesh-ancestor
24842167|NCT02219867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24842168|NCT02219867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24842169|NCT02219867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24842171|NCT02219893|Immunotoxins|immunotoxins|mesh-list
24842180|NCT02219906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24842182|NCT02220023|Nitric Oxide|nitric oxide|mesh-list
24842183|NCT02220023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25270207|NCT02406066|GABA Modulators|gaba modulators|mesh-ancestor
25270208|NCT02406066|GABA Agents|gaba agents|mesh-ancestor
25270209|NCT02406066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25270210|NCT02406092|Prednisone|prednisone|mesh-list
25270211|NCT02406092|Cyclophosphamide|cyclophosphamide|mesh-list
25675696|NCT01788215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25675697|NCT01788215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675698|NCT01788215|Antimalarials|antimalarials|mesh-ancestor
25675699|NCT01788215|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25675700|NCT01788215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25675701|NCT01788228|Vaccines|vaccines|mesh-list
25675702|NCT01788228|Immunologic Factors|immunologic factors|mesh-ancestor
25675703|NCT01788228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675704|NCT01788358|Candesartan|candesartan|mesh-list
25675705|NCT01788358|Candesartan cilexetil|candesartan cilexetil|mesh-list
25675706|NCT01788358|Nifedipine|nifedipine|mesh-list
25675707|NCT01788358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25675708|NCT01788358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25270212|NCT02406092|Rituximab|rituximab|mesh-list
25675709|NCT01788358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24569057|NCT00798876|Antioxidants|antioxidants|mesh-ancestor
24569058|NCT00798876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569059|NCT00798876|Protective Agents|protective agents|mesh-ancestor
24569060|NCT00798915|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
24569061|NCT00798915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24569062|NCT00798915|Incretins|incretins|mesh-ancestor
24569063|NCT00798915|Hormones|hormones|mesh-ancestor
24569102|NCT00799045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24569103|NCT00799045|Purinergic Agents|purinergic agents|mesh-ancestor
24569104|NCT00799045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24591275|NCT00915733|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24591276|NCT00915733|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24591277|NCT00915746|Ketoconazole|ketoconazole|mesh-list
25270213|NCT02406092|Doxorubicin|doxorubicin|mesh-list
24476892|NCT00416819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476903|NCT00416819|Antidotes|antidotes|mesh-ancestor
24842197|NCT02220036|Magnesium Oxide|magnesium oxide|mesh-list
24842199|NCT02220036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842200|NCT02220036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24842201|NCT02220049|Bortezomib|bortezomib|mesh-list
24842202|NCT02220049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24842203|NCT02220088|Leucovorin|leucovorin|mesh-list
24842204|NCT02220088|Fluorouracil|fluorouracil|mesh-list
24842205|NCT02220088|Oxaliplatin|oxaliplatin|mesh-list
24842206|NCT02220088|Sorafenib|sorafenib|mesh-list
24842207|NCT02220088|Antimetabolites|antimetabolites|mesh-ancestor
24842208|NCT02220088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842209|NCT02220088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24842210|NCT02220088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24842211|NCT02220088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24842220|NCT02220088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842221|NCT02220114|Vigabatrin|vigabatrin|mesh-list
24842222|NCT02220114|Anticonvulsants|anticonvulsants|mesh-ancestor
24842223|NCT02220114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842224|NCT02220114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842225|NCT02220114|GABA Agents|gaba agents|mesh-ancestor
24842226|NCT02220114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24842236|NCT02220218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24842237|NCT02220218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842239|NCT02220296|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24842264|NCT02220361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24842265|NCT02220361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25675710|NCT01788358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675711|NCT01788358|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25675712|NCT01788358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25675713|NCT01788358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25675714|NCT01788358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675715|NCT01788358|Vasodilator Agents|vasodilator agents|mesh-ancestor
25675716|NCT01788358|Tocolytic Agents|tocolytic agents|mesh-ancestor
25675717|NCT01788358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25675718|NCT01788566|Gemcitabine|gemcitabine|mesh-list
25675719|NCT01788566|Cisplatin|cisplatin|mesh-list
25675720|NCT01788566|Necitumumab|necitumumab|mesh-list
25675721|NCT01788566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675722|NCT01788566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25675723|NCT01788566|Antimetabolites|antimetabolites|mesh-ancestor
25675724|NCT01788566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675725|NCT01788566|Antiviral Agents|antiviral agents|mesh-ancestor
25675726|NCT01788566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675727|NCT01788566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675728|NCT01788566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25675729|NCT01788566|Immunologic Factors|immunologic factors|mesh-ancestor
25675730|NCT01788566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675731|NCT01788566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24569156|NCT00799149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24569172|NCT00799175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24569173|NCT00799175|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24569175|NCT00799175|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24842282|NCT02220400|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24842283|NCT02220400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24842284|NCT02220400|Anesthetics, General|anesthetics, general|mesh-ancestor
24842286|NCT02220400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24842287|NCT02220400|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24842288|NCT02220400|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24842289|NCT02220400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24842290|NCT02220400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842291|NCT02220504|Antipsychotic Agents|antipsychotic agents|mesh-list
24842292|NCT02220504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24842293|NCT02220504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24842294|NCT02220504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842295|NCT02220504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24842305|NCT02220530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24842306|NCT02220530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24842308|NCT02220530|Anesthetics|anesthetics|mesh-ancestor
24842309|NCT02220530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24842310|NCT02220530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24842313|NCT02220530|GABA Modulators|gaba modulators|mesh-ancestor
24474333|NCT00405717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24842340|NCT02220647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842341|NCT02220647|Incretins|incretins|mesh-ancestor
24842342|NCT02220647|Hormones|hormones|mesh-ancestor
25270214|NCT02406092|Fludarabine|fludarabine|mesh-list
25270215|NCT02406092|Vincristine|vincristine|mesh-list
25270216|NCT02406092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24842343|NCT02220647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24842344|NCT02220647|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24842345|NCT02220647|Protease Inhibitors|protease inhibitors|mesh-ancestor
24842346|NCT02220647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842347|NCT02220647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842348|NCT02220660|Olodaterol|olodaterol|mesh-list
24842349|NCT02220660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24842494|NCT02221492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24842496|NCT02221492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24602218|NCT00967655|Panitumumab|panitumumab|mesh-list
24842497|NCT02221531|Carbetocin|carbetocin|mesh-list
24842498|NCT02221531|Oxytocin|oxytocin|mesh-list
24842499|NCT02221531|Oxytocics|oxytocics|mesh-ancestor
24842500|NCT02221531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24842501|NCT02221531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842503|NCT02221570|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24842504|NCT02221570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842505|NCT02221570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24842506|NCT02221570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24842507|NCT02221570|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24842508|NCT02221570|GABA Agonists|gaba agonists|mesh-ancestor
24842509|NCT02221570|GABA Agents|gaba agents|mesh-ancestor
24842513|NCT02221583|Tacrolimus|tacrolimus|mesh-list
24842530|NCT02221596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24842531|NCT02221622|Pregnanolone|pregnanolone|mesh-list
24842532|NCT02221622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24842533|NCT02221622|Anesthetics|anesthetics|mesh-ancestor
24842534|NCT02221622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24842535|NCT02221622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842536|NCT02221635|Risperidone|risperidone|mesh-list
24842563|NCT02221960|Durvalumab|durvalumab|mesh-list
25675732|NCT01788631|Regadenoson|regadenoson|mesh-list
25675733|NCT01788631|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25675734|NCT01788631|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25675735|NCT01788631|Purinergic Agonists|purinergic agonists|mesh-ancestor
25675736|NCT01788631|Purinergic Agents|purinergic agents|mesh-ancestor
24569191|NCT00799188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569193|NCT00799201|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24569194|NCT00799201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008931|NCT03837873|Antimitotic Agents|antimitotic agents|mesh-ancestor
25246354|NCT03034642|Sequestering Agents|sequestering agents|mesh-ancestor
25246355|NCT03034642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274364|NCT02378415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25274365|NCT02378415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25274366|NCT02378415|Anesthetics, General|anesthetics, general|mesh-ancestor
25274367|NCT02378415|Anesthetics|anesthetics|mesh-ancestor
25274368|NCT02378415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25274369|NCT02378415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24869937|NCT05070650|Analgesics|analgesics|mesh-ancestor
24842595|NCT02222220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24842596|NCT02222220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842597|NCT02222220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24842598|NCT02222220|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24842599|NCT02222220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24842600|NCT02222220|Dopamine Agents|dopamine agents|mesh-ancestor
24842601|NCT02222220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24842602|NCT02222220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842603|NCT02222324|Moxifloxacin|moxifloxacin|mesh-list
24842604|NCT02222324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24842605|NCT02222324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24842606|NCT02222324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24842607|NCT02222324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24842608|NCT02222324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842609|NCT02222324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842610|NCT02222324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24842611|NCT02222350|Firuglipel|firuglipel|mesh-list
24842612|NCT02222350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24842613|NCT02222350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842614|NCT02222376|Pirfenidone|pirfenidone|mesh-list
24842615|NCT02222376|Analgesics|analgesics|mesh-ancestor
24842616|NCT02222376|Sensory System Agents|sensory system agents|mesh-ancestor
24842617|NCT02222376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24842618|NCT02222376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842619|NCT02222376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24842620|NCT02222376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24842621|NCT02222376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24842622|NCT02222376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25270217|NCT02406092|Immunologic Factors|immunologic factors|mesh-ancestor
25270218|NCT02406092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270219|NCT02406092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25270220|NCT02406092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24476926|NCT00416832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24842623|NCT02222376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24842624|NCT02222428|Olodaterol|olodaterol|mesh-list
24842625|NCT02222428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24842654|NCT02222519|Anticonvulsants|anticonvulsants|mesh-ancestor
24842655|NCT02222519|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24602437|NCT00968877|Vitamins|vitamins|mesh-ancestor
24842656|NCT02222519|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24842657|NCT02222519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24842658|NCT02222519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25675737|NCT01788631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25675738|NCT01788631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675739|NCT01788631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675740|NCT01789047|Topiramate|topiramate|mesh-list
25675741|NCT01789047|Amantadine|amantadine|mesh-list
25675742|NCT01789047|Anticonvulsants|anticonvulsants|mesh-ancestor
25675743|NCT01789047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25675744|NCT01789047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675745|NCT01789047|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25675746|NCT01789047|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25675747|NCT01789047|Antiviral Agents|antiviral agents|mesh-ancestor
25675748|NCT01789047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675749|NCT01789047|Dopamine Agents|dopamine agents|mesh-ancestor
25675750|NCT01789047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24842662|NCT02222623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842664|NCT02222636|Dexmedetomidine|dexmedetomidine|mesh-list
24842701|NCT02222727|Nootropic Agents|nootropic agents|mesh-ancestor
24842702|NCT02222740|Hydrocodone|hydrocodone|mesh-list
24842703|NCT02222740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24842704|NCT02222740|Narcotics|narcotics|mesh-ancestor
24842705|NCT02222740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24842706|NCT02222740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842707|NCT02222740|Analgesics|analgesics|mesh-ancestor
24842708|NCT02222740|Sensory System Agents|sensory system agents|mesh-ancestor
24842709|NCT02222740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24842710|NCT02222740|Antitussive Agents|antitussive agents|mesh-ancestor
24842711|NCT02222740|Respiratory System Agents|respiratory system agents|mesh-ancestor
24842712|NCT02222987|Clopidogrel|clopidogrel|mesh-list
24842713|NCT02222987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24842727|NCT02223026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24842728|NCT02223026|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24842730|NCT02223026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842731|NCT02223026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842732|NCT02223052|Azacitidine|azacitidine|mesh-list
24842733|NCT02223052|Cc-486|cc-486|mesh-list
24842734|NCT02223052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24842794|NCT02223832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842797|NCT02223884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24842798|NCT02223884|Tubulin Modulators|tubulin modulators|mesh-ancestor
24842799|NCT02223884|Antimitotic Agents|antimitotic agents|mesh-ancestor
24842800|NCT02223884|Mitosis Modulators|mitosis modulators|mesh-ancestor
24842801|NCT02223884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842802|NCT02223949|Alprostadil|alprostadil|mesh-list
24842803|NCT02223949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24842804|NCT02223949|Vasodilator Agents|vasodilator agents|mesh-ancestor
24842805|NCT02223949|Urological Agents|urological agents|mesh-ancestor
24842806|NCT02224014|Brotizolam|brotizolam|mesh-list
24842807|NCT02224014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24842808|NCT02224014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24842809|NCT02224014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842810|NCT02224040|Azithromycin|azithromycin|mesh-list
24842811|NCT02224040|Ceftriaxone|ceftriaxone|mesh-list
24842812|NCT02224040|Cefixime|cefixime|mesh-list
24842813|NCT02224040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24842814|NCT02224040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24842815|NCT02224066|Aspirin|aspirin|mesh-list
24842816|NCT02224066|Clopidogrel|clopidogrel|mesh-list
24842817|NCT02224066|Ticagrelor|ticagrelor|mesh-list
24842818|NCT02224066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24842819|NCT02224066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24842820|NCT02224066|Analgesics|analgesics|mesh-ancestor
24842821|NCT02224066|Sensory System Agents|sensory system agents|mesh-ancestor
24842840|NCT02224105|Methylprednisolone|methylprednisolone|mesh-list
25270221|NCT02406092|Alkylating Agents|alkylating agents|mesh-ancestor
25270222|NCT02406092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270223|NCT02406092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270224|NCT02406092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24476927|NCT00416832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24476928|NCT00416832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24476929|NCT00416832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24476930|NCT00416832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675751|NCT01789047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675752|NCT01789047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25675753|NCT01789047|Analgesics|analgesics|mesh-ancestor
24842847|NCT02224105|Hormones|hormones|mesh-ancestor
24842848|NCT02224105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24842849|NCT02224105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842850|NCT02224105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24842851|NCT02224105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24842852|NCT02224105|Antiemetics|antiemetics|mesh-ancestor
24842853|NCT02224105|Autonomic Agents|autonomic agents|mesh-ancestor
24842854|NCT02224105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24842855|NCT02224105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24842856|NCT02224105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24842857|NCT02224105|Protective Agents|protective agents|mesh-ancestor
24842858|NCT02224131|Aspirin|aspirin|mesh-list
24842859|NCT02224131|Clopidogrel|clopidogrel|mesh-list
24842860|NCT02224131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24842861|NCT02224131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24842862|NCT02224131|Analgesics|analgesics|mesh-ancestor
24842863|NCT02224131|Sensory System Agents|sensory system agents|mesh-ancestor
24842864|NCT02224131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24842865|NCT02224131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842866|NCT02224131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24842867|NCT02224131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24842868|NCT02224131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24755246|NCT01725412|Thiamine|thiamine|mesh-list
24842971|NCT02224534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842974|NCT02224768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24842975|NCT02224768|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24842976|NCT02224768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842978|NCT02224937|Antioxidants|antioxidants|mesh-ancestor
24842979|NCT02224937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842980|NCT02224937|Protective Agents|protective agents|mesh-ancestor
24842981|NCT02224937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870394|NCT05162456|Immunoglobulin G|immunoglobulin g|mesh-list
24842982|NCT02224937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24842983|NCT02224950|Emollients|emollients|mesh-list
24842984|NCT02224950|Chitosan|chitosan|mesh-list
24842985|NCT02224950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24842986|NCT02224950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24842987|NCT02224950|Antimetabolites|antimetabolites|mesh-ancestor
24843011|NCT02225054|Anesthetics|anesthetics|mesh-ancestor
24843013|NCT02225067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24843014|NCT02225067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843015|NCT02225093|Dextromethorphan|dextromethorphan|mesh-list
24843016|NCT02225093|Caffeine|caffeine|mesh-list
24843017|NCT02225093|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24843018|NCT02225093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843019|NCT02225093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24843020|NCT02225093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24843021|NCT02225093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843022|NCT02225093|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24843023|NCT02225093|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25270225|NCT02406092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25270226|NCT02406092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25270227|NCT02406092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25270228|NCT02406092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24476933|NCT00416832|Hormones|hormones|mesh-ancestor
24728224|NCT01615042|Lenalidomide|lenalidomide|mesh-list
24843048|NCT02225210|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24843049|NCT02225210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24843111|NCT02225652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24843112|NCT02225652|Alkylating Agents|alkylating agents|mesh-ancestor
24843113|NCT02225652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24843114|NCT02225652|Antimetabolites|antimetabolites|mesh-ancestor
24843115|NCT02225652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24843116|NCT02225652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24843117|NCT02225652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24843118|NCT02225652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24843119|NCT02225652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24843120|NCT02225756|Cyclosporine|cyclosporine|mesh-list
24843121|NCT02225756|Cyclosporins|cyclosporins|mesh-list
24843123|NCT02225756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843125|NCT02225756|Immunologic Factors|immunologic factors|mesh-ancestor
24843126|NCT02225756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843127|NCT02225756|Antifungal Agents|antifungal agents|mesh-ancestor
24843168|NCT02225977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843169|NCT02226068|Cyclosporine|cyclosporine|mesh-list
24843170|NCT02226068|Cyclosporins|cyclosporins|mesh-list
24843171|NCT02226068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25270229|NCT02406092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25270230|NCT02406092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25270231|NCT02406092|Glucocorticoids|glucocorticoids|mesh-ancestor
25270232|NCT02406092|Hormones|hormones|mesh-ancestor
24476935|NCT00416832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24942176|NCT03983915|Adrenergic Agents|adrenergic agents|mesh-ancestor
24843200|NCT02226289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24843201|NCT02226289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843202|NCT02226289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24843274|NCT02226601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24843275|NCT02226601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843276|NCT02226757|Paclitaxel|paclitaxel|mesh-list
24843277|NCT02226757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24843278|NCT02226757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843279|NCT02226757|Tubulin Modulators|tubulin modulators|mesh-ancestor
24843280|NCT02226757|Antimitotic Agents|antimitotic agents|mesh-ancestor
24843281|NCT02226757|Mitosis Modulators|mitosis modulators|mesh-ancestor
24843282|NCT02226757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843283|NCT02226783|Omeprazole|omeprazole|mesh-list
24843284|NCT02226783|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24843285|NCT02226783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24843286|NCT02226783|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25675754|NCT01789047|Sensory System Agents|sensory system agents|mesh-ancestor
25675755|NCT01789047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25675756|NCT01789203|Ciprofloxacin|ciprofloxacin|mesh-list
25675757|NCT01789203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25675758|NCT01789203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675759|NCT01789203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25675760|NCT01789203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25675761|NCT01789203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675762|NCT01789203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843288|NCT02226783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843289|NCT02226913|Lidocaine|lidocaine|mesh-list
24843318|NCT02226926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24843356|NCT02226991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24843357|NCT02226991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24843358|NCT02226991|Antiviral Agents|antiviral agents|mesh-ancestor
24843359|NCT02226991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24843360|NCT02226991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24843361|NCT02226991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24843362|NCT02226991|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24843363|NCT02226991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24843364|NCT02226991|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24843365|NCT02226991|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24843386|NCT02227173|Digoxin|digoxin|mesh-list
24648631|NCT01216111|Paclitaxel|paclitaxel|mesh-list
25270233|NCT02406092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25270234|NCT02406092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25270235|NCT02406092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24476937|NCT00416832|Tubulin Modulators|tubulin modulators|mesh-ancestor
24942180|NCT03983915|Narcotics|narcotics|mesh-ancestor
24843427|NCT02227433|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24843428|NCT02227433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24843429|NCT02227433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843430|NCT02227550|Vitamin K|vitamin k|mesh-list
24843431|NCT02227550|Warfarin|warfarin|mesh-list
24843432|NCT02227550|Apixaban|apixaban|mesh-list
24843433|NCT02227550|Phenprocoumon|phenprocoumon|mesh-list
24843434|NCT02227550|Fluindione|fluindione|mesh-list
24843435|NCT02227550|Vitamins|vitamins|mesh-ancestor
24843436|NCT02227550|Micronutrients|micronutrients|mesh-ancestor
24843437|NCT02227550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843438|NCT02227550|Anticoagulants|anticoagulants|mesh-ancestor
24843439|NCT02227550|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24843440|NCT02227550|Antithrombins|antithrombins|mesh-ancestor
24680947|NCT01377220|Choline|choline|mesh-list
24843441|NCT02227550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24843442|NCT02227550|Protease Inhibitors|protease inhibitors|mesh-ancestor
24843443|NCT02227550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24843444|NCT02227550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843445|NCT02227550|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24843447|NCT02227550|Hemostatics|hemostatics|mesh-ancestor
24843453|NCT02227745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843454|NCT02227745|Viscosupplements|viscosupplements|mesh-ancestor
24843455|NCT02227745|Protective Agents|protective agents|mesh-ancestor
24844220|NCT02231879|Antiviral Agents|antiviral agents|mesh-ancestor
24843456|NCT02227745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24843457|NCT02227745|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24843458|NCT02227745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24843459|NCT02227745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843460|NCT02227797|Voriconazole|voriconazole|mesh-list
24843461|NCT02227797|Antifungal Agents|antifungal agents|mesh-ancestor
24843462|NCT02227797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24843466|NCT02227797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843467|NCT02227797|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24843468|NCT02227797|Hormone Antagonists|hormone antagonists|mesh-ancestor
24843469|NCT02227797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24843470|NCT02227797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843471|NCT02227797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24843473|NCT02227823|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
24843474|NCT02227823|Anticonvulsants|anticonvulsants|mesh-ancestor
24843475|NCT02227823|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24843476|NCT02227823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24844353|NCT02232399|Vasodilator Agents|vasodilator agents|mesh-ancestor
25270236|NCT02406092|Tubulin Modulators|tubulin modulators|mesh-ancestor
25270237|NCT02406092|Antimitotic Agents|antimitotic agents|mesh-ancestor
25270238|NCT02406092|Mitosis Modulators|mitosis modulators|mesh-ancestor
24476938|NCT00416832|Antimitotic Agents|antimitotic agents|mesh-ancestor
24476939|NCT00416832|Mitosis Modulators|mitosis modulators|mesh-ancestor
24476952|NCT00416858|Immunologic Factors|immunologic factors|mesh-ancestor
24476953|NCT00416858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843551|NCT02228083|Mydriatics|mydriatics|mesh-ancestor
24843552|NCT02228083|Sympathomimetics|sympathomimetics|mesh-ancestor
24843553|NCT02228083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24843554|NCT02228122|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24843555|NCT02228122|Laxatives|laxatives|mesh-ancestor
24603521|NCT00974155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24843556|NCT02228122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24843557|NCT02228135|Dexamethasone|dexamethasone|mesh-list
24843558|NCT02228135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24843559|NCT02228135|Antiemetics|antiemetics|mesh-ancestor
24843560|NCT02228135|Autonomic Agents|autonomic agents|mesh-ancestor
24843561|NCT02228135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24843562|NCT02228135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843563|NCT02228135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24843619|NCT02228512|Doxorubicin|doxorubicin|mesh-list
24843621|NCT02228512|Vincristine|vincristine|mesh-list
24843622|NCT02228512|Pomalidomide|pomalidomide|mesh-list
24843623|NCT02228512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24843624|NCT02228512|Immunologic Factors|immunologic factors|mesh-ancestor
24843625|NCT02228512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843626|NCT02228512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24843627|NCT02228512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24843628|NCT02228512|Alkylating Agents|alkylating agents|mesh-ancestor
24843652|NCT02228616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24843653|NCT02228616|Laxatives|laxatives|mesh-ancestor
24843654|NCT02228616|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24843659|NCT02228616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843660|NCT02228772|Cytarabine|cytarabine|mesh-list
24843661|NCT02228772|Cyclophosphamide|cyclophosphamide|mesh-list
24843662|NCT02228772|Doxorubicin|doxorubicin|mesh-list
24843663|NCT02228772|Methotrexate|methotrexate|mesh-list
24843664|NCT02228772|Vincristine|vincristine|mesh-list
24843665|NCT02228772|Mercaptopurine|mercaptopurine|mesh-list
24843666|NCT02228772|Ixazomib|ixazomib|mesh-list
24843701|NCT02228863|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24843702|NCT02228863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24843703|NCT02228863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452609|NCT05457998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24452610|NCT05457998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452611|NCT05457972|Estradiol|estradiol|mesh-list
24452612|NCT05457972|Estrogens|estrogens|mesh-ancestor
24452613|NCT05457972|Hormones|hormones|mesh-ancestor
24452614|NCT05457972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24452615|NCT05457972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843723|NCT02229045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24843724|NCT02229045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843725|NCT02229045|Tubulin Modulators|tubulin modulators|mesh-ancestor
24843726|NCT02229045|Antimitotic Agents|antimitotic agents|mesh-ancestor
24843727|NCT02229045|Mitosis Modulators|mitosis modulators|mesh-ancestor
25270239|NCT02405988|Remifentanil|remifentanil|mesh-list
25270240|NCT02405988|Naloxone|naloxone|mesh-list
25270241|NCT02405988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25270242|NCT02405988|Narcotics|narcotics|mesh-ancestor
25270243|NCT02405988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24476956|NCT00416871|Aldesleukin|aldesleukin|mesh-list
24843728|NCT02229045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843729|NCT02229058|Paclitaxel|paclitaxel|mesh-list
24843730|NCT02229058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24843731|NCT02229058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24843754|NCT02229201|Anesthetics, General|anesthetics, general|mesh-ancestor
24843756|NCT02229201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24843757|NCT02229201|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24843758|NCT02229240|rGLP-1 protein|rglp-1 protein|mesh-list
24843759|NCT02229240|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24843760|NCT02229240|Incretins|incretins|mesh-ancestor
24843761|NCT02229240|Hormones|hormones|mesh-ancestor
24843762|NCT02229240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24843763|NCT02229240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843764|NCT02229266|Cytarabine|cytarabine|mesh-list
24843765|NCT02229266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24843766|NCT02229266|Antimetabolites|antimetabolites|mesh-ancestor
24843767|NCT02229266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843768|NCT02229266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843769|NCT02229266|Antiviral Agents|antiviral agents|mesh-ancestor
24843770|NCT02229266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24843771|NCT02229266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24843772|NCT02229266|Immunologic Factors|immunologic factors|mesh-ancestor
24843773|NCT02229266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843774|NCT02229292|Tranexamic Acid|tranexamic acid|mesh-list
25675763|NCT01789203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675764|NCT01789203|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25675765|NCT01789203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25675766|NCT01789255|Cyclosporine|cyclosporine|mesh-list
25675767|NCT01789255|Methotrexate|methotrexate|mesh-list
25675768|NCT01789255|Vorinostat|vorinostat|mesh-list
25675769|NCT01789255|Tacrolimus|tacrolimus|mesh-list
25675770|NCT01789255|Cyclosporins|cyclosporins|mesh-list
25246486|NCT02732288|Antioxidants|antioxidants|mesh-ancestor
25246487|NCT02732288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843775|NCT02229292|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24843776|NCT02229292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24843777|NCT02229292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843778|NCT02229292|Hemostatics|hemostatics|mesh-ancestor
24843816|NCT02229747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843817|NCT02229747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24843818|NCT02229747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24843819|NCT02229747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24843820|NCT02229747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24844777|NCT02234466|Antiemetics|antiemetics|mesh-ancestor
24843826|NCT02229760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24843827|NCT02229760|Protease Inhibitors|protease inhibitors|mesh-ancestor
24843828|NCT02229760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24843830|NCT02229760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24843840|NCT02229773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843841|NCT02229773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24756449|NCT01733394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24649245|NCT01219062|Narcotics|narcotics|mesh-ancestor
24843857|NCT02229786|Cholinergic Agents|cholinergic agents|mesh-ancestor
24843858|NCT02229786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24843859|NCT02229786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843860|NCT02229786|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24843861|NCT02229786|Antiemetics|antiemetics|mesh-ancestor
24843862|NCT02229786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24843863|NCT02229786|Mydriatics|mydriatics|mesh-ancestor
24843864|NCT02229799|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24843865|NCT02229799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24843866|NCT02229799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24843867|NCT02229799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843868|NCT02229812|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25675771|NCT01789255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25675772|NCT01789255|Abortifacient Agents|abortifacient agents|mesh-ancestor
25675773|NCT01789255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25675774|NCT01789255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675775|NCT01789255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25675776|NCT01789255|Antimetabolites|antimetabolites|mesh-ancestor
25675777|NCT01789255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675778|NCT01789255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675779|NCT01789255|Dermatologic Agents|dermatologic agents|mesh-ancestor
25675780|NCT01789255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24843869|NCT02229812|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24942189|NCT03983460|Clobetasol|clobetasol|mesh-list
24843891|NCT02229890|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24843892|NCT02229890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24843893|NCT02229890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24843894|NCT02229890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843895|NCT02229942|Rituximab|rituximab|mesh-list
24843896|NCT02229942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24843897|NCT02229942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843898|NCT02229942|Immunologic Factors|immunologic factors|mesh-ancestor
24843899|NCT02229942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843900|NCT02229942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24843901|NCT02229955|Cyclosporine|cyclosporine|mesh-list
24843902|NCT02229955|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24843903|NCT02229955|Cyclosporins|cyclosporins|mesh-list
24843904|NCT02229955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24843905|NCT02229955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843937|NCT02230046|Hormone Antagonists|hormone antagonists|mesh-ancestor
24843938|NCT02230046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24843939|NCT02230046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843940|NCT02230046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24843941|NCT02230163|Immunoglobulins|immunoglobulins|mesh-list
24843969|NCT02230319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24843970|NCT02230319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843971|NCT02230319|Tubulin Modulators|tubulin modulators|mesh-ancestor
24843972|NCT02230319|Antimitotic Agents|antimitotic agents|mesh-ancestor
24843973|NCT02230319|Mitosis Modulators|mitosis modulators|mesh-ancestor
24843974|NCT02230319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843975|NCT02230358|Anesthetics|anesthetics|mesh-list
24843976|NCT02230358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24843977|NCT02230358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843978|NCT02230371|Granisetron|granisetron|mesh-list
24843979|NCT02230371|Antiemetics|antiemetics|mesh-ancestor
24844086|NCT02231281|Tenofovir|tenofovir|mesh-list
25675781|NCT01789255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25675782|NCT01789255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24844128|NCT02231333|Vasodilator Agents|vasodilator agents|mesh-ancestor
25270248|NCT02405988|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25270249|NCT02406053|Antioxidants|antioxidants|mesh-list
25270250|NCT02406053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270251|NCT02406053|Protective Agents|protective agents|mesh-ancestor
24844129|NCT02231333|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24844130|NCT02231333|Antioxidants|antioxidants|mesh-ancestor
24844131|NCT02231346|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
24649447|NCT01219920|Irinotecan|irinotecan|mesh-list
24844195|NCT02231658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24844196|NCT02231658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844197|NCT02231658|Incretins|incretins|mesh-ancestor
24844198|NCT02231658|Hormones|hormones|mesh-ancestor
24844200|NCT02231762|Temozolomide|temozolomide|mesh-list
24844210|NCT02231788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24844211|NCT02231788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844212|NCT02231788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24844213|NCT02231788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844215|NCT02231788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24844216|NCT02231788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24844217|NCT02231879|Plerixafor|plerixafor|mesh-list
24844218|NCT02231879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24844219|NCT02231879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24844221|NCT02231879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24844222|NCT02231905|Pramipexole|pramipexole|mesh-list
24844223|NCT02231905|Antioxidants|antioxidants|mesh-ancestor
24844232|NCT02231931|Metformin|metformin|mesh-list
24844244|NCT02231931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24844245|NCT02231931|Diuretics|diuretics|mesh-ancestor
24844246|NCT02231931|Natriuretic Agents|natriuretic agents|mesh-ancestor
24844247|NCT02231931|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25675783|NCT01789255|Immunologic Factors|immunologic factors|mesh-ancestor
25675784|NCT01789255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25675785|NCT01789255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25675786|NCT01789255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25675787|NCT01789255|Antifungal Agents|antifungal agents|mesh-ancestor
25675788|NCT01789255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675789|NCT01789255|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25675790|NCT01789281|Everolimus|everolimus|mesh-list
25675791|NCT01789281|Octreotide|octreotide|mesh-list
25675792|NCT01789281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24844249|NCT02231931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24844250|NCT02231931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24844251|NCT02231931|Protective Agents|protective agents|mesh-ancestor
24844252|NCT02231957|Vaccines|vaccines|mesh-list
24683562|NCT01392833|Antiemetics|antiemetics|mesh-ancestor
24649497|NCT01220154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25270252|NCT02406053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270253|NCT02405858|Prednisolone|prednisolone|mesh-list
25270254|NCT02405858|Abiraterone Acetate|abiraterone acetate|mesh-list
25270255|NCT02405858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25270256|NCT02405858|Glucocorticoids|glucocorticoids|mesh-ancestor
25270257|NCT02405858|Hormones|hormones|mesh-ancestor
25270258|NCT02405858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24477077|NCT00417144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477078|NCT00417144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24844351|NCT02232399|Milrinone|milrinone|mesh-list
24844352|NCT02232399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24844355|NCT02232399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24844356|NCT02232399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24844357|NCT02232399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844358|NCT02232399|Protective Agents|protective agents|mesh-ancestor
24844359|NCT02232399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844426|NCT02232672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24844427|NCT02232672|Nootropic Agents|nootropic agents|mesh-ancestor
24844429|NCT02232685|Lipotropic Agents|lipotropic agents|mesh-ancestor
24844430|NCT02232685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24844431|NCT02232685|Antimetabolites|antimetabolites|mesh-ancestor
24649648|NCT01221103|Dexamethasone|dexamethasone|mesh-list
24844471|NCT02232789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24844472|NCT02232789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844473|NCT02232789|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24844474|NCT02232789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24844475|NCT02232789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24844476|NCT02232789|Adrenergic Agents|adrenergic agents|mesh-ancestor
24844478|NCT02232932|Liver Extracts|liver extracts|mesh-list
24844479|NCT02232932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24844480|NCT02232932|Antimetabolites|antimetabolites|mesh-ancestor
24844481|NCT02232932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844482|NCT02232932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24844483|NCT02232932|Hematinics|hematinics|mesh-ancestor
24844484|NCT02232945|Oseltamivir|oseltamivir|mesh-list
24844485|NCT02232945|Antiviral Agents|antiviral agents|mesh-ancestor
24844486|NCT02232945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675793|NCT01789281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25675794|NCT01789281|Immunologic Factors|immunologic factors|mesh-ancestor
25675795|NCT01789281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675796|NCT01789281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25675797|NCT01789281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25675798|NCT01789320|Triamcinolone|triamcinolone|mesh-list
25675799|NCT01789320|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25675800|NCT01789320|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25675801|NCT01789320|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25270263|NCT02405858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24844764|NCT02234193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24844765|NCT02234193|Respiratory System Agents|respiratory system agents|mesh-ancestor
24844767|NCT02234193|Sympathomimetics|sympathomimetics|mesh-ancestor
24844768|NCT02234193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24604894|NCT00982124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604905|NCT00982254|Insulin|insulin|mesh-list
24844769|NCT02234349|Pancrelipase|pancrelipase|mesh-list
24844770|NCT02234349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24844771|NCT02234440|Metformin|metformin|mesh-list
24844772|NCT02234440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24844774|NCT02234466|Dexamethasone|dexamethasone|mesh-list
24844779|NCT02234466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24844780|NCT02234466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844781|NCT02234466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24844782|NCT02234466|Glucocorticoids|glucocorticoids|mesh-ancestor
24844784|NCT02234466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24844785|NCT02234466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24844786|NCT02234466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24844787|NCT02234466|Antipruritics|antipruritics|mesh-ancestor
24844788|NCT02234466|Dermatologic Agents|dermatologic agents|mesh-ancestor
24844789|NCT02234466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24844790|NCT02234466|Serotonin Agents|serotonin agents|mesh-ancestor
24844791|NCT02234466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24844792|NCT02234466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844793|NCT02234466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24844794|NCT02234466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24844795|NCT02234466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24844796|NCT02234466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24844797|NCT02234466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24844798|NCT02234492|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24844799|NCT02234492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24844800|NCT02234492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24844801|NCT02234492|Antimetabolites|antimetabolites|mesh-ancestor
24844802|NCT02234492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844823|NCT02234739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25675802|NCT01789320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25675803|NCT01789320|Glucocorticoids|glucocorticoids|mesh-ancestor
25675804|NCT01789320|Hormones|hormones|mesh-ancestor
24844825|NCT02234739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844835|NCT02234843|Protease Inhibitors|protease inhibitors|mesh-ancestor
24844902|NCT02235233|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24844903|NCT02235233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844904|NCT02235246|Magnesium Sulfate|magnesium sulfate|mesh-list
24844905|NCT02235246|Analgesics|analgesics|mesh-ancestor
24844906|NCT02235246|Sensory System Agents|sensory system agents|mesh-ancestor
24844907|NCT02235246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24844908|NCT02235246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844909|NCT02235246|Anesthetics|anesthetics|mesh-ancestor
24844911|NCT02235246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24844964|NCT02235415|Lacidipine|lacidipine|mesh-list
24844965|NCT02235415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24844966|NCT02235415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24844967|NCT02235415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24844968|NCT02235415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844969|NCT02235415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24844970|NCT02235415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844971|NCT02235428|Bromides|bromides|mesh-list
24844972|NCT02235428|Albuterol|albuterol|mesh-list
24844987|NCT02235428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24844988|NCT02235428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844989|NCT02235428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24844990|NCT02235428|Cholinergic Agents|cholinergic agents|mesh-ancestor
24844991|NCT02235480|Tazarotene|tazarotene|mesh-list
24845003|NCT02235558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24477079|NCT00417144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24477080|NCT00417144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24845021|NCT02235584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24845022|NCT02235662|Tenofovir|tenofovir|mesh-list
24845023|NCT02235662|Levonorgestrel|levonorgestrel|mesh-list
24845024|NCT02235662|Antiviral Agents|antiviral agents|mesh-ancestor
24845025|NCT02235662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24845026|NCT02235662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24845027|NCT02235662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24845028|NCT02235662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24845029|NCT02235662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845030|NCT02235662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24845031|NCT02235662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24845051|NCT02235948|Vitamin B Complex|vitamin b complex|mesh-ancestor
24845052|NCT02235948|Vitamins|vitamins|mesh-ancestor
24845053|NCT02235948|Micronutrients|micronutrients|mesh-ancestor
24845196|NCT02236962|Pioglitazone|pioglitazone|mesh-list
24845054|NCT02235948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845055|NCT02235961|Liraglutide|liraglutide|mesh-list
24845056|NCT02235961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24845057|NCT02235961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845058|NCT02235961|Incretins|incretins|mesh-ancestor
24845059|NCT02235961|Hormones|hormones|mesh-ancestor
24845060|NCT02235961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24605176|NCT00983554|Hormones|hormones|mesh-ancestor
24845077|NCT02236026|Moxifloxacin|moxifloxacin|mesh-list
24845078|NCT02236026|ST 1435|st 1435|mesh-list
24845079|NCT02236026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24845080|NCT02236026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24845081|NCT02236026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25675805|NCT01789320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25675806|NCT01789320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845082|NCT02236026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24845088|NCT02236026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24845113|NCT02236169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845114|NCT02236169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845115|NCT02236169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24845116|NCT02236169|Respiratory System Agents|respiratory system agents|mesh-ancestor
24845127|NCT02236182|Autonomic Agents|autonomic agents|mesh-ancestor
24845128|NCT02236182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845129|NCT02236182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845130|NCT02236182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24845131|NCT02236182|Respiratory System Agents|respiratory system agents|mesh-ancestor
24845140|NCT02236260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845141|NCT02236260|Sensory System Agents|sensory system agents|mesh-ancestor
24845142|NCT02236260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845143|NCT02236260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24845144|NCT02236260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24845145|NCT02236260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24845146|NCT02236260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24845147|NCT02236260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845148|NCT02236403|Metronidazole|metronidazole|mesh-list
25270264|NCT02405858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270265|NCT02405858|Hormone Antagonists|hormone antagonists|mesh-ancestor
24477081|NCT00417144|Hormone Antagonists|hormone antagonists|mesh-ancestor
24477082|NCT00417144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24477133|NCT00417430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24477134|NCT00417430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24477135|NCT00417430|Hormone Antagonists|hormone antagonists|mesh-ancestor
24477136|NCT00417430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24424244|NCT00228410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24477174|NCT00417690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24477175|NCT00417690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24477177|NCT00417716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24845150|NCT02236403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24845151|NCT02236403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24845152|NCT02236403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24845153|NCT02236403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24845154|NCT02236481|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24845194|NCT02236936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24845195|NCT02236936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24845197|NCT02236962|Ephedrine|ephedrine|mesh-list
24845198|NCT02236962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24845199|NCT02236962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845200|NCT02236962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24845201|NCT02236962|Sympathomimetics|sympathomimetics|mesh-ancestor
24845202|NCT02236962|Autonomic Agents|autonomic agents|mesh-ancestor
24845203|NCT02236962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845204|NCT02236962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24845205|NCT02236962|Adrenergic Agents|adrenergic agents|mesh-ancestor
24845244|NCT02237209|Vaccines|vaccines|mesh-list
24845253|NCT02237261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24845254|NCT02237261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845255|NCT02237261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24845256|NCT02237261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24845257|NCT02237261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24845258|NCT02237261|Alkylating Agents|alkylating agents|mesh-ancestor
24845259|NCT02237261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845326|NCT02237495|Adrenergic Agents|adrenergic agents|mesh-ancestor
24845327|NCT02237495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845328|NCT02237495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845417|NCT02237937|Amitriptyline|amitriptyline|mesh-list
24845418|NCT02237937|Citalopram|citalopram|mesh-list
24845419|NCT02237937|Paroxetine|paroxetine|mesh-list
24845420|NCT02237937|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24845421|NCT02237937|Sertraline|sertraline|mesh-list
24845422|NCT02237937|Nortriptyline|nortriptyline|mesh-list
24845423|NCT02237937|Trimipramine|trimipramine|mesh-list
24845424|NCT02237937|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24845425|NCT02237937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24845426|NCT02237937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24845427|NCT02237937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845428|NCT02237937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845429|NCT02237937|Serotonin Agents|serotonin agents|mesh-ancestor
24845430|NCT02237937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845431|NCT02237937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24845432|NCT02237937|Antidepressive Agents|antidepressive agents|mesh-ancestor
25270266|NCT02405858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25270267|NCT02405715|Oxytocin|oxytocin|mesh-list
25270268|NCT02405715|Oxytocics|oxytocics|mesh-ancestor
25270269|NCT02405715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25270270|NCT02405715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270271|NCT02405598|Albuterol|albuterol|mesh-list
25270272|NCT02405598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25270273|NCT02405598|Autonomic Agents|autonomic agents|mesh-ancestor
25068666|NCT03432442|Ivermectin|ivermectin|mesh-list
24953809|NCT03881423|Bromides|bromides|mesh-list
25270274|NCT02405598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25270275|NCT02405598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270276|NCT02405598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24477178|NCT00417716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477179|NCT00417716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24845433|NCT02237937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24845434|NCT02237937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845435|NCT02237937|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24845436|NCT02237937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24845437|NCT02237937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24845441|NCT02237937|Analgesics|analgesics|mesh-ancestor
24845445|NCT02238106|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24845446|NCT02238106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24845447|NCT02238106|Autonomic Agents|autonomic agents|mesh-ancestor
24845448|NCT02238106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845449|NCT02238106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845450|NCT02238106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24845462|NCT02238119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24452670|NCT05457855|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24452671|NCT05457855|Hormone Antagonists|hormone antagonists|mesh-ancestor
24845463|NCT02238119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845464|NCT02238119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24845465|NCT02238119|Respiratory System Agents|respiratory system agents|mesh-ancestor
24845466|NCT02238119|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24845467|NCT02238119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24845468|NCT02238119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24845469|NCT02238119|Adrenergic Agents|adrenergic agents|mesh-ancestor
24845470|NCT02238119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845487|NCT02238145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24845488|NCT02238145|Autonomic Agents|autonomic agents|mesh-ancestor
24845489|NCT02238145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845490|NCT02238145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845491|NCT02238145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24845492|NCT02238145|Respiratory System Agents|respiratory system agents|mesh-ancestor
24845493|NCT02238145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24845494|NCT02238145|Cholinergic Agents|cholinergic agents|mesh-ancestor
24845495|NCT02238145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845496|NCT02238145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270277|NCT02405598|Respiratory System Agents|respiratory system agents|mesh-ancestor
25270278|NCT02405598|Tocolytic Agents|tocolytic agents|mesh-ancestor
24611520|NCT01009892|Analgesics|analgesics|mesh-ancestor
24845571|NCT02238288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845572|NCT02238288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24845573|NCT02238288|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24845574|NCT02238288|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24476300|NCT00414024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675807|NCT01789320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25675808|NCT01789320|Immunologic Factors|immunologic factors|mesh-ancestor
25675809|NCT01789320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675810|NCT01789320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692351|NCT01998919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24846023|NCT02240641|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
24846024|NCT02240641|Natriuretic Agents|natriuretic agents|mesh-ancestor
24846025|NCT02240641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846026|NCT02240641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24650672|NCT01227408|Paclitaxel|paclitaxel|mesh-list
24846117|NCT02241278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24846118|NCT02241278|Anesthetics, General|anesthetics, general|mesh-ancestor
24846119|NCT02241278|Anesthetics|anesthetics|mesh-ancestor
24846120|NCT02241278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24846121|NCT02241278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24846122|NCT02241278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25270282|NCT02405598|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25270283|NCT02405598|Adrenergic Agents|adrenergic agents|mesh-ancestor
25270284|NCT02405598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25270285|NCT02405598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685018|NCT03040726|Palonosetron|palonosetron|mesh-list
24454855|NCT03474029|Antimetabolites|antimetabolites|mesh-ancestor
24454857|NCT03451799|Temozolomide|temozolomide|mesh-list
24519631|NCT05332028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24942259|NCT03982849|Silymarin|silymarin|mesh-list
24846123|NCT02241278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24846124|NCT02241278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846125|NCT02241356|Methamphetamine|methamphetamine|mesh-list
24846126|NCT02241356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24846133|NCT02241356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846134|NCT02241356|Adrenergic Agents|adrenergic agents|mesh-ancestor
24846135|NCT02241356|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24846136|NCT02241356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24846137|NCT02241356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24846138|NCT02241356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24846140|NCT02241421|Vancomycin|vancomycin|mesh-list
24846141|NCT02241421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24846142|NCT02241421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675811|NCT01789606|Ibuprofen|ibuprofen|mesh-list
25270288|NCT02405793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25270289|NCT02405793|Analgesics|analgesics|mesh-ancestor
25270290|NCT02405793|Sensory System Agents|sensory system agents|mesh-ancestor
25270291|NCT02405793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25270292|NCT02405793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270293|NCT02405793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25270294|NCT02405793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25270295|NCT02405793|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25270296|NCT02405793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25270297|NCT02405793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25270298|NCT02405793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270299|NCT02405689|Dexmedetomidine|dexmedetomidine|mesh-list
25270300|NCT02405689|Remifentanil|remifentanil|mesh-list
25270301|NCT02405689|Sevoflurane|sevoflurane|mesh-list
25270302|NCT02405689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25270303|NCT02405689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25270304|NCT02405689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270305|NCT02405689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25270306|NCT02405689|Analgesics|analgesics|mesh-ancestor
25270307|NCT02405689|Sensory System Agents|sensory system agents|mesh-ancestor
25270308|NCT02405689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24477321|NCT00418249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24477323|NCT00418249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477325|NCT00418249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24477326|NCT00418275|Plasminogen|plasminogen|mesh-list
24477327|NCT00418275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24477328|NCT00418275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24477329|NCT00418275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675812|NCT01789606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25675813|NCT01789606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25675814|NCT01789606|Analgesics|analgesics|mesh-ancestor
25675815|NCT01789606|Sensory System Agents|sensory system agents|mesh-ancestor
24846335|NCT02242383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24846336|NCT02242383|Diuretics|diuretics|mesh-ancestor
24846337|NCT02242383|Natriuretic Agents|natriuretic agents|mesh-ancestor
25270309|NCT02405689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25270314|NCT02405689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270315|NCT02405689|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25270316|NCT02405689|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25270317|NCT02405689|Anesthetics, General|anesthetics, general|mesh-ancestor
25270318|NCT02405689|Anesthetics|anesthetics|mesh-ancestor
25270319|NCT02405689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25270320|NCT02405689|Narcotics|narcotics|mesh-ancestor
25275498|NCT02371993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275499|NCT02371993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24456950|NCT00332774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24456951|NCT00332774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24846338|NCT02242383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846339|NCT02242383|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24846340|NCT02242383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24846343|NCT02242383|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24846344|NCT02242396|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24759556|NCT01752517|Ifosfamide|ifosfamide|mesh-list
25241753|NCT05300009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24846346|NCT02242396|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
24846348|NCT02242396|Diuretics|diuretics|mesh-ancestor
24846349|NCT02242396|Natriuretic Agents|natriuretic agents|mesh-ancestor
24592429|NCT00921700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24592430|NCT00921700|Narcotics|narcotics|mesh-ancestor
24592431|NCT00921700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24592432|NCT00921700|Antitussive Agents|antitussive agents|mesh-ancestor
24592433|NCT00921700|Respiratory System Agents|respiratory system agents|mesh-ancestor
24592434|NCT00921726|Oseltamivir|oseltamivir|mesh-list
24592436|NCT00921726|Antiviral Agents|antiviral agents|mesh-ancestor
24592437|NCT00921726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24592438|NCT00921726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24846384|NCT02242474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24461368|NCT00352144|Zopiclone|zopiclone|mesh-list
24650900|NCT01228357|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25270327|NCT02405364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270328|NCT02405364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25270329|NCT02405364|Glucocorticoids|glucocorticoids|mesh-ancestor
25270330|NCT02405364|Hormones|hormones|mesh-ancestor
25270331|NCT02405364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25270332|NCT02405364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25270333|NCT02405364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270334|NCT02405364|Immunologic Factors|immunologic factors|mesh-ancestor
25270335|NCT02405364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25270336|NCT02405364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25270337|NCT02405364|Growth Substances|growth substances|mesh-ancestor
24477446|NCT00418600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24477447|NCT00418600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24846388|NCT02242474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846389|NCT02242474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24846390|NCT02242474|Immunologic Factors|immunologic factors|mesh-ancestor
25675822|NCT01789606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675823|NCT01789814|Clopidogrel|clopidogrel|mesh-list
25675824|NCT01789814|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25675825|NCT01789814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25675826|NCT01789814|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25675827|NCT01789814|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25675828|NCT01789814|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25675829|NCT01789814|Purinergic Agents|purinergic agents|mesh-ancestor
25675830|NCT01789814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25675831|NCT01789814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675832|NCT01789814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675833|NCT01789905|Tigecycline|tigecycline|mesh-list
25675834|NCT01789905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25675835|NCT01789905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675836|NCT01789905|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25675837|NCT01789905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692352|NCT01998919|Immunologic Factors|immunologic factors|mesh-ancestor
25270363|NCT02405130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270364|NCT02405130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477531|NCT00418873|Dopamine Agents|dopamine agents|mesh-ancestor
24477532|NCT00418925|Dronabinol|dronabinol|mesh-list
24477533|NCT00418925|Hallucinogens|hallucinogens|mesh-ancestor
24477534|NCT00418925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050954|NCT00458978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24846453|NCT02242799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24846454|NCT02242799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24846455|NCT02242799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24846456|NCT02242799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24846457|NCT02242799|Antiviral Agents|antiviral agents|mesh-ancestor
24846458|NCT02242799|Schistosomicides|schistosomicides|mesh-ancestor
24846459|NCT02242799|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24846460|NCT02242799|Anthelmintics|anthelmintics|mesh-ancestor
24846461|NCT02242799|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24846462|NCT02242799|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24846463|NCT02242799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24846464|NCT02242799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846465|NCT02242799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25270365|NCT02405130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25270366|NCT02405130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25675838|NCT01789905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675839|NCT01789970|Hydrocodone|hydrocodone|mesh-list
25675840|NCT01789970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25675841|NCT01789970|Narcotics|narcotics|mesh-ancestor
25675842|NCT01789970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25270403|NCT02405013|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25270405|NCT02405013|Antimetabolites|antimetabolites|mesh-ancestor
25270406|NCT02405013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270407|NCT02405013|Antiviral Agents|antiviral agents|mesh-ancestor
24846580|NCT02243137|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
24846581|NCT02243137|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24846582|NCT02243137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24846583|NCT02243137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25270408|NCT02405013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25270409|NCT02404688|Ethanol|ethanol|mesh-list
25270410|NCT02404688|Dronabinol|dronabinol|mesh-list
25270411|NCT02404688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24846634|NCT02243358|Antiviral Agents|antiviral agents|mesh-ancestor
24651655|NCT01232777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846649|NCT02243436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846650|NCT02243436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24846651|NCT02243436|Antimetabolites|antimetabolites|mesh-ancestor
24846652|NCT02243436|Antiviral Agents|antiviral agents|mesh-ancestor
24846653|NCT02243436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24846654|NCT02243436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24846655|NCT02243436|Immunologic Factors|immunologic factors|mesh-ancestor
24846656|NCT02243436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652353|NCT01237977|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25270412|NCT02404688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25270413|NCT02404688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25270414|NCT02404688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270415|NCT02404688|Hallucinogens|hallucinogens|mesh-ancestor
25270416|NCT02404688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25270417|NCT02404688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25270418|NCT02404688|Analgesics|analgesics|mesh-ancestor
25270419|NCT02404688|Sensory System Agents|sensory system agents|mesh-ancestor
25675845|NCT01789970|Sensory System Agents|sensory system agents|mesh-ancestor
24453022|NCT05354258|Pyrimethamine|pyrimethamine|mesh-list
24453023|NCT05354258|Sulfadoxine|sulfadoxine|mesh-list
24453024|NCT05354258|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24453025|NCT05354258|Amodiaquine|amodiaquine|mesh-list
24453026|NCT05354258|Albendazole|albendazole|mesh-list
24453027|NCT05354258|Praziquantel|praziquantel|mesh-list
24453028|NCT05354258|Antimalarials|antimalarials|mesh-ancestor
24453029|NCT05354258|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24453030|NCT05354258|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24453031|NCT05354258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675846|NCT01789970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25675847|NCT01789970|Antitussive Agents|antitussive agents|mesh-ancestor
25675848|NCT01789970|Respiratory System Agents|respiratory system agents|mesh-ancestor
25675849|NCT01790126|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25675850|NCT01790126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25675851|NCT01790126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479414|NCT00426712|1018 oligonucleotide|1018 oligonucleotide|mesh-list
25675852|NCT01790126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25675853|NCT01790126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675854|NCT01790126|Luteolytic Agents|luteolytic agents|mesh-ancestor
25675855|NCT01790126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25675856|NCT01790126|Contraceptive Agents|contraceptive agents|mesh-ancestor
25675857|NCT01790126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25675859|NCT01790438|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25675860|NCT01790438|Isophane Insulin, Human|isophane insulin, human|mesh-list
25270457|NCT02404363|Purinergic Agents|purinergic agents|mesh-ancestor
25270458|NCT02404363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24457008|NCT00332904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24457009|NCT00332904|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24457011|NCT00332904|Natriuretic Agents|natriuretic agents|mesh-ancestor
24405626|NCT00167817|Aripiprazole|aripiprazole|mesh-list
24478382|NCT00422604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478383|NCT00422604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25675861|NCT01790438|Insulin, Isophane|insulin, isophane|mesh-list
25675862|NCT01790438|Isophane insulin, beef|isophane insulin, beef|mesh-list
25675863|NCT01790438|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25675864|NCT01790438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675865|NCT01790490|Ketamine|ketamine|mesh-list
25675866|NCT01790490|Lorazepam|lorazepam|mesh-list
25675867|NCT01790490|Analgesics|analgesics|mesh-ancestor
25675868|NCT01790490|Sensory System Agents|sensory system agents|mesh-ancestor
25675869|NCT01790490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24480353|NCT00430794|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24846886|NCT02244242|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24846887|NCT02244242|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24846888|NCT02244242|Adrenergic Agents|adrenergic agents|mesh-ancestor
24846889|NCT02244242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24846890|NCT02244242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846891|NCT02244242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846892|NCT02244242|Urological Agents|urological agents|mesh-ancestor
24846893|NCT02244255|Tamsulosin|tamsulosin|mesh-list
24846894|NCT02244255|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24846895|NCT02244255|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24631114|NCT01116167|Letrozole|letrozole|mesh-list
24846898|NCT02244255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24846899|NCT02244255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846900|NCT02244255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846921|NCT02244294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25270506|NCT02404142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270507|NCT02404077|Clonidine|clonidine|mesh-list
25270508|NCT02404077|Analgesics|analgesics|mesh-ancestor
25270509|NCT02404077|Sensory System Agents|sensory system agents|mesh-ancestor
25270510|NCT02404077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25270511|NCT02404077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270512|NCT02404077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25270513|NCT02404077|Sympatholytics|sympatholytics|mesh-ancestor
24457035|NCT00333008|Alkylating Agents|alkylating agents|mesh-ancestor
24457036|NCT00333008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457037|NCT00333008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675875|NCT01790490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25675876|NCT01790490|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25675877|NCT01790490|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25270518|NCT02404077|Adrenergic Agents|adrenergic agents|mesh-ancestor
25270519|NCT02404077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25270520|NCT02404077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270522|NCT02404233|Cobicistat|cobicistat|mesh-list
25270523|NCT02404233|Rilpivirine|rilpivirine|mesh-list
25270524|NCT02404233|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
25270525|NCT02404233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25270526|NCT02404233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25270527|NCT02404233|Protease Inhibitors|protease inhibitors|mesh-ancestor
25270528|NCT02404233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478753|NCT00424229|Growth Inhibitors|growth inhibitors|mesh-ancestor
24478754|NCT00424229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478755|NCT00424242|Pemetrexed|pemetrexed|mesh-list
24478756|NCT00424242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478757|NCT00424242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478758|NCT00424242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675879|NCT01790490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675880|NCT01790490|Anticonvulsants|anticonvulsants|mesh-ancestor
25675881|NCT01790490|Antiemetics|antiemetics|mesh-ancestor
25675882|NCT01790490|Autonomic Agents|autonomic agents|mesh-ancestor
25675883|NCT01790490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25675884|NCT01790490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25675885|NCT01790490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25675886|NCT01790490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25270529|NCT02404233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270530|NCT02404233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25270531|NCT02404233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25270532|NCT02404233|Antiviral Agents|antiviral agents|mesh-ancestor
25270533|NCT02404233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25270534|NCT02404233|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25270535|NCT02404233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24457061|NCT00333034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24457062|NCT00333034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24457063|NCT00333034|Analgesics|analgesics|mesh-ancestor
24453160|NCT05238831|Paclitaxel|paclitaxel|mesh-list
25675900|NCT01790568|Vorinostat|vorinostat|mesh-list
25675901|NCT01790568|Tacrolimus|tacrolimus|mesh-list
25675902|NCT01790568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25675903|NCT01790568|Abortifacient Agents|abortifacient agents|mesh-ancestor
25675904|NCT01790568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25675905|NCT01790568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675906|NCT01790568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25675907|NCT01790568|Antimetabolites|antimetabolites|mesh-ancestor
25675908|NCT01790568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675909|NCT01790568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675910|NCT01790568|Dermatologic Agents|dermatologic agents|mesh-ancestor
25675911|NCT01790568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675912|NCT01790568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25675913|NCT01790568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25675914|NCT01790568|Immunologic Factors|immunologic factors|mesh-ancestor
25675915|NCT01790568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25675916|NCT01790568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25247108|NCT00492050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247109|NCT00492050|Immunologic Factors|immunologic factors|mesh-ancestor
25247110|NCT00492050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247114|NCT00488072|Mirtazapine|mirtazapine|mesh-list
24846969|NCT02244502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24846970|NCT02244502|Tubulin Modulators|tubulin modulators|mesh-ancestor
24846971|NCT02244502|Antimitotic Agents|antimitotic agents|mesh-ancestor
24846972|NCT02244502|Mitosis Modulators|mitosis modulators|mesh-ancestor
24846973|NCT02244502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846974|NCT02244515|Dexmedetomidine|dexmedetomidine|mesh-list
25270536|NCT02404233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25270537|NCT02404233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25270538|NCT02404064|Metronidazole|metronidazole|mesh-list
25270540|NCT02404064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25270541|NCT02404064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25270542|NCT02404064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25270543|NCT02404064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25270544|NCT02404038|NuvaRing|nuvaring|mesh-list
25270545|NCT02404038|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
25270546|NCT02404038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25270547|NCT02404038|Contraceptive Agents|contraceptive agents|mesh-ancestor
25270548|NCT02404038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25270549|NCT02404038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270550|NCT02404038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25270551|NCT02404038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25270552|NCT02404038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24478872|NCT00424814|Protease Inhibitors|protease inhibitors|mesh-ancestor
25675917|NCT01790568|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25675918|NCT01790568|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25675919|NCT01790594|Mycophenolic Acid|mycophenolic acid|mesh-list
25675920|NCT01790594|Methylprednisolone|methylprednisolone|mesh-list
25675921|NCT01790594|Abatacept|abatacept|mesh-list
25675922|NCT01790594|Tacrolimus|tacrolimus|mesh-list
25675923|NCT01790594|Thymoglobulin|thymoglobulin|mesh-list
25675924|NCT01790594|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25675925|NCT01790594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25675926|NCT01790594|Immunologic Factors|immunologic factors|mesh-ancestor
25675927|NCT01790594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675928|NCT01790594|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25675929|NCT01790594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675930|NCT01790594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675931|NCT01790594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24478987|NCT00425191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24478988|NCT00425191|Antimetabolites|antimetabolites|mesh-ancestor
24478989|NCT00425191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478990|NCT00425191|Antiviral Agents|antiviral agents|mesh-ancestor
24478991|NCT00425191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24478992|NCT00425191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732426|NCT01639326|Irinotecan|irinotecan|mesh-list
25675932|NCT01790594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675933|NCT01790594|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25675934|NCT01790594|Antitubercular Agents|antitubercular agents|mesh-ancestor
25675935|NCT01790594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25675936|NCT01790594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25675937|NCT01790594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25675938|NCT01790594|Antiemetics|antiemetics|mesh-ancestor
25675939|NCT01790594|Autonomic Agents|autonomic agents|mesh-ancestor
24479078|NCT00425490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479079|NCT00425490|Incretins|incretins|mesh-ancestor
24479080|NCT00425490|Hormones|hormones|mesh-ancestor
24479081|NCT00425490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24479082|NCT00425490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24479113|NCT00425594|Bisacodyl|bisacodyl|mesh-list
24942374|NCT03981627|Insulin Aspart|insulin aspart|mesh-list
25270601|NCT02403596|Tranexamic Acid|tranexamic acid|mesh-list
25270602|NCT02403596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25270603|NCT02403596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25675940|NCT01790594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25270604|NCT02403596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270605|NCT02403596|Hemostatics|hemostatics|mesh-ancestor
25270653|NCT02403687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25270654|NCT02403687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25270655|NCT02403687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25270656|NCT02403687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25270657|NCT02403687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25270658|NCT02403687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25270659|NCT02403687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25270660|NCT02403687|Antipruritics|antipruritics|mesh-ancestor
25270661|NCT02403687|Dermatologic Agents|dermatologic agents|mesh-ancestor
25270662|NCT02403687|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25270663|NCT02403687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25270664|NCT02403687|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25270665|NCT02403687|GABA Agonists|gaba agonists|mesh-ancestor
25270666|NCT02403687|GABA Agents|gaba agents|mesh-ancestor
25270667|NCT02403687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24479211|NCT00426010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24479212|NCT00426010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479213|NCT00426010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479214|NCT00426010|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24847118|NCT02245256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847119|NCT02245256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24847120|NCT02245256|Analgesics|analgesics|mesh-ancestor
24847121|NCT02245256|Sensory System Agents|sensory system agents|mesh-ancestor
24847122|NCT02245256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24847123|NCT02245256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24847124|NCT02245256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24847125|NCT02245256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24847126|NCT02245256|Adrenergic Agents|adrenergic agents|mesh-ancestor
24453189|NCT05238831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25270668|NCT02403687|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25270669|NCT02403687|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25270670|NCT02403687|Serotonin Agents|serotonin agents|mesh-ancestor
25270671|NCT02403687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25270672|NCT02403687|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25270673|NCT02403687|Antidepressive Agents|antidepressive agents|mesh-ancestor
25270674|NCT02403687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25275508|NCT02371577|Growth Inhibitors|growth inhibitors|mesh-ancestor
24479217|NCT00426010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24479218|NCT00426023|Ketotifen|ketotifen|mesh-list
25069613|NCT03425461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069614|NCT03425448|Heparin|heparin|mesh-list
24479220|NCT00426023|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24479221|NCT00426023|Cyclosporins|cyclosporins|mesh-list
24479222|NCT00426023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479223|NCT00426023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479224|NCT00426023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24479225|NCT00426023|Immunologic Factors|immunologic factors|mesh-ancestor
24479226|NCT00426023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479251|NCT00426101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24847130|NCT02245269|Tipranavir|tipranavir|mesh-list
24847131|NCT02245269|Atorvastatin|atorvastatin|mesh-list
24632846|NCT01125904|Crizotinib|crizotinib|mesh-list
24847132|NCT02245269|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24847133|NCT02245269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24847134|NCT02245269|Antimetabolites|antimetabolites|mesh-ancestor
25241755|NCT05300009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24847135|NCT02245269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847136|NCT02245269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24847137|NCT02245269|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24847138|NCT02245269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24847139|NCT02245269|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24847140|NCT02245269|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25270675|NCT02403687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25270677|NCT02403687|Parasympatholytics|parasympatholytics|mesh-ancestor
25270678|NCT02403687|Autonomic Agents|autonomic agents|mesh-ancestor
25270679|NCT02403687|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25270680|NCT02403687|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25270681|NCT02403687|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25270682|NCT02403687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25270683|NCT02403687|Sympatholytics|sympatholytics|mesh-ancestor
25270684|NCT02403713|Fluticasone|fluticasone|mesh-list
25270685|NCT02403713|Xhance|xhance|mesh-list
25270686|NCT02403713|Formoterol Fumarate|formoterol fumarate|mesh-list
25675946|NCT01790594|Protective Agents|protective agents|mesh-ancestor
25675947|NCT01790594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25675948|NCT01790594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25675949|NCT01790659|Gentamicins|gentamicins|mesh-list
25675950|NCT01790659|Paromomycin|paromomycin|mesh-list
25675951|NCT01790659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25675952|NCT01790659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24453225|NCT05222152|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24453227|NCT05222152|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24453228|NCT05222152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25270698|NCT02403713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25270699|NCT02403713|Adrenergic Agents|adrenergic agents|mesh-ancestor
25270700|NCT02403713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24479337|NCT00426478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24479346|NCT00426491|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24482232|NCT00438217|Hormones|hormones|mesh-ancestor
24482233|NCT00438217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24847172|NCT02245438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847173|NCT02245438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24847174|NCT02245438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24847175|NCT02245438|Antiviral Agents|antiviral agents|mesh-ancestor
25675962|NCT01790685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25675963|NCT01790685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675964|NCT01790685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25675965|NCT01790685|Glucocorticoids|glucocorticoids|mesh-ancestor
25675966|NCT01790685|Hormones|hormones|mesh-ancestor
25675967|NCT01790685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25675968|NCT01790685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25675969|NCT01790685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25675970|NCT01790828|Factor VIII|factor viii|mesh-list
25675971|NCT01790828|Coagulants|coagulants|mesh-ancestor
25675972|NCT01791153|Prednisone|prednisone|mesh-list
25270725|NCT02403349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479391|NCT00426621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24847194|NCT02245451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25270732|NCT02403401|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25270733|NCT02403401|Contraceptive Agents|contraceptive agents|mesh-ancestor
25270734|NCT02403401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25270735|NCT02403401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270736|NCT02403401|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25270737|NCT02403401|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25270738|NCT02403401|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25270739|NCT02403219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25270740|NCT02403219|Botulinum Toxins|botulinum toxins|mesh-list
25270741|NCT02403219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25270742|NCT02403219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25270743|NCT02403219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25270744|NCT02403219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25270745|NCT02403219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270746|NCT02403219|Cholinergic Agents|cholinergic agents|mesh-ancestor
25270747|NCT02403219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25270748|NCT02403219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270749|NCT02403219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25270750|NCT02403219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25270751|NCT02403284|Liraglutide|liraglutide|mesh-list
25270752|NCT02403284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25270753|NCT02403284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270754|NCT02403284|Incretins|incretins|mesh-ancestor
25270755|NCT02403284|Hormones|hormones|mesh-ancestor
25270756|NCT02403284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25270757|NCT02403128|Aflibercept|aflibercept|mesh-list
24479455|NCT00426972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479457|NCT00426985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24453350|NCT05126836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24453351|NCT05126836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24453352|NCT05126836|Respiratory System Agents|respiratory system agents|mesh-ancestor
24453353|NCT05126836|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24453354|NCT05126836|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24453355|NCT05126836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675973|NCT01791153|Methotrexate|methotrexate|mesh-list
24847242|NCT02245503|Urological Agents|urological agents|mesh-ancestor
24847243|NCT02245529|Tamsulosin|tamsulosin|mesh-list
24847244|NCT02245529|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24847245|NCT02245529|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25675974|NCT01791153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25675975|NCT01791153|Glucocorticoids|glucocorticoids|mesh-ancestor
25270786|NCT02403037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25270787|NCT02403037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25270789|NCT02403037|Protease Inhibitors|protease inhibitors|mesh-ancestor
25270790|NCT02403037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25270791|NCT02403037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479589|NCT00427388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24479590|NCT00427388|Glucocorticoids|glucocorticoids|mesh-ancestor
24847257|NCT02245555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24654572|NCT01250470|Sargramostim|sargramostim|mesh-list
24847259|NCT02245555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847260|NCT02245555|Urological Agents|urological agents|mesh-ancestor
24847261|NCT02245789|Remifentanil|remifentanil|mesh-list
24847262|NCT02245789|Propofol|propofol|mesh-list
24847263|NCT02245789|Anesthetics|anesthetics|mesh-ancestor
24847264|NCT02245789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24847265|NCT02245789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847266|NCT02245789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24847267|NCT02245789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25675976|NCT01791153|Hormones|hormones|mesh-ancestor
25675977|NCT01791153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25675978|NCT01791153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25675979|NCT01791153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25270809|NCT02402868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25270810|NCT02402868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270811|NCT02402868|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25270812|NCT02402868|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25270814|NCT02402868|Anesthetics|anesthetics|mesh-ancestor
25270815|NCT02402868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25270816|NCT02402868|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24847299|NCT02246049|Oxaliplatin|oxaliplatin|mesh-list
24847300|NCT02246049|Irinotecan|irinotecan|mesh-list
24847301|NCT02246049|Calcium|calcium|mesh-list
25270817|NCT02402868|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25270818|NCT02402868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25270819|NCT02402868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270820|NCT02402725|Dexamethasone|dexamethasone|mesh-list
25270821|NCT02402725|Dexamethasone acetate|dexamethasone acetate|mesh-list
25270822|NCT02402725|BB 1101|bb 1101|mesh-list
25270823|NCT02402725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25270824|NCT02402725|Antiemetics|antiemetics|mesh-ancestor
25270825|NCT02402725|Autonomic Agents|autonomic agents|mesh-ancestor
24479734|NCT00428168|Betahistine|betahistine|mesh-list
24479735|NCT00428168|Vasodilator Agents|vasodilator agents|mesh-ancestor
25675981|NCT01791153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25675982|NCT01791153|Abortifacient Agents|abortifacient agents|mesh-ancestor
25675983|NCT01791153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25675984|NCT01791153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25675985|NCT01791153|Antimetabolites|antimetabolites|mesh-ancestor
25675986|NCT01791153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25675987|NCT01791153|Dermatologic Agents|dermatologic agents|mesh-ancestor
25675988|NCT01791153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25675989|NCT01791153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25675990|NCT01791153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25675991|NCT01791153|Immunologic Factors|immunologic factors|mesh-ancestor
25270840|NCT02402712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270841|NCT02402712|Tubulin Modulators|tubulin modulators|mesh-ancestor
25270842|NCT02402712|Antimitotic Agents|antimitotic agents|mesh-ancestor
25676000|NCT01791413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25676001|NCT01791413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247608|NCT03292250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25247609|NCT03292250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25247610|NCT03292250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595848|NCT00940693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24595849|NCT00940693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270850|NCT02402621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270851|NCT02402621|Analgesics|analgesics|mesh-ancestor
25270852|NCT02402621|Sensory System Agents|sensory system agents|mesh-ancestor
25270853|NCT02402621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25270854|NCT02402621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25270855|NCT02402621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24479936|NCT00429065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24479937|NCT00429065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479938|NCT00429065|Immunologic Factors|immunologic factors|mesh-ancestor
24457123|NCT00333151|Liraglutide|liraglutide|mesh-list
24457124|NCT00333151|Rosiglitazone|rosiglitazone|mesh-list
24457125|NCT00333151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25676013|NCT01791465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25676014|NCT01791491|Abatacept|abatacept|mesh-list
25676015|NCT01791491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25676016|NCT01791491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676017|NCT01791491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25676018|NCT01791491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25676019|NCT01791491|Immunologic Factors|immunologic factors|mesh-ancestor
25676020|NCT01791491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676021|NCT01791491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25676022|NCT01791517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25676023|NCT01791803|Nicotine|nicotine|mesh-list
25676024|NCT01791803|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25676025|NCT01791803|Autonomic Agents|autonomic agents|mesh-ancestor
25676026|NCT01791803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25676027|NCT01791803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676028|NCT01791803|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25676029|NCT01791803|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25676030|NCT01791803|Cholinergic Agents|cholinergic agents|mesh-ancestor
25676031|NCT01791803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24847368|NCT02246244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24847369|NCT02246595|Vilobelimab|vilobelimab|mesh-list
24634993|NCT01136395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270856|NCT02402621|Anesthetics, General|anesthetics, general|mesh-ancestor
25270857|NCT02402621|Anesthetics|anesthetics|mesh-ancestor
25270858|NCT02402595|Itraconazole|itraconazole|mesh-list
25270859|NCT02402595|Antifungal Agents|antifungal agents|mesh-ancestor
25270860|NCT02402595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25270861|NCT02402595|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25270862|NCT02402595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25270863|NCT02402595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25270864|NCT02402595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270865|NCT02402595|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25270866|NCT02402595|Hormone Antagonists|hormone antagonists|mesh-ancestor
25270867|NCT02402595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25270868|NCT02402595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270869|NCT02402595|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25270870|NCT02402491|Aspirin|aspirin|mesh-list
25270871|NCT02402491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
25270872|NCT02402491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25270873|NCT02402491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25270874|NCT02402491|Analgesics|analgesics|mesh-ancestor
24457127|NCT00333151|Incretins|incretins|mesh-ancestor
24457128|NCT00333151|Hormones|hormones|mesh-ancestor
24457129|NCT00333151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24457130|NCT00333164|Cilostazol|cilostazol|mesh-list
24479955|NCT00429208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25676032|NCT01791803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676033|NCT01791894|Arsenic Trioxide|arsenic trioxide|mesh-list
25676034|NCT01791894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25676035|NCT01791972|Albuterol|albuterol|mesh-list
25676036|NCT01791972|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25676037|NCT01791972|Autonomic Agents|autonomic agents|mesh-ancestor
25676038|NCT01791972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25676039|NCT01791972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676040|NCT01791972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25270885|NCT02402491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25270886|NCT02402491|Antipyretics|antipyretics|mesh-ancestor
25270887|NCT02402491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24479965|NCT00429234|Antiviral Agents|antiviral agents|mesh-ancestor
24479966|NCT00429234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24479967|NCT00429234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479968|NCT00429234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24479969|NCT00429234|Immunologic Factors|immunologic factors|mesh-ancestor
25279172|NCT02346110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676041|NCT01791972|Respiratory System Agents|respiratory system agents|mesh-ancestor
25676042|NCT01791972|Tocolytic Agents|tocolytic agents|mesh-ancestor
25676043|NCT01791972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25676044|NCT01791972|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25676045|NCT01791972|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25676046|NCT01791972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25676047|NCT01791972|Adrenergic Agents|adrenergic agents|mesh-ancestor
25676048|NCT01791972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25676049|NCT01791972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484063|NCT00446420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24847440|NCT02247128|Sensory System Agents|sensory system agents|mesh-ancestor
24847441|NCT02247128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24847442|NCT02247128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847443|NCT02247128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24847444|NCT02247128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24847445|NCT02247128|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24847446|NCT02247128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24847455|NCT02247128|Purinergic Agents|purinergic agents|mesh-ancestor
24847456|NCT02247128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24847457|NCT02247141|Immunoglobulins|immunoglobulins|mesh-list
24847458|NCT02247141|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24847460|NCT02247141|Immunologic Factors|immunologic factors|mesh-ancestor
24847483|NCT02247310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847484|NCT02247310|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24847486|NCT02247362|Hemagglutinins|hemagglutinins|mesh-list
24847494|NCT02247414|Dalteparin|dalteparin|mesh-list
24847495|NCT02247414|Dipyridamole|dipyridamole|mesh-list
24847496|NCT02247414|Warfarin|warfarin|mesh-list
24847497|NCT02247414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24847498|NCT02247414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24847499|NCT02247414|Analgesics|analgesics|mesh-ancestor
24847500|NCT02247414|Sensory System Agents|sensory system agents|mesh-ancestor
24847505|NCT02247414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24847506|NCT02247414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24847507|NCT02247414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847508|NCT02247414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24635447|NCT01139437|Vaccines|vaccines|mesh-list
24847512|NCT02247414|Anticoagulants|anticoagulants|mesh-ancestor
24847513|NCT02247414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24847514|NCT02247414|Vasodilator Agents|vasodilator agents|mesh-ancestor
24847515|NCT02247505|Tadalafil|tadalafil|mesh-list
24847516|NCT02247505|Tamsulosin|tamsulosin|mesh-list
24847517|NCT02247505|Vasodilator Agents|vasodilator agents|mesh-ancestor
24847524|NCT02247505|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24847525|NCT02247505|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24847526|NCT02247505|Adrenergic Agents|adrenergic agents|mesh-ancestor
24847527|NCT02247505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24847528|NCT02247505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847530|NCT02247518|Tamsulosin|tamsulosin|mesh-list
24847531|NCT02247518|Vasodilator Agents|vasodilator agents|mesh-ancestor
24847532|NCT02247518|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24847533|NCT02247518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24847534|NCT02247518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24847535|NCT02247518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847536|NCT02247518|Urological Agents|urological agents|mesh-ancestor
24847537|NCT02247518|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24847538|NCT02247518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24847565|NCT02247648|Tramadol|tramadol|mesh-list
24847575|NCT02247687|Protease Inhibitors|protease inhibitors|mesh-list
25676065|NCT01792518|Linagliptin|linagliptin|mesh-list
24847673|NCT02248220|Dopamine Agonists|dopamine agonists|mesh-ancestor
24847674|NCT02248220|Dopamine Agents|dopamine agents|mesh-ancestor
24847675|NCT02248220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24847677|NCT02248233|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
24847678|NCT02248233|Nootropic Agents|nootropic agents|mesh-ancestor
25270902|NCT02402465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25270903|NCT02402465|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25676066|NCT01792518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25676067|NCT01792518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676068|NCT01792518|Incretins|incretins|mesh-ancestor
25676069|NCT01792518|Hormones|hormones|mesh-ancestor
25676070|NCT01792518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25270905|NCT02402465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270906|NCT02402465|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24480044|NCT00429676|Haloperidol|haloperidol|mesh-list
24480045|NCT00429676|Haloperidol decanoate|haloperidol decanoate|mesh-list
24480046|NCT00429676|Antiemetics|antiemetics|mesh-ancestor
24847679|NCT02248233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24847680|NCT02248233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24847681|NCT02248233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24847682|NCT02248233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847683|NCT02248233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24847684|NCT02248233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847685|NCT02248233|Vasodilator Agents|vasodilator agents|mesh-ancestor
24847686|NCT02248259|Itraconazole|itraconazole|mesh-list
24847687|NCT02248259|BI 409306|bi 409306|mesh-list
24847688|NCT02248259|Antifungal Agents|antifungal agents|mesh-ancestor
24847695|NCT02248259|Hormone Antagonists|hormone antagonists|mesh-ancestor
24425110|NCT00232024|Tegaserod|tegaserod|mesh-list
24859043|NCT02301286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847726|NCT02248428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24847727|NCT02248428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24847728|NCT02248428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24847729|NCT02248428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24847730|NCT02248428|Growth Substances|growth substances|mesh-ancestor
24847731|NCT02248428|Growth Inhibitors|growth inhibitors|mesh-ancestor
24847732|NCT02248428|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24847733|NCT02248428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24847734|NCT02248428|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24847735|NCT02248428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24847737|NCT02248454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24847738|NCT02248454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847740|NCT02248493|Ketoprofen|ketoprofen|mesh-list
24847741|NCT02248493|Morphine|morphine|mesh-list
24847742|NCT02248493|Tramadol|tramadol|mesh-list
24847743|NCT02248493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24635915|NCT01141894|Dobutamine|dobutamine|mesh-list
24635916|NCT01141894|Oxymetazoline|oxymetazoline|mesh-list
24635940|NCT01141972|Micronutrients|micronutrients|mesh-ancestor
24847744|NCT02248493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24847745|NCT02248493|Narcotics|narcotics|mesh-ancestor
24847746|NCT02248493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24847747|NCT02248493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847748|NCT02248493|Analgesics|analgesics|mesh-ancestor
24847749|NCT02248493|Sensory System Agents|sensory system agents|mesh-ancestor
24847750|NCT02248493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24847751|NCT02248493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24847752|NCT02248493|Antipyretics|antipyretics|mesh-ancestor
24847753|NCT02248493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24847754|NCT02248493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24847778|NCT05354635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24847779|NCT05354479|Acetaminophen|acetaminophen|mesh-list
24847780|NCT05354479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24847781|NCT05354479|Analgesics|analgesics|mesh-ancestor
24847782|NCT05354479|Sensory System Agents|sensory system agents|mesh-ancestor
24847783|NCT05354479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24847785|NCT05354479|Antipyretics|antipyretics|mesh-ancestor
24484708|NCT00449657|Paclitaxel|paclitaxel|mesh-list
24484709|NCT00449657|Carboplatin|carboplatin|mesh-list
24484710|NCT00449657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24484711|NCT00449657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484712|NCT00449657|Tubulin Modulators|tubulin modulators|mesh-ancestor
24484713|NCT00449657|Antimitotic Agents|antimitotic agents|mesh-ancestor
24484714|NCT00449657|Mitosis Modulators|mitosis modulators|mesh-ancestor
24484715|NCT00449657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484716|NCT00449657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24484717|NCT00449657|Antimetabolites|antimetabolites|mesh-ancestor
24484718|NCT00449657|Antiviral Agents|antiviral agents|mesh-ancestor
24693307|NCT01419405|Anticonvulsants|anticonvulsants|mesh-ancestor
24484719|NCT00449657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25270907|NCT02402465|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24480112|NCT00429871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480113|NCT00429871|Tubulin Modulators|tubulin modulators|mesh-ancestor
25247941|NCT02535104|Ranpirnase|ranpirnase|mesh-list
24480114|NCT00429871|Antimitotic Agents|antimitotic agents|mesh-ancestor
24480115|NCT00429871|Mitosis Modulators|mitosis modulators|mesh-ancestor
24480116|NCT00429871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480117|NCT00429871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24480118|NCT00429871|Antimetabolites|antimetabolites|mesh-ancestor
24480119|NCT00429871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24457136|NCT00333164|Respiratory System Agents|respiratory system agents|mesh-ancestor
24457138|NCT00333164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24457139|NCT00333164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636324|NCT01144754|Rituximab|rituximab|mesh-list
24847894|NCT05353101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24847895|NCT05353101|Dermatologic Agents|dermatologic agents|mesh-ancestor
24847896|NCT05353101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24847897|NCT05353101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24847898|NCT05353101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24847899|NCT05353101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24847900|NCT05353101|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24847902|NCT05353010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24636374|NCT01144988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24636375|NCT01144988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270917|NCT02402400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25270918|NCT02402400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25270919|NCT02402400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270920|NCT02402413|Androgens|androgens|mesh-list
25270921|NCT02402413|Hormones|hormones|mesh-ancestor
25270922|NCT02402413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25270923|NCT02402413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270924|NCT02402283|Metronidazole|metronidazole|mesh-list
25270925|NCT02402283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25270926|NCT02402283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25270927|NCT02402283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25270928|NCT02402283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25270929|NCT02402231|Omalizumab|omalizumab|mesh-list
25270930|NCT02402231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25270931|NCT02402231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25270932|NCT02402231|Respiratory System Agents|respiratory system agents|mesh-ancestor
25270933|NCT02402543|Acetaminophen|acetaminophen|mesh-list
25270934|NCT02402543|Dexamethasone|dexamethasone|mesh-list
25270935|NCT02402543|Ketamine|ketamine|mesh-list
25270936|NCT02402543|Gabapentin|gabapentin|mesh-list
25270937|NCT02402543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25270938|NCT02402543|Antiemetics|antiemetics|mesh-ancestor
25270939|NCT02402543|Autonomic Agents|autonomic agents|mesh-ancestor
25270940|NCT02402543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24457141|NCT00333164|Vasodilator Agents|vasodilator agents|mesh-ancestor
24457142|NCT00333164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24693600|NCT01421264|Gabapentin|gabapentin|mesh-list
24457143|NCT00333164|Protective Agents|protective agents|mesh-ancestor
24942612|NCT03979469|Narcotics|narcotics|mesh-ancestor
24847907|NCT05353010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847917|NCT05352854|Cholinergic Agents|cholinergic agents|mesh-ancestor
24847918|NCT05352854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24847919|NCT05352854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485088|NCT00451594|Dexamethasone|dexamethasone|mesh-list
24485089|NCT00451594|Prednisolone|prednisolone|mesh-list
24485090|NCT00451594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24485091|NCT00451594|Antiemetics|antiemetics|mesh-ancestor
24485092|NCT00451594|Autonomic Agents|autonomic agents|mesh-ancestor
24485093|NCT00451594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24485094|NCT00451594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847931|NCT05340452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24847932|NCT05339399|Oxytocin|oxytocin|mesh-list
24847933|NCT05339399|Oxytocics|oxytocics|mesh-ancestor
24847939|NCT05338983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24636580|NCT01146093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25270941|NCT02402543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270942|NCT02402543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25270943|NCT02402543|Glucocorticoids|glucocorticoids|mesh-ancestor
25270944|NCT02402543|Hormones|hormones|mesh-ancestor
25270945|NCT02402543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25270946|NCT02402543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25270947|NCT02402543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480206|NCT00430118|Etoposide|etoposide|mesh-list
24480207|NCT00430118|Vincristine|vincristine|mesh-list
24480208|NCT00430118|Daunorubicin|daunorubicin|mesh-list
24480209|NCT00430118|Asparaginase|asparaginase|mesh-list
24847972|NCT05298696|Cilostazol|cilostazol|mesh-list
24636653|NCT01146548|Fluoxetine|fluoxetine|mesh-list
24485233|NCT00452075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485234|NCT00452075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485235|NCT00452166|Rosiglitazone|rosiglitazone|mesh-list
24485236|NCT00452166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24485237|NCT00452166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693752|NCT01422109|Aspirin|aspirin|mesh-list
24485238|NCT00452192|Telmisartan|telmisartan|mesh-list
24485239|NCT00452192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24485256|NCT00452231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485257|NCT00452244|Gefitinib|gefitinib|mesh-list
24485258|NCT00452244|Simvastatin|simvastatin|mesh-list
25270979|NCT02401945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25270980|NCT02401945|Growth Inhibitors|growth inhibitors|mesh-ancestor
25270981|NCT02401945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270982|NCT02401971|Thalidomide|thalidomide|mesh-list
25676075|NCT01792830|Metformin|metformin|mesh-list
25676076|NCT01792830|Insulin Glargine|insulin glargine|mesh-list
25676077|NCT01792830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25676078|NCT01792830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676079|NCT01793051|Minocycline|minocycline|mesh-list
24656318|NCT01261078|Racepinephrine|racepinephrine|mesh-list
24848221|NCT04876066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24848223|NCT04876066|Anesthetics, General|anesthetics, general|mesh-ancestor
24848224|NCT04876066|Anesthetics|anesthetics|mesh-ancestor
24848225|NCT04876066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24848226|NCT04876066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24848227|NCT04876066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24848228|NCT04876066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24848229|NCT04876066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848230|NCT04866706|Hyaluronic Acid|hyaluronic acid|mesh-list
24848240|NCT04856007|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24848241|NCT04856007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848243|NCT04849715|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24848244|NCT04849715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25270986|NCT02401971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25270987|NCT02401971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457147|NCT00333242|Dextromethorphan|dextromethorphan|mesh-list
24457148|NCT00333242|Antitussive Agents|antitussive agents|mesh-ancestor
25676080|NCT01793051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25676081|NCT01793051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25676083|NCT01793285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25676084|NCT01793285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25676085|NCT01793285|Analgesics|analgesics|mesh-ancestor
25676086|NCT01793285|Sensory System Agents|sensory system agents|mesh-ancestor
25676087|NCT01793285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25676088|NCT01793285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848260|NCT04759339|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24848292|NCT04697576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859044|NCT02301286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24848305|NCT04659369|Nivolumab|nivolumab|mesh-list
24848306|NCT04659369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24486300|NCT00457106|Paroxetine|paroxetine|mesh-list
24486301|NCT00457106|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24486302|NCT00457106|Serotonin Agents|serotonin agents|mesh-ancestor
24486303|NCT00457106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24486304|NCT00457106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486305|NCT00457106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486306|NCT00457106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24486307|NCT00457106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24848315|NCT04578535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848316|NCT04574713|Candesartan|candesartan|mesh-list
24848317|NCT04574713|Candesartan cilexetil|candesartan cilexetil|mesh-list
24848318|NCT04574713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25270988|NCT02401971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25270989|NCT02401971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25270990|NCT02401971|Immunologic Factors|immunologic factors|mesh-ancestor
25270991|NCT02401971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457151|NCT00333242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24457152|NCT00333242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25279365|NCT02345044|Eplerenone|eplerenone|mesh-list
24848456|NCT04167813|Dermatologic Agents|dermatologic agents|mesh-ancestor
24694440|NCT01425580|Metformin|metformin|mesh-list
24848457|NCT04167813|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24848458|NCT04167813|Serotonin Agents|serotonin agents|mesh-ancestor
24848459|NCT04167813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24848460|NCT04167813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848461|NCT04167813|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24848462|NCT04167813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24848463|NCT04167813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24848464|NCT04167813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24848465|NCT04167813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25271013|NCT02401828|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25271014|NCT02401828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480389|NCT00430924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24480390|NCT00430924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480391|NCT00430924|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24480396|NCT00430963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24480397|NCT00430963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24480398|NCT00430963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480399|NCT00430963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24480400|NCT00430963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24942693|NCT03978884|Diuretics|diuretics|mesh-ancestor
24848469|NCT04110080|Anesthetics|anesthetics|mesh-list
24848470|NCT04110080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24848471|NCT04110080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848472|NCT04099901|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24848473|NCT04099901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24848474|NCT04079621|Primaquine|primaquine|mesh-list
24486992|NCT00460863|Dialysis Solutions|dialysis solutions|mesh-list
24848476|NCT04079621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24848477|NCT04079621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24848478|NCT04079621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24848479|NCT04042727|Dexmedetomidine|dexmedetomidine|mesh-list
24848480|NCT04042727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24848481|NCT04042727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24487016|NCT00460954|Levodopa|levodopa|mesh-list
24487017|NCT00460954|Carbidopa|carbidopa|mesh-list
24487018|NCT00460954|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24487019|NCT00460954|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24487020|NCT00460954|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24694570|NCT05386121|Analgesics|analgesics|mesh-ancestor
24694571|NCT05386121|Sensory System Agents|sensory system agents|mesh-ancestor
24694572|NCT05386121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24694573|NCT05386121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24480545|NCT00431236|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24480547|NCT00431249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24480548|NCT00431249|Autonomic Agents|autonomic agents|mesh-ancestor
24480549|NCT00431249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24480550|NCT00431249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271026|NCT02401594|Enoxaparin|enoxaparin|mesh-list
25271027|NCT02401594|Rivaroxaban|rivaroxaban|mesh-list
25271028|NCT02401594|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25271029|NCT02401594|Antithrombins|antithrombins|mesh-ancestor
25271030|NCT02401594|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25271031|NCT02401594|Protease Inhibitors|protease inhibitors|mesh-ancestor
25271032|NCT02401594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271033|NCT02401594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271049|NCT02401425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271050|NCT02401425|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25271051|NCT02401425|Abortifacient Agents|abortifacient agents|mesh-ancestor
25271052|NCT02401425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25271053|NCT02401425|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25271054|NCT02401425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25271056|NCT02401347|Talazoparib|talazoparib|mesh-list
25271057|NCT02401347|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25271058|NCT02401347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271059|NCT02401347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271060|NCT02401347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25271061|NCT02401269|Aspirin|aspirin|mesh-list
25271062|NCT02401269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25271063|NCT02401269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24694643|NCT05385406|Retinol acetate|retinol acetate|mesh-list
24694644|NCT05385406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24694645|NCT05385406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24694646|NCT05385406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24694647|NCT05385406|Immunologic Factors|immunologic factors|mesh-ancestor
24694648|NCT05385406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694656|NCT05385185|Endostatins|endostatins|mesh-list
25271064|NCT02401269|Analgesics|analgesics|mesh-ancestor
25271065|NCT02401269|Sensory System Agents|sensory system agents|mesh-ancestor
24457162|NCT00333255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24480603|NCT00431392|Nasal Decongestants|nasal decongestants|mesh-ancestor
24480604|NCT00431392|Respiratory System Agents|respiratory system agents|mesh-ancestor
24480605|NCT00431392|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24480633|NCT00431522|Anticonvulsants|anticonvulsants|mesh-ancestor
24848509|NCT04014387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848510|NCT04014387|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24848511|NCT04014387|GABA Agonists|gaba agonists|mesh-ancestor
24848512|NCT04014387|GABA Agents|gaba agents|mesh-ancestor
24480693|NCT00431678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24480694|NCT00431678|Contraceptive Agents|contraceptive agents|mesh-ancestor
24480695|NCT00431678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24480696|NCT00431678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480697|NCT00431678|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24480698|NCT00431678|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24480699|NCT00431678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24480700|NCT00431678|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24480701|NCT00431678|Renal Agents|renal agents|mesh-ancestor
24480702|NCT00431678|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24480703|NCT00431678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24480704|NCT00431691|Nitroglycerin|nitroglycerin|mesh-list
24480705|NCT00431691|Vasodilator Agents|vasodilator agents|mesh-ancestor
24457172|NCT00333294|Gefitinib|gefitinib|mesh-list
24848525|NCT03993912|Glucocorticoids|glucocorticoids|mesh-ancestor
25271082|NCT02401295|Analgesics|analgesics|mesh-ancestor
25271083|NCT02401295|Sensory System Agents|sensory system agents|mesh-ancestor
25271084|NCT02401295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25271085|NCT02401295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271086|NCT02401295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25271087|NCT02401295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25271088|NCT02401295|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25271089|NCT02401295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25271090|NCT02401295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271091|NCT02401295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271092|NCT02401295|Antifungal Agents|antifungal agents|mesh-ancestor
25271093|NCT02401295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25271094|NCT02401295|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25271095|NCT02401295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25271096|NCT02401295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25271097|NCT02401295|Hormone Antagonists|hormone antagonists|mesh-ancestor
25271098|NCT02401295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25271099|NCT02401295|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25271100|NCT02401295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25271101|NCT02401295|Keratolytic Agents|keratolytic agents|mesh-ancestor
25271102|NCT02401295|Dermatologic Agents|dermatologic agents|mesh-ancestor
24457174|NCT00333294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24457175|NCT00333294|Tubulin Modulators|tubulin modulators|mesh-ancestor
24457176|NCT00333294|Antimitotic Agents|antimitotic agents|mesh-ancestor
24480716|NCT00431769|Bortezomib|bortezomib|mesh-list
24480717|NCT00431769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480718|NCT00431795|Doxorubicin|doxorubicin|mesh-list
24480719|NCT00431795|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24480720|NCT00431795|Epirubicin|epirubicin|mesh-list
24480721|NCT00431795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24480722|NCT00431795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480784|NCT00432120|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24480785|NCT00432120|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24480786|NCT00432120|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24480787|NCT00432120|Purinergic Agents|purinergic agents|mesh-ancestor
24480788|NCT00432120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25241756|NCT05300009|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25070050|NCT03422315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24480894|NCT00432575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24480895|NCT00432575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480896|NCT00432588|Misoprostol|misoprostol|mesh-list
25271111|NCT02401243|Insulin Glargine|insulin glargine|mesh-list
25271126|NCT02401139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25271127|NCT02401139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271128|NCT02400931|Rocuronium|rocuronium|mesh-list
25271129|NCT02400931|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25271130|NCT02400931|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25271131|NCT02400931|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25271132|NCT02400931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24457198|NCT00333372|Cholinergic Agents|cholinergic agents|mesh-ancestor
25271133|NCT02400931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271135|NCT02400879|Remifentanil|remifentanil|mesh-list
25271136|NCT02400879|Sevoflurane|sevoflurane|mesh-list
24597889|NCT00952497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597891|NCT00952562|Vitamin D|vitamin d|mesh-list
24597892|NCT00952562|Vitamins|vitamins|mesh-ancestor
24597893|NCT00952562|Micronutrients|micronutrients|mesh-ancestor
24597894|NCT00952562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597895|NCT00952562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24597896|NCT00952562|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24597897|NCT00952575|Immunoglobulins|immunoglobulins|mesh-list
24597898|NCT00952575|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24597899|NCT00952575|Antibodies|antibodies|mesh-list
24597908|NCT00952627|Antioxidants|antioxidants|mesh-ancestor
25271137|NCT02400879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25271138|NCT02400879|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25271139|NCT02400879|Anesthetics, General|anesthetics, general|mesh-ancestor
25271140|NCT02400879|Anesthetics|anesthetics|mesh-ancestor
25271141|NCT02400879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25271142|NCT02400879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271143|NCT02400879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24480907|NCT00432614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24480926|NCT00432653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24480928|NCT00432653|Immunologic Factors|immunologic factors|mesh-ancestor
24480935|NCT00432757|Histamine Antagonists|histamine antagonists|mesh-ancestor
24453789|NCT04790513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24848536|NCT03970096|Sirolimus|sirolimus|mesh-list
24848537|NCT03970096|Cyclophosphamide|cyclophosphamide|mesh-list
24487329|NCT00462696|Docetaxel|docetaxel|mesh-list
25676106|NCT01793883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676107|NCT01794000|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25676108|NCT01794000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25676109|NCT01794039|Dexamethasone|dexamethasone|mesh-list
25676110|NCT01794039|Dexamethasone acetate|dexamethasone acetate|mesh-list
25676111|NCT01794039|Lenalidomide|lenalidomide|mesh-list
25676112|NCT01794039|Pomalidomide|pomalidomide|mesh-list
25676113|NCT01794039|Ichthammol|ichthammol|mesh-list
25676114|NCT01794039|BB 1101|bb 1101|mesh-list
25676115|NCT01794039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25676116|NCT01794039|Antiemetics|antiemetics|mesh-ancestor
25676117|NCT01794039|Autonomic Agents|autonomic agents|mesh-ancestor
25676118|NCT01794039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25676119|NCT01794039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676120|NCT01794039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25676121|NCT01794039|Glucocorticoids|glucocorticoids|mesh-ancestor
25676122|NCT01794039|Hormones|hormones|mesh-ancestor
25676123|NCT01794039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25676124|NCT01794039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25676125|NCT01794039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25271145|NCT02400879|Analgesics|analgesics|mesh-ancestor
25271146|NCT02400879|Sensory System Agents|sensory system agents|mesh-ancestor
25271147|NCT02400879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25271148|NCT02400879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25271149|NCT02400879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25271150|NCT02400645|Ketorolac|ketorolac|mesh-list
25271151|NCT02400645|Bupivacaine|bupivacaine|mesh-list
25271152|NCT02400645|Anesthetics, Local|anesthetics, local|mesh-ancestor
25271153|NCT02400645|Anesthetics|anesthetics|mesh-ancestor
25271154|NCT02400645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25271155|NCT02400645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480958|NCT00432887|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24480960|NCT00432887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24480962|NCT00432978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24480963|NCT00432978|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24480964|NCT00432978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480965|NCT00433043|Metoprolol|metoprolol|mesh-list
24480966|NCT00433043|Carvedilol|carvedilol|mesh-list
24481062|NCT00433225|Ketorolac|ketorolac|mesh-list
24481064|NCT00433225|Prednisolone phosphate|prednisolone phosphate|mesh-list
24481065|NCT00433225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24425728|NCT00234143|Hematinics|hematinics|mesh-ancestor
25271156|NCT02400645|Sensory System Agents|sensory system agents|mesh-ancestor
25271157|NCT02400645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25271158|NCT02400645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25271159|NCT02400645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25271160|NCT02400645|Analgesics|analgesics|mesh-ancestor
25271161|NCT02400645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25271162|NCT02400645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25271163|NCT02400645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25271164|NCT02400645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271165|NCT02400645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271166|NCT02400866|Olanzapine|olanzapine|mesh-list
25271167|NCT02400866|Antiemetics|antiemetics|mesh-ancestor
25271168|NCT02400866|Autonomic Agents|autonomic agents|mesh-ancestor
25271169|NCT02400866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24487471|NCT00463268|Alendronate|alendronate|mesh-list
25271170|NCT02400866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271171|NCT02400866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25271172|NCT02400866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25271173|NCT02400866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25271174|NCT02400866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25271175|NCT02400866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25271176|NCT02400866|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25271177|NCT02400866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25271178|NCT02400866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25271179|NCT02400866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271180|NCT02400866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25271181|NCT02400866|Serotonin Agents|serotonin agents|mesh-ancestor
25271182|NCT02400775|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25271183|NCT02400775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25271184|NCT02400775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25676126|NCT01794039|Immunologic Factors|immunologic factors|mesh-ancestor
25676127|NCT01794039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25676128|NCT01794039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25271185|NCT02400775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271186|NCT02400788|Sorafenib|sorafenib|mesh-list
25271187|NCT02400788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25271188|NCT02400788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25271189|NCT02400788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271190|NCT02400788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271191|NCT02400801|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25271192|NCT02400801|Dienogest|dienogest|mesh-list
25271193|NCT02400801|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25271194|NCT02400801|Luteolytic Agents|luteolytic agents|mesh-ancestor
25271195|NCT02400801|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25271196|NCT02400801|Contraceptive Agents|contraceptive agents|mesh-ancestor
25271197|NCT02400801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25271198|NCT02400801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481172|NCT00433498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481174|NCT00433498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24481175|NCT00433498|Antimetabolites|antimetabolites|mesh-ancestor
24481176|NCT00433498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24481177|NCT00433498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24481178|NCT00433576|Resveratrol|resveratrol|mesh-list
24481179|NCT00433576|Antioxidants|antioxidants|mesh-ancestor
24481180|NCT00433576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481181|NCT00433576|Protective Agents|protective agents|mesh-ancestor
24481182|NCT00433576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457194|NCT00333372|Z 338|z 338|mesh-list
24457195|NCT00333372|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24457196|NCT00333372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457197|NCT00333372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425751|NCT00234234|Adalimumab|adalimumab|mesh-list
24481264|NCT00433927|Vitamin B Complex|vitamin b complex|mesh-ancestor
24481267|NCT00433927|Hematinics|hematinics|mesh-ancestor
24481268|NCT00433940|Prednisolone|prednisolone|mesh-list
24481269|NCT00433940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24481270|NCT00433940|Glucocorticoids|glucocorticoids|mesh-ancestor
24481271|NCT00433940|Hormones|hormones|mesh-ancestor
24481272|NCT00433940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24481273|NCT00433940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481274|NCT00433940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24481275|NCT00433940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481276|NCT00433953|Mycophenolic Acid|mycophenolic acid|mesh-list
25271199|NCT02400801|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25271200|NCT02400801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25271201|NCT02400801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25271202|NCT02400801|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25271203|NCT02400801|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25271204|NCT02400801|Estrogens|estrogens|mesh-ancestor
25271205|NCT02400801|Hormones|hormones|mesh-ancestor
25271206|NCT02400801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25271207|NCT02400801|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25271208|NCT02400801|Hormone Antagonists|hormone antagonists|mesh-ancestor
25271209|NCT02400619|Botulinum Toxins|botulinum toxins|mesh-list
25271210|NCT02400619|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25271212|NCT02400619|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25271213|NCT02400619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25271214|NCT02400619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271215|NCT02400619|Cholinergic Agents|cholinergic agents|mesh-ancestor
25271216|NCT02400619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25271217|NCT02400619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271218|NCT02400619|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25271219|NCT02400619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25271220|NCT02400268|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25271221|NCT02400268|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25271222|NCT02400268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25271223|NCT02400268|Antitubercular Agents|antitubercular agents|mesh-ancestor
25271224|NCT02400151|Vitamin D|vitamin d|mesh-list
25271225|NCT02400151|Vitamins|vitamins|mesh-ancestor
25271226|NCT02400151|Micronutrients|micronutrients|mesh-ancestor
25271227|NCT02400151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271228|NCT02400151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25271229|NCT02400385|Nivolumab|nivolumab|mesh-list
25271230|NCT02400385|Sunitinib|sunitinib|mesh-list
25271231|NCT02400385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25271232|NCT02400385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25271233|NCT02400385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25271234|NCT02400385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271235|NCT02400385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25271236|NCT02400385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25271237|NCT02400385|Growth Substances|growth substances|mesh-ancestor
25271238|NCT02400385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271239|NCT02400385|Growth Inhibitors|growth inhibitors|mesh-ancestor
25271240|NCT02400385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25271242|NCT02400281|Cytarabine|cytarabine|mesh-list
25271243|NCT02400281|Fludarabine|fludarabine|mesh-list
25271244|NCT02400281|Fludarabine phosphate|fludarabine phosphate|mesh-list
25271245|NCT02400281|Etoposide|etoposide|mesh-list
25271246|NCT02400281|Etoposide phosphate|etoposide phosphate|mesh-list
25271247|NCT02400281|Azacitidine|azacitidine|mesh-list
25271248|NCT02400281|Mitoxantrone|mitoxantrone|mesh-list
24942800|NCT03978052|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24942801|NCT03978052|Antioxidants|antioxidants|mesh-ancestor
24942802|NCT03978052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942803|NCT03978052|Protective Agents|protective agents|mesh-ancestor
24942804|NCT03978052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942805|NCT03978052|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24942806|NCT03978052|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24942807|NCT03978052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24457200|NCT00333372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457201|NCT00333372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24457202|NCT00333385|Ceftazidime|ceftazidime|mesh-list
24457203|NCT00333385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24457204|NCT00333385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24457205|NCT00333398|Vaccines|vaccines|mesh-list
24457206|NCT00333398|Immunologic Factors|immunologic factors|mesh-ancestor
24457209|NCT00333424|Immunologic Factors|immunologic factors|mesh-ancestor
24457210|NCT00333424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481400|NCT00434317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24481401|NCT00434317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481402|NCT00434382|Fentanyl|fentanyl|mesh-list
24481403|NCT00434382|Sufentanil|sufentanil|mesh-list
24481404|NCT00434382|Remifentanil|remifentanil|mesh-list
25271249|NCT02400281|Idarubicin|idarubicin|mesh-list
25271250|NCT02400281|Crenolanib|crenolanib|mesh-list
25271251|NCT02400281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25271252|NCT02400281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25271253|NCT02400281|Antimetabolites|antimetabolites|mesh-ancestor
25271254|NCT02400281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271255|NCT02400281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25271256|NCT02400281|Immunologic Factors|immunologic factors|mesh-ancestor
25271257|NCT02400281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271258|NCT02400281|Antiviral Agents|antiviral agents|mesh-ancestor
25271259|NCT02400281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25271260|NCT02400281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25271261|NCT02400281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25271262|NCT02400281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25271263|NCT02400281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271264|NCT02400281|Analgesics|analgesics|mesh-ancestor
25271265|NCT02400281|Sensory System Agents|sensory system agents|mesh-ancestor
25271266|NCT02400281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25271267|NCT02400281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25271268|NCT02400255|Crenolanib|crenolanib|mesh-list
25271269|NCT02400255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25275515|NCT02371603|Antimetabolites|antimetabolites|mesh-ancestor
25275516|NCT02371603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275517|NCT02371603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25275518|NCT02371603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25275519|NCT02371603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275520|NCT02371603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25275521|NCT02371603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275522|NCT02371603|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25275523|NCT02371603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25275524|NCT02371603|Renal Agents|renal agents|mesh-ancestor
25271278|NCT02400047|Dexamethasone|dexamethasone|mesh-list
25271279|NCT02400047|Dexamethasone acetate|dexamethasone acetate|mesh-list
25271280|NCT02400047|Ketoprofen|ketoprofen|mesh-list
25271281|NCT02400047|BB 1101|bb 1101|mesh-list
25271282|NCT02400047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25271283|NCT02400047|Antiemetics|antiemetics|mesh-ancestor
24695120|NCT04425902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25271284|NCT02400047|Autonomic Agents|autonomic agents|mesh-ancestor
25271285|NCT02400047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25271286|NCT02400047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271293|NCT02400047|Protease Inhibitors|protease inhibitors|mesh-ancestor
25271294|NCT02400047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271295|NCT02400047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271296|NCT02400047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25271297|NCT02400047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25271298|NCT02400047|Analgesics|analgesics|mesh-ancestor
25271299|NCT02400047|Sensory System Agents|sensory system agents|mesh-ancestor
25676129|NCT01794039|Growth Substances|growth substances|mesh-ancestor
25271301|NCT02400047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25271302|NCT02399800|Triamcinolone|triamcinolone|mesh-list
25271303|NCT02399800|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25271304|NCT02399800|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25271305|NCT02399800|Bupivacaine|bupivacaine|mesh-list
25271306|NCT02399800|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25271307|NCT02399800|Anesthetics, Local|anesthetics, local|mesh-ancestor
25271308|NCT02399800|Anesthetics|anesthetics|mesh-ancestor
25271309|NCT02399800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25271310|NCT02399800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271311|NCT02399800|Sensory System Agents|sensory system agents|mesh-ancestor
25271312|NCT02399800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25271313|NCT02399800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25271314|NCT02399800|Glucocorticoids|glucocorticoids|mesh-ancestor
25271315|NCT02399800|Hormones|hormones|mesh-ancestor
25045546|NCT00945269|Antiviral Agents|antiviral agents|mesh-ancestor
25045547|NCT00945269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25045548|NCT00945269|Immunologic Factors|immunologic factors|mesh-ancestor
25045550|NCT00944970|Binodenoson|binodenoson|mesh-list
25045551|NCT00944970|Analgesics|analgesics|mesh-ancestor
25045552|NCT00944970|Sensory System Agents|sensory system agents|mesh-ancestor
25045553|NCT00944970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045554|NCT00944970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045555|NCT00944970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25045556|NCT00944970|Vasodilator Agents|vasodilator agents|mesh-ancestor
25045557|NCT00944970|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25045558|NCT00944970|Purinergic Agonists|purinergic agonists|mesh-ancestor
24852951|NCT02264847|Zuclomiphene|zuclomiphene|mesh-list
24852952|NCT02264847|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24852953|NCT02264847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24598353|NCT00955604|Protective Agents|protective agents|mesh-ancestor
24598354|NCT00955604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598356|NCT00955630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24598357|NCT00955630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25045559|NCT00944970|Purinergic Agents|purinergic agents|mesh-ancestor
25045560|NCT00944970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25045561|NCT00944970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045562|NCT00944892|Fasinumab|fasinumab|mesh-list
25045563|NCT00944892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25045564|NCT00944892|Analgesics|analgesics|mesh-ancestor
25045565|NCT00944892|Sensory System Agents|sensory system agents|mesh-ancestor
25045566|NCT00944892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045567|NCT00944892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045568|NCT00944294|Adenosine|adenosine|mesh-list
24848622|NCT03843463|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24848623|NCT03843463|Antidepressive Agents|antidepressive agents|mesh-ancestor
24848624|NCT03843463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25271316|NCT02399800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25271317|NCT02399800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25271318|NCT02399800|Immunologic Factors|immunologic factors|mesh-ancestor
25271319|NCT02399800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271320|NCT02399800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271321|NCT02399566|Pemetrexed|pemetrexed|mesh-list
25271322|NCT02399566|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25271323|NCT02399566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25271324|NCT02399566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271325|NCT02399566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481661|NCT00436267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481662|NCT00436267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24481663|NCT00436267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481664|NCT00436267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24481665|NCT00436267|Immunologic Factors|immunologic factors|mesh-ancestor
24481666|NCT00436267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271348|NCT02399657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25271349|NCT02399709|Simvastatin|simvastatin|mesh-list
24695379|NCT03713424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24695380|NCT03713424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271350|NCT02399709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25271351|NCT02399709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25271352|NCT02399709|Antimetabolites|antimetabolites|mesh-ancestor
25271353|NCT02399709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271354|NCT02399709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25271355|NCT02399709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25271356|NCT02399709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271357|NCT02399462|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25271360|NCT02399462|Hormones|hormones|mesh-ancestor
25271361|NCT02399462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25271362|NCT02399462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271363|NCT02399462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25271364|NCT02399462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271368|NCT02399397|Fentanyl|fentanyl|mesh-list
25271369|NCT02399397|Midazolam|midazolam|mesh-list
25271370|NCT02399397|Anesthetics|anesthetics|mesh-list
25271371|NCT02399397|Propofol|propofol|mesh-list
25271372|NCT02399397|Rocuronium|rocuronium|mesh-list
25676130|NCT01794039|Growth Inhibitors|growth inhibitors|mesh-ancestor
25676131|NCT01794039|Protease Inhibitors|protease inhibitors|mesh-ancestor
25676132|NCT01794039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676133|NCT01794039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676134|NCT01794039|Dermatologic Agents|dermatologic agents|mesh-ancestor
25676135|NCT01794117|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25676136|NCT01794117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25676137|NCT01794455|Candesartan|candesartan|mesh-list
25676138|NCT01794455|Sertraline|sertraline|mesh-list
25676139|NCT01794455|Antidepressive Agents|antidepressive agents|mesh-ancestor
25271378|NCT02399397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25271379|NCT02399397|Narcotics|narcotics|mesh-ancestor
25271380|NCT02399397|Analgesics|analgesics|mesh-ancestor
25271381|NCT02399397|Sensory System Agents|sensory system agents|mesh-ancestor
25271382|NCT02399397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25271383|NCT02399397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25271384|NCT02399397|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25271385|NCT02399397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25271386|NCT02399397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25271387|NCT02399397|GABA Modulators|gaba modulators|mesh-ancestor
25271388|NCT02399397|GABA Agents|gaba agents|mesh-ancestor
25271389|NCT02399397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25275531|NCT02371603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24481722|NCT00436709|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24481723|NCT00436709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24481724|NCT00436709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481725|NCT00436709|Tubulin Modulators|tubulin modulators|mesh-ancestor
24481732|NCT00436709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24481797|NCT00436800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481798|NCT00436800|Antiviral Agents|antiviral agents|mesh-ancestor
24481799|NCT00436800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24481800|NCT00436800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481801|NCT00436800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24481802|NCT00436800|Immunologic Factors|immunologic factors|mesh-ancestor
24481803|NCT00436800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481827|NCT00436839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481828|NCT00436839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24481829|NCT00436839|Analgesics|analgesics|mesh-ancestor
24481830|NCT00436839|Sensory System Agents|sensory system agents|mesh-ancestor
24481831|NCT00436839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24848642|NCT03842709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25271526|NCT02398552|Growth Inhibitors|growth inhibitors|mesh-ancestor
25271397|NCT02399410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25271398|NCT02399410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25271399|NCT02399410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25271400|NCT02399410|Growth Substances|growth substances|mesh-ancestor
25271401|NCT02399410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271402|NCT02399410|Growth Inhibitors|growth inhibitors|mesh-ancestor
25271403|NCT02399059|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25271404|NCT02399059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25271405|NCT02399189|Methotrexate|methotrexate|mesh-list
25271406|NCT02399189|Temozolomide|temozolomide|mesh-list
25271407|NCT02399189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25271408|NCT02399189|Immunologic Factors|immunologic factors|mesh-ancestor
25271409|NCT02399189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271410|NCT02399189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25271411|NCT02399189|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25271412|NCT02399189|Abortifacient Agents|abortifacient agents|mesh-ancestor
25271413|NCT02399189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25271414|NCT02399189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25271415|NCT02399189|Antimetabolites|antimetabolites|mesh-ancestor
25271416|NCT02399189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271417|NCT02399189|Dermatologic Agents|dermatologic agents|mesh-ancestor
25271418|NCT02399189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481916|NCT00437229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25676140|NCT01794455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24481961|NCT00437359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24481963|NCT00437372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481964|NCT00437372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24481965|NCT00437372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24481966|NCT00437372|Growth Substances|growth substances|mesh-ancestor
24457231|NCT00333567|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24482008|NCT00437606|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24482009|NCT00437606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24482010|NCT00437606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24482011|NCT00437606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271449|NCT02398994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25271450|NCT02398994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271452|NCT02398994|Glucocorticoids|glucocorticoids|mesh-ancestor
25271454|NCT02398994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25271455|NCT02398994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25271456|NCT02398994|Protective Agents|protective agents|mesh-ancestor
25271457|NCT02398994|Immunologic Factors|immunologic factors|mesh-ancestor
25271459|NCT02398929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25271460|NCT02398929|Sympatholytics|sympatholytics|mesh-ancestor
25271461|NCT02398929|Autonomic Agents|autonomic agents|mesh-ancestor
25271462|NCT02398929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25271463|NCT02398929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271464|NCT02398929|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25271465|NCT02398929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25271466|NCT02398929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25271467|NCT02398929|Adrenergic Agents|adrenergic agents|mesh-ancestor
25271468|NCT02398929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25271469|NCT02398929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271470|NCT02398838|Misoprostol|misoprostol|mesh-list
25271471|NCT02398838|Mifepristone|mifepristone|mesh-list
25271472|NCT02398838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25271473|NCT02398838|Abortifacient Agents|abortifacient agents|mesh-ancestor
25271474|NCT02398838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25271475|NCT02398838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271476|NCT02398838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24482013|NCT00437619|Dermatologic Agents|dermatologic agents|mesh-ancestor
24482014|NCT00437632|Caffeine|caffeine|mesh-list
24482015|NCT00437632|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24482016|NCT00437632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482017|NCT00437632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24482018|NCT00437632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24482019|NCT00437632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482020|NCT00437632|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24482021|NCT00437632|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24482022|NCT00437632|Purinergic Agents|purinergic agents|mesh-ancestor
24482023|NCT00437632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24482024|NCT00437671|Immunoglobulins|immunoglobulins|mesh-list
24482025|NCT00437671|Antibodies|antibodies|mesh-list
24482026|NCT00437671|gamma-Globulins|gamma-globulins|mesh-list
24482064|NCT00437814|Anesthetics, General|anesthetics, general|mesh-ancestor
24482065|NCT00437814|Anesthetics|anesthetics|mesh-ancestor
24482066|NCT00437814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24482067|NCT00437814|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24482068|NCT00437814|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24482069|NCT00437814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24482070|NCT00437814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482071|NCT00437853|Anastrozole|anastrozole|mesh-list
24482072|NCT00437853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24482073|NCT00437853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24482074|NCT00437853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24482075|NCT00437853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24482076|NCT00437853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24482077|NCT00437853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482078|NCT00437853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24457232|NCT00333567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24457233|NCT00333567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405852|NCT00168584|Vitamin A|vitamin a|mesh-list
24457234|NCT00333567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457235|NCT00333567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24457236|NCT00333567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25271477|NCT02398838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25271478|NCT02398838|Oxytocics|oxytocics|mesh-ancestor
25271479|NCT02398838|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25271480|NCT02398838|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25271481|NCT02398838|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25271482|NCT02398838|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25271483|NCT02398838|Contraceptive Agents|contraceptive agents|mesh-ancestor
25271484|NCT02398838|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25271485|NCT02398838|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25271486|NCT02398838|Hormone Antagonists|hormone antagonists|mesh-ancestor
25271524|NCT02398552|Growth Substances|growth substances|mesh-ancestor
25271491|NCT02398682|Tin Fluorides|tin fluorides|mesh-list
25271492|NCT02398682|Cariostatic Agents|cariostatic agents|mesh-ancestor
25271493|NCT02398682|Protective Agents|protective agents|mesh-ancestor
25271494|NCT02398682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271495|NCT02398448|Allopurinol|allopurinol|mesh-list
25271496|NCT02398448|Antimetabolites|antimetabolites|mesh-ancestor
25271497|NCT02398448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271498|NCT02398448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271499|NCT02398448|Gout Suppressants|gout suppressants|mesh-ancestor
25271500|NCT02398448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25271501|NCT02398448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25271502|NCT02398448|Antioxidants|antioxidants|mesh-ancestor
25271503|NCT02398448|Protective Agents|protective agents|mesh-ancestor
25271504|NCT02398448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275532|NCT02371590|Lenalidomide|lenalidomide|mesh-list
25275533|NCT02371590|Obinutuzumab|obinutuzumab|mesh-list
25275534|NCT02371590|Immunologic Factors|immunologic factors|mesh-ancestor
25275535|NCT02371590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275536|NCT02371590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25275537|NCT02371590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25275538|NCT02371590|Growth Substances|growth substances|mesh-ancestor
25275539|NCT02371590|Growth Inhibitors|growth inhibitors|mesh-ancestor
25275540|NCT02371590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24457238|NCT00333567|Sensory System Agents|sensory system agents|mesh-ancestor
24457239|NCT00333567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24457240|NCT00333567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457241|NCT00333567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24457242|NCT00333567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24457243|NCT00333632|Fentanyl|fentanyl|mesh-list
24457244|NCT00333632|Midazolam|midazolam|mesh-list
24457245|NCT00333632|Dexmedetomidine|dexmedetomidine|mesh-list
24967181|NCT03762148|Vitamins|vitamins|mesh-list
24457246|NCT00333632|Propofol|propofol|mesh-list
24457247|NCT00333632|Isoflurane|isoflurane|mesh-list
24457248|NCT00333632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24695886|NCT01426165|Anesthetics|anesthetics|mesh-ancestor
24482128|NCT00437996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24482129|NCT00437996|Adrenergic Agents|adrenergic agents|mesh-ancestor
24482130|NCT00437996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24482131|NCT00437996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482132|NCT00437996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24482133|NCT00437996|Narcotics|narcotics|mesh-ancestor
24482134|NCT00437996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24482135|NCT00437996|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24482136|NCT00437996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24482137|NCT00437996|Anesthetics, General|anesthetics, general|mesh-ancestor
24482138|NCT00437996|Anesthetics|anesthetics|mesh-ancestor
24482139|NCT00437996|Anesthetics, Local|anesthetics, local|mesh-ancestor
24482140|NCT00438048|Pilocarpine|pilocarpine|mesh-list
25271505|NCT02398383|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25271506|NCT02398383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271507|NCT02398630|Hormones|hormones|mesh-list
25271508|NCT02398630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25271509|NCT02398630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271510|NCT02398487|Nicotine|nicotine|mesh-list
25271511|NCT02398487|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25271512|NCT02398487|Autonomic Agents|autonomic agents|mesh-ancestor
25271513|NCT02398487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25271514|NCT02398487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271515|NCT02398487|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25271516|NCT02398487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25271517|NCT02398487|Cholinergic Agents|cholinergic agents|mesh-ancestor
25271518|NCT02398487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25271519|NCT02398487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271520|NCT02398552|Sunitinib|sunitinib|mesh-list
25271521|NCT02398552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25271522|NCT02398552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25271523|NCT02398552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25271531|NCT02398357|Warfarin|warfarin|mesh-list
25271532|NCT02398357|Calcium|calcium|mesh-list
25271533|NCT02398357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25271534|NCT02398357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271535|NCT02398357|Anticoagulants|anticoagulants|mesh-ancestor
25271536|NCT02398357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25271537|NCT02398357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25271538|NCT02398357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271539|NCT02398474|Ropivacaine|ropivacaine|mesh-list
25271540|NCT02398474|Anesthetics, Local|anesthetics, local|mesh-ancestor
24696097|NCT01427283|Oxycodone|oxycodone|mesh-list
24848731|NCT03617328|Interferon Inducers|interferon inducers|mesh-ancestor
24848732|NCT03573947|Paclitaxel|paclitaxel|mesh-list
24848733|NCT03573947|Nivolumab|nivolumab|mesh-list
25047208|NCT00830102|Fluticasone|fluticasone|mesh-list
25271545|NCT02398474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25271546|NCT02398539|Silver Nitrate|silver nitrate|mesh-list
25271548|NCT02398539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25271549|NCT02398539|Glucocorticoids|glucocorticoids|mesh-ancestor
25271550|NCT02398539|Hormones|hormones|mesh-ancestor
25271551|NCT02398539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25271552|NCT02398539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271553|NCT02398539|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25271554|NCT02398539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25271555|NCT02398201|Bezafibrate|bezafibrate|mesh-list
24482200|NCT00438139|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24521751|NCT04551547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848734|NCT03573947|Ipilimumab|ipilimumab|mesh-list
24848735|NCT03573947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24848736|NCT03573947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24848737|NCT03573947|Tubulin Modulators|tubulin modulators|mesh-ancestor
24848738|NCT03573947|Antimitotic Agents|antimitotic agents|mesh-ancestor
24848739|NCT03573947|Mitosis Modulators|mitosis modulators|mesh-ancestor
24848740|NCT03573947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848741|NCT03573947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24657227|NCT01266252|Dexmedetomidine|dexmedetomidine|mesh-list
24848756|NCT03529110|Mitosis Modulators|mitosis modulators|mesh-ancestor
24848757|NCT03529110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848758|NCT03524417|Immunoglobulins|immunoglobulins|mesh-list
24848759|NCT03524417|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24848760|NCT03524417|Antibodies|antibodies|mesh-list
24848761|NCT03524417|Immunologic Factors|immunologic factors|mesh-ancestor
24848762|NCT03524417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848763|NCT03517540|Cenicriviroc|cenicriviroc|mesh-list
24848764|NCT03517540|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24848765|NCT03517540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848766|NCT03517540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24848767|NCT03517540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24848768|NCT03517540|Antiviral Agents|antiviral agents|mesh-ancestor
25271556|NCT02398201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25271557|NCT02398201|Antimetabolites|antimetabolites|mesh-ancestor
25271559|NCT02398201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25271560|NCT02398123|Bupivacaine|bupivacaine|mesh-list
25271561|NCT02398123|Anesthetics, Local|anesthetics, local|mesh-ancestor
25271562|NCT02398123|Anesthetics|anesthetics|mesh-ancestor
25676141|NCT01794455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25676142|NCT01794455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25676143|NCT01794455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25676144|NCT01794455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676145|NCT01794455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25676146|NCT01794455|Serotonin Agents|serotonin agents|mesh-ancestor
25676147|NCT01794455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271563|NCT02398123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24598917|NCT05351736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24598918|NCT05351736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24598919|NCT05351736|Dopamine Agents|dopamine agents|mesh-ancestor
25271564|NCT02398123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271565|NCT02398123|Sensory System Agents|sensory system agents|mesh-ancestor
25271566|NCT02398123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25271569|NCT02398136|Analgesics|analgesics|mesh-ancestor
25271570|NCT02398136|Sensory System Agents|sensory system agents|mesh-ancestor
25271571|NCT02398136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25271572|NCT02398136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271573|NCT02398136|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24482202|NCT00438139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24482203|NCT00438139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482204|NCT00438139|Hormones|hormones|mesh-ancestor
24848769|NCT03517540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24848770|NCT03497169|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
24848771|NCT03497169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24848772|NCT03497169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848773|NCT03497169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24848774|NCT03497169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24848775|NCT03497169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24848776|NCT03497169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848777|NCT03497169|Dopamine Agents|dopamine agents|mesh-ancestor
25271574|NCT02398136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25271575|NCT02398136|Anesthetics, General|anesthetics, general|mesh-ancestor
25271576|NCT02398136|Anesthetics|anesthetics|mesh-ancestor
25271577|NCT02398136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25271578|NCT02398136|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25271579|NCT02398136|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25271580|NCT02398136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25271581|NCT02398136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271582|NCT02398136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25271583|NCT02398136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25271584|NCT02398136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25271585|NCT02398136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25271586|NCT02398136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25271587|NCT02398136|GABA Modulators|gaba modulators|mesh-ancestor
25271588|NCT02398136|GABA Agents|gaba agents|mesh-ancestor
25271589|NCT02397928|Carboplatin|carboplatin|mesh-list
25271590|NCT02397928|Pemetrexed|pemetrexed|mesh-list
25271591|NCT02397928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25271593|NCT02397928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271594|NCT02397928|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25676148|NCT01794455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25676149|NCT01794455|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25676150|NCT01794455|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25249077|NCT02528825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25249078|NCT02528825|Narcotics|narcotics|mesh-ancestor
25249079|NCT02528825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25249080|NCT02528825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271595|NCT02397928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25271597|NCT02397720|Ipilimumab|ipilimumab|mesh-list
25271598|NCT02397720|Azacitidine|azacitidine|mesh-list
25271599|NCT02397720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25271600|NCT02397720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25271601|NCT02397720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25271602|NCT02397720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271603|NCT02397720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24482261|NCT00438269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24482322|NCT00438737|Fluorouracil|fluorouracil|mesh-list
24482323|NCT00438737|Oxaliplatin|oxaliplatin|mesh-list
24482324|NCT00438737|Calcium|calcium|mesh-list
24482325|NCT00438737|Levoleucovorin|levoleucovorin|mesh-list
24482326|NCT00438737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24488030|NCT00466232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488031|NCT00466232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24488032|NCT00466232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657277|NCT01266681|Dronedarone|dronedarone|mesh-list
24848821|NCT03440190|Methylphenidate|methylphenidate|mesh-list
24848822|NCT03440190|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24848823|NCT03440190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848824|NCT03440190|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24657310|NCT01266720|Antimetabolites|antimetabolites|mesh-ancestor
24848829|NCT03440190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24488109|NCT00466609|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24488110|NCT00466609|Fluoxetine|fluoxetine|mesh-list
24488111|NCT00466609|Clomipramine|clomipramine|mesh-list
24488112|NCT00466609|Antidepressive Agents|antidepressive agents|mesh-ancestor
24488113|NCT00466609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25142396|NCT02950155|Rituximab|rituximab|mesh-list
24488114|NCT00466609|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24488115|NCT00466609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24488116|NCT00466609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24488117|NCT00466609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488118|NCT00466609|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24488119|NCT00466609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24848852|NCT03374332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24848853|NCT03374332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24848854|NCT03360721|Prednisone|prednisone|mesh-list
24848855|NCT03360721|Cortisone|cortisone|mesh-list
24848856|NCT03360721|Abiraterone Acetate|abiraterone acetate|mesh-list
24848857|NCT03360721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24848859|NCT03360721|Hormones|hormones|mesh-ancestor
24488135|NCT00466791|Methylphenidate|methylphenidate|mesh-list
24488136|NCT00466791|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24848883|NCT03298893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24848884|NCT03298893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25676151|NCT01794689|Morphine|morphine|mesh-list
25676152|NCT01794689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25676153|NCT01794689|Narcotics|narcotics|mesh-ancestor
25676154|NCT01794689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25676155|NCT01794689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676156|NCT01794689|Analgesics|analgesics|mesh-ancestor
25676157|NCT01794689|Sensory System Agents|sensory system agents|mesh-ancestor
25676158|NCT01794689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25676159|NCT01794702|Cytarabine|cytarabine|mesh-list
25676160|NCT01794702|Decitabine|decitabine|mesh-list
25676161|NCT01794702|Clofarabine|clofarabine|mesh-list
24482327|NCT00438737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24482328|NCT00438737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24457273|NCT00333645|Caspofungin|caspofungin|mesh-list
24482456|NCT00439049|Dopamine Agents|dopamine agents|mesh-ancestor
24482457|NCT00439049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24482458|NCT00439049|Adrenergic Agents|adrenergic agents|mesh-ancestor
24482459|NCT00439049|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24943158|NCT03973879|Atezolizumab|atezolizumab|mesh-list
24488206|NCT00467116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488207|NCT00467116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25271614|NCT02397772|Antimitotic Agents|antimitotic agents|mesh-ancestor
25271615|NCT02397772|Mitosis Modulators|mitosis modulators|mesh-ancestor
25271616|NCT02397772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271617|NCT02397772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25271618|NCT02397863|Cannabidiol|cannabidiol|mesh-list
25271619|NCT02397863|Anticonvulsants|anticonvulsants|mesh-ancestor
25271620|NCT02398058|Olaparib|olaparib|mesh-list
25271621|NCT02398058|Trabectedin|trabectedin|mesh-list
25271622|NCT02398058|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25271623|NCT02398058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271624|NCT02398058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271625|NCT02398058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25271633|NCT02397382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25271634|NCT02397382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25271635|NCT02397382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24482460|NCT00439049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24482461|NCT00439049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24482462|NCT00439049|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24736823|NCT01665248|Listerine|listerine|mesh-list
24848954|NCT03176953|Topiramate|topiramate|mesh-list
24848955|NCT03176953|Anticonvulsants|anticonvulsants|mesh-ancestor
25676162|NCT01794702|Idarubicin|idarubicin|mesh-list
25676163|NCT01794702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25676164|NCT01794702|Antimetabolites|antimetabolites|mesh-ancestor
25676165|NCT01794702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676166|NCT01794702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25676167|NCT01794702|Antiviral Agents|antiviral agents|mesh-ancestor
25676168|NCT01794702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25676169|NCT01794702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25676170|NCT01794702|Immunologic Factors|immunologic factors|mesh-ancestor
24848988|NCT03170882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848989|NCT03165994|Paclitaxel|paclitaxel|mesh-list
25676171|NCT01794702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676172|NCT01794702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676173|NCT01794702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25676174|NCT01794702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25676175|NCT01794702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25676176|NCT01794741|Fluticasone|fluticasone|mesh-list
25676177|NCT01794741|Xhance|xhance|mesh-list
25676178|NCT01794741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25676179|NCT01794741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25676180|NCT01794741|Autonomic Agents|autonomic agents|mesh-ancestor
25676181|NCT01794741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25676182|NCT01794741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676183|NCT01794741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24853012|NCT02265406|Anti-Infective Agents|anti-infective agents|mesh-list
24853013|NCT02265445|beta-Lactams|beta-lactams|mesh-list
24853014|NCT02265445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24853015|NCT02265445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24853016|NCT02265562|Alprostadil|alprostadil|mesh-list
24849003|NCT03126435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25271636|NCT02397382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271637|NCT02397382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25271638|NCT02397382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25271639|NCT02397382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25271640|NCT02397382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25271641|NCT02397382|Anesthetics, General|anesthetics, general|mesh-ancestor
25271642|NCT02397382|Anesthetics|anesthetics|mesh-ancestor
25271643|NCT02397382|GABA Modulators|gaba modulators|mesh-ancestor
25271644|NCT02397382|GABA Agents|gaba agents|mesh-ancestor
24457275|NCT00333645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24457276|NCT00333645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24482498|NCT00439283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696588|NCT01430078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849004|NCT03126435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849005|NCT03126435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24849006|NCT03126435|Immunologic Factors|immunologic factors|mesh-ancestor
24488367|NCT00468182|Immunologic Factors|immunologic factors|mesh-ancestor
24488368|NCT00468182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488369|NCT00468182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24488370|NCT00468234|Nicotine|nicotine|mesh-list
24488371|NCT00468234|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24849030|NCT03043924|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24849031|NCT03043924|Contraceptive Agents|contraceptive agents|mesh-ancestor
24849032|NCT03043924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24849033|NCT03043924|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24849034|NCT03043924|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24849035|NCT03043924|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24849036|NCT03043924|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24849037|NCT03043924|Androgen Antagonists|androgen antagonists|mesh-ancestor
24849038|NCT03043924|Hormone Antagonists|hormone antagonists|mesh-ancestor
24849042|NCT03041740|Bromides|bromides|mesh-list
24488403|NCT00468351|Immunologic Factors|immunologic factors|mesh-ancestor
24488404|NCT00468351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271645|NCT02397382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25271646|NCT02397382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271647|NCT02397382|Anticoagulants|anticoagulants|mesh-ancestor
25271648|NCT02397382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25271649|NCT02397382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25271650|NCT02397382|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25271651|NCT02397382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271652|NCT02397382|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25271653|NCT02397382|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25271698|NCT02397538|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25271654|NCT02397382|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25271656|NCT02397382|Purinergic Agents|purinergic agents|mesh-ancestor
25271657|NCT02397382|Antitussive Agents|antitussive agents|mesh-ancestor
25271658|NCT02397382|Respiratory System Agents|respiratory system agents|mesh-ancestor
25271659|NCT02397382|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25271660|NCT02397382|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25271661|NCT02397603|Dexmedetomidine|dexmedetomidine|mesh-list
25271662|NCT02397603|Bupivacaine|bupivacaine|mesh-list
25271663|NCT02397603|Anesthetics, Local|anesthetics, local|mesh-ancestor
25271664|NCT02397603|Anesthetics|anesthetics|mesh-ancestor
25271665|NCT02397603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25271666|NCT02397603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271667|NCT02397603|Sensory System Agents|sensory system agents|mesh-ancestor
25676184|NCT01794741|Respiratory System Agents|respiratory system agents|mesh-ancestor
25676185|NCT01794741|Dermatologic Agents|dermatologic agents|mesh-ancestor
25676186|NCT01794741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25676187|NCT01794780|Fluticasone|fluticasone|mesh-list
25676188|NCT01794780|Budesonide|budesonide|mesh-list
25271668|NCT02397603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25271669|NCT02397603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25271670|NCT02397603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24599363|NCT04699604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271671|NCT02397603|Analgesics|analgesics|mesh-ancestor
24482583|NCT00439829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482585|NCT00439829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24482586|NCT00439855|Heparin|heparin|mesh-list
24482587|NCT00439855|Enoxaparin|enoxaparin|mesh-list
24482608|NCT00439972|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24482609|NCT00439972|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24482611|NCT00440024|Dermatologic Agents|dermatologic agents|mesh-ancestor
24482612|NCT00440024|Keratolytic Agents|keratolytic agents|mesh-ancestor
24482613|NCT00440063|Epoetin Alfa|epoetin alfa|mesh-list
24482614|NCT00440063|Hematinics|hematinics|mesh-ancestor
24457277|NCT00333645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457278|NCT00333671|Glycerol|glycerol|mesh-list
24457279|NCT00333671|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24457280|NCT00333671|Protective Agents|protective agents|mesh-ancestor
24457281|NCT00333671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457282|NCT00333723|Rosiglitazone|rosiglitazone|mesh-list
24457283|NCT00333723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24457284|NCT00333723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457292|NCT00333918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24488405|NCT00468351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488406|NCT00468364|Insulin|insulin|mesh-list
24488407|NCT00468364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24488408|NCT00468364|Insulin Glargine|insulin glargine|mesh-list
24488409|NCT00468364|Insulin, Isophane|insulin, isophane|mesh-list
24488410|NCT00468364|Isophane Insulin, Human|isophane insulin, human|mesh-list
24488411|NCT00468364|Isophane insulin, beef|isophane insulin, beef|mesh-list
24696648|NCT01430533|Azelaic acid|azelaic acid|mesh-list
25271672|NCT02397603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25271673|NCT02397603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25271674|NCT02397603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25271675|NCT02397603|Adrenergic Agents|adrenergic agents|mesh-ancestor
25271676|NCT02397603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25271677|NCT02397603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271678|NCT02397395|Simeprevir|simeprevir|mesh-list
25271679|NCT02397395|Antiviral Agents|antiviral agents|mesh-ancestor
25271680|NCT02397395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25271681|NCT02397395|Protease Inhibitors|protease inhibitors|mesh-ancestor
25271682|NCT02397395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271683|NCT02397395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271684|NCT02397551|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25271685|NCT02397551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25271686|NCT02397551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271687|NCT02397512|Lactulose|lactulose|mesh-list
25271688|NCT02397512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25271689|NCT02397421|Dapagliflozin|dapagliflozin|mesh-list
25271690|NCT02397421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25271691|NCT02397421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271692|NCT02397421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25271693|NCT02397421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271694|NCT02397642|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25271695|NCT02397642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25271696|NCT02397642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271697|NCT02397538|Amlodipine|amlodipine|mesh-list
25271699|NCT02397538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25271700|NCT02397538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25271701|NCT02397538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25271702|NCT02397538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457293|NCT00333918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482741|NCT00440349|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24482742|NCT00440349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24482744|NCT00440375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24482745|NCT00440375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482746|NCT00440414|Pemetrexed|pemetrexed|mesh-list
24482747|NCT00440414|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24482748|NCT00440414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24482749|NCT00440414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24482750|NCT00440414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676189|NCT01794780|Theophylline|theophylline|mesh-list
25676190|NCT01794780|Formoterol Fumarate|formoterol fumarate|mesh-list
24599448|NCT04562129|Ipilimumab|ipilimumab|mesh-list
24599449|NCT04562129|Interleukin-2|interleukin-2|mesh-list
24599450|NCT04562129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24599451|NCT04562129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579887|NCT00858624|Analgesics|analgesics|mesh-ancestor
24579947|NCT00858767|Hemostatics|hemostatics|mesh-ancestor
24482751|NCT00440414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24482752|NCT00440414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24488455|NCT00468689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24446908|NCT00306475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24849079|NCT02940548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849080|NCT02940548|Vasodilator Agents|vasodilator agents|mesh-ancestor
24849081|NCT02940548|Tocolytic Agents|tocolytic agents|mesh-ancestor
24849082|NCT02940548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24849083|NCT02915016|Vaccines|vaccines|mesh-list
24849084|NCT02915016|MF59 oil emulsion|mf59 oil emulsion|mesh-list
24849085|NCT02915016|Immunologic Factors|immunologic factors|mesh-ancestor
24849086|NCT02915016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640161|NCT01166451|Trace Elements|trace elements|mesh-ancestor
24488487|NCT00468936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488488|NCT00468936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24488489|NCT00468936|Antitubercular Agents|antitubercular agents|mesh-ancestor
24488490|NCT00468936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24488491|NCT00468936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24488492|NCT00468936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488493|NCT00468936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488494|NCT00468988|Travoprost|travoprost|mesh-list
24488512|NCT00469131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849118|NCT02621398|Tubulin Modulators|tubulin modulators|mesh-ancestor
24849119|NCT02621398|Antimitotic Agents|antimitotic agents|mesh-ancestor
24849120|NCT02621398|Mitosis Modulators|mitosis modulators|mesh-ancestor
24849121|NCT02621398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849122|NCT02621398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24849123|NCT02590393|Nicotine|nicotine|mesh-list
24849124|NCT02590393|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24849125|NCT02590393|Autonomic Agents|autonomic agents|mesh-ancestor
25271703|NCT02397538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25271704|NCT02397538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271705|NCT02397538|Vasodilator Agents|vasodilator agents|mesh-ancestor
25271706|NCT02397538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25271707|NCT02397538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25271708|NCT02397538|Antimetabolites|antimetabolites|mesh-ancestor
25271709|NCT02397538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25271710|NCT02397538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25271711|NCT02397538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271712|NCT02397486|Vitamin E|vitamin e|mesh-list
25271713|NCT02397486|Pentoxifylline|pentoxifylline|mesh-list
25271714|NCT02397486|Vitamins|vitamins|mesh-ancestor
25271715|NCT02397486|Micronutrients|micronutrients|mesh-ancestor
25676191|NCT01794780|Tiotropium Bromide|tiotropium bromide|mesh-list
25676192|NCT01794780|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25676193|NCT01794780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25676194|NCT01794780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25676195|NCT01794780|Autonomic Agents|autonomic agents|mesh-ancestor
25676196|NCT01794780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25676197|NCT01794780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271716|NCT02397486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271717|NCT02397486|Antioxidants|antioxidants|mesh-ancestor
24457295|NCT00333918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24457297|NCT00333931|Anticonvulsants|anticonvulsants|mesh-ancestor
24457298|NCT00333931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24482788|NCT00440622|Immunologic Factors|immunologic factors|mesh-ancestor
24482817|NCT00440713|Antidepressive Agents|antidepressive agents|mesh-ancestor
24482818|NCT00440713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24482819|NCT00440713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24482847|NCT00440739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482848|NCT00440739|Parasympatholytics|parasympatholytics|mesh-ancestor
24943244|NCT03973203|Vitamins|vitamins|mesh-ancestor
24849126|NCT02590393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24849127|NCT02590393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849128|NCT02590393|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25271718|NCT02397486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271719|NCT02397486|Protective Agents|protective agents|mesh-ancestor
25271720|NCT02397486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25271721|NCT02397486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271722|NCT02397486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25271723|NCT02397486|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25271724|NCT02397486|Vasodilator Agents|vasodilator agents|mesh-ancestor
25271725|NCT02397486|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25271726|NCT02397590|Atorvastatin|atorvastatin|mesh-list
25271727|NCT02397590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25271728|NCT02397590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24696891|NCT01431547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25271729|NCT02397590|Antimetabolites|antimetabolites|mesh-ancestor
25271730|NCT02397590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271731|NCT02397590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25271732|NCT02397590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25271733|NCT02397590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271734|NCT02397356|Ketamine|ketamine|mesh-list
25271735|NCT02397356|Analgesics|analgesics|mesh-ancestor
25271736|NCT02397356|Sensory System Agents|sensory system agents|mesh-ancestor
25271737|NCT02397356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25271738|NCT02397356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271739|NCT02397356|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25271740|NCT02397356|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25271741|NCT02397356|Anesthetics, General|anesthetics, general|mesh-ancestor
25271742|NCT02397356|Anesthetics|anesthetics|mesh-ancestor
25271743|NCT02397356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25271744|NCT02397356|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25271745|NCT02397356|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25271746|NCT02397356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25271747|NCT02397356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271748|NCT02397499|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25271749|NCT02397499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25271750|NCT02397499|Autonomic Agents|autonomic agents|mesh-ancestor
25271751|NCT02397499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24482910|NCT00440960|Sensory System Agents|sensory system agents|mesh-ancestor
24482911|NCT00440960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24482912|NCT00440960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24482913|NCT00440960|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24482914|NCT00440960|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24433471|NCT00258557|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24482915|NCT00440960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24482916|NCT00440960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482917|NCT00440960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24522039|NCT04340882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25676198|NCT01794780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24580008|NCT00859352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24580009|NCT00859352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24849129|NCT02590393|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24849130|NCT02590393|Cholinergic Agents|cholinergic agents|mesh-ancestor
24488558|NCT00469352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488559|NCT00469352|Growth Inhibitors|growth inhibitors|mesh-ancestor
25271752|NCT02397499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271753|NCT02397499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25271754|NCT02397499|Respiratory System Agents|respiratory system agents|mesh-ancestor
25271755|NCT02397499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25271756|NCT02397499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25271757|NCT02397499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25271758|NCT02397499|Adrenergic Agents|adrenergic agents|mesh-ancestor
25271759|NCT02397499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25271760|NCT02397499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271761|NCT02397330|Morphine|morphine|mesh-list
25271762|NCT02397330|Bupivacaine|bupivacaine|mesh-list
25271763|NCT02397330|Anesthetics, Local|anesthetics, local|mesh-ancestor
25271764|NCT02397330|Anesthetics|anesthetics|mesh-ancestor
25271765|NCT02397330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25271766|NCT02397330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271767|NCT02397330|Sensory System Agents|sensory system agents|mesh-ancestor
25271768|NCT02397330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25271769|NCT02397330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25271770|NCT02397330|Narcotics|narcotics|mesh-ancestor
25271771|NCT02397330|Analgesics|analgesics|mesh-ancestor
25271772|NCT02396979|Methadone|methadone|mesh-list
24482919|NCT00440960|Anesthetics, General|anesthetics, general|mesh-ancestor
24482920|NCT00440960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24482950|NCT00441051|Sensory System Agents|sensory system agents|mesh-ancestor
24482951|NCT00441051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24482952|NCT00441051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482953|NCT00441051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24482954|NCT00441051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24482955|NCT00441051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24482956|NCT00441051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457315|NCT00333996|Antiemetics|antiemetics|mesh-ancestor
25676199|NCT01794780|Respiratory System Agents|respiratory system agents|mesh-ancestor
25676200|NCT01794780|Dermatologic Agents|dermatologic agents|mesh-ancestor
25676201|NCT01794780|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25676202|NCT01794780|Glucocorticoids|glucocorticoids|mesh-ancestor
25676203|NCT01794780|Hormones|hormones|mesh-ancestor
25676204|NCT01794780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25676205|NCT01794780|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24457316|NCT00333996|Autonomic Agents|autonomic agents|mesh-ancestor
25249359|NCT02527577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249360|NCT02527577|Sensory System Agents|sensory system agents|mesh-ancestor
25249361|NCT02527577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24457317|NCT00333996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24457318|NCT00333996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457319|NCT00333996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25271785|NCT02397070|Keratolytic Agents|keratolytic agents|mesh-ancestor
25271786|NCT02397070|Dermatologic Agents|dermatologic agents|mesh-ancestor
25271787|NCT02397213|Cyclosporine|cyclosporine|mesh-list
25271788|NCT02397213|Cyclosporins|cyclosporins|mesh-list
25271789|NCT02397213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271790|NCT02397213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271791|NCT02397213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25271792|NCT02397213|Immunologic Factors|immunologic factors|mesh-ancestor
25271793|NCT02397213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271794|NCT02397213|Antifungal Agents|antifungal agents|mesh-ancestor
25271795|NCT02397213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25271796|NCT02397213|Dermatologic Agents|dermatologic agents|mesh-ancestor
25271797|NCT02397213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25271798|NCT02397213|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25271799|NCT02396888|Insulin|insulin|mesh-list
25271800|NCT02396888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25271801|NCT02396888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275541|NCT02371590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25275542|NCT02371473|Acetazolamide|acetazolamide|mesh-list
25275543|NCT02371473|Anticonvulsants|anticonvulsants|mesh-ancestor
25275544|NCT02371473|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25275545|NCT02371473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457328|NCT00334022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457330|NCT00334022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24457331|NCT00334022|Antiviral Agents|antiviral agents|mesh-ancestor
25142777|NCT02947243|Morphine|morphine|mesh-list
24457332|NCT00334022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24457333|NCT00334035|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24457334|NCT00334035|Antidepressive Agents|antidepressive agents|mesh-ancestor
24457335|NCT00334035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24457336|NCT00334035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24457337|NCT00334035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24457338|NCT00334035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24457339|NCT00334035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483097|NCT00441844|Simvastatin|simvastatin|mesh-list
24483098|NCT00441844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24483099|NCT00441844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24483100|NCT00441844|Antimetabolites|antimetabolites|mesh-ancestor
24483101|NCT00441844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676206|NCT01794780|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25676207|NCT01794780|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25676208|NCT01794780|Adrenergic Agents|adrenergic agents|mesh-ancestor
25676209|NCT01794780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25676210|NCT01794780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676211|NCT01794780|Parasympatholytics|parasympatholytics|mesh-ancestor
25676212|NCT01794780|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25676213|NCT01794780|Cholinergic Agents|cholinergic agents|mesh-ancestor
25676214|NCT01794780|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25676215|NCT01794780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676216|NCT01794780|Vasodilator Agents|vasodilator agents|mesh-ancestor
25676217|NCT01794780|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24599682|NCT04079452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24599683|NCT04009824|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24599684|NCT04009824|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25249395|NCT02527109|Tocolytic Agents|tocolytic agents|mesh-ancestor
25271802|NCT02396563|Ropivacaine|ropivacaine|mesh-list
25271804|NCT02396563|Anesthetics|anesthetics|mesh-ancestor
25271805|NCT02396563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25271806|NCT02396563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271807|NCT02396563|Sensory System Agents|sensory system agents|mesh-ancestor
25271808|NCT02396563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25271809|NCT02396862|Factor VIII|factor viii|mesh-list
25271810|NCT02396862|Coagulants|coagulants|mesh-ancestor
25271811|NCT02396225|Voriconazole|voriconazole|mesh-list
25271812|NCT02396225|Antifungal Agents|antifungal agents|mesh-ancestor
25271813|NCT02396225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25271814|NCT02396225|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25271815|NCT02396225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25271816|NCT02396225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271817|NCT02396225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271818|NCT02396225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25271819|NCT02396225|Hormone Antagonists|hormone antagonists|mesh-ancestor
25241757|NCT05300009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24697080|NCT01432587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25271820|NCT02396225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25271821|NCT02396225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271822|NCT02396225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25271824|NCT02396303|Oxytocics|oxytocics|mesh-ancestor
25271825|NCT02396303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25271826|NCT02396303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271827|NCT02396329|Chlorhexidine|chlorhexidine|mesh-list
25271828|NCT02396329|Povidone-Iodine|povidone-iodine|mesh-list
25271829|NCT02396329|Povidone|povidone|mesh-list
25271830|NCT02396329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25271831|NCT02396329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25271832|NCT02396329|Disinfectants|disinfectants|mesh-ancestor
24483102|NCT00441844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24457344|NCT00334048|Dopamine Agents|dopamine agents|mesh-ancestor
24457348|NCT00334126|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24457349|NCT00334126|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24483103|NCT00441844|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24483104|NCT00441844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483106|NCT00441870|Vitamin B Complex|vitamin b complex|mesh-list
24483107|NCT00441870|Hematinics|hematinics|mesh-ancestor
24483108|NCT00441870|Vitamins|vitamins|mesh-ancestor
24483109|NCT00441870|Micronutrients|micronutrients|mesh-ancestor
24483110|NCT00441870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483112|NCT00441909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24483113|NCT00441909|Antiviral Agents|antiviral agents|mesh-ancestor
24483114|NCT00441909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24483115|NCT00441922|Docetaxel|docetaxel|mesh-list
24483116|NCT00441922|Vinorelbine|vinorelbine|mesh-list
24483117|NCT00441922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943392|NCT03971487|Ocrelizumab|ocrelizumab|mesh-list
25676218|NCT01794780|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25676219|NCT01794780|Purinergic Agents|purinergic agents|mesh-ancestor
25676220|NCT01794845|Docetaxel|docetaxel|mesh-list
25676221|NCT01794845|Cetuximab|cetuximab|mesh-list
25676222|NCT01794845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25676223|NCT01794845|Tubulin Modulators|tubulin modulators|mesh-ancestor
25676224|NCT01794845|Antimitotic Agents|antimitotic agents|mesh-ancestor
24483179|NCT00442221|Sumatriptan|sumatriptan|mesh-list
24483180|NCT00442221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24483181|NCT00442221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24483182|NCT00442221|Analgesics|analgesics|mesh-ancestor
24483183|NCT00442221|Sensory System Agents|sensory system agents|mesh-ancestor
24483184|NCT00442221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24483185|NCT00442221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943415|NCT03970798|Midazolam|midazolam|mesh-list
24849230|NCT01866111|Cenobamate|cenobamate|mesh-list
24849231|NCT01866111|Anticonvulsants|anticonvulsants|mesh-ancestor
24488786|NCT00470015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488787|NCT00470015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24488788|NCT00470015|Analgesics|analgesics|mesh-ancestor
24849233|NCT01767129|Dextromethorphan|dextromethorphan|mesh-list
24849234|NCT01767129|Antitussive Agents|antitussive agents|mesh-ancestor
25271856|NCT02396108|Carboplatin|carboplatin|mesh-list
25271857|NCT02396108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25271858|NCT02396108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25271859|NCT02396108|Tubulin Modulators|tubulin modulators|mesh-ancestor
25271860|NCT02396108|Antimitotic Agents|antimitotic agents|mesh-ancestor
25271861|NCT02396108|Mitosis Modulators|mitosis modulators|mesh-ancestor
25271862|NCT02396108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271863|NCT02396043|Cytarabine|cytarabine|mesh-list
25271864|NCT02396043|Dexamethasone|dexamethasone|mesh-list
25271865|NCT02396043|Prednisone|prednisone|mesh-list
25271866|NCT02396043|Cyclophosphamide|cyclophosphamide|mesh-list
25271867|NCT02396043|Methotrexate|methotrexate|mesh-list
25271868|NCT02396043|Vincristine|vincristine|mesh-list
25271869|NCT02396043|Mercaptopurine|mercaptopurine|mesh-list
25271870|NCT02396043|Pegaspargase|pegaspargase|mesh-list
25271871|NCT02396043|Asparaginase|asparaginase|mesh-list
25271872|NCT02396043|Pirarubicin|pirarubicin|mesh-list
25271873|NCT02396043|Doxorubicin|doxorubicin|mesh-list
25271874|NCT02396043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25271875|NCT02396043|Immunologic Factors|immunologic factors|mesh-ancestor
24483209|NCT00442312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483210|NCT00442312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24483211|NCT00442312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24483212|NCT00442312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24483213|NCT00442325|Atorvastatin|atorvastatin|mesh-list
24483221|NCT00442390|Hydrocortisone|hydrocortisone|mesh-list
24483254|NCT00442546|Sensory System Agents|sensory system agents|mesh-ancestor
24483255|NCT00442546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24483256|NCT00442546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943444|NCT03971045|Pembrolizumab|pembrolizumab|mesh-list
24849256|NCT01767129|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24849257|NCT01767129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24849259|NCT01659606|Mycophenolic Acid|mycophenolic acid|mesh-list
24849260|NCT01659606|Fludarabine|fludarabine|mesh-list
24849261|NCT01659606|Alemtuzumab|alemtuzumab|mesh-list
24849262|NCT01659606|Tacrolimus|tacrolimus|mesh-list
24849263|NCT01659606|Cyclosporins|cyclosporins|mesh-list
25271884|NCT02396043|Antiemetics|antiemetics|mesh-ancestor
25271885|NCT02396043|Autonomic Agents|autonomic agents|mesh-ancestor
25271886|NCT02396043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25241758|NCT05300009|Immunologic Factors|immunologic factors|mesh-ancestor
25271887|NCT02396043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25271888|NCT02396043|Glucocorticoids|glucocorticoids|mesh-ancestor
25271889|NCT02396043|Hormones|hormones|mesh-ancestor
25271890|NCT02396043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25271891|NCT02396043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25271892|NCT02396043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25271893|NCT02396043|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25271894|NCT02396043|Abortifacient Agents|abortifacient agents|mesh-ancestor
25271895|NCT02396043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25271896|NCT02396043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25271897|NCT02396043|Antimetabolites|antimetabolites|mesh-ancestor
25676225|NCT01794845|Mitosis Modulators|mitosis modulators|mesh-ancestor
25271904|NCT02396043|Tubulin Modulators|tubulin modulators|mesh-ancestor
25271905|NCT02396043|Antimitotic Agents|antimitotic agents|mesh-ancestor
25271906|NCT02396043|Mitosis Modulators|mitosis modulators|mesh-ancestor
25271907|NCT02396043|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25271908|NCT02396043|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25271909|NCT02396043|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25271910|NCT02395783|Melatonin|melatonin|mesh-list
25271911|NCT02395783|Antioxidants|antioxidants|mesh-ancestor
25271912|NCT02395783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271913|NCT02395783|Protective Agents|protective agents|mesh-ancestor
25271914|NCT02395783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271915|NCT02395783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25271916|NCT02395705|Paclitaxel|paclitaxel|mesh-list
25271918|NCT02395705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25271919|NCT02395705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25271920|NCT02395705|Tubulin Modulators|tubulin modulators|mesh-ancestor
24483360|NCT00443170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24483381|NCT00443170|Sensory System Agents|sensory system agents|mesh-ancestor
24483382|NCT00443170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24483383|NCT00443170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24483384|NCT00443170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24483385|NCT00443170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24483392|NCT00443235|Thalidomide|thalidomide|mesh-list
24483393|NCT00443235|Prednisone|prednisone|mesh-list
24483394|NCT00443235|Melphalan|melphalan|mesh-list
24483395|NCT00443235|Bortezomib|bortezomib|mesh-list
24483396|NCT00443235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24483397|NCT00443235|Glucocorticoids|glucocorticoids|mesh-ancestor
24483398|NCT00443235|Hormones|hormones|mesh-ancestor
24483399|NCT00443235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24451317|NCT00323154|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25249559|NCT02526199|Dexamethasone|dexamethasone|mesh-list
25249560|NCT02526199|Epinephrine|epinephrine|mesh-list
25249561|NCT02526199|Bupivacaine|bupivacaine|mesh-list
24849349|NCT00559936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24849350|NCT00559936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24849351|NCT00559936|Growth Substances|growth substances|mesh-ancestor
24849352|NCT00559936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849353|NCT00559936|Growth Inhibitors|growth inhibitors|mesh-ancestor
25271921|NCT02395705|Antimitotic Agents|antimitotic agents|mesh-ancestor
25271922|NCT02395705|Mitosis Modulators|mitosis modulators|mesh-ancestor
25271923|NCT02395705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271924|NCT02395848|Fidaxomicin|fidaxomicin|mesh-list
24643466|NCT01185769|Vitamins|vitamins|mesh-ancestor
24697504|NCT01435213|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25070303|NCT03420638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25070304|NCT03420638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25070305|NCT03420638|Adrenergic Agents|adrenergic agents|mesh-ancestor
25070306|NCT03420638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25070307|NCT03420638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070308|NCT03420638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25070309|NCT03420638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25271925|NCT02395848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25271926|NCT02395848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25271927|NCT02395926|Choline|choline|mesh-list
25271928|NCT02395926|Lipotropic Agents|lipotropic agents|mesh-ancestor
25271929|NCT02395926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25271930|NCT02395926|Antimetabolites|antimetabolites|mesh-ancestor
25271931|NCT02395926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271932|NCT02395926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25271941|NCT02395744|Tubulin Modulators|tubulin modulators|mesh-ancestor
25271942|NCT02395744|Antimitotic Agents|antimitotic agents|mesh-ancestor
25271943|NCT02395744|Mitosis Modulators|mitosis modulators|mesh-ancestor
25271944|NCT02395744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426768|NCT00236587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24457366|NCT00334139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457369|NCT00334152|Autonomic Agents|autonomic agents|mesh-ancestor
24457370|NCT00334152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25676226|NCT01794845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676227|NCT01794845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25676228|NCT01795495|Magnesium Sulfate|magnesium sulfate|mesh-list
25676229|NCT01795495|Remifentanil|remifentanil|mesh-list
25676230|NCT01795495|Methadone|methadone|mesh-list
25676231|NCT01795495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25676232|NCT01795495|Narcotics|narcotics|mesh-ancestor
25676233|NCT01795495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25676234|NCT01795495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676235|NCT01795495|Analgesics|analgesics|mesh-ancestor
25676236|NCT01795495|Sensory System Agents|sensory system agents|mesh-ancestor
25676237|NCT01795495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25676238|NCT01795495|Anesthetics|anesthetics|mesh-ancestor
25249602|NCT02526030|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25249603|NCT02526030|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25249605|NCT02526030|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25249606|NCT02526030|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25249607|NCT02526030|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24457371|NCT00334152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526155|NCT00934700|Xenon|xenon|mesh-list
24849354|NCT00504582|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24849355|NCT00504582|Hemostatics|hemostatics|mesh-ancestor
24849356|NCT00504582|Coagulants|coagulants|mesh-ancestor
24849357|NCT00494182|Paclitaxel|paclitaxel|mesh-list
24849358|NCT00494182|Carboplatin|carboplatin|mesh-list
24849359|NCT00494182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24849360|NCT00494182|Sorafenib|sorafenib|mesh-list
24849361|NCT00494182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24697539|NCT01435343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24697540|NCT01435343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24697541|NCT01435343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24697542|NCT01435343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24697544|NCT01435395|Bevacizumab|bevacizumab|mesh-list
24697545|NCT01435395|Temozolomide|temozolomide|mesh-list
24697546|NCT01435395|Bortezomib|bortezomib|mesh-list
24697547|NCT01435395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24697552|NCT01435395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697553|NCT01435395|Growth Inhibitors|growth inhibitors|mesh-ancestor
24849362|NCT00494182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24849363|NCT00494182|Tubulin Modulators|tubulin modulators|mesh-ancestor
24849364|NCT00494182|Antimitotic Agents|antimitotic agents|mesh-ancestor
24849365|NCT00494182|Mitosis Modulators|mitosis modulators|mesh-ancestor
24849366|NCT00494182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849367|NCT00494182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24849368|NCT00494182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849369|NCT00454753|Dasatinib|dasatinib|mesh-list
25271945|NCT02395458|Amoxicillin|amoxicillin|mesh-list
25676239|NCT01795495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25676240|NCT01795495|Anticonvulsants|anticonvulsants|mesh-ancestor
25676241|NCT01795495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25676242|NCT01795495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25676243|NCT01795495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676244|NCT01795495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25676245|NCT01795495|Tocolytic Agents|tocolytic agents|mesh-ancestor
25676246|NCT01795495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25676247|NCT01795495|Antitussive Agents|antitussive agents|mesh-ancestor
25676248|NCT01795495|Respiratory System Agents|respiratory system agents|mesh-ancestor
25676249|NCT01795547|Aripiprazole|aripiprazole|mesh-list
25676250|NCT01795547|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25271946|NCT02395458|Metronidazole|metronidazole|mesh-list
25676251|NCT01795547|Antidepressive Agents|antidepressive agents|mesh-ancestor
25271957|NCT02395458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271959|NCT02395458|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25271960|NCT02395458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25271961|NCT02395510|Vortioxetine|vortioxetine|mesh-list
24457372|NCT00334152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24457373|NCT00334152|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24457374|NCT00334152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24457375|NCT00334152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457376|NCT00334256|Tenofovir|tenofovir|mesh-list
24457377|NCT00334256|Emtricitabine|emtricitabine|mesh-list
24457378|NCT00334256|Antiviral Agents|antiviral agents|mesh-ancestor
24457379|NCT00334256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24457380|NCT00334256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24457381|NCT00334256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24457382|NCT00334256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483528|NCT00443937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24483529|NCT00443937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483530|NCT00443937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943482|NCT03970577|Prednisone|prednisone|mesh-list
24657918|NCT01269528|Antioxidants|antioxidants|mesh-ancestor
24849387|NCT00358163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24849388|NCT00358163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849389|NCT02248571|Bevacizumab|bevacizumab|mesh-list
24849390|NCT02248571|Capecitabine|capecitabine|mesh-list
25241759|NCT05300009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24697629|NCT01435954|Tamsulosin|tamsulosin|mesh-list
24489381|NCT00472927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25271962|NCT02395510|Antidepressive Agents|antidepressive agents|mesh-ancestor
25271963|NCT02395510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25271964|NCT02395510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25271965|NCT02395510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25271966|NCT02395510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25271967|NCT02395510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271968|NCT02395510|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25271969|NCT02395510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25271970|NCT02395510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25271971|NCT02395510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25271972|NCT02395510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25271973|NCT02395510|Serotonin Agents|serotonin agents|mesh-ancestor
25271974|NCT02395510|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25271975|NCT02395510|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25271976|NCT02395510|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25271977|NCT02395510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25676252|NCT01795547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25676253|NCT01795547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25676254|NCT01795547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25676255|NCT01795547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25676256|NCT01795547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676257|NCT01795547|Dopamine Agonists|dopamine agonists|mesh-ancestor
25676258|NCT01795547|Dopamine Agents|dopamine agents|mesh-ancestor
25676259|NCT01795547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25271987|NCT02395237|Glimepiride|glimepiride|mesh-list
25271988|NCT02395237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25271989|NCT02395237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24457383|NCT00334256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457384|NCT00334256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24457385|NCT00334256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24457387|NCT00334308|Chelating Agents|chelating agents|mesh-ancestor
24457388|NCT00334308|Sequestering Agents|sequestering agents|mesh-ancestor
24457389|NCT00334308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457390|NCT00334321|Paclitaxel|paclitaxel|mesh-list
24457391|NCT00334321|Carboplatin|carboplatin|mesh-list
24457392|NCT00334321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24457393|NCT00334321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24457394|NCT00334321|Tubulin Modulators|tubulin modulators|mesh-ancestor
24457395|NCT00334321|Antimitotic Agents|antimitotic agents|mesh-ancestor
24457396|NCT00334321|Mitosis Modulators|mitosis modulators|mesh-ancestor
24457397|NCT00334321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483555|NCT00444015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24483557|NCT00444015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24483565|NCT00444041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24483566|NCT00444041|Growth Substances|growth substances|mesh-ancestor
24483567|NCT00444041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483568|NCT00444041|Growth Inhibitors|growth inhibitors|mesh-ancestor
25271990|NCT02395237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271991|NCT02395237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25271992|NCT02395237|Immunologic Factors|immunologic factors|mesh-ancestor
25271993|NCT02394847|Propofol|propofol|mesh-list
25271994|NCT02394847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25271995|NCT02394847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25271996|NCT02394847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25271997|NCT02394847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25271998|NCT02394847|Anesthetics, General|anesthetics, general|mesh-ancestor
25271999|NCT02394847|Anesthetics|anesthetics|mesh-ancestor
25272000|NCT02395068|Irinotecan|irinotecan|mesh-list
25272001|NCT02395068|Nimotuzumab|nimotuzumab|mesh-list
25272002|NCT02395068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25272003|NCT02395068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25272004|NCT02395068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272005|NCT02395068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272006|NCT02395068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272007|NCT02395068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25275546|NCT02371473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275547|NCT02371473|Diuretics|diuretics|mesh-ancestor
25275548|NCT02371473|Natriuretic Agents|natriuretic agents|mesh-ancestor
25275549|NCT02371473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275550|NCT02371421|Allopurinol|allopurinol|mesh-list
25275551|NCT02371421|Antimetabolites|antimetabolites|mesh-ancestor
25275552|NCT02371421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275553|NCT02371421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275554|NCT02371421|Gout Suppressants|gout suppressants|mesh-ancestor
25275555|NCT02371421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25275556|NCT02371421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25275557|NCT02371421|Antioxidants|antioxidants|mesh-ancestor
25275558|NCT02371421|Protective Agents|protective agents|mesh-ancestor
25275559|NCT02371421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275560|NCT02371408|Ribavirin|ribavirin|mesh-list
25275561|NCT02371408|Sofosbuvir|sofosbuvir|mesh-list
25275562|NCT02371408|Antimetabolites|antimetabolites|mesh-ancestor
25275563|NCT02371408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275564|NCT02371408|Antiviral Agents|antiviral agents|mesh-ancestor
25275565|NCT02371408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25275566|NCT02371226|Insulin|insulin|mesh-list
25275567|NCT02371226|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25275568|NCT02371226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25275569|NCT02371226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275570|NCT02371304|Capecitabine|capecitabine|mesh-list
25275571|NCT02371304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25275572|NCT02371304|Antimetabolites|antimetabolites|mesh-ancestor
25275573|NCT02371304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275574|NCT02371304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24483608|NCT00444249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24697690|NCT01436539|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
25070344|NCT03420469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25070345|NCT03420469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25070347|NCT03420378|Vitamins|vitamins|mesh-ancestor
25070348|NCT03420378|Micronutrients|micronutrients|mesh-ancestor
25070349|NCT03420378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070350|NCT03420378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25070351|NCT03420339|Adderall|adderall|mesh-list
24483609|NCT00444249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483610|NCT00444249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483612|NCT00444314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24483613|NCT00444314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24483614|NCT00444314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24483615|NCT00444314|Growth Substances|growth substances|mesh-ancestor
24483616|NCT00444314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249735|NCT02525016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25249736|NCT02525016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249737|NCT02525003|Vitamin D|vitamin d|mesh-list
25249738|NCT02525003|Ergocalciferols|ergocalciferols|mesh-list
25249739|NCT02525003|Cholecalciferol|cholecalciferol|mesh-list
24483640|NCT00444379|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24483641|NCT00444379|Protease Inhibitors|protease inhibitors|mesh-ancestor
24483642|NCT00444379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483643|NCT00444379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483644|NCT00444379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24483645|NCT00444379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24454027|NCT04520217|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24454028|NCT04520217|Antidepressive Agents|antidepressive agents|mesh-ancestor
24454029|NCT04520217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24454030|NCT04520217|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25272008|NCT02395016|Gemcitabine|gemcitabine|mesh-list
25272009|NCT02395016|Nimotuzumab|nimotuzumab|mesh-list
25272010|NCT02395016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25272011|NCT02395016|Antimetabolites|antimetabolites|mesh-ancestor
25272012|NCT02395016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272013|NCT02395016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272014|NCT02395016|Antiviral Agents|antiviral agents|mesh-ancestor
25272015|NCT02395016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25272016|NCT02395016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272017|NCT02395016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25272018|NCT02395016|Immunologic Factors|immunologic factors|mesh-ancestor
25272019|NCT02395016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272020|NCT02395016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25272021|NCT02394821|Metronidazole|metronidazole|mesh-list
25272022|NCT02394821|Polihexanide|polihexanide|mesh-list
25272023|NCT02394821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24697732|NCT01436929|Silymarin|silymarin|mesh-list
25272024|NCT02394821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25272025|NCT02394821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25272026|NCT02394821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25272027|NCT02394821|Disinfectants|disinfectants|mesh-ancestor
25272028|NCT02394743|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25272029|NCT02394743|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25272030|NCT02394743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272031|NCT02394652|Metformin|metformin|mesh-list
25272032|NCT02394652|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
25272033|NCT02394652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25272034|NCT02394652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272035|NCT02394652|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24483648|NCT00444379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24457412|NCT00334360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24483745|NCT00444808|Salmon calcitonin|salmon calcitonin|mesh-list
24483746|NCT00444808|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
24454031|NCT04520217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24454032|NCT04520217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24454033|NCT04520217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24454034|NCT04520217|Adrenergic Agents|adrenergic agents|mesh-ancestor
24849463|NCT02248753|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24849464|NCT02248753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24849465|NCT02248753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25676260|NCT01795547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676261|NCT01795547|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25676262|NCT01795547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25676263|NCT01795547|Serotonin Agents|serotonin agents|mesh-ancestor
25676264|NCT01795547|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24849466|NCT02248753|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25676265|NCT01795547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25676266|NCT01795547|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25676267|NCT01795547|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24483749|NCT00444808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483750|NCT00444808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24483751|NCT00444808|Vasodilator Agents|vasodilator agents|mesh-ancestor
24483752|NCT00444834|Carvedilol|carvedilol|mesh-list
24483775|NCT00444886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483776|NCT00444886|Cholinergic Agents|cholinergic agents|mesh-ancestor
24483777|NCT00444886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24483778|NCT00444886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483779|NCT00444886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24483780|NCT00444886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24483781|NCT00445016|Anesthetics|anesthetics|mesh-list
24483811|NCT00445081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24697823|NCT01437462|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24697854|NCT01437644|Cholinergic Agents|cholinergic agents|mesh-ancestor
24612798|NCT01015456|Cyclophosphamide|cyclophosphamide|mesh-list
24612799|NCT01015456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24612800|NCT01015456|Immunologic Factors|immunologic factors|mesh-ancestor
24612801|NCT01015456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612802|NCT01015456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24612803|NCT01015456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24849529|NCT02248987|Antipsychotic Agents|antipsychotic agents|mesh-list
25676268|NCT01795716|Imatinib Mesylate|imatinib mesylate|mesh-list
25676269|NCT01795716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25676270|NCT01795716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25676271|NCT01795716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272050|NCT02394496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25272052|NCT02394496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25272053|NCT02394496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272054|NCT02394496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272055|NCT02394496|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24697855|NCT01437644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24697887|NCT01437748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697888|NCT01437748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24697889|NCT01437748|Respiratory System Agents|respiratory system agents|mesh-ancestor
25272056|NCT02394483|Olorofim|olorofim|mesh-list
25272057|NCT02394483|Antifungal Agents|antifungal agents|mesh-ancestor
25272058|NCT02394483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25272059|NCT02394418|Dexmedetomidine|dexmedetomidine|mesh-list
25272060|NCT02394418|Propofol|propofol|mesh-list
25272061|NCT02394418|Sevoflurane|sevoflurane|mesh-list
25272062|NCT02394418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25272063|NCT02394418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24483814|NCT00445081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24483815|NCT00445081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483816|NCT00445081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483817|NCT00445081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24483818|NCT00445081|Immunologic Factors|immunologic factors|mesh-ancestor
24483819|NCT00445081|Antifungal Agents|antifungal agents|mesh-ancestor
24483820|NCT00445081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24483821|NCT00445081|Dermatologic Agents|dermatologic agents|mesh-ancestor
24483822|NCT00445081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24483823|NCT00445081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24483825|NCT00445094|Imipenem|imipenem|mesh-list
24483826|NCT00445094|Amikacin|amikacin|mesh-list
24483827|NCT00445094|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24483828|NCT00445094|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
24483829|NCT00445094|Cilastatin|cilastatin|mesh-list
24483830|NCT00445094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24483907|NCT00445861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24483909|NCT00445874|Antipruritics|antipruritics|mesh-ancestor
24483910|NCT00445874|Dermatologic Agents|dermatologic agents|mesh-ancestor
24849537|NCT02249013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25272064|NCT02394418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272065|NCT02394418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25272066|NCT02394418|Anesthetics, General|anesthetics, general|mesh-ancestor
25272067|NCT02394418|Anesthetics|anesthetics|mesh-ancestor
25272068|NCT02394418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25272069|NCT02394418|Analgesics|analgesics|mesh-ancestor
25272070|NCT02394418|Sensory System Agents|sensory system agents|mesh-ancestor
24626424|NCT01087398|Cyclophosphamide|cyclophosphamide|mesh-list
25272073|NCT02394418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25272074|NCT02394418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25272075|NCT02394418|Adrenergic Agents|adrenergic agents|mesh-ancestor
25272076|NCT02394418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25272077|NCT02394418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272078|NCT02394418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25272079|NCT02394418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25272080|NCT02394145|Clopidogrel|clopidogrel|mesh-list
25272081|NCT02394145|Ticagrelor|ticagrelor|mesh-list
25272082|NCT02394145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25272083|NCT02394145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25272084|NCT02394145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25272085|NCT02394145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25272086|NCT02394145|Purinergic Agents|purinergic agents|mesh-ancestor
25272087|NCT02394145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25272088|NCT02394145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272089|NCT02394145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272090|NCT02394158|Metformin|metformin|mesh-list
25272091|NCT02394158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25272092|NCT02394158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272093|NCT02394197|Chloroquine|chloroquine|mesh-list
24483914|NCT00445874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24483944|NCT00445965|Immunologic Factors|immunologic factors|mesh-ancestor
24483972|NCT00446017|Sympathomimetics|sympathomimetics|mesh-ancestor
24483973|NCT00446017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24483974|NCT00446017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24483975|NCT00446017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24483976|NCT00446017|Vasodilator Agents|vasodilator agents|mesh-ancestor
24697935|NCT01437982|Hormones|hormones|mesh-ancestor
24697975|NCT01438112|Antiviral Agents|antiviral agents|mesh-ancestor
24697976|NCT01438112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24697977|NCT01438112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24697978|NCT01438112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24697979|NCT01438112|Immunologic Factors|immunologic factors|mesh-ancestor
24483977|NCT00446017|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24483978|NCT00446017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24483979|NCT00446017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483980|NCT00446017|Protective Agents|protective agents|mesh-ancestor
24483981|NCT00446043|Adapalene|adapalene|mesh-list
24483982|NCT00446043|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
24849539|NCT02249013|Tubulin Modulators|tubulin modulators|mesh-ancestor
24849540|NCT02249013|Antimitotic Agents|antimitotic agents|mesh-ancestor
24849541|NCT02249013|Mitosis Modulators|mitosis modulators|mesh-ancestor
24849542|NCT02249013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849543|NCT02249026|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
24849555|NCT02249039|Analgesics|analgesics|mesh-ancestor
24849556|NCT02249039|Sensory System Agents|sensory system agents|mesh-ancestor
25275723|NCT02369939|Immunologic Factors|immunologic factors|mesh-ancestor
24849557|NCT02249039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25272094|NCT02394197|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
25272095|NCT02394197|Primaquine|primaquine|mesh-list
25272096|NCT02394197|Amebicides|amebicides|mesh-ancestor
25272097|NCT02394197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25272098|NCT02394197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25272099|NCT02394197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25272100|NCT02394197|Antimalarials|antimalarials|mesh-ancestor
25272101|NCT02394197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25272102|NCT02394197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25272103|NCT02394197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25272104|NCT02394197|Analgesics|analgesics|mesh-ancestor
25272105|NCT02394197|Sensory System Agents|sensory system agents|mesh-ancestor
25272107|NCT02394197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272109|NCT02394197|Filaricides|filaricides|mesh-ancestor
25272110|NCT02394197|Antinematodal Agents|antinematodal agents|mesh-ancestor
25272111|NCT02394197|Anthelmintics|anthelmintics|mesh-ancestor
25272112|NCT02394119|Rituximab|rituximab|mesh-list
25272113|NCT02394119|Ofatumumab|ofatumumab|mesh-list
24697980|NCT01438112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272114|NCT02394119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25272115|NCT02394119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272116|NCT02394119|Immunologic Factors|immunologic factors|mesh-ancestor
25272117|NCT02394119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272118|NCT02394119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25272119|NCT02394106|Ofatumumab|ofatumumab|mesh-list
25272120|NCT02394106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272121|NCT02394015|Doxorubicin|doxorubicin|mesh-list
25272122|NCT02394015|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25272123|NCT02394015|Trabectedin|trabectedin|mesh-list
25272124|NCT02394015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24883308|NCT03991403|Bevacizumab|bevacizumab|mesh-list
24483997|NCT00446069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483998|NCT00446069|Analgesics|analgesics|mesh-ancestor
24483999|NCT00446069|Sensory System Agents|sensory system agents|mesh-ancestor
24484001|NCT00446082|Pasireotide|pasireotide|mesh-list
24484002|NCT00446082|Hormones|hormones|mesh-ancestor
24484003|NCT00446082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24484004|NCT00446082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849573|NCT02249130|Stavudine|stavudine|mesh-list
24849574|NCT02249130|Tipranavir|tipranavir|mesh-list
24849575|NCT02249130|Delavirdine|delavirdine|mesh-list
24849576|NCT02249130|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24849577|NCT02249130|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24849578|NCT02249130|Protease Inhibitors|protease inhibitors|mesh-ancestor
24849579|NCT02249130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490136|NCT00476515|Immunologic Factors|immunologic factors|mesh-ancestor
24490138|NCT00476515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24849605|NCT02249364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24849606|NCT02249364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24849607|NCT02249364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849608|NCT02249364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24849609|NCT02249364|Anesthetics, General|anesthetics, general|mesh-ancestor
24849610|NCT02249364|Anesthetics|anesthetics|mesh-ancestor
24849611|NCT02249416|Ritonavir|ritonavir|mesh-list
24849612|NCT02249416|Zidovudine|zidovudine|mesh-list
24849613|NCT02249416|Tipranavir|tipranavir|mesh-list
24849614|NCT02249416|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25272125|NCT02394015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486804|NCT00460174|Growth Inhibitors|growth inhibitors|mesh-ancestor
25272126|NCT02394015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25272127|NCT02394015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25272128|NCT02394015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272129|NCT02394015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272130|NCT02394015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25272131|NCT02394015|Alkylating Agents|alkylating agents|mesh-ancestor
25272133|NCT02393846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25272134|NCT02393846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25272135|NCT02393846|Analgesics|analgesics|mesh-ancestor
25272136|NCT02393846|Sensory System Agents|sensory system agents|mesh-ancestor
25272137|NCT02393846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25272138|NCT02393846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272139|NCT02393846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25272140|NCT02393846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25272141|NCT02393846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25272142|NCT02393846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25249894|NCT02524184|Vasodilator Agents|vasodilator agents|mesh-ancestor
25249895|NCT02524184|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25249896|NCT02524184|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25249897|NCT02524184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25249898|NCT02524184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249899|NCT02524184|Urological Agents|urological agents|mesh-ancestor
25249900|NCT02523833|Albuterol|albuterol|mesh-list
25249915|NCT02523859|Propofol|propofol|mesh-list
25272143|NCT02393846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272144|NCT02394093|Aspirin|aspirin|mesh-list
24484156|NCT00446836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484157|NCT00446836|Tubulin Modulators|tubulin modulators|mesh-ancestor
24484158|NCT00446836|Antimitotic Agents|antimitotic agents|mesh-ancestor
24484159|NCT00446836|Mitosis Modulators|mitosis modulators|mesh-ancestor
24484160|NCT00446836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484162|NCT00446862|Enalapril|enalapril|mesh-list
24484163|NCT00446862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24484164|NCT00446862|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24484188|NCT00446953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24484198|NCT00446979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24484199|NCT00447018|Mannitol|mannitol|mesh-list
24484200|NCT00447018|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24484201|NCT00447018|Diuretics|diuretics|mesh-ancestor
24484202|NCT00447018|Natriuretic Agents|natriuretic agents|mesh-ancestor
24522703|NCT03411031|Elotuzumab|elotuzumab|mesh-list
24522704|NCT03411031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24522705|NCT03411031|Antiemetics|antiemetics|mesh-ancestor
24522706|NCT03411031|Autonomic Agents|autonomic agents|mesh-ancestor
24522707|NCT03411031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24849615|NCT02249416|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24698120|NCT01439100|Naloxone|naloxone|mesh-list
24671382|NCT01325298|Vitamins|vitamins|mesh-ancestor
24849616|NCT02249416|Protease Inhibitors|protease inhibitors|mesh-ancestor
24849617|NCT02249416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610127|NCT00999869|Glucocorticoids|glucocorticoids|mesh-ancestor
24849618|NCT02249416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849619|NCT02249416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24658307|NCT01271166|Antidotes|antidotes|mesh-ancestor
24454099|NCT04432012|Dexamethasone|dexamethasone|mesh-list
24454100|NCT04432012|Dexamethasone acetate|dexamethasone acetate|mesh-list
24454101|NCT04432012|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24454103|NCT04432012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24454104|NCT04432012|Antiemetics|antiemetics|mesh-ancestor
24454105|NCT04432012|Autonomic Agents|autonomic agents|mesh-ancestor
24454106|NCT04432012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24454115|NCT04432012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272145|NCT02394093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25272146|NCT02394093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25272147|NCT02394093|Analgesics|analgesics|mesh-ancestor
25272148|NCT02394093|Sensory System Agents|sensory system agents|mesh-ancestor
25272149|NCT02394093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25272150|NCT02394093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272151|NCT02394093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25272152|NCT02394093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25272153|NCT02394093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25272154|NCT02394093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25272155|NCT02394093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272156|NCT02394093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25272157|NCT02394093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25272158|NCT02394093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272159|NCT02394093|Antipyretics|antipyretics|mesh-ancestor
25272160|NCT02393898|Paclitaxel|paclitaxel|mesh-list
25272161|NCT02393898|Bevacizumab|bevacizumab|mesh-list
25272162|NCT02393898|Carboplatin|carboplatin|mesh-list
24698165|NCT01439243|Donepezil|donepezil|mesh-list
24698166|NCT01439243|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25676272|NCT01795716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676273|NCT01795898|Fentanyl|fentanyl|mesh-list
25676274|NCT01795898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25676275|NCT01795898|Narcotics|narcotics|mesh-ancestor
25676276|NCT01795898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25676277|NCT01795898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676278|NCT01795898|Analgesics|analgesics|mesh-ancestor
25676279|NCT01795898|Sensory System Agents|sensory system agents|mesh-ancestor
24600880|NCT00960960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600881|NCT00960960|Growth Inhibitors|growth inhibitors|mesh-ancestor
24600882|NCT00960960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24600883|NCT00960960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24600884|NCT00960960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600885|NCT00960960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24600886|NCT00960960|Hormone Antagonists|hormone antagonists|mesh-ancestor
24600887|NCT00960960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24600896|NCT00961038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600897|NCT00961038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600898|NCT00961038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600899|NCT00961038|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24600900|NCT00961038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24600901|NCT00961077|Oxaliplatin|oxaliplatin|mesh-list
24600902|NCT00961077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600903|NCT00961155|Formoterol Fumarate|formoterol fumarate|mesh-list
24600911|NCT00961155|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24600912|NCT00961155|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24600913|NCT00961155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24600914|NCT00961155|Adrenergic Agents|adrenergic agents|mesh-ancestor
24600915|NCT00961155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24600916|NCT00961155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600917|NCT00961155|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24600918|NCT00961155|Hormone Antagonists|hormone antagonists|mesh-ancestor
24600919|NCT00961155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24600920|NCT00961155|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24600921|NCT00961155|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24600923|NCT00961194|Analgesics|analgesics|mesh-ancestor
24600924|NCT00961194|Sensory System Agents|sensory system agents|mesh-ancestor
24600925|NCT00961194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24600926|NCT00961194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600927|NCT00961194|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24600941|NCT00961363|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24600942|NCT00961363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24698167|NCT01439243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676280|NCT01795898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25676281|NCT01795898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25676282|NCT01795898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25676283|NCT01795898|Anesthetics, General|anesthetics, general|mesh-ancestor
25676284|NCT01795898|Anesthetics|anesthetics|mesh-ancestor
25676285|NCT01795937|Itraconazole|itraconazole|mesh-list
25676286|NCT01795937|Atorvastatin|atorvastatin|mesh-list
25676287|NCT01795937|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25676288|NCT01795937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25676289|NCT01795937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25676290|NCT01795937|Antimetabolites|antimetabolites|mesh-ancestor
25676291|NCT01795937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676292|NCT01795937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25676293|NCT01795937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25676294|NCT01795937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676295|NCT01795937|Antifungal Agents|antifungal agents|mesh-ancestor
25676296|NCT01795937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25676297|NCT01795937|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25676298|NCT01795937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25676299|NCT01795937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25676300|NCT01795937|Hormone Antagonists|hormone antagonists|mesh-ancestor
25676301|NCT01795937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25676302|NCT01795937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676303|NCT01795937|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25676304|NCT01796301|Teriparatide|teriparatide|mesh-list
25676305|NCT01796301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25676306|NCT01796301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676307|NCT01796301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25676309|NCT01796470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25676310|NCT01796470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676311|NCT01796470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676312|NCT01796665|Clindamycin|clindamycin|mesh-list
25676313|NCT01796665|Clindamycin palmitate|clindamycin palmitate|mesh-list
25676314|NCT01796665|Clindamycin phosphate|clindamycin phosphate|mesh-list
24698168|NCT01439243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698170|NCT01439243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24484206|NCT00447031|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24484237|NCT00447213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24484238|NCT00447213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484239|NCT00447239|Insulin|insulin|mesh-list
24849677|NCT02249663|Dermatologic Agents|dermatologic agents|mesh-ancestor
24849678|NCT02249663|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24849679|NCT02249663|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24849680|NCT02249663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849681|NCT02249663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849682|NCT02249663|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24849683|NCT02249663|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24849684|NCT02249663|Histamine Antagonists|histamine antagonists|mesh-ancestor
24849685|NCT02249663|Histamine Agents|histamine agents|mesh-ancestor
24849686|NCT02249663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24849687|NCT02249702|Gemcitabine|gemcitabine|mesh-list
24849688|NCT02249702|Docetaxel|docetaxel|mesh-list
24849689|NCT02249702|Trabectedin|trabectedin|mesh-list
24849690|NCT02249702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24849691|NCT02249702|Antimetabolites|antimetabolites|mesh-ancestor
24698221|NCT01439984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698222|NCT01439984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24849692|NCT02249702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849693|NCT02249702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272169|NCT02393898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25272170|NCT02393898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24883706|NCT05097768|Hormones|hormones|mesh-ancestor
25272171|NCT02393898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25272172|NCT02393898|Growth Substances|growth substances|mesh-ancestor
25272173|NCT02393898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272174|NCT02393898|Growth Inhibitors|growth inhibitors|mesh-ancestor
25272175|NCT02394028|Etrolizumab|etrolizumab|mesh-list
25272176|NCT02394028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25272177|NCT02394028|Immunologic Factors|immunologic factors|mesh-ancestor
25272178|NCT02394028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272179|NCT02394002|Propofol|propofol|mesh-list
25272180|NCT02394002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25272181|NCT02394002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25676315|NCT01796665|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25676316|NCT01796665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25676317|NCT01796665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25676318|NCT01796665|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25676319|NCT01796665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692353|NCT01998919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272182|NCT02394002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272184|NCT02394002|Anesthetics, General|anesthetics, general|mesh-ancestor
25272185|NCT02394002|Anesthetics|anesthetics|mesh-ancestor
25272186|NCT02394054|Vasopressins|vasopressins|mesh-list
25272187|NCT02394054|Arginine Vasopressin|arginine vasopressin|mesh-list
24484281|NCT00447473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457424|NCT00334360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24457449|NCT00334412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24457450|NCT00334412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24457451|NCT00334425|Menotropins|menotropins|mesh-list
24484282|NCT00447473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484283|NCT00447473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24484284|NCT00447473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24484285|NCT00447473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484286|NCT00447473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484287|NCT00447473|Antifungal Agents|antifungal agents|mesh-ancestor
24484288|NCT00447473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24484289|NCT00447473|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24484290|NCT00447473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24484291|NCT00447473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24457452|NCT00334425|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24457453|NCT00334425|Fertility Agents|fertility agents|mesh-ancestor
24698223|NCT01439984|Serotonin Agents|serotonin agents|mesh-ancestor
24484561|NCT00449202|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25272189|NCT02394054|Coagulants|coagulants|mesh-ancestor
25272190|NCT02394054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25272191|NCT02394054|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25272192|NCT02394054|Natriuretic Agents|natriuretic agents|mesh-ancestor
25272193|NCT02394054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272194|NCT02393963|Tranexamic Acid|tranexamic acid|mesh-list
25272195|NCT02393963|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25272196|NCT02393963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25272197|NCT02393963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272198|NCT02393963|Hemostatics|hemostatics|mesh-ancestor
25272199|NCT02393963|Coagulants|coagulants|mesh-ancestor
25272200|NCT02393664|Bupivacaine|bupivacaine|mesh-list
25272201|NCT02393664|Propofol|propofol|mesh-list
25272202|NCT02393664|Sevoflurane|sevoflurane|mesh-list
25272203|NCT02393664|Rocuronium|rocuronium|mesh-list
25272204|NCT02393664|Anesthetics, Local|anesthetics, local|mesh-ancestor
25272205|NCT02393664|Anesthetics|anesthetics|mesh-ancestor
25272206|NCT02393664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25272207|NCT02393664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272208|NCT02393664|Sensory System Agents|sensory system agents|mesh-ancestor
25272209|NCT02393664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25272210|NCT02393664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25272211|NCT02393664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25272212|NCT02393664|Anesthetics, General|anesthetics, general|mesh-ancestor
25272213|NCT02393664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25272214|NCT02393664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25272215|NCT02393664|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24849879|NCT02251041|Tezosentan|tezosentan|mesh-list
25272219|NCT02393599|Anesthetics, Local|anesthetics, local|mesh-ancestor
24484598|NCT00449410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24484599|NCT00449410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24484600|NCT00449410|Antimetabolites|antimetabolites|mesh-ancestor
25692354|NCT01998919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24484796|NCT00450086|Glucocorticoids|glucocorticoids|mesh-ancestor
24484909|NCT00450736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24484944|NCT00450840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484945|NCT00450840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25272220|NCT02393599|Anesthetics|anesthetics|mesh-ancestor
25272221|NCT02393599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25272222|NCT02393599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272223|NCT02393599|Sensory System Agents|sensory system agents|mesh-ancestor
25272224|NCT02393599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25272225|NCT02393599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25272226|NCT02393599|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25272227|NCT02393599|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25272228|NCT02393599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24698301|NCT01440582|Lenalidomide|lenalidomide|mesh-list
25272229|NCT02393599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272230|NCT02393599|Dopamine Agents|dopamine agents|mesh-ancestor
25272231|NCT02393599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25272232|NCT02393482|Cholecalciferol|cholecalciferol|mesh-list
25272233|NCT02393482|Vitamin D|vitamin d|mesh-list
25272234|NCT02393482|Leuprolide|leuprolide|mesh-list
25272235|NCT02393482|Tibolone|tibolone|mesh-list
25272236|NCT02393482|Calcium Carbonate|calcium carbonate|mesh-list
25272237|NCT02393482|Hormones|hormones|mesh-list
25272238|NCT02393482|Estradiol|estradiol|mesh-list
25272239|NCT02393482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25272240|NCT02393482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272241|NCT02393482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25272242|NCT02393482|Estrogens|estrogens|mesh-ancestor
24484946|NCT00450840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24484947|NCT00450840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676320|NCT01796665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676321|NCT01796665|Dermatologic Agents|dermatologic agents|mesh-ancestor
25676322|NCT01796964|Aflibercept|aflibercept|mesh-list
25676323|NCT01796964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25692355|NCT01998958|Esketamine|esketamine|mesh-list
25692356|NCT01998958|Antidepressive Agents|antidepressive agents|mesh-ancestor
25692357|NCT01998958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25692358|NCT01999114|Moxifloxacin|moxifloxacin|mesh-list
25692359|NCT01999114|Naltrexone|naltrexone|mesh-list
24484951|NCT00450853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24484952|NCT00450853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484954|NCT00450853|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24484955|NCT00450853|Serotonin Agents|serotonin agents|mesh-ancestor
24484956|NCT00450853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24484957|NCT00450853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484959|NCT00450892|Trastuzumab|trastuzumab|mesh-list
24484960|NCT00450892|Lapatinib|lapatinib|mesh-list
24484961|NCT00450892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427165|NCT00237575|Antimetabolites|antimetabolites|mesh-ancestor
24457463|NCT00334438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24457464|NCT00334464|Warfarin|warfarin|mesh-list
24457465|NCT00334464|Anticoagulants|anticoagulants|mesh-ancestor
24457466|NCT00334477|Tadalafil|tadalafil|mesh-list
24457467|NCT00334477|Vasodilator Agents|vasodilator agents|mesh-ancestor
24457468|NCT00334477|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24457469|NCT00334477|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24457470|NCT00334477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457471|NCT00334477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457472|NCT00334477|Urological Agents|urological agents|mesh-ancestor
24457473|NCT00334490|Sildenafil Citrate|sildenafil citrate|mesh-list
24457474|NCT00334490|Vasodilator Agents|vasodilator agents|mesh-ancestor
24457475|NCT00334490|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24698358|NCT01440751|Mitomycins|mitomycins|mesh-list
24698439|NCT01441206|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24698440|NCT01441206|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24698441|NCT01441206|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25272243|NCT02393482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25272244|NCT02393482|Antacids|antacids|mesh-ancestor
25272245|NCT02393482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272246|NCT02393482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25272247|NCT02393482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25272248|NCT02393482|Fertility Agents|fertility agents|mesh-ancestor
25272249|NCT02393482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25272250|NCT02393482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272251|NCT02393482|Androgen Antagonists|androgen antagonists|mesh-ancestor
25272252|NCT02393482|Hormone Antagonists|hormone antagonists|mesh-ancestor
25272253|NCT02393482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25272254|NCT02393482|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25272255|NCT02393482|Anabolic Agents|anabolic agents|mesh-ancestor
25272256|NCT02393482|Vitamins|vitamins|mesh-ancestor
25272257|NCT02393482|Micronutrients|micronutrients|mesh-ancestor
25272258|NCT02393482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25272259|NCT02393573|Metformin|metformin|mesh-list
25272260|NCT02393573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25272261|NCT02393573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272262|NCT02393586|Amoxicillin|amoxicillin|mesh-list
25272263|NCT02393586|Rifampin|rifampin|mesh-list
25272264|NCT02393586|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25272265|NCT02393586|Clavulanic Acids|clavulanic acids|mesh-list
25272266|NCT02393586|Clavulanic Acid|clavulanic acid|mesh-list
25272267|NCT02393586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25272268|NCT02393586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25272269|NCT02393586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25272270|NCT02393586|Antitubercular Agents|antitubercular agents|mesh-ancestor
25272271|NCT02393586|Leprostatic Agents|leprostatic agents|mesh-ancestor
25272272|NCT02393586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24485167|NCT00451828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24485168|NCT00451828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24485169|NCT00451828|Antimetabolites|antimetabolites|mesh-ancestor
24485170|NCT00451828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485171|NCT00451828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24485172|NCT00451828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24485173|NCT00451828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485175|NCT00451867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24485176|NCT00451867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485177|NCT00451867|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24485178|NCT00451867|Antitubercular Agents|antitubercular agents|mesh-ancestor
24485179|NCT00451867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24485218|NCT00452062|Dexamethasone|dexamethasone|mesh-list
24485546|NCT00453635|Tubulin Modulators|tubulin modulators|mesh-ancestor
24485547|NCT00453635|Antimitotic Agents|antimitotic agents|mesh-ancestor
24485618|NCT00453960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24485619|NCT00453960|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24485620|NCT00454168|Sargramostim|sargramostim|mesh-list
24485621|NCT00454168|Immunologic Factors|immunologic factors|mesh-ancestor
24485658|NCT00454402|Adrenergic Agents|adrenergic agents|mesh-ancestor
25272273|NCT02393586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272274|NCT02393586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272275|NCT02393586|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24698485|NCT01441427|Lenograstim|lenograstim|mesh-list
25272276|NCT02393586|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25272277|NCT02393586|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25272278|NCT02393586|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25272279|NCT02393586|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25272280|NCT02393586|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25272281|NCT02393586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25272282|NCT02393456|Oxytocin|oxytocin|mesh-list
25272283|NCT02393456|Oxytocics|oxytocics|mesh-ancestor
25272284|NCT02393456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25272285|NCT02393456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272286|NCT02393612|Sarpogrelate|sarpogrelate|mesh-list
25272287|NCT02393612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25272288|NCT02393612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25272289|NCT02393612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272290|NCT02393612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25272291|NCT02393612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25272292|NCT02393612|Serotonin Agents|serotonin agents|mesh-ancestor
25272293|NCT02393612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25272294|NCT02393612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272295|NCT02393430|Rebamipide|rebamipide|mesh-list
25272296|NCT02393430|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25272297|NCT02393430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25272298|NCT02393430|Antioxidants|antioxidants|mesh-ancestor
25272299|NCT02393430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272300|NCT02393430|Protective Agents|protective agents|mesh-ancestor
25272301|NCT02393430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485659|NCT00454402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25692360|NCT01999114|Buprenorphine|buprenorphine|mesh-list
24698583|NCT01441986|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24849736|NCT02249936|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24849768|NCT02250534|Autonomic Agents|autonomic agents|mesh-ancestor
24849769|NCT02250534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24849770|NCT02250534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272302|NCT02393430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676324|NCT01796964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25676325|NCT01796964|Growth Substances|growth substances|mesh-ancestor
25676326|NCT01796964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676327|NCT01796964|Growth Inhibitors|growth inhibitors|mesh-ancestor
25250202|NCT02522013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25272303|NCT02393443|Oxytocin|oxytocin|mesh-list
25272304|NCT02393443|Oxytocics|oxytocics|mesh-ancestor
25272305|NCT02393443|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25272306|NCT02393443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272307|NCT02393300|Tranexamic Acid|tranexamic acid|mesh-list
25272308|NCT02393300|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25272309|NCT02393300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25275724|NCT02369939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272310|NCT02393300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272311|NCT02393300|Hemostatics|hemostatics|mesh-ancestor
25272312|NCT02393300|Coagulants|coagulants|mesh-ancestor
25272313|NCT02393261|Dialysis Solutions|dialysis solutions|mesh-list
24485818|NCT00455130|Diuretics|diuretics|mesh-ancestor
24485890|NCT00455351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485891|NCT00455351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485893|NCT00455364|Antifungal Agents|antifungal agents|mesh-ancestor
24485894|NCT00455364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24485895|NCT00455364|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24485896|NCT00455364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24485897|NCT00455364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485931|NCT00455442|Contraceptive Agents|contraceptive agents|mesh-ancestor
24485932|NCT00455442|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24485933|NCT00455442|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24485934|NCT00455442|Hormone Antagonists|hormone antagonists|mesh-ancestor
24485935|NCT00455442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24485936|NCT00455442|Luteolytic Agents|luteolytic agents|mesh-ancestor
24485957|NCT00455585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24485958|NCT00455585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24485959|NCT00455585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485960|NCT00455585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485961|NCT00455585|Antiviral Agents|antiviral agents|mesh-ancestor
24485989|NCT00455715|Urological Agents|urological agents|mesh-ancestor
24485990|NCT00455754|Esomeprazole|esomeprazole|mesh-list
24485991|NCT00455754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24485992|NCT00455754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24485993|NCT00455754|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24485994|NCT00455754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272314|NCT02393261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25275576|NCT02371096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25275577|NCT02371096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25275578|NCT02371096|Immunologic Factors|immunologic factors|mesh-ancestor
25275579|NCT02371096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275580|NCT02371096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25275581|NCT02371031|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
25275582|NCT02371031|Dopamine Agents|dopamine agents|mesh-ancestor
25275583|NCT02371031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25275584|NCT02371031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275585|NCT02371031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275586|NCT02371148|Rituximab|rituximab|mesh-list
25275587|NCT02371148|Bortezomib|bortezomib|mesh-list
25275588|NCT02371148|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25275589|NCT02371148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25275590|NCT02371148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25275591|NCT02371148|Immunologic Factors|immunologic factors|mesh-ancestor
25275592|NCT02371148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275593|NCT02371148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25275594|NCT02371148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25275595|NCT02371148|Alkylating Agents|alkylating agents|mesh-ancestor
25275596|NCT02371148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275706|NCT02369965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275707|NCT02369965|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25275708|NCT02369965|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25275709|NCT02369965|Antiviral Agents|antiviral agents|mesh-ancestor
25275710|NCT02369965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25275711|NCT02369965|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25275712|NCT02369965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25275713|NCT02369965|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24698635|NCT01442428|Hormones|hormones|mesh-ancestor
25676328|NCT01796964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25676329|NCT01797081|Botulinum Toxins|botulinum toxins|mesh-list
25250242|NCT02521441|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25250243|NCT02521441|Immunologic Factors|immunologic factors|mesh-ancestor
25250244|NCT02521441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601507|NCT00964535|Adrenergic Agents|adrenergic agents|mesh-ancestor
24601532|NCT00964626|Tubulin Modulators|tubulin modulators|mesh-ancestor
24601533|NCT00964626|Antimitotic Agents|antimitotic agents|mesh-ancestor
24601534|NCT00964626|Mitosis Modulators|mitosis modulators|mesh-ancestor
24601537|NCT00964639|Anesthetics, Local|anesthetics, local|mesh-ancestor
24601538|NCT00964639|Anesthetics|anesthetics|mesh-ancestor
24601539|NCT00964639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24601540|NCT00964639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601541|NCT00964639|Sensory System Agents|sensory system agents|mesh-ancestor
24601542|NCT00964639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24601543|NCT00964665|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24601544|NCT00964665|Interferon-alpha|interferon-alpha|mesh-list
24601545|NCT00964665|Antiviral Agents|antiviral agents|mesh-ancestor
24636568|NCT01146041|Protective Agents|protective agents|mesh-ancestor
24601546|NCT00964665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24601547|NCT00964665|Immunologic Factors|immunologic factors|mesh-ancestor
24601548|NCT00964665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601550|NCT00964691|Pyrimethamine|pyrimethamine|mesh-list
24601551|NCT00964691|Sulfadoxine|sulfadoxine|mesh-list
24601552|NCT00964691|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24601553|NCT00964691|Amebicides|amebicides|mesh-ancestor
24601554|NCT00964691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24601555|NCT00964691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24601557|NCT00964691|Antimalarials|antimalarials|mesh-ancestor
24698686|NCT01442558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275714|NCT02369965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25275715|NCT02369939|Fluorouracil|fluorouracil|mesh-list
25275716|NCT02369939|Mitomycins|mitomycins|mesh-list
25275717|NCT02369939|Mitomycin|mitomycin|mesh-list
25275718|NCT02369939|Antimetabolites|antimetabolites|mesh-ancestor
25275719|NCT02369939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275720|NCT02369939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25275721|NCT02369939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25275722|NCT02369939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25275726|NCT02369939|Alkylating Agents|alkylating agents|mesh-ancestor
24486133|NCT00456482|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
24486134|NCT00456482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24486202|NCT00456833|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24486398|NCT00457717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24486399|NCT00457717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25272315|NCT02393196|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24486400|NCT00457717|Autonomic Agents|autonomic agents|mesh-ancestor
24486434|NCT00457899|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24486435|NCT00457899|Antidepressive Agents|antidepressive agents|mesh-ancestor
24486436|NCT00457899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24486437|NCT00457899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24486438|NCT00457899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25676330|NCT01797081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25676331|NCT01797081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25676332|NCT01797081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25676333|NCT01797081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25676334|NCT01797081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676335|NCT01797081|Cholinergic Agents|cholinergic agents|mesh-ancestor
25676336|NCT01797081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25676337|NCT01797081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676338|NCT01797081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25676339|NCT01797081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25676340|NCT01797094|Botulinum Toxins|botulinum toxins|mesh-list
25676341|NCT01797094|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25676342|NCT01797094|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25143673|NCT02940990|Pemetrexed|pemetrexed|mesh-list
25676343|NCT01797094|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25676344|NCT01797094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25676345|NCT01797094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676346|NCT01797094|Cholinergic Agents|cholinergic agents|mesh-ancestor
25676347|NCT01797094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25676348|NCT01797094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676349|NCT01797094|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25676350|NCT01797094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25676351|NCT01797120|Everolimus|everolimus|mesh-list
25676352|NCT01797120|Fulvestrant|fulvestrant|mesh-list
25676353|NCT01797120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25676354|NCT01797120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24486439|NCT00457899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24486440|NCT00457899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486477|NCT00458185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24486478|NCT00458185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486479|NCT00458185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24486480|NCT00458185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24486515|NCT00458315|Gemcitabine|gemcitabine|mesh-list
24486550|NCT00458367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486551|NCT00458367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24486552|NCT00458367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24486553|NCT00458367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24486554|NCT00458367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24486555|NCT00458367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24486558|NCT00458419|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24486559|NCT00458419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486560|NCT00458419|Sensory System Agents|sensory system agents|mesh-ancestor
24486561|NCT00458419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25070525|NCT03418610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25070526|NCT03418610|Dermatologic Agents|dermatologic agents|mesh-ancestor
24612889|NCT01015664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612890|NCT01015729|Aspirin|aspirin|mesh-list
24698698|NCT01442610|Protective Agents|protective agents|mesh-ancestor
24698699|NCT01442610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698700|NCT01442662|Gemcitabine|gemcitabine|mesh-list
25272319|NCT02393144|Analgesics, Opioid|analgesics, opioid|mesh-list
25272320|NCT02393144|Analgesics|analgesics|mesh-list
25272321|NCT02393144|Oxytocin|oxytocin|mesh-list
25272322|NCT02393144|Dinoprostone|dinoprostone|mesh-list
25272323|NCT02393144|Oxytocics|oxytocics|mesh-ancestor
25272324|NCT02393144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25272325|NCT02393144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272326|NCT02393144|Narcotics|narcotics|mesh-ancestor
25272327|NCT02393144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25272328|NCT02393144|Sensory System Agents|sensory system agents|mesh-ancestor
25272329|NCT02393144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25272330|NCT02393144|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25272344|NCT02392910|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25272345|NCT02392910|Hematinics|hematinics|mesh-ancestor
25272346|NCT02392845|Docetaxel|docetaxel|mesh-list
25272347|NCT02392845|Epirubicin|epirubicin|mesh-list
25272348|NCT02392845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272349|NCT02392845|Tubulin Modulators|tubulin modulators|mesh-ancestor
25272350|NCT02392845|Antimitotic Agents|antimitotic agents|mesh-ancestor
25272351|NCT02392845|Mitosis Modulators|mitosis modulators|mesh-ancestor
25272352|NCT02392845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272353|NCT02392845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25272354|NCT02392845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25272355|NCT02392845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25272356|NCT02392845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272357|NCT02392780|Methylprednisolone|methylprednisolone|mesh-list
25272358|NCT02392780|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25272359|NCT02392780|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25272360|NCT02392780|Prednisolone|prednisolone|mesh-list
25272361|NCT02392780|Prednisolone acetate|prednisolone acetate|mesh-list
25272362|NCT02392780|Cannabidiol|cannabidiol|mesh-list
24486645|NCT00458991|Purinergic Agents|purinergic agents|mesh-ancestor
24486646|NCT00458991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24486679|NCT00459407|Protective Agents|protective agents|mesh-ancestor
24486801|NCT00460174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24486802|NCT00460174|Growth Substances|growth substances|mesh-ancestor
24486803|NCT00460174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486805|NCT00460174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24486806|NCT00460174|Antimetabolites|antimetabolites|mesh-ancestor
25143771|NCT02940756|Artemether|artemether|mesh-list
24486807|NCT00460174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486808|NCT00460174|Antiviral Agents|antiviral agents|mesh-ancestor
24486886|NCT00460473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486887|NCT00460473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24943877|NCT03966235|Melatonin|melatonin|mesh-list
24849772|NCT02250534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24658782|NCT01274026|Verapamil|verapamil|mesh-list
25272376|NCT02392780|Protective Agents|protective agents|mesh-ancestor
25272377|NCT02392780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25272378|NCT02392780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272379|NCT02392780|Anticonvulsants|anticonvulsants|mesh-ancestor
24486928|NCT00460642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24642739|NCT01181193|Cholecalciferol|cholecalciferol|mesh-list
24454162|NCT04368988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24849827|NCT02250820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24849828|NCT02250820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24859049|NCT02301481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491747|NCT00483834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24491748|NCT00483834|Antimetabolites|antimetabolites|mesh-ancestor
24491749|NCT00483834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491750|NCT00483834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24444181|NCT00296933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444182|NCT00296933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24444183|NCT00296933|Serotonin Agents|serotonin agents|mesh-ancestor
25272382|NCT02393066|Dexmedetomidine|dexmedetomidine|mesh-list
25272383|NCT02393066|Propofol|propofol|mesh-list
25272384|NCT02393066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25272385|NCT02393066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25272386|NCT02393066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272387|NCT02393066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25272388|NCT02393066|Anesthetics, General|anesthetics, general|mesh-ancestor
25272389|NCT02393066|Anesthetics|anesthetics|mesh-ancestor
24444198|NCT00296946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24444199|NCT00296946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444200|NCT00296946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24444201|NCT00296946|Respiratory System Agents|respiratory system agents|mesh-ancestor
24444202|NCT00296946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24444203|NCT00296946|Cholinergic Agents|cholinergic agents|mesh-ancestor
24444204|NCT00296946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24444205|NCT00296946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444207|NCT00296959|Anticonvulsants|anticonvulsants|mesh-ancestor
24491790|NCT00483990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24444218|NCT00297011|Clobetasol|clobetasol|mesh-list
24444219|NCT00297011|Antiviral Agents|antiviral agents|mesh-ancestor
24849882|NCT02251041|Antithrombin III|antithrombin iii|mesh-list
24849883|NCT02251041|Epoetin Alfa|epoetin alfa|mesh-list
24849884|NCT02251041|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
24849885|NCT02251041|Antioxidants|antioxidants|mesh-ancestor
25272390|NCT02393066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25272391|NCT02393066|Analgesics|analgesics|mesh-ancestor
25272392|NCT02393066|Sensory System Agents|sensory system agents|mesh-ancestor
25272393|NCT02393066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25272394|NCT02393066|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25272395|NCT02393066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25272396|NCT02393066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25272397|NCT02393066|Adrenergic Agents|adrenergic agents|mesh-ancestor
25272398|NCT02393066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25275597|NCT02370862|Glycopyrrolate|glycopyrrolate|mesh-list
24486933|NCT00460681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24486934|NCT00460681|Immunologic Factors|immunologic factors|mesh-ancestor
24444332|NCT00297505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444333|NCT00297505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24444334|NCT00297505|Serotonin Agents|serotonin agents|mesh-ancestor
24444335|NCT00297505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444468|NCT00298168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24444469|NCT00298168|Immunologic Factors|immunologic factors|mesh-ancestor
25143821|NCT02940379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24444470|NCT00298168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444492|NCT00298194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444493|NCT00298194|Cholinergic Agents|cholinergic agents|mesh-ancestor
24444494|NCT00298194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24444495|NCT00298194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444496|NCT00298194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24444497|NCT00298285|Enoxaparin|enoxaparin|mesh-list
24492096|NCT00485160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24492098|NCT00485238|Anticonvulsants|anticonvulsants|mesh-ancestor
24699033|NCT01444547|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24699034|NCT01444547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24699035|NCT01444547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272399|NCT02393066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272400|NCT02392793|Irinotecan|irinotecan|mesh-list
25272401|NCT02392793|Temozolomide|temozolomide|mesh-list
25272402|NCT02392793|Talazoparib|talazoparib|mesh-list
25272403|NCT02392793|Lenograstim|lenograstim|mesh-list
25272404|NCT02392793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25272405|NCT02392793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25272406|NCT02392793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272407|NCT02392793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487122|NCT00461747|Thalidomide|thalidomide|mesh-list
25676355|NCT01797120|Immunologic Factors|immunologic factors|mesh-ancestor
25676356|NCT01797120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676357|NCT01797120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25676358|NCT01797120|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25676359|NCT01797120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25676360|NCT01797120|Hormone Antagonists|hormone antagonists|mesh-ancestor
25676361|NCT01797120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25676362|NCT01797302|Vitamin D|vitamin d|mesh-list
25676363|NCT01797302|Cholecalciferol|cholecalciferol|mesh-list
25676364|NCT01797302|Vitamins|vitamins|mesh-ancestor
25676365|NCT01797302|Micronutrients|micronutrients|mesh-ancestor
24492135|NCT00485459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492136|NCT00485459|Adrenergic Agents|adrenergic agents|mesh-ancestor
24492139|NCT00485498|Olanzapine|olanzapine|mesh-list
24444513|NCT00298324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444514|NCT00298324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24849957|NCT02251158|Ritonavir|ritonavir|mesh-list
24849958|NCT02251158|Tipranavir|tipranavir|mesh-list
24659523|NCT01278238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24492165|NCT00485550|Methylphenidate|methylphenidate|mesh-list
24444568|NCT00298506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272408|NCT02392793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272409|NCT02392793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25272410|NCT02392793|Immunologic Factors|immunologic factors|mesh-ancestor
24492190|NCT00485667|Moxifloxacin|moxifloxacin|mesh-list
24699228|NCT01445561|Analgesics|analgesics|mesh-ancestor
24699229|NCT01445561|Sensory System Agents|sensory system agents|mesh-ancestor
24699230|NCT01445561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953736|NCT03882255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24953737|NCT03882255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24953738|NCT03882255|Vasodilator Agents|vasodilator agents|mesh-ancestor
24953740|NCT03882255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24699231|NCT01445561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272411|NCT02392793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272412|NCT02392793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25272413|NCT02392793|Alkylating Agents|alkylating agents|mesh-ancestor
25272414|NCT02392793|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25272415|NCT02392390|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
25272416|NCT02392390|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25272417|NCT02392390|Dermatologic Agents|dermatologic agents|mesh-ancestor
25272418|NCT02392520|Cetrorelix|cetrorelix|mesh-list
25272419|NCT02392520|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24492616|NCT00487032|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24850067|NCT02251509|Protective Agents|protective agents|mesh-ancestor
24850068|NCT02251509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24850069|NCT02251509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24850070|NCT02251509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24850071|NCT02251509|Vasodilator Agents|vasodilator agents|mesh-ancestor
24850072|NCT02251509|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24850073|NCT02251509|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24850074|NCT02251600|Deflazacort|deflazacort|mesh-list
24850075|NCT02251600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24850081|NCT02251626|Micronutrients|micronutrients|mesh-ancestor
24850082|NCT02251626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850083|NCT02251626|Vitamins|vitamins|mesh-ancestor
24850084|NCT02251691|Tacrolimus|tacrolimus|mesh-list
24850085|NCT02251691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24850086|NCT02251691|Immunologic Factors|immunologic factors|mesh-ancestor
24850087|NCT02251691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850088|NCT02251691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24850089|NCT02251691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850090|NCT02251691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850115|NCT02251795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24850163|NCT02251964|Rituximab|rituximab|mesh-list
24850164|NCT02251964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24850165|NCT02251964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850214|NCT02252328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660101|NCT01281761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850284|NCT02252614|Naproxen|naproxen|mesh-list
24444667|NCT00298857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24444719|NCT00298974|Respiratory System Agents|respiratory system agents|mesh-ancestor
24444720|NCT00298974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25250569|NCT02519608|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25272433|NCT02392364|Aflibercept|aflibercept|mesh-list
25272434|NCT02392364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25272435|NCT02392364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25272436|NCT02392364|Growth Substances|growth substances|mesh-ancestor
25272437|NCT02392364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272438|NCT02392364|Growth Inhibitors|growth inhibitors|mesh-ancestor
24493389|NCT00490789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24493390|NCT00490789|Immunologic Factors|immunologic factors|mesh-ancestor
24493391|NCT00490789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850422|NCT02252926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24850423|NCT02252926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24850424|NCT02252926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24850425|NCT02252926|Antimanic Agents|antimanic agents|mesh-ancestor
24850426|NCT02252978|Ciprofloxacin|ciprofloxacin|mesh-list
24850427|NCT02252978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24850428|NCT02252978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24850429|NCT02252978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24850430|NCT02252978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24850431|NCT02252978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850432|NCT02252978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850433|NCT02252978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850434|NCT02252978|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24850435|NCT02252978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24850436|NCT02253004|Cilostazol|cilostazol|mesh-list
24850437|NCT02253004|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24850438|NCT02253004|Autonomic Agents|autonomic agents|mesh-ancestor
24850475|NCT02253199|Dexmedetomidine|dexmedetomidine|mesh-list
24493427|NCT00490893|Insulin Detemir|insulin detemir|mesh-list
24850476|NCT02253199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24850477|NCT02253199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24850478|NCT02253199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850479|NCT02253199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24850480|NCT02253199|Analgesics|analgesics|mesh-ancestor
24850481|NCT02253199|Sensory System Agents|sensory system agents|mesh-ancestor
24850482|NCT02253199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24646870|NCT01205321|Bombesin|bombesin|mesh-list
24850514|NCT02253420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24850515|NCT02253420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850516|NCT02253420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24850517|NCT02253420|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24850518|NCT02253420|Antitubercular Agents|antitubercular agents|mesh-ancestor
25272442|NCT02392676|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25272443|NCT02392676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272444|NCT02392676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272445|NCT02392676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272446|NCT02392117|Insulin|insulin|mesh-list
25272447|NCT02392117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25272448|NCT02392117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850637|NCT02253849|Tipranavir|tipranavir|mesh-list
24850638|NCT02253849|Carbamazepine|carbamazepine|mesh-list
24850639|NCT02253849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24493515|NCT00491166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24493516|NCT00491166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25676366|NCT01797302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676367|NCT01797302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25676368|NCT01797302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25676369|NCT01797432|Triamcinolone|triamcinolone|mesh-list
25676370|NCT01797432|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25676371|NCT01797432|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25676372|NCT01797432|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25676373|NCT01797432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25676374|NCT01797432|Glucocorticoids|glucocorticoids|mesh-ancestor
25250624|NCT02519400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25250625|NCT02519400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250626|NCT02519400|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25250627|NCT02519400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25250628|NCT02519400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24493518|NCT00491166|Sensory System Agents|sensory system agents|mesh-ancestor
24493519|NCT00491166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24493520|NCT00491166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699604|NCT01448018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850710|NCT02253888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24850712|NCT02253901|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24850713|NCT02253901|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24850714|NCT02253901|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24850715|NCT02253901|Protease Inhibitors|protease inhibitors|mesh-ancestor
24850716|NCT02253901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812192|NCT02050178|Mitosis Modulators|mitosis modulators|mesh-ancestor
24812193|NCT02050178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812194|NCT02050178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24812195|NCT02050178|Antimetabolites|antimetabolites|mesh-ancestor
24812196|NCT02050178|Antiviral Agents|antiviral agents|mesh-ancestor
24672400|NCT01331928|Antimetabolites|antimetabolites|mesh-ancestor
24850799|NCT02253966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24850800|NCT02253966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24850801|NCT02253966|Protective Agents|protective agents|mesh-ancestor
24850802|NCT02253966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24850803|NCT02253966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272449|NCT02392039|Loratadine|loratadine|mesh-list
25272450|NCT02392039|Antipruritics|antipruritics|mesh-ancestor
25272451|NCT02392039|Dermatologic Agents|dermatologic agents|mesh-ancestor
25272452|NCT02392039|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25272453|NCT02392039|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25272454|NCT02392039|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25272457|NCT02392039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25272458|NCT02392039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272459|NCT02392039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699663|NCT01448330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24613012|NCT01016249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24613013|NCT01016249|Respiratory System Agents|respiratory system agents|mesh-ancestor
25272461|NCT02392130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25272462|NCT02392130|Glucocorticoids|glucocorticoids|mesh-ancestor
25272463|NCT02392130|Hormones|hormones|mesh-ancestor
24851226|NCT02256033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851229|NCT02256124|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25272479|NCT02391844|Narcotics|narcotics|mesh-ancestor
25272480|NCT02391844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25272481|NCT02391844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272482|NCT02391844|Analgesics|analgesics|mesh-ancestor
25272483|NCT02391844|Sensory System Agents|sensory system agents|mesh-ancestor
25272484|NCT02391844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25272485|NCT02391883|Clopidogrel|clopidogrel|mesh-list
24487626|NCT00464217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851240|NCT02256150|Cyclophosphamide|cyclophosphamide|mesh-list
25159894|NCT03539744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25676375|NCT01797432|Hormones|hormones|mesh-ancestor
25676376|NCT01797432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25676377|NCT01797432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676378|NCT01797432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25676379|NCT01797432|Immunologic Factors|immunologic factors|mesh-ancestor
25676380|NCT01797432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676381|NCT01797432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250668|NCT02518763|Vitamin D|vitamin d|mesh-list
25250669|NCT02518763|Ergocalciferols|ergocalciferols|mesh-list
25250670|NCT02518763|Cholecalciferol|cholecalciferol|mesh-list
25250671|NCT02518763|Vitamins|vitamins|mesh-list
25250672|NCT02518763|Micronutrients|micronutrients|mesh-ancestor
25250673|NCT02518763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494794|NCT00497029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494795|NCT00497107|Calcium, Dietary|calcium, dietary|mesh-list
24494796|NCT00497107|Leucovorin|leucovorin|mesh-list
24851280|NCT02256254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24851281|NCT02256254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24851282|NCT02256254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851283|NCT02256280|Neostigmine|neostigmine|mesh-list
24851284|NCT02256280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24851285|NCT02256280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851286|NCT02256280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851287|NCT02256280|Cholinergic Agents|cholinergic agents|mesh-ancestor
24851288|NCT02256280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24494865|NCT00497328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24494867|NCT00497328|Respiratory System Agents|respiratory system agents|mesh-ancestor
24494868|NCT00497328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24494869|NCT00497328|Antioxidants|antioxidants|mesh-ancestor
24661234|NCT01288547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24699830|NCT01449253|Vasodilator Agents|vasodilator agents|mesh-ancestor
24699870|NCT01449435|Miotics|miotics|mesh-ancestor
24851366|NCT02256722|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24851368|NCT02256722|Antimetabolites|antimetabolites|mesh-ancestor
24851369|NCT02256722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24851370|NCT02256735|Moxifloxacin|moxifloxacin|mesh-list
24851371|NCT02256735|p-Hydroxyamphetamine|p-hydroxyamphetamine|mesh-list
24494906|NCT00497497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24494907|NCT00497497|Growth Substances|growth substances|mesh-ancestor
24494908|NCT00497497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494910|NCT00497497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24494911|NCT00497497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24494912|NCT00497497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851379|NCT02256735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24851381|NCT02256735|Mydriatics|mydriatics|mesh-ancestor
25272488|NCT02391883|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25272489|NCT02391883|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25272490|NCT02391883|Purinergic Agents|purinergic agents|mesh-ancestor
25272491|NCT02391883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25676382|NCT01797445|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25676383|NCT01797445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25676384|NCT01797445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25676385|NCT01797445|Antiviral Agents|antiviral agents|mesh-ancestor
25676386|NCT01797445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25692361|NCT01999114|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25692362|NCT01999114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25692363|NCT01999114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25692364|NCT01999114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25692365|NCT01999114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25692366|NCT01999114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692367|NCT01999114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692368|NCT01999114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25692369|NCT01999114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25692370|NCT01999114|Contraceptive Agents|contraceptive agents|mesh-ancestor
25692371|NCT01999114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25692372|NCT01999114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692373|NCT01999114|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25692374|NCT01999114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25692375|NCT01999114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25692376|NCT01999114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25692377|NCT01999114|Narcotics|narcotics|mesh-ancestor
25692378|NCT01999114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25692379|NCT01999114|Analgesics|analgesics|mesh-ancestor
25692380|NCT01999114|Sensory System Agents|sensory system agents|mesh-ancestor
25692381|NCT01999114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25692382|NCT01999114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25692383|NCT01999114|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24851466|NCT02256826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851468|NCT02256826|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24851469|NCT02256826|Antiviral Agents|antiviral agents|mesh-ancestor
24851470|NCT02256826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24851471|NCT02256826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24851472|NCT02256826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24851473|NCT02256878|Amitriptyline|amitriptyline|mesh-list
24851474|NCT02256878|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24851475|NCT02256878|Antidepressive Agents|antidepressive agents|mesh-ancestor
24851478|NCT02256878|Analgesics|analgesics|mesh-ancestor
24812243|NCT02050802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812244|NCT02050802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812245|NCT02050802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812246|NCT02050802|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
24812247|NCT02050802|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24812248|NCT02050802|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
24812250|NCT02050893|Propofol|propofol|mesh-list
24812251|NCT02050893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
24812252|NCT02050893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24812253|NCT02050893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661723|NCT01290471|U3-1565|u3-1565|mesh-list
25272499|NCT02391805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24487664|NCT00464347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943936|NCT03965546|Sorafenib|sorafenib|mesh-list
24495626|NCT00501267|Adrenergic Agents|adrenergic agents|mesh-ancestor
24495627|NCT00501384|Satavaptan|satavaptan|mesh-list
24495628|NCT00501384|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24495629|NCT00501384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851518|NCT02256956|Antidepressive Agents|antidepressive agents|mesh-ancestor
24851519|NCT02256956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24851520|NCT02256956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24851521|NCT02256956|Analgesics|analgesics|mesh-ancestor
24851522|NCT02256956|Sensory System Agents|sensory system agents|mesh-ancestor
24851523|NCT02256956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851524|NCT02256956|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24851525|NCT02256956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24495656|NCT00501410|Antidotes|antidotes|mesh-ancestor
24495657|NCT00501410|Protective Agents|protective agents|mesh-ancestor
24495658|NCT00501410|Vitamin B Complex|vitamin b complex|mesh-ancestor
25272503|NCT02391805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25272504|NCT02391662|Gemcitabine|gemcitabine|mesh-list
25272505|NCT02391662|Paclitaxel|paclitaxel|mesh-list
25272506|NCT02391662|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25250743|NCT02518373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24851536|NCT02257008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24851537|NCT02257008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24851538|NCT02257008|Antiviral Agents|antiviral agents|mesh-ancestor
24851539|NCT02257008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24851540|NCT02257008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24851541|NCT02257008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24851542|NCT02257021|Ritonavir|ritonavir|mesh-list
24851543|NCT02257021|Tipranavir|tipranavir|mesh-list
24851544|NCT02257021|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24851545|NCT02257021|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24851546|NCT02257021|Protease Inhibitors|protease inhibitors|mesh-ancestor
24851547|NCT02257021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851548|NCT02257021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851549|NCT02257021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24851550|NCT02257021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24851551|NCT02257021|Antiviral Agents|antiviral agents|mesh-ancestor
24851552|NCT02257021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24851561|NCT02257242|Rituximab|rituximab|mesh-list
24851562|NCT02257242|Vincristine|vincristine|mesh-list
24851563|NCT02257242|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24851579|NCT02257294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851581|NCT02257398|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24851582|NCT02257398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25272513|NCT02391662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25272514|NCT02391662|Antimetabolites|antimetabolites|mesh-ancestor
24851658|NCT02257697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851659|NCT02257697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24851660|NCT02257697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24851661|NCT02257697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24851662|NCT02257697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24851663|NCT02257697|Antimalarials|antimalarials|mesh-ancestor
24851664|NCT02257697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24851665|NCT02257697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24851666|NCT02257697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851667|NCT02257788|Leronlimab|leronlimab|mesh-list
24444883|NCT00299559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24444885|NCT00299572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24444886|NCT00299572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444887|NCT00299598|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24444888|NCT00299598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24444927|NCT00299754|Abortifacient Agents|abortifacient agents|mesh-ancestor
24444928|NCT00299754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24953806|NCT03881787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24953807|NCT03881306|Oxaliplatin|oxaliplatin|mesh-list
24953808|NCT03881306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25676387|NCT01797484|Ranolazine|ranolazine|mesh-list
25676388|NCT01797484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25676389|NCT01797484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25676390|NCT01797484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676391|NCT01797575|Aspirin|aspirin|mesh-list
25676392|NCT01797575|Acetylcysteine|acetylcysteine|mesh-list
25676393|NCT01797575|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25676394|NCT01797575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25676395|NCT01797575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25676396|NCT01797575|Analgesics|analgesics|mesh-ancestor
24953811|NCT03881423|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
24953812|NCT03881423|Anticonvulsants|anticonvulsants|mesh-ancestor
24953813|NCT03881423|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24953814|NCT03881423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24700246|NCT01451489|Alkylating Agents|alkylating agents|mesh-ancestor
24700247|NCT01451489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700248|NCT01451489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24700251|NCT01451489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445037|NCT00300118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24496501|NCT00505154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24496502|NCT00505154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24496503|NCT00505154|Antimetabolites|antimetabolites|mesh-ancestor
24496504|NCT00505154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496505|NCT00505154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24496506|NCT00505154|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24496507|NCT00505154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445227|NCT00300846|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24445228|NCT00300846|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24445229|NCT00300846|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25272521|NCT02391688|Fexofenadine|fexofenadine|mesh-list
25272522|NCT02391688|Flurbiprofen|flurbiprofen|mesh-list
25272523|NCT02391688|Midazolam|midazolam|mesh-list
25272524|NCT02391688|Dextromethorphan|dextromethorphan|mesh-list
25272525|NCT02391688|Caffeine|caffeine|mesh-list
25272526|NCT02391688|Bupropion|bupropion|mesh-list
25272527|NCT02391688|Omeprazole|omeprazole|mesh-list
25272528|NCT02391688|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25272536|NCT02391688|Anesthetics, General|anesthetics, general|mesh-ancestor
25272537|NCT02391688|Anesthetics|anesthetics|mesh-ancestor
25272538|NCT02391688|GABA Modulators|gaba modulators|mesh-ancestor
25272539|NCT02391688|GABA Agents|gaba agents|mesh-ancestor
25272540|NCT02391688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25071135|NCT03412994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25071136|NCT03412994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25071137|NCT03412994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071138|NCT03412773|Sorafenib|sorafenib|mesh-list
25071139|NCT03412773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071140|NCT03412773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25071141|NCT03412773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25071142|NCT03412773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071143|NCT03412721|Analgesics|analgesics|mesh-list
25272541|NCT02391688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272542|NCT02391688|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25071161|NCT03412682|Analgesics|analgesics|mesh-ancestor
25272543|NCT02391688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25272544|NCT02391688|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25272546|NCT02391688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25272547|NCT02391688|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25272548|NCT02391688|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25272549|NCT02391688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25272550|NCT02391688|Purinergic Agents|purinergic agents|mesh-ancestor
25272551|NCT02391688|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25272552|NCT02391688|Antidepressive Agents|antidepressive agents|mesh-ancestor
25272553|NCT02391688|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24852006|NCT02259985|Serotonin Agents|serotonin agents|mesh-ancestor
24852007|NCT02259985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24852008|NCT02259985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852020|NCT02260011|Autonomic Agents|autonomic agents|mesh-ancestor
24852021|NCT02260011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24662717|NCT01296464|Dopamine Agents|dopamine agents|mesh-ancestor
24852119|NCT02260661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24852120|NCT02260661|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24852121|NCT02260661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24852122|NCT02260661|Hormone Antagonists|hormone antagonists|mesh-ancestor
24655375|NCT01256151|GABA Modulators|gaba modulators|mesh-ancestor
25071165|NCT03412552|Analgesics|analgesics|mesh-ancestor
24852131|NCT02260687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24852133|NCT02260908|Anticoagulants|anticoagulants|mesh-ancestor
24852134|NCT02260908|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24852135|NCT02260908|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24852136|NCT02260908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852137|NCT02260947|Ibuprofen|ibuprofen|mesh-list
24852138|NCT02260947|Pregabalin|pregabalin|mesh-list
24852139|NCT02260947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24445887|NCT00302913|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24445888|NCT00302913|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24445889|NCT00302913|Purinergic Agents|purinergic agents|mesh-ancestor
24445890|NCT00302913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24445895|NCT00303004|Vasodilator Agents|vasodilator agents|mesh-ancestor
25272557|NCT02391688|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25272561|NCT02391688|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24852210|NCT02261090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24852212|NCT02261103|Antioxidants|antioxidants|mesh-ancestor
24852213|NCT02261103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852214|NCT02261103|Protective Agents|protective agents|mesh-ancestor
24852215|NCT02261103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852216|NCT02261103|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24852217|NCT02261103|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24852229|NCT02261129|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24852230|NCT02261129|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24852231|NCT02261129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852232|NCT02261155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
24852233|NCT02261155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24852234|NCT02261155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852235|NCT02261207|Axitinib|axitinib|mesh-list
24852236|NCT02261207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24852272|NCT02261675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24852273|NCT02261675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24852274|NCT02261675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852275|NCT02261675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24852276|NCT02261675|Analgesics|analgesics|mesh-ancestor
24852277|NCT02261675|Sensory System Agents|sensory system agents|mesh-ancestor
25272562|NCT02391688|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25272563|NCT02391688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25272564|NCT02391688|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25272565|NCT02391688|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25272566|NCT02391688|Histamine Antagonists|histamine antagonists|mesh-ancestor
25272573|NCT02391688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25272574|NCT02391688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25272575|NCT02391688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25272576|NCT02391636|Oxytocin|oxytocin|mesh-list
25272577|NCT02391636|Carbetocin|carbetocin|mesh-list
25272578|NCT02391636|Oxytocics|oxytocics|mesh-ancestor
24852357|NCT02262299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24852358|NCT02262299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24852359|NCT02262299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24852360|NCT02262299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24852361|NCT02262299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24852362|NCT02262325|Etoposide|etoposide|mesh-list
24852363|NCT02262325|Etoposide phosphate|etoposide phosphate|mesh-list
24589456|NCT00907504|Gemcitabine|gemcitabine|mesh-list
24589457|NCT00907504|Cisplatin|cisplatin|mesh-list
24589458|NCT00907504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589459|NCT00907504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24589460|NCT00907504|Antimetabolites|antimetabolites|mesh-ancestor
24589461|NCT00907504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589463|NCT00907504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24589484|NCT00907829|Lidocaine|lidocaine|mesh-list
24589501|NCT00907894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589503|NCT00907972|Ergocalciferols|ergocalciferols|mesh-list
24589504|NCT00907972|Cholecalciferol|cholecalciferol|mesh-list
24589505|NCT00907972|Vitamins|vitamins|mesh-list
24589506|NCT00907972|Micronutrients|micronutrients|mesh-ancestor
24589507|NCT00907972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589508|NCT00907972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24589509|NCT00907972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24589510|NCT00907985|Lamotrigine|lamotrigine|mesh-list
24589511|NCT00907985|Vofopitant|vofopitant|mesh-list
24589512|NCT00907985|Anticonvulsants|anticonvulsants|mesh-ancestor
24589513|NCT00907985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24589570|NCT00908089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24589571|NCT00908089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24589572|NCT00908089|Analgesics|analgesics|mesh-ancestor
24589574|NCT00908089|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24589575|NCT00908089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24589576|NCT00908089|Antimalarials|antimalarials|mesh-ancestor
24589577|NCT00908089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24589578|NCT00908089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24589579|NCT00908089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589580|NCT00908089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589581|NCT00908167|Cytarabine|cytarabine|mesh-list
24589582|NCT00908167|Clofarabine|clofarabine|mesh-list
24589583|NCT00908167|Sorafenib|sorafenib|mesh-list
24589584|NCT00908167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24589585|NCT00908167|Antimetabolites|antimetabolites|mesh-ancestor
24589586|NCT00908167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589587|NCT00908167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589588|NCT00908167|Antiviral Agents|antiviral agents|mesh-ancestor
24589589|NCT00908167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24589590|NCT00908167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24852406|NCT02262533|Antithrombins|antithrombins|mesh-ancestor
24852407|NCT02262533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24852408|NCT02262533|Protease Inhibitors|protease inhibitors|mesh-ancestor
24852409|NCT02262533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852410|NCT02262533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852411|NCT02262533|Anticoagulants|anticoagulants|mesh-ancestor
24852412|NCT02262533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24589624|NCT00908219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24589625|NCT00908219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589626|NCT00908219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24589627|NCT00908219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24589628|NCT00908219|Growth Substances|growth substances|mesh-ancestor
24663131|NCT01298401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589691|NCT00908531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24589692|NCT00908531|Hormone Antagonists|hormone antagonists|mesh-ancestor
25272579|NCT02391636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25272580|NCT02391636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272581|NCT02391480|Venetoclax|venetoclax|mesh-list
24488005|NCT00466180|Nevirapine|nevirapine|mesh-list
24488006|NCT00466180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24967287|NCT03760848|Anesthetics|anesthetics|mesh-ancestor
24589693|NCT00908531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24589694|NCT00908531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589695|NCT00908661|Cellulose, Oxidized|cellulose, oxidized|mesh-list
24589696|NCT00908661|Hemostatics|hemostatics|mesh-ancestor
24589801|NCT00909077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24589802|NCT00909077|Antiemetics|antiemetics|mesh-ancestor
24589803|NCT00909077|Autonomic Agents|autonomic agents|mesh-ancestor
24589804|NCT00909077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24589805|NCT00909077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24589806|NCT00909077|Glucocorticoids|glucocorticoids|mesh-ancestor
24589808|NCT00909077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24589809|NCT00909077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24589810|NCT00909077|Protease Inhibitors|protease inhibitors|mesh-ancestor
24589811|NCT00909077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589869|NCT00909519|Naproxen|naproxen|mesh-list
24589870|NCT00909519|Furosemide|furosemide|mesh-list
24589871|NCT00909519|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
25274549|NCT02377180|Antipruritics|antipruritics|mesh-ancestor
24589872|NCT00909519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24589873|NCT00909519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24589874|NCT00909519|Analgesics|analgesics|mesh-ancestor
24589875|NCT00909519|Sensory System Agents|sensory system agents|mesh-ancestor
24589897|NCT00909688|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24589898|NCT00909688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589899|NCT00909688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590009|NCT00910351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24590010|NCT00910351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24590011|NCT00910351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24590061|NCT00910455|Natriuretic Agents|natriuretic agents|mesh-ancestor
24590062|NCT00910455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590063|NCT00910533|Ceftriaxone|ceftriaxone|mesh-list
24590064|NCT00910533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24590068|NCT00910598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24590069|NCT00910598|Immunologic Factors|immunologic factors|mesh-ancestor
24590070|NCT00910598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590095|NCT00910741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24590096|NCT00910741|Immunologic Factors|immunologic factors|mesh-ancestor
24590097|NCT00910741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590098|NCT00910754|Prednisone|prednisone|mesh-list
24590099|NCT00910754|Abiraterone Acetate|abiraterone acetate|mesh-list
24590100|NCT00910754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24590101|NCT00910754|Glucocorticoids|glucocorticoids|mesh-ancestor
24590102|NCT00910754|Hormones|hormones|mesh-ancestor
24852439|NCT02262546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24852440|NCT02262546|Antioxidants|antioxidants|mesh-ancestor
25071369|NCT03410836|Lidocaine|lidocaine|mesh-list
24852441|NCT02262546|Protective Agents|protective agents|mesh-ancestor
24590172|NCT00910897|Immunologic Factors|immunologic factors|mesh-ancestor
24590173|NCT00910897|Leprostatic Agents|leprostatic agents|mesh-ancestor
24590174|NCT00910897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24590175|NCT00910897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24590176|NCT00910897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24590280|NCT00911651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24590281|NCT00911651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590282|NCT00911651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24590283|NCT00911651|Respiratory System Agents|respiratory system agents|mesh-ancestor
24590321|NCT00911716|Mitosis Modulators|mitosis modulators|mesh-ancestor
24852447|NCT02262559|Telmisartan|telmisartan|mesh-list
24852448|NCT02262559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24852449|NCT02262559|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24852450|NCT02262559|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24852451|NCT02262559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852452|NCT02262572|Telmisartan|telmisartan|mesh-list
24852453|NCT02262572|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24852454|NCT02262572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24852455|NCT02262572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24852456|NCT02262572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24488008|NCT00466180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488009|NCT00466180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488538|NCT00469261|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24488539|NCT00469261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24488541|NCT00469261|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24488542|NCT00469261|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24488543|NCT00469300|Acyclovir|acyclovir|mesh-list
24488544|NCT00469300|Antiviral Agents|antiviral agents|mesh-ancestor
24488545|NCT00469300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24488546|NCT00469326|Atorvastatin|atorvastatin|mesh-list
24852457|NCT02262572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852458|NCT02262572|Diuretics|diuretics|mesh-ancestor
24852459|NCT02262572|Natriuretic Agents|natriuretic agents|mesh-ancestor
24852460|NCT02262572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852461|NCT02262572|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24852462|NCT02262572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24852463|NCT02262585|Telmisartan|telmisartan|mesh-list
24852464|NCT02262585|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24590401|NCT00912444|Epirubicin|epirubicin|mesh-list
24590402|NCT00912444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24590403|NCT00912444|Immunologic Factors|immunologic factors|mesh-ancestor
24590404|NCT00912444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590405|NCT00912444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24590468|NCT00912678|Immunologic Factors|immunologic factors|mesh-ancestor
25159896|NCT03539744|Growth Inhibitors|growth inhibitors|mesh-ancestor
25692384|NCT01999218|Metformin|metformin|mesh-list
24590469|NCT00912678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590470|NCT00912678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24852465|NCT02262585|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24852466|NCT02262585|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24852467|NCT02262585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852468|NCT02262598|Telmisartan|telmisartan|mesh-list
24852469|NCT02262598|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24852470|NCT02262598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24674082|NCT01341964|Aspirin|aspirin|mesh-list
24852471|NCT02262598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24590826|NCT00913952|Clomipramine|clomipramine|mesh-list
24852472|NCT02262598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24852473|NCT02262598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852474|NCT02262598|Diuretics|diuretics|mesh-ancestor
24852475|NCT02262598|Natriuretic Agents|natriuretic agents|mesh-ancestor
24852476|NCT02262598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852477|NCT02262598|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24657087|NCT01265589|Vitamin A|vitamin a|mesh-list
24590512|NCT00912938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590514|NCT00913029|Latanoprost|latanoprost|mesh-list
24590515|NCT00913029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24590516|NCT00913029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24590517|NCT00913029|Adrenergic Agents|adrenergic agents|mesh-ancestor
24852478|NCT02262598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24852479|NCT02262611|Telmisartan|telmisartan|mesh-list
24657128|NCT01265888|Nitric Oxide|nitric oxide|mesh-list
24590518|NCT00913029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24590605|NCT00913315|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24634946|NCT01136213|Fluoxetine|fluoxetine|mesh-list
24590606|NCT00913315|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24590607|NCT00913315|Cholinergic Agents|cholinergic agents|mesh-ancestor
24590608|NCT00913328|Montelukast|montelukast|mesh-list
24590609|NCT00913328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24590610|NCT00913328|Respiratory System Agents|respiratory system agents|mesh-ancestor
24590676|NCT00913549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24590686|NCT00913562|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24590687|NCT00913562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590689|NCT00913588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25208354|NCT02601586|Oxycodone|oxycodone|mesh-list
25208355|NCT02601586|Levodopa|levodopa|mesh-list
25208356|NCT02601586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25208357|NCT02601586|Narcotics|narcotics|mesh-ancestor
25208358|NCT02601586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25208359|NCT02601586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208360|NCT02601586|Analgesics|analgesics|mesh-ancestor
25208361|NCT02601586|Sensory System Agents|sensory system agents|mesh-ancestor
25208362|NCT02601586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25208363|NCT02601586|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25208364|NCT02601586|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25208365|NCT02601586|Dopamine Agents|dopamine agents|mesh-ancestor
24488639|NCT00469599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24590690|NCT00913588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24590691|NCT00913588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24590692|NCT00913588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590693|NCT00913588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24852483|NCT02262611|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24852484|NCT02262611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852485|NCT02262611|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24852486|NCT02262611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24852488|NCT02262611|Natriuretic Agents|natriuretic agents|mesh-ancestor
24590725|NCT00913718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24590726|NCT00913718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24590727|NCT00913718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590729|NCT00913718|Serotonin Agents|serotonin agents|mesh-ancestor
24590730|NCT00913718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590731|NCT00913718|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24590732|NCT00913718|Antidepressive Agents|antidepressive agents|mesh-ancestor
24590733|NCT00913718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24590734|NCT00913718|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24590735|NCT00913718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24590736|NCT00913718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590737|NCT00913783|Clomipramine|clomipramine|mesh-list
24590738|NCT00913783|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24590739|NCT00913783|Antidepressive Agents|antidepressive agents|mesh-ancestor
24590740|NCT00913783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24590741|NCT00913783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24590742|NCT00913783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24590743|NCT00913783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24590821|NCT00913887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24590822|NCT00913887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24590823|NCT00913887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24590824|NCT00913887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590825|NCT00913887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590827|NCT00913952|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24590828|NCT00913952|Antidepressive Agents|antidepressive agents|mesh-ancestor
24590829|NCT00913952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24590830|NCT00913952|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24590831|NCT00913952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24590832|NCT00913952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25071527|NCT03408093|Interferons|interferons|mesh-list
25071528|NCT03408093|Interferon-beta|interferon-beta|mesh-list
25071529|NCT03408093|Interferon beta-1b|interferon beta-1b|mesh-list
25071530|NCT03408093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071531|NCT03408093|Antiviral Agents|antiviral agents|mesh-ancestor
25071532|NCT03408093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25071533|NCT03408093|Immunologic Factors|immunologic factors|mesh-ancestor
25071534|NCT03408093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071535|NCT03408093|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25071537|NCT03408054|Oxytocin|oxytocin|mesh-list
24590833|NCT00913952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590834|NCT00913952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24590835|NCT00913952|Serotonin Agents|serotonin agents|mesh-ancestor
24590836|NCT00913952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590838|NCT00913965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24590839|NCT00913965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24590874|NCT00914095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591040|NCT00914771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591042|NCT00914797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24591043|NCT00914797|Autonomic Agents|autonomic agents|mesh-ancestor
24591044|NCT00914797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24591045|NCT00914797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591046|NCT00914797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24591047|NCT00914797|Respiratory System Agents|respiratory system agents|mesh-ancestor
24852528|NCT02262676|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24852529|NCT02262676|Protease Inhibitors|protease inhibitors|mesh-ancestor
24852530|NCT02262676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852531|NCT02262676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591109|NCT00915200|Antiviral Agents|antiviral agents|mesh-ancestor
24591110|NCT00915200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24591112|NCT00915200|Respiratory System Agents|respiratory system agents|mesh-ancestor
24591113|NCT00915200|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24591114|NCT00915200|Antioxidants|antioxidants|mesh-ancestor
24591115|NCT00915200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591116|NCT00915200|Protective Agents|protective agents|mesh-ancestor
24591117|NCT00915200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591118|NCT00915200|Antidotes|antidotes|mesh-ancestor
25208366|NCT02601586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24591121|NCT00915239|Pantoprazole|pantoprazole|mesh-list
24591122|NCT00915239|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24591123|NCT00915239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24591124|NCT00915239|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24591125|NCT00915239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591126|NCT00915239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591127|NCT00915252|Cytarabine|cytarabine|mesh-list
24591128|NCT00915252|Azacitidine|azacitidine|mesh-list
24591129|NCT00915252|Daunorubicin|daunorubicin|mesh-list
24591151|NCT00915382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591153|NCT00915408|Cyclophosphamide|cyclophosphamide|mesh-list
24591154|NCT00915408|Lenalidomide|lenalidomide|mesh-list
24591155|NCT00915408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24591156|NCT00915408|Immunologic Factors|immunologic factors|mesh-ancestor
24591157|NCT00915408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591158|NCT00915408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24591160|NCT00915408|Alkylating Agents|alkylating agents|mesh-ancestor
24852541|NCT02262715|Antiviral Agents|antiviral agents|mesh-ancestor
24852542|NCT02262715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24604619|NCT00980473|Timolol|timolol|mesh-list
24852543|NCT02262715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657648|NCT01268735|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24591254|NCT00915733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24591255|NCT00915733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24591256|NCT00915733|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24591257|NCT00915733|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24663453|NCT01301586|Doxycycline|doxycycline|mesh-list
24852552|NCT02262767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24852553|NCT02262767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852554|NCT02262767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24852555|NCT02262780|Telmisartan|telmisartan|mesh-list
24852556|NCT02262780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24852557|NCT02262780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24852558|NCT02262780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24852559|NCT02262780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852560|NCT02262793|Telmisartan|telmisartan|mesh-list
24852568|NCT02262858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24852569|NCT02262858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24591431|NCT00916526|Natriuretic Agents|natriuretic agents|mesh-ancestor
24591432|NCT00916526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591433|NCT00916552|Epoetin Alfa|epoetin alfa|mesh-list
24591434|NCT00916552|Hematinics|hematinics|mesh-ancestor
24591436|NCT00916630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591441|NCT00916669|Etoposide|etoposide|mesh-list
24591535|NCT00917241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24591536|NCT00917241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591537|NCT00917241|Antithyroid Agents|antithyroid agents|mesh-ancestor
24591538|NCT00917241|Hormone Antagonists|hormone antagonists|mesh-ancestor
24591540|NCT00917254|Anticoagulants|anticoagulants|mesh-ancestor
24591541|NCT00917254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24591542|NCT00917254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24657897|NCT01269515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24657898|NCT01269515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24657900|NCT01269515|Sensory System Agents|sensory system agents|mesh-ancestor
24657912|NCT01269528|Autonomic Agents|autonomic agents|mesh-ancestor
24591631|NCT00918021|Autonomic Agents|autonomic agents|mesh-ancestor
24591632|NCT00918021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24591633|NCT00918021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071625|NCT03407196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071626|NCT03407105|Ipilimumab|ipilimumab|mesh-list
24591634|NCT00918021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24591635|NCT00918021|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24591636|NCT00918021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24591637|NCT00918021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25208367|NCT02601586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208368|NCT02569476|Obinutuzumab|obinutuzumab|mesh-list
25208369|NCT02569476|Zanubrutinib|zanubrutinib|mesh-list
24488646|NCT00469664|Guanfacine|guanfacine|mesh-list
24651484|NCT01231802|Leucovorin|leucovorin|mesh-list
24591713|NCT00918307|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24591714|NCT00918307|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24591795|NCT00919022|Cyproterone Acetate|cyproterone acetate|mesh-list
24591796|NCT00919022|Cyproterone|cyproterone|mesh-list
24591797|NCT00919022|Androgen Antagonists|androgen antagonists|mesh-ancestor
24591798|NCT00919022|Hormone Antagonists|hormone antagonists|mesh-ancestor
24591799|NCT00919022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24591800|NCT00919022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591801|NCT00919022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591802|NCT00919022|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24591803|NCT00919022|Contraceptive Agents|contraceptive agents|mesh-ancestor
24591845|NCT00919282|Protective Agents|protective agents|mesh-ancestor
24591846|NCT00919282|Vitamin B Complex|vitamin b complex|mesh-ancestor
24591847|NCT00919282|Vitamins|vitamins|mesh-ancestor
24591848|NCT00919282|Micronutrients|micronutrients|mesh-ancestor
24591849|NCT00919282|Hematinics|hematinics|mesh-ancestor
24591866|NCT00919295|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24591867|NCT00919295|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24591871|NCT00919321|Immunologic Factors|immunologic factors|mesh-ancestor
24591872|NCT00919321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591874|NCT00919399|Exemestane|exemestane|mesh-list
24591875|NCT00919399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24591876|NCT00919399|Hormone Antagonists|hormone antagonists|mesh-ancestor
24591877|NCT00919399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24591878|NCT00919399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591880|NCT00919399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591881|NCT00919399|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24591882|NCT00919399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25071657|NCT03406936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24591883|NCT00919399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24591884|NCT00919399|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24591885|NCT00919399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24591886|NCT00919399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591887|NCT00919399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591888|NCT00919438|Diuretics|diuretics|mesh-list
24591889|NCT00919438|Natriuretic Agents|natriuretic agents|mesh-ancestor
24591890|NCT00919438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591892|NCT00919451|Cyclosporins|cyclosporins|mesh-list
24591893|NCT00919451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591894|NCT00919451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852611|NCT02263170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852612|NCT02263170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24592561|NCT00922649|Insulin|insulin|mesh-list
24591895|NCT00919451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24591896|NCT00919451|Immunologic Factors|immunologic factors|mesh-ancestor
24591897|NCT00919451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591898|NCT00919451|Antifungal Agents|antifungal agents|mesh-ancestor
24591899|NCT00919451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24663603|NCT01302496|Ipilimumab|ipilimumab|mesh-list
24591948|NCT00919776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24591949|NCT00919776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24591950|NCT00919776|Glucocorticoids|glucocorticoids|mesh-ancestor
24591952|NCT00919776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24591953|NCT00919776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24591954|NCT00919776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591988|NCT00919984|Paclitaxel|paclitaxel|mesh-list
24591989|NCT00919984|Carboplatin|carboplatin|mesh-list
24591990|NCT00919984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24591991|NCT00919984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208370|NCT02569476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25208371|NCT02569476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208372|NCT02569476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25208373|NCT02569476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208374|NCT02569476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943989|NCT03965208|Heparin|heparin|mesh-list
24591992|NCT00919984|Tubulin Modulators|tubulin modulators|mesh-ancestor
24591993|NCT00919984|Antimitotic Agents|antimitotic agents|mesh-ancestor
24591994|NCT00919984|Mitosis Modulators|mitosis modulators|mesh-ancestor
24591995|NCT00919984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592028|NCT00920088|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24592031|NCT00920088|Sensory System Agents|sensory system agents|mesh-ancestor
24592077|NCT00920153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24592078|NCT00920153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592079|NCT00920153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24592080|NCT00920153|Immunologic Factors|immunologic factors|mesh-ancestor
24592103|NCT00920244|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24592105|NCT00920244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24592106|NCT00920244|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24592107|NCT00920244|Respiratory System Agents|respiratory system agents|mesh-ancestor
24592108|NCT00920244|Mydriatics|mydriatics|mesh-ancestor
24592109|NCT00920244|Sympathomimetics|sympathomimetics|mesh-ancestor
24592110|NCT00920244|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24592111|NCT00920244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24592112|NCT00920244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24592113|NCT00920244|Parasympatholytics|parasympatholytics|mesh-ancestor
24592164|NCT00920465|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24592165|NCT00920465|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24592166|NCT00920465|Contraceptive Agents|contraceptive agents|mesh-ancestor
24592167|NCT00920465|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24592168|NCT00920465|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24592169|NCT00920465|Hormone Antagonists|hormone antagonists|mesh-ancestor
24592170|NCT00920465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24592171|NCT00920465|Luteolytic Agents|luteolytic agents|mesh-ancestor
24592172|NCT00920465|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24592173|NCT00920465|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24592174|NCT00920608|Methotrexate|methotrexate|mesh-list
24592207|NCT00920803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592209|NCT00920803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24592211|NCT00920868|Capecitabine|capecitabine|mesh-list
24592212|NCT00920868|Oxaliplatin|oxaliplatin|mesh-list
24592213|NCT00920868|Dasatinib|dasatinib|mesh-list
24592214|NCT00920868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24592215|NCT00920868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24592242|NCT00921063|Alprazolam|alprazolam|mesh-list
24592254|NCT00921102|Morphine|morphine|mesh-list
24592255|NCT00921102|Bupivacaine|bupivacaine|mesh-list
24592256|NCT00921102|Anesthetics, Local|anesthetics, local|mesh-list
24592257|NCT00921102|Anesthetics|anesthetics|mesh-list
24592258|NCT00921102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24592259|NCT00921102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592260|NCT00921102|Sensory System Agents|sensory system agents|mesh-ancestor
24592261|NCT00921102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24592262|NCT00921102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24592297|NCT00921167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24592298|NCT00921167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24592299|NCT00921167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592300|NCT00921167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592301|NCT00921180|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24592302|NCT00921180|Interferon-alpha|interferon-alpha|mesh-list
25071775|NCT03406299|Leucovorin|leucovorin|mesh-list
24592304|NCT00921180|Antiviral Agents|antiviral agents|mesh-ancestor
24592312|NCT00921245|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24592313|NCT00921245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25208375|NCT02549209|Paclitaxel|paclitaxel|mesh-list
25208376|NCT02549209|Carboplatin|carboplatin|mesh-list
25208377|NCT02549209|Pembrolizumab|pembrolizumab|mesh-list
25208378|NCT02549209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24488649|NCT00469664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24488650|NCT00469664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24488651|NCT00469664|Adrenergic Agents|adrenergic agents|mesh-ancestor
24488661|NCT00469690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812379|NCT02051868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812380|NCT02051894|Dobutamine|dobutamine|mesh-list
24812381|NCT02051894|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24812382|NCT02051894|Sympathomimetics|sympathomimetics|mesh-ancestor
24812383|NCT02051894|Autonomic Agents|autonomic agents|mesh-ancestor
24812384|NCT02051894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812385|NCT02051894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812386|NCT02051894|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24812387|NCT02051894|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24812388|NCT02051894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24812389|NCT02051894|Adrenergic Agents|adrenergic agents|mesh-ancestor
24592314|NCT00921245|Cholinergic Agents|cholinergic agents|mesh-ancestor
24592315|NCT00921245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24592316|NCT00921245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592317|NCT00921245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592329|NCT00921284|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24592330|NCT00921284|Adrenergic Agents|adrenergic agents|mesh-ancestor
24592331|NCT00921284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24592332|NCT00921284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592333|NCT00921349|Nadolol|nadolol|mesh-list
24592334|NCT00921349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24592335|NCT00921349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25071807|NCT03406169|Antioxidants|antioxidants|mesh-ancestor
24592336|NCT00921349|Adrenergic Agents|adrenergic agents|mesh-ancestor
24592337|NCT00921349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24592338|NCT00921349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592339|NCT00921349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592340|NCT00921349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24592341|NCT00921349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24592342|NCT00921349|Sympatholytics|sympatholytics|mesh-ancestor
24592343|NCT00921349|Autonomic Agents|autonomic agents|mesh-ancestor
24592344|NCT00921349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24592345|NCT00921388|Varenicline|varenicline|mesh-list
24663706|NCT01303471|Narcotics|narcotics|mesh-ancestor
24592350|NCT00921388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592351|NCT00921388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592352|NCT00921414|Rituximab|rituximab|mesh-list
24592353|NCT00921414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24592356|NCT00921414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592357|NCT00921414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24592359|NCT00921505|Ibuprofen|ibuprofen|mesh-list
25208379|NCT02549209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208380|NCT02549209|Tubulin Modulators|tubulin modulators|mesh-ancestor
25208381|NCT02549209|Antimitotic Agents|antimitotic agents|mesh-ancestor
25208382|NCT02549209|Mitosis Modulators|mitosis modulators|mesh-ancestor
25208383|NCT02549209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208384|NCT02549209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25208385|NCT02549170|Immunoglobulins|immunoglobulins|mesh-list
24592360|NCT00921505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25071850|NCT03405584|Antacids|antacids|mesh-ancestor
24592361|NCT00921505|Analgesics|analgesics|mesh-ancestor
24592362|NCT00921505|Sensory System Agents|sensory system agents|mesh-ancestor
24592363|NCT00921505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24592364|NCT00921505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812391|NCT02051894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812392|NCT02051894|Protective Agents|protective agents|mesh-ancestor
24812394|NCT02051946|Diuretics|diuretics|mesh-ancestor
24812395|NCT02051946|Natriuretic Agents|natriuretic agents|mesh-ancestor
24812396|NCT02051946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812397|NCT02051946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812398|NCT02051946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812399|NCT02052024|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
24812400|NCT02052024|Botulinum Toxins|botulinum toxins|mesh-list
24812401|NCT02052024|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24812402|NCT02052024|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24592365|NCT00921505|Antipyretics|antipyretics|mesh-ancestor
24592366|NCT00921505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24592367|NCT00921505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24592368|NCT00921505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24592378|NCT00921531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24592379|NCT00921531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24592413|NCT00921674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24592414|NCT00921700|Acetaminophen|acetaminophen|mesh-list
24592416|NCT00921700|Codeine|codeine|mesh-list
24592441|NCT00921765|Naloxone|naloxone|mesh-list
24592442|NCT00921765|Analgesics|analgesics|mesh-ancestor
24592443|NCT00921765|Sensory System Agents|sensory system agents|mesh-ancestor
24592444|NCT00921765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24592445|NCT00921765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592446|NCT00921765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24592447|NCT00921765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24592448|NCT00921765|Anesthetics, General|anesthetics, general|mesh-ancestor
24592449|NCT00921765|Anesthetics|anesthetics|mesh-ancestor
24592450|NCT00921765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24592451|NCT00921765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24592452|NCT00921765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24592453|NCT00921765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24592454|NCT00921765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592491|NCT00922129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592492|NCT00922129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592493|NCT00922129|Antifungal Agents|antifungal agents|mesh-ancestor
24592494|NCT00922129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24592495|NCT00922129|Dermatologic Agents|dermatologic agents|mesh-ancestor
24592496|NCT00922129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24592497|NCT00922129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24592500|NCT00922389|Lenograstim|lenograstim|mesh-list
24592501|NCT00922389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24592502|NCT00922389|Immunologic Factors|immunologic factors|mesh-ancestor
24592503|NCT00922389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592504|NCT00922402|Insulin|insulin|mesh-list
24592505|NCT00922402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25692385|NCT01999218|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25692386|NCT01999218|Glimepiride|glimepiride|mesh-list
25692387|NCT01999218|Ertugliflozin|ertugliflozin|mesh-list
25692388|NCT01999218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25692389|NCT01999218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692390|NCT01999218|Incretins|incretins|mesh-ancestor
25692391|NCT01999218|Hormones|hormones|mesh-ancestor
25692392|NCT01999218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24605321|NCT00984464|Mitosis Modulators|mitosis modulators|mesh-ancestor
24605322|NCT00984464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605323|NCT00984633|Bromides|bromides|mesh-list
24605324|NCT00984633|Propofol|propofol|mesh-list
24592506|NCT00922402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592507|NCT00922467|Esmolol|esmolol|mesh-list
24592508|NCT00922467|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24592509|NCT00922467|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24592510|NCT00922467|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24592511|NCT00922467|Adrenergic Agents|adrenergic agents|mesh-ancestor
24592512|NCT00922467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24592515|NCT00922506|Doxazosin|doxazosin|mesh-list
24592553|NCT00922584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24592554|NCT00922584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24592555|NCT00922584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592556|NCT00922584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592557|NCT00922597|Factor VIII|factor viii|mesh-list
24592558|NCT00922597|Coagulants|coagulants|mesh-ancestor
24592559|NCT00922610|Epoetin Alfa|epoetin alfa|mesh-list
24592560|NCT00922610|Hematinics|hematinics|mesh-ancestor
25208386|NCT02549170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24592562|NCT00922649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24592579|NCT00922896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24592580|NCT00922896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592581|NCT00922896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24592582|NCT00922896|Immunologic Factors|immunologic factors|mesh-ancestor
24592583|NCT00922896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592584|NCT00922896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24592586|NCT00923000|Nalbuphine|nalbuphine|mesh-list
24592587|NCT00923000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24592588|NCT00923000|Narcotics|narcotics|mesh-ancestor
24592589|NCT00923000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24592590|NCT00923000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592591|NCT00923000|Analgesics|analgesics|mesh-ancestor
24592592|NCT00923000|Sensory System Agents|sensory system agents|mesh-ancestor
24592593|NCT00923000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24592594|NCT00923169|Mitogens|mitogens|mesh-list
24592595|NCT00923169|Mitosis Modulators|mitosis modulators|mesh-ancestor
24592596|NCT00923169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592597|NCT00923182|Alemtuzumab|alemtuzumab|mesh-list
24592598|NCT00923182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24592599|NCT00923182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24592600|NCT00923234|Lenalidomide|lenalidomide|mesh-list
24592601|NCT00923234|Azacitidine|azacitidine|mesh-list
24592602|NCT00923234|Immunologic Factors|immunologic factors|mesh-ancestor
24592603|NCT00923234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663870|NCT01303926|Bevacizumab|bevacizumab|mesh-list
24592611|NCT00923234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592613|NCT00923247|Bortezomib|bortezomib|mesh-list
24592614|NCT00923247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24592615|NCT00923299|Trastuzumab|trastuzumab|mesh-list
24592616|NCT00923299|Cetuximab|cetuximab|mesh-list
24592617|NCT00923299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24592618|NCT00923299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24592644|NCT00923533|Diuretics|diuretics|mesh-ancestor
24592645|NCT00923533|Natriuretic Agents|natriuretic agents|mesh-ancestor
24592646|NCT00923533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592647|NCT00923533|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24592648|NCT00923533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24592649|NCT00923533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592650|NCT00923572|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
24812413|NCT02052128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812414|NCT02052128|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24592652|NCT00923572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592709|NCT00924014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24592710|NCT00924014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592711|NCT00924014|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24592713|NCT00924079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25676397|NCT01797575|Sensory System Agents|sensory system agents|mesh-ancestor
25676398|NCT01797575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25676399|NCT01797575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676400|NCT01797575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24592714|NCT00924079|Narcotics|narcotics|mesh-ancestor
24592715|NCT00924079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24592716|NCT00924079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592717|NCT00924079|Analgesics|analgesics|mesh-ancestor
24592718|NCT00924079|Sensory System Agents|sensory system agents|mesh-ancestor
24592719|NCT00924079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24592720|NCT00924222|Propofol|propofol|mesh-list
24592721|NCT00924222|Sevoflurane|sevoflurane|mesh-list
24592722|NCT00924222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24592723|NCT00924222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24592724|NCT00924222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592725|NCT00924222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24592754|NCT00924742|Piperacillin|piperacillin|mesh-list
24592755|NCT00924742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24592756|NCT00924742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25208388|NCT02549170|Immunoglobulin G|immunoglobulin g|mesh-list
25208389|NCT02549170|gamma-Globulins|gamma-globulins|mesh-list
25208390|NCT02549170|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25208391|NCT02549170|Immunologic Factors|immunologic factors|mesh-ancestor
24592757|NCT00924742|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24592758|NCT00924742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592759|NCT00924742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592760|NCT00924755|Caffeine|caffeine|mesh-list
24592761|NCT00924755|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24592762|NCT00924755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592763|NCT00924755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24592764|NCT00924755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592765|NCT00924755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592766|NCT00924755|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24635521|NCT01139905|Ritonavir|ritonavir|mesh-list
24592809|NCT00925327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592810|NCT00925327|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24592811|NCT00925327|Dermatologic Agents|dermatologic agents|mesh-ancestor
24592862|NCT00925873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24592863|NCT00925912|Bupivacaine|bupivacaine|mesh-list
24592864|NCT00925912|Anesthetics, Local|anesthetics, local|mesh-ancestor
24592865|NCT00925912|Anesthetics|anesthetics|mesh-ancestor
24812416|NCT02052128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24812417|NCT02052128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812419|NCT02052128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25241760|NCT05300009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24812420|NCT02052154|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24812421|NCT02052154|Immunologic Factors|immunologic factors|mesh-ancestor
24812422|NCT02052154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812423|NCT02052167|Methotrexate|methotrexate|mesh-list
24658574|NCT01272609|Adrenergic Agents|adrenergic agents|mesh-ancestor
24592866|NCT00925912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24592867|NCT00925912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592891|NCT00926055|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
24592922|NCT00926341|Telmisartan|telmisartan|mesh-list
24592923|NCT00926341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24592924|NCT00926341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592925|NCT00926341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24592926|NCT00926341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24635544|NCT01140100|Thiopental|thiopental|mesh-list
24592927|NCT00926341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24592928|NCT00926341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592929|NCT00926354|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
24592951|NCT00926614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24592952|NCT00926614|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24592953|NCT00926614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592954|NCT00926614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24592955|NCT00926614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592956|NCT00926627|Bosentan|bosentan|mesh-list
24592957|NCT00926627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24592958|NCT00926627|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24592959|NCT00926627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592960|NCT00926640|Etoposide|etoposide|mesh-list
24592961|NCT00926640|Belinostat|belinostat|mesh-list
24592962|NCT00926640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24592963|NCT00926640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24592964|NCT00926640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24606062|NCT00988780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24606063|NCT00988780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592965|NCT00926640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24592966|NCT00926640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852621|NCT02263196|Ethanol|ethanol|mesh-list
24852622|NCT02263196|Povidone-Iodine|povidone-iodine|mesh-list
24852623|NCT02263196|Povidone|povidone|mesh-list
24852624|NCT02263196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24852625|NCT02263196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24852632|NCT02263248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24592967|NCT00926640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592968|NCT00926640|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24592969|NCT00926653|Citalopram|citalopram|mesh-list
24592970|NCT00926653|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24592971|NCT00926653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24592972|NCT00926653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25208392|NCT02549170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208393|NCT02509546|Adenosine|adenosine|mesh-list
25208394|NCT02509546|Analgesics|analgesics|mesh-ancestor
24488699|NCT00469768|Dapivirine|dapivirine|mesh-list
24488700|NCT00469768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24488701|NCT00469768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24592973|NCT00926653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593417|NCT00928837|Gout Suppressants|gout suppressants|mesh-ancestor
24592974|NCT00926653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24592975|NCT00926653|Serotonin Agents|serotonin agents|mesh-ancestor
24592976|NCT00926653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071993|NCT03404544|Oxytocics|oxytocics|mesh-ancestor
24592977|NCT00926653|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24592978|NCT00926653|Antidepressive Agents|antidepressive agents|mesh-ancestor
24592979|NCT00926653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24592980|NCT00926666|Levobupivacaine|levobupivacaine|mesh-list
24592981|NCT00926666|Anesthetics, Local|anesthetics, local|mesh-ancestor
24593010|NCT00926718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24593011|NCT00926718|Narcotics|narcotics|mesh-ancestor
24593012|NCT00926718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24593013|NCT00926718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593015|NCT00926718|Sensory System Agents|sensory system agents|mesh-ancestor
24593016|NCT00926718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24593017|NCT00926718|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24501831|NCT00531310|Fludarabine|fludarabine|mesh-list
24593018|NCT00926718|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24593019|NCT00926718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24593020|NCT00926731|Cytarabine|cytarabine|mesh-list
24593021|NCT00926731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24593022|NCT00926731|Antimetabolites|antimetabolites|mesh-ancestor
24593032|NCT00926757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24593033|NCT00926809|Amoxicillin|amoxicillin|mesh-list
25072048|NCT03403842|Sufentanil|sufentanil|mesh-list
25072049|NCT03403842|Morphine|morphine|mesh-list
25072050|NCT03403842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25072051|NCT03403842|Narcotics|narcotics|mesh-ancestor
25072052|NCT03403842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25072053|NCT03403842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072054|NCT03403842|Analgesics|analgesics|mesh-ancestor
25072055|NCT03403842|Sensory System Agents|sensory system agents|mesh-ancestor
25072056|NCT03403842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25072057|NCT03403842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25072058|NCT03403842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25072059|NCT03403842|Anesthetics, General|anesthetics, general|mesh-ancestor
25072060|NCT03403842|Anesthetics|anesthetics|mesh-ancestor
25072061|NCT03403829|Gemcitabine|gemcitabine|mesh-list
25072062|NCT03403829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25072075|NCT03403790|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25072076|NCT03403790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25072077|NCT03403790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25072078|NCT03403790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072079|NCT03403777|Avelumab|avelumab|mesh-list
25676401|NCT01797575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25676402|NCT01797575|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24593034|NCT00926809|Clarithromycin|clarithromycin|mesh-list
25676403|NCT01797575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25676404|NCT01797575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853433|NCT02268149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24853434|NCT02268149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24853435|NCT02268201|Tacrolimus|tacrolimus|mesh-list
24853437|NCT02268201|Immunologic Factors|immunologic factors|mesh-ancestor
24658690|NCT01273532|Tapentadol|tapentadol|mesh-list
24658691|NCT01273532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24658692|NCT01273532|Narcotics|narcotics|mesh-ancestor
24852640|NCT02263248|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24852641|NCT02263248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24852642|NCT02263248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24852643|NCT02263248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852644|NCT02263248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24852645|NCT02263248|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24852646|NCT02263248|Antidepressive Agents|antidepressive agents|mesh-ancestor
24852647|NCT02263248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24852648|NCT02263352|Carotenoids|carotenoids|mesh-list
24852649|NCT02263352|Antioxidants|antioxidants|mesh-ancestor
24852650|NCT02263352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658693|NCT01273532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24593035|NCT00926809|Lansoprazole|lansoprazole|mesh-list
24593036|NCT00926809|Dexlansoprazole|dexlansoprazole|mesh-list
24593037|NCT00926809|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24593038|NCT00926809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24593047|NCT00926835|Lamotrigine|lamotrigine|mesh-list
24593049|NCT00926835|Aripiprazole|aripiprazole|mesh-list
24593050|NCT00926835|Mirtazapine|mirtazapine|mesh-list
24593051|NCT00926835|Citalopram|citalopram|mesh-list
24593052|NCT00926835|Bupropion|bupropion|mesh-list
24593053|NCT00926835|Paroxetine|paroxetine|mesh-list
24593054|NCT00926835|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24593055|NCT00926835|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24593056|NCT00926835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24593057|NCT00926835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24593058|NCT00926835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593059|NCT00926835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24593060|NCT00926835|Serotonin Agents|serotonin agents|mesh-ancestor
24593061|NCT00926835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593062|NCT00926835|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24593063|NCT00926835|Antidepressive Agents|antidepressive agents|mesh-ancestor
24593064|NCT00926835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24593065|NCT00926835|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24593066|NCT00926835|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24593067|NCT00926835|Parasympatholytics|parasympatholytics|mesh-ancestor
25208395|NCT02509546|Sensory System Agents|sensory system agents|mesh-ancestor
25208396|NCT02509546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24488702|NCT00469768|Antiviral Agents|antiviral agents|mesh-ancestor
24488703|NCT00469768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24488704|NCT00469781|Bromfenac|bromfenac|mesh-list
24488705|NCT00469781|Prednisolone acetate|prednisolone acetate|mesh-list
24488706|NCT00469781|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24427541|NCT00238368|Cytarabine|cytarabine|mesh-list
24944012|NCT03965013|Insulin Glargine|insulin glargine|mesh-list
24593068|NCT00926835|Autonomic Agents|autonomic agents|mesh-ancestor
24593069|NCT00926835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24593070|NCT00926835|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24593096|NCT00926835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24593097|NCT00926835|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24593098|NCT00926835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24593099|NCT00926835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24593100|NCT00926835|Adrenergic Agents|adrenergic agents|mesh-ancestor
24852651|NCT02263352|Protective Agents|protective agents|mesh-ancestor
24852652|NCT02263352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593132|NCT00926965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24593133|NCT00926965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24593134|NCT00926965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24593135|NCT00926965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24593136|NCT00926965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676405|NCT01797575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25676406|NCT01797575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25676407|NCT01797575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676408|NCT01797575|Antipyretics|antipyretics|mesh-ancestor
24606417|NCT00990392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24606418|NCT00990405|Amoxicillin|amoxicillin|mesh-list
24606419|NCT00990405|Clarithromycin|clarithromycin|mesh-list
24606420|NCT00990405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24606421|NCT00990405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24606514|NCT00990795|Cyclosporine|cyclosporine|mesh-list
24593137|NCT00926965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24593139|NCT00926965|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24593140|NCT00926965|Dopamine Agents|dopamine agents|mesh-ancestor
24593141|NCT00926965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24593142|NCT00926965|Antidepressive Agents|antidepressive agents|mesh-ancestor
24593143|NCT00927004|Etoricoxib|etoricoxib|mesh-list
24593144|NCT00927004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24593145|NCT00927004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24593146|NCT00927004|Analgesics|analgesics|mesh-ancestor
24593147|NCT00927004|Sensory System Agents|sensory system agents|mesh-ancestor
24593148|NCT00927004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24593149|NCT00927004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593150|NCT00927004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24593151|NCT00927004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24593152|NCT00927004|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24593153|NCT00927004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24593186|NCT00927290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24593187|NCT00927290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593188|NCT00927407|Malathion|malathion|mesh-list
24593189|NCT00927407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24664176|NCT01305707|Dexetimide|dexetimide|mesh-list
24593192|NCT00927407|Cholinergic Agents|cholinergic agents|mesh-ancestor
24593231|NCT00927537|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24593232|NCT00927537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24593233|NCT00927537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593234|NCT00927537|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24593235|NCT00927537|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24593236|NCT00927550|Lithium Carbonate|lithium carbonate|mesh-list
24593237|NCT00927550|Antidepressive Agents|antidepressive agents|mesh-ancestor
24593238|NCT00927550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25072150|NCT03403023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25072151|NCT03403023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24593239|NCT00927550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593240|NCT00927550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593241|NCT00927550|Antimanic Agents|antimanic agents|mesh-ancestor
24593242|NCT00927550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24593243|NCT00927550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24593244|NCT00927550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593246|NCT00927602|Fondaparinux|fondaparinux|mesh-list
25208397|NCT02509546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208398|NCT02509546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25208399|NCT02509546|Vasodilator Agents|vasodilator agents|mesh-ancestor
25208400|NCT02509546|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25208401|NCT02509546|Purinergic Agonists|purinergic agonists|mesh-ancestor
25208402|NCT02509546|Purinergic Agents|purinergic agents|mesh-ancestor
25208403|NCT02509546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25208404|NCT02509546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857270|NCT02290431|Glucocorticoids|glucocorticoids|mesh-ancestor
24593247|NCT00927602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24593297|NCT00927771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593298|NCT00927771|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24593299|NCT00927797|Cyclophosphamide|cyclophosphamide|mesh-list
24593300|NCT00927797|Rituximab|rituximab|mesh-list
24593301|NCT00927797|Pentostatin|pentostatin|mesh-list
24593302|NCT00927797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24593303|NCT00927797|Immunologic Factors|immunologic factors|mesh-ancestor
24593304|NCT00927797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593305|NCT00927797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24593306|NCT00927797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24593307|NCT00927797|Alkylating Agents|alkylating agents|mesh-ancestor
25676409|NCT01797575|Antiviral Agents|antiviral agents|mesh-ancestor
25676410|NCT01797575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25676411|NCT01797575|Expectorants|expectorants|mesh-ancestor
25676412|NCT01797575|Respiratory System Agents|respiratory system agents|mesh-ancestor
25676413|NCT01797575|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25676414|NCT01797575|Antioxidants|antioxidants|mesh-ancestor
24606593|NCT00991159|Antimetabolites|antimetabolites|mesh-ancestor
25251377|NCT02514200|Vitamins|vitamins|mesh-ancestor
24593308|NCT00927797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593309|NCT00927797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24593334|NCT00927979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24593335|NCT00927979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593336|NCT00927979|Sensory System Agents|sensory system agents|mesh-ancestor
24593337|NCT00927979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24593339|NCT00928148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25072152|NCT03402984|Z 338|z 338|mesh-list
24953939|NCT03880487|Narcotics|narcotics|mesh-ancestor
24953940|NCT03880487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24953941|NCT03880487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953942|NCT03880487|Analgesics|analgesics|mesh-ancestor
24953943|NCT03880487|Sensory System Agents|sensory system agents|mesh-ancestor
24613090|NCT01016990|Valproic Acid|valproic acid|mesh-list
24593340|NCT00928148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593342|NCT00928148|Autonomic Agents|autonomic agents|mesh-ancestor
24593343|NCT00928148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24593344|NCT00928148|Dopamine Agents|dopamine agents|mesh-ancestor
24506146|NCT00544219|Rituximab|rituximab|mesh-list
24593345|NCT00928148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24593346|NCT00928148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593347|NCT00928148|Adrenergic Agents|adrenergic agents|mesh-ancestor
24593384|NCT00928525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24593385|NCT00928525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593386|NCT00928525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593387|NCT00928655|Acetazolamide|acetazolamide|mesh-list
24593388|NCT00928655|Anticonvulsants|anticonvulsants|mesh-ancestor
24593389|NCT00928655|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24593390|NCT00928655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593391|NCT00928655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593392|NCT00928655|Diuretics|diuretics|mesh-ancestor
24593393|NCT00928655|Natriuretic Agents|natriuretic agents|mesh-ancestor
24593394|NCT00928655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593395|NCT00928798|Sirolimus|sirolimus|mesh-list
24593405|NCT00928811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24593406|NCT00928811|Immunologic Factors|immunologic factors|mesh-ancestor
24593407|NCT00928811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593408|NCT00928837|Naproxen|naproxen|mesh-list
24593409|NCT00928837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24593411|NCT00928837|Analgesics|analgesics|mesh-ancestor
24593412|NCT00928837|Sensory System Agents|sensory system agents|mesh-ancestor
24593413|NCT00928837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24593414|NCT00928837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593415|NCT00928837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24593416|NCT00928837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24593418|NCT00928837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24593420|NCT00928837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593421|NCT00928876|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24593422|NCT00928876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24593423|NCT00928915|Thrombin|thrombin|mesh-list
24593424|NCT00928915|Hemostatics|hemostatics|mesh-ancestor
24593425|NCT00928915|Coagulants|coagulants|mesh-ancestor
24593426|NCT00928967|Interferons|interferons|mesh-list
24593427|NCT00928967|Interferon-beta|interferon-beta|mesh-list
24593428|NCT00928967|Interferon beta-1b|interferon beta-1b|mesh-list
24593429|NCT00928967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24593430|NCT00928967|Antiviral Agents|antiviral agents|mesh-ancestor
24593431|NCT00928967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25208405|NCT02496676|Magnesium Sulfate|magnesium sulfate|mesh-list
25208406|NCT02496676|Analgesics|analgesics|mesh-ancestor
24488845|NCT00470249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488881|NCT00470405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488882|NCT00470405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24488883|NCT00470405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24488913|NCT00470522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24488914|NCT00470522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24488915|NCT00470522|Immunologic Factors|immunologic factors|mesh-ancestor
24488916|NCT00470522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25676415|NCT01797575|Protective Agents|protective agents|mesh-ancestor
25676416|NCT01797575|Antidotes|antidotes|mesh-ancestor
25676417|NCT01797822|Dexamethasone|dexamethasone|mesh-list
25676418|NCT01797822|Lubricant Eye Drops|lubricant eye drops|mesh-list
25676419|NCT01797822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24606818|NCT05408065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24606819|NCT05408065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606820|NCT05408065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24488917|NCT00470522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24488918|NCT00470522|Hematinics|hematinics|mesh-ancestor
24488919|NCT00470522|Vitamin B Complex|vitamin b complex|mesh-ancestor
24488920|NCT00470522|Vitamins|vitamins|mesh-ancestor
24488921|NCT00470522|Micronutrients|micronutrients|mesh-ancestor
24944014|NCT03965013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944015|NCT03965195|Vaccines|vaccines|mesh-list
24944016|NCT03965195|Immunologic Factors|immunologic factors|mesh-ancestor
24944017|NCT03965195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944018|NCT03964753|Paclitaxel|paclitaxel|mesh-list
24944019|NCT03964753|Cisplatin|cisplatin|mesh-list
24743052|NCT05022901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24743083|NCT05013229|Insulin|insulin|mesh-list
24593432|NCT00928967|Immunologic Factors|immunologic factors|mesh-ancestor
24593433|NCT00928967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593434|NCT00928967|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24593435|NCT00929045|Hormones|hormones|mesh-list
24593436|NCT00929045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24593437|NCT00929045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593438|NCT00929058|Bevacizumab|bevacizumab|mesh-list
24593465|NCT00929591|Alkylating Agents|alkylating agents|mesh-ancestor
24593466|NCT00929591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593467|NCT00929591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24852670|NCT02263638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24852671|NCT02263677|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24852672|NCT02263677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24664321|NCT01306097|Astringents|astringents|mesh-ancestor
24852684|NCT02263690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24852685|NCT02263690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593468|NCT00929591|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24593469|NCT00929591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24593470|NCT00929591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24593471|NCT00929591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24593472|NCT00929591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593473|NCT00929591|Antimetabolites|antimetabolites|mesh-ancestor
24593474|NCT00929591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24593475|NCT00929591|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24593476|NCT00929591|Hormone Antagonists|hormone antagonists|mesh-ancestor
24593477|NCT00929591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24593478|NCT00929591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24593532|NCT00929955|Antipruritics|antipruritics|mesh-ancestor
24593533|NCT00929955|Dermatologic Agents|dermatologic agents|mesh-ancestor
25208407|NCT02496676|Sensory System Agents|sensory system agents|mesh-ancestor
25208408|NCT02496676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25208409|NCT02496676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208410|NCT02496676|Anesthetics|anesthetics|mesh-ancestor
25208411|NCT02496676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25208412|NCT02496676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25208413|NCT02496676|Anticonvulsants|anticonvulsants|mesh-ancestor
25208414|NCT02496676|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25208415|NCT02496676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25208416|NCT02496676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208417|NCT02496676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25208418|NCT02496676|Tocolytic Agents|tocolytic agents|mesh-ancestor
25208419|NCT02496676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25208420|NCT02494141|Curcumin|curcumin|mesh-list
25208421|NCT02494141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25208422|NCT02494141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25208423|NCT02494141|Analgesics|analgesics|mesh-ancestor
25208424|NCT02494141|Sensory System Agents|sensory system agents|mesh-ancestor
25208425|NCT02494141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25208426|NCT02494141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208427|NCT02494141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24488923|NCT00470561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24488924|NCT00470561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25072202|NCT03402295|Bortezomib|bortezomib|mesh-list
25072203|NCT03402295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25676420|NCT01797822|Antiemetics|antiemetics|mesh-ancestor
25676421|NCT01797822|Autonomic Agents|autonomic agents|mesh-ancestor
25676422|NCT01797822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25676423|NCT01797822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853493|NCT02268565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24606969|NCT05398731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251458|NCT02513693|Autonomic Agents|autonomic agents|mesh-ancestor
25251459|NCT02513433|Bupivacaine|bupivacaine|mesh-list
25251460|NCT02513433|Ropivacaine|ropivacaine|mesh-list
25251461|NCT02513433|Levobupivacaine|levobupivacaine|mesh-list
25251462|NCT02513433|Anesthetics, Local|anesthetics, local|mesh-ancestor
25251463|NCT02513433|Anesthetics|anesthetics|mesh-ancestor
25084368|NCT03307746|Rituximab|rituximab|mesh-list
25251464|NCT02513433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25251465|NCT02513433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593534|NCT00929955|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24593535|NCT00929955|Serotonin Agents|serotonin agents|mesh-ancestor
24593536|NCT00929955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24593537|NCT00929955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24593538|NCT00929955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24593539|NCT00929955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24593540|NCT00929955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24593541|NCT00929955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24593543|NCT00930020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24593544|NCT00930020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24593545|NCT00930033|Sunitinib|sunitinib|mesh-list
24593546|NCT00930033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24593547|NCT00930033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24593555|NCT00930072|Clonidine|clonidine|mesh-list
24593559|NCT00930072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24593560|NCT00930072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593561|NCT00930072|Sensory System Agents|sensory system agents|mesh-ancestor
24593562|NCT00930072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24593563|NCT00930072|Analgesics|analgesics|mesh-ancestor
24593564|NCT00930072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24593591|NCT00930202|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24593592|NCT00930202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593593|NCT00930202|Natriuretic Agents|natriuretic agents|mesh-ancestor
24593594|NCT00930202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593595|NCT00930241|Tacrolimus|tacrolimus|mesh-list
24593596|NCT00930241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24593597|NCT00930241|Immunologic Factors|immunologic factors|mesh-ancestor
24593598|NCT00930241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593599|NCT00930241|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24593600|NCT00930241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593601|NCT00930241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593602|NCT00930306|Tolbutamide|tolbutamide|mesh-list
24593603|NCT00930306|Midazolam|midazolam|mesh-list
24593604|NCT00930306|Caffeine|caffeine|mesh-list
25072204|NCT03402295|Immunologic Factors|immunologic factors|mesh-ancestor
25072205|NCT03402295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072206|NCT03402295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24700624|NCT01453738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24700626|NCT01453881|Formoterol Fumarate|formoterol fumarate|mesh-list
24700627|NCT01453881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24700628|NCT01453881|Autonomic Agents|autonomic agents|mesh-ancestor
24700629|NCT01453881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24700630|NCT01453881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593605|NCT00930306|Omeprazole|omeprazole|mesh-list
24593606|NCT00930306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24593607|NCT00930306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24593661|NCT00930488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24852701|NCT02263924|Protective Agents|protective agents|mesh-ancestor
24852702|NCT02263924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852703|NCT02263924|Vitamins|vitamins|mesh-ancestor
24852704|NCT02263924|Micronutrients|micronutrients|mesh-ancestor
24852705|NCT02263950|Artemether|artemether|mesh-list
24852706|NCT02263950|Antimalarials|antimalarials|mesh-ancestor
24852707|NCT02263950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25676424|NCT01797822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25676425|NCT01797822|Glucocorticoids|glucocorticoids|mesh-ancestor
25676426|NCT01797822|Hormones|hormones|mesh-ancestor
25676427|NCT01797822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25676428|NCT01797822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25676429|NCT01797822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25676430|NCT01797822|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25676431|NCT01797822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25676432|NCT01797965|Daclizumab|daclizumab|mesh-list
25676433|NCT01797965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24852708|NCT02263950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24852709|NCT02263950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24593662|NCT00930488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24593679|NCT00930514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593680|NCT00930514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24593682|NCT00930566|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24593683|NCT00930566|Dermatologic Agents|dermatologic agents|mesh-ancestor
24593684|NCT00930579|Metformin|metformin|mesh-list
24593685|NCT00930579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24593686|NCT00930579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593687|NCT00930605|Alemtuzumab|alemtuzumab|mesh-list
24593688|NCT00930605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24593689|NCT00930605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24593690|NCT00930670|Esomeprazole|esomeprazole|mesh-list
24593691|NCT00930670|Omeprazole|omeprazole|mesh-list
24593692|NCT00930670|Pantoprazole|pantoprazole|mesh-list
24593693|NCT00930670|Ranitidine|ranitidine|mesh-list
24593694|NCT00930670|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
24593695|NCT00930670|Atorvastatin|atorvastatin|mesh-list
24593696|NCT00930670|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24593697|NCT00930670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24593698|NCT00930670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24593699|NCT00930670|Antimetabolites|antimetabolites|mesh-ancestor
24593700|NCT00930670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593703|NCT00930670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593704|NCT00930670|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25208428|NCT02494141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25208429|NCT02494141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208430|NCT02494141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488926|NCT00470561|Sensory System Agents|sensory system agents|mesh-ancestor
24593705|NCT00930670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24593706|NCT00930670|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24593707|NCT00930670|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24593708|NCT00930670|Histamine Antagonists|histamine antagonists|mesh-ancestor
24593709|NCT00930670|Histamine Agents|histamine agents|mesh-ancestor
24593710|NCT00930670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24593711|NCT00930670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700637|NCT01453881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24700638|NCT01453881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700639|NCT01453881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24700640|NCT01453881|Glucocorticoids|glucocorticoids|mesh-ancestor
24700641|NCT01453881|Hormones|hormones|mesh-ancestor
25072255|NCT03402165|Sofosbuvir|sofosbuvir|mesh-list
24593712|NCT00930683|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24593713|NCT00930683|Immunologic Factors|immunologic factors|mesh-ancestor
24593741|NCT00930839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24593742|NCT00930839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24593743|NCT00930839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24593744|NCT00930839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24593745|NCT00930839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593746|NCT00930839|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24593747|NCT00930839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24593748|NCT00930839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593750|NCT00930839|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24593751|NCT00930839|Antimetabolites|antimetabolites|mesh-ancestor
24593752|NCT00930839|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24593753|NCT00930839|Vasodilator Agents|vasodilator agents|mesh-ancestor
24852714|NCT02263976|Autonomic Agents|autonomic agents|mesh-ancestor
24852715|NCT02263976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24852716|NCT02263976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852717|NCT02263976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24852718|NCT02263976|Respiratory System Agents|respiratory system agents|mesh-ancestor
24659140|NCT01275885|Vitamins|vitamins|mesh-ancestor
24593761|NCT00930865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24593762|NCT00930865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593771|NCT00930891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24593772|NCT00930891|Growth Substances|growth substances|mesh-ancestor
24593773|NCT00930891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593774|NCT00930891|Growth Inhibitors|growth inhibitors|mesh-ancestor
24593775|NCT00930943|Oxymorphone|oxymorphone|mesh-list
24593776|NCT00930943|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24593777|NCT00930943|Narcotics|narcotics|mesh-ancestor
24593778|NCT00930943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24593779|NCT00930943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593780|NCT00930943|Analgesics|analgesics|mesh-ancestor
24593781|NCT00930943|Sensory System Agents|sensory system agents|mesh-ancestor
24593782|NCT00930943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24593783|NCT00930943|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24593784|NCT00930995|Candesartan|candesartan|mesh-list
24593785|NCT00930995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24593786|NCT00930995|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24593787|NCT00930995|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24593788|NCT00930995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593789|NCT00931008|Docetaxel|docetaxel|mesh-list
24593790|NCT00931008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24593791|NCT00931008|Tubulin Modulators|tubulin modulators|mesh-ancestor
24593792|NCT00931008|Antimitotic Agents|antimitotic agents|mesh-ancestor
24593793|NCT00931008|Mitosis Modulators|mitosis modulators|mesh-ancestor
24593794|NCT00931008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593795|NCT00931021|Nicotine|nicotine|mesh-list
24593796|NCT00931021|Varenicline|varenicline|mesh-list
24593797|NCT00931021|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24593798|NCT00931021|Autonomic Agents|autonomic agents|mesh-ancestor
24593799|NCT00931021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24593800|NCT00931021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593801|NCT00931021|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24593802|NCT00931021|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25208431|NCT02494141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208432|NCT02478099|Atezolizumab|atezolizumab|mesh-list
25208433|NCT02478099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208434|NCT02462538|Imatinib Mesylate|imatinib mesylate|mesh-list
24488989|NCT00470912|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24593811|NCT00931073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593812|NCT00931073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593814|NCT00931073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24593815|NCT00931073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24593816|NCT00931073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24593836|NCT00931138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24593837|NCT00931138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24593838|NCT00931138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24593839|NCT00931138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852719|NCT02263976|Parasympatholytics|parasympatholytics|mesh-ancestor
24852721|NCT02263976|Cholinergic Agents|cholinergic agents|mesh-ancestor
24852722|NCT02263976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24852723|NCT02263976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852725|NCT02263976|Miotics|miotics|mesh-ancestor
24852726|NCT02263976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24852727|NCT02263976|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
24852728|NCT02263976|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24593841|NCT00931138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24593842|NCT00931138|Antimetabolites|antimetabolites|mesh-ancestor
24635696|NCT01140932|Prednisolone|prednisolone|mesh-list
24593843|NCT00931138|Antiviral Agents|antiviral agents|mesh-ancestor
24593844|NCT00931138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24593845|NCT00931138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24593846|NCT00931138|Immunologic Factors|immunologic factors|mesh-ancestor
24593847|NCT00931138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593848|NCT00931203|Celecoxib|celecoxib|mesh-list
24593849|NCT00931203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24593850|NCT00931203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24593851|NCT00931203|Analgesics|analgesics|mesh-ancestor
24593852|NCT00931203|Sensory System Agents|sensory system agents|mesh-ancestor
24593853|NCT00931203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24593854|NCT00931203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593855|NCT00931203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24593856|NCT00931203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24593857|NCT00931203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24593858|NCT00931203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24593859|NCT00931203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593860|NCT00931203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593861|NCT00931229|Entecavir|entecavir|mesh-list
24593862|NCT00931229|Antiviral Agents|antiviral agents|mesh-ancestor
24593863|NCT00931229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24593864|NCT00931281|Ritonavir|ritonavir|mesh-list
24593881|NCT00931398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593882|NCT00931398|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25676434|NCT01797965|Immunologic Factors|immunologic factors|mesh-ancestor
24593883|NCT00931398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24593884|NCT00931398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24593885|NCT00931398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593887|NCT00931398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24852737|NCT02264002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24852738|NCT02264002|Sympatholytics|sympatholytics|mesh-ancestor
24852752|NCT02264015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24852753|NCT02264015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852754|NCT02264015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852755|NCT02264015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24852756|NCT02264028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24593889|NCT00931437|Vitamins|vitamins|mesh-ancestor
24593890|NCT00931437|Micronutrients|micronutrients|mesh-ancestor
24593891|NCT00931437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593892|NCT00931437|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24593893|NCT00931437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24593894|NCT00931437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593895|NCT00931437|Hemostatics|hemostatics|mesh-ancestor
24593896|NCT00931437|Coagulants|coagulants|mesh-ancestor
24593897|NCT00931450|Sunitinib|sunitinib|mesh-list
24593898|NCT00931450|Exemestane|exemestane|mesh-list
24593899|NCT00931450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208435|NCT02462538|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24488990|NCT00470912|Protective Agents|protective agents|mesh-ancestor
24613192|NCT01017666|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
24613193|NCT01017666|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24613210|NCT01017770|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24613211|NCT01017770|Amodiaquine|amodiaquine|mesh-list
24613212|NCT01017770|Antimalarials|antimalarials|mesh-ancestor
24593901|NCT00931450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24593902|NCT00931450|Growth Substances|growth substances|mesh-ancestor
24593903|NCT00931450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593904|NCT00931450|Growth Inhibitors|growth inhibitors|mesh-ancestor
24593905|NCT00931450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24593906|NCT00931450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593907|NCT00931450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593908|NCT00931450|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24593909|NCT00931450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24593910|NCT00931450|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24593911|NCT00931450|Hormone Antagonists|hormone antagonists|mesh-ancestor
24593912|NCT00931450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24593913|NCT00931580|Vitamin D|vitamin d|mesh-list
24593914|NCT00931580|Cholecalciferol|cholecalciferol|mesh-list
24593915|NCT00931580|Vitamins|vitamins|mesh-ancestor
24593916|NCT00931580|Micronutrients|micronutrients|mesh-ancestor
24593917|NCT00931580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593918|NCT00931580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24664666|NCT01308229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24852762|NCT02264041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852763|NCT02264041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852764|NCT02264041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24613213|NCT01017770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24852765|NCT02264041|Hormone Antagonists|hormone antagonists|mesh-ancestor
24852766|NCT02264041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24593922|NCT00931645|Cyclophosphamide|cyclophosphamide|mesh-list
24593923|NCT00931645|Cisplatin|cisplatin|mesh-list
24593939|NCT00931645|Glucocorticoids|glucocorticoids|mesh-ancestor
24593940|NCT00931645|Hormones|hormones|mesh-ancestor
24593990|NCT00931827|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24593991|NCT00931827|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24635724|NCT01140984|Methylprednisolone|methylprednisolone|mesh-list
24635725|NCT01140984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24852767|NCT02264041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593998|NCT00931840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594000|NCT00931840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24594001|NCT00931866|Diclofenac|diclofenac|mesh-list
24594002|NCT00931866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24594003|NCT00931866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24594005|NCT00931866|Sensory System Agents|sensory system agents|mesh-ancestor
24594006|NCT00931866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24594007|NCT00931866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208436|NCT02462538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208437|NCT02462538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24488991|NCT00470912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488992|NCT00470912|Dermatologic Agents|dermatologic agents|mesh-ancestor
24488993|NCT00470977|Ranibizumab|ranibizumab|mesh-list
25045570|NCT00944294|Analgesics|analgesics|mesh-ancestor
24594008|NCT00931866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24594009|NCT00931866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24594010|NCT00931866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24594011|NCT00931866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594012|NCT00931866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594013|NCT00931957|Prednisolone|prednisolone|mesh-list
24594014|NCT00931957|Etanercept|etanercept|mesh-list
24594015|NCT00931957|Methotrexate|methotrexate|mesh-list
24594016|NCT00931957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24594017|NCT00931957|Abortifacient Agents|abortifacient agents|mesh-ancestor
24594018|NCT00931957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24594019|NCT00931957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594020|NCT00931957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24594021|NCT00931957|Antimetabolites|antimetabolites|mesh-ancestor
24594022|NCT00931957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594023|NCT00931957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24594024|NCT00931957|Dermatologic Agents|dermatologic agents|mesh-ancestor
24594025|NCT00931957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594026|NCT00931957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24664752|NCT01308541|Propofol|propofol|mesh-list
24594083|NCT00932529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24594084|NCT00932529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594085|NCT00932529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594086|NCT00932529|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24594087|NCT00932529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24594088|NCT00932529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24594089|NCT00932529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24594090|NCT00932529|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24594091|NCT00932529|Dopamine Agents|dopamine agents|mesh-ancestor
24594092|NCT00932529|Antiemetics|antiemetics|mesh-ancestor
24594093|NCT00932529|Autonomic Agents|autonomic agents|mesh-ancestor
24594094|NCT00932529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24594095|NCT00932529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24594096|NCT00932529|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24594097|NCT00932529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24594098|NCT00932529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24594099|NCT00932529|Antidepressive Agents|antidepressive agents|mesh-ancestor
24594100|NCT00932542|Lidocaine|lidocaine|mesh-list
24594101|NCT00932542|Prilocaine|prilocaine|mesh-list
24594102|NCT00932542|Anesthetics, Local|anesthetics, local|mesh-ancestor
24594103|NCT00932542|Anesthetics|anesthetics|mesh-ancestor
24594104|NCT00932542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24594105|NCT00932542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594106|NCT00932542|Sensory System Agents|sensory system agents|mesh-ancestor
24594107|NCT00932542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24502468|NCT05061654|Renal Agents|renal agents|mesh-ancestor
25676435|NCT01797965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676436|NCT01798056|Vaccines|vaccines|mesh-list
25676437|NCT01798056|Immunologic Factors|immunologic factors|mesh-ancestor
25676438|NCT01798056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676439|NCT01798225|Doxycycline|doxycycline|mesh-list
25676440|NCT01798225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25676441|NCT01798225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25676442|NCT01798225|Antimalarials|antimalarials|mesh-ancestor
24594108|NCT00932542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24594109|NCT00932542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24594110|NCT00932542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24594111|NCT00932542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24635757|NCT01141036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24594112|NCT00932542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594113|NCT00932555|Factor VIII|factor viii|mesh-list
24852768|NCT02264041|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24852769|NCT02264093|Propranolol|propranolol|mesh-list
25208438|NCT02462538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208439|NCT02462538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208440|NCT02462538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25208441|NCT02453984|Atezolizumab|atezolizumab|mesh-list
24488994|NCT00470977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24852770|NCT02264093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24852771|NCT02264093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24594138|NCT00932802|Moxifloxacin|moxifloxacin|mesh-list
24594139|NCT00932802|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24594140|NCT00932802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24594141|NCT00932802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24594142|NCT00932802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24594143|NCT00932802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24594144|NCT00932802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594145|NCT00932802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594146|NCT00932802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24594147|NCT00932802|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24594148|NCT00932802|Contraceptive Agents|contraceptive agents|mesh-ancestor
24594177|NCT00932971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594178|NCT00932971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24594179|NCT00932971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24594180|NCT00932971|Immunologic Factors|immunologic factors|mesh-ancestor
24594181|NCT00932971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594182|NCT00932971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24594184|NCT00933023|Betamethasone|betamethasone|mesh-list
24594185|NCT00933023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24594186|NCT00933023|Glucocorticoids|glucocorticoids|mesh-ancestor
24594188|NCT00933023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24594189|NCT00933023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594190|NCT00933023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24594191|NCT00933023|Respiratory System Agents|respiratory system agents|mesh-ancestor
24594192|NCT00933049|Amoxicillin|amoxicillin|mesh-list
24594193|NCT00933049|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24594194|NCT00933049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24594195|NCT00933049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24594196|NCT00933049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24594197|NCT00933049|Renal Agents|renal agents|mesh-ancestor
24594198|NCT00933049|Antimalarials|antimalarials|mesh-ancestor
24594199|NCT00933049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24594200|NCT00933049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24594201|NCT00933179|Levonorgestrel|levonorgestrel|mesh-list
24594224|NCT00933205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24594225|NCT00933231|Mycophenolic Acid|mycophenolic acid|mesh-list
24594226|NCT00933231|Prednisone|prednisone|mesh-list
24594227|NCT00933231|Methylprednisolone|methylprednisolone|mesh-list
24594228|NCT00933231|Ramipril|ramipril|mesh-list
24594229|NCT00933231|Irbesartan|irbesartan|mesh-list
24594230|NCT00933231|Tacrolimus|tacrolimus|mesh-list
24594231|NCT00933231|Basiliximab|basiliximab|mesh-list
24594232|NCT00933231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24594233|NCT00933231|Glucocorticoids|glucocorticoids|mesh-ancestor
24594234|NCT00933231|Hormones|hormones|mesh-ancestor
24594235|NCT00933231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24594236|NCT00933231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676443|NCT01798225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25676444|NCT01798225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25676445|NCT01798264|Exenatide|exenatide|mesh-list
25676446|NCT01798264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25676447|NCT01798264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676448|NCT01798264|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24631464|NCT01118286|Vasodilator Agents|vasodilator agents|mesh-ancestor
24594237|NCT00933231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24594238|NCT00933231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24594239|NCT00933231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24594240|NCT00933231|Immunologic Factors|immunologic factors|mesh-ancestor
24594241|NCT00933231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24594242|NCT00933231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594243|NCT00933231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594309|NCT00933426|Mitosis Modulators|mitosis modulators|mesh-ancestor
24594310|NCT00933426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852774|NCT02264093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852775|NCT02264093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594311|NCT00933426|Immunologic Factors|immunologic factors|mesh-ancestor
24594312|NCT00933426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635805|NCT01141244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24594313|NCT00933426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24594314|NCT00933426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24594315|NCT00933426|Growth Substances|growth substances|mesh-ancestor
24594316|NCT00933426|Growth Inhibitors|growth inhibitors|mesh-ancestor
24594321|NCT00933439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594349|NCT00933517|Epirubicin|epirubicin|mesh-list
25208442|NCT02453984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208443|NCT02412618|Misoprostol|misoprostol|mesh-list
24523360|NCT01721746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24594350|NCT00933517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24594351|NCT00933517|Immunologic Factors|immunologic factors|mesh-ancestor
24594352|NCT00933517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594353|NCT00933517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24594354|NCT00933517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24594355|NCT00933517|Alkylating Agents|alkylating agents|mesh-ancestor
24594356|NCT00933517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953956|NCT03880357|Hormones|hormones|mesh-ancestor
24594357|NCT00933517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24594358|NCT00933517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24594359|NCT00933517|Tubulin Modulators|tubulin modulators|mesh-ancestor
24594360|NCT00933517|Antimitotic Agents|antimitotic agents|mesh-ancestor
24594361|NCT00933517|Mitosis Modulators|mitosis modulators|mesh-ancestor
24594362|NCT00933517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24594363|NCT00933517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24594364|NCT00933517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24594365|NCT00933517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24594366|NCT00933517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594367|NCT00933582|Naproxen|naproxen|mesh-list
24594382|NCT00933634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24594383|NCT00933634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24594384|NCT00933634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24594385|NCT00933634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594387|NCT00933777|Sorafenib|sorafenib|mesh-list
24594388|NCT00933777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24594389|NCT00933777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24594390|NCT00933777|Immunologic Factors|immunologic factors|mesh-ancestor
24594391|NCT00933777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594392|NCT00933777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24594393|NCT00933777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594394|NCT00933777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594395|NCT00933790|Rifampin|rifampin|mesh-list
24594396|NCT00933790|Pyrazinamide|pyrazinamide|mesh-list
24594397|NCT00933790|Ethambutol|ethambutol|mesh-list
24594398|NCT00933790|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24594399|NCT00933790|Antitubercular Agents|antitubercular agents|mesh-ancestor
24594400|NCT00933790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25676449|NCT01798264|Incretins|incretins|mesh-ancestor
25676450|NCT01798264|Hormones|hormones|mesh-ancestor
25676451|NCT01798264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25676452|NCT01798316|Acetaminophen|acetaminophen|mesh-list
25676453|NCT01798316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24594401|NCT00933790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24594402|NCT00933790|Leprostatic Agents|leprostatic agents|mesh-ancestor
24594403|NCT00933790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24594404|NCT00933790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594405|NCT00933790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594406|NCT00933790|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24594412|NCT00933816|Fluorouracil|fluorouracil|mesh-list
24594440|NCT00933985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24594441|NCT00933985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24594442|NCT00933985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24594443|NCT00933985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24594444|NCT00933985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594445|NCT00933985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594451|NCT00933985|Protective Agents|protective agents|mesh-ancestor
25208444|NCT02412618|Mifepristone|mifepristone|mesh-list
25208445|NCT02412618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25208446|NCT02412618|Abortifacient Agents|abortifacient agents|mesh-ancestor
25208447|NCT02412618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25208448|NCT02412618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208449|NCT02412618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25208450|NCT02412618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25208451|NCT02412618|Oxytocics|oxytocics|mesh-ancestor
24523362|NCT01721746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25072370|NCT03401736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25072371|NCT03401736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25072372|NCT03401736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072373|NCT03401736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25072374|NCT03401736|Analgesics|analgesics|mesh-ancestor
25072375|NCT03401736|Sensory System Agents|sensory system agents|mesh-ancestor
25072376|NCT03401736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25072377|NCT03401736|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24594452|NCT00933985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594455|NCT00933998|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
24594460|NCT00934011|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24594461|NCT00934011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24594462|NCT00934011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24594463|NCT00934011|Antitubercular Agents|antitubercular agents|mesh-ancestor
24594464|NCT00934076|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24594465|NCT00934076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24594466|NCT00934076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24594467|NCT00934076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594468|NCT00934076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594469|NCT00934154|Thalidomide|thalidomide|mesh-list
24594470|NCT00934154|Prednisolone|prednisolone|mesh-list
24594472|NCT00934154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24594473|NCT00934154|Alkylating Agents|alkylating agents|mesh-ancestor
24594474|NCT00934154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594475|NCT00934154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24594476|NCT00934154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24594477|NCT00934154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24594478|NCT00934154|Immunologic Factors|immunologic factors|mesh-ancestor
24594479|NCT00934154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594480|NCT00934154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24594497|NCT00934167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072378|NCT03401736|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25072379|NCT03401736|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25072380|NCT03401736|Adrenergic Agents|adrenergic agents|mesh-ancestor
25072381|NCT03401736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25072382|NCT03401736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072383|NCT03401736|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25072384|NCT03401736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25072385|NCT03401736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25072386|NCT03401736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25072387|NCT03401736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25072388|NCT03401736|Anesthetics, General|anesthetics, general|mesh-ancestor
25072392|NCT03401619|Vitamin D|vitamin d|mesh-list
24594498|NCT00934193|Gabapentin|gabapentin|mesh-list
24594499|NCT00934193|Analgesics|analgesics|mesh-ancestor
24594500|NCT00934193|Sensory System Agents|sensory system agents|mesh-ancestor
24594501|NCT00934193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24594502|NCT00934193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594503|NCT00934193|Anticonvulsants|anticonvulsants|mesh-ancestor
24594504|NCT00934193|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24594505|NCT00934193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24594507|NCT00934193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24594508|NCT00934193|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24594509|NCT00934193|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24594510|NCT00934193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24594512|NCT00934193|Antimanic Agents|antimanic agents|mesh-ancestor
24594532|NCT00934258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24594546|NCT00934466|Dextromethorphan|dextromethorphan|mesh-list
24594547|NCT00934466|Antitussive Agents|antitussive agents|mesh-ancestor
24594548|NCT00934466|Respiratory System Agents|respiratory system agents|mesh-ancestor
24594549|NCT00934466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24594550|NCT00934466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24594551|NCT00934466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24594552|NCT00934466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594553|NCT00934466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594554|NCT00934479|Lubiprostone|lubiprostone|mesh-list
24594555|NCT00934479|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24594556|NCT00934479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24594557|NCT00934479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594558|NCT00934492|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24594559|NCT00934492|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24594611|NCT00934739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594613|NCT00934739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24594614|NCT00934739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24594615|NCT00934739|Antiemetics|antiemetics|mesh-ancestor
24594616|NCT00934739|Autonomic Agents|autonomic agents|mesh-ancestor
24594617|NCT00934739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24594618|NCT00934739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24594619|NCT00934739|Glucocorticoids|glucocorticoids|mesh-ancestor
24594620|NCT00934739|Hormones|hormones|mesh-ancestor
25208452|NCT02412618|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25208453|NCT02412618|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24489091|NCT00471419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489093|NCT00471432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489132|NCT00471523|Hormone Antagonists|hormone antagonists|mesh-ancestor
24489133|NCT00471523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24594621|NCT00934739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24594622|NCT00934739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24594623|NCT00934739|Leprostatic Agents|leprostatic agents|mesh-ancestor
24594624|NCT00934739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24594692|NCT00935246|Citalopram|citalopram|mesh-list
24594693|NCT00935246|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24594694|NCT00935246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24594695|NCT00935246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24594696|NCT00935246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594697|NCT00935246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24594698|NCT00935246|Serotonin Agents|serotonin agents|mesh-ancestor
24594699|NCT00935246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594700|NCT00935246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24594701|NCT00935246|Antidepressive Agents|antidepressive agents|mesh-ancestor
24594702|NCT00935246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24594703|NCT00935246|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24594704|NCT00935246|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24594705|NCT00935246|Parasympatholytics|parasympatholytics|mesh-ancestor
24594706|NCT00935246|Autonomic Agents|autonomic agents|mesh-ancestor
24594707|NCT00935246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24594708|NCT00935246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24594709|NCT00935246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24594710|NCT00935246|Cholinergic Agents|cholinergic agents|mesh-ancestor
24594718|NCT00935363|Glyburide|glyburide|mesh-list
24594719|NCT00935363|Rifampin|rifampin|mesh-list
24594720|NCT00935363|Fluconazole|fluconazole|mesh-list
24594721|NCT00935363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24594722|NCT00935363|Antitubercular Agents|antitubercular agents|mesh-ancestor
24594723|NCT00935363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24594724|NCT00935363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24594725|NCT00935363|Leprostatic Agents|leprostatic agents|mesh-ancestor
24594726|NCT00935363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25676454|NCT01798316|Analgesics|analgesics|mesh-ancestor
24594741|NCT00935363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594742|NCT00935363|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24594743|NCT00935363|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24594761|NCT00935467|Protease Inhibitors|protease inhibitors|mesh-ancestor
24594774|NCT00935506|Aspirin|aspirin|mesh-list
24594801|NCT00935558|Exemestane|exemestane|mesh-list
24594802|NCT00935558|Anastrozole|anastrozole|mesh-list
24594803|NCT00935558|Letrozole|letrozole|mesh-list
24594804|NCT00935558|Lactitol|lactitol|mesh-list
24594805|NCT00935558|Vaccines|vaccines|mesh-list
24594806|NCT00935558|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24594807|NCT00935558|Immunologic Factors|immunologic factors|mesh-ancestor
24594808|NCT00935558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594809|NCT00935558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24594810|NCT00935558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24594811|NCT00935558|Analgesics|analgesics|mesh-ancestor
24594812|NCT00935558|Sensory System Agents|sensory system agents|mesh-ancestor
24594813|NCT00935558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24594814|NCT00935558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24594815|NCT00935558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594816|NCT00935558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208454|NCT02412618|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25208455|NCT02412618|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25208456|NCT02412618|Contraceptive Agents|contraceptive agents|mesh-ancestor
24701413|NCT01458769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25208457|NCT02412618|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25208458|NCT02412618|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25208459|NCT02412618|Hormone Antagonists|hormone antagonists|mesh-ancestor
25208460|NCT02412618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25208461|NCT02412618|Luteolytic Agents|luteolytic agents|mesh-ancestor
25208462|NCT02412618|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25208463|NCT02412618|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24489171|NCT00471640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24594817|NCT00935558|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24594818|NCT00935558|Hormone Antagonists|hormone antagonists|mesh-ancestor
24594819|NCT00935558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24594820|NCT00935558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24594821|NCT00935558|Cathartics|cathartics|mesh-ancestor
24594822|NCT00935558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24594823|NCT00935571|Remifentanil|remifentanil|mesh-list
24594824|NCT00935571|Propofol|propofol|mesh-list
24594902|NCT00936091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594903|NCT00936143|Infliximab|infliximab|mesh-list
24594904|NCT00936143|Dermatologic Agents|dermatologic agents|mesh-ancestor
24594905|NCT00936143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24594906|NCT00936143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24594907|NCT00936156|Carboplatin|carboplatin|mesh-list
24594908|NCT00936156|Etoposide|etoposide|mesh-list
24594909|NCT00936156|Thiotepa|thiotepa|mesh-list
24594910|NCT00936156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24594911|NCT00936156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24594912|NCT00936156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24594913|NCT00936156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24594914|NCT00936156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852790|NCT02264119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852791|NCT02264132|Pramipexole|pramipexole|mesh-list
24852792|NCT02264132|Antioxidants|antioxidants|mesh-ancestor
25072469|NCT03401476|Analgesics|analgesics|mesh-ancestor
24852793|NCT02264132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594989|NCT00936390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24594990|NCT00936390|Contraceptive Agents|contraceptive agents|mesh-ancestor
24594991|NCT00936390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24594993|NCT00936429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24594994|NCT00936429|Immunologic Factors|immunologic factors|mesh-ancestor
24594995|NCT00936429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594997|NCT00936429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594998|NCT00936429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24594999|NCT00936442|Anastrozole|anastrozole|mesh-list
24595000|NCT00936442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24595001|NCT00936442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24595002|NCT00936442|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24595003|NCT00936442|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24595004|NCT00936442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595005|NCT00936442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595006|NCT00936442|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24595007|NCT00936442|Hormone Antagonists|hormone antagonists|mesh-ancestor
24595008|NCT00936442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24595009|NCT00936442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595010|NCT00936520|Lifitegrast|lifitegrast|mesh-list
24595011|NCT00936520|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24595012|NCT00936520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24595013|NCT00936533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24595014|NCT00936533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24595015|NCT00936533|Botulinum Toxins|botulinum toxins|mesh-list
24635880|NCT01141465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595016|NCT00936533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24595017|NCT00936533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24595018|NCT00936533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595035|NCT00936624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25208464|NCT02402660|Vitamin A|vitamin a|mesh-list
25208465|NCT02402660|Retinol acetate|retinol acetate|mesh-list
25208466|NCT02402660|Vitamins|vitamins|mesh-ancestor
25208467|NCT02402660|Micronutrients|micronutrients|mesh-ancestor
25208468|NCT02402660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208469|NCT02402660|Protective Agents|protective agents|mesh-ancestor
24523427|NCT00887536|Tubulin Modulators|tubulin modulators|mesh-ancestor
24595285|NCT00937807|Sevoflurane|sevoflurane|mesh-list
24595036|NCT00936624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595037|NCT00936624|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24595038|NCT00936624|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24595039|NCT00936624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595041|NCT00936650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24595042|NCT00936650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595043|NCT00936650|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24595044|NCT00936650|Hormone Antagonists|hormone antagonists|mesh-ancestor
24595045|NCT00936650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24595047|NCT00936676|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24595048|NCT00936676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671128|NCT01323712|Vitamins|vitamins|mesh-ancestor
24671129|NCT01323712|Micronutrients|micronutrients|mesh-ancestor
24671130|NCT01323712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671131|NCT01323712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24595049|NCT00936676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595050|NCT00936676|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24595060|NCT00936689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595061|NCT00936689|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24595062|NCT00936689|Estrogens|estrogens|mesh-ancestor
24595064|NCT00936689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24595065|NCT00936689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595066|NCT00936689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24595067|NCT00936767|Artesunate|artesunate|mesh-list
24595068|NCT00936767|Mefloquine|mefloquine|mesh-list
24595069|NCT00936767|Antimalarials|antimalarials|mesh-ancestor
24595070|NCT00936767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24595071|NCT00936767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24595075|NCT00936767|Schistosomicides|schistosomicides|mesh-ancestor
24595077|NCT00936767|Anthelmintics|anthelmintics|mesh-ancestor
24595078|NCT00936780|Paclitaxel|paclitaxel|mesh-list
24595079|NCT00936780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24595080|NCT00936780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24595081|NCT00936780|Tubulin Modulators|tubulin modulators|mesh-ancestor
24595082|NCT00936780|Antimitotic Agents|antimitotic agents|mesh-ancestor
24595083|NCT00936780|Mitosis Modulators|mitosis modulators|mesh-ancestor
24595084|NCT00936780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595086|NCT00936793|Darunavir|darunavir|mesh-list
24595087|NCT00936793|Beclomethasone|beclomethasone|mesh-list
24595088|NCT00936793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24595089|NCT00936793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24595090|NCT00936793|Protease Inhibitors|protease inhibitors|mesh-ancestor
24595091|NCT00936793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595092|NCT00936793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595093|NCT00936793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24595094|NCT00936793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24595095|NCT00936793|Antiviral Agents|antiviral agents|mesh-ancestor
25208470|NCT02402660|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25208471|NCT02402660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208472|NCT02402660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24595096|NCT00936793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24595190|NCT00937144|Urological Agents|urological agents|mesh-ancestor
24595191|NCT00937183|Vaccines|vaccines|mesh-list
24595192|NCT00937183|Immunologic Factors|immunologic factors|mesh-ancestor
24595193|NCT00937183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595194|NCT00937261|Risperidone|risperidone|mesh-list
24595195|NCT00937261|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24595196|NCT00937261|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24595197|NCT00937261|Serotonin Agents|serotonin agents|mesh-ancestor
24595198|NCT00937261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24595199|NCT00937261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595200|NCT00937261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595201|NCT00937261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24595202|NCT00937261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24635920|NCT01141894|Autonomic Agents|autonomic agents|mesh-ancestor
24595234|NCT00937417|Antimitotic Agents|antimitotic agents|mesh-ancestor
24595235|NCT00937417|Mitosis Modulators|mitosis modulators|mesh-ancestor
24595236|NCT00937417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595237|NCT00937482|Cediranib|cediranib|mesh-list
24595238|NCT00937482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595239|NCT00937482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595240|NCT00937482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24635938|NCT01141972|Vitamin D|vitamin d|mesh-list
24595241|NCT00937482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24595242|NCT00937508|Varenicline|varenicline|mesh-list
24595243|NCT00937508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24595244|NCT00937508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24595245|NCT00937508|Cholinergic Agents|cholinergic agents|mesh-ancestor
25208473|NCT02402660|Immunologic Factors|immunologic factors|mesh-ancestor
24489173|NCT00471640|Autonomic Agents|autonomic agents|mesh-ancestor
24489204|NCT00471809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24595246|NCT00937508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24595247|NCT00937508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595248|NCT00937508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595250|NCT00937625|Cyclophosphamide|cyclophosphamide|mesh-list
24595282|NCT00937677|Natalizumab|natalizumab|mesh-list
24595283|NCT00937677|Immunologic Factors|immunologic factors|mesh-ancestor
24595284|NCT00937677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595288|NCT00937807|Anesthetics, General|anesthetics, general|mesh-ancestor
24595289|NCT00937807|Anesthetics|anesthetics|mesh-ancestor
24595290|NCT00937807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24595291|NCT00937807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595292|NCT00937820|Darexaban|darexaban|mesh-list
25676455|NCT01798316|Sensory System Agents|sensory system agents|mesh-ancestor
24595293|NCT00937820|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24595294|NCT00937820|Antithrombins|antithrombins|mesh-ancestor
25676456|NCT01798316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25676457|NCT01798316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676458|NCT01798316|Antipyretics|antipyretics|mesh-ancestor
25676459|NCT01798394|Progesterone|progesterone|mesh-list
25676460|NCT01798394|Progestins|progestins|mesh-ancestor
25676461|NCT01798394|Hormones|hormones|mesh-ancestor
25676462|NCT01798394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25676463|NCT01798394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595295|NCT00937820|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24595296|NCT00937820|Protease Inhibitors|protease inhibitors|mesh-ancestor
24595297|NCT00937820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595298|NCT00937820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595299|NCT00937820|Anticoagulants|anticoagulants|mesh-ancestor
24595301|NCT00937911|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24595302|NCT00937911|Antithrombins|antithrombins|mesh-ancestor
24595303|NCT00937911|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24595304|NCT00937911|Protease Inhibitors|protease inhibitors|mesh-ancestor
24595305|NCT00937911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595306|NCT00937911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595307|NCT00937911|Anticoagulants|anticoagulants|mesh-ancestor
24595308|NCT00937924|Diphenhydramine|diphenhydramine|mesh-list
24595309|NCT00937924|Promethazine|promethazine|mesh-list
24852802|NCT02264145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24852803|NCT02264145|Anesthetics|anesthetics|mesh-ancestor
24660294|NCT01282632|Risperidone|risperidone|mesh-list
24595310|NCT00937924|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24503091|NCT03288545|Carboplatin|carboplatin|mesh-list
24503092|NCT03288545|Pembrolizumab|pembrolizumab|mesh-list
24595328|NCT00937924|Dermatologic Agents|dermatologic agents|mesh-ancestor
24595329|NCT00938132|Warfarin|warfarin|mesh-list
24595330|NCT00938132|Anticoagulants|anticoagulants|mesh-ancestor
24595331|NCT00938158|rGLP-1 protein|rglp-1 protein|mesh-list
24595332|NCT00938158|Incretins|incretins|mesh-ancestor
24595333|NCT00938158|Hormones|hormones|mesh-ancestor
24635949|NCT01141998|Vitamins|vitamins|mesh-ancestor
24595334|NCT00938158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24595335|NCT00938158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595336|NCT00938171|Anesthetics|anesthetics|mesh-list
24595345|NCT00938184|Serotonin Agents|serotonin agents|mesh-ancestor
24595374|NCT00938262|Ketoconazole|ketoconazole|mesh-list
24595375|NCT00938262|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24595390|NCT00938262|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24595391|NCT00938262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24595392|NCT00938262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24595394|NCT00938262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24595395|NCT00938262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852804|NCT02264145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24595396|NCT00938262|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24595397|NCT00938353|Beclomethasone|beclomethasone|mesh-list
24595398|NCT00938353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24595399|NCT00938353|Glucocorticoids|glucocorticoids|mesh-ancestor
24595400|NCT00938353|Hormones|hormones|mesh-ancestor
24595401|NCT00938353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24595402|NCT00938353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595403|NCT00938353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24595404|NCT00938353|Respiratory System Agents|respiratory system agents|mesh-ancestor
24595405|NCT00938379|Insect Repellents|insect repellents|mesh-list
24595448|NCT00938600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595449|NCT00938600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24595450|NCT00938600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25208474|NCT02351180|Beclomethasone|beclomethasone|mesh-list
25208475|NCT02351180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24489205|NCT00471809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24489206|NCT00471809|Autonomic Agents|autonomic agents|mesh-ancestor
24489207|NCT00471809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24595452|NCT00938613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24595453|NCT00938613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24595454|NCT00938613|Autonomic Agents|autonomic agents|mesh-ancestor
24595455|NCT00938613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24595456|NCT00938613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595457|NCT00938613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24595458|NCT00938613|Respiratory System Agents|respiratory system agents|mesh-ancestor
24595459|NCT00938613|Glucocorticoids|glucocorticoids|mesh-ancestor
24595460|NCT00938613|Hormones|hormones|mesh-ancestor
24595461|NCT00938613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24595462|NCT00938626|Antibodies|antibodies|mesh-list
24595463|NCT00938626|Antibodies, Bispecific|antibodies, bispecific|mesh-list
24595464|NCT00938626|Immunologic Factors|immunologic factors|mesh-ancestor
24595465|NCT00938626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595466|NCT00938730|Warfarin|warfarin|mesh-list
24595467|NCT00938730|Anticoagulants|anticoagulants|mesh-ancestor
24595499|NCT00938990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24595500|NCT00938990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24595501|NCT00938990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24595502|NCT00938990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25146516|NCT02920931|Tenofovir|tenofovir|mesh-list
24595503|NCT00938990|Anesthetics, General|anesthetics, general|mesh-ancestor
24595504|NCT00938990|Anesthetics|anesthetics|mesh-ancestor
24595505|NCT00938990|GABA Modulators|gaba modulators|mesh-ancestor
24595507|NCT00938990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24595508|NCT00938990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595509|NCT00939068|Telbivudine|telbivudine|mesh-list
24595510|NCT00939068|Antiviral Agents|antiviral agents|mesh-ancestor
24595511|NCT00939068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24595512|NCT00939068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24595522|NCT00939328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24595523|NCT00939328|Immunologic Factors|immunologic factors|mesh-ancestor
24595524|NCT00939328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595525|NCT00939328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24595545|NCT00939497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595546|NCT00939497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595547|NCT00939497|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24595548|NCT00939497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24595549|NCT00939497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24595550|NCT00939497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24595551|NCT00939497|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24595552|NCT00939497|Dopamine Agents|dopamine agents|mesh-ancestor
24595553|NCT00939549|Cyclophosphamide|cyclophosphamide|mesh-list
24595554|NCT00939549|Glatiramer Acetate|glatiramer acetate|mesh-list
24595556|NCT00939549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24595557|NCT00939549|Immunologic Factors|immunologic factors|mesh-ancestor
24595558|NCT00939549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595559|NCT00939549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24595560|NCT00939549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24595561|NCT00939549|Alkylating Agents|alkylating agents|mesh-ancestor
24595562|NCT00939549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595563|NCT00939549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24595564|NCT00939549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24595565|NCT00939549|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24595566|NCT00939588|Valsartan|valsartan|mesh-list
24595567|NCT00939588|Telmisartan|telmisartan|mesh-list
24595568|NCT00939588|Ramipril|ramipril|mesh-list
24595569|NCT00939588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24595573|NCT00939588|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24595598|NCT00939757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24595599|NCT00939757|Adrenergic Agents|adrenergic agents|mesh-ancestor
24595600|NCT00939757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24595601|NCT00939757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595602|NCT00939757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595603|NCT00939757|Urological Agents|urological agents|mesh-ancestor
24852823|NCT02264171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660564|NCT01284439|Protective Agents|protective agents|mesh-ancestor
24595605|NCT00939835|Citalopram|citalopram|mesh-list
25208476|NCT02351180|Glucocorticoids|glucocorticoids|mesh-ancestor
25208477|NCT02351180|Hormones|hormones|mesh-ancestor
25208478|NCT02351180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25208479|NCT02351180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489208|NCT00471809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489209|NCT00471809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24595606|NCT00939835|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24595607|NCT00939835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24595608|NCT00939835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24595609|NCT00939835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595610|NCT00939835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24595611|NCT00939835|Serotonin Agents|serotonin agents|mesh-ancestor
24595612|NCT00939835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595613|NCT00939835|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24595617|NCT00939835|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24595618|NCT00939835|Parasympatholytics|parasympatholytics|mesh-ancestor
24595619|NCT00939835|Autonomic Agents|autonomic agents|mesh-ancestor
24595620|NCT00939835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24595621|NCT00939835|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24595622|NCT00939835|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24595623|NCT00939835|Cholinergic Agents|cholinergic agents|mesh-ancestor
24595624|NCT00939848|Gemcitabine|gemcitabine|mesh-list
24595628|NCT00939848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24595644|NCT00939926|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24595645|NCT00939926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24595646|NCT00939926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24595648|NCT00939926|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24595649|NCT00939926|Dopamine Agents|dopamine agents|mesh-ancestor
24595650|NCT00939939|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24595651|NCT00939939|Glimepiride|glimepiride|mesh-list
24595652|NCT00939939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24595653|NCT00939939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595654|NCT00939939|Incretins|incretins|mesh-ancestor
24595655|NCT00939939|Hormones|hormones|mesh-ancestor
24595656|NCT00939939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24595657|NCT00939939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24595658|NCT00939939|Protease Inhibitors|protease inhibitors|mesh-ancestor
24595659|NCT00939939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595660|NCT00939939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595661|NCT00939939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24595662|NCT00939939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24595663|NCT00939939|Immunologic Factors|immunologic factors|mesh-ancestor
24595664|NCT00939965|Isotretinoin|isotretinoin|mesh-list
24595687|NCT00940238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24595688|NCT00940238|Serotonin Agents|serotonin agents|mesh-ancestor
24595689|NCT00940238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595690|NCT00940238|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24595691|NCT00940238|Antidepressive Agents|antidepressive agents|mesh-ancestor
24595692|NCT00940238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24595717|NCT00940303|Protective Agents|protective agents|mesh-ancestor
24595718|NCT00940303|Vitamin B Complex|vitamin b complex|mesh-ancestor
24595720|NCT00940303|Micronutrients|micronutrients|mesh-ancestor
24595721|NCT00940381|Sirolimus|sirolimus|mesh-list
24595722|NCT00940381|Cetuximab|cetuximab|mesh-list
24595728|NCT00940381|Antifungal Agents|antifungal agents|mesh-ancestor
24595795|NCT00940550|GABA Agents|gaba agents|mesh-ancestor
24595796|NCT00940550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24852825|NCT02264171|Urological Agents|urological agents|mesh-ancestor
24852826|NCT02264171|Antifungal Agents|antifungal agents|mesh-ancestor
24852827|NCT02264171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24852828|NCT02264171|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24660709|NCT01285388|Beta-lapachone|beta-lapachone|mesh-list
24595797|NCT00940550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24595810|NCT00940628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24595811|NCT00940654|Acetaminophen|acetaminophen|mesh-list
24595812|NCT00940654|Antipyretics|antipyretics|mesh-list
24595813|NCT00940654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24595814|NCT00940654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24595815|NCT00940654|Analgesics|analgesics|mesh-ancestor
24595816|NCT00940654|Sensory System Agents|sensory system agents|mesh-ancestor
25208480|NCT02351180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25208481|NCT02351180|Respiratory System Agents|respiratory system agents|mesh-ancestor
24489210|NCT00471809|Respiratory System Agents|respiratory system agents|mesh-ancestor
24489211|NCT00471809|Glucocorticoids|glucocorticoids|mesh-ancestor
24489213|NCT00471809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24489214|NCT00471809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24489215|NCT00471809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25241762|NCT05299944|Anticonvulsants|anticonvulsants|mesh-ancestor
24489216|NCT00471809|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24489217|NCT00471809|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24489218|NCT00471809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24489254|NCT00471965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24489255|NCT00471965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24489256|NCT00471965|Immunologic Factors|immunologic factors|mesh-ancestor
24489322|NCT00472355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24489323|NCT00472355|Dopamine Agonists|dopamine agonists|mesh-ancestor
24489324|NCT00472355|Dopamine Agents|dopamine agents|mesh-ancestor
24489325|NCT00472355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24489342|NCT00472472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24595817|NCT00940654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24595818|NCT00940654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595819|NCT00940667|Losartan|losartan|mesh-list
24595820|NCT00940667|Amlodipine|amlodipine|mesh-list
24595821|NCT00940667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24595822|NCT00940667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24595853|NCT00940693|Antidepressive Agents|antidepressive agents|mesh-ancestor
24595854|NCT00940693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24595855|NCT00940693|Dopamine Agents|dopamine agents|mesh-ancestor
24595856|NCT00940719|Vitamin D|vitamin d|mesh-list
24595857|NCT00940719|Cholecalciferol|cholecalciferol|mesh-list
25676464|NCT01798485|Docetaxel|docetaxel|mesh-list
24595875|NCT00940784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595876|NCT00940784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24595877|NCT00940784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24595878|NCT00940784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595879|NCT00940784|Antipyretics|antipyretics|mesh-ancestor
24595880|NCT00940784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24665811|NCT01314898|Spironolactone|spironolactone|mesh-list
24596013|NCT00941161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24596014|NCT00941161|Immunologic Factors|immunologic factors|mesh-ancestor
24596016|NCT00941174|Calcium|calcium|mesh-list
24596017|NCT00941174|Levoleucovorin|levoleucovorin|mesh-list
24596018|NCT00941174|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24596019|NCT00941174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596021|NCT00941174|Protective Agents|protective agents|mesh-ancestor
24596022|NCT00941174|Vitamin B Complex|vitamin b complex|mesh-ancestor
24596032|NCT00941252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596033|NCT00941252|Interferon Inducers|interferon inducers|mesh-ancestor
24596034|NCT00941265|Levodopa|levodopa|mesh-list
24596035|NCT00941265|Benserazide|benserazide|mesh-list
24596036|NCT00941265|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24596037|NCT00941265|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24596038|NCT00941265|Dopamine Agents|dopamine agents|mesh-ancestor
24596039|NCT00941265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24596040|NCT00941265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596041|NCT00941265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596042|NCT00941265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596043|NCT00941343|Alfuzosin|alfuzosin|mesh-list
24596044|NCT00941343|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24596045|NCT00941343|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24596046|NCT00941343|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25208482|NCT02327403|Abatacept|abatacept|mesh-list
25208483|NCT02327403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25208484|NCT02327403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208485|NCT02327403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208486|NCT02327403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25208487|NCT02327403|Immunologic Factors|immunologic factors|mesh-ancestor
25208488|NCT02327403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208489|NCT02327403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25208490|NCT02313389|Rituximab|rituximab|mesh-list
25208491|NCT02313389|Methotrexate|methotrexate|mesh-list
25208492|NCT02313389|Temozolomide|temozolomide|mesh-list
25208493|NCT02313389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25208494|NCT02313389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208495|NCT02313389|Immunologic Factors|immunologic factors|mesh-ancestor
25208496|NCT02313389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208497|NCT02313389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25208498|NCT02313389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24489412|NCT00473005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489413|NCT00473070|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
24596047|NCT00941343|Adrenergic Agents|adrenergic agents|mesh-ancestor
24596048|NCT00941343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24596049|NCT00941343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852835|NCT02264184|Paroxetine|paroxetine|mesh-list
24852836|NCT02264184|Tamsulosin|tamsulosin|mesh-list
24852837|NCT02264184|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24852838|NCT02264184|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24674402|NCT05249712|Androgens|androgens|mesh-list
24852839|NCT02264184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25676465|NCT01798485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25676466|NCT01798485|Tubulin Modulators|tubulin modulators|mesh-ancestor
25676467|NCT01798485|Antimitotic Agents|antimitotic agents|mesh-ancestor
25676468|NCT01798485|Mitosis Modulators|mitosis modulators|mesh-ancestor
25676469|NCT01798485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676470|NCT01798550|Enoxaparin|enoxaparin|mesh-list
25676471|NCT01798550|Anticoagulants|anticoagulants|mesh-ancestor
25676472|NCT01798550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24812425|NCT02052167|Abortifacient Agents|abortifacient agents|mesh-ancestor
25251974|NCT02509429|Insulin|insulin|mesh-list
24660923|NCT01287130|Cetuximab|cetuximab|mesh-list
24596050|NCT00941343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596051|NCT00941343|Urological Agents|urological agents|mesh-ancestor
24596052|NCT00941369|Insulin|insulin|mesh-list
24596053|NCT00941369|Insulin Glargine|insulin glargine|mesh-list
24596054|NCT00941369|Insulin, Isophane|insulin, isophane|mesh-list
24596055|NCT00941369|Isophane Insulin, Human|isophane insulin, human|mesh-list
24596056|NCT00941369|Isophane insulin, beef|isophane insulin, beef|mesh-list
24596057|NCT00941369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24596058|NCT00941369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596059|NCT00941382|Metformin|metformin|mesh-list
24596060|NCT00941382|Sibutramine|sibutramine|mesh-list
24596061|NCT00941382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24596062|NCT00941382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596063|NCT00941382|Antidepressive Agents|antidepressive agents|mesh-ancestor
24596064|NCT00941382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24596065|NCT00941382|Appetite Depressants|appetite depressants|mesh-ancestor
24596066|NCT00941382|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24596067|NCT00941460|Temozolomide|temozolomide|mesh-list
24596145|NCT00942006|Ceftriaxone|ceftriaxone|mesh-list
24596146|NCT00942006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24812431|NCT02052167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812432|NCT02052167|Dermatologic Agents|dermatologic agents|mesh-ancestor
24812433|NCT02052167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812435|NCT02052167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24596148|NCT00942006|Antimalarials|antimalarials|mesh-ancestor
24596149|NCT00942006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24596150|NCT00942006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24596151|NCT00942136|Dolutegravir|dolutegravir|mesh-list
24596153|NCT00942136|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24596154|NCT00942136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24596155|NCT00942136|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24596156|NCT00942136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596157|NCT00942136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596158|NCT00942136|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24596159|NCT00942136|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24596160|NCT00942136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24596161|NCT00942136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24596162|NCT00942136|Antiviral Agents|antiviral agents|mesh-ancestor
24596163|NCT00942136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24596164|NCT00942201|Dexamethasone|dexamethasone|mesh-list
24596165|NCT00942201|Dexamethasone acetate|dexamethasone acetate|mesh-list
24596167|NCT00942201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24596168|NCT00942201|Antiemetics|antiemetics|mesh-ancestor
24596169|NCT00942201|Autonomic Agents|autonomic agents|mesh-ancestor
24596170|NCT00942201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24596178|NCT00942201|Protease Inhibitors|protease inhibitors|mesh-ancestor
24596179|NCT00942201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596209|NCT00942344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24596210|NCT00942344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24596211|NCT00942344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24596213|NCT00942435|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24596214|NCT00942435|Antithrombins|antithrombins|mesh-ancestor
25208499|NCT02313389|Abortifacient Agents|abortifacient agents|mesh-ancestor
25208500|NCT02313389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25208501|NCT02313389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25208502|NCT02313389|Antimetabolites|antimetabolites|mesh-ancestor
24489414|NCT00473070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24489415|NCT00473070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24503527|NCT00532168|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24596294|NCT00942617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596295|NCT00942617|Antipyretics|antipyretics|mesh-ancestor
24596296|NCT00942682|Sorafenib|sorafenib|mesh-list
24596297|NCT00942682|Everolimus|everolimus|mesh-list
24596298|NCT00942682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596299|NCT00942682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24596300|NCT00942682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596301|NCT00942682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596302|NCT00942682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24596303|NCT00942682|Immunologic Factors|immunologic factors|mesh-ancestor
24596304|NCT00942682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596305|NCT00942747|Sirolimus|sirolimus|mesh-list
24596306|NCT00942747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24596307|NCT00942747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24596308|NCT00942747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24596309|NCT00942747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596310|NCT00942747|Antifungal Agents|antifungal agents|mesh-ancestor
24596313|NCT00942747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596315|NCT00942773|Antifungal Agents|antifungal agents|mesh-ancestor
24596316|NCT00942773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24596317|NCT00942773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24812445|NCT02052180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812446|NCT02052193|Vemurafenib|vemurafenib|mesh-list
24812447|NCT02052193|Dabrafenib|dabrafenib|mesh-list
24812448|NCT02052193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812449|NCT02052193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24812450|NCT02052193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812456|NCT02052323|Artesunate|artesunate|mesh-list
24812457|NCT02052323|Mefloquine|mefloquine|mesh-list
24812458|NCT02052323|Antimalarials|antimalarials|mesh-ancestor
24812459|NCT02052323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24812460|NCT02052323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24812461|NCT02052323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24812462|NCT02052323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812463|NCT02052323|Antiviral Agents|antiviral agents|mesh-ancestor
24661116|NCT01287962|Apatinib|apatinib|mesh-list
24596389|NCT00943345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24596417|NCT00943540|Raltegravir Potassium|raltegravir potassium|mesh-list
24596418|NCT00943540|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24596419|NCT00943540|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24596420|NCT00943540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24596421|NCT00943540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596422|NCT00943540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596423|NCT00943540|Antiviral Agents|antiviral agents|mesh-ancestor
24596424|NCT00943540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24596425|NCT00943540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24596426|NCT00943540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24596427|NCT00943540|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24596428|NCT00943540|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24596429|NCT00943540|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24596430|NCT00943540|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24596431|NCT00943540|Protease Inhibitors|protease inhibitors|mesh-ancestor
24596432|NCT00943553|Decitabine|decitabine|mesh-list
24596433|NCT00943553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24596434|NCT00943553|Antimetabolites|antimetabolites|mesh-ancestor
24596435|NCT00943553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596436|NCT00943553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596437|NCT00943553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596448|NCT00943566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24596449|NCT00943566|Anesthetics, General|anesthetics, general|mesh-ancestor
24596450|NCT00943566|Anesthetics|anesthetics|mesh-ancestor
24596451|NCT00943709|Insulin|insulin|mesh-list
24596452|NCT00943709|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24596453|NCT00943709|Insulin Glargine|insulin glargine|mesh-list
24596454|NCT00943709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24596455|NCT00943709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596456|NCT00943748|Deferiprone|deferiprone|mesh-list
24596457|NCT00943748|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25208503|NCT02313389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489416|NCT00473070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24489417|NCT00473070|Glucocorticoids|glucocorticoids|mesh-ancestor
24596458|NCT00943748|Chelating Agents|chelating agents|mesh-ancestor
24596459|NCT00943748|Sequestering Agents|sequestering agents|mesh-ancestor
24596460|NCT00943748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596464|NCT00943839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24596465|NCT00943839|Growth Substances|growth substances|mesh-ancestor
24596466|NCT00943839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596467|NCT00943839|Growth Inhibitors|growth inhibitors|mesh-ancestor
24596468|NCT00943839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24596469|NCT00943839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812473|NCT02052336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24812474|NCT02052336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24596539|NCT00944242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24596540|NCT00944242|Serotonin Agents|serotonin agents|mesh-ancestor
24596541|NCT00944242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596557|NCT00944307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596558|NCT00944333|Clopidogrel|clopidogrel|mesh-list
24596559|NCT00944333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24852872|NCT02264587|Domperidone|domperidone|mesh-list
24596560|NCT00944333|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24596561|NCT00944333|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24596563|NCT00944333|Purinergic Agents|purinergic agents|mesh-ancestor
24596564|NCT00944333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24596565|NCT00944333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812477|NCT02052388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24812479|NCT02052492|Vitamins|vitamins|mesh-ancestor
24812480|NCT02052492|Micronutrients|micronutrients|mesh-ancestor
24812481|NCT02052492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072896|NCT03398837|Hormones|hormones|mesh-ancestor
24812482|NCT02052492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24812483|NCT02052609|Brodalumab|brodalumab|mesh-list
24812484|NCT02052609|Dermatologic Agents|dermatologic agents|mesh-ancestor
24596600|NCT00944424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596601|NCT00944424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24596613|NCT00944463|Immunologic Factors|immunologic factors|mesh-ancestor
24596614|NCT00944463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596615|NCT00944463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24596616|NCT00944463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24596617|NCT00944463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24596618|NCT00944463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24596620|NCT00944502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24596621|NCT00944502|Antiemetics|antiemetics|mesh-ancestor
24596622|NCT00944502|Autonomic Agents|autonomic agents|mesh-ancestor
24596623|NCT00944502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24596647|NCT00944606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24596649|NCT00944619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24596650|NCT00944619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596651|NCT00944684|Ribavirin|ribavirin|mesh-list
24812491|NCT02052713|Tamsulosin|tamsulosin|mesh-list
24812492|NCT02052713|Dutasteride|dutasteride|mesh-list
24812493|NCT02052713|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24812494|NCT02052713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24812495|NCT02052713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24812496|NCT02052713|Adrenergic Agents|adrenergic agents|mesh-ancestor
24596652|NCT00944684|Antimetabolites|antimetabolites|mesh-ancestor
24596654|NCT00944684|Antiviral Agents|antiviral agents|mesh-ancestor
24596680|NCT00944840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24596681|NCT00944840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24596682|NCT00944853|Zinc|zinc|mesh-list
24596683|NCT00944853|Trace Elements|trace elements|mesh-ancestor
24596684|NCT00944853|Micronutrients|micronutrients|mesh-ancestor
24596685|NCT00944853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596686|NCT00944918|Fulvestrant|fulvestrant|mesh-list
24596687|NCT00944918|Anastrozole|anastrozole|mesh-list
24596688|NCT00944918|Exemestane|exemestane|mesh-list
24596689|NCT00944918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24596690|NCT00944918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596691|NCT00944918|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24596702|NCT00944957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25208504|NCT02313389|Dermatologic Agents|dermatologic agents|mesh-ancestor
25208505|NCT02313389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208506|NCT02313389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24489419|NCT00473070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24489420|NCT00473070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489421|NCT00473070|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24489422|NCT00473070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24489451|NCT00473460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24489453|NCT00473460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489454|NCT00473460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489455|NCT00473460|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24489456|NCT00473460|Contraceptive Agents|contraceptive agents|mesh-ancestor
24489457|NCT00473460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24489458|NCT00473460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489459|NCT00473460|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24596703|NCT00944957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24596735|NCT00944996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24596737|NCT00944996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24596738|NCT00944996|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24852873|NCT02264587|Mosapride|mosapride|mesh-list
24596747|NCT00945178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24596748|NCT00945178|Analgesics|analgesics|mesh-ancestor
24596749|NCT00945178|Sensory System Agents|sensory system agents|mesh-ancestor
24596750|NCT00945178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25000612|NCT04147351|Growth Inhibitors|growth inhibitors|mesh-ancestor
25252104|NCT02509091|Sequestering Agents|sequestering agents|mesh-ancestor
25102662|NCT03167164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25252106|NCT02509052|Leflunomide|leflunomide|mesh-list
24596751|NCT00945178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596766|NCT00945347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24596767|NCT00945347|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24596768|NCT00945347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24596769|NCT00945347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596771|NCT00945360|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24596772|NCT00945360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596773|NCT00945360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24596774|NCT00945360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596775|NCT00945360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596776|NCT00945360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24596777|NCT00945360|Hormone Antagonists|hormone antagonists|mesh-ancestor
24596778|NCT00945360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24596779|NCT00945360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596780|NCT00945373|Calcium Dobesilate|calcium dobesilate|mesh-list
24596781|NCT00945373|Calcium|calcium|mesh-list
24596782|NCT00945373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24596786|NCT00945438|Vaccines|vaccines|mesh-list
24596787|NCT00945438|Immunologic Factors|immunologic factors|mesh-ancestor
24596788|NCT00945438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596789|NCT00945529|Nitric Oxide|nitric oxide|mesh-list
24596790|NCT00945529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24596791|NCT00945529|Autonomic Agents|autonomic agents|mesh-ancestor
24596792|NCT00945529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24596793|NCT00945529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596794|NCT00945529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25208507|NCT02313389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25208508|NCT02313389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25208509|NCT02313389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25208510|NCT02313389|Alkylating Agents|alkylating agents|mesh-ancestor
25208514|NCT02281383|BCG Vaccine|bcg vaccine|mesh-list
25208515|NCT02281383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25208516|NCT02281383|Immunologic Factors|immunologic factors|mesh-ancestor
25208517|NCT02281383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208518|NCT02273375|Durvalumab|durvalumab|mesh-list
25208519|NCT02273375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25208520|NCT02273375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596795|NCT00945529|Respiratory System Agents|respiratory system agents|mesh-ancestor
24852843|NCT02264184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852844|NCT02264184|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24852845|NCT02264184|Antidepressive Agents|antidepressive agents|mesh-ancestor
24852846|NCT02264184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24852847|NCT02264184|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24852848|NCT02264184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24852849|NCT02264184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852850|NCT02264184|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24852851|NCT02264184|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24852852|NCT02264184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24596800|NCT00945529|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24596801|NCT00945529|Vasodilator Agents|vasodilator agents|mesh-ancestor
24596803|NCT00945529|Protective Agents|protective agents|mesh-ancestor
24596804|NCT00945542|Hemostatics|hemostatics|mesh-list
24596805|NCT00945542|Coagulants|coagulants|mesh-ancestor
24596806|NCT00945620|Ropivacaine|ropivacaine|mesh-list
24596807|NCT00945620|Anesthetics, Local|anesthetics, local|mesh-ancestor
24596808|NCT00945620|Anesthetics|anesthetics|mesh-ancestor
24852871|NCT02264561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24596811|NCT00945620|Sensory System Agents|sensory system agents|mesh-ancestor
24596812|NCT00945620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24596813|NCT00945789|Nitric Oxide|nitric oxide|mesh-list
24596826|NCT00945789|Vasodilator Agents|vasodilator agents|mesh-ancestor
25676473|NCT01798550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25676474|NCT01798550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676475|NCT01798706|Lixisenatide|lixisenatide|mesh-list
25676476|NCT01798706|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25676477|NCT01798706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676478|NCT01798992|Metoprolol|metoprolol|mesh-list
25010117|NCT04625803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010118|NCT04625803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25010142|NCT04617821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596827|NCT00945789|Gasotransmitters|gasotransmitters|mesh-ancestor
24596828|NCT00945789|Protective Agents|protective agents|mesh-ancestor
24596830|NCT00945919|Oxymorphone|oxymorphone|mesh-list
24596856|NCT00946036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596858|NCT00946166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24596859|NCT00946166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24596860|NCT00946166|Antimetabolites|antimetabolites|mesh-ancestor
24596861|NCT00946166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596862|NCT00946166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24596863|NCT00946166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24596864|NCT00946166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596865|NCT00946179|Vaccines|vaccines|mesh-list
24596866|NCT00946179|Immunologic Factors|immunologic factors|mesh-ancestor
24596867|NCT00946179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596868|NCT00946335|Temozolomide|temozolomide|mesh-list
24596869|NCT00946335|Veliparib|veliparib|mesh-list
24596870|NCT00946335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24596871|NCT00946335|Alkylating Agents|alkylating agents|mesh-ancestor
24596887|NCT00946374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24503861|NCT00533247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24596922|NCT00946491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24596923|NCT00946491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24596924|NCT00946491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24596925|NCT00946491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24596926|NCT00946491|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24596927|NCT00946491|Dopamine Agents|dopamine agents|mesh-ancestor
24596940|NCT00946595|Efavirenz|efavirenz|mesh-list
24596941|NCT00946595|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24596942|NCT00946595|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24596943|NCT00946595|Protease Inhibitors|protease inhibitors|mesh-ancestor
24596944|NCT00946595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596945|NCT00946595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596946|NCT00946595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24596947|NCT00946595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24596948|NCT00946595|Antiviral Agents|antiviral agents|mesh-ancestor
24596949|NCT00946595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24596950|NCT00946595|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24596951|NCT00946595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24596952|NCT00946595|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24596953|NCT00946595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24596954|NCT00946595|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24596955|NCT00946595|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24596965|NCT00946608|Histamine Antagonists|histamine antagonists|mesh-ancestor
24596966|NCT00946608|Histamine Agents|histamine agents|mesh-ancestor
24596967|NCT00946608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24596968|NCT00946608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596969|NCT00946608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596970|NCT00946621|Ramipril|ramipril|mesh-list
24596971|NCT00946621|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24596972|NCT00946621|Protease Inhibitors|protease inhibitors|mesh-ancestor
24597004|NCT00946764|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24597005|NCT00946764|Antidepressive Agents|antidepressive agents|mesh-ancestor
24597006|NCT00946764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24597007|NCT00946764|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24852879|NCT02264587|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24852880|NCT02264587|Dopamine Agents|dopamine agents|mesh-ancestor
24661683|NCT01290328|Hematinics|hematinics|mesh-ancestor
24597008|NCT00946764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25073004|NCT03398044|Hormones|hormones|mesh-ancestor
24597009|NCT00946764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24597010|NCT00946764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676479|NCT01798992|Carvedilol|carvedilol|mesh-list
25676480|NCT01798992|Doxazosin|doxazosin|mesh-list
25676481|NCT01798992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25676482|NCT01798992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24597011|NCT00946764|Adrenergic Agents|adrenergic agents|mesh-ancestor
25676483|NCT01798992|Sympatholytics|sympatholytics|mesh-ancestor
25676484|NCT01798992|Autonomic Agents|autonomic agents|mesh-ancestor
24597012|NCT00946764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24597013|NCT00946764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597014|NCT00946790|Hydroxychloroquine|hydroxychloroquine|mesh-list
24597015|NCT00946790|Antimalarials|antimalarials|mesh-ancestor
24597016|NCT00946790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24597017|NCT00946790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24597018|NCT00946790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24597019|NCT00946790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597042|NCT00946907|Antipyretics|antipyretics|mesh-ancestor
24597044|NCT00946946|Azathioprine|azathioprine|mesh-list
24597045|NCT00946946|Antimetabolites|antimetabolites|mesh-ancestor
24597046|NCT00946946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597047|NCT00946946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24597048|NCT00946946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597049|NCT00946946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24597050|NCT00946946|Immunologic Factors|immunologic factors|mesh-ancestor
24597051|NCT00946946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597052|NCT00946946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24597053|NCT00946946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24597054|NCT00946946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24597055|NCT00946946|Analgesics|analgesics|mesh-ancestor
24597056|NCT00946946|Sensory System Agents|sensory system agents|mesh-ancestor
24597057|NCT00946946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24597058|NCT00946946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24597059|NCT00947024|Glipizide|glipizide|mesh-list
24597060|NCT00947024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24597061|NCT00947024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597062|NCT00947063|Promethazine|promethazine|mesh-list
24597063|NCT00947063|Diphenhydramine|diphenhydramine|mesh-list
24597064|NCT00947063|Antipruritics|antipruritics|mesh-ancestor
24597107|NCT00947128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24597108|NCT00947128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597109|NCT00947128|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24597113|NCT00947128|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24489535|NCT00473980|Sensory System Agents|sensory system agents|mesh-ancestor
24489536|NCT00473980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489566|NCT00474071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24489567|NCT00474071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597114|NCT00947141|Valganciclovir|valganciclovir|mesh-list
24597115|NCT00947141|Ganciclovir|ganciclovir|mesh-list
24597116|NCT00947141|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
24597118|NCT00947141|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
24597119|NCT00947141|Antiviral Agents|antiviral agents|mesh-ancestor
24597139|NCT00947336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597140|NCT00947336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597141|NCT00947336|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24597142|NCT00947336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24597143|NCT00947375|Lamotrigine|lamotrigine|mesh-list
24597144|NCT00947375|Haloperidol|haloperidol|mesh-list
24597145|NCT00947375|Haloperidol decanoate|haloperidol decanoate|mesh-list
24597146|NCT00947375|Antiemetics|antiemetics|mesh-ancestor
24597147|NCT00947375|Autonomic Agents|autonomic agents|mesh-ancestor
24597148|NCT00947375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24597149|NCT00947375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597150|NCT00947375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24597151|NCT00947375|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24597152|NCT00947375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24597167|NCT00947388|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24597168|NCT00947388|Antibodies|antibodies|mesh-list
24597169|NCT00947388|Immunoglobulins|immunoglobulins|mesh-list
24597170|NCT00947388|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24597171|NCT00947388|Immunologic Factors|immunologic factors|mesh-ancestor
24597172|NCT00947388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597179|NCT00947453|Respiratory System Agents|respiratory system agents|mesh-ancestor
24597181|NCT00947453|Hormone Antagonists|hormone antagonists|mesh-ancestor
24597182|NCT00947453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24597183|NCT00947453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597184|NCT00947453|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24597185|NCT00947453|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24597186|NCT00947453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597187|NCT00947466|Buprenorphine|buprenorphine|mesh-list
24597188|NCT00947466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24597219|NCT00947739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25252198|NCT02508402|Dexamethasone|dexamethasone|mesh-list
25252199|NCT02508402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25252200|NCT02508402|Antiemetics|antiemetics|mesh-ancestor
25252201|NCT02508402|Autonomic Agents|autonomic agents|mesh-ancestor
25252202|NCT02508402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25252203|NCT02508402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252204|NCT02508402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25252205|NCT02508402|Glucocorticoids|glucocorticoids|mesh-ancestor
25252206|NCT02508402|Hormones|hormones|mesh-ancestor
25102664|NCT03167164|Growth Inhibitors|growth inhibitors|mesh-ancestor
25252207|NCT02508402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25252208|NCT02508402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25252209|NCT02508402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25252210|NCT02508311|Albuterol|albuterol|mesh-list
25252212|NCT02508311|Autonomic Agents|autonomic agents|mesh-ancestor
24597220|NCT00947739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597221|NCT00947739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597224|NCT00947843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24597225|NCT00947843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25073051|NCT03397797|Rocuronium|rocuronium|mesh-list
24597235|NCT00947843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24597236|NCT00947843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24597237|NCT00947843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597238|NCT00947843|Antipyretics|antipyretics|mesh-ancestor
24597239|NCT00947843|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24597247|NCT00947895|Prednisolone|prednisolone|mesh-list
24597248|NCT00947895|Prednisolone acetate|prednisolone acetate|mesh-list
24597249|NCT00947895|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24597250|NCT00947895|Prednisolone phosphate|prednisolone phosphate|mesh-list
24597251|NCT00947895|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24597252|NCT00947895|Hormones|hormones|mesh-ancestor
24597253|NCT00947895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24597254|NCT00947895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597255|NCT00947895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24597256|NCT00947895|Antiemetics|antiemetics|mesh-ancestor
24597257|NCT00947895|Autonomic Agents|autonomic agents|mesh-ancestor
24597258|NCT00947895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24597267|NCT00948077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24597268|NCT00948077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24597269|NCT00948103|Nitrous Oxide|nitrous oxide|mesh-list
24597270|NCT00948103|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24597271|NCT00948103|Anesthetics, General|anesthetics, general|mesh-ancestor
24597272|NCT00948103|Anesthetics|anesthetics|mesh-ancestor
25208529|NCT02227875|Insulin Glargine|insulin glargine|mesh-list
25208530|NCT02227875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25208531|NCT02227875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208532|NCT02227862|Insulin Glargine|insulin glargine|mesh-list
24489568|NCT00474071|Analgesics|analgesics|mesh-ancestor
24489611|NCT00474435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24489614|NCT00474435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24489615|NCT00474435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489616|NCT00474435|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24489617|NCT00474435|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24489618|NCT00474435|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24489619|NCT00474435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24489620|NCT00474435|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24597273|NCT00948103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24597274|NCT00948103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597275|NCT00948103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25676485|NCT01798992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25676486|NCT01798992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676487|NCT01798992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25676488|NCT01798992|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25676489|NCT01798992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25676490|NCT01798992|Adrenergic Agents|adrenergic agents|mesh-ancestor
25676491|NCT01798992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25676492|NCT01798992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676493|NCT01798992|Antioxidants|antioxidants|mesh-ancestor
25676494|NCT01798992|Protective Agents|protective agents|mesh-ancestor
25676495|NCT01798992|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25676496|NCT01798992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25676497|NCT01798992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24597277|NCT00948103|Sensory System Agents|sensory system agents|mesh-ancestor
24597278|NCT00948103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24597280|NCT00948168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24597281|NCT00948168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597282|NCT00948168|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24597283|NCT00948168|Incretins|incretins|mesh-ancestor
24597285|NCT00948168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24597287|NCT00948220|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24597322|NCT00948662|Ketoconazole|ketoconazole|mesh-list
24597323|NCT00948662|Antifungal Agents|antifungal agents|mesh-ancestor
24597355|NCT00948779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24597367|NCT00948987|Sensory System Agents|sensory system agents|mesh-ancestor
24597368|NCT00948987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24597369|NCT00948987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597370|NCT00948987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24597371|NCT00948987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24597372|NCT00948987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24852898|NCT02264665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852899|NCT02264665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24852900|NCT02264665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24852901|NCT02264665|Growth Substances|growth substances|mesh-ancestor
24597373|NCT00948987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24597374|NCT00948987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597375|NCT00948987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24597376|NCT00948987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24597420|NCT00949247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597440|NCT00949364|Immunologic Factors|immunologic factors|mesh-ancestor
24597441|NCT00949364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597442|NCT00949364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24597443|NCT00949364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24597444|NCT00949364|Growth Substances|growth substances|mesh-ancestor
24597445|NCT00949364|Growth Inhibitors|growth inhibitors|mesh-ancestor
24597446|NCT00949364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24636109|NCT01142778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24636110|NCT01142778|Growth Substances|growth substances|mesh-ancestor
24597448|NCT00949377|Methylnaltrexone|methylnaltrexone|mesh-list
24597602|NCT00950196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24597603|NCT00950209|Heparin|heparin|mesh-list
24597604|NCT00950209|Anticoagulants|anticoagulants|mesh-ancestor
24597605|NCT00950209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24597606|NCT00950209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24597607|NCT00950209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597608|NCT00950222|Imipenem|imipenem|mesh-list
24597609|NCT00950222|Amikacin|amikacin|mesh-list
24597610|NCT00950222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24597611|NCT00950222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24597614|NCT00950339|Omeprazole|omeprazole|mesh-list
24597615|NCT00950339|Pantoprazole|pantoprazole|mesh-list
24597616|NCT00950339|Famotidine|famotidine|mesh-list
24597617|NCT00950339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25208533|NCT02227862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25208534|NCT02227862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208535|NCT02179853|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25208536|NCT02179853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25208537|NCT02145143|Vemurafenib|vemurafenib|mesh-list
25208538|NCT02145143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208540|NCT02145143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208541|NCT02145143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944148|NCT03963128|Vitamins|vitamins|mesh-ancestor
24597618|NCT00950339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24597656|NCT00950586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597657|NCT00950625|Lidocaine|lidocaine|mesh-list
24597658|NCT00950625|Anesthetics, Local|anesthetics, local|mesh-ancestor
24597659|NCT00950625|Anesthetics|anesthetics|mesh-ancestor
24597660|NCT00950625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24597661|NCT00950625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597662|NCT00950625|Sensory System Agents|sensory system agents|mesh-ancestor
24597663|NCT00950625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24597664|NCT00950625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24597665|NCT00950625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24597667|NCT00950625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24597668|NCT00950625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597670|NCT00950677|Pramlintide|pramlintide|mesh-list
24597671|NCT00950677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24597672|NCT00950677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597673|NCT00950677|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24597674|NCT00950677|Incretins|incretins|mesh-ancestor
24597675|NCT00950677|Hormones|hormones|mesh-ancestor
24597676|NCT00950677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24597678|NCT00950794|Tulobuterol|tulobuterol|mesh-list
24852911|NCT02264743|Hormones|hormones|mesh-ancestor
24597714|NCT00951106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24597715|NCT00951106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24597716|NCT00951106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597717|NCT00951106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597718|NCT00951132|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25073126|NCT03397069|Midazolam|midazolam|mesh-list
24597719|NCT00951132|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24597720|NCT00951132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24597721|NCT00951132|Antimetabolites|antimetabolites|mesh-ancestor
24597722|NCT00951132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597723|NCT00951132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24597724|NCT00951132|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24597725|NCT00951132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597726|NCT00951223|Interferons|interferons|mesh-list
24597765|NCT00951600|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24597766|NCT00951600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24597767|NCT00951834|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24597768|NCT00951834|Antioxidants|antioxidants|mesh-ancestor
24597769|NCT00951834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597770|NCT00951834|Protective Agents|protective agents|mesh-ancestor
24597771|NCT00951834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597772|NCT00951834|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24597773|NCT00951834|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24597774|NCT00951834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597775|NCT00951834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24597776|NCT00951847|Oxcarbazepine|oxcarbazepine|mesh-list
24597777|NCT00951847|Anticonvulsants|anticonvulsants|mesh-ancestor
24597778|NCT00951847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24597779|NCT00951847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24852913|NCT02264743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852914|NCT02264743|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24662322|NCT01294059|Milnacipran|milnacipran|mesh-list
24597810|NCT00952016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597811|NCT00952016|Dermatologic Agents|dermatologic agents|mesh-ancestor
24597812|NCT00952016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208542|NCT02131493|Gemcitabine|gemcitabine|mesh-list
25208543|NCT02131493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25208544|NCT02131493|Antimetabolites|antimetabolites|mesh-ancestor
25208545|NCT02131493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208546|NCT02131493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597813|NCT00952016|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24597814|NCT00952016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24597815|NCT00952016|Immunologic Factors|immunologic factors|mesh-ancestor
24597816|NCT00952016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24597817|NCT00952016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24597819|NCT00952029|Bevacizumab|bevacizumab|mesh-list
24597820|NCT00952029|Fluorouracil|fluorouracil|mesh-list
24597821|NCT00952029|Irinotecan|irinotecan|mesh-list
24597822|NCT00952029|Calcium|calcium|mesh-list
24597824|NCT00952029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24597825|NCT00952029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597826|NCT00952029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24597827|NCT00952029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24597828|NCT00952029|Growth Substances|growth substances|mesh-ancestor
24597829|NCT00952029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597830|NCT00952029|Growth Inhibitors|growth inhibitors|mesh-ancestor
25404881|NCT03646188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24597831|NCT00952029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24597832|NCT00952029|Antimetabolites|antimetabolites|mesh-ancestor
24597833|NCT00952029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597834|NCT00952029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24597835|NCT00952029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24597881|NCT00952432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24597882|NCT00952432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597884|NCT00952432|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24597886|NCT00952497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597887|NCT00952497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24597888|NCT00952497|Antimetabolites|antimetabolites|mesh-ancestor
24597939|NCT00952913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597940|NCT00952913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597941|NCT00952952|Mesalamine|mesalamine|mesh-list
24597942|NCT00952952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25241763|NCT05299931|Ustekinumab|ustekinumab|mesh-list
24634941|NCT01136031|Mitosis Modulators|mitosis modulators|mesh-ancestor
24634942|NCT01136031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634943|NCT01136031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25073180|NCT03396523|Losartan|losartan|mesh-list
24597943|NCT00952952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24597944|NCT00952952|Analgesics|analgesics|mesh-ancestor
24852917|NCT02264743|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24598035|NCT00953394|Fluorouracil|fluorouracil|mesh-list
24598036|NCT00953394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24636167|NCT01143584|Dopamine|dopamine|mesh-list
24598037|NCT00953394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24598038|NCT00953394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598039|NCT00953394|Antimetabolites|antimetabolites|mesh-ancestor
24598040|NCT00953394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852923|NCT02264795|Anesthetics, Local|anesthetics, local|mesh-ancestor
24852924|NCT02264795|Anesthetics|anesthetics|mesh-ancestor
24598041|NCT00953394|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24598042|NCT00953394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24598043|NCT00953394|Immunologic Factors|immunologic factors|mesh-ancestor
24598044|NCT00953394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598046|NCT00953459|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24598047|NCT00953459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598048|NCT00953459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24598101|NCT00953914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598102|NCT00953914|Cholinergic Agents|cholinergic agents|mesh-ancestor
24598103|NCT00953914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24598104|NCT00953914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598107|NCT00954005|Oxaliplatin|oxaliplatin|mesh-list
24598108|NCT00954005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24598109|NCT00954005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598110|NCT00954005|Immunologic Factors|immunologic factors|mesh-ancestor
24598180|NCT00954395|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24598181|NCT00954395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24598182|NCT00954395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598183|NCT00954395|Hemostatics|hemostatics|mesh-ancestor
24598184|NCT00954395|Coagulants|coagulants|mesh-ancestor
24598185|NCT00954395|Anticoagulants|anticoagulants|mesh-ancestor
24598186|NCT00954486|Epoetin Alfa|epoetin alfa|mesh-list
24598187|NCT00954486|Hematinics|hematinics|mesh-ancestor
25208547|NCT02131493|Antiviral Agents|antiviral agents|mesh-ancestor
25208548|NCT02131493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24598188|NCT00954525|Ascorbic Acid|ascorbic acid|mesh-list
24598189|NCT00954525|Gemcitabine|gemcitabine|mesh-list
24598190|NCT00954525|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24598250|NCT00954785|Analgesics|analgesics|mesh-ancestor
24598251|NCT00954785|Sensory System Agents|sensory system agents|mesh-ancestor
24598252|NCT00954785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24598253|NCT00954785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598254|NCT00954785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24598255|NCT00954785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24598256|NCT00954785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24598257|NCT00954785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598258|NCT00954785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598259|NCT00954785|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24598260|NCT00954798|Vaccines|vaccines|mesh-list
24598261|NCT00954798|Immunologic Factors|immunologic factors|mesh-ancestor
24598262|NCT00954798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598263|NCT00954811|Progesterone|progesterone|mesh-list
24598264|NCT00954811|Progestins|progestins|mesh-ancestor
24852940|NCT02264834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852942|NCT02264834|Sensory System Agents|sensory system agents|mesh-ancestor
24852943|NCT02264834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24852944|NCT02264834|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24852945|NCT02264834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24852946|NCT02264834|Anesthetics, General|anesthetics, general|mesh-ancestor
24852947|NCT02264834|Anesthetics|anesthetics|mesh-ancestor
24598292|NCT00955149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598293|NCT00955149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598294|NCT00955162|Buprenorphine|buprenorphine|mesh-list
24598295|NCT00955162|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
24598296|NCT00955162|Naloxone|naloxone|mesh-list
24598297|NCT00955162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24598298|NCT00955162|Narcotics|narcotics|mesh-ancestor
24598299|NCT00955162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24598300|NCT00955162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598301|NCT00955162|Analgesics|analgesics|mesh-ancestor
24598302|NCT00955162|Sensory System Agents|sensory system agents|mesh-ancestor
24598303|NCT00955162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24598304|NCT00955162|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24598305|NCT00955214|Paclitaxel|paclitaxel|mesh-list
24598306|NCT00955214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24598307|NCT00955214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598308|NCT00955214|Tubulin Modulators|tubulin modulators|mesh-ancestor
24598309|NCT00955214|Antimitotic Agents|antimitotic agents|mesh-ancestor
24598310|NCT00955214|Mitosis Modulators|mitosis modulators|mesh-ancestor
24598312|NCT00955227|Ezetimibe|ezetimibe|mesh-list
24852954|NCT02264847|Hormone Antagonists|hormone antagonists|mesh-ancestor
24852955|NCT02264847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24852956|NCT02264847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666836|NCT01321125|Chlorhexidine|chlorhexidine|mesh-list
24598502|NCT00956319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24598503|NCT00956319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598504|NCT00956319|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24598505|NCT00956319|GABA Agonists|gaba agonists|mesh-ancestor
24598506|NCT00956319|GABA Agents|gaba agents|mesh-ancestor
24598507|NCT00956319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24598508|NCT00956319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598509|NCT00956319|Anticonvulsants|anticonvulsants|mesh-ancestor
24598510|NCT00956319|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24598511|NCT00956319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24598512|NCT00956319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24598513|NCT00956319|GABA Modulators|gaba modulators|mesh-ancestor
24598514|NCT00956397|Rifaximin|rifaximin|mesh-list
24598515|NCT00956397|Lactulose|lactulose|mesh-list
24598516|NCT00956397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24598557|NCT00956644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24598558|NCT00956644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598559|NCT00956644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25208549|NCT02131493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208550|NCT02131493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25208551|NCT02131493|Immunologic Factors|immunologic factors|mesh-ancestor
24489621|NCT00474435|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24489622|NCT00474435|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24489623|NCT00474435|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24489625|NCT00474591|Fondaparinux|fondaparinux|mesh-list
24489626|NCT00474591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24489656|NCT00474721|Antipyretics|antipyretics|mesh-ancestor
24489657|NCT00474721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24489658|NCT00474721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24489659|NCT00474721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24489660|NCT00474721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24489661|NCT00474721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24489662|NCT00474721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489663|NCT00474721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24489664|NCT00474721|Narcotics|narcotics|mesh-ancestor
24598560|NCT00956644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598561|NCT00956644|Vasodilator Agents|vasodilator agents|mesh-ancestor
25252346|NCT02507440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25252347|NCT02507440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252348|NCT02507440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25252349|NCT02507440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25252350|NCT02507440|Anesthetics, General|anesthetics, general|mesh-ancestor
25252351|NCT02507362|Riboflavin|riboflavin|mesh-list
25252352|NCT02507362|Dextrans|dextrans|mesh-list
25252353|NCT02507362|Vitamin B Complex|vitamin b complex|mesh-ancestor
25252354|NCT02507362|Vitamins|vitamins|mesh-ancestor
25252355|NCT02507362|Micronutrients|micronutrients|mesh-ancestor
25252356|NCT02507362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252357|NCT02507362|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25252358|NCT02507362|Dermatologic Agents|dermatologic agents|mesh-ancestor
25252359|NCT02507362|Anticoagulants|anticoagulants|mesh-ancestor
25252360|NCT02507362|Plasma Substitutes|plasma substitutes|mesh-ancestor
25252374|NCT02507323|Ticagrelor|ticagrelor|mesh-list
24598562|NCT00956644|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24598563|NCT00956644|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24852963|NCT02264873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24852964|NCT02264873|Antimetabolites|antimetabolites|mesh-ancestor
24598802|NCT00958204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24852965|NCT02264873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852966|NCT02264873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24852967|NCT02264873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852968|NCT02264912|Clopidogrel|clopidogrel|mesh-list
24852970|NCT02264912|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24852971|NCT02264912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
24852972|NCT02264912|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24852973|NCT02264912|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24852974|NCT02264912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24852975|NCT02264912|Purinergic Agents|purinergic agents|mesh-ancestor
24852976|NCT02264912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24598565|NCT00956696|Anticonvulsants|anticonvulsants|mesh-ancestor
24598566|NCT00956696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24598567|NCT00956696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598568|NCT00956748|Acetylcysteine|acetylcysteine|mesh-list
24598569|NCT00956748|Ciprofloxacin|ciprofloxacin|mesh-list
24598570|NCT00956748|Dexamethasone|dexamethasone|mesh-list
24598571|NCT00956748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24598572|NCT00956748|Antiemetics|antiemetics|mesh-ancestor
24598573|NCT00956748|Autonomic Agents|autonomic agents|mesh-ancestor
24666910|NCT01321489|Sildenafil Citrate|sildenafil citrate|mesh-list
24598675|NCT00957203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598676|NCT00957203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598678|NCT00957216|Coenzyme Q10|coenzyme q10|mesh-list
24598679|NCT00957216|Micronutrients|micronutrients|mesh-ancestor
24598680|NCT00957216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598681|NCT00957216|Vitamins|vitamins|mesh-ancestor
24598682|NCT00957320|Sirolimus|sirolimus|mesh-list
24598683|NCT00957320|Asparaginase|asparaginase|mesh-list
24598685|NCT00957320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24598686|NCT00957320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24598687|NCT00957320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24598752|NCT00957879|Vitamins|vitamins|mesh-ancestor
24598767|NCT00958022|Keratolytic Agents|keratolytic agents|mesh-ancestor
24598768|NCT00958022|Dermatologic Agents|dermatologic agents|mesh-ancestor
24598769|NCT00958022|Tubulin Modulators|tubulin modulators|mesh-ancestor
24598770|NCT00958022|Antimitotic Agents|antimitotic agents|mesh-ancestor
25208552|NCT02131493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208553|NCT02115295|Cytarabine|cytarabine|mesh-list
25676499|NCT01798992|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25676500|NCT01798992|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25676501|NCT01799213|Meloxicam|meloxicam|mesh-list
25676502|NCT01799213|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25676503|NCT01799213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25676504|NCT01799213|Analgesics|analgesics|mesh-ancestor
25676505|NCT01799213|Sensory System Agents|sensory system agents|mesh-ancestor
25676506|NCT01799213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25676507|NCT01799213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676508|NCT01799213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25676509|NCT01799213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25676510|NCT01799213|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25676511|NCT01799213|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25676512|NCT01799213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208554|NCT02115295|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
25252387|NCT02507245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252388|NCT02507232|Temozolomide|temozolomide|mesh-list
25252389|NCT02507232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25252390|NCT02507232|Alkylating Agents|alkylating agents|mesh-ancestor
25252391|NCT02507232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252392|NCT02507232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25252393|NCT02507284|SRX246|srx246|mesh-list
25252394|NCT02507284|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25252395|NCT02507284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252396|NCT02507284|Natriuretic Agents|natriuretic agents|mesh-ancestor
25252397|NCT02507284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252398|NCT02506998|Histamine|histamine|mesh-list
25252399|NCT02506998|Histamine Antagonists|histamine antagonists|mesh-list
25252407|NCT02507167|Rifampin|rifampin|mesh-list
25208555|NCT02115295|Venetoclax|venetoclax|mesh-list
25208556|NCT02115295|Idarubicin|idarubicin|mesh-list
25208557|NCT02115295|Cladribine|cladribine|mesh-list
25208558|NCT02115295|Midostaurin|midostaurin|mesh-list
25208559|NCT02115295|Staurosporine|staurosporine|mesh-list
25208560|NCT02115295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25208561|NCT02115295|Antimetabolites|antimetabolites|mesh-ancestor
25208562|NCT02115295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208563|NCT02115295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208564|NCT02115295|Antiviral Agents|antiviral agents|mesh-ancestor
25208565|NCT02115295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25208566|NCT02115295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25208567|NCT02115295|Immunologic Factors|immunologic factors|mesh-ancestor
25208568|NCT02115295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598771|NCT00958022|Mitosis Modulators|mitosis modulators|mesh-ancestor
24598773|NCT00958100|Lamivudine|lamivudine|mesh-list
24598774|NCT00958100|Emtricitabine|emtricitabine|mesh-list
24598775|NCT00958100|Raltegravir Potassium|raltegravir potassium|mesh-list
24598776|NCT00958100|Abacavir|abacavir|mesh-list
24598777|NCT00958100|Dideoxynucleosides|dideoxynucleosides|mesh-list
24598778|NCT00958100|Antiviral Agents|antiviral agents|mesh-ancestor
24598779|NCT00958100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24598780|NCT00958100|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24598781|NCT00958100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24598787|NCT00958100|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24598788|NCT00958100|Antimetabolites|antimetabolites|mesh-ancestor
24636216|NCT01143987|Cinacalcet|cinacalcet|mesh-list
24598790|NCT00958139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598791|NCT00958139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598793|NCT00958204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24598794|NCT00958204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24598795|NCT00958204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24598796|NCT00958204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598797|NCT00958204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24598798|NCT00958204|Serotonin Agents|serotonin agents|mesh-ancestor
24598799|NCT00958204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852990|NCT02265068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598968|NCT05351385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852991|NCT02265068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852993|NCT02265276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24852994|NCT02265276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852995|NCT02265289|Clopidogrel|clopidogrel|mesh-list
24852996|NCT02265289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24599054|NCT05350371|Pirfenidone|pirfenidone|mesh-list
25676513|NCT01799213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676514|NCT01799226|Triclosan|triclosan|mesh-list
25676515|NCT01799226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25676516|NCT01799226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25676517|NCT01799226|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25676518|NCT01799226|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25676519|NCT01799226|Antimetabolites|antimetabolites|mesh-ancestor
25676520|NCT01799226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676521|NCT01799226|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25676522|NCT01799590|Topiramate|topiramate|mesh-list
25676523|NCT01799590|Anticonvulsants|anticonvulsants|mesh-ancestor
25676524|NCT01799590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25676525|NCT01799590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676526|NCT01799941|Quinidine|quinidine|mesh-list
25252422|NCT02507076|Melphalan|melphalan|mesh-list
24599055|NCT05350371|Analgesics|analgesics|mesh-ancestor
24599056|NCT05350371|Sensory System Agents|sensory system agents|mesh-ancestor
24599057|NCT05350371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24599058|NCT05350371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599059|NCT05350371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24599060|NCT05350371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24599061|NCT05350371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24599062|NCT05350371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24599183|NCT05014061|Sensory System Agents|sensory system agents|mesh-ancestor
24599184|NCT05014061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24599185|NCT05014061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599186|NCT05014061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24599187|NCT05014061|Vasodilator Agents|vasodilator agents|mesh-ancestor
24599188|NCT05014061|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25073256|NCT03396250|Antiemetics|antiemetics|mesh-ancestor
25208569|NCT02115295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25208570|NCT02115295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24599189|NCT05014061|Purinergic Agonists|purinergic agonists|mesh-ancestor
24599190|NCT05014061|Purinergic Agents|purinergic agents|mesh-ancestor
24599191|NCT05014061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24599192|NCT05014061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853005|NCT02265328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24853006|NCT02265328|Glucocorticoids|glucocorticoids|mesh-ancestor
24853007|NCT02265328|Hormones|hormones|mesh-ancestor
24853008|NCT02265328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24599193|NCT05003245|Ranibizumab|ranibizumab|mesh-list
24599194|NCT05003245|Antibodies|antibodies|mesh-list
24599195|NCT05003245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24599196|NCT05003245|Mitogens|mitogens|mesh-list
24599197|NCT05003245|Endothelial Growth Factors|endothelial growth factors|mesh-list
24599198|NCT05003245|Immunologic Factors|immunologic factors|mesh-ancestor
24599199|NCT05003245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599200|NCT05003245|Mitosis Modulators|mitosis modulators|mesh-ancestor
24599201|NCT05003245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599202|NCT05003245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24599203|NCT05003245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24599338|NCT04720547|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24599339|NCT04720547|GABA Agonists|gaba agonists|mesh-ancestor
24599348|NCT04718285|Hormone Antagonists|hormone antagonists|mesh-ancestor
24599803|NCT03867383|Calcium|calcium|mesh-list
24599349|NCT04718285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24599356|NCT04699604|Levocetirizine|levocetirizine|mesh-list
24599415|NCT04591431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24599416|NCT04591431|Immunologic Factors|immunologic factors|mesh-ancestor
24599417|NCT04591431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599418|NCT04591431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24599419|NCT04591431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24599420|NCT04591431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24599421|NCT04591431|Tubulin Modulators|tubulin modulators|mesh-ancestor
24599422|NCT04591431|Antimitotic Agents|antimitotic agents|mesh-ancestor
24599436|NCT04577014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599437|NCT04577014|Antiviral Agents|antiviral agents|mesh-ancestor
24599438|NCT04577014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24599439|NCT04577014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24599440|NCT04577014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24599441|NCT04577014|Immunologic Factors|immunologic factors|mesh-ancestor
24599442|NCT04577014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635410|NCT01138956|Antidotes|antidotes|mesh-ancestor
24599443|NCT04577014|Tubulin Modulators|tubulin modulators|mesh-ancestor
24636292|NCT01144650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24636293|NCT01144650|Antimalarials|antimalarials|mesh-ancestor
24599503|NCT04476992|Nitric Oxide|nitric oxide|mesh-list
24599504|NCT04476992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24599505|NCT04476992|Autonomic Agents|autonomic agents|mesh-ancestor
24599506|NCT04476992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24599507|NCT04476992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599508|NCT04476992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24599509|NCT04476992|Respiratory System Agents|respiratory system agents|mesh-ancestor
24599510|NCT04476992|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24599511|NCT04476992|Antioxidants|antioxidants|mesh-ancestor
24599512|NCT04476992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676527|NCT01799941|Dextromethorphan|dextromethorphan|mesh-list
24599513|NCT04476992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25208571|NCT02115295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25208572|NCT02115295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24599514|NCT04476992|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24599515|NCT04476992|Vasodilator Agents|vasodilator agents|mesh-ancestor
24599516|NCT04476992|Gasotransmitters|gasotransmitters|mesh-ancestor
24599517|NCT04476992|Protective Agents|protective agents|mesh-ancestor
24599518|NCT04444804|Rivaroxaban|rivaroxaban|mesh-list
24599519|NCT04444804|Phenprocoumon|phenprocoumon|mesh-list
24599540|NCT04413799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24599541|NCT04413799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599542|NCT04413799|Sensory System Agents|sensory system agents|mesh-ancestor
24599543|NCT04413799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24599544|NCT04413799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24599545|NCT04413799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24599560|NCT04370509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24599629|NCT04119024|Cyclophosphamide|cyclophosphamide|mesh-list
24599630|NCT04119024|Fludarabine|fludarabine|mesh-list
24599631|NCT04119024|Fludarabine phosphate|fludarabine phosphate|mesh-list
24599632|NCT04119024|Interleukin-2|interleukin-2|mesh-list
24599633|NCT04119024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24599634|NCT04119024|Immunologic Factors|immunologic factors|mesh-ancestor
24599635|NCT04119024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599636|NCT04119024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24599643|NCT04119024|Antimetabolites|antimetabolites|mesh-ancestor
24599700|NCT03973177|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24599701|NCT03973177|Prednisolone|prednisolone|mesh-list
24599702|NCT03973177|Prednisolone acetate|prednisolone acetate|mesh-list
24599703|NCT03973177|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24599704|NCT03973177|Prednisolone phosphate|prednisolone phosphate|mesh-list
24599705|NCT03973177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24599706|NCT03973177|Antiemetics|antiemetics|mesh-ancestor
24599707|NCT03973177|Autonomic Agents|autonomic agents|mesh-ancestor
24599708|NCT03973177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24599709|NCT03973177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599710|NCT03973177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24599711|NCT03973177|Glucocorticoids|glucocorticoids|mesh-ancestor
24599781|NCT03913559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24599782|NCT03913559|Histamine Antagonists|histamine antagonists|mesh-ancestor
24599783|NCT03913559|Histamine Agents|histamine agents|mesh-ancestor
24599784|NCT03913559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24599785|NCT03913559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24599786|NCT03913559|Antipruritics|antipruritics|mesh-ancestor
24599787|NCT03913559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24599788|NCT03913559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24599804|NCT03867383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24599805|NCT03867383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599806|NCT03867383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24599808|NCT03866499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599809|NCT03866499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24599810|NCT03866499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24599811|NCT03866499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853037|NCT02265718|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24853038|NCT02265718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24853039|NCT02265718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24853040|NCT02265718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853041|NCT02265718|Dopamine Agents|dopamine agents|mesh-ancestor
24853042|NCT02265718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24853044|NCT02265731|Venetoclax|venetoclax|mesh-list
24853045|NCT02265731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24853046|NCT02265731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24853047|NCT02265731|Immunologic Factors|immunologic factors|mesh-ancestor
24663888|NCT01303952|Eculizumab|eculizumab|mesh-list
24599812|NCT03844750|Pembrolizumab|pembrolizumab|mesh-list
24599813|NCT03844750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24599814|NCT03844750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599815|NCT03824561|Vedolizumab|vedolizumab|mesh-list
25208573|NCT02115295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25208574|NCT02108964|Nazartinib|nazartinib|mesh-list
25208575|NCT02108964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599857|NCT03449758|Leflunomide|leflunomide|mesh-list
24599858|NCT03449758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25252495|NCT02506777|Melatonin|melatonin|mesh-list
24599859|NCT03449758|Abortifacient Agents|abortifacient agents|mesh-ancestor
24599860|NCT03449758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24599861|NCT03449758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599863|NCT03449758|Antimetabolites|antimetabolites|mesh-ancestor
24853050|NCT02265770|Cyclophosphamide|cyclophosphamide|mesh-list
24853051|NCT02265770|Cisplatin|cisplatin|mesh-list
24853052|NCT02265770|Carboplatin|carboplatin|mesh-list
24853054|NCT02265770|Etoposide|etoposide|mesh-list
24853055|NCT02265770|Etoposide phosphate|etoposide phosphate|mesh-list
24853056|NCT02265770|Vincristine|vincristine|mesh-list
24599907|NCT03047070|Lidocaine|lidocaine|mesh-list
24599908|NCT03047070|Anesthetics, Local|anesthetics, local|mesh-ancestor
24599909|NCT03047070|Anesthetics|anesthetics|mesh-ancestor
24599910|NCT03047070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24599911|NCT03047070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635514|NCT01139840|Ergocalciferols|ergocalciferols|mesh-list
24635560|NCT01140126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635561|NCT01140126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24635562|NCT01140126|Antiviral Agents|antiviral agents|mesh-ancestor
24635563|NCT01140126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24635564|NCT01140308|Ubiquinone|ubiquinone|mesh-list
24599912|NCT03047070|Sensory System Agents|sensory system agents|mesh-ancestor
24599913|NCT03047070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24599914|NCT03047070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24599915|NCT03047070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24599916|NCT03047070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24599917|NCT03047070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24667179|NCT01322867|GABA Agents|gaba agents|mesh-ancestor
24599933|NCT03040778|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24599934|NCT03040778|Vasodilator Agents|vasodilator agents|mesh-ancestor
24599935|NCT03040778|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24599943|NCT03024684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24599944|NCT03024684|Antimetabolites|antimetabolites|mesh-ancestor
24599945|NCT03024684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599946|NCT03024684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24599947|NCT03024684|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24599948|NCT03024684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24599949|NCT02985541|Levonorgestrel|levonorgestrel|mesh-list
24599950|NCT02985541|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24599951|NCT02985541|Contraceptive Agents|contraceptive agents|mesh-ancestor
24599952|NCT02985541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24599953|NCT02985541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599954|NCT02985541|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24599955|NCT02985541|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24599957|NCT02968108|Ustekinumab|ustekinumab|mesh-list
24599958|NCT02968108|Dermatologic Agents|dermatologic agents|mesh-ancestor
24599959|NCT02942095|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24599961|NCT02942095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599976|NCT02923739|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24599977|NCT02923739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24599978|NCT02923739|Endothelial Growth Factors|endothelial growth factors|mesh-list
24599980|NCT02923739|Immunoglobulins|immunoglobulins|mesh-list
24599981|NCT02923739|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24599982|NCT02923739|Immunoglobulin G|immunoglobulin g|mesh-list
24599983|NCT02923739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24853060|NCT02265770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853061|NCT02265770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24853062|NCT02265770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24853063|NCT02265770|Alkylating Agents|alkylating agents|mesh-ancestor
24599993|NCT02923739|Growth Inhibitors|growth inhibitors|mesh-ancestor
24599994|NCT02923739|Immunologic Factors|immunologic factors|mesh-ancestor
25208576|NCT02096159|Trimethoprim|trimethoprim|mesh-list
25208577|NCT02096159|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24635565|NCT01140308|Coenzyme Q10|coenzyme q10|mesh-list
24600001|NCT02897778|Entinostat|entinostat|mesh-list
24600002|NCT02897778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600003|NCT02897778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24600004|NCT02897778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600005|NCT02897778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676528|NCT01799941|Antitussive Agents|antitussive agents|mesh-ancestor
24600006|NCT02882282|Pembrolizumab|pembrolizumab|mesh-list
24600007|NCT02882282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24600008|NCT02882282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600009|NCT02879409|Insulin|insulin|mesh-list
24600010|NCT02879409|Metformin|metformin|mesh-list
24600021|NCT02879409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24600026|NCT02879409|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24600027|NCT02826486|Leucovorin|leucovorin|mesh-list
24600028|NCT02826486|Pembrolizumab|pembrolizumab|mesh-list
24600029|NCT02826486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24600030|NCT02826486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600031|NCT02826486|Antidotes|antidotes|mesh-ancestor
24600032|NCT02826486|Protective Agents|protective agents|mesh-ancestor
24600038|NCT02815592|Etoposide|etoposide|mesh-list
24600039|NCT02815592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24853068|NCT02265770|Abortifacient Agents|abortifacient agents|mesh-ancestor
24853086|NCT02265770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24853087|NCT02265770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24853088|NCT02265770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24853089|NCT02265809|Aldesleukin|aldesleukin|mesh-list
24664135|NCT01305317|Atorvastatin|atorvastatin|mesh-list
24600155|NCT02343120|Zanubrutinib|zanubrutinib|mesh-list
24600156|NCT02343120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600157|NCT02343120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24600158|NCT02343120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600159|NCT02343120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853090|NCT02265809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24853092|NCT02265809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24853093|NCT02265809|Antiviral Agents|antiviral agents|mesh-ancestor
24853094|NCT02265809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24853095|NCT02265822|Midazolam|midazolam|mesh-list
24853096|NCT02265822|Melatonin|melatonin|mesh-list
24853097|NCT02265822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24853098|NCT02265822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24853099|NCT02265822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24853100|NCT02265822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853101|NCT02265822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24853102|NCT02265822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24600160|NCT02296684|Cisplatin|cisplatin|mesh-list
24600161|NCT02296684|Pembrolizumab|pembrolizumab|mesh-list
25208578|NCT02096159|Sulfamethoxazole|sulfamethoxazole|mesh-list
25208579|NCT02096159|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25208580|NCT02096159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25208581|NCT02096159|Renal Agents|renal agents|mesh-ancestor
24600238|NCT01590069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600239|NCT01590069|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24853103|NCT02265822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24853104|NCT02265822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24853105|NCT02265822|Anesthetics, General|anesthetics, general|mesh-ancestor
24853106|NCT02265822|Anesthetics|anesthetics|mesh-ancestor
24600240|NCT01590069|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24600241|NCT01590069|Antiviral Agents|antiviral agents|mesh-ancestor
24600242|NCT01590069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24600360|NCT00567567|Vitamin A|vitamin a|mesh-list
24600361|NCT00567567|Cyclophosphamide|cyclophosphamide|mesh-list
24600362|NCT00567567|Melphalan|melphalan|mesh-list
24600363|NCT00567567|Mechlorethamine|mechlorethamine|mesh-list
24600364|NCT00567567|Thiotepa|thiotepa|mesh-list
24600365|NCT00567567|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
24600366|NCT00567567|Cisplatin|cisplatin|mesh-list
24600412|NCT00346164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600413|NCT00346164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600414|NCT00346164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24600415|NCT00346164|Alkylating Agents|alkylating agents|mesh-ancestor
24600417|NCT00082706|Gemcitabine|gemcitabine|mesh-list
24600418|NCT00082706|Cisplatin|cisplatin|mesh-list
24600419|NCT00082706|Fluorouracil|fluorouracil|mesh-list
24600420|NCT00082706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600421|NCT00082706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24600422|NCT00082706|Antimetabolites|antimetabolites|mesh-ancestor
24600427|NCT00082706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24600428|NCT00082706|Immunologic Factors|immunologic factors|mesh-ancestor
24600500|NCT00959075|Micronutrients|micronutrients|mesh-ancestor
24600501|NCT00959075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600502|NCT00959075|Vitamin B Complex|vitamin b complex|mesh-ancestor
24600503|NCT00959101|Metformin|metformin|mesh-list
24600504|NCT00959101|Repaglinide|repaglinide|mesh-list
24600505|NCT00959101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24600506|NCT00959101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600507|NCT00959218|Dronabinol|dronabinol|mesh-list
24600508|NCT00959218|Hallucinogens|hallucinogens|mesh-ancestor
24600509|NCT00959218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600510|NCT00959218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24600511|NCT00959218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24600512|NCT00959218|Analgesics|analgesics|mesh-ancestor
24600524|NCT00959231|Fludarabine|fludarabine|mesh-list
24600525|NCT00959231|Fludarabine phosphate|fludarabine phosphate|mesh-list
24600526|NCT00959231|Cyclosporins|cyclosporins|mesh-list
24600527|NCT00959231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24600528|NCT00959231|Immunologic Factors|immunologic factors|mesh-ancestor
24600529|NCT00959231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600530|NCT00959231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24600531|NCT00959231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24600566|NCT00959400|Analgesics|analgesics|mesh-ancestor
24600567|NCT00959400|Sensory System Agents|sensory system agents|mesh-ancestor
24600568|NCT00959400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24600569|NCT00959400|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24600570|NCT00959400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24600571|NCT00959400|Anesthetics, General|anesthetics, general|mesh-ancestor
25208582|NCT02096159|Antimalarials|antimalarials|mesh-ancestor
24635808|NCT01141244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208583|NCT02096159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25208584|NCT02096159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24600572|NCT00959400|Anesthetics|anesthetics|mesh-ancestor
24600722|NCT00960284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600723|NCT00960284|Antiviral Agents|antiviral agents|mesh-ancestor
24600724|NCT00960284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24600725|NCT00960284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600726|NCT00960284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24600727|NCT00960284|Immunologic Factors|immunologic factors|mesh-ancestor
24600728|NCT00960284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600729|NCT00960284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24600730|NCT00960284|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24600731|NCT00960284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24600732|NCT00960310|Bicalutamide|bicalutamide|mesh-list
24600733|NCT00960310|Androgen Antagonists|androgen antagonists|mesh-ancestor
24600734|NCT00960310|Hormone Antagonists|hormone antagonists|mesh-ancestor
24600735|NCT00960310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24636409|NCT01145326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24600742|NCT00960336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24636413|NCT01145326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636415|NCT01145365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24636417|NCT01145404|Capecitabine|capecitabine|mesh-list
24636418|NCT01145404|Lapatinib|lapatinib|mesh-list
24636419|NCT01145404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24636420|NCT01145404|Antimetabolites|antimetabolites|mesh-ancestor
24636422|NCT01145404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24853143|NCT02266030|Respiratory System Agents|respiratory system agents|mesh-ancestor
24600853|NCT00960830|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24600854|NCT00960830|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24600855|NCT00960830|Adrenergic Agents|adrenergic agents|mesh-ancestor
24600856|NCT00960830|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24636439|NCT01145456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636440|NCT01145456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24636441|NCT01145456|Antiviral Agents|antiviral agents|mesh-ancestor
24636442|NCT01145456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24636443|NCT01145456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636444|NCT01145456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24636445|NCT01145456|Immunologic Factors|immunologic factors|mesh-ancestor
24636446|NCT01145456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600857|NCT00960830|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24600858|NCT00960830|Serotonin Agents|serotonin agents|mesh-ancestor
24600859|NCT00960830|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24600861|NCT00960921|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24600862|NCT00960921|Trace Elements|trace elements|mesh-ancestor
24600904|NCT00961155|Montelukast|montelukast|mesh-list
24600905|NCT00961155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24600906|NCT00961155|Autonomic Agents|autonomic agents|mesh-ancestor
24600907|NCT00961155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24636447|NCT01145534|Glyburide|glyburide|mesh-list
24636448|NCT01145534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24636449|NCT01145534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636450|NCT01145573|Calcium|calcium|mesh-list
24636451|NCT01145573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24636452|NCT01145573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636453|NCT01145612|Losartan|losartan|mesh-list
24636454|NCT01145612|Atenolol|atenolol|mesh-list
24636455|NCT01145612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24636456|NCT01145612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24853145|NCT02266030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24853146|NCT02266030|Protective Agents|protective agents|mesh-ancestor
24853147|NCT02266030|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24853148|NCT02266030|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24853149|NCT02266056|Rocuronium|rocuronium|mesh-list
24853150|NCT02266056|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24600910|NCT00961155|Respiratory System Agents|respiratory system agents|mesh-ancestor
24600946|NCT00961363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24600947|NCT00961363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25208585|NCT02096159|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25208586|NCT02096159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208587|NCT02096159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489765|NCT00475358|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24489766|NCT00475358|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24489767|NCT00475358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24489768|NCT00475358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24489769|NCT00475358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489770|NCT00475358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24636002|NCT01142401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24636003|NCT01142401|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24489771|NCT00475358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489773|NCT00475358|Sensory System Agents|sensory system agents|mesh-ancestor
24489774|NCT00475358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489775|NCT00475358|Antidepressive Agents|antidepressive agents|mesh-ancestor
24489776|NCT00475358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24489819|NCT00475527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24600949|NCT00961363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601362|NCT00964080|Micronutrients|micronutrients|mesh-ancestor
24600950|NCT00961363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600951|NCT00961467|Thalidomide|thalidomide|mesh-list
24600952|NCT00961467|Prednisone|prednisone|mesh-list
24636458|NCT01145612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24636459|NCT01145612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600953|NCT00961467|Melphalan|melphalan|mesh-list
24600954|NCT00961467|Lenalidomide|lenalidomide|mesh-list
24600955|NCT00961467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24600975|NCT00961480|Metformin|metformin|mesh-list
24601048|NCT00962312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24601049|NCT00962312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601051|NCT00962442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24601052|NCT00962442|Antiviral Agents|antiviral agents|mesh-ancestor
24601053|NCT00962442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24601054|NCT00962442|Expectorants|expectorants|mesh-ancestor
24601055|NCT00962442|Respiratory System Agents|respiratory system agents|mesh-ancestor
24601056|NCT00962442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24601057|NCT00962442|Antioxidants|antioxidants|mesh-ancestor
24601058|NCT00962442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601059|NCT00962442|Protective Agents|protective agents|mesh-ancestor
24601060|NCT00962442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601061|NCT00962442|Antidotes|antidotes|mesh-ancestor
24601063|NCT00962507|Panobinostat|panobinostat|mesh-list
24601064|NCT00962507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24601065|NCT00962507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24601066|NCT00962507|Immunologic Factors|immunologic factors|mesh-ancestor
24601067|NCT00962507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601068|NCT00962507|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24601069|NCT00962507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601070|NCT00962507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601071|NCT00962533|Telbivudine|telbivudine|mesh-list
25208588|NCT02096159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25208589|NCT02096159|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25208590|NCT02096159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25208591|NCT02096159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25208592|NCT01989598|Trametinib|trametinib|mesh-list
25208593|NCT01989598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208595|NCT01989598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208596|NCT01989598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208597|NCT01939275|Copper|copper|mesh-list
25208598|NCT01939275|Trastuzumab|trastuzumab|mesh-list
25208599|NCT01939275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25208600|NCT01939275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208601|NCT01939275|Trace Elements|trace elements|mesh-ancestor
25208602|NCT01939275|Micronutrients|micronutrients|mesh-ancestor
25208603|NCT01939275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208604|NCT01831076|Tamoxifen|tamoxifen|mesh-list
25208605|NCT01831076|Exemestane|exemestane|mesh-list
25208606|NCT01831076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25208607|NCT01831076|Hormone Antagonists|hormone antagonists|mesh-ancestor
25208608|NCT01831076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24457511|NCT00334646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24457512|NCT00334646|Alkylating Agents|alkylating agents|mesh-ancestor
24489854|NCT00475618|Fluorides|fluorides|mesh-list
24601072|NCT00962533|Antiviral Agents|antiviral agents|mesh-ancestor
24601103|NCT00962663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24601104|NCT00962663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24601105|NCT00962663|Analgesics|analgesics|mesh-ancestor
24601106|NCT00962663|Sensory System Agents|sensory system agents|mesh-ancestor
24601107|NCT00962663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24601108|NCT00962663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601109|NCT00962663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24601110|NCT00962663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24601111|NCT00962663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24812513|NCT02052908|Sensory System Agents|sensory system agents|mesh-ancestor
24812514|NCT02052908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812515|NCT02052908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812516|NCT02052908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24812517|NCT02052908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24812518|NCT02052908|Gout Suppressants|gout suppressants|mesh-ancestor
24601227|NCT00963573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24601360|NCT00964080|Vitamin B Complex|vitamin b complex|mesh-ancestor
24601361|NCT00964080|Vitamins|vitamins|mesh-ancestor
24601364|NCT00964106|Rifampin|rifampin|mesh-list
24601365|NCT00964106|Fluconazole|fluconazole|mesh-list
24601366|NCT00964106|Ketoconazole|ketoconazole|mesh-list
24601367|NCT00964106|Flurbiprofen|flurbiprofen|mesh-list
24601368|NCT00964106|Midazolam|midazolam|mesh-list
24601369|NCT00964106|Dextromethorphan|dextromethorphan|mesh-list
24601460|NCT00964275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601462|NCT00964288|Anesthetics, Local|anesthetics, local|mesh-ancestor
24601463|NCT00964288|Anesthetics|anesthetics|mesh-ancestor
24601464|NCT00964288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24601465|NCT00964288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601466|NCT00964288|Sensory System Agents|sensory system agents|mesh-ancestor
24601494|NCT00964535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24601495|NCT00964535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24601496|NCT00964535|Autonomic Agents|autonomic agents|mesh-ancestor
24601497|NCT00964535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24601498|NCT00964535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601499|NCT00964535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24601500|NCT00964535|Respiratory System Agents|respiratory system agents|mesh-ancestor
24601501|NCT00964535|Glucocorticoids|glucocorticoids|mesh-ancestor
24601502|NCT00964535|Hormones|hormones|mesh-ancestor
24601503|NCT00964535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24601504|NCT00964535|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24601559|NCT00964691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24601560|NCT00964691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601561|NCT00964691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601562|NCT00964691|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24601563|NCT00964691|Renal Agents|renal agents|mesh-ancestor
24853174|NCT02266329|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24601564|NCT00964704|Bevacizumab|bevacizumab|mesh-list
24601682|NCT00965549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601683|NCT00965640|Botulinum Toxins|botulinum toxins|mesh-list
24601684|NCT00965640|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24601685|NCT00965640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25404882|NCT03646188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24601686|NCT00965640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601687|NCT00965640|Cholinergic Agents|cholinergic agents|mesh-ancestor
24853178|NCT02266329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24853179|NCT02266329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853180|NCT02266329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853181|NCT02266355|Omalizumab|omalizumab|mesh-list
24853182|NCT02266355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24674717|NCT04736394|Epirubicin|epirubicin|mesh-list
25208609|NCT01831076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208610|NCT01831076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25208611|NCT01831076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208612|NCT01831076|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24490003|NCT00476138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24853183|NCT02266355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24853184|NCT02266355|Respiratory System Agents|respiratory system agents|mesh-ancestor
24601794|NCT00965991|Glyburide|glyburide|mesh-list
24601796|NCT00965991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601798|NCT00966004|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24601832|NCT00966121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24601833|NCT00966121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853188|NCT02266485|Antimetabolites|antimetabolites|mesh-ancestor
24667828|NCT05275907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24853195|NCT02266511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24602009|NCT00967031|Lapatinib|lapatinib|mesh-list
24602010|NCT00967031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24602011|NCT00967031|Antimetabolites|antimetabolites|mesh-ancestor
24602012|NCT00967031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602013|NCT00967031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602014|NCT00967031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24602015|NCT00967031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24602016|NCT00967057|Dexamethasone|dexamethasone|mesh-list
24602017|NCT00967057|Methotrexate|methotrexate|mesh-list
24602018|NCT00967057|Vincristine|vincristine|mesh-list
24602019|NCT00967057|Asparaginase|asparaginase|mesh-list
24602020|NCT00967057|Mitoxantrone|mitoxantrone|mesh-list
24602021|NCT00967057|Idarubicin|idarubicin|mesh-list
24602022|NCT00967057|Pegaspargase|pegaspargase|mesh-list
24602023|NCT00967057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24602024|NCT00967057|Antiemetics|antiemetics|mesh-ancestor
24602025|NCT00967057|Autonomic Agents|autonomic agents|mesh-ancestor
24602026|NCT00967057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24602085|NCT00967135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24602086|NCT00967135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24602087|NCT00967135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602088|NCT00967135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24602089|NCT00967135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24602090|NCT00967135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24602091|NCT00967135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24602092|NCT00967135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24602093|NCT00967148|Tinzaparin|tinzaparin|mesh-list
24602172|NCT00967512|Antiviral Agents|antiviral agents|mesh-ancestor
24602173|NCT00967512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24602174|NCT00967512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24602175|NCT00967512|Immunologic Factors|immunologic factors|mesh-ancestor
24602176|NCT00967512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602177|NCT00967512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24602178|NCT00967512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24602179|NCT00967512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24602180|NCT00967512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24602182|NCT00967538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24602183|NCT00967538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24602184|NCT00967538|Analgesics|analgesics|mesh-ancestor
24602185|NCT00967538|Sensory System Agents|sensory system agents|mesh-ancestor
25149484|NCT05467189|Paclitaxel|paclitaxel|mesh-list
24602186|NCT00967538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24602187|NCT00967538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602188|NCT00967538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24602189|NCT00967538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24602236|NCT00967707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24602237|NCT00967707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24602238|NCT00967707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24602239|NCT00967707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24602240|NCT00967707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24602241|NCT00967707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24602242|NCT00967707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602243|NCT00967707|Antimanic Agents|antimanic agents|mesh-ancestor
24602244|NCT00967707|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25208613|NCT01831076|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25208614|NCT01831076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24490005|NCT00476164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24490006|NCT00476164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490007|NCT00476164|Immunologic Factors|immunologic factors|mesh-ancestor
24602245|NCT00967707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24602246|NCT00967707|Cholinergic Agents|cholinergic agents|mesh-ancestor
24602248|NCT00967707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24602249|NCT00967707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24602250|NCT00967707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24667926|NCT05247619|Growth Substances|growth substances|mesh-ancestor
24602332|NCT00968383|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24602334|NCT00968383|Adrenergic Antagonists|adrenergic antagonists|mesh-list
24602335|NCT00968383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24602336|NCT00968383|Protease Inhibitors|protease inhibitors|mesh-ancestor
24602337|NCT00968383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24602338|NCT00968383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602339|NCT00968383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24602340|NCT00968383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602341|NCT00968396|Melphalan|melphalan|mesh-list
24602342|NCT00968396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24602343|NCT00968396|Alkylating Agents|alkylating agents|mesh-ancestor
24602344|NCT00968396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602345|NCT00968396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602346|NCT00968396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24602347|NCT00968396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24602348|NCT00968396|Immunologic Factors|immunologic factors|mesh-ancestor
24602383|NCT00968578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24602384|NCT00968578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602385|NCT00968578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24602386|NCT00968578|Glucocorticoids|glucocorticoids|mesh-ancestor
24602387|NCT00968578|Hormones|hormones|mesh-ancestor
24602418|NCT00968760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602419|NCT00968760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24602420|NCT00968760|Antimetabolites|antimetabolites|mesh-ancestor
24602421|NCT00968760|Antiviral Agents|antiviral agents|mesh-ancestor
24602422|NCT00968760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24602423|NCT00968760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24602424|NCT00968760|Immunologic Factors|immunologic factors|mesh-ancestor
24602425|NCT00968760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602426|NCT00968760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24602427|NCT00968760|Alkylating Agents|alkylating agents|mesh-ancestor
24602447|NCT00968903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24602448|NCT00968903|Antiemetics|antiemetics|mesh-ancestor
24602449|NCT00968903|Autonomic Agents|autonomic agents|mesh-ancestor
24602450|NCT00968903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24602451|NCT00968903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602452|NCT00968903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24602453|NCT00968903|Glucocorticoids|glucocorticoids|mesh-ancestor
24602454|NCT00968903|Hormones|hormones|mesh-ancestor
24602455|NCT00968903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24602456|NCT00968903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24602457|NCT00968903|Protective Agents|protective agents|mesh-ancestor
24602458|NCT00968903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24853230|NCT02266784|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24853231|NCT02266784|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24602459|NCT00968903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602534|NCT00969293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24602535|NCT00969293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602536|NCT00969293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24602537|NCT00969293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24602538|NCT00969293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24602577|NCT00969566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24602578|NCT00969566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676529|NCT01799941|Respiratory System Agents|respiratory system agents|mesh-ancestor
24602579|NCT00969566|Incretins|incretins|mesh-ancestor
24602581|NCT00969566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24602582|NCT00969566|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24602583|NCT00969566|Protease Inhibitors|protease inhibitors|mesh-ancestor
25208615|NCT01831076|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25208616|NCT01831076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25208617|NCT01831076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490008|NCT00476164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490009|NCT00476164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24602584|NCT00969566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759028|NCT01749085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24602593|NCT00969592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853232|NCT02266784|Cholinergic Agents|cholinergic agents|mesh-ancestor
24853233|NCT02266784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24853234|NCT02266784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853236|NCT02266849|Antidiarrheals|antidiarrheals|mesh-list
24853237|NCT02266849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24853238|NCT02265484|Rifaximin|rifaximin|mesh-list
24853239|NCT02265484|Bromocriptine|bromocriptine|mesh-list
24853240|NCT02265484|Lactulose|lactulose|mesh-list
24853241|NCT02265484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24853242|NCT02265484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24853247|NCT02265484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24853248|NCT02265484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853249|NCT02265484|Dopamine Agonists|dopamine agonists|mesh-ancestor
24602595|NCT00969631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24602596|NCT00969631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602598|NCT00969696|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24602599|NCT00969696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24602600|NCT00969696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602601|NCT00969696|Cholinergic Agents|cholinergic agents|mesh-ancestor
24602602|NCT00969696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24602603|NCT00969696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602604|NCT00969696|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24602605|NCT00969696|Autonomic Agents|autonomic agents|mesh-ancestor
24602606|NCT00969696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24602607|NCT00969696|Nootropic Agents|nootropic agents|mesh-ancestor
24602608|NCT00969800|Chlorine dioxide|chlorine dioxide|mesh-list
24602609|NCT00969800|Dental Disinfectants|dental disinfectants|mesh-ancestor
24602610|NCT00969800|Disinfectants|disinfectants|mesh-ancestor
24602611|NCT00969800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24602612|NCT00969813|Tofacitinib|tofacitinib|mesh-list
24602613|NCT00969813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24602615|NCT00969813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602616|NCT00969852|Sertraline|sertraline|mesh-list
24602617|NCT00969852|Antidepressive Agents|antidepressive agents|mesh-ancestor
24602618|NCT00969852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24602619|NCT00969852|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24602620|NCT00969852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24602621|NCT00969852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24602622|NCT00969852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602623|NCT00969852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24462335|NCT00355771|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24462336|NCT00355771|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24462337|NCT00355771|Histamine Antagonists|histamine antagonists|mesh-ancestor
24462368|NCT00355901|Visilizumab|visilizumab|mesh-list
24602633|NCT00969904|Antioxidants|antioxidants|mesh-ancestor
24853251|NCT02265484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24853252|NCT02265484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853253|NCT02266927|Fluticasone|fluticasone|mesh-list
24602634|NCT00969904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602635|NCT00969904|Protective Agents|protective agents|mesh-ancestor
24602636|NCT00969904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602637|NCT00969904|Antidotes|antidotes|mesh-ancestor
24602638|NCT00969982|Misoprostol|misoprostol|mesh-list
24602639|NCT00969982|Mifepristone|mifepristone|mesh-list
24602640|NCT00969982|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24602673|NCT00970138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208618|NCT01831076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272582|NCT02391480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25275599|NCT02370862|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25275601|NCT02370862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602674|NCT00970138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24602675|NCT00970138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24602676|NCT00970138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602677|NCT00970450|Acetaminophen|acetaminophen|mesh-list
24602678|NCT00970450|Tropisetron|tropisetron|mesh-list
24602679|NCT00970450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24602791|NCT00970970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602793|NCT00970996|Interferon-alpha|interferon-alpha|mesh-list
24602794|NCT00970996|Interferon alpha-2|interferon alpha-2|mesh-list
24602796|NCT00970996|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24602797|NCT00970996|Cisplatin|cisplatin|mesh-list
24602798|NCT00970996|Temozolomide|temozolomide|mesh-list
24602799|NCT00970996|Interleukin-2|interleukin-2|mesh-list
24602800|NCT00970996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24602801|NCT00970996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602802|NCT00970996|Tubulin Modulators|tubulin modulators|mesh-ancestor
24602803|NCT00970996|Antimitotic Agents|antimitotic agents|mesh-ancestor
24602804|NCT00970996|Mitosis Modulators|mitosis modulators|mesh-ancestor
24602805|NCT00970996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602806|NCT00970996|Antiviral Agents|antiviral agents|mesh-ancestor
24602807|NCT00970996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24602808|NCT00970996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24602809|NCT00970996|Alkylating Agents|alkylating agents|mesh-ancestor
24602810|NCT00970996|Immunologic Factors|immunologic factors|mesh-ancestor
24602811|NCT00970996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602812|NCT00970996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24602813|NCT00970996|Analgesics|analgesics|mesh-ancestor
24602814|NCT00970996|Sensory System Agents|sensory system agents|mesh-ancestor
24602815|NCT00970996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24602817|NCT00971074|Viscosupplements|viscosupplements|mesh-ancestor
24602818|NCT00971074|Protective Agents|protective agents|mesh-ancestor
24602819|NCT00971074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602820|NCT00971126|Thalidomide|thalidomide|mesh-list
24602821|NCT00971126|Sorafenib|sorafenib|mesh-list
24602822|NCT00971126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602834|NCT00971126|Growth Substances|growth substances|mesh-ancestor
24602835|NCT00971126|Growth Inhibitors|growth inhibitors|mesh-ancestor
24602836|NCT00971152|Menotropins|menotropins|mesh-list
24602837|NCT00971152|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24602838|NCT00971152|Fertility Agents|fertility agents|mesh-ancestor
24602863|NCT00971399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602864|NCT00971399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24602865|NCT00971399|Antipruritics|antipruritics|mesh-ancestor
24602866|NCT00971399|Dermatologic Agents|dermatologic agents|mesh-ancestor
24602926|NCT00971685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24602927|NCT00971685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602928|NCT00971685|Immunologic Factors|immunologic factors|mesh-ancestor
24602929|NCT00971685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24602930|NCT00971685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24602931|NCT00971685|Growth Substances|growth substances|mesh-ancestor
24602932|NCT00971685|Growth Inhibitors|growth inhibitors|mesh-ancestor
24602934|NCT00971724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24853259|NCT02266927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853260|NCT02266927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24853261|NCT02266927|Respiratory System Agents|respiratory system agents|mesh-ancestor
24603026|NCT00972101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603027|NCT00972101|Immunologic Factors|immunologic factors|mesh-ancestor
24603028|NCT00972101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603062|NCT00972218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24603064|NCT00972257|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24603065|NCT00972257|Dorzolamide|dorzolamide|mesh-list
24603066|NCT00972257|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24603067|NCT00972257|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24603068|NCT00972257|Adrenergic Agents|adrenergic agents|mesh-ancestor
24603069|NCT00972257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24603070|NCT00972257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603071|NCT00972257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25150098|NCT05324761|Pregabalin|pregabalin|mesh-list
24490211|NCT00477035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24490212|NCT00477035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24490214|NCT00477035|Antimitotic Agents|antimitotic agents|mesh-ancestor
24490215|NCT00477035|Mitosis Modulators|mitosis modulators|mesh-ancestor
24490216|NCT00477048|Saquinavir|saquinavir|mesh-list
24490217|NCT00477048|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24944204|NCT03962725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24603072|NCT00972257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24603073|NCT00972257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24603074|NCT00972257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24603075|NCT00972257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24603076|NCT00972257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24603077|NCT00972257|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24603078|NCT00972257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603079|NCT00972296|Carbon Fiber|carbon fiber|mesh-list
24603080|NCT00972296|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24853264|NCT02266940|DS-1971a|ds-1971a|mesh-list
24603120|NCT00972426|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24603121|NCT00972426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24603146|NCT00972660|Immunologic Factors|immunologic factors|mesh-ancestor
24636681|NCT01146925|Deferiprone|deferiprone|mesh-list
24603147|NCT00972660|Antifungal Agents|antifungal agents|mesh-ancestor
24603148|NCT00972660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24603149|NCT00972660|Dermatologic Agents|dermatologic agents|mesh-ancestor
24636925|NCT01148147|Adenosine|adenosine|mesh-list
24603150|NCT00972660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24603151|NCT00972660|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24603152|NCT00972660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24603153|NCT00972660|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24603154|NCT00972660|Antitubercular Agents|antitubercular agents|mesh-ancestor
24603155|NCT00972660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24603157|NCT00972712|Tipifarnib|tipifarnib|mesh-list
24603158|NCT00972712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603159|NCT00972790|Bupivacaine|bupivacaine|mesh-list
24603160|NCT00972790|Anesthetics, Local|anesthetics, local|mesh-ancestor
24603161|NCT00972790|Anesthetics|anesthetics|mesh-ancestor
24603162|NCT00972790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24603163|NCT00972790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603164|NCT00972790|Sensory System Agents|sensory system agents|mesh-ancestor
24603165|NCT00972790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24603166|NCT00972803|Chlorhexidine|chlorhexidine|mesh-list
24603167|NCT00972803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24603168|NCT00972803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24603169|NCT00972803|Disinfectants|disinfectants|mesh-ancestor
24603173|NCT00972829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24603209|NCT00972907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24603210|NCT00972907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24603211|NCT00972907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603220|NCT00972933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24603221|NCT00972933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603222|NCT00972946|Dextrans|dextrans|mesh-list
24603223|NCT00972946|Anticoagulants|anticoagulants|mesh-ancestor
24603234|NCT00972985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603236|NCT00972985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24603237|NCT00972985|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24853268|NCT02266940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603266|NCT00973050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603267|NCT00973050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603268|NCT00973115|Simvastatin|simvastatin|mesh-list
24603269|NCT00973115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24603270|NCT00973115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24603271|NCT00973115|Antimetabolites|antimetabolites|mesh-ancestor
24603272|NCT00973115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603273|NCT00973115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24603274|NCT00973115|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25208625|NCT01595581|Methyltestosterone|methyltestosterone|mesh-list
25208626|NCT01595581|Testosterone|testosterone|mesh-list
25208627|NCT01595581|Testosterone undecanoate|testosterone undecanoate|mesh-list
25208628|NCT01595581|Testosterone enanthate|testosterone enanthate|mesh-list
24637039|NCT01148446|Epirubicin|epirubicin|mesh-list
24490218|NCT00477048|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24490219|NCT00477048|Protease Inhibitors|protease inhibitors|mesh-ancestor
24490220|NCT00477048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603275|NCT00973115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603276|NCT00973128|Meglumine Antimoniate|meglumine antimoniate|mesh-list
24603277|NCT00973128|Sargramostim|sargramostim|mesh-list
24603278|NCT00973128|Immunologic Factors|immunologic factors|mesh-ancestor
24603279|NCT00973128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603280|NCT00973128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24603281|NCT00973128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25252914|NCT02504450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25252915|NCT02504450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252916|NCT02504450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25252917|NCT02504450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25252918|NCT02504450|Serotonin Agents|serotonin agents|mesh-ancestor
24924524|NCT04159155|Paclitaxel|paclitaxel|mesh-list
24924525|NCT04159155|Carboplatin|carboplatin|mesh-list
24603282|NCT00973128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24853289|NCT02267122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24853290|NCT02267122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24603284|NCT00973154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24603286|NCT00973154|Hormones|hormones|mesh-ancestor
24603287|NCT00973154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24603288|NCT00973154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603289|NCT00973154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24603290|NCT00973154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603291|NCT00973193|Panitumumab|panitumumab|mesh-list
24603315|NCT00973232|Analgesics|analgesics|mesh-ancestor
24603316|NCT00973232|Sensory System Agents|sensory system agents|mesh-ancestor
24603317|NCT00973232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24603318|NCT00973232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603319|NCT00973232|Antipyretics|antipyretics|mesh-ancestor
24603320|NCT00973232|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24603329|NCT00973245|Protease Inhibitors|protease inhibitors|mesh-ancestor
24603330|NCT00973245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603331|NCT00973245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603332|NCT00973271|Atorvastatin|atorvastatin|mesh-list
24603333|NCT00973271|Fenofibric acid|fenofibric acid|mesh-list
24603334|NCT00973271|Fenofibrate|fenofibrate|mesh-list
24603335|NCT00973271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24603336|NCT00973271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24603337|NCT00973271|Antimetabolites|antimetabolites|mesh-ancestor
24603338|NCT00973271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603339|NCT00973271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24603340|NCT00973271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24603341|NCT00973271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603342|NCT00973310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24603770|NCT00975494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24853295|NCT02267239|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24853296|NCT02267239|Listerine|listerine|mesh-list
24853297|NCT02267239|Hexetidine|hexetidine|mesh-list
24853298|NCT02267239|Menthol|menthol|mesh-list
24603461|NCT00973882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603462|NCT00973882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24603463|NCT00973882|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24603465|NCT00973882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603466|NCT00973882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603467|NCT00973986|Atorvastatin|atorvastatin|mesh-list
24603468|NCT00973986|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24603469|NCT00973986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24603470|NCT00973986|Antimetabolites|antimetabolites|mesh-ancestor
24603471|NCT00973986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603472|NCT00973986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24603473|NCT00973986|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24603474|NCT00973986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603475|NCT00973999|Botulinum Toxins|botulinum toxins|mesh-list
24603476|NCT00973999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24603500|NCT00974155|Dexetimide|dexetimide|mesh-list
24603501|NCT00974155|Citalopram|citalopram|mesh-list
24603502|NCT00974155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24603503|NCT00974155|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24603504|NCT00974155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24603505|NCT00974155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24603506|NCT00974155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603507|NCT00974155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24603508|NCT00974155|Serotonin Agents|serotonin agents|mesh-ancestor
25676530|NCT01799941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25676531|NCT01799941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25676532|NCT01799941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25676533|NCT01799941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676534|NCT01799941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676535|NCT01799941|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25252948|NCT02504398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252949|NCT02504398|Sympathomimetics|sympathomimetics|mesh-ancestor
24924547|NCT04159077|Tamsulosin|tamsulosin|mesh-list
24603524|NCT00974181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25208629|NCT01595581|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25208630|NCT01595581|Androgens|androgens|mesh-ancestor
25208631|NCT01595581|Hormones|hormones|mesh-ancestor
24490221|NCT00477048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490222|NCT00477048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24490223|NCT00477048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24603525|NCT00974181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603526|NCT00974181|Tubulin Modulators|tubulin modulators|mesh-ancestor
24603527|NCT00974181|Antimitotic Agents|antimitotic agents|mesh-ancestor
24603528|NCT00974181|Mitosis Modulators|mitosis modulators|mesh-ancestor
24603563|NCT00974441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603565|NCT00974441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24603598|NCT00974740|Antimetabolites|antimetabolites|mesh-ancestor
24603599|NCT00974740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603600|NCT00974740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24603601|NCT00974740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24603602|NCT00974740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603603|NCT00974753|Ketorolac|ketorolac|mesh-list
24603604|NCT00974753|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24603605|NCT00974753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24603606|NCT00974753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24603607|NCT00974753|Analgesics|analgesics|mesh-ancestor
24603609|NCT00974753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24603610|NCT00974753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853300|NCT02267239|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24853301|NCT02267239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24853302|NCT02267239|Disinfectants|disinfectants|mesh-ancestor
24853303|NCT02267239|Dermatologic Agents|dermatologic agents|mesh-ancestor
24853304|NCT02267239|Cariostatic Agents|cariostatic agents|mesh-ancestor
24853305|NCT02267239|Protective Agents|protective agents|mesh-ancestor
24853307|NCT02267239|Antipruritics|antipruritics|mesh-ancestor
24603618|NCT00974766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24603635|NCT00974792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24603636|NCT00974792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24603637|NCT00974792|Alkylating Agents|alkylating agents|mesh-ancestor
24603638|NCT00974792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603658|NCT00974792|Protective Agents|protective agents|mesh-ancestor
24603659|NCT00974792|Vitamin B Complex|vitamin b complex|mesh-ancestor
24603661|NCT00974792|Micronutrients|micronutrients|mesh-ancestor
24603662|NCT00974792|Tubulin Modulators|tubulin modulators|mesh-ancestor
24603663|NCT00974792|Antimitotic Agents|antimitotic agents|mesh-ancestor
24603664|NCT00974792|Mitosis Modulators|mitosis modulators|mesh-ancestor
24603665|NCT00974805|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24853322|NCT02267616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24853323|NCT02267616|Contraceptive Agents|contraceptive agents|mesh-ancestor
24853324|NCT02267616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24853325|NCT02267616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853326|NCT02267616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24853327|NCT02267655|Nitric Oxide|nitric oxide|mesh-list
24853328|NCT02267655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24628841|NCT01101659|Ketamine|ketamine|mesh-list
24603668|NCT00974805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24603669|NCT00974805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603670|NCT00974805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24603671|NCT00974805|Respiratory System Agents|respiratory system agents|mesh-ancestor
24603672|NCT00974805|Glucocorticoids|glucocorticoids|mesh-ancestor
24603673|NCT00974805|Hormones|hormones|mesh-ancestor
24603674|NCT00974805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24603675|NCT00974805|Sympathomimetics|sympathomimetics|mesh-ancestor
24603676|NCT00974935|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24603677|NCT00974935|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24603678|NCT00974935|Immunologic Factors|immunologic factors|mesh-ancestor
24603679|NCT00974935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603680|NCT00974935|Antacids|antacids|mesh-ancestor
24603681|NCT00974935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676536|NCT01799941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25676537|NCT01799941|Adrenergic Agents|adrenergic agents|mesh-ancestor
25676538|NCT01799941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24603682|NCT00974935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24603684|NCT00974961|Levobupivacaine|levobupivacaine|mesh-list
24603685|NCT00974961|Anesthetics, Local|anesthetics, local|mesh-ancestor
24603686|NCT00974961|Anesthetics|anesthetics|mesh-ancestor
24603687|NCT00974961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25208632|NCT01595581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25208633|NCT01595581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208634|NCT01595581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24490224|NCT00477048|Antiviral Agents|antiviral agents|mesh-ancestor
24490258|NCT00477282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490259|NCT00477282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490260|NCT00477282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490262|NCT00477373|Anticonvulsants|anticonvulsants|mesh-ancestor
24490342|NCT00477776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24490373|NCT00477815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24490374|NCT00477815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24490375|NCT00477815|Alkylating Agents|alkylating agents|mesh-ancestor
24490376|NCT00477815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490377|NCT00477815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24490378|NCT00477815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24490379|NCT00477854|Chromium|chromium|mesh-list
24490380|NCT00477854|Picolinic acid|picolinic acid|mesh-list
24490381|NCT00477854|Trace Elements|trace elements|mesh-ancestor
24490382|NCT00477854|Micronutrients|micronutrients|mesh-ancestor
24490383|NCT00477854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490384|NCT00477854|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24490385|NCT00477854|Chelating Agents|chelating agents|mesh-ancestor
24603688|NCT00974961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603689|NCT00974961|Sensory System Agents|sensory system agents|mesh-ancestor
24603690|NCT00974961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24603706|NCT00975052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603708|NCT00975065|Vildagliptin|vildagliptin|mesh-list
24603709|NCT00975065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24603726|NCT00975182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24603735|NCT00975312|Tretinoin|tretinoin|mesh-list
24603758|NCT00975390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603759|NCT00975390|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24603760|NCT00975390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603761|NCT00975390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603762|NCT00975390|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24603763|NCT00975390|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24603764|NCT00975390|Purinergic Agents|purinergic agents|mesh-ancestor
24603765|NCT00975390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24603766|NCT00975494|Sildenafil Citrate|sildenafil citrate|mesh-list
24603767|NCT00975494|Vasodilator Agents|vasodilator agents|mesh-ancestor
24603768|NCT00975494|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24603769|NCT00975494|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24603772|NCT00975494|Urological Agents|urological agents|mesh-ancestor
24603815|NCT00975819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24603816|NCT00975819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24603817|NCT00975819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24603818|NCT00975819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603819|NCT00975819|Antifungal Agents|antifungal agents|mesh-ancestor
24603820|NCT00975819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24603821|NCT00975819|Immunologic Factors|immunologic factors|mesh-ancestor
24603822|NCT00975819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603823|NCT00975897|Leucovorin|leucovorin|mesh-list
24603824|NCT00975897|Bevacizumab|bevacizumab|mesh-list
24603825|NCT00975897|Cetuximab|cetuximab|mesh-list
24603826|NCT00975897|Fluorouracil|fluorouracil|mesh-list
24603838|NCT00975897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25208635|NCT01595581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208636|NCT01595581|Anabolic Agents|anabolic agents|mesh-ancestor
25208637|NCT01542021|Androgens|androgens|mesh-list
25208638|NCT01542021|Hormones|hormones|mesh-ancestor
25208639|NCT01542021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25208640|NCT01542021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798257|NCT01961843|Hormone Antagonists|hormone antagonists|mesh-ancestor
25208641|NCT01514682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25208642|NCT01455389|Diphenhydramine|diphenhydramine|mesh-list
25208643|NCT01455389|Promethazine|promethazine|mesh-list
25208644|NCT01455389|Dexamethasone|dexamethasone|mesh-list
25208645|NCT01455389|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25208646|NCT01455389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25208647|NCT01455389|Antiemetics|antiemetics|mesh-ancestor
25208648|NCT01455389|Autonomic Agents|autonomic agents|mesh-ancestor
25208649|NCT01455389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25208650|NCT01455389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208651|NCT01455389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25208652|NCT01455389|Glucocorticoids|glucocorticoids|mesh-ancestor
25208653|NCT01455389|Hormones|hormones|mesh-ancestor
25272583|NCT02391181|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24490386|NCT00477854|Sequestering Agents|sequestering agents|mesh-ancestor
24603839|NCT00975897|Antimetabolites|antimetabolites|mesh-ancestor
24603840|NCT00975897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603841|NCT00975897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24603842|NCT00975897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24603843|NCT00975897|Immunologic Factors|immunologic factors|mesh-ancestor
24603844|NCT00975897|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24603845|NCT00975897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24603846|NCT00975897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603848|NCT00975897|Protective Agents|protective agents|mesh-ancestor
24603849|NCT00975897|Vitamin B Complex|vitamin b complex|mesh-ancestor
24603851|NCT00975897|Micronutrients|micronutrients|mesh-ancestor
24603852|NCT00975910|Lidocaine|lidocaine|mesh-list
24603853|NCT00975910|Anesthetics, Local|anesthetics, local|mesh-ancestor
24603854|NCT00975910|Anesthetics|anesthetics|mesh-ancestor
24636748|NCT01147146|Analgesics|analgesics|mesh-ancestor
24853338|NCT02267655|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24853339|NCT02267655|Vasodilator Agents|vasodilator agents|mesh-ancestor
24603863|NCT00975910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603865|NCT00975936|Antifungal Agents|antifungal agents|mesh-ancestor
24603866|NCT00975936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24603867|NCT00975936|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24603868|NCT00975936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24603869|NCT00975936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603986|NCT00976690|Immunologic Factors|immunologic factors|mesh-ancestor
24603987|NCT00976690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604007|NCT00976768|Immunologic Factors|immunologic factors|mesh-ancestor
24604008|NCT00976768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604009|NCT00976794|Carbamazepine|carbamazepine|mesh-list
24604010|NCT00976794|Valproic Acid|valproic acid|mesh-list
24604011|NCT00976794|Lithium Carbonate|lithium carbonate|mesh-list
24604012|NCT00976794|Antidepressive Agents|antidepressive agents|mesh-ancestor
24604013|NCT00976794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24604014|NCT00976794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604015|NCT00976794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604016|NCT00976794|Antimanic Agents|antimanic agents|mesh-ancestor
24853341|NCT02267655|Protective Agents|protective agents|mesh-ancestor
24853343|NCT02267681|Alfentanil|alfentanil|mesh-list
24604017|NCT00976794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24604018|NCT00976794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24604019|NCT00976794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604020|NCT00976794|Anticonvulsants|anticonvulsants|mesh-ancestor
24604021|NCT00976794|GABA Agents|gaba agents|mesh-ancestor
24604022|NCT00976794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24604023|NCT00976794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24604024|NCT00976794|Analgesics|analgesics|mesh-ancestor
24604025|NCT00976794|Sensory System Agents|sensory system agents|mesh-ancestor
24604026|NCT00976794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24604027|NCT00976794|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24604028|NCT00976794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24604029|NCT00976794|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24604158|NCT00977353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24604159|NCT00977353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24604160|NCT00977353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604161|NCT00977353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24604162|NCT00977353|Serotonin Agents|serotonin agents|mesh-ancestor
24604163|NCT00977353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604164|NCT00977353|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24604165|NCT00977353|Antidepressive Agents|antidepressive agents|mesh-ancestor
24604166|NCT00977353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24604168|NCT00977405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24604169|NCT00977405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24604170|NCT00977405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25274728|NCT02376335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25274729|NCT02376335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25274730|NCT02376335|Immunologic Factors|immunologic factors|mesh-ancestor
25274731|NCT02376335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274732|NCT02376335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25275680|NCT02370433|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25275681|NCT02370433|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24924711|NCT04157257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24924712|NCT04157257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24924714|NCT04156984|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24397184|NCT00141011|Ancrod|ancrod|mesh-list
24924720|NCT04157010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24604171|NCT00977405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604172|NCT00977405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604173|NCT00977444|Prednisolone|prednisolone|mesh-list
24604174|NCT00977444|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25208654|NCT01455389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24604175|NCT00977444|Methylprednisolone|methylprednisolone|mesh-list
24604176|NCT00977444|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24604177|NCT00977444|Prednisolone acetate|prednisolone acetate|mesh-list
24604197|NCT00977756|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24604198|NCT00977756|Darunavir|darunavir|mesh-list
24604199|NCT00977756|Tenofovir|tenofovir|mesh-list
24604200|NCT00977756|Raltegravir Potassium|raltegravir potassium|mesh-list
24604202|NCT00977756|Etravirine|etravirine|mesh-list
24604203|NCT00977756|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24604204|NCT00977756|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24604205|NCT00977756|Protease Inhibitors|protease inhibitors|mesh-ancestor
24604206|NCT00977756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604207|NCT00977756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604208|NCT00977756|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24604224|NCT00977873|Cholecalciferol|cholecalciferol|mesh-list
24604271|NCT00978172|Anthelmintics|anthelmintics|mesh-ancestor
24604273|NCT00978211|Somatostatin|somatostatin|mesh-list
24604274|NCT00978211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24604275|NCT00978211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24604301|NCT00978354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604302|NCT00978354|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24604303|NCT00978354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24604304|NCT00978354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604306|NCT00978393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24604307|NCT00978393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604309|NCT00978393|Hormones|hormones|mesh-ancestor
24604333|NCT00978653|Allopurinol|allopurinol|mesh-list
24604334|NCT00978653|Antimetabolites|antimetabolites|mesh-ancestor
24604335|NCT00978653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604336|NCT00978653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604337|NCT00978653|Gout Suppressants|gout suppressants|mesh-ancestor
24604338|NCT00978653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24604339|NCT00978653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24604340|NCT00978653|Antioxidants|antioxidants|mesh-ancestor
24604341|NCT00978653|Protective Agents|protective agents|mesh-ancestor
24604342|NCT00978653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604343|NCT00978718|Selenium|selenium|mesh-list
24604344|NCT00978718|Antioxidants|antioxidants|mesh-ancestor
24604345|NCT00978718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604346|NCT00978718|Protective Agents|protective agents|mesh-ancestor
24604347|NCT00978718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676539|NCT01799941|Antimalarials|antimalarials|mesh-ancestor
25676540|NCT01799941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25676541|NCT01799941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25676542|NCT01799941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25676543|NCT01799941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676544|NCT01799941|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25676545|NCT01799941|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25676546|NCT01799941|Cholinergic Agents|cholinergic agents|mesh-ancestor
25676547|NCT01799941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25676548|NCT01799941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25676549|NCT01799941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25676550|NCT01799941|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25676551|NCT01799941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25253053|NCT02504164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25253054|NCT02504164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253055|NCT02504138|Anesthetics|anesthetics|mesh-list
24533600|NCT00644605|Vasodilator Agents|vasodilator agents|mesh-ancestor
24604413|NCT00979316|Moxifloxacin|moxifloxacin|mesh-list
24604414|NCT00979316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24604415|NCT00979316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24604416|NCT00979316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24604417|NCT00979316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24604418|NCT00979316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604725|NCT00981487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24604419|NCT00979316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604420|NCT00979316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604422|NCT00979472|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24604423|NCT00979472|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24604424|NCT00979472|Cholinergic Agents|cholinergic agents|mesh-ancestor
24671165|NCT01324089|Piperine|piperine|mesh-list
24853374|NCT02267720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24853375|NCT02267720|Antifungal Agents|antifungal agents|mesh-ancestor
24853376|NCT02267720|Keratolytic Agents|keratolytic agents|mesh-ancestor
24853377|NCT02267720|Dermatologic Agents|dermatologic agents|mesh-ancestor
24853378|NCT02267915|Rituximab|rituximab|mesh-list
24853379|NCT02267915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24853380|NCT02267915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24853381|NCT02267915|Immunologic Factors|immunologic factors|mesh-ancestor
24671170|NCT01324089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671171|NCT01324089|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24671172|NCT01324089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24671173|NCT01324115|Nitroarginine|nitroarginine|mesh-list
24671174|NCT01324115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671175|NCT01324115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671176|NCT01324180|Metformin|metformin|mesh-list
25208655|NCT01455389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25208656|NCT01455389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24671177|NCT01324180|Dexamethasone|dexamethasone|mesh-list
24604432|NCT00979537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24604433|NCT00979537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604566|NCT00980213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604567|NCT00980213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604568|NCT00980239|Bevacizumab|bevacizumab|mesh-list
24604569|NCT00980239|Cetuximab|cetuximab|mesh-list
24604602|NCT00980408|Cycloserine|cycloserine|mesh-list
24604603|NCT00980408|Memantine|memantine|mesh-list
24604604|NCT00980408|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24604605|NCT00980408|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24853382|NCT02267915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853384|NCT02267980|Ketamine|ketamine|mesh-list
24853385|NCT02267980|Sevoflurane|sevoflurane|mesh-list
24853386|NCT02267980|Analgesics|analgesics|mesh-ancestor
24853387|NCT02267980|Sensory System Agents|sensory system agents|mesh-ancestor
24604614|NCT00980408|Renal Agents|renal agents|mesh-ancestor
24604647|NCT00980616|Ropivacaine|ropivacaine|mesh-list
24604648|NCT00980616|Anesthetics, Local|anesthetics, local|mesh-ancestor
24604649|NCT00980616|Anesthetics|anesthetics|mesh-ancestor
24604650|NCT00980616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24604651|NCT00980616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604652|NCT00980616|Sensory System Agents|sensory system agents|mesh-ancestor
24604653|NCT00980616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24604654|NCT00980707|Fluticasone|fluticasone|mesh-list
24604656|NCT00980707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24604657|NCT00980707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24604658|NCT00980707|Autonomic Agents|autonomic agents|mesh-ancestor
24604659|NCT00980707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24604660|NCT00980707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604661|NCT00980707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24604662|NCT00980707|Respiratory System Agents|respiratory system agents|mesh-ancestor
24604663|NCT00980707|Dermatologic Agents|dermatologic agents|mesh-ancestor
24604664|NCT00980707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24604666|NCT00980850|Immunologic Factors|immunologic factors|mesh-ancestor
25676552|NCT01799993|Amikacin|amikacin|mesh-list
25676553|NCT01799993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25676554|NCT01799993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24604667|NCT00980850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676555|NCT01800838|Silicon|silicon|mesh-list
25253087|NCT02503826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25253088|NCT02503826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253089|NCT02503826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24604668|NCT00980876|Ciprofloxacin|ciprofloxacin|mesh-list
24604669|NCT00980876|Hydrocortisone|hydrocortisone|mesh-list
24604670|NCT00980876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25073686|NCT03393767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24604671|NCT00980876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24604716|NCT00981318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24604717|NCT00981318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24604719|NCT00981318|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24604720|NCT00981318|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24604721|NCT00981318|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24604723|NCT00981487|Antiemetics|antiemetics|mesh-ancestor
24604724|NCT00981487|Autonomic Agents|autonomic agents|mesh-ancestor
24605118|NCT00983320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24604726|NCT00981487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604727|NCT00981487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24604728|NCT00981487|Antipruritics|antipruritics|mesh-ancestor
24604729|NCT00981487|Dermatologic Agents|dermatologic agents|mesh-ancestor
24604730|NCT00981487|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24604731|NCT00981487|Serotonin Agents|serotonin agents|mesh-ancestor
24604732|NCT00981487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24604762|NCT00981708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24604763|NCT00981708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24604765|NCT00981708|Hormones|hormones|mesh-ancestor
24604766|NCT00981708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24604767|NCT00981708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24604768|NCT00981708|Protease Inhibitors|protease inhibitors|mesh-ancestor
24604769|NCT00981708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604770|NCT00981708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24604771|NCT00981708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24636813|NCT01147523|Vitamin E|vitamin e|mesh-list
24604772|NCT00981708|Growth Substances|growth substances|mesh-ancestor
24604774|NCT00981721|Cediranib|cediranib|mesh-list
24604777|NCT00981721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208657|NCT01455389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25208658|NCT01455389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272584|NCT02391181|Hematinics|hematinics|mesh-ancestor
24523714|NCT05340803|Analgesics|analgesics|mesh-ancestor
24490489|NCT00478543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25117004|NCT03105466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24604800|NCT00981786|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24604802|NCT00981786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24604803|NCT00981786|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24604804|NCT00981786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604806|NCT00981838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24604807|NCT00981838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24853397|NCT02267980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24853398|NCT02267980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853399|NCT02267980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24853400|NCT02267980|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24666936|NCT01321671|Analgesics|analgesics|mesh-ancestor
24604826|NCT00981851|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24604827|NCT00981851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24604828|NCT00981851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24604829|NCT00981851|Adrenergic Agents|adrenergic agents|mesh-ancestor
24604830|NCT00981890|Sunitinib|sunitinib|mesh-list
24604831|NCT00981890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604832|NCT00981890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24604833|NCT00981890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24604834|NCT00981890|Growth Substances|growth substances|mesh-ancestor
24604835|NCT00981890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676556|NCT01800838|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
25676557|NCT01800838|Trace Elements|trace elements|mesh-ancestor
25676558|NCT01800838|Micronutrients|micronutrients|mesh-ancestor
24604836|NCT00981890|Growth Inhibitors|growth inhibitors|mesh-ancestor
25676559|NCT01800838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604837|NCT00981890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24604839|NCT00981890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604840|NCT00981903|Tinzaparin|tinzaparin|mesh-list
24604841|NCT00981903|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24604842|NCT00981903|Dalteparin|dalteparin|mesh-list
24604843|NCT00981903|Anticoagulants|anticoagulants|mesh-ancestor
24604844|NCT00981903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24604845|NCT00981903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24604846|NCT00981903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604847|NCT00981929|Losartan|losartan|mesh-list
24604848|NCT00981929|Tramadol|tramadol|mesh-list
24604849|NCT00981929|Caffeine|caffeine|mesh-list
24604851|NCT00981929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24604852|NCT00981929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24604853|NCT00981929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24604854|NCT00981929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24604855|NCT00981929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604856|NCT00981929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24604857|NCT00981929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25208689|NCT01453140|Antifungal Agents|antifungal agents|mesh-ancestor
24604860|NCT00981929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24604924|NCT00982436|Docetaxel|docetaxel|mesh-list
24853402|NCT02268006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24853403|NCT02268006|Antimetabolites|antimetabolites|mesh-ancestor
24853404|NCT02268006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853405|NCT02268006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604925|NCT00982436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208659|NCT01455389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208660|NCT01455389|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25208661|NCT01455389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25208662|NCT01455389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25208663|NCT01455389|Anesthetics, Local|anesthetics, local|mesh-ancestor
25208664|NCT01455389|Anesthetics|anesthetics|mesh-ancestor
25208665|NCT01455389|Sensory System Agents|sensory system agents|mesh-ancestor
25208666|NCT01455389|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25208667|NCT01455389|Histamine Antagonists|histamine antagonists|mesh-ancestor
25208668|NCT01455389|Histamine Agents|histamine agents|mesh-ancestor
25208669|NCT01455389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24490490|NCT00478543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604926|NCT00982436|Tubulin Modulators|tubulin modulators|mesh-ancestor
24604930|NCT00982449|Fialuridine|fialuridine|mesh-list
24671195|NCT01324180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24604948|NCT00982540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24604949|NCT00982540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604950|NCT00982540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604959|NCT00982540|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24604963|NCT00982618|Morphine|morphine|mesh-list
24604964|NCT00982618|Anesthetics, Local|anesthetics, local|mesh-list
24604965|NCT00982618|Anesthetics|anesthetics|mesh-list
24604966|NCT00982618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24604967|NCT00982618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604968|NCT00982618|Sensory System Agents|sensory system agents|mesh-ancestor
24604969|NCT00982618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24604970|NCT00982618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24604971|NCT00982618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24604972|NCT00982618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24604973|NCT00982618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24605010|NCT00982800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24605011|NCT00982800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24605012|NCT00982800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24605013|NCT00982800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605014|NCT00982800|Antimanic Agents|antimanic agents|mesh-ancestor
24605015|NCT00982891|Morphine|morphine|mesh-list
24605016|NCT00982891|Hydromorphone|hydromorphone|mesh-list
24605039|NCT00983034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25253161|NCT02503319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253162|NCT02503319|Hemostatics|hemostatics|mesh-ancestor
25253163|NCT02503319|Coagulants|coagulants|mesh-ancestor
24924879|NCT04155879|Mitosis Modulators|mitosis modulators|mesh-ancestor
24924880|NCT04155879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924881|NCT04155879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924882|NCT04155983|Ropivacaine|ropivacaine|mesh-list
24924883|NCT04155983|Anesthetics, Local|anesthetics, local|mesh-ancestor
24605040|NCT00983034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24605041|NCT00983034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605056|NCT00983112|Thrombin|thrombin|mesh-list
24605057|NCT00983112|Hemostatics|hemostatics|mesh-ancestor
24605058|NCT00983112|Coagulants|coagulants|mesh-ancestor
24605059|NCT00983125|Clonidine|clonidine|mesh-list
24605060|NCT00983125|Analgesics|analgesics|mesh-ancestor
24605061|NCT00983125|Sensory System Agents|sensory system agents|mesh-ancestor
24605062|NCT00983125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24605063|NCT00983125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605064|NCT00983125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24605065|NCT00983125|Sympatholytics|sympatholytics|mesh-ancestor
24605066|NCT00983125|Autonomic Agents|autonomic agents|mesh-ancestor
24605067|NCT00983125|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24605068|NCT00983125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24605069|NCT00983125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24605116|NCT00983320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24605117|NCT00983320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24605119|NCT00983320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24605124|NCT00983398|Mechlorethamine|mechlorethamine|mesh-list
24605125|NCT00983398|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
24605128|NCT00983398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605129|NCT00983398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24605130|NCT00983398|Alkylating Agents|alkylating agents|mesh-ancestor
24605131|NCT00983398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605132|NCT00983398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24605133|NCT00983398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24605134|NCT00983398|Immunologic Factors|immunologic factors|mesh-ancestor
24605135|NCT00983398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605136|NCT00983398|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24605138|NCT00983398|Natriuretic Agents|natriuretic agents|mesh-ancestor
24605139|NCT00983398|Protective Agents|protective agents|mesh-ancestor
24605140|NCT00983398|Antioxidants|antioxidants|mesh-ancestor
24605141|NCT00983398|Antitubercular Agents|antitubercular agents|mesh-ancestor
25208670|NCT01455389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24490491|NCT00478621|Vaccines|vaccines|mesh-list
24490492|NCT00478621|Immunologic Factors|immunologic factors|mesh-ancestor
24457515|NCT00334646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24457516|NCT00334646|Antiemetics|antiemetics|mesh-ancestor
24457517|NCT00334646|Autonomic Agents|autonomic agents|mesh-ancestor
24457518|NCT00334646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24605142|NCT00983398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24605143|NCT00983398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24605144|NCT00983398|Chelating Agents|chelating agents|mesh-ancestor
24605145|NCT00983398|Sequestering Agents|sequestering agents|mesh-ancestor
24605146|NCT00983424|Cyclosporine|cyclosporine|mesh-list
24605147|NCT00983424|Paclitaxel|paclitaxel|mesh-list
24605148|NCT00983424|Cyclosporins|cyclosporins|mesh-list
24605149|NCT00983424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24605150|NCT00983424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605168|NCT00983450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24605169|NCT00983450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605170|NCT00983450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24853412|NCT02268019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853413|NCT02268019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24853414|NCT02268019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24812520|NCT02052908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812521|NCT02052908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812523|NCT02052934|Immunologic Factors|immunologic factors|mesh-ancestor
24812524|NCT02052934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676560|NCT01800838|Antimalarials|antimalarials|mesh-ancestor
25676561|NCT01800838|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25676562|NCT01800838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25676563|NCT01800838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25676564|NCT01800838|Antiviral Agents|antiviral agents|mesh-ancestor
25676565|NCT01800838|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25676566|NCT01800838|Dermatologic Agents|dermatologic agents|mesh-ancestor
25676567|NCT01800877|Phenylephrine|phenylephrine|mesh-list
25676568|NCT01800877|Dopamine|dopamine|mesh-list
24605171|NCT00983450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605172|NCT00983554|Anastrozole|anastrozole|mesh-list
24605173|NCT00983554|Testosterone|testosterone|mesh-list
24605174|NCT00983554|Dutasteride|dutasteride|mesh-list
24605175|NCT00983554|Androgens|androgens|mesh-ancestor
24605177|NCT00983554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24605178|NCT00983554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605179|NCT00983554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24605180|NCT00983554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638389|NCT01156350|Alkylating Agents|alkylating agents|mesh-ancestor
24605181|NCT00983554|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24605183|NCT00983554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605216|NCT00983944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24605217|NCT00983944|Alkylating Agents|alkylating agents|mesh-ancestor
24605218|NCT00983944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605219|NCT00983944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605220|NCT00983944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25102355|NCT03169504|Xhance|xhance|mesh-list
24605221|NCT00983944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24605222|NCT00983944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24605223|NCT00983944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24605226|NCT00983944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24605227|NCT00983944|Glucocorticoids|glucocorticoids|mesh-ancestor
24605230|NCT00983944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24605279|NCT00984386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605293|NCT00984399|Contraceptive Agents|contraceptive agents|mesh-ancestor
24605294|NCT00984399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24605295|NCT00984399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24605296|NCT00984425|Sorafenib|sorafenib|mesh-list
24605297|NCT00984425|Lapatinib|lapatinib|mesh-list
24605343|NCT00984724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24605344|NCT00984724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605345|NCT00984724|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24605346|NCT00984724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24605347|NCT00984724|Cholinergic Agents|cholinergic agents|mesh-ancestor
24605348|NCT00984724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24605349|NCT00984724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605350|NCT00984737|Insulin|insulin|mesh-list
24605351|NCT00984737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24605352|NCT00984737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208671|NCT01455389|Antipruritics|antipruritics|mesh-ancestor
25208672|NCT01455389|Dermatologic Agents|dermatologic agents|mesh-ancestor
25208673|NCT01453140|Sirolimus|sirolimus|mesh-list
25208674|NCT01453140|Cyclophosphamide|cyclophosphamide|mesh-list
25208675|NCT01453140|Interleukin-2|interleukin-2|mesh-list
25208676|NCT01453140|Azacitidine|azacitidine|mesh-list
25208677|NCT01453140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24457519|NCT00334646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24427920|NCT00239291|Gefitinib|gefitinib|mesh-list
24605353|NCT00984750|Acetylcarnitine|acetylcarnitine|mesh-list
24605354|NCT00984750|Simvastatin|simvastatin|mesh-list
24605355|NCT00984750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24605356|NCT00984750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24605357|NCT00984750|Antimetabolites|antimetabolites|mesh-ancestor
24605358|NCT00984750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605359|NCT00984750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24605360|NCT00984750|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24605361|NCT00984750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605366|NCT00984750|Nootropic Agents|nootropic agents|mesh-ancestor
24605367|NCT00984763|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24605368|NCT00984763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24605369|NCT00984763|Immunologic Factors|immunologic factors|mesh-ancestor
24605401|NCT00984932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605402|NCT00984932|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24605403|NCT00984932|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24605404|NCT00984932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605405|NCT00984945|Vaccines|vaccines|mesh-list
24605406|NCT00984945|Immunologic Factors|immunologic factors|mesh-ancestor
24605407|NCT00984945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605408|NCT00984971|Tenofovir|tenofovir|mesh-list
24605409|NCT00984971|Antiviral Agents|antiviral agents|mesh-ancestor
24605410|NCT00984971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24605411|NCT00984971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24605412|NCT00984971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24605413|NCT00984971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608036|NCT02557672|Hemostatics|hemostatics|mesh-ancestor
24608037|NCT02557672|Coagulants|coagulants|mesh-ancestor
24605417|NCT00984984|Methylprednisolone|methylprednisolone|mesh-list
24605418|NCT00984984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24605419|NCT00984984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24605420|NCT00984984|Prednisolone|prednisolone|mesh-list
24605421|NCT00984984|Prednisolone acetate|prednisolone acetate|mesh-list
24605422|NCT00984984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25208678|NCT01453140|Immunologic Factors|immunologic factors|mesh-ancestor
25208679|NCT01453140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490575|NCT00478959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490576|NCT00478985|Imatinib Mesylate|imatinib mesylate|mesh-list
24490621|NCT00479206|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24638690|NCT01157559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24638691|NCT01157559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24638692|NCT01157559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24638693|NCT01157559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24490622|NCT00479206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24490623|NCT00479206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490653|NCT00479479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490654|NCT00479479|Vitamin B Complex|vitamin b complex|mesh-ancestor
24490656|NCT00479609|Testosterone|testosterone|mesh-list
24490657|NCT00479609|Androgens|androgens|mesh-ancestor
24490658|NCT00479609|Hormones|hormones|mesh-ancestor
24944255|NCT03961958|Propofol|propofol|mesh-list
24605423|NCT00984984|Prednisolone phosphate|prednisolone phosphate|mesh-list
24605424|NCT00984984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24605425|NCT00984984|Antiemetics|antiemetics|mesh-ancestor
24605426|NCT00984984|Autonomic Agents|autonomic agents|mesh-ancestor
24605427|NCT00984984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24605428|NCT00984984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605429|NCT00984984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24605430|NCT00984984|Glucocorticoids|glucocorticoids|mesh-ancestor
24605431|NCT00984984|Hormones|hormones|mesh-ancestor
24605432|NCT00984984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24605433|NCT00984984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24605434|NCT00984984|Protective Agents|protective agents|mesh-ancestor
24605435|NCT00984984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24605436|NCT00984984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605437|NCT00984997|Etoposide|etoposide|mesh-list
24605438|NCT00984997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605439|NCT00984997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24605440|NCT00984997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24605441|NCT00984997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24605443|NCT00984997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605445|NCT00985244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24605446|NCT00985244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24605447|NCT00985270|Rifampin|rifampin|mesh-list
24605448|NCT00985270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24605470|NCT00985348|Nootropic Agents|nootropic agents|mesh-ancestor
24605471|NCT00985361|Vitamin D|vitamin d|mesh-list
24605472|NCT00985361|Cholecalciferol|cholecalciferol|mesh-list
24605473|NCT00985361|Vitamins|vitamins|mesh-list
24605474|NCT00985361|Ascorbic Acid|ascorbic acid|mesh-list
24605475|NCT00985361|Micronutrients|micronutrients|mesh-ancestor
25253259|NCT02502500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25253260|NCT02502500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253261|NCT02502500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25253262|NCT02502500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25155419|NCT05374564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796926|NCT01953172|Micronutrients|micronutrients|mesh-ancestor
24924958|NCT04154852|Methotrexate|methotrexate|mesh-list
24605476|NCT00985361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605477|NCT00985361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24605478|NCT00985361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24605479|NCT00985361|Antioxidants|antioxidants|mesh-ancestor
24605480|NCT00985361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605481|NCT00985361|Protective Agents|protective agents|mesh-ancestor
24605483|NCT00985374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605484|NCT00985374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24605485|NCT00985374|Immunologic Factors|immunologic factors|mesh-ancestor
24671217|NCT01324258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24671218|NCT01324258|Antimetabolites|antimetabolites|mesh-ancestor
24671219|NCT01324258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812547|NCT02053402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24812548|NCT02053402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24812549|NCT02053519|Vitamin D|vitamin d|mesh-list
24605540|NCT00985855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605541|NCT00985855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605542|NCT00985855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25208680|NCT01453140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25208681|NCT01453140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25208682|NCT01453140|Alkylating Agents|alkylating agents|mesh-ancestor
25208683|NCT01453140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208684|NCT01453140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208685|NCT01453140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25208686|NCT01453140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25208687|NCT01453140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25208688|NCT01453140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25208690|NCT01453140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24490662|NCT00479661|Propofol|propofol|mesh-list
24490663|NCT00479661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24490664|NCT00479661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24490665|NCT00479661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490666|NCT00479661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24605543|NCT00985920|Tranexamic Acid|tranexamic acid|mesh-list
24605544|NCT00985920|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24605545|NCT00985920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24605546|NCT00985920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605547|NCT00985920|Hemostatics|hemostatics|mesh-ancestor
24605548|NCT00985920|Coagulants|coagulants|mesh-ancestor
24605549|NCT00985998|Nimotuzumab|nimotuzumab|mesh-list
24605550|NCT00985998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24605551|NCT00985998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605559|NCT00986050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24605560|NCT00986050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605561|NCT00986050|Antifungal Agents|antifungal agents|mesh-ancestor
24605562|NCT00986050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24605563|NCT00986050|Immunologic Factors|immunologic factors|mesh-ancestor
24605564|NCT00986050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605565|NCT00986050|Anticoagulants|anticoagulants|mesh-ancestor
24605566|NCT00986050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24605567|NCT00986076|Enoxaparin|enoxaparin|mesh-list
24605568|NCT00986076|Anticoagulants|anticoagulants|mesh-ancestor
24605569|NCT00986076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24605570|NCT00986076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24605606|NCT00986336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24605607|NCT00986336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24605608|NCT00986336|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25676569|NCT01800877|Vasopressins|vasopressins|mesh-list
25676570|NCT01800877|Epinephrine|epinephrine|mesh-list
25676571|NCT01800877|Norepinephrine|norepinephrine|mesh-list
25676572|NCT01800877|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25676573|NCT01800877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25676574|NCT01800877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25676575|NCT01800877|Adrenergic Agents|adrenergic agents|mesh-ancestor
25676576|NCT01800877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24605670|NCT00986713|Antifungal Agents|antifungal agents|mesh-ancestor
24605671|NCT00986765|Aspirin|aspirin|mesh-list
24605672|NCT00986765|Enoxaparin|enoxaparin|mesh-list
24605673|NCT00986765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24605674|NCT00986765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24605675|NCT00986765|Analgesics|analgesics|mesh-ancestor
24605676|NCT00986765|Sensory System Agents|sensory system agents|mesh-ancestor
24605677|NCT00986765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24605678|NCT00986765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812550|NCT02053519|Cholecalciferol|cholecalciferol|mesh-list
24812551|NCT02053519|Vitamins|vitamins|mesh-ancestor
24605755|NCT00987116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24605757|NCT00987168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24605758|NCT00987168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24605794|NCT00987376|Lipotropic Agents|lipotropic agents|mesh-ancestor
24605795|NCT00987376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24605796|NCT00987376|Antimetabolites|antimetabolites|mesh-ancestor
24605797|NCT00987376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605798|NCT00987376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24605802|NCT00987441|Dsuvia|dsuvia|mesh-list
24605803|NCT00987441|Ropivacaine|ropivacaine|mesh-list
24605804|NCT00987441|Anesthetics, Local|anesthetics, local|mesh-ancestor
24605805|NCT00987441|Anesthetics|anesthetics|mesh-ancestor
24605806|NCT00987441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24863058|NCT03635788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25208691|NCT01453140|Analgesics|analgesics|mesh-ancestor
25208692|NCT01453140|Sensory System Agents|sensory system agents|mesh-ancestor
25208693|NCT01453140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25208694|NCT01453140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25208695|NCT01453140|Antimetabolites|antimetabolites|mesh-ancestor
25208696|NCT01453140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208697|NCT01408641|Topiramate|topiramate|mesh-list
25208698|NCT01408641|Anticonvulsants|anticonvulsants|mesh-ancestor
25208699|NCT01408641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24490697|NCT00479739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24605807|NCT00987441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605808|NCT00987441|Sensory System Agents|sensory system agents|mesh-ancestor
24605809|NCT00987441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24605810|NCT00987441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24605811|NCT00987441|Narcotics|narcotics|mesh-ancestor
24605812|NCT00987441|Analgesics|analgesics|mesh-ancestor
24605813|NCT00987441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24605844|NCT00987636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24605845|NCT00987636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24605848|NCT00987662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24605849|NCT00987662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24605850|NCT00987662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24605851|NCT00987662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605852|NCT00987662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24605853|NCT00987662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605854|NCT00987662|Vasodilator Agents|vasodilator agents|mesh-ancestor
24446978|NCT00306813|Lenalidomide|lenalidomide|mesh-list
24605884|NCT00987779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605886|NCT00987792|Moxifloxacin|moxifloxacin|mesh-list
24812554|NCT02053519|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25253311|NCT02502708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24925038|NCT04155008|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24925039|NCT04155008|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25253312|NCT02502708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25253313|NCT02502708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25253314|NCT02502708|Antidepressive Agents|antidepressive agents|mesh-ancestor
25253315|NCT02502708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25253316|NCT02501941|Ketamine|ketamine|mesh-list
25253317|NCT02501941|Analgesics|analgesics|mesh-ancestor
24812559|NCT02053558|Anesthetics|anesthetics|mesh-ancestor
24812560|NCT02053558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24812561|NCT02053558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667673|NCT05343572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24667674|NCT05343572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24667675|NCT05343572|Antiviral Agents|antiviral agents|mesh-ancestor
24667676|NCT05343572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25208705|NCT01246310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208706|NCT01203722|Mycophenolic Acid|mycophenolic acid|mesh-list
25208707|NCT01203722|Sirolimus|sirolimus|mesh-list
25208708|NCT01203722|Fludarabine|fludarabine|mesh-list
25208709|NCT01203722|Cyclophosphamide|cyclophosphamide|mesh-list
24490698|NCT00479739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24490699|NCT00479739|Autonomic Agents|autonomic agents|mesh-ancestor
24490700|NCT00479739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24490701|NCT00479739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490702|NCT00479739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24490703|NCT00479739|Respiratory System Agents|respiratory system agents|mesh-ancestor
24490704|NCT00479739|Dermatologic Agents|dermatologic agents|mesh-ancestor
24490714|NCT00479739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490715|NCT00479752|Oxaliplatin|oxaliplatin|mesh-list
24490716|NCT00479752|Cetuximab|cetuximab|mesh-list
24490717|NCT00479752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605888|NCT00987792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24605889|NCT00987792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24605890|NCT00987792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24605891|NCT00987792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24605892|NCT00987792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605893|NCT00987792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605894|NCT00987792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605895|NCT00987792|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24605896|NCT00987792|Contraceptive Agents|contraceptive agents|mesh-ancestor
24605914|NCT00987870|Glucocorticoids|glucocorticoids|mesh-ancestor
24605915|NCT00987870|Hormones|hormones|mesh-ancestor
24605916|NCT00987870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24605917|NCT00987870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605918|NCT00987870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24605919|NCT00987870|Respiratory System Agents|respiratory system agents|mesh-ancestor
24605921|NCT00987909|Immunologic Factors|immunologic factors|mesh-list
24605922|NCT00987909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605924|NCT00987974|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24605925|NCT00987974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24630178|NCT01109823|Renal Agents|renal agents|mesh-ancestor
24630179|NCT01109823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24630180|NCT01109823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24630181|NCT01109823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24605926|NCT00987974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24605927|NCT00987974|Antimetabolites|antimetabolites|mesh-ancestor
24605941|NCT00988039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24605942|NCT00988039|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25676577|NCT01800877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676578|NCT01800877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676579|NCT01800877|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25676580|NCT01800877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25676581|NCT01800877|Autonomic Agents|autonomic agents|mesh-ancestor
25676582|NCT01800877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25676583|NCT01800877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25676584|NCT01800877|Respiratory System Agents|respiratory system agents|mesh-ancestor
24605943|NCT00988039|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24605944|NCT00988039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605945|NCT00988039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605946|NCT00988039|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24812562|NCT02053558|Sensory System Agents|sensory system agents|mesh-ancestor
24812563|NCT02053558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812564|NCT02053558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24667726|NCT05320107|Anesthetics|anesthetics|mesh-ancestor
24605947|NCT00988039|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24605948|NCT00988039|Protease Inhibitors|protease inhibitors|mesh-ancestor
24605949|NCT00988039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24605976|NCT00988403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605977|NCT00988481|Topiramate|topiramate|mesh-list
24630210|NCT01110304|Analgesics|analgesics|mesh-list
24605979|NCT00988481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24605980|NCT00988481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605981|NCT00988494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24605982|NCT00988494|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25208710|NCT01203722|Tacrolimus|tacrolimus|mesh-list
25208711|NCT01203722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208712|NCT01203722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208713|NCT01203722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25208714|NCT01203722|Immunologic Factors|immunologic factors|mesh-ancestor
25208715|NCT01203722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208716|NCT01203722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25208717|NCT01203722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208718|NCT01203722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25208719|NCT01203722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25208720|NCT01203722|Alkylating Agents|alkylating agents|mesh-ancestor
24490785|NCT00480142|Oxycodone|oxycodone|mesh-list
24490786|NCT00480142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24490787|NCT00480142|Narcotics|narcotics|mesh-ancestor
24490788|NCT00480142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24490929|NCT00480584|Antimetabolites|antimetabolites|mesh-ancestor
24490930|NCT00480584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490931|NCT00480584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490932|NCT00480584|Antiviral Agents|antiviral agents|mesh-ancestor
24605983|NCT00988507|Artesunate|artesunate|mesh-list
24605984|NCT00988507|Ferroquine|ferroquine|mesh-list
24605985|NCT00988507|Antimalarials|antimalarials|mesh-ancestor
24671233|NCT01324336|Antimetabolites|antimetabolites|mesh-ancestor
24605986|NCT00988507|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24605988|NCT00988507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24605989|NCT00988507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605990|NCT00988507|Antiviral Agents|antiviral agents|mesh-ancestor
24605991|NCT00988507|Schistosomicides|schistosomicides|mesh-ancestor
24605992|NCT00988507|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24605993|NCT00988507|Anthelmintics|anthelmintics|mesh-ancestor
24605994|NCT00988520|Bromides|bromides|mesh-list
24605995|NCT00988520|Propofol|propofol|mesh-list
24605996|NCT00988520|Sevoflurane|sevoflurane|mesh-list
24605997|NCT00988520|Rocuronium|rocuronium|mesh-list
24605998|NCT00988520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24605999|NCT00988520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24606000|NCT00988520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606001|NCT00988520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24606002|NCT00988520|Anesthetics, General|anesthetics, general|mesh-ancestor
24606003|NCT00988520|Anesthetics|anesthetics|mesh-ancestor
24606050|NCT00988728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24606051|NCT00988728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24606052|NCT00988728|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24671235|NCT01324336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24671236|NCT01324336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24671237|NCT01324336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24671238|NCT01324336|Immunologic Factors|immunologic factors|mesh-ancestor
24671239|NCT01324336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671240|NCT01324336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24671241|NCT01324336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671243|NCT01324492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24671244|NCT01324492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24606090|NCT00988845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606091|NCT00988845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24853416|NCT02268019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24853417|NCT02268019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24853418|NCT02268019|Respiratory System Agents|respiratory system agents|mesh-ancestor
24853420|NCT02268019|Sympathomimetics|sympathomimetics|mesh-ancestor
24523405|NCT01253161|Pasireotide|pasireotide|mesh-list
24853421|NCT02268019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24853422|NCT02268032|Androgens|androgens|mesh-list
24853423|NCT02268032|Hormones|hormones|mesh-ancestor
24853424|NCT02268032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24853425|NCT02268032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606093|NCT00988897|Bevacizumab|bevacizumab|mesh-list
24606094|NCT00988897|Fluorouracil|fluorouracil|mesh-list
24606095|NCT00988897|Oxaliplatin|oxaliplatin|mesh-list
24606096|NCT00988897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24606097|NCT00988897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24606098|NCT00988897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24606118|NCT00988910|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24606120|NCT00988949|Analgesics|analgesics|mesh-ancestor
24606121|NCT00988949|Sensory System Agents|sensory system agents|mesh-ancestor
25208721|NCT01203722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25208722|NCT01203722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25208723|NCT01203722|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25208724|NCT01203722|Antitubercular Agents|antitubercular agents|mesh-ancestor
25208728|NCT01087619|Parathyroid Hormone|parathyroid hormone|mesh-list
25208729|NCT01087619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25208730|NCT01087619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208731|NCT01029717|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24606124|NCT00988949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24606126|NCT00988949|Natriuretic Agents|natriuretic agents|mesh-ancestor
24606127|NCT00989027|Oxytocin|oxytocin|mesh-list
24606128|NCT00989027|Ergonovine|ergonovine|mesh-list
24606129|NCT00989027|Carboprost tromethamine|carboprost tromethamine|mesh-list
24606130|NCT00989027|Carboprost|carboprost|mesh-list
24606131|NCT00989027|Oxytocics|oxytocics|mesh-ancestor
24606133|NCT00989027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606134|NCT00989027|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24606135|NCT00989027|Abortifacient Agents|abortifacient agents|mesh-ancestor
24606136|NCT00989053|Citalopram|citalopram|mesh-list
24606137|NCT00989053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24606146|NCT00989053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24606147|NCT00989079|Ertugliflozin|ertugliflozin|mesh-list
24606148|NCT00989079|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24606149|NCT00989079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606150|NCT00989079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24606151|NCT00989079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606152|NCT00989209|Botulinum Toxins|botulinum toxins|mesh-list
24606153|NCT00989209|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24959456|NCT03824665|Fentanyl|fentanyl|mesh-list
24606154|NCT00989209|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24606155|NCT00989209|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24606156|NCT00989209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24606157|NCT00989209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606158|NCT00989209|Cholinergic Agents|cholinergic agents|mesh-ancestor
24606159|NCT00989209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24853426|NCT02268071|Antihypertensive Agents|antihypertensive agents|mesh-list
24853428|NCT02268149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24853429|NCT02268149|Glucocorticoids|glucocorticoids|mesh-ancestor
24853430|NCT02268149|Hormones|hormones|mesh-ancestor
24853431|NCT02268149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24606160|NCT00989209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606161|NCT00989209|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24606162|NCT00989209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24606163|NCT00989274|Vaccines|vaccines|mesh-list
24606165|NCT00989274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606167|NCT00989300|Rabeprazole|rabeprazole|mesh-list
24606168|NCT00989300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24606169|NCT00989300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24606170|NCT00989300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25676585|NCT01800877|Mydriatics|mydriatics|mesh-ancestor
24606171|NCT00989300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606173|NCT00989352|Rituximab|rituximab|mesh-list
25676586|NCT01800877|Sympathomimetics|sympathomimetics|mesh-ancestor
25676587|NCT01800877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25676588|NCT01800877|Nasal Decongestants|nasal decongestants|mesh-ancestor
24500889|NCT00526175|Alkylating Agents|alkylating agents|mesh-ancestor
24523486|NCT05342558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523487|NCT05342558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24523503|NCT05342532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24523521|NCT05342272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24523522|NCT05342272|Lipotropic Agents|lipotropic agents|mesh-ancestor
24523523|NCT05342272|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24523524|NCT05342272|Antimetabolites|antimetabolites|mesh-ancestor
24398195|NCT00143728|Lamivudine|lamivudine|mesh-list
24523562|NCT05341856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523563|NCT05341843|Sertraline|sertraline|mesh-list
24500968|NCT00526305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606188|NCT00989352|Dermatologic Agents|dermatologic agents|mesh-ancestor
24606189|NCT00989352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606190|NCT00989352|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24606191|NCT00989352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24606192|NCT00989352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25208732|NCT01029717|Minocycline|minocycline|mesh-list
25208733|NCT01029717|Rifampin|rifampin|mesh-list
25208734|NCT01029717|Heparin|heparin|mesh-list
25208735|NCT01029717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25208736|NCT01029717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25208737|NCT01029717|Antitubercular Agents|antitubercular agents|mesh-ancestor
25208738|NCT01029717|Anticoagulants|anticoagulants|mesh-ancestor
24491108|NCT00481273|Azacitidine|azacitidine|mesh-list
24491142|NCT00481364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606193|NCT00989352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24606195|NCT00989404|Zanamivir|zanamivir|mesh-list
24606196|NCT00989404|Antiviral Agents|antiviral agents|mesh-ancestor
24606197|NCT00989404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24606198|NCT00989404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606251|NCT00989651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24606253|NCT00989651|Tubulin Modulators|tubulin modulators|mesh-ancestor
24606254|NCT00989651|Antimitotic Agents|antimitotic agents|mesh-ancestor
24606255|NCT00989651|Mitosis Modulators|mitosis modulators|mesh-ancestor
24606256|NCT00989651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606257|NCT00989651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24606258|NCT00989651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24606259|NCT00989651|Growth Substances|growth substances|mesh-ancestor
24606260|NCT00989651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606261|NCT00989651|Growth Inhibitors|growth inhibitors|mesh-ancestor
24606262|NCT00989651|Immunologic Factors|immunologic factors|mesh-ancestor
24606263|NCT00989651|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24606264|NCT00989651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606265|NCT00989690|Docetaxel|docetaxel|mesh-list
24606266|NCT00989690|Pemetrexed|pemetrexed|mesh-list
24606267|NCT00989690|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24606268|NCT00989690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24606269|NCT00989690|Tubulin Modulators|tubulin modulators|mesh-ancestor
24606270|NCT00989690|Antimitotic Agents|antimitotic agents|mesh-ancestor
24606271|NCT00989690|Mitosis Modulators|mitosis modulators|mesh-ancestor
24606272|NCT00989690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606273|NCT00989690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606274|NCT00989690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24853445|NCT02268305|Dimethyl sulfone|dimethyl sulfone|mesh-list
24853446|NCT02268305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24853447|NCT02268357|Propranolol|propranolol|mesh-list
24853448|NCT02268357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24853449|NCT02268357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24853450|NCT02268357|Adrenergic Agents|adrenergic agents|mesh-ancestor
24606308|NCT00989729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24606309|NCT00989729|Glucocorticoids|glucocorticoids|mesh-ancestor
25676589|NCT01800877|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25676590|NCT01800877|Protective Agents|protective agents|mesh-ancestor
25676591|NCT01800877|Hemostatics|hemostatics|mesh-ancestor
25676592|NCT01800877|Coagulants|coagulants|mesh-ancestor
25676593|NCT01800877|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25676594|NCT01800877|Natriuretic Agents|natriuretic agents|mesh-ancestor
25676595|NCT01800877|Dopamine Agents|dopamine agents|mesh-ancestor
25676596|NCT01800968|Liraglutide|liraglutide|mesh-list
25676597|NCT01800968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25676598|NCT01800968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676599|NCT01800968|Incretins|incretins|mesh-ancestor
24606310|NCT00989729|Hormones|hormones|mesh-ancestor
25676600|NCT01800968|Hormones|hormones|mesh-ancestor
24523631|NCT05341193|Gemcitabine|gemcitabine|mesh-list
24523632|NCT05341193|Bevacizumab|bevacizumab|mesh-list
24523634|NCT05341193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24523644|NCT05341193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24523645|NCT05341193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24523646|NCT05341193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24523647|NCT05341193|Immunologic Factors|immunologic factors|mesh-ancestor
24606311|NCT00989729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24606312|NCT00989729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24606313|NCT00989729|Protective Agents|protective agents|mesh-ancestor
24606314|NCT00989729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24606315|NCT00989729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24606316|NCT00989742|Doxycycline|doxycycline|mesh-list
24606317|NCT00989742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24606318|NCT00989742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24606319|NCT00989742|Antimalarials|antimalarials|mesh-ancestor
24606320|NCT00989742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24606321|NCT00989742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24606323|NCT00989807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24606325|NCT00989820|Coal Tar|coal tar|mesh-list
24606333|NCT00990028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24606334|NCT00990028|Antimetabolites|antimetabolites|mesh-ancestor
24606335|NCT00990028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606359|NCT00990067|Serotonin Agents|serotonin agents|mesh-ancestor
24606360|NCT00990067|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24606361|NCT00990067|Adrenergic Agents|adrenergic agents|mesh-ancestor
24606362|NCT00990158|Vitamin K|vitamin k|mesh-list
24606363|NCT00990158|Vitamin K 1|vitamin k 1|mesh-list
24606364|NCT00990158|Vitamins|vitamins|mesh-ancestor
24606365|NCT00990158|Micronutrients|micronutrients|mesh-ancestor
24606366|NCT00990158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606367|NCT00990158|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24671248|NCT01324544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24606368|NCT00990158|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24606369|NCT00990158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208739|NCT01029717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25208740|NCT01029717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25208741|NCT01029717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208742|NCT01029717|Leprostatic Agents|leprostatic agents|mesh-ancestor
24491144|NCT00481364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24491145|NCT00481364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491147|NCT00481429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24491148|NCT00481429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491149|NCT00481442|Phenylephrine|phenylephrine|mesh-list
24606370|NCT00990158|Hemostatics|hemostatics|mesh-ancestor
24606371|NCT00990158|Coagulants|coagulants|mesh-ancestor
24606372|NCT00990197|Nicotine|nicotine|mesh-list
24606373|NCT00990197|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24606374|NCT00990197|Autonomic Agents|autonomic agents|mesh-ancestor
24606375|NCT00990197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24606376|NCT00990197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606381|NCT00990197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606383|NCT00990223|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24606384|NCT00990223|Hormone Antagonists|hormone antagonists|mesh-ancestor
24606394|NCT00990275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24606395|NCT00990275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606396|NCT00990301|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24606398|NCT00990301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24606399|NCT00990301|Diuretics|diuretics|mesh-ancestor
24606400|NCT00990301|Natriuretic Agents|natriuretic agents|mesh-ancestor
24853451|NCT02268357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24853452|NCT02268357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853453|NCT02268357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853454|NCT02268357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25676601|NCT01800968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25676602|NCT01801111|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25676603|NCT01801111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25676604|NCT01801111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25676605|NCT01801111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676606|NCT01801111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253494|NCT02500667|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25253495|NCT02500667|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25253496|NCT02500667|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25253497|NCT02500667|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25253498|NCT02500667|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25253500|NCT02500680|Immunologic Factors|immunologic factors|mesh-ancestor
25253501|NCT02500680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274754|NCT02375867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25274755|NCT02375867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274756|NCT02375867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24853455|NCT02268357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24606401|NCT00990301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606402|NCT00990301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24606403|NCT00990301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24606404|NCT00990301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606405|NCT00990301|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24606426|NCT00990405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24606428|NCT00990418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24606447|NCT00990496|Cyclophosphamide|cyclophosphamide|mesh-list
24606448|NCT00990496|Fludarabine|fludarabine|mesh-list
24606449|NCT00990496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24606450|NCT00990496|Immunologic Factors|immunologic factors|mesh-ancestor
24606451|NCT00990496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606452|NCT00990496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24606453|NCT00990496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24606454|NCT00990496|Alkylating Agents|alkylating agents|mesh-ancestor
24606455|NCT00990496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606456|NCT00990496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24606457|NCT00990496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24606459|NCT00990535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24606460|NCT00990535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24671249|NCT01324544|Narcotics|narcotics|mesh-ancestor
24606461|NCT00990535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24606462|NCT00990574|Anesthetics|anesthetics|mesh-list
24606463|NCT00990574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24606464|NCT00990574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606465|NCT00990587|Ciclopirox|ciclopirox|mesh-list
24606466|NCT00990587|Antifungal Agents|antifungal agents|mesh-ancestor
24606467|NCT00990587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24606487|NCT00990639|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25208743|NCT01029717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25208744|NCT01029717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208745|NCT01029717|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25208746|NCT01029717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25208747|NCT01029717|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25208748|NCT01029717|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25208749|NCT01029717|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25208750|NCT01029717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25208751|NCT00951457|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24491172|NCT00481455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491173|NCT00481455|Tubulin Modulators|tubulin modulators|mesh-ancestor
24491174|NCT00481455|Antimitotic Agents|antimitotic agents|mesh-ancestor
24491175|NCT00481455|Mitosis Modulators|mitosis modulators|mesh-ancestor
24457530|NCT00334672|Busulfan|busulfan|mesh-list
24457531|NCT00334672|Methotrexate|methotrexate|mesh-list
24457532|NCT00334672|Etoposide|etoposide|mesh-list
24457533|NCT00334672|Cyclosporins|cyclosporins|mesh-list
24606488|NCT00990639|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25676607|NCT01801124|Bupivacaine|bupivacaine|mesh-list
25676608|NCT01801124|Anesthetics, Local|anesthetics, local|mesh-ancestor
25676609|NCT01801124|Anesthetics|anesthetics|mesh-ancestor
25676610|NCT01801124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25676611|NCT01801124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676612|NCT01801124|Sensory System Agents|sensory system agents|mesh-ancestor
25676613|NCT01801124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25676614|NCT01801280|Mycophenolic Acid|mycophenolic acid|mesh-list
25676615|NCT01801280|Pantoprazole|pantoprazole|mesh-list
25676616|NCT01801280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25676617|NCT01801280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25676618|NCT01801280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25676619|NCT01801280|Antitubercular Agents|antitubercular agents|mesh-ancestor
24606489|NCT00990639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606491|NCT00990678|Calcitriol|calcitriol|mesh-list
24606492|NCT00990678|Calcium|calcium|mesh-list
24606493|NCT00990678|Vitamins|vitamins|mesh-ancestor
24606494|NCT00990678|Micronutrients|micronutrients|mesh-ancestor
24606495|NCT00990678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606497|NCT00990678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24606498|NCT00990678|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24606499|NCT00990678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24859003|NCT02301000|Metronidazole|metronidazole|mesh-list
24606500|NCT00990678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853456|NCT02268357|Vasodilator Agents|vasodilator agents|mesh-ancestor
24853458|NCT02268370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24853459|NCT02268370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24853460|NCT02268370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24853461|NCT02268370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853462|NCT02268383|Luspatercept|luspatercept|mesh-list
24853463|NCT02268383|Hematinics|hematinics|mesh-ancestor
24853464|NCT02268409|Luspatercept|luspatercept|mesh-list
24853465|NCT02268409|Hematinics|hematinics|mesh-ancestor
24853466|NCT02268422|Buprenorphine|buprenorphine|mesh-list
24853467|NCT02268422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24853468|NCT02268422|Narcotics|narcotics|mesh-ancestor
24606501|NCT00990678|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24606502|NCT00990691|Desipramine|desipramine|mesh-list
24606560|NCT00990860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24606561|NCT00990860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24606562|NCT00990860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606563|NCT00990860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606564|NCT00990886|Oxybutynin|oxybutynin|mesh-list
24606565|NCT00990886|Parasympatholytics|parasympatholytics|mesh-ancestor
24639765|NCT01164085|Ketorolac|ketorolac|mesh-list
24606566|NCT00990886|Autonomic Agents|autonomic agents|mesh-ancestor
24606567|NCT00990886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24606568|NCT00990886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606584|NCT00991055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606585|NCT00991133|Clofarabine|clofarabine|mesh-list
24606586|NCT00991133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24606587|NCT00991133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606588|NCT00991133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24853470|NCT02268422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853471|NCT02268422|Analgesics|analgesics|mesh-ancestor
24853472|NCT02268422|Sensory System Agents|sensory system agents|mesh-ancestor
24853473|NCT02268422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24853474|NCT02268422|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24853475|NCT02268435|Imatinib Mesylate|imatinib mesylate|mesh-list
24853476|NCT02268435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24853477|NCT02268435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24606603|NCT00991211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24606604|NCT00991211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24606605|NCT00991211|Alkylating Agents|alkylating agents|mesh-ancestor
24671250|NCT01324544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24606606|NCT00991211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606608|NCT00991211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24606609|NCT00991211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24606610|NCT00991211|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24606611|NCT00991211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24606612|NCT00991211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606613|NCT00991211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25208752|NCT00951457|Alemtuzumab|alemtuzumab|mesh-list
25208753|NCT00951457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25208754|NCT00951457|Alkylating Agents|alkylating agents|mesh-ancestor
25208755|NCT00951457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208756|NCT00951457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208757|NCT00951457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25208758|NCT00700076|Ketamine|ketamine|mesh-list
24393227|NCT00129168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491183|NCT00481533|Oxytocin|oxytocin|mesh-list
24491184|NCT00481533|Ergonovine|ergonovine|mesh-list
24491239|NCT00481728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24491240|NCT00481728|Cholinergic Agents|cholinergic agents|mesh-ancestor
24491241|NCT00481728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24491242|NCT00481728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606618|NCT00991250|Dacarbazine|dacarbazine|mesh-list
24606619|NCT00991250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24606620|NCT00991250|Alkylating Agents|alkylating agents|mesh-ancestor
24606624|NCT00991562|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24606775|NCT05408221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24606794|NCT05408208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24606804|NCT05408104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606805|NCT05408091|Antibodies|antibodies|mesh-list
24606806|NCT05408091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24606807|NCT05408091|Immunologic Factors|immunologic factors|mesh-ancestor
24606808|NCT05408091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606809|NCT05408065|Triamcinolone|triamcinolone|mesh-list
24606810|NCT05408065|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24606811|NCT05408065|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24606812|NCT05408065|Cortisone|cortisone|mesh-list
24606813|NCT05408065|Hyaluronic Acid|hyaluronic acid|mesh-list
24606933|NCT05406934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24606934|NCT05406856|Cisplatin|cisplatin|mesh-list
24606935|NCT05406856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24606936|NCT05406466|Lenvatinib|lenvatinib|mesh-list
24606937|NCT05406466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24606938|NCT05406466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24606939|NCT05406466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606964|NCT05398731|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24606965|NCT05398731|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24606966|NCT05398731|Adrenergic Agents|adrenergic agents|mesh-ancestor
24606967|NCT05398731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25208759|NCT00700076|Analgesics|analgesics|mesh-ancestor
25208760|NCT00700076|Sensory System Agents|sensory system agents|mesh-ancestor
25208761|NCT00700076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25208762|NCT00700076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208763|NCT00700076|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25208764|NCT00700076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25208765|NCT00700076|Anesthetics, General|anesthetics, general|mesh-ancestor
25208766|NCT00700076|Anesthetics|anesthetics|mesh-ancestor
25208767|NCT00700076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25208768|NCT00700076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25208769|NCT00700076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25208770|NCT00700076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25208771|NCT00700076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208772|NCT00653068|Calcium, Dietary|calcium, dietary|mesh-list
24853492|NCT02268565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25073952|NCT03391856|Antidotes|antidotes|mesh-ancestor
24640119|NCT01166087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25208784|NCT00653068|Lenograstim|lenograstim|mesh-list
25208773|NCT00653068|Leucovorin|leucovorin|mesh-list
25208774|NCT00653068|Folic Acid|folic acid|mesh-list
25208775|NCT00653068|Cyclophosphamide|cyclophosphamide|mesh-list
25208776|NCT00653068|Thiotepa|thiotepa|mesh-list
25208777|NCT00653068|Cisplatin|cisplatin|mesh-list
25208779|NCT00653068|Methotrexate|methotrexate|mesh-list
25208780|NCT00653068|Etoposide|etoposide|mesh-list
25208781|NCT00653068|Vincristine|vincristine|mesh-list
25208782|NCT00653068|Etoposide phosphate|etoposide phosphate|mesh-list
25208783|NCT00653068|Podophyllotoxin|podophyllotoxin|mesh-list
25208789|NCT00653068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491359|NCT00482222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491422|NCT00482456|Anesthetics, General|anesthetics, general|mesh-ancestor
25117005|NCT03105466|Immunologic Factors|immunologic factors|mesh-ancestor
24640271|NCT01167127|Naloxone|naloxone|mesh-list
24640286|NCT01167465|Zinc Oxide|zinc oxide|mesh-list
24458303|NCT00337389|Growth Inhibitors|growth inhibitors|mesh-ancestor
24458304|NCT00337389|Antimetabolites|antimetabolites|mesh-ancestor
24458305|NCT00337389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458306|NCT00337389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24458307|NCT00337389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24533508|NCT00644215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24533509|NCT00644215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25074018|NCT03391427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25074019|NCT03391427|Anesthetics, General|anesthetics, general|mesh-ancestor
25074020|NCT03391427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24925512|NCT04149626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24925513|NCT04149626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24925514|NCT04149626|Anesthetics, General|anesthetics, general|mesh-ancestor
25208794|NCT00653068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208795|NCT00653068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25208796|NCT00653068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25208797|NCT00653068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24491431|NCT00482495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25676620|NCT01801280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25676621|NCT01801280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25676622|NCT01801280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676623|NCT01801280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676624|NCT01801280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25676625|NCT01801280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25676626|NCT01801280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25208798|NCT00653068|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25208799|NCT00653068|Abortifacient Agents|abortifacient agents|mesh-ancestor
25208800|NCT00653068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25208801|NCT00653068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25208802|NCT00653068|Antimetabolites|antimetabolites|mesh-ancestor
24491442|NCT00482521|Pomalidomide|pomalidomide|mesh-list
24491443|NCT00482521|Immunologic Factors|immunologic factors|mesh-ancestor
24491444|NCT00482521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491501|NCT00482807|Goserelin|goserelin|mesh-list
24491502|NCT00482807|Bicalutamide|bicalutamide|mesh-list
24491503|NCT00482807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491504|NCT00482807|Tubulin Modulators|tubulin modulators|mesh-ancestor
24491505|NCT00482807|Antimitotic Agents|antimitotic agents|mesh-ancestor
25676627|NCT01801436|Bortezomib|bortezomib|mesh-list
25676628|NCT01801436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25676629|NCT01801449|Rilonacept|rilonacept|mesh-list
24523795|NCT05340413|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24863059|NCT03635788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24450033|NCT00317655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24450035|NCT00317655|Sensory System Agents|sensory system agents|mesh-ancestor
24450036|NCT00317655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24450037|NCT00317655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450072|NCT00317746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25208803|NCT00653068|Dermatologic Agents|dermatologic agents|mesh-ancestor
25208804|NCT00653068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208805|NCT00653068|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25208806|NCT00653068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25208807|NCT00653068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25208808|NCT00653068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25208809|NCT00653068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25208810|NCT00653068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25208811|NCT00653068|Antidotes|antidotes|mesh-ancestor
25208812|NCT00653068|Protective Agents|protective agents|mesh-ancestor
25208813|NCT00653068|Vitamin B Complex|vitamin b complex|mesh-ancestor
25208814|NCT00653068|Vitamins|vitamins|mesh-ancestor
24491506|NCT00482807|Mitosis Modulators|mitosis modulators|mesh-ancestor
24491703|NCT00483743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24491704|NCT00483743|Autonomic Agents|autonomic agents|mesh-ancestor
24491705|NCT00483743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24625932|NCT01084408|Paclitaxel|paclitaxel|mesh-list
24450073|NCT00317759|Fludarabine|fludarabine|mesh-list
24533548|NCT00644319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24533549|NCT00644319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24533550|NCT00644319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492275|NCT00485823|Olanzapine|olanzapine|mesh-list
24533553|NCT00644371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25676630|NCT01801449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25676631|NCT01801475|Ondansetron|ondansetron|mesh-list
25676632|NCT01801475|Antiemetics|antiemetics|mesh-ancestor
25676633|NCT01801475|Autonomic Agents|autonomic agents|mesh-ancestor
25074088|NCT03390790|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25074089|NCT03390790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24837015|NCT02188472|Trimethoprim|trimethoprim|mesh-list
24640803|NCT01170130|Sensory System Agents|sensory system agents|mesh-ancestor
24640804|NCT01170130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24640805|NCT01170130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24640806|NCT01170130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25208815|NCT00653068|Micronutrients|micronutrients|mesh-ancestor
25208816|NCT00653068|Tubulin Modulators|tubulin modulators|mesh-ancestor
25208817|NCT00653068|Antimitotic Agents|antimitotic agents|mesh-ancestor
25208818|NCT00653068|Mitosis Modulators|mitosis modulators|mesh-ancestor
25208819|NCT00653068|Hematinics|hematinics|mesh-ancestor
25208820|NCT00653068|Keratolytic Agents|keratolytic agents|mesh-ancestor
24857467|NCT02291705|Tramadol|tramadol|mesh-list
24533565|NCT00644449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24533566|NCT00644449|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24533567|NCT00644449|Renal Agents|renal agents|mesh-ancestor
24533568|NCT00644449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24533575|NCT00644475|Candesartan|candesartan|mesh-list
24925605|NCT04149132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24458320|NCT00337493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24458321|NCT00337493|Immunologic Factors|immunologic factors|mesh-ancestor
24458322|NCT00337493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458323|NCT00337493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24458324|NCT00337493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458325|NCT00337493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458326|NCT00337493|Antifungal Agents|antifungal agents|mesh-ancestor
25208821|NCT00482157|Vitamin D|vitamin d|mesh-list
25208822|NCT00482157|Calcitriol|calcitriol|mesh-list
25208823|NCT00482157|Vitamins|vitamins|mesh-ancestor
25208824|NCT00482157|Micronutrients|micronutrients|mesh-ancestor
25208825|NCT00482157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208826|NCT00482157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24491917|NCT00484510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492272|NCT00485810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492274|NCT00485810|Serotonin Agents|serotonin agents|mesh-ancestor
24641054|NCT01171651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24492276|NCT00485823|Antiemetics|antiemetics|mesh-ancestor
24492277|NCT00485823|Autonomic Agents|autonomic agents|mesh-ancestor
24492278|NCT00485823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25676634|NCT01801475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24925624|NCT04148898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925625|NCT04148898|Growth Inhibitors|growth inhibitors|mesh-ancestor
24925626|NCT04148898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24458327|NCT00337493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24458328|NCT00337493|Dermatologic Agents|dermatologic agents|mesh-ancestor
24458329|NCT00337493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24458330|NCT00337493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24458331|NCT00337493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24533620|NCT00644631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24533621|NCT00644631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533622|NCT00644631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533623|NCT00644631|Urological Agents|urological agents|mesh-ancestor
24533624|NCT00644670|Atorvastatin|atorvastatin|mesh-list
24533625|NCT00644670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24533626|NCT00644670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24641056|NCT01171651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25074123|NCT03390608|Hormones|hormones|mesh-ancestor
25208827|NCT00482157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25208828|NCT00482157|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25208829|NCT00482157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25208830|NCT00482157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208831|NCT00482157|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25208832|NCT00193479|Prednisone|prednisone|mesh-list
25208833|NCT00193479|Cyclophosphamide|cyclophosphamide|mesh-list
25208834|NCT00193479|Rituximab|rituximab|mesh-list
25208835|NCT00193479|Vincristine|vincristine|mesh-list
25208836|NCT00193479|Mitoxantrone|mitoxantrone|mesh-list
25208837|NCT00193479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25676635|NCT01801475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676636|NCT01801475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25676637|NCT01801475|Antipruritics|antipruritics|mesh-ancestor
25676638|NCT01801475|Dermatologic Agents|dermatologic agents|mesh-ancestor
24925710|NCT04148846|Autonomic Agents|autonomic agents|mesh-ancestor
24925711|NCT04148846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24925727|NCT04148846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25208838|NCT00193479|Immunologic Factors|immunologic factors|mesh-ancestor
25208839|NCT00193479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208840|NCT00193479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25272585|NCT02391077|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25272586|NCT02391077|Chlorhexidine|chlorhexidine|mesh-list
25272587|NCT02391077|Povidone-Iodine|povidone-iodine|mesh-list
25272589|NCT02391077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25272590|NCT02391077|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25272591|NCT02391077|Disinfectants|disinfectants|mesh-ancestor
24492283|NCT00485823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24492363|NCT00485979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208841|NCT00193479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25676639|NCT01801475|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25676640|NCT01801475|Serotonin Agents|serotonin agents|mesh-ancestor
25676641|NCT01801475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25676642|NCT01801475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676643|NCT01801475|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25676644|NCT01801475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25676645|NCT01801475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25676646|NCT01801475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25676647|NCT01801475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25676648|NCT01801735|Meloxicam|meloxicam|mesh-list
25676649|NCT01801735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25676650|NCT01801735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25676651|NCT01801735|Analgesics|analgesics|mesh-ancestor
25676652|NCT01801735|Sensory System Agents|sensory system agents|mesh-ancestor
25676653|NCT01801735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25676654|NCT01801735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676655|NCT01801735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25676656|NCT01801735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24583053|NCT00873262|Estrogens|estrogens|mesh-ancestor
24533639|NCT00644696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533640|NCT00644696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24533641|NCT00644696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24533642|NCT00644696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24533644|NCT00644709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24533645|NCT00644709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24533646|NCT00644709|Antimetabolites|antimetabolites|mesh-ancestor
24533647|NCT00644709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533648|NCT00644709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24533649|NCT00644709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24533650|NCT00644709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208842|NCT00193479|Alkylating Agents|alkylating agents|mesh-ancestor
25208843|NCT00193479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208844|NCT00193479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208845|NCT00193479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24863060|NCT03635788|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24632015|NCT01121705|Antiviral Agents|antiviral agents|mesh-ancestor
24450135|NCT00317811|Antioxidants|antioxidants|mesh-ancestor
25676657|NCT01801735|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25676658|NCT01801735|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25676659|NCT01801735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676660|NCT01801735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676661|NCT01801917|Siponimod|siponimod|mesh-list
25676662|NCT01801917|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25676663|NCT01801917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676664|NCT01801917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25676665|NCT01801917|Immunologic Factors|immunologic factors|mesh-ancestor
25676666|NCT01801917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208846|NCT00193479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25208848|NCT00193479|Glucocorticoids|glucocorticoids|mesh-ancestor
24533664|NCT00644748|Sensory System Agents|sensory system agents|mesh-ancestor
24533665|NCT00644748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24533666|NCT00644748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533668|NCT00644748|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24533669|NCT00644748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24444234|NCT00297076|Aplaviroc|aplaviroc|mesh-list
25208849|NCT00193479|Hormones|hormones|mesh-ancestor
25208850|NCT00193479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25208851|NCT00193479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25208852|NCT00193479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25208853|NCT00193479|Tubulin Modulators|tubulin modulators|mesh-ancestor
25208854|NCT00193479|Antimitotic Agents|antimitotic agents|mesh-ancestor
24492682|NCT00487253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583067|NCT00873275|Calcium|calcium|mesh-list
24533670|NCT00644748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24533671|NCT00644748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24446010|NCT00303576|Dapivirine|dapivirine|mesh-list
24533672|NCT00644748|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24641826|NCT01175577|Antioxidants|antioxidants|mesh-ancestor
24642080|NCT01177514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24533673|NCT00644748|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24533674|NCT00644748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25208855|NCT00193479|Mitosis Modulators|mitosis modulators|mesh-ancestor
25208856|NCT00193479|Analgesics|analgesics|mesh-ancestor
25208857|NCT00193479|Sensory System Agents|sensory system agents|mesh-ancestor
25208858|NCT00193479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25208859|NCT00193479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25208862|NCT00193427|Gemcitabine|gemcitabine|mesh-list
24492684|NCT00487253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24492685|NCT00487422|Prucalopride|prucalopride|mesh-list
24492686|NCT00487422|Laxatives|laxatives|mesh-ancestor
24492687|NCT00487422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24492688|NCT00487422|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24492689|NCT00487422|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24492690|NCT00487422|Serotonin Agents|serotonin agents|mesh-ancestor
24944368|NCT03961126|Hormones|hormones|mesh-ancestor
24450085|NCT00317785|Cyclophosphamide|cyclophosphamide|mesh-list
24450087|NCT00317785|Tacrolimus|tacrolimus|mesh-list
24450088|NCT00317785|Cyclosporins|cyclosporins|mesh-list
24450089|NCT00317785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24450090|NCT00317785|Immunologic Factors|immunologic factors|mesh-ancestor
24533675|NCT00644748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533676|NCT00644748|Antimanic Agents|antimanic agents|mesh-ancestor
24632196|NCT01122602|Analgesics|analgesics|mesh-ancestor
24632220|NCT01122615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24533677|NCT00644761|Adefovir|adefovir|mesh-list
24533678|NCT00644761|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
24533679|NCT00644761|Antiviral Agents|antiviral agents|mesh-ancestor
25208863|NCT00193427|Carboplatin|carboplatin|mesh-list
25208864|NCT00193427|Docetaxel|docetaxel|mesh-list
25208865|NCT00193427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208866|NCT00193427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25208867|NCT00193427|Antimetabolites|antimetabolites|mesh-ancestor
25208868|NCT00193427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208869|NCT00193427|Antiviral Agents|antiviral agents|mesh-ancestor
25208870|NCT00193427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25208871|NCT00193427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24524042|NCT05319093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524043|NCT05319093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24944379|NCT03960905|Meropenem|meropenem|mesh-list
24533680|NCT00644761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24458333|NCT00337493|Antitubercular Agents|antitubercular agents|mesh-ancestor
24458334|NCT00337493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24583381|NCT00874328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010347|NCT04218240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25010348|NCT04218240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25010349|NCT04218240|Adrenergic Agents|adrenergic agents|mesh-ancestor
25010350|NCT04218240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24513832|NCT00585520|Progesterone|progesterone|mesh-list
24533682|NCT00644761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24533683|NCT00644761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208872|NCT00193427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25208873|NCT00193427|Immunologic Factors|immunologic factors|mesh-ancestor
25208874|NCT00193427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208875|NCT00193427|Tubulin Modulators|tubulin modulators|mesh-ancestor
25208876|NCT00193427|Antimitotic Agents|antimitotic agents|mesh-ancestor
25208877|NCT00193427|Mitosis Modulators|mitosis modulators|mesh-ancestor
25208878|NCT00193414|Gemcitabine|gemcitabine|mesh-list
24492692|NCT00487422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492693|NCT00487422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676667|NCT01802073|Vancomycin|vancomycin|mesh-list
25676668|NCT01802073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25676669|NCT01802073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25676670|NCT01802216|Minocycline|minocycline|mesh-list
25676671|NCT01802216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25676672|NCT01802216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25676673|NCT01802333|Cytarabine|cytarabine|mesh-list
25676674|NCT01802333|Daunorubicin|daunorubicin|mesh-list
24450121|NCT00317798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24450122|NCT00317798|Immunologic Factors|immunologic factors|mesh-ancestor
24450123|NCT00317798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450124|NCT00317811|Ascorbic Acid|ascorbic acid|mesh-list
24450127|NCT00317811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450129|NCT00317811|Alkylating Agents|alkylating agents|mesh-ancestor
24450130|NCT00317811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450131|NCT00317811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24450132|NCT00317811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25208879|NCT00193414|Pemetrexed|pemetrexed|mesh-list
25208880|NCT00193414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25208881|NCT00193414|Antimetabolites|antimetabolites|mesh-ancestor
25208882|NCT00193414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208883|NCT00193414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208884|NCT00193414|Antiviral Agents|antiviral agents|mesh-ancestor
24492828|NCT00488176|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24492829|NCT00488176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24492830|NCT00488176|Histamine Antagonists|histamine antagonists|mesh-ancestor
24492831|NCT00488176|Histamine Agents|histamine agents|mesh-ancestor
24944389|NCT03961087|Vitamins|vitamins|mesh-ancestor
24450133|NCT00317811|Immunologic Factors|immunologic factors|mesh-ancestor
24450134|NCT00317811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450136|NCT00317811|Protective Agents|protective agents|mesh-ancestor
24450138|NCT00317811|Micronutrients|micronutrients|mesh-ancestor
24450139|NCT00317850|Gabapentin|gabapentin|mesh-list
24450140|NCT00317850|Analgesics|analgesics|mesh-ancestor
24450141|NCT00317850|Sensory System Agents|sensory system agents|mesh-ancestor
24450142|NCT00317850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25676675|NCT01802333|Vorinostat|vorinostat|mesh-list
25676676|NCT01802333|Idarubicin|idarubicin|mesh-list
24926193|NCT04143906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24926194|NCT04143906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24926195|NCT04143906|Immunologic Factors|immunologic factors|mesh-ancestor
24940059|NCT04004117|Anesthetics, General|anesthetics, general|mesh-ancestor
24583591|NCT00875407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583592|NCT00875407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633011|NCT01126814|Imatinib Mesylate|imatinib mesylate|mesh-list
24583594|NCT00875537|Antipruritics|antipruritics|mesh-ancestor
24533703|NCT00644891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24533704|NCT00644891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25208885|NCT00193414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25208886|NCT00193414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208887|NCT00193414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25208888|NCT00193414|Immunologic Factors|immunologic factors|mesh-ancestor
25208889|NCT00193414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208890|NCT00193414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24492832|NCT00488176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492889|NCT00488566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944398|NCT03960775|Analgesics|analgesics|mesh-ancestor
24458336|NCT00337506|Bortezomib|bortezomib|mesh-list
24458337|NCT00337506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24458338|NCT00337506|Antiemetics|antiemetics|mesh-ancestor
24458339|NCT00337506|Autonomic Agents|autonomic agents|mesh-ancestor
24404270|NCT00162955|Valsartan|valsartan|mesh-list
24533705|NCT00644904|Vitamin D|vitamin d|mesh-list
24626435|NCT01087398|Alkylating Agents|alkylating agents|mesh-ancestor
25676677|NCT01802333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25676678|NCT01802333|Antimetabolites|antimetabolites|mesh-ancestor
25676679|NCT01802333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676680|NCT01802333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25676681|NCT01802333|Antiviral Agents|antiviral agents|mesh-ancestor
25676682|NCT01802333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25676683|NCT01802333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24926196|NCT04143906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926197|NCT04143906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24926198|NCT04143906|Tubulin Modulators|tubulin modulators|mesh-ancestor
24926199|NCT04143906|Antimitotic Agents|antimitotic agents|mesh-ancestor
25254036|NCT02497157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25254039|NCT02497157|Antidotes|antidotes|mesh-ancestor
25208891|NCT00193414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25208892|NCT00085735|Cyclophosphamide|cyclophosphamide|mesh-list
25208893|NCT00085735|Lomustine|lomustine|mesh-list
25208894|NCT00085735|Cisplatin|cisplatin|mesh-list
25208895|NCT00085735|Vincristine|vincristine|mesh-list
25208896|NCT00085735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24492890|NCT00488566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24492891|NCT00488566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676684|NCT01802333|Immunologic Factors|immunologic factors|mesh-ancestor
25676685|NCT01802333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676686|NCT01802333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25676687|NCT01802333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25676688|NCT01802333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25676689|NCT01802333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533711|NCT00644904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24533738|NCT00645034|Sildenafil Citrate|sildenafil citrate|mesh-list
24533739|NCT00645034|Vasodilator Agents|vasodilator agents|mesh-ancestor
24533740|NCT00645034|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24533741|NCT00645034|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24533742|NCT00645034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208897|NCT00085735|Immunologic Factors|immunologic factors|mesh-ancestor
25208898|NCT00085735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208899|NCT00085735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24492919|NCT00488605|Immunologic Factors|immunologic factors|mesh-ancestor
24492920|NCT00488605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24492921|NCT00488605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24492922|NCT00488605|Antidotes|antidotes|mesh-ancestor
24944407|NCT03960866|Phentolamine|phentolamine|mesh-list
24863062|NCT03601455|Durvalumab|durvalumab|mesh-list
25254123|NCT02496715|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25254124|NCT02496715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25254125|NCT02496715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25254126|NCT02496715|Autonomic Agents|autonomic agents|mesh-ancestor
25254129|NCT02496715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25208900|NCT00085735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25208901|NCT00085735|Alkylating Agents|alkylating agents|mesh-ancestor
25208902|NCT00085735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074409|NCT03388671|Anesthetics|anesthetics|mesh-ancestor
25208903|NCT00085735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208904|NCT00085735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25208905|NCT00085735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24457541|NCT00334672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457543|NCT00334672|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24457544|NCT00334672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24458340|NCT00337506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24458341|NCT00337506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404334|NCT00163150|Atorvastatin|atorvastatin|mesh-list
25676690|NCT01802333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25676691|NCT01802385|Sertraline|sertraline|mesh-list
25676692|NCT01802385|Antidepressive Agents|antidepressive agents|mesh-ancestor
25676693|NCT01802385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25676694|NCT01802385|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25676695|NCT01802385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25676696|NCT01802385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25676697|NCT01802385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676698|NCT01802385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24533750|NCT00645073|Ofloxacin|ofloxacin|mesh-list
24533751|NCT00645073|Cefdinir|cefdinir|mesh-list
24533752|NCT00645073|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24533753|NCT00645073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24533754|NCT00645073|Renal Agents|renal agents|mesh-ancestor
24450169|NCT00317876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24450170|NCT00317876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24450172|NCT00317876|Dermatologic Agents|dermatologic agents|mesh-ancestor
24450173|NCT00317876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450174|NCT00317876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24450175|NCT00317876|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24450176|NCT00317876|Antifungal Agents|antifungal agents|mesh-ancestor
24450177|NCT00317876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24450178|NCT00317876|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24633058|NCT01127022|Nootropic Agents|nootropic agents|mesh-ancestor
25208906|NCT00085735|Tubulin Modulators|tubulin modulators|mesh-ancestor
25208907|NCT00085735|Antimitotic Agents|antimitotic agents|mesh-ancestor
25208908|NCT00085735|Mitosis Modulators|mitosis modulators|mesh-ancestor
25208909|NCT00003042|Tamoxifen|tamoxifen|mesh-list
25208910|NCT00003042|Paclitaxel|paclitaxel|mesh-list
24457546|NCT00334672|Autonomic Agents|autonomic agents|mesh-ancestor
24457547|NCT00334672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24457548|NCT00334672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24457549|NCT00334672|Glucocorticoids|glucocorticoids|mesh-ancestor
24457550|NCT00334672|Hormones|hormones|mesh-ancestor
25117007|NCT03105466|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25676699|NCT01802385|Serotonin Agents|serotonin agents|mesh-ancestor
25254209|NCT02496182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25254211|NCT02496078|Protease Inhibitors|protease inhibitors|mesh-ancestor
25254212|NCT02496078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25254213|NCT02496078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926402|NCT04142151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926403|NCT04142151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24926404|NCT04142151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24926405|NCT04142151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24954225|NCT03877705|Listerine|listerine|mesh-list
25208911|NCT00003042|Cyclophosphamide|cyclophosphamide|mesh-list
25208912|NCT00003042|Doxorubicin|doxorubicin|mesh-list
25676700|NCT01802385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676701|NCT01802437|Fluoxetine|fluoxetine|mesh-list
25676702|NCT01802437|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25676703|NCT01802437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25676704|NCT01802437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25676705|NCT01802437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676706|NCT01802437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25676707|NCT01802437|Serotonin Agents|serotonin agents|mesh-ancestor
25676708|NCT01802437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676709|NCT01802437|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25676710|NCT01802437|Antidepressive Agents|antidepressive agents|mesh-ancestor
25676711|NCT01802437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24633125|NCT01127295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24584052|NCT00878345|Dexmedetomidine|dexmedetomidine|mesh-list
24584053|NCT00878345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24584066|NCT00878345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25208913|NCT00003042|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25208914|NCT00003042|Melphalan|melphalan|mesh-list
25208915|NCT00003042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25208916|NCT00003042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25208917|NCT00003042|Tubulin Modulators|tubulin modulators|mesh-ancestor
24428125|NCT00239538|Natriuretic Agents|natriuretic agents|mesh-ancestor
24492937|NCT00488670|Serotonin Agents|serotonin agents|mesh-ancestor
24492938|NCT00488670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492939|NCT00488670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24492940|NCT00488670|Antidepressive Agents|antidepressive agents|mesh-ancestor
24492941|NCT00488670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24492943|NCT00488709|Fludarabine|fludarabine|mesh-list
24492944|NCT00488709|Topotecan|topotecan|mesh-list
24492972|NCT00488787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24492973|NCT00488787|Anesthetics, General|anesthetics, general|mesh-ancestor
24492975|NCT00488787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24533767|NCT00645086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533768|NCT00645086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533769|NCT00645086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25208918|NCT00003042|Antimitotic Agents|antimitotic agents|mesh-ancestor
25208919|NCT00003042|Mitosis Modulators|mitosis modulators|mesh-ancestor
25208920|NCT00003042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208921|NCT00003042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25208922|NCT00003042|Immunologic Factors|immunologic factors|mesh-ancestor
25208923|NCT00003042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208924|NCT00003042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25208925|NCT00003042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25208926|NCT00003042|Alkylating Agents|alkylating agents|mesh-ancestor
25208927|NCT00003042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25208928|NCT00003042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25676712|NCT01802437|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25676713|NCT01802437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25676714|NCT01802437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676715|NCT01802515|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25676716|NCT01802515|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25676717|NCT01802515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25110128|NCT05465330|Anesthetics|anesthetics|mesh-ancestor
25110129|NCT05465330|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24793583|NCT03091881|Serotonin Agents|serotonin agents|mesh-ancestor
24793587|NCT03032406|Everolimus|everolimus|mesh-list
25254243|NCT02495922|Glucocorticoids|glucocorticoids|mesh-ancestor
25254244|NCT02495922|Hormones|hormones|mesh-ancestor
25102756|NCT03166787|Ascorbic Acid|ascorbic acid|mesh-list
25102758|NCT03166787|Charcoal|charcoal|mesh-list
25254245|NCT02495922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25254246|NCT02495922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25254247|NCT02495922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25254248|NCT02495922|Immunologic Factors|immunologic factors|mesh-ancestor
25208929|NCT00003042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25208930|NCT00003042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25208931|NCT00003042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208932|NCT00003042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24492979|NCT00488787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492980|NCT00488800|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24492981|NCT00488800|Immunologic Factors|immunologic factors|mesh-ancestor
25074556|NCT03387592|Vitamins|vitamins|mesh-ancestor
24863063|NCT03601455|Ipilimumab|ipilimumab|mesh-list
24633332|NCT01128699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24633333|NCT01128699|Growth Substances|growth substances|mesh-ancestor
24633334|NCT01128699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633335|NCT01128699|Growth Inhibitors|growth inhibitors|mesh-ancestor
24633336|NCT01128712|Pregabalin|pregabalin|mesh-list
24633337|NCT01128712|Analgesics|analgesics|mesh-ancestor
24633338|NCT01128712|Sensory System Agents|sensory system agents|mesh-ancestor
24633339|NCT01128712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24633340|NCT01128712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074622|NCT03387111|Growth Inhibitors|growth inhibitors|mesh-ancestor
25074623|NCT03387111|Antimetabolites|antimetabolites|mesh-ancestor
25074624|NCT03387111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25074625|NCT03387111|Antidotes|antidotes|mesh-ancestor
25074626|NCT03387111|Protective Agents|protective agents|mesh-ancestor
25074627|NCT03387111|Vitamin B Complex|vitamin b complex|mesh-ancestor
24633341|NCT01128712|Anticonvulsants|anticonvulsants|mesh-ancestor
25676718|NCT01802515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25676719|NCT01802515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676720|NCT01802515|Adrenergic Agents|adrenergic agents|mesh-ancestor
25676721|NCT01802515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25676722|NCT01802515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676723|NCT01802580|Fluocinonide|fluocinonide|mesh-list
25676724|NCT01802580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25676725|NCT01802580|Glucocorticoids|glucocorticoids|mesh-ancestor
25676726|NCT01802580|Hormones|hormones|mesh-ancestor
25676727|NCT01802580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24393501|NCT00130195|Autonomic Agents|autonomic agents|mesh-ancestor
24493065|NCT00489372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493067|NCT00489385|Antimetabolites|antimetabolites|mesh-ancestor
24533779|NCT00645138|Anesthetics|anesthetics|mesh-list
24533780|NCT00645138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24533781|NCT00645138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533782|NCT00645151|Atorvastatin|atorvastatin|mesh-list
24533783|NCT00645151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24633425|NCT01129375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633426|NCT01129375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24633431|NCT01129388|Clopidogrel|clopidogrel|mesh-list
24863064|NCT03601455|Tremelimumab|tremelimumab|mesh-list
24633454|NCT01129414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24633455|NCT01129414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24633456|NCT01129414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24633457|NCT01129414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633458|NCT01129427|Pantoprazole|pantoprazole|mesh-list
24633459|NCT01129427|Clopidogrel|clopidogrel|mesh-list
25208939|NCT02706158|Vitamin D|vitamin d|mesh-list
25208940|NCT02706158|Calcium|calcium|mesh-list
25208941|NCT02706158|Vitamins|vitamins|mesh-ancestor
25208942|NCT02706158|Micronutrients|micronutrients|mesh-ancestor
25208943|NCT02706158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208944|NCT02706158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25208945|NCT02706158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24493123|NCT00489645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24493124|NCT00489645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493125|NCT00489645|Appetite Depressants|appetite depressants|mesh-ancestor
24493126|NCT00489645|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24493127|NCT00489645|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
24493128|NCT00489645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493130|NCT00489658|Nifurtimox|nifurtimox|mesh-list
24493131|NCT00489658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493196|NCT00489944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493198|NCT00489944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24493199|NCT00489944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493200|NCT00489944|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24493201|NCT00489944|Hormone Antagonists|hormone antagonists|mesh-ancestor
24493283|NCT00490243|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24493284|NCT00490243|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24493365|NCT00490711|Carboplatin|carboplatin|mesh-list
24493366|NCT00490711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24493374|NCT00490711|Antiviral Agents|antiviral agents|mesh-ancestor
24493375|NCT00490711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493376|NCT00490711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493377|NCT00490711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24493378|NCT00490711|Immunologic Factors|immunologic factors|mesh-ancestor
24493379|NCT00490711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493380|NCT00490737|Daptomycin|daptomycin|mesh-list
25208947|NCT02706119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25208948|NCT02706119|Insulin Glargine|insulin glargine|mesh-list
25208949|NCT02706119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25208950|NCT02706119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208954|NCT02705950|Baclofen|baclofen|mesh-list
25208955|NCT02705950|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25208956|NCT02705950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208957|NCT02705950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25208958|NCT02705950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25208959|NCT02705950|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25208960|NCT02705950|GABA Agonists|gaba agonists|mesh-ancestor
25208961|NCT02705950|GABA Agents|gaba agents|mesh-ancestor
25208962|NCT02705950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25208963|NCT02705950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208964|NCT02705872|Sufentanil|sufentanil|mesh-list
25208965|NCT02705872|Dsuvia|dsuvia|mesh-list
25208966|NCT02705872|Levobupivacaine|levobupivacaine|mesh-list
25208967|NCT02705872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25208968|NCT02705872|Narcotics|narcotics|mesh-ancestor
25208969|NCT02705872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25208970|NCT02705872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208971|NCT02705872|Analgesics|analgesics|mesh-ancestor
25208972|NCT02705872|Sensory System Agents|sensory system agents|mesh-ancestor
25208973|NCT02705872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25208974|NCT02705872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25208975|NCT02705872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24960247|NCT03818919|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24960248|NCT03818919|Anesthetics, General|anesthetics, general|mesh-ancestor
24960249|NCT03818919|Anesthetics|anesthetics|mesh-ancestor
24960250|NCT03818919|GABA Modulators|gaba modulators|mesh-ancestor
24960251|NCT03818919|GABA Agents|gaba agents|mesh-ancestor
25208976|NCT02705872|Anesthetics, General|anesthetics, general|mesh-ancestor
25208977|NCT02705872|Anesthetics|anesthetics|mesh-ancestor
25208978|NCT02705872|Anesthetics, Local|anesthetics, local|mesh-ancestor
25208980|NCT02706054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25208981|NCT02706054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25208982|NCT02706054|Analgesics|analgesics|mesh-ancestor
25208983|NCT02706054|Sensory System Agents|sensory system agents|mesh-ancestor
25208984|NCT02706054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24960261|NCT03818581|Suvorexant|suvorexant|mesh-list
24960262|NCT03818581|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24960263|NCT03818581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24960264|NCT03818581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24493381|NCT00490737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24493544|NCT00491348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24493545|NCT00491348|Antidepressive Agents|antidepressive agents|mesh-ancestor
24493547|NCT00491348|Dopamine Agents|dopamine agents|mesh-ancestor
24493604|NCT00491712|Glucocorticoids|glucocorticoids|mesh-ancestor
24493606|NCT00491712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24493706|NCT00492128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24493707|NCT00492128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24493708|NCT00492128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493709|NCT00492128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24493710|NCT00492128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493711|NCT00492128|Vasodilator Agents|vasodilator agents|mesh-ancestor
24493777|NCT00492414|Antidepressive Agents|antidepressive agents|mesh-ancestor
24493778|NCT00492414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24493779|NCT00492414|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24493780|NCT00492414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24493781|NCT00492414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493782|NCT00492427|Epoetin Alfa|epoetin alfa|mesh-list
24493783|NCT00492427|Hematinics|hematinics|mesh-ancestor
24493784|NCT00492466|Interferons|interferons|mesh-list
25208985|NCT02706054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208986|NCT02706054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25208987|NCT02706054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25208988|NCT02706054|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25208989|NCT02706054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25208990|NCT02706054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208991|NCT02706054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25208992|NCT02706015|Dipyrone|dipyrone|mesh-list
25208993|NCT02706015|Dihydroergotamine|dihydroergotamine|mesh-list
25208994|NCT02706015|Caffeine|caffeine|mesh-list
25208995|NCT02706015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25208996|NCT02706015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25208997|NCT02706015|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25208998|NCT02706015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25208999|NCT02706015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209000|NCT02706015|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25209001|NCT02706015|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25209002|NCT02706015|Purinergic Agents|purinergic agents|mesh-ancestor
25209003|NCT02706015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25209004|NCT02706015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25209005|NCT02706015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25209006|NCT02706015|Analgesics|analgesics|mesh-ancestor
25209007|NCT02706015|Sensory System Agents|sensory system agents|mesh-ancestor
25209008|NCT02706015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25209009|NCT02706015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25209010|NCT02706015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25209011|NCT02706015|Antipyretics|antipyretics|mesh-ancestor
25209012|NCT02706015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25209013|NCT02706015|Dopamine Agonists|dopamine agonists|mesh-ancestor
25209014|NCT02706015|Dopamine Agents|dopamine agents|mesh-ancestor
25209015|NCT02705976|Warfarin|warfarin|mesh-list
25209016|NCT02705976|Anticoagulants|anticoagulants|mesh-ancestor
25209017|NCT02705820|Pembrolizumab|pembrolizumab|mesh-list
25209018|NCT02705820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24494052|NCT00493480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24494053|NCT00493480|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24494056|NCT00493532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24494057|NCT00493532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254344|NCT02495220|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25254349|NCT02495285|Polygeline|polygeline|mesh-list
24533793|NCT00645190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533794|NCT00645190|Cholinergic Agents|cholinergic agents|mesh-ancestor
25074852|NCT03385382|Dexamethasone|dexamethasone|mesh-list
25209019|NCT02705820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25209020|NCT02705989|Branebrutinib|branebrutinib|mesh-list
25209021|NCT02705989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25209022|NCT02705989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25209023|NCT02705989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209024|NCT02706067|Orlistat|orlistat|mesh-list
25209025|NCT02706067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24494061|NCT00493545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494062|NCT00493610|Acetylcysteine|acetylcysteine|mesh-list
24751075|NCT01701921|Pregabalin|pregabalin|mesh-list
24458342|NCT00337506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24458343|NCT00337506|Glucocorticoids|glucocorticoids|mesh-ancestor
25676728|NCT01802580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676729|NCT01802580|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25676730|NCT01802775|Aspirin|aspirin|mesh-list
25676731|NCT01802775|Edoxaban|edoxaban|mesh-list
25676732|NCT01802775|Clopidogrel|clopidogrel|mesh-list
25676733|NCT01802775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25676734|NCT01802775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25676735|NCT01802775|Analgesics|analgesics|mesh-ancestor
25676736|NCT01802775|Sensory System Agents|sensory system agents|mesh-ancestor
25676737|NCT01802775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254367|NCT02495363|Sensory System Agents|sensory system agents|mesh-ancestor
25254368|NCT02495363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24940436|NCT04001465|Respiratory System Agents|respiratory system agents|mesh-ancestor
24940437|NCT04001465|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24940438|NCT04001465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25002853|NCT04257500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25002854|NCT04257500|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24524257|NCT05074823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524258|NCT05074823|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24524259|NCT05074823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24624433|NCT01076322|Sympathomimetics|sympathomimetics|mesh-ancestor
24624434|NCT01076439|Fluticasone|fluticasone|mesh-list
25254385|NCT02494999|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25254386|NCT02494999|Immunologic Factors|immunologic factors|mesh-ancestor
25254387|NCT02494999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533796|NCT00645190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533797|NCT00645190|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24533798|NCT00645190|Autonomic Agents|autonomic agents|mesh-ancestor
24533799|NCT00645190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24533800|NCT00645190|Nootropic Agents|nootropic agents|mesh-ancestor
24533802|NCT00645203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24533804|NCT00645229|Ziprasidone|ziprasidone|mesh-list
25209026|NCT02706067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209027|NCT02706067|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25209028|NCT02706067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25676738|NCT01802775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676739|NCT01802775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25676740|NCT01802775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25676741|NCT01802775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25676742|NCT01802775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25676743|NCT01802775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676744|NCT01802775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25676745|NCT01802775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25676746|NCT01802775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676747|NCT01802775|Antipyretics|antipyretics|mesh-ancestor
24809901|NCT02036697|Fentanyl|fentanyl|mesh-list
25676748|NCT01802775|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25676749|NCT01802775|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25676750|NCT01802775|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25676751|NCT01802775|Purinergic Agents|purinergic agents|mesh-ancestor
25209030|NCT02705768|Oxcarbazepine|oxcarbazepine|mesh-list
25209031|NCT02705768|Anticonvulsants|anticonvulsants|mesh-ancestor
24494065|NCT00493610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24494066|NCT00493610|Expectorants|expectorants|mesh-ancestor
24428225|NCT00239980|Tinzaparin|tinzaparin|mesh-list
24494217|NCT00494377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24533805|NCT00645229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24533806|NCT00645229|Serotonin Agents|serotonin agents|mesh-ancestor
24533807|NCT00645229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24922983|NCT04173832|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25209032|NCT02705768|Antimanic Agents|antimanic agents|mesh-ancestor
25209033|NCT02705768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25209034|NCT02705768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25209035|NCT02705768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209036|NCT02705768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25209037|NCT02705768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24494222|NCT00494429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24633228|NCT01127672|Glucocorticoids|glucocorticoids|mesh-ancestor
24584858|NCT00881816|Mitosis Modulators|mitosis modulators|mesh-ancestor
24584868|NCT00881907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24584869|NCT00881907|Antitubercular Agents|antitubercular agents|mesh-ancestor
24584871|NCT00882024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25254405|NCT02494804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254406|NCT02494804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25254407|NCT02494973|Oxaliplatin|oxaliplatin|mesh-list
25254408|NCT02494973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624456|NCT01076439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926579|NCT04139928|Cathartics|cathartics|mesh-ancestor
24926580|NCT04139928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24926581|NCT04139928|Antacids|antacids|mesh-ancestor
24926582|NCT04139915|Dactolisib|dactolisib|mesh-list
24926583|NCT04139915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926584|NCT04139941|Antibodies|antibodies|mesh-list
24926617|NCT04140201|Simvastatin|simvastatin|mesh-list
24926618|NCT04140201|Fenofibrate|fenofibrate|mesh-list
24926619|NCT04140201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24926620|NCT04140201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24926621|NCT04140201|Antimetabolites|antimetabolites|mesh-ancestor
24926622|NCT04140201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926623|NCT04140201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24926624|NCT04140201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24926625|NCT04140201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24926626|NCT04139824|Naproxen|naproxen|mesh-list
25676752|NCT01802775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25676753|NCT01802775|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25676754|NCT01802775|Antithrombins|antithrombins|mesh-ancestor
25676755|NCT01802775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25676756|NCT01802775|Protease Inhibitors|protease inhibitors|mesh-ancestor
25676757|NCT01802775|Anticoagulants|anticoagulants|mesh-ancestor
25676758|NCT01802879|Panobinostat|panobinostat|mesh-list
25676759|NCT01802879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25676760|NCT01802879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25676761|NCT01802879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676762|NCT01802879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676763|NCT01803074|Ritonavir|ritonavir|mesh-list
25676764|NCT01803074|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25676765|NCT01803074|Tenofovir|tenofovir|mesh-list
25676766|NCT01803074|Emtricitabine|emtricitabine|mesh-list
25676767|NCT01803074|BMS-955176|bms-955176|mesh-list
25676768|NCT01803074|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25676769|NCT01803074|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25676770|NCT01803074|Protease Inhibitors|protease inhibitors|mesh-ancestor
25676771|NCT01803074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676772|NCT01803074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676773|NCT01803074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25676774|NCT01803074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25676775|NCT01803074|Antiviral Agents|antiviral agents|mesh-ancestor
25676776|NCT01803074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25676777|NCT01803074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25676778|NCT01803074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24926635|NCT04139824|Gout Suppressants|gout suppressants|mesh-ancestor
24509697|NCT00561717|Azelastine|azelastine|mesh-list
24926636|NCT04139824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24926637|NCT04139824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24926638|NCT04139824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926639|NCT04139668|Naltrexone|naltrexone|mesh-list
24926640|NCT04139668|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24926641|NCT04139668|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24926642|NCT04139668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926643|NCT04139668|Sensory System Agents|sensory system agents|mesh-ancestor
24926644|NCT04139668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24926645|NCT04139850|Antiviral Agents|antiviral agents|mesh-list
25155435|NCT05371899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045286|NCT00975091|Antiviral Agents|antiviral agents|mesh-ancestor
24926646|NCT04139850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24926647|NCT04139772|Docetaxel|docetaxel|mesh-list
24926648|NCT04139772|Abiraterone Acetate|abiraterone acetate|mesh-list
24926649|NCT04139772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926650|NCT04139772|Tubulin Modulators|tubulin modulators|mesh-ancestor
24926651|NCT04139772|Antimitotic Agents|antimitotic agents|mesh-ancestor
24926652|NCT04139772|Mitosis Modulators|mitosis modulators|mesh-ancestor
24926653|NCT04139772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926654|NCT04139772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24926655|NCT04139772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676779|NCT01803074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24584959|NCT00882388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25254462|NCT02494895|Aspirin|aspirin|mesh-list
25254463|NCT02494895|Ticagrelor|ticagrelor|mesh-list
25254464|NCT02494895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25254465|NCT02494895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24533818|NCT00645242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24533819|NCT00645242|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25676780|NCT01803074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25676781|NCT01803269|Topotecan|topotecan|mesh-list
25676782|NCT01803269|Camptothecin|camptothecin|mesh-list
25676783|NCT01803269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25676784|NCT01803269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25676785|NCT01803269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676786|NCT01803269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676787|NCT01803269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25676788|NCT01803269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25676789|NCT01803282|Leucovorin|leucovorin|mesh-list
25676790|NCT01803282|Gemcitabine|gemcitabine|mesh-list
25676791|NCT01803282|Paclitaxel|paclitaxel|mesh-list
25676792|NCT01803282|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25676793|NCT01803282|Bevacizumab|bevacizumab|mesh-list
25676794|NCT01803282|Carboplatin|carboplatin|mesh-list
25676795|NCT01803282|Oxaliplatin|oxaliplatin|mesh-list
25676796|NCT01803282|Irinotecan|irinotecan|mesh-list
25676797|NCT01803282|Pemetrexed|pemetrexed|mesh-list
25676798|NCT01803282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25676799|NCT01803282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25676800|NCT01803282|Tubulin Modulators|tubulin modulators|mesh-ancestor
25676801|NCT01803282|Antimitotic Agents|antimitotic agents|mesh-ancestor
25676802|NCT01803282|Mitosis Modulators|mitosis modulators|mesh-ancestor
25676803|NCT01803282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676804|NCT01803282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25676805|NCT01803282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25676806|NCT01803282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25676807|NCT01803282|Growth Substances|growth substances|mesh-ancestor
25676808|NCT01803282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676809|NCT01803282|Growth Inhibitors|growth inhibitors|mesh-ancestor
25676810|NCT01803282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25676811|NCT01803282|Antimetabolites|antimetabolites|mesh-ancestor
25676812|NCT01803282|Antiviral Agents|antiviral agents|mesh-ancestor
25254474|NCT02494895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254475|NCT02494895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25254476|NCT02494895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25254478|NCT02494895|Antipyretics|antipyretics|mesh-ancestor
25254479|NCT02494895|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24498562|NCT00515281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209038|NCT02705768|Analgesics|analgesics|mesh-ancestor
25209039|NCT02705768|Sensory System Agents|sensory system agents|mesh-ancestor
25209040|NCT02705768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25209041|NCT02705768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25209042|NCT02705768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24494223|NCT00494429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494224|NCT00494429|Analgesics|analgesics|mesh-ancestor
24494225|NCT00494429|Sensory System Agents|sensory system agents|mesh-ancestor
24922948|NCT04174378|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24922949|NCT04174378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24922950|NCT04174378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922951|NCT04174365|Brexpiprazole|brexpiprazole|mesh-list
24922952|NCT04174365|Serotonin Agents|serotonin agents|mesh-ancestor
24922953|NCT04174365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24922954|NCT04174365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922955|NCT04174365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922956|NCT04174365|Dopamine Agonists|dopamine agonists|mesh-ancestor
24922957|NCT04174365|Dopamine Agents|dopamine agents|mesh-ancestor
24922969|NCT04174261|Ticagrelor|ticagrelor|mesh-list
24394791|NCT00134212|Norepinephrine|norepinephrine|mesh-list
24624152|NCT01074905|Antiviral Agents|antiviral agents|mesh-ancestor
24922980|NCT04173871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24922981|NCT04173871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922987|NCT04173832|Dopamine Agents|dopamine agents|mesh-ancestor
24922988|NCT04173832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24922989|NCT04173832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922990|NCT04173832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922991|NCT04173832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24922992|NCT04173832|Analgesics|analgesics|mesh-ancestor
24922993|NCT04173832|Sensory System Agents|sensory system agents|mesh-ancestor
24922994|NCT04173832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24922996|NCT04174131|Hyaluronic Acid|hyaluronic acid|mesh-list
24922997|NCT04174131|Anesthetics, Local|anesthetics, local|mesh-ancestor
24922998|NCT04174131|Anesthetics|anesthetics|mesh-ancestor
24922999|NCT04174131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24923000|NCT04174131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923001|NCT04174131|Sensory System Agents|sensory system agents|mesh-ancestor
24923002|NCT04174131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24498600|NCT00515489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498601|NCT00515489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498602|NCT00515489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25676813|NCT01803282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25676814|NCT01803282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676815|NCT01803282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25676816|NCT01803282|Immunologic Factors|immunologic factors|mesh-ancestor
25676817|NCT01803282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25676818|NCT01803282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25676819|NCT01803282|Antidotes|antidotes|mesh-ancestor
25676820|NCT01803282|Protective Agents|protective agents|mesh-ancestor
25676821|NCT01803282|Vitamin B Complex|vitamin b complex|mesh-ancestor
25676822|NCT01803282|Vitamins|vitamins|mesh-ancestor
25676823|NCT01803282|Micronutrients|micronutrients|mesh-ancestor
24498603|NCT00515489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24498604|NCT00515489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24498605|NCT00515489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24498606|NCT00515489|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24498607|NCT00515489|Dopamine Agents|dopamine agents|mesh-ancestor
24498608|NCT00515554|Rituximab|rituximab|mesh-list
24923005|NCT04174131|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24923006|NCT04174131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24923023|NCT04173988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24923069|NCT04173611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923070|NCT04173611|Sensory System Agents|sensory system agents|mesh-ancestor
24923071|NCT04173611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24923072|NCT04173039|Antibodies|antibodies|mesh-list
24923073|NCT04173039|Immunologic Factors|immunologic factors|mesh-ancestor
24923074|NCT04173039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923075|NCT04172961|Cyclosporine|cyclosporine|mesh-list
24923076|NCT04172961|Lifitegrast|lifitegrast|mesh-list
24923077|NCT04172961|Cyclosporins|cyclosporins|mesh-list
24923078|NCT04172961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24923079|NCT04172961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923080|NCT04172961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24923081|NCT04172961|Immunologic Factors|immunologic factors|mesh-ancestor
24923082|NCT04172961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923083|NCT04172961|Antifungal Agents|antifungal agents|mesh-ancestor
24923084|NCT04172961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25209043|NCT02705768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209044|NCT02705768|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24494226|NCT00494429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24494712|NCT00496561|Immunologic Factors|immunologic factors|mesh-list
24495153|NCT00498888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24923085|NCT04172961|Dermatologic Agents|dermatologic agents|mesh-ancestor
24923086|NCT04172961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24923087|NCT04172961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24923088|NCT04172961|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24498728|NCT00516113|Antidepressive Agents|antidepressive agents|mesh-ancestor
24498729|NCT00516113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24498730|NCT00516113|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24498731|NCT00516113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24498732|NCT00516113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498733|NCT00516152|Methotrexate|methotrexate|mesh-list
24498734|NCT00516152|Fludarabine phosphate|fludarabine phosphate|mesh-list
25075182|NCT03383068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498735|NCT00516152|Fludarabine|fludarabine|mesh-list
24498736|NCT00516152|Busulfan|busulfan|mesh-list
24498737|NCT00516152|Tacrolimus|tacrolimus|mesh-list
24498738|NCT00516152|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24498739|NCT00516152|Abortifacient Agents|abortifacient agents|mesh-ancestor
24923147|NCT04172220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923148|NCT04172220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24923149|NCT04172220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24923150|NCT04172220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24923151|NCT04172220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24923152|NCT04172220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24923184|NCT04172259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923185|NCT04172259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923186|NCT04172259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24923187|NCT04172259|Tubulin Modulators|tubulin modulators|mesh-ancestor
24923188|NCT04172259|Antimitotic Agents|antimitotic agents|mesh-ancestor
24923189|NCT04172259|Mitosis Modulators|mitosis modulators|mesh-ancestor
24923190|NCT04172259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24923191|NCT04172259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24923192|NCT04172259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24923193|NCT04172259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24923194|NCT04172259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24923196|NCT04171791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923216|NCT04171687|Clopidogrel|clopidogrel|mesh-list
24923217|NCT04171687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24923218|NCT04171687|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24923219|NCT04171687|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24923220|NCT04171687|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24923221|NCT04171687|Purinergic Agents|purinergic agents|mesh-ancestor
24923222|NCT04171687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25254543|NCT02494466|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24923223|NCT04171687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923224|NCT04171687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498848|NCT00516542|Letrozole|letrozole|mesh-list
24498849|NCT00516542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498850|NCT00516542|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25209045|NCT02705768|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25209046|NCT02705768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24495154|NCT00498888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24495155|NCT00498888|Cholinergic Agents|cholinergic agents|mesh-ancestor
24457567|NCT00334672|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24944461|NCT03960151|Olanzapine|olanzapine|mesh-list
24498851|NCT00516542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24498852|NCT00516542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498853|NCT00516542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498854|NCT00516542|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24498855|NCT00516542|Hormone Antagonists|hormone antagonists|mesh-ancestor
24498863|NCT00516672|Lapatinib|lapatinib|mesh-list
24923234|NCT04171843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923272|NCT04171739|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24923273|NCT04171739|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24923274|NCT04171739|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24923275|NCT04171739|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24923277|NCT04171674|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
24923278|NCT04171674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24923279|NCT04171674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24923280|NCT04171466|Metronidazole|metronidazole|mesh-list
24923281|NCT04171466|Ciprofloxacin|ciprofloxacin|mesh-list
24923282|NCT04171466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24923283|NCT04171466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24923284|NCT04171466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24923285|NCT04171466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24923335|NCT04171349|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24923336|NCT04171349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24923337|NCT04171349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24923338|NCT04171349|Adrenergic Agents|adrenergic agents|mesh-ancestor
24923339|NCT04171349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24923340|NCT04171349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923341|NCT04171349|Anesthetics, Local|anesthetics, local|mesh-ancestor
24923413|NCT04170439|Citric Acid|citric acid|mesh-list
24923414|NCT04170439|Sodium Citrate|sodium citrate|mesh-list
24923415|NCT04170439|Clomiphene|clomiphene|mesh-list
24923416|NCT04170439|Enclomiphene|enclomiphene|mesh-list
24923417|NCT04170439|Zuclomiphene|zuclomiphene|mesh-list
24923418|NCT04170439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24923419|NCT04170439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923420|NCT04170439|Anticoagulants|anticoagulants|mesh-ancestor
24923421|NCT04170439|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24923422|NCT04170439|Chelating Agents|chelating agents|mesh-ancestor
24923423|NCT04170439|Sequestering Agents|sequestering agents|mesh-ancestor
24923427|NCT04170439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24923429|NCT04170439|Fertility Agents|fertility agents|mesh-ancestor
24923435|NCT04170504|Methotrexate|methotrexate|mesh-list
25209048|NCT02705729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25209049|NCT02705729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209050|NCT02705729|Sympathomimetics|sympathomimetics|mesh-ancestor
25209051|NCT02705729|Autonomic Agents|autonomic agents|mesh-ancestor
24457568|NCT00334672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24457569|NCT00334672|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24457570|NCT00334672|Antitubercular Agents|antitubercular agents|mesh-ancestor
24944462|NCT03960151|Palonosetron|palonosetron|mesh-list
24923520|NCT04169841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24923521|NCT04169841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24923522|NCT04169841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923523|NCT04169919|Povidone-Iodine|povidone-iodine|mesh-list
24923524|NCT04169919|Povidone|povidone|mesh-list
24923525|NCT04169919|Plasma Substitutes|plasma substitutes|mesh-ancestor
24923526|NCT04169919|Blood Substitutes|blood substitutes|mesh-ancestor
24499119|NCT00517764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24923528|NCT04169919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24923530|NCT04169763|Cisplatin|cisplatin|mesh-list
24923531|NCT04169763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923532|NCT04169763|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25676824|NCT01803282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24923591|NCT04168879|Anesthetics|anesthetics|mesh-ancestor
24923658|NCT04168138|Immunologic Factors|immunologic factors|mesh-ancestor
24923659|NCT04168138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923660|NCT04168138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24923661|NCT04168138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24923662|NCT04168138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24923667|NCT04168099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24923668|NCT04168099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24923669|NCT04168099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24923670|NCT04168099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24923671|NCT04168099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24923672|NCT04168099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923673|NCT04168099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923675|NCT04167774|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24923725|NCT04167592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24923726|NCT04167137|Atezolizumab|atezolizumab|mesh-list
24923727|NCT04167137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923728|NCT04167228|Ceftazidime|ceftazidime|mesh-list
24923729|NCT04167228|Avibactam|avibactam|mesh-list
24923730|NCT04167228|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
24923731|NCT04167228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24923732|NCT04167228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24923733|NCT04167228|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24923734|NCT04167228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24923735|NCT04167228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923736|NCT04167280|Ipratropium|ipratropium|mesh-list
24923737|NCT04167280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24923738|NCT04167280|Autonomic Agents|autonomic agents|mesh-ancestor
24923739|NCT04167280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24923740|NCT04167280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923783|NCT04166604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24923784|NCT04167007|Gemcitabine|gemcitabine|mesh-list
24923786|NCT04167007|Antimetabolites|antimetabolites|mesh-ancestor
24923788|NCT04167007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923789|NCT04167007|Antiviral Agents|antiviral agents|mesh-ancestor
24923790|NCT04167007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24923791|NCT04167007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24923792|NCT04167007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24923793|NCT04167007|Immunologic Factors|immunologic factors|mesh-ancestor
24923794|NCT04167007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923796|NCT04166786|Methyltestosterone|methyltestosterone|mesh-list
24923797|NCT04166786|Petrolatum|petrolatum|mesh-list
24923798|NCT04166786|Testosterone|testosterone|mesh-list
24923799|NCT04166786|Testosterone undecanoate|testosterone undecanoate|mesh-list
24923800|NCT04166786|Testosterone enanthate|testosterone enanthate|mesh-list
24923801|NCT04166786|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25209052|NCT02705729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24923802|NCT04166786|Androgens|androgens|mesh-ancestor
24923803|NCT04166786|Hormones|hormones|mesh-ancestor
25209053|NCT02705729|Dopamine Agents|dopamine agents|mesh-ancestor
25209054|NCT02705729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25209055|NCT02705729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457571|NCT00334672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24457573|NCT00334685|Reboxetine|reboxetine|mesh-list
24457574|NCT00334685|Analgesics|analgesics|mesh-ancestor
24457575|NCT00334685|Sensory System Agents|sensory system agents|mesh-ancestor
24923805|NCT04166786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923832|NCT04166578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24923833|NCT04166578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923834|NCT04166578|Sensory System Agents|sensory system agents|mesh-ancestor
24923835|NCT04166578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24923836|NCT04166578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24923837|NCT04166578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24923838|NCT04166578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24923839|NCT04166578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24923878|NCT04166253|Alfacalcidol|alfacalcidol|mesh-list
24923879|NCT04166253|Vitamins|vitamins|mesh-ancestor
24923880|NCT04166253|Micronutrients|micronutrients|mesh-ancestor
24923881|NCT04166253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923882|NCT04166253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24923883|NCT04165967|Nivolumab|nivolumab|mesh-list
24923884|NCT04165967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24923885|NCT04165967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923886|NCT04165967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24923887|NCT04165967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254610|NCT02493894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24924090|NCT04163419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24924091|NCT04163419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924093|NCT04163471|Coagulants|coagulants|mesh-ancestor
24924094|NCT04163354|Listerine|listerine|mesh-list
24924095|NCT04163354|Fluorides|fluorides|mesh-list
24924096|NCT04163354|Sodium Fluoride|sodium fluoride|mesh-list
24522952|NCT03012971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522953|NCT03012971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24924126|NCT04162743|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24924127|NCT04162743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24924128|NCT04162743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24924129|NCT04162743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924130|NCT04162743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24924131|NCT04162743|Serotonin Agents|serotonin agents|mesh-ancestor
24924132|NCT04162743|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24924133|NCT04162743|Antidepressive Agents|antidepressive agents|mesh-ancestor
24924134|NCT04162834|Papaverine|papaverine|mesh-list
24924135|NCT04162834|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24924136|NCT04162834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924137|NCT04162834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924138|NCT04162834|Vasodilator Agents|vasodilator agents|mesh-ancestor
24499784|NCT00521092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499785|NCT00521131|Levocetirizine|levocetirizine|mesh-list
25209056|NCT02705729|Adrenergic Agents|adrenergic agents|mesh-ancestor
25209057|NCT02705729|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25209058|NCT02705729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24457576|NCT00334685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24457577|NCT00334685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457578|NCT00334685|Anticonvulsants|anticonvulsants|mesh-ancestor
24495156|NCT00498888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24499786|NCT00521131|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24499787|NCT00521131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24499788|NCT00521131|Histamine Antagonists|histamine antagonists|mesh-ancestor
24499789|NCT00521131|Histamine Agents|histamine agents|mesh-ancestor
24499790|NCT00521131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24499791|NCT00521131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499792|NCT00521131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522957|NCT02992522|Obinutuzumab|obinutuzumab|mesh-list
24522958|NCT02992522|Immunologic Factors|immunologic factors|mesh-ancestor
24626794|NCT01088750|Cyclophosphamide|cyclophosphamide|mesh-list
24624223|NCT01075464|Antimitotic Agents|antimitotic agents|mesh-ancestor
24624224|NCT01075464|Mitosis Modulators|mitosis modulators|mesh-ancestor
24624225|NCT01075464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624226|NCT01075464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24624227|NCT01075464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24624228|NCT01075464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24624229|NCT01075464|Growth Substances|growth substances|mesh-ancestor
24624230|NCT01075464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624231|NCT01075464|Growth Inhibitors|growth inhibitors|mesh-ancestor
24624233|NCT01075477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24624234|NCT01075477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624235|NCT01075477|Immunologic Factors|immunologic factors|mesh-ancestor
24624236|NCT01075477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624237|NCT01075477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25075471|NCT03380936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24924232|NCT04161729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924233|NCT04161729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24924234|NCT04161729|Tocolytic Agents|tocolytic agents|mesh-ancestor
24924235|NCT04161729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24924236|NCT04161586|Prilocaine|prilocaine|mesh-list
24924237|NCT04161586|Anesthetics, Local|anesthetics, local|mesh-ancestor
24924238|NCT04161586|Anesthetics|anesthetics|mesh-ancestor
24924239|NCT04161586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24924240|NCT04161586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499901|NCT00521482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24499902|NCT00521482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24499903|NCT00521482|Immunologic Factors|immunologic factors|mesh-ancestor
24499904|NCT00521482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499905|NCT00521482|Leprostatic Agents|leprostatic agents|mesh-ancestor
24499906|NCT00521482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25676825|NCT01803282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25274820|NCT02375191|Analgesics|analgesics|mesh-ancestor
25274821|NCT02375191|Sensory System Agents|sensory system agents|mesh-ancestor
25274822|NCT02375191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25274823|NCT02375191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25274824|NCT02375191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25274825|NCT02375191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24926870|NCT04137640|Docetaxel|docetaxel|mesh-list
24499907|NCT00521482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24924295|NCT04161404|Analgesics|analgesics|mesh-ancestor
24924296|NCT04161404|Sensory System Agents|sensory system agents|mesh-ancestor
24924297|NCT04161404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24924298|NCT04161404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24924299|NCT04161404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24924300|NCT04161404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24924301|NCT04161404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24924302|NCT04161404|Antiviral Agents|antiviral agents|mesh-ancestor
24924303|NCT04161404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24924304|NCT04161209|Citalopram|citalopram|mesh-list
24924305|NCT04161209|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24924306|NCT04161209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24924307|NCT04161209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24924308|NCT04161209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924309|NCT04161209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24924310|NCT04161209|Serotonin Agents|serotonin agents|mesh-ancestor
24522961|NCT02992522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24522962|NCT02992522|Growth Substances|growth substances|mesh-ancestor
24522963|NCT02992522|Growth Inhibitors|growth inhibitors|mesh-ancestor
24522964|NCT02992522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924312|NCT04161209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24924313|NCT04161209|Antidepressive Agents|antidepressive agents|mesh-ancestor
25209059|NCT02705729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25209060|NCT02705729|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25209061|NCT02705534|Ribavirin|ribavirin|mesh-list
25209062|NCT02705534|Sofosbuvir|sofosbuvir|mesh-list
25209063|NCT02705534|Ledipasvir|ledipasvir|mesh-list
24495157|NCT00498888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495158|NCT00498888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495391|NCT00499850|Immunologic Factors|immunologic factors|mesh-ancestor
24495392|NCT00499850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924314|NCT04161209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24924316|NCT04161014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924317|NCT04161014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24924318|NCT04161014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924351|NCT04160936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924352|NCT04160936|Sensory System Agents|sensory system agents|mesh-ancestor
24924353|NCT04160936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24500009|NCT00522132|Anthelmintics|anthelmintics|mesh-ancestor
24500012|NCT00522158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24500013|NCT00522158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24780046|NCT01880749|Everolimus|everolimus|mesh-list
24500014|NCT00522158|Antimetabolites|antimetabolites|mesh-ancestor
24500015|NCT00522158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500016|NCT00522158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24500017|NCT00522158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24500018|NCT00522158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24500019|NCT00522184|Etanercept|etanercept|mesh-list
24500022|NCT00522184|Analgesics|analgesics|mesh-ancestor
24924355|NCT04161027|Analgesics|analgesics|mesh-ancestor
24924356|NCT04161027|Sensory System Agents|sensory system agents|mesh-ancestor
24924357|NCT04161027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24924358|NCT04161027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924359|NCT04161027|Anticonvulsants|anticonvulsants|mesh-ancestor
24924682|NCT04157998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24924360|NCT04161027|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24924361|NCT04161027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24924362|NCT04161027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676826|NCT01804036|Zolpidem|zolpidem|mesh-list
25676827|NCT01804036|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25676828|NCT01804036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25676829|NCT01804036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25676830|NCT01804036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676831|NCT01804036|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25676832|NCT01804036|GABA Agonists|gaba agonists|mesh-ancestor
25676833|NCT01804036|GABA Agents|gaba agents|mesh-ancestor
24924363|NCT04161027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24924364|NCT04161027|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24924380|NCT04160598|Narcotics|narcotics|mesh-ancestor
24924381|NCT04160598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24924382|NCT04160598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924383|NCT04160598|Analgesics|analgesics|mesh-ancestor
24924384|NCT04160598|Sensory System Agents|sensory system agents|mesh-ancestor
24924385|NCT04160598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24924386|NCT04160598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24924387|NCT04160598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24924388|NCT04160598|Anesthetics, General|anesthetics, general|mesh-ancestor
24924389|NCT04160598|Anesthetics|anesthetics|mesh-ancestor
24924390|NCT04160676|Ascorbic Acid|ascorbic acid|mesh-list
24924393|NCT04160676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24924394|NCT04160676|Antioxidants|antioxidants|mesh-ancestor
24924395|NCT04160676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924396|NCT04160676|Protective Agents|protective agents|mesh-ancestor
24534976|NCT00648362|Glimepiride|glimepiride|mesh-list
24924430|NCT04160611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24924431|NCT04160611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24924432|NCT04160611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924433|NCT04160611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24924434|NCT04160611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24924435|NCT04160611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24924436|NCT04160611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24924437|NCT04160611|Anesthetics, General|anesthetics, general|mesh-ancestor
24924439|NCT04160611|GABA Modulators|gaba modulators|mesh-ancestor
24924440|NCT04160611|GABA Agents|gaba agents|mesh-ancestor
24924441|NCT04160611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24924442|NCT04160611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924443|NCT04160195|Cyclophosphamide|cyclophosphamide|mesh-list
24924444|NCT04160195|Fludarabine|fludarabine|mesh-list
24924445|NCT04160195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24924446|NCT04160195|Immunologic Factors|immunologic factors|mesh-ancestor
24924454|NCT04160026|Pyrimethamine|pyrimethamine|mesh-list
24924493|NCT04159649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924494|NCT04159649|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25075545|NCT03380442|Anesthetics|anesthetics|mesh-ancestor
24924495|NCT04159649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25209064|NCT02705534|Antimetabolites|antimetabolites|mesh-ancestor
25209065|NCT02705534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209066|NCT02705534|Antiviral Agents|antiviral agents|mesh-ancestor
25209067|NCT02705534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24495393|NCT00499850|Antidotes|antidotes|mesh-ancestor
24495394|NCT00499850|Protective Agents|protective agents|mesh-ancestor
24495395|NCT00499850|Vitamin B Complex|vitamin b complex|mesh-ancestor
24495396|NCT00499850|Vitamins|vitamins|mesh-ancestor
24495397|NCT00499850|Micronutrients|micronutrients|mesh-ancestor
24496036|NCT00503204|Alkylating Agents|alkylating agents|mesh-ancestor
24496146|NCT00503542|Hormone Antagonists|hormone antagonists|mesh-ancestor
24924496|NCT04159649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924497|NCT04159649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924498|NCT04159649|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24924499|NCT04159649|Hormone Antagonists|hormone antagonists|mesh-ancestor
24924500|NCT04159649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24924501|NCT04159649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924502|NCT04160000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
24924504|NCT04159597|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
24500140|NCT00522886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24500141|NCT00522938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24500142|NCT00522938|Tosedostat|tosedostat|mesh-list
24924505|NCT04159597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24924506|NCT04159597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924507|NCT04159597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924508|NCT04159597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24924509|NCT04159610|Glycopyrrolate|glycopyrrolate|mesh-list
24924510|NCT04159610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24924511|NCT04159610|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24924512|NCT04159610|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24924513|NCT04159610|Cholinergic Agents|cholinergic agents|mesh-ancestor
24924514|NCT04159610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24924515|NCT04159610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924516|NCT04159610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924517|NCT04159181|Lactulose|lactulose|mesh-list
24924518|NCT04159181|Picosulfate sodium|picosulfate sodium|mesh-list
24924519|NCT04159181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25254673|NCT02493192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25254674|NCT02493192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25254675|NCT02493192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25254676|NCT02493192|Dopamine Agents|dopamine agents|mesh-ancestor
25254677|NCT02493192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25254678|NCT02493192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254679|NCT02493192|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25254680|NCT02493192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25254681|NCT02493192|Narcotics|narcotics|mesh-ancestor
24522976|NCT02990338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24522977|NCT02990338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24522978|NCT02990338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522981|NCT02990338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24522982|NCT02990338|Growth Substances|growth substances|mesh-ancestor
24522983|NCT02990338|Growth Inhibitors|growth inhibitors|mesh-ancestor
24522984|NCT02978612|Capecitabine|capecitabine|mesh-list
24522985|NCT02978612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25075599|NCT03379909|Metformin|metformin|mesh-list
24522986|NCT02978612|Antimetabolites|antimetabolites|mesh-ancestor
24624252|NCT01075503|Ropivacaine|ropivacaine|mesh-list
24624253|NCT01075503|Anesthetics, Local|anesthetics, local|mesh-ancestor
24624254|NCT01075503|Anesthetics|anesthetics|mesh-ancestor
24624255|NCT01075503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24624256|NCT01075503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624257|NCT01075503|Sensory System Agents|sensory system agents|mesh-ancestor
24626878|NCT01089088|Sunitinib|sunitinib|mesh-list
24500186|NCT00523159|Immunologic Factors|immunologic factors|mesh-ancestor
24500187|NCT00523159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500188|NCT00523185|Diazepam|diazepam|mesh-list
24500189|NCT00523185|Lorazepam|lorazepam|mesh-list
24500190|NCT00523185|Anticonvulsants|anticonvulsants|mesh-ancestor
24500191|NCT00523185|Antiemetics|antiemetics|mesh-ancestor
24624258|NCT01075503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24624260|NCT01075529|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24624261|NCT01075529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24624262|NCT01075529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24624264|NCT01075529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24924561|NCT04158947|Afatinib|afatinib|mesh-list
24924562|NCT04158947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24924563|NCT04158947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924564|NCT04158947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24924565|NCT04158947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24523011|NCT02954991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24523012|NCT02954991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209068|NCT02705547|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25209069|NCT02705547|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25209070|NCT02705547|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25209071|NCT02705547|Antimetabolites|antimetabolites|mesh-ancestor
25209072|NCT02705547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209073|NCT02705547|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24496147|NCT00503542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24523013|NCT02954991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24523014|NCT02954991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24523016|NCT02947516|Hematinics|hematinics|mesh-ancestor
24523017|NCT02932956|Cyclophosphamide|cyclophosphamide|mesh-list
24523018|NCT02932956|Fludarabine|fludarabine|mesh-list
24523019|NCT02932956|Fludarabine phosphate|fludarabine phosphate|mesh-list
24523020|NCT02932956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24924626|NCT04158076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924627|NCT04158076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24924628|NCT04158076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924629|NCT04158076|Vasodilator Agents|vasodilator agents|mesh-ancestor
24924630|NCT04158076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24924642|NCT04158102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676834|NCT01804036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25676835|NCT01804036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676836|NCT01804049|Metformin|metformin|mesh-list
25676837|NCT01804049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25676838|NCT01804049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676839|NCT01804075|Morphine|morphine|mesh-list
25676840|NCT01804075|Methadone|methadone|mesh-list
25676841|NCT01804075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25676842|NCT01804075|Narcotics|narcotics|mesh-ancestor
25254735|NCT02492945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25254736|NCT02492945|Anesthetics, Local|anesthetics, local|mesh-ancestor
25254737|NCT02492945|Anesthetics|anesthetics|mesh-ancestor
25254738|NCT02492945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25003166|NCT03959085|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25003167|NCT03959085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25003168|NCT03959085|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25003169|NCT03959085|Abortifacient Agents|abortifacient agents|mesh-ancestor
25003170|NCT03959085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24926967|NCT04137029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25254747|NCT02492503|Paclitaxel|paclitaxel|mesh-list
24924643|NCT04158102|Sensory System Agents|sensory system agents|mesh-ancestor
24924668|NCT04157803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924669|NCT04157803|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24924670|NCT04157803|Protective Agents|protective agents|mesh-ancestor
24924671|NCT04157803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924673|NCT04157959|Gout Suppressants|gout suppressants|mesh-ancestor
24924674|NCT04157959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24924675|NCT04157998|Metoclopramide|metoclopramide|mesh-list
24924676|NCT04157998|Antiemetics|antiemetics|mesh-ancestor
24924677|NCT04157998|Autonomic Agents|autonomic agents|mesh-ancestor
24924678|NCT04157998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25075655|NCT03378960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924679|NCT04157998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924680|NCT04157998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24924681|NCT04157998|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24924683|NCT04157998|Dopamine Agents|dopamine agents|mesh-ancestor
24924684|NCT04157998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24924685|NCT04157998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500350|NCT00523952|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24500351|NCT00523952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24500352|NCT00523952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500353|NCT00523965|Amphotericin B|amphotericin b|mesh-list
24500354|NCT00523965|Paromomycin|paromomycin|mesh-list
24500355|NCT00523965|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24500356|NCT00523965|Miltefosine|miltefosine|mesh-list
24500357|NCT00523965|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
24500358|NCT00523965|Deoxycholic Acid|deoxycholic acid|mesh-list
24523026|NCT02932956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523027|NCT02932956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24523028|NCT02932956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24523029|NCT02932956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24523030|NCT02932956|Antimetabolites|antimetabolites|mesh-ancestor
24523031|NCT02909361|Fulvestrant|fulvestrant|mesh-list
24523032|NCT02909361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24523033|NCT02909361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24523034|NCT02909361|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24523055|NCT02897050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24523056|NCT02897050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24523057|NCT02897050|Tubulin Modulators|tubulin modulators|mesh-ancestor
24523058|NCT02897050|Antimitotic Agents|antimitotic agents|mesh-ancestor
24523059|NCT02897050|Mitosis Modulators|mitosis modulators|mesh-ancestor
24523061|NCT02897050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24523062|NCT02897050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24523063|NCT02897050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24924687|NCT04157491|Immunologic Factors|immunologic factors|mesh-ancestor
24924688|NCT04157491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924689|NCT04157478|Temozolomide|temozolomide|mesh-list
24924690|NCT04157478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24924691|NCT04157478|Alkylating Agents|alkylating agents|mesh-ancestor
25676843|NCT01804075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25676844|NCT01804075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676845|NCT01804075|Analgesics|analgesics|mesh-ancestor
25676846|NCT01804075|Sensory System Agents|sensory system agents|mesh-ancestor
25676847|NCT01804075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25676848|NCT01804075|Antitussive Agents|antitussive agents|mesh-ancestor
25676849|NCT01804075|Respiratory System Agents|respiratory system agents|mesh-ancestor
25676850|NCT01804101|Cytarabine|cytarabine|mesh-list
25676851|NCT01804101|Daunorubicin|daunorubicin|mesh-list
25676852|NCT01804101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25676853|NCT01804101|Antimetabolites|antimetabolites|mesh-ancestor
24924692|NCT04157478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523065|NCT02897050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25254785|NCT02492386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25254786|NCT02492386|Immunologic Factors|immunologic factors|mesh-ancestor
25254787|NCT02492386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254788|NCT02492438|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24523066|NCT02865551|Anesthetics|anesthetics|mesh-list
24523067|NCT02865551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24523068|NCT02865551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523069|NCT02864953|Glyburide|glyburide|mesh-list
25209074|NCT02705547|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25209075|NCT02705547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496148|NCT00503542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496149|NCT00503542|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24496150|NCT00503542|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24496152|NCT00503568|Immunologic Factors|immunologic factors|mesh-ancestor
24496153|NCT00503568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496304|NCT00504192|Antiviral Agents|antiviral agents|mesh-ancestor
24496305|NCT00504192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24496306|NCT00504192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496307|NCT00504192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24496308|NCT00504192|Immunologic Factors|immunologic factors|mesh-ancestor
24523070|NCT02864953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24523071|NCT02864953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523072|NCT02821507|Sirolimus|sirolimus|mesh-list
24523073|NCT02821507|Cyclophosphamide|cyclophosphamide|mesh-list
24523074|NCT02821507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24523075|NCT02821507|Immunologic Factors|immunologic factors|mesh-ancestor
24523076|NCT02821507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523077|NCT02821507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24523078|NCT02821507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24523079|NCT02821507|Alkylating Agents|alkylating agents|mesh-ancestor
24523081|NCT02821507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924715|NCT04156984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24924716|NCT04156984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24924717|NCT04156984|Immunologic Factors|immunologic factors|mesh-ancestor
24924718|NCT04156984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924719|NCT04157010|Methotrexate|methotrexate|mesh-list
24500389|NCT00524095|Fluticasone|fluticasone|mesh-list
24500391|NCT00524095|Azithromycin|azithromycin|mesh-list
24500392|NCT00524095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24500393|NCT00524095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24500394|NCT00524095|Autonomic Agents|autonomic agents|mesh-ancestor
24500395|NCT00524095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24523083|NCT02821507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24523084|NCT02821507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24500413|NCT00524160|Anesthetics, General|anesthetics, general|mesh-ancestor
24924788|NCT04156425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24924789|NCT04156425|Serotonin Agents|serotonin agents|mesh-ancestor
24924790|NCT04156425|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24924791|NCT04156425|Antidepressive Agents|antidepressive agents|mesh-ancestor
24924792|NCT04156425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24924793|NCT04156425|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24924794|NCT04156425|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24924795|NCT04156425|Parasympatholytics|parasympatholytics|mesh-ancestor
24924796|NCT04156425|Autonomic Agents|autonomic agents|mesh-ancestor
25209076|NCT02705573|Mannitol|mannitol|mesh-list
25209077|NCT02705573|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25209078|NCT02705573|Diuretics|diuretics|mesh-ancestor
25209079|NCT02705573|Natriuretic Agents|natriuretic agents|mesh-ancestor
25209080|NCT02705573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209081|NCT02705508|Gemcitabine|gemcitabine|mesh-list
25209082|NCT02705508|Etoposide|etoposide|mesh-list
25209083|NCT02705508|Etoposide phosphate|etoposide phosphate|mesh-list
25209084|NCT02705508|Pegaspargase|pegaspargase|mesh-list
25209085|NCT02705508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25209086|NCT02705508|Antimetabolites|antimetabolites|mesh-ancestor
25209087|NCT02705508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496309|NCT00504192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496310|NCT00504244|Mycophenolic Acid|mycophenolic acid|mesh-list
24496312|NCT00504244|Antimetabolites|antimetabolites|mesh-ancestor
24496313|NCT00504244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924797|NCT04156425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25676854|NCT01804101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676855|NCT01804101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25676856|NCT01804101|Antiviral Agents|antiviral agents|mesh-ancestor
25676857|NCT01804101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24924798|NCT04156425|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24924799|NCT04156425|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24924800|NCT04156425|Cholinergic Agents|cholinergic agents|mesh-ancestor
24924801|NCT04156425|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24924802|NCT04156425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24924803|NCT04156425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24924804|NCT04156425|Immunologic Factors|immunologic factors|mesh-ancestor
24924807|NCT04156451|Natriuretic Agents|natriuretic agents|mesh-ancestor
24924808|NCT04156451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924809|NCT04156451|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24924838|NCT04156204|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24924839|NCT04156204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924840|NCT04156204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924841|NCT04156035|Lamotrigine|lamotrigine|mesh-list
24924842|NCT04156035|Ketamine|ketamine|mesh-list
24924843|NCT04156035|Analgesics|analgesics|mesh-ancestor
24397394|NCT00141427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924844|NCT04156035|Sensory System Agents|sensory system agents|mesh-ancestor
24500501|NCT00524693|Hormone Antagonists|hormone antagonists|mesh-ancestor
24500502|NCT00524693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24523087|NCT02607215|Vinorelbine|vinorelbine|mesh-list
24523088|NCT02607215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24500563|NCT00524927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24500564|NCT00524927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500565|NCT00524966|Hemostatics|hemostatics|mesh-list
24500566|NCT00524966|Coagulants|coagulants|mesh-ancestor
24523141|NCT02512497|Fludarabine|fludarabine|mesh-list
24523142|NCT02512497|Fludarabine phosphate|fludarabine phosphate|mesh-list
24523145|NCT02512497|Thymoglobulin|thymoglobulin|mesh-list
24523146|NCT02512497|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24523147|NCT02512497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24523148|NCT02512497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24523149|NCT02512497|Antimetabolites|antimetabolites|mesh-ancestor
24523150|NCT02512497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523151|NCT02512497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24523152|NCT02512497|Immunologic Factors|immunologic factors|mesh-ancestor
24523153|NCT02512497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523154|NCT02512497|Antiviral Agents|antiviral agents|mesh-ancestor
24523155|NCT02512497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24924905|NCT04155697|Hand Sanitizers|hand sanitizers|mesh-list
24924906|NCT04155697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24924907|NCT04155697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24924908|NCT04155697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24924909|NCT04155697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748883|NCT01997463|Albuterol|albuterol|mesh-list
24924911|NCT04155554|Tenofovir|tenofovir|mesh-list
24924912|NCT04155554|Lamivudine|lamivudine|mesh-list
24924913|NCT04155554|Emtricitabine|emtricitabine|mesh-list
24924914|NCT04155554|Abacavir|abacavir|mesh-list
24924915|NCT04155554|Dolutegravir|dolutegravir|mesh-list
24500588|NCT00525096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24500589|NCT00525096|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24500590|NCT00525096|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24500591|NCT00525096|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24500592|NCT00525096|Hormone Antagonists|hormone antagonists|mesh-ancestor
24624325|NCT01075776|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
24624327|NCT01075776|Vasodilator Agents|vasodilator agents|mesh-ancestor
24924928|NCT04155515|Ribavirin|ribavirin|mesh-list
24500627|NCT00525239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24500628|NCT00525239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24523170|NCT02414269|Alkylating Agents|alkylating agents|mesh-ancestor
25209088|NCT02705508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25209089|NCT02705508|Antiviral Agents|antiviral agents|mesh-ancestor
25209090|NCT02705508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25209091|NCT02705508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25209092|NCT02705508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24496314|NCT00504244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25254848|NCT02492178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254850|NCT02492178|Analgesics|analgesics|mesh-ancestor
24496315|NCT00504244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496316|NCT00504244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24496317|NCT00504244|Immunologic Factors|immunologic factors|mesh-ancestor
24496372|NCT00504413|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24496386|NCT00504413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24496387|NCT00504413|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24496388|NCT00504413|Protective Agents|protective agents|mesh-ancestor
24496389|NCT00504439|Simvastatin|simvastatin|mesh-list
24496390|NCT00504439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24496391|NCT00504439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24496392|NCT00504439|Antimetabolites|antimetabolites|mesh-ancestor
24496393|NCT00504439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496394|NCT00504439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24496395|NCT00504439|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24496466|NCT00504946|Hormone Antagonists|hormone antagonists|mesh-ancestor
24496467|NCT00504946|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24496468|NCT00504946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24496469|NCT00504946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496470|NCT00504946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24523171|NCT02414269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523172|NCT02414269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24523173|NCT02414269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24523174|NCT02414269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24523176|NCT02403310|Daunorubicin|daunorubicin|mesh-list
24523177|NCT02403310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24523178|NCT02403310|Antimetabolites|antimetabolites|mesh-ancestor
24523179|NCT02403310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523180|NCT02403310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24397594|NCT00141960|Histamine Agents|histamine agents|mesh-ancestor
24397595|NCT00141960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24397597|NCT00141960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924984|NCT04154813|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24924985|NCT04154813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24924986|NCT04154813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24924987|NCT04154813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924988|NCT04154813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24500688|NCT00525473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500689|NCT00525473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24500690|NCT00525486|Nifedipine|nifedipine|mesh-list
24500691|NCT00525486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24523203|NCT02389036|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24925005|NCT04154982|Protective Agents|protective agents|mesh-ancestor
24925006|NCT04154982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925007|NCT04154982|Antidotes|antidotes|mesh-ancestor
24925008|NCT04154748|Omeprazole|omeprazole|mesh-list
25209093|NCT02705508|Immunologic Factors|immunologic factors|mesh-ancestor
25209094|NCT02705508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209095|NCT02705508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25209096|NCT02705508|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25209097|NCT02705508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25209098|NCT02705482|Durvalumab|durvalumab|mesh-list
25209099|NCT02705482|Tremelimumab|tremelimumab|mesh-list
25209100|NCT02705482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25209101|NCT02705482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25209102|NCT02705612|Nimotuzumab|nimotuzumab|mesh-list
25209103|NCT02705612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25209104|NCT02705612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25209105|NCT02705664|Amorolfine|amorolfine|mesh-list
25209106|NCT02705664|Bifonazole|bifonazole|mesh-list
25209107|NCT02705664|Antifungal Agents|antifungal agents|mesh-ancestor
25209108|NCT02705664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25209109|NCT02705378|Naloxegol|naloxegol|mesh-list
25209110|NCT02705378|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25209111|NCT02705378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209112|NCT02705378|Sensory System Agents|sensory system agents|mesh-ancestor
24925100|NCT04153708|Immunoglobulins|immunoglobulins|mesh-list
25676858|NCT01804101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25676859|NCT01804101|Immunologic Factors|immunologic factors|mesh-ancestor
25676860|NCT01804101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209114|NCT02705638|Rituximab|rituximab|mesh-list
25209115|NCT02705638|Lenalidomide|lenalidomide|mesh-list
24769645|NCT01815073|Vaccines|vaccines|mesh-list
24925009|NCT04154748|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24925010|NCT04154748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24925011|NCT04154748|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24925012|NCT04154748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925013|NCT04154748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925014|NCT04155008|Dexamethasone|dexamethasone|mesh-list
24925015|NCT04155008|Dronabinol|dronabinol|mesh-list
24925055|NCT04154735|Alemtuzumab|alemtuzumab|mesh-list
24523263|NCT02336750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24523281|NCT02268175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24523282|NCT02268175|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24523283|NCT02268175|Fertility Agents|fertility agents|mesh-ancestor
24523284|NCT02268175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24523285|NCT02268175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24523286|NCT02268175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24523287|NCT02268175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523288|NCT02268175|Hormone Antagonists|hormone antagonists|mesh-ancestor
24523289|NCT02268175|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24523291|NCT02178709|Oxaliplatin|oxaliplatin|mesh-list
24523292|NCT02178709|Irinotecan|irinotecan|mesh-list
24523293|NCT02178709|Folfirinox|folfirinox|mesh-list
24523294|NCT02178709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24523295|NCT02178709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25075906|NCT03377348|Immunologic Factors|immunologic factors|mesh-ancestor
24523296|NCT02178709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24523297|NCT02178709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24523298|NCT02178709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523299|NCT02178709|Antidotes|antidotes|mesh-ancestor
24925058|NCT04154735|Immunologic Factors|immunologic factors|mesh-ancestor
24500781|NCT00525681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24500782|NCT00525694|Cocaine|cocaine|mesh-list
24523334|NCT01855867|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24523335|NCT01754857|Rituximab|rituximab|mesh-list
24523336|NCT01754857|Lenalidomide|lenalidomide|mesh-list
24535179|NCT00648726|Erythromycin stearate|erythromycin stearate|mesh-list
24925086|NCT04153968|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24925087|NCT04153968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24925088|NCT04153981|Insulin Glargine|insulin glargine|mesh-list
24925089|NCT04153981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24925090|NCT04153981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925092|NCT04154033|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24925093|NCT04154033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24925094|NCT04154033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925095|NCT04154033|Sensory System Agents|sensory system agents|mesh-ancestor
24500790|NCT00525694|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24500791|NCT00525694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24500792|NCT00525694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24523347|NCT01754857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24523349|NCT01754857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523350|NCT01721746|Paclitaxel|paclitaxel|mesh-list
24523351|NCT01721746|Carboplatin|carboplatin|mesh-list
24523352|NCT01721746|Nivolumab|nivolumab|mesh-list
24523353|NCT01721746|Dacarbazine|dacarbazine|mesh-list
24523354|NCT01721746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24523355|NCT01721746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24523356|NCT01721746|Tubulin Modulators|tubulin modulators|mesh-ancestor
24523357|NCT01721746|Antimitotic Agents|antimitotic agents|mesh-ancestor
24523358|NCT01721746|Mitosis Modulators|mitosis modulators|mesh-ancestor
24523359|NCT01721746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925096|NCT04154033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25209116|NCT02705638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25209117|NCT02705638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25209118|NCT02705638|Immunologic Factors|immunologic factors|mesh-ancestor
24496545|NCT00505336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24496547|NCT00505427|Antioxidants|antioxidants|mesh-ancestor
24496548|NCT00505427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496549|NCT00505427|Protective Agents|protective agents|mesh-ancestor
24496550|NCT00505427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925106|NCT04153487|Micronutrients|micronutrients|mesh-ancestor
24500814|NCT00525759|Mitosis Modulators|mitosis modulators|mesh-ancestor
24500822|NCT00525772|Ciclesonide|ciclesonide|mesh-list
25274845|NCT02375100|Tramadol|tramadol|mesh-list
25274846|NCT02375100|Analgesics|analgesics|mesh-list
25274847|NCT02375100|Bupivacaine|bupivacaine|mesh-list
25274848|NCT02375100|Anesthetics, Local|anesthetics, local|mesh-ancestor
25274849|NCT02375100|Anesthetics|anesthetics|mesh-ancestor
24927142|NCT04135378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927143|NCT04135378|Protective Agents|protective agents|mesh-ancestor
24927144|NCT04135690|Sorafenib|sorafenib|mesh-list
24927149|NCT04135456|Mannitol|mannitol|mesh-list
24523365|NCT01716312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24523366|NCT01716312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24523367|NCT01716312|Respiratory System Agents|respiratory system agents|mesh-ancestor
24523368|NCT01661400|Thalidomide|thalidomide|mesh-list
24523369|NCT01661400|Cyclophosphamide|cyclophosphamide|mesh-list
24523370|NCT01661400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24523371|NCT01661400|Immunologic Factors|immunologic factors|mesh-ancestor
24523372|NCT01661400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523373|NCT01661400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24523400|NCT01293682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523401|NCT01293682|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24925122|NCT04153734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24523450|NCT00467142|Calcium|calcium|mesh-list
24523473|NCT05342597|Edaravone|edaravone|mesh-list
24523474|NCT05342597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24523475|NCT05342597|Antioxidants|antioxidants|mesh-ancestor
24523476|NCT05342597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523477|NCT05342597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24523478|NCT05342597|Protective Agents|protective agents|mesh-ancestor
24523479|NCT05342597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523480|NCT05342558|Fluticasone|fluticasone|mesh-list
24523481|NCT05342558|Xhance|xhance|mesh-list
24523482|NCT05342558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24523483|NCT05342558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24523484|NCT05342558|Autonomic Agents|autonomic agents|mesh-ancestor
24523485|NCT05342558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24925137|NCT04153383|Vasodilator Agents|vasodilator agents|mesh-ancestor
24925138|NCT04153383|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24925139|NCT04153383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24925140|NCT04153383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925141|NCT04153383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398090|NCT00143429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24925161|NCT04153123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24925162|NCT04153123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24925163|NCT04153123|Respiratory System Agents|respiratory system agents|mesh-ancestor
24925164|NCT04153123|Mydriatics|mydriatics|mesh-ancestor
24925165|NCT04153123|Sympathomimetics|sympathomimetics|mesh-ancestor
24925166|NCT04153123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24624328|NCT01075776|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24925167|NCT04153084|Picosulfate sodium|picosulfate sodium|mesh-list
24925178|NCT04152655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925218|NCT04152629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925219|NCT04152629|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24925220|NCT04152629|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25209119|NCT02705638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209120|NCT02705638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25209121|NCT02705638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25209122|NCT02705638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25209123|NCT02705638|Growth Substances|growth substances|mesh-ancestor
25209124|NCT02705638|Growth Inhibitors|growth inhibitors|mesh-ancestor
24496551|NCT00505427|Vitamin B Complex|vitamin b complex|mesh-ancestor
24496552|NCT00505427|Vitamins|vitamins|mesh-ancestor
24496553|NCT00505427|Micronutrients|micronutrients|mesh-ancestor
24496571|NCT00505531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24496572|NCT00505531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496640|NCT00505804|Antiemetics|antiemetics|mesh-ancestor
24496678|NCT00506051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496711|NCT00506259|Protective Agents|protective agents|mesh-ancestor
24496712|NCT00506259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676861|NCT01804101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25676862|NCT01804101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25676863|NCT01804101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25676864|NCT01804101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676865|NCT01804465|Ipilimumab|ipilimumab|mesh-list
25676866|NCT01804465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25676867|NCT01804465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25676868|NCT01804465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25254964|NCT02491268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254965|NCT02491268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25254966|NCT02491268|Vasodilator Agents|vasodilator agents|mesh-ancestor
24524946|NCT04176783|Narcotics|narcotics|mesh-ancestor
24496713|NCT00506259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24496714|NCT00506272|Insulin|insulin|mesh-list
24925221|NCT04152629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24925222|NCT04152629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925224|NCT04152629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24925225|NCT04152291|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
24925226|NCT04152291|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24500921|NCT00526214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24523514|NCT05342389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24925227|NCT04152291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24925228|NCT04152369|Anti-Infective Agents|anti-infective agents|mesh-list
24925229|NCT04152369|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24925231|NCT04152317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24925232|NCT04152317|Abortifacient Agents|abortifacient agents|mesh-ancestor
24925233|NCT04152317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24925234|NCT04152317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925235|NCT04152317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24925236|NCT04152317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24925237|NCT04152317|Oxytocics|oxytocics|mesh-ancestor
24925238|NCT04152356|Sorafenib|sorafenib|mesh-list
24925241|NCT04152356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925242|NCT04152356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398228|NCT00143871|Rituximab|rituximab|mesh-list
24925244|NCT04152161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24925245|NCT04152161|Immunologic Factors|immunologic factors|mesh-ancestor
24925246|NCT04152161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925247|NCT04152057|Paclitaxel|paclitaxel|mesh-list
24925248|NCT04152057|Trastuzumab|trastuzumab|mesh-list
24925249|NCT04152057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24925250|NCT04152057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24925251|NCT04152057|Tubulin Modulators|tubulin modulators|mesh-ancestor
24925252|NCT04152057|Antimitotic Agents|antimitotic agents|mesh-ancestor
24523543|NCT05341999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24523544|NCT05341999|Analgesics|analgesics|mesh-ancestor
24523545|NCT05341999|Sensory System Agents|sensory system agents|mesh-ancestor
24523546|NCT05341999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24523558|NCT05341856|Natriuretic Agents|natriuretic agents|mesh-ancestor
24523559|NCT05341856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523560|NCT05341856|Vasodilator Agents|vasodilator agents|mesh-ancestor
24523561|NCT05341856|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25209125|NCT02705651|Somatostatin|somatostatin|mesh-list
25209126|NCT02705651|Hormones|hormones|mesh-ancestor
25209127|NCT02705651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25209128|NCT02705651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209129|NCT02705287|Vitamin D|vitamin d|mesh-list
25209130|NCT02705287|Ergocalciferols|ergocalciferols|mesh-list
25209131|NCT02705287|Cholecalciferol|cholecalciferol|mesh-list
25209132|NCT02705287|Vitamins|vitamins|mesh-list
25209133|NCT02705287|Micronutrients|micronutrients|mesh-ancestor
25209134|NCT02705287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209135|NCT02705287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25272592|NCT02391077|Plasma Substitutes|plasma substitutes|mesh-ancestor
24496715|NCT00506272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24496716|NCT00506272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457596|NCT00334698|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24457597|NCT00334698|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24457598|NCT00334698|Histamine Antagonists|histamine antagonists|mesh-ancestor
24497095|NCT00507975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676869|NCT01804465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676870|NCT01804673|Fentanyl|fentanyl|mesh-list
25676871|NCT01804673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25676872|NCT01804673|Narcotics|narcotics|mesh-ancestor
24497096|NCT00508040|Interferons|interferons|mesh-list
24497129|NCT00508326|Antimitotic Agents|antimitotic agents|mesh-ancestor
24497130|NCT00508326|Mitosis Modulators|mitosis modulators|mesh-ancestor
24523569|NCT05341843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523570|NCT05341843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24523571|NCT05341843|Serotonin Agents|serotonin agents|mesh-ancestor
24523572|NCT05341843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523573|NCT05341817|Letrozole|letrozole|mesh-list
24523574|NCT05341817|Mifepristone|mifepristone|mesh-list
24523575|NCT05341817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24523576|NCT05341817|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24523577|NCT05341817|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24523578|NCT05341817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24926134|NCT04144933|Narcotics|narcotics|mesh-ancestor
24523612|NCT05341401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24523613|NCT05341401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24523614|NCT05341401|Respiratory System Agents|respiratory system agents|mesh-ancestor
24925278|NCT04151706|Cyclophosphamide|cyclophosphamide|mesh-list
24925279|NCT04151706|Busulfan|busulfan|mesh-list
24925280|NCT04151706|Thiotepa|thiotepa|mesh-list
24925281|NCT04151706|Fludarabine|fludarabine|mesh-list
24925282|NCT04151706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24925283|NCT04151706|Immunologic Factors|immunologic factors|mesh-ancestor
24925284|NCT04151706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925285|NCT04151706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24925286|NCT04151706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24925287|NCT04151706|Alkylating Agents|alkylating agents|mesh-ancestor
24925288|NCT04151706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925289|NCT04151706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24925290|NCT04151706|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24925291|NCT04151472|Ubiquinone|ubiquinone|mesh-list
24925301|NCT04151719|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24925302|NCT04151719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925303|NCT04151719|Sensory System Agents|sensory system agents|mesh-ancestor
24925304|NCT04151719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24925305|NCT04151459|Metformin|metformin|mesh-list
24925306|NCT04151459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24925307|NCT04151459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925308|NCT04151355|Atorvastatin|atorvastatin|mesh-list
24925309|NCT04151355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24925310|NCT04151355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24925311|NCT04151355|Antimetabolites|antimetabolites|mesh-ancestor
24925312|NCT04151355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925313|NCT04151355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24925314|NCT04151355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24925315|NCT04151355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925316|NCT04151381|Aminophylline|aminophylline|mesh-list
24925317|NCT04151381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24925324|NCT04151381|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24925325|NCT04151381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925326|NCT04151381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925327|NCT04151381|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24925328|NCT04151381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24925329|NCT04151381|Purinergic Agents|purinergic agents|mesh-ancestor
24925332|NCT04151147|Mitogens|mitogens|mesh-list
24925348|NCT04150965|Hormones|hormones|mesh-ancestor
25209136|NCT02705287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25209137|NCT02705313|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25209138|NCT02705313|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25209139|NCT02705313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209140|NCT02705066|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
25209141|NCT02705066|Nootropic Agents|nootropic agents|mesh-ancestor
25209142|NCT02705053|Insulin|insulin|mesh-list
25209143|NCT02705053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25209144|NCT02705053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272593|NCT02391077|Blood Substitutes|blood substitutes|mesh-ancestor
25272594|NCT02391142|Lidocaine|lidocaine|mesh-list
24497131|NCT00508326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497133|NCT00508365|Lisinopril|lisinopril|mesh-list
24497134|NCT00508365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24497135|NCT00508365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24497136|NCT00508365|Adrenergic Agents|adrenergic agents|mesh-ancestor
24497137|NCT00508365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24524544|NCT04739592|Vitamins|vitamins|mesh-ancestor
24944543|NCT03959306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927213|NCT04134468|Gemcitabine|gemcitabine|mesh-list
24925349|NCT04150965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24925350|NCT04150965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24925351|NCT04150965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24925352|NCT04150965|Protease Inhibitors|protease inhibitors|mesh-ancestor
24925353|NCT04150965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925354|NCT04150965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925355|NCT04150965|Immunologic Factors|immunologic factors|mesh-ancestor
24925356|NCT04150965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24925357|NCT04150965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24925358|NCT04150965|Growth Substances|growth substances|mesh-ancestor
24925359|NCT04150965|Growth Inhibitors|growth inhibitors|mesh-ancestor
24501092|NCT00526734|Melphalan|melphalan|mesh-list
24523699|NCT05340985|Micronutrients|micronutrients|mesh-ancestor
24523700|NCT05340985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523701|NCT05340985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24523702|NCT05340985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24523703|NCT05340985|Provitamins|provitamins|mesh-ancestor
24523704|NCT05340946|Anesthetics|anesthetics|mesh-list
24523705|NCT05340946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24523706|NCT05340946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523707|NCT05340803|Magnesium Sulfate|magnesium sulfate|mesh-list
24523708|NCT05340803|Midazolam|midazolam|mesh-list
24523709|NCT05340803|Dexmedetomidine|dexmedetomidine|mesh-list
24523710|NCT05340803|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24523711|NCT05340803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24523712|NCT05340803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925415|NCT04150289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925416|NCT04150289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925417|NCT04150367|Rifampin|rifampin|mesh-list
24925418|NCT04150367|Isoniazid|isoniazid|mesh-list
24925419|NCT04150367|Ethambutol|ethambutol|mesh-list
24925420|NCT04150367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24925421|NCT04150367|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24925422|NCT04150367|Antitubercular Agents|antitubercular agents|mesh-ancestor
24925423|NCT04150367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24925424|NCT04150367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24925425|NCT04150367|Leprostatic Agents|leprostatic agents|mesh-ancestor
24925426|NCT04150367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24523717|NCT05340803|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24523718|NCT05340803|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24523719|NCT05340803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24523720|NCT05340803|Adrenergic Agents|adrenergic agents|mesh-ancestor
24523721|NCT05340803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24523722|NCT05340803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925427|NCT04150367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925428|NCT04150367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925429|NCT04150367|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24925430|NCT04150367|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24925431|NCT04150367|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24925494|NCT04149626|Dexmedetomidine|dexmedetomidine|mesh-list
24925496|NCT04149626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24925497|NCT04149626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24925498|NCT04149626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209145|NCT02705274|Bevacizumab|bevacizumab|mesh-list
25209146|NCT02705274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25209147|NCT02705274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25209148|NCT02705274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25209149|NCT02705274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25209150|NCT02705274|Growth Substances|growth substances|mesh-ancestor
25209151|NCT02705274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209152|NCT02705274|Growth Inhibitors|growth inhibitors|mesh-ancestor
24497416|NCT00510003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24497417|NCT00510003|Analgesics|analgesics|mesh-ancestor
24497450|NCT00510159|Praziquantel|praziquantel|mesh-list
24497451|NCT00510159|Antimalarials|antimalarials|mesh-ancestor
24497452|NCT00510159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24497453|NCT00510159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24497454|NCT00510159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24497455|NCT00510159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497456|NCT00510159|Antiviral Agents|antiviral agents|mesh-ancestor
24497457|NCT00510159|Schistosomicides|schistosomicides|mesh-ancestor
24497458|NCT00510159|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25676873|NCT01804673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24927244|NCT04134130|Testosterone undecanoate|testosterone undecanoate|mesh-list
24927245|NCT04134130|Testosterone enanthate|testosterone enanthate|mesh-list
24927246|NCT04134130|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24497459|NCT00510159|Anthelmintics|anthelmintics|mesh-ancestor
24497460|NCT00510159|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24944555|NCT03959501|Dapagliflozin|dapagliflozin|mesh-list
24925499|NCT04149626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24925500|NCT04149626|Analgesics|analgesics|mesh-ancestor
24925501|NCT04149626|Sensory System Agents|sensory system agents|mesh-ancestor
24501201|NCT00527267|Cinacalcet|cinacalcet|mesh-list
24501202|NCT00527267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24501203|NCT00527267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523764|NCT05340530|Meropenem|meropenem|mesh-list
24925530|NCT04149444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24501230|NCT00527540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501231|NCT00527540|Antiviral Agents|antiviral agents|mesh-ancestor
24501233|NCT00527540|Antimetabolites|antimetabolites|mesh-ancestor
24523769|NCT05340530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24523770|NCT05340530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523789|NCT05340439|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24523790|NCT05340439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24523791|NCT05340439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523792|NCT05340439|Cholinergic Agents|cholinergic agents|mesh-ancestor
24925531|NCT04149262|Insulin Aspart|insulin aspart|mesh-list
24925532|NCT04149262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24523948|NCT05338489|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24523949|NCT05338489|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24523958|NCT05338476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24925633|NCT04148885|Tubulin Modulators|tubulin modulators|mesh-ancestor
24925634|NCT04148885|Antimitotic Agents|antimitotic agents|mesh-ancestor
24925635|NCT04148885|Mitosis Modulators|mitosis modulators|mesh-ancestor
24497496|NCT00510263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24497497|NCT00510263|Glucocorticoids|glucocorticoids|mesh-ancestor
24457599|NCT00334698|Histamine Agents|histamine agents|mesh-ancestor
24457600|NCT00334698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24457601|NCT00334698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925636|NCT04148885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925638|NCT04148820|Perindopril|perindopril|mesh-list
24925639|NCT04148820|Atorvastatin|atorvastatin|mesh-list
24925640|NCT04148820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24998836|NCT05422183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998837|NCT05422131|Clozapine|clozapine|mesh-list
24643532|NCT01185951|Polidocanol|polidocanol|mesh-list
24643533|NCT01185951|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
24643534|NCT01185951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24643535|NCT01185977|Fluoxetine|fluoxetine|mesh-list
24643536|NCT01185977|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24925641|NCT04148820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24925642|NCT04148820|Analgesics|analgesics|mesh-ancestor
24925643|NCT04148820|Sensory System Agents|sensory system agents|mesh-ancestor
24925644|NCT04148820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24925645|NCT04148820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925646|NCT04148820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24925647|NCT04148820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24925648|NCT04148820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24925649|NCT04148820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24925650|NCT04148820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925651|NCT04148820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24925652|NCT04148820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24925653|NCT04148820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925654|NCT04148820|Antipyretics|antipyretics|mesh-ancestor
24925655|NCT04148820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24925656|NCT04148820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24925657|NCT04148820|Antimetabolites|antimetabolites|mesh-ancestor
24925658|NCT04148820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24925683|NCT04148599|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24925684|NCT04148599|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24925685|NCT04148599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24925686|NCT04148599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925687|NCT04148599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24925688|NCT04148599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25676874|NCT01804673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676875|NCT01804673|Analgesics|analgesics|mesh-ancestor
25676876|NCT01804673|Sensory System Agents|sensory system agents|mesh-ancestor
24927273|NCT04134598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24927274|NCT04134598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927275|NCT04134598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25010586|NCT03665129|Durvalumab|durvalumab|mesh-list
24925690|NCT04148599|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24925691|NCT04148599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24925729|NCT04148846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925730|NCT04148846|Antimanic Agents|antimanic agents|mesh-ancestor
24925731|NCT04148846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24925732|NCT04148846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24925733|NCT04148846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24925734|NCT04148846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24925735|NCT04148846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925736|NCT04148846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24925737|NCT04148846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24925738|NCT04148846|Respiratory System Agents|respiratory system agents|mesh-ancestor
24925739|NCT04148846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24925740|NCT04148846|Vasodilator Agents|vasodilator agents|mesh-ancestor
24925741|NCT04148846|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24925742|NCT04148846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24925743|NCT04148846|Purinergic Agents|purinergic agents|mesh-ancestor
24925744|NCT04148261|Hydrocortisone|hydrocortisone|mesh-list
24925745|NCT04148261|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24925746|NCT04148261|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24925747|NCT04148261|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24925748|NCT04148261|Epinephrine|epinephrine|mesh-list
24925749|NCT04148261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24925777|NCT04147572|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24925778|NCT04147572|Cholinergic Agents|cholinergic agents|mesh-ancestor
25209170|NCT02704988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25209171|NCT02705014|Hormones|hormones|mesh-list
25272595|NCT02391142|Ropivacaine|ropivacaine|mesh-list
24457604|NCT00334698|Autonomic Agents|autonomic agents|mesh-ancestor
24394028|NCT00131742|Telbivudine|telbivudine|mesh-list
24497499|NCT00510263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24497500|NCT00510263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497501|NCT00510263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24497556|NCT00510419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24497557|NCT00510419|Serotonin Agents|serotonin agents|mesh-ancestor
24497558|NCT00510419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24497828|NCT00512057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752755|NCT01711827|Prednisone|prednisone|mesh-list
24925779|NCT04147572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24925780|NCT04147572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925781|NCT04147806|Dexamethasone|dexamethasone|mesh-list
24925782|NCT04147806|Tamsulosin|tamsulosin|mesh-list
24925783|NCT04147806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24925784|NCT04147806|Antiemetics|antiemetics|mesh-ancestor
24925785|NCT04147806|Autonomic Agents|autonomic agents|mesh-ancestor
24925786|NCT04147806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24925787|NCT04147806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925788|NCT04147806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24925813|NCT04147845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24925814|NCT04147845|Glucocorticoids|glucocorticoids|mesh-ancestor
24925816|NCT04147845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24925817|NCT04147845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925818|NCT04147845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25676877|NCT01804673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25676878|NCT01804673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25676879|NCT01804673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25676880|NCT01804673|Anesthetics, General|anesthetics, general|mesh-ancestor
25676881|NCT01804673|Anesthetics|anesthetics|mesh-ancestor
25676882|NCT01804946|Oseltamivir|oseltamivir|mesh-list
25676883|NCT01804946|Antiviral Agents|antiviral agents|mesh-ancestor
25676884|NCT01804946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25676885|NCT01804946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927311|NCT04134052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24927312|NCT04134052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24927313|NCT04134052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925820|NCT04147845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925821|NCT04147845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925822|NCT04147728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
24925823|NCT04147728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24925824|NCT04147728|Growth Substances|growth substances|mesh-ancestor
24925825|NCT04147728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925890|NCT04146610|Immunologic Factors|immunologic factors|mesh-ancestor
24925891|NCT04146610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925892|NCT04146220|Prednisolone|prednisolone|mesh-list
24925893|NCT04146220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24925894|NCT04146220|Glucocorticoids|glucocorticoids|mesh-ancestor
24925895|NCT04146220|Hormones|hormones|mesh-ancestor
25209172|NCT02705014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25209173|NCT02705014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209174|NCT02704962|Olanzapine|olanzapine|mesh-list
25209175|NCT02704962|Antiemetics|antiemetics|mesh-ancestor
25209176|NCT02704962|Autonomic Agents|autonomic agents|mesh-ancestor
25209177|NCT02704962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25209178|NCT02704962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209179|NCT02704962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25209180|NCT02704962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25209181|NCT02704962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25209182|NCT02704962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25209183|NCT02704962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25209184|NCT02704962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24497829|NCT00512057|Gout Suppressants|gout suppressants|mesh-ancestor
24497830|NCT00512057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24497831|NCT00512057|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24497833|NCT00512057|Protective Agents|protective agents|mesh-ancestor
24497834|NCT00512057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523977|NCT05338398|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24523978|NCT05338398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24523979|NCT05338398|Benzydamine|benzydamine|mesh-list
24523980|NCT05338398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24523981|NCT05338320|Fentanyl|fentanyl|mesh-list
24523982|NCT05338320|Morphine|morphine|mesh-list
24523983|NCT05338320|Anesthetics|anesthetics|mesh-ancestor
24523984|NCT05338320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24523985|NCT05338320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524002|NCT05331859|Insulin|insulin|mesh-list
24524003|NCT05331859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24524004|NCT05331859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524008|NCT05326490|Metformin|metformin|mesh-list
24925903|NCT04146376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925904|NCT04146376|Hemostatics|hemostatics|mesh-ancestor
24925905|NCT04146376|Coagulants|coagulants|mesh-ancestor
24524054|NCT05307003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24524055|NCT05307003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24524056|NCT05307003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24524057|NCT05307003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524058|NCT05307003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24524059|NCT05307003|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24524060|NCT05307003|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24524061|NCT05307003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24925997|NCT04145921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24925998|NCT04145921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925999|NCT04145921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926000|NCT04145921|Cholinergic Agents|cholinergic agents|mesh-ancestor
24926001|NCT04145921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24926002|NCT04145921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926003|NCT04145921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24926004|NCT04145921|Autonomic Agents|autonomic agents|mesh-ancestor
24926005|NCT04145921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24926006|NCT04145921|Nootropic Agents|nootropic agents|mesh-ancestor
24926007|NCT04145687|Metformin|metformin|mesh-list
24926008|NCT04145687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24926009|NCT04145687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676886|NCT01804946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676887|NCT01805037|Rituximab|rituximab|mesh-list
25676888|NCT01805037|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25676889|NCT01805037|Antibodies|antibodies|mesh-list
24926010|NCT04145193|Leucovorin|leucovorin|mesh-list
24926011|NCT04145193|Fluorouracil|fluorouracil|mesh-list
24926012|NCT04145193|Oxaliplatin|oxaliplatin|mesh-list
24926013|NCT04145193|Durvalumab|durvalumab|mesh-list
24926014|NCT04145193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24926015|NCT04145193|Antimetabolites|antimetabolites|mesh-ancestor
24926016|NCT04145193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926017|NCT04145193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24926018|NCT04145193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926019|NCT04145193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24624384|NCT01075945|Artemether|artemether|mesh-list
24624385|NCT01075945|Piperaquine|piperaquine|mesh-list
24624386|NCT01075945|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24624387|NCT01075945|Artenimol|artenimol|mesh-list
24624388|NCT01075945|Antimalarials|antimalarials|mesh-ancestor
24624389|NCT01075945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24628031|NCT01096225|Vaccines|vaccines|mesh-list
24926098|NCT04144933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24926099|NCT04144933|Glucocorticoids|glucocorticoids|mesh-ancestor
24926101|NCT04144933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24926102|NCT04144933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24926103|NCT04144933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926104|NCT04144933|Anesthetics, Local|anesthetics, local|mesh-ancestor
24926105|NCT04144933|Anesthetics|anesthetics|mesh-ancestor
24926106|NCT04144933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24926107|NCT04144933|Sensory System Agents|sensory system agents|mesh-ancestor
24926108|NCT04144933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25209185|NCT02704962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25209186|NCT02704962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25209187|NCT02704962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209188|NCT02704962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24497835|NCT00512070|Olanzapine|olanzapine|mesh-list
24497836|NCT00512070|Melatonin|melatonin|mesh-list
24497837|NCT00512070|Antioxidants|antioxidants|mesh-ancestor
24497838|NCT00512070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457606|NCT00334698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24457607|NCT00334698|Respiratory System Agents|respiratory system agents|mesh-ancestor
24926109|NCT04144933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24926110|NCT04144933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24926111|NCT04144933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24926136|NCT04144933|Dermatologic Agents|dermatologic agents|mesh-ancestor
24926137|NCT04144933|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24926138|NCT04144933|Serotonin Agents|serotonin agents|mesh-ancestor
24926139|NCT04144933|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24926140|NCT04144933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24926141|NCT04144933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24926142|NCT04144933|Tocolytic Agents|tocolytic agents|mesh-ancestor
24926143|NCT04144933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24926144|NCT04144933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24926145|NCT04144439|Butyric Acid|butyric acid|mesh-list
24926147|NCT04144439|Histamine Agents|histamine agents|mesh-ancestor
24926148|NCT04144439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24926178|NCT04144101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926179|NCT04143880|Progesterone|progesterone|mesh-list
24926242|NCT04143451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24926243|NCT04143451|Immunologic Factors|immunologic factors|mesh-ancestor
24926244|NCT04143451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926245|NCT04143451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926246|NCT04143451|Interferon Inducers|interferon inducers|mesh-ancestor
24926247|NCT04143815|Botulinum Toxins|botulinum toxins|mesh-list
24926248|NCT04143815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24926249|NCT04143815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24926250|NCT04143815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24850750|NCT02253940|Ritonavir|ritonavir|mesh-list
24926251|NCT04143815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24926252|NCT04143815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926253|NCT04143815|Cholinergic Agents|cholinergic agents|mesh-ancestor
24926254|NCT04143815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24926255|NCT04143815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926334|NCT04142762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24926335|NCT04142762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24926336|NCT04142762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24926337|NCT04142762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24926359|NCT04142762|Hormone Antagonists|hormone antagonists|mesh-ancestor
24926360|NCT04142762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24926361|NCT04142762|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24926362|NCT04142762|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24926363|NCT04142762|Antitubercular Agents|antitubercular agents|mesh-ancestor
24926452|NCT04141787|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24926454|NCT04141787|Ceftriaxone|ceftriaxone|mesh-list
24926455|NCT04141787|Daptomycin|daptomycin|mesh-list
24926456|NCT04141787|Cloxacillin|cloxacillin|mesh-list
24926457|NCT04141787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24926458|NCT04141410|Simendan|simendan|mesh-list
24926459|NCT04141410|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24926460|NCT04141410|Vasodilator Agents|vasodilator agents|mesh-ancestor
24926461|NCT04141410|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24926462|NCT04141410|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24926463|NCT04141410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24926465|NCT04141410|Protective Agents|protective agents|mesh-ancestor
24926506|NCT04141163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926507|NCT04140786|Gentamicins|gentamicins|mesh-list
25209189|NCT02704962|Serotonin Agents|serotonin agents|mesh-ancestor
25209190|NCT02704715|Anesthetics|anesthetics|mesh-list
25209191|NCT02704715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25209192|NCT02704715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209193|NCT02704624|Vitamin D|vitamin d|mesh-list
25209194|NCT02704624|Vitamins|vitamins|mesh-ancestor
24457608|NCT00334698|Nasal Decongestants|nasal decongestants|mesh-ancestor
24457609|NCT00334698|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24498136|NCT00513266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498137|NCT00513266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25048705|NCT00675844|Antiviral Agents|antiviral agents|mesh-ancestor
24926508|NCT04140786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24926509|NCT04140786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24926510|NCT04140786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24926511|NCT04140786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24926512|NCT04140786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926513|NCT04140578|Ertapenem|ertapenem|mesh-list
24624412|NCT01076140|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24624413|NCT01076140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24624414|NCT01076140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24624415|NCT01076140|Adrenergic Agents|adrenergic agents|mesh-ancestor
24624416|NCT01076140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24524262|NCT05074823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24524264|NCT05074823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24524265|NCT05074823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24524266|NCT05074823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524271|NCT05052229|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24524272|NCT05052229|Autonomic Agents|autonomic agents|mesh-ancestor
24524273|NCT05052229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24524274|NCT05052229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524275|NCT05052229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24524276|NCT05052229|Respiratory System Agents|respiratory system agents|mesh-ancestor
24524277|NCT05052229|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24524278|NCT05052229|Antioxidants|antioxidants|mesh-ancestor
24524279|NCT05052229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524280|NCT05052229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24624459|NCT01076478|Autonomic Agents|autonomic agents|mesh-ancestor
24628325|NCT01098084|Antimetabolites|antimetabolites|mesh-ancestor
24628405|NCT01098656|Lenalidomide|lenalidomide|mesh-list
24926590|NCT04140058|Autonomic Agents|autonomic agents|mesh-ancestor
24926591|NCT04140058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24926592|NCT04140058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926593|NCT04140058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24926594|NCT04140058|Antipruritics|antipruritics|mesh-ancestor
24926595|NCT04140058|Dermatologic Agents|dermatologic agents|mesh-ancestor
24926596|NCT04140058|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24926597|NCT04140058|Serotonin Agents|serotonin agents|mesh-ancestor
24926598|NCT04140058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24926599|NCT04140058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926600|NCT04140058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24926672|NCT04139681|Menthol|menthol|mesh-list
24926673|NCT04139681|Antipruritics|antipruritics|mesh-ancestor
24926674|NCT04139681|Dermatologic Agents|dermatologic agents|mesh-ancestor
24926675|NCT04139226|CC-11050|cc-11050|mesh-list
24926676|NCT04139226|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24926677|NCT04139226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24926678|NCT04139226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25209195|NCT02704624|Micronutrients|micronutrients|mesh-ancestor
25209196|NCT02704624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927403|NCT04133506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927404|NCT04133506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24927405|NCT04133506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24927406|NCT04133506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24927407|NCT04133506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24927412|NCT04133506|Antipyretics|antipyretics|mesh-ancestor
25209197|NCT02704624|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25209198|NCT02704754|Suvorexant|suvorexant|mesh-list
25272596|NCT02391142|Anesthetics, Local|anesthetics, local|mesh-ancestor
24498138|NCT00513266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24498139|NCT00513266|Immunologic Factors|immunologic factors|mesh-ancestor
24498140|NCT00513266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24498389|NCT00514228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498391|NCT00514293|Docetaxel|docetaxel|mesh-list
24926679|NCT04139226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502514|NCT04988685|Sirolimus|sirolimus|mesh-list
24524551|NCT04710277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24524552|NCT04710277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524553|NCT04710277|Analgesics|analgesics|mesh-ancestor
24524554|NCT04710277|Sensory System Agents|sensory system agents|mesh-ancestor
24926850|NCT04138004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24926851|NCT04138004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926853|NCT04138238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24926854|NCT04138238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24524615|NCT04657562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24524616|NCT04657562|Immunologic Factors|immunologic factors|mesh-ancestor
24524617|NCT04657562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524618|NCT04657562|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24524619|NCT04657562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24524620|NCT04657562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524621|NCT04646837|Paclitaxel|paclitaxel|mesh-list
24926940|NCT04137328|Hormones|hormones|mesh-ancestor
24926968|NCT04137029|Autonomic Agents|autonomic agents|mesh-ancestor
24926986|NCT04136613|Trace Elements|trace elements|mesh-ancestor
24926987|NCT04136613|Micronutrients|micronutrients|mesh-ancestor
24926988|NCT04136613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926989|NCT04136743|Dexamethasone|dexamethasone|mesh-list
24926990|NCT04136743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24926991|NCT04136743|Antiemetics|antiemetics|mesh-ancestor
24926994|NCT04136743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926995|NCT04136743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24926996|NCT04136743|Glucocorticoids|glucocorticoids|mesh-ancestor
24926997|NCT04136743|Hormones|hormones|mesh-ancestor
24926998|NCT04136743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24927000|NCT04136743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927103|NCT04135833|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24927104|NCT04135833|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24927105|NCT04135833|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24927106|NCT04135833|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24927107|NCT04135677|Rivaroxaban|rivaroxaban|mesh-list
24927108|NCT04135677|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24502950|NCT04000854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502951|NCT03981341|Bazedoxifene|bazedoxifene|mesh-list
25209199|NCT02704754|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25209200|NCT02704754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25209201|NCT02704754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25209202|NCT02704754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209203|NCT02704754|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
24498392|NCT00514293|Capecitabine|capecitabine|mesh-list
24498393|NCT00514293|Tretinoin|tretinoin|mesh-list
24498394|NCT00514293|Bexarotene|bexarotene|mesh-list
24498395|NCT00514293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498396|NCT00514293|Tubulin Modulators|tubulin modulators|mesh-ancestor
24498397|NCT00514293|Antimitotic Agents|antimitotic agents|mesh-ancestor
24498398|NCT00514293|Mitosis Modulators|mitosis modulators|mesh-ancestor
25676890|NCT01805037|Immunoglobulins|immunoglobulins|mesh-list
25676891|NCT01805037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25676892|NCT01805037|Immunoconjugates|immunoconjugates|mesh-list
25676893|NCT01805037|Immunologic Factors|immunologic factors|mesh-ancestor
25676894|NCT01805037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676895|NCT01805037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25676896|NCT01805037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25676897|NCT01805037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24397557|NCT00141843|Factor VIII|factor viii|mesh-list
24927434|NCT04133259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24524862|NCT04243278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24524863|NCT04243278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24524913|NCT04230031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24524914|NCT04213404|Spartalizumab|spartalizumab|mesh-list
24524915|NCT04213404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24524916|NCT04213404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524917|NCT04213404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24524918|NCT04200417|Mitomycins|mitomycins|mesh-list
24524919|NCT04200417|Mitomycin|mitomycin|mesh-list
24524920|NCT04200417|Ethiodized Oil|ethiodized oil|mesh-list
24401499|NCT00153049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24927179|NCT04135014|Adrenergic Agents|adrenergic agents|mesh-ancestor
24927180|NCT04135014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24927181|NCT04135014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927182|NCT04135014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24927185|NCT04135014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24927186|NCT04135014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24927187|NCT04135014|Anesthetics, General|anesthetics, general|mesh-ancestor
24927188|NCT04135014|Anesthetics|anesthetics|mesh-ancestor
24927189|NCT04135014|GABA Modulators|gaba modulators|mesh-ancestor
24927190|NCT04135014|GABA Agents|gaba agents|mesh-ancestor
24927191|NCT04134611|Hyaluronic Acid|hyaluronic acid|mesh-list
24624498|NCT01076556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24624499|NCT01076556|Alkylating Agents|alkylating agents|mesh-ancestor
24503061|NCT03481634|Growth Substances|growth substances|mesh-ancestor
24524968|NCT04171258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524969|NCT04171258|Cholinergic Agents|cholinergic agents|mesh-ancestor
24524970|NCT04171258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24525080|NCT03987802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525081|NCT03983668|Pembrolizumab|pembrolizumab|mesh-list
24525082|NCT03983668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24525083|NCT03983668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624500|NCT01076556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624501|NCT01076556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624502|NCT01076556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24624503|NCT01076556|Growth Inhibitors|growth inhibitors|mesh-ancestor
24624504|NCT01076556|Growth Substances|growth substances|mesh-ancestor
24624505|NCT01076556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25209204|NCT02704754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24498507|NCT00515138|Etoposide|etoposide|mesh-list
25209205|NCT02704754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209207|NCT02704923|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25209208|NCT02704923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25209209|NCT02704923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24498436|NCT00514618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24624506|NCT01076556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24624507|NCT01076582|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24624508|NCT01076582|Desogestrel|desogestrel|mesh-list
24624509|NCT01076582|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24624510|NCT01076582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24624511|NCT01076582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24624512|NCT01076582|Contraceptive Agents|contraceptive agents|mesh-ancestor
24628792|NCT01101412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24624513|NCT01076582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24624514|NCT01076582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525232|NCT03809988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24927223|NCT04134468|Immunologic Factors|immunologic factors|mesh-ancestor
24927224|NCT04134468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927228|NCT04134416|Donepezil|donepezil|mesh-list
24927229|NCT04134416|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24927230|NCT04134416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927235|NCT04134416|Nootropic Agents|nootropic agents|mesh-ancestor
24927294|NCT04134065|Vitamin D|vitamin d|mesh-list
24927295|NCT04134065|Vitamins|vitamins|mesh-ancestor
24525237|NCT03809884|Natriuretic Agents|natriuretic agents|mesh-ancestor
24927296|NCT04134065|Micronutrients|micronutrients|mesh-ancestor
25676898|NCT01805089|Melatonin|melatonin|mesh-list
24927297|NCT04134065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676899|NCT01805089|Antioxidants|antioxidants|mesh-ancestor
25676900|NCT01805089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676901|NCT01805089|Protective Agents|protective agents|mesh-ancestor
25676902|NCT01805089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927298|NCT04134065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24927299|NCT04134052|Midazolam|midazolam|mesh-list
24927300|NCT04134052|Ketamine|ketamine|mesh-list
24927301|NCT04134052|Analgesics|analgesics|mesh-ancestor
24927302|NCT04134052|Sensory System Agents|sensory system agents|mesh-ancestor
24927303|NCT04134052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24927304|NCT04134052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927305|NCT04134052|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24927306|NCT04134052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24927336|NCT04133961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24927337|NCT04133961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927338|NCT04133961|Protective Agents|protective agents|mesh-ancestor
24927341|NCT04133974|Methadone|methadone|mesh-list
24927342|NCT04133974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24927343|NCT04133974|Narcotics|narcotics|mesh-ancestor
24525397|NCT03521102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24525398|NCT03521102|Analgesics|analgesics|mesh-ancestor
24927824|NCT04128787|Omeprazole|omeprazole|mesh-list
24525399|NCT03521102|Sensory System Agents|sensory system agents|mesh-ancestor
24525400|NCT03521102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24525401|NCT03521102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927465|NCT04132479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927466|NCT04132479|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24927467|NCT04132479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24525498|NCT03259867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525499|NCT03255915|Tenofovir|tenofovir|mesh-list
24927482|NCT04132674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927483|NCT04132674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927484|NCT04132674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24927485|NCT04132674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24927486|NCT04132713|Capecitabine|capecitabine|mesh-list
24927487|NCT04132713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24927488|NCT04132713|Antimetabolites|antimetabolites|mesh-ancestor
24927489|NCT04132713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927490|NCT04132713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927491|NCT04132635|Mitogens|mitogens|mesh-list
24927492|NCT04132635|Mitosis Modulators|mitosis modulators|mesh-ancestor
24927493|NCT04132635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209210|NCT02704923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25209211|NCT02704923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25209212|NCT02704923|Autonomic Agents|autonomic agents|mesh-ancestor
24498506|NCT00515138|Carboplatin|carboplatin|mesh-list
24419528|NCT00212342|Estrogens|estrogens|mesh-ancestor
24927494|NCT04132648|Curcumin|curcumin|mesh-list
24525531|NCT03188068|Immunologic Factors|immunologic factors|mesh-ancestor
24525532|NCT03188068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535711|NCT00649610|Valdecoxib|valdecoxib|mesh-list
24927523|NCT04132557|Methylphenidate|methylphenidate|mesh-list
24927524|NCT04132557|Amphetamine|amphetamine|mesh-list
24525622|NCT03015974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24525623|NCT03015974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525624|NCT03015974|Protease Inhibitors|protease inhibitors|mesh-ancestor
24525625|NCT03015974|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24525626|NCT03015974|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24525627|NCT03015974|Vasodilator Agents|vasodilator agents|mesh-ancestor
24525628|NCT03013504|Cyclophosphamide|cyclophosphamide|mesh-list
24525629|NCT03013504|Docetaxel|docetaxel|mesh-list
24525630|NCT03013504|Trastuzumab|trastuzumab|mesh-list
24525640|NCT03013504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24927550|NCT04132115|Daptomycin|daptomycin|mesh-list
24927551|NCT04132115|Amikacin|amikacin|mesh-list
24927552|NCT04132115|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24927553|NCT04132115|Ceftobiprole|ceftobiprole|mesh-list
24927554|NCT04132115|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
24927555|NCT04132115|Acyclovir|acyclovir|mesh-list
24927556|NCT04132115|Ganciclovir|ganciclovir|mesh-list
24525651|NCT02974049|Diethylcarbamazine|diethylcarbamazine|mesh-list
24525652|NCT02974049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24525653|NCT02974049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24525654|NCT02974049|Anthelmintics|anthelmintics|mesh-ancestor
24525670|NCT02937766|Hormone Antagonists|hormone antagonists|mesh-ancestor
24525671|NCT02937766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24525672|NCT02937766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525404|NCT03521102|Narcotics|narcotics|mesh-ancestor
24525410|NCT03405090|Fentanyl|fentanyl|mesh-list
24525673|NCT02937766|Progestins|progestins|mesh-ancestor
24525678|NCT02927938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525679|NCT02927938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525680|NCT02927938|Antiviral Agents|antiviral agents|mesh-ancestor
24525681|NCT02927938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24525682|NCT02927938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24525688|NCT02883400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24525689|NCT02883400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525742|NCT02799134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24525743|NCT02799134|Antiemetics|antiemetics|mesh-ancestor
24525744|NCT02799134|Autonomic Agents|autonomic agents|mesh-ancestor
24525745|NCT02799134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24525746|NCT02799134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24402476|NCT00157508|Nitroaspirin|nitroaspirin|mesh-list
24525747|NCT02799134|Glucocorticoids|glucocorticoids|mesh-ancestor
24525749|NCT02799134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24525754|NCT02799134|Protective Agents|protective agents|mesh-ancestor
24525756|NCT02792413|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24525757|NCT02792413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525758|NCT02773212|Amphetamine|amphetamine|mesh-list
24525759|NCT02773212|Dextroamphetamine|dextroamphetamine|mesh-list
24927626|NCT04131309|Bortezomib|bortezomib|mesh-list
24927627|NCT04131309|Daratumumab|daratumumab|mesh-list
24927628|NCT04131309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24927629|NCT04131309|Antiemetics|antiemetics|mesh-ancestor
24927630|NCT04131309|Autonomic Agents|autonomic agents|mesh-ancestor
24927631|NCT04131309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24927632|NCT04131309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503518|NCT00532168|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24927634|NCT04131309|Glucocorticoids|glucocorticoids|mesh-ancestor
24927635|NCT04131309|Hormones|hormones|mesh-ancestor
24503600|NCT00532350|Autonomic Agents|autonomic agents|mesh-ancestor
24503601|NCT00532350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25209213|NCT02704923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24503605|NCT00532350|Parasympatholytics|parasympatholytics|mesh-ancestor
25209214|NCT02704923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209215|NCT02704923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24419606|NCT00213096|ST 1435|st 1435|mesh-list
24525769|NCT02773212|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24525770|NCT02773212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24525771|NCT02773212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24525772|NCT02773212|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24525774|NCT02757872|Ergocalciferols|ergocalciferols|mesh-list
24525775|NCT02757872|Cholecalciferol|cholecalciferol|mesh-list
24525776|NCT02757872|Vitamins|vitamins|mesh-list
24525799|NCT02743819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525800|NCT02719392|Acetylcysteine|acetylcysteine|mesh-list
24525801|NCT02719392|Minocycline|minocycline|mesh-list
24525802|NCT02719392|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24525803|NCT02719392|Antiviral Agents|antiviral agents|mesh-ancestor
24525804|NCT02719392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24525805|NCT02719392|Expectorants|expectorants|mesh-ancestor
24927706|NCT04130399|Folfirinox|folfirinox|mesh-list
24927707|NCT04130399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927708|NCT04130477|Nickel|nickel|mesh-list
24927709|NCT04130477|Trace Elements|trace elements|mesh-ancestor
24927710|NCT04130477|Micronutrients|micronutrients|mesh-ancestor
24535809|NCT00649740|Topiramate|topiramate|mesh-list
24927728|NCT04130230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24927729|NCT04130087|Selegiline|selegiline|mesh-list
24927730|NCT04130087|Antidepressive Agents|antidepressive agents|mesh-ancestor
24927731|NCT04130087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24927732|NCT04130087|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24503620|NCT00532415|Glucocorticoids|glucocorticoids|mesh-ancestor
24503621|NCT00532415|Hormones|hormones|mesh-ancestor
25676903|NCT01805089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25676904|NCT01805297|Aflibercept|aflibercept|mesh-list
25676905|NCT01805297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25676906|NCT01805297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25676907|NCT01805297|Growth Substances|growth substances|mesh-ancestor
25676908|NCT01805297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676909|NCT01805297|Growth Inhibitors|growth inhibitors|mesh-ancestor
25676910|NCT01805297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25676911|NCT01805323|Dexamethasone|dexamethasone|mesh-list
25676912|NCT01805323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25155436|NCT05371899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525502|NCT03255915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25010845|NCT02929589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25010846|NCT02929589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402628|NCT00158093|Moxifloxacin|moxifloxacin|mesh-list
24927733|NCT04130087|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24927734|NCT04130087|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24927735|NCT04130087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927736|NCT04130087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927737|NCT04130087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24927738|NCT04130087|Protective Agents|protective agents|mesh-ancestor
24927739|NCT04130087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927740|NCT04130100|Hyaluronic Acid|hyaluronic acid|mesh-list
24927741|NCT04130100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24927742|NCT04130100|Immunologic Factors|immunologic factors|mesh-ancestor
24927743|NCT04130100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927744|NCT04130100|Viscosupplements|viscosupplements|mesh-ancestor
24927745|NCT04130100|Protective Agents|protective agents|mesh-ancestor
24927746|NCT04129697|Dexamethasone|dexamethasone|mesh-list
24503647|NCT00532519|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24525820|NCT02697448|Anesthetics, General|anesthetics, general|mesh-ancestor
24525821|NCT02697448|Anesthetics|anesthetics|mesh-ancestor
24525822|NCT02697448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24525823|NCT02697448|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24525824|NCT02685709|Octreotide|octreotide|mesh-list
24525865|NCT02571725|Tremelimumab|tremelimumab|mesh-list
25209216|NCT02704923|Respiratory System Agents|respiratory system agents|mesh-ancestor
24525866|NCT02571725|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24498927|NCT00516841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498928|NCT00516841|Growth Inhibitors|growth inhibitors|mesh-ancestor
24498929|NCT00516841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498930|NCT00516854|Chlordiazepoxide|chlordiazepoxide|mesh-list
24498931|NCT00516854|Clidinium|clidinium|mesh-list
24498932|NCT00516854|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24498933|NCT00516854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24498934|NCT00516854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24498935|NCT00516854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498936|NCT00516854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24753233|NCT01714297|Dalteparin|dalteparin|mesh-list
24525867|NCT02571725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525868|NCT02571725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525869|NCT02571725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525870|NCT02546934|Gemcitabine|gemcitabine|mesh-list
24525871|NCT02546934|Cisplatin|cisplatin|mesh-list
24525872|NCT02546934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525873|NCT02546934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24525874|NCT02546934|Antimetabolites|antimetabolites|mesh-ancestor
24525875|NCT02546934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525876|NCT02546934|Antiviral Agents|antiviral agents|mesh-ancestor
24525877|NCT02546934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24525878|NCT02546934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525879|NCT02546934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24525880|NCT02546934|Immunologic Factors|immunologic factors|mesh-ancestor
24525881|NCT02546934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525882|NCT02519777|Maraviroc|maraviroc|mesh-list
24525883|NCT02519777|Dolutegravir|dolutegravir|mesh-list
24525884|NCT02519777|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24525885|NCT02519777|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24927747|NCT04129697|Methylprednisolone|methylprednisolone|mesh-list
24927748|NCT04129697|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24927749|NCT04129697|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25676913|NCT01805323|Antiemetics|antiemetics|mesh-ancestor
25676914|NCT01805323|Autonomic Agents|autonomic agents|mesh-ancestor
25676915|NCT01805323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25676916|NCT01805323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927750|NCT04129697|Prednisolone|prednisolone|mesh-list
25676917|NCT01805323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25676918|NCT01805323|Glucocorticoids|glucocorticoids|mesh-ancestor
25676919|NCT01805323|Hormones|hormones|mesh-ancestor
25676920|NCT01805323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25676921|NCT01805323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25676922|NCT01805323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25676923|NCT01805687|Zileuton|zileuton|mesh-list
24624548|NCT01076634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503402|NCT01582776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24927751|NCT04129697|Prednisolone acetate|prednisolone acetate|mesh-list
24927752|NCT04129697|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24927753|NCT04129697|Prednisolone phosphate|prednisolone phosphate|mesh-list
24927754|NCT04129697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24927755|NCT04129697|Antiemetics|antiemetics|mesh-ancestor
24927756|NCT04129697|Autonomic Agents|autonomic agents|mesh-ancestor
24927764|NCT04129697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927765|NCT04129697|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24927766|NCT04129697|Protective Agents|protective agents|mesh-ancestor
24927767|NCT04129736|Teriflunomide|teriflunomide|mesh-list
24927768|NCT04129736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24927769|NCT04129736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24927770|NCT04129736|Analgesics|analgesics|mesh-ancestor
24927771|NCT04129736|Sensory System Agents|sensory system agents|mesh-ancestor
24535836|NCT00649818|Lorazepam|lorazepam|mesh-list
24525908|NCT02441491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24525909|NCT02441491|Alkylating Agents|alkylating agents|mesh-ancestor
24525910|NCT02441491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525911|NCT02441491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525912|NCT02441491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24525913|NCT02395666|Eflornithine|eflornithine|mesh-list
24624551|NCT01076673|Immunologic Factors|immunologic factors|mesh-ancestor
24624552|NCT01076673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624555|NCT01076790|Dexmedetomidine|dexmedetomidine|mesh-list
24624571|NCT01076816|Dexmedetomidine|dexmedetomidine|mesh-list
24624572|NCT01076816|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24624573|NCT01076816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24624574|NCT01076816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624575|NCT01076816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24624576|NCT01076816|Analgesics|analgesics|mesh-ancestor
25209217|NCT02704923|Mydriatics|mydriatics|mesh-ancestor
25209218|NCT02704923|Parasympatholytics|parasympatholytics|mesh-ancestor
25209219|NCT02704923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25209220|NCT02704923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25209221|NCT02704923|Cholinergic Agents|cholinergic agents|mesh-ancestor
25209222|NCT02704923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25209223|NCT02704923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209224|NCT02704598|Warfarin|warfarin|mesh-list
25209225|NCT02704598|Rivaroxaban|rivaroxaban|mesh-list
25209226|NCT02704598|Anticoagulants|anticoagulants|mesh-ancestor
25209227|NCT02704598|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25209228|NCT02704598|Antithrombins|antithrombins|mesh-ancestor
24498937|NCT00516854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24498938|NCT00516854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24498939|NCT00516854|GABA Modulators|gaba modulators|mesh-ancestor
24498940|NCT00516854|GABA Agents|gaba agents|mesh-ancestor
24624577|NCT01076816|Sensory System Agents|sensory system agents|mesh-ancestor
24624578|NCT01076816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24525914|NCT02395666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525915|NCT02395666|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24525916|NCT02395666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24525917|NCT02395666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24525918|NCT02395666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24525919|NCT02395666|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
24525920|NCT02395666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525921|NCT02395666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525923|NCT02357810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24525924|NCT02357810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24525925|NCT02357810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525937|NCT02343549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24525938|NCT02343549|Alkylating Agents|alkylating agents|mesh-ancestor
24525939|NCT02343549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624579|NCT01076816|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24624585|NCT01076842|Insulin|insulin|mesh-list
24402888|NCT00158704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927793|NCT04129710|Dermatologic Agents|dermatologic agents|mesh-ancestor
24927794|NCT04129710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927795|NCT04129710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24927796|NCT04129710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24927797|NCT04129710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25676924|NCT01805687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25676925|NCT01805687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24927798|NCT04129710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25676926|NCT01805687|Analgesics|analgesics|mesh-ancestor
24927799|NCT04129710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24927800|NCT04129710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24927801|NCT04129710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24927802|NCT04129710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24525940|NCT02329847|Nivolumab|nivolumab|mesh-list
24525943|NCT02329847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24525944|NCT02329847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927815|NCT04129255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927816|NCT04129489|Cannabidiol|cannabidiol|mesh-list
24927817|NCT04129489|Anticonvulsants|anticonvulsants|mesh-ancestor
24927818|NCT04128891|Valsartan|valsartan|mesh-list
24927819|NCT04128891|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24927820|NCT04128891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24927821|NCT04128891|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24927822|NCT04128891|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24927823|NCT04128891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927827|NCT04128787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24927828|NCT04128787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927829|NCT04128787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503752|NCT00532727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525954|NCT02326311|Imatinib Mesylate|imatinib mesylate|mesh-list
24525955|NCT02326311|Dasatinib|dasatinib|mesh-list
24525956|NCT02326311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525957|NCT02326311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24525958|NCT02326311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525959|NCT02326311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209229|NCT02704598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25209230|NCT02704598|Protease Inhibitors|protease inhibitors|mesh-ancestor
25209231|NCT02704598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498941|NCT00516854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24498942|NCT00516854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498980|NCT00517062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24498981|NCT00517062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498991|NCT00517179|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24498992|NCT00517179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498993|NCT00517179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498995|NCT00517218|Oblimersen|oblimersen|mesh-list
24498996|NCT00517218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525960|NCT02315066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24525961|NCT02315066|Immunoglobulin G|immunoglobulin g|mesh-list
24525962|NCT02315066|Immunologic Factors|immunologic factors|mesh-ancestor
24525963|NCT02315066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525964|NCT02265367|Milnacipran|milnacipran|mesh-list
24525965|NCT02265367|Levomilnacipran|levomilnacipran|mesh-list
24927845|NCT04129008|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24927846|NCT04129008|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24927847|NCT04129008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927848|NCT04129008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24927849|NCT04129008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24927850|NCT04129008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927851|NCT04129008|Antipyretics|antipyretics|mesh-ancestor
24927852|NCT04129112|Propofol|propofol|mesh-list
24525969|NCT02265367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525970|NCT02265367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24525971|NCT02265367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525972|NCT02265367|Antidepressive Agents|antidepressive agents|mesh-ancestor
24525973|NCT02265367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24525974|NCT02265367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24525982|NCT02161783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525983|NCT02161783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24525984|NCT02161783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24525985|NCT02161783|Alkylating Agents|alkylating agents|mesh-ancestor
24525986|NCT02161783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525987|NCT02161783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526045|NCT01921166|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24927534|NCT04132557|Dopamine Agents|dopamine agents|mesh-ancestor
24526046|NCT01921166|Fertility Agents|fertility agents|mesh-ancestor
24526047|NCT01921166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24526048|NCT01921166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526049|NCT01921166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24927853|NCT04129112|Anesthetics|anesthetics|mesh-ancestor
24927854|NCT04129112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24927855|NCT04129112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927856|NCT04129112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24927857|NCT04129112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24927858|NCT04129112|Anesthetics, General|anesthetics, general|mesh-ancestor
24927859|NCT04128878|Sotalol|sotalol|mesh-list
24927860|NCT04128878|Dofetilide|dofetilide|mesh-list
24927861|NCT04128878|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24927862|NCT04128878|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24927863|NCT04128878|Adrenergic Agents|adrenergic agents|mesh-ancestor
24526150|NCT01059071|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24526151|NCT01059071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24927874|NCT04128462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24526240|NCT00605215|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24526241|NCT00605215|Immunologic Factors|immunologic factors|mesh-ancestor
24526242|NCT00605215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526244|NCT00302744|Psilocybin|psilocybin|mesh-list
24526245|NCT00302744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25209232|NCT02704598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209233|NCT02704767|Apatinib|apatinib|mesh-list
25209234|NCT02704767|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25209235|NCT02704767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25209236|NCT02704767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25209237|NCT02704767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25209238|NCT02704767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209239|NCT02704780|Misoprostol|misoprostol|mesh-list
25209240|NCT02704780|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25209241|NCT02704780|Abortifacient Agents|abortifacient agents|mesh-ancestor
24498998|NCT00517257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24498999|NCT00517257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24499000|NCT00517257|Antimetabolites|antimetabolites|mesh-ancestor
24499001|NCT00517257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499002|NCT00517257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24499003|NCT00517257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24499004|NCT00517257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499005|NCT00517270|Rabeprazole|rabeprazole|mesh-list
24526246|NCT00302744|Antimetabolites|antimetabolites|mesh-ancestor
24526247|NCT00302744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526248|NCT00302744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24526249|NCT00302744|Vasodilator Agents|vasodilator agents|mesh-ancestor
24526250|NCT00302744|Vitamin B Complex|vitamin b complex|mesh-ancestor
24526274|NCT00290511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24526275|NCT00290511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24526276|NCT00290511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24526278|NCT00290511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526279|NCT00290511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24526280|NCT00290511|Antiviral Agents|antiviral agents|mesh-ancestor
24526281|NCT00290511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24526282|NCT00290511|Analgesics|analgesics|mesh-ancestor
24526283|NCT00290511|Sensory System Agents|sensory system agents|mesh-ancestor
24526284|NCT00290511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24526285|NCT00290511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24928184|NCT04124887|Sequestering Agents|sequestering agents|mesh-ancestor
24927937|NCT04128020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927938|NCT04128020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24927939|NCT04128020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526298|NCT00255216|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24526299|NCT00248703|Docetaxel|docetaxel|mesh-list
24526300|NCT00248703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526329|NCT00611169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24526357|NCT00611286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24526358|NCT00611286|Immunologic Factors|immunologic factors|mesh-ancestor
24526359|NCT00611286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676927|NCT01805687|Sensory System Agents|sensory system agents|mesh-ancestor
25676928|NCT01805687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24526360|NCT00611286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24526361|NCT00611286|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24526362|NCT00611286|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24526363|NCT00611286|Purinergic Agents|purinergic agents|mesh-ancestor
24526364|NCT00611286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24526365|NCT00611286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24526366|NCT00611286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24526367|NCT00611286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24526368|NCT00611286|Antifungal Agents|antifungal agents|mesh-ancestor
24526369|NCT00611416|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24526371|NCT00611416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24624594|NCT01076842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24624596|NCT01076868|Antimalarials|antimalarials|mesh-ancestor
24503887|NCT00533312|Niacin|niacin|mesh-list
24499007|NCT00517270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24499008|NCT00517270|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24499009|NCT00517270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24624603|NCT01076998|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24624604|NCT01076998|Lubricant Eye Drops|lubricant eye drops|mesh-list
24624605|NCT01076998|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24624606|NCT01077011|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24624607|NCT01077011|Lubricant Eye Drops|lubricant eye drops|mesh-list
24503915|NCT00533416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24526428|NCT00611676|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24526430|NCT00611676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24526431|NCT00611676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624608|NCT01077011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24624609|NCT01077206|Simvastatin|simvastatin|mesh-list
24624610|NCT01077206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24624611|NCT01077206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24624612|NCT01077206|Antimetabolites|antimetabolites|mesh-ancestor
24624613|NCT01077206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624614|NCT01077206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24624615|NCT01077206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24624616|NCT01077206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927994|NCT04127357|Cariostatic Agents|cariostatic agents|mesh-ancestor
24937591|NCT04027192|Midazolam|midazolam|mesh-list
24999709|NCT03501368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927995|NCT04127357|Protective Agents|protective agents|mesh-ancestor
24927996|NCT04127357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927997|NCT04127084|Empagliflozin|empagliflozin|mesh-list
24927998|NCT04127084|Canagliflozin|canagliflozin|mesh-list
24927999|NCT04127084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24928000|NCT04127084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928001|NCT04127084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24503982|NCT00533611|Antimetabolites|antimetabolites|mesh-ancestor
24526432|NCT00611676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24526433|NCT00611676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526434|NCT00611676|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24526435|NCT00611676|Antidepressive Agents|antidepressive agents|mesh-ancestor
24526436|NCT00611676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24928089|NCT04126330|Micronutrients|micronutrients|mesh-ancestor
24928090|NCT04126330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629946|NCT01108848|Complement C1s|complement c1s|mesh-list
24928091|NCT04126330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24928092|NCT04126382|Pulmonary Surfactants|pulmonary surfactants|mesh-list
24535969|NCT00650117|Fentanyl|fentanyl|mesh-list
24928105|NCT04126252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928107|NCT04126252|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24928108|NCT04126252|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24928109|NCT04126252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24928110|NCT04126252|Urological Agents|urological agents|mesh-ancestor
24928111|NCT04126044|Bevacizumab|bevacizumab|mesh-list
24927602|NCT04131582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927603|NCT04131582|Incretins|incretins|mesh-ancestor
25209250|NCT02704546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25209251|NCT02704546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25209252|NCT02704546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25272597|NCT02391142|Anesthetics|anesthetics|mesh-ancestor
24499011|NCT00517283|Exenatide|exenatide|mesh-list
24499012|NCT00517283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24999737|NCT03477630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499013|NCT00517283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499014|NCT00517283|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24499015|NCT00517283|Incretins|incretins|mesh-ancestor
24499016|NCT00517283|Hormones|hormones|mesh-ancestor
24928112|NCT04126044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24928113|NCT04126044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526599|NCT00612274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24526600|NCT00612274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24526601|NCT00612274|Antifungal Agents|antifungal agents|mesh-ancestor
24526602|NCT00612287|Buprenorphine|buprenorphine|mesh-list
24526603|NCT00612287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24526604|NCT00612287|Narcotics|narcotics|mesh-ancestor
24526607|NCT00612287|Analgesics|analgesics|mesh-ancestor
24403552|NCT00160888|Cholinergic Agents|cholinergic agents|mesh-ancestor
24526620|NCT00612469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24526621|NCT00612469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24526622|NCT00612469|Disinfectants|disinfectants|mesh-ancestor
24526623|NCT00612469|Dermatologic Agents|dermatologic agents|mesh-ancestor
24526624|NCT00612469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24526625|NCT00612495|Fluorouracil|fluorouracil|mesh-list
24526626|NCT00612495|Oxaliplatin|oxaliplatin|mesh-list
24526627|NCT00612495|Antimetabolites|antimetabolites|mesh-ancestor
24526628|NCT00612495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526629|NCT00612495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24526630|NCT00612495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526631|NCT00612495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24928114|NCT04126044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24928115|NCT04126044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24928116|NCT04126044|Growth Substances|growth substances|mesh-ancestor
24928117|NCT04126044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928118|NCT04126044|Growth Inhibitors|growth inhibitors|mesh-ancestor
24928119|NCT04125862|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24928120|NCT04125862|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24928121|NCT04125862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928122|NCT04125719|Nivolumab|nivolumab|mesh-list
24526634|NCT00612521|Adenosine|adenosine|mesh-list
24526635|NCT00612521|Analgesics|analgesics|mesh-ancestor
24526636|NCT00612521|Sensory System Agents|sensory system agents|mesh-ancestor
24526637|NCT00612521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24526638|NCT00612521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526639|NCT00612521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24526640|NCT00612521|Vasodilator Agents|vasodilator agents|mesh-ancestor
24526641|NCT00612521|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24526642|NCT00612521|Purinergic Agonists|purinergic agonists|mesh-ancestor
24928145|NCT04125121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24928146|NCT04125121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928147|NCT04125121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24928148|NCT04125121|Anesthetics, General|anesthetics, general|mesh-ancestor
24928153|NCT04124822|Piroxicam|piroxicam|mesh-list
24928179|NCT04124887|Cariostatic Agents|cariostatic agents|mesh-ancestor
24928185|NCT04124887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928186|NCT04124913|Progesterone|progesterone|mesh-list
24928187|NCT04124913|Dydrogesterone|dydrogesterone|mesh-list
24928188|NCT04124913|Progestins|progestins|mesh-ancestor
24928189|NCT04124913|Hormones|hormones|mesh-ancestor
24499478|NCT00519688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24499479|NCT00519688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24499480|NCT00519688|Growth Substances|growth substances|mesh-ancestor
24499481|NCT00519688|Growth Inhibitors|growth inhibitors|mesh-ancestor
24499482|NCT00519688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25676929|NCT01805687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676930|NCT01805687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25676931|NCT01805687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24499483|NCT00519688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24499484|NCT00519688|Antimetabolites|antimetabolites|mesh-ancestor
25003910|NCT02924038|Poly ICLC|poly iclc|mesh-list
25011166|NCT01578954|Immunologic Factors|immunologic factors|mesh-ancestor
25011167|NCT01578954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011168|NCT01578954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25011169|NCT01578954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25011170|NCT01578954|Growth Substances|growth substances|mesh-ancestor
24499485|NCT00519688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499487|NCT00519701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24499488|NCT00519701|Antisickling Agents|antisickling agents|mesh-ancestor
24499489|NCT00519701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499490|NCT00519701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944627|NCT03959124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944628|NCT03959124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944629|NCT03959124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24944630|NCT03959124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24944631|NCT03959124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24944632|NCT03959124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24944633|NCT03959124|Cholinergic Agents|cholinergic agents|mesh-ancestor
24944634|NCT03959124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24944635|NCT03959124|Protective Agents|protective agents|mesh-ancestor
24944636|NCT03958708|Rifaximin|rifaximin|mesh-list
24999773|NCT03341936|Nivolumab|nivolumab|mesh-list
24928203|NCT04124757|Rocuronium|rocuronium|mesh-list
24928204|NCT04124757|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24536056|NCT00650247|Serotonin Agents|serotonin agents|mesh-ancestor
24928218|NCT04124302|Insulin glulisine|insulin glulisine|mesh-list
24928219|NCT04124302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24928220|NCT04124302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209259|NCT02704481|Abortifacient Agents|abortifacient agents|mesh-ancestor
25209260|NCT02704481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25209261|NCT02704481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209262|NCT02704481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25209263|NCT02704481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25209264|NCT02704481|Oxytocics|oxytocics|mesh-ancestor
25209265|NCT02704481|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25209266|NCT02704481|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25209267|NCT02704481|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25209268|NCT02704481|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25209269|NCT02704481|Contraceptive Agents|contraceptive agents|mesh-ancestor
25209270|NCT02704481|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25209271|NCT02704481|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25209272|NCT02704481|Hormone Antagonists|hormone antagonists|mesh-ancestor
25209276|NCT02704481|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25209277|NCT02704494|Losartan|losartan|mesh-list
25209278|NCT02704494|Resveratrol|resveratrol|mesh-list
25209279|NCT02704494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25209280|NCT02704494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25209281|NCT02704494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24499491|NCT00519701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24499492|NCT00519753|Timolol|timolol|mesh-list
24499493|NCT00519753|Travoprost|travoprost|mesh-list
24499494|NCT00519753|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24499529|NCT00519987|Analgesics|analgesics|mesh-ancestor
24457619|NCT00334763|Antimitotic Agents|antimitotic agents|mesh-ancestor
24457620|NCT00334763|Mitosis Modulators|mitosis modulators|mesh-ancestor
24394279|NCT00132821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499530|NCT00519987|Sensory System Agents|sensory system agents|mesh-ancestor
24526687|NCT00612638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24526689|NCT00612638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526721|NCT00612898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24526722|NCT00612898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24526723|NCT00612898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24526724|NCT00612950|Glucagon|glucagon|mesh-list
24928236|NCT04124003|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24928237|NCT04124003|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24928238|NCT04124003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24928239|NCT04124003|Antimetabolites|antimetabolites|mesh-ancestor
24928240|NCT04124003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676932|NCT01805687|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25676933|NCT01805687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676934|NCT01805687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676935|NCT01805687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25676936|NCT01805687|Hormone Antagonists|hormone antagonists|mesh-ancestor
24928241|NCT04124003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24928242|NCT04124003|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24928245|NCT04124016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24928246|NCT04124016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24928247|NCT04124016|Antioxidants|antioxidants|mesh-ancestor
24928248|NCT04124016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928249|NCT04124016|Protective Agents|protective agents|mesh-ancestor
24928250|NCT04124016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928251|NCT04124107|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
24928252|NCT04124107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24928253|NCT04124107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928254|NCT04124094|Fluticasone|fluticasone|mesh-list
24928255|NCT04124094|Xhance|xhance|mesh-list
24504229|NCT00534625|Hydroxyurea|hydroxyurea|mesh-list
24526725|NCT00612950|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
24928256|NCT04124094|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24928257|NCT04124094|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24928259|NCT04124094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24928260|NCT04124094|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24928292|NCT04123587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624641|NCT01077466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624642|NCT01077479|Metformin|metformin|mesh-list
24624643|NCT01077479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24624644|NCT01077479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624645|NCT01077505|Contraceptive Agents|contraceptive agents|mesh-list
24624646|NCT01077505|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
24624647|NCT01077505|Contraceptives, Oral|contraceptives, oral|mesh-list
24624652|NCT01077505|Incretins|incretins|mesh-ancestor
24928313|NCT04123652|Sensory System Agents|sensory system agents|mesh-ancestor
24526790|NCT00613223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24526791|NCT00613223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24999956|NCT02532660|Citalopram|citalopram|mesh-list
24526792|NCT00613223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526794|NCT00613249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24526795|NCT00613249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24526796|NCT00613249|Antiviral Agents|antiviral agents|mesh-ancestor
24526797|NCT00613249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24526943|NCT00613782|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24928335|NCT04123392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25209282|NCT02704494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25209283|NCT02704494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209284|NCT02704494|Antioxidants|antioxidants|mesh-ancestor
25209285|NCT02704494|Protective Agents|protective agents|mesh-ancestor
25209286|NCT02704494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209287|NCT02704494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25209288|NCT02704494|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25209289|NCT02704520|Leucovorin|leucovorin|mesh-list
25209290|NCT02704520|Folic Acid|folic acid|mesh-list
25209291|NCT02704520|Fluorouracil|fluorouracil|mesh-list
24499531|NCT00519987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24499532|NCT00519987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928336|NCT04123392|Immunologic Factors|immunologic factors|mesh-ancestor
24928337|NCT04123392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928338|NCT04123392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24928339|NCT04123392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24928340|NCT04123392|Alkylating Agents|alkylating agents|mesh-ancestor
24527144|NCT00615173|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24527145|NCT00615173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527147|NCT00615173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24928428|NCT04121975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928429|NCT04121975|Growth Inhibitors|growth inhibitors|mesh-ancestor
24928430|NCT04122040|Roxithromycin|roxithromycin|mesh-list
24928431|NCT04122040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24928432|NCT04122040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24928433|NCT04121910|Itraconazole|itraconazole|mesh-list
24928434|NCT04121910|Antifungal Agents|antifungal agents|mesh-ancestor
24928435|NCT04121910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24928436|NCT04121910|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24928437|NCT04121910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24928438|NCT04121910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24929326|NCT04113889|Vitamins|vitamins|mesh-ancestor
24928439|NCT04121910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928449|NCT04121767|Antithrombins|antithrombins|mesh-ancestor
24928450|NCT04121767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24928451|NCT04121767|Protease Inhibitors|protease inhibitors|mesh-ancestor
24928452|NCT04121767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24928453|NCT04121767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928454|NCT04121689|Caseins|caseins|mesh-list
24928455|NCT04121689|Chelating Agents|chelating agents|mesh-ancestor
24928456|NCT04121689|Sequestering Agents|sequestering agents|mesh-ancestor
24928458|NCT04121611|Aspirin|aspirin|mesh-list
24928521|NCT04121338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24928522|NCT04121091|Pramipexole|pramipexole|mesh-list
24527179|NCT00615212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527180|NCT00615303|Simethicone|simethicone|mesh-list
24527181|NCT00615303|Antifoaming Agents|antifoaming agents|mesh-ancestor
24928524|NCT04121091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928525|NCT04121091|Protective Agents|protective agents|mesh-ancestor
24928526|NCT04121091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928619|NCT04120311|Protease Inhibitors|protease inhibitors|mesh-ancestor
24928620|NCT04120311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504628|NCT00537472|Anesthetics, Local|anesthetics, local|mesh-ancestor
24527244|NCT00615615|Anticonvulsants|anticonvulsants|mesh-ancestor
24527245|NCT00615615|Nootropic Agents|nootropic agents|mesh-ancestor
24527246|NCT00615667|Tacrolimus|tacrolimus|mesh-list
24527354|NCT00616070|Hormones|hormones|mesh-ancestor
24527362|NCT00616187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24527363|NCT00616187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24527364|NCT00616187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24527365|NCT00616187|Antimetabolites|antimetabolites|mesh-ancestor
24928656|NCT04120519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404600|NCT00164164|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24928657|NCT04120519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24928658|NCT04120519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24928659|NCT04120519|Alkylating Agents|alkylating agents|mesh-ancestor
24928660|NCT04120519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928661|NCT04120519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527514|NCT00616915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24527515|NCT00616915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527516|NCT00616915|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24527554|NCT00617370|Mitosis Modulators|mitosis modulators|mesh-ancestor
24527555|NCT00617370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527556|NCT00617370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24928724|NCT04119752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24928725|NCT04119752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928726|NCT04119622|Capecitabine|capecitabine|mesh-list
24928727|NCT04119622|Oxaliplatin|oxaliplatin|mesh-list
24928728|NCT04119622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25209292|NCT02704520|Capecitabine|capecitabine|mesh-list
25209293|NCT02704520|Oxaliplatin|oxaliplatin|mesh-list
25209294|NCT02704520|Levoleucovorin|levoleucovorin|mesh-list
24499569|NCT00520091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499570|NCT00520091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24499572|NCT00520091|Analgesics|analgesics|mesh-ancestor
24499573|NCT00520091|Sensory System Agents|sensory system agents|mesh-ancestor
24499574|NCT00520091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24944657|NCT03958344|Glucocorticoids|glucocorticoids|mesh-ancestor
24928729|NCT04119622|Antimetabolites|antimetabolites|mesh-ancestor
24928730|NCT04119622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527729|NCT00618176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527742|NCT00618202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24527743|NCT00618202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527744|NCT00618202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24527745|NCT00618202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24527746|NCT00618202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24527747|NCT00618228|Balsalazide|balsalazide|mesh-list
24527748|NCT00618228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24527749|NCT00618228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24527750|NCT00618228|Analgesics|analgesics|mesh-ancestor
24928796|NCT04118842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24928797|NCT04118842|Antitubercular Agents|antitubercular agents|mesh-ancestor
24928798|NCT04118842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24999980|NCT02419417|Nivolumab|nivolumab|mesh-list
24928799|NCT04118842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24928800|NCT04118842|Leprostatic Agents|leprostatic agents|mesh-ancestor
24929327|NCT04113889|Micronutrients|micronutrients|mesh-ancestor
25011279|NCT00477412|Antiemetics|antiemetics|mesh-ancestor
25011280|NCT00477412|Autonomic Agents|autonomic agents|mesh-ancestor
24929043|NCT04115904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24929044|NCT04115904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929045|NCT04115904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24929046|NCT04115904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24528078|NCT00619541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528079|NCT00619541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24528080|NCT00619541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528081|NCT00619541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24528082|NCT00619541|Immunologic Factors|immunologic factors|mesh-ancestor
24528083|NCT00619541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528095|NCT00619697|Insulin Glargine|insulin glargine|mesh-list
24528096|NCT00619697|Insulin Aspart|insulin aspart|mesh-list
24929116|NCT04115449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24929117|NCT04115449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24929118|NCT04115449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929119|NCT04115449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24929120|NCT04115449|Analgesics|analgesics|mesh-ancestor
24929121|NCT04115449|Sensory System Agents|sensory system agents|mesh-ancestor
24929122|NCT04115449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24929413|NCT04113005|Coagulants|coagulants|mesh-ancestor
25209295|NCT02704520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209296|NCT02704520|Antimetabolites|antimetabolites|mesh-ancestor
25209297|NCT02704520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209298|NCT02704520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25209299|NCT02704520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25209300|NCT02704520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25209301|NCT02704520|Immunologic Factors|immunologic factors|mesh-ancestor
24499575|NCT00520091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499576|NCT00520091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24929190|NCT04115163|Mitosis Modulators|mitosis modulators|mesh-ancestor
24929191|NCT04115163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929214|NCT04114630|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
24929215|NCT04114630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929216|NCT04114630|Analgesics|analgesics|mesh-ancestor
24929217|NCT04114630|Sensory System Agents|sensory system agents|mesh-ancestor
24929218|NCT04114630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24929219|NCT04114630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929220|NCT04114383|Deuterium Oxide|deuterium oxide|mesh-list
24929221|NCT04114383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929222|NCT04114383|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24929225|NCT04114526|Nicotine|nicotine|mesh-list
24929282|NCT04113863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929283|NCT04113863|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24929284|NCT04113863|Hormone Antagonists|hormone antagonists|mesh-ancestor
24929285|NCT04113863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24929286|NCT04113863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929287|NCT04113863|Keratolytic Agents|keratolytic agents|mesh-ancestor
24929288|NCT04113863|Dermatologic Agents|dermatologic agents|mesh-ancestor
24929289|NCT04113954|Prilocaine|prilocaine|mesh-list
24929324|NCT04113889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929325|NCT04113889|Vitamin B Complex|vitamin b complex|mesh-ancestor
24528317|NCT00620724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24528318|NCT00620789|Dexetimide|dexetimide|mesh-list
24528319|NCT00620789|Citalopram|citalopram|mesh-list
24528320|NCT00620789|Antidepressive Agents|antidepressive agents|mesh-list
24624722|NCT01077947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24624723|NCT01077947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624724|NCT01077986|Capecitabine|capecitabine|mesh-list
24624725|NCT01077986|Cetuximab|cetuximab|mesh-list
25676937|NCT01805687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25676938|NCT01805882|Sofosbuvir|sofosbuvir|mesh-list
25676939|NCT01805882|Ledipasvir|ledipasvir|mesh-list
25676940|NCT01805882|Antiviral Agents|antiviral agents|mesh-ancestor
25676941|NCT01805882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25676942|NCT01805895|Minocycline|minocycline|mesh-list
25090412|NCT03257930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110220|NCT05464862|Lidocaine|lidocaine|mesh-list
25110221|NCT05464862|Anesthetics, Local|anesthetics, local|mesh-ancestor
25110222|NCT05464862|Anesthetics|anesthetics|mesh-ancestor
25110223|NCT05464862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25110224|NCT05464862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110225|NCT05464862|Sensory System Agents|sensory system agents|mesh-ancestor
24624726|NCT01077986|Everolimus|everolimus|mesh-list
24624727|NCT01077986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24624728|NCT01077986|Antimetabolites|antimetabolites|mesh-ancestor
24624729|NCT01077986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624730|NCT01077986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624731|NCT01077986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24624732|NCT01077986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24624733|NCT01077986|Immunologic Factors|immunologic factors|mesh-ancestor
24624734|NCT01077986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624735|NCT01077999|Paclitaxel|paclitaxel|mesh-list
24624736|NCT01077999|Carboplatin|carboplatin|mesh-list
24624737|NCT01077999|Panitumumab|panitumumab|mesh-list
24624739|NCT01077999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624747|NCT01078038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624748|NCT01078038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24624749|NCT01078038|Immunologic Factors|immunologic factors|mesh-ancestor
24624750|NCT01078038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624751|NCT01078038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24624752|NCT01078038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24624753|NCT01078038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24624754|NCT01078038|Antifungal Agents|antifungal agents|mesh-ancestor
24624755|NCT01078142|Sirolimus|sirolimus|mesh-list
24624756|NCT01078142|Rituximab|rituximab|mesh-list
24624757|NCT01078142|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24624758|NCT01078142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24624759|NCT01078142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929408|NCT04113226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24929409|NCT04113226|Growth Substances|growth substances|mesh-ancestor
24929410|NCT04113226|Growth Inhibitors|growth inhibitors|mesh-ancestor
24929411|NCT04113005|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24929412|NCT04113005|Hemostatics|hemostatics|mesh-ancestor
24929415|NCT04113005|Natriuretic Agents|natriuretic agents|mesh-ancestor
24929416|NCT04113005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209302|NCT02704520|Antidotes|antidotes|mesh-ancestor
25209303|NCT02704520|Protective Agents|protective agents|mesh-ancestor
24499632|NCT00520260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499642|NCT00520338|Sensory System Agents|sensory system agents|mesh-ancestor
24499643|NCT00520338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24499644|NCT00520338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624814|NCT01078870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24929642|NCT04110535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24929643|NCT04110535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24929644|NCT04110535|Anesthetics, General|anesthetics, general|mesh-ancestor
24929646|NCT04110535|GABA Modulators|gaba modulators|mesh-ancestor
24929647|NCT04110535|GABA Agents|gaba agents|mesh-ancestor
24929648|NCT04110535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24929650|NCT04110418|Terlipressin|terlipressin|mesh-list
24528489|NCT00621400|Autonomic Agents|autonomic agents|mesh-ancestor
24528490|NCT00621400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24528491|NCT00621400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528492|NCT00621400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24528493|NCT00621400|Glucocorticoids|glucocorticoids|mesh-ancestor
24528495|NCT00621400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24528496|NCT00621400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24528497|NCT00621400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528498|NCT00621400|Immunologic Factors|immunologic factors|mesh-ancestor
25676943|NCT01805895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25676944|NCT01805895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25676945|NCT01806064|Axitinib|axitinib|mesh-list
25676946|NCT01806064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25676947|NCT01806064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25676948|NCT01806064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676949|NCT01806064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676950|NCT01806259|Ketorolac|ketorolac|mesh-list
25676951|NCT01806259|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24528499|NCT00621400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25011344|NCT05216237|Tegafur|tegafur|mesh-list
25011359|NCT05215743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011360|NCT05215743|Protective Agents|protective agents|mesh-ancestor
25011361|NCT05215743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011362|NCT05215743|Siderophores|siderophores|mesh-ancestor
24528500|NCT00621400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24528501|NCT00621400|Growth Substances|growth substances|mesh-ancestor
24528520|NCT00621452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24528521|NCT00621452|Analgesics|analgesics|mesh-ancestor
24528522|NCT00621452|Sensory System Agents|sensory system agents|mesh-ancestor
24528523|NCT00621452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24528524|NCT00621452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24528525|NCT00621452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24528526|NCT00621452|Antiviral Agents|antiviral agents|mesh-ancestor
24528548|NCT00621478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24528549|NCT00621478|Anesthetics, General|anesthetics, general|mesh-ancestor
24929915|NCT04107194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24929916|NCT04107194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24929917|NCT04107194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929918|NCT04107194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24929919|NCT04107194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24929920|NCT04107194|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24929922|NCT04107194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24929923|NCT04107194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24406155|NCT00169169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24528614|NCT00621998|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24930053|NCT04106011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930054|NCT04106011|Antimanic Agents|antimanic agents|mesh-ancestor
24930056|NCT04106050|Anesthetics, Local|anesthetics, local|mesh-ancestor
24930057|NCT04106050|Anesthetics|anesthetics|mesh-ancestor
24930058|NCT04106050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24406264|NCT00169546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24930135|NCT04105283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209304|NCT02704520|Vitamin B Complex|vitamin b complex|mesh-ancestor
25209305|NCT02704520|Vitamins|vitamins|mesh-ancestor
25209306|NCT02704520|Micronutrients|micronutrients|mesh-ancestor
25209307|NCT02704520|Hematinics|hematinics|mesh-ancestor
25209308|NCT02704507|Triamcinolone|triamcinolone|mesh-list
25209309|NCT02704507|Tretinoin|tretinoin|mesh-list
25209310|NCT02704507|Emollients|emollients|mesh-list
24499645|NCT00520338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24499646|NCT00520338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24457621|NCT00334763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457622|NCT00334763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24499647|NCT00520338|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24499648|NCT00520338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24499649|NCT00520338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499650|NCT00520338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930136|NCT04105023|Genistein|genistein|mesh-list
24930137|NCT04105023|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24930138|NCT04105023|Protective Agents|protective agents|mesh-ancestor
24930139|NCT04105023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930140|NCT04105023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624828|NCT01078870|Dopamine Agents|dopamine agents|mesh-ancestor
24930141|NCT04105023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24528615|NCT00621998|Serotonin Agents|serotonin agents|mesh-ancestor
24930142|NCT04105023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24930143|NCT04105023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930144|NCT04105023|Phytoestrogens|phytoestrogens|mesh-ancestor
24930145|NCT04105023|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24930147|NCT04105023|Hormones|hormones|mesh-ancestor
24930149|NCT04104893|Pembrolizumab|pembrolizumab|mesh-list
24930152|NCT04104867|Domperidone|domperidone|mesh-list
24930173|NCT04104789|Anesthetics|anesthetics|mesh-ancestor
24930174|NCT04104789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24930175|NCT04104789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930176|NCT04104789|Sensory System Agents|sensory system agents|mesh-ancestor
25676952|NCT01806259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25676953|NCT01806259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25676954|NCT01806259|Analgesics|analgesics|mesh-ancestor
25676955|NCT01806259|Sensory System Agents|sensory system agents|mesh-ancestor
25676956|NCT01806259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25676957|NCT01806259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930177|NCT04104789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24930178|NCT04104789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24930179|NCT04104789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24930180|NCT04104789|Adrenergic Agents|adrenergic agents|mesh-ancestor
24930181|NCT04104789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24930182|NCT04104789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930183|NCT04104789|Sympathomimetics|sympathomimetics|mesh-ancestor
24930317|NCT04102449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24930318|NCT04102449|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24930319|NCT04102449|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24930320|NCT04102449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24930321|NCT04102449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930324|NCT04102566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24930356|NCT04102072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24930357|NCT04102072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930358|NCT04102072|Protective Agents|protective agents|mesh-ancestor
24930359|NCT04101812|Doxorubicin|doxorubicin|mesh-list
24930360|NCT04101812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24930361|NCT04101812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24930362|NCT04101812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24930363|NCT04101812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24528861|NCT00623168|Antiviral Agents|antiviral agents|mesh-ancestor
24930405|NCT04101682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24930406|NCT04101682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930407|NCT04101682|Sensory System Agents|sensory system agents|mesh-ancestor
24930408|NCT04101682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24930409|NCT04101578|Cyclosporine|cyclosporine|mesh-list
24930410|NCT04101578|Mycophenolic Acid|mycophenolic acid|mesh-list
24930411|NCT04101578|Prednisone|prednisone|mesh-list
24930412|NCT04101578|Methylprednisolone|methylprednisolone|mesh-list
24930413|NCT04101578|Cyclophosphamide|cyclophosphamide|mesh-list
24930414|NCT04101578|Methotrexate|methotrexate|mesh-list
24930415|NCT04101578|Azathioprine|azathioprine|mesh-list
24930708|NCT04098081|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
24930710|NCT04098081|Antimetabolites|antimetabolites|mesh-ancestor
24528961|NCT00623987|Anticoagulants|anticoagulants|mesh-ancestor
25209311|NCT02704507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25209312|NCT02704507|Glucocorticoids|glucocorticoids|mesh-ancestor
25209313|NCT02704507|Hormones|hormones|mesh-ancestor
25209314|NCT02704507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25209315|NCT02704507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209316|NCT02704507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25209317|NCT02704507|Keratolytic Agents|keratolytic agents|mesh-ancestor
25209318|NCT02704507|Dermatologic Agents|dermatologic agents|mesh-ancestor
25209319|NCT02703857|Cefoxitin|cefoxitin|mesh-list
25209320|NCT02703857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24499651|NCT00520442|Ibuprofen|ibuprofen|mesh-list
24499661|NCT00520442|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24499683|NCT00520507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24499684|NCT00520507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24499685|NCT00520507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24499686|NCT00520507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24499687|NCT00520507|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24499688|NCT00520507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24499689|NCT00520507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24499690|NCT00520507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944675|NCT03958201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528962|NCT00624000|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24528963|NCT00624000|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24930759|NCT04097574|Dermatologic Agents|dermatologic agents|mesh-ancestor
24930761|NCT04097444|Bevacizumab|bevacizumab|mesh-list
24930838|NCT04096742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24930841|NCT04096638|Atezolizumab|atezolizumab|mesh-list
24930842|NCT04096638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24930843|NCT04096690|Pegaspargase|pegaspargase|mesh-list
24930845|NCT04096690|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24528999|NCT00624143|Antifungal Agents|antifungal agents|mesh-ancestor
24529000|NCT00624143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24529001|NCT00624143|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24529002|NCT00624143|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24930910|NCT04095455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24930911|NCT04095455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931127|NCT04092725|Antifungal Agents|antifungal agents|mesh-ancestor
24931128|NCT04092725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25676958|NCT01806259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25011417|NCT05201170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25011418|NCT05193487|Anesthetics|anesthetics|mesh-list
25011419|NCT05193487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25011420|NCT05193487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011421|NCT05189145|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25110306|NCT05464303|Antibodies|antibodies|mesh-list
25110307|NCT05464303|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25011493|NCT04899986|Chlorhexidine|chlorhexidine|mesh-list
25011494|NCT04899986|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25011549|NCT04793685|Prazosin|prazosin|mesh-list
24931130|NCT04092868|Heparin Antagonists|heparin antagonists|mesh-ancestor
24931131|NCT04092868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931132|NCT04092868|Coagulants|coagulants|mesh-ancestor
24931134|NCT04092621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24931135|NCT04092621|Vasodilator Agents|vasodilator agents|mesh-ancestor
24931286|NCT04090801|Ethanol|ethanol|mesh-list
24529290|NCT00625339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24529291|NCT00625339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529292|NCT00625339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529293|NCT00625339|Antiviral Agents|antiviral agents|mesh-ancestor
24529294|NCT00625339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24529296|NCT00625339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24529297|NCT00625352|Gemcitabine|gemcitabine|mesh-list
24529298|NCT00625352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24529299|NCT00625352|Antimetabolites|antimetabolites|mesh-ancestor
24529300|NCT00625352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931332|NCT04090021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24624998|NCT01079754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24529343|NCT00625547|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24931484|NCT04088292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24408296|NCT00177242|Gefitinib|gefitinib|mesh-list
24931485|NCT04088292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931486|NCT04088266|Buprenorphine|buprenorphine|mesh-list
24931487|NCT04088266|Naloxone|naloxone|mesh-list
24931488|NCT04088266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24931489|NCT04088266|Narcotics|narcotics|mesh-ancestor
24931490|NCT04088266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24625063|NCT01080417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625064|NCT01080417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625065|NCT01080443|Mycophenolic Acid|mycophenolic acid|mesh-list
25209321|NCT02703857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25209322|NCT02704052|Enoxaparin|enoxaparin|mesh-list
25209323|NCT02704052|Enoxaparin sodium|enoxaparin sodium|mesh-list
25209324|NCT02704052|Anticoagulants|anticoagulants|mesh-ancestor
25209325|NCT02704052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25209326|NCT02704052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25209327|NCT02704052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209328|NCT02703896|Esomeprazole|esomeprazole|mesh-list
25209329|NCT02703896|Omeprazole|omeprazole|mesh-list
25209330|NCT02703896|Pantoprazole|pantoprazole|mesh-list
25209331|NCT02703896|Lansoprazole|lansoprazole|mesh-list
25209332|NCT02703896|Famotidine|famotidine|mesh-list
25209333|NCT02703896|Ranitidine|ranitidine|mesh-list
25209334|NCT02703896|Cimetidine|cimetidine|mesh-list
25209335|NCT02703896|Nizatidine|nizatidine|mesh-list
24499691|NCT00520507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24625069|NCT01080443|Antitubercular Agents|antitubercular agents|mesh-ancestor
24625074|NCT01080456|Tacrolimus|tacrolimus|mesh-list
24931756|NCT04085770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24931757|NCT04085770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931758|NCT04085770|Vitamins|vitamins|mesh-ancestor
24931759|NCT04085770|Micronutrients|micronutrients|mesh-ancestor
24931760|NCT04085757|Dinoprostone|dinoprostone|mesh-list
24931794|NCT04085640|Anesthetics|anesthetics|mesh-ancestor
24931795|NCT04085640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24931796|NCT04085640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931797|NCT04085640|Sensory System Agents|sensory system agents|mesh-ancestor
25676959|NCT01806259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25676960|NCT01806259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25676961|NCT01806259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676962|NCT01806259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676963|NCT01806298|Hormones|hormones|mesh-list
25676964|NCT01806298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25676965|NCT01806298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676966|NCT01806545|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
25676967|NCT01806545|Hemostatics|hemostatics|mesh-ancestor
25011579|NCT04703036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931798|NCT04085640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24931799|NCT04085094|Pilocarpine|pilocarpine|mesh-list
24931800|NCT04085094|Miotics|miotics|mesh-ancestor
24931872|NCT04085237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931873|NCT04085237|Sensory System Agents|sensory system agents|mesh-ancestor
24931874|NCT04085237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24931875|NCT04084977|Antibodies|antibodies|mesh-list
24932013|NCT04083066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24932014|NCT04083066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24932015|NCT04083066|Antimetabolites|antimetabolites|mesh-ancestor
24932016|NCT04083066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932017|NCT04083066|Dermatologic Agents|dermatologic agents|mesh-ancestor
24932018|NCT04083066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24932019|NCT04083066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24932020|NCT04083066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24932021|NCT04083066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24932022|NCT04083066|Antiviral Agents|antiviral agents|mesh-ancestor
24932023|NCT04083066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24932024|NCT04083118|Listerine|listerine|mesh-list
24932025|NCT04083118|Fluorides|fluorides|mesh-list
24529512|NCT00626509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529518|NCT00626535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24932120|NCT04082858|Anesthetics|anesthetics|mesh-ancestor
24932121|NCT04082858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24932122|NCT04082858|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24932123|NCT04082858|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24932124|NCT04082858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24932125|NCT04082858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932126|NCT04082858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24932127|NCT04082858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24932128|NCT04082858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24932170|NCT04082598|Clavulanic Acid|clavulanic acid|mesh-list
24932171|NCT04082598|Clavulanic Acids|clavulanic acids|mesh-list
24932172|NCT04082598|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24932173|NCT04082598|Lactoferrin|lactoferrin|mesh-list
24932174|NCT04082598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24932175|NCT04082598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24932312|NCT04081077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24932313|NCT04081077|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24932314|NCT04081077|Antitubercular Agents|antitubercular agents|mesh-ancestor
24932315|NCT04081077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24932316|NCT04081077|Leprostatic Agents|leprostatic agents|mesh-ancestor
25209336|NCT02703896|Lafutidine|lafutidine|mesh-list
25209337|NCT02703896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25209338|NCT02703896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25209339|NCT02703896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25209340|NCT02703896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25209341|NCT02703896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499697|NCT00520585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753987|NCT01718626|Docetaxel|docetaxel|mesh-list
24932417|NCT04079517|Tamoxifen|tamoxifen|mesh-list
24625145|NCT01080612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24932631|NCT04077957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24932632|NCT04077892|Budesonide|budesonide|mesh-list
24932633|NCT04077892|Montelukast|montelukast|mesh-list
24932634|NCT04077892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24932635|NCT04077892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24932636|NCT04077892|Autonomic Agents|autonomic agents|mesh-ancestor
24932637|NCT04077892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24932638|NCT04077892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932639|NCT04077892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24932640|NCT04077892|Respiratory System Agents|respiratory system agents|mesh-ancestor
24529765|NCT00627731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24529766|NCT00627731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24529767|NCT00627731|Protective Agents|protective agents|mesh-ancestor
24529791|NCT00627835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932668|NCT04077983|Immunologic Factors|immunologic factors|mesh-ancestor
24932669|NCT04077983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932670|NCT04077905|Methylprednisolone|methylprednisolone|mesh-list
24529804|NCT00627887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529805|NCT00627887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529806|NCT00627887|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25676968|NCT01806545|Coagulants|coagulants|mesh-ancestor
25011732|NCT04231084|Epoprostenol|epoprostenol|mesh-list
25011733|NCT04231084|Nitric Oxide|nitric oxide|mesh-list
24529811|NCT00627900|Sirolimus|sirolimus|mesh-list
24932750|NCT04076865|Lidocaine|lidocaine|mesh-list
24932751|NCT04076865|Histamine|histamine|mesh-list
24932752|NCT04076865|Anesthetics, Local|anesthetics, local|mesh-ancestor
24932753|NCT04076865|Anesthetics|anesthetics|mesh-ancestor
24932754|NCT04076865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24932755|NCT04076865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932756|NCT04076865|Sensory System Agents|sensory system agents|mesh-ancestor
24932870|NCT04075955|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24932871|NCT04075955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24932872|NCT04075955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24932873|NCT04075955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932875|NCT04075955|Serotonin Agents|serotonin agents|mesh-ancestor
24932876|NCT04075955|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24932877|NCT04075721|Dexamethasone|dexamethasone|mesh-list
24932878|NCT04075721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24932879|NCT04075721|Antiemetics|antiemetics|mesh-ancestor
24932880|NCT04075721|Autonomic Agents|autonomic agents|mesh-ancestor
24932881|NCT04075721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24932882|NCT04075721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529955|NCT00628550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24625209|NCT01080911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24625210|NCT01080911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625211|NCT01080911|Analgesics|analgesics|mesh-ancestor
24625212|NCT01080911|Sensory System Agents|sensory system agents|mesh-ancestor
24625213|NCT01080911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25209342|NCT02703896|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25209343|NCT02703896|Histamine Antagonists|histamine antagonists|mesh-ancestor
24499698|NCT00520585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24499720|NCT00520754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24499721|NCT00520754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24625222|NCT01081002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24625223|NCT01081002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625224|NCT01081002|Sensory System Agents|sensory system agents|mesh-ancestor
24625225|NCT01081002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24625226|NCT01081002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24625227|NCT01081002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24625231|NCT01081158|Ritonavir|ritonavir|mesh-list
24451836|NCT00324922|Antimalarials|antimalarials|mesh-ancestor
24625236|NCT01081158|Protease Inhibitors|protease inhibitors|mesh-ancestor
24625237|NCT01081158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625238|NCT01081158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625239|NCT01081158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24625240|NCT01081158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24625241|NCT01081158|Antiviral Agents|antiviral agents|mesh-ancestor
24625242|NCT01081158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24529956|NCT00628550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24529957|NCT00628550|Autonomic Agents|autonomic agents|mesh-ancestor
24536624|NCT00651781|Bortezomib|bortezomib|mesh-list
24409813|NCT00183235|Serotonin Agents|serotonin agents|mesh-ancestor
24625264|NCT01081353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625265|NCT01081353|Antipyretics|antipyretics|mesh-ancestor
24625266|NCT01081431|Lenalidomide|lenalidomide|mesh-list
24625267|NCT01081431|Immunologic Factors|immunologic factors|mesh-ancestor
24625268|NCT01081431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625269|NCT01081431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24625270|NCT01081431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24625271|NCT01081431|Growth Substances|growth substances|mesh-ancestor
25209344|NCT02703896|Histamine Agents|histamine agents|mesh-ancestor
25209345|NCT02703896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25209346|NCT02703896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209347|NCT02703896|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25209348|NCT02703896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25209349|NCT02704013|Oxybutynin|oxybutynin|mesh-list
25209350|NCT02704013|Parasympatholytics|parasympatholytics|mesh-ancestor
25209351|NCT02704013|Autonomic Agents|autonomic agents|mesh-ancestor
25209352|NCT02704013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25209353|NCT02704013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209354|NCT02704013|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25209355|NCT02704013|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25676969|NCT01806571|Cytarabine|cytarabine|mesh-list
25676970|NCT01806571|Daunorubicin|daunorubicin|mesh-list
25209356|NCT02704013|Cholinergic Agents|cholinergic agents|mesh-ancestor
24499731|NCT00520806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24457623|NCT00334763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24394423|NCT00133276|Citalopram|citalopram|mesh-list
24944688|NCT03958123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24933037|NCT04074551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24933038|NCT04074551|Antimetabolites|antimetabolites|mesh-ancestor
24933039|NCT04074551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24933040|NCT04074551|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24933041|NCT04074551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933042|NCT04074551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24933043|NCT04074551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24933044|NCT04074551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24933045|NCT04074421|Rifaximin|rifaximin|mesh-list
24933046|NCT04074421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24933047|NCT04074421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24933048|NCT04074421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24933049|NCT04074213|Clozapine|clozapine|mesh-list
24933050|NCT04074213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24933051|NCT04074213|Serotonin Agents|serotonin agents|mesh-ancestor
24933052|NCT04074213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24530037|NCT00628810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24530038|NCT00628810|Growth Substances|growth substances|mesh-ancestor
24530039|NCT00628810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530040|NCT00628810|Growth Inhibitors|growth inhibitors|mesh-ancestor
24530041|NCT00628810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24530084|NCT00629031|Paromomycin|paromomycin|mesh-list
24530085|NCT00629031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24530086|NCT00629031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24530087|NCT00629031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24530088|NCT00629031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24530089|NCT00629135|Moxifloxacin|moxifloxacin|mesh-list
24530090|NCT00629135|Metronidazole|metronidazole|mesh-list
24530091|NCT00629135|Tazobactam|tazobactam|mesh-list
24530092|NCT00629135|Piperacillin|piperacillin|mesh-list
24530093|NCT00629135|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24530094|NCT00629135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24530095|NCT00629135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24530096|NCT00629135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24530097|NCT00629135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24530098|NCT00629135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933104|NCT04073537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24933105|NCT04073537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24933106|NCT04073537|Tubulin Modulators|tubulin modulators|mesh-ancestor
24933107|NCT04073537|Antimitotic Agents|antimitotic agents|mesh-ancestor
24933108|NCT04073537|Mitosis Modulators|mitosis modulators|mesh-ancestor
24933109|NCT04073537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933134|NCT04074265|Anesthetics|anesthetics|mesh-ancestor
24933135|NCT04074265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24933145|NCT04074265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24933146|NCT04074265|Autonomic Agents|autonomic agents|mesh-ancestor
24933147|NCT04074265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24933148|NCT04074265|Respiratory System Agents|respiratory system agents|mesh-ancestor
24933150|NCT04074265|Sympathomimetics|sympathomimetics|mesh-ancestor
24933151|NCT04074265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24933152|NCT04074265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24933153|NCT04074265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24933155|NCT04074265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24933156|NCT04074265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24933157|NCT04074265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24933158|NCT04074265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25209357|NCT02704013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25209358|NCT02704013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209359|NCT02704013|Urological Agents|urological agents|mesh-ancestor
25209360|NCT02703961|Cisplatin|cisplatin|mesh-list
25209361|NCT02703961|Docetaxel|docetaxel|mesh-list
25209362|NCT02703961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25209363|NCT02703961|Tubulin Modulators|tubulin modulators|mesh-ancestor
24499744|NCT00520897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499745|NCT00520949|Amoxicillin|amoxicillin|mesh-list
24499746|NCT00520949|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24499747|NCT00520949|Furazolidone|furazolidone|mesh-list
25676971|NCT01806571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24499898|NCT00521482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24499900|NCT00521482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499960|NCT00521820|Glyburide|glyburide|mesh-list
24499961|NCT00521820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24499962|NCT00521820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500063|NCT00522444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24500129|NCT00522821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24500130|NCT00522821|Immunoglobulins|immunoglobulins|mesh-list
24500131|NCT00522821|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24457626|NCT00334763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525072|NCT04001829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24501052|NCT00526409|Antiviral Agents|antiviral agents|mesh-ancestor
24501053|NCT00526409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24501054|NCT00526409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24501055|NCT00526409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24944695|NCT03958123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960554|NCT03815838|Fallypride|fallypride|mesh-list
24933159|NCT04073160|Durvalumab|durvalumab|mesh-list
24933160|NCT04073160|Tremelimumab|tremelimumab|mesh-list
24933176|NCT04074122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933177|NCT04074122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933178|NCT04074122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24933179|NCT04074122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24933180|NCT04074122|Autonomic Agents|autonomic agents|mesh-ancestor
24933181|NCT04074122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24933182|NCT04074122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24933183|NCT04074122|Respiratory System Agents|respiratory system agents|mesh-ancestor
24933184|NCT04074122|Mydriatics|mydriatics|mesh-ancestor
24933185|NCT04074122|Sympathomimetics|sympathomimetics|mesh-ancestor
24933186|NCT04074122|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24933187|NCT04074122|Analgesics|analgesics|mesh-ancestor
24933188|NCT04074122|Sensory System Agents|sensory system agents|mesh-ancestor
24933189|NCT04074122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24933190|NCT04074122|Vasodilator Agents|vasodilator agents|mesh-ancestor
24933191|NCT04074122|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25209364|NCT02703961|Antimitotic Agents|antimitotic agents|mesh-ancestor
25209365|NCT02703961|Mitosis Modulators|mitosis modulators|mesh-ancestor
25209366|NCT02703961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209367|NCT02703649|Letrozole|letrozole|mesh-list
25209368|NCT02703649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25209369|NCT02703649|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25209370|NCT02703649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25209371|NCT02703649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25209372|NCT02703649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209373|NCT02703649|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25209374|NCT02703649|Hormone Antagonists|hormone antagonists|mesh-ancestor
25209375|NCT02703649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25209376|NCT02703649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209377|NCT02703571|Trametinib|trametinib|mesh-list
25209378|NCT02703571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25209379|NCT02703571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25209380|NCT02703571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25209381|NCT02703571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209382|NCT02703740|Lidocaine|lidocaine|mesh-list
25209383|NCT02703740|Hyaluronic Acid|hyaluronic acid|mesh-list
25209384|NCT02703740|Anesthetics, Local|anesthetics, local|mesh-ancestor
25209385|NCT02703740|Anesthetics|anesthetics|mesh-ancestor
25209386|NCT02703740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25209387|NCT02703740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209388|NCT02703740|Sensory System Agents|sensory system agents|mesh-ancestor
25209389|NCT02703740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25209390|NCT02703740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24501439|NCT00528619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501441|NCT00528619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24501442|NCT00528619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24501443|NCT00528619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24501444|NCT00528619|Growth Substances|growth substances|mesh-ancestor
24501445|NCT00528619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501446|NCT00528619|Growth Inhibitors|growth inhibitors|mesh-ancestor
24501447|NCT00528619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24501448|NCT00528658|Acetaminophen|acetaminophen|mesh-list
24501449|NCT00528658|Ibuprofen|ibuprofen|mesh-list
24501450|NCT00528658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24968701|NCT03749096|Immunoglobulins|immunoglobulins|mesh-list
24501451|NCT00528658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24501502|NCT00528918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501504|NCT00528983|Cc-486|cc-486|mesh-list
24501575|NCT00529620|Antimalarials|antimalarials|mesh-ancestor
24501576|NCT00529620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24501577|NCT00529620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24501578|NCT00529620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24501579|NCT00529620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24501580|NCT00529620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933192|NCT04074122|Purinergic Agonists|purinergic agonists|mesh-ancestor
24933193|NCT04074122|Purinergic Agents|purinergic agents|mesh-ancestor
24933196|NCT04073927|Butyric Acid|butyric acid|mesh-list
24933215|NCT04073056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933216|NCT04073056|Sensory System Agents|sensory system agents|mesh-ancestor
24933217|NCT04073056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24933219|NCT04072640|Amphotericin B|amphotericin b|mesh-list
24933220|NCT04072640|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24933221|NCT04072640|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
24933222|NCT04072640|Deoxycholic Acid|deoxycholic acid|mesh-list
24933223|NCT04072640|Antifungal Agents|antifungal agents|mesh-ancestor
24933224|NCT04072640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24933249|NCT04072601|Antimetabolites|antimetabolites|mesh-ancestor
24933250|NCT04072601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933251|NCT04072601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24933252|NCT04072601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24933253|NCT04072601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933254|NCT04072497|Vaccines|vaccines|mesh-list
24933255|NCT04072497|Immunologic Factors|immunologic factors|mesh-ancestor
24933256|NCT04072497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933257|NCT04072263|Interferons|interferons|mesh-list
24933258|NCT04072263|Interferon-alpha|interferon-alpha|mesh-list
24933259|NCT04072263|Interferon alpha-2|interferon alpha-2|mesh-list
24933260|NCT04072263|Paclitaxel|paclitaxel|mesh-list
24933261|NCT04072263|Carboplatin|carboplatin|mesh-list
24933262|NCT04072263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24933270|NCT04072263|Immunologic Factors|immunologic factors|mesh-ancestor
24933271|NCT04072263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933272|NCT04072471|Lesinurad|lesinurad|mesh-list
24933273|NCT04072471|Gout Suppressants|gout suppressants|mesh-ancestor
24933274|NCT04072471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24933275|NCT04072471|Uricosuric Agents|uricosuric agents|mesh-ancestor
25209391|NCT02703740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25209392|NCT02703740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25209393|NCT02703740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25209394|NCT02703740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209395|NCT02703740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25209396|NCT02703740|Immunologic Factors|immunologic factors|mesh-ancestor
25209397|NCT02703740|Viscosupplements|viscosupplements|mesh-ancestor
25209398|NCT02703740|Protective Agents|protective agents|mesh-ancestor
25209399|NCT02703363|Minocycline|minocycline|mesh-list
25209400|NCT02703363|Celecoxib|celecoxib|mesh-list
25209401|NCT02703363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25209402|NCT02703363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25209403|NCT02703363|Analgesics|analgesics|mesh-ancestor
25209404|NCT02703363|Sensory System Agents|sensory system agents|mesh-ancestor
25209405|NCT02703363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25209406|NCT02703363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209407|NCT02703363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25209408|NCT02703363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25209409|NCT02703363|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25209410|NCT02703363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25209411|NCT02703363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24944712|NCT03958097|Immunologic Factors|immunologic factors|mesh-ancestor
24933276|NCT04072471|Renal Agents|renal agents|mesh-ancestor
24933277|NCT04072068|Edoxaban|edoxaban|mesh-list
24933278|NCT04072068|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24933279|NCT04072068|Antithrombins|antithrombins|mesh-ancestor
24933280|NCT04072068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24933281|NCT04072068|Protease Inhibitors|protease inhibitors|mesh-ancestor
24933287|NCT04072198|Nivolumab|nivolumab|mesh-list
24933288|NCT04072198|Oxaliplatin|oxaliplatin|mesh-list
24933293|NCT04072198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24933294|NCT04072198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24933295|NCT04072198|Growth Substances|growth substances|mesh-ancestor
24933296|NCT04072198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676972|NCT01806571|Antimetabolites|antimetabolites|mesh-ancestor
24933297|NCT04072198|Growth Inhibitors|growth inhibitors|mesh-ancestor
24933298|NCT04072198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24530156|NCT00629278|Tamoxifen|tamoxifen|mesh-list
24530157|NCT00629278|Docetaxel|docetaxel|mesh-list
24530158|NCT00629278|Cyclophosphamide|cyclophosphamide|mesh-list
24530159|NCT00629278|Doxorubicin|doxorubicin|mesh-list
24530160|NCT00629278|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24530161|NCT00629278|Fluorouracil|fluorouracil|mesh-list
24933301|NCT04072198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24933302|NCT04072198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933304|NCT04072198|Protective Agents|protective agents|mesh-ancestor
24933305|NCT04072198|Vitamin B Complex|vitamin b complex|mesh-ancestor
24933306|NCT04072198|Vitamins|vitamins|mesh-ancestor
24933307|NCT04072198|Micronutrients|micronutrients|mesh-ancestor
24933308|NCT04072198|Antimetabolites|antimetabolites|mesh-ancestor
24530181|NCT00629278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530182|NCT00629278|Antimetabolites|antimetabolites|mesh-ancestor
24530183|NCT00629278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24530184|NCT00629278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24530185|NCT00629278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24530186|NCT00629278|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24530187|NCT00629278|Hormone Antagonists|hormone antagonists|mesh-ancestor
24530188|NCT00629278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24530189|NCT00629278|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24530190|NCT00629278|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24530191|NCT00629278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24530192|NCT00629278|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24530193|NCT00629304|Antithrombin III|antithrombin iii|mesh-list
24530194|NCT00629304|Antithrombins|antithrombins|mesh-list
24530195|NCT00629304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24530196|NCT00629304|Protease Inhibitors|protease inhibitors|mesh-ancestor
24530197|NCT00629304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530198|NCT00629304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530199|NCT00629304|Anticoagulants|anticoagulants|mesh-ancestor
24530200|NCT00629317|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24530201|NCT00629317|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
24530221|NCT00629447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530222|NCT00629473|Dexamethasone|dexamethasone|mesh-list
24530223|NCT00629473|Proteasome Inhibitors|proteasome inhibitors|mesh-list
24530262|NCT00629616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530263|NCT00629642|Solifenacin Succinate|solifenacin succinate|mesh-list
24530265|NCT00629642|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24530266|NCT00629642|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24530267|NCT00629642|Cholinergic Agents|cholinergic agents|mesh-ancestor
24530268|NCT00629642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24933309|NCT04072198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24933310|NCT04072198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24933311|NCT04072198|Immunologic Factors|immunologic factors|mesh-ancestor
25275602|NCT02370862|Cholinergic Agents|cholinergic agents|mesh-ancestor
24933312|NCT04071756|Tazarotene|tazarotene|mesh-list
24933313|NCT04071756|Dermatologic Agents|dermatologic agents|mesh-ancestor
24933314|NCT04071756|Keratolytic Agents|keratolytic agents|mesh-ancestor
24933315|NCT04072328|Midazolam|midazolam|mesh-list
24933316|NCT04072328|Propofol|propofol|mesh-list
24933317|NCT04072328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24501596|NCT00529750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501597|NCT00529750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24501598|NCT00529750|Sympatholytics|sympatholytics|mesh-ancestor
24501599|NCT00529750|Autonomic Agents|autonomic agents|mesh-ancestor
24933368|NCT04071574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24933373|NCT04071574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24933374|NCT04071574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24933375|NCT04071574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24933377|NCT04071574|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24933378|NCT04071574|Fertility Agents|fertility agents|mesh-ancestor
24933379|NCT04071574|Hormone Antagonists|hormone antagonists|mesh-ancestor
24933380|NCT04071262|Prednisolone|prednisolone|mesh-list
24933381|NCT04071262|Abiraterone Acetate|abiraterone acetate|mesh-list
24933382|NCT04071262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24933383|NCT04071262|Glucocorticoids|glucocorticoids|mesh-ancestor
24933384|NCT04071262|Hormones|hormones|mesh-ancestor
24933385|NCT04071262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24933386|NCT04071262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933387|NCT04071262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24933388|NCT04071262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24933403|NCT04071106|Petrolatum|petrolatum|mesh-list
24933404|NCT04071106|Turmeric extract|turmeric extract|mesh-list
24933405|NCT04071106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24933406|NCT04071106|Glucocorticoids|glucocorticoids|mesh-ancestor
24933407|NCT04071106|Hormones|hormones|mesh-ancestor
24933408|NCT04071106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24933409|NCT04071106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933410|NCT04071106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24933411|NCT04071106|Respiratory System Agents|respiratory system agents|mesh-ancestor
24933412|NCT04071106|Dermatologic Agents|dermatologic agents|mesh-ancestor
24933413|NCT04071106|Antioxidants|antioxidants|mesh-ancestor
24933414|NCT04071106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933416|NCT04071106|Emollients|emollients|mesh-ancestor
24933434|NCT04070690|Dialysis Solutions|dialysis solutions|mesh-list
24933435|NCT04070690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24933436|NCT04070729|Hyaluronic Acid|hyaluronic acid|mesh-list
24933440|NCT04070729|Viscosupplements|viscosupplements|mesh-ancestor
25000721|NCT03777319|Diuretics|diuretics|mesh-ancestor
24625289|NCT01081535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24625290|NCT01081535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24625291|NCT01081535|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24625292|NCT01081535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625293|NCT01081535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625294|NCT01081548|Atorvastatin|atorvastatin|mesh-list
24933443|NCT04070495|Rifampin|rifampin|mesh-list
24933470|NCT04070391|Vitamin B Complex|vitamin b complex|mesh-ancestor
24933471|NCT04070482|Tenofovir|tenofovir|mesh-list
24933472|NCT04070482|Antiviral Agents|antiviral agents|mesh-ancestor
24933473|NCT04070482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24933474|NCT04070482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24933475|NCT04070482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24933476|NCT04070482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933477|NCT04070482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933478|NCT04070482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24933479|NCT04070482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24933480|NCT04070079|Tenofovir|tenofovir|mesh-list
24933481|NCT04070079|Antiviral Agents|antiviral agents|mesh-ancestor
24933482|NCT04070079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24933483|NCT04070079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24933484|NCT04070079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24933485|NCT04070079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933486|NCT04070079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933487|NCT04070079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25209412|NCT02703363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209413|NCT02703363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25209414|NCT02703363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25209415|NCT02703376|Prednisone|prednisone|mesh-list
25209416|NCT02703376|Prednisolone|prednisolone|mesh-list
24501990|NCT00531908|Diuretics|diuretics|mesh-ancestor
24501991|NCT00531908|Natriuretic Agents|natriuretic agents|mesh-ancestor
24501992|NCT00531908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933494|NCT04070001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24933495|NCT04070001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933497|NCT04070001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24933498|NCT04070001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24933499|NCT04070001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24938653|NCT04017377|Paclitaxel|paclitaxel|mesh-list
24933517|NCT04069845|Doxorubicin|doxorubicin|mesh-list
24933518|NCT04069845|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24933519|NCT04069845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24933520|NCT04069845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24933521|NCT04069845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24933522|NCT04069845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24933523|NCT04069845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536855|NCT00652704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24530278|NCT00629681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24536880|NCT00652808|Naproxen|naproxen|mesh-list
24530297|NCT00629720|Urological Agents|urological agents|mesh-ancestor
24530298|NCT00629811|Mitogens|mitogens|mesh-list
24530311|NCT00629824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530312|NCT00629837|Factor VIII|factor viii|mesh-list
24530313|NCT00629837|Coagulants|coagulants|mesh-ancestor
24530314|NCT00629863|Fluorouracil|fluorouracil|mesh-list
24530315|NCT00629863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530316|NCT00629863|Antimetabolites|antimetabolites|mesh-ancestor
24530337|NCT00629889|Nootropic Agents|nootropic agents|mesh-ancestor
24530338|NCT00629928|Esomeprazole|esomeprazole|mesh-list
24530339|NCT00629928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24933600|NCT04069065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933601|NCT04069065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24933602|NCT04069065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933603|NCT04069065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410527|NCT00185835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25209417|NCT02703376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25048952|NCT00656357|Anesthetics|anesthetics|mesh-ancestor
25209418|NCT02703376|Glucocorticoids|glucocorticoids|mesh-ancestor
25209419|NCT02703376|Hormones|hormones|mesh-ancestor
25209420|NCT02703376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25209421|NCT02703376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209422|NCT02703376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25209423|NCT02703376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24502147|NCT05319301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502148|NCT05319301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24933625|NCT04068766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24933626|NCT04068974|Apatinib|apatinib|mesh-list
24933704|NCT04067986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933706|NCT04067791|Antioxidants|antioxidants|mesh-ancestor
24933750|NCT04067531|Clindamycin phosphate|clindamycin phosphate|mesh-list
24933751|NCT04067531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24933752|NCT04067531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24933753|NCT04067531|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24933754|NCT04067531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933755|NCT04067531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933768|NCT04067505|Nadroparin|nadroparin|mesh-list
24933769|NCT04067505|Warfarin|warfarin|mesh-list
24933770|NCT04067505|Rivaroxaban|rivaroxaban|mesh-list
24933771|NCT04067505|Anticoagulants|anticoagulants|mesh-ancestor
24933772|NCT04067505|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24933773|NCT04067505|Antithrombins|antithrombins|mesh-ancestor
24933774|NCT04067505|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24933775|NCT04067505|Protease Inhibitors|protease inhibitors|mesh-ancestor
24933776|NCT04067505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933777|NCT04067505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933778|NCT04067505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24933779|NCT04067505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24933793|NCT04067024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24933795|NCT04067102|Paclitaxel|paclitaxel|mesh-list
24933813|NCT04067102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24933814|NCT04067102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24933815|NCT04067102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24933816|NCT04067102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933817|NCT04067037|Vincristine|vincristine|mesh-list
24933818|NCT04067037|Epirubicin|epirubicin|mesh-list
24502150|NCT05319249|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24502151|NCT05319249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24502152|NCT05319249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502153|NCT05319249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24502154|NCT05318794|Doxorubicin|doxorubicin|mesh-list
24525158|NCT03874715|Insulin|insulin|mesh-list
24502309|NCT05302388|Protective Agents|protective agents|mesh-ancestor
24502310|NCT05302388|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24933819|NCT04067037|Dacarbazine|dacarbazine|mesh-list
24933820|NCT04067037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24933821|NCT04067037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24933822|NCT04067037|Tubulin Modulators|tubulin modulators|mesh-ancestor
24933823|NCT04067037|Antimitotic Agents|antimitotic agents|mesh-ancestor
24933824|NCT04067037|Mitosis Modulators|mitosis modulators|mesh-ancestor
24933825|NCT04067037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933826|NCT04067037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24933827|NCT04067037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24933828|NCT04067037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24933829|NCT04067037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933830|NCT04067037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25256023|NCT02485106|Rifaximin|rifaximin|mesh-list
25256024|NCT02485106|Pentoxifylline|pentoxifylline|mesh-list
25256025|NCT02485106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25256026|NCT02485106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25256027|NCT02485106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25256028|NCT02485106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25256029|NCT02485106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530350|NCT00629967|Antiviral Agents|antiviral agents|mesh-ancestor
24933846|NCT04066790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24933902|NCT04066257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24933903|NCT04066257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933905|NCT04066231|Erythromycin Estolate|erythromycin estolate|mesh-list
24933906|NCT04066231|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25272598|NCT02391142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25272599|NCT02391142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272600|NCT02391142|Sensory System Agents|sensory system agents|mesh-ancestor
25272601|NCT02391142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25272602|NCT02391142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25272603|NCT02391142|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25272604|NCT02391142|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25272605|NCT02391142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25272606|NCT02391142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272607|NCT02390921|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25272608|NCT02390921|Hematinics|hematinics|mesh-ancestor
25272609|NCT02390882|Tamsulosin|tamsulosin|mesh-list
25272610|NCT02390882|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24502311|NCT05302388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24502349|NCT05238233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24502756|NCT04447716|Piperidine|piperidine|mesh-list
24502757|NCT04447716|Antibodies|antibodies|mesh-list
24502758|NCT04447716|Immunoglobulins|immunoglobulins|mesh-list
24502759|NCT04447716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24502760|NCT04447716|Immunologic Factors|immunologic factors|mesh-ancestor
24502761|NCT04447716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502762|NCT04447716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24428683|NCT00240942|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24503576|NCT00532285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503577|NCT00532285|Tubulin Modulators|tubulin modulators|mesh-ancestor
24503578|NCT00532285|Antimitotic Agents|antimitotic agents|mesh-ancestor
24503579|NCT00532285|Mitosis Modulators|mitosis modulators|mesh-ancestor
24503580|NCT00532285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503581|NCT00532285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24933907|NCT04066231|Erythromycin stearate|erythromycin stearate|mesh-list
24933908|NCT04066231|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
24933909|NCT04066231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24933910|NCT04066231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25209443|NCT02703415|Tramadol|tramadol|mesh-list
25209444|NCT02703415|Bupivacaine|bupivacaine|mesh-list
25209445|NCT02703415|Anesthetics, Local|anesthetics, local|mesh-ancestor
25209446|NCT02703415|Anesthetics|anesthetics|mesh-ancestor
25209447|NCT02703415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25209448|NCT02703415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209449|NCT02703415|Sensory System Agents|sensory system agents|mesh-ancestor
25209450|NCT02703415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25209451|NCT02703415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25209452|NCT02703415|Narcotics|narcotics|mesh-ancestor
25209453|NCT02703415|Analgesics|analgesics|mesh-ancestor
25209454|NCT02703181|Diketopiperazines|diketopiperazines|mesh-list
25209455|NCT02703181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25209456|NCT02703181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25209457|NCT02703233|Nitrous Oxide|nitrous oxide|mesh-list
25209458|NCT02703233|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25209459|NCT02703233|Anesthetics, General|anesthetics, general|mesh-ancestor
25209460|NCT02703233|Anesthetics|anesthetics|mesh-ancestor
25209461|NCT02703233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25676973|NCT01806571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676974|NCT01806571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25676975|NCT01806571|Antiviral Agents|antiviral agents|mesh-ancestor
25676976|NCT01806571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25676977|NCT01806571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25676978|NCT01806571|Immunologic Factors|immunologic factors|mesh-ancestor
25676979|NCT01806571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209462|NCT02703233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011855|NCT03424525|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25011856|NCT03424525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25256053|NCT02484677|Docetaxel|docetaxel|mesh-list
25209463|NCT02703233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25209464|NCT02703233|Analgesics|analgesics|mesh-ancestor
25209465|NCT02703233|Sensory System Agents|sensory system agents|mesh-ancestor
25209466|NCT02703233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25209467|NCT02703272|Dexamethasone|dexamethasone|mesh-list
25209468|NCT02703272|Rituximab|rituximab|mesh-list
25209469|NCT02703272|Carboplatin|carboplatin|mesh-list
25209470|NCT02703272|Etoposide|etoposide|mesh-list
25209471|NCT02703272|Vincristine|vincristine|mesh-list
25209472|NCT02703272|Ifosfamide|ifosfamide|mesh-list
25209473|NCT02703272|Idarubicin|idarubicin|mesh-list
25209474|NCT02703272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25209475|NCT02703272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25209476|NCT02703272|Immunologic Factors|immunologic factors|mesh-ancestor
25209477|NCT02703272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209478|NCT02703272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25209479|NCT02703272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25209480|NCT02703272|Antiemetics|antiemetics|mesh-ancestor
24503584|NCT00532285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24503585|NCT00532285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503586|NCT00532285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24503587|NCT00532285|Immunologic Factors|immunologic factors|mesh-ancestor
24503588|NCT00532285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503589|NCT00532324|Chlorhexidine|chlorhexidine|mesh-list
24503590|NCT00532324|Mupirocin|mupirocin|mesh-list
24503591|NCT00532324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24503592|NCT00532324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24503593|NCT00532324|Disinfectants|disinfectants|mesh-ancestor
24503594|NCT00532324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24503599|NCT00532350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24457644|NCT00334854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24457645|NCT00334854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504035|NCT00533858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24504175|NCT00534391|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24504176|NCT00534391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504177|NCT00534391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504504|NCT00536653|Androgen Antagonists|androgen antagonists|mesh-ancestor
24504505|NCT00536653|Hormone Antagonists|hormone antagonists|mesh-ancestor
24504506|NCT00536653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24504915|NCT00538525|Mitosis Modulators|mitosis modulators|mesh-ancestor
24504916|NCT00538525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933911|NCT04066231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24933912|NCT04066231|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24933913|NCT04066231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933914|NCT04066231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933955|NCT04065919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24933956|NCT04065919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24933957|NCT04065919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24933958|NCT04065919|Adrenergic Agents|adrenergic agents|mesh-ancestor
25209481|NCT02703272|Autonomic Agents|autonomic agents|mesh-ancestor
25209482|NCT02703272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25209483|NCT02703272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25209484|NCT02703272|Glucocorticoids|glucocorticoids|mesh-ancestor
25209486|NCT02703272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25209487|NCT02703272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25209488|NCT02703272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25209489|NCT02703272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25209490|NCT02703272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25209491|NCT02703272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25209492|NCT02703272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209493|NCT02703272|Tubulin Modulators|tubulin modulators|mesh-ancestor
25209494|NCT02703272|Antimitotic Agents|antimitotic agents|mesh-ancestor
25209495|NCT02703272|Mitosis Modulators|mitosis modulators|mesh-ancestor
25209496|NCT02703272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25209497|NCT02703272|Alkylating Agents|alkylating agents|mesh-ancestor
25209498|NCT02703272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25676980|NCT01806571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25676981|NCT01806571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25676982|NCT01806571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25676983|NCT01806571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011950|NCT02872025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25011951|NCT02872025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011955|NCT02767804|Crizotinib|crizotinib|mesh-list
25011956|NCT02767804|Ensartinib|ensartinib|mesh-list
25209499|NCT02703194|Prednisone|prednisone|mesh-list
25209500|NCT02703194|Prednisolone|prednisolone|mesh-list
25209501|NCT02703194|Leflunomide|leflunomide|mesh-list
25209502|NCT02703194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25209503|NCT02703194|Glucocorticoids|glucocorticoids|mesh-ancestor
25209504|NCT02703194|Hormones|hormones|mesh-ancestor
25209505|NCT02703194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25209506|NCT02703194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209507|NCT02703194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25209508|NCT02703194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25209509|NCT02703194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504917|NCT00538525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24504918|NCT00538525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24504919|NCT00538525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24505307|NCT00540826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505309|NCT00540826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24505486|NCT00541177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505487|NCT00541177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24505488|NCT00541177|Respiratory System Agents|respiratory system agents|mesh-ancestor
24505489|NCT00541177|Mydriatics|mydriatics|mesh-ancestor
24505490|NCT00541177|Parasympatholytics|parasympatholytics|mesh-ancestor
24933959|NCT04065919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24933960|NCT04065919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933966|NCT04065919|Mydriatics|mydriatics|mesh-ancestor
24530481|NCT00630513|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24934038|NCT04064619|Solifenacin Succinate|solifenacin succinate|mesh-list
24934039|NCT04064619|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24934040|NCT04064619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24934041|NCT04064619|Cholinergic Agents|cholinergic agents|mesh-ancestor
24934042|NCT04064619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24934043|NCT04064619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934044|NCT04064619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934045|NCT04064619|Urological Agents|urological agents|mesh-ancestor
24934047|NCT04064632|Cobicistat|cobicistat|mesh-list
24934048|NCT04064632|Rilpivirine|rilpivirine|mesh-list
24934049|NCT04064632|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
24934050|NCT04064632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24934051|NCT04064632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24934052|NCT04064632|Protease Inhibitors|protease inhibitors|mesh-ancestor
24934053|NCT04064632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24934054|NCT04064632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625343|NCT01081730|Ustekinumab|ustekinumab|mesh-list
24934067|NCT04064125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24934068|NCT04064125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24934069|NCT04063839|Sofosbuvir|sofosbuvir|mesh-list
24934070|NCT04063839|Grazoprevir|grazoprevir|mesh-list
24934071|NCT04063839|Ledipasvir|ledipasvir|mesh-list
24934072|NCT04063839|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
24934073|NCT04063839|Antiviral Agents|antiviral agents|mesh-ancestor
24934074|NCT04063839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24934075|NCT04064138|Anesthetics|anesthetics|mesh-list
24934076|NCT04064138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24934077|NCT04064138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934150|NCT04063449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25676984|NCT01806584|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
25676985|NCT01806584|Hemostatics|hemostatics|mesh-ancestor
25676986|NCT01806584|Coagulants|coagulants|mesh-ancestor
25676987|NCT01806597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25676988|NCT01806597|Immunologic Factors|immunologic factors|mesh-ancestor
25676989|NCT01806597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676990|NCT01806623|Fluconazole|fluconazole|mesh-list
25676991|NCT01806623|Antifungal Agents|antifungal agents|mesh-ancestor
25676992|NCT01806623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24934152|NCT04063449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934153|NCT04063449|Growth Inhibitors|growth inhibitors|mesh-ancestor
24934154|NCT04063449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934155|NCT04063449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934156|NCT04063358|Ranibizumab|ranibizumab|mesh-list
24934157|NCT04063358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24934158|NCT04063358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24934159|NCT04063358|Growth Substances|growth substances|mesh-ancestor
24934160|NCT04063358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934209|NCT04062890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934210|NCT04063033|Ferric gluconate|ferric gluconate|mesh-list
24934211|NCT04063033|Hematinics|hematinics|mesh-ancestor
25209510|NCT02703194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209511|NCT02703194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25209512|NCT02703194|Immunologic Factors|immunologic factors|mesh-ancestor
25209513|NCT02702960|Mycophenolic Acid|mycophenolic acid|mesh-list
25209514|NCT02702960|Prednisone|prednisone|mesh-list
25209515|NCT02702960|Cyclophosphamide|cyclophosphamide|mesh-list
25209516|NCT02702960|Fludarabine|fludarabine|mesh-list
25209517|NCT02702960|Tacrolimus|tacrolimus|mesh-list
25209518|NCT02702960|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25209519|NCT02702960|Mesna|mesna|mesh-list
25209520|NCT02702960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25209521|NCT02702960|Immunologic Factors|immunologic factors|mesh-ancestor
24505491|NCT00541177|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24505492|NCT00541177|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24505493|NCT00541177|Cholinergic Agents|cholinergic agents|mesh-ancestor
24505494|NCT00541177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24505495|NCT00541177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505496|NCT00541216|Ephedrine|ephedrine|mesh-list
24505497|NCT00541216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24457646|NCT00334854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24457647|NCT00334854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24934218|NCT04062656|Docetaxel|docetaxel|mesh-list
24934219|NCT04062656|Fluorouracil|fluorouracil|mesh-list
24934220|NCT04062656|Oxaliplatin|oxaliplatin|mesh-list
24934221|NCT04062656|Nivolumab|nivolumab|mesh-list
24934222|NCT04062656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934223|NCT04062656|Tubulin Modulators|tubulin modulators|mesh-ancestor
24934224|NCT04062656|Antimitotic Agents|antimitotic agents|mesh-ancestor
24934225|NCT04062656|Mitosis Modulators|mitosis modulators|mesh-ancestor
24934226|NCT04062656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934227|NCT04062656|Antimetabolites|antimetabolites|mesh-ancestor
24934228|NCT04062656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24934229|NCT04062656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24934230|NCT04062656|Immunologic Factors|immunologic factors|mesh-ancestor
24934231|NCT04062656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934259|NCT04062565|Enzyme Activators|enzyme activators|mesh-ancestor
24934260|NCT04062565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934261|NCT04062201|Levofloxacin|levofloxacin|mesh-list
24934262|NCT04062201|Ofloxacin|ofloxacin|mesh-list
24934263|NCT04062201|Isoniazid|isoniazid|mesh-list
24934264|NCT04062201|Linezolid|linezolid|mesh-list
24934265|NCT04062201|Pyrazinamide|pyrazinamide|mesh-list
24934266|NCT04062201|Ethambutol|ethambutol|mesh-list
24934267|NCT04062201|Bedaquiline|bedaquiline|mesh-list
24934268|NCT04062201|Clofazimine|clofazimine|mesh-list
24934269|NCT04062201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25209522|NCT02702960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209523|NCT02702960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25209524|NCT02702960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25209525|NCT02702960|Alkylating Agents|alkylating agents|mesh-ancestor
25209526|NCT02702960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209527|NCT02702960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25209528|NCT02702960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25209529|NCT02702960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25209530|NCT02702960|Glucocorticoids|glucocorticoids|mesh-ancestor
25209531|NCT02702960|Hormones|hormones|mesh-ancestor
25209532|NCT02702960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25209533|NCT02702960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25209534|NCT02702960|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25209535|NCT02702960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25209536|NCT02702960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25209537|NCT02702960|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25209539|NCT02702960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25209540|NCT02702960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25209541|NCT02702960|Protective Agents|protective agents|mesh-ancestor
25209542|NCT02703051|Lenograstim|lenograstim|mesh-list
25209543|NCT02703051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24505515|NCT00541281|Glucocorticoids|glucocorticoids|mesh-ancestor
24505516|NCT00541281|Hormones|hormones|mesh-ancestor
24505517|NCT00541281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24505518|NCT00541281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505519|NCT00541281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24505520|NCT00541281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24505521|NCT00541281|Alkylating Agents|alkylating agents|mesh-ancestor
24505522|NCT00541320|2-(5-chlorothien-2-yl)-N-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide|2-(5-chlorothien-2-yl)-n-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide|mesh-list
24505523|NCT00541320|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24505524|NCT00541320|Antithrombins|antithrombins|mesh-ancestor
24505525|NCT00541320|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24505531|NCT00541333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24505532|NCT00541333|Immunologic Factors|immunologic factors|mesh-ancestor
24505533|NCT00541333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505534|NCT00541333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24505535|NCT00541333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24505538|NCT00541359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505539|NCT00541359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24505540|NCT00541359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24505541|NCT00541359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505542|NCT00541359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505543|NCT00541372|Insulin|insulin|mesh-list
24505544|NCT00541372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24525440|NCT03341962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525441|NCT03333408|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24525442|NCT03333408|Clindamycin|clindamycin|mesh-list
24525443|NCT03333408|Clindamycin palmitate|clindamycin palmitate|mesh-list
25209544|NCT02703051|Immunologic Factors|immunologic factors|mesh-ancestor
25209545|NCT02703051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209546|NCT02703090|Remifentanil|remifentanil|mesh-list
25209547|NCT02703090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25209548|NCT02703090|Narcotics|narcotics|mesh-ancestor
25209549|NCT02703090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25209550|NCT02703090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209551|NCT02703090|Analgesics|analgesics|mesh-ancestor
25209552|NCT02703090|Sensory System Agents|sensory system agents|mesh-ancestor
24815529|NCT02070718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25209553|NCT02703090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25209554|NCT02702843|Xenon|xenon|mesh-list
25209555|NCT02702843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25209556|NCT02702843|Anesthetics, General|anesthetics, general|mesh-ancestor
25209557|NCT02702843|Anesthetics|anesthetics|mesh-ancestor
25209558|NCT02702843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25209559|NCT02702843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209560|NCT02702817|Naproxen|naproxen|mesh-list
25209561|NCT02702817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25209562|NCT02702817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25209563|NCT02702817|Analgesics|analgesics|mesh-ancestor
25209564|NCT02702817|Sensory System Agents|sensory system agents|mesh-ancestor
25209565|NCT02702817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25209566|NCT02702817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209567|NCT02702817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25209568|NCT02702817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25209569|NCT02702817|Gout Suppressants|gout suppressants|mesh-ancestor
25209570|NCT02702817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25209571|NCT02702817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25209572|NCT02702817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209573|NCT02702700|Verteporfin|verteporfin|mesh-list
25209574|NCT02702700|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25209575|NCT02702700|Dermatologic Agents|dermatologic agents|mesh-ancestor
25209576|NCT02702674|Propranolol|propranolol|mesh-list
25209577|NCT02702674|Oxytocin|oxytocin|mesh-list
25209578|NCT02702674|Oxytocics|oxytocics|mesh-ancestor
25209579|NCT02702674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25209580|NCT02702674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209581|NCT02702674|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25209582|NCT02702674|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25209583|NCT02702674|Adrenergic Agents|adrenergic agents|mesh-ancestor
24505805|NCT00542555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25012181|NCT01503515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25012182|NCT01503515|Hormone Antagonists|hormone antagonists|mesh-ancestor
25012204|NCT01180374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012205|NCT01180374|Hormones|hormones|mesh-ancestor
25012206|NCT01180374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25012207|NCT00357565|Cyclosporine|cyclosporine|mesh-list
25012208|NCT00357565|Mycophenolic Acid|mycophenolic acid|mesh-list
25012209|NCT00357565|Fludarabine|fludarabine|mesh-list
25256169|NCT02483793|Parasympatholytics|parasympatholytics|mesh-ancestor
25256170|NCT02483793|Autonomic Agents|autonomic agents|mesh-ancestor
25256171|NCT02483793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25256172|NCT02483793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25256173|NCT02483793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24505806|NCT00542555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505807|NCT00542555|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24505808|NCT00542568|Epoetin Alfa|epoetin alfa|mesh-list
24505823|NCT00542711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24525520|NCT03193216|Antacids|antacids|mesh-ancestor
24505824|NCT00542711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505825|NCT00542711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24505827|NCT00542711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505859|NCT00542893|Dacarbazine|dacarbazine|mesh-list
24505860|NCT00542893|Oblimersen|oblimersen|mesh-list
24505861|NCT00542893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24505862|NCT00542893|Alkylating Agents|alkylating agents|mesh-ancestor
24505863|NCT00542893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505864|NCT00542893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505865|NCT00542984|Teriparatide|teriparatide|mesh-list
24505866|NCT00542984|Calcitonin|calcitonin|mesh-list
24505867|NCT00542984|Salmon calcitonin|salmon calcitonin|mesh-list
24505868|NCT00542984|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
24505869|NCT00542984|Katacalcin|katacalcin|mesh-list
24505902|NCT00543114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24505903|NCT00543114|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24505904|NCT00543114|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24505905|NCT00543114|Growth Substances|growth substances|mesh-ancestor
24505906|NCT00543114|Growth Inhibitors|growth inhibitors|mesh-ancestor
24505907|NCT00543166|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24505908|NCT00543166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24505909|NCT00543166|Immunologic Factors|immunologic factors|mesh-ancestor
24505910|NCT00543166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209584|NCT02702674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25209585|NCT02702674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209586|NCT02702674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25209587|NCT02702674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25209588|NCT02702674|Vasodilator Agents|vasodilator agents|mesh-ancestor
25209589|NCT02702739|Ribavirin|ribavirin|mesh-list
25209590|NCT02702739|Sofosbuvir|sofosbuvir|mesh-list
25209591|NCT02702739|Simeprevir|simeprevir|mesh-list
25209592|NCT02702739|Antimetabolites|antimetabolites|mesh-ancestor
25209593|NCT02702739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209594|NCT02702739|Antiviral Agents|antiviral agents|mesh-ancestor
25209595|NCT02702739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25209596|NCT02702739|Protease Inhibitors|protease inhibitors|mesh-ancestor
25209597|NCT02702739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25209598|NCT02702622|Provitamins|provitamins|mesh-list
25209599|NCT02702622|Beta Carotene|beta carotene|mesh-list
25209600|NCT02702622|Vitamins|vitamins|mesh-ancestor
25209601|NCT02702622|Micronutrients|micronutrients|mesh-ancestor
25209602|NCT02702622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25676993|NCT01806623|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25676994|NCT01806623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25676995|NCT01806623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25676996|NCT01806623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25676997|NCT01806623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25676998|NCT01806623|Hormone Antagonists|hormone antagonists|mesh-ancestor
25676999|NCT01806623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25677000|NCT01806623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677001|NCT01806623|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25677002|NCT01806623|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25677003|NCT01806662|Ustekinumab|ustekinumab|mesh-list
25209603|NCT02702661|Anesthetics|anesthetics|mesh-list
25209604|NCT02702661|Levobupivacaine|levobupivacaine|mesh-list
25209605|NCT02702661|Anesthetics, Local|anesthetics, local|mesh-list
25209606|NCT02702661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25209607|NCT02702661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209608|NCT02702661|Sensory System Agents|sensory system agents|mesh-ancestor
25209609|NCT02702661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25209610|NCT02702778|Prednisone|prednisone|mesh-list
25209611|NCT02702778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25209612|NCT02702778|Glucocorticoids|glucocorticoids|mesh-ancestor
25209613|NCT02702778|Hormones|hormones|mesh-ancestor
25209614|NCT02702778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25209615|NCT02702778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209616|NCT02702778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25209617|NCT02702778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25209618|NCT02702492|Niacin|niacin|mesh-list
25209619|NCT02702492|Nivolumab|nivolumab|mesh-list
25209620|NCT02702492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25209621|NCT02702492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25209622|NCT02702492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25209623|NCT02702492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506071|NCT00544011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24506072|NCT00544011|Growth Substances|growth substances|mesh-ancestor
24506073|NCT00544011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506074|NCT00544011|Growth Inhibitors|growth inhibitors|mesh-ancestor
24506075|NCT00544011|Antimetabolites|antimetabolites|mesh-ancestor
24506076|NCT00544011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506077|NCT00544011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24506078|NCT00544011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24506079|NCT00544011|Immunologic Factors|immunologic factors|mesh-ancestor
24506080|NCT00544011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24934270|NCT04062201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24934271|NCT04062201|Renal Agents|renal agents|mesh-ancestor
24934272|NCT04062201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24934273|NCT04062201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24934281|NCT04062201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24934283|NCT04062201|Antimetabolites|antimetabolites|mesh-ancestor
24934284|NCT04062201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24934285|NCT04062201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24644662|NCT01192308|Hormone Antagonists|hormone antagonists|mesh-ancestor
24934286|NCT04062201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24934293|NCT04062370|Growth Inhibitors|growth inhibitors|mesh-ancestor
24934294|NCT04062370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934295|NCT04062357|Lidocaine|lidocaine|mesh-list
24934296|NCT04062357|Anesthetics, Local|anesthetics, local|mesh-ancestor
24934297|NCT04062357|Anesthetics|anesthetics|mesh-ancestor
24815588|NCT02071303|Tramadol|tramadol|mesh-list
24934298|NCT04062357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24411139|NCT00187941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934299|NCT04062357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934300|NCT04062357|Sensory System Agents|sensory system agents|mesh-ancestor
24934301|NCT04062357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24934302|NCT04062357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24934303|NCT04062357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24934304|NCT04062357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24934305|NCT04062357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24934306|NCT04062357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934307|NCT04061824|Olmesartan|olmesartan|mesh-list
24934308|NCT04061824|Angiotensin II|angiotensin ii|mesh-list
24934309|NCT04061824|Giapreza|giapreza|mesh-list
24934310|NCT04061824|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24934311|NCT04061824|Angiotensinogen|angiotensinogen|mesh-list
24934312|NCT04061824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24934313|NCT04061824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24934314|NCT04061824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24934315|NCT04061824|Antimetabolites|antimetabolites|mesh-ancestor
24934316|NCT04061824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934317|NCT04061824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24934318|NCT04061824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24934319|NCT04061824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256244|NCT02483624|Protective Agents|protective agents|mesh-ancestor
24934320|NCT04061824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24934322|NCT04061824|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24934356|NCT04062019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934357|NCT04062019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24934358|NCT04062019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25209624|NCT02702492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25209625|NCT02702492|Antimetabolites|antimetabolites|mesh-ancestor
25209626|NCT02702492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25209627|NCT02702492|Vasodilator Agents|vasodilator agents|mesh-ancestor
25209628|NCT02702492|Vitamin B Complex|vitamin b complex|mesh-ancestor
25209629|NCT02702492|Vitamins|vitamins|mesh-ancestor
25209630|NCT02702492|Micronutrients|micronutrients|mesh-ancestor
25209631|NCT02702492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209632|NCT02702206|Triamcinolone|triamcinolone|mesh-list
25209633|NCT02702206|Hyaluronic Acid|hyaluronic acid|mesh-list
25209634|NCT02702206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25209635|NCT02702206|Glucocorticoids|glucocorticoids|mesh-ancestor
25209636|NCT02702206|Hormones|hormones|mesh-ancestor
24506195|NCT00544232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24506197|NCT00544232|Dermatologic Agents|dermatologic agents|mesh-ancestor
24506198|NCT00544232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506199|NCT00544232|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24506200|NCT00544232|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24506201|NCT00544232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24506202|NCT00544232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24506203|NCT00544232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24506204|NCT00544232|Hematinics|hematinics|mesh-ancestor
24506205|NCT00544284|Temozolomide|temozolomide|mesh-list
24506207|NCT00544284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24934360|NCT04062019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24934361|NCT04062045|Ropivacaine|ropivacaine|mesh-list
24934362|NCT04062045|Anesthetics, Local|anesthetics, local|mesh-ancestor
24934363|NCT04062045|Anesthetics|anesthetics|mesh-ancestor
24934364|NCT04062045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24934365|NCT04062045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510772|NCT00565591|Tocolytic Agents|tocolytic agents|mesh-ancestor
24510773|NCT00565591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24530505|NCT00630695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530506|NCT00630708|Losartan|losartan|mesh-list
24934426|NCT04061265|Lidocaine|lidocaine|mesh-list
24934449|NCT04061265|Mydriatics|mydriatics|mesh-ancestor
24934450|NCT04061265|Sympathomimetics|sympathomimetics|mesh-ancestor
24934451|NCT04061265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24934452|NCT04061538|Zinc|zinc|mesh-list
24934453|NCT04061538|Zinc Sulfate|zinc sulfate|mesh-list
24934454|NCT04061538|Trace Elements|trace elements|mesh-ancestor
24934455|NCT04061538|Micronutrients|micronutrients|mesh-ancestor
24934456|NCT04061538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934457|NCT04061538|Astringents|astringents|mesh-ancestor
24530587|NCT00631124|Estradiol|estradiol|mesh-list
24530588|NCT00631124|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24530589|NCT00631124|Estrogens|estrogens|mesh-ancestor
24530590|NCT00631124|Hormones|hormones|mesh-ancestor
24530591|NCT00631124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24530592|NCT00631124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530593|NCT00631124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24530594|NCT00631124|Contraceptive Agents|contraceptive agents|mesh-ancestor
24530595|NCT00631124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24530596|NCT00631124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25209637|NCT02702206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25209638|NCT02702206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209639|NCT02702206|Immunologic Factors|immunologic factors|mesh-ancestor
25209640|NCT02702206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25209641|NCT02702206|Viscosupplements|viscosupplements|mesh-ancestor
25209642|NCT02702206|Protective Agents|protective agents|mesh-ancestor
25209643|NCT02702323|Apatinib|apatinib|mesh-list
25209644|NCT02702323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25209645|NCT02702323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25209646|NCT02702323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25209647|NCT02702323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209648|NCT02702349|Penicillins|penicillins|mesh-list
25209649|NCT02702349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25677004|NCT01806662|Dermatologic Agents|dermatologic agents|mesh-ancestor
25209650|NCT02702349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25209651|NCT02702076|Apomorphine|apomorphine|mesh-list
25209652|NCT02702076|Emetics|emetics|mesh-ancestor
25209653|NCT02702076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209654|NCT02702076|Autonomic Agents|autonomic agents|mesh-ancestor
25209655|NCT02702076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24506208|NCT00544284|Alkylating Agents|alkylating agents|mesh-ancestor
24506323|NCT00544609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506325|NCT00544687|Nortriptyline|nortriptyline|mesh-list
24506326|NCT00544687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24506327|NCT00544687|Dermatologic Agents|dermatologic agents|mesh-ancestor
24506328|NCT00544687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24506329|NCT00544687|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24506331|NCT00544687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24506336|NCT00544687|Adrenergic Agents|adrenergic agents|mesh-ancestor
24506337|NCT00544687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24506338|NCT00544687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506339|NCT00544700|Bevacizumab|bevacizumab|mesh-list
24798540|NCT01964040|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24798541|NCT01964040|Adrenergic Agents|adrenergic agents|mesh-ancestor
24798542|NCT01964040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24798544|NCT01964079|Losartan|losartan|mesh-list
24506340|NCT00544700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24506341|NCT00544700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506342|NCT00544700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24506343|NCT00544700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24506344|NCT00544700|Growth Substances|growth substances|mesh-ancestor
24506345|NCT00544700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506346|NCT00544700|Growth Inhibitors|growth inhibitors|mesh-ancestor
24506348|NCT00544791|Antioxidants|antioxidants|mesh-ancestor
24506349|NCT00544791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506419|NCT00545194|Dinoprostone|dinoprostone|mesh-list
24506576|NCT00546039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506577|NCT00546039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506578|NCT00546039|Phytoestrogens|phytoestrogens|mesh-ancestor
24506579|NCT00546039|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24506581|NCT00546039|Hormones|hormones|mesh-ancestor
24506582|NCT00546039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24506588|NCT00546065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506590|NCT00546130|Cisplatin|cisplatin|mesh-list
24506626|NCT00546234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24506627|NCT00546234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045573|NCT00944294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045574|NCT00944294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24530597|NCT00631124|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25209656|NCT02702076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25209657|NCT02702076|Dopamine Agonists|dopamine agonists|mesh-ancestor
25209658|NCT02702076|Dopamine Agents|dopamine agents|mesh-ancestor
25209659|NCT02702076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25209660|NCT02702076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209661|NCT02702128|Tranexamic Acid|tranexamic acid|mesh-list
25209662|NCT02702128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25209663|NCT02702128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25209664|NCT02702128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209665|NCT02702128|Hemostatics|hemostatics|mesh-ancestor
25209666|NCT02702128|Coagulants|coagulants|mesh-ancestor
25209667|NCT02701933|Ketamine|ketamine|mesh-list
25209668|NCT02701933|Analgesics|analgesics|mesh-ancestor
25209669|NCT02701933|Sensory System Agents|sensory system agents|mesh-ancestor
25209670|NCT02701933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25209671|NCT02701933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209672|NCT02701933|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25209673|NCT02701933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25209674|NCT02701933|Anesthetics, General|anesthetics, general|mesh-ancestor
25209675|NCT02701933|Anesthetics|anesthetics|mesh-ancestor
25209676|NCT02701933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25209677|NCT02701933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25209678|NCT02701933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25209679|NCT02701933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25209680|NCT02701933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209681|NCT02701673|Pyridoxine|pyridoxine|mesh-list
25209682|NCT02701673|Gemcitabine|gemcitabine|mesh-list
25209683|NCT02701673|Azacitidine|azacitidine|mesh-list
25209684|NCT02701673|Melphalan|melphalan|mesh-list
25209685|NCT02701673|Busulfan|busulfan|mesh-list
25209686|NCT02701673|Belinostat|belinostat|mesh-list
25209687|NCT02701673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25209688|NCT02701673|Antimetabolites|antimetabolites|mesh-ancestor
25012274|NCT00136903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25012275|NCT00136903|Antitubercular Agents|antitubercular agents|mesh-ancestor
25012276|NCT00136903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25012277|NCT00136903|Antiemetics|antiemetics|mesh-ancestor
25012278|NCT00136903|Autonomic Agents|autonomic agents|mesh-ancestor
25012279|NCT00136903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25012280|NCT00136903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25012286|NCT05218915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256315|NCT02483169|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25256316|NCT02483169|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25256317|NCT02483169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25256318|NCT02483169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25256319|NCT02483169|Antimetabolites|antimetabolites|mesh-ancestor
25256320|NCT02483169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25256321|NCT02483169|Antioxidants|antioxidants|mesh-ancestor
25256322|NCT02483156|Ribavirin|ribavirin|mesh-list
25256323|NCT02483156|Sofosbuvir|sofosbuvir|mesh-list
25209689|NCT02701673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209690|NCT02701673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25209691|NCT02701673|Antiviral Agents|antiviral agents|mesh-ancestor
25209692|NCT02701673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25045575|NCT00944294|Vasodilator Agents|vasodilator agents|mesh-ancestor
25045576|NCT00944294|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25045577|NCT00944294|Purinergic Agonists|purinergic agonists|mesh-ancestor
25045578|NCT00944294|Purinergic Agents|purinergic agents|mesh-ancestor
24506628|NCT00546286|Timolol|timolol|mesh-list
24457683|NCT00334880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457684|NCT00334880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24395120|NCT00135122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24506630|NCT00546286|Maleic acid|maleic acid|mesh-list
24506631|NCT00546286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24506661|NCT00546494|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24506662|NCT00546494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24506663|NCT00546494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24506664|NCT00546494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506665|NCT00546494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24506666|NCT00546494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506667|NCT00546494|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24506668|NCT00546494|Antidepressive Agents|antidepressive agents|mesh-ancestor
24506669|NCT00546494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24506670|NCT00546507|Celecoxib|celecoxib|mesh-list
24506705|NCT00546546|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24506706|NCT00546546|Abortifacient Agents|abortifacient agents|mesh-ancestor
24506709|NCT00546546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24506743|NCT00546741|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24506744|NCT00546741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506746|NCT00546832|Diclofenac|diclofenac|mesh-list
24525715|NCT02856594|Adrenergic Agents|adrenergic agents|mesh-ancestor
24506781|NCT00547001|Hormones|hormones|mesh-ancestor
24506782|NCT00547001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24506783|NCT00547001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530598|NCT00631124|Hormone Antagonists|hormone antagonists|mesh-ancestor
24530599|NCT00631124|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24530647|NCT00631527|Fertility Agents|fertility agents|mesh-ancestor
24530648|NCT00631527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25209693|NCT02701673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25209694|NCT02701673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25677005|NCT01806675|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25677006|NCT01806675|Glycine|glycine|mesh-list
25677007|NCT01806675|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25677008|NCT01806675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677009|NCT01806675|Glycine Agents|glycine agents|mesh-ancestor
25677010|NCT01806675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25677011|NCT01806675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677012|NCT01806740|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
25677013|NCT01806740|Chelating Agents|chelating agents|mesh-ancestor
25677014|NCT01806740|Sequestering Agents|sequestering agents|mesh-ancestor
25677015|NCT01806740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677016|NCT01806779|Bupropion|bupropion|mesh-list
25677017|NCT01806779|Nicotine|nicotine|mesh-list
25677018|NCT01806779|Varenicline|varenicline|mesh-list
25677019|NCT01806779|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25677020|NCT01806779|Autonomic Agents|autonomic agents|mesh-ancestor
25209695|NCT02701673|Immunologic Factors|immunologic factors|mesh-ancestor
25209696|NCT02701673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209697|NCT02701673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25209698|NCT02701673|Alkylating Agents|alkylating agents|mesh-ancestor
25209699|NCT02701673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25209700|NCT02701673|Vitamin B Complex|vitamin b complex|mesh-ancestor
25209701|NCT02701673|Vitamins|vitamins|mesh-ancestor
25209702|NCT02701673|Micronutrients|micronutrients|mesh-ancestor
25209703|NCT02701673|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25209704|NCT02701699|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
25209705|NCT02701699|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25209706|NCT02701699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272611|NCT02390882|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25272612|NCT02390882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25272613|NCT02390882|Adrenergic Agents|adrenergic agents|mesh-ancestor
25272614|NCT02390882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25272615|NCT02390882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272616|NCT02390882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272617|NCT02390882|Urological Agents|urological agents|mesh-ancestor
25272618|NCT02390700|Golimumab|golimumab|mesh-list
25272619|NCT02390700|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25272620|NCT02390700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25272621|NCT02390700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25272622|NCT02390700|Immunologic Factors|immunologic factors|mesh-ancestor
25272623|NCT02390700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272624|NCT02390635|Deoxyglucose|deoxyglucose|mesh-list
25272625|NCT02390635|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25272626|NCT02390635|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25272627|NCT02390635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272628|NCT02390635|Antimetabolites|antimetabolites|mesh-ancestor
25272629|NCT02390635|Antiviral Agents|antiviral agents|mesh-ancestor
25272630|NCT02390635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25272631|NCT02390674|Cyclosporine|cyclosporine|mesh-list
24506784|NCT00547053|Amiloride|amiloride|mesh-list
24506785|NCT00547053|Diuretics|diuretics|mesh-ancestor
24506786|NCT00547053|Natriuretic Agents|natriuretic agents|mesh-ancestor
24506787|NCT00547053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506788|NCT00547053|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24506865|NCT00547209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24506866|NCT00547209|Analgesics|analgesics|mesh-ancestor
24506867|NCT00547209|Sensory System Agents|sensory system agents|mesh-ancestor
24506868|NCT00547209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24506869|NCT00547287|Sildenafil Citrate|sildenafil citrate|mesh-list
24506870|NCT00547287|Tadalafil|tadalafil|mesh-list
24506871|NCT00547287|Vasodilator Agents|vasodilator agents|mesh-ancestor
24506901|NCT00547443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24506903|NCT00547495|Tadalafil|tadalafil|mesh-list
24506904|NCT00547495|Vasodilator Agents|vasodilator agents|mesh-ancestor
24506905|NCT00547495|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24506906|NCT00547495|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24506907|NCT00547495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506908|NCT00547495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506909|NCT00547495|Urological Agents|urological agents|mesh-ancestor
24457685|NCT00334880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24457686|NCT00334880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24507293|NCT00549666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25209714|NCT02701595|Penicillin G Procaine|penicillin g procaine|mesh-list
25209716|NCT02701595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25209717|NCT02701595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25209718|NCT02701595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25209720|NCT02701595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209721|NCT02701608|Levofloxacin|levofloxacin|mesh-list
25209722|NCT02701608|Ofloxacin|ofloxacin|mesh-list
25209723|NCT02701608|Rifampin|rifampin|mesh-list
25209724|NCT02701608|Fluoroquinolones|fluoroquinolones|mesh-list
25209725|NCT02701608|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25209726|NCT02701608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25209727|NCT02701608|Renal Agents|renal agents|mesh-ancestor
25209728|NCT02701608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25209729|NCT02701608|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25209730|NCT02701608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25209731|NCT02701608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25209732|NCT02701608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209733|NCT02701608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25209734|NCT02701608|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25209735|NCT02701608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25209736|NCT02701608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25209737|NCT02701608|Antitubercular Agents|antitubercular agents|mesh-ancestor
25209738|NCT02701608|Leprostatic Agents|leprostatic agents|mesh-ancestor
25209739|NCT02701608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25209740|NCT02701608|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25209741|NCT02701608|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25209742|NCT02701608|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25209743|NCT02701608|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25209744|NCT02701608|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24457692|NCT00334906|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24457693|NCT00334906|Dopamine Agents|dopamine agents|mesh-ancestor
24506913|NCT00547508|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24506966|NCT00547768|Fexofenadine|fexofenadine|mesh-list
24506967|NCT00547768|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24506968|NCT00547768|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24506969|NCT00547768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24506970|NCT00547768|Histamine Antagonists|histamine antagonists|mesh-ancestor
24506971|NCT00547768|Histamine Agents|histamine agents|mesh-ancestor
24506972|NCT00547768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24506973|NCT00547768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507011|NCT00548067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507045|NCT00548483|Dexamethasone|dexamethasone|mesh-list
24507046|NCT00548483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24507047|NCT00548483|Antiemetics|antiemetics|mesh-ancestor
24507048|NCT00548483|Autonomic Agents|autonomic agents|mesh-ancestor
24507287|NCT00549614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24507288|NCT00549666|Moxifloxacin|moxifloxacin|mesh-list
24507289|NCT00549666|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
24507290|NCT00549666|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24507291|NCT00549666|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24507292|NCT00549666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24507296|NCT00549666|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24507297|NCT00549666|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25051298|NCT00424697|GABA Agents|gaba agents|mesh-ancestor
24530649|NCT00631527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24530650|NCT00631527|Androgen Antagonists|androgen antagonists|mesh-ancestor
24530683|NCT00631722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24934520|NCT04060914|Clopidogrel|clopidogrel|mesh-list
24934521|NCT04060914|Ticagrelor|ticagrelor|mesh-list
24934522|NCT04060914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24934523|NCT04060914|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24934524|NCT04060914|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24934525|NCT04060914|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25209745|NCT02701608|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25209746|NCT02701348|Letrozole|letrozole|mesh-list
25209747|NCT02701348|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25209748|NCT02701348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25209749|NCT02701348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25209750|NCT02701348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25209751|NCT02701348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209752|NCT02701348|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25209753|NCT02701348|Hormone Antagonists|hormone antagonists|mesh-ancestor
25209754|NCT02701348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25209755|NCT02701348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209756|NCT02701478|Nitrous Oxide|nitrous oxide|mesh-list
25209757|NCT02701478|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25209758|NCT02701478|Anesthetics, General|anesthetics, general|mesh-ancestor
25209759|NCT02701478|Anesthetics|anesthetics|mesh-ancestor
25209760|NCT02701478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25209761|NCT02701478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209762|NCT02701478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25209763|NCT02701478|Analgesics|analgesics|mesh-ancestor
25209764|NCT02701478|Sensory System Agents|sensory system agents|mesh-ancestor
25209765|NCT02701478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25209766|NCT02701517|Cyclosporine|cyclosporine|mesh-list
25209767|NCT02701517|Methotrexate|methotrexate|mesh-list
25209768|NCT02701517|Alemtuzumab|alemtuzumab|mesh-list
25209769|NCT02701517|Cyclosporins|cyclosporins|mesh-list
25209770|NCT02701517|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25209771|NCT02701517|Abortifacient Agents|abortifacient agents|mesh-ancestor
25209772|NCT02701517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25256364|NCT02483078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25256365|NCT02483078|Antiviral Agents|antiviral agents|mesh-ancestor
25256366|NCT02483078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25256367|NCT02483104|Paclitaxel|paclitaxel|mesh-list
25256368|NCT02483104|Carboplatin|carboplatin|mesh-list
25256369|NCT02483104|Veliparib|veliparib|mesh-list
25256370|NCT02483104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25256371|NCT02483104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256372|NCT02483104|Tubulin Modulators|tubulin modulators|mesh-ancestor
25256373|NCT02483104|Antimitotic Agents|antimitotic agents|mesh-ancestor
25209773|NCT02701517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209774|NCT02701517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25209775|NCT02701517|Antimetabolites|antimetabolites|mesh-ancestor
24507298|NCT00549666|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24507360|NCT00550095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507362|NCT00550108|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24525797|NCT02743819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525798|NCT02743819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24644713|NCT01192724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24934526|NCT04060914|Purinergic Agents|purinergic agents|mesh-ancestor
24934527|NCT04060914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24934529|NCT04060914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511000|NCT00566904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934602|NCT04060381|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24934603|NCT04060381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24934604|NCT04060381|Autonomic Agents|autonomic agents|mesh-ancestor
24934605|NCT04060381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24934606|NCT04060381|Respiratory System Agents|respiratory system agents|mesh-ancestor
24934607|NCT04060381|Mydriatics|mydriatics|mesh-ancestor
24934657|NCT04060095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530723|NCT00632073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530724|NCT00632086|Aspirin|aspirin|mesh-list
24530725|NCT00632086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24530726|NCT00632086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24530727|NCT00632086|Analgesics|analgesics|mesh-ancestor
24530728|NCT00632086|Sensory System Agents|sensory system agents|mesh-ancestor
24511047|NCT00567099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209776|NCT02701517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209777|NCT02701517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25209778|NCT02701517|Dermatologic Agents|dermatologic agents|mesh-ancestor
25209779|NCT02701517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677021|NCT01806779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25677022|NCT01806779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677023|NCT01806779|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25677024|NCT01806779|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25677025|NCT01806779|Cholinergic Agents|cholinergic agents|mesh-ancestor
25677026|NCT01806779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25677027|NCT01806779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677028|NCT01806779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25677029|NCT01806779|Antidepressive Agents|antidepressive agents|mesh-ancestor
25677030|NCT01806779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25012494|NCT05065294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012495|NCT05065294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25256387|NCT02482740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25256388|NCT02482740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256389|NCT02482740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25256390|NCT02482740|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25209780|NCT02701517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25209781|NCT02701517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25209782|NCT02701517|Immunologic Factors|immunologic factors|mesh-ancestor
25209783|NCT02701517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25209784|NCT02701517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25209785|NCT02701517|Antifungal Agents|antifungal agents|mesh-ancestor
25209786|NCT02701517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25209787|NCT02701517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25209788|NCT02701517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25209790|NCT02701309|Protoporphyrin IX|protoporphyrin ix|mesh-list
25209791|NCT02701309|Zinc protoporphyrin|zinc protoporphyrin|mesh-list
25209792|NCT02701309|Trace Elements|trace elements|mesh-ancestor
25209793|NCT02701309|Micronutrients|micronutrients|mesh-ancestor
25209794|NCT02701309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209795|NCT02701309|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25209796|NCT02701309|Dermatologic Agents|dermatologic agents|mesh-ancestor
25209797|NCT02701309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25209798|NCT02701309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507363|NCT00550108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24507364|NCT00550108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24507365|NCT00550108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507367|NCT00550121|Vitamins|vitamins|mesh-ancestor
24507368|NCT00550121|Micronutrients|micronutrients|mesh-ancestor
24507369|NCT00550121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507370|NCT00550121|Antioxidants|antioxidants|mesh-ancestor
24507371|NCT00550121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507372|NCT00550121|Protective Agents|protective agents|mesh-ancestor
24507373|NCT00550160|Artesunate|artesunate|mesh-list
24507374|NCT00550160|Amodiaquine|amodiaquine|mesh-list
24507375|NCT00550160|Antimalarials|antimalarials|mesh-ancestor
24507376|NCT00550160|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24507377|NCT00550160|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24507378|NCT00550160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24507379|NCT00550160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507380|NCT00550160|Antiviral Agents|antiviral agents|mesh-ancestor
24507381|NCT00550160|Schistosomicides|schistosomicides|mesh-ancestor
24507458|NCT00550784|Antimitotic Agents|antimitotic agents|mesh-ancestor
24507459|NCT00550784|Mitosis Modulators|mitosis modulators|mesh-ancestor
24507460|NCT00550784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530742|NCT00632216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25209800|NCT02701179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25209801|NCT02701179|Anesthetics, Local|anesthetics, local|mesh-ancestor
25209802|NCT02701179|Anesthetics|anesthetics|mesh-ancestor
25209803|NCT02701179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25677031|NCT01806779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25677032|NCT01806779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25677033|NCT01806779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25677034|NCT01806779|Dopamine Agents|dopamine agents|mesh-ancestor
25677035|NCT01806779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25677036|NCT01806779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25677037|NCT01806779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677038|NCT01806857|Quinidine|quinidine|mesh-list
25012557|NCT04903210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012558|NCT04903210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25209804|NCT02701179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209805|NCT02701179|Sensory System Agents|sensory system agents|mesh-ancestor
25209806|NCT02701179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25209807|NCT02701179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25209808|NCT02701179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25209809|NCT02701179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25209810|NCT02701179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25209811|NCT02701179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209812|NCT02701127|Niacinamide|niacinamide|mesh-list
25209813|NCT02701127|Niacin|niacin|mesh-list
25209814|NCT02701127|Nicotinic Acids|nicotinic acids|mesh-list
25209815|NCT02701127|Vitamin B Complex|vitamin b complex|mesh-ancestor
25209816|NCT02701127|Vitamins|vitamins|mesh-ancestor
25209817|NCT02701127|Micronutrients|micronutrients|mesh-ancestor
25209818|NCT02701127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209819|NCT02701127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25209820|NCT02701127|Antimetabolites|antimetabolites|mesh-ancestor
25209821|NCT02701127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209824|NCT02701166|Bezafibrate|bezafibrate|mesh-list
25209825|NCT02701166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25209826|NCT02701166|Antimetabolites|antimetabolites|mesh-ancestor
25209827|NCT02701166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209828|NCT02701166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25209829|NCT02700893|Atropine|atropine|mesh-list
25209830|NCT02700893|Sufentanil|sufentanil|mesh-list
25209831|NCT02700893|Propofol|propofol|mesh-list
25209832|NCT02700893|Atracurium|atracurium|mesh-list
25209833|NCT02700893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25209834|NCT02700893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24429002|NCT00242203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24507797|NCT00552266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507798|NCT00552266|Dopamine Agents|dopamine agents|mesh-ancestor
24507799|NCT00552266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24507800|NCT00552370|Insulin Glargine|insulin glargine|mesh-list
24507801|NCT00552370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24507802|NCT00552370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507803|NCT00552461|Rituximab|rituximab|mesh-list
24507804|NCT00552461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24507805|NCT00552461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507840|NCT00552682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24507841|NCT00552682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24507842|NCT00552682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507843|NCT00552682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24507844|NCT00552682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507902|NCT00553137|Antifungal Agents|antifungal agents|mesh-ancestor
24507903|NCT00553137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24457695|NCT00334906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457699|NCT00334919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24507914|NCT00553189|Topotecan|topotecan|mesh-list
24507915|NCT00553189|Veliparib|veliparib|mesh-list
24507916|NCT00553189|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24507917|NCT00553189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24507918|NCT00553189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507919|NCT00553189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507920|NCT00553189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507987|NCT00553709|Autonomic Agents|autonomic agents|mesh-ancestor
24507988|NCT00553709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24507989|NCT00553709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507990|NCT00553709|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24530743|NCT00632216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530744|NCT00632216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24530745|NCT00632216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530746|NCT00632216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24530798|NCT00632554|Antiemetics|antiemetics|mesh-ancestor
25209835|NCT02700893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209836|NCT02700893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25209837|NCT02700893|Anesthetics, General|anesthetics, general|mesh-ancestor
25209838|NCT02700893|Anesthetics|anesthetics|mesh-ancestor
25677039|NCT01806857|Dextromethorphan|dextromethorphan|mesh-list
25677040|NCT01806857|Antitussive Agents|antitussive agents|mesh-ancestor
25209839|NCT02700893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25209840|NCT02700893|Narcotics|narcotics|mesh-ancestor
25209841|NCT02700893|Analgesics|analgesics|mesh-ancestor
25209842|NCT02700893|Sensory System Agents|sensory system agents|mesh-ancestor
25209843|NCT02700893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25209844|NCT02700893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25209845|NCT02700893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25209846|NCT02700893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25209847|NCT02700893|Autonomic Agents|autonomic agents|mesh-ancestor
25209848|NCT02700893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25209849|NCT02700893|Respiratory System Agents|respiratory system agents|mesh-ancestor
25209850|NCT02700893|Mydriatics|mydriatics|mesh-ancestor
25209851|NCT02700893|Parasympatholytics|parasympatholytics|mesh-ancestor
25209852|NCT02700893|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25209853|NCT02700893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25209854|NCT02700893|Cholinergic Agents|cholinergic agents|mesh-ancestor
25209855|NCT02700893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25209856|NCT02700893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209857|NCT02700893|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25209858|NCT02700893|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25209859|NCT02700893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25209860|NCT02700893|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25209861|NCT02700906|Lidocaine|lidocaine|mesh-list
25209862|NCT02700906|Anesthetics, Local|anesthetics, local|mesh-ancestor
25209863|NCT02700906|Anesthetics|anesthetics|mesh-ancestor
25209864|NCT02700906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25209865|NCT02700906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209866|NCT02700906|Sensory System Agents|sensory system agents|mesh-ancestor
25209867|NCT02700906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25209868|NCT02700906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24507991|NCT00553709|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24507992|NCT00553709|Cholinergic Agents|cholinergic agents|mesh-ancestor
24507993|NCT00553709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24507994|NCT00553709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507995|NCT00553722|Eplerenone|eplerenone|mesh-list
24507996|NCT00553722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24507997|NCT00553722|Hormone Antagonists|hormone antagonists|mesh-ancestor
24507998|NCT00553722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24507999|NCT00553722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508000|NCT00553722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24508001|NCT00553722|Diuretics|diuretics|mesh-ancestor
24508002|NCT00553722|Natriuretic Agents|natriuretic agents|mesh-ancestor
24508003|NCT00553722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24508037|NCT00553943|Antiviral Agents|antiviral agents|mesh-ancestor
24508038|NCT00553943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24508039|NCT00553943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24508040|NCT00553995|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
24508041|NCT00553995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24429074|NCT00242541|Octreotide|octreotide|mesh-list
24508143|NCT00554346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24508144|NCT00554346|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24508145|NCT00554346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24508146|NCT00554346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508147|NCT00554346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457701|NCT00334932|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24457702|NCT00334932|Bortezomib|bortezomib|mesh-list
24457703|NCT00334932|Melphalan|melphalan|mesh-list
24395380|NCT00135863|Tinzaparin|tinzaparin|mesh-list
24508148|NCT00554398|Raltegravir Potassium|raltegravir potassium|mesh-list
24508149|NCT00554398|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24508150|NCT00554398|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25209869|NCT02700906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25209870|NCT02700906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25209871|NCT02700906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25209872|NCT02700906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209873|NCT02700828|Hydrocortisone|hydrocortisone|mesh-list
25209874|NCT02700828|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25209875|NCT02700828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25209876|NCT02700568|Axitinib|axitinib|mesh-list
25209877|NCT02700568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25209878|NCT02700568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25209879|NCT02700568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25012694|NCT04573777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25256427|NCT02482818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25256428|NCT02482818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25256429|NCT02482649|Methylphenidate|methylphenidate|mesh-list
25256430|NCT02482649|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25256431|NCT02482649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25256432|NCT02482649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256433|NCT02482649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25256434|NCT02482649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25209880|NCT02700568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209881|NCT02700711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25209882|NCT02700711|Methylphenidate|methylphenidate|mesh-list
25209883|NCT02700711|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25209884|NCT02700711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209885|NCT02700711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25209886|NCT02700711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25209887|NCT02700711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25209888|NCT02700711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209889|NCT02700711|Dopamine Agents|dopamine agents|mesh-ancestor
25209890|NCT02700711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25209891|NCT02700711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25209893|NCT02700711|Sensory System Agents|sensory system agents|mesh-ancestor
25209894|NCT02700711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25209895|NCT02700711|Antidepressive Agents|antidepressive agents|mesh-ancestor
25209896|NCT02700711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25209897|NCT02700685|Methylphenidate|methylphenidate|mesh-list
25209899|NCT02700685|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25209901|NCT02700685|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25209902|NCT02700685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25209903|NCT02700685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25209904|NCT02700685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209905|NCT02700685|Dopamine Agents|dopamine agents|mesh-ancestor
24508327|NCT00555087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508328|NCT00555087|Anabolic Agents|anabolic agents|mesh-ancestor
24508329|NCT00555100|Dexamethasone|dexamethasone|mesh-list
24508330|NCT00555100|Lenalidomide|lenalidomide|mesh-list
24508331|NCT00555100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24508332|NCT00555100|Antiemetics|antiemetics|mesh-ancestor
24508333|NCT00555100|Autonomic Agents|autonomic agents|mesh-ancestor
24508334|NCT00555100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24525981|NCT02161783|Immunologic Factors|immunologic factors|mesh-ancestor
24508342|NCT00555100|Immunologic Factors|immunologic factors|mesh-ancestor
24508343|NCT00555100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24508344|NCT00555100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24508345|NCT00555100|Growth Substances|growth substances|mesh-ancestor
24508544|NCT00556127|Melphalan|melphalan|mesh-list
24508545|NCT00556127|Carmustine|carmustine|mesh-list
24508546|NCT00556127|Rituximab|rituximab|mesh-list
24508547|NCT00556127|Etoposide|etoposide|mesh-list
24508548|NCT00556127|Vincristine|vincristine|mesh-list
24508549|NCT00556127|Epirubicin|epirubicin|mesh-list
24508550|NCT00556127|Mitoxantrone|mitoxantrone|mesh-list
24508551|NCT00556127|Lenograstim|lenograstim|mesh-list
24508552|NCT00556127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24508553|NCT00556127|Immunologic Factors|immunologic factors|mesh-ancestor
24508554|NCT00556127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508555|NCT00556127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24508556|NCT00556127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24508557|NCT00556127|Alkylating Agents|alkylating agents|mesh-ancestor
24526033|NCT01999569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526034|NCT01999569|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24526035|NCT01999569|Hormone Antagonists|hormone antagonists|mesh-ancestor
24508807|NCT00557180|Autonomic Agents|autonomic agents|mesh-ancestor
25677041|NCT01806857|Respiratory System Agents|respiratory system agents|mesh-ancestor
25677042|NCT01806857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25677043|NCT01806857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25677044|NCT01806857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25677045|NCT01806857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677046|NCT01806857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677047|NCT01806857|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25677048|NCT01806857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25677049|NCT01806857|Adrenergic Agents|adrenergic agents|mesh-ancestor
25012794|NCT04423588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25012795|NCT04423588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25012796|NCT04423588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574313|NCT00825019|Amibegron|amibegron|mesh-list
24508808|NCT00557180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24530799|NCT00632554|Autonomic Agents|autonomic agents|mesh-ancestor
24530800|NCT00632554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25049210|NCT00629551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24530801|NCT00632554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24530802|NCT00632554|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24530803|NCT00632554|Protective Agents|protective agents|mesh-ancestor
24530804|NCT00632580|Ropivacaine|ropivacaine|mesh-list
24934716|NCT04059536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24934717|NCT04059536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24934718|NCT04059536|Analgesics|analgesics|mesh-ancestor
24934719|NCT04059536|Sensory System Agents|sensory system agents|mesh-ancestor
24934720|NCT04059536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24934721|NCT04059536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934722|NCT04059536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25209906|NCT02700685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25209907|NCT02700685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25209908|NCT02700685|Immunologic Factors|immunologic factors|mesh-ancestor
25209909|NCT02700685|Antioxidants|antioxidants|mesh-ancestor
25209910|NCT02700685|Protective Agents|protective agents|mesh-ancestor
25209911|NCT02700685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25209912|NCT02700763|Dabrafenib|dabrafenib|mesh-list
25209913|NCT02700763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25209914|NCT02700763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25209915|NCT02700763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25209916|NCT02700763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209917|NCT02700347|Pyrazinamide|pyrazinamide|mesh-list
25209918|NCT02700347|Allopurinol|allopurinol|mesh-list
25209919|NCT02700347|Antimetabolites|antimetabolites|mesh-ancestor
25209920|NCT02700347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209921|NCT02700347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25209922|NCT02700347|Gout Suppressants|gout suppressants|mesh-ancestor
25209923|NCT02700347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25209924|NCT02700347|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25209925|NCT02700347|Antioxidants|antioxidants|mesh-ancestor
25209926|NCT02700347|Protective Agents|protective agents|mesh-ancestor
25209928|NCT02700347|Antitubercular Agents|antitubercular agents|mesh-ancestor
25209929|NCT02700347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25209930|NCT02700347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25209931|NCT02700438|Nitroglycerin|nitroglycerin|mesh-list
25209932|NCT02700438|Vasodilator Agents|vasodilator agents|mesh-ancestor
25209933|NCT02700217|Remifentanil|remifentanil|mesh-list
25209934|NCT02700217|Heroin|heroin|mesh-list
25209935|NCT02700217|Bupivacaine|bupivacaine|mesh-list
25209936|NCT02700217|Propofol|propofol|mesh-list
25209937|NCT02700217|Anesthetics, Local|anesthetics, local|mesh-ancestor
24508809|NCT00557180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508840|NCT00557219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508841|NCT00557219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508842|NCT00557219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24508887|NCT00557544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24508888|NCT00557544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24508893|NCT00557700|Bromides|bromides|mesh-list
24526075|NCT01845441|Dexmedetomidine|dexmedetomidine|mesh-list
24526076|NCT01845441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24509058|NCT00558181|Hormones|hormones|mesh-ancestor
24644945|NCT01194115|Cephalexin|cephalexin|mesh-list
24509059|NCT00558181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24509060|NCT00558181|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24509061|NCT00558181|Protective Agents|protective agents|mesh-ancestor
24509062|NCT00558181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24509063|NCT00558298|Risperidone|risperidone|mesh-list
24509064|NCT00558298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24509065|NCT00558298|Serotonin Agents|serotonin agents|mesh-ancestor
25677050|NCT01806857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25677051|NCT01806857|Antimalarials|antimalarials|mesh-ancestor
25677052|NCT01806857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25677053|NCT01806857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24509075|NCT00558337|Levodopa|levodopa|mesh-list
24509219|NCT00559429|Docetaxel|docetaxel|mesh-list
24509220|NCT00559429|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
24509221|NCT00559429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509222|NCT00559429|Tubulin Modulators|tubulin modulators|mesh-ancestor
24509223|NCT00559429|Antimitotic Agents|antimitotic agents|mesh-ancestor
24509224|NCT00559429|Mitosis Modulators|mitosis modulators|mesh-ancestor
24774979|NCT01849042|Donepezil|donepezil|mesh-list
24509225|NCT00559429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509226|NCT00559429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24509227|NCT00559429|Analgesics|analgesics|mesh-ancestor
24509263|NCT00559481|Antifungal Agents|antifungal agents|mesh-ancestor
24509264|NCT00559481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24509265|NCT00559481|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24509266|NCT00559481|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24509267|NCT00559481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25209939|NCT02700217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25209940|NCT02700217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209941|NCT02700217|Sensory System Agents|sensory system agents|mesh-ancestor
25209942|NCT02700217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25209943|NCT02700217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25209944|NCT02700217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25209945|NCT02700217|Anesthetics, General|anesthetics, general|mesh-ancestor
25209946|NCT02700217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25209947|NCT02700217|Narcotics|narcotics|mesh-ancestor
25209948|NCT02700217|Analgesics|analgesics|mesh-ancestor
25209949|NCT02701205|Etanercept|etanercept|mesh-list
25209950|NCT02701205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25209951|NCT02701205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25209952|NCT02701205|Analgesics|analgesics|mesh-ancestor
25209953|NCT02701205|Sensory System Agents|sensory system agents|mesh-ancestor
25209954|NCT02701205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25209955|NCT02701205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209956|NCT02701205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25209957|NCT02701205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25209958|NCT02701205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25209959|NCT02701205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25209960|NCT02701205|Immunologic Factors|immunologic factors|mesh-ancestor
25209961|NCT02700087|Famotidine|famotidine|mesh-list
25209962|NCT02700087|Ranitidine|ranitidine|mesh-list
25209963|NCT02700087|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
25209964|NCT02700087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25209965|NCT02700087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25209966|NCT02700087|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25209967|NCT02700087|Histamine Antagonists|histamine antagonists|mesh-ancestor
25209968|NCT02700087|Histamine Agents|histamine agents|mesh-ancestor
25209969|NCT02700087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24510068|NCT00563251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25209970|NCT02700087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25209971|NCT02700087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509404|NCT00560170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509405|NCT00560170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24509406|NCT00560170|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24509408|NCT00560209|Landiolol|landiolol|mesh-list
24509409|NCT00560209|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24509410|NCT00560209|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24509411|NCT00560209|Adrenergic Agents|adrenergic agents|mesh-ancestor
24509412|NCT00560209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24394210|NCT00132561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24509475|NCT00560443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457707|NCT00334932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24457708|NCT00334932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24509516|NCT00560599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509616|NCT00561132|Magnesium Oxide|magnesium oxide|mesh-list
24509617|NCT00561132|Antacids|antacids|mesh-ancestor
24509618|NCT00561132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509619|NCT00561132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24509620|NCT00561132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24509942|NCT00562835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24509943|NCT00562835|Glucocorticoids|glucocorticoids|mesh-ancestor
24510058|NCT00563238|Autonomic Agents|autonomic agents|mesh-ancestor
24510059|NCT00563238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24510060|NCT00563238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510061|NCT00563238|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24510062|NCT00563238|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24510063|NCT00563238|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24510064|NCT00563238|Adrenergic Agents|adrenergic agents|mesh-ancestor
24770077|NCT01817816|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24934723|NCT04059536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24934728|NCT04059536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25013206|NCT03353922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934729|NCT04059536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24934730|NCT04059536|Antipyretics|antipyretics|mesh-ancestor
24934731|NCT04059536|Anticoagulants|anticoagulants|mesh-ancestor
24934736|NCT04059224|Trametinib|trametinib|mesh-list
24934737|NCT04059224|Dabrafenib|dabrafenib|mesh-list
24934738|NCT04059224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934739|NCT04059224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24934740|NCT04059224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25209977|NCT02699879|Pirfenidone|pirfenidone|mesh-list
25209978|NCT02699879|Analgesics|analgesics|mesh-ancestor
25209979|NCT02699879|Sensory System Agents|sensory system agents|mesh-ancestor
25209980|NCT02699879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25209981|NCT02699879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209982|NCT02699879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25209983|NCT02699879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25209984|NCT02699879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25209985|NCT02699879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25209986|NCT02699879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25209987|NCT02699827|Magnesium Sulfate|magnesium sulfate|mesh-list
25209988|NCT02699827|Levobupivacaine|levobupivacaine|mesh-list
25209989|NCT02699827|Analgesics|analgesics|mesh-ancestor
25209990|NCT02699827|Sensory System Agents|sensory system agents|mesh-ancestor
25209991|NCT02699827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25209992|NCT02699827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25209993|NCT02699827|Anesthetics|anesthetics|mesh-ancestor
25209994|NCT02699827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25209995|NCT02699827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25209996|NCT02699827|Anticonvulsants|anticonvulsants|mesh-ancestor
25209997|NCT02699827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25209998|NCT02699827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25209999|NCT02699827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210000|NCT02699827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25210001|NCT02699827|Tocolytic Agents|tocolytic agents|mesh-ancestor
25210002|NCT02699827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25210003|NCT02699827|Anesthetics, Local|anesthetics, local|mesh-ancestor
25210004|NCT02699723|Itraconazole|itraconazole|mesh-list
25210005|NCT02699723|Arsenic Trioxide|arsenic trioxide|mesh-list
25210006|NCT02699723|Antifungal Agents|antifungal agents|mesh-ancestor
24510065|NCT00563238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24510066|NCT00563238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510067|NCT00563251|Azithromycin|azithromycin|mesh-list
24510069|NCT00563251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24510100|NCT00563433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510101|NCT00563433|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24510102|NCT00563433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24510103|NCT00563446|Darbepoetin alfa|darbepoetin alfa|mesh-list
24510104|NCT00563446|Hematinics|hematinics|mesh-ancestor
24510105|NCT00563472|Desogestrel|desogestrel|mesh-list
24443946|NCT00296348|Mycophenolic Acid|mycophenolic acid|mesh-list
24510138|NCT00563589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510220|NCT00563914|Ferroquine|ferroquine|mesh-list
24510223|NCT00563914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24510224|NCT00563914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24510225|NCT00563927|Fluorouracil|fluorouracil|mesh-list
24510226|NCT00563927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510342|NCT00564252|Hormone Antagonists|hormone antagonists|mesh-ancestor
24510343|NCT00564252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24510344|NCT00564252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510345|NCT00564252|Urological Agents|urological agents|mesh-ancestor
24510346|NCT00564330|Esomeprazole|esomeprazole|mesh-list
24510347|NCT00564330|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24510376|NCT00564512|Rituximab|rituximab|mesh-list
24510377|NCT00564512|Fludarabine|fludarabine|mesh-list
24510378|NCT00564512|Alemtuzumab|alemtuzumab|mesh-list
24510379|NCT00564512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24510380|NCT00564512|Immunologic Factors|immunologic factors|mesh-ancestor
24510381|NCT00564512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510382|NCT00564512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24510383|NCT00564512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24510384|NCT00564512|Alkylating Agents|alkylating agents|mesh-ancestor
25677054|NCT01806857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24770091|NCT01817829|Antipyretics|antipyretics|mesh-ancestor
24934742|NCT04059081|Obinutuzumab|obinutuzumab|mesh-list
24934743|NCT04059081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25210007|NCT02699723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25256460|NCT02482402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25256461|NCT02482402|Vasodilator Agents|vasodilator agents|mesh-ancestor
25256463|NCT02482077|Antiviral Agents|antiviral agents|mesh-ancestor
25256464|NCT02482077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25256465|NCT02482207|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25256466|NCT02482207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25256467|NCT02482207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25256468|NCT02482207|Antimetabolites|antimetabolites|mesh-ancestor
25256469|NCT02482207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256470|NCT02482207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25256471|NCT02482207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25256472|NCT02482207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256473|NCT02482155|Ibuprofen|ibuprofen|mesh-list
25256474|NCT02482155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25256475|NCT02482155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25256476|NCT02482155|Analgesics|analgesics|mesh-ancestor
25210008|NCT02699723|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25210009|NCT02699723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25210010|NCT02699723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25210011|NCT02699723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210012|NCT02699723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25210013|NCT02699723|Hormone Antagonists|hormone antagonists|mesh-ancestor
25210014|NCT02699723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25210015|NCT02699723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210016|NCT02699723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25210017|NCT02699723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25210018|NCT02699645|Amlodipine|amlodipine|mesh-list
25210019|NCT02699645|Telmisartan|telmisartan|mesh-list
25210020|NCT02699645|Indapamide|indapamide|mesh-list
25210021|NCT02699645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25210022|NCT02699645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25210023|NCT02699645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25210024|NCT02699645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210025|NCT02699645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25210026|NCT02699645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210027|NCT02699645|Vasodilator Agents|vasodilator agents|mesh-ancestor
25210028|NCT02699645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25210029|NCT02699645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25210030|NCT02699645|Diuretics|diuretics|mesh-ancestor
25210031|NCT02699645|Natriuretic Agents|natriuretic agents|mesh-ancestor
25210032|NCT02699645|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25210033|NCT02700022|Prednisone|prednisone|mesh-list
25210034|NCT02700022|Cyclophosphamide|cyclophosphamide|mesh-list
25210035|NCT02700022|Doxorubicin|doxorubicin|mesh-list
25210036|NCT02700022|Etoposide|etoposide|mesh-list
25210037|NCT02700022|Vincristine|vincristine|mesh-list
25210038|NCT02700022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25210039|NCT02700022|Immunologic Factors|immunologic factors|mesh-ancestor
25210040|NCT02700022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510385|NCT00564512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510386|NCT00564512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510387|NCT00564512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24457714|NCT00334932|Immunologic Factors|immunologic factors|mesh-ancestor
24457715|NCT00334932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457717|NCT00335010|Vasodilator Agents|vasodilator agents|mesh-ancestor
25677055|NCT01806857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677056|NCT01806857|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25677057|NCT01806857|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25677058|NCT01806857|Cholinergic Agents|cholinergic agents|mesh-ancestor
25677059|NCT01806857|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25677060|NCT01806857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25677061|NCT01806857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25677062|NCT01806857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25677063|NCT01806857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25677064|NCT01807000|Prucalopride|prucalopride|mesh-list
25677065|NCT01807000|Laxatives|laxatives|mesh-ancestor
25677066|NCT01807000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25677067|NCT01807000|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
25677068|NCT01807000|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25677069|NCT01807000|Serotonin Agents|serotonin agents|mesh-ancestor
25677070|NCT01807000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25013426|NCT02733042|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25013471|NCT02575144|Growth Inhibitors|growth inhibitors|mesh-ancestor
24457718|NCT00335075|Temozolomide|temozolomide|mesh-list
24457719|NCT00335075|Semustine|semustine|mesh-list
24511127|NCT00567554|Paclitaxel|paclitaxel|mesh-list
24510389|NCT00564525|Amitriptyline|amitriptyline|mesh-list
24510978|NCT00566865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510980|NCT00566865|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24510981|NCT00566865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24510982|NCT00566865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510984|NCT00566891|Clopidogrel|clopidogrel|mesh-list
24510985|NCT00566891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24510986|NCT00566891|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24510987|NCT00566891|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24510988|NCT00566891|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24510989|NCT00566891|Purinergic Agents|purinergic agents|mesh-ancestor
24510990|NCT00566891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24510991|NCT00566891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510992|NCT00566891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510993|NCT00566891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24934744|NCT04059081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934745|NCT04059198|Tenofovir|tenofovir|mesh-list
24934746|NCT04059198|Antiviral Agents|antiviral agents|mesh-ancestor
24934806|NCT04058132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24934807|NCT04058132|Urological Agents|urological agents|mesh-ancestor
24934808|NCT04057755|Botulinum Toxins|botulinum toxins|mesh-list
24934809|NCT04057755|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24530849|NCT00632645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530851|NCT00632645|Serotonin Agents|serotonin agents|mesh-ancestor
24530852|NCT00632645|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24530853|NCT00632645|Adrenergic Agents|adrenergic agents|mesh-ancestor
24530854|NCT00632645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24530855|NCT00632645|Dopamine Agents|dopamine agents|mesh-ancestor
24530856|NCT00632697|Pentoxifylline|pentoxifylline|mesh-list
24530857|NCT00632697|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24530858|NCT00632697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25210041|NCT02700022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25210042|NCT02700022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25210043|NCT02700022|Alkylating Agents|alkylating agents|mesh-ancestor
25210044|NCT02700022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210045|NCT02700022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25210046|NCT02700022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25210047|NCT02700022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25210048|NCT02700022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25210049|NCT02700022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25210050|NCT02700022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25210051|NCT02700022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25210052|NCT02700022|Glucocorticoids|glucocorticoids|mesh-ancestor
25210053|NCT02700022|Hormones|hormones|mesh-ancestor
25210054|NCT02700022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25210055|NCT02700022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25210056|NCT02700022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25210057|NCT02700022|Tubulin Modulators|tubulin modulators|mesh-ancestor
25210058|NCT02700022|Antimitotic Agents|antimitotic agents|mesh-ancestor
25210059|NCT02700022|Mitosis Modulators|mitosis modulators|mesh-ancestor
25272633|NCT02390674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272634|NCT02390674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272635|NCT02390674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25272636|NCT02390674|Immunologic Factors|immunologic factors|mesh-ancestor
24645144|NCT01196234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25272637|NCT02390674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272638|NCT02390674|Antifungal Agents|antifungal agents|mesh-ancestor
25272639|NCT02390674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25272640|NCT02390674|Dermatologic Agents|dermatologic agents|mesh-ancestor
24510995|NCT00566904|Aspirin|aspirin|mesh-list
24510996|NCT00566904|Lidocaine|lidocaine|mesh-list
24510997|NCT00566904|Anesthetics, Local|anesthetics, local|mesh-list
24510998|NCT00566904|Anesthetics|anesthetics|mesh-list
24526370|NCT00611416|Caffeine|caffeine|mesh-list
24944917|NCT03955939|Anesthetics|anesthetics|mesh-ancestor
25677071|NCT01807000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256488|NCT02482090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25256489|NCT02482090|Immunologic Factors|immunologic factors|mesh-ancestor
24530859|NCT00632697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530860|NCT00632697|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24530861|NCT00632697|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24625392|NCT01082003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24625393|NCT01082003|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24625394|NCT01082003|Protective Agents|protective agents|mesh-ancestor
24625395|NCT01082003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625396|NCT01082003|Vasodilator Agents|vasodilator agents|mesh-ancestor
24625397|NCT01082003|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24511196|NCT00567762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24530882|NCT00632762|Analgesics|analgesics|mesh-ancestor
24530883|NCT00632762|Sensory System Agents|sensory system agents|mesh-ancestor
24530884|NCT00632762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24530885|NCT00632840|Atorvastatin|atorvastatin|mesh-list
24530886|NCT00632840|Fenofibrate|fenofibrate|mesh-list
24530887|NCT00632840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24530888|NCT00632840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24530889|NCT00632840|Antimetabolites|antimetabolites|mesh-ancestor
24445698|NCT00302341|Trimethoprim|trimethoprim|mesh-list
24934812|NCT04057755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24934813|NCT04057755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934815|NCT04057755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24934816|NCT04057755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934817|NCT04057755|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24934818|NCT04057755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24934834|NCT04057989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24934835|NCT04057989|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24934837|NCT04057989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24934838|NCT04057989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934840|NCT04057365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24645145|NCT01196234|Carboplatin|carboplatin|mesh-list
24934841|NCT04057365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934842|NCT04057365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24934843|NCT04057365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934844|NCT04057456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24934845|NCT04057456|Nabilone|nabilone|mesh-list
24934846|NCT04057456|Antiemetics|antiemetics|mesh-ancestor
24934847|NCT04057456|Autonomic Agents|autonomic agents|mesh-ancestor
24934848|NCT04057456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24934849|NCT04057456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934850|NCT04057456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24934851|NCT04057456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24934852|NCT04057456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24934853|NCT04057456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24934854|NCT04057456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24934856|NCT04057261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24934857|NCT04057261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934923|NCT04056806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24934924|NCT04056806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25210060|NCT02699658|Levofloxacin|levofloxacin|mesh-list
25210061|NCT02699658|Ofloxacin|ofloxacin|mesh-list
25210062|NCT02699658|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25210063|NCT02699658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25210064|NCT02699658|Renal Agents|renal agents|mesh-ancestor
25210065|NCT02699658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25210066|NCT02699658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25210067|NCT02699658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25210068|NCT02699658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25210069|NCT02699658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677072|NCT01807000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677073|NCT01807221|Eplerenone|eplerenone|mesh-list
24934925|NCT04056806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24934926|NCT04056845|Acetaminophen|acetaminophen|mesh-list
24934928|NCT04056845|Analgesics|analgesics|mesh-list
24934929|NCT04056845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24934930|NCT04056845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24934931|NCT04056845|Sensory System Agents|sensory system agents|mesh-ancestor
24934932|NCT04056845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24934933|NCT04056845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511307|NCT00568152|Antipyretics|antipyretics|mesh-ancestor
24530890|NCT00632840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530891|NCT00632840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24934934|NCT04056845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24934945|NCT04056650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934946|NCT04056650|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24934947|NCT04056650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24934948|NCT04056650|Purinergic Agents|purinergic agents|mesh-ancestor
24934949|NCT04056650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24934950|NCT04056754|Prednisone|prednisone|mesh-list
24934951|NCT04056754|Abiraterone Acetate|abiraterone acetate|mesh-list
24934952|NCT04056754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24934953|NCT04056754|Glucocorticoids|glucocorticoids|mesh-ancestor
24934954|NCT04056754|Hormones|hormones|mesh-ancestor
24934955|NCT04056754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24934956|NCT04056754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934957|NCT04056754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24934958|NCT04056754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935032|NCT04055480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935034|NCT04055506|BMS-986165|bms-986165|mesh-list
24935053|NCT04055623|Sensory System Agents|sensory system agents|mesh-ancestor
24935054|NCT04055623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24935055|NCT04055623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210070|NCT02699658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25210071|NCT02699658|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25210072|NCT02699658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25210073|NCT02699801|Dexmedetomidine|dexmedetomidine|mesh-list
25210074|NCT02699801|Propofol|propofol|mesh-list
25210075|NCT02699801|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25210076|NCT02699801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25210077|NCT02699801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210078|NCT02699801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25210079|NCT02699801|Anesthetics, General|anesthetics, general|mesh-ancestor
25210080|NCT02699801|Anesthetics|anesthetics|mesh-ancestor
25210081|NCT02699801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25210082|NCT02699801|Analgesics|analgesics|mesh-ancestor
25210083|NCT02699801|Sensory System Agents|sensory system agents|mesh-ancestor
25210084|NCT02699801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25210085|NCT02699801|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25210086|NCT02699801|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25210087|NCT02699801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24511134|NCT00567554|Epirubicin|epirubicin|mesh-list
24511135|NCT00567554|Lapatinib|lapatinib|mesh-list
24511136|NCT00567554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24511137|NCT00567554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511138|NCT00567554|Tubulin Modulators|tubulin modulators|mesh-ancestor
24935056|NCT04055623|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24935057|NCT04055623|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24935058|NCT04055623|Antiviral Agents|antiviral agents|mesh-ancestor
24645252|NCT01197001|Vasodilator Agents|vasodilator agents|mesh-ancestor
24935059|NCT04055623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24935060|NCT04055415|Bronchodilator Agents|bronchodilator agents|mesh-list
24625399|NCT01082029|Lansoprazole|lansoprazole|mesh-list
24625400|NCT01082029|Dexlansoprazole|dexlansoprazole|mesh-list
24625401|NCT01082029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24625402|NCT01082029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24625403|NCT01082029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24625404|NCT01082029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625406|NCT01082120|Pioglitazone|pioglitazone|mesh-list
24625407|NCT01082120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24625408|NCT01082120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625409|NCT01082146|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
24511449|NCT00568763|Sargramostim|sargramostim|mesh-list
25256510|NCT02482324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25256511|NCT02482324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256512|NCT02482324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256513|NCT02481960|Irinotecan|irinotecan|mesh-list
25256514|NCT02481960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25256515|NCT02481960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25256519|NCT02481791|Remifentanil|remifentanil|mesh-list
24530936|NCT00633347|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24530937|NCT00633347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24530938|NCT00633347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530939|NCT00633373|Cyclosporine|cyclosporine|mesh-list
24625463|NCT01082250|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24625464|NCT01082250|Dopamine Agents|dopamine agents|mesh-ancestor
24625465|NCT01082263|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
24625466|NCT01082263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24625467|NCT01082263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24935126|NCT04054518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24935128|NCT04054362|Gemcitabine|gemcitabine|mesh-list
24935129|NCT04054362|Paclitaxel|paclitaxel|mesh-list
24935177|NCT04054089|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24935178|NCT04054089|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24935179|NCT04054089|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24935180|NCT04054063|Etomidate|etomidate|mesh-list
24935181|NCT04054063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24935190|NCT04053959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935191|NCT04053972|Lenvatinib|lenvatinib|mesh-list
24935192|NCT04053972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935193|NCT04053972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24531055|NCT00633685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24531056|NCT00633685|Antidepressive Agents|antidepressive agents|mesh-ancestor
24531057|NCT00633685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24531058|NCT00633685|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24531059|NCT00633685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24531060|NCT00633685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24531061|NCT00633698|Niacin|niacin|mesh-list
24531062|NCT00633698|Nicotinic Acids|nicotinic acids|mesh-list
24531089|NCT00633776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24531090|NCT00633776|Adrenergic Agents|adrenergic agents|mesh-ancestor
24531091|NCT00633776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24531092|NCT00633776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24668466|NCT04918147|Histamine Agents|histamine agents|mesh-ancestor
24668467|NCT04918147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24668468|NCT04918147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24668469|NCT04918147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24668471|NCT04918147|Dermatologic Agents|dermatologic agents|mesh-ancestor
24668472|NCT04918147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24668473|NCT04918147|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25210088|NCT02699801|Adrenergic Agents|adrenergic agents|mesh-ancestor
25210089|NCT02699801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25210090|NCT02699801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210091|NCT02699710|Folic Acid|folic acid|mesh-list
25210092|NCT02699710|Methotrexate|methotrexate|mesh-list
24511139|NCT00567554|Antimitotic Agents|antimitotic agents|mesh-ancestor
24511140|NCT00567554|Mitosis Modulators|mitosis modulators|mesh-ancestor
24511141|NCT00567554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511142|NCT00567554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24511143|NCT00567554|Immunologic Factors|immunologic factors|mesh-ancestor
24511144|NCT00567554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511145|NCT00567554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24944940|NCT03956134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511659|NCT00570050|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24531103|NCT00633802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24531104|NCT00633802|Dopamine Agents|dopamine agents|mesh-ancestor
24531105|NCT00633958|Alovudine|alovudine|mesh-list
24531106|NCT00633958|Antiviral Agents|antiviral agents|mesh-ancestor
24531107|NCT00633958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24531108|NCT00634062|Lamotrigine|lamotrigine|mesh-list
24531109|NCT00634062|Anticonvulsants|anticonvulsants|mesh-ancestor
24531110|NCT00634062|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25677074|NCT01807221|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25677075|NCT01807221|Hormone Antagonists|hormone antagonists|mesh-ancestor
25677076|NCT01807221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25677077|NCT01807221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677078|NCT01807221|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25677079|NCT01807221|Diuretics|diuretics|mesh-ancestor
25677080|NCT01807221|Natriuretic Agents|natriuretic agents|mesh-ancestor
25014279|NCT04814433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25014280|NCT04814433|Respiratory System Agents|respiratory system agents|mesh-ancestor
25014281|NCT04814433|Mydriatics|mydriatics|mesh-ancestor
25014282|NCT04814433|Sympathomimetics|sympathomimetics|mesh-ancestor
25014283|NCT04814433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25014284|NCT04814433|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25014285|NCT04814433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25014286|NCT04814433|Hemostatics|hemostatics|mesh-ancestor
24531111|NCT00634062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24531112|NCT00634062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531113|NCT00634062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24531114|NCT00634062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511683|NCT00570219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24512819|NCT00576914|Growth Inhibitors|growth inhibitors|mesh-ancestor
24531136|NCT00634205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531138|NCT00634205|GABA Agents|gaba agents|mesh-ancestor
24531139|NCT00634205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24668515|NCT04889547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511698|NCT00570245|Gasotransmitters|gasotransmitters|mesh-ancestor
24531173|NCT00634361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24531174|NCT00634361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24531176|NCT00634400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24531177|NCT00634400|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24531178|NCT00634400|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24531179|NCT00634400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531181|NCT00634413|Theophylline|theophylline|mesh-list
24531182|NCT00634413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24668570|NCT04837716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24668571|NCT04837716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24668572|NCT04837716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24668573|NCT04837716|Growth Substances|growth substances|mesh-ancestor
24668574|NCT04837716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24668575|NCT04837716|Growth Inhibitors|growth inhibitors|mesh-ancestor
24668576|NCT04837716|Immunologic Factors|immunologic factors|mesh-ancestor
24668577|NCT04837716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25210093|NCT02699710|Rabeprazole|rabeprazole|mesh-list
25210094|NCT02699710|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25210095|NCT02699710|Abortifacient Agents|abortifacient agents|mesh-ancestor
25210096|NCT02699710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25210097|NCT02699710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210098|NCT02699710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25210099|NCT02699710|Antimetabolites|antimetabolites|mesh-ancestor
25210100|NCT02699710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511147|NCT00567554|Alkylating Agents|alkylating agents|mesh-ancestor
24511148|NCT00567554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24511149|NCT00567554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24511150|NCT00567554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24511282|NCT00568113|Antiviral Agents|antiviral agents|mesh-ancestor
24511283|NCT00568113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24511284|NCT00568113|Expectorants|expectorants|mesh-ancestor
24511285|NCT00568113|Respiratory System Agents|respiratory system agents|mesh-ancestor
24668578|NCT04837716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537200|NCT00653926|Autonomic Agents|autonomic agents|mesh-ancestor
24531231|NCT00634595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531233|NCT00634634|Letrozole|letrozole|mesh-list
24531234|NCT00634634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531235|NCT00634634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24531245|NCT00634686|Calcium|calcium|mesh-list
24531246|NCT00634686|Vitamins|vitamins|mesh-ancestor
24531247|NCT00634686|Micronutrients|micronutrients|mesh-ancestor
25677081|NCT01807221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25677082|NCT01807234|Ketorolac|ketorolac|mesh-list
25677083|NCT01807234|Sumatriptan|sumatriptan|mesh-list
25677084|NCT01807234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25677085|NCT01807234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25677086|NCT01807234|Analgesics|analgesics|mesh-ancestor
25677087|NCT01807234|Sensory System Agents|sensory system agents|mesh-ancestor
25677088|NCT01807234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25014479|NCT04484922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25014486|NCT04446390|Listerine|listerine|mesh-list
24971132|NCT03728192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256527|NCT02481791|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25256528|NCT02481791|Narcotics|narcotics|mesh-ancestor
25256529|NCT02481791|Analgesics|analgesics|mesh-ancestor
25256530|NCT02481791|Sensory System Agents|sensory system agents|mesh-ancestor
25256531|NCT02481791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25256532|NCT02481726|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25256533|NCT02481726|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25256534|NCT02481726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256535|NCT02481635|Gemcitabine|gemcitabine|mesh-list
24531248|NCT00634686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24668674|NCT04650542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24668675|NCT04650542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25210101|NCT02699710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25210102|NCT02699710|Dermatologic Agents|dermatologic agents|mesh-ancestor
25210103|NCT02699710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25210104|NCT02699710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25210105|NCT02699710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25210106|NCT02699710|Immunologic Factors|immunologic factors|mesh-ancestor
25210107|NCT02699710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25210108|NCT02699710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25210109|NCT02699710|Hematinics|hematinics|mesh-ancestor
25210110|NCT02699710|Vitamin B Complex|vitamin b complex|mesh-ancestor
25210111|NCT02699710|Vitamins|vitamins|mesh-ancestor
25210112|NCT02699710|Micronutrients|micronutrients|mesh-ancestor
25210113|NCT02699710|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25210114|NCT02699710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24526416|NCT00611650|Antioxidants|antioxidants|mesh-ancestor
24526417|NCT00611650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511286|NCT00568113|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24511287|NCT00568113|Antioxidants|antioxidants|mesh-ancestor
24511288|NCT00568113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511289|NCT00568113|Protective Agents|protective agents|mesh-ancestor
24511290|NCT00568113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511291|NCT00568113|Antidotes|antidotes|mesh-ancestor
24531303|NCT00634985|Eletriptan|eletriptan|mesh-list
24531304|NCT00634985|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24531305|NCT00634985|Serotonin Agents|serotonin agents|mesh-ancestor
24531306|NCT00634985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24668808|NCT04591353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24668809|NCT04591353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24668810|NCT04591353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24668811|NCT04591353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24668812|NCT04591353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24668813|NCT04591353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24668854|NCT04551131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24668855|NCT04551131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24668856|NCT04551131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24668857|NCT04551131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24668858|NCT04551131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24668859|NCT04551131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456329|NCT00330902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24456330|NCT00330902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456331|NCT00330902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456332|NCT00330902|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24456333|NCT00330902|Renal Agents|renal agents|mesh-ancestor
24456334|NCT00330941|Lidocaine|lidocaine|mesh-list
24456340|NCT00330941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25677089|NCT01807234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677090|NCT01807234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25677091|NCT01807234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25677092|NCT01807234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25677093|NCT01807234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677094|NCT01807234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677095|NCT01807234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25677096|NCT01807234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25677097|NCT01807234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25677098|NCT01807234|Serotonin Agents|serotonin agents|mesh-ancestor
25677099|NCT01807234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24456342|NCT00330941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25014639|NCT04183452|Progestins|progestins|mesh-ancestor
25014661|NCT04067609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25102763|NCT03166787|Antioxidants|antioxidants|mesh-ancestor
25256537|NCT02481635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25256538|NCT02481635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256539|NCT02481635|Tubulin Modulators|tubulin modulators|mesh-ancestor
25256540|NCT02481635|Antimitotic Agents|antimitotic agents|mesh-ancestor
25256541|NCT02481635|Mitosis Modulators|mitosis modulators|mesh-ancestor
25256542|NCT02481635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256543|NCT02481635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25256544|NCT02481635|Antimetabolites|antimetabolites|mesh-ancestor
25256545|NCT02481635|Antiviral Agents|antiviral agents|mesh-ancestor
24456343|NCT00330941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24412658|NCT00191737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24531324|NCT00635076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24531325|NCT00635076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24531326|NCT00635076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531327|NCT00635076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24531328|NCT00635076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24531329|NCT00635076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24531330|NCT00635076|GABA Modulators|gaba modulators|mesh-ancestor
24531331|NCT00635076|GABA Agents|gaba agents|mesh-ancestor
24456346|NCT00330980|Simvastatin|simvastatin|mesh-list
24456347|NCT00330980|Pravastatin|pravastatin|mesh-list
24456348|NCT00330980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24456349|NCT00330980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24456350|NCT00330980|Antimetabolites|antimetabolites|mesh-ancestor
24456351|NCT00330980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456352|NCT00330980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24456353|NCT00330980|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25210115|NCT02699710|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25210116|NCT02699437|Antibodies|antibodies|mesh-list
25210117|NCT02699437|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
25210118|NCT02699437|Immunologic Factors|immunologic factors|mesh-ancestor
25210119|NCT02699437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210120|NCT02699281|Palmidrol|palmidrol|mesh-list
25210121|NCT02699281|Analgesics|analgesics|mesh-ancestor
25210122|NCT02699281|Sensory System Agents|sensory system agents|mesh-ancestor
25210123|NCT02699281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25210124|NCT02699281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395848|NCT00137033|Celecoxib|celecoxib|mesh-list
24511294|NCT00568152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24511295|NCT00568152|Analgesics|analgesics|mesh-ancestor
24511296|NCT00568152|Sensory System Agents|sensory system agents|mesh-ancestor
24511297|NCT00568152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24511298|NCT00568152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511299|NCT00568152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24511300|NCT00568152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24511301|NCT00568152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24511302|NCT00568152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24511303|NCT00568152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511304|NCT00568152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24511370|NCT00568412|Dermatologic Agents|dermatologic agents|mesh-ancestor
24511371|NCT00568412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24511568|NCT00569712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24511569|NCT00569712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24512349|NCT00574366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512426|NCT00574769|Mitosis Modulators|mitosis modulators|mesh-ancestor
24456354|NCT00330980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24531336|NCT00635258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25677100|NCT01807520|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25677101|NCT01807520|Immunologic Factors|immunologic factors|mesh-ancestor
25677102|NCT01807520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677103|NCT01807598|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25677104|NCT01807598|Immunoconjugates|immunoconjugates|mesh-list
25677105|NCT01807598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25677106|NCT01807598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25677107|NCT01807598|Immunologic Factors|immunologic factors|mesh-ancestor
25677108|NCT01807598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677109|NCT01807624|Phenylephrine|phenylephrine|mesh-list
25677110|NCT01807624|Oxymetazoline|oxymetazoline|mesh-list
25677111|NCT01807624|Tetracaine|tetracaine|mesh-list
25677112|NCT01807624|Anesthetics, Local|anesthetics, local|mesh-ancestor
25014829|NCT03811847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25256546|NCT02481635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25256547|NCT02481635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256548|NCT02481635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25256549|NCT02481635|Immunologic Factors|immunologic factors|mesh-ancestor
25256550|NCT02481635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256551|NCT02481609|Acetylcysteine|acetylcysteine|mesh-list
25256552|NCT02481609|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24531337|NCT00635258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531348|NCT00635284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24531349|NCT00635284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24531350|NCT00635284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531351|NCT00635284|Antifungal Agents|antifungal agents|mesh-ancestor
24531361|NCT00635323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531362|NCT00635323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531363|NCT00635323|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24512155|NCT00573326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24531389|NCT00635531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531390|NCT00635557|Carboplatin|carboplatin|mesh-list
24531391|NCT00635557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531392|NCT00635713|Fulvestrant|fulvestrant|mesh-list
24531393|NCT00635713|Anastrozole|anastrozole|mesh-list
24531394|NCT00635713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24531395|NCT00635713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25210125|NCT02699281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25210126|NCT02699281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25210127|NCT02699281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25210128|NCT02699281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25210129|NCT02699281|Antiviral Agents|antiviral agents|mesh-ancestor
25210130|NCT02699281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25210131|NCT02699281|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25210132|NCT02699281|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25210133|NCT02699281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25210134|NCT02699281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210135|NCT02699281|Hormones|hormones|mesh-ancestor
25210136|NCT02699281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25210137|NCT02699385|Domperidone|domperidone|mesh-list
25210138|NCT02699385|Antiemetics|antiemetics|mesh-ancestor
25210139|NCT02699385|Autonomic Agents|autonomic agents|mesh-ancestor
25210140|NCT02699385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25210141|NCT02699385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210142|NCT02699385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25210143|NCT02699385|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25210144|NCT02699385|Dopamine Agents|dopamine agents|mesh-ancestor
25210145|NCT02699385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25210146|NCT02699385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210147|NCT02699528|Methylphenidate|methylphenidate|mesh-list
24512427|NCT00574769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512428|NCT00574769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24512429|NCT00574769|Immunologic Factors|immunologic factors|mesh-ancestor
24512431|NCT00574925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24512432|NCT00574925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24512433|NCT00574925|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24512434|NCT00574925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512435|NCT00574925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512436|NCT00574964|Temozolomide|temozolomide|mesh-list
24531397|NCT00635713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24531398|NCT00635713|Hormone Antagonists|hormone antagonists|mesh-ancestor
24531399|NCT00635713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24531400|NCT00635713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531402|NCT00635713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24531403|NCT00635713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677113|NCT01807624|Anesthetics|anesthetics|mesh-ancestor
25677114|NCT01807624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25677115|NCT01807624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677116|NCT01807624|Sensory System Agents|sensory system agents|mesh-ancestor
25677117|NCT01807624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25677118|NCT01807624|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25677119|NCT01807624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24531404|NCT00635713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531405|NCT00635726|Gemcitabine|gemcitabine|mesh-list
24531419|NCT00635726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531420|NCT00635726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24531421|NCT00635726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24531422|NCT00635726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24531423|NCT00635726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24531424|NCT00635726|Abortifacient Agents|abortifacient agents|mesh-ancestor
24531442|NCT00635856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531443|NCT00635856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24531444|NCT00635856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24531445|NCT00635856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531447|NCT00635921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24531449|NCT00635921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24531450|NCT00635921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531451|NCT00635921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531452|NCT00635921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24531453|NCT00635921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24531454|NCT00635921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24531455|NCT00635921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24531456|NCT00635921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24531535|NCT00636298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24531536|NCT00636298|Growth Substances|growth substances|mesh-ancestor
24531537|NCT00636298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531565|NCT00636415|Sensory System Agents|sensory system agents|mesh-ancestor
24531566|NCT00636415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24531567|NCT00636428|Midazolam|midazolam|mesh-list
24531568|NCT00636428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24531569|NCT00636428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24531570|NCT00636428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24456371|NCT00330993|Hormone Antagonists|hormone antagonists|mesh-ancestor
24531621|NCT00636831|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24531623|NCT00636831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24531624|NCT00636870|Fexofenadine|fexofenadine|mesh-list
24531687|NCT00636909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24531688|NCT00636909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24531689|NCT00636909|Antifungal Agents|antifungal agents|mesh-ancestor
24531744|NCT00637065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531746|NCT00637078|Spironolactone|spironolactone|mesh-list
24531747|NCT00637078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24531748|NCT00637078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25210148|NCT02699528|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25210149|NCT02699528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210150|NCT02699528|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25210151|NCT02699528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25210152|NCT02699528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25210153|NCT02699528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210154|NCT02699528|Dopamine Agents|dopamine agents|mesh-ancestor
25210155|NCT02699528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25210156|NCT02699008|Clopidogrel|clopidogrel|mesh-list
25210157|NCT02699008|Ticagrelor|ticagrelor|mesh-list
24512640|NCT00575952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24512641|NCT00575952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512643|NCT00575978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24457728|NCT00335088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24512644|NCT00575978|Vasodilator Agents|vasodilator agents|mesh-ancestor
24512645|NCT00576017|Fentanyl|fentanyl|mesh-list
24512675|NCT00576069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24512676|NCT00576069|Respiratory System Agents|respiratory system agents|mesh-ancestor
24512677|NCT00576069|Dermatologic Agents|dermatologic agents|mesh-ancestor
24512678|NCT00576069|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24512679|NCT00576069|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24512680|NCT00576069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24512681|NCT00576069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24512682|NCT00576069|Adrenergic Agents|adrenergic agents|mesh-ancestor
24512683|NCT00576069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24512684|NCT00576069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512686|NCT00576173|Acetaminophen|acetaminophen|mesh-list
25014992|NCT03568630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25014993|NCT03568630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256570|NCT02481453|Immunologic Factors|immunologic factors|mesh-ancestor
25256571|NCT02481453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256572|NCT02481323|Cilostazol|cilostazol|mesh-list
25256573|NCT02481323|Isosorbide|isosorbide|mesh-list
25256574|NCT02481323|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25256575|NCT02481323|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
24527462|NCT00616746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24512817|NCT00576914|Growth Substances|growth substances|mesh-ancestor
24512818|NCT00576914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512964|NCT00577837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24531749|NCT00637078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24531750|NCT00637078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531752|NCT00637078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531754|NCT00637078|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24531755|NCT00637078|Hormone Antagonists|hormone antagonists|mesh-ancestor
24531756|NCT00637078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24531757|NCT00637078|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24531760|NCT00637091|Irinotecan|irinotecan|mesh-list
24531767|NCT00637091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24531768|NCT00637104|Chromium|chromium|mesh-list
24531769|NCT00637104|Trace Elements|trace elements|mesh-ancestor
24531770|NCT00637104|Micronutrients|micronutrients|mesh-ancestor
24531771|NCT00637104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531772|NCT00637117|Interferons|interferons|mesh-list
24531958|NCT00637663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24669112|NCT04258410|Protective Agents|protective agents|mesh-ancestor
24669113|NCT04258410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24669114|NCT04253626|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24456388|NCT00331071|Contraceptives, Oral|contraceptives, oral|mesh-list
24456389|NCT00331071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24456390|NCT00331071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210158|NCT02699008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25210159|NCT02699008|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25210160|NCT02699008|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25210161|NCT02699008|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24645876|NCT01200537|Norinyl|norinyl|mesh-list
25210162|NCT02699008|Purinergic Agents|purinergic agents|mesh-ancestor
25210163|NCT02699008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25210164|NCT02699008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210165|NCT02699008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210166|NCT02699138|Trazodone|trazodone|mesh-list
25210167|NCT02699138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25210168|NCT02699138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25210169|NCT02699138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25210170|NCT02699138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210171|NCT02699138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25210172|NCT02699138|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25210173|NCT02699138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25210174|NCT02699138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25210175|NCT02699138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210176|NCT02699138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25210177|NCT02699138|Serotonin Agents|serotonin agents|mesh-ancestor
25210178|NCT02699138|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25210179|NCT02699138|Antidepressive Agents|antidepressive agents|mesh-ancestor
25210180|NCT02698982|Anesthetics|anesthetics|mesh-list
25272641|NCT02390674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24512965|NCT00577837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512966|NCT00577837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25677120|NCT01807624|Adrenergic Agents|adrenergic agents|mesh-ancestor
25677121|NCT01807624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25677122|NCT01807624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677123|NCT01807624|Sympathomimetics|sympathomimetics|mesh-ancestor
25677124|NCT01807624|Autonomic Agents|autonomic agents|mesh-ancestor
25677125|NCT01807624|Nasal Decongestants|nasal decongestants|mesh-ancestor
25677126|NCT01807624|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25677127|NCT01807624|Respiratory System Agents|respiratory system agents|mesh-ancestor
25677128|NCT01807624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25677129|NCT01807624|Mydriatics|mydriatics|mesh-ancestor
25256579|NCT02481323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512967|NCT00577837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512968|NCT00577837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24513480|NCT00582582|Micronutrients|micronutrients|mesh-ancestor
24513481|NCT00582582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513482|NCT00582582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513483|NCT00582582|Tubulin Modulators|tubulin modulators|mesh-ancestor
24513484|NCT00582582|Antimitotic Agents|antimitotic agents|mesh-ancestor
24513485|NCT00582582|Mitosis Modulators|mitosis modulators|mesh-ancestor
24513486|NCT00582582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513487|NCT00582582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24513488|NCT00582634|Docetaxel|docetaxel|mesh-list
24513489|NCT00582634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513492|NCT00582634|Mitosis Modulators|mitosis modulators|mesh-ancestor
24513601|NCT00583986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24513602|NCT00583986|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24513603|NCT00583986|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24513604|NCT00583986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24513605|NCT00583986|Adrenergic Agents|adrenergic agents|mesh-ancestor
24513606|NCT00583986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24513607|NCT00583986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513608|NCT00584090|Solifenacin Succinate|solifenacin succinate|mesh-list
24513609|NCT00584090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24513610|NCT00584090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24513611|NCT00584090|Cholinergic Agents|cholinergic agents|mesh-ancestor
24513612|NCT00584090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25210181|NCT02698982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25210182|NCT02698982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210183|NCT02698969|Atropine|atropine|mesh-list
25210184|NCT02698969|Fentanyl|fentanyl|mesh-list
25210185|NCT02698969|Propofol|propofol|mesh-list
25210186|NCT02698969|Sevoflurane|sevoflurane|mesh-list
25210187|NCT02698969|Rocuronium|rocuronium|mesh-list
25210188|NCT02698969|Neostigmine|neostigmine|mesh-list
25210189|NCT02698969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25210190|NCT02698969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25210203|NCT02698969|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25210204|NCT02698969|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25210205|NCT02698969|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25210206|NCT02698969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25210207|NCT02698969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25210208|NCT02698969|Autonomic Agents|autonomic agents|mesh-ancestor
25210209|NCT02698969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25210210|NCT02698969|Respiratory System Agents|respiratory system agents|mesh-ancestor
25210211|NCT02698969|Mydriatics|mydriatics|mesh-ancestor
25210212|NCT02698969|Parasympatholytics|parasympatholytics|mesh-ancestor
25210213|NCT02698969|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25210214|NCT02698969|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25210215|NCT02698969|Cholinergic Agents|cholinergic agents|mesh-ancestor
25210216|NCT02698969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25210217|NCT02698969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210218|NCT02698969|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25210219|NCT02698969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25210220|NCT02698969|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25210221|NCT02698930|Dexmedetomidine|dexmedetomidine|mesh-list
25210222|NCT02698930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24513665|NCT00584389|Hormones|hormones|mesh-ancestor
24513666|NCT00584389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24513667|NCT00584389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513727|NCT00584662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24513728|NCT00584662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24513729|NCT00584662|Adrenergic Agents|adrenergic agents|mesh-ancestor
24513730|NCT00584662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24513731|NCT00584662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456391|NCT00331071|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24456392|NCT00331071|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24456393|NCT00331084|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24456395|NCT00331084|Dexamethasone|dexamethasone|mesh-list
24456396|NCT00331084|Dexamethasone acetate|dexamethasone acetate|mesh-list
24456397|NCT00331084|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24456398|NCT00331084|BB 1101|bb 1101|mesh-list
24669115|NCT04253626|Hematinics|hematinics|mesh-ancestor
25677130|NCT01807624|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25275014|NCT02374567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25275015|NCT02374567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25275016|NCT02374567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25275017|NCT02374567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24928676|NCT04120519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24928677|NCT04120519|Growth Substances|growth substances|mesh-ancestor
24928678|NCT04120519|Growth Inhibitors|growth inhibitors|mesh-ancestor
24928679|NCT04120337|Lidocaine|lidocaine|mesh-list
24928680|NCT04120337|Anesthetics, Local|anesthetics, local|mesh-ancestor
24928681|NCT04120337|Anesthetics|anesthetics|mesh-ancestor
24928682|NCT04120337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24928683|NCT04120337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015237|NCT02947750|Vitamins|vitamins|mesh-ancestor
24669116|NCT04253626|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24669117|NCT04253626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24514020|NCT00587327|Atosiban|atosiban|mesh-list
24513883|NCT00585871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24513884|NCT00585871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24513885|NCT00585871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24513886|NCT00586092|Bevacizumab|bevacizumab|mesh-list
24513887|NCT00586092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24457733|NCT00335088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457734|NCT00335088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513888|NCT00586092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513889|NCT00586092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24513890|NCT00586092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24513891|NCT00586092|Growth Substances|growth substances|mesh-ancestor
24513892|NCT00586092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646140|NCT01202149|Emollients|emollients|mesh-list
24513965|NCT00586560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513966|NCT00586560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513967|NCT00586560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24513968|NCT00586794|Sildenafil Citrate|sildenafil citrate|mesh-list
24513969|NCT00586794|Vasodilator Agents|vasodilator agents|mesh-ancestor
24513970|NCT00586794|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24513971|NCT00586794|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24513972|NCT00586794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24513973|NCT00586794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513974|NCT00586794|Urological Agents|urological agents|mesh-ancestor
24513975|NCT00586833|Neurotransmitter Agents|neurotransmitter agents|mesh-list
24513976|NCT00586833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513977|NCT00586833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945034|NCT03954873|Incretins|incretins|mesh-ancestor
24669412|NCT04005053|Acetylcysteine|acetylcysteine|mesh-list
25677131|NCT01807624|Protective Agents|protective agents|mesh-ancestor
25677132|NCT01807871|Nicotine|nicotine|mesh-list
25677133|NCT01807871|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25677134|NCT01807871|Autonomic Agents|autonomic agents|mesh-ancestor
25677135|NCT01807871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25677136|NCT01807871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677137|NCT01807871|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25677138|NCT01807871|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25677139|NCT01807871|Cholinergic Agents|cholinergic agents|mesh-ancestor
25677140|NCT01807871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25677141|NCT01807871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677142|NCT01807923|Ivacaftor|ivacaftor|mesh-list
25677143|NCT01807923|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25677144|NCT01807923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25677145|NCT01807923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256599|NCT02481479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25256600|NCT02481479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256601|NCT02481479|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25256602|NCT02481479|Protease Inhibitors|protease inhibitors|mesh-ancestor
25256603|NCT02481479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256604|NCT02481479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256605|NCT02481479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25256606|NCT02481193|Cisatracurium|cisatracurium|mesh-list
24527511|NCT00616915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24669413|NCT04005053|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24669414|NCT04005053|Antiviral Agents|antiviral agents|mesh-ancestor
24532216|NCT00638677|Cathartics|cathartics|mesh-ancestor
24532217|NCT00638677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24532218|NCT00638729|Clonidine|clonidine|mesh-list
24532219|NCT00638729|Midazolam|midazolam|mesh-list
24532220|NCT00638729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24532221|NCT00638729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24532222|NCT00638729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24532223|NCT00638729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532224|NCT00638729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24532225|NCT00638729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25210233|NCT02698930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25210234|NCT02698930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210235|NCT02698995|Acetaminophen|acetaminophen|mesh-list
25210236|NCT02698995|Dexamethasone|dexamethasone|mesh-list
25210237|NCT02698995|Lidocaine|lidocaine|mesh-list
25210238|NCT02698995|Morphine|morphine|mesh-list
25210239|NCT02698995|Ropivacaine|ropivacaine|mesh-list
25210240|NCT02698995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25210241|NCT02698995|Antiemetics|antiemetics|mesh-ancestor
25210242|NCT02698995|Autonomic Agents|autonomic agents|mesh-ancestor
25210243|NCT02698995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25210244|NCT02698995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210245|NCT02698995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25210246|NCT02698995|Glucocorticoids|glucocorticoids|mesh-ancestor
25210247|NCT02698995|Hormones|hormones|mesh-ancestor
25210248|NCT02698995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25210249|NCT02698995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25210250|NCT02698995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25210251|NCT02698995|Anesthetics, Local|anesthetics, local|mesh-ancestor
25210252|NCT02698995|Anesthetics|anesthetics|mesh-ancestor
25210253|NCT02698995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25210254|NCT02698995|Sensory System Agents|sensory system agents|mesh-ancestor
25210255|NCT02698995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24646143|NCT01202149|Analgesics|analgesics|mesh-ancestor
25210256|NCT02698995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25210257|NCT02698995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25210258|NCT02698995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25210259|NCT02698995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210260|NCT02698995|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25210261|NCT02698995|Narcotics|narcotics|mesh-ancestor
24513983|NCT00586911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513984|NCT00586911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24513985|NCT00586924|Immunotoxin HA22|immunotoxin ha22|mesh-list
24513986|NCT00586924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513987|NCT00586976|Ropivacaine|ropivacaine|mesh-list
24513988|NCT00586976|Anesthetics, Local|anesthetics, local|mesh-ancestor
24513989|NCT00586976|Anesthetics|anesthetics|mesh-ancestor
24513990|NCT00586976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24514017|NCT00587249|Antacids|antacids|mesh-ancestor
25677146|NCT01807949|Ivacaftor|ivacaftor|mesh-list
25677147|NCT01807949|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25677148|NCT01807949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25677149|NCT01807949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677150|NCT01808092|Meropenem|meropenem|mesh-list
25677151|NCT01808092|Ceftazidime|ceftazidime|mesh-list
25677152|NCT01808092|Avibactam|avibactam|mesh-list
25677153|NCT01808092|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
25677154|NCT01808092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25677155|NCT01808092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25677156|NCT01808092|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25015512|NCT02245230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25015513|NCT02245230|Cholinergic Agents|cholinergic agents|mesh-ancestor
25015514|NCT02224573|Cannabidiol|cannabidiol|mesh-list
25015515|NCT02224573|Anticonvulsants|anticonvulsants|mesh-ancestor
25015516|NCT02164643|Flutemetamol|flutemetamol|mesh-list
24532291|NCT00639015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24532294|NCT00639015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24456451|NCT00331123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456453|NCT00331149|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24456454|NCT00331149|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24456455|NCT00331149|Dopamine Agonists|dopamine agonists|mesh-ancestor
24456456|NCT00331149|Dopamine Agents|dopamine agents|mesh-ancestor
24456457|NCT00331149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24456458|NCT00331149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456459|NCT00331149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456461|NCT00331188|Analgesics|analgesics|mesh-ancestor
24532339|NCT00639483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532341|NCT00639496|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24532342|NCT00639496|Antiviral Agents|antiviral agents|mesh-ancestor
24532343|NCT00639496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24532344|NCT00639496|Expectorants|expectorants|mesh-ancestor
24532345|NCT00639496|Respiratory System Agents|respiratory system agents|mesh-ancestor
24646338|NCT01203254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24532346|NCT00639496|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24532347|NCT00639496|Antioxidants|antioxidants|mesh-ancestor
24532348|NCT00639496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532349|NCT00639496|Protective Agents|protective agents|mesh-ancestor
24532350|NCT00639496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532351|NCT00639496|Antidotes|antidotes|mesh-ancestor
24532355|NCT00639522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24532356|NCT00639522|Tubulin Modulators|tubulin modulators|mesh-ancestor
24532357|NCT00639522|Antimitotic Agents|antimitotic agents|mesh-ancestor
24532358|NCT00639522|Mitosis Modulators|mitosis modulators|mesh-ancestor
24532359|NCT00639522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532360|NCT00639522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24532361|NCT00639522|Antimetabolites|antimetabolites|mesh-ancestor
24413676|NCT00194909|Sildenafil Citrate|sildenafil citrate|mesh-list
24456474|NCT00331240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24669638|NCT03772314|Modafinil|modafinil|mesh-list
25210262|NCT02698995|Analgesics|analgesics|mesh-ancestor
25210263|NCT02698995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25210264|NCT02698995|Antipyretics|antipyretics|mesh-ancestor
25210265|NCT02698813|Hyaluronic Acid|hyaluronic acid|mesh-list
25210266|NCT02698813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25210267|NCT02698813|Immunologic Factors|immunologic factors|mesh-ancestor
25210268|NCT02698813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210269|NCT02698813|Viscosupplements|viscosupplements|mesh-ancestor
25210270|NCT02698813|Protective Agents|protective agents|mesh-ancestor
25210271|NCT02698553|Bupropion|bupropion|mesh-list
25210272|NCT02698553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25210273|NCT02698553|Antidepressive Agents|antidepressive agents|mesh-ancestor
25210274|NCT02698553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24457735|NCT00335088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514018|NCT00587249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514019|NCT00587249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24514021|NCT00587327|Hormone Antagonists|hormone antagonists|mesh-ancestor
24514022|NCT00587327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24514023|NCT00587327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514024|NCT00587327|Tocolytic Agents|tocolytic agents|mesh-ancestor
24514025|NCT00587327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24514026|NCT00587379|Atorvastatin|atorvastatin|mesh-list
24514027|NCT00587379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24514028|NCT00587379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24514029|NCT00587379|Antimetabolites|antimetabolites|mesh-ancestor
25677157|NCT01808092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677158|NCT01808092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677159|NCT01808118|Adalimumab|adalimumab|mesh-list
25677160|NCT01808118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25677161|NCT01808118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25677162|NCT01808144|Febuxostat|febuxostat|mesh-list
25677163|NCT01808144|Lesinurad|lesinurad|mesh-list
25677164|NCT01808144|Gout Suppressants|gout suppressants|mesh-ancestor
25677165|NCT01808144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25256623|NCT02480946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256624|NCT02480946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256625|NCT02480946|Dermatologic Agents|dermatologic agents|mesh-ancestor
25256626|NCT02480946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256627|NCT02480946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25256628|NCT02480946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25256629|NCT02480946|Immunologic Factors|immunologic factors|mesh-ancestor
25256630|NCT02480946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24928687|NCT04120337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24928688|NCT04120337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24646429|NCT01203709|Tacrolimus|tacrolimus|mesh-list
24514092|NCT00587873|Thioguanine|thioguanine|mesh-list
24514093|NCT00587873|Calcium|calcium|mesh-list
24514094|NCT00587873|Levoleucovorin|levoleucovorin|mesh-list
24514095|NCT00587873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24514096|NCT00587873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514097|NCT00587873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24514098|NCT00587873|Abortifacient Agents|abortifacient agents|mesh-ancestor
24514099|NCT00587873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24514100|NCT00587873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24669639|NCT03772314|Amphetamine|amphetamine|mesh-list
24669640|NCT03772314|Adderall|adderall|mesh-list
24669641|NCT03772314|Dextroamphetamine|dextroamphetamine|mesh-list
24669642|NCT03772314|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24669643|NCT03772314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24669644|NCT03772314|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24669645|NCT03772314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24669646|NCT03772314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24669647|NCT03772314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24669648|NCT03772314|Sympathomimetics|sympathomimetics|mesh-ancestor
24669649|NCT03772314|Autonomic Agents|autonomic agents|mesh-ancestor
25210281|NCT02698553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210282|NCT02698553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25210283|NCT02698553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25210284|NCT02698553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25210286|NCT02698514|Desflurane|desflurane|mesh-list
25210287|NCT02698514|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25210288|NCT02698514|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25210289|NCT02698514|Anesthetics, General|anesthetics, general|mesh-ancestor
25210290|NCT02698514|Anesthetics|anesthetics|mesh-ancestor
25210291|NCT02698514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25210292|NCT02698514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210293|NCT02698527|Lidocaine|lidocaine|mesh-list
25210294|NCT02698527|Anesthetics, Local|anesthetics, local|mesh-ancestor
25210295|NCT02698527|Anesthetics|anesthetics|mesh-ancestor
25210296|NCT02698527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25210297|NCT02698527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210298|NCT02698527|Sensory System Agents|sensory system agents|mesh-ancestor
25210299|NCT02698527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24514101|NCT00587873|Antimetabolites|antimetabolites|mesh-ancestor
24457736|NCT00335088|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24457737|NCT00335088|Trace Elements|trace elements|mesh-ancestor
24457738|NCT00335088|Micronutrients|micronutrients|mesh-ancestor
24457739|NCT00335088|Plasma Substitutes|plasma substitutes|mesh-ancestor
24457740|NCT00335088|Blood Substitutes|blood substitutes|mesh-ancestor
24457741|NCT00335114|Cyclosporine|cyclosporine|mesh-list
24457742|NCT00335114|Cyclosporins|cyclosporins|mesh-list
24457743|NCT00335114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677166|NCT01808144|Uricosuric Agents|uricosuric agents|mesh-ancestor
25677167|NCT01808144|Renal Agents|renal agents|mesh-ancestor
25677168|NCT01808196|Losartan|losartan|mesh-list
25677169|NCT01808196|Angiotensin II|angiotensin ii|mesh-list
25677170|NCT01808196|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
25677171|NCT01808196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25677172|NCT01808196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25677173|NCT01808196|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25677174|NCT01808196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677175|NCT01808196|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25677176|NCT01808248|Sofosbuvir|sofosbuvir|mesh-list
25256640|NCT02481076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256641|NCT02481076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514206|NCT00588926|Sensory System Agents|sensory system agents|mesh-ancestor
24514207|NCT00588926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24514208|NCT00589082|Daunorubicin|daunorubicin|mesh-list
24514209|NCT00589082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24532504|NCT00640159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24669710|NCT03702725|Dexamethasone|dexamethasone|mesh-list
24669711|NCT03702725|Lenalidomide|lenalidomide|mesh-list
24669712|NCT03702725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24669713|NCT03702725|Antiemetics|antiemetics|mesh-ancestor
24669714|NCT03702725|Autonomic Agents|autonomic agents|mesh-ancestor
24669715|NCT03702725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24669743|NCT03691376|Sensory System Agents|sensory system agents|mesh-ancestor
24669746|NCT03691376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24669747|NCT03691376|Antiviral Agents|antiviral agents|mesh-ancestor
24669748|NCT03691376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24669749|NCT03663712|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
24669750|NCT03663712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24669751|NCT03663712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513094|NCT00578721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24513095|NCT00578721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24513099|NCT00578721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532506|NCT00640159|Protective Agents|protective agents|mesh-ancestor
24532507|NCT00640159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532508|NCT00640198|Memantine|memantine|mesh-list
24532509|NCT00640198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24532510|NCT00640198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24532511|NCT00640198|Dopamine Agents|dopamine agents|mesh-ancestor
24669806|NCT03611010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25210300|NCT02698527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25210301|NCT02698527|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25210302|NCT02698527|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25210303|NCT02698527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25210304|NCT02698527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210305|NCT02698748|Chloroquine|chloroquine|mesh-list
25210306|NCT02698748|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
25210307|NCT02698748|Amebicides|amebicides|mesh-ancestor
25210308|NCT02698748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25210309|NCT02698748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25210310|NCT02698748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25210311|NCT02698748|Antimalarials|antimalarials|mesh-ancestor
24514211|NCT00589082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24514212|NCT00589082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24514213|NCT00589082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24514214|NCT00589082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514215|NCT00589134|Ganirelix|ganirelix|mesh-list
24514216|NCT00589134|Hormone Antagonists|hormone antagonists|mesh-ancestor
24514217|NCT00589134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24514218|NCT00589134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514219|NCT00589186|Celecoxib|celecoxib|mesh-list
24669867|NCT03476798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24669868|NCT03476798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24669869|NCT03476798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24669899|NCT03414034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24669900|NCT03414034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24669901|NCT03414034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24669902|NCT03414034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24669903|NCT03414034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513250|NCT00580190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532690|NCT00640809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24532691|NCT00640809|Analgesics|analgesics|mesh-ancestor
24532692|NCT00640809|Sensory System Agents|sensory system agents|mesh-ancestor
24532693|NCT00640809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24532694|NCT00640809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532695|NCT00640809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24532696|NCT00640809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25677177|NCT01808248|Antiviral Agents|antiviral agents|mesh-ancestor
25677178|NCT01808248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25677179|NCT01808313|Ambrisentan|ambrisentan|mesh-list
24532697|NCT00640809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25677180|NCT01808313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24532698|NCT00640809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532699|NCT00640809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532730|NCT00640887|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24532731|NCT00640887|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24532732|NCT00640887|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25210322|NCT02698748|Anthelmintics|anthelmintics|mesh-ancestor
24514220|NCT00589186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24514221|NCT00589186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24514222|NCT00589186|Analgesics|analgesics|mesh-ancestor
24514223|NCT00589186|Sensory System Agents|sensory system agents|mesh-ancestor
24514313|NCT00589862|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24945068|NCT03953950|Losartan|losartan|mesh-list
24533120|NCT00642330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533122|NCT00642395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24533198|NCT00642551|Hemostatics|hemostatics|mesh-ancestor
24533199|NCT00642551|Coagulants|coagulants|mesh-ancestor
24533200|NCT00642551|Vitamins|vitamins|mesh-ancestor
24533201|NCT00642551|Micronutrients|micronutrients|mesh-ancestor
24533202|NCT00642551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533203|NCT00642577|Leucovorin|leucovorin|mesh-list
24533204|NCT00642577|Bevacizumab|bevacizumab|mesh-list
24533229|NCT00642655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24533230|NCT00642655|Immunologic Factors|immunologic factors|mesh-ancestor
24533231|NCT00642655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210325|NCT02698267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25210326|NCT02698267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25210327|NCT02698267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25210328|NCT02698267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533260|NCT00642824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24456524|NCT00331513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456525|NCT00331513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24456535|NCT00331604|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24456536|NCT00331604|Insulin Aspart|insulin aspart|mesh-list
24456537|NCT00331604|Insulin, Long-Acting|insulin, long-acting|mesh-list
24456538|NCT00331604|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24456539|NCT00331604|Insulin Detemir|insulin detemir|mesh-list
24513549|NCT00583271|Hormones|hormones|mesh-ancestor
24533266|NCT00642824|Growth Inhibitors|growth inhibitors|mesh-ancestor
24533267|NCT00642837|Acetaminophen|acetaminophen|mesh-list
24533268|NCT00642837|Tramadol|tramadol|mesh-list
24533269|NCT00642837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24533270|NCT00642837|Analgesics|analgesics|mesh-ancestor
24533271|NCT00642837|Sensory System Agents|sensory system agents|mesh-ancestor
24394644|NCT00133822|Risperidone|risperidone|mesh-list
25210345|NCT02698124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25210329|NCT02698267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514316|NCT00589862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24514317|NCT00589862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414678|NCT00198393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456549|NCT00331695|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
24670219|NCT03181100|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24670220|NCT03181100|Bevacizumab|bevacizumab|mesh-list
24670221|NCT03181100|Atezolizumab|atezolizumab|mesh-list
24670222|NCT03181100|Vemurafenib|vemurafenib|mesh-list
24414818|NCT00198848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24670247|NCT03119064|Irinotecan|irinotecan|mesh-list
24670248|NCT03119064|Temozolomide|temozolomide|mesh-list
24670249|NCT03119064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24670250|NCT03119064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24670251|NCT03119064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24670252|NCT03119064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24670253|NCT03119064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24670254|NCT03119064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24670255|NCT03119064|Alkylating Agents|alkylating agents|mesh-ancestor
24670256|NCT03117049|Paclitaxel|paclitaxel|mesh-list
24670257|NCT03117049|Bevacizumab|bevacizumab|mesh-list
24670258|NCT03117049|Carboplatin|carboplatin|mesh-list
24670259|NCT03117049|Nivolumab|nivolumab|mesh-list
24670260|NCT03117049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24513732|NCT00584662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456551|NCT00331695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24670273|NCT03101748|Paclitaxel|paclitaxel|mesh-list
25256700|NCT02480686|Antiviral Agents|antiviral agents|mesh-ancestor
25256701|NCT02480686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24670292|NCT03101748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24670293|NCT03101748|Immunologic Factors|immunologic factors|mesh-ancestor
24670294|NCT03101748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24670295|NCT03101748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24670296|NCT03101748|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24415098|NCT00199069|Mercaptopurine|mercaptopurine|mesh-list
25210333|NCT02698267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210334|NCT02698267|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25210335|NCT02698280|Bevacizumab|bevacizumab|mesh-list
25210336|NCT02698280|Nimustine|nimustine|mesh-list
25210337|NCT02698280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24514692|NCT00592280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24514693|NCT00592306|Thymoglobulin|thymoglobulin|mesh-list
24514694|NCT00592306|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24514695|NCT00592306|Immunologic Factors|immunologic factors|mesh-ancestor
24514696|NCT00592306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514697|NCT00592306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24533313|NCT00643071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533315|NCT00643136|Analgesics|analgesics|mesh-ancestor
24533316|NCT00643136|Sensory System Agents|sensory system agents|mesh-ancestor
24533317|NCT00643136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24670410|NCT02663622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24670411|NCT02663622|Immunologic Factors|immunologic factors|mesh-ancestor
24670412|NCT02663622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24670413|NCT02663622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24670435|NCT02575404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24670436|NCT02575404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24670437|NCT02567825|Amoxicillin|amoxicillin|mesh-list
24670438|NCT02567825|Ceftriaxone|ceftriaxone|mesh-list
25677181|NCT01808326|Chlorambucil|chlorambucil|mesh-list
25677182|NCT01808326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25677183|NCT01808326|Alkylating Agents|alkylating agents|mesh-ancestor
24670439|NCT02567825|Clavulanic Acid|clavulanic acid|mesh-list
25677184|NCT01808326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677185|NCT01808326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25677186|NCT01808339|Fluticasone|fluticasone|mesh-list
25677187|NCT01808339|Xhance|xhance|mesh-list
25677188|NCT01808339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25677189|NCT01808339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25677190|NCT01808339|Autonomic Agents|autonomic agents|mesh-ancestor
24670443|NCT02567825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25210339|NCT02698280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25210340|NCT02698280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25210341|NCT02698280|Growth Substances|growth substances|mesh-ancestor
25210342|NCT02698280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210343|NCT02698280|Growth Inhibitors|growth inhibitors|mesh-ancestor
25210344|NCT02698124|Decitabine|decitabine|mesh-list
24670459|NCT02536755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24670460|NCT02536755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24670463|NCT02516241|Gemcitabine|gemcitabine|mesh-list
24670464|NCT02516241|Carboplatin|carboplatin|mesh-list
24670465|NCT02516241|Durvalumab|durvalumab|mesh-list
24670466|NCT02516241|Tremelimumab|tremelimumab|mesh-list
24670467|NCT02516241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24670468|NCT02516241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24670469|NCT02516241|Antimetabolites|antimetabolites|mesh-ancestor
24670470|NCT02516241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24670471|NCT02516241|Antiviral Agents|antiviral agents|mesh-ancestor
24670472|NCT02516241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24670473|NCT02516241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24670474|NCT02516241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24670475|NCT02516241|Immunologic Factors|immunologic factors|mesh-ancestor
24670476|NCT02516241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514082|NCT00587717|Simvastatin|simvastatin|mesh-list
25210347|NCT02698124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210349|NCT02698124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24514725|NCT00592566|Hormones|hormones|mesh-ancestor
24514729|NCT00592566|Hemostatics|hemostatics|mesh-ancestor
24514733|NCT00592579|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
24514734|NCT00592579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514735|NCT00592579|Tubulin Modulators|tubulin modulators|mesh-ancestor
24514736|NCT00592579|Antimitotic Agents|antimitotic agents|mesh-ancestor
24670763|NCT01998971|Anesthetics, Local|anesthetics, local|mesh-ancestor
24670764|NCT01998971|Anesthetics|anesthetics|mesh-ancestor
24670765|NCT01998971|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24670766|NCT01998971|Histamine Antagonists|histamine antagonists|mesh-ancestor
24670767|NCT01998971|Histamine Agents|histamine agents|mesh-ancestor
24670768|NCT01998971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24670769|NCT01998971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24670770|NCT01998971|Antipruritics|antipruritics|mesh-ancestor
24670840|NCT01759459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24670841|NCT01759459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24670842|NCT01759459|Sensory System Agents|sensory system agents|mesh-ancestor
24670843|NCT01759459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24670844|NCT01759459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24670845|NCT01759459|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24670846|NCT01759459|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24670848|NCT01759459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514332|NCT00589927|Cilostazol|cilostazol|mesh-list
24415875|NCT00201357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24415876|NCT00201357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24415877|NCT00201357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24415878|NCT00201357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24393351|NCT00129818|Famciclovir|famciclovir|mesh-list
24393426|NCT00130026|Caffeine|caffeine|mesh-list
24393500|NCT00130195|Antiemetics|antiemetics|mesh-ancestor
24393633|NCT00130546|Sirolimus|sirolimus|mesh-list
24527660|NCT00617955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527661|NCT00617968|Docetaxel|docetaxel|mesh-list
24527662|NCT00617968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527663|NCT00617968|Tubulin Modulators|tubulin modulators|mesh-ancestor
24527664|NCT00617968|Antimitotic Agents|antimitotic agents|mesh-ancestor
24527665|NCT00617968|Mitosis Modulators|mitosis modulators|mesh-ancestor
25016352|NCT00090142|Hormone Antagonists|hormone antagonists|mesh-ancestor
25016358|NCT00076973|Montelukast|montelukast|mesh-list
24394495|NCT00133380|Atorvastatin|atorvastatin|mesh-list
24395535|NCT00136344|Renal Agents|renal agents|mesh-ancestor
25210361|NCT02698306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25210362|NCT02698306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25210363|NCT02698306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25210364|NCT02698306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25210365|NCT02698306|Analgesics|analgesics|mesh-ancestor
24398462|NCT00144417|Antimetabolites|antimetabolites|mesh-ancestor
24398816|NCT00145847|Naltrexone|naltrexone|mesh-list
24399929|NCT00149019|Antibodies|antibodies|mesh-list
24400337|NCT00150371|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24402281|NCT00156312|Docetaxel|docetaxel|mesh-list
24446793|NCT00305903|Cholinergic Agents|cholinergic agents|mesh-ancestor
24538420|NCT00659178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24455677|NCT00328497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455678|NCT00328497|Growth Inhibitors|growth inhibitors|mesh-ancestor
24455679|NCT00328497|Tubulin Modulators|tubulin modulators|mesh-ancestor
24455680|NCT00328497|Antimitotic Agents|antimitotic agents|mesh-ancestor
24455681|NCT00328497|Mitosis Modulators|mitosis modulators|mesh-ancestor
24455682|NCT00328497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455683|NCT00328549|Interferons|interferons|mesh-list
24455684|NCT00328549|Ribavirin|ribavirin|mesh-list
24455689|NCT00328549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455690|NCT00328692|Rolofylline|rolofylline|mesh-list
24455691|NCT00328692|Diuretics|diuretics|mesh-ancestor
24455692|NCT00328692|Natriuretic Agents|natriuretic agents|mesh-ancestor
24455693|NCT00328692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455694|NCT00328718|Fluticasone|fluticasone|mesh-list
24455696|NCT00328718|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24455710|NCT00328718|Adrenergic Agents|adrenergic agents|mesh-ancestor
24455711|NCT00328718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24455712|NCT00328718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455713|NCT00328718|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25677191|NCT01808339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25677192|NCT01808339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677193|NCT01808339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25677194|NCT01808339|Respiratory System Agents|respiratory system agents|mesh-ancestor
25677195|NCT01808339|Dermatologic Agents|dermatologic agents|mesh-ancestor
25677196|NCT01808339|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25677197|NCT01808534|Isophosphamide mustard|isophosphamide mustard|mesh-list
25677198|NCT01808534|Ifosfamide|ifosfamide|mesh-list
25677199|NCT01808534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24455714|NCT00328718|Hormone Antagonists|hormone antagonists|mesh-ancestor
24455715|NCT00328718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25210368|NCT02698306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25210369|NCT02698306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272642|NCT02390674|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25272643|NCT02390739|Aldesleukin|aldesleukin|mesh-list
25272644|NCT02390739|Cyclophosphamide|cyclophosphamide|mesh-list
25272646|NCT02390739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24527004|NCT00614328|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24455716|NCT00328718|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24455717|NCT00328718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24455719|NCT00328796|Anesthetics, Local|anesthetics, local|mesh-ancestor
24455720|NCT00328796|Anesthetics|anesthetics|mesh-ancestor
24455721|NCT00328796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24455722|NCT00328796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455723|NCT00328796|Sensory System Agents|sensory system agents|mesh-ancestor
24455724|NCT00328796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24455725|NCT00328796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24455953|NCT00329446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24455726|NCT00328796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24455727|NCT00328796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24455728|NCT00328796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24416381|NCT00202982|Immunologic Factors|immunologic factors|mesh-ancestor
24416424|NCT00203099|Glatiramer Acetate|glatiramer acetate|mesh-list
24455729|NCT00328796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455739|NCT00328822|Antidepressive Agents|antidepressive agents|mesh-ancestor
24455740|NCT00328822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24455741|NCT00328822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24455742|NCT00328822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24455882|NCT00329329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24455883|NCT00329355|Naproxen|naproxen|mesh-list
24455884|NCT00329355|Sumatriptan|sumatriptan|mesh-list
24455885|NCT00329355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24455886|NCT00329355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24455887|NCT00329355|Analgesics|analgesics|mesh-ancestor
24455888|NCT00329355|Sensory System Agents|sensory system agents|mesh-ancestor
24456704|NCT00332033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456705|NCT00332033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24456706|NCT00332033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24455891|NCT00329355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24455892|NCT00329355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24455893|NCT00329355|Gout Suppressants|gout suppressants|mesh-ancestor
24416617|NCT00203567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24455894|NCT00329355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24455895|NCT00329355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24455896|NCT00329355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455897|NCT00329355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24515072|NCT00594269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533388|NCT00643643|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25210370|NCT02698306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210371|NCT02698098|Methadone|methadone|mesh-list
25210372|NCT02698098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25210374|NCT02698098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24455942|NCT00329446|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24455944|NCT00329446|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24455945|NCT00329446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24455946|NCT00329446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24455947|NCT00329446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455948|NCT00329446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24455949|NCT00329446|Serotonin Agents|serotonin agents|mesh-ancestor
24515087|NCT00594373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24515088|NCT00594373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515089|NCT00594373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455950|NCT00329446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455951|NCT00329446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24455952|NCT00329446|Antidepressive Agents|antidepressive agents|mesh-ancestor
24455990|NCT00329498|Protective Agents|protective agents|mesh-ancestor
24455991|NCT00329498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455992|NCT00329498|Vitamins|vitamins|mesh-ancestor
24455994|NCT00329511|Clonidine|clonidine|mesh-list
24455995|NCT00329511|Methyldopa|methyldopa|mesh-list
24455996|NCT00329511|Analgesics|analgesics|mesh-ancestor
24533390|NCT00643643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24533391|NCT00643643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24533392|NCT00643643|Antiviral Agents|antiviral agents|mesh-ancestor
24533393|NCT00643643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24533394|NCT00643643|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24455997|NCT00329511|Sensory System Agents|sensory system agents|mesh-ancestor
24455998|NCT00329511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24456001|NCT00329511|Sympatholytics|sympatholytics|mesh-ancestor
24456002|NCT00329511|Autonomic Agents|autonomic agents|mesh-ancestor
24456714|NCT00332046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538729|NCT00660621|Temozolomide|temozolomide|mesh-list
24394645|NCT00133822|Sertraline|sertraline|mesh-list
24456008|NCT00329511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456009|NCT00329537|Sargramostim|sargramostim|mesh-list
24456010|NCT00329537|Immunologic Factors|immunologic factors|mesh-ancestor
24456011|NCT00329537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533406|NCT00643734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25210375|NCT02698098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457762|NCT00335166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24457764|NCT00335179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24514891|NCT00593294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24514892|NCT00593294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24514893|NCT00593294|Diuretics|diuretics|mesh-ancestor
24514894|NCT00593294|Natriuretic Agents|natriuretic agents|mesh-ancestor
24456018|NCT00329615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456019|NCT00329628|Enoxaparin|enoxaparin|mesh-list
24456020|NCT00329628|Rivaroxaban|rivaroxaban|mesh-list
24456021|NCT00329628|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24456022|NCT00329628|Antithrombins|antithrombins|mesh-ancestor
24456023|NCT00329628|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24456024|NCT00329628|Protease Inhibitors|protease inhibitors|mesh-ancestor
24456025|NCT00329628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456026|NCT00329628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527716|NCT00618163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24527717|NCT00618163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24527718|NCT00618163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24527719|NCT00618163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527720|NCT00618163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016658|NCT04840264|Tubulin Modulators|tubulin modulators|mesh-ancestor
25016659|NCT04840264|Antimitotic Agents|antimitotic agents|mesh-ancestor
25016660|NCT04840264|Mitosis Modulators|mitosis modulators|mesh-ancestor
24456027|NCT00329628|Anticoagulants|anticoagulants|mesh-ancestor
24456028|NCT00329628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24456029|NCT00329628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24456030|NCT00329680|Evening primrose oil|evening primrose oil|mesh-list
24456035|NCT00329680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24456036|NCT00329680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24456037|NCT00329680|Analgesics|analgesics|mesh-ancestor
24456041|NCT00329680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24533415|NCT00643799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24533416|NCT00643799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533418|NCT00643799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25210376|NCT02698098|Analgesics|analgesics|mesh-ancestor
25210377|NCT02698098|Sensory System Agents|sensory system agents|mesh-ancestor
25210378|NCT02698098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25210379|NCT02698098|Antitussive Agents|antitussive agents|mesh-ancestor
25210380|NCT02698098|Respiratory System Agents|respiratory system agents|mesh-ancestor
25210381|NCT02698228|Morphine|morphine|mesh-list
25210382|NCT02698228|Bupivacaine|bupivacaine|mesh-list
25210383|NCT02698228|Anesthetics, Local|anesthetics, local|mesh-ancestor
25210384|NCT02698228|Anesthetics|anesthetics|mesh-ancestor
25210385|NCT02698228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25210386|NCT02698228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210387|NCT02698228|Sensory System Agents|sensory system agents|mesh-ancestor
25210388|NCT02698228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25210389|NCT02698228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25210390|NCT02698228|Narcotics|narcotics|mesh-ancestor
25210391|NCT02698228|Analgesics|analgesics|mesh-ancestor
24514994|NCT00593710|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24456057|NCT00329758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24456058|NCT00329758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24456059|NCT00329758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456060|NCT00329810|Aripiprazole|aripiprazole|mesh-list
25677200|NCT01808534|Alkylating Agents|alkylating agents|mesh-ancestor
25677201|NCT01808534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677202|NCT01808534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25677203|NCT01808547|Bromfenac|bromfenac|mesh-list
25677204|NCT01808547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25677205|NCT01808547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25677206|NCT01808547|Analgesics|analgesics|mesh-ancestor
25677207|NCT01808547|Sensory System Agents|sensory system agents|mesh-ancestor
24456094|NCT00329914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456096|NCT00329940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24456097|NCT00329940|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24456098|NCT00329940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24456099|NCT00329940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456110|NCT00330044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24456111|NCT00330135|Hyaluronic Acid|hyaluronic acid|mesh-list
24456112|NCT00330135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24456113|NCT00330135|Immunologic Factors|immunologic factors|mesh-ancestor
24456114|NCT00330135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417170|NCT00205751|Dexamethasone|dexamethasone|mesh-list
24456134|NCT00330239|Serotonin Agents|serotonin agents|mesh-ancestor
24456135|NCT00330239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456136|NCT00330239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24456137|NCT00330239|Antidepressive Agents|antidepressive agents|mesh-ancestor
24533433|NCT00644020|Mitomycin|mitomycin|mesh-list
24533434|NCT00644020|Antimetabolites|antimetabolites|mesh-ancestor
24533437|NCT00644020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25210392|NCT02697955|Epinephrine|epinephrine|mesh-list
25210393|NCT02697955|Bupivacaine|bupivacaine|mesh-list
25210394|NCT02697955|Anesthetics, Local|anesthetics, local|mesh-ancestor
24514997|NCT00593710|Adrenergic Agents|adrenergic agents|mesh-ancestor
24514998|NCT00593710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24514999|NCT00593801|Epoetin Alfa|epoetin alfa|mesh-list
24515000|NCT00593801|Hematinics|hematinics|mesh-ancestor
24515001|NCT00593853|Methylphenidate|methylphenidate|mesh-list
24515002|NCT00593853|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24456139|NCT00330239|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24456140|NCT00330239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24456144|NCT00330252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24456145|NCT00330252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24456146|NCT00330252|Immunologic Factors|immunologic factors|mesh-ancestor
24456147|NCT00330252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456150|NCT00330278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24456151|NCT00330278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24456153|NCT00330304|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24456154|NCT00330304|Antitubercular Agents|antitubercular agents|mesh-ancestor
24456155|NCT00330304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24456156|NCT00330304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24456157|NCT00330304|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24456159|NCT00330304|Antimetabolites|antimetabolites|mesh-ancestor
24456724|NCT00332059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24538771|NCT00660764|Antimetabolites|antimetabolites|mesh-ancestor
24456198|NCT00330577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456199|NCT00330577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456200|NCT00330577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24456201|NCT00330577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24456202|NCT00330577|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24456203|NCT00330577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24456205|NCT00330655|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24456206|NCT00330655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24456207|NCT00330655|Dopamine Agents|dopamine agents|mesh-ancestor
24456208|NCT00330655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24456209|NCT00330655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210395|NCT02697955|Anesthetics|anesthetics|mesh-ancestor
25210396|NCT02697955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25210397|NCT02697955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210398|NCT02697955|Sensory System Agents|sensory system agents|mesh-ancestor
25210399|NCT02697955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25210400|NCT02697955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24515004|NCT00593853|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24516124|NCT00600639|Antitubercular Agents|antitubercular agents|mesh-ancestor
24619694|NCT01053390|Vitamins|vitamins|mesh-ancestor
24456210|NCT00330655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456212|NCT00330655|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24456214|NCT00330707|Interferon-alpha|interferon-alpha|mesh-list
25677208|NCT01808547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25677209|NCT01808547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677210|NCT01808547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25677211|NCT01808547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25677212|NCT01808573|Capecitabine|capecitabine|mesh-list
25677213|NCT01808573|Lapatinib|lapatinib|mesh-list
25677214|NCT01808573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25677215|NCT01808573|Antimetabolites|antimetabolites|mesh-ancestor
25677216|NCT01808573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017084|NCT02668783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25017085|NCT02668783|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25017086|NCT02668783|Contraceptive Agents|contraceptive agents|mesh-ancestor
25017087|NCT02668783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25017088|NCT02668783|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25017145|NCT02409342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25017146|NCT02409342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24456226|NCT00330746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210401|NCT02697955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25210402|NCT02697955|Adrenergic Agents|adrenergic agents|mesh-ancestor
25210403|NCT02697955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25210404|NCT02697955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210405|NCT02697955|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24516128|NCT00600639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24770365|NCT01819961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24456227|NCT00330746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24456229|NCT00330746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24456230|NCT00330746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456231|NCT00330746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24456232|NCT00330746|Immunologic Factors|immunologic factors|mesh-ancestor
24456253|NCT00330772|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24456254|NCT00330772|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24456255|NCT00330772|Purinergic Agents|purinergic agents|mesh-ancestor
24456256|NCT00330772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24456258|NCT00330785|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
24456260|NCT00330785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24456261|NCT00330785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24456262|NCT00330785|Antimetabolites|antimetabolites|mesh-ancestor
24456263|NCT00330785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677217|NCT01808573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25677218|NCT01808573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25677219|NCT01808573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677220|NCT01808612|Fluoxetine|fluoxetine|mesh-list
25677221|NCT01808612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25677222|NCT01808612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25677223|NCT01808612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25677224|NCT01808612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456264|NCT00330785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24456265|NCT00330785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24456266|NCT00330785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456267|NCT00330785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24456268|NCT00330785|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24456269|NCT00330785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24456270|NCT00330785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24456271|NCT00330785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456272|NCT00330785|Vasodilator Agents|vasodilator agents|mesh-ancestor
24456273|NCT00330798|Ketorolac|ketorolac|mesh-list
24456732|NCT00332072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24456733|NCT00332072|Adrenergic Agents|adrenergic agents|mesh-ancestor
24456734|NCT00332072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24515425|NCT00597064|Hormones|hormones|mesh-ancestor
24647835|NCT01211080|Propranolol|propranolol|mesh-list
24456740|NCT00332085|Picolinic acid|picolinic acid|mesh-list
24456741|NCT00332085|Trace Elements|trace elements|mesh-ancestor
24456742|NCT00332085|Micronutrients|micronutrients|mesh-ancestor
24456274|NCT00330798|Nepafenac|nepafenac|mesh-list
24456275|NCT00330798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24456276|NCT00330798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24456279|NCT00330798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24456280|NCT00330798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456282|NCT00330798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24456283|NCT00330798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24456284|NCT00330798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456285|NCT00330798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456286|NCT00330824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24456287|NCT00330824|Moxifloxacin|moxifloxacin|mesh-list
24456288|NCT00330824|Dexamethasone|dexamethasone|mesh-list
24456289|NCT00330824|Dexamethasone acetate|dexamethasone acetate|mesh-list
24456290|NCT00330824|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24456292|NCT00330824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24456293|NCT00330824|Antiemetics|antiemetics|mesh-ancestor
24456294|NCT00330824|Autonomic Agents|autonomic agents|mesh-ancestor
24456299|NCT00330824|Hormones|hormones|mesh-ancestor
24535720|NCT00649610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24535722|NCT00649610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535723|NCT00649610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25210406|NCT02697955|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25210407|NCT02697955|Autonomic Agents|autonomic agents|mesh-ancestor
25210408|NCT02697955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25210409|NCT02697955|Respiratory System Agents|respiratory system agents|mesh-ancestor
25210410|NCT02697955|Mydriatics|mydriatics|mesh-ancestor
25210411|NCT02697955|Sympathomimetics|sympathomimetics|mesh-ancestor
24535726|NCT00649623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24536440|NCT00651287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536442|NCT00651300|Valdecoxib|valdecoxib|mesh-list
24536448|NCT00651300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24536449|NCT00651300|Analgesics|analgesics|mesh-ancestor
24456743|NCT00332085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456744|NCT00332085|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24456745|NCT00332085|Chelating Agents|chelating agents|mesh-ancestor
24536450|NCT00651300|Sensory System Agents|sensory system agents|mesh-ancestor
24536451|NCT00651300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24536452|NCT00651300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536453|NCT00651300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24536850|NCT00652691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24536851|NCT00652691|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24536852|NCT00652691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25017509|NCT00620464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25017510|NCT00620464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017511|NCT00620464|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25017512|NCT00620464|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25017513|NCT00620464|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25017514|NCT00620464|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25017515|NCT00620464|Progestins|progestins|mesh-ancestor
25017547|NCT00431431|Hormones|hormones|mesh-ancestor
24536853|NCT00652691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537346|NCT00654303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24537347|NCT00654303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24537348|NCT00654303|Antimetabolites|antimetabolites|mesh-ancestor
24537350|NCT00654303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24537360|NCT00654394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537361|NCT00654407|Atorvastatin|atorvastatin|mesh-list
24537362|NCT00654407|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24537363|NCT00654407|Simvastatin|simvastatin|mesh-list
24537364|NCT00654407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24798718|NCT01964781|Epinephrine|epinephrine|mesh-list
25049491|NCT00602329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25049493|NCT00602329|Growth Substances|growth substances|mesh-ancestor
24538835|NCT00660920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25210412|NCT02697955|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25210413|NCT02697851|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25210414|NCT02697851|Cobicistat|cobicistat|mesh-list
25210415|NCT02697851|Levonorgestrel|levonorgestrel|mesh-list
24517021|NCT00605410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24517102|NCT00605930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24517103|NCT00605930|Vasodilator Agents|vasodilator agents|mesh-ancestor
24537433|NCT00654576|Dopamine Agents|dopamine agents|mesh-ancestor
24537434|NCT00654576|Antiemetics|antiemetics|mesh-ancestor
24537435|NCT00654576|Autonomic Agents|autonomic agents|mesh-ancestor
24537436|NCT00654576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24537437|NCT00654576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24537438|NCT00654576|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24537439|NCT00654576|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24537440|NCT00654576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24537441|NCT00654576|Antidepressive Agents|antidepressive agents|mesh-ancestor
24537442|NCT00654576|GABA Antagonists|gaba antagonists|mesh-ancestor
24446395|NCT00304629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24446396|NCT00304629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449587|NCT00316160|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25677225|NCT01808612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25677226|NCT01808612|Serotonin Agents|serotonin agents|mesh-ancestor
25677227|NCT01808612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677228|NCT01808612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25677229|NCT01808612|Antidepressive Agents|antidepressive agents|mesh-ancestor
25677230|NCT01808612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25677231|NCT01808612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25677232|NCT01808612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25677233|NCT01808612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677234|NCT01808651|Fluoxetine|fluoxetine|mesh-list
25017775|NCT03704623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25017776|NCT03704623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24449588|NCT00316160|Antidepressive Agents|antidepressive agents|mesh-ancestor
24449589|NCT00316160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24449590|NCT00316160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24449591|NCT00316160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24449592|NCT00316160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24449593|NCT00316160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449594|NCT00316160|Dopamine Agents|dopamine agents|mesh-ancestor
24537445|NCT00654589|Deferasirox|deferasirox|mesh-list
24537465|NCT00654680|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24537466|NCT00654680|Vasodilator Agents|vasodilator agents|mesh-ancestor
24537467|NCT00654680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24537469|NCT00654680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537470|NCT00654680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537471|NCT00654680|Urological Agents|urological agents|mesh-ancestor
25210416|NCT02697851|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25210417|NCT02697851|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25210418|NCT02697851|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
24517104|NCT00605995|Simvastatin|simvastatin|mesh-list
24517105|NCT00605995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24517106|NCT00605995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24517107|NCT00605995|Antimetabolites|antimetabolites|mesh-ancestor
24517108|NCT00605995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537472|NCT00654758|Paclitaxel|paclitaxel|mesh-list
24537473|NCT00654758|Carboplatin|carboplatin|mesh-list
24537474|NCT00654758|Volociximab|volociximab|mesh-list
24456746|NCT00332085|Sequestering Agents|sequestering agents|mesh-ancestor
24456747|NCT00332085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537475|NCT00654758|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24537476|NCT00654758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24537477|NCT00654758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24537478|NCT00654758|Tubulin Modulators|tubulin modulators|mesh-ancestor
24537480|NCT00654758|Mitosis Modulators|mitosis modulators|mesh-ancestor
24537481|NCT00654758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537482|NCT00654758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25677235|NCT01808651|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25677236|NCT01808651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25677237|NCT01808651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25677238|NCT01808651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677239|NCT01808651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25677240|NCT01808651|Serotonin Agents|serotonin agents|mesh-ancestor
25677241|NCT01808651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677242|NCT01808651|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25677243|NCT01808651|Antidepressive Agents|antidepressive agents|mesh-ancestor
25677244|NCT01808651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24648188|NCT01212913|Insulin|insulin|mesh-list
24538084|NCT00657423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24538085|NCT00657423|Growth Substances|growth substances|mesh-ancestor
24538086|NCT00657423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538087|NCT00657423|Growth Inhibitors|growth inhibitors|mesh-ancestor
24538088|NCT00657449|Valdecoxib|valdecoxib|mesh-list
24538089|NCT00657449|Rofecoxib|rofecoxib|mesh-list
24538090|NCT00657449|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24538119|NCT00657488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538120|NCT00657514|Ranolazine|ranolazine|mesh-list
25210424|NCT02697851|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25210425|NCT02697851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24517111|NCT00605995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517112|NCT00606060|Factor VIII|factor viii|mesh-list
24517113|NCT00606060|Coagulants|coagulants|mesh-ancestor
24517114|NCT00606099|Adefovir|adefovir|mesh-list
24517115|NCT00606099|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
24517581|NCT00608712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517884|NCT00610506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517887|NCT00610506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625980|NCT01084876|Paclitaxel|paclitaxel|mesh-list
24538121|NCT00657514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24538122|NCT00657514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24538123|NCT00657514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538124|NCT00657527|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24538125|NCT00657527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24456756|NCT00332137|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24456757|NCT00332137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24456758|NCT00332137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24456759|NCT00332137|Cholinergic Agents|cholinergic agents|mesh-ancestor
24456760|NCT00332137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24456761|NCT00332137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456762|NCT00332137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648253|NCT01213355|Cholinergic Agents|cholinergic agents|mesh-ancestor
25677246|NCT01808651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25677247|NCT01808651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677248|NCT01808690|Metformin|metformin|mesh-list
25677249|NCT01808690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25677250|NCT01808690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677251|NCT01808755|Trimethoprim|trimethoprim|mesh-list
25018176|NCT03701321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018177|NCT03701321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018178|NCT03701321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24974746|NCT05303324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24928812|NCT04118556|Everolimus|everolimus|mesh-list
25210426|NCT02697851|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25210427|NCT02697851|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25210428|NCT02697851|Protease Inhibitors|protease inhibitors|mesh-ancestor
25210429|NCT02697851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25210430|NCT02697851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210431|NCT02697851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25210432|NCT02697851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25210433|NCT02697851|Antiviral Agents|antiviral agents|mesh-ancestor
25210434|NCT02697851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25210435|NCT02697851|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25210436|NCT02697851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25210437|NCT02697851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24517888|NCT00610506|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24517889|NCT00610506|Antidepressive Agents|antidepressive agents|mesh-ancestor
24517890|NCT00610506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24648319|NCT01213550|Disinfectants|disinfectants|mesh-ancestor
24417957|NCT00208221|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24538273|NCT00658255|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25677252|NCT01808755|Sulfamethoxazole|sulfamethoxazole|mesh-list
25677253|NCT01808755|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25677254|NCT01808755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25677255|NCT01808755|Renal Agents|renal agents|mesh-ancestor
25677256|NCT01808755|Antimalarials|antimalarials|mesh-ancestor
25677257|NCT01808755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25677258|NCT01808755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25677259|NCT01808755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25677260|NCT01808755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677261|NCT01808755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677262|NCT01808755|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24449665|NCT00316472|Niacinamide|niacinamide|mesh-list
24449667|NCT00316472|Nicotinic Acids|nicotinic acids|mesh-list
24449668|NCT00316472|Vitamin B Complex|vitamin b complex|mesh-ancestor
24449670|NCT00316472|Micronutrients|micronutrients|mesh-ancestor
24515780|NCT00599274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515804|NCT00599287|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24515805|NCT00599287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515806|NCT00599287|Cholinergic Agents|cholinergic agents|mesh-ancestor
24538600|NCT00660036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24538601|NCT00660036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538602|NCT00660036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24538603|NCT00660062|Dexetimide|dexetimide|mesh-list
24538604|NCT00660062|Citalopram|citalopram|mesh-list
24538605|NCT00660062|Nortriptyline|nortriptyline|mesh-list
24538606|NCT00660062|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24538607|NCT00660062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24538608|NCT00660062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25210438|NCT02697851|Estrogens|estrogens|mesh-ancestor
25210439|NCT02697851|Hormones|hormones|mesh-ancestor
25210440|NCT02697851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24517893|NCT00610506|Parasympatholytics|parasympatholytics|mesh-ancestor
24757364|NCT01739556|Ticagrelor|ticagrelor|mesh-list
24538609|NCT00660062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538610|NCT00660062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24538611|NCT00660062|Serotonin Agents|serotonin agents|mesh-ancestor
24538612|NCT00660062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538613|NCT00660062|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25018246|NCT03700788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25018247|NCT03700788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018248|NCT03700788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25018249|NCT03700788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25018250|NCT03700788|Disinfectants|disinfectants|mesh-ancestor
25018252|NCT03700749|Chlorhexidine|chlorhexidine|mesh-list
25018275|NCT03700645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210441|NCT02697851|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25210442|NCT02697851|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
25210443|NCT02697851|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24517975|NCT00610909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24418335|NCT00209222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516199|NCT00600977|Doxorubicin|doxorubicin|mesh-list
24539774|NCT00665600|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24539775|NCT00665600|Autonomic Agents|autonomic agents|mesh-ancestor
24539776|NCT00665600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24539818|NCT00665717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24539819|NCT00665717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24539820|NCT00665717|Antimetabolites|antimetabolites|mesh-ancestor
24451444|NCT00323791|Antiviral Agents|antiviral agents|mesh-ancestor
24540162|NCT00666783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24540163|NCT00666783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540164|NCT00666796|Ethanol|ethanol|mesh-list
24540165|NCT00666796|Gabapentin|gabapentin|mesh-list
24540167|NCT00666796|Sensory System Agents|sensory system agents|mesh-ancestor
24540168|NCT00666796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24540169|NCT00666796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540170|NCT00666796|Anticonvulsants|anticonvulsants|mesh-ancestor
24540171|NCT00666796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24544478|NCT00689169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25677263|NCT01808755|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25677264|NCT01808755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25677265|NCT01809054|Aspirin|aspirin|mesh-list
25677266|NCT01809054|Fondaparinux|fondaparinux|mesh-list
25677267|NCT01809054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25677268|NCT01809054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25677269|NCT01809054|Analgesics|analgesics|mesh-ancestor
25677270|NCT01809054|Sensory System Agents|sensory system agents|mesh-ancestor
25677271|NCT01809054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25677272|NCT01809054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677273|NCT01809054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24544479|NCT00689169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24545856|NCT00695344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24545857|NCT00695344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24546226|NCT00697151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24546227|NCT00697151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546228|NCT00697151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24546230|NCT00697151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24546231|NCT00697151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25210444|NCT02697851|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25272647|NCT02390739|Immunologic Factors|immunologic factors|mesh-ancestor
24517977|NCT00610948|Fluorouracil|fluorouracil|mesh-list
24517978|NCT00610948|Oxaliplatin|oxaliplatin|mesh-list
24517980|NCT00610948|Panitumumab|panitumumab|mesh-list
24517981|NCT00610948|Calcium|calcium|mesh-list
24517982|NCT00610948|Levoleucovorin|levoleucovorin|mesh-list
24394216|NCT00132561|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24518114|NCT05331183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24518115|NCT05331183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518233|NCT05330000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24518234|NCT05330000|Hormone Antagonists|hormone antagonists|mesh-ancestor
25117009|NCT03105466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516200|NCT00600977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24546452|NCT00698607|Sirolimus|sirolimus|mesh-list
24546453|NCT00698607|Everolimus|everolimus|mesh-list
24546454|NCT00698607|Clopidogrel|clopidogrel|mesh-list
24546455|NCT00698607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24546456|NCT00698607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24546553|NCT00699049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546555|NCT00699049|Urological Agents|urological agents|mesh-ancestor
25210446|NCT02697877|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25210447|NCT02697877|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25210448|NCT02697877|Purinergic Agonists|purinergic agonists|mesh-ancestor
25210449|NCT02697877|Purinergic Agents|purinergic agents|mesh-ancestor
25210450|NCT02697877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25210451|NCT02697877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210452|NCT02697877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210453|NCT02697929|Neostigmine|neostigmine|mesh-list
25210454|NCT02697929|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25210455|NCT02697929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004359|NCT01941875|Hormones|hormones|mesh-ancestor
25210456|NCT02697929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210457|NCT02697929|Cholinergic Agents|cholinergic agents|mesh-ancestor
25210459|NCT02697929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210460|NCT02697929|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25210461|NCT02697929|Autonomic Agents|autonomic agents|mesh-ancestor
25210462|NCT02697929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25210463|NCT02697838|Paclitaxel|paclitaxel|mesh-list
25210464|NCT02697838|Apatinib|apatinib|mesh-list
25210465|NCT02697838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25210466|NCT02697838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24518235|NCT05330000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24518236|NCT05330000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018544|NCT03698630|Prednisolone acetate|prednisolone acetate|mesh-list
24518237|NCT05330000|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24518240|NCT05329857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24518241|NCT05329857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546805|NCT00700466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546808|NCT00700492|Hormones|hormones|mesh-ancestor
24546809|NCT00700492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24546842|NCT00700687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24546843|NCT00700687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546844|NCT00700687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24546845|NCT00700687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24648570|NCT01215578|Sunitinib|sunitinib|mesh-list
24515993|NCT00600210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24515994|NCT00600210|Growth Substances|growth substances|mesh-ancestor
24418607|NCT00209833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25210472|NCT02697838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24518242|NCT05329857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24457770|NCT00335192|Lamivudine|lamivudine|mesh-list
24457771|NCT00335192|Abacavir|abacavir|mesh-list
24457772|NCT00335192|Antiviral Agents|antiviral agents|mesh-ancestor
24648677|NCT01216345|Gemcitabine|gemcitabine|mesh-list
25677274|NCT01809054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25677275|NCT01809054|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25018702|NCT03697681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018703|NCT03697681|Hemostatics|hemostatics|mesh-ancestor
25018704|NCT03697681|Coagulants|coagulants|mesh-ancestor
25018706|NCT03697668|Artenimol|artenimol|mesh-list
25018782|NCT03697044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018792|NCT03697018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018793|NCT03696940|Atorvastatin|atorvastatin|mesh-list
25018794|NCT03696940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24546850|NCT00700687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24546914|NCT00701246|Hematinics|hematinics|mesh-ancestor
24546915|NCT00701246|Vitamins|vitamins|mesh-ancestor
24546916|NCT00701246|Micronutrients|micronutrients|mesh-ancestor
24546917|NCT00701246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546918|NCT00701259|Lansoprazole|lansoprazole|mesh-list
24546919|NCT00701259|Dexlansoprazole|dexlansoprazole|mesh-list
24547100|NCT00702416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24547102|NCT00702442|Droperidol|droperidol|mesh-list
24547105|NCT00702442|Autonomic Agents|autonomic agents|mesh-ancestor
24547106|NCT00702442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24547141|NCT00702637|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24548073|NCT00707473|Tubulin Modulators|tubulin modulators|mesh-ancestor
24516080|NCT00600548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24449709|NCT00316745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449710|NCT00316745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25210474|NCT05324839|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25210475|NCT05324839|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25210476|NCT05324839|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24457773|NCT00335192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24457774|NCT00335192|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24457778|NCT00335192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24518350|NCT05214807|Coagulants|coagulants|mesh-ancestor
24518426|NCT05069740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24518427|NCT05069740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24518429|NCT05059626|Simvastatin|simvastatin|mesh-list
25677276|NCT01809054|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25677277|NCT01809054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677278|NCT01809054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25677279|NCT01809054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25677280|NCT01809054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677281|NCT01809054|Antipyretics|antipyretics|mesh-ancestor
25677282|NCT01809054|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25677283|NCT01809054|Antithrombins|antithrombins|mesh-ancestor
24518461|NCT04981041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018929|NCT03695640|Sensory System Agents|sensory system agents|mesh-ancestor
24548754|NCT00711906|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24548757|NCT00711906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24548758|NCT00711906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24548759|NCT00711906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24548760|NCT00711906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548761|NCT00711906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548762|NCT00711906|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24548763|NCT00711906|Renal Agents|renal agents|mesh-ancestor
24548764|NCT00711906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24548765|NCT00711919|Pitavastatin|pitavastatin|mesh-list
24548801|NCT00712114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516129|NCT00600639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550089|NCT00719056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550090|NCT00719056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550091|NCT00719056|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24550092|NCT00719056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24550093|NCT00719095|Naltrexone|naltrexone|mesh-list
24550094|NCT00719095|Buprenorphine|buprenorphine|mesh-list
24550095|NCT00719095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24550187|NCT00719602|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24516130|NCT00600639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24516131|NCT00600639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24592660|NCT00923663|Lenalidomide|lenalidomide|mesh-list
24550188|NCT00719602|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24550189|NCT00719602|Protease Inhibitors|protease inhibitors|mesh-ancestor
24550190|NCT00719602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25210477|NCT05324839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25210478|NCT05324839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210480|NCT05324839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25210481|NCT05324839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210482|NCT05324839|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25210483|NCT05324839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25210484|NCT05324800|Turmeric extract|turmeric extract|mesh-list
25677284|NCT01809054|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25677285|NCT01809054|Protease Inhibitors|protease inhibitors|mesh-ancestor
25677286|NCT01809054|Anticoagulants|anticoagulants|mesh-ancestor
25677287|NCT01809106|Fentanyl|fentanyl|mesh-list
25677288|NCT01809106|Morphine|morphine|mesh-list
25677289|NCT01809106|Oxycodone|oxycodone|mesh-list
25677290|NCT01809106|Buprenorphine|buprenorphine|mesh-list
25677291|NCT01809106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25677292|NCT01809106|Narcotics|narcotics|mesh-ancestor
25677293|NCT01809106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25677307|NCT01809132|Prednisolone|prednisolone|mesh-list
25677308|NCT01809132|Prednisolone acetate|prednisolone acetate|mesh-list
25677309|NCT01809132|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25677310|NCT01809132|Pentoxifylline|pentoxifylline|mesh-list
25677311|NCT01809132|Zinc Sulfate|zinc sulfate|mesh-list
25210492|NCT05324774|Growth Substances|growth substances|mesh-ancestor
25210493|NCT05324774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210494|NCT05324774|Growth Inhibitors|growth inhibitors|mesh-ancestor
24518541|NCT04871412|Cholecalciferol|cholecalciferol|mesh-list
24518542|NCT04871412|Vitamins|vitamins|mesh-list
24518543|NCT04871412|Curcumin|curcumin|mesh-list
24518544|NCT04871412|Micronutrients|micronutrients|mesh-ancestor
24518568|NCT04808934|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24518570|NCT04808934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677312|NCT01809132|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25677313|NCT01809132|Prednisolone phosphate|prednisolone phosphate|mesh-list
25677314|NCT01809132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25677315|NCT01809132|Antiemetics|antiemetics|mesh-ancestor
25677316|NCT01809132|Autonomic Agents|autonomic agents|mesh-ancestor
25677317|NCT01809132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25677318|NCT01809132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677319|NCT01809132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25210507|NCT05324748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210508|NCT05324748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25210509|NCT05324748|Glucocorticoids|glucocorticoids|mesh-ancestor
25210510|NCT05324748|Hormones|hormones|mesh-ancestor
25210511|NCT05324748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24518617|NCT04666740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24518618|NCT04666740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24518619|NCT04666740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24518621|NCT04666740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518749|NCT04372927|Etoposide|etoposide|mesh-list
25677320|NCT01809132|Glucocorticoids|glucocorticoids|mesh-ancestor
25677321|NCT01809132|Hormones|hormones|mesh-ancestor
25677322|NCT01809132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25677323|NCT01809132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25677324|NCT01809132|Protective Agents|protective agents|mesh-ancestor
25677325|NCT01809132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25677326|NCT01809132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25677327|NCT01809132|Trace Elements|trace elements|mesh-ancestor
25677328|NCT01809132|Micronutrients|micronutrients|mesh-ancestor
25677329|NCT01809132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24518750|NCT04372927|Pemetrexed|pemetrexed|mesh-list
25051318|NCT00417209|Immunologic Factors|immunologic factors|mesh-ancestor
24516416|NCT00601978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677339|NCT01809132|Dermatologic Agents|dermatologic agents|mesh-ancestor
25677340|NCT01809197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25677341|NCT01809210|Gemcitabine|gemcitabine|mesh-list
25677342|NCT01809210|Cisplatin|cisplatin|mesh-list
25677343|NCT01809210|Carboplatin|carboplatin|mesh-list
25677344|NCT01809210|Pemetrexed|pemetrexed|mesh-list
25677345|NCT01809210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25677346|NCT01809210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24798818|NCT01965353|Antiemetics|antiemetics|mesh-ancestor
25677347|NCT01809210|Antimetabolites|antimetabolites|mesh-ancestor
25677348|NCT01809210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677349|NCT01809210|Antiviral Agents|antiviral agents|mesh-ancestor
25677350|NCT01809210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25677351|NCT01809210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677352|NCT01809210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24518824|NCT04151082|Prednisolone acetate|prednisolone acetate|mesh-list
24518825|NCT04151082|Cortisone|cortisone|mesh-list
24518826|NCT04151082|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24518827|NCT04151082|Prednisolone phosphate|prednisolone phosphate|mesh-list
24518828|NCT04151082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25677361|NCT01809327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25677362|NCT01809327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677363|NCT01809327|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25677364|NCT01809327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677365|NCT01809639|Progesterone|progesterone|mesh-list
25677366|NCT01809639|Progestins|progestins|mesh-ancestor
25677367|NCT01809639|Hormones|hormones|mesh-ancestor
24518986|NCT03710772|Methotrexate|methotrexate|mesh-list
24518987|NCT03710772|Vincristine|vincristine|mesh-list
24518988|NCT03710772|Venetoclax|venetoclax|mesh-list
24518989|NCT03710772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24518991|NCT03710772|Immunoglobulins|immunoglobulins|mesh-list
25020737|NCT03678012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25020738|NCT03678012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25020784|NCT03677323|Dopamine Agents|dopamine agents|mesh-ancestor
25020785|NCT03677323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25020786|NCT03677323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020787|NCT03677297|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25020788|NCT03677297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25020789|NCT03677297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25020790|NCT03677297|Antimetabolites|antimetabolites|mesh-ancestor
25020791|NCT03677297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020792|NCT03677297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25020793|NCT03677297|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25020794|NCT03677297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25020795|NCT03677258|Hyaluronic Acid|hyaluronic acid|mesh-list
24518992|NCT03710772|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24518993|NCT03710772|BB 1101|bb 1101|mesh-list
24539304|NCT00663195|Hormone Antagonists|hormone antagonists|mesh-ancestor
24449780|NCT00316927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449781|NCT00316927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24449782|NCT00316927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24449783|NCT00316927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449785|NCT00316927|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24449786|NCT00316927|Estrogens|estrogens|mesh-ancestor
24449788|NCT00316940|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
24449789|NCT00316940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449790|NCT00316940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24449791|NCT00316940|Analgesics|analgesics|mesh-ancestor
24449792|NCT00316940|Sensory System Agents|sensory system agents|mesh-ancestor
24449793|NCT00316940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24449794|NCT00316940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449795|NCT00316953|Dasatinib|dasatinib|mesh-list
24449796|NCT00316953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449797|NCT00316953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24449798|NCT00316953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449799|NCT00316953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449800|NCT00317031|Naltrexone|naltrexone|mesh-list
24449801|NCT00317031|Acamprosate|acamprosate|mesh-list
24449802|NCT00317031|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24449803|NCT00317031|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25210536|NCT05324618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25210537|NCT05324618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210538|NCT05324618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25210539|NCT05324592|Aflibercept|aflibercept|mesh-list
25210540|NCT05324592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25210541|NCT05324592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25210542|NCT05324592|Growth Substances|growth substances|mesh-ancestor
25210543|NCT05324592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677368|NCT01809639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25677369|NCT01809639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677370|NCT01810016|Poly I-C|poly i-c|mesh-list
25677371|NCT01810016|Ipilimumab|ipilimumab|mesh-list
25677372|NCT01810016|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25677373|NCT01810016|Vaccines|vaccines|mesh-list
25677374|NCT01810016|Poly ICLC|poly iclc|mesh-list
25677375|NCT01810016|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25677376|NCT01810016|Immunologic Factors|immunologic factors|mesh-ancestor
25677377|NCT01810016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677378|NCT01810016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25677379|NCT01810016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25677380|NCT01810016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25677381|NCT01810016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677382|NCT01810016|Interferon Inducers|interferon inducers|mesh-ancestor
24584748|NCT00881556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25021111|NCT03674606|Antipyretics|antipyretics|mesh-ancestor
25021112|NCT03674541|Bromides|bromides|mesh-list
25021113|NCT03674541|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
25021114|NCT03674541|Anticonvulsants|anticonvulsants|mesh-ancestor
25021116|NCT03674541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25021179|NCT03674294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25210544|NCT05324592|Growth Inhibitors|growth inhibitors|mesh-ancestor
25210545|NCT05324592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24518994|NCT03710772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24518995|NCT03710772|Immunologic Factors|immunologic factors|mesh-ancestor
24519023|NCT03710772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24519024|NCT03710772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24519025|NCT03710772|Antiviral Agents|antiviral agents|mesh-ancestor
24519026|NCT03710772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24650136|NCT01224301|Vaccines|vaccines|mesh-list
24519027|NCT03710772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24519028|NCT03710772|Tubulin Modulators|tubulin modulators|mesh-ancestor
24519029|NCT03710772|Antimitotic Agents|antimitotic agents|mesh-ancestor
24519030|NCT03710772|Mitosis Modulators|mitosis modulators|mesh-ancestor
24519031|NCT03690089|Atropine|atropine|mesh-list
24519032|NCT03690089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24519033|NCT03690089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24519034|NCT03690089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24519035|NCT03690089|Autonomic Agents|autonomic agents|mesh-ancestor
24519036|NCT03690089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24519037|NCT03690089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519038|NCT03690089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24457782|NCT00335205|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24519192|NCT03112603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24519193|NCT03112603|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
24519238|NCT02702180|Molgramostim|molgramostim|mesh-list
25051339|NCT00415142|Citalopram|citalopram|mesh-list
25210551|NCT05324462|Xultophy|xultophy|mesh-list
25210552|NCT05324462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24460554|NCT00348725|Antimetabolites|antimetabolites|mesh-ancestor
25677383|NCT01810016|Laxatives|laxatives|mesh-ancestor
25677384|NCT01810016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25677385|NCT01810016|Antiviral Agents|antiviral agents|mesh-ancestor
25677386|NCT01810016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25677387|NCT01810016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25677388|NCT01810042|Ranibizumab|ranibizumab|mesh-list
25677389|NCT01810042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25677390|NCT01810042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25677391|NCT01810042|Growth Substances|growth substances|mesh-ancestor
25677392|NCT01810042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677393|NCT01810042|Growth Inhibitors|growth inhibitors|mesh-ancestor
25677394|NCT01810042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24456812|NCT00332306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24456813|NCT00332306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24456815|NCT00332319|Casopitant|casopitant|mesh-list
25210588|NCT05323955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210590|NCT05323955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25210591|NCT05323812|Edaravone|edaravone|mesh-list
25210592|NCT05323812|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25210593|NCT05323812|Antioxidants|antioxidants|mesh-ancestor
25210594|NCT05323812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210595|NCT05323812|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25210596|NCT05323812|Protective Agents|protective agents|mesh-ancestor
25210597|NCT05323812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210598|NCT05323786|Anesthetics|anesthetics|mesh-list
25210599|NCT05323786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25210600|NCT05323786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210680|NCT05322681|Pregabalin|pregabalin|mesh-list
24449841|NCT00317252|Protease Inhibitors|protease inhibitors|mesh-ancestor
24449842|NCT00317252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677396|NCT01810380|Brexpiprazole|brexpiprazole|mesh-list
25677397|NCT01810380|Antidepressive Agents|antidepressive agents|mesh-ancestor
25677398|NCT01810380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25677399|NCT01810380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25677400|NCT01810380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25677401|NCT01810380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25677402|NCT01810380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677403|NCT01810380|Serotonin Agents|serotonin agents|mesh-ancestor
25257118|NCT02478294|Anticoagulants|anticoagulants|mesh-list
25257119|NCT02478281|Methylene Blue|methylene blue|mesh-list
25257120|NCT02478281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257121|NCT02478281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257122|NCT02478268|Xenon|xenon|mesh-list
25257123|NCT02478268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25257128|NCT02478125|Docetaxel|docetaxel|mesh-list
24519705|NCT05280743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24587556|NCT00895609|Autonomic Agents|autonomic agents|mesh-ancestor
24519706|NCT05280743|Narcotics|narcotics|mesh-ancestor
24519707|NCT05280743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24519743|NCT05242874|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24519782|NCT05151471|Antioxidants|antioxidants|mesh-ancestor
25210614|NCT05323565|Dexamethasone|dexamethasone|mesh-list
25210615|NCT05323565|Dexmedetomidine|dexmedetomidine|mesh-list
25210616|NCT05323565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25210617|NCT05323565|Antiemetics|antiemetics|mesh-ancestor
25210618|NCT05323565|Autonomic Agents|autonomic agents|mesh-ancestor
25210619|NCT05323565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25210620|NCT05323565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210621|NCT05323565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25210622|NCT05323565|Glucocorticoids|glucocorticoids|mesh-ancestor
25210623|NCT05323565|Hormones|hormones|mesh-ancestor
25210624|NCT05323565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25210625|NCT05323565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25210626|NCT05323565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25210627|NCT05323565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210628|NCT05323565|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25210629|NCT05323565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25210630|NCT05323565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25210631|NCT05323565|Analgesics|analgesics|mesh-ancestor
25210632|NCT05323565|Sensory System Agents|sensory system agents|mesh-ancestor
25210633|NCT05323565|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25210634|NCT05323565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25210635|NCT05323565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25210636|NCT05323565|Adrenergic Agents|adrenergic agents|mesh-ancestor
25210637|NCT05323565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25210641|NCT05323422|Ketamine|ketamine|mesh-list
25210642|NCT05323422|Analgesics|analgesics|mesh-ancestor
25210643|NCT05323422|Sensory System Agents|sensory system agents|mesh-ancestor
25210644|NCT05323422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25210645|NCT05323422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210646|NCT05323422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25210647|NCT05323422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25210649|NCT05323422|Anesthetics|anesthetics|mesh-ancestor
25210650|NCT05323422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25210651|NCT05323422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25210652|NCT05323422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25210653|NCT05323422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25210654|NCT05323422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272648|NCT02390739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272649|NCT02390739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25272650|NCT02390739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25272651|NCT02390739|Alkylating Agents|alkylating agents|mesh-ancestor
25272652|NCT02390739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272653|NCT02390739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272654|NCT02390739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25272655|NCT02390739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25272656|NCT02390739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25272657|NCT02390739|Antiviral Agents|antiviral agents|mesh-ancestor
25677404|NCT01810380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25677405|NCT01810380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677406|NCT01810380|Dopamine Agonists|dopamine agonists|mesh-ancestor
25677407|NCT01810380|Dopamine Agents|dopamine agents|mesh-ancestor
25677408|NCT01810432|Evacetrapib|evacetrapib|mesh-list
25677409|NCT01810432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25677410|NCT01810432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24449861|NCT00317330|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24449864|NCT00317330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24449866|NCT00317343|Bivalirudin|bivalirudin|mesh-list
24449867|NCT00317343|Thrombin|thrombin|mesh-list
24449868|NCT00317343|Hemostatics|hemostatics|mesh-ancestor
24449869|NCT00317343|Coagulants|coagulants|mesh-ancestor
24449870|NCT00317343|Antithrombins|antithrombins|mesh-ancestor
24449871|NCT00317343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24650819|NCT01228214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24454606|NCT03878524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24454607|NCT03878524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24454608|NCT03878524|Tubulin Modulators|tubulin modulators|mesh-ancestor
25677411|NCT01810432|Antimetabolites|antimetabolites|mesh-ancestor
25677412|NCT01810432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677413|NCT01810432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25677414|NCT01810666|Factor VIII|factor viii|mesh-list
25677415|NCT01810666|Coagulants|coagulants|mesh-ancestor
25677416|NCT01810692|Tiotropium Bromide|tiotropium bromide|mesh-list
25677417|NCT01810692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25677418|NCT01810692|Autonomic Agents|autonomic agents|mesh-ancestor
25677419|NCT01810692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25677420|NCT01810692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677421|NCT01810692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25210659|NCT05323201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210660|NCT05323201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25272661|NCT02390843|Simvastatin|simvastatin|mesh-list
25272662|NCT02390843|Lenograstim|lenograstim|mesh-list
25272663|NCT02390843|Mitogens|mitogens|mesh-list
25210691|NCT05322681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24650889|NCT01228357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24520543|NCT05337332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24520544|NCT05337332|Glucocorticoids|glucocorticoids|mesh-ancestor
24520545|NCT05337332|Hormones|hormones|mesh-ancestor
24520546|NCT05337332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24520547|NCT05337332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520576|NCT05337085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24520577|NCT05337085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520578|NCT05337085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24520579|NCT05337085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24520580|NCT05337085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24527544|NCT00617253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24527545|NCT00617253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24520581|NCT05337085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24520582|NCT05337085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24520744|NCT05333640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520745|NCT05333640|Tubulin Modulators|tubulin modulators|mesh-ancestor
24520746|NCT05333640|Antimitotic Agents|antimitotic agents|mesh-ancestor
24790355|NCT01942187|Aripiprazole|aripiprazole|mesh-list
24520747|NCT05333640|Mitosis Modulators|mitosis modulators|mesh-ancestor
24520748|NCT05333640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457789|NCT00335231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24520749|NCT05333640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24520893|NCT05246007|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24520930|NCT05237141|Contraceptive Agents|contraceptive agents|mesh-ancestor
24520931|NCT05237141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25210661|NCT05323201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25210662|NCT05323201|Alkylating Agents|alkylating agents|mesh-ancestor
25210663|NCT05323201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210664|NCT05323201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25210665|NCT05323201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25210666|NCT05322967|Antihypertensive Agents|antihypertensive agents|mesh-list
25210667|NCT05322889|Telmisartan|telmisartan|mesh-list
25210668|NCT05322889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25210669|NCT05322889|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25210670|NCT05322889|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25210671|NCT05322889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210672|NCT05322720|Paclitaxel|paclitaxel|mesh-list
25210673|NCT05322720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25210674|NCT05322720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25677422|NCT01810692|Respiratory System Agents|respiratory system agents|mesh-ancestor
25677423|NCT01810692|Parasympatholytics|parasympatholytics|mesh-ancestor
24978650|NCT03432741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24978651|NCT03432741|Pembrolizumab|pembrolizumab|mesh-list
24978652|NCT03432741|Nivolumab|nivolumab|mesh-list
24978653|NCT03432741|Trastuzumab|trastuzumab|mesh-list
24978654|NCT03432741|Obinutuzumab|obinutuzumab|mesh-list
24978655|NCT03432741|Daratumumab|daratumumab|mesh-list
24978656|NCT03432741|Romidepsin|romidepsin|mesh-list
24978657|NCT03432741|Belinostat|belinostat|mesh-list
24978658|NCT03432741|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
24978659|NCT03432741|Antibodies|antibodies|mesh-list
24978660|NCT03432741|Immunoglobulins|immunoglobulins|mesh-list
24978661|NCT03432741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24978662|NCT03432741|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24978663|NCT03432741|Immunologic Factors|immunologic factors|mesh-ancestor
24978664|NCT03432741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978665|NCT03432741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25210675|NCT05322720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25210676|NCT05322720|Tubulin Modulators|tubulin modulators|mesh-ancestor
25210677|NCT05322720|Antimitotic Agents|antimitotic agents|mesh-ancestor
25210678|NCT05322720|Mitosis Modulators|mitosis modulators|mesh-ancestor
25210679|NCT05322720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210681|NCT05322681|Analgesics|analgesics|mesh-ancestor
25210682|NCT05322681|Sensory System Agents|sensory system agents|mesh-ancestor
25210683|NCT05322681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25210684|NCT05322681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210685|NCT05322681|Anticonvulsants|anticonvulsants|mesh-ancestor
25210686|NCT05322681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25210687|NCT05322681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25210688|NCT05322681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210689|NCT05322681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25210690|NCT05322681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25210695|NCT05322603|Morphine|morphine|mesh-list
25210696|NCT05322603|Analgesics|analgesics|mesh-list
25210697|NCT05322603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
25210698|NCT05322603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25210699|NCT05322603|Narcotics|narcotics|mesh-ancestor
25210700|NCT05322603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25210701|NCT05322603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210702|NCT05322603|Sensory System Agents|sensory system agents|mesh-ancestor
25210703|NCT05322603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25210704|NCT05322603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25210705|NCT05322603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25210706|NCT05322603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25210707|NCT05322603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25210708|NCT05322603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25210709|NCT05322603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210710|NCT05322564|Opiate Alkaloids|opiate alkaloids|mesh-list
25210711|NCT05322564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25210712|NCT05322564|Narcotics|narcotics|mesh-ancestor
25210713|NCT05322564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25210714|NCT05322564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210715|NCT05322564|Analgesics|analgesics|mesh-ancestor
25210716|NCT05322564|Sensory System Agents|sensory system agents|mesh-ancestor
25210717|NCT05322564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25210727|NCT05321602|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25210728|NCT05321602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25210729|NCT05321602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25210730|NCT05321602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25210731|NCT05321602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210732|NCT05321602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25210733|NCT05321602|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25677424|NCT01810692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25677425|NCT01810692|Cholinergic Agents|cholinergic agents|mesh-ancestor
25677426|NCT01810692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25677427|NCT01810692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677428|NCT01810783|Brexpiprazole|brexpiprazole|mesh-list
25677429|NCT01810783|Serotonin Agents|serotonin agents|mesh-ancestor
25677430|NCT01810783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25677431|NCT01810783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677432|NCT01810783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677433|NCT01810783|Dopamine Agonists|dopamine agonists|mesh-ancestor
25677434|NCT01810783|Dopamine Agents|dopamine agents|mesh-ancestor
25677435|NCT01810952|Insulin|insulin|mesh-list
25677436|NCT01810952|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25677437|NCT01810952|Insulin Glargine|insulin glargine|mesh-list
25275034|NCT02374567|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25275035|NCT02374567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25275036|NCT02374567|Cholinergic Agents|cholinergic agents|mesh-ancestor
25275037|NCT02374567|Antiemetics|antiemetics|mesh-ancestor
25210734|NCT05321602|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25210735|NCT05321602|Serotonin Agents|serotonin agents|mesh-ancestor
25210736|NCT05321602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25210737|NCT05321602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210738|NCT05321602|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25210739|NCT05321602|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25210740|NCT05321602|Dopamine Agents|dopamine agents|mesh-ancestor
25210741|NCT05321394|Ritonavir|ritonavir|mesh-list
25210742|NCT05321394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25210743|NCT05321394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25210744|NCT05321394|Protease Inhibitors|protease inhibitors|mesh-ancestor
25210745|NCT05321394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25210746|NCT05321394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210747|NCT05321394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25210748|NCT05321394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25210749|NCT05321394|Antiviral Agents|antiviral agents|mesh-ancestor
25210750|NCT05321394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25210751|NCT05321394|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25210752|NCT05321394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24451536|NCT00324051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677438|NCT01810952|Insulin, Isophane|insulin, isophane|mesh-list
25677439|NCT01810952|Isophane Insulin, Human|isophane insulin, human|mesh-list
25677440|NCT01810952|Isophane insulin, beef|isophane insulin, beef|mesh-list
25677441|NCT01810952|Insulin Lispro|insulin lispro|mesh-list
25677442|NCT01810952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25677443|NCT01810952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677444|NCT01811147|Norepinephrine|norepinephrine|mesh-list
25677445|NCT01811147|Serotonin|serotonin|mesh-list
25677446|NCT01811147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25022380|NCT03663478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25022381|NCT03663465|Antipsychotic Agents|antipsychotic agents|mesh-list
25022382|NCT03663465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25022432|NCT03662620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25257184|NCT02477956|Ergocalciferols|ergocalciferols|mesh-list
25257185|NCT02477956|Cholecalciferol|cholecalciferol|mesh-list
25257186|NCT02477956|Vitamins|vitamins|mesh-list
24451537|NCT00324051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24451538|NCT00324051|Serotonin Agents|serotonin agents|mesh-ancestor
24451539|NCT00324077|Imatinib Mesylate|imatinib mesylate|mesh-list
25210759|NCT05300594|Vitamins|vitamins|mesh-list
25210760|NCT05300594|Micronutrients|micronutrients|mesh-ancestor
25210761|NCT05300594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210762|NCT05300451|Daratumumab|daratumumab|mesh-list
25210763|NCT05300451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25117011|NCT03105466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25210911|NCT05036226|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24517625|NCT00608816|Autonomic Agents|autonomic agents|mesh-ancestor
24422429|NCT00222495|Olanzapine|olanzapine|mesh-list
24465618|NCT00370318|Acetaminophen|acetaminophen|mesh-list
24465739|NCT00370656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677447|NCT01811147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25677448|NCT01811147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25677449|NCT01811147|Adrenergic Agents|adrenergic agents|mesh-ancestor
25677450|NCT01811147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25677451|NCT01811147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677452|NCT01811147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677453|NCT01811147|Sympathomimetics|sympathomimetics|mesh-ancestor
25677454|NCT01811147|Autonomic Agents|autonomic agents|mesh-ancestor
25677462|NCT01811186|Naloxone|naloxone|mesh-list
25022614|NCT03661515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022615|NCT03661515|Antiviral Agents|antiviral agents|mesh-ancestor
25210776|NCT05297851|Dermatologic Agents|dermatologic agents|mesh-ancestor
25210777|NCT05297851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25210778|NCT05297851|Antimetabolites|antimetabolites|mesh-ancestor
24521875|NCT04456439|Anesthetics|anesthetics|mesh-ancestor
24521876|NCT04456439|Sensory System Agents|sensory system agents|mesh-ancestor
24466130|NCT00372216|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24466131|NCT00372216|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24466132|NCT00372216|Purinergic Agents|purinergic agents|mesh-ancestor
24466133|NCT00372216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24466134|NCT00372216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466135|NCT00372216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466136|NCT00372229|Valganciclovir|valganciclovir|mesh-list
24466141|NCT00372229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24466142|NCT00372229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517824|NCT00610103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517825|NCT00610142|Hydrocortisone|hydrocortisone|mesh-list
24517826|NCT00610142|Pimecrolimus|pimecrolimus|mesh-list
24517827|NCT00610142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24517828|NCT00610142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24517829|NCT00610142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24517830|NCT00610142|Analgesics|analgesics|mesh-ancestor
24517845|NCT00610246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210779|NCT05297851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210780|NCT05297851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25210781|NCT05297851|Vasodilator Agents|vasodilator agents|mesh-ancestor
25210782|NCT05295394|Lamivudine|lamivudine|mesh-list
25210783|NCT05295394|Dolutegravir|dolutegravir|mesh-list
25210784|NCT05295394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25210785|NCT05295394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25210786|NCT05295394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25210787|NCT05295394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210788|NCT05295394|Antiviral Agents|antiviral agents|mesh-ancestor
25210789|NCT05295394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25210790|NCT05295394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25210791|NCT05295394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25210792|NCT05295394|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25210793|NCT05295394|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25210794|NCT05273632|Tranexamic Acid|tranexamic acid|mesh-list
24522098|NCT04275661|Ketamine|ketamine|mesh-list
24522099|NCT04275661|Levobupivacaine|levobupivacaine|mesh-list
24522100|NCT04275661|Analgesics|analgesics|mesh-ancestor
24522101|NCT04275661|Sensory System Agents|sensory system agents|mesh-ancestor
25677463|NCT01811186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25677464|NCT01811186|Narcotics|narcotics|mesh-ancestor
25677465|NCT01811186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25677466|NCT01811186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677467|NCT01811186|Analgesics|analgesics|mesh-ancestor
25677468|NCT01811186|Sensory System Agents|sensory system agents|mesh-ancestor
25677469|NCT01811186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25677470|NCT01811186|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25677471|NCT01811225|Progesterone|progesterone|mesh-list
25677472|NCT01811225|Progestins|progestins|mesh-ancestor
25257210|NCT02477852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257211|NCT02477852|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25257212|NCT02477852|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25257213|NCT02477852|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25257214|NCT02477852|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25257215|NCT02477852|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24928986|NCT04116528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24928987|NCT04116528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24928988|NCT04116528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24522102|NCT04275661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24522103|NCT04275661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522104|NCT04275661|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24522105|NCT04275661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24522106|NCT04275661|Anesthetics, General|anesthetics, general|mesh-ancestor
24522107|NCT04275661|Anesthetics|anesthetics|mesh-ancestor
24522108|NCT04275661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24522109|NCT04275661|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24522110|NCT04275661|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24517847|NCT00610324|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24517848|NCT00610324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24517849|NCT00610324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24517850|NCT00610324|Disinfectants|disinfectants|mesh-ancestor
24456887|NCT00332553|Estradiol|estradiol|mesh-list
24456888|NCT00332553|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24517896|NCT00610506|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24517897|NCT00610506|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24517898|NCT00610506|Cholinergic Agents|cholinergic agents|mesh-ancestor
24517899|NCT00610545|Atorvastatin|atorvastatin|mesh-list
24517900|NCT00610545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24517901|NCT00610545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24517907|NCT00610571|Temozolomide|temozolomide|mesh-list
25210796|NCT05273632|Oxytocics|oxytocics|mesh-ancestor
25210797|NCT05273632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25677473|NCT01811225|Hormones|hormones|mesh-ancestor
25677474|NCT01811225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25677475|NCT01811225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677476|NCT01811238|Oxycodone|oxycodone|mesh-list
25677477|NCT01811238|Naloxone|naloxone|mesh-list
25677478|NCT01811238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25677479|NCT01811238|Narcotics|narcotics|mesh-ancestor
25677480|NCT01811238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25677481|NCT01811238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677482|NCT01811238|Analgesics|analgesics|mesh-ancestor
25677483|NCT01811238|Sensory System Agents|sensory system agents|mesh-ancestor
25210801|NCT05273632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210803|NCT05273632|Coagulants|coagulants|mesh-ancestor
25210804|NCT05257629|Nicotine|nicotine|mesh-list
25210805|NCT05257629|Varenicline|varenicline|mesh-list
25210806|NCT05257629|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25210807|NCT05257629|Autonomic Agents|autonomic agents|mesh-ancestor
25210808|NCT05257629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25210809|NCT05257629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210810|NCT05257629|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25210811|NCT05257629|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24522139|NCT04207177|Mycophenolic Acid|mycophenolic acid|mesh-list
24522140|NCT04207177|Tacrolimus|tacrolimus|mesh-list
24522141|NCT04207177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24522142|NCT04207177|Immunologic Factors|immunologic factors|mesh-ancestor
24522143|NCT04207177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522144|NCT04207177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24522145|NCT04207177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24522146|NCT04207177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522147|NCT04207177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24430543|NCT00248209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24522303|NCT04004078|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24522304|NCT04004078|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24522305|NCT04001621|Capecitabine|capecitabine|mesh-list
24522340|NCT03961165|Antiemetics|antiemetics|mesh-ancestor
24522341|NCT03961165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24522342|NCT03961165|Mydriatics|mydriatics|mesh-ancestor
24522381|NCT03896477|Immunologic Factors|immunologic factors|mesh-ancestor
24522382|NCT03896477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522416|NCT03853044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24522417|NCT03853044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24522418|NCT03853044|Alkylating Agents|alkylating agents|mesh-ancestor
24517932|NCT00610610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517933|NCT00610610|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24517934|NCT00610610|Antidepressive Agents|antidepressive agents|mesh-ancestor
24517935|NCT00610610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24467919|NCT00379041|Glucocorticoids|glucocorticoids|mesh-ancestor
24467920|NCT00379041|Hormones|hormones|mesh-ancestor
24467921|NCT00379041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24467922|NCT00379041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210812|NCT05257629|Cholinergic Agents|cholinergic agents|mesh-ancestor
25210813|NCT05257629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25210814|NCT05257629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210815|NCT05234606|Pembrolizumab|pembrolizumab|mesh-list
25210816|NCT05234606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25210817|NCT05234606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25210818|NCT05228041|Benralizumab|benralizumab|mesh-list
25210819|NCT05228041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25210820|NCT05228041|Respiratory System Agents|respiratory system agents|mesh-ancestor
25210821|NCT05210062|Succinylcholine|succinylcholine|mesh-list
25210822|NCT05210062|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
25210823|NCT05210062|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25210824|NCT05210062|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25210825|NCT05210062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25210826|NCT05210062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210827|NCT05182658|Empagliflozin|empagliflozin|mesh-list
25210828|NCT05182658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25210829|NCT05182658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210830|NCT05182658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25210831|NCT05182658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022827|NCT03659058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022828|NCT03659058|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25022829|NCT03659058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25022830|NCT03658993|Rifaximin|rifaximin|mesh-list
25022831|NCT03658993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25022832|NCT03658993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25022833|NCT03658993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25022834|NCT03658850|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25257238|NCT02477631|Sequestering Agents|sequestering agents|mesh-ancestor
25257239|NCT02477631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257240|NCT02477514|Tedizolid|tedizolid|mesh-list
25257241|NCT02477514|Tedizolid phosphate|tedizolid phosphate|mesh-list
25257242|NCT02477514|Midazolam|midazolam|mesh-list
25257243|NCT02477514|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25257244|NCT02477514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24627386|NCT01092520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24522420|NCT03853044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522582|NCT03637062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24945386|NCT03950830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467923|NCT00379041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24467924|NCT00379041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24467930|NCT00379067|Tamsulosin|tamsulosin|mesh-list
24468108|NCT00379886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468109|NCT00379886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24468110|NCT00379886|Anesthetics, General|anesthetics, general|mesh-ancestor
24468112|NCT00379886|Anticonvulsants|anticonvulsants|mesh-ancestor
24468113|NCT00379886|GABA Modulators|gaba modulators|mesh-ancestor
24468114|NCT00379886|GABA Agents|gaba agents|mesh-ancestor
24468115|NCT00379886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24468119|NCT00379951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24468120|NCT00379964|Caspofungin|caspofungin|mesh-list
24468121|NCT00379964|Antifungal Agents|antifungal agents|mesh-ancestor
24468122|NCT00379964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24468123|NCT00379964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24468124|NCT00379964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468652|NCT00382538|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24468653|NCT00382538|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24468823|NCT00383539|Vaccines|vaccines|mesh-list
24469373|NCT00385554|Antiviral Agents|antiviral agents|mesh-ancestor
24469374|NCT00385554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24469375|NCT00385606|Gemcitabine|gemcitabine|mesh-list
24469376|NCT00385606|Rofecoxib|rofecoxib|mesh-list
24469377|NCT00385606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470093|NCT00388739|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24470264|NCT00389415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470265|NCT00389415|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24470266|NCT00389415|Protease Inhibitors|protease inhibitors|mesh-ancestor
24470267|NCT00389415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677484|NCT01811238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25677485|NCT01811238|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25692393|NCT01999218|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25692394|NCT01999218|Protease Inhibitors|protease inhibitors|mesh-ancestor
25692395|NCT01999218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692396|NCT01999218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692397|NCT01999218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25692398|NCT01999218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25692399|NCT01999218|Immunologic Factors|immunologic factors|mesh-ancestor
25692400|NCT01999218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25692401|NCT01999322|Insulin|insulin|mesh-list
25692402|NCT01999322|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25692403|NCT01999322|Insulin Aspart|insulin aspart|mesh-list
25692404|NCT01999322|Insulin, Long-Acting|insulin, long-acting|mesh-list
25257260|NCT02477514|Antimetabolites|antimetabolites|mesh-ancestor
25257261|NCT02477514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25257262|NCT02477514|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25257263|NCT02477514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257264|NCT02477514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25257265|NCT02477514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25257266|NCT02477501|Norepinephrine|norepinephrine|mesh-list
25257268|NCT02477501|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25257269|NCT02477501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24470356|NCT00389922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24470357|NCT00389922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24470358|NCT00389935|Thalidomide|thalidomide|mesh-list
24470359|NCT00389935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24470360|NCT00389935|Immunologic Factors|immunologic factors|mesh-ancestor
24471256|NCT00394186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471257|NCT00394303|Insulin|insulin|mesh-list
24471258|NCT00394303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25272664|NCT02390843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25272665|NCT02390843|Immunologic Factors|immunologic factors|mesh-ancestor
25272666|NCT02390843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272667|NCT02390843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25272668|NCT02390843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25272669|NCT02390843|Alkylating Agents|alkylating agents|mesh-ancestor
25272670|NCT02390843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272671|NCT02390843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522618|NCT03567720|Paclitaxel|paclitaxel|mesh-list
24522619|NCT03567720|Pembrolizumab|pembrolizumab|mesh-list
24522620|NCT03567720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24522621|NCT03567720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522622|NCT03567720|Tubulin Modulators|tubulin modulators|mesh-ancestor
24522660|NCT03491059|Cholinergic Agents|cholinergic agents|mesh-ancestor
24522687|NCT03412266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24522688|NCT03412266|Immunologic Factors|immunologic factors|mesh-ancestor
24522689|NCT03412266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522690|NCT03412266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24522691|NCT03412266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24522692|NCT03412266|Alkylating Agents|alkylating agents|mesh-ancestor
24522693|NCT03412266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945400|NCT03951051|Olmesartan|olmesartan|mesh-list
24471259|NCT00394303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471260|NCT00394368|Fluticasone|fluticasone|mesh-list
24471341|NCT00394628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24471342|NCT00394628|Alkylating Agents|alkylating agents|mesh-ancestor
24471343|NCT00394628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210837|NCT05149768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25210838|NCT05149768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522777|NCT03127592|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24522778|NCT03127592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24522779|NCT03127592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24522780|NCT03127592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24522781|NCT03127592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24522782|NCT03127592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24522851|NCT03103750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24522852|NCT03103750|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24522884|NCT03102047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522885|NCT03097796|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
24522886|NCT03097796|Respiratory System Agents|respiratory system agents|mesh-ancestor
24472008|NCT00397735|Antiviral Agents|antiviral agents|mesh-ancestor
24472009|NCT00397735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25677486|NCT01811355|Mexiletine|mexiletine|mesh-list
25677487|NCT01811355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25677488|NCT01811355|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25677489|NCT01811355|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25677490|NCT01811355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25677491|NCT01811355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677492|NCT01811654|Hyaluronic Acid|hyaluronic acid|mesh-list
25677493|NCT01811654|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25677494|NCT01811654|Immunologic Factors|immunologic factors|mesh-ancestor
25022963|NCT03658421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25022964|NCT03658421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022965|NCT03658421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24426830|NCT00236717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24476781|NCT00416468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476808|NCT00416533|Glucocorticoids|glucocorticoids|mesh-ancestor
24476810|NCT00416533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24476811|NCT00416533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476813|NCT00416585|Isotretinoin|isotretinoin|mesh-list
24476893|NCT00416819|Dermatologic Agents|dermatologic agents|mesh-ancestor
24476894|NCT00416819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476898|NCT00416819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24476899|NCT00416819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24476900|NCT00416819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24476901|NCT00416819|Antiviral Agents|antiviral agents|mesh-ancestor
24477168|NCT00417677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24477169|NCT00417677|Antifungal Agents|antifungal agents|mesh-ancestor
24477170|NCT00417677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24477171|NCT00417677|Immunologic Factors|immunologic factors|mesh-ancestor
24477172|NCT00417690|Aminosalicylic Acid|aminosalicylic acid|mesh-list
24477173|NCT00417690|Antitubercular Agents|antitubercular agents|mesh-ancestor
25210868|NCT05110313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24430661|NCT00248963|Levonorgestrel|levonorgestrel|mesh-list
24457799|NCT00335270|Amprenavir|amprenavir|mesh-list
24457800|NCT00335270|Fosamprenavir|fosamprenavir|mesh-list
24457801|NCT00335270|Lamivudine|lamivudine|mesh-list
24522895|NCT03071926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522916|NCT03049735|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24522917|NCT03049735|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24522923|NCT03044613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24522924|NCT03044613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522929|NCT03044613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24522930|NCT03044613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24522931|NCT03028519|Vitamin D|vitamin d|mesh-list
24522932|NCT03028519|Cholecalciferol|cholecalciferol|mesh-list
24522933|NCT03028519|Vitamins|vitamins|mesh-ancestor
24522934|NCT03028519|Micronutrients|micronutrients|mesh-ancestor
24522935|NCT03028519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522936|NCT03028519|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24522937|NCT03028519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24522938|NCT03012971|Dexmedetomidine|dexmedetomidine|mesh-list
24522939|NCT03012971|Morphine|morphine|mesh-list
24522940|NCT03012971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24522941|NCT03012971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24522979|NCT02990338|Immunologic Factors|immunologic factors|mesh-ancestor
24522980|NCT02990338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24523042|NCT02901717|Antitubercular Agents|antitubercular agents|mesh-ancestor
24477397|NCT00418496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457054|NCT00333021|Protease Inhibitors|protease inhibitors|mesh-ancestor
24457055|NCT00333021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478740|NCT00424203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210869|NCT05110313|Immunologic Factors|immunologic factors|mesh-ancestor
25210870|NCT05110313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210871|NCT05063656|Gabapentin|gabapentin|mesh-list
25210872|NCT05063656|Analgesics|analgesics|mesh-ancestor
25210873|NCT05063656|Sensory System Agents|sensory system agents|mesh-ancestor
25210874|NCT05063656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25210875|NCT05063656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210876|NCT05063656|Anticonvulsants|anticonvulsants|mesh-ancestor
25210877|NCT05063656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25210878|NCT05063656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25210879|NCT05063656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25210880|NCT05063656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25210881|NCT05063656|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25677495|NCT01811654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677496|NCT01811654|Viscosupplements|viscosupplements|mesh-ancestor
25677497|NCT01811654|Protective Agents|protective agents|mesh-ancestor
25677498|NCT01811693|Nitroglycerin|nitroglycerin|mesh-list
25257281|NCT02477488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257286|NCT02477488|Antioxidants|antioxidants|mesh-ancestor
25210882|NCT05063656|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25210883|NCT05063656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25210884|NCT05063656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210885|NCT05063656|Antimanic Agents|antimanic agents|mesh-ancestor
25210886|NCT05059860|Insulin|insulin|mesh-list
25210887|NCT05059860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25210888|NCT05059860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210889|NCT05058092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25210890|NCT05048498|Azacitidine|azacitidine|mesh-list
25210891|NCT05048498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25210892|NCT05048498|Antimetabolites|antimetabolites|mesh-ancestor
25210893|NCT05048498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210894|NCT05048498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25210895|NCT05048498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25210896|NCT05036226|Metformin|metformin|mesh-list
25210897|NCT05036226|Sirolimus|sirolimus|mesh-list
25210898|NCT05036226|Hydroxychloroquine|hydroxychloroquine|mesh-list
25210899|NCT05036226|Nelfinavir|nelfinavir|mesh-list
25210900|NCT05036226|Dasatinib|dasatinib|mesh-list
24523049|NCT02897050|Immunologic Factors|immunologic factors|mesh-ancestor
24523050|NCT02897050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523116|NCT02584309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24523117|NCT02584309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24523265|NCT02336750|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24523266|NCT02336750|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24523267|NCT02336750|Adrenergic Agents|adrenergic agents|mesh-ancestor
24523268|NCT02336750|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24523269|NCT02336750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24523270|NCT02336750|Serotonin Agents|serotonin agents|mesh-ancestor
24523273|NCT02268175|Leuprolide|leuprolide|mesh-list
24523274|NCT02268175|Abiraterone Acetate|abiraterone acetate|mesh-list
24523275|NCT02268175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24651997|NCT01234974|Somatostatin|somatostatin|mesh-list
24652110|NCT01236495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24523276|NCT02268175|Glucocorticoids|glucocorticoids|mesh-ancestor
24523277|NCT02268175|Hormones|hormones|mesh-ancestor
24457802|NCT00335270|Abacavir|abacavir|mesh-list
24457803|NCT00335270|Calcium|calcium|mesh-list
25117012|NCT03105466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24478862|NCT00424801|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24478865|NCT00424814|Ritonavir|ritonavir|mesh-list
24478866|NCT00424814|Lopinavir|lopinavir|mesh-list
24478867|NCT00424814|Lamivudine|lamivudine|mesh-list
24478868|NCT00424814|Zidovudine|zidovudine|mesh-list
24479034|NCT00425360|Gemcitabine|gemcitabine|mesh-list
24479035|NCT00425360|Capecitabine|capecitabine|mesh-list
24479036|NCT00425360|Sargramostim|sargramostim|mesh-list
24479037|NCT00425360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24479038|NCT00425360|Antimetabolites|antimetabolites|mesh-ancestor
25210901|NCT05036226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25210902|NCT05036226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210903|NCT05036226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25210904|NCT05036226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25210905|NCT05036226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25210906|NCT05036226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25210907|NCT05036226|Antifungal Agents|antifungal agents|mesh-ancestor
25210908|NCT05036226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25210909|NCT05036226|Immunologic Factors|immunologic factors|mesh-ancestor
25210910|NCT05036226|Antimalarials|antimalarials|mesh-ancestor
25210912|NCT05036226|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25210913|NCT05036226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677499|NCT01811693|Vasodilator Agents|vasodilator agents|mesh-ancestor
25677500|NCT01811706|4-Aminopyridine|4-aminopyridine|mesh-list
25210914|NCT05036226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210915|NCT05036226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25677501|NCT01811706|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25023133|NCT03657420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023134|NCT03657420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112044|NCT04527055|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
25112045|NCT04527055|Esomeprazole|esomeprazole|mesh-list
25112047|NCT04527055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25257296|NCT02477397|Formoterol Fumarate|formoterol fumarate|mesh-list
25257297|NCT02477397|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25257298|NCT02477397|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25257299|NCT02477397|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24929033|NCT04116255|Salicylic Acid|salicylic acid|mesh-list
25210916|NCT05036226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25210917|NCT05036226|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25210918|NCT05036226|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25210919|NCT05036226|Protease Inhibitors|protease inhibitors|mesh-ancestor
25210920|NCT05036226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25210921|NCT05036226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25210922|NCT05036226|Antiviral Agents|antiviral agents|mesh-ancestor
25210923|NCT05000658|Dexamethasone|dexamethasone|mesh-list
25210924|NCT05000658|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25210925|NCT05000658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25210926|NCT05000658|Antiemetics|antiemetics|mesh-ancestor
25117013|NCT03105466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24479468|NCT00426998|Bevacizumab|bevacizumab|mesh-list
24479469|NCT00426998|Verteporfin|verteporfin|mesh-list
24479592|NCT00427388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24480034|NCT00429559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480035|NCT00429559|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24480036|NCT00429559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24480038|NCT00429624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24480039|NCT00429624|Analgesics|analgesics|mesh-ancestor
24480040|NCT00429624|Sensory System Agents|sensory system agents|mesh-ancestor
24457131|NCT00333164|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24457132|NCT00333164|Autonomic Agents|autonomic agents|mesh-ancestor
24480042|NCT00429624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457166|NCT00333281|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24457167|NCT00333281|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24457168|NCT00333281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481097|NCT00433277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24481262|NCT00433927|Antidotes|antidotes|mesh-ancestor
24481263|NCT00433927|Protective Agents|protective agents|mesh-ancestor
24481266|NCT00433927|Micronutrients|micronutrients|mesh-ancestor
24457211|NCT00333450|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24457213|NCT00333450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457214|NCT00333476|Squalamine|squalamine|mesh-list
24457215|NCT00333476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24457216|NCT00333476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25677502|NCT01811706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25677503|NCT01811706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677504|NCT01811732|Vancomycin|vancomycin|mesh-list
25677505|NCT01811732|Aztreonam|aztreonam|mesh-list
25677506|NCT01811732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25677507|NCT01811732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25677508|NCT01811940|Topiramate|topiramate|mesh-list
25677509|NCT01811940|Adderall|adderall|mesh-list
25677510|NCT01811940|Anticonvulsants|anticonvulsants|mesh-ancestor
25677511|NCT01811940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25677512|NCT01811940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677513|NCT01811940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25677514|NCT01811953|Metformin|metformin|mesh-list
25257315|NCT02477397|Adrenergic Agents|adrenergic agents|mesh-ancestor
25257316|NCT02477397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25257317|NCT02477397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257318|NCT02477397|Sympathomimetics|sympathomimetics|mesh-ancestor
25257319|NCT02477267|Buprenorphine|buprenorphine|mesh-list
24772926|NCT01836653|Cetuximab|cetuximab|mesh-list
25257321|NCT02477267|Naloxone|naloxone|mesh-list
24481396|NCT00434239|Growth Substances|growth substances|mesh-ancestor
24481397|NCT00434239|Growth Inhibitors|growth inhibitors|mesh-ancestor
24481398|NCT00434239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481399|NCT00434317|Zoledronic Acid|zoledronic acid|mesh-list
24481454|NCT00434824|Testosterone undecanoate|testosterone undecanoate|mesh-list
24481456|NCT00434824|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24481457|NCT00434824|Androgens|androgens|mesh-ancestor
24481458|NCT00434824|Hormones|hormones|mesh-ancestor
24481460|NCT00434824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481461|NCT00434824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24481795|NCT00436800|Antimetabolites|antimetabolites|mesh-ancestor
24457224|NCT00333476|Growth Inhibitors|growth inhibitors|mesh-ancestor
24457226|NCT00333489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24457227|NCT00333489|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24481796|NCT00436800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481833|NCT00436839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24481834|NCT00436839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25210927|NCT05000658|Autonomic Agents|autonomic agents|mesh-ancestor
24481842|NCT00436943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24481843|NCT00436943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481844|NCT00436943|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24481845|NCT00436943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24481846|NCT00436943|Cholinergic Agents|cholinergic agents|mesh-ancestor
24481847|NCT00436943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24457249|NCT00333632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24482196|NCT00438139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24482197|NCT00438139|Analgesics|analgesics|mesh-ancestor
24482205|NCT00438139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24482206|NCT00438152|Ritonavir|ritonavir|mesh-list
24482207|NCT00438152|Lopinavir|lopinavir|mesh-list
24482208|NCT00438152|Saquinavir|saquinavir|mesh-list
24482209|NCT00438152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24482210|NCT00438152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24482211|NCT00438152|Protease Inhibitors|protease inhibitors|mesh-ancestor
24482212|NCT00438152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24482213|NCT00438152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432726|NCT00255788|Everolimus|everolimus|mesh-list
24482214|NCT00438152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24482238|NCT00438230|Warfarin|warfarin|mesh-list
24482239|NCT00438230|Anticoagulants|anticoagulants|mesh-ancestor
24482240|NCT00438243|Bromfenac|bromfenac|mesh-list
24482241|NCT00438243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24482242|NCT00438243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24482243|NCT00438243|Analgesics|analgesics|mesh-ancestor
24482244|NCT00438243|Sensory System Agents|sensory system agents|mesh-ancestor
24482245|NCT00438243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24482246|NCT00438243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482247|NCT00438243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24482248|NCT00438243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24482249|NCT00438269|Metronidazole|metronidazole|mesh-list
24482250|NCT00438269|Ciprofloxacin|ciprofloxacin|mesh-list
24482251|NCT00438269|Meropenem|meropenem|mesh-list
25677515|NCT01811953|Empagliflozin|empagliflozin|mesh-list
25677516|NCT01811953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25677517|NCT01811953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677518|NCT01811953|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25677519|NCT01811953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677520|NCT01812005|Rituximab|rituximab|mesh-list
25677521|NCT01812005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25257331|NCT02477280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25257332|NCT02477280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257333|NCT02477280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25257334|NCT02477280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25257335|NCT02477280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25257336|NCT02477280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257337|NCT02477280|Dopamine Agents|dopamine agents|mesh-ancestor
24540307|NCT00667264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24426913|NCT00236821|Renal Agents|renal agents|mesh-ancestor
24483597|NCT00444223|Protective Agents|protective agents|mesh-ancestor
24483598|NCT00444223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483599|NCT00444236|Esomeprazole|esomeprazole|mesh-list
24483600|NCT00444236|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24457398|NCT00334347|Valproic Acid|valproic acid|mesh-list
24457399|NCT00334347|Anticonvulsants|anticonvulsants|mesh-ancestor
24457402|NCT00334347|GABA Agents|gaba agents|mesh-ancestor
24483601|NCT00444236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24483602|NCT00444236|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24846640|NCT02243436|Cytarabine|cytarabine|mesh-list
24483939|NCT00445900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24483940|NCT00445900|Growth Substances|growth substances|mesh-ancestor
25210928|NCT05000658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25210929|NCT05000658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523642|NCT05341193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528061|NCT00619398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24523785|NCT05340439|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24523786|NCT05340439|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24523787|NCT05340439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24523788|NCT05340439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523811|NCT05340192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24523812|NCT05340192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24523813|NCT05340192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24523814|NCT05340153|Lumefantrine|lumefantrine|mesh-list
24523815|NCT05340153|Artemether|artemether|mesh-list
24523816|NCT05340153|Piperaquine|piperaquine|mesh-list
24483941|NCT00445900|Growth Inhibitors|growth inhibitors|mesh-ancestor
25210930|NCT05000658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25210931|NCT05000658|Glucocorticoids|glucocorticoids|mesh-ancestor
25210932|NCT05000658|Hormones|hormones|mesh-ancestor
25210933|NCT05000658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25210934|NCT05000658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25210935|NCT05000658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25210936|NCT04965272|Cariprazine|cariprazine|mesh-list
24944318|NCT03961360|Analgesics|analgesics|mesh-ancestor
25210937|NCT04965272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25210938|NCT04965272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25210939|NCT04965272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25210940|NCT04965272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210941|NCT04965272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25210942|NCT04958772|Lenograstim|lenograstim|mesh-list
25210943|NCT04958772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25210944|NCT04958772|Immunologic Factors|immunologic factors|mesh-ancestor
25210945|NCT04958772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210946|NCT04954989|Epoetin Alfa|epoetin alfa|mesh-list
25210947|NCT04954989|Hematinics|hematinics|mesh-ancestor
25210948|NCT04937738|Leucovorin|leucovorin|mesh-list
25210949|NCT04937738|Docetaxel|docetaxel|mesh-list
25210950|NCT04937738|Fluorouracil|fluorouracil|mesh-list
25210951|NCT04937738|Capecitabine|capecitabine|mesh-list
25210952|NCT04937738|Oxaliplatin|oxaliplatin|mesh-list
25210953|NCT04937738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25210954|NCT04937738|Tubulin Modulators|tubulin modulators|mesh-ancestor
25210955|NCT04937738|Antimitotic Agents|antimitotic agents|mesh-ancestor
25210956|NCT04937738|Mitosis Modulators|mitosis modulators|mesh-ancestor
25677522|NCT01812005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25677523|NCT01812005|Immunologic Factors|immunologic factors|mesh-ancestor
25677524|NCT01812005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677525|NCT01812005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25677526|NCT01812044|Lidocaine|lidocaine|mesh-list
25677527|NCT01812044|Bupivacaine|bupivacaine|mesh-list
25677528|NCT01812044|Anesthetics, Local|anesthetics, local|mesh-list
25677529|NCT01812044|Anesthetics|anesthetics|mesh-list
25677530|NCT01812044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25257344|NCT02477306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257346|NCT02476955|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25257347|NCT02476955|Carboplatin|carboplatin|mesh-list
25257348|NCT02476955|Anastrozole|anastrozole|mesh-list
25257349|NCT02476955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24929082|NCT04115423|Infliximab|infliximab|mesh-list
25210957|NCT04937738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210958|NCT04937738|Antimetabolites|antimetabolites|mesh-ancestor
25210959|NCT04937738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25210960|NCT04937738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25210961|NCT04937738|Immunologic Factors|immunologic factors|mesh-ancestor
25210962|NCT04937738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210963|NCT04937738|Antidotes|antidotes|mesh-ancestor
25210964|NCT04937738|Protective Agents|protective agents|mesh-ancestor
25210965|NCT04937738|Vitamin B Complex|vitamin b complex|mesh-ancestor
25210966|NCT04937738|Vitamins|vitamins|mesh-ancestor
25210967|NCT04937738|Micronutrients|micronutrients|mesh-ancestor
25210968|NCT04924621|Midazolam|midazolam|mesh-list
25210969|NCT04924621|Sufentanil|sufentanil|mesh-list
24523819|NCT05340153|Antimalarials|antimalarials|mesh-ancestor
24523820|NCT05340153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24523821|NCT05340153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24523822|NCT05340153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24486754|NCT00459901|Antimetabolites|antimetabolites|mesh-ancestor
24486755|NCT00459901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486756|NCT00459901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487238|NCT00462358|Mitosis Modulators|mitosis modulators|mesh-ancestor
24523128|NCT02512926|Immunologic Factors|immunologic factors|mesh-ancestor
24487503|NCT00463541|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24487504|NCT00463541|Cholinergic Agents|cholinergic agents|mesh-ancestor
24488843|NCT00470249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24523328|NCT01855867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24489008|NCT00471003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489009|NCT00471029|Esomeprazole|esomeprazole|mesh-list
24489010|NCT00471029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24489011|NCT00471029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24489012|NCT00471029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24489013|NCT00471029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24489014|NCT00471029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489047|NCT00471289|Paclitaxel|paclitaxel|mesh-list
24489048|NCT00471289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24489049|NCT00471289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489050|NCT00471289|Tubulin Modulators|tubulin modulators|mesh-ancestor
24489051|NCT00471289|Antimitotic Agents|antimitotic agents|mesh-ancestor
24489575|NCT00474110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489576|NCT00474110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489577|NCT00474110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24489579|NCT00474110|Anesthetics, General|anesthetics, general|mesh-ancestor
24489580|NCT00474110|Anesthetics|anesthetics|mesh-ancestor
25210970|NCT04924621|Propofol|propofol|mesh-list
25210971|NCT04924621|Tetracaine|tetracaine|mesh-list
25210972|NCT04924621|Rocuronium|rocuronium|mesh-list
25210973|NCT04924621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25210974|NCT04924621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25210975|NCT04924621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210976|NCT04924621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25210977|NCT04924621|Anesthetics, General|anesthetics, general|mesh-ancestor
25210978|NCT04924621|Anesthetics|anesthetics|mesh-ancestor
25210979|NCT04924621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25210980|NCT04924621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25210981|NCT04924621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25210982|NCT04924621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25210983|NCT04924621|GABA Modulators|gaba modulators|mesh-ancestor
25210984|NCT04924621|GABA Agents|gaba agents|mesh-ancestor
25677531|NCT01812044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677532|NCT01812044|Sensory System Agents|sensory system agents|mesh-ancestor
25677533|NCT01812044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25677534|NCT01812044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25677535|NCT01812044|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25677536|NCT01812044|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25257355|NCT02476955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25257356|NCT02476955|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25257357|NCT02476955|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25257358|NCT02476955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257359|NCT02476955|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25257360|NCT02476955|Hormone Antagonists|hormone antagonists|mesh-ancestor
25257361|NCT02476955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25257362|NCT02476955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25210985|NCT04924621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25210986|NCT04924621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25210987|NCT04924621|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25210988|NCT04924621|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24523915|NCT05338502|Omeprazole|omeprazole|mesh-list
24523916|NCT05338502|Ranitidine|ranitidine|mesh-list
24523917|NCT05338502|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
24523918|NCT05338502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24523952|NCT05338476|Midazolam|midazolam|mesh-list
24523953|NCT05338476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24523954|NCT05338476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24523955|NCT05338476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24524029|NCT05322031|Dopamine Agonists|dopamine agonists|mesh-ancestor
24524030|NCT05322031|Dopamine Agents|dopamine agents|mesh-ancestor
24489605|NCT00474279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24489606|NCT00474279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489608|NCT00474435|Emtricitabine|emtricitabine|mesh-list
24446923|NCT00306618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490176|NCT00476983|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24457513|NCT00334646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490178|NCT00476983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24490179|NCT00476983|Protease Inhibitors|protease inhibitors|mesh-ancestor
24490180|NCT00476983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490213|NCT00477035|Tubulin Modulators|tubulin modulators|mesh-ancestor
24490263|NCT00477373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490316|NCT00477737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24490317|NCT00477737|Anesthetics, General|anesthetics, general|mesh-ancestor
24490318|NCT00477737|Anesthetics|anesthetics|mesh-ancestor
24490327|NCT00477763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490328|NCT00477763|Antifungal Agents|antifungal agents|mesh-ancestor
24490329|NCT00477763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24490330|NCT00477763|Dermatologic Agents|dermatologic agents|mesh-ancestor
24490331|NCT00477763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24490332|NCT00477763|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24490334|NCT00477776|Antiemetics|antiemetics|mesh-ancestor
24490335|NCT00477776|Autonomic Agents|autonomic agents|mesh-ancestor
24492927|NCT00488605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24492929|NCT00488605|Antimitotic Agents|antimitotic agents|mesh-ancestor
24492930|NCT00488605|Mitosis Modulators|mitosis modulators|mesh-ancestor
24492932|NCT00488670|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24492933|NCT00488670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25210989|NCT04924621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25210990|NCT04924621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25210991|NCT04924621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25210992|NCT04924621|Narcotics|narcotics|mesh-ancestor
25210993|NCT04924621|Analgesics|analgesics|mesh-ancestor
25210994|NCT04924621|Sensory System Agents|sensory system agents|mesh-ancestor
25210995|NCT04924621|Anesthetics, Local|anesthetics, local|mesh-ancestor
25210996|NCT04909073|Afatinib|afatinib|mesh-list
25210997|NCT04909073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25210998|NCT04909073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25210999|NCT04909073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25211000|NCT04909073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524031|NCT05322031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25677537|NCT01812044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25677538|NCT01812044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677539|NCT01812057|Dexamethasone|dexamethasone|mesh-list
25677540|NCT01812057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25677541|NCT01812057|Antiemetics|antiemetics|mesh-ancestor
25677542|NCT01812057|Autonomic Agents|autonomic agents|mesh-ancestor
25677543|NCT01812057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25677544|NCT01812057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677545|NCT01812057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25257363|NCT02477007|Acetaminophen|acetaminophen|mesh-list
25257364|NCT02477007|Ibuprofen|ibuprofen|mesh-list
25257365|NCT02477007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25257366|NCT02477007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25257367|NCT02477007|Analgesics|analgesics|mesh-ancestor
25257368|NCT02477007|Sensory System Agents|sensory system agents|mesh-ancestor
24528099|NCT00619697|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24528100|NCT00619697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24528101|NCT00619697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624707|NCT01077752|Sensory System Agents|sensory system agents|mesh-ancestor
24624708|NCT01077752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24624709|NCT01077752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24524032|NCT05322031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524033|NCT05322031|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24524170|NCT05206110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24524171|NCT05206110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24524173|NCT05206110|Sensory System Agents|sensory system agents|mesh-ancestor
24524174|NCT05206110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24524175|NCT05206110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524211|NCT05158686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24524212|NCT05158686|Tubulin Modulators|tubulin modulators|mesh-ancestor
24524213|NCT05158686|Antimitotic Agents|antimitotic agents|mesh-ancestor
24524234|NCT05128071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24524235|NCT05128071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652675|NCT01239563|Thymoglobulin|thymoglobulin|mesh-list
24524236|NCT05117853|Parathyroid Hormone|parathyroid hormone|mesh-list
24524237|NCT05117853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24524238|NCT05117853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492934|NCT00488670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24492935|NCT00488670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492936|NCT00488670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492942|NCT00488709|Cytarabine|cytarabine|mesh-list
24428223|NCT00239967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428224|NCT00239980|Dalteparin|dalteparin|mesh-list
24493367|NCT00490711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25211008|NCT04897919|Lumefantrine|lumefantrine|mesh-list
25211010|NCT04897919|Piperaquine|piperaquine|mesh-list
25211011|NCT04897919|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25211012|NCT04897919|Artenimol|artenimol|mesh-list
25211013|NCT04897919|Antimalarials|antimalarials|mesh-ancestor
25211014|NCT04897919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25211015|NCT04897919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25211016|NCT04897919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493370|NCT00490711|Mitosis Modulators|mitosis modulators|mesh-ancestor
24493371|NCT00490711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495473|NCT00500409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495474|NCT00500409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24495476|NCT00500422|Doxorubicin|doxorubicin|mesh-list
24495477|NCT00500422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24495478|NCT00500422|Bortezomib|bortezomib|mesh-list
24495479|NCT00500422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24393757|NCT00130910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24496022|NCT00503152|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24496023|NCT00503152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24496024|NCT00503152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24445410|NCT00301535|HBOC 201|hboc 201|mesh-list
25080493|NCT03337672|Midazolam|midazolam|mesh-list
24497559|NCT00510419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497560|NCT00510419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497561|NCT00510445|Imetelstat|imetelstat|mesh-list
25677546|NCT01812057|Glucocorticoids|glucocorticoids|mesh-ancestor
25677547|NCT01812057|Hormones|hormones|mesh-ancestor
25677548|NCT01812057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25677549|NCT01812057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25677550|NCT01812057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25677551|NCT01812668|Fluorides|fluorides|mesh-list
25677552|NCT01812668|Cariostatic Agents|cariostatic agents|mesh-ancestor
25677553|NCT01812668|Protective Agents|protective agents|mesh-ancestor
25677554|NCT01812668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677555|NCT01812707|Atorvastatin|atorvastatin|mesh-list
25677556|NCT01812707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25677557|NCT01812707|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25677558|NCT01812707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25677559|NCT01812707|Antimetabolites|antimetabolites|mesh-ancestor
24497567|NCT00510471|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24497569|NCT00510471|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
24497662|NCT00511212|gamma-Globulins|gamma-globulins|mesh-list
24497698|NCT00511446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497750|NCT00511654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497751|NCT00511719|Insulin|insulin|mesh-list
24497752|NCT00511719|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24497753|NCT00511719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24652802|NCT01240213|Vitamin D|vitamin d|mesh-list
24497754|NCT00511719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497755|NCT00511732|Insulin|insulin|mesh-list
24497756|NCT00511732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24497757|NCT00511732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497758|NCT00511771|Tegaserod|tegaserod|mesh-list
24497759|NCT00511771|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24497760|NCT00511771|Serotonin Agents|serotonin agents|mesh-ancestor
24497797|NCT00511953|Gabapentin|gabapentin|mesh-list
24497798|NCT00511953|Analgesics|analgesics|mesh-ancestor
24497799|NCT00511953|Sensory System Agents|sensory system agents|mesh-ancestor
24498509|NCT00515138|Ifosfamide|ifosfamide|mesh-list
24498801|NCT00516399|Antifungal Agents|antifungal agents|mesh-ancestor
24498802|NCT00516412|Everolimus|everolimus|mesh-list
24498835|NCT00516464|Growth Substances|growth substances|mesh-ancestor
24498836|NCT00516464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211048|NCT04865042|Gabapentin|gabapentin|mesh-list
25211049|NCT04865042|Analgesics|analgesics|mesh-ancestor
25211050|NCT04865042|Sensory System Agents|sensory system agents|mesh-ancestor
25211051|NCT04865042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25211052|NCT04865042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211053|NCT04865042|Anticonvulsants|anticonvulsants|mesh-ancestor
25211054|NCT04865042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25211055|NCT04865042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25211056|NCT04865042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25211057|NCT04865042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25211058|NCT04865042|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25211059|NCT04865042|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25211060|NCT04865042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24524500|NCT04792190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524507|NCT04772196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524508|NCT04772196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24524509|NCT04772196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24524510|NCT04771741|Acetaminophen|acetaminophen|mesh-list
24524511|NCT04771741|Ketorolac|ketorolac|mesh-list
24524512|NCT04771741|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24524513|NCT04771741|Meloxicam|meloxicam|mesh-list
24524514|NCT04771741|Pregabalin|pregabalin|mesh-list
24524515|NCT04771741|Cyclobenzaprine|cyclobenzaprine|mesh-list
24524516|NCT04771741|Analgesics|analgesics|mesh-ancestor
24524517|NCT04771741|Sensory System Agents|sensory system agents|mesh-ancestor
24498837|NCT00516464|Growth Inhibitors|growth inhibitors|mesh-ancestor
24498838|NCT00516464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498839|NCT00516490|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24498840|NCT00516490|Luteolytic Agents|luteolytic agents|mesh-ancestor
24498841|NCT00516490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24498842|NCT00516490|Contraceptive Agents|contraceptive agents|mesh-ancestor
24652846|NCT01240629|Doxorubicin|doxorubicin|mesh-list
24498843|NCT00516490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24498844|NCT00516490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499249|NCT00518466|Anticonvulsants|anticonvulsants|mesh-ancestor
24499250|NCT00518466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24457611|NCT00334698|Sympathomimetics|sympathomimetics|mesh-ancestor
24457612|NCT00334698|Adrenergic Agents|adrenergic agents|mesh-ancestor
24457614|NCT00334763|Bevacizumab|bevacizumab|mesh-list
24457615|NCT00334763|Carboplatin|carboplatin|mesh-list
24457616|NCT00334763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24457617|NCT00334763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24457618|NCT00334763|Tubulin Modulators|tubulin modulators|mesh-ancestor
24499251|NCT00518466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499551|NCT00520026|Lithium Carbonate|lithium carbonate|mesh-list
24499552|NCT00520026|Antidepressive Agents|antidepressive agents|mesh-ancestor
24499553|NCT00520026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24499554|NCT00520026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499555|NCT00520026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499556|NCT00520026|Antimanic Agents|antimanic agents|mesh-ancestor
24499557|NCT00520026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25257389|NCT02476799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25257390|NCT02476799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25257391|NCT02476799|Anesthetics, General|anesthetics, general|mesh-ancestor
24929092|NCT04115423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929094|NCT04115423|Immunologic Factors|immunologic factors|mesh-ancestor
24799117|NCT01967368|Vaccines|vaccines|mesh-list
25023786|NCT03651726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25023787|NCT03651726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25023788|NCT03651726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24499558|NCT00520026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24499559|NCT00520026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499560|NCT00520052|Zoledronic Acid|zoledronic acid|mesh-list
24499561|NCT00520052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24499562|NCT00520052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499564|NCT00520091|Irinotecan|irinotecan|mesh-list
24499565|NCT00520091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24499566|NCT00520091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24499567|NCT00520091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24499568|NCT00520091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499571|NCT00520091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24499653|NCT00520442|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24499654|NCT00520442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24499655|NCT00520442|Analgesics|analgesics|mesh-ancestor
24499656|NCT00520442|Sensory System Agents|sensory system agents|mesh-ancestor
24499657|NCT00520442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24499658|NCT00520442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499659|NCT00520442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25211061|NCT04865042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211062|NCT04865042|Antimanic Agents|antimanic agents|mesh-ancestor
25211063|NCT04857671|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25211064|NCT04857671|Botulinum Toxins|botulinum toxins|mesh-list
25211065|NCT04857671|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25211066|NCT04857671|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25211067|NCT04857671|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25211068|NCT04857671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25211069|NCT04857671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211070|NCT04857671|Cholinergic Agents|cholinergic agents|mesh-ancestor
25211071|NCT04857671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25211072|NCT04857671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211073|NCT04857671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24524520|NCT04771741|Anticonvulsants|anticonvulsants|mesh-ancestor
24524521|NCT04771741|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24528293|NCT00620646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24524523|NCT04771741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524524|NCT04771741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24524525|NCT04771741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24499660|NCT00520442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24500462|NCT00524381|Immunologic Factors|immunologic factors|mesh-ancestor
24500463|NCT00524407|Epoetin Alfa|epoetin alfa|mesh-list
24503173|NCT02978391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505310|NCT00540826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505312|NCT00540891|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24505313|NCT00540891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24505314|NCT00540891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24505315|NCT00540891|Adrenergic Agents|adrenergic agents|mesh-ancestor
24505403|NCT00541086|Hormone Antagonists|hormone antagonists|mesh-ancestor
24505404|NCT00541086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25677560|NCT01812707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677561|NCT01812707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25677562|NCT01812707|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25677563|NCT01812707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677564|NCT01812707|Immunologic Factors|immunologic factors|mesh-ancestor
25677565|NCT01812707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677566|NCT01812759|Fentanyl|fentanyl|mesh-list
25677567|NCT01812759|Hydromorphone|hydromorphone|mesh-list
25677568|NCT01812759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25677569|NCT01812759|Narcotics|narcotics|mesh-ancestor
25257402|NCT02477098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24505405|NCT00541086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505481|NCT00541177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24505482|NCT00541177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24505483|NCT00541177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24505484|NCT00541177|Autonomic Agents|autonomic agents|mesh-ancestor
24525295|NCT03695510|Afatinib|afatinib|mesh-list
24505804|NCT00542555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24506083|NCT00544037|Interferons|interferons|mesh-list
24506084|NCT00544037|Interferon-beta|interferon-beta|mesh-list
24506085|NCT00544037|Interferon beta-1b|interferon beta-1b|mesh-list
24506172|NCT00544219|Mitosis Modulators|mitosis modulators|mesh-ancestor
24506173|NCT00544232|Paclitaxel|paclitaxel|mesh-list
24506174|NCT00544232|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24506175|NCT00544232|Cyclophosphamide|cyclophosphamide|mesh-list
24506176|NCT00544232|Methotrexate|methotrexate|mesh-list
24506177|NCT00544232|Epirubicin|epirubicin|mesh-list
24506178|NCT00544232|Darbepoetin alfa|darbepoetin alfa|mesh-list
24506179|NCT00544232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24506574|NCT00546039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506575|NCT00546039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24506580|NCT00546039|Estrogens|estrogens|mesh-ancestor
24506860|NCT00547209|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24506861|NCT00547209|Anesthetics, General|anesthetics, general|mesh-ancestor
24506862|NCT00547209|Anesthetics|anesthetics|mesh-ancestor
24506863|NCT00547209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24506864|NCT00547209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507300|NCT00549666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24507301|NCT00549666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507357|NCT00550095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25211074|NCT04857671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25211075|NCT04855617|Ocrelizumab|ocrelizumab|mesh-list
25211076|NCT04855617|Immunologic Factors|immunologic factors|mesh-ancestor
25211077|NCT04855617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272672|NCT02390843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25272673|NCT02390843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25272674|NCT02390843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25272675|NCT02390843|Antimetabolites|antimetabolites|mesh-ancestor
25272676|NCT02390843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24524526|NCT04771741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24524527|NCT04771741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24524528|NCT04771741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24524529|NCT04771741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24524530|NCT04771741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24524531|NCT04771741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24524532|NCT04771741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24524533|NCT04771741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24524534|NCT04771741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24524535|NCT04771741|Antipyretics|antipyretics|mesh-ancestor
24524536|NCT04771741|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24524581|NCT04688658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524639|NCT04639986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24524640|NCT04639986|Antimetabolites|antimetabolites|mesh-ancestor
25117014|NCT03105466|Glucocorticoids|glucocorticoids|mesh-ancestor
24507358|NCT00550095|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24507359|NCT00550095|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24395243|NCT00135525|Paroxetine|paroxetine|mesh-list
24507361|NCT00550108|Ethanol|ethanol|mesh-list
24507495|NCT00550927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507762|NCT00551889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24507790|NCT00552227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507792|NCT00552266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25677570|NCT01812759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25677571|NCT01812759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677572|NCT01812759|Analgesics|analgesics|mesh-ancestor
24528102|NCT00619697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24528103|NCT00619697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24528104|NCT00619697|Immunologic Factors|immunologic factors|mesh-ancestor
24528106|NCT00619710|Imipenem|imipenem|mesh-list
25024026|NCT03649334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024027|NCT03649334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25024029|NCT03649334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25024030|NCT03649334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25024031|NCT03649334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24507793|NCT00552266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507794|NCT00552266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24507795|NCT00552266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24507796|NCT00552266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24508042|NCT00553995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24508138|NCT00554346|Analgesics|analgesics|mesh-ancestor
24508139|NCT00554346|Sensory System Agents|sensory system agents|mesh-ancestor
24508140|NCT00554346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24508141|NCT00554346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508142|NCT00554346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24508844|NCT00557219|Serotonin Agents|serotonin agents|mesh-ancestor
24508845|NCT00557232|Bevacizumab|bevacizumab|mesh-list
24508846|NCT00557232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24508847|NCT00557232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508848|NCT00557232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24508849|NCT00557232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24508850|NCT00557232|Growth Substances|growth substances|mesh-ancestor
24510539|NCT00564772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24526315|NCT00195091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510540|NCT00564772|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24510542|NCT00564824|Caffeine|caffeine|mesh-list
24510543|NCT00564824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24510570|NCT00565006|Anacetrapib|anacetrapib|mesh-list
24510571|NCT00565006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24510572|NCT00565006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24510573|NCT00565006|Antimetabolites|antimetabolites|mesh-ancestor
25211078|NCT04808531|Oxycodone|oxycodone|mesh-list
25211079|NCT04808531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25211080|NCT04808531|Narcotics|narcotics|mesh-ancestor
25211081|NCT04808531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25211082|NCT04808531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211083|NCT04808531|Analgesics|analgesics|mesh-ancestor
25211084|NCT04808531|Sensory System Agents|sensory system agents|mesh-ancestor
25211085|NCT04808531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25211086|NCT04804644|Memantine|memantine|mesh-list
25211087|NCT04804644|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25211088|NCT04804644|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25211089|NCT04804644|Dopamine Agents|dopamine agents|mesh-ancestor
25211090|NCT04804644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25211091|NCT04804644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211092|NCT04804644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211093|NCT04804644|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25211094|NCT04804644|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24524645|NCT04639986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24524646|NCT04639986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24524653|NCT04572451|Nivolumab|nivolumab|mesh-list
24524763|NCT04403698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524765|NCT04377204|Bupivacaine|bupivacaine|mesh-list
24524766|NCT04377204|Anesthetics, Local|anesthetics, local|mesh-ancestor
24524767|NCT04377204|Anesthetics|anesthetics|mesh-ancestor
24524768|NCT04377204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24524769|NCT04377204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961464|NCT03808129|Lidocaine|lidocaine|mesh-list
25677573|NCT01812759|Sensory System Agents|sensory system agents|mesh-ancestor
25677574|NCT01812759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25677575|NCT01812759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25677576|NCT01812759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25677577|NCT01812759|Anesthetics, General|anesthetics, general|mesh-ancestor
25677578|NCT01812759|Anesthetics|anesthetics|mesh-ancestor
25677579|NCT01812837|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25677580|NCT01812837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25677581|NCT01812837|Dermatologic Agents|dermatologic agents|mesh-ancestor
25677582|NCT01813058|Tranexamic Acid|tranexamic acid|mesh-list
25677583|NCT01813058|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24457723|NCT00335075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510830|NCT00565708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24511374|NCT00568412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24511375|NCT00568412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511377|NCT00568477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24511502|NCT00569101|Immunologic Factors|immunologic factors|mesh-ancestor
24511503|NCT00569101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511504|NCT00569101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24511505|NCT00569101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24511506|NCT00569101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511507|NCT00569244|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
24511508|NCT00569244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24511570|NCT00569712|Autonomic Agents|autonomic agents|mesh-ancestor
24512822|NCT00577018|Laxatives|laxatives|mesh-ancestor
24513669|NCT00584493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513722|NCT00584636|Glucocorticoids|glucocorticoids|mesh-ancestor
24513723|NCT00584636|Hormones|hormones|mesh-ancestor
24513724|NCT00584636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24513725|NCT00584662|Phenylephrine|phenylephrine|mesh-list
24513726|NCT00584662|Oxymetazoline|oxymetazoline|mesh-list
24429704|NCT00244920|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24429705|NCT00244920|Fertility Agents|fertility agents|mesh-ancestor
24429706|NCT00244920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24429707|NCT00244920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24429708|NCT00244920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429709|NCT00244920|Hormone Antagonists|hormone antagonists|mesh-ancestor
24514030|NCT00587379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514031|NCT00587379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24514032|NCT00587379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24514033|NCT00587379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25211095|NCT04803084|TEMPO|tempo|mesh-list
25211096|NCT04803084|Antioxidants|antioxidants|mesh-ancestor
25211097|NCT04803084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211098|NCT04803084|Protective Agents|protective agents|mesh-ancestor
25211099|NCT04803084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524770|NCT04377204|Sensory System Agents|sensory system agents|mesh-ancestor
24524771|NCT04377204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24524772|NCT04377204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24524773|NCT04377204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24524774|NCT04377204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24524775|NCT04377204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24524776|NCT04377204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524777|NCT04369742|Hydroxychloroquine|hydroxychloroquine|mesh-list
24524778|NCT04369742|Calcium|calcium|mesh-list
24524801|NCT04318691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211127|NCT04760132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211133|NCT04741139|Acetaminophen|acetaminophen|mesh-list
25211134|NCT04741139|Diphenhydramine|diphenhydramine|mesh-list
25211135|NCT04741139|Promethazine|promethazine|mesh-list
25211136|NCT04741139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25211137|NCT04741139|Analgesics|analgesics|mesh-ancestor
25211138|NCT04741139|Sensory System Agents|sensory system agents|mesh-ancestor
25211139|NCT04741139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25211140|NCT04741139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211141|NCT04741139|Antipyretics|antipyretics|mesh-ancestor
25211142|NCT04741139|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25211143|NCT04741139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25211144|NCT04741139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25211145|NCT04741139|Anesthetics, Local|anesthetics, local|mesh-ancestor
25211146|NCT04741139|Anesthetics|anesthetics|mesh-ancestor
25211147|NCT04741139|Antiemetics|antiemetics|mesh-ancestor
24524882|NCT04243122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24525011|NCT04115644|Immunologic Factors|immunologic factors|mesh-ancestor
24525012|NCT04115644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525013|NCT04115644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525014|NCT04115644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24525015|NCT04115644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24525016|NCT04115644|Analgesics|analgesics|mesh-ancestor
24525017|NCT04115644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24525018|NCT04115644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24525019|NCT04109729|Nivolumab|nivolumab|mesh-list
24514035|NCT00587444|Calcium heparin|calcium heparin|mesh-list
24528113|NCT00619710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948088|NCT03923231|Ritonavir|ritonavir|mesh-list
25024296|NCT03647579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25024297|NCT03647579|GABA Modulators|gaba modulators|mesh-ancestor
25024298|NCT03647579|GABA Agents|gaba agents|mesh-ancestor
25112170|NCT04335201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112171|NCT04335201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25112172|NCT04328714|Interferons|interferons|mesh-list
25112173|NCT04328714|Interferon-gamma|interferon-gamma|mesh-list
25112174|NCT04328714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25112175|NCT04328714|Antiviral Agents|antiviral agents|mesh-ancestor
24514036|NCT00587444|Anticoagulants|anticoagulants|mesh-ancestor
24514037|NCT00587444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24514038|NCT00587444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24514039|NCT00587444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514040|NCT00587470|Candesartan|candesartan|mesh-list
24514041|NCT00587470|Candesartan cilexetil|candesartan cilexetil|mesh-list
24514042|NCT00587470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24514046|NCT00587496|Aspirin|aspirin|mesh-list
24514079|NCT00587665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24514080|NCT00587665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24514105|NCT00587873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24514106|NCT00587873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24514107|NCT00587873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24514108|NCT00587873|Immunologic Factors|immunologic factors|mesh-ancestor
24514109|NCT00587873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24514110|NCT00587873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24514111|NCT00587873|Antidotes|antidotes|mesh-ancestor
24514112|NCT00587873|Protective Agents|protective agents|mesh-ancestor
24514113|NCT00587873|Vitamin B Complex|vitamin b complex|mesh-ancestor
24514114|NCT00587873|Vitamins|vitamins|mesh-ancestor
24514115|NCT00587873|Micronutrients|micronutrients|mesh-ancestor
24514116|NCT00588003|Anastrozole|anastrozole|mesh-list
24514117|NCT00588003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24526935|NCT00613769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514683|NCT00592215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25211148|NCT04741139|Autonomic Agents|autonomic agents|mesh-ancestor
25211149|NCT04741139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25211150|NCT04741139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25211151|NCT04741139|Histamine Antagonists|histamine antagonists|mesh-ancestor
25211152|NCT04741139|Histamine Agents|histamine agents|mesh-ancestor
25211153|NCT04741139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25211154|NCT04741139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211155|NCT04741139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25211156|NCT04741139|Antipruritics|antipruritics|mesh-ancestor
25211157|NCT04741139|Dermatologic Agents|dermatologic agents|mesh-ancestor
25211158|NCT04734197|Cyclosporine|cyclosporine|mesh-list
25211159|NCT04734197|Mycophenolic Acid|mycophenolic acid|mesh-list
25211160|NCT04734197|Betamethasone|betamethasone|mesh-list
24525020|NCT04109729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24525021|NCT04109729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525022|NCT04109729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24525023|NCT04109729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525024|NCT04090528|Pembrolizumab|pembrolizumab|mesh-list
24525026|NCT04090528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514684|NCT00592215|Luteolytic Agents|luteolytic agents|mesh-ancestor
24514685|NCT00592215|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24514686|NCT00592215|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24514785|NCT00592930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24457766|NCT00335179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517018|NCT00605410|Respiratory System Agents|respiratory system agents|mesh-ancestor
24517019|NCT00605410|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24518232|NCT05330000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677584|NCT01813058|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25677585|NCT01813058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677586|NCT01813058|Hemostatics|hemostatics|mesh-ancestor
25677587|NCT01813058|Coagulants|coagulants|mesh-ancestor
25677588|NCT01813149|Clonidine|clonidine|mesh-list
25677589|NCT01813149|Phenylephrine|phenylephrine|mesh-list
25677590|NCT01813149|Oxymetazoline|oxymetazoline|mesh-list
25677591|NCT01813149|Anesthetics|anesthetics|mesh-list
25677592|NCT01813149|Anesthetics, Local|anesthetics, local|mesh-list
25677593|NCT01813149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25677594|NCT01813149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528117|NCT00619840|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24528118|NCT00619840|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24528119|NCT00619840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25024489|NCT03645187|Sensory System Agents|sensory system agents|mesh-ancestor
25024498|NCT03645109|Vitamin D|vitamin d|mesh-list
24518239|NCT05329857|Vildagliptin|vildagliptin|mesh-list
24457781|NCT00335205|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24518747|NCT04417049|Antioxidants|antioxidants|mesh-ancestor
24520655|NCT05335278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520656|NCT05335278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24520657|NCT05335278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24520658|NCT05335278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520659|NCT05335122|Bimatoprost|bimatoprost|mesh-list
24520661|NCT05335122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24520662|NCT05334745|Hyaluronic Acid|hyaluronic acid|mesh-list
24520663|NCT05334745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24520664|NCT05334745|Immunologic Factors|immunologic factors|mesh-ancestor
24520665|NCT05334745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520666|NCT05334745|Viscosupplements|viscosupplements|mesh-ancestor
24520667|NCT05334745|Protective Agents|protective agents|mesh-ancestor
25211161|NCT04734197|Betamethasone Valerate|betamethasone valerate|mesh-list
25211162|NCT04734197|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25211163|NCT04734197|Betamethasone benzoate|betamethasone benzoate|mesh-list
25211164|NCT04734197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25211165|NCT04734197|Lifitegrast|lifitegrast|mesh-list
25211166|NCT04734197|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25211167|NCT04734197|Cyclosporins|cyclosporins|mesh-list
25211168|NCT04734197|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25211171|NCT04734197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24525070|NCT04001829|Docetaxel|docetaxel|mesh-list
24525071|NCT04001829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24525092|NCT03974152|Autonomic Agents|autonomic agents|mesh-ancestor
24525093|NCT03974152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24525094|NCT03974152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525095|NCT03974152|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24527612|NCT00617656|Immunologic Factors|immunologic factors|mesh-ancestor
24521235|NCT04951388|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24521877|NCT04456439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24521878|NCT04456439|Antiemetics|antiemetics|mesh-ancestor
24521879|NCT04456439|Autonomic Agents|autonomic agents|mesh-ancestor
24521880|NCT04456439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24521881|NCT04456439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24521882|NCT04456439|Histamine Antagonists|histamine antagonists|mesh-ancestor
24521883|NCT04456439|Histamine Agents|histamine agents|mesh-ancestor
24521884|NCT04456439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24522269|NCT04047251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522270|NCT04032964|Doxorubicin|doxorubicin|mesh-list
24523633|NCT05341193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24523635|NCT05341193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24523636|NCT05341193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24523637|NCT05341193|Growth Substances|growth substances|mesh-ancestor
24523638|NCT05341193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523639|NCT05341193|Growth Inhibitors|growth inhibitors|mesh-ancestor
24523640|NCT05341193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24523641|NCT05341193|Antimetabolites|antimetabolites|mesh-ancestor
24523866|NCT05339217|Interleukin-2|interleukin-2|mesh-list
24523867|NCT05339217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24523868|NCT05339217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24523869|NCT05339217|Analgesics|analgesics|mesh-ancestor
24523870|NCT05339217|Sensory System Agents|sensory system agents|mesh-ancestor
24523871|NCT05339217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24394647|NCT00133822|Serotonin Agents|serotonin agents|mesh-ancestor
24523872|NCT05339217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523873|NCT05339217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24523874|NCT05339217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25677595|NCT01813149|Sensory System Agents|sensory system agents|mesh-ancestor
25677596|NCT01813149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25677597|NCT01813149|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25677598|NCT01813149|Mydriatics|mydriatics|mesh-ancestor
24523875|NCT05339217|Antiviral Agents|antiviral agents|mesh-ancestor
25211172|NCT04734197|Immunologic Factors|immunologic factors|mesh-ancestor
25677599|NCT01813149|Autonomic Agents|autonomic agents|mesh-ancestor
25677600|NCT01813149|Sympathomimetics|sympathomimetics|mesh-ancestor
24929131|NCT04115410|Carboplatin|carboplatin|mesh-list
24929132|NCT04115410|Docetaxel|docetaxel|mesh-list
24929133|NCT04115410|Pemetrexed|pemetrexed|mesh-list
24929134|NCT04115410|Vinorelbine|vinorelbine|mesh-list
24929135|NCT04115410|Gefitinib|gefitinib|mesh-list
24929136|NCT04115410|Mitomycins|mitomycins|mesh-list
25112244|NCT04267120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211173|NCT04734197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211174|NCT04734197|Antifungal Agents|antifungal agents|mesh-ancestor
25211175|NCT04734197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25211176|NCT04734197|Dermatologic Agents|dermatologic agents|mesh-ancestor
25211177|NCT04734197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25211178|NCT04734197|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25211179|NCT04734197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25211180|NCT04734197|Glucocorticoids|glucocorticoids|mesh-ancestor
24525096|NCT03974152|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24525097|NCT03974152|Cholinergic Agents|cholinergic agents|mesh-ancestor
24525098|NCT03974152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24525099|NCT03974152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525123|NCT03933904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24525124|NCT03933904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525125|NCT03933904|Antifungal Agents|antifungal agents|mesh-ancestor
24525126|NCT03933904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24525127|NCT03933904|Immunologic Factors|immunologic factors|mesh-ancestor
24523876|NCT05339217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24523904|NCT05338671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24523907|NCT05338658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24524036|NCT05322031|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24524037|NCT05322031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24524039|NCT05322031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24524165|NCT05227391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524166|NCT05227391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24457807|NCT00335270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24457808|NCT00335270|Protease Inhibitors|protease inhibitors|mesh-ancestor
24457809|NCT00335270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457810|NCT00335270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457817|NCT00335270|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24524167|NCT05227391|Hormone Antagonists|hormone antagonists|mesh-ancestor
25211181|NCT04734197|Hormones|hormones|mesh-ancestor
25211182|NCT04734197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25211183|NCT04734197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25211184|NCT04734197|Respiratory System Agents|respiratory system agents|mesh-ancestor
25211185|NCT04734197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25211186|NCT04734197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25211187|NCT04734197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25211188|NCT04734197|Antitubercular Agents|antitubercular agents|mesh-ancestor
25211189|NCT04734197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25211190|NCT04733144|Dexamethasone|dexamethasone|mesh-list
25211191|NCT04733144|Prednisolone|prednisolone|mesh-list
25211192|NCT04733144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25211193|NCT04733144|Antiemetics|antiemetics|mesh-ancestor
25211194|NCT04733144|Autonomic Agents|autonomic agents|mesh-ancestor
25211195|NCT04733144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25211196|NCT04733144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211197|NCT04733144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25211198|NCT04733144|Glucocorticoids|glucocorticoids|mesh-ancestor
25211199|NCT04733144|Hormones|hormones|mesh-ancestor
25211200|NCT04733144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25677601|NCT01813149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25677602|NCT01813149|Nasal Decongestants|nasal decongestants|mesh-ancestor
25677603|NCT01813149|Respiratory System Agents|respiratory system agents|mesh-ancestor
25677604|NCT01813149|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25677605|NCT01813149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25677606|NCT01813149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25677607|NCT01813149|Adrenergic Agents|adrenergic agents|mesh-ancestor
25211201|NCT04733144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25211202|NCT04733144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25211203|NCT04724720|Famotidine|famotidine|mesh-list
24525130|NCT03927989|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24525131|NCT03927989|Autonomic Agents|autonomic agents|mesh-ancestor
24525132|NCT03927989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24525133|NCT03927989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525134|NCT03927989|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24525203|NCT03823768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24525204|NCT03823768|Immunologic Factors|immunologic factors|mesh-ancestor
24525205|NCT03823768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525206|NCT03823768|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24525207|NCT03823768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24524169|NCT05206110|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24524177|NCT05206110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24653755|NCT01245569|Hormones|hormones|mesh-ancestor
24524481|NCT04818229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525005|NCT04115644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24525006|NCT04115644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24525007|NCT04115644|Glucocorticoids|glucocorticoids|mesh-ancestor
24525008|NCT04115644|Hormones|hormones|mesh-ancestor
24525009|NCT04115644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24525010|NCT04115644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24528637|NCT00622011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526693|NCT00612651|Lonafarnib|lonafarnib|mesh-list
24526694|NCT00612651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24526695|NCT00612651|Alkylating Agents|alkylating agents|mesh-ancestor
24526696|NCT00612651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526697|NCT00612651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526884|NCT00613600|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
24526903|NCT00613717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526904|NCT00613717|Trace Elements|trace elements|mesh-ancestor
24526905|NCT00613717|Hematinics|hematinics|mesh-ancestor
24526906|NCT00613717|Antioxidants|antioxidants|mesh-ancestor
24526907|NCT00613717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526908|NCT00613717|Protective Agents|protective agents|mesh-ancestor
24526909|NCT00613717|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24526910|NCT00613717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526911|NCT00613717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25211204|NCT04724720|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25211205|NCT04724720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25211206|NCT04724720|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25211207|NCT04724720|Histamine Antagonists|histamine antagonists|mesh-ancestor
25211208|NCT04724720|Histamine Agents|histamine agents|mesh-ancestor
25211209|NCT04724720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25211210|NCT04724720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211211|NCT04724720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211212|NCT04682405|Melphalan|melphalan|mesh-list
25211213|NCT04682405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25211214|NCT04682405|Alkylating Agents|alkylating agents|mesh-ancestor
25211215|NCT04682405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211216|NCT04682405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25211217|NCT04682405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24525208|NCT03823768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525209|NCT03812588|Citalopram|citalopram|mesh-list
24525210|NCT03812588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24525211|NCT03812588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24525212|NCT03812588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24525273|NCT03724994|Immunologic Factors|immunologic factors|mesh-ancestor
24525274|NCT03724994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525275|NCT03709758|Cytarabine|cytarabine|mesh-list
24431373|NCT00251524|Pemetrexed|pemetrexed|mesh-list
24525436|NCT03345771|Anti-Infective Agents|anti-infective agents|mesh-list
24525437|NCT03345771|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24525438|NCT03341962|Calcium|calcium|mesh-list
24525439|NCT03341962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24525449|NCT03333408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525450|NCT03333408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24525451|NCT03326856|Botulinum Toxins|botulinum toxins|mesh-list
24525452|NCT03326856|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24528689|NCT00622258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528691|NCT00622349|Cisplatin|cisplatin|mesh-list
24528692|NCT00622349|Docetaxel|docetaxel|mesh-list
24528693|NCT00622349|Ifosfamide|ifosfamide|mesh-list
24525545|NCT03181789|Growth Substances|growth substances|mesh-ancestor
24525546|NCT03181789|Growth Inhibitors|growth inhibitors|mesh-ancestor
24525547|NCT03181789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525556|NCT03133221|Idelalisib|idelalisib|mesh-list
24525787|NCT02746796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525788|NCT02746796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526912|NCT00613743|Morphine|morphine|mesh-list
24526913|NCT00613743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24526914|NCT00613743|Narcotics|narcotics|mesh-ancestor
24526915|NCT00613743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24526916|NCT00613743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526917|NCT00613743|Analgesics|analgesics|mesh-ancestor
24526998|NCT00614159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24527091|NCT00614835|Antimitotic Agents|antimitotic agents|mesh-ancestor
24527092|NCT00614835|Mitosis Modulators|mitosis modulators|mesh-ancestor
24527094|NCT00614965|Pemetrexed|pemetrexed|mesh-list
24527295|NCT00615810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24527296|NCT00615810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24783668|NCT01903109|Cevimeline|cevimeline|mesh-list
24527298|NCT00615810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211218|NCT04682405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25211219|NCT04682405|Immunologic Factors|immunologic factors|mesh-ancestor
25211220|NCT04682405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211221|NCT04668144|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25211222|NCT04668144|Cangrelor|cangrelor|mesh-list
25211223|NCT04668144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25211224|NCT04668144|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25211225|NCT04668144|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25211226|NCT04668144|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25211227|NCT04668144|Purinergic Agents|purinergic agents|mesh-ancestor
25211228|NCT04668144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25211229|NCT04668144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211230|NCT04668144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211231|NCT04662515|Warfarin|warfarin|mesh-list
25211232|NCT04662515|Rivaroxaban|rivaroxaban|mesh-list
25211236|NCT04662515|Anticoagulants|anticoagulants|mesh-ancestor
25211237|NCT04662515|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25211238|NCT04662515|Antithrombins|antithrombins|mesh-ancestor
25211239|NCT04662515|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25211240|NCT04662515|Protease Inhibitors|protease inhibitors|mesh-ancestor
25211241|NCT04662515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25211242|NCT04662515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211243|NCT04660097|Etoposide|etoposide|mesh-list
25211244|NCT04660097|Etoposide phosphate|etoposide phosphate|mesh-list
25211245|NCT04660097|Durvalumab|durvalumab|mesh-list
25211246|NCT04660097|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24525789|NCT02746796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24525790|NCT02746796|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24525792|NCT02744976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24525793|NCT02744976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525794|NCT02743819|Pembrolizumab|pembrolizumab|mesh-list
24525795|NCT02743819|Ipilimumab|ipilimumab|mesh-list
24525796|NCT02743819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24525852|NCT02619253|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24525853|NCT02619253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525854|NCT02619253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525855|NCT02612194|Crizotinib|crizotinib|mesh-list
24525856|NCT02612194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525857|NCT02612194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24525858|NCT02612194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525859|NCT02612194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525860|NCT02586207|Cisplatin|cisplatin|mesh-list
24526017|NCT02051933|Botulinum Toxins|botulinum toxins|mesh-list
24526018|NCT02051933|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24527330|NCT00616005|Irinotecan|irinotecan|mesh-list
24527446|NCT00616720|Aldesleukin|aldesleukin|mesh-list
24527447|NCT00616720|Interferon-gamma|interferon-gamma|mesh-list
24527448|NCT00616720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527449|NCT00616720|Antiviral Agents|antiviral agents|mesh-ancestor
24527450|NCT00616720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24527451|NCT00616720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24527452|NCT00616720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24527453|NCT00616746|Ethanol|ethanol|mesh-list
24527454|NCT00616746|Nicotine|nicotine|mesh-list
24527455|NCT00616746|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24653983|NCT01246557|Growth Inhibitors|growth inhibitors|mesh-ancestor
24527456|NCT00616746|Autonomic Agents|autonomic agents|mesh-ancestor
24432114|NCT00253565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527701|NCT00618124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24527702|NCT00618124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24527703|NCT00618124|Growth Substances|growth substances|mesh-ancestor
24527704|NCT00618124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527731|NCT00618176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24527732|NCT00618176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24527733|NCT00618176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25211247|NCT04660097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25211248|NCT04660097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25211249|NCT04660097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25211250|NCT04660097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25211251|NCT04660097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25211252|NCT04660097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211253|NCT04660097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25211254|NCT04660097|Immunologic Factors|immunologic factors|mesh-ancestor
25211255|NCT04660097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211260|NCT04648540|Acetaminophen|acetaminophen|mesh-list
25211261|NCT04648540|Celecoxib|celecoxib|mesh-list
25211262|NCT04648540|Ketorolac|ketorolac|mesh-list
25211263|NCT04648540|Lidocaine|lidocaine|mesh-list
25211264|NCT04648540|Pregabalin|pregabalin|mesh-list
25211265|NCT04648540|Fentanyl|fentanyl|mesh-list
25211266|NCT04648540|Dexmedetomidine|dexmedetomidine|mesh-list
25211267|NCT04648540|Morphine|morphine|mesh-list
25211268|NCT04648540|Anesthetics, Local|anesthetics, local|mesh-ancestor
25211269|NCT04648540|Anesthetics|anesthetics|mesh-ancestor
25211270|NCT04648540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25211271|NCT04648540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211272|NCT04648540|Sensory System Agents|sensory system agents|mesh-ancestor
24526019|NCT02051933|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24526088|NCT01845441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526091|NCT01845441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24526092|NCT01845441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24526093|NCT01845441|Anesthetics, General|anesthetics, general|mesh-ancestor
24526095|NCT01845441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24526096|NCT01845441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24526097|NCT01845441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24526099|NCT01845441|GABA Agents|gaba agents|mesh-ancestor
24527734|NCT00618176|Antimetabolites|antimetabolites|mesh-ancestor
24527735|NCT00618176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24527736|NCT00618176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24527737|NCT00618202|Balsalazide|balsalazide|mesh-list
24527738|NCT00618202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24457855|NCT00335439|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24527854|NCT00618501|Abortifacient Agents|abortifacient agents|mesh-ancestor
24527855|NCT00618501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24528256|NCT00620581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528257|NCT00620581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24528259|NCT00620581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528260|NCT00620581|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24528261|NCT00620581|Antidepressive Agents|antidepressive agents|mesh-ancestor
24528262|NCT00620581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24528263|NCT00620581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24528264|NCT00620581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24399626|NCT00148278|Autonomic Agents|autonomic agents|mesh-ancestor
24528265|NCT00620581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528266|NCT00620594|Dactolisib|dactolisib|mesh-list
24528267|NCT00620594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528268|NCT00620620|Zaleplon|zaleplon|mesh-list
24528269|NCT00620620|Anticonvulsants|anticonvulsants|mesh-ancestor
24528270|NCT00620620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24528271|NCT00620620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24528408|NCT00621036|Abortifacient Agents|abortifacient agents|mesh-ancestor
24528412|NCT00621036|Antimetabolites|antimetabolites|mesh-ancestor
24528447|NCT00621166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24528815|NCT00623064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528816|NCT00623064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24528817|NCT00623064|Immunologic Factors|immunologic factors|mesh-ancestor
24528818|NCT00623064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528854|NCT00623155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528855|NCT00623155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528880|NCT00623220|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24929156|NCT04115410|Mitosis Modulators|mitosis modulators|mesh-ancestor
24929157|NCT04115410|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24929158|NCT04115410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24929159|NCT04115410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24982097|NCT04246996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24982098|NCT04246996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24982099|NCT04246996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25025323|NCT03638310|Gentamicins|gentamicins|mesh-list
25025324|NCT03638310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25025325|NCT03638310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24528881|NCT00623220|Anesthetics, General|anesthetics, general|mesh-ancestor
24528882|NCT00623220|Anesthetics|anesthetics|mesh-ancestor
24528883|NCT00623220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24528884|NCT00623220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528885|NCT00623220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24528886|NCT00623220|Analgesics|analgesics|mesh-ancestor
24528887|NCT00623220|Sensory System Agents|sensory system agents|mesh-ancestor
24528888|NCT00623220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24528889|NCT00623285|Pregabalin|pregabalin|mesh-list
24528890|NCT00623285|Analgesics|analgesics|mesh-ancestor
24528891|NCT00623285|Sensory System Agents|sensory system agents|mesh-ancestor
24529620|NCT00627003|Cabergoline|cabergoline|mesh-list
24529683|NCT00627575|Atorvastatin|atorvastatin|mesh-list
25211273|NCT04648540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25211274|NCT04648540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25211275|NCT04648540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25211276|NCT04648540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25211277|NCT04648540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24654037|NCT01247077|Selenium|selenium|mesh-list
25211278|NCT04648540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211279|NCT04648540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25211280|NCT04648540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25211281|NCT04648540|Analgesics|analgesics|mesh-ancestor
25211282|NCT04648540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24526100|NCT01821833|Paclitaxel|paclitaxel|mesh-list
24526101|NCT01821833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24526102|NCT01821833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526103|NCT01821833|Tubulin Modulators|tubulin modulators|mesh-ancestor
24526104|NCT01821833|Antimitotic Agents|antimitotic agents|mesh-ancestor
24526105|NCT01821833|Mitosis Modulators|mitosis modulators|mesh-ancestor
24526106|NCT01821833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526109|NCT01505608|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24526110|NCT01505608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24526111|NCT01505608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24526112|NCT01505608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526113|NCT01505608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526114|NCT01505608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24526115|NCT01505608|Alkylating Agents|alkylating agents|mesh-ancestor
24526116|NCT01227616|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24526117|NCT01227616|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24529684|NCT00627575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24529685|NCT00627575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24529686|NCT00627575|Antimetabolites|antimetabolites|mesh-ancestor
24529687|NCT00627575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529688|NCT00627575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24529689|NCT00627575|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24529690|NCT00627575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529691|NCT00627575|Anticonvulsants|anticonvulsants|mesh-ancestor
24529692|NCT00627575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24432855|NCT00256542|Heparin|heparin|mesh-list
24400408|NCT00150527|Autonomic Agents|autonomic agents|mesh-ancestor
25677608|NCT01813149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25677609|NCT01813149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677610|NCT01813149|Protective Agents|protective agents|mesh-ancestor
25677611|NCT01813149|Analgesics|analgesics|mesh-ancestor
25677612|NCT01813149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25677613|NCT01813149|Sympatholytics|sympatholytics|mesh-ancestor
25677614|NCT01813149|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25677615|NCT01813214|Vemurafenib|vemurafenib|mesh-list
25677616|NCT01813214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25677617|NCT01813214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25677618|NCT01813214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692714|NCT02004093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025402|NCT03637582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025404|NCT03637543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25025405|NCT03637543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25025406|NCT03637543|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24529853|NCT00628056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529854|NCT00628056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24529855|NCT00628056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529856|NCT00628056|Vasodilator Agents|vasodilator agents|mesh-ancestor
24529857|NCT00628121|Cetrorelix|cetrorelix|mesh-list
24529858|NCT00628121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24529859|NCT00628121|Fertility Agents|fertility agents|mesh-ancestor
24529860|NCT00628121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24529861|NCT00628121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529862|NCT00628121|Hormone Antagonists|hormone antagonists|mesh-ancestor
24529892|NCT00628225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24529893|NCT00628225|Antidepressive Agents|antidepressive agents|mesh-ancestor
24654147|NCT01247909|Penicillins|penicillins|mesh-list
24529894|NCT00628225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24529895|NCT00628225|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24529896|NCT00628225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24529897|NCT00628225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24529989|NCT00628706|Hallucinogens|hallucinogens|mesh-ancestor
24530485|NCT00630630|Anticonvulsants|anticonvulsants|mesh-ancestor
24530486|NCT00630630|Nootropic Agents|nootropic agents|mesh-ancestor
24530487|NCT00630643|Muromonab-CD3|muromonab-cd3|mesh-list
24530488|NCT00630643|Immunologic Factors|immunologic factors|mesh-ancestor
24530489|NCT00630643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211283|NCT04648540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25211284|NCT04648540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25211285|NCT04648540|Adrenergic Agents|adrenergic agents|mesh-ancestor
25211286|NCT04648540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25211287|NCT04648540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25211288|NCT04648540|Narcotics|narcotics|mesh-ancestor
25211289|NCT04648540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25211290|NCT04648540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25211291|NCT04648540|Anesthetics, General|anesthetics, general|mesh-ancestor
25211292|NCT04648540|Antipyretics|antipyretics|mesh-ancestor
25211293|NCT04648540|Anticonvulsants|anticonvulsants|mesh-ancestor
25211294|NCT04648540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25211295|NCT04648540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25211296|NCT04648540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25211297|NCT04648540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25211298|NCT04648540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25211299|NCT04648540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25211300|NCT04648540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25211301|NCT04648540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24526119|NCT01227616|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24526120|NCT01227616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24526121|NCT01192698|Interferons|interferons|mesh-list
24526122|NCT01192698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526228|NCT00621751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24526251|NCT00302744|Vitamins|vitamins|mesh-ancestor
24526252|NCT00302744|Micronutrients|micronutrients|mesh-ancestor
24526253|NCT00302744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526254|NCT00302744|Hallucinogens|hallucinogens|mesh-ancestor
24526255|NCT00302744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24531128|NCT00634192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24531131|NCT00634205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24531132|NCT00634205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531133|NCT00634205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24531134|NCT00634205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24531135|NCT00634205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24531196|NCT00634413|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24531197|NCT00634413|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24531198|NCT00634413|Purinergic Agents|purinergic agents|mesh-ancestor
24531199|NCT00634413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24531200|NCT00634439|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24445839|NCT00302705|Valsartan|valsartan|mesh-list
24531511|NCT00636246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24531544|NCT00636311|Antimetabolites|antimetabolites|mesh-ancestor
25677619|NCT01813214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677620|NCT01813357|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25677621|NCT01813357|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25677622|NCT01813357|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25677623|NCT01813357|Antimetabolites|antimetabolites|mesh-ancestor
24590849|NCT00913965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112443|NCT04098237|Pancreatin|pancreatin|mesh-list
25112444|NCT04098237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24590887|NCT00914121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531583|NCT00636493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24531636|NCT00636883|Antimetabolites|antimetabolites|mesh-ancestor
24394648|NCT00133822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24531637|NCT00636883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531638|NCT00636883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531639|NCT00636883|Antiviral Agents|antiviral agents|mesh-ancestor
24531640|NCT00636883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24531641|NCT00636883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24531674|NCT00636909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24531868|NCT00637468|Analgesics|analgesics|mesh-ancestor
24531882|NCT00637468|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24531898|NCT00637533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24401116|NCT00152178|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24531899|NCT00637533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24531900|NCT00637533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24531901|NCT00637533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531902|NCT00637533|Cholinergic Agents|cholinergic agents|mesh-ancestor
24531903|NCT00637533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24532064|NCT00637949|Sensory System Agents|sensory system agents|mesh-ancestor
24532065|NCT00637949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24532066|NCT00637949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532067|NCT00637949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24532068|NCT00637949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24532069|NCT00637962|polysaccharide-K|polysaccharide-k|mesh-list
24532070|NCT00637962|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25211302|NCT04648540|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25211303|NCT04648540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25211304|NCT04648540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25211312|NCT04555798|Meropenem|meropenem|mesh-list
25211313|NCT04555798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25211314|NCT04555798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25211315|NCT04521647|Nicotine|nicotine|mesh-list
24526258|NCT00290511|Rituximab|rituximab|mesh-list
24526259|NCT00290511|Fludarabine|fludarabine|mesh-list
24526260|NCT00290511|Fludarabine phosphate|fludarabine phosphate|mesh-list
24526262|NCT00290511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24526263|NCT00290511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526264|NCT00290511|Immunologic Factors|immunologic factors|mesh-ancestor
24526265|NCT00290511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526266|NCT00290511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24526267|NCT00290511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24526351|NCT00611286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24526352|NCT00611286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526353|NCT00611286|Tubulin Modulators|tubulin modulators|mesh-ancestor
24526354|NCT00611286|Antimitotic Agents|antimitotic agents|mesh-ancestor
24526355|NCT00611286|Mitosis Modulators|mitosis modulators|mesh-ancestor
24526356|NCT00611286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526446|NCT00611728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24526449|NCT00611728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526450|NCT00611728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24526451|NCT00611728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24526452|NCT00611728|Growth Substances|growth substances|mesh-ancestor
24526453|NCT00611728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526454|NCT00611728|Growth Inhibitors|growth inhibitors|mesh-ancestor
24526455|NCT00611728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24526456|NCT00611741|Furosemide|furosemide|mesh-list
24526457|NCT00611741|Diuretics|diuretics|mesh-ancestor
24526458|NCT00611741|Natriuretic Agents|natriuretic agents|mesh-ancestor
24526459|NCT00611741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532171|NCT00638326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24532172|NCT00638326|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24532469|NCT00640029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677624|NCT01813357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677625|NCT01813357|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25677626|NCT01813357|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25677627|NCT01813357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677628|NCT01813422|Evolocumab|evolocumab|mesh-list
25677629|NCT01813422|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24587760|NCT00896831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587762|NCT00896948|Immunologic Factors|immunologic factors|mesh-ancestor
24587763|NCT00896948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587764|NCT00896987|Lamotrigine|lamotrigine|mesh-list
24587765|NCT00896987|Carbamazepine|carbamazepine|mesh-list
24587766|NCT00896987|Anticonvulsants|anticonvulsants|mesh-ancestor
24587767|NCT00896987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25097861|NCT03200886|Triamcinolone|triamcinolone|mesh-list
24587768|NCT00896987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24587769|NCT00896987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769697|NCT01815255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532557|NCT00640432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532558|NCT00640432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24532559|NCT00640432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24532560|NCT00640432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24532561|NCT00640432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24532562|NCT00640432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25211419|NCT04360681|Lofexidine|lofexidine|mesh-list
25211324|NCT04521647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526460|NCT00611741|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24526461|NCT00611741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24526462|NCT00611741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526464|NCT00611754|Oxaliplatin|oxaliplatin|mesh-list
24526465|NCT00611754|Antimetabolites|antimetabolites|mesh-ancestor
24526466|NCT00611754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526467|NCT00611754|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24526468|NCT00611754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526475|NCT00611793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24790883|NCT05410782|Vitamins|vitamins|mesh-list
24776189|NCT01857011|Teferrol|teferrol|mesh-list
24526476|NCT00611793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24526477|NCT00611793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24532567|NCT00640458|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24532568|NCT00640458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532569|NCT00640458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532570|NCT00640458|Urological Agents|urological agents|mesh-ancestor
24532573|NCT00640471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24532631|NCT00640640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24532632|NCT00640640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24532633|NCT00640640|Growth Substances|growth substances|mesh-ancestor
24532634|NCT00640640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532635|NCT00640640|Growth Inhibitors|growth inhibitors|mesh-ancestor
24532636|NCT00640679|Clopidogrel|clopidogrel|mesh-list
24532637|NCT00640679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24532638|NCT00640679|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24532639|NCT00640679|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24532640|NCT00640679|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24532641|NCT00640679|Purinergic Agents|purinergic agents|mesh-ancestor
24532642|NCT00640679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24457915|NCT00335647|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24457916|NCT00335647|Dopamine Agents|dopamine agents|mesh-ancestor
24457917|NCT00335647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24457918|NCT00335647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457920|NCT00335673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25211457|NCT04336748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24532829|NCT00641212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24532881|NCT00641446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24445916|NCT00303056|Icatibant|icatibant|mesh-list
24532898|NCT00641472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532899|NCT00641537|Cladribine|cladribine|mesh-list
24532900|NCT00641537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25677630|NCT01813422|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25677631|NCT01813422|Antimetabolites|antimetabolites|mesh-ancestor
25677632|NCT01813422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677633|NCT01813422|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25677634|NCT01813474|Olaparib|olaparib|mesh-list
25677635|NCT01813474|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25677636|NCT01813474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677637|NCT01813474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677638|NCT01813474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25677639|NCT01813734|Ponatinib|ponatinib|mesh-list
25026579|NCT03626753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026585|NCT03626727|Sodium Oxybate|sodium oxybate|mesh-list
24532901|NCT00641537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24532902|NCT00641537|Immunologic Factors|immunologic factors|mesh-ancestor
24532903|NCT00641537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532904|NCT00641589|Epoetin Alfa|epoetin alfa|mesh-list
24532905|NCT00641589|Hematinics|hematinics|mesh-ancestor
24532989|NCT00641927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24532990|NCT00641927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532999|NCT00641979|Autonomic Agents|autonomic agents|mesh-ancestor
25211349|NCT04485546|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25211350|NCT04485546|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25272677|NCT02390843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25272678|NCT02390843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272679|NCT02390843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25272680|NCT02390843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25272681|NCT02390843|Mitosis Modulators|mitosis modulators|mesh-ancestor
25272682|NCT02390843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25272683|NCT02390544|Melphalan|melphalan|mesh-list
25272684|NCT02390544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24526478|NCT00611793|Growth Substances|growth substances|mesh-ancestor
24526479|NCT00611793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526482|NCT00611793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24526483|NCT00611793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526484|NCT00611819|Interferons|interferons|mesh-list
24526486|NCT00611819|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24526487|NCT00611819|Interferon-alpha|interferon-alpha|mesh-list
24526488|NCT00611819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526489|NCT00611819|Antiviral Agents|antiviral agents|mesh-ancestor
24526490|NCT00611819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24526491|NCT00611819|Antimetabolites|antimetabolites|mesh-ancestor
24526492|NCT00611819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526493|NCT00611819|Immunologic Factors|immunologic factors|mesh-ancestor
24526494|NCT00611819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526496|NCT00611845|Hemostatics|hemostatics|mesh-ancestor
24526497|NCT00611845|Coagulants|coagulants|mesh-ancestor
24526498|NCT00611845|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24526499|NCT00611845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24526500|NCT00611845|Protease Inhibitors|protease inhibitors|mesh-ancestor
24526501|NCT00611845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24526502|NCT00611845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526562|NCT00612183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24526564|NCT00612183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526565|NCT00612183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526567|NCT00612261|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24526568|NCT00612261|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24526569|NCT00612261|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24526570|NCT00612261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24526571|NCT00612261|Glucocorticoids|glucocorticoids|mesh-ancestor
24533000|NCT00641979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24533001|NCT00641979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533002|NCT00641979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24533003|NCT00641979|Respiratory System Agents|respiratory system agents|mesh-ancestor
24533004|NCT00641979|Glucocorticoids|glucocorticoids|mesh-ancestor
24533005|NCT00641979|Hormones|hormones|mesh-ancestor
24533006|NCT00641979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24654417|NCT01249443|Paclitaxel|paclitaxel|mesh-list
24533007|NCT00642057|Tetrabenazine|tetrabenazine|mesh-list
24527001|NCT00614328|Naltrexone|naltrexone|mesh-list
25211362|NCT04430894|Autonomic Agents|autonomic agents|mesh-ancestor
25211363|NCT04430894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25211364|NCT04430894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211365|NCT04430894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25211366|NCT04430894|Glucocorticoids|glucocorticoids|mesh-ancestor
25211367|NCT04430894|Hormones|hormones|mesh-ancestor
25211368|NCT04430894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25211369|NCT04430894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25211370|NCT04430894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25211371|NCT04430894|Immunologic Factors|immunologic factors|mesh-ancestor
25211372|NCT04430894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25211373|NCT04430894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25211374|NCT04430894|Growth Substances|growth substances|mesh-ancestor
25677640|NCT01813734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25677641|NCT01813734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25211375|NCT04430894|Growth Inhibitors|growth inhibitors|mesh-ancestor
25211377|NCT04409834|Calcium heparin|calcium heparin|mesh-list
25211378|NCT04409834|Enoxaparin|enoxaparin|mesh-list
25211379|NCT04409834|Enoxaparin sodium|enoxaparin sodium|mesh-list
25211380|NCT04409834|Clopidogrel|clopidogrel|mesh-list
25211381|NCT04409834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25211382|NCT04409834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24526572|NCT00612261|Hormones|hormones|mesh-ancestor
25117015|NCT03105466|Hormones|hormones|mesh-ancestor
24533011|NCT00642057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533012|NCT00642057|Adrenergic Agents|adrenergic agents|mesh-ancestor
24533013|NCT00642057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24533014|NCT00642057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533015|NCT00642096|Metoprolol|metoprolol|mesh-list
24457927|NCT00335686|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24457928|NCT00335686|Protease Inhibitors|protease inhibitors|mesh-ancestor
24533163|NCT00642499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533165|NCT00642499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24533166|NCT00642512|Dronabinol|dronabinol|mesh-list
24401680|NCT00153673|Celecoxib|celecoxib|mesh-list
24457940|NCT00335686|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24531758|NCT00637078|Diuretics|diuretics|mesh-ancestor
25211383|NCT04409834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24526574|NCT00612261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526576|NCT00612261|Immunologic Factors|immunologic factors|mesh-ancestor
24526577|NCT00612261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398851|NCT00145990|Miotics|miotics|mesh-ancestor
24526578|NCT00612261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526579|NCT00612274|Sirolimus|sirolimus|mesh-list
24526580|NCT00612274|Methotrexate|methotrexate|mesh-list
24526581|NCT00612274|Tacrolimus|tacrolimus|mesh-list
24526582|NCT00612274|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24526583|NCT00612274|Abortifacient Agents|abortifacient agents|mesh-ancestor
24526584|NCT00612274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24526587|NCT00612274|Antimetabolites|antimetabolites|mesh-ancestor
24529052|NCT00624273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529053|NCT00624273|Urological Agents|urological agents|mesh-ancestor
25211424|NCT04360681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24526588|NCT00612274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526590|NCT00612274|Dermatologic Agents|dermatologic agents|mesh-ancestor
24526655|NCT00612547|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24526656|NCT00612547|Anthelmintics|anthelmintics|mesh-ancestor
24526658|NCT00612599|Biphasic Insulins|biphasic insulins|mesh-list
24526659|NCT00612599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24526660|NCT00612599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526661|NCT00612612|Rituximab|rituximab|mesh-list
25026919|NCT03624244|Letrozole|letrozole|mesh-list
24408493|NCT00178035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24408494|NCT00178035|Antidepressive Agents|antidepressive agents|mesh-ancestor
24408495|NCT00178035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24408496|NCT00178035|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24408497|NCT00178035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24408498|NCT00178035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408499|NCT00178048|Paroxetine|paroxetine|mesh-list
24408500|NCT00178048|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24408501|NCT00178048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24408502|NCT00178048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24408503|NCT00178048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541799|NCT00675246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446659|NCT00305552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24820239|NCT02099240|Sulfadiazine|sulfadiazine|mesh-list
24541810|NCT00675285|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24541811|NCT00675285|Hormone Antagonists|hormone antagonists|mesh-ancestor
25211396|NCT04399356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25211397|NCT04399356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25211398|NCT04399356|Antinematodal Agents|antinematodal agents|mesh-ancestor
25211400|NCT04397003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25211401|NCT04397003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25211411|NCT04382885|Cariprazine|cariprazine|mesh-list
24526665|NCT00612612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24526667|NCT00612612|Immunologic Factors|immunologic factors|mesh-ancestor
24526668|NCT00612612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526669|NCT00612612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24526698|NCT00612651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24526699|NCT00612755|Ribavirin|ribavirin|mesh-list
24526700|NCT00612755|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24526701|NCT00612755|Antimetabolites|antimetabolites|mesh-ancestor
24526702|NCT00612755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526703|NCT00612755|Antiviral Agents|antiviral agents|mesh-ancestor
24526705|NCT00612794|Exenatide|exenatide|mesh-list
24526711|NCT00612794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24526713|NCT00612859|Anticonvulsants|anticonvulsants|mesh-ancestor
24526736|NCT00612989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526737|NCT00612989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526739|NCT00613054|Imatinib Mesylate|imatinib mesylate|mesh-list
24526740|NCT00613054|Hydroxyurea|hydroxyurea|mesh-list
24526741|NCT00613054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526742|NCT00613054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24526743|NCT00613054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24945944|NCT03944317|Pyrimethamine|pyrimethamine|mesh-list
24541812|NCT00675285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24408556|NCT00178698|Gemcitabine|gemcitabine|mesh-list
24408557|NCT00178698|Interferons|interferons|mesh-list
24408558|NCT00178698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408559|NCT00178698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24408560|NCT00178698|Antimetabolites|antimetabolites|mesh-ancestor
24408561|NCT00178698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408562|NCT00178698|Antiviral Agents|antiviral agents|mesh-ancestor
24408563|NCT00178698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24408564|NCT00178698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408565|NCT00178698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24408566|NCT00178698|Immunologic Factors|immunologic factors|mesh-ancestor
24820258|NCT02099240|Penicillin V|penicillin v|mesh-list
24820259|NCT02099240|Cefpodoxime|cefpodoxime|mesh-list
25211412|NCT04382885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25211413|NCT04382885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25211414|NCT04382885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25211415|NCT04382885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211416|NCT04382885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25211428|NCT04360681|Adrenergic Agents|adrenergic agents|mesh-ancestor
25211429|NCT04360681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25211430|NCT04360681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211431|NCT04355832|Glucagon|glucagon|mesh-list
25211432|NCT04355832|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25211433|NCT04355832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25211434|NCT04355832|Hormones|hormones|mesh-ancestor
25211435|NCT04355832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25027073|NCT03623048|Propolis|propolis|mesh-list
25211436|NCT04355832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526746|NCT00613054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24526748|NCT00613067|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24526749|NCT00613067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24526750|NCT00613067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24526751|NCT00613067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799029|NCT01966692|Xhance|xhance|mesh-list
24526752|NCT00613067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24526753|NCT00613067|Serotonin Agents|serotonin agents|mesh-ancestor
24457832|NCT00335348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24457833|NCT00335348|Antiemetics|antiemetics|mesh-ancestor
24457834|NCT00335348|Autonomic Agents|autonomic agents|mesh-ancestor
24457835|NCT00335348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24457836|NCT00335348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526782|NCT00613145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526783|NCT00613145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24526784|NCT00613145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24526811|NCT00613457|Ifosfamide|ifosfamide|mesh-list
24526812|NCT00613457|Doxorubicin|doxorubicin|mesh-list
24526813|NCT00613457|Methotrexate|methotrexate|mesh-list
24526814|NCT00613457|Etoposide|etoposide|mesh-list
24526815|NCT00613457|Vincristine|vincristine|mesh-list
24526816|NCT00613457|Daunorubicin|daunorubicin|mesh-list
24526817|NCT00613457|Asparaginase|asparaginase|mesh-list
24526818|NCT00613457|Mercaptopurine|mercaptopurine|mesh-list
24526819|NCT00613457|Thioguanine|thioguanine|mesh-list
24408576|NCT00178763|Antiviral Agents|antiviral agents|mesh-ancestor
24408577|NCT00178763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24408578|NCT00178763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408579|NCT00178763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24408580|NCT00178763|Immunologic Factors|immunologic factors|mesh-ancestor
24704944|NCT01481259|Pemetrexed|pemetrexed|mesh-list
25211437|NCT04355832|Incretins|incretins|mesh-ancestor
25211438|NCT04349982|Fibrin fragment D|fibrin fragment d|mesh-list
25211439|NCT04349982|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25211440|NCT04349982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25211441|NCT04349982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211442|NCT04349982|Hemostatics|hemostatics|mesh-ancestor
25211443|NCT04349982|Coagulants|coagulants|mesh-ancestor
25211444|NCT04340947|Nicotine|nicotine|mesh-list
25211445|NCT04340947|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25211446|NCT04340947|Autonomic Agents|autonomic agents|mesh-ancestor
25211447|NCT04340947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25211448|NCT04340947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211449|NCT04340947|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25211450|NCT04340947|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25211451|NCT04340947|Cholinergic Agents|cholinergic agents|mesh-ancestor
25211452|NCT04340947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25211453|NCT04340947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211454|NCT04336748|Hydroxychloroquine|hydroxychloroquine|mesh-list
25211455|NCT04336748|Antimalarials|antimalarials|mesh-ancestor
25211456|NCT04336748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25211461|NCT04336748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24799046|NCT01966783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24408616|NCT00178854|Risperidone|risperidone|mesh-list
24408617|NCT00178854|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24408618|NCT00178854|Serotonin Agents|serotonin agents|mesh-ancestor
24408619|NCT00178854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24541837|NCT00675649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24541838|NCT00675649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24408649|NCT00179023|Trimethaphan|trimethaphan|mesh-list
25027224|NCT03621618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24820325|NCT02099240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24820326|NCT02099240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820327|NCT02099240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820328|NCT02099240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24820329|NCT02099240|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24820330|NCT02099240|Contraceptive Agents|contraceptive agents|mesh-ancestor
24820331|NCT02099240|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24820332|NCT02099240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820333|NCT02099240|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24820334|NCT02099240|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24820335|NCT02099240|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24820336|NCT02099240|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24820337|NCT02099240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24681348|NCT01379898|Vasodilator Agents|vasodilator agents|mesh-ancestor
24408699|NCT00179114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408700|NCT00179114|Cholinergic Agents|cholinergic agents|mesh-ancestor
24408701|NCT00179114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24408702|NCT00179114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408703|NCT00179114|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24408704|NCT00179114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24408705|NCT00179114|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24408706|NCT00179114|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25211465|NCT04315350|Prednisolone|prednisolone|mesh-list
25211466|NCT04315350|Curcumin|curcumin|mesh-list
25211467|NCT04315350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25211468|NCT04315350|Glucocorticoids|glucocorticoids|mesh-ancestor
25211469|NCT04315350|Hormones|hormones|mesh-ancestor
25211470|NCT04315350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24526875|NCT00613561|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24526876|NCT00613561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526877|NCT00613561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526878|NCT00613561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24526879|NCT00613561|Immunologic Factors|immunologic factors|mesh-ancestor
24526880|NCT00613561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526881|NCT00613561|Alkylating Agents|alkylating agents|mesh-ancestor
24526882|NCT00613561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25211488|NCT04314219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25211489|NCT04314219|Alkylating Agents|alkylating agents|mesh-ancestor
25211490|NCT04314219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211491|NCT04314219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25211492|NCT04314219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25211493|NCT04314219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25211494|NCT04314219|Abortifacient Agents|abortifacient agents|mesh-ancestor
25211495|NCT04314219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25211496|NCT04314219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25211497|NCT04314219|Antimetabolites|antimetabolites|mesh-ancestor
25211498|NCT04314219|Dermatologic Agents|dermatologic agents|mesh-ancestor
25211499|NCT04314219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25211500|NCT04314219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25211501|NCT04314219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25211502|NCT04309552|Alovudine|alovudine|mesh-list
25211504|NCT04309552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25211505|NCT04304625|Tranexamic Acid|tranexamic acid|mesh-list
25211506|NCT04304625|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25211507|NCT04304625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25211508|NCT04304625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211509|NCT04304625|Hemostatics|hemostatics|mesh-ancestor
25211510|NCT04304625|Coagulants|coagulants|mesh-ancestor
25211511|NCT04298541|Edotreotide|edotreotide|mesh-list
25211512|NCT04298541|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25211513|NCT04298541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527255|NCT00615745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24527256|NCT00615745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677642|NCT01813734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25112736|NCT03919526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25112737|NCT03919526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25257566|NCT02476136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25257567|NCT02476136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257568|NCT02476136|Analgesics|analgesics|mesh-ancestor
25257569|NCT02476136|Sensory System Agents|sensory system agents|mesh-ancestor
25257570|NCT02476136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25257571|NCT02476136|Antidepressive Agents|antidepressive agents|mesh-ancestor
25257572|NCT02476136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25257573|NCT02476136|Dopamine Agents|dopamine agents|mesh-ancestor
25257574|NCT02476136|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25257575|NCT02476136|Serotonin Agents|serotonin agents|mesh-ancestor
25257576|NCT02476136|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24527257|NCT00615745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527258|NCT00615745|Antiviral Agents|antiviral agents|mesh-ancestor
24527259|NCT00615745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24527261|NCT00615745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24527262|NCT00615758|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24527264|NCT00615758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24527265|NCT00615758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527266|NCT00615758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527267|NCT00615797|Penicillins|penicillins|mesh-list
24527285|NCT00615797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24527286|NCT00615797|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24431902|NCT00253201|Galantamine|galantamine|mesh-list
24527299|NCT00615810|Antiviral Agents|antiviral agents|mesh-ancestor
24527300|NCT00615810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24527325|NCT00615875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24457845|NCT00335400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457846|NCT00335413|Spironolactone|spironolactone|mesh-list
24457847|NCT00335413|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24527326|NCT00615875|Gout Suppressants|gout suppressants|mesh-ancestor
24527327|NCT00615875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24527328|NCT00615875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408707|NCT00179114|GABA Agonists|gaba agonists|mesh-ancestor
24820352|NCT02099240|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24541875|NCT00675714|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
25211532|NCT04288206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25211533|NCT04288206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25211534|NCT04278625|Acetaminophen|acetaminophen|mesh-list
25211535|NCT04278625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25211536|NCT04278625|Analgesics|analgesics|mesh-ancestor
25211537|NCT04278625|Sensory System Agents|sensory system agents|mesh-ancestor
25211538|NCT04278625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25211539|NCT04278625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211540|NCT04278625|Antipyretics|antipyretics|mesh-ancestor
25211549|NCT04210310|Oxytocin|oxytocin|mesh-list
25211550|NCT04210310|Oxytocics|oxytocics|mesh-ancestor
25211551|NCT04210310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25211552|NCT04210310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211553|NCT04160377|Fluvoxamine|fluvoxamine|mesh-list
25211554|NCT04160377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25211555|NCT04160377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211556|NCT04160377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25211557|NCT04160377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25677643|NCT01813734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677644|NCT01813890|Tapentadol|tapentadol|mesh-list
25677645|NCT01813890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25677646|NCT01813890|Narcotics|narcotics|mesh-ancestor
25677647|NCT01813890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25677648|NCT01813890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677649|NCT01813890|Analgesics|analgesics|mesh-ancestor
25677650|NCT01813890|Sensory System Agents|sensory system agents|mesh-ancestor
25677651|NCT01813890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25677652|NCT01813890|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25677653|NCT01813890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25677654|NCT01813890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25677655|NCT01813890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677656|NCT01813890|Adrenergic Agents|adrenergic agents|mesh-ancestor
25027551|NCT03619330|Hormones|hormones|mesh-ancestor
25027552|NCT03619330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25027553|NCT03619330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027554|NCT03619330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25027555|NCT03619330|Incretins|incretins|mesh-ancestor
25027561|NCT03619057|Anesthetics|anesthetics|mesh-list
25027562|NCT03619057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25211558|NCT04160377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25211559|NCT04160377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211560|NCT04160377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25211561|NCT04160377|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25211562|NCT04160377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25211563|NCT04160377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25211564|NCT04160377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25211565|NCT04160377|Serotonin Agents|serotonin agents|mesh-ancestor
25272685|NCT02390544|Alkylating Agents|alkylating agents|mesh-ancestor
24527329|NCT00615875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527331|NCT00616005|Temozolomide|temozolomide|mesh-list
24527332|NCT00616005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24527333|NCT00616005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24527335|NCT00616005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527337|NCT00616005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24527338|NCT00616005|Alkylating Agents|alkylating agents|mesh-ancestor
24527340|NCT00616031|Carboplatin|carboplatin|mesh-list
24527341|NCT00616031|Nitroglycerin|nitroglycerin|mesh-list
24527342|NCT00616031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24527343|NCT00616031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527344|NCT00616031|Tubulin Modulators|tubulin modulators|mesh-ancestor
24527370|NCT00616187|Immunologic Factors|immunologic factors|mesh-ancestor
24527371|NCT00616187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527372|NCT00616213|Lenograstim|lenograstim|mesh-list
24527373|NCT00616213|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24527374|NCT00616213|Immunologic Factors|immunologic factors|mesh-ancestor
24527376|NCT00616382|Indomethacin|indomethacin|mesh-list
25211566|NCT04160377|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25211567|NCT04160377|Antidepressive Agents|antidepressive agents|mesh-ancestor
25211568|NCT04160377|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25211569|NCT04160377|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25211570|NCT04160377|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25211572|NCT04147013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25211573|NCT04147013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25211574|NCT04147013|Analgesics|analgesics|mesh-ancestor
25211575|NCT04147013|Sensory System Agents|sensory system agents|mesh-ancestor
25211576|NCT04147013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25211577|NCT04147013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211578|NCT04147013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25211579|NCT04147013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25211580|NCT04147013|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25211581|NCT04147013|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25211582|NCT04147013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25211583|NCT04147013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211587|NCT04126070|Docetaxel|docetaxel|mesh-list
25211588|NCT04126070|Nivolumab|nivolumab|mesh-list
25211589|NCT04126070|Leuprolide|leuprolide|mesh-list
25211590|NCT04126070|Goserelin|goserelin|mesh-list
25211591|NCT04126070|Androgens|androgens|mesh-list
25211592|NCT04126070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25211593|NCT04126070|Tubulin Modulators|tubulin modulators|mesh-ancestor
25211594|NCT04126070|Antimitotic Agents|antimitotic agents|mesh-ancestor
25211595|NCT04126070|Mitosis Modulators|mitosis modulators|mesh-ancestor
25211596|NCT04126070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211597|NCT04126070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25211598|NCT04126070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25211599|NCT04126070|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25211600|NCT04126070|Fertility Agents|fertility agents|mesh-ancestor
25211601|NCT04126070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25677657|NCT01813890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25677658|NCT01814046|Aldesleukin|aldesleukin|mesh-list
25677659|NCT01814046|Cyclophosphamide|cyclophosphamide|mesh-list
25677660|NCT01814046|Fludarabine|fludarabine|mesh-list
25677661|NCT01814046|Interleukin-2|interleukin-2|mesh-list
25677662|NCT01814046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25677663|NCT01814046|Immunologic Factors|immunologic factors|mesh-ancestor
25677664|NCT01814046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593071|NCT00926835|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24593072|NCT00926835|Cholinergic Agents|cholinergic agents|mesh-ancestor
25027687|NCT03617900|Sensory System Agents|sensory system agents|mesh-ancestor
25027688|NCT03617900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027689|NCT03617900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027690|NCT03617900|Antipyretics|antipyretics|mesh-ancestor
25027691|NCT03617705|Ethanol|ethanol|mesh-list
25027692|NCT03617705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25027693|NCT03617705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25027694|NCT03617705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25257586|NCT02476045|Leucovorin|leucovorin|mesh-list
25257587|NCT02476045|Fluorouracil|fluorouracil|mesh-list
25211602|NCT04126070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211603|NCT04126070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25211604|NCT04126070|Hormones|hormones|mesh-ancestor
25211605|NCT04126070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25211606|NCT04064697|Valganciclovir|valganciclovir|mesh-list
25211607|NCT04064697|Antiviral Agents|antiviral agents|mesh-ancestor
25211608|NCT04064697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25272686|NCT02390544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527530|NCT00617045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527532|NCT00617045|Sensory System Agents|sensory system agents|mesh-ancestor
24527533|NCT00617045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24527534|NCT00617045|Antidepressive Agents|antidepressive agents|mesh-ancestor
24527535|NCT00617045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24527537|NCT00617253|Sunitinib|sunitinib|mesh-list
24527538|NCT00617253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527539|NCT00617253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24527540|NCT00617253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24527541|NCT00617253|Growth Substances|growth substances|mesh-ancestor
24527542|NCT00617253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527543|NCT00617253|Growth Inhibitors|growth inhibitors|mesh-ancestor
24527599|NCT00617643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24527600|NCT00617643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24541876|NCT00675714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24541877|NCT00675714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541878|NCT00675714|Androgens|androgens|mesh-ancestor
24541879|NCT00675714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24541880|NCT00675714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541881|NCT00675714|Anabolic Agents|anabolic agents|mesh-ancestor
24820781|NCT02101632|Petrolatum|petrolatum|mesh-list
24654954|NCT01252342|Oxytocin|oxytocin|mesh-list
24541883|NCT00675714|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24541884|NCT00675714|Adrenergic Agents|adrenergic agents|mesh-ancestor
24820353|NCT02099240|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24820355|NCT02099240|Antimetabolites|antimetabolites|mesh-ancestor
24820356|NCT02099240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24820357|NCT02099240|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24820358|NCT02099240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24820359|NCT02099240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24820360|NCT02099240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24820361|NCT02099240|Analgesics|analgesics|mesh-ancestor
25677665|NCT01814046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25677666|NCT01814046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25677667|NCT01814046|Alkylating Agents|alkylating agents|mesh-ancestor
25677668|NCT01814046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677669|NCT01814046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25677670|NCT01814046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25677671|NCT01814046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25677672|NCT01814046|Analgesics|analgesics|mesh-ancestor
25677673|NCT01814046|Sensory System Agents|sensory system agents|mesh-ancestor
25677674|NCT01814046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25677675|NCT01814046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25211623|NCT04052620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211625|NCT04048278|Anesthetics, Local|anesthetics, local|mesh-ancestor
25211626|NCT04048278|Anesthetics|anesthetics|mesh-ancestor
25211627|NCT04048278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25211628|NCT04048278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211629|NCT04048278|Sensory System Agents|sensory system agents|mesh-ancestor
24527676|NCT00618059|Miotics|miotics|mesh-ancestor
24527689|NCT00618111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527690|NCT00618111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24527691|NCT00618111|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24527692|NCT00618111|Serotonin Agents|serotonin agents|mesh-ancestor
24527693|NCT00618111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24527694|NCT00618111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527695|NCT00618124|Capecitabine|capecitabine|mesh-list
24527696|NCT00618124|Sunitinib|sunitinib|mesh-list
24527697|NCT00618124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24527698|NCT00618124|Antimetabolites|antimetabolites|mesh-ancestor
24527699|NCT00618124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527700|NCT00618124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527739|NCT00618202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24527740|NCT00618202|Analgesics|analgesics|mesh-ancestor
24527741|NCT00618202|Sensory System Agents|sensory system agents|mesh-ancestor
24527801|NCT00618345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527802|NCT00618358|Thrombin|thrombin|mesh-list
24529486|NCT00626262|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24946090|NCT03943043|Antimetabolites|antimetabolites|mesh-ancestor
24820380|NCT02099253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25211630|NCT04048278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25211631|NCT04048278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25211632|NCT04048278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25211633|NCT04048278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25211634|NCT04048278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25211635|NCT04048278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257600|NCT02476045|Vitamin B Complex|vitamin b complex|mesh-ancestor
25257601|NCT02476045|Vitamins|vitamins|mesh-ancestor
25257602|NCT02476045|Micronutrients|micronutrients|mesh-ancestor
25257603|NCT02476045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25257604|NCT02475876|Clindamycin|clindamycin|mesh-list
25257605|NCT02475876|Clindamycin palmitate|clindamycin palmitate|mesh-list
25257606|NCT02475876|Clindamycin phosphate|clindamycin phosphate|mesh-list
25257608|NCT02475876|Trimethoprim|trimethoprim|mesh-list
25211636|NCT03969420|Cytarabine|cytarabine|mesh-list
25211637|NCT03969420|Alvocidib|alvocidib|mesh-list
25211638|NCT03969420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25211639|NCT03969420|Antimetabolites|antimetabolites|mesh-ancestor
25211640|NCT03969420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211641|NCT03969420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25211642|NCT03969420|Antiviral Agents|antiviral agents|mesh-ancestor
25211643|NCT03969420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25211644|NCT03969420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25211645|NCT03969420|Immunologic Factors|immunologic factors|mesh-ancestor
25211646|NCT03969420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211647|NCT03969420|Growth Inhibitors|growth inhibitors|mesh-ancestor
25211648|NCT03969420|Growth Substances|growth substances|mesh-ancestor
25211649|NCT03969420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24527803|NCT00618358|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
24527804|NCT00618358|Hemostatics|hemostatics|mesh-ancestor
24527805|NCT00618358|Coagulants|coagulants|mesh-ancestor
24527806|NCT00618384|Sorafenib|sorafenib|mesh-list
24527807|NCT00618384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527808|NCT00618384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24527809|NCT00618384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527810|NCT00618384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527811|NCT00618397|Ketamine|ketamine|mesh-list
24527812|NCT00618397|Analgesics|analgesics|mesh-ancestor
24527813|NCT00618397|Sensory System Agents|sensory system agents|mesh-ancestor
24527814|NCT00618397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24527815|NCT00618397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527816|NCT00618397|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25211651|NCT03950037|Albendazole|albendazole|mesh-list
25211652|NCT03950037|Anthelmintics|anthelmintics|mesh-ancestor
25211653|NCT03950037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25211654|NCT03950037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25211655|NCT03950037|Anticestodal Agents|anticestodal agents|mesh-ancestor
25211656|NCT03950037|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25211657|NCT03950037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25211658|NCT03950037|Tubulin Modulators|tubulin modulators|mesh-ancestor
25211659|NCT03950037|Antimitotic Agents|antimitotic agents|mesh-ancestor
25211660|NCT03950037|Mitosis Modulators|mitosis modulators|mesh-ancestor
25211665|NCT03936309|Anesthetics|anesthetics|mesh-ancestor
25211666|NCT03936309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25211667|NCT03936309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211668|NCT03936309|Sensory System Agents|sensory system agents|mesh-ancestor
25211669|NCT03936309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25211670|NCT03936309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25211671|NCT03936309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25211672|NCT03936309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25211673|NCT03936309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25211674|NCT03936309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527892|NCT00618527|Antiviral Agents|antiviral agents|mesh-ancestor
24527893|NCT00618527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25677676|NCT01814046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25677677|NCT01814046|Antiviral Agents|antiviral agents|mesh-ancestor
25677678|NCT01814046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25677679|NCT01814137|Insulin|insulin|mesh-list
25677680|NCT01814137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25677681|NCT01814137|Insulin Aspart|insulin aspart|mesh-list
25677682|NCT01814137|Insulin, Long-Acting|insulin, long-acting|mesh-list
25677683|NCT01814137|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25112922|NCT03787680|Olaparib|olaparib|mesh-list
24527894|NCT00618527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24527895|NCT00618527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24527896|NCT00618527|Antitubercular Agents|antitubercular agents|mesh-ancestor
24527897|NCT00618527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24527898|NCT00618527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527899|NCT00618527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527937|NCT00618657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24527938|NCT00618657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527939|NCT00618657|Tubulin Modulators|tubulin modulators|mesh-ancestor
24527940|NCT00618657|Antimitotic Agents|antimitotic agents|mesh-ancestor
24527964|NCT00618969|Melphalan|melphalan|mesh-list
24527965|NCT00618969|Alkylating Agents|alkylating agents|mesh-ancestor
24527973|NCT00619021|Gemcitabine|gemcitabine|mesh-list
24946153|NCT03942601|Sirolimus|sirolimus|mesh-list
24408789|NCT00179686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408790|NCT00179686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24408791|NCT00179686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24408793|NCT00179686|Growth Inhibitors|growth inhibitors|mesh-ancestor
24408794|NCT00179686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408796|NCT00179699|Lenalidomide|lenalidomide|mesh-list
24408797|NCT00179699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408798|NCT00179699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408799|NCT00179699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408887|NCT00179881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24408888|NCT00179881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24408889|NCT00179881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24408890|NCT00179881|Growth Substances|growth substances|mesh-ancestor
24542001|NCT00676377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542002|NCT00676377|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24542003|NCT00676377|Autonomic Agents|autonomic agents|mesh-ancestor
24542004|NCT00676377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25211697|NCT03915496|Abrocitinib|abrocitinib|mesh-list
25211698|NCT03915496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25211699|NCT03915496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25211700|NCT03915496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408989|NCT00180128|Analgesics|analgesics|mesh-ancestor
24542009|NCT00676416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24542010|NCT00676416|Anesthetics, General|anesthetics, general|mesh-ancestor
24542011|NCT00676416|Anesthetics|anesthetics|mesh-ancestor
24542012|NCT00676429|Ziprasidone|ziprasidone|mesh-list
24542013|NCT00676429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24542014|NCT00676429|Serotonin Agents|serotonin agents|mesh-ancestor
24542015|NCT00676429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24542016|NCT00676429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542017|NCT00676429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542022|NCT00676429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24542025|NCT00676468|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24409754|NCT00182871|Hormones|hormones|mesh-ancestor
24542027|NCT00676468|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24542028|NCT00676468|Hormone Antagonists|hormone antagonists|mesh-ancestor
24820492|NCT02099825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24820493|NCT02099825|Renal Agents|renal agents|mesh-ancestor
25677684|NCT01814137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25677685|NCT01814137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028200|NCT03612947|Anticonvulsants|anticonvulsants|mesh-ancestor
25028201|NCT03612947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25028202|NCT03612947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25028203|NCT03612947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817723|NCT02085317|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25028271|NCT03612349|Dermatologic Agents|dermatologic agents|mesh-ancestor
25028273|NCT03612323|Carticaine|carticaine|mesh-list
25028274|NCT03612323|Anesthetics, Local|anesthetics, local|mesh-ancestor
25028275|NCT03612323|Anesthetics|anesthetics|mesh-ancestor
25028276|NCT03612323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25028277|NCT03612323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257631|NCT02475915|Hydroxychloroquine|hydroxychloroquine|mesh-list
25257632|NCT02475915|Vorinostat|vorinostat|mesh-list
25257633|NCT02475915|Antiviral Agents|antiviral agents|mesh-ancestor
25257634|NCT02475915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24405615|NCT00167739|Analgesics|analgesics|mesh-ancestor
24929290|NCT04113954|Mepivacaine|mepivacaine|mesh-list
24929291|NCT04113954|Anesthetics, Local|anesthetics, local|mesh-ancestor
24929292|NCT04113954|Anesthetics|anesthetics|mesh-ancestor
24409034|NCT00180622|Protective Agents|protective agents|mesh-ancestor
24409035|NCT00180622|Antimetabolites|antimetabolites|mesh-ancestor
24409036|NCT00180635|Pimagedine|pimagedine|mesh-list
24409037|NCT00180635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409038|NCT00180635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409039|NCT00180791|Carboplatin|carboplatin|mesh-list
24409105|NCT00180908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409106|NCT00180908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24409107|NCT00180908|Antimetabolites|antimetabolites|mesh-ancestor
24409108|NCT00180908|Dermatologic Agents|dermatologic agents|mesh-ancestor
24409109|NCT00180908|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24409110|NCT00180908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24409111|NCT00180908|Immunologic Factors|immunologic factors|mesh-ancestor
24409112|NCT00180908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24409113|NCT00180908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24409114|NCT00180908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24409123|NCT00180947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24409124|NCT00180947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409125|NCT00180947|Tubulin Modulators|tubulin modulators|mesh-ancestor
24409126|NCT00180947|Antimitotic Agents|antimitotic agents|mesh-ancestor
24820504|NCT02099877|Analgesics|analgesics|mesh-ancestor
24820505|NCT02099877|Sensory System Agents|sensory system agents|mesh-ancestor
24820506|NCT02099877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24820507|NCT02099877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24402696|NCT00158171|Vitamins|vitamins|mesh-ancestor
24820508|NCT02099877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24820509|NCT02099877|Anesthetics, General|anesthetics, general|mesh-ancestor
24820510|NCT02099877|Anesthetics|anesthetics|mesh-ancestor
24820511|NCT02099890|Curcumin|curcumin|mesh-list
24820512|NCT02099890|Antioxidants|antioxidants|mesh-list
24820513|NCT02099890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24820514|NCT02099890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24820515|NCT02099890|Analgesics|analgesics|mesh-ancestor
24820516|NCT02099890|Sensory System Agents|sensory system agents|mesh-ancestor
24820517|NCT02099890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25677686|NCT01814371|Mupirocin|mupirocin|mesh-list
25677687|NCT01814371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25677688|NCT01814371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25677689|NCT01814371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25677690|NCT01814371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677691|NCT01814371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677692|NCT01814397|Letrozole|letrozole|mesh-list
25677693|NCT01814397|Anastrozole|anastrozole|mesh-list
25677694|NCT01814397|Exemestane|exemestane|mesh-list
25677695|NCT01814397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25677696|NCT01814397|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25677697|NCT01814397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25677698|NCT01814397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677699|NCT01814397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677700|NCT01814397|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25677701|NCT01814397|Hormone Antagonists|hormone antagonists|mesh-ancestor
25677702|NCT01814397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25677703|NCT01814397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820518|NCT02099890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820519|NCT02099890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25028466|NCT03610347|Mitosis Modulators|mitosis modulators|mesh-ancestor
25028467|NCT03610347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028468|NCT03610321|Gefarnate|gefarnate|mesh-list
25028469|NCT03610321|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25028470|NCT03610321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25028471|NCT03610282|Propofol|propofol|mesh-list
24820520|NCT02099890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24820521|NCT02099890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24820522|NCT02099890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820523|NCT02099890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542041|NCT00676533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542042|NCT00676533|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24542043|NCT00676533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24409148|NCT00181012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24409149|NCT00181012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24820533|NCT02099955|Micronutrients|micronutrients|mesh-ancestor
24820534|NCT02099955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820535|NCT02099955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24542048|NCT00676559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542050|NCT00676559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542051|NCT00676637|Timolol|timolol|mesh-list
24542052|NCT00676637|Travoprost|travoprost|mesh-list
24542053|NCT00676637|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24542054|NCT00676637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24542055|NCT00676637|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24542056|NCT00676637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24542057|NCT00676637|Adrenergic Agents|adrenergic agents|mesh-ancestor
24542058|NCT00676637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24542059|NCT00676637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820559|NCT02100267|Methacholine Chloride|methacholine chloride|mesh-list
24820560|NCT02100267|Miotics|miotics|mesh-ancestor
24820561|NCT02100267|Autonomic Agents|autonomic agents|mesh-ancestor
24820610|NCT02100462|Analgesics|analgesics|mesh-ancestor
24820611|NCT02100462|Sensory System Agents|sensory system agents|mesh-ancestor
24576427|NCT00838396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457856|NCT00335439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24820620|NCT02100462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24820621|NCT02100462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409209|NCT00181298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409210|NCT00181298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409211|NCT00181298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24409212|NCT00181298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24409213|NCT00181532|Celecoxib|celecoxib|mesh-list
24409214|NCT00181532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24409215|NCT00181532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24409216|NCT00181532|Analgesics|analgesics|mesh-ancestor
24409217|NCT00181532|Sensory System Agents|sensory system agents|mesh-ancestor
24409218|NCT00181532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24409219|NCT00181532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820631|NCT02100488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820633|NCT02100553|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
24820634|NCT02100553|Antifungal Agents|antifungal agents|mesh-ancestor
24409222|NCT00181532|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25677704|NCT01814397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25677705|NCT01814553|Afatinib|afatinib|mesh-list
25677706|NCT01814553|Loperamide|loperamide|mesh-list
25677707|NCT01814553|Antidiarrheals|antidiarrheals|mesh-list
25677708|NCT01814553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25677709|NCT01814553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24409223|NCT00181532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25677710|NCT01814553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692715|NCT02004093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25692716|NCT02004132|Testosterone|testosterone|mesh-list
25257644|NCT02475915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25257645|NCT02475915|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25257646|NCT02475915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25257647|NCT02475915|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25257648|NCT02475915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25257649|NCT02475915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25257650|NCT02475915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24409224|NCT00181532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409225|NCT00181532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409226|NCT00181558|Zoledronic Acid|zoledronic acid|mesh-list
24409228|NCT00181558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24409229|NCT00181558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409249|NCT00181597|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24409257|NCT00181636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24409259|NCT00181636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409260|NCT00181636|Cholinergic Agents|cholinergic agents|mesh-ancestor
24409261|NCT00181636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24409262|NCT00181636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409263|NCT00181636|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24542081|NCT00676741|Biphasic Insulins|biphasic insulins|mesh-list
24542082|NCT00676741|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24820667|NCT02100761|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24820668|NCT02100761|Hormone Antagonists|hormone antagonists|mesh-ancestor
24820669|NCT02100761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24820670|NCT02100761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820671|NCT02100761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24820672|NCT02100787|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24820673|NCT02100787|Laxatives|laxatives|mesh-ancestor
24820674|NCT02100787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24528130|NCT00619944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24528131|NCT00619944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24528132|NCT00619944|Protease Inhibitors|protease inhibitors|mesh-ancestor
24528150|NCT00619996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528151|NCT00619996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24528152|NCT00619996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528154|NCT00620100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528155|NCT00620100|Tubulin Modulators|tubulin modulators|mesh-ancestor
24528156|NCT00620100|Antimitotic Agents|antimitotic agents|mesh-ancestor
24528157|NCT00620100|Mitosis Modulators|mitosis modulators|mesh-ancestor
24528158|NCT00620100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528159|NCT00620165|Levetiracetam|levetiracetam|mesh-list
24528160|NCT00620165|Anticonvulsants|anticonvulsants|mesh-ancestor
24528161|NCT00620165|Nootropic Agents|nootropic agents|mesh-ancestor
24528162|NCT00620178|Losartan|losartan|mesh-list
24528163|NCT00620178|Candesartan|candesartan|mesh-list
24528164|NCT00620178|Candesartan cilexetil|candesartan cilexetil|mesh-list
24528171|NCT00620204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24946206|NCT03941925|Levan|levan|mesh-list
25211734|NCT03838263|Cisplatin|cisplatin|mesh-list
25211735|NCT03838263|Nivolumab|nivolumab|mesh-list
25211736|NCT03838263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25211737|NCT03838263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25211738|NCT03838263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25211739|NCT03838263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820709|NCT02101125|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24820710|NCT02101125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820711|NCT02101138|Pramipexole|pramipexole|mesh-list
25677711|NCT01814553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677712|NCT01814553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25677713|NCT01814670|Botulinum Toxins|botulinum toxins|mesh-list
25677714|NCT01814670|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25677715|NCT01814670|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25677716|NCT01814670|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25677717|NCT01814670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25692717|NCT02004132|Androgens|androgens|mesh-ancestor
24409423|NCT00181948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409424|NCT00181974|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24409425|NCT00181974|Hemostatics|hemostatics|mesh-ancestor
24409426|NCT00181974|Coagulants|coagulants|mesh-ancestor
24409427|NCT00181987|Methylphenidate|methylphenidate|mesh-list
24409428|NCT00181987|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24705596|NCT01485744|Antidotes|antidotes|mesh-ancestor
24409463|NCT00182039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24409464|NCT00182039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409465|NCT00182039|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24409466|NCT00182039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24409482|NCT00182143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24409483|NCT00182143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24409484|NCT00182143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409486|NCT00182169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24705635|NCT01485926|Tubulin Modulators|tubulin modulators|mesh-ancestor
24409511|NCT00182351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409512|NCT00182351|Hemostatics|hemostatics|mesh-ancestor
24409513|NCT00182351|Coagulants|coagulants|mesh-ancestor
24409514|NCT00182364|Heparin|heparin|mesh-list
24409515|NCT00182364|Calcium heparin|calcium heparin|mesh-list
24409516|NCT00182364|Dalteparin|dalteparin|mesh-list
24409517|NCT00182364|Tinzaparin|tinzaparin|mesh-list
25211756|NCT03801642|Dapagliflozin|dapagliflozin|mesh-list
25211757|NCT03801642|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25211758|NCT03801642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211759|NCT03801642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25211760|NCT03801642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211761|NCT03771651|Aspirin|aspirin|mesh-list
25211762|NCT03771651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25211763|NCT03771651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25211764|NCT03771651|Analgesics|analgesics|mesh-ancestor
24528255|NCT00620581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24409518|NCT00182364|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24451829|NCT00324922|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24451830|NCT00324922|Trimethoprim|trimethoprim|mesh-list
24410219|NCT00184899|Calcium heparin|calcium heparin|mesh-list
24409543|NCT00182429|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24409546|NCT00182442|Antiemetics|antiemetics|mesh-ancestor
24409547|NCT00182442|Autonomic Agents|autonomic agents|mesh-ancestor
24409548|NCT00182442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24409549|NCT00182442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409550|NCT00182442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24409551|NCT00182442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24409552|NCT00182442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24409553|NCT00182442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24409554|NCT00182442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24947362|NCT03929744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24409555|NCT00182442|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24409556|NCT00182442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24409557|NCT00182442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24409593|NCT00182533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25029138|NCT03604744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029139|NCT03604744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25029140|NCT03604679|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25257672|NCT02475824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25029141|NCT03604679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25029142|NCT03604679|Alkylating Agents|alkylating agents|mesh-ancestor
25029143|NCT03604679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029144|NCT03604679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25257673|NCT02475824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25257674|NCT02475824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25211766|NCT03771651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25211767|NCT03771651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211768|NCT03771651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25211769|NCT03771651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25211770|NCT03771651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25211771|NCT03771651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25211772|NCT03771651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211773|NCT03771651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25211774|NCT03771651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25211775|NCT03771651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25211776|NCT03771651|Antipyretics|antipyretics|mesh-ancestor
24528349|NCT00620867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24528350|NCT00620867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24528351|NCT00620867|Analgesics|analgesics|mesh-ancestor
24528352|NCT00620867|Sensory System Agents|sensory system agents|mesh-ancestor
24528353|NCT00620867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24528354|NCT00620867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528355|NCT00620867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24528356|NCT00620867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24528357|NCT00620867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24528358|NCT00620867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776580|NCT01858610|Irbesartan|irbesartan|mesh-list
24528359|NCT00620867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409594|NCT00182533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24409595|NCT00182533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409596|NCT00182533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24409597|NCT00182533|Serotonin Agents|serotonin agents|mesh-ancestor
24820775|NCT02101567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24820776|NCT02101567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820777|NCT02101606|Tenecteplase|tenecteplase|mesh-list
24820778|NCT02101606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24820779|NCT02101606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24820780|NCT02101606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409643|NCT00182650|Antiviral Agents|antiviral agents|mesh-ancestor
24409644|NCT00182650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24409645|NCT00182663|Thalidomide|thalidomide|mesh-list
24409646|NCT00182663|Clarithromycin|clarithromycin|mesh-list
24528803|NCT00622843|Immunologic Factors|immunologic factors|mesh-ancestor
24820834|NCT02102139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24820835|NCT02102139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24820836|NCT02102139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677718|NCT01814670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677719|NCT01814670|Cholinergic Agents|cholinergic agents|mesh-ancestor
25677720|NCT01814670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25677721|NCT01814670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677722|NCT01814670|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25677723|NCT01814670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25677724|NCT01814748|Metformin|metformin|mesh-list
25677725|NCT01814748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25677726|NCT01814748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677727|NCT01814761|Bimatoprost|bimatoprost|mesh-list
25677728|NCT01814761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25029360|NCT03603119|Dermatologic Agents|dermatologic agents|mesh-ancestor
25029361|NCT03603119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25029362|NCT03603119|Serotonin Agents|serotonin agents|mesh-ancestor
25029363|NCT03603119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25257687|NCT02475746|Itraconazole|itraconazole|mesh-list
25257688|NCT02475746|PF-06372865|pf-06372865|mesh-list
25257689|NCT02475746|Antifungal Agents|antifungal agents|mesh-ancestor
25257690|NCT02475746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24820837|NCT02102139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24820838|NCT02102139|Anesthetics, General|anesthetics, general|mesh-ancestor
24820839|NCT02102139|Anesthetics|anesthetics|mesh-ancestor
24820840|NCT02102152|Tobramycin|tobramycin|mesh-list
25211783|NCT03738215|Cariprazine|cariprazine|mesh-list
25211784|NCT03738215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25211785|NCT03738215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25211786|NCT03738215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25211787|NCT03738215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211788|NCT03738215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25211789|NCT03735901|Levodopa|levodopa|mesh-list
25211790|NCT03735901|Carbidopa|carbidopa|mesh-list
25211791|NCT03735901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25211792|NCT03735901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25211793|NCT03735901|Dopamine Agents|dopamine agents|mesh-ancestor
25211794|NCT03735901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24528360|NCT00620867|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24528361|NCT00620893|Lubricant Eye Drops|lubricant eye drops|mesh-list
24528362|NCT00620893|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24528363|NCT00620893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24528365|NCT00620919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24528366|NCT00620919|Hormones|hormones|mesh-ancestor
24528367|NCT00620919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24528368|NCT00620919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528369|NCT00620971|Gemcitabine|gemcitabine|mesh-list
24528373|NCT00620971|Vinorelbine|vinorelbine|mesh-list
24528374|NCT00620971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24528375|NCT00620971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528376|NCT00620971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24528400|NCT00621036|Methotrexate|methotrexate|mesh-list
25211795|NCT03735901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211796|NCT03735901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211797|NCT03735901|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25211798|NCT03735901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25211799|NCT03725007|Upadacitinib|upadacitinib|mesh-list
25211800|NCT03725007|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25211801|NCT03725007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25211802|NCT03725007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25211803|NCT03725007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211804|NCT03725007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25211805|NCT03703856|Memantine|memantine|mesh-list
25211806|NCT03703856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25211807|NCT03703856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25211808|NCT03703856|Dopamine Agents|dopamine agents|mesh-ancestor
25211809|NCT03703856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25211810|NCT03703856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406675|NCT00171002|Amlodipine|amlodipine|mesh-list
25211811|NCT03703856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211812|NCT03703856|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25211813|NCT03703856|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25211814|NCT03699995|Lidocaine|lidocaine|mesh-list
25211815|NCT03699995|Anesthetics, Local|anesthetics, local|mesh-ancestor
25211816|NCT03699995|Anesthetics|anesthetics|mesh-ancestor
25211817|NCT03699995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25211818|NCT03699995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211819|NCT03699995|Sensory System Agents|sensory system agents|mesh-ancestor
25211820|NCT03699995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25211821|NCT03699995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25211822|NCT03699995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25211823|NCT03699995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25211824|NCT03699995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25677729|NCT01814800|Immunoglobulins|immunoglobulins|mesh-list
25677730|NCT01814800|Immunologic Factors|immunologic factors|mesh-ancestor
25677731|NCT01814800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677732|NCT01814813|Bevacizumab|bevacizumab|mesh-list
25677733|NCT01814813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25677734|NCT01814813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25677735|NCT01814813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25692718|NCT02004132|Hormones|hormones|mesh-ancestor
25211825|NCT03699995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211827|NCT03664180|Calcium heparin|calcium heparin|mesh-list
25211829|NCT03664180|Hirudins|hirudins|mesh-list
25211830|NCT03664180|Enoxaparin sodium|enoxaparin sodium|mesh-list
25211831|NCT03664180|Bivalirudin|bivalirudin|mesh-list
25211832|NCT03664180|Anticoagulants|anticoagulants|mesh-ancestor
25211833|NCT03664180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25211834|NCT03664180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25211835|NCT03664180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211836|NCT03664180|Antithrombins|antithrombins|mesh-ancestor
25211837|NCT03664180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25211838|NCT03664180|Protease Inhibitors|protease inhibitors|mesh-ancestor
25211839|NCT03664180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25211840|NCT03601923|Niraparib|niraparib|mesh-list
25211841|NCT03601923|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25211842|NCT03601923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25211843|NCT03601923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211844|NCT03601923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25211845|NCT03600909|Cyclophosphamide|cyclophosphamide|mesh-list
25211846|NCT03600909|Busulfan|busulfan|mesh-list
25211847|NCT03600909|Fludarabine|fludarabine|mesh-list
25211848|NCT03600909|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25211849|NCT03600909|Thymoglobulin|thymoglobulin|mesh-list
25211850|NCT03600909|Lenograstim|lenograstim|mesh-list
25211851|NCT03600909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25211852|NCT03600909|Immunologic Factors|immunologic factors|mesh-ancestor
24528649|NCT00622115|Anticoagulants|anticoagulants|mesh-ancestor
24528650|NCT00622115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24528651|NCT00622115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24528652|NCT00622115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528677|NCT00622206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24528679|NCT00622245|Antidepressive Agents|antidepressive agents|mesh-ancestor
24528680|NCT00622245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24528681|NCT00622245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24528682|NCT00622245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24409679|NCT00182702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409680|NCT00182715|Leucovorin|leucovorin|mesh-list
24409681|NCT00182715|Fluorouracil|fluorouracil|mesh-list
24820856|NCT02102321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24820857|NCT02102321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24820858|NCT02102321|Anticestodal Agents|anticestodal agents|mesh-ancestor
24820859|NCT02102321|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24820860|NCT02102321|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24820861|NCT02102321|Tubulin Modulators|tubulin modulators|mesh-ancestor
24820862|NCT02102321|Antimitotic Agents|antimitotic agents|mesh-ancestor
24820863|NCT02102321|Mitosis Modulators|mitosis modulators|mesh-ancestor
24820864|NCT02102321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820865|NCT02102321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24820866|NCT02102373|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24820867|NCT02102373|Laxatives|laxatives|mesh-ancestor
24820868|NCT02102373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24820870|NCT02102438|Carboplatin|carboplatin|mesh-list
24820871|NCT02102438|Trastuzumab|trastuzumab|mesh-list
24820872|NCT02102438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24820873|NCT02102438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24820874|NCT02102438|Tubulin Modulators|tubulin modulators|mesh-ancestor
24820875|NCT02102438|Antimitotic Agents|antimitotic agents|mesh-ancestor
24820879|NCT02102516|Ketorolac|ketorolac|mesh-list
24820886|NCT02102516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820918|NCT02102633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820919|NCT02102633|Anticoagulants|anticoagulants|mesh-ancestor
24409747|NCT00182845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409748|NCT00182845|Cholinergic Agents|cholinergic agents|mesh-ancestor
24409749|NCT00182845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24409750|NCT00182845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409751|NCT00182845|Nootropic Agents|nootropic agents|mesh-ancestor
24409752|NCT00182871|Testosterone|testosterone|mesh-list
24409753|NCT00182871|Androgens|androgens|mesh-ancestor
24409755|NCT00182871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24409756|NCT00182871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595858|NCT00940719|Vitamins|vitamins|mesh-ancestor
24595859|NCT00940719|Micronutrients|micronutrients|mesh-ancestor
25113224|NCT03240211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257704|NCT02475499|Pioglitazone|pioglitazone|mesh-list
25257705|NCT02475499|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25257706|NCT02475499|Liraglutide|liraglutide|mesh-list
25257707|NCT02475499|Exenatide|exenatide|mesh-list
25257708|NCT02475499|Glimepiride|glimepiride|mesh-list
25257709|NCT02475499|Rosiglitazone|rosiglitazone|mesh-list
25257710|NCT02475499|Vildagliptin|vildagliptin|mesh-list
25257711|NCT02475499|Saxagliptin|saxagliptin|mesh-list
25257712|NCT02475499|Acarbose|acarbose|mesh-list
25257713|NCT02475499|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25257714|NCT02475499|Repaglinide|repaglinide|mesh-list
25257715|NCT02475499|Gliclazide|gliclazide|mesh-list
25257716|NCT02475499|Glipizide|glipizide|mesh-list
25257717|NCT02475499|Biguanides|biguanides|mesh-list
24451835|NCT00324922|Renal Agents|renal agents|mesh-ancestor
25211853|NCT03600909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211854|NCT03600909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25211855|NCT03600909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25211856|NCT03600909|Alkylating Agents|alkylating agents|mesh-ancestor
25211857|NCT03600909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211858|NCT03600909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25211859|NCT03600909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25211860|NCT03600909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25211861|NCT03563560|Cytarabine|cytarabine|mesh-list
25211862|NCT03563560|Mitoxantrone|mitoxantrone|mesh-list
25211863|NCT03563560|Alvocidib|alvocidib|mesh-list
25211864|NCT03563560|Daunorubicin|daunorubicin|mesh-list
24528707|NCT00622349|Mitosis Modulators|mitosis modulators|mesh-ancestor
24528708|NCT00622349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24528709|NCT00622349|Alkylating Agents|alkylating agents|mesh-ancestor
24528711|NCT00622375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24528712|NCT00622375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24409873|NCT00183807|Analgesics|analgesics|mesh-ancestor
24409874|NCT00183807|Sensory System Agents|sensory system agents|mesh-ancestor
24409875|NCT00183807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24409876|NCT00183807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409877|NCT00183807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24451841|NCT00324922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451842|NCT00324922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24451843|NCT00324922|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24451844|NCT00324922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24451845|NCT00324948|Alprostadil|alprostadil|mesh-list
24542192|NCT00677443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24542193|NCT00677443|Antimetabolites|antimetabolites|mesh-ancestor
24656155|NCT01260233|Autonomic Agents|autonomic agents|mesh-ancestor
24542194|NCT00677443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542195|NCT00677443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542196|NCT00677469|Cholestyramine Resin|cholestyramine resin|mesh-list
25677736|NCT01814813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25677737|NCT01814813|Growth Substances|growth substances|mesh-ancestor
25677738|NCT01814813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677739|NCT01814813|Growth Inhibitors|growth inhibitors|mesh-ancestor
25677740|NCT01814878|Acetaminophen|acetaminophen|mesh-list
25677741|NCT01814878|Tramadol|tramadol|mesh-list
25677742|NCT01814878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25677743|NCT01814878|Analgesics|analgesics|mesh-ancestor
25677744|NCT01814878|Sensory System Agents|sensory system agents|mesh-ancestor
25677745|NCT01814878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25677746|NCT01814878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677747|NCT01814878|Antipyretics|antipyretics|mesh-ancestor
25677748|NCT01814878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25677749|NCT01814878|Narcotics|narcotics|mesh-ancestor
24542197|NCT00677469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24542198|NCT00677469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24542199|NCT00677469|Antimetabolites|antimetabolites|mesh-ancestor
25030185|NCT03597945|Respiratory System Agents|respiratory system agents|mesh-ancestor
25030186|NCT03597945|Mydriatics|mydriatics|mesh-ancestor
25030187|NCT03597945|Sympathomimetics|sympathomimetics|mesh-ancestor
25030188|NCT03597945|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25030189|NCT03597945|Analgesics|analgesics|mesh-ancestor
24820925|NCT02102646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820926|NCT02102646|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24820927|NCT02102646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24820928|NCT02102646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542200|NCT00677469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542201|NCT00677469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24542202|NCT00677521|Acarbose|acarbose|mesh-list
24409940|NCT00183911|Immunologic Factors|immunologic factors|mesh-ancestor
24409941|NCT00183911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211866|NCT03563560|Antimetabolites|antimetabolites|mesh-ancestor
25211867|NCT03563560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211868|NCT03563560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25211869|NCT03563560|Antiviral Agents|antiviral agents|mesh-ancestor
25211870|NCT03563560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25211871|NCT03563560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25211872|NCT03563560|Immunologic Factors|immunologic factors|mesh-ancestor
25211873|NCT03563560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528714|NCT00622375|Sensory System Agents|sensory system agents|mesh-ancestor
24528715|NCT00622375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24528726|NCT00622414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528727|NCT00622479|Sorafenib|sorafenib|mesh-list
24528728|NCT00622479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528729|NCT00622479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24528730|NCT00622479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528731|NCT00622479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528732|NCT00622570|Pentobarbital|pentobarbital|mesh-list
24528733|NCT00622570|Thiopental|thiopental|mesh-list
24528734|NCT00622570|Anticonvulsants|anticonvulsants|mesh-ancestor
24528735|NCT00622570|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24410096|NCT00184496|Respiratory System Agents|respiratory system agents|mesh-ancestor
24410097|NCT00184522|Esomeprazole|esomeprazole|mesh-list
24410098|NCT00184522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24410099|NCT00184522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24410100|NCT00184522|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24410101|NCT00184522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24410102|NCT00184522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410140|NCT00184665|Insulin Detemir|insulin detemir|mesh-list
24410141|NCT00184665|Isophane Insulin, Human|isophane insulin, human|mesh-list
24410142|NCT00184665|Insulin, Isophane|insulin, isophane|mesh-list
24410143|NCT00184665|Isophane insulin, beef|isophane insulin, beef|mesh-list
24542224|NCT00677729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542226|NCT00677729|Respiratory System Agents|respiratory system agents|mesh-ancestor
24542227|NCT00677729|Tocolytic Agents|tocolytic agents|mesh-ancestor
24542228|NCT00677729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24542229|NCT00677729|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24410165|NCT00184821|Diazoxide|diazoxide|mesh-list
25677750|NCT01814878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25677751|NCT01815008|Aspirin|aspirin|mesh-list
25677752|NCT01815008|Clopidogrel|clopidogrel|mesh-list
25677753|NCT01815008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25677754|NCT01815008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25677755|NCT01815008|Analgesics|analgesics|mesh-ancestor
25677756|NCT01815008|Sensory System Agents|sensory system agents|mesh-ancestor
25677757|NCT01815008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24596438|NCT00943566|Sufentanil|sufentanil|mesh-list
24596439|NCT00943566|Morphine|morphine|mesh-list
24596440|NCT00943566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24410199|NCT00184847|Purinergic Agonists|purinergic agonists|mesh-ancestor
24410200|NCT00184847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24410201|NCT00184847|Cholinergic Agents|cholinergic agents|mesh-ancestor
24410202|NCT00184886|Methotrexate|methotrexate|mesh-list
24394679|NCT00133887|Immunologic Factors|immunologic factors|mesh-ancestor
24410203|NCT00184886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24821034|NCT02103166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821035|NCT02103166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24821036|NCT02103166|Mydriatics|mydriatics|mesh-ancestor
24821037|NCT02103166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24821038|NCT02103166|Cholinergic Agents|cholinergic agents|mesh-ancestor
24821042|NCT02103192|Antioxidants|antioxidants|mesh-list
24821045|NCT02103192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821046|NCT02103205|Iron|iron|mesh-list
24821047|NCT02103205|Lactoferrin|lactoferrin|mesh-list
24821048|NCT02103205|Trace Elements|trace elements|mesh-ancestor
25211878|NCT03563560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25211879|NCT03563560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25211880|NCT03563560|Growth Inhibitors|growth inhibitors|mesh-ancestor
25211881|NCT03563560|Growth Substances|growth substances|mesh-ancestor
25211882|NCT03563560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25211883|NCT03563560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25211884|NCT03551691|Omeprazole|omeprazole|mesh-list
25211885|NCT03551691|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25211886|NCT03551691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25211887|NCT03551691|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25211888|NCT03551691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528756|NCT00622622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528758|NCT00622648|Anticoagulants|anticoagulants|mesh-ancestor
24528759|NCT00622648|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24821051|NCT02103205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24821052|NCT02103244|Carboplatin|carboplatin|mesh-list
24821053|NCT02103244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24821054|NCT02103335|Dexamethasone|dexamethasone|mesh-list
24821055|NCT02103335|Pomalidomide|pomalidomide|mesh-list
24821056|NCT02103335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24821057|NCT02103335|Antiemetics|antiemetics|mesh-ancestor
24821058|NCT02103335|Autonomic Agents|autonomic agents|mesh-ancestor
24821059|NCT02103335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24410204|NCT00184886|Abortifacient Agents|abortifacient agents|mesh-ancestor
24705920|NCT01487564|Hydromorphone|hydromorphone|mesh-list
25677758|NCT01815008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677759|NCT01815008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25677760|NCT01815008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24410213|NCT00184886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24410214|NCT00184886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24410215|NCT00184886|Immunologic Factors|immunologic factors|mesh-ancestor
24410216|NCT00184886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25677761|NCT01815008|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25677762|NCT01815008|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25677763|NCT01815008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677764|NCT01815008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25677765|NCT01815008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24410222|NCT00184899|Anticoagulants|anticoagulants|mesh-ancestor
24410223|NCT00184899|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24410224|NCT00184899|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24410225|NCT00184899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410335|NCT00185107|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24410336|NCT00185107|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24410338|NCT00185107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410339|NCT00185107|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24410340|NCT00185107|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24410341|NCT00185107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24410342|NCT00185120|Amlodipine|amlodipine|mesh-list
24410343|NCT00185120|Olmesartan|olmesartan|mesh-list
24410344|NCT00185120|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24410345|NCT00185120|Benazepril|benazepril|mesh-list
24410346|NCT00185120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24410347|NCT00185120|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24410348|NCT00185120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24410349|NCT00185120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821108|NCT02103569|Hormones|hormones|mesh-ancestor
24821109|NCT02103569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24821110|NCT02103569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821111|NCT02103569|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24821112|NCT02103569|Contraceptive Agents|contraceptive agents|mesh-ancestor
24821113|NCT02103569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24821114|NCT02103569|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24542283|NCT00678145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24821120|NCT02103569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821121|NCT02103647|Pregabalin|pregabalin|mesh-list
24821122|NCT02103647|Analgesics|analgesics|mesh-ancestor
24821123|NCT02103647|Sensory System Agents|sensory system agents|mesh-ancestor
24821124|NCT02103647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24821125|NCT02103647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821126|NCT02103647|Anticonvulsants|anticonvulsants|mesh-ancestor
24821127|NCT02103647|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24821131|NCT02103647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24706060|NCT01488305|Micronutrients|micronutrients|mesh-list
24410475|NCT00185445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410476|NCT00185510|Methylprednisolone|methylprednisolone|mesh-list
24410477|NCT00185510|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24410478|NCT00185510|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25211898|NCT03535116|Ketorolac|ketorolac|mesh-list
25211899|NCT03535116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24457866|NCT00335439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528798|NCT00622830|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
24528799|NCT00622830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528800|NCT00622830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410559|NCT00185952|Vasodilator Agents|vasodilator agents|mesh-ancestor
24528804|NCT00622843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528806|NCT00622934|Hematinics|hematinics|mesh-ancestor
24528807|NCT00623064|Gemcitabine|gemcitabine|mesh-list
24528808|NCT00623064|Lapatinib|lapatinib|mesh-list
24528809|NCT00623064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528893|NCT00623285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528894|NCT00623285|Anticonvulsants|anticonvulsants|mesh-ancestor
24528895|NCT00623285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24528896|NCT00623285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24528897|NCT00623285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528898|NCT00623285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24528899|NCT00623285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24528900|NCT00623285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24528901|NCT00623285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24528914|NCT00623376|Hallucinogens|hallucinogens|mesh-ancestor
24528915|NCT00623376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24528916|NCT00623376|Analgesics|analgesics|mesh-ancestor
24528917|NCT00623376|Sensory System Agents|sensory system agents|mesh-ancestor
24410479|NCT00185510|Prednisolone|prednisolone|mesh-list
24410480|NCT00185510|Prednisolone acetate|prednisolone acetate|mesh-list
24410481|NCT00185510|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
24410482|NCT00185510|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24410483|NCT00185510|Prednisolone phosphate|prednisolone phosphate|mesh-list
24410484|NCT00185510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24410485|NCT00185510|Antiemetics|antiemetics|mesh-ancestor
24410486|NCT00185510|Autonomic Agents|autonomic agents|mesh-ancestor
24821140|NCT02103660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821141|NCT02103660|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24821142|NCT02103660|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24821143|NCT02103660|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24821144|NCT02103660|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25211900|NCT03535116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25211901|NCT03535116|Analgesics|analgesics|mesh-ancestor
25211902|NCT03535116|Sensory System Agents|sensory system agents|mesh-ancestor
25211903|NCT03535116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25211904|NCT03535116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211905|NCT03535116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25211906|NCT03535116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25211907|NCT03535116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25211908|NCT03535116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25211909|NCT03535116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211910|NCT03471143|Betadex|betadex|mesh-list
25211911|NCT03471143|Sequestering Agents|sequestering agents|mesh-ancestor
25211912|NCT03471143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272687|NCT02390544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272688|NCT02390544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25272689|NCT02390544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25272690|NCT02390544|Immunologic Factors|immunologic factors|mesh-ancestor
25272691|NCT02390544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272692|NCT02390817|Neostigmine|neostigmine|mesh-list
25272693|NCT02390817|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25272694|NCT02390817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272695|NCT02390817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272696|NCT02390817|Cholinergic Agents|cholinergic agents|mesh-ancestor
25272697|NCT02390817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25272698|NCT02390817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272699|NCT02390817|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25272700|NCT02390817|Autonomic Agents|autonomic agents|mesh-ancestor
24821145|NCT02103660|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25257778|NCT02475356|Contraceptive Agents|contraceptive agents|mesh-ancestor
25257779|NCT02475356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25257780|NCT02475356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257781|NCT02475356|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25257782|NCT02475356|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25257783|NCT02475356|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25257784|NCT02475135|Tenofovir|tenofovir|mesh-list
25257785|NCT02475135|Emtricitabine|emtricitabine|mesh-list
25257786|NCT02475135|Darunavir|darunavir|mesh-list
25257788|NCT02475135|Cobicistat|cobicistat|mesh-list
24821146|NCT02103660|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24821147|NCT02103660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24821174|NCT02103725|Dermatologic Agents|dermatologic agents|mesh-ancestor
24821175|NCT02103725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24821176|NCT02103725|Immunologic Factors|immunologic factors|mesh-ancestor
24542308|NCT00678236|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24542309|NCT00678236|Histamine Antagonists|histamine antagonists|mesh-ancestor
24542310|NCT00678236|Histamine Agents|histamine agents|mesh-ancestor
24821177|NCT02103725|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24821178|NCT02103725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821179|NCT02103725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821181|NCT02103738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24821182|NCT02103738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24821183|NCT02103738|Growth Substances|growth substances|mesh-ancestor
24410604|NCT00186589|Immunologic Factors|immunologic factors|mesh-ancestor
24410605|NCT00186589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410606|NCT00186706|Selenium|selenium|mesh-list
24410607|NCT00186706|Antioxidants|antioxidants|mesh-ancestor
24410628|NCT00186797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410629|NCT00186797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24410630|NCT00186797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24821214|NCT02103777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24410726|NCT00187005|Vincristine|vincristine|mesh-list
24410727|NCT00187005|Daunorubicin|daunorubicin|mesh-list
24410728|NCT00187005|Asparaginase|asparaginase|mesh-list
24410729|NCT00187005|Mercaptopurine|mercaptopurine|mesh-list
24410730|NCT00187005|Idarubicin|idarubicin|mesh-list
24410731|NCT00187005|Pegaspargase|pegaspargase|mesh-list
24410732|NCT00187005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24410733|NCT00187005|Immunologic Factors|immunologic factors|mesh-ancestor
24410734|NCT00187005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677766|NCT01815008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677767|NCT01815008|Antipyretics|antipyretics|mesh-ancestor
25677768|NCT01815008|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25677769|NCT01815008|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25677770|NCT01815008|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25677771|NCT01815008|Purinergic Agents|purinergic agents|mesh-ancestor
25677772|NCT01815008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25677773|NCT01815138|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25677774|NCT01815138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25677775|NCT01815138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677776|NCT01815333|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25677777|NCT01815333|Hematinics|hematinics|mesh-ancestor
25257795|NCT02475135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25257796|NCT02475135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257797|NCT02475135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257798|NCT02475135|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25257799|NCT02475135|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25257800|NCT02475135|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25211913|NCT03434366|Dexmedetomidine|dexmedetomidine|mesh-list
25211914|NCT03434366|Ketamine|ketamine|mesh-list
25211915|NCT03434366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25211916|NCT03434366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25211917|NCT03434366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25211918|NCT03434366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25211919|NCT03434366|Analgesics|analgesics|mesh-ancestor
25211920|NCT03434366|Sensory System Agents|sensory system agents|mesh-ancestor
25211921|NCT03434366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25211922|NCT03434366|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25211923|NCT03434366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25211924|NCT03434366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25211925|NCT03434366|Adrenergic Agents|adrenergic agents|mesh-ancestor
25211926|NCT03434366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25211927|NCT03434366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211928|NCT03434366|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25211929|NCT03434366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25211930|NCT03434366|Anesthetics, General|anesthetics, general|mesh-ancestor
25211931|NCT03434366|Anesthetics|anesthetics|mesh-ancestor
25211932|NCT03434366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25211933|NCT03434366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25211934|NCT03418818|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
25211935|NCT03418818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25211936|NCT03418818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821283|NCT02104284|Diuretics|diuretics|mesh-ancestor
24821284|NCT02104284|Natriuretic Agents|natriuretic agents|mesh-ancestor
24821285|NCT02104284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821296|NCT02104284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821298|NCT02104297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24821299|NCT02104297|Narcotics|narcotics|mesh-ancestor
24821300|NCT02104297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24821301|NCT02104297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821302|NCT02104297|Analgesics|analgesics|mesh-ancestor
24821303|NCT02104297|Sensory System Agents|sensory system agents|mesh-ancestor
24821304|NCT02104297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24821310|NCT02104323|Endostatins|endostatins|mesh-list
24821311|NCT02104323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24821312|NCT02104323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24821313|NCT02104323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24542463|NCT00678769|Immunologic Factors|immunologic factors|mesh-ancestor
24542464|NCT00678769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542465|NCT00678782|Etanercept|etanercept|mesh-list
24542466|NCT00678782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24542467|NCT00678782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24542468|NCT00678782|Analgesics|analgesics|mesh-ancestor
24542469|NCT00678782|Sensory System Agents|sensory system agents|mesh-ancestor
25677778|NCT01815333|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25677779|NCT01815333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25677780|NCT01815424|Tofacitinib|tofacitinib|mesh-list
25677781|NCT01815424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25677782|NCT01815424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677783|NCT01815424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677784|NCT01815736|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25677785|NCT01815736|Antiviral Agents|antiviral agents|mesh-ancestor
25677786|NCT01815736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25677787|NCT01815736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24821346|NCT02104661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821347|NCT02104661|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24821348|NCT02104661|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24821355|NCT02104674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821381|NCT02104778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24821382|NCT02104778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24821383|NCT02104778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24821384|NCT02104778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24821385|NCT02104778|Adrenergic Agents|adrenergic agents|mesh-ancestor
24821386|NCT02104778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24821387|NCT02104778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25211995|NCT03014648|Atezolizumab|atezolizumab|mesh-list
25211996|NCT03014648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25211997|NCT02756611|Venetoclax|venetoclax|mesh-list
25211998|NCT02756611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25155880|NCT05243524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25155881|NCT05243524|Alkylating Agents|alkylating agents|mesh-ancestor
24821388|NCT02104778|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24411055|NCT00187525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411056|NCT00187525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24411057|NCT00187525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24821433|NCT02105155|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24821434|NCT02105155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656651|NCT01263171|Antidotes|antidotes|mesh-ancestor
24411171|NCT00188071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411172|NCT00188071|Antipyretics|antipyretics|mesh-ancestor
24411173|NCT00188071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24411174|NCT00188071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24411175|NCT00188071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24411176|NCT00188071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24411177|NCT00188071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411178|NCT00188071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411179|NCT00188136|Fludarabine|fludarabine|mesh-list
24411180|NCT00188136|Melphalan|melphalan|mesh-list
24411181|NCT00188136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411183|NCT00188136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24411306|NCT00188643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24411307|NCT00188643|Antidepressive Agents|antidepressive agents|mesh-ancestor
24411308|NCT00188643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24411309|NCT00188643|Anticonvulsants|anticonvulsants|mesh-ancestor
24411310|NCT00188643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24411311|NCT00188643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24411312|NCT00188643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24411313|NCT00188643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24821485|NCT02105792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24411390|NCT00188942|Olanzapine|olanzapine|mesh-list
24542622|NCT00679614|Tramadol|tramadol|mesh-list
24656691|NCT01263548|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24656692|NCT01263548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24656693|NCT01263548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24656694|NCT01263548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656695|NCT01263548|Dopamine Agents|dopamine agents|mesh-ancestor
24542623|NCT00679614|Naloxone|naloxone|mesh-list
24542624|NCT00679614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24706261|NCT01489488|Riociguat|riociguat|mesh-list
24542650|NCT00679653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542651|NCT00679653|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24542652|NCT00679653|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24542653|NCT00679653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25257848|NCT02474654|Anesthetics, Local|anesthetics, local|mesh-ancestor
25257850|NCT02474654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25257851|NCT02474654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257852|NCT02474654|Sensory System Agents|sensory system agents|mesh-ancestor
25257853|NCT02474654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24542654|NCT00679653|Adrenergic Agents|adrenergic agents|mesh-ancestor
24542655|NCT00679653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24542656|NCT00679653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542657|NCT00679653|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24542658|NCT00679653|Protease Inhibitors|protease inhibitors|mesh-ancestor
24411417|NCT00188955|Antifungal Agents|antifungal agents|mesh-ancestor
24542659|NCT00679653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411418|NCT00188955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24411419|NCT00188955|Immunologic Factors|immunologic factors|mesh-ancestor
24411425|NCT00189007|Mannitol|mannitol|mesh-list
24542680|NCT00679705|Hormone Antagonists|hormone antagonists|mesh-ancestor
24542681|NCT00679705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24542682|NCT00679705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542683|NCT00679705|Tocolytic Agents|tocolytic agents|mesh-ancestor
24542684|NCT00679705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25211999|NCT02740335|Protein C|protein c|mesh-list
25212000|NCT02740335|Protein S|protein s|mesh-list
25212001|NCT02740335|Thrombin|thrombin|mesh-list
25212002|NCT02740335|Hemostatics|hemostatics|mesh-ancestor
25212003|NCT02740335|Coagulants|coagulants|mesh-ancestor
25114839|NCT03120221|Iodine|iodine|mesh-list
25155882|NCT05243524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25155883|NCT05243524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25155884|NCT05243524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24799135|NCT01967459|Vitamin D|vitamin d|mesh-list
24656782|NCT01264133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24656783|NCT01264133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24656784|NCT01264133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411461|NCT00189072|Sensory System Agents|sensory system agents|mesh-ancestor
24411462|NCT00189072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24411463|NCT00189072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411464|NCT00189072|Anticonvulsants|anticonvulsants|mesh-ancestor
24821530|NCT02106286|Autonomic Agents|autonomic agents|mesh-ancestor
24821556|NCT02106481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821588|NCT02106650|Vitamins|vitamins|mesh-ancestor
24821589|NCT02106650|Micronutrients|micronutrients|mesh-ancestor
24821590|NCT02106650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821591|NCT02106650|Antidotes|antidotes|mesh-ancestor
24542759|NCT00680277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542760|NCT00680277|Protective Agents|protective agents|mesh-ancestor
24542761|NCT00680277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411649|NCT00189644|Immunologic Factors|immunologic factors|mesh-ancestor
24411671|NCT00189657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25212004|NCT02740335|Anticoagulants|anticoagulants|mesh-ancestor
25212005|NCT02740335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25212006|NCT02740335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25212007|NCT02740335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212013|NCT02724878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25212014|NCT02724878|Growth Substances|growth substances|mesh-ancestor
25212015|NCT02724878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212016|NCT02724878|Growth Inhibitors|growth inhibitors|mesh-ancestor
24821668|NCT02107170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24821669|NCT02107170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821670|NCT02107170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24821671|NCT02107170|Anesthetics, General|anesthetics, general|mesh-ancestor
24821672|NCT02107170|Anesthetics|anesthetics|mesh-ancestor
24821673|NCT02107170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24577669|NCT00845546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677788|NCT01815736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25677789|NCT01815918|Hydrocortisone|hydrocortisone|mesh-list
25677790|NCT01815918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25677791|NCT01816048|Listerine|listerine|mesh-list
25677792|NCT01816048|Fluorides|fluorides|mesh-list
25677793|NCT01816048|Sodium Fluoride|sodium fluoride|mesh-list
25677794|NCT01816048|Cariostatic Agents|cariostatic agents|mesh-ancestor
25677795|NCT01816048|Protective Agents|protective agents|mesh-ancestor
25257870|NCT02474654|Mydriatics|mydriatics|mesh-ancestor
24577670|NCT00845546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24577671|NCT00845546|Autonomic Agents|autonomic agents|mesh-ancestor
24821674|NCT02107170|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24821675|NCT02107170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24821676|NCT02107170|Narcotics|narcotics|mesh-ancestor
24821677|NCT02107170|Analgesics|analgesics|mesh-ancestor
24821678|NCT02107170|Sensory System Agents|sensory system agents|mesh-ancestor
24821679|NCT02107170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24821680|NCT02107235|ON 01910|on 01910|mesh-list
24821681|NCT02107235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24821682|NCT02107235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24411751|NCT00189878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411752|NCT00189878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24411818|NCT00190099|Antiemetics|antiemetics|mesh-ancestor
24411819|NCT00190099|Autonomic Agents|autonomic agents|mesh-ancestor
24411840|NCT00190229|Immunologic Factors|immunologic factors|mesh-ancestor
24411856|NCT00190294|Mifepristone|mifepristone|mesh-list
24411857|NCT00190294|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24411858|NCT00190294|Abortifacient Agents|abortifacient agents|mesh-ancestor
24411859|NCT00190294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24411860|NCT00190294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706343|NCT01489709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656901|NCT01264575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24656902|NCT01264575|Respiratory System Agents|respiratory system agents|mesh-ancestor
24656903|NCT01264575|Mydriatics|mydriatics|mesh-ancestor
24656904|NCT01264575|Sympathomimetics|sympathomimetics|mesh-ancestor
24656905|NCT01264575|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24411928|NCT00190463|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24411930|NCT00190463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24656941|NCT01264653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24656942|NCT01264653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24656943|NCT01264653|Respiratory System Agents|respiratory system agents|mesh-ancestor
24656988|NCT01265017|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24656989|NCT01265017|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24656990|NCT01265017|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24410075|NCT00184171|Hormones|hormones|mesh-ancestor
24411931|NCT00190463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24411932|NCT00190463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24411933|NCT00190463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24411934|NCT00190463|Antifungal Agents|antifungal agents|mesh-ancestor
24411936|NCT00190476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411937|NCT00190476|Tubulin Modulators|tubulin modulators|mesh-ancestor
24411938|NCT00190476|Antimitotic Agents|antimitotic agents|mesh-ancestor
24411970|NCT00190567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24411974|NCT00190567|Analgesics|analgesics|mesh-ancestor
24542861|NCT00680602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25155973|NCT05208307|Hormones|hormones|mesh-ancestor
24411979|NCT00190567|Dopamine Agents|dopamine agents|mesh-ancestor
24542872|NCT00680641|Simvastatin|simvastatin|mesh-list
24542873|NCT00680641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24542874|NCT00680641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24542875|NCT00680641|Antimetabolites|antimetabolites|mesh-ancestor
24412126|NCT00190866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412127|NCT00190866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412128|NCT00190866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412129|NCT00190866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412153|NCT00190892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24412154|NCT00190892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24412155|NCT00190892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24412208|NCT00190957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706390|NCT01489943|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25677796|NCT01816048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677797|NCT01816048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25677798|NCT01816048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25677799|NCT01816074|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25677800|NCT01816074|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25677801|NCT01816074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677802|NCT01816074|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24821901|NCT02108639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821903|NCT02108743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24821904|NCT02108743|Autonomic Agents|autonomic agents|mesh-ancestor
24821905|NCT02108743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24821906|NCT02108743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212043|NCT02692313|Epinephrine|epinephrine|mesh-list
24799153|NCT01967472|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24799154|NCT01967472|Anthelmintics|anthelmintics|mesh-ancestor
24799155|NCT01967498|Montelukast|montelukast|mesh-list
24799156|NCT01967498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24847158|NCT02245334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25212044|NCT02692313|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25212045|NCT02692313|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25212046|NCT02692313|Adrenergic Agents|adrenergic agents|mesh-ancestor
25212047|NCT02692313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25212048|NCT02692313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25155932|NCT05209412|Aspirin|aspirin|mesh-list
25155933|NCT05209412|Paclitaxel|paclitaxel|mesh-list
25155934|NCT05209412|Clopidogrel|clopidogrel|mesh-list
25155935|NCT05209412|Ticagrelor|ticagrelor|mesh-list
25155936|NCT05209412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25155937|NCT05209412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25155938|NCT05209412|Tubulin Modulators|tubulin modulators|mesh-ancestor
25155939|NCT05209412|Antimitotic Agents|antimitotic agents|mesh-ancestor
25155940|NCT05209412|Mitosis Modulators|mitosis modulators|mesh-ancestor
25155941|NCT05209412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25155942|NCT05209412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25155943|NCT05209412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25155944|NCT05209412|Analgesics|analgesics|mesh-ancestor
25155945|NCT05209412|Sensory System Agents|sensory system agents|mesh-ancestor
25155946|NCT05209412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25155947|NCT05209412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155948|NCT05209412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25155949|NCT05209412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25155950|NCT05209412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25155951|NCT05209412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24946522|NCT03938363|Cholinergic Agents|cholinergic agents|mesh-ancestor
24821907|NCT02108743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24821908|NCT02108743|Respiratory System Agents|respiratory system agents|mesh-ancestor
24821909|NCT02108743|Tocolytic Agents|tocolytic agents|mesh-ancestor
24821910|NCT02108743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24821911|NCT02108743|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24821912|NCT02108743|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24821913|NCT02108743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24685010|NCT03089866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24685013|NCT03089866|Anesthetics|anesthetics|mesh-ancestor
24412425|NCT00191399|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24412426|NCT00191399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24412427|NCT00191399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212049|NCT02692313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412428|NCT00191412|Pemetrexed|pemetrexed|mesh-list
24412429|NCT00191412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412430|NCT00191412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212050|NCT02692313|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25212051|NCT02692313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25212052|NCT02692313|Autonomic Agents|autonomic agents|mesh-ancestor
25212053|NCT02692313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25212054|NCT02692313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25212055|NCT02692313|Respiratory System Agents|respiratory system agents|mesh-ancestor
25212056|NCT02692313|Mydriatics|mydriatics|mesh-ancestor
25212057|NCT02692313|Sympathomimetics|sympathomimetics|mesh-ancestor
25212058|NCT02692313|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25212060|NCT02666105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212061|NCT02666105|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25212062|NCT02666105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25212063|NCT02666105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212064|NCT02666105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212065|NCT02666105|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25212066|NCT02666105|Hormone Antagonists|hormone antagonists|mesh-ancestor
25212067|NCT02666105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25212068|NCT02666105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212069|NCT02641873|Leucovorin|leucovorin|mesh-list
25212070|NCT02641873|Bevacizumab|bevacizumab|mesh-list
25212071|NCT02641873|Irinotecan|irinotecan|mesh-list
25212072|NCT02641873|Levoleucovorin|levoleucovorin|mesh-list
25212074|NCT02641873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212075|NCT02641873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25212076|NCT02641873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25212077|NCT02641873|Growth Substances|growth substances|mesh-ancestor
25212078|NCT02641873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155952|NCT05209412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25155953|NCT05209412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25155954|NCT05209412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25155955|NCT05209412|Antipyretics|antipyretics|mesh-ancestor
25155956|NCT05209412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25155957|NCT05209412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25155958|NCT05209412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25155959|NCT05209412|Purinergic Agents|purinergic agents|mesh-ancestor
25155960|NCT05209412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25155961|NCT05208307|Dexamethasone|dexamethasone|mesh-list
25155962|NCT05208307|Dexamethasone acetate|dexamethasone acetate|mesh-list
25155963|NCT05208307|Pomalidomide|pomalidomide|mesh-list
25155965|NCT05208307|BB 1101|bb 1101|mesh-list
25155966|NCT05208307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25155967|NCT05208307|Antiemetics|antiemetics|mesh-ancestor
25155968|NCT05208307|Autonomic Agents|autonomic agents|mesh-ancestor
25155969|NCT05208307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25155970|NCT05208307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155971|NCT05208307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25155972|NCT05208307|Glucocorticoids|glucocorticoids|mesh-ancestor
25212086|NCT02641873|Vitamin B Complex|vitamin b complex|mesh-ancestor
25212087|NCT02641873|Vitamins|vitamins|mesh-ancestor
24799165|NCT01967524|Ropivacaine|ropivacaine|mesh-list
25212088|NCT02641873|Micronutrients|micronutrients|mesh-ancestor
25212107|NCT02605993|Ravulizumab|ravulizumab|mesh-list
25212108|NCT02605993|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25212109|NCT02605993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25212110|NCT02605993|Immunologic Factors|immunologic factors|mesh-ancestor
25212111|NCT02605993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155994|NCT05189223|Analgesics|analgesics|mesh-ancestor
25155995|NCT05189223|Sensory System Agents|sensory system agents|mesh-ancestor
25155996|NCT05189223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25155997|NCT05189223|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25156002|NCT05186675|Epinephrine|epinephrine|mesh-list
25156003|NCT05186675|Racepinephrine|racepinephrine|mesh-list
25156004|NCT05186675|Epinephryl borate|epinephryl borate|mesh-list
25156005|NCT05186675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25156006|NCT05186675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25156007|NCT05186675|Adrenergic Agents|adrenergic agents|mesh-ancestor
25156008|NCT05186675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25156009|NCT05186675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25156010|NCT05186675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412431|NCT00191412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821926|NCT02108795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24821947|NCT02108847|Sensory System Agents|sensory system agents|mesh-ancestor
24821948|NCT02108847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24821949|NCT02108886|Montelukast|montelukast|mesh-list
24821950|NCT02108886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24821951|NCT02108886|Respiratory System Agents|respiratory system agents|mesh-ancestor
24821952|NCT02108886|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24821953|NCT02108886|Hormone Antagonists|hormone antagonists|mesh-ancestor
24821954|NCT02108886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24821955|NCT02108886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821956|NCT02108886|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24821957|NCT02108886|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24412583|NCT00191620|Antimetabolites|antimetabolites|mesh-ancestor
24412584|NCT00191620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412610|NCT00191672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24821971|NCT02109289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24821972|NCT02109289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24821973|NCT02109289|Analgesics|analgesics|mesh-ancestor
24821974|NCT02109289|Sensory System Agents|sensory system agents|mesh-ancestor
24821975|NCT02109289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24412621|NCT00191672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24412622|NCT00191672|Immunologic Factors|immunologic factors|mesh-ancestor
24412623|NCT00191672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412624|NCT00191685|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24412625|NCT00191685|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24412626|NCT00191685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412627|NCT00191685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25212129|NCT02487095|Topotecan|topotecan|mesh-list
25212130|NCT02487095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25212131|NCT02487095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25212132|NCT02487095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212133|NCT02487095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657241|NCT01266434|Simvastatin|simvastatin|mesh-list
24657242|NCT01266434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24657243|NCT01266434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24657244|NCT01266434|Antimetabolites|antimetabolites|mesh-ancestor
24657245|NCT01266434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657246|NCT01266434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24657247|NCT01266434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24657249|NCT01266486|Metformin|metformin|mesh-list
25212134|NCT02487095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212135|NCT02471911|Dexamethasone|dexamethasone|mesh-list
25156011|NCT05186675|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25156012|NCT05186675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25156013|NCT05186675|Autonomic Agents|autonomic agents|mesh-ancestor
25156014|NCT05186675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25156015|NCT05186675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25156016|NCT05186675|Respiratory System Agents|respiratory system agents|mesh-ancestor
25156017|NCT05186675|Mydriatics|mydriatics|mesh-ancestor
25156018|NCT05186675|Sympathomimetics|sympathomimetics|mesh-ancestor
25156019|NCT05186675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24412728|NCT00191919|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24412729|NCT00191919|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24706565|NCT01490658|Metformin|metformin|mesh-list
24412774|NCT00191997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24412775|NCT00191997|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24412776|NCT00191997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412777|NCT00191997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412778|NCT00191997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412779|NCT00191997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412780|NCT00191997|Serotonin Agents|serotonin agents|mesh-ancestor
24412781|NCT00192049|Gemcitabine|gemcitabine|mesh-list
24412782|NCT00192049|Mitomycins|mitomycins|mesh-list
24412783|NCT00192049|Mitomycin|mitomycin|mesh-list
24412784|NCT00192049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25212136|NCT02471911|Rituximab|rituximab|mesh-list
25212137|NCT02471911|Carboplatin|carboplatin|mesh-list
25212138|NCT02471911|Etoposide|etoposide|mesh-list
25212139|NCT02471911|Ifosfamide|ifosfamide|mesh-list
25212140|NCT02471911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25212141|NCT02471911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212142|NCT02471911|Immunologic Factors|immunologic factors|mesh-ancestor
25212143|NCT02471911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212144|NCT02471911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25212145|NCT02471911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25212146|NCT02471911|Antiemetics|antiemetics|mesh-ancestor
25212147|NCT02471911|Autonomic Agents|autonomic agents|mesh-ancestor
25212148|NCT02471911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25212149|NCT02471911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25212150|NCT02471911|Glucocorticoids|glucocorticoids|mesh-ancestor
25212151|NCT02471911|Hormones|hormones|mesh-ancestor
24394680|NCT00133887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212152|NCT02471911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25212153|NCT02471911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25212154|NCT02471911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25212155|NCT02471911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25212156|NCT02471911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25212157|NCT02471911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212158|NCT02471911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115027|NCT03118830|Contraceptive Agents|contraceptive agents|mesh-ancestor
25115028|NCT03118830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25115029|NCT03118830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25212175|NCT02407119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25212176|NCT02407119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25212177|NCT02407119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212178|NCT02407119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212179|NCT02407119|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24799198|NCT01967758|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25212180|NCT02407119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25212181|NCT02407119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25212183|NCT02364713|Paclitaxel|paclitaxel|mesh-list
25212184|NCT02364713|Bevacizumab|bevacizumab|mesh-list
25212185|NCT02364713|Doxorubicin|doxorubicin|mesh-list
25212186|NCT02364713|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25212187|NCT02364713|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25212188|NCT02364713|Topotecan|topotecan|mesh-list
25212189|NCT02364713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25212190|NCT02364713|Endothelial Growth Factors|endothelial growth factors|mesh-list
25212191|NCT02364713|Antibodies|antibodies|mesh-list
25212192|NCT02364713|Immunoglobulins|immunoglobulins|mesh-list
25212193|NCT02364713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25212194|NCT02364713|Immunoglobulin G|immunoglobulin g|mesh-list
25212195|NCT02364713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25212196|NCT02364713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212197|NCT02364713|Tubulin Modulators|tubulin modulators|mesh-ancestor
25212198|NCT02364713|Antimitotic Agents|antimitotic agents|mesh-ancestor
25212199|NCT02364713|Mitosis Modulators|mitosis modulators|mesh-ancestor
25212200|NCT02364713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212201|NCT02364713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25212202|NCT02364713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25212203|NCT02364713|Growth Substances|growth substances|mesh-ancestor
25212204|NCT02364713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799199|NCT01967823|Aldesleukin|aldesleukin|mesh-list
24657408|NCT01267214|Hyaluronic Acid|hyaluronic acid|mesh-list
24657409|NCT01267214|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24657410|NCT01267214|Immunologic Factors|immunologic factors|mesh-ancestor
24657411|NCT01267214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25156067|NCT05168163|Lenvatinib|lenvatinib|mesh-list
25156068|NCT05168163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25156069|NCT05168163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25156070|NCT05168163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25156071|NCT05168163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25156072|NCT05168163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25156073|NCT05168163|Immunologic Factors|immunologic factors|mesh-ancestor
25156074|NCT05168163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25156075|NCT05163483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25156076|NCT05163483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412785|NCT00192049|Antimetabolites|antimetabolites|mesh-ancestor
24412786|NCT00192049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412804|NCT00192062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24412805|NCT00192062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412807|NCT00192062|Immunologic Factors|immunologic factors|mesh-ancestor
24412808|NCT00192062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412809|NCT00192062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25212205|NCT02364713|Growth Inhibitors|growth inhibitors|mesh-ancestor
25212206|NCT02364713|Immunologic Factors|immunologic factors|mesh-ancestor
25212207|NCT02364713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25212208|NCT02364713|Antimetabolites|antimetabolites|mesh-ancestor
25212209|NCT02364713|Antiviral Agents|antiviral agents|mesh-ancestor
25212210|NCT02364713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25212211|NCT02364713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212212|NCT02364713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25212213|NCT02364713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25212214|NCT02364713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25212215|NCT02364713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25212216|NCT02364713|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25212217|NCT02358395|Sorafenib|sorafenib|mesh-list
25212218|NCT02358395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212219|NCT02358395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25212220|NCT02358395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212221|NCT02358395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212222|NCT02354898|Sorafenib|sorafenib|mesh-list
25212223|NCT02354898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212224|NCT02354898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25212225|NCT02354898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212226|NCT02354898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212227|NCT02347917|Pemetrexed|pemetrexed|mesh-list
25212228|NCT02347917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212229|NCT02347917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212230|NCT02347917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212231|NCT02347917|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25212232|NCT02347917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25156079|NCT05163106|Goserelin|goserelin|mesh-list
25156080|NCT05163106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25156081|NCT05163106|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25156082|NCT05163106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25156083|NCT05163106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412857|NCT00192595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24412833|NCT00192413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412845|NCT00192569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412847|NCT00192595|Lamivudine|lamivudine|mesh-list
24412848|NCT00192595|Zidovudine|zidovudine|mesh-list
24412849|NCT00192595|Efavirenz|efavirenz|mesh-list
24412850|NCT00192595|Antiviral Agents|antiviral agents|mesh-ancestor
24412851|NCT00192595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24412852|NCT00192595|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24412853|NCT00192595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24412854|NCT00192595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212236|NCT02303795|Warfarin|warfarin|mesh-list
25212237|NCT02303795|Rivaroxaban|rivaroxaban|mesh-list
25212238|NCT02303795|Anticoagulants|anticoagulants|mesh-ancestor
25212239|NCT02303795|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25212240|NCT02303795|Antithrombins|antithrombins|mesh-ancestor
25212241|NCT02303795|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25212242|NCT02303795|Protease Inhibitors|protease inhibitors|mesh-ancestor
25212243|NCT02303795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212244|NCT02303795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212245|NCT02178566|Treprostinil|treprostinil|mesh-list
25212246|NCT02178566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25212247|NCT02167763|Copper|copper|mesh-list
25212248|NCT02167763|Contraceptive Agents|contraceptive agents|mesh-list
25212249|NCT02167763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25212250|NCT02167763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212251|NCT02167763|Trace Elements|trace elements|mesh-ancestor
25212252|NCT02167763|Micronutrients|micronutrients|mesh-ancestor
25212253|NCT01986114|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25212254|NCT01986114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25212255|NCT01986114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25212256|NCT01986114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25212257|NCT01986114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212258|NCT01986114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25212259|NCT01986114|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25212260|NCT01986114|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25212261|NCT01986114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25212262|NCT01986114|Adrenergic Agents|adrenergic agents|mesh-ancestor
25212264|NCT01986114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212265|NCT01986114|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25212266|NCT01986114|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25212267|NCT01986114|Serotonin Agents|serotonin agents|mesh-ancestor
24412855|NCT00192595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822020|NCT02109510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24611579|NCT01010022|Blood Substitutes|blood substitutes|mesh-ancestor
24412856|NCT00192595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24822030|NCT02109510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24822031|NCT02109510|Anesthetics, General|anesthetics, general|mesh-ancestor
24822032|NCT02109510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24822034|NCT02109510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24822035|NCT02109510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24413056|NCT00193076|Carboplatin|carboplatin|mesh-list
24413057|NCT00193076|Trastuzumab|trastuzumab|mesh-list
24413058|NCT00193076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413059|NCT00193076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24413060|NCT00193076|Antimetabolites|antimetabolites|mesh-ancestor
24413062|NCT00193076|Antiviral Agents|antiviral agents|mesh-ancestor
24413295|NCT00193505|Etoposide|etoposide|mesh-list
24413296|NCT00193505|Ifosfamide|ifosfamide|mesh-list
24413297|NCT00193505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24413298|NCT00193505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413299|NCT00193505|Immunologic Factors|immunologic factors|mesh-ancestor
24822044|NCT02109510|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24822046|NCT02109510|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24822048|NCT02109614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24822049|NCT02109614|Antimetabolites|antimetabolites|mesh-ancestor
24822050|NCT02109614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543117|NCT00681980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543119|NCT00681980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24413361|NCT00193622|Growth Substances|growth substances|mesh-ancestor
24413362|NCT00193622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413363|NCT00193622|Growth Inhibitors|growth inhibitors|mesh-ancestor
24413364|NCT00193622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24413365|NCT00193622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413366|NCT00193622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413399|NCT00193726|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24413401|NCT00193726|Hormones|hormones|mesh-ancestor
24413482|NCT00193973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24413483|NCT00193973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24413484|NCT00193973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24413485|NCT00193973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24413486|NCT00193973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24413487|NCT00194038|Aripiprazole|aripiprazole|mesh-list
24413488|NCT00194038|Antidepressive Agents|antidepressive agents|mesh-ancestor
24413489|NCT00194038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24413490|NCT00194038|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24413491|NCT00194038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25212268|NCT01986114|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25212269|NCT01986114|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25212270|NCT01986114|Dopamine Agents|dopamine agents|mesh-ancestor
24799223|NCT01967875|Antimetabolites|antimetabolites|mesh-ancestor
24413578|NCT00194402|Vitamins|vitamins|mesh-ancestor
24413579|NCT00194402|Micronutrients|micronutrients|mesh-ancestor
24413580|NCT00194402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413581|NCT00194467|Valganciclovir|valganciclovir|mesh-list
24413582|NCT00194467|Antiviral Agents|antiviral agents|mesh-ancestor
24413583|NCT00194467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24413584|NCT00194480|Interferons|interferons|mesh-list
24413585|NCT00194480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413586|NCT00194480|Antiviral Agents|antiviral agents|mesh-ancestor
24413605|NCT00194623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24822122|NCT02109900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24822123|NCT02109900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822124|NCT02109913|Everolimus|everolimus|mesh-list
24413703|NCT00194974|Clonidine|clonidine|mesh-list
24413704|NCT00194974|Labetalol|labetalol|mesh-list
24413705|NCT00194974|Methyldopa|methyldopa|mesh-list
24413706|NCT00194974|Nifedipine|nifedipine|mesh-list
24413707|NCT00194974|Analgesics|analgesics|mesh-ancestor
25677803|NCT01816074|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25677804|NCT01816074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25677805|NCT01816074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413708|NCT00194974|Sensory System Agents|sensory system agents|mesh-ancestor
24413709|NCT00194974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24413710|NCT00194974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413711|NCT00194974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25677806|NCT01816074|Dopamine Agents|dopamine agents|mesh-ancestor
25677807|NCT01816074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25677808|NCT01816243|Fentanyl|fentanyl|mesh-list
25677809|NCT01816243|Morphine|morphine|mesh-list
25677810|NCT01816243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24929751|NCT04109872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929752|NCT04109742|Curcumin|curcumin|mesh-list
24413800|NCT00195299|Immunologic Factors|immunologic factors|mesh-ancestor
25212271|NCT01986101|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25212272|NCT01986101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25212273|NCT01986101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25212274|NCT01986101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25212275|NCT01986101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212276|NCT01986101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25212277|NCT01986101|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25212278|NCT01986101|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25212279|NCT01986101|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25212280|NCT01986101|Adrenergic Agents|adrenergic agents|mesh-ancestor
25212281|NCT01986101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25212282|NCT01986101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212283|NCT01986101|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24657767|NCT01269203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212284|NCT01986101|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25212285|NCT01986101|Serotonin Agents|serotonin agents|mesh-ancestor
25212286|NCT01986101|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25212287|NCT01986101|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25212288|NCT01986101|Dopamine Agents|dopamine agents|mesh-ancestor
25212289|NCT01972035|Valacyclovir|valacyclovir|mesh-list
25212290|NCT01972035|Valganciclovir|valganciclovir|mesh-list
25212291|NCT01972035|Antiviral Agents|antiviral agents|mesh-ancestor
24413808|NCT00195312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24413810|NCT00195364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24413811|NCT00195364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24413812|NCT00195364|Analgesics|analgesics|mesh-ancestor
24413813|NCT00195364|Sensory System Agents|sensory system agents|mesh-ancestor
24413814|NCT00195364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24413815|NCT00195364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413816|NCT00195364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24413817|NCT00195364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24413818|NCT00195364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24413819|NCT00195364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24413820|NCT00195364|Immunologic Factors|immunologic factors|mesh-ancestor
24413821|NCT00195377|Etanercept|etanercept|mesh-list
24413822|NCT00195377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24413823|NCT00195377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24413907|NCT00195585|Protective Agents|protective agents|mesh-ancestor
24413908|NCT00195585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543259|NCT00682760|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25212293|NCT01955980|Budesonide|budesonide|mesh-list
25212294|NCT01955980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25212295|NCT01955980|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25212296|NCT01955980|Autonomic Agents|autonomic agents|mesh-ancestor
25212297|NCT01955980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25212298|NCT01955980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212299|NCT01955980|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25212300|NCT01955980|Respiratory System Agents|respiratory system agents|mesh-ancestor
25212301|NCT01955980|Glucocorticoids|glucocorticoids|mesh-ancestor
25212302|NCT01955980|Hormones|hormones|mesh-ancestor
24822283|NCT02110745|Anesthetics, General|anesthetics, general|mesh-ancestor
25212305|NCT01953900|Fludarabine|fludarabine|mesh-list
25212306|NCT01953900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25212307|NCT01953900|Immunologic Factors|immunologic factors|mesh-ancestor
25212308|NCT01953900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212309|NCT01953900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25212310|NCT01953900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25212311|NCT01953900|Alkylating Agents|alkylating agents|mesh-ancestor
25212312|NCT01953900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212313|NCT01953900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212314|NCT01953900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24543262|NCT00682760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24543263|NCT00682760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543264|NCT00682760|Cholinergic Agents|cholinergic agents|mesh-ancestor
24413925|NCT00195598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24413926|NCT00195598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677811|NCT01816243|Narcotics|narcotics|mesh-ancestor
25677812|NCT01816243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25677813|NCT01816243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929785|NCT04109534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929786|NCT04109534|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24929787|NCT04109534|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
24929788|NCT04109534|Respiratory System Agents|respiratory system agents|mesh-ancestor
24929789|NCT04109534|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24929790|NCT04109534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24413927|NCT00195598|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24822163|NCT02110082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24822164|NCT02110082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822165|NCT02110134|Hydroquinone|hydroquinone|mesh-list
24822166|NCT02110134|Antioxidants|antioxidants|mesh-ancestor
24413931|NCT00195637|Immunoglobulins|immunoglobulins|mesh-list
24543275|NCT00682955|Zinc Sulfate|zinc sulfate|mesh-list
24543276|NCT00682955|Trace Elements|trace elements|mesh-ancestor
24543277|NCT00682955|Micronutrients|micronutrients|mesh-ancestor
24543278|NCT00682955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543279|NCT00682955|Astringents|astringents|mesh-ancestor
24413970|NCT00195741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24413971|NCT00195741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24413972|NCT00195741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24413973|NCT00195754|Valproic Acid|valproic acid|mesh-list
24413974|NCT00195754|Anticonvulsants|anticonvulsants|mesh-ancestor
24413975|NCT00195754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413976|NCT00195754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413978|NCT00195754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24414000|NCT00195780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24657819|NCT01269294|Protease Inhibitors|protease inhibitors|mesh-ancestor
24657820|NCT01269307|Ketamine|ketamine|mesh-list
24414001|NCT00195780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414002|NCT00195780|Antimanic Agents|antimanic agents|mesh-ancestor
24414003|NCT00195780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24414004|NCT00195780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24414005|NCT00195780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24414007|NCT00195793|Ezetimibe|ezetimibe|mesh-list
24414024|NCT00195806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24414025|NCT00195806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24822215|NCT02110524|Antimitotic Agents|antimitotic agents|mesh-ancestor
24543317|NCT00683137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414107|NCT00195988|Immunologic Factors|immunologic factors|mesh-ancestor
24414108|NCT00195988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414109|NCT00195988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24822216|NCT02110524|Mitosis Modulators|mitosis modulators|mesh-ancestor
24822240|NCT02110719|Ibuprofen|ibuprofen|mesh-list
24822268|NCT02110719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24543332|NCT00683176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24543333|NCT00683176|Lipotropic Agents|lipotropic agents|mesh-ancestor
24543334|NCT00683176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24543335|NCT00683176|Nootropic Agents|nootropic agents|mesh-ancestor
24543336|NCT00683189|Warfarin|warfarin|mesh-list
24543337|NCT00683189|Anticoagulants|anticoagulants|mesh-ancestor
24446624|NCT00305487|Glucocorticoids|glucocorticoids|mesh-ancestor
24822269|NCT02110719|Anticonvulsants|anticonvulsants|mesh-ancestor
24822270|NCT02110719|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24822271|NCT02110719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24822272|NCT02110719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24414110|NCT00195988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414111|NCT00195988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414113|NCT00195988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24414114|NCT00195988|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24414115|NCT00195988|Antitubercular Agents|antitubercular agents|mesh-ancestor
24414116|NCT00195988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24414143|NCT00196378|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25212316|NCT01946711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25212317|NCT01946711|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25212319|NCT01946711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24414159|NCT00196417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414161|NCT00196469|Anticoagulants|anticoagulants|mesh-ancestor
24822293|NCT02110810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25677814|NCT01816243|Analgesics|analgesics|mesh-ancestor
25677815|NCT01816243|Sensory System Agents|sensory system agents|mesh-ancestor
25677816|NCT01816243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25677817|NCT01816243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25677818|NCT01816243|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25677819|NCT01816243|Anesthetics, General|anesthetics, general|mesh-ancestor
24822294|NCT02110810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25212320|NCT01946711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929798|NCT04108468|Methotrexate|methotrexate|mesh-list
24929799|NCT04108468|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24929800|NCT04108468|Abortifacient Agents|abortifacient agents|mesh-ancestor
24929801|NCT04108468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24929802|NCT04108468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929803|NCT04108468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24929804|NCT04108468|Antimetabolites|antimetabolites|mesh-ancestor
24929806|NCT04108468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212321|NCT01946711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25212322|NCT01946711|Respiratory System Agents|respiratory system agents|mesh-ancestor
25212323|NCT01946711|Glucocorticoids|glucocorticoids|mesh-ancestor
25212324|NCT01946711|Hormones|hormones|mesh-ancestor
24657939|NCT01269541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657940|NCT01269541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657941|NCT01269541|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24657956|NCT01269671|Melatonin|melatonin|mesh-list
25212325|NCT01946711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25212326|NCT01899404|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25212327|NCT01899404|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25212328|NCT01899404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212329|NCT01864746|Palbociclib|palbociclib|mesh-list
25212330|NCT01864746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212331|NCT01864746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25212332|NCT01864746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212333|NCT01864746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272701|NCT02390817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25272702|NCT02390596|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25272703|NCT02390596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25272704|NCT02390505|Ascorbic Acid|ascorbic acid|mesh-list
25272705|NCT02390505|Vitamins|vitamins|mesh-ancestor
25272706|NCT02390505|Micronutrients|micronutrients|mesh-ancestor
25272707|NCT02390505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272708|NCT02390505|Antioxidants|antioxidants|mesh-ancestor
25272709|NCT02390505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272712|NCT02390440|Anesthetics, Local|anesthetics, local|mesh-ancestor
25272713|NCT02390440|Anesthetics|anesthetics|mesh-ancestor
25272714|NCT02390440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25272715|NCT02390440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272716|NCT02390440|Sensory System Agents|sensory system agents|mesh-ancestor
25272717|NCT02390440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25156196|NCT05098470|Insulin Glargine|insulin glargine|mesh-list
25156197|NCT05098470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25156198|NCT05098470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25156200|NCT05093205|Atorvastatin|atorvastatin|mesh-list
25156201|NCT05093205|Levonorgestrel|levonorgestrel|mesh-list
25156202|NCT05093205|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25156203|NCT05093205|Estradiol|estradiol|mesh-list
25156204|NCT05093205|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25156205|NCT05093205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25156206|NCT05093205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25156207|NCT05093205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25156208|NCT05093205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25156209|NCT05093205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25156210|NCT05093205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25156211|NCT05093205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25156212|NCT05093205|Anesthetics, General|anesthetics, general|mesh-ancestor
25156213|NCT05093205|Anesthetics|anesthetics|mesh-ancestor
25156214|NCT05093205|GABA Modulators|gaba modulators|mesh-ancestor
25156215|NCT05093205|GABA Agents|gaba agents|mesh-ancestor
25156216|NCT05093205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25156217|NCT05093205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25156222|NCT05093205|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25156223|NCT05093205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677820|NCT01816243|Anesthetics|anesthetics|mesh-ancestor
25677821|NCT01816295|Methyltestosterone|methyltestosterone|mesh-list
25677822|NCT01816295|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25677823|NCT01816295|Testosterone|testosterone|mesh-list
25677824|NCT01816295|Testosterone undecanoate|testosterone undecanoate|mesh-list
25677825|NCT01816295|Testosterone enanthate|testosterone enanthate|mesh-list
25677826|NCT01816295|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25677827|NCT01816295|Androgens|androgens|mesh-ancestor
25677828|NCT01816295|Hormones|hormones|mesh-ancestor
25156225|NCT05093205|Hormones|hormones|mesh-ancestor
25156226|NCT05093205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25156227|NCT05093205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25156228|NCT05093205|Contraceptive Agents|contraceptive agents|mesh-ancestor
25212334|NCT01858896|Glucagon|glucagon|mesh-list
25212335|NCT01858896|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25212336|NCT01858896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25212337|NCT01858896|Hormones|hormones|mesh-ancestor
25212338|NCT01858896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25212339|NCT01858896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212340|NCT01858896|Incretins|incretins|mesh-ancestor
25212341|NCT01723202|Trametinib|trametinib|mesh-list
25212342|NCT01723202|Dabrafenib|dabrafenib|mesh-list
25212343|NCT01723202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212344|NCT01723202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25212345|NCT01723202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212346|NCT01723202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212347|NCT01680965|Ofatumumab|ofatumumab|mesh-list
25212348|NCT01680965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212349|NCT01678027|Clarithromycin|clarithromycin|mesh-list
25212350|NCT01678027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25212351|NCT01678027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25212352|NCT01678027|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25212353|NCT01678027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212354|NCT01678027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212355|NCT01678027|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25212356|NCT01678027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25212357|NCT01672255|Fluoxetine|fluoxetine|mesh-list
25212358|NCT01672255|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25212359|NCT01672255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25212360|NCT01672255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25212361|NCT01672255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212362|NCT01672255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25212363|NCT01672255|Serotonin Agents|serotonin agents|mesh-ancestor
25212364|NCT01672255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212365|NCT01672255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25212366|NCT01672255|Antidepressive Agents|antidepressive agents|mesh-ancestor
25212367|NCT01672255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25156229|NCT05093205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25156230|NCT05093205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24552690|NCT00726960|Narcotics|narcotics|mesh-ancestor
24706910|NCT01492972|Hormones|hormones|mesh-ancestor
24414467|NCT00197639|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24414468|NCT00197639|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24414469|NCT00197639|Antiviral Agents|antiviral agents|mesh-ancestor
24414470|NCT00197639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24414471|NCT00197639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24414472|NCT00197639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24414473|NCT00197730|Folic Acid|folic acid|mesh-list
24414474|NCT00197730|Vitamin B Complex|vitamin b complex|mesh-list
24414475|NCT00197730|Vitamins|vitamins|mesh-ancestor
24414476|NCT00197730|Micronutrients|micronutrients|mesh-ancestor
24822386|NCT02111421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24822387|NCT02111421|Analgesics|analgesics|mesh-ancestor
24822388|NCT02111421|Sensory System Agents|sensory system agents|mesh-ancestor
24822389|NCT02111421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24822390|NCT02111421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24822391|NCT02111421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24822392|NCT02111421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24822393|NCT02111421|Adrenergic Agents|adrenergic agents|mesh-ancestor
24706931|NCT01493102|Norepinephrine|norepinephrine|mesh-list
24822452|NCT02111941|Immunologic Factors|immunologic factors|mesh-ancestor
24414734|NCT00198536|Protease Inhibitors|protease inhibitors|mesh-ancestor
24414735|NCT00198536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414736|NCT00198536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414737|NCT00198536|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24414738|NCT00198536|Protective Agents|protective agents|mesh-ancestor
24414739|NCT00198536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414740|NCT00198536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24414742|NCT00198562|Amlodipine|amlodipine|mesh-list
24414743|NCT00198562|Antihypertensive Agents|antihypertensive agents|mesh-list
24414764|NCT00198601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24414765|NCT00198601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24658048|NCT01270152|Micronutrients|micronutrients|mesh-ancestor
24658054|NCT01270165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414766|NCT00198601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414768|NCT00198614|Carvedilol|carvedilol|mesh-list
24414769|NCT00198614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24414770|NCT00198614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24414771|NCT00198614|Sympatholytics|sympatholytics|mesh-ancestor
24414772|NCT00198614|Autonomic Agents|autonomic agents|mesh-ancestor
24414773|NCT00198614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24414774|NCT00198614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414775|NCT00198614|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24706986|NCT01493336|Capecitabine|capecitabine|mesh-list
24414942|NCT00199004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24658078|NCT01270373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658079|NCT01270386|Apatinib|apatinib|mesh-list
24658080|NCT01270386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24658081|NCT01270386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24658099|NCT01270438|R04929097|r04929097|mesh-list
24658100|NCT01270438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24658110|NCT01270438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24414944|NCT00199004|Autonomic Agents|autonomic agents|mesh-ancestor
24414945|NCT00199004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24414946|NCT00199004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24414947|NCT00199004|Glucocorticoids|glucocorticoids|mesh-ancestor
24414948|NCT00199004|Hormones|hormones|mesh-ancestor
24414949|NCT00199004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24414959|NCT00199004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24414960|NCT00199004|Antiviral Agents|antiviral agents|mesh-ancestor
24414961|NCT00199004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24414997|NCT00199017|Hormones|hormones|mesh-ancestor
24415005|NCT00199017|Dermatologic Agents|dermatologic agents|mesh-ancestor
25212368|NCT01672255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24415006|NCT00199017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212369|NCT01672255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25156231|NCT05093205|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25156232|NCT05093205|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25156233|NCT05093205|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25156262|NCT05080530|Vitamin D|vitamin d|mesh-list
25156263|NCT05080530|Cholecalciferol|cholecalciferol|mesh-list
25156264|NCT05080530|Vitamins|vitamins|mesh-ancestor
25156265|NCT05080530|Micronutrients|micronutrients|mesh-ancestor
25156266|NCT05080530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25156267|NCT05080530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24415007|NCT00199017|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25212370|NCT01672255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212371|NCT01614912|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25212372|NCT01614912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25212373|NCT01614912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25212374|NCT01614912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25212375|NCT01614912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212377|NCT01614912|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25212378|NCT01614912|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25212379|NCT01614912|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25212380|NCT01614912|Adrenergic Agents|adrenergic agents|mesh-ancestor
25212381|NCT01614912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25212382|NCT01614912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658181|NCT01270776|Disinfectants|disinfectants|mesh-ancestor
24847308|NCT02246049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607507|NCT04469842|Antitubercular Agents|antitubercular agents|mesh-ancestor
24847309|NCT02246049|Growth Inhibitors|growth inhibitors|mesh-ancestor
24658182|NCT01270776|Dermatologic Agents|dermatologic agents|mesh-ancestor
24658183|NCT01270789|Liraglutide|liraglutide|mesh-list
24658184|NCT01270789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24658185|NCT01270789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212383|NCT01614912|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25212384|NCT01614912|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25212385|NCT01614912|Serotonin Agents|serotonin agents|mesh-ancestor
25212386|NCT01614912|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25212388|NCT01614912|Dopamine Agents|dopamine agents|mesh-ancestor
25212389|NCT01614899|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25212390|NCT01614899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25212391|NCT01614899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25212392|NCT01614899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25212393|NCT01614899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212394|NCT01614899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25212395|NCT01614899|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25212396|NCT01614899|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25212397|NCT01614899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25212398|NCT01614899|Adrenergic Agents|adrenergic agents|mesh-ancestor
25212399|NCT01614899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25212400|NCT01614899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212401|NCT01614899|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25212402|NCT01614899|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25212403|NCT01614899|Serotonin Agents|serotonin agents|mesh-ancestor
24415008|NCT00199017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24613748|NCT01020643|Anesthetics, General|anesthetics, general|mesh-ancestor
24415023|NCT00199030|Immunologic Factors|immunologic factors|mesh-ancestor
24415024|NCT00199030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415025|NCT00199043|Allopurinol|allopurinol|mesh-list
24415026|NCT00199043|Rasburicase|rasburicase|mesh-list
24822511|NCT02112292|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24822512|NCT02112292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24822513|NCT02112292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822514|NCT02112292|Hormones|hormones|mesh-ancestor
24822515|NCT02112292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24415074|NCT00199056|Dermatologic Agents|dermatologic agents|mesh-ancestor
24415075|NCT00199056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24658281|NCT01271153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658282|NCT01271153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415076|NCT00199056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24415077|NCT00199056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24415078|NCT00199056|Antiviral Agents|antiviral agents|mesh-ancestor
24415079|NCT00199056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24822523|NCT02112305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24822524|NCT02112305|Anticonvulsants|anticonvulsants|mesh-ancestor
24822525|NCT02112305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24822538|NCT02112422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822539|NCT02112422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24822540|NCT02112422|Glucocorticoids|glucocorticoids|mesh-ancestor
24822542|NCT02112422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24822543|NCT02112422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24822544|NCT02112422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822545|NCT02112422|Protease Inhibitors|protease inhibitors|mesh-ancestor
24822548|NCT02112487|Macitentan|macitentan|mesh-list
24822558|NCT02112552|Antimitotic Agents|antimitotic agents|mesh-ancestor
24822559|NCT02112552|Mitosis Modulators|mitosis modulators|mesh-ancestor
24822560|NCT02112552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822562|NCT02112578|Dimenhydrinate|dimenhydrinate|mesh-list
24822563|NCT02112578|Antiemetics|antiemetics|mesh-ancestor
24822564|NCT02112578|Autonomic Agents|autonomic agents|mesh-ancestor
24415515|NCT00199784|Oxymetazoline|oxymetazoline|mesh-list
24822565|NCT02112578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24822566|NCT02112578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822567|NCT02112578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24415274|NCT00199147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24415275|NCT00199147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24415276|NCT00199147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24415278|NCT00199147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24415279|NCT00199147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24822573|NCT02112578|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24822574|NCT02112604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
24658303|NCT01271166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658304|NCT01271166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24658324|NCT01271179|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24658325|NCT01271179|Purinergic Agonists|purinergic agonists|mesh-ancestor
24822575|NCT02112604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24822576|NCT02112604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822577|NCT02112630|Interferons|interferons|mesh-list
24415280|NCT00199160|Sorafenib|sorafenib|mesh-list
24415281|NCT00199160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415282|NCT00199160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24415314|NCT00199186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24415315|NCT00199186|Abortifacient Agents|abortifacient agents|mesh-ancestor
24415316|NCT00199186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24415317|NCT00199186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24415318|NCT00199186|Antimetabolites|antimetabolites|mesh-ancestor
24415400|NCT00199394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24415401|NCT00199394|Purinergic Agents|purinergic agents|mesh-ancestor
24415402|NCT00199394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24415403|NCT00199394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415404|NCT00199394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415405|NCT00199407|Istradefylline|istradefylline|mesh-list
24415406|NCT00199407|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
24415407|NCT00199407|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24415426|NCT00199433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24415427|NCT00199433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415498|NCT00199745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24415499|NCT00199758|Gemcitabine|gemcitabine|mesh-list
24415500|NCT00199758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212404|NCT01614899|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25156269|NCT05077969|Celecoxib|celecoxib|mesh-list
25156270|NCT05077969|Famotidine|famotidine|mesh-list
25156271|NCT05077969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25156272|NCT05077969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24658393|NCT01271374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24658394|NCT01271374|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24658395|NCT01271374|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24658396|NCT01271374|Diuretics|diuretics|mesh-ancestor
24658397|NCT01271374|Natriuretic Agents|natriuretic agents|mesh-ancestor
24658398|NCT01271374|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24658399|NCT01271374|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24658400|NCT01271374|Hormone Antagonists|hormone antagonists|mesh-ancestor
24658401|NCT01271374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24658402|NCT01271374|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24658403|NCT01271439|Cetuximab|cetuximab|mesh-list
24658404|NCT01271439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25156273|NCT05077969|Analgesics|analgesics|mesh-ancestor
25156274|NCT05077969|Sensory System Agents|sensory system agents|mesh-ancestor
24946826|NCT03934450|Primaquine|primaquine|mesh-list
24415501|NCT00199758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24415502|NCT00199758|Antimetabolites|antimetabolites|mesh-ancestor
24415503|NCT00199758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415504|NCT00199758|Antiviral Agents|antiviral agents|mesh-ancestor
24415505|NCT00199758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24415506|NCT00199758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24415507|NCT00199758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24415508|NCT00199758|Immunologic Factors|immunologic factors|mesh-ancestor
24415509|NCT00199758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415511|NCT00199771|Anticoagulants|anticoagulants|mesh-ancestor
24415512|NCT00199771|Plasma Substitutes|plasma substitutes|mesh-ancestor
24415513|NCT00199771|Blood Substitutes|blood substitutes|mesh-ancestor
24415514|NCT00199784|Phenylephrine|phenylephrine|mesh-list
24415591|NCT00200226|Pyridoxine|pyridoxine|mesh-list
24415592|NCT00200226|Misoprostol|misoprostol|mesh-list
24415593|NCT00200226|Vitamins|vitamins|mesh-ancestor
24415594|NCT00200226|Micronutrients|micronutrients|mesh-ancestor
24415595|NCT00200226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543774|NCT00685425|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24543775|NCT00685425|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24543776|NCT00685425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24543777|NCT00685425|Adrenergic Agents|adrenergic agents|mesh-ancestor
24543778|NCT00685425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24543780|NCT00685464|Abciximab|abciximab|mesh-list
24415596|NCT00200226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24822579|NCT02112630|Interferon-alpha|interferon-alpha|mesh-list
24822580|NCT02112630|Interferon alpha-2|interferon alpha-2|mesh-list
24822581|NCT02112630|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24822582|NCT02112630|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
24822583|NCT02112630|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24822584|NCT02112630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822585|NCT02112630|Antiviral Agents|antiviral agents|mesh-ancestor
24822586|NCT02112630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24822587|NCT02112630|Antimetabolites|antimetabolites|mesh-ancestor
24822588|NCT02112630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528602|NCT00621881|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
24528603|NCT00621881|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24528604|NCT00621881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822589|NCT02112630|Immunologic Factors|immunologic factors|mesh-ancestor
24822590|NCT02112630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707208|NCT01494636|Lidocaine|lidocaine|mesh-list
24415638|NCT00200434|Adrenergic Agents|adrenergic agents|mesh-ancestor
24415639|NCT00200434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24415640|NCT00200434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415641|NCT00200434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415642|NCT00200447|Carbidopa|carbidopa|mesh-list
24415643|NCT00200447|Levodopa|levodopa|mesh-list
24415644|NCT00200447|Entacapone|entacapone|mesh-list
24415645|NCT00200447|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
24415726|NCT00200551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24415727|NCT00200551|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24415728|NCT00200551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24415729|NCT00200551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415730|NCT00200551|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24415731|NCT00200551|Antitubercular Agents|antitubercular agents|mesh-ancestor
24415732|NCT00200551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24415734|NCT00200564|Analgesics|analgesics|mesh-ancestor
25212405|NCT01614899|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25212406|NCT01614899|Dopamine Agents|dopamine agents|mesh-ancestor
25212407|NCT01526603|Carboplatin|carboplatin|mesh-list
25212408|NCT01526603|Etoposide|etoposide|mesh-list
25212409|NCT01526603|Melphalan|melphalan|mesh-list
25212410|NCT01526603|Tretinoin|tretinoin|mesh-list
25212411|NCT01526603|Isotretinoin|isotretinoin|mesh-list
25212412|NCT01526603|Lenograstim|lenograstim|mesh-list
25156275|NCT05077969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25156276|NCT05077969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25156277|NCT05077969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25156278|NCT05077969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25156279|NCT05077969|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24658529|NCT01272310|Antimetabolites|antimetabolites|mesh-ancestor
24658530|NCT01272310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658531|NCT01272310|Immunologic Factors|immunologic factors|mesh-ancestor
25049685|NCT00578955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25156280|NCT05077969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25156281|NCT05077969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25156282|NCT05077969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25156283|NCT05077969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25156284|NCT05077969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25156285|NCT05077969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25156286|NCT05077969|Histamine Antagonists|histamine antagonists|mesh-ancestor
25156287|NCT05077969|Histamine Agents|histamine agents|mesh-ancestor
25156288|NCT05077969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24822641|NCT02112916|Calcium, Dietary|calcium, dietary|mesh-list
24822642|NCT02112916|Leucovorin|leucovorin|mesh-list
24822643|NCT02112916|Folic Acid|folic acid|mesh-list
24822644|NCT02112916|Cytarabine|cytarabine|mesh-list
24822645|NCT02112916|Dexamethasone|dexamethasone|mesh-list
24822646|NCT02112916|Dexamethasone acetate|dexamethasone acetate|mesh-list
24822647|NCT02112916|Hydrocortisone|hydrocortisone|mesh-list
24822648|NCT02112916|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24822649|NCT02112916|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24822650|NCT02112916|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24822651|NCT02112916|Cyclophosphamide|cyclophosphamide|mesh-list
24822652|NCT02112916|Ifosfamide|ifosfamide|mesh-list
24822653|NCT02112916|Isophosphamide mustard|isophosphamide mustard|mesh-list
24822654|NCT02112916|Doxorubicin|doxorubicin|mesh-list
24822655|NCT02112916|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24415839|NCT00201318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677829|NCT01816295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25677830|NCT01816295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677831|NCT01816295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24415841|NCT00201318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24447535|NCT00308841|Lidocaine|lidocaine|mesh-list
24415842|NCT00201318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24415843|NCT00201318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25677832|NCT01816295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25677833|NCT01816295|Anabolic Agents|anabolic agents|mesh-ancestor
25677834|NCT01816477|Ropivacaine|ropivacaine|mesh-list
25677835|NCT01816477|Anesthetics, Local|anesthetics, local|mesh-ancestor
24930036|NCT04105985|Autonomic Agents|autonomic agents|mesh-ancestor
24930037|NCT04105985|Nasal Decongestants|nasal decongestants|mesh-ancestor
24415844|NCT00201318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24415845|NCT00201318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707261|NCT01495026|Adrenergic Agents|adrenergic agents|mesh-ancestor
24822673|NCT02112916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822674|NCT02112916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24822675|NCT02112916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24822676|NCT02112916|Alkylating Agents|alkylating agents|mesh-ancestor
24822677|NCT02112916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212413|NCT01526603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212414|NCT01526603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25212415|NCT01526603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25212416|NCT01526603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25212417|NCT01526603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212418|NCT01526603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212419|NCT01526603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25212420|NCT01526603|Alkylating Agents|alkylating agents|mesh-ancestor
25212421|NCT01526603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25212422|NCT01526603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25212423|NCT01526603|Immunologic Factors|immunologic factors|mesh-ancestor
25212424|NCT01526603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212425|NCT01526603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25212426|NCT01526603|Keratolytic Agents|keratolytic agents|mesh-ancestor
25212427|NCT01526603|Dermatologic Agents|dermatologic agents|mesh-ancestor
25212428|NCT01475123|Nicorandil|nicorandil|mesh-list
25212429|NCT01475123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25212430|NCT01475123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25212431|NCT01475123|Vasodilator Agents|vasodilator agents|mesh-ancestor
24428769|NCT00241150|Valsartan|valsartan|mesh-list
24822678|NCT02112916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822679|NCT02112916|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24822680|NCT02112916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24822682|NCT02112916|Autonomic Agents|autonomic agents|mesh-ancestor
24822683|NCT02112916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24822684|NCT02112916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24822685|NCT02112916|Glucocorticoids|glucocorticoids|mesh-ancestor
24822686|NCT02112916|Hormones|hormones|mesh-ancestor
24822687|NCT02112916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24822688|NCT02112916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24822689|NCT02112916|Protease Inhibitors|protease inhibitors|mesh-ancestor
24822692|NCT02112916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24822693|NCT02112916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24822694|NCT02112916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24822695|NCT02112916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24415853|NCT00201318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24415854|NCT00201318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24415855|NCT00201318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24415856|NCT00201331|Leucovorin|leucovorin|mesh-list
24415857|NCT00201331|Antidotes|antidotes|mesh-ancestor
24415858|NCT00201331|Protective Agents|protective agents|mesh-ancestor
24415859|NCT00201331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415861|NCT00201331|Vitamins|vitamins|mesh-ancestor
24394681|NCT00133887|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24658748|NCT01273779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24658749|NCT01273831|Cisatracurium|cisatracurium|mesh-list
24658750|NCT01273831|Atracurium|atracurium|mesh-list
24658789|NCT01274026|Vasodilator Agents|vasodilator agents|mesh-ancestor
24658793|NCT01274039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24658795|NCT01274039|Diuretics|diuretics|mesh-ancestor
24658829|NCT01274247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24658830|NCT01274247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658831|NCT01274247|Sensory System Agents|sensory system agents|mesh-ancestor
24658832|NCT01274247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658833|NCT01274260|Methylprednisolone|methylprednisolone|mesh-list
24658834|NCT01274260|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24658835|NCT01274260|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24658836|NCT01274260|Prednisolone|prednisolone|mesh-list
24658837|NCT01274260|Prednisolone acetate|prednisolone acetate|mesh-list
24658838|NCT01274260|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24658839|NCT01274260|Prednisolone phosphate|prednisolone phosphate|mesh-list
25159897|NCT03518060|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
25677836|NCT01816477|Anesthetics|anesthetics|mesh-ancestor
25677837|NCT01816477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24588248|NCT00901732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24588249|NCT00901732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033352|NCT03574090|Amoxicillin|amoxicillin|mesh-list
25033353|NCT03574090|Clavulanic Acid|clavulanic acid|mesh-list
25033354|NCT03574090|Clavulanic Acids|clavulanic acids|mesh-list
25033355|NCT03574090|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25033356|NCT03574090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25033357|NCT03574090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25033358|NCT03574090|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24416054|NCT00201812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24416055|NCT00201812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24416056|NCT00201812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24416078|NCT00201981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24416080|NCT00201981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416081|NCT00201981|Protective Agents|protective agents|mesh-ancestor
24416082|NCT00201981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416083|NCT00201981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416084|NCT00201994|Tolvaptan|tolvaptan|mesh-list
24416085|NCT00201994|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24416086|NCT00201994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416087|NCT00201994|Natriuretic Agents|natriuretic agents|mesh-ancestor
24416088|NCT00201994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416089|NCT00202007|Risperidone|risperidone|mesh-list
24822712|NCT02112916|Tubulin Modulators|tubulin modulators|mesh-ancestor
24822713|NCT02112916|Antimitotic Agents|antimitotic agents|mesh-ancestor
24822714|NCT02112916|Mitosis Modulators|mitosis modulators|mesh-ancestor
24822715|NCT02112916|Hematinics|hematinics|mesh-ancestor
24822716|NCT02112916|Keratolytic Agents|keratolytic agents|mesh-ancestor
24822718|NCT02112929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24822719|NCT02112929|Anesthetics, General|anesthetics, general|mesh-ancestor
24822720|NCT02112929|Anesthetics|anesthetics|mesh-ancestor
24416211|NCT00202306|Antidepressive Agents|antidepressive agents|mesh-ancestor
24416237|NCT00202397|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24416238|NCT00202397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24416239|NCT00202397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416240|NCT00202397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416241|NCT00202397|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24658845|NCT01274260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24658846|NCT01274260|Glucocorticoids|glucocorticoids|mesh-ancestor
24658847|NCT01274260|Hormones|hormones|mesh-ancestor
24658848|NCT01274260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24416242|NCT00202397|Protective Agents|protective agents|mesh-ancestor
24416243|NCT00202423|Nabiximols|nabiximols|mesh-list
24416244|NCT00202423|Analgesics|analgesics|mesh-ancestor
24416245|NCT00202423|Sensory System Agents|sensory system agents|mesh-ancestor
24416246|NCT00202423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24416247|NCT00202423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212432|NCT01475123|Vitamin B Complex|vitamin b complex|mesh-ancestor
25212433|NCT01475123|Vitamins|vitamins|mesh-ancestor
25212434|NCT01475123|Micronutrients|micronutrients|mesh-ancestor
25212435|NCT01475123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212436|NCT01207011|Docetaxel|docetaxel|mesh-list
25212438|NCT01207011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212439|NCT01207011|Tubulin Modulators|tubulin modulators|mesh-ancestor
25212440|NCT01207011|Antimitotic Agents|antimitotic agents|mesh-ancestor
24822730|NCT02112981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24822731|NCT02112981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24822732|NCT02112981|Antifungal Agents|antifungal agents|mesh-ancestor
24822734|NCT02113072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24822735|NCT02113072|Glucocorticoids|glucocorticoids|mesh-ancestor
24822736|NCT02113072|Hormones|hormones|mesh-ancestor
24822737|NCT02113072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24822738|NCT02113072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416258|NCT00202514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25677838|NCT01816477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677839|NCT01816477|Sensory System Agents|sensory system agents|mesh-ancestor
25677840|NCT01816477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25677841|NCT01816594|Paclitaxel|paclitaxel|mesh-list
25677842|NCT01816594|Trastuzumab|trastuzumab|mesh-list
25677843|NCT01816594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25677844|NCT01816594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25677845|NCT01816594|Tubulin Modulators|tubulin modulators|mesh-ancestor
25677846|NCT01816594|Antimitotic Agents|antimitotic agents|mesh-ancestor
25677847|NCT01816594|Mitosis Modulators|mitosis modulators|mesh-ancestor
24930066|NCT04106050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754398|NCT01720394|Dinoprostone|dinoprostone|mesh-list
24600387|NCT00567567|Vitamins|vitamins|mesh-ancestor
25033421|NCT03573284|Nitric Oxide|nitric oxide|mesh-list
25033422|NCT03573284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25033471|NCT03573050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25033472|NCT03573050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416259|NCT00202514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394682|NCT00133887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24658940|NCT01274780|Emtricitabine|emtricitabine|mesh-list
24416377|NCT00202969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24416379|NCT00202982|(T,G)-A-L|(t,g)-a-l|mesh-list
24416411|NCT00203073|Sensory System Agents|sensory system agents|mesh-ancestor
24416412|NCT00203073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24416413|NCT00203073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416414|NCT00203073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24416423|NCT00203099|Acetylcysteine|acetylcysteine|mesh-list
24416477|NCT00203164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416478|NCT00203164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24416479|NCT00203164|Protective Agents|protective agents|mesh-ancestor
24416480|NCT00203164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416482|NCT00203177|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24416483|NCT00203177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416484|NCT00203177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416495|NCT00203281|Immunoglobulins|immunoglobulins|mesh-list
24416496|NCT00203281|Antibodies|antibodies|mesh-list
24416497|NCT00203281|gamma-Globulins|gamma-globulins|mesh-list
24416498|NCT00203281|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24416499|NCT00203281|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24416500|NCT00203281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24416501|NCT00203281|Immunologic Factors|immunologic factors|mesh-ancestor
24416502|NCT00203281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416565|NCT00203385|GABA Agents|gaba agents|mesh-ancestor
24822748|NCT02113150|Sensory System Agents|sensory system agents|mesh-ancestor
24822749|NCT02113150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24613846|NCT01021358|Navitoclax|navitoclax|mesh-list
24416578|NCT00203450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416580|NCT00203463|Anticonvulsants|anticonvulsants|mesh-ancestor
24416587|NCT00203528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24416588|NCT00203528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416589|NCT00203528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416590|NCT00203528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24822763|NCT02113176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24822764|NCT02113176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24822765|NCT02113202|Bevacizumab|bevacizumab|mesh-list
24822766|NCT02113202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25212441|NCT01207011|Mitosis Modulators|mitosis modulators|mesh-ancestor
25212442|NCT01207011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946854|NCT03934047|Coagulants|coagulants|mesh-ancestor
24822767|NCT02113202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822768|NCT02113202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24822769|NCT02113202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24822770|NCT02113202|Growth Substances|growth substances|mesh-ancestor
24822771|NCT02113202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822772|NCT02113202|Growth Inhibitors|growth inhibitors|mesh-ancestor
24822773|NCT02113267|Mometasone Furoate|mometasone furoate|mesh-list
24822774|NCT02113267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24822775|NCT02113267|Dermatologic Agents|dermatologic agents|mesh-ancestor
24822776|NCT02113267|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24822777|NCT02113319|Dasatinib|dasatinib|mesh-list
24822792|NCT02113540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24822793|NCT02113540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24822794|NCT02113540|Antimetabolites|antimetabolites|mesh-ancestor
24822795|NCT02113540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822796|NCT02113540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25159898|NCT03518060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25677848|NCT01816594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677849|NCT01816594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25677850|NCT01816893|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25677851|NCT01816893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677852|NCT01816984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25677853|NCT01816984|Cetuximab|cetuximab|mesh-list
25677854|NCT01816984|Antibodies|antibodies|mesh-list
25677855|NCT01816984|Immunoglobulins|immunoglobulins|mesh-list
24930120|NCT04105231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24930121|NCT04105231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930122|NCT04105231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930123|NCT04105231|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24822797|NCT02113540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24416641|NCT00203632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24416642|NCT00203632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416643|NCT00203658|Tinzaparin|tinzaparin|mesh-list
24416644|NCT00203658|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24416645|NCT00203658|Dalteparin|dalteparin|mesh-list
24416646|NCT00203658|Anticoagulants|anticoagulants|mesh-ancestor
24416647|NCT00203658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24416648|NCT00203658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24416649|NCT00203658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416650|NCT00203684|Flunisolide|flunisolide|mesh-list
24416651|NCT00203684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24416862|NCT00204308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416891|NCT00204438|Desogestrel|desogestrel|mesh-list
24659146|NCT01275911|Narcotics|narcotics|mesh-ancestor
24659149|NCT01275911|Analgesics|analgesics|mesh-ancestor
24416892|NCT00204438|Estradiol|estradiol|mesh-list
24416893|NCT00204438|Estrogens|estrogens|mesh-ancestor
24416894|NCT00204438|Hormones|hormones|mesh-ancestor
24416895|NCT00204438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24416896|NCT00204438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416897|NCT00204438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24416899|NCT00204438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24416900|NCT00204438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24416901|NCT00204438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24416902|NCT00204438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24416903|NCT00204438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24416904|NCT00204438|Progestins|progestins|mesh-ancestor
24416905|NCT00204451|Levonorgestrel|levonorgestrel|mesh-list
24416906|NCT00204451|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24416907|NCT00204451|Estradiol|estradiol|mesh-list
25156312|NCT05073627|Dabigatran|dabigatran|mesh-list
25156313|NCT05073627|Antithrombins|antithrombins|mesh-ancestor
25156314|NCT05073627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25156315|NCT05073627|Protease Inhibitors|protease inhibitors|mesh-ancestor
24416946|NCT00204542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24416947|NCT00204542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24416948|NCT00204542|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24416959|NCT00204568|Trofosfamide|trofosfamide|mesh-list
24416960|NCT00204568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24416961|NCT00204568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24416962|NCT00204568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24416963|NCT00204568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24416964|NCT00204568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416965|NCT00204568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416966|NCT00204568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24416967|NCT00204568|Immunologic Factors|immunologic factors|mesh-ancestor
24416968|NCT00204568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416969|NCT00204568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24416987|NCT00204620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24416988|NCT00204633|Darbepoetin alfa|darbepoetin alfa|mesh-list
24416989|NCT00204633|Hematinics|hematinics|mesh-ancestor
24416991|NCT00204646|Etoposide|etoposide|mesh-list
24544053|NCT00686621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24417015|NCT00204698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417223|NCT00205946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24417236|NCT00206050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24417238|NCT00206050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24417239|NCT00206050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677856|NCT01816984|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25677857|NCT01816984|Immunologic Factors|immunologic factors|mesh-ancestor
25677858|NCT01816984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677859|NCT01816984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25677860|NCT01817075|Chlorhexidine|chlorhexidine|mesh-list
24417309|NCT00206167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24417310|NCT00206167|Adrenergic Agents|adrenergic agents|mesh-ancestor
25677861|NCT01817075|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25677862|NCT01817075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25677863|NCT01817075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25677864|NCT01817075|Disinfectants|disinfectants|mesh-ancestor
25212453|NCT01165632|Fluorides|fluorides|mesh-list
25212454|NCT01165632|Cariostatic Agents|cariostatic agents|mesh-ancestor
25212455|NCT01165632|Protective Agents|protective agents|mesh-ancestor
25212456|NCT01165632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212457|NCT01003964|Gemcitabine|gemcitabine|mesh-list
24417312|NCT00206167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417401|NCT00206414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417402|NCT00206414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24417403|NCT00206414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417404|NCT00206414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659334|NCT01276925|Bupivacaine|bupivacaine|mesh-list
24659335|NCT01276925|Ropivacaine|ropivacaine|mesh-list
24417486|NCT00206596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417487|NCT00206622|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24417488|NCT00206622|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24417490|NCT00206622|Estradiol|estradiol|mesh-list
24822925|NCT02114099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24822926|NCT02114099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24822928|NCT02114333|Immunologic Factors|immunologic factors|mesh-ancestor
24822929|NCT02114333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417532|NCT00206739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24417533|NCT00206739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24417534|NCT00206739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24417553|NCT00206765|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24417554|NCT00206765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24417555|NCT00206765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24417556|NCT00206765|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24417557|NCT00206765|Antidepressive Agents|antidepressive agents|mesh-ancestor
24417558|NCT00206765|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24417559|NCT00206765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24783501|NCT01902238|Ethanol|ethanol|mesh-list
24659379|NCT01277185|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24659380|NCT01277185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659382|NCT01277289|Dexamethasone|dexamethasone|mesh-list
24659401|NCT01277484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24659402|NCT01277497|Calcium|calcium|mesh-list
24659403|NCT01277497|Sevelamer|sevelamer|mesh-list
24659410|NCT01277627|Efavirenz|efavirenz|mesh-list
24417560|NCT00206765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212458|NCT01003964|Cisplatin|cisplatin|mesh-list
25212459|NCT01003964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212460|NCT01003964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25212461|NCT01003964|Antimetabolites|antimetabolites|mesh-ancestor
25212462|NCT01003964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212463|NCT01003964|Antiviral Agents|antiviral agents|mesh-ancestor
25156326|NCT05071352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115293|NCT03116971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25115294|NCT03116971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417563|NCT00206778|Anticonvulsants|anticonvulsants|mesh-ancestor
24417564|NCT00206778|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24417565|NCT00206778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24417566|NCT00206778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417568|NCT00206778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417609|NCT00206947|Nootropic Agents|nootropic agents|mesh-ancestor
24417610|NCT00206947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24417611|NCT00206947|Serotonin Agents|serotonin agents|mesh-ancestor
24417612|NCT00206947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24417613|NCT00206947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24417614|NCT00206947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24417615|NCT00206947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24417699|NCT00207311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417700|NCT00207311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417701|NCT00207311|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24417702|NCT00207311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24417704|NCT00207363|Ribavirin|ribavirin|mesh-list
24417718|NCT00207402|Interferon alfacon-1|interferon alfacon-1|mesh-list
24417719|NCT00207402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417720|NCT00207402|Antiviral Agents|antiviral agents|mesh-ancestor
24417721|NCT00207402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24417722|NCT00207402|Antimetabolites|antimetabolites|mesh-ancestor
24417723|NCT00207402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417724|NCT00207402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24417725|NCT00207402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659474|NCT01277913|Vitamin D|vitamin d|mesh-list
24417750|NCT00207558|Vitamin B Complex|vitamin b complex|mesh-ancestor
24417751|NCT00207558|Vitamins|vitamins|mesh-ancestor
24417752|NCT00207558|Micronutrients|micronutrients|mesh-ancestor
24417866|NCT00208117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417867|NCT00208130|Topiramate|topiramate|mesh-list
24417868|NCT00208130|Anticonvulsants|anticonvulsants|mesh-ancestor
24417869|NCT00208130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24417871|NCT00208143|Risperidone|risperidone|mesh-list
24417879|NCT00208143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24417880|NCT00208143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24417881|NCT00208143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24417882|NCT00208143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24417883|NCT00208143|Dopamine Agents|dopamine agents|mesh-ancestor
24417884|NCT00208143|Antidepressive Agents|antidepressive agents|mesh-ancestor
24417885|NCT00208156|Mifepristone|mifepristone|mesh-list
24417886|NCT00208156|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24822965|NCT02114476|Progestins|progestins|mesh-list
24417915|NCT00208169|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24417919|NCT00208182|Risperidone|risperidone|mesh-list
25115295|NCT03116971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115296|NCT03116971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25115298|NCT03116945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115299|NCT03116945|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25115300|NCT03117023|Dexmedetomidine|dexmedetomidine|mesh-list
25115301|NCT03117023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25115302|NCT03117023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25115303|NCT03117023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115304|NCT03117023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25115305|NCT03117023|Analgesics|analgesics|mesh-ancestor
25115306|NCT03117023|Sensory System Agents|sensory system agents|mesh-ancestor
25115307|NCT03117023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25115308|NCT03117023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25115309|NCT03117023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25115310|NCT03117023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24418047|NCT00208520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24418048|NCT00208520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24418049|NCT00208520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24418050|NCT00208520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24418051|NCT00208520|Antimanic Agents|antimanic agents|mesh-ancestor
25212472|NCT00980954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212473|NCT00980954|Tubulin Modulators|tubulin modulators|mesh-ancestor
25212474|NCT00980954|Antimitotic Agents|antimitotic agents|mesh-ancestor
25212475|NCT00980954|Mitosis Modulators|mitosis modulators|mesh-ancestor
25212476|NCT00980954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212477|NCT00890266|Riboflavin|riboflavin|mesh-list
25212478|NCT00890266|Vitamin B Complex|vitamin b complex|mesh-ancestor
25212479|NCT00890266|Vitamins|vitamins|mesh-ancestor
25212480|NCT00890266|Micronutrients|micronutrients|mesh-ancestor
25212481|NCT00890266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212482|NCT00890266|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25212483|NCT00890266|Dermatologic Agents|dermatologic agents|mesh-ancestor
25212484|NCT00711269|Risperidone|risperidone|mesh-list
25212485|NCT00711269|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25212486|NCT00711269|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25212487|NCT00711269|Serotonin Agents|serotonin agents|mesh-ancestor
24659535|NCT01278290|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25212488|NCT00711269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25212489|NCT00711269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212490|NCT00711269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212491|NCT00711269|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25212492|NCT00711269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25212493|NCT00711269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25212494|NCT00711269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25212495|NCT00711269|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25212496|NCT00711269|Dopamine Agents|dopamine agents|mesh-ancestor
25212497|NCT00711269|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25212498|NCT00711269|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25212499|NCT00711269|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25212500|NCT00711269|Adrenergic Agents|adrenergic agents|mesh-ancestor
24946904|NCT03933865|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24418387|NCT00209495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24418388|NCT00209495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24823010|NCT02114528|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24823011|NCT02114528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24418447|NCT00209625|Antidotes|antidotes|mesh-ancestor
24418448|NCT00209625|Protective Agents|protective agents|mesh-ancestor
24418449|NCT00209625|Vitamin B Complex|vitamin b complex|mesh-ancestor
24418451|NCT00209625|Micronutrients|micronutrients|mesh-ancestor
24418453|NCT00209638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24418454|NCT00209638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24418455|NCT00209638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24418456|NCT00209638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418457|NCT00209638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24418459|NCT00209651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24418460|NCT00209651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24418461|NCT00209651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24418464|NCT00209664|Irinotecan|irinotecan|mesh-list
24418538|NCT00209742|Micronutrients|micronutrients|mesh-ancestor
24418539|NCT00209742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24418540|NCT00209742|Antimetabolites|antimetabolites|mesh-ancestor
24418541|NCT00209742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418542|NCT00209742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24418543|NCT00209742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25212501|NCT00711269|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25212502|NCT00711269|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25212503|NCT00411138|Paclitaxel|paclitaxel|mesh-list
25212504|NCT00411138|Carboplatin|carboplatin|mesh-list
25212505|NCT00411138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25212506|NCT00411138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212507|NCT00411138|Tubulin Modulators|tubulin modulators|mesh-ancestor
25212508|NCT00411138|Antimitotic Agents|antimitotic agents|mesh-ancestor
25212509|NCT00411138|Mitosis Modulators|mitosis modulators|mesh-ancestor
25212510|NCT00411138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949665|NCT03898895|Antibodies|antibodies|mesh-list
24418544|NCT00209742|Immunologic Factors|immunologic factors|mesh-ancestor
24418545|NCT00209742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24418546|NCT00209742|Antiviral Agents|antiviral agents|mesh-ancestor
24418547|NCT00209742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24418548|NCT00209742|Interferon Inducers|interferon inducers|mesh-ancestor
24418549|NCT00209742|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24418550|NCT00209755|Ribavirin|ribavirin|mesh-list
24418551|NCT00209755|Antimetabolites|antimetabolites|mesh-ancestor
24418552|NCT00209755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418553|NCT00209755|Antiviral Agents|antiviral agents|mesh-ancestor
24418558|NCT00209781|Antimalarials|antimalarials|mesh-ancestor
24418559|NCT00209781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24418560|NCT00209781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24418587|NCT00209807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418588|NCT00209807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24707931|NCT01498861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24418720|NCT00209924|Anticonvulsants|anticonvulsants|mesh-ancestor
24418726|NCT00209937|Analgesics|analgesics|mesh-ancestor
24418727|NCT00209937|Sensory System Agents|sensory system agents|mesh-ancestor
24418756|NCT00209989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24418757|NCT00210002|Darbepoetin alfa|darbepoetin alfa|mesh-list
24823034|NCT02114645|Progesterone|progesterone|mesh-list
24823035|NCT02114645|Estrogens|estrogens|mesh-ancestor
24418901|NCT00210496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24418902|NCT00210496|Serotonin Agents|serotonin agents|mesh-ancestor
24418903|NCT00210496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24418905|NCT00210509|Almotriptan|almotriptan|mesh-list
24418952|NCT00210665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24418953|NCT00210691|Risperidone|risperidone|mesh-list
24418954|NCT00210691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24418955|NCT00210691|Serotonin Agents|serotonin agents|mesh-ancestor
24418956|NCT00210691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24418957|NCT00210691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418959|NCT00210691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24418960|NCT00210691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24418961|NCT00210691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24418962|NCT00210691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24418963|NCT00210691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25212513|NCT00286169|Amrubicin|amrubicin|mesh-list
25212514|NCT00286169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212515|NCT00188539|Anesthetics|anesthetics|mesh-list
25212516|NCT00188539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25212517|NCT00188539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212518|NCT00152477|Paclitaxel|paclitaxel|mesh-list
24624852|NCT01079065|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25033958|NCT03569696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24600976|NCT00961480|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24600977|NCT00961480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24600978|NCT00961480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600980|NCT00961480|Hormones|hormones|mesh-ancestor
25212519|NCT00152477|Carboplatin|carboplatin|mesh-list
24418964|NCT00210691|Dopamine Agents|dopamine agents|mesh-ancestor
24418965|NCT00210717|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24799343|NCT01968564|Sensory System Agents|sensory system agents|mesh-ancestor
24544691|NCT00689845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544692|NCT00689845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24419111|NCT00211302|Antidepressive Agents|antidepressive agents|mesh-ancestor
24419112|NCT00211302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24419113|NCT00211302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24419114|NCT00211302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24419115|NCT00211302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24419116|NCT00211302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419117|NCT00211302|Dopamine Agonists|dopamine agonists|mesh-ancestor
24419118|NCT00211302|Dopamine Agents|dopamine agents|mesh-ancestor
24419119|NCT00211302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24419120|NCT00211302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419121|NCT00211302|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24419141|NCT00211328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419143|NCT00211341|Vitamins|vitamins|mesh-ancestor
24419144|NCT00211341|Micronutrients|micronutrients|mesh-ancestor
24419145|NCT00211341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419146|NCT00211354|Anecortave|anecortave|mesh-list
24823067|NCT02114697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212520|NCT00152477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25212521|NCT00152477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212522|NCT00152477|Tubulin Modulators|tubulin modulators|mesh-ancestor
25212523|NCT00152477|Antimitotic Agents|antimitotic agents|mesh-ancestor
25212524|NCT00152477|Mitosis Modulators|mitosis modulators|mesh-ancestor
25212525|NCT00152477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212526|NCT02697669|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25212527|NCT02697669|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25212528|NCT02697669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212529|NCT02697630|Pembrolizumab|pembrolizumab|mesh-list
25212530|NCT02697630|Entinostat|entinostat|mesh-list
25212531|NCT02697630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25212532|NCT02697630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212533|NCT02697630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25212534|NCT02697630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212535|NCT02697630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212536|NCT02697253|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24823068|NCT02114697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24823069|NCT02114697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24419148|NCT00211354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24799372|NCT01968759|Protease Inhibitors|protease inhibitors|mesh-ancestor
24419149|NCT00211354|Growth Substances|growth substances|mesh-ancestor
24419150|NCT00211354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823072|NCT02114710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24823073|NCT02114736|Botulinum Toxins|botulinum toxins|mesh-list
24419264|NCT00211562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24419265|NCT00211562|Serotonin Agents|serotonin agents|mesh-ancestor
24419266|NCT00211562|Antioxidants|antioxidants|mesh-ancestor
24419310|NCT00211705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24419311|NCT00211705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24419312|NCT00211705|Antimetabolites|antimetabolites|mesh-ancestor
24419313|NCT00211705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049762|NCT00566202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25049763|NCT00566202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25049764|NCT00566202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24419605|NCT00213096|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24419607|NCT00213096|Contraceptive Agents|contraceptive agents|mesh-list
24419608|NCT00213096|Contraceptives, Oral|contraceptives, oral|mesh-list
25677865|NCT01817075|Dermatologic Agents|dermatologic agents|mesh-ancestor
25677866|NCT01817530|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25677867|NCT01817530|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25677868|NCT01817530|Norethindrone|norethindrone|mesh-list
25677869|NCT01817530|Norethindrone Acetate|norethindrone acetate|mesh-list
25677870|NCT01817530|Estradiol|estradiol|mesh-list
24624872|NCT01079117|Sensory System Agents|sensory system agents|mesh-ancestor
24624873|NCT01079117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24624874|NCT01079117|Antitussive Agents|antitussive agents|mesh-ancestor
24624875|NCT01079117|Respiratory System Agents|respiratory system agents|mesh-ancestor
24624876|NCT01079286|Sirolimus|sirolimus|mesh-list
24624877|NCT01079286|Nelfinavir|nelfinavir|mesh-list
24624878|NCT01079286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24990850|NCT03873675|Hormones|hormones|mesh-list
24588322|NCT00902057|Coagulants|coagulants|mesh-ancestor
25212537|NCT02697253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25212538|NCT02697253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212539|NCT02697253|Incretins|incretins|mesh-ancestor
25212540|NCT02697253|Hormones|hormones|mesh-ancestor
25212541|NCT02697253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25212542|NCT02697253|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25212543|NCT02697253|Protease Inhibitors|protease inhibitors|mesh-ancestor
25212544|NCT02697253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212545|NCT02697253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272718|NCT02390375|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25272719|NCT02390375|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25272720|NCT02390375|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25272721|NCT02390375|Antimetabolites|antimetabolites|mesh-ancestor
25272722|NCT02390375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272723|NCT02390375|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25272724|NCT02390375|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25272725|NCT02390375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419609|NCT00213096|Estradiol|estradiol|mesh-list
24419610|NCT00213096|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24419842|NCT00214266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419843|NCT00214266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24419844|NCT00214266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24419845|NCT00214266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24419846|NCT00214266|Antitubercular Agents|antitubercular agents|mesh-ancestor
24419847|NCT00214266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24419848|NCT00214266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24419849|NCT00214266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24659914|NCT01280682|Rituximab|rituximab|mesh-list
24419850|NCT00214266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419852|NCT00214318|Carvedilol|carvedilol|mesh-list
24419860|NCT00214318|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24419861|NCT00214318|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24419862|NCT00214318|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24419863|NCT00214318|Adrenergic Agents|adrenergic agents|mesh-ancestor
24419864|NCT00214318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24419986|NCT00214825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25212548|NCT02697162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25212549|NCT02697201|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25212550|NCT02697201|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25212551|NCT02697201|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25212552|NCT02697201|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25212553|NCT02697331|Progesterone|progesterone|mesh-list
25212554|NCT02697331|Progestins|progestins|mesh-ancestor
25212555|NCT02697331|Hormones|hormones|mesh-ancestor
25212556|NCT02697331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25212557|NCT02697331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212558|NCT02697370|Factor VIII|factor viii|mesh-list
25212559|NCT02697370|Coagulants|coagulants|mesh-ancestor
25212560|NCT02697045|Aripiprazole|aripiprazole|mesh-list
25212561|NCT02697045|Antidepressive Agents|antidepressive agents|mesh-ancestor
25212562|NCT02697045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25212563|NCT02697045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25212564|NCT02697045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25272726|NCT02390258|S66913|s66913|mesh-list
24420159|NCT00215280|Tubulin Modulators|tubulin modulators|mesh-ancestor
24420160|NCT00215280|Antimitotic Agents|antimitotic agents|mesh-ancestor
24420161|NCT00215280|Mitosis Modulators|mitosis modulators|mesh-ancestor
24420281|NCT00215449|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25677871|NCT01817530|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25677872|NCT01817530|Estrogens|estrogens|mesh-ancestor
25677873|NCT01817530|Hormones|hormones|mesh-ancestor
25677874|NCT01817530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25677875|NCT01817530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677876|NCT01817530|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25677877|NCT01817530|Contraceptive Agents|contraceptive agents|mesh-ancestor
25677878|NCT01817530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24420314|NCT00215514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420315|NCT00215514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24420316|NCT00215514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24420317|NCT00215514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24420318|NCT00215514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420332|NCT00215592|Anticonvulsants|anticonvulsants|mesh-ancestor
24420333|NCT00215592|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24420334|NCT00215592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24420335|NCT00215592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420398|NCT00215956|Topotecan|topotecan|mesh-list
24420428|NCT00216008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420430|NCT00216021|Oxaliplatin|oxaliplatin|mesh-list
24420431|NCT00216021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24420432|NCT00216021|Antimetabolites|antimetabolites|mesh-ancestor
24420433|NCT00216021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544931|NCT00691067|Mifepristone|mifepristone|mesh-list
24544932|NCT00691067|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24544933|NCT00691067|Abortifacient Agents|abortifacient agents|mesh-ancestor
24544934|NCT00691067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24420457|NCT00216073|Capecitabine|capecitabine|mesh-list
24420458|NCT00216073|Oxaliplatin|oxaliplatin|mesh-list
24420490|NCT00216164|Immunologic Factors|immunologic factors|mesh-ancestor
24420491|NCT00216164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420492|NCT00216164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24420493|NCT00216164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24420494|NCT00216164|Antimetabolites|antimetabolites|mesh-ancestor
24420495|NCT00216164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420496|NCT00216164|Antiviral Agents|antiviral agents|mesh-ancestor
24420497|NCT00216164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25212565|NCT02697045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25212566|NCT02697045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212567|NCT02697045|Dopamine Agonists|dopamine agonists|mesh-ancestor
25212568|NCT02697045|Dopamine Agents|dopamine agents|mesh-ancestor
25212569|NCT02697045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25212570|NCT02697045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212571|NCT02697045|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24420552|NCT00216281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24420553|NCT00216281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24420554|NCT00216281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24420555|NCT00216281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24420584|NCT00216385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24420760|NCT00216723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24420761|NCT00216723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420762|NCT00216723|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24420763|NCT00216723|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24660054|NCT01281696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420764|NCT00216723|Serotonin Agents|serotonin agents|mesh-ancestor
24420932|NCT00217282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420934|NCT00217282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25212574|NCT02697045|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25212575|NCT02697045|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25212576|NCT02697045|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25212577|NCT02697045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25212578|NCT02697058|Calcium, Dietary|calcium, dietary|mesh-list
25212579|NCT02697058|Leucovorin|leucovorin|mesh-list
25212580|NCT02697058|Fluorouracil|fluorouracil|mesh-list
25212581|NCT02697058|Calcium|calcium|mesh-list
25212582|NCT02697058|Levoleucovorin|levoleucovorin|mesh-list
25212583|NCT02697058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25212584|NCT02697058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212585|NCT02697058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25212586|NCT02697058|Antimetabolites|antimetabolites|mesh-ancestor
25212587|NCT02697058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212588|NCT02697058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25212589|NCT02697058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212590|NCT02697058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25212591|NCT02697058|Immunologic Factors|immunologic factors|mesh-ancestor
25212592|NCT02697058|Antidotes|antidotes|mesh-ancestor
25212593|NCT02697058|Protective Agents|protective agents|mesh-ancestor
25212594|NCT02697058|Vitamin B Complex|vitamin b complex|mesh-ancestor
25212595|NCT02697058|Vitamins|vitamins|mesh-ancestor
25212596|NCT02697058|Micronutrients|micronutrients|mesh-ancestor
25212598|NCT02697318|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25212599|NCT02697318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25212600|NCT02697318|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25212601|NCT02697318|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25156448|NCT05026593|Carboplatin|carboplatin|mesh-list
25156449|NCT05026593|Etoposide|etoposide|mesh-list
25156450|NCT05026593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420935|NCT00217282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420983|NCT00217451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420984|NCT00217451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420985|NCT00217477|Gemcitabine|gemcitabine|mesh-list
24420986|NCT00217477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24420987|NCT00217477|Antimetabolites|antimetabolites|mesh-ancestor
24420988|NCT00217477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420989|NCT00217477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420990|NCT00217477|Antiviral Agents|antiviral agents|mesh-ancestor
24420991|NCT00217477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24420992|NCT00217477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823275|NCT02116257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24823276|NCT02116257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24823277|NCT02116348|Cerebrolysin|cerebrolysin|mesh-list
24421551|NCT00219570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24421552|NCT00219570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24421553|NCT00219570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421554|NCT00219596|Timolol|timolol|mesh-list
24421555|NCT00219596|Latanoprost|latanoprost|mesh-list
24421556|NCT00219596|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24421557|NCT00219596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24421593|NCT00219739|Interferons|interferons|mesh-list
24421779|NCT00220168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421780|NCT00220168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24421781|NCT00220168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24421782|NCT00220168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421810|NCT00220233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24421811|NCT00220233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421814|NCT00220233|Natriuretic Agents|natriuretic agents|mesh-ancestor
24421841|NCT00220298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421842|NCT00220298|Anabolic Agents|anabolic agents|mesh-ancestor
24421843|NCT00220311|Fludarabine|fludarabine|mesh-list
24421844|NCT00220311|Fludarabine phosphate|fludarabine phosphate|mesh-list
24421845|NCT00220311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421846|NCT00220311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24421847|NCT00220311|Antimetabolites|antimetabolites|mesh-ancestor
25212602|NCT02697318|Adrenergic Agents|adrenergic agents|mesh-ancestor
25212603|NCT02697318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25212604|NCT02697318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212605|NCT02697318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212606|NCT02697318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25212607|NCT02697318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25212608|NCT02697032|Bicalutamide|bicalutamide|mesh-list
25212609|NCT02697032|Androgen Antagonists|androgen antagonists|mesh-ancestor
25212610|NCT02697032|Hormone Antagonists|hormone antagonists|mesh-ancestor
24660113|NCT01281787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24660114|NCT01281787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24660115|NCT01281787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24660118|NCT01281787|Autonomic Agents|autonomic agents|mesh-ancestor
25212611|NCT02697032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25212612|NCT02697032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25156452|NCT05026593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25156453|NCT05026593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25156454|NCT05026593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25156455|NCT05026593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25156456|NCT05026567|Midazolam|midazolam|mesh-list
25156457|NCT05026567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25156458|NCT05026567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25156459|NCT05026567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25156460|NCT05026567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25156461|NCT05026567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25159899|NCT03518060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24930301|NCT04102267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24421848|NCT00220311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421849|NCT00220311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24421850|NCT00220311|Immunologic Factors|immunologic factors|mesh-ancestor
24421851|NCT00220311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421852|NCT00220324|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
24421853|NCT00220324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24421854|NCT00220324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24421855|NCT00220324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24421856|NCT00220324|Contraceptive Agents|contraceptive agents|mesh-ancestor
24421857|NCT00220324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24421858|NCT00220324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421859|NCT00220324|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24421860|NCT00220324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24823328|NCT02116790|Carbidopa|carbidopa|mesh-list
24823329|NCT02116790|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24691216|NCT01405521|Vaccines|vaccines|mesh-list
24421873|NCT00220350|Fertility Agents|fertility agents|mesh-ancestor
24421886|NCT00220480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24421887|NCT00220480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421888|NCT00220480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24421890|NCT00220480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421891|NCT00220480|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24421892|NCT00220480|Antidepressive Agents|antidepressive agents|mesh-ancestor
24421893|NCT00220480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24421915|NCT00220532|Micronutrients|micronutrients|mesh-ancestor
24421916|NCT00220532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421952|NCT00220675|Hematinics|hematinics|mesh-ancestor
25212613|NCT02697032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212614|NCT02696837|Rocuronium|rocuronium|mesh-list
25212615|NCT02696837|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25212616|NCT02696837|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25212617|NCT02696837|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25212618|NCT02696837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25212619|NCT02696837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212620|NCT05368974|Antiviral Agents|antiviral agents|mesh-list
25212621|NCT05368974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25212622|NCT05368961|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
25212623|NCT05368961|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25212624|NCT05368961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24422291|NCT00221962|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24422292|NCT00221962|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24422294|NCT00221975|Lamotrigine|lamotrigine|mesh-list
24422295|NCT00221975|Valproic Acid|valproic acid|mesh-list
24422296|NCT00221975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24422297|NCT00221975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422335|NCT00222144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422346|NCT00222183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24422347|NCT00222183|Analgesics|analgesics|mesh-ancestor
24422348|NCT00222183|Sensory System Agents|sensory system agents|mesh-ancestor
24579669|NCT00856882|Caseins|caseins|mesh-list
24799461|NCT01969071|Simendan|simendan|mesh-list
24823486|NCT02117583|Sensory System Agents|sensory system agents|mesh-ancestor
24579731|NCT00857168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823487|NCT02117583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24823488|NCT02117596|Sirolimus|sirolimus|mesh-list
24823489|NCT02117596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24823490|NCT02117596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24823491|NCT02117596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24823492|NCT02117596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823539|NCT02117739|Antimalarials|antimalarials|mesh-ancestor
24823540|NCT02117739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24823541|NCT02117739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25212625|NCT05368961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212626|NCT05368961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25212627|NCT05368935|Nitazoxanide|nitazoxanide|mesh-list
24823543|NCT02117739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823544|NCT02117739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823545|NCT02117739|Leprostatic Agents|leprostatic agents|mesh-ancestor
24823546|NCT02117739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24823548|NCT02117752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24614026|NCT01022125|Simeprevir|simeprevir|mesh-list
24799473|NCT01969071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24422604|NCT00223054|Antifungal Agents|antifungal agents|mesh-ancestor
24422605|NCT00223054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24422606|NCT00223054|Dermatologic Agents|dermatologic agents|mesh-ancestor
24422621|NCT00223249|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24422622|NCT00223249|Antidepressive Agents|antidepressive agents|mesh-ancestor
24422623|NCT00223249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24823702|NCT02118675|Protective Agents|protective agents|mesh-ancestor
24660182|NCT01281943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24660183|NCT01281943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24660190|NCT01281943|Immunologic Factors|immunologic factors|mesh-ancestor
24660191|NCT01281943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799491|NCT01969227|Sensory System Agents|sensory system agents|mesh-ancestor
24799492|NCT01969227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24799493|NCT01969227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799494|NCT01969227|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24799495|NCT01969227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24799496|NCT01969227|Anesthetics, General|anesthetics, general|mesh-ancestor
24799498|NCT01969227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24799499|NCT01969227|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24799500|NCT01969227|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24823703|NCT02118675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823705|NCT02118688|Trazodone|trazodone|mesh-list
24823706|NCT02118688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24823707|NCT02118688|Serotonin Agents|serotonin agents|mesh-ancestor
24823708|NCT02118688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24823709|NCT02118688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823710|NCT02118688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692184|NCT01411930|Serotonin Agents|serotonin agents|mesh-ancestor
24422666|NCT00223418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24422693|NCT00223561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422694|NCT00223561|Dopamine Agents|dopamine agents|mesh-ancestor
24422695|NCT00223561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24422696|NCT00223613|Insulin|insulin|mesh-list
24422697|NCT00223613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24422698|NCT00223613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422699|NCT00223626|Topiramate|topiramate|mesh-list
24422700|NCT00223626|Anticonvulsants|anticonvulsants|mesh-ancestor
24422701|NCT00223626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24422703|NCT00223639|Topiramate|topiramate|mesh-list
24422722|NCT00223691|Levodopa|levodopa|mesh-list
24422723|NCT00223691|Carbidopa|carbidopa|mesh-list
24422724|NCT00223691|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24422725|NCT00223691|Tranylcypromine|tranylcypromine|mesh-list
24422726|NCT00223691|Methylphenidate|methylphenidate|mesh-list
24422727|NCT00223691|Caffeine|caffeine|mesh-list
24422728|NCT00223691|Modafinil|modafinil|mesh-list
24422729|NCT00223691|Rivastigmine|rivastigmine|mesh-list
24422730|NCT00223691|Ranitidine|ranitidine|mesh-list
24422731|NCT00223691|Yohimbine|yohimbine|mesh-list
24422732|NCT00223691|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
24422733|NCT00223691|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24823711|NCT02118688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24823725|NCT02118727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24422781|NCT00223691|Gout Suppressants|gout suppressants|mesh-ancestor
24422782|NCT00223691|Tocolytic Agents|tocolytic agents|mesh-ancestor
24422783|NCT00223691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24823759|NCT02118870|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24823760|NCT02118870|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24823761|NCT02118870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823762|NCT02118870|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24823763|NCT02118870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24823764|NCT02118870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422988|NCT00224393|Etanercept|etanercept|mesh-list
24422989|NCT00224393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24423020|NCT00224445|Antiviral Agents|antiviral agents|mesh-ancestor
24423021|NCT00224445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24423022|NCT00224445|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24588382|NCT00902421|Cholinergic Agents|cholinergic agents|mesh-ancestor
24588383|NCT00902460|Midazolam|midazolam|mesh-list
24588384|NCT00902460|Tofacitinib|tofacitinib|mesh-list
24588415|NCT00902603|Iloprost|iloprost|mesh-list
24423023|NCT00224445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24423029|NCT00224458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24423030|NCT00224458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423031|NCT00224458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423032|NCT00224458|Antiviral Agents|antiviral agents|mesh-ancestor
24423048|NCT00224510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24423049|NCT00224510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423050|NCT00224510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24423051|NCT00224510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423052|NCT00224510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24423053|NCT00224510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24423054|NCT00224510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24423373|NCT00225706|Ibuprofen|ibuprofen|mesh-list
24423374|NCT00225706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24823824|NCT02119234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24799517|NCT01969578|Carboplatin|carboplatin|mesh-list
24823825|NCT02119234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24823826|NCT02119234|Adrenergic Agents|adrenergic agents|mesh-ancestor
25212632|NCT05368805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25212633|NCT05368805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25212634|NCT05368805|Antimetabolites|antimetabolites|mesh-ancestor
25212635|NCT05368805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212636|NCT05368805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25156473|NCT05021978|Anesthetics|anesthetics|mesh-ancestor
25156474|NCT05021978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25156475|NCT05021978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25156476|NCT05021978|Sensory System Agents|sensory system agents|mesh-ancestor
25156477|NCT05021978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25156488|NCT05018091|Dexamethasone|dexamethasone|mesh-list
25156491|NCT05018091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25156492|NCT05018091|Antiemetics|antiemetics|mesh-ancestor
25156493|NCT05018091|Autonomic Agents|autonomic agents|mesh-ancestor
25156494|NCT05018091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25156495|NCT05018091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25156496|NCT05018091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25156497|NCT05018091|Glucocorticoids|glucocorticoids|mesh-ancestor
25156498|NCT05018091|Hormones|hormones|mesh-ancestor
25082586|NCT03321825|Lidocaine|lidocaine|mesh-list
24947049|NCT03932981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823827|NCT02119234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24823828|NCT02119234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823829|NCT02119234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24823830|NCT02119234|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24823831|NCT02119234|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24823832|NCT02119234|Cholinergic Agents|cholinergic agents|mesh-ancestor
24823833|NCT02119234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24823834|NCT02119234|Glucocorticoids|glucocorticoids|mesh-ancestor
24823836|NCT02119234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24823837|NCT02119273|Prednisone|prednisone|mesh-list
24823838|NCT02119273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24823840|NCT02119273|Hormones|hormones|mesh-ancestor
24823841|NCT02119273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24692656|NCT01415713|Antidotes|antidotes|mesh-ancestor
24423407|NCT00225849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24423408|NCT00225849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423409|NCT00225849|Antipyretics|antipyretics|mesh-ancestor
24423410|NCT00225862|Ropinirole|ropinirole|mesh-list
24423411|NCT00225862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24423412|NCT00225862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25212637|NCT05368805|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25212638|NCT05368805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212639|NCT05368805|Antithrombins|antithrombins|mesh-ancestor
25212640|NCT05368805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25212641|NCT05368805|Protease Inhibitors|protease inhibitors|mesh-ancestor
25212642|NCT05368805|Anticoagulants|anticoagulants|mesh-ancestor
25677879|NCT01817530|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25677880|NCT01817530|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25677881|NCT01817530|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25677882|NCT01817530|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25212643|NCT05368766|Diuretics|diuretics|mesh-list
25212644|NCT05368766|Natriuretic Agents|natriuretic agents|mesh-ancestor
25212645|NCT05368766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212646|NCT05368753|Lidocaine|lidocaine|mesh-list
25212647|NCT05368753|Ropivacaine|ropivacaine|mesh-list
25212648|NCT05368753|Anesthetics, Local|anesthetics, local|mesh-ancestor
25212649|NCT05368753|Anesthetics|anesthetics|mesh-ancestor
25212650|NCT05368753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25212651|NCT05368753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212652|NCT05368753|Sensory System Agents|sensory system agents|mesh-ancestor
25212653|NCT05368753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25212654|NCT05368753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25212655|NCT05368753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25212656|NCT05368753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25212657|NCT05368753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25212658|NCT05368753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212659|NCT05368675|Buprenorphine|buprenorphine|mesh-list
25212660|NCT05368675|Methadone|methadone|mesh-list
25212661|NCT05368675|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25212662|NCT05368675|Naloxone|naloxone|mesh-list
25212663|NCT05368675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25156499|NCT05018091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25156500|NCT05018091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25156501|NCT05018091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25156502|NCT05018091|Protease Inhibitors|protease inhibitors|mesh-ancestor
25156503|NCT05018091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25156504|NCT05018091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947078|NCT03932721|Evolocumab|evolocumab|mesh-list
24423413|NCT00225862|Dopamine Agonists|dopamine agonists|mesh-ancestor
24423414|NCT00225862|Dopamine Agents|dopamine agents|mesh-ancestor
24423415|NCT00225862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24423424|NCT00225901|Mitogens|mitogens|mesh-list
24423425|NCT00225901|Mitosis Modulators|mitosis modulators|mesh-ancestor
24423426|NCT00225901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423427|NCT00225914|Paroxetine|paroxetine|mesh-list
25049816|NCT00562497|Prednisone|prednisone|mesh-list
24423438|NCT00225914|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24423439|NCT00225914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24423440|NCT00225914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423441|NCT00225979|Octreotide|octreotide|mesh-list
24423442|NCT00225979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24423443|NCT00225979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24423444|NCT00225979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24423445|NCT00225992|Arsenic Trioxide|arsenic trioxide|mesh-list
24423446|NCT00225992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24423448|NCT00226005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24423449|NCT00226005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423450|NCT00226005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423453|NCT00226044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24423454|NCT00226044|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24423455|NCT00226044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423495|NCT00226096|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24823905|NCT02120092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24823906|NCT02120092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24823907|NCT02120092|Purinergic Agents|purinergic agents|mesh-ancestor
24823908|NCT02120092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25212664|NCT05368675|Narcotics|narcotics|mesh-ancestor
25212665|NCT05368675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25212666|NCT05368675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212667|NCT05368675|Analgesics|analgesics|mesh-ancestor
25212668|NCT05368675|Sensory System Agents|sensory system agents|mesh-ancestor
25212669|NCT05368675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25212670|NCT05368675|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25212671|NCT05368675|Antitussive Agents|antitussive agents|mesh-ancestor
25212672|NCT05368675|Respiratory System Agents|respiratory system agents|mesh-ancestor
25212673|NCT05368623|Mydriatics|mydriatics|mesh-list
25212674|NCT05368623|Autonomic Agents|autonomic agents|mesh-ancestor
24660247|NCT01282385|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24423547|NCT00226317|Dopamine Agonists|dopamine agonists|mesh-ancestor
24423548|NCT00226317|Dopamine Agents|dopamine agents|mesh-ancestor
24545742|NCT00694733|Anastrozole|anastrozole|mesh-list
24545743|NCT00694733|Leuprolide|leuprolide|mesh-list
25034519|NCT03563963|Anesthetics|anesthetics|mesh-ancestor
25034520|NCT03563963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25034521|NCT03563963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034522|NCT03563963|Sensory System Agents|sensory system agents|mesh-ancestor
25034524|NCT03563963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24545744|NCT00694733|Methyltestosterone|methyltestosterone|mesh-list
24423549|NCT00226317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24423550|NCT00226317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423551|NCT00226317|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24823927|NCT02120196|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24823928|NCT02120196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24823929|NCT02120274|Vitamin D|vitamin d|mesh-list
24823930|NCT02120274|Vitamins|vitamins|mesh-list
24423606|NCT00226421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24423607|NCT00226421|Narcotics|narcotics|mesh-ancestor
24423609|NCT00226421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423646|NCT00226538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24423647|NCT00226538|Analgesics|analgesics|mesh-ancestor
24423655|NCT00226538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423657|NCT00226538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24423658|NCT00226538|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24423659|NCT00226538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24423660|NCT00226538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24423662|NCT00226538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24423663|NCT00226538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24423664|NCT00226538|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24423665|NCT00226538|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24423666|NCT00226538|Antitubercular Agents|antitubercular agents|mesh-ancestor
25212675|NCT05368623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25212676|NCT05368623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212677|NCT05368545|Atorvastatin|atorvastatin|mesh-list
25212678|NCT05368545|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25212679|NCT05368545|Ezetimibe|ezetimibe|mesh-list
25212680|NCT05368545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25212681|NCT05368545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25212682|NCT05368545|Antimetabolites|antimetabolites|mesh-ancestor
25212683|NCT05368545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212684|NCT05368545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25212685|NCT05368545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25212686|NCT05368545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212687|NCT05368441|Midazolam|midazolam|mesh-list
25212688|NCT05368441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25212689|NCT05368441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25212690|NCT05368441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25212691|NCT05368441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212692|NCT05368441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25212693|NCT05368441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25212694|NCT05368441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24423668|NCT00226538|Leprostatic Agents|leprostatic agents|mesh-ancestor
24423669|NCT00226538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24423703|NCT00226564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24423704|NCT00226564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24423705|NCT00226564|Anesthetics, General|anesthetics, general|mesh-ancestor
24423706|NCT00226564|Anesthetics|anesthetics|mesh-ancestor
24423707|NCT00226668|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
24423708|NCT00226668|Hormones|hormones|mesh-ancestor
24423716|NCT00226694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24423718|NCT00226694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423720|NCT00226694|Antidepressive Agents|antidepressive agents|mesh-ancestor
24824028|NCT02120872|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24824029|NCT02120872|Antimetabolites|antimetabolites|mesh-ancestor
24824030|NCT02120872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824031|NCT02120872|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24824032|NCT02120872|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25677883|NCT01817582|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25677884|NCT01817582|Cyclosporine|cyclosporine|mesh-list
25677885|NCT01817582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25677886|NCT01817582|Lubricant Eye Drops|lubricant eye drops|mesh-list
25677887|NCT01817582|Cyclosporins|cyclosporins|mesh-list
25677888|NCT01817582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423740|NCT00226746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24423741|NCT00226746|Tubulin Modulators|tubulin modulators|mesh-ancestor
24423742|NCT00226746|Antimitotic Agents|antimitotic agents|mesh-ancestor
24423743|NCT00226746|Mitosis Modulators|mitosis modulators|mesh-ancestor
24423744|NCT00226746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423745|NCT00226746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24824042|NCT02121119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24824043|NCT02121119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824044|NCT02121119|Sensory System Agents|sensory system agents|mesh-ancestor
24824045|NCT02121119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24824046|NCT02121119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24824047|NCT02121119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24824048|NCT02121119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24824049|NCT02121119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24824050|NCT02121119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824052|NCT02121197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24824053|NCT02121197|Antiemetics|antiemetics|mesh-ancestor
24824065|NCT02121288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24824066|NCT02121288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24824067|NCT02121288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24824068|NCT02121288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24824069|NCT02121288|Purinergic Agents|purinergic agents|mesh-ancestor
24824070|NCT02121288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24693166|NCT01418586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24423833|NCT00226980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24423834|NCT00226980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24423864|NCT00227136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24423866|NCT00227136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24423867|NCT00227136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423868|NCT00227136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423888|NCT00227318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25212695|NCT05368441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25212696|NCT05368441|Anesthetics, General|anesthetics, general|mesh-ancestor
25212697|NCT05368441|Anesthetics|anesthetics|mesh-ancestor
25212698|NCT05368441|GABA Modulators|gaba modulators|mesh-ancestor
25212699|NCT05368441|GABA Agents|gaba agents|mesh-ancestor
25212700|NCT05368441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25156535|NCT05011513|Ritonavir|ritonavir|mesh-list
25156536|NCT05011513|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25156537|NCT05011513|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25156538|NCT05011513|Protease Inhibitors|protease inhibitors|mesh-ancestor
25156539|NCT05011513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25156540|NCT05011513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799607|NCT01969903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24947113|NCT03932123|Azlocillin|azlocillin|mesh-list
24423889|NCT00227318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24824071|NCT02121288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824072|NCT02121288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824073|NCT02121353|Ranibizumab|ranibizumab|mesh-list
24824074|NCT02121353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24824075|NCT02121353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24824076|NCT02121353|Growth Substances|growth substances|mesh-ancestor
24824077|NCT02121353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824078|NCT02121353|Growth Inhibitors|growth inhibitors|mesh-ancestor
24824079|NCT02121353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24824080|NCT02121366|Ethanol|ethanol|mesh-list
24824081|NCT02121366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24824082|NCT02121366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24824083|NCT02121366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24824084|NCT02121366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824085|NCT02121444|Interferons|interferons|mesh-list
24824086|NCT02121444|Interferon-beta|interferon-beta|mesh-list
24580418|NCT00861731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24824087|NCT02121444|Interferon beta-1b|interferon beta-1b|mesh-list
24824102|NCT02121613|Saw palmetto extract|saw palmetto extract|mesh-list
24824103|NCT02121613|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24824104|NCT02121613|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24824105|NCT02121613|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24824106|NCT02121613|Adrenergic Agents|adrenergic agents|mesh-ancestor
24824107|NCT02121613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24991513|NCT05150652|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24824108|NCT02121613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824109|NCT02121613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824110|NCT02121613|Urological Agents|urological agents|mesh-ancestor
24824111|NCT02121782|Vaccines|vaccines|mesh-list
24545937|NCT00696007|Immunologic Factors|immunologic factors|mesh-ancestor
24545938|NCT00696007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423937|NCT00227448|Adrenergic Agents|adrenergic agents|mesh-ancestor
24423938|NCT00227448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24423939|NCT00227448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423940|NCT00227448|Protective Agents|protective agents|mesh-ancestor
24423941|NCT00227461|Levetiracetam|levetiracetam|mesh-list
24423942|NCT00227461|Anticonvulsants|anticonvulsants|mesh-ancestor
24423944|NCT00227474|Vaccines|vaccines|mesh-list
24423945|NCT00227474|Immunologic Factors|immunologic factors|mesh-ancestor
25212701|NCT05368441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25156542|NCT05011513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25156543|NCT05011513|Antiviral Agents|antiviral agents|mesh-ancestor
25156544|NCT05011513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25156545|NCT05011513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25156546|NCT05011513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25156547|NCT05010304|Amoxicillin|amoxicillin|mesh-list
25156548|NCT05010304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25156549|NCT05010304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24424014|NCT00227682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24424015|NCT00227682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24424016|NCT00227682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424017|NCT00227682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24424019|NCT00227682|Leprostatic Agents|leprostatic agents|mesh-ancestor
24424020|NCT00227682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24424021|NCT00227682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24424022|NCT00227682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24424023|NCT00227682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24424024|NCT00227682|Growth Substances|growth substances|mesh-ancestor
24424025|NCT00227682|Growth Inhibitors|growth inhibitors|mesh-ancestor
24424051|NCT00227747|Capecitabine|capecitabine|mesh-list
24424052|NCT00227747|Oxaliplatin|oxaliplatin|mesh-list
24424053|NCT00227747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24424054|NCT00227747|Antimetabolites|antimetabolites|mesh-ancestor
24824128|NCT02121951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24824129|NCT02121951|Anesthetics, General|anesthetics, general|mesh-ancestor
24824132|NCT02121951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24824133|NCT02121951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24824134|NCT02121951|GABA Modulators|gaba modulators|mesh-ancestor
24824135|NCT02121951|GABA Agents|gaba agents|mesh-ancestor
24824136|NCT02121951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24424064|NCT00227773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424065|NCT00227773|Mitosis Modulators|mitosis modulators|mesh-ancestor
24424066|NCT00227773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424067|NCT00227773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24424068|NCT00227773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24709810|NCT01507194|Serotonin Agents|serotonin agents|mesh-ancestor
24824147|NCT02121990|Tubulin Modulators|tubulin modulators|mesh-ancestor
24824148|NCT02121990|Antimitotic Agents|antimitotic agents|mesh-ancestor
24824149|NCT02121990|Mitosis Modulators|mitosis modulators|mesh-ancestor
24824150|NCT02121990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824151|NCT02121990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24824152|NCT02121990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24824153|NCT02121990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24824154|NCT02121990|Growth Substances|growth substances|mesh-ancestor
24824155|NCT02121990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824156|NCT02121990|Growth Inhibitors|growth inhibitors|mesh-ancestor
24693453|NCT01420523|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25212713|NCT05368207|Pembrolizumab|pembrolizumab|mesh-list
25212714|NCT05368207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25212715|NCT05368207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272727|NCT02390258|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25272728|NCT02390258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25272729|NCT02390258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272730|NCT02390310|Lidocaine|lidocaine|mesh-list
25272731|NCT02390310|Prilocaine|prilocaine|mesh-list
25272732|NCT02390310|Anesthetics|anesthetics|mesh-list
25272733|NCT02390310|Anesthetics, Local|anesthetics, local|mesh-ancestor
25677889|NCT01817582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272734|NCT02390310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25272735|NCT02390310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424183|NCT00228163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24424185|NCT00228163|Sensory System Agents|sensory system agents|mesh-ancestor
24424186|NCT00228163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24424187|NCT00228163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424188|NCT00228163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24424189|NCT00228163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24424190|NCT00228163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24424191|NCT00228163|Immunologic Factors|immunologic factors|mesh-ancestor
24709937|NCT01507701|Clonidine|clonidine|mesh-list
24424237|NCT00228397|Antifungal Agents|antifungal agents|mesh-ancestor
24424238|NCT00228397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24424239|NCT00228397|Immunologic Factors|immunologic factors|mesh-ancestor
24660628|NCT01284868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24424240|NCT00228397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824222|NCT02122211|Betaine|betaine|mesh-list
24824223|NCT02122211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24824224|NCT02122211|Lipotropic Agents|lipotropic agents|mesh-ancestor
24824225|NCT02122211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24824226|NCT02122211|Antimetabolites|antimetabolites|mesh-ancestor
24824227|NCT02122211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824228|NCT02122211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24824229|NCT02122393|Sertraline|sertraline|mesh-list
24824230|NCT02122393|Antidepressive Agents|antidepressive agents|mesh-ancestor
24824231|NCT02122393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24824232|NCT02122393|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24824233|NCT02122393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24824234|NCT02122393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24824235|NCT02122393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824236|NCT02122393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24824237|NCT02122393|Serotonin Agents|serotonin agents|mesh-ancestor
24824238|NCT02122393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824239|NCT02122484|Colchicine|colchicine|mesh-list
24824240|NCT02122484|Gout Suppressants|gout suppressants|mesh-ancestor
24824241|NCT02122484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24824242|NCT02122484|Tubulin Modulators|tubulin modulators|mesh-ancestor
24824243|NCT02122484|Antimitotic Agents|antimitotic agents|mesh-ancestor
25212717|NCT05368181|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25212718|NCT05368181|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25212719|NCT05368181|Prednisolone|prednisolone|mesh-list
25212720|NCT05368181|Prednisolone acetate|prednisolone acetate|mesh-list
25212721|NCT05368181|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25212722|NCT05368181|Prednisolone phosphate|prednisolone phosphate|mesh-list
25115494|NCT03115736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25115495|NCT03115736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25115496|NCT03115736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25115497|NCT03115736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824246|NCT02122484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24824247|NCT02122510|Dexmedetomidine|dexmedetomidine|mesh-list
24660773|NCT01285674|Cisplatin|cisplatin|mesh-list
24824248|NCT02122510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24824249|NCT02122510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24424291|NCT00228540|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24824260|NCT02122510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824261|NCT02122536|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24693713|NCT01421940|Udenafil|udenafil|mesh-list
24424292|NCT00228540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424293|NCT00228592|Immunoglobulins|immunoglobulins|mesh-list
24424294|NCT00228592|Antibodies|antibodies|mesh-list
24424295|NCT00228592|gamma-Globulins|gamma-globulins|mesh-list
24424296|NCT00228592|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24546102|NCT00696748|Methyltestosterone|methyltestosterone|mesh-list
24546103|NCT00696748|Testosterone|testosterone|mesh-list
24546104|NCT00696748|Testosterone undecanoate|testosterone undecanoate|mesh-list
24546105|NCT00696748|Testosterone enanthate|testosterone enanthate|mesh-list
24424306|NCT00228605|Sensory System Agents|sensory system agents|mesh-ancestor
24424307|NCT00228605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24424309|NCT00228605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24424315|NCT00228839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24424318|NCT00228852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799722|NCT01970748|Propranolol|propranolol|mesh-list
24424319|NCT00228852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424320|NCT00228852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24424321|NCT00228852|Immunologic Factors|immunologic factors|mesh-ancestor
24424322|NCT00228852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424323|NCT00228852|Alkylating Agents|alkylating agents|mesh-ancestor
24424335|NCT00228891|Insulin|insulin|mesh-list
24424336|NCT00228891|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24424337|NCT00228891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24424338|NCT00228891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424339|NCT00228904|Insulin|insulin|mesh-list
24424340|NCT00228904|Insulin Lispro|insulin lispro|mesh-list
24546176|NCT00697021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25212723|NCT05368181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25212724|NCT05368181|Antiemetics|antiemetics|mesh-ancestor
25212725|NCT05368181|Autonomic Agents|autonomic agents|mesh-ancestor
25212726|NCT05368181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25212727|NCT05368181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212728|NCT05368181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25212729|NCT05368181|Glucocorticoids|glucocorticoids|mesh-ancestor
25212730|NCT05368181|Hormones|hormones|mesh-ancestor
24424499|NCT00229567|Anesthetics, Local|anesthetics, local|mesh-ancestor
24424500|NCT00229567|Anesthetics|anesthetics|mesh-ancestor
24424501|NCT00229567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24424502|NCT00229567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424503|NCT00229567|Sensory System Agents|sensory system agents|mesh-ancestor
24424504|NCT00229567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24824278|NCT02122627|Vitamin D|vitamin d|mesh-list
24424542|NCT00229697|Tamoxifen|tamoxifen|mesh-list
24424543|NCT00229697|Gefitinib|gefitinib|mesh-list
24424544|NCT00229697|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24424545|NCT00229697|Hormone Antagonists|hormone antagonists|mesh-ancestor
24424546|NCT00229697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24424550|NCT00229697|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24424551|NCT00229697|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24424552|NCT00229697|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24424553|NCT00229697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24424576|NCT00229918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24424577|NCT00229918|Glucocorticoids|glucocorticoids|mesh-ancestor
24661056|NCT01287715|Analgesics|analgesics|mesh-ancestor
25212731|NCT05368181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25212732|NCT05368181|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25212733|NCT05368181|Protective Agents|protective agents|mesh-ancestor
24424579|NCT00229918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24424580|NCT00229918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424581|NCT00229918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24424582|NCT00229918|Immunologic Factors|immunologic factors|mesh-ancestor
24424583|NCT00229918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24424584|NCT00229918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424585|NCT00229944|Azithromycin|azithromycin|mesh-list
24424586|NCT00229944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24424587|NCT00229944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24424589|NCT00229996|Contraceptive Agents|contraceptive agents|mesh-list
24424590|NCT00229996|Norethindrone|norethindrone|mesh-list
24710340|NCT01509742|Hormones|hormones|mesh-ancestor
24424651|NCT00230217|Gout Suppressants|gout suppressants|mesh-ancestor
24424652|NCT00230217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24424653|NCT00230321|Darbepoetin alfa|darbepoetin alfa|mesh-list
24424654|NCT00230321|Hematinics|hematinics|mesh-ancestor
24424655|NCT00230334|Imatinib Mesylate|imatinib mesylate|mesh-list
24424656|NCT00230334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424657|NCT00230334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24424658|NCT00230334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24424659|NCT00230334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424660|NCT00230373|Imiquimod|imiquimod|mesh-list
24424661|NCT00230373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25034922|NCT03561181|Immunologic Factors|immunologic factors|mesh-ancestor
25034923|NCT03561181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034974|NCT03560583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034975|NCT03560583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25034976|NCT03560583|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25034977|NCT03560583|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24424662|NCT00230373|Immunologic Factors|immunologic factors|mesh-ancestor
24424663|NCT00230373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424664|NCT00230373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424665|NCT00230373|Interferon Inducers|interferon inducers|mesh-ancestor
24424666|NCT00230399|Celecoxib|celecoxib|mesh-list
24424667|NCT00230399|Capecitabine|capecitabine|mesh-list
24424668|NCT00230399|Irinotecan|irinotecan|mesh-list
24424669|NCT00230399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24424670|NCT00230399|Antimetabolites|antimetabolites|mesh-ancestor
24424756|NCT00230568|Cholinergic Agents|cholinergic agents|mesh-ancestor
24424757|NCT00230568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24424758|NCT00230568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424762|NCT00230594|Coagulants|coagulants|mesh-ancestor
24424763|NCT00230594|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24424764|NCT00230594|Natriuretic Agents|natriuretic agents|mesh-ancestor
24424765|NCT00230594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424766|NCT00230698|Topiramate|topiramate|mesh-list
24424767|NCT00230698|Anticonvulsants|anticonvulsants|mesh-ancestor
24424768|NCT00230698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24424769|NCT00230698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424933|NCT00231348|Antidepressive Agents|antidepressive agents|mesh-ancestor
24424934|NCT00231348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24424935|NCT00231348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24424936|NCT00231348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24424937|NCT00231348|Serotonin Agents|serotonin agents|mesh-ancestor
24424938|NCT00231387|Rosiglitazone|rosiglitazone|mesh-list
24424939|NCT00231387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24424940|NCT00231387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424941|NCT00231452|Artesunate|artesunate|mesh-list
24424942|NCT00231452|Pyrimethamine|pyrimethamine|mesh-list
24424943|NCT00231452|Sulfadoxine|sulfadoxine|mesh-list
24424944|NCT00231452|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24425044|NCT00231764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24425045|NCT00231764|Immunologic Factors|immunologic factors|mesh-ancestor
24425046|NCT00231764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425047|NCT00231829|Celecoxib|celecoxib|mesh-list
24425048|NCT00231829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24425072|NCT00231959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425073|NCT00231959|Protective Agents|protective agents|mesh-ancestor
24425074|NCT00231959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425075|NCT00231959|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24425076|NCT00231959|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24425077|NCT00231959|Dopamine Agonists|dopamine agonists|mesh-ancestor
24425078|NCT00231959|Dopamine Agents|dopamine agents|mesh-ancestor
24425079|NCT00231959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24425080|NCT00231998|Pimecrolimus|pimecrolimus|mesh-list
24425081|NCT00231998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24425082|NCT00231998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24425083|NCT00231998|Analgesics|analgesics|mesh-ancestor
24425084|NCT00231998|Sensory System Agents|sensory system agents|mesh-ancestor
24425085|NCT00231998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25212736|NCT05368142|Cell Wall Skeleton|cell wall skeleton|mesh-list
25212737|NCT05368142|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25212738|NCT05368142|Immunologic Factors|immunologic factors|mesh-ancestor
25212739|NCT05368142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25156577|NCT05007132|Growth Substances|growth substances|mesh-ancestor
25156578|NCT05007132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25156579|NCT05007132|Growth Inhibitors|growth inhibitors|mesh-ancestor
25156580|NCT05007132|Antimetabolites|antimetabolites|mesh-ancestor
25156581|NCT05007132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25156582|NCT05007132|Antiviral Agents|antiviral agents|mesh-ancestor
25677890|NCT01817582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25677891|NCT01817582|Immunologic Factors|immunologic factors|mesh-ancestor
25677892|NCT01817582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677893|NCT01817582|Antifungal Agents|antifungal agents|mesh-ancestor
25677894|NCT01817582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25677895|NCT01817582|Dermatologic Agents|dermatologic agents|mesh-ancestor
25677896|NCT01817582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24947157|NCT03931863|Antipruritics|antipruritics|mesh-ancestor
24425086|NCT00231998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425087|NCT00231998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24425088|NCT00231998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24425089|NCT00231998|Dermatologic Agents|dermatologic agents|mesh-ancestor
24661396|NCT01289301|Antifungal Agents|antifungal agents|mesh-ancestor
24425090|NCT00231998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24425091|NCT00231998|Immunologic Factors|immunologic factors|mesh-ancestor
24425092|NCT00231998|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24425093|NCT00231998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24425094|NCT00231998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425095|NCT00232011|Pimecrolimus|pimecrolimus|mesh-list
24425138|NCT00232076|Cyclosporine|cyclosporine|mesh-list
24425139|NCT00232076|Cyclosporins|cyclosporins|mesh-list
24425140|NCT00232076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24710484|NCT01510795|Diuretics|diuretics|mesh-ancestor
24425234|NCT00232362|Pioglitazone|pioglitazone|mesh-list
24425235|NCT00232362|Rosiglitazone|rosiglitazone|mesh-list
24425236|NCT00232362|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24425237|NCT00232362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425238|NCT00232375|Insulin|insulin|mesh-list
24425394|NCT00232882|Adrenergic Agents|adrenergic agents|mesh-ancestor
24425395|NCT00232882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24425396|NCT00232882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24425397|NCT00232882|Diuretics|diuretics|mesh-ancestor
24425398|NCT00232882|Natriuretic Agents|natriuretic agents|mesh-ancestor
24425437|NCT00233025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425438|NCT00233025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24425439|NCT00233025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425440|NCT00233025|Analgesics|analgesics|mesh-ancestor
24425441|NCT00233025|Sensory System Agents|sensory system agents|mesh-ancestor
24425601|NCT00233766|Immunologic Factors|immunologic factors|mesh-ancestor
24425602|NCT00233766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425604|NCT00233779|Heparin|heparin|mesh-list
24425605|NCT00233779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24661448|NCT01289561|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24661449|NCT01289561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24661450|NCT01289561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24425684|NCT00234026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24425685|NCT00234026|Antimetabolites|antimetabolites|mesh-ancestor
24425686|NCT00234026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425687|NCT00234026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24824337|NCT02122939|Antidepressive Agents|antidepressive agents|mesh-ancestor
24824338|NCT02122939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24824339|NCT02123004|Clopidogrel|clopidogrel|mesh-list
24824340|NCT02123004|Ticagrelor|ticagrelor|mesh-list
24425688|NCT00234026|Antiviral Agents|antiviral agents|mesh-ancestor
24425689|NCT00234026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24425690|NCT00234026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24425691|NCT00234026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24425692|NCT00234026|Immunologic Factors|immunologic factors|mesh-ancestor
24425693|NCT00234026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425694|NCT00234091|Ritonavir|ritonavir|mesh-list
25156586|NCT04982029|Cannabidiol|cannabidiol|mesh-list
25156587|NCT04982029|Anticonvulsants|anticonvulsants|mesh-ancestor
25156588|NCT04977232|Citalopram|citalopram|mesh-list
25156589|NCT04977232|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25156590|NCT04977232|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24425765|NCT00234299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425766|NCT00234299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24425767|NCT00234299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24425768|NCT00234299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24425770|NCT00234312|Citalopram|citalopram|mesh-list
24425771|NCT00234312|Sertraline|sertraline|mesh-list
24425772|NCT00234312|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24425773|NCT00234312|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24425774|NCT00234312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24425775|NCT00234312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425776|NCT00234312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24614251|NCT01023243|Analgesics|analgesics|mesh-ancestor
24425881|NCT00234598|Disinfectants|disinfectants|mesh-ancestor
24425882|NCT00234598|Dermatologic Agents|dermatologic agents|mesh-ancestor
24425883|NCT00234637|Memantine|memantine|mesh-list
24425884|NCT00234637|Rivastigmine|rivastigmine|mesh-list
24991857|NCT04860804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24991858|NCT04860804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24991859|NCT04860804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991860|NCT04860804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24991869|NCT04860804|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24991870|NCT04860804|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24991871|NCT04860804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24991872|NCT04856488|Lugol's solution|lugol's solution|mesh-list
24991873|NCT04856488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24425885|NCT00234637|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24425886|NCT00234637|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24425890|NCT00234637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824343|NCT02123004|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24824344|NCT02123004|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24824345|NCT02123004|Purinergic Agents|purinergic agents|mesh-ancestor
24824346|NCT02123004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24824349|NCT02123056|Metoprolol|metoprolol|mesh-list
24425948|NCT00234858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425949|NCT00234858|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24425950|NCT00234858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24425952|NCT00234858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24425953|NCT00234858|Vasodilator Agents|vasodilator agents|mesh-ancestor
24426693|NCT00236496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24824358|NCT02123056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24426012|NCT00234936|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25049847|NCT00561743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24426082|NCT00235014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24426083|NCT00235014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426084|NCT00235014|Vasodilator Agents|vasodilator agents|mesh-ancestor
24426096|NCT00235053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212758|NCT05368051|Capecitabine|capecitabine|mesh-list
25212759|NCT05368051|Antibodies|antibodies|mesh-list
25156592|NCT04977232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25156594|NCT04977232|Serotonin Agents|serotonin agents|mesh-ancestor
25156595|NCT04977232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25156596|NCT04977232|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25156597|NCT04977232|Antidepressive Agents|antidepressive agents|mesh-ancestor
24426097|NCT00235053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24426098|NCT00235053|Respiratory System Agents|respiratory system agents|mesh-ancestor
24426101|NCT00235053|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24426102|NCT00235053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24426103|NCT00235053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24426104|NCT00235053|Adrenergic Agents|adrenergic agents|mesh-ancestor
24426105|NCT00235053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24426106|NCT00235053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426107|NCT00235053|Glucocorticoids|glucocorticoids|mesh-ancestor
24426146|NCT00235157|Sirolimus|sirolimus|mesh-list
24426162|NCT00235222|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24426163|NCT00235222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24426165|NCT00235222|Antiviral Agents|antiviral agents|mesh-ancestor
24426166|NCT00235222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24426167|NCT00235222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24694860|NCT05113615|Tiotropium Bromide|tiotropium bromide|mesh-list
24426168|NCT00235222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24426169|NCT00235235|Gemcitabine|gemcitabine|mesh-list
24426170|NCT00235235|Cyclophosphamide|cyclophosphamide|mesh-list
24426171|NCT00235235|Doxorubicin|doxorubicin|mesh-list
25677897|NCT01817582|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25677898|NCT01817582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25677899|NCT01817582|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25677900|NCT01817764|Fluticasone|fluticasone|mesh-list
25677901|NCT01817764|Xhance|xhance|mesh-list
25677902|NCT01817764|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25677903|NCT01817764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25677904|NCT01817764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25677905|NCT01817764|Autonomic Agents|autonomic agents|mesh-ancestor
25677906|NCT01817764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24426172|NCT00235235|Capecitabine|capecitabine|mesh-list
24426183|NCT00235235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24426184|NCT00235235|Antimetabolites|antimetabolites|mesh-ancestor
24426197|NCT00235248|Clopidogrel|clopidogrel|mesh-list
24426198|NCT00235248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24426199|NCT00235248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24426200|NCT00235248|Analgesics|analgesics|mesh-ancestor
24426201|NCT00235248|Sensory System Agents|sensory system agents|mesh-ancestor
24426202|NCT00235248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24426203|NCT00235248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426243|NCT00235274|Secretin|secretin|mesh-list
24426248|NCT00235287|Candesartan|candesartan|mesh-list
24546834|NCT00700648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24426688|NCT00236483|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24546835|NCT00700648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426371|NCT00235911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24426372|NCT00235911|Respiratory System Agents|respiratory system agents|mesh-ancestor
24426373|NCT00235911|Glucocorticoids|glucocorticoids|mesh-ancestor
24426374|NCT00235911|Hormones|hormones|mesh-ancestor
24426695|NCT00236509|Topiramate|topiramate|mesh-list
24426375|NCT00235911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24426376|NCT00235911|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24426377|NCT00235911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24426378|NCT00235911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24426379|NCT00235911|Adrenergic Agents|adrenergic agents|mesh-ancestor
24426380|NCT00235911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24426424|NCT00236015|Anticonvulsants|anticonvulsants|mesh-ancestor
24426425|NCT00236015|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
24426426|NCT00236015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24426427|NCT00236015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24426428|NCT00236015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426429|NCT00236015|GABA Agents|gaba agents|mesh-ancestor
24426432|NCT00236028|Infliximab|infliximab|mesh-list
24426475|NCT00236106|Dermatologic Agents|dermatologic agents|mesh-ancestor
24824370|NCT02123069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25212760|NCT05368051|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25212761|NCT05368051|Immunologic Factors|immunologic factors|mesh-ancestor
25212762|NCT05368051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212763|NCT05368051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25212764|NCT05368051|Antimetabolites|antimetabolites|mesh-ancestor
25212765|NCT05368051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212766|NCT05368051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212767|NCT05367765|Imatinib Mesylate|imatinib mesylate|mesh-list
24947180|NCT03931889|Vitamins|vitamins|mesh-ancestor
24824371|NCT02123069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824372|NCT02123069|Sympathomimetics|sympathomimetics|mesh-ancestor
24824373|NCT02123069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24426476|NCT00236106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24426478|NCT00236145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24426536|NCT00236275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24426537|NCT00236275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24426538|NCT00236275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426539|NCT00236288|Bupropion|bupropion|mesh-list
24426540|NCT00236288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24426541|NCT00236288|Antidepressive Agents|antidepressive agents|mesh-ancestor
24426542|NCT00236288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24426592|NCT00236366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24426593|NCT00236366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426594|NCT00236366|Analgesics|analgesics|mesh-ancestor
24426595|NCT00236366|Sensory System Agents|sensory system agents|mesh-ancestor
24426596|NCT00236366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24426597|NCT00236366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24426598|NCT00236366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24426599|NCT00236366|Anesthetics, General|anesthetics, general|mesh-ancestor
24426600|NCT00236366|Anesthetics|anesthetics|mesh-ancestor
24426621|NCT00236392|Rabeprazole|rabeprazole|mesh-list
24426622|NCT00236392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24824380|NCT02123069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24695149|NCT04425902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24426623|NCT00236392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24426669|NCT00236470|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24426670|NCT00236470|Serotonin Agents|serotonin agents|mesh-ancestor
24426671|NCT00236470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24426672|NCT00236470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426673|NCT00236470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426674|NCT00236470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24426675|NCT00236470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24426676|NCT00236470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24426677|NCT00236470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24426678|NCT00236470|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24426679|NCT00236470|Dopamine Agents|dopamine agents|mesh-ancestor
24426680|NCT00236483|Acetaminophen|acetaminophen|mesh-list
24426681|NCT00236483|Tramadol|tramadol|mesh-list
24426682|NCT00236483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24426683|NCT00236483|Analgesics|analgesics|mesh-ancestor
24426684|NCT00236483|Sensory System Agents|sensory system agents|mesh-ancestor
24426685|NCT00236483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24426686|NCT00236483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426687|NCT00236483|Antipyretics|antipyretics|mesh-ancestor
25212771|NCT05367765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25156606|NCT04974814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25156607|NCT04974814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661713|NCT01290458|Vitamins|vitamins|mesh-list
25156616|NCT04971356|Aspirin|aspirin|mesh-list
24426793|NCT00236652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24426794|NCT00236652|Renal Agents|renal agents|mesh-ancestor
24426856|NCT00236769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24426857|NCT00236769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426858|NCT00236769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24426859|NCT00236769|Contraceptive Agents|contraceptive agents|mesh-ancestor
24426860|NCT00236769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24426861|NCT00236769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24426862|NCT00236769|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24426863|NCT00236769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24426864|NCT00236782|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24426865|NCT00236782|Norelgestromin|norelgestromin|mesh-list
24426869|NCT00236782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24711186|NCT01513941|Ribavirin|ribavirin|mesh-list
24426883|NCT00236795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24547215|NCT00702975|Growth Inhibitors|growth inhibitors|mesh-ancestor
24547216|NCT00702975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25212772|NCT05367765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212773|NCT05367687|Apatinib|apatinib|mesh-list
25212774|NCT05367687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212775|NCT05367687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25212776|NCT05367687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212777|NCT05367687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426907|NCT00236808|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24426908|NCT00236808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24426910|NCT00236821|Ofloxacin|ofloxacin|mesh-list
24426911|NCT00236821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24426912|NCT00236821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24711231|NCT01514175|Ketorolac|ketorolac|mesh-list
24547255|NCT00703235|Bevacizumab|bevacizumab|mesh-list
24427386|NCT00238147|Docetaxel|docetaxel|mesh-list
24427387|NCT00238147|Capecitabine|capecitabine|mesh-list
24426942|NCT00236860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24426943|NCT00236860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824452|NCT02123498|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24824453|NCT02123498|Histamine Antagonists|histamine antagonists|mesh-ancestor
24427049|NCT00237237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427069|NCT00237302|Anticonvulsants|anticonvulsants|mesh-ancestor
24427070|NCT00237302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25035289|NCT03557437|Expectorants|expectorants|mesh-ancestor
25035290|NCT03557437|Respiratory System Agents|respiratory system agents|mesh-ancestor
25035291|NCT03557424|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
25035292|NCT03557424|Cathartics|cathartics|mesh-ancestor
25035293|NCT03557424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25258680|NCT02468661|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25258681|NCT02468661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25258682|NCT02468661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25258685|NCT02468518|Vitamin E|vitamin e|mesh-list
24824461|NCT02123524|Protease Inhibitors|protease inhibitors|mesh-ancestor
24824462|NCT02123524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427112|NCT00237471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24427113|NCT00237471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427115|NCT00237484|Ribavirin|ribavirin|mesh-list
24427116|NCT00237484|Interferon-alpha|interferon-alpha|mesh-list
24427150|NCT00237536|Lonidamine|lonidamine|mesh-list
24427151|NCT00237536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427152|NCT00237536|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
24427153|NCT00237536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427154|NCT00237536|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24427155|NCT00237536|Contraceptive Agents|contraceptive agents|mesh-ancestor
24427185|NCT00237614|Acetylcysteine|acetylcysteine|mesh-list
24427186|NCT00237614|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24427187|NCT00237614|Antiviral Agents|antiviral agents|mesh-ancestor
24427188|NCT00237614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24427189|NCT00237614|Expectorants|expectorants|mesh-ancestor
24427190|NCT00237614|Respiratory System Agents|respiratory system agents|mesh-ancestor
25212786|NCT05367479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25212787|NCT05367414|Tea Tree Oil|tea tree oil|mesh-list
25212788|NCT05367414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25212789|NCT05367414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24427239|NCT00237861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24427240|NCT00237861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24427289|NCT00237900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427290|NCT00237913|Olanzapine|olanzapine|mesh-list
24427291|NCT00237913|Risperidone|risperidone|mesh-list
24427292|NCT00237913|Aripiprazole|aripiprazole|mesh-list
24427293|NCT00237913|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24427294|NCT00237913|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24427295|NCT00237913|Serotonin Agents|serotonin agents|mesh-ancestor
24427320|NCT00237939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24427321|NCT00237939|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24427322|NCT00237939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24427323|NCT00237939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24427324|NCT00237939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661904|NCT01291472|Analgesics|analgesics|mesh-ancestor
24427325|NCT00237939|Dopamine Agonists|dopamine agonists|mesh-ancestor
24427326|NCT00237939|Dopamine Agents|dopamine agents|mesh-ancestor
24427327|NCT00237939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24427328|NCT00237939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427329|NCT00237939|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24427330|NCT00237939|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24427331|NCT00237939|Serotonin Agents|serotonin agents|mesh-ancestor
24427332|NCT00237939|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24427333|NCT00237939|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24427378|NCT00238082|Hormones|hormones|mesh-ancestor
24427379|NCT00238082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24427380|NCT00238082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427381|NCT00238082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24427382|NCT00238082|Respiratory System Agents|respiratory system agents|mesh-ancestor
24427383|NCT00238082|Anesthetics|anesthetics|mesh-ancestor
24427384|NCT00238082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25677907|NCT01817764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677908|NCT01817764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25677909|NCT01817764|Respiratory System Agents|respiratory system agents|mesh-ancestor
25677910|NCT01817764|Dermatologic Agents|dermatologic agents|mesh-ancestor
25677911|NCT01817764|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25677912|NCT01817764|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25677913|NCT01817764|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25677914|NCT01817764|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24427385|NCT00238147|Carboplatin|carboplatin|mesh-list
24824479|NCT02123589|Anesthetics, General|anesthetics, general|mesh-ancestor
24824480|NCT02123589|Anesthetics|anesthetics|mesh-ancestor
24824482|NCT02123589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24824483|NCT02123589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25212790|NCT05367362|Minocycline|minocycline|mesh-list
25212791|NCT05367362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24427562|NCT00238368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24427563|NCT00238368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24427594|NCT00238407|Antimitotic Agents|antimitotic agents|mesh-ancestor
24427595|NCT00238407|Mitosis Modulators|mitosis modulators|mesh-ancestor
24427596|NCT00238407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427613|NCT00238537|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24427614|NCT00238537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24427615|NCT00238537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24427616|NCT00238537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427617|NCT00238563|Triamcinolone|triamcinolone|mesh-list
24427618|NCT00238563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24427621|NCT00238563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24427623|NCT00238628|Bexarotene|bexarotene|mesh-list
24427624|NCT00238628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427643|NCT00238667|Dipyridamole|dipyridamole|mesh-list
24427687|NCT00238732|Hormone Antagonists|hormone antagonists|mesh-ancestor
24427688|NCT00238732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24427689|NCT00238745|Bazedoxifene|bazedoxifene|mesh-list
24427690|NCT00238745|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24824521|NCT02123628|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24824522|NCT02123628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24824523|NCT02123628|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24824525|NCT02123628|Leprostatic Agents|leprostatic agents|mesh-ancestor
24824526|NCT02123628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24824527|NCT02123628|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24824528|NCT02123628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24824529|NCT02123628|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24824555|NCT02124070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24824557|NCT02124148|Leucovorin|leucovorin|mesh-list
24824558|NCT02124148|Fluorouracil|fluorouracil|mesh-list
24824559|NCT02124148|Pemetrexed|pemetrexed|mesh-list
24824560|NCT02124148|Cetuximab|cetuximab|mesh-list
24824561|NCT02124148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24824562|NCT02124148|Antimetabolites|antimetabolites|mesh-ancestor
24824563|NCT02124148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824564|NCT02124148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24824565|NCT02124148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24824566|NCT02124148|Immunologic Factors|immunologic factors|mesh-ancestor
24824567|NCT02124148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824568|NCT02124148|Antidotes|antidotes|mesh-ancestor
24824569|NCT02124148|Protective Agents|protective agents|mesh-ancestor
24824570|NCT02124148|Vitamin B Complex|vitamin b complex|mesh-ancestor
24824571|NCT02124148|Vitamins|vitamins|mesh-ancestor
24824572|NCT02124148|Micronutrients|micronutrients|mesh-ancestor
24824573|NCT02124148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824605|NCT02124226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24824606|NCT02124226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824607|NCT02124226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24824608|NCT02124226|Antimetabolites|antimetabolites|mesh-ancestor
24824609|NCT02124226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25156622|NCT04971356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25156623|NCT04971356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25156624|NCT04971356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25156625|NCT04971356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25156626|NCT04971356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25156627|NCT04971356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25156628|NCT04971356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25156629|NCT04971356|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24824610|NCT02124226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24824611|NCT02124226|Dermatologic Agents|dermatologic agents|mesh-ancestor
24824612|NCT02124226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824613|NCT02124226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24824614|NCT02124226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24824615|NCT02124226|Immunologic Factors|immunologic factors|mesh-ancestor
24824616|NCT02124226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24824617|NCT02124226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24824618|NCT02124278|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
24824619|NCT02124278|Respiratory System Agents|respiratory system agents|mesh-ancestor
24824620|NCT02124317|Paclitaxel|paclitaxel|mesh-list
24547588|NCT00704743|Calpastatin|calpastatin|mesh-list
24824621|NCT02124317|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24824622|NCT02124317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24581104|NCT00864435|Antioxidants|antioxidants|mesh-ancestor
24824623|NCT02124317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24824624|NCT02124317|Tubulin Modulators|tubulin modulators|mesh-ancestor
24427723|NCT00238901|Immunologic Factors|immunologic factors|mesh-ancestor
24427724|NCT00238901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427725|NCT00238914|Naltrexone|naltrexone|mesh-list
24427726|NCT00238914|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24427727|NCT00238914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24427728|NCT00238914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427729|NCT00238914|Sensory System Agents|sensory system agents|mesh-ancestor
24427730|NCT00238914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24427731|NCT00238927|Fluticasone|fluticasone|mesh-list
24427732|NCT00238927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24427754|NCT00238953|Antitubercular Agents|antitubercular agents|mesh-ancestor
24427755|NCT00238953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24427756|NCT00238953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24427757|NCT00238953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427758|NCT00238953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427759|NCT00238966|Mycophenolic Acid|mycophenolic acid|mesh-list
24824664|NCT02124525|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24824666|NCT02124525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824689|NCT02124733|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24824690|NCT02124733|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24824691|NCT02124733|Dermatologic Agents|dermatologic agents|mesh-ancestor
24824692|NCT02124850|Nivolumab|nivolumab|mesh-list
24824693|NCT02124850|Cetuximab|cetuximab|mesh-list
24824694|NCT02124850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24824695|NCT02124850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24824735|NCT02125201|Sensory System Agents|sensory system agents|mesh-ancestor
24824736|NCT02125201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24824737|NCT02125201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24824738|NCT02125201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24824739|NCT02125201|Anesthetics, General|anesthetics, general|mesh-ancestor
24824740|NCT02125201|Anesthetics|anesthetics|mesh-ancestor
24427802|NCT00239031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212792|NCT05367362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25212793|NCT05367336|Fentanyl|fentanyl|mesh-list
25212794|NCT05367336|Morphine|morphine|mesh-list
25212795|NCT05367336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25212796|NCT05367336|Narcotics|narcotics|mesh-ancestor
25212797|NCT05367336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25212798|NCT05367336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212799|NCT05367336|Analgesics|analgesics|mesh-ancestor
25212800|NCT05367336|Sensory System Agents|sensory system agents|mesh-ancestor
25156631|NCT04971356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25156632|NCT04971356|Antipyretics|antipyretics|mesh-ancestor
25156633|NCT04971356|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24427804|NCT00239044|Mycophenolic Acid|mycophenolic acid|mesh-list
24427805|NCT00239044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24427806|NCT00239044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427807|NCT00239044|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24427809|NCT00239044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24427810|NCT00239044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24427811|NCT00239044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25159900|NCT03518060|Antiviral Agents|antiviral agents|mesh-ancestor
25258752|NCT02468128|Narcotics|narcotics|mesh-ancestor
25258753|NCT02468128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25258754|NCT02468128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258755|NCT02468128|Analgesics|analgesics|mesh-ancestor
25258756|NCT02468128|Sensory System Agents|sensory system agents|mesh-ancestor
25258757|NCT02468128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25258758|NCT02468063|Terlipressin|terlipressin|mesh-list
25258759|NCT02468063|Norepinephrine|norepinephrine|mesh-list
25258760|NCT02468063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25258761|NCT02468063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24427812|NCT00239044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662245|NCT01293643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24662246|NCT01293643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24455770|NCT00328939|Enoxaparin|enoxaparin|mesh-list
24662247|NCT01293643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427830|NCT00239070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427831|NCT00239083|Mycophenolic Acid|mycophenolic acid|mesh-list
24427832|NCT00239083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24427833|NCT00239083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427834|NCT00239083|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24427835|NCT00239083|Antitubercular Agents|antitubercular agents|mesh-ancestor
24427836|NCT00239083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24427837|NCT00239083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24427838|NCT00239083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824763|NCT02125344|Doxorubicin|doxorubicin|mesh-list
24824764|NCT02125344|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24824765|NCT02125344|Trastuzumab|trastuzumab|mesh-list
24824766|NCT02125344|Epirubicin|epirubicin|mesh-list
24824767|NCT02125344|Pertuzumab|pertuzumab|mesh-list
24824768|NCT02125344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24824769|NCT02125344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24824770|NCT02125344|Tubulin Modulators|tubulin modulators|mesh-ancestor
24824771|NCT02125344|Antimitotic Agents|antimitotic agents|mesh-ancestor
24696346|NCT01428908|Vaccines|vaccines|mesh-list
24427959|NCT00239382|Sensory System Agents|sensory system agents|mesh-ancestor
24427960|NCT00239382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24427961|NCT00239382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427962|NCT00239382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24427963|NCT00239382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24427964|NCT00239382|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24427965|NCT00239382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24427973|NCT00239395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24427974|NCT00239395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427975|NCT00239395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24427976|NCT00239395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24427977|NCT00239395|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24427978|NCT00239395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24427979|NCT00239395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427980|NCT00239395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427981|NCT00239408|Bromides|bromides|mesh-list
24427982|NCT00239408|Tiotropium Bromide|tiotropium bromide|mesh-list
24427983|NCT00239408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24428055|NCT00239460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24428056|NCT00239460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824789|NCT02125357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824790|NCT02125357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824791|NCT02125357|Hormone Antagonists|hormone antagonists|mesh-ancestor
24824792|NCT02125357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24774949|NCT01848808|Wobenzym|wobenzym|mesh-list
25212801|NCT05367336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25212802|NCT05367336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25677915|NCT01817764|Adrenergic Agents|adrenergic agents|mesh-ancestor
25677916|NCT01817764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25677917|NCT01817764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677918|NCT01817777|Metformin|metformin|mesh-list
25677919|NCT01817777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25677920|NCT01817777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677921|NCT01817790|Fluticasone|fluticasone|mesh-list
25677922|NCT01817790|Xhance|xhance|mesh-list
25677923|NCT01817790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25677924|NCT01817790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25212803|NCT05367336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25212804|NCT05367336|Anesthetics, General|anesthetics, general|mesh-ancestor
25156634|NCT04971356|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24428112|NCT00239512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428113|NCT00239512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428114|NCT00239512|Gout Suppressants|gout suppressants|mesh-ancestor
24428115|NCT00239512|Tocolytic Agents|tocolytic agents|mesh-ancestor
24428116|NCT00239512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24428117|NCT00239538|Valsartan|valsartan|mesh-list
24428118|NCT00239538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24428138|NCT00239629|Strontium ranelate|strontium ranelate|mesh-list
24824794|NCT02125357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24824795|NCT02125409|Aspirin|aspirin|mesh-list
24824796|NCT02125409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24824797|NCT02125409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24824798|NCT02125409|Analgesics|analgesics|mesh-ancestor
24824799|NCT02125409|Sensory System Agents|sensory system agents|mesh-ancestor
24428139|NCT00239629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24428140|NCT00239629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428141|NCT00239629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24428142|NCT00239707|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
24428143|NCT00239707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24428144|NCT00239707|Incretins|incretins|mesh-ancestor
24428145|NCT00239707|Hormones|hormones|mesh-ancestor
24428146|NCT00239707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24712125|NCT01518634|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24428150|NCT00239746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24428151|NCT00239746|Analgesics|analgesics|mesh-ancestor
24428152|NCT00239746|Sensory System Agents|sensory system agents|mesh-ancestor
24428153|NCT00239746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24428154|NCT00239746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428155|NCT00239746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24428156|NCT00239746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24428157|NCT00239746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24428158|NCT00239746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428159|NCT00239746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428160|NCT00239785|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24428161|NCT00239785|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24428162|NCT00239785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428189|NCT00239876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428190|NCT00239889|Calcitonin|calcitonin|mesh-list
24428191|NCT00239889|Salmon calcitonin|salmon calcitonin|mesh-list
24622215|NCT01066195|Pemetrexed|pemetrexed|mesh-list
24428192|NCT00239889|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
24428193|NCT00239889|Katacalcin|katacalcin|mesh-list
24428194|NCT00239889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24824800|NCT02125409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24824801|NCT02125409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824802|NCT02125409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24824803|NCT02125409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24824804|NCT02125409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24824805|NCT02125409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24774997|NCT01849211|Rocuronium|rocuronium|mesh-list
24824815|NCT02125513|Paclitaxel|paclitaxel|mesh-list
24824816|NCT02125513|Carboplatin|carboplatin|mesh-list
24824817|NCT02125513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24696617|NCT01430351|Metformin|metformin|mesh-list
24428238|NCT00240006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24428239|NCT00240019|Furosemide|furosemide|mesh-list
24428240|NCT00240019|Diuretics|diuretics|mesh-ancestor
24428241|NCT00240019|Natriuretic Agents|natriuretic agents|mesh-ancestor
24428242|NCT00240019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446765|NCT00305825|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24662378|NCT01294410|Antibodies|antibodies|mesh-list
24428257|NCT00240032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24428258|NCT00240032|Immunologic Factors|immunologic factors|mesh-ancestor
25258806|NCT02467647|Immunologic Factors|immunologic factors|mesh-ancestor
24428259|NCT00240032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24428260|NCT00240032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24428262|NCT00240045|Midodrine|midodrine|mesh-list
24428263|NCT00240045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24428264|NCT00240045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24428265|NCT00240045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24428266|NCT00240045|Sympathomimetics|sympathomimetics|mesh-ancestor
24428327|NCT00240149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824818|NCT02125513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24824820|NCT02125513|Antimitotic Agents|antimitotic agents|mesh-ancestor
24824821|NCT02125513|Mitosis Modulators|mitosis modulators|mesh-ancestor
24824822|NCT02125513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824823|NCT02125565|Lidocaine|lidocaine|mesh-list
24824824|NCT02125565|Anesthetics, Local|anesthetics, local|mesh-ancestor
24824825|NCT02125565|Anesthetics|anesthetics|mesh-ancestor
24824826|NCT02125565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24824827|NCT02125565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824828|NCT02125565|Sensory System Agents|sensory system agents|mesh-ancestor
24824829|NCT02125565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24824830|NCT02125565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24824831|NCT02125565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24824832|NCT02125565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24824833|NCT02125565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24428442|NCT00240474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428443|NCT00240474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24428444|NCT00240474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428445|NCT00240474|Vasodilator Agents|vasodilator agents|mesh-ancestor
24428446|NCT00240474|Diuretics|diuretics|mesh-ancestor
24428447|NCT00240474|Natriuretic Agents|natriuretic agents|mesh-ancestor
24428448|NCT00240474|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25049879|NCT00557973|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
24428449|NCT00240474|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24824885|NCT02125890|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25115561|NCT03115060|Plasma-lyte 148|plasma-lyte 148|mesh-list
24824886|NCT02125890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24824887|NCT02125890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428737|NCT00241072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24428738|NCT00241072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428739|NCT00241085|Valsartan|valsartan|mesh-list
24428742|NCT00241085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24428743|NCT00241085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428754|NCT00241124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24428828|NCT00241254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428829|NCT00241254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24428830|NCT00241254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24428831|NCT00241254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24428832|NCT00241254|Antiemetics|antiemetics|mesh-ancestor
24428833|NCT00241254|Autonomic Agents|autonomic agents|mesh-ancestor
24428850|NCT00241332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24428851|NCT00241332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24428852|NCT00241332|Anesthetics, General|anesthetics, general|mesh-ancestor
24428853|NCT00241332|Anesthetics|anesthetics|mesh-ancestor
24428854|NCT00241345|Valganciclovir|valganciclovir|mesh-list
24428855|NCT00241345|Ganciclovir|ganciclovir|mesh-list
24774820|NCT01848132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24774821|NCT01848132|Immunologic Factors|immunologic factors|mesh-ancestor
24774822|NCT01848132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951254|NCT03906669|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24774823|NCT01848132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24774824|NCT01848132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24774861|NCT01848301|Vasodilator Agents|vasodilator agents|mesh-ancestor
25677925|NCT01817790|Autonomic Agents|autonomic agents|mesh-ancestor
25677926|NCT01817790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25677927|NCT01817790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677928|NCT01817790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25677929|NCT01817790|Respiratory System Agents|respiratory system agents|mesh-ancestor
25677930|NCT01817790|Dermatologic Agents|dermatologic agents|mesh-ancestor
25677931|NCT01817790|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25677932|NCT01817855|AZD7624|azd7624|mesh-list
25677933|NCT01817855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25677934|NCT01817855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774862|NCT01848301|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24774863|NCT01848301|Cholinergic Agents|cholinergic agents|mesh-ancestor
24774864|NCT01848301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24774865|NCT01848301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774866|NCT01848301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774882|NCT01848613|Antimitotic Agents|antimitotic agents|mesh-ancestor
24774883|NCT01848613|Mitosis Modulators|mitosis modulators|mesh-ancestor
24774884|NCT01848613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774923|NCT01848743|Antiviral Agents|antiviral agents|mesh-ancestor
24774924|NCT01848743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24774925|NCT01848743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24774926|NCT01848743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24774927|NCT01848743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774928|NCT01848743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774929|NCT01848743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24774930|NCT01848743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24774932|NCT01848769|Formoterol Fumarate|formoterol fumarate|mesh-list
24774933|NCT01848769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24712722|NCT01522612|Leucovorin|leucovorin|mesh-list
24627327|NCT01091870|Sildenafil Citrate|sildenafil citrate|mesh-list
24627328|NCT01091870|Citric Acid|citric acid|mesh-list
24627329|NCT01091870|Sodium Citrate|sodium citrate|mesh-list
24627337|NCT01091870|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24774944|NCT01848769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774945|NCT01848769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25212833|NCT05367245|Butyric Acid|butyric acid|mesh-list
25212834|NCT05367245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212835|NCT05367245|Histamine Antagonists|histamine antagonists|mesh-ancestor
25212836|NCT05367245|Histamine Agents|histamine agents|mesh-ancestor
25212837|NCT05367245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25212838|NCT05367245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212839|NCT05367206|Paclitaxel|paclitaxel|mesh-list
25212840|NCT05367206|Carboplatin|carboplatin|mesh-list
24947237|NCT03931135|Analgesics|analgesics|mesh-ancestor
24774946|NCT01848769|Glucocorticoids|glucocorticoids|mesh-ancestor
24774947|NCT01848769|Hormones|hormones|mesh-ancestor
24774948|NCT01848769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24774950|NCT01848808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24774951|NCT01848808|Immunologic Factors|immunologic factors|mesh-ancestor
24774952|NCT01848808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485183|NCT00451880|Famotidine|famotidine|mesh-list
24485190|NCT00451880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485191|NCT00451880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774958|NCT01848873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24774959|NCT01848873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774960|NCT01848873|Vasodilator Agents|vasodilator agents|mesh-ancestor
24774962|NCT01848925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774963|NCT01848925|Antisickling Agents|antisickling agents|mesh-ancestor
24774964|NCT01848925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774965|NCT01848925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774966|NCT01848925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24774967|NCT01849016|Acetylcysteine|acetylcysteine|mesh-list
24774968|NCT01849016|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24774969|NCT01849016|Antiviral Agents|antiviral agents|mesh-ancestor
24774970|NCT01849016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24774971|NCT01849016|Expectorants|expectorants|mesh-ancestor
24774972|NCT01849016|Respiratory System Agents|respiratory system agents|mesh-ancestor
24774973|NCT01849016|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25081333|NCT03330990|Midazolam|midazolam|mesh-list
25081334|NCT03330990|Entrectinib|entrectinib|mesh-list
25081339|NCT03330990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25081340|NCT03330990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25081341|NCT03330990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25081342|NCT03330990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25212841|NCT05367206|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25212842|NCT05367206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25212843|NCT05367206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212844|NCT05367206|Tubulin Modulators|tubulin modulators|mesh-ancestor
25212845|NCT05367206|Antimitotic Agents|antimitotic agents|mesh-ancestor
25212846|NCT05367206|Mitosis Modulators|mitosis modulators|mesh-ancestor
25212847|NCT05367206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212848|NCT05367089|Fluconazole|fluconazole|mesh-list
25212849|NCT05367089|Antifungal Agents|antifungal agents|mesh-ancestor
25212850|NCT05367089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25258865|NCT02467595|Analgesics|analgesics|mesh-ancestor
25258866|NCT02467595|Sensory System Agents|sensory system agents|mesh-ancestor
25258867|NCT02467595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25258868|NCT02467595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25258869|NCT02467595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25212851|NCT05367089|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25212852|NCT05367089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25212853|NCT05367089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212854|NCT05367089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212855|NCT05367089|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25212856|NCT05367089|Hormone Antagonists|hormone antagonists|mesh-ancestor
25212857|NCT05367089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24485195|NCT00451971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25081352|NCT03330886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081353|NCT03330860|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25081354|NCT03330860|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
25081355|NCT03330860|beta-Endorphin|beta-endorphin|mesh-list
24627339|NCT01091870|Urological Agents|urological agents|mesh-ancestor
24774974|NCT01849016|Antioxidants|antioxidants|mesh-ancestor
24774975|NCT01849016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774976|NCT01849016|Protective Agents|protective agents|mesh-ancestor
24774977|NCT01849016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774980|NCT01849042|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24774981|NCT01849042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774982|NCT01849042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774983|NCT01849042|Cholinergic Agents|cholinergic agents|mesh-ancestor
24774984|NCT01849042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24774985|NCT01849042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774986|NCT01849042|Nootropic Agents|nootropic agents|mesh-ancestor
24774988|NCT01849094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24774989|NCT01849094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24774990|NCT01849094|Vasodilator Agents|vasodilator agents|mesh-ancestor
24774991|NCT01849094|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24774992|NCT01849094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24774993|NCT01849094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774994|NCT01849094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774995|NCT01849094|Protective Agents|protective agents|mesh-ancestor
24774996|NCT01849094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566233|NCT00784862|Tamoxifen|tamoxifen|mesh-list
24566234|NCT00784862|Anastrozole|anastrozole|mesh-list
24774998|NCT01849211|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24774999|NCT01849211|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24775000|NCT01849211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24775001|NCT01849211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24775033|NCT01849861|Methimazole|methimazole|mesh-list
24775038|NCT01849926|Amdinocillin|amdinocillin|mesh-list
24775039|NCT01849926|Ibuprofen|ibuprofen|mesh-list
24775040|NCT01849926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24775041|NCT01849926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24775042|NCT01849926|Analgesics|analgesics|mesh-ancestor
24775043|NCT01849926|Sensory System Agents|sensory system agents|mesh-ancestor
24775046|NCT01849926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24775047|NCT01849926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24775048|NCT01849926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25081356|NCT03330860|Hormones|hormones|mesh-ancestor
24775075|NCT01850095|Hormones|hormones|mesh-ancestor
24775076|NCT01850095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24775077|NCT01850095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775078|NCT01850095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24775079|NCT01850095|Dermatologic Agents|dermatologic agents|mesh-ancestor
24775080|NCT01850121|Infliximab|infliximab|mesh-list
24775081|NCT01850121|Dermatologic Agents|dermatologic agents|mesh-ancestor
24775082|NCT01850121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24775083|NCT01850121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24775084|NCT01850147|Sunitinib|sunitinib|mesh-list
24775106|NCT01850160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25677935|NCT01817855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677936|NCT01817907|Trazodone|trazodone|mesh-list
25677937|NCT01817907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25677938|NCT01817907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25677939|NCT01817907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25035690|NCT03553628|Dermatologic Agents|dermatologic agents|mesh-ancestor
25035691|NCT03553615|Ivermectin|ivermectin|mesh-list
25035692|NCT03553615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25035693|NCT03553615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25035706|NCT03553537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25035707|NCT03553537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25035708|NCT03553537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25035709|NCT03553537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25035710|NCT03553537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25035711|NCT03553537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25035712|NCT03553537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25035713|NCT03553537|Glucocorticoids|glucocorticoids|mesh-ancestor
24603123|NCT00972426|Autonomic Agents|autonomic agents|mesh-ancestor
24775107|NCT01850251|Vitamin D|vitamin d|mesh-list
24775108|NCT01850251|Vitamins|vitamins|mesh-ancestor
24775109|NCT01850251|Micronutrients|micronutrients|mesh-ancestor
24775110|NCT01850251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775111|NCT01850251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25212858|NCT05367089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212859|NCT05367089|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25212860|NCT05367089|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25212861|NCT05367063|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24775112|NCT01850277|Amiodarone|amiodarone|mesh-list
24775113|NCT01850277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24775114|NCT01850277|Vasodilator Agents|vasodilator agents|mesh-ancestor
24775115|NCT01850277|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24775116|NCT01850277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24775117|NCT01850277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775118|NCT01850277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24775119|NCT01850277|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24775120|NCT01850277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24775121|NCT01850277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775122|NCT01850277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24775123|NCT01850277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24775124|NCT01850277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24775125|NCT01850303|Gemcitabine|gemcitabine|mesh-list
24775126|NCT01850303|Pemetrexed|pemetrexed|mesh-list
24775127|NCT01850303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24775128|NCT01850303|Antimetabolites|antimetabolites|mesh-ancestor
24775129|NCT01850303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775130|NCT01850303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24775131|NCT01850303|Antiviral Agents|antiviral agents|mesh-ancestor
24775132|NCT01850303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24775133|NCT01850303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775168|NCT01850680|Methotrexate|methotrexate|mesh-list
24775169|NCT01850680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24775170|NCT01850680|Abortifacient Agents|abortifacient agents|mesh-ancestor
24775171|NCT01850680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24775172|NCT01850680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775173|NCT01850680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24775174|NCT01850680|Antimetabolites|antimetabolites|mesh-ancestor
24775175|NCT01850680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775176|NCT01850680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24775177|NCT01850680|Dermatologic Agents|dermatologic agents|mesh-ancestor
24775178|NCT01850680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566522|NCT00786253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566523|NCT00786253|Urological Agents|urological agents|mesh-ancestor
24566527|NCT00786279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24775925|NCT01855581|Analgesics|analgesics|mesh-ancestor
24566528|NCT00786279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566529|NCT00786305|Amikacin|amikacin|mesh-list
25677940|NCT01817907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677941|NCT01817907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25677942|NCT01817907|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25677943|NCT01817907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25677944|NCT01817907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25677945|NCT01817907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677946|NCT01817907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25677947|NCT01817907|Serotonin Agents|serotonin agents|mesh-ancestor
25677948|NCT01817907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25677949|NCT01817907|Antidepressive Agents|antidepressive agents|mesh-ancestor
25677950|NCT01818063|Paclitaxel|paclitaxel|mesh-list
25677951|NCT01818063|Cyclophosphamide|cyclophosphamide|mesh-list
24566530|NCT00786305|Ceftazidime|ceftazidime|mesh-list
24566531|NCT00786305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24566532|NCT00786305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24566533|NCT00786318|Ziprasidone|ziprasidone|mesh-list
24566534|NCT00786318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24775195|NCT01850953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24775196|NCT01850953|Cholinergic Agents|cholinergic agents|mesh-ancestor
24775197|NCT01850953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24775202|NCT01850979|Immunologic Factors|immunologic factors|mesh-ancestor
24775203|NCT01850979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775204|NCT01850979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24775205|NCT01850979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775206|NCT01850979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775207|NCT01851005|Dexmedetomidine|dexmedetomidine|mesh-list
24775208|NCT01851005|Remifentanil|remifentanil|mesh-list
24775209|NCT01851005|Anesthetics|anesthetics|mesh-list
24775210|NCT01851005|Propofol|propofol|mesh-list
24775211|NCT01851005|Sevoflurane|sevoflurane|mesh-list
24775212|NCT01851005|Rocuronium|rocuronium|mesh-list
24775213|NCT01851005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24775214|NCT01851005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775215|NCT01851005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24713128|NCT01524315|Micronutrients|micronutrients|mesh-ancestor
24775238|NCT01851148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24775239|NCT01851148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212862|NCT05367063|Canagliflozin|canagliflozin|mesh-list
25212863|NCT05367063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25212864|NCT05367063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801460|NCT01983722|Stiripentol|stiripentol|mesh-list
24775240|NCT01851148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775241|NCT01851200|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24775242|NCT01851200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24775243|NCT01851200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24775244|NCT01851265|Olaparib|olaparib|mesh-list
24775245|NCT01851265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24775246|NCT01851265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775247|NCT01851265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775248|NCT01851265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24775249|NCT01851278|Triamcinolone|triamcinolone|mesh-list
24775250|NCT01851278|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24775251|NCT01851278|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24775252|NCT01851278|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24775253|NCT01851278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24775254|NCT01851278|Glucocorticoids|glucocorticoids|mesh-ancestor
24775255|NCT01851278|Hormones|hormones|mesh-ancestor
24627340|NCT01091896|Bevacizumab|bevacizumab|mesh-list
24627341|NCT01091896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24627342|NCT01091896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24627343|NCT01091896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24627344|NCT01091896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24627345|NCT01091896|Growth Substances|growth substances|mesh-ancestor
24485261|NCT00452244|Antimetabolites|antimetabolites|mesh-ancestor
24627346|NCT01091896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627347|NCT01091896|Growth Inhibitors|growth inhibitors|mesh-ancestor
24627349|NCT01092039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24627350|NCT01092091|BCT-100|bct-100|mesh-list
24627351|NCT01092091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24794082|NCT05413902|Acetaminophen|acetaminophen|mesh-list
24587549|NCT00895609|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24587550|NCT00895609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621745|NCT01063660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24775256|NCT01851278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24775258|NCT01851278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24775259|NCT01851278|Immunologic Factors|immunologic factors|mesh-ancestor
24775260|NCT01851278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775261|NCT01851278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775262|NCT01851408|Sirolimus|sirolimus|mesh-list
24775263|NCT01851408|Sorafenib|sorafenib|mesh-list
24775264|NCT01851408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24775265|NCT01851408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24775266|NCT01851408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775268|NCT01851408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25081357|NCT03330860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25081358|NCT03330860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081359|NCT03330860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25081370|NCT03330782|Narcotics|narcotics|mesh-ancestor
25035854|NCT03552653|Vitamin D|vitamin d|mesh-list
25081371|NCT03330782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25081372|NCT03330782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081373|NCT03330782|Analgesics|analgesics|mesh-ancestor
25081374|NCT03330782|Sensory System Agents|sensory system agents|mesh-ancestor
25081375|NCT03330782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25212865|NCT05367063|Incretins|incretins|mesh-ancestor
25212866|NCT05367063|Hormones|hormones|mesh-ancestor
25212867|NCT05367063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25212868|NCT05367063|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25212869|NCT05367063|Protease Inhibitors|protease inhibitors|mesh-ancestor
25156702|NCT04961541|Vaccines|vaccines|mesh-list
25156703|NCT04961541|Immunologic Factors|immunologic factors|mesh-ancestor
25156704|NCT04961541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081376|NCT03330769|Antirheumatic Agents|antirheumatic agents|mesh-list
25081377|NCT03330717|Anesthetics|anesthetics|mesh-list
25081378|NCT03330717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25081379|NCT03330717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081380|NCT03330639|Capsaicin|capsaicin|mesh-list
25081381|NCT03330639|Antipruritics|antipruritics|mesh-ancestor
25081382|NCT03330639|Dermatologic Agents|dermatologic agents|mesh-ancestor
25081383|NCT03330639|Sensory System Agents|sensory system agents|mesh-ancestor
25081384|NCT03330639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24775272|NCT01851408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24775273|NCT01851408|Immunologic Factors|immunologic factors|mesh-ancestor
24775330|NCT01851551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24775331|NCT01851551|Tubulin Modulators|tubulin modulators|mesh-ancestor
24775332|NCT01851551|Antimitotic Agents|antimitotic agents|mesh-ancestor
24775333|NCT01851551|Mitosis Modulators|mitosis modulators|mesh-ancestor
24775334|NCT01851551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775350|NCT01851681|Amoxicillin|amoxicillin|mesh-list
24775351|NCT01851681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24775352|NCT01851681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24775353|NCT01851733|Doxorubicin|doxorubicin|mesh-list
24775354|NCT01851733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24775357|NCT01851733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24775358|NCT01851733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625012|NCT01079884|Esomeprazole|esomeprazole|mesh-list
24775359|NCT01851733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212871|NCT05367063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212872|NCT05367063|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25115633|NCT03114371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088248|NCT05074628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24775367|NCT01851824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775369|NCT01851850|Opicapone|opicapone|mesh-list
24775370|NCT01851850|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24775371|NCT01851850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775372|NCT01851850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775373|NCT01851850|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24775374|NCT01851850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24775375|NCT01851941|Leucovorin|leucovorin|mesh-list
24775376|NCT01851941|Folic Acid|folic acid|mesh-list
24775377|NCT01851941|Fluorouracil|fluorouracil|mesh-list
24775378|NCT01851941|Oxaliplatin|oxaliplatin|mesh-list
24775379|NCT01851941|Levoleucovorin|levoleucovorin|mesh-list
24775390|NCT01851941|Vitamins|vitamins|mesh-ancestor
24775391|NCT01851941|Micronutrients|micronutrients|mesh-ancestor
24775392|NCT01851941|Hematinics|hematinics|mesh-ancestor
24775394|NCT01851954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24775395|NCT01851954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24775396|NCT01851954|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24819196|NCT02094066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24819197|NCT02094066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819198|NCT02094066|Hemostatics|hemostatics|mesh-ancestor
24819199|NCT02094066|Coagulants|coagulants|mesh-ancestor
24819200|NCT02094157|Heparin|heparin|mesh-list
24819201|NCT02094157|Calcium heparin|calcium heparin|mesh-list
24819202|NCT02094157|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24819203|NCT02094157|Tinzaparin|tinzaparin|mesh-list
24775397|NCT01851954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775398|NCT01851954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775399|NCT01851954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24775400|NCT01851954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24775401|NCT01851980|Furosemide|furosemide|mesh-list
24775402|NCT01851980|Diuretics|diuretics|mesh-ancestor
24775403|NCT01851980|Natriuretic Agents|natriuretic agents|mesh-ancestor
25677952|NCT01818063|Carboplatin|carboplatin|mesh-list
25035913|NCT03552146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25258913|NCT02467400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25258914|NCT02467400|Vasodilator Agents|vasodilator agents|mesh-ancestor
25258915|NCT02467400|Sympatholytics|sympatholytics|mesh-ancestor
25258916|NCT02467400|Autonomic Agents|autonomic agents|mesh-ancestor
25258917|NCT02467400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25258918|NCT02467400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25258919|NCT02467400|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25258920|NCT02467400|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25258923|NCT02467517|Ketamine|ketamine|mesh-list
24775404|NCT01851980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775405|NCT01851980|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24775406|NCT01851980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24775407|NCT01851980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775408|NCT01851993|Ondansetron|ondansetron|mesh-list
24775409|NCT01851993|Antiemetics|antiemetics|mesh-ancestor
24775447|NCT01852318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24775449|NCT01852318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24775450|NCT01852318|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24775451|NCT01852318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24566861|NCT00788164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24566862|NCT00788164|Immunologic Factors|immunologic factors|mesh-ancestor
24566863|NCT00788164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566864|NCT00788164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566865|NCT00788164|Interferon Inducers|interferon inducers|mesh-ancestor
24566866|NCT00788242|Insulin|insulin|mesh-list
24566867|NCT00788242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24566868|NCT00788242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566869|NCT00788294|Tanezumab|tanezumab|mesh-list
24566870|NCT00788294|Analgesics|analgesics|mesh-ancestor
24566871|NCT00788294|Sensory System Agents|sensory system agents|mesh-ancestor
24566872|NCT00788294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24566873|NCT00788294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566874|NCT00788320|Vitamin D|vitamin d|mesh-list
24566875|NCT00788320|Cholecalciferol|cholecalciferol|mesh-list
24566876|NCT00788320|Vitamins|vitamins|mesh-ancestor
24566877|NCT00788320|Micronutrients|micronutrients|mesh-ancestor
24566878|NCT00788320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566879|NCT00788320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24775475|NCT01852539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24566880|NCT00788320|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25088410|NCT04630002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24775487|NCT01852565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24775488|NCT01852565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24775489|NCT01852565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24775494|NCT01852565|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
24775495|NCT01852565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775497|NCT01852604|Ritonavir|ritonavir|mesh-list
24775498|NCT01852604|Ribavirin|ribavirin|mesh-list
24775499|NCT01852604|Simeprevir|simeprevir|mesh-list
24775550|NCT01853111|Sensory System Agents|sensory system agents|mesh-ancestor
24775551|NCT01853111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24794801|NCT04524663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24794802|NCT04524663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794803|NCT04524663|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24794804|NCT04524663|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24588041|NCT00900445|Antiemetics|antiemetics|mesh-ancestor
24627368|NCT01092351|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24627369|NCT01092351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24627370|NCT01092351|Renal Agents|renal agents|mesh-ancestor
24627371|NCT01092351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24627373|NCT01092455|Calcium heparin|calcium heparin|mesh-list
24627374|NCT01092455|Anticoagulants|anticoagulants|mesh-ancestor
24627375|NCT01092455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25081387|NCT03330613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25677953|NCT01818063|Doxorubicin|doxorubicin|mesh-list
25677954|NCT01818063|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25677955|NCT01818063|Veliparib|veliparib|mesh-list
25677956|NCT01818063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25677957|NCT01818063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25677958|NCT01818063|Tubulin Modulators|tubulin modulators|mesh-ancestor
25677959|NCT01818063|Antimitotic Agents|antimitotic agents|mesh-ancestor
25677960|NCT01818063|Mitosis Modulators|mitosis modulators|mesh-ancestor
25677961|NCT01818063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677962|NCT01818063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25677963|NCT01818063|Immunologic Factors|immunologic factors|mesh-ancestor
25258931|NCT02467517|Anesthetics|anesthetics|mesh-ancestor
25081388|NCT03330613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081389|NCT03330223|Clopidogrel|clopidogrel|mesh-list
25081390|NCT03330223|Ticagrelor|ticagrelor|mesh-list
25081391|NCT03330223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25081392|NCT03330223|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24485262|NCT00452244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081415|NCT03330106|Mitosis Modulators|mitosis modulators|mesh-ancestor
25081416|NCT03330106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081417|NCT03330106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25081418|NCT03329898|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25081419|NCT03329898|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24775585|NCT01853540|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24775586|NCT01853540|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24775587|NCT01853540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775588|NCT01853540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775589|NCT01853540|Urological Agents|urological agents|mesh-ancestor
24775591|NCT01853566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24775592|NCT01853566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775593|NCT01853709|Bisacodyl|bisacodyl|mesh-list
24775594|NCT01853709|Cathartics|cathartics|mesh-ancestor
24775595|NCT01853709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24775597|NCT01853787|Formoterol Fumarate|formoterol fumarate|mesh-list
24775598|NCT01853787|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24775599|NCT01853787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24775600|NCT01853787|Autonomic Agents|autonomic agents|mesh-ancestor
24775601|NCT01853787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25212922|NCT05321576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25156760|NCT04946526|Mechlorethamine|mechlorethamine|mesh-list
24947300|NCT03930069|Vasopressins|vasopressins|mesh-list
24775651|NCT01854073|Antiemetics|antiemetics|mesh-ancestor
24775652|NCT01854073|Autonomic Agents|autonomic agents|mesh-ancestor
24800044|NCT01973010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24775653|NCT01854073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24775654|NCT01854073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775655|NCT01854073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24775656|NCT01854073|Mydriatics|mydriatics|mesh-ancestor
24566967|NCT00788918|Ribavirin|ribavirin|mesh-list
24775657|NCT01854073|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24775658|NCT01854073|Cholinergic Agents|cholinergic agents|mesh-ancestor
25089122|NCT03269162|Docetaxel|docetaxel|mesh-list
24775659|NCT01854073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24775660|NCT01854073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775661|NCT01854073|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24775662|NCT01854073|Parasympatholytics|parasympatholytics|mesh-ancestor
24775664|NCT01854086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24775720|NCT01854489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24775721|NCT01854489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775722|NCT01854489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775723|NCT01854489|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24775724|NCT01854489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24775725|NCT01854489|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24775726|NCT01854489|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24775727|NCT01854489|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24775728|NCT01854489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24775730|NCT01854502|Cariostatic Agents|cariostatic agents|mesh-ancestor
24775731|NCT01854502|Protective Agents|protective agents|mesh-ancestor
24775732|NCT01854502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775733|NCT01854515|Dexamethasone|dexamethasone|mesh-list
24775734|NCT01854515|Budesonide|budesonide|mesh-list
24775735|NCT01854515|Dexamethasone acetate|dexamethasone acetate|mesh-list
24775736|NCT01854515|BB 1101|bb 1101|mesh-list
24775737|NCT01854515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24775738|NCT01854515|Antiemetics|antiemetics|mesh-ancestor
24775739|NCT01854515|Autonomic Agents|autonomic agents|mesh-ancestor
24775740|NCT01854515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24775754|NCT01854606|Everolimus|everolimus|mesh-list
24663439|NCT01301248|Cisplatin|cisplatin|mesh-list
24775755|NCT01854606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24775756|NCT01854606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24775757|NCT01854606|Immunologic Factors|immunologic factors|mesh-ancestor
24775758|NCT01854606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775759|NCT01854619|Anti-Infective Agents|anti-infective agents|mesh-list
24775760|NCT01854619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24775765|NCT01854723|Insulin|insulin|mesh-list
25677964|NCT01818063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775766|NCT01854723|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24775767|NCT01854723|Insulin Glargine|insulin glargine|mesh-list
24775768|NCT01854723|Insulin, Isophane|insulin, isophane|mesh-list
24775769|NCT01854723|Isophane Insulin, Human|isophane insulin, human|mesh-list
24775770|NCT01854723|Isophane insulin, beef|isophane insulin, beef|mesh-list
24775771|NCT01854723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24775772|NCT01854723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775773|NCT01854749|Cisplatin|cisplatin|mesh-list
24775774|NCT01854749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212923|NCT05320705|Dexmedetomidine|dexmedetomidine|mesh-list
25212924|NCT05320705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25212925|NCT05320705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25212926|NCT05320705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212927|NCT05320705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25212928|NCT05320705|Analgesics|analgesics|mesh-ancestor
25212929|NCT05320705|Sensory System Agents|sensory system agents|mesh-ancestor
25212930|NCT05320705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25212931|NCT05320705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25212932|NCT05320705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25212933|NCT05320705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25156761|NCT04946526|Alkylating Agents|alkylating agents|mesh-ancestor
25156762|NCT04946526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25156763|NCT04946526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25156764|NCT04946526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24775776|NCT01854762|Lopinavir|lopinavir|mesh-list
24775777|NCT01854762|Raltegravir Potassium|raltegravir potassium|mesh-list
24775778|NCT01854762|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24775779|NCT01854762|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24775780|NCT01854762|Protease Inhibitors|protease inhibitors|mesh-ancestor
24775781|NCT01854762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775783|NCT01854762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24775797|NCT01855009|Calcium, Dietary|calcium, dietary|mesh-list
24775798|NCT01855009|Vitamin D|vitamin d|mesh-list
24775799|NCT01855009|Cholecalciferol|cholecalciferol|mesh-list
24775800|NCT01855009|Calcium Carbonate|calcium carbonate|mesh-list
24775801|NCT01855009|Calcium|calcium|mesh-list
24775802|NCT01855009|Vitamins|vitamins|mesh-ancestor
24775803|NCT01855009|Micronutrients|micronutrients|mesh-ancestor
24627387|NCT01092520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24627388|NCT01092520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24713740|NCT01527318|Clofibric Acid|clofibric acid|mesh-list
24775849|NCT01855256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24775850|NCT01855256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775851|NCT01855256|Urological Agents|urological agents|mesh-ancestor
24775852|NCT01855321|Vitamin D|vitamin d|mesh-list
24775853|NCT01855321|Cholecalciferol|cholecalciferol|mesh-list
24775854|NCT01855321|Vitamins|vitamins|mesh-ancestor
24775855|NCT01855321|Micronutrients|micronutrients|mesh-ancestor
24775856|NCT01855321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775857|NCT01855321|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24775858|NCT01855321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24775859|NCT01855334|Spironolactone|spironolactone|mesh-list
24775860|NCT01855334|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24775861|NCT01855334|Hormone Antagonists|hormone antagonists|mesh-ancestor
24775862|NCT01855334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24775863|NCT01855334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775864|NCT01855334|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24775865|NCT01855334|Diuretics|diuretics|mesh-ancestor
24775866|NCT01855334|Natriuretic Agents|natriuretic agents|mesh-ancestor
24775868|NCT01855386|Hematinics|hematinics|mesh-ancestor
25081437|NCT03329781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25081438|NCT03329781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775878|NCT01855490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24775879|NCT01855516|Heparin|heparin|mesh-list
24775880|NCT01855516|Anticoagulants|anticoagulants|mesh-ancestor
24775881|NCT01855516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24775882|NCT01855516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24775883|NCT01855516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775884|NCT01855529|Ropivacaine|ropivacaine|mesh-list
24775885|NCT01855529|Anesthetics, Local|anesthetics, local|mesh-ancestor
24775886|NCT01855529|Anesthetics|anesthetics|mesh-ancestor
24775887|NCT01855529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24775888|NCT01855529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775889|NCT01855529|Sensory System Agents|sensory system agents|mesh-ancestor
24775890|NCT01855529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24775891|NCT01855542|Plasma-lyte 148|plasma-lyte 148|mesh-list
24775892|NCT01855542|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24775893|NCT01855542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24775894|NCT01855555|Propofol|propofol|mesh-list
24775895|NCT01855555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24775896|NCT01855555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24775897|NCT01855555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775898|NCT01855555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25272736|NCT02390310|Sensory System Agents|sensory system agents|mesh-ancestor
25272737|NCT02390310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25051500|NCT00401011|Dexamethasone|dexamethasone|mesh-list
24775904|NCT01855568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24775905|NCT01855568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775906|NCT01855568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24713874|NCT01527890|Fentanyl|fentanyl|mesh-list
24567239|NCT00790244|Doxorubicin|doxorubicin|mesh-list
24567240|NCT00790244|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24567241|NCT00790244|Ifosfamide|ifosfamide|mesh-list
24567242|NCT00790244|Isophosphamide mustard|isophosphamide mustard|mesh-list
24567243|NCT00790244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24567244|NCT00790244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24567245|NCT00790244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24567246|NCT00790244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24567247|NCT00790244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775926|NCT01855581|Sensory System Agents|sensory system agents|mesh-ancestor
24775927|NCT01855581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24775928|NCT01855581|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24775929|NCT01855581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24775930|NCT01855581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24775931|NCT01855581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24913348|NCT04266132|Bupivacaine|bupivacaine|mesh-list
24485301|NCT00452556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24485302|NCT00452569|Thalidomide|thalidomide|mesh-list
24485303|NCT00452569|Dexamethasone|dexamethasone|mesh-list
24800088|NCT01973400|Vitamin E|vitamin e|mesh-list
24485304|NCT00452569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24485305|NCT00452569|Antiemetics|antiemetics|mesh-ancestor
24485306|NCT00452569|Autonomic Agents|autonomic agents|mesh-ancestor
24775932|NCT01855581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775934|NCT01855594|Antidepressive Agents|antidepressive agents|mesh-ancestor
24775935|NCT01855594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24775936|NCT01855594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775937|NCT01855594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775938|NCT01855594|Antimanic Agents|antimanic agents|mesh-ancestor
24775939|NCT01855594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24775940|NCT01855594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24775941|NCT01855594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775942|NCT01855607|Menthol|menthol|mesh-list
24775943|NCT01855607|Antipruritics|antipruritics|mesh-ancestor
24775955|NCT01855724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775957|NCT01855724|Antiviral Agents|antiviral agents|mesh-ancestor
24775958|NCT01855724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24775959|NCT01855724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775960|NCT01855724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24775961|NCT01855724|Immunologic Factors|immunologic factors|mesh-ancestor
24775962|NCT01855724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775976|NCT01855971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24775977|NCT01855971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24775978|NCT01855971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24775979|NCT01855984|Tocotrienols|tocotrienols|mesh-list
24775980|NCT01855984|Vitamin E|vitamin e|mesh-list
24775981|NCT01855984|Tocopherols|tocopherols|mesh-list
24775982|NCT01855984|Tocovid|tocovid|mesh-list
24775983|NCT01855984|Antioxidants|antioxidants|mesh-ancestor
25212937|NCT05297682|Propofol|propofol|mesh-list
25212938|NCT05297682|Anesthetics|anesthetics|mesh-ancestor
25212945|NCT05296629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25212946|NCT05296629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25212947|NCT05296629|Antimalarials|antimalarials|mesh-ancestor
25212948|NCT05296629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24775984|NCT01855984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775985|NCT01855984|Protective Agents|protective agents|mesh-ancestor
24775986|NCT01855984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775987|NCT01855984|Vitamins|vitamins|mesh-ancestor
24775988|NCT01855984|Micronutrients|micronutrients|mesh-ancestor
24775989|NCT01856023|Aldesleukin|aldesleukin|mesh-list
24775990|NCT01856023|Ipilimumab|ipilimumab|mesh-list
24775991|NCT01856023|Interleukin-2|interleukin-2|mesh-list
24775992|NCT01856023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25258988|NCT02467127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528969|NCT00624026|Dopamine Agents|dopamine agents|mesh-ancestor
24528990|NCT00624130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24528991|NCT00624130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528992|NCT00624130|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24528993|NCT00624130|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24528995|NCT00624130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24528996|NCT00624143|Voriconazole|voriconazole|mesh-list
25036392|NCT03547830|Plerixafor|plerixafor|mesh-list
24775993|NCT01856023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24775994|NCT01856023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24775995|NCT01856023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775996|NCT01856023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24775997|NCT01856023|Analgesics|analgesics|mesh-ancestor
24775998|NCT01856023|Sensory System Agents|sensory system agents|mesh-ancestor
24775999|NCT01856023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24776000|NCT01856023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567306|NCT00790595|Sunitinib|sunitinib|mesh-list
24776001|NCT01856023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24776002|NCT01856023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24776003|NCT01856023|Antiviral Agents|antiviral agents|mesh-ancestor
24776004|NCT01856023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24776005|NCT01856062|Dexamethasone|dexamethasone|mesh-list
24776006|NCT01856062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24485307|NCT00452569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24485308|NCT00452569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485309|NCT00452569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24485310|NCT00452569|Glucocorticoids|glucocorticoids|mesh-ancestor
24485311|NCT00452569|Hormones|hormones|mesh-ancestor
24485312|NCT00452569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24485313|NCT00452569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24776007|NCT01856062|Antiemetics|antiemetics|mesh-ancestor
24713963|NCT01528371|GABA Agents|gaba agents|mesh-ancestor
24776030|NCT01856127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24776031|NCT01856127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24776032|NCT01856166|Sufentanil|sufentanil|mesh-list
24776033|NCT01856166|Levobupivacaine|levobupivacaine|mesh-list
24776034|NCT01856166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24776035|NCT01856166|Narcotics|narcotics|mesh-ancestor
24776036|NCT01856166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24776037|NCT01856166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776038|NCT01856166|Analgesics|analgesics|mesh-ancestor
24776039|NCT01856166|Sensory System Agents|sensory system agents|mesh-ancestor
24776040|NCT01856166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24776050|NCT01856205|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24776051|NCT01856205|Immunologic Factors|immunologic factors|mesh-ancestor
24776052|NCT01856205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776054|NCT01856348|Vitamins|vitamins|mesh-ancestor
24776055|NCT01856348|Micronutrients|micronutrients|mesh-ancestor
24776056|NCT01856348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776057|NCT01856348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24776058|NCT01856374|Sirolimus|sirolimus|mesh-list
24776059|NCT01856374|Everolimus|everolimus|mesh-list
24776060|NCT01856374|Atorvastatin|atorvastatin|mesh-list
24776061|NCT01856374|Pravastatin|pravastatin|mesh-list
24776062|NCT01856374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24776063|NCT01856374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25212949|NCT05296629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24776079|NCT01856413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776081|NCT01856517|Analgesics|analgesics|mesh-ancestor
24776082|NCT01856517|Sensory System Agents|sensory system agents|mesh-ancestor
24776083|NCT01856517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24913470|NCT04264039|Alkylating Agents|alkylating agents|mesh-ancestor
24776084|NCT01856517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776085|NCT01856517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24776086|NCT01856517|Sympatholytics|sympatholytics|mesh-ancestor
25677965|NCT01818063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25677966|NCT01818063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25677967|NCT01818063|Alkylating Agents|alkylating agents|mesh-ancestor
25677968|NCT01818063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25677969|NCT01818063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25677970|NCT01818063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25677971|NCT01818063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25677972|NCT01818063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776087|NCT01856517|Autonomic Agents|autonomic agents|mesh-ancestor
24776088|NCT01856517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24776089|NCT01856517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24776090|NCT01856517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24776091|NCT01856517|Adrenergic Agents|adrenergic agents|mesh-ancestor
24776092|NCT01856517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24627397|NCT01092533|Prednisone|prednisone|mesh-list
24627398|NCT01092533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24627399|NCT01092533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24627400|NCT01092533|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24627401|NCT01092533|Antitubercular Agents|antitubercular agents|mesh-ancestor
24627402|NCT01092533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24627403|NCT01092533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24627404|NCT01092533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627405|NCT01092533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627406|NCT01092533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24794987|NCT04070352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24794988|NCT04070352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24794991|NCT04065152|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
24794992|NCT04065152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24794993|NCT04065152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485464|NCT00453115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24485466|NCT00453115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485467|NCT00453141|Betamethasone|betamethasone|mesh-list
24485468|NCT00453141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24485469|NCT00453141|Glucocorticoids|glucocorticoids|mesh-ancestor
24485470|NCT00453141|Hormones|hormones|mesh-ancestor
24485471|NCT00453141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25212956|NCT05271721|Dexamethasone acetate|dexamethasone acetate|mesh-list
25212957|NCT05271721|BB 1101|bb 1101|mesh-list
25212958|NCT05271721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25212959|NCT05271721|Antiemetics|antiemetics|mesh-ancestor
24776112|NCT01856621|Protective Agents|protective agents|mesh-ancestor
24776113|NCT01856738|Rivastigmine|rivastigmine|mesh-list
24485472|NCT00453141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485473|NCT00453141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24485474|NCT00453141|Respiratory System Agents|respiratory system agents|mesh-ancestor
24485475|NCT00453167|Gemcitabine|gemcitabine|mesh-list
24485476|NCT00453167|Paclitaxel|paclitaxel|mesh-list
24485477|NCT00453167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24485478|NCT00453167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081439|NCT03329781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24776114|NCT01856738|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24776115|NCT01856738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25081440|NCT03329781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25081441|NCT03329781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081442|NCT03329781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25081443|NCT03329781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081444|NCT03329729|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25081445|NCT03329729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25081446|NCT03329729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25081447|NCT03329729|Antimetabolites|antimetabolites|mesh-ancestor
24663745|NCT01303549|Anidulafungin|anidulafungin|mesh-list
25081448|NCT03329729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081449|NCT03329729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25081450|NCT03329729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25081451|NCT03329729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25081452|NCT03329651|Metformin|metformin|mesh-list
25081453|NCT03329651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25081454|NCT03329651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081455|NCT03329638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25081456|NCT03329638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25212962|NCT05271721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212963|NCT05271721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25212964|NCT05271721|Glucocorticoids|glucocorticoids|mesh-ancestor
25212965|NCT05271721|Hormones|hormones|mesh-ancestor
25212966|NCT05271721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25115708|NCT03113344|Amoxicillin|amoxicillin|mesh-list
24930866|NCT04095754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24930867|NCT04095754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930868|NCT04095754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24930869|NCT04095754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24930871|NCT04095754|Sensory System Agents|sensory system agents|mesh-ancestor
24930872|NCT04095754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24930881|NCT04096027|Cabergoline|cabergoline|mesh-list
25081457|NCT03329547|Cefixime|cefixime|mesh-list
25081458|NCT03329547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25081459|NCT03329547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25081460|NCT03329508|Pramipexole|pramipexole|mesh-list
25081461|NCT03329508|Rasagiline|rasagiline|mesh-list
25081462|NCT03329508|Antioxidants|antioxidants|mesh-ancestor
25081463|NCT03329508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776136|NCT01856959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24776137|NCT01856959|Autonomic Agents|autonomic agents|mesh-ancestor
24776138|NCT01856959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24776147|NCT01856959|Adrenergic Agents|adrenergic agents|mesh-ancestor
24776148|NCT01856959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24776149|NCT01856959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776150|NCT01856959|Analgesics|analgesics|mesh-ancestor
24776151|NCT01856959|Sensory System Agents|sensory system agents|mesh-ancestor
24776152|NCT01856959|Anesthetics|anesthetics|mesh-ancestor
24776153|NCT01856959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24776154|NCT01856959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24776155|NCT01856959|Anticonvulsants|anticonvulsants|mesh-ancestor
24776156|NCT01856959|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24776157|NCT01856959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24776158|NCT01856959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24776159|NCT01856985|Misoprostol|misoprostol|mesh-list
24776160|NCT01856985|Mifepristone|mifepristone|mesh-list
24776161|NCT01856985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24776162|NCT01856985|Abortifacient Agents|abortifacient agents|mesh-ancestor
24776163|NCT01856985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24776164|NCT01856985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776165|NCT01856985|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24776166|NCT01856985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24776168|NCT01856985|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24776169|NCT01856985|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24776170|NCT01856985|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24776171|NCT01856985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24776172|NCT01856985|Contraceptive Agents|contraceptive agents|mesh-ancestor
24776173|NCT01856985|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24776174|NCT01856985|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24776175|NCT01856985|Hormone Antagonists|hormone antagonists|mesh-ancestor
24776176|NCT01856985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24776177|NCT01856985|Luteolytic Agents|luteolytic agents|mesh-ancestor
24714352|NCT01530230|Oxytocin|oxytocin|mesh-list
25212967|NCT05271721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25212968|NCT05271721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25212969|NCT05271721|Protease Inhibitors|protease inhibitors|mesh-ancestor
25212970|NCT05271721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25212971|NCT05271721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212976|NCT05267821|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24776198|NCT01857024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776199|NCT01857141|Dexmedetomidine|dexmedetomidine|mesh-list
24776200|NCT01857141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24776201|NCT01857141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24776202|NCT01857141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776203|NCT01857141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24776204|NCT01857141|Analgesics|analgesics|mesh-ancestor
24776205|NCT01857141|Sensory System Agents|sensory system agents|mesh-ancestor
24776206|NCT01857141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25677973|NCT01818063|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25677974|NCT01818141|Vancomycin|vancomycin|mesh-list
25677975|NCT01818141|Fidaxomicin|fidaxomicin|mesh-list
25677976|NCT01818141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25677977|NCT01818141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25677978|NCT01818258|Ritonavir|ritonavir|mesh-list
25677979|NCT01818258|Lopinavir|lopinavir|mesh-list
25677980|NCT01818258|Lamivudine|lamivudine|mesh-list
25677981|NCT01818258|Zidovudine|zidovudine|mesh-list
25677982|NCT01818258|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24930893|NCT04095312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24930894|NCT04095390|Capecitabine|capecitabine|mesh-list
24930895|NCT04095390|Letrozole|letrozole|mesh-list
24930896|NCT04095390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24930897|NCT04095390|Antimetabolites|antimetabolites|mesh-ancestor
24930898|NCT04095390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930899|NCT04095390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24930900|NCT04095390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24930901|NCT04095390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24930902|NCT04095390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24930903|NCT04095390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24776207|NCT01857141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24776208|NCT01857141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24776209|NCT01857141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24776221|NCT01857154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24776222|NCT01857154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24776223|NCT01857154|Antacids|antacids|mesh-ancestor
24776224|NCT01857154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776225|NCT01857154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24776259|NCT01857453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24776261|NCT01857453|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24776262|NCT01857453|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24776263|NCT01857453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776264|NCT01857453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776265|NCT01857479|Amphotericin B|amphotericin b|mesh-list
24776266|NCT01857479|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24776267|NCT01857479|Budesonide|budesonide|mesh-list
24776268|NCT01857479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24776269|NCT01857479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24776270|NCT01857479|Autonomic Agents|autonomic agents|mesh-ancestor
25212977|NCT05267821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25212985|NCT05260593|Vitamins|vitamins|mesh-list
25212986|NCT05260593|Hydroxocobalamin|hydroxocobalamin|mesh-list
25212987|NCT05260593|Vitamin B 12|vitamin b 12|mesh-list
25212988|NCT05260593|Vitamin B Complex|vitamin b complex|mesh-list
25212989|NCT05260593|Micronutrients|micronutrients|mesh-ancestor
25212990|NCT05260593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212991|NCT05260593|Hematinics|hematinics|mesh-ancestor
25212992|NCT05240391|Midodrine|midodrine|mesh-list
25212993|NCT05240391|Sympathomimetics|sympathomimetics|mesh-ancestor
24776271|NCT01857479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24776272|NCT01857479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776273|NCT01857479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24776274|NCT01857479|Respiratory System Agents|respiratory system agents|mesh-ancestor
24776275|NCT01857479|Glucocorticoids|glucocorticoids|mesh-ancestor
24776276|NCT01857479|Hormones|hormones|mesh-ancestor
24776277|NCT01857479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24776278|NCT01857479|Amebicides|amebicides|mesh-ancestor
24776279|NCT01857479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24776280|NCT01857479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24776281|NCT01857479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24776282|NCT01857479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24776283|NCT01857479|Antifungal Agents|antifungal agents|mesh-ancestor
24776284|NCT01857544|Aflibercept|aflibercept|mesh-list
24776291|NCT01857596|Trazodone|trazodone|mesh-list
24776292|NCT01857596|Bupropion|bupropion|mesh-list
24776293|NCT01857596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24776294|NCT01857596|Antidepressive Agents|antidepressive agents|mesh-ancestor
24776295|NCT01857596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24776296|NCT01857596|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24776297|NCT01857596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24776298|NCT01857596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24776299|NCT01857596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776300|NCT01857596|Dopamine Agents|dopamine agents|mesh-ancestor
24776301|NCT01857596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25677983|NCT01818258|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25677984|NCT01818258|Protease Inhibitors|protease inhibitors|mesh-ancestor
25677985|NCT01818258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25677986|NCT01818258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25677987|NCT01818258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25677988|NCT01818258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25677989|NCT01818258|Antiviral Agents|antiviral agents|mesh-ancestor
25677990|NCT01818258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25677991|NCT01818258|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25677992|NCT01818258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24507114|NCT00548704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529024|NCT00624182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529025|NCT00624208|Droperidol|droperidol|mesh-list
24529026|NCT00624208|Ondansetron|ondansetron|mesh-list
24529027|NCT00624208|Antiemetics|antiemetics|mesh-ancestor
25036773|NCT03543683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036774|NCT03543683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25036775|NCT03543683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25036776|NCT03543683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25036777|NCT03543683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24776302|NCT01857596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776303|NCT01857596|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24776304|NCT01857596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24776305|NCT01857596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25093661|NCT03233035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24776320|NCT01857609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25212994|NCT05240391|Autonomic Agents|autonomic agents|mesh-ancestor
25212995|NCT05240391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25212996|NCT05240391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25212997|NCT05240391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25212998|NCT05240391|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25212999|NCT05240391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25213000|NCT05240391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25213001|NCT05240391|Adrenergic Agents|adrenergic agents|mesh-ancestor
25213002|NCT05240391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25213003|NCT05240391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213004|NCT05234554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25213005|NCT05234554|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25213006|NCT05212311|Chitosan|chitosan|mesh-list
25156843|NCT04910178|Empagliflozin|empagliflozin|mesh-list
25156844|NCT04910178|Pentoxifylline|pentoxifylline|mesh-list
25156845|NCT04910178|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25156846|NCT04910178|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25156847|NCT04910178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25156848|NCT04910178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25156849|NCT04910178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25156850|NCT04910178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25156851|NCT04910178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25156852|NCT04910178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24776322|NCT01857726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776323|NCT01857726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24776324|NCT01857726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24776325|NCT01857726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24776326|NCT01857726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776327|NCT01857726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776328|NCT01857752|Temozolomide|temozolomide|mesh-list
24776330|NCT01857752|Alkylating Agents|alkylating agents|mesh-ancestor
24776331|NCT01857752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776332|NCT01857752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776333|NCT01857804|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24776334|NCT01857804|Amoxicillin|amoxicillin|mesh-list
24776335|NCT01857804|Chlorhexidine|chlorhexidine|mesh-list
24776336|NCT01857804|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24776337|NCT01857804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24776338|NCT01857804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24776339|NCT01857804|Disinfectants|disinfectants|mesh-ancestor
24776340|NCT01857804|Dermatologic Agents|dermatologic agents|mesh-ancestor
24776342|NCT01857817|Propranolol|propranolol|mesh-list
24776343|NCT01857817|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24776344|NCT01857817|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24776345|NCT01857817|Adrenergic Agents|adrenergic agents|mesh-ancestor
24776346|NCT01857817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24776347|NCT01857817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776348|NCT01857817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25677993|NCT01818258|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25677994|NCT01818258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25677995|NCT01818258|Antimetabolites|antimetabolites|mesh-ancestor
25692405|NCT01999322|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25692406|NCT01999322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25692407|NCT01999322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692408|NCT01999335|Dexamethasone|dexamethasone|mesh-list
25692409|NCT01999335|Pomalidomide|pomalidomide|mesh-list
25692410|NCT01999335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25692411|NCT01999335|Antiemetics|antiemetics|mesh-ancestor
24529036|NCT00624208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24529038|NCT00624208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24776349|NCT01857817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24776350|NCT01857817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24776351|NCT01857817|Vasodilator Agents|vasodilator agents|mesh-ancestor
24776352|NCT01857817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24776353|NCT01857817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24776354|NCT01857817|Analgesics|analgesics|mesh-ancestor
24776355|NCT01857817|Sensory System Agents|sensory system agents|mesh-ancestor
25156853|NCT04910178|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24896590|NCT04434404|Antioxidants|antioxidants|mesh-ancestor
25156854|NCT04910178|Protective Agents|protective agents|mesh-ancestor
25156855|NCT04910178|Vasodilator Agents|vasodilator agents|mesh-ancestor
25156856|NCT04910178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25156858|NCT04910178|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24776356|NCT01857817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24486095|NCT00456313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486096|NCT00456313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24486343|NCT00457405|Dipyridamole|dipyridamole|mesh-list
24776357|NCT01857817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24776358|NCT01857817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24776378|NCT01857856|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24776379|NCT01857856|Hormone Antagonists|hormone antagonists|mesh-ancestor
24776380|NCT01857856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24776381|NCT01857856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776382|NCT01857856|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24776383|NCT01857856|Diuretics|diuretics|mesh-ancestor
24913765|NCT04261023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486540|NCT00458328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486541|NCT00458328|Cholinergic Agents|cholinergic agents|mesh-ancestor
24486542|NCT00458328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24486543|NCT00458328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486544|NCT00458328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24486545|NCT00458367|Risperidone|risperidone|mesh-list
24486546|NCT00458367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24486547|NCT00458367|Serotonin Agents|serotonin agents|mesh-ancestor
24486556|NCT00458367|Dopamine Agents|dopamine agents|mesh-ancestor
24486567|NCT00458458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24486568|NCT00458458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776384|NCT01857856|Natriuretic Agents|natriuretic agents|mesh-ancestor
24776385|NCT01857856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24776386|NCT01857895|Exenatide|exenatide|mesh-list
24776387|NCT01857895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24776388|NCT01857895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567699|NCT00792181|Anesthetics|anesthetics|mesh-ancestor
24776389|NCT01857895|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24776390|NCT01857895|Incretins|incretins|mesh-ancestor
24776391|NCT01857895|Hormones|hormones|mesh-ancestor
24776392|NCT01857895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24776394|NCT01857921|Atorvastatin|atorvastatin|mesh-list
24776395|NCT01857921|Pravastatin|pravastatin|mesh-list
24443408|NCT00294892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486607|NCT00458718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486608|NCT00458731|Bevacizumab|bevacizumab|mesh-list
24486609|NCT00458731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24486610|NCT00458731|Cediranib|cediranib|mesh-list
24486611|NCT00458731|Antibodies|antibodies|mesh-list
24486612|NCT00458731|Immunoglobulins|immunoglobulins|mesh-list
24486613|NCT00458731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24486614|NCT00458731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486615|NCT00458731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24486620|NCT00458731|Immunologic Factors|immunologic factors|mesh-ancestor
25213027|NCT05208892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25213028|NCT05208892|Analgesics|analgesics|mesh-ancestor
25213029|NCT05208892|Sensory System Agents|sensory system agents|mesh-ancestor
25213030|NCT05208892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25213031|NCT05208892|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25213032|NCT05208892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25213033|NCT05208892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25156859|NCT04910178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25081511|NCT03329248|Oxaliplatin|oxaliplatin|mesh-list
25677996|NCT01818284|Plerixafor|plerixafor|mesh-list
24664139|NCT01305317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776408|NCT01857999|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25677997|NCT01818284|Lenograstim|lenograstim|mesh-list
25102789|NCT03166306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930926|NCT04095182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776409|NCT01857999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776411|NCT01858025|Mitomycins|mitomycins|mesh-list
24776412|NCT01858025|Mitomycin|mitomycin|mesh-list
24776413|NCT01858025|Antimetabolites|antimetabolites|mesh-ancestor
24776414|NCT01858025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776415|NCT01858025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24776416|NCT01858025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776417|NCT01858025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24776418|NCT01858025|Immunologic Factors|immunologic factors|mesh-ancestor
24776419|NCT01858025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081465|NCT03329508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795003|NCT04026009|Vaccines|vaccines|mesh-list
24795004|NCT04026009|Immunologic Factors|immunologic factors|mesh-ancestor
24795005|NCT04026009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627407|NCT01092533|Glucocorticoids|glucocorticoids|mesh-ancestor
24627408|NCT01092533|Hormones|hormones|mesh-ancestor
24627409|NCT01092533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24627410|NCT01092533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627411|NCT01092533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24627412|NCT01092572|Simvastatin|simvastatin|mesh-list
24627413|NCT01092572|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24627414|NCT01092572|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24627415|NCT01092572|Antimetabolites|antimetabolites|mesh-ancestor
24627416|NCT01092572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486669|NCT00459173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486670|NCT00459264|Folic Acid|folic acid|mesh-list
24486671|NCT00459264|Hematinics|hematinics|mesh-ancestor
24486672|NCT00459264|Vitamin B Complex|vitamin b complex|mesh-ancestor
24653263|NCT01242787|Entecavir|entecavir|mesh-list
24627417|NCT01092572|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24627418|NCT01092572|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24627419|NCT01092572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627420|NCT01092624|Solifenacin Succinate|solifenacin succinate|mesh-list
24627421|NCT01092624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24627422|NCT01092624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25081466|NCT03329508|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25081467|NCT03329508|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25081468|NCT03329508|Dopamine Agonists|dopamine agonists|mesh-ancestor
25081469|NCT03329508|Dopamine Agents|dopamine agents|mesh-ancestor
25081470|NCT03329508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25081471|NCT03329508|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25081472|NCT03329508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25081473|NCT03329508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25081474|NCT03329456|Ropivacaine|ropivacaine|mesh-list
25081475|NCT03329456|Anesthetics, Local|anesthetics, local|mesh-ancestor
25081476|NCT03329456|Anesthetics|anesthetics|mesh-ancestor
25081477|NCT03329456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25081478|NCT03329456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081479|NCT03329456|Sensory System Agents|sensory system agents|mesh-ancestor
25081480|NCT03329456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25081481|NCT03329443|Spironolactone|spironolactone|mesh-list
25081482|NCT03329443|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25081483|NCT03329443|Hormone Antagonists|hormone antagonists|mesh-ancestor
25081484|NCT03329443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24486702|NCT00459563|Calcitriol|calcitriol|mesh-list
25081488|NCT03329443|Natriuretic Agents|natriuretic agents|mesh-ancestor
25081489|NCT03329339|Ascorbic Acid|ascorbic acid|mesh-list
24486674|NCT00459264|Micronutrients|micronutrients|mesh-ancestor
24486675|NCT00459264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664174|NCT01305707|Lorazepam|lorazepam|mesh-list
24486676|NCT00459407|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24486677|NCT00459407|Antioxidants|antioxidants|mesh-ancestor
25213034|NCT05208892|Adrenergic Agents|adrenergic agents|mesh-ancestor
25213035|NCT05208892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25213036|NCT05208892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213037|NCT05197192|Venetoclax|venetoclax|mesh-list
25213038|NCT05197192|Obinutuzumab|obinutuzumab|mesh-list
25677998|NCT01818284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25677999|NCT01818284|Immunologic Factors|immunologic factors|mesh-ancestor
25678000|NCT01818284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678001|NCT01818284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24930934|NCT04095169|Complement C3d|complement c3d|mesh-list
24930935|NCT04095169|Immunologic Factors|immunologic factors|mesh-ancestor
24930936|NCT04095169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800106|NCT01973517|Hematinics|hematinics|mesh-ancestor
24588914|NCT00904644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588915|NCT00904644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588917|NCT00904657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588918|NCT00904657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24588919|NCT00904657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24588920|NCT00904657|Growth Substances|growth substances|mesh-ancestor
24588921|NCT00904657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588922|NCT00904657|Growth Inhibitors|growth inhibitors|mesh-ancestor
25037017|NCT03541681|Hormones|hormones|mesh-ancestor
24486678|NCT00459407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486685|NCT00459420|Caffeine|caffeine|mesh-list
24486690|NCT00459420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486691|NCT00459420|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24714815|NCT01532856|Growth Inhibitors|growth inhibitors|mesh-ancestor
25081514|NCT03329248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081515|NCT03329248|Tubulin Modulators|tubulin modulators|mesh-ancestor
25081516|NCT03329248|Antimitotic Agents|antimitotic agents|mesh-ancestor
24791113|NCT05273567|Guanfacine|guanfacine|mesh-list
24776427|NCT01858051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776428|NCT01858051|Vitamins|vitamins|mesh-ancestor
24776429|NCT01858051|Micronutrients|micronutrients|mesh-ancestor
24776446|NCT01858090|Levobupivacaine|levobupivacaine|mesh-list
24776447|NCT01858090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24776448|NCT01858090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24776449|NCT01858090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776450|NCT01858090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24776451|NCT01858090|Anesthetics, General|anesthetics, general|mesh-ancestor
24776453|NCT01858090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24776454|NCT01858090|Narcotics|narcotics|mesh-ancestor
24776455|NCT01858090|Analgesics|analgesics|mesh-ancestor
24776456|NCT01858090|Sensory System Agents|sensory system agents|mesh-ancestor
24776457|NCT01858090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24776458|NCT01858090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24776459|NCT01858090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24776460|NCT01858090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24776461|NCT01858090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24776462|NCT01858090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24776463|NCT01858090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24567765|NCT00792584|Efavirenz|efavirenz|mesh-list
24776464|NCT01858090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776477|NCT01858090|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24776478|NCT01858090|Anesthetics, Local|anesthetics, local|mesh-ancestor
24776479|NCT01858090|Antiemetics|antiemetics|mesh-ancestor
24776486|NCT01858090|Dermatologic Agents|dermatologic agents|mesh-ancestor
24776487|NCT01858090|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24776488|NCT01858090|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24776489|NCT01858090|Dopamine Agents|dopamine agents|mesh-ancestor
24776490|NCT01858090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24776491|NCT01858090|Sympathomimetics|sympathomimetics|mesh-ancestor
24776492|NCT01858090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24664302|NCT01305850|Losartan|losartan|mesh-list
24776493|NCT01858090|Adrenergic Agents|adrenergic agents|mesh-ancestor
24776495|NCT01858155|Antioxidants|antioxidants|mesh-ancestor
24776496|NCT01858155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776497|NCT01858155|Protective Agents|protective agents|mesh-ancestor
24776498|NCT01858155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776499|NCT01858155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24486695|NCT00459485|Zinc Sulfate|zinc sulfate|mesh-list
24486696|NCT00459485|Astringents|astringents|mesh-ancestor
25678002|NCT01818284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25678003|NCT01818284|Antiviral Agents|antiviral agents|mesh-ancestor
25678004|NCT01818284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25678005|NCT01818336|Amoxicillin|amoxicillin|mesh-list
25678006|NCT01818336|Penicillins|penicillins|mesh-list
25678007|NCT01818336|Penicillin G|penicillin g|mesh-list
25678008|NCT01818336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25678009|NCT01818336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25678010|NCT01818414|Vitamins|vitamins|mesh-list
25678011|NCT01818414|Folic Acid|folic acid|mesh-list
25678012|NCT01818414|Misoprostol|misoprostol|mesh-list
25678013|NCT01818414|Micronutrients|micronutrients|mesh-ancestor
25678014|NCT01818414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678015|NCT01818414|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24930973|NCT04094805|Calcitriol|calcitriol|mesh-list
24930974|NCT04094805|Dexamethasone|dexamethasone|mesh-list
24930975|NCT04094805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24930976|NCT04094805|Antiemetics|antiemetics|mesh-ancestor
24930977|NCT04094805|Autonomic Agents|autonomic agents|mesh-ancestor
24507170|NCT00549107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529062|NCT00624325|Immunologic Factors|immunologic factors|mesh-ancestor
24529063|NCT00624325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529064|NCT00624364|Metformin|metformin|mesh-list
24529065|NCT00624364|Insulin Aspart|insulin aspart|mesh-list
24663866|NCT01303887|Hormones|hormones|mesh-ancestor
25037029|NCT03541603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037030|NCT03541603|Protective Agents|protective agents|mesh-ancestor
24486697|NCT00459485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486698|NCT00459485|Dermatologic Agents|dermatologic agents|mesh-ancestor
24486699|NCT00459511|Hydrocortisone|hydrocortisone|mesh-list
24486700|NCT00459511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24486701|NCT00459563|Vitamin D|vitamin d|mesh-list
24486716|NCT00459615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24486717|NCT00459615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25213039|NCT05197192|Acalabrutinib|acalabrutinib|mesh-list
25213040|NCT05197192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25213041|NCT05197192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25213042|NCT05194111|Valsartan|valsartan|mesh-list
25156877|NCT04902703|Molgramostim|molgramostim|mesh-list
25156878|NCT04902703|Sargramostim|sargramostim|mesh-list
25156879|NCT04902703|Immunologic Factors|immunologic factors|mesh-ancestor
24772739|NCT01835418|Amlodipine|amlodipine|mesh-list
24486718|NCT00459615|Antiviral Agents|antiviral agents|mesh-ancestor
24486719|NCT00459615|Schistosomicides|schistosomicides|mesh-ancestor
24486848|NCT00460369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486849|NCT00460369|Antiviral Agents|antiviral agents|mesh-ancestor
24486850|NCT00460369|Schistosomicides|schistosomicides|mesh-ancestor
24486851|NCT00460369|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24486852|NCT00460369|Anthelmintics|anthelmintics|mesh-ancestor
24486853|NCT00460369|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24486854|NCT00460369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486855|NCT00460369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486856|NCT00460369|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24776505|NCT01858168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776506|NCT01858168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776507|NCT01858168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776509|NCT01858168|Alkylating Agents|alkylating agents|mesh-ancestor
24776510|NCT01858168|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24776512|NCT01858207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24776513|NCT01858207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776514|NCT01858207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24776515|NCT01858207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24776516|NCT01858207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776517|NCT01858207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776518|NCT01858311|Tocotrienols|tocotrienols|mesh-list
24776519|NCT01858311|Vitamin E|vitamin e|mesh-list
24776520|NCT01858311|Tocopherols|tocopherols|mesh-list
24776521|NCT01858311|Antioxidants|antioxidants|mesh-ancestor
24776522|NCT01858311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776523|NCT01858311|Protective Agents|protective agents|mesh-ancestor
24776524|NCT01858311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776525|NCT01858311|Vitamins|vitamins|mesh-ancestor
24776526|NCT01858311|Micronutrients|micronutrients|mesh-ancestor
24776527|NCT01858402|Acetaminophen|acetaminophen|mesh-list
24776528|NCT01858402|Dipyrone|dipyrone|mesh-list
24776529|NCT01858402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25213043|NCT05194111|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25213044|NCT05194111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25678016|NCT01818414|Abortifacient Agents|abortifacient agents|mesh-ancestor
25678017|NCT01818414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25678018|NCT01818414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25678019|NCT01818414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25678020|NCT01818414|Oxytocics|oxytocics|mesh-ancestor
25678021|NCT01818414|Hematinics|hematinics|mesh-ancestor
25678022|NCT01818414|Vitamin B Complex|vitamin b complex|mesh-ancestor
25678023|NCT01818596|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25678024|NCT01818596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25678025|NCT01818596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25678026|NCT01818596|Antiviral Agents|antiviral agents|mesh-ancestor
25678027|NCT01818596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25213045|NCT05194111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24993866|NCT05328336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24993867|NCT05328336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993869|NCT05328336|Antimitotic Agents|antimitotic agents|mesh-ancestor
24993870|NCT05328336|Mitosis Modulators|mitosis modulators|mesh-ancestor
24993871|NCT05328336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797824|NCT01958580|Antimitotic Agents|antimitotic agents|mesh-ancestor
24588929|NCT00904709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588930|NCT00904709|Hemostatics|hemostatics|mesh-ancestor
25037281|NCT03538704|Metformin|metformin|mesh-list
25213046|NCT05194111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25213047|NCT05194111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25156880|NCT04902703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25156881|NCT04902703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25156882|NCT04902443|Nivolumab|nivolumab|mesh-list
25156883|NCT04902443|Pomalidomide|pomalidomide|mesh-list
25156884|NCT04902443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24486971|NCT00460759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24486973|NCT00460759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776535|NCT01858402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24776536|NCT01858402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24776537|NCT01858402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24776538|NCT01858441|Abiraterone Acetate|abiraterone acetate|mesh-list
24776539|NCT01858441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776540|NCT01858441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24776541|NCT01858441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776542|NCT01858441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776544|NCT01858441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24776545|NCT01858441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776546|NCT01858441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24776547|NCT01858571|Thalidomide|thalidomide|mesh-list
24776548|NCT01858571|Celecoxib|celecoxib|mesh-list
24776549|NCT01858571|Cyclophosphamide|cyclophosphamide|mesh-list
24776550|NCT01858571|Etoposide|etoposide|mesh-list
24776551|NCT01858571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24776552|NCT01858571|Immunologic Factors|immunologic factors|mesh-ancestor
24776553|NCT01858571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776554|NCT01858571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24913965|NCT04258956|Avelumab|avelumab|mesh-list
24487023|NCT00460954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487025|NCT00460954|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24487026|NCT00460954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487027|NCT00460954|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24487028|NCT00460954|Immunologic Factors|immunologic factors|mesh-ancestor
24487029|NCT00460954|Dopamine Agonists|dopamine agonists|mesh-ancestor
24487030|NCT00461084|Clarithromycin|clarithromycin|mesh-list
24487031|NCT00461084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24487032|NCT00461084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24487033|NCT00461084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24487038|NCT00461149|Octreotide|octreotide|mesh-list
24487058|NCT00461344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24487124|NCT00461747|Dexamethasone acetate|dexamethasone acetate|mesh-list
24487125|NCT00461747|Bortezomib|bortezomib|mesh-list
24487126|NCT00461747|BB 1101|bb 1101|mesh-list
24487127|NCT00461747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24487129|NCT00461747|Autonomic Agents|autonomic agents|mesh-ancestor
24487130|NCT00461747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24487131|NCT00461747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678028|NCT01818700|Buprenorphine|buprenorphine|mesh-list
25678029|NCT01818700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25678030|NCT01818700|Narcotics|narcotics|mesh-ancestor
25678031|NCT01818700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25678032|NCT01818700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678033|NCT01818700|Analgesics|analgesics|mesh-ancestor
25678034|NCT01818700|Sensory System Agents|sensory system agents|mesh-ancestor
25678035|NCT01818700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25678036|NCT01818700|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25678037|NCT01818726|Deferasirox|deferasirox|mesh-list
25678038|NCT01818726|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24487132|NCT00461747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24776555|NCT01858571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24776557|NCT01858571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776559|NCT01858571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24776560|NCT01858571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24776561|NCT01858571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24776562|NCT01858571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24776563|NCT01858571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776564|NCT01858571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24776565|NCT01858571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24776566|NCT01858571|Analgesics|analgesics|mesh-ancestor
25156886|NCT04902443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25156887|NCT04902443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25156888|NCT04902443|Immunologic Factors|immunologic factors|mesh-ancestor
25156889|NCT04902443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25156890|NCT04902443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24776568|NCT01858571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24776569|NCT01858571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24776603|NCT01858649|Oxaliplatin|oxaliplatin|mesh-list
24776604|NCT01858649|Irinotecan|irinotecan|mesh-list
24776605|NCT01858649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24776606|NCT01858649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776607|NCT01858649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24776608|NCT01858649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24776609|NCT01858649|Growth Substances|growth substances|mesh-ancestor
24776610|NCT01858649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776611|NCT01858649|Growth Inhibitors|growth inhibitors|mesh-ancestor
24776668|NCT01858961|Antiviral Agents|antiviral agents|mesh-ancestor
24776669|NCT01858961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24776670|NCT01858961|Antimetabolites|antimetabolites|mesh-ancestor
24776671|NCT01858961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567991|NCT00793767|Epoetin Alfa|epoetin alfa|mesh-list
24568062|NCT00794235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24568064|NCT00794235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568065|NCT00794235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24568066|NCT00794235|Alkylating Agents|alkylating agents|mesh-ancestor
24568067|NCT00794261|Lenograstim|lenograstim|mesh-list
24568068|NCT00794261|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24568069|NCT00794261|Immunologic Factors|immunologic factors|mesh-ancestor
24568070|NCT00794261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568071|NCT00794326|Dialysis Solutions|dialysis solutions|mesh-list
24568072|NCT00794326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24568073|NCT00794443|Diphosphonates|diphosphonates|mesh-list
24568074|NCT00794443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24568075|NCT00794443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620786|NCT01059110|Salicylates|salicylates|mesh-list
24620787|NCT01059110|Imiquimod|imiquimod|mesh-list
24620788|NCT01059110|Fluorouracil|fluorouracil|mesh-list
24620789|NCT01059110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24620790|NCT01059110|Immunologic Factors|immunologic factors|mesh-ancestor
24620791|NCT01059110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620792|NCT01059110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24620793|NCT01059110|Interferon Inducers|interferon inducers|mesh-ancestor
24620794|NCT01059110|Antimetabolites|antimetabolites|mesh-ancestor
24776673|NCT01859234|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
24776674|NCT01859234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24776675|NCT01859234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800237|NCT01974258|Vemurafenib|vemurafenib|mesh-list
25213072|NCT05170672|Abatacept|abatacept|mesh-list
25213073|NCT05170672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25213074|NCT05170672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213075|NCT05170672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25213076|NCT05170672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25156901|NCT04899778|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25156902|NCT04899778|Trace Elements|trace elements|mesh-ancestor
25156903|NCT04899778|Micronutrients|micronutrients|mesh-ancestor
24776676|NCT01859234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24776677|NCT01859234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24776678|NCT01859234|Growth Substances|growth substances|mesh-ancestor
24776679|NCT01859234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776680|NCT01859234|Growth Inhibitors|growth inhibitors|mesh-ancestor
24776684|NCT01859377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24776685|NCT01859377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24776687|NCT01859377|Sensory System Agents|sensory system agents|mesh-ancestor
25037480|NCT03537144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25037511|NCT03536806|Hormone Antagonists|hormone antagonists|mesh-ancestor
25037512|NCT03536806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25037513|NCT03536806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037514|NCT03536806|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25037515|NCT03536806|Diuretics|diuretics|mesh-ancestor
25037516|NCT03536806|Natriuretic Agents|natriuretic agents|mesh-ancestor
25037517|NCT03536780|Gemcitabine|gemcitabine|mesh-list
25037518|NCT03536780|Avelumab|avelumab|mesh-list
25037520|NCT03536780|Antimetabolites|antimetabolites|mesh-ancestor
24776688|NCT01859377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24776689|NCT01859377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776690|NCT01859377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24776691|NCT01859377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24776692|NCT01859377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24776693|NCT01859377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776694|NCT01859377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776696|NCT01859455|Simvastatin|simvastatin|mesh-list
24776697|NCT01859455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24776698|NCT01859455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24776699|NCT01859455|Antimetabolites|antimetabolites|mesh-ancestor
24776700|NCT01859455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776701|NCT01859455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24776702|NCT01859455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24776703|NCT01859455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776704|NCT01859468|Calcium Carbonate|calcium carbonate|mesh-list
24776705|NCT01859468|Calcium|calcium|mesh-list
24776706|NCT01859468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24776707|NCT01859468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776708|NCT01859468|Antacids|antacids|mesh-ancestor
24776709|NCT01859468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776710|NCT01859468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24776711|NCT01859481|Eletriptan|eletriptan|mesh-list
24487133|NCT00461747|Glucocorticoids|glucocorticoids|mesh-ancestor
24487134|NCT00461747|Hormones|hormones|mesh-ancestor
24487135|NCT00461747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24776726|NCT01859585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24776727|NCT01859585|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24776728|NCT01859585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776729|NCT01859585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776730|NCT01859585|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24776731|NCT01859624|Albuterol|albuterol|mesh-list
24776732|NCT01859624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24568971|NCT00798343|Vaccines|vaccines|mesh-list
24776733|NCT01859624|Autonomic Agents|autonomic agents|mesh-ancestor
24776734|NCT01859624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24776735|NCT01859624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776736|NCT01859624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24776737|NCT01859624|Respiratory System Agents|respiratory system agents|mesh-ancestor
24776738|NCT01859624|Tocolytic Agents|tocolytic agents|mesh-ancestor
24776739|NCT01859624|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24776740|NCT01859624|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24776741|NCT01859624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24776742|NCT01859624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24776743|NCT01859624|Adrenergic Agents|adrenergic agents|mesh-ancestor
24776744|NCT01859624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24776745|NCT01859624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776747|NCT01859728|Cisplatin|cisplatin|mesh-list
24776748|NCT01859728|Irinotecan|irinotecan|mesh-list
24776749|NCT01859728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776750|NCT01859728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24776751|NCT01859728|Antimetabolites|antimetabolites|mesh-ancestor
24776752|NCT01859728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159901|NCT03518060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25678039|NCT01818726|Chelating Agents|chelating agents|mesh-ancestor
25678040|NCT01818726|Sequestering Agents|sequestering agents|mesh-ancestor
25678041|NCT01818726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678042|NCT01818752|Prednisone|prednisone|mesh-list
25678043|NCT01818752|Bortezomib|bortezomib|mesh-list
25678044|NCT01818752|Melphalan|melphalan|mesh-list
25678045|NCT01818752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25678046|NCT01818752|Glucocorticoids|glucocorticoids|mesh-ancestor
25678047|NCT01818752|Hormones|hormones|mesh-ancestor
25678048|NCT01818752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24931006|NCT04094909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24800156|NCT01973816|Estradiol|estradiol|mesh-list
25081518|NCT03329248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213077|NCT05170672|Immunologic Factors|immunologic factors|mesh-ancestor
25213078|NCT05170672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213079|NCT05170672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25156904|NCT04899778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25156905|NCT04899778|Estrogens|estrogens|mesh-ancestor
24795460|NCT02518009|Estrogens|estrogens|mesh-list
24588970|NCT00905047|Leucovorin|leucovorin|mesh-list
24795850|NCT01946386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589207|NCT00906126|Misoprostol|misoprostol|mesh-list
24627442|NCT01092858|Testosterone undecanoate|testosterone undecanoate|mesh-list
24627443|NCT01092858|Testosterone enanthate|testosterone enanthate|mesh-list
24627444|NCT01092858|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24627445|NCT01092858|Androgens|androgens|mesh-ancestor
24627446|NCT01092858|Hormones|hormones|mesh-ancestor
24627447|NCT01092858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24627448|NCT01092858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627449|NCT01092858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24627450|NCT01092858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081534|NCT03329248|Protective Agents|protective agents|mesh-ancestor
25081535|NCT03329248|Vitamin B Complex|vitamin b complex|mesh-ancestor
25081536|NCT03329248|Vitamins|vitamins|mesh-ancestor
25081537|NCT03329248|Micronutrients|micronutrients|mesh-ancestor
25081538|NCT03329183|Irinotecan|irinotecan|mesh-list
25081539|NCT03329183|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25081540|NCT03329183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25081541|NCT03329183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25081542|NCT03329183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081543|NCT03329183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776758|NCT01859728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776759|NCT01859728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24776760|NCT01859728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24776761|NCT01859754|gamma-Globulins|gamma-globulins|mesh-list
24776762|NCT01859754|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24776763|NCT01859754|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24776764|NCT01859754|Immunologic Factors|immunologic factors|mesh-ancestor
24776765|NCT01859754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776766|NCT01859819|Cytarabine|cytarabine|mesh-list
24776767|NCT01859819|Rituximab|rituximab|mesh-list
24776768|NCT01859819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24776769|NCT01859819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776770|NCT01859819|Immunologic Factors|immunologic factors|mesh-ancestor
24776771|NCT01859819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776772|NCT01859819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24776773|NCT01859819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24776774|NCT01859819|Antimetabolites|antimetabolites|mesh-ancestor
24776775|NCT01859819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776776|NCT01859819|Antiviral Agents|antiviral agents|mesh-ancestor
24776777|NCT01859819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24776778|NCT01859819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24776779|NCT01859858|Curcumin|curcumin|mesh-list
24776780|NCT01859858|Irinotecan|irinotecan|mesh-list
24776781|NCT01859858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24776782|NCT01859858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24776783|NCT01859858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776784|NCT01859858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776785|NCT01859858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776786|NCT01859858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24776788|NCT01859858|Analgesics|analgesics|mesh-ancestor
24776802|NCT01860066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24776803|NCT01860066|Autonomic Agents|autonomic agents|mesh-ancestor
24776804|NCT01860066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24776805|NCT01860066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776806|NCT01860066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24776833|NCT01860144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24776834|NCT01860144|Growth Substances|growth substances|mesh-ancestor
24776835|NCT01860144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776837|NCT01860183|Mycophenolic Acid|mycophenolic acid|mesh-list
24776838|NCT01860183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24776839|NCT01860183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776840|NCT01860183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25678049|NCT01818752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678050|NCT01818752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24415204|NCT00199095|Antiemetics|antiemetics|mesh-ancestor
24588991|NCT00905073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588992|NCT00905073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24588993|NCT00905073|Antimetabolites|antimetabolites|mesh-ancestor
24588994|NCT00905073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588995|NCT00905073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588996|NCT00905073|Dermatologic Agents|dermatologic agents|mesh-ancestor
24588997|NCT00905073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588998|NCT00905073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24588999|NCT00905073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24589000|NCT00905073|Immunologic Factors|immunologic factors|mesh-ancestor
24589001|NCT00905073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24589002|NCT00905073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25095561|NCT03218059|Antimetabolites|antimetabolites|mesh-ancestor
24589003|NCT00905073|Antifungal Agents|antifungal agents|mesh-ancestor
24589017|NCT00905190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589018|NCT00905190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25037810|NCT03535220|Proteasome Inhibitors|proteasome inhibitors|mesh-list
25037811|NCT03535220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037812|NCT03535220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037813|NCT03535220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24776841|NCT01860183|Antitubercular Agents|antitubercular agents|mesh-ancestor
24776842|NCT01860183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24776843|NCT01860183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25213080|NCT05165433|Pembrolizumab|pembrolizumab|mesh-list
25213081|NCT05165433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25156906|NCT04899778|Hormones|hormones|mesh-ancestor
25156907|NCT04899778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25156908|NCT04899778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25156909|NCT04899778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25156910|NCT04899778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24776844|NCT01860183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776845|NCT01860183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776849|NCT01860196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776850|NCT01860196|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24776861|NCT01860235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24776885|NCT01860482|Rabeprazole|rabeprazole|mesh-list
24776886|NCT01860482|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24776887|NCT01860482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24776888|NCT01860482|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24776889|NCT01860482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776890|NCT01860482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776891|NCT01860508|Carboplatin|carboplatin|mesh-list
24776892|NCT01860508|Pemetrexed|pemetrexed|mesh-list
24776893|NCT01860508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776894|NCT01860508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776895|NCT01860508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776896|NCT01860508|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24776897|NCT01860508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24776898|NCT01860625|Donepezil|donepezil|mesh-list
24627487|NCT01093092|Calcitriol|calcitriol|mesh-list
24791650|NCT03649048|Cisplatin|cisplatin|mesh-list
24776899|NCT01860625|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25678051|NCT01818752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678052|NCT01818752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25678053|NCT01818752|Alkylating Agents|alkylating agents|mesh-ancestor
25678054|NCT01818752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678055|NCT01818752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25678056|NCT01818752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25678057|NCT01818752|Immunologic Factors|immunologic factors|mesh-ancestor
25678058|NCT01819129|Insulin|insulin|mesh-list
25678059|NCT01819129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25678060|NCT01819129|Insulin Glargine|insulin glargine|mesh-list
25678061|NCT01819129|Insulin Aspart|insulin aspart|mesh-list
25678062|NCT01819129|Insulin, Long-Acting|insulin, long-acting|mesh-list
25678063|NCT01819129|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25678064|NCT01819129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25678065|NCT01819129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678066|NCT01819935|Vancomycin|vancomycin|mesh-list
25678067|NCT01819935|Linezolid|linezolid|mesh-list
25678068|NCT01819935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25678069|NCT01819935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25678070|NCT01819935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25678071|NCT01819935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24931032|NCT04094532|Anesthetics|anesthetics|mesh-ancestor
24776900|NCT01860625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776901|NCT01860625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776936|NCT01860690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24776937|NCT01860716|Melatonin|melatonin|mesh-list
24776938|NCT01860716|Antioxidants|antioxidants|mesh-ancestor
24776939|NCT01860716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776940|NCT01860716|Protective Agents|protective agents|mesh-ancestor
24776941|NCT01860716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776942|NCT01860716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24776943|NCT01860729|Anacetrapib|anacetrapib|mesh-list
24776944|NCT01860729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24776945|NCT01860729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24776946|NCT01860729|Antimetabolites|antimetabolites|mesh-ancestor
24776947|NCT01860729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776948|NCT01860729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24776949|NCT01860742|Interferons|interferons|mesh-list
24776950|NCT01860742|Interferon-alpha|interferon-alpha|mesh-list
24776951|NCT01860742|Interferon alpha-2|interferon alpha-2|mesh-list
24776952|NCT01860742|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
24776953|NCT01860742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776957|NCT01860742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776958|NCT01860742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24776959|NCT01860742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776960|NCT01860781|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24776961|NCT01860781|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24776962|NCT01860781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24776963|NCT01860781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24776964|NCT01860781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776965|NCT01860781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24776966|NCT01860781|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24776967|NCT01860781|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24776968|NCT01860781|Serotonin Agents|serotonin agents|mesh-ancestor
24776969|NCT01860781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24791684|NCT03580928|Venetoclax|venetoclax|mesh-list
24777012|NCT01861015|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24777013|NCT01861015|Natriuretic Agents|natriuretic agents|mesh-ancestor
24777014|NCT01861041|Bupivacaine|bupivacaine|mesh-list
25213082|NCT05165433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25213083|NCT05160493|Pregabalin|pregabalin|mesh-list
25213084|NCT05160493|Ketamine|ketamine|mesh-list
25213085|NCT05160493|Esketamine|esketamine|mesh-list
25213086|NCT05160493|Analgesics|analgesics|mesh-ancestor
25213087|NCT05160493|Sensory System Agents|sensory system agents|mesh-ancestor
25213088|NCT05160493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25156914|NCT04891302|Clevudine|clevudine|mesh-list
25156915|NCT04891302|Antiviral Agents|antiviral agents|mesh-ancestor
24947432|NCT03928691|Tocolytic Agents|tocolytic agents|mesh-ancestor
24777015|NCT01861041|Anesthetics, Local|anesthetics, local|mesh-ancestor
24777016|NCT01861041|Anesthetics|anesthetics|mesh-ancestor
24777017|NCT01861041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24777116|NCT01862081|Mitosis Modulators|mitosis modulators|mesh-ancestor
24777026|NCT01861223|Nimotuzumab|nimotuzumab|mesh-list
24777031|NCT01861223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24777032|NCT01861340|Dexamethasone|dexamethasone|mesh-list
24777033|NCT01861340|Lenalidomide|lenalidomide|mesh-list
24777034|NCT01861340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24777035|NCT01861340|Antiemetics|antiemetics|mesh-ancestor
24777036|NCT01861340|Autonomic Agents|autonomic agents|mesh-ancestor
24777037|NCT01861340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24777038|NCT01861340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777039|NCT01861340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24777040|NCT01861340|Glucocorticoids|glucocorticoids|mesh-ancestor
24777042|NCT01861340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24777043|NCT01861340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24777044|NCT01861340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24777045|NCT01861340|Immunologic Factors|immunologic factors|mesh-ancestor
24777046|NCT01861340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24777047|NCT01861340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24777048|NCT01861340|Growth Substances|growth substances|mesh-ancestor
24777049|NCT01861340|Growth Inhibitors|growth inhibitors|mesh-ancestor
24777051|NCT01861535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24777052|NCT01861535|Immunologic Factors|immunologic factors|mesh-ancestor
24715654|NCT01537861|Bortezomib|bortezomib|mesh-list
24627490|NCT01093092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24627491|NCT01093092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25692412|NCT01999335|Autonomic Agents|autonomic agents|mesh-ancestor
24627492|NCT01093092|Antimetabolites|antimetabolites|mesh-ancestor
24627493|NCT01093092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627494|NCT01093092|Antiviral Agents|antiviral agents|mesh-ancestor
24627497|NCT01093092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24627498|NCT01093092|Immunologic Factors|immunologic factors|mesh-ancestor
24627499|NCT01093092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627500|NCT01093092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24627501|NCT01093092|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24627502|NCT01093092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25095997|NCT03214770|Calcium, Dietary|calcium, dietary|mesh-list
24627503|NCT01093092|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24795853|NCT01946399|Dexamethasone|dexamethasone|mesh-list
24795922|NCT01946620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24795996|NCT01947114|Narcotics|narcotics|mesh-ancestor
24796064|NCT01947803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24796065|NCT01947803|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24796066|NCT01947803|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24796067|NCT01947803|Serotonin Agents|serotonin agents|mesh-ancestor
24796068|NCT01947803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24796069|NCT01947803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796070|NCT01947803|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24796071|NCT01947803|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24796072|NCT01947803|Dopamine Agents|dopamine agents|mesh-ancestor
24796206|NCT01948505|Antipyretics|antipyretics|mesh-ancestor
24796373|NCT01949571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24796374|NCT01949571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24777060|NCT01861561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24777061|NCT01861561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24777062|NCT01861561|Alkylating Agents|alkylating agents|mesh-ancestor
25213089|NCT05160493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213090|NCT05160493|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25213091|NCT05160493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25213092|NCT05160493|Anesthetics, General|anesthetics, general|mesh-ancestor
25213093|NCT05160493|Anesthetics|anesthetics|mesh-ancestor
25213094|NCT05160493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25156916|NCT04891302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24777071|NCT01861951|Doxorubicin|doxorubicin|mesh-list
25081549|NCT03329118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25081552|NCT03328975|Dexamethasone|dexamethasone|mesh-list
25081553|NCT03328975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25081554|NCT03328975|Antiemetics|antiemetics|mesh-ancestor
25081555|NCT03328975|Autonomic Agents|autonomic agents|mesh-ancestor
25081556|NCT03328975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25081557|NCT03328975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081558|NCT03328975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25081559|NCT03328975|Glucocorticoids|glucocorticoids|mesh-ancestor
25081560|NCT03328975|Hormones|hormones|mesh-ancestor
25081561|NCT03328975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24664639|NCT01308086|Antidotes|antidotes|mesh-ancestor
25081562|NCT03328975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25081563|NCT03328975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081564|NCT03328936|Melphalan|melphalan|mesh-list
25081565|NCT03328936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25081566|NCT03328936|Alkylating Agents|alkylating agents|mesh-ancestor
24777095|NCT01862003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777097|NCT01862003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24777098|NCT01862003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24777099|NCT01862003|Immunologic Factors|immunologic factors|mesh-ancestor
24777100|NCT01862003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777101|NCT01862003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24777102|NCT01862003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24777103|NCT01862003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24777104|NCT01862003|Antidotes|antidotes|mesh-ancestor
24777105|NCT01862003|Protective Agents|protective agents|mesh-ancestor
24777106|NCT01862003|Vitamin B Complex|vitamin b complex|mesh-ancestor
24777107|NCT01862003|Vitamins|vitamins|mesh-ancestor
24777108|NCT01862003|Micronutrients|micronutrients|mesh-ancestor
24777109|NCT01862003|Hematinics|hematinics|mesh-ancestor
24777110|NCT01862081|Paclitaxel|paclitaxel|mesh-list
24777111|NCT01862081|Docetaxel|docetaxel|mesh-list
25213095|NCT05160493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25213096|NCT05160493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25213097|NCT05160493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25213098|NCT05160493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213099|NCT05160493|Anticonvulsants|anticonvulsants|mesh-ancestor
25213100|NCT05160493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25159902|NCT03504956|Metoprolol|metoprolol|mesh-list
24529104|NCT00624546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24931043|NCT04094467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24931044|NCT04094467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931045|NCT04094467|Hormone Antagonists|hormone antagonists|mesh-ancestor
24407320|NCT00174304|Antimetabolites|antimetabolites|mesh-ancestor
25213101|NCT05160493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25213102|NCT05160493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25213103|NCT05160493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25213104|NCT05160493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25213105|NCT05160493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25213106|NCT05160493|Antidepressive Agents|antidepressive agents|mesh-ancestor
25213107|NCT05154734|Belimumab|belimumab|mesh-list
25213108|NCT05154734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25213109|NCT05154734|Immunologic Factors|immunologic factors|mesh-ancestor
25213110|NCT05154734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213111|NCT05143164|Gentamicins|gentamicins|mesh-list
24777112|NCT01862081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24777113|NCT01862081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24777114|NCT01862081|Tubulin Modulators|tubulin modulators|mesh-ancestor
24777115|NCT01862081|Antimitotic Agents|antimitotic agents|mesh-ancestor
24777119|NCT01862120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24777120|NCT01862120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24777121|NCT01862120|Analgesics|analgesics|mesh-ancestor
24777122|NCT01862120|Sensory System Agents|sensory system agents|mesh-ancestor
24777123|NCT01862120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24777124|NCT01862120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777125|NCT01862263|Vildagliptin|vildagliptin|mesh-list
24777126|NCT01862263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24777127|NCT01862263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777131|NCT01862263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777132|NCT01862302|Haloperidol|haloperidol|mesh-list
24777133|NCT01862302|Haloperidol decanoate|haloperidol decanoate|mesh-list
24777134|NCT01862302|Antiemetics|antiemetics|mesh-ancestor
24777135|NCT01862302|Autonomic Agents|autonomic agents|mesh-ancestor
24777136|NCT01862302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24715765|NCT01538459|Hormones|hormones|mesh-ancestor
24568602|NCT00796497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24568603|NCT00796497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568604|NCT00796497|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24568605|NCT00796497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24568606|NCT00796497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24568607|NCT00796497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24568608|NCT00796497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24620834|NCT01059383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24620835|NCT01059383|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24620836|NCT01059383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620837|NCT01059383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620839|NCT01059396|Carvedilol|carvedilol|mesh-list
24620840|NCT01059396|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24620842|NCT01059396|Adrenergic Agents|adrenergic agents|mesh-ancestor
24620843|NCT01059396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24620844|NCT01059396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620845|NCT01059396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620846|NCT01059396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24620847|NCT01059396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24620848|NCT01059396|Vasodilator Agents|vasodilator agents|mesh-ancestor
24620849|NCT01059396|Antioxidants|antioxidants|mesh-ancestor
24620850|NCT01059396|Protective Agents|protective agents|mesh-ancestor
24620852|NCT01059396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24620853|NCT01059396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24620854|NCT01059396|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24620855|NCT01059396|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24620856|NCT01059422|Lamivudine|lamivudine|mesh-list
24620857|NCT01059422|Abacavir|abacavir|mesh-list
24620858|NCT01059422|Raltegravir Potassium|raltegravir potassium|mesh-list
24620859|NCT01059422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24620860|NCT01059422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24620861|NCT01059422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678072|NCT01819935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678073|NCT01820559|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25678074|NCT01820559|Anticonvulsants|anticonvulsants|mesh-ancestor
25678075|NCT01820559|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25678076|NCT01820559|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24620862|NCT01059422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931102|NCT04093271|Anesthetics|anesthetics|mesh-ancestor
24620863|NCT01059422|Antiviral Agents|antiviral agents|mesh-ancestor
24620864|NCT01059422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24620865|NCT01059422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24620866|NCT01059422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24620867|NCT01059422|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24777174|NCT01862835|Anastrozole|anastrozole|mesh-list
24777175|NCT01862835|Testosterone|testosterone|mesh-list
24777191|NCT01862887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24777192|NCT01862887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25213112|NCT05143164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25213113|NCT05143164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25213114|NCT05143164|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25213115|NCT05143164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25213116|NCT05143164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25156940|NCT04878211|Interferons|interferons|mesh-list
25156941|NCT04878211|Ofatumumab|ofatumumab|mesh-list
25156942|NCT04878211|Glatiramer Acetate|glatiramer acetate|mesh-list
25156943|NCT04878211|(T,G)-A-L|(t,g)-a-l|mesh-list
25156944|NCT04878211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25156945|NCT04878211|Antiviral Agents|antiviral agents|mesh-ancestor
25115864|NCT03112148|Tofacitinib|tofacitinib|mesh-list
25156946|NCT04878211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25156947|NCT04878211|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25156948|NCT04878211|Immunologic Factors|immunologic factors|mesh-ancestor
25156949|NCT04878211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777193|NCT01862887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24777194|NCT01862887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24777195|NCT01862887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777196|NCT01862887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24777197|NCT01862926|Cyclophosphamide|cyclophosphamide|mesh-list
24777199|NCT01862926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24777200|NCT01862926|Immunologic Factors|immunologic factors|mesh-ancestor
24777201|NCT01862926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777202|NCT01862926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24777203|NCT01862926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24777204|NCT01862926|Alkylating Agents|alkylating agents|mesh-ancestor
24777205|NCT01862926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777206|NCT01862926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24777207|NCT01862926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24487136|NCT00461747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24487137|NCT00461747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487138|NCT00461747|Protease Inhibitors|protease inhibitors|mesh-ancestor
24487139|NCT00461747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24777208|NCT01862926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24777209|NCT01862952|Anticonvulsants|anticonvulsants|mesh-list
24777211|NCT01862978|Nadroparin|nadroparin|mesh-list
24777212|NCT01862978|Anticoagulants|anticoagulants|mesh-ancestor
24777213|NCT01862978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24777214|NCT01862978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24777215|NCT01862978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777216|NCT01863004|Bortezomib|bortezomib|mesh-list
24777217|NCT01863004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24777218|NCT01863069|Interferons|interferons|mesh-list
24777219|NCT01863069|Interferon-beta|interferon-beta|mesh-list
24777220|NCT01863069|Interferon beta-1a|interferon beta-1a|mesh-list
24777221|NCT01863069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24777222|NCT01863069|Antiviral Agents|antiviral agents|mesh-ancestor
24777223|NCT01863069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24777224|NCT01863069|Immunologic Factors|immunologic factors|mesh-ancestor
24777225|NCT01863069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777226|NCT01863069|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24777227|NCT01863147|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24777229|NCT01863147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24777230|NCT01863147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777231|NCT01863147|Incretins|incretins|mesh-ancestor
24777270|NCT01863238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24777271|NCT01863238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777272|NCT01863251|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24777273|NCT01863251|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24777274|NCT01863251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24777275|NCT01863251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24777276|NCT01863251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777277|NCT01863251|Adrenergic Agents|adrenergic agents|mesh-ancestor
24777280|NCT01863277|Melatonin|melatonin|mesh-list
25678077|NCT01820559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25213118|NCT05141552|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25213119|NCT05141552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213120|NCT05141552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25213121|NCT05141552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213122|NCT05136157|Insulin|insulin|mesh-list
25213123|NCT05136157|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25213124|NCT05136157|Insulin, Short-Acting|insulin, short-acting|mesh-list
25213125|NCT05136157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25213126|NCT05136157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213127|NCT05131646|Axitinib|axitinib|mesh-list
25156950|NCT04878211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25156951|NCT04878211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25156952|NCT04877093|Clonidine|clonidine|mesh-list
25156953|NCT04877093|Analgesics|analgesics|mesh-ancestor
25156954|NCT04877093|Sensory System Agents|sensory system agents|mesh-ancestor
25156955|NCT04877093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25156956|NCT04877093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25156957|NCT04877093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25156958|NCT04877093|Sympatholytics|sympatholytics|mesh-ancestor
25156959|NCT04877093|Autonomic Agents|autonomic agents|mesh-ancestor
25156960|NCT04877093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25156961|NCT04877093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25156962|NCT04877093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24777300|NCT01863407|Allantoin|allantoin|mesh-list
24777301|NCT01863407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24777302|NCT01863407|Antiemetics|antiemetics|mesh-ancestor
24777303|NCT01863407|Autonomic Agents|autonomic agents|mesh-ancestor
24777304|NCT01863407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24935292|NCT04052178|Capsaicin|capsaicin|mesh-list
24777305|NCT01863407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777306|NCT01863407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24796378|NCT01949675|Immunologic Factors|immunologic factors|mesh-ancestor
24796379|NCT01949675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627504|NCT01093092|Vitamins|vitamins|mesh-ancestor
24627505|NCT01093092|Micronutrients|micronutrients|mesh-ancestor
24627506|NCT01093092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24627507|NCT01093157|Hormones|hormones|mesh-list
24627508|NCT01093157|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24627509|NCT01093157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24627510|NCT01093157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627511|NCT01093235|Cyclophosphamide|cyclophosphamide|mesh-list
24627512|NCT01093235|Bevacizumab|bevacizumab|mesh-list
24627513|NCT01093235|Docetaxel|docetaxel|mesh-list
24627514|NCT01093235|Fluorouracil|fluorouracil|mesh-list
24627515|NCT01093235|Epirubicin|epirubicin|mesh-list
24627516|NCT01093235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24627517|NCT01093235|Immunologic Factors|immunologic factors|mesh-ancestor
25081608|NCT03328481|Anesthetics|anesthetics|mesh-list
25081611|NCT03328364|Docetaxel|docetaxel|mesh-list
24777342|NCT01863589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24777343|NCT01863589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24777344|NCT01863589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777345|NCT01863602|Lamotrigine|lamotrigine|mesh-list
24777346|NCT01863602|Anticonvulsants|anticonvulsants|mesh-ancestor
24777347|NCT01863602|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24777348|NCT01863602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24777349|NCT01863602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777350|NCT01863602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24777351|NCT01863602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777352|NCT01863602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24777353|NCT01863602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24777354|NCT01863602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24777355|NCT01863602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24777356|NCT01863602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24777357|NCT01863615|Isotretinoin|isotretinoin|mesh-list
24777358|NCT01863615|Dermatologic Agents|dermatologic agents|mesh-ancestor
24777359|NCT01863641|Calcitriol|calcitriol|mesh-list
25213128|NCT05131646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25213129|NCT05131646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25213130|NCT05131646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25213131|NCT05131646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213132|NCT05096468|Pregabalin|pregabalin|mesh-list
25213133|NCT05096468|Ketamine|ketamine|mesh-list
25213134|NCT05096468|Esketamine|esketamine|mesh-list
25213135|NCT05096468|Analgesics|analgesics|mesh-ancestor
25213136|NCT05096468|Sensory System Agents|sensory system agents|mesh-ancestor
24624991|NCT01079715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624992|NCT01079715|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24624993|NCT01079715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24624995|NCT01079754|Morphine|morphine|mesh-list
25213137|NCT05096468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25213138|NCT05096468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213139|NCT05096468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25213140|NCT05096468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25213141|NCT05096468|Anesthetics, General|anesthetics, general|mesh-ancestor
25213142|NCT05096468|Anesthetics|anesthetics|mesh-ancestor
25156964|NCT04877093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25156965|NCT04877093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777360|NCT01863641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24777361|NCT01863641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777362|NCT01863641|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24777363|NCT01863641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24777668|NCT01865630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24777389|NCT01863719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24777390|NCT01863719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24777392|NCT01863810|Analgesics|analgesics|mesh-ancestor
24777393|NCT01863810|Sensory System Agents|sensory system agents|mesh-ancestor
24664797|NCT01308671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664798|NCT01308671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777394|NCT01863810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24777395|NCT01863810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777396|NCT01863810|Anticonvulsants|anticonvulsants|mesh-ancestor
24777397|NCT01863810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24777398|NCT01863810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24777399|NCT01863810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777400|NCT01863810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24777401|NCT01863810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24777402|NCT01863810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24777403|NCT01863810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24777404|NCT01863810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24777405|NCT01863823|Amoxicillin|amoxicillin|mesh-list
24777406|NCT01863823|Tetracycline|tetracycline|mesh-list
24777407|NCT01863823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24777408|NCT01863823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24716052|NCT01539655|Ranitidine|ranitidine|mesh-list
24777443|NCT01864057|Micronutrients|micronutrients|mesh-ancestor
24777444|NCT01864057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777445|NCT01864070|Everolimus|everolimus|mesh-list
24568910|NCT00798083|Ketamine|ketamine|mesh-list
24568911|NCT00798083|Amitriptyline|amitriptyline|mesh-list
24568912|NCT00798083|Anesthetics, Local|anesthetics, local|mesh-ancestor
24568913|NCT00798083|Anesthetics|anesthetics|mesh-ancestor
24568914|NCT00798083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24568915|NCT00798083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568916|NCT00798083|Sensory System Agents|sensory system agents|mesh-ancestor
24568917|NCT00798083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24568918|NCT00798083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24777446|NCT01864070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24568919|NCT00798083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24777447|NCT01864070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24777448|NCT01864070|Immunologic Factors|immunologic factors|mesh-ancestor
24777449|NCT01864070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777450|NCT01864083|Fluorides|fluorides|mesh-list
24777451|NCT01864083|Cariostatic Agents|cariostatic agents|mesh-ancestor
24777452|NCT01864083|Protective Agents|protective agents|mesh-ancestor
24777453|NCT01864083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777454|NCT01864096|Metformin|metformin|mesh-list
24777455|NCT01864096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24777456|NCT01864096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777457|NCT01864161|Iron|iron|mesh-list
24777489|NCT01864551|Lamotrigine|lamotrigine|mesh-list
24777491|NCT01864551|Antiemetics|antiemetics|mesh-ancestor
24777492|NCT01864551|Autonomic Agents|autonomic agents|mesh-ancestor
24777493|NCT01864551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24777494|NCT01864551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678078|NCT01820559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678079|NCT01820572|Cyclosporine|cyclosporine|mesh-list
25678080|NCT01820572|Abatacept|abatacept|mesh-list
25678081|NCT01820572|Tacrolimus|tacrolimus|mesh-list
25678082|NCT01820572|Cyclosporins|cyclosporins|mesh-list
24529212|NCT00625079|Urological Agents|urological agents|mesh-ancestor
24529213|NCT00625092|Leucovorin|leucovorin|mesh-list
24529214|NCT00625092|Fluorouracil|fluorouracil|mesh-list
24529215|NCT00625092|Oxaliplatin|oxaliplatin|mesh-list
24529216|NCT00625092|Calcium|calcium|mesh-list
24529217|NCT00625092|Levoleucovorin|levoleucovorin|mesh-list
24624996|NCT01079754|Analgesics, Opioid|analgesics, opioid|mesh-list
24777496|NCT01864551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24777497|NCT01864551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24777498|NCT01864551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24777499|NCT01864551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25213143|NCT05096468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25213144|NCT05096468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25213145|NCT05096468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25213146|NCT05096468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25213147|NCT05096468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213148|NCT05096468|Anticonvulsants|anticonvulsants|mesh-ancestor
24777500|NCT01864551|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24777501|NCT01864551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24777502|NCT01864551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24777503|NCT01864551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777504|NCT01864551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24777505|NCT01864551|Serotonin Agents|serotonin agents|mesh-ancestor
24777506|NCT01864551|Anticonvulsants|anticonvulsants|mesh-ancestor
24777554|NCT01864915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777555|NCT01864915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777589|NCT01865175|Iron|iron|mesh-list
24777590|NCT01865175|Trace Elements|trace elements|mesh-ancestor
24777591|NCT01865175|Micronutrients|micronutrients|mesh-ancestor
24615024|NCT01027494|Hormones|hormones|mesh-ancestor
24777599|NCT01865188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24777601|NCT01865188|Vasodilator Agents|vasodilator agents|mesh-ancestor
24777602|NCT01865188|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24777603|NCT01865201|Mannitol|mannitol|mesh-list
24777604|NCT01865201|Edaravone|edaravone|mesh-list
24777605|NCT01865201|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24777606|NCT01865201|Diuretics|diuretics|mesh-ancestor
24777607|NCT01865201|Natriuretic Agents|natriuretic agents|mesh-ancestor
24777608|NCT01865201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777609|NCT01865201|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24777610|NCT01865201|Antioxidants|antioxidants|mesh-ancestor
24777632|NCT01865305|Biphasic Insulins|biphasic insulins|mesh-list
24777633|NCT01865305|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24777634|NCT01865305|Insulin, Isophane|insulin, isophane|mesh-list
24777635|NCT01865305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24777636|NCT01865305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777637|NCT01865318|Insulin|insulin|mesh-list
24777638|NCT01865318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24777653|NCT01865500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24777654|NCT01865500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24777655|NCT01865500|Autonomic Agents|autonomic agents|mesh-ancestor
24777656|NCT01865500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24777657|NCT01865500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24777658|NCT01865500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24777659|NCT01865500|Respiratory System Agents|respiratory system agents|mesh-ancestor
24777660|NCT01865630|Etanercept|etanercept|mesh-list
24777661|NCT01865630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24777662|NCT01865630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24777663|NCT01865630|Analgesics|analgesics|mesh-ancestor
24777664|NCT01865630|Sensory System Agents|sensory system agents|mesh-ancestor
24777665|NCT01865630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25050017|NCT00547066|Veltuzumab|veltuzumab|mesh-list
25213149|NCT05096468|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25213150|NCT05096468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25156977|NCT04863950|Lomustine|lomustine|mesh-list
25156978|NCT04863950|Imipramine|imipramine|mesh-list
25678083|NCT01820572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25678084|NCT01820572|Immunologic Factors|immunologic factors|mesh-ancestor
25678085|NCT01820572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678086|NCT01820572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25678087|NCT01820572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692413|NCT01999335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25156979|NCT04863950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25115934|NCT03112031|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24777666|NCT01865630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777667|NCT01865630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25081629|NCT03328312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25081630|NCT03328312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25081631|NCT03328312|Cholinergic Agents|cholinergic agents|mesh-ancestor
25081632|NCT03328312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25081633|NCT03328312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081634|NCT03328312|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25081635|NCT03328312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716231|NCT01540734|Antipyretics|antipyretics|mesh-ancestor
25081643|NCT03328299|Sensory System Agents|sensory system agents|mesh-ancestor
25081644|NCT03328299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25081645|NCT03328299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25081646|NCT03328299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25081647|NCT03328299|Analgesics|analgesics|mesh-ancestor
25081648|NCT03328299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25081649|NCT03328299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25081650|NCT03328299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25081651|NCT03328299|Adrenergic Agents|adrenergic agents|mesh-ancestor
25081652|NCT03328299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25081653|NCT03328299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081655|NCT03328234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25081656|NCT03328234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25081657|NCT03328234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081658|NCT03328234|Tubulin Modulators|tubulin modulators|mesh-ancestor
25081659|NCT03328234|Antimitotic Agents|antimitotic agents|mesh-ancestor
25081660|NCT03328234|Mitosis Modulators|mitosis modulators|mesh-ancestor
25081662|NCT03328117|Imatinib Mesylate|imatinib mesylate|mesh-list
25081666|NCT03328117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213151|NCT05096468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25213152|NCT05096468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25213153|NCT05096468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25213154|NCT05096468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25213155|NCT05096468|Antidepressive Agents|antidepressive agents|mesh-ancestor
25213156|NCT05086874|3-n-butylphthalide|3-n-butylphthalide|mesh-list
25213157|NCT05086874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25213158|NCT05086874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25115935|NCT03112031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25115937|NCT03112031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25115938|NCT03112031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24947510|NCT03927963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627545|NCT01093300|Paclitaxel|paclitaxel|mesh-list
25081683|NCT03328052|Antidepressive Agents|antidepressive agents|mesh-list
24777671|NCT01865630|Immunologic Factors|immunologic factors|mesh-ancestor
24777673|NCT01865669|Oxytocics|oxytocics|mesh-ancestor
24777674|NCT01865669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24777675|NCT01865669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777676|NCT01865721|Entonox|entonox|mesh-list
24777677|NCT01865721|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24777678|NCT01865721|Anesthetics|anesthetics|mesh-ancestor
24777679|NCT01865721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24777680|NCT01865721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777681|NCT01865760|Octreotide|octreotide|mesh-list
24777682|NCT01865760|Somatostatin|somatostatin|mesh-list
24777683|NCT01865760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24777684|NCT01865760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24915134|NCT04669132|Serotonin Agents|serotonin agents|mesh-ancestor
24777685|NCT01865760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24777686|NCT01865760|Hormones|hormones|mesh-ancestor
24777687|NCT01865760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24777688|NCT01865760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777702|NCT01865968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777703|NCT01866007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24777704|NCT01866007|Immunologic Factors|immunologic factors|mesh-ancestor
24777705|NCT01866007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777706|NCT01866059|Methamphetamine|methamphetamine|mesh-list
24777707|NCT01866059|Calcium|calcium|mesh-list
24777708|NCT01866059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24777709|NCT01866059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777710|NCT01866059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24777711|NCT01866059|Sympathomimetics|sympathomimetics|mesh-ancestor
24777712|NCT01866059|Autonomic Agents|autonomic agents|mesh-ancestor
24777713|NCT01866059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24777714|NCT01866059|Dopamine Agents|dopamine agents|mesh-ancestor
24777715|NCT01866059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24777716|NCT01866059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529254|NCT00625196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24931191|NCT04091971|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24931192|NCT04091971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24931193|NCT04091971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931195|NCT04092101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24931196|NCT04092101|Autonomic Agents|autonomic agents|mesh-ancestor
24931208|NCT04091815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24931210|NCT04091698|Coenzyme Q10|coenzyme q10|mesh-list
24931211|NCT04091698|Ubiquinone|ubiquinone|mesh-list
24931212|NCT04091698|Vitamins|vitamins|mesh-ancestor
24931213|NCT04091698|Micronutrients|micronutrients|mesh-ancestor
24931214|NCT04091698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931215|NCT04091932|Pembrolizumab|pembrolizumab|mesh-list
24931216|NCT04091932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24931217|NCT04091932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24931218|NCT04091932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931219|NCT04091932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931234|NCT04091412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25038332|NCT05224401|Renal Agents|renal agents|mesh-ancestor
24777717|NCT01866059|Adrenergic Agents|adrenergic agents|mesh-ancestor
24777718|NCT01866059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24777719|NCT01866059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24777721|NCT01866059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24777723|NCT01866241|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24777724|NCT01866241|Abortifacient Agents|abortifacient agents|mesh-ancestor
24777725|NCT01866241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24777726|NCT01866241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777727|NCT01866241|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24777728|NCT01866241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24777729|NCT01866241|Oxytocics|oxytocics|mesh-ancestor
24777730|NCT01866254|Morphine|morphine|mesh-list
24777731|NCT01866254|Hydromorphone|hydromorphone|mesh-list
24777732|NCT01866254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24777733|NCT01866254|Narcotics|narcotics|mesh-ancestor
24777734|NCT01866254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24777735|NCT01866254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777737|NCT01866254|Sensory System Agents|sensory system agents|mesh-ancestor
24777738|NCT01866254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25213159|NCT05086874|Protective Agents|protective agents|mesh-ancestor
25213160|NCT05086874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115939|NCT03112031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25115940|NCT03112031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24947513|NCT03927963|Anesthetics|anesthetics|mesh-ancestor
24777739|NCT01866267|Maraviroc|maraviroc|mesh-list
24777740|NCT01866267|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24569261|NCT00799838|Amoxicillin|amoxicillin|mesh-list
24569262|NCT00799838|Ketoprofen|ketoprofen|mesh-list
24569263|NCT00799838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24569264|NCT00799838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24569265|NCT00799838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24569266|NCT00799838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24569267|NCT00799838|Analgesics|analgesics|mesh-ancestor
24569268|NCT00799838|Sensory System Agents|sensory system agents|mesh-ancestor
24569269|NCT00799838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24569270|NCT00799838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678088|NCT01820572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678089|NCT01820572|Antifungal Agents|antifungal agents|mesh-ancestor
25678090|NCT01820572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25678091|NCT01820572|Dermatologic Agents|dermatologic agents|mesh-ancestor
25678092|NCT01820572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25678093|NCT01820572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25678094|NCT01820572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678095|NCT01820585|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25678096|NCT01820585|Anticonvulsants|anticonvulsants|mesh-ancestor
25678097|NCT01820585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25678098|NCT01820585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25678099|NCT01820585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25678100|NCT01820585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678101|NCT01820637|Paclitaxel|paclitaxel|mesh-list
25678102|NCT01820637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25678103|NCT01820637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678104|NCT01820637|Tubulin Modulators|tubulin modulators|mesh-ancestor
25678105|NCT01820637|Antimitotic Agents|antimitotic agents|mesh-ancestor
25678106|NCT01820637|Mitosis Modulators|mitosis modulators|mesh-ancestor
24931243|NCT04091074|Clopidogrel|clopidogrel|mesh-list
24777751|NCT01866397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716410|NCT01541436|Capsaicin|capsaicin|mesh-list
24777763|NCT01866514|Anesthetics|anesthetics|mesh-ancestor
24777764|NCT01866514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24777765|NCT01866514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777766|NCT01866514|Sensory System Agents|sensory system agents|mesh-ancestor
24777767|NCT01866514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24777768|NCT01866514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24777769|NCT01866514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24777770|NCT01866514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24777771|NCT01866514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24777772|NCT01866514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777773|NCT01866553|Interferons|interferons|mesh-list
24777774|NCT01866553|Interferon-alpha|interferon-alpha|mesh-list
24777775|NCT01866553|Interferon alpha-2|interferon alpha-2|mesh-list
24777776|NCT01866553|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24777777|NCT01866553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24777778|NCT01866553|Antiviral Agents|antiviral agents|mesh-ancestor
24777779|NCT01866553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24777792|NCT01866605|Anesthetics|anesthetics|mesh-ancestor
24777796|NCT01866605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777797|NCT01866644|Acetylcysteine|acetylcysteine|mesh-list
24777798|NCT01866644|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24777799|NCT01866644|Antiviral Agents|antiviral agents|mesh-ancestor
24777800|NCT01866644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24777801|NCT01866644|Expectorants|expectorants|mesh-ancestor
24777802|NCT01866644|Respiratory System Agents|respiratory system agents|mesh-ancestor
24792640|NCT04898478|Analgesics, Opioid|analgesics, opioid|mesh-list
24777803|NCT01866644|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24777804|NCT01866644|Antioxidants|antioxidants|mesh-ancestor
24777805|NCT01866644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777806|NCT01866644|Protective Agents|protective agents|mesh-ancestor
24777807|NCT01866644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777808|NCT01866644|Antidotes|antidotes|mesh-ancestor
24777809|NCT01867138|Vancomycin|vancomycin|mesh-list
24777810|NCT01867138|Cefazolin|cefazolin|mesh-list
24777811|NCT01867138|Amikacin|amikacin|mesh-list
24777812|NCT01867138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24777813|NCT01867138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24777814|NCT01867255|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24777815|NCT01867255|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24777816|NCT01867255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24777817|NCT01867255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24777818|NCT01867255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777819|NCT01867255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24777820|NCT01867255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777821|NCT01867255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24777822|NCT01867255|Antidepressive Agents|antidepressive agents|mesh-ancestor
24777823|NCT01867255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24777824|NCT01867268|Acetazolamide|acetazolamide|mesh-list
24777825|NCT01867268|Anticonvulsants|anticonvulsants|mesh-ancestor
24777826|NCT01867268|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24777827|NCT01867268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24777835|NCT01867281|Analgesics|analgesics|mesh-ancestor
25115941|NCT03112031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777836|NCT01867281|Sensory System Agents|sensory system agents|mesh-ancestor
24777837|NCT01867281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24777855|NCT01867502|Metformin|metformin|mesh-list
24777856|NCT01867502|Vildagliptin|vildagliptin|mesh-list
24777857|NCT01867502|Glyburide|glyburide|mesh-list
24777858|NCT01867502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24777859|NCT01867502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777860|NCT01867502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24777861|NCT01867502|Protease Inhibitors|protease inhibitors|mesh-ancestor
24777862|NCT01867502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24777863|NCT01867502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777864|NCT01867593|Carbon-11 methionine|carbon-11 methionine|mesh-list
24777865|NCT01867593|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24777979|NCT01868360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24777867|NCT01867645|Immunoglobulins|immunoglobulins|mesh-list
24627596|NCT01093937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777876|NCT01867697|Oxaliplatin|oxaliplatin|mesh-list
25692414|NCT01999335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777877|NCT01867697|Irinotecan|irinotecan|mesh-list
24777878|NCT01867697|Cetuximab|cetuximab|mesh-list
24777879|NCT01867697|Calcium Carbonate|calcium carbonate|mesh-list
24777881|NCT01867697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777882|NCT01867697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24777883|NCT01867697|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24777884|NCT01867697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24496573|NCT00505531|Analgesics|analgesics|mesh-ancestor
24777885|NCT01867697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24777886|NCT01867697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777887|NCT01867697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24777888|NCT01867697|Antidotes|antidotes|mesh-ancestor
24777889|NCT01867697|Protective Agents|protective agents|mesh-ancestor
24777890|NCT01867697|Vitamin B Complex|vitamin b complex|mesh-ancestor
24777891|NCT01867697|Vitamins|vitamins|mesh-ancestor
24665117|NCT01310283|Fluorides|fluorides|mesh-list
24777892|NCT01867697|Micronutrients|micronutrients|mesh-ancestor
24777893|NCT01867697|Hematinics|hematinics|mesh-ancestor
24777894|NCT01867697|Antacids|antacids|mesh-ancestor
24777895|NCT01867697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24777896|NCT01867775|Mirtazapine|mirtazapine|mesh-list
24777897|NCT01867775|Antidepressive Agents|antidepressive agents|mesh-ancestor
24777898|NCT01867775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24777899|NCT01867775|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24777900|NCT01867775|Histamine Antagonists|histamine antagonists|mesh-ancestor
24777901|NCT01867775|Histamine Agents|histamine agents|mesh-ancestor
24777902|NCT01867775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24777904|NCT01867775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716568|NCT01542437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24777937|NCT01867892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24777938|NCT01867892|Antidotes|antidotes|mesh-ancestor
24777939|NCT01867892|Protective Agents|protective agents|mesh-ancestor
24777940|NCT01867892|Vitamin B Complex|vitamin b complex|mesh-ancestor
24777941|NCT01867892|Vitamins|vitamins|mesh-ancestor
24777942|NCT01867892|Micronutrients|micronutrients|mesh-ancestor
24777943|NCT01868048|Nabiximols|nabiximols|mesh-list
24777944|NCT01868048|Analgesics|analgesics|mesh-ancestor
24777945|NCT01868048|Sensory System Agents|sensory system agents|mesh-ancestor
24777946|NCT01868048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24777947|NCT01868048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777948|NCT01868113|Fluticasone|fluticasone|mesh-list
24777949|NCT01868113|Xhance|xhance|mesh-list
24777950|NCT01868113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24777951|NCT01868113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24777952|NCT01868113|Autonomic Agents|autonomic agents|mesh-ancestor
24777953|NCT01868113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24777954|NCT01868113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081685|NCT03327987|Vaccines|vaccines|mesh-list
25081686|NCT03327987|Immunologic Factors|immunologic factors|mesh-ancestor
25081687|NCT03327987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627598|NCT01093963|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
24777955|NCT01868113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24777956|NCT01868113|Respiratory System Agents|respiratory system agents|mesh-ancestor
24777957|NCT01868113|Dermatologic Agents|dermatologic agents|mesh-ancestor
24777958|NCT01868113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24777959|NCT01868126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24777964|NCT01868191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24777965|NCT01868191|Immunologic Factors|immunologic factors|mesh-ancestor
24777966|NCT01868191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777967|NCT01868191|Chelating Agents|chelating agents|mesh-ancestor
24777968|NCT01868191|Sequestering Agents|sequestering agents|mesh-ancestor
24777969|NCT01868191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777972|NCT01868191|Micronutrients|micronutrients|mesh-ancestor
24777973|NCT01868360|Aflibercept|aflibercept|mesh-list
24777974|NCT01868360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24777975|NCT01868360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24777976|NCT01868360|Growth Substances|growth substances|mesh-ancestor
24935480|NCT04050059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24777977|NCT01868360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777978|NCT01868360|Growth Inhibitors|growth inhibitors|mesh-ancestor
24777981|NCT01868438|Pyronaridine|pyronaridine|mesh-list
24777982|NCT01868438|Antimalarials|antimalarials|mesh-ancestor
24777983|NCT01868438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24777984|NCT01868438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24777985|NCT01868438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24777986|NCT01868438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24777987|NCT01868438|Antiviral Agents|antiviral agents|mesh-ancestor
24777988|NCT01868438|Schistosomicides|schistosomicides|mesh-ancestor
24777989|NCT01868438|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24777990|NCT01868438|Anthelmintics|anthelmintics|mesh-ancestor
24777991|NCT01868464|BCG Vaccine|bcg vaccine|mesh-list
24931301|NCT04090112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24507497|NCT00550927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24507498|NCT00550927|Growth Substances|growth substances|mesh-ancestor
24529255|NCT00625196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24529257|NCT00625196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24529258|NCT00625196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529264|NCT00625209|Hydrocortisone|hydrocortisone|mesh-list
24777992|NCT01868464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24777993|NCT01868464|Immunologic Factors|immunologic factors|mesh-ancestor
24777994|NCT01868464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777995|NCT01868529|Insulin|insulin|mesh-list
24777996|NCT01868529|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24778012|NCT01868568|Biphasic Insulins|biphasic insulins|mesh-list
24778013|NCT01868568|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24778014|NCT01868568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24778015|NCT01868568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778017|NCT01868581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24778018|NCT01868581|Insulin Aspart|insulin aspart|mesh-list
24778019|NCT01868581|Insulin, Long-Acting|insulin, long-acting|mesh-list
24778020|NCT01868581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24778021|NCT01868581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778022|NCT01868750|Calcitriol|calcitriol|mesh-list
24778023|NCT01868750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24778024|NCT01868750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778025|NCT01868750|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24778026|NCT01868750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24778027|NCT01868750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778028|NCT01868750|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24778029|NCT01868750|Vitamins|vitamins|mesh-ancestor
24778030|NCT01868750|Micronutrients|micronutrients|mesh-ancestor
25081688|NCT03327831|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24778031|NCT01868750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24778032|NCT01868802|Ketamine|ketamine|mesh-list
24778033|NCT01868802|Analgesics|analgesics|mesh-ancestor
24778034|NCT01868802|Sensory System Agents|sensory system agents|mesh-ancestor
24778035|NCT01868802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24778036|NCT01868802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778050|NCT01868880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24778051|NCT01868880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778052|NCT01868880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778053|NCT01868880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24778054|NCT01868880|Sympatholytics|sympatholytics|mesh-ancestor
24778055|NCT01868880|Autonomic Agents|autonomic agents|mesh-ancestor
24778056|NCT01868880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24778057|NCT01868880|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24778058|NCT01868906|Temozolomide|temozolomide|mesh-list
24778059|NCT01868906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24778060|NCT01868906|Alkylating Agents|alkylating agents|mesh-ancestor
24778061|NCT01868906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778062|NCT01868906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24778063|NCT01868945|Vitamin D|vitamin d|mesh-list
24778064|NCT01868945|Cholecalciferol|cholecalciferol|mesh-list
24778065|NCT01868945|Calcifediol|calcifediol|mesh-list
24778066|NCT01868945|Vitamins|vitamins|mesh-ancestor
24778067|NCT01868945|Micronutrients|micronutrients|mesh-ancestor
24778068|NCT01868945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569619|NCT00801281|Hormones|hormones|mesh-ancestor
25115942|NCT03112031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25115943|NCT03112031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25115944|NCT03112031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25115946|NCT03112031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25115948|NCT03112031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25115949|NCT03111901|Pembrolizumab|pembrolizumab|mesh-list
25115950|NCT03111901|Interleukin-2|interleukin-2|mesh-list
25115951|NCT03111901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25115952|NCT03111901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25115953|NCT03111901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25678107|NCT01820637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678108|NCT01820754|Paclitaxel|paclitaxel|mesh-list
25678109|NCT01820754|Cisplatin|cisplatin|mesh-list
25678110|NCT01820754|Carboplatin|carboplatin|mesh-list
25678111|NCT01820754|Ipilimumab|ipilimumab|mesh-list
25678112|NCT01820754|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25678113|NCT01820754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678114|NCT01820754|Tubulin Modulators|tubulin modulators|mesh-ancestor
25115954|NCT03111901|Analgesics|analgesics|mesh-ancestor
25115958|NCT03111797|Morphine|morphine|mesh-list
25156980|NCT04863950|Alkylating Agents|alkylating agents|mesh-ancestor
24778073|NCT01868984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24778075|NCT01868984|Tubulin Modulators|tubulin modulators|mesh-ancestor
24778076|NCT01868984|Antimitotic Agents|antimitotic agents|mesh-ancestor
24778077|NCT01868984|Mitosis Modulators|mitosis modulators|mesh-ancestor
24778078|NCT01868984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778079|NCT01868984|Anticoagulants|anticoagulants|mesh-ancestor
24778080|NCT01868984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24778081|NCT01868984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24778082|NCT01869010|Tenofovir|tenofovir|mesh-list
24665251|NCT01311050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25213170|NCT05062356|Ketorolac|ketorolac|mesh-list
25213171|NCT05062356|Epinephrine|epinephrine|mesh-list
25213172|NCT05062356|Bupivacaine|bupivacaine|mesh-list
25213173|NCT05062356|Prilocaine|prilocaine|mesh-list
25213174|NCT05062356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25213175|NCT05062356|Anesthetics, Local|anesthetics, local|mesh-ancestor
25213176|NCT05062356|Anesthetics|anesthetics|mesh-ancestor
25213177|NCT05062356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25213178|NCT05062356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213179|NCT05062356|Sensory System Agents|sensory system agents|mesh-ancestor
25213180|NCT05062356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25213181|NCT05062356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25213182|NCT05062356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25213183|NCT05062356|Adrenergic Agents|adrenergic agents|mesh-ancestor
25213184|NCT05062356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25213185|NCT05062356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213186|NCT05062356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25213187|NCT05062356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25213188|NCT05062356|Autonomic Agents|autonomic agents|mesh-ancestor
25213189|NCT05062356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25213190|NCT05062356|Respiratory System Agents|respiratory system agents|mesh-ancestor
25213191|NCT05062356|Mydriatics|mydriatics|mesh-ancestor
25213192|NCT05062356|Sympathomimetics|sympathomimetics|mesh-ancestor
25213193|NCT05062356|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25213194|NCT05062356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25213195|NCT05062356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25213196|NCT05062356|Analgesics|analgesics|mesh-ancestor
25213197|NCT05062356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25213198|NCT05062356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25156997|NCT04852679|Lanreotide|lanreotide|mesh-list
25156998|NCT04852679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487211|NCT00462111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24487212|NCT00462111|Analgesics|analgesics|mesh-ancestor
24487213|NCT00462111|Sensory System Agents|sensory system agents|mesh-ancestor
24487214|NCT00462111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24487215|NCT00462111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487216|NCT00462111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24778123|NCT01869257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24778124|NCT01869309|Ticagrelor|ticagrelor|mesh-list
24778125|NCT01869309|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24778126|NCT01869309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24778137|NCT01869413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778139|NCT01869413|Coagulants|coagulants|mesh-ancestor
24778140|NCT01869491|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
24778141|NCT01869491|Antacids|antacids|mesh-ancestor
24569695|NCT00801515|Maraviroc|maraviroc|mesh-list
24569773|NCT00801879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620873|NCT01059461|Nootropic Agents|nootropic agents|mesh-ancestor
24620901|NCT01059890|Cefotaxime|cefotaxime|mesh-list
24620902|NCT01059890|Cefoxitin|cefoxitin|mesh-list
24620903|NCT01059890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24620904|NCT01059890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24620905|NCT01059890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24620906|NCT01059890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24620907|NCT01059890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24620908|NCT01059890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24620909|NCT01059890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620910|NCT01059890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620911|NCT01059890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665359|NCT01311882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25678115|NCT01820754|Antimitotic Agents|antimitotic agents|mesh-ancestor
24625020|NCT01079910|Fluorides|fluorides|mesh-list
24620912|NCT01059890|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25213199|NCT05062356|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25213200|NCT05062356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25213202|NCT05025397|Sevoflurane|sevoflurane|mesh-list
25213203|NCT05025397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25213204|NCT05025397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25213205|NCT05025397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213206|NCT05025397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25213207|NCT05025397|Anesthetics, General|anesthetics, general|mesh-ancestor
25213208|NCT05025397|Anesthetics|anesthetics|mesh-ancestor
25213209|NCT05025397|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25213210|NCT05025397|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25272738|NCT02390310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25272739|NCT02390310|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25272740|NCT02390310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25272741|NCT02390310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25272742|NCT02390310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272743|NCT02390102|Epoetin Alfa|epoetin alfa|mesh-list
25272744|NCT02390102|Hematinics|hematinics|mesh-ancestor
25272745|NCT02390089|Capsaicin|capsaicin|mesh-list
24620913|NCT01059890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24620914|NCT01059955|Dexamethasone|dexamethasone|mesh-list
24620915|NCT01059955|Dexamethasone acetate|dexamethasone acetate|mesh-list
24620916|NCT01059955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24620917|NCT01059955|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24620918|NCT01059955|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24620919|NCT01059955|BB 1101|bb 1101|mesh-list
24620920|NCT01059955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24620921|NCT01059955|Antiemetics|antiemetics|mesh-ancestor
24778142|NCT01869491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778143|NCT01869491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24778145|NCT01869556|Ergonovine|ergonovine|mesh-list
24778146|NCT01869556|Carboprost|carboprost|mesh-list
24778147|NCT01869556|Oxytocics|oxytocics|mesh-ancestor
24778150|NCT01869556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24778151|NCT01869556|Abortifacient Agents|abortifacient agents|mesh-ancestor
24778152|NCT01869569|Pregabalin|pregabalin|mesh-list
24778153|NCT01869569|Analgesics|analgesics|mesh-ancestor
24778166|NCT01869621|Metformin|metformin|mesh-list
24778167|NCT01869621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24778168|NCT01869621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778169|NCT01869673|Anesthetics|anesthetics|mesh-list
24778170|NCT01869673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24778171|NCT01869673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778172|NCT01869751|Prucalopride|prucalopride|mesh-list
24778173|NCT01869751|Laxatives|laxatives|mesh-ancestor
24778174|NCT01869751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24778175|NCT01869751|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24778176|NCT01869751|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24778177|NCT01869751|Serotonin Agents|serotonin agents|mesh-ancestor
24778178|NCT01869751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24778192|NCT01869881|Serotonin Agents|serotonin agents|mesh-ancestor
24778193|NCT01869881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24778194|NCT01869881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778195|NCT01869907|Minocycline|minocycline|mesh-list
24778196|NCT01869907|Amitriptyline|amitriptyline|mesh-list
24778197|NCT01869907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24778198|NCT01869907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24487217|NCT00462111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24487218|NCT00462111|Gout Suppressants|gout suppressants|mesh-ancestor
24487220|NCT00462111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24487221|NCT00462111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24487222|NCT00462111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487239|NCT00462358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487240|NCT00462358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24778199|NCT01869907|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24778200|NCT01869907|Antidepressive Agents|antidepressive agents|mesh-ancestor
24778201|NCT01869907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24778202|NCT01869907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24778204|NCT01869907|Sensory System Agents|sensory system agents|mesh-ancestor
24778205|NCT01869907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24778206|NCT01869907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778207|NCT01869907|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24778208|NCT01869907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25678116|NCT01820754|Mitosis Modulators|mitosis modulators|mesh-ancestor
24897369|NCT04426123|Botulinum Toxins|botulinum toxins|mesh-list
24625060|NCT01080417|Antitubercular Agents|antitubercular agents|mesh-ancestor
24507599|NCT00551044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529303|NCT00625352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24529304|NCT00625352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529305|NCT00625352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24778209|NCT01869907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24778210|NCT01869907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778211|NCT01869907|Adrenergic Agents|adrenergic agents|mesh-ancestor
24778212|NCT01869907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24778213|NCT01869946|Ropivacaine|ropivacaine|mesh-list
24778214|NCT01869946|Anesthetics, Local|anesthetics, local|mesh-ancestor
24778215|NCT01869946|Anesthetics|anesthetics|mesh-ancestor
24778216|NCT01869946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24778217|NCT01869946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778218|NCT01869946|Sensory System Agents|sensory system agents|mesh-ancestor
24778219|NCT01869946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24778220|NCT01870011|Anesthetics|anesthetics|mesh-list
24778222|NCT01870011|Desflurane|desflurane|mesh-list
24778223|NCT01870011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24778224|NCT01870011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778225|NCT01870011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25213211|NCT05011617|Anesthetics|anesthetics|mesh-list
25272746|NCT02390089|Antipruritics|antipruritics|mesh-ancestor
24778226|NCT01870011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24778227|NCT01870011|Anesthetics, General|anesthetics, general|mesh-ancestor
24778228|NCT01870011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24778229|NCT01870024|Fosphenytoin|fosphenytoin|mesh-list
24778230|NCT01870024|Lorazepam|lorazepam|mesh-list
24778231|NCT01870024|Clonazepam|clonazepam|mesh-list
24778232|NCT01870024|Anticonvulsants|anticonvulsants|mesh-ancestor
24778233|NCT01870024|Antiemetics|antiemetics|mesh-ancestor
24778234|NCT01870024|Autonomic Agents|autonomic agents|mesh-ancestor
24778252|NCT01870050|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24778253|NCT01870050|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24778254|NCT01870050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24778255|NCT01870050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24778256|NCT01870050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778257|NCT01870050|Leprostatic Agents|leprostatic agents|mesh-ancestor
24778258|NCT01870050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24778260|NCT01870115|Cholecalciferol|cholecalciferol|mesh-list
24778261|NCT01870115|Melatonin|melatonin|mesh-list
24778262|NCT01870115|Vitamins|vitamins|mesh-ancestor
24778263|NCT01870115|Micronutrients|micronutrients|mesh-ancestor
24778264|NCT01870115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778265|NCT01870115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24778266|NCT01870115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778267|NCT01870115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24778268|NCT01870115|Antioxidants|antioxidants|mesh-ancestor
24778269|NCT01870115|Protective Agents|protective agents|mesh-ancestor
24778277|NCT01870128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24627599|NCT01093963|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24627600|NCT01093963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627601|NCT01093963|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24627602|NCT01093963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24627603|NCT01093963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24627604|NCT01093963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627605|NCT01093963|Dopamine Agents|dopamine agents|mesh-ancestor
24627606|NCT01093963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24627607|NCT01094015|Lidocaine|lidocaine|mesh-list
24627608|NCT01094015|Prilocaine|prilocaine|mesh-list
24627609|NCT01094015|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24627610|NCT01094015|Anesthetics, Local|anesthetics, local|mesh-ancestor
24627611|NCT01094015|Anesthetics|anesthetics|mesh-ancestor
24627612|NCT01094015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24655863|NCT01258491|Niacin|niacin|mesh-list
24655940|NCT01258777|Golimumab|golimumab|mesh-list
24627613|NCT01094015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627614|NCT01094015|Sensory System Agents|sensory system agents|mesh-ancestor
24627615|NCT01094015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25081691|NCT03327766|Calcifediol|calcifediol|mesh-list
25678117|NCT01820754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678118|NCT01820754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25678119|NCT01820754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25678120|NCT01821105|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25081692|NCT03327766|Vitamins|vitamins|mesh-ancestor
25081693|NCT03327766|Micronutrients|micronutrients|mesh-ancestor
24931353|NCT04089722|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24931354|NCT04089722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24931355|NCT04089813|Metformin|metformin|mesh-list
24931356|NCT04089813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25155516|NCT05353140|Purinergic Agents|purinergic agents|mesh-ancestor
24931369|NCT04089904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24931370|NCT04089904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931371|NCT04089631|Capecitabine|capecitabine|mesh-list
24931372|NCT04089631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24931373|NCT04089631|Antimetabolites|antimetabolites|mesh-ancestor
25081694|NCT03327766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081695|NCT03327766|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25081696|NCT03327727|Voriconazole|voriconazole|mesh-list
25081697|NCT03327727|Amphotericin B|amphotericin b|mesh-list
25081698|NCT03327727|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25081699|NCT03327727|Isavuconazole|isavuconazole|mesh-list
25081709|NCT03327727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25081710|NCT03327727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081711|NCT03327727|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25081712|NCT03327727|Amebicides|amebicides|mesh-ancestor
25081713|NCT03327727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25081714|NCT03327727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25081715|NCT03327727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25081716|NCT03327701|Benralizumab|benralizumab|mesh-list
25081717|NCT03327701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25081718|NCT03327701|Respiratory System Agents|respiratory system agents|mesh-ancestor
25081719|NCT03327675|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
24935625|NCT04048707|Sympathomimetics|sympathomimetics|mesh-ancestor
24796791|NCT01951911|Anesthetics, General|anesthetics, general|mesh-ancestor
25081720|NCT03327675|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25081721|NCT03327675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081722|NCT03327558|Mesalamine|mesalamine|mesh-list
25081723|NCT03327558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25081724|NCT03327558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25213212|NCT05011617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25213213|NCT05011617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25157020|NCT04840342|Eplerenone|eplerenone|mesh-list
25157021|NCT04840342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25157022|NCT04840342|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25157023|NCT04840342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25157024|NCT04840342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25157025|NCT04840342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25157026|NCT04840342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25157027|NCT04840342|Vasodilator Agents|vasodilator agents|mesh-ancestor
25157028|NCT04840342|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25157029|NCT04840342|Hormone Antagonists|hormone antagonists|mesh-ancestor
25157030|NCT04840342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25157031|NCT04840342|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25157032|NCT04840342|Diuretics|diuretics|mesh-ancestor
25081730|NCT03327558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25081731|NCT03327506|Alprazolam|alprazolam|mesh-list
25081732|NCT03327506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25081733|NCT03327506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25081734|NCT03327506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081735|NCT03327506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25081736|NCT03327506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25081737|NCT03327506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25081738|NCT03327506|GABA Modulators|gaba modulators|mesh-ancestor
24778285|NCT01870128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24778286|NCT01870128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24778287|NCT01870128|Immunologic Factors|immunologic factors|mesh-ancestor
24778288|NCT01870128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24665492|NCT01312441|Vitamin D|vitamin d|mesh-list
24778289|NCT01870128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25678121|NCT01821105|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25099886|NCT03186755|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25678122|NCT01821105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678123|NCT01821378|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25678124|NCT01821378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25678125|NCT01821378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25678126|NCT01821378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25678127|NCT01821378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678128|NCT01821378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25678129|NCT01821378|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24931389|NCT04089605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24778290|NCT01870128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24778291|NCT01870128|Antiemetics|antiemetics|mesh-ancestor
24778292|NCT01870128|Autonomic Agents|autonomic agents|mesh-ancestor
24778293|NCT01870128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24778294|NCT01870128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24778295|NCT01870128|Glucocorticoids|glucocorticoids|mesh-ancestor
24778297|NCT01870128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24778298|NCT01870128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24778299|NCT01870128|Protective Agents|protective agents|mesh-ancestor
24778300|NCT01870128|Antimalarials|antimalarials|mesh-ancestor
24778301|NCT01870128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24778302|NCT01870128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24778303|NCT01870128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24778304|NCT01870128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24778305|NCT01870128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24778306|NCT01870128|Analgesics|analgesics|mesh-ancestor
24778307|NCT01870128|Sensory System Agents|sensory system agents|mesh-ancestor
24778308|NCT01870167|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24778309|NCT01870167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24778310|NCT01870167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24778311|NCT01870167|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24778312|NCT01870167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615120|NCT01028079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24778334|NCT01870284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24778335|NCT01870284|Dermatologic Agents|dermatologic agents|mesh-ancestor
25213214|NCT05003102|Fentanyl|fentanyl|mesh-list
25213215|NCT05003102|Dexmedetomidine|dexmedetomidine|mesh-list
25213216|NCT05003102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25213217|NCT05003102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25213218|NCT05003102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213219|NCT05003102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25213220|NCT05003102|Analgesics|analgesics|mesh-ancestor
25213221|NCT05003102|Sensory System Agents|sensory system agents|mesh-ancestor
25213222|NCT05003102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25213223|NCT05003102|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25213224|NCT05003102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25213225|NCT05003102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25213226|NCT05003102|Adrenergic Agents|adrenergic agents|mesh-ancestor
25213227|NCT05003102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25272747|NCT02390089|Dermatologic Agents|dermatologic agents|mesh-ancestor
25157041|NCT04831593|Anesthetics|anesthetics|mesh-list
24558833|NCT05428306|Acetaminophen|acetaminophen|mesh-list
24778337|NCT01870427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24778338|NCT01870427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24778339|NCT01870427|Growth Substances|growth substances|mesh-ancestor
24778340|NCT01870427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778341|NCT01870427|Growth Inhibitors|growth inhibitors|mesh-ancestor
24778342|NCT01870427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24778343|NCT01870440|Dexamethasone|dexamethasone|mesh-list
24778348|NCT01870440|Autonomic Agents|autonomic agents|mesh-ancestor
24778349|NCT01870440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24778350|NCT01870440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778351|NCT01870440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24778352|NCT01870440|Glucocorticoids|glucocorticoids|mesh-ancestor
24778353|NCT01870440|Hormones|hormones|mesh-ancestor
24778354|NCT01870440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24778355|NCT01870440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24778356|NCT01870440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24778357|NCT01870440|Protease Inhibitors|protease inhibitors|mesh-ancestor
24778358|NCT01870440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24778360|NCT01870466|Cilostazol|cilostazol|mesh-list
24778374|NCT01870466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24778375|NCT01870466|Respiratory System Agents|respiratory system agents|mesh-ancestor
24778376|NCT01870466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24778377|NCT01870466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24778378|NCT01870466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24778379|NCT01870466|Vasodilator Agents|vasodilator agents|mesh-ancestor
24778380|NCT01870466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24778381|NCT01870466|Protective Agents|protective agents|mesh-ancestor
24778382|NCT01870466|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24665602|NCT01313611|Immunologic Factors|immunologic factors|mesh-ancestor
24778383|NCT01870466|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24778384|NCT01870492|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25678130|NCT01821378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24931422|NCT04089163|Antifungal Agents|antifungal agents|mesh-ancestor
24931423|NCT04089163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24931424|NCT04089163|Antimetabolites|antimetabolites|mesh-ancestor
24931425|NCT04089163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408013|NCT00176267|Paclitaxel|paclitaxel|mesh-list
24529345|NCT00625547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24529346|NCT00625547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529347|NCT00625547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038682|NCT04747236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038683|NCT04747236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25038684|NCT04747236|Immunologic Factors|immunologic factors|mesh-ancestor
25038685|NCT04747236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038686|NCT04747236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25038688|NCT04676555|Ofatumumab|ofatumumab|mesh-list
24778385|NCT01870492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24778386|NCT01870492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24778387|NCT01870492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778389|NCT01870635|Antiemetics|antiemetics|mesh-ancestor
24778390|NCT01870635|Autonomic Agents|autonomic agents|mesh-ancestor
24778391|NCT01870635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24778392|NCT01870635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778393|NCT01870635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24778394|NCT01870635|Antipruritics|antipruritics|mesh-ancestor
24778395|NCT01870635|Dermatologic Agents|dermatologic agents|mesh-ancestor
24778396|NCT01870635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24778397|NCT01870635|Serotonin Agents|serotonin agents|mesh-ancestor
24778398|NCT01870635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24778399|NCT01870635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778424|NCT01870674|Laxatives|laxatives|mesh-ancestor
24778425|NCT01870674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24778426|NCT01870674|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
25081742|NCT03327454|Etanercept|etanercept|mesh-list
24778427|NCT01870674|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24778428|NCT01870674|Serotonin Agents|serotonin agents|mesh-ancestor
24778429|NCT01870674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24778430|NCT01870674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778431|NCT01870674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778432|NCT01870804|Atorvastatin|atorvastatin|mesh-list
25213228|NCT05003102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213229|NCT05003102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25213230|NCT05003102|Narcotics|narcotics|mesh-ancestor
25213231|NCT05003102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25213232|NCT05003102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25213233|NCT05003102|Anesthetics, General|anesthetics, general|mesh-ancestor
25213234|NCT05003102|Anesthetics|anesthetics|mesh-ancestor
25213235|NCT05001750|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25213236|NCT05001750|Doxycycline|doxycycline|mesh-list
25157042|NCT04831593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25157043|NCT04831593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947577|NCT03927495|Paclitaxel|paclitaxel|mesh-list
24665638|NCT01313819|Antiviral Agents|antiviral agents|mesh-ancestor
24778476|NCT01871311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24778477|NCT01871311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24778478|NCT01871363|Capecitabine|capecitabine|mesh-list
24778479|NCT01871363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24778480|NCT01871363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24778481|NCT01871363|Antimetabolites|antimetabolites|mesh-ancestor
25081747|NCT03327454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24778495|NCT01871454|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24778497|NCT01871454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678131|NCT01821378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25678132|NCT01821378|Adrenergic Agents|adrenergic agents|mesh-ancestor
25678133|NCT01821378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25678134|NCT01821378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678135|NCT01821378|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25678136|NCT01821378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25678137|NCT01821378|Serotonin Agents|serotonin agents|mesh-ancestor
25678138|NCT01821378|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25678139|NCT01821378|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25678140|NCT01821378|Dopamine Agents|dopamine agents|mesh-ancestor
25678141|NCT01821391|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
25678142|NCT01821391|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25678143|NCT01821391|Dermatologic Agents|dermatologic agents|mesh-ancestor
25678144|NCT01821560|Baclofen|baclofen|mesh-list
24931448|NCT04089176|Oxytocics|oxytocics|mesh-ancestor
24778498|NCT01871454|Vasodilator Agents|vasodilator agents|mesh-ancestor
24778499|NCT01871454|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24778500|NCT01871454|Antioxidants|antioxidants|mesh-ancestor
24778501|NCT01871467|Sargramostim|sargramostim|mesh-list
24778502|NCT01871467|Immunologic Factors|immunologic factors|mesh-ancestor
24778503|NCT01871467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778504|NCT01871480|Gefitinib|gefitinib|mesh-list
24778505|NCT01871480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24778506|NCT01871480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24778507|NCT01871480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24778508|NCT01871480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778509|NCT01871493|Insulin Lispro|insulin lispro|mesh-list
24778510|NCT01871493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24778511|NCT01871493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050097|NCT00542724|Insulin|insulin|mesh-list
24797532|NCT01956006|Protective Agents|protective agents|mesh-ancestor
24797605|NCT01956786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24797606|NCT01956786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797607|NCT01956786|Vasodilator Agents|vasodilator agents|mesh-ancestor
24797608|NCT01956864|Vitamin D|vitamin d|mesh-list
24797609|NCT01956864|Vitamins|vitamins|mesh-ancestor
24797618|NCT01956955|Heparin|heparin|mesh-list
24797619|NCT01956955|Enoxaparin|enoxaparin|mesh-list
24797620|NCT01956955|Calcium heparin|calcium heparin|mesh-list
24797621|NCT01956955|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24797622|NCT01956955|Anticoagulants|anticoagulants|mesh-ancestor
24797623|NCT01956955|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24797624|NCT01956955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24797625|NCT01956955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213237|NCT05001750|Nafcillin|nafcillin|mesh-list
25213238|NCT05001750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25213239|NCT05001750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25213240|NCT05001750|Antitubercular Agents|antitubercular agents|mesh-ancestor
25213241|NCT05001750|Antimalarials|antimalarials|mesh-ancestor
25213242|NCT05001750|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25213243|NCT05001750|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25213244|NCT04992572|Lidocaine|lidocaine|mesh-list
25081743|NCT03327454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25081744|NCT03327454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25081745|NCT03327454|Analgesics|analgesics|mesh-ancestor
25081746|NCT03327454|Sensory System Agents|sensory system agents|mesh-ancestor
24779077|NCT01873768|Tranexamic Acid|tranexamic acid|mesh-list
25081763|NCT03327389|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24935649|NCT04048226|Ketamine|ketamine|mesh-list
25081765|NCT03327389|Adrenergic Agents|adrenergic agents|mesh-ancestor
24797626|NCT01956981|Magnesium Sulfate|magnesium sulfate|mesh-list
25081766|NCT03327389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25081767|NCT03327389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797627|NCT01956981|Dexmedetomidine|dexmedetomidine|mesh-list
25081768|NCT03327350|Anticoagulants|anticoagulants|mesh-list
24778537|NCT01871649|Golimumab|golimumab|mesh-list
24778538|NCT01871649|Methotrexate|methotrexate|mesh-list
24778539|NCT01871649|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24778540|NCT01871649|Abortifacient Agents|abortifacient agents|mesh-ancestor
24778541|NCT01871649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24778542|NCT01871649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778543|NCT01871649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24778544|NCT01871649|Antimetabolites|antimetabolites|mesh-ancestor
24778545|NCT01871649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778546|NCT01871649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24778547|NCT01871649|Dermatologic Agents|dermatologic agents|mesh-ancestor
24778548|NCT01871649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24778549|NCT01871649|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24778550|NCT01871649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24778551|NCT01871649|Immunologic Factors|immunologic factors|mesh-ancestor
24570214|NCT00803842|Doxycycline|doxycycline|mesh-list
24570215|NCT00803842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24570232|NCT00803907|Interferon Inducers|interferon inducers|mesh-ancestor
24620922|NCT01059955|Autonomic Agents|autonomic agents|mesh-ancestor
24620923|NCT01059955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24620924|NCT01059955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620925|NCT01059955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24620926|NCT01059955|Glucocorticoids|glucocorticoids|mesh-ancestor
25678145|NCT01821560|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24620927|NCT01059955|Hormones|hormones|mesh-ancestor
24620928|NCT01059955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24620929|NCT01059955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25038781|NCT04528563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620930|NCT01059955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24620931|NCT01059955|Protease Inhibitors|protease inhibitors|mesh-ancestor
24620932|NCT01059955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717355|NCT01547312|Hematinics|hematinics|mesh-ancestor
24620941|NCT01060137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24620942|NCT01060137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24620943|NCT01060137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24620944|NCT01060137|Anesthetics, General|anesthetics, general|mesh-ancestor
24620945|NCT01060137|Anesthetics|anesthetics|mesh-ancestor
24620946|NCT01060163|Tranexamic Acid|tranexamic acid|mesh-list
24778563|NCT01871662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24778564|NCT01871662|Antiviral Agents|antiviral agents|mesh-ancestor
25213245|NCT04992572|Propofol|propofol|mesh-list
25213246|NCT04992572|Anesthetics, Local|anesthetics, local|mesh-ancestor
25213247|NCT04992572|Anesthetics|anesthetics|mesh-ancestor
25213248|NCT04992572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25213249|NCT04992572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213250|NCT04992572|Sensory System Agents|sensory system agents|mesh-ancestor
25213251|NCT04992572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25213252|NCT04992572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24947590|NCT03927118|Antiemetics|antiemetics|mesh-ancestor
24778565|NCT01871662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24778566|NCT01871662|Antimetabolites|antimetabolites|mesh-ancestor
24778567|NCT01871662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778568|NCT01871662|Immunologic Factors|immunologic factors|mesh-ancestor
24778569|NCT01871662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778570|NCT01871662|Antioxidants|antioxidants|mesh-ancestor
24778571|NCT01871662|Protective Agents|protective agents|mesh-ancestor
24778578|NCT01871675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778579|NCT01871675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24778580|NCT01871675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24778581|NCT01871675|Alkylating Agents|alkylating agents|mesh-ancestor
24778582|NCT01871675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778583|NCT01871701|Moxifloxacin|moxifloxacin|mesh-list
24778584|NCT01871701|Dexetimide|dexetimide|mesh-list
24778585|NCT01871701|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24778586|NCT01871701|Citalopram|citalopram|mesh-list
24778587|NCT01871701|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24778588|NCT01871701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24778589|NCT01871701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24778590|NCT01871701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24778591|NCT01871701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24778592|NCT01871701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24778593|NCT01871701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778594|NCT01871701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24778595|NCT01871701|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24778596|NCT01871701|Contraceptive Agents|contraceptive agents|mesh-ancestor
24778598|NCT01871701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778599|NCT01871701|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24778600|NCT01871701|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24778601|NCT01871701|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24778602|NCT01871701|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24778603|NCT01871701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24778604|NCT01871701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24778605|NCT01871701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24778606|NCT01871701|Serotonin Agents|serotonin agents|mesh-ancestor
24778607|NCT01871701|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24778608|NCT01871701|Antidepressive Agents|antidepressive agents|mesh-ancestor
24778609|NCT01871701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24778610|NCT01871701|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24778611|NCT01871701|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24778612|NCT01871701|Parasympatholytics|parasympatholytics|mesh-ancestor
24778614|NCT01871701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24778615|NCT01871701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24778629|NCT01871740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778641|NCT01871792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778642|NCT01871792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24778643|NCT01871792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24778644|NCT01871844|Octreotide|octreotide|mesh-list
24778645|NCT01871844|Somatostatin|somatostatin|mesh-list
24778646|NCT01871844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25678146|NCT01821560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778647|NCT01871844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24778648|NCT01871844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24778649|NCT01871844|Hormones|hormones|mesh-ancestor
24778650|NCT01871844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24778651|NCT01871844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778652|NCT01871857|Epinephrine|epinephrine|mesh-list
24778653|NCT01871857|Racepinephrine|racepinephrine|mesh-list
25213253|NCT04992572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25213254|NCT04992572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25213255|NCT04992572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25213256|NCT04992572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25157067|NCT04824911|Aspirin|aspirin|mesh-list
25157068|NCT04824911|Clopidogrel|clopidogrel|mesh-list
25157069|NCT04824911|Atorvastatin|atorvastatin|mesh-list
25157070|NCT04824911|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25157071|NCT04824911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25157072|NCT04824911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25157073|NCT04824911|Analgesics|analgesics|mesh-ancestor
25157077|NCT04824911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25157078|NCT04824911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25157079|NCT04824911|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25157080|NCT04824911|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25157081|NCT04824911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935683|NCT04048200|Adrenergic Agents|adrenergic agents|mesh-ancestor
25157082|NCT04824911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25157083|NCT04824911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25157084|NCT04824911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25157085|NCT04824911|Antipyretics|antipyretics|mesh-ancestor
25157086|NCT04824911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24947596|NCT03927118|Hormones|hormones|mesh-ancestor
24778654|NCT01871857|Epinephryl borate|epinephryl borate|mesh-list
24778655|NCT01871857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24778656|NCT01871857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24778657|NCT01871857|Adrenergic Agents|adrenergic agents|mesh-ancestor
24778658|NCT01871857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24778659|NCT01871857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778660|NCT01871857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778661|NCT01871857|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24778662|NCT01871857|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24778663|NCT01871857|Autonomic Agents|autonomic agents|mesh-ancestor
24778664|NCT01871857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24778665|NCT01871857|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24778666|NCT01871857|Respiratory System Agents|respiratory system agents|mesh-ancestor
24778667|NCT01871857|Mydriatics|mydriatics|mesh-ancestor
24778668|NCT01871857|Sympathomimetics|sympathomimetics|mesh-ancestor
24778688|NCT01871935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24778689|NCT01871935|Narcotics|narcotics|mesh-ancestor
24778690|NCT01871935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24778691|NCT01871935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778692|NCT01871935|Analgesics|analgesics|mesh-ancestor
25213257|NCT04992572|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25213258|NCT04992572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25213259|NCT04992572|Anesthetics, General|anesthetics, general|mesh-ancestor
25213260|NCT04988256|Cyclosporine|cyclosporine|mesh-list
25213261|NCT04988256|Prednisone|prednisone|mesh-list
25213262|NCT04988256|Methylprednisolone|methylprednisolone|mesh-list
25213263|NCT04988256|Cyclosporins|cyclosporins|mesh-list
25213264|NCT04988256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25213265|NCT04988256|Glucocorticoids|glucocorticoids|mesh-ancestor
25213266|NCT04988256|Hormones|hormones|mesh-ancestor
25213267|NCT04988256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25213268|NCT04988256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213269|NCT04988256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25213270|NCT04988256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25213271|NCT04988256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25213272|NCT04988256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213273|NCT04988256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25213274|NCT04988256|Immunologic Factors|immunologic factors|mesh-ancestor
25213275|NCT04988256|Antifungal Agents|antifungal agents|mesh-ancestor
25213276|NCT04988256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25213277|NCT04988256|Dermatologic Agents|dermatologic agents|mesh-ancestor
25213278|NCT04988256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25213279|NCT04988256|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25213280|NCT04988256|Antiemetics|antiemetics|mesh-ancestor
25213281|NCT04988256|Autonomic Agents|autonomic agents|mesh-ancestor
25678147|NCT01821560|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24951857|NCT03900637|Fertility Agents|fertility agents|mesh-ancestor
25039029|NCT04207736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25039030|NCT04207736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25039031|NCT04189133|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25039032|NCT04189133|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25039033|NCT04189133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039034|NCT04174612|Cytarabine|cytarabine|mesh-list
25213282|NCT04988256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25213283|NCT04988256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25213284|NCT04988256|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25157087|NCT04824911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25157088|NCT04824911|Antimetabolites|antimetabolites|mesh-ancestor
25157089|NCT04824911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25157090|NCT04824911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25157091|NCT04824911|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25157092|NCT04824911|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25157093|NCT04824911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25157094|NCT04824911|Purinergic Agents|purinergic agents|mesh-ancestor
25157095|NCT04824911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665977|NCT01316445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25157103|NCT04816877|Analgesics, Opioid|analgesics, opioid|mesh-list
25157104|NCT04816877|Narcotics|narcotics|mesh-ancestor
25157105|NCT04816877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25157106|NCT04816877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25157107|NCT04816877|Analgesics|analgesics|mesh-ancestor
25157108|NCT04816877|Sensory System Agents|sensory system agents|mesh-ancestor
24778693|NCT01871935|Sensory System Agents|sensory system agents|mesh-ancestor
24778694|NCT01871935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24778695|NCT01871935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24778696|NCT01871935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24778697|NCT01871935|Anesthetics, General|anesthetics, general|mesh-ancestor
24778698|NCT01871935|Anesthetics|anesthetics|mesh-ancestor
24778699|NCT01871961|Methotrexate|methotrexate|mesh-list
24778700|NCT01871961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24778701|NCT01871961|Abortifacient Agents|abortifacient agents|mesh-ancestor
24778702|NCT01871961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24778703|NCT01871961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778704|NCT01871961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24778705|NCT01871961|Antimetabolites|antimetabolites|mesh-ancestor
24778706|NCT01871961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778707|NCT01871961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24778708|NCT01871961|Dermatologic Agents|dermatologic agents|mesh-ancestor
24778732|NCT01872013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24778733|NCT01872013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778734|NCT01872026|ASP7991|asp7991|mesh-list
24778735|NCT01872026|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24778736|NCT01872026|Hormone Antagonists|hormone antagonists|mesh-ancestor
24778737|NCT01872026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24778738|NCT01872026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778739|NCT01872039|Nicardipine|nicardipine|mesh-list
24778740|NCT01872039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24778741|NCT01872039|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24778742|NCT01872039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24935718|NCT04047706|Linrodostat|linrodostat|mesh-list
24935729|NCT04047940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25213285|NCT04988256|Protective Agents|protective agents|mesh-ancestor
25213290|NCT04962841|Metformin|metformin|mesh-list
25213291|NCT04962841|Amlodipine|amlodipine|mesh-list
25213292|NCT04962841|Ramipril|ramipril|mesh-list
25213293|NCT04962841|Nebivolol|nebivolol|mesh-list
25213294|NCT04962841|Rivastigmine|rivastigmine|mesh-list
25213295|NCT04962841|Sertraline|sertraline|mesh-list
25213296|NCT04962841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25213297|NCT04962841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213298|NCT04962841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25213299|NCT04962841|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25213300|NCT04962841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25678148|NCT01821560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25678149|NCT01821560|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25678150|NCT01821560|GABA Agonists|gaba agonists|mesh-ancestor
25678151|NCT01821560|GABA Agents|gaba agents|mesh-ancestor
25678152|NCT01821560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25678153|NCT01821560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678154|NCT01821729|Leucovorin|leucovorin|mesh-list
25213301|NCT04962841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039128|NCT04104685|Minocycline|minocycline|mesh-list
25039129|NCT04104685|Adapalene|adapalene|mesh-list
25039130|NCT04104685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25039131|NCT04104685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25039133|NCT04104685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25039175|NCT04030143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25039176|NCT04030143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039177|NCT04030143|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25039178|NCT04030143|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25039179|NCT04030143|Serotonin Agents|serotonin agents|mesh-ancestor
25039180|NCT04030143|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25039181|NCT04030143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25039182|NCT04030143|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25039183|NCT04030143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25039184|NCT04029610|Lidocaine|lidocaine|mesh-list
25039185|NCT04029610|Epinephrine|epinephrine|mesh-list
25213302|NCT04962841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25213303|NCT04962841|Vasodilator Agents|vasodilator agents|mesh-ancestor
25213304|NCT04962841|Antidepressive Agents|antidepressive agents|mesh-ancestor
25213305|NCT04962841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25213306|NCT04962841|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25213307|NCT04962841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25213308|NCT04962841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25157109|NCT04816877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25157111|NCT04805541|Mydriatics|mydriatics|mesh-list
24778743|NCT01872039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778744|NCT01872039|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24778745|NCT01872039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778746|NCT01872039|Vasodilator Agents|vasodilator agents|mesh-ancestor
24778747|NCT01872351|Thioctic Acid|thioctic acid|mesh-list
24778748|NCT01872351|Acetylcarnitine|acetylcarnitine|mesh-list
24778749|NCT01872351|Antioxidants|antioxidants|mesh-ancestor
24778750|NCT01872351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935730|NCT04047940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935731|NCT04047940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24935732|NCT04047940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24935733|NCT04047940|Antimetabolites|antimetabolites|mesh-ancestor
24935734|NCT04047940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778751|NCT01872351|Protective Agents|protective agents|mesh-ancestor
24778752|NCT01872351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778753|NCT01872351|Vitamin B Complex|vitamin b complex|mesh-ancestor
24778754|NCT01872351|Vitamins|vitamins|mesh-ancestor
24778755|NCT01872351|Micronutrients|micronutrients|mesh-ancestor
24778756|NCT01872351|Nootropic Agents|nootropic agents|mesh-ancestor
24778757|NCT01872403|Paclitaxel|paclitaxel|mesh-list
24627620|NCT01094015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627621|NCT01094015|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24627622|NCT01094028|Oxytocin|oxytocin|mesh-list
24778774|NCT01872416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778775|NCT01872416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24778776|NCT01872416|Alkylating Agents|alkylating agents|mesh-ancestor
24778777|NCT01872442|Interferons|interferons|mesh-list
24778778|NCT01872442|Interferon-alpha|interferon-alpha|mesh-list
24778779|NCT01872442|Interferon alpha-2|interferon alpha-2|mesh-list
24778780|NCT01872442|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24778781|NCT01872442|Dasatinib|dasatinib|mesh-list
24778782|NCT01872442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24778783|NCT01872442|Antiviral Agents|antiviral agents|mesh-ancestor
24778784|NCT01872442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25678155|NCT01821729|Fluorouracil|fluorouracil|mesh-list
25678156|NCT01821729|Oxaliplatin|oxaliplatin|mesh-list
25678157|NCT01821729|Folfirinox|folfirinox|mesh-list
25678158|NCT01821729|Losartan|losartan|mesh-list
25678159|NCT01821729|Antimetabolites|antimetabolites|mesh-ancestor
25678160|NCT01821729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678161|NCT01821729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25678162|NCT01821729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678163|NCT01821729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25678164|NCT01821729|Immunologic Factors|immunologic factors|mesh-ancestor
25678165|NCT01821729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678166|NCT01821729|Antidotes|antidotes|mesh-ancestor
25678167|NCT01821729|Protective Agents|protective agents|mesh-ancestor
25678168|NCT01821729|Vitamin B Complex|vitamin b complex|mesh-ancestor
25678169|NCT01821729|Vitamins|vitamins|mesh-ancestor
25678170|NCT01821729|Micronutrients|micronutrients|mesh-ancestor
25678171|NCT01821729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24529357|NCT00625560|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24529358|NCT00625560|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24529359|NCT00625573|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25039353|NCT03879408|Naproxen|naproxen|mesh-list
24778785|NCT01872442|Immunologic Factors|immunologic factors|mesh-ancestor
24778786|NCT01872442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666045|NCT01316874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24666046|NCT01316874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24666047|NCT01316874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666048|NCT01316874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666049|NCT01316952|Carvedilol|carvedilol|mesh-list
24666050|NCT01316952|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24666051|NCT01316952|Adrenergic Agents|adrenergic agents|mesh-list
24666052|NCT01316952|Adrenergic Antagonists|adrenergic antagonists|mesh-list
24666053|NCT01316952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24666054|NCT01316952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666055|NCT01316952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666056|NCT01316952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24666057|NCT01316952|Antioxidants|antioxidants|mesh-ancestor
24666058|NCT01316952|Protective Agents|protective agents|mesh-ancestor
24666059|NCT01316952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24666060|NCT01316952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24935745|NCT04047758|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24778787|NCT01872442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24778788|NCT01872442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24778789|NCT01872442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778790|NCT01872494|Flurbiprofen|flurbiprofen|mesh-list
24778791|NCT01872494|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
24778792|NCT01872494|Pentazocine|pentazocine|mesh-list
24778793|NCT01872494|Palonosetron|palonosetron|mesh-list
24778794|NCT01872494|Ropivacaine|ropivacaine|mesh-list
24778795|NCT01872494|Anesthetics, Local|anesthetics, local|mesh-ancestor
24778796|NCT01872494|Anesthetics|anesthetics|mesh-ancestor
24778797|NCT01872494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24778798|NCT01872494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778799|NCT01872494|Sensory System Agents|sensory system agents|mesh-ancestor
24778800|NCT01872494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24778801|NCT01872494|Antiemetics|antiemetics|mesh-ancestor
24778827|NCT01872702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24778828|NCT01872702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24778829|NCT01872702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24778830|NCT01872728|Anesthetics|anesthetics|mesh-list
24778831|NCT01872728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24778832|NCT01872728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778833|NCT01872754|Remifentanil|remifentanil|mesh-list
24778835|NCT01872754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25081778|NCT03327272|Autonomic Agents|autonomic agents|mesh-ancestor
24793825|NCT01618357|Veliparib|veliparib|mesh-list
24778836|NCT01872754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24778845|NCT01872754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24778846|NCT01872780|Rosiglitazone|rosiglitazone|mesh-list
24778847|NCT01872780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24778848|NCT01872780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778850|NCT01872832|Gout Suppressants|gout suppressants|mesh-ancestor
24778851|NCT01872832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24778852|NCT01872845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25213309|NCT04962841|Serotonin Agents|serotonin agents|mesh-ancestor
25213310|NCT04962841|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24935748|NCT04047758|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25157113|NCT04805541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25157114|NCT04805541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25157115|NCT04805541|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25157116|NCT04805541|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25157117|NCT04805541|Cholinergic Agents|cholinergic agents|mesh-ancestor
24443049|NCT00293501|Dalteparin|dalteparin|mesh-list
24778853|NCT01872845|Pravastatin|pravastatin|mesh-list
24778854|NCT01872845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24778855|NCT01872845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24778856|NCT01872845|Antimetabolites|antimetabolites|mesh-ancestor
24778857|NCT01872845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778858|NCT01872845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24778859|NCT01872845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25678172|NCT01821729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25678173|NCT01821729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25678174|NCT01821729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24625087|NCT01080469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625088|NCT01080482|Tacrolimus|tacrolimus|mesh-list
24625089|NCT01080482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24625090|NCT01080482|Immunologic Factors|immunologic factors|mesh-ancestor
24625091|NCT01080482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625092|NCT01080482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24625093|NCT01080482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625094|NCT01080482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625095|NCT01080534|Tacrolimus|tacrolimus|mesh-list
24625096|NCT01080534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24778860|NCT01872845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24778861|NCT01872858|Aspirin|aspirin|mesh-list
24778862|NCT01872858|Cilostazol|cilostazol|mesh-list
24615145|NCT01028092|Analgesics|analgesics|mesh-ancestor
24778929|NCT01872962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24778930|NCT01872962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24778931|NCT01872962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24778932|NCT01872962|Immunologic Factors|immunologic factors|mesh-ancestor
24778933|NCT01872962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778934|NCT01872988|Tenofovir|tenofovir|mesh-list
24778935|NCT01872988|Antiviral Agents|antiviral agents|mesh-ancestor
24778936|NCT01872988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24778937|NCT01872988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25081779|NCT03327272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24778938|NCT01872988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24778940|NCT01872988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778941|NCT01872988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24778942|NCT01872988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24778943|NCT01873001|Pioglitazone|pioglitazone|mesh-list
24778944|NCT01873001|Abiraterone Acetate|abiraterone acetate|mesh-list
24778945|NCT01873001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24778946|NCT01873001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778947|NCT01873001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24778948|NCT01873001|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24778949|NCT01873001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24778950|NCT01873001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778951|NCT01873001|Hormone Antagonists|hormone antagonists|mesh-ancestor
24778952|NCT01873001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24778953|NCT01873001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24778954|NCT01873027|Sirolimus|sirolimus|mesh-list
24778955|NCT01873027|Umirolimus|umirolimus|mesh-list
24778966|NCT01873079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24778967|NCT01873079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24778968|NCT01873079|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24778969|NCT01873079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24778970|NCT01873079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778983|NCT01873144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24778984|NCT01873144|Adrenergic Agents|adrenergic agents|mesh-ancestor
24778985|NCT01873144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24778986|NCT01873144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570599|NCT00805311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25213311|NCT04962841|Protease Inhibitors|protease inhibitors|mesh-ancestor
25213312|NCT04962841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25213313|NCT04962841|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25213314|NCT04962841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25213315|NCT04962841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25213316|NCT04962841|Adrenergic Agents|adrenergic agents|mesh-ancestor
25157118|NCT04805541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24570671|NCT00805649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570672|NCT00805649|Growth Inhibitors|growth inhibitors|mesh-ancestor
24570673|NCT00805649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24666142|NCT01317589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24570674|NCT00805649|Antiemetics|antiemetics|mesh-ancestor
24570675|NCT00805649|Autonomic Agents|autonomic agents|mesh-ancestor
25678175|NCT01822132|Naltrexone|naltrexone|mesh-list
25678176|NCT01822132|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25678177|NCT01822132|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25678178|NCT01822132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678179|NCT01822132|Sensory System Agents|sensory system agents|mesh-ancestor
25678180|NCT01822132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25678181|NCT01822496|Paclitaxel|paclitaxel|mesh-list
25678182|NCT01822496|Etoposide|etoposide|mesh-list
25678183|NCT01822496|Podophyllotoxin|podophyllotoxin|mesh-list
25678184|NCT01822496|Cisplatin|cisplatin|mesh-list
25678185|NCT01822496|Carboplatin|carboplatin|mesh-list
25678186|NCT01822496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24570698|NCT00805701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24570699|NCT00805701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570700|NCT00805701|Hormone Antagonists|hormone antagonists|mesh-ancestor
24570701|NCT00805701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24570702|NCT00805701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620960|NCT01060189|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24620961|NCT01060189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24620962|NCT01060189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620963|NCT01060189|Hemostatics|hemostatics|mesh-ancestor
24620964|NCT01060189|Coagulants|coagulants|mesh-ancestor
24620965|NCT01060189|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24620966|NCT01060189|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24620967|NCT01060189|Protease Inhibitors|protease inhibitors|mesh-ancestor
24620968|NCT01060189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24778987|NCT01873144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778988|NCT01873144|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24778989|NCT01873144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24778990|NCT01873144|Autonomic Agents|autonomic agents|mesh-ancestor
24778991|NCT01873144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24778992|NCT01873144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24778993|NCT01873144|Respiratory System Agents|respiratory system agents|mesh-ancestor
24778994|NCT01873144|Mydriatics|mydriatics|mesh-ancestor
24778995|NCT01873144|Sympathomimetics|sympathomimetics|mesh-ancestor
24778996|NCT01873144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24778998|NCT01873157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779001|NCT01873222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24779002|NCT01873222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24779003|NCT01873222|Immunologic Factors|immunologic factors|mesh-ancestor
24779004|NCT01873222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779005|NCT01873222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24779006|NCT01873222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24779007|NCT01873222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24779008|NCT01873222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779009|NCT01873222|Antifungal Agents|antifungal agents|mesh-ancestor
24779011|NCT01873313|Anesthetics, Local|anesthetics, local|mesh-ancestor
24779012|NCT01873313|Anesthetics|anesthetics|mesh-ancestor
24779013|NCT01873313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24779014|NCT01873313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779015|NCT01873313|Sensory System Agents|sensory system agents|mesh-ancestor
24627629|NCT01094210|Fluorides, Topical|fluorides, topical|mesh-list
24627630|NCT01094210|Cariostatic Agents|cariostatic agents|mesh-ancestor
24627631|NCT01094210|Protective Agents|protective agents|mesh-ancestor
24627632|NCT01094210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627634|NCT01094249|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24627635|NCT01094249|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24627636|NCT01094249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24627637|NCT01094249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24627638|NCT01094249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627639|NCT01094249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24779078|NCT01873768|Aminocaproic Acid|aminocaproic acid|mesh-list
24627640|NCT01094249|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24627641|NCT01094249|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24627642|NCT01094249|Serotonin Agents|serotonin agents|mesh-ancestor
24627643|NCT01094249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24627644|NCT01094249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627645|NCT01094249|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24627646|NCT01094249|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24627647|NCT01094249|Dopamine Agents|dopamine agents|mesh-ancestor
24627648|NCT01094249|Anticonvulsants|anticonvulsants|mesh-ancestor
24627649|NCT01094249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25081781|NCT03327272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25081782|NCT03327272|Glucocorticoids|glucocorticoids|mesh-ancestor
25081783|NCT03327272|Hormones|hormones|mesh-ancestor
25081784|NCT03327272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25081785|NCT03327272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25081786|NCT03327272|Protective Agents|protective agents|mesh-ancestor
25081787|NCT03327272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25213317|NCT04962841|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25157119|NCT04805541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25157120|NCT04800302|Morphine|morphine|mesh-list
25157121|NCT04800302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25157122|NCT04800302|Narcotics|narcotics|mesh-ancestor
24626113|NCT01085617|Antiviral Agents|antiviral agents|mesh-ancestor
24900816|NCT04391283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039585|NCT03772964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25039586|NCT03772964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039587|NCT03766295|Gemcitabine|gemcitabine|mesh-list
25039588|NCT03766295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25039589|NCT03766295|Antimetabolites|antimetabolites|mesh-ancestor
25039591|NCT03766295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081788|NCT03327272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081789|NCT03327168|Adenosine|adenosine|mesh-list
25081790|NCT03327168|Analgesics|analgesics|mesh-ancestor
25081791|NCT03327168|Sensory System Agents|sensory system agents|mesh-ancestor
25081792|NCT03327168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25081793|NCT03327168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081794|NCT03327168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24487245|NCT00462397|Carboplatin|carboplatin|mesh-list
25081796|NCT03327168|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25081800|NCT03327168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081801|NCT03327155|Tenofovir|tenofovir|mesh-list
25081802|NCT03327155|Emtricitabine|emtricitabine|mesh-list
25081803|NCT03327155|Antiviral Agents|antiviral agents|mesh-ancestor
25081804|NCT03327155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25081805|NCT03327155|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25081806|NCT03327155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25081807|NCT03327155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25081808|NCT03327155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081809|NCT03327155|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25081810|NCT03327155|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25081811|NCT03327116|Methotrexate|methotrexate|mesh-list
25081812|NCT03327116|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25081813|NCT03327116|Abortifacient Agents|abortifacient agents|mesh-ancestor
24935800|NCT04047576|Sirolimus|sirolimus|mesh-list
25081814|NCT03327116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25081815|NCT03327116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081816|NCT03327116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25081817|NCT03327116|Antimetabolites|antimetabolites|mesh-ancestor
24779053|NCT01873443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779054|NCT01873443|Immunologic Factors|immunologic factors|mesh-ancestor
24779055|NCT01873443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779056|NCT01873443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24779057|NCT01873443|Hematinics|hematinics|mesh-ancestor
24779058|NCT01873443|Vitamin B Complex|vitamin b complex|mesh-ancestor
24779059|NCT01873443|Vitamins|vitamins|mesh-ancestor
24779060|NCT01873443|Micronutrients|micronutrients|mesh-ancestor
24779061|NCT01873573|Triamcinolone|triamcinolone|mesh-list
24779062|NCT01873573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24779063|NCT01873573|Glucocorticoids|glucocorticoids|mesh-ancestor
24779064|NCT01873573|Hormones|hormones|mesh-ancestor
24779065|NCT01873573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24779066|NCT01873573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779067|NCT01873690|Ciprofloxacin|ciprofloxacin|mesh-list
24779068|NCT01873690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24779069|NCT01873690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24779070|NCT01873690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24779071|NCT01873690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24779072|NCT01873690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24779073|NCT01873690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779074|NCT01873690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779075|NCT01873690|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24779076|NCT01873690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24779079|NCT01873768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24779080|NCT01873768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24779081|NCT01873768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779082|NCT01873768|Hemostatics|hemostatics|mesh-ancestor
24779083|NCT01873768|Coagulants|coagulants|mesh-ancestor
24779084|NCT01873807|Cyclophosphamide|cyclophosphamide|mesh-list
24779085|NCT01873807|Etoposide|etoposide|mesh-list
24779086|NCT01873807|Idarubicin|idarubicin|mesh-list
24779087|NCT01873807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25678187|NCT01822496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25678188|NCT01822496|Etoposide phosphate|etoposide phosphate|mesh-list
25678189|NCT01822496|Crizotinib|crizotinib|mesh-list
25678190|NCT01822496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25678191|NCT01822496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678192|NCT01822496|Tubulin Modulators|tubulin modulators|mesh-ancestor
25678193|NCT01822496|Antimitotic Agents|antimitotic agents|mesh-ancestor
25039707|NCT03704584|Prednisolone|prednisolone|mesh-list
25039708|NCT03704584|Prednisolone acetate|prednisolone acetate|mesh-list
25039709|NCT03704584|Lidocaine|lidocaine|mesh-list
25039710|NCT03704584|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24779088|NCT01873807|Immunologic Factors|immunologic factors|mesh-ancestor
24779089|NCT01873807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779092|NCT01873807|Alkylating Agents|alkylating agents|mesh-ancestor
24779093|NCT01873807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213318|NCT04962841|Cholinergic Agents|cholinergic agents|mesh-ancestor
25213319|NCT04962841|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25213320|NCT04962841|Protective Agents|protective agents|mesh-ancestor
25213321|NCT04908800|Itraconazole|itraconazole|mesh-list
25213322|NCT04908800|Antifungal Agents|antifungal agents|mesh-ancestor
25157123|NCT04800302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25157124|NCT04800302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779094|NCT01873807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779095|NCT01873807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24779096|NCT01873807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24779097|NCT01873807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24779098|NCT01873807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24779099|NCT01873807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24779100|NCT01873807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24779101|NCT01873820|Ascorbic Acid|ascorbic acid|mesh-list
24779102|NCT01873820|Calcium ascorbate|calcium ascorbate|mesh-list
24779141|NCT01874028|Chelating Agents|chelating agents|mesh-ancestor
24779142|NCT01874028|Sequestering Agents|sequestering agents|mesh-ancestor
24779143|NCT01874028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779144|NCT01874041|Salicylic Acid|salicylic acid|mesh-list
24779145|NCT01874041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24779146|NCT01874041|Antifungal Agents|antifungal agents|mesh-ancestor
24779147|NCT01874041|Keratolytic Agents|keratolytic agents|mesh-ancestor
24779148|NCT01874041|Dermatologic Agents|dermatologic agents|mesh-ancestor
24779149|NCT01874080|Metformin|metformin|mesh-list
24779150|NCT01874080|Saxagliptin|saxagliptin|mesh-list
24779151|NCT01874080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24779152|NCT01874080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779153|NCT01874080|Incretins|incretins|mesh-ancestor
24779154|NCT01874080|Hormones|hormones|mesh-ancestor
24779155|NCT01874080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24779156|NCT01874080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24779157|NCT01874080|Protease Inhibitors|protease inhibitors|mesh-ancestor
24779158|NCT01874080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24779159|NCT01874080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779160|NCT01874171|Cetuximab|cetuximab|mesh-list
24779161|NCT01874171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779162|NCT01874171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24779163|NCT01874236|Bupivacaine|bupivacaine|mesh-list
24779164|NCT01874236|Anesthetics, Local|anesthetics, local|mesh-ancestor
24779165|NCT01874236|Anesthetics|anesthetics|mesh-ancestor
24779166|NCT01874236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24779167|NCT01874236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779168|NCT01874236|Sensory System Agents|sensory system agents|mesh-ancestor
24779169|NCT01874236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24779207|NCT01874639|Coagulants|coagulants|mesh-ancestor
24779208|NCT01874678|Cisplatin|cisplatin|mesh-list
24779209|NCT01874678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779219|NCT01874717|Anesthetics, General|anesthetics, general|mesh-ancestor
24779220|NCT01874717|Anesthetics|anesthetics|mesh-ancestor
24779221|NCT01874717|GABA Modulators|gaba modulators|mesh-ancestor
24779222|NCT01874717|GABA Agents|gaba agents|mesh-ancestor
24779223|NCT01874717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24779224|NCT01874717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081828|NCT03326960|Sevoflurane|sevoflurane|mesh-list
24627662|NCT01094275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24627663|NCT01094275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24627664|NCT01094275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24627665|NCT01094275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627666|NCT01094340|Thalidomide|thalidomide|mesh-list
24656634|NCT01263158|Oxytocin|oxytocin|mesh-list
24627667|NCT01094340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24627668|NCT01094340|Immunologic Factors|immunologic factors|mesh-ancestor
24627669|NCT01094340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718183|NCT01552798|Aspirin|aspirin|mesh-list
25678194|NCT01822496|Mitosis Modulators|mitosis modulators|mesh-ancestor
25678195|NCT01822496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678196|NCT01822496|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25159903|NCT03504956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25039973|NCT03541655|Anesthetics, Local|anesthetics, local|mesh-ancestor
25039975|NCT03541655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25039976|NCT03541655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996571|NCT03265145|Cholinergic Agents|cholinergic agents|mesh-list
25039977|NCT03541655|Sensory System Agents|sensory system agents|mesh-ancestor
25039978|NCT03541655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039988|NCT03521934|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25039990|NCT03521934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040009|NCT03512964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25040047|NCT03475706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040053|NCT03471767|Dextromethorphan|dextromethorphan|mesh-list
24779232|NCT01874743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779233|NCT01874743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24779234|NCT01874743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24779235|NCT01874743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24779236|NCT01874847|Melatonin|melatonin|mesh-list
24779237|NCT01874847|Antioxidants|antioxidants|mesh-ancestor
24779239|NCT01874847|Protective Agents|protective agents|mesh-ancestor
24779240|NCT01874847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779241|NCT01874847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24779242|NCT01874860|Doxycycline|doxycycline|mesh-list
25213323|NCT04908800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25213324|NCT04908800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25157126|NCT04800302|Sensory System Agents|sensory system agents|mesh-ancestor
25157127|NCT04800302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24779243|NCT01874860|Clindamycin|clindamycin|mesh-list
24779244|NCT01874860|Clindamycin palmitate|clindamycin palmitate|mesh-list
24779245|NCT01874860|Clindamycin phosphate|clindamycin phosphate|mesh-list
24779246|NCT01874860|Hydrocortisone|hydrocortisone|mesh-list
24779247|NCT01874860|Methylprednisolone|methylprednisolone|mesh-list
24779248|NCT01874860|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24779249|NCT01874860|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24779250|NCT01874860|Prednisolone|prednisolone|mesh-list
24779251|NCT01874860|Prednisolone acetate|prednisolone acetate|mesh-list
24779252|NCT01874860|Sunscreening Agents|sunscreening agents|mesh-list
24779253|NCT01874860|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24779254|NCT01874860|Prednisolone phosphate|prednisolone phosphate|mesh-list
24779255|NCT01874860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24779256|NCT01874860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24779257|NCT01874860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24779258|NCT01874860|Antimalarials|antimalarials|mesh-ancestor
24779259|NCT01874860|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24779260|NCT01874860|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24779261|NCT01874860|Antiemetics|antiemetics|mesh-ancestor
24779262|NCT01874860|Autonomic Agents|autonomic agents|mesh-ancestor
24779263|NCT01874860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24779264|NCT01874860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779265|NCT01874860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25081829|NCT03326960|Desflurane|desflurane|mesh-list
24779266|NCT01874860|Glucocorticoids|glucocorticoids|mesh-ancestor
24779267|NCT01874860|Hormones|hormones|mesh-ancestor
25081830|NCT03326960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25081831|NCT03326960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25081832|NCT03326960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081833|NCT03326960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25081834|NCT03326960|Anesthetics, General|anesthetics, general|mesh-ancestor
25081835|NCT03326960|Anesthetics|anesthetics|mesh-ancestor
25081836|NCT03326960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24916765|NCT04237246|Tacrolimus|tacrolimus|mesh-list
25678197|NCT01822496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25678198|NCT01822496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678199|NCT01822496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25678200|NCT01822496|Keratolytic Agents|keratolytic agents|mesh-ancestor
25678201|NCT01822496|Dermatologic Agents|dermatologic agents|mesh-ancestor
25678202|NCT01822535|Midodrine|midodrine|mesh-list
25678203|NCT01822535|Sympathomimetics|sympathomimetics|mesh-ancestor
25678204|NCT01822535|Autonomic Agents|autonomic agents|mesh-ancestor
25678205|NCT01822535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25678206|NCT01822535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678207|NCT01822535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25678208|NCT01822535|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25678209|NCT01822535|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25678210|NCT01822535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24931729|NCT04085562|Autonomic Agents|autonomic agents|mesh-ancestor
24931730|NCT04085562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24931731|NCT04085562|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24931732|NCT04085562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25040112|NCT03412890|Estradiol|estradiol|mesh-list
25040113|NCT03412890|Relugolix|relugolix|mesh-list
25040114|NCT03412890|Estrogens|estrogens|mesh-ancestor
25040115|NCT03412890|Hormones|hormones|mesh-ancestor
25040116|NCT03412890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25040117|NCT03412890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487246|NCT00462397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24487247|NCT00462397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081837|NCT03326960|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25081838|NCT03326947|Docetaxel|docetaxel|mesh-list
25081839|NCT03326947|Fluorouracil|fluorouracil|mesh-list
25081840|NCT03326947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081841|NCT03326947|Tubulin Modulators|tubulin modulators|mesh-ancestor
25081842|NCT03326947|Antimitotic Agents|antimitotic agents|mesh-ancestor
24779272|NCT01874860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779273|NCT01874860|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24779274|NCT01874860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24779275|NCT01874860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779276|NCT01874860|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24779277|NCT01874860|Dermatologic Agents|dermatologic agents|mesh-ancestor
24779279|NCT01874964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24779280|NCT01874964|Narcotics|narcotics|mesh-ancestor
24570919|NCT00807222|Dopamine Agents|dopamine agents|mesh-ancestor
24570993|NCT00807625|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24570998|NCT00807690|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24571000|NCT00807690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571001|NCT00807755|Carboplatin|carboplatin|mesh-list
24487248|NCT00462397|Tubulin Modulators|tubulin modulators|mesh-ancestor
24487249|NCT00462397|Antimitotic Agents|antimitotic agents|mesh-ancestor
24487250|NCT00462397|Mitosis Modulators|mitosis modulators|mesh-ancestor
25213325|NCT04908800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25213326|NCT04908800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25213327|NCT04908800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213328|NCT04908800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25213329|NCT04908800|Hormone Antagonists|hormone antagonists|mesh-ancestor
25213330|NCT04908800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24487372|NCT00462813|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24487373|NCT00462813|Protective Agents|protective agents|mesh-ancestor
24487374|NCT00462813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487375|NCT00462813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487377|NCT00462852|Dalteparin|dalteparin|mesh-list
24487378|NCT00462852|Tinzaparin|tinzaparin|mesh-list
24487384|NCT00462852|Antiviral Agents|antiviral agents|mesh-ancestor
24571004|NCT00807755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24571005|NCT00807755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24571006|NCT00807755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24571007|NCT00807755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24571008|NCT00807755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571009|NCT00807755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571010|NCT00807755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24571011|NCT00807755|Immunologic Factors|immunologic factors|mesh-ancestor
24571012|NCT00807755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620969|NCT01060228|Valproic Acid|valproic acid|mesh-list
24620970|NCT01060228|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24620971|NCT01060228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24620972|NCT01060228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24620973|NCT01060228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24620974|NCT01060228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620975|NCT01060228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24620976|NCT01060228|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25678211|NCT01822535|Adrenergic Agents|adrenergic agents|mesh-ancestor
25678212|NCT01822535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25678213|NCT01822535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678214|NCT01822548|Metformin|metformin|mesh-list
25678215|NCT01822548|Vildagliptin|vildagliptin|mesh-list
25678216|NCT01822548|Glyburide|glyburide|mesh-list
25678217|NCT01822548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25678218|NCT01822548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678219|NCT01822548|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25678220|NCT01822548|Protease Inhibitors|protease inhibitors|mesh-ancestor
24529373|NCT00625794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529374|NCT00625794|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24529375|NCT00625794|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25040236|NCT03288454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040237|NCT03288454|Anticoagulants|anticoagulants|mesh-ancestor
25040238|NCT03287232|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25040239|NCT03287232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25040240|NCT03287232|Immunologic Factors|immunologic factors|mesh-ancestor
25040241|NCT03287232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040270|NCT03228394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040271|NCT03228394|GABA Modulators|gaba modulators|mesh-ancestor
25040272|NCT03228394|GABA Agents|gaba agents|mesh-ancestor
24620977|NCT01060228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24620978|NCT01060228|Serotonin Agents|serotonin agents|mesh-ancestor
24620979|NCT01060228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24620980|NCT01060228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620981|NCT01060228|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24620982|NCT01060228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24620983|NCT01060228|Dopamine Agents|dopamine agents|mesh-ancestor
24487385|NCT00462852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24487386|NCT00462852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487387|NCT00462852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24620987|NCT01060228|Antimanic Agents|antimanic agents|mesh-ancestor
24620988|NCT01060267|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24620989|NCT01060267|Erythromycin|erythromycin|mesh-list
24620990|NCT01060267|Erythromycin Estolate|erythromycin estolate|mesh-list
24620991|NCT01060267|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24620992|NCT01060267|Erythromycin stearate|erythromycin stearate|mesh-list
24620993|NCT01060267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24620994|NCT01060267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24620995|NCT01060267|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24620996|NCT01060267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620997|NCT01060267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621000|NCT01060293|Diuretics|diuretics|mesh-ancestor
24621001|NCT01060293|Natriuretic Agents|natriuretic agents|mesh-ancestor
24779281|NCT01874964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24779282|NCT01874964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779283|NCT01874964|Analgesics|analgesics|mesh-ancestor
24779284|NCT01874964|Sensory System Agents|sensory system agents|mesh-ancestor
24779285|NCT01874964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24779286|NCT01874964|Antitussive Agents|antitussive agents|mesh-ancestor
25081846|NCT03326947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24779296|NCT01875172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24779297|NCT01875172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24779298|NCT01875172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779311|NCT01875185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779312|NCT01875185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24779313|NCT01875185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24779314|NCT01875185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24779315|NCT01875185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24779316|NCT01875185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779317|NCT01875185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24779318|NCT01875185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24779319|NCT01875185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24779320|NCT01875185|Antipyretics|antipyretics|mesh-ancestor
24779321|NCT01875224|Abatacept|abatacept|mesh-list
24779322|NCT01875224|Tacrolimus|tacrolimus|mesh-list
24779323|NCT01875224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24779324|NCT01875224|Immunologic Factors|immunologic factors|mesh-ancestor
24779325|NCT01875224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779326|NCT01875224|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24779327|NCT01875224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678221|NCT01822548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678222|NCT01822548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678223|NCT01822561|Eplerenone|eplerenone|mesh-list
25678224|NCT01822561|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25678225|NCT01822561|Hormone Antagonists|hormone antagonists|mesh-ancestor
25678226|NCT01822561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25678227|NCT01822561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678228|NCT01822561|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25678229|NCT01822561|Diuretics|diuretics|mesh-ancestor
25678230|NCT01822561|Natriuretic Agents|natriuretic agents|mesh-ancestor
25678231|NCT01822561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24931772|NCT04085627|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
24931773|NCT04085627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24931774|NCT04085627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24931775|NCT04085627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24508077|NCT00554164|Immunologic Factors|immunologic factors|mesh-ancestor
25040389|NCT03123783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25040390|NCT03123783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25040391|NCT03123783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24779328|NCT01875224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779329|NCT01875224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24779330|NCT01875224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779331|NCT01875224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24779332|NCT01875263|Levofloxacin|levofloxacin|mesh-list
24779333|NCT01875263|Ofloxacin|ofloxacin|mesh-list
24779334|NCT01875263|Cloxacillin|cloxacillin|mesh-list
24779339|NCT01875263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24779340|NCT01875263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24779341|NCT01875263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24779342|NCT01875263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779343|NCT01875263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779344|NCT01875263|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24779345|NCT01875263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24779346|NCT01875653|Molgramostim|molgramostim|mesh-list
24779347|NCT01875653|Sargramostim|sargramostim|mesh-list
24779348|NCT01875653|Immunologic Factors|immunologic factors|mesh-ancestor
24779349|NCT01875653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779350|NCT01875653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779351|NCT01875666|Trastuzumab|trastuzumab|mesh-list
24779352|NCT01875666|Pertuzumab|pertuzumab|mesh-list
24779353|NCT01875666|Lapatinib|lapatinib|mesh-list
24625442|NCT01082237|Serotonin Agents|serotonin agents|mesh-ancestor
24779354|NCT01875666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24779355|NCT01875666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779356|NCT01875666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24779357|NCT01875666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24779358|NCT01875666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779359|NCT01875705|Ravoxertinib|ravoxertinib|mesh-list
24779360|NCT01875705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25213344|NCT04834206|Docetaxel|docetaxel|mesh-list
25213345|NCT04834206|Fluorouracil|fluorouracil|mesh-list
25213346|NCT04834206|Nedaplatin|nedaplatin|mesh-list
24779363|NCT01875705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779365|NCT01875757|Cholecalciferol|cholecalciferol|mesh-list
24487411|NCT00463008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24779375|NCT01875822|Sensory System Agents|sensory system agents|mesh-ancestor
24779376|NCT01875822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24779377|NCT01875822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779378|NCT01875822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24779379|NCT01875822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24779380|NCT01875822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779381|NCT01875822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24779382|NCT01875822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779384|NCT01875926|Antiviral Agents|antiviral agents|mesh-ancestor
24779385|NCT01875926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24779387|NCT01875952|Antitubercular Agents|antitubercular agents|mesh-ancestor
24779388|NCT01875952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24779389|NCT01875952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24779390|NCT01875952|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24779391|NCT01875952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24779392|NCT01875952|Antimetabolites|antimetabolites|mesh-ancestor
24779393|NCT01875952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779394|NCT01875952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24779396|NCT01876004|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24779397|NCT01876004|Abortifacient Agents|abortifacient agents|mesh-ancestor
25678232|NCT01822587|Propranolol|propranolol|mesh-list
25678233|NCT01822587|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25678234|NCT01822587|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25678235|NCT01822587|Adrenergic Agents|adrenergic agents|mesh-ancestor
25678236|NCT01822587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25678237|NCT01822587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678238|NCT01822587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678239|NCT01822587|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24779398|NCT01876004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25678240|NCT01822587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24931778|NCT04085627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931779|NCT04085627|Vasodilator Agents|vasodilator agents|mesh-ancestor
24931780|NCT04085627|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24931783|NCT04085393|Antiemetics|antiemetics|mesh-ancestor
24779399|NCT01876004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779400|NCT01876004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24779401|NCT01876004|Antimetabolites|antimetabolites|mesh-ancestor
24779402|NCT01876004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666501|NCT01319448|Antimetabolites|antimetabolites|mesh-ancestor
24779403|NCT01876004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779404|NCT01876004|Dermatologic Agents|dermatologic agents|mesh-ancestor
24779405|NCT01876004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24779406|NCT01876004|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24779407|NCT01876004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24779408|NCT01876004|Immunologic Factors|immunologic factors|mesh-ancestor
24779409|NCT01876004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24779410|NCT01876004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24487412|NCT00463008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487413|NCT00463008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24487414|NCT00463008|Antimetabolites|antimetabolites|mesh-ancestor
24487415|NCT00463008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779411|NCT01876108|Amoxicillin|amoxicillin|mesh-list
24779412|NCT01876108|Azithromycin|azithromycin|mesh-list
24779413|NCT01876108|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
24779414|NCT01876108|Omeprazole|omeprazole|mesh-list
24779415|NCT01876108|Bismuth|bismuth|mesh-list
24779416|NCT01876108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24779417|NCT01876108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24779418|NCT01876108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24779419|NCT01876108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24779420|NCT01876108|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24779422|NCT01876108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779424|NCT01876121|Celecoxib|celecoxib|mesh-list
24779425|NCT01876121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24779426|NCT01876121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24779427|NCT01876121|Analgesics|analgesics|mesh-ancestor
25213350|NCT04834206|Mitosis Modulators|mitosis modulators|mesh-ancestor
25213351|NCT04834206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626134|NCT01085708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24626135|NCT01085708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24487416|NCT00463008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487417|NCT00463008|Dermatologic Agents|dermatologic agents|mesh-ancestor
24487418|NCT00463008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487419|NCT00463008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24487424|NCT00463021|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
24487425|NCT00463021|Vitamins|vitamins|mesh-ancestor
24487426|NCT00463021|Micronutrients|micronutrients|mesh-ancestor
24487427|NCT00463021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487428|NCT00463021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24487429|NCT00463073|Bevacizumab|bevacizumab|mesh-list
24487430|NCT00463073|Cetuximab|cetuximab|mesh-list
24487447|NCT00463086|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24487448|NCT00463086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24476339|NCT00414245|Metformin|metformin|mesh-list
24627683|NCT01094444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24627684|NCT01094444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24627685|NCT01094444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627686|NCT01094444|Hemostatics|hemostatics|mesh-ancestor
24627687|NCT01094444|Coagulants|coagulants|mesh-ancestor
24627688|NCT01094457|Aspirin|aspirin|mesh-list
24627689|NCT01094457|Cilostazol|cilostazol|mesh-list
24794434|NCT05173896|Tadalafil|tadalafil|mesh-list
24779436|NCT01876121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779437|NCT01876186|Solifenacin Succinate|solifenacin succinate|mesh-list
24779438|NCT01876186|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24779439|NCT01876186|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24779440|NCT01876186|Cholinergic Agents|cholinergic agents|mesh-ancestor
25678241|NCT01822587|Vasodilator Agents|vasodilator agents|mesh-ancestor
25678242|NCT01822665|Acetaminophen|acetaminophen|mesh-list
25678243|NCT01822665|Ibuprofen|ibuprofen|mesh-list
25678244|NCT01822665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25678245|NCT01822665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24931849|NCT04085120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24931850|NCT04085120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24931851|NCT04085120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25050043|NCT00544466|Alkylating Agents|alkylating agents|mesh-ancestor
24857409|NCT02291562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857410|NCT02291562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24857411|NCT02291562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24857412|NCT02291562|Analgesics|analgesics|mesh-ancestor
25040553|NCT03011450|Antimetabolites|antimetabolites|mesh-ancestor
25040554|NCT03011450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040555|NCT03011450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24779441|NCT01876186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24779442|NCT01876186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779443|NCT01876186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779444|NCT01876186|Urological Agents|urological agents|mesh-ancestor
24779445|NCT01876290|Dexamethasone|dexamethasone|mesh-list
24779446|NCT01876290|Ondansetron|ondansetron|mesh-list
24779447|NCT01876290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24779448|NCT01876290|Antiemetics|antiemetics|mesh-ancestor
24779469|NCT01876316|Moxifloxacin|moxifloxacin|mesh-list
24779470|NCT01876316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24779471|NCT01876316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24779472|NCT01876316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24779473|NCT01876316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24779474|NCT01876316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24779475|NCT01876316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779476|NCT01876316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779477|NCT01876355|Clonidine|clonidine|mesh-list
24779478|NCT01876355|Analgesics|analgesics|mesh-ancestor
24487484|NCT00463359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25213352|NCT04834206|Antimetabolites|antimetabolites|mesh-ancestor
25213353|NCT04834206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25213354|NCT04834206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25213355|NCT04834206|Immunologic Factors|immunologic factors|mesh-ancestor
25213357|NCT04829344|Carticaine|carticaine|mesh-list
25213358|NCT04829344|Anesthetics, Local|anesthetics, local|mesh-ancestor
25213359|NCT04829344|Anesthetics|anesthetics|mesh-ancestor
25213360|NCT04829344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25213361|NCT04829344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213362|NCT04829344|Sensory System Agents|sensory system agents|mesh-ancestor
25213363|NCT04829344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25213364|NCT04788641|Cyclosporine|cyclosporine|mesh-list
25213365|NCT04788641|Tacrolimus|tacrolimus|mesh-list
25157164|NCT04794699|Gemcitabine|gemcitabine|mesh-list
25157165|NCT04794699|Paclitaxel|paclitaxel|mesh-list
25157168|NCT04794699|Pemetrexed|pemetrexed|mesh-list
25157169|NCT04794699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25157170|NCT04794699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626139|NCT01085721|Chlorpheniramine|chlorpheniramine|mesh-list
24487485|NCT00463359|Interferon Inducers|interferon inducers|mesh-ancestor
24487486|NCT00463502|Metformin|metformin|mesh-list
24487487|NCT00463502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24487488|NCT00463502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487489|NCT00463515|Gemcitabine|gemcitabine|mesh-list
24487490|NCT00463515|Carboplatin|carboplatin|mesh-list
24487491|NCT00463515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779486|NCT01876355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24779487|NCT01876355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24935921|NCT04046679|Bleomycin|bleomycin|mesh-list
24666647|NCT01320254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779488|NCT01876355|Adrenergic Agents|adrenergic agents|mesh-ancestor
25678246|NCT01822665|Analgesics|analgesics|mesh-ancestor
25678247|NCT01822665|Sensory System Agents|sensory system agents|mesh-ancestor
25678248|NCT01822665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25678249|NCT01822665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678250|NCT01822665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25678251|NCT01822665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25678252|NCT01822665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25678253|NCT01822665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678254|NCT01822665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678255|NCT01822665|Antipyretics|antipyretics|mesh-ancestor
25678256|NCT01822678|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25678257|NCT01822678|Anticonvulsants|anticonvulsants|mesh-ancestor
24779489|NCT01876355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24779490|NCT01876355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931853|NCT04085120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931854|NCT04085250|Nivolumab|nivolumab|mesh-list
24529382|NCT00625859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24529390|NCT00625859|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24529391|NCT00625859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24779492|NCT01876433|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24779493|NCT01876433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24779494|NCT01876433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24779495|NCT01876433|Adrenergic Agents|adrenergic agents|mesh-ancestor
24779496|NCT01876433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24779497|NCT01876433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779498|NCT01876433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779499|NCT01876433|Urological Agents|urological agents|mesh-ancestor
24779500|NCT01876550|Mupirocin|mupirocin|mesh-list
24779501|NCT01876550|Calcium|calcium|mesh-list
24779502|NCT01876550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24779503|NCT01876550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779504|NCT01876550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24779505|NCT01876550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24779506|NCT01876550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24779507|NCT01876550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25081847|NCT03326947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25081848|NCT03326947|Immunologic Factors|immunologic factors|mesh-ancestor
25081849|NCT03326947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081850|NCT03326752|Nivolumab|nivolumab|mesh-list
25081851|NCT03326752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25081852|NCT03326752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25081855|NCT03326674|Capecitabine|capecitabine|mesh-list
25081856|NCT03326674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25081857|NCT03326674|Antimetabolites|antimetabolites|mesh-ancestor
24779508|NCT01876550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779510|NCT01876563|Vitamins|vitamins|mesh-ancestor
24779511|NCT01876563|Micronutrients|micronutrients|mesh-ancestor
24779512|NCT01876563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779513|NCT01876563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24779514|NCT01876615|Diclofenac|diclofenac|mesh-list
24779515|NCT01876615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24779516|NCT01876615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24779517|NCT01876615|Analgesics|analgesics|mesh-ancestor
24779518|NCT01876615|Sensory System Agents|sensory system agents|mesh-ancestor
24779519|NCT01876615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24779520|NCT01876615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779521|NCT01876615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24779522|NCT01876615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24779523|NCT01876615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24779525|NCT01876615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213366|NCT04788641|Cyclosporins|cyclosporins|mesh-list
25213374|NCT04788641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25157171|NCT04794699|Tubulin Modulators|tubulin modulators|mesh-ancestor
25157172|NCT04794699|Antimitotic Agents|antimitotic agents|mesh-ancestor
25157173|NCT04794699|Mitosis Modulators|mitosis modulators|mesh-ancestor
25157174|NCT04794699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25157175|NCT04794699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25157176|NCT04794699|Antimetabolites|antimetabolites|mesh-ancestor
25157177|NCT04794699|Antiviral Agents|antiviral agents|mesh-ancestor
25157178|NCT04794699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25157179|NCT04794699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25157180|NCT04794699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25157181|NCT04794699|Immunologic Factors|immunologic factors|mesh-ancestor
25157182|NCT04794699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487696|NCT00464503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25678258|NCT01822678|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25678259|NCT01822678|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25678260|NCT01822678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25678261|NCT01822678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678262|NCT01822756|Gemcitabine|gemcitabine|mesh-list
25678263|NCT01822756|Paclitaxel|paclitaxel|mesh-list
25678264|NCT01822756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25678265|NCT01822756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931865|NCT04085419|Denosumab|denosumab|mesh-list
24931866|NCT04085419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24931867|NCT04085419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931868|NCT04085237|Ropivacaine|ropivacaine|mesh-list
24931869|NCT04085237|Anesthetics, Local|anesthetics, local|mesh-ancestor
24931870|NCT04085237|Anesthetics|anesthetics|mesh-ancestor
24931871|NCT04085237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24443876|NCT00296049|Vancomycin|vancomycin|mesh-list
24487779|NCT00464971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487780|NCT00465036|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
24487784|NCT00465075|Estrogens|estrogens|mesh-list
24487793|NCT00465192|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24487794|NCT00465192|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24487796|NCT00465192|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24487797|NCT00465192|Estrogens|estrogens|mesh-ancestor
24487798|NCT00465192|Hormones|hormones|mesh-ancestor
24487799|NCT00465192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24487805|NCT00465205|Valacyclovir|valacyclovir|mesh-list
24487824|NCT00465244|Anticonvulsants|anticonvulsants|mesh-ancestor
24487839|NCT00465244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487841|NCT00465257|Amodiaquine|amodiaquine|mesh-list
24487842|NCT00465257|Antimalarials|antimalarials|mesh-ancestor
24487843|NCT00465257|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24487844|NCT00465257|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24779535|NCT01876641|Decitabine|decitabine|mesh-list
24779536|NCT01876641|Vemurafenib|vemurafenib|mesh-list
24779537|NCT01876641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24779538|NCT01876641|Antimetabolites|antimetabolites|mesh-ancestor
24779539|NCT01876641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779540|NCT01876641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779541|NCT01876641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571239|NCT00808795|Acetylcysteine|acetylcysteine|mesh-list
24779542|NCT01876641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24779544|NCT01876771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779545|NCT01876771|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24779546|NCT01876797|Ticagrelor|ticagrelor|mesh-list
24779547|NCT01876797|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24779548|NCT01876797|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24779549|NCT01876797|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24779550|NCT01876797|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24779551|NCT01876797|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24779552|NCT01876797|Purinergic Agents|purinergic agents|mesh-ancestor
24779553|NCT01876797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24779554|NCT01876797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779555|NCT01876797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779557|NCT01876849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24779558|NCT01876849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779559|NCT01876849|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25213375|NCT04788641|Dermatologic Agents|dermatologic agents|mesh-ancestor
25213376|NCT04788641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25213377|NCT04769362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25213378|NCT04769362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25213379|NCT04769362|Adrenergic Agents|adrenergic agents|mesh-ancestor
25102496|NCT03168191|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25157184|NCT04794699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25157191|NCT04784754|Melatonin|melatonin|mesh-list
25157192|NCT04784754|Antioxidants|antioxidants|mesh-ancestor
24626148|NCT01085721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24626149|NCT01085721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779560|NCT01876849|Incretins|incretins|mesh-ancestor
24779573|NCT01876966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24779574|NCT01876966|Protease Inhibitors|protease inhibitors|mesh-ancestor
24779590|NCT01877122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24779591|NCT01877122|Analgesics|analgesics|mesh-ancestor
24779592|NCT01877122|Sensory System Agents|sensory system agents|mesh-ancestor
24779593|NCT01877122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24779594|NCT01877122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779595|NCT01877122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25678266|NCT01822756|Tubulin Modulators|tubulin modulators|mesh-ancestor
25678267|NCT01822756|Antimitotic Agents|antimitotic agents|mesh-ancestor
25678268|NCT01822756|Mitosis Modulators|mitosis modulators|mesh-ancestor
25678269|NCT01822756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678270|NCT01822756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25678271|NCT01822756|Antimetabolites|antimetabolites|mesh-ancestor
25678272|NCT01822756|Antiviral Agents|antiviral agents|mesh-ancestor
24779596|NCT01877122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24779597|NCT01877122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24779599|NCT01877122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779600|NCT01877226|Tapentadol|tapentadol|mesh-list
24779601|NCT01877226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24779602|NCT01877226|Narcotics|narcotics|mesh-ancestor
24779605|NCT01877226|Analgesics|analgesics|mesh-ancestor
24779614|NCT01877356|Anesthetics|anesthetics|mesh-list
24779619|NCT01877512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779620|NCT01877577|Vitamin D|vitamin d|mesh-list
24779621|NCT01877577|Ergocalciferols|ergocalciferols|mesh-list
24779622|NCT01877577|Cholecalciferol|cholecalciferol|mesh-list
24779623|NCT01877577|Vitamins|vitamins|mesh-list
24779624|NCT01877577|Micronutrients|micronutrients|mesh-ancestor
24779625|NCT01877577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779626|NCT01877577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24779627|NCT01877577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24779629|NCT01877590|Antioxidants|antioxidants|mesh-ancestor
24779630|NCT01877590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779631|NCT01877590|Protective Agents|protective agents|mesh-ancestor
24779632|NCT01877590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779633|NCT01877590|Vitamin B Complex|vitamin b complex|mesh-ancestor
24779634|NCT01877590|Vitamins|vitamins|mesh-ancestor
24779635|NCT01877590|Micronutrients|micronutrients|mesh-ancestor
24779636|NCT01877746|Prednisone|prednisone|mesh-list
24779637|NCT01877746|Azathioprine|azathioprine|mesh-list
24779638|NCT01877746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24779639|NCT01877746|Glucocorticoids|glucocorticoids|mesh-ancestor
24779640|NCT01877746|Hormones|hormones|mesh-ancestor
24779641|NCT01877746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24779642|NCT01877746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779643|NCT01877746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24779644|NCT01877746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779645|NCT01877746|Antimetabolites|antimetabolites|mesh-ancestor
24779646|NCT01877746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213387|NCT04750343|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25213388|NCT04742738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25213389|NCT04742738|Aluminum sulfate|aluminum sulfate|mesh-list
25213390|NCT04742738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25213391|NCT04742738|Immunologic Factors|immunologic factors|mesh-ancestor
25213392|NCT04742738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213393|NCT04740645|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25213394|NCT04740645|Hemostatics|hemostatics|mesh-ancestor
24487931|NCT00465673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24487932|NCT00465673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487933|NCT00465673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24779700|NCT01878318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24779701|NCT01878318|Antimetabolites|antimetabolites|mesh-ancestor
24779702|NCT01878318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779703|NCT01878318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779704|NCT01878318|Dermatologic Agents|dermatologic agents|mesh-ancestor
24779705|NCT01878318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24779706|NCT01878318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24779708|NCT01878318|Immunologic Factors|immunologic factors|mesh-ancestor
24487995|NCT00466154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487996|NCT00466154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24779709|NCT01878318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24779710|NCT01878318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24779711|NCT01878357|Piperaquine|piperaquine|mesh-list
24779714|NCT01878357|Antimalarials|antimalarials|mesh-ancestor
24779715|NCT01878357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24779716|NCT01878357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24779717|NCT01878357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24779718|NCT01878422|Leucovorin|leucovorin|mesh-list
24779719|NCT01878422|Bevacizumab|bevacizumab|mesh-list
24779720|NCT01878422|Cetuximab|cetuximab|mesh-list
24779721|NCT01878422|Fluorouracil|fluorouracil|mesh-list
24779722|NCT01878422|Oxaliplatin|oxaliplatin|mesh-list
24779723|NCT01878422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24779724|NCT01878422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779725|NCT01878422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24779726|NCT01878422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24779727|NCT01878422|Growth Substances|growth substances|mesh-ancestor
24779728|NCT01878422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779729|NCT01878422|Growth Inhibitors|growth inhibitors|mesh-ancestor
24779730|NCT01878422|Antimetabolites|antimetabolites|mesh-ancestor
24779731|NCT01878422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931910|NCT04084171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24931911|NCT04084093|Pulmonary Surfactants|pulmonary surfactants|mesh-list
24931912|NCT04084093|Respiratory System Agents|respiratory system agents|mesh-ancestor
24779732|NCT01878422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24779733|NCT01878422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24779734|NCT01878422|Immunologic Factors|immunologic factors|mesh-ancestor
24779735|NCT01878422|Antidotes|antidotes|mesh-ancestor
24779736|NCT01878422|Protective Agents|protective agents|mesh-ancestor
24779737|NCT01878422|Vitamin B Complex|vitamin b complex|mesh-ancestor
24779738|NCT01878422|Vitamins|vitamins|mesh-ancestor
24779739|NCT01878422|Micronutrients|micronutrients|mesh-ancestor
24779740|NCT01878513|Risperidone|risperidone|mesh-list
24487998|NCT00466154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24487999|NCT00466154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24779747|NCT01878513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24779748|NCT01878513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24779749|NCT01878513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24779750|NCT01878513|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24779751|NCT01878513|Dopamine Agents|dopamine agents|mesh-ancestor
24935980|NCT04045769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779761|NCT01878578|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24779763|NCT01878643|Gentamicins|gentamicins|mesh-list
24779764|NCT01878643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24779765|NCT01878643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24779766|NCT01878643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24779767|NCT01878643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428856|NCT00241345|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
24779768|NCT01878643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779769|NCT01878695|Acetylcysteine|acetylcysteine|mesh-list
24779770|NCT01878695|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24779771|NCT01878695|Antiviral Agents|antiviral agents|mesh-ancestor
24779772|NCT01878695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24779773|NCT01878695|Expectorants|expectorants|mesh-ancestor
24779774|NCT01878695|Respiratory System Agents|respiratory system agents|mesh-ancestor
24779775|NCT01878695|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24779776|NCT01878695|Antioxidants|antioxidants|mesh-ancestor
24779777|NCT01878695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779778|NCT01878695|Protective Agents|protective agents|mesh-ancestor
24779779|NCT01878695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779780|NCT01878695|Antidotes|antidotes|mesh-ancestor
24779781|NCT01878708|Dexamethasone|dexamethasone|mesh-list
24779782|NCT01878708|Dexamethasone acetate|dexamethasone acetate|mesh-list
24572223|NCT00813735|Dexetimide|dexetimide|mesh-list
24779783|NCT01878708|Asparaginase|asparaginase|mesh-list
24917184|NCT04232332|Mitogens|mitogens|mesh-list
24779784|NCT01878708|Pegaspargase|pegaspargase|mesh-list
24779785|NCT01878708|BB 1101|bb 1101|mesh-list
24779786|NCT01878708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24779787|NCT01878708|Antiemetics|antiemetics|mesh-ancestor
24779788|NCT01878708|Autonomic Agents|autonomic agents|mesh-ancestor
24779789|NCT01878708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24779790|NCT01878708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779791|NCT01878708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24779792|NCT01878708|Glucocorticoids|glucocorticoids|mesh-ancestor
24779793|NCT01878708|Hormones|hormones|mesh-ancestor
24779794|NCT01878708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24779795|NCT01878708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24779796|NCT01878708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779797|NCT01878708|Protease Inhibitors|protease inhibitors|mesh-ancestor
24779798|NCT01878708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24779799|NCT01878708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779800|NCT01878734|Micronutrients|micronutrients|mesh-list
24779801|NCT01878734|Trace Elements|trace elements|mesh-list
24779802|NCT01878734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779803|NCT01878864|Lidocaine|lidocaine|mesh-list
24779804|NCT01878864|Bupivacaine|bupivacaine|mesh-list
24488185|NCT00467012|Bevacizumab|bevacizumab|mesh-list
24488186|NCT00467012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24627696|NCT01094457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627697|NCT01094457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24627698|NCT01094457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24627699|NCT01094457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24627700|NCT01094457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24627701|NCT01094457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627702|NCT01094457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25678273|NCT01822756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25678274|NCT01822756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678275|NCT01822756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24798329|NCT01962636|Cyclosporine|cyclosporine|mesh-list
24607468|NCT04558281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24607469|NCT04558281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607470|NCT04558281|Sensory System Agents|sensory system agents|mesh-ancestor
24607471|NCT04558281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24607472|NCT04477512|Prednisone|prednisone|mesh-list
24607473|NCT04477512|Nivolumab|nivolumab|mesh-list
24607474|NCT04477512|Abiraterone Acetate|abiraterone acetate|mesh-list
24607475|NCT04477512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24607476|NCT04477512|Glucocorticoids|glucocorticoids|mesh-ancestor
24607477|NCT04477512|Hormones|hormones|mesh-ancestor
24607537|NCT04424264|Lamivudine|lamivudine|mesh-list
24607538|NCT04424264|Emtricitabine|emtricitabine|mesh-list
24798330|NCT01962636|Cyclophosphamide|cyclophosphamide|mesh-list
24798331|NCT01962636|Fludarabine|fludarabine|mesh-list
24798339|NCT01962636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798340|NCT01962636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24798341|NCT01962636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24798342|NCT01962636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24798343|NCT01962636|Antifungal Agents|antifungal agents|mesh-ancestor
24798344|NCT01962636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24798345|NCT01962636|Dermatologic Agents|dermatologic agents|mesh-ancestor
24798346|NCT01962636|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24627703|NCT01094457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25081858|NCT03326674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081859|NCT03326674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081860|NCT03326661|Clindamycin|clindamycin|mesh-list
25081861|NCT03326661|Clindamycin palmitate|clindamycin palmitate|mesh-list
25081862|NCT03326661|Clindamycin phosphate|clindamycin phosphate|mesh-list
25081863|NCT03326661|Penicillins|penicillins|mesh-list
24627704|NCT01094457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627705|NCT01094457|Antipyretics|antipyretics|mesh-ancestor
25081881|NCT03326596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25081882|NCT03326596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25081883|NCT03326596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081886|NCT03326258|Nivolumab|nivolumab|mesh-list
25081887|NCT03326258|Ipilimumab|ipilimumab|mesh-list
25081888|NCT03326258|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
25081889|NCT03326258|Antibodies|antibodies|mesh-list
25081890|NCT03326258|Immunoglobulins|immunoglobulins|mesh-list
25081891|NCT03326258|Immunoconjugates|immunoconjugates|mesh-list
25081892|NCT03326258|Immunotoxins|immunotoxins|mesh-list
25081893|NCT03326258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25081894|NCT03326258|Immunologic Factors|immunologic factors|mesh-ancestor
25081895|NCT03326258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081896|NCT03326258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25081897|NCT03326258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081898|NCT03326258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24779811|NCT01878864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24779812|NCT01878864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24779813|NCT01878864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24779814|NCT01878864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24488190|NCT00467012|Mitosis Modulators|mitosis modulators|mesh-ancestor
24779815|NCT01878864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779816|NCT01878942|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
24779817|NCT01878942|Hallucinogens|hallucinogens|mesh-ancestor
24779818|NCT01878942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779819|NCT01878942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24779820|NCT01878942|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24779821|NCT01878942|Serotonin Agents|serotonin agents|mesh-ancestor
24779822|NCT01878942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24779823|NCT01878942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779824|NCT01878942|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24779825|NCT01879007|Gemifloxacin|gemifloxacin|mesh-list
24779826|NCT01879007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24779835|NCT01879033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678276|NCT01822756|Immunologic Factors|immunologic factors|mesh-ancestor
25678277|NCT01822756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678278|NCT01822821|Acetaminophen|acetaminophen|mesh-list
25678279|NCT01822821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25678280|NCT01822821|Analgesics|analgesics|mesh-ancestor
25678281|NCT01822821|Sensory System Agents|sensory system agents|mesh-ancestor
25678282|NCT01822821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25678283|NCT01822821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678284|NCT01822821|Antipyretics|antipyretics|mesh-ancestor
25678285|NCT01822886|Gemcitabine|gemcitabine|mesh-list
25678286|NCT01822886|Romidepsin|romidepsin|mesh-list
25678287|NCT01822886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24609898|NCT00998920|Equol|equol|mesh-list
24853573|NCT02269046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853574|NCT02269046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24853575|NCT02269046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24853576|NCT02269046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24853577|NCT02269072|Anastrozole|anastrozole|mesh-list
24853578|NCT02269072|Leuprolide|leuprolide|mesh-list
24607919|NCT03185208|Lithium Carbonate|lithium carbonate|mesh-list
24779836|NCT01879202|Methylphenidate|methylphenidate|mesh-list
24779837|NCT01879202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24779838|NCT01879202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779839|NCT01879202|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24779840|NCT01879202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24779841|NCT01879202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24667062|NCT01322061|Protective Agents|protective agents|mesh-ancestor
24779842|NCT01879202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779865|NCT01879423|Anticonvulsants|anticonvulsants|mesh-list
24779866|NCT01879423|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24779867|NCT01879423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24779868|NCT01879423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779869|NCT01879423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24779870|NCT01879423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779871|NCT01879423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24779872|NCT01879423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24779873|NCT01879423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24779874|NCT01879423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24779875|NCT01879423|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24779876|NCT01879488|Edetic Acid|edetic acid|mesh-list
24779877|NCT01879488|Pentetic Acid|pentetic acid|mesh-list
24779878|NCT01879488|Antidotes|antidotes|mesh-ancestor
24779879|NCT01879488|Protective Agents|protective agents|mesh-ancestor
24667131|NCT01322438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24936000|NCT04045821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24779880|NCT01879488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779881|NCT01879488|Chelating Agents|chelating agents|mesh-ancestor
24779883|NCT01879488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779884|NCT01879488|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24779885|NCT01879488|Anticoagulants|anticoagulants|mesh-ancestor
24779886|NCT01879488|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24779903|NCT01879527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24779904|NCT01879527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779905|NCT01879527|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24571761|NCT00811681|Pioglitazone|pioglitazone|mesh-list
24571762|NCT00811681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24571763|NCT00811681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571764|NCT00811746|Eszopiclone|eszopiclone|mesh-list
24571766|NCT00811746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24571767|NCT00811746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571768|NCT00811759|Temozolomide|temozolomide|mesh-list
24571769|NCT00811759|Sorafenib|sorafenib|mesh-list
24571770|NCT00811759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24571771|NCT00811759|Alkylating Agents|alkylating agents|mesh-ancestor
24571772|NCT00811759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571773|NCT00811759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24571774|NCT00811759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24571775|NCT00811759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621009|NCT01060293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24621011|NCT01060293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24621012|NCT01060293|Protective Agents|protective agents|mesh-ancestor
24621013|NCT01060410|Cyclophosphamide|cyclophosphamide|mesh-list
24621014|NCT01060410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24621015|NCT01060410|Immunologic Factors|immunologic factors|mesh-ancestor
24621016|NCT01060410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621017|NCT01060410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24621018|NCT01060410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25678288|NCT01822886|Antimetabolites|antimetabolites|mesh-ancestor
25678289|NCT01822886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678290|NCT01822886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678291|NCT01822886|Antiviral Agents|antiviral agents|mesh-ancestor
25678292|NCT01822886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25678293|NCT01822886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678294|NCT01822886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25678295|NCT01822886|Immunologic Factors|immunologic factors|mesh-ancestor
24621020|NCT01060410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621021|NCT01060410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24621022|NCT01060410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24621023|NCT01060423|Irinotecan|irinotecan|mesh-list
24621025|NCT01060423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24621026|NCT01060423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24621027|NCT01060423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621031|NCT01060475|Tacrolimus|tacrolimus|mesh-list
24621032|NCT01060475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24621033|NCT01060475|Immunologic Factors|immunologic factors|mesh-ancestor
24621034|NCT01060475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621035|NCT01060475|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24621036|NCT01060475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24779933|NCT01880112|Cefazolin|cefazolin|mesh-list
24779934|NCT01880112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24779935|NCT01880112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24779936|NCT01880125|Acetaminophen|acetaminophen|mesh-list
24779937|NCT01880125|Tramadol|tramadol|mesh-list
24779938|NCT01880125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24779939|NCT01880125|Analgesics|analgesics|mesh-ancestor
24779940|NCT01880125|Sensory System Agents|sensory system agents|mesh-ancestor
24779941|NCT01880125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24779942|NCT01880125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779943|NCT01880125|Antipyretics|antipyretics|mesh-ancestor
24779944|NCT01880125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24779945|NCT01880125|Narcotics|narcotics|mesh-ancestor
24779946|NCT01880125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24779964|NCT01880307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779965|NCT01880307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24779966|NCT01880307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779967|NCT01880307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24779968|NCT01880307|Dermatologic Agents|dermatologic agents|mesh-ancestor
24779969|NCT01880307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24779970|NCT01880307|Antimetabolites|antimetabolites|mesh-ancestor
24779971|NCT01880307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779972|NCT01880307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24779973|NCT01880307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24779975|NCT01880346|Vitamin D|vitamin d|mesh-list
24936016|NCT04046185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779976|NCT01880346|Ergocalciferols|ergocalciferols|mesh-list
24779977|NCT01880346|Cholecalciferol|cholecalciferol|mesh-list
24779978|NCT01880346|Vitamins|vitamins|mesh-list
24779979|NCT01880346|Micronutrients|micronutrients|mesh-ancestor
24779980|NCT01880346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779981|NCT01880346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24779982|NCT01880346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24779983|NCT01880372|Thioctic Acid|thioctic acid|mesh-list
24779984|NCT01880372|Antioxidants|antioxidants|mesh-ancestor
24779985|NCT01880372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780007|NCT01880385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24780008|NCT01880385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24627712|NCT01094457|Autonomic Agents|autonomic agents|mesh-ancestor
24780009|NCT01880385|Growth Substances|growth substances|mesh-ancestor
24780013|NCT01880385|Mitosis Modulators|mitosis modulators|mesh-ancestor
24780014|NCT01880385|Antimetabolites|antimetabolites|mesh-ancestor
24780015|NCT01880385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24780016|NCT01880385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24780017|NCT01880385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24780018|NCT01880385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24780019|NCT01880385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780020|NCT01880463|Vitamin D|vitamin d|mesh-list
24780021|NCT01880463|Ergocalciferols|ergocalciferols|mesh-list
24780022|NCT01880463|Cholecalciferol|cholecalciferol|mesh-list
24780023|NCT01880463|Vitamins|vitamins|mesh-list
24780024|NCT01880463|Micronutrients|micronutrients|mesh-ancestor
24780025|NCT01880463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780026|NCT01880463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24780027|NCT01880463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24780028|NCT01880619|Tamsulosin|tamsulosin|mesh-list
24780029|NCT01880619|Solifenacin Succinate|solifenacin succinate|mesh-list
25213427|NCT04699123|Pembrolizumab|pembrolizumab|mesh-list
25213428|NCT04699123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25213429|NCT04699123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25213430|NCT04697485|Eplerenone|eplerenone|mesh-list
25213431|NCT04697485|Bumetanide|bumetanide|mesh-list
24780030|NCT01880619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24780031|NCT01880619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24780032|NCT01880619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24780033|NCT01880619|Adrenergic Agents|adrenergic agents|mesh-ancestor
24780034|NCT01880619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24780035|NCT01880619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24667267|NCT05459974|Gout Suppressants|gout suppressants|mesh-ancestor
24780036|NCT01880619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780037|NCT01880619|Urological Agents|urological agents|mesh-ancestor
24780038|NCT01880619|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24780039|NCT01880619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24780040|NCT01880619|Cholinergic Agents|cholinergic agents|mesh-ancestor
24780042|NCT01880658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24780043|NCT01880658|Antimetabolites|antimetabolites|mesh-ancestor
24780044|NCT01880658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780045|NCT01880658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24780047|NCT01880749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24780048|NCT01880749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24780049|NCT01880749|Immunologic Factors|immunologic factors|mesh-ancestor
24780050|NCT01880749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780051|NCT01880775|Bupivacaine|bupivacaine|mesh-list
24780052|NCT01880775|Prilocaine|prilocaine|mesh-list
24780053|NCT01880775|Anesthetics, Local|anesthetics, local|mesh-ancestor
24780054|NCT01880775|Anesthetics|anesthetics|mesh-ancestor
24780055|NCT01880775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24780078|NCT01881074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780084|NCT01881100|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
25081899|NCT03326258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627713|NCT01094457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24627714|NCT01094457|Respiratory System Agents|respiratory system agents|mesh-ancestor
24627715|NCT01094457|Vasodilator Agents|vasodilator agents|mesh-ancestor
24627716|NCT01094457|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24627717|NCT01094457|Protective Agents|protective agents|mesh-ancestor
24627718|NCT01094457|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24627719|NCT01094457|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24627721|NCT01094535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24627723|NCT01094535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24627724|NCT01094535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627725|NCT01094600|Secretin|secretin|mesh-list
24627726|NCT01094600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24627727|NCT01094600|Hormones|hormones|mesh-ancestor
24627728|NCT01094600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24627729|NCT01094600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627730|NCT01094613|Mercaptopurine|mercaptopurine|mesh-list
24627731|NCT01094613|Antimetabolites|antimetabolites|mesh-ancestor
24936058|NCT04044651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25241957|NCT05147493|Growth Substances|growth substances|mesh-ancestor
24627732|NCT01094613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627734|NCT01094613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24627735|NCT01094613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24627736|NCT01094613|Immunologic Factors|immunologic factors|mesh-ancestor
24627737|NCT01094613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627738|NCT01094613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24627739|NCT01094613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24798495|NCT01963910|Diuretics|diuretics|mesh-ancestor
24798706|NCT01964586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25081915|NCT03326128|Dopamine Agents|dopamine agents|mesh-ancestor
25081916|NCT03326128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25081917|NCT03326128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081918|NCT03326128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25081919|NCT03326128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25081920|NCT03326128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25081921|NCT03326102|Paclitaxel|paclitaxel|mesh-list
25081922|NCT03326102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25081923|NCT03326102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25081924|NCT03326102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25213432|NCT04697485|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25213433|NCT04697485|Hormone Antagonists|hormone antagonists|mesh-ancestor
25081925|NCT03326102|Tubulin Modulators|tubulin modulators|mesh-ancestor
25081926|NCT03326102|Antimitotic Agents|antimitotic agents|mesh-ancestor
25081927|NCT03326102|Mitosis Modulators|mitosis modulators|mesh-ancestor
25081928|NCT03326102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081929|NCT03326063|Ifetroban|ifetroban|mesh-list
25081930|NCT03326063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25081931|NCT03326050|Ciprofloxacin|ciprofloxacin|mesh-list
25081932|NCT03326050|Rifampin|rifampin|mesh-list
25081933|NCT03326050|Gemifloxacin|gemifloxacin|mesh-list
25081934|NCT03326050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24780085|NCT01881100|Cariostatic Agents|cariostatic agents|mesh-ancestor
24780086|NCT01881100|Protective Agents|protective agents|mesh-ancestor
24780087|NCT01881100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780088|NCT01881100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24780089|NCT01881100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24780091|NCT01881347|Antioxidants|antioxidants|mesh-ancestor
24780092|NCT01881347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780093|NCT01881347|Protective Agents|protective agents|mesh-ancestor
24780094|NCT01881347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780095|NCT01881347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780096|NCT01881347|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24780097|NCT01881464|Adalimumab|adalimumab|mesh-list
24780098|NCT01881464|Infliximab|infliximab|mesh-list
24780099|NCT01881464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24780100|NCT01881464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24780101|NCT01881464|Dermatologic Agents|dermatologic agents|mesh-ancestor
24780102|NCT01881464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24780123|NCT01881763|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24780124|NCT01881763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24780125|NCT01881763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780126|NCT01881919|Quercetin|quercetin|mesh-list
24780127|NCT01881919|Antioxidants|antioxidants|mesh-ancestor
24780132|NCT01881971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24780133|NCT01881971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780135|NCT01881997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24780136|NCT01881997|Narcotics|narcotics|mesh-ancestor
24780137|NCT01881997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24780138|NCT01881997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780139|NCT01881997|Analgesics|analgesics|mesh-ancestor
24780140|NCT01881997|Sensory System Agents|sensory system agents|mesh-ancestor
24780141|NCT01881997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24780142|NCT01881997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24780143|NCT01881997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24780144|NCT01881997|Anesthetics, General|anesthetics, general|mesh-ancestor
24780145|NCT01881997|Anesthetics|anesthetics|mesh-ancestor
24780146|NCT01882010|Sargramostim|sargramostim|mesh-list
24780147|NCT01882010|Immunologic Factors|immunologic factors|mesh-ancestor
24780148|NCT01882010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780149|NCT01882075|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24936056|NCT04044651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24936057|NCT04044651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24780156|NCT01882127|Autonomic Agents|autonomic agents|mesh-ancestor
24780157|NCT01882127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24780158|NCT01882127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780160|NCT01882127|Glucocorticoids|glucocorticoids|mesh-ancestor
24780161|NCT01882127|Hormones|hormones|mesh-ancestor
24917713|NCT04226963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24488191|NCT00467012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488192|NCT00467012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24488193|NCT00467012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25213434|NCT04697485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24488302|NCT00467571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24488303|NCT00467571|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24488304|NCT00467636|Insulin glulisine|insulin glulisine|mesh-list
24780163|NCT01882127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24780165|NCT01882127|Keratolytic Agents|keratolytic agents|mesh-ancestor
24780166|NCT01882127|Dermatologic Agents|dermatologic agents|mesh-ancestor
24780167|NCT01882179|Canrenoic Acid|canrenoic acid|mesh-list
24780168|NCT01882179|Mineralocorticoids|mineralocorticoids|mesh-list
24780169|NCT01882179|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
24780170|NCT01882179|Hormones|hormones|mesh-ancestor
24780171|NCT01882179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24780172|NCT01882179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780174|NCT01882179|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24780175|NCT01882179|Diuretics|diuretics|mesh-ancestor
24780176|NCT01882179|Natriuretic Agents|natriuretic agents|mesh-ancestor
24780177|NCT01882296|Pantoprazole|pantoprazole|mesh-list
24780178|NCT01882296|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24780179|NCT01882296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24780180|NCT01882296|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24608419|NCT00992082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24608420|NCT00992082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24608421|NCT00992082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24608422|NCT00992082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24608423|NCT00992082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24608424|NCT00992082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608425|NCT00992095|Buprenorphine|buprenorphine|mesh-list
24608426|NCT00992095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24608438|NCT00992121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24608439|NCT00992121|Growth Substances|growth substances|mesh-ancestor
24608440|NCT00992121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608441|NCT00992121|Growth Inhibitors|growth inhibitors|mesh-ancestor
24780181|NCT01882296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780182|NCT01882296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780183|NCT01882322|Tacrolimus|tacrolimus|mesh-list
24780184|NCT01882322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24780185|NCT01882322|Immunologic Factors|immunologic factors|mesh-ancestor
24780186|NCT01882322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780187|NCT01882322|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24780188|NCT01882322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780189|NCT01882322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780190|NCT01882361|Naltrexone|naltrexone|mesh-list
24780191|NCT01882361|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24780192|NCT01882361|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24780193|NCT01882361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780194|NCT01882361|Sensory System Agents|sensory system agents|mesh-ancestor
24780200|NCT01882387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24780201|NCT01882387|Vasodilator Agents|vasodilator agents|mesh-ancestor
24780202|NCT01882400|Alendronate|alendronate|mesh-list
24780203|NCT01882400|Risedronic Acid|risedronic acid|mesh-list
24780204|NCT01882400|Diphosphonates|diphosphonates|mesh-list
24780205|NCT01882400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24780206|NCT01882400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780207|NCT01882400|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24780208|NCT01882400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24760603|NCT01758913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24780209|NCT01882400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780210|NCT01882400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24780211|NCT01882530|Acetaminophen|acetaminophen|mesh-list
24780212|NCT01882530|Ketoprofen|ketoprofen|mesh-list
24780213|NCT01882530|Morphine|morphine|mesh-list
24780214|NCT01882530|Nefopam|nefopam|mesh-list
24780215|NCT01882530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24780216|NCT01882530|Narcotics|narcotics|mesh-ancestor
24780217|NCT01882530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24780218|NCT01882530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780219|NCT01882530|Analgesics|analgesics|mesh-ancestor
24780220|NCT01882530|Sensory System Agents|sensory system agents|mesh-ancestor
25213435|NCT04697485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213436|NCT04697485|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25213437|NCT04697485|Diuretics|diuretics|mesh-ancestor
25213438|NCT04697485|Natriuretic Agents|natriuretic agents|mesh-ancestor
25213439|NCT04697485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25213440|NCT04697485|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25213441|NCT04697485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25157234|NCT04766853|Dexamethasone|dexamethasone|mesh-list
25157235|NCT04766853|Hyaluronic Acid|hyaluronic acid|mesh-list
25157236|NCT04766853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25157237|NCT04766853|Antiemetics|antiemetics|mesh-ancestor
25157238|NCT04766853|Autonomic Agents|autonomic agents|mesh-ancestor
25157239|NCT04766853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25051535|NCT00396357|Protease Inhibitors|protease inhibitors|mesh-ancestor
24780221|NCT01882530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25678296|NCT01822886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678297|NCT01822886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25678298|NCT01822899|Fluticasone|fluticasone|mesh-list
25678299|NCT01822899|Xhance|xhance|mesh-list
25678300|NCT01822899|Bromides|bromides|mesh-list
25678301|NCT01822899|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25678302|NCT01822899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25678303|NCT01822899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25678304|NCT01822899|Autonomic Agents|autonomic agents|mesh-ancestor
25678305|NCT01822899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25678306|NCT01822899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678307|NCT01822899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25678308|NCT01822899|Respiratory System Agents|respiratory system agents|mesh-ancestor
24529513|NCT00626509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529514|NCT00626535|Esomeprazole|esomeprazole|mesh-list
24529515|NCT00626535|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24529516|NCT00626535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24529543|NCT00626613|Cholinergic Agents|cholinergic agents|mesh-ancestor
24780222|NCT01882530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24780223|NCT01882530|Antipyretics|antipyretics|mesh-ancestor
24780224|NCT01882530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24780225|NCT01882530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24780226|NCT01882530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24780227|NCT01882530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24780228|NCT01882530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637413|NCT01150162|Omeprazole|omeprazole|mesh-list
24780244|NCT01882660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780246|NCT01882660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780247|NCT01882920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24572158|NCT00813436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24572159|NCT00813436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572160|NCT00813449|Dacarbazine|dacarbazine|mesh-list
24572161|NCT00813449|Endostar protein|endostar protein|mesh-list
24572162|NCT00813449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24572163|NCT00813449|Alkylating Agents|alkylating agents|mesh-ancestor
24572164|NCT00813449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572165|NCT00813449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572166|NCT00813449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24572167|NCT00813449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24572168|NCT00813449|Growth Substances|growth substances|mesh-ancestor
24572169|NCT00813449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572170|NCT00813449|Growth Inhibitors|growth inhibitors|mesh-ancestor
24488315|NCT00467766|Cholinergic Agents|cholinergic agents|mesh-ancestor
24488316|NCT00467766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24572172|NCT00813475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24572173|NCT00813475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24572174|NCT00813475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572175|NCT00813501|Immunosuppressive Agents|immunosuppressive agents|mesh-list
24572176|NCT00813501|Immunologic Factors|immunologic factors|mesh-ancestor
24572177|NCT00813501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572179|NCT00813527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24572180|NCT00813527|Antimetabolites|antimetabolites|mesh-ancestor
24572181|NCT00813527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572182|NCT00813527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24572183|NCT00813631|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24572184|NCT00813631|Laxatives|laxatives|mesh-ancestor
24572185|NCT00813631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24621037|NCT01060475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621038|NCT01060488|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
24621040|NCT01060488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24621041|NCT01060488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621042|NCT01060501|Leucovorin|leucovorin|mesh-list
25050167|NCT00535366|Parasympatholytics|parasympatholytics|mesh-ancestor
24621043|NCT01060501|Folic Acid|folic acid|mesh-list
24621044|NCT01060501|Interferons|interferons|mesh-list
24780261|NCT01883102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780262|NCT01883167|Febuxostat|febuxostat|mesh-list
24488319|NCT00467883|Amphotericin B|amphotericin b|mesh-list
24488320|NCT00467883|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25081938|NCT03326050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627741|NCT01094626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24627743|NCT01094626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25678309|NCT01822899|Dermatologic Agents|dermatologic agents|mesh-ancestor
25678310|NCT01822899|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25678311|NCT01822899|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25678312|NCT01822899|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25678313|NCT01822899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25678314|NCT01822899|Adrenergic Agents|adrenergic agents|mesh-ancestor
25678315|NCT01822899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25678316|NCT01822899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678317|NCT01822899|Anticonvulsants|anticonvulsants|mesh-ancestor
25678318|NCT01823146|Oxytocin|oxytocin|mesh-list
24608633|NCT00992849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24608634|NCT00992849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24608635|NCT00992849|Growth Substances|growth substances|mesh-ancestor
24608636|NCT00992849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608637|NCT00992849|Growth Inhibitors|growth inhibitors|mesh-ancestor
24608638|NCT00992862|Moexipril|moexipril|mesh-list
24608639|NCT00992862|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25213442|NCT04697485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272748|NCT02390089|Sensory System Agents|sensory system agents|mesh-ancestor
25272749|NCT02390089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25272750|NCT02390089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272751|NCT02389842|Palbociclib|palbociclib|mesh-list
25272752|NCT02389842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272753|NCT02389842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25272754|NCT02389842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25157241|NCT04766853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25157242|NCT04766853|Glucocorticoids|glucocorticoids|mesh-ancestor
25157244|NCT04766853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25157245|NCT04766853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25157246|NCT04766853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25157247|NCT04766853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25157248|NCT04766853|Immunologic Factors|immunologic factors|mesh-ancestor
25157249|NCT04766853|Viscosupplements|viscosupplements|mesh-ancestor
25051544|NCT00394199|Xhance|xhance|mesh-list
24627744|NCT01094626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627745|NCT01094769|Moxonidine|moxonidine|mesh-list
24627746|NCT01094769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24627747|NCT01094821|ATI 7505|ati 7505|mesh-list
24627748|NCT01094821|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24657700|NCT01268917|Antipyretics|antipyretics|mesh-ancestor
24657780|NCT01269216|Antidotes|antidotes|mesh-ancestor
24657921|NCT01269528|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24657922|NCT01269528|Vasodilator Agents|vasodilator agents|mesh-ancestor
24657923|NCT01269528|Gasotransmitters|gasotransmitters|mesh-ancestor
24657924|NCT01269528|Protective Agents|protective agents|mesh-ancestor
24780275|NCT01883232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24780276|NCT01883232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24780277|NCT01883232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24780279|NCT01883232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24780280|NCT01883232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780281|NCT01883232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24780282|NCT01883232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24780283|NCT01883232|Adrenergic Agents|adrenergic agents|mesh-ancestor
24780284|NCT01883232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24780285|NCT01883232|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24780286|NCT01883232|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24780287|NCT01883232|Autonomic Agents|autonomic agents|mesh-ancestor
24780288|NCT01883232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24780289|NCT01883232|Respiratory System Agents|respiratory system agents|mesh-ancestor
24780290|NCT01883232|Mydriatics|mydriatics|mesh-ancestor
24780291|NCT01883232|Sympathomimetics|sympathomimetics|mesh-ancestor
24780292|NCT01883232|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24488321|NCT00467883|Amebicides|amebicides|mesh-ancestor
24488374|NCT00468234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488375|NCT00468234|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24488376|NCT00468234|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24488378|NCT00468234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24488379|NCT00468234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780293|NCT01883323|Aldesleukin|aldesleukin|mesh-list
24780314|NCT01883505|Levodopa|levodopa|mesh-list
24780315|NCT01883505|Carbidopa|carbidopa|mesh-list
24780316|NCT01883505|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24780317|NCT01883505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24615327|NCT01028846|Diazoxide|diazoxide|mesh-list
24780327|NCT01883531|Mannitol|mannitol|mesh-list
24780328|NCT01883531|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25678319|NCT01823146|Oxytocics|oxytocics|mesh-ancestor
25678320|NCT01823146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25678321|NCT01823146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678322|NCT01823224|Acetaminophen|acetaminophen|mesh-list
25678323|NCT01823224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25678324|NCT01823224|Analgesics|analgesics|mesh-ancestor
25678325|NCT01823224|Sensory System Agents|sensory system agents|mesh-ancestor
25678326|NCT01823224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24608849|NCT00994006|Cathartics|cathartics|mesh-ancestor
24608850|NCT00994006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24608851|NCT00994006|Antacids|antacids|mesh-ancestor
24608852|NCT00994006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780329|NCT01883531|Diuretics|diuretics|mesh-ancestor
24780330|NCT01883531|Natriuretic Agents|natriuretic agents|mesh-ancestor
24780331|NCT01883531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780332|NCT01883596|Chlorhexidine|chlorhexidine|mesh-list
24780333|NCT01883596|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24780334|NCT01883596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24780335|NCT01883596|Disinfectants|disinfectants|mesh-ancestor
24780336|NCT01883869|Ticagrelor|ticagrelor|mesh-list
25213443|NCT04672525|Rifampin|rifampin|mesh-list
25213444|NCT04672525|Rifabutin|rifabutin|mesh-list
25213445|NCT04672525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25213446|NCT04672525|Antitubercular Agents|antitubercular agents|mesh-ancestor
25213447|NCT04672525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25213448|NCT04672525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25213449|NCT04672525|Leprostatic Agents|leprostatic agents|mesh-ancestor
25213450|NCT04672525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25213451|NCT04672525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25213452|NCT04672525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213453|NCT04672525|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25157250|NCT04766853|Protective Agents|protective agents|mesh-ancestor
25116209|NCT03110172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116210|NCT03110172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25116211|NCT03110172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116212|NCT03110172|Analgesics|analgesics|mesh-ancestor
25116213|NCT03110172|Sensory System Agents|sensory system agents|mesh-ancestor
24780337|NCT01883869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24780338|NCT01883869|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24780339|NCT01883869|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24780340|NCT01883869|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24780341|NCT01883869|Purinergic Agents|purinergic agents|mesh-ancestor
24780342|NCT01883869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25081939|NCT03326050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081940|NCT03326050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081941|NCT03326050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25081943|NCT03326050|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25081949|NCT03326050|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25081950|NCT03326050|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24780343|NCT01883869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780344|NCT01883869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780347|NCT01883882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24780348|NCT01883882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780349|NCT01883882|Analgesics|analgesics|mesh-ancestor
24780350|NCT01883882|Sensory System Agents|sensory system agents|mesh-ancestor
24780351|NCT01883882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24780352|NCT01883921|Immunoglobulins|immunoglobulins|mesh-list
24780353|NCT01883921|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24780354|NCT01883921|Antibodies|antibodies|mesh-list
24780355|NCT01883921|Immunologic Factors|immunologic factors|mesh-ancestor
24780356|NCT01883921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780357|NCT01884038|Treprostinil|treprostinil|mesh-list
24780358|NCT01884038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24780359|NCT01884116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
24780360|NCT01884116|Capsaicin|capsaicin|mesh-list
24780361|NCT01884116|Antipruritics|antipruritics|mesh-ancestor
24780362|NCT01884116|Dermatologic Agents|dermatologic agents|mesh-ancestor
24780363|NCT01884116|Sensory System Agents|sensory system agents|mesh-ancestor
24780364|NCT01884116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24780365|NCT01884116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780366|NCT01884116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24780367|NCT01884116|Analgesics|analgesics|mesh-ancestor
24780368|NCT01884116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24488381|NCT00468260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488413|NCT00468364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488414|NCT00468429|Bevacizumab|bevacizumab|mesh-list
24488415|NCT00468429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25678327|NCT01823224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678328|NCT01823224|Antipyretics|antipyretics|mesh-ancestor
25678329|NCT01823289|Itraconazole|itraconazole|mesh-list
25678330|NCT01823289|Antifungal Agents|antifungal agents|mesh-ancestor
25260293|NCT02459613|Annexin A5|annexin a5|mesh-list
24488416|NCT00468429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488417|NCT00468429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24488418|NCT00468429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24780387|NCT01884272|Uricosuric Agents|uricosuric agents|mesh-ancestor
24780388|NCT01884272|Renal Agents|renal agents|mesh-ancestor
24780389|NCT01884285|Abiraterone Acetate|abiraterone acetate|mesh-list
24780390|NCT01884285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24780391|NCT01884285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24780392|NCT01884285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780393|NCT01884285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780394|NCT01884285|Hormone Antagonists|hormone antagonists|mesh-ancestor
24780395|NCT01884285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24780396|NCT01884285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780397|NCT01884285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24780399|NCT01884298|Remifentanil|remifentanil|mesh-list
24780400|NCT01884298|Anesthetics, Local|anesthetics, local|mesh-ancestor
25213454|NCT04672525|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25213455|NCT04672525|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25213456|NCT04672525|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25213457|NCT04672525|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25213458|NCT04672525|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25213459|NCT04650269|Emtricitabine|emtricitabine|mesh-list
25116214|NCT03110172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116215|NCT03110172|Antidepressive Agents|antidepressive agents|mesh-ancestor
25116216|NCT03110172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25116217|NCT03110172|Dopamine Agents|dopamine agents|mesh-ancestor
25116218|NCT03109886|Maleic acid|maleic acid|mesh-list
25116219|NCT03109886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25116220|NCT03109886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116221|NCT03110198|Hydrocortisone|hydrocortisone|mesh-list
25116222|NCT03110198|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25116223|NCT03110198|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25116224|NCT03110198|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24780401|NCT01884298|Anesthetics|anesthetics|mesh-ancestor
24780402|NCT01884298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24780404|NCT01884298|Sensory System Agents|sensory system agents|mesh-ancestor
24780409|NCT01884298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24780410|NCT01884298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780419|NCT01884402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24780421|NCT01884415|Immunologic Factors|immunologic factors|mesh-ancestor
24780422|NCT01884415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780423|NCT01884428|Gemcitabine|gemcitabine|mesh-list
24780424|NCT01884428|Prednisolone|prednisolone|mesh-list
24780425|NCT01884428|Vinorelbine|vinorelbine|mesh-list
24780426|NCT01884428|Ifosfamide|ifosfamide|mesh-list
24780427|NCT01884428|Panobinostat|panobinostat|mesh-list
24780428|NCT01884428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24780429|NCT01884428|Antimetabolites|antimetabolites|mesh-ancestor
24780430|NCT01884428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780440|NCT01884428|Hormones|hormones|mesh-ancestor
24780457|NCT01884441|Antiviral Agents|antiviral agents|mesh-ancestor
24780458|NCT01884441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24780459|NCT01884441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780460|NCT01884441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24780461|NCT01884441|Immunologic Factors|immunologic factors|mesh-ancestor
24780462|NCT01884441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780463|NCT01884441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24780465|NCT01884441|Antimitotic Agents|antimitotic agents|mesh-ancestor
24780466|NCT01884441|Mitosis Modulators|mitosis modulators|mesh-ancestor
24780467|NCT01884441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24780468|NCT01884441|Alkylating Agents|alkylating agents|mesh-ancestor
24780469|NCT01884467|Gentamicins|gentamicins|mesh-list
24780470|NCT01884467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24780471|NCT01884467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24780472|NCT01884467|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24780473|NCT01884467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780474|NCT01884467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780476|NCT01884506|Ascorbic Acid|ascorbic acid|mesh-list
24780477|NCT01884506|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24780486|NCT01884558|Isavuconazole|isavuconazole|mesh-list
24780506|NCT01884623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24780507|NCT01884623|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25678331|NCT01823289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24780508|NCT01884623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24780510|NCT01884636|Methotrexate|methotrexate|mesh-list
24780511|NCT01884636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24780512|NCT01884636|Abortifacient Agents|abortifacient agents|mesh-ancestor
25213460|NCT04650269|Antiviral Agents|antiviral agents|mesh-ancestor
25213461|NCT04650269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25213462|NCT04650269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25213463|NCT04650269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25213464|NCT04650269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25213465|NCT04650269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213466|NCT04650269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25213467|NCT04650269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25116225|NCT03110198|Mesalamine|mesalamine|mesh-list
25116226|NCT03110198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25116227|NCT03110198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25116228|NCT03110198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25116229|NCT03110198|Analgesics|analgesics|mesh-ancestor
24780513|NCT01884636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24780514|NCT01884636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780515|NCT01884636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24780516|NCT01884636|Antimetabolites|antimetabolites|mesh-ancestor
24780517|NCT01884636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780518|NCT01884636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24780519|NCT01884636|Dermatologic Agents|dermatologic agents|mesh-ancestor
24780520|NCT01884636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780521|NCT01884636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24720102|NCT01566474|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24780537|NCT01884857|Metoprolol|metoprolol|mesh-list
24780538|NCT01884857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24780540|NCT01884857|Sympatholytics|sympatholytics|mesh-ancestor
24780541|NCT01884857|Autonomic Agents|autonomic agents|mesh-ancestor
24780542|NCT01884857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24780544|NCT01884857|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24780545|NCT01884857|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24780546|NCT01884857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24780547|NCT01884857|Adrenergic Agents|adrenergic agents|mesh-ancestor
24780548|NCT01884857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24780549|NCT01884857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780551|NCT01884896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24780552|NCT01884896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24780553|NCT01884896|Sympatholytics|sympatholytics|mesh-ancestor
24780554|NCT01884896|Autonomic Agents|autonomic agents|mesh-ancestor
24780555|NCT01884896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24780556|NCT01884896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780557|NCT01884896|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24780558|NCT01884896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24780559|NCT01884896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24780560|NCT01884896|Adrenergic Agents|adrenergic agents|mesh-ancestor
24780561|NCT01884896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24780562|NCT01884896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780563|NCT01884909|Metoprolol|metoprolol|mesh-list
24780570|NCT01884909|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24780571|NCT01884909|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24780572|NCT01884909|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24780574|NCT01884909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24780583|NCT01885013|Immunologic Factors|immunologic factors|mesh-ancestor
24780584|NCT01885013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780585|NCT01885013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24780586|NCT01885013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24780587|NCT01885013|Alkylating Agents|alkylating agents|mesh-ancestor
24780588|NCT01885013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780589|NCT01885013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24780590|NCT01885013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24780591|NCT01885013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24780592|NCT01885013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24720194|NCT01566890|Regadenoson|regadenoson|mesh-list
24780626|NCT01885364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24780627|NCT01885364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24780628|NCT01885364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116231|NCT03110198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116232|NCT03110198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780629|NCT01885364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24780630|NCT01885364|Anesthetics, General|anesthetics, general|mesh-ancestor
24780631|NCT01885364|Anesthetics|anesthetics|mesh-ancestor
24780632|NCT01885364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24780633|NCT01885364|Narcotics|narcotics|mesh-ancestor
24780634|NCT01885364|Analgesics|analgesics|mesh-ancestor
24780635|NCT01885364|Sensory System Agents|sensory system agents|mesh-ancestor
24780636|NCT01885364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24780637|NCT01885364|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24780638|NCT01885364|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24780639|NCT01885364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24780640|NCT01885364|Adrenergic Agents|adrenergic agents|mesh-ancestor
24780641|NCT01885364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24780642|NCT01885364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780644|NCT01885481|Dexamethasone acetate|dexamethasone acetate|mesh-list
24780645|NCT01885481|Betamethasone|betamethasone|mesh-list
24780646|NCT01885481|Betamethasone Valerate|betamethasone valerate|mesh-list
24780647|NCT01885481|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24780648|NCT01885481|Betamethasone benzoate|betamethasone benzoate|mesh-list
24780649|NCT01885481|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24780650|NCT01885481|BB 1101|bb 1101|mesh-list
24780651|NCT01885481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24780652|NCT01885481|Antiemetics|antiemetics|mesh-ancestor
24780653|NCT01885481|Autonomic Agents|autonomic agents|mesh-ancestor
24780654|NCT01885481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24780655|NCT01885481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780656|NCT01885481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24572546|NCT00815373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24572547|NCT00815373|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24720249|NCT01567475|Everolimus|everolimus|mesh-list
24780673|NCT01885585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780676|NCT01885598|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24780677|NCT01885598|Antithrombins|antithrombins|mesh-ancestor
24780678|NCT01885598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24780679|NCT01885598|Protease Inhibitors|protease inhibitors|mesh-ancestor
24780680|NCT01885598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780681|NCT01885598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780682|NCT01885598|Anticoagulants|anticoagulants|mesh-ancestor
24780683|NCT01885715|Neostigmine|neostigmine|mesh-list
24780698|NCT01885988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24780699|NCT01885988|Adrenergic Agents|adrenergic agents|mesh-ancestor
24780700|NCT01885988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24780701|NCT01885988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780702|NCT01885988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627749|NCT01094821|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24963367|NCT03791515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24627752|NCT01094821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627753|NCT01094821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627754|NCT01094912|Analgesics, Opioid|analgesics, opioid|mesh-list
24627755|NCT01094912|Narcotics|narcotics|mesh-ancestor
24627756|NCT01094912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24627757|NCT01094912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627758|NCT01094912|Analgesics|analgesics|mesh-ancestor
24627759|NCT01094912|Sensory System Agents|sensory system agents|mesh-ancestor
24627760|NCT01094912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24627761|NCT01094925|Gabapentin|gabapentin|mesh-list
24627762|NCT01094925|Analgesics|analgesics|mesh-ancestor
24627763|NCT01094925|Sensory System Agents|sensory system agents|mesh-ancestor
25081967|NCT03325868|Ulipristal acetate|ulipristal acetate|mesh-list
25081968|NCT03325868|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25081969|NCT03325868|Contraceptive Agents|contraceptive agents|mesh-ancestor
25081970|NCT03325868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25081971|NCT03325868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081972|NCT03325868|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25081974|NCT03325803|Prilocaine|prilocaine|mesh-list
25081975|NCT03325803|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25081976|NCT03325803|Anesthetics, Local|anesthetics, local|mesh-ancestor
25081977|NCT03325803|Anesthetics|anesthetics|mesh-ancestor
25081978|NCT03325803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25081979|NCT03325803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081980|NCT03325803|Sensory System Agents|sensory system agents|mesh-ancestor
25081981|NCT03325803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25081982|NCT03325803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25081983|NCT03325803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25081984|NCT03325803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25081985|NCT03325803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24918293|NCT04221529|Atezolizumab|atezolizumab|mesh-list
24439827|NCT00280501|Sulpiride|sulpiride|mesh-list
24488834|NCT00470249|Gemcitabine|gemcitabine|mesh-list
24488839|NCT00470249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488840|NCT00470249|Antiviral Agents|antiviral agents|mesh-ancestor
25081986|NCT03325803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081987|NCT03325803|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25081988|NCT03325790|Ebselen|ebselen|mesh-list
25081989|NCT03325790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24720380|NCT01568125|Incretins|incretins|mesh-list
25081998|NCT03325790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24780704|NCT01886001|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24780705|NCT01886001|Povidone-Iodine|povidone-iodine|mesh-list
24780706|NCT01886001|Povidone|povidone|mesh-list
24780708|NCT01886001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24780710|NCT01886001|Dermatologic Agents|dermatologic agents|mesh-ancestor
24780711|NCT01886001|Plasma Substitutes|plasma substitutes|mesh-ancestor
24780712|NCT01886001|Blood Substitutes|blood substitutes|mesh-ancestor
24780713|NCT01886014|Oxytocin|oxytocin|mesh-list
24780714|NCT01886014|Oxytocics|oxytocics|mesh-ancestor
24780715|NCT01886014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24780716|NCT01886014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780717|NCT01886053|Ertapenem|ertapenem|mesh-list
24780718|NCT01886053|beta-Lactams|beta-lactams|mesh-list
24780719|NCT01886053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24780720|NCT01886053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24780721|NCT01886079|Dexmedetomidine|dexmedetomidine|mesh-list
24780722|NCT01886079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24780723|NCT01886079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24780724|NCT01886079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780725|NCT01886079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24780726|NCT01886079|Analgesics|analgesics|mesh-ancestor
24780727|NCT01886079|Sensory System Agents|sensory system agents|mesh-ancestor
24780728|NCT01886079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24488841|NCT00470249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24488842|NCT00470249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488846|NCT00470314|N-Methylaspartate|n-methylaspartate|mesh-list
24488847|NCT00470314|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
24780729|NCT01886079|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24780730|NCT01886079|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24780731|NCT01886079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24780732|NCT01886079|Adrenergic Agents|adrenergic agents|mesh-ancestor
24780733|NCT01886079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24780734|NCT01886079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780735|NCT01886196|Ibuprofen|ibuprofen|mesh-list
24780736|NCT01886196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
24780737|NCT01886196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24780738|NCT01886196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24780739|NCT01886196|Analgesics|analgesics|mesh-ancestor
24780740|NCT01886196|Sensory System Agents|sensory system agents|mesh-ancestor
24780741|NCT01886196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24780742|NCT01886196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780743|NCT01886196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24780744|NCT01886196|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24780745|NCT01886196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780746|NCT01886196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780747|NCT01886209|Prednisone|prednisone|mesh-list
24780748|NCT01886209|Methylprednisolone|methylprednisolone|mesh-list
24780749|NCT01886209|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24780750|NCT01886209|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24780751|NCT01886209|Prednisolone|prednisolone|mesh-list
24780752|NCT01886209|Prednisolone acetate|prednisolone acetate|mesh-list
24780753|NCT01886209|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24780754|NCT01886209|Prednisolone phosphate|prednisolone phosphate|mesh-list
24780755|NCT01886209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24780756|NCT01886209|Glucocorticoids|glucocorticoids|mesh-ancestor
24780757|NCT01886209|Hormones|hormones|mesh-ancestor
24780758|NCT01886209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24780759|NCT01886209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780771|NCT01886248|Protease Inhibitors|protease inhibitors|mesh-ancestor
24780791|NCT01886404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24780792|NCT01886404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24780793|NCT01886404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24780796|NCT01886404|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24780797|NCT01886404|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24780799|NCT01886443|Vitamin E|vitamin e|mesh-list
24780800|NCT01886443|alpha-Tocopherol|alpha-tocopherol|mesh-list
24780801|NCT01886443|Infliximab|infliximab|mesh-list
24780802|NCT01886443|Epoprostenol|epoprostenol|mesh-list
24780803|NCT01886443|Tezosentan|tezosentan|mesh-list
24780813|NCT01886443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24780814|NCT01886443|Dermatologic Agents|dermatologic agents|mesh-ancestor
24780815|NCT01886443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24780816|NCT01886443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24780817|NCT01886443|Hematinics|hematinics|mesh-ancestor
24780818|NCT01886443|Vitamins|vitamins|mesh-ancestor
24780819|NCT01886443|Micronutrients|micronutrients|mesh-ancestor
24780820|NCT01886443|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24780822|NCT01886443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780823|NCT01886443|Anticoagulants|anticoagulants|mesh-ancestor
24780824|NCT01886443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24780825|NCT01886443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25213482|NCT04608448|Sirolimus|sirolimus|mesh-list
25213483|NCT04608448|Petrolatum|petrolatum|mesh-list
25213484|NCT04608448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24780859|NCT01886638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24780860|NCT01886664|Sevoflurane|sevoflurane|mesh-list
24780861|NCT01886664|Desflurane|desflurane|mesh-list
24780862|NCT01886664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24780863|NCT01886664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24780899|NCT01887184|Adrenergic Agents|adrenergic agents|mesh-ancestor
24780900|NCT01887184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24780901|NCT01887184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780903|NCT01887197|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24780904|NCT01887197|Diuretics|diuretics|mesh-ancestor
24780905|NCT01887197|Natriuretic Agents|natriuretic agents|mesh-ancestor
24780906|NCT01887197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780907|NCT01887223|Timolol|timolol|mesh-list
24780908|NCT01887223|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24780909|NCT01887223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24780910|NCT01887223|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24780911|NCT01887223|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24780912|NCT01887223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24780913|NCT01887223|Adrenergic Agents|adrenergic agents|mesh-ancestor
24488848|NCT00470314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24488849|NCT00470314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24488850|NCT00470314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488851|NCT00470314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488852|NCT00470340|Gemcitabine|gemcitabine|mesh-list
24488853|NCT00470340|Oxaliplatin|oxaliplatin|mesh-list
24488854|NCT00470340|Ethiodized Oil|ethiodized oil|mesh-list
24488855|NCT00470340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488856|NCT00470340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24488857|NCT00470340|Antimetabolites|antimetabolites|mesh-ancestor
24488858|NCT00470340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488859|NCT00470340|Antiviral Agents|antiviral agents|mesh-ancestor
24533507|NCT00644215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489045|NCT00471185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24489046|NCT00471185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489058|NCT00471341|Sensory System Agents|sensory system agents|mesh-ancestor
24489059|NCT00471341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489060|NCT00471341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529624|NCT00627003|Dopamine Agents|dopamine agents|mesh-ancestor
25155306|NCT05426161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24625140|NCT01080612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625141|NCT01080612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24625142|NCT01080612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24756592|NCT01734408|Antacids|antacids|mesh-ancestor
24932136|NCT04082793|Analgesics|analgesics|mesh-ancestor
24932137|NCT04082793|Sensory System Agents|sensory system agents|mesh-ancestor
25155519|NCT05353140|Antithrombins|antithrombins|mesh-ancestor
24671516|NCT01326325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24671517|NCT01326325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671518|NCT01326338|Nitazoxanide|nitazoxanide|mesh-list
24671519|NCT01326338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24671520|NCT01326338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24489061|NCT00471341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24489062|NCT00471341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24489063|NCT00471341|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24489064|NCT00471341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24489065|NCT00471341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780914|NCT01887223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24780915|NCT01887223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780916|NCT01887223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780917|NCT01887223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24780918|NCT01887223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24780919|NCT01887223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24780921|NCT01887249|Clarithromycin|clarithromycin|mesh-list
24780922|NCT01887249|Esomeprazole|esomeprazole|mesh-list
24780923|NCT01887249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25213485|NCT04608448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25213486|NCT04608448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24780924|NCT01887249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24780941|NCT01887301|Sensory System Agents|sensory system agents|mesh-ancestor
24780942|NCT01887301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24780946|NCT01887340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24780947|NCT01887340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24780948|NCT01887340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24780949|NCT01887340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24780950|NCT01887340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780963|NCT01887405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24780964|NCT01887405|Adrenergic Agents|adrenergic agents|mesh-ancestor
24780965|NCT01887405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24780966|NCT01887405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780967|NCT01887405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780968|NCT01887405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24489145|NCT00471549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24489147|NCT00471562|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
24489148|NCT00471562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25213487|NCT04608448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25213488|NCT04608448|Antifungal Agents|antifungal agents|mesh-ancestor
25213489|NCT04608448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25213490|NCT04608448|Immunologic Factors|immunologic factors|mesh-ancestor
25213491|NCT04608448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213493|NCT04608448|Dermatologic Agents|dermatologic agents|mesh-ancestor
25213494|NCT04599075|Insulin|insulin|mesh-list
25213495|NCT04599075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25213496|NCT04599075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25213497|NCT04599075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780978|NCT01887457|Antifungal Agents|antifungal agents|mesh-ancestor
24780979|NCT01887457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24780980|NCT01887457|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24780981|NCT01887457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25678332|NCT01823289|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25678333|NCT01823289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25678334|NCT01823289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678335|NCT01823289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678336|NCT01823289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24406792|NCT00171288|Antimetabolites|antimetabolites|mesh-ancestor
25678337|NCT01823289|Hormone Antagonists|hormone antagonists|mesh-ancestor
25678338|NCT01823289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25678339|NCT01823289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678340|NCT01823289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25678341|NCT01823328|Ketamine|ketamine|mesh-list
25678342|NCT01823328|Etomidate|etomidate|mesh-list
25678343|NCT01823328|Analgesics|analgesics|mesh-ancestor
24671613|NCT01326767|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24671614|NCT01326767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24671615|NCT01326767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24671616|NCT01326767|Tubulin Modulators|tubulin modulators|mesh-ancestor
24671617|NCT01326767|Antimitotic Agents|antimitotic agents|mesh-ancestor
24780982|NCT01887457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780983|NCT01887457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780984|NCT01887457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24780985|NCT01887457|Hormone Antagonists|hormone antagonists|mesh-ancestor
24780986|NCT01887457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24780987|NCT01887457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780988|NCT01887457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24780989|NCT01887561|Dasatinib|dasatinib|mesh-list
24780990|NCT01887561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24780991|NCT01887561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24780992|NCT01887561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918476|NCT04219280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489149|NCT00471562|Vasodilator Agents|vasodilator agents|mesh-ancestor
24489152|NCT00471588|Antioxidants|antioxidants|mesh-ancestor
24489153|NCT00471588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489154|NCT00471588|Protective Agents|protective agents|mesh-ancestor
24489155|NCT00471588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489156|NCT00471588|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24489157|NCT00471588|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24489158|NCT00471588|Dopamine Agonists|dopamine agonists|mesh-ancestor
24489159|NCT00471588|Dopamine Agents|dopamine agents|mesh-ancestor
24489160|NCT00471588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24489161|NCT00471588|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24936191|NCT04043494|Mercaptopurine|mercaptopurine|mesh-list
24849933|NCT02251132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24489270|NCT00471991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24489272|NCT00471991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24489273|NCT00471991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24489274|NCT00471991|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24489275|NCT00471991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24489277|NCT00471991|Hormone Antagonists|hormone antagonists|mesh-ancestor
24489278|NCT00471991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24489279|NCT00471991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489280|NCT00472004|Tibolone|tibolone|mesh-list
24489281|NCT00472004|Estradiol|estradiol|mesh-list
24489282|NCT00472004|Estrogens|estrogens|mesh-ancestor
24780995|NCT01887613|Analgesics|analgesics|mesh-ancestor
24947693|NCT03926962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780996|NCT01887613|Sensory System Agents|sensory system agents|mesh-ancestor
24780997|NCT01887613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24780998|NCT01887613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780999|NCT01887613|Anticonvulsants|anticonvulsants|mesh-ancestor
24781000|NCT01887613|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24781001|NCT01887613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24781002|NCT01887613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24781003|NCT01887613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24781004|NCT01887613|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24781005|NCT01887613|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24781006|NCT01887613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24781007|NCT01887613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781008|NCT01887613|Antimanic Agents|antimanic agents|mesh-ancestor
24781009|NCT01887626|Ticagrelor|ticagrelor|mesh-list
24781010|NCT01887626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24781011|NCT01887626|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24781012|NCT01887626|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24781013|NCT01887626|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24781014|NCT01887626|Purinergic Agents|purinergic agents|mesh-ancestor
24781015|NCT01887626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24781016|NCT01887626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678344|NCT01823328|Sensory System Agents|sensory system agents|mesh-ancestor
25678345|NCT01823328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25678346|NCT01823328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678347|NCT01823328|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25678348|NCT01823328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25678349|NCT01823328|Anesthetics, General|anesthetics, general|mesh-ancestor
25678350|NCT01823328|Anesthetics|anesthetics|mesh-ancestor
25678351|NCT01823328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24853850|NCT02270606|Immunologic Factors|immunologic factors|mesh-ancestor
24853851|NCT02270606|Antidotes|antidotes|mesh-ancestor
24853852|NCT02270606|Protective Agents|protective agents|mesh-ancestor
24534747|NCT00647920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24534748|NCT00647920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24853853|NCT02270606|Vitamin B Complex|vitamin b complex|mesh-ancestor
24853854|NCT02270606|Vitamins|vitamins|mesh-ancestor
24853855|NCT02270606|Micronutrients|micronutrients|mesh-ancestor
24853856|NCT02270749|Vitamin B 12|vitamin b 12|mesh-list
24853857|NCT02270749|Hydroxocobalamin|hydroxocobalamin|mesh-list
24456613|NCT00331825|Olanzapine|olanzapine|mesh-list
24918487|NCT04219046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489409|NCT00473005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489410|NCT00473005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24489439|NCT00473239|Micronutrients|micronutrients|mesh-ancestor
24489440|NCT00473239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489441|NCT00473239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24781017|NCT01887626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781018|NCT01887691|Eszopiclone|eszopiclone|mesh-list
24781019|NCT01887691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24781020|NCT01887691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24781021|NCT01887691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781022|NCT01887704|Aspirin|aspirin|mesh-list
24781023|NCT01887704|Sirolimus|sirolimus|mesh-list
24781024|NCT01887704|Paclitaxel|paclitaxel|mesh-list
24781025|NCT01887704|Everolimus|everolimus|mesh-list
24572950|NCT00817284|Alkylating Agents|alkylating agents|mesh-ancestor
24572951|NCT00817375|Milnacipran|milnacipran|mesh-list
24572952|NCT00817375|Mirtazapine|mirtazapine|mesh-list
24572953|NCT00817375|Sertraline|sertraline|mesh-list
24572954|NCT00817375|Fluoxetine|fluoxetine|mesh-list
24572955|NCT00817375|Paroxetine|paroxetine|mesh-list
24798984|NCT01966289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24798986|NCT01966302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24798987|NCT01966302|Vasodilator Agents|vasodilator agents|mesh-ancestor
24798988|NCT01966341|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24798989|NCT01966341|Laxatives|laxatives|mesh-list
24798990|NCT01966341|Parasympatholytics|parasympatholytics|mesh-list
24798991|NCT01966341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24798992|NCT01966341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25213514|NCT04579367|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
25213515|NCT04579367|Ezetimibe|ezetimibe|mesh-list
25213516|NCT04579367|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25213517|NCT04579367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24798993|NCT01966341|Autonomic Agents|autonomic agents|mesh-ancestor
24798994|NCT01966341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24798995|NCT01966341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489495|NCT00473603|Anticoagulants|anticoagulants|mesh-ancestor
24489496|NCT00473603|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24489497|NCT00473603|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24489498|NCT00473603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489500|NCT00473616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24489501|NCT00473616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24798996|NCT01966484|Succinylcholine|succinylcholine|mesh-list
24798997|NCT01966484|Mivacurium|mivacurium|mesh-list
24798998|NCT01966484|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
24798999|NCT01966484|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25678352|NCT01823328|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25678353|NCT01823328|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25678354|NCT01823328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25678355|NCT01823328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678356|NCT01823328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25678357|NCT01823497|Morphine|morphine|mesh-list
25678358|NCT01823497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25678359|NCT01823497|Narcotics|narcotics|mesh-ancestor
25678360|NCT01823497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25678361|NCT01823497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678362|NCT01823497|Analgesics|analgesics|mesh-ancestor
25678363|NCT01823497|Sensory System Agents|sensory system agents|mesh-ancestor
25678364|NCT01823497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24799000|NCT01966484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24799001|NCT01966484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24799002|NCT01966484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671936|NCT01328470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24671937|NCT01328470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671938|NCT01328470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671939|NCT01328470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24671940|NCT01328470|Autonomic Agents|autonomic agents|mesh-ancestor
24671941|NCT01328470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24671942|NCT01328470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24671943|NCT01328470|Respiratory System Agents|respiratory system agents|mesh-ancestor
24671944|NCT01328470|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24853869|NCT02270788|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24799003|NCT01966484|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24799169|NCT01967524|Anesthetics, Local|anesthetics, local|mesh-ancestor
24799244|NCT01967979|Serotonin Agents|serotonin agents|mesh-ancestor
24799312|NCT01968239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799314|NCT01968395|Antifungal Agents|antifungal agents|mesh-ancestor
24799315|NCT01968395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24799316|NCT01968395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24799317|NCT01968395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799318|NCT01968460|Pramipexole|pramipexole|mesh-list
24799319|NCT01968460|Rasagiline|rasagiline|mesh-list
24799320|NCT01968460|Antioxidants|antioxidants|mesh-ancestor
25082000|NCT03325790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082001|NCT03325790|Protective Agents|protective agents|mesh-ancestor
25082002|NCT03325790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25082003|NCT03325790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25082006|NCT03325686|Vitamins|vitamins|mesh-ancestor
25082007|NCT03325686|Micronutrients|micronutrients|mesh-ancestor
25082008|NCT03325686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082009|NCT03325686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24572962|NCT00817375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24572975|NCT00817375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24572976|NCT00817375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24572977|NCT00817375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24572978|NCT00817375|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24572979|NCT00817375|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24720910|NCT01571414|Ritonavir|ritonavir|mesh-list
24781031|NCT01887704|Mitosis Modulators|mitosis modulators|mesh-ancestor
24781032|NCT01887704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781033|NCT01887704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24781034|NCT01887704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24781035|NCT01887704|Analgesics|analgesics|mesh-ancestor
24781036|NCT01887704|Sensory System Agents|sensory system agents|mesh-ancestor
24781037|NCT01887704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24781038|NCT01887704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781039|NCT01887704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24781040|NCT01887704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24781041|NCT01887704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24781042|NCT01887704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24781043|NCT01887704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24781066|NCT01887795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24781067|NCT01887795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781068|NCT01887795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781069|NCT01887821|Chloroquine|chloroquine|mesh-list
24781070|NCT01887821|Piperaquine|piperaquine|mesh-list
24781072|NCT01887821|Amebicides|amebicides|mesh-ancestor
24781073|NCT01887821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24781074|NCT01887821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25213518|NCT04579367|Antimetabolites|antimetabolites|mesh-ancestor
25213519|NCT04579367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213520|NCT04579367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24781075|NCT01887821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25678365|NCT01823510|Aspirin|aspirin|mesh-list
25678366|NCT01823510|Clopidogrel|clopidogrel|mesh-list
25678367|NCT01823510|Ticagrelor|ticagrelor|mesh-list
25678368|NCT01823510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25678369|NCT01823510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25678370|NCT01823510|Analgesics|analgesics|mesh-ancestor
25678371|NCT01823510|Sensory System Agents|sensory system agents|mesh-ancestor
25678372|NCT01823510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25678373|NCT01823510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678374|NCT01823510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25678375|NCT01823510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25678376|NCT01823510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24781076|NCT01887821|Antimalarials|antimalarials|mesh-ancestor
24781077|NCT01887821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24781079|NCT01887847|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24781080|NCT01887847|Autonomic Agents|autonomic agents|mesh-ancestor
24781081|NCT01887847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24781082|NCT01887847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781083|NCT01887847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24781084|NCT01887847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24781085|NCT01887847|Cholinergic Agents|cholinergic agents|mesh-ancestor
24781086|NCT01887847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24781087|NCT01887847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781088|NCT01887873|Hyaluronic Acid|hyaluronic acid|mesh-list
24781089|NCT01887873|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24781090|NCT01887873|Immunologic Factors|immunologic factors|mesh-ancestor
24781091|NCT01887873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781092|NCT01887873|Viscosupplements|viscosupplements|mesh-ancestor
24781093|NCT01887873|Protective Agents|protective agents|mesh-ancestor
24781095|NCT01887951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24781096|NCT01887951|Narcotics|narcotics|mesh-ancestor
24781097|NCT01887951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24781098|NCT01887951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781099|NCT01887951|Analgesics|analgesics|mesh-ancestor
24781100|NCT01887951|Sensory System Agents|sensory system agents|mesh-ancestor
24781101|NCT01887951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24781103|NCT01888042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24781104|NCT01888042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24781105|NCT01888042|Immunologic Factors|immunologic factors|mesh-ancestor
24489502|NCT00473616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781107|NCT01888107|Risperidone|risperidone|mesh-list
24781108|NCT01888107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24781112|NCT01888107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781113|NCT01888107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24781114|NCT01888107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24781115|NCT01888107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24781116|NCT01888107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24781117|NCT01888107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24781125|NCT01888120|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24781126|NCT01888120|Protective Agents|protective agents|mesh-ancestor
24781127|NCT01888120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24781128|NCT01888120|Analgesics|analgesics|mesh-ancestor
24781129|NCT01888120|Sensory System Agents|sensory system agents|mesh-ancestor
24781130|NCT01888120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24781131|NCT01888224|Isotretinoin|isotretinoin|mesh-list
24781149|NCT01888263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781151|NCT01888263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781152|NCT01888263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24781153|NCT01888263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24781154|NCT01888263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24781155|NCT01888263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24781156|NCT01888263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24781157|NCT01888289|Isotretinoin|isotretinoin|mesh-list
24781158|NCT01888289|Dermatologic Agents|dermatologic agents|mesh-ancestor
24489505|NCT00473707|Oxytocin|oxytocin|mesh-list
24489544|NCT00473980|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24489545|NCT00473980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24781159|NCT01888302|Gemcitabine|gemcitabine|mesh-list
24781162|NCT01888302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24781163|NCT01888302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24781164|NCT01888302|Antimetabolites|antimetabolites|mesh-ancestor
24781165|NCT01888302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781166|NCT01888302|Antiviral Agents|antiviral agents|mesh-ancestor
24781167|NCT01888302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25213521|NCT04579367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25213522|NCT04579367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25213523|NCT04579367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213524|NCT04572763|Venetoclax|venetoclax|mesh-list
24947704|NCT03926663|Bupivacaine|bupivacaine|mesh-list
24781168|NCT01888302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849971|NCT02251171|Ritonavir|ritonavir|mesh-list
24849972|NCT02251171|Tipranavir|tipranavir|mesh-list
24849973|NCT02251171|Rifabutin|rifabutin|mesh-list
24849974|NCT02251171|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24849975|NCT02251171|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24781179|NCT01888354|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24781180|NCT01888354|Hormones|hormones|mesh-ancestor
24781181|NCT01888354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24781182|NCT01888354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781183|NCT01888393|Ivacaftor|ivacaftor|mesh-list
24781184|NCT01888393|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24781185|NCT01888393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24781186|NCT01888393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781188|NCT01888445|Hematinics|hematinics|mesh-ancestor
24781189|NCT01888458|Micafungin|micafungin|mesh-list
24781190|NCT01888458|Antifungal Agents|antifungal agents|mesh-ancestor
24781191|NCT01888458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24781194|NCT01888536|Analgesics|analgesics|mesh-ancestor
24781195|NCT01888536|Sensory System Agents|sensory system agents|mesh-ancestor
24781196|NCT01888536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24781197|NCT01888536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781198|NCT01888536|Anticonvulsants|anticonvulsants|mesh-ancestor
24781206|NCT01888536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24781207|NCT01888536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24781208|NCT01888536|Vasodilator Agents|vasodilator agents|mesh-ancestor
24781219|NCT01888575|Sensory System Agents|sensory system agents|mesh-ancestor
24781220|NCT01888575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24781221|NCT01888575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781222|NCT01888575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24781223|NCT01888575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24781224|NCT01888575|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24781225|NCT01888575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24781226|NCT01888575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781227|NCT01888575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24781228|NCT01888575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24781229|NCT01888575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781230|NCT01888575|Antipyretics|antipyretics|mesh-ancestor
24781231|NCT01888718|Fexofenadine|fexofenadine|mesh-list
24781232|NCT01888718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24781233|NCT01888718|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24936241|NCT04042948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781234|NCT01888718|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24781235|NCT01888718|Histamine Antagonists|histamine antagonists|mesh-ancestor
24781236|NCT01888718|Histamine Agents|histamine agents|mesh-ancestor
24781237|NCT01888718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24550687|NCT00721747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24781238|NCT01888718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781239|NCT01888718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781240|NCT01888731|Lamotrigine|lamotrigine|mesh-list
24781241|NCT01888731|Anticonvulsants|anticonvulsants|mesh-ancestor
24781242|NCT01888731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24781243|NCT01888731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24781244|NCT01888731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781245|NCT01888731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24781246|NCT01888731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781247|NCT01888731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25082010|NCT03325491|Acipimox|acipimox|mesh-list
25082011|NCT03325491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24799327|NCT01968460|Dopamine Agents|dopamine agents|mesh-ancestor
24799328|NCT01968460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24902316|NCT04374929|Hormones|hormones|mesh-ancestor
24420843|NCT00216892|Calcipotriene|calcipotriene|mesh-list
24799329|NCT01968460|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25213525|NCT04572763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25213526|NCT04551495|Letrozole|letrozole|mesh-list
25213527|NCT04551495|Goserelin|goserelin|mesh-list
25213528|NCT04551495|Entrectinib|entrectinib|mesh-list
25213529|NCT04551495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25213530|NCT04551495|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24799330|NCT01968460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24799331|NCT01968460|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24799332|NCT01968486|Ranibizumab|ranibizumab|mesh-list
24799333|NCT01968486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24799334|NCT01968486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24799335|NCT01968486|Growth Substances|growth substances|mesh-ancestor
24799336|NCT01968486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799337|NCT01968486|Growth Inhibitors|growth inhibitors|mesh-ancestor
24799338|NCT01968486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24593207|NCT00927498|Antiviral Agents|antiviral agents|mesh-ancestor
24593208|NCT00927498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24799339|NCT01968564|Curcumin|curcumin|mesh-list
24799667|NCT01970072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24799668|NCT01970072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24799669|NCT01970072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24799670|NCT01970072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24799671|NCT01970072|Anesthetics, General|anesthetics, general|mesh-ancestor
25082014|NCT03325491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25082015|NCT03325465|Pembrolizumab|pembrolizumab|mesh-list
25082016|NCT03325465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25082017|NCT03325465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25082018|NCT03325413|Anesthetics|anesthetics|mesh-list
25082019|NCT03325413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25082020|NCT03325413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082021|NCT03325400|Fluorides|fluorides|mesh-list
25082022|NCT03325400|Cariostatic Agents|cariostatic agents|mesh-ancestor
25082023|NCT03325400|Protective Agents|protective agents|mesh-ancestor
25082024|NCT03325400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082025|NCT03325348|Labetalol|labetalol|mesh-list
25082026|NCT03325348|Nifedipine|nifedipine|mesh-list
25082027|NCT03325348|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25082028|NCT03325348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25082029|NCT03325348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082030|NCT03325348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25082031|NCT03325348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082032|NCT03325348|Vasodilator Agents|vasodilator agents|mesh-ancestor
25082033|NCT03325348|Tocolytic Agents|tocolytic agents|mesh-ancestor
25082034|NCT03325348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24781266|NCT01888757|Anticonvulsants|anticonvulsants|mesh-ancestor
24781267|NCT01888757|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24781268|NCT01888757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24781269|NCT01888757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781270|NCT01888757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24781271|NCT01888757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781272|NCT01888757|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24781273|NCT01888757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24781274|NCT01888757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24781275|NCT01888757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24781276|NCT01888757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24781277|NCT01888796|Linagliptin|linagliptin|mesh-list
24781278|NCT01888796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24781279|NCT01888796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781280|NCT01888796|Incretins|incretins|mesh-ancestor
24781281|NCT01888796|Hormones|hormones|mesh-ancestor
24936243|NCT04043195|Oxaliplatin|oxaliplatin|mesh-list
24781282|NCT01888796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24781283|NCT01888796|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24781284|NCT01888796|Protease Inhibitors|protease inhibitors|mesh-ancestor
24781285|NCT01888796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781286|NCT01888796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781287|NCT01888822|Ciprofloxacin|ciprofloxacin|mesh-list
24781288|NCT01888822|Ampicillin|ampicillin|mesh-list
24781289|NCT01888822|Sulbactam|sulbactam|mesh-list
24781290|NCT01888822|Sultamicillin|sultamicillin|mesh-list
24781291|NCT01888822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24781292|NCT01888822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24781293|NCT01888822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24781294|NCT01888822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25678377|NCT01823510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24932298|NCT04081012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781295|NCT01888822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25213531|NCT04551495|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24781326|NCT01888861|Vitamin B Complex|vitamin b complex|mesh-ancestor
24781327|NCT01888861|Vitamins|vitamins|mesh-ancestor
24781328|NCT01888861|Micronutrients|micronutrients|mesh-ancestor
24781329|NCT01888978|Leucovorin|leucovorin|mesh-list
24781330|NCT01888978|Gemcitabine|gemcitabine|mesh-list
24781331|NCT01888978|Fluorouracil|fluorouracil|mesh-list
24781332|NCT01888978|Docetaxel|docetaxel|mesh-list
24781333|NCT01888978|Oxaliplatin|oxaliplatin|mesh-list
24781334|NCT01888978|Irinotecan|irinotecan|mesh-list
24781335|NCT01888978|Levoleucovorin|levoleucovorin|mesh-list
24781336|NCT01888978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24781340|NCT01888978|Antiviral Agents|antiviral agents|mesh-ancestor
24721249|NCT01572688|Melphalan|melphalan|mesh-list
24781355|NCT01888978|Micronutrients|micronutrients|mesh-ancestor
24781356|NCT01889004|Dexmedetomidine|dexmedetomidine|mesh-list
24781357|NCT01889004|Propofol|propofol|mesh-list
24781358|NCT01889004|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24781362|NCT01889004|Anesthetics, General|anesthetics, general|mesh-ancestor
24781363|NCT01889004|Anesthetics|anesthetics|mesh-ancestor
24781364|NCT01889004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24781365|NCT01889004|Analgesics|analgesics|mesh-ancestor
24781367|NCT01889004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24781368|NCT01889004|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24781369|NCT01889004|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24781370|NCT01889004|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24781384|NCT01889173|Antidepressive Agents|antidepressive agents|mesh-ancestor
24781385|NCT01889173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24781386|NCT01889173|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24781387|NCT01889173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781388|NCT01889173|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24781389|NCT01889173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24781390|NCT01889173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24781391|NCT01889173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24781392|NCT01889212|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24781393|NCT01889212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24781394|NCT01889212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24781395|NCT01889212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781396|NCT01889212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781397|NCT01889290|Methylnaltrexone|methylnaltrexone|mesh-list
24781398|NCT01889290|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24781399|NCT01889290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781400|NCT01889290|Sensory System Agents|sensory system agents|mesh-ancestor
24781401|NCT01889290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24781402|NCT01889368|Grape Seed Extract|grape seed extract|mesh-list
24781403|NCT01889368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24781404|NCT01889368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24781405|NCT01889368|Antioxidants|antioxidants|mesh-ancestor
24573271|NCT00819065|Botulinum Toxins|botulinum toxins|mesh-list
24781406|NCT01889368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621052|NCT01060501|Antidotes|antidotes|mesh-ancestor
24621053|NCT01060501|Protective Agents|protective agents|mesh-ancestor
24621054|NCT01060501|Vitamin B Complex|vitamin b complex|mesh-ancestor
24621056|NCT01060501|Micronutrients|micronutrients|mesh-ancestor
24621057|NCT01060501|Hematinics|hematinics|mesh-ancestor
25082040|NCT03325348|Sympathomimetics|sympathomimetics|mesh-ancestor
24621058|NCT01060514|Vinorelbine|vinorelbine|mesh-list
24621059|NCT01060514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24621086|NCT01060618|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24621087|NCT01060631|Propofol|propofol|mesh-list
24621088|NCT01060631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24621089|NCT01060631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24781407|NCT01889368|Protective Agents|protective agents|mesh-ancestor
24781408|NCT01889368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781409|NCT01889407|Idarubicin|idarubicin|mesh-list
24781410|NCT01889407|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25213532|NCT04551495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25213533|NCT04551495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213534|NCT04551495|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25213535|NCT04551495|Hormone Antagonists|hormone antagonists|mesh-ancestor
24551328|NCT00725400|Cetuximab|cetuximab|mesh-list
25678378|NCT01823510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781411|NCT01889407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24781412|NCT01889407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24781413|NCT01889407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24781414|NCT01889407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781415|NCT01889407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781416|NCT01889433|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24781417|NCT01889433|Antiviral Agents|antiviral agents|mesh-ancestor
24781418|NCT01889433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24781420|NCT01889446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24573861|NCT00822380|Iron|iron|mesh-list
24781421|NCT01889446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781424|NCT01889498|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24781426|NCT01889498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781463|NCT01889771|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24781464|NCT01889771|Autonomic Agents|autonomic agents|mesh-ancestor
24781465|NCT01889771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24781466|NCT01889771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760740|NCT01759732|Alkylating Agents|alkylating agents|mesh-ancestor
24936297|NCT04042714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24936298|NCT04042233|Vancomycin|vancomycin|mesh-list
24936299|NCT04042233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24936300|NCT04042233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24936301|NCT04041934|Tryptophan|tryptophan|mesh-list
24850003|NCT02251184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781467|NCT01889771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24781468|NCT01889771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24781469|NCT01889771|Cholinergic Agents|cholinergic agents|mesh-ancestor
24781470|NCT01889771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24781471|NCT01889771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781473|NCT01889810|Cholecalciferol|cholecalciferol|mesh-list
24781474|NCT01889810|Vitamins|vitamins|mesh-ancestor
24781475|NCT01889810|Micronutrients|micronutrients|mesh-ancestor
24781483|NCT01889914|Insulin|insulin|mesh-list
24781484|NCT01889914|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24781485|NCT01889914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25082042|NCT03325348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082043|NCT03325348|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25082044|NCT03325348|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25082045|NCT03325335|Midazolam|midazolam|mesh-list
25082046|NCT03325335|Remifentanil|remifentanil|mesh-list
25082047|NCT03325335|Propofol|propofol|mesh-list
25082048|NCT03325335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25082049|NCT03325335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25082050|NCT03325335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082051|NCT03325335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25082052|NCT03325335|Anesthetics, General|anesthetics, general|mesh-ancestor
25082053|NCT03325335|Anesthetics|anesthetics|mesh-ancestor
25082054|NCT03325335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25082055|NCT03325335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25082056|NCT03325335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24799697|NCT01970358|Poly ICLC|poly iclc|mesh-list
24781495|NCT01889979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24781496|NCT01889979|Narcotics|narcotics|mesh-ancestor
24573925|NCT00822549|Morphine|morphine|mesh-list
24781497|NCT01889979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24781528|NCT01890200|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24781529|NCT01890200|Antimetabolites|antimetabolites|mesh-ancestor
24781530|NCT01890200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781531|NCT01890200|Antiviral Agents|antiviral agents|mesh-ancestor
24781532|NCT01890200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24781533|NCT01890408|Ropivacaine|ropivacaine|mesh-list
24781534|NCT01890408|Anesthetics, Local|anesthetics, local|mesh-ancestor
24781535|NCT01890408|Anesthetics|anesthetics|mesh-ancestor
24781536|NCT01890408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24781537|NCT01890408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781538|NCT01890408|Sensory System Agents|sensory system agents|mesh-ancestor
24781539|NCT01890408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24781540|NCT01890538|Dimenhydrinate|dimenhydrinate|mesh-list
24781541|NCT01890538|Piracetam|piracetam|mesh-list
24781551|NCT01890538|Histamine Antagonists|histamine antagonists|mesh-ancestor
24781552|NCT01890538|Histamine Agents|histamine agents|mesh-ancestor
24781553|NCT01890538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24781554|NCT01890538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781555|NCT01890629|Metformin|metformin|mesh-list
25213536|NCT04551495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25213537|NCT04551495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781557|NCT01890629|Glimepiride|glimepiride|mesh-list
24781558|NCT01890629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24781559|NCT01890629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781560|NCT01890629|Incretins|incretins|mesh-ancestor
24781561|NCT01890629|Hormones|hormones|mesh-ancestor
24781562|NCT01890629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24781563|NCT01890629|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24781564|NCT01890629|Protease Inhibitors|protease inhibitors|mesh-ancestor
24781565|NCT01890629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781566|NCT01890629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781569|NCT01890629|Immunologic Factors|immunologic factors|mesh-ancestor
24781570|NCT01890772|Vitamin D|vitamin d|mesh-list
24781571|NCT01890772|Ribavirin|ribavirin|mesh-list
24781572|NCT01890772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24781573|NCT01890772|Vitamins|vitamins|mesh-ancestor
24781574|NCT01890772|Micronutrients|micronutrients|mesh-ancestor
24781575|NCT01890772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781595|NCT01890863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24781596|NCT01890863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24781597|NCT01890863|Adrenergic Agents|adrenergic agents|mesh-ancestor
24781598|NCT01890863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25082057|NCT03325335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25082058|NCT03325335|GABA Modulators|gaba modulators|mesh-ancestor
24799698|NCT01970358|Interferon Inducers|interferon inducers|mesh-ancestor
24781599|NCT01890863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781600|NCT01890863|Glucocorticoids|glucocorticoids|mesh-ancestor
24781601|NCT01890863|Hormones|hormones|mesh-ancestor
24781602|NCT01890863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24781603|NCT01890863|Sympathomimetics|sympathomimetics|mesh-ancestor
24781604|NCT01890889|Ezetimibe|ezetimibe|mesh-list
24781605|NCT01890889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24781606|NCT01890889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24781607|NCT01890889|Antimetabolites|antimetabolites|mesh-ancestor
24781608|NCT01890889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781609|NCT01890889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24781610|NCT01890902|Ketoprofen|ketoprofen|mesh-list
24781611|NCT01890902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24781612|NCT01890902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24781613|NCT01890902|Analgesics|analgesics|mesh-ancestor
24781614|NCT01890902|Sensory System Agents|sensory system agents|mesh-ancestor
24781615|NCT01890902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24919205|NCT04213781|Analgesics|analgesics|mesh-ancestor
24781627|NCT01890993|Incretins|incretins|mesh-ancestor
24781628|NCT01890993|Hormones|hormones|mesh-ancestor
24781629|NCT01890993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24781630|NCT01891019|Thalidomide|thalidomide|mesh-list
24781631|NCT01891019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24781632|NCT01891019|Immunologic Factors|immunologic factors|mesh-ancestor
24781633|NCT01891019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781652|NCT01891084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24489561|NCT00474019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24489562|NCT00474019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489563|NCT00474071|Remifentanil|remifentanil|mesh-list
24489564|NCT00474071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24489565|NCT00474071|Narcotics|narcotics|mesh-ancestor
24489581|NCT00474110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24489582|NCT00474110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24489583|NCT00474110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24489584|NCT00474110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24489585|NCT00474110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489586|NCT00474110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24489588|NCT00474136|Diclofenac|diclofenac|mesh-list
24489589|NCT00474136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24489590|NCT00474136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24489591|NCT00474136|Analgesics|analgesics|mesh-ancestor
24489597|NCT00474136|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24781653|NCT01891084|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24781655|NCT01891084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781657|NCT01891175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24781658|NCT01891175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781659|NCT01891201|Oxytocin|oxytocin|mesh-list
24781660|NCT01891201|Oxytocics|oxytocics|mesh-ancestor
24781661|NCT01891201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24781662|NCT01891201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781663|NCT01891227|Capecitabine|capecitabine|mesh-list
24781664|NCT01891227|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24781665|NCT01891227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24781666|NCT01891227|Antimetabolites|antimetabolites|mesh-ancestor
24781667|NCT01891227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781668|NCT01891227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24721594|NCT01575717|Vitamins|vitamins|mesh-list
24489704|NCT00474916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489706|NCT00474916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24489707|NCT00474916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489708|NCT00475059|Cimetidine|cimetidine|mesh-list
24489709|NCT00475059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24489754|NCT00475189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489755|NCT00475189|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24489756|NCT00475189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24489757|NCT00475189|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
24489758|NCT00475189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24489759|NCT00475189|Estrogens|estrogens|mesh-ancestor
24489760|NCT00475189|Hormones|hormones|mesh-ancestor
24489761|NCT00475189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24489762|NCT00475293|Panitumumab|panitumumab|mesh-list
24489763|NCT00475293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489772|NCT00475358|Analgesics|analgesics|mesh-ancestor
25082059|NCT03325335|GABA Agents|gaba agents|mesh-ancestor
24781671|NCT01891292|Acetylcysteine|acetylcysteine|mesh-list
24781672|NCT01891292|Enalapril|enalapril|mesh-list
24781673|NCT01891292|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24781674|NCT01891292|Antiviral Agents|antiviral agents|mesh-ancestor
24781675|NCT01891292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24573532|NCT00820547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24573605|NCT00821028|Mitosis Modulators|mitosis modulators|mesh-ancestor
24573606|NCT00821028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573608|NCT00821054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24573609|NCT00821054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24573610|NCT00821054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573611|NCT00821054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573612|NCT00821080|Sirolimus|sirolimus|mesh-list
24573613|NCT00821080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24721673|NCT01576315|Voriconazole|voriconazole|mesh-list
24621113|NCT01060696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24621114|NCT01060696|Cholinergic Agents|cholinergic agents|mesh-ancestor
24621115|NCT01060696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24781676|NCT01891292|Expectorants|expectorants|mesh-ancestor
24781677|NCT01891292|Respiratory System Agents|respiratory system agents|mesh-ancestor
24781678|NCT01891292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24781679|NCT01891292|Antioxidants|antioxidants|mesh-ancestor
24781680|NCT01891292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781681|NCT01891292|Protective Agents|protective agents|mesh-ancestor
24781682|NCT01891292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781683|NCT01891292|Antidotes|antidotes|mesh-ancestor
24781692|NCT01891435|Sensory System Agents|sensory system agents|mesh-ancestor
24781693|NCT01891435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24781703|NCT01891461|Coagulants|coagulants|mesh-ancestor
24781705|NCT01891487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24781706|NCT01891500|Nitric Oxide|nitric oxide|mesh-list
24781707|NCT01891500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24781708|NCT01891500|Autonomic Agents|autonomic agents|mesh-ancestor
24781709|NCT01891500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24781710|NCT01891500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781711|NCT01891500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24781712|NCT01891500|Respiratory System Agents|respiratory system agents|mesh-ancestor
24781713|NCT01891500|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24781714|NCT01891500|Antioxidants|antioxidants|mesh-ancestor
24781715|NCT01891500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781716|NCT01891500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24781717|NCT01891500|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24781718|NCT01891500|Vasodilator Agents|vasodilator agents|mesh-ancestor
24781719|NCT01891500|Gasotransmitters|gasotransmitters|mesh-ancestor
24781720|NCT01891500|Protective Agents|protective agents|mesh-ancestor
24781722|NCT01891513|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24781723|NCT01891513|Perindopril|perindopril|mesh-list
24781724|NCT01891513|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24781725|NCT01891513|Diuretics|diuretics|mesh-list
24781726|NCT01891513|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
24781727|NCT01891513|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24781728|NCT01891513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24674125|NCT01342198|Erythromycin Estolate|erythromycin estolate|mesh-list
24674126|NCT01342198|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24674127|NCT01342198|Erythromycin stearate|erythromycin stearate|mesh-list
24674128|NCT01342198|Pregabalin|pregabalin|mesh-list
24674129|NCT01342198|Analgesics|analgesics|mesh-ancestor
24674171|NCT01342237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24674172|NCT01342237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24674173|NCT01342237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674199|NCT01342289|Antitubercular Agents|antitubercular agents|mesh-ancestor
24674200|NCT01342289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24674201|NCT01342289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24674214|NCT01342328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24781729|NCT01891513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24781730|NCT01891513|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24781836|NCT01892332|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24781731|NCT01891513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781732|NCT01891513|Natriuretic Agents|natriuretic agents|mesh-ancestor
24781733|NCT01891513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781734|NCT01891513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24781735|NCT01891513|Protease Inhibitors|protease inhibitors|mesh-ancestor
24781736|NCT01891513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781737|NCT01891526|Tretinoin|tretinoin|mesh-list
24781738|NCT01891526|Alitretinoin|alitretinoin|mesh-list
24781741|NCT01891526|Keratolytic Agents|keratolytic agents|mesh-ancestor
24781742|NCT01891526|Dermatologic Agents|dermatologic agents|mesh-ancestor
24781743|NCT01891643|Dexamethasone|dexamethasone|mesh-list
24781744|NCT01891643|Dexamethasone acetate|dexamethasone acetate|mesh-list
24781745|NCT01891643|Lenalidomide|lenalidomide|mesh-list
24781747|NCT01891643|BB 1101|bb 1101|mesh-list
24781748|NCT01891643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24781749|NCT01891643|Antiemetics|antiemetics|mesh-ancestor
24781750|NCT01891643|Autonomic Agents|autonomic agents|mesh-ancestor
24533746|NCT00645060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24533747|NCT00645060|Immunologic Factors|immunologic factors|mesh-ancestor
24533748|NCT00645060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781751|NCT01891643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24781752|NCT01891643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781753|NCT01891643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24781754|NCT01891643|Glucocorticoids|glucocorticoids|mesh-ancestor
24781755|NCT01891643|Hormones|hormones|mesh-ancestor
24781756|NCT01891643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24781757|NCT01891643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24781758|NCT01891643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24781759|NCT01891643|Protease Inhibitors|protease inhibitors|mesh-ancestor
24781760|NCT01891643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781761|NCT01891643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781764|NCT01891643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24781765|NCT01891643|Growth Substances|growth substances|mesh-ancestor
24489841|NCT00475553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24781769|NCT01891708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24781770|NCT01891708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24781771|NCT01891708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24781773|NCT01891708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799699|NCT01970358|Immunologic Factors|immunologic factors|mesh-ancestor
24799700|NCT01970358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796748|NCT01951872|Purinergic Agents|purinergic agents|mesh-ancestor
24781776|NCT01891812|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24781785|NCT01891851|Ritonavir|ritonavir|mesh-list
24781786|NCT01891851|Simeprevir|simeprevir|mesh-list
25678379|NCT01823510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25678380|NCT01823510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25678381|NCT01823510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678382|NCT01823510|Antipyretics|antipyretics|mesh-ancestor
25678383|NCT01823510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25678384|NCT01823510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25678385|NCT01823510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25678386|NCT01823510|Purinergic Agents|purinergic agents|mesh-ancestor
25678387|NCT01823510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25678388|NCT01823679|Capecitabine|capecitabine|mesh-list
25678389|NCT01823679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25678390|NCT01823679|Antimetabolites|antimetabolites|mesh-ancestor
25692415|NCT01999335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24533749|NCT00645073|Levofloxacin|levofloxacin|mesh-list
24854051|NCT02271464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24854052|NCT02271464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24674463|NCT05211024|Penicillin G Procaine|penicillin g procaine|mesh-list
24674464|NCT05211024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24674465|NCT05211024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24674467|NCT05198128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24674468|NCT05198128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674469|NCT05193396|Hydrocortisone|hydrocortisone|mesh-list
24519301|NCT02437279|Ipilimumab|ipilimumab|mesh-list
24462931|NCT00357981|Ortho Evra|ortho evra|mesh-list
24781787|NCT01891851|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24781788|NCT01891851|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24781789|NCT01891851|Protease Inhibitors|protease inhibitors|mesh-ancestor
24781790|NCT01891851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781791|NCT01891851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781792|NCT01891851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24781793|NCT01891851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24781794|NCT01891851|Antiviral Agents|antiviral agents|mesh-ancestor
24781795|NCT01891851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24781796|NCT01891851|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24781797|NCT01891851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24781798|NCT01891916|Caseins|caseins|mesh-list
24781799|NCT01891916|Chelating Agents|chelating agents|mesh-ancestor
24781800|NCT01891916|Sequestering Agents|sequestering agents|mesh-ancestor
24781801|NCT01891916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781802|NCT01891981|Immunotoxin HA22|immunotoxin ha22|mesh-list
24781803|NCT01891981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24781804|NCT01892098|Zinc Sulfate|zinc sulfate|mesh-list
24781805|NCT01892098|Astringents|astringents|mesh-ancestor
24781825|NCT01892319|Insulin Detemir|insulin detemir|mesh-list
24781826|NCT01892319|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24781827|NCT01892319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781828|NCT01892332|Lidocaine|lidocaine|mesh-list
24781829|NCT01892332|Fentanyl|fentanyl|mesh-list
24781830|NCT01892332|Anesthetics, Local|anesthetics, local|mesh-ancestor
24781831|NCT01892332|Anesthetics|anesthetics|mesh-ancestor
24781832|NCT01892332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24781833|NCT01892332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781834|NCT01892332|Sensory System Agents|sensory system agents|mesh-ancestor
24781835|NCT01892332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24781837|NCT01892332|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24781838|NCT01892332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24781839|NCT01892332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24919395|NCT04212078|Cefuroxime|cefuroxime|mesh-list
24489843|NCT00475553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24489844|NCT00475553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24489845|NCT00475553|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24489846|NCT00475553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24489847|NCT00475553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24489848|NCT00475553|Progestins|progestins|mesh-ancestor
24489849|NCT00475566|Everolimus|everolimus|mesh-list
24489850|NCT00475566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440818|NCT00284947|Prednisone|prednisone|mesh-list
24489851|NCT00475566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24489852|NCT00475566|Immunologic Factors|immunologic factors|mesh-ancestor
24489931|NCT00475956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213551|NCT04494880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213552|NCT04494880|Sensory System Agents|sensory system agents|mesh-ancestor
25213553|NCT04494880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25213554|NCT04489888|Paclitaxel|paclitaxel|mesh-list
24489933|NCT00475969|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24489934|NCT00475969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24781840|NCT01892332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678391|NCT01823679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678392|NCT01823679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678393|NCT01823835|Palbociclib|palbociclib|mesh-list
25678394|NCT01823835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678395|NCT01823835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25678396|NCT01823835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678397|NCT01823835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678398|NCT01824290|Tadalafil|tadalafil|mesh-list
25678399|NCT01824290|Vasodilator Agents|vasodilator agents|mesh-ancestor
24781841|NCT01892332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24781842|NCT01892332|Narcotics|narcotics|mesh-ancestor
24781843|NCT01892332|Analgesics|analgesics|mesh-ancestor
24781844|NCT01892332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24781853|NCT01892488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25082061|NCT03325335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781854|NCT01892488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24781855|NCT01892488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781856|NCT01892488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781860|NCT01892618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24781861|NCT01892618|Immunologic Factors|immunologic factors|mesh-ancestor
24781862|NCT01892618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781864|NCT01892644|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24781866|NCT01892644|Sequestering Agents|sequestering agents|mesh-ancestor
24781867|NCT01892644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781868|NCT01892683|Propofol|propofol|mesh-list
24781869|NCT01892683|Anesthetics|anesthetics|mesh-ancestor
24919421|NCT04211961|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24489935|NCT00475969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24489939|NCT00475969|Analgesics|analgesics|mesh-ancestor
24490075|NCT00476268|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24490076|NCT00476268|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24490077|NCT00476268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24490078|NCT00476268|Adrenergic Agents|adrenergic agents|mesh-ancestor
24441105|NCT00286117|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24781870|NCT01892683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24781871|NCT01892683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781872|NCT01892683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24781873|NCT01892683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24781874|NCT01892683|Anesthetics, General|anesthetics, general|mesh-ancestor
24781875|NCT01892748|Vitamin D|vitamin d|mesh-list
24781876|NCT01892748|Cholecalciferol|cholecalciferol|mesh-list
24781877|NCT01892748|Vitamins|vitamins|mesh-ancestor
24781878|NCT01892748|Micronutrients|micronutrients|mesh-ancestor
24781879|NCT01892748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781880|NCT01892748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24781881|NCT01892748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24781882|NCT01892787|Formoterol Fumarate|formoterol fumarate|mesh-list
24781883|NCT01892787|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24781884|NCT01892787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24781885|NCT01892787|Autonomic Agents|autonomic agents|mesh-ancestor
24781886|NCT01892787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24781887|NCT01892787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781888|NCT01892787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24781889|NCT01892787|Respiratory System Agents|respiratory system agents|mesh-ancestor
24781890|NCT01892787|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24781891|NCT01892787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24781892|NCT01892787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24490091|NCT00476346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24490094|NCT00476359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24490137|NCT00476515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490139|NCT00476541|Gemtuzumab|gemtuzumab|mesh-list
25213555|NCT04489888|Carboplatin|carboplatin|mesh-list
25213556|NCT04489888|Pembrolizumab|pembrolizumab|mesh-list
25213557|NCT04489888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25213558|NCT04489888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490140|NCT00476541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24490141|NCT00476541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24781901|NCT01892813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24781902|NCT01892813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781903|NCT01892813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24781904|NCT01892813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24781905|NCT01892813|Cholinergic Agents|cholinergic agents|mesh-ancestor
24781906|NCT01892813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24781907|NCT01892813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781908|NCT01892813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24781909|NCT01892813|Antidepressive Agents|antidepressive agents|mesh-ancestor
24781910|NCT01892813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24781911|NCT01892813|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24781912|NCT01892813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24781913|NCT01892813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24781914|NCT01892813|Dopamine Agents|dopamine agents|mesh-ancestor
24781915|NCT01892813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24781916|NCT01892813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24781917|NCT01892813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781918|NCT01892839|Dialysis Solutions|dialysis solutions|mesh-list
24781919|NCT01892839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24781921|NCT01892995|Analgesics|analgesics|mesh-ancestor
24781922|NCT01892995|Sensory System Agents|sensory system agents|mesh-ancestor
24936364|NCT04041362|Antiviral Agents|antiviral agents|mesh-ancestor
24781923|NCT01892995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24781924|NCT01892995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781925|NCT01892995|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24781926|NCT01892995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24781927|NCT01892995|Anesthetics, General|anesthetics, general|mesh-ancestor
25082062|NCT03325335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24627792|NCT01094964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24627793|NCT01094977|Tranexamic Acid|tranexamic acid|mesh-list
24627794|NCT01094977|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24627795|NCT01094977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24919467|NCT04211805|Tenofovir|tenofovir|mesh-list
24490202|NCT00477035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490249|NCT00477126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24627796|NCT01094977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627797|NCT01094977|Hemostatics|hemostatics|mesh-ancestor
24627798|NCT01094977|Coagulants|coagulants|mesh-ancestor
24627799|NCT01094990|Dexamethasone|dexamethasone|mesh-list
24799701|NCT01970449|Vaccines|vaccines|mesh-list
24799849|NCT01971632|Oxycodone|oxycodone|mesh-list
24799925|NCT01972113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799926|NCT01972113|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24799927|NCT01972113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24799928|NCT01972113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799929|NCT01972113|Hemostatics|hemostatics|mesh-ancestor
24799930|NCT01972113|Coagulants|coagulants|mesh-ancestor
24627800|NCT01094990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24627801|NCT01094990|Antiemetics|antiemetics|mesh-ancestor
24627802|NCT01094990|Autonomic Agents|autonomic agents|mesh-ancestor
24936387|NCT04041167|Vitamins|vitamins|mesh-ancestor
24573837|NCT00822263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24573838|NCT00822263|Antioxidants|antioxidants|mesh-ancestor
24781933|NCT01892995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781934|NCT01893060|Chlorhexidine|chlorhexidine|mesh-list
24781935|NCT01893060|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24781936|NCT01893060|Povidone-Iodine|povidone-iodine|mesh-list
24781938|NCT01893060|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24781939|NCT01893060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24781940|NCT01893060|Disinfectants|disinfectants|mesh-ancestor
24490250|NCT00477126|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24781941|NCT01893060|Dermatologic Agents|dermatologic agents|mesh-ancestor
24781942|NCT01893060|Plasma Substitutes|plasma substitutes|mesh-ancestor
25213559|NCT04489888|Tubulin Modulators|tubulin modulators|mesh-ancestor
25213560|NCT04489888|Antimitotic Agents|antimitotic agents|mesh-ancestor
25157345|NCT04748809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25157346|NCT04745234|Mogamulizumab|mogamulizumab|mesh-list
24947770|NCT03925818|Bismuth|bismuth|mesh-list
24781943|NCT01893060|Blood Substitutes|blood substitutes|mesh-ancestor
24781945|NCT01893099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24781946|NCT01893099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24781947|NCT01893099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781948|NCT01893099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781949|NCT01893177|Vaccines|vaccines|mesh-list
25082063|NCT03325335|Narcotics|narcotics|mesh-ancestor
25082064|NCT03325335|Analgesics|analgesics|mesh-ancestor
25082065|NCT03325335|Sensory System Agents|sensory system agents|mesh-ancestor
25082066|NCT03325335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082067|NCT03325270|Ferrous fumarate|ferrous fumarate|mesh-list
25082068|NCT03325270|Trace Elements|trace elements|mesh-ancestor
25082069|NCT03325270|Micronutrients|micronutrients|mesh-ancestor
25082070|NCT03325270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082078|NCT03325127|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25082079|NCT03325127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25082080|NCT03324867|Insulin|insulin|mesh-list
25082081|NCT03324867|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25082082|NCT03324867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25082083|NCT03324867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082084|NCT03324828|Hydroxyzine|hydroxyzine|mesh-list
25082085|NCT03324828|Antipruritics|antipruritics|mesh-ancestor
25082086|NCT03324828|Dermatologic Agents|dermatologic agents|mesh-ancestor
25082087|NCT03324828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24781981|NCT01893229|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24781982|NCT01893229|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25213562|NCT04489888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213563|NCT04489888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25157347|NCT04745234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25157348|NCT04743934|Androgens|androgens|mesh-list
25157349|NCT04743934|Hormones|hormones|mesh-ancestor
24781983|NCT01893229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24781984|NCT01893229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24781985|NCT01893294|Gemcitabine|gemcitabine|mesh-list
24781986|NCT01893294|Fluorouracil|fluorouracil|mesh-list
24781987|NCT01893294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24781988|NCT01893294|Antimetabolites|antimetabolites|mesh-ancestor
24781989|NCT01893294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936401|NCT04040491|Immunologic Factors|immunologic factors|mesh-ancestor
24850132|NCT02251795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24781990|NCT01893294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24781991|NCT01893294|Antiviral Agents|antiviral agents|mesh-ancestor
24781992|NCT01893294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24781993|NCT01893294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781994|NCT01893294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24781995|NCT01893294|Immunologic Factors|immunologic factors|mesh-ancestor
24781996|NCT01893294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781997|NCT01893385|Vitamin D|vitamin d|mesh-list
24781998|NCT01893385|Vitamins|vitamins|mesh-ancestor
24781999|NCT01893385|Micronutrients|micronutrients|mesh-ancestor
24782000|NCT01893385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782001|NCT01893385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24782002|NCT01893424|Dronabinol|dronabinol|mesh-list
24782003|NCT01893424|Nabiximols|nabiximols|mesh-list
24782004|NCT01893424|Cannabidiol|cannabidiol|mesh-list
24782006|NCT01893424|Anticonvulsants|anticonvulsants|mesh-ancestor
24782007|NCT01893424|Hallucinogens|hallucinogens|mesh-ancestor
24782008|NCT01893424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573981|NCT00822809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24573982|NCT00822848|Sorafenib|sorafenib|mesh-list
24573983|NCT00822848|Epirubicin|epirubicin|mesh-list
24573984|NCT00822848|Ifosfamide|ifosfamide|mesh-list
24490281|NCT00477503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24490282|NCT00477516|Dialysis Solutions|dialysis solutions|mesh-list
24490293|NCT00477581|Exenatide|exenatide|mesh-list
24490294|NCT00477581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24490295|NCT00477581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490296|NCT00477581|Incretins|incretins|mesh-ancestor
24490297|NCT00477581|Hormones|hormones|mesh-ancestor
24490298|NCT00477581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24490299|NCT00477581|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24490300|NCT00477581|Protease Inhibitors|protease inhibitors|mesh-ancestor
24573994|NCT00822913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24573995|NCT00822913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24573996|NCT00822913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24573997|NCT00822913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082090|NCT03324828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24573999|NCT00822913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24574000|NCT00822913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24574001|NCT00822913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574002|NCT00822913|Cholinergic Agents|cholinergic agents|mesh-ancestor
24574003|NCT00822913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24621116|NCT01060696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621117|NCT01060696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24621118|NCT01060696|Parasympatholytics|parasympatholytics|mesh-ancestor
24621119|NCT01060696|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24621120|NCT01060696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24621122|NCT01060696|Sensory System Agents|sensory system agents|mesh-ancestor
24621123|NCT01060696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24621124|NCT01060696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24621125|NCT01060696|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24621126|NCT01060696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621128|NCT01060735|Vitamins|vitamins|mesh-ancestor
24621129|NCT01060735|Micronutrients|micronutrients|mesh-ancestor
24621130|NCT01060735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692416|NCT01999335|Glucocorticoids|glucocorticoids|mesh-ancestor
24932403|NCT04079933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24932404|NCT04079933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621131|NCT01060735|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24621133|NCT01060774|Bupivacaine|bupivacaine|mesh-list
24621134|NCT01060774|Anesthetics, Local|anesthetics, local|mesh-ancestor
24621135|NCT01060774|Anesthetics|anesthetics|mesh-ancestor
25157350|NCT04743934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25157351|NCT04743934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25157352|NCT04742959|Paclitaxel|paclitaxel|mesh-list
25157353|NCT04742959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24621136|NCT01060774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24618109|NCT01046838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490365|NCT00477815|Rituximab|rituximab|mesh-list
24490366|NCT00477815|Melphalan|melphalan|mesh-list
24490367|NCT00477815|Sargramostim|sargramostim|mesh-list
24490368|NCT00477815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24621139|NCT01060774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24621140|NCT01060774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24936421|NCT04040465|Analgesics|analgesics|mesh-ancestor
24850146|NCT02251925|Estradiol|estradiol|mesh-list
24936453|NCT04040309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24621141|NCT01060774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24621142|NCT01060774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24782009|NCT01893424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24782010|NCT01893424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24782012|NCT01893424|Sensory System Agents|sensory system agents|mesh-ancestor
24782013|NCT01893424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24782014|NCT01893424|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24782015|NCT01893424|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24782016|NCT01893424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24782017|NCT01893424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782019|NCT01893424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24782020|NCT01893424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24782021|NCT01893424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24782022|NCT01893450|Pentoxifylline|pentoxifylline|mesh-list
24782023|NCT01893450|Bromocriptine|bromocriptine|mesh-list
24782024|NCT01893450|Methimazole|methimazole|mesh-list
24782025|NCT01893450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24782026|NCT01893450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24782027|NCT01893450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782028|NCT01893450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24782029|NCT01893450|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24782030|NCT01893450|Protective Agents|protective agents|mesh-ancestor
24782031|NCT01893450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782053|NCT01893658|Omalizumab|omalizumab|mesh-list
24782054|NCT01893658|Prednisone|prednisone|mesh-list
24782055|NCT01893658|Prednisolone|prednisolone|mesh-list
24782056|NCT01893658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24782057|NCT01893658|Glucocorticoids|glucocorticoids|mesh-ancestor
24782058|NCT01893658|Hormones|hormones|mesh-ancestor
24782060|NCT01893658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782061|NCT01893658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24782062|NCT01893658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25082091|NCT03324828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782069|NCT01893723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24782070|NCT01893723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782071|NCT01893723|Analgesics|analgesics|mesh-ancestor
24782072|NCT01893723|Sensory System Agents|sensory system agents|mesh-ancestor
24782073|NCT01893723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24782075|NCT01893788|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24782076|NCT01893788|Hormone Antagonists|hormone antagonists|mesh-ancestor
24782077|NCT01893788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24782078|NCT01893788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782079|NCT01893788|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24782080|NCT01893788|Diuretics|diuretics|mesh-ancestor
24782081|NCT01893788|Natriuretic Agents|natriuretic agents|mesh-ancestor
24782082|NCT01893788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24782083|NCT01893996|Adalimumab|adalimumab|mesh-list
24782084|NCT01893996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25678400|NCT01824290|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25678401|NCT01824290|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25678402|NCT01824290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678403|NCT01824290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529713|NCT00627666|Busulfan|busulfan|mesh-list
24782085|NCT01893996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24782086|NCT01894035|Iloprost|iloprost|mesh-list
25157354|NCT04742959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25157355|NCT04742959|Tubulin Modulators|tubulin modulators|mesh-ancestor
25157356|NCT04742959|Antimitotic Agents|antimitotic agents|mesh-ancestor
25157357|NCT04742959|Mitosis Modulators|mitosis modulators|mesh-ancestor
25157358|NCT04742959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782087|NCT01894035|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24782093|NCT01894048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24782094|NCT01894048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782096|NCT01894048|Respiratory System Agents|respiratory system agents|mesh-ancestor
24782097|NCT01894061|Bevacizumab|bevacizumab|mesh-list
24782098|NCT01894061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24782099|NCT01894061|Antibodies|antibodies|mesh-list
24782100|NCT01894061|Immunoglobulins|immunoglobulins|mesh-list
24782101|NCT01894061|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24782102|NCT01894061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24782103|NCT01894061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24782104|NCT01894061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24782105|NCT01894061|Growth Substances|growth substances|mesh-ancestor
24782106|NCT01894061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782107|NCT01894061|Growth Inhibitors|growth inhibitors|mesh-ancestor
24782108|NCT01894061|Immunologic Factors|immunologic factors|mesh-ancestor
24782109|NCT01894269|Lamivudine|lamivudine|mesh-list
24782110|NCT01894269|Entecavir|entecavir|mesh-list
24782111|NCT01894269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24782112|NCT01894269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24782113|NCT01894269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24782114|NCT01894269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782115|NCT01894269|Antiviral Agents|antiviral agents|mesh-ancestor
24782116|NCT01894269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24782117|NCT01894269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24936483|NCT04039880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24782118|NCT01894269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24490434|NCT00478101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24490435|NCT00478101|Anesthetics, General|anesthetics, general|mesh-ancestor
24490436|NCT00478101|Anesthetics|anesthetics|mesh-ancestor
24490465|NCT00478504|Clomiphene|clomiphene|mesh-list
24490467|NCT00478504|Zuclomiphene|zuclomiphene|mesh-list
25082095|NCT03324815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24490468|NCT00478504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490469|NCT00478504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490470|NCT00478504|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24490471|NCT00478504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24490472|NCT00478504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490473|NCT00478504|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24490474|NCT00478504|Hormone Antagonists|hormone antagonists|mesh-ancestor
24782125|NCT01894334|Edaravone|edaravone|mesh-list
24782133|NCT01894334|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24782137|NCT01894334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782139|NCT01894334|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24782140|NCT01894334|Protease Inhibitors|protease inhibitors|mesh-ancestor
24782141|NCT01894334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24782142|NCT01894360|Belimumab|belimumab|mesh-list
24782143|NCT01894360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24782144|NCT01894360|Immunologic Factors|immunologic factors|mesh-ancestor
25082092|NCT03324828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627810|NCT01094990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24627812|NCT01095016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24627813|NCT01095016|Autonomic Agents|autonomic agents|mesh-ancestor
24627814|NCT01095016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24627815|NCT01095016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936484|NCT04040023|Vitamins|vitamins|mesh-list
24936485|NCT04040023|Micronutrients|micronutrients|mesh-ancestor
24627816|NCT01095016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24627817|NCT01095016|Respiratory System Agents|respiratory system agents|mesh-ancestor
24627818|NCT01095016|Sympathomimetics|sympathomimetics|mesh-ancestor
25213587|NCT04474938|Dexamethasone|dexamethasone|mesh-list
25213588|NCT04474938|Bortezomib|bortezomib|mesh-list
25213589|NCT04474938|Daratumumab|daratumumab|mesh-list
24627819|NCT01095016|Tocolytic Agents|tocolytic agents|mesh-ancestor
24627820|NCT01095016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24782145|NCT01894360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782146|NCT01894412|Etanercept|etanercept|mesh-list
24932432|NCT04079725|Mitomycins|mitomycins|mesh-list
24932433|NCT04079725|Mitomycin|mitomycin|mesh-list
24932434|NCT04079725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24932435|NCT04079725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24932440|NCT04079413|Insulin|insulin|mesh-list
24932449|NCT04079426|Sequestering Agents|sequestering agents|mesh-ancestor
24952492|NCT03893734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24952493|NCT03893734|Antitussive Agents|antitussive agents|mesh-ancestor
24952494|NCT03893734|Respiratory System Agents|respiratory system agents|mesh-ancestor
24952495|NCT03893591|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24675541|NCT01343862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24782147|NCT01894412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24782149|NCT01894412|Analgesics|analgesics|mesh-ancestor
24782150|NCT01894412|Sensory System Agents|sensory system agents|mesh-ancestor
24782151|NCT01894412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24782152|NCT01894412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782153|NCT01894412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24782154|NCT01894412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24782155|NCT01894412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24782156|NCT01894412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24782157|NCT01894412|Immunologic Factors|immunologic factors|mesh-ancestor
24782159|NCT01894451|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
24782160|NCT01894451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24782161|NCT01894451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24782162|NCT01894451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24782163|NCT01894451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24782164|NCT01894451|Growth Substances|growth substances|mesh-ancestor
24782165|NCT01894451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782166|NCT01894451|Growth Inhibitors|growth inhibitors|mesh-ancestor
24782167|NCT01894451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24782168|NCT01894451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782169|NCT01894633|Chloroquine|chloroquine|mesh-list
24782170|NCT01894633|Amebicides|amebicides|mesh-ancestor
24782171|NCT01894633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24782172|NCT01894633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24782173|NCT01894633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24782174|NCT01894633|Antimalarials|antimalarials|mesh-ancestor
24782175|NCT01894633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24782176|NCT01894685|Mesalamine|mesalamine|mesh-list
24490479|NCT00478504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24490480|NCT00478504|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24490481|NCT00478504|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24490483|NCT00478517|Hematinics|hematinics|mesh-ancestor
24490484|NCT00478543|Furosemide|furosemide|mesh-list
24782183|NCT01894685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24782184|NCT01894685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24782194|NCT01894789|Purinergic Agents|purinergic agents|mesh-ancestor
24782195|NCT01894789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24782196|NCT01894789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782197|NCT01894789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782198|NCT01894815|Dexetimide|dexetimide|mesh-list
24782199|NCT01894815|Citalopram|citalopram|mesh-list
25082093|NCT03324815|Morphine|morphine|mesh-list
25082094|NCT03324815|Methadone|methadone|mesh-list
25082096|NCT03324815|Narcotics|narcotics|mesh-ancestor
25082097|NCT03324815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25082098|NCT03324815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082099|NCT03324815|Analgesics|analgesics|mesh-ancestor
25082100|NCT03324815|Sensory System Agents|sensory system agents|mesh-ancestor
25082101|NCT03324815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082102|NCT03324815|Antitussive Agents|antitussive agents|mesh-ancestor
25082103|NCT03324815|Respiratory System Agents|respiratory system agents|mesh-ancestor
24782200|NCT01894815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25213590|NCT04474938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25213591|NCT04474938|Antiemetics|antiemetics|mesh-ancestor
25213592|NCT04474938|Autonomic Agents|autonomic agents|mesh-ancestor
25678404|NCT01824290|Urological Agents|urological agents|mesh-ancestor
25678405|NCT01824342|Denosumab|denosumab|mesh-list
25678406|NCT01824342|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25678407|NCT01824342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678408|NCT01824602|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25678409|NCT01824602|Anticonvulsants|anticonvulsants|mesh-ancestor
25678410|NCT01824602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25678411|NCT01824602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25678412|NCT01824602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25678413|NCT01824602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932472|NCT04079374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25213593|NCT04474938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25213594|NCT04474938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782201|NCT01894815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24782202|NCT01894815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24574151|NCT00823875|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24850219|NCT02252341|Expectorants|expectorants|mesh-ancestor
25050215|NCT00531622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782203|NCT01894815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782204|NCT01894815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24782205|NCT01894815|Serotonin Agents|serotonin agents|mesh-ancestor
24919760|NCT04208581|Fluticasone|fluticasone|mesh-list
24490485|NCT00478543|Diuretics|diuretics|mesh-ancestor
24490486|NCT00478543|Natriuretic Agents|natriuretic agents|mesh-ancestor
24550694|NCT00721747|Mitosis Modulators|mitosis modulators|mesh-ancestor
24782206|NCT01894815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782207|NCT01894815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24782208|NCT01894815|Antidepressive Agents|antidepressive agents|mesh-ancestor
24782210|NCT01894815|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24782211|NCT01894815|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24782212|NCT01894815|Parasympatholytics|parasympatholytics|mesh-ancestor
24782213|NCT01894815|Autonomic Agents|autonomic agents|mesh-ancestor
24782214|NCT01894815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24782215|NCT01894815|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24782216|NCT01894815|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24782217|NCT01894815|Cholinergic Agents|cholinergic agents|mesh-ancestor
24782218|NCT01894867|Magnesium Oxide|magnesium oxide|mesh-list
24782220|NCT01894867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490593|NCT00479076|Growth Substances|growth substances|mesh-ancestor
24490594|NCT00479076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490595|NCT00479076|Growth Inhibitors|growth inhibitors|mesh-ancestor
24490596|NCT00479076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24782235|NCT01895023|GABA Modulators|gaba modulators|mesh-list
24782236|NCT01895023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24782237|NCT01895023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24782238|NCT01895023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782239|NCT01895023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24782240|NCT01895023|Analgesics|analgesics|mesh-ancestor
24782246|NCT01895023|Adrenergic Agents|adrenergic agents|mesh-ancestor
24782247|NCT01895023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24782248|NCT01895023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782267|NCT01895049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782268|NCT01895049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24782269|NCT01895049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24782270|NCT01895049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24782271|NCT01895049|Immunologic Factors|immunologic factors|mesh-ancestor
24782272|NCT01895049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24782273|NCT01895049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24797297|NCT01955135|Propofol|propofol|mesh-list
24782274|NCT01895049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782275|NCT01895049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25213595|NCT04474938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25213596|NCT04474938|Glucocorticoids|glucocorticoids|mesh-ancestor
25213597|NCT04474938|Hormones|hormones|mesh-ancestor
25213598|NCT04474938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25213599|NCT04474938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25213600|NCT04474938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24533832|NCT00645255|Appetite Depressants|appetite depressants|mesh-ancestor
24533833|NCT00645255|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24533834|NCT00645268|Sildenafil Citrate|sildenafil citrate|mesh-list
24533835|NCT00645268|Vasodilator Agents|vasodilator agents|mesh-ancestor
24533836|NCT00645268|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24533837|NCT00645268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24533838|NCT00645268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24782276|NCT01895049|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24782277|NCT01895049|Antitubercular Agents|antitubercular agents|mesh-ancestor
24574299|NCT00824811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24574300|NCT00824863|Ketoconazole|ketoconazole|mesh-list
24490688|NCT00479726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24490689|NCT00479726|Antidepressive Agents|antidepressive agents|mesh-ancestor
24490690|NCT00479726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24490692|NCT00479739|Fluticasone|fluticasone|mesh-list
24490694|NCT00479739|Budesonide|budesonide|mesh-list
25678414|NCT01824693|Mycophenolic Acid|mycophenolic acid|mesh-list
24490695|NCT00479739|Formoterol Fumarate|formoterol fumarate|mesh-list
24490696|NCT00479739|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24490718|NCT00479752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24490719|NCT00479778|Bazedoxifene|bazedoxifene|mesh-list
24490720|NCT00479778|Estrogens|estrogens|mesh-list
24490721|NCT00479778|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24490722|NCT00479778|Hormones|hormones|mesh-ancestor
24490723|NCT00479778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24490724|NCT00479778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490725|NCT00479778|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24490726|NCT00479778|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24490727|NCT00479778|Hormone Antagonists|hormone antagonists|mesh-ancestor
25050221|NCT00529503|Carboplatin|carboplatin|mesh-list
25050222|NCT00529503|Etoposide|etoposide|mesh-list
25050223|NCT00529503|Ifosfamide|ifosfamide|mesh-list
25050224|NCT00529503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24574307|NCT00824863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24574308|NCT00824863|Hormone Antagonists|hormone antagonists|mesh-ancestor
24574309|NCT00824863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24574310|NCT00824863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574311|NCT00824863|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24621143|NCT01060774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24722648|NCT01581866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639547|NCT01162824|Adenosine|adenosine|mesh-list
24621153|NCT01060826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24621154|NCT01060826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621156|NCT01060891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24621157|NCT01060891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24621158|NCT01060904|Doxorubicin|doxorubicin|mesh-list
24621159|NCT01060904|Bleomycin|bleomycin|mesh-list
24621160|NCT01060904|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24621161|NCT01060904|Dacarbazine|dacarbazine|mesh-list
24621162|NCT01060904|Vinblastine|vinblastine|mesh-list
24621163|NCT01060904|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24618505|NCT01048619|ON 01910|on 01910|mesh-list
24490728|NCT00479778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24490729|NCT00479895|Chrysarobin|chrysarobin|mesh-list
24490730|NCT00479895|HBOC 201|hboc 201|mesh-list
24490731|NCT00479895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24490732|NCT00479895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24490733|NCT00479895|Analgesics|analgesics|mesh-ancestor
24490734|NCT00479895|Sensory System Agents|sensory system agents|mesh-ancestor
24621164|NCT01060904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25213606|NCT04468815|Esomeprazole|esomeprazole|mesh-list
25213607|NCT04468815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25213608|NCT04468815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25213609|NCT04468815|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25213610|NCT04468815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25213611|NCT04468815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213612|NCT04460885|Insulin|insulin|mesh-list
25213613|NCT04460885|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24621165|NCT01060904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24621166|NCT01060904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24621167|NCT01060904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24621168|NCT01060904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621169|NCT01060904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621170|NCT01060904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24621171|NCT01060904|Immunologic Factors|immunologic factors|mesh-ancestor
24621172|NCT01060904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621173|NCT01060904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24621174|NCT01060904|Alkylating Agents|alkylating agents|mesh-ancestor
24621175|NCT01060904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24936498|NCT04039698|Sofosbuvir|sofosbuvir|mesh-list
24936511|NCT04039373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24936512|NCT04039373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24936513|NCT04039373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24936514|NCT04039373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621176|NCT01060904|Tubulin Modulators|tubulin modulators|mesh-ancestor
24621179|NCT01060917|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24621180|NCT01060917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621181|NCT01060930|Epinephrine|epinephrine|mesh-list
24621182|NCT01060930|Norepinephrine|norepinephrine|mesh-list
24621183|NCT01060930|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
24621184|NCT01060930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24621185|NCT01060930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24621186|NCT01060930|Adrenergic Agents|adrenergic agents|mesh-ancestor
24621187|NCT01060930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24782278|NCT01895049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24782279|NCT01895049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24782281|NCT01895075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24782282|NCT01895075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24782283|NCT01895075|Autonomic Agents|autonomic agents|mesh-ancestor
24782284|NCT01895075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24782285|NCT01895075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082104|NCT03324776|Insulin|insulin|mesh-list
25082105|NCT03324776|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24797384|NCT01955252|Azithromycin|azithromycin|mesh-list
24782286|NCT01895075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24782287|NCT01895075|Respiratory System Agents|respiratory system agents|mesh-ancestor
24782288|NCT01895075|Glucocorticoids|glucocorticoids|mesh-ancestor
24782289|NCT01895075|Hormones|hormones|mesh-ancestor
24782290|NCT01895075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24782325|NCT01895348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24782326|NCT01895348|Analgesics|analgesics|mesh-ancestor
24782327|NCT01895348|Sensory System Agents|sensory system agents|mesh-ancestor
24782328|NCT01895348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24936515|NCT04039516|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
24936516|NCT04039516|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24936517|NCT04039516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936519|NCT04039126|Cadexomer iodine|cadexomer iodine|mesh-list
24936520|NCT04039126|Povidone-Iodine|povidone-iodine|mesh-list
24533849|NCT00645294|Adefovir|adefovir|mesh-list
24533850|NCT00645294|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
24919857|NCT04207632|Botulinum Toxins|botulinum toxins|mesh-list
24490735|NCT00479895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24490736|NCT00479895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490737|NCT00479895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24490738|NCT00479895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24490739|NCT00479895|Blood Substitutes|blood substitutes|mesh-ancestor
24490740|NCT00479908|Sildenafil Citrate|sildenafil citrate|mesh-list
24490741|NCT00479908|Nitroglycerin|nitroglycerin|mesh-list
24490742|NCT00479908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490743|NCT00479908|Vasodilator Agents|vasodilator agents|mesh-ancestor
24490744|NCT00479908|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24490745|NCT00479908|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24490746|NCT00479908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490797|NCT00480181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213614|NCT04460885|Insulin Glargine|insulin glargine|mesh-list
25213615|NCT04460885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25213616|NCT04460885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213617|NCT04451330|Doxycycline|doxycycline|mesh-list
25213618|NCT04451330|Trifarotene|trifarotene|mesh-list
25213619|NCT04451330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25213620|NCT04451330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24533851|NCT00645294|Antiviral Agents|antiviral agents|mesh-ancestor
24533852|NCT00645294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24936528|NCT04039126|Plasma Substitutes|plasma substitutes|mesh-ancestor
25213621|NCT04451330|Antimalarials|antimalarials|mesh-ancestor
25213622|NCT04451330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24490803|NCT00480194|Xylometazoline|xylometazoline|mesh-list
24490848|NCT00480298|Prednisolone|prednisolone|mesh-list
24490849|NCT00480298|Prednisolone acetate|prednisolone acetate|mesh-list
24490850|NCT00480298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24490851|NCT00480298|Prednisolone phosphate|prednisolone phosphate|mesh-list
24490852|NCT00480298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24490853|NCT00480298|Antiemetics|antiemetics|mesh-ancestor
24490854|NCT00480298|Autonomic Agents|autonomic agents|mesh-ancestor
24782329|NCT01895348|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24782330|NCT01895348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24782331|NCT01895348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24782332|NCT01895348|Adrenergic Agents|adrenergic agents|mesh-ancestor
24782333|NCT01895348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24782336|NCT01895348|Narcotics|narcotics|mesh-ancestor
24782337|NCT01895400|Cilostazol|cilostazol|mesh-list
24782338|NCT01895400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24782339|NCT01895400|Autonomic Agents|autonomic agents|mesh-ancestor
24782340|NCT01895400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24782341|NCT01895400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722807|NCT01582672|Sunitinib|sunitinib|mesh-list
24782360|NCT01895569|Hormones|hormones|mesh-ancestor
24782361|NCT01895569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24854127|NCT02272049|Xenon|xenon|mesh-list
24782362|NCT01895569|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24782363|NCT01895569|Protease Inhibitors|protease inhibitors|mesh-ancestor
24782364|NCT01895569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24782365|NCT01895569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782366|NCT01895621|Thioctic Acid|thioctic acid|mesh-list
24782367|NCT01895621|Antioxidants|antioxidants|mesh-ancestor
24782368|NCT01895621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782369|NCT01895621|Protective Agents|protective agents|mesh-ancestor
24782370|NCT01895621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782371|NCT01895621|Vitamin B Complex|vitamin b complex|mesh-ancestor
24782372|NCT01895621|Vitamins|vitamins|mesh-ancestor
24782373|NCT01895621|Micronutrients|micronutrients|mesh-ancestor
24782374|NCT01895764|Adalimumab|adalimumab|mesh-list
25082106|NCT03324776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24936529|NCT04039126|Blood Substitutes|blood substitutes|mesh-ancestor
24782376|NCT01895764|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24782377|NCT01895764|Abortifacient Agents|abortifacient agents|mesh-ancestor
24782378|NCT01895764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24782379|NCT01895764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782380|NCT01895764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24782381|NCT01895764|Antimetabolites|antimetabolites|mesh-ancestor
24782382|NCT01895764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782383|NCT01895764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24782384|NCT01895764|Dermatologic Agents|dermatologic agents|mesh-ancestor
24782385|NCT01895764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24782386|NCT01895764|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24919917|NCT04207723|Antidepressive Agents|antidepressive agents|mesh-ancestor
24490855|NCT00480298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24490856|NCT00480298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490857|NCT00480298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24490858|NCT00480298|Glucocorticoids|glucocorticoids|mesh-ancestor
24490859|NCT00480298|Hormones|hormones|mesh-ancestor
24490860|NCT00480298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24490861|NCT00480298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24490862|NCT00480298|Protective Agents|protective agents|mesh-ancestor
24490863|NCT00480298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24490953|NCT00480597|Tubulin Modulators|tubulin modulators|mesh-ancestor
24490954|NCT00480597|Antimitotic Agents|antimitotic agents|mesh-ancestor
24490955|NCT00480597|Mitosis Modulators|mitosis modulators|mesh-ancestor
24490956|NCT00480610|Tacrolimus|tacrolimus|mesh-list
24782387|NCT01895764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24782388|NCT01895764|Immunologic Factors|immunologic factors|mesh-ancestor
24782389|NCT01895764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24782390|NCT01895764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24782391|NCT01895764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24936546|NCT04038970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24936547|NCT04038970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936548|NCT04038970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24936549|NCT04038970|Antimetabolites|antimetabolites|mesh-ancestor
24936560|NCT04038853|Cholecalciferol|cholecalciferol|mesh-list
24936562|NCT04038853|Calcitriol|calcitriol|mesh-list
24782392|NCT01895829|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24782394|NCT01895829|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24444856|NCT00299377|Abciximab|abciximab|mesh-list
25213623|NCT04451330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25213624|NCT04451330|Dermatologic Agents|dermatologic agents|mesh-ancestor
24782395|NCT01895829|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24782396|NCT01895881|Estradiol|estradiol|mesh-list
24782397|NCT01895881|Estrogens|estrogens|mesh-ancestor
24782398|NCT01895881|Hormones|hormones|mesh-ancestor
24782399|NCT01895881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24782400|NCT01895881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782401|NCT01895894|Mycophenolic Acid|mycophenolic acid|mesh-list
24782402|NCT01895894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24782403|NCT01895894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24782404|NCT01895894|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24782405|NCT01895894|Antitubercular Agents|antitubercular agents|mesh-ancestor
24782406|NCT01895894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24782413|NCT01895998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24782414|NCT01895998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782415|NCT01895998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24782416|NCT01895998|Respiratory System Agents|respiratory system agents|mesh-ancestor
24782417|NCT01895998|Tocolytic Agents|tocolytic agents|mesh-ancestor
24782418|NCT01895998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25678415|NCT01824693|Cyclophosphamide|cyclophosphamide|mesh-list
25678416|NCT01824693|Melphalan|melphalan|mesh-list
24782420|NCT01895998|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24782421|NCT01895998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24919938|NCT04207021|Curcumin|curcumin|mesh-list
24490957|NCT00480610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24490958|NCT00480610|Immunologic Factors|immunologic factors|mesh-ancestor
24782422|NCT01895998|Adrenergic Agents|adrenergic agents|mesh-ancestor
24782423|NCT01895998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24782424|NCT01895998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782425|NCT01896011|Teriparatide|teriparatide|mesh-list
24491034|NCT00480883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491035|NCT00480883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491098|NCT00481182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24491100|NCT00481182|Narcotics|narcotics|mesh-ancestor
24491101|NCT00481182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24491102|NCT00481182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491103|NCT00481182|Analgesics|analgesics|mesh-ancestor
24491104|NCT00481182|Sensory System Agents|sensory system agents|mesh-ancestor
24812098|NCT02049606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812099|NCT02049671|Hormones|hormones|mesh-list
24812100|NCT02049671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24491105|NCT00481182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24491106|NCT00481182|Antitussive Agents|antitussive agents|mesh-ancestor
24782456|NCT01896323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782457|NCT01896323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24782459|NCT01896336|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24782460|NCT01896336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24782461|NCT01896336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24782462|NCT01896336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782463|NCT01896336|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24782465|NCT01896336|GABA Agents|gaba agents|mesh-ancestor
24782466|NCT01896336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24782467|NCT01896336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782468|NCT01896349|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24782469|NCT01896349|Amitriptyline|amitriptyline|mesh-list
24782470|NCT01896349|Risperidone|risperidone|mesh-list
24782471|NCT01896349|Sulpiride|sulpiride|mesh-list
24782472|NCT01896349|Mirtazapine|mirtazapine|mesh-list
24782473|NCT01896349|Trazodone|trazodone|mesh-list
24782474|NCT01896349|Fluvoxamine|fluvoxamine|mesh-list
24782475|NCT01896349|Tranylcypromine|tranylcypromine|mesh-list
24936584|NCT04038411|Lenalidomide|lenalidomide|mesh-list
24936585|NCT04038411|Antibodies|antibodies|mesh-list
24936586|NCT04038411|Immunologic Factors|immunologic factors|mesh-ancestor
24936587|NCT04038411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936588|NCT04038411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24936589|NCT04038411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24936590|NCT04038411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24936591|NCT04038411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24782476|NCT01896349|Citalopram|citalopram|mesh-list
24782489|NCT01896349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782490|NCT01896349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782491|NCT01896349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24782493|NCT01896349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24782494|NCT01896349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24782495|NCT01896349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24782496|NCT01896349|Dopamine Agents|dopamine agents|mesh-ancestor
24782497|NCT01896349|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24782498|NCT01896349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24782499|NCT01896349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24782500|NCT01896349|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24782501|NCT01896349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24782502|NCT01896349|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24782503|NCT01896349|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24782504|NCT01896349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24782506|NCT01896349|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24782507|NCT01896349|Analgesics|analgesics|mesh-ancestor
24627826|NCT01095016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627827|NCT01095133|Amiloride|amiloride|mesh-list
24627828|NCT01095133|Diuretics|diuretics|mesh-ancestor
24627829|NCT01095133|Natriuretic Agents|natriuretic agents|mesh-ancestor
24627830|NCT01095133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627831|NCT01095133|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24627832|NCT01095133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24627833|NCT01095133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24627834|NCT01095133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627835|NCT01095133|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24627836|NCT01095133|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24627837|NCT01095172|Prednisolone|prednisolone|mesh-list
24627838|NCT01095172|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24627839|NCT01095172|Methylprednisolone|methylprednisolone|mesh-list
24627840|NCT01095172|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24627841|NCT01095172|Prednisolone acetate|prednisolone acetate|mesh-list
24627842|NCT01095172|Hydrocortisone|hydrocortisone|mesh-list
24627843|NCT01095172|Rituximab|rituximab|mesh-list
24627844|NCT01095172|Tacrolimus|tacrolimus|mesh-list
24627845|NCT01095172|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24627846|NCT01095172|Prednisolone phosphate|prednisolone phosphate|mesh-list
24723111|NCT01584921|Epoetin Alfa|epoetin alfa|mesh-list
24491220|NCT00481663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491223|NCT00481689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24491224|NCT00481689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24491225|NCT00481689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24936602|NCT04038320|Ledipasvir|ledipasvir|mesh-list
24782522|NCT01896349|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24782523|NCT01896349|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24782524|NCT01896349|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24782525|NCT01896388|Ifenprodil|ifenprodil|mesh-list
24782526|NCT01896388|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24782527|NCT01896388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24782528|NCT01896388|Adrenergic Agents|adrenergic agents|mesh-ancestor
24782529|NCT01896388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24782530|NCT01896388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782531|NCT01896388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782532|NCT01896388|Vasodilator Agents|vasodilator agents|mesh-ancestor
24782533|NCT01896388|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24782534|NCT01896388|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24782536|NCT01896440|Antiemetics|antiemetics|mesh-ancestor
24782537|NCT01896440|Autonomic Agents|autonomic agents|mesh-ancestor
24782538|NCT01896440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24782539|NCT01896440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623866|NCT01073826|Protease Inhibitors|protease inhibitors|mesh-ancestor
24491226|NCT00481689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491227|NCT00481689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491228|NCT00481689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491229|NCT00481689|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25213632|NCT04437329|Mitosis Modulators|mitosis modulators|mesh-ancestor
24491230|NCT00481689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25213629|NCT04437329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25157398|NCT04730258|Azacitidine|azacitidine|mesh-list
25157400|NCT04730258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25157401|NCT04730258|Antimetabolites|antimetabolites|mesh-ancestor
25157402|NCT04730258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936603|NCT04038320|Antiviral Agents|antiviral agents|mesh-ancestor
24936604|NCT04038320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24936615|NCT04038307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24936616|NCT04038307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936618|NCT04038008|Fluconazole|fluconazole|mesh-list
24936619|NCT04038008|Antifungal Agents|antifungal agents|mesh-ancestor
24936620|NCT04038008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24850300|NCT02252614|Narcotics|narcotics|mesh-ancestor
25157403|NCT04730258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25157404|NCT04730258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25157405|NCT04721457|Povidone-Iodine|povidone-iodine|mesh-list
25157406|NCT04721457|Listerine|listerine|mesh-list
25157407|NCT04721457|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25157408|NCT04721457|Cetylpyridinium|cetylpyridinium|mesh-list
25157409|NCT04721457|Sodium Hypochlorite|sodium hypochlorite|mesh-list
25157410|NCT04721457|Eusol|eusol|mesh-list
24491231|NCT00481702|Metronidazole|metronidazole|mesh-list
24491232|NCT00481702|Ceftriaxone|ceftriaxone|mesh-list
24491233|NCT00481702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24491234|NCT00481702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24491243|NCT00481728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491244|NCT00481728|Urological Agents|urological agents|mesh-ancestor
24491245|NCT00481741|Hemostatics|hemostatics|mesh-list
24491246|NCT00481741|Coagulants|coagulants|mesh-ancestor
24491247|NCT00481819|Mycophenolic Acid|mycophenolic acid|mesh-list
24491248|NCT00481819|Methylprednisolone|methylprednisolone|mesh-list
24491249|NCT00481819|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24491250|NCT00481819|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24491251|NCT00481819|Prednisolone|prednisolone|mesh-list
24491252|NCT00481819|Prednisolone acetate|prednisolone acetate|mesh-list
24491253|NCT00481819|Tacrolimus|tacrolimus|mesh-list
24491254|NCT00481819|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24491255|NCT00481819|Prednisolone phosphate|prednisolone phosphate|mesh-list
24491256|NCT00481819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24491257|NCT00481819|Immunologic Factors|immunologic factors|mesh-ancestor
25082108|NCT03324685|Levonorgestrel|levonorgestrel|mesh-list
25082109|NCT03324685|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25082110|NCT03324685|Estradiol|estradiol|mesh-list
25082111|NCT03324685|Estrogens|estrogens|mesh-ancestor
25082112|NCT03324685|Hormones|hormones|mesh-ancestor
25082113|NCT03324685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25082114|NCT03324685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082115|NCT03324685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25082116|NCT03324685|Contraceptive Agents|contraceptive agents|mesh-ancestor
25082117|NCT03324685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25082118|NCT03324685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25082119|NCT03324685|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25082120|NCT03324685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25082121|NCT03324685|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25082122|NCT03324542|Ranibizumab|ranibizumab|mesh-list
25082123|NCT03324542|Aflibercept|aflibercept|mesh-list
25082124|NCT03324542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24936625|NCT04038008|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25082125|NCT03324542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25082126|NCT03324542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25082127|NCT03324542|Growth Substances|growth substances|mesh-ancestor
25082128|NCT03324542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082129|NCT03324542|Growth Inhibitors|growth inhibitors|mesh-ancestor
25082130|NCT03324503|Prednisone|prednisone|mesh-list
25082131|NCT03324503|Prednisolone|prednisolone|mesh-list
25082132|NCT03324503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25082133|NCT03324503|Methylprednisolone|methylprednisolone|mesh-list
25082134|NCT03324503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25082135|NCT03324503|Prednisolone acetate|prednisolone acetate|mesh-list
24797672|NCT01957293|Albuterol|albuterol|mesh-list
24782540|NCT01896440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24782541|NCT01896440|Antipruritics|antipruritics|mesh-ancestor
24782542|NCT01896440|Dermatologic Agents|dermatologic agents|mesh-ancestor
24782543|NCT01896440|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24491304|NCT00481975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25213630|NCT04437329|Tubulin Modulators|tubulin modulators|mesh-ancestor
25213631|NCT04437329|Antimitotic Agents|antimitotic agents|mesh-ancestor
25213636|NCT04437329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25213637|NCT04437329|Immunologic Factors|immunologic factors|mesh-ancestor
25213638|NCT04437329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213639|NCT04430192|177Lu-PSMA-617|177lu-psma-617|mesh-list
25213640|NCT04430192|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25275603|NCT02370862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24936626|NCT04038008|Hormone Antagonists|hormone antagonists|mesh-ancestor
24936627|NCT04038008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24936628|NCT04038008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936629|NCT04038008|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24936630|NCT04038008|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24936632|NCT04038034|Vitamins|vitamins|mesh-ancestor
24936633|NCT04038034|Micronutrients|micronutrients|mesh-ancestor
24936634|NCT04038034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936635|NCT04037878|Tramadol|tramadol|mesh-list
24936636|NCT04037878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24936637|NCT04037878|Narcotics|narcotics|mesh-ancestor
24761268|NCT01761994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24830796|NCT02161614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491307|NCT00482027|Immunologic Factors|immunologic factors|mesh-ancestor
24491308|NCT00482027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491309|NCT00482066|Abatacept|abatacept|mesh-list
24491310|NCT00482066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24782544|NCT01896440|Serotonin Agents|serotonin agents|mesh-ancestor
24782545|NCT01896440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24782546|NCT01896440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932588|NCT04077853|Hormone Antagonists|hormone antagonists|mesh-ancestor
24932589|NCT04077853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24782547|NCT01896440|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24782548|NCT01896440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24782549|NCT01896440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24782550|NCT01896440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24782551|NCT01896440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24782552|NCT01896518|Nicotine|nicotine|mesh-list
24782553|NCT01896518|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24782554|NCT01896518|Autonomic Agents|autonomic agents|mesh-ancestor
24782555|NCT01896518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24782556|NCT01896518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782557|NCT01896518|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24782558|NCT01896518|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24574533|NCT00825864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24574534|NCT00825864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24782573|NCT01896609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782575|NCT01896609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782576|NCT01896609|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24782577|NCT01896609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24782578|NCT01896609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24782580|NCT01896622|Cobicistat|cobicistat|mesh-list
24782581|NCT01896622|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24782582|NCT01896622|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24782583|NCT01896622|Protease Inhibitors|protease inhibitors|mesh-ancestor
24782589|NCT01896622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24782590|NCT01896622|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24782591|NCT01896622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24782592|NCT01896661|Amlodipine|amlodipine|mesh-list
24782593|NCT01896661|Chlorthalidone|chlorthalidone|mesh-list
24782594|NCT01896661|Calcium Channel Blockers|calcium channel blockers|mesh-list
24782595|NCT01896661|Amiloride|amiloride|mesh-list
24782596|NCT01896661|Calcium|calcium|mesh-list
24491343|NCT00482209|Contraceptive Agents|contraceptive agents|mesh-ancestor
24491344|NCT00482209|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24491345|NCT00482209|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24491346|NCT00482209|Hormone Antagonists|hormone antagonists|mesh-ancestor
24491475|NCT00482690|Cholinergic Agents|cholinergic agents|mesh-ancestor
24442644|NCT00291863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24491476|NCT00482690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24491477|NCT00482690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782597|NCT01896661|Diuretics|diuretics|mesh-list
24782598|NCT01896661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24782599|NCT01896661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782600|NCT01896661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24782601|NCT01896661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25213641|NCT04430192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25157416|NCT04721457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25157417|NCT04721457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24782602|NCT01896661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782603|NCT01896661|Vasodilator Agents|vasodilator agents|mesh-ancestor
24782604|NCT01896661|Natriuretic Agents|natriuretic agents|mesh-ancestor
24782605|NCT01896661|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24575125|NCT00829647|Lenalidomide|lenalidomide|mesh-list
24782607|NCT01896661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24782608|NCT01896661|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24782609|NCT01896661|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24782610|NCT01896739|Vaccines|vaccines|mesh-list
25082136|NCT03324503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24797738|NCT01957631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24782611|NCT01896739|Immunologic Factors|immunologic factors|mesh-ancestor
24782612|NCT01896739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782613|NCT01896960|Fentanyl|fentanyl|mesh-list
24782614|NCT01896960|Bupivacaine|bupivacaine|mesh-list
25050247|NCT00529152|Sequestering Agents|sequestering agents|mesh-ancestor
25050248|NCT00529152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050249|NCT00528697|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25678417|NCT01824693|Busulfan|busulfan|mesh-list
25678418|NCT01824693|Mechlorethamine|mechlorethamine|mesh-list
25050250|NCT00528697|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25678419|NCT01824693|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25155542|NCT05346601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24932620|NCT04077957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24932621|NCT04077957|Antimalarials|antimalarials|mesh-ancestor
24932622|NCT04077957|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24932623|NCT04077957|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24932624|NCT04077957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24677218|NCT01354860|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24677219|NCT01354860|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25050251|NCT00528697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25050252|NCT00528697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25050254|NCT00528697|Adrenergic Agents|adrenergic agents|mesh-ancestor
24920109|NCT04205227|Pembrolizumab|pembrolizumab|mesh-list
24491493|NCT00482755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24491494|NCT00482755|Growth Substances|growth substances|mesh-ancestor
24491495|NCT00482755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491496|NCT00482755|Growth Inhibitors|growth inhibitors|mesh-ancestor
24491497|NCT00482755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24491498|NCT00482755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491499|NCT00482755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491500|NCT00482807|Docetaxel|docetaxel|mesh-list
24723427|NCT01587339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24491539|NCT00482963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491540|NCT00482963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24491541|NCT00482963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24491542|NCT00482963|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24491543|NCT00482976|Ruboxistaurin|ruboxistaurin|mesh-list
24491544|NCT00482976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491545|NCT00482976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491546|NCT00482989|Sifalimumab|sifalimumab|mesh-list
24491547|NCT00482989|Immunologic Factors|immunologic factors|mesh-ancestor
24491548|NCT00482989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442673|NCT00292110|Methadone|methadone|mesh-list
24491549|NCT00483028|Donepezil|donepezil|mesh-list
24920117|NCT04205305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24920118|NCT04205305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920121|NCT04205305|Sympathomimetics|sympathomimetics|mesh-ancestor
24782615|NCT01896960|Anesthetics, Local|anesthetics, local|mesh-ancestor
24782616|NCT01896960|Anesthetics|anesthetics|mesh-ancestor
24782617|NCT01896960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24782618|NCT01896960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782622|NCT01896960|Narcotics|narcotics|mesh-ancestor
24574593|NCT00826527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574594|NCT00826527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574595|NCT00826527|Urological Agents|urological agents|mesh-ancestor
24574596|NCT00826553|Midazolam|midazolam|mesh-list
24574597|NCT00826553|Dexmedetomidine|dexmedetomidine|mesh-list
24574598|NCT00826553|Lorazepam|lorazepam|mesh-list
24574599|NCT00826553|Propofol|propofol|mesh-list
24574600|NCT00826553|GABA Agonists|gaba agonists|mesh-list
24782623|NCT01896960|Analgesics|analgesics|mesh-ancestor
24639932|NCT01164943|Hormones|hormones|mesh-ancestor
24782624|NCT01896960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24782625|NCT01896960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24574601|NCT00826553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24574602|NCT00826553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24574603|NCT00826553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574604|NCT00826553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24574605|NCT00826553|Anesthetics, General|anesthetics, general|mesh-ancestor
24782626|NCT01896960|Anesthetics, General|anesthetics, general|mesh-ancestor
24782627|NCT01897012|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25157418|NCT04721457|Cariostatic Agents|cariostatic agents|mesh-ancestor
25157419|NCT04721457|Protective Agents|protective agents|mesh-ancestor
25157420|NCT04721457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116335|NCT03109080|Olaparib|olaparib|mesh-list
25157426|NCT04711304|Hyaluronic Acid|hyaluronic acid|mesh-list
25678420|NCT01824693|Fludarabine|fludarabine|mesh-list
25678421|NCT01824693|Fludarabine phosphate|fludarabine phosphate|mesh-list
25678422|NCT01824693|Tacrolimus|tacrolimus|mesh-list
25678423|NCT01824693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25678424|NCT01824693|Immunologic Factors|immunologic factors|mesh-ancestor
25678425|NCT01824693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678426|NCT01824693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25678427|NCT01824693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25157427|NCT04711304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25157428|NCT04711304|Immunologic Factors|immunologic factors|mesh-ancestor
24932627|NCT04077957|Analgesics|analgesics|mesh-ancestor
25157429|NCT04711304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25157430|NCT04711304|Viscosupplements|viscosupplements|mesh-ancestor
25157431|NCT04711304|Protective Agents|protective agents|mesh-ancestor
24850370|NCT02252809|Hormones|hormones|mesh-ancestor
24782628|NCT01897012|Romidepsin|romidepsin|mesh-list
24782629|NCT01897012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24782630|NCT01897012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24782631|NCT01897012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24782632|NCT01897038|Sorafenib|sorafenib|mesh-list
24491550|NCT00483028|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24491551|NCT00483028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491552|NCT00483028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491553|NCT00483028|Cholinergic Agents|cholinergic agents|mesh-ancestor
24491554|NCT00483028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24491555|NCT00483028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491556|NCT00483028|Nootropic Agents|nootropic agents|mesh-ancestor
24920126|NCT04205305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24920127|NCT04205305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24920128|NCT04205305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24782673|NCT01897337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782675|NCT01897428|Salicylates|salicylates|mesh-list
24782676|NCT01897428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24782677|NCT01897428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24782678|NCT01897428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24782679|NCT01897428|Analgesics|analgesics|mesh-ancestor
24782680|NCT01897428|Sensory System Agents|sensory system agents|mesh-ancestor
24782681|NCT01897428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24782682|NCT01897428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782683|NCT01897428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24782684|NCT01897428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24782685|NCT01897428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24491605|NCT00483145|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
25213648|NCT04400929|Molgramostim|molgramostim|mesh-list
25213649|NCT04400929|Sargramostim|sargramostim|mesh-list
25213650|NCT04400929|Immunologic Factors|immunologic factors|mesh-ancestor
25213651|NCT04400929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213652|NCT04400929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25213653|NCT04395469|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
25213654|NCT04395469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25213655|NCT04395469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213656|NCT04324229|Liraglutide|liraglutide|mesh-list
25213657|NCT04324229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25213658|NCT04324229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213659|NCT04324229|Incretins|incretins|mesh-ancestor
25213660|NCT04324229|Hormones|hormones|mesh-ancestor
25213661|NCT04324229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25157436|NCT04710719|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25157437|NCT04710719|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25157438|NCT04710719|Fluorouracil|fluorouracil|mesh-list
25157439|NCT04710719|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25157440|NCT04710719|Antimetabolites|antimetabolites|mesh-ancestor
25157441|NCT04710719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25157442|NCT04710719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25157443|NCT04710719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25157444|NCT04710719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25157445|NCT04710719|Immunologic Factors|immunologic factors|mesh-ancestor
25157446|NCT04710719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25157447|NCT04710719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25157448|NCT04710719|Glucocorticoids|glucocorticoids|mesh-ancestor
25157449|NCT04710719|Hormones|hormones|mesh-ancestor
25157450|NCT04710719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25157455|NCT04704271|Dronabinol|dronabinol|mesh-list
25157456|NCT04704271|Hallucinogens|hallucinogens|mesh-ancestor
24782686|NCT01897428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24782687|NCT01897428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082137|NCT03324503|Prednisolone phosphate|prednisolone phosphate|mesh-list
25157460|NCT04704271|Analgesics|analgesics|mesh-ancestor
25157461|NCT04704271|Sensory System Agents|sensory system agents|mesh-ancestor
25157462|NCT04704271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25157463|NCT04704271|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25157464|NCT04704271|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25157465|NCT04704271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25678428|NCT01824693|Alkylating Agents|alkylating agents|mesh-ancestor
25260824|NCT02456597|Sensory System Agents|sensory system agents|mesh-ancestor
24947887|NCT03925233|Antiviral Agents|antiviral agents|mesh-ancestor
24782789|NCT01898065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24782781|NCT01898052|Levobupivacaine|levobupivacaine|mesh-list
24782782|NCT01898052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24782783|NCT01898052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782784|NCT01898052|Anesthetics, Local|anesthetics, local|mesh-ancestor
24782785|NCT01898052|Sensory System Agents|sensory system agents|mesh-ancestor
24782786|NCT01898052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24782787|NCT01898065|Misonidazole|misonidazole|mesh-list
25082139|NCT03324503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24627849|NCT01095172|Immunologic Factors|immunologic factors|mesh-ancestor
24627850|NCT01095172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627851|NCT01095172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24627852|NCT01095172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24627853|NCT01095172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24627854|NCT01095172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627855|NCT01095172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627856|NCT01095172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24627857|NCT01095172|Glucocorticoids|glucocorticoids|mesh-ancestor
24800051|NCT01973010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24800200|NCT01973933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24625525|NCT01082393|Mometasone Furoate|mometasone furoate|mesh-list
24625526|NCT01082393|Pimecrolimus|pimecrolimus|mesh-list
24625527|NCT01082393|Tacrolimus|tacrolimus|mesh-list
24625528|NCT01082393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24625529|NCT01082393|Immunologic Factors|immunologic factors|mesh-ancestor
24625530|NCT01082393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625531|NCT01082393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24625532|NCT01082393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625533|NCT01082393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625534|NCT01082393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24625535|NCT01082393|Dermatologic Agents|dermatologic agents|mesh-ancestor
24625539|NCT01082393|Analgesics|analgesics|mesh-ancestor
25213695|NCT04321746|Ketamine|ketamine|mesh-list
25213696|NCT04321746|Analgesics|analgesics|mesh-ancestor
25213697|NCT04321746|Sensory System Agents|sensory system agents|mesh-ancestor
25213698|NCT04321746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25157466|NCT04704271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25157468|NCT04704271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25157469|NCT04699630|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
25157470|NCT04699630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25157471|NCT04699630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24947917|NCT03925285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24627859|NCT01095172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24627860|NCT01095172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24782788|NCT01898065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24782794|NCT01898104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24782795|NCT01898104|Antimetabolites|antimetabolites|mesh-ancestor
24782796|NCT01898104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782797|NCT01898104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24782798|NCT01898104|Anticonvulsants|anticonvulsants|mesh-ancestor
24782799|NCT01898104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24782800|NCT01898104|GABA Agents|gaba agents|mesh-ancestor
24782801|NCT01898104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24782802|NCT01898104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782803|NCT01898104|Antimanic Agents|antimanic agents|mesh-ancestor
24782804|NCT01898104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24936684|NCT04037657|Propofol|propofol|mesh-list
24723792|NCT01589081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25082148|NCT03324503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25082149|NCT03324503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25082150|NCT03324503|Protective Agents|protective agents|mesh-ancestor
25082151|NCT03324490|Fentanyl|fentanyl|mesh-list
25082152|NCT03324490|Dexmedetomidine|dexmedetomidine|mesh-list
25082153|NCT03324490|Bupivacaine|bupivacaine|mesh-list
25082154|NCT03324490|Anesthetics|anesthetics|mesh-list
25082155|NCT03324490|Anesthetics, Local|anesthetics, local|mesh-ancestor
25082156|NCT03324490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24782830|NCT01898377|Mycophenolic Acid|mycophenolic acid|mesh-list
24782831|NCT01898377|Imatinib Mesylate|imatinib mesylate|mesh-list
25678429|NCT01824693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782832|NCT01898377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24782833|NCT01898377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24782834|NCT01898377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25260840|NCT02456454|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25260845|NCT02456454|Dopamine Agents|dopamine agents|mesh-ancestor
24782835|NCT01898377|Antitubercular Agents|antitubercular agents|mesh-ancestor
24782836|NCT01898377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24782837|NCT01898377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24782839|NCT01898377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782840|NCT01898377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24782841|NCT01898416|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24782842|NCT01898416|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24782843|NCT01898416|Dermatologic Agents|dermatologic agents|mesh-ancestor
24782844|NCT01898507|Nicotine|nicotine|mesh-list
24782845|NCT01898507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24782846|NCT01898507|Autonomic Agents|autonomic agents|mesh-ancestor
24782847|NCT01898507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24782848|NCT01898507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574861|NCT00827996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25213699|NCT04321746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213700|NCT04321746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25213701|NCT04321746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25213702|NCT04321746|Anesthetics, General|anesthetics, general|mesh-ancestor
25213703|NCT04321746|Anesthetics|anesthetics|mesh-ancestor
25213704|NCT04321746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25213705|NCT04321746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25213706|NCT04321746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25213707|NCT04321746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25213708|NCT04321746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213709|NCT04309773|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25213710|NCT04309773|Bezafibrate|bezafibrate|mesh-list
24936706|NCT04037514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24936707|NCT04037514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936708|NCT04037514|Antipyretics|antipyretics|mesh-ancestor
24936709|NCT04037085|Ketamine|ketamine|mesh-list
24936710|NCT04037085|Analgesics|analgesics|mesh-ancestor
24936711|NCT04037085|Sensory System Agents|sensory system agents|mesh-ancestor
24936712|NCT04037085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24936713|NCT04037085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936714|NCT04037085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24552191|NCT04098003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812115|NCT02049762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24812116|NCT02049762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24812117|NCT02049762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24812118|NCT02049762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24574863|NCT00828087|Chromium|chromium|mesh-list
24574864|NCT00828087|Everolimus|everolimus|mesh-list
24574865|NCT00828087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24574866|NCT00828087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24574867|NCT00828087|Immunologic Factors|immunologic factors|mesh-ancestor
24574878|NCT00828230|Respiratory System Agents|respiratory system agents|mesh-ancestor
24574879|NCT00828230|Glucocorticoids|glucocorticoids|mesh-ancestor
24574880|NCT00828230|Hormones|hormones|mesh-ancestor
24574882|NCT00828282|Simvastatin|simvastatin|mesh-list
24782851|NCT01898507|Cholinergic Agents|cholinergic agents|mesh-ancestor
24782852|NCT01898507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24782853|NCT01898507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782854|NCT01898520|Nabiximols|nabiximols|mesh-list
24782855|NCT01898520|Analgesics|analgesics|mesh-ancestor
24782856|NCT01898520|Sensory System Agents|sensory system agents|mesh-ancestor
24782857|NCT01898520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24782858|NCT01898520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782859|NCT01898585|Vemurafenib|vemurafenib|mesh-list
24491650|NCT00483366|Imatinib Mesylate|imatinib mesylate|mesh-list
24491651|NCT00483366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24491652|NCT00483366|Antimetabolites|antimetabolites|mesh-ancestor
24491653|NCT00483366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491654|NCT00483366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491655|NCT00483366|Antiviral Agents|antiviral agents|mesh-ancestor
24491656|NCT00483366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24491657|NCT00483366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491658|NCT00483366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25678430|NCT01824693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678431|NCT01824693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25678432|NCT01824693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25678433|NCT01824693|Antimetabolites|antimetabolites|mesh-ancestor
24491659|NCT00483366|Immunologic Factors|immunologic factors|mesh-ancestor
24491660|NCT00483366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491661|NCT00483366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24491662|NCT00483392|Metformin|metformin|mesh-list
24491717|NCT00483782|Carboplatin|carboplatin|mesh-list
24491751|NCT00483834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24812119|NCT02049762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812122|NCT02049762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491753|NCT00483860|Topotecan|topotecan|mesh-list
24491754|NCT00483860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24491755|NCT00483860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24491756|NCT00483860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491757|NCT00483860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782860|NCT01898585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24782862|NCT01898585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24782863|NCT01898585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782864|NCT01898624|Mirabegron|mirabegron|mesh-list
24782865|NCT01898624|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24782866|NCT01898624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24782867|NCT01898624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24782868|NCT01898624|Adrenergic Agents|adrenergic agents|mesh-ancestor
24782869|NCT01898624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24782870|NCT01898624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782881|NCT01898676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24782882|NCT01898676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24782883|NCT01898676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24782884|NCT01898728|Iodine|iodine|mesh-list
24782885|NCT01898728|Cadexomer iodine|cadexomer iodine|mesh-list
24782886|NCT01898728|Povidone-Iodine|povidone-iodine|mesh-list
24782887|NCT01898728|Povidone|povidone|mesh-list
24782888|NCT01898728|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24782889|NCT01898728|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24782890|NCT01898728|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24782891|NCT01898728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25213711|NCT04309773|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24936732|NCT04036890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24812132|NCT02049801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24812133|NCT02049801|Immunologic Factors|immunologic factors|mesh-ancestor
24812134|NCT02049801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782995|NCT01899703|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25213713|NCT04309773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25213714|NCT04309773|Antimetabolites|antimetabolites|mesh-ancestor
25213715|NCT04309773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213716|NCT04309773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25213717|NCT04300010|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25213718|NCT04300010|Dermatologic Agents|dermatologic agents|mesh-ancestor
24782892|NCT01898728|Trace Elements|trace elements|mesh-ancestor
24782893|NCT01898728|Micronutrients|micronutrients|mesh-ancestor
24782894|NCT01898728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782915|NCT01899027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782916|NCT01899027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24782917|NCT01899027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24782918|NCT01899027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24782920|NCT01899066|Etoposide|etoposide|mesh-list
24782921|NCT01899066|Vincristine|vincristine|mesh-list
24782922|NCT01899066|Ranibizumab|ranibizumab|mesh-list
24782923|NCT01899066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24782924|NCT01899066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24782925|NCT01899066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24782926|NCT01899066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24782927|NCT01899066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24782928|NCT01899066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782929|NCT01899066|Tubulin Modulators|tubulin modulators|mesh-ancestor
24782930|NCT01899066|Antimitotic Agents|antimitotic agents|mesh-ancestor
24782931|NCT01899066|Mitosis Modulators|mitosis modulators|mesh-ancestor
24782932|NCT01899066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24936749|NCT04036487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782933|NCT01899066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24782934|NCT01899066|Growth Substances|growth substances|mesh-ancestor
24782935|NCT01899066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782936|NCT01899066|Growth Inhibitors|growth inhibitors|mesh-ancestor
24782937|NCT01899105|Ivacaftor|ivacaftor|mesh-list
24782938|NCT01899105|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24782939|NCT01899105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24920364|NCT04202809|Durvalumab|durvalumab|mesh-list
25260891|NCT02456428|Tolbutamide|tolbutamide|mesh-list
25260892|NCT02456428|Voglibose|voglibose|mesh-list
24491758|NCT00483860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491759|NCT00483886|Prucalopride|prucalopride|mesh-list
24491760|NCT00483886|Laxatives|laxatives|mesh-ancestor
24491761|NCT00483886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24491762|NCT00483886|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24491763|NCT00483886|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24491764|NCT00483886|Serotonin Agents|serotonin agents|mesh-ancestor
24491765|NCT00483886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24491766|NCT00483886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491767|NCT00483886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491768|NCT00483964|Olanzapine|olanzapine|mesh-list
24491769|NCT00483964|Antiemetics|antiemetics|mesh-ancestor
24782940|NCT01899105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782941|NCT01899118|Capecitabine|capecitabine|mesh-list
24782942|NCT01899118|Oxaliplatin|oxaliplatin|mesh-list
24782943|NCT01899118|Nimotuzumab|nimotuzumab|mesh-list
24640228|NCT01167010|Budesonide|budesonide|mesh-list
24782944|NCT01899118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24491770|NCT00483964|Autonomic Agents|autonomic agents|mesh-ancestor
24491771|NCT00483964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24491791|NCT00483990|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24491792|NCT00484003|Pimecrolimus|pimecrolimus|mesh-list
25213721|NCT04285853|Narcotics|narcotics|mesh-ancestor
25213722|NCT04285853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25213723|NCT04285853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213724|NCT04285853|Analgesics|analgesics|mesh-ancestor
25213725|NCT04285853|Sensory System Agents|sensory system agents|mesh-ancestor
25213726|NCT04285853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25213727|NCT04224701|Vaccines|vaccines|mesh-list
25213728|NCT04224701|Immunologic Factors|immunologic factors|mesh-ancestor
24554983|NCT00739128|Vaccines|vaccines|mesh-list
24491816|NCT00484068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491818|NCT00484068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24491829|NCT00484120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24491830|NCT00484120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491831|NCT00484120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24491832|NCT00484120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24491833|NCT00484120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24491834|NCT00484120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491835|NCT00484120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491837|NCT00484133|Dopamine|dopamine|mesh-list
24491838|NCT00484133|Enoximone|enoximone|mesh-list
24491839|NCT00484133|Norepinephrine|norepinephrine|mesh-list
24491840|NCT00484133|Nitroglycerin|nitroglycerin|mesh-list
24491841|NCT00484133|Vasodilator Agents|vasodilator agents|mesh-ancestor
24491842|NCT00484133|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24782964|NCT01899248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782966|NCT01899326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782967|NCT01899326|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24782968|NCT01899326|Antidepressive Agents|antidepressive agents|mesh-ancestor
24782969|NCT01899326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25082157|NCT03324490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782970|NCT01899326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24782971|NCT01899326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782972|NCT01899326|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24782973|NCT01899326|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24724115|NCT01591135|Paclitaxel|paclitaxel|mesh-list
24782982|NCT01899430|Hormones|hormones|mesh-ancestor
24782983|NCT01899430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24782984|NCT01899521|Zinc Sulfate|zinc sulfate|mesh-list
24782985|NCT01899521|Astringents|astringents|mesh-ancestor
24782986|NCT01899521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782987|NCT01899521|Dermatologic Agents|dermatologic agents|mesh-ancestor
24782988|NCT01899690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24782989|NCT01899690|Clindamycin|clindamycin|mesh-list
24782990|NCT01899690|Cephalexin|cephalexin|mesh-list
24782991|NCT01899690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24920402|NCT04202835|Alkylating Agents|alkylating agents|mesh-ancestor
24491843|NCT00484133|Sympathomimetics|sympathomimetics|mesh-ancestor
24491844|NCT00484133|Autonomic Agents|autonomic agents|mesh-ancestor
24491845|NCT00484133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24491846|NCT00484133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678434|NCT01824693|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24491847|NCT00484133|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24491849|NCT00484133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24491850|NCT00484133|Adrenergic Agents|adrenergic agents|mesh-ancestor
24491851|NCT00484133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24491909|NCT00484484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24782993|NCT01899690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24782994|NCT01899690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272759|NCT02389972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272760|NCT02389972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272761|NCT02389751|Paclitaxel|paclitaxel|mesh-list
24782999|NCT01899755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24783000|NCT01899755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24783001|NCT01899755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24783002|NCT01899781|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24783003|NCT01899781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783004|NCT01899794|Mandelic Acids|mandelic acids|mesh-list
24783005|NCT01899794|Oxybutynin|oxybutynin|mesh-list
24783006|NCT01899794|Parasympatholytics|parasympatholytics|mesh-ancestor
24783007|NCT01899794|Autonomic Agents|autonomic agents|mesh-ancestor
24783008|NCT01899794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24783009|NCT01899794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783010|NCT01899794|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24783011|NCT01899794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24783012|NCT01899794|Cholinergic Agents|cholinergic agents|mesh-ancestor
24783013|NCT01899794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24783014|NCT01899794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783015|NCT01899794|Urological Agents|urological agents|mesh-ancestor
24783016|NCT01899794|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24783017|NCT01899794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783018|NCT01899794|Renal Agents|renal agents|mesh-ancestor
24783019|NCT01899820|Lumefantrine|lumefantrine|mesh-list
24783020|NCT01899820|Artemether|artemether|mesh-list
24783021|NCT01899820|Piperaquine|piperaquine|mesh-list
24783022|NCT01899820|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24491910|NCT00484484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24850485|NCT02253199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24491911|NCT00484484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491923|NCT00484575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491924|NCT00484575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24491925|NCT00484575|Anesthetics, General|anesthetics, general|mesh-ancestor
24491926|NCT00484575|Anesthetics|anesthetics|mesh-ancestor
24491927|NCT00484575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24783023|NCT01899820|Artenimol|artenimol|mesh-list
24783024|NCT01899820|Antimalarials|antimalarials|mesh-ancestor
24783025|NCT01899820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24783026|NCT01899820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24783027|NCT01899820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783028|NCT01899833|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
24783029|NCT01899833|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24783030|NCT01899833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783031|NCT01899846|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
24783032|NCT01899846|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
24783033|NCT01899846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24783034|NCT01899846|Hormone Antagonists|hormone antagonists|mesh-ancestor
24783035|NCT01899846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24783036|NCT01899846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783037|NCT01899846|Progestins|progestins|mesh-ancestor
24783038|NCT01899846|Hormones|hormones|mesh-ancestor
24783039|NCT01899898|Anticonvulsants|anticonvulsants|mesh-list
24783040|NCT01900015|Efavirenz|efavirenz|mesh-list
25213730|NCT04174196|Lenalidomide|lenalidomide|mesh-list
25213731|NCT04174196|Cc-486|cc-486|mesh-list
25213732|NCT04174196|Immunologic Factors|immunologic factors|mesh-ancestor
25213735|NCT04174196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25213737|NCT04174196|Growth Inhibitors|growth inhibitors|mesh-ancestor
25213738|NCT04174196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25213739|NCT04173962|Midazolam|midazolam|mesh-list
25213740|NCT04173962|Ketamine|ketamine|mesh-list
25213741|NCT04173962|Analgesics|analgesics|mesh-ancestor
25213742|NCT04173962|Sensory System Agents|sensory system agents|mesh-ancestor
25213743|NCT04173962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25272762|NCT02389751|Carboplatin|carboplatin|mesh-list
25157520|NCT04664972|Cyclophosphamide|cyclophosphamide|mesh-list
25157521|NCT04664972|Docetaxel|docetaxel|mesh-list
25157522|NCT04664972|Doxorubicin|doxorubicin|mesh-list
24936877|NCT04035096|Micronutrients|micronutrients|mesh-ancestor
24936878|NCT04035005|Ocrelizumab|ocrelizumab|mesh-list
24936879|NCT04035005|Immunologic Factors|immunologic factors|mesh-ancestor
24936880|NCT04035005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936881|NCT04034823|Docetaxel|docetaxel|mesh-list
24936882|NCT04034823|Trastuzumab|trastuzumab|mesh-list
24936883|NCT04034823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24936884|NCT04034823|Tubulin Modulators|tubulin modulators|mesh-ancestor
24936885|NCT04034823|Antimitotic Agents|antimitotic agents|mesh-ancestor
24936886|NCT04034823|Mitosis Modulators|mitosis modulators|mesh-ancestor
24936887|NCT04034823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25157523|NCT04664972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25157524|NCT04664972|Immunologic Factors|immunologic factors|mesh-ancestor
25157525|NCT04664972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25157526|NCT04664972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25157527|NCT04664972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25157528|NCT04664972|Alkylating Agents|alkylating agents|mesh-ancestor
25157529|NCT04664972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25157530|NCT04664972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25157531|NCT04664972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25157532|NCT04664972|Tubulin Modulators|tubulin modulators|mesh-ancestor
25116477|NCT03108300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25116478|NCT03108300|Adrenergic Agents|adrenergic agents|mesh-ancestor
25116479|NCT03108300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24783041|NCT01900015|Raltegravir Potassium|raltegravir potassium|mesh-list
24783042|NCT01900015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24783043|NCT01900015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24783044|NCT01900015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25082158|NCT03324490|Sensory System Agents|sensory system agents|mesh-ancestor
24461030|NCT00350597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783045|NCT01900015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783046|NCT01900015|Antiviral Agents|antiviral agents|mesh-ancestor
24783047|NCT01900015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783048|NCT01900015|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24783049|NCT01900015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24783050|NCT01900015|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24783051|NCT01900015|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24783052|NCT01900015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24783053|NCT01900015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24783054|NCT01900015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24783055|NCT01900015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24783056|NCT01900015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24783057|NCT01900015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24783060|NCT01900028|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24783061|NCT01900028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783062|NCT01900028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783063|NCT01900028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783064|NCT01900028|Antifungal Agents|antifungal agents|mesh-ancestor
24783065|NCT01900028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783066|NCT01900028|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24936889|NCT04035070|Clindamycin|clindamycin|mesh-list
24783067|NCT01900028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24783068|NCT01900028|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24783069|NCT01900028|Hormone Antagonists|hormone antagonists|mesh-ancestor
24783070|NCT01900028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24783071|NCT01900028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082169|NCT03324490|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24783072|NCT01900028|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24783074|NCT01900041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24783075|NCT01900041|Vasodilator Agents|vasodilator agents|mesh-ancestor
24783076|NCT01900093|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25213744|NCT04173962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213745|NCT04173962|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25213746|NCT04173962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25213747|NCT04173962|Anesthetics, General|anesthetics, general|mesh-ancestor
25213748|NCT04173962|Anesthetics|anesthetics|mesh-ancestor
24492050|NCT00485030|Antifungal Agents|antifungal agents|mesh-ancestor
25213753|NCT04173962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213754|NCT04173962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25213755|NCT04173962|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25213756|NCT04173962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25213757|NCT04173962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25213758|NCT04173962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25213759|NCT04173962|GABA Modulators|gaba modulators|mesh-ancestor
25213760|NCT04173962|GABA Agents|gaba agents|mesh-ancestor
25116480|NCT03108300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116481|NCT03108300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25116482|NCT03108300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25116483|NCT03108300|Vasodilator Agents|vasodilator agents|mesh-ancestor
25116484|NCT03108326|Infliximab|infliximab|mesh-list
25116485|NCT03108326|Ustekinumab|ustekinumab|mesh-list
25116486|NCT03108326|Vedolizumab|vedolizumab|mesh-list
25116487|NCT03108326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25116488|NCT03108326|Dermatologic Agents|dermatologic agents|mesh-ancestor
25116489|NCT03108326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25116490|NCT03108365|Hemostatics|hemostatics|mesh-list
25116491|NCT03108365|Chitosan|chitosan|mesh-list
25116492|NCT03108365|Coagulants|coagulants|mesh-ancestor
25116493|NCT03108365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25116494|NCT03108365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25116495|NCT03108365|Antimetabolites|antimetabolites|mesh-ancestor
24947983|NCT03924492|GABA Agents|gaba agents|mesh-ancestor
24783077|NCT01900093|Hormones|hormones|mesh-ancestor
24783078|NCT01900093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24783079|NCT01900093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491988|NCT00484809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24491989|NCT00484809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24491990|NCT00484809|Immunologic Factors|immunologic factors|mesh-ancestor
24491992|NCT00484822|Calcium heparin|calcium heparin|mesh-list
24783088|NCT01900106|Protease Inhibitors|protease inhibitors|mesh-ancestor
24783089|NCT01900106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783090|NCT01900106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783091|NCT01900106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24783092|NCT01900106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24783093|NCT01900106|Antiviral Agents|antiviral agents|mesh-ancestor
24783094|NCT01900106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783095|NCT01900106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24783096|NCT01900106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24783097|NCT01900106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24783098|NCT01900106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24783099|NCT01900106|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24783100|NCT01900106|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24783101|NCT01900106|Antimetabolites|antimetabolites|mesh-ancestor
24783102|NCT01900158|Gemcitabine|gemcitabine|mesh-list
24783103|NCT01900158|Cisplatin|cisplatin|mesh-list
24783104|NCT01900158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783105|NCT01900158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24783106|NCT01900158|Antimetabolites|antimetabolites|mesh-ancestor
24783107|NCT01900158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783108|NCT01900158|Antiviral Agents|antiviral agents|mesh-ancestor
24783109|NCT01900158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783110|NCT01900158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783111|NCT01900158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24491993|NCT00484822|Anticoagulants|anticoagulants|mesh-ancestor
24491994|NCT00484822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25116499|NCT03108365|Sequestering Agents|sequestering agents|mesh-ancestor
25116500|NCT03108248|Doxorubicin|doxorubicin|mesh-list
25116501|NCT03108248|Ethiodized Oil|ethiodized oil|mesh-list
25116502|NCT03108248|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
25116515|NCT03108287|Bismuth|bismuth|mesh-list
25157533|NCT04664972|Antimitotic Agents|antimitotic agents|mesh-ancestor
25157534|NCT04664972|Mitosis Modulators|mitosis modulators|mesh-ancestor
25157535|NCT04664972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25157536|NCT04664972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25157537|NCT04664972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25157538|NCT04664972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615886|NCT01032304|Erdosteine|erdosteine|mesh-list
24627863|NCT01095172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24627864|NCT01095172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24627865|NCT01095172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24627866|NCT01095172|Protective Agents|protective agents|mesh-ancestor
24627867|NCT01095185|Simvastatin|simvastatin|mesh-list
24627868|NCT01095185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24627869|NCT01095185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24627870|NCT01095185|Antimetabolites|antimetabolites|mesh-ancestor
24627871|NCT01095185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627872|NCT01095185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24627873|NCT01095185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24627874|NCT01095185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627875|NCT01095211|Vitamin B Complex|vitamin b complex|mesh-list
24627876|NCT01095211|Vitamins|vitamins|mesh-ancestor
25260958|NCT02456194|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25260959|NCT02456194|Calcium|calcium|mesh-list
25260960|NCT02456194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24932707|NCT04077333|Pulmonary Surfactants|pulmonary surfactants|mesh-list
24932708|NCT04077333|Respiratory System Agents|respiratory system agents|mesh-ancestor
24679330|NCT01367912|Estrogens|estrogens|mesh-ancestor
24627877|NCT01095211|Micronutrients|micronutrients|mesh-ancestor
24627878|NCT01095211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627879|NCT01095302|Docetaxel|docetaxel|mesh-list
24627880|NCT01095302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24627881|NCT01095302|Tubulin Modulators|tubulin modulators|mesh-ancestor
24627882|NCT01095302|Antimitotic Agents|antimitotic agents|mesh-ancestor
24627883|NCT01095302|Mitosis Modulators|mitosis modulators|mesh-ancestor
24627884|NCT01095302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213805|NCT04115189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25213807|NCT04115189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213808|NCT04115189|Growth Inhibitors|growth inhibitors|mesh-ancestor
25213809|NCT04115189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25213810|NCT04115189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051567|NCT00394121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24622454|NCT01067053|Antimetabolites|antimetabolites|mesh-ancestor
24555201|NCT00740415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24555202|NCT00740415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24555203|NCT00740415|Glucocorticoids|glucocorticoids|mesh-ancestor
24590355|NCT00912171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555205|NCT00740415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24555210|NCT00740467|Cyclosporine|cyclosporine|mesh-list
24783118|NCT01900301|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24783119|NCT01900301|Antiemetics|antiemetics|mesh-ancestor
24783120|NCT01900301|Autonomic Agents|autonomic agents|mesh-ancestor
24783121|NCT01900301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24783122|NCT01900301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783124|NCT01900301|Mydriatics|mydriatics|mesh-ancestor
24783134|NCT01900327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783135|NCT01900327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783136|NCT01900327|Antiviral Agents|antiviral agents|mesh-ancestor
24783137|NCT01900327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783138|NCT01900327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783139|NCT01900327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24783140|NCT01900327|Immunologic Factors|immunologic factors|mesh-ancestor
24783141|NCT01900327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783142|NCT01900405|Dexmedetomidine|dexmedetomidine|mesh-list
24783143|NCT01900405|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24783144|NCT01900405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25082164|NCT03324490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25082165|NCT03324490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25082166|NCT03324490|Adrenergic Agents|adrenergic agents|mesh-ancestor
25082167|NCT03324490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25082168|NCT03324490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082171|NCT03324490|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25082172|NCT03324490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25082173|NCT03324490|Anesthetics, General|anesthetics, general|mesh-ancestor
25082174|NCT03324425|Simvastatin|simvastatin|mesh-list
25082175|NCT03324425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25082176|NCT03324425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25082181|NCT03324425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783150|NCT01900405|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24783151|NCT01900405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25213811|NCT04115189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213812|NCT04077437|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25213813|NCT04077437|Hallucinogens|hallucinogens|mesh-ancestor
25213814|NCT04077437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213815|NCT04077437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25213816|NCT04077437|Serotonin Agents|serotonin agents|mesh-ancestor
25213817|NCT04077437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25213818|NCT04077437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678435|NCT01824693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678436|NCT01824693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25678437|NCT01824693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25678438|NCT01824693|Antitubercular Agents|antitubercular agents|mesh-ancestor
25678439|NCT01824693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25678440|NCT01824693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25692417|NCT01999335|Hormones|hormones|mesh-ancestor
25260970|NCT02456129|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25260971|NCT02456129|Hormone Antagonists|hormone antagonists|mesh-ancestor
24932729|NCT04077684|Interleukin-2|interleukin-2|mesh-list
25213819|NCT04077437|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25213820|NCT04077437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25213821|NCT04077437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25157569|NCT04647916|Camptothecin|camptothecin|mesh-list
25157571|NCT04647916|Immunoconjugates|immunoconjugates|mesh-list
25157572|NCT04647916|Immunologic Factors|immunologic factors|mesh-ancestor
25157573|NCT04647916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25157574|NCT04647916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25157575|NCT04647916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25157576|NCT04647916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25157577|NCT04647916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25157578|NCT04647916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25157579|NCT04647916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783152|NCT01900405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24783153|NCT01900405|Adrenergic Agents|adrenergic agents|mesh-ancestor
24783154|NCT01900405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24783155|NCT01900405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783156|NCT01900496|Rituximab|rituximab|mesh-list
24783157|NCT01900496|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24783158|NCT01900496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24783159|NCT01900496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24575137|NCT00829660|Acarbose|acarbose|mesh-list
24783160|NCT01900496|Immunologic Factors|immunologic factors|mesh-ancestor
24783161|NCT01900496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783162|NCT01900496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24783163|NCT01900509|Dexamethasone|dexamethasone|mesh-list
24783164|NCT01900509|Etoposide|etoposide|mesh-list
24783165|NCT01900509|Etoposide phosphate|etoposide phosphate|mesh-list
24783166|NCT01900509|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24783167|NCT01900509|Clofarabine|clofarabine|mesh-list
24783168|NCT01900509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24783169|NCT01900509|Antiemetics|antiemetics|mesh-ancestor
24783170|NCT01900509|Autonomic Agents|autonomic agents|mesh-ancestor
24850726|NCT02253914|Ritonavir|ritonavir|mesh-list
24783171|NCT01900509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24783172|NCT01900509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783173|NCT01900509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24783174|NCT01900509|Glucocorticoids|glucocorticoids|mesh-ancestor
24783175|NCT01900509|Hormones|hormones|mesh-ancestor
24783176|NCT01900509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24783177|NCT01900509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24783178|NCT01900509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783179|NCT01900509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24783180|NCT01900509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24783181|NCT01900509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24783182|NCT01900509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783183|NCT01900509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920540|NCT04201769|Dexamethasone|dexamethasone|mesh-list
24783184|NCT01900509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24783185|NCT01900509|Alkylating Agents|alkylating agents|mesh-ancestor
24783186|NCT01900509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24783187|NCT01900509|Antimetabolites|antimetabolites|mesh-ancestor
24783204|NCT01900639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24492070|NCT00485108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24492099|NCT00485238|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24492100|NCT00485238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492101|NCT00485238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492102|NCT00485238|Diuretics|diuretics|mesh-ancestor
24492103|NCT00485238|Natriuretic Agents|natriuretic agents|mesh-ancestor
24492104|NCT00485238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492105|NCT00485342|Interferons|interferons|mesh-list
24492106|NCT00485342|Ribavirin|ribavirin|mesh-list
24492107|NCT00485342|Interferon-alpha|interferon-alpha|mesh-list
24492113|NCT00485342|Antimetabolites|antimetabolites|mesh-ancestor
24492114|NCT00485342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678441|NCT01824823|Afatinib|afatinib|mesh-list
25678442|NCT01824823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678443|NCT01824823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25260984|NCT02456116|Sensory System Agents|sensory system agents|mesh-ancestor
25260985|NCT02456116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24936242|NCT04042948|Antipyretics|antipyretics|mesh-ancestor
24679657|NCT01369667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24854377|NCT02273466|Adrenergic Agents|adrenergic agents|mesh-ancestor
24905088|NCT04350645|Hemostatics|hemostatics|mesh-ancestor
24492115|NCT00485342|Immunologic Factors|immunologic factors|mesh-ancestor
24492116|NCT00485342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492117|NCT00485368|Perindopril|perindopril|mesh-list
24937162|NCT04032366|Antioxidants|antioxidants|mesh-ancestor
24492118|NCT00485368|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24492119|NCT00485368|Protease Inhibitors|protease inhibitors|mesh-ancestor
24492120|NCT00485368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492121|NCT00485368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492122|NCT00485368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24492123|NCT00485407|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24492137|NCT00485459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24783211|NCT01900639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24783212|NCT01900639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24783213|NCT01900639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783214|NCT01900639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24783215|NCT01900639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24783216|NCT01900639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783217|NCT01900639|Antipyretics|antipyretics|mesh-ancestor
24783218|NCT01900717|Leucovorin|leucovorin|mesh-list
24783219|NCT01900717|Bevacizumab|bevacizumab|mesh-list
24783220|NCT01900717|Fluorouracil|fluorouracil|mesh-list
24783221|NCT01900717|Oxaliplatin|oxaliplatin|mesh-list
24783222|NCT01900717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24783223|NCT01900717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783224|NCT01900717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24783225|NCT01900717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24783226|NCT01900717|Growth Substances|growth substances|mesh-ancestor
24783227|NCT01900717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783269|NCT01900860|Ergocalciferols|ergocalciferols|mesh-list
24783270|NCT01900860|Cholecalciferol|cholecalciferol|mesh-list
24783271|NCT01900860|Vitamins|vitamins|mesh-list
24783286|NCT01900938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783287|NCT01900938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24783288|NCT01900938|Anesthetics, General|anesthetics, general|mesh-ancestor
24850762|NCT02253953|Ritonavir|ritonavir|mesh-list
24937130|NCT04032834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24937131|NCT04032834|Autonomic Agents|autonomic agents|mesh-ancestor
24937154|NCT04032366|Nitric Oxide|nitric oxide|mesh-list
24783290|NCT01900938|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24783291|NCT01900938|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24783292|NCT01900938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24783293|NCT01900938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24783294|NCT01900938|GABA Modulators|gaba modulators|mesh-ancestor
24783295|NCT01900938|GABA Agents|gaba agents|mesh-ancestor
24783296|NCT01900938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24783297|NCT01900938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783298|NCT01900951|Temozolomide|temozolomide|mesh-list
24783299|NCT01900951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24783300|NCT01900951|Alkylating Agents|alkylating agents|mesh-ancestor
24783301|NCT01900951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783302|NCT01900951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783304|NCT01901003|Anticonvulsants|anticonvulsants|mesh-ancestor
24783305|NCT01901003|Antiemetics|antiemetics|mesh-ancestor
24783306|NCT01901003|Autonomic Agents|autonomic agents|mesh-ancestor
24783307|NCT01901003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25678444|NCT01824823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678445|NCT01824823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678446|NCT01824901|Docetaxel|docetaxel|mesh-list
25678447|NCT01824901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678448|NCT01824901|Tubulin Modulators|tubulin modulators|mesh-ancestor
25678449|NCT01824901|Antimitotic Agents|antimitotic agents|mesh-ancestor
25678450|NCT01824901|Mitosis Modulators|mitosis modulators|mesh-ancestor
25678451|NCT01824901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678452|NCT01825122|Nadolol|nadolol|mesh-list
24783308|NCT01901003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783309|NCT01901003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25260992|NCT02456025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260993|NCT02456025|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24679912|NCT01371474|Paroxetine|paroxetine|mesh-list
25157581|NCT04641247|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25157582|NCT04641247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25157583|NCT04641247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25157584|NCT04641247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783310|NCT01901003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24783311|NCT01901003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24783339|NCT01901172|Hormone Antagonists|hormone antagonists|mesh-ancestor
24783340|NCT01901172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24783341|NCT01901172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783342|NCT01901198|Interferons|interferons|mesh-list
24783343|NCT01901198|Interferon-alpha|interferon-alpha|mesh-list
24783344|NCT01901198|Interferon alpha-2|interferon alpha-2|mesh-list
24783345|NCT01901198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783346|NCT01901198|Antiviral Agents|antiviral agents|mesh-ancestor
24783347|NCT01901198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783348|NCT01901198|Immunologic Factors|immunologic factors|mesh-ancestor
24783349|NCT01901198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492138|NCT00485459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492140|NCT00485498|Risperidone|risperidone|mesh-list
24492141|NCT00485498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24937155|NCT04032366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24937161|NCT04032366|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24937164|NCT04032366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492142|NCT00485498|Serotonin Agents|serotonin agents|mesh-ancestor
24492143|NCT00485498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492144|NCT00485498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783351|NCT01901276|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24783352|NCT01901276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24783353|NCT01901276|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24783354|NCT01901276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783355|NCT01901276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783356|NCT01901380|Caseins|caseins|mesh-list
24783357|NCT01901380|Chelating Agents|chelating agents|mesh-ancestor
24783358|NCT01901380|Sequestering Agents|sequestering agents|mesh-ancestor
24783359|NCT01901380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783360|NCT01901432|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
24783361|NCT01901432|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24783362|NCT01901432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724833|NCT01594918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24492166|NCT00485550|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24492167|NCT00485550|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24492168|NCT00485550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492169|NCT00485550|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24492170|NCT00485550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24492179|NCT00485576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24492181|NCT00485576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492182|NCT00485628|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24492183|NCT00485628|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24492184|NCT00485628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24492185|NCT00485628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24937180|NCT04032132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937181|NCT04032184|Chlorhexidine|chlorhexidine|mesh-list
24850824|NCT02254031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24850825|NCT02254031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850826|NCT02254031|Tubulin Modulators|tubulin modulators|mesh-ancestor
24850827|NCT02254031|Antimitotic Agents|antimitotic agents|mesh-ancestor
24850828|NCT02254031|Mitosis Modulators|mitosis modulators|mesh-ancestor
24850829|NCT02254031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492186|NCT00485628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492187|NCT00485628|Adrenergic Agents|adrenergic agents|mesh-ancestor
24492188|NCT00485628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492189|NCT00485628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678453|NCT01825122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25678454|NCT01825122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25678455|NCT01825122|Adrenergic Agents|adrenergic agents|mesh-ancestor
24932736|NCT04077398|Ropivacaine|ropivacaine|mesh-list
25213842|NCT03991819|Pembrolizumab|pembrolizumab|mesh-list
25213843|NCT03991819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24492198|NCT00485680|Olanzapine|olanzapine|mesh-list
24492199|NCT00485680|Lithium Carbonate|lithium carbonate|mesh-list
24492200|NCT00485680|Antiemetics|antiemetics|mesh-ancestor
24492201|NCT00485680|Autonomic Agents|autonomic agents|mesh-ancestor
24783364|NCT01901471|Cyclosporine|cyclosporine|mesh-list
24783365|NCT01901471|Cyclosporins|cyclosporins|mesh-list
24783366|NCT01901471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783367|NCT01901471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783368|NCT01901471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24783369|NCT01901471|Immunologic Factors|immunologic factors|mesh-ancestor
24783370|NCT01901471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783371|NCT01901471|Antifungal Agents|antifungal agents|mesh-ancestor
24783372|NCT01901471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783373|NCT01901471|Dermatologic Agents|dermatologic agents|mesh-ancestor
24783374|NCT01901471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24783375|NCT01901471|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24783376|NCT01901484|Praziquantel|praziquantel|mesh-list
24783377|NCT01901484|Anthelmintics|anthelmintics|mesh-ancestor
24783378|NCT01901484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24783379|NCT01901484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783380|NCT01901549|Metoprolol|metoprolol|mesh-list
24783381|NCT01901549|Lisinopril|lisinopril|mesh-list
24783382|NCT01901549|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24783383|NCT01901549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24783384|NCT01901549|Sympatholytics|sympatholytics|mesh-ancestor
24920708|NCT04199013|Anesthetics, General|anesthetics, general|mesh-ancestor
24492202|NCT00485680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24492203|NCT00485680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492204|NCT00485680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24492205|NCT00485680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24492206|NCT00485680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24492207|NCT00485680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24492208|NCT00485680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24492209|NCT00485680|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24937240|NCT04031703|Cyclophosphamide|cyclophosphamide|mesh-list
24492210|NCT00485680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24492211|NCT00485680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24492212|NCT00485680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492213|NCT00485680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492214|NCT00485680|Serotonin Agents|serotonin agents|mesh-ancestor
24783393|NCT01901549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783394|NCT01901549|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24783395|NCT01901549|Protease Inhibitors|protease inhibitors|mesh-ancestor
24783396|NCT01901549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783397|NCT01901549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24783399|NCT01901601|Anesthetics|anesthetics|mesh-list
24783400|NCT01901601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25082182|NCT03324334|Antibodies|antibodies|mesh-list
25082183|NCT03324334|Immunologic Factors|immunologic factors|mesh-ancestor
24627886|NCT01095445|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24627887|NCT01095445|Antimetabolites|antimetabolites|mesh-ancestor
24627888|NCT01095445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627889|NCT01095445|Antiviral Agents|antiviral agents|mesh-ancestor
24627890|NCT01095445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24627891|NCT01095471|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25213844|NCT03991819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25213845|NCT03983031|Rituximab|rituximab|mesh-list
25213846|NCT03983031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25213847|NCT03983031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25213848|NCT03983031|Immunologic Factors|immunologic factors|mesh-ancestor
25213849|NCT03983031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213850|NCT03983031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25213851|NCT03983018|Rituximab|rituximab|mesh-list
24627893|NCT01095471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627894|NCT01095484|Rotigotine|rotigotine|mesh-list
24627895|NCT01095484|Dopamine Agonists|dopamine agonists|mesh-ancestor
24627896|NCT01095484|Dopamine Agents|dopamine agents|mesh-ancestor
24627897|NCT01095484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24627898|NCT01095484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627899|NCT01095484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627900|NCT01095575|Morphine|morphine|mesh-list
24783401|NCT01901601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783402|NCT01901640|Udenafil|udenafil|mesh-list
24783403|NCT01901640|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24783404|NCT01901640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24783504|NCT01902238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783505|NCT01902238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24783506|NCT01902238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783507|NCT01902238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783509|NCT01902342|Antiviral Agents|antiviral agents|mesh-ancestor
24783510|NCT01902342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783511|NCT01902342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783613|NCT01902862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850840|NCT02254148|Metoprolol|metoprolol|mesh-list
24783614|NCT01902862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24783616|NCT01902875|Cisplatin|cisplatin|mesh-list
24783617|NCT01902875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24783618|NCT01902875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783628|NCT01903057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25082184|NCT03324334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082185|NCT03324243|Cytarabine|cytarabine|mesh-list
25082186|NCT03324243|Fludarabine|fludarabine|mesh-list
25082187|NCT03324243|Crenolanib|crenolanib|mesh-list
24492215|NCT00485680|Antidepressive Agents|antidepressive agents|mesh-ancestor
24492216|NCT00485680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492217|NCT00485680|Antimanic Agents|antimanic agents|mesh-ancestor
24492219|NCT00485706|Calcium|calcium|mesh-list
24783694|NCT01903200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492220|NCT00485706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24492221|NCT00485706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492222|NCT00485706|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24492223|NCT00485771|Lamotrigine|lamotrigine|mesh-list
24492224|NCT00485771|Olanzapine|olanzapine|mesh-list
24492225|NCT00485771|Fluoxetine|fluoxetine|mesh-list
24492226|NCT00485771|Antiemetics|antiemetics|mesh-ancestor
25082188|NCT03324243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25082189|NCT03324243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25082190|NCT03324243|Antimetabolites|antimetabolites|mesh-ancestor
25082191|NCT03324243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213853|NCT03983018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25213854|NCT03983018|Immunologic Factors|immunologic factors|mesh-ancestor
25213855|NCT03983018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213856|NCT03983018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25213857|NCT03967847|Ketorolac|ketorolac|mesh-list
25213858|NCT03967847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25213859|NCT03967847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25213860|NCT03967847|Analgesics|analgesics|mesh-ancestor
25157604|NCT04635007|Tranexamic Acid|tranexamic acid|mesh-list
25157605|NCT04635007|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25157606|NCT04635007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25157607|NCT04635007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25157608|NCT04635007|Hemostatics|hemostatics|mesh-ancestor
25157609|NCT04635007|Coagulants|coagulants|mesh-ancestor
25157610|NCT04635007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25157611|NCT04635007|Abortifacient Agents|abortifacient agents|mesh-ancestor
25157612|NCT04635007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25157613|NCT04635007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25157614|NCT04635007|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25157615|NCT04635007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25157616|NCT04635007|Oxytocics|oxytocics|mesh-ancestor
25157617|NCT04634604|Bevacizumab|bevacizumab|mesh-list
25157618|NCT04634604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25082192|NCT03324243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25082193|NCT03324243|Immunologic Factors|immunologic factors|mesh-ancestor
25082194|NCT03324243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082195|NCT03324243|Antiviral Agents|antiviral agents|mesh-ancestor
25082196|NCT03324243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25082197|NCT03324139|Heparin|heparin|mesh-list
25082198|NCT03324139|Calcium heparin|calcium heparin|mesh-list
25082199|NCT03324139|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25082200|NCT03324139|Tinzaparin|tinzaparin|mesh-list
24783629|NCT01903057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783630|NCT01903057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24783631|NCT01903057|Anthelmintics|anthelmintics|mesh-ancestor
24783632|NCT01903057|Anticestodal Agents|anticestodal agents|mesh-ancestor
24932797|NCT04076826|Anesthetics|anesthetics|mesh-ancestor
24783633|NCT01903057|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24783634|NCT01903057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24783635|NCT01903057|Tubulin Modulators|tubulin modulators|mesh-ancestor
24783636|NCT01903057|Antimitotic Agents|antimitotic agents|mesh-ancestor
24783637|NCT01903057|Mitosis Modulators|mitosis modulators|mesh-ancestor
24579504|NCT00855660|Enzyme Activators|enzyme activators|mesh-ancestor
24783656|NCT01903083|Antiviral Agents|antiviral agents|mesh-ancestor
24783657|NCT01903083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783658|NCT01903083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783659|NCT01903083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24783660|NCT01903083|Immunologic Factors|immunologic factors|mesh-ancestor
24783661|NCT01903083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783662|NCT01903083|Vasodilator Agents|vasodilator agents|mesh-ancestor
24783663|NCT01903083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24783664|NCT01903083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24783680|NCT01903122|Autonomic Agents|autonomic agents|mesh-ancestor
24783681|NCT01903122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24783682|NCT01903122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783683|NCT01903122|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24783684|NCT01903122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24783685|NCT01903122|Cholinergic Agents|cholinergic agents|mesh-ancestor
24783686|NCT01903122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24783687|NCT01903122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783688|NCT01903200|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24783689|NCT01903200|Antidepressive Agents|antidepressive agents|mesh-ancestor
24783690|NCT01903200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24783691|NCT01903200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24783692|NCT01903200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24783693|NCT01903200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24783817|NCT01904162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25213861|NCT03967847|Sensory System Agents|sensory system agents|mesh-ancestor
25213862|NCT03967847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25213863|NCT03967847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213864|NCT03967847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25213865|NCT03967847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25213868|NCT03967847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213870|NCT03944954|Hallucinogens|hallucinogens|mesh-ancestor
25213871|NCT03944954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213872|NCT03944954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24937263|NCT04031157|Antidepressive Agents|antidepressive agents|mesh-list
24937264|NCT04031157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25213873|NCT03944954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25213874|NCT03944954|Analgesics|analgesics|mesh-ancestor
25213875|NCT03944954|Sensory System Agents|sensory system agents|mesh-ancestor
25157619|NCT04634604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25157620|NCT04634604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25157621|NCT04634604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25157622|NCT04634604|Growth Substances|growth substances|mesh-ancestor
25157623|NCT04634604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25157624|NCT04634604|Growth Inhibitors|growth inhibitors|mesh-ancestor
25157625|NCT04634578|Bevacizumab|bevacizumab|mesh-list
24492309|NCT00485862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492310|NCT00485862|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24492311|NCT00485862|Adrenergic Agents|adrenergic agents|mesh-ancestor
24492312|NCT00485875|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24492313|NCT00485875|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24492317|NCT00485875|Adrenergic Agents|adrenergic agents|mesh-ancestor
24492371|NCT00486005|Antiemetics|antiemetics|mesh-ancestor
24492372|NCT00486005|Autonomic Agents|autonomic agents|mesh-ancestor
24492373|NCT00486005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24492374|NCT00486005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492375|NCT00486005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24492376|NCT00486005|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24492377|NCT00486005|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24492378|NCT00486005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24492379|NCT00486005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24725161|NCT01596647|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24783746|NCT01903694|Antimetabolites|antimetabolites|mesh-ancestor
24783747|NCT01903694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24783748|NCT01903694|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25678456|NCT01825122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24783749|NCT01903785|Albuterol|albuterol|mesh-list
24783750|NCT01903785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24783751|NCT01903785|Autonomic Agents|autonomic agents|mesh-ancestor
24783752|NCT01903785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24783753|NCT01903785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783754|NCT01903785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24783756|NCT01903785|Tocolytic Agents|tocolytic agents|mesh-ancestor
24783757|NCT01903785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24783758|NCT01903785|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24783759|NCT01903785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24783764|NCT01903824|Modafinil|modafinil|mesh-list
24783781|NCT01904045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24937265|NCT04031027|Apremilast|apremilast|mesh-list
24783782|NCT01904045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783783|NCT01904045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783785|NCT01904097|Analgesics|analgesics|mesh-ancestor
24783786|NCT01904097|Sensory System Agents|sensory system agents|mesh-ancestor
24783787|NCT01904097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24783788|NCT01904097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783789|NCT01904097|Anticonvulsants|anticonvulsants|mesh-ancestor
24783790|NCT01904097|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24783791|NCT01904097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24783792|NCT01904097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783793|NCT01904097|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24783794|NCT01904097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24783795|NCT01904097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24783796|NCT01904097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24783797|NCT01904097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24783798|NCT01904110|Cholecalciferol|cholecalciferol|mesh-list
24783799|NCT01904110|Vitamin D|vitamin d|mesh-list
24783800|NCT01904110|Risedronic Acid|risedronic acid|mesh-list
24783801|NCT01904110|Etidronic Acid|etidronic acid|mesh-list
24783804|NCT01904110|Vitamins|vitamins|mesh-ancestor
24783805|NCT01904110|Micronutrients|micronutrients|mesh-ancestor
24783806|NCT01904110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24783807|NCT01904110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24783808|NCT01904110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25213876|NCT03944954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25213877|NCT03944954|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25213878|NCT03944954|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25213879|NCT03944954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25213880|NCT03944954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213881|NCT03944954|Hormones|hormones|mesh-ancestor
25157626|NCT04634578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25157627|NCT04634578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25157628|NCT04634578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25157629|NCT04634578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24783809|NCT01904110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783810|NCT01904162|Finafloxacin|finafloxacin|mesh-list
24575804|NCT00834457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24621192|NCT01060930|Autonomic Agents|autonomic agents|mesh-ancestor
24850895|NCT02254174|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24621193|NCT01060930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24621194|NCT01060930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24621195|NCT01060930|Respiratory System Agents|respiratory system agents|mesh-ancestor
24621196|NCT01060930|Mydriatics|mydriatics|mesh-ancestor
24621197|NCT01060930|Sympathomimetics|sympathomimetics|mesh-ancestor
24621198|NCT01060930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24621199|NCT01060930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621200|NCT01060969|Acetazolamide|acetazolamide|mesh-list
24621201|NCT01060969|Tadalafil|tadalafil|mesh-list
24621202|NCT01060969|Vasodilator Agents|vasodilator agents|mesh-ancestor
24621203|NCT01060969|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24621204|NCT01060969|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24621205|NCT01060969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621225|NCT01061112|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24621226|NCT01061112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24621227|NCT01061112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621228|NCT01061112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621229|NCT01061112|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24621230|NCT01061112|Hormone Antagonists|hormone antagonists|mesh-ancestor
24621231|NCT01061112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24621232|NCT01061112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621233|NCT01061112|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24621234|NCT01061112|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24621235|NCT01061112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24492380|NCT00486005|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24492381|NCT00486005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24492438|NCT00486343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24492439|NCT00486343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24492440|NCT00486343|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24492441|NCT00486343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492442|NCT00486343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492443|NCT00486343|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24621238|NCT01061112|Sensory System Agents|sensory system agents|mesh-ancestor
24621239|NCT01061112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24621240|NCT01061112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24783811|NCT01904162|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24783812|NCT01904162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783813|NCT01904162|Renal Agents|renal agents|mesh-ancestor
24783814|NCT01904162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24783815|NCT01904162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24783816|NCT01904162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24783818|NCT01904162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783835|NCT01904357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783837|NCT01904487|Flumazenil|flumazenil|mesh-list
24783838|NCT01904487|Antidotes|antidotes|mesh-ancestor
24783839|NCT01904487|Protective Agents|protective agents|mesh-ancestor
24783840|NCT01904487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783841|NCT01904487|GABA Modulators|gaba modulators|mesh-ancestor
24783842|NCT01904487|GABA Agents|gaba agents|mesh-ancestor
24784052|NCT01905631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24784053|NCT01905631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784054|NCT01905631|Anesthetics, Local|anesthetics, local|mesh-ancestor
24784055|NCT01905631|Anesthetics|anesthetics|mesh-ancestor
24590357|NCT00912262|Antipruritics|antipruritics|mesh-ancestor
25213882|NCT03944954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25157630|NCT04634578|Growth Substances|growth substances|mesh-ancestor
25116530|NCT03108274|Fexofenadine|fexofenadine|mesh-list
25157631|NCT04634578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25157632|NCT04634578|Growth Inhibitors|growth inhibitors|mesh-ancestor
25157633|NCT04632927|Ustekinumab|ustekinumab|mesh-list
25157634|NCT04632927|Dermatologic Agents|dermatologic agents|mesh-ancestor
24784056|NCT01905631|Sensory System Agents|sensory system agents|mesh-ancestor
24784057|NCT01905631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24784058|NCT01905631|Antiemetics|antiemetics|mesh-ancestor
24784069|NCT01905696|Acetylcysteine|acetylcysteine|mesh-list
24576148|NCT00837174|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24576149|NCT00837174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24784132|NCT01906411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784133|NCT01906411|Dopamine Agents|dopamine agents|mesh-ancestor
24784134|NCT01906411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24784135|NCT01906411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784136|NCT01906411|Protective Agents|protective agents|mesh-ancestor
24784137|NCT01906450|Azithromycin|azithromycin|mesh-list
24784138|NCT01906450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24784139|NCT01906450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24784140|NCT01906528|Mivacurium|mivacurium|mesh-list
24784141|NCT01906528|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24784142|NCT01906528|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24784143|NCT01906528|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24784144|NCT01906528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24784145|NCT01906528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784146|NCT01906580|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24784147|NCT01906580|Entecavir|entecavir|mesh-list
24784148|NCT01906580|Antiviral Agents|antiviral agents|mesh-ancestor
24784149|NCT01906580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24784150|NCT01906671|Mercaptopurine|mercaptopurine|mesh-list
24492447|NCT00486356|Capecitabine|capecitabine|mesh-list
24492448|NCT00486356|Epirubicin|epirubicin|mesh-list
24492449|NCT00486356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24492506|NCT00486486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261061|NCT02455921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261062|NCT02455921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25261063|NCT02455921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24932853|NCT04076137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932855|NCT04076137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24932857|NCT04076228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24932858|NCT04076228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24932859|NCT04075955|Olanzapine|olanzapine|mesh-list
24932860|NCT04075955|Aprepitant|aprepitant|mesh-list
24932861|NCT04075955|Antiemetics|antiemetics|mesh-ancestor
24932862|NCT04075955|Autonomic Agents|autonomic agents|mesh-ancestor
24932863|NCT04075955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24409544|NCT00182442|Olanzapine|olanzapine|mesh-list
24492507|NCT00486486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24492508|NCT00486486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24492510|NCT00486564|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24492511|NCT00486564|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24492512|NCT00486564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24492513|NCT00486564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24492514|NCT00486668|Paclitaxel|paclitaxel|mesh-list
24492515|NCT00486668|Cyclophosphamide|cyclophosphamide|mesh-list
24492516|NCT00486668|Doxorubicin|doxorubicin|mesh-list
24784161|NCT01906749|Gout Suppressants|gout suppressants|mesh-ancestor
24784162|NCT01906749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24784163|NCT01906749|Tubulin Modulators|tubulin modulators|mesh-ancestor
24784164|NCT01906749|Antimitotic Agents|antimitotic agents|mesh-ancestor
24784165|NCT01906749|Mitosis Modulators|mitosis modulators|mesh-ancestor
24784166|NCT01906749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784167|NCT01906749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24627901|NCT01095575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24627903|NCT01095575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24627904|NCT01095575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627905|NCT01095575|Analgesics|analgesics|mesh-ancestor
24627906|NCT01095575|Sensory System Agents|sensory system agents|mesh-ancestor
24784552|NCT01908556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24784173|NCT01906762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784174|NCT01906762|Analgesics|analgesics|mesh-ancestor
24784175|NCT01906762|Sensory System Agents|sensory system agents|mesh-ancestor
24784176|NCT01906762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24784177|NCT01906762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24784179|NCT01906788|Lumefantrine|lumefantrine|mesh-list
24784209|NCT01906879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213889|NCT03913234|Trastuzumab|trastuzumab|mesh-list
25213890|NCT03913234|Letrozole|letrozole|mesh-list
25213891|NCT03913234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24784210|NCT01906879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24784211|NCT01906944|Triamcinolone|triamcinolone|mesh-list
24784212|NCT01906944|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24784213|NCT01906944|Bupivacaine|bupivacaine|mesh-list
24784214|NCT01906944|Anesthetics, Local|anesthetics, local|mesh-ancestor
24784215|NCT01906944|Anesthetics|anesthetics|mesh-ancestor
24784216|NCT01906944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24784217|NCT01906944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784218|NCT01906944|Sensory System Agents|sensory system agents|mesh-ancestor
24492561|NCT00486772|Calcium acetate|calcium acetate|mesh-list
24492562|NCT00486772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24492563|NCT00486772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492564|NCT00486772|Chelating Agents|chelating agents|mesh-ancestor
24492565|NCT00486772|Sequestering Agents|sequestering agents|mesh-ancestor
25678457|NCT01825122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678458|NCT01825122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678459|NCT01825122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25678460|NCT01825122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25678461|NCT01825122|Sympatholytics|sympatholytics|mesh-ancestor
25678462|NCT01825122|Autonomic Agents|autonomic agents|mesh-ancestor
25678463|NCT01825122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25678464|NCT01825408|Azithromycin|azithromycin|mesh-list
25678465|NCT01825408|Doxycycline|doxycycline|mesh-list
25678466|NCT01825408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25678467|NCT01825408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25678468|NCT01825408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25678469|NCT01825408|Antimalarials|antimalarials|mesh-ancestor
25678470|NCT01825408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24529876|NCT00628160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24529877|NCT00628160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24529878|NCT00628160|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24529879|NCT00628160|Dopamine Agents|dopamine agents|mesh-ancestor
24529880|NCT00628160|Protective Agents|protective agents|mesh-ancestor
24529881|NCT00628225|Bupropion|bupropion|mesh-list
24529882|NCT00628225|Nicotine|nicotine|mesh-list
24492647|NCT00487123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24492648|NCT00487136|Warfarin|warfarin|mesh-list
24492649|NCT00487136|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24492650|NCT00487136|Fenofibric acid|fenofibric acid|mesh-list
24492651|NCT00487136|Fenofibrate|fenofibrate|mesh-list
24492652|NCT00487136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24492653|NCT00487136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24492654|NCT00487136|Antimetabolites|antimetabolites|mesh-ancestor
24492655|NCT00487136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492656|NCT00487136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24492657|NCT00487136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24492658|NCT00487136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492659|NCT00487136|Anticoagulants|anticoagulants|mesh-ancestor
24492661|NCT00487175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24492662|NCT00487175|Narcotics|narcotics|mesh-ancestor
24492663|NCT00487175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24492664|NCT00487175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492665|NCT00487175|Analgesics|analgesics|mesh-ancestor
24492666|NCT00487175|Sensory System Agents|sensory system agents|mesh-ancestor
24921097|NCT04194294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24921098|NCT04194294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24921099|NCT04194294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24784231|NCT01907009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784232|NCT01907009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24784233|NCT01907009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25082201|NCT03324139|Dalteparin|dalteparin|mesh-list
25082202|NCT03324139|Anticoagulants|anticoagulants|mesh-ancestor
25082203|NCT03324139|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25082204|NCT03324139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25082205|NCT03324139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082206|NCT03324061|Fulvestrant|fulvestrant|mesh-list
25082207|NCT03324061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24784234|NCT01907009|Immunologic Factors|immunologic factors|mesh-ancestor
24784235|NCT01907009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784236|NCT01907009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24784237|NCT01907048|Rivaroxaban|rivaroxaban|mesh-list
24784247|NCT01907061|Antiviral Agents|antiviral agents|mesh-ancestor
24784249|NCT01907061|Expectorants|expectorants|mesh-ancestor
24784253|NCT01907061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784254|NCT01907061|Protective Agents|protective agents|mesh-ancestor
24784255|NCT01907061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784263|NCT01907165|Alkylating Agents|alkylating agents|mesh-ancestor
24784264|NCT01907165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784265|NCT01907165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784266|NCT01907165|Trace Elements|trace elements|mesh-ancestor
24784267|NCT01907165|Micronutrients|micronutrients|mesh-ancestor
24784268|NCT01907165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784269|NCT01907165|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24784283|NCT01907204|Prednisolone acetate|prednisolone acetate|mesh-list
24784285|NCT01907204|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24784286|NCT01907204|Prednisolone phosphate|prednisolone phosphate|mesh-list
25213892|NCT03913234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25213893|NCT03913234|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24784693|NCT01910077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678471|NCT01825408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25678472|NCT01825408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25678473|NCT01825408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678474|NCT01825408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678475|NCT01825512|Deferasirox|deferasirox|mesh-list
25678476|NCT01825512|Deferiprone|deferiprone|mesh-list
25678477|NCT01825512|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25678478|NCT01825512|Chelating Agents|chelating agents|mesh-ancestor
25678479|NCT01825512|Sequestering Agents|sequestering agents|mesh-ancestor
25678480|NCT01825512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533997|NCT00645632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24533999|NCT00645632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24784287|NCT01907204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24784288|NCT01907204|Antiemetics|antiemetics|mesh-ancestor
24784289|NCT01907204|Autonomic Agents|autonomic agents|mesh-ancestor
24784290|NCT01907204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24784291|NCT01907204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784292|NCT01907204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24784293|NCT01907204|Glucocorticoids|glucocorticoids|mesh-ancestor
24784294|NCT01907204|Hormones|hormones|mesh-ancestor
24784295|NCT01907204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24784296|NCT01907204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24784297|NCT01907204|Protective Agents|protective agents|mesh-ancestor
24784298|NCT01907204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24784299|NCT01907204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784300|NCT01907204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24784301|NCT01907204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24784302|NCT01907204|Respiratory System Agents|respiratory system agents|mesh-ancestor
24784303|NCT01907230|Entecavir|entecavir|mesh-list
24784304|NCT01907230|Antiviral Agents|antiviral agents|mesh-ancestor
24784305|NCT01907230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24784306|NCT01907308|Docetaxel|docetaxel|mesh-list
24784307|NCT01907308|Trebananib|trebananib|mesh-list
24784308|NCT01907308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784309|NCT01907308|Tubulin Modulators|tubulin modulators|mesh-ancestor
24784318|NCT01907373|Probenecid|probenecid|mesh-list
24784320|NCT01907373|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24784321|NCT01907373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24784322|NCT01907373|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24784323|NCT01907373|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24784353|NCT01907594|Cycloserine|cycloserine|mesh-list
24784354|NCT01907594|Nicotine|nicotine|mesh-list
24784356|NCT01907594|Autonomic Agents|autonomic agents|mesh-ancestor
24784357|NCT01907594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24784358|NCT01907594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784359|NCT01907594|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24784360|NCT01907594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24784361|NCT01907594|Cholinergic Agents|cholinergic agents|mesh-ancestor
24784395|NCT01907776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24784397|NCT01907802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784398|NCT01907802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24784399|NCT01907802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725610|NCT01598558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784429|NCT01907984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576545|NCT00839163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576546|NCT00839163|Anticoagulants|anticoagulants|mesh-ancestor
24576547|NCT00839163|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24576548|NCT00839163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24492667|NCT00487175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24534022|NCT00645723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24492668|NCT00487227|Caffeine|caffeine|mesh-list
24492669|NCT00487227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24492670|NCT00487227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492674|NCT00487227|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24492707|NCT00487448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24492708|NCT00487448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24492709|NCT00487448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492710|NCT00487591|Simvastatin|simvastatin|mesh-list
24576549|NCT00839163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24576550|NCT00839163|Hemostatics|hemostatics|mesh-ancestor
24576551|NCT00839163|Coagulants|coagulants|mesh-ancestor
24576552|NCT00839228|Perhexiline|perhexiline|mesh-list
24576553|NCT00839228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24576554|NCT00839228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25213894|NCT03913234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25213895|NCT03913234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272763|NCT02389751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24948021|NCT03923829|Astringents|astringents|mesh-ancestor
24784692|NCT01910077|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24576556|NCT00839228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24576557|NCT00839228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576558|NCT00839228|Vasodilator Agents|vasodilator agents|mesh-ancestor
24576559|NCT00839280|Pantothenic Acid|pantothenic acid|mesh-list
24576560|NCT00839280|Vitamin B Complex|vitamin b complex|mesh-ancestor
24576561|NCT00839280|Vitamins|vitamins|mesh-ancestor
24576562|NCT00839280|Micronutrients|micronutrients|mesh-ancestor
24576563|NCT00839280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621241|NCT01061112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24586291|NCT00890175|Loxapine|loxapine|mesh-list
24784434|NCT01907984|Sensory System Agents|sensory system agents|mesh-ancestor
24784435|NCT01907984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24784436|NCT01907984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24784437|NCT01907984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24784438|NCT01907984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24784439|NCT01907984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24784441|NCT01907997|Anesthetics, Local|anesthetics, local|mesh-ancestor
24492724|NCT00487734|Testosterone enanthate|testosterone enanthate|mesh-list
24492725|NCT00487734|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24492727|NCT00487734|Hormones|hormones|mesh-ancestor
24492728|NCT00487734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24492734|NCT00487773|Budesonide|budesonide|mesh-list
24492745|NCT00487773|Respiratory System Agents|respiratory system agents|mesh-ancestor
24492747|NCT00487773|Hormones|hormones|mesh-ancestor
24492748|NCT00487773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24784455|NCT01908075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24784456|NCT01908075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784457|NCT01908075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24784458|NCT01908075|Respiratory System Agents|respiratory system agents|mesh-ancestor
24784459|NCT01908075|Glucocorticoids|glucocorticoids|mesh-ancestor
24784460|NCT01908075|Hormones|hormones|mesh-ancestor
24586624|NCT00891475|Interferon-alpha|interferon-alpha|mesh-list
24784510|NCT01908335|Interferon-alpha|interferon-alpha|mesh-list
24784542|NCT01908478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24784543|NCT01908478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24784544|NCT01908478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24784545|NCT01908478|Immunologic Factors|immunologic factors|mesh-ancestor
24784546|NCT01908478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784547|NCT01908478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24784549|NCT01908556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784550|NCT01908556|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24784551|NCT01908556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24553659|NCT00732485|Fenofibrate|fenofibrate|mesh-list
24850990|NCT02254759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24850991|NCT02254759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850992|NCT02254824|Atorvastatin|atorvastatin|mesh-list
24850993|NCT02254824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24850994|NCT02254824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24784645|NCT01909752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24784646|NCT01909752|Alkylating Agents|alkylating agents|mesh-ancestor
24784647|NCT01909752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784648|NCT01909752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784649|NCT01909752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24784650|NCT01909752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24784651|NCT01909752|Interferon Inducers|interferon inducers|mesh-ancestor
24784652|NCT01909830|Gemcitabine|gemcitabine|mesh-list
25213896|NCT03913234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213897|NCT03913234|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25213898|NCT03913234|Hormone Antagonists|hormone antagonists|mesh-ancestor
24784653|NCT01909830|Pemetrexed|pemetrexed|mesh-list
24784654|NCT01909830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24784655|NCT01909830|Antimetabolites|antimetabolites|mesh-ancestor
24784689|NCT01910077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24784690|NCT01910077|Immunologic Factors|immunologic factors|mesh-ancestor
24784691|NCT01910077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784698|NCT01910090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24784699|NCT01910090|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24784700|NCT01910090|Histamine Antagonists|histamine antagonists|mesh-ancestor
24784701|NCT01910090|Histamine Agents|histamine agents|mesh-ancestor
24932909|NCT04075474|Protective Agents|protective agents|mesh-ancestor
24932910|NCT04075474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784702|NCT01910090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24784740|NCT01910155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24784741|NCT01910155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24784742|NCT01910155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24784743|NCT01910155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784744|NCT01910155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24784745|NCT01910155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24784746|NCT01910194|Insulin Glargine|insulin glargine|mesh-list
24784747|NCT01910194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24850999|NCT02254824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851000|NCT02254889|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24851001|NCT02254889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859053|NCT02301494|Immunologic Factors|immunologic factors|mesh-ancestor
24784748|NCT01910194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784749|NCT01910246|Metformin|metformin|mesh-list
24784750|NCT01910246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24784751|NCT01910246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784752|NCT01910259|Amiloride|amiloride|mesh-list
24784753|NCT01910259|Riluzole|riluzole|mesh-list
24784754|NCT01910259|Fluoxetine|fluoxetine|mesh-list
24784755|NCT01910259|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24785449|NCT01914432|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24576936|NCT00841074|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24576937|NCT00841074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24576938|NCT00841074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24576939|NCT00841074|Disinfectants|disinfectants|mesh-ancestor
24576940|NCT00841074|Dermatologic Agents|dermatologic agents|mesh-ancestor
24784949|NCT01911299|Antimetabolites|antimetabolites|mesh-ancestor
24785008|NCT01911494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785009|NCT01911494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24785011|NCT01911494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24785031|NCT01911598|Mitosis Modulators|mitosis modulators|mesh-ancestor
24785032|NCT01911598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785033|NCT01911624|Enoxaparin|enoxaparin|mesh-list
24785034|NCT01911624|Dabigatran|dabigatran|mesh-list
24785035|NCT01911624|Argatroban|argatroban|mesh-list
24785036|NCT01911624|Thrombin|thrombin|mesh-list
24785037|NCT01911624|Anticoagulants|anticoagulants|mesh-ancestor
24785038|NCT01911624|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24590358|NCT00912262|Dermatologic Agents|dermatologic agents|mesh-ancestor
25213899|NCT03913234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25213900|NCT03913234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851003|NCT02254915|BCG Vaccine|bcg vaccine|mesh-list
24785039|NCT01911624|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24785040|NCT01911624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785041|NCT01911624|Antithrombins|antithrombins|mesh-ancestor
24785042|NCT01911624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24785043|NCT01911624|Protease Inhibitors|protease inhibitors|mesh-ancestor
24785044|NCT01911624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24785045|NCT01911624|Hemostatics|hemostatics|mesh-ancestor
24785046|NCT01911624|Coagulants|coagulants|mesh-ancestor
24785047|NCT01911624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24785048|NCT01911728|Pioglitazone|pioglitazone|mesh-list
24627909|NCT01095640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24627910|NCT01095640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24627911|NCT01095640|Analgesics|analgesics|mesh-ancestor
24785049|NCT01911728|Midazolam|midazolam|mesh-list
24785050|NCT01911728|Omeprazole|omeprazole|mesh-list
24785051|NCT01911728|Warfarin|warfarin|mesh-list
24785052|NCT01911728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24785053|NCT01911728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24785054|NCT01911728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24785055|NCT01911728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785057|NCT01911728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24785058|NCT01911728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24785059|NCT01911728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24785060|NCT01911728|Anesthetics, General|anesthetics, general|mesh-ancestor
25678481|NCT01825577|Methylphenidate|methylphenidate|mesh-list
25678482|NCT01825577|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24785061|NCT01911728|Anesthetics|anesthetics|mesh-ancestor
24785062|NCT01911728|GABA Modulators|gaba modulators|mesh-ancestor
24785063|NCT01911728|GABA Agents|gaba agents|mesh-ancestor
25159904|NCT03504956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25678483|NCT01825577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678484|NCT01825577|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24625206|NCT01080911|Morphine|morphine|mesh-list
24625207|NCT01080911|Analgesics, Opioid|analgesics, opioid|mesh-list
24625208|NCT01080911|Narcotics|narcotics|mesh-ancestor
24529934|NCT00628316|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24529935|NCT00628316|Purinergic Agents|purinergic agents|mesh-ancestor
24625228|NCT01081002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24625229|NCT01081002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24785084|NCT01911949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785086|NCT01911949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24785087|NCT01911949|Autonomic Agents|autonomic agents|mesh-ancestor
24785088|NCT01911949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24785089|NCT01911949|Respiratory System Agents|respiratory system agents|mesh-ancestor
24785116|NCT01912066|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24785125|NCT01912066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24785126|NCT01912118|Remifentanil|remifentanil|mesh-list
24785128|NCT01912118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24785129|NCT01912118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24785130|NCT01912118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785131|NCT01912118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24785132|NCT01912118|Anesthetics, General|anesthetics, general|mesh-ancestor
24785133|NCT01912118|Anesthetics|anesthetics|mesh-ancestor
24785134|NCT01912118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24785135|NCT01912118|Narcotics|narcotics|mesh-ancestor
24785136|NCT01912118|Analgesics|analgesics|mesh-ancestor
25213912|NCT03894891|Docetaxel|docetaxel|mesh-list
25213913|NCT03894891|Nivolumab|nivolumab|mesh-list
25213914|NCT03894891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25213915|NCT03894891|Tubulin Modulators|tubulin modulators|mesh-ancestor
25213916|NCT03894891|Antimitotic Agents|antimitotic agents|mesh-ancestor
25213917|NCT03894891|Mitosis Modulators|mitosis modulators|mesh-ancestor
24785137|NCT01912118|Sensory System Agents|sensory system agents|mesh-ancestor
24534144|NCT00646139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534145|NCT00646139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534146|NCT00646152|Poly ICLC|poly iclc|mesh-list
24785138|NCT01912118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24785139|NCT01912378|Oxytocin|oxytocin|mesh-list
24785140|NCT01912378|Oxytocics|oxytocics|mesh-ancestor
24577259|NCT00842660|Antiviral Agents|antiviral agents|mesh-ancestor
24577260|NCT00842660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24577261|NCT00842660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921357|NCT04192656|Hormones|hormones|mesh-ancestor
24492763|NCT00487786|Docetaxel|docetaxel|mesh-list
24492764|NCT00487786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24492765|NCT00487786|Tubulin Modulators|tubulin modulators|mesh-ancestor
24492780|NCT00487812|Sympathomimetics|sympathomimetics|mesh-ancestor
24785197|NCT01912677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24785198|NCT01912677|Adrenergic Agents|adrenergic agents|mesh-ancestor
25082208|NCT03324061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25082209|NCT03324061|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25082210|NCT03324061|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24785199|NCT01912677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24785200|NCT01912677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24785201|NCT01912677|Sympathomimetics|sympathomimetics|mesh-ancestor
24785202|NCT01912677|Autonomic Agents|autonomic agents|mesh-ancestor
24785203|NCT01912677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24785204|NCT01912677|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24785213|NCT01912755|Carticaine|carticaine|mesh-list
24785214|NCT01912755|Epinephryl borate|epinephryl borate|mesh-list
24785215|NCT01912755|Anesthetics, Local|anesthetics, local|mesh-ancestor
24785216|NCT01912755|Anesthetics|anesthetics|mesh-ancestor
24785217|NCT01912755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24785218|NCT01912755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785219|NCT01912755|Sensory System Agents|sensory system agents|mesh-ancestor
24534147|NCT00646152|Interferon Inducers|interferon inducers|mesh-ancestor
24762099|NCT01766089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24851029|NCT02255006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24851030|NCT02255006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24851031|NCT02255006|Analgesics|analgesics|mesh-ancestor
25678485|NCT01825577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25678486|NCT01825577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25678487|NCT01825577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678488|NCT01825577|Dopamine Agents|dopamine agents|mesh-ancestor
25678489|NCT01825577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25678490|NCT01825655|Cetirizine|cetirizine|mesh-list
24851032|NCT02255006|Sensory System Agents|sensory system agents|mesh-ancestor
24851033|NCT02255006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851034|NCT02255006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851035|NCT02255006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24933002|NCT04075201|Immunologic Factors|immunologic factors|mesh-ancestor
24933003|NCT04075201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933005|NCT04074473|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24933006|NCT04074473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24933007|NCT04074473|Adrenergic Agents|adrenergic agents|mesh-ancestor
24933008|NCT04074473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24785220|NCT01912755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24492781|NCT00487812|Autonomic Agents|autonomic agents|mesh-ancestor
24492782|NCT00487812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24492783|NCT00487812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492784|NCT00487812|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24492785|NCT00487812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24492786|NCT00487812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24492787|NCT00487812|Adrenergic Agents|adrenergic agents|mesh-ancestor
24492788|NCT00487812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492789|NCT00487812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492790|NCT00487812|Protective Agents|protective agents|mesh-ancestor
24785221|NCT01912755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24785222|NCT01912755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24785223|NCT01912755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25213918|NCT03894891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213919|NCT03894891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25213920|NCT03894891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25213921|NCT03892785|Prednisone|prednisone|mesh-list
25213922|NCT03892785|Methotrexate|methotrexate|mesh-list
25213923|NCT03892785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25213924|NCT03892785|Glucocorticoids|glucocorticoids|mesh-ancestor
25213925|NCT03892785|Hormones|hormones|mesh-ancestor
25213926|NCT03892785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25213927|NCT03892785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213928|NCT03892785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24948052|NCT03923140|Tranilast|tranilast|mesh-list
24577324|NCT00843063|Pantoprazole|pantoprazole|mesh-list
24785254|NCT01913002|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
24785255|NCT01913002|Moxifloxacin|moxifloxacin|mesh-list
24785256|NCT01913002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24785257|NCT01913002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24785258|NCT01913002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24785259|NCT01913002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24785260|NCT01913002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24785261|NCT01913002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785262|NCT01913002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24785263|NCT01913002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785302|NCT01913379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24786409|NCT01919892|Lithium Carbonate|lithium carbonate|mesh-list
24785304|NCT01913379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24785305|NCT01913379|Hormone Antagonists|hormone antagonists|mesh-ancestor
24785306|NCT01913379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24785307|NCT01913379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785308|NCT01913379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24785309|NCT01913379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24785310|NCT01913379|Antimetabolites|antimetabolites|mesh-ancestor
24785311|NCT01913379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24785312|NCT01913379|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24785313|NCT01913431|Entecavir|entecavir|mesh-list
24785314|NCT01913431|Antiviral Agents|antiviral agents|mesh-ancestor
24785315|NCT01913431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24785316|NCT01913444|Antithrombins|antithrombins|mesh-list
24785317|NCT01913444|Antithrombin III|antithrombin iii|mesh-list
24785318|NCT01913444|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24837182|NCT02189655|Bupivacaine|bupivacaine|mesh-list
24785402|NCT01914081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785403|NCT01914081|Protective Agents|protective agents|mesh-ancestor
25678491|NCT01825655|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25678492|NCT01825655|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25678493|NCT01825655|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25678494|NCT01825655|Histamine Antagonists|histamine antagonists|mesh-ancestor
25678495|NCT01825655|Histamine Agents|histamine agents|mesh-ancestor
25678496|NCT01825655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25678497|NCT01825655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785404|NCT01914081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785405|NCT01914081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24785406|NCT01914081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24785408|NCT01914133|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
24785409|NCT01914133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24785410|NCT01914133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785411|NCT01914133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25082211|NCT03324061|Hormone Antagonists|hormone antagonists|mesh-ancestor
24785412|NCT01914133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785414|NCT01914146|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24785415|NCT01914146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24785416|NCT01914146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785417|NCT01914211|Tranexamic Acid|tranexamic acid|mesh-list
24785418|NCT01914211|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24785419|NCT01914211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24626276|NCT01086345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24785420|NCT01914211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785421|NCT01914211|Hemostatics|hemostatics|mesh-ancestor
24785422|NCT01914211|Coagulants|coagulants|mesh-ancestor
24492861|NCT00488384|Dermatologic Agents|dermatologic agents|mesh-ancestor
24492862|NCT00488436|Cyclosporine|cyclosporine|mesh-list
25213929|NCT03892785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25213930|NCT03892785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25213931|NCT03892785|Abortifacient Agents|abortifacient agents|mesh-ancestor
25213932|NCT03892785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25213933|NCT03892785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25213934|NCT03892785|Antimetabolites|antimetabolites|mesh-ancestor
25213935|NCT03892785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213936|NCT03892785|Dermatologic Agents|dermatologic agents|mesh-ancestor
25213937|NCT03892785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492863|NCT00488436|Cyclosporins|cyclosporins|mesh-list
24492864|NCT00488436|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24492865|NCT00488436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492866|NCT00488436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492867|NCT00488436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24785431|NCT01914250|Anesthetics, Local|anesthetics, local|mesh-ancestor
24785432|NCT01914250|Anesthetics|anesthetics|mesh-ancestor
24785433|NCT01914250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24785434|NCT01914367|Vaccines|vaccines|mesh-list
24785435|NCT01914367|Immunologic Factors|immunologic factors|mesh-ancestor
24785436|NCT01914367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785437|NCT01914380|Aflibercept|aflibercept|mesh-list
24785438|NCT01914380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24785439|NCT01914380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24785440|NCT01914380|Growth Substances|growth substances|mesh-ancestor
24785441|NCT01914380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785442|NCT01914380|Growth Inhibitors|growth inhibitors|mesh-ancestor
24785443|NCT01914380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24785444|NCT01914419|Oxytocin|oxytocin|mesh-list
24785445|NCT01914419|Oxytocics|oxytocics|mesh-ancestor
24785446|NCT01914419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24785447|NCT01914419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785448|NCT01914432|Telmisartan|telmisartan|mesh-list
24785453|NCT01914432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785454|NCT01914432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24577601|NCT00845104|Bevacizumab|bevacizumab|mesh-list
24921465|NCT04190927|Estradiol|estradiol|mesh-list
24492868|NCT00488436|Immunologic Factors|immunologic factors|mesh-ancestor
24492869|NCT00488436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492870|NCT00488436|Antifungal Agents|antifungal agents|mesh-ancestor
24492871|NCT00488436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24492872|NCT00488436|Dermatologic Agents|dermatologic agents|mesh-ancestor
24492873|NCT00488436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24492874|NCT00488436|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24492875|NCT00488527|Insulin Glargine|insulin glargine|mesh-list
24492876|NCT00488527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24492877|NCT00488527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492878|NCT00488540|Acetaminophen|acetaminophen|mesh-list
24492879|NCT00488540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24492880|NCT00488540|Analgesics|analgesics|mesh-ancestor
24492902|NCT00488605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24492903|NCT00488605|Glucocorticoids|glucocorticoids|mesh-ancestor
24492904|NCT00488605|Hormones|hormones|mesh-ancestor
24492945|NCT00488709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24785547|NCT01915069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785548|NCT01915069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24785549|NCT01915069|Respiratory System Agents|respiratory system agents|mesh-ancestor
24785550|NCT01915069|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24785561|NCT01915082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24785562|NCT01915082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24785563|NCT01915134|Gemcitabine|gemcitabine|mesh-list
24785565|NCT01915134|Endostatins|endostatins|mesh-list
24785566|NCT01915134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24785567|NCT01915134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24785568|NCT01915134|Antimetabolites|antimetabolites|mesh-ancestor
24785569|NCT01915134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785570|NCT01915134|Antiviral Agents|antiviral agents|mesh-ancestor
24785571|NCT01915134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24785577|NCT01915134|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24785578|NCT01915134|Growth Substances|growth substances|mesh-ancestor
24785579|NCT01915134|Growth Inhibitors|growth inhibitors|mesh-ancestor
24785580|NCT01915186|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24785581|NCT01915186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24785595|NCT01915277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24785596|NCT01915277|Analgesics|analgesics|mesh-ancestor
24785597|NCT01915277|Sensory System Agents|sensory system agents|mesh-ancestor
24785598|NCT01915277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24785599|NCT01915277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25213938|NCT03892785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25213939|NCT03892785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24785600|NCT01915277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24785601|NCT01915277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24785602|NCT01915277|Adrenergic Agents|adrenergic agents|mesh-ancestor
24785603|NCT01915277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24785604|NCT01915277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785605|NCT01915459|Botulinum Toxins|botulinum toxins|mesh-list
24785606|NCT01915459|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24785607|NCT01915459|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24785608|NCT01915459|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24785609|NCT01915459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24492953|NCT00488709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24492954|NCT00488709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24492955|NCT00488709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24492956|NCT00488709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492990|NCT00488891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785610|NCT01915459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785612|NCT01915459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24840027|NCT02206867|Adalimumab|adalimumab|mesh-list
24785623|NCT01915472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24785624|NCT01915472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785634|NCT01915550|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
24785635|NCT01915550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24785636|NCT01915550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785637|NCT01915602|Sorafenib|sorafenib|mesh-list
24785638|NCT01915602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24785639|NCT01915602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24785640|NCT01915602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534189|NCT00646386|Adalimumab|adalimumab|mesh-list
24785641|NCT01915602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785642|NCT01915758|Clindamycin|clindamycin|mesh-list
24785643|NCT01915758|Clindamycin palmitate|clindamycin palmitate|mesh-list
24785644|NCT01915758|Clindamycin phosphate|clindamycin phosphate|mesh-list
24785667|NCT01915979|Mitosis Modulators|mitosis modulators|mesh-ancestor
24785668|NCT01915979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785669|NCT01915979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24785670|NCT01915979|Glucocorticoids|glucocorticoids|mesh-ancestor
24785671|NCT01915979|Hormones|hormones|mesh-ancestor
24785672|NCT01915979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24785673|NCT01915979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785674|NCT01915979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24785675|NCT01915979|Respiratory System Agents|respiratory system agents|mesh-ancestor
24785676|NCT01916005|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24785677|NCT01916005|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24785730|NCT01916252|Glucocorticoids|glucocorticoids|mesh-ancestor
24785731|NCT01916252|Hormones|hormones|mesh-ancestor
24785732|NCT01916252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24785733|NCT01916252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24785735|NCT01916252|Immunologic Factors|immunologic factors|mesh-ancestor
24785736|NCT01916252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24785737|NCT01916252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24785738|NCT01916252|Growth Substances|growth substances|mesh-ancestor
24785739|NCT01916252|Growth Inhibitors|growth inhibitors|mesh-ancestor
24785740|NCT01916252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24785741|NCT01916252|Alkylating Agents|alkylating agents|mesh-ancestor
24785742|NCT01916252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785743|NCT01916252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25213940|NCT03892785|Immunologic Factors|immunologic factors|mesh-ancestor
25213941|NCT03892785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25213942|NCT03892785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24534192|NCT00646425|Basiliximab|basiliximab|mesh-list
24948067|NCT03923140|Histamine Agents|histamine agents|mesh-ancestor
24785744|NCT01916252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24785745|NCT01916252|Protease Inhibitors|protease inhibitors|mesh-ancestor
24785747|NCT01916265|Glucagon|glucagon|mesh-list
24785748|NCT01916265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24785749|NCT01916265|Hormones|hormones|mesh-ancestor
24578045|NCT00846703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578046|NCT00846703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24578048|NCT00846703|Hormones|hormones|mesh-ancestor
24578049|NCT00846703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24578050|NCT00846703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24785811|NCT01916642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785821|NCT01916733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24785822|NCT01916733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785824|NCT01916785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25082212|NCT03324061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25082213|NCT03324061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851083|NCT02255253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24851084|NCT02255253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24851085|NCT02255253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627912|NCT01095640|Sensory System Agents|sensory system agents|mesh-ancestor
24785825|NCT01916785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24785826|NCT01916785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24785846|NCT01916902|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24785847|NCT01916902|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24785848|NCT01916902|Purinergic Agents|purinergic agents|mesh-ancestor
24785849|NCT01916902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24785850|NCT01916902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785851|NCT01916902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785852|NCT01916915|Tramadol|tramadol|mesh-list
24785853|NCT01916915|Levobupivacaine|levobupivacaine|mesh-list
24785854|NCT01916915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24785855|NCT01916915|Narcotics|narcotics|mesh-ancestor
24785856|NCT01916915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24785857|NCT01916915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785858|NCT01916915|Analgesics|analgesics|mesh-ancestor
24785859|NCT01916915|Sensory System Agents|sensory system agents|mesh-ancestor
24785860|NCT01916915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24785861|NCT01916915|Anesthetics, Local|anesthetics, local|mesh-ancestor
24785862|NCT01916915|Anesthetics|anesthetics|mesh-ancestor
24785863|NCT01916954|Lumefantrine|lumefantrine|mesh-list
24785864|NCT01916954|Artemether|artemether|mesh-list
24785865|NCT01916954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24785866|NCT01916954|Antimalarials|antimalarials|mesh-ancestor
25213943|NCT03889743|Dexamethasone|dexamethasone|mesh-list
25213944|NCT03889743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25213945|NCT03889743|Antiemetics|antiemetics|mesh-ancestor
25213946|NCT03889743|Autonomic Agents|autonomic agents|mesh-ancestor
25213947|NCT03889743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25213948|NCT03889743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213949|NCT03889743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25213950|NCT03889743|Glucocorticoids|glucocorticoids|mesh-ancestor
24534199|NCT00646503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24534200|NCT00646503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534202|NCT00646516|Budesonide|budesonide|mesh-list
24933200|NCT04073927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933201|NCT04073927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785912|NCT01917097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24785913|NCT01917097|Analgesics|analgesics|mesh-ancestor
24785914|NCT01917097|Sensory System Agents|sensory system agents|mesh-ancestor
24785915|NCT01917097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24785924|NCT01917149|Benazepril|benazepril|mesh-list
24785925|NCT01917149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24785926|NCT01917149|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24785927|NCT01917149|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24785928|NCT01917149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785929|NCT01917149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24785930|NCT01917149|Sympatholytics|sympatholytics|mesh-ancestor
24785931|NCT01917149|Autonomic Agents|autonomic agents|mesh-ancestor
24785932|NCT01917149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24726383|NCT01603030|Glucocorticoids|glucocorticoids|mesh-ancestor
24785942|NCT01917279|Docetaxel|docetaxel|mesh-list
24785943|NCT01917279|Capecitabine|capecitabine|mesh-list
24785953|NCT01917318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24785954|NCT01917318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24785955|NCT01917318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785956|NCT01917318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24785957|NCT01917331|Beclomethasone|beclomethasone|mesh-list
24785958|NCT01917331|Glycopyrrolate|glycopyrrolate|mesh-list
24785959|NCT01917331|Formoterol Fumarate|formoterol fumarate|mesh-list
24785960|NCT01917331|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24785961|NCT01917331|Autonomic Agents|autonomic agents|mesh-ancestor
24785962|NCT01917331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24785988|NCT01917552|Capecitabine|capecitabine|mesh-list
24785989|NCT01917552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24785990|NCT01917552|Antimetabolites|antimetabolites|mesh-ancestor
24785991|NCT01917552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785992|NCT01917552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24785993|NCT01917578|Paclitaxel|paclitaxel|mesh-list
24785994|NCT01917578|Docetaxel|docetaxel|mesh-list
24785995|NCT01917578|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24785996|NCT01917578|Cyclophosphamide|cyclophosphamide|mesh-list
24785997|NCT01917578|Carboplatin|carboplatin|mesh-list
24785998|NCT01917578|Doxorubicin|doxorubicin|mesh-list
24785999|NCT01917578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24786000|NCT01917578|Fluorouracil|fluorouracil|mesh-list
24786001|NCT01917578|Trastuzumab|trastuzumab|mesh-list
24786002|NCT01917578|Epirubicin|epirubicin|mesh-list
24786003|NCT01917578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24786004|NCT01917578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24786005|NCT01917578|Tubulin Modulators|tubulin modulators|mesh-ancestor
24786006|NCT01917578|Antimitotic Agents|antimitotic agents|mesh-ancestor
24786007|NCT01917578|Mitosis Modulators|mitosis modulators|mesh-ancestor
24786008|NCT01917578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786009|NCT01917578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24786010|NCT01917578|Immunologic Factors|immunologic factors|mesh-ancestor
24786011|NCT01917578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786012|NCT01917578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24786013|NCT01917578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24492995|NCT00488891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492996|NCT00488891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492997|NCT00488891|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25678498|NCT01825655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678499|NCT01825798|Metformin|metformin|mesh-list
25678500|NCT01825798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25678501|NCT01825798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678502|NCT01825837|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25678503|NCT01825837|Anticonvulsants|anticonvulsants|mesh-ancestor
25678504|NCT01825837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25678505|NCT01825837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25678506|NCT01825837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25213951|NCT03889743|Hormones|hormones|mesh-ancestor
25159905|NCT03504956|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25213952|NCT03889743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25213953|NCT03889743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25213954|NCT03889743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24937563|NCT04027751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937564|NCT04027751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786014|NCT01917578|Alkylating Agents|alkylating agents|mesh-ancestor
24786015|NCT01917578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24786026|NCT01917617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24786027|NCT01917617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24786028|NCT01917617|Antimetabolites|antimetabolites|mesh-ancestor
24786029|NCT01917617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786038|NCT01917708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786039|NCT01917708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24786040|NCT01917708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24786041|NCT01917708|Immunologic Factors|immunologic factors|mesh-ancestor
24786042|NCT01917708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786043|NCT01917708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24786044|NCT01917721|Doxycycline|doxycycline|mesh-list
24843088|NCT02225548|Urological Agents|urological agents|mesh-ancestor
24786086|NCT01917877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24786087|NCT01917890|Curcumin|curcumin|mesh-list
24921739|NCT04187469|Rifampin|rifampin|mesh-list
24492998|NCT00488891|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24492999|NCT00488891|Dopamine Agents|dopamine agents|mesh-ancestor
24493000|NCT00488969|Morphine|morphine|mesh-list
24493001|NCT00488969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24493002|NCT00488969|Narcotics|narcotics|mesh-ancestor
24786088|NCT01917890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24786089|NCT01917890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24786090|NCT01917890|Analgesics|analgesics|mesh-ancestor
24786091|NCT01917890|Sensory System Agents|sensory system agents|mesh-ancestor
24786344|NCT01919255|Cathartics|cathartics|mesh-ancestor
24786092|NCT01917890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24786093|NCT01917890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786094|NCT01917890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24786095|NCT01917890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24786096|NCT01917890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24786097|NCT01917890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24786098|NCT01917890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578316|NCT00848523|Panobinostat|panobinostat|mesh-list
24578391|NCT00848861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24578392|NCT00848861|GABA Modulators|gaba modulators|mesh-ancestor
24578393|NCT00848861|GABA Agents|gaba agents|mesh-ancestor
24578394|NCT00848861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24578395|NCT00848861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578396|NCT00848861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24578397|NCT00848861|Narcotics|narcotics|mesh-ancestor
24578398|NCT00848861|Analgesics|analgesics|mesh-ancestor
24578399|NCT00848861|Sensory System Agents|sensory system agents|mesh-ancestor
24578400|NCT00848861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24621283|NCT01061372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24621284|NCT01061372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24621311|NCT01061450|Antimetabolites|antimetabolites|mesh-ancestor
24921803|NCT04186936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24921804|NCT04186936|Antifoaming Agents|antifoaming agents|mesh-ancestor
24921805|NCT04186936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621326|NCT01061697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24786113|NCT01918111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786114|NCT01918111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24786115|NCT01918111|Vasodilator Agents|vasodilator agents|mesh-ancestor
24786116|NCT01918111|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24786117|NCT01918111|Purinergic Agonists|purinergic agonists|mesh-ancestor
24786118|NCT01918111|Purinergic Agents|purinergic agents|mesh-ancestor
24786119|NCT01918111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24786231|NCT01918709|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24786232|NCT01918709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24786233|NCT01918709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24786234|NCT01918709|Antimetabolites|antimetabolites|mesh-ancestor
24786235|NCT01918709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786236|NCT01918709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24786237|NCT01918709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24786239|NCT01918709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24786240|NCT01918709|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24786241|NCT01918709|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24786242|NCT01918813|Vancomycin|vancomycin|mesh-list
24786243|NCT01918813|Mupirocin|mupirocin|mesh-list
24786244|NCT01918813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24786245|NCT01918813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24786246|NCT01918813|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24786247|NCT01918813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24786249|NCT01918852|Bevacizumab|bevacizumab|mesh-list
24786272|NCT01918904|Antidotes|antidotes|mesh-ancestor
24786273|NCT01918904|Protective Agents|protective agents|mesh-ancestor
24786274|NCT01918904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786275|NCT01918904|Antioxidants|antioxidants|mesh-ancestor
24786276|NCT01918904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786312|NCT01919008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24786313|NCT01919008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24786314|NCT01919008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24847558|NCT02247596|Resveratrol|resveratrol|mesh-list
24786329|NCT01919203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24786330|NCT01919203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786331|NCT01919203|Analgesics|analgesics|mesh-ancestor
24578547|NCT00849459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578548|NCT00849511|Melatonin|melatonin|mesh-list
24786343|NCT01919255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082228|NCT03323710|Sunitinib|sunitinib|mesh-list
25082229|NCT03323710|Propranolol|propranolol|mesh-list
25082230|NCT03323710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25082231|NCT03323710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25082232|NCT03323710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25082233|NCT03323710|Growth Substances|growth substances|mesh-ancestor
24558805|NCT05434546|Pregnanolone|pregnanolone|mesh-list
24786354|NCT01919294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24786355|NCT01919294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213966|NCT03863587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25213967|NCT03854500|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24786356|NCT01919294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24786357|NCT01919294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493003|NCT00488969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24493004|NCT00488969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493005|NCT00488969|Analgesics|analgesics|mesh-ancestor
24786360|NCT01919346|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24786371|NCT01919424|Respiratory System Agents|respiratory system agents|mesh-ancestor
24786372|NCT01919424|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24786373|NCT01919424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24786374|NCT01919424|Cholinergic Agents|cholinergic agents|mesh-ancestor
24786375|NCT01919424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24786376|NCT01919424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786377|NCT01919593|Chlorhexidine|chlorhexidine|mesh-list
24786378|NCT01919593|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24786379|NCT01919593|Povidone-Iodine|povidone-iodine|mesh-list
24786380|NCT01919593|Povidone|povidone|mesh-list
24786381|NCT01919593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24786382|NCT01919593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24786383|NCT01919593|Disinfectants|disinfectants|mesh-ancestor
24786384|NCT01919593|Dermatologic Agents|dermatologic agents|mesh-ancestor
24578696|NCT00850850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578697|NCT00850850|Miotics|miotics|mesh-ancestor
24578698|NCT00850850|Autonomic Agents|autonomic agents|mesh-ancestor
24578699|NCT00850850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24621336|NCT01061788|Everolimus|everolimus|mesh-list
24621337|NCT01061788|Panitumumab|panitumumab|mesh-list
24621338|NCT01061788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24621339|NCT01061788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24621340|NCT01061788|Immunologic Factors|immunologic factors|mesh-ancestor
24621341|NCT01061788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621342|NCT01061788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24621343|NCT01061814|Mipomersen|mipomersen|mesh-list
24921923|NCT04185233|Analgesics|analgesics|mesh-ancestor
24493006|NCT00488969|Sensory System Agents|sensory system agents|mesh-ancestor
24621344|NCT01061814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24621345|NCT01061814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24621346|NCT01061814|Antimetabolites|antimetabolites|mesh-ancestor
24621347|NCT01061814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621349|NCT01061853|Sirolimus|sirolimus|mesh-list
24621350|NCT01061853|Betamethasone|betamethasone|mesh-list
24621351|NCT01061853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24621352|NCT01061853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24621353|NCT01061853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24621354|NCT01061853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24621355|NCT01061853|Antifungal Agents|antifungal agents|mesh-ancestor
24621356|NCT01061853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24621381|NCT01062087|Anesthetics, Local|anesthetics, local|mesh-ancestor
24621383|NCT01062087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24621384|NCT01062087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621385|NCT01062087|Sensory System Agents|sensory system agents|mesh-ancestor
24621386|NCT01062087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24621387|NCT01062087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24621388|NCT01062087|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24621389|NCT01062087|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24786400|NCT01919788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24786401|NCT01919788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786402|NCT01919879|Cetuximab|cetuximab|mesh-list
25213968|NCT03854500|Tenecteplase|tenecteplase|mesh-list
25213969|NCT03854500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25213970|NCT03854500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24786403|NCT01919879|Afatinib|afatinib|mesh-list
25008460|NCT05207735|Capecitabine|capecitabine|mesh-list
24786405|NCT01919879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24786418|NCT01919905|Vitamin D|vitamin d|mesh-list
24786419|NCT01919905|Vitamins|vitamins|mesh-ancestor
24786420|NCT01919905|Micronutrients|micronutrients|mesh-ancestor
24786421|NCT01919905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786422|NCT01919905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24786423|NCT01919918|Adenosine|adenosine|mesh-list
24786424|NCT01919918|Analgesics|analgesics|mesh-ancestor
24786426|NCT01919918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24786427|NCT01919918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786428|NCT01919918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24786429|NCT01919918|Vasodilator Agents|vasodilator agents|mesh-ancestor
24786430|NCT01919918|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24786432|NCT01919918|Purinergic Agents|purinergic agents|mesh-ancestor
24786433|NCT01919918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24786434|NCT01919918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786435|NCT01920022|Contraceptive Agents|contraceptive agents|mesh-list
24786436|NCT01920022|Mifepristone|mifepristone|mesh-list
24786437|NCT01920022|Etonogestrel|etonogestrel|mesh-list
24786438|NCT01920022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24786439|NCT01920022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786440|NCT01920022|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24786441|NCT01920022|Abortifacient Agents|abortifacient agents|mesh-ancestor
24786480|NCT01920204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578708|NCT00851175|Caffeine|caffeine|mesh-list
24786481|NCT01920204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24786482|NCT01920204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24786483|NCT01920204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786484|NCT01920269|Mitomycins|mitomycins|mesh-list
24786485|NCT01920269|Mitomycin|mitomycin|mesh-list
24786486|NCT01920269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24786487|NCT01920269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24786488|NCT01920269|Alkylating Agents|alkylating agents|mesh-ancestor
24786489|NCT01920269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800861|NCT01978782|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24800862|NCT01978782|Antidepressive Agents|antidepressive agents|mesh-ancestor
24800863|NCT01978782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24800866|NCT01978873|Androgens|androgens|mesh-list
24801026|NCT01980472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25213971|NCT03854500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25213972|NCT03847506|Amlodipine|amlodipine|mesh-list
25213973|NCT03847506|Candesartan|candesartan|mesh-list
25213974|NCT03847506|Candesartan cilexetil|candesartan cilexetil|mesh-list
25213975|NCT03847506|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25213976|NCT03847506|Ezetimibe|ezetimibe|mesh-list
25213977|NCT03847506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25213978|NCT03847506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24933451|NCT04070495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25213979|NCT03847506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25213980|NCT03847506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948140|NCT03923036|Panitumumab|panitumumab|mesh-list
24801116|NCT01980966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24801117|NCT01980966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801118|NCT01980979|Treprostinil|treprostinil|mesh-list
24801119|NCT01980979|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24786493|NCT01920334|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24786494|NCT01920334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24786495|NCT01920334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24786496|NCT01920334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786497|NCT01920334|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24786498|NCT01920334|GABA Agonists|gaba agonists|mesh-ancestor
25082234|NCT03323710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082235|NCT03323710|Growth Inhibitors|growth inhibitors|mesh-ancestor
25082236|NCT03323710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25082237|NCT03323710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25082238|NCT03323710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082239|NCT03323710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25082240|NCT03323710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25082241|NCT03323710|Adrenergic Agents|adrenergic agents|mesh-ancestor
25082242|NCT03323710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25082243|NCT03323710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25082244|NCT03323710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25082245|NCT03323710|Vasodilator Agents|vasodilator agents|mesh-ancestor
24922029|NCT04184505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493007|NCT00488969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24493008|NCT00488995|Tremelimumab|tremelimumab|mesh-list
24493009|NCT00488995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493010|NCT00489073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24493011|NCT00489073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24493012|NCT00489073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24493013|NCT00489073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24493014|NCT00489073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493015|NCT00489073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24493017|NCT00489073|Analgesics|analgesics|mesh-ancestor
24493036|NCT00489151|Antiviral Agents|antiviral agents|mesh-ancestor
24493037|NCT00489151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493038|NCT00489151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24493039|NCT00489151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24493040|NCT00489164|Sirolimus|sirolimus|mesh-list
25082251|NCT03323697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25082252|NCT03323697|Serotonin Agents|serotonin agents|mesh-ancestor
25082253|NCT03323697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082254|NCT03323697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25082255|NCT03323697|Antidepressive Agents|antidepressive agents|mesh-ancestor
25082256|NCT03323697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25082257|NCT03323684|Acetaminophen|acetaminophen|mesh-list
25082258|NCT03323684|Ketorolac|ketorolac|mesh-list
25082259|NCT03323684|Fentanyl|fentanyl|mesh-list
25082260|NCT03323684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25082261|NCT03323684|Narcotics|narcotics|mesh-ancestor
25082262|NCT03323684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25082263|NCT03323684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082264|NCT03323684|Analgesics|analgesics|mesh-ancestor
25082265|NCT03323684|Sensory System Agents|sensory system agents|mesh-ancestor
25082266|NCT03323684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24786499|NCT01920334|GABA Agents|gaba agents|mesh-ancestor
24786500|NCT01920334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24786501|NCT01920334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786502|NCT01920386|Acetaminophen|acetaminophen|mesh-list
24786503|NCT01920386|Tramadol|tramadol|mesh-list
24786504|NCT01920386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24786505|NCT01920386|Analgesics|analgesics|mesh-ancestor
24493105|NCT00489593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25213981|NCT03847506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25213982|NCT03847506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25213983|NCT03847506|Vasodilator Agents|vasodilator agents|mesh-ancestor
25157732|NCT04615949|Anticonvulsants|anticonvulsants|mesh-ancestor
24948143|NCT03923036|Irinotecan|irinotecan|mesh-list
24493106|NCT00489593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24493107|NCT00489593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25159906|NCT03504956|Sympatholytics|sympatholytics|mesh-ancestor
24534251|NCT00646594|Autonomic Agents|autonomic agents|mesh-ancestor
24534252|NCT00646594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937664|NCT04026464|Acetaminophen|acetaminophen|mesh-list
24937665|NCT04026464|Ibuprofen|ibuprofen|mesh-list
24937666|NCT04026464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24937667|NCT04026464|Analgesics|analgesics|mesh-ancestor
24937668|NCT04026464|Sensory System Agents|sensory system agents|mesh-ancestor
24937669|NCT04026464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937670|NCT04026464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937671|NCT04026464|Antipyretics|antipyretics|mesh-ancestor
24937673|NCT04026464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24493112|NCT00489593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24493113|NCT00489593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493114|NCT00489593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24493115|NCT00489593|Serotonin Agents|serotonin agents|mesh-ancestor
24493116|NCT00489593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24493117|NCT00489593|Antidepressive Agents|antidepressive agents|mesh-ancestor
24493118|NCT00489593|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24493164|NCT00489775|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24493165|NCT00489775|Serotonin Agents|serotonin agents|mesh-ancestor
24493166|NCT00489775|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24786506|NCT01920386|Sensory System Agents|sensory system agents|mesh-ancestor
24786507|NCT01920386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24786508|NCT01920386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786509|NCT01920386|Antipyretics|antipyretics|mesh-ancestor
24786510|NCT01920386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24786511|NCT01920386|Narcotics|narcotics|mesh-ancestor
24786512|NCT01920386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24786514|NCT01920503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24786515|NCT01920503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24786516|NCT01920503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24786517|NCT01920503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24786518|NCT01920503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24786519|NCT01920503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786603|NCT01920919|Hormones|hormones|mesh-ancestor
24786604|NCT01920919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24786605|NCT01920919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24786606|NCT01920919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24786607|NCT01920945|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24786608|NCT01920945|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24786609|NCT01920945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24786610|NCT01920945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24786611|NCT01920945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786612|NCT01920945|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24786613|NCT01920945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24786614|NCT01920945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786615|NCT01920945|Cholinergic Agents|cholinergic agents|mesh-ancestor
24786694|NCT01921374|Vitamin B 12|vitamin b 12|mesh-list
24786695|NCT01921374|Interferons|interferons|mesh-list
24786696|NCT01921374|Interferon-gamma|interferon-gamma|mesh-list
24786697|NCT01921374|Interleukin-2|interleukin-2|mesh-list
24786698|NCT01921374|Interleukin-4|interleukin-4|mesh-list
24786699|NCT01921374|Dinoprostone|dinoprostone|mesh-list
24786700|NCT01921374|Hormones|hormones|mesh-list
24786701|NCT01921374|Estradiol|estradiol|mesh-list
24786702|NCT01921374|Testosterone|testosterone|mesh-list
24786703|NCT01921374|Progesterone|progesterone|mesh-list
24786704|NCT01921374|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24786705|NCT01921374|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24786706|NCT01921374|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
24786707|NCT01921374|Immunoglobulins|immunoglobulins|mesh-list
24786708|NCT01921374|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24786709|NCT01921374|Antibodies|antibodies|mesh-list
24786710|NCT01921374|Immunoglobulin G|immunoglobulin g|mesh-list
25213985|NCT03847506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25213986|NCT03847506|Antimetabolites|antimetabolites|mesh-ancestor
25213987|NCT03847506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25213988|NCT03847506|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25157738|NCT04599634|Obinutuzumab|obinutuzumab|mesh-list
25157739|NCT04599634|Magrolimab|magrolimab|mesh-list
25157740|NCT04599634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25157741|NCT04599634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24802106|NCT01987310|Atorvastatin|atorvastatin|mesh-list
24493168|NCT00489775|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24933650|NCT04068948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933651|NCT04068948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24933652|NCT04068948|Narcotics|narcotics|mesh-ancestor
24933653|NCT04068948|Analgesics|analgesics|mesh-ancestor
24933654|NCT04068948|Sensory System Agents|sensory system agents|mesh-ancestor
24933655|NCT04068948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24933656|NCT04068948|Antipruritics|antipruritics|mesh-ancestor
24933657|NCT04068948|Dermatologic Agents|dermatologic agents|mesh-ancestor
24933658|NCT04068948|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24933659|NCT04068948|Histamine Antagonists|histamine antagonists|mesh-ancestor
24493169|NCT00489775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493170|NCT00489840|Hydrocortisone|hydrocortisone|mesh-list
24493171|NCT00489840|Anecortave|anecortave|mesh-list
24493172|NCT00489840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24493173|NCT00489840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24493174|NCT00489840|Growth Substances|growth substances|mesh-ancestor
24493175|NCT00489840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493176|NCT00489840|Growth Inhibitors|growth inhibitors|mesh-ancestor
24493177|NCT00489840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493178|NCT00489840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24493179|NCT00489892|Modafinil|modafinil|mesh-list
24493180|NCT00489892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24786712|NCT01921374|Immunoglobulin A|immunoglobulin a|mesh-list
24786713|NCT01921374|Immunoglobulin M|immunoglobulin m|mesh-list
24786714|NCT01921374|beta-Endorphin|beta-endorphin|mesh-list
24786715|NCT01921374|Uric Acid|uric acid|mesh-list
24786716|NCT01921374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786717|NCT01921374|Vitamins|vitamins|mesh-ancestor
24786718|NCT01921374|Micronutrients|micronutrients|mesh-ancestor
24786719|NCT01921374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24786720|NCT01921374|Antiviral Agents|antiviral agents|mesh-ancestor
24786721|NCT01921374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24786739|NCT01921374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24578953|NCT00852670|Ponesimod|ponesimod|mesh-list
24578956|NCT00852670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24786740|NCT01921426|Avasopasem manganese|avasopasem manganese|mesh-list
24786741|NCT01921426|Antioxidants|antioxidants|mesh-ancestor
24786742|NCT01921426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786743|NCT01921426|Protective Agents|protective agents|mesh-ancestor
24786744|NCT01921426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786745|NCT01921582|Methylphenidate|methylphenidate|mesh-list
24493216|NCT00489983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24493217|NCT00489983|Immunologic Factors|immunologic factors|mesh-ancestor
24493218|NCT00489983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493219|NCT00489983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24786746|NCT01921582|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24786747|NCT01921582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786748|NCT01921582|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24786749|NCT01921582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24786750|NCT01921582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24786751|NCT01921582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786752|NCT01921582|Dopamine Agents|dopamine agents|mesh-ancestor
24786753|NCT01921582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24786754|NCT01921647|Amoxicillin|amoxicillin|mesh-list
24786755|NCT01921647|Clarithromycin|clarithromycin|mesh-list
24786756|NCT01921647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24786757|NCT01921647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24786758|NCT01921647|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24786759|NCT01921647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24786760|NCT01921647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786761|NCT01921647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24786762|NCT01921647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24786764|NCT01921673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24786765|NCT01921673|Tubulin Modulators|tubulin modulators|mesh-ancestor
25678507|NCT01825837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678508|NCT01825876|Warfarin|warfarin|mesh-list
25678509|NCT01825876|Evacetrapib|evacetrapib|mesh-list
25678510|NCT01825876|Anticoagulants|anticoagulants|mesh-ancestor
25678511|NCT01825876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25678512|NCT01825876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25678513|NCT01825876|Antimetabolites|antimetabolites|mesh-ancestor
25678514|NCT01825876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678515|NCT01825876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25678516|NCT01825889|Evacetrapib|evacetrapib|mesh-list
25678517|NCT01825889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24561502|NCT00760981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933707|NCT04067791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933708|NCT04067791|Protective Agents|protective agents|mesh-ancestor
24933709|NCT04067791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933710|NCT04067791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24786766|NCT01921673|Antimitotic Agents|antimitotic agents|mesh-ancestor
24786793|NCT01921790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24786794|NCT01921790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24786795|NCT01921790|Immunologic Factors|immunologic factors|mesh-ancestor
24786796|NCT01921790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24786797|NCT01921790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25213989|NCT03847506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24786836|NCT01921972|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24786837|NCT01921972|Autonomic Agents|autonomic agents|mesh-ancestor
24786838|NCT01921972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24786839|NCT01921972|Nootropic Agents|nootropic agents|mesh-ancestor
24786840|NCT01921985|Terlipressin|terlipressin|mesh-list
24786841|NCT01921985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24786842|NCT01921985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24786843|NCT01922141|Amlodipine|amlodipine|mesh-list
24786844|NCT01922141|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24786845|NCT01922141|Ramipril|ramipril|mesh-list
24786846|NCT01922141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24786847|NCT01922141|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24786848|NCT01922141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24786849|NCT01922141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786850|NCT01922141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24786851|NCT01922141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786852|NCT01922141|Vasodilator Agents|vasodilator agents|mesh-ancestor
24786853|NCT01922141|Diuretics|diuretics|mesh-ancestor
24786854|NCT01922141|Natriuretic Agents|natriuretic agents|mesh-ancestor
24786855|NCT01922141|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24786856|NCT01922141|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24786857|NCT01922141|Protease Inhibitors|protease inhibitors|mesh-ancestor
24786858|NCT01922141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24786859|NCT01922154|Ranibizumab|ranibizumab|mesh-list
24786860|NCT01922154|Mitomycin|mitomycin|mesh-list
24786861|NCT01922154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24786862|NCT01922154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24786863|NCT01922154|Growth Substances|growth substances|mesh-ancestor
24786864|NCT01922154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786865|NCT01922154|Growth Inhibitors|growth inhibitors|mesh-ancestor
24786867|NCT01922154|Alkylating Agents|alkylating agents|mesh-ancestor
24786868|NCT01922154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786869|NCT01922154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24853736|NCT02269735|Insulin Aspart|insulin aspart|mesh-list
24787003|NCT01923012|Hemostatics|hemostatics|mesh-ancestor
24787023|NCT01923090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787024|NCT01923090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787025|NCT01923090|Hormone Antagonists|hormone antagonists|mesh-ancestor
24787026|NCT01923090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24787027|NCT01923090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787028|NCT01923090|Urological Agents|urological agents|mesh-ancestor
24787029|NCT01923194|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24787455|NCT01925300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24787031|NCT01923194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24787032|NCT01923194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787033|NCT01923259|Donepezil|donepezil|mesh-list
24787034|NCT01923259|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24787035|NCT01923259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800081|NCT01973322|Vaccines|vaccines|mesh-list
24787045|NCT01923337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787046|NCT01923337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787047|NCT01923376|Lactulose|lactulose|mesh-list
24787049|NCT01923376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24787252|NCT01924104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787254|NCT01924104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24787255|NCT01924104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787256|NCT01924104|Antipyretics|antipyretics|mesh-ancestor
25678518|NCT01825889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25678519|NCT01825889|Antimetabolites|antimetabolites|mesh-ancestor
24562038|NCT00764244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678520|NCT01825889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678521|NCT01825889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25261557|NCT02452970|Antimetabolites|antimetabolites|mesh-ancestor
25261558|NCT02452970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933743|NCT04067856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24933744|NCT04067856|Glucocorticoids|glucocorticoids|mesh-ancestor
24787257|NCT01924104|Anticoagulants|anticoagulants|mesh-ancestor
24787259|NCT01924234|Remifentanil|remifentanil|mesh-list
24787260|NCT01924234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24787261|NCT01924234|Narcotics|narcotics|mesh-ancestor
24787262|NCT01924234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24787263|NCT01924234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787264|NCT01924234|Analgesics|analgesics|mesh-ancestor
24787265|NCT01924234|Sensory System Agents|sensory system agents|mesh-ancestor
24788167|NCT01929824|Vasodilator Agents|vasodilator agents|mesh-ancestor
24787281|NCT01924273|Dermatologic Agents|dermatologic agents|mesh-ancestor
24787282|NCT01924286|Prednisone|prednisone|mesh-list
24787283|NCT01924286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24787284|NCT01924286|Glucocorticoids|glucocorticoids|mesh-ancestor
24937735|NCT04025671|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24787285|NCT01924286|Hormones|hormones|mesh-ancestor
24787309|NCT01924325|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24787310|NCT01924325|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24787311|NCT01924325|Purinergic Agents|purinergic agents|mesh-ancestor
24787312|NCT01924325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24787313|NCT01924325|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24787314|NCT01924325|Antithrombins|antithrombins|mesh-ancestor
24787315|NCT01924325|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24787316|NCT01924325|Protease Inhibitors|protease inhibitors|mesh-ancestor
24787317|NCT01924325|Anticoagulants|anticoagulants|mesh-ancestor
24787318|NCT01924468|Haloperidol|haloperidol|mesh-list
24787319|NCT01924468|Haloperidol decanoate|haloperidol decanoate|mesh-list
24787323|NCT01924468|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24787324|NCT01924468|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24787325|NCT01924468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24787326|NCT01924468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787327|NCT01924468|Dopamine Agents|dopamine agents|mesh-ancestor
24787328|NCT01924468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25082267|NCT03323684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25082268|NCT03323684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24787329|NCT01924468|Antiemetics|antiemetics|mesh-ancestor
24616346|NCT01036412|Chlorhexidine|chlorhexidine|mesh-list
24787371|NCT01924624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24787373|NCT01924624|Growth Inhibitors|growth inhibitors|mesh-ancestor
24787374|NCT01924624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787375|NCT01924637|Insulin|insulin|mesh-list
24787376|NCT01924637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24787377|NCT01924637|Insulin Aspart|insulin aspart|mesh-list
24787378|NCT01924637|Insulin, Long-Acting|insulin, long-acting|mesh-list
24787379|NCT01924637|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24787380|NCT01924637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24787381|NCT01924637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787382|NCT01924676|Oxycodone|oxycodone|mesh-list
24787383|NCT01924676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24787384|NCT01924676|Narcotics|narcotics|mesh-ancestor
24787385|NCT01924676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24787386|NCT01924676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787387|NCT01924676|Analgesics|analgesics|mesh-ancestor
24787388|NCT01924676|Sensory System Agents|sensory system agents|mesh-ancestor
24787389|NCT01924676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24787390|NCT01924832|Dimethyl Fumarate|dimethyl fumarate|mesh-list
24787391|NCT01924832|Dermatologic Agents|dermatologic agents|mesh-ancestor
24787392|NCT01924832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24787393|NCT01924832|Immunologic Factors|immunologic factors|mesh-ancestor
24787453|NCT01925300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24787454|NCT01925300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787456|NCT01925300|Sympatholytics|sympatholytics|mesh-ancestor
24787457|NCT01925300|Autonomic Agents|autonomic agents|mesh-ancestor
24787458|NCT01925300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24787459|NCT01925300|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24801121|NCT01981031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24801122|NCT01981031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678522|NCT01825941|Diphenhydramine|diphenhydramine|mesh-list
25678523|NCT01825941|Promethazine|promethazine|mesh-list
25678524|NCT01825941|Metoclopramide|metoclopramide|mesh-list
25678525|NCT01825941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25678526|NCT01825941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24627937|NCT01095731|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24627938|NCT01095731|Immunologic Factors|immunologic factors|mesh-ancestor
24627939|NCT01095731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24627940|NCT01095731|Protective Agents|protective agents|mesh-ancestor
24627941|NCT01095731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24627942|NCT01095809|Triamcinolone|triamcinolone|mesh-list
24627943|NCT01095809|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24627944|NCT01095809|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24627945|NCT01095809|Bevacizumab|bevacizumab|mesh-list
24627946|NCT01095809|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24787460|NCT01925300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24787461|NCT01925300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24787462|NCT01925300|Adrenergic Agents|adrenergic agents|mesh-ancestor
24787463|NCT01925300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24787465|NCT01925352|Mitosis Modulators|mitosis modulators|mesh-ancestor
24787468|NCT01925378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24787469|NCT01925378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24787470|NCT01925378|Protease Inhibitors|protease inhibitors|mesh-ancestor
24787471|NCT01925378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787472|NCT01925378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787473|NCT01925378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24787474|NCT01925378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24787475|NCT01925378|Antiviral Agents|antiviral agents|mesh-ancestor
24787476|NCT01925378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24787477|NCT01925456|Fesoterodine|fesoterodine|mesh-list
24787478|NCT01925456|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24787479|NCT01925456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24787480|NCT01925456|Cholinergic Agents|cholinergic agents|mesh-ancestor
24787481|NCT01925456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24787541|NCT01925755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787543|NCT01925820|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24787544|NCT01925820|Entecavir|entecavir|mesh-list
24787545|NCT01925820|Antiviral Agents|antiviral agents|mesh-ancestor
24787546|NCT01925820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24787547|NCT01925859|Dexamethasone|dexamethasone|mesh-list
24787548|NCT01925859|Dexamethasone acetate|dexamethasone acetate|mesh-list
24787549|NCT01925859|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24787550|NCT01925859|BB 1101|bb 1101|mesh-list
24787551|NCT01925859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24787552|NCT01925859|Antiemetics|antiemetics|mesh-ancestor
24787611|NCT01925937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25082269|NCT03323684|Anesthetics, General|anesthetics, general|mesh-ancestor
25082270|NCT03323684|Anesthetics|anesthetics|mesh-ancestor
24800276|NCT01974518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787613|NCT01925937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579900|NCT00858663|Everolimus|everolimus|mesh-list
24579901|NCT00858663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579902|NCT00858663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24579903|NCT00858663|Immunologic Factors|immunologic factors|mesh-ancestor
24579904|NCT00858663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579905|NCT00858676|Acarbose|acarbose|mesh-list
24954074|NCT03879460|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25157756|NCT04588311|Epoetin Alfa|epoetin alfa|mesh-list
25157757|NCT04588311|Hematinics|hematinics|mesh-ancestor
24621440|NCT01062360|Respiratory System Agents|respiratory system agents|mesh-ancestor
24621441|NCT01062360|Nasal Decongestants|nasal decongestants|mesh-ancestor
24787662|NCT01926288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787663|NCT01926288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787664|NCT01926288|Antiviral Agents|antiviral agents|mesh-ancestor
24787665|NCT01926288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24787666|NCT01926379|Isoniazid|isoniazid|mesh-list
24787667|NCT01926379|Antitubercular Agents|antitubercular agents|mesh-ancestor
24787668|NCT01926379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24787669|NCT01926379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24787670|NCT01926379|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24787671|NCT01926379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24787672|NCT01926379|Antimetabolites|antimetabolites|mesh-ancestor
24787673|NCT01926379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787674|NCT01926379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24787675|NCT01926392|Sulfadiazine|sulfadiazine|mesh-list
24787676|NCT01926392|Silver Sulfadiazine|silver sulfadiazine|mesh-list
24787713|NCT01926652|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24787715|NCT01926665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24787716|NCT01926665|Antiemetics|antiemetics|mesh-ancestor
24787717|NCT01926665|Autonomic Agents|autonomic agents|mesh-ancestor
24787718|NCT01926665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24787719|NCT01926665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787720|NCT01926665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25261621|NCT02452606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25261622|NCT02452606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261623|NCT02452606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261625|NCT02452606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787721|NCT01926665|Glucocorticoids|glucocorticoids|mesh-ancestor
24787722|NCT01926665|Hormones|hormones|mesh-ancestor
24787723|NCT01926665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24787724|NCT01926665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24787725|NCT01926665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787726|NCT01926769|Metformin|metformin|mesh-list
24787727|NCT01926769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24787728|NCT01926769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787729|NCT01926821|Sizofiran|sizofiran|mesh-list
24787730|NCT01926821|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24787731|NCT01926821|Immunologic Factors|immunologic factors|mesh-ancestor
24787732|NCT01926821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787733|NCT01926821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24787734|NCT01926821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787735|NCT01926847|Riociguat|riociguat|mesh-list
24787736|NCT01926847|Enzyme Activators|enzyme activators|mesh-ancestor
24787737|NCT01926847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787738|NCT01926860|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24787739|NCT01926860|Immunologic Factors|immunologic factors|mesh-ancestor
24787759|NCT01927315|Antimetabolites|antimetabolites|mesh-ancestor
24787760|NCT01927315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787761|NCT01927315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24579989|NCT00859235|Chlorhexidine|chlorhexidine|mesh-list
24787762|NCT01927328|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
24787763|NCT01927328|Hematinics|hematinics|mesh-ancestor
24787765|NCT01927406|Bimatoprost|bimatoprost|mesh-list
24787766|NCT01927406|Travoprost|travoprost|mesh-list
24787767|NCT01927406|Latanoprost|latanoprost|mesh-list
24787768|NCT01927406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24787769|NCT01927406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24787770|NCT01927406|Adrenergic Agents|adrenergic agents|mesh-ancestor
24787771|NCT01927406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24787772|NCT01927406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787785|NCT01927484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787787|NCT01927484|Dermatologic Agents|dermatologic agents|mesh-ancestor
24787788|NCT01927484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787789|NCT01927484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24787790|NCT01927484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24787791|NCT01927484|Immunologic Factors|immunologic factors|mesh-ancestor
24787792|NCT01927484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24787793|NCT01927484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24787794|NCT01927588|Prednisone|prednisone|mesh-list
24787798|NCT01927588|Glucocorticoids|glucocorticoids|mesh-ancestor
24787799|NCT01927588|Hormones|hormones|mesh-ancestor
24450927|NCT00321009|Enoxaparin|enoxaparin|mesh-list
24762614|NCT01768884|Protective Agents|protective agents|mesh-ancestor
24762615|NCT01768897|Thioctic Acid|thioctic acid|mesh-list
24762616|NCT01768897|Cytarabine|cytarabine|mesh-list
24762617|NCT01768897|Mitoxantrone|mitoxantrone|mesh-list
24762618|NCT01768897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24762619|NCT01768897|Antimetabolites|antimetabolites|mesh-ancestor
24762620|NCT01768897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787800|NCT01927588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24787801|NCT01927588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787802|NCT01927588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24787803|NCT01927588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787804|NCT01927588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24787805|NCT01927588|Immunologic Factors|immunologic factors|mesh-ancestor
24787806|NCT01927588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24787807|NCT01927588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787823|NCT01927640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787824|NCT01927640|Anesthetics, Local|anesthetics, local|mesh-ancestor
24787825|NCT01927640|Anesthetics|anesthetics|mesh-ancestor
25678527|NCT01825941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25678528|NCT01825941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678529|NCT01825941|Anesthetics, Local|anesthetics, local|mesh-ancestor
25678530|NCT01825941|Anesthetics|anesthetics|mesh-ancestor
24787827|NCT01927640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24787828|NCT01927640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24787829|NCT01927640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24787830|NCT01927640|Dopamine Agents|dopamine agents|mesh-ancestor
24787832|NCT01927679|Antioxidants|antioxidants|mesh-list
24787833|NCT01927679|Vitamins|vitamins|mesh-ancestor
24787834|NCT01927679|Micronutrients|micronutrients|mesh-ancestor
24787835|NCT01927679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787836|NCT01927679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580135|NCT00860496|Antifungal Agents|antifungal agents|mesh-ancestor
24580136|NCT00860496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24580137|NCT00860496|Dermatologic Agents|dermatologic agents|mesh-ancestor
24580138|NCT00860496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24580139|NCT00860496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24580140|NCT00860626|Interferons|interferons|mesh-list
24580141|NCT00860626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24580142|NCT00860626|Antiviral Agents|antiviral agents|mesh-ancestor
24580143|NCT00860626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24580145|NCT00860639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24580146|NCT00860639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24621457|NCT01062503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621458|NCT01062516|Esomeprazole|esomeprazole|mesh-list
24621459|NCT01062516|Famotidine|famotidine|mesh-list
24621460|NCT01062516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24621461|NCT01062516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24621462|NCT01062516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24621463|NCT01062516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621478|NCT01062633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24621479|NCT01062698|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24621480|NCT01062698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24621481|NCT01062698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25082290|NCT03323671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627948|NCT01095809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24627956|NCT01095809|Hormones|hormones|mesh-ancestor
24627957|NCT01095809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24627958|NCT01095809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24627959|NCT01095809|Immunologic Factors|immunologic factors|mesh-ancestor
24627960|NCT01095809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24659870|NCT01280162|Piperaquine|piperaquine|mesh-list
24627963|NCT01095822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24627964|NCT01095822|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24627965|NCT01095822|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24627966|NCT01095822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627967|NCT01095848|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
24627968|NCT01095848|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24627969|NCT01095848|Immunologic Factors|immunologic factors|mesh-ancestor
24621482|NCT01062698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621483|NCT01062776|Furosemide|furosemide|mesh-list
24621484|NCT01062776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24621485|NCT01062776|Diuretics|diuretics|mesh-ancestor
24621486|NCT01062776|Natriuretic Agents|natriuretic agents|mesh-ancestor
24621487|NCT01062776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621488|NCT01062776|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24621489|NCT01062776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24621490|NCT01062776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621492|NCT01062802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24621493|NCT01062802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24621494|NCT01062802|Antimetabolites|antimetabolites|mesh-ancestor
24621495|NCT01062802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621496|NCT01062802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24621497|NCT01062802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24621498|NCT01062802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621499|NCT01062906|Lidocaine|lidocaine|mesh-list
24621500|NCT01062906|Fentanyl|fentanyl|mesh-list
24787837|NCT01927679|Protective Agents|protective agents|mesh-ancestor
24787838|NCT01927835|Vaccines|vaccines|mesh-list
24787839|NCT01927835|Immunologic Factors|immunologic factors|mesh-ancestor
24787840|NCT01927835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787841|NCT01927874|Bupivacaine|bupivacaine|mesh-list
24787842|NCT01927874|Anesthetics, Local|anesthetics, local|mesh-ancestor
24787843|NCT01927874|Anesthetics|anesthetics|mesh-ancestor
25082291|NCT03323619|Anesthetics|anesthetics|mesh-list
25082294|NCT03323593|Dexmedetomidine|dexmedetomidine|mesh-list
25082300|NCT03323593|Sensory System Agents|sensory system agents|mesh-ancestor
25082301|NCT03323593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24787986|NCT01928888|Hydrotalcite|hydrotalcite|mesh-list
25082302|NCT03323593|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25082303|NCT03323593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25082304|NCT03323593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25082305|NCT03323593|Adrenergic Agents|adrenergic agents|mesh-ancestor
24787844|NCT01927874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25272764|NCT02389751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24948177|NCT03921736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24787849|NCT01927913|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24787864|NCT01928043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787865|NCT01928043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24787866|NCT01928043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24787867|NCT01928043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787868|NCT01928043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787869|NCT01928043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787870|NCT01928056|Montelukast|montelukast|mesh-list
24787871|NCT01928056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24787872|NCT01928056|Respiratory System Agents|respiratory system agents|mesh-ancestor
24787873|NCT01928056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24787874|NCT01928056|Hormone Antagonists|hormone antagonists|mesh-ancestor
24787875|NCT01928056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24787878|NCT01928056|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24787879|NCT01928056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787880|NCT01928069|Montelukast|montelukast|mesh-list
24787881|NCT01928069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24787882|NCT01928069|Respiratory System Agents|respiratory system agents|mesh-ancestor
24787883|NCT01928069|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24787923|NCT01928407|Antiviral Agents|antiviral agents|mesh-ancestor
24787924|NCT01928407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24787925|NCT01928459|Infigratinib|infigratinib|mesh-list
24787926|NCT01928459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787927|NCT01928498|Paclitaxel|paclitaxel|mesh-list
24787928|NCT01928498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24787929|NCT01928498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787930|NCT01928498|Tubulin Modulators|tubulin modulators|mesh-ancestor
24787931|NCT01928498|Antimitotic Agents|antimitotic agents|mesh-ancestor
24787932|NCT01928498|Mitosis Modulators|mitosis modulators|mesh-ancestor
24787933|NCT01928498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787934|NCT01928511|Interferons|interferons|mesh-list
24787935|NCT01928511|Tenofovir|tenofovir|mesh-list
24787936|NCT01928511|Interferon-alpha|interferon-alpha|mesh-list
24787937|NCT01928511|Lamivudine|lamivudine|mesh-list
24787938|NCT01928511|Interferon alpha-2|interferon alpha-2|mesh-list
24787939|NCT01928511|Entecavir|entecavir|mesh-list
24787940|NCT01928511|Adefovir|adefovir|mesh-list
24787941|NCT01928511|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24787942|NCT01928511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787943|NCT01928511|Antiviral Agents|antiviral agents|mesh-ancestor
24787944|NCT01928511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24787945|NCT01928511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24787946|NCT01928511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24787947|NCT01928511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787948|NCT01928511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787949|NCT01928511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24787950|NCT01928511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24787951|NCT01928511|Immunologic Factors|immunologic factors|mesh-ancestor
24787957|NCT01928537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787959|NCT01928563|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24787967|NCT01928628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24534393|NCT00646854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24534394|NCT00646854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24590359|NCT00912262|Sensory System Agents|sensory system agents|mesh-ancestor
24787968|NCT01928628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787969|NCT01928628|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24787970|NCT01928628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24787971|NCT01928628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24787972|NCT01928628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727683|NCT01612247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24787983|NCT01928875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24948180|NCT03921736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787984|NCT01928875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787987|NCT01928888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24787988|NCT01928888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24787989|NCT01928888|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24788039|NCT01929213|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24788040|NCT01929213|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24788041|NCT01929213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788042|NCT01929252|Dexmedetomidine|dexmedetomidine|mesh-list
24788043|NCT01929252|Levobupivacaine|levobupivacaine|mesh-list
24788044|NCT01929252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24788045|NCT01929252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24788046|NCT01929252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788047|NCT01929252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24788048|NCT01929252|Analgesics|analgesics|mesh-ancestor
24788049|NCT01929252|Sensory System Agents|sensory system agents|mesh-ancestor
24788050|NCT01929252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24788051|NCT01929252|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24788052|NCT01929252|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24788053|NCT01929252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24788054|NCT01929252|Adrenergic Agents|adrenergic agents|mesh-ancestor
24580294|NCT00861315|Amikacin|amikacin|mesh-list
24788055|NCT01929252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24788056|NCT01929252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788057|NCT01929252|Anesthetics, Local|anesthetics, local|mesh-ancestor
24788058|NCT01929252|Anesthetics|anesthetics|mesh-ancestor
24788059|NCT01929265|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24788060|NCT01929265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24788061|NCT01929265|Alkylating Agents|alkylating agents|mesh-ancestor
24446091|NCT00303771|Vitamins|vitamins|mesh-ancestor
24788062|NCT01929265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788063|NCT01929265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24788064|NCT01929278|Clindamycin|clindamycin|mesh-list
24788065|NCT01929278|Clindamycin palmitate|clindamycin palmitate|mesh-list
24788066|NCT01929278|Clindamycin phosphate|clindamycin phosphate|mesh-list
24788067|NCT01929278|Tretinoin|tretinoin|mesh-list
24788068|NCT01929278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24788069|NCT01929278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24788070|NCT01929278|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24788071|NCT01929278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788113|NCT01929577|Peficitinib|peficitinib|mesh-list
24788115|NCT01929577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788117|NCT01929577|Immunologic Factors|immunologic factors|mesh-ancestor
24788138|NCT01929603|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24788139|NCT01929603|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24788140|NCT01929655|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
24788141|NCT01929655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779909|NCT01879605|Bisacodyl|bisacodyl|mesh-list
24779910|NCT01879605|Sorbitol|sorbitol|mesh-list
24779911|NCT01879605|Cathartics|cathartics|mesh-ancestor
24788143|NCT01929668|Antioxidants|antioxidants|mesh-ancestor
24624102|NCT01074697|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24493220|NCT00489983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24493221|NCT00489996|Gemcitabine|gemcitabine|mesh-list
24493222|NCT00489996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493223|NCT00489996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24493224|NCT00489996|Antimetabolites|antimetabolites|mesh-ancestor
24493225|NCT00489996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493226|NCT00489996|Antiviral Agents|antiviral agents|mesh-ancestor
24788144|NCT01929668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788145|NCT01929668|Protective Agents|protective agents|mesh-ancestor
24788146|NCT01929668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788148|NCT01929668|Micronutrients|micronutrients|mesh-ancestor
24788150|NCT01929746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24788151|NCT01929746|Immunologic Factors|immunologic factors|mesh-ancestor
24791613|NCT03785691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24788152|NCT01929746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788153|NCT01929798|Pancrelipase|pancrelipase|mesh-list
24788154|NCT01929798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24788155|NCT01929824|Nitric Oxide|nitric oxide|mesh-list
24788156|NCT01929824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24788157|NCT01929824|Autonomic Agents|autonomic agents|mesh-ancestor
24788158|NCT01929824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24788159|NCT01929824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788160|NCT01929824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24788161|NCT01929824|Respiratory System Agents|respiratory system agents|mesh-ancestor
24788162|NCT01929824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24788163|NCT01929824|Antioxidants|antioxidants|mesh-ancestor
24788307|NCT01930734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24788164|NCT01929824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788165|NCT01929824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24788166|NCT01929824|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24788174|NCT01929941|Tubulin Modulators|tubulin modulators|mesh-ancestor
24621521|NCT01062932|Renal Agents|renal agents|mesh-ancestor
24621522|NCT01062932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25214042|NCT03683251|Ranibizumab|ranibizumab|mesh-list
25214043|NCT03683251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25214044|NCT03683251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25214045|NCT03683251|Growth Substances|growth substances|mesh-ancestor
25214046|NCT03683251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214047|NCT03683251|Growth Inhibitors|growth inhibitors|mesh-ancestor
25214048|NCT03683251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25214049|NCT03577704|Gemcitabine|gemcitabine|mesh-list
25214050|NCT03577704|Paclitaxel|paclitaxel|mesh-list
25214051|NCT03577704|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25214052|NCT03577704|Cisplatin|cisplatin|mesh-list
24851405|NCT02256774|Ritonavir|ritonavir|mesh-list
24451021|NCT00321490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24948203|NCT03921567|Anesthetics|anesthetics|mesh-ancestor
24621523|NCT01062932|Antitubercular Agents|antitubercular agents|mesh-ancestor
24621532|NCT01062945|Adrenergic Agents|adrenergic agents|mesh-ancestor
24621533|NCT01062945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24621534|NCT01062945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621535|NCT01062945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621536|NCT01062958|Vitamins|vitamins|mesh-list
25082315|NCT03323567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24621537|NCT01062958|Folic Acid|folic acid|mesh-list
24788239|NCT01930396|Anticoagulants|anticoagulants|mesh-ancestor
24788240|NCT01930396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24788241|NCT01930396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24788242|NCT01930396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788243|NCT01930461|Immunologic Factors|immunologic factors|mesh-list
24788244|NCT01930461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788250|NCT01930552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788251|NCT01930552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24788252|NCT01930552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24788253|NCT01930552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24788254|NCT01930552|Immunologic Factors|immunologic factors|mesh-ancestor
24788255|NCT01930552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788256|NCT01930552|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24788257|NCT01930552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24788258|NCT01930552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788260|NCT01930552|Protective Agents|protective agents|mesh-ancestor
24788271|NCT01930591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24788272|NCT01930591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24788273|NCT01930591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24788274|NCT01930591|Purinergic Agents|purinergic agents|mesh-ancestor
24788275|NCT01930591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24788276|NCT01930591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788277|NCT01930591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788278|NCT01930604|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
24788279|NCT01930604|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24788280|NCT01930604|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24788281|NCT01930604|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24788282|NCT01930604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24788283|NCT01930604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788284|NCT01930604|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24788285|NCT01930604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24788286|NCT01930604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534581|NCT00647647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788287|NCT01930604|Cholinergic Agents|cholinergic agents|mesh-ancestor
24788288|NCT01930604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24788289|NCT01930604|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24788290|NCT01930682|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24788301|NCT01930734|Sympathomimetics|sympathomimetics|mesh-ancestor
24788302|NCT01930734|Autonomic Agents|autonomic agents|mesh-ancestor
25261782|NCT02451748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25261783|NCT02451748|Glucocorticoids|glucocorticoids|mesh-ancestor
25261784|NCT02451748|Hormones|hormones|mesh-ancestor
25261785|NCT02451748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25261786|NCT02451748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788303|NCT01930734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24788304|NCT01930734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788305|NCT01930734|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24493227|NCT00489996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24788306|NCT01930734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24627975|NCT01095900|Cholinergic Agents|cholinergic agents|mesh-ancestor
24627976|NCT01095900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24627977|NCT01095900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627979|NCT01095926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25214053|NCT03577704|Carboplatin|carboplatin|mesh-list
25214054|NCT03577704|Oxaliplatin|oxaliplatin|mesh-list
25214055|NCT03577704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25116753|NCT03106623|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25116754|NCT03106623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25116755|NCT03106623|Adrenergic Agents|adrenergic agents|mesh-ancestor
25116756|NCT03106610|Nivolumab|nivolumab|mesh-list
24948206|NCT03921567|Sensory System Agents|sensory system agents|mesh-ancestor
24627980|NCT01095926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24627981|NCT01095926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24534583|NCT00647660|Nadolol|nadolol|mesh-list
24627982|NCT01095926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24627983|NCT01095926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627984|NCT01095926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627986|NCT01095939|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24627987|NCT01095939|Protease Inhibitors|protease inhibitors|mesh-ancestor
24627988|NCT01095939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627989|NCT01095939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627990|NCT01095939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24627991|NCT01095991|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24660218|NCT01282151|Cisplatin|cisplatin|mesh-list
24627992|NCT01095991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24627993|NCT01095991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627995|NCT01095991|Hormones|hormones|mesh-ancestor
24627996|NCT01095991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24800895|NCT01979354|Analgesics|analgesics|mesh-ancestor
24788308|NCT01930734|Adrenergic Agents|adrenergic agents|mesh-ancestor
24788309|NCT01930734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24788359|NCT01930877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24788360|NCT01930877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24788361|NCT01930877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24788362|NCT01930877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24788363|NCT01930877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082316|NCT03323567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25082317|NCT03323567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25082318|NCT03323567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25082319|NCT03323567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25082330|NCT03323528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082331|NCT03323528|Sensory System Agents|sensory system agents|mesh-ancestor
25082332|NCT03323528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082333|NCT03323528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25082334|NCT03323528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25214056|NCT03577704|Antibodies|antibodies|mesh-list
25214057|NCT03577704|Immunoglobulins|immunoglobulins|mesh-list
25214058|NCT03577704|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25214059|NCT03577704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25214060|NCT03577704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678531|NCT01825941|Sensory System Agents|sensory system agents|mesh-ancestor
25678532|NCT01825941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25678533|NCT01825941|Antiemetics|antiemetics|mesh-ancestor
25678534|NCT01825941|Autonomic Agents|autonomic agents|mesh-ancestor
25678535|NCT01825941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25678536|NCT01825941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25214062|NCT03577704|Antimitotic Agents|antimitotic agents|mesh-ancestor
25214063|NCT03577704|Mitosis Modulators|mitosis modulators|mesh-ancestor
25214064|NCT03577704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214065|NCT03577704|Immunologic Factors|immunologic factors|mesh-ancestor
25214066|NCT03577704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214067|NCT03577704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25214068|NCT03577704|Antimetabolites|antimetabolites|mesh-ancestor
25214069|NCT03577704|Antiviral Agents|antiviral agents|mesh-ancestor
25116757|NCT03106610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25116758|NCT03106610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25116759|NCT03106610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25116760|NCT03106610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116761|NCT03106571|Methamphetamine|methamphetamine|mesh-list
25116762|NCT03106571|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25116764|NCT03106571|Sympathomimetics|sympathomimetics|mesh-ancestor
25116765|NCT03106571|Autonomic Agents|autonomic agents|mesh-ancestor
25116766|NCT03106571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116767|NCT03106571|Dopamine Agents|dopamine agents|mesh-ancestor
25116768|NCT03106571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25116769|NCT03106571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116770|NCT03106571|Adrenergic Agents|adrenergic agents|mesh-ancestor
25116771|NCT03106571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24773575|NCT01840696|Regadenoson|regadenoson|mesh-list
24788365|NCT01930916|Antibodies|antibodies|mesh-list
24788368|NCT01930916|Immunologic Factors|immunologic factors|mesh-ancestor
24788369|NCT01930916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788370|NCT01930955|Amoxicillin|amoxicillin|mesh-list
24788371|NCT01930955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24788372|NCT01930955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24788382|NCT01931098|Topotecan|topotecan|mesh-list
24788383|NCT01931098|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24788384|NCT01931098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24788385|NCT01931098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788386|NCT01931098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788387|NCT01931098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24580678|NCT00863161|GABA Agonists|gaba agonists|mesh-ancestor
24937913|NCT04024241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24937914|NCT04024241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24937915|NCT04024241|Immunologic Factors|immunologic factors|mesh-ancestor
24937917|NCT04024241|Analgesics|analgesics|mesh-ancestor
24788399|NCT01931215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24788400|NCT01931215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788401|NCT01931215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25214070|NCT03577704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25214071|NCT03577704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25214072|NCT03577704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25214073|NCT03557931|Olanzapine|olanzapine|mesh-list
25214074|NCT03557931|Risperidone|risperidone|mesh-list
25214075|NCT03557931|Aripiprazole|aripiprazole|mesh-list
25214076|NCT03557931|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25214077|NCT03557931|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25214078|NCT03557931|Ziprasidone|ziprasidone|mesh-list
25214079|NCT03557931|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25214080|NCT03557931|Brexpiprazole|brexpiprazole|mesh-list
25214081|NCT03557931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25214082|NCT03557931|Serotonin Agents|serotonin agents|mesh-ancestor
25214083|NCT03557931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25214084|NCT03557931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214085|NCT03557931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214086|NCT03557931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25214087|NCT03557931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25116772|NCT03106571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25116773|NCT03106571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25116774|NCT03106571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25116775|NCT03106532|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24773582|NCT01840696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773583|NCT01840774|Ketamine|ketamine|mesh-list
24788413|NCT01931215|Adrenergic Agents|adrenergic agents|mesh-ancestor
24788414|NCT01931215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24788415|NCT01931215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788418|NCT01931293|Vitamins|vitamins|mesh-ancestor
24788419|NCT01931293|Micronutrients|micronutrients|mesh-ancestor
24788420|NCT01931293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788422|NCT01931306|Afatinib|afatinib|mesh-list
24788423|NCT01931306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24788424|NCT01931306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24788425|NCT01931306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788426|NCT01931306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788427|NCT01931319|Baclofen|baclofen|mesh-list
24788428|NCT01931319|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24788429|NCT01931319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788430|NCT01931319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24788431|NCT01931319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24788432|NCT01931319|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24788433|NCT01931319|GABA Agonists|gaba agonists|mesh-ancestor
24788434|NCT01931319|GABA Agents|gaba agents|mesh-ancestor
24788435|NCT01931319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24788436|NCT01931319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214089|NCT03557931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25214090|NCT03557931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25214091|NCT03557931|Dopamine Agents|dopamine agents|mesh-ancestor
25214093|NCT03557931|Autonomic Agents|autonomic agents|mesh-ancestor
25214094|NCT03557931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25214095|NCT03557931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25214096|NCT03557931|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25214097|NCT03557931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25214098|NCT03557931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25214099|NCT03557931|Antidepressive Agents|antidepressive agents|mesh-ancestor
25214100|NCT03557931|Dopamine Agonists|dopamine agonists|mesh-ancestor
25214101|NCT03557931|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25214102|NCT03557931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25214103|NCT03557931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25214104|NCT03557931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25214105|NCT03557931|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25214106|NCT03557931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24802187|NCT01988545|Exenatide|exenatide|mesh-list
24788580|NCT01932268|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24788582|NCT01932320|Antifungal Agents|antifungal agents|mesh-ancestor
24788583|NCT01932320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24788584|NCT01932320|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24788585|NCT01932320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24788586|NCT01932320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788587|NCT01932320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788588|NCT01932320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24788589|NCT01932320|Hormone Antagonists|hormone antagonists|mesh-ancestor
24788590|NCT01932320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24788591|NCT01932320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788592|NCT01932320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24788593|NCT01932372|Etanercept|etanercept|mesh-list
24788594|NCT01932372|Antirheumatic Agents|antirheumatic agents|mesh-list
24788596|NCT01932372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24788597|NCT01932372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24788598|NCT01932372|Analgesics|analgesics|mesh-ancestor
24788599|NCT01932372|Sensory System Agents|sensory system agents|mesh-ancestor
24788600|NCT01932372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24788601|NCT01932372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788602|NCT01932372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24788610|NCT01932385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24788611|NCT01932385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24788615|NCT01932424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24788616|NCT01932424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24788617|NCT01932424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788618|NCT01932424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24788619|NCT01932424|Anesthetics, General|anesthetics, general|mesh-ancestor
24788620|NCT01932424|Anesthetics|anesthetics|mesh-ancestor
24788621|NCT01932450|Antihypertensive Agents|antihypertensive agents|mesh-list
24788622|NCT01932502|Clobazam|clobazam|mesh-list
24788623|NCT01932502|Anticonvulsants|anticonvulsants|mesh-ancestor
25214107|NCT03557931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25214108|NCT03557931|Adrenergic Agents|adrenergic agents|mesh-ancestor
25214109|NCT03539822|Durvalumab|durvalumab|mesh-list
25214110|NCT03539822|Tremelimumab|tremelimumab|mesh-list
25214111|NCT03539822|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25214112|NCT03539822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25261872|NCT02451293|Melatonin|melatonin|mesh-list
25214113|NCT03539822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25214114|NCT03539822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214118|NCT03385655|Carboplatin|carboplatin|mesh-list
25214119|NCT03385655|Durvalumab|durvalumab|mesh-list
25214120|NCT03385655|Tremelimumab|tremelimumab|mesh-list
25214121|NCT03385655|Adavosertib|adavosertib|mesh-list
25214122|NCT03385655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25214123|NCT03385655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25157844|NCT04561739|Aspirin|aspirin|mesh-list
25157845|NCT04561739|Sirolimus|sirolimus|mesh-list
25157846|NCT04561739|Paclitaxel|paclitaxel|mesh-list
25157847|NCT04561739|Clopidogrel|clopidogrel|mesh-list
25157848|NCT04561739|Ticagrelor|ticagrelor|mesh-list
25157849|NCT04561739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25157850|NCT04561739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25157851|NCT04561739|Tubulin Modulators|tubulin modulators|mesh-ancestor
24788624|NCT01932502|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24788625|NCT01932502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24788626|NCT01932502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24788627|NCT01932502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788628|NCT01932502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24788629|NCT01932502|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24788630|NCT01932502|GABA Agonists|gaba agonists|mesh-ancestor
24788631|NCT01932502|GABA Agents|gaba agents|mesh-ancestor
24788632|NCT01932502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24788633|NCT01932502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788634|NCT01932541|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
24788635|NCT01932541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24788636|NCT01932541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24788637|NCT01932541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24788638|NCT01932541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788639|NCT01932541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24788640|NCT01932541|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24788641|NCT01932541|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24788642|NCT01932541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24610156|NCT01000220|Omeprazole|omeprazole|mesh-list
24788693|NCT01932918|Narcotics|narcotics|mesh-ancestor
24788694|NCT01932918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24788702|NCT01932918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24788703|NCT01932918|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24788724|NCT01933061|Tubulin Modulators|tubulin modulators|mesh-ancestor
24788725|NCT01933061|Antimitotic Agents|antimitotic agents|mesh-ancestor
24788726|NCT01933061|Mitosis Modulators|mitosis modulators|mesh-ancestor
24788727|NCT01933061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788728|NCT01933152|Ranibizumab|ranibizumab|mesh-list
24564256|NCT00775736|Insulin Aspart|insulin aspart|mesh-list
24788729|NCT01933152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24788730|NCT01933152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24788731|NCT01933152|Growth Substances|growth substances|mesh-ancestor
24788732|NCT01933152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788733|NCT01933152|Growth Inhibitors|growth inhibitors|mesh-ancestor
24788734|NCT01933152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24788735|NCT01933347|Gefitinib|gefitinib|mesh-list
24788736|NCT01933347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24788737|NCT01933347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24788738|NCT01933347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788739|NCT01933347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788745|NCT01933360|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24788746|NCT01933360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24788747|NCT01933360|Oxytocics|oxytocics|mesh-ancestor
24788749|NCT01933412|Immunologic Factors|immunologic factors|mesh-ancestor
24788750|NCT01933412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788751|NCT01933490|Insulin Aspart|insulin aspart|mesh-list
24788752|NCT01933490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24812215|NCT02050529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812218|NCT02050529|Sympathomimetics|sympathomimetics|mesh-ancestor
24788753|NCT01933490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788754|NCT01933503|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
24788755|NCT01933503|Cathartics|cathartics|mesh-ancestor
24788756|NCT01933503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24788757|NCT01933516|Rituximab|rituximab|mesh-list
25214124|NCT03385655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25214125|NCT03385655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214126|NCT03365882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25214127|NCT03365882|Trastuzumab|trastuzumab|mesh-list
25214128|NCT03365882|Cetuximab|cetuximab|mesh-list
25214129|NCT03365882|Pertuzumab|pertuzumab|mesh-list
25214130|NCT03365882|Irinotecan|irinotecan|mesh-list
25214131|NCT03365882|Camptothecin|camptothecin|mesh-list
25214132|NCT03365882|Antibodies|antibodies|mesh-list
25214133|NCT03365882|Immunoglobulins|immunoglobulins|mesh-list
25214134|NCT03365882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25214135|NCT03365882|Immunologic Factors|immunologic factors|mesh-ancestor
25157852|NCT04561739|Antimitotic Agents|antimitotic agents|mesh-ancestor
25157853|NCT04561739|Mitosis Modulators|mitosis modulators|mesh-ancestor
25157854|NCT04561739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25157855|NCT04561739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24788760|NCT01933516|Immunologic Factors|immunologic factors|mesh-ancestor
24788761|NCT01933516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788762|NCT01933516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24788763|NCT01933542|Morphine|morphine|mesh-list
24788764|NCT01933542|Chlorzoxazone|chlorzoxazone|mesh-list
24788765|NCT01933542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24788777|NCT01933698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24788778|NCT01933698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24788779|NCT01933711|Rituximab|rituximab|mesh-list
24788780|NCT01933711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24788781|NCT01933711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24788782|NCT01933711|Immunologic Factors|immunologic factors|mesh-ancestor
24788783|NCT01933711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788784|NCT01933711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24788795|NCT01933906|Interferon alpha-2|interferon alpha-2|mesh-list
24788796|NCT01933906|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24788797|NCT01933906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24788798|NCT01933906|Antiviral Agents|antiviral agents|mesh-ancestor
24788921|NCT01934712|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24788923|NCT01934712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788924|NCT01934777|Vitamin E|vitamin e|mesh-list
24788925|NCT01934777|Choline|choline|mesh-list
24788926|NCT01934777|Vitamins|vitamins|mesh-ancestor
24788927|NCT01934777|Micronutrients|micronutrients|mesh-ancestor
24870041|NCT04274361|Anesthetics|anesthetics|mesh-ancestor
24789000|NCT01935115|Anesthetics|anesthetics|mesh-ancestor
24789001|NCT01935115|Analgesics|analgesics|mesh-ancestor
24789002|NCT01935115|Sensory System Agents|sensory system agents|mesh-ancestor
24789037|NCT01935492|Paclitaxel|paclitaxel|mesh-list
24789038|NCT01935492|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24789044|NCT01935492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789045|NCT01935492|Tubulin Modulators|tubulin modulators|mesh-ancestor
24789046|NCT01935492|Antimitotic Agents|antimitotic agents|mesh-ancestor
24789047|NCT01935492|Mitosis Modulators|mitosis modulators|mesh-ancestor
24789048|NCT01935492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789049|NCT01935492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24789050|NCT01935492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24789051|NCT01935492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24789052|NCT01935492|Growth Substances|growth substances|mesh-ancestor
24789053|NCT01935492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789054|NCT01935492|Growth Inhibitors|growth inhibitors|mesh-ancestor
24789055|NCT01935492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24789060|NCT01935492|Antimetabolites|antimetabolites|mesh-ancestor
24789066|NCT01935505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24789067|NCT01935505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789068|NCT01935505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24789069|NCT01935505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24789070|NCT01935505|Cholinergic Agents|cholinergic agents|mesh-ancestor
24789071|NCT01935505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24789072|NCT01935505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789073|NCT01935505|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24789074|NCT01935505|Antidepressive Agents|antidepressive agents|mesh-ancestor
24789075|NCT01935505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24789076|NCT01935505|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25214136|NCT03365882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214137|NCT03365882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25214138|NCT03365882|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25214139|NCT03365882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25214140|NCT03365882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25214141|NCT03365882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25157857|NCT04561739|Analgesics|analgesics|mesh-ancestor
25157858|NCT04561739|Sensory System Agents|sensory system agents|mesh-ancestor
25157859|NCT04561739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25157860|NCT04561739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25157861|NCT04561739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25157862|NCT04561739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24789077|NCT01935505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24789078|NCT01935505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24789079|NCT01935505|Dopamine Agents|dopamine agents|mesh-ancestor
24789080|NCT01935505|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24789081|NCT01935505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24789082|NCT01935505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24789084|NCT01935518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24789085|NCT01935518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24627997|NCT01095991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24728357|NCT01615627|Treprostinil|treprostinil|mesh-list
25082351|NCT03323385|Sensory System Agents|sensory system agents|mesh-ancestor
25082352|NCT03323385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082353|NCT03323385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082354|NCT03323385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25082355|NCT03323385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25082356|NCT03323385|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25082357|NCT03323385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25082358|NCT03323385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25082359|NCT03323385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082361|NCT03323372|Fluorides|fluorides|mesh-list
25082362|NCT03323372|Sodium Fluoride|sodium fluoride|mesh-list
25082363|NCT03323372|Cariostatic Agents|cariostatic agents|mesh-ancestor
25082364|NCT03323372|Protective Agents|protective agents|mesh-ancestor
25082365|NCT03323372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082366|NCT03323372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25082367|NCT03323372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25082383|NCT03323047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25082384|NCT03323047|Glucocorticoids|glucocorticoids|mesh-ancestor
25082386|NCT03323047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25082389|NCT03323047|Protease Inhibitors|protease inhibitors|mesh-ancestor
25082390|NCT03323047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25082391|NCT03323047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082392|NCT03323047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25082393|NCT03323047|Analgesics|analgesics|mesh-ancestor
25082394|NCT03323047|Sensory System Agents|sensory system agents|mesh-ancestor
25082395|NCT03323047|Antipyretics|antipyretics|mesh-ancestor
24534842|NCT00648128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24534844|NCT00648141|Celecoxib|celecoxib|mesh-list
25214142|NCT03365882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25214143|NCT03186638|Ibuprofen|ibuprofen|mesh-list
25214144|NCT03186638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25214145|NCT03186638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25214146|NCT03186638|Analgesics|analgesics|mesh-ancestor
25214147|NCT03186638|Sensory System Agents|sensory system agents|mesh-ancestor
25157864|NCT04561739|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25157865|NCT04561739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25157866|NCT04561739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25157867|NCT04561739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25157868|NCT04561739|Antipyretics|antipyretics|mesh-ancestor
25157869|NCT04561739|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24789086|NCT01935518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789088|NCT01935518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789089|NCT01935518|Vasodilator Agents|vasodilator agents|mesh-ancestor
24789090|NCT01935518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24789091|NCT01935518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24789092|NCT01935531|Diclofenac|diclofenac|mesh-list
24789093|NCT01935531|Hyaluronic Acid|hyaluronic acid|mesh-list
24789128|NCT01935596|Sensory System Agents|sensory system agents|mesh-ancestor
24789129|NCT01935596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24789130|NCT01935648|Ropivacaine|ropivacaine|mesh-list
24789131|NCT01935648|Anesthetics, Local|anesthetics, local|mesh-ancestor
24789132|NCT01935648|Anesthetics|anesthetics|mesh-ancestor
24870904|NCT02966873|Acetylcysteine|acetylcysteine|mesh-list
24789251|NCT01936025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24789255|NCT01936064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24789256|NCT01936064|Immunologic Factors|immunologic factors|mesh-ancestor
24789257|NCT01936064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789258|NCT01936064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24789259|NCT01936064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24581704|NCT00865878|Dermatologic Agents|dermatologic agents|mesh-ancestor
24581705|NCT00865891|Nifedipine|nifedipine|mesh-list
24581706|NCT00865891|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24581707|NCT00865891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25261947|NCT02450838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261948|NCT02450838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25261949|NCT02450773|Furosemide|furosemide|mesh-list
25261950|NCT02450773|Diuretics|diuretics|mesh-ancestor
25261951|NCT02450773|Natriuretic Agents|natriuretic agents|mesh-ancestor
25261952|NCT02450773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261953|NCT02450773|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25261954|NCT02450773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24934495|NCT04061057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24934496|NCT04061057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934497|NCT04061057|Sensory System Agents|sensory system agents|mesh-ancestor
24934498|NCT04061057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24581708|NCT00865891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581709|NCT00865891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24581710|NCT00865891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581711|NCT00865891|Vasodilator Agents|vasodilator agents|mesh-ancestor
24621598|NCT01063179|Leprostatic Agents|leprostatic agents|mesh-ancestor
24621599|NCT01063179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24621600|NCT01063179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24621601|NCT01063179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24621602|NCT01063179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24621603|NCT01063179|Growth Substances|growth substances|mesh-ancestor
24621604|NCT01063179|Growth Inhibitors|growth inhibitors|mesh-ancestor
24621605|NCT01063192|Leucovorin|leucovorin|mesh-list
24621606|NCT01063192|Gemcitabine|gemcitabine|mesh-list
24789260|NCT01936064|Alkylating Agents|alkylating agents|mesh-ancestor
24789261|NCT01936064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789262|NCT01936064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789263|NCT01936064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24789264|NCT01936064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24789265|NCT01936064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24789266|NCT01936064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24789267|NCT01936064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24789268|NCT01936090|Bortezomib|bortezomib|mesh-list
24789269|NCT01936090|Melphalan|melphalan|mesh-list
24789270|NCT01936090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789271|NCT01936090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24789275|NCT01936090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24789276|NCT01936090|Immunologic Factors|immunologic factors|mesh-ancestor
24789277|NCT01936090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789278|NCT01936103|Atorvastatin|atorvastatin|mesh-list
24789279|NCT01936103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24789280|NCT01936103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24789281|NCT01936103|Antimetabolites|antimetabolites|mesh-ancestor
24789282|NCT01936103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789283|NCT01936103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24789284|NCT01936103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24789285|NCT01936103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24789295|NCT01936220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25214148|NCT03186638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25214149|NCT03186638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214150|NCT03186638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25214151|NCT03186638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25214152|NCT03186638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25214153|NCT03186638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25157870|NCT04561739|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25157871|NCT04561739|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25157872|NCT04561739|Purinergic Agents|purinergic agents|mesh-ancestor
25157873|NCT04561739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25678537|NCT01825941|Histamine Antagonists|histamine antagonists|mesh-ancestor
25678538|NCT01825941|Histamine Agents|histamine agents|mesh-ancestor
25678539|NCT01825941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25678540|NCT01825941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678541|NCT01825941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25678542|NCT01825941|Antipruritics|antipruritics|mesh-ancestor
25678543|NCT01825941|Dermatologic Agents|dermatologic agents|mesh-ancestor
25678544|NCT01825941|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25678545|NCT01825941|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25678546|NCT01825941|Dopamine Agents|dopamine agents|mesh-ancestor
25678547|NCT01826370|Linagliptin|linagliptin|mesh-list
25678548|NCT01826370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25678549|NCT01826370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678550|NCT01826370|Incretins|incretins|mesh-ancestor
25157874|NCT04561739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25157875|NCT04561739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25157876|NCT04561739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25157877|NCT04561739|Antifungal Agents|antifungal agents|mesh-ancestor
25157878|NCT04561739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25157879|NCT04561739|Immunologic Factors|immunologic factors|mesh-ancestor
25157880|NCT04557189|Ondansetron|ondansetron|mesh-list
25157881|NCT04557189|Antiemetics|antiemetics|mesh-ancestor
25157882|NCT04557189|Autonomic Agents|autonomic agents|mesh-ancestor
25157883|NCT04557189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25157884|NCT04557189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25157885|NCT04557189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25157886|NCT04557189|Antipruritics|antipruritics|mesh-ancestor
25157887|NCT04557189|Dermatologic Agents|dermatologic agents|mesh-ancestor
25157888|NCT04557189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24948253|NCT03920631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24948254|NCT03920631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948255|NCT03920813|Mercaptopurine|mercaptopurine|mesh-list
24948256|NCT03920813|Antimetabolites|antimetabolites|mesh-ancestor
24789296|NCT01936220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789297|NCT01936220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24789299|NCT01936233|Lamivudine|lamivudine|mesh-list
24789300|NCT01936233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24789301|NCT01936233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24789302|NCT01936233|Analgesics|analgesics|mesh-ancestor
24789303|NCT01936233|Sensory System Agents|sensory system agents|mesh-ancestor
24789304|NCT01936233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24789305|NCT01936233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789306|NCT01936233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24789403|NCT01937078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789404|NCT01937078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789405|NCT01937104|Remifentanil|remifentanil|mesh-list
24789407|NCT01937104|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25214154|NCT03186638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272765|NCT02389751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272766|NCT02389751|Tubulin Modulators|tubulin modulators|mesh-ancestor
24938064|NCT04022941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24938065|NCT04022785|Azacitidine|azacitidine|mesh-list
25272767|NCT02389751|Antimitotic Agents|antimitotic agents|mesh-ancestor
25272768|NCT02389751|Mitosis Modulators|mitosis modulators|mesh-ancestor
25272769|NCT02389751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272770|NCT02389868|Lovastatin|lovastatin|mesh-list
25272771|NCT02389868|L 647318|l 647318|mesh-list
25157889|NCT04557189|Serotonin Agents|serotonin agents|mesh-ancestor
25157890|NCT04557189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25157891|NCT04557189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25157892|NCT04557189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25157893|NCT04557189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25157894|NCT04557189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25157895|NCT04557189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25157896|NCT04557189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25157897|NCT04556617|Prednisone|prednisone|mesh-list
24789408|NCT01937104|Narcotics|narcotics|mesh-ancestor
24789409|NCT01937104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24789410|NCT01937104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789411|NCT01937104|Analgesics|analgesics|mesh-ancestor
24789412|NCT01937104|Sensory System Agents|sensory system agents|mesh-ancestor
24789413|NCT01937104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24789414|NCT01937104|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24789415|NCT01937104|Anesthetics, General|anesthetics, general|mesh-ancestor
24789416|NCT01937104|Anesthetics|anesthetics|mesh-ancestor
24789417|NCT01937156|Granisetron|granisetron|mesh-list
24789418|NCT01937156|Antiemetics|antiemetics|mesh-ancestor
24789419|NCT01937156|Autonomic Agents|autonomic agents|mesh-ancestor
24789420|NCT01937156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24789421|NCT01937156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789431|NCT01937169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24789432|NCT01937169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789433|NCT01937169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789435|NCT01937182|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
24789437|NCT01937182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24789438|NCT01937182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24801886|NCT01986127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24938067|NCT04022785|Antimetabolites|antimetabolites|mesh-ancestor
24789439|NCT01937182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789440|NCT01937182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24789441|NCT01937182|Serotonin Agents|serotonin agents|mesh-ancestor
24789442|NCT01937182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789443|NCT01937182|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24789482|NCT01937494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24789483|NCT01937494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789484|NCT01937494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789485|NCT01937494|Anesthetics, Local|anesthetics, local|mesh-ancestor
24789486|NCT01937494|Anesthetics|anesthetics|mesh-ancestor
24789519|NCT01937728|Interferons|interferons|mesh-list
24789520|NCT01937728|Ribavirin|ribavirin|mesh-list
24789521|NCT01937728|Interferon-alpha|interferon-alpha|mesh-list
24789522|NCT01937728|Interferon alpha-2|interferon alpha-2|mesh-list
24789523|NCT01937728|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24789534|NCT01937754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24789535|NCT01937754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789536|NCT01937754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24789537|NCT01937754|Respiratory System Agents|respiratory system agents|mesh-ancestor
24789538|NCT01937754|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24581937|NCT00866736|Dasatinib|dasatinib|mesh-list
24789540|NCT01937754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789541|NCT01937754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24789542|NCT01937754|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24789544|NCT01937754|Gasotransmitters|gasotransmitters|mesh-ancestor
24789545|NCT01937754|Protective Agents|protective agents|mesh-ancestor
24789546|NCT01937767|Fentanyl|fentanyl|mesh-list
24789547|NCT01937767|Remifentanil|remifentanil|mesh-list
24789548|NCT01937767|Propofol|propofol|mesh-list
24789549|NCT01937767|Sevoflurane|sevoflurane|mesh-list
24789550|NCT01937767|Rocuronium|rocuronium|mesh-list
24789551|NCT01937767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24789552|NCT01937767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25214170|NCT03087448|Trametinib|trametinib|mesh-list
25214171|NCT03087448|Ceritinib|ceritinib|mesh-list
25214172|NCT03087448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25214173|NCT03087448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25214174|NCT03087448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25214175|NCT03087448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938085|NCT04022525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938086|NCT04022525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24451066|NCT00321724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451067|NCT00321724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451068|NCT00321724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24451069|NCT00321750|Pimecrolimus|pimecrolimus|mesh-list
24534922|NCT00648271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272772|NCT02389868|Dihydromevinolin|dihydromevinolin|mesh-list
25157899|NCT04556617|Abiraterone Acetate|abiraterone acetate|mesh-list
25157900|NCT04556617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25157901|NCT04556617|Glucocorticoids|glucocorticoids|mesh-ancestor
25157902|NCT04556617|Hormones|hormones|mesh-ancestor
25157903|NCT04556617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25157904|NCT04556617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25157905|NCT04556617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25157906|NCT04556617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24948278|NCT03920618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621611|NCT01063192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621612|NCT01063192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24621613|NCT01063192|Antiviral Agents|antiviral agents|mesh-ancestor
24621614|NCT01063192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24621615|NCT01063192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621616|NCT01063192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24621617|NCT01063192|Immunologic Factors|immunologic factors|mesh-ancestor
24621621|NCT01063192|Vitamin B Complex|vitamin b complex|mesh-ancestor
24621622|NCT01063192|Vitamins|vitamins|mesh-ancestor
24621623|NCT01063192|Micronutrients|micronutrients|mesh-ancestor
24621624|NCT01063205|Acetylcysteine|acetylcysteine|mesh-list
25262060|NCT02450045|Sensory System Agents|sensory system agents|mesh-ancestor
25262061|NCT02450045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25262062|NCT02449954|Ketorolac|ketorolac|mesh-list
25262063|NCT02449954|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25262064|NCT02449954|Morphine|morphine|mesh-list
25262065|NCT02449954|Tramadol|tramadol|mesh-list
25262066|NCT02449954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25262067|NCT02449954|Narcotics|narcotics|mesh-ancestor
24621625|NCT01063205|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24621626|NCT01063205|Antiviral Agents|antiviral agents|mesh-ancestor
24621627|NCT01063205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24621630|NCT01063205|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24621631|NCT01063205|Antioxidants|antioxidants|mesh-ancestor
25082410|NCT03322969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801887|NCT01986192|Warfarin|warfarin|mesh-list
24801888|NCT01986192|Rivaroxaban|rivaroxaban|mesh-list
24801889|NCT01986192|Anticoagulants|anticoagulants|mesh-ancestor
24801890|NCT01986192|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24801891|NCT01986192|Antithrombins|antithrombins|mesh-ancestor
24801892|NCT01986192|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24801893|NCT01986192|Protease Inhibitors|protease inhibitors|mesh-ancestor
24802024|NCT01986894|Moxifloxacin|moxifloxacin|mesh-list
24802154|NCT01988116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802155|NCT01988116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24802156|NCT01988116|Vitamins|vitamins|mesh-ancestor
24802157|NCT01988116|Micronutrients|micronutrients|mesh-ancestor
24802158|NCT01988116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24628026|NCT01096212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24628034|NCT01096277|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24628035|NCT01096277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24451116|NCT00322062|Micronutrients|micronutrients|mesh-ancestor
24451117|NCT00322062|Laxatives|laxatives|mesh-ancestor
24628036|NCT01096277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628037|NCT01096277|Incretins|incretins|mesh-ancestor
24628038|NCT01096277|Hormones|hormones|mesh-ancestor
24628039|NCT01096277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24584539|NCT00880828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25082421|NCT03322878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25082422|NCT03322878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082423|NCT03322878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25082425|NCT03322878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25082426|NCT03322800|Ziresovir|ziresovir|mesh-list
25082427|NCT03322800|Antiviral Agents|antiviral agents|mesh-ancestor
25082428|NCT03322800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25082429|NCT03322735|Cyclophosphamide|cyclophosphamide|mesh-list
25082430|NCT03322735|Fludarabine|fludarabine|mesh-list
25082431|NCT03322735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25082432|NCT03322735|Immunologic Factors|immunologic factors|mesh-ancestor
25082433|NCT03322735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082434|NCT03322735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25082435|NCT03322735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25214182|NCT02744092|Enoxaparin|enoxaparin|mesh-list
25214183|NCT02744092|Dalteparin|dalteparin|mesh-list
25214184|NCT02744092|PENTA|penta|mesh-list
25214185|NCT02744092|Warfarin|warfarin|mesh-list
25214186|NCT02744092|Rivaroxaban|rivaroxaban|mesh-list
25214187|NCT02744092|Dabigatran|dabigatran|mesh-list
25214188|NCT02744092|Apixaban|apixaban|mesh-list
25214189|NCT02744092|Edoxaban|edoxaban|mesh-list
25214190|NCT02744092|Fondaparinux|fondaparinux|mesh-list
25214191|NCT02744092|Anticoagulants|anticoagulants|mesh-ancestor
25157907|NCT04556617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25157908|NCT04556617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25157909|NCT04556617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082436|NCT03322735|Alkylating Agents|alkylating agents|mesh-ancestor
25082437|NCT03322735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082438|NCT03322735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25082439|NCT03322735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25082440|NCT03322631|Tirzepatide|tirzepatide|mesh-list
25082441|NCT03322631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25082442|NCT03322631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678551|NCT01826370|Hormones|hormones|mesh-ancestor
25678552|NCT01826370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25678553|NCT01826370|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25678554|NCT01826370|Protease Inhibitors|protease inhibitors|mesh-ancestor
25678555|NCT01826370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678556|NCT01826370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534949|NCT00648310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082443|NCT03322631|Incretins|incretins|mesh-ancestor
25262101|NCT02449811|Natriuretic Agents|natriuretic agents|mesh-ancestor
25262102|NCT02449811|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25262103|NCT02449811|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25262104|NCT02449811|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25262105|NCT02449811|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25262106|NCT02449811|Protease Inhibitors|protease inhibitors|mesh-ancestor
25262107|NCT02449811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24934678|NCT04059978|Sensory System Agents|sensory system agents|mesh-ancestor
25082444|NCT03322631|Hormones|hormones|mesh-ancestor
25082445|NCT03322631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25082446|NCT03322488|Metronidazole|metronidazole|mesh-list
25082447|NCT03322488|Doxycycline|doxycycline|mesh-list
25082448|NCT03322488|Ciprofloxacin|ciprofloxacin|mesh-list
25082450|NCT03322488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25082451|NCT03322488|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25082452|NCT03322488|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24789734|NCT01938859|Antidepressive Agents|antidepressive agents|mesh-ancestor
24789735|NCT01938859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24789736|NCT01938859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24789737|NCT01938859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24789738|NCT01938859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24789739|NCT01938859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789740|NCT01938872|Paclitaxel|paclitaxel|mesh-list
24789741|NCT01938872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24789742|NCT01938872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789743|NCT01938872|Tubulin Modulators|tubulin modulators|mesh-ancestor
24789744|NCT01938872|Antimitotic Agents|antimitotic agents|mesh-ancestor
24789745|NCT01938872|Mitosis Modulators|mitosis modulators|mesh-ancestor
24789746|NCT01938872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789749|NCT01938911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24789750|NCT01938911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789751|NCT01939054|Docetaxel|docetaxel|mesh-list
24789752|NCT01939054|Capecitabine|capecitabine|mesh-list
24789753|NCT01939054|Nimotuzumab|nimotuzumab|mesh-list
24789754|NCT01939054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789755|NCT01939054|Tubulin Modulators|tubulin modulators|mesh-ancestor
24789756|NCT01939054|Antimitotic Agents|antimitotic agents|mesh-ancestor
24789757|NCT01939054|Mitosis Modulators|mitosis modulators|mesh-ancestor
24789758|NCT01939054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789759|NCT01939054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24789760|NCT01939054|Antimetabolites|antimetabolites|mesh-ancestor
24789803|NCT01939327|Immunologic Factors|immunologic factors|mesh-ancestor
24789804|NCT01939327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789805|NCT01939327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24789806|NCT01939327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24789807|NCT01939327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24789808|NCT01939327|Growth Substances|growth substances|mesh-ancestor
24789809|NCT01939327|Growth Inhibitors|growth inhibitors|mesh-ancestor
24789810|NCT01939379|Acetaminophen|acetaminophen|mesh-list
24789811|NCT01939379|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
24789812|NCT01939379|Morphine|morphine|mesh-list
24789813|NCT01939379|Oxycodone|oxycodone|mesh-list
24789814|NCT01939379|Analgesics|analgesics|mesh-list
24789815|NCT01939379|Ropivacaine|ropivacaine|mesh-list
24789816|NCT01939379|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24789817|NCT01939379|Narcotics|narcotics|mesh-ancestor
24789818|NCT01939379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24789819|NCT01939379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789820|NCT01939379|Sensory System Agents|sensory system agents|mesh-ancestor
24789821|NCT01939379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24789822|NCT01939379|Anesthetics, Local|anesthetics, local|mesh-ancestor
24789823|NCT01939379|Anesthetics|anesthetics|mesh-ancestor
24789824|NCT01939379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24789825|NCT01939379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24789826|NCT01939379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24789827|NCT01939379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24789828|NCT01939379|Antipyretics|antipyretics|mesh-ancestor
25678557|NCT01826448|Vemurafenib|vemurafenib|mesh-list
25678558|NCT01826448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678559|NCT01826448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25678560|NCT01826448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678561|NCT01826448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678562|NCT01826851|Bupivacaine|bupivacaine|mesh-list
25678563|NCT01826851|Anesthetics, Local|anesthetics, local|mesh-ancestor
25678564|NCT01826851|Anesthetics|anesthetics|mesh-ancestor
25678565|NCT01826851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25262139|NCT02449564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789829|NCT01939418|Gemcitabine|gemcitabine|mesh-list
25214192|NCT02744092|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25214193|NCT02744092|Antithrombins|antithrombins|mesh-ancestor
25214194|NCT02744092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25214195|NCT02744092|Protease Inhibitors|protease inhibitors|mesh-ancestor
25157910|NCT04556617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25157911|NCT04556617|Hormone Antagonists|hormone antagonists|mesh-ancestor
24789830|NCT01939418|Everolimus|everolimus|mesh-list
24789834|NCT01939418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789835|NCT01939418|Antiviral Agents|antiviral agents|mesh-ancestor
24789836|NCT01939418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24789837|NCT01939418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628057|NCT01096355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24789838|NCT01939418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24789839|NCT01939418|Immunologic Factors|immunologic factors|mesh-ancestor
24789840|NCT01939418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789842|NCT01939444|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24789894|NCT01939574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789895|NCT01939574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24649029|NCT01218386|Estradiol|estradiol|mesh-list
24789910|NCT01939691|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24789927|NCT01939691|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24789928|NCT01939691|Protective Agents|protective agents|mesh-ancestor
24789929|NCT01939691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24789930|NCT01939691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24789931|NCT01939691|Analgesics|analgesics|mesh-ancestor
24789932|NCT01939691|Sensory System Agents|sensory system agents|mesh-ancestor
24789933|NCT01939691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24789934|NCT01939730|Rituximab|rituximab|mesh-list
24789935|NCT01939730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24789936|NCT01939730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789937|NCT01939730|Immunologic Factors|immunologic factors|mesh-ancestor
24789938|NCT01939730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789939|NCT01939730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24789940|NCT01939743|Diclofenac|diclofenac|mesh-list
24789941|NCT01939743|Lidocaine|lidocaine|mesh-list
24789942|NCT01939743|Anesthetics, Local|anesthetics, local|mesh-ancestor
24789943|NCT01939743|Anesthetics|anesthetics|mesh-ancestor
24789944|NCT01939743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24789945|NCT01939743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789946|NCT01939743|Sensory System Agents|sensory system agents|mesh-ancestor
24789960|NCT01939834|Insulin|insulin|mesh-list
24789961|NCT01939834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24789962|NCT01939834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789963|NCT01939886|Artesunate|artesunate|mesh-list
24789964|NCT01939886|Lumefantrine|lumefantrine|mesh-list
24789965|NCT01939886|Artemether|artemether|mesh-list
24789966|NCT01939886|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24789967|NCT01939886|Mefloquine|mefloquine|mesh-list
24789968|NCT01939886|Antimalarials|antimalarials|mesh-ancestor
24789969|NCT01939886|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24789970|NCT01939886|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24789971|NCT01939886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24789972|NCT01939886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789973|NCT01939886|Antiviral Agents|antiviral agents|mesh-ancestor
24582397|NCT00869427|Vitamins|vitamins|mesh-ancestor
24582466|NCT00869869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082453|NCT03322488|Antimalarials|antimalarials|mesh-ancestor
24628061|NCT01096420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24628062|NCT01096420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628064|NCT01096472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24628065|NCT01096472|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24628066|NCT01096485|Levonorgestrel|levonorgestrel|mesh-list
24628084|NCT01096511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24628085|NCT01096511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24628086|NCT01096511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24628087|NCT01096511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24628089|NCT01096511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678566|NCT01826851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582467|NCT00869869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24621679|NCT01063439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24621680|NCT01063439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24625383|NCT01081990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625384|NCT01081990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24625385|NCT01081990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24621681|NCT01063439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25214196|NCT02744092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25214197|NCT02744092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214198|NCT02744092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25157912|NCT04556617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25157913|NCT04550624|Pembrolizumab|pembrolizumab|mesh-list
25157914|NCT04550624|Lenvatinib|lenvatinib|mesh-list
25157915|NCT04550624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25157916|NCT04550624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25157917|NCT04550624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25157918|NCT04550624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25157919|NCT04550624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621682|NCT01063439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24621686|NCT01063439|Antimetabolites|antimetabolites|mesh-ancestor
25082454|NCT03322488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25082456|NCT03322488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25082457|NCT03322488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082458|NCT03322488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25082459|NCT03322488|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25082460|NCT03322488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25082461|NCT03322358|Diphenhydramine|diphenhydramine|mesh-list
25082462|NCT03322358|Promethazine|promethazine|mesh-list
25082463|NCT03322358|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25082464|NCT03322358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25082465|NCT03322358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25082466|NCT03322358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082467|NCT03322358|Anesthetics, Local|anesthetics, local|mesh-ancestor
25082468|NCT03322358|Anesthetics|anesthetics|mesh-ancestor
25082469|NCT03322358|Sensory System Agents|sensory system agents|mesh-ancestor
25082470|NCT03322358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082471|NCT03322358|Antiemetics|antiemetics|mesh-ancestor
25082472|NCT03322358|Autonomic Agents|autonomic agents|mesh-ancestor
25082473|NCT03322358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25082474|NCT03322358|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25082475|NCT03322358|Histamine Antagonists|histamine antagonists|mesh-ancestor
25082476|NCT03322358|Histamine Agents|histamine agents|mesh-ancestor
25082477|NCT03322358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25082478|NCT03322358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082479|NCT03322358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24621708|NCT01063556|Donepezil|donepezil|mesh-list
24621709|NCT01063556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24621710|NCT01063556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24879367|NCT04796454|Temozolomide|temozolomide|mesh-list
24790011|NCT01940224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24790012|NCT01940224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790013|NCT01940224|Analgesics|analgesics|mesh-ancestor
24626795|NCT01088750|Vinblastine|vinblastine|mesh-list
24790014|NCT01940224|Sensory System Agents|sensory system agents|mesh-ancestor
24790015|NCT01940224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24790016|NCT01940224|Anticonvulsants|anticonvulsants|mesh-ancestor
24790017|NCT01940224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24790018|NCT01940224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24790019|NCT01940224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790020|NCT01940224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24790025|NCT01940250|Analgesics|analgesics|mesh-ancestor
24790069|NCT01940627|Ubiquinone|ubiquinone|mesh-list
24790070|NCT01940627|Coenzyme Q10|coenzyme q10|mesh-list
24790071|NCT01940627|Micronutrients|micronutrients|mesh-ancestor
24790072|NCT01940627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790073|NCT01940627|Vitamins|vitamins|mesh-ancestor
24790074|NCT01940653|Estradiol|estradiol|mesh-list
24790075|NCT01940653|Progesterone|progesterone|mesh-list
25214199|NCT02744092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25214200|NCT02596035|Nivolumab|nivolumab|mesh-list
25214201|NCT02596035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25214202|NCT02596035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25214203|NCT02596035|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25678567|NCT01826851|Sensory System Agents|sensory system agents|mesh-ancestor
25678568|NCT01826851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25678569|NCT01826981|Sofosbuvir|sofosbuvir|mesh-list
25678570|NCT01826981|Antiviral Agents|antiviral agents|mesh-ancestor
25214204|NCT02596035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214205|NCT02580994|Carboplatin|carboplatin|mesh-list
25214206|NCT02580994|Pembrolizumab|pembrolizumab|mesh-list
24535030|NCT00648427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24535032|NCT00648427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25214207|NCT02580994|Etoposide|etoposide|mesh-list
25214208|NCT02580994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25214209|NCT02580994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25214210|NCT02580994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25157927|NCT04547907|Paclitaxel|paclitaxel|mesh-list
25157928|NCT04547907|Docetaxel|docetaxel|mesh-list
25157929|NCT04547907|Carboplatin|carboplatin|mesh-list
25157930|NCT04547907|Trastuzumab|trastuzumab|mesh-list
25157931|NCT04547907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24790076|NCT01940653|Estrogens|estrogens|mesh-ancestor
24790077|NCT01940653|Hormones|hormones|mesh-ancestor
24790078|NCT01940653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24790080|NCT01940653|Progestins|progestins|mesh-ancestor
24790081|NCT01940692|Tranexamic Acid|tranexamic acid|mesh-list
24790082|NCT01940692|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24790083|NCT01940692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24790084|NCT01940692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790085|NCT01940692|Hemostatics|hemostatics|mesh-ancestor
24790086|NCT01940692|Coagulants|coagulants|mesh-ancestor
24790087|NCT01940718|Methyltestosterone|methyltestosterone|mesh-list
24790088|NCT01940718|Testosterone|testosterone|mesh-list
24790089|NCT01940718|Testosterone undecanoate|testosterone undecanoate|mesh-list
24790090|NCT01940718|Testosterone enanthate|testosterone enanthate|mesh-list
24790091|NCT01940718|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24790092|NCT01940718|Androgens|androgens|mesh-ancestor
24790093|NCT01940718|Hormones|hormones|mesh-ancestor
24790094|NCT01940718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24574391|NCT00825123|Metoprolol|metoprolol|mesh-list
24790095|NCT01940718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790096|NCT01940718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24790097|NCT01940718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24790098|NCT01940718|Anabolic Agents|anabolic agents|mesh-ancestor
24790099|NCT01940796|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24790100|NCT01940796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24790161|NCT01941173|Leucovorin|leucovorin|mesh-list
24790162|NCT01941173|Fluorouracil|fluorouracil|mesh-list
24535066|NCT00648505|Glipizide|glipizide|mesh-list
24790163|NCT01941173|Irinotecan|irinotecan|mesh-list
24790164|NCT01941173|Aflibercept|aflibercept|mesh-list
24790169|NCT01941173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790170|NCT01941173|Antimetabolites|antimetabolites|mesh-ancestor
24790171|NCT01941173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790172|NCT01941173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24790173|NCT01941173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24790174|NCT01941173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24790175|NCT01941173|Immunologic Factors|immunologic factors|mesh-ancestor
24790176|NCT01941173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24790177|NCT01941173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24790205|NCT01941316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790207|NCT01941329|Ranibizumab|ranibizumab|mesh-list
24790214|NCT01941407|Bevacizumab|bevacizumab|mesh-list
24790216|NCT01941407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24790217|NCT01941407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24790218|NCT01941407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24790219|NCT01941407|Growth Substances|growth substances|mesh-ancestor
24790220|NCT01941407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082486|NCT03322150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24790221|NCT01941407|Growth Inhibitors|growth inhibitors|mesh-ancestor
24790223|NCT01941524|Beractant|beractant|mesh-list
24790224|NCT01941524|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
24582765|NCT00871455|GABA Agents|gaba agents|mesh-ancestor
24582766|NCT00871455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24582767|NCT00871455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582768|NCT00871507|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24582769|NCT00871507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24582770|NCT00871507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582771|NCT00871507|Incretins|incretins|mesh-ancestor
24582772|NCT00871507|Hormones|hormones|mesh-ancestor
25214211|NCT02580994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25214214|NCT02580994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25157933|NCT04547907|Tubulin Modulators|tubulin modulators|mesh-ancestor
25157935|NCT04547907|Mitosis Modulators|mitosis modulators|mesh-ancestor
25157936|NCT04547907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582773|NCT00871507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24582774|NCT00871507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24582775|NCT00871507|Protease Inhibitors|protease inhibitors|mesh-ancestor
24582776|NCT00871507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24582777|NCT00871507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582786|NCT00871533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24790230|NCT01941602|Anticoagulants|anticoagulants|mesh-ancestor
24790231|NCT01941602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24790232|NCT01941602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24790389|NCT01942291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790390|NCT01942291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24790391|NCT01942291|Vasodilator Agents|vasodilator agents|mesh-ancestor
24790392|NCT01942304|Calcium|calcium|mesh-list
24790393|NCT01942304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24790394|NCT01942304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582876|NCT00872274|Serotonin Agents|serotonin agents|mesh-ancestor
24790396|NCT01942343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24790397|NCT01942343|Antiemetics|antiemetics|mesh-ancestor
24790398|NCT01942343|Autonomic Agents|autonomic agents|mesh-ancestor
24790399|NCT01942343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24790400|NCT01942343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790401|NCT01942343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24790402|NCT01942343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24790403|NCT01942343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24790404|NCT01942343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24790405|NCT01942343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24790406|NCT01942343|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24790407|NCT01942343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24790408|NCT01942343|Dopamine Agents|dopamine agents|mesh-ancestor
24790409|NCT01942343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24790414|NCT01942369|Contraceptive Agents|contraceptive agents|mesh-ancestor
24790415|NCT01942369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24790416|NCT01942369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801868|NCT01986049|Bupivacaine|bupivacaine|mesh-list
24790417|NCT01942369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24626864|NCT01088932|SRX246|srx246|mesh-list
24790418|NCT01942369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24790419|NCT01942369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24790420|NCT01942382|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24790421|NCT01942382|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24790422|NCT01942382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24790423|NCT01942382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24790424|NCT01942382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790425|NCT01942382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24790426|NCT01942382|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24790427|NCT01942382|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24790428|NCT01942382|Serotonin Agents|serotonin agents|mesh-ancestor
24790467|NCT01942889|Antioxidants|antioxidants|mesh-list
24729192|NCT01620320|Protective Agents|protective agents|mesh-ancestor
24790478|NCT01943019|Protease Inhibitors|protease inhibitors|mesh-ancestor
24790479|NCT01943019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24790480|NCT01943019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790481|NCT01943058|Megestrol|megestrol|mesh-list
24790482|NCT01943058|Megestrol Acetate|megestrol acetate|mesh-list
24790483|NCT01943058|Levonorgestrel|levonorgestrel|mesh-list
24923795|NCT04166786|Ethanol|ethanol|mesh-list
25157937|NCT04547907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24493255|NCT00490204|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24790485|NCT01943058|Contraceptive Agents|contraceptive agents|mesh-ancestor
24790486|NCT01943058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24790487|NCT01943058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790488|NCT01943058|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24790489|NCT01943058|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24790490|NCT01943058|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24790491|NCT01943058|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25159907|NCT03504956|Autonomic Agents|autonomic agents|mesh-ancestor
24790492|NCT01943058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24790493|NCT01943058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24790494|NCT01943058|Appetite Stimulants|appetite stimulants|mesh-ancestor
24790495|NCT01943058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24790496|NCT01943136|Mupirocin|mupirocin|mesh-list
24790497|NCT01943136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24790498|NCT01943136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24790499|NCT01943136|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24790500|NCT01943136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24790519|NCT01943305|Vaccines|vaccines|mesh-list
24790547|NCT01943487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790548|NCT01943487|Urological Agents|urological agents|mesh-ancestor
24790549|NCT01943487|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24790550|NCT01943487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24790551|NCT01943487|Cholinergic Agents|cholinergic agents|mesh-ancestor
24790552|NCT01943487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24790553|NCT01943487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24790554|NCT01943487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24790555|NCT01943487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24790556|NCT01943487|Vasodilator Agents|vasodilator agents|mesh-ancestor
24790558|NCT01943526|Immunologic Factors|immunologic factors|mesh-ancestor
24790559|NCT01943526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790560|NCT01943617|Entecavir|entecavir|mesh-list
24790561|NCT01943617|Antiviral Agents|antiviral agents|mesh-ancestor
24790562|NCT01943617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24790563|NCT01943630|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
24790564|NCT01943630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24790565|NCT01943630|Immunologic Factors|immunologic factors|mesh-ancestor
24790566|NCT01943630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790567|NCT01943630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24790568|NCT01943630|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24790569|NCT01943630|Protective Agents|protective agents|mesh-ancestor
24790570|NCT01943630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24790571|NCT01943630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24790572|NCT01943630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621780|NCT01063920|Gout Suppressants|gout suppressants|mesh-ancestor
24621781|NCT01063920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24621782|NCT01063920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621783|NCT01063920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621784|NCT01063933|Peramivir|peramivir|mesh-list
24621785|NCT01063933|Antiviral Agents|antiviral agents|mesh-ancestor
24621786|NCT01063933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24621787|NCT01063933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621788|NCT01063933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621789|NCT01064102|Cetirizine|cetirizine|mesh-list
24621790|NCT01064102|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24621791|NCT01064102|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24621792|NCT01064102|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24621793|NCT01064102|Histamine Antagonists|histamine antagonists|mesh-ancestor
24621794|NCT01064102|Histamine Agents|histamine agents|mesh-ancestor
24621795|NCT01064102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535136|NCT00648622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25082505|NCT03322098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25082506|NCT03322098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25082507|NCT03322098|Autonomic Agents|autonomic agents|mesh-ancestor
25082508|NCT03322098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24790666|NCT01944176|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24790667|NCT01944176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24790668|NCT01944176|Antimetabolites|antimetabolites|mesh-ancestor
24790669|NCT01944176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790670|NCT01944176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24790671|NCT01944176|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24790672|NCT01944176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24790673|NCT01944189|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24790674|NCT01944189|Antimalarials|antimalarials|mesh-ancestor
24790676|NCT01944189|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24790677|NCT01944189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24790715|NCT01944618|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24790716|NCT01944618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790717|NCT01944618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24790718|NCT01944618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790719|NCT01944657|Antidepressive Agents|antidepressive agents|mesh-list
24790780|NCT01945047|GABA Agents|gaba agents|mesh-ancestor
24790782|NCT01945099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24790810|NCT01945450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24790811|NCT01945450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790812|NCT01945476|Midazolam|midazolam|mesh-list
24790813|NCT01945476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24790824|NCT01945476|GABA Agents|gaba agents|mesh-ancestor
24790825|NCT01945476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24790826|NCT01945476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790828|NCT01945528|Anesthetics, Local|anesthetics, local|mesh-list
24790829|NCT01945528|Anesthetics|anesthetics|mesh-list
24790830|NCT01945528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24621813|NCT01064154|Adrenergic Agents|adrenergic agents|mesh-ancestor
24621814|NCT01064154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24621815|NCT01064154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621816|NCT01064154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790867|NCT01945788|Teriparatide|teriparatide|mesh-list
24790868|NCT01945788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24790869|NCT01945788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790870|NCT01945788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24790871|NCT01945801|Furosemide|furosemide|mesh-list
24790872|NCT01945801|Spironolactone|spironolactone|mesh-list
24790873|NCT01945801|Diuretics|diuretics|mesh-ancestor
24790874|NCT01945801|Natriuretic Agents|natriuretic agents|mesh-ancestor
24790875|NCT01945801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790876|NCT01945801|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24790884|NCT05410782|Micronutrients|micronutrients|mesh-ancestor
24790885|NCT05410782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790886|NCT05410626|Methylphenidate|methylphenidate|mesh-list
24790887|NCT05410626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24790888|NCT05410626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790889|NCT05410626|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24790890|NCT05410626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24790891|NCT05410626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24790892|NCT05410626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790893|NCT05410626|Dopamine Agents|dopamine agents|mesh-ancestor
24790894|NCT05410626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24493256|NCT00490204|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24493257|NCT00490204|Histamine Antagonists|histamine antagonists|mesh-ancestor
24493258|NCT00490204|Histamine Agents|histamine agents|mesh-ancestor
24493259|NCT00490204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24790895|NCT05410535|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24790896|NCT05410535|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24790897|NCT05410535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24790921|NCT05410275|Rivaroxaban|rivaroxaban|mesh-list
24790922|NCT05410275|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24924125|NCT04162743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24790923|NCT05410275|Antithrombins|antithrombins|mesh-ancestor
24790924|NCT05410275|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24790925|NCT05410275|Protease Inhibitors|protease inhibitors|mesh-ancestor
24790926|NCT05410275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24790935|NCT05410158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24790937|NCT05410158|Anesthetics|anesthetics|mesh-ancestor
24790938|NCT05410158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24790939|NCT05410158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25214297|NCT02200978|Antimetabolites|antimetabolites|mesh-ancestor
24790940|NCT05410158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24790941|NCT05410158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24790942|NCT05410158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790943|NCT05410093|Vitamin E|vitamin e|mesh-list
24790944|NCT05410093|Tocopherols|tocopherols|mesh-list
24790945|NCT05410093|Resveratrol|resveratrol|mesh-list
24790946|NCT05410093|Vitamins|vitamins|mesh-ancestor
24790947|NCT05410093|Micronutrients|micronutrients|mesh-ancestor
24790948|NCT05410093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790949|NCT05410093|Antioxidants|antioxidants|mesh-ancestor
25262356|NCT02448550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25262357|NCT02448550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25262359|NCT02448550|Antithrombins|antithrombins|mesh-ancestor
24628112|NCT01096654|Respiratory System Agents|respiratory system agents|mesh-ancestor
24628114|NCT01096654|Sympathomimetics|sympathomimetics|mesh-ancestor
24628115|NCT01096654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24628116|NCT01096693|Substance P|substance p|mesh-list
24938194|NCT04021420|Nivolumab|nivolumab|mesh-list
24628117|NCT01096693|Neurokinin A|neurokinin a|mesh-list
24628118|NCT01096693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24802869|NCT01992796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24802870|NCT01992796|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24802871|NCT01992796|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24802872|NCT01992796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802873|NCT01992900|Piperaquine|piperaquine|mesh-list
24802874|NCT01992900|Artenimol|artenimol|mesh-list
24802875|NCT01992900|Artemisinins|artemisinins|mesh-list
24802876|NCT01992900|Antimalarials|antimalarials|mesh-ancestor
24802877|NCT01992900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24802878|NCT01992900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25214234|NCT02436707|Gemcitabine|gemcitabine|mesh-list
25214235|NCT02436707|Dexamethasone|dexamethasone|mesh-list
25214236|NCT02436707|Cyclophosphamide|cyclophosphamide|mesh-list
25214237|NCT02436707|Rituximab|rituximab|mesh-list
24560763|NCT01451515|Cytarabine|cytarabine|mesh-list
24560764|NCT01451515|Dexamethasone|dexamethasone|mesh-list
24560765|NCT01451515|Prednisone|prednisone|mesh-list
24560804|NCT01451515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24560805|NCT01451515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24802879|NCT01992900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24803235|NCT01995214|Propofol|propofol|mesh-list
24803236|NCT01995214|Sevoflurane|sevoflurane|mesh-list
24803237|NCT01995214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24803238|NCT01995214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24803239|NCT01995214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803240|NCT01995214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24803241|NCT01995214|Anesthetics, General|anesthetics, general|mesh-ancestor
24803242|NCT01995214|Anesthetics|anesthetics|mesh-ancestor
24803243|NCT01995214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24803244|NCT01995214|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24803245|NCT01995292|Anesthetics|anesthetics|mesh-list
24803246|NCT01995292|Anesthetics, Local|anesthetics, local|mesh-list
24803247|NCT01995292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24803248|NCT01995292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803249|NCT01995292|Sensory System Agents|sensory system agents|mesh-ancestor
24803250|NCT01995292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25243540|NCT05294965|Autonomic Agents|autonomic agents|mesh-ancestor
24628119|NCT01096693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802213|NCT01988649|Oxytocin|oxytocin|mesh-list
25214241|NCT02436707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214242|NCT02436707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25214243|NCT02436707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25214244|NCT02436707|Alkylating Agents|alkylating agents|mesh-ancestor
25214245|NCT02436707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214246|NCT02436707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25214247|NCT02436707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25214248|NCT02436707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25214249|NCT02436707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25214250|NCT02436707|Antiemetics|antiemetics|mesh-ancestor
25214251|NCT02436707|Autonomic Agents|autonomic agents|mesh-ancestor
25214252|NCT02436707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25214253|NCT02436707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24762958|NCT01770301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25214262|NCT02436707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25214263|NCT02436707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25214264|NCT02436707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25214265|NCT02436707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24729531|NCT01622322|Analgesics|analgesics|mesh-ancestor
25082543|NCT03321955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082544|NCT03321955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25082545|NCT03321955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082547|NCT03321955|Protective Agents|protective agents|mesh-ancestor
25678571|NCT01826981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25678572|NCT01827046|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25678573|NCT01827046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24668514|NCT04889547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24684320|NCT01396707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24684322|NCT01396720|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24684323|NCT01396720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24684324|NCT01396720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25262398|NCT02448199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25262399|NCT02448199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25262400|NCT02448199|Analgesics|analgesics|mesh-ancestor
25262401|NCT02448199|Sensory System Agents|sensory system agents|mesh-ancestor
25262402|NCT02448199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25262403|NCT02448199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262404|NCT02448199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25262405|NCT02448199|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25262406|NCT02448199|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25262407|NCT02448199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262408|NCT02448199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262409|NCT02448082|Ichthammol|ichthammol|mesh-list
25262410|NCT02448082|Dermatologic Agents|dermatologic agents|mesh-ancestor
25262411|NCT02448069|Argatroban|argatroban|mesh-list
25082548|NCT03321955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25082549|NCT03321955|Analgesics|analgesics|mesh-ancestor
25082550|NCT03321955|Sensory System Agents|sensory system agents|mesh-ancestor
25082551|NCT03321955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082552|NCT03321903|Charcoal|charcoal|mesh-list
25082553|NCT03321903|Antidotes|antidotes|mesh-ancestor
25082554|NCT03321903|Protective Agents|protective agents|mesh-ancestor
25082555|NCT03321903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802247|NCT01989052|Lomustine|lomustine|mesh-list
24791015|NCT05406895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24493312|NCT00490373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24493313|NCT00490373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24791016|NCT05406895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791017|NCT05406895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24791018|NCT05406895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24791019|NCT05406895|Adrenergic Agents|adrenergic agents|mesh-ancestor
24791020|NCT05406895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24791021|NCT05406895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24791022|NCT05406895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24791023|NCT05406895|Autonomic Agents|autonomic agents|mesh-ancestor
24791024|NCT05406895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24791025|NCT05406895|Respiratory System Agents|respiratory system agents|mesh-ancestor
24791026|NCT05406895|Mydriatics|mydriatics|mesh-ancestor
24791027|NCT05406895|Sympathomimetics|sympathomimetics|mesh-ancestor
24791028|NCT05406895|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24791029|NCT05405621|Exatecan|exatecan|mesh-list
24791030|NCT05405621|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24791031|NCT05405621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24791032|NCT05405621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24791033|NCT05405621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791034|NCT05405621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791043|NCT05390476|Capecitabine|capecitabine|mesh-list
24791044|NCT05390476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24791045|NCT05390476|Antimetabolites|antimetabolites|mesh-ancestor
25678574|NCT01827046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25678575|NCT01827046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678576|NCT01827163|Paclitaxel|paclitaxel|mesh-list
25678577|NCT01827163|Trastuzumab|trastuzumab|mesh-list
25678578|NCT01827163|Lapatinib|lapatinib|mesh-list
25678579|NCT01827163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25678580|NCT01827163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678581|NCT01827163|Tubulin Modulators|tubulin modulators|mesh-ancestor
25678582|NCT01827163|Antimitotic Agents|antimitotic agents|mesh-ancestor
25678583|NCT01827163|Mitosis Modulators|mitosis modulators|mesh-ancestor
25678584|NCT01827163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678585|NCT01827163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25678586|NCT01827163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25678587|NCT01827163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678588|NCT01827254|Sunitinib|sunitinib|mesh-list
25678589|NCT01827254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678590|NCT01827254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25678591|NCT01827254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25678592|NCT01827254|Growth Substances|growth substances|mesh-ancestor
25678593|NCT01827254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262437|NCT02447809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25262438|NCT02447809|Purinergic Agents|purinergic agents|mesh-ancestor
24791046|NCT05390476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791047|NCT05390476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791048|NCT05375747|Propofol|propofol|mesh-list
24791049|NCT05375747|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24583800|NCT00876967|Dermatologic Agents|dermatologic agents|mesh-ancestor
24583801|NCT00877097|Clodronic Acid|clodronic acid|mesh-list
24791093|NCT05285124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791094|NCT05285124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24791128|NCT05248321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24791129|NCT05248321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24791130|NCT05248321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791131|NCT05248321|Hemostatics|hemostatics|mesh-ancestor
24791132|NCT05248321|Coagulants|coagulants|mesh-ancestor
24791146|NCT05165082|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24791147|NCT05165082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24791148|NCT05165082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24791149|NCT05165082|Adrenergic Agents|adrenergic agents|mesh-ancestor
24791150|NCT05165082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24791151|NCT05165082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791152|NCT05165082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791153|NCT05165082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24791154|NCT05165082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24791155|NCT05155527|Ivermectin|ivermectin|mesh-list
24791156|NCT05155527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24791198|NCT05043870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24791199|NCT05043870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24791200|NCT05043870|Immunologic Factors|immunologic factors|mesh-ancestor
24791201|NCT05043870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214277|NCT02318095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214279|NCT02318095|Antimetabolites|antimetabolites|mesh-ancestor
25214280|NCT02318095|Antiviral Agents|antiviral agents|mesh-ancestor
25051608|NCT00393952|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25082557|NCT03321890|Cyclophosphamide|cyclophosphamide|mesh-list
25082558|NCT03321890|Methotrexate|methotrexate|mesh-list
24493315|NCT00490399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493316|NCT00490399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24493317|NCT00490399|Antimetabolites|antimetabolites|mesh-ancestor
24493318|NCT00490399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621817|NCT01064154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24621818|NCT01064154|Antioxidants|antioxidants|mesh-ancestor
24621819|NCT01064154|Protective Agents|protective agents|mesh-ancestor
24621820|NCT01064154|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24535311|NCT00648973|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24621821|NCT01064154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24621822|NCT01064154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24621823|NCT01064154|Vasodilator Agents|vasodilator agents|mesh-ancestor
24621824|NCT01064154|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24621825|NCT01064154|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24621838|NCT01064180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24621839|NCT01064180|Vasodilator Agents|vasodilator agents|mesh-ancestor
24621840|NCT01064180|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24621841|NCT01064180|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24621842|NCT01064219|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24621843|NCT01064219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24621844|NCT01064219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621845|NCT01064232|Risperidone|risperidone|mesh-list
24621846|NCT01064232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24621847|NCT01064232|Serotonin Agents|serotonin agents|mesh-ancestor
24621848|NCT01064232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24791301|NCT04773392|Methylprednisolone|methylprednisolone|mesh-list
24791302|NCT04773392|Azathioprine|azathioprine|mesh-list
24791303|NCT04773392|Tacrolimus|tacrolimus|mesh-list
24791304|NCT04773392|Thymoglobulin|thymoglobulin|mesh-list
24791305|NCT04773392|Basiliximab|basiliximab|mesh-list
24791306|NCT04773392|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24791307|NCT04773392|Antimetabolites|antimetabolites|mesh-list
24791308|NCT04773392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24791309|NCT04773392|Glucocorticoids|glucocorticoids|mesh-ancestor
24791310|NCT04773392|Hormones|hormones|mesh-ancestor
24791311|NCT04773392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25678594|NCT01827254|Growth Inhibitors|growth inhibitors|mesh-ancestor
25678595|NCT01827254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24791312|NCT04773392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262485|NCT02447835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262486|NCT02447835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24791313|NCT04773392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24791314|NCT04773392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791315|NCT04773392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24791316|NCT04773392|Immunologic Factors|immunologic factors|mesh-ancestor
24791317|NCT04773392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24791318|NCT04773392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24791319|NCT04773392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791320|NCT04773392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24791321|NCT04773392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24791322|NCT04773392|Antitubercular Agents|antitubercular agents|mesh-ancestor
24791323|NCT04773392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24791324|NCT04773392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24791325|NCT04773392|Antiemetics|antiemetics|mesh-ancestor
24791326|NCT04773392|Autonomic Agents|autonomic agents|mesh-ancestor
25214283|NCT02318095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25214284|NCT02318095|Immunologic Factors|immunologic factors|mesh-ancestor
24829871|NCT02155088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829872|NCT02155088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24829873|NCT02155088|Antimetabolites|antimetabolites|mesh-ancestor
24829874|NCT02155088|Antiviral Agents|antiviral agents|mesh-ancestor
25051615|NCT00393068|Paclitaxel|paclitaxel|mesh-list
25082565|NCT03321890|Alkylating Agents|alkylating agents|mesh-ancestor
25082566|NCT03321890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082567|NCT03321890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25082568|NCT03321890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25082569|NCT03321890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25082570|NCT03321890|Glucocorticoids|glucocorticoids|mesh-ancestor
25082571|NCT03321890|Hormones|hormones|mesh-ancestor
25082572|NCT03321890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25082573|NCT03321890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25082574|NCT03321890|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25082575|NCT03321890|Abortifacient Agents|abortifacient agents|mesh-ancestor
25082576|NCT03321890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25082577|NCT03321890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25082578|NCT03321890|Antimetabolites|antimetabolites|mesh-ancestor
25082579|NCT03321890|Dermatologic Agents|dermatologic agents|mesh-ancestor
25082580|NCT03321890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25082581|NCT03321890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25082582|NCT03321890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25082583|NCT03321890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25082584|NCT03321890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25082589|NCT03321825|Anesthetics|anesthetics|mesh-ancestor
25082590|NCT03321825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25082591|NCT03321825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082592|NCT03321825|Sensory System Agents|sensory system agents|mesh-ancestor
25082593|NCT03321825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082594|NCT03321825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25082595|NCT03321825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25082596|NCT03321825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25082597|NCT03321825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25082598|NCT03321825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082599|NCT03321825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25082600|NCT03321825|Immunologic Factors|immunologic factors|mesh-ancestor
24628138|NCT01096706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25082601|NCT03321825|Viscosupplements|viscosupplements|mesh-ancestor
25082602|NCT03321825|Protective Agents|protective agents|mesh-ancestor
25082605|NCT03321773|Amoxicillin|amoxicillin|mesh-list
25082606|NCT03321773|Metronidazole|metronidazole|mesh-list
25082607|NCT03321773|Clarithromycin|clarithromycin|mesh-list
24791345|NCT04722835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24791346|NCT04722835|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24791347|NCT04722835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24791348|NCT04722835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24791349|NCT04722835|Adrenergic Agents|adrenergic agents|mesh-ancestor
24791350|NCT04722835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24791351|NCT04722835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678596|NCT01827254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678597|NCT01827254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678598|NCT01827267|Sirolimus|sirolimus|mesh-list
24684350|NCT01397006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25262521|NCT02447601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262522|NCT02447601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25262523|NCT02447601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25262524|NCT02447601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262525|NCT02447393|Cetirizine|cetirizine|mesh-list
25262526|NCT02447393|Levocetirizine|levocetirizine|mesh-list
25262527|NCT02447393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25262528|NCT02447393|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25262529|NCT02447393|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25262530|NCT02447393|Histamine Antagonists|histamine antagonists|mesh-ancestor
25262531|NCT02447393|Histamine Agents|histamine agents|mesh-ancestor
25262532|NCT02447393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25262533|NCT02447393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262534|NCT02447393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262535|NCT02447510|Mitogens|mitogens|mesh-list
25262536|NCT02447510|Mitosis Modulators|mitosis modulators|mesh-ancestor
25262537|NCT02447510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262538|NCT02447289|Midazolam|midazolam|mesh-list
25262539|NCT02447289|Ketamine|ketamine|mesh-list
25262540|NCT02447289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25262541|NCT02447289|Analgesics|analgesics|mesh-ancestor
25262542|NCT02447289|Sensory System Agents|sensory system agents|mesh-ancestor
24791352|NCT04722835|Chelating Agents|chelating agents|mesh-ancestor
24791353|NCT04722835|Sequestering Agents|sequestering agents|mesh-ancestor
24448791|NCT00313131|Antifungal Agents|antifungal agents|mesh-ancestor
24448792|NCT00313131|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24791389|NCT04561115|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24791390|NCT04561115|Immunologic Factors|immunologic factors|mesh-ancestor
24791391|NCT04561115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791428|NCT04411953|Benztropine|benztropine|mesh-list
24791429|NCT04411953|Haloperidol decanoate|haloperidol decanoate|mesh-list
24791430|NCT04411953|Antiemetics|antiemetics|mesh-ancestor
24791431|NCT04411953|Autonomic Agents|autonomic agents|mesh-ancestor
24791432|NCT04411953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24791433|NCT04411953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791434|NCT04411953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24791435|NCT04411953|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24791436|NCT04411953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24791437|NCT04411953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24791438|NCT04411953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24791439|NCT04411953|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24791440|NCT04411953|Dopamine Agents|dopamine agents|mesh-ancestor
24791442|NCT04411953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791443|NCT04411953|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24791444|NCT04411953|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24791445|NCT04411953|Parasympatholytics|parasympatholytics|mesh-ancestor
24791446|NCT04411953|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24791447|NCT04411953|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24791448|NCT04411953|Cholinergic Agents|cholinergic agents|mesh-ancestor
24791449|NCT04411953|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25678599|NCT01827267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25678600|NCT01827267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25678601|NCT01827267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25678602|NCT01827267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678603|NCT01827267|Antifungal Agents|antifungal agents|mesh-ancestor
25678604|NCT01827267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25678605|NCT01827267|Immunologic Factors|immunologic factors|mesh-ancestor
25678606|NCT01827267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678607|NCT01827332|Oxytocin|oxytocin|mesh-list
25678608|NCT01827332|Oxytocics|oxytocics|mesh-ancestor
25678609|NCT01827332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25678610|NCT01827332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678611|NCT01827358|Calcium, Dietary|calcium, dietary|mesh-list
25678612|NCT01827358|Mupirocin|mupirocin|mesh-list
25678613|NCT01827358|Calcium|calcium|mesh-list
25678614|NCT01827358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25678615|NCT01827358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678616|NCT01827358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25678617|NCT01827358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25678618|NCT01827358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25678619|NCT01827358|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25678620|NCT01827358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678621|NCT01827358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262554|NCT02447289|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25262555|NCT02447289|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25262556|NCT02447289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25262557|NCT02447289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25262558|NCT02447289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24791450|NCT04411953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24791451|NCT04411953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24791452|NCT04411940|Haloperidol|haloperidol|mesh-list
24791453|NCT04411940|Benztropine|benztropine|mesh-list
24791454|NCT04411940|Haloperidol decanoate|haloperidol decanoate|mesh-list
24791455|NCT04411940|Antiemetics|antiemetics|mesh-ancestor
24791456|NCT04411940|Autonomic Agents|autonomic agents|mesh-ancestor
24535341|NCT00648999|Ritonavir|ritonavir|mesh-list
24791457|NCT04411940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24791458|NCT04411940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791459|NCT04411940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24791460|NCT04411940|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24791485|NCT04150614|Dexamethasone|dexamethasone|mesh-list
24791486|NCT04150614|Ondansetron|ondansetron|mesh-list
24791487|NCT04150614|Granisetron|granisetron|mesh-list
24791488|NCT04150614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25214293|NCT02200978|Abortifacient Agents|abortifacient agents|mesh-ancestor
25214294|NCT02200978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25214295|NCT02200978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214296|NCT02200978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25214298|NCT02200978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214299|NCT02200978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25214300|NCT02200978|Dermatologic Agents|dermatologic agents|mesh-ancestor
24448793|NCT00313131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24448794|NCT00313131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829876|NCT02155088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829877|NCT02155088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24829878|NCT02155088|Immunologic Factors|immunologic factors|mesh-ancestor
24493404|NCT00490854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493405|NCT00490854|Heparin Antagonists|heparin antagonists|mesh-ancestor
24493406|NCT00490854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493407|NCT00490854|Coagulants|coagulants|mesh-ancestor
24493408|NCT00490867|Thioctic Acid|thioctic acid|mesh-list
24493409|NCT00490867|Antioxidants|antioxidants|mesh-ancestor
24493410|NCT00490867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493411|NCT00490867|Protective Agents|protective agents|mesh-ancestor
24493412|NCT00490867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493413|NCT00490867|Vitamin B Complex|vitamin b complex|mesh-ancestor
24493414|NCT00490867|Vitamins|vitamins|mesh-ancestor
24493415|NCT00490867|Micronutrients|micronutrients|mesh-ancestor
24535362|NCT00649038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535363|NCT00649038|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24535364|NCT00649038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24493416|NCT00490880|Gemcitabine|gemcitabine|mesh-list
24493417|NCT00490880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493429|NCT00490893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493430|NCT00490906|Interferons|interferons|mesh-list
24493431|NCT00490906|Interferon-beta|interferon-beta|mesh-list
24791491|NCT04150614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24791492|NCT04150614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791493|NCT04150614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24791494|NCT04150614|Glucocorticoids|glucocorticoids|mesh-ancestor
24791495|NCT04150614|Hormones|hormones|mesh-ancestor
24791496|NCT04150614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24791497|NCT04150614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24791498|NCT04150614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791500|NCT04150614|Dermatologic Agents|dermatologic agents|mesh-ancestor
25678622|NCT01827462|Vaccines|vaccines|mesh-list
25678623|NCT01827462|Immunologic Factors|immunologic factors|mesh-ancestor
25678624|NCT01827462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678625|NCT01827475|Acetaminophen|acetaminophen|mesh-list
25678626|NCT01827475|Ibuprofen|ibuprofen|mesh-list
25678627|NCT01827475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25678628|NCT01827475|Analgesics|analgesics|mesh-ancestor
25678629|NCT01827475|Sensory System Agents|sensory system agents|mesh-ancestor
25678630|NCT01827475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24684584|NCT05054439|Antimitotic Agents|antimitotic agents|mesh-ancestor
24684585|NCT05054439|Mitosis Modulators|mitosis modulators|mesh-ancestor
24684586|NCT05054439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262561|NCT02447380|Docetaxel|docetaxel|mesh-list
25262562|NCT02447380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262563|NCT02447380|Tubulin Modulators|tubulin modulators|mesh-ancestor
25262564|NCT02447380|Antimitotic Agents|antimitotic agents|mesh-ancestor
25262565|NCT02447380|Mitosis Modulators|mitosis modulators|mesh-ancestor
25262566|NCT02447380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262567|NCT02447315|Pilocarpine|pilocarpine|mesh-list
25262568|NCT02447315|Miotics|miotics|mesh-ancestor
25262569|NCT02447315|Autonomic Agents|autonomic agents|mesh-ancestor
25262570|NCT02447315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25262571|NCT02447315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791501|NCT04150614|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24791502|NCT04150614|Serotonin Agents|serotonin agents|mesh-ancestor
24791503|NCT04150614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24791522|NCT04035109|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24791523|NCT04035109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24791527|NCT04030429|Crizotinib|crizotinib|mesh-list
24791528|NCT04030429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791529|NCT04030429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24791530|NCT04030429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24791531|NCT04030429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791532|NCT03987503|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
24791533|NCT03987503|Antiviral Agents|antiviral agents|mesh-ancestor
24791534|NCT03987503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24791535|NCT03982186|JNJ-56136379|jnj-56136379|mesh-list
24791536|NCT03982186|Antiviral Agents|antiviral agents|mesh-ancestor
24791537|NCT03982186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24791552|NCT03962062|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24791553|NCT03962062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25050339|NCT00517439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050341|NCT00517153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24791554|NCT03962062|Antinematodal Agents|antinematodal agents|mesh-ancestor
24791555|NCT03941132|Ustekinumab|ustekinumab|mesh-list
24791556|NCT03941132|Dermatologic Agents|dermatologic agents|mesh-ancestor
24791557|NCT03920007|Trimethoprim|trimethoprim|mesh-list
24791558|NCT03920007|Polymyxins|polymyxins|mesh-list
24791559|NCT03920007|Polymyxin B|polymyxin b|mesh-list
24791560|NCT03920007|Prednisone|prednisone|mesh-list
24791561|NCT03920007|Prednisolone|prednisolone|mesh-list
25214301|NCT02200978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25214302|NCT02200978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25214303|NCT02200978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25214304|NCT02200978|Immunologic Factors|immunologic factors|mesh-ancestor
25214305|NCT02200978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25214306|NCT02200978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25214307|NCT02200978|Antiviral Agents|antiviral agents|mesh-ancestor
25214308|NCT02200978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25214309|NCT02200978|Analgesics|analgesics|mesh-ancestor
25214310|NCT02200978|Sensory System Agents|sensory system agents|mesh-ancestor
24791617|NCT03785691|Antidepressive Agents|antidepressive agents|mesh-ancestor
24791618|NCT03785691|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24791619|NCT03785691|Histamine Antagonists|histamine antagonists|mesh-ancestor
24791620|NCT03785691|Histamine Agents|histamine agents|mesh-ancestor
25678631|NCT01827475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678632|NCT01827475|Antipyretics|antipyretics|mesh-ancestor
25678633|NCT01827475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25678634|NCT01827475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25678635|NCT01827475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25678636|NCT01827475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25678637|NCT01827475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678638|NCT01827475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678639|NCT01827670|Fluorides|fluorides|mesh-list
25678640|NCT01827670|Tin Fluorides|tin fluorides|mesh-list
25678641|NCT01827670|Fluorophosphate|fluorophosphate|mesh-list
25678642|NCT01827670|Cariostatic Agents|cariostatic agents|mesh-ancestor
25678643|NCT01827670|Protective Agents|protective agents|mesh-ancestor
25678644|NCT01827670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678645|NCT01827839|Vaccines|vaccines|mesh-list
25262592|NCT02447211|Histamine Antagonists|histamine antagonists|mesh-ancestor
25262593|NCT02447211|Histamine Agents|histamine agents|mesh-ancestor
25262594|NCT02447211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25262595|NCT02447211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262596|NCT02447185|Triamcinolone|triamcinolone|mesh-list
25262597|NCT02447185|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25262598|NCT02447185|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25262599|NCT02447185|Ranibizumab|ranibizumab|mesh-list
24791621|NCT03785691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24791622|NCT03785691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24791623|NCT03785691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24791624|NCT03785691|Adrenergic Agents|adrenergic agents|mesh-ancestor
24791625|NCT03785691|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24791626|NCT03785691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24791627|NCT03714880|Mifepristone|mifepristone|mesh-list
24791628|NCT03714880|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24791629|NCT03714880|Abortifacient Agents|abortifacient agents|mesh-ancestor
24791630|NCT03714880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24791631|NCT03714880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791632|NCT03714880|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24812305|NCT02051387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050353|NCT00517049|Immunologic Factors|immunologic factors|mesh-ancestor
24791939|NCT02330562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24791940|NCT02330562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791941|NCT02330562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24791942|NCT02330562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24791943|NCT02330562|Growth Substances|growth substances|mesh-ancestor
24802655|NCT01991327|Clomiphene|clomiphene|mesh-list
24791944|NCT02330562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791945|NCT02330562|Growth Inhibitors|growth inhibitors|mesh-ancestor
24791946|NCT02138617|Leucovorin|leucovorin|mesh-list
24791947|NCT02138617|Bevacizumab|bevacizumab|mesh-list
24791948|NCT02138617|Fluorouracil|fluorouracil|mesh-list
24791949|NCT02138617|Irinotecan|irinotecan|mesh-list
24791950|NCT02138617|Levoleucovorin|levoleucovorin|mesh-list
24791951|NCT02138617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24791952|NCT02138617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791953|NCT02138617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24791955|NCT02138617|Growth Substances|growth substances|mesh-ancestor
24791987|NCT02035137|Tubulin Modulators|tubulin modulators|mesh-ancestor
24791988|NCT02035137|Antimitotic Agents|antimitotic agents|mesh-ancestor
24791989|NCT02035137|Mitosis Modulators|mitosis modulators|mesh-ancestor
24791990|NCT02035137|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24791991|NCT02035137|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24791993|NCT01589523|Glycocholic Acid|glycocholic acid|mesh-list
24791994|NCT01589523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24791995|NCT01589523|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24791996|NCT01100775|Galantamine|galantamine|mesh-list
24791997|NCT01100775|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24791998|NCT01100775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24791999|NCT01100775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792000|NCT01100775|Cholinergic Agents|cholinergic agents|mesh-ancestor
24792001|NCT01100775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24792002|NCT01100775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792003|NCT01100775|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24792009|NCT00777036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24792010|NCT00777036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24792068|NCT05412888|Micronutrients|micronutrients|mesh-ancestor
24792069|NCT05412888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214311|NCT02200978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25214312|NCT02200978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25214313|NCT02200978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25214314|NCT02200978|Keratolytic Agents|keratolytic agents|mesh-ancestor
25214315|NCT02173405|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25214316|NCT02173405|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25214317|NCT02173405|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25678646|NCT01827839|Immunologic Factors|immunologic factors|mesh-ancestor
25678647|NCT01827839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678648|NCT01827930|Imatinib Mesylate|imatinib mesylate|mesh-list
25678649|NCT01827930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678650|NCT01827930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25678651|NCT01827930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678652|NCT01827930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678653|NCT01827943|Sirolimus|sirolimus|mesh-list
24451965|NCT00325546|Rimonabant|rimonabant|mesh-list
24895492|NCT04020601|Sensory System Agents|sensory system agents|mesh-ancestor
24792099|NCT05412576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24792100|NCT05412576|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24792101|NCT05412576|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24792102|NCT05412576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24803555|NCT01997099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24803556|NCT01997099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24803557|NCT01997099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24803558|NCT01997099|Anesthetics, General|anesthetics, general|mesh-ancestor
24803560|NCT01997099|GABA Modulators|gaba modulators|mesh-ancestor
24803561|NCT01997099|GABA Agents|gaba agents|mesh-ancestor
24803562|NCT01997099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24924598|NCT04158713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24924599|NCT04158830|Aspirin|aspirin|mesh-list
24493432|NCT00490906|Interferon beta-1a|interferon beta-1a|mesh-list
24493433|NCT00490906|Glatiramer Acetate|glatiramer acetate|mesh-list
24493434|NCT00490906|(T,G)-A-L|(t,g)-a-l|mesh-list
24493435|NCT00490906|Interferon beta-1b|interferon beta-1b|mesh-list
25243838|NCT05183139|Antiemetics|antiemetics|mesh-ancestor
24493436|NCT00490906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493437|NCT00490906|Antiviral Agents|antiviral agents|mesh-ancestor
24493438|NCT00490906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493439|NCT00490906|Immunologic Factors|immunologic factors|mesh-ancestor
24493440|NCT00490906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493441|NCT00490906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24493442|NCT00490906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24493443|NCT00490906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24493444|NCT00490958|Telmisartan|telmisartan|mesh-list
24493445|NCT00490958|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24493531|NCT00491192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24792103|NCT05412576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792104|NCT05412472|Avasopasem manganese|avasopasem manganese|mesh-list
24792105|NCT05412472|Antioxidants|antioxidants|mesh-ancestor
24792106|NCT05412472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792107|NCT05412472|Protective Agents|protective agents|mesh-ancestor
24792108|NCT05412472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792109|NCT05412394|Prednisolone|prednisolone|mesh-list
24792110|NCT05412394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25214319|NCT02173405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214320|NCT02173405|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25214321|NCT02173405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25214322|NCT02173405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214323|NCT02173405|Cholinergic Agents|cholinergic agents|mesh-ancestor
25214324|NCT02173405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25214325|NCT02155647|Avelumab|avelumab|mesh-list
25214326|NCT02155647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25214327|NCT02155647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25214328|NCT02120365|Anticonvulsants|anticonvulsants|mesh-list
25050369|NCT00514267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954463|NCT03876444|Methylprednisolone|methylprednisolone|mesh-list
25272773|NCT02389868|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25041738|NCT01590719|Oxaliplatin|oxaliplatin|mesh-list
25041739|NCT01590719|Levoleucovorin|levoleucovorin|mesh-list
25041740|NCT01590719|Antimetabolites|antimetabolites|mesh-ancestor
25041741|NCT01590719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041742|NCT01590719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25041743|NCT01590719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041744|NCT01590719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25041745|NCT01590719|Immunologic Factors|immunologic factors|mesh-ancestor
25041746|NCT01590719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262669|NCT02447094|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25262670|NCT02447094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041747|NCT01590719|Antidotes|antidotes|mesh-ancestor
25041748|NCT01590719|Protective Agents|protective agents|mesh-ancestor
25041749|NCT01590719|Vitamin B Complex|vitamin b complex|mesh-ancestor
25041750|NCT01590719|Vitamins|vitamins|mesh-ancestor
25041751|NCT01590719|Micronutrients|micronutrients|mesh-ancestor
25041752|NCT01590719|Hematinics|hematinics|mesh-ancestor
25041753|NCT01588535|Benzocaine|benzocaine|mesh-list
25041754|NCT01588535|Anesthetics, Local|anesthetics, local|mesh-ancestor
25041755|NCT01588535|Anesthetics|anesthetics|mesh-ancestor
25041760|NCT01587144|Lucanthone|lucanthone|mesh-list
25051656|NCT00389779|Adrenergic Agents|adrenergic agents|mesh-ancestor
24792111|NCT05412394|Glucocorticoids|glucocorticoids|mesh-ancestor
24792112|NCT05412394|Hormones|hormones|mesh-ancestor
24792113|NCT05412394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24792114|NCT05412394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792115|NCT05412394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24792116|NCT05412394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24792117|NCT05412147|Vitamins|vitamins|mesh-list
24792143|NCT05411900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24792144|NCT05411900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082617|NCT03321773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214337|NCT02012114|Cysteamine|cysteamine|mesh-list
25214338|NCT02012114|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
25214339|NCT02012114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214340|NCT01979211|Cetuximab|cetuximab|mesh-list
25214341|NCT01979211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25214342|NCT01979211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25214343|NCT01962415|Fludarabine|fludarabine|mesh-list
25214344|NCT01962415|Melphalan|melphalan|mesh-list
25214345|NCT01962415|Alemtuzumab|alemtuzumab|mesh-list
25214346|NCT01962415|Thiotepa|thiotepa|mesh-list
25214347|NCT01962415|Hydroxyurea|hydroxyurea|mesh-list
25214348|NCT01962415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25214349|NCT01962415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214350|NCT01962415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25214351|NCT01962415|Immunologic Factors|immunologic factors|mesh-ancestor
25214352|NCT01962415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214353|NCT01962415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25214354|NCT01962415|Alkylating Agents|alkylating agents|mesh-ancestor
25214355|NCT01962415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25214356|NCT01962415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25214357|NCT01962415|Antisickling Agents|antisickling agents|mesh-ancestor
25214358|NCT01962415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25214359|NCT01962415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25214360|NCT01904903|Trastuzumab|trastuzumab|mesh-list
25214361|NCT01904903|Pertuzumab|pertuzumab|mesh-list
25214362|NCT01904903|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25214363|NCT01904903|Maytansine|maytansine|mesh-list
25214364|NCT01904903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24829924|NCT02155439|Glucocorticoids|glucocorticoids|mesh-ancestor
24829925|NCT02155439|Hormones|hormones|mesh-ancestor
24829926|NCT02155439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24829927|NCT02155504|Itraconazole|itraconazole|mesh-list
24954471|NCT03876444|Antiemetics|antiemetics|mesh-ancestor
25678654|NCT01827943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25678655|NCT01827943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24535472|NCT00649194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24535473|NCT00649194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25678656|NCT01827943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25262712|NCT02446795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262713|NCT02446834|Metformin|metformin|mesh-list
25262714|NCT02446834|Acarbose|acarbose|mesh-list
25262715|NCT02446834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25262716|NCT02446834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262717|NCT02446834|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25262718|NCT02446834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262719|NCT02446834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262720|NCT02446574|Paclitaxel|paclitaxel|mesh-list
25262721|NCT02446574|Cisplatin|cisplatin|mesh-list
25262722|NCT02446574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25262723|NCT02446574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262724|NCT02446574|Tubulin Modulators|tubulin modulators|mesh-ancestor
25262728|NCT02446704|Temozolomide|temozolomide|mesh-list
24829953|NCT02155530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24829955|NCT02155634|Lenalidomide|lenalidomide|mesh-list
24829956|NCT02155634|Immunologic Factors|immunologic factors|mesh-ancestor
24829957|NCT02155634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829958|NCT02155634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24829959|NCT02155634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25082618|NCT03321773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25082619|NCT03321773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25082620|NCT03321773|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25082621|NCT03321773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25082622|NCT03321773|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25082623|NCT03321773|Antacids|antacids|mesh-ancestor
25082624|NCT03321734|Caffeine|caffeine|mesh-list
25082625|NCT03321734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25082626|NCT03321734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082627|NCT03321734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25082628|NCT03321734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25082629|NCT03321734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082630|NCT03321734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25082631|NCT03321734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24730273|NCT01627236|Prednisolone phosphate|prednisolone phosphate|mesh-list
24493650|NCT00491868|Hematinics|hematinics|mesh-ancestor
25214365|NCT01904903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25214366|NCT01904903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25214367|NCT01904903|Tubulin Modulators|tubulin modulators|mesh-ancestor
25214368|NCT01904903|Antimitotic Agents|antimitotic agents|mesh-ancestor
25214369|NCT01904903|Mitosis Modulators|mitosis modulators|mesh-ancestor
25214370|NCT01904903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214371|NCT01880359|Nimorazole|nimorazole|mesh-list
25214372|NCT01880359|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25214373|NCT01880359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25214374|NCT01880359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25214375|NCT01880359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25214376|NCT01827384|Carboplatin|carboplatin|mesh-list
25214377|NCT01827384|Everolimus|everolimus|mesh-list
25214378|NCT01827384|Temozolomide|temozolomide|mesh-list
25214379|NCT01827384|Trametinib|trametinib|mesh-list
25214380|NCT01827384|Veliparib|veliparib|mesh-list
25214381|NCT01827384|Adavosertib|adavosertib|mesh-list
25214382|NCT01827384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25214383|NCT01827384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25214384|NCT01827384|Immunologic Factors|immunologic factors|mesh-ancestor
25214385|NCT01827384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214386|NCT01827384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25678657|NCT01827943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678658|NCT01827943|Antifungal Agents|antifungal agents|mesh-ancestor
25678659|NCT01827943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25678660|NCT01827943|Immunologic Factors|immunologic factors|mesh-ancestor
25678661|NCT01827943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678662|NCT01828034|Gemcitabine|gemcitabine|mesh-list
25678663|NCT01828034|Cisplatin|cisplatin|mesh-list
25678664|NCT01828034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678665|NCT01828034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25678666|NCT01828034|Antimetabolites|antimetabolites|mesh-ancestor
25678667|NCT01828034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678668|NCT01828034|Antiviral Agents|antiviral agents|mesh-ancestor
25678669|NCT01828034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25678670|NCT01828034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262757|NCT02446431|Sirolimus|sirolimus|mesh-list
25262758|NCT02446431|Cyclophosphamide|cyclophosphamide|mesh-list
25262759|NCT02446431|Bevacizumab|bevacizumab|mesh-list
25262760|NCT02446431|Valproic Acid|valproic acid|mesh-list
25214387|NCT01827384|Alkylating Agents|alkylating agents|mesh-ancestor
25214388|NCT01827384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214389|NCT01827384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25214390|NCT01827384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25214391|NCT01827384|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25214392|NCT01778946|Nicotine|nicotine|mesh-list
25214393|NCT01778946|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25214394|NCT01778946|Autonomic Agents|autonomic agents|mesh-ancestor
24829960|NCT02155634|Growth Substances|growth substances|mesh-ancestor
24829961|NCT02155634|Growth Inhibitors|growth inhibitors|mesh-ancestor
24448808|NCT00313157|Carvedilol|carvedilol|mesh-list
24494041|NCT00493480|Adrenergic Agents|adrenergic agents|mesh-ancestor
24493651|NCT00491907|Folic Acid|folic acid|mesh-list
24493652|NCT00491907|Hematinics|hematinics|mesh-ancestor
24493653|NCT00491907|Vitamin B Complex|vitamin b complex|mesh-ancestor
24493654|NCT00491907|Vitamins|vitamins|mesh-ancestor
24493655|NCT00491907|Micronutrients|micronutrients|mesh-ancestor
24493656|NCT00491907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493657|NCT00491920|Vitamin D|vitamin d|mesh-list
24493658|NCT00491920|Cholecalciferol|cholecalciferol|mesh-list
24493659|NCT00491920|Vitamins|vitamins|mesh-ancestor
24493723|NCT00492141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493724|NCT00492141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24792155|NCT05411887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24792156|NCT05411887|Antimetabolites|antimetabolites|mesh-ancestor
24792157|NCT05411887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792158|NCT05411887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24792159|NCT05411887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24792160|NCT05411887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24792161|NCT05411887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24792162|NCT05411887|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24792163|NCT05411887|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24792164|NCT05411757|Bevacizumab|bevacizumab|mesh-list
24792165|NCT05411757|Lenvatinib|lenvatinib|mesh-list
24792186|NCT05411744|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24792187|NCT05411744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24792188|NCT05411744|Antimetabolites|antimetabolites|mesh-ancestor
24792189|NCT05411744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792190|NCT05411744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24792191|NCT05411744|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24792192|NCT05411744|Leprostatic Agents|leprostatic agents|mesh-ancestor
24792193|NCT05411718|Aspirin|aspirin|mesh-list
24792194|NCT05411718|Naproxen|naproxen|mesh-list
24792195|NCT05411718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25214395|NCT01778946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25214396|NCT01778946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214397|NCT01778946|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25214400|NCT01778946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25214401|NCT01778946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214403|NCT01706692|Adalimumab|adalimumab|mesh-list
25214404|NCT01706692|Etanercept|etanercept|mesh-list
25214405|NCT01706692|Methotrexate|methotrexate|mesh-list
25214406|NCT01706692|Infliximab|infliximab|mesh-list
25214407|NCT01706692|Ustekinumab|ustekinumab|mesh-list
25214408|NCT01706692|Cyclosporins|cyclosporins|mesh-list
25214409|NCT01706692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25214410|NCT01706692|Abortifacient Agents|abortifacient agents|mesh-ancestor
25214411|NCT01706692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25214412|NCT01706692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214413|NCT01706692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25678671|NCT01828034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25678672|NCT01828034|Immunologic Factors|immunologic factors|mesh-ancestor
25678673|NCT01828034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214414|NCT01706692|Antimetabolites|antimetabolites|mesh-ancestor
25214415|NCT01706692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262795|NCT02446353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25262796|NCT02446353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792196|NCT05411718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24792197|NCT05411718|Analgesics|analgesics|mesh-ancestor
24792198|NCT05411718|Sensory System Agents|sensory system agents|mesh-ancestor
24792201|NCT05411718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24493725|NCT00492141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24493726|NCT00492141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24493727|NCT00492141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24493728|NCT00492141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24792204|NCT05411718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24938418|NCT04018833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24792205|NCT05411718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585227|NCT00884494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24585228|NCT00884494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585229|NCT00884533|Moxifloxacin|moxifloxacin|mesh-list
24585230|NCT00884533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24585231|NCT00884533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24585232|NCT00884533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24585233|NCT00884533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24585234|NCT00884533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24585235|NCT00884533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585236|NCT00884533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585237|NCT00884546|Dexamethasone|dexamethasone|mesh-list
24585238|NCT00884546|Lenalidomide|lenalidomide|mesh-list
24585239|NCT00884546|Bortezomib|bortezomib|mesh-list
24566906|NCT00788515|Lormetazepam|lormetazepam|mesh-list
24585240|NCT00884546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24585255|NCT00884546|Growth Inhibitors|growth inhibitors|mesh-ancestor
24621856|NCT01064232|Dopamine Agents|dopamine agents|mesh-ancestor
24621857|NCT01064271|Risperidone|risperidone|mesh-list
24621858|NCT01064271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24621859|NCT01064271|Serotonin Agents|serotonin agents|mesh-ancestor
24621860|NCT01064271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24621861|NCT01064271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621862|NCT01064271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621863|NCT01064271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24621864|NCT01064271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24621865|NCT01064271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24621866|NCT01064271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24621867|NCT01064271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24621868|NCT01064271|Dopamine Agents|dopamine agents|mesh-ancestor
24621869|NCT01064349|Trastuzumab|trastuzumab|mesh-list
24621870|NCT01064349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24493807|NCT00492479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493808|NCT00492505|Tamoxifen|tamoxifen|mesh-list
24493809|NCT00492505|Sorafenib|sorafenib|mesh-list
24493810|NCT00492505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493811|NCT00492505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214423|NCT01706692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25214424|NCT01706692|Antifungal Agents|antifungal agents|mesh-ancestor
24829962|NCT02155634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24829964|NCT02155777|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24829969|NCT02155777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792304|NCT05327595|Atorvastatin|atorvastatin|mesh-list
24792305|NCT05327595|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24792306|NCT05327595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24792307|NCT05327595|Antimetabolites|antimetabolites|mesh-ancestor
24792308|NCT05327595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792309|NCT05327595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24792310|NCT05327595|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24792311|NCT05327595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24792312|NCT05327595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24792313|NCT05327595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24792314|NCT05327595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24792315|NCT05327595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678674|NCT01828073|Raltegravir Potassium|raltegravir potassium|mesh-list
25678675|NCT01828073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25678676|NCT01828073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25678677|NCT01828073|Antiviral Agents|antiviral agents|mesh-ancestor
25678678|NCT01828073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25262824|NCT02445989|NuvaRing|nuvaring|mesh-list
25262825|NCT02445989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25262826|NCT02445989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262827|NCT02445989|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25262828|NCT02446002|Lofexidine|lofexidine|mesh-list
25262829|NCT02446002|Clonidine|clonidine|mesh-list
25262830|NCT02446002|Naltrexone|naltrexone|mesh-list
25262831|NCT02446002|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25262832|NCT02446002|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25262833|NCT02446002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262834|NCT02446002|Sensory System Agents|sensory system agents|mesh-ancestor
25262835|NCT02446002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25262836|NCT02446002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25262837|NCT02446002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25262838|NCT02446002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24792316|NCT05327595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24792317|NCT05327595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24792318|NCT05327595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24792319|NCT05327595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24792320|NCT05327595|Anesthetics, General|anesthetics, general|mesh-ancestor
24792321|NCT05327595|Anesthetics|anesthetics|mesh-ancestor
24792322|NCT05327595|GABA Modulators|gaba modulators|mesh-ancestor
24792323|NCT05327595|GABA Agents|gaba agents|mesh-ancestor
25244092|NCT05059535|Acetaminophen|acetaminophen|mesh-list
24792324|NCT05327595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24792326|NCT05320406|Relugolix|relugolix|mesh-list
24763175|NCT01771874|Dopamine Agents|dopamine agents|mesh-ancestor
24792327|NCT05320406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24792328|NCT05320406|Fertility Agents|fertility agents|mesh-ancestor
24792329|NCT05320406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24792330|NCT05320406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792331|NCT05320406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24792332|NCT05320406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24792333|NCT05320406|Androgen Antagonists|androgen antagonists|mesh-ancestor
24792334|NCT05320406|Hormone Antagonists|hormone antagonists|mesh-ancestor
24802916|NCT01993225|Fertility Agents|fertility agents|mesh-ancestor
24792336|NCT05312892|Amlodipine|amlodipine|mesh-list
24792343|NCT05312892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792344|NCT05312892|Vasodilator Agents|vasodilator agents|mesh-ancestor
24792345|NCT05303038|Bevacizumab|bevacizumab|mesh-list
24792346|NCT05303038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24792356|NCT05302986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792357|NCT05302986|Hemostatics|hemostatics|mesh-ancestor
24792358|NCT05302986|Coagulants|coagulants|mesh-ancestor
24792359|NCT05302297|Cemiplimab|cemiplimab|mesh-list
24792360|NCT05302297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24792361|NCT05302297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24792362|NCT05280704|Lidocaine|lidocaine|mesh-list
24792363|NCT05280704|Anesthetics, Local|anesthetics, local|mesh-ancestor
24792364|NCT05280704|Anesthetics|anesthetics|mesh-ancestor
24792365|NCT05280704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24829974|NCT02155803|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
24829976|NCT02155803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24829977|NCT02155803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829978|NCT02155803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24829979|NCT02155803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792377|NCT05275894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24792378|NCT05275894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24792408|NCT05223075|Lidocaine|lidocaine|mesh-list
24792409|NCT05223075|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25678679|NCT01828073|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25678680|NCT01828073|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25678681|NCT01828073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678682|NCT01828073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678683|NCT01828476|Hydroxychloroquine|hydroxychloroquine|mesh-list
25678684|NCT01828476|Navitoclax|navitoclax|mesh-list
25678685|NCT01828476|Antimalarials|antimalarials|mesh-ancestor
25678686|NCT01828476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25678687|NCT01828476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25678688|NCT01828476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25678689|NCT01828476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678690|NCT01828476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678691|NCT01828476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25678692|NCT01828476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678693|NCT01828515|Hydrocortisone|hydrocortisone|mesh-list
25678694|NCT01828515|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
24792411|NCT05223075|Anesthetics, Local|anesthetics, local|mesh-ancestor
24792412|NCT05223075|Anesthetics|anesthetics|mesh-ancestor
24792413|NCT05223075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25082632|NCT03321734|Purinergic Agents|purinergic agents|mesh-ancestor
25082633|NCT03321734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24792520|NCT05085002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792521|NCT05085002|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24792522|NCT05085002|Hormone Antagonists|hormone antagonists|mesh-ancestor
24897899|NCT04420533|Urological Agents|urological agents|mesh-ancestor
24792533|NCT05070585|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
24924816|NCT04156464|Autonomic Agents|autonomic agents|mesh-ancestor
24493840|NCT00492518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493841|NCT00492518|Vasodilator Agents|vasodilator agents|mesh-ancestor
24493842|NCT00492518|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24493843|NCT00492518|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24829984|NCT02156375|Ustekinumab|ustekinumab|mesh-list
24829985|NCT02156375|Dermatologic Agents|dermatologic agents|mesh-ancestor
24792535|NCT05070585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792536|NCT05070585|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24792537|NCT05070585|Protective Agents|protective agents|mesh-ancestor
24792538|NCT05070585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792539|NCT05070585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24792540|NCT05062902|Botulinum Toxins|botulinum toxins|mesh-list
24792554|NCT05028062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24792555|NCT05028062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792556|NCT05028062|Sensory System Agents|sensory system agents|mesh-ancestor
24792557|NCT05028062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24792558|NCT05025488|Poly ICLC|poly iclc|mesh-list
24792559|NCT05025488|Interferon Inducers|interferon inducers|mesh-ancestor
24792560|NCT05025488|Immunologic Factors|immunologic factors|mesh-ancestor
24792561|NCT05025488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493847|NCT00492635|Vasodilator Agents|vasodilator agents|mesh-ancestor
24493848|NCT00492635|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24493849|NCT00492635|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24493850|NCT00492635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493851|NCT00492635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493852|NCT00492635|Urological Agents|urological agents|mesh-ancestor
24493854|NCT00492661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24493855|NCT00492661|Immunologic Factors|immunologic factors|mesh-ancestor
24493856|NCT00492661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792566|NCT05022342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24792567|NCT05022342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24792568|NCT05022342|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24792569|NCT05022342|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24792570|NCT05022342|Hormone Antagonists|hormone antagonists|mesh-ancestor
24792571|NCT05022342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24792572|NCT05022342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792573|NCT04999644|Nicotine|nicotine|mesh-list
24792574|NCT04999644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24792575|NCT04999644|Autonomic Agents|autonomic agents|mesh-ancestor
24792576|NCT04999644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24792577|NCT04999644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792578|NCT04999644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24792579|NCT04999644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24792580|NCT04999644|Cholinergic Agents|cholinergic agents|mesh-ancestor
24585556|NCT00886028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585557|NCT00886106|Midazolam|midazolam|mesh-list
24585558|NCT00886106|Remifentanil|remifentanil|mesh-list
24585568|NCT00886106|Anesthetics|anesthetics|mesh-ancestor
24792581|NCT04999644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24792582|NCT04999644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792583|NCT04992312|Glucagon|glucagon|mesh-list
25214452|NCT01517802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24792612|NCT04917055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24792613|NCT04917055|Anesthetics, Local|anesthetics, local|mesh-ancestor
24792614|NCT04917055|Anesthetics|anesthetics|mesh-ancestor
24792615|NCT04917055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25262906|NCT02445599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25262907|NCT02445599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25262908|NCT02445599|Anesthetics, General|anesthetics, general|mesh-ancestor
25262909|NCT02445599|Anesthetics|anesthetics|mesh-ancestor
25262910|NCT02445599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25262911|NCT02445599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25262912|NCT02445599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24512713|NCT00576238|Hormones|hormones|mesh-ancestor
25274224|NCT02380053|Sympathomimetics|sympathomimetics|mesh-ancestor
24792616|NCT04917055|Sensory System Agents|sensory system agents|mesh-ancestor
24792617|NCT04917055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24792618|NCT04917055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24792619|NCT04917055|Adrenergic Agents|adrenergic agents|mesh-ancestor
24792620|NCT04917055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24792621|NCT04917055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792622|NCT04917055|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24792623|NCT04917055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24792624|NCT04917055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24792625|NCT04917055|Respiratory System Agents|respiratory system agents|mesh-ancestor
24792626|NCT04917055|Mydriatics|mydriatics|mesh-ancestor
24792627|NCT04917055|Sympathomimetics|sympathomimetics|mesh-ancestor
24792628|NCT04917055|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24493874|NCT00492687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24493877|NCT00492700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493878|NCT00492765|Interferons|interferons|mesh-list
24493879|NCT00492765|Interferon-beta|interferon-beta|mesh-list
24493880|NCT00492765|Interferon beta-1a|interferon beta-1a|mesh-list
24493881|NCT00492765|Simvastatin|simvastatin|mesh-list
24493882|NCT00492765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493883|NCT00492765|Antiviral Agents|antiviral agents|mesh-ancestor
24493884|NCT00492765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493885|NCT00492765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24493886|NCT00492765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24493887|NCT00492765|Antimetabolites|antimetabolites|mesh-ancestor
24792641|NCT04898478|Narcotics|narcotics|mesh-ancestor
24792642|NCT04898478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24792643|NCT04898478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792644|NCT04898478|Analgesics|analgesics|mesh-ancestor
24792645|NCT04898478|Sensory System Agents|sensory system agents|mesh-ancestor
24792646|NCT04898478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24792647|NCT04887831|Gemcitabine|gemcitabine|mesh-list
24792648|NCT04887831|Carboplatin|carboplatin|mesh-list
24792649|NCT04887831|Avelumab|avelumab|mesh-list
24792650|NCT04887831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24792687|NCT04792385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24792688|NCT04792385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792689|NCT04792385|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24493890|NCT00492765|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24493892|NCT00492765|Immunologic Factors|immunologic factors|mesh-ancestor
24792751|NCT04733534|Dasatinib|dasatinib|mesh-list
24792752|NCT04733534|Quercetin|quercetin|mesh-list
24792753|NCT04733534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24792754|NCT04733534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24792755|NCT04733534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24792756|NCT04733534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792757|NCT04733534|Antioxidants|antioxidants|mesh-ancestor
24792758|NCT04733534|Protective Agents|protective agents|mesh-ancestor
24792759|NCT04733534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082634|NCT03321318|Cholecalciferol|cholecalciferol|mesh-list
24803135|NCT01994759|Autonomic Agents|autonomic agents|mesh-ancestor
24792760|NCT04725864|Progesterone|progesterone|mesh-list
24792761|NCT04725864|Progestins|progestins|mesh-ancestor
24792762|NCT04725864|Hormones|hormones|mesh-ancestor
24792763|NCT04725864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24792764|NCT04725864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792765|NCT04721821|Tofacitinib|tofacitinib|mesh-list
24792766|NCT04721821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24792767|NCT04721821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24792768|NCT04721821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678695|NCT01828515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25678696|NCT01828515|Antidepressive Agents|antidepressive agents|mesh-ancestor
25678697|NCT01828515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25678698|NCT01828515|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25678699|NCT01828515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25678700|NCT01828515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25262940|NCT02445716|Testosterone undecanoate|testosterone undecanoate|mesh-list
25262941|NCT02445716|Testosterone enanthate|testosterone enanthate|mesh-list
25262942|NCT02445716|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25262943|NCT02445716|Androgens|androgens|mesh-ancestor
25262944|NCT02445716|Hormones|hormones|mesh-ancestor
24792769|NCT04721353|Prazosin|prazosin|mesh-list
24792770|NCT04721353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24792771|NCT04721353|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24792772|NCT04721353|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24792773|NCT04721353|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24792774|NCT04721353|Adrenergic Agents|adrenergic agents|mesh-ancestor
24792778|NCT04714619|Letrozole|letrozole|mesh-list
24792802|NCT04681339|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24792803|NCT04681339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24792804|NCT04681339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24792805|NCT04681339|Antitubercular Agents|antitubercular agents|mesh-ancestor
24792806|NCT04655391|Decitabine|decitabine|mesh-list
24792851|NCT04493333|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24792852|NCT04493333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24792853|NCT04493333|Immunologic Factors|immunologic factors|mesh-ancestor
24792854|NCT04493333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792855|NCT04493333|Antidiarrheals|antidiarrheals|mesh-ancestor
24792856|NCT04493333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24493893|NCT00492765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493894|NCT00492765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24493896|NCT00492778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493897|NCT00492830|Antibodies|antibodies|mesh-list
24493898|NCT00492830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24493902|NCT00492843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24493903|NCT00492843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493905|NCT00492934|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24493906|NCT00492934|Fertility Agents|fertility agents|mesh-ancestor
24493907|NCT00492934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24493908|NCT00492934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493909|NCT00492986|Sorafenib|sorafenib|mesh-list
24493920|NCT00493077|Immunologic Factors|immunologic factors|mesh-ancestor
24493921|NCT00493077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493922|NCT00493077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24493998|NCT00493324|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24494000|NCT00493324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494001|NCT00493324|Dermatologic Agents|dermatologic agents|mesh-ancestor
25214457|NCT01517802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25214458|NCT01517802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214459|NCT01517802|Hormone Antagonists|hormone antagonists|mesh-ancestor
24829995|NCT02156596|Narcotics|narcotics|mesh-ancestor
24829996|NCT02156596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24829997|NCT02156596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494003|NCT00493363|Mefloquine|mefloquine|mesh-list
24494040|NCT00493480|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24585932|NCT00888186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585933|NCT00888186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585934|NCT00888186|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24585935|NCT00888186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24585936|NCT00888303|Dexamethasone|dexamethasone|mesh-list
24585937|NCT00888303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25082635|NCT03321318|Vitamin D|vitamin d|mesh-list
24585938|NCT00888303|Antiemetics|antiemetics|mesh-ancestor
24585939|NCT00888303|Autonomic Agents|autonomic agents|mesh-ancestor
24585940|NCT00888303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24628161|NCT01096745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628162|NCT01096797|Sevoflurane|sevoflurane|mesh-list
24628163|NCT01096797|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24628164|NCT01096797|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24628165|NCT01096797|Anesthetics, General|anesthetics, general|mesh-ancestor
24628166|NCT01096797|Anesthetics|anesthetics|mesh-ancestor
24628167|NCT01096797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24628168|NCT01096797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678701|NCT01828515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678702|NCT01828515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25678703|NCT01828515|Serotonin Agents|serotonin agents|mesh-ancestor
25678704|NCT01828515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628169|NCT01096927|Amoxicillin|amoxicillin|mesh-list
24628170|NCT01096927|Clavulanic Acids|clavulanic acids|mesh-list
24628171|NCT01096927|Clavulanic Acid|clavulanic acid|mesh-list
24628172|NCT01096927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25275292|NCT02373163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275294|NCT02373163|Diuretics|diuretics|mesh-ancestor
25275295|NCT02373163|Natriuretic Agents|natriuretic agents|mesh-ancestor
25275296|NCT02373163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25275299|NCT02372903|Palmidrol|palmidrol|mesh-list
24628173|NCT01096927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24628174|NCT01096927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24803583|NCT01997203|Vitamin D|vitamin d|mesh-list
24803811|NCT01998685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803812|NCT01998685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24803813|NCT01998685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24803814|NCT01998685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24803815|NCT01998685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24803817|NCT01998685|GABA Agents|gaba agents|mesh-ancestor
24803818|NCT01998685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24803820|NCT01998685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24803828|NCT01998698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803829|NCT01998698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082644|NCT03321318|Hormone Antagonists|hormone antagonists|mesh-ancestor
25082645|NCT03321318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25082646|NCT03321292|Aspirin|aspirin|mesh-list
25082647|NCT03321292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25082648|NCT03321292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25082649|NCT03321292|Analgesics|analgesics|mesh-ancestor
25082650|NCT03321292|Sensory System Agents|sensory system agents|mesh-ancestor
24924970|NCT04154852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24494120|NCT00493870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24494121|NCT00493870|Immunologic Factors|immunologic factors|mesh-ancestor
24494122|NCT00493870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494123|NCT00493870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24494124|NCT00493870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24494125|NCT00493870|Alkylating Agents|alkylating agents|mesh-ancestor
24829999|NCT02156596|Sensory System Agents|sensory system agents|mesh-ancestor
24830000|NCT02156596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24830001|NCT02156596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24830002|NCT02156596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24830003|NCT02156596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24830004|NCT02156596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24830005|NCT02156596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24830006|NCT02156596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448818|NCT00313157|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24448819|NCT00313157|Adrenergic Agents|adrenergic agents|mesh-ancestor
24448820|NCT00313157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24448821|NCT00313157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448822|NCT00313157|Antioxidants|antioxidants|mesh-ancestor
24448823|NCT00313157|Protective Agents|protective agents|mesh-ancestor
24448824|NCT00313157|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24448825|NCT00313157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24448826|NCT00313157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24448827|NCT00313157|Vasodilator Agents|vasodilator agents|mesh-ancestor
25082651|NCT03321292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082652|NCT03321292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082653|NCT03321292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25082654|NCT03321292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25082655|NCT03321292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25244427|NCT04748848|Venetoclax|venetoclax|mesh-list
25082656|NCT03321292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25082657|NCT03321292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082658|NCT03321292|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25082659|NCT03321292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25082660|NCT03321292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25082661|NCT03321292|Antipyretics|antipyretics|mesh-ancestor
25082662|NCT03321201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25082663|NCT03321201|Hemostatics|hemostatics|mesh-ancestor
25678705|NCT01828515|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25678706|NCT01828515|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25678707|NCT01828554|Capecitabine|capecitabine|mesh-list
25678708|NCT01828554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25678709|NCT01828554|Antimetabolites|antimetabolites|mesh-ancestor
25262969|NCT02445300|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25262970|NCT02445300|Laxatives|laxatives|mesh-ancestor
25262971|NCT02445300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25262973|NCT02445339|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25262974|NCT02445339|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25262975|NCT02445339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262976|NCT02445339|Sensory System Agents|sensory system agents|mesh-ancestor
25262979|NCT02445404|Prednisone|prednisone|mesh-list
25082664|NCT03321201|Coagulants|coagulants|mesh-ancestor
25082665|NCT03321136|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
24731062|NCT01631968|Colistin|colistin|mesh-list
24585949|NCT00888342|Zopiclone|zopiclone|mesh-list
24585950|NCT00888342|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24585951|NCT00888342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24792883|NCT04475016|Nimotuzumab|nimotuzumab|mesh-list
24792884|NCT04475016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24792885|NCT04475016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24792886|NCT04475016|Tubulin Modulators|tubulin modulators|mesh-ancestor
24792887|NCT04475016|Antimitotic Agents|antimitotic agents|mesh-ancestor
24792888|NCT04475016|Mitosis Modulators|mitosis modulators|mesh-ancestor
24792889|NCT04475016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792890|NCT04475016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24792892|NCT04475016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24792895|NCT04420598|Trastuzumab|trastuzumab|mesh-list
24494144|NCT00493987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24494145|NCT00493987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494146|NCT00493987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24494147|NCT00493987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494158|NCT00494078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792901|NCT04408118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24792902|NCT04408118|Tubulin Modulators|tubulin modulators|mesh-ancestor
24792903|NCT04408118|Antimitotic Agents|antimitotic agents|mesh-ancestor
24792904|NCT04408118|Mitosis Modulators|mitosis modulators|mesh-ancestor
24792905|NCT04408118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792906|NCT04352777|Fulvestrant|fulvestrant|mesh-list
24792907|NCT04352777|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24792908|NCT04352777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24792909|NCT04352777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24792910|NCT04352777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24792911|NCT04352777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24792912|NCT04352777|Hormone Antagonists|hormone antagonists|mesh-ancestor
24792913|NCT04352777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24792914|NCT04352777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792915|NCT04352777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24792916|NCT04352777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24792917|NCT04352777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900114|NCT04397510|Heparin|heparin|mesh-list
24792954|NCT04327934|Methyltestosterone|methyltestosterone|mesh-list
24494166|NCT00494156|Clopidogrel|clopidogrel|mesh-list
24494167|NCT00494156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25214486|NCT00715611|Carboplatin|carboplatin|mesh-list
25214487|NCT00715611|Pemetrexed|pemetrexed|mesh-list
25214488|NCT00715611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25214489|NCT00715611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830069|NCT02157207|Vitamins|vitamins|mesh-list
24830070|NCT02157207|Vitamin E|vitamin e|mesh-list
24830071|NCT02157207|Antioxidants|antioxidants|mesh-list
24830072|NCT02157207|Micronutrients|micronutrients|mesh-ancestor
25244458|NCT04731467|Paclitaxel|paclitaxel|mesh-list
24830073|NCT02157207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727441|NCT01609881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24494168|NCT00494156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24494170|NCT00494156|Sensory System Agents|sensory system agents|mesh-ancestor
25678710|NCT01828554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678711|NCT01828554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678712|NCT01828593|Immunoglobulins|immunoglobulins|mesh-list
25678713|NCT01828593|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25678714|NCT01828593|Antibodies|antibodies|mesh-list
25678715|NCT01828593|Immunologic Factors|immunologic factors|mesh-ancestor
25678716|NCT01828593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678717|NCT01829217|Sunitinib|sunitinib|mesh-list
25263016|NCT02445391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263018|NCT02445066|Cholecalciferol|cholecalciferol|mesh-list
25263019|NCT02445066|Vitamins|vitamins|mesh-ancestor
25263020|NCT02445066|Micronutrients|micronutrients|mesh-ancestor
25263021|NCT02445066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263022|NCT02445066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25263023|NCT02445066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25263024|NCT02444949|Cisplatin|cisplatin|mesh-list
25263025|NCT02444949|Endostar protein|endostar protein|mesh-list
25263026|NCT02444949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25263027|NCT02444949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25263028|NCT02444949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24669510|NCT03884101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456450|NCT00331123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25045425|NCT00953420|Autonomic Agents|autonomic agents|mesh-ancestor
24494171|NCT00494156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24494172|NCT00494156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494173|NCT00494156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24494174|NCT00494156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24494175|NCT00494156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24792955|NCT04327934|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24792956|NCT04327934|Testosterone|testosterone|mesh-list
24792957|NCT04327934|Testosterone undecanoate|testosterone undecanoate|mesh-list
24792958|NCT04327934|Testosterone enanthate|testosterone enanthate|mesh-list
24792959|NCT04327934|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24792960|NCT04327934|Hormones|hormones|mesh-ancestor
24792961|NCT04327934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24792962|NCT04327934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792963|NCT04327934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24792964|NCT04327934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24792965|NCT04327934|Anabolic Agents|anabolic agents|mesh-ancestor
24792966|NCT04327934|Androgens|androgens|mesh-ancestor
24792967|NCT04321551|Letrozole|letrozole|mesh-list
24792968|NCT04321551|Methyltestosterone|methyltestosterone|mesh-list
24792969|NCT04321551|Testosterone|testosterone|mesh-list
24792970|NCT04321551|Testosterone undecanoate|testosterone undecanoate|mesh-list
24900319|NCT04395365|Renal Agents|renal agents|mesh-ancestor
24793006|NCT04302324|Glucocorticoids|glucocorticoids|mesh-ancestor
24793007|NCT04302324|Hormones|hormones|mesh-ancestor
24938479|NCT04018768|Acetaminophen|acetaminophen|mesh-list
24550683|NCT00721747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24793008|NCT04302324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24494203|NCT00494338|Antimitotic Agents|antimitotic agents|mesh-ancestor
24494204|NCT00494338|Mitosis Modulators|mitosis modulators|mesh-ancestor
24494205|NCT00494338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494206|NCT00494377|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24494256|NCT00494598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494257|NCT00494598|Analgesics|analgesics|mesh-ancestor
24494290|NCT00494715|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24494291|NCT00494715|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24494292|NCT00494715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494293|NCT00494715|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25244522|NCT04688788|Rituximab|rituximab|mesh-list
24494294|NCT00494715|Protease Inhibitors|protease inhibitors|mesh-ancestor
24793014|NCT04302324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678718|NCT01829217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678719|NCT01829217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25678720|NCT01829217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25678721|NCT01829217|Growth Substances|growth substances|mesh-ancestor
25678722|NCT01829217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678723|NCT01829217|Growth Inhibitors|growth inhibitors|mesh-ancestor
25678724|NCT01829217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25678725|NCT01829217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678726|NCT01829217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678727|NCT01829243|Milnacipran|milnacipran|mesh-list
25678728|NCT01829243|Levomilnacipran|levomilnacipran|mesh-list
25678729|NCT01829243|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25678730|NCT01829243|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25678731|NCT01829243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25263067|NCT02444637|Rivastigmine|rivastigmine|mesh-list
25263068|NCT02444637|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25263069|NCT02444637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25263070|NCT02444637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263071|NCT02444637|Cholinergic Agents|cholinergic agents|mesh-ancestor
25263072|NCT02444637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24793015|NCT04302324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793016|NCT04302324|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24793017|NCT04302324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24793018|NCT04302324|Immunologic Factors|immunologic factors|mesh-ancestor
24793019|NCT04302324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24793020|NCT04302324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24793021|NCT04302324|Growth Substances|growth substances|mesh-ancestor
24793022|NCT04302324|Growth Inhibitors|growth inhibitors|mesh-ancestor
24793024|NCT04270175|Daratumumab|daratumumab|mesh-list
24793025|NCT04270175|Pomalidomide|pomalidomide|mesh-list
24793026|NCT04270175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24793027|NCT04270175|Antiemetics|antiemetics|mesh-ancestor
24793028|NCT04270175|Autonomic Agents|autonomic agents|mesh-ancestor
24793029|NCT04270175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24793030|NCT04270175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214490|NCT00715611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214491|NCT00715611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25214492|NCT00715611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25214493|NCT00455325|Chloroquine|chloroquine|mesh-list
24830112|NCT02157337|Atorvastatin|atorvastatin|mesh-list
24793031|NCT04270175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24793032|NCT04270175|Glucocorticoids|glucocorticoids|mesh-ancestor
24793033|NCT04270175|Hormones|hormones|mesh-ancestor
24793034|NCT04270175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24793035|NCT04270175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24793036|NCT04270175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793037|NCT04270175|Immunologic Factors|immunologic factors|mesh-ancestor
24494574|NCT00495872|Growth Inhibitors|growth inhibitors|mesh-ancestor
24494307|NCT00494741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24494308|NCT00494741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24494309|NCT00494741|Immunologic Factors|immunologic factors|mesh-ancestor
24494310|NCT00494741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494311|NCT00494741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24494339|NCT00494897|Asparaginase|asparaginase|mesh-list
24494340|NCT00494897|Mercaptopurine|mercaptopurine|mesh-list
24494341|NCT00494897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24494342|NCT00494897|Immunologic Factors|immunologic factors|mesh-ancestor
24494343|NCT00494897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494344|NCT00494897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24494345|NCT00494897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24494346|NCT00494897|Alkylating Agents|alkylating agents|mesh-ancestor
24494381|NCT00494988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494382|NCT00495066|Ipilimumab|ipilimumab|mesh-list
24494383|NCT00495066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24494387|NCT00495092|Biperiden|biperiden|mesh-list
24494420|NCT00495183|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24494422|NCT00495183|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24494423|NCT00495183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25214496|NCT00455325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25214497|NCT00455325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25214498|NCT00455325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25214499|NCT00455325|Antimalarials|antimalarials|mesh-ancestor
25214500|NCT00455325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25214501|NCT00455325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25214502|NCT00455325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25214503|NCT00455325|Analgesics|analgesics|mesh-ancestor
25214504|NCT00455325|Sensory System Agents|sensory system agents|mesh-ancestor
25214505|NCT00455325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25214506|NCT00455325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678732|NCT01829243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678733|NCT01829243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25678734|NCT01829243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678735|NCT01829243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25678736|NCT01829243|Analgesics|analgesics|mesh-ancestor
25678737|NCT01829243|Sensory System Agents|sensory system agents|mesh-ancestor
25678738|NCT01829243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25263111|NCT02444559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25263112|NCT02444559|Analgesics|analgesics|mesh-ancestor
25263113|NCT02444559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25263114|NCT02444559|Sympatholytics|sympatholytics|mesh-ancestor
25263115|NCT02444559|Autonomic Agents|autonomic agents|mesh-ancestor
25263116|NCT02444559|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25263117|NCT02444559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25263118|NCT02444559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25263119|NCT02444559|Adrenergic Agents|adrenergic agents|mesh-ancestor
24532393|NCT00639756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25214507|NCT00455325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24494427|NCT00495183|Purinergic Agents|purinergic agents|mesh-ancestor
24494428|NCT00495183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24494429|NCT00495183|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24494430|NCT00495183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24494431|NCT00495183|Parasympatholytics|parasympatholytics|mesh-ancestor
24494432|NCT00495183|Autonomic Agents|autonomic agents|mesh-ancestor
24494433|NCT00495183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24494434|NCT00495183|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24793144|NCT04073303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24793145|NCT04073303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793146|NCT04073303|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24793147|NCT04073303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24793149|NCT03993327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24793150|NCT03993327|Antibodies|antibodies|mesh-list
24793151|NCT03993327|Immunoglobulins|immunoglobulins|mesh-list
24793152|NCT03993327|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24793153|NCT03993327|Immunologic Factors|immunologic factors|mesh-ancestor
24793154|NCT03993327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793155|NCT03993327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793156|NCT03993327|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24793157|NCT03993327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24793158|NCT03993327|Trace Elements|trace elements|mesh-ancestor
24793159|NCT03993327|Micronutrients|micronutrients|mesh-ancestor
24793160|NCT03977233|Leucovorin|leucovorin|mesh-list
24793161|NCT03977233|Oxaliplatin|oxaliplatin|mesh-list
24793162|NCT03977233|Irinotecan|irinotecan|mesh-list
24793163|NCT03977233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793164|NCT03977233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24793165|NCT03977233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24793166|NCT03977233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24793186|NCT03831334|Minoxidil|minoxidil|mesh-list
24793187|NCT03831334|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24793188|NCT03831334|Vasodilator Agents|vasodilator agents|mesh-ancestor
24586346|NCT00890279|Cilnidipine|cilnidipine|mesh-list
24586347|NCT00890279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24586348|NCT00890279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24586349|NCT00890279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586350|NCT00890279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24586351|NCT00890279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901650|NCT04382170|Dexmedetomidine|dexmedetomidine|mesh-list
24793255|NCT03690011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24793268|NCT03655002|Nivolumab|nivolumab|mesh-list
24793269|NCT03655002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24793270|NCT03655002|Immunologic Factors|immunologic factors|mesh-ancestor
25214509|NCT00455325|Antinematodal Agents|antinematodal agents|mesh-ancestor
25214510|NCT00455325|Anthelmintics|anthelmintics|mesh-ancestor
25678739|NCT01829243|Antidepressive Agents|antidepressive agents|mesh-ancestor
25678740|NCT01829243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25678741|NCT01829295|Mycophenolic Acid|mycophenolic acid|mesh-list
25678742|NCT01829295|Prednisone|prednisone|mesh-list
25678743|NCT01829295|Methotrexate|methotrexate|mesh-list
25678744|NCT01829295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25678745|NCT01829295|Glucocorticoids|glucocorticoids|mesh-ancestor
25678746|NCT01829295|Hormones|hormones|mesh-ancestor
25678747|NCT01829295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25678748|NCT01829295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532495|NCT00640094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532496|NCT00640094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24532498|NCT00640159|Antidepressive Agents|antidepressive agents|mesh-ancestor
24532499|NCT00640159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24532500|NCT00640159|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24532501|NCT00640159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25214511|NCT00382200|Decitabine|decitabine|mesh-list
24830114|NCT02157337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24793271|NCT03655002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793272|NCT03655002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24793273|NCT03655002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24793274|NCT03655002|Alkylating Agents|alkylating agents|mesh-ancestor
24793275|NCT03655002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793276|NCT03655002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793277|NCT03655002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24793278|NCT03655002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24793279|NCT03655002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24793280|NCT03651271|Nivolumab|nivolumab|mesh-list
24793281|NCT03651271|Ipilimumab|ipilimumab|mesh-list
24793282|NCT03651271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24793283|NCT03651271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793284|NCT03651271|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24793285|NCT03651271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793286|NCT03637764|Atezolizumab|atezolizumab|mesh-list
24793287|NCT03637764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793288|NCT03581370|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
24494559|NCT00495846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24494560|NCT00495846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24494561|NCT00495846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494562|NCT00495872|Lenalidomide|lenalidomide|mesh-list
24494563|NCT00495872|Sunitinib|sunitinib|mesh-list
24494564|NCT00495872|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24494565|NCT00495872|Sorafenib|sorafenib|mesh-list
24494566|NCT00495872|Dasatinib|dasatinib|mesh-list
24494567|NCT00495872|Lapatinib|lapatinib|mesh-list
24494568|NCT00495872|Valproic Acid|valproic acid|mesh-list
24494569|NCT00495872|Immunologic Factors|immunologic factors|mesh-ancestor
24494570|NCT00495872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494571|NCT00495872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24494572|NCT00495872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24494573|NCT00495872|Growth Substances|growth substances|mesh-ancestor
24494577|NCT00495872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678749|NCT01829295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25678750|NCT01829295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678751|NCT01829295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25678752|NCT01829295|Abortifacient Agents|abortifacient agents|mesh-ancestor
25678753|NCT01829295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25678754|NCT01829295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25678755|NCT01829295|Antimetabolites|antimetabolites|mesh-ancestor
25678756|NCT01829295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678757|NCT01829295|Dermatologic Agents|dermatologic agents|mesh-ancestor
25678758|NCT01829295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678759|NCT01829295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25678760|NCT01829295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25263165|NCT03651804|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25263166|NCT03651804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25263167|NCT03608163|Diazoxide|diazoxide|mesh-list
25263168|NCT03608163|Naloxone|naloxone|mesh-list
25263169|NCT03608163|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25263170|NCT03608163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263171|NCT03608163|Sensory System Agents|sensory system agents|mesh-ancestor
24669739|NCT03691376|Immunologic Factors|immunologic factors|mesh-ancestor
24669740|NCT03691376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494649|NCT00496275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494650|NCT00496275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25214519|NCT00382200|Dermatologic Agents|dermatologic agents|mesh-ancestor
25214520|NCT00321555|Immunotoxins|immunotoxins|mesh-list
25157989|NCT04537598|Morphine|morphine|mesh-list
24793309|NCT03539055|Antithrombins|antithrombins|mesh-ancestor
24793310|NCT03539055|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24793311|NCT03539055|Protease Inhibitors|protease inhibitors|mesh-ancestor
24793312|NCT03539055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24793313|NCT03539055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793314|NCT03539055|Anticoagulants|anticoagulants|mesh-ancestor
24925230|NCT04152317|Misoprostol|misoprostol|mesh-list
24494652|NCT00496275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494653|NCT00496275|Antiviral Agents|antiviral agents|mesh-ancestor
24494654|NCT00496275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24494655|NCT00496275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24494656|NCT00496275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24494657|NCT00496275|Immunologic Factors|immunologic factors|mesh-ancestor
24494658|NCT00496275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494659|NCT00496275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24494660|NCT00496275|Tubulin Modulators|tubulin modulators|mesh-ancestor
24494697|NCT00496444|Azacitidine|azacitidine|mesh-list
24494698|NCT00496444|Valproic Acid|valproic acid|mesh-list
24494699|NCT00496444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24494700|NCT00496444|Antimetabolites|antimetabolites|mesh-ancestor
24494701|NCT00496444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494702|NCT00496444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494703|NCT00496444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24494704|NCT00496444|Anticonvulsants|anticonvulsants|mesh-ancestor
24494705|NCT00496444|GABA Agents|gaba agents|mesh-ancestor
24494706|NCT00496444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25082673|NCT03321136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24804050|NCT02000700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925254|NCT04152057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925255|NCT04152057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24925256|NCT04151823|Vitamin D|vitamin d|mesh-list
24925257|NCT04151823|Cholecalciferol|cholecalciferol|mesh-list
24925258|NCT04151823|Vitamins|vitamins|mesh-ancestor
24925259|NCT04151823|Micronutrients|micronutrients|mesh-ancestor
24925260|NCT04151823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803492|NCT01996501|Olanzapine|olanzapine|mesh-list
24793452|NCT03467386|Tacrolimus|tacrolimus|mesh-list
24793453|NCT03467386|Lenograstim|lenograstim|mesh-list
24793454|NCT03467386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24494746|NCT00496665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24494747|NCT00496704|Gemcitabine|gemcitabine|mesh-list
24494748|NCT00496704|Capecitabine|capecitabine|mesh-list
24494749|NCT00496704|Oxaliplatin|oxaliplatin|mesh-list
24494750|NCT00496704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24494751|NCT00496704|Antimetabolites|antimetabolites|mesh-ancestor
24494811|NCT00497120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494812|NCT00497120|Diuretics|diuretics|mesh-ancestor
24494813|NCT00497120|Natriuretic Agents|natriuretic agents|mesh-ancestor
24494814|NCT00497120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494815|NCT00497172|Sirolimus|sirolimus|mesh-list
24494816|NCT00497172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25678761|NCT01829295|Immunologic Factors|immunologic factors|mesh-ancestor
25678762|NCT01829295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25678763|NCT01829295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25678764|NCT01829295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25678765|NCT01829295|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25678766|NCT01829295|Antitubercular Agents|antitubercular agents|mesh-ancestor
25678767|NCT01829295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25678768|NCT01829295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25263197|NCT03471611|Lenograstim|lenograstim|mesh-list
25263198|NCT03471611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25263199|NCT03471611|Immunologic Factors|immunologic factors|mesh-ancestor
25263200|NCT03471611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263201|NCT03388788|CGP 12177|cgp 12177|mesh-list
25263202|NCT03388788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24532548|NCT00640367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24532549|NCT00640367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494817|NCT00497172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24793455|NCT03467386|Immunologic Factors|immunologic factors|mesh-ancestor
24793456|NCT03467386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793457|NCT03467386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24793458|NCT03467386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24793459|NCT03467386|Alkylating Agents|alkylating agents|mesh-ancestor
24793464|NCT03467386|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24793465|NCT03467386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24793467|NCT03439345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24793468|NCT03439345|Antimetabolites|antimetabolites|mesh-ancestor
24793469|NCT03439345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793484|NCT03427736|Anesthetics|anesthetics|mesh-ancestor
24793485|NCT03427736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24793486|NCT03427736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24793487|NCT03427736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24793488|NCT03427736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24793489|NCT03427736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793490|NCT03427736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24793491|NCT03427736|Narcotics|narcotics|mesh-ancestor
24793492|NCT03427736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24793493|NCT03427736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24793494|NCT03427736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24793495|NCT03427736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24494890|NCT00497471|Dapsone|dapsone|mesh-list
24793496|NCT03427736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24793500|NCT03328884|Irinotecan|irinotecan|mesh-list
25082677|NCT03321110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082678|NCT03321110|Vitamins|vitamins|mesh-ancestor
25082679|NCT03320967|Arginine Vasopressin|arginine vasopressin|mesh-list
25082680|NCT03320967|Hemostatics|hemostatics|mesh-ancestor
25082681|NCT03320967|Coagulants|coagulants|mesh-ancestor
24803580|NCT01997190|Valacyclovir|valacyclovir|mesh-list
25214524|NCT02696928|Primaquine|primaquine|mesh-list
25214525|NCT02696928|Antimalarials|antimalarials|mesh-ancestor
25214526|NCT02696928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25214527|NCT02696928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25214528|NCT02696928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25214529|NCT02696720|Lidocaine|lidocaine|mesh-list
25214530|NCT02696720|Anesthetics, Local|anesthetics, local|mesh-ancestor
25214531|NCT02696720|Anesthetics|anesthetics|mesh-ancestor
25214532|NCT02696720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25214533|NCT02696720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214534|NCT02696720|Sensory System Agents|sensory system agents|mesh-ancestor
24793510|NCT03299309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793511|NCT03291847|Buprenorphine|buprenorphine|mesh-list
24793512|NCT03291847|Methadone|methadone|mesh-list
24793513|NCT03291847|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
24793514|NCT03291847|Naloxone|naloxone|mesh-list
24793515|NCT03291847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25678769|NCT01829399|Epinephrine|epinephrine|mesh-list
25678770|NCT01829399|Bupivacaine|bupivacaine|mesh-list
25678771|NCT01829399|Anesthetics, Local|anesthetics, local|mesh-ancestor
25678772|NCT01829399|Anesthetics|anesthetics|mesh-ancestor
25678773|NCT01829399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25678774|NCT01829399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678775|NCT01829399|Sensory System Agents|sensory system agents|mesh-ancestor
25678776|NCT01829399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24793516|NCT03291847|Narcotics|narcotics|mesh-ancestor
25263209|NCT03388788|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25263210|NCT03369717|Clavulanic Acid|clavulanic acid|mesh-list
25263211|NCT03369717|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24532571|NCT00640471|Cetuximab|cetuximab|mesh-list
24532581|NCT00640549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532582|NCT00640575|Triamcinolone|triamcinolone|mesh-list
24532583|NCT00640575|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24532584|NCT00640575|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24532585|NCT00640575|Lidocaine|lidocaine|mesh-list
24532586|NCT00640575|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24532587|NCT00640575|Anesthetics, Local|anesthetics, local|mesh-ancestor
24532588|NCT00640575|Anesthetics|anesthetics|mesh-ancestor
24532589|NCT00640575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24532590|NCT00640575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685663|NCT05248724|Epinephrine|epinephrine|mesh-list
24685664|NCT05248724|Racepinephrine|racepinephrine|mesh-list
24685665|NCT05248724|Morphine|morphine|mesh-list
24685666|NCT05248724|Ropivacaine|ropivacaine|mesh-list
24586591|NCT00891332|Leucovorin|leucovorin|mesh-list
24793517|NCT03291847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24793518|NCT03291847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793519|NCT03291847|Analgesics|analgesics|mesh-ancestor
24793520|NCT03291847|Sensory System Agents|sensory system agents|mesh-ancestor
24550684|NCT00721747|Immunologic Factors|immunologic factors|mesh-ancestor
24793521|NCT03291847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24793522|NCT03291847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24793523|NCT03291847|Antitussive Agents|antitussive agents|mesh-ancestor
24793524|NCT03291847|Respiratory System Agents|respiratory system agents|mesh-ancestor
24793525|NCT03275857|Cisplatin|cisplatin|mesh-list
24793526|NCT03275857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793527|NCT03246503|Bilirubin|bilirubin|mesh-list
24793528|NCT03246503|Antioxidants|antioxidants|mesh-ancestor
24793529|NCT03246503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793530|NCT03246503|Protective Agents|protective agents|mesh-ancestor
24793531|NCT03246503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793584|NCT03091881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24494832|NCT00497237|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24494833|NCT00497237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24494834|NCT00497237|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24494835|NCT00497237|Autonomic Agents|autonomic agents|mesh-ancestor
24494836|NCT00497237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24494837|NCT00497237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494838|NCT00497237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24494839|NCT00497237|Respiratory System Agents|respiratory system agents|mesh-ancestor
24494840|NCT00497237|Dermatologic Agents|dermatologic agents|mesh-ancestor
24494841|NCT00497237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24494842|NCT00497237|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24494843|NCT00497237|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24494844|NCT00497237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24494845|NCT00497237|Adrenergic Agents|adrenergic agents|mesh-ancestor
24731738|NCT01636323|Nicotine|nicotine|mesh-list
24494848|NCT00497237|Glucocorticoids|glucocorticoids|mesh-ancestor
24494880|NCT00497354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24494881|NCT00497354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494882|NCT00497354|Sensory System Agents|sensory system agents|mesh-ancestor
24494883|NCT00497354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24494885|NCT00497458|Androgens|androgens|mesh-ancestor
25678777|NCT01829399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25678778|NCT01829399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25678779|NCT01829399|Adrenergic Agents|adrenergic agents|mesh-ancestor
25678780|NCT01829399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25678781|NCT01829399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678782|NCT01829399|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25678783|NCT01829399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25678784|NCT01829399|Autonomic Agents|autonomic agents|mesh-ancestor
25678785|NCT01829399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25678786|NCT01829399|Respiratory System Agents|respiratory system agents|mesh-ancestor
25678787|NCT01829399|Mydriatics|mydriatics|mesh-ancestor
25678788|NCT01829399|Sympathomimetics|sympathomimetics|mesh-ancestor
25678789|NCT01829399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25678790|NCT01829425|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25678791|NCT01829425|Oxybutynin|oxybutynin|mesh-list
25678792|NCT01829425|Cholinergic Antagonists|cholinergic antagonists|mesh-list
25678793|NCT01829425|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25678794|NCT01829425|Cholinergic Agents|cholinergic agents|mesh-ancestor
24494887|NCT00497458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25275309|NCT02372903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25275696|NCT02369861|Lubricant Eye Drops|lubricant eye drops|mesh-list
24532591|NCT00640575|Sensory System Agents|sensory system agents|mesh-ancestor
24532592|NCT00640575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24532593|NCT00640575|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24532594|NCT00640575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24532595|NCT00640575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24494888|NCT00497458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494889|NCT00497471|Pyrimethamine|pyrimethamine|mesh-list
25214535|NCT02696720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25214536|NCT02696720|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25214537|NCT02696720|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25214538|NCT02696720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25214539|NCT02696720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25214540|NCT02696720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214541|NCT02696694|Progesterone|progesterone|mesh-list
24830144|NCT02157467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830145|NCT02157467|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24830146|NCT02157467|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24830147|NCT02157467|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24830148|NCT02157467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24830149|NCT02157467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24830150|NCT02157467|Antiviral Agents|antiviral agents|mesh-ancestor
24830151|NCT02157558|Fexofenadine|fexofenadine|mesh-list
25051683|NCT00388960|Etoposide|etoposide|mesh-list
24494933|NCT00497523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24793607|NCT02996825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24793608|NCT02996825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24967314|NCT03760770|Vitamin B Complex|vitamin b complex|mesh-ancestor
24967331|NCT03760614|Entinostat|entinostat|mesh-list
24967332|NCT03760614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967333|NCT03760614|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24967334|NCT03760614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24967335|NCT03760614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967336|NCT03760588|Valsartan|valsartan|mesh-list
24967337|NCT03760588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25082682|NCT03320967|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24967338|NCT03760588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24967339|NCT03760588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24967340|NCT03760588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24967341|NCT03760588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967342|NCT03760445|Cytarabine|cytarabine|mesh-list
24967343|NCT03760445|Posaconazole|posaconazole|mesh-list
24494935|NCT00497536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24494936|NCT00497536|Insulin Aspart|insulin aspart|mesh-list
24494937|NCT00497536|Insulin, Long-Acting|insulin, long-acting|mesh-list
24494938|NCT00497536|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24494939|NCT00497536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24494940|NCT00497536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494941|NCT00497562|Tramadol|tramadol|mesh-list
25678795|NCT01829425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25678796|NCT01829425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678797|NCT01829425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678798|NCT01829425|Urological Agents|urological agents|mesh-ancestor
25678799|NCT01829425|Parasympatholytics|parasympatholytics|mesh-ancestor
25678800|NCT01829425|Autonomic Agents|autonomic agents|mesh-ancestor
25678801|NCT01829425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25678802|NCT01829503|Cytarabine|cytarabine|mesh-list
25263235|NCT03295240|Venetoclax|venetoclax|mesh-list
24967345|NCT03760445|Idarubicin|idarubicin|mesh-list
24967346|NCT03760445|Midostaurin|midostaurin|mesh-list
24967347|NCT03760445|Midazolam|midazolam|mesh-list
24967348|NCT03760445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24967349|NCT03760445|Antimetabolites|antimetabolites|mesh-ancestor
24967350|NCT03760445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967351|NCT03760445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967352|NCT03760445|Antiviral Agents|antiviral agents|mesh-ancestor
24967353|NCT03760445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24967354|NCT03760445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24967355|NCT03760445|Immunologic Factors|immunologic factors|mesh-ancestor
24967356|NCT03760445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967357|NCT03760445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24967358|NCT03760445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24967359|NCT03760445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25214542|NCT02696694|Progestins|progestins|mesh-ancestor
25214544|NCT02696694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25214545|NCT02696694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214546|NCT02696941|Metformin|metformin|mesh-list
25214547|NCT02696941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25214548|NCT02696941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25214549|NCT02696941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214550|NCT02696941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214551|NCT02696954|Lumefantrine|lumefantrine|mesh-list
25214552|NCT02696954|Artemether|artemether|mesh-list
25214553|NCT02696954|Primaquine|primaquine|mesh-list
24393837|NCT00131053|Hydrocortisone|hydrocortisone|mesh-list
24967360|NCT03760445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24536285|NCT00650624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24967361|NCT03760445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24967362|NCT03760445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24967363|NCT03760445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24967364|NCT03760445|Anesthetics, General|anesthetics, general|mesh-ancestor
24967365|NCT03760445|Anesthetics|anesthetics|mesh-ancestor
24967366|NCT03760445|GABA Modulators|gaba modulators|mesh-ancestor
24967367|NCT03760445|GABA Agents|gaba agents|mesh-ancestor
24967368|NCT03760445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24967369|NCT03760445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24967370|NCT03760445|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24967371|NCT03760445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24520264|NCT03335488|Glycerol|glycerol|mesh-list
24967382|NCT03760445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24967383|NCT03760354|Methylprednisolone|methylprednisolone|mesh-list
24967384|NCT03760354|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24967385|NCT03760354|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24967386|NCT03760354|Prednisolone|prednisolone|mesh-list
24967387|NCT03760354|Prednisolone acetate|prednisolone acetate|mesh-list
25274298|NCT02379000|Glucocorticoids|glucocorticoids|mesh-ancestor
24967388|NCT03760354|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24967389|NCT03760354|Prednisolone phosphate|prednisolone phosphate|mesh-list
24967390|NCT03760354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24967391|NCT03760354|Antiemetics|antiemetics|mesh-ancestor
24967392|NCT03760354|Autonomic Agents|autonomic agents|mesh-ancestor
24967393|NCT03760354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24967394|NCT03760354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967395|NCT03760354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24967396|NCT03760354|Glucocorticoids|glucocorticoids|mesh-ancestor
24967397|NCT03760354|Hormones|hormones|mesh-ancestor
24967398|NCT03760354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24967399|NCT03760354|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24967400|NCT03760354|Protective Agents|protective agents|mesh-ancestor
24967401|NCT03760354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24967402|NCT03760354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967403|NCT03760302|Analgesics|analgesics|mesh-list
24967404|NCT03760302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
24967405|NCT03760302|Sensory System Agents|sensory system agents|mesh-ancestor
24967406|NCT03760302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24967407|NCT03760302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967408|NCT03760302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24967409|NCT03760276|Voriconazole|voriconazole|mesh-list
25678803|NCT01829503|Decitabine|decitabine|mesh-list
24669841|NCT03504163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24669842|NCT03504163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24669843|NCT03504163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24669844|NCT03504163|Immunologic Factors|immunologic factors|mesh-ancestor
24669845|NCT03504163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413938|NCT00195689|Adalimumab|adalimumab|mesh-list
24669871|NCT03476798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24669872|NCT03476798|Growth Inhibitors|growth inhibitors|mesh-ancestor
24669873|NCT03476798|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24686203|NCT05001724|Mitosis Modulators|mitosis modulators|mesh-ancestor
24686204|NCT05001724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686205|NCT05001724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24686207|NCT04997759|Neostigmine|neostigmine|mesh-list
24494945|NCT00497562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24494946|NCT00497562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494947|NCT00497562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24494948|NCT00497562|Narcotics|narcotics|mesh-ancestor
24494951|NCT00497562|Sensory System Agents|sensory system agents|mesh-ancestor
24494967|NCT00497562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24494968|NCT00497562|Adrenergic Agents|adrenergic agents|mesh-ancestor
24494970|NCT00497601|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24494971|NCT00497601|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24494973|NCT00497601|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24494974|NCT00497601|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24494975|NCT00497601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24967411|NCT03760276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24967412|NCT03760276|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24803667|NCT01997801|Ketamine|ketamine|mesh-list
24967413|NCT03760276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24967414|NCT03760276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731986|NCT01637454|Norepinephrine|norepinephrine|mesh-list
24967430|NCT03759938|Rivaroxaban|rivaroxaban|mesh-list
24967431|NCT03759938|Apixaban|apixaban|mesh-list
24967432|NCT03759938|Edoxaban|edoxaban|mesh-list
25214554|NCT02696954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25214555|NCT02696954|Amodiaquine|amodiaquine|mesh-list
25214556|NCT02696954|Antimalarials|antimalarials|mesh-ancestor
25214557|NCT02696954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25214558|NCT02696954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25214559|NCT02696954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24938578|NCT04017741|Autonomic Agents|autonomic agents|mesh-ancestor
25051699|NCT00384904|Tenofovir|tenofovir|mesh-list
24967433|NCT03759938|Dabigatran|dabigatran|mesh-list
24967434|NCT03759938|Anticoagulants|anticoagulants|mesh-list
24967435|NCT03759938|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24967436|NCT03759938|Antithrombins|antithrombins|mesh-ancestor
24967437|NCT03759938|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24967438|NCT03759938|Protease Inhibitors|protease inhibitors|mesh-ancestor
25678804|NCT01829503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25678805|NCT01829503|Antimetabolites|antimetabolites|mesh-ancestor
24567165|NCT00789945|Insulin|insulin|mesh-list
25678806|NCT01829503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678807|NCT01829503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678808|NCT01829503|Antiviral Agents|antiviral agents|mesh-ancestor
25678809|NCT01829503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25678810|NCT01829503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25678811|NCT01829503|Immunologic Factors|immunologic factors|mesh-ancestor
25678812|NCT01829503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678813|NCT01829503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678814|NCT01829516|Oxytocin|oxytocin|mesh-list
25678815|NCT01829516|Oxytocics|oxytocics|mesh-ancestor
25678816|NCT01829516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25678817|NCT01829516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678818|NCT01829919|Paroxetine|paroxetine|mesh-list
25678819|NCT01829919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24532655|NCT00640705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532656|NCT00640705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532657|NCT00640744|Atorvastatin|atorvastatin|mesh-list
24532658|NCT00640744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24532659|NCT00640744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24532688|NCT00640809|Omeprazole|omeprazole|mesh-list
24532689|NCT00640809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24686251|NCT04961801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686252|NCT04961801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678820|NCT01829919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24686253|NCT04961801|Dermatologic Agents|dermatologic agents|mesh-ancestor
24967439|NCT03759938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24967440|NCT03759938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494976|NCT00497601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24495113|NCT00498537|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24495114|NCT00498537|Hormone Antagonists|hormone antagonists|mesh-ancestor
24495116|NCT00498537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495134|NCT00498589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24495135|NCT00498589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24495136|NCT00498680|Sildenafil Citrate|sildenafil citrate|mesh-list
24967441|NCT03759886|Metronidazole|metronidazole|mesh-list
24967442|NCT03759886|Paromomycin|paromomycin|mesh-list
24967443|NCT03759886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24967444|NCT03759886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24967445|NCT03759886|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24967446|NCT03759886|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24967447|NCT03759860|Ranibizumab|ranibizumab|mesh-list
24967448|NCT03759860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24967449|NCT03759860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24967450|NCT03759860|Growth Substances|growth substances|mesh-ancestor
24967451|NCT03759860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967452|NCT03759860|Growth Inhibitors|growth inhibitors|mesh-ancestor
24967453|NCT03759860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967454|NCT03759782|Tenofovir|tenofovir|mesh-list
24967455|NCT03759782|Ribavirin|ribavirin|mesh-list
24967456|NCT03759782|Antiviral Agents|antiviral agents|mesh-ancestor
24967457|NCT03759782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24967458|NCT03759782|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24967459|NCT03759782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24967460|NCT03759782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24967461|NCT03759782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967462|NCT03759782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24495138|NCT00498680|Vasodilator Agents|vasodilator agents|mesh-ancestor
24495139|NCT00498680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24495140|NCT00498680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24495141|NCT00498680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495143|NCT00498680|Urological Agents|urological agents|mesh-ancestor
24495204|NCT00498979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495205|NCT00498979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24495206|NCT00498979|Alkylating Agents|alkylating agents|mesh-ancestor
24967474|NCT03759301|Hormone Antagonists|hormone antagonists|mesh-ancestor
24967476|NCT03759262|Cholecalciferol|cholecalciferol|mesh-list
24967477|NCT03759262|Vitamins|vitamins|mesh-ancestor
25214560|NCT02696733|Cephalosporins|cephalosporins|mesh-list
25214561|NCT02696733|Lidocaine|lidocaine|mesh-list
25214562|NCT02696733|Anesthetics, Local|anesthetics, local|mesh-ancestor
25214563|NCT02696733|Anesthetics|anesthetics|mesh-ancestor
25214564|NCT02696733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25214565|NCT02696733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214566|NCT02696733|Sensory System Agents|sensory system agents|mesh-ancestor
25214567|NCT02696733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25214568|NCT02696733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25214569|NCT02696733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25678821|NCT01829919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25678822|NCT01829919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678823|NCT01829919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25678824|NCT01829919|Serotonin Agents|serotonin agents|mesh-ancestor
25678825|NCT01829919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678826|NCT01829919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25678827|NCT01829919|Antidepressive Agents|antidepressive agents|mesh-ancestor
25678828|NCT01829919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25678829|NCT01829919|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24669897|NCT03414034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24669898|NCT03414034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532733|NCT00640887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24532734|NCT00640887|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24532735|NCT00640887|Antitubercular Agents|antitubercular agents|mesh-ancestor
24532736|NCT00640939|Diclofenac|diclofenac|mesh-list
24532737|NCT00640939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24532738|NCT00640939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24532741|NCT00640939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24532742|NCT00640939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532743|NCT00640939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24937414|NCT04029272|Metformin|metformin|mesh-list
25214570|NCT02696733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25214571|NCT02696733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25272775|NCT02389868|Antimetabolites|antimetabolites|mesh-ancestor
24830207|NCT02157792|Antimetabolites|antimetabolites|mesh-ancestor
24830208|NCT02157792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830209|NCT02157792|Antiviral Agents|antiviral agents|mesh-ancestor
24830210|NCT02157792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24830211|NCT02157792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830212|NCT02157792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24830213|NCT02157792|Immunologic Factors|immunologic factors|mesh-ancestor
24830214|NCT02157792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830215|NCT02157792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24830216|NCT02157792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24830217|NCT02157792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24967478|NCT03759262|Micronutrients|micronutrients|mesh-ancestor
24967479|NCT03759262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967480|NCT03759262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24793667|NCT02856698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793668|NCT02793375|Montelukast|montelukast|mesh-list
24793669|NCT02793375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24793670|NCT02793375|Respiratory System Agents|respiratory system agents|mesh-ancestor
24793671|NCT02793375|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24793672|NCT02793375|Hormone Antagonists|hormone antagonists|mesh-ancestor
25082683|NCT03320967|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24804055|NCT02000726|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24804056|NCT02000726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24804057|NCT02000726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24804058|NCT02000726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804059|NCT02000726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24804060|NCT02000726|Serotonin Agents|serotonin agents|mesh-ancestor
25245071|NCT04286295|Nicotine|nicotine|mesh-list
24804061|NCT02000726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804062|NCT02000726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24804063|NCT02000726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24495207|NCT00498979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495208|NCT00498979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24495209|NCT00498979|Tubulin Modulators|tubulin modulators|mesh-ancestor
24938685|NCT04017221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678830|NCT01829919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25678831|NCT01829919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678832|NCT01830127|Ribavirin|ribavirin|mesh-list
25678833|NCT01830127|Antimetabolites|antimetabolites|mesh-ancestor
25678834|NCT01830127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678835|NCT01830127|Antiviral Agents|antiviral agents|mesh-ancestor
25678836|NCT01830127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25678837|NCT01830140|Bimatoprost|bimatoprost|mesh-list
25678838|NCT01830140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25678839|NCT01830543|Aspirin|aspirin|mesh-list
25678840|NCT01830543|Vitamin K|vitamin k|mesh-list
25678841|NCT01830543|Rivaroxaban|rivaroxaban|mesh-list
25678842|NCT01830543|Clopidogrel|clopidogrel|mesh-list
25678843|NCT01830543|Ticagrelor|ticagrelor|mesh-list
25678844|NCT01830543|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24532754|NCT00640991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532755|NCT00641004|Esomeprazole|esomeprazole|mesh-list
24532756|NCT00641004|Rebamipide|rebamipide|mesh-list
24532757|NCT00641004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24532758|NCT00641004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24732109|NCT01637766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24628185|NCT01097148|Atracurium|atracurium|mesh-list
25082684|NCT03320967|Natriuretic Agents|natriuretic agents|mesh-ancestor
25082685|NCT03320967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082686|NCT03320928|Methotrexate|methotrexate|mesh-list
25082687|NCT03320928|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25082688|NCT03320928|Abortifacient Agents|abortifacient agents|mesh-ancestor
25214572|NCT02696733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214573|NCT02696733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25214574|NCT02696733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25214575|NCT02696915|Fentanyl|fentanyl|mesh-list
25214576|NCT02696915|Bupivacaine|bupivacaine|mesh-list
25214577|NCT02696915|Anesthetics, Local|anesthetics, local|mesh-ancestor
25214578|NCT02696915|Anesthetics|anesthetics|mesh-ancestor
25214579|NCT02696915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25214580|NCT02696915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214581|NCT02696915|Sensory System Agents|sensory system agents|mesh-ancestor
25214582|NCT02696915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25214583|NCT02696915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25214584|NCT02696915|Narcotics|narcotics|mesh-ancestor
25214585|NCT02696915|Analgesics|analgesics|mesh-ancestor
25214586|NCT02696915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25082689|NCT03320928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25082690|NCT03320928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082691|NCT03320928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25082692|NCT03320928|Antimetabolites|antimetabolites|mesh-ancestor
25082693|NCT03320928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082694|NCT03320928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25082695|NCT03320928|Dermatologic Agents|dermatologic agents|mesh-ancestor
25082696|NCT03320928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25082697|NCT03320928|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25082698|NCT03320928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25082699|NCT03320928|Immunologic Factors|immunologic factors|mesh-ancestor
25082700|NCT03320928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25082701|NCT03320928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25082702|NCT03320915|Cholecalciferol|cholecalciferol|mesh-list
25082703|NCT03320915|Vitamin D|vitamin d|mesh-list
25082704|NCT03320915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25082705|NCT03320915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082706|NCT03320915|Vitamins|vitamins|mesh-ancestor
25082707|NCT03320915|Micronutrients|micronutrients|mesh-ancestor
25082708|NCT03320915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25082709|NCT03320707|Daratumumab|daratumumab|mesh-list
25082710|NCT03320707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25082711|NCT03320694|Insulin|insulin|mesh-list
25082712|NCT03320694|Metformin|metformin|mesh-list
25082713|NCT03320694|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25082714|NCT03320694|Isophane Insulin, Human|isophane insulin, human|mesh-list
25082715|NCT03320694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25082716|NCT03320694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082717|NCT03320629|Apatinib|apatinib|mesh-list
25082718|NCT03320629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25082719|NCT03320629|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25082720|NCT03320629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25082721|NCT03320629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082722|NCT03320603|Thrombin|thrombin|mesh-list
25678845|NCT01830543|Vitamins|vitamins|mesh-ancestor
25678846|NCT01830543|Micronutrients|micronutrients|mesh-ancestor
25678847|NCT01830543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678848|NCT01830543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24732189|NCT01638247|Hormones|hormones|mesh-ancestor
24495263|NCT00499018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24532849|NCT00641329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24532850|NCT00641329|Sympatholytics|sympatholytics|mesh-ancestor
24532851|NCT00641329|Autonomic Agents|autonomic agents|mesh-ancestor
24532852|NCT00641329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24532853|NCT00641329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24532854|NCT00641329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24532855|NCT00641329|Adrenergic Agents|adrenergic agents|mesh-ancestor
24532856|NCT00641329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24495264|NCT00499018|Analgesics|analgesics|mesh-ancestor
24495265|NCT00499018|Sensory System Agents|sensory system agents|mesh-ancestor
24495266|NCT00499018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24495267|NCT00499018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24495268|NCT00499018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24495269|NCT00499018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495270|NCT00499018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24495271|NCT00499018|Alkylating Agents|alkylating agents|mesh-ancestor
24495426|NCT00500188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495427|NCT00500188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495428|NCT00500253|Nitric Oxide|nitric oxide|mesh-list
24495429|NCT00500253|Methacholine Chloride|methacholine chloride|mesh-list
24495430|NCT00500253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24495531|NCT00500721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24967501|NCT03759093|Immunologic Factors|immunologic factors|mesh-ancestor
24793705|NCT02638090|Pembrolizumab|pembrolizumab|mesh-list
24793706|NCT02638090|Vorinostat|vorinostat|mesh-list
24793707|NCT02638090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24793708|NCT02638090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793709|NCT02638090|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24793710|NCT02638090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24793711|NCT02638090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793712|NCT02625610|Leucovorin|leucovorin|mesh-list
24793713|NCT02625610|Fluorouracil|fluorouracil|mesh-list
24793714|NCT02625610|Capecitabine|capecitabine|mesh-list
24793715|NCT02625610|Oxaliplatin|oxaliplatin|mesh-list
24793716|NCT02625610|Avelumab|avelumab|mesh-list
24793717|NCT02625610|Levoleucovorin|levoleucovorin|mesh-list
24793718|NCT02625610|Antimetabolites|antimetabolites|mesh-ancestor
24793719|NCT02625610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793720|NCT02625610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24793721|NCT02625610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793722|NCT02625610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24793723|NCT02625610|Immunologic Factors|immunologic factors|mesh-ancestor
24967481|NCT03759262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24967482|NCT03759158|Acetylcysteine|acetylcysteine|mesh-list
24967483|NCT03759158|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24967484|NCT03759158|Antiviral Agents|antiviral agents|mesh-ancestor
24967485|NCT03759158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24967486|NCT03759158|Expectorants|expectorants|mesh-ancestor
24536587|NCT00651703|Imiquimod|imiquimod|mesh-list
25245142|NCT04250064|Growth Inhibitors|growth inhibitors|mesh-ancestor
24967487|NCT03759158|Respiratory System Agents|respiratory system agents|mesh-ancestor
24967488|NCT03759158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24967489|NCT03759158|Antioxidants|antioxidants|mesh-ancestor
24967490|NCT03759158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967491|NCT03759158|Protective Agents|protective agents|mesh-ancestor
24967492|NCT03759158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967493|NCT03759158|Antidotes|antidotes|mesh-ancestor
24967494|NCT03759093|Thalidomide|thalidomide|mesh-list
24967495|NCT03759093|Dexamethasone|dexamethasone|mesh-list
24967496|NCT03759093|Dexamethasone acetate|dexamethasone acetate|mesh-list
24967497|NCT03759093|Cyclophosphamide|cyclophosphamide|mesh-list
24495554|NCT00501098|Caspofungin|caspofungin|mesh-list
24967498|NCT03759093|Bortezomib|bortezomib|mesh-list
24967499|NCT03759093|BB 1101|bb 1101|mesh-list
25678849|NCT01830543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25678850|NCT01830543|Analgesics|analgesics|mesh-ancestor
25678851|NCT01830543|Sensory System Agents|sensory system agents|mesh-ancestor
25678852|NCT01830543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25678853|NCT01830543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25678854|NCT01830543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25678855|NCT01830543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25678856|NCT01830543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24967500|NCT03759093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24532951|NCT00641693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24532953|NCT00641758|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24532954|NCT00641758|Immunologic Factors|immunologic factors|mesh-ancestor
24456507|NCT00331500|Sensory System Agents|sensory system agents|mesh-ancestor
24967502|NCT03759093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967503|NCT03759093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24967504|NCT03759093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24967505|NCT03759093|Alkylating Agents|alkylating agents|mesh-ancestor
24967506|NCT03759093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967507|NCT03759093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967520|NCT03759093|Leprostatic Agents|leprostatic agents|mesh-ancestor
24967521|NCT03759093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24967522|NCT03759093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24967523|NCT03759093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25214590|NCT02696590|Cholecalciferol|cholecalciferol|mesh-list
25214591|NCT02696590|Vitamins|vitamins|mesh-ancestor
25041797|NCT01581203|Asunaprevir|asunaprevir|mesh-list
24967524|NCT03759093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24967525|NCT03759093|Growth Substances|growth substances|mesh-ancestor
24967526|NCT03759093|Growth Inhibitors|growth inhibitors|mesh-ancestor
24967527|NCT03759067|Clopidogrel|clopidogrel|mesh-list
24967542|NCT03758859|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24967543|NCT03758859|Immunologic Factors|immunologic factors|mesh-ancestor
24967544|NCT03758859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967545|NCT03758859|Viscosupplements|viscosupplements|mesh-ancestor
24967546|NCT03758859|Protective Agents|protective agents|mesh-ancestor
24967547|NCT03758859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24967549|NCT03758729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24967550|NCT03758729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967551|NCT03758729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24967552|NCT03758729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967553|NCT03758677|Gemcitabine|gemcitabine|mesh-list
24967554|NCT03758677|Docetaxel|docetaxel|mesh-list
24967555|NCT03758677|Pemetrexed|pemetrexed|mesh-list
24967556|NCT03758677|Apatinib|apatinib|mesh-list
24967573|NCT03758469|Rifampin|rifampin|mesh-list
24967574|NCT03758469|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24967575|NCT03758469|Antitubercular Agents|antitubercular agents|mesh-ancestor
24967576|NCT03758469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24967577|NCT03758469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24967578|NCT03758469|Leprostatic Agents|leprostatic agents|mesh-ancestor
24967579|NCT03758469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24967580|NCT03758469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24967581|NCT03758469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967588|NCT03758339|Tucatinib|tucatinib|mesh-list
24967607|NCT03758144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24967608|NCT03758118|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
24967609|NCT03758118|Nootropic Agents|nootropic agents|mesh-ancestor
24967610|NCT03758079|Gabapentin|gabapentin|mesh-list
24967611|NCT03758079|Doxepin|doxepin|mesh-list
24967612|NCT03758079|Analgesics|analgesics|mesh-ancestor
24967613|NCT03758079|Sensory System Agents|sensory system agents|mesh-ancestor
24967614|NCT03758079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24967615|NCT03758079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967616|NCT03758079|Anticonvulsants|anticonvulsants|mesh-ancestor
24967617|NCT03758079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24967618|NCT03758079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24967619|NCT03758079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24967620|NCT03758079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24967621|NCT03758079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24967622|NCT03758079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24967623|NCT03758079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24967624|NCT03758079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967625|NCT03758079|Antimanic Agents|antimanic agents|mesh-ancestor
24967626|NCT03758079|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24967663|NCT03757559|Hydromorphone|hydromorphone|mesh-list
25678857|NCT01830543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678858|NCT01830543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25678859|NCT01830543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25678860|NCT01830543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678861|NCT01830543|Antipyretics|antipyretics|mesh-ancestor
24533111|NCT00642330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24533112|NCT00642330|Analgesics|analgesics|mesh-ancestor
24533113|NCT00642330|Sensory System Agents|sensory system agents|mesh-ancestor
24533114|NCT00642330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24686639|NCT04674514|Immunologic Factors|immunologic factors|mesh-ancestor
24967664|NCT03757559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24967665|NCT03757559|Narcotics|narcotics|mesh-ancestor
24967666|NCT03757559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24967667|NCT03757559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967668|NCT03757559|Analgesics|analgesics|mesh-ancestor
24967669|NCT03757559|Sensory System Agents|sensory system agents|mesh-ancestor
24967670|NCT03757559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24967692|NCT03757390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24967693|NCT03757390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24967694|NCT03757390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24967695|NCT03757364|Methotrexate|methotrexate|mesh-list
24967696|NCT03757364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24967700|NCT03757364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24967701|NCT03757364|Antimetabolites|antimetabolites|mesh-ancestor
24793725|NCT02625610|Antidotes|antidotes|mesh-ancestor
24804630|NCT02004067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24804631|NCT02004067|Cathartics|cathartics|mesh-ancestor
24804632|NCT02004067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25214592|NCT02696590|Micronutrients|micronutrients|mesh-ancestor
25214593|NCT02696590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041798|NCT01581203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804634|NCT02004171|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24804635|NCT02004171|Autonomic Agents|autonomic agents|mesh-ancestor
24804636|NCT02004171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804637|NCT02004171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804638|NCT02004171|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24804639|NCT02004171|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24804640|NCT02004171|Cholinergic Agents|cholinergic agents|mesh-ancestor
24804641|NCT02004171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24804642|NCT02004171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804643|NCT02004184|Pemetrexed|pemetrexed|mesh-list
24804644|NCT02004184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804645|NCT02004184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590360|NCT00912262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804646|NCT02004184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804647|NCT02004184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24495679|NCT00501579|Prednisolone acetate|prednisolone acetate|mesh-list
24804650|NCT02004197|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
24804652|NCT02004197|Ranitidine|ranitidine|mesh-list
24804653|NCT02004197|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
24804657|NCT02004197|Antacids|antacids|mesh-ancestor
24804665|NCT02004301|Diclofenac|diclofenac|mesh-list
24804931|NCT02005783|Antimitotic Agents|antimitotic agents|mesh-ancestor
24495555|NCT00501098|Antifungal Agents|antifungal agents|mesh-ancestor
24495556|NCT00501098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24495557|NCT00501098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495558|NCT00501098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967742|NCT03757143|Chlorhexidine|chlorhexidine|mesh-list
24967743|NCT03757143|Povidone-Iodine|povidone-iodine|mesh-list
24967744|NCT03757143|Povidone|povidone|mesh-list
24967745|NCT03757143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24967746|NCT03757143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24967747|NCT03757143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24967748|NCT03757143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967749|NCT03757143|Disinfectants|disinfectants|mesh-ancestor
24967750|NCT03757143|Plasma Substitutes|plasma substitutes|mesh-ancestor
24967751|NCT03757143|Blood Substitutes|blood substitutes|mesh-ancestor
24967752|NCT03757117|Hormones|hormones|mesh-list
24967753|NCT03757117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25678862|NCT01830543|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25678863|NCT01830543|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25678864|NCT01830543|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25678865|NCT01830543|Purinergic Agents|purinergic agents|mesh-ancestor
25678866|NCT01830543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25678867|NCT01830543|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25678868|NCT01830543|Antithrombins|antithrombins|mesh-ancestor
25678869|NCT01830543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24533191|NCT00642512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24533193|NCT00642551|Vitamin K|vitamin k|mesh-list
24533194|NCT00642551|Vitamin MK 7|vitamin mk 7|mesh-list
24533195|NCT00642551|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24533196|NCT00642551|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24533197|NCT00642551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686835|NCT04561648|Calcium heparin|calcium heparin|mesh-list
24686836|NCT04561648|Anticoagulants|anticoagulants|mesh-ancestor
24686837|NCT04561648|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24686898|NCT04525755|Varenicline|varenicline|mesh-list
24686899|NCT04525755|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24686900|NCT04525755|Autonomic Agents|autonomic agents|mesh-ancestor
24686930|NCT04515628|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24686931|NCT04515628|Branebrutinib|branebrutinib|mesh-list
24448476|NCT00311961|Hormones|hormones|mesh-ancestor
24967754|NCT03757117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967755|NCT03757052|Amoxicillin|amoxicillin|mesh-list
24967756|NCT03757052|Penicillins|penicillins|mesh-list
24967757|NCT03757052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25082738|NCT03320486|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25082739|NCT03320486|Hormone Antagonists|hormone antagonists|mesh-ancestor
25082740|NCT03320486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25082741|NCT03320486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082742|NCT03320486|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25082743|NCT03320460|Clobetasol|clobetasol|mesh-list
25082744|NCT03320460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25082745|NCT03320460|Glucocorticoids|glucocorticoids|mesh-ancestor
25082746|NCT03320460|Hormones|hormones|mesh-ancestor
25082747|NCT03320460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25082748|NCT03320460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082749|NCT03320447|Lidocaine|lidocaine|mesh-list
25082750|NCT03320447|Prilocaine|prilocaine|mesh-list
25082751|NCT03320447|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25082752|NCT03320447|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25082753|NCT03320447|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
25082757|NCT03320447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082758|NCT03320447|Sensory System Agents|sensory system agents|mesh-ancestor
25082759|NCT03320447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082760|NCT03320447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25082761|NCT03320447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25082762|NCT03320447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25214594|NCT02696590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25041800|NCT01581203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24830220|NCT02157818|Dexmedetomidine|dexmedetomidine|mesh-list
25082763|NCT03320447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25082764|NCT03320447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804105|NCT02001103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967758|NCT03757052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24967760|NCT03756987|Anesthetics, Local|anesthetics, local|mesh-ancestor
24967761|NCT03756987|Anesthetics|anesthetics|mesh-ancestor
24967762|NCT03756987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24967763|NCT03756987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732548|NCT01640210|Insulin|insulin|mesh-list
24495674|NCT00501566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495676|NCT00501579|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24495677|NCT00501579|Methylprednisolone|methylprednisolone|mesh-list
25678870|NCT01830543|Protease Inhibitors|protease inhibitors|mesh-ancestor
25678871|NCT01830543|Anticoagulants|anticoagulants|mesh-ancestor
25678872|NCT01830543|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25678873|NCT01830543|Hemostatics|hemostatics|mesh-ancestor
25678874|NCT01830543|Coagulants|coagulants|mesh-ancestor
25678875|NCT01830595|Lactoferrin|lactoferrin|mesh-list
25678876|NCT01830595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25678877|NCT01830699|Triamcinolone|triamcinolone|mesh-list
25678878|NCT01830699|Rilonacept|rilonacept|mesh-list
25678879|NCT01830699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25678880|NCT01830699|Glucocorticoids|glucocorticoids|mesh-ancestor
25678881|NCT01830699|Hormones|hormones|mesh-ancestor
25678882|NCT01830699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25678883|NCT01830699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678884|NCT01830816|Ixazomib|ixazomib|mesh-list
24456522|NCT00331513|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24669999|NCT03395080|Mitosis Modulators|mitosis modulators|mesh-ancestor
24670000|NCT03395080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263507|NCT01453179|Immunologic Factors|immunologic factors|mesh-ancestor
25263508|NCT01453179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25263509|NCT01453179|Interferon Inducers|interferon inducers|mesh-ancestor
25263510|NCT01336530|Oxethazaine|oxethazaine|mesh-list
24495678|NCT00501579|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24495680|NCT00501579|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24495730|NCT00501722|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24495731|NCT00501722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495732|NCT00501722|Natriuretic Agents|natriuretic agents|mesh-ancestor
24495733|NCT00501722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967776|NCT03756896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24967777|NCT03756896|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24967778|NCT03756896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967779|NCT03756896|Immunologic Factors|immunologic factors|mesh-ancestor
24967780|NCT03756896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24967781|NCT03756896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24967782|NCT03756896|Growth Substances|growth substances|mesh-ancestor
24967783|NCT03756896|Growth Inhibitors|growth inhibitors|mesh-ancestor
24967785|NCT03756818|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24967786|NCT03756818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24967787|NCT03756818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967788|NCT03756818|Tubulin Modulators|tubulin modulators|mesh-ancestor
24967789|NCT03756818|Antimitotic Agents|antimitotic agents|mesh-ancestor
24967790|NCT03756818|Mitosis Modulators|mitosis modulators|mesh-ancestor
24967791|NCT03756818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967792|NCT03756727|Ascorbic Acid|ascorbic acid|mesh-list
24967799|NCT03756623|Metformin|metformin|mesh-list
24967800|NCT03756623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24967801|NCT03756623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967802|NCT03756324|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24967803|NCT03756324|Cefdinir|cefdinir|mesh-list
24967804|NCT03756324|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24967805|NCT03756324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24967806|NCT03756324|Antitubercular Agents|antitubercular agents|mesh-ancestor
24967807|NCT03756298|Capecitabine|capecitabine|mesh-list
24967808|NCT03756298|Atezolizumab|atezolizumab|mesh-list
24732627|NCT01640587|Antimalarials|antimalarials|mesh-ancestor
24495751|NCT00501839|Fertility Agents|fertility agents|mesh-ancestor
24495752|NCT00501839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24495753|NCT00501839|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24967812|NCT03756298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967813|NCT03756272|Bupivacaine|bupivacaine|mesh-list
24967814|NCT03756272|Anesthetics, Local|anesthetics, local|mesh-ancestor
24967815|NCT03756272|Anesthetics|anesthetics|mesh-ancestor
24967816|NCT03756272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24967817|NCT03756272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967818|NCT03756272|Sensory System Agents|sensory system agents|mesh-ancestor
24967819|NCT03756272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24967820|NCT03756246|Vaccines|vaccines|mesh-list
24967821|NCT03756246|Immunologic Factors|immunologic factors|mesh-ancestor
24967822|NCT03756246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967823|NCT03756233|Remifentanil|remifentanil|mesh-list
24967824|NCT03756233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24967825|NCT03756233|Narcotics|narcotics|mesh-ancestor
24967826|NCT03756233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24967827|NCT03756233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214595|NCT02696590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25214596|NCT02696512|Thioctic Acid|thioctic acid|mesh-list
25214597|NCT02696512|Minocycline|minocycline|mesh-list
25214598|NCT02696512|Lamotrigine|lamotrigine|mesh-list
25214599|NCT02696512|Flumazenil|flumazenil|mesh-list
25678885|NCT01830816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678886|NCT01830816|Protease Inhibitors|protease inhibitors|mesh-ancestor
25678887|NCT01830816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678888|NCT01830816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678889|NCT01830842|Nicotine|nicotine|mesh-list
25678890|NCT01830842|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25678891|NCT01830842|Autonomic Agents|autonomic agents|mesh-ancestor
25678892|NCT01830842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25678893|NCT01830842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24670088|NCT03300947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24448511|NCT00312039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24687466|NCT03974243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687470|NCT03967925|Prednisone|prednisone|mesh-list
24687471|NCT03967925|Prednisolone|prednisolone|mesh-list
24687472|NCT03967925|Rituximab|rituximab|mesh-list
24687473|NCT03967925|Belimumab|belimumab|mesh-list
24855154|NCT02277730|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
24830221|NCT02157818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24967828|NCT03756233|Analgesics|analgesics|mesh-ancestor
24967829|NCT03756233|Sensory System Agents|sensory system agents|mesh-ancestor
24967830|NCT03756233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24967831|NCT03756220|Ascorbic Acid|ascorbic acid|mesh-list
24967832|NCT03756220|Thiamine|thiamine|mesh-list
24967833|NCT03756220|Vitamins|vitamins|mesh-ancestor
24967834|NCT03756220|Micronutrients|micronutrients|mesh-ancestor
24967835|NCT03756220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967836|NCT03756220|Antioxidants|antioxidants|mesh-ancestor
24967837|NCT03756220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967838|NCT03756220|Protective Agents|protective agents|mesh-ancestor
24967839|NCT03756220|Vitamin B Complex|vitamin b complex|mesh-ancestor
24967840|NCT03756194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24967841|NCT03756116|Epinephrine|epinephrine|mesh-list
24967842|NCT03756116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24967843|NCT03756116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24967844|NCT03756116|Adrenergic Agents|adrenergic agents|mesh-ancestor
24967845|NCT03756116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24967846|NCT03756116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245289|NCT04122625|Nivolumab|nivolumab|mesh-list
24788706|NCT01932931|Vitamin D|vitamin d|mesh-list
24967847|NCT03756116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967848|NCT03756116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24925994|NCT04145492|Hemostatics|hemostatics|mesh-ancestor
24967849|NCT03756116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24967850|NCT03756116|Autonomic Agents|autonomic agents|mesh-ancestor
24967851|NCT03756116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24967852|NCT03756116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24967853|NCT03756116|Respiratory System Agents|respiratory system agents|mesh-ancestor
24967854|NCT03756116|Mydriatics|mydriatics|mesh-ancestor
24967855|NCT03756116|Sympathomimetics|sympathomimetics|mesh-ancestor
24967891|NCT03755947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24967892|NCT03755778|Itraconazole|itraconazole|mesh-list
24967893|NCT03755778|Rifampin|rifampin|mesh-list
24967894|NCT03755778|Quinidine|quinidine|mesh-list
24967895|NCT03755778|Antifungal Agents|antifungal agents|mesh-ancestor
24967896|NCT03755778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24967897|NCT03755778|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24967898|NCT03755778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24967899|NCT03755778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732798|NCT01641419|BB 1101|bb 1101|mesh-list
24793755|NCT02542696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24793756|NCT02542696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24793757|NCT02542696|Dopamine Agonists|dopamine agonists|mesh-ancestor
24793758|NCT02542696|Dopamine Agents|dopamine agents|mesh-ancestor
24793759|NCT02542696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24793760|NCT02542696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793762|NCT02515591|Chelating Agents|chelating agents|mesh-ancestor
24793763|NCT02515591|Sequestering Agents|sequestering agents|mesh-ancestor
24793764|NCT02515591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793765|NCT02514447|Topotecan|topotecan|mesh-list
24793766|NCT02514447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24793767|NCT02514447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24793768|NCT02514447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24793769|NCT02514447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793770|NCT02514447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678894|NCT01830842|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25678895|NCT01830842|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25678896|NCT01830842|Cholinergic Agents|cholinergic agents|mesh-ancestor
25678897|NCT01830842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25678898|NCT01830842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678899|NCT01830881|Ibuprofen|ibuprofen|mesh-list
25678900|NCT01830881|Lidocaine|lidocaine|mesh-list
25678901|NCT01830881|Midazolam|midazolam|mesh-list
24793771|NCT02484924|Clopidogrel|clopidogrel|mesh-list
24793772|NCT02484924|Ticagrelor|ticagrelor|mesh-list
24793773|NCT02484924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24781160|NCT01888302|Sirolimus|sirolimus|mesh-list
24953800|NCT03881787|Cetuximab|cetuximab|mesh-list
24687654|NCT03845270|Mitosis Modulators|mitosis modulators|mesh-ancestor
24687656|NCT03845270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24967901|NCT03755778|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24793774|NCT02484924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24967967|NCT03755609|Anesthetics|anesthetics|mesh-ancestor
24793775|NCT02484924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24793776|NCT02484924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24967902|NCT03755778|Hormone Antagonists|hormone antagonists|mesh-ancestor
24967903|NCT03755778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24967904|NCT03755778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732822|NCT01641510|Clopidogrel|clopidogrel|mesh-list
24967913|NCT03755778|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24967914|NCT03755778|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25214600|NCT02696512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25214601|NCT02696512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25214602|NCT02696512|Anticonvulsants|anticonvulsants|mesh-ancestor
25214603|NCT02696512|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24967915|NCT03755778|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24967916|NCT03755778|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24967917|NCT03755778|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24967918|NCT03755778|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24967919|NCT03755778|Adrenergic Agents|adrenergic agents|mesh-ancestor
24967920|NCT03755778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24938760|NCT04016116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967921|NCT03755778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24967922|NCT03755778|Antimalarials|antimalarials|mesh-ancestor
24967923|NCT03755778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24967924|NCT03755778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24967925|NCT03755778|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24967926|NCT03755778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24968396|NCT03751202|Xhance|xhance|mesh-list
24967927|NCT03755778|Cholinergic Agents|cholinergic agents|mesh-ancestor
24967928|NCT03755778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24967929|NCT03755778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24967930|NCT03755778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24967931|NCT03755778|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24967932|NCT03755752|Diminazene aceturate|diminazene aceturate|mesh-list
24967933|NCT03755752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24967934|NCT03755752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24967935|NCT03755752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24804934|NCT02005783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24804935|NCT02005783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24804936|NCT02005783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24804937|NCT02005822|Valganciclovir|valganciclovir|mesh-list
24804938|NCT02005822|Antiviral Agents|antiviral agents|mesh-ancestor
24495832|NCT00502112|Growth Inhibitors|growth inhibitors|mesh-ancestor
24495833|NCT00502112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495834|NCT00502112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24495835|NCT00502138|Pramlintide|pramlintide|mesh-list
24804939|NCT02005822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24804940|NCT02005848|Protease Inhibitors|protease inhibitors|mesh-list
24804941|NCT02005848|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
24967952|NCT03755700|Respiratory System Agents|respiratory system agents|mesh-ancestor
24967953|NCT03755700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24967955|NCT03755609|Fentanyl|fentanyl|mesh-list
24967956|NCT03755609|Oxycodone|oxycodone|mesh-list
24967957|NCT03755609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25678902|NCT01830881|Anesthetics, Local|anesthetics, local|mesh-ancestor
25678903|NCT01830881|Anesthetics|anesthetics|mesh-ancestor
25678904|NCT01830881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25678905|NCT01830881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967958|NCT03755609|Narcotics|narcotics|mesh-ancestor
24926155|NCT04144218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24495850|NCT00502190|Micronutrients|micronutrients|mesh-ancestor
24495851|NCT00502190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967960|NCT03755609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967961|NCT03755609|Analgesics|analgesics|mesh-ancestor
24967962|NCT03755609|Sensory System Agents|sensory system agents|mesh-ancestor
24967963|NCT03755609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24967964|NCT03755609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24967965|NCT03755609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24967966|NCT03755609|Anesthetics, General|anesthetics, general|mesh-ancestor
25214605|NCT02696512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214606|NCT02696512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25214607|NCT02696512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214608|NCT02696512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25214609|NCT02696512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25157991|NCT04537598|Narcotics|narcotics|mesh-ancestor
24732975|NCT01642745|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24967977|NCT03755557|Hormones|hormones|mesh-ancestor
24967978|NCT03755557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24967979|NCT03755531|Oxytocin|oxytocin|mesh-list
24967980|NCT03755531|Carbetocin|carbetocin|mesh-list
24967981|NCT03755531|Oxytocics|oxytocics|mesh-ancestor
24967982|NCT03755531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24967983|NCT03755531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967984|NCT03755479|Insulin|insulin|mesh-list
24968000|NCT03755427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24968003|NCT03755310|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24968004|NCT03755310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24968005|NCT03755310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968006|NCT03755310|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
24968007|NCT03755310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24968008|NCT03755310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968009|NCT03755193|Diphosphonates|diphosphonates|mesh-list
24968010|NCT03755193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24968011|NCT03755193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968012|NCT03755115|Epirubicin|epirubicin|mesh-list
24968013|NCT03755115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24968014|NCT03755115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24968015|NCT03755115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24968016|NCT03755115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24968017|NCT03755115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24968018|NCT03755115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938795|NCT04015908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24968024|NCT03755089|Lidocaine|lidocaine|mesh-list
24968025|NCT03755089|Anesthetics, Local|anesthetics, local|mesh-ancestor
24968026|NCT03755089|Anesthetics|anesthetics|mesh-ancestor
24968027|NCT03755089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25214610|NCT02696512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25214611|NCT02696512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25214612|NCT02696512|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25214613|NCT02696512|Antioxidants|antioxidants|mesh-ancestor
25214614|NCT02696512|Protective Agents|protective agents|mesh-ancestor
25214615|NCT02696512|Vitamin B Complex|vitamin b complex|mesh-ancestor
25214616|NCT02696512|Vitamins|vitamins|mesh-ancestor
25214617|NCT02696512|Micronutrients|micronutrients|mesh-ancestor
25214618|NCT02696512|Antidotes|antidotes|mesh-ancestor
25678906|NCT01830881|Sensory System Agents|sensory system agents|mesh-ancestor
25678907|NCT01830881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24687904|NCT03618550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24687905|NCT03618550|Tubulin Modulators|tubulin modulators|mesh-ancestor
24687906|NCT03618550|Antimitotic Agents|antimitotic agents|mesh-ancestor
24687907|NCT03618550|Mitosis Modulators|mitosis modulators|mesh-ancestor
24687941|NCT03584516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24855175|NCT02277847|Idarubicin|idarubicin|mesh-list
24457694|NCT00334906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24687942|NCT03584516|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25214619|NCT02696512|GABA Modulators|gaba modulators|mesh-ancestor
25214620|NCT02696512|GABA Agents|gaba agents|mesh-ancestor
25214621|NCT02696512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25214622|NCT02696577|Aspirin|aspirin|mesh-list
25214623|NCT02696577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25214624|NCT02696577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25214625|NCT02696577|Analgesics|analgesics|mesh-ancestor
25214626|NCT02696577|Sensory System Agents|sensory system agents|mesh-ancestor
25214627|NCT02696577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25214628|NCT02696577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214629|NCT02696577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24968028|NCT03755089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968029|NCT03755089|Sensory System Agents|sensory system agents|mesh-ancestor
24968030|NCT03755089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24968031|NCT03755089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24968032|NCT03755089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24968033|NCT03755089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24926236|NCT04143581|Empagliflozin|empagliflozin|mesh-list
24968034|NCT03755089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24968035|NCT03755089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968036|NCT03755037|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24968037|NCT03755037|Estradiol|estradiol|mesh-list
24968038|NCT03755037|Estrogens|estrogens|mesh-ancestor
24968039|NCT03755037|Hormones|hormones|mesh-ancestor
24968040|NCT03755037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24968041|NCT03755037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968042|NCT03755037|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24968043|NCT03755037|Contraceptive Agents|contraceptive agents|mesh-ancestor
24617263|NCT01042028|Capecitabine|capecitabine|mesh-list
24495875|NCT00502294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495877|NCT00502385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495878|NCT00502385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24495879|NCT00502385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495942|NCT00502567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24495944|NCT00502658|Micronutrients|micronutrients|mesh-ancestor
24495945|NCT00502658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495946|NCT00502684|Etodolac|etodolac|mesh-list
24495993|NCT00502879|Immunologic Factors|immunologic factors|mesh-ancestor
24495996|NCT00502892|Ifosfamide|ifosfamide|mesh-list
24495997|NCT00502892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495998|NCT00502892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24968082|NCT03754712|Vitamin D|vitamin d|mesh-list
24968083|NCT03754712|Cholecalciferol|cholecalciferol|mesh-list
24968084|NCT03754712|Vitamins|vitamins|mesh-ancestor
24968085|NCT03754712|Micronutrients|micronutrients|mesh-ancestor
24968086|NCT03754712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968087|NCT03754712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24968088|NCT03754712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24968089|NCT03754686|Acetaminophen|acetaminophen|mesh-list
24968090|NCT03754686|Oseltamivir|oseltamivir|mesh-list
24968091|NCT03754686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24968092|NCT03754686|Analgesics|analgesics|mesh-ancestor
24968093|NCT03754686|Sensory System Agents|sensory system agents|mesh-ancestor
25678908|NCT01830881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25678909|NCT01830881|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25678910|NCT01830881|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25678911|NCT01830881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25678912|NCT01830881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678913|NCT01830881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25678914|NCT01830881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24968094|NCT03754686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24453063|NCT05339087|Enzyme Activators|enzyme activators|mesh-ancestor
24453065|NCT05338580|Pembrolizumab|pembrolizumab|mesh-list
24670130|NCT03251326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24670131|NCT03251326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24670132|NCT03251326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24851092|NCT02255266|Hormones|hormones|mesh-ancestor
24855184|NCT02277847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688319|NCT03141671|Androgen Antagonists|androgen antagonists|mesh-ancestor
24968095|NCT03754686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968096|NCT03754686|Antipyretics|antipyretics|mesh-ancestor
24968097|NCT03754686|Antiviral Agents|antiviral agents|mesh-ancestor
24968098|NCT03754686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24968099|NCT03754686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24968100|NCT03754686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496060|NCT00503321|Protective Agents|protective agents|mesh-ancestor
24496061|NCT00503347|Bavituximab|bavituximab|mesh-list
24496093|NCT00503490|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24496094|NCT00503490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24496095|NCT00503490|Renal Agents|renal agents|mesh-ancestor
24968111|NCT03754543|Trace Elements|trace elements|mesh-ancestor
24968112|NCT03754543|Micronutrients|micronutrients|mesh-ancestor
24968113|NCT03754543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968114|NCT03754387|Ceftazidime|ceftazidime|mesh-list
24968119|NCT03754179|Dabrafenib|dabrafenib|mesh-list
24968120|NCT03754179|Antimalarials|antimalarials|mesh-ancestor
24968121|NCT03754179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25214630|NCT02696577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25214631|NCT02696577|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25214632|NCT02696577|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24968122|NCT03754179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24968123|NCT03754179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24968124|NCT03754179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24968125|NCT03754179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968126|NCT03754179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24968127|NCT03754179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24968128|NCT03754179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24968129|NCT03754062|Haloperidol|haloperidol|mesh-list
24968130|NCT03754062|Haloperidol decanoate|haloperidol decanoate|mesh-list
24968131|NCT03754062|Antiemetics|antiemetics|mesh-ancestor
24968132|NCT03754062|Autonomic Agents|autonomic agents|mesh-ancestor
24968133|NCT03754062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24733182|NCT01643889|Domperidone|domperidone|mesh-list
24496103|NCT00503490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24496105|NCT00503503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24496106|NCT00503503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24496107|NCT00503503|Analgesics|analgesics|mesh-ancestor
24496108|NCT00503503|Sensory System Agents|sensory system agents|mesh-ancestor
24496136|NCT00503542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24496137|NCT00503542|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24496138|NCT00503542|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24968138|NCT03754062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24968139|NCT03754062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24968140|NCT03754062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24968141|NCT03754062|Dopamine Agents|dopamine agents|mesh-ancestor
24968142|NCT03754062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24968143|NCT03754062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968144|NCT03754062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24968145|NCT03754010|Hyaluronic Acid|hyaluronic acid|mesh-list
24968146|NCT03754010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24968147|NCT03754010|Immunologic Factors|immunologic factors|mesh-ancestor
25678915|NCT01830881|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25678916|NCT01830881|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25678917|NCT01830881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25678918|NCT01830881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25678919|NCT01830881|Anesthetics, General|anesthetics, general|mesh-ancestor
25678920|NCT01830881|GABA Modulators|gaba modulators|mesh-ancestor
25678921|NCT01830881|GABA Agents|gaba agents|mesh-ancestor
25678922|NCT01830881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25678923|NCT01830881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24968148|NCT03754010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968149|NCT03754010|Viscosupplements|viscosupplements|mesh-ancestor
24968150|NCT03754010|Protective Agents|protective agents|mesh-ancestor
24905897|NCT04344288|Prednisone|prednisone|mesh-list
24968152|NCT03753867|Keratolytic Agents|keratolytic agents|mesh-ancestor
24968153|NCT03753867|Dermatologic Agents|dermatologic agents|mesh-ancestor
24968155|NCT03753685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24968156|NCT03753685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24968157|NCT03753685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24968158|NCT03753685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968162|NCT03753581|Cytarabine|cytarabine|mesh-list
24968163|NCT03753581|Methotrexate|methotrexate|mesh-list
24968164|NCT03753581|Etoposide|etoposide|mesh-list
24968165|NCT03753581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24968185|NCT03753477|Amlodipine|amlodipine|mesh-list
24968186|NCT03753477|Olmesartan|olmesartan|mesh-list
24968187|NCT03753477|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24968188|NCT03753477|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
24968189|NCT03753477|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25214633|NCT02696577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214634|NCT02696577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25214635|NCT02696577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25214636|NCT02696577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25214637|NCT02696577|Antipyretics|antipyretics|mesh-ancestor
25214638|NCT02696642|Maytansine|maytansine|mesh-list
25214639|NCT02696642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25214640|NCT02696642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25214641|NCT02696642|Tubulin Modulators|tubulin modulators|mesh-ancestor
25214642|NCT02696642|Antimitotic Agents|antimitotic agents|mesh-ancestor
24968190|NCT03753477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24968191|NCT03753477|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24968192|NCT03753477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24793786|NCT02436733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24793788|NCT02352883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24793789|NCT02352883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793790|NCT02257346|Lidocaine|lidocaine|mesh-list
24793791|NCT02257346|Anesthetics, Local|anesthetics, local|mesh-ancestor
24793792|NCT02257346|Anesthetics|anesthetics|mesh-ancestor
24793793|NCT02257346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24793794|NCT02257346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793795|NCT02257346|Sensory System Agents|sensory system agents|mesh-ancestor
24793796|NCT02257346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24793797|NCT02257346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24793798|NCT02257346|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24496139|NCT00503542|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24793799|NCT02257346|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24793800|NCT02257346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24793826|NCT01618357|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24599550|NCT04413799|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24599551|NCT04413799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24599552|NCT04413799|Anesthetics, General|anesthetics, general|mesh-ancestor
24599553|NCT04413799|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24793827|NCT01618357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905988|NCT04343729|Hormones|hormones|mesh-ancestor
24938874|NCT04015687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24968232|NCT03752749|Prednisolone|prednisolone|mesh-list
24968233|NCT03752749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24968234|NCT03752749|Glucocorticoids|glucocorticoids|mesh-ancestor
24968235|NCT03752749|Hormones|hormones|mesh-ancestor
24968236|NCT03752749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24968238|NCT03752749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24968239|NCT03752749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678924|NCT01830881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24968240|NCT03752736|Sunscreening Agents|sunscreening agents|mesh-list
24968241|NCT03752736|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24968242|NCT03752736|Protective Agents|protective agents|mesh-ancestor
24968243|NCT03752736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968244|NCT03752736|Dermatologic Agents|dermatologic agents|mesh-ancestor
24968245|NCT03752658|Tenofovir|tenofovir|mesh-list
24968246|NCT03752658|Antiviral Agents|antiviral agents|mesh-ancestor
24968247|NCT03752658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24968248|NCT03752658|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24968249|NCT03752658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24968250|NCT03752658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24968251|NCT03752658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968287|NCT03752229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25082770|NCT03320187|Vasodilator Agents|vasodilator agents|mesh-ancestor
25082771|NCT03320187|Oxytocics|oxytocics|mesh-ancestor
25082772|NCT03320187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25082773|NCT03320187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082774|NCT03320174|Tafenoquine|tafenoquine|mesh-list
24599554|NCT04413799|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24599555|NCT04413799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25214643|NCT02696642|Mitosis Modulators|mitosis modulators|mesh-ancestor
25214644|NCT02696642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214645|NCT02696460|Lidocaine|lidocaine|mesh-list
25214646|NCT02696460|Prilocaine|prilocaine|mesh-list
25214647|NCT02696460|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25214648|NCT02696460|Anesthetics, Local|anesthetics, local|mesh-ancestor
25214649|NCT02696460|Anesthetics|anesthetics|mesh-ancestor
25214650|NCT02696460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25214651|NCT02696460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214652|NCT02696460|Sensory System Agents|sensory system agents|mesh-ancestor
24599556|NCT04370509|Pembrolizumab|pembrolizumab|mesh-list
24599557|NCT04370509|Axitinib|axitinib|mesh-list
24599558|NCT04370509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24599559|NCT04370509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24628199|NCT01097213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24628200|NCT01097213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628201|NCT01097252|Cisplatin|cisplatin|mesh-list
24628202|NCT01097252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24628203|NCT01097265|Capecitabine|capecitabine|mesh-list
24628204|NCT01097265|Oxaliplatin|oxaliplatin|mesh-list
24628205|NCT01097265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24628206|NCT01097265|Antimetabolites|antimetabolites|mesh-ancestor
24628207|NCT01097265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628208|NCT01097265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24628209|NCT01097278|Cholecalciferol|cholecalciferol|mesh-list
24628210|NCT01097278|Vitamin D|vitamin d|mesh-list
25082775|NCT03320174|Antimalarials|antimalarials|mesh-ancestor
25082776|NCT03320174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25082777|NCT03320174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25082778|NCT03320174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25082779|NCT03320109|Vitamin D|vitamin d|mesh-list
25082780|NCT03320109|Ergocalciferols|ergocalciferols|mesh-list
25082781|NCT03320109|Cholecalciferol|cholecalciferol|mesh-list
25082782|NCT03320109|Vitamins|vitamins|mesh-list
25082783|NCT03320109|Micronutrients|micronutrients|mesh-ancestor
25082784|NCT03320109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082787|NCT03320031|Insulin Lispro|insulin lispro|mesh-list
25082793|NCT03320031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25082794|NCT03320031|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25082795|NCT03320031|Protease Inhibitors|protease inhibitors|mesh-ancestor
25082796|NCT03320031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25082797|NCT03320031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082798|NCT03319901|Venetoclax|venetoclax|mesh-list
25082799|NCT03319901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25082800|NCT03319823|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
25082801|NCT03319823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25082802|NCT03319823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082803|NCT03319823|Diuretics|diuretics|mesh-ancestor
25082804|NCT03319823|Natriuretic Agents|natriuretic agents|mesh-ancestor
24670299|NCT03101748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24858767|NCT02299401|Oxytocics|oxytocics|mesh-ancestor
24553178|NCT00729794|Protective Agents|protective agents|mesh-ancestor
24474170|NCT00405158|Analgesics|analgesics|mesh-ancestor
24689052|NCT02427581|Poly I-C|poly i-c|mesh-list
24689053|NCT02427581|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24689054|NCT02427581|Poly ICLC|poly iclc|mesh-list
24689092|NCT02299999|Docetaxel|docetaxel|mesh-list
24689093|NCT02299999|Vinca Alkaloids|vinca alkaloids|mesh-list
25082805|NCT03319823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082806|NCT03319784|Triamcinolone|triamcinolone|mesh-list
25082807|NCT03319784|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25082808|NCT03319784|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25082809|NCT03319784|Ketorolac|ketorolac|mesh-list
25082810|NCT03319784|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25082811|NCT03319784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25082812|NCT03319784|Glucocorticoids|glucocorticoids|mesh-ancestor
25082813|NCT03319784|Hormones|hormones|mesh-ancestor
24733393|NCT01645774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25082822|NCT03319784|Analgesics|analgesics|mesh-ancestor
25082823|NCT03319784|Sensory System Agents|sensory system agents|mesh-ancestor
25082824|NCT03319784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082828|NCT03319706|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25082829|NCT03319706|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24968297|NCT03752229|Anesthetics|anesthetics|mesh-ancestor
24968298|NCT03752229|GABA Modulators|gaba modulators|mesh-ancestor
24968299|NCT03752229|GABA Agents|gaba agents|mesh-ancestor
24968300|NCT03752229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24968301|NCT03752229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968302|NCT03752190|Cosyntropin|cosyntropin|mesh-list
25214653|NCT02696460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25214654|NCT02696460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25214674|NCT02696369|Epinephrine|epinephrine|mesh-list
25214655|NCT02696460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25214657|NCT02696460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25214658|NCT02696460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214659|NCT02696460|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24830313|NCT02158624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24830315|NCT02158624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968303|NCT03752190|Hormones|hormones|mesh-ancestor
24968304|NCT03752190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24968305|NCT03752190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968306|NCT03752138|Decitabine|decitabine|mesh-list
24968307|NCT03752138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24968308|NCT03752138|Antimetabolites|antimetabolites|mesh-ancestor
24968309|NCT03752138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968310|NCT03752138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24968311|NCT03752138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24968312|NCT03752125|Caffeine|caffeine|mesh-list
24968313|NCT03752125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24938881|NCT04015778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24968314|NCT03752125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968315|NCT03752125|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24968316|NCT03752125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24968317|NCT03752125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968318|NCT03752125|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24968319|NCT03752125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24968320|NCT03752125|Purinergic Agents|purinergic agents|mesh-ancestor
24968321|NCT03752125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24968322|NCT03752112|Penicillins|penicillins|mesh-list
24968323|NCT03752112|Cefixime|cefixime|mesh-list
24496142|NCT00503542|Antifungal Agents|antifungal agents|mesh-ancestor
24496143|NCT00503542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24496144|NCT00503542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24496145|NCT00503542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25245514|NCT03926754|Urological Agents|urological agents|mesh-ancestor
24496159|NCT00503594|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24496160|NCT00503594|Abortifacient Agents|abortifacient agents|mesh-ancestor
25678925|NCT01830881|Analgesics|analgesics|mesh-ancestor
25678926|NCT01830881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25678927|NCT01830881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25678928|NCT01830881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25678929|NCT01830881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678930|NCT01831089|Paclitaxel|paclitaxel|mesh-list
25678931|NCT01831089|Bevacizumab|bevacizumab|mesh-list
25678932|NCT01831089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25678933|NCT01831089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689297|NCT01829958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24689298|NCT01805271|Everolimus|everolimus|mesh-list
24689299|NCT01805271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689300|NCT01805271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24689301|NCT01805271|Immunologic Factors|immunologic factors|mesh-ancestor
24855203|NCT02277938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855205|NCT02277938|Analgesics|analgesics|mesh-ancestor
24855206|NCT02277938|Sensory System Agents|sensory system agents|mesh-ancestor
24689302|NCT01805271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689303|NCT01779557|Dialysis Solutions|dialysis solutions|mesh-list
24689311|NCT01740297|Ipilimumab|ipilimumab|mesh-list
24496161|NCT00503594|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24496162|NCT00503594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496163|NCT00503594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24496164|NCT00503594|Antimetabolites|antimetabolites|mesh-ancestor
24496165|NCT00503594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496166|NCT00503594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496167|NCT00503594|Dermatologic Agents|dermatologic agents|mesh-ancestor
24496168|NCT00503594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24968324|NCT03752112|Penicillin G Benzathine|penicillin g benzathine|mesh-list
24968325|NCT03752112|Penicillin G|penicillin g|mesh-list
24968326|NCT03752112|Penicillin G Procaine|penicillin g procaine|mesh-list
24968327|NCT03752112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24968328|NCT03752112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24968329|NCT03751917|Arsenic Trioxide|arsenic trioxide|mesh-list
24968336|NCT03751761|Tubulin Modulators|tubulin modulators|mesh-ancestor
24968337|NCT03751761|Antimitotic Agents|antimitotic agents|mesh-ancestor
24968338|NCT03751761|Mitosis Modulators|mitosis modulators|mesh-ancestor
24968339|NCT03751761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968340|NCT03751761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24968342|NCT03751514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24968343|NCT03751514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24968344|NCT03751488|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24968345|NCT03751488|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24968346|NCT03751488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24968347|NCT03751488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24968348|NCT03751488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968349|NCT03751488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24624435|NCT01076439|Xhance|xhance|mesh-list
24496169|NCT00503594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24496170|NCT00503594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24496171|NCT00503594|Immunologic Factors|immunologic factors|mesh-ancestor
24496172|NCT00503594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24496173|NCT00503594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24496180|NCT00503594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24496181|NCT00503594|Alkylating Agents|alkylating agents|mesh-ancestor
24496182|NCT00503607|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24496183|NCT00503607|Laxatives|laxatives|mesh-ancestor
24496187|NCT00503620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24496188|NCT00503620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24496189|NCT00503620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24496190|NCT00503620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496191|NCT00503620|Cholinergic Agents|cholinergic agents|mesh-ancestor
24496198|NCT00503659|Autonomic Agents|autonomic agents|mesh-ancestor
24496199|NCT00503659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24496200|NCT00503659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496201|NCT00503659|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24968350|NCT03751488|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24968351|NCT03751488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24968352|NCT03751488|Serotonin Agents|serotonin agents|mesh-ancestor
24968353|NCT03751488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25678934|NCT01831089|Tubulin Modulators|tubulin modulators|mesh-ancestor
25678935|NCT01831089|Antimitotic Agents|antimitotic agents|mesh-ancestor
25678936|NCT01831089|Mitosis Modulators|mitosis modulators|mesh-ancestor
25678937|NCT01831089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678938|NCT01831089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25678939|NCT01831089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25678940|NCT01831089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25678941|NCT01831089|Growth Substances|growth substances|mesh-ancestor
25678942|NCT01831089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678943|NCT01831089|Growth Inhibitors|growth inhibitors|mesh-ancestor
24689564|NCT01104350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968354|NCT03751488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968355|NCT03751488|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24968356|NCT03751488|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24968357|NCT03751488|Dopamine Agents|dopamine agents|mesh-ancestor
24394241|NCT00132652|Lamivudine|lamivudine|mesh-list
24537035|NCT00653341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24968387|NCT03751332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24968388|NCT03751332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24968389|NCT03751332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214663|NCT02696330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25214664|NCT02696330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25214665|NCT02696330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25214666|NCT02696330|Purinergic Agents|purinergic agents|mesh-ancestor
25214667|NCT02696330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25214668|NCT02696330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214669|NCT02696330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214670|NCT02696330|Anticoagulants|anticoagulants|mesh-ancestor
25214671|NCT02696330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25214672|NCT02696330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25214673|NCT02696369|Lidocaine|lidocaine|mesh-list
25214675|NCT02696369|Racepinephrine|racepinephrine|mesh-list
25214676|NCT02696369|Epinephryl borate|epinephryl borate|mesh-list
25214677|NCT02696369|Anesthetics, Local|anesthetics, local|mesh-ancestor
25214678|NCT02696369|Anesthetics|anesthetics|mesh-ancestor
25214679|NCT02696369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24968390|NCT03751228|BMS-986165|bms-986165|mesh-list
24968391|NCT03751228|Dermatologic Agents|dermatologic agents|mesh-ancestor
24968392|NCT03751228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24968393|NCT03751228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24968394|NCT03751228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968395|NCT03751202|Fluticasone|fluticasone|mesh-list
24968397|NCT03751202|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24968398|NCT03751202|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24968399|NCT03751202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24968400|NCT03751202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24968401|NCT03751202|Autonomic Agents|autonomic agents|mesh-ancestor
24968402|NCT03751202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24968403|NCT03751202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968404|NCT03751202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24968405|NCT03751202|Respiratory System Agents|respiratory system agents|mesh-ancestor
24926607|NCT04140188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926608|NCT04140136|Tocotrienols|tocotrienols|mesh-list
24926609|NCT04140136|Vitamin E|vitamin e|mesh-list
24926610|NCT04140136|Tocopherols|tocopherols|mesh-list
24926611|NCT04140136|Antioxidants|antioxidants|mesh-ancestor
24926612|NCT04140136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926613|NCT04140136|Protective Agents|protective agents|mesh-ancestor
24496202|NCT00503659|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
24496203|NCT00503659|Respiratory System Agents|respiratory system agents|mesh-ancestor
24496204|NCT00503659|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24496205|NCT00503659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25050457|NCT00498836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050458|NCT00498836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050459|NCT00498212|1018 oligonucleotide|1018 oligonucleotide|mesh-list
25050460|NCT00498212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24496206|NCT00503659|Cholinergic Agents|cholinergic agents|mesh-ancestor
24496245|NCT00504062|Fluticasone|fluticasone|mesh-list
24496246|NCT00504062|Budesonide|budesonide|mesh-list
24496247|NCT00504062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24496248|NCT00504062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24496249|NCT00504062|Autonomic Agents|autonomic agents|mesh-ancestor
24496250|NCT00504062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24496251|NCT00504062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678944|NCT01831232|Cytarabine|cytarabine|mesh-list
24496269|NCT00504101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678945|NCT01831232|Idarubicin|idarubicin|mesh-list
25678946|NCT01831232|Pravastatin|pravastatin|mesh-list
25678947|NCT01831232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25678948|NCT01831232|Antimetabolites|antimetabolites|mesh-ancestor
25678949|NCT01831232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263788|NCT00189293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25263789|NCT00189293|Immunologic Factors|immunologic factors|mesh-ancestor
25263790|NCT00189293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263791|NCT00189293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25263792|NCT00189293|Interferon Inducers|interferon inducers|mesh-ancestor
25263793|NCT00189267|Imiquimod|imiquimod|mesh-list
25263794|NCT00189267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25263795|NCT00189267|Immunologic Factors|immunologic factors|mesh-ancestor
25263796|NCT00189267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263799|NCT00189254|Imiquimod|imiquimod|mesh-list
24496271|NCT00504127|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
24496272|NCT00504127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24496273|NCT00504127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24496274|NCT00504127|Analgesics|analgesics|mesh-ancestor
24496275|NCT00504127|Sensory System Agents|sensory system agents|mesh-ancestor
24968406|NCT03751202|Dermatologic Agents|dermatologic agents|mesh-ancestor
24968407|NCT03751202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24968408|NCT03751202|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24968409|NCT03751202|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24968410|NCT03751202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24968411|NCT03751202|Adrenergic Agents|adrenergic agents|mesh-ancestor
24968420|NCT03751176|Fluorouracil|fluorouracil|mesh-list
24968421|NCT03751176|Irinotecan|irinotecan|mesh-list
24968422|NCT03751176|Panitumumab|panitumumab|mesh-list
24968423|NCT03751176|Levoleucovorin|levoleucovorin|mesh-list
24968424|NCT03751176|Antimetabolites|antimetabolites|mesh-ancestor
24968425|NCT03751176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968426|NCT03751176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24968427|NCT03751176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24968428|NCT03751176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24968429|NCT03751176|Immunologic Factors|immunologic factors|mesh-ancestor
24968430|NCT03751176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968431|NCT03751176|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24968432|NCT03751176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24968433|NCT03751176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24968434|NCT03751176|Antidotes|antidotes|mesh-ancestor
24968435|NCT03751176|Protective Agents|protective agents|mesh-ancestor
24926627|NCT04139824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
24926628|NCT04139824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24926629|NCT04139824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24496276|NCT00504127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24496277|NCT00504127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496278|NCT00504127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24496279|NCT00504127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24938882|NCT04015778|Tubulin Modulators|tubulin modulators|mesh-ancestor
25214680|NCT02696369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214681|NCT02696369|Sensory System Agents|sensory system agents|mesh-ancestor
24830342|NCT02158702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24496280|NCT00504127|Gout Suppressants|gout suppressants|mesh-ancestor
24496281|NCT00504127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24496285|NCT00504140|Interferons|interferons|mesh-list
24968436|NCT03751176|Vitamin B Complex|vitamin b complex|mesh-ancestor
24968437|NCT03751176|Vitamins|vitamins|mesh-ancestor
24968438|NCT03751176|Micronutrients|micronutrients|mesh-ancestor
24968439|NCT03751176|Hematinics|hematinics|mesh-ancestor
24968440|NCT03751176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24968441|NCT03751163|Sunscreening Agents|sunscreening agents|mesh-list
24968442|NCT03751163|Tranexamic Acid|tranexamic acid|mesh-list
24968443|NCT03751163|Hydroquinone|hydroquinone|mesh-list
24968444|NCT03751163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24628215|NCT01097278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24628216|NCT01097317|Carboplatin|carboplatin|mesh-list
24628217|NCT01097317|Vinorelbine|vinorelbine|mesh-list
25678950|NCT01831232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678951|NCT01831232|Antiviral Agents|antiviral agents|mesh-ancestor
25678952|NCT01831232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25678953|NCT01831232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25678954|NCT01831232|Immunologic Factors|immunologic factors|mesh-ancestor
25678955|NCT01831232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678956|NCT01831232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25678957|NCT01831232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25678958|NCT01831232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24628218|NCT01097317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678959|NCT01831232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689794|NCT00309985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628219|NCT01097317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24628220|NCT01097317|Tubulin Modulators|tubulin modulators|mesh-ancestor
24628221|NCT01097317|Antimitotic Agents|antimitotic agents|mesh-ancestor
24628222|NCT01097317|Mitosis Modulators|mitosis modulators|mesh-ancestor
24968445|NCT03751163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24968446|NCT03751163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968447|NCT03751163|Hemostatics|hemostatics|mesh-ancestor
24968448|NCT03751163|Coagulants|coagulants|mesh-ancestor
24968449|NCT03751163|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24968450|NCT03751163|Protective Agents|protective agents|mesh-ancestor
24968451|NCT03751163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968452|NCT03751163|Dermatologic Agents|dermatologic agents|mesh-ancestor
24968453|NCT03751163|Antioxidants|antioxidants|mesh-ancestor
24968454|NCT03751111|Naloxone|naloxone|mesh-list
24968455|NCT03751111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24968456|NCT03751111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968477|NCT03750916|Docetaxel|docetaxel|mesh-list
24968478|NCT03750916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24968479|NCT03750916|Tubulin Modulators|tubulin modulators|mesh-ancestor
24968480|NCT03750916|Antimitotic Agents|antimitotic agents|mesh-ancestor
24968489|NCT03750773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24968490|NCT03750773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24968491|NCT03750773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24968492|NCT03750773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24968493|NCT03750773|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24968494|NCT03750773|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24968495|NCT03750773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24968496|NCT03750773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968497|NCT03750773|Antimanic Agents|antimanic agents|mesh-ancestor
24968498|NCT03750760|Atorvastatin|atorvastatin|mesh-list
24968500|NCT03750760|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24968501|NCT03750760|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24968502|NCT03750760|Antimetabolites|antimetabolites|mesh-ancestor
24968503|NCT03750760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968504|NCT03750760|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24968505|NCT03750760|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24968506|NCT03750760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24968507|NCT03750721|Rifampin|rifampin|mesh-list
24968508|NCT03750721|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24968509|NCT03750721|Antitubercular Agents|antitubercular agents|mesh-ancestor
24968510|NCT03750721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24496346|NCT00504400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24496347|NCT00504400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24496348|NCT00504400|Growth Substances|growth substances|mesh-ancestor
24496464|NCT00504946|Respiratory System Agents|respiratory system agents|mesh-ancestor
25214682|NCT02696369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25214683|NCT02696369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25214684|NCT02696369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25214685|NCT02696369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25214686|NCT02696369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24830343|NCT02158702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24830344|NCT02158702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24830345|NCT02158702|Immunologic Factors|immunologic factors|mesh-ancestor
24496465|NCT00504946|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24496471|NCT00504946|Autonomic Agents|autonomic agents|mesh-ancestor
24496476|NCT00504946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24496478|NCT00504959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24968513|NCT03750721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24968514|NCT03750721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24968515|NCT03750721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968516|NCT03750721|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24968517|NCT03750721|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24968518|NCT03750721|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24968519|NCT03750721|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25678960|NCT01831232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25678961|NCT01831232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25678962|NCT01831232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24968520|NCT03750721|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24968521|NCT03750721|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24968523|NCT03750669|Gemcitabine|gemcitabine|mesh-list
25082830|NCT03319706|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25082831|NCT03319706|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25082832|NCT03319706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082833|NCT03319680|Dialysis Solutions|dialysis solutions|mesh-list
25082834|NCT03319680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25082835|NCT03319563|Epinephrine|epinephrine|mesh-list
25082836|NCT03319563|Anesthetics|anesthetics|mesh-list
24804808|NCT02005315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24968525|NCT03750669|Fluorouracil|fluorouracil|mesh-list
24968526|NCT03750669|Oxaliplatin|oxaliplatin|mesh-list
24968527|NCT03750669|Irinotecan|irinotecan|mesh-list
24968534|NCT03750669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24968535|NCT03750669|Antimetabolites|antimetabolites|mesh-ancestor
24793828|NCT01618357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793829|NCT01618357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793830|NCT01530373|Clonidine|clonidine|mesh-list
24793835|NCT01530373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793836|NCT01530373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24793837|NCT01530373|Sympatholytics|sympatholytics|mesh-ancestor
24793838|NCT01530373|Autonomic Agents|autonomic agents|mesh-ancestor
24793839|NCT01530373|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24793840|NCT01530373|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24793841|NCT01530373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24793842|NCT01530373|Adrenergic Agents|adrenergic agents|mesh-ancestor
24968536|NCT03750669|Antiviral Agents|antiviral agents|mesh-ancestor
24968537|NCT03750669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24968538|NCT03750669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24968539|NCT03750669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24968540|NCT03750669|Immunologic Factors|immunologic factors|mesh-ancestor
24968541|NCT03750669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968542|NCT03750669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24968543|NCT03750669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24968544|NCT03750669|Hematinics|hematinics|mesh-ancestor
24968545|NCT03750669|Vitamin B Complex|vitamin b complex|mesh-ancestor
24968546|NCT03750669|Vitamins|vitamins|mesh-ancestor
24968547|NCT03750669|Micronutrients|micronutrients|mesh-ancestor
24968548|NCT03750656|Hyoscyamine|hyoscyamine|mesh-list
24968549|NCT03750656|Tamsulosin|tamsulosin|mesh-list
24968550|NCT03750656|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24968551|NCT03750656|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24968552|NCT03750656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24968553|NCT03750656|Adrenergic Agents|adrenergic agents|mesh-ancestor
25214687|NCT02696369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214688|NCT02696369|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25214689|NCT02696369|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25214690|NCT02696369|Adrenergic Agents|adrenergic agents|mesh-ancestor
25214691|NCT02696369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25214692|NCT02696369|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25214693|NCT02696369|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25214694|NCT02696369|Autonomic Agents|autonomic agents|mesh-ancestor
25214695|NCT02696369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25157992|NCT04537598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24968554|NCT03750656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24968555|NCT03750656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968556|NCT03750656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968557|NCT03750656|Urological Agents|urological agents|mesh-ancestor
24968558|NCT03750656|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24968559|NCT03750656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24968560|NCT03750656|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24968561|NCT03750656|Autonomic Agents|autonomic agents|mesh-ancestor
24968562|NCT03750656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24926783|NCT04138719|Paclitaxel|paclitaxel|mesh-list
24496479|NCT00504959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24496480|NCT00504959|Growth Substances|growth substances|mesh-ancestor
24496481|NCT00504959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968563|NCT03750656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24968564|NCT03750656|Respiratory System Agents|respiratory system agents|mesh-ancestor
24968565|NCT03750656|Mydriatics|mydriatics|mesh-ancestor
24968566|NCT03750656|Parasympatholytics|parasympatholytics|mesh-ancestor
24968567|NCT03750656|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24968568|NCT03750656|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24968569|NCT03750656|Cholinergic Agents|cholinergic agents|mesh-ancestor
24968570|NCT03750383|Cyclosporine|cyclosporine|mesh-list
25263889|NCT02444260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25263890|NCT02443935|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
25263894|NCT02443727|Oxytocin|oxytocin|mesh-list
24968571|NCT03750383|Prednisone|prednisone|mesh-list
24968572|NCT03750383|Cyclosporins|cyclosporins|mesh-list
24968573|NCT03750383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24968574|NCT03750383|Glucocorticoids|glucocorticoids|mesh-ancestor
24968575|NCT03750383|Hormones|hormones|mesh-ancestor
24968576|NCT03750383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24968577|NCT03750383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968578|NCT03750383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24968579|NCT03750383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24968580|NCT03750383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733787|NCT01648556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24968591|NCT03750136|Natriuretic Agents|natriuretic agents|mesh-ancestor
24968592|NCT03750136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968593|NCT03750136|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24968594|NCT03750136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24968595|NCT03750136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968605|NCT03749915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24968606|NCT03749850|Cyclophosphamide|cyclophosphamide|mesh-list
24968607|NCT03749850|Doxorubicin|doxorubicin|mesh-list
24968608|NCT03749850|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24968609|NCT03749850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24968610|NCT03749850|Immunologic Factors|immunologic factors|mesh-ancestor
24968611|NCT03749850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968612|NCT03749850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24968613|NCT03749850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24968614|NCT03749850|Alkylating Agents|alkylating agents|mesh-ancestor
24968615|NCT03749850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968616|NCT03749850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24968617|NCT03749850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24968618|NCT03749850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24968619|NCT03749850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24968620|NCT03749850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24968621|NCT03749850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24968623|NCT03749733|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24968624|NCT03749733|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24968625|NCT03749733|Estradiol|estradiol|mesh-list
24968626|NCT03749733|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24968627|NCT03749733|Estrogens|estrogens|mesh-ancestor
24968628|NCT03749733|Hormones|hormones|mesh-ancestor
24968629|NCT03749733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24968630|NCT03749733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968631|NCT03749733|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24968632|NCT03749733|Contraceptive Agents|contraceptive agents|mesh-ancestor
24968633|NCT03749733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24968634|NCT03749733|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24496527|NCT00505258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24496528|NCT00505258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24496529|NCT00505336|Eplerenone|eplerenone|mesh-list
24496530|NCT00505336|Atorvastatin|atorvastatin|mesh-list
24496531|NCT00505336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25214696|NCT02696369|Respiratory System Agents|respiratory system agents|mesh-ancestor
24802576|NCT01991054|Vitamin D|vitamin d|mesh-list
24496532|NCT00505336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24496533|NCT00505336|Antimetabolites|antimetabolites|mesh-ancestor
24496534|NCT00505336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496535|NCT00505336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24496536|NCT00505336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24496537|NCT00505336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24968635|NCT03749733|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24968636|NCT03749733|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24968637|NCT03749733|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24968638|NCT03749733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24968639|NCT03749733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25678963|NCT01831232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25678964|NCT01831427|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25263923|NCT02443844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263924|NCT02443844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263925|NCT02443844|Urological Agents|urological agents|mesh-ancestor
25263927|NCT02443922|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25263928|NCT02443922|Glimepiride|glimepiride|mesh-list
25263929|NCT02443922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25263930|NCT02443922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263931|NCT02443922|Incretins|incretins|mesh-ancestor
25263932|NCT02443922|Hormones|hormones|mesh-ancestor
24968641|NCT03749642|Trazodone|trazodone|mesh-list
24968642|NCT03749642|Analgesics|analgesics|mesh-ancestor
24733906|NCT01649544|Amiodarone|amiodarone|mesh-list
24793843|NCT01530373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24793844|NCT01530373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793845|NCT01530373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24793846|NCT01530373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24793847|NCT01530373|Cholinergic Agents|cholinergic agents|mesh-ancestor
24793848|NCT01530373|Urological Agents|urological agents|mesh-ancestor
24793850|NCT01442246|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24793851|NCT01442246|Fertility Agents|fertility agents|mesh-ancestor
24793852|NCT01442246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24793853|NCT01442246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793854|NCT01442246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24793855|NCT01442246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793856|NCT01062399|Everolimus|everolimus|mesh-list
24793857|NCT01062399|Temozolomide|temozolomide|mesh-list
24793858|NCT01062399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793859|NCT01062399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24793860|NCT01062399|Immunologic Factors|immunologic factors|mesh-ancestor
24926917|NCT04137432|Oxytocin|oxytocin|mesh-list
24926918|NCT04137432|Oxytocics|oxytocics|mesh-ancestor
24926919|NCT04137432|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24496538|NCT00505336|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24496539|NCT00505336|Hormone Antagonists|hormone antagonists|mesh-ancestor
24496540|NCT00505336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24496541|NCT00505336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496542|NCT00505336|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24496543|NCT00505336|Diuretics|diuretics|mesh-ancestor
24496544|NCT00505336|Natriuretic Agents|natriuretic agents|mesh-ancestor
24496546|NCT00505427|Thioctic Acid|thioctic acid|mesh-list
24496578|NCT00505531|Anesthetics, Local|anesthetics, local|mesh-ancestor
24496579|NCT00505531|Anesthetics|anesthetics|mesh-ancestor
24496580|NCT00505531|Antiemetics|antiemetics|mesh-ancestor
24496665|NCT00505843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496667|NCT00505843|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24496668|NCT00505843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496672|NCT00505947|Infliximab|infliximab|mesh-list
24496730|NCT00506298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24496731|NCT00506298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24496732|NCT00506298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496733|NCT00506311|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24496734|NCT00506311|Hemostatics|hemostatics|mesh-ancestor
24496735|NCT00506311|Coagulants|coagulants|mesh-ancestor
24496736|NCT00506506|Acetylcysteine|acetylcysteine|mesh-list
24496737|NCT00506506|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24793871|NCT00712322|Cholinergic Agents|cholinergic agents|mesh-ancestor
24793872|NCT00712322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24793873|NCT00712322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793874|NCT00712322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793875|NCT00712322|Urological Agents|urological agents|mesh-ancestor
24793877|NCT00572169|Dexamethasone|dexamethasone|mesh-list
24793878|NCT00572169|Cyclophosphamide|cyclophosphamide|mesh-list
25214697|NCT02696369|Mydriatics|mydriatics|mesh-ancestor
25214698|NCT02696369|Sympathomimetics|sympathomimetics|mesh-ancestor
25214699|NCT02696369|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25678965|NCT01831427|Immunologic Factors|immunologic factors|mesh-ancestor
25678966|NCT01831427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678967|NCT01831466|Tofacitinib|tofacitinib|mesh-list
25678968|NCT01831466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25678969|NCT01831466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678970|NCT01831466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678971|NCT01831765|Insulin|insulin|mesh-list
25678972|NCT01831765|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25678973|NCT01831765|Insulin Aspart|insulin aspart|mesh-list
25678974|NCT01831765|Insulin, Long-Acting|insulin, long-acting|mesh-list
25272776|NCT02389868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263954|NCT02443285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25263955|NCT02443285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25263956|NCT02443246|Vitamin D|vitamin d|mesh-list
25263957|NCT02443246|Cholecalciferol|cholecalciferol|mesh-list
25263958|NCT02443246|Vitamins|vitamins|mesh-ancestor
25263959|NCT02443246|Micronutrients|micronutrients|mesh-ancestor
25263960|NCT02443246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263961|NCT02443246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25263962|NCT02443246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25263963|NCT02443311|Betamethasone|betamethasone|mesh-list
25263964|NCT02443311|Betamethasone Valerate|betamethasone valerate|mesh-list
25263965|NCT02443311|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25263966|NCT02443311|Betamethasone benzoate|betamethasone benzoate|mesh-list
25263967|NCT02443311|Pimecrolimus|pimecrolimus|mesh-list
25263968|NCT02443311|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25263969|NCT02443311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25263971|NCT02443311|Hormones|hormones|mesh-ancestor
25272777|NCT02389868|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24948547|NCT03918590|Analgesics|analgesics|mesh-ancestor
24793880|NCT00572169|Doxorubicin|doxorubicin|mesh-list
25082838|NCT03319563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24628223|NCT01097317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628224|NCT01097382|Zolpidem|zolpidem|mesh-list
24628225|NCT01097382|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24628226|NCT01097382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24628227|NCT01097382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24628228|NCT01097382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926939|NCT04137328|Incretins|incretins|mesh-ancestor
24496741|NCT00506506|Respiratory System Agents|respiratory system agents|mesh-ancestor
24496742|NCT00506506|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24496743|NCT00506506|Antioxidants|antioxidants|mesh-ancestor
24496744|NCT00506506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496745|NCT00506506|Protective Agents|protective agents|mesh-ancestor
24496746|NCT00506506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496747|NCT00506506|Antidotes|antidotes|mesh-ancestor
24496748|NCT00506532|Pulmonary Surfactants|pulmonary surfactants|mesh-list
24496749|NCT00506532|Calfactant|calfactant|mesh-list
24496750|NCT00506532|Respiratory System Agents|respiratory system agents|mesh-ancestor
24496751|NCT00506545|Rolapitant|rolapitant|mesh-list
24496752|NCT00506545|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24496753|NCT00506545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24496764|NCT00506623|Irinotecan|irinotecan|mesh-list
24496839|NCT00507052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24938941|NCT04014192|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24446364|NCT00304616|Aripiprazole|aripiprazole|mesh-list
24496840|NCT00507052|Expectorants|expectorants|mesh-ancestor
24496841|NCT00507052|Respiratory System Agents|respiratory system agents|mesh-ancestor
24496842|NCT00507052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24628229|NCT01097382|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24628231|NCT01097382|GABA Agents|gaba agents|mesh-ancestor
24628232|NCT01097382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24628233|NCT01097382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628234|NCT01097512|Gemcitabine|gemcitabine|mesh-list
24628235|NCT01097512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25678975|NCT01831765|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25678976|NCT01831765|Insulin Detemir|insulin detemir|mesh-list
25678977|NCT01831765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25678978|NCT01831765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678979|NCT01831791|Dutasteride|dutasteride|mesh-list
25678980|NCT01831791|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25678981|NCT01831791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25678982|NCT01831791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25678983|NCT01831791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25678984|NCT01831791|Hormone Antagonists|hormone antagonists|mesh-ancestor
25678985|NCT01831791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25678986|NCT01831791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692418|NCT01999335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25692419|NCT01999335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24628236|NCT01097512|Antimetabolites|antimetabolites|mesh-ancestor
25263993|NCT02443194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25263994|NCT02443194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263995|NCT02443194|Analgesics|analgesics|mesh-ancestor
25263996|NCT02443194|Sensory System Agents|sensory system agents|mesh-ancestor
25263997|NCT02443194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25263998|NCT02443194|Antidepressive Agents|antidepressive agents|mesh-ancestor
25263999|NCT02443194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25264000|NCT02443194|Dopamine Agents|dopamine agents|mesh-ancestor
24628237|NCT01097512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628238|NCT01097512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24628239|NCT01097512|Antiviral Agents|antiviral agents|mesh-ancestor
24628240|NCT01097512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24628241|NCT01097512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628242|NCT01097512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24496928|NCT00507234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496929|NCT00507234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24496930|NCT00507234|Respiratory System Agents|respiratory system agents|mesh-ancestor
24496931|NCT00507234|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24496932|NCT00507234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24496933|NCT00507234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24496934|NCT00507234|Adrenergic Agents|adrenergic agents|mesh-ancestor
24496935|NCT00507234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24497010|NCT00507793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24497057|NCT00507858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24497058|NCT00507858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497059|NCT00507858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497060|NCT00507858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948551|NCT03918590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24497157|NCT00508456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497158|NCT00508495|Acetaminophen|acetaminophen|mesh-list
24497159|NCT00508495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24497160|NCT00508495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24497161|NCT00508495|Analgesics|analgesics|mesh-ancestor
24497162|NCT00508495|Sensory System Agents|sensory system agents|mesh-ancestor
24628248|NCT01097551|Vasodilator Agents|vasodilator agents|mesh-ancestor
24628249|NCT01097551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24628250|NCT01097551|Cholinergic Agents|cholinergic agents|mesh-ancestor
24628251|NCT01097551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24628252|NCT01097551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628253|NCT01097551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628254|NCT01097551|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24628255|NCT01097551|Mydriatics|mydriatics|mesh-ancestor
24628256|NCT01097551|Autonomic Agents|autonomic agents|mesh-ancestor
25082839|NCT03319563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082840|NCT03319563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25082841|NCT03319563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25082842|NCT03319563|Adrenergic Agents|adrenergic agents|mesh-ancestor
25082843|NCT03319563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25082844|NCT03319563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628258|NCT01097551|Sympathomimetics|sympathomimetics|mesh-ancestor
25082845|NCT03319563|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25082846|NCT03319563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25082847|NCT03319563|Autonomic Agents|autonomic agents|mesh-ancestor
25082848|NCT03319563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082849|NCT03319563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24497163|NCT00508495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24497201|NCT00508885|Niacin|niacin|mesh-list
24497202|NCT00508885|Nicotinic Acids|nicotinic acids|mesh-list
24497203|NCT00508885|Vitamin B Complex|vitamin b complex|mesh-ancestor
24497204|NCT00508885|Vitamins|vitamins|mesh-ancestor
24497205|NCT00508885|Micronutrients|micronutrients|mesh-ancestor
24497206|NCT00508885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25678987|NCT01831817|Calcium, Dietary|calcium, dietary|mesh-list
25678988|NCT01831817|Listerine|listerine|mesh-list
25678989|NCT01831817|Calcium|calcium|mesh-list
25678990|NCT01831817|Fluorides|fluorides|mesh-list
25678991|NCT01831817|Sodium Fluoride|sodium fluoride|mesh-list
25678992|NCT01831817|Fluorophosphate|fluorophosphate|mesh-list
25678993|NCT01831817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25678994|NCT01831817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264017|NCT02443142|Sensory System Agents|sensory system agents|mesh-ancestor
25264018|NCT02443142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25264019|NCT02443142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264020|NCT02443142|Antipyretics|antipyretics|mesh-ancestor
25264021|NCT02443142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25264022|NCT02443142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25264023|NCT02443142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25264024|NCT02443142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25264025|NCT02443142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264026|NCT02443142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264027|NCT02442921|Colchicine|colchicine|mesh-list
25264028|NCT02442921|Gout Suppressants|gout suppressants|mesh-ancestor
24670939|NCT00680901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456617|NCT00331825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24568199|NCT00795223|Morphine|morphine|mesh-list
24497207|NCT00508885|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24497208|NCT00508885|Antimetabolites|antimetabolites|mesh-ancestor
24497209|NCT00508885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497210|NCT00508885|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24497211|NCT00508885|Vasodilator Agents|vasodilator agents|mesh-ancestor
24497267|NCT00509158|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
24497271|NCT00509158|Antacids|antacids|mesh-ancestor
25082866|NCT03319498|Peppermint oil|peppermint oil|mesh-list
25082867|NCT03319498|Mineral Oil|mineral oil|mesh-list
25082868|NCT03319498|Antiemetics|antiemetics|mesh-ancestor
25082869|NCT03319498|Autonomic Agents|autonomic agents|mesh-ancestor
25082870|NCT03319498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082871|NCT03319498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082872|NCT03319498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25082873|NCT03319498|Parasympatholytics|parasympatholytics|mesh-ancestor
25082874|NCT03319498|Emollients|emollients|mesh-ancestor
24793882|NCT00572169|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24793883|NCT00572169|Bortezomib|bortezomib|mesh-list
24793884|NCT00572169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25214710|NCT02696122|Anesthetics|anesthetics|mesh-list
25214711|NCT02696122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24830402|NCT02159131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830403|NCT02159131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948559|NCT03918694|Antioxidants|antioxidants|mesh-ancestor
24793885|NCT00572169|Immunologic Factors|immunologic factors|mesh-ancestor
24793886|NCT00572169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793887|NCT00572169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24793888|NCT00572169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24793889|NCT00572169|Alkylating Agents|alkylating agents|mesh-ancestor
24793890|NCT00572169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793891|NCT00572169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793892|NCT00572169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24793893|NCT00572169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24793894|NCT00572169|Antiemetics|antiemetics|mesh-ancestor
24793895|NCT00572169|Autonomic Agents|autonomic agents|mesh-ancestor
24793896|NCT00572169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24927062|NCT04136080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
24927063|NCT04136015|Dasatinib|dasatinib|mesh-list
24927064|NCT04136015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927065|NCT04136015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24927066|NCT04136015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927067|NCT04136015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927068|NCT04135898|Bevacizumab|bevacizumab|mesh-list
24927069|NCT04135898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24793901|NCT00572169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25678995|NCT01831817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25678996|NCT01831817|Cariostatic Agents|cariostatic agents|mesh-ancestor
25678997|NCT01831817|Protective Agents|protective agents|mesh-ancestor
25678998|NCT01831817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25678999|NCT01831817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25679000|NCT01831934|Vaccines|vaccines|mesh-list
25679001|NCT01831934|Immunologic Factors|immunologic factors|mesh-ancestor
25679002|NCT01831934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679003|NCT01832038|Lacosamide|lacosamide|mesh-list
25679004|NCT01832038|Anticonvulsants|anticonvulsants|mesh-ancestor
25679005|NCT01832038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25679006|NCT01832038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25679007|NCT01832038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25679008|NCT01832038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275330|NCT02372526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968717|NCT03748940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24968718|NCT03748940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24968720|NCT03748537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24968721|NCT03748446|Xenon|xenon|mesh-list
24968722|NCT03748446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24968723|NCT03748446|Anesthetics, General|anesthetics, general|mesh-ancestor
24968724|NCT03748446|Anesthetics|anesthetics|mesh-ancestor
24968725|NCT03748446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24968726|NCT03748446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968727|NCT03748303|Pregnanolone|pregnanolone|mesh-list
24968728|NCT03748303|Anesthetics|anesthetics|mesh-ancestor
24968729|NCT03748303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24968730|NCT03748303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968731|NCT03748290|Pregabalin|pregabalin|mesh-list
24968732|NCT03748290|Analgesics|analgesics|mesh-ancestor
24968733|NCT03748290|Sensory System Agents|sensory system agents|mesh-ancestor
24968734|NCT03748290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24968735|NCT03748290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968740|NCT03748290|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24968741|NCT03748290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24968742|NCT03748290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24968743|NCT03748290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24968744|NCT03748290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24968745|NCT03748173|Calfactant|calfactant|mesh-list
24968746|NCT03748173|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
24968747|NCT03748173|Respiratory System Agents|respiratory system agents|mesh-ancestor
24968748|NCT03748147|Misoprostol|misoprostol|mesh-list
24968749|NCT03748147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24968750|NCT03748147|Abortifacient Agents|abortifacient agents|mesh-ancestor
24968751|NCT03748147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24968752|NCT03748147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968753|NCT03748147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24968754|NCT03748147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24968755|NCT03748147|Oxytocics|oxytocics|mesh-ancestor
24968756|NCT03748108|Lidocaine|lidocaine|mesh-list
24968757|NCT03748108|Anesthetics, Local|anesthetics, local|mesh-ancestor
24968758|NCT03748108|Anesthetics|anesthetics|mesh-ancestor
24968759|NCT03748108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24968760|NCT03748108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968761|NCT03748108|Sensory System Agents|sensory system agents|mesh-ancestor
24968762|NCT03748108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082879|NCT03319238|Analgesics|analgesics|mesh-ancestor
24497277|NCT00509184|Immunologic Factors|immunologic factors|mesh-ancestor
24497278|NCT00509184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214712|NCT02696122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214713|NCT02696148|Liraglutide|liraglutide|mesh-list
25214714|NCT02696148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25214715|NCT02696148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214716|NCT02696148|Incretins|incretins|mesh-ancestor
25214717|NCT02696148|Hormones|hormones|mesh-ancestor
24948561|NCT03918694|Protective Agents|protective agents|mesh-ancestor
24497279|NCT00509184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24497280|NCT00509327|Bisacodyl|bisacodyl|mesh-list
24497281|NCT00509327|Cathartics|cathartics|mesh-ancestor
24497282|NCT00509327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24497283|NCT00509327|Laxatives|laxatives|mesh-ancestor
24497284|NCT00509353|Irinotecan|irinotecan|mesh-list
24497285|NCT00509353|Vincristine|vincristine|mesh-list
24497286|NCT00509353|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24497287|NCT00509353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24497288|NCT00509353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24497289|NCT00509353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497290|NCT00509353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497291|NCT00509353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497292|NCT00509353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24497293|NCT00509353|Tubulin Modulators|tubulin modulators|mesh-ancestor
24497428|NCT00510003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497430|NCT00510016|Analgesics|analgesics|mesh-ancestor
24497481|NCT00510211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24497483|NCT00510250|Sorafenib|sorafenib|mesh-list
24497484|NCT00510250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24968763|NCT03748108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24968764|NCT03748108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24968765|NCT03748108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25679009|NCT01832532|Liraglutide|liraglutide|mesh-list
25679010|NCT01832532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25264075|NCT02442648|Rituximab|rituximab|mesh-list
24968766|NCT03748108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24968767|NCT03748108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968769|NCT03748082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24968770|NCT03748082|Autonomic Agents|autonomic agents|mesh-ancestor
24968771|NCT03748082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24968772|NCT03748082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968773|NCT03748082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24968774|NCT03748082|Respiratory System Agents|respiratory system agents|mesh-ancestor
24968775|NCT03748082|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24968776|NCT03748082|Antioxidants|antioxidants|mesh-ancestor
24568366|NCT00795808|Zuclomiphene|zuclomiphene|mesh-list
24968777|NCT03748082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968778|NCT03748082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25214783|NCT02695563|Lactoferrin|lactoferrin|mesh-list
24968779|NCT03748082|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24537549|NCT00655135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24968780|NCT03748082|Vasodilator Agents|vasodilator agents|mesh-ancestor
24968781|NCT03748082|Gasotransmitters|gasotransmitters|mesh-ancestor
24968782|NCT03748082|Protective Agents|protective agents|mesh-ancestor
24968783|NCT03748043|Lactoferrin|lactoferrin|mesh-list
24968784|NCT03748043|Teferrol|teferrol|mesh-list
24968785|NCT03748043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24968786|NCT03748043|Hematinics|hematinics|mesh-ancestor
24968787|NCT03747978|Amlodipine|amlodipine|mesh-list
24968788|NCT03747978|Perindopril|perindopril|mesh-list
24968789|NCT03747978|Indapamide|indapamide|mesh-list
24497485|NCT00510250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24497486|NCT00510250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497487|NCT00510250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497488|NCT00510263|Valacyclovir|valacyclovir|mesh-list
24497489|NCT00510263|Prednisolone|prednisolone|mesh-list
24497490|NCT00510263|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24497491|NCT00510263|Methylprednisolone|methylprednisolone|mesh-list
24497548|NCT00510406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497549|NCT00510406|Urological Agents|urological agents|mesh-ancestor
24497550|NCT00510406|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24497551|NCT00510406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24497615|NCT00510666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24497616|NCT00510666|Antitussive Agents|antitussive agents|mesh-ancestor
24497617|NCT00510666|Respiratory System Agents|respiratory system agents|mesh-ancestor
24497618|NCT00510666|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24497620|NCT00510705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24497621|NCT00510705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497622|NCT00510913|Tacrolimus|tacrolimus|mesh-list
24497623|NCT00510913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24497624|NCT00510913|Immunologic Factors|immunologic factors|mesh-ancestor
24968790|NCT03747978|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
24968791|NCT03747978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24968792|NCT03747978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24968794|NCT03747978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968795|NCT03747978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25275604|NCT02370862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968796|NCT03747978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830428|NCT02159196|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24830429|NCT02159196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24968797|NCT03747978|Vasodilator Agents|vasodilator agents|mesh-ancestor
24968798|NCT03747978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24968799|NCT03747978|Protease Inhibitors|protease inhibitors|mesh-ancestor
24968800|NCT03747978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24968801|NCT03747978|Diuretics|diuretics|mesh-ancestor
24968802|NCT03747978|Natriuretic Agents|natriuretic agents|mesh-ancestor
24968803|NCT03747978|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24968804|NCT03747900|Botulinum Toxins|botulinum toxins|mesh-list
24968805|NCT03747900|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24968815|NCT03747744|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
24968816|NCT03747744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24968817|NCT03747744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24968818|NCT03747679|Mannitol|mannitol|mesh-list
24968819|NCT03747679|Sorbitol|sorbitol|mesh-list
24968820|NCT03747679|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24497664|NCT00511212|Immunologic Factors|immunologic factors|mesh-ancestor
24497665|NCT00511212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497666|NCT00511225|Cholecalciferol|cholecalciferol|mesh-list
24497667|NCT00511225|Vitamin D|vitamin d|mesh-list
25679011|NCT01832532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264101|NCT02442362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264102|NCT02442739|Ketamine|ketamine|mesh-list
25264103|NCT02442739|Analgesics|analgesics|mesh-ancestor
25264104|NCT02442739|Sensory System Agents|sensory system agents|mesh-ancestor
25264105|NCT02442739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25264106|NCT02442739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264107|NCT02442739|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25264108|NCT02442739|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24497668|NCT00511225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24497669|NCT00511225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497670|NCT00511225|Vitamins|vitamins|mesh-ancestor
24497671|NCT00511225|Micronutrients|micronutrients|mesh-ancestor
24497672|NCT00511225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24968821|NCT03747679|Diuretics|diuretics|mesh-ancestor
24968822|NCT03747679|Natriuretic Agents|natriuretic agents|mesh-ancestor
24968823|NCT03747679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968824|NCT03747679|Cathartics|cathartics|mesh-ancestor
24968825|NCT03747679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24968826|NCT03747614|Fluorometholone|fluorometholone|mesh-list
24968827|NCT03747614|Tacrolimus|tacrolimus|mesh-list
24968828|NCT03747614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24968829|NCT03747614|Immunologic Factors|immunologic factors|mesh-ancestor
24968830|NCT03747614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968831|NCT03747614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24968832|NCT03747614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24968833|NCT03747614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968834|NCT03747614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24968836|NCT03747614|Hormones|hormones|mesh-ancestor
24968837|NCT03747614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24968838|NCT03747614|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24968839|NCT03747562|Gabapentin|gabapentin|mesh-list
24968840|NCT03747562|Analgesics|analgesics|mesh-ancestor
24968841|NCT03747562|Sensory System Agents|sensory system agents|mesh-ancestor
24968842|NCT03747562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24968843|NCT03747562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968844|NCT03747562|Anticonvulsants|anticonvulsants|mesh-ancestor
24968845|NCT03747562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24968846|NCT03747562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24968847|NCT03747562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24968848|NCT03747562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24968849|NCT03747562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24968850|NCT03747562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24968851|NCT03747562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24968852|NCT03747562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968853|NCT03747562|Antimanic Agents|antimanic agents|mesh-ancestor
24968854|NCT03747536|Bromides|bromides|mesh-list
25679012|NCT01832532|Incretins|incretins|mesh-ancestor
25679013|NCT01832532|Hormones|hormones|mesh-ancestor
25679014|NCT01832532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25679015|NCT01832727|Dexamethasone|dexamethasone|mesh-list
25679016|NCT01832727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25679017|NCT01832727|Antiemetics|antiemetics|mesh-ancestor
25679018|NCT01832727|Autonomic Agents|autonomic agents|mesh-ancestor
25679019|NCT01832727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25679020|NCT01832727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679021|NCT01832727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25679022|NCT01832727|Glucocorticoids|glucocorticoids|mesh-ancestor
25679023|NCT01832727|Hormones|hormones|mesh-ancestor
25679024|NCT01832727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25679025|NCT01832727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25679026|NCT01832727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25679027|NCT01832766|Dronabinol|dronabinol|mesh-list
25679028|NCT01832766|Hallucinogens|hallucinogens|mesh-ancestor
24968855|NCT03747536|Ipratropium|ipratropium|mesh-list
24968856|NCT03747536|Anticonvulsants|anticonvulsants|mesh-ancestor
24968860|NCT03747536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968861|NCT03747536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24734478|NCT01652378|Lidocaine|lidocaine|mesh-list
24968882|NCT03747341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968883|NCT03747341|Analgesics|analgesics|mesh-ancestor
25214718|NCT02696148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25214719|NCT02695901|Chlorhexidine|chlorhexidine|mesh-list
25214720|NCT02695901|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25214721|NCT02695901|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24516449|NCT00602017|Amlodipine|amlodipine|mesh-list
24968884|NCT03747341|Sensory System Agents|sensory system agents|mesh-ancestor
24968885|NCT03747341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24968886|NCT03747341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24968887|NCT03747341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24968888|NCT03747341|Anesthetics, General|anesthetics, general|mesh-ancestor
24968889|NCT03747341|Anesthetics|anesthetics|mesh-ancestor
24968890|NCT03747341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24968891|NCT03747341|Antiemetics|antiemetics|mesh-ancestor
24968892|NCT03747341|Autonomic Agents|autonomic agents|mesh-ancestor
24968893|NCT03747341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24968894|NCT03747341|Antipruritics|antipruritics|mesh-ancestor
24968895|NCT03747341|Dermatologic Agents|dermatologic agents|mesh-ancestor
24968896|NCT03747341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24968897|NCT03747341|Serotonin Agents|serotonin agents|mesh-ancestor
24968898|NCT03747341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24968899|NCT03747341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968900|NCT03747341|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24968901|NCT03747341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24968902|NCT03747341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24927197|NCT04134650|Metformin|metformin|mesh-list
24497673|NCT00511277|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24497674|NCT00511277|Antidepressive Agents|antidepressive agents|mesh-ancestor
24497675|NCT00511277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24497734|NCT00511628|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24497735|NCT00511628|Dopamine Agents|dopamine agents|mesh-ancestor
24497736|NCT00511654|Midazolam|midazolam|mesh-list
24497737|NCT00511654|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24497822|NCT00512044|Anesthetics|anesthetics|mesh-list
24497823|NCT00512044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24497824|NCT00512044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497825|NCT00512057|Allopurinol|allopurinol|mesh-list
24968904|NCT03747198|Dimethyl sulfone|dimethyl sulfone|mesh-list
24968905|NCT03747198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24968906|NCT03747094|Fentanyl|fentanyl|mesh-list
24968907|NCT03747094|Ketamine|ketamine|mesh-list
24968908|NCT03747094|Analgesics|analgesics|mesh-ancestor
24968909|NCT03747094|Sensory System Agents|sensory system agents|mesh-ancestor
24968910|NCT03747094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24968911|NCT03747094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968912|NCT03747094|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24968913|NCT03747094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24968914|NCT03747094|Anesthetics, General|anesthetics, general|mesh-ancestor
24968915|NCT03747094|Anesthetics|anesthetics|mesh-ancestor
24968916|NCT03747094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24968917|NCT03747094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24968918|NCT03747094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24968919|NCT03747094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24497826|NCT00512057|Antimetabolites|antimetabolites|mesh-ancestor
24497827|NCT00512057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497832|NCT00512057|Antioxidants|antioxidants|mesh-ancestor
24497850|NCT00512070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24497851|NCT00512070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24497852|NCT00512070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24497853|NCT00512070|Serotonin Agents|serotonin agents|mesh-ancestor
24497854|NCT00512265|Acetylcysteine|acetylcysteine|mesh-list
24497855|NCT00512265|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24497856|NCT00512265|Antiviral Agents|antiviral agents|mesh-ancestor
24734516|NCT01652417|Glucocorticoids|glucocorticoids|mesh-ancestor
24497925|NCT00512668|Nilutamide|nilutamide|mesh-list
24497926|NCT00512668|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24497927|NCT00512668|Fertility Agents|fertility agents|mesh-ancestor
24497928|NCT00512668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24497929|NCT00512668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497930|NCT00512668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24497931|NCT00512668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497932|NCT00512668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24497933|NCT00512668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24497934|NCT00512668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24497935|NCT00512668|Antifungal Agents|antifungal agents|mesh-ancestor
24497936|NCT00512668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24497937|NCT00512668|Immunologic Factors|immunologic factors|mesh-ancestor
25214722|NCT02695901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25214723|NCT02695901|Disinfectants|disinfectants|mesh-ancestor
24497975|NCT00512928|Acenocoumarol|acenocoumarol|mesh-list
24497976|NCT00512928|Vitamin MK 7|vitamin mk 7|mesh-list
24497977|NCT00512928|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24497978|NCT00512928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24497979|NCT00512928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497980|NCT00512928|Hemostatics|hemostatics|mesh-ancestor
24497981|NCT00512928|Coagulants|coagulants|mesh-ancestor
24497982|NCT00512928|Vitamins|vitamins|mesh-ancestor
24497983|NCT00512928|Micronutrients|micronutrients|mesh-ancestor
24497984|NCT00512928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497985|NCT00512928|Anticoagulants|anticoagulants|mesh-ancestor
24497986|NCT00512980|Gemcitabine|gemcitabine|mesh-list
24968920|NCT03747094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968921|NCT03747094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24968922|NCT03747094|Narcotics|narcotics|mesh-ancestor
24968923|NCT03747094|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24968924|NCT03747081|Warfarin|warfarin|mesh-list
24968925|NCT03747081|Rivaroxaban|rivaroxaban|mesh-list
24968926|NCT03747081|Anticoagulants|anticoagulants|mesh-ancestor
24968927|NCT03747081|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24968928|NCT03747081|Antithrombins|antithrombins|mesh-ancestor
24968929|NCT03747081|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24968930|NCT03747081|Protease Inhibitors|protease inhibitors|mesh-ancestor
24968931|NCT03747081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24968932|NCT03747081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968934|NCT03746821|Vitamin B Complex|vitamin b complex|mesh-ancestor
24968936|NCT03746821|Micronutrients|micronutrients|mesh-ancestor
24968937|NCT03746821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968938|NCT03746782|Thrombin|thrombin|mesh-list
24497987|NCT00512980|Prednisone|prednisone|mesh-list
24498055|NCT00513162|Anticonvulsants|anticonvulsants|mesh-ancestor
24498056|NCT00513162|GABA Agents|gaba agents|mesh-ancestor
24498057|NCT00513162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24498058|NCT00513162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498059|NCT00513162|Antimanic Agents|antimanic agents|mesh-ancestor
24498060|NCT00513162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24498117|NCT00513253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25679029|NCT01832766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679030|NCT01832766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25679031|NCT01832766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25679032|NCT01832766|Analgesics|analgesics|mesh-ancestor
25679033|NCT01832766|Sensory System Agents|sensory system agents|mesh-ancestor
25679034|NCT01832766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25679035|NCT01832766|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25679036|NCT01832766|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25679037|NCT01832766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25679038|NCT01832766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679039|NCT01832766|Hormones|hormones|mesh-ancestor
25679040|NCT01832766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25679041|NCT01832961|Bronchodilator Agents|bronchodilator agents|mesh-list
25679042|NCT01832961|Autonomic Agents|autonomic agents|mesh-ancestor
24498277|NCT00513864|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24498279|NCT00513864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498281|NCT00513877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498282|NCT00513929|Zinc Sulfate|zinc sulfate|mesh-list
24498351|NCT00514072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498352|NCT00514072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24498354|NCT00514111|Ribavirin|ribavirin|mesh-list
24734601|NCT01652794|Carboplatin|carboplatin|mesh-list
24498486|NCT00514982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24498570|NCT00515320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24498571|NCT00515320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24498572|NCT00515320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498573|NCT00515320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24498635|NCT00515736|Antioxidants|antioxidants|mesh-ancestor
24968940|NCT03746782|Coagulants|coagulants|mesh-ancestor
24968941|NCT03746691|Citalopram|citalopram|mesh-list
24968942|NCT03746691|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24968943|NCT03746691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24968944|NCT03746691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24968945|NCT03746691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968946|NCT03746691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24968949|NCT03746691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24968950|NCT03746691|Antidepressive Agents|antidepressive agents|mesh-ancestor
25214724|NCT02695901|Dermatologic Agents|dermatologic agents|mesh-ancestor
25214725|NCT02695810|Metformin|metformin|mesh-list
25214726|NCT02695810|Dapagliflozin|dapagliflozin|mesh-list
24948590|NCT03918499|Pembrolizumab|pembrolizumab|mesh-list
24968952|NCT03746652|Dexamethasone|dexamethasone|mesh-list
24968953|NCT03746652|Daratumumab|daratumumab|mesh-list
24968955|NCT03746652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24968956|NCT03746652|Antiemetics|antiemetics|mesh-ancestor
24968957|NCT03746652|Autonomic Agents|autonomic agents|mesh-ancestor
24968958|NCT03746652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24968959|NCT03746652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968960|NCT03746652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24968961|NCT03746652|Glucocorticoids|glucocorticoids|mesh-ancestor
24968962|NCT03746652|Hormones|hormones|mesh-ancestor
24968963|NCT03746652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24968964|NCT03746652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24968965|NCT03746652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24968966|NCT03746652|Protease Inhibitors|protease inhibitors|mesh-ancestor
25679043|NCT01832961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25679044|NCT01832961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679045|NCT01832961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25679046|NCT01832961|Respiratory System Agents|respiratory system agents|mesh-ancestor
25679047|NCT01833026|Albuterol|albuterol|mesh-list
25679048|NCT01833026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25679049|NCT01833026|Autonomic Agents|autonomic agents|mesh-ancestor
25679050|NCT01833026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25679051|NCT01833026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679052|NCT01833026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25679053|NCT01833026|Respiratory System Agents|respiratory system agents|mesh-ancestor
24968967|NCT03746652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24968968|NCT03746652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968969|NCT03746444|Anesthetics|anesthetics|mesh-list
24968970|NCT03746444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24968971|NCT03746444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968972|NCT03746366|Corticosterone|corticosterone|mesh-list
24968973|NCT03746366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24968974|NCT03746340|Propofol|propofol|mesh-list
24624517|NCT01076582|Hormones|hormones|mesh-ancestor
24968975|NCT03746340|Sevoflurane|sevoflurane|mesh-list
24968976|NCT03746340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24968977|NCT03746340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24968978|NCT03746340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734718|NCT01653457|Memantine|memantine|mesh-list
24793918|NCT00240916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793920|NCT00103038|Hematinics|hematinics|mesh-ancestor
24793921|NCT00103038|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24793922|NCT00103038|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24793923|NCT05415150|Fibrinolytic Agents|fibrinolytic agents|mesh-list
24793924|NCT05415150|Eptifibatide|eptifibatide|mesh-list
24793925|NCT05415150|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24793926|NCT05415150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24793927|NCT05415150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793928|NCT05414942|Analgesics, Opioid|analgesics, opioid|mesh-list
24793929|NCT05414942|Narcotics|narcotics|mesh-ancestor
24793930|NCT05414942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24793931|NCT05414942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793932|NCT05414942|Analgesics|analgesics|mesh-ancestor
24793933|NCT05414942|Sensory System Agents|sensory system agents|mesh-ancestor
24793934|NCT05414942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24968979|NCT03746340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24968985|NCT03746327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24968986|NCT03746327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24968987|NCT03746249|Lenvatinib|lenvatinib|mesh-list
24968988|NCT03746249|Antibodies|antibodies|mesh-list
24968989|NCT03746249|Immunoglobulins|immunoglobulins|mesh-list
24968990|NCT03746249|Immunologic Factors|immunologic factors|mesh-ancestor
24968991|NCT03746249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968992|NCT03746249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24968993|NCT03746249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24968994|NCT03746249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24968995|NCT03746249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968996|NCT03746223|Rituximab|rituximab|mesh-list
24968997|NCT03746223|Methotrexate|methotrexate|mesh-list
24968998|NCT03746223|Lenalidomide|lenalidomide|mesh-list
24968999|NCT03746223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24969000|NCT03746223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24969001|NCT03746223|Immunologic Factors|immunologic factors|mesh-ancestor
25214727|NCT02695810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25214728|NCT02695810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214729|NCT02695810|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25214730|NCT02695810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830430|NCT02159196|Adrenergic Agents|adrenergic agents|mesh-ancestor
24830431|NCT02159196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24830432|NCT02159248|Gemcitabine|gemcitabine|mesh-list
24830433|NCT02159248|Tolfenamic acid|tolfenamic acid|mesh-list
24830434|NCT02159248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24830435|NCT02159248|Antimetabolites|antimetabolites|mesh-ancestor
24830436|NCT02159248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830437|NCT02159248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24830438|NCT02159248|Antiviral Agents|antiviral agents|mesh-ancestor
24830439|NCT02159248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24830440|NCT02159248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830441|NCT02159248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24830442|NCT02159248|Immunologic Factors|immunologic factors|mesh-ancestor
24830443|NCT02159248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264210|NCT02441907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24969002|NCT03746223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969003|NCT03746223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24969004|NCT03746223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24969005|NCT03746223|Abortifacient Agents|abortifacient agents|mesh-ancestor
24969006|NCT03746223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24969007|NCT03746223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24969008|NCT03746223|Antimetabolites|antimetabolites|mesh-ancestor
24969009|NCT03746223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969010|NCT03746223|Dermatologic Agents|dermatologic agents|mesh-ancestor
24969011|NCT03746223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24969012|NCT03746223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24969013|NCT03746223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24969014|NCT03746223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24969015|NCT03746223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24969016|NCT03746223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24969017|NCT03746223|Growth Substances|growth substances|mesh-ancestor
24969018|NCT03746223|Growth Inhibitors|growth inhibitors|mesh-ancestor
24969019|NCT03746158|Curcumin|curcumin|mesh-list
24969027|NCT03746158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24969028|NCT03746158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24969029|NCT03746158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24969030|NCT03746158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969032|NCT03746119|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24969033|NCT03746119|Autonomic Agents|autonomic agents|mesh-ancestor
24969034|NCT03746119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25214732|NCT02695797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25214733|NCT02695797|Glucocorticoids|glucocorticoids|mesh-ancestor
25214734|NCT02695797|Hormones|hormones|mesh-ancestor
25214735|NCT02695797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25214736|NCT02695797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214737|NCT02695797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25214738|NCT02695797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25214739|NCT02695654|Clonidine|clonidine|mesh-list
25214740|NCT02695654|Levobupivacaine|levobupivacaine|mesh-list
25214741|NCT02695654|Analgesics|analgesics|mesh-ancestor
25214742|NCT02695654|Sensory System Agents|sensory system agents|mesh-ancestor
25214743|NCT02695654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25214744|NCT02695654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214745|NCT02695654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25214746|NCT02695654|Sympatholytics|sympatholytics|mesh-ancestor
25214747|NCT02695654|Autonomic Agents|autonomic agents|mesh-ancestor
25214748|NCT02695654|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25214749|NCT02695654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25214750|NCT02695654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25214751|NCT02695654|Adrenergic Agents|adrenergic agents|mesh-ancestor
25214752|NCT02695654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25214753|NCT02695654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214754|NCT02695654|Anesthetics, Local|anesthetics, local|mesh-ancestor
24948600|NCT03918499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24948601|NCT03918265|Tacrolimus|tacrolimus|mesh-list
24948602|NCT03918265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24948603|NCT03918265|Immunologic Factors|immunologic factors|mesh-ancestor
24773892|NCT01842672|Mitoxantrone|mitoxantrone|mesh-list
25214755|NCT02695654|Anesthetics|anesthetics|mesh-ancestor
25214756|NCT02695654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25214757|NCT02695771|Gemcitabine|gemcitabine|mesh-list
25214758|NCT02695771|Mitomycins|mitomycins|mesh-list
25214759|NCT02695771|Mitomycin|mitomycin|mesh-list
25214760|NCT02695771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24948614|NCT03918187|Midazolam|midazolam|mesh-list
25679054|NCT01833026|Tocolytic Agents|tocolytic agents|mesh-ancestor
25264233|NCT02441842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25264234|NCT02441894|Diphenhydramine|diphenhydramine|mesh-list
25264235|NCT02441894|Promethazine|promethazine|mesh-list
24612146|NCT01012193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612147|NCT01012193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24448894|NCT00313521|Thiotepa|thiotepa|mesh-list
24692222|NCT01412073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24692223|NCT01412073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948615|NCT03918187|Nalbuphine|nalbuphine|mesh-list
24969035|NCT03746119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969036|NCT03746119|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24969037|NCT03746119|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24969038|NCT03746119|Cholinergic Agents|cholinergic agents|mesh-ancestor
24969039|NCT03746119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24969040|NCT03746119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969041|NCT03746106|Thiamine|thiamine|mesh-list
24969042|NCT03746106|Metformin|metformin|mesh-list
24969043|NCT03746106|Trimethoprim|trimethoprim|mesh-list
24969044|NCT03746106|Vitamins|vitamins|mesh-ancestor
24969045|NCT03746106|Micronutrients|micronutrients|mesh-ancestor
24969046|NCT03746106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969047|NCT03746106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24969048|NCT03746106|Vitamin B Complex|vitamin b complex|mesh-ancestor
24498636|NCT00515736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498637|NCT00515736|Protective Agents|protective agents|mesh-ancestor
24498638|NCT00515736|Vitamin B Complex|vitamin b complex|mesh-ancestor
24498639|NCT00515788|Cytarabine|cytarabine|mesh-list
24498640|NCT00515788|Temozolomide|temozolomide|mesh-list
24498641|NCT00515788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24498642|NCT00515788|Antimetabolites|antimetabolites|mesh-ancestor
24498643|NCT00515788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498644|NCT00515788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498645|NCT00515788|Antiviral Agents|antiviral agents|mesh-ancestor
24498646|NCT00515788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24498647|NCT00515788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24498648|NCT00515788|Immunologic Factors|immunologic factors|mesh-ancestor
24498649|NCT00515788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498650|NCT00515788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24498651|NCT00515788|Alkylating Agents|alkylating agents|mesh-ancestor
24498710|NCT00516009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24498712|NCT00516100|Pemetrexed|pemetrexed|mesh-list
24498713|NCT00516100|Bortezomib|bortezomib|mesh-list
24498714|NCT00516100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24969049|NCT03746106|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25214761|NCT02695771|Antimetabolites|antimetabolites|mesh-ancestor
25214762|NCT02695771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214763|NCT02695771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25214764|NCT02695771|Antiviral Agents|antiviral agents|mesh-ancestor
25214765|NCT02695771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25214766|NCT02695771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25214767|NCT02695771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25214768|NCT02695771|Immunologic Factors|immunologic factors|mesh-ancestor
25214769|NCT02695771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214770|NCT02695771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25214771|NCT02695771|Alkylating Agents|alkylating agents|mesh-ancestor
25214772|NCT02695771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25214773|NCT02695862|Terlipressin|terlipressin|mesh-list
25214774|NCT02695862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25214775|NCT02695862|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25679055|NCT01833026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25679056|NCT01833026|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25679057|NCT01833026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25679058|NCT01833026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25679059|NCT01833026|Adrenergic Agents|adrenergic agents|mesh-ancestor
25679060|NCT01833026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25679061|NCT01833026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679062|NCT01833130|Botulinum Toxins|botulinum toxins|mesh-list
25679063|NCT01833130|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25679064|NCT01833130|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24830445|NCT02159248|Sensory System Agents|sensory system agents|mesh-ancestor
24830446|NCT02159248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24830447|NCT02159248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24628263|NCT01097551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24628264|NCT01097551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24628265|NCT01097551|Adrenergic Agents|adrenergic agents|mesh-ancestor
24628266|NCT01097551|Protective Agents|protective agents|mesh-ancestor
24628267|NCT01097681|Ipragliflozin|ipragliflozin|mesh-list
24628268|NCT01097681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24628269|NCT01097681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628270|NCT01097681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24628271|NCT01097681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628272|NCT01097811|Erythromycin|erythromycin|mesh-list
24628273|NCT01097811|Erythromycin Estolate|erythromycin estolate|mesh-list
24628274|NCT01097811|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24628275|NCT01097811|Erythromycin stearate|erythromycin stearate|mesh-list
24628276|NCT01097811|Neomycin|neomycin|mesh-list
25082880|NCT03319238|Sensory System Agents|sensory system agents|mesh-ancestor
25214776|NCT02695758|Bupivacaine|bupivacaine|mesh-list
25214777|NCT02695758|Anesthetics, Local|anesthetics, local|mesh-ancestor
25214778|NCT02695758|Anesthetics|anesthetics|mesh-ancestor
25214779|NCT02695758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25214780|NCT02695758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214781|NCT02695758|Sensory System Agents|sensory system agents|mesh-ancestor
25214782|NCT02695758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25214786|NCT02695459|Cisplatin|cisplatin|mesh-list
25214787|NCT02695459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25214788|NCT02695459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25214789|NCT02695459|Immunologic Factors|immunologic factors|mesh-ancestor
25214790|NCT02695459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214791|NCT02695641|Bevacizumab|bevacizumab|mesh-list
25214792|NCT02695641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25214793|NCT02695641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25214794|NCT02695641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25214795|NCT02695641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25214796|NCT02695641|Growth Substances|growth substances|mesh-ancestor
25214797|NCT02695641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214798|NCT02695641|Growth Inhibitors|growth inhibitors|mesh-ancestor
25214799|NCT02695745|Celecoxib|celecoxib|mesh-list
25214800|NCT02695745|Capsaicin|capsaicin|mesh-list
25214801|NCT02695745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25214802|NCT02695745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25214804|NCT02695745|Sensory System Agents|sensory system agents|mesh-ancestor
25214805|NCT02695745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082891|NCT03319238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082892|NCT03319121|Theophylline|theophylline|mesh-list
25082893|NCT03319121|Dexlansoprazole|dexlansoprazole|mesh-list
25082894|NCT03319121|Lansoprazole|lansoprazole|mesh-list
25082895|NCT03319121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25082896|NCT03319121|Autonomic Agents|autonomic agents|mesh-ancestor
25082905|NCT03319121|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24455513|NCT00327665|Vaccines|vaccines|mesh-list
25082906|NCT03319121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25082907|NCT03319121|Purinergic Agents|purinergic agents|mesh-ancestor
25082908|NCT03319121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25082909|NCT03319121|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25082910|NCT03319121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25082911|NCT03319121|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25082913|NCT03319043|Formoterol Fumarate|formoterol fumarate|mesh-list
25082914|NCT03319043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25082915|NCT03319043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25082916|NCT03319043|Autonomic Agents|autonomic agents|mesh-ancestor
25082917|NCT03319043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082918|NCT03319043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082919|NCT03319043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25082920|NCT03319043|Respiratory System Agents|respiratory system agents|mesh-ancestor
25082921|NCT03319043|Glucocorticoids|glucocorticoids|mesh-ancestor
25082923|NCT03319043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25082924|NCT03319043|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24805895|NCT02012595|Donepezil|donepezil|mesh-list
25082925|NCT03319043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25082926|NCT03319043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25082927|NCT03319043|Adrenergic Agents|adrenergic agents|mesh-ancestor
25082928|NCT03319043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25082929|NCT03319043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082930|NCT03318887|Ribavirin|ribavirin|mesh-list
25082931|NCT03318887|Sofosbuvir|sofosbuvir|mesh-list
25082932|NCT03318887|Antimetabolites|antimetabolites|mesh-ancestor
25082933|NCT03318887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082934|NCT03318887|Antiviral Agents|antiviral agents|mesh-ancestor
24498715|NCT00516100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498716|NCT00516100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498782|NCT00516282|Temozolomide|temozolomide|mesh-list
24498875|NCT00516711|Anesthetics, General|anesthetics, general|mesh-ancestor
24498876|NCT00516711|Anesthetics|anesthetics|mesh-ancestor
24498877|NCT00516711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25082935|NCT03318887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25082936|NCT03318835|Thalidomide|thalidomide|mesh-list
25082937|NCT03318835|Prednisone|prednisone|mesh-list
25082938|NCT03318835|Cyclophosphamide|cyclophosphamide|mesh-list
25082939|NCT03318835|Vincristine|vincristine|mesh-list
24955135|NCT03867994|Antimetabolites|antimetabolites|mesh-ancestor
24969050|NCT03746106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24969051|NCT03746106|Renal Agents|renal agents|mesh-ancestor
24969052|NCT03746106|Antimalarials|antimalarials|mesh-ancestor
24969054|NCT03746106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24498884|NCT00516750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24498885|NCT00516750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24498886|NCT00516750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24498887|NCT00516750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498888|NCT00516750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498889|NCT00516750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24498890|NCT00516750|Abortifacient Agents|abortifacient agents|mesh-ancestor
24498891|NCT00516750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25214806|NCT02695745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214807|NCT02695745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25214808|NCT02695745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24830469|NCT02159313|Enzyme Activators|enzyme activators|mesh-ancestor
24830470|NCT02159313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498892|NCT00516750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498893|NCT00516750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24498894|NCT00516750|Antimetabolites|antimetabolites|mesh-ancestor
24498895|NCT00516750|Dermatologic Agents|dermatologic agents|mesh-ancestor
24969072|NCT03745807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969073|NCT03745664|Methylprednisolone|methylprednisolone|mesh-list
24969074|NCT03745664|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24969075|NCT03745664|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24969076|NCT03745664|Prednisolone|prednisolone|mesh-list
24969077|NCT03745664|Prednisolone acetate|prednisolone acetate|mesh-list
24969078|NCT03745664|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24969079|NCT03745664|Prednisolone phosphate|prednisolone phosphate|mesh-list
24969080|NCT03745664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24969081|NCT03745664|Antiemetics|antiemetics|mesh-ancestor
24969082|NCT03745664|Autonomic Agents|autonomic agents|mesh-ancestor
24969083|NCT03745664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969084|NCT03745664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969094|NCT03745625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24969095|NCT03745625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24969096|NCT03745625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969097|NCT03745625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24969098|NCT03745625|Anesthetics, General|anesthetics, general|mesh-ancestor
24969099|NCT03745625|Anesthetics|anesthetics|mesh-ancestor
24969100|NCT03745599|Diclofenac|diclofenac|mesh-list
24969101|NCT03745599|Flurbiprofen|flurbiprofen|mesh-list
24969102|NCT03745599|Benzydamine|benzydamine|mesh-list
24969103|NCT03745599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24969104|NCT03745599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24969105|NCT03745599|Analgesics|analgesics|mesh-ancestor
24969106|NCT03745599|Sensory System Agents|sensory system agents|mesh-ancestor
24498896|NCT00516750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24498897|NCT00516750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24498898|NCT00516750|Immunologic Factors|immunologic factors|mesh-ancestor
24498922|NCT00516828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498923|NCT00516841|Volociximab|volociximab|mesh-list
24969107|NCT03745599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969108|NCT03745599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969109|NCT03745599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24969110|NCT03745599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24969111|NCT03745599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24969112|NCT03745599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24969113|NCT03745599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969114|NCT03745586|Glucocorticoids|glucocorticoids|mesh-list
24969115|NCT03745586|Hormones|hormones|mesh-ancestor
24969116|NCT03745586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24969117|NCT03745586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969118|NCT03745404|Lidocaine|lidocaine|mesh-list
24969119|NCT03745404|Anesthetics, Local|anesthetics, local|mesh-ancestor
24927451|NCT04132583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498924|NCT00516841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24498925|NCT00516841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24498962|NCT00516958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24498963|NCT00516958|Renal Agents|renal agents|mesh-ancestor
24498964|NCT00516958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24498965|NCT00516958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24498966|NCT00516958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25214809|NCT02695745|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25214810|NCT02695745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25214811|NCT02695745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25214812|NCT02695745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214813|NCT02695745|Antipruritics|antipruritics|mesh-ancestor
25214814|NCT02695745|Dermatologic Agents|dermatologic agents|mesh-ancestor
25214815|NCT02695732|Carvedilol|carvedilol|mesh-list
25214816|NCT02695732|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25214817|NCT02695732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24948660|NCT03918135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498967|NCT00516958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498968|NCT00516958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498969|NCT00516958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498970|NCT00516958|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24498971|NCT00516958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24498972|NCT00516958|Disinfectants|disinfectants|mesh-ancestor
24498973|NCT00516971|Esomeprazole|esomeprazole|mesh-list
24498974|NCT00516971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24455591|NCT00327925|Immunologic Factors|immunologic factors|mesh-ancestor
24498975|NCT00516971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24498976|NCT00516971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24499113|NCT00517764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499114|NCT00517764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24499115|NCT00517764|Serotonin Agents|serotonin agents|mesh-ancestor
24499118|NCT00517764|Antidepressive Agents|antidepressive agents|mesh-ancestor
24499120|NCT00517803|Micronutrients|micronutrients|mesh-list
24499121|NCT00517803|Trace Elements|trace elements|mesh-list
24499176|NCT00518141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24969121|NCT03745404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24969122|NCT03745404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969123|NCT03745404|Sensory System Agents|sensory system agents|mesh-ancestor
24628298|NCT01097980|Trazodone|trazodone|mesh-list
24969124|NCT03745404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969125|NCT03745404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24969126|NCT03745404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24969127|NCT03745404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24969128|NCT03745404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24969129|NCT03745404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969130|NCT03745300|Atorvastatin|atorvastatin|mesh-list
24969131|NCT03745300|Simvastatin|simvastatin|mesh-list
24969132|NCT03745300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24969133|NCT03745300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24969134|NCT03745300|Antimetabolites|antimetabolites|mesh-ancestor
24969135|NCT03745300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969136|NCT03745300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24927464|NCT04132479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927468|NCT04132479|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24499177|NCT00518141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24499283|NCT00518583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24499284|NCT00518583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24499285|NCT00518583|Tubulin Modulators|tubulin modulators|mesh-ancestor
24499286|NCT00518583|Antimitotic Agents|antimitotic agents|mesh-ancestor
24499287|NCT00518583|Mitosis Modulators|mitosis modulators|mesh-ancestor
24499288|NCT00518583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499289|NCT00518583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24499290|NCT00518583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24499291|NCT00518583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24499292|NCT00518583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499294|NCT00518635|Hormones|hormones|mesh-list
24499347|NCT00519051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24499412|NCT00519259|Respiratory System Agents|respiratory system agents|mesh-ancestor
24499414|NCT00519298|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25214818|NCT02695732|Adrenergic Agents|adrenergic agents|mesh-ancestor
25214819|NCT02695732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25214820|NCT02695732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214821|NCT02695732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214822|NCT02695732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25214824|NCT02695732|Protective Agents|protective agents|mesh-ancestor
25214825|NCT02695732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25214826|NCT02695732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24969137|NCT03745300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24499504|NCT00519805|Dalteparin|dalteparin|mesh-list
24499505|NCT00519805|Tinzaparin|tinzaparin|mesh-list
24499506|NCT00519805|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24499507|NCT00519805|Anticoagulants|anticoagulants|mesh-ancestor
24499508|NCT00519805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24499509|NCT00519805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24499605|NCT00520169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24499606|NCT00520169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24499612|NCT00520247|Vitamins|vitamins|mesh-ancestor
24499613|NCT00520247|Micronutrients|micronutrients|mesh-ancestor
24499614|NCT00520247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499615|NCT00520247|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24499616|NCT00520247|Protease Inhibitors|protease inhibitors|mesh-ancestor
24499633|NCT00520325|Lectins|lectins|mesh-list
24499779|NCT00521092|Growth Substances|growth substances|mesh-ancestor
24499780|NCT00521092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499781|NCT00521092|Growth Inhibitors|growth inhibitors|mesh-ancestor
24499782|NCT00521092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24499783|NCT00521092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499823|NCT00521222|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24499824|NCT00521222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24499825|NCT00521222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24499826|NCT00521222|Adrenergic Agents|adrenergic agents|mesh-ancestor
24499827|NCT00521222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24499828|NCT00521222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499829|NCT00521222|Glucocorticoids|glucocorticoids|mesh-ancestor
24499830|NCT00521222|Hormones|hormones|mesh-ancestor
24499832|NCT00521222|Sympathomimetics|sympathomimetics|mesh-ancestor
24499840|NCT00521248|Sensory System Agents|sensory system agents|mesh-ancestor
25214827|NCT02695732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24948668|NCT03917940|Immunologic Factors|immunologic factors|mesh-ancestor
24499841|NCT00521248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24499842|NCT00521248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24499844|NCT00521261|Antibodies, Bispecific|antibodies, bispecific|mesh-list
24499882|NCT00521430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24499883|NCT00521430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24499884|NCT00521430|Antiemetics|antiemetics|mesh-ancestor
24793973|NCT05414721|Desflurane|desflurane|mesh-list
24793974|NCT05414721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24793975|NCT05414721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793976|NCT05414721|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24793977|NCT05414721|Anesthetics, General|anesthetics, general|mesh-ancestor
24793978|NCT05414669|Allopurinol|allopurinol|mesh-list
24793979|NCT05414669|Antimetabolites|antimetabolites|mesh-ancestor
24793980|NCT05414669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793981|NCT05414669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24793982|NCT05414669|Gout Suppressants|gout suppressants|mesh-ancestor
24793983|NCT05414669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24793984|NCT05414669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24793985|NCT05414669|Antioxidants|antioxidants|mesh-ancestor
24793986|NCT05414669|Protective Agents|protective agents|mesh-ancestor
25082940|NCT03318835|Rituximab|rituximab|mesh-list
24628299|NCT01097980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24793987|NCT05414669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907005|NCT04334512|Vitamin D|vitamin d|mesh-list
24969154|NCT03745261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24969155|NCT03745261|Parasympatholytics|parasympatholytics|mesh-ancestor
24624549|NCT01076673|Hyaluronic Acid|hyaluronic acid|mesh-list
24538327|NCT00658892|Antibodies|antibodies|mesh-list
24499892|NCT00521430|Protective Agents|protective agents|mesh-ancestor
24499893|NCT00521430|Alkylating Agents|alkylating agents|mesh-ancestor
24499945|NCT00521781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24499947|NCT00521781|Bicalutamide|bicalutamide|mesh-list
24499948|NCT00521781|Androgen Antagonists|androgen antagonists|mesh-list
24499949|NCT00521781|Androgens|androgens|mesh-list
24499950|NCT00521781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24499951|NCT00521781|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24499952|NCT00521781|Fertility Agents|fertility agents|mesh-ancestor
24499953|NCT00521781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24499954|NCT00521781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499955|NCT00521781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24499956|NCT00521781|Hormone Antagonists|hormone antagonists|mesh-ancestor
24499957|NCT00521781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24499958|NCT00521781|Hormones|hormones|mesh-ancestor
24499959|NCT00521820|Pioglitazone|pioglitazone|mesh-list
24499964|NCT00521859|Fludarabine|fludarabine|mesh-list
24499965|NCT00521859|Fludarabine phosphate|fludarabine phosphate|mesh-list
24499966|NCT00521859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24969156|NCT03745261|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24969157|NCT03745261|Cholinergic Agents|cholinergic agents|mesh-ancestor
24969158|NCT03745261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24969159|NCT03745261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969160|NCT03745261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24969161|NCT03745261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24969162|NCT03745261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24969163|NCT03745261|Adrenergic Agents|adrenergic agents|mesh-ancestor
24969164|NCT03745261|Anticonvulsants|anticonvulsants|mesh-ancestor
24969165|NCT03745261|Tocolytic Agents|tocolytic agents|mesh-ancestor
24969166|NCT03745261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24969167|NCT03745261|Glucocorticoids|glucocorticoids|mesh-ancestor
24969168|NCT03745261|Hormones|hormones|mesh-ancestor
24969169|NCT03745261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24969170|NCT03745261|Sympathomimetics|sympathomimetics|mesh-ancestor
24969181|NCT03745105|Dexamethasone|dexamethasone|mesh-list
25214828|NCT02695732|Vasodilator Agents|vasodilator agents|mesh-ancestor
24969182|NCT03745105|Dexamethasone acetate|dexamethasone acetate|mesh-list
24969183|NCT03745105|Piroxicam|piroxicam|mesh-list
24948669|NCT03917784|Curcumin|curcumin|mesh-list
24969184|NCT03745105|Mepivacaine|mepivacaine|mesh-list
24969185|NCT03745105|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24969186|NCT03745105|BB 1101|bb 1101|mesh-list
24500024|NCT00522184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24500058|NCT00522444|Anesthetics|anesthetics|mesh-ancestor
24500059|NCT00522444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24500060|NCT00522444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24500061|NCT00522444|Anticonvulsants|anticonvulsants|mesh-ancestor
24500062|NCT00522444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24500066|NCT00522444|Tocolytic Agents|tocolytic agents|mesh-ancestor
24500067|NCT00522444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24500068|NCT00522470|Rosiglitazone|rosiglitazone|mesh-list
24500069|NCT00522470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24969187|NCT03745105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24969189|NCT03745105|Autonomic Agents|autonomic agents|mesh-ancestor
24969190|NCT03745105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969191|NCT03745105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969192|NCT03745105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24969193|NCT03745105|Glucocorticoids|glucocorticoids|mesh-ancestor
24969194|NCT03745105|Hormones|hormones|mesh-ancestor
24969195|NCT03745105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24969196|NCT03745105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24969197|NCT03745105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24969198|NCT03745105|Anesthetics, Local|anesthetics, local|mesh-ancestor
24969199|NCT03745105|Anesthetics|anesthetics|mesh-ancestor
24969200|NCT03745105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24969201|NCT03745105|Sensory System Agents|sensory system agents|mesh-ancestor
24969202|NCT03745105|Protease Inhibitors|protease inhibitors|mesh-ancestor
24969203|NCT03745105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24969204|NCT03745105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969205|NCT03745105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24969206|NCT03745105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24969207|NCT03745105|Analgesics|analgesics|mesh-ancestor
24969210|NCT03745040|Bupivacaine|bupivacaine|mesh-list
24969211|NCT03745040|Anesthetics, Local|anesthetics, local|mesh-ancestor
24500070|NCT00522470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500071|NCT00522509|Floxuridine|floxuridine|mesh-list
24500072|NCT00522509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24500073|NCT00522509|Antimetabolites|antimetabolites|mesh-ancestor
24500122|NCT00522782|Antioxidants|antioxidants|mesh-ancestor
24500123|NCT00522782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500124|NCT00522782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24500125|NCT00522782|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24500126|NCT00522782|Vasodilator Agents|vasodilator agents|mesh-ancestor
24500127|NCT00522782|Gasotransmitters|gasotransmitters|mesh-ancestor
24500128|NCT00522782|Protective Agents|protective agents|mesh-ancestor
24500143|NCT00522938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24969216|NCT03745040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969219|NCT03744988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24969220|NCT03744988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907023|NCT04334382|Azithromycin|azithromycin|mesh-list
24969221|NCT03744949|Remifentanil|remifentanil|mesh-list
25082941|NCT03318835|Doxorubicin|doxorubicin|mesh-list
24969222|NCT03744949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24969223|NCT03744949|Narcotics|narcotics|mesh-ancestor
24538539|NCT00659750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24969224|NCT03744949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24969225|NCT03744949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969226|NCT03744949|Analgesics|analgesics|mesh-ancestor
24969227|NCT03744949|Sensory System Agents|sensory system agents|mesh-ancestor
25214829|NCT02695732|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25214830|NCT02695732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25157993|NCT04537598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500261|NCT00523445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24500262|NCT00523445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24500263|NCT00523445|Cholinergic Agents|cholinergic agents|mesh-ancestor
24500264|NCT00523445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24500265|NCT00523445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500266|NCT00523445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969232|NCT03744806|Bevacizumab|bevacizumab|mesh-list
24969233|NCT03744806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24969234|NCT03744806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24969235|NCT03744806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24969236|NCT03744806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24969237|NCT03744806|Growth Substances|growth substances|mesh-ancestor
24969238|NCT03744806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969239|NCT03744806|Growth Inhibitors|growth inhibitors|mesh-ancestor
24451358|NCT00323323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24969240|NCT03744767|Spironolactone|spironolactone|mesh-list
24969241|NCT03744767|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24969242|NCT03744767|Hormone Antagonists|hormone antagonists|mesh-ancestor
24969243|NCT03744767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24969244|NCT03744767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969245|NCT03744767|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24969246|NCT03744767|Diuretics|diuretics|mesh-ancestor
24969247|NCT03744767|Natriuretic Agents|natriuretic agents|mesh-ancestor
24969248|NCT03744702|Ascorbic Acid|ascorbic acid|mesh-list
24969249|NCT03744702|Antioxidants|antioxidants|mesh-ancestor
24969250|NCT03744702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969251|NCT03744702|Protective Agents|protective agents|mesh-ancestor
24969252|NCT03744702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969253|NCT03744702|Vitamins|vitamins|mesh-ancestor
24969254|NCT03744702|Micronutrients|micronutrients|mesh-ancestor
24969255|NCT03744689|Bupivacaine|bupivacaine|mesh-list
24969256|NCT03744689|Anesthetics, Local|anesthetics, local|mesh-ancestor
24969257|NCT03744689|Anesthetics|anesthetics|mesh-ancestor
24969258|NCT03744689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24969259|NCT03744689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969260|NCT03744689|Sensory System Agents|sensory system agents|mesh-ancestor
24969261|NCT03744689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969262|NCT03744364|Misoprostol|misoprostol|mesh-list
24969263|NCT03744364|Dinoprostone|dinoprostone|mesh-list
24969264|NCT03744364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24969265|NCT03744364|Abortifacient Agents|abortifacient agents|mesh-ancestor
24969266|NCT03744364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24969267|NCT03744364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969268|NCT03744364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24969269|NCT03744364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24969271|NCT03744247|Lenvatinib|lenvatinib|mesh-list
24969272|NCT03744247|Antibodies|antibodies|mesh-list
24969273|NCT03744247|Immunoglobulins|immunoglobulins|mesh-list
24969274|NCT03744247|Immunologic Factors|immunologic factors|mesh-ancestor
25214831|NCT02695381|Etodolac|etodolac|mesh-list
25214832|NCT02695381|Lidocaine|lidocaine|mesh-list
25214833|NCT02695381|Anesthetics, Local|anesthetics, local|mesh-ancestor
25214834|NCT02695381|Anesthetics|anesthetics|mesh-ancestor
25041870|NCT01573351|Protease Inhibitors|protease inhibitors|mesh-ancestor
25041871|NCT01573351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24969275|NCT03744247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969276|NCT03744247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24969277|NCT03744247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24969278|NCT03744247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451359|NCT00323323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852585|NCT02262936|Fesoterodine|fesoterodine|mesh-list
24969279|NCT03744247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969280|NCT03744208|Antibodies|antibodies|mesh-list
24969281|NCT03744208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24969282|NCT03744208|Immunologic Factors|immunologic factors|mesh-ancestor
24969283|NCT03744208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969284|NCT03744104|Vaccines|vaccines|mesh-list
24969285|NCT03744104|Immunologic Factors|immunologic factors|mesh-ancestor
24735550|NCT01657578|Omeprazole|omeprazole|mesh-list
24806291|NCT02014753|Immunologic Factors|immunologic factors|mesh-ancestor
24806292|NCT02014753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806293|NCT02014753|Trace Elements|trace elements|mesh-ancestor
24806294|NCT02014753|Micronutrients|micronutrients|mesh-ancestor
24601092|NCT00962637|Hormones|hormones|mesh-ancestor
24628303|NCT01097980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24628304|NCT01097980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24628305|NCT01097980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24663148|NCT01298466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24628306|NCT01097980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24628307|NCT01097980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628308|NCT01097980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24628309|NCT01097980|Serotonin Agents|serotonin agents|mesh-ancestor
24628310|NCT01097980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24628311|NCT01097980|Antidepressive Agents|antidepressive agents|mesh-ancestor
24805764|NCT02012062|Nimotuzumab|nimotuzumab|mesh-list
25082942|NCT03318835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24538731|NCT00660621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538732|NCT00660621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24538733|NCT00660621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24538734|NCT00660621|Growth Substances|growth substances|mesh-ancestor
24500424|NCT00524186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500470|NCT00524524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24500471|NCT00524524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25082943|NCT03318835|Immunologic Factors|immunologic factors|mesh-ancestor
25082944|NCT03318835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082945|NCT03318835|Leprostatic Agents|leprostatic agents|mesh-ancestor
25082946|NCT03318835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25082947|NCT03318835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25082948|NCT03318835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25082949|NCT03318835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25082950|NCT03318835|Growth Substances|growth substances|mesh-ancestor
25082951|NCT03318835|Growth Inhibitors|growth inhibitors|mesh-ancestor
25214835|NCT02695381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25214836|NCT02695381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214837|NCT02695381|Sensory System Agents|sensory system agents|mesh-ancestor
25214838|NCT02695381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25041874|NCT01567904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25041875|NCT01567904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082952|NCT03318835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25082953|NCT03318835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25082959|NCT03318835|Glucocorticoids|glucocorticoids|mesh-ancestor
25082960|NCT03318835|Hormones|hormones|mesh-ancestor
25082962|NCT03318835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25082963|NCT03318835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25082964|NCT03318835|Tubulin Modulators|tubulin modulators|mesh-ancestor
25082965|NCT03318835|Antimitotic Agents|antimitotic agents|mesh-ancestor
25082966|NCT03318835|Mitosis Modulators|mitosis modulators|mesh-ancestor
25082967|NCT03318835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25082968|NCT03318835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25082969|NCT03318835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25082970|NCT03318835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25082971|NCT03318835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24500472|NCT00524524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24500473|NCT00524524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24500474|NCT00524524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500475|NCT00524524|Antiviral Agents|antiviral agents|mesh-ancestor
24500476|NCT00524615|Spironolactone|spironolactone|mesh-list
25082973|NCT03318770|Blinatumomab|blinatumomab|mesh-list
25082974|NCT03318770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25082975|NCT03318770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25082976|NCT03318770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25082977|NCT03318770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969298|NCT03744091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969300|NCT03744091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24969302|NCT03743987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24969303|NCT03743987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24969304|NCT03743987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969306|NCT03743987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24969307|NCT03743922|Ergocalciferols|ergocalciferols|mesh-list
24500602|NCT00525200|Antimetabolites|antimetabolites|mesh-ancestor
24500620|NCT00525239|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24500621|NCT00525239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24500622|NCT00525239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24500623|NCT00525239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24500624|NCT00525239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25214839|NCT02695381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25214840|NCT02695381|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25214841|NCT02695381|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25214842|NCT02695381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25041878|NCT01567059|Azacitidine|azacitidine|mesh-list
25041879|NCT01567059|Tosedostat|tosedostat|mesh-list
25041880|NCT01567059|Glycine|glycine|mesh-list
25041881|NCT01567059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25041882|NCT01567059|Antimetabolites|antimetabolites|mesh-ancestor
25041884|NCT01567059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25157994|NCT04537598|Analgesics|analgesics|mesh-ancestor
24500756|NCT00525642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24500757|NCT00525642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24500758|NCT00525642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24500759|NCT00525642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24500760|NCT00525668|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24969308|NCT03743922|Cholecalciferol|cholecalciferol|mesh-list
24969309|NCT03743922|Vitamin D|vitamin d|mesh-list
24969310|NCT03743922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24969311|NCT03743922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969312|NCT03743922|Vitamins|vitamins|mesh-ancestor
24969313|NCT03743922|Micronutrients|micronutrients|mesh-ancestor
24969314|NCT03743922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24969315|NCT03743896|Capsaicin|capsaicin|mesh-list
24969316|NCT03743896|Antipruritics|antipruritics|mesh-ancestor
24969317|NCT03743896|Dermatologic Agents|dermatologic agents|mesh-ancestor
24969318|NCT03743896|Sensory System Agents|sensory system agents|mesh-ancestor
25214843|NCT02695381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214844|NCT02695381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25214845|NCT02695381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25214846|NCT02695381|Analgesics|analgesics|mesh-ancestor
25214847|NCT02695381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25214848|NCT02695381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25214849|NCT02695381|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25214850|NCT02695381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25214851|NCT02695381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25214852|NCT02695355|Methylphenidate|methylphenidate|mesh-list
25214853|NCT02695355|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25214854|NCT02695355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214855|NCT02695355|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25214856|NCT02695355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25214857|NCT02695355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25214858|NCT02695355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214859|NCT02695355|Dopamine Agents|dopamine agents|mesh-ancestor
25214860|NCT02695355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25214861|NCT02695212|Apremilast|apremilast|mesh-list
25214862|NCT02695212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25214863|NCT02695212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25214864|NCT02695212|Analgesics|analgesics|mesh-ancestor
25214865|NCT02695212|Sensory System Agents|sensory system agents|mesh-ancestor
24948705|NCT03917420|Tenofovir|tenofovir|mesh-list
24969319|NCT03743896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969320|NCT03743896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969321|NCT03743883|Aspirin|aspirin|mesh-list
24969322|NCT03743883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24969323|NCT03743883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24969324|NCT03743883|Analgesics|analgesics|mesh-ancestor
24969325|NCT03743883|Sensory System Agents|sensory system agents|mesh-ancestor
24969383|NCT03743649|GABA Agents|gaba agents|mesh-ancestor
24969328|NCT03743883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24969329|NCT03743883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24969331|NCT03743883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24969332|NCT03743883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969333|NCT03743883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24969334|NCT03743883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24969335|NCT03743883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24969336|NCT03743883|Antipyretics|antipyretics|mesh-ancestor
24969337|NCT03743870|Bupivacaine|bupivacaine|mesh-list
24969338|NCT03743870|Levobupivacaine|levobupivacaine|mesh-list
24969339|NCT03743870|Anesthetics, Local|anesthetics, local|mesh-ancestor
24500761|NCT00525668|Antioxidants|antioxidants|mesh-ancestor
24500762|NCT00525668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500763|NCT00525668|Protective Agents|protective agents|mesh-ancestor
24500764|NCT00525668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500765|NCT00525668|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24500766|NCT00525668|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24500767|NCT00525668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24500768|NCT00525668|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24500769|NCT00525681|Cyclosporine|cyclosporine|mesh-list
24500770|NCT00525681|Tacrolimus|tacrolimus|mesh-list
24969340|NCT03743870|Anesthetics|anesthetics|mesh-ancestor
24969341|NCT03743870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24969342|NCT03743870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969343|NCT03743870|Sensory System Agents|sensory system agents|mesh-ancestor
24969344|NCT03743870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969345|NCT03743805|Naloxone|naloxone|mesh-list
24969346|NCT03743805|Flumazenil|flumazenil|mesh-list
24793995|NCT05414474|Protective Agents|protective agents|mesh-ancestor
24793996|NCT05414474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793997|NCT05414474|Vitamins|vitamins|mesh-ancestor
24793998|NCT05414474|Micronutrients|micronutrients|mesh-ancestor
24624560|NCT01076790|Analgesics|analgesics|mesh-ancestor
24500795|NCT00525694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24500797|NCT00525707|Vasodilator Agents|vasodilator agents|mesh-ancestor
24500798|NCT00525759|Zoledronic Acid|zoledronic acid|mesh-list
24500799|NCT00525759|Cyclophosphamide|cyclophosphamide|mesh-list
24500801|NCT00525759|Fluorouracil|fluorouracil|mesh-list
24907131|NCT04332536|Codeine|codeine|mesh-list
24969368|NCT03743649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969369|NCT03743649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24969370|NCT03743649|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24969371|NCT03743649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24969372|NCT03743649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24969373|NCT03743649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24969374|NCT03743649|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25214866|NCT02695212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25214867|NCT02695212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948706|NCT03917420|Emtricitabine|emtricitabine|mesh-list
24969375|NCT03743649|Dopamine Agents|dopamine agents|mesh-ancestor
24969376|NCT03743649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24969377|NCT03743649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969378|NCT03743649|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24969379|NCT03743649|Anticonvulsants|anticonvulsants|mesh-ancestor
24969380|NCT03743649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24969381|NCT03743649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24969382|NCT03743649|GABA Modulators|gaba modulators|mesh-ancestor
24500815|NCT00525759|Antimetabolites|antimetabolites|mesh-ancestor
24500816|NCT00525759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24500817|NCT00525759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24500818|NCT00525759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24500819|NCT00525759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24969398|NCT03743285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969400|NCT03743259|Antidotes|antidotes|mesh-ancestor
24699965|NCT01449825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699967|NCT01449877|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24699968|NCT01449877|Sulfamethoxazole|sulfamethoxazole|mesh-list
24613068|NCT01016860|Irinotecan|irinotecan|mesh-list
24969401|NCT03743259|Protective Agents|protective agents|mesh-ancestor
24969402|NCT03743259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969403|NCT03743103|Nitroprusside|nitroprusside|mesh-list
24969404|NCT03743103|Esmolol|esmolol|mesh-list
24969405|NCT03743103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24969406|NCT03743103|Vasodilator Agents|vasodilator agents|mesh-ancestor
24969407|NCT03743103|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24969408|NCT03743103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969409|NCT03743103|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24969410|NCT03743103|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24969411|NCT03743103|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24969412|NCT03743103|Adrenergic Agents|adrenergic agents|mesh-ancestor
24969413|NCT03743103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24969414|NCT03743103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969418|NCT03742947|Hemostatics|hemostatics|mesh-list
24969419|NCT03742947|Coagulants|coagulants|mesh-ancestor
24969420|NCT03742921|Romidepsin|romidepsin|mesh-list
24969421|NCT03742921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24969422|NCT03742921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24969423|NCT03742908|Clindamycin|clindamycin|mesh-list
24969424|NCT03742908|Clindamycin palmitate|clindamycin palmitate|mesh-list
24969425|NCT03742908|Clindamycin phosphate|clindamycin phosphate|mesh-list
24969426|NCT03742908|Cefazolin|cefazolin|mesh-list
24969427|NCT03742908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24500845|NCT00525967|Methadone|methadone|mesh-list
24969439|NCT03742557|Analgesics|analgesics|mesh-ancestor
24969440|NCT03742557|Sensory System Agents|sensory system agents|mesh-ancestor
24969441|NCT03742557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969442|NCT03742557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969443|NCT03742557|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24969444|NCT03742557|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24969445|NCT03742557|Anesthetics, General|anesthetics, general|mesh-ancestor
24969446|NCT03742557|Anesthetics|anesthetics|mesh-ancestor
24969447|NCT03742557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24628312|NCT01098019|Botulinum Toxins|botulinum toxins|mesh-list
24969448|NCT03742557|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25214868|NCT02695212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24969449|NCT03742557|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24969465|NCT03742466|Autonomic Agents|autonomic agents|mesh-ancestor
24969466|NCT03742466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969467|NCT03742466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969468|NCT03742466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24969469|NCT03742466|Glucocorticoids|glucocorticoids|mesh-ancestor
24969470|NCT03742466|Hormones|hormones|mesh-ancestor
24500961|NCT00526305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24501017|NCT00526396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501019|NCT00526409|Prednisolone|prednisolone|mesh-list
24501020|NCT00526409|Cyclophosphamide|cyclophosphamide|mesh-list
24501021|NCT00526409|Methotrexate|methotrexate|mesh-list
24501022|NCT00526409|Vincristine|vincristine|mesh-list
24501023|NCT00526409|Daunorubicin|daunorubicin|mesh-list
24501024|NCT00526409|Asparaginase|asparaginase|mesh-list
24501025|NCT00526409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24501026|NCT00526409|Immunologic Factors|immunologic factors|mesh-ancestor
24501027|NCT00526409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501028|NCT00526409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24501029|NCT00526409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24501030|NCT00526409|Alkylating Agents|alkylating agents|mesh-ancestor
24501031|NCT00526409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214870|NCT02695212|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25214871|NCT02695212|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25679065|NCT01833130|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25679066|NCT01833130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25679067|NCT01833130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679068|NCT01833130|Cholinergic Agents|cholinergic agents|mesh-ancestor
25159908|NCT03504956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25679069|NCT01833130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24700450|NCT01452607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24700451|NCT01452607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24700452|NCT01452607|Analgesics|analgesics|mesh-ancestor
24700453|NCT01452607|Sensory System Agents|sensory system agents|mesh-ancestor
24700535|NCT01452828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700536|NCT01452867|Chlorhexidine|chlorhexidine|mesh-list
24969471|NCT03742466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24969472|NCT03742466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24969473|NCT03742466|Protective Agents|protective agents|mesh-ancestor
24969474|NCT03742466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24969475|NCT03742466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24969476|NCT03742336|Dabigatran|dabigatran|mesh-list
24969477|NCT03742336|Abrocitinib|abrocitinib|mesh-list
24969478|NCT03742336|Antithrombins|antithrombins|mesh-ancestor
24969479|NCT03742336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24969480|NCT03742336|Protease Inhibitors|protease inhibitors|mesh-ancestor
24969481|NCT03742336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24969482|NCT03742336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969483|NCT03742336|Anticoagulants|anticoagulants|mesh-ancestor
24969484|NCT03742336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24969489|NCT03742310|Vitamin D|vitamin d|mesh-list
24969497|NCT03742310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24969498|NCT03742310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969499|NCT03742310|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24927873|NCT04128462|Phenylacetic acid|phenylacetic acid|mesh-list
24501111|NCT00526760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24501112|NCT00526760|Adrenergic Agents|adrenergic agents|mesh-ancestor
24501113|NCT00526760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24501114|NCT00526760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501116|NCT00526877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24501117|NCT00526877|Serotonin Agents|serotonin agents|mesh-ancestor
24501118|NCT00526877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24501171|NCT00527085|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24501172|NCT00527085|Hormone Antagonists|hormone antagonists|mesh-ancestor
25214872|NCT02695212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25214873|NCT02695212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214874|NCT02695004|Donepezil|donepezil|mesh-list
25214875|NCT02695004|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25214876|NCT02695004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830521|NCT02159690|Abiraterone Acetate|abiraterone acetate|mesh-list
24830522|NCT02159690|Dutasteride|dutasteride|mesh-list
24830523|NCT02159690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24830524|NCT02159690|Glucocorticoids|glucocorticoids|mesh-ancestor
25679070|NCT01833130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679071|NCT01833130|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25679072|NCT01833130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25679073|NCT01833143|Acyclovir|acyclovir|mesh-list
25679074|NCT01833143|Bortezomib|bortezomib|mesh-list
25679075|NCT01833143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25679076|NCT01833143|Antiviral Agents|antiviral agents|mesh-ancestor
25679077|NCT01833143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24533386|NCT00643643|Maraviroc|maraviroc|mesh-list
24501173|NCT00527085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24501175|NCT00527137|Hematinics|hematinics|mesh-ancestor
24501176|NCT00527150|Varenicline|varenicline|mesh-list
24501177|NCT00527150|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24501178|NCT00527150|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24501179|NCT00527150|Cholinergic Agents|cholinergic agents|mesh-ancestor
25214877|NCT02695004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214878|NCT02695004|Cholinergic Agents|cholinergic agents|mesh-ancestor
25214879|NCT02695004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25214880|NCT02695004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214881|NCT02695004|Nootropic Agents|nootropic agents|mesh-ancestor
25214882|NCT02694874|Rosiglitazone|rosiglitazone|mesh-list
25214883|NCT02694874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25214884|NCT02694874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214885|NCT02694809|Bazedoxifene|bazedoxifene|mesh-list
25214886|NCT02694809|Estrogens|estrogens|mesh-list
25214887|NCT02694809|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25214888|NCT02694809|Hormones|hormones|mesh-ancestor
25214889|NCT02694809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25214890|NCT02694809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214891|NCT02694809|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25214892|NCT02694809|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25214893|NCT02694809|Hormone Antagonists|hormone antagonists|mesh-ancestor
25214894|NCT02694809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25214895|NCT02694848|Aspirin|aspirin|mesh-list
25214896|NCT02694848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25214897|NCT02694848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25214898|NCT02694848|Analgesics|analgesics|mesh-ancestor
25214899|NCT02694848|Sensory System Agents|sensory system agents|mesh-ancestor
25214900|NCT02694848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25214901|NCT02694848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214902|NCT02694848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25214903|NCT02694848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25214904|NCT02694848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25214905|NCT02694848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25214906|NCT02694848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214907|NCT02694848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25214908|NCT02694848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24448948|NCT00313625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448949|NCT00313625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24448950|NCT00313625|Antimetabolites|antimetabolites|mesh-ancestor
24448951|NCT00313625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448952|NCT00313625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448953|NCT00313625|Dermatologic Agents|dermatologic agents|mesh-ancestor
24448954|NCT00313625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24940159|NCT04003350|Narcotics|narcotics|mesh-ancestor
24448955|NCT00313625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24448956|NCT00313625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24448966|NCT00313690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25679078|NCT01833455|Flecainide|flecainide|mesh-list
25679079|NCT01833455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25679080|NCT01833455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25679081|NCT01833455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24830526|NCT02159690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24830528|NCT02159690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25214988|NCT02693860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25214916|NCT02694653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214917|NCT02694653|Antipyretics|antipyretics|mesh-ancestor
25214918|NCT02694458|Vancomycin|vancomycin|mesh-list
25214919|NCT02694458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25214920|NCT02694458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25272778|NCT02389868|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25272779|NCT02389868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272780|NCT02390063|Cyclophosphamide|cyclophosphamide|mesh-list
25272781|NCT02390063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25272782|NCT02390063|Immunologic Factors|immunologic factors|mesh-ancestor
25272783|NCT02390063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272784|NCT02390063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25272785|NCT02390063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25272786|NCT02390063|Alkylating Agents|alkylating agents|mesh-ancestor
25272787|NCT02390063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272788|NCT02390063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272789|NCT02390063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25272790|NCT02389933|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25272791|NCT02389933|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25272792|NCT02389933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275605|NCT02370862|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25275606|NCT02370862|Autonomic Agents|autonomic agents|mesh-ancestor
25275607|NCT02370862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275608|NCT02370862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25275609|NCT02370862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25275610|NCT02370862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25275611|NCT02370680|Aspirin|aspirin|mesh-list
25275612|NCT02370680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25275613|NCT02370680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25275614|NCT02370680|Analgesics|analgesics|mesh-ancestor
25275615|NCT02370680|Sensory System Agents|sensory system agents|mesh-ancestor
25275616|NCT02370680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275617|NCT02370680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275618|NCT02370680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25275619|NCT02370680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24830556|NCT02160028|Anesthetics|anesthetics|mesh-list
25082978|NCT03318757|Bupivacaine|bupivacaine|mesh-list
25082979|NCT03318757|Anesthetics, Local|anesthetics, local|mesh-ancestor
24969527|NCT03742258|Prednisone|prednisone|mesh-list
24969528|NCT03742258|Cortisone|cortisone|mesh-list
24969529|NCT03742258|Cyclophosphamide|cyclophosphamide|mesh-list
25214921|NCT02694289|Metformin|metformin|mesh-list
25214922|NCT02694289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25214923|NCT02694289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214924|NCT02694263|Pioglitazone|pioglitazone|mesh-list
25214925|NCT02694263|Glimepiride|glimepiride|mesh-list
25214926|NCT02694263|Canagliflozin|canagliflozin|mesh-list
25214927|NCT02694263|Repaglinide|repaglinide|mesh-list
25214928|NCT02694263|Gliclazide|gliclazide|mesh-list
25214929|NCT02694263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25214934|NCT02694263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25214935|NCT02694263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214937|NCT02694146|Viscosupplements|viscosupplements|mesh-ancestor
25214938|NCT02694146|Protective Agents|protective agents|mesh-ancestor
25214939|NCT02694146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214940|NCT02693769|Fluticasone|fluticasone|mesh-list
25214941|NCT02693769|Xhance|xhance|mesh-list
25214944|NCT02693769|Formoterol Fumarate|formoterol fumarate|mesh-list
25214945|NCT02693769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25214946|NCT02693769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24830597|NCT02160158|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24830598|NCT02160158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24830599|NCT02160158|Cholinergic Agents|cholinergic agents|mesh-ancestor
24830600|NCT02160158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25214947|NCT02693769|Autonomic Agents|autonomic agents|mesh-ancestor
25214948|NCT02693769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25214949|NCT02693769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214965|NCT02694224|Paclitaxel|paclitaxel|mesh-list
25214966|NCT02694224|Cyclophosphamide|cyclophosphamide|mesh-list
25214967|NCT02694224|Epirubicin|epirubicin|mesh-list
25214968|NCT02694224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25214969|NCT02694224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25214970|NCT02694224|Tubulin Modulators|tubulin modulators|mesh-ancestor
25214971|NCT02694224|Antimitotic Agents|antimitotic agents|mesh-ancestor
25214972|NCT02694224|Mitosis Modulators|mitosis modulators|mesh-ancestor
25214973|NCT02694224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25214974|NCT02694224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25214975|NCT02694224|Immunologic Factors|immunologic factors|mesh-ancestor
25214976|NCT02694224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25214977|NCT02694224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25214978|NCT02694224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25214979|NCT02694224|Alkylating Agents|alkylating agents|mesh-ancestor
25214980|NCT02694224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25214981|NCT02694224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25214982|NCT02694224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25214983|NCT02694224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25214984|NCT02694224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25214985|NCT02693951|Cefotiam|cefotiam|mesh-list
24830697|NCT02160548|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24830698|NCT02160548|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24830699|NCT02160548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24969530|NCT03742258|Rituximab|rituximab|mesh-list
25214986|NCT02693951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25214987|NCT02693951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25214999|NCT02693574|Levofloxacin|levofloxacin|mesh-list
25215000|NCT02693574|Ofloxacin|ofloxacin|mesh-list
25215009|NCT02693574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25215010|NCT02693574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25215011|NCT02693574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25215012|NCT02693574|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25215013|NCT02693574|Renal Agents|renal agents|mesh-ancestor
25215014|NCT02693574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25215015|NCT02693574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25215016|NCT02693574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215017|NCT02693574|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25215018|NCT02693470|Ustekinumab|ustekinumab|mesh-list
25215019|NCT02693470|Dermatologic Agents|dermatologic agents|mesh-ancestor
25215020|NCT02693444|Lidocaine|lidocaine|mesh-list
25215021|NCT02693444|Anesthetics, Local|anesthetics, local|mesh-ancestor
25215022|NCT02693444|Anesthetics|anesthetics|mesh-ancestor
24633962|NCT01131754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24633963|NCT01131754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633964|NCT01131767|Naproxen|naproxen|mesh-list
24633965|NCT01131767|Pseudoephedrine|pseudoephedrine|mesh-list
24633966|NCT01131767|Ephedrine|ephedrine|mesh-list
25215023|NCT02693444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25215024|NCT02693444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830705|NCT02160548|Mydriatics|mydriatics|mesh-ancestor
24830706|NCT02160548|Parasympatholytics|parasympatholytics|mesh-ancestor
24830707|NCT02160548|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24830708|NCT02160548|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25041933|NCT01554696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041934|NCT01554696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041935|NCT01554696|Dermatologic Agents|dermatologic agents|mesh-ancestor
25041936|NCT01554696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041937|NCT01554696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25041938|NCT01554696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25041939|NCT01554696|Immunologic Factors|immunologic factors|mesh-ancestor
25041940|NCT01554696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24969531|NCT03742258|Doxorubicin|doxorubicin|mesh-list
24969532|NCT03742258|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24969533|NCT03742258|Vincristine|vincristine|mesh-list
24969534|NCT03742258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24969535|NCT03742258|Antibodies|antibodies|mesh-list
24969536|NCT03742258|Immunoglobulins|immunoglobulins|mesh-list
24969537|NCT03742258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24969538|NCT03742258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24969539|NCT03742258|Immunologic Factors|immunologic factors|mesh-ancestor
24501283|NCT00527800|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24501284|NCT00527800|Renal Agents|renal agents|mesh-ancestor
24501285|NCT00527800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25215025|NCT02693444|Sensory System Agents|sensory system agents|mesh-ancestor
25215026|NCT02693444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25215027|NCT02693444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25215028|NCT02693444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25215029|NCT02693444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25215030|NCT02693444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25215031|NCT02693444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215032|NCT02693288|Anesthetics|anesthetics|mesh-list
25215033|NCT02693288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25215034|NCT02693288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215035|NCT02693392|Metformin|metformin|mesh-list
25215036|NCT02693392|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25215037|NCT02693392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215038|NCT02693483|Povidone-Iodine|povidone-iodine|mesh-list
25215039|NCT02693483|Povidone|povidone|mesh-list
25215040|NCT02693483|Plasma Substitutes|plasma substitutes|mesh-ancestor
25215041|NCT02693483|Blood Substitutes|blood substitutes|mesh-ancestor
25215042|NCT02693483|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25215043|NCT02693483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25215044|NCT02693145|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25215045|NCT02693145|Antiviral Agents|antiviral agents|mesh-ancestor
25215046|NCT02693145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25215047|NCT02693210|Cyclophosphamide|cyclophosphamide|mesh-list
25215048|NCT02693210|Rituximab|rituximab|mesh-list
25215049|NCT02693210|Methotrexate|methotrexate|mesh-list
25041941|NCT01554696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25041942|NCT01545453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25041943|NCT01545453|Immunologic Factors|immunologic factors|mesh-ancestor
25041944|NCT01545453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041945|NCT01536041|Montelukast|montelukast|mesh-list
25041946|NCT01536041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25679082|NCT01833455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25679083|NCT01833455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679084|NCT01833533|Ribavirin|ribavirin|mesh-list
25679085|NCT01833533|Antimetabolites|antimetabolites|mesh-ancestor
25041947|NCT01536041|Respiratory System Agents|respiratory system agents|mesh-ancestor
25041948|NCT01536041|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25041950|NCT01536041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25041951|NCT01536041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041952|NCT01536041|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25041953|NCT01536041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25041954|NCT01536041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462932|NCT00357981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24462933|NCT00357981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462934|NCT00357981|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24462936|NCT00358020|Bortezomib|bortezomib|mesh-list
24501286|NCT00527800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501287|NCT00527800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538940|NCT00661297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538941|NCT00661297|Urological Agents|urological agents|mesh-ancestor
24501288|NCT00527800|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24501289|NCT00527800|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24501290|NCT00527800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24501297|NCT00527995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24501298|NCT00527995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501299|NCT00527995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501300|NCT00527995|Urological Agents|urological agents|mesh-ancestor
24501302|NCT00528008|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24501303|NCT00528008|Povidone-Iodine|povidone-iodine|mesh-list
24969540|NCT03742258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969541|NCT03742258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24969542|NCT03742258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25215050|NCT02693210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25215051|NCT02693210|Immunologic Factors|immunologic factors|mesh-ancestor
25215052|NCT02693210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215053|NCT02693210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25215054|NCT02693210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25215055|NCT02693210|Alkylating Agents|alkylating agents|mesh-ancestor
25215056|NCT02693210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215057|NCT02693210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215058|NCT02693210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25215059|NCT02693210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25215060|NCT02693210|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25215062|NCT02693210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25215063|NCT02693210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25215064|NCT02693210|Antimetabolites|antimetabolites|mesh-ancestor
25215065|NCT02693210|Dermatologic Agents|dermatologic agents|mesh-ancestor
25215066|NCT02693210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215067|NCT02693210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25215068|NCT02693210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25215069|NCT02692989|Anesthetics|anesthetics|mesh-list
25215070|NCT02692989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25215071|NCT02692989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215072|NCT02692599|Vaccines|vaccines|mesh-list
25215073|NCT02692599|Immunologic Factors|immunologic factors|mesh-ancestor
25215074|NCT02692599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215075|NCT02692534|Cocaine|cocaine|mesh-list
25215076|NCT02692534|Anesthetics, Local|anesthetics, local|mesh-ancestor
25215077|NCT02692534|Anesthetics|anesthetics|mesh-ancestor
25272793|NCT02389582|Enoxaparin|enoxaparin|mesh-list
24830712|NCT02160548|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
24830713|NCT02160548|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
24830715|NCT02160574|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24830716|NCT02160574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24830717|NCT02160574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24830718|NCT02160574|Disinfectants|disinfectants|mesh-ancestor
24830719|NCT02160574|Dermatologic Agents|dermatologic agents|mesh-ancestor
25215078|NCT02692534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25215079|NCT02692534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215080|NCT02692534|Sensory System Agents|sensory system agents|mesh-ancestor
25215081|NCT02692534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25215082|NCT02692534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25215083|NCT02692534|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25215084|NCT02692534|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25215085|NCT02692534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25215086|NCT02692534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215087|NCT02692534|Dopamine Agents|dopamine agents|mesh-ancestor
25215088|NCT02692534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25272794|NCT02389582|Dabigatran|dabigatran|mesh-list
25272795|NCT02389582|Anticoagulants|anticoagulants|mesh-ancestor
25272796|NCT02389582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25272797|NCT02389582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25272798|NCT02389582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272799|NCT02389582|Antithrombins|antithrombins|mesh-ancestor
25272800|NCT02389582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25272801|NCT02389582|Protease Inhibitors|protease inhibitors|mesh-ancestor
25272802|NCT02389582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272803|NCT02389543|Dexamethasone|dexamethasone|mesh-list
25272804|NCT02389543|Lenalidomide|lenalidomide|mesh-list
25272805|NCT02389543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25272806|NCT02389543|Antiemetics|antiemetics|mesh-ancestor
25272807|NCT02389543|Autonomic Agents|autonomic agents|mesh-ancestor
25272808|NCT02389543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25272809|NCT02389543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272810|NCT02389543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25272811|NCT02389543|Glucocorticoids|glucocorticoids|mesh-ancestor
25272812|NCT02389543|Hormones|hormones|mesh-ancestor
25272813|NCT02389543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25272814|NCT02389543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25272822|NCT02389400|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25272823|NCT02389400|Abortifacient Agents|abortifacient agents|mesh-ancestor
25272824|NCT02389400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25272825|NCT02389400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272826|NCT02389400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25272827|NCT02389400|Antimetabolites|antimetabolites|mesh-ancestor
24969543|NCT03742258|Alkylating Agents|alkylating agents|mesh-ancestor
24969544|NCT03742258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969545|NCT03742258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24969556|NCT03742258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24969557|NCT03742258|Tubulin Modulators|tubulin modulators|mesh-ancestor
24969558|NCT03742258|Antimitotic Agents|antimitotic agents|mesh-ancestor
24969559|NCT03742258|Mitosis Modulators|mitosis modulators|mesh-ancestor
24969567|NCT03742232|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24969568|NCT03742232|Laxatives|laxatives|mesh-ancestor
24969569|NCT03742232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24969571|NCT03742180|Dexmedetomidine|dexmedetomidine|mesh-list
24501304|NCT00528008|Povidone|povidone|mesh-list
24501305|NCT00528008|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24501306|NCT00528008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25215089|NCT02692248|Gemcitabine|gemcitabine|mesh-list
25215090|NCT02692248|Dexamethasone|dexamethasone|mesh-list
25215091|NCT02692248|Rituximab|rituximab|mesh-list
25215092|NCT02692248|Oxaliplatin|oxaliplatin|mesh-list
25215093|NCT02692248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25215094|NCT02692248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215095|NCT02692248|Immunologic Factors|immunologic factors|mesh-ancestor
25215096|NCT02692248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215097|NCT02692248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25215098|NCT02692248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25215099|NCT02692248|Antiemetics|antiemetics|mesh-ancestor
25215100|NCT02692248|Autonomic Agents|autonomic agents|mesh-ancestor
25215101|NCT02692248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25215102|NCT02692248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25215103|NCT02692248|Glucocorticoids|glucocorticoids|mesh-ancestor
25215105|NCT02692248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25215106|NCT02692248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25215107|NCT02692248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25215108|NCT02692248|Antimetabolites|antimetabolites|mesh-ancestor
25215109|NCT02692248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215110|NCT02692248|Antiviral Agents|antiviral agents|mesh-ancestor
25215111|NCT02692248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25215112|NCT02692248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215113|NCT02692248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24830767|NCT02161237|Tacrolimus|tacrolimus|mesh-list
24830768|NCT02161237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24830857|NCT02161770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215115|NCT02692365|Trace Elements|trace elements|mesh-ancestor
25215116|NCT02692365|Micronutrients|micronutrients|mesh-ancestor
25215117|NCT02692365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215118|NCT02691949|Mycophenolic Acid|mycophenolic acid|mesh-list
25215119|NCT02691949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25215120|NCT02691949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215121|NCT02691949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25215122|NCT02691949|Antitubercular Agents|antitubercular agents|mesh-ancestor
25215123|NCT02691949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25215124|NCT02691949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25215125|NCT02691949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215126|NCT02691949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215127|NCT02691910|Chloroquine|chloroquine|mesh-list
25215128|NCT02691910|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
25215129|NCT02691910|Primaquine|primaquine|mesh-list
25215130|NCT02691910|Amebicides|amebicides|mesh-ancestor
25215131|NCT02691910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25215132|NCT02691910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25215133|NCT02691910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25215134|NCT02691910|Antimalarials|antimalarials|mesh-ancestor
25215135|NCT02691910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25215136|NCT02691910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25215137|NCT02691910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25215138|NCT02691910|Analgesics|analgesics|mesh-ancestor
25215139|NCT02691910|Sensory System Agents|sensory system agents|mesh-ancestor
25215140|NCT02691910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25215141|NCT02691910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215142|NCT02691910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25215143|NCT02691910|Filaricides|filaricides|mesh-ancestor
25215144|NCT02691910|Antinematodal Agents|antinematodal agents|mesh-ancestor
25215145|NCT02691910|Anthelmintics|anthelmintics|mesh-ancestor
25215146|NCT02691858|Hydrocortisone|hydrocortisone|mesh-list
24538980|NCT00661401|gamma-Globulins|gamma-globulins|mesh-list
25215147|NCT02691858|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25215148|NCT02691858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25215149|NCT02691871|Docetaxel|docetaxel|mesh-list
25215150|NCT02691871|Apatinib|apatinib|mesh-list
25215151|NCT02691871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215152|NCT02691871|Tubulin Modulators|tubulin modulators|mesh-ancestor
25215153|NCT02691871|Antimitotic Agents|antimitotic agents|mesh-ancestor
25215154|NCT02691871|Mitosis Modulators|mitosis modulators|mesh-ancestor
25215155|NCT02691871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215156|NCT02691871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25215161|NCT02691754|Sensory System Agents|sensory system agents|mesh-ancestor
25215162|NCT02691754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969572|NCT03742180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24969573|NCT03742180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24969574|NCT03742180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969575|NCT03742180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24969576|NCT03742180|Analgesics|analgesics|mesh-ancestor
24969577|NCT03742180|Sensory System Agents|sensory system agents|mesh-ancestor
24969578|NCT03742180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969579|NCT03742180|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25215163|NCT02691754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215164|NCT02691754|Antipyretics|antipyretics|mesh-ancestor
25215165|NCT02691897|Melatonin|melatonin|mesh-list
25215166|NCT02691897|Antioxidants|antioxidants|mesh-ancestor
25215167|NCT02691897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215168|NCT02691897|Protective Agents|protective agents|mesh-ancestor
25215169|NCT02691897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215170|NCT02691897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25215171|NCT02691676|Plasma-lyte 148|plasma-lyte 148|mesh-list
25215172|NCT02691676|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25215173|NCT02691676|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25215174|NCT02691780|Sorafenib|sorafenib|mesh-list
25215175|NCT02691780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215176|NCT02691780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25215177|NCT02691780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215178|NCT02691780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215182|NCT02691533|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25215183|NCT02691533|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25215184|NCT02691533|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25215185|NCT02691533|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25215186|NCT02691325|Charcoal|charcoal|mesh-list
25215190|NCT02691325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215191|NCT02691325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25215192|NCT02691325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215193|NCT02691325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969581|NCT03742180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24501383|NCT00528359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501384|NCT00528359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24501385|NCT00528359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24501386|NCT00528359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24501387|NCT00528359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24501388|NCT00528359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24501389|NCT00528359|Dopamine Agents|dopamine agents|mesh-ancestor
24501390|NCT00528359|Antiemetics|antiemetics|mesh-ancestor
24501391|NCT00528359|Autonomic Agents|autonomic agents|mesh-ancestor
24501392|NCT00528359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24501393|NCT00528359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24501394|NCT00528359|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24501395|NCT00528359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24501422|NCT00528502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501424|NCT00528515|Desflurane|desflurane|mesh-list
24969582|NCT03742180|Adrenergic Agents|adrenergic agents|mesh-ancestor
24969583|NCT03742180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24969584|NCT03742180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969585|NCT03742180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24969586|NCT03742180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24969587|NCT03742180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24969588|NCT03742180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24969589|NCT03742180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24969590|NCT03742115|Dexamethasone|dexamethasone|mesh-list
24969591|NCT03742115|Etoposide|etoposide|mesh-list
24969592|NCT03742115|Etoposide phosphate|etoposide phosphate|mesh-list
24969593|NCT03742115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24969594|NCT03742115|Antiemetics|antiemetics|mesh-ancestor
24969595|NCT03742115|Autonomic Agents|autonomic agents|mesh-ancestor
24628313|NCT01098019|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25215194|NCT02691403|Bupivacaine|bupivacaine|mesh-list
25215195|NCT02691403|Levobupivacaine|levobupivacaine|mesh-list
25215196|NCT02691403|Anesthetics, Local|anesthetics, local|mesh-ancestor
25215197|NCT02691403|Anesthetics|anesthetics|mesh-ancestor
25215198|NCT02691403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25215199|NCT02691403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215200|NCT02691403|Sensory System Agents|sensory system agents|mesh-ancestor
25215201|NCT02691403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25215202|NCT02691442|Epinephrine|epinephrine|mesh-list
25215203|NCT02691442|Ropivacaine|ropivacaine|mesh-list
25215204|NCT02691442|Levobupivacaine|levobupivacaine|mesh-list
24628314|NCT01098019|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24628315|NCT01098019|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24628316|NCT01098019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24628317|NCT01098019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628318|NCT01098019|Cholinergic Agents|cholinergic agents|mesh-ancestor
24628319|NCT01098019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24628320|NCT01098019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628321|NCT01098019|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24628322|NCT01098019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24628324|NCT01098084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25082985|NCT03318744|Aspirin|aspirin|mesh-list
25082986|NCT03318744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25082987|NCT03318744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25082988|NCT03318744|Analgesics|analgesics|mesh-ancestor
25082989|NCT03318744|Sensory System Agents|sensory system agents|mesh-ancestor
25082990|NCT03318744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082991|NCT03318744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082992|NCT03318744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25082993|NCT03318744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25082994|NCT03318744|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25082995|NCT03318744|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25082996|NCT03318744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082997|NCT03318744|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25082998|NCT03318744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25082999|NCT03318744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25083000|NCT03318744|Antipyretics|antipyretics|mesh-ancestor
25083001|NCT03318731|Fenugreek seed meal|fenugreek seed meal|mesh-list
25083002|NCT03318731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25083003|NCT03318731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083004|NCT03318718|Rocuronium|rocuronium|mesh-list
25215205|NCT02691442|Anesthetics, Local|anesthetics, local|mesh-ancestor
25215206|NCT02691442|Anesthetics|anesthetics|mesh-ancestor
25215207|NCT02691442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25215208|NCT02691442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215209|NCT02691442|Sensory System Agents|sensory system agents|mesh-ancestor
25215210|NCT02691442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25215211|NCT02691442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25215212|NCT02691442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25215213|NCT02691442|Adrenergic Agents|adrenergic agents|mesh-ancestor
25215214|NCT02691442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25215215|NCT02691442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215216|NCT02691442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25215217|NCT02691442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25215218|NCT02691442|Autonomic Agents|autonomic agents|mesh-ancestor
25215219|NCT02691442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25215220|NCT02691442|Respiratory System Agents|respiratory system agents|mesh-ancestor
25215221|NCT02691442|Mydriatics|mydriatics|mesh-ancestor
25215222|NCT02691442|Sympathomimetics|sympathomimetics|mesh-ancestor
25215223|NCT02691442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25215224|NCT02691156|Carbon Monoxide|carbon monoxide|mesh-list
25215225|NCT02691156|Bilirubin|bilirubin|mesh-list
25083005|NCT03318718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215226|NCT02691156|Antimetabolites|antimetabolites|mesh-ancestor
25215227|NCT02691156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215228|NCT02691156|Gasotransmitters|gasotransmitters|mesh-ancestor
25215229|NCT02691156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25215230|NCT02691156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215231|NCT02691156|Antioxidants|antioxidants|mesh-ancestor
25215232|NCT02691156|Protective Agents|protective agents|mesh-ancestor
25215233|NCT02691026|Pembrolizumab|pembrolizumab|mesh-list
25215234|NCT02691026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25215235|NCT02691026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215236|NCT02691195|Ropivacaine|ropivacaine|mesh-list
25215237|NCT02691195|Anesthetics, Local|anesthetics, local|mesh-list
25215238|NCT02691195|Anesthetics|anesthetics|mesh-list
25215239|NCT02691195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25215240|NCT02691195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215241|NCT02691195|Sensory System Agents|sensory system agents|mesh-ancestor
25215242|NCT02691195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25215244|NCT02691078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25215245|NCT02691078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25215246|NCT02691078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215247|NCT02691065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
25215248|NCT02691065|Integrase Inhibitors|integrase inhibitors|mesh-list
25215249|NCT02691065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215250|NCT02691065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215251|NCT02691065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25215252|NCT02691065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25215255|NCT02690987|Exenatide|exenatide|mesh-list
25215256|NCT02690987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25215257|NCT02690987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215258|NCT02690987|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25215259|NCT02690987|Incretins|incretins|mesh-ancestor
25215260|NCT02690987|Hormones|hormones|mesh-ancestor
25215261|NCT02690987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25215262|NCT02690922|Dexamethasone|dexamethasone|mesh-list
24830855|NCT02161770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24830856|NCT02161770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24830858|NCT02161770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830859|NCT02161822|Simvastatin|simvastatin|mesh-list
24830860|NCT02161822|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25041957|NCT01535508|Micronutrients|micronutrients|mesh-ancestor
25041958|NCT01535508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041959|NCT01535508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25041960|NCT01534403|Epratuzumab|epratuzumab|mesh-list
25041961|NCT01534403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25041962|NCT01534403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041963|NCT01531699|Povidone-Iodine|povidone-iodine|mesh-list
25041964|NCT01531699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25041965|NCT01531699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25041966|NCT01531699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25041967|NCT01527916|Donepezil|donepezil|mesh-list
25041968|NCT01527916|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25041969|NCT01527916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041970|NCT01527916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041971|NCT01527916|Cholinergic Agents|cholinergic agents|mesh-ancestor
25083006|NCT03318718|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25083007|NCT03318718|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25083008|NCT03318718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25215263|NCT02690922|Prednisone|prednisone|mesh-list
25215264|NCT02690922|Methotrexate|methotrexate|mesh-list
25215265|NCT02690922|Dasatinib|dasatinib|mesh-list
25215266|NCT02690922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25215267|NCT02690922|Antiemetics|antiemetics|mesh-ancestor
25215268|NCT02690922|Autonomic Agents|autonomic agents|mesh-ancestor
25215269|NCT02690922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25215270|NCT02690922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215271|NCT02690922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25215272|NCT02690922|Glucocorticoids|glucocorticoids|mesh-ancestor
25215273|NCT02690922|Hormones|hormones|mesh-ancestor
25215274|NCT02690922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25215275|NCT02690922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25215276|NCT02690922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215277|NCT02690922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25215278|NCT02690922|Abortifacient Agents|abortifacient agents|mesh-ancestor
25215279|NCT02690922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25215280|NCT02690922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25215281|NCT02690922|Antimetabolites|antimetabolites|mesh-ancestor
25215282|NCT02690922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215283|NCT02690922|Dermatologic Agents|dermatologic agents|mesh-ancestor
25215284|NCT02690922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215285|NCT02690922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25215286|NCT02690922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25215287|NCT02690922|Immunologic Factors|immunologic factors|mesh-ancestor
25215288|NCT02690922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25215289|NCT02690922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25215290|NCT02690922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25215291|NCT02690883|Exenatide|exenatide|mesh-list
25215292|NCT02690883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25215293|NCT02690883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215294|NCT02690883|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25215295|NCT02690883|Incretins|incretins|mesh-ancestor
25215297|NCT02690883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25215298|NCT02690844|Clonazepam|clonazepam|mesh-list
25041975|NCT01522469|Crenolanib|crenolanib|mesh-list
25041976|NCT01522469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041977|NCT01522196|Varespladib methyl|varespladib methyl|mesh-list
25041978|NCT01522196|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
25041979|NCT01522196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041980|NCT01522196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041981|NCT01520545|Baclofen|baclofen|mesh-list
25041982|NCT01520545|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25041983|NCT01520545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041984|NCT01520545|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25272829|NCT02389400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927975|NCT04127396|Hormones|hormones|mesh-ancestor
24501425|NCT00528515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24501426|NCT00528515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24501427|NCT00528515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501428|NCT00528515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24501429|NCT00528515|Anesthetics, General|anesthetics, general|mesh-ancestor
24501430|NCT00528515|Anesthetics|anesthetics|mesh-ancestor
24501431|NCT00528515|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24501432|NCT00528593|Epoetin Alfa|epoetin alfa|mesh-list
24501433|NCT00528593|Hematinics|hematinics|mesh-ancestor
24501434|NCT00528619|Carboplatin|carboplatin|mesh-list
24501435|NCT00528619|Pemetrexed|pemetrexed|mesh-list
24501436|NCT00528619|Sunitinib|sunitinib|mesh-list
24501437|NCT00528619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501438|NCT00528619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501440|NCT00528619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25083009|NCT03318718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25083010|NCT03318536|Granisetron|granisetron|mesh-list
25215299|NCT02690844|Anticonvulsants|anticonvulsants|mesh-ancestor
25215300|NCT02690844|GABA Modulators|gaba modulators|mesh-ancestor
25215301|NCT02690844|GABA Agents|gaba agents|mesh-ancestor
25215302|NCT02690844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25215303|NCT02690844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215304|NCT02690844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215305|NCT02690870|Tamoxifen|tamoxifen|mesh-list
25215306|NCT02690870|Clomiphene|clomiphene|mesh-list
25215307|NCT02690870|Enclomiphene|enclomiphene|mesh-list
25215308|NCT02690870|Zuclomiphene|zuclomiphene|mesh-list
25215309|NCT02690870|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25215310|NCT02690870|Hormone Antagonists|hormone antagonists|mesh-ancestor
25215311|NCT02690870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25215312|NCT02690870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215313|NCT02690870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25215314|NCT02690870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215315|NCT02690870|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25215316|NCT02690870|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25215317|NCT02690870|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25215318|NCT02690870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25215319|NCT02690870|Fertility Agents|fertility agents|mesh-ancestor
25215320|NCT02690870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25272830|NCT02389400|Dermatologic Agents|dermatologic agents|mesh-ancestor
25272831|NCT02389400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272832|NCT02389400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25272833|NCT02389400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25272834|NCT02389400|Immunologic Factors|immunologic factors|mesh-ancestor
25272835|NCT02389400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25275620|NCT02370680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25215322|NCT02690792|Vitamins|vitamins|mesh-ancestor
25215323|NCT02690792|Micronutrients|micronutrients|mesh-ancestor
25215324|NCT02690792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215325|NCT02690792|Antioxidants|antioxidants|mesh-ancestor
25215326|NCT02690792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215327|NCT02690792|Protective Agents|protective agents|mesh-ancestor
25215328|NCT02690506|Pregabalin|pregabalin|mesh-list
25215329|NCT02690506|Analgesics|analgesics|mesh-ancestor
25215330|NCT02690506|Sensory System Agents|sensory system agents|mesh-ancestor
25215331|NCT02690506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25215332|NCT02690506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215333|NCT02690506|Anticonvulsants|anticonvulsants|mesh-ancestor
25215334|NCT02690506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25215335|NCT02690506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25215336|NCT02690506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215337|NCT02690506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25215338|NCT02690506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25215339|NCT02690506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25215340|NCT02690506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25215341|NCT02690506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25215342|NCT02690389|Flumazenil|flumazenil|mesh-list
25215343|NCT02690389|Antidotes|antidotes|mesh-ancestor
25215344|NCT02690389|Protective Agents|protective agents|mesh-ancestor
25215345|NCT02690389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215346|NCT02690389|GABA Modulators|gaba modulators|mesh-ancestor
25215347|NCT02690389|GABA Agents|gaba agents|mesh-ancestor
25215348|NCT02690389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25215349|NCT02690389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215350|NCT02690415|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25215351|NCT02690415|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25215352|NCT02690415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25215353|NCT02690415|Antitubercular Agents|antitubercular agents|mesh-ancestor
25215354|NCT02690480|Fulvestrant|fulvestrant|mesh-list
25215355|NCT02690480|Palbociclib|palbociclib|mesh-list
25215356|NCT02690480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25215357|NCT02690480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215358|NCT02690480|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25215359|NCT02690480|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25215360|NCT02690480|Hormone Antagonists|hormone antagonists|mesh-ancestor
25215361|NCT02690480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25215362|NCT02690480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215363|NCT02690480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25215364|NCT02690480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215365|NCT02690480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215366|NCT02689999|Rabeprazole|rabeprazole|mesh-list
25215367|NCT02689999|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25215368|NCT02689999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25215369|NCT02689999|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25215370|NCT02689999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215371|NCT02689999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215372|NCT02690038|Immunoglobulins|immunoglobulins|mesh-list
25215373|NCT02690038|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25215374|NCT02690038|Antibodies|antibodies|mesh-list
24463224|NCT00359567|Antiemetics|antiemetics|mesh-ancestor
24636737|NCT01147146|Anesthetics, Local|anesthetics, local|mesh-ancestor
24636738|NCT01147146|Anesthetics|anesthetics|mesh-ancestor
25264624|NCT02439632|Prulifloxacin|prulifloxacin|mesh-list
25264625|NCT02439632|Fluoroquinolones|fluoroquinolones|mesh-list
25264626|NCT02439632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25264627|NCT02439632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25264628|NCT02439632|Renal Agents|renal agents|mesh-ancestor
25264629|NCT02439632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25264630|NCT02439632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25264631|NCT02439632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25275700|NCT02369965|Tenofovir|tenofovir|mesh-list
25215375|NCT02690038|gamma-Globulins|gamma-globulins|mesh-list
25215376|NCT02690038|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25215377|NCT02690038|Immunologic Factors|immunologic factors|mesh-ancestor
25215378|NCT02690038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215380|NCT02690103|Antimetabolites|antimetabolites|mesh-ancestor
25215381|NCT02690103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215382|NCT02690103|Antiviral Agents|antiviral agents|mesh-ancestor
25215383|NCT02690103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25215384|NCT02690155|Vitamin K|vitamin k|mesh-list
25215385|NCT02690155|Rivaroxaban|rivaroxaban|mesh-list
25215386|NCT02690155|Vitamins|vitamins|mesh-ancestor
25215387|NCT02690155|Micronutrients|micronutrients|mesh-ancestor
25215388|NCT02690155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215389|NCT02690155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25215390|NCT02690155|Antithrombins|antithrombins|mesh-ancestor
25215391|NCT02690155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25215392|NCT02690155|Protease Inhibitors|protease inhibitors|mesh-ancestor
25215393|NCT02690155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215394|NCT02690155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215395|NCT02690155|Anticoagulants|anticoagulants|mesh-ancestor
25215396|NCT02690155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25215397|NCT02690155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25215398|NCT02690155|Hemostatics|hemostatics|mesh-ancestor
25215399|NCT02690155|Coagulants|coagulants|mesh-ancestor
25215400|NCT02690129|Progesterone|progesterone|mesh-list
25215401|NCT02690129|Progestins|progestins|mesh-ancestor
25215402|NCT02690129|Hormones|hormones|mesh-ancestor
25215403|NCT02690129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25215404|NCT02690129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215405|NCT02689960|Prednisone|prednisone|mesh-list
25215406|NCT02689960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25215407|NCT02689960|Glucocorticoids|glucocorticoids|mesh-ancestor
25215408|NCT02689960|Hormones|hormones|mesh-ancestor
25215409|NCT02689960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25215410|NCT02689960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215411|NCT02689960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25215412|NCT02689960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215413|NCT02689882|Niacinamide|niacinamide|mesh-list
25215414|NCT02689882|Niacin|niacin|mesh-list
25215415|NCT02689882|Nicotinic Acids|nicotinic acids|mesh-list
25215416|NCT02689882|Vitamin B Complex|vitamin b complex|mesh-ancestor
25215417|NCT02689882|Vitamins|vitamins|mesh-ancestor
25215418|NCT02689882|Micronutrients|micronutrients|mesh-ancestor
25215419|NCT02689882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215420|NCT02689882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25215421|NCT02689882|Antimetabolites|antimetabolites|mesh-ancestor
25215422|NCT02689882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215423|NCT02689882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25215424|NCT02689882|Vasodilator Agents|vasodilator agents|mesh-ancestor
25679086|NCT01833533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679087|NCT01833533|Antiviral Agents|antiviral agents|mesh-ancestor
25679088|NCT01833533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25679089|NCT01833546|Gemcitabine|gemcitabine|mesh-list
25679090|NCT01833546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25679091|NCT01833546|Antimetabolites|antimetabolites|mesh-ancestor
25679092|NCT01833546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679093|NCT01833546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25679094|NCT01833546|Antiviral Agents|antiviral agents|mesh-ancestor
25679095|NCT01833546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25215425|NCT02690012|Magnesium citrate|magnesium citrate|mesh-list
25215426|NCT02690012|Magnesium Oxide|magnesium oxide|mesh-list
25215427|NCT02690012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215428|NCT02690012|Cathartics|cathartics|mesh-ancestor
25215429|NCT02690012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25215430|NCT02690012|Antacids|antacids|mesh-ancestor
25215431|NCT02689986|Rituximab|rituximab|mesh-list
25215432|NCT02689986|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25215433|NCT02689986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25215434|NCT02689986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215435|NCT02689986|Immunologic Factors|immunologic factors|mesh-ancestor
25215436|NCT02689986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215437|NCT02689986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25215438|NCT02689986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25215439|NCT02689986|Alkylating Agents|alkylating agents|mesh-ancestor
25215440|NCT02689986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215441|NCT02689921|Trastuzumab|trastuzumab|mesh-list
25215442|NCT02689921|Pertuzumab|pertuzumab|mesh-list
25215443|NCT02689921|Letrozole|letrozole|mesh-list
25215444|NCT02689921|Anastrozole|anastrozole|mesh-list
25215445|NCT02689921|Leuprolide|leuprolide|mesh-list
25215446|NCT02689921|Exemestane|exemestane|mesh-list
25215447|NCT02689921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25215448|NCT02689921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215449|NCT02689921|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25215450|NCT02689921|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25215451|NCT02689921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215452|NCT02689921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215453|NCT02689921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25215454|NCT02689921|Hormone Antagonists|hormone antagonists|mesh-ancestor
25215455|NCT02689921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25215456|NCT02689921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215457|NCT02689921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25215458|NCT02689921|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25215459|NCT02689921|Fertility Agents|fertility agents|mesh-ancestor
25215460|NCT02689921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25215461|NCT02689895|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25215462|NCT02689895|Antiviral Agents|antiviral agents|mesh-ancestor
25215463|NCT02689895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25215464|NCT02689856|Hydrocortisone|hydrocortisone|mesh-list
25215465|NCT02689856|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25215466|NCT02689856|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24940704|NCT03999125|Growth Substances|growth substances|mesh-ancestor
24830897|NCT02161991|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24830898|NCT02161991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25157995|NCT04537598|Sensory System Agents|sensory system agents|mesh-ancestor
25083012|NCT03318536|Antiemetics|antiemetics|mesh-ancestor
25083013|NCT03318536|Autonomic Agents|autonomic agents|mesh-ancestor
25083014|NCT03318536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25083015|NCT03318536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083016|NCT03318536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25083017|NCT03318536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25083018|NCT03318536|Serotonin Agents|serotonin agents|mesh-ancestor
24628342|NCT01098344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24969596|NCT03742115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969597|NCT03742115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969598|NCT03742115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25215467|NCT02689856|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25215468|NCT02689856|Lidocaine|lidocaine|mesh-list
25215469|NCT02689856|Anesthetics, Local|anesthetics, local|mesh-ancestor
25215470|NCT02689856|Anesthetics|anesthetics|mesh-ancestor
25215471|NCT02689856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25215472|NCT02689856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215473|NCT02689856|Sensory System Agents|sensory system agents|mesh-ancestor
25215474|NCT02689856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25215475|NCT02689856|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25215476|NCT02689856|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25215477|NCT02689856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25215478|NCT02689856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25215479|NCT02689856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215480|NCT02689856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25215481|NCT02689869|Obinutuzumab|obinutuzumab|mesh-list
25215482|NCT02689869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25215483|NCT02689869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215484|NCT02689843|Metformin|metformin|mesh-list
25215485|NCT02689843|Pioglitazone|pioglitazone|mesh-list
25215486|NCT02689843|Cyproterone Acetate|cyproterone acetate|mesh-list
25215487|NCT02689843|Spironolactone|spironolactone|mesh-list
25215488|NCT02689843|Cyproterone|cyproterone|mesh-list
25215489|NCT02689843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25215490|NCT02689843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215491|NCT02689843|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25215492|NCT02689843|Hormone Antagonists|hormone antagonists|mesh-ancestor
25215493|NCT02689843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25215494|NCT02689843|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25215496|NCT02689843|Natriuretic Agents|natriuretic agents|mesh-ancestor
25215497|NCT02689843|Androgen Antagonists|androgen antagonists|mesh-ancestor
25215498|NCT02689843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215499|NCT02689843|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25215500|NCT02689843|Contraceptive Agents|contraceptive agents|mesh-ancestor
25215501|NCT02689843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25215502|NCT02689726|Imiquimod|imiquimod|mesh-list
25215503|NCT02689726|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25215504|NCT02689726|Immunologic Factors|immunologic factors|mesh-ancestor
25215505|NCT02689726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215506|NCT02689726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215507|NCT02689726|Interferon Inducers|interferon inducers|mesh-ancestor
25215508|NCT02689713|Voriconazole|voriconazole|mesh-list
25215509|NCT02689713|Antifungal Agents|antifungal agents|mesh-ancestor
25215510|NCT02689713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25215511|NCT02689713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25215512|NCT02689713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25215513|NCT02689713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215514|NCT02689713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215515|NCT02689713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25215516|NCT02689713|Hormone Antagonists|hormone antagonists|mesh-ancestor
25215517|NCT02689713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25215518|NCT02689713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215519|NCT02689713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25215520|NCT02689778|Pirfenidone|pirfenidone|mesh-list
25215521|NCT02689778|Analgesics|analgesics|mesh-ancestor
25215522|NCT02689778|Sensory System Agents|sensory system agents|mesh-ancestor
25215523|NCT02689778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25215524|NCT02689778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215525|NCT02689778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25215526|NCT02689778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25215527|NCT02689778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25215528|NCT02689778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25215529|NCT02689778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215530|NCT02689362|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25215531|NCT02689362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25215532|NCT02689362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679096|NCT01833546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272838|NCT02389439|Pyronaridine|pyronaridine|mesh-list
25272839|NCT02389439|Antimalarials|antimalarials|mesh-ancestor
25057164|NCT03507062|Plasma-lyte 148|plasma-lyte 148|mesh-list
25272840|NCT02389439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25215533|NCT02689362|Incretins|incretins|mesh-ancestor
25215534|NCT02689362|Hormones|hormones|mesh-ancestor
25215535|NCT02689362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25215536|NCT02689362|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25215537|NCT02689362|Protease Inhibitors|protease inhibitors|mesh-ancestor
25215538|NCT02689362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215539|NCT02689362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215540|NCT02689596|Oxytocin|oxytocin|mesh-list
25215541|NCT02689596|Oxytocics|oxytocics|mesh-ancestor
25215542|NCT02689596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25215543|NCT02689596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215544|NCT02689583|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25215545|NCT02689583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25215546|NCT02689583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25215547|NCT02689583|Antitubercular Agents|antitubercular agents|mesh-ancestor
25215548|NCT02689401|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25215549|NCT02689401|Hematinics|hematinics|mesh-ancestor
25215550|NCT02689401|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25215551|NCT02689401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25215552|NCT02689141|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25215553|NCT02689141|Ofatumumab|ofatumumab|mesh-list
25215554|NCT02689141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25215555|NCT02689141|Alkylating Agents|alkylating agents|mesh-ancestor
25215556|NCT02689141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215557|NCT02689141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215558|NCT02689297|Chlorine dioxide|chlorine dioxide|mesh-list
25215559|NCT02689297|Dental Disinfectants|dental disinfectants|mesh-ancestor
25215560|NCT02689297|Disinfectants|disinfectants|mesh-ancestor
25215561|NCT02689297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25215562|NCT02689180|Furosemide|furosemide|mesh-list
25215563|NCT02689180|Diuretics|diuretics|mesh-ancestor
25215564|NCT02689180|Natriuretic Agents|natriuretic agents|mesh-ancestor
25215565|NCT02689180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215566|NCT02689180|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25215567|NCT02689180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25215568|NCT02689180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272841|NCT02389439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25272842|NCT02389439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25272843|NCT02389439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272844|NCT02389439|Antiviral Agents|antiviral agents|mesh-ancestor
25159909|NCT03504956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969599|NCT03742115|Glucocorticoids|glucocorticoids|mesh-ancestor
24969620|NCT03741933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24969621|NCT03741933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969622|NCT03741894|Chlorhexidine|chlorhexidine|mesh-list
24969623|NCT03741894|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24969624|NCT03741894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24969625|NCT03741894|Disinfectants|disinfectants|mesh-ancestor
24969626|NCT03741686|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
25215569|NCT02689245|Tenofovir|tenofovir|mesh-list
25215570|NCT02689245|Antiviral Agents|antiviral agents|mesh-ancestor
25215571|NCT02689245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25215572|NCT02689245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25215573|NCT02689245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25215574|NCT02689245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215575|NCT02689245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215576|NCT02689245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24539263|NCT00662948|Rituximab|rituximab|mesh-list
25215577|NCT02689245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25215578|NCT02689336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25215579|NCT02689336|Temozolomide|temozolomide|mesh-list
25215580|NCT02689336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215581|NCT02689336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25215582|NCT02689336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215583|NCT02689336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215584|NCT02689336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25215585|NCT02689336|Alkylating Agents|alkylating agents|mesh-ancestor
25215590|NCT02689089|Rifapentine|rifapentine|mesh-list
25215591|NCT02689089|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25215592|NCT02689089|Antitubercular Agents|antitubercular agents|mesh-ancestor
25215594|NCT02689089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25215595|NCT02689089|Leprostatic Agents|leprostatic agents|mesh-ancestor
25215596|NCT02689024|Acetaminophen|acetaminophen|mesh-list
25215597|NCT02689024|Dipyrone|dipyrone|mesh-list
25215598|NCT02689024|Ibuprofen|ibuprofen|mesh-list
25215599|NCT02689024|Diclofenac|diclofenac|mesh-list
25215600|NCT02689024|Naproxen|naproxen|mesh-list
25215601|NCT02689024|Fentanyl|fentanyl|mesh-list
25215602|NCT02689024|Morphine|morphine|mesh-list
24830932|NCT02162134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24830933|NCT02162134|Anesthetics, General|anesthetics, general|mesh-ancestor
24830934|NCT02162134|Anesthetics|anesthetics|mesh-ancestor
24830935|NCT02162134|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24830936|NCT02162134|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24830937|NCT02162134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25041985|NCT01520545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25041986|NCT01520545|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25041988|NCT01520545|GABA Agents|gaba agents|mesh-ancestor
25041989|NCT01520545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25041990|NCT01520545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041991|NCT01519804|Paclitaxel|paclitaxel|mesh-list
25041992|NCT01519804|Carboplatin|carboplatin|mesh-list
25215603|NCT02689024|Bupivacaine|bupivacaine|mesh-list
25215604|NCT02689024|Ropivacaine|ropivacaine|mesh-list
25215605|NCT02689024|Levobupivacaine|levobupivacaine|mesh-list
25215606|NCT02689024|Anesthetics, Local|anesthetics, local|mesh-ancestor
25215607|NCT02689024|Anesthetics|anesthetics|mesh-ancestor
25215608|NCT02689024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25215609|NCT02689024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215610|NCT02689024|Sensory System Agents|sensory system agents|mesh-ancestor
25215611|NCT02689024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25215612|NCT02689024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25215613|NCT02689024|Narcotics|narcotics|mesh-ancestor
25215614|NCT02689024|Analgesics|analgesics|mesh-ancestor
25215615|NCT02689024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25215616|NCT02689024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25215617|NCT02689024|Anesthetics, General|anesthetics, general|mesh-ancestor
25215618|NCT02689024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25215619|NCT02689024|Antipyretics|antipyretics|mesh-ancestor
25215620|NCT02689024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25215621|NCT02689024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25215622|NCT02689024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25215623|NCT02689024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25215624|NCT02689024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215625|NCT02689024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215626|NCT02689024|Gout Suppressants|gout suppressants|mesh-ancestor
25215627|NCT02689037|Aspirin|aspirin|mesh-list
25215628|NCT02689037|Clopidogrel|clopidogrel|mesh-list
25215629|NCT02689037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25215630|NCT02689037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25215631|NCT02689037|Analgesics|analgesics|mesh-ancestor
25215632|NCT02689037|Sensory System Agents|sensory system agents|mesh-ancestor
25215633|NCT02689037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25215634|NCT02689037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215635|NCT02689037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25215636|NCT02689037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25215637|NCT02689037|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25215638|NCT02689037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25215639|NCT02689037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215640|NCT02689037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25215643|NCT02689037|Antipyretics|antipyretics|mesh-ancestor
24539363|NCT00663455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539364|NCT00663455|Antifungal Agents|antifungal agents|mesh-ancestor
24539365|NCT00663455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24830942|NCT02162134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830943|NCT02162134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24731639|NCT01635829|Analgesics|analgesics|mesh-ancestor
25215644|NCT02689037|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25215645|NCT02689037|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25215646|NCT02689037|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25215647|NCT02689037|Purinergic Agents|purinergic agents|mesh-ancestor
25215648|NCT02689037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25215649|NCT02688803|Paclitaxel|paclitaxel|mesh-list
25215650|NCT02688803|Docetaxel|docetaxel|mesh-list
25215651|NCT02688803|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25215652|NCT02688803|Cyclophosphamide|cyclophosphamide|mesh-list
25215653|NCT02688803|Doxorubicin|doxorubicin|mesh-list
25215654|NCT02688803|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25215655|NCT02688803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25215656|NCT02688803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215657|NCT02688803|Tubulin Modulators|tubulin modulators|mesh-ancestor
25215658|NCT02688803|Antimitotic Agents|antimitotic agents|mesh-ancestor
25215659|NCT02688803|Mitosis Modulators|mitosis modulators|mesh-ancestor
25215660|NCT02688803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215661|NCT02688803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25679097|NCT01833546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25215662|NCT02688803|Immunologic Factors|immunologic factors|mesh-ancestor
25215663|NCT02688803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215664|NCT02688803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25215665|NCT02688803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25215666|NCT02688803|Alkylating Agents|alkylating agents|mesh-ancestor
25215667|NCT02688803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25215668|NCT02688803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25215669|NCT02688803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25215670|NCT02688803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25215671|NCT02688803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215672|NCT02688738|Doxycycline|doxycycline|mesh-list
25215673|NCT02688738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25215674|NCT02688738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25215675|NCT02688738|Antimalarials|antimalarials|mesh-ancestor
25215676|NCT02688738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25215677|NCT02688738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25215682|NCT02688465|Apomorphine|apomorphine|mesh-list
25215683|NCT02688465|Emetics|emetics|mesh-ancestor
25215684|NCT02688465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215685|NCT02688465|Autonomic Agents|autonomic agents|mesh-ancestor
25215686|NCT02688465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24731769|NCT01636505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25215687|NCT02688465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25215688|NCT02688465|Dopamine Agonists|dopamine agonists|mesh-ancestor
25215689|NCT02688465|Dopamine Agents|dopamine agents|mesh-ancestor
25215690|NCT02688465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25215691|NCT02688465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215693|NCT02688907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215694|NCT02688907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215695|NCT02688634|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25215696|NCT02688634|Amoxicillin|amoxicillin|mesh-list
25215697|NCT02688634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25215698|NCT02688491|Sunitinib|sunitinib|mesh-list
25215699|NCT02688491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215700|NCT02688491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25215701|NCT02688491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25215702|NCT02688491|Growth Substances|growth substances|mesh-ancestor
25215703|NCT02688491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215704|NCT02688491|Growth Inhibitors|growth inhibitors|mesh-ancestor
25215705|NCT02688491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25215706|NCT02688491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215707|NCT02688491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215708|NCT02688595|Anesthetics|anesthetics|mesh-list
25215709|NCT02688595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25215710|NCT02688595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215711|NCT02688400|Celecoxib|celecoxib|mesh-list
25215712|NCT02688400|Diacetylrhein|diacetylrhein|mesh-list
25215713|NCT02688400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25215714|NCT02688400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25215715|NCT02688400|Analgesics|analgesics|mesh-ancestor
25215716|NCT02688400|Sensory System Agents|sensory system agents|mesh-ancestor
25215717|NCT02688400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25215718|NCT02688400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215719|NCT02688400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25215720|NCT02688400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25215721|NCT02688400|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25215722|NCT02688400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25215723|NCT02688400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215724|NCT02688400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215725|NCT02688361|Acetylcysteine|acetylcysteine|mesh-list
25215726|NCT02688361|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25215727|NCT02688361|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25264830|NCT02438072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830968|NCT02162251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830970|NCT02162264|Donepezil|donepezil|mesh-list
24830971|NCT02162264|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24830972|NCT02162264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830973|NCT02162264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830974|NCT02162264|Cholinergic Agents|cholinergic agents|mesh-ancestor
24830975|NCT02162264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24830976|NCT02162264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830977|NCT02162264|Nootropic Agents|nootropic agents|mesh-ancestor
25215728|NCT02688361|Antiviral Agents|antiviral agents|mesh-ancestor
25215729|NCT02688361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25215730|NCT02688361|Expectorants|expectorants|mesh-ancestor
25215731|NCT02688361|Respiratory System Agents|respiratory system agents|mesh-ancestor
25215732|NCT02688361|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25215733|NCT02688361|Antioxidants|antioxidants|mesh-ancestor
25215734|NCT02688361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215735|NCT02688361|Protective Agents|protective agents|mesh-ancestor
25215736|NCT02688361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215737|NCT02688361|Antidotes|antidotes|mesh-ancestor
25215738|NCT02688127|Tranexamic Acid|tranexamic acid|mesh-list
25215739|NCT02688127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25215740|NCT02688127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25215741|NCT02688127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215742|NCT02688127|Hemostatics|hemostatics|mesh-ancestor
25215743|NCT02688127|Coagulants|coagulants|mesh-ancestor
25215744|NCT02688270|Nitroglycerin|nitroglycerin|mesh-list
25215745|NCT02688270|Vasodilator Agents|vasodilator agents|mesh-ancestor
25215746|NCT02688374|Nicotine|nicotine|mesh-list
25215747|NCT02688374|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25215748|NCT02688374|Autonomic Agents|autonomic agents|mesh-ancestor
25215749|NCT02688374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25215750|NCT02688374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215751|NCT02688374|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25215752|NCT02688374|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25215753|NCT02688374|Cholinergic Agents|cholinergic agents|mesh-ancestor
25215754|NCT02688374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25215755|NCT02688374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215756|NCT02688088|Midazolam|midazolam|mesh-list
25215757|NCT02688088|Dextromethorphan|dextromethorphan|mesh-list
25215758|NCT02688088|Caffeine|caffeine|mesh-list
25215759|NCT02688088|Warfarin|warfarin|mesh-list
25215760|NCT02688088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25215761|NCT02688088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25215762|NCT02688088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25215763|NCT02688088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215764|NCT02688088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25215765|NCT02688088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25215766|NCT02688088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25215767|NCT02688088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25215768|NCT02688088|Anesthetics, General|anesthetics, general|mesh-ancestor
24830989|NCT02162381|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24830990|NCT02162381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24830991|NCT02162381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24830992|NCT02162381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830993|NCT02162381|Dopamine Agents|dopamine agents|mesh-ancestor
24830994|NCT02162381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24830995|NCT02162407|Insulin|insulin|mesh-list
24830996|NCT02162407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24830997|NCT02162407|Insulin Detemir|insulin detemir|mesh-list
25679098|NCT01833546|Immunologic Factors|immunologic factors|mesh-ancestor
25679099|NCT01833546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969627|NCT03741686|Cathartics|cathartics|mesh-ancestor
24969628|NCT03741686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24969629|NCT03741660|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
24969630|NCT03741660|Cathartics|cathartics|mesh-ancestor
24969631|NCT03741660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24969632|NCT03741621|Psyllium|psyllium|mesh-list
24969633|NCT03741621|Cathartics|cathartics|mesh-ancestor
24969634|NCT03741621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24969635|NCT03741478|Insulin|insulin|mesh-list
24969636|NCT03741478|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24969637|NCT03741478|Insulin Lispro|insulin lispro|mesh-list
24969638|NCT03741478|Olanzapine|olanzapine|mesh-list
24969639|NCT03741478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24969640|NCT03741478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969641|NCT03741478|Antiemetics|antiemetics|mesh-ancestor
24969642|NCT03741478|Autonomic Agents|autonomic agents|mesh-ancestor
24969643|NCT03741478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969644|NCT03741478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24969645|NCT03741478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24969646|NCT03741478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24969647|NCT03741478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24969648|NCT03741478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24969649|NCT03741478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24501455|NCT00528658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501456|NCT00528658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24501469|NCT00528723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24501470|NCT00528723|Respiratory System Agents|respiratory system agents|mesh-ancestor
24501471|NCT00528723|Tocolytic Agents|tocolytic agents|mesh-ancestor
24501472|NCT00528723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25215769|NCT02688088|Anesthetics|anesthetics|mesh-ancestor
25215770|NCT02688088|GABA Modulators|gaba modulators|mesh-ancestor
25215771|NCT02688088|GABA Agents|gaba agents|mesh-ancestor
25215772|NCT02688088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25215773|NCT02688088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215774|NCT02688088|Anticoagulants|anticoagulants|mesh-ancestor
25215775|NCT02688088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25215776|NCT02688088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25215778|NCT02688088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25215779|NCT02688088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25215780|NCT02688088|Purinergic Agents|purinergic agents|mesh-ancestor
25215781|NCT02688088|Antitussive Agents|antitussive agents|mesh-ancestor
25215782|NCT02688088|Respiratory System Agents|respiratory system agents|mesh-ancestor
25215783|NCT02688088|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25215784|NCT02688088|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25215785|NCT02688322|Sulbactam|sulbactam|mesh-list
25215786|NCT02688322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25215787|NCT02688322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25215788|NCT02688322|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24939352|NCT04011033|Analgesics|analgesics|mesh-ancestor
25215789|NCT02688322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215790|NCT02688322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215791|NCT02687984|Risperidone|risperidone|mesh-list
25215794|NCT02687984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25215795|NCT02687984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215796|NCT02687984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215797|NCT02687984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25215798|NCT02687984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25215799|NCT02687984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25215800|NCT02687984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25215801|NCT02687984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25215802|NCT02687984|Dopamine Agents|dopamine agents|mesh-ancestor
25215803|NCT02687971|Miltefosine|miltefosine|mesh-list
25215804|NCT02687971|Antifungal Agents|antifungal agents|mesh-ancestor
25215805|NCT02687971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25215806|NCT02687971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215807|NCT02687971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25215808|NCT02687971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25215809|NCT02688023|Leucovorin|leucovorin|mesh-list
25215810|NCT02688023|Fluorouracil|fluorouracil|mesh-list
25215811|NCT02688023|Capecitabine|capecitabine|mesh-list
25215812|NCT02688023|Oxaliplatin|oxaliplatin|mesh-list
25215813|NCT02688023|Irinotecan|irinotecan|mesh-list
25215814|NCT02688023|Antimetabolites|antimetabolites|mesh-ancestor
25215815|NCT02688023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215816|NCT02688023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25215817|NCT02688023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215818|NCT02688023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25215819|NCT02688023|Immunologic Factors|immunologic factors|mesh-ancestor
25215820|NCT02688023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215821|NCT02688023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25215822|NCT02688023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25215823|NCT02688023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215824|NCT02688023|Antidotes|antidotes|mesh-ancestor
25215825|NCT02688023|Protective Agents|protective agents|mesh-ancestor
25215826|NCT02688023|Vitamin B Complex|vitamin b complex|mesh-ancestor
25215827|NCT02688023|Vitamins|vitamins|mesh-ancestor
25215828|NCT02688023|Micronutrients|micronutrients|mesh-ancestor
25215829|NCT02687724|Golimumab|golimumab|mesh-list
25215830|NCT02687724|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25215831|NCT02687724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25215832|NCT02687724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25215833|NCT02687724|Immunologic Factors|immunologic factors|mesh-ancestor
25215834|NCT02687724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215835|NCT02687958|Everolimus|everolimus|mesh-list
25215836|NCT02687958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215837|NCT02687958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25215838|NCT02687958|Immunologic Factors|immunologic factors|mesh-ancestor
25215839|NCT02687958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215840|NCT02687841|Pentoxifylline|pentoxifylline|mesh-list
25215841|NCT02687841|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25215842|NCT02687841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215843|NCT02687841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215844|NCT02687841|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25215845|NCT02687841|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25215846|NCT02687841|Protective Agents|protective agents|mesh-ancestor
24831018|NCT02162485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24449112|NCT00314457|Anesthetics, Local|anesthetics, local|mesh-ancestor
24449113|NCT00314457|Anesthetics|anesthetics|mesh-ancestor
24449114|NCT00314457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24449115|NCT00314457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449116|NCT00314457|Sensory System Agents|sensory system agents|mesh-ancestor
25215847|NCT02687841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215848|NCT02687841|Vasodilator Agents|vasodilator agents|mesh-ancestor
25215849|NCT02687841|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25215850|NCT02687841|Antioxidants|antioxidants|mesh-ancestor
25215851|NCT02687906|Meropenem|meropenem|mesh-list
25215852|NCT02687906|Vaborbactam|vaborbactam|mesh-list
25215853|NCT02687906|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
25215854|NCT02687906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25215855|NCT02687906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25215856|NCT02687906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215857|NCT02687906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215858|NCT02687932|Valsartan|valsartan|mesh-list
25215859|NCT02687932|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25215860|NCT02687932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24539523|NCT00664222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24539524|NCT00664222|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24539525|NCT00664248|Clindamycin|clindamycin|mesh-list
24539526|NCT00664248|Clindamycin palmitate|clindamycin palmitate|mesh-list
25215861|NCT02687932|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25215862|NCT02687932|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25215863|NCT02687932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215864|NCT02687867|Vitamin K|vitamin k|mesh-list
25215865|NCT02687867|Dabigatran|dabigatran|mesh-list
25215866|NCT02687867|Vitamins|vitamins|mesh-ancestor
25215867|NCT02687867|Micronutrients|micronutrients|mesh-ancestor
25215868|NCT02687867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215869|NCT02687867|Antithrombins|antithrombins|mesh-ancestor
25215870|NCT02687867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25215871|NCT02687867|Protease Inhibitors|protease inhibitors|mesh-ancestor
25215872|NCT02687867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215873|NCT02687867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215874|NCT02687867|Anticoagulants|anticoagulants|mesh-ancestor
25215875|NCT02687867|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25215876|NCT02687867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25215877|NCT02687867|Hemostatics|hemostatics|mesh-ancestor
25215878|NCT02687867|Coagulants|coagulants|mesh-ancestor
25215879|NCT02687854|Vitamin K|vitamin k|mesh-list
25215880|NCT02687854|Apixaban|apixaban|mesh-list
25215881|NCT02687854|Vitamins|vitamins|mesh-ancestor
25215882|NCT02687854|Micronutrients|micronutrients|mesh-ancestor
25215883|NCT02687854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215884|NCT02687854|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25215885|NCT02687854|Antithrombins|antithrombins|mesh-ancestor
25215886|NCT02687854|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25215887|NCT02687854|Protease Inhibitors|protease inhibitors|mesh-ancestor
25215888|NCT02687854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215889|NCT02687854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215890|NCT02687854|Anticoagulants|anticoagulants|mesh-ancestor
25215891|NCT02687854|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25215892|NCT02687854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25215893|NCT02687854|Hemostatics|hemostatics|mesh-ancestor
25215894|NCT02687854|Coagulants|coagulants|mesh-ancestor
25215895|NCT02687490|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25215896|NCT02687490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215897|NCT02687347|Morphine|morphine|mesh-list
25215898|NCT02687347|Methadone|methadone|mesh-list
24501476|NCT00528723|Adrenergic Agents|adrenergic agents|mesh-ancestor
24501477|NCT00528723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24501479|NCT00528814|Hand Sanitizers|hand sanitizers|mesh-list
24501505|NCT00528983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24501506|NCT00528983|Antimetabolites|antimetabolites|mesh-ancestor
24501507|NCT00528983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501508|NCT00528983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24969689|NCT03740893|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24969690|NCT03740893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24969691|NCT03740893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969692|NCT03740581|Insulin|insulin|mesh-list
24969693|NCT03740581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24539547|NCT00664313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042012|NCT01516541|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24969695|NCT03740568|Progesterone|progesterone|mesh-list
24969696|NCT03740568|Progestins|progestins|mesh-ancestor
24969697|NCT03740568|Hormones|hormones|mesh-ancestor
25083022|NCT03318471|Magnesium Sulfate|magnesium sulfate|mesh-list
24969698|NCT03740568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24969699|NCT03740568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969700|NCT03740516|Apremilast|apremilast|mesh-list
24969701|NCT03740516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24969702|NCT03740516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24969703|NCT03740516|Analgesics|analgesics|mesh-ancestor
25215899|NCT02687347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25215900|NCT02687347|Narcotics|narcotics|mesh-ancestor
25215901|NCT02687347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25215902|NCT02687347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215903|NCT02687347|Analgesics|analgesics|mesh-ancestor
25215904|NCT02687347|Sensory System Agents|sensory system agents|mesh-ancestor
25215905|NCT02687347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25215906|NCT02687347|Antitussive Agents|antitussive agents|mesh-ancestor
25215907|NCT02687347|Respiratory System Agents|respiratory system agents|mesh-ancestor
25215908|NCT02687425|Pioglitazone|pioglitazone|mesh-list
25215909|NCT02687425|Imatinib Mesylate|imatinib mesylate|mesh-list
25215910|NCT02687425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25215911|NCT02687425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215912|NCT02687425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215913|NCT02687425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25215914|NCT02687425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215915|NCT02687425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215916|NCT02687438|Mometasone Furoate|mometasone furoate|mesh-list
25215917|NCT02687438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25215918|NCT02687438|Dermatologic Agents|dermatologic agents|mesh-ancestor
25215919|NCT02687438|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25272849|NCT02389426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25272850|NCT02389426|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25272851|NCT02389426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272852|NCT02389348|Artefenomel|artefenomel|mesh-list
25679100|NCT01833741|Bimatoprost|bimatoprost|mesh-list
24928070|NCT04126668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25215920|NCT02687256|Heparin|heparin|mesh-list
25215921|NCT02687256|Anticoagulants|anticoagulants|mesh-ancestor
25215922|NCT02687256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25215923|NCT02687256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25215924|NCT02687256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215925|NCT02687269|Ranolazine|ranolazine|mesh-list
25215926|NCT02687269|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25215927|NCT02687269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25215928|NCT02687269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215929|NCT02687204|Enoxaparin|enoxaparin|mesh-list
25215930|NCT02687204|Enoxaparin sodium|enoxaparin sodium|mesh-list
25215931|NCT02687204|Anticoagulants|anticoagulants|mesh-ancestor
25215932|NCT02687204|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25215933|NCT02687204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25215934|NCT02687204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25215935|NCT02686983|Betamethasone|betamethasone|mesh-list
25215936|NCT02686983|Anesthetics|anesthetics|mesh-list
25215937|NCT02686983|Anesthetics, Local|anesthetics, local|mesh-list
25215938|NCT02686983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25215939|NCT02686983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215940|NCT02686983|Sensory System Agents|sensory system agents|mesh-ancestor
25215941|NCT02686983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25215942|NCT02686983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25215943|NCT02686983|Glucocorticoids|glucocorticoids|mesh-ancestor
25215944|NCT02686983|Hormones|hormones|mesh-ancestor
25215945|NCT02686983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25215946|NCT02686983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25215947|NCT02686983|Respiratory System Agents|respiratory system agents|mesh-ancestor
25215948|NCT02687178|Canrenone|canrenone|mesh-list
25215949|NCT02687178|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25215950|NCT02687178|Hormone Antagonists|hormone antagonists|mesh-ancestor
25215951|NCT02687178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25215952|NCT02687178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215953|NCT02687178|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25215954|NCT02687178|Diuretics|diuretics|mesh-ancestor
25215955|NCT02687178|Natriuretic Agents|natriuretic agents|mesh-ancestor
25041993|NCT01519804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25041994|NCT01519804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041995|NCT01519804|Tubulin Modulators|tubulin modulators|mesh-ancestor
25041996|NCT01519804|Antimitotic Agents|antimitotic agents|mesh-ancestor
25041997|NCT01519804|Mitosis Modulators|mitosis modulators|mesh-ancestor
25041998|NCT01519804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041999|NCT01517776|Temozolomide|temozolomide|mesh-list
25042000|NCT01517776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25042001|NCT01517776|Alkylating Agents|alkylating agents|mesh-ancestor
25042002|NCT01517776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501513|NCT00529022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215956|NCT02687009|Niclosamide|niclosamide|mesh-list
25215957|NCT02687009|Anticestodal Agents|anticestodal agents|mesh-ancestor
25215958|NCT02687009|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25215959|NCT02687009|Anthelmintics|anthelmintics|mesh-ancestor
25215960|NCT02687009|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25215961|NCT02687009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25215962|NCT02687009|Antinematodal Agents|antinematodal agents|mesh-ancestor
25215963|NCT02687100|Beclomethasone|beclomethasone|mesh-list
25215964|NCT02687100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25215965|NCT02687100|Glucocorticoids|glucocorticoids|mesh-ancestor
25215966|NCT02687100|Hormones|hormones|mesh-ancestor
25404883|NCT03646188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25215967|NCT02687100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25215969|NCT02687100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25215970|NCT02687100|Respiratory System Agents|respiratory system agents|mesh-ancestor
25215971|NCT02686905|Calcium, Dietary|calcium, dietary|mesh-list
25215972|NCT02686905|Vitamin D|vitamin d|mesh-list
25215973|NCT02686905|Vitamins|vitamins|mesh-list
25215974|NCT02686905|Hydroxocobalamin|hydroxocobalamin|mesh-list
25215975|NCT02686905|Vitamin B 12|vitamin b 12|mesh-list
25215976|NCT02686905|Calcium|calcium|mesh-list
25215977|NCT02686905|Micronutrients|micronutrients|mesh-ancestor
25215978|NCT02686905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215979|NCT02686905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25215980|NCT02686905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25215981|NCT02686905|Hematinics|hematinics|mesh-ancestor
25215982|NCT02686905|Vitamin B Complex|vitamin b complex|mesh-ancestor
25215983|NCT02686593|Mitoxantrone|mitoxantrone|mesh-list
25215984|NCT02686593|Clofarabine|clofarabine|mesh-list
25215985|NCT02686593|Analgesics|analgesics|mesh-ancestor
25215986|NCT02686593|Sensory System Agents|sensory system agents|mesh-ancestor
25215987|NCT02686593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25215988|NCT02686593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25215989|NCT02686593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25215990|NCT02686593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25215991|NCT02686593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25215992|NCT02686593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539806|NCT00665678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25215993|NCT02686593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042004|NCT01516918|Ribavirin|ribavirin|mesh-list
25042005|NCT01516918|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25042006|NCT01516918|Antimetabolites|antimetabolites|mesh-ancestor
25042007|NCT01516918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042008|NCT01516918|Antiviral Agents|antiviral agents|mesh-ancestor
25042009|NCT01516918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042010|NCT01516541|Dalcetrapib|dalcetrapib|mesh-list
25042011|NCT01516541|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24501514|NCT00529022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24501515|NCT00529022|Antimetabolites|antimetabolites|mesh-ancestor
24501516|NCT00529022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501517|NCT00529022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501518|NCT00529022|Anticonvulsants|anticonvulsants|mesh-ancestor
24501519|NCT00529022|GABA Agents|gaba agents|mesh-ancestor
24764098|NCT01779401|Purinergic Agents|purinergic agents|mesh-ancestor
24764099|NCT01779401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24501532|NCT00529269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24501533|NCT00529269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501534|NCT00529269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501536|NCT00529295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24969704|NCT03740516|Sensory System Agents|sensory system agents|mesh-ancestor
25215994|NCT02686593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25215995|NCT02686593|Antimetabolites|antimetabolites|mesh-ancestor
25215996|NCT02686619|Cyclosporine|cyclosporine|mesh-list
25215997|NCT02686619|Sirolimus|sirolimus|mesh-list
25215998|NCT02686619|Prednisolone|prednisolone|mesh-list
25215999|NCT02686619|Cyclosporins|cyclosporins|mesh-list
25216001|NCT02686619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25216002|NCT02686619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216003|NCT02686619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25216004|NCT02686619|Immunologic Factors|immunologic factors|mesh-ancestor
25216005|NCT02686619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216006|NCT02686619|Antifungal Agents|antifungal agents|mesh-ancestor
25216007|NCT02686619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25216008|NCT02686619|Dermatologic Agents|dermatologic agents|mesh-ancestor
25216009|NCT02686619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25216010|NCT02686619|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25216011|NCT02686619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25216012|NCT02686619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25216013|NCT02686619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25216014|NCT02686619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25216015|NCT02686619|Glucocorticoids|glucocorticoids|mesh-ancestor
25216016|NCT02686619|Hormones|hormones|mesh-ancestor
25216017|NCT02686619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25216018|NCT02686619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25216019|NCT02686710|Propofol|propofol|mesh-list
25216020|NCT02686710|Sevoflurane|sevoflurane|mesh-list
25216021|NCT02686710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25216022|NCT02686710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25216023|NCT02686710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216024|NCT02686710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25216025|NCT02686710|Anesthetics, General|anesthetics, general|mesh-ancestor
25216026|NCT02686710|Anesthetics|anesthetics|mesh-ancestor
25216027|NCT02686710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25216028|NCT02686710|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25216029|NCT02686684|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25216030|NCT02686684|Dermatologic Agents|dermatologic agents|mesh-ancestor
25216031|NCT02686684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25216032|NCT02686684|Immunologic Factors|immunologic factors|mesh-ancestor
25216033|NCT02686684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216035|NCT02686645|Vancomycin|vancomycin|mesh-list
25216036|NCT02686645|Loperamide|loperamide|mesh-list
25216037|NCT02686645|Antidiarrheals|antidiarrheals|mesh-list
25216038|NCT02686645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25216039|NCT02686645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25216040|NCT02686645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25216041|NCT02686645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25216042|NCT02686645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25216043|NCT02686853|Amphotericin B|amphotericin b|mesh-list
25216044|NCT02686853|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25216045|NCT02686853|Amebicides|amebicides|mesh-ancestor
25216046|NCT02686853|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25216047|NCT02686853|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25216048|NCT02686853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25216049|NCT02686853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25216050|NCT02686853|Antifungal Agents|antifungal agents|mesh-ancestor
25216051|NCT02686749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
25216052|NCT02686840|Misoprostol|misoprostol|mesh-list
25216053|NCT02686840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25216054|NCT02686840|Abortifacient Agents|abortifacient agents|mesh-ancestor
25216055|NCT02686840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25216056|NCT02686840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216057|NCT02686840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25216058|NCT02686840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25216059|NCT02686840|Oxytocics|oxytocics|mesh-ancestor
25216060|NCT02686827|Vitamin D|vitamin d|mesh-list
25216061|NCT02686827|Ergocalciferols|ergocalciferols|mesh-list
25216062|NCT02686827|Vitamins|vitamins|mesh-ancestor
25216063|NCT02686827|Micronutrients|micronutrients|mesh-ancestor
24831065|NCT02162784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25057628|NCT03503604|Immunologic Factors|immunologic factors|mesh-ancestor
25216064|NCT02686827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216065|NCT02686827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25216066|NCT02686827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25216067|NCT02686476|Empagliflozin|empagliflozin|mesh-list
25216068|NCT02686476|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25216069|NCT02686476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216070|NCT02686476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25216071|NCT02686476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216072|NCT02686385|Acetylcysteine|acetylcysteine|mesh-list
25216073|NCT02686385|Prednisolone|prednisolone|mesh-list
25216074|NCT02686385|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25216075|NCT02686385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25216076|NCT02686385|Glucocorticoids|glucocorticoids|mesh-ancestor
25216077|NCT02686385|Hormones|hormones|mesh-ancestor
25216078|NCT02686385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25216079|NCT02686385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216080|NCT02686385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25216081|NCT02686385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25216082|NCT02686385|Protective Agents|protective agents|mesh-ancestor
25216083|NCT02686385|Antiviral Agents|antiviral agents|mesh-ancestor
25216084|NCT02686385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25216085|NCT02686385|Expectorants|expectorants|mesh-ancestor
25216089|NCT02686385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216090|NCT02686385|Antidotes|antidotes|mesh-ancestor
25216091|NCT02686151|Dexamethasone|dexamethasone|mesh-list
25216092|NCT02686151|Letrozole|letrozole|mesh-list
25216093|NCT02686151|Polygeline|polygeline|mesh-list
25216094|NCT02686151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25216095|NCT02686151|Antiemetics|antiemetics|mesh-ancestor
25216096|NCT02686151|Autonomic Agents|autonomic agents|mesh-ancestor
25216097|NCT02686151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25216098|NCT02686151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216099|NCT02686151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25216100|NCT02686151|Glucocorticoids|glucocorticoids|mesh-ancestor
25216101|NCT02686151|Hormones|hormones|mesh-ancestor
25216102|NCT02686151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25216103|NCT02686151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25216104|NCT02686151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25216105|NCT02686151|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25216106|NCT02686151|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24764103|NCT01779401|Respiratory System Agents|respiratory system agents|mesh-ancestor
24764104|NCT01779401|Vasodilator Agents|vasodilator agents|mesh-ancestor
25216107|NCT02686151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25216108|NCT02686151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463578|NCT00361452|Mydriatics|mydriatics|mesh-ancestor
24831093|NCT02163070|Micronutrients|micronutrients|mesh-ancestor
24831094|NCT02163070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831095|NCT02163070|Antioxidants|antioxidants|mesh-ancestor
24831096|NCT02163070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831097|NCT02163070|Protective Agents|protective agents|mesh-ancestor
24831098|NCT02163161|Abrocitinib|abrocitinib|mesh-list
24831099|NCT02163161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24831100|NCT02163161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24831101|NCT02163161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831102|NCT02163174|Pentoxifylline|pentoxifylline|mesh-list
25216109|NCT02686151|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25216110|NCT02686151|Hormone Antagonists|hormone antagonists|mesh-ancestor
25216111|NCT02686151|Plasma Substitutes|plasma substitutes|mesh-ancestor
25216112|NCT02686151|Blood Substitutes|blood substitutes|mesh-ancestor
25216113|NCT02686242|Anesthetics|anesthetics|mesh-list
25216114|NCT02686242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25216115|NCT02686242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216117|NCT02686086|Ipratropium|ipratropium|mesh-list
25216118|NCT02686086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25216119|NCT02686086|Autonomic Agents|autonomic agents|mesh-ancestor
25216120|NCT02686086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25216121|NCT02686086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216122|NCT02686086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25216123|NCT02686086|Respiratory System Agents|respiratory system agents|mesh-ancestor
25216124|NCT02686086|Tocolytic Agents|tocolytic agents|mesh-ancestor
25216125|NCT02686086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25216126|NCT02686086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25216127|NCT02686086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25216128|NCT02686086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25216129|NCT02686086|Adrenergic Agents|adrenergic agents|mesh-ancestor
25216140|NCT02686177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25216155|NCT02685852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25216156|NCT02685852|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25216157|NCT02685852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25216158|NCT02685852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589261|NCT00906360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589262|NCT00906360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24589263|NCT00906360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24589264|NCT00906360|Growth Substances|growth substances|mesh-ancestor
24589265|NCT00906360|Growth Inhibitors|growth inhibitors|mesh-ancestor
24589266|NCT00906360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24589267|NCT00906360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24969705|NCT03740516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969706|NCT03740516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969707|NCT03740516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24969709|NCT03740516|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24969710|NCT03740516|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24969711|NCT03740516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24969712|NCT03740516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969713|NCT03740464|Lenograstim|lenograstim|mesh-list
24969714|NCT03740464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24969715|NCT03740464|Immunologic Factors|immunologic factors|mesh-ancestor
24969716|NCT03740464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969717|NCT03740438|Chrysarobin|chrysarobin|mesh-list
24736648|NCT01664013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24501571|NCT00529620|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24501573|NCT00529620|Artenimol|artenimol|mesh-list
24501574|NCT00529620|Sulfalene|sulfalene|mesh-list
24501581|NCT00529620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501582|NCT00529620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24501583|NCT00529620|Renal Agents|renal agents|mesh-ancestor
24501585|NCT00529646|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24501586|NCT00529646|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24501587|NCT00529646|Serotonin Agents|serotonin agents|mesh-ancestor
24501588|NCT00529646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24501591|NCT00529750|Atenolol|atenolol|mesh-list
24501664|NCT00530387|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25216159|NCT02686021|Dipyrone|dipyrone|mesh-list
25216160|NCT02686021|Ibuprofen|ibuprofen|mesh-list
25216161|NCT02686021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25216162|NCT02686021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25216164|NCT02686021|Sensory System Agents|sensory system agents|mesh-ancestor
25216165|NCT02686021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25216166|NCT02686021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216167|NCT02686021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25216168|NCT02686021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25216169|NCT02686021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25216170|NCT02686021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25216171|NCT02686021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216172|NCT02686021|Antipyretics|antipyretics|mesh-ancestor
25216173|NCT02685748|Aspirin|aspirin|mesh-list
25216174|NCT02685748|Pantoprazole|pantoprazole|mesh-list
24831103|NCT02163174|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24831104|NCT02163174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24831105|NCT02163174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831106|NCT02163174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24831107|NCT02163174|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24831108|NCT02163174|Protective Agents|protective agents|mesh-ancestor
24831124|NCT02163291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969721|NCT03740438|Sensory System Agents|sensory system agents|mesh-ancestor
24969722|NCT03740438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969723|NCT03740438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969724|NCT03740438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24969725|NCT03740438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24969727|NCT03740399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24969728|NCT03740399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216178|NCT02685748|Sensory System Agents|sensory system agents|mesh-ancestor
25216179|NCT02685748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25216180|NCT02685748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216181|NCT02685748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25216182|NCT02685748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25216183|NCT02685748|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25216184|NCT02685748|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25216185|NCT02685748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216186|NCT02685748|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25216187|NCT02685748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25216188|NCT02685748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25216189|NCT02685748|Antipyretics|antipyretics|mesh-ancestor
25216190|NCT02685748|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25216191|NCT02685748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25216192|NCT02685748|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25216193|NCT02685930|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25216194|NCT02685930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25216195|NCT02685930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25216196|NCT02685930|Antitubercular Agents|antitubercular agents|mesh-ancestor
25216197|NCT02685969|Flutemetamol|flutemetamol|mesh-list
25216198|NCT02685969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25216199|NCT02685969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216200|NCT02685657|Cyclophosphamide|cyclophosphamide|mesh-list
24540292|NCT00667160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24540293|NCT00667160|Analgesics|analgesics|mesh-ancestor
24540294|NCT00667160|Sensory System Agents|sensory system agents|mesh-ancestor
24540295|NCT00667160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25216203|NCT02685657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25216204|NCT02685657|Immunologic Factors|immunologic factors|mesh-ancestor
25216205|NCT02685657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216206|NCT02685657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25216207|NCT02685657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25216208|NCT02685657|Alkylating Agents|alkylating agents|mesh-ancestor
24969730|NCT03740386|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25216209|NCT02685657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216210|NCT02685657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25216211|NCT02685657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25216212|NCT02685657|Tubulin Modulators|tubulin modulators|mesh-ancestor
25216213|NCT02685657|Antimitotic Agents|antimitotic agents|mesh-ancestor
25216214|NCT02685657|Mitosis Modulators|mitosis modulators|mesh-ancestor
25216215|NCT02685657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25216216|NCT02685657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25216217|NCT02685657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25216218|NCT02685657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25216219|NCT02685774|Metformin|metformin|mesh-list
25216220|NCT02685774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25216221|NCT02685774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216222|NCT02685670|Cyclophosphamide|cyclophosphamide|mesh-list
25216223|NCT02685670|Fludarabine|fludarabine|mesh-list
25216224|NCT02685670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25216225|NCT02685670|Immunologic Factors|immunologic factors|mesh-ancestor
25216226|NCT02685670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216227|NCT02685670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25216228|NCT02685670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25216229|NCT02685670|Alkylating Agents|alkylating agents|mesh-ancestor
25216230|NCT02685670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216231|NCT02685670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25216232|NCT02685670|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25216233|NCT02686008|Olaparib|olaparib|mesh-list
25216234|NCT02686008|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25216235|NCT02686008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25216236|NCT02686008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216237|NCT02686008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272857|NCT02389322|BCG Vaccine|bcg vaccine|mesh-list
25272858|NCT02389322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25272859|NCT02389322|Immunologic Factors|immunologic factors|mesh-ancestor
25272860|NCT02389322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969731|NCT03740386|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24969732|NCT03740386|Adrenergic Agents|adrenergic agents|mesh-ancestor
24969733|NCT03740386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24969734|NCT03740386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501688|NCT00530413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24969752|NCT03740373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24969753|NCT03740373|Adrenergic Agents|adrenergic agents|mesh-ancestor
24969754|NCT03740373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24969755|NCT03740373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969756|NCT03740373|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24907520|NCT04329611|Hydroxychloroquine|hydroxychloroquine|mesh-list
24969757|NCT03740373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24969760|NCT03740295|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24969761|NCT03740295|Antioxidants|antioxidants|mesh-ancestor
24969762|NCT03740295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969763|NCT03740295|Protective Agents|protective agents|mesh-ancestor
24969764|NCT03740295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969765|NCT03740295|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24969766|NCT03740295|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24969767|NCT03740295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24969768|NCT03740295|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24969769|NCT03740243|Buprenorphine|buprenorphine|mesh-list
24969770|NCT03740243|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
24794022|NCT05414292|Sirolimus|sirolimus|mesh-list
24794023|NCT05414292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24794024|NCT05414292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24794025|NCT05414292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24794026|NCT05414292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25216238|NCT02685618|Iloprost|iloprost|mesh-list
25216239|NCT02685618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25216241|NCT02685397|Leuprolide|leuprolide|mesh-list
25216242|NCT02685397|Goserelin|goserelin|mesh-list
25216243|NCT02685397|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25216244|NCT02685397|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25216245|NCT02685397|Fertility Agents|fertility agents|mesh-ancestor
25216246|NCT02685397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25216247|NCT02685397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216248|NCT02685397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24764126|NCT01779492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764127|NCT01779492|Analgesics|analgesics|mesh-ancestor
24764128|NCT01779492|Sensory System Agents|sensory system agents|mesh-ancestor
24939378|NCT04010669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24939379|NCT04010669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939380|NCT04010578|Vitamin D|vitamin d|mesh-list
24939381|NCT04010578|Cholecalciferol|cholecalciferol|mesh-list
24939382|NCT04010578|Vitamins|vitamins|mesh-ancestor
24939383|NCT04010578|Micronutrients|micronutrients|mesh-ancestor
24939384|NCT04010578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812426|NCT02052167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24794049|NCT05414149|Ranibizumab|ranibizumab|mesh-list
24587241|NCT00893880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24587242|NCT00893880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587243|NCT00893880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25216249|NCT02685397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25216250|NCT02685397|Luteolytic Agents|luteolytic agents|mesh-ancestor
25216251|NCT02685397|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25216252|NCT02685397|Contraceptive Agents|contraceptive agents|mesh-ancestor
25216253|NCT02685397|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25216254|NCT02685345|Firuglipel|firuglipel|mesh-list
25216255|NCT02685345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25216256|NCT02685345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216257|NCT02685462|Digoxin|digoxin|mesh-list
25216258|NCT02685462|Caffeine|caffeine|mesh-list
25216259|NCT02685462|Atorvastatin|atorvastatin|mesh-list
25216260|NCT02685462|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25216261|NCT02685462|Simvastatin|simvastatin|mesh-list
25216262|NCT02685462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25216263|NCT02685462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25216264|NCT02685462|Antimetabolites|antimetabolites|mesh-ancestor
25216265|NCT02685462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216266|NCT02685462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25216267|NCT02685462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25216268|NCT02685462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25216269|NCT02685462|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25216270|NCT02685462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216272|NCT02685462|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25216273|NCT02685462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25216274|NCT02685462|Purinergic Agents|purinergic agents|mesh-ancestor
25216275|NCT02685462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25216276|NCT02685462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25216277|NCT02685462|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25216278|NCT02685462|Protective Agents|protective agents|mesh-ancestor
24443805|NCT00295997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24443974|NCT00296387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24444011|NCT00296530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24444012|NCT00296530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444013|NCT00296530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24444014|NCT00296530|Respiratory System Agents|respiratory system agents|mesh-ancestor
25216279|NCT02685306|Paclitaxel|paclitaxel|mesh-list
25216280|NCT02685306|Taxane|taxane|mesh-list
25216281|NCT02685306|Bavituximab|bavituximab|mesh-list
24831146|NCT02163655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24831147|NCT02163655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831148|NCT02163707|Psilocybin|psilocybin|mesh-list
24831149|NCT02163707|Hallucinogens|hallucinogens|mesh-ancestor
24831150|NCT02163707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587244|NCT00893880|Respiratory System Agents|respiratory system agents|mesh-ancestor
24587245|NCT00893880|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24587246|NCT00893880|Antioxidants|antioxidants|mesh-ancestor
24587247|NCT00893880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587248|NCT00893880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24587249|NCT00893880|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25216282|NCT02685306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25216283|NCT02685306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25216284|NCT02685306|Tubulin Modulators|tubulin modulators|mesh-ancestor
25216285|NCT02685306|Antimitotic Agents|antimitotic agents|mesh-ancestor
25216286|NCT02685306|Mitosis Modulators|mitosis modulators|mesh-ancestor
25216287|NCT02685306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216288|NCT02685306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25216289|NCT02685449|Insulin|insulin|mesh-list
25216290|NCT02685449|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25216291|NCT02685449|Insulin Aspart|insulin aspart|mesh-list
25216292|NCT02685449|Insulin Lispro|insulin lispro|mesh-list
25216293|NCT02685449|Insulin glulisine|insulin glulisine|mesh-list
25216294|NCT02685449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25216295|NCT02685449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216296|NCT02685592|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25216297|NCT02685592|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25216298|NCT02685592|Dermatologic Agents|dermatologic agents|mesh-ancestor
25216299|NCT02685228|Gemcitabine|gemcitabine|mesh-list
25216300|NCT02685228|Decitabine|decitabine|mesh-list
25216301|NCT02685228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24540406|NCT00667901|Anticonvulsants|anticonvulsants|mesh-ancestor
25216302|NCT02685228|Antimetabolites|antimetabolites|mesh-ancestor
25216303|NCT02685228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216304|NCT02685228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25216305|NCT02685228|Antiviral Agents|antiviral agents|mesh-ancestor
25216306|NCT02685228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25216307|NCT02685228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25216309|NCT02685228|Immunologic Factors|immunologic factors|mesh-ancestor
25216310|NCT02685228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216311|NCT02685163|Antioxidants|antioxidants|mesh-list
25216312|NCT02685163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216313|NCT02685163|Protective Agents|protective agents|mesh-ancestor
25216314|NCT02685163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216315|NCT02685137|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
25042046|NCT01516203|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25042047|NCT01516203|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25042048|NCT01516203|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25042049|NCT01516203|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25042050|NCT01516203|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25042051|NCT01516203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25042053|NCT01516203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25042054|NCT01516086|Fluticasone|fluticasone|mesh-list
25042056|NCT01516086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25042057|NCT01516086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25042058|NCT01516086|Autonomic Agents|autonomic agents|mesh-ancestor
25042059|NCT01516086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25042060|NCT01516086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042061|NCT01516086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25042062|NCT01516086|Respiratory System Agents|respiratory system agents|mesh-ancestor
25042063|NCT01516086|Dermatologic Agents|dermatologic agents|mesh-ancestor
25042065|NCT01516073|Fluticasone|fluticasone|mesh-list
25042066|NCT01516073|Xhance|xhance|mesh-list
25042067|NCT01516073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25042068|NCT01516073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25042069|NCT01516073|Autonomic Agents|autonomic agents|mesh-ancestor
24540426|NCT00667966|Vasodilator Agents|vasodilator agents|mesh-ancestor
24540427|NCT00667966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24540428|NCT00667966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24969771|NCT03740243|Naloxone|naloxone|mesh-list
24969772|NCT03740243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24969774|NCT03740243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24969775|NCT03740243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969776|NCT03740243|Analgesics|analgesics|mesh-ancestor
24969777|NCT03740243|Sensory System Agents|sensory system agents|mesh-ancestor
24969778|NCT03740243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969779|NCT03740243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24969780|NCT03740178|Donepezil|donepezil|mesh-list
24501689|NCT00530478|Donepezil|donepezil|mesh-list
24501690|NCT00530478|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24501691|NCT00530478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501692|NCT00530478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216316|NCT02685137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25216317|NCT02685137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216318|NCT02685111|Lenograstim|lenograstim|mesh-list
25216319|NCT02685111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25216320|NCT02685111|Immunologic Factors|immunologic factors|mesh-ancestor
25216321|NCT02685111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216322|NCT02685150|Omeprazole|omeprazole|mesh-list
25216323|NCT02685150|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25216324|NCT02685150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25216325|NCT02685150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25216326|NCT02685150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25216327|NCT02685150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216328|NCT02684812|Tranexamic Acid|tranexamic acid|mesh-list
25216329|NCT02684812|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25216330|NCT02684812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25216331|NCT02684812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216332|NCT02684812|Hemostatics|hemostatics|mesh-ancestor
25216333|NCT02684812|Coagulants|coagulants|mesh-ancestor
25216334|NCT02684786|Lidocaine|lidocaine|mesh-list
25216335|NCT02684786|Reserpine|reserpine|mesh-list
25216336|NCT02684786|Anesthetics, Local|anesthetics, local|mesh-ancestor
25216337|NCT02684786|Anesthetics|anesthetics|mesh-ancestor
25216338|NCT02684786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25216339|NCT02684786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216340|NCT02684786|Sensory System Agents|sensory system agents|mesh-ancestor
25216341|NCT02684786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25216342|NCT02684786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24540460|NCT00668031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540462|NCT00668044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25216343|NCT02684786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25216344|NCT02684786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25216345|NCT02684786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24831157|NCT02163720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24831158|NCT02163720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25216346|NCT02684786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216347|NCT02684786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25216348|NCT02684786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25216349|NCT02684786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25216350|NCT02684786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25216351|NCT02684786|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25216352|NCT02684786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25216353|NCT02684786|Adrenergic Agents|adrenergic agents|mesh-ancestor
25216354|NCT02684786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25216356|NCT02684799|Omeprazole|omeprazole|mesh-list
25216357|NCT02684799|Famotidine|famotidine|mesh-list
25216358|NCT02684799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25216359|NCT02684799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25216360|NCT02684799|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25216361|NCT02684799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25216362|NCT02684799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216363|NCT02684799|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25216364|NCT02684799|Histamine Antagonists|histamine antagonists|mesh-ancestor
25216365|NCT02684799|Histamine Agents|histamine agents|mesh-ancestor
25216366|NCT02684799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25216367|NCT02684799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216368|NCT02684799|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25216369|NCT02684799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24540501|NCT00668122|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24540502|NCT00668122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24540505|NCT00668135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25216370|NCT02684799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25216371|NCT02684799|Antiviral Agents|antiviral agents|mesh-ancestor
25216372|NCT02684799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25216373|NCT02685176|Charcoal|charcoal|mesh-list
25216374|NCT02685176|Antidotes|antidotes|mesh-ancestor
25216375|NCT02685176|Protective Agents|protective agents|mesh-ancestor
25216376|NCT02685176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216377|NCT02685085|Misoprostol|misoprostol|mesh-list
25216378|NCT02685085|Dinoprostone|dinoprostone|mesh-list
25216379|NCT02685085|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25216380|NCT02685085|Abortifacient Agents|abortifacient agents|mesh-ancestor
25216381|NCT02685085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25216382|NCT02685085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216383|NCT02685085|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25216384|NCT02685085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25216385|NCT02685085|Oxytocics|oxytocics|mesh-ancestor
25216386|NCT02685059|Paclitaxel|paclitaxel|mesh-list
24831194|NCT02164006|Immunologic Factors|immunologic factors|mesh-ancestor
24831195|NCT02164006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216391|NCT02685059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25216392|NCT02685059|Tubulin Modulators|tubulin modulators|mesh-ancestor
25216393|NCT02685059|Antimitotic Agents|antimitotic agents|mesh-ancestor
25216394|NCT02685059|Mitosis Modulators|mitosis modulators|mesh-ancestor
25216395|NCT02685059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216396|NCT02685059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25216397|NCT02685059|Immunologic Factors|immunologic factors|mesh-ancestor
25216398|NCT02685059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216399|NCT02685059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25216400|NCT02685059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25216401|NCT02685059|Alkylating Agents|alkylating agents|mesh-ancestor
25216402|NCT02685059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25216403|NCT02685059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25216404|NCT02685059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25216405|NCT02685059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25216406|NCT02685059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25216407|NCT02685059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24955584|NCT03864016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955585|NCT03864016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24955586|NCT03864016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24812472|NCT02052336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216409|NCT02685189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25216410|NCT02685189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216411|NCT02685046|Imatinib Mesylate|imatinib mesylate|mesh-list
25216412|NCT02685046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25216413|NCT02685046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25216414|NCT02685046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25216415|NCT02685046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679101|NCT01833741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24640573|NCT01169012|Antimetabolites|antimetabolites|mesh-ancestor
25216417|NCT02684708|Cyclophosphamide|cyclophosphamide|mesh-list
25216418|NCT02684708|Dacarbazine|dacarbazine|mesh-list
25216419|NCT02684708|Vincristine|vincristine|mesh-list
25216420|NCT02684708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25216421|NCT02684708|Immunologic Factors|immunologic factors|mesh-ancestor
25216422|NCT02684708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216423|NCT02684708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25216424|NCT02684708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25216425|NCT02684708|Alkylating Agents|alkylating agents|mesh-ancestor
24501698|NCT00530517|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24501708|NCT00530556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24501709|NCT00530556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501710|NCT00530556|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24501712|NCT00530556|GABA Agents|gaba agents|mesh-ancestor
24501713|NCT00530556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24969781|NCT03740178|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24969782|NCT03740178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24969783|NCT03740178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083023|NCT03318471|Analgesics|analgesics|mesh-ancestor
24969784|NCT03740178|Cholinergic Agents|cholinergic agents|mesh-ancestor
24969785|NCT03740178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24969786|NCT03740178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969787|NCT03740178|Nootropic Agents|nootropic agents|mesh-ancestor
25216426|NCT02684708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216427|NCT02684708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25216428|NCT02684708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25216429|NCT02684708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25216430|NCT02684708|Glucocorticoids|glucocorticoids|mesh-ancestor
25216431|NCT02684708|Hormones|hormones|mesh-ancestor
25216432|NCT02684708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25216433|NCT02684708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25216435|NCT02684708|Tubulin Modulators|tubulin modulators|mesh-ancestor
25216436|NCT02684708|Antimitotic Agents|antimitotic agents|mesh-ancestor
25216437|NCT02684708|Mitosis Modulators|mitosis modulators|mesh-ancestor
25216438|NCT02684487|Vitamin D|vitamin d|mesh-list
25216439|NCT02684487|Cholecalciferol|cholecalciferol|mesh-list
25216440|NCT02684487|Vitamins|vitamins|mesh-ancestor
25216441|NCT02684487|Micronutrients|micronutrients|mesh-ancestor
25216442|NCT02684487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216443|NCT02684487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25216444|NCT02684487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25216445|NCT02684409|Sumatriptan|sumatriptan|mesh-list
25216446|NCT02684409|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25216447|NCT02684409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25216448|NCT02684409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25216452|NCT02684409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216459|NCT02684669|Naloxone|naloxone|mesh-list
25216460|NCT02684669|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25216461|NCT02684669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216462|NCT02684669|Sensory System Agents|sensory system agents|mesh-ancestor
25216463|NCT02684669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25216464|NCT02684019|Magnesium Sulfate|magnesium sulfate|mesh-list
25216465|NCT02684019|Dexmedetomidine|dexmedetomidine|mesh-list
25216466|NCT02684019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25216467|NCT02684019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25216468|NCT02684019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216469|NCT02684019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25216470|NCT02684019|Analgesics|analgesics|mesh-ancestor
24540603|NCT00668616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25679102|NCT01833832|Sodium thiosulfate|sodium thiosulfate|mesh-list
25216471|NCT02684019|Sensory System Agents|sensory system agents|mesh-ancestor
25679103|NCT01833832|Cisplatin|cisplatin|mesh-list
25216472|NCT02684019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25216473|NCT02684019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25216474|NCT02684019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25216475|NCT02684019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25216476|NCT02684019|Adrenergic Agents|adrenergic agents|mesh-ancestor
25216477|NCT02684019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25216478|NCT02684019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216479|NCT02684019|Anesthetics|anesthetics|mesh-ancestor
25216480|NCT02684019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25216481|NCT02684019|Anticonvulsants|anticonvulsants|mesh-ancestor
25216482|NCT02684019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25216483|NCT02684019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25216484|NCT02684019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25216485|NCT02684019|Tocolytic Agents|tocolytic agents|mesh-ancestor
25216486|NCT02684019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25216487|NCT02684071|Cyclophosphamide|cyclophosphamide|mesh-list
25216488|NCT02684071|Methotrexate|methotrexate|mesh-list
25216489|NCT02684071|Topotecan|topotecan|mesh-list
25216490|NCT02684071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25216491|NCT02684071|Immunologic Factors|immunologic factors|mesh-ancestor
25216492|NCT02684071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216493|NCT02684071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25216494|NCT02684071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25216495|NCT02684071|Alkylating Agents|alkylating agents|mesh-ancestor
25216496|NCT02684071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216497|NCT02684071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25216498|NCT02684071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25216499|NCT02684071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25216500|NCT02684071|Abortifacient Agents|abortifacient agents|mesh-ancestor
25216501|NCT02684071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25216502|NCT02684071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25216503|NCT02684071|Antimetabolites|antimetabolites|mesh-ancestor
25216504|NCT02684071|Dermatologic Agents|dermatologic agents|mesh-ancestor
25216505|NCT02684071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25216506|NCT02684071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25216507|NCT02684071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25216508|NCT02684071|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25216509|NCT02684071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25216510|NCT02684240|Nitazoxanide|nitazoxanide|mesh-list
25216511|NCT02684240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25216512|NCT02684240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25216513|NCT02684084|Dexamethasone|dexamethasone|mesh-list
25216514|NCT02684084|Ranibizumab|ranibizumab|mesh-list
25216515|NCT02684084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25216516|NCT02684084|Antiemetics|antiemetics|mesh-ancestor
25216517|NCT02684084|Autonomic Agents|autonomic agents|mesh-ancestor
25216518|NCT02684084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25216519|NCT02684084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216520|NCT02684084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25216521|NCT02684084|Glucocorticoids|glucocorticoids|mesh-ancestor
25216522|NCT02684084|Hormones|hormones|mesh-ancestor
25216523|NCT02684084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25216524|NCT02684084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25216525|NCT02684084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25216526|NCT02684084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25216527|NCT02684084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25216528|NCT02684084|Growth Substances|growth substances|mesh-ancestor
25216529|NCT02684084|Growth Inhibitors|growth inhibitors|mesh-ancestor
25216530|NCT02684305|Oxytocin|oxytocin|mesh-list
25216531|NCT02684305|Oxytocics|oxytocics|mesh-ancestor
25216532|NCT02684305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25216533|NCT02684305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216534|NCT02684318|Olaparib|olaparib|mesh-list
25216535|NCT02684318|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25216536|NCT02684318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25216537|NCT02684318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831226|NCT02164214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24831227|NCT02164214|Immunologic Factors|immunologic factors|mesh-ancestor
24831228|NCT02164253|Deferiprone|deferiprone|mesh-list
24831229|NCT02164253|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24831230|NCT02164253|Chelating Agents|chelating agents|mesh-ancestor
24831231|NCT02164253|Sequestering Agents|sequestering agents|mesh-ancestor
24831232|NCT02164253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831233|NCT02164357|Fibrinolytic Agents|fibrinolytic agents|mesh-list
24950321|NCT00999804|Letrozole|letrozole|mesh-list
25216539|NCT02684123|Apremilast|apremilast|mesh-list
25216540|NCT02684123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25216541|NCT02684123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25216542|NCT02684123|Analgesics|analgesics|mesh-ancestor
25216543|NCT02684123|Sensory System Agents|sensory system agents|mesh-ancestor
25216544|NCT02684123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25216545|NCT02684123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216546|NCT02684123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25216547|NCT02684123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25216548|NCT02684123|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25216549|NCT02684123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25216550|NCT02684123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540683|NCT00669149|Analgesics|analgesics|mesh-ancestor
25216551|NCT02684123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216552|NCT02683837|Remifentanil|remifentanil|mesh-list
25216553|NCT02683837|Sevoflurane|sevoflurane|mesh-list
25216554|NCT02683837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25216555|NCT02683837|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25216556|NCT02683837|Anesthetics, General|anesthetics, general|mesh-ancestor
25216557|NCT02683837|Anesthetics|anesthetics|mesh-ancestor
25216558|NCT02683837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25216559|NCT02683837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216560|NCT02683837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25216561|NCT02683837|Narcotics|narcotics|mesh-ancestor
25216562|NCT02683837|Analgesics|analgesics|mesh-ancestor
25216563|NCT02683837|Sensory System Agents|sensory system agents|mesh-ancestor
25216564|NCT02683837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25216565|NCT02683759|Curcumin|curcumin|mesh-list
25216566|NCT02683759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25216567|NCT02683759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25216568|NCT02683759|Analgesics|analgesics|mesh-ancestor
25216569|NCT02683759|Sensory System Agents|sensory system agents|mesh-ancestor
25216570|NCT02683759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25216571|NCT02683759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216572|NCT02683759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25265083|NCT02436083|Cefuroxime|cefuroxime|mesh-list
24831234|NCT02164357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24831235|NCT02164357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831236|NCT02164448|Dexmedetomidine|dexmedetomidine|mesh-list
24831237|NCT02164448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24831238|NCT02164448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25216573|NCT02683759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25216574|NCT02683759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25216575|NCT02683759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25216576|NCT02683759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831240|NCT02164448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24540684|NCT00669149|Sensory System Agents|sensory system agents|mesh-ancestor
25216577|NCT02683863|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25216578|NCT02683863|Dermatologic Agents|dermatologic agents|mesh-ancestor
25216579|NCT02683863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25216580|NCT02683863|Immunologic Factors|immunologic factors|mesh-ancestor
25216596|NCT02683733|Antitubercular Agents|antitubercular agents|mesh-ancestor
25216597|NCT02683733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25216598|NCT02683733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25272880|NCT02389231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272881|NCT02389231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25272882|NCT02389231|Analgesics|analgesics|mesh-ancestor
25272883|NCT02389231|Sensory System Agents|sensory system agents|mesh-ancestor
24831253|NCT02164552|Vitamins|vitamins|mesh-list
24831254|NCT02164552|Micronutrients|micronutrients|mesh-ancestor
24463790|NCT00362245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24540710|NCT00669344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24540711|NCT00669344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042097|NCT01510119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042098|NCT01510119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25042099|NCT01508026|Valsartan|valsartan|mesh-list
25042100|NCT01508026|Nebivolol|nebivolol|mesh-list
25042101|NCT01508026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25042102|NCT01508026|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25042103|NCT01508026|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25042104|NCT01508026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458167|NCT00336882|Anesthetics|anesthetics|mesh-ancestor
25042105|NCT01508026|Vasodilator Agents|vasodilator agents|mesh-ancestor
25042106|NCT01508026|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25042107|NCT01508026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25042108|NCT01508026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25042109|NCT01508026|Adrenergic Agents|adrenergic agents|mesh-ancestor
25216604|NCT02683564|Infliximab|infliximab|mesh-list
25216605|NCT02683564|Dermatologic Agents|dermatologic agents|mesh-ancestor
25216606|NCT02683564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25216607|NCT02683564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25216608|NCT02683603|Imipenem|imipenem|mesh-list
25216609|NCT02683603|Colistin|colistin|mesh-list
25216610|NCT02683603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25216611|NCT02683603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25216612|NCT02683369|Iron|iron|mesh-list
25216613|NCT02683369|Trace Elements|trace elements|mesh-ancestor
25216614|NCT02683369|Micronutrients|micronutrients|mesh-ancestor
25216615|NCT02683369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216616|NCT02682953|Plerixafor|plerixafor|mesh-list
25216617|NCT02682953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25216618|NCT02682953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25216619|NCT02682953|Antiviral Agents|antiviral agents|mesh-ancestor
25216620|NCT02682953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25216621|NCT02683031|Ionophores|ionophores|mesh-list
25216622|NCT02683031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25216623|NCT02683031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216624|NCT02683213|Fluoxetine|fluoxetine|mesh-list
24540714|NCT00669370|Docetaxel|docetaxel|mesh-list
25216625|NCT02683213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25216626|NCT02683213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25216627|NCT02683213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25216628|NCT02683213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216629|NCT02683213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25216630|NCT02683213|Serotonin Agents|serotonin agents|mesh-ancestor
25216631|NCT02683213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216633|NCT02683213|Antidepressive Agents|antidepressive agents|mesh-ancestor
25216634|NCT02683213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25216635|NCT02683213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25042114|NCT01501513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25042116|NCT01499563|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25042117|NCT01499563|Serotonin Agents|serotonin agents|mesh-ancestor
25042118|NCT01499563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25042119|NCT01499563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042120|NCT01499563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042121|NCT01499563|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25042122|NCT01499563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25042123|NCT01499563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24831259|NCT02164565|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24831260|NCT02164565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24831261|NCT02164565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831262|NCT02164565|Hemostatics|hemostatics|mesh-ancestor
24831263|NCT02164565|Coagulants|coagulants|mesh-ancestor
25216636|NCT02683213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25216637|NCT02683213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25216638|NCT02683005|Sofosbuvir|sofosbuvir|mesh-list
25216639|NCT02683005|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25216640|NCT02683005|Ledipasvir|ledipasvir|mesh-list
25216641|NCT02683005|Antiviral Agents|antiviral agents|mesh-ancestor
25216642|NCT02683005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25216643|NCT02683148|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25216644|NCT02683148|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25216645|NCT02683148|Immunologic Factors|immunologic factors|mesh-ancestor
25216646|NCT02683148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216647|NCT02683070|Tramadol|tramadol|mesh-list
25216648|NCT02683070|Ropivacaine|ropivacaine|mesh-list
25216649|NCT02683070|Anesthetics, Local|anesthetics, local|mesh-ancestor
25216650|NCT02683070|Anesthetics|anesthetics|mesh-ancestor
25216651|NCT02683070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25216652|NCT02683070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216653|NCT02683070|Sensory System Agents|sensory system agents|mesh-ancestor
25216654|NCT02683070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25216655|NCT02683070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25216656|NCT02683070|Narcotics|narcotics|mesh-ancestor
25216657|NCT02683070|Analgesics|analgesics|mesh-ancestor
25216658|NCT02682927|Fenfluramine|fenfluramine|mesh-list
25216659|NCT02682927|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25216660|NCT02682927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25216661|NCT02682927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25216662|NCT02682927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216663|NCT02682927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25216664|NCT02682927|Serotonin Agents|serotonin agents|mesh-ancestor
25216665|NCT02682927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216666|NCT02683291|Mycophenolic Acid|mycophenolic acid|mesh-list
25216667|NCT02683291|Sirolimus|sirolimus|mesh-list
25216668|NCT02683291|Prednisone|prednisone|mesh-list
25216669|NCT02683291|Tacrolimus|tacrolimus|mesh-list
25216670|NCT02683291|Thymoglobulin|thymoglobulin|mesh-list
25216671|NCT02683291|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24831267|NCT02164578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24831268|NCT02164578|Analgesics|analgesics|mesh-ancestor
24831269|NCT02164578|Sensory System Agents|sensory system agents|mesh-ancestor
24831270|NCT02164578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24733735|NCT01648218|Coagulants|coagulants|mesh-ancestor
25216672|NCT02683291|Basiliximab|basiliximab|mesh-list
25216673|NCT02683291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25216674|NCT02683291|Glucocorticoids|glucocorticoids|mesh-ancestor
25216675|NCT02683291|Hormones|hormones|mesh-ancestor
25216676|NCT02683291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25216677|NCT02683291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216678|NCT02683291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25216679|NCT02683291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25216680|NCT02683291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25216681|NCT02683291|Immunologic Factors|immunologic factors|mesh-ancestor
25216682|NCT02683291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25216683|NCT02683291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25216684|NCT02683291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216685|NCT02683291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25216686|NCT02683291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25216687|NCT02683291|Antitubercular Agents|antitubercular agents|mesh-ancestor
25216688|NCT02683291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25216689|NCT02683291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25216690|NCT02683291|Antifungal Agents|antifungal agents|mesh-ancestor
25216691|NCT02682862|Bromides|bromides|mesh-list
25216692|NCT02682862|Tiotropium Bromide|tiotropium bromide|mesh-list
25216693|NCT02682862|Olodaterol|olodaterol|mesh-list
25216694|NCT02682862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25216695|NCT02682862|Autonomic Agents|autonomic agents|mesh-ancestor
25216696|NCT02682862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25216697|NCT02682862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216698|NCT02682862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25216699|NCT02682862|Respiratory System Agents|respiratory system agents|mesh-ancestor
25216700|NCT02682862|Parasympatholytics|parasympatholytics|mesh-ancestor
25216701|NCT02682862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25216702|NCT02682862|Cholinergic Agents|cholinergic agents|mesh-ancestor
25216703|NCT02682862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25216704|NCT02682862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216705|NCT02682862|Anticonvulsants|anticonvulsants|mesh-ancestor
25216706|NCT02682693|Denosumab|denosumab|mesh-list
25216707|NCT02682693|Paclitaxel|paclitaxel|mesh-list
25216708|NCT02682693|Cyclophosphamide|cyclophosphamide|mesh-list
25216709|NCT02682693|Carboplatin|carboplatin|mesh-list
25216710|NCT02682693|Trastuzumab|trastuzumab|mesh-list
25216711|NCT02682693|Epirubicin|epirubicin|mesh-list
25216712|NCT02682693|Pertuzumab|pertuzumab|mesh-list
25216713|NCT02682693|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25216714|NCT02682693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25216715|NCT02682693|Tubulin Modulators|tubulin modulators|mesh-ancestor
24855795|NCT02281045|Citric Acid|citric acid|mesh-list
25216716|NCT02682693|Antimitotic Agents|antimitotic agents|mesh-ancestor
25216717|NCT02682693|Mitosis Modulators|mitosis modulators|mesh-ancestor
25216718|NCT02682693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216719|NCT02682693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25216720|NCT02682693|Immunologic Factors|immunologic factors|mesh-ancestor
25216721|NCT02682693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216722|NCT02682693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25216723|NCT02682693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25216724|NCT02682693|Alkylating Agents|alkylating agents|mesh-ancestor
25272885|NCT02389231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272886|NCT02389218|Sotalol|sotalol|mesh-list
24449163|NCT00314626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24449164|NCT00314626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449165|NCT00314626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449166|NCT00314626|Antiviral Agents|antiviral agents|mesh-ancestor
24449167|NCT00314626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24449168|NCT00314626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24449169|NCT00314626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24449170|NCT00314626|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24449171|NCT00314626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24831274|NCT02164578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24831275|NCT02164578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24831276|NCT02164578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831277|NCT02164578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25216725|NCT02682693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25216726|NCT02682693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25216727|NCT02682693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25216728|NCT02682693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25216729|NCT02682693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25216730|NCT02682693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25216731|NCT02682693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25216732|NCT02682680|Ezetimibe|ezetimibe|mesh-list
25216733|NCT02682680|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
25216734|NCT02682680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25216735|NCT02682680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25216736|NCT02682680|Antimetabolites|antimetabolites|mesh-ancestor
25216737|NCT02682680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216738|NCT02682680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25216739|NCT02682758|Xenon|xenon|mesh-list
25216740|NCT02682758|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25216741|NCT02682758|Anesthetics, General|anesthetics, general|mesh-ancestor
25216742|NCT02682758|Anesthetics|anesthetics|mesh-ancestor
25216743|NCT02682758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25216744|NCT02682758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216745|NCT02682524|Aceclofenac|aceclofenac|mesh-list
25216746|NCT02682524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25216747|NCT02682524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25216748|NCT02682524|Analgesics|analgesics|mesh-ancestor
25216749|NCT02682524|Sensory System Agents|sensory system agents|mesh-ancestor
25216789|NCT02682134|Autonomic Agents|autonomic agents|mesh-ancestor
25216758|NCT02682485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25216759|NCT02682485|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25216760|NCT02682485|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25216761|NCT02682485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25216762|NCT02682485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25216763|NCT02682485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25272887|NCT02389218|Flecainide|flecainide|mesh-list
25272888|NCT02389218|Propafenone|propafenone|mesh-list
25679104|NCT01833832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24831290|NCT02164604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831291|NCT02164604|Growth Inhibitors|growth inhibitors|mesh-ancestor
25042143|NCT01497704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25216815|NCT02682459|Protease Inhibitors|protease inhibitors|mesh-ancestor
25216764|NCT02682485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216765|NCT02682485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25216766|NCT02682485|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25216767|NCT02682485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25216768|NCT02682485|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25216769|NCT02682186|Ropivacaine|ropivacaine|mesh-list
25216770|NCT02682186|Anesthetics, Local|anesthetics, local|mesh-ancestor
25216771|NCT02682186|Anesthetics|anesthetics|mesh-ancestor
25216772|NCT02682186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25216773|NCT02682186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216774|NCT02682186|Sensory System Agents|sensory system agents|mesh-ancestor
25216775|NCT02682186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25216783|NCT02682134|Dexamethasone|dexamethasone|mesh-list
25216784|NCT02682134|Dexamethasone acetate|dexamethasone acetate|mesh-list
25216786|NCT02682134|BB 1101|bb 1101|mesh-list
25216787|NCT02682134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25216788|NCT02682134|Antiemetics|antiemetics|mesh-ancestor
25216790|NCT02682134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25216791|NCT02682134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216792|NCT02682134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25216793|NCT02682134|Glucocorticoids|glucocorticoids|mesh-ancestor
25216794|NCT02682134|Hormones|hormones|mesh-ancestor
25216795|NCT02682134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25216796|NCT02682134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25216797|NCT02682134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25216798|NCT02682134|Protease Inhibitors|protease inhibitors|mesh-ancestor
25216799|NCT02682134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25679106|NCT01833832|Protective Agents|protective agents|mesh-ancestor
25679107|NCT01833832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679108|NCT01833832|Antioxidants|antioxidants|mesh-ancestor
24831299|NCT02164734|Sensory System Agents|sensory system agents|mesh-ancestor
24831300|NCT02164734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24831302|NCT02164773|Analgesics|analgesics|mesh-ancestor
24831303|NCT02164773|Sensory System Agents|sensory system agents|mesh-ancestor
24831304|NCT02164773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24831305|NCT02164773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216800|NCT02682134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216801|NCT02682134|Anesthetics, Local|anesthetics, local|mesh-ancestor
25216802|NCT02682134|Anesthetics|anesthetics|mesh-ancestor
25216803|NCT02682134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25216804|NCT02682134|Sensory System Agents|sensory system agents|mesh-ancestor
25216805|NCT02682134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25216806|NCT02682134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25216807|NCT02682134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25216808|NCT02682134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25216809|NCT02682329|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25216810|NCT02682329|Carbamide Peroxide|carbamide peroxide|mesh-list
25216811|NCT02682329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25216812|NCT02682329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25216813|NCT02682459|Lisinopril|lisinopril|mesh-list
25216814|NCT02682459|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25216817|NCT02682459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216818|NCT02682459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25216819|NCT02682459|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25216820|NCT02682459|Protective Agents|protective agents|mesh-ancestor
25216821|NCT02682459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216822|NCT02682225|Ketamine|ketamine|mesh-list
25216823|NCT02682225|Esketamine|esketamine|mesh-list
25216824|NCT02682225|Analgesics|analgesics|mesh-ancestor
25216825|NCT02682225|Sensory System Agents|sensory system agents|mesh-ancestor
25216826|NCT02682225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25216827|NCT02682225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216828|NCT02682225|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25216829|NCT02682225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25216830|NCT02682225|Anesthetics, General|anesthetics, general|mesh-ancestor
25216831|NCT02682225|Anesthetics|anesthetics|mesh-ancestor
25216832|NCT02682225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25216833|NCT02682225|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25216834|NCT02682225|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25216835|NCT02682225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25216842|NCT02682017|Fucoidan|fucoidan|mesh-list
25216843|NCT02682017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25216844|NCT02682017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25216845|NCT02682017|Anticoagulants|anticoagulants|mesh-ancestor
25042144|NCT01497704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042145|NCT01495247|Paclitaxel|paclitaxel|mesh-list
25042146|NCT01495247|Dactolisib|dactolisib|mesh-list
25042147|NCT01495247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25042148|NCT01495247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042149|NCT01495247|Tubulin Modulators|tubulin modulators|mesh-ancestor
25042150|NCT01495247|Antimitotic Agents|antimitotic agents|mesh-ancestor
25042151|NCT01495247|Mitosis Modulators|mitosis modulators|mesh-ancestor
24501714|NCT00530556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501715|NCT00530582|Progesterone|progesterone|mesh-list
24501716|NCT00530582|Progestins|progestins|mesh-ancestor
24969813|NCT03739801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969815|NCT03739788|BMS-986165|bms-986165|mesh-list
24969816|NCT03739788|Dermatologic Agents|dermatologic agents|mesh-ancestor
24969817|NCT03739788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25216846|NCT02682017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855840|NCT02281292|Ranibizumab|ranibizumab|mesh-list
25216847|NCT02682082|Bupivacaine|bupivacaine|mesh-list
25216848|NCT02682082|Anesthetics, Local|anesthetics, local|mesh-ancestor
25216849|NCT02682082|Anesthetics|anesthetics|mesh-ancestor
25216850|NCT02682082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25216851|NCT02682082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216852|NCT02682082|Sensory System Agents|sensory system agents|mesh-ancestor
25216853|NCT02682082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25216854|NCT02681848|Nicotine|nicotine|mesh-list
25216855|NCT02681848|Varenicline|varenicline|mesh-list
25216856|NCT02681848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25216857|NCT02681848|Autonomic Agents|autonomic agents|mesh-ancestor
25216858|NCT02681848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25216859|NCT02681848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216860|NCT02681848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25216861|NCT02681848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25216862|NCT02681848|Cholinergic Agents|cholinergic agents|mesh-ancestor
25216863|NCT02681848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25216864|NCT02681848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216865|NCT02681887|Melatonin|melatonin|mesh-list
25216866|NCT02681887|Antioxidants|antioxidants|mesh-ancestor
25216867|NCT02681887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216868|NCT02681887|Protective Agents|protective agents|mesh-ancestor
25216869|NCT02681887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216870|NCT02681887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25216871|NCT02681913|Adenosine|adenosine|mesh-list
25216872|NCT02681913|Analgesics|analgesics|mesh-ancestor
25216873|NCT02681913|Sensory System Agents|sensory system agents|mesh-ancestor
25216874|NCT02681913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25216875|NCT02681913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042157|NCT01495013|Antimetabolites|antimetabolites|mesh-ancestor
25042158|NCT01495013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042160|NCT01495013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25042161|NCT01495013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25042162|NCT01495013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25042163|NCT01495013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25042164|NCT01495013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042165|NCT01495013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25042169|NCT01493505|Trebananib|trebananib|mesh-list
25042171|NCT01493505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626198|NCT01085981|Niacin|niacin|mesh-list
24969818|NCT03739788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24969819|NCT03739788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969820|NCT03739671|Vitamin D|vitamin d|mesh-list
24969821|NCT03739671|Ergocalciferols|ergocalciferols|mesh-list
24969822|NCT03739671|Cholecalciferol|cholecalciferol|mesh-list
24969823|NCT03739671|Vitamins|vitamins|mesh-list
24969824|NCT03739671|Micronutrients|micronutrients|mesh-ancestor
24969825|NCT03739671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969826|NCT03739671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24969827|NCT03739671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24501734|NCT00530868|Growth Substances|growth substances|mesh-ancestor
24501735|NCT00530868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501736|NCT00530868|Growth Inhibitors|growth inhibitors|mesh-ancestor
24541008|NCT00670475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24501737|NCT00530868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24501738|NCT00530868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24501739|NCT00530868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501740|NCT00530868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501741|NCT00530868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24501742|NCT00530868|Hormone Antagonists|hormone antagonists|mesh-ancestor
24501743|NCT00530868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24501744|NCT00530907|Bevacizumab|bevacizumab|mesh-list
24501745|NCT00530907|Valproic Acid|valproic acid|mesh-list
24736900|NCT01665586|Analgesics|analgesics|mesh-ancestor
24501750|NCT00530907|Growth Substances|growth substances|mesh-ancestor
25216876|NCT02681913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25216877|NCT02681913|Vasodilator Agents|vasodilator agents|mesh-ancestor
25216878|NCT02681913|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25216879|NCT02681913|Purinergic Agonists|purinergic agonists|mesh-ancestor
25216880|NCT02681913|Purinergic Agents|purinergic agents|mesh-ancestor
25216881|NCT02681913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25404884|NCT03646188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25216882|NCT02681913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216884|NCT02681783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25216885|NCT02681783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25216886|NCT02681783|Growth Substances|growth substances|mesh-ancestor
25216887|NCT02681783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216888|NCT02681783|Growth Inhibitors|growth inhibitors|mesh-ancestor
25216889|NCT02681783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272889|NCT02389218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25272890|NCT02389218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25272891|NCT02389218|Adrenergic Agents|adrenergic agents|mesh-ancestor
25272892|NCT02389218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25272893|NCT02389218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272894|NCT02389218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272895|NCT02389218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24541009|NCT00670475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24541010|NCT00670475|Analgesics|analgesics|mesh-ancestor
24541011|NCT00670475|Sensory System Agents|sensory system agents|mesh-ancestor
25247222|NCT00075387|Protective Agents|protective agents|mesh-ancestor
24541012|NCT00670475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24541013|NCT00670475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541014|NCT00670475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24541015|NCT00670475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25272896|NCT02389218|Sympatholytics|sympatholytics|mesh-ancestor
25272897|NCT02389218|Autonomic Agents|autonomic agents|mesh-ancestor
25272898|NCT02389218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24831308|NCT02164773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24831309|NCT02164773|Anticonvulsants|anticonvulsants|mesh-ancestor
24831310|NCT02164773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24734094|NCT01650649|Clonidine|clonidine|mesh-list
24501751|NCT00530907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501752|NCT00530907|Growth Inhibitors|growth inhibitors|mesh-ancestor
24501753|NCT00530907|Anticonvulsants|anticonvulsants|mesh-ancestor
24501754|NCT00530907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501755|NCT00530907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501756|NCT00530907|GABA Agents|gaba agents|mesh-ancestor
25216890|NCT02681679|Bromfenac|bromfenac|mesh-list
25216891|NCT02681679|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25216892|NCT02681679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25216893|NCT02681679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25216894|NCT02681679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25216895|NCT02681679|Analgesics|analgesics|mesh-ancestor
25216896|NCT02681679|Sensory System Agents|sensory system agents|mesh-ancestor
25216897|NCT02681679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25216898|NCT02681679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216899|NCT02681679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25216900|NCT02681679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25216901|NCT02681562|Olaparib|olaparib|mesh-list
25216902|NCT02681562|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25216903|NCT02681562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25216904|NCT02681562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216905|NCT02681562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25216906|NCT02681705|Temozolomide|temozolomide|mesh-list
25216907|NCT02681705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25216908|NCT02681705|Alkylating Agents|alkylating agents|mesh-ancestor
25216909|NCT02681705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216910|NCT02681705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25216911|NCT02681653|Atorvastatin|atorvastatin|mesh-list
25216912|NCT02681653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25216913|NCT02681653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25216914|NCT02681653|Antimetabolites|antimetabolites|mesh-ancestor
25216915|NCT02681653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216916|NCT02681653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25216917|NCT02681653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25216918|NCT02681653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25216920|NCT02681471|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25216921|NCT02681471|Diuretics|diuretics|mesh-ancestor
25216922|NCT02681471|Natriuretic Agents|natriuretic agents|mesh-ancestor
24939508|NCT04009044|Tamoxifen|tamoxifen|mesh-list
24939509|NCT04009044|Afimoxifene|afimoxifene|mesh-list
24939510|NCT04009044|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24939511|NCT04009044|Hormone Antagonists|hormone antagonists|mesh-ancestor
24852908|NCT02264743|Estradiol|estradiol|mesh-list
24831315|NCT02164773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24831318|NCT02164812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24831319|NCT02164812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24831320|NCT02164812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24831321|NCT02164812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24831322|NCT02164812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24831323|NCT02164812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831324|NCT02164812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24831325|NCT02164812|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24831326|NCT02164812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24831327|NCT02164812|Antiviral Agents|antiviral agents|mesh-ancestor
24449193|NCT00314665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24449194|NCT00314665|Immunologic Factors|immunologic factors|mesh-ancestor
24449195|NCT00314665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216923|NCT02681471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216924|NCT02681536|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25216925|NCT02681536|Contraceptive Agents|contraceptive agents|mesh-list
25216926|NCT02681536|Contraceptives, Oral|contraceptives, oral|mesh-list
25216927|NCT02681536|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25216928|NCT02681536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25216929|NCT02681536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216930|NCT02681536|Luteolytic Agents|luteolytic agents|mesh-ancestor
25216931|NCT02681536|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25216932|NCT02681536|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25216933|NCT02681536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25216934|NCT02681536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25216935|NCT02681796|Bupivacaine|bupivacaine|mesh-list
25216936|NCT02681796|Anesthetics, Local|anesthetics, local|mesh-ancestor
25216937|NCT02681796|Anesthetics|anesthetics|mesh-ancestor
25216938|NCT02681796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25216939|NCT02681796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216940|NCT02681796|Sensory System Agents|sensory system agents|mesh-ancestor
24541131|NCT00671112|Immunologic Factors|immunologic factors|mesh-ancestor
24541132|NCT00671112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541133|NCT00671151|Theophylline|theophylline|mesh-list
24541134|NCT00671151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24541135|NCT00671151|Autonomic Agents|autonomic agents|mesh-ancestor
24541136|NCT00671151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24541143|NCT00671151|Vasodilator Agents|vasodilator agents|mesh-ancestor
25216941|NCT02681796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25216942|NCT02681198|Lofexidine|lofexidine|mesh-list
25216943|NCT02681198|Paroxetine|paroxetine|mesh-list
25216944|NCT02681198|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25216945|NCT02681198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25216946|NCT02681198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25216947|NCT02681198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216948|NCT02681198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25216949|NCT02681198|Serotonin Agents|serotonin agents|mesh-ancestor
25216950|NCT02681198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216951|NCT02681198|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25216952|NCT02681198|Antidepressive Agents|antidepressive agents|mesh-ancestor
25216953|NCT02681198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25216954|NCT02681198|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25216955|NCT02681198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25216956|NCT02681198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25216957|NCT02681198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25216958|NCT02681198|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25216959|NCT02681198|Sensory System Agents|sensory system agents|mesh-ancestor
25216960|NCT02681198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25216961|NCT02681198|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25216962|NCT02681198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24831328|NCT02164812|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24831329|NCT02164812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24831330|NCT02164812|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24831331|NCT02164812|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24831332|NCT02164812|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24831333|NCT02164812|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24831335|NCT02164825|Ropivacaine|ropivacaine|mesh-list
24831336|NCT02164825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25217005|NCT02680977|Dopamine Agents|dopamine agents|mesh-ancestor
24831347|NCT02164838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24831348|NCT02164838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24831349|NCT02164838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831350|NCT02164890|Micafungin|micafungin|mesh-list
24831351|NCT02164890|Antifungal Agents|antifungal agents|mesh-ancestor
24831352|NCT02164890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24541227|NCT00671593|Protective Agents|protective agents|mesh-ancestor
25216963|NCT02681198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25216964|NCT02681198|Adrenergic Agents|adrenergic agents|mesh-ancestor
25216965|NCT02681263|Temocillin|temocillin|mesh-list
25216966|NCT02681263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25216967|NCT02681263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25216968|NCT02681211|Diphenhydramine|diphenhydramine|mesh-list
25216969|NCT02681211|Promethazine|promethazine|mesh-list
25216970|NCT02681211|Ketorolac|ketorolac|mesh-list
25216971|NCT02681211|Metoclopramide|metoclopramide|mesh-list
25216972|NCT02681211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25216973|NCT02681211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25216974|NCT02681211|Analgesics|analgesics|mesh-ancestor
25216975|NCT02681211|Sensory System Agents|sensory system agents|mesh-ancestor
25216976|NCT02681211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25216977|NCT02681211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25216978|NCT02681211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25216979|NCT02681211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25216980|NCT02681211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25216981|NCT02681211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25216982|NCT02681211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25216983|NCT02681211|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25216984|NCT02681211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25216985|NCT02681211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25216986|NCT02681211|Anesthetics, Local|anesthetics, local|mesh-ancestor
25216987|NCT02681211|Anesthetics|anesthetics|mesh-ancestor
25216988|NCT02681211|Antiemetics|antiemetics|mesh-ancestor
25216989|NCT02681211|Autonomic Agents|autonomic agents|mesh-ancestor
25216990|NCT02681211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25216991|NCT02681211|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25216992|NCT02681211|Histamine Antagonists|histamine antagonists|mesh-ancestor
25216993|NCT02681211|Histamine Agents|histamine agents|mesh-ancestor
25216994|NCT02681211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25216995|NCT02681211|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25216996|NCT02681211|Antipruritics|antipruritics|mesh-ancestor
25216997|NCT02681211|Dermatologic Agents|dermatologic agents|mesh-ancestor
25216998|NCT02681211|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25216999|NCT02681211|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25217000|NCT02681211|Dopamine Agents|dopamine agents|mesh-ancestor
25217001|NCT02680977|Levodopa|levodopa|mesh-list
25217002|NCT02680977|Benserazide|benserazide|mesh-list
24939516|NCT04009044|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24939517|NCT04009044|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24939518|NCT04009044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25217003|NCT02680977|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25217004|NCT02680977|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25217007|NCT02680977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831363|NCT02165020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24831364|NCT02165020|Immunologic Factors|immunologic factors|mesh-ancestor
24831365|NCT02165020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042191|NCT01489046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25042192|NCT01489046|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25042193|NCT01489046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24541263|NCT00671697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541264|NCT00671710|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24541265|NCT00671710|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24541266|NCT00671710|Dermatologic Agents|dermatologic agents|mesh-ancestor
25042194|NCT01489046|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25042195|NCT01489046|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25042196|NCT01489046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25042197|NCT01489046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25042198|NCT01486849|Riluzole|riluzole|mesh-list
25042199|NCT01486849|Anticonvulsants|anticonvulsants|mesh-ancestor
25042200|NCT01486849|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25042201|NCT01486849|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24998753|NCT00979212|Paclitaxel|paclitaxel|mesh-list
25217008|NCT02680977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217009|NCT02680977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217010|NCT02680938|Oxytocin|oxytocin|mesh-list
25217011|NCT02680938|Oxytocics|oxytocics|mesh-ancestor
25217012|NCT02680938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25217013|NCT02680938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217014|NCT02680951|Cytarabine|cytarabine|mesh-list
25217015|NCT02680951|Fludarabine|fludarabine|mesh-list
25217016|NCT02680951|Dasatinib|dasatinib|mesh-list
25217017|NCT02680951|Idarubicin|idarubicin|mesh-list
25217018|NCT02680951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25217019|NCT02680951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25217020|NCT02680951|Antimetabolites|antimetabolites|mesh-ancestor
25217021|NCT02680951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217022|NCT02680951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25217023|NCT02680951|Immunologic Factors|immunologic factors|mesh-ancestor
25217024|NCT02680951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217025|NCT02680951|Antiviral Agents|antiviral agents|mesh-ancestor
25217026|NCT02680951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25217027|NCT02680951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25217028|NCT02680951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217029|NCT02680951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25217030|NCT02680951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24642713|NCT01181063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217031|NCT02680951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25217033|NCT02680717|Calcipotriene|calcipotriene|mesh-list
25217034|NCT02680717|Tacrolimus|tacrolimus|mesh-list
25217035|NCT02680717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25217036|NCT02680717|Immunologic Factors|immunologic factors|mesh-ancestor
25217037|NCT02680717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217038|NCT02680717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25217039|NCT02680717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217040|NCT02680717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831430|NCT02165332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24831431|NCT02165332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24831432|NCT02165332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831433|NCT02165332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24831434|NCT02165332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24541363|NCT00672399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541364|NCT00672399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24541365|NCT00672399|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24541366|NCT00672399|Incretins|incretins|mesh-ancestor
24831443|NCT02165449|Sensory System Agents|sensory system agents|mesh-ancestor
24831444|NCT02165449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24831445|NCT02165449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831446|NCT02165449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24831447|NCT02165449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24950770|NCT03912285|Losartan|losartan|mesh-list
24501757|NCT00530907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24501758|NCT00530907|Antimanic Agents|antimanic agents|mesh-ancestor
25217047|NCT02680795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25217048|NCT02680795|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25217049|NCT02680795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217050|NCT02680795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217051|NCT02680600|Cefepime|cefepime|mesh-list
25217052|NCT02680600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24541367|NCT00672399|Hormones|hormones|mesh-ancestor
24505096|NCT00539786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217053|NCT02680600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25217054|NCT02680678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25217055|NCT02680548|Methylprednisolone|methylprednisolone|mesh-list
25217056|NCT02680548|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25217057|NCT02680548|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25217058|NCT02680548|Prednisolone|prednisolone|mesh-list
25217059|NCT02680548|Prednisolone acetate|prednisolone acetate|mesh-list
25217060|NCT02680548|Bupivacaine|bupivacaine|mesh-list
25217066|NCT02680548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217067|NCT02680548|Sensory System Agents|sensory system agents|mesh-ancestor
25217068|NCT02680548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25217069|NCT02680548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25217071|NCT02680548|Autonomic Agents|autonomic agents|mesh-ancestor
25217072|NCT02680548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25217073|NCT02680548|Glucocorticoids|glucocorticoids|mesh-ancestor
25217074|NCT02680548|Hormones|hormones|mesh-ancestor
25217075|NCT02680548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25217076|NCT02680548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24969846|NCT03739606|Immunoglobulins|immunoglobulins|mesh-list
25679109|NCT01833832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265228|NCT02435108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25265229|NCT02435108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265230|NCT02435108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969847|NCT03739606|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24969848|NCT03739606|Antibodies, Bispecific|antibodies, bispecific|mesh-list
24969849|NCT03739606|Immunologic Factors|immunologic factors|mesh-ancestor
24969850|NCT03739606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969852|NCT03739541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25217077|NCT02680548|Protective Agents|protective agents|mesh-ancestor
25217079|NCT02680548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25217081|NCT02680626|Ropivacaine|ropivacaine|mesh-list
25217082|NCT02680626|Anesthetics, Local|anesthetics, local|mesh-ancestor
25217083|NCT02680626|Anesthetics|anesthetics|mesh-ancestor
25217084|NCT02680626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25217085|NCT02680626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217086|NCT02680626|Sensory System Agents|sensory system agents|mesh-ancestor
25217087|NCT02680626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25217088|NCT02680626|Analgesics|analgesics|mesh-ancestor
25217089|NCT02680626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25217090|NCT02680626|Anticonvulsants|anticonvulsants|mesh-ancestor
25217091|NCT02680626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25217092|NCT02680626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24594900|NCT00936091|Vitamins|vitamins|mesh-ancestor
25217093|NCT02680626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217094|NCT02680626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25217095|NCT02680626|Tocolytic Agents|tocolytic agents|mesh-ancestor
25217096|NCT02680626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25217097|NCT02680808|Olorofim|olorofim|mesh-list
25217098|NCT02680808|Midazolam|midazolam|mesh-list
25217099|NCT02680808|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25217100|NCT02680808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25217101|NCT02680808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25217102|NCT02680808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217103|NCT02680808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25217104|NCT02680808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25217105|NCT02680808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25217106|NCT02680808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25217107|NCT02680808|Anesthetics, General|anesthetics, general|mesh-ancestor
24831460|NCT02165566|Insulin Lispro|insulin lispro|mesh-list
24831461|NCT02165566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24831462|NCT02165566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831463|NCT02165644|Nimodipine|nimodipine|mesh-list
24831464|NCT02165644|Acetazolamide|acetazolamide|mesh-list
24831465|NCT02165644|Anticonvulsants|anticonvulsants|mesh-ancestor
24831466|NCT02165644|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24831467|NCT02165644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24831468|NCT02165644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831469|NCT02165644|Diuretics|diuretics|mesh-ancestor
24831470|NCT02165644|Natriuretic Agents|natriuretic agents|mesh-ancestor
24831471|NCT02165644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831472|NCT02165644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24831473|NCT02165644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24831474|NCT02165644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24831475|NCT02165644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24831476|NCT02165644|Vasodilator Agents|vasodilator agents|mesh-ancestor
25217108|NCT02680808|Anesthetics|anesthetics|mesh-ancestor
25217109|NCT02680808|GABA Modulators|gaba modulators|mesh-ancestor
25217110|NCT02680808|GABA Agents|gaba agents|mesh-ancestor
25217111|NCT02680808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25217112|NCT02680808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217113|NCT02680808|Antifungal Agents|antifungal agents|mesh-ancestor
25217114|NCT02680808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25217115|NCT02680379|Minocycline|minocycline|mesh-list
25217116|NCT02680379|Lovastatin|lovastatin|mesh-list
25217117|NCT02680379|L 647318|l 647318|mesh-list
25217118|NCT02680379|Dihydromevinolin|dihydromevinolin|mesh-list
25217119|NCT02680379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25679110|NCT01833832|Antitubercular Agents|antitubercular agents|mesh-ancestor
25679111|NCT01833832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25679112|NCT01833832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25217120|NCT02680379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25217121|NCT02680379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25217122|NCT02680379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25217123|NCT02680379|Antimetabolites|antimetabolites|mesh-ancestor
25217124|NCT02680379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217125|NCT02680379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25217127|NCT02680379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217128|NCT02680119|Esomeprazole|esomeprazole|mesh-list
25217129|NCT02680119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25217130|NCT02680119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25217131|NCT02680119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25217132|NCT02680119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217133|NCT02680119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217134|NCT02680080|Moxifloxacin|moxifloxacin|mesh-list
25217135|NCT02680080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25217136|NCT02680080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25217137|NCT02680080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25217138|NCT02680080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25217139|NCT02680080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217140|NCT02680080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217141|NCT02680080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25217142|NCT02680132|Esomeprazole|esomeprazole|mesh-list
25217143|NCT02680132|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25217144|NCT02680132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25217145|NCT02680132|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25217146|NCT02680132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217147|NCT02680132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272899|NCT02389218|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25272900|NCT02389218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25272901|NCT02389218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25272902|NCT02389179|Vitamin D|vitamin d|mesh-list
25272903|NCT02389179|Cholecalciferol|cholecalciferol|mesh-list
25272904|NCT02389179|Vitamins|vitamins|mesh-ancestor
25272905|NCT02389179|Micronutrients|micronutrients|mesh-ancestor
25272906|NCT02389179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272907|NCT02389179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25272908|NCT02389179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25272909|NCT02388802|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25272910|NCT02388802|Immunologic Factors|immunologic factors|mesh-ancestor
25272911|NCT02388802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272912|NCT02388750|Palonosetron|palonosetron|mesh-list
25272913|NCT02388750|Antiemetics|antiemetics|mesh-ancestor
24831543|NCT02166632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24589573|NCT00908089|Sensory System Agents|sensory system agents|mesh-ancestor
24831544|NCT02166814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24831545|NCT02166814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24831546|NCT02166814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24831547|NCT02166814|Antimetabolites|antimetabolites|mesh-ancestor
24831548|NCT02166814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831549|NCT02166814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24831550|NCT02166814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24831551|NCT02166814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939541|NCT04008966|Luteolytic Agents|luteolytic agents|mesh-ancestor
24939542|NCT04008966|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24852935|NCT02264834|Dsuvia|dsuvia|mesh-list
24831552|NCT02166853|Midazolam|midazolam|mesh-list
24831553|NCT02166853|Sevoflurane|sevoflurane|mesh-list
24831607|NCT02167321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831608|NCT02167321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24831609|NCT02167321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24831610|NCT02167321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24831627|NCT02167425|Respiratory System Agents|respiratory system agents|mesh-ancestor
24831629|NCT02167464|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
24831630|NCT02167464|Keratolytic Agents|keratolytic agents|mesh-ancestor
24831631|NCT02167464|Dermatologic Agents|dermatologic agents|mesh-ancestor
24831632|NCT02167464|Hormone Antagonists|hormone antagonists|mesh-ancestor
24831633|NCT02167464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24831634|NCT02167464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831635|NCT02167464|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24642980|NCT01182662|Immunologic Factors|immunologic factors|mesh-ancestor
24831636|NCT02167464|Diuretics|diuretics|mesh-ancestor
24831637|NCT02167464|Natriuretic Agents|natriuretic agents|mesh-ancestor
24831638|NCT02167620|Metformin|metformin|mesh-list
24831639|NCT02167620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24831640|NCT02167620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831641|NCT02167633|Pantoprazole|pantoprazole|mesh-list
24831642|NCT02167633|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24969853|NCT03739541|Immunologic Factors|immunologic factors|mesh-ancestor
24969854|NCT03739541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969855|NCT03739541|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24969856|NCT03739541|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24969857|NCT03739541|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24969858|NCT03739541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24969859|NCT03739333|Carbon-11 methionine|carbon-11 methionine|mesh-list
24969860|NCT03739333|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24969861|NCT03739333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969862|NCT03739294|Fluticasone|fluticasone|mesh-list
25217148|NCT02679963|Olaparib|olaparib|mesh-list
25217149|NCT02679963|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25217150|NCT02679963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217151|NCT02679963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217152|NCT02679963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25217153|NCT02679924|Hyaluronic Acid|hyaluronic acid|mesh-list
25217154|NCT02679924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25217155|NCT02679924|Immunologic Factors|immunologic factors|mesh-ancestor
25217156|NCT02679924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217157|NCT02679924|Viscosupplements|viscosupplements|mesh-ancestor
25217158|NCT02679924|Protective Agents|protective agents|mesh-ancestor
25217159|NCT02679664|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25217160|NCT02679664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25217161|NCT02679664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25217162|NCT02679664|Antimetabolites|antimetabolites|mesh-ancestor
25217163|NCT02679664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217164|NCT02679664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25217165|NCT02679664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25217166|NCT02679664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217167|NCT02679833|Vitamin B 12|vitamin b 12|mesh-list
25217168|NCT02679833|Hydroxocobalamin|hydroxocobalamin|mesh-list
25217169|NCT02679833|Vitamin B Complex|vitamin b complex|mesh-ancestor
25217170|NCT02679833|Vitamins|vitamins|mesh-ancestor
25217171|NCT02679833|Micronutrients|micronutrients|mesh-ancestor
25217172|NCT02679833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217173|NCT02679833|Hematinics|hematinics|mesh-ancestor
25217174|NCT02679820|Copper|copper|mesh-list
25217175|NCT02679820|Trace Elements|trace elements|mesh-ancestor
25217176|NCT02679820|Micronutrients|micronutrients|mesh-ancestor
25217177|NCT02679820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217178|NCT02679339|Lidocaine|lidocaine|mesh-list
25217179|NCT02679339|Anesthetics, Local|anesthetics, local|mesh-ancestor
25217180|NCT02679339|Anesthetics|anesthetics|mesh-ancestor
24831645|NCT02167633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24831646|NCT02167633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24831647|NCT02167633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831648|NCT02167633|Hormones|hormones|mesh-ancestor
24831745|NCT02168569|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24831650|NCT02167633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831651|NCT02167685|Brincidofovir|brincidofovir|mesh-list
24831652|NCT02167685|Antiviral Agents|antiviral agents|mesh-ancestor
24831653|NCT02167685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24831654|NCT02167698|Methylprednisolone|methylprednisolone|mesh-list
24831655|NCT02167698|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24831656|NCT02167698|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24950899|NCT03910231|Natriuretic Agents|natriuretic agents|mesh-ancestor
24969864|NCT03739294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24969865|NCT03739294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25679113|NCT01833832|Chelating Agents|chelating agents|mesh-ancestor
25679114|NCT01833832|Sequestering Agents|sequestering agents|mesh-ancestor
25679115|NCT01833845|Ribavirin|ribavirin|mesh-list
25679116|NCT01833845|Hydroxychloroquine|hydroxychloroquine|mesh-list
25679117|NCT01833845|Antimetabolites|antimetabolites|mesh-ancestor
25679118|NCT01833845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928258|NCT04124094|Charcoal|charcoal|mesh-list
24969866|NCT03739294|Autonomic Agents|autonomic agents|mesh-ancestor
24969867|NCT03739294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969868|NCT03739294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969869|NCT03739294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24969870|NCT03739294|Respiratory System Agents|respiratory system agents|mesh-ancestor
25217181|NCT02679339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25217182|NCT02679339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217183|NCT02679339|Sensory System Agents|sensory system agents|mesh-ancestor
25217184|NCT02679339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25217185|NCT02679339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25217186|NCT02679339|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25217187|NCT02679339|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25217188|NCT02679339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25217189|NCT02679339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217190|NCT02679456|Fluconazole|fluconazole|mesh-list
25217191|NCT02679456|Ibrexafungerp|ibrexafungerp|mesh-list
25217192|NCT02679456|Antifungal Agents|antifungal agents|mesh-ancestor
25217193|NCT02679456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25217194|NCT02679456|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25217195|NCT02679456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25217196|NCT02679456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217197|NCT02679456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217198|NCT02679456|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25217199|NCT02679456|Hormone Antagonists|hormone antagonists|mesh-ancestor
25217200|NCT02679456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25217201|NCT02679456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217202|NCT02679456|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25217203|NCT02679456|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25217204|NCT02679261|Atorvastatin|atorvastatin|mesh-list
25217205|NCT02679261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25217206|NCT02679261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25217207|NCT02679261|Antimetabolites|antimetabolites|mesh-ancestor
25217208|NCT02679261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831667|NCT02167698|Glucocorticoids|glucocorticoids|mesh-ancestor
24464044|NCT00363090|Alkylating Agents|alkylating agents|mesh-ancestor
24831705|NCT02168127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24831706|NCT02168127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831708|NCT02168127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24831709|NCT02168127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24831710|NCT02168127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831734|NCT02168426|Viscosupplements|viscosupplements|mesh-ancestor
24831735|NCT02168426|Protective Agents|protective agents|mesh-ancestor
24831736|NCT02168543|Alendronate|alendronate|mesh-list
24969871|NCT03739294|Dermatologic Agents|dermatologic agents|mesh-ancestor
24969872|NCT03739294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24969873|NCT03739112|Vaccines|vaccines|mesh-list
24969874|NCT03739112|Immunologic Factors|immunologic factors|mesh-ancestor
24969875|NCT03739112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969876|NCT03739021|Ropivacaine|ropivacaine|mesh-list
24939554|NCT04008888|Melphalan|melphalan|mesh-list
24939555|NCT04008888|BB 1101|bb 1101|mesh-list
24939556|NCT04008888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24969877|NCT03739021|Anesthetics, Local|anesthetics, local|mesh-ancestor
24969878|NCT03739021|Anesthetics|anesthetics|mesh-ancestor
24969879|NCT03739021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24969889|NCT03738943|Vitamin B 6|vitamin b 6|mesh-list
24969890|NCT03738943|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
24969891|NCT03738943|Adenosine|adenosine|mesh-list
24969892|NCT03738943|Nitroprusside|nitroprusside|mesh-list
24969893|NCT03738943|Acetylcholine|acetylcholine|mesh-list
24969894|NCT03738943|Vitamins|vitamins|mesh-ancestor
24969895|NCT03738943|Micronutrients|micronutrients|mesh-ancestor
24969896|NCT03738943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969897|NCT03738943|Vitamin B Complex|vitamin b complex|mesh-ancestor
24969898|NCT03738943|Analgesics|analgesics|mesh-ancestor
24969899|NCT03738943|Sensory System Agents|sensory system agents|mesh-ancestor
25217209|NCT02679261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25217210|NCT02679261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25217211|NCT02679261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217212|NCT02678975|Copper|copper|mesh-list
25217213|NCT02678975|Temozolomide|temozolomide|mesh-list
25217214|NCT02678975|Lomustine|lomustine|mesh-list
25217215|NCT02678975|Disulfiram|disulfiram|mesh-list
25217216|NCT02678975|Alkylating Agents|alkylating agents|mesh-list
25217217|NCT02678975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25217218|NCT02678975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217219|NCT02678975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25217220|NCT02678975|Trace Elements|trace elements|mesh-ancestor
25217221|NCT02678975|Micronutrients|micronutrients|mesh-ancestor
25217222|NCT02678975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217223|NCT02678975|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25217224|NCT02678975|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25217225|NCT02678975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217226|NCT02679014|Petesicatib|petesicatib|mesh-list
25217227|NCT02679014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217228|NCT02679014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217229|NCT02679001|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
25217230|NCT02679001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25217231|NCT02679131|Belinostat|belinostat|mesh-list
24541723|NCT00674752|Sensory System Agents|sensory system agents|mesh-ancestor
24939557|NCT04008888|Antiemetics|antiemetics|mesh-ancestor
24939603|NCT04008225|Chelating Agents|chelating agents|mesh-ancestor
24852948|NCT02264834|Anesthetics, Local|anesthetics, local|mesh-ancestor
25217232|NCT02679131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25217233|NCT02679131|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25217234|NCT02679131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217235|NCT02679131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217236|NCT02679092|Misoprostol|misoprostol|mesh-list
24831738|NCT02168543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831740|NCT02168569|Lumefantrine|lumefantrine|mesh-list
24831741|NCT02168569|Artemether|artemether|mesh-list
24831742|NCT02168569|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24831743|NCT02168569|Amodiaquine|amodiaquine|mesh-list
24831744|NCT02168569|Antimalarials|antimalarials|mesh-ancestor
24831746|NCT02168569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24831747|NCT02168569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24831748|NCT02168569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24831749|NCT02168569|Antiviral Agents|antiviral agents|mesh-ancestor
24831750|NCT02168569|Schistosomicides|schistosomicides|mesh-ancestor
24831751|NCT02168569|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24831752|NCT02168569|Anthelmintics|anthelmintics|mesh-ancestor
24831753|NCT02168634|Botulinum Toxins|botulinum toxins|mesh-list
24831754|NCT02168634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24831755|NCT02168634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24831756|NCT02168634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404885|NCT03646188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217237|NCT02679092|Mifepristone|mifepristone|mesh-list
24831760|NCT02168751|Propofol|propofol|mesh-list
25217238|NCT02679092|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25217239|NCT02679092|Abortifacient Agents|abortifacient agents|mesh-ancestor
25217240|NCT02679092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25217241|NCT02679092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217242|NCT02679092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25217243|NCT02679092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25217244|NCT02679092|Oxytocics|oxytocics|mesh-ancestor
25217245|NCT02679092|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25217246|NCT02679092|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25217247|NCT02679092|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25217248|NCT02679092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25217249|NCT02679092|Contraceptive Agents|contraceptive agents|mesh-ancestor
25217250|NCT02679092|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24501786|NCT00531076|Growth Substances|growth substances|mesh-ancestor
25217264|NCT02678949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25217265|NCT02678949|Autonomic Agents|autonomic agents|mesh-ancestor
25217266|NCT02678949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25217267|NCT02678949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217268|NCT02678949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25217269|NCT02678949|Respiratory System Agents|respiratory system agents|mesh-ancestor
25217270|NCT02678949|Dermatologic Agents|dermatologic agents|mesh-ancestor
25217271|NCT02678949|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25217272|NCT02678949|Tocolytic Agents|tocolytic agents|mesh-ancestor
25217273|NCT02678949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25217274|NCT02678949|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25217275|NCT02678949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25217276|NCT02678949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25217277|NCT02678949|Adrenergic Agents|adrenergic agents|mesh-ancestor
25217278|NCT02678949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25272914|NCT02388750|Autonomic Agents|autonomic agents|mesh-ancestor
24831771|NCT02168881|Dinoprostone|dinoprostone|mesh-list
24831772|NCT02168881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24831773|NCT02168881|Abortifacient Agents|abortifacient agents|mesh-ancestor
24969900|NCT03738943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969901|NCT03738943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24501764|NCT00530972|Antimetabolites|antimetabolites|mesh-ancestor
24969902|NCT03738943|Vasodilator Agents|vasodilator agents|mesh-ancestor
24969903|NCT03738943|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24969904|NCT03738943|Purinergic Agonists|purinergic agonists|mesh-ancestor
24969905|NCT03738943|Purinergic Agents|purinergic agents|mesh-ancestor
24969906|NCT03738943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24969907|NCT03738943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969908|NCT03738943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24969909|NCT03738943|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24969910|NCT03738943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24969911|NCT03738943|Cholinergic Agents|cholinergic agents|mesh-ancestor
24939615|NCT04008186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939616|NCT04008186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24969933|NCT03738527|Tranexamic Acid|tranexamic acid|mesh-list
24969934|NCT03738527|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24969935|NCT03738527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24577487|NCT00844337|Amoxicillin|amoxicillin|mesh-list
24969936|NCT03738527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969937|NCT03738527|Hemostatics|hemostatics|mesh-ancestor
24969938|NCT03738527|Coagulants|coagulants|mesh-ancestor
24969939|NCT03738176|Triamcinolone|triamcinolone|mesh-list
24501765|NCT00530972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501766|NCT00530972|Antiviral Agents|antiviral agents|mesh-ancestor
24501767|NCT00530972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24501768|NCT00531024|Bevacizumab|bevacizumab|mesh-list
24501769|NCT00531024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25217279|NCT02678949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217280|NCT02678884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25217281|NCT02678884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25217282|NCT02678884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217283|NCT02678728|Dexmedetomidine|dexmedetomidine|mesh-list
25217284|NCT02678728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25217285|NCT02678728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25217286|NCT02678728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217287|NCT02678728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25217288|NCT02678728|Analgesics|analgesics|mesh-ancestor
25217289|NCT02678728|Sensory System Agents|sensory system agents|mesh-ancestor
25217290|NCT02678728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25217291|NCT02678728|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24831820|NCT02169154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24831821|NCT02169154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25042203|NCT01486849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042204|NCT01486849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042205|NCT01486849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25042206|NCT01486849|Protective Agents|protective agents|mesh-ancestor
25042207|NCT01484119|Cetirizine|cetirizine|mesh-list
25042208|NCT01484119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25042209|NCT01484119|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25042210|NCT01484119|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25042211|NCT01484119|Histamine Antagonists|histamine antagonists|mesh-ancestor
25042212|NCT01484119|Histamine Agents|histamine agents|mesh-ancestor
25042213|NCT01484119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25042214|NCT01484119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951029|NCT03908944|Methadone|methadone|mesh-list
24501770|NCT00531024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501771|NCT00531024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24628357|NCT01098383|Cholinergic Agents|cholinergic agents|mesh-ancestor
24628358|NCT01098383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24628359|NCT01098383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628360|NCT01098383|Nootropic Agents|nootropic agents|mesh-ancestor
24663218|NCT01299558|Fluticasone|fluticasone|mesh-list
25083024|NCT03318471|Sensory System Agents|sensory system agents|mesh-ancestor
24501775|NCT00531024|Growth Inhibitors|growth inhibitors|mesh-ancestor
24501776|NCT00531063|Everolimus|everolimus|mesh-list
24501777|NCT00531063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501778|NCT00531063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24501779|NCT00531063|Immunologic Factors|immunologic factors|mesh-ancestor
24501780|NCT00531063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501781|NCT00531076|Bevacizumab|bevacizumab|mesh-list
24501782|NCT00531076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24501783|NCT00531076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501784|NCT00531076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24501785|NCT00531076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24501787|NCT00531076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501788|NCT00531076|Growth Inhibitors|growth inhibitors|mesh-ancestor
24501789|NCT00531089|Rituximab|rituximab|mesh-list
25679119|NCT01833845|Antiviral Agents|antiviral agents|mesh-ancestor
25679120|NCT01833845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25679121|NCT01833845|Antimalarials|antimalarials|mesh-ancestor
25679122|NCT01833845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25679123|NCT01833845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25679124|NCT01833845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501790|NCT00531089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24501791|NCT00531089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501792|NCT00531089|Immunologic Factors|immunologic factors|mesh-ancestor
24501810|NCT00531167|Antiviral Agents|antiviral agents|mesh-ancestor
24501811|NCT00531167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24501812|NCT00531167|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24501813|NCT00531167|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24501814|NCT00531193|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
24501815|NCT00531193|SCH 442416|sch 442416|mesh-list
24501816|NCT00531193|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
25217292|NCT02678728|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25217293|NCT02678728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25217294|NCT02678728|Adrenergic Agents|adrenergic agents|mesh-ancestor
25217295|NCT02678728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25217296|NCT02678728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217297|NCT02678780|Lenvatinib|lenvatinib|mesh-list
25217298|NCT02678780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25217299|NCT02678780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25217300|NCT02678780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217301|NCT02678780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217302|NCT02678767|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25217303|NCT02678767|Hematinics|hematinics|mesh-ancestor
25217304|NCT02678767|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25217305|NCT02678767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25217306|NCT02678520|Goserelin|goserelin|mesh-list
25217307|NCT02678520|Bicalutamide|bicalutamide|mesh-list
25217308|NCT02678520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25217309|NCT02678520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217310|NCT02678520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25217311|NCT02678520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042218|NCT01483742|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25042219|NCT01483742|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25042220|NCT01483742|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25042221|NCT01483742|Protease Inhibitors|protease inhibitors|mesh-ancestor
25042222|NCT01483742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25042223|NCT01483742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042224|NCT01483742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25042225|NCT01483742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25042226|NCT01483742|Antiviral Agents|antiviral agents|mesh-ancestor
25042227|NCT01483742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24951033|NCT03908944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501817|NCT00531193|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25083025|NCT03318471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737127|NCT01667094|Ceftazidime|ceftazidime|mesh-list
25083033|NCT03318471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083034|NCT03318471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25083035|NCT03318471|Tocolytic Agents|tocolytic agents|mesh-ancestor
25083036|NCT03318471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25083037|NCT03318445|Irinotecan|irinotecan|mesh-list
25083038|NCT03318445|Rucaparib|rucaparib|mesh-list
25083039|NCT03318445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25083040|NCT03318445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25083041|NCT03318445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25083042|NCT03318445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083043|NCT03318445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083044|NCT03318445|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25083045|NCT03318419|Cytarabine|cytarabine|mesh-list
25083046|NCT03318419|Pegaspargase|pegaspargase|mesh-list
25083047|NCT03318419|Asparaginase|asparaginase|mesh-list
25083048|NCT03318419|Cladribine|cladribine|mesh-list
25083049|NCT03318419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25083050|NCT03318419|Antimetabolites|antimetabolites|mesh-ancestor
24501818|NCT00531193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24501819|NCT00531193|Purinergic Agents|purinergic agents|mesh-ancestor
24501820|NCT00531193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24643777|NCT01187264|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25265402|NCT02433587|Analgesics|analgesics|mesh-ancestor
24501832|NCT00531310|Busulfan|busulfan|mesh-list
24501833|NCT00531310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501834|NCT00531310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501835|NCT00531310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24501836|NCT00531310|Immunologic Factors|immunologic factors|mesh-ancestor
24501837|NCT00531310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501838|NCT00531310|Alkylating Agents|alkylating agents|mesh-ancestor
25083051|NCT03318419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083052|NCT03318419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083053|NCT03318419|Antiviral Agents|antiviral agents|mesh-ancestor
25083054|NCT03318419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25217312|NCT02678520|Androgen Antagonists|androgen antagonists|mesh-ancestor
25217313|NCT02678520|Hormone Antagonists|hormone antagonists|mesh-ancestor
25217314|NCT02678377|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25217315|NCT02678377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25217316|NCT02678377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25217317|NCT02678377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25217318|NCT02678377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217319|NCT02678377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25217320|NCT02678377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25217321|NCT02678377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217322|NCT02678377|Cholinergic Agents|cholinergic agents|mesh-ancestor
25217323|NCT02678377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25217324|NCT02678650|Anesthetics|anesthetics|mesh-list
25042228|NCT01483742|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25042229|NCT01483742|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25042230|NCT01483742|Antimetabolites|antimetabolites|mesh-ancestor
25042231|NCT01482403|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25042232|NCT01482403|Interferon-alpha|interferon-alpha|mesh-list
25042234|NCT01482403|Antiviral Agents|antiviral agents|mesh-ancestor
25042236|NCT01482403|Immunologic Factors|immunologic factors|mesh-ancestor
25042245|NCT01482390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24831822|NCT02169154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831823|NCT02169154|Antipruritics|antipruritics|mesh-ancestor
24831824|NCT02169154|Dermatologic Agents|dermatologic agents|mesh-ancestor
24831825|NCT02169167|Octenidine|octenidine|mesh-list
24831826|NCT02169167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24831827|NCT02169167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24831828|NCT02169544|Abatacept|abatacept|mesh-list
24734984|NCT01655095|Prucalopride|prucalopride|mesh-list
25083055|NCT03318419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25083056|NCT03318419|Immunologic Factors|immunologic factors|mesh-ancestor
25083057|NCT03318419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083058|NCT03318354|Olmesartan|olmesartan|mesh-list
24663238|NCT01299662|Poly ICLC|poly iclc|mesh-list
24628361|NCT01098383|Lipotropic Agents|lipotropic agents|mesh-ancestor
24628362|NCT01098383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25083059|NCT03318354|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25083060|NCT03318354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24501884|NCT00531401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25083061|NCT03318354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25083062|NCT03318354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25083063|NCT03318354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083064|NCT03318211|Magnesium Sulfate|magnesium sulfate|mesh-list
25083065|NCT03318211|Analgesics|analgesics|mesh-ancestor
25679125|NCT01833845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25083066|NCT03318211|Sensory System Agents|sensory system agents|mesh-ancestor
25083067|NCT03318211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24501840|NCT00531310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24501841|NCT00531323|Etravirine|etravirine|mesh-list
25679126|NCT01833897|Cycloserine|cycloserine|mesh-list
25679127|NCT01833897|Ketamine|ketamine|mesh-list
25679128|NCT01833897|Olanzapine|olanzapine|mesh-list
24501842|NCT00531323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24501843|NCT00531323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24501852|NCT00531336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24501854|NCT00531336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501855|NCT00531336|Growth Inhibitors|growth inhibitors|mesh-ancestor
24501857|NCT00531349|Sevoflurane|sevoflurane|mesh-list
24501858|NCT00531349|Anesthetics|anesthetics|mesh-ancestor
24501859|NCT00531349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25083074|NCT03318211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25083075|NCT03318211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806501|NCT02016274|Cisplatin|cisplatin|mesh-list
24969945|NCT03738137|Lidocaine|lidocaine|mesh-list
24969946|NCT03738137|Midazolam|midazolam|mesh-list
25217325|NCT02678650|Propofol|propofol|mesh-list
25217326|NCT02678650|Isoflurane|isoflurane|mesh-list
25217327|NCT02678650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25217328|NCT02678650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217329|NCT02678650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25217330|NCT02678650|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25217331|NCT02678650|Anesthetics, General|anesthetics, general|mesh-ancestor
25217332|NCT02678650|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25217333|NCT02678338|Magrolimab|magrolimab|mesh-list
25217334|NCT02678338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25217335|NCT02678338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25217336|NCT02678507|Analgesics, Opioid|analgesics, opioid|mesh-list
25217337|NCT02678507|Narcotics|narcotics|mesh-ancestor
25217338|NCT02678507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25217339|NCT02678507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217340|NCT02678507|Analgesics|analgesics|mesh-ancestor
25217341|NCT02678507|Sensory System Agents|sensory system agents|mesh-ancestor
24776625|NCT01858662|Antidotes|antidotes|mesh-ancestor
24587250|NCT00893880|Vasodilator Agents|vasodilator agents|mesh-ancestor
24587251|NCT00893880|Gasotransmitters|gasotransmitters|mesh-ancestor
24587252|NCT00893880|Protective Agents|protective agents|mesh-ancestor
24627251|NCT01091493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621884|NCT01064453|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
24621885|NCT01064453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24501862|NCT00531349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24542840|NCT00680511|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24542841|NCT00680511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542843|NCT00680511|Autonomic Agents|autonomic agents|mesh-ancestor
24501863|NCT00531349|Anesthetics, General|anesthetics, general|mesh-ancestor
25217342|NCT02678507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25217344|NCT02678598|Antifungal Agents|antifungal agents|mesh-ancestor
25217345|NCT02678598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25217346|NCT02678364|Vitamin D|vitamin d|mesh-list
25217347|NCT02678364|Cholecalciferol|cholecalciferol|mesh-list
25217348|NCT02678364|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
25217349|NCT02678364|Calcifediol|calcifediol|mesh-list
25217350|NCT02678364|Vitamins|vitamins|mesh-ancestor
25217351|NCT02678364|Micronutrients|micronutrients|mesh-ancestor
25217352|NCT02678364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217353|NCT02678364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24644166|NCT01189526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265426|NCT02433457|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25265428|NCT02433457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265429|NCT02433535|Simvastatin|simvastatin|mesh-list
25265430|NCT02433535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25265431|NCT02433535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25265432|NCT02433535|Antimetabolites|antimetabolites|mesh-ancestor
25265433|NCT02433535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265434|NCT02433535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25265435|NCT02433535|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25217354|NCT02678364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25217355|NCT02678585|Lidocaine|lidocaine|mesh-list
25217356|NCT02678585|Nalbuphine|nalbuphine|mesh-list
25217357|NCT02678585|Anesthetics, Local|anesthetics, local|mesh-ancestor
24501897|NCT00531544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501898|NCT00531544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24501899|NCT00531544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24501900|NCT00531544|Growth Substances|growth substances|mesh-ancestor
24501901|NCT00531544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501902|NCT00531544|Growth Inhibitors|growth inhibitors|mesh-ancestor
24501903|NCT00531544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24501904|NCT00531544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501938|NCT00531635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501939|NCT00531674|Tocopherols|tocopherols|mesh-list
24501940|NCT00531674|Antioxidants|antioxidants|mesh-ancestor
24501941|NCT00531674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501942|NCT00531674|Protective Agents|protective agents|mesh-ancestor
24501943|NCT00531674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501944|NCT00531674|Vitamins|vitamins|mesh-ancestor
24502010|NCT00531986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502011|NCT00531986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24502012|NCT00531986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24502013|NCT00531986|Antiviral Agents|antiviral agents|mesh-ancestor
24502014|NCT00531986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24502015|NCT00531986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24502016|NCT00531986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24502030|NCT00531999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24502052|NCT05319912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502053|NCT05319912|Growth Inhibitors|growth inhibitors|mesh-ancestor
24502054|NCT05319912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24502056|NCT05319912|Micronutrients|micronutrients|mesh-ancestor
24502057|NCT05319899|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
24502058|NCT05319899|Choline|choline|mesh-list
24502059|NCT05319899|Omeprazole|omeprazole|mesh-list
24502060|NCT05319899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24502061|NCT05319899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24502062|NCT05319899|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24969981|NCT03738059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25679129|NCT01833897|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25679130|NCT01833897|Fluoxetine|fluoxetine|mesh-list
25679131|NCT01833897|Analgesics|analgesics|mesh-ancestor
25679132|NCT01833897|Sensory System Agents|sensory system agents|mesh-ancestor
25679133|NCT01833897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25679134|NCT01833897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679135|NCT01833897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25679136|NCT01833897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25679137|NCT01833897|Anesthetics, General|anesthetics, general|mesh-ancestor
25679138|NCT01833897|Anesthetics|anesthetics|mesh-ancestor
25679139|NCT01833897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25679140|NCT01833897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25679141|NCT01833897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25679142|NCT01833897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25679143|NCT01833897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265450|NCT02433418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24969982|NCT03738059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24969983|NCT03738059|Adrenergic Agents|adrenergic agents|mesh-ancestor
24969984|NCT03738059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24969985|NCT03738059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969987|NCT03737968|Tremelimumab|tremelimumab|mesh-list
24969988|NCT03737968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25083076|NCT03318211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24806592|NCT02016664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24969989|NCT03737968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24969990|NCT03737968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24969991|NCT03737968|Immunologic Factors|immunologic factors|mesh-ancestor
24969992|NCT03737968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969993|NCT03737773|Methamphetamine|methamphetamine|mesh-list
24969994|NCT03737773|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24969995|NCT03737773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217358|NCT02678585|Anesthetics|anesthetics|mesh-ancestor
25217359|NCT02678585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25217360|NCT02678585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217361|NCT02678585|Sensory System Agents|sensory system agents|mesh-ancestor
25217362|NCT02678585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25217363|NCT02678585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24831861|NCT02169609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24831863|NCT02169609|Sensory System Agents|sensory system agents|mesh-ancestor
24831864|NCT02169609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24831865|NCT02169609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805043|NCT02007148|Docetaxel|docetaxel|mesh-list
24969996|NCT03737773|Sympathomimetics|sympathomimetics|mesh-ancestor
24969997|NCT03737773|Autonomic Agents|autonomic agents|mesh-ancestor
24969998|NCT03737773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969999|NCT03737773|Dopamine Agents|dopamine agents|mesh-ancestor
24970000|NCT03737773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24970001|NCT03737773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970002|NCT03737773|Adrenergic Agents|adrenergic agents|mesh-ancestor
24970003|NCT03737773|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24970004|NCT03737773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24970005|NCT03737773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24970006|NCT03737773|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24970007|NCT03737721|Avelumab|avelumab|mesh-list
24970008|NCT03737721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24970014|NCT03737708|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24970015|NCT03737708|Abortifacient Agents|abortifacient agents|mesh-ancestor
24970016|NCT03737708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24970017|NCT03737708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970018|NCT03737708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24970019|NCT03737708|Antimetabolites|antimetabolites|mesh-ancestor
24970020|NCT03737708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970021|NCT03737708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970022|NCT03737708|Dermatologic Agents|dermatologic agents|mesh-ancestor
24970023|NCT03737708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24970024|NCT03737708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24617882|NCT01045941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24970042|NCT03737474|Dopamine Agonists|dopamine agonists|mesh-ancestor
24970043|NCT03737474|Dopamine Agents|dopamine agents|mesh-ancestor
24970044|NCT03737448|Trimetazidine|trimetazidine|mesh-list
24970045|NCT03737448|Vasodilator Agents|vasodilator agents|mesh-ancestor
24970046|NCT03737344|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24970047|NCT03737344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24970048|NCT03737201|Chlorhexidine|chlorhexidine|mesh-list
24928487|NCT04121780|Hormones|hormones|mesh-list
24970102|NCT03736161|Abortifacient Agents|abortifacient agents|mesh-ancestor
24970103|NCT03736161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24970104|NCT03736161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970105|NCT03736161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24970106|NCT03736161|Antimetabolites|antimetabolites|mesh-ancestor
24970107|NCT03736161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679144|NCT01833897|Antiemetics|antiemetics|mesh-ancestor
24970108|NCT03736161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970109|NCT03736161|Dermatologic Agents|dermatologic agents|mesh-ancestor
25217364|NCT02678585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25217365|NCT02678585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25217366|NCT02678585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25217367|NCT02678585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217368|NCT02678585|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25217369|NCT02678585|Narcotics|narcotics|mesh-ancestor
25217370|NCT02678585|Analgesics|analgesics|mesh-ancestor
25217371|NCT02678208|Tranexamic Acid|tranexamic acid|mesh-list
25217372|NCT02678208|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25217373|NCT02678208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24831867|NCT02169609|Dermatologic Agents|dermatologic agents|mesh-ancestor
24831868|NCT02169648|Ranibizumab|ranibizumab|mesh-list
24831869|NCT02169648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24831870|NCT02169648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24831871|NCT02169648|Growth Substances|growth substances|mesh-ancestor
24831872|NCT02169648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831873|NCT02169648|Growth Inhibitors|growth inhibitors|mesh-ancestor
24831874|NCT02169648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24831875|NCT02169713|Tamsulosin|tamsulosin|mesh-list
24831876|NCT02169713|Solifenacin Succinate|solifenacin succinate|mesh-list
24831877|NCT02169713|Mirabegron|mirabegron|mesh-list
24831878|NCT02169713|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24831879|NCT02169713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24831880|NCT02169713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24970110|NCT03736161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24970111|NCT03736161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24970112|NCT03736161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24970113|NCT03736161|Immunologic Factors|immunologic factors|mesh-ancestor
24970114|NCT03736161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24970115|NCT03736161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24970116|NCT03736161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24970117|NCT03736044|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
24970118|NCT03736044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24970119|NCT03735966|Carboplatin|carboplatin|mesh-list
24970120|NCT03735966|Docetaxel|docetaxel|mesh-list
24451276|NCT00322985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502071|NCT05319899|Sequestering Agents|sequestering agents|mesh-ancestor
24502072|NCT05319899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24970121|NCT03735966|Trastuzumab|trastuzumab|mesh-list
24970122|NCT03735966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970123|NCT03735966|Tubulin Modulators|tubulin modulators|mesh-ancestor
24970124|NCT03735966|Antimitotic Agents|antimitotic agents|mesh-ancestor
24970125|NCT03735966|Mitosis Modulators|mitosis modulators|mesh-ancestor
24970126|NCT03735966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970127|NCT03735966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24970130|NCT03735771|Bupivacaine|bupivacaine|mesh-list
24543049|NCT00681746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24970131|NCT03735771|Anesthetics, Local|anesthetics, local|mesh-ancestor
24970132|NCT03735771|Anesthetics|anesthetics|mesh-ancestor
24970133|NCT03735771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24970134|NCT03735771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970135|NCT03735771|Sensory System Agents|sensory system agents|mesh-ancestor
25217455|NCT02678117|Tocolytic Agents|tocolytic agents|mesh-ancestor
24970136|NCT03735771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970137|NCT03735563|Fentanyl|fentanyl|mesh-list
24970138|NCT03735563|Ketamine|ketamine|mesh-list
24970139|NCT03735563|Analgesics|analgesics|mesh-ancestor
24970140|NCT03735563|Sensory System Agents|sensory system agents|mesh-ancestor
24970141|NCT03735563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25217374|NCT02678208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217375|NCT02678208|Hemostatics|hemostatics|mesh-ancestor
25217376|NCT02678208|Coagulants|coagulants|mesh-ancestor
25217377|NCT02678260|Spartalizumab|spartalizumab|mesh-list
25217378|NCT02678260|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25217379|NCT02678260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217380|NCT02678260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272915|NCT02388750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25272916|NCT02388750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272917|NCT02388750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25405034|NCT03634488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265492|NCT02433184|Etanercept|etanercept|mesh-list
25272918|NCT02388750|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25272919|NCT02388750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25272920|NCT02388750|Serotonin Agents|serotonin agents|mesh-ancestor
25272921|NCT02388750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24831881|NCT02169713|Adrenergic Agents|adrenergic agents|mesh-ancestor
24831882|NCT02169713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24831883|NCT02169713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831884|NCT02169713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831886|NCT02169713|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24735072|NCT01655524|Autonomic Agents|autonomic agents|mesh-ancestor
24831887|NCT02169713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24831888|NCT02169713|Cholinergic Agents|cholinergic agents|mesh-ancestor
24831919|NCT02169843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24831920|NCT02169843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25042246|NCT01481077|Latanoprost|latanoprost|mesh-list
24970142|NCT03735563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970143|NCT03735563|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24970144|NCT03735563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24970145|NCT03735563|Anesthetics, General|anesthetics, general|mesh-ancestor
24970146|NCT03735563|Anesthetics|anesthetics|mesh-ancestor
24970147|NCT03735563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24806816|NCT02018263|Sensory System Agents|sensory system agents|mesh-ancestor
24806817|NCT02018263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24806818|NCT02018263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24806819|NCT02018263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24502073|NCT05319899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24502074|NCT05319899|Growth Substances|growth substances|mesh-ancestor
24502075|NCT05319899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806821|NCT02018263|Dopamine Agents|dopamine agents|mesh-ancestor
24628379|NCT01098513|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24628380|NCT01098513|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24628381|NCT01098513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217381|NCT02678195|Amoxicillin|amoxicillin|mesh-list
25217382|NCT02678195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25217383|NCT02678195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25217384|NCT02678104|Chlorhexidine|chlorhexidine|mesh-list
25217385|NCT02678104|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25217386|NCT02678104|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25217387|NCT02678104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25217388|NCT02678104|Disinfectants|disinfectants|mesh-ancestor
25217389|NCT02678104|Dermatologic Agents|dermatologic agents|mesh-ancestor
25217390|NCT02678221|Aspirin|aspirin|mesh-list
25217391|NCT02678221|Sildenafil Citrate|sildenafil citrate|mesh-list
24970246|NCT03735134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25217404|NCT02678221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25217405|NCT02678221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217406|NCT02678221|Antipyretics|antipyretics|mesh-ancestor
25217407|NCT02678221|Vasodilator Agents|vasodilator agents|mesh-ancestor
24951140|NCT03908372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24628382|NCT01098513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502086|NCT05319834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24502087|NCT05319834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24502088|NCT05319834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25679145|NCT01833897|Autonomic Agents|autonomic agents|mesh-ancestor
24502089|NCT05319834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502090|NCT05319834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24502091|NCT05319834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25083081|NCT03318159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25083083|NCT03318159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25083091|NCT03318159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25083093|NCT03318146|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25083094|NCT03318146|Latanoprost|latanoprost|mesh-list
25083095|NCT03318146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25083099|NCT03318029|Vitamin D|vitamin d|mesh-list
25083100|NCT03318029|Vitamins|vitamins|mesh-ancestor
25083101|NCT03318029|Micronutrients|micronutrients|mesh-ancestor
25217408|NCT02678221|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25217409|NCT02678221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25217410|NCT02678221|Urological Agents|urological agents|mesh-ancestor
25217411|NCT02678234|Acetaminophen|acetaminophen|mesh-list
25217412|NCT02678234|Ascorbic Acid|ascorbic acid|mesh-list
25217413|NCT02678234|Phenylephrine|phenylephrine|mesh-list
25217414|NCT02678234|Oxymetazoline|oxymetazoline|mesh-list
24831921|NCT02169843|Anesthetics, General|anesthetics, general|mesh-ancestor
24831922|NCT02169843|Anesthetics|anesthetics|mesh-ancestor
24831923|NCT02169856|Cefuroxime|cefuroxime|mesh-list
24831924|NCT02169856|Cefuroxime axetil|cefuroxime axetil|mesh-list
24831925|NCT02169856|Ketorolac|ketorolac|mesh-list
24831926|NCT02169856|Midazolam|midazolam|mesh-list
24831927|NCT02169856|Propofol|propofol|mesh-list
24831928|NCT02169856|Sevoflurane|sevoflurane|mesh-list
24831929|NCT02169856|Atracurium|atracurium|mesh-list
24831930|NCT02169856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24831931|NCT02169856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24831932|NCT02169856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831933|NCT02169856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24831934|NCT02169856|Anesthetics, General|anesthetics, general|mesh-ancestor
24831935|NCT02169856|Anesthetics|anesthetics|mesh-ancestor
24831936|NCT02169856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24831937|NCT02169856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24502191|NCT05318248|Sympatholytics|sympatholytics|mesh-ancestor
25083105|NCT03318016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25083106|NCT03318016|Immunologic Factors|immunologic factors|mesh-ancestor
25217416|NCT02678234|Micronutrients|micronutrients|mesh-ancestor
25217417|NCT02678234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217418|NCT02678234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25217419|NCT02678234|Analgesics|analgesics|mesh-ancestor
25217420|NCT02678234|Sensory System Agents|sensory system agents|mesh-ancestor
25217421|NCT02678234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25217422|NCT02678234|Antipyretics|antipyretics|mesh-ancestor
25217423|NCT02678234|Antioxidants|antioxidants|mesh-ancestor
25217424|NCT02678234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217425|NCT02678234|Protective Agents|protective agents|mesh-ancestor
25217426|NCT02678234|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25217427|NCT02678234|Mydriatics|mydriatics|mesh-ancestor
25217428|NCT02678234|Autonomic Agents|autonomic agents|mesh-ancestor
25217429|NCT02678234|Sympathomimetics|sympathomimetics|mesh-ancestor
25217430|NCT02678234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25217431|NCT02678234|Nasal Decongestants|nasal decongestants|mesh-ancestor
25217432|NCT02678234|Respiratory System Agents|respiratory system agents|mesh-ancestor
25217433|NCT02678234|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25217434|NCT02678234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25217435|NCT02678234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25217436|NCT02678234|Adrenergic Agents|adrenergic agents|mesh-ancestor
25217437|NCT02678234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25217438|NCT02678117|Magnesium Sulfate|magnesium sulfate|mesh-list
24831945|NCT02169856|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24831946|NCT02169856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24831966|NCT02169882|Antiemetics|antiemetics|mesh-ancestor
25679146|NCT01833897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25083107|NCT03318016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083108|NCT03318016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25083109|NCT03318016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25083110|NCT03318016|Alkylating Agents|alkylating agents|mesh-ancestor
25083111|NCT03318016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083112|NCT03318016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083113|NCT03318016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25083115|NCT03317912|Anesthetics, Local|anesthetics, local|mesh-ancestor
25083116|NCT03317912|Anesthetics|anesthetics|mesh-ancestor
25083117|NCT03317912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25083118|NCT03317912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083119|NCT03317912|Sensory System Agents|sensory system agents|mesh-ancestor
25083120|NCT03317912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24502211|NCT05317936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24502218|NCT05317767|Vaccines|vaccines|mesh-list
24502219|NCT05317767|Immunologic Factors|immunologic factors|mesh-ancestor
24502220|NCT05317767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217439|NCT02678117|Pregabalin|pregabalin|mesh-list
25217440|NCT02678117|Analgesics|analgesics|mesh-ancestor
25217441|NCT02678117|Sensory System Agents|sensory system agents|mesh-ancestor
25217442|NCT02678117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25217443|NCT02678117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217444|NCT02678117|Anticonvulsants|anticonvulsants|mesh-ancestor
25217445|NCT02678117|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25217446|NCT02678117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25217447|NCT02678117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217448|NCT02678117|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25217449|NCT02678117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25217450|NCT02678117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25217451|NCT02678117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25217452|NCT02678117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25217453|NCT02678117|Anesthetics|anesthetics|mesh-ancestor
25217454|NCT02678117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24831967|NCT02169882|Autonomic Agents|autonomic agents|mesh-ancestor
24502221|NCT05317676|Palmidrol|palmidrol|mesh-list
24502222|NCT05317676|Analgesics|analgesics|mesh-ancestor
24502223|NCT05317676|Sensory System Agents|sensory system agents|mesh-ancestor
24502224|NCT05317676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24502225|NCT05317676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502226|NCT05317676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24502227|NCT05317676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25083125|NCT03317912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083126|NCT03317899|Lenograstim|lenograstim|mesh-list
25083127|NCT03317899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25083128|NCT03317899|Immunologic Factors|immunologic factors|mesh-ancestor
25083129|NCT03317899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083130|NCT03317847|Dexamethasone|dexamethasone|mesh-list
25083131|NCT03317847|Bromfenac|bromfenac|mesh-list
25083132|NCT03317847|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25083133|NCT03317847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25083134|NCT03317847|Antiemetics|antiemetics|mesh-ancestor
25083135|NCT03317847|Autonomic Agents|autonomic agents|mesh-ancestor
25083136|NCT03317847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25083137|NCT03317847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083138|NCT03317847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25083139|NCT03317847|Glucocorticoids|glucocorticoids|mesh-ancestor
24970151|NCT03735563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970152|NCT03735563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24970153|NCT03735563|Narcotics|narcotics|mesh-ancestor
24970154|NCT03735563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24970155|NCT03735446|Cytarabine|cytarabine|mesh-list
24970156|NCT03735446|Etoposide|etoposide|mesh-list
24970157|NCT03735446|Mitoxantrone|mitoxantrone|mesh-list
24970158|NCT03735446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24970159|NCT03735446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24621907|NCT01064726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24621908|NCT01064726|Autonomic Agents|autonomic agents|mesh-ancestor
25217461|NCT02678182|Rucaparib|rucaparib|mesh-list
25217462|NCT02678182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25217463|NCT02678182|Antimetabolites|antimetabolites|mesh-ancestor
25217464|NCT02678182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217465|NCT02678182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25217466|NCT02678182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25217467|NCT02678182|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25217468|NCT02678182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217469|NCT02677597|Paclitaxel|paclitaxel|mesh-list
25217470|NCT02677597|Cisplatin|cisplatin|mesh-list
25217471|NCT02677597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24831968|NCT02169882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24831969|NCT02169882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831971|NCT02169882|Glucocorticoids|glucocorticoids|mesh-ancestor
24621909|NCT01064726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24621910|NCT01064726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621911|NCT01064726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24621913|NCT01064726|Dermatologic Agents|dermatologic agents|mesh-ancestor
24907999|NCT04325581|Liraglutide|liraglutide|mesh-list
24970176|NCT03735433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24970178|NCT03735433|Sensory System Agents|sensory system agents|mesh-ancestor
24970179|NCT03735433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970180|NCT03735433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970181|NCT03735433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24970182|NCT03735433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24970183|NCT03735433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24970184|NCT03735433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24970185|NCT03735433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970186|NCT03735433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24970187|NCT03735433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24970188|NCT03735433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24970189|NCT03735433|Antipyretics|antipyretics|mesh-ancestor
24970190|NCT03735368|Pregabalin|pregabalin|mesh-list
24970191|NCT03735368|Dexmedetomidine|dexmedetomidine|mesh-list
24970192|NCT03735368|Benoxinate|benoxinate|mesh-list
24970193|NCT03735368|Anesthetics|anesthetics|mesh-ancestor
24970194|NCT03735368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24970195|NCT03735368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970196|NCT03735368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24970197|NCT03735368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24970198|NCT03735368|Analgesics|analgesics|mesh-ancestor
24502295|NCT05302388|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24502296|NCT05302388|Prednisolone phosphate|prednisolone phosphate|mesh-list
24502297|NCT05302388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24502298|NCT05302388|Antiemetics|antiemetics|mesh-ancestor
24502299|NCT05302388|Autonomic Agents|autonomic agents|mesh-ancestor
24502300|NCT05302388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24502301|NCT05302388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502302|NCT05302388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24502303|NCT05302388|Glucocorticoids|glucocorticoids|mesh-ancestor
24502304|NCT05302388|Hormones|hormones|mesh-ancestor
24502305|NCT05302388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24502312|NCT05302388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24502313|NCT05302388|Anesthetics, Local|anesthetics, local|mesh-ancestor
24502314|NCT05302388|Anesthetics|anesthetics|mesh-ancestor
24502315|NCT05302388|Sensory System Agents|sensory system agents|mesh-ancestor
24543877|NCT00685841|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24543878|NCT00685841|Autonomic Agents|autonomic agents|mesh-ancestor
24543879|NCT00685841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24543880|NCT00685841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543881|NCT00685841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24543882|NCT00685841|Respiratory System Agents|respiratory system agents|mesh-ancestor
24543883|NCT00685841|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25050518|NCT00488839|Baclofen|baclofen|mesh-list
25050519|NCT00488839|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25050520|NCT00488839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050521|NCT00488839|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25050522|NCT00488839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24543888|NCT00685841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502319|NCT05302388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24502320|NCT05302388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502321|NCT05302388|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24502322|NCT05302388|Antipruritics|antipruritics|mesh-ancestor
24502323|NCT05302388|Dermatologic Agents|dermatologic agents|mesh-ancestor
24855996|NCT02282085|Adrenergic Agents|adrenergic agents|mesh-ancestor
25265560|NCT02433041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25265561|NCT02433041|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25265562|NCT02433041|Dopamine Agents|dopamine agents|mesh-ancestor
25265563|NCT02433041|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24970199|NCT03735368|Sensory System Agents|sensory system agents|mesh-ancestor
24502337|NCT05273671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24502338|NCT05273671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502341|NCT05238233|Proxymetacaine|proxymetacaine|mesh-list
24502342|NCT05238233|Pilocarpine|pilocarpine|mesh-list
25217472|NCT02677597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25217473|NCT02677597|Tubulin Modulators|tubulin modulators|mesh-ancestor
25217474|NCT02677597|Antimitotic Agents|antimitotic agents|mesh-ancestor
25217475|NCT02677597|Mitosis Modulators|mitosis modulators|mesh-ancestor
24831993|NCT02170038|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
24502343|NCT05238233|Tropicamide|tropicamide|mesh-list
24502344|NCT05238233|Miotics|miotics|mesh-ancestor
24502345|NCT05238233|Autonomic Agents|autonomic agents|mesh-ancestor
24502354|NCT05238233|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24502355|NCT05238233|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24502356|NCT05238233|Anesthetics, Local|anesthetics, local|mesh-ancestor
24502358|NCT05238233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24502359|NCT05238233|Sensory System Agents|sensory system agents|mesh-ancestor
25217480|NCT02677584|Sodium Citrate|sodium citrate|mesh-list
25217481|NCT02677584|Anticoagulants|anticoagulants|mesh-ancestor
25217482|NCT02677584|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25217483|NCT02677584|Chelating Agents|chelating agents|mesh-ancestor
25217484|NCT02677584|Sequestering Agents|sequestering agents|mesh-ancestor
25217485|NCT02677584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217486|NCT02677584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24464234|NCT00363909|Dexetimide|dexetimide|mesh-list
24832069|NCT02170610|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24832070|NCT02170610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951214|NCT03907215|Serotonin Agents|serotonin agents|mesh-ancestor
24970226|NCT03735264|Mitosis Modulators|mitosis modulators|mesh-ancestor
24970227|NCT03735264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970228|NCT03735251|Metoprolol|metoprolol|mesh-list
25679147|NCT01833897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25679148|NCT01833897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25679149|NCT01833897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25679150|NCT01833897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25679151|NCT01833897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25679152|NCT01833897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25679153|NCT01833897|Serotonin Agents|serotonin agents|mesh-ancestor
25679154|NCT01833897|Antidepressive Agents|antidepressive agents|mesh-ancestor
25679155|NCT01833897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25679156|NCT01833897|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24970229|NCT03735251|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
24970230|NCT03735251|Diuretics|diuretics|mesh-list
25050531|NCT00488267|Analgesics|analgesics|mesh-ancestor
24447038|NCT00307203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24447039|NCT00307203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24447040|NCT00307255|Gemcitabine|gemcitabine|mesh-list
24447041|NCT00307255|Paclitaxel|paclitaxel|mesh-list
24447042|NCT00307255|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24970231|NCT03735251|Natriuretic Agents|natriuretic agents|mesh-ancestor
24970232|NCT03735251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970233|NCT03735251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24970234|NCT03735251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24970235|NCT03735251|Sympatholytics|sympatholytics|mesh-ancestor
24970236|NCT03735251|Autonomic Agents|autonomic agents|mesh-ancestor
24970237|NCT03735251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970238|NCT03735251|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24970239|NCT03735251|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24970240|NCT03735251|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24970241|NCT03735251|Adrenergic Agents|adrenergic agents|mesh-ancestor
24970242|NCT03735251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24970243|NCT03735251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970245|NCT03735134|Gout Suppressants|gout suppressants|mesh-ancestor
24970248|NCT03735134|Antimitotic Agents|antimitotic agents|mesh-ancestor
24970249|NCT03735134|Mitosis Modulators|mitosis modulators|mesh-ancestor
24970250|NCT03735134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970251|NCT03735134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970252|NCT03735082|Paclitaxel|paclitaxel|mesh-list
24970253|NCT03735082|Carboplatin|carboplatin|mesh-list
24970254|NCT03735082|Apatinib|apatinib|mesh-list
24970255|NCT03735082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24502386|NCT05165212|Amoxicillin|amoxicillin|mesh-list
24502419|NCT05096702|Tafenoquine|tafenoquine|mesh-list
24502420|NCT05096702|Antimalarials|antimalarials|mesh-ancestor
25217487|NCT02677584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543934|NCT00685971|Micronutrients|micronutrients|mesh-ancestor
25217488|NCT02677584|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25217489|NCT02677584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217490|NCT02677584|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25217491|NCT02677584|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25217492|NCT02677584|Purinergic Agents|purinergic agents|mesh-ancestor
25217493|NCT02677584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25217494|NCT02677571|Morphine|morphine|mesh-list
25217495|NCT02677571|Levobupivacaine|levobupivacaine|mesh-list
25217496|NCT02677571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25217497|NCT02677571|Narcotics|narcotics|mesh-ancestor
25217498|NCT02677571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25217499|NCT02677571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217500|NCT02677571|Analgesics|analgesics|mesh-ancestor
24832071|NCT02170610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832073|NCT02170610|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832074|NCT02170610|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832106|NCT02170675|Antifungal Agents|antifungal agents|mesh-ancestor
24832107|NCT02170675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24832108|NCT02170675|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24832109|NCT02170675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24832110|NCT02170675|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24832111|NCT02170675|Hormone Antagonists|hormone antagonists|mesh-ancestor
24832112|NCT02170675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24832113|NCT02170675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832114|NCT02170675|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24832116|NCT02170701|Antithrombins|antithrombins|mesh-ancestor
24502421|NCT05096702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24502422|NCT05096702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24502423|NCT05096702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24502424|NCT05085808|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24502425|NCT05085808|Trazodone|trazodone|mesh-list
24502426|NCT05085808|Antidepressive Agents|antidepressive agents|mesh-ancestor
24502427|NCT05085808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24502428|NCT05085808|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24502429|NCT05085808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24502430|NCT05085808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24970264|NCT03734627|Sulfasalazine|sulfasalazine|mesh-list
24970265|NCT03734627|Octreotide|octreotide|mesh-list
24970266|NCT03734627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24970267|NCT03734627|Analgesics|analgesics|mesh-ancestor
24970268|NCT03734627|Sensory System Agents|sensory system agents|mesh-ancestor
24970269|NCT03734627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970270|NCT03734627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970271|NCT03734627|Antipyretics|antipyretics|mesh-ancestor
24970272|NCT03734627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24970273|NCT03734627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24970274|NCT03734627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970275|NCT03734627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24970276|NCT03734627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24970277|NCT03734627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24970278|NCT03734627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24970279|NCT03734614|Aspirin|aspirin|mesh-list
24970280|NCT03734614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24970281|NCT03734614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24970282|NCT03734614|Analgesics|analgesics|mesh-ancestor
24970283|NCT03734614|Sensory System Agents|sensory system agents|mesh-ancestor
24970284|NCT03734614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970285|NCT03734614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970286|NCT03734614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24970287|NCT03734614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24970288|NCT03734614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24970303|NCT03734562|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24970304|NCT03734562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25217503|NCT02677571|Anesthetics, Local|anesthetics, local|mesh-ancestor
25217505|NCT02677532|Acetaminophen|acetaminophen|mesh-list
25217506|NCT02677532|Sufentanil|sufentanil|mesh-list
25217507|NCT02677532|Morphine|morphine|mesh-list
25217509|NCT02677532|Levobupivacaine|levobupivacaine|mesh-list
25217510|NCT02677532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25217511|NCT02677532|Narcotics|narcotics|mesh-ancestor
25217512|NCT02677532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25217513|NCT02677532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217514|NCT02677532|Analgesics|analgesics|mesh-ancestor
25217515|NCT02677532|Sensory System Agents|sensory system agents|mesh-ancestor
25217516|NCT02677532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25217517|NCT02677532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24970306|NCT03734562|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24970307|NCT03734562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24970308|NCT03734562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24970309|NCT03734562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24970310|NCT03734562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24970311|NCT03734562|Adrenergic Agents|adrenergic agents|mesh-ancestor
24970312|NCT03734562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24970313|NCT03734562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970314|NCT03734562|Sympatholytics|sympatholytics|mesh-ancestor
24970315|NCT03734562|Autonomic Agents|autonomic agents|mesh-ancestor
24970316|NCT03734562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970318|NCT03734445|Micronutrients|micronutrients|mesh-ancestor
24970319|NCT03734445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970320|NCT03734354|Brexpiprazole|brexpiprazole|mesh-list
24502443|NCT05085067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502444|NCT05085067|Viscosupplements|viscosupplements|mesh-ancestor
24502464|NCT05061654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24502465|NCT05061654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24970324|NCT03734354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970325|NCT03734354|Dopamine Agonists|dopamine agonists|mesh-ancestor
24970326|NCT03734354|Dopamine Agents|dopamine agents|mesh-ancestor
24908121|NCT04324294|Pancrelipase|pancrelipase|mesh-list
24621922|NCT01064726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621923|NCT01064752|Minocycline|minocycline|mesh-list
24794050|NCT05414149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24794051|NCT05414149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24794052|NCT05414149|Growth Substances|growth substances|mesh-ancestor
24794053|NCT05414149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794054|NCT05414149|Growth Inhibitors|growth inhibitors|mesh-ancestor
24794055|NCT05414149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24794056|NCT05414136|Trastuzumab|trastuzumab|mesh-list
24794057|NCT05414136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24794058|NCT05414136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24794077|NCT05413915|Imatinib Mesylate|imatinib mesylate|mesh-list
24502477|NCT05035316|Calcium|calcium|mesh-list
24502478|NCT05035316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24502479|NCT05035316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502480|NCT05035316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24502481|NCT05035316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24502482|NCT05035316|Analgesics|analgesics|mesh-ancestor
24970349|NCT03733873|Hemostatics|hemostatics|mesh-ancestor
24970350|NCT03733873|Coagulants|coagulants|mesh-ancestor
24628422|NCT01098890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807405|NCT02021851|BB 1101|bb 1101|mesh-list
24807406|NCT02021851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24970369|NCT03733691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970371|NCT03733652|Interferon-alpha|interferon-alpha|mesh-list
24970372|NCT03733652|Interferon alpha-2|interferon alpha-2|mesh-list
24970373|NCT03733652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970374|NCT03733652|Antiviral Agents|antiviral agents|mesh-ancestor
24970375|NCT03733652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24970376|NCT03733652|Immunologic Factors|immunologic factors|mesh-ancestor
24970377|NCT03733652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970378|NCT03733639|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24970379|NCT03733639|Hemostatics|hemostatics|mesh-ancestor
24970380|NCT03733639|Coagulants|coagulants|mesh-ancestor
24970381|NCT03733587|Cyclophosphamide|cyclophosphamide|mesh-list
24970382|NCT03733587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24970383|NCT03733587|Immunologic Factors|immunologic factors|mesh-ancestor
24970384|NCT03733587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970385|NCT03733587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24970386|NCT03733587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24970387|NCT03733587|Alkylating Agents|alkylating agents|mesh-ancestor
24970388|NCT03733587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738374|NCT01675076|Anticoagulants|anticoagulants|mesh-ancestor
24970396|NCT03733574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24970397|NCT03733574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970398|NCT03733574|Antidepressive Agents|antidepressive agents|mesh-ancestor
24970399|NCT03733574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25083141|NCT03317847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25083142|NCT03317847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25083143|NCT03317847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083144|NCT03317847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25083145|NCT03317847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25083146|NCT03317847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25083148|NCT03317847|Sensory System Agents|sensory system agents|mesh-ancestor
25083149|NCT03317847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25083150|NCT03317730|Oxycodone|oxycodone|mesh-list
25217524|NCT02677519|Methylphenidate|methylphenidate|mesh-list
25217525|NCT02677519|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25217526|NCT02677519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217527|NCT02677519|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25217528|NCT02677519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25217529|NCT02677519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25083154|NCT03317730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083155|NCT03317730|Analgesics|analgesics|mesh-ancestor
25083156|NCT03317730|Sensory System Agents|sensory system agents|mesh-ancestor
25083158|NCT03317717|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24970401|NCT03733561|Dopamine Agonists|dopamine agonists|mesh-ancestor
24970402|NCT03733561|Dopamine Agents|dopamine agents|mesh-ancestor
24970403|NCT03733561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24970404|NCT03733561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970405|NCT03733561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970406|NCT03733535|Benralizumab|benralizumab|mesh-list
24970407|NCT03733535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24970408|NCT03733535|Respiratory System Agents|respiratory system agents|mesh-ancestor
24970409|NCT03733379|Amoxicillin|amoxicillin|mesh-list
24970410|NCT03733379|Metronidazole|metronidazole|mesh-list
24970411|NCT03733379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24970423|NCT03733327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970424|NCT03733327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24970425|NCT03733327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24970426|NCT03733327|Alkylating Agents|alkylating agents|mesh-ancestor
24447155|NCT00307632|Estradiol|estradiol|mesh-list
24544377|NCT00688857|Choline|choline|mesh-list
24544378|NCT00688857|Lipotropic Agents|lipotropic agents|mesh-ancestor
24544379|NCT00688857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24544380|NCT00688857|Antimetabolites|antimetabolites|mesh-ancestor
24544381|NCT00688857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544382|NCT00688857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24856134|NCT02282891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24856135|NCT02282891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856136|NCT02282956|Droperidol|droperidol|mesh-list
24856137|NCT02282956|Morphine|morphine|mesh-list
24856178|NCT02283060|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24856179|NCT02283060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24856180|NCT02283060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24856181|NCT02283060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24544410|NCT00688922|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24970427|NCT03733327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970428|NCT03733327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970429|NCT03733327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24970430|NCT03733327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24970431|NCT03733327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24970432|NCT03733327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24970433|NCT03733327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24970435|NCT03733275|Bupivacaine|bupivacaine|mesh-list
24970436|NCT03733275|Anesthetics, Local|anesthetics, local|mesh-ancestor
24970437|NCT03733275|Anesthetics|anesthetics|mesh-ancestor
24970438|NCT03733275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24970439|NCT03733275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970440|NCT03733275|Sensory System Agents|sensory system agents|mesh-ancestor
24970441|NCT03733275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970442|NCT03733275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24970443|NCT03733275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24970444|NCT03733275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24970451|NCT03733171|Adrenergic Agents|adrenergic agents|mesh-ancestor
24970452|NCT03733171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24970453|NCT03733171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970454|NCT03733171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970455|NCT03733171|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24970456|NCT03733171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24970457|NCT03733171|Autonomic Agents|autonomic agents|mesh-ancestor
24970458|NCT03733171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970459|NCT03733171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24970460|NCT03733171|Respiratory System Agents|respiratory system agents|mesh-ancestor
24970461|NCT03733171|Mydriatics|mydriatics|mesh-ancestor
24970462|NCT03733171|Sympathomimetics|sympathomimetics|mesh-ancestor
24970463|NCT03733171|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24970464|NCT03733171|Coagulants|coagulants|mesh-ancestor
24970465|NCT03732963|Melatonin|melatonin|mesh-list
24970466|NCT03732963|Antioxidants|antioxidants|mesh-ancestor
24970467|NCT03732963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970468|NCT03732963|Protective Agents|protective agents|mesh-ancestor
24738470|NCT01675648|GABA Agents|gaba agents|mesh-ancestor
24502507|NCT05013892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502508|NCT05013892|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24502509|NCT05013892|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24502510|NCT04998240|Myeloma Proteins|myeloma proteins|mesh-list
24502511|NCT04998240|Paraproteins|paraproteins|mesh-list
25217530|NCT02677519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217531|NCT02677519|Dopamine Agents|dopamine agents|mesh-ancestor
25217532|NCT02677519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25217533|NCT02677415|Anesthetics|anesthetics|mesh-list
24832122|NCT02170740|Pantoprazole|pantoprazole|mesh-list
24832123|NCT02170740|Dabigatran|dabigatran|mesh-list
24832124|NCT02170740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24970477|NCT03732703|Ixazomib|ixazomib|mesh-list
25217534|NCT02677415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
25217535|NCT02677415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25217536|NCT02677415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217537|NCT02677415|Anesthetics, General|anesthetics, general|mesh-ancestor
25217538|NCT02677376|Listerine|listerine|mesh-list
25217539|NCT02677376|Fluorides|fluorides|mesh-list
25217540|NCT02677376|Sodium Fluoride|sodium fluoride|mesh-list
25217541|NCT02677376|Cariostatic Agents|cariostatic agents|mesh-ancestor
25679157|NCT01833897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25679158|NCT01833897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25679159|NCT01833897|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25679160|NCT01833897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25679161|NCT01833897|Renal Agents|renal agents|mesh-ancestor
25679162|NCT01833897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25679163|NCT01833897|Antitubercular Agents|antitubercular agents|mesh-ancestor
25679164|NCT01833897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25217542|NCT02677376|Protective Agents|protective agents|mesh-ancestor
25217543|NCT02677376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217544|NCT02677376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25217545|NCT02677376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25217546|NCT02677155|Rituximab|rituximab|mesh-list
25217547|NCT02677155|Pembrolizumab|pembrolizumab|mesh-list
25217548|NCT02677155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25217549|NCT02677155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25217550|NCT02677155|Immunologic Factors|immunologic factors|mesh-ancestor
25217551|NCT02677155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217552|NCT02677155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25217553|NCT02677051|Sulforaphane|sulforaphane|mesh-list
25217554|NCT02677051|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25217555|NCT02677051|Protective Agents|protective agents|mesh-ancestor
25217556|NCT02677051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217557|NCT02677051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939734|NCT04007328|Autonomic Agents|autonomic agents|mesh-ancestor
25217558|NCT02677259|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25217559|NCT02677259|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25217560|NCT02677259|Estradiol|estradiol|mesh-list
25217561|NCT02677259|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24832136|NCT02170766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24832137|NCT02170766|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24832138|NCT02170766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832139|NCT02170766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832140|NCT02170766|Antithrombins|antithrombins|mesh-ancestor
24832141|NCT02170766|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832142|NCT02170766|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832143|NCT02170766|Anticoagulants|anticoagulants|mesh-ancestor
24832145|NCT02170792|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
24970478|NCT03732703|BB 1101|bb 1101|mesh-list
24970479|NCT03732703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24970480|NCT03732703|Glycine|glycine|mesh-list
24970481|NCT03732703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24970482|NCT03732703|Antiemetics|antiemetics|mesh-ancestor
24970485|NCT03732703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970486|NCT03732703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24970487|NCT03732703|Glucocorticoids|glucocorticoids|mesh-ancestor
24970489|NCT03732703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24970490|NCT03732703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24970491|NCT03732703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970492|NCT03732703|Protease Inhibitors|protease inhibitors|mesh-ancestor
24502513|NCT04998240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502515|NCT04988685|Paclitaxel|paclitaxel|mesh-list
24502516|NCT04988685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24502541|NCT04974684|Apixaban|apixaban|mesh-list
24502582|NCT04817033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24502583|NCT04817033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24502584|NCT04817033|Analgesics|analgesics|mesh-ancestor
24502585|NCT04817033|Sensory System Agents|sensory system agents|mesh-ancestor
24502586|NCT04817033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970493|NCT03732703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24970494|NCT03732703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970495|NCT03732703|Immunologic Factors|immunologic factors|mesh-ancestor
24970496|NCT03732703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24794080|NCT05413915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24970497|NCT03732703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24970498|NCT03732703|Growth Substances|growth substances|mesh-ancestor
24970499|NCT03732703|Growth Inhibitors|growth inhibitors|mesh-ancestor
24970500|NCT03732703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24970501|NCT03732703|Leprostatic Agents|leprostatic agents|mesh-ancestor
24970502|NCT03732703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24970503|NCT03732703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24970504|NCT03732703|Glycine Agents|glycine agents|mesh-ancestor
24970505|NCT03732703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24970506|NCT03732625|Raltegravir Potassium|raltegravir potassium|mesh-list
24970507|NCT03732625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24970508|NCT03732625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24970509|NCT03732625|Antiviral Agents|antiviral agents|mesh-ancestor
24970510|NCT03732625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24970511|NCT03732625|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24970512|NCT03732625|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24970513|NCT03732625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24970514|NCT03732625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970515|NCT03732547|Poly I-C|poly i-c|mesh-list
25217562|NCT02677259|Progesterone|progesterone|mesh-list
24646319|NCT01203228|Cyclophosphamide|cyclophosphamide|mesh-list
25217563|NCT02677259|Estrogens|estrogens|mesh-ancestor
25217564|NCT02677259|Hormones|hormones|mesh-ancestor
25217565|NCT02677259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25217566|NCT02677259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217567|NCT02677259|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25217568|NCT02677259|Contraceptive Agents|contraceptive agents|mesh-ancestor
25217569|NCT02677259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25217570|NCT02677259|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25217571|NCT02677259|Progestins|progestins|mesh-ancestor
25217572|NCT02677246|Denosumab|denosumab|mesh-list
25217573|NCT02677246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25217574|NCT02677246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832147|NCT02170792|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24832148|NCT02170792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24832149|NCT02170792|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24832150|NCT02170792|Histamine Antagonists|histamine antagonists|mesh-ancestor
24832151|NCT02170792|Histamine Agents|histamine agents|mesh-ancestor
24832152|NCT02170792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24832153|NCT02170792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832154|NCT02170792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447183|NCT00307645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24447184|NCT00307645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24447185|NCT00307645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24832155|NCT02170792|Antithrombins|antithrombins|mesh-ancestor
24832156|NCT02170792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832157|NCT02170792|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832160|NCT02170805|Pantoprazole|pantoprazole|mesh-list
24832161|NCT02170805|Dabigatran|dabigatran|mesh-list
24832162|NCT02170805|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24832163|NCT02170805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24832164|NCT02170805|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24832165|NCT02170805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832169|NCT02170805|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832170|NCT02170805|Anticoagulants|anticoagulants|mesh-ancestor
24832171|NCT02170831|Dabigatran|dabigatran|mesh-list
24832172|NCT02170831|Antithrombins|antithrombins|mesh-ancestor
24832173|NCT02170831|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832174|NCT02170831|Protease Inhibitors|protease inhibitors|mesh-ancestor
24951224|NCT03907163|Analgesics|analgesics|mesh-ancestor
24502592|NCT04817033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443519|NCT00295347|Spironolactone|spironolactone|mesh-list
24502594|NCT04817033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24502595|NCT04817033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24502596|NCT04817033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24970524|NCT03732508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970525|NCT03732508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24970526|NCT03732508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970527|NCT03732508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24970528|NCT03732508|Immunologic Factors|immunologic factors|mesh-ancestor
24970529|NCT03732508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970530|NCT03732508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24970532|NCT03732508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24970534|NCT03732482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24970535|NCT03732482|Alkylating Agents|alkylating agents|mesh-ancestor
24970536|NCT03732482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970537|NCT03732482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970538|NCT03732469|Acetaminophen|acetaminophen|mesh-list
24970539|NCT03732469|Fentanyl|fentanyl|mesh-list
24970540|NCT03732469|Propofol|propofol|mesh-list
24970541|NCT03732469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25217575|NCT02677077|Natalizumab|natalizumab|mesh-list
25217576|NCT02677077|Immunologic Factors|immunologic factors|mesh-ancestor
25217577|NCT02677077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217578|NCT02676986|Exemestane|exemestane|mesh-list
25217579|NCT02676986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25217580|NCT02676986|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25217581|NCT02676986|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25217582|NCT02676986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217583|NCT02676986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217584|NCT02676986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25217585|NCT02676986|Hormone Antagonists|hormone antagonists|mesh-ancestor
25679165|NCT01833897|Antimetabolites|antimetabolites|mesh-ancestor
25679166|NCT01833988|Pancrelipase|pancrelipase|mesh-list
24939757|NCT04007341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24939758|NCT04007341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217586|NCT02676986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25217587|NCT02676986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217588|NCT02676934|Anesthetics|anesthetics|mesh-list
25217589|NCT02676934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25217590|NCT02676934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217591|NCT02676622|Aldesleukin|aldesleukin|mesh-list
25217592|NCT02676622|Cyclophosphamide|cyclophosphamide|mesh-list
25217593|NCT02676622|Thymoglobulin|thymoglobulin|mesh-list
25217594|NCT02676622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25217595|NCT02676622|Immunologic Factors|immunologic factors|mesh-ancestor
25217596|NCT02676622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217597|NCT02676622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25217598|NCT02676622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25217599|NCT02676622|Alkylating Agents|alkylating agents|mesh-ancestor
24832176|NCT02170831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832177|NCT02170831|Anticoagulants|anticoagulants|mesh-ancestor
24832178|NCT02170844|Dabigatran|dabigatran|mesh-list
24832179|NCT02170844|Antithrombins|antithrombins|mesh-ancestor
24951242|NCT03907111|Coagulants|coagulants|mesh-ancestor
24970542|NCT03732469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24970543|NCT03732469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970553|NCT03732469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24970554|NCT03732469|Antipyretics|antipyretics|mesh-ancestor
24502597|NCT04817033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24502598|NCT04817033|Anesthetics, General|anesthetics, general|mesh-ancestor
24502599|NCT04817033|GABA Modulators|gaba modulators|mesh-ancestor
24502600|NCT04817033|GABA Agents|gaba agents|mesh-ancestor
24502601|NCT04759144|Insulin|insulin|mesh-list
24502602|NCT04759144|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24502603|NCT04759144|Insulin Aspart|insulin aspart|mesh-list
24738671|NCT01676597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24970570|NCT03732235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24908386|NCT04321096|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24970571|NCT03732235|Growth Substances|growth substances|mesh-ancestor
24970572|NCT03732235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970573|NCT03732235|Growth Inhibitors|growth inhibitors|mesh-ancestor
24970574|NCT03732235|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24970575|NCT03732235|Estrogens|estrogens|mesh-ancestor
24970576|NCT03732235|Hormones|hormones|mesh-ancestor
24970577|NCT03732235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24970578|NCT03732235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24970579|NCT03732105|Apatinib|apatinib|mesh-list
24970580|NCT03732105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
24794081|NCT05413915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794083|NCT05413902|Methylprednisolone|methylprednisolone|mesh-list
24502604|NCT04759144|Insulin, Long-Acting|insulin, long-acting|mesh-list
24502605|NCT04759144|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24502606|NCT04759144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24502607|NCT04759144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502616|NCT04748172|Immunologic Factors|immunologic factors|mesh-ancestor
24794084|NCT05413902|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24794085|NCT05413902|Lidocaine|lidocaine|mesh-list
24794086|NCT05413902|Epinephrine|epinephrine|mesh-list
24794087|NCT05413902|Morphine|morphine|mesh-list
24794088|NCT05413902|Narcotics|narcotics|mesh-list
24794089|NCT05413902|Gabapentin|gabapentin|mesh-list
24794090|NCT05413902|Orphenadrine|orphenadrine|mesh-list
24794091|NCT05413902|Bupivacaine|bupivacaine|mesh-list
24794092|NCT05413902|Anesthetics, Local|anesthetics, local|mesh-ancestor
24794093|NCT05413902|Anesthetics|anesthetics|mesh-ancestor
24794094|NCT05413902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25217600|NCT02676622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217601|NCT02676622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25217602|NCT02676622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25217603|NCT02676622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25217604|NCT02676622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24832180|NCT02170844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832181|NCT02170844|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832182|NCT02170844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832183|NCT02170844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832208|NCT02170909|Anticoagulants|anticoagulants|mesh-ancestor
24832210|NCT02170922|Antithrombins|antithrombins|mesh-ancestor
25275393|NCT02372760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24832211|NCT02170922|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832212|NCT02170922|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832213|NCT02170922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24794096|NCT05413902|Sensory System Agents|sensory system agents|mesh-ancestor
24794097|NCT05413902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24794109|NCT05413902|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24794110|NCT05413902|Protective Agents|protective agents|mesh-ancestor
24794111|NCT05413902|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24794112|NCT05413902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24794113|NCT05413902|Adrenergic Agents|adrenergic agents|mesh-ancestor
24794114|NCT05413902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24794115|NCT05413902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794116|NCT05413902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24794117|NCT05413902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24794118|NCT05413902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24794119|NCT05413902|Respiratory System Agents|respiratory system agents|mesh-ancestor
24502653|NCT04724044|Lactams|lactams|mesh-list
24502654|NCT04724044|beta-Lactams|beta-lactams|mesh-list
24502655|NCT04724044|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24502656|NCT04724044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24794121|NCT05413902|Sympathomimetics|sympathomimetics|mesh-ancestor
24794122|NCT05413902|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24794123|NCT05413902|Anticonvulsants|anticonvulsants|mesh-ancestor
24794124|NCT05413902|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24794125|NCT05413902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25083160|NCT03317717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24794126|NCT05413902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24794127|NCT05413902|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24544893|NCT00690872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24794128|NCT05413902|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24794129|NCT05413902|Antimanic Agents|antimanic agents|mesh-ancestor
24794130|NCT05413902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24794131|NCT05413902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24794132|NCT05413902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24794133|NCT05413902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24794134|NCT05413902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24794135|NCT05413902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24794136|NCT05413902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24794137|NCT05413902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24794138|NCT05413902|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24794139|NCT05413902|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24794140|NCT05413902|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24794141|NCT05413902|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24794142|NCT05413902|Parasympatholytics|parasympatholytics|mesh-ancestor
24794143|NCT05413902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24794144|NCT05413902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24794145|NCT05413902|Cholinergic Agents|cholinergic agents|mesh-ancestor
24794146|NCT05413902|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
24502657|NCT04724044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24502658|NCT04724044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24502659|NCT04724044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25217607|NCT02676674|Vitamin D|vitamin d|mesh-list
25217608|NCT02676674|Cholecalciferol|cholecalciferol|mesh-list
25217609|NCT02676674|Vitamins|vitamins|mesh-ancestor
25217610|NCT02676674|Micronutrients|micronutrients|mesh-ancestor
25217611|NCT02676674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217612|NCT02676674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25217613|NCT02676674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25217614|NCT02676609|Insulin|insulin|mesh-list
25217615|NCT02676609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24502663|NCT04724044|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24502664|NCT04724044|Contraceptive Agents|contraceptive agents|mesh-ancestor
24794148|NCT05413863|Insulin|insulin|mesh-list
24794149|NCT05413863|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24970590|NCT03732040|Cariostatic Agents|cariostatic agents|mesh-ancestor
24970591|NCT03732040|Protective Agents|protective agents|mesh-ancestor
24970598|NCT03732001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970599|NCT03731988|Lidocaine|lidocaine|mesh-list
24970600|NCT03731988|Prilocaine|prilocaine|mesh-list
25679167|NCT01833988|Pancreatin|pancreatin|mesh-list
25679168|NCT01833988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25679169|NCT01834261|Oxytocin|oxytocin|mesh-list
24970601|NCT03731988|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24970602|NCT03731988|Anesthetics, Local|anesthetics, local|mesh-ancestor
24970603|NCT03731988|Anesthetics|anesthetics|mesh-ancestor
24970604|NCT03731988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24970605|NCT03731988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970606|NCT03731988|Sensory System Agents|sensory system agents|mesh-ancestor
24970607|NCT03731988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970608|NCT03731988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24970609|NCT03731988|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24970610|NCT03731988|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24970611|NCT03731988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24970612|NCT03731988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970613|NCT03731988|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24970614|NCT03731897|Lidocaine|lidocaine|mesh-list
24970615|NCT03731897|Anesthetics, Local|anesthetics, local|mesh-ancestor
24970616|NCT03731897|Anesthetics|anesthetics|mesh-ancestor
24970617|NCT03731897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24502673|NCT04684420|Metformin|metformin|mesh-list
24502674|NCT04684420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24502675|NCT04684420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502689|NCT04642378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24970618|NCT03731897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970619|NCT03731897|Sensory System Agents|sensory system agents|mesh-ancestor
24970620|NCT03731897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970621|NCT03731897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24970622|NCT03731897|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24970623|NCT03731897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24970624|NCT03731897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24970625|NCT03731897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970626|NCT03731832|Dexamethasone|dexamethasone|mesh-list
24970627|NCT03731832|Cyclophosphamide|cyclophosphamide|mesh-list
24970628|NCT03731832|Pomalidomide|pomalidomide|mesh-list
24970629|NCT03731832|Ixazomib|ixazomib|mesh-list
24970630|NCT03731832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24970639|NCT03731832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24970641|NCT03731832|Autonomic Agents|autonomic agents|mesh-ancestor
24929152|NCT04115410|Immunologic Factors|immunologic factors|mesh-ancestor
25217616|NCT02676609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217617|NCT02676739|Adderall|adderall|mesh-list
25217618|NCT02676739|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25217619|NCT02676739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217620|NCT02676869|Pembrolizumab|pembrolizumab|mesh-list
24502692|NCT04630886|Epinephrine|epinephrine|mesh-list
24502707|NCT04630886|Adrenergic Agents|adrenergic agents|mesh-ancestor
24502708|NCT04630886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24502709|NCT04630886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24502710|NCT04630886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24502711|NCT04630886|Autonomic Agents|autonomic agents|mesh-ancestor
24502729|NCT04502667|Vitamin D|vitamin d|mesh-list
24502730|NCT04502667|Cholecalciferol|cholecalciferol|mesh-list
24502731|NCT04502667|Vitamins|vitamins|mesh-ancestor
24502732|NCT04502667|Micronutrients|micronutrients|mesh-ancestor
24502733|NCT04502667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502734|NCT04502667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24502735|NCT04502667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24502736|NCT04497168|Citalopram|citalopram|mesh-list
24502737|NCT04497168|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24502772|NCT04447040|Acetaminophen|acetaminophen|mesh-list
24502773|NCT04447040|Naproxen|naproxen|mesh-list
24970642|NCT03731832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970643|NCT03731832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24970644|NCT03731832|Glucocorticoids|glucocorticoids|mesh-ancestor
24970645|NCT03731832|Hormones|hormones|mesh-ancestor
24970646|NCT03731832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24970647|NCT03731832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24970648|NCT03731832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24970649|NCT03731832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24970650|NCT03731832|Growth Substances|growth substances|mesh-ancestor
24970651|NCT03731832|Growth Inhibitors|growth inhibitors|mesh-ancestor
24970652|NCT03731832|Protease Inhibitors|protease inhibitors|mesh-ancestor
24970653|NCT03731832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24970654|NCT03731780|Chlorhexidine|chlorhexidine|mesh-list
24970655|NCT03731780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24970656|NCT03731780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24970657|NCT03731780|Disinfectants|disinfectants|mesh-ancestor
24970658|NCT03731741|Pentoxifylline|pentoxifylline|mesh-list
24970659|NCT03731741|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24970660|NCT03731741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908514|NCT04319588|Anesthetics|anesthetics|mesh-list
24970661|NCT03731741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929177|NCT04115397|Zoledronic Acid|zoledronic acid|mesh-list
24502774|NCT04447040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24502775|NCT04447040|Analgesics|analgesics|mesh-ancestor
24502776|NCT04447040|Sensory System Agents|sensory system agents|mesh-ancestor
24502777|NCT04447040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24502778|NCT04447040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502779|NCT04447040|Antipyretics|antipyretics|mesh-ancestor
24502780|NCT04447040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24502781|NCT04447040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24502793|NCT04416984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24502794|NCT04416984|Alkylating Agents|alkylating agents|mesh-ancestor
24502795|NCT04416984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502796|NCT04416984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24502797|NCT04416984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24502798|NCT04380740|Abatacept|abatacept|mesh-list
24502799|NCT04380740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24502800|NCT04380740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502801|NCT04380740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25217621|NCT02676869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25217622|NCT02676869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25217623|NCT02676297|Tiotropium Bromide|tiotropium bromide|mesh-list
25217624|NCT02676297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25217625|NCT02676297|Autonomic Agents|autonomic agents|mesh-ancestor
24449222|NCT00314704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449223|NCT00314704|Sympathomimetics|sympathomimetics|mesh-ancestor
24449224|NCT00314704|Autonomic Agents|autonomic agents|mesh-ancestor
24951286|NCT03905837|Remifentanil|remifentanil|mesh-list
24502802|NCT04380740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24502819|NCT04288323|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24970662|NCT03731741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24970663|NCT03731741|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24970665|NCT03731741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970666|NCT03731741|Vasodilator Agents|vasodilator agents|mesh-ancestor
24970667|NCT03731741|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24970668|NCT03731741|Antioxidants|antioxidants|mesh-ancestor
24970670|NCT03731494|Trace Elements|trace elements|mesh-ancestor
24970671|NCT03731494|Micronutrients|micronutrients|mesh-ancestor
24970672|NCT03731494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970673|NCT03731468|Dexamethasone|dexamethasone|mesh-list
24970674|NCT03731468|Anesthetics|anesthetics|mesh-list
24970675|NCT03731468|Anesthetics, Local|anesthetics, local|mesh-list
24970676|NCT03731468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24970677|NCT03731468|Antiemetics|antiemetics|mesh-ancestor
24970678|NCT03731468|Autonomic Agents|autonomic agents|mesh-ancestor
24970679|NCT03731468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970680|NCT03731468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970681|NCT03731468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24970682|NCT03731468|Glucocorticoids|glucocorticoids|mesh-ancestor
24970683|NCT03731468|Hormones|hormones|mesh-ancestor
24970684|NCT03731468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24970685|NCT03731468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24970686|NCT03731468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970687|NCT03731468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24970688|NCT03731468|Sensory System Agents|sensory system agents|mesh-ancestor
24970689|NCT03731442|Paclitaxel|paclitaxel|mesh-list
24970690|NCT03731442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24970691|NCT03731442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970692|NCT03731442|Tubulin Modulators|tubulin modulators|mesh-ancestor
24970693|NCT03731442|Antimitotic Agents|antimitotic agents|mesh-ancestor
24970694|NCT03731442|Mitosis Modulators|mitosis modulators|mesh-ancestor
24970695|NCT03731442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970696|NCT03731429|Lidocaine|lidocaine|mesh-list
24970697|NCT03731429|Anesthetics, Local|anesthetics, local|mesh-ancestor
24970698|NCT03731429|Anesthetics|anesthetics|mesh-ancestor
24970699|NCT03731429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24929200|NCT04115020|Naltrexone|naltrexone|mesh-list
24970700|NCT03731429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970701|NCT03731429|Sensory System Agents|sensory system agents|mesh-ancestor
25679170|NCT01834261|Oxytocics|oxytocics|mesh-ancestor
24970702|NCT03731429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24446620|NCT00305474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24970703|NCT03731429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24970704|NCT03731429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24970705|NCT03731429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24970706|NCT03731429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24970707|NCT03731429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970708|NCT03731403|Fluorides|fluorides|mesh-list
24970717|NCT03731286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970718|NCT03731286|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24970719|NCT03731286|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24970721|NCT03731286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24970722|NCT03731169|Voriconazole|voriconazole|mesh-list
24970723|NCT03731169|Antifungal Agents|antifungal agents|mesh-ancestor
24970724|NCT03731169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24970725|NCT03731169|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24970726|NCT03731169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24970727|NCT03731169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24970728|NCT03731169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970729|NCT03731169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24794154|NCT05413772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24794155|NCT05413746|Antioxidants|antioxidants|mesh-list
24794156|NCT05413746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794157|NCT05413746|Protective Agents|protective agents|mesh-ancestor
24794158|NCT05413746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217626|NCT02676297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25217627|NCT02676297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217628|NCT02676297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24449225|NCT00314704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24449226|NCT00314704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24449227|NCT00314704|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24794175|NCT05413343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794177|NCT05413330|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24794178|NCT05413330|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24502820|NCT04288323|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24502821|NCT04283578|Oxytocin|oxytocin|mesh-list
24502822|NCT04283578|Oxytocics|oxytocics|mesh-ancestor
24502823|NCT04283578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24502824|NCT04283578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502825|NCT04259346|Ixekizumab|ixekizumab|mesh-list
24502826|NCT04259346|Dermatologic Agents|dermatologic agents|mesh-ancestor
24502830|NCT04231968|Ziresovir|ziresovir|mesh-list
24502831|NCT04231968|Antiviral Agents|antiviral agents|mesh-ancestor
24502832|NCT04231968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24502833|NCT04167163|Abaloparatide|abaloparatide|mesh-list
24502834|NCT04167163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24502835|NCT04167163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807413|NCT02021851|Hormones|hormones|mesh-ancestor
24807414|NCT02021851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24807415|NCT02021851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24807416|NCT02021851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807417|NCT02021851|Protease Inhibitors|protease inhibitors|mesh-ancestor
24807418|NCT02021851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25083162|NCT03317717|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25083163|NCT03317717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25083164|NCT03317717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083165|NCT03317717|Cholinergic Agents|cholinergic agents|mesh-ancestor
25083166|NCT03317717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25083167|NCT03317652|Nitroprusside|nitroprusside|mesh-list
25217629|NCT02676297|Respiratory System Agents|respiratory system agents|mesh-ancestor
25217630|NCT02676297|Parasympatholytics|parasympatholytics|mesh-ancestor
25217631|NCT02676297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25217632|NCT02676297|Cholinergic Agents|cholinergic agents|mesh-ancestor
25217633|NCT02676297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25217634|NCT02676297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042248|NCT01481077|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25042249|NCT01481051|Latanoprost|latanoprost|mesh-list
25042250|NCT01481051|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25042251|NCT01481051|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25042252|NCT01480583|Alovudine|alovudine|mesh-list
25042253|NCT01480583|Trastuzumab|trastuzumab|mesh-list
25042254|NCT01480583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25042255|NCT01480583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25058987|NCT03491969|Antioxidants|antioxidants|mesh-ancestor
24970853|NCT03730558|Aflibercept|aflibercept|mesh-list
25083176|NCT03317600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083177|NCT03317600|Sensory System Agents|sensory system agents|mesh-ancestor
25083178|NCT03317600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25083179|NCT03317600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25083180|NCT03317600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25083181|NCT03317600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25083182|NCT03317600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25083183|NCT03317600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083184|NCT03317574|Botulinum Toxins|botulinum toxins|mesh-list
25083185|NCT03317574|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25083186|NCT03317574|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25083187|NCT03317574|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25083193|NCT03317574|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25083194|NCT03317574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25083196|NCT03317548|Progestins|progestins|mesh-ancestor
25083197|NCT03317548|Hormones|hormones|mesh-ancestor
25083198|NCT03317548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25083199|NCT03317548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083214|NCT03317327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25083215|NCT03317327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083216|NCT03317327|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25083217|NCT03317327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083218|NCT03317275|Fluorides|fluorides|mesh-list
24502836|NCT04152551|Risedronic Acid|risedronic acid|mesh-list
24502837|NCT04152551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24502843|NCT04151667|Dexamethasone|dexamethasone|mesh-list
24502953|NCT03981341|Hormones|hormones|mesh-ancestor
24502954|NCT03981341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24502955|NCT03981341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217635|NCT02676154|Fesoterodine|fesoterodine|mesh-list
25217636|NCT02676154|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25217637|NCT02676154|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25217638|NCT02676154|Cholinergic Agents|cholinergic agents|mesh-ancestor
25217639|NCT02676154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25217640|NCT02676154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217641|NCT02676154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217642|NCT02676154|Urological Agents|urological agents|mesh-ancestor
25217643|NCT02676310|Bimatoprost|bimatoprost|mesh-list
25217644|NCT02676310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25272922|NCT02388750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272923|NCT02388594|Cyclophosphamide|cyclophosphamide|mesh-list
24502956|NCT03981341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24502957|NCT03981341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24502958|NCT03981341|Hormone Antagonists|hormone antagonists|mesh-ancestor
25083219|NCT03317275|Cariostatic Agents|cariostatic agents|mesh-ancestor
25083220|NCT03317275|Protective Agents|protective agents|mesh-ancestor
25083221|NCT03317275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083222|NCT03317236|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24622727|NCT01068301|Plerixafor|plerixafor|mesh-list
24794203|NCT05409365|Immunoglobulins|immunoglobulins|mesh-list
24794204|NCT05409365|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24794205|NCT05409365|Immunologic Factors|immunologic factors|mesh-ancestor
24794206|NCT05409365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794207|NCT05397587|Vaccines|vaccines|mesh-list
24794208|NCT05397587|Immunologic Factors|immunologic factors|mesh-ancestor
24970738|NCT03731117|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24970739|NCT03731117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24970740|NCT03731117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970741|NCT03731091|Calcitriol|calcitriol|mesh-list
24970742|NCT03731091|Betamethasone|betamethasone|mesh-list
24970743|NCT03731091|Betamethasone Valerate|betamethasone valerate|mesh-list
24970744|NCT03731091|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24970745|NCT03731091|Betamethasone benzoate|betamethasone benzoate|mesh-list
25217645|NCT02676323|Leucovorin|leucovorin|mesh-list
25217646|NCT02676323|Cytarabine|cytarabine|mesh-list
25217647|NCT02676323|Hydrocortisone|hydrocortisone|mesh-list
25217648|NCT02676323|Methotrexate|methotrexate|mesh-list
25217649|NCT02676323|Fludarabine phosphate|fludarabine phosphate|mesh-list
25217650|NCT02676323|Fludarabine|fludarabine|mesh-list
25217651|NCT02676323|Panobinostat|panobinostat|mesh-list
25217652|NCT02676323|Levoleucovorin|levoleucovorin|mesh-list
25217653|NCT02676323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217654|NCT02676323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25217655|NCT02676323|Abortifacient Agents|abortifacient agents|mesh-ancestor
25217656|NCT02676323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24951313|NCT03905967|Lenvatinib|lenvatinib|mesh-list
24970746|NCT03731091|Calcipotriene|calcipotriene|mesh-list
24970747|NCT03731091|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24970748|NCT03731091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24970749|NCT03731091|Glucocorticoids|glucocorticoids|mesh-ancestor
24970750|NCT03731091|Hormones|hormones|mesh-ancestor
24970751|NCT03731091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24970752|NCT03731091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970753|NCT03731091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24970754|NCT03731091|Respiratory System Agents|respiratory system agents|mesh-ancestor
24970755|NCT03731091|Dermatologic Agents|dermatologic agents|mesh-ancestor
24970756|NCT03731091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24970790|NCT03730766|Esomeprazole|esomeprazole|mesh-list
24970792|NCT03730766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970793|NCT03730766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24970794|NCT03730766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24970795|NCT03730766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24970796|NCT03730766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24970797|NCT03730766|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24970798|NCT03730766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24970799|NCT03730766|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24970800|NCT03730766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24970802|NCT03730766|Diuretics|diuretics|mesh-ancestor
24970803|NCT03730766|Natriuretic Agents|natriuretic agents|mesh-ancestor
24970804|NCT03730766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970805|NCT03730766|Expectorants|expectorants|mesh-ancestor
24970806|NCT03730766|Respiratory System Agents|respiratory system agents|mesh-ancestor
24970817|NCT03730714|Morphine|morphine|mesh-list
24970849|NCT03730584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24970850|NCT03730584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970851|NCT03730584|Sensory System Agents|sensory system agents|mesh-ancestor
24970852|NCT03730584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970911|NCT03730038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970913|NCT03730038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24970914|NCT03729973|Lidocaine|lidocaine|mesh-list
24970915|NCT03729973|Magnesium Sulfate|magnesium sulfate|mesh-list
24970916|NCT03729973|Ketamine|ketamine|mesh-list
24970917|NCT03729973|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24970918|NCT03729973|Anesthetics, Local|anesthetics, local|mesh-ancestor
24970919|NCT03729973|Anesthetics|anesthetics|mesh-ancestor
24970920|NCT03729973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24970921|NCT03729973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970922|NCT03729973|Sensory System Agents|sensory system agents|mesh-ancestor
24970923|NCT03729973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970924|NCT03729973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25217657|NCT02676323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24970925|NCT03729973|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24970926|NCT03729973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24970927|NCT03729973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25217658|NCT02676323|Antimetabolites|antimetabolites|mesh-ancestor
25217659|NCT02676323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217660|NCT02676323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25217661|NCT02676323|Dermatologic Agents|dermatologic agents|mesh-ancestor
25217662|NCT02676323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217663|NCT02676323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25217664|NCT02676323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25217665|NCT02676323|Immunologic Factors|immunologic factors|mesh-ancestor
25217666|NCT02676323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25217667|NCT02676323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25217668|NCT02676323|Antiviral Agents|antiviral agents|mesh-ancestor
24970928|NCT03729973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970929|NCT03729973|Analgesics|analgesics|mesh-ancestor
24970930|NCT03729973|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24970931|NCT03729973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24970932|NCT03729973|Anesthetics, General|anesthetics, general|mesh-ancestor
24970933|NCT03729973|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24970934|NCT03729973|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24970935|NCT03729973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24970936|NCT03729973|Anticonvulsants|anticonvulsants|mesh-ancestor
24970937|NCT03729973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24970938|NCT03729973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24970939|NCT03729973|Tocolytic Agents|tocolytic agents|mesh-ancestor
24970940|NCT03729973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24970941|NCT03729804|Dexamethasone|dexamethasone|mesh-list
24970942|NCT03729804|Lenalidomide|lenalidomide|mesh-list
24970943|NCT03729804|Bortezomib|bortezomib|mesh-list
24970945|NCT03729804|Antiemetics|antiemetics|mesh-ancestor
24970946|NCT03729804|Autonomic Agents|autonomic agents|mesh-ancestor
24970947|NCT03729804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970948|NCT03729804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970949|NCT03729804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24970950|NCT03729804|Glucocorticoids|glucocorticoids|mesh-ancestor
24970951|NCT03729804|Hormones|hormones|mesh-ancestor
24970968|NCT03729687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970970|NCT03729674|Dermatologic Agents|dermatologic agents|mesh-ancestor
24970971|NCT03729674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24970972|NCT03729674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24970973|NCT03729505|Lidocaine|lidocaine|mesh-list
24970974|NCT03729505|Magnesium Sulfate|magnesium sulfate|mesh-list
24970975|NCT03729505|Anesthetics, Local|anesthetics, local|mesh-ancestor
24970976|NCT03729505|Anesthetics|anesthetics|mesh-ancestor
24970977|NCT03729505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24970978|NCT03729505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970985|NCT03729505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970986|NCT03729505|Analgesics|analgesics|mesh-ancestor
24970987|NCT03729505|Anticonvulsants|anticonvulsants|mesh-ancestor
24970988|NCT03729505|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24970993|NCT03729375|Anesthetics, Local|anesthetics, local|mesh-ancestor
24970994|NCT03729375|Anesthetics|anesthetics|mesh-ancestor
24970995|NCT03729375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24970996|NCT03729375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970997|NCT03729375|Sensory System Agents|sensory system agents|mesh-ancestor
24970998|NCT03729375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970999|NCT03729310|Triamcinolone|triamcinolone|mesh-list
24971000|NCT03729310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24971001|NCT03729310|Glucocorticoids|glucocorticoids|mesh-ancestor
24971002|NCT03729310|Hormones|hormones|mesh-ancestor
25217669|NCT02676323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25217670|NCT02676323|Antidotes|antidotes|mesh-ancestor
25217671|NCT02676323|Protective Agents|protective agents|mesh-ancestor
25217672|NCT02676323|Vitamin B Complex|vitamin b complex|mesh-ancestor
25217673|NCT02676323|Vitamins|vitamins|mesh-ancestor
25217674|NCT02676323|Micronutrients|micronutrients|mesh-ancestor
25217675|NCT02676323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25217676|NCT02676323|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25217677|NCT02676336|Iodine|iodine|mesh-list
25217678|NCT02676336|Cadexomer iodine|cadexomer iodine|mesh-list
25217679|NCT02676336|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25217680|NCT02676336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25217681|NCT02676336|Trace Elements|trace elements|mesh-ancestor
25679171|NCT01834261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24971006|NCT03729284|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24971007|NCT03729284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24971008|NCT03729284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24971009|NCT03729284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971010|NCT03729284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24971011|NCT03729284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971012|NCT03729284|Analgesics|analgesics|mesh-ancestor
24971013|NCT03729284|Sensory System Agents|sensory system agents|mesh-ancestor
24971014|NCT03729284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25083226|NCT03317236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24808103|NCT02025166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808104|NCT02025166|Antipyretics|antipyretics|mesh-ancestor
24971024|NCT03729128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971026|NCT03729128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24971027|NCT03729128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24971028|NCT03729128|Antitussive Agents|antitussive agents|mesh-ancestor
24971029|NCT03729128|Respiratory System Agents|respiratory system agents|mesh-ancestor
24971030|NCT03729063|Carbon Monoxide|carbon monoxide|mesh-list
24971031|NCT03729063|Antimetabolites|antimetabolites|mesh-ancestor
24971032|NCT03729063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971033|NCT03729063|Gasotransmitters|gasotransmitters|mesh-ancestor
24971034|NCT03729063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24971035|NCT03729063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083237|NCT03317197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25083238|NCT03317197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25083239|NCT03317197|Adrenergic Agents|adrenergic agents|mesh-ancestor
25217682|NCT02676336|Micronutrients|micronutrients|mesh-ancestor
25217683|NCT02676336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217685|NCT02675868|Vasopressins|vasopressins|mesh-list
25217686|NCT02675868|Arginine Vasopressin|arginine vasopressin|mesh-list
25217687|NCT02675868|Oxymetazoline|oxymetazoline|mesh-list
25217688|NCT02675868|Norepinephrine|norepinephrine|mesh-list
25217689|NCT02675868|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25217690|NCT02675868|Mydriatics|mydriatics|mesh-ancestor
24832292|NCT02171039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24832293|NCT02171039|Antimetabolites|antimetabolites|mesh-ancestor
24832294|NCT02171039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832295|NCT02171039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24832296|NCT02171039|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24832297|NCT02171039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832298|NCT02171039|Antithrombins|antithrombins|mesh-ancestor
24832299|NCT02171039|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25083240|NCT03317197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25083241|NCT03317197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794269|NCT05310916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971062|NCT03728894|Hydroxyzine|hydroxyzine|mesh-list
24971063|NCT03728894|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24971064|NCT03728894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24971065|NCT03728894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24808117|NCT02025192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24971066|NCT03728894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971067|NCT03728894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24971068|NCT03728894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24971069|NCT03728894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24971070|NCT03728894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24971071|NCT03728894|Anesthetics, General|anesthetics, general|mesh-ancestor
24971073|NCT03728894|GABA Modulators|gaba modulators|mesh-ancestor
24971074|NCT03728894|GABA Agents|gaba agents|mesh-ancestor
24971075|NCT03728894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24971076|NCT03728894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971077|NCT03728894|Antipruritics|antipruritics|mesh-ancestor
24971078|NCT03728894|Dermatologic Agents|dermatologic agents|mesh-ancestor
24971118|NCT03728465|Nivolumab|nivolumab|mesh-list
25679172|NCT01834261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679173|NCT01834274|Metformin|metformin|mesh-list
24971119|NCT03728465|Ipilimumab|ipilimumab|mesh-list
24971120|NCT03728465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24971121|NCT03728465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24971151|NCT03728101|Dabigatran|dabigatran|mesh-list
24971152|NCT03728101|Simvastatin|simvastatin|mesh-list
24971153|NCT03728101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24971154|NCT03728101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24971155|NCT03728101|Antimetabolites|antimetabolites|mesh-ancestor
24971156|NCT03728101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971157|NCT03728101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24971158|NCT03728101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24971159|NCT03728101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24971160|NCT03728101|Antithrombins|antithrombins|mesh-ancestor
24971161|NCT03728101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24971162|NCT03728101|Protease Inhibitors|protease inhibitors|mesh-ancestor
24971172|NCT03727763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24971173|NCT03727763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971176|NCT03727646|Nicotinic Acids|nicotinic acids|mesh-list
24971177|NCT03727646|Vitamin B Complex|vitamin b complex|mesh-ancestor
24971178|NCT03727646|Vitamins|vitamins|mesh-ancestor
25217691|NCT02675868|Autonomic Agents|autonomic agents|mesh-ancestor
25217692|NCT02675868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25217693|NCT02675868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217694|NCT02675868|Sympathomimetics|sympathomimetics|mesh-ancestor
25217695|NCT02675868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25217696|NCT02675868|Nasal Decongestants|nasal decongestants|mesh-ancestor
25217697|NCT02675868|Respiratory System Agents|respiratory system agents|mesh-ancestor
25217698|NCT02675868|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25217699|NCT02675868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25217700|NCT02675868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24503542|NCT00532194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24503543|NCT00532194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503544|NCT00532194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503545|NCT00532207|Teriparatide|teriparatide|mesh-list
24503546|NCT00532207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24503547|NCT00532207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503548|NCT00532207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24503549|NCT00532220|Ibandronic Acid|ibandronic acid|mesh-list
24503550|NCT00532220|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24503551|NCT00532220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503552|NCT00532246|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
24503553|NCT00532246|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24503554|NCT00532246|Hormone Antagonists|hormone antagonists|mesh-ancestor
24971225|NCT03727412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971227|NCT03727295|Antioxidants|antioxidants|mesh-ancestor
24503633|NCT00532428|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24503634|NCT00532428|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24503635|NCT00532428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24503641|NCT00532454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24971316|NCT03726593|Antimalarials|antimalarials|mesh-ancestor
24971317|NCT03726593|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24971318|NCT03726593|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24971319|NCT03726593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24971320|NCT03726593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24971321|NCT03726593|Antiviral Agents|antiviral agents|mesh-ancestor
25083243|NCT03317197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25083244|NCT03317197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25083245|NCT03317197|Autonomic Agents|autonomic agents|mesh-ancestor
25083246|NCT03317197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24739809|NCT01684319|Chelating Agents|chelating agents|mesh-ancestor
24971325|NCT03726593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24971326|NCT03726593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971327|NCT03726593|Antimetabolites|antimetabolites|mesh-ancestor
24971329|NCT03726580|Sevoflurane|sevoflurane|mesh-list
24971330|NCT03726580|Isoflurane|isoflurane|mesh-list
24971331|NCT03726580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24971332|NCT03726580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25679174|NCT01834274|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25679175|NCT01834274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24971333|NCT03726580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971334|NCT03726580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24856559|NCT02285491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856560|NCT02285491|Sensory System Agents|sensory system agents|mesh-ancestor
24856561|NCT02285491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24856562|NCT02285647|Rolapitant|rolapitant|mesh-list
24856563|NCT02285647|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24856564|NCT02285647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24856566|NCT02285647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971335|NCT03726580|Anesthetics, General|anesthetics, general|mesh-ancestor
24971336|NCT03726580|Anesthetics|anesthetics|mesh-ancestor
24971337|NCT03726580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24971338|NCT03726580|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24971350|NCT03726372|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24971351|NCT03726372|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24971353|NCT03726372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24971354|NCT03726372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971355|NCT03726281|Nivolumab|nivolumab|mesh-list
24971356|NCT03726281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24971409|NCT03726125|Insulin, Long-Acting|insulin, long-acting|mesh-list
24971410|NCT03726125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24587578|NCT00895713|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24587579|NCT00895713|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24587580|NCT00895713|Immunologic Factors|immunologic factors|mesh-ancestor
24587581|NCT00895713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621924|NCT01064752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24621925|NCT01064752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24621926|NCT01064921|Vorinostat|vorinostat|mesh-list
24621927|NCT01064921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24621928|NCT01064921|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24621929|NCT01064921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621930|NCT01064921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621931|NCT01064973|Baclofen|baclofen|mesh-list
24971422|NCT03726099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971423|NCT03726099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24971424|NCT03726099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24971425|NCT03726099|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24971427|NCT03726099|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
24971428|NCT03726099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24971429|NCT03726099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24971430|NCT03726099|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24971431|NCT03726021|Oxaliplatin|oxaliplatin|mesh-list
24971432|NCT03726021|Irinotecan|irinotecan|mesh-list
24971447|NCT03725995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24971448|NCT03725995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24971449|NCT03725995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24971450|NCT03725995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971451|NCT03725995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24971452|NCT03725995|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24971453|NCT03725995|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24971454|NCT03725995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24971455|NCT03725995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24971456|NCT03725995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24971457|NCT03725995|Anesthetics, General|anesthetics, general|mesh-ancestor
24971475|NCT03725904|Progesterone|progesterone|mesh-list
24971476|NCT03725904|Progestins|progestins|mesh-ancestor
24971477|NCT03725904|Hormones|hormones|mesh-ancestor
25679176|NCT01834274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679177|NCT01834274|Incretins|incretins|mesh-ancestor
25679178|NCT01834274|Hormones|hormones|mesh-ancestor
25679179|NCT01834274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25679180|NCT01834274|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25679181|NCT01834274|Protease Inhibitors|protease inhibitors|mesh-ancestor
25679182|NCT01834274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25679183|NCT01834274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679184|NCT01834404|Topiramate|topiramate|mesh-list
25679185|NCT01834404|Phentermine|phentermine|mesh-list
25679186|NCT01834404|Anticonvulsants|anticonvulsants|mesh-ancestor
25679187|NCT01834404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24647018|NCT01205997|Magnesium Sulfate|magnesium sulfate|mesh-list
24971478|NCT03725904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24971480|NCT03725891|Aspirin|aspirin|mesh-list
24971481|NCT03725891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24971482|NCT03725891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24971483|NCT03725891|Analgesics|analgesics|mesh-ancestor
24971538|NCT03725228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25217708|NCT02675868|Natriuretic Agents|natriuretic agents|mesh-ancestor
24971544|NCT03725228|Analgesics|analgesics|mesh-ancestor
24971545|NCT03725228|Anticonvulsants|anticonvulsants|mesh-ancestor
24971546|NCT03725228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24971547|NCT03725228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24971549|NCT03725228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24971550|NCT03725020|Fluorides|fluorides|mesh-list
24971551|NCT03725020|Fluorides, Topical|fluorides, topical|mesh-list
24971552|NCT03725020|Cariostatic Agents|cariostatic agents|mesh-ancestor
24971553|NCT03725020|Protective Agents|protective agents|mesh-ancestor
24971554|NCT03725020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971555|NCT03724955|Estradiol|estradiol|mesh-list
24971556|NCT03724955|Estrogens|estrogens|mesh-ancestor
24971557|NCT03724955|Hormones|hormones|mesh-ancestor
24971558|NCT03724955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24971559|NCT03724955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971560|NCT03724838|Sildenafil Citrate|sildenafil citrate|mesh-list
24971561|NCT03724838|Esomeprazole|esomeprazole|mesh-list
24971562|NCT03724838|Citric Acid|citric acid|mesh-list
24971563|NCT03724838|Sodium Citrate|sodium citrate|mesh-list
24971581|NCT03724578|Cariostatic Agents|cariostatic agents|mesh-ancestor
24971582|NCT03724578|Protective Agents|protective agents|mesh-ancestor
24808650|NCT02028507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24808651|NCT02028507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808652|NCT02028507|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24545696|NCT00694408|Glucocorticoids|glucocorticoids|mesh-ancestor
24808653|NCT02028507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24808654|NCT02028533|Oxytocin|oxytocin|mesh-list
24808655|NCT02028533|Oxytocics|oxytocics|mesh-ancestor
24808656|NCT02028533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24808657|NCT02028533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808658|NCT02028598|Sildenafil Citrate|sildenafil citrate|mesh-list
24808659|NCT02028598|Clomipramine|clomipramine|mesh-list
24808660|NCT02028598|Citric Acid|citric acid|mesh-list
24808661|NCT02028598|Sodium Citrate|sodium citrate|mesh-list
24808662|NCT02028598|Anticoagulants|anticoagulants|mesh-ancestor
24808663|NCT02028598|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24808664|NCT02028598|Chelating Agents|chelating agents|mesh-ancestor
24808665|NCT02028598|Sequestering Agents|sequestering agents|mesh-ancestor
24808666|NCT02028598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808667|NCT02028598|Vasodilator Agents|vasodilator agents|mesh-ancestor
24808668|NCT02028598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24808669|NCT02028598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24808670|NCT02028598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808671|NCT02028598|Urological Agents|urological agents|mesh-ancestor
24808672|NCT02028598|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24808673|NCT02028598|Antidepressive Agents|antidepressive agents|mesh-ancestor
24808674|NCT02028598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24808675|NCT02028598|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24808676|NCT02028598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25217709|NCT02676011|Atropine|atropine|mesh-list
25217710|NCT02676011|Succinylcholine|succinylcholine|mesh-list
25217711|NCT02676011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25217712|NCT02676011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25217713|NCT02676011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25217714|NCT02676011|Autonomic Agents|autonomic agents|mesh-ancestor
25217715|NCT02676011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25217716|NCT02676011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217717|NCT02676011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25217718|NCT02676011|Respiratory System Agents|respiratory system agents|mesh-ancestor
25217719|NCT02676011|Mydriatics|mydriatics|mesh-ancestor
25217720|NCT02676011|Parasympatholytics|parasympatholytics|mesh-ancestor
24832311|NCT02171052|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24832312|NCT02171052|Protective Agents|protective agents|mesh-ancestor
24832313|NCT02171052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083277|NCT03317067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25083304|NCT03316963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24503803|NCT00532961|Loteprednol Etabonate|loteprednol etabonate|mesh-list
24503805|NCT00532961|Dexamethasone|dexamethasone|mesh-list
24503806|NCT00532961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25679188|NCT01834404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503807|NCT00532961|Antiemetics|antiemetics|mesh-ancestor
24503808|NCT00532961|Autonomic Agents|autonomic agents|mesh-ancestor
24503809|NCT00532961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24503810|NCT00532961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503811|NCT00532961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24503812|NCT00532961|Glucocorticoids|glucocorticoids|mesh-ancestor
24503814|NCT00532961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24503815|NCT00532961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24503816|NCT00532961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25217721|NCT02676011|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25217722|NCT02676011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25217723|NCT02676011|Cholinergic Agents|cholinergic agents|mesh-ancestor
25217724|NCT02676011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25217725|NCT02676011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217726|NCT02676011|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
25217727|NCT02676011|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25217728|NCT02676011|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25217729|NCT02676089|Tiotropium Bromide|tiotropium bromide|mesh-list
25217730|NCT02676089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25217731|NCT02676089|Autonomic Agents|autonomic agents|mesh-ancestor
25217732|NCT02676089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25217733|NCT02676089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217734|NCT02676089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25217735|NCT02676089|Respiratory System Agents|respiratory system agents|mesh-ancestor
25217736|NCT02676089|Parasympatholytics|parasympatholytics|mesh-ancestor
25217737|NCT02676089|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25217738|NCT02676089|Cholinergic Agents|cholinergic agents|mesh-ancestor
25217739|NCT02676089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24832318|NCT02171156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832319|NCT02171182|Capsaicin|capsaicin|mesh-list
24832320|NCT02171182|Antipruritics|antipruritics|mesh-ancestor
24832321|NCT02171182|Dermatologic Agents|dermatologic agents|mesh-ancestor
24832322|NCT02171182|Sensory System Agents|sensory system agents|mesh-ancestor
24971598|NCT03724266|Sequestering Agents|sequestering agents|mesh-ancestor
24971599|NCT03724266|Hemostatics|hemostatics|mesh-ancestor
24971600|NCT03724266|Coagulants|coagulants|mesh-ancestor
24971601|NCT03724071|Flucytosine|flucytosine|mesh-list
24971602|NCT03724071|Antifungal Agents|antifungal agents|mesh-ancestor
24971603|NCT03724071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24971604|NCT03724071|Antimetabolites|antimetabolites|mesh-ancestor
24971605|NCT03724071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971606|NCT03723941|Etoposide|etoposide|mesh-list
24971610|NCT03723941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24740243|NCT01687348|Lidocaine|lidocaine|mesh-list
24545885|NCT00695630|GABA Agents|gaba agents|mesh-ancestor
24971611|NCT03723941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24971612|NCT03723941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24971616|NCT03723824|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
24971617|NCT03723824|Antiviral Agents|antiviral agents|mesh-ancestor
25217744|NCT02675647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25217745|NCT02675647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25217746|NCT02675647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217747|NCT02675647|Heparin Antagonists|heparin antagonists|mesh-ancestor
25217748|NCT02675647|Coagulants|coagulants|mesh-ancestor
25217749|NCT02675413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25217750|NCT02675413|Dermatologic Agents|dermatologic agents|mesh-ancestor
25217751|NCT02675413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25217752|NCT02675413|Immunologic Factors|immunologic factors|mesh-ancestor
25217753|NCT02675413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217754|NCT02675530|Ketamine|ketamine|mesh-list
25217755|NCT02675530|Analgesics|analgesics|mesh-ancestor
25217756|NCT02675530|Sensory System Agents|sensory system agents|mesh-ancestor
24971621|NCT03723785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24971622|NCT03723785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971623|NCT03723759|Insulin Aspart|insulin aspart|mesh-list
24971624|NCT03723759|Insulin, Long-Acting|insulin, long-acting|mesh-list
24971625|NCT03723759|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24647134|NCT01206530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24971626|NCT03723759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24971627|NCT03723759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971629|NCT03723395|Tolbutamide|tolbutamide|mesh-list
24971630|NCT03723395|Itraconazole|itraconazole|mesh-list
24971632|NCT03723395|Tucatinib|tucatinib|mesh-list
24971633|NCT03723395|Digoxin|digoxin|mesh-list
24971634|NCT03723395|Midazolam|midazolam|mesh-list
24971635|NCT03723395|Gemfibrozil|gemfibrozil|mesh-list
24971636|NCT03723395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24971637|NCT03723395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24971638|NCT03723395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25083318|NCT03316898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24971639|NCT03723395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971640|NCT03723395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24971641|NCT03723395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24971683|NCT03723291|alpha-Tocopherol|alpha-tocopherol|mesh-list
24971684|NCT03723291|Pentoxifylline|pentoxifylline|mesh-list
24971685|NCT03723291|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24971686|NCT03723291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24971687|NCT03723291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971688|NCT03723291|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24971689|NCT03723291|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24971690|NCT03723291|Protective Agents|protective agents|mesh-ancestor
24971691|NCT03723291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971692|NCT03723291|Vasodilator Agents|vasodilator agents|mesh-ancestor
24971693|NCT03723291|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24971694|NCT03723291|Antioxidants|antioxidants|mesh-ancestor
24971695|NCT03723291|Vitamins|vitamins|mesh-ancestor
24971696|NCT03723291|Micronutrients|micronutrients|mesh-ancestor
24971697|NCT03723252|Dapagliflozin|dapagliflozin|mesh-list
24971705|NCT03723187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24971706|NCT03723187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971707|NCT03723135|Azacitidine|azacitidine|mesh-list
24971708|NCT03723135|Cc-486|cc-486|mesh-list
24971709|NCT03723135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24971710|NCT03723135|Antimetabolites|antimetabolites|mesh-ancestor
24971711|NCT03723135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971712|NCT03723135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24971713|NCT03723135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24971715|NCT03723109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24971716|NCT03723109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971752|NCT03722940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24971754|NCT03722940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24971755|NCT03722940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24971756|NCT03722940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971757|NCT03722940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24971758|NCT03722940|Tocolytic Agents|tocolytic agents|mesh-ancestor
24545940|NCT00696033|Lorazepam|lorazepam|mesh-list
25217757|NCT02675530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25217758|NCT02675530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217760|NCT02675530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25217761|NCT02675530|Anesthetics, General|anesthetics, general|mesh-ancestor
25217762|NCT02675530|Anesthetics|anesthetics|mesh-ancestor
25217763|NCT02675530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25217764|NCT02675530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24832346|NCT02171325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832348|NCT02171338|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24832349|NCT02171338|Azithromycin|azithromycin|mesh-list
24832350|NCT02171338|Clarithromycin|clarithromycin|mesh-list
24832351|NCT02171338|Ciprofloxacin|ciprofloxacin|mesh-list
24832354|NCT02171338|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24971759|NCT03722940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24971760|NCT03722927|Bupivacaine|bupivacaine|mesh-list
24971761|NCT03722927|Anesthetics, Local|anesthetics, local|mesh-ancestor
24971762|NCT03722927|Anesthetics|anesthetics|mesh-ancestor
24971763|NCT03722927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24971764|NCT03722927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679189|NCT01834404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24971765|NCT03722927|Sensory System Agents|sensory system agents|mesh-ancestor
24971766|NCT03722927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24971767|NCT03722914|Benzonatate|benzonatate|mesh-list
24971768|NCT03722914|Antitussive Agents|antitussive agents|mesh-ancestor
24971769|NCT03722914|Respiratory System Agents|respiratory system agents|mesh-ancestor
24971771|NCT03722875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24971772|NCT03722875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24971773|NCT03722875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24971774|NCT03722875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971775|NCT03722823|Tucatinib|tucatinib|mesh-list
24971776|NCT03722823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24971777|NCT03722823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24971778|NCT03722823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24971779|NCT03722823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794355|NCT05259137|Enalapril|enalapril|mesh-list
24794356|NCT05259137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24794357|NCT05259137|Protease Inhibitors|protease inhibitors|mesh-ancestor
24794358|NCT05259137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24971865|NCT03721874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971867|NCT03721757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24971868|NCT03721757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24971869|NCT03721757|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24971870|NCT03721757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971871|NCT03721744|Gemcitabine|gemcitabine|mesh-list
24971872|NCT03721744|Paclitaxel|paclitaxel|mesh-list
25217773|NCT02675400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25217774|NCT02675400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25217775|NCT02675400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217776|NCT02675400|Dopamine Agents|dopamine agents|mesh-ancestor
24832357|NCT02171338|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24832358|NCT02171338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832359|NCT02171338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951365|NCT03905564|Vitamin B 6|vitamin b 6|mesh-list
24971926|NCT03721627|Sofosbuvir|sofosbuvir|mesh-list
24971927|NCT03721627|Ledipasvir|ledipasvir|mesh-list
24971984|NCT03721081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24794372|NCT05252416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24794373|NCT05252416|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24794374|NCT05252416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24794375|NCT05252416|Hormone Antagonists|hormone antagonists|mesh-ancestor
24628453|NCT01099072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24794376|NCT05252416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24794377|NCT05252416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217790|NCT02675374|Histamine Agents|histamine agents|mesh-ancestor
24832361|NCT02171338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24832362|NCT02171338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24832363|NCT02171338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24764636|NCT01782976|Bevacizumab|bevacizumab|mesh-list
24503911|NCT00533390|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24503913|NCT00533416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503914|NCT00533416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24794381|NCT05251493|Trace Elements|trace elements|mesh-ancestor
24794382|NCT05251493|Micronutrients|micronutrients|mesh-ancestor
24794383|NCT05251493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794384|NCT05251493|Hematinics|hematinics|mesh-ancestor
24972046|NCT03720483|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24972047|NCT03720483|Antiviral Agents|antiviral agents|mesh-ancestor
24972048|NCT03720483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25679190|NCT01834404|Appetite Depressants|appetite depressants|mesh-ancestor
25679191|NCT01834404|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25679192|NCT01834404|Sympathomimetics|sympathomimetics|mesh-ancestor
24972049|NCT03720483|Expectorants|expectorants|mesh-ancestor
24972050|NCT03720483|Respiratory System Agents|respiratory system agents|mesh-ancestor
24972051|NCT03720483|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24972052|NCT03720483|Antioxidants|antioxidants|mesh-ancestor
24972053|NCT03720483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972054|NCT03720483|Protective Agents|protective agents|mesh-ancestor
24972055|NCT03720483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083319|NCT03316690|Metformin|metformin|mesh-list
24972056|NCT03720483|Antidotes|antidotes|mesh-ancestor
25217791|NCT02675374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25217792|NCT02675374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217793|NCT02675374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217794|NCT02675387|Lidocaine|lidocaine|mesh-list
25217795|NCT02675387|Anesthetics, Local|anesthetics, local|mesh-ancestor
25217796|NCT02675387|Anesthetics|anesthetics|mesh-ancestor
25217797|NCT02675387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25217798|NCT02675387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217799|NCT02675387|Sensory System Agents|sensory system agents|mesh-ancestor
25217800|NCT02675387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25217801|NCT02675387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25217802|NCT02675387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25217803|NCT02675387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24449233|NCT00314743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24449234|NCT00314743|Antiemetics|antiemetics|mesh-ancestor
24972060|NCT03720340|Oprelvekin|oprelvekin|mesh-list
24972061|NCT03720340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24972062|NCT03720288|Acetazolamide|acetazolamide|mesh-list
24972063|NCT03720288|Anticonvulsants|anticonvulsants|mesh-ancestor
24972064|NCT03720288|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24972065|NCT03720288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972068|NCT03720288|Natriuretic Agents|natriuretic agents|mesh-ancestor
24972069|NCT03720288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972070|NCT03720249|Vitamins|vitamins|mesh-list
24972071|NCT03720249|Vitamin B 12|vitamin b 12|mesh-list
24972072|NCT03720249|Vitamin B 6|vitamin b 6|mesh-list
24972073|NCT03720249|Vitamin B Complex|vitamin b complex|mesh-list
24972074|NCT03720249|Betaine|betaine|mesh-list
24972075|NCT03720249|Micronutrients|micronutrients|mesh-ancestor
24972076|NCT03720249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972077|NCT03720249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24972078|NCT03720249|Lipotropic Agents|lipotropic agents|mesh-ancestor
24972079|NCT03720249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24972080|NCT03720249|Antimetabolites|antimetabolites|mesh-ancestor
24972081|NCT03720249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972082|NCT03720249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24972083|NCT03720223|Bupivacaine|bupivacaine|mesh-list
24972147|NCT03719989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972148|NCT03719820|Aspirin|aspirin|mesh-list
24972149|NCT03719820|Clopidogrel|clopidogrel|mesh-list
24972150|NCT03719820|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24972151|NCT03719820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24972152|NCT03719820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24972153|NCT03719820|Analgesics|analgesics|mesh-ancestor
24972154|NCT03719820|Sensory System Agents|sensory system agents|mesh-ancestor
24972155|NCT03719820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24972156|NCT03719820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972157|NCT03719820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24808991|NCT02030483|Immunologic Factors|immunologic factors|mesh-ancestor
24503951|NCT00533533|Docetaxel|docetaxel|mesh-list
24503969|NCT00533585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503970|NCT00533585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24503971|NCT00533585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24972158|NCT03719820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24972159|NCT03719820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24972160|NCT03719820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24972161|NCT03719820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972162|NCT03719820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24972163|NCT03719820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24972164|NCT03719820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972165|NCT03719820|Antipyretics|antipyretics|mesh-ancestor
24972166|NCT03719820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25217804|NCT02675387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25217805|NCT02675387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217806|NCT02675335|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25217807|NCT02675335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25217808|NCT02675335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217809|NCT02675335|Incretins|incretins|mesh-ancestor
25217810|NCT02675335|Hormones|hormones|mesh-ancestor
25245795|NCT03719326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217811|NCT02675335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25217812|NCT02675335|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25217813|NCT02675335|Protease Inhibitors|protease inhibitors|mesh-ancestor
25217814|NCT02675335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449235|NCT00314743|Autonomic Agents|autonomic agents|mesh-ancestor
24449247|NCT00314743|Serotonin Agents|serotonin agents|mesh-ancestor
24449248|NCT00314743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24449249|NCT00314743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449250|NCT00314743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24972167|NCT03719820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24972168|NCT03719820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24972169|NCT03719820|Purinergic Agents|purinergic agents|mesh-ancestor
24972170|NCT03719820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24972171|NCT03719820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24972172|NCT03719820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24972173|NCT03719820|Antimetabolites|antimetabolites|mesh-ancestor
24972174|NCT03719820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24972175|NCT03719820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24972176|NCT03719729|Rifaximin|rifaximin|mesh-list
24972177|NCT03719729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24972178|NCT03719729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24972179|NCT03719729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24972180|NCT03719690|Tipifarnib|tipifarnib|mesh-list
24972181|NCT03719690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24972182|NCT03719625|Norepinephrine|norepinephrine|mesh-list
24972183|NCT03719625|Ephedrine|ephedrine|mesh-list
24972184|NCT03719625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24972185|NCT03719625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24972209|NCT03719560|Immunologic Factors|immunologic factors|mesh-ancestor
24972210|NCT03719560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24972211|NCT03719560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24546257|NCT00697385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546258|NCT00697385|Hemostatics|hemostatics|mesh-ancestor
24972217|NCT03719404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24972218|NCT03719404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24972219|NCT03719404|Disinfectants|disinfectants|mesh-ancestor
24972220|NCT03719391|Nicotine|nicotine|mesh-list
24972221|NCT03719391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24972222|NCT03719391|Autonomic Agents|autonomic agents|mesh-ancestor
24503972|NCT00533585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24503973|NCT00533585|Growth Substances|growth substances|mesh-ancestor
24503974|NCT00533585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503975|NCT00533585|Growth Inhibitors|growth inhibitors|mesh-ancestor
24503976|NCT00533585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24503977|NCT00533585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503979|NCT00533611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503984|NCT00533611|Vasodilator Agents|vasodilator agents|mesh-ancestor
24503985|NCT00533611|Vitamin B Complex|vitamin b complex|mesh-ancestor
25083320|NCT03316690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24972232|NCT03719313|Interferon-alpha|interferon-alpha|mesh-list
24972233|NCT03719313|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24972234|NCT03719313|Interferon alpha-2|interferon alpha-2|mesh-list
24972235|NCT03719313|Lonafarnib|lonafarnib|mesh-list
24972236|NCT03719313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24972237|NCT03719313|Antiviral Agents|antiviral agents|mesh-ancestor
24972238|NCT03719313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24972239|NCT03719313|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24972240|NCT03719313|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25265905|NCT02431065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25265906|NCT02430909|Certolizumab Pegol|certolizumab pegol|mesh-list
25265907|NCT02430909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25265908|NCT02430909|Immunologic Factors|immunologic factors|mesh-ancestor
25265909|NCT02430909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265910|NCT02430909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25265911|NCT02430714|Lenvatinib|lenvatinib|mesh-list
25265912|NCT02430714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265913|NCT02430714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25265914|NCT02430714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265915|NCT02430714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265916|NCT02430896|Methylphenidate|methylphenidate|mesh-list
25155673|NCT05292755|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24647382|NCT01208649|Exenatide|exenatide|mesh-list
24972241|NCT03719313|Protease Inhibitors|protease inhibitors|mesh-ancestor
24972242|NCT03719313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972243|NCT03719313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972244|NCT03719313|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24972245|NCT03719313|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25217815|NCT02675335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217816|NCT02675205|Aspirin|aspirin|mesh-list
25217817|NCT02675205|Clopidogrel|clopidogrel|mesh-list
25217818|NCT02675205|Ticagrelor|ticagrelor|mesh-list
25217819|NCT02675205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25217820|NCT02675205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25217821|NCT02675205|Analgesics|analgesics|mesh-ancestor
24449251|NCT00314743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24449252|NCT00314743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24449253|NCT00314743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24449254|NCT00314743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24546259|NCT00697385|Coagulants|coagulants|mesh-ancestor
24972246|NCT03719313|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24972247|NCT03719313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24972248|NCT03719313|Immunologic Factors|immunologic factors|mesh-ancestor
24972249|NCT03719313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972250|NCT03719274|Ascorbic Acid|ascorbic acid|mesh-list
24972251|NCT03719274|Vitamins|vitamins|mesh-ancestor
24972252|NCT03719274|Micronutrients|micronutrients|mesh-ancestor
24972253|NCT03719274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972254|NCT03719274|Antioxidants|antioxidants|mesh-ancestor
24972255|NCT03719274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972256|NCT03719274|Protective Agents|protective agents|mesh-ancestor
24972257|NCT03719261|Sodium Hypochlorite|sodium hypochlorite|mesh-list
24972259|NCT03719261|Chitosan|chitosan|mesh-list
24972260|NCT03719261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24972261|NCT03719261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24972262|NCT03719261|Antimetabolites|antimetabolites|mesh-ancestor
24972263|NCT03719261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972264|NCT03719261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24972265|NCT03719261|Chelating Agents|chelating agents|mesh-ancestor
24972266|NCT03719261|Sequestering Agents|sequestering agents|mesh-ancestor
24972268|NCT03719261|Coagulants|coagulants|mesh-ancestor
24972269|NCT03719261|Disinfectants|disinfectants|mesh-ancestor
24972270|NCT03719261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24794416|NCT05233709|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24794417|NCT05233709|Cholinergic Agents|cholinergic agents|mesh-ancestor
24794418|NCT05233709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25679193|NCT01834404|Autonomic Agents|autonomic agents|mesh-ancestor
25679194|NCT01834404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25679195|NCT01834404|Adrenergic Agents|adrenergic agents|mesh-ancestor
25679196|NCT01834404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25679197|NCT01834404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679198|NCT01834586|Anesthetics|anesthetics|mesh-list
25679199|NCT01834586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25679200|NCT01834586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679201|NCT01834729|Alfuzosin|alfuzosin|mesh-list
25679202|NCT01834729|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25679203|NCT01834729|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25679204|NCT01834729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25679205|NCT01834729|Adrenergic Agents|adrenergic agents|mesh-ancestor
24794419|NCT05233709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972271|NCT03719157|Anesthetics|anesthetics|mesh-list
24647401|NCT01208766|Prednisone|prednisone|mesh-list
24972272|NCT03719157|Anesthetics, Local|anesthetics, local|mesh-list
24972273|NCT03719157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24972274|NCT03719157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972275|NCT03719157|Sensory System Agents|sensory system agents|mesh-ancestor
24972276|NCT03719157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24972329|NCT03718884|Analgesics|analgesics|mesh-ancestor
24972330|NCT03718884|Sensory System Agents|sensory system agents|mesh-ancestor
24972331|NCT03718884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24972332|NCT03718884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972333|NCT03718884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24972334|NCT03718884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24972335|NCT03718884|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24972336|NCT03718884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24972337|NCT03718715|Metformin|metformin|mesh-list
24972338|NCT03718715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24972339|NCT03718715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972340|NCT03718676|Pemetrexed|pemetrexed|mesh-list
24972341|NCT03718676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24972342|NCT03718676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972343|NCT03718676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972344|NCT03718676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24972345|NCT03718676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25217822|NCT02675205|Sensory System Agents|sensory system agents|mesh-ancestor
25217823|NCT02675205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25217824|NCT02675205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217825|NCT02675205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24449255|NCT00314743|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24449257|NCT00314756|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24449258|NCT00314756|Immunologic Factors|immunologic factors|mesh-ancestor
24449259|NCT00314756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972346|NCT03718624|Paclitaxel|paclitaxel|mesh-list
24972347|NCT03718624|Apatinib|apatinib|mesh-list
24972348|NCT03718624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24504087|NCT00533962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504088|NCT00533962|Growth Inhibitors|growth inhibitors|mesh-ancestor
24504089|NCT00533962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24546375|NCT00697892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24972356|NCT03718507|Atropine|atropine|mesh-list
24972357|NCT03718507|Fentanyl|fentanyl|mesh-list
24972358|NCT03718507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24972359|NCT03718507|Narcotics|narcotics|mesh-ancestor
24972360|NCT03718507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24972361|NCT03718507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972362|NCT03718507|Analgesics|analgesics|mesh-ancestor
24972363|NCT03718507|Sensory System Agents|sensory system agents|mesh-ancestor
24972364|NCT03718507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24972365|NCT03718507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24972366|NCT03718507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24972367|NCT03718507|Anesthetics, General|anesthetics, general|mesh-ancestor
24972368|NCT03718507|Anesthetics|anesthetics|mesh-ancestor
24972369|NCT03718507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24972370|NCT03718507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24972371|NCT03718507|Autonomic Agents|autonomic agents|mesh-ancestor
24972372|NCT03718507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24972373|NCT03718507|Respiratory System Agents|respiratory system agents|mesh-ancestor
24972374|NCT03718507|Mydriatics|mydriatics|mesh-ancestor
24972375|NCT03718507|Parasympatholytics|parasympatholytics|mesh-ancestor
24794426|NCT05216952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24794427|NCT05216952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794428|NCT05216952|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24794429|NCT05216952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24794431|NCT05216952|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24794432|NCT05216952|Contraceptive Agents|contraceptive agents|mesh-ancestor
24794433|NCT05216952|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24794435|NCT05173896|Vasodilator Agents|vasodilator agents|mesh-ancestor
24695096|NCT04622020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695097|NCT04560556|Antibodies|antibodies|mesh-list
24695098|NCT04560556|Immunologic Factors|immunologic factors|mesh-ancestor
24794436|NCT05173896|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24794437|NCT05173896|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24794438|NCT05173896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24794439|NCT05173896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972430|NCT03718039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972431|NCT03717909|Valproic Acid|valproic acid|mesh-list
24972432|NCT03717909|Anticonvulsants|anticonvulsants|mesh-ancestor
24972433|NCT03717909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972434|NCT03717909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972435|NCT03717909|GABA Agents|gaba agents|mesh-ancestor
24972436|NCT03717909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24972437|NCT03717909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972462|NCT03717688|Incretins|incretins|mesh-ancestor
24972463|NCT03717688|Hormones|hormones|mesh-ancestor
24972464|NCT03717688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24972465|NCT03717688|Protease Inhibitors|protease inhibitors|mesh-ancestor
24972466|NCT03717688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972467|NCT03717688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972468|NCT03717688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24972469|NCT03717662|Nicotine|nicotine|mesh-list
24972470|NCT03717662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24972471|NCT03717662|Autonomic Agents|autonomic agents|mesh-ancestor
25217826|NCT02675205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25217827|NCT02675205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25217828|NCT02675205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25217829|NCT02675205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217830|NCT02675205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24449261|NCT00314756|Interferon Inducers|interferon inducers|mesh-ancestor
24832376|NCT02171390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24832377|NCT02171390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24832378|NCT02171390|Anabolic Agents|anabolic agents|mesh-ancestor
24832379|NCT02171416|Rilonacept|rilonacept|mesh-list
24832380|NCT02171416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24832381|NCT02171442|Dabigatran|dabigatran|mesh-list
24832382|NCT02171442|Antithrombins|antithrombins|mesh-ancestor
24832383|NCT02171442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832384|NCT02171442|Protease Inhibitors|protease inhibitors|mesh-ancestor
24972472|NCT03717662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24972473|NCT03717662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972474|NCT03717662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24972475|NCT03717662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24972476|NCT03717662|Cholinergic Agents|cholinergic agents|mesh-ancestor
24972477|NCT03717662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24972478|NCT03717662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972479|NCT03717558|Ivermectin|ivermectin|mesh-list
24972480|NCT03717558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24972481|NCT03717558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24972482|NCT03717467|Magnesium Sulfate|magnesium sulfate|mesh-list
24972483|NCT03717467|Analgesics|analgesics|mesh-ancestor
24504220|NCT00534586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24504221|NCT00534586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504222|NCT00534586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24504223|NCT00534586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24504224|NCT00534586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24504225|NCT00534586|Narcotics|narcotics|mesh-ancestor
24504226|NCT00534586|Antidepressive Agents|antidepressive agents|mesh-ancestor
24504227|NCT00534586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24504228|NCT00534625|Zileuton|zileuton|mesh-list
25679206|NCT01834729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25679207|NCT01834729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679208|NCT01834729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679209|NCT01834729|Urological Agents|urological agents|mesh-ancestor
25679210|NCT01835158|Sunitinib|sunitinib|mesh-list
25679211|NCT01835158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25679212|NCT01835158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25679213|NCT01835158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25679214|NCT01835158|Growth Substances|growth substances|mesh-ancestor
25679215|NCT01835158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695130|NCT04425902|GABA Agents|gaba agents|mesh-ancestor
24695131|NCT04425902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25679216|NCT01835158|Growth Inhibitors|growth inhibitors|mesh-ancestor
25679217|NCT01835158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25679218|NCT01835158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25679219|NCT01835158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679220|NCT01835262|Ketamine|ketamine|mesh-list
25679221|NCT01835262|Morphine|morphine|mesh-list
25679222|NCT01835262|Analgesics|analgesics|mesh-ancestor
25679223|NCT01835262|Sensory System Agents|sensory system agents|mesh-ancestor
24695132|NCT04425902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972500|NCT03717415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24972501|NCT03717415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972502|NCT03717415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972504|NCT03717350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24972505|NCT03717350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24931171|NCT04092309|Valsartan|valsartan|mesh-list
24504273|NCT00534807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25217831|NCT02675205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25217832|NCT02675205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217833|NCT02675205|Antipyretics|antipyretics|mesh-ancestor
25217834|NCT02675205|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25217835|NCT02675205|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25217836|NCT02675205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25217837|NCT02675205|Purinergic Agents|purinergic agents|mesh-ancestor
25217838|NCT02675205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25217839|NCT02675101|Sucrose polyester|sucrose polyester|mesh-list
25217840|NCT02675101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25217841|NCT02675101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24832386|NCT02171442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832387|NCT02171442|Anticoagulants|anticoagulants|mesh-ancestor
24832388|NCT02171455|Dabigatran|dabigatran|mesh-list
24832389|NCT02171455|Antithrombins|antithrombins|mesh-ancestor
24832390|NCT02171455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832391|NCT02171455|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832392|NCT02171455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832393|NCT02171455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832394|NCT02171455|Anticoagulants|anticoagulants|mesh-ancestor
24832395|NCT02171468|Dabigatran|dabigatran|mesh-list
24832396|NCT02171468|Antithrombins|antithrombins|mesh-ancestor
24832397|NCT02171468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832398|NCT02171468|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832399|NCT02171468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24943009|NCT03975166|Xhance|xhance|mesh-list
24504274|NCT00534807|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24504275|NCT00534807|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24504276|NCT00534807|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24504277|NCT00534807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24504279|NCT00534846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24504280|NCT00534846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504281|NCT00534846|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24504282|NCT00534846|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24504283|NCT00534846|Hormone Antagonists|hormone antagonists|mesh-ancestor
24972512|NCT03717168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24972514|NCT03717116|Parathyroid Hormone|parathyroid hormone|mesh-list
24972515|NCT03717116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24972516|NCT03717116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972517|NCT03717038|Trifluridine|trifluridine|mesh-list
24972518|NCT03717038|Antimetabolites|antimetabolites|mesh-ancestor
25679224|NCT01835262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25679225|NCT01835262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679226|NCT01835262|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25679227|NCT01835262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25679228|NCT01835262|Anesthetics, General|anesthetics, general|mesh-ancestor
24647553|NCT01209403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24647554|NCT01209403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972519|NCT03717038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972532|NCT03716856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24972534|NCT03716804|Cefuroxime|cefuroxime|mesh-list
24972535|NCT03716804|Cefuroxime axetil|cefuroxime axetil|mesh-list
24972536|NCT03716804|Nitrofurantoin|nitrofurantoin|mesh-list
24972537|NCT03716804|Cefixime|cefixime|mesh-list
24972637|NCT03716388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25217847|NCT02675153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25217848|NCT02675153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25217849|NCT02675153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25217850|NCT02675153|Antifungal Agents|antifungal agents|mesh-ancestor
25217851|NCT02675153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25217852|NCT02675153|Immunologic Factors|immunologic factors|mesh-ancestor
24546860|NCT00700856|Pioglitazone|pioglitazone|mesh-list
25217853|NCT02675153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217854|NCT02675049|Dexmedetomidine|dexmedetomidine|mesh-list
25217855|NCT02675049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25217856|NCT02675049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25217857|NCT02675049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832404|NCT02171481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832405|NCT02171481|Protease Inhibitors|protease inhibitors|mesh-ancestor
24972568|NCT03716700|Immunoglobulins|immunoglobulins|mesh-list
24972569|NCT03716700|gamma-Globulins|gamma-globulins|mesh-list
24972570|NCT03716700|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24972571|NCT03716700|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24972572|NCT03716700|Immunologic Factors|immunologic factors|mesh-ancestor
24972573|NCT03716700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972574|NCT03716622|Clarithromycin|clarithromycin|mesh-list
24972575|NCT03716622|Furazolidone|furazolidone|mesh-list
24972576|NCT03716622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24972577|NCT03716622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24972578|NCT03716622|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24972579|NCT03716622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972581|NCT03716622|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24972582|NCT03716622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24972583|NCT03716622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24972584|NCT03716622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24972585|NCT03716622|Renal Agents|renal agents|mesh-ancestor
24972586|NCT03716622|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
24504289|NCT00534898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504290|NCT00534898|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24972615|NCT03716427|Anesthetics|anesthetics|mesh-ancestor
24972616|NCT03716427|GABA Modulators|gaba modulators|mesh-ancestor
24972617|NCT03716427|GABA Agents|gaba agents|mesh-ancestor
24972618|NCT03716427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24972619|NCT03716427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972620|NCT03716427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24972621|NCT03716427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24972622|NCT03716427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24972623|NCT03716427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972636|NCT03716388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24972639|NCT03716115|Teduglutide|teduglutide|mesh-list
24972640|NCT03716115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24972641|NCT03716115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24972642|NCT03716115|Autonomic Agents|autonomic agents|mesh-ancestor
24972643|NCT03716115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24972644|NCT03716115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972645|NCT03716115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24504291|NCT00534898|Protective Agents|protective agents|mesh-ancestor
24504292|NCT00534898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504293|NCT00535080|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
24504294|NCT00535080|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24504308|NCT00535119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504310|NCT00535158|Ergocalciferols|ergocalciferols|mesh-list
24504311|NCT00535158|Vitamins|vitamins|mesh-ancestor
24504312|NCT00535158|Micronutrients|micronutrients|mesh-ancestor
24504313|NCT00535158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504373|NCT00535691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972646|NCT03716115|Respiratory System Agents|respiratory system agents|mesh-ancestor
24972647|NCT03716115|Glucocorticoids|glucocorticoids|mesh-ancestor
24972648|NCT03716115|Hormones|hormones|mesh-ancestor
25217858|NCT02675049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25217859|NCT02675049|Analgesics|analgesics|mesh-ancestor
25679229|NCT01835262|Anesthetics|anesthetics|mesh-ancestor
25679230|NCT01835262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25217860|NCT02675049|Sensory System Agents|sensory system agents|mesh-ancestor
25217861|NCT02675049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25217862|NCT02675049|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24449263|NCT00314782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449264|NCT00314782|Tubulin Modulators|tubulin modulators|mesh-ancestor
24449265|NCT00314782|Antimitotic Agents|antimitotic agents|mesh-ancestor
24449266|NCT00314782|Mitosis Modulators|mitosis modulators|mesh-ancestor
24449267|NCT00314782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449268|NCT00314821|Ropinirole|ropinirole|mesh-list
24449269|NCT00314821|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24449270|NCT00314821|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24546856|NCT00700765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546857|NCT00700830|Insulin Detemir|insulin detemir|mesh-list
24546858|NCT00700830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24546859|NCT00700830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546861|NCT00700856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24546862|NCT00700856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546863|NCT00700895|Warfarin|warfarin|mesh-list
24546865|NCT00700921|Lovastatin|lovastatin|mesh-list
24464421|NCT00364806|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24972649|NCT03716115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24972650|NCT03716115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24972651|NCT03716115|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24972652|NCT03716115|Protective Agents|protective agents|mesh-ancestor
24972653|NCT03715998|Ramipril|ramipril|mesh-list
24972654|NCT03715998|Firibastat|firibastat|mesh-list
24972655|NCT03715998|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24972656|NCT03715998|Protease Inhibitors|protease inhibitors|mesh-ancestor
24972657|NCT03715998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972658|NCT03715998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972659|NCT03715998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24972660|NCT03715881|Prednisolone|prednisolone|mesh-list
24972661|NCT03715881|Epoetin Alfa|epoetin alfa|mesh-list
24972662|NCT03715881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24972663|NCT03715881|Glucocorticoids|glucocorticoids|mesh-ancestor
24972664|NCT03715881|Hormones|hormones|mesh-ancestor
24972665|NCT03715881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24972666|NCT03715881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972667|NCT03715881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24972668|NCT03715881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24972669|NCT03715881|Hematinics|hematinics|mesh-ancestor
24972670|NCT03715777|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24972671|NCT03715777|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24972672|NCT03715777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24972673|NCT03715777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972693|NCT03715699|Glucocorticoids|glucocorticoids|mesh-ancestor
24972694|NCT03715699|Hormones|hormones|mesh-ancestor
24546900|NCT00701220|Antimetabolites|antimetabolites|mesh-ancestor
24546901|NCT00701220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546902|NCT00701220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24546903|NCT00701220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24972695|NCT03715699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24972696|NCT03715699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972697|NCT03715699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24972698|NCT03715699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24972699|NCT03715699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972700|NCT03715699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972701|NCT03715699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24972702|NCT03715699|Immunologic Factors|immunologic factors|mesh-ancestor
24972703|NCT03715634|Buprenorphine|buprenorphine|mesh-list
25217863|NCT02675049|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25217864|NCT02675049|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25217865|NCT02675049|Adrenergic Agents|adrenergic agents|mesh-ancestor
25217866|NCT02675049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25217867|NCT02675049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647649|NCT01209845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647650|NCT01209858|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
24647651|NCT01209858|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
24647669|NCT01209988|Tamsulosin|tamsulosin|mesh-list
25217868|NCT02675140|Vitamins|vitamins|mesh-list
25217869|NCT02675140|Vitamin A|vitamin a|mesh-list
25217870|NCT02675140|Albendazole|albendazole|mesh-list
25217871|NCT02675140|Retinol palmitate|retinol palmitate|mesh-list
25217872|NCT02675140|Micronutrients|micronutrients|mesh-ancestor
25217873|NCT02675140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217874|NCT02675140|Antioxidants|antioxidants|mesh-ancestor
25217875|NCT02675140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217876|NCT02675140|Protective Agents|protective agents|mesh-ancestor
25217877|NCT02675140|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25217878|NCT02675140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25217879|NCT02675140|Anthelmintics|anthelmintics|mesh-ancestor
25217880|NCT02675140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25217881|NCT02675140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25217882|NCT02675140|Anticestodal Agents|anticestodal agents|mesh-ancestor
25217899|NCT02674737|Flurbiprofen|flurbiprofen|mesh-list
24832410|NCT02171494|Anticoagulants|anticoagulants|mesh-ancestor
24832411|NCT02171507|Diclofenac|diclofenac|mesh-list
24832412|NCT02171507|Dabigatran|dabigatran|mesh-list
24832413|NCT02171507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24446748|NCT00305812|Growth Substances|growth substances|mesh-ancestor
24446749|NCT00305812|Growth Inhibitors|growth inhibitors|mesh-ancestor
24446750|NCT00305812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24446751|NCT00305812|Alkylating Agents|alkylating agents|mesh-ancestor
24832414|NCT02171507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24832415|NCT02171507|Analgesics|analgesics|mesh-ancestor
24832416|NCT02171507|Sensory System Agents|sensory system agents|mesh-ancestor
25052029|NCT00345748|Abatacept|abatacept|mesh-list
24972704|NCT03715634|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24972705|NCT03715634|Narcotics|narcotics|mesh-ancestor
24972706|NCT03715634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24972707|NCT03715634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910666|NCT04295551|Ritonavir|ritonavir|mesh-list
24504376|NCT00535691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504377|NCT00535808|Nitroprusside|nitroprusside|mesh-list
24504400|NCT00536003|Progestins|progestins|mesh-ancestor
24504402|NCT00536003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24741144|NCT01692210|Dexmedetomidine|dexmedetomidine|mesh-list
24972732|NCT03715517|Anesthetics|anesthetics|mesh-ancestor
24972733|NCT03715517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24972734|NCT03715517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972735|NCT03715517|Sensory System Agents|sensory system agents|mesh-ancestor
24972736|NCT03715517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24972737|NCT03715517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24972738|NCT03715517|Narcotics|narcotics|mesh-ancestor
24972739|NCT03715517|Analgesics|analgesics|mesh-ancestor
24972740|NCT03715478|Dexamethasone|dexamethasone|mesh-list
24972741|NCT03715478|Pomalidomide|pomalidomide|mesh-list
24972742|NCT03715478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24972747|NCT03715478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25679231|NCT01835262|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25679232|NCT01835262|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25679233|NCT01835262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24972750|NCT03715478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24547265|NCT00703300|Azacitidine|azacitidine|mesh-list
24547266|NCT00703300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25679234|NCT01835262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679235|NCT01835262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25679236|NCT01835262|Narcotics|narcotics|mesh-ancestor
25679237|NCT01835431|Insulin|insulin|mesh-list
24856846|NCT02287181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24647680|NCT01210014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647681|NCT01210014|Dermatologic Agents|dermatologic agents|mesh-ancestor
24647682|NCT01210040|Folic Acid|folic acid|mesh-list
24647683|NCT01210040|Vitamin B Complex|vitamin b complex|mesh-list
24647685|NCT01210040|Vitamins|vitamins|mesh-ancestor
24547268|NCT00703300|Antimetabolites|antimetabolites|mesh-ancestor
24939922|NCT04005664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24939952|NCT04005365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972751|NCT03715478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24972752|NCT03715478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25217883|NCT02675140|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25217884|NCT02675140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25217885|NCT02675140|Tubulin Modulators|tubulin modulators|mesh-ancestor
25217886|NCT02675140|Antimitotic Agents|antimitotic agents|mesh-ancestor
25217887|NCT02675140|Mitosis Modulators|mitosis modulators|mesh-ancestor
25217888|NCT02675023|Adalimumab|adalimumab|mesh-list
25217889|NCT02675023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25217890|NCT02675023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25217891|NCT02674906|Heparin|heparin|mesh-list
25217892|NCT02674906|Calcium heparin|calcium heparin|mesh-list
25217893|NCT02674906|Anticoagulants|anticoagulants|mesh-list
25217894|NCT02674906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217895|NCT02674906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25217896|NCT02674906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25217897|NCT02674997|Factor VIII|factor viii|mesh-list
25217898|NCT02674997|Coagulants|coagulants|mesh-ancestor
24972754|NCT03715478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24972755|NCT03715478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24972756|NCT03715478|Growth Substances|growth substances|mesh-ancestor
24972757|NCT03715478|Growth Inhibitors|growth inhibitors|mesh-ancestor
24972771|NCT03715387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24972772|NCT03715387|Immunologic Factors|immunologic factors|mesh-ancestor
24972773|NCT03715387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972774|NCT03715387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24972775|NCT03715387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972776|NCT03715387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972777|NCT03715387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24972778|NCT03715387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24972779|NCT03715387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24972780|NCT03715348|Thrombin|thrombin|mesh-list
24972781|NCT03715348|Hemostatics|hemostatics|mesh-ancestor
24972782|NCT03715348|Coagulants|coagulants|mesh-ancestor
24972785|NCT03715322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24972786|NCT03715309|Lenalidomide|lenalidomide|mesh-list
24972787|NCT03715309|Immunologic Factors|immunologic factors|mesh-ancestor
24972788|NCT03715309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972789|NCT03715309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24972790|NCT03715309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24972791|NCT03715309|Growth Substances|growth substances|mesh-ancestor
24972792|NCT03715309|Growth Inhibitors|growth inhibitors|mesh-ancestor
24972793|NCT03715309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24972795|NCT03715296|Immunologic Factors|immunologic factors|mesh-ancestor
24972796|NCT03715296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972797|NCT03715296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24972798|NCT03715296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24972799|NCT03715296|Growth Substances|growth substances|mesh-ancestor
24972813|NCT03715101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24972814|NCT03715101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24587657|NCT00896285|Analgesics|analgesics|mesh-list
24794488|NCT05111821|Deferiprone|deferiprone|mesh-list
24794489|NCT05111821|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24794490|NCT05111821|Chelating Agents|chelating agents|mesh-ancestor
24529340|NCT00625547|Levodopa|levodopa|mesh-list
24504463|NCT00536419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24504464|NCT00536419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741198|NCT01692717|Losartan|losartan|mesh-list
24794503|NCT05101122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794505|NCT05101122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25679238|NCT01835431|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25679239|NCT01835431|Insulin Aspart|insulin aspart|mesh-list
25679240|NCT01835431|Insulin, Long-Acting|insulin, long-acting|mesh-list
25679241|NCT01835431|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25679242|NCT01835431|Insulin Detemir|insulin detemir|mesh-list
25679243|NCT01835431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24647765|NCT01210521|Micronutrients|micronutrients|mesh-ancestor
24647766|NCT01210521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647768|NCT01210599|Pamidronate|pamidronate|mesh-list
24794506|NCT05101122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794507|NCT05082610|Pembrolizumab|pembrolizumab|mesh-list
24794508|NCT05082610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24794509|NCT05082610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25217902|NCT02674737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25217903|NCT02674737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25217904|NCT02674737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794523|NCT05067387|Analgesics|analgesics|mesh-ancestor
24547307|NCT00703365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24547308|NCT00703365|Antimetabolites|antimetabolites|mesh-ancestor
24547332|NCT00703430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24547333|NCT00703469|Nivolumab|nivolumab|mesh-list
24972826|NCT03714867|Pregabalin|pregabalin|mesh-list
24972827|NCT03714867|Analgesics|analgesics|mesh-ancestor
24972828|NCT03714867|Sensory System Agents|sensory system agents|mesh-ancestor
25083322|NCT03316599|Gemcitabine|gemcitabine|mesh-list
24972829|NCT03714867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24972830|NCT03714867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972882|NCT03714555|Antimitotic Agents|antimitotic agents|mesh-ancestor
24972883|NCT03714555|Mitosis Modulators|mitosis modulators|mesh-ancestor
24972884|NCT03714555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972885|NCT03714555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24972886|NCT03714555|Antimetabolites|antimetabolites|mesh-ancestor
24972887|NCT03714555|Antiviral Agents|antiviral agents|mesh-ancestor
24972888|NCT03714555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24972945|NCT03713762|Bupivacaine|bupivacaine|mesh-list
24741268|NCT01693276|Gemcitabine|gemcitabine|mesh-list
24972962|NCT03713762|Anesthetics, General|anesthetics, general|mesh-ancestor
24972963|NCT03713658|Risperidone|risperidone|mesh-list
24972964|NCT03713658|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24972965|NCT03713658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24972966|NCT03713658|Serotonin Agents|serotonin agents|mesh-ancestor
24972967|NCT03713658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24972968|NCT03713658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972969|NCT03713658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972970|NCT03713658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24972971|NCT03713658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24972972|NCT03713658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24972973|NCT03713658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24972974|NCT03713658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24972975|NCT03713658|Dopamine Agents|dopamine agents|mesh-ancestor
24972976|NCT03713658|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24794531|NCT05067387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24547339|NCT00703482|Ubiquinone|ubiquinone|mesh-list
24794544|NCT05005455|Bevacizumab|bevacizumab|mesh-list
24794545|NCT05005455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25217905|NCT02674737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25217906|NCT02674737|Analgesics|analgesics|mesh-ancestor
25217907|NCT02674737|Sensory System Agents|sensory system agents|mesh-ancestor
25217908|NCT02674737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25217909|NCT02674737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25217910|NCT02674737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25679244|NCT01835431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679245|NCT01835470|Abatacept|abatacept|mesh-list
25679246|NCT01835470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24794546|NCT05005455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24794547|NCT05005455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24794548|NCT05005455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24794549|NCT05005455|Growth Substances|growth substances|mesh-ancestor
24794550|NCT05005455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973046|NCT03712735|Analgesics|analgesics|mesh-ancestor
24973047|NCT03712735|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24973048|NCT03712735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24973049|NCT03712735|Anesthetics, General|anesthetics, general|mesh-ancestor
24973050|NCT03712670|Pyranoprofen|pyranoprofen|mesh-list
24973051|NCT03712670|Aflibercept|aflibercept|mesh-list
24973052|NCT03712670|Carotenoids|carotenoids|mesh-list
24973053|NCT03712670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24973118|NCT03712241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24973119|NCT03712241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24973120|NCT03712241|Gout Suppressants|gout suppressants|mesh-ancestor
24939987|NCT04004871|Fluorouracil|fluorouracil|mesh-list
24973121|NCT03712241|Tocolytic Agents|tocolytic agents|mesh-ancestor
24973122|NCT03712241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24973123|NCT03712241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24973124|NCT03712241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973125|NCT03712241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973126|NCT03712163|Ketotifen|ketotifen|mesh-list
24973127|NCT03712163|Antipruritics|antipruritics|mesh-ancestor
24973128|NCT03712163|Dermatologic Agents|dermatologic agents|mesh-ancestor
24973129|NCT03712163|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24973130|NCT03712163|Histamine Antagonists|histamine antagonists|mesh-ancestor
24973131|NCT03712163|Histamine Agents|histamine agents|mesh-ancestor
24973132|NCT03712163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24973150|NCT03712111|Autonomic Agents|autonomic agents|mesh-ancestor
24973151|NCT03712111|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24973152|NCT03712046|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24973153|NCT03712046|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24973154|NCT03712046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217911|NCT02674737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25217912|NCT02674737|Adrenergic Agents|adrenergic agents|mesh-ancestor
25217913|NCT02674737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25217914|NCT02674737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217915|NCT02674737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25217916|NCT02674737|Narcotics|narcotics|mesh-ancestor
25217917|NCT02674737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25217918|NCT02674737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25217919|NCT02674737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25217920|NCT02674737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25217921|NCT02674737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217922|NCT02674893|Liraglutide|liraglutide|mesh-list
25217923|NCT02674893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25217924|NCT02674893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217925|NCT02674893|Incretins|incretins|mesh-ancestor
25217926|NCT02674893|Hormones|hormones|mesh-ancestor
25217927|NCT02674893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25217928|NCT02674581|Fostemsavir|fostemsavir|mesh-list
25042256|NCT01480583|Antiviral Agents|antiviral agents|mesh-ancestor
25042257|NCT01480583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042258|NCT01480479|Temozolomide|temozolomide|mesh-list
25042259|NCT01480479|Molgramostim|molgramostim|mesh-list
25042260|NCT01480479|Rindopepimut|rindopepimut|mesh-list
25042261|NCT01480479|Sargramostim|sargramostim|mesh-list
24939989|NCT04004871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447542|NCT00308841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25042262|NCT01480479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25042263|NCT01480479|Alkylating Agents|alkylating agents|mesh-ancestor
25042264|NCT01480479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042265|NCT01480479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042266|NCT01480479|Immunologic Factors|immunologic factors|mesh-ancestor
24626288|NCT01086527|Montelukast|montelukast|mesh-list
24973155|NCT03711708|Sertraline|sertraline|mesh-list
24973156|NCT03711708|Antidepressive Agents|antidepressive agents|mesh-ancestor
24973157|NCT03711708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24973158|NCT03711708|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25266043|NCT02429960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24973159|NCT03711708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24973160|NCT03711708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24973161|NCT03711708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973162|NCT03711708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24973163|NCT03711708|Serotonin Agents|serotonin agents|mesh-ancestor
24973164|NCT03711708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973165|NCT03711474|Dexamethasone|dexamethasone|mesh-list
24973184|NCT03711253|Tenofovir|tenofovir|mesh-list
24973185|NCT03711253|Emtricitabine|emtricitabine|mesh-list
24973186|NCT03711253|Antiviral Agents|antiviral agents|mesh-ancestor
24973187|NCT03711253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24973188|NCT03711253|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24973189|NCT03711253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24973190|NCT03711253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973191|NCT03711253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973192|NCT03711253|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24973193|NCT03711253|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24973194|NCT03711240|Leucovorin|leucovorin|mesh-list
24973195|NCT03711240|Bevacizumab|bevacizumab|mesh-list
24973196|NCT03711240|Oxaliplatin|oxaliplatin|mesh-list
24973197|NCT03711240|Irinotecan|irinotecan|mesh-list
24973198|NCT03711240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24911150|NCT04291118|Budesonide|budesonide|mesh-list
24973199|NCT03711240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25217960|NCT02673931|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24973203|NCT03711240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973204|NCT03711240|Growth Inhibitors|growth inhibitors|mesh-ancestor
24973205|NCT03711240|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24973209|NCT03711240|Antidotes|antidotes|mesh-ancestor
25217929|NCT02674581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25217930|NCT02674581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25217931|NCT02674581|Antiviral Agents|antiviral agents|mesh-ancestor
25217932|NCT02674581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25217933|NCT02674581|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25217934|NCT02674581|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25217935|NCT02674581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272924|NCT02388594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25272925|NCT02388594|Immunologic Factors|immunologic factors|mesh-ancestor
25272926|NCT02388594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272927|NCT02388594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25272928|NCT02388594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25272929|NCT02388594|Alkylating Agents|alkylating agents|mesh-ancestor
25272930|NCT02388594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272931|NCT02388594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042273|NCT01478178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042274|NCT01476904|Epinephrine|epinephrine|mesh-list
25042275|NCT01476904|Racepinephrine|racepinephrine|mesh-list
25042276|NCT01476904|Epinephryl borate|epinephryl borate|mesh-list
25042277|NCT01476904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25042278|NCT01476904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25042279|NCT01476904|Adrenergic Agents|adrenergic agents|mesh-ancestor
24626301|NCT01086553|Autonomic Agents|autonomic agents|mesh-ancestor
24587812|NCT00897130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587813|NCT00897130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587814|NCT00897221|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25217936|NCT02674295|Esketamine|esketamine|mesh-list
25217937|NCT02674295|Antidepressive Agents|antidepressive agents|mesh-ancestor
25217938|NCT02674295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25217939|NCT02674308|Vedolizumab|vedolizumab|mesh-list
25217940|NCT02674308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25217941|NCT02674555|Naquotinib|naquotinib|mesh-list
25217942|NCT02674555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25217943|NCT02674555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25217944|NCT02674555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217945|NCT02674555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217946|NCT02674243|Povidone-Iodine|povidone-iodine|mesh-list
24547541|NCT00704548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25679247|NCT01835470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679248|NCT01835470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25679249|NCT01835470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25679250|NCT01835470|Immunologic Factors|immunologic factors|mesh-ancestor
25679251|NCT01835470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679252|NCT01835470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25679253|NCT01835496|Deferiprone|deferiprone|mesh-list
25679254|NCT01835496|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24856876|NCT02287259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24459388|NCT00344526|Glucocorticoids|glucocorticoids|mesh-ancestor
24648107|NCT01212406|Micronutrients|micronutrients|mesh-ancestor
24648108|NCT01212406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648109|NCT01212406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24648110|NCT01212432|Daptomycin|daptomycin|mesh-list
24648111|NCT01212432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24648112|NCT01212432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24547542|NCT00704574|Insulin Detemir|insulin detemir|mesh-list
24547545|NCT00704600|Nelfinavir|nelfinavir|mesh-list
25217947|NCT02674243|Povidone|povidone|mesh-list
25217948|NCT02674243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25217949|NCT02674243|Plasma Substitutes|plasma substitutes|mesh-ancestor
25217950|NCT02674243|Blood Substitutes|blood substitutes|mesh-ancestor
25245796|NCT03719326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24973279|NCT03710356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24973280|NCT03710356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973281|NCT03710343|Metformin|metformin|mesh-list
24973282|NCT03710343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24973283|NCT03710343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741605|NCT05291104|Choline|choline|mesh-list
24973311|NCT03710304|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25217961|NCT02673931|Incretins|incretins|mesh-ancestor
24973312|NCT03710304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24973313|NCT03710304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973320|NCT03710252|Ritonavir|ritonavir|mesh-list
24973321|NCT03710252|Ribavirin|ribavirin|mesh-list
24973322|NCT03710252|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24973323|NCT03710252|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24973324|NCT03710252|Protease Inhibitors|protease inhibitors|mesh-ancestor
24973325|NCT03710252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973326|NCT03710252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973327|NCT03710252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24973328|NCT03710252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24973329|NCT03710252|Antiviral Agents|antiviral agents|mesh-ancestor
24973330|NCT03710252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25083326|NCT03316599|Tubulin Modulators|tubulin modulators|mesh-ancestor
24810180|NCT02038452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24973357|NCT03709992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24973358|NCT03709992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973359|NCT03709992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973360|NCT03709992|Urological Agents|urological agents|mesh-ancestor
24973361|NCT03709992|Parasympatholytics|parasympatholytics|mesh-ancestor
24973362|NCT03709992|Autonomic Agents|autonomic agents|mesh-ancestor
24973363|NCT03709992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24973364|NCT03709992|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24973365|NCT03709992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24973366|NCT03709992|Cholinergic Agents|cholinergic agents|mesh-ancestor
24973367|NCT03709953|Apatinib|apatinib|mesh-list
24973368|NCT03709953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973369|NCT03709953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24973370|NCT03709953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973371|NCT03709953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973411|NCT03709745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24973412|NCT03709745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24973413|NCT03709745|Growth Substances|growth substances|mesh-ancestor
24932001|NCT04083066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25679255|NCT01835496|Chelating Agents|chelating agents|mesh-ancestor
25679256|NCT01835496|Sequestering Agents|sequestering agents|mesh-ancestor
25679257|NCT01835496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679258|NCT01835587|Cc-486|cc-486|mesh-list
25679259|NCT01835587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25679260|NCT01835912|Citric Acid|citric acid|mesh-list
25679261|NCT01835912|Sodium Citrate|sodium citrate|mesh-list
25679262|NCT01835912|Anticoagulants|anticoagulants|mesh-ancestor
25679263|NCT01835912|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25679264|NCT01835912|Chelating Agents|chelating agents|mesh-ancestor
24648381|NCT01213979|Iron|iron|mesh-list
25217951|NCT02674243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25217952|NCT02674243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25217954|NCT02674139|Trace Elements|trace elements|mesh-ancestor
24547563|NCT00704665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24504853|NCT00538382|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24504854|NCT00538382|Anthelmintics|anthelmintics|mesh-ancestor
24973435|NCT03709160|Diuretics|diuretics|mesh-ancestor
24973436|NCT03709160|Natriuretic Agents|natriuretic agents|mesh-ancestor
24973437|NCT03709160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973438|NCT03709160|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24973439|NCT03709160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24973440|NCT03709160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973441|NCT03709147|Metformin|metformin|mesh-list
24973442|NCT03709147|Carboplatin|carboplatin|mesh-list
24973443|NCT03709147|Pembrolizumab|pembrolizumab|mesh-list
25217955|NCT02674139|Micronutrients|micronutrients|mesh-ancestor
25217956|NCT02674139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217957|NCT02673931|Exenatide|exenatide|mesh-list
25217958|NCT02673931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25217959|NCT02673931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217964|NCT02674113|Bupivacaine|bupivacaine|mesh-list
25217965|NCT02674113|Anesthetics|anesthetics|mesh-list
25217966|NCT02674113|Anesthetics, Local|anesthetics, local|mesh-ancestor
25217967|NCT02674113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24832422|NCT02171507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24736497|NCT01662622|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24973444|NCT03709147|Pemetrexed|pemetrexed|mesh-list
24973445|NCT03709147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973446|NCT03709147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24973447|NCT03709147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973448|NCT03709147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24973449|NCT03709147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973573|NCT03708497|Tranexamic Acid|tranexamic acid|mesh-list
24973450|NCT03709147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973451|NCT03709147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24973452|NCT03709147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24973453|NCT03709082|Trastuzumab|trastuzumab|mesh-list
24973454|NCT03709082|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24973455|NCT03709082|Letrozole|letrozole|mesh-list
24973456|NCT03709082|Palbociclib|palbociclib|mesh-list
24973457|NCT03709082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24911473|NCT04287842|Desflurane|desflurane|mesh-list
24973458|NCT03709082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973459|NCT03709082|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24973460|NCT03709082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24973461|NCT03709082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759047|NCT01749111|Cyclophosphamide|cyclophosphamide|mesh-list
24759087|NCT01749150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24759088|NCT01749228|Etodolac|etodolac|mesh-list
24759089|NCT01749228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24759090|NCT01749228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24759091|NCT01749228|Analgesics|analgesics|mesh-ancestor
24973462|NCT03709082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973464|NCT03709082|Hormone Antagonists|hormone antagonists|mesh-ancestor
24973465|NCT03709082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25679265|NCT01835912|Sequestering Agents|sequestering agents|mesh-ancestor
25679266|NCT01835912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679267|NCT01836029|Cisplatin|cisplatin|mesh-list
25679268|NCT01836029|Carboplatin|carboplatin|mesh-list
25679269|NCT01836029|Fluorouracil|fluorouracil|mesh-list
25679270|NCT01836029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25679271|NCT01836029|Antimetabolites|antimetabolites|mesh-ancestor
25679272|NCT01836029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973466|NCT03709082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973467|NCT03709082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24973468|NCT03709082|Tubulin Modulators|tubulin modulators|mesh-ancestor
24973469|NCT03709082|Antimitotic Agents|antimitotic agents|mesh-ancestor
24973470|NCT03709082|Mitosis Modulators|mitosis modulators|mesh-ancestor
24973471|NCT03709056|Propofol|propofol|mesh-list
24973472|NCT03709056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24973473|NCT03709056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24973474|NCT03709056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973475|NCT03709056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24973476|NCT03709056|Anesthetics, General|anesthetics, general|mesh-ancestor
24973477|NCT03709056|Anesthetics|anesthetics|mesh-ancestor
24759172|NCT01749475|GABA Modulators|gaba modulators|mesh-ancestor
24759173|NCT01749475|GABA Agents|gaba agents|mesh-ancestor
24759174|NCT01749475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25217968|NCT02674113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217969|NCT02674113|Sensory System Agents|sensory system agents|mesh-ancestor
25217970|NCT02674113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25217971|NCT02674048|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
25217972|NCT02674048|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25217973|NCT02674048|Dermatologic Agents|dermatologic agents|mesh-ancestor
25217974|NCT02674191|Clindamycin|clindamycin|mesh-list
25217975|NCT02674191|Clindamycin palmitate|clindamycin palmitate|mesh-list
25217976|NCT02674191|Clindamycin phosphate|clindamycin phosphate|mesh-list
25217977|NCT02674191|Povidone-Iodine|povidone-iodine|mesh-list
25217978|NCT02674191|Mepivacaine|mepivacaine|mesh-list
25217979|NCT02674191|Benzocaine|benzocaine|mesh-list
24547686|NCT00705120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25217980|NCT02674191|Povidone|povidone|mesh-list
25217981|NCT02674191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25217982|NCT02674191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24759175|NCT01749475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759176|NCT01749514|Luspatercept|luspatercept|mesh-list
24759177|NCT01749514|Hematinics|hematinics|mesh-ancestor
24759178|NCT01749540|Luspatercept|luspatercept|mesh-list
24759179|NCT01749540|Hematinics|hematinics|mesh-ancestor
24759180|NCT01749566|Maraviroc|maraviroc|mesh-list
24759181|NCT01749566|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24759182|NCT01749566|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24759183|NCT01749566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759184|NCT01749566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24759185|NCT01749566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24759186|NCT01749566|Antiviral Agents|antiviral agents|mesh-ancestor
24973487|NCT03708861|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24973488|NCT03708861|Maraviroc|maraviroc|mesh-list
24973489|NCT03708861|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24973574|NCT03708497|Carbetocin|carbetocin|mesh-list
24973490|NCT03708861|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24973491|NCT03708861|Protease Inhibitors|protease inhibitors|mesh-ancestor
24973492|NCT03708861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973493|NCT03708861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973494|NCT03708861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24973495|NCT03708861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24973496|NCT03708861|Antiviral Agents|antiviral agents|mesh-ancestor
24973497|NCT03708861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24973498|NCT03708861|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24973499|NCT03708861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24973500|NCT03708861|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24973501|NCT03708861|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24973502|NCT03708861|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24973503|NCT03708848|Metronidazole|metronidazole|mesh-list
24973504|NCT03708848|Clarithromycin|clarithromycin|mesh-list
24973505|NCT03708848|Levofloxacin|levofloxacin|mesh-list
24973506|NCT03708848|Ofloxacin|ofloxacin|mesh-list
24973507|NCT03708848|Tetracycline|tetracycline|mesh-list
24973508|NCT03708848|Potassium Citrate|potassium citrate|mesh-list
24940016|NCT04004507|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24940017|NCT04004507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24940018|NCT04004507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24940019|NCT04004507|Adrenergic Agents|adrenergic agents|mesh-ancestor
24853415|NCT02268019|Autonomic Agents|autonomic agents|mesh-ancestor
24856928|NCT02287870|Sensory System Agents|sensory system agents|mesh-ancestor
24648392|NCT01213992|Micronutrients|micronutrients|mesh-ancestor
24648393|NCT01213992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973509|NCT03708848|Esomeprazole|esomeprazole|mesh-list
24973510|NCT03708848|Bismuth|bismuth|mesh-list
24973511|NCT03708848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973512|NCT03708848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24973513|NCT03708848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24973514|NCT03708848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24973526|NCT03708848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24973527|NCT03708848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973528|NCT03708848|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24973530|NCT03708848|Diuretics|diuretics|mesh-ancestor
24973531|NCT03708848|Natriuretic Agents|natriuretic agents|mesh-ancestor
24911507|NCT04287387|Metformin|metformin|mesh-list
24973532|NCT03708848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973553|NCT03708588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24973554|NCT03708588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24973555|NCT03708588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24973556|NCT03708588|Purinergic Agents|purinergic agents|mesh-ancestor
24973557|NCT03708588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24973558|NCT03708588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973559|NCT03708588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973560|NCT03708536|Bevacizumab|bevacizumab|mesh-list
24973561|NCT03708536|Capecitabine|capecitabine|mesh-list
24973562|NCT03708536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24973563|NCT03708536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973564|NCT03708536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24973565|NCT03708536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24973566|NCT03708536|Growth Substances|growth substances|mesh-ancestor
24973567|NCT03708536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973568|NCT03708536|Growth Inhibitors|growth inhibitors|mesh-ancestor
24973569|NCT03708536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25217983|NCT02674191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25217984|NCT02674191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217985|NCT02674191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217986|NCT02674191|Plasma Substitutes|plasma substitutes|mesh-ancestor
24973570|NCT03708536|Antimetabolites|antimetabolites|mesh-ancestor
24973571|NCT03708536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973572|NCT03708497|Misoprostol|misoprostol|mesh-list
24973576|NCT03708497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24973577|NCT03708497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973578|NCT03708497|Hemostatics|hemostatics|mesh-ancestor
24625139|NCT01080612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24759187|NCT01749566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24973580|NCT03708497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24973581|NCT03708497|Abortifacient Agents|abortifacient agents|mesh-ancestor
24973582|NCT03708497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24973583|NCT03708497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973584|NCT03708497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24973585|NCT03708497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24973586|NCT03708497|Oxytocics|oxytocics|mesh-ancestor
24911576|NCT04286503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24973587|NCT03708458|Acetylcysteine|acetylcysteine|mesh-list
24973588|NCT03708458|Indomethacin|indomethacin|mesh-list
24973589|NCT03708458|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24973590|NCT03708458|Antiviral Agents|antiviral agents|mesh-ancestor
24973591|NCT03708458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24973592|NCT03708458|Expectorants|expectorants|mesh-ancestor
25679273|NCT01836029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25679274|NCT01836029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25679275|NCT01836029|Immunologic Factors|immunologic factors|mesh-ancestor
25679276|NCT01836029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679277|NCT01836133|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25679278|NCT01836133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459452|NCT00344695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24648405|NCT01214226|Vasodilator Agents|vasodilator agents|mesh-ancestor
24648406|NCT01214226|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24648407|NCT01214226|Antioxidants|antioxidants|mesh-ancestor
24648408|NCT01214291|Toremifene|toremifene|mesh-list
24648420|NCT01214343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973593|NCT03708458|Respiratory System Agents|respiratory system agents|mesh-ancestor
24973594|NCT03708458|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24794630|NCT04868565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24625143|NCT01080612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24932290|NCT04081012|Acetylcysteine|acetylcysteine|mesh-list
24973614|NCT03708341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973615|NCT03708341|Protective Agents|protective agents|mesh-ancestor
24973616|NCT03708341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973617|NCT03708341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24973618|NCT03708146|Zamicastat|zamicastat|mesh-list
24973619|NCT03708146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973620|NCT03708146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973621|NCT03708133|Nifurtimox|nifurtimox|mesh-list
24973622|NCT03708133|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24973623|NCT03708133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24973653|NCT03707899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24973654|NCT03707899|Antimetabolites|antimetabolites|mesh-ancestor
24973655|NCT03707899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24973656|NCT03707899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24973657|NCT03707899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973658|NCT03707899|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24973659|NCT03707899|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24973660|NCT03707847|Etoposide|etoposide|mesh-list
24973661|NCT03707847|Crizotinib|crizotinib|mesh-list
24973662|NCT03707847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24973663|NCT03707847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973664|NCT03707847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24973665|NCT03707847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24973666|NCT03707847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25217987|NCT02674191|Blood Substitutes|blood substitutes|mesh-ancestor
25217988|NCT02674191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25217989|NCT02674191|Anesthetics, Local|anesthetics, local|mesh-ancestor
25217990|NCT02674191|Anesthetics|anesthetics|mesh-ancestor
25217991|NCT02674191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25217992|NCT02674191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25217993|NCT02674191|Sensory System Agents|sensory system agents|mesh-ancestor
25217994|NCT02674191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25217995|NCT02673879|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25217996|NCT02673879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24832471|NCT02171546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24832433|NCT02171520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832434|NCT02171520|Anticoagulants|anticoagulants|mesh-ancestor
24832435|NCT02171533|Verapamil|verapamil|mesh-list
24832436|NCT02171533|Dabigatran|dabigatran|mesh-list
25217997|NCT02673879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25217998|NCT02673879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25217999|NCT02673866|Pregabalin|pregabalin|mesh-list
25218000|NCT02673866|DS-1971a|ds-1971a|mesh-list
25218001|NCT02673866|Analgesics|analgesics|mesh-ancestor
25218002|NCT02673866|Sensory System Agents|sensory system agents|mesh-ancestor
25218003|NCT02673866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25218006|NCT02673866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25218007|NCT02673866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25218008|NCT02673866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218009|NCT02673866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25218010|NCT02673866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25679279|NCT01836133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25679280|NCT01836133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25679281|NCT01836133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679282|NCT01836185|Evacetrapib|evacetrapib|mesh-list
25679283|NCT01836185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25679284|NCT01836185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25218011|NCT02673866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25218012|NCT02673866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25218013|NCT02673866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25218014|NCT02673866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25218015|NCT02673866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25218016|NCT02673840|Ketotifen|ketotifen|mesh-list
25218017|NCT02673840|Antipruritics|antipruritics|mesh-ancestor
25218018|NCT02673840|Dermatologic Agents|dermatologic agents|mesh-ancestor
25218019|NCT02673840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25218020|NCT02673840|Histamine Antagonists|histamine antagonists|mesh-ancestor
25218021|NCT02673840|Histamine Agents|histamine agents|mesh-ancestor
25218022|NCT02673840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25218023|NCT02673840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218024|NCT02673840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218025|NCT02673840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25218026|NCT02673814|Durvalumab|durvalumab|mesh-list
25218027|NCT02673814|Bavituximab|bavituximab|mesh-list
25218028|NCT02673814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25218029|NCT02673814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218030|NCT02673606|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25218031|NCT02673606|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25218032|NCT02673606|Estradiol|estradiol|mesh-list
24832441|NCT02171533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832442|NCT02171533|Anticoagulants|anticoagulants|mesh-ancestor
24832443|NCT02171533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24832444|NCT02171533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24832445|NCT02171533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24547803|NCT00705796|Testosterone undecanoate|testosterone undecanoate|mesh-list
24547804|NCT00705796|Testosterone enanthate|testosterone enanthate|mesh-list
24547805|NCT00705796|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24547806|NCT00705796|Androgens|androgens|mesh-ancestor
24547807|NCT00705796|Hormones|hormones|mesh-ancestor
25218034|NCT02673606|Estrogens|estrogens|mesh-ancestor
25218036|NCT02673606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25218037|NCT02673606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218038|NCT02673606|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25218039|NCT02673606|Contraceptive Agents|contraceptive agents|mesh-ancestor
25218040|NCT02673606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25218041|NCT02673606|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25218042|NCT02673632|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25218043|NCT02673632|Luteolytic Agents|luteolytic agents|mesh-ancestor
25218044|NCT02673632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25218045|NCT02673632|Contraceptive Agents|contraceptive agents|mesh-ancestor
25218046|NCT02673632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25218047|NCT02673632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218048|NCT02673632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25218049|NCT02673632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25218050|NCT02673632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218051|NCT02673463|Spironolactone|spironolactone|mesh-list
25218052|NCT02673463|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25218053|NCT02673463|Hormone Antagonists|hormone antagonists|mesh-ancestor
25405113|NCT03630211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25218054|NCT02673463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25218055|NCT02673463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218056|NCT02673463|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25218058|NCT02673463|Natriuretic Agents|natriuretic agents|mesh-ancestor
25218059|NCT02673359|Progesterone|progesterone|mesh-list
25218060|NCT02673359|Progestins|progestins|mesh-ancestor
24547824|NCT00705822|Hormones|hormones|mesh-ancestor
25218061|NCT02673359|Hormones|hormones|mesh-ancestor
25218062|NCT02673359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25218063|NCT02673359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218064|NCT02673229|Bacitracin|bacitracin|mesh-list
25218065|NCT02673229|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25218066|NCT02673229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25218067|NCT02673229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25218068|NCT02673047|Botulinum Toxins|botulinum toxins|mesh-list
25218069|NCT02673047|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25218070|NCT02673047|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25218071|NCT02673047|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25218072|NCT02673047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24832448|NCT02171533|Vasodilator Agents|vasodilator agents|mesh-ancestor
24832449|NCT02171546|Fexofenadine|fexofenadine|mesh-list
24951594|NCT03902912|Prednisolone|prednisolone|mesh-list
25218073|NCT02673047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218074|NCT02673047|Cholinergic Agents|cholinergic agents|mesh-ancestor
25218075|NCT02673047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25218076|NCT02673047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218077|NCT02673047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25218078|NCT02673047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25218079|NCT02672839|Betadex|betadex|mesh-list
25218080|NCT02672839|Sequestering Agents|sequestering agents|mesh-ancestor
25218081|NCT02672839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218082|NCT02672995|Bevacizumab|bevacizumab|mesh-list
25218083|NCT02672995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25218084|NCT02672995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218085|NCT02672995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25218086|NCT02672995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25218087|NCT02672995|Growth Substances|growth substances|mesh-ancestor
25218088|NCT02672995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218089|NCT02672995|Growth Inhibitors|growth inhibitors|mesh-ancestor
25218090|NCT02672709|Apixaban|apixaban|mesh-list
25218091|NCT02672709|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25218092|NCT02672709|Antithrombins|antithrombins|mesh-ancestor
25218093|NCT02672709|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25218094|NCT02672709|Protease Inhibitors|protease inhibitors|mesh-ancestor
25218095|NCT02672709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25218096|NCT02672709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218097|NCT02672709|Anticoagulants|anticoagulants|mesh-ancestor
25272932|NCT02388594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25272933|NCT02388581|Amoxicillin|amoxicillin|mesh-list
25272934|NCT02388581|Metronidazole|metronidazole|mesh-list
24648648|NCT01216111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24648650|NCT01216111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24648651|NCT01216111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24857004|NCT02288741|Dexamethasone|dexamethasone|mesh-list
25272935|NCT02388581|Clarithromycin|clarithromycin|mesh-list
25272936|NCT02388581|Lansoprazole|lansoprazole|mesh-list
25272937|NCT02388581|Dexlansoprazole|dexlansoprazole|mesh-list
25272938|NCT02388581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25272939|NCT02388581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25272940|NCT02388581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25272941|NCT02388581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25272942|NCT02388581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25272943|NCT02388581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973667|NCT03707847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973668|NCT03707847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24973670|NCT03707808|Ipilimumab|ipilimumab|mesh-list
24973671|NCT03707808|Avelumab|avelumab|mesh-list
24973672|NCT03707808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24973673|NCT03707808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973674|NCT03707808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24973675|NCT03707808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940085|NCT04003844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940086|NCT04003844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24940087|NCT04003844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24973676|NCT03707795|Betamethasone|betamethasone|mesh-list
24973677|NCT03707795|Betamethasone Valerate|betamethasone valerate|mesh-list
24973678|NCT03707795|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24973679|NCT03707795|Betamethasone benzoate|betamethasone benzoate|mesh-list
24973680|NCT03707795|Betamethasone acetate|betamethasone acetate|mesh-list
24973681|NCT03707795|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
24973682|NCT03707795|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24973683|NCT03707795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24973684|NCT03707795|Glucocorticoids|glucocorticoids|mesh-ancestor
24973686|NCT03707795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24759188|NCT01749566|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24759189|NCT01749579|Fentanyl|fentanyl|mesh-list
24759190|NCT01749579|Midazolam|midazolam|mesh-list
24759191|NCT01749579|Propofol|propofol|mesh-list
24741940|NCT05294666|Tacrolimus|tacrolimus|mesh-list
24759225|NCT01750060|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24759227|NCT01750099|Epinephrine|epinephrine|mesh-list
24759228|NCT01750099|Fentanyl|fentanyl|mesh-list
24759229|NCT01750099|Bupivacaine|bupivacaine|mesh-list
24759273|NCT01750385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24759274|NCT01750437|Esomeprazole|esomeprazole|mesh-list
24759275|NCT01750437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24620086|NCT01055392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24620087|NCT01055392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620088|NCT01055392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620089|NCT01055392|Antimanic Agents|antimanic agents|mesh-ancestor
24620090|NCT01055392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24620091|NCT01055392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24620092|NCT01055392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620093|NCT01055405|Sildenafil Citrate|sildenafil citrate|mesh-list
24620094|NCT01055405|Vasodilator Agents|vasodilator agents|mesh-ancestor
25218098|NCT02672592|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25218099|NCT02672592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25218100|NCT02672527|Dexamethasone|dexamethasone|mesh-list
25679285|NCT01836185|Antimetabolites|antimetabolites|mesh-ancestor
25679286|NCT01836185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679287|NCT01836185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25679288|NCT01836198|Clarithromycin|clarithromycin|mesh-list
24648704|NCT01216449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25218101|NCT02672527|Trabectedin|trabectedin|mesh-list
25218102|NCT02672527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25218103|NCT02672527|Antiemetics|antiemetics|mesh-ancestor
25218104|NCT02672527|Autonomic Agents|autonomic agents|mesh-ancestor
25218105|NCT02672527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25218106|NCT02672527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218107|NCT02672527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25218108|NCT02672527|Glucocorticoids|glucocorticoids|mesh-ancestor
25218109|NCT02672527|Hormones|hormones|mesh-ancestor
25218110|NCT02672527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25218111|NCT02672527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25218112|NCT02672527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218113|NCT02672527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25218114|NCT02672527|Alkylating Agents|alkylating agents|mesh-ancestor
24832466|NCT02171546|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24832467|NCT02171546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24832468|NCT02171546|Adrenergic Agents|adrenergic agents|mesh-ancestor
24832469|NCT02171546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24832470|NCT02171546|Antimalarials|antimalarials|mesh-ancestor
24832472|NCT02171546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24832473|NCT02171546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24832474|NCT02171546|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24832475|NCT02171546|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24832476|NCT02171546|Cholinergic Agents|cholinergic agents|mesh-ancestor
24966749|NCT03765645|Tazobactam|tazobactam|mesh-list
24620095|NCT01055405|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24759280|NCT01750463|Chrysarobin|chrysarobin|mesh-list
24664594|NCT01307969|Racepinephrine|racepinephrine|mesh-list
24759320|NCT01750541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759321|NCT01750541|GABA Agents|gaba agents|mesh-ancestor
24759322|NCT01750541|Antimanic Agents|antimanic agents|mesh-ancestor
24759323|NCT01750580|Ipilimumab|ipilimumab|mesh-list
24759324|NCT01750580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24759325|NCT01750580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759326|NCT01750580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24759327|NCT01750580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741989|NCT05294484|Indapamide|indapamide|mesh-list
24973718|NCT03707652|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24973719|NCT03707652|Vasodilator Agents|vasodilator agents|mesh-ancestor
24973720|NCT03707639|Apatinib|apatinib|mesh-list
24973721|NCT03707639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973722|NCT03707639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24973723|NCT03707639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973724|NCT03707639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973725|NCT03707535|Infliximab|infliximab|mesh-list
24548049|NCT00707408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548051|NCT00707421|Fluorometholone|fluorometholone|mesh-list
24548089|NCT00707551|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24548090|NCT00707551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25218115|NCT02672527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218116|NCT02672566|Enoxaparin|enoxaparin|mesh-list
25679289|NCT01836198|Ketoconazole|ketoconazole|mesh-list
25218117|NCT02672566|Anticoagulants|anticoagulants|mesh-ancestor
24857100|NCT02289274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25218118|NCT02672566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25218119|NCT02672566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25218120|NCT02672566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218121|NCT02672488|Metformin|metformin|mesh-list
25218122|NCT02672488|Sorafenib|sorafenib|mesh-list
25218123|NCT02672488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25218124|NCT02672488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218125|NCT02672488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218126|NCT02672488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25218127|NCT02672488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25218128|NCT02672488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218129|NCT02672345|Sevoflurane|sevoflurane|mesh-list
25218130|NCT02672345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25218131|NCT02672345|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25218132|NCT02672345|Anesthetics, General|anesthetics, general|mesh-ancestor
25218133|NCT02672345|Anesthetics|anesthetics|mesh-ancestor
25218134|NCT02672345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25218135|NCT02672345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218136|NCT02672358|Trametinib|trametinib|mesh-list
25218137|NCT02672358|Dabrafenib|dabrafenib|mesh-list
25218138|NCT02672358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218139|NCT02672358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25218140|NCT02672358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25218141|NCT02672358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464721|NCT00366236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24832478|NCT02171546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24832479|NCT02171546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24832480|NCT02171546|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24832481|NCT02171546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25218142|NCT02672202|Pregabalin|pregabalin|mesh-list
25218143|NCT02672202|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25218144|NCT02672202|Analgesics|analgesics|mesh-ancestor
25218145|NCT02672202|Sensory System Agents|sensory system agents|mesh-ancestor
25218146|NCT02672202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25218147|NCT02672202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218148|NCT02672202|Anticonvulsants|anticonvulsants|mesh-ancestor
25218149|NCT02672202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25218150|NCT02672202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25218151|NCT02672202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218152|NCT02672202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25218153|NCT02672202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25218154|NCT02672202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25405114|NCT03630159|Pembrolizumab|pembrolizumab|mesh-list
25679290|NCT01836198|Gemfibrozil|gemfibrozil|mesh-list
25218155|NCT02672202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25218156|NCT02672202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25218157|NCT02672202|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25218158|NCT02672202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25218159|NCT02672202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25218160|NCT02672202|Antidepressive Agents|antidepressive agents|mesh-ancestor
25218161|NCT02672202|Dopamine Agents|dopamine agents|mesh-ancestor
25218162|NCT02672241|Temozolomide|temozolomide|mesh-list
25218163|NCT02672241|Nimotuzumab|nimotuzumab|mesh-list
25218164|NCT02672241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25218165|NCT02672241|Alkylating Agents|alkylating agents|mesh-ancestor
25218166|NCT02672241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218167|NCT02672241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218168|NCT02672241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25218169|NCT02671864|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25218170|NCT02671864|Incretins|incretins|mesh-list
25218171|NCT02671864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218172|NCT02671864|Hormones|hormones|mesh-ancestor
25218173|NCT02671864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25218174|NCT02671851|Acetaminophen|acetaminophen|mesh-list
25218175|NCT02671851|Dipyrone|dipyrone|mesh-list
25218176|NCT02671851|Fentanyl|fentanyl|mesh-list
25218177|NCT02671851|Tramadol|tramadol|mesh-list
25218178|NCT02671851|Bupivacaine|bupivacaine|mesh-list
25218179|NCT02671851|Anesthetics, Local|anesthetics, local|mesh-ancestor
24449318|NCT00314990|Vitamin B 12|vitamin b 12|mesh-list
25042282|NCT01476904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042283|NCT01476904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25042284|NCT01476904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25042285|NCT01476904|Autonomic Agents|autonomic agents|mesh-ancestor
25042286|NCT01476904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25042287|NCT01476904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25042288|NCT01476904|Respiratory System Agents|respiratory system agents|mesh-ancestor
24943414|NCT03971214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25157996|NCT04537598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24973726|NCT03707535|Dermatologic Agents|dermatologic agents|mesh-ancestor
24973727|NCT03707535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24548171|NCT00707941|Oseltamivir|oseltamivir|mesh-list
24548172|NCT00707941|Antiviral Agents|antiviral agents|mesh-ancestor
24548173|NCT00707941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25083328|NCT03316599|Mitosis Modulators|mitosis modulators|mesh-ancestor
24810637|NCT02041338|Carboplatin|carboplatin|mesh-list
24973728|NCT03707535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24973729|NCT03707509|Gemcitabine|gemcitabine|mesh-list
24973730|NCT03707509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973731|NCT03707509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24973732|NCT03707509|Antimetabolites|antimetabolites|mesh-ancestor
24973733|NCT03707509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973734|NCT03707509|Antiviral Agents|antiviral agents|mesh-ancestor
24973735|NCT03707509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24973736|NCT03707509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973744|NCT03707483|Antioxidants|antioxidants|mesh-ancestor
24973745|NCT03707483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973746|NCT03707483|Protective Agents|protective agents|mesh-ancestor
24973748|NCT03707457|Ipilimumab|ipilimumab|mesh-list
24973749|NCT03707457|Antibodies|antibodies|mesh-list
24973750|NCT03707457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24973751|NCT03707457|Immunologic Factors|immunologic factors|mesh-ancestor
24973752|NCT03707457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973753|NCT03707457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24973754|NCT03707457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973755|NCT03707457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24742050|NCT05293808|Analgesics|analgesics|mesh-ancestor
24973775|NCT03707171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24973777|NCT03706950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24973778|NCT03706950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25218180|NCT02671851|Anesthetics|anesthetics|mesh-ancestor
25218181|NCT02671851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25218182|NCT02671851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218183|NCT02671851|Sensory System Agents|sensory system agents|mesh-ancestor
25218184|NCT02671851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25218185|NCT02671851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25218186|NCT02671851|Narcotics|narcotics|mesh-ancestor
25218187|NCT02671851|Analgesics|analgesics|mesh-ancestor
25218188|NCT02671851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25218189|NCT02671851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25218190|NCT02671851|Anesthetics, General|anesthetics, general|mesh-ancestor
25218191|NCT02671851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25218192|NCT02671851|Antipyretics|antipyretics|mesh-ancestor
25218193|NCT02671851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25218194|NCT02671851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25218195|NCT02671851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25218196|NCT02671578|Nitrous Oxide|nitrous oxide|mesh-list
25218197|NCT02671578|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25218198|NCT02671578|Anesthetics, General|anesthetics, general|mesh-ancestor
25218199|NCT02671578|Anesthetics|anesthetics|mesh-ancestor
25218200|NCT02671578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25218201|NCT02671578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218202|NCT02671578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25218203|NCT02671578|Analgesics|analgesics|mesh-ancestor
24759386|NCT01750983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759388|NCT01751009|Vitamin A|vitamin a|mesh-list
24759389|NCT01751009|Retinol palmitate|retinol palmitate|mesh-list
24759390|NCT01751009|Micronutrients|micronutrients|mesh-ancestor
24759391|NCT01751009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973779|NCT03706950|Antiviral Agents|antiviral agents|mesh-ancestor
24973780|NCT03706950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24973781|NCT03706924|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24973782|NCT03706924|Elsulfavirine|elsulfavirine|mesh-list
24973783|NCT03706924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25218204|NCT02671578|Sensory System Agents|sensory system agents|mesh-ancestor
25218205|NCT02671578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25218206|NCT02671695|Amlodipine|amlodipine|mesh-list
25218207|NCT02671695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25218208|NCT02671695|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25218209|NCT02671695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25218210|NCT02671695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218211|NCT02671695|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25218212|NCT02671695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218213|NCT02671695|Vasodilator Agents|vasodilator agents|mesh-ancestor
25218215|NCT02671708|Busulfan|busulfan|mesh-list
25218216|NCT02671708|Idarubicin|idarubicin|mesh-list
25218217|NCT02671708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25218218|NCT02671708|Immunologic Factors|immunologic factors|mesh-ancestor
25218219|NCT02671708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218220|NCT02671708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25218221|NCT02671708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25218222|NCT02671708|Alkylating Agents|alkylating agents|mesh-ancestor
25218223|NCT02671708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218224|NCT02671708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218225|NCT02671708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25218226|NCT02671708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25218227|NCT02671708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25218228|NCT02671708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25218229|NCT02671708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25218230|NCT02671565|Hyaluronic Acid|hyaluronic acid|mesh-list
25218231|NCT02671565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25218232|NCT02671565|Immunologic Factors|immunologic factors|mesh-ancestor
25218233|NCT02671565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218234|NCT02671565|Viscosupplements|viscosupplements|mesh-ancestor
24548306|NCT00708812|Growth Inhibitors|growth inhibitors|mesh-ancestor
24449334|NCT00315016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449335|NCT00315016|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24449336|NCT00315016|Diuretics|diuretics|mesh-ancestor
24449337|NCT00315016|Natriuretic Agents|natriuretic agents|mesh-ancestor
24449338|NCT00315016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24449339|NCT00315016|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24449340|NCT00315016|Protease Inhibitors|protease inhibitors|mesh-ancestor
24449348|NCT00315081|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24449349|NCT00315081|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24449350|NCT00315081|Hormone Antagonists|hormone antagonists|mesh-ancestor
24449351|NCT00315081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24449352|NCT00315081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449353|NCT00315081|Dopamine Agonists|dopamine agonists|mesh-ancestor
24449354|NCT00315081|Dopamine Agents|dopamine agents|mesh-ancestor
24449355|NCT00315081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24449369|NCT00315211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449371|NCT00315276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24449372|NCT00315276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449373|NCT00315276|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24449374|NCT00315276|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24449375|NCT00315276|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24973784|NCT03706924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24973785|NCT03706924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973786|NCT03706924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973787|NCT03706924|Antiviral Agents|antiviral agents|mesh-ancestor
24973788|NCT03706924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24973789|NCT03706924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24973790|NCT03706924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24973791|NCT03706781|Cetylpyridinium|cetylpyridinium|mesh-list
24973792|NCT03706781|Benzydamine|benzydamine|mesh-list
25218235|NCT02671565|Protective Agents|protective agents|mesh-ancestor
25218236|NCT02671383|Lopinavir|lopinavir|mesh-list
25218237|NCT02671383|Darunavir|darunavir|mesh-list
25218238|NCT02671383|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25218239|NCT02671383|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25218240|NCT02671383|Protease Inhibitors|protease inhibitors|mesh-ancestor
25218241|NCT02671383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25218242|NCT02671383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218243|NCT02671383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25218244|NCT02671383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25218245|NCT02671383|Antiviral Agents|antiviral agents|mesh-ancestor
25218246|NCT02671383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25218247|NCT02671383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25218248|NCT02671383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25218249|NCT02671318|Sirolimus|sirolimus|mesh-list
25218250|NCT02671318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25218251|NCT02671318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25218252|NCT02671318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25218253|NCT02671318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218254|NCT02671318|Antifungal Agents|antifungal agents|mesh-ancestor
25218255|NCT02671318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25218256|NCT02671318|Immunologic Factors|immunologic factors|mesh-ancestor
25218257|NCT02671318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218258|NCT02671227|Bupivacaine|bupivacaine|mesh-list
25218259|NCT02671227|Anesthetics, Local|anesthetics, local|mesh-ancestor
25218260|NCT02671227|Anesthetics|anesthetics|mesh-ancestor
25218261|NCT02671227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25218262|NCT02671227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218263|NCT02671227|Sensory System Agents|sensory system agents|mesh-ancestor
25218264|NCT02671227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25218265|NCT02671058|Hydrocortisone|hydrocortisone|mesh-list
25218266|NCT02671058|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25218267|NCT02671058|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24951726|NCT03901768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24449376|NCT00315276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449377|NCT00315367|Donepezil|donepezil|mesh-list
24449378|NCT00315367|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24449379|NCT00315367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449380|NCT00315367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449381|NCT00315367|Cholinergic Agents|cholinergic agents|mesh-ancestor
24449383|NCT00315367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449384|NCT00315367|Nootropic Agents|nootropic agents|mesh-ancestor
24832501|NCT02171585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24832502|NCT02171585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24973793|NCT03706781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24973794|NCT03706781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24973795|NCT03706781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24973796|NCT03706755|Norepinephrine|norepinephrine|mesh-list
24973797|NCT03706755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24973798|NCT03706755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24973799|NCT03706755|Adrenergic Agents|adrenergic agents|mesh-ancestor
24973800|NCT03706755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24973801|NCT03706755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973802|NCT03706755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973803|NCT03706755|Sympathomimetics|sympathomimetics|mesh-ancestor
24973804|NCT03706755|Autonomic Agents|autonomic agents|mesh-ancestor
24973805|NCT03706755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24973859|NCT03706300|Expectorants|expectorants|mesh-ancestor
24973867|NCT03706287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218268|NCT02671058|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25218269|NCT02671058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25218270|NCT02671084|Sevoflurane|sevoflurane|mesh-list
25218271|NCT02671084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25218272|NCT02671084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25218273|NCT02671084|Anesthetics, General|anesthetics, general|mesh-ancestor
25218274|NCT02671084|Anesthetics|anesthetics|mesh-ancestor
25218275|NCT02671084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25218276|NCT02671084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272944|NCT02388581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272945|NCT02388581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25272946|NCT02388581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25272947|NCT02388581|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25272948|NCT02388581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25272949|NCT02388581|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25272950|NCT02388490|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25272951|NCT02388490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25272952|NCT02388490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272953|NCT02388516|Vitamin D|vitamin d|mesh-list
25272954|NCT02388516|Cholecalciferol|cholecalciferol|mesh-list
25272955|NCT02388516|Vitamins|vitamins|mesh-ancestor
25272956|NCT02388516|Micronutrients|micronutrients|mesh-ancestor
25272957|NCT02388516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272958|NCT02388516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25272959|NCT02388516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25272960|NCT02388477|Doxycycline|doxycycline|mesh-list
25272961|NCT02388477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25272962|NCT02388477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24832503|NCT02171585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24794651|NCT04809233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24794652|NCT04776850|Mycophenolic Acid|mycophenolic acid|mesh-list
24794653|NCT04776850|Dexamethasone|dexamethasone|mesh-list
24794680|NCT04776850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24794681|NCT04776850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24587928|NCT00898846|Antimetabolites|antimetabolites|mesh-ancestor
24587929|NCT00898846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973868|NCT03706287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973869|NCT03706287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973871|NCT03706287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24973873|NCT03706222|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
24973874|NCT03706222|Antiviral Agents|antiviral agents|mesh-ancestor
24973875|NCT03706222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24973876|NCT03706157|Doxorubicin|doxorubicin|mesh-list
24973877|NCT03706157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24973881|NCT03706157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24973882|NCT03706157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973883|NCT03706157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956153|NCT03856970|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24973884|NCT03705949|Lubricant Eye Drops|lubricant eye drops|mesh-list
24973885|NCT03705949|Hyaluronic Acid|hyaluronic acid|mesh-list
24973886|NCT03705949|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24973887|NCT03705949|Immunologic Factors|immunologic factors|mesh-ancestor
24973888|NCT03705949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973889|NCT03705949|Viscosupplements|viscosupplements|mesh-ancestor
24973890|NCT03705949|Protective Agents|protective agents|mesh-ancestor
24973891|NCT03705949|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24973892|NCT03705949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24973930|NCT03705728|Sensory System Agents|sensory system agents|mesh-ancestor
24973974|NCT05177406|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
24973975|NCT05177406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973976|NCT05177406|Analgesics|analgesics|mesh-ancestor
24973977|NCT05177406|Sensory System Agents|sensory system agents|mesh-ancestor
24932611|NCT04077957|Antimetabolites|antimetabolites|mesh-ancestor
25218277|NCT02671175|Piperaquine|piperaquine|mesh-list
25218278|NCT02671175|Artenimol|artenimol|mesh-list
25218279|NCT02671175|Artemisinins|artemisinins|mesh-list
25218280|NCT02671175|Antimalarials|antimalarials|mesh-ancestor
25218281|NCT02671175|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25218282|NCT02671175|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25218283|NCT02671175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25218284|NCT02671097|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25218285|NCT02671097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25218286|NCT02671097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25218287|NCT02671097|Antimetabolites|antimetabolites|mesh-ancestor
25218288|NCT02671097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218289|NCT02671097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25218290|NCT02671097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25218291|NCT02671097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25218292|NCT02670954|Flurbiprofen|flurbiprofen|mesh-list
25218293|NCT02670954|Dexmedetomidine|dexmedetomidine|mesh-list
25218294|NCT02670954|Tramadol|tramadol|mesh-list
25218295|NCT02670954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24832511|NCT02171585|Anticoagulants|anticoagulants|mesh-ancestor
24832512|NCT02171598|Dabigatran|dabigatran|mesh-list
24832513|NCT02171598|Clopidogrel|clopidogrel|mesh-list
24832514|NCT02171598|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24832515|NCT02171598|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24832516|NCT02171598|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24832517|NCT02171598|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24759393|NCT01751009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759394|NCT01751009|Protective Agents|protective agents|mesh-ancestor
24759395|NCT01751009|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24759396|NCT01751009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759397|NCT01751074|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24759399|NCT01751074|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24759400|NCT01751074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24759401|NCT01751074|Antimetabolites|antimetabolites|mesh-ancestor
24973978|NCT05177406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25218296|NCT02670954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25218297|NCT02670954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218298|NCT02670954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25218299|NCT02670954|Analgesics|analgesics|mesh-ancestor
25218300|NCT02670954|Sensory System Agents|sensory system agents|mesh-ancestor
25218301|NCT02670954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25218302|NCT02670954|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25218303|NCT02670954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25218304|NCT02670954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25218305|NCT02670954|Adrenergic Agents|adrenergic agents|mesh-ancestor
25218306|NCT02670954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25218307|NCT02670954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218308|NCT02670954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25218309|NCT02670954|Narcotics|narcotics|mesh-ancestor
25218310|NCT02670954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24650335|NCT01225237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052052|NCT00345618|Vitamins|vitamins|mesh-ancestor
24759403|NCT01751074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24759421|NCT01751295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759422|NCT01751295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24759423|NCT01751295|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24620097|NCT01055405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759424|NCT01751295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759425|NCT01751321|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24625662|NCT01082809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625663|NCT01082809|Growth Inhibitors|growth inhibitors|mesh-ancestor
24625664|NCT01082809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24625665|NCT01082809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759426|NCT01751321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24853469|NCT02268422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24548454|NCT00709553|Anesthetics|anesthetics|mesh-ancestor
24759489|NCT01751854|Antidepressive Agents|antidepressive agents|mesh-ancestor
24759490|NCT01751854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24974023|NCT05176119|Ketamine|ketamine|mesh-list
24974024|NCT05176119|Nalbuphine|nalbuphine|mesh-list
24974079|NCT05175430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25218336|NCT02670564|Busulfan|busulfan|mesh-list
25218337|NCT02670564|Alkylating Agents|alkylating agents|mesh-ancestor
25218338|NCT02670564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218339|NCT02670564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25218340|NCT02670564|Immunologic Factors|immunologic factors|mesh-ancestor
25218341|NCT02670564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218342|NCT02670564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24449386|NCT00315432|Ribavirin|ribavirin|mesh-list
24449387|NCT00315432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449388|NCT00315432|Antiviral Agents|antiviral agents|mesh-ancestor
24449389|NCT00315432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24449390|NCT00315432|Antimetabolites|antimetabolites|mesh-ancestor
24974080|NCT05175430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24974081|NCT05175430|Hallucinogens|hallucinogens|mesh-ancestor
24974082|NCT05175430|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24974083|NCT05175430|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24974084|NCT05175131|Mebeverine|mebeverine|mesh-list
24974085|NCT05175131|Simethicone|simethicone|mesh-list
24974086|NCT05175131|Alverine|alverine|mesh-list
25679291|NCT01836198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25679292|NCT01836198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24759546|NCT01752322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24759564|NCT01752517|Alkylating Agents|alkylating agents|mesh-ancestor
24759598|NCT01752959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24759599|NCT01752959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974088|NCT05175131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974089|NCT05175131|Emollients|emollients|mesh-ancestor
24974090|NCT05175131|Dermatologic Agents|dermatologic agents|mesh-ancestor
24974091|NCT05175131|Anticonvulsants|anticonvulsants|mesh-ancestor
24974092|NCT05175131|Parasympatholytics|parasympatholytics|mesh-ancestor
25218343|NCT02670564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218344|NCT02670564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25218345|NCT02670655|Lidocaine|lidocaine|mesh-list
25218346|NCT02670655|Prilocaine|prilocaine|mesh-list
25218347|NCT02670655|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25218348|NCT02670655|Anesthetics, Local|anesthetics, local|mesh-ancestor
25218349|NCT02670655|Anesthetics|anesthetics|mesh-ancestor
24548545|NCT00710125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548546|NCT00710138|Vitamins|vitamins|mesh-list
24548547|NCT00710138|Vitamin B 12|vitamin b 12|mesh-list
24548548|NCT00710138|Hydroxocobalamin|hydroxocobalamin|mesh-list
24548549|NCT00710138|Vitamin B Complex|vitamin b complex|mesh-list
24548550|NCT00710138|Micronutrients|micronutrients|mesh-ancestor
24548551|NCT00710138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548552|NCT00710138|Hematinics|hematinics|mesh-ancestor
24548553|NCT00710216|Lamivudine|lamivudine|mesh-list
24548554|NCT00710216|Telbivudine|telbivudine|mesh-list
25218350|NCT02670655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25218351|NCT02670655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218352|NCT02670655|Sensory System Agents|sensory system agents|mesh-ancestor
25218353|NCT02670655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25218354|NCT02670655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25218355|NCT02670655|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25218356|NCT02670655|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25218357|NCT02670655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25218358|NCT02670655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218359|NCT02670655|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25218360|NCT02670759|Bupivacaine|bupivacaine|mesh-list
25218361|NCT02670759|Anesthetics, Local|anesthetics, local|mesh-ancestor
25218362|NCT02670759|Anesthetics|anesthetics|mesh-ancestor
25218363|NCT02670759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25218364|NCT02670759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218365|NCT02670759|Sensory System Agents|sensory system agents|mesh-ancestor
25218366|NCT02670759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25218367|NCT02670785|Estradiol|estradiol|mesh-list
25218368|NCT02670785|Estrogens|estrogens|mesh-ancestor
24449395|NCT00315510|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24449396|NCT00315510|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24449397|NCT00315510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24449399|NCT00315510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449400|NCT00315510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24449401|NCT00315510|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24449402|NCT00315510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449403|NCT00315523|Levocetirizine|levocetirizine|mesh-list
24449404|NCT00315523|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24449405|NCT00315523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24449406|NCT00315523|Histamine Antagonists|histamine antagonists|mesh-ancestor
25272963|NCT02388477|Antimalarials|antimalarials|mesh-ancestor
25042350|NCT01460511|Respiratory System Agents|respiratory system agents|mesh-ancestor
24548555|NCT00710216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25042352|NCT01460511|Sympathomimetics|sympathomimetics|mesh-ancestor
25042353|NCT01460511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25218369|NCT02670785|Hormones|hormones|mesh-ancestor
25218370|NCT02670785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25218371|NCT02670785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218372|NCT02670616|Prednisolone|prednisolone|mesh-list
25218373|NCT02670616|Cyclophosphamide|cyclophosphamide|mesh-list
25218374|NCT02670616|Rituximab|rituximab|mesh-list
25218375|NCT02670616|Doxorubicin|doxorubicin|mesh-list
25218376|NCT02670616|Vincristine|vincristine|mesh-list
25218377|NCT02670616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24651534|NCT01232023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25218378|NCT02670616|Immunologic Factors|immunologic factors|mesh-ancestor
25218379|NCT02670616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218380|NCT02670616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25218381|NCT02670616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25218382|NCT02670616|Alkylating Agents|alkylating agents|mesh-ancestor
25218383|NCT02670616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218384|NCT02670616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218385|NCT02670616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25218386|NCT02670616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25218387|NCT02670616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25218388|NCT02670616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25218389|NCT02670616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25218390|NCT02670616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25218391|NCT02670616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25218392|NCT02670616|Tubulin Modulators|tubulin modulators|mesh-ancestor
25218393|NCT02670616|Antimitotic Agents|antimitotic agents|mesh-ancestor
25218394|NCT02670616|Mitosis Modulators|mitosis modulators|mesh-ancestor
25218395|NCT02670616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25218396|NCT02670616|Glucocorticoids|glucocorticoids|mesh-ancestor
25218397|NCT02670616|Hormones|hormones|mesh-ancestor
25218398|NCT02670616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25218399|NCT02670616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25218401|NCT02670772|Tenofovir|tenofovir|mesh-list
25218402|NCT02670772|Stavudine|stavudine|mesh-list
25218403|NCT02670772|Antiviral Agents|antiviral agents|mesh-ancestor
25218404|NCT02670772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25218405|NCT02670772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25272964|NCT02388477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24548643|NCT00711074|Antiviral Agents|antiviral agents|mesh-ancestor
24548644|NCT00711074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24548645|NCT00711165|Mometasone Furoate|mometasone furoate|mesh-list
24966784|NCT03765450|Infliximab|infliximab|mesh-list
24974093|NCT05175131|Autonomic Agents|autonomic agents|mesh-ancestor
24974094|NCT05175131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24974095|NCT05175131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974096|NCT05175066|Bisoprolol|bisoprolol|mesh-list
24974097|NCT05175066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24974099|NCT05175066|Autonomic Agents|autonomic agents|mesh-ancestor
24974100|NCT05175066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24974101|NCT05175066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974102|NCT05175066|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24974103|NCT05175066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24974104|NCT05175066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24974105|NCT05175066|Adrenergic Agents|adrenergic agents|mesh-ancestor
24974106|NCT05175066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24974107|NCT05175066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974108|NCT05175027|Povidone-Iodine|povidone-iodine|mesh-list
24974109|NCT05175027|Povidone|povidone|mesh-list
24974110|NCT05175027|Plasma Substitutes|plasma substitutes|mesh-ancestor
24974111|NCT05175027|Blood Substitutes|blood substitutes|mesh-ancestor
24974112|NCT05175027|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24974113|NCT05175027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24974118|NCT05173441|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24458546|NCT00338338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24458547|NCT00338338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24458548|NCT00338338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458549|NCT00338338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24458550|NCT00338338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458551|NCT00338338|Vasodilator Agents|vasodilator agents|mesh-ancestor
24974120|NCT05173441|Immunologic Factors|immunologic factors|mesh-ancestor
24974121|NCT05173441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974168|NCT05155540|Plasminogen|plasminogen|mesh-list
25679293|NCT01836198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24794683|NCT04776850|Autonomic Agents|autonomic agents|mesh-ancestor
24794684|NCT04776850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24912183|NCT04278703|Oxycodone|oxycodone|mesh-list
24974193|NCT05148637|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24974194|NCT05148637|Anesthetics, General|anesthetics, general|mesh-ancestor
24974195|NCT05148637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24974196|NCT05148637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24974197|NCT05133310|Simvastatin|simvastatin|mesh-list
24974198|NCT05133310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24974199|NCT05133310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24974200|NCT05133310|Antimetabolites|antimetabolites|mesh-ancestor
24974201|NCT05133310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218406|NCT02670772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25218407|NCT02670772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25218408|NCT02670772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218409|NCT02670772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25218410|NCT02670772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25218411|NCT02670772|Antimetabolites|antimetabolites|mesh-ancestor
25218412|NCT02670642|Esomeprazole|esomeprazole|mesh-list
25218413|NCT02670642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25218414|NCT02670642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25218415|NCT02670642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24974202|NCT05133310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24974203|NCT05133310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24974204|NCT05133310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24974205|NCT05122559|Acetylcysteine|acetylcysteine|mesh-list
24974206|NCT05122559|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24974207|NCT05122559|Antiviral Agents|antiviral agents|mesh-ancestor
24974208|NCT05122559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24974209|NCT05122559|Expectorants|expectorants|mesh-ancestor
24974210|NCT05122559|Respiratory System Agents|respiratory system agents|mesh-ancestor
24974211|NCT05122559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24974212|NCT05122559|Antioxidants|antioxidants|mesh-ancestor
24974213|NCT05122559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974214|NCT05122559|Protective Agents|protective agents|mesh-ancestor
24974215|NCT05122559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974238|NCT05051436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24974239|NCT05051436|Adrenergic Agents|adrenergic agents|mesh-ancestor
24974240|NCT05051436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24974241|NCT05051436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974247|NCT05035277|Edoxaban|edoxaban|mesh-list
24974248|NCT05035277|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24974249|NCT05035277|Antithrombins|antithrombins|mesh-ancestor
24974250|NCT05035277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24974251|NCT05035277|Protease Inhibitors|protease inhibitors|mesh-ancestor
24974252|NCT05035277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24974253|NCT05035277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974254|NCT05035277|Anticoagulants|anticoagulants|mesh-ancestor
24974255|NCT05035277|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24974284|NCT05003037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24974285|NCT05003037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24974286|NCT04996771|Cisplatin|cisplatin|mesh-list
24974287|NCT04996771|Etoposide|etoposide|mesh-list
24974288|NCT04996771|Etoposide phosphate|etoposide phosphate|mesh-list
24974289|NCT04996771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24974290|NCT04996771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24974291|NCT04996771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24974292|NCT04996771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24974293|NCT04996771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24974294|NCT04996771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932874|NCT04075955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24664779|NCT01308658|Ritonavir|ritonavir|mesh-list
24458911|NCT00343096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459331|NCT00344383|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24459333|NCT00344409|Hematinics|hematinics|mesh-ancestor
24459334|NCT00344422|Dexamethasone|dexamethasone|mesh-list
24459335|NCT00344422|Dexamethasone acetate|dexamethasone acetate|mesh-list
24459336|NCT00344422|Doxorubicin|doxorubicin|mesh-list
24459337|NCT00344422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24459338|NCT00344422|Vincristine|vincristine|mesh-list
24742727|NCT05189444|Expectorants|expectorants|mesh-ancestor
25218416|NCT02670642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25218417|NCT02670642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679294|NCT01836198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24742796|NCT05159427|Glipizide|glipizide|mesh-list
24461337|NCT00351975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24974313|NCT04976790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24418494|NCT00209703|Leucovorin|leucovorin|mesh-list
24974314|NCT04976790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24974315|NCT04976790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24974316|NCT04976790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24974317|NCT04976790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974318|NCT04973670|Sivelestat|sivelestat|mesh-list
24974319|NCT04973670|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24974320|NCT04973670|Protease Inhibitors|protease inhibitors|mesh-ancestor
24974321|NCT04973670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24974322|NCT04973670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974381|NCT04763928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24974410|NCT04724668|Melatonin|melatonin|mesh-list
24974411|NCT04724668|Antioxidants|antioxidants|mesh-ancestor
24832531|NCT02171624|Protease Inhibitors|protease inhibitors|mesh-ancestor
24974412|NCT04724668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974413|NCT04724668|Protective Agents|protective agents|mesh-ancestor
24974414|NCT04724668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974415|NCT04724668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24974416|NCT04722848|Imatinib Mesylate|imatinib mesylate|mesh-list
24974417|NCT04722848|Blinatumomab|blinatumomab|mesh-list
24974418|NCT04722848|Ponatinib|ponatinib|mesh-list
24974419|NCT04722848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218418|NCT02670317|Prednisone|prednisone|mesh-list
25218419|NCT02670317|Cyclophosphamide|cyclophosphamide|mesh-list
25218420|NCT02670317|Doxorubicin|doxorubicin|mesh-list
25218421|NCT02670317|Vincristine|vincristine|mesh-list
25218422|NCT02670317|Obinutuzumab|obinutuzumab|mesh-list
25218423|NCT02670317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25218424|NCT02670317|Immunologic Factors|immunologic factors|mesh-ancestor
25218425|NCT02670317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218426|NCT02670317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25218427|NCT02670317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24974420|NCT04722848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24974421|NCT04722848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24974422|NCT04722848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974423|NCT04682860|Scopolamine|scopolamine|mesh-list
24974425|NCT04682860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24974426|NCT04682860|Antiemetics|antiemetics|mesh-ancestor
24974427|NCT04682860|Autonomic Agents|autonomic agents|mesh-ancestor
24974428|NCT04682860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24532447|NCT00640003|Baclofen|baclofen|mesh-list
24974436|NCT04682860|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24974437|NCT04682860|Parasympatholytics|parasympatholytics|mesh-ancestor
24418680|NCT00209885|Ketamine|ketamine|mesh-list
24418681|NCT00209885|Gabapentin|gabapentin|mesh-list
24418686|NCT00209885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418687|NCT00209885|Sensory System Agents|sensory system agents|mesh-ancestor
24418688|NCT00209885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24418689|NCT00209885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24461750|NCT00353561|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24461752|NCT00353561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24461753|NCT00353561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461754|NCT00353561|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24461755|NCT00353561|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24461757|NCT00353665|Memantine|memantine|mesh-list
24461758|NCT00353665|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24461759|NCT00353665|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24461760|NCT00353665|Dopamine Agents|dopamine agents|mesh-ancestor
24461761|NCT00353665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24461762|NCT00353665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461763|NCT00353665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218428|NCT02670317|Alkylating Agents|alkylating agents|mesh-ancestor
25218429|NCT02670317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218430|NCT02670317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218431|NCT02670317|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25218432|NCT02670317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25218433|NCT02670317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25218434|NCT02670317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25218435|NCT02670317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25218436|NCT02670317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25218437|NCT02670317|Glucocorticoids|glucocorticoids|mesh-ancestor
25218438|NCT02670317|Hormones|hormones|mesh-ancestor
24453177|NCT05238831|Niraparib|niraparib|mesh-list
24832532|NCT02171624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832533|NCT02171624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832534|NCT02171624|Anticoagulants|anticoagulants|mesh-ancestor
24832535|NCT02171624|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24832536|NCT02171624|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24461792|NCT00353717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461793|NCT00353717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24461794|NCT00353743|Metronidazole|metronidazole|mesh-list
24461795|NCT00353743|Doxycycline|doxycycline|mesh-list
24461796|NCT00353743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24461797|NCT00353743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24461798|NCT00353743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24461858|NCT00354185|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24743139|NCT04981912|Venetoclax|venetoclax|mesh-list
24974506|NCT04552197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974507|NCT04533568|Ibuprofen|ibuprofen|mesh-list
24933090|NCT04073797|Evolocumab|evolocumab|mesh-list
24461866|NCT00354198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24461867|NCT00354198|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24461868|NCT00354198|Protective Agents|protective agents|mesh-ancestor
24461869|NCT00354198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461870|NCT00354198|Vasodilator Agents|vasodilator agents|mesh-ancestor
24461875|NCT00354198|Hormones|hormones|mesh-ancestor
24461917|NCT00354354|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24461918|NCT00354354|Cholinergic Agents|cholinergic agents|mesh-ancestor
24461919|NCT00354367|Certolizumab Pegol|certolizumab pegol|mesh-list
24461920|NCT00354367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24461930|NCT00354380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24461931|NCT00354380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461932|NCT00354380|Antiviral Agents|antiviral agents|mesh-ancestor
24461933|NCT00354380|Schistosomicides|schistosomicides|mesh-ancestor
24461934|NCT00354380|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24743235|NCT04936854|Prednisolone|prednisolone|mesh-list
24461936|NCT00354380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431226|NCT00250874|Docetaxel|docetaxel|mesh-list
24461974|NCT00354419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24461975|NCT00354419|Alkylating Agents|alkylating agents|mesh-ancestor
24461976|NCT00354419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461977|NCT00354419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461978|NCT00354419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24461979|NCT00354419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24461980|NCT00354419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461981|NCT00354419|Antifungal Agents|antifungal agents|mesh-ancestor
24461982|NCT00354419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24974508|NCT04533568|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
24974509|NCT04533568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24974510|NCT04533568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24974511|NCT04533568|Analgesics|analgesics|mesh-ancestor
24974512|NCT04533568|Sensory System Agents|sensory system agents|mesh-ancestor
24974513|NCT04533568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24974514|NCT04533568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218439|NCT02670317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24652397|NCT01238133|Paclitaxel|paclitaxel|mesh-list
25218440|NCT02670317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25218441|NCT02670317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25218442|NCT02670317|Tubulin Modulators|tubulin modulators|mesh-ancestor
25218443|NCT02670317|Antimitotic Agents|antimitotic agents|mesh-ancestor
25218444|NCT02670317|Mitosis Modulators|mitosis modulators|mesh-ancestor
25218445|NCT02670317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25218446|NCT02670434|Pitavastatin|pitavastatin|mesh-list
25218447|NCT02670434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25218448|NCT02670434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25218449|NCT02670434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25218450|NCT02670434|Antimetabolites|antimetabolites|mesh-ancestor
25218451|NCT02670434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832537|NCT02171624|Adrenergic Agents|adrenergic agents|mesh-ancestor
24832538|NCT02171624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24590598|NCT00913315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24832539|NCT02171624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832540|NCT02171624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24832541|NCT02171624|Antimalarials|antimalarials|mesh-ancestor
24832542|NCT02171624|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24832543|NCT02171624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24832544|NCT02171624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24832545|NCT02171624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24832546|NCT02171624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24832547|NCT02171624|Cholinergic Agents|cholinergic agents|mesh-ancestor
24832548|NCT02171624|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24832549|NCT02171624|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24418847|NCT00210366|Idarubicin|idarubicin|mesh-list
24418848|NCT00210366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24418849|NCT00210366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24832550|NCT02171624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24832551|NCT02171624|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24832552|NCT02171624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24832554|NCT02171637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24832555|NCT02171637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24832563|NCT02171663|Afatinib|afatinib|mesh-list
24832564|NCT02171663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24832565|NCT02171663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24832566|NCT02171663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25249759|NCT02524964|Tanshinone|tanshinone|mesh-list
24832567|NCT02171663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974515|NCT04533568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24974516|NCT04533568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24974517|NCT04533568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24974518|NCT04533568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24974519|NCT04533568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974521|NCT04511078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24974522|NCT04511078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24974523|NCT04510636|Pembrolizumab|pembrolizumab|mesh-list
25083329|NCT03316599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974524|NCT04510636|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24974525|NCT04510636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24974526|NCT04510636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24974527|NCT04510636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24974528|NCT04510636|Alkylating Agents|alkylating agents|mesh-ancestor
24974529|NCT04510636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974530|NCT04507373|Simvastatin|simvastatin|mesh-list
24974531|NCT04507373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24974532|NCT04507373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24974533|NCT04507373|Antimetabolites|antimetabolites|mesh-ancestor
24974534|NCT04507373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974535|NCT04507373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24974536|NCT04507373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25218452|NCT02670434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25218453|NCT02670434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25218454|NCT02670304|Aspirin|aspirin|mesh-list
25218455|NCT02670304|Letrozole|letrozole|mesh-list
25218456|NCT02670304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25218457|NCT02670304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25218458|NCT02670304|Analgesics|analgesics|mesh-ancestor
25218459|NCT02670304|Sensory System Agents|sensory system agents|mesh-ancestor
25218460|NCT02670304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25679295|NCT01836198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218461|NCT02670304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218462|NCT02670304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25218463|NCT02670304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25218464|NCT02670304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25218465|NCT02670304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25218466|NCT02670304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218467|NCT02670304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25218468|NCT02670304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25218469|NCT02670304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25218471|NCT02670304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218472|NCT02670304|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25218473|NCT02670304|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25218474|NCT02670304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25218475|NCT02670304|Hormone Antagonists|hormone antagonists|mesh-ancestor
25272965|NCT02388477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24951770|NCT03901170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218476|NCT02670304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25218478|NCT02670018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25218479|NCT02670018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218480|NCT02670070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25218481|NCT02670070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25218482|NCT02670070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25218487|NCT02670070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25218488|NCT02670096|Acetazolamide|acetazolamide|mesh-list
24590157|NCT00910897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24590158|NCT00910897|Antiemetics|antiemetics|mesh-ancestor
24590159|NCT00910897|Autonomic Agents|autonomic agents|mesh-ancestor
24590160|NCT00910897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24590161|NCT00910897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590164|NCT00910897|Hormones|hormones|mesh-ancestor
24634824|NCT01135550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24590205|NCT00911092|Immunologic Factors|immunologic factors|mesh-ancestor
24590206|NCT00911092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590207|NCT00911235|Fluconazole|fluconazole|mesh-list
24590208|NCT00911235|Fesoterodine|fesoterodine|mesh-list
24590209|NCT00911235|Antifungal Agents|antifungal agents|mesh-ancestor
24832568|NCT02171676|Docetaxel|docetaxel|mesh-list
24832569|NCT02171676|Afatinib|afatinib|mesh-list
24832570|NCT02171676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24832571|NCT02171676|Tubulin Modulators|tubulin modulators|mesh-ancestor
24832572|NCT02171676|Antimitotic Agents|antimitotic agents|mesh-ancestor
24832573|NCT02171676|Mitosis Modulators|mitosis modulators|mesh-ancestor
24832574|NCT02171676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832575|NCT02171676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24832576|NCT02171676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24418918|NCT00210548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24418920|NCT00210548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24418934|NCT00210561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24418935|NCT00210561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418937|NCT00210561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24832578|NCT02171689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24832579|NCT02171689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24832580|NCT02171689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24974537|NCT04507373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933124|NCT04073173|Analgesics|analgesics|mesh-list
24461983|NCT00354419|Dermatologic Agents|dermatologic agents|mesh-ancestor
24461984|NCT00354419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24461985|NCT00354419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24461986|NCT00354419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24461987|NCT00354419|Antitubercular Agents|antitubercular agents|mesh-ancestor
24974539|NCT04481009|Paclitaxel|paclitaxel|mesh-list
24974540|NCT04481009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24974541|NCT04481009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24974542|NCT04481009|Tubulin Modulators|tubulin modulators|mesh-ancestor
24974543|NCT04481009|Antimitotic Agents|antimitotic agents|mesh-ancestor
24974544|NCT04481009|Mitosis Modulators|mitosis modulators|mesh-ancestor
24974545|NCT04481009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974546|NCT04481009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24974547|NCT04481009|Antimetabolites|antimetabolites|mesh-ancestor
24974594|NCT04370847|Ephedrine|ephedrine|mesh-list
24974595|NCT04370847|Fentanyl|fentanyl|mesh-list
24974596|NCT04370847|Bupivacaine|bupivacaine|mesh-list
24974597|NCT04370847|Oxytocin|oxytocin|mesh-list
24974598|NCT04370847|Anesthetics, Local|anesthetics, local|mesh-ancestor
24652919|NCT01240928|Hormone Antagonists|hormone antagonists|mesh-ancestor
24974599|NCT04370847|Anesthetics|anesthetics|mesh-ancestor
24974600|NCT04370847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24743354|NCT04871425|Narcotics|narcotics|mesh-ancestor
25218489|NCT02670096|Anticonvulsants|anticonvulsants|mesh-ancestor
25218490|NCT02670096|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25218491|NCT02670096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25218492|NCT02670096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218493|NCT02670096|Diuretics|diuretics|mesh-ancestor
25218494|NCT02670096|Natriuretic Agents|natriuretic agents|mesh-ancestor
25218495|NCT02670096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218496|NCT02670135|Triclosan|triclosan|mesh-list
25218497|NCT02670135|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25218498|NCT02670135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25218499|NCT02670135|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25218502|NCT02670135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218503|NCT02670135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25218505|NCT02670109|Busulfan|busulfan|mesh-list
25218506|NCT02670109|Carmustine|carmustine|mesh-list
25218507|NCT02670109|Carboplatin|carboplatin|mesh-list
24951796|NCT03900871|Aspirin|aspirin|mesh-list
24777458|NCT01864161|Trace Elements|trace elements|mesh-ancestor
24777459|NCT01864161|Micronutrients|micronutrients|mesh-ancestor
25218508|NCT02670109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25218509|NCT02670109|Immunologic Factors|immunologic factors|mesh-ancestor
25218510|NCT02670109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218511|NCT02670109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25218512|NCT02670109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25218513|NCT02670109|Alkylating Agents|alkylating agents|mesh-ancestor
24805804|NCT02012088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24805805|NCT02012088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24805806|NCT02012088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24805807|NCT02012088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24805808|NCT02012088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25218516|NCT02670109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25218523|NCT02669719|Pemetrexed|pemetrexed|mesh-list
25218524|NCT02669719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978235|NCT05025865|Protective Agents|protective agents|mesh-ancestor
24978236|NCT05018481|Hyaluronic Acid|hyaluronic acid|mesh-list
24978237|NCT05018481|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24978238|NCT05018481|Immunologic Factors|immunologic factors|mesh-ancestor
25218525|NCT02669719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25218526|NCT02669719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218527|NCT02669719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25218528|NCT02669719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25218529|NCT02669732|Firuglipel|firuglipel|mesh-list
25218530|NCT02669732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25218531|NCT02669732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218532|NCT02669706|Pentamidine|pentamidine|mesh-list
25218533|NCT02669706|Antifungal Agents|antifungal agents|mesh-ancestor
25218534|NCT02669706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25218535|NCT02669706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25218536|NCT02669706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25218537|NCT02669706|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25218538|NCT02669641|Choline|choline|mesh-list
25218539|NCT02669641|Lipotropic Agents|lipotropic agents|mesh-ancestor
25218540|NCT02669641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25218541|NCT02669641|Antimetabolites|antimetabolites|mesh-ancestor
25218542|NCT02669641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832595|NCT02171728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737645|NCT01670084|Vincristine|vincristine|mesh-list
24462099|NCT00354900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462100|NCT00354939|Insulin Glargine|insulin glargine|mesh-list
24462101|NCT00354939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24974611|NCT04370847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24974639|NCT04353271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24974640|NCT04353271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974641|NCT04353271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24974644|NCT05310344|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24974645|NCT05310344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24974646|NCT05310344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24974647|NCT05310344|Tubulin Modulators|tubulin modulators|mesh-ancestor
24974648|NCT05310344|Antimitotic Agents|antimitotic agents|mesh-ancestor
24974649|NCT05310344|Mitosis Modulators|mitosis modulators|mesh-ancestor
24974650|NCT05310344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974651|NCT05310344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24974652|NCT05310344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24974653|NCT05310344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24974654|NCT05310344|Growth Substances|growth substances|mesh-ancestor
25218543|NCT02669641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25218544|NCT02669641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25218545|NCT02669641|Nootropic Agents|nootropic agents|mesh-ancestor
25218546|NCT02669589|Heparin|heparin|mesh-list
25218547|NCT02669589|Anticoagulants|anticoagulants|mesh-ancestor
25218548|NCT02669589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218549|NCT02669589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25218550|NCT02669589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25218551|NCT02669459|Imiquimod|imiquimod|mesh-list
25218552|NCT02669459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25218553|NCT02669459|Immunologic Factors|immunologic factors|mesh-ancestor
25218554|NCT02669459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218555|NCT02669459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218556|NCT02669459|Interferon Inducers|interferon inducers|mesh-ancestor
24978247|NCT05011149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24777473|NCT01864187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24974655|NCT05310344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974656|NCT05310344|Growth Inhibitors|growth inhibitors|mesh-ancestor
24974657|NCT05310331|Paclitaxel|paclitaxel|mesh-list
24974658|NCT05310331|Antibodies|antibodies|mesh-list
24912736|NCT04272476|Fluoxetine|fluoxetine|mesh-list
24974659|NCT05310331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24974667|NCT05310305|Antibodies|antibodies|mesh-list
24974668|NCT05310305|Immunologic Factors|immunologic factors|mesh-ancestor
24974669|NCT05310305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588113|NCT00900978|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24588114|NCT00900978|Immunologic Factors|immunologic factors|mesh-ancestor
24588115|NCT00900978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588116|NCT00901069|Cyclophosphamide|cyclophosphamide|mesh-list
24588130|NCT00901069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24588131|NCT00901069|Tubulin Modulators|tubulin modulators|mesh-ancestor
24462160|NCT00355277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24462213|NCT00355537|Testosterone|testosterone|mesh-list
24462214|NCT00355537|Androgens|androgens|mesh-ancestor
24462216|NCT00355537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24462217|NCT00355537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462218|NCT00355576|Minocycline|minocycline|mesh-list
24462219|NCT00355576|Celecoxib|celecoxib|mesh-list
24462220|NCT00355576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24431955|NCT00253318|Dexamethasone|dexamethasone|mesh-list
24462221|NCT00355576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24462223|NCT00355576|Sensory System Agents|sensory system agents|mesh-ancestor
24462224|NCT00355576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24462225|NCT00355576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462226|NCT00355576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24432011|NCT00253461|Topotecan|topotecan|mesh-list
24462227|NCT00355576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24462228|NCT00355576|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24462229|NCT00355576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24462230|NCT00355576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24743600|NCT04731480|Propofol|propofol|mesh-list
24743660|NCT04672772|Paclitaxel|paclitaxel|mesh-list
25266324|NCT02429037|Cisplatin|cisplatin|mesh-list
24462317|NCT00355719|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24462318|NCT00355719|Nevirapine|nevirapine|mesh-list
24462319|NCT00355719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24462320|NCT00355719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24462321|NCT00355719|Protease Inhibitors|protease inhibitors|mesh-ancestor
24462322|NCT00355719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462323|NCT00355719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462324|NCT00355719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24462325|NCT00355719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24462326|NCT00355719|Antiviral Agents|antiviral agents|mesh-ancestor
24462327|NCT00355719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24433007|NCT00257257|Hormones|hormones|mesh-ancestor
24462328|NCT00355719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24433144|NCT00257699|Ciprofloxacin|ciprofloxacin|mesh-list
25218557|NCT02669303|Methylprednisolone|methylprednisolone|mesh-list
25218558|NCT02669303|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25218559|NCT02669303|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25218560|NCT02669303|Prednisolone|prednisolone|mesh-list
25218561|NCT02669303|Prednisolone acetate|prednisolone acetate|mesh-list
25218562|NCT02669303|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25218563|NCT02669303|Prednisolone phosphate|prednisolone phosphate|mesh-list
25218564|NCT02669303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25218565|NCT02669303|Antiemetics|antiemetics|mesh-ancestor
25218566|NCT02669303|Autonomic Agents|autonomic agents|mesh-ancestor
25218567|NCT02669303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24978285|NCT04939636|Vitamins|vitamins|mesh-list
25059802|NCT03484845|Ferrous fumarate|ferrous fumarate|mesh-list
24805828|NCT02012166|Octreotide|octreotide|mesh-list
24433222|NCT00257959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462338|NCT00355771|Histamine Agents|histamine agents|mesh-ancestor
24462357|NCT00355862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24462358|NCT00355862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24462359|NCT00355862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24462360|NCT00355862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24743701|NCT04658823|Protective Agents|protective agents|mesh-ancestor
24974683|NCT05309538|Betahistine|betahistine|mesh-list
24974684|NCT05309538|Vasodilator Agents|vasodilator agents|mesh-ancestor
24974685|NCT05309538|Histamine Agonists|histamine agonists|mesh-ancestor
24974686|NCT05309538|Histamine Agents|histamine agents|mesh-ancestor
24974687|NCT05309538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24974688|NCT05309538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974689|NCT05309538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811601|NCT02047422|Metolazone|metolazone|mesh-list
24974693|NCT05309187|Pembrolizumab|pembrolizumab|mesh-list
24974694|NCT05309187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24974695|NCT05309187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24974696|NCT05309070|Acetylcysteine|acetylcysteine|mesh-list
24974717|NCT05308602|Vaccines|vaccines|mesh-list
24974718|NCT05308602|Immunologic Factors|immunologic factors|mesh-ancestor
24974719|NCT05308602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974720|NCT05308576|Vaccines|vaccines|mesh-list
24974721|NCT05308576|Immunologic Factors|immunologic factors|mesh-ancestor
24974722|NCT05308576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974723|NCT05308342|Hormones|hormones|mesh-list
24974724|NCT05308342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24974725|NCT05308342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974726|NCT05308212|Vaccines|vaccines|mesh-list
24974727|NCT05308212|Immunologic Factors|immunologic factors|mesh-ancestor
24974728|NCT05308212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974729|NCT05303324|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
24974730|NCT05303324|Choline|choline|mesh-list
24974731|NCT05303324|Lipotropic Agents|lipotropic agents|mesh-ancestor
24974732|NCT05303324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24974733|NCT05303324|Antimetabolites|antimetabolites|mesh-ancestor
24974734|NCT05303324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978286|NCT04939636|Micronutrients|micronutrients|mesh-ancestor
24974735|NCT05303324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24974788|NCT05277402|Pembrolizumab|pembrolizumab|mesh-list
24974789|NCT05277402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24974790|NCT05277402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24974791|NCT05275569|Antiemetics|antiemetics|mesh-list
24974792|NCT05275569|Autonomic Agents|autonomic agents|mesh-ancestor
24974793|NCT05275569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25218568|NCT02669303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218569|NCT02669303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25218570|NCT02669303|Glucocorticoids|glucocorticoids|mesh-ancestor
25218571|NCT02669303|Hormones|hormones|mesh-ancestor
25218572|NCT02669303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24832611|NCT02171754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24974800|NCT05254847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974801|NCT05254847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978337|NCT04728646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24978338|NCT04728646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24974802|NCT05254847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24974803|NCT05254847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24974804|NCT05249725|Irsogladine|irsogladine|mesh-list
24974805|NCT05249725|Hydrotalcite|hydrotalcite|mesh-list
24974806|NCT05249725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974807|NCT05249725|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24974808|NCT05249725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24974809|NCT05249725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24974812|NCT05249725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974813|NCT05249725|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24974814|NCT05249725|Antacids|antacids|mesh-ancestor
24974815|NCT05249699|Isoniazid|isoniazid|mesh-list
24794830|NCT04354103|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24794831|NCT04354103|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25218581|NCT02669238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218582|NCT02669238|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25272966|NCT02388373|Fluticasone|fluticasone|mesh-list
25272967|NCT02388373|Xhance|xhance|mesh-list
25272968|NCT02388373|Formoterol Fumarate|formoterol fumarate|mesh-list
25272969|NCT02388373|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25272970|NCT02388373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25272971|NCT02388373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25272972|NCT02388373|Autonomic Agents|autonomic agents|mesh-ancestor
25272973|NCT02388373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25272974|NCT02388373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25272975|NCT02388373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25272976|NCT02388373|Respiratory System Agents|respiratory system agents|mesh-ancestor
25272977|NCT02388373|Dermatologic Agents|dermatologic agents|mesh-ancestor
25272978|NCT02388373|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25272979|NCT02388373|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25272980|NCT02388373|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25272981|NCT02388373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25272982|NCT02388373|Adrenergic Agents|adrenergic agents|mesh-ancestor
25272983|NCT02388373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24832596|NCT02171728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832597|NCT02171741|Docetaxel|docetaxel|mesh-list
24832598|NCT02171741|Afatinib|afatinib|mesh-list
24794833|NCT04354103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24794834|NCT04354103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794836|NCT04354103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24462370|NCT00355901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462372|NCT00355927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25083332|NCT03316599|Antiviral Agents|antiviral agents|mesh-ancestor
24794839|NCT04350593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24794840|NCT04350593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794841|NCT04350593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24794842|NCT04350593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794843|NCT04263038|Rivaroxaban|rivaroxaban|mesh-list
24794844|NCT04263038|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24794845|NCT04263038|Antithrombins|antithrombins|mesh-ancestor
24794846|NCT04263038|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24794847|NCT04263038|Protease Inhibitors|protease inhibitors|mesh-ancestor
24794848|NCT04263038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24794849|NCT04263038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794850|NCT04263038|Anticoagulants|anticoagulants|mesh-ancestor
24794854|NCT04240106|Niraparib|niraparib|mesh-list
24794855|NCT04240106|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24794856|NCT04240106|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24794857|NCT04240106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24794858|NCT04240106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794859|NCT04240106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24794860|NCT04240106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24794861|NCT04240106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24794862|NCT04240106|Hormone Antagonists|hormone antagonists|mesh-ancestor
24794863|NCT04240106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24794864|NCT04240106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794865|NCT04233866|Calcium, Dietary|calcium, dietary|mesh-list
24794866|NCT04233866|Leucovorin|leucovorin|mesh-list
24794867|NCT04233866|Folic Acid|folic acid|mesh-list
24794868|NCT04233866|Gemcitabine|gemcitabine|mesh-list
24794869|NCT04233866|Paclitaxel|paclitaxel|mesh-list
24794870|NCT04233866|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24794887|NCT04233866|Immunologic Factors|immunologic factors|mesh-ancestor
24794888|NCT04233866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794889|NCT04233866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24794890|NCT04233866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24794891|NCT04233866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24794892|NCT04233866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24794893|NCT04233866|Antidotes|antidotes|mesh-ancestor
24794894|NCT04233866|Protective Agents|protective agents|mesh-ancestor
24794895|NCT04233866|Vitamin B Complex|vitamin b complex|mesh-ancestor
24794896|NCT04233866|Vitamins|vitamins|mesh-ancestor
24794897|NCT04233866|Micronutrients|micronutrients|mesh-ancestor
24794898|NCT04233866|Hematinics|hematinics|mesh-ancestor
24974873|NCT05180591|BCG Vaccine|bcg vaccine|mesh-list
25218583|NCT02669277|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25218584|NCT02669277|gamma-Globulins|gamma-globulins|mesh-list
25218585|NCT02669277|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25218586|NCT02669277|Immunologic Factors|immunologic factors|mesh-ancestor
25218587|NCT02669277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218588|NCT02669368|Magnesium Sulfate|magnesium sulfate|mesh-list
25218589|NCT02669368|Rocuronium|rocuronium|mesh-list
25218590|NCT02669368|Analgesics|analgesics|mesh-ancestor
25218591|NCT02669368|Sensory System Agents|sensory system agents|mesh-ancestor
25218592|NCT02669368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24832601|NCT02171741|Antimitotic Agents|antimitotic agents|mesh-ancestor
24832602|NCT02171741|Mitosis Modulators|mitosis modulators|mesh-ancestor
24832603|NCT02171741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832604|NCT02171741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24832605|NCT02171741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832607|NCT02171754|Afatinib|afatinib|mesh-list
24832608|NCT02171754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24832609|NCT02171754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24832610|NCT02171754|Protease Inhibitors|protease inhibitors|mesh-ancestor
24462376|NCT00355927|Anesthetics, General|anesthetics, general|mesh-ancestor
24462377|NCT00355927|Anesthetics|anesthetics|mesh-ancestor
24462378|NCT00355953|Genistein|genistein|mesh-list
24811798|NCT02048384|Sirolimus|sirolimus|mesh-list
24974886|NCT05031897|Mycophenolic Acid|mycophenolic acid|mesh-list
24974887|NCT05031897|Cyclophosphamide|cyclophosphamide|mesh-list
24974888|NCT05031897|Melphalan|melphalan|mesh-list
24974889|NCT05031897|Fludarabine|fludarabine|mesh-list
24974890|NCT05031897|Tacrolimus|tacrolimus|mesh-list
24974891|NCT05031897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24974892|NCT05031897|Immunologic Factors|immunologic factors|mesh-ancestor
24974893|NCT05031897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974894|NCT05031897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25266352|NCT02428972|Propofol|propofol|mesh-list
24974895|NCT05031897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24974896|NCT05031897|Alkylating Agents|alkylating agents|mesh-ancestor
24974897|NCT05031897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974898|NCT05031897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24974899|NCT05031897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24974900|NCT05031897|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24743859|NCT04584684|Ethanol|ethanol|mesh-list
24974917|NCT05023369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24974918|NCT05023369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419611|NCT00213096|Estrogens|estrogens|mesh-ancestor
24419612|NCT00213096|Hormones|hormones|mesh-ancestor
24419614|NCT00213096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974929|NCT04981145|Hydroxychloroquine|hydroxychloroquine|mesh-list
24974930|NCT04981145|Antimalarials|antimalarials|mesh-ancestor
24974931|NCT04981145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24974932|NCT04981145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24974933|NCT04981145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24974934|NCT04981145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24974935|NCT04981145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218593|NCT02669368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218594|NCT02669368|Anesthetics|anesthetics|mesh-ancestor
25218595|NCT02669368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25218596|NCT02669368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25218597|NCT02669368|Anticonvulsants|anticonvulsants|mesh-ancestor
25218598|NCT02669368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25218599|NCT02669368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25218600|NCT02669368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218601|NCT02669368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24974936|NCT04981145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24974937|NCT04959812|Sufentanil|sufentanil|mesh-list
24974938|NCT04959812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24974939|NCT04959812|Narcotics|narcotics|mesh-ancestor
24974940|NCT04959812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24974949|NCT04952610|Etripamil|etripamil|mesh-list
24974950|NCT04952610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24974951|NCT04952610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24974952|NCT04952610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974953|NCT04952610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24974954|NCT04952610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974955|NCT04928339|Bupivacaine|bupivacaine|mesh-list
24974956|NCT04928339|Anesthetics, Local|anesthetics, local|mesh-ancestor
24974957|NCT04928339|Anesthetics|anesthetics|mesh-ancestor
24974958|NCT04928339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24974959|NCT04928339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083333|NCT03316599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24628456|NCT01099072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628457|NCT01099072|Dopamine Agents|dopamine agents|mesh-ancestor
24628458|NCT01099072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24808759|NCT02029001|Durvalumab|durvalumab|mesh-list
24808912|NCT02029794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808913|NCT02029794|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24811871|NCT02048761|Metformin|metformin|mesh-list
24974960|NCT04928339|Sensory System Agents|sensory system agents|mesh-ancestor
24974961|NCT04928339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24974979|NCT04862585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24974980|NCT04862585|Tubulin Modulators|tubulin modulators|mesh-ancestor
24974981|NCT04862585|Antimitotic Agents|antimitotic agents|mesh-ancestor
24974982|NCT04862585|Mitosis Modulators|mitosis modulators|mesh-ancestor
24974983|NCT04862585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408599|NCT00178828|Bupropion|bupropion|mesh-list
24975009|NCT04862585|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24975010|NCT04862585|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24975011|NCT04862585|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25266360|NCT02428972|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25266361|NCT02428972|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24975021|NCT04818216|Vitamin B Complex|vitamin b complex|mesh-ancestor
24975022|NCT04818216|Vitamins|vitamins|mesh-ancestor
24975023|NCT04818216|Micronutrients|micronutrients|mesh-ancestor
25083334|NCT03316599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25083335|NCT03316599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25083336|NCT03316599|Immunologic Factors|immunologic factors|mesh-ancestor
25083337|NCT03316599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083341|NCT03316534|Aspirin|aspirin|mesh-list
25083342|NCT03316534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25083343|NCT03316534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25083344|NCT03316534|Analgesics|analgesics|mesh-ancestor
25083345|NCT03316534|Sensory System Agents|sensory system agents|mesh-ancestor
25083346|NCT03316534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25083347|NCT03316534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083348|NCT03316534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25083349|NCT03316534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25218602|NCT02669368|Tocolytic Agents|tocolytic agents|mesh-ancestor
25218603|NCT02669368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25218604|NCT02669368|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25218605|NCT02669368|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25218606|NCT02669368|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25218607|NCT02669030|Suvorexant|suvorexant|mesh-list
25218608|NCT02669030|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25218609|NCT02669030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25218610|NCT02669030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25083379|NCT03316352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25083380|NCT03316352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083381|NCT03316352|Sensory System Agents|sensory system agents|mesh-ancestor
25083382|NCT03316352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25083383|NCT03316339|Dexmedetomidine|dexmedetomidine|mesh-list
25083384|NCT03316339|Remifentanil|remifentanil|mesh-list
25083385|NCT03316339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25083386|NCT03316339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25083387|NCT03316339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083388|NCT03316339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25083389|NCT03316339|Analgesics|analgesics|mesh-ancestor
25083390|NCT03316339|Sensory System Agents|sensory system agents|mesh-ancestor
25083391|NCT03316339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25083392|NCT03316339|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25083393|NCT03316339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25083394|NCT03316339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25083395|NCT03316339|Adrenergic Agents|adrenergic agents|mesh-ancestor
25083396|NCT03316339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25083397|NCT03316339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083398|NCT03316339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25083399|NCT03316339|Narcotics|narcotics|mesh-ancestor
25083400|NCT03316326|Oxaliplatin|oxaliplatin|mesh-list
25083401|NCT03316326|Irinotecan|irinotecan|mesh-list
25083402|NCT03316326|Tegafur|tegafur|mesh-list
25083403|NCT03316326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083404|NCT03316326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25083405|NCT03316326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25083406|NCT03316326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25083408|NCT03316326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25083412|NCT03316313|Immunologic Factors|immunologic factors|mesh-ancestor
25083413|NCT03316313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808914|NCT02029794|Protective Agents|protective agents|mesh-ancestor
24809178|NCT02031692|Vitamins|vitamins|mesh-ancestor
25083421|NCT03316066|Ropivacaine|ropivacaine|mesh-list
25083422|NCT03316066|Anesthetics, Local|anesthetics, local|mesh-ancestor
25083423|NCT03316066|Anesthetics|anesthetics|mesh-ancestor
24744110|NCT04505280|Lidocaine|lidocaine|mesh-list
25679296|NCT01836198|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25083434|NCT03315923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083435|NCT03315923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25083436|NCT03315923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25083437|NCT03315923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25218611|NCT02669030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218612|NCT02669030|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25218616|NCT02669004|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25218617|NCT02669004|Narcotics|narcotics|mesh-ancestor
25218618|NCT02669004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25218619|NCT02669004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218620|NCT02669004|Analgesics|analgesics|mesh-ancestor
25218621|NCT02669004|Sensory System Agents|sensory system agents|mesh-ancestor
25083463|NCT03315520|Etoposide|etoposide|mesh-list
25083464|NCT03315520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25083465|NCT03315520|Immunologic Factors|immunologic factors|mesh-ancestor
25083466|NCT03315520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083467|NCT03315520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25083468|NCT03315520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25083469|NCT03315520|Alkylating Agents|alkylating agents|mesh-ancestor
25083470|NCT03315520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083471|NCT03315520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083472|NCT03315520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25083473|NCT03315520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25083474|NCT03315520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25083475|NCT03315520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25083476|NCT03315520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25083477|NCT03315520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25083478|NCT03315520|Antimetabolites|antimetabolites|mesh-ancestor
25083479|NCT03315520|Antiviral Agents|antiviral agents|mesh-ancestor
25083480|NCT03315520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25083481|NCT03315507|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
24809734|NCT02036060|Hormones|hormones|mesh-ancestor
25083482|NCT03315507|Vasodilator Agents|vasodilator agents|mesh-ancestor
25083483|NCT03315442|Caffeine|caffeine|mesh-list
25083484|NCT03315442|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25083485|NCT03315442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462464|NCT00356356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462465|NCT00356356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24462466|NCT00356356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24462467|NCT00356356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24462468|NCT00356356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24462469|NCT00356356|Immunologic Factors|immunologic factors|mesh-ancestor
24462490|NCT00356460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083486|NCT03315442|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25083487|NCT03315442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25083488|NCT03315442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083489|NCT03315442|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25218622|NCT02669004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25042397|NCT01454089|Gemcitabine|gemcitabine|mesh-list
25042398|NCT01454089|Carboplatin|carboplatin|mesh-list
25042399|NCT01454089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042400|NCT01454089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25042401|NCT01454089|Antimetabolites|antimetabolites|mesh-ancestor
25042402|NCT01454089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042403|NCT01454089|Antiviral Agents|antiviral agents|mesh-ancestor
25083490|NCT03315442|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25083491|NCT03315442|Purinergic Agents|purinergic agents|mesh-ancestor
25083492|NCT03315442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25083493|NCT03315364|Paclitaxel|paclitaxel|mesh-list
24462510|NCT00356486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462513|NCT00356616|Antiviral Agents|antiviral agents|mesh-ancestor
24462514|NCT00356616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24462515|NCT00356616|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25083515|NCT03315091|Adavosertib|adavosertib|mesh-list
25083516|NCT03315091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25083517|NCT03315091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083518|NCT03315078|Busulfan|busulfan|mesh-list
25083519|NCT03315078|Alkylating Agents|alkylating agents|mesh-ancestor
25083520|NCT03315078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083521|NCT03315078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25083522|NCT03315078|Immunologic Factors|immunologic factors|mesh-ancestor
25083523|NCT03315078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083524|NCT03315078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25083525|NCT03315078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24462556|NCT00356941|Tubulin Modulators|tubulin modulators|mesh-ancestor
24462557|NCT00356941|Antimitotic Agents|antimitotic agents|mesh-ancestor
24462558|NCT00356941|Mitosis Modulators|mitosis modulators|mesh-ancestor
24462559|NCT00356941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462561|NCT00356954|Antioxidants|antioxidants|mesh-ancestor
24462562|NCT00356954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462564|NCT00356954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462566|NCT00356954|Micronutrients|micronutrients|mesh-ancestor
24462567|NCT00357019|Isospaglumic acid|isospaglumic acid|mesh-list
24462568|NCT00357019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24462569|NCT00357019|Autonomic Agents|autonomic agents|mesh-ancestor
25083542|NCT03315052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083543|NCT03315052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25083544|NCT03315052|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25083545|NCT03315052|Antitubercular Agents|antitubercular agents|mesh-ancestor
25083546|NCT03315052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25083547|NCT03315052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25083548|NCT03315052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25083549|NCT03315052|Autonomic Agents|autonomic agents|mesh-ancestor
25083550|NCT03315052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25083551|NCT03315052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25083552|NCT03315052|Respiratory System Agents|respiratory system agents|mesh-ancestor
25083553|NCT03315000|Fluticasone|fluticasone|mesh-list
25083555|NCT03315000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25083556|NCT03315000|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25083557|NCT03315000|Autonomic Agents|autonomic agents|mesh-ancestor
24744196|NCT04464577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25083569|NCT03314792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083570|NCT03314792|Analgesics|analgesics|mesh-ancestor
25083571|NCT03314792|Sensory System Agents|sensory system agents|mesh-ancestor
25083572|NCT03314792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25083573|NCT03314792|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25083582|NCT03314740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25083583|NCT03314740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083584|NCT03314740|Tubulin Modulators|tubulin modulators|mesh-ancestor
25083585|NCT03314740|Antimitotic Agents|antimitotic agents|mesh-ancestor
24978533|NCT04078568|Hormones|hormones|mesh-ancestor
24978544|NCT03979365|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24978545|NCT03979365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978546|NCT03979365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978547|NCT03948035|Dexamethasone|dexamethasone|mesh-list
24978548|NCT03948035|Dexamethasone acetate|dexamethasone acetate|mesh-list
24978549|NCT03948035|Lenalidomide|lenalidomide|mesh-list
24978550|NCT03948035|Elotuzumab|elotuzumab|mesh-list
24978551|NCT03948035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25083586|NCT03314740|Mitosis Modulators|mitosis modulators|mesh-ancestor
25083587|NCT03314740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218637|NCT02668796|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25218638|NCT02668796|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25218639|NCT02668796|Estradiol|estradiol|mesh-list
25218640|NCT02668796|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25218641|NCT02668796|Estrogens|estrogens|mesh-ancestor
25042404|NCT01454089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042405|NCT01454089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25042406|NCT01454089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25042407|NCT01454089|Immunologic Factors|immunologic factors|mesh-ancestor
25042408|NCT01454089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042409|NCT01452451|Exenatide|exenatide|mesh-list
25042410|NCT01452451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25042411|NCT01452451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042412|NCT01452451|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25083588|NCT03314740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25083589|NCT03314740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25679297|NCT01836198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25679298|NCT01836198|Antifungal Agents|antifungal agents|mesh-ancestor
25679299|NCT01836198|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25083593|NCT03314636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25083595|NCT03314636|Autonomic Agents|autonomic agents|mesh-ancestor
25083596|NCT03314636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25083597|NCT03314636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083598|NCT03314636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25083599|NCT03314636|Glucocorticoids|glucocorticoids|mesh-ancestor
25083601|NCT03314636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25083602|NCT03314636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25083603|NCT03314636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083604|NCT03314636|Immunologic Factors|immunologic factors|mesh-ancestor
25083605|NCT03314636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25083606|NCT03314636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25083607|NCT03314636|Growth Substances|growth substances|mesh-ancestor
25083608|NCT03314636|Growth Inhibitors|growth inhibitors|mesh-ancestor
25083609|NCT03314493|Spironolactone|spironolactone|mesh-list
25083624|NCT03314298|Hormones|hormones|mesh-ancestor
25083625|NCT03314298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25083626|NCT03314298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083627|NCT03314298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25083628|NCT03314298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083629|NCT03314298|Anabolic Agents|anabolic agents|mesh-ancestor
25083630|NCT03314298|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25083631|NCT03314298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25083632|NCT03314298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25083633|NCT03314298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083634|NCT03314298|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25083635|NCT03314298|Hormone Antagonists|hormone antagonists|mesh-ancestor
25083636|NCT03314259|Tamsulosin|tamsulosin|mesh-list
25083637|NCT03314259|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25083638|NCT03314259|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24744211|NCT04460924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462607|NCT00357084|Hormones|hormones|mesh-ancestor
24462608|NCT00357084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24436386|NCT00269828|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
24462609|NCT00357084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462610|NCT00357084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24462611|NCT00357084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24462612|NCT00357084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24462613|NCT00357084|Abortifacient Agents|abortifacient agents|mesh-ancestor
24462614|NCT00357084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24436601|NCT00270543|Micronutrients|micronutrients|mesh-ancestor
24436677|NCT00270777|Anesthetics, Local|anesthetics, local|mesh-ancestor
24462615|NCT00357084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24462616|NCT00357084|Antimetabolites|antimetabolites|mesh-ancestor
24462617|NCT00357084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083646|NCT03314064|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25083647|NCT03314064|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25083648|NCT03314064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25083649|NCT03314064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218642|NCT02668796|Hormones|hormones|mesh-ancestor
25218643|NCT02668796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25218644|NCT02668796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218645|NCT02668796|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25218646|NCT02668796|Contraceptive Agents|contraceptive agents|mesh-ancestor
25218647|NCT02668796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25218648|NCT02668796|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25218649|NCT02668861|Vitamin D|vitamin d|mesh-list
25042413|NCT01452451|Incretins|incretins|mesh-ancestor
25042414|NCT01452451|Hormones|hormones|mesh-ancestor
25218666|NCT02668926|Dextroamphetamine|dextroamphetamine|mesh-list
25042415|NCT01452451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25042416|NCT01449591|Metronidazole|metronidazole|mesh-list
25042417|NCT01449591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25679300|NCT01836198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25679301|NCT01836198|Hormone Antagonists|hormone antagonists|mesh-ancestor
25692420|NCT01999335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042418|NCT01449591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25042419|NCT01449591|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25042420|NCT01449591|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24805880|NCT02012465|Insulin|insulin|mesh-list
25083650|NCT03314064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25083651|NCT03314064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25083652|NCT03314064|Antiviral Agents|antiviral agents|mesh-ancestor
25083653|NCT03314064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25083655|NCT03314025|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25083656|NCT03314025|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25083657|NCT03314025|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25083658|NCT03314025|Adrenergic Agents|adrenergic agents|mesh-ancestor
25083659|NCT03314025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25083660|NCT03314025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083661|NCT03314025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083662|NCT03314025|Urological Agents|urological agents|mesh-ancestor
25083669|NCT03313934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083670|NCT03313934|Viscosupplements|viscosupplements|mesh-ancestor
25083671|NCT03313934|Protective Agents|protective agents|mesh-ancestor
25083672|NCT03313869|Vitamin E|vitamin e|mesh-list
25083673|NCT03313869|Selenium|selenium|mesh-list
25083674|NCT03313869|Vitamins|vitamins|mesh-ancestor
25083675|NCT03313869|Micronutrients|micronutrients|mesh-ancestor
25083676|NCT03313869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083677|NCT03313869|Antioxidants|antioxidants|mesh-ancestor
25083678|NCT03313869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083679|NCT03313869|Protective Agents|protective agents|mesh-ancestor
24933982|NCT04065529|Zinc|zinc|mesh-list
24462618|NCT00357084|Dermatologic Agents|dermatologic agents|mesh-ancestor
24462619|NCT00357084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462620|NCT00357084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24462621|NCT00357084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24462622|NCT00357084|Immunologic Factors|immunologic factors|mesh-ancestor
24462623|NCT00357084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25083680|NCT03313869|Trace Elements|trace elements|mesh-ancestor
25083681|NCT03313856|Magnesium Oxide|magnesium oxide|mesh-list
25083682|NCT03313856|Antacids|antacids|mesh-ancestor
25083683|NCT03313856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083684|NCT03313856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25083685|NCT03313804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25083686|NCT03313804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083687|NCT03313804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083688|NCT03313791|Caseins|caseins|mesh-list
25083689|NCT03313791|Chelating Agents|chelating agents|mesh-ancestor
25083690|NCT03313791|Sequestering Agents|sequestering agents|mesh-ancestor
25083691|NCT03313791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083692|NCT03313752|Dapagliflozin|dapagliflozin|mesh-list
25083693|NCT03313752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25083694|NCT03313752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083695|NCT03313752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25083696|NCT03313752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083697|NCT03313726|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25083698|NCT03313726|Hormones|hormones|mesh-ancestor
25083699|NCT03313726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25083700|NCT03313726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083701|NCT03313661|Gliclazide|gliclazide|mesh-list
25083702|NCT03313661|Cabergoline|cabergoline|mesh-list
25083703|NCT03313661|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25083704|NCT03313661|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25083705|NCT03313661|Dopamine Agonists|dopamine agonists|mesh-ancestor
25083706|NCT03313661|Dopamine Agents|dopamine agents|mesh-ancestor
25083707|NCT03313661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25218650|NCT02668861|Budesonide|budesonide|mesh-list
25218651|NCT02668861|Vitamins|vitamins|mesh-ancestor
25218652|NCT02668861|Micronutrients|micronutrients|mesh-ancestor
25218653|NCT02668861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218654|NCT02668861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25218655|NCT02668861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25218656|NCT02668861|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25218657|NCT02668861|Autonomic Agents|autonomic agents|mesh-ancestor
25218658|NCT02668861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25042421|NCT01449071|Epratuzumab|epratuzumab|mesh-list
25042423|NCT01449071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405115|NCT03630159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24832612|NCT02171754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419957|NCT00214643|Clindamycin phosphate|clindamycin phosphate|mesh-list
24419958|NCT00214643|Fosmidomycin|fosmidomycin|mesh-list
24419959|NCT00214643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24419960|NCT00214643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24832613|NCT02171754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24832614|NCT02171754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24832615|NCT02171754|Antiviral Agents|antiviral agents|mesh-ancestor
24592704|NCT00924014|Conivaptan|conivaptan|mesh-list
25083708|NCT03313661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084052|NCT03310060|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25083709|NCT03313661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083710|NCT03313661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25083711|NCT03313557|Adavosertib|adavosertib|mesh-list
25083712|NCT03313557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24744332|NCT04353284|Gabexate|gabexate|mesh-list
25083724|NCT03313479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25083725|NCT03313479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083726|NCT03313479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25083727|NCT03313479|Analgesics|analgesics|mesh-ancestor
25083728|NCT03313479|Sensory System Agents|sensory system agents|mesh-ancestor
25083729|NCT03313479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25083730|NCT03313479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25083731|NCT03313479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25083732|NCT03313479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25083733|NCT03313479|Adrenergic Agents|adrenergic agents|mesh-ancestor
25083734|NCT03313479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24628568|NCT01099839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25083735|NCT03313479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083736|NCT03313414|Sofosbuvir|sofosbuvir|mesh-list
25083737|NCT03313414|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
24628636|NCT01100203|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25083738|NCT03313414|Velpatasvir|velpatasvir|mesh-list
25083739|NCT03313414|Antiviral Agents|antiviral agents|mesh-ancestor
25083740|NCT03313414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25083741|NCT03313401|Aflibercept|aflibercept|mesh-list
25083742|NCT03313401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25083754|NCT03313336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25083755|NCT03313336|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25083757|NCT03313323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25083758|NCT03313323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083759|NCT03313323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25083760|NCT03313323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083761|NCT03313206|Pembrolizumab|pembrolizumab|mesh-list
25083762|NCT03313206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25083763|NCT03313206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813652|NCT02059759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25083764|NCT03312855|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
25083765|NCT03312855|Immunologic Factors|immunologic factors|mesh-ancestor
25083766|NCT03312855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083767|NCT03312777|Tramadol|tramadol|mesh-list
25083768|NCT03312777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25083769|NCT03312777|Narcotics|narcotics|mesh-ancestor
25083770|NCT03312777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24419961|NCT00214643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25083771|NCT03312777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083772|NCT03312777|Analgesics|analgesics|mesh-ancestor
25083773|NCT03312777|Sensory System Agents|sensory system agents|mesh-ancestor
25083774|NCT03312777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25083775|NCT03312699|Vaccines|vaccines|mesh-list
25083776|NCT03312699|Immunologic Factors|immunologic factors|mesh-ancestor
25083777|NCT03312699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083778|NCT03312582|Metformin|metformin|mesh-list
25083779|NCT03312582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25083793|NCT03312413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083794|NCT03312413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25083795|NCT03312413|Analgesics|analgesics|mesh-ancestor
25218659|NCT02668861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25218660|NCT02668861|Respiratory System Agents|respiratory system agents|mesh-ancestor
25218661|NCT02668861|Glucocorticoids|glucocorticoids|mesh-ancestor
25218662|NCT02668861|Hormones|hormones|mesh-ancestor
25218663|NCT02668861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25218664|NCT02668926|Amphetamine|amphetamine|mesh-list
25218665|NCT02668926|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25218667|NCT02668926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25266425|NCT02428374|Clopidogrel|clopidogrel|mesh-list
24832616|NCT02171754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24832617|NCT02171754|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24832618|NCT02171754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24832619|NCT02171754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24832620|NCT02171754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24832622|NCT02171767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24832623|NCT02171767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24737777|NCT01670552|Analgesics|analgesics|mesh-ancestor
24951913|NCT03899506|Serotonin Agents|serotonin agents|mesh-ancestor
25083796|NCT03312413|Sensory System Agents|sensory system agents|mesh-ancestor
25083797|NCT03312413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25083798|NCT03312413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25083799|NCT03312413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25083800|NCT03312413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25083801|NCT03312413|Adrenergic Agents|adrenergic agents|mesh-ancestor
25083802|NCT03312413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25083803|NCT03312413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083804|NCT03312335|Aldesleukin|aldesleukin|mesh-list
25083805|NCT03312335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083806|NCT03312335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25083807|NCT03312335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25083808|NCT03312335|Antiviral Agents|antiviral agents|mesh-ancestor
25083809|NCT03312335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25083810|NCT03312283|Ranibizumab|ranibizumab|mesh-list
25083811|NCT03312283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25083812|NCT03312283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25083813|NCT03312283|Growth Substances|growth substances|mesh-ancestor
25083814|NCT03312283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083815|NCT03312283|Growth Inhibitors|growth inhibitors|mesh-ancestor
25083816|NCT03312283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083818|NCT03312257|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25083826|NCT03312257|Mydriatics|mydriatics|mesh-ancestor
24814214|NCT02063334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083839|NCT03312244|Cholinergic Agents|cholinergic agents|mesh-ancestor
25083840|NCT03312244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25083841|NCT03312244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083842|NCT03312179|Incretins|incretins|mesh-list
25083843|NCT03312179|Hormones|hormones|mesh-ancestor
25083844|NCT03312179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25083845|NCT03312179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083846|NCT03312153|Sodium Hypochlorite|sodium hypochlorite|mesh-list
25083847|NCT03312153|Eusol|eusol|mesh-list
25083848|NCT03312153|Disinfectants|disinfectants|mesh-ancestor
25083849|NCT03312153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25083850|NCT03312140|Choline|choline|mesh-list
25083851|NCT03312140|Lipotropic Agents|lipotropic agents|mesh-ancestor
25083852|NCT03312140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25083853|NCT03312140|Antimetabolites|antimetabolites|mesh-ancestor
25083854|NCT03312140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083855|NCT03312140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25083856|NCT03312140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25083857|NCT03312140|Nootropic Agents|nootropic agents|mesh-ancestor
25218668|NCT02668926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218669|NCT02668926|Sympathomimetics|sympathomimetics|mesh-ancestor
25218670|NCT02668926|Autonomic Agents|autonomic agents|mesh-ancestor
25218671|NCT02668926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25218672|NCT02668926|Dopamine Agents|dopamine agents|mesh-ancestor
25218673|NCT02668926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25218674|NCT02668926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218675|NCT02668926|Adrenergic Agents|adrenergic agents|mesh-ancestor
25218676|NCT02668926|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25218677|NCT02668926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25218678|NCT02668926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25218679|NCT02668926|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25218680|NCT02668679|Hormones|hormones|mesh-list
25218681|NCT02668679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24449431|NCT00315601|Telithromycin|telithromycin|mesh-list
25692421|NCT01999335|Immunologic Factors|immunologic factors|mesh-ancestor
25083860|NCT03311984|Anticoagulants|anticoagulants|mesh-ancestor
25083861|NCT03311984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25083862|NCT03311984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25083863|NCT03311984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083864|NCT03311971|Methamphetamine|methamphetamine|mesh-list
25083865|NCT03311971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25083866|NCT03311971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083867|NCT03311971|Sympathomimetics|sympathomimetics|mesh-ancestor
25083868|NCT03311971|Autonomic Agents|autonomic agents|mesh-ancestor
25083869|NCT03311971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25083895|NCT03311906|Protective Agents|protective agents|mesh-ancestor
25083897|NCT03311828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083900|NCT03311789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25083901|NCT03311789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083902|NCT03311789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25083903|NCT03311789|Antimetabolites|antimetabolites|mesh-ancestor
25083904|NCT03311789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083905|NCT03311789|Antiviral Agents|antiviral agents|mesh-ancestor
25083906|NCT03311789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25083907|NCT03311789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25083908|NCT03311789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25083909|NCT03311789|Immunologic Factors|immunologic factors|mesh-ancestor
25083910|NCT03311789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083911|NCT03311789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25083912|NCT03311750|Panitumumab|panitumumab|mesh-list
24814888|NCT02067078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24814889|NCT02067078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24814890|NCT02067078|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25083913|NCT03311750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25083914|NCT03311750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083915|NCT03311737|Anesthetics|anesthetics|mesh-list
25083916|NCT03311737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25083917|NCT03311737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083918|NCT03311672|Pembrolizumab|pembrolizumab|mesh-list
25083919|NCT03311672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25083920|NCT03311672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083921|NCT03311607|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25083922|NCT03311607|Antifungal Agents|antifungal agents|mesh-ancestor
25083923|NCT03311607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25083924|NCT03311607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25083925|NCT03311607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25083934|NCT03311581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25083935|NCT03311581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083936|NCT03311581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25083937|NCT03311581|Anesthetics, General|anesthetics, general|mesh-ancestor
25083938|NCT03311581|Anesthetics|anesthetics|mesh-ancestor
25083939|NCT03311581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25083940|NCT03311581|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25083941|NCT03311542|Pembrolizumab|pembrolizumab|mesh-list
25083942|NCT03311542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25083943|NCT03311542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083944|NCT03311516|Insulin|insulin|mesh-list
25083945|NCT03311516|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25083946|NCT03311516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24934216|NCT04062656|Leucovorin|leucovorin|mesh-list
24462626|NCT00357084|Autonomic Agents|autonomic agents|mesh-ancestor
24462635|NCT00357123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083947|NCT03311516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083948|NCT03311464|Adalimumab|adalimumab|mesh-list
25083949|NCT03311464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25083950|NCT03311464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25218682|NCT02668679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218683|NCT02668965|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24449433|NCT00315601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24449434|NCT00315601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24978680|NCT03410706|Antithrombins|antithrombins|mesh-ancestor
24978681|NCT03410706|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24978682|NCT03410706|Protease Inhibitors|protease inhibitors|mesh-ancestor
24449437|NCT00315601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449439|NCT00315666|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24449440|NCT00315666|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24449441|NCT00315666|Dopamine Agents|dopamine agents|mesh-ancestor
24806081|NCT02013492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449442|NCT00315666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24449443|NCT00315666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449444|NCT00315666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449445|NCT00315666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24449446|NCT00315666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24449448|NCT00315679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24449449|NCT00315679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449450|NCT00315679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951928|NCT03899337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25083951|NCT03311425|Dexamethasone|dexamethasone|mesh-list
25083952|NCT03311425|Methylprednisolone|methylprednisolone|mesh-list
25083953|NCT03311425|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25083954|NCT03311425|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25083955|NCT03311425|Prednisolone|prednisolone|mesh-list
25083956|NCT03311425|Prednisolone acetate|prednisolone acetate|mesh-list
25083957|NCT03311425|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25083958|NCT03311425|Prednisolone phosphate|prednisolone phosphate|mesh-list
25083959|NCT03311425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25083960|NCT03311425|Antiemetics|antiemetics|mesh-ancestor
25083961|NCT03311425|Autonomic Agents|autonomic agents|mesh-ancestor
25083962|NCT03311425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25083963|NCT03311425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083964|NCT03311425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25083965|NCT03311425|Glucocorticoids|glucocorticoids|mesh-ancestor
25083966|NCT03311425|Hormones|hormones|mesh-ancestor
25083967|NCT03311425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25083968|NCT03311425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25083969|NCT03311425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083970|NCT03311425|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25083971|NCT03311425|Protective Agents|protective agents|mesh-ancestor
25083972|NCT03311386|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25083973|NCT03311386|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25083974|NCT03311386|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25083975|NCT03311386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083976|NCT03311321|Vitamin K|vitamin k|mesh-list
25083977|NCT03311321|Vitamin K 2|vitamin k 2|mesh-list
25083978|NCT03311321|Vitamin MK 7|vitamin mk 7|mesh-list
25083979|NCT03311321|Vitamins|vitamins|mesh-ancestor
24814891|NCT02067078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25083980|NCT03311321|Micronutrients|micronutrients|mesh-ancestor
25083985|NCT03311321|Hemostatics|hemostatics|mesh-ancestor
24978685|NCT03410706|Anticoagulants|anticoagulants|mesh-ancestor
24628685|NCT01100372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25218684|NCT02668965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25218685|NCT02668965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218686|NCT02668536|Sunscreening Agents|sunscreening agents|mesh-list
25218687|NCT02668536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25218688|NCT02668536|Protective Agents|protective agents|mesh-ancestor
25218689|NCT02668536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218690|NCT02668536|Dermatologic Agents|dermatologic agents|mesh-ancestor
25218691|NCT02668289|Anesthetics|anesthetics|mesh-list
25218692|NCT02668289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25218693|NCT02668289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218694|NCT02668497|Botulinum Toxins|botulinum toxins|mesh-list
25218695|NCT02668497|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25218696|NCT02668497|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25218697|NCT02668497|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25218698|NCT02668497|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25218699|NCT02668497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25218700|NCT02668497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218701|NCT02668497|Cholinergic Agents|cholinergic agents|mesh-ancestor
25218702|NCT02668497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25679305|NCT01836198|Antimetabolites|antimetabolites|mesh-ancestor
25679306|NCT01836198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25679307|NCT01836198|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25679308|NCT01836276|Varenicline|varenicline|mesh-list
25083993|NCT03311178|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25083994|NCT03311178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25083995|NCT03311178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25083996|NCT03311178|Adrenergic Agents|adrenergic agents|mesh-ancestor
25084003|NCT03311022|Nefopam|nefopam|mesh-list
25084004|NCT03311022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25084005|NCT03311022|Analgesics|analgesics|mesh-ancestor
25084006|NCT03311022|Sensory System Agents|sensory system agents|mesh-ancestor
25084007|NCT03311022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084008|NCT03311022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084009|NCT03310762|Silicon|silicon|mesh-list
25084010|NCT03310762|Trace Elements|trace elements|mesh-ancestor
25084011|NCT03310762|Micronutrients|micronutrients|mesh-ancestor
25084012|NCT03310762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084013|NCT03310749|Metformin|metformin|mesh-list
25084014|NCT03310749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25084015|NCT03310749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084016|NCT03310736|Hepcidins|hepcidins|mesh-list
25084018|NCT03310606|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25084037|NCT03310242|Micronutrients|micronutrients|mesh-ancestor
25084038|NCT03310242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084039|NCT03310242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25084049|NCT03310073|Immunologic Factors|immunologic factors|mesh-ancestor
25084050|NCT03310073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084051|NCT03310060|Tranexamic Acid|tranexamic acid|mesh-list
25084053|NCT03310060|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25084054|NCT03310060|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25084055|NCT03310060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084056|NCT03310060|Hemostatics|hemostatics|mesh-ancestor
25084057|NCT03310060|Coagulants|coagulants|mesh-ancestor
25084058|NCT03310047|Lidocaine|lidocaine|mesh-list
25084059|NCT03310047|Anesthetics, Local|anesthetics, local|mesh-ancestor
24628732|NCT01101152|Antidepressive Agents|antidepressive agents|mesh-ancestor
25084060|NCT03310047|Anesthetics|anesthetics|mesh-ancestor
25084061|NCT03310047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25084062|NCT03310047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084063|NCT03310047|Sensory System Agents|sensory system agents|mesh-ancestor
25084064|NCT03310047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084066|NCT03310047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25084067|NCT03310047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25084068|NCT03310047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25084069|NCT03310047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084070|NCT03309865|Vedolizumab|vedolizumab|mesh-list
25084071|NCT03309865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25084072|NCT03309748|Anti-Infective Agents|anti-infective agents|mesh-list
25084073|NCT03309748|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25084074|NCT03309735|Progesterone|progesterone|mesh-list
25084075|NCT03309735|Dydrogesterone|dydrogesterone|mesh-list
25084076|NCT03309735|Progestins|progestins|mesh-ancestor
25084077|NCT03309735|Hormones|hormones|mesh-ancestor
25084078|NCT03309735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25084079|NCT03309735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084080|NCT03309709|Progesterone|progesterone|mesh-list
25084081|NCT03309709|Progestins|progestins|mesh-ancestor
25084082|NCT03309709|Hormones|hormones|mesh-ancestor
25084083|NCT03309709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25218704|NCT02668497|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25218705|NCT02668497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24832625|NCT02171767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951953|NCT03899571|Oseltamivir|oseltamivir|mesh-list
25084084|NCT03309709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084104|NCT03309592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25084105|NCT03309566|Tenofovir|tenofovir|mesh-list
25084106|NCT03309566|Emtricitabine|emtricitabine|mesh-list
25084107|NCT03309566|Efavirenz|efavirenz|mesh-list
25084108|NCT03309566|Antiviral Agents|antiviral agents|mesh-ancestor
25084109|NCT03309566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25084110|NCT03309566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25084111|NCT03309566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25084112|NCT03309566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25084113|NCT03309566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084114|NCT03309566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25084115|NCT03309566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25679309|NCT01836276|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25084116|NCT03309566|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25084117|NCT03309566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25084118|NCT03309566|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25084119|NCT03309566|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25084121|NCT03309566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24462690|NCT00357253|Capecitabine|capecitabine|mesh-list
24462691|NCT00357253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24462692|NCT00357253|Antimetabolites|antimetabolites|mesh-ancestor
24462693|NCT00357253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462694|NCT00357253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24462695|NCT00357292|Azithromycin|azithromycin|mesh-list
24462696|NCT00357292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24462697|NCT00357292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24462698|NCT00357305|Cytarabine|cytarabine|mesh-list
24462699|NCT00357305|Etoposide|etoposide|mesh-list
24462700|NCT00357305|Etoposide phosphate|etoposide phosphate|mesh-list
24462701|NCT00357305|Vorinostat|vorinostat|mesh-list
24462702|NCT00357305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24462703|NCT00357305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420366|NCT00215774|Flecainide|flecainide|mesh-list
24462704|NCT00357305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24462705|NCT00357305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24438323|NCT00275535|Sirolimus|sirolimus|mesh-list
24462706|NCT00357305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462707|NCT00357305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462708|NCT00357305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24462710|NCT00357305|Antiviral Agents|antiviral agents|mesh-ancestor
24462711|NCT00357305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24462712|NCT00357305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24462713|NCT00357305|Immunologic Factors|immunologic factors|mesh-ancestor
24462714|NCT00357305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462715|NCT00357305|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24462716|NCT00357318|Bevacizumab|bevacizumab|mesh-list
24744726|NCT04169451|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25084134|NCT03309527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25084135|NCT03309527|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25084136|NCT03309527|Histamine Antagonists|histamine antagonists|mesh-ancestor
25084137|NCT03309527|Histamine Agents|histamine agents|mesh-ancestor
25084138|NCT03309527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25084139|NCT03309527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084140|NCT03309527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25084141|NCT03309527|Antipruritics|antipruritics|mesh-ancestor
25084142|NCT03309527|Dermatologic Agents|dermatologic agents|mesh-ancestor
25084144|NCT03309436|Clomiphene|clomiphene|mesh-list
25084145|NCT03309436|Enclomiphene|enclomiphene|mesh-list
25084146|NCT03309436|Zuclomiphene|zuclomiphene|mesh-list
25084147|NCT03309436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25084148|NCT03309436|Hormone Antagonists|hormone antagonists|mesh-ancestor
24934438|NCT04061265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25218706|NCT02668588|Octreotide|octreotide|mesh-list
25218707|NCT02668588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25218708|NCT02668588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25218709|NCT02668588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218710|NCT02667886|Axitinib|axitinib|mesh-list
24832627|NCT02171780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24832629|NCT02171780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24439788|NCT00280371|Autonomic Agents|autonomic agents|mesh-ancestor
24439949|NCT00280969|Efavirenz|efavirenz|mesh-list
24462741|NCT00357448|Denileukin diftitox|denileukin diftitox|mesh-list
24462743|NCT00357448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24462744|NCT00357448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24462745|NCT00357448|Analgesics|analgesics|mesh-ancestor
24462746|NCT00357448|Sensory System Agents|sensory system agents|mesh-ancestor
24462747|NCT00357448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24462748|NCT00357448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462749|NCT00357448|Immunologic Factors|immunologic factors|mesh-ancestor
24462751|NCT00357461|Vaccines|vaccines|mesh-list
24462752|NCT00357461|Freund's Adjuvant|freund's adjuvant|mesh-list
24441484|NCT00287560|Propofol|propofol|mesh-list
24462753|NCT00357461|Immunologic Factors|immunologic factors|mesh-ancestor
24441547|NCT00287794|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24462754|NCT00357461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462755|NCT00357461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24462756|NCT00357461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25084149|NCT03309436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24657623|NCT01268670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25084150|NCT03309436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084151|NCT03309436|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25084152|NCT03309436|Fertility Agents|fertility agents|mesh-ancestor
25084153|NCT03309436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25084154|NCT03309436|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25084155|NCT03309436|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25084156|NCT03309319|Rosiglitazone|rosiglitazone|mesh-list
24628824|NCT01101581|Sequestering Agents|sequestering agents|mesh-ancestor
24628826|NCT01101620|Simendan|simendan|mesh-list
25084168|NCT03309176|Contraceptive Agents|contraceptive agents|mesh-ancestor
24817311|NCT02082496|Hormones|hormones|mesh-ancestor
25084169|NCT03309176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25084170|NCT03309176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462757|NCT00357461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24462758|NCT00357461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441699|NCT00288158|Probenecid|probenecid|mesh-list
24462759|NCT00357461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24441765|NCT00288262|Protective Agents|protective agents|mesh-ancestor
24462761|NCT00357474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24462762|NCT00357474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24441911|NCT00288782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24462763|NCT00357474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24462764|NCT00357474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462765|NCT00357539|Azithromycin|azithromycin|mesh-list
24462766|NCT00357539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24442132|NCT00290082|Anesthetics|anesthetics|mesh-ancestor
24462767|NCT00357539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24462783|NCT00357604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462784|NCT00357604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24462785|NCT00357604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24462786|NCT00357604|Antiviral Agents|antiviral agents|mesh-ancestor
24628835|NCT01101646|Rabeprazole|rabeprazole|mesh-list
24628836|NCT01101646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24628837|NCT01101646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25084171|NCT03309176|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25084172|NCT03309176|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25084173|NCT03309176|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25084174|NCT03309176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25084175|NCT03309176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25084176|NCT03309163|Tramadol|tramadol|mesh-list
25084177|NCT03309163|Hydromorphone|hydromorphone|mesh-list
25084178|NCT03309163|Ropivacaine|ropivacaine|mesh-list
25084179|NCT03309163|Anesthetics, Local|anesthetics, local|mesh-ancestor
24420566|NCT00216346|Amebicides|amebicides|mesh-ancestor
25084180|NCT03309163|Anesthetics|anesthetics|mesh-ancestor
25084181|NCT03309163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25084182|NCT03309163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084183|NCT03309163|Sensory System Agents|sensory system agents|mesh-ancestor
25218711|NCT02667886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218712|NCT02667886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25218713|NCT02667886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275621|NCT02370680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25275622|NCT02370680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832630|NCT02171780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832631|NCT02171780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24832632|NCT02171780|Respiratory System Agents|respiratory system agents|mesh-ancestor
24832633|NCT02171793|Olodaterol|olodaterol|mesh-list
24832634|NCT02171793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24832635|NCT02171793|Autonomic Agents|autonomic agents|mesh-ancestor
24832636|NCT02171793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24832637|NCT02171793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832638|NCT02171793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24832639|NCT02171793|Respiratory System Agents|respiratory system agents|mesh-ancestor
25084184|NCT03309163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084185|NCT03309163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25084186|NCT03309163|Narcotics|narcotics|mesh-ancestor
25084187|NCT03309163|Analgesics|analgesics|mesh-ancestor
25084188|NCT03309059|Zinc Oxide|zinc oxide|mesh-list
25084189|NCT03309059|Dermatologic Agents|dermatologic agents|mesh-ancestor
25084190|NCT03309059|Sunscreening Agents|sunscreening agents|mesh-ancestor
25084191|NCT03309059|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25084192|NCT03309059|Protective Agents|protective agents|mesh-ancestor
25084193|NCT03309059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679310|NCT01836276|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25084194|NCT03308955|Tramadol|tramadol|mesh-list
25679311|NCT01836276|Cholinergic Agents|cholinergic agents|mesh-ancestor
25679312|NCT01836276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25084195|NCT03308955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24628840|NCT01101646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628842|NCT01101659|Analgesics|analgesics|mesh-ancestor
24628843|NCT01101659|Sensory System Agents|sensory system agents|mesh-ancestor
25084226|NCT03308708|Sympathomimetics|sympathomimetics|mesh-ancestor
25084227|NCT03308708|Autonomic Agents|autonomic agents|mesh-ancestor
25084228|NCT03308708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084229|NCT03308708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25084230|NCT03308682|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
25084231|NCT03308682|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25084232|NCT03308682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084233|NCT03308643|Oxytocin|oxytocin|mesh-list
25084234|NCT03308643|Oxytocics|oxytocics|mesh-ancestor
25084235|NCT03308643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25084236|NCT03308643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084237|NCT03308604|Cisplatin|cisplatin|mesh-list
25084238|NCT03308604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25084239|NCT03308552|Paclitaxel|paclitaxel|mesh-list
25084240|NCT03308552|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25084241|NCT03308552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25084242|NCT03308552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25084243|NCT03308552|Tubulin Modulators|tubulin modulators|mesh-ancestor
25084244|NCT03308552|Antimitotic Agents|antimitotic agents|mesh-ancestor
25218714|NCT02667886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218715|NCT02668016|Atorvastatin|atorvastatin|mesh-list
25218716|NCT02668016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
25218717|NCT02668016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25218718|NCT02668016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25218719|NCT02668016|Antimetabolites|antimetabolites|mesh-ancestor
25218720|NCT02668016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218721|NCT02668016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25218722|NCT02668016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25218723|NCT02668159|Vitamin D|vitamin d|mesh-list
24832640|NCT02171806|Olodaterol|olodaterol|mesh-list
24832641|NCT02171806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24832642|NCT02171806|Autonomic Agents|autonomic agents|mesh-ancestor
24832643|NCT02171806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24832644|NCT02171806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550526|NCT00720915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084245|NCT03308552|Mitosis Modulators|mitosis modulators|mesh-ancestor
24420649|NCT00216515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24420685|NCT00216580|Risperidone|risperidone|mesh-list
25084246|NCT03308552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084247|NCT03308487|Vitamin D|vitamin d|mesh-list
25084248|NCT03308487|Ergocalciferols|ergocalciferols|mesh-list
25084249|NCT03308487|Cholecalciferol|cholecalciferol|mesh-list
25084250|NCT03308487|Vitamins|vitamins|mesh-list
25084251|NCT03308487|Micronutrients|micronutrients|mesh-ancestor
25084252|NCT03308487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084300|NCT03308149|Hormones|hormones|mesh-ancestor
25084301|NCT03308149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25084303|NCT03308136|Anesthetics, Local|anesthetics, local|mesh-list
25084304|NCT03308136|Anesthetics|anesthetics|mesh-list
25084305|NCT03308136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25084306|NCT03308136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084307|NCT03308136|Sensory System Agents|sensory system agents|mesh-ancestor
25084308|NCT03308136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084309|NCT03308136|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25084310|NCT03308136|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25084311|NCT03308136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25084312|NCT03308136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25679313|NCT01836276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084313|NCT03308136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084314|NCT03308084|Dexamethasone|dexamethasone|mesh-list
25084315|NCT03308084|Methylprednisolone|methylprednisolone|mesh-list
25084316|NCT03308084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25084317|NCT03308084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25084319|NCT03308084|Prednisolone acetate|prednisolone acetate|mesh-list
25084320|NCT03308084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25084321|NCT03308084|Prednisolone phosphate|prednisolone phosphate|mesh-list
25084322|NCT03308084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25084323|NCT03308084|Antiemetics|antiemetics|mesh-ancestor
25084324|NCT03308084|Autonomic Agents|autonomic agents|mesh-ancestor
25084325|NCT03308084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084326|NCT03308084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084327|NCT03308084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24628846|NCT01101659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24442890|NCT00293150|Eplerenone|eplerenone|mesh-list
24628847|NCT01101659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24628848|NCT01101659|Anesthetics, General|anesthetics, general|mesh-ancestor
24628849|NCT01101659|Anesthetics|anesthetics|mesh-ancestor
24628850|NCT01101659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25084328|NCT03308084|Glucocorticoids|glucocorticoids|mesh-ancestor
25084329|NCT03308084|Hormones|hormones|mesh-ancestor
24745042|NCT04012177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24628852|NCT01101659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24628853|NCT01101659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24628854|NCT01101659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218724|NCT02668159|Ergocalciferols|ergocalciferols|mesh-list
25218725|NCT02668159|Cholecalciferol|cholecalciferol|mesh-list
25218726|NCT02668159|Vitamins|vitamins|mesh-list
25218727|NCT02668159|Micronutrients|micronutrients|mesh-ancestor
25218728|NCT02668159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218729|NCT02668159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25218730|NCT02668159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25218731|NCT02668172|Pasireotide|pasireotide|mesh-list
25218736|NCT02667925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218737|NCT02668094|Lidocaine|lidocaine|mesh-list
24832645|NCT02171806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24832646|NCT02171806|Respiratory System Agents|respiratory system agents|mesh-ancestor
24832647|NCT02171832|Olodaterol|olodaterol|mesh-list
24832648|NCT02171832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24832649|NCT02171832|Autonomic Agents|autonomic agents|mesh-ancestor
24832650|NCT02171832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24832651|NCT02171832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832652|NCT02171832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24628856|NCT01101685|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24628857|NCT01101685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24628858|NCT01101685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24420798|NCT00216827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24420799|NCT00216827|Glucocorticoids|glucocorticoids|mesh-ancestor
24978792|NCT02903381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420806|NCT00216840|Betamethasone|betamethasone|mesh-list
24628859|NCT01101685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628860|NCT01101685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24628899|NCT01101802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24628900|NCT01101802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24628901|NCT01101802|Antitubercular Agents|antitubercular agents|mesh-ancestor
24628902|NCT01101802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24628903|NCT01101802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24628904|NCT01101802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462826|NCT00357630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628906|NCT01101815|Naltrexone|naltrexone|mesh-list
25084356|NCT03307863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24745116|NCT03990883|Sensory System Agents|sensory system agents|mesh-ancestor
24658423|NCT01271556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658424|NCT01271556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658425|NCT01271556|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25084380|NCT03307603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24628922|NCT01101919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24462827|NCT00357630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24628924|NCT01101919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628925|NCT01101984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24628926|NCT01101984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24628927|NCT01101984|Hyaluronic Acid|hyaluronic acid|mesh-list
24628928|NCT01101984|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24628929|NCT01101984|Immunologic Factors|immunologic factors|mesh-ancestor
24628930|NCT01101984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628931|NCT01101984|Viscosupplements|viscosupplements|mesh-ancestor
25218738|NCT02668094|Pregabalin|pregabalin|mesh-list
25218739|NCT02668094|Propofol|propofol|mesh-list
25218740|NCT02668094|Anesthetics, Local|anesthetics, local|mesh-ancestor
25218741|NCT02668094|Anesthetics|anesthetics|mesh-ancestor
25218742|NCT02668094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25218743|NCT02668094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218744|NCT02668094|Sensory System Agents|sensory system agents|mesh-ancestor
25218745|NCT02668094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25218746|NCT02668094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25218747|NCT02668094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25218787|NCT02667561|Testosterone|testosterone|mesh-list
25218749|NCT02668094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25218750|NCT02668094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218751|NCT02668094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25218752|NCT02668094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25218753|NCT02668094|Anesthetics, General|anesthetics, general|mesh-ancestor
25218755|NCT02668094|Anticonvulsants|anticonvulsants|mesh-ancestor
25218756|NCT02668094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25218757|NCT02668094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25218758|NCT02668094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25218759|NCT02668094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25218760|NCT02668094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24420905|NCT00217204|Pancrelipase|pancrelipase|mesh-list
24628932|NCT01101984|Protective Agents|protective agents|mesh-ancestor
24628933|NCT01102101|Remifentanil|remifentanil|mesh-list
24628934|NCT01102101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24628935|NCT01102101|Narcotics|narcotics|mesh-ancestor
24628936|NCT01102101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24628946|NCT01102244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24628947|NCT01102244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25084382|NCT03307603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25084383|NCT03307603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084384|NCT03307590|Dexmedetomidine|dexmedetomidine|mesh-list
25084423|NCT03307213|Antifungal Agents|antifungal agents|mesh-ancestor
25084424|NCT03307148|Gemcitabine|gemcitabine|mesh-list
25084425|NCT03307148|Paclitaxel|paclitaxel|mesh-list
25084426|NCT03307148|Tretinoin|tretinoin|mesh-list
25084427|NCT03307148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25084428|NCT03307148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25084429|NCT03307148|Tubulin Modulators|tubulin modulators|mesh-ancestor
25084430|NCT03307148|Antimitotic Agents|antimitotic agents|mesh-ancestor
25084431|NCT03307148|Mitosis Modulators|mitosis modulators|mesh-ancestor
25679314|NCT01836276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679315|NCT01836471|Fluticasone|fluticasone|mesh-list
25679316|NCT01836471|Xhance|xhance|mesh-list
25218761|NCT02667730|Acetaminophen|acetaminophen|mesh-list
24658679|NCT01273506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24658680|NCT01273506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658681|NCT01273506|Analgesics|analgesics|mesh-ancestor
24658682|NCT01273506|Sensory System Agents|sensory system agents|mesh-ancestor
25218762|NCT02667730|Celecoxib|celecoxib|mesh-list
25218763|NCT02667730|Naproxen|naproxen|mesh-list
25218764|NCT02667730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25218765|NCT02667730|Analgesics|analgesics|mesh-ancestor
25218766|NCT02667730|Sensory System Agents|sensory system agents|mesh-ancestor
25218767|NCT02667730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25218768|NCT02667730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218769|NCT02667730|Antipyretics|antipyretics|mesh-ancestor
25218770|NCT02667730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25218771|NCT02667730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25218772|NCT02667730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25218773|NCT02667730|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25218774|NCT02667730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25218775|NCT02667730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25218776|NCT02667730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218777|NCT02667730|Gout Suppressants|gout suppressants|mesh-ancestor
25218778|NCT02667743|Paclitaxel|paclitaxel|mesh-list
25218779|NCT02667743|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25218780|NCT02667743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25218781|NCT02667743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218782|NCT02667743|Tubulin Modulators|tubulin modulators|mesh-ancestor
25218783|NCT02667743|Antimitotic Agents|antimitotic agents|mesh-ancestor
25218784|NCT02667743|Mitosis Modulators|mitosis modulators|mesh-ancestor
25218785|NCT02667743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218786|NCT02667561|Methyltestosterone|methyltestosterone|mesh-list
24832653|NCT02171832|Respiratory System Agents|respiratory system agents|mesh-ancestor
24832654|NCT02171871|Respiratory System Agents|respiratory system agents|mesh-list
24832655|NCT02171910|Doxapram|doxapram|mesh-list
25084443|NCT03306940|Botulinum Toxins|botulinum toxins|mesh-list
25084457|NCT03306836|Heparin|heparin|mesh-list
25084470|NCT03306732|Vitamin B Complex|vitamin b complex|mesh-ancestor
25084472|NCT03306732|Micronutrients|micronutrients|mesh-ancestor
25084473|NCT03306732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084474|NCT03306667|Dotinurad|dotinurad|mesh-list
25084475|NCT03306667|Uricosuric Agents|uricosuric agents|mesh-ancestor
25084476|NCT03306667|Gout Suppressants|gout suppressants|mesh-ancestor
25084477|NCT03306667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25084478|NCT03306667|Renal Agents|renal agents|mesh-ancestor
25084480|NCT03306602|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25084481|NCT03306602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25084482|NCT03306602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25084488|NCT03306550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25084490|NCT03306550|Analgesics|analgesics|mesh-ancestor
25084491|NCT03306550|Sensory System Agents|sensory system agents|mesh-ancestor
24978811|NCT02774265|Tinzaparin|tinzaparin|mesh-list
25084492|NCT03306550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084493|NCT03306550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084494|NCT03306550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24819071|NCT02092974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25084495|NCT03306550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25084496|NCT03306550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25084497|NCT03306550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25084498|NCT03306550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084499|NCT03306550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25084500|NCT03306550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25084501|NCT03306550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25084502|NCT03306550|Antipyretics|antipyretics|mesh-ancestor
25084503|NCT03306472|Letrozole|letrozole|mesh-list
25084504|NCT03306472|Megestrol|megestrol|mesh-list
25084505|NCT03306472|Megestrol Acetate|megestrol acetate|mesh-list
25084507|NCT03306472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25084508|NCT03306472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25084509|NCT03306472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25084510|NCT03306472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084511|NCT03306472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25084512|NCT03306472|Hormone Antagonists|hormone antagonists|mesh-ancestor
25679317|NCT01836471|Indoleacetic Acids|indoleacetic acids|mesh-list
25679318|NCT01836471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25679319|NCT01836471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25679320|NCT01836471|Autonomic Agents|autonomic agents|mesh-ancestor
25084513|NCT03306472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24658860|NCT01274273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25084514|NCT03306472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084515|NCT03306472|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25084516|NCT03306472|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25084517|NCT03306472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25084518|NCT03306472|Contraceptive Agents|contraceptive agents|mesh-ancestor
25084519|NCT03306472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24745281|NCT03838367|Leronlimab|leronlimab|mesh-list
24628973|NCT01102439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24628974|NCT01102439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24628975|NCT01102439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628976|NCT01102439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24628977|NCT01102439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24628978|NCT01102439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628979|NCT01102439|Antipyretics|antipyretics|mesh-ancestor
24628980|NCT01102439|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24628981|NCT01102439|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25218788|NCT02667561|Testosterone undecanoate|testosterone undecanoate|mesh-list
25218789|NCT02667561|Testosterone enanthate|testosterone enanthate|mesh-list
25218790|NCT02667561|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25218791|NCT02667561|Androgens|androgens|mesh-ancestor
25218792|NCT02667561|Hormones|hormones|mesh-ancestor
25218793|NCT02667561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24421242|NCT00218166|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24421243|NCT00218166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24421244|NCT00218166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24421245|NCT00218166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24421246|NCT00218166|GABA Modulators|gaba modulators|mesh-ancestor
24421247|NCT00218166|Anticonvulsants|anticonvulsants|mesh-ancestor
24421250|NCT00218166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25084524|NCT03306472|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25084526|NCT03306446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25084527|NCT03306446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25084528|NCT03306368|Analgesics, Opioid|analgesics, opioid|mesh-list
25084529|NCT03306368|Narcotics|narcotics|mesh-ancestor
25084530|NCT03306368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25084531|NCT03306368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084532|NCT03306368|Analgesics|analgesics|mesh-ancestor
25084533|NCT03306368|Sensory System Agents|sensory system agents|mesh-ancestor
25084534|NCT03306368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084535|NCT03306290|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25084536|NCT03306290|Cefoxitin|cefoxitin|mesh-list
25084537|NCT03306290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25084552|NCT03306212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421251|NCT00218205|Celecoxib|celecoxib|mesh-list
24421274|NCT00218218|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24421275|NCT00218218|Autonomic Agents|autonomic agents|mesh-ancestor
25084553|NCT03306212|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25084554|NCT03306212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24819635|NCT02096289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218794|NCT02667561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218795|NCT02667561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25218796|NCT02667561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218797|NCT02667561|Anabolic Agents|anabolic agents|mesh-ancestor
25218798|NCT02667535|Isosorbide|isosorbide|mesh-list
25218799|NCT02667535|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25218800|NCT02667535|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25218801|NCT02667535|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25218802|NCT02667535|Diuretics|diuretics|mesh-ancestor
25218803|NCT02667535|Natriuretic Agents|natriuretic agents|mesh-ancestor
25218804|NCT02667535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218805|NCT02667535|Vasodilator Agents|vasodilator agents|mesh-ancestor
25218806|NCT02667535|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25218807|NCT02667535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679321|NCT01836471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084558|NCT03305978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25084559|NCT03305536|Vitamin D|vitamin d|mesh-list
25084560|NCT03305536|Vitamins|vitamins|mesh-list
25084561|NCT03305536|Vitamin K|vitamin k|mesh-list
25084562|NCT03305536|Vitamin K 2|vitamin k 2|mesh-list
24421278|NCT00218218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25084563|NCT03305536|Vitamin MK 7|vitamin mk 7|mesh-list
25084564|NCT03305536|Micronutrients|micronutrients|mesh-ancestor
25084565|NCT03305536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084566|NCT03305536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25084567|NCT03305536|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25084568|NCT03305536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25084569|NCT03305536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084570|NCT03305536|Hemostatics|hemostatics|mesh-ancestor
25084571|NCT03305536|Coagulants|coagulants|mesh-ancestor
25084572|NCT03305510|Vitamin D|vitamin d|mesh-list
25084573|NCT03305510|Vitamins|vitamins|mesh-ancestor
25084574|NCT03305510|Micronutrients|micronutrients|mesh-ancestor
25084575|NCT03305510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084576|NCT03305510|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25084577|NCT03305471|Sevelamer|sevelamer|mesh-list
25084578|NCT03305471|Chelating Agents|chelating agents|mesh-ancestor
25084579|NCT03305471|Sequestering Agents|sequestering agents|mesh-ancestor
25084580|NCT03305471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084581|NCT03305445|Nivolumab|nivolumab|mesh-list
25084582|NCT03305445|Ipilimumab|ipilimumab|mesh-list
25084583|NCT03305445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25084584|NCT03305445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25084585|NCT03305445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25084586|NCT03305445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084587|NCT03305263|Hydroxychloroquine|hydroxychloroquine|mesh-list
25084588|NCT03305263|Antimalarials|antimalarials|mesh-ancestor
25084589|NCT03305263|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25084590|NCT03305263|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25084591|NCT03305263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25084592|NCT03305263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25084593|NCT03305263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084594|NCT03305263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25218808|NCT02667470|Solifenacin Succinate|solifenacin succinate|mesh-list
25218809|NCT02667470|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25218810|NCT02667470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25218811|NCT02667470|Cholinergic Agents|cholinergic agents|mesh-ancestor
25218812|NCT02667470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25218813|NCT02667470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218814|NCT02667470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218815|NCT02667470|Urological Agents|urological agents|mesh-ancestor
25272984|NCT02388373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272989|NCT02388048|Ofatumumab|ofatumumab|mesh-list
25272990|NCT02388048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25272991|NCT02388061|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25272992|NCT02388061|Plasminogen|plasminogen|mesh-list
25272993|NCT02388061|Tenecteplase|tenecteplase|mesh-list
25272994|NCT02388061|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25272995|NCT02388061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24978855|NCT02652468|Cyclophosphamide|cyclophosphamide|mesh-list
25084597|NCT03305068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25084598|NCT03305068|Analgesics|analgesics|mesh-ancestor
25084599|NCT03305068|Sensory System Agents|sensory system agents|mesh-ancestor
25084600|NCT03305068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084601|NCT03305068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084602|NCT03305068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25084603|NCT03305068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25084604|NCT03305068|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24618518|NCT01048684|Diuretics|diuretics|mesh-ancestor
25084641|NCT03304457|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25084648|NCT03304444|Anesthetics|anesthetics|mesh-ancestor
25084649|NCT03304444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25084650|NCT03304444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084651|NCT03304444|Sensory System Agents|sensory system agents|mesh-ancestor
25084652|NCT03304444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084653|NCT03304431|Lidocaine|lidocaine|mesh-list
25084654|NCT03304431|Anesthetics, Local|anesthetics, local|mesh-ancestor
25084655|NCT03304431|Anesthetics|anesthetics|mesh-ancestor
25084656|NCT03304431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25084657|NCT03304431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084658|NCT03304431|Sensory System Agents|sensory system agents|mesh-ancestor
25084659|NCT03304431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084660|NCT03304431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25084661|NCT03304431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25084662|NCT03304431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25084663|NCT03304431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25084664|NCT03304431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084665|NCT03304418|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25084666|NCT03304418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25084667|NCT03304288|Rituximab|rituximab|mesh-list
25084668|NCT03304288|Tretinoin|tretinoin|mesh-list
25084669|NCT03304288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25218816|NCT02667197|Analgesics, Opioid|analgesics, opioid|mesh-list
25218817|NCT02667197|Narcotics|narcotics|mesh-ancestor
25218818|NCT02667197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25218819|NCT02667197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218820|NCT02667197|Analgesics|analgesics|mesh-ancestor
25218821|NCT02667197|Sensory System Agents|sensory system agents|mesh-ancestor
25218822|NCT02667197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25218823|NCT02667262|Analgesics, Opioid|analgesics, opioid|mesh-list
25218824|NCT02667262|Narcotics|narcotics|mesh-ancestor
24978857|NCT02652468|Fludarabine|fludarabine|mesh-list
25218825|NCT02667262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25218826|NCT02667262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218827|NCT02667262|Analgesics|analgesics|mesh-ancestor
25218828|NCT02667262|Sensory System Agents|sensory system agents|mesh-ancestor
25218829|NCT02667262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25218830|NCT02667223|Bococizumab|bococizumab|mesh-list
25218831|NCT02667223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25218832|NCT02667223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25218833|NCT02667223|Antimetabolites|antimetabolites|mesh-ancestor
24832675|NCT02171988|Autonomic Agents|autonomic agents|mesh-ancestor
24832676|NCT02171988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084670|NCT03304288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25084671|NCT03304288|Immunologic Factors|immunologic factors|mesh-ancestor
25084672|NCT03304288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266562|NCT02427334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25266563|NCT02427334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25084673|NCT03304288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25084674|NCT03304288|Keratolytic Agents|keratolytic agents|mesh-ancestor
25084675|NCT03304288|Dermatologic Agents|dermatologic agents|mesh-ancestor
24759784|NCT01754831|Fluorides|fluorides|mesh-list
24759853|NCT01755182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25084676|NCT03304210|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25084677|NCT03304210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25084697|NCT03304080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25084698|NCT03304080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084700|NCT03303976|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25084701|NCT03303976|Immunologic Factors|immunologic factors|mesh-ancestor
25084702|NCT03303976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084717|NCT03303677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25084718|NCT03303677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25084719|NCT03303677|Autonomic Agents|autonomic agents|mesh-ancestor
25084720|NCT03303677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084721|NCT03303677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084722|NCT03303677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25084723|NCT03303677|Respiratory System Agents|respiratory system agents|mesh-ancestor
25084724|NCT03303677|Glucocorticoids|glucocorticoids|mesh-ancestor
25084725|NCT03303677|Hormones|hormones|mesh-ancestor
24421805|NCT00220233|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25084726|NCT03303677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25084727|NCT03303677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25084728|NCT03303677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25084729|NCT03303677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25084730|NCT03303677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25084731|NCT03303677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084732|NCT03303677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25084733|NCT03303677|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25218834|NCT02667223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218835|NCT02667223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25218836|NCT02667353|Anesthetics|anesthetics|mesh-list
25218837|NCT02667353|Etomidate|etomidate|mesh-list
25218838|NCT02667353|Succinylcholine|succinylcholine|mesh-list
25218839|NCT02667353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25218840|NCT02667353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218841|NCT02667353|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25218842|NCT02667353|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25218843|NCT02667353|Anesthetics, General|anesthetics, general|mesh-ancestor
25218844|NCT02667353|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
25218845|NCT02667353|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25218846|NCT02667353|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25218847|NCT02667353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25218848|NCT02667496|Sargramostim|sargramostim|mesh-list
25218849|NCT02667496|Immunologic Factors|immunologic factors|mesh-ancestor
25218850|NCT02667496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218851|NCT02666898|Cyclophosphamide|cyclophosphamide|mesh-list
25218852|NCT02666898|Fludarabine|fludarabine|mesh-list
25084734|NCT03303677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25679322|NCT01836471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679323|NCT01836471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25679324|NCT01836471|Respiratory System Agents|respiratory system agents|mesh-ancestor
25679325|NCT01836471|Dermatologic Agents|dermatologic agents|mesh-ancestor
25084735|NCT03303677|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25084736|NCT03303677|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25084737|NCT03303677|Renal Agents|renal agents|mesh-ancestor
25084738|NCT03303677|Antimalarials|antimalarials|mesh-ancestor
25084739|NCT03303677|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25084740|NCT03303677|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25084741|NCT03303677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25084742|NCT03303677|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25084743|NCT03303677|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25084744|NCT03303651|Analgesics, Opioid|analgesics, opioid|mesh-list
25084767|NCT03303495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25084768|NCT03303495|Immunologic Factors|immunologic factors|mesh-ancestor
25084769|NCT03303495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25084770|NCT03303495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25084771|NCT03303495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25084773|NCT03303495|Protective Agents|protective agents|mesh-ancestor
25084774|NCT03303495|Vitamin B Complex|vitamin b complex|mesh-ancestor
25084775|NCT03303495|Vitamins|vitamins|mesh-ancestor
25084776|NCT03303495|Micronutrients|micronutrients|mesh-ancestor
25084777|NCT03303378|Melatonin|melatonin|mesh-list
25084778|NCT03303378|Antioxidants|antioxidants|mesh-ancestor
25084779|NCT03303378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084780|NCT03303378|Protective Agents|protective agents|mesh-ancestor
25084781|NCT03303378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084782|NCT03303378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25084783|NCT03303235|Methylergonovine|methylergonovine|mesh-list
25084784|NCT03303235|Oxytocics|oxytocics|mesh-ancestor
25084785|NCT03303235|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25084786|NCT03303235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084787|NCT03303209|Analgesics, Opioid|analgesics, opioid|mesh-list
25084788|NCT03303209|Narcotics|narcotics|mesh-ancestor
25084789|NCT03303209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25084790|NCT03303209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628993|NCT01102465|Natriuretic Agents|natriuretic agents|mesh-ancestor
24628994|NCT01102465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628995|NCT01102465|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24628996|NCT01102465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25084791|NCT03303209|Analgesics|analgesics|mesh-ancestor
25084792|NCT03303209|Sensory System Agents|sensory system agents|mesh-ancestor
25084793|NCT03303209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084794|NCT03303053|Prednisolone|prednisolone|mesh-list
25218853|NCT02666898|Obinutuzumab|obinutuzumab|mesh-list
25218854|NCT02666898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25218855|NCT02666898|Immunologic Factors|immunologic factors|mesh-ancestor
25218856|NCT02666898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218857|NCT02666898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25218858|NCT02666898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25218859|NCT02666898|Alkylating Agents|alkylating agents|mesh-ancestor
25218860|NCT02666898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218861|NCT02666898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218862|NCT02666898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25218863|NCT02666898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25218864|NCT02666703|Methylprednisolone|methylprednisolone|mesh-list
25218865|NCT02666703|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25218866|NCT02666703|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25218867|NCT02666703|Prednisolone|prednisolone|mesh-list
25218868|NCT02666703|Prednisolone acetate|prednisolone acetate|mesh-list
25042437|NCT01444365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25042438|NCT01444365|Analgesics|analgesics|mesh-ancestor
25042439|NCT01444365|Sensory System Agents|sensory system agents|mesh-ancestor
25042440|NCT01444365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25042441|NCT01444365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042442|NCT01444365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25042443|NCT01444365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25042444|NCT01443728|Vitamin D|vitamin d|mesh-list
25042445|NCT01443728|Ergocalciferols|ergocalciferols|mesh-list
24419454|NCT00212108|Celecoxib|celecoxib|mesh-list
25042446|NCT01443728|Cholecalciferol|cholecalciferol|mesh-list
25042447|NCT01443728|Vitamins|vitamins|mesh-list
25042448|NCT01443728|Micronutrients|micronutrients|mesh-ancestor
25042449|NCT01443728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042450|NCT01443728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25042451|NCT01443728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25042452|NCT01442090|Everolimus|everolimus|mesh-list
25042453|NCT01442090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042454|NCT01442090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25042455|NCT01442090|Immunologic Factors|immunologic factors|mesh-ancestor
25084795|NCT03303053|Cholestyramine Resin|cholestyramine resin|mesh-list
25084796|NCT03303053|Carbimazole|carbimazole|mesh-list
25084797|NCT03303053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25084798|NCT03303053|Glucocorticoids|glucocorticoids|mesh-ancestor
25084799|NCT03303053|Hormones|hormones|mesh-ancestor
25084800|NCT03303053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25084801|NCT03303053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629063|NCT01103050|Histamine Agents|histamine agents|mesh-ancestor
24629064|NCT01103050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24629065|NCT01103050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629066|NCT01103050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629067|NCT01103115|Calcium, Dietary|calcium, dietary|mesh-list
24629081|NCT01103154|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24629082|NCT01103154|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24629083|NCT01103154|Adrenergic Agents|adrenergic agents|mesh-ancestor
24629084|NCT01103154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24629085|NCT01103154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629086|NCT01103154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629087|NCT01103154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24629089|NCT01103154|Protective Agents|protective agents|mesh-ancestor
24629090|NCT01103154|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25084812|NCT03302871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25084813|NCT03302871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25084814|NCT03302871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25218869|NCT02666703|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25218870|NCT02666703|Prednisolone phosphate|prednisolone phosphate|mesh-list
25218871|NCT02666703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25218872|NCT02666703|Antiemetics|antiemetics|mesh-ancestor
25218873|NCT02666703|Autonomic Agents|autonomic agents|mesh-ancestor
25218874|NCT02666703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25218875|NCT02666703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218876|NCT02666703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25218877|NCT02666703|Glucocorticoids|glucocorticoids|mesh-ancestor
25218878|NCT02666703|Hormones|hormones|mesh-ancestor
25218879|NCT02666703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25218880|NCT02666703|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25218881|NCT02666703|Protective Agents|protective agents|mesh-ancestor
25218882|NCT02666703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25218883|NCT02666703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218884|NCT02667054|Anesthetics|anesthetics|mesh-list
25218885|NCT02667054|Anesthetics, Local|anesthetics, local|mesh-list
25218886|NCT02667054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25218887|NCT02667054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218888|NCT02667054|Sensory System Agents|sensory system agents|mesh-ancestor
25218889|NCT02667054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25218890|NCT02666716|Fluconazole|fluconazole|mesh-list
25218891|NCT02666716|Antifungal Agents|antifungal agents|mesh-ancestor
25218892|NCT02666716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042456|NCT01442090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042457|NCT01437735|Montelukast|montelukast|mesh-list
25042458|NCT01437735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25042459|NCT01437735|Respiratory System Agents|respiratory system agents|mesh-ancestor
25042460|NCT01437735|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25060064|NCT03483142|Misoprostol|misoprostol|mesh-list
25084815|NCT03302871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25084816|NCT03302871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084835|NCT03302754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25084837|NCT03302689|Ropivacaine|ropivacaine|mesh-list
25084838|NCT03302689|Levobupivacaine|levobupivacaine|mesh-list
25084839|NCT03302689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25084840|NCT03302689|Anesthetics, Local|anesthetics, local|mesh-ancestor
25084841|NCT03302689|Anesthetics|anesthetics|mesh-ancestor
25084855|NCT03302650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084856|NCT03302650|Sympathomimetics|sympathomimetics|mesh-ancestor
25084857|NCT03302650|Autonomic Agents|autonomic agents|mesh-ancestor
25084858|NCT03302650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084859|NCT03302650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25084860|NCT03302650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25084861|NCT03302650|Protease Inhibitors|protease inhibitors|mesh-ancestor
25084862|NCT03302650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25084864|NCT03302585|Ergocalciferols|ergocalciferols|mesh-list
25084865|NCT03302585|Cholecalciferol|cholecalciferol|mesh-list
25084866|NCT03302585|Vitamins|vitamins|mesh-list
25084867|NCT03302585|Micronutrients|micronutrients|mesh-ancestor
25084868|NCT03302585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084869|NCT03302585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25084870|NCT03302585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24760030|NCT01755923|Docetaxel|docetaxel|mesh-list
25084871|NCT03302403|Cyclophosphamide|cyclophosphamide|mesh-list
25084872|NCT03302403|Fludarabine|fludarabine|mesh-list
24422246|NCT00221702|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24422247|NCT00221702|Antiviral Agents|antiviral agents|mesh-ancestor
24422248|NCT00221702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25084873|NCT03302403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25084874|NCT03302403|Immunologic Factors|immunologic factors|mesh-ancestor
25084875|NCT03302403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084876|NCT03302403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25084877|NCT03302403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25084878|NCT03302403|Alkylating Agents|alkylating agents|mesh-ancestor
25084879|NCT03302403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084880|NCT03302403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25084881|NCT03302403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24629091|NCT01103154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24629092|NCT01103154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24629162|NCT01103401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24629163|NCT01103401|Analgesics|analgesics|mesh-ancestor
24629164|NCT01103401|Sensory System Agents|sensory system agents|mesh-ancestor
25218893|NCT02666716|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25218894|NCT02666716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25218895|NCT02666716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25218896|NCT02666716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218897|NCT02666716|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25218898|NCT02666716|Hormone Antagonists|hormone antagonists|mesh-ancestor
25218899|NCT02666716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25218900|NCT02666716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218901|NCT02666716|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25218902|NCT02666716|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25218903|NCT02666768|Interferons|interferons|mesh-list
25218904|NCT02666768|Interferon-gamma|interferon-gamma|mesh-list
25218905|NCT02666768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218906|NCT02666768|Antiviral Agents|antiviral agents|mesh-ancestor
25218907|NCT02666768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25218908|NCT02666651|Tolvaptan|tolvaptan|mesh-list
24832677|NCT02171988|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24832678|NCT02171988|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24832679|NCT02171988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832680|NCT02171988|Cholinergic Agents|cholinergic agents|mesh-ancestor
25679326|NCT01836471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24629165|NCT01103401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24629166|NCT01103401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24629167|NCT01103401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25084884|NCT03302390|Anesthetics, Local|anesthetics, local|mesh-ancestor
25084885|NCT03302390|Anesthetics|anesthetics|mesh-ancestor
24783778|NCT01904045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24422315|NCT00222053|Leprostatic Agents|leprostatic agents|mesh-ancestor
24422316|NCT00222053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24422317|NCT00222053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24422318|NCT00222053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24422342|NCT00222170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24629171|NCT01103518|Cyproterone Acetate|cyproterone acetate|mesh-list
24422343|NCT00222170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422344|NCT00222183|Pimecrolimus|pimecrolimus|mesh-list
25105857|NCT04850495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25105858|NCT04850495|Tubulin Modulators|tubulin modulators|mesh-ancestor
25084886|NCT03302390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25084887|NCT03302390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084888|NCT03302390|Sensory System Agents|sensory system agents|mesh-ancestor
25084889|NCT03302390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084890|NCT03302390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25084891|NCT03302390|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25084892|NCT03302390|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25084893|NCT03302390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25084894|NCT03302390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084895|NCT03302390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25084896|NCT03302390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25084897|NCT03302390|Adrenergic Agents|adrenergic agents|mesh-ancestor
25084898|NCT03302390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25084899|NCT03302390|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25084900|NCT03302390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25084901|NCT03302390|Autonomic Agents|autonomic agents|mesh-ancestor
25084902|NCT03302390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25084903|NCT03302390|Respiratory System Agents|respiratory system agents|mesh-ancestor
25084904|NCT03302390|Mydriatics|mydriatics|mesh-ancestor
25084905|NCT03302390|Sympathomimetics|sympathomimetics|mesh-ancestor
25084906|NCT03302390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25084907|NCT03302364|Risperidone|risperidone|mesh-list
25084908|NCT03302364|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25084909|NCT03302364|Serotonin Agents|serotonin agents|mesh-ancestor
25084910|NCT03302364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25084911|NCT03302364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084912|NCT03302364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084918|NCT03302364|Dopamine Agents|dopamine agents|mesh-ancestor
25084924|NCT03302351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25084925|NCT03302351|Analgesics|analgesics|mesh-ancestor
25084926|NCT03302351|Sensory System Agents|sensory system agents|mesh-ancestor
25084927|NCT03302351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084928|NCT03302351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25084929|NCT03302351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25084930|NCT03302351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25084931|NCT03302351|Adrenergic Agents|adrenergic agents|mesh-ancestor
25084932|NCT03302351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25084933|NCT03302351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218913|NCT02666534|Lidocaine|lidocaine|mesh-list
25218914|NCT02666534|Prilocaine|prilocaine|mesh-list
25218915|NCT02666534|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25218916|NCT02666534|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25218917|NCT02666534|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
25218918|NCT02666534|Anesthetics, Local|anesthetics, local|mesh-ancestor
25218919|NCT02666534|Anesthetics|anesthetics|mesh-ancestor
25218920|NCT02666534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25218921|NCT02666534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042461|NCT01437735|Hormone Antagonists|hormone antagonists|mesh-ancestor
25084935|NCT03302351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25084936|NCT03302351|Anesthetics, General|anesthetics, general|mesh-ancestor
25084937|NCT03302351|Anesthetics|anesthetics|mesh-ancestor
25084968|NCT03302208|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25084969|NCT03302208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25084970|NCT03302208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084971|NCT03302208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25084972|NCT03302208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25084973|NCT03302208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25084974|NCT03302208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25084975|NCT03302208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25084981|NCT03302182|Ritonavir|ritonavir|mesh-list
25084982|NCT03302182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25084983|NCT03302182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25084984|NCT03302182|Protease Inhibitors|protease inhibitors|mesh-ancestor
25084985|NCT03302182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25084986|NCT03302182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629169|NCT01103401|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24629170|NCT01103401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24629178|NCT01103518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629179|NCT01103518|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24629181|NCT01103518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24629182|NCT01103518|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24629183|NCT01103518|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24629184|NCT01103518|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24629185|NCT01103518|Androgen Antagonists|androgen antagonists|mesh-ancestor
24629186|NCT01103518|Hormone Antagonists|hormone antagonists|mesh-ancestor
24629187|NCT01103518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629188|NCT01103518|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24629190|NCT01103583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629191|NCT01103583|Antisickling Agents|antisickling agents|mesh-ancestor
24629192|NCT01103583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24629193|NCT01103583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629243|NCT01103830|Moxifloxacin|moxifloxacin|mesh-list
24629244|NCT01103830|Lumefantrine|lumefantrine|mesh-list
24629245|NCT01103830|Artemether|artemether|mesh-list
24629246|NCT01103830|Piperaquine|piperaquine|mesh-list
24629247|NCT01103830|Artenimol|artenimol|mesh-list
25085017|NCT03302039|Sympathomimetics|sympathomimetics|mesh-ancestor
25085018|NCT03302039|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25085019|NCT03302039|Nasal Decongestants|nasal decongestants|mesh-ancestor
25085020|NCT03302039|Respiratory System Agents|respiratory system agents|mesh-ancestor
25085021|NCT03302039|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24422443|NCT00222495|Antiemetics|antiemetics|mesh-ancestor
25085022|NCT03302039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25085024|NCT03302039|Adrenergic Agents|adrenergic agents|mesh-ancestor
25085025|NCT03302039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25085026|NCT03302039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085027|NCT03302039|Protective Agents|protective agents|mesh-ancestor
25085028|NCT03301974|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25085029|NCT03301974|Hemostatics|hemostatics|mesh-ancestor
25085030|NCT03301974|Coagulants|coagulants|mesh-ancestor
25085031|NCT03301766|Lidocaine|lidocaine|mesh-list
25085032|NCT03301766|Anesthetics, Local|anesthetics, local|mesh-ancestor
25218922|NCT02666534|Sensory System Agents|sensory system agents|mesh-ancestor
25218923|NCT02666534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25218924|NCT02666534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25218925|NCT02666534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25218926|NCT02666534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25085033|NCT03301766|Anesthetics|anesthetics|mesh-ancestor
25085034|NCT03301766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25085035|NCT03301766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085036|NCT03301766|Sensory System Agents|sensory system agents|mesh-ancestor
25085037|NCT03301766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25266624|NCT02426866|Efavirenz|efavirenz|mesh-list
25085038|NCT03301766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25085039|NCT03301766|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25085040|NCT03301766|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25085041|NCT03301766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25245797|NCT03719326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25085042|NCT03301766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629269|NCT01103843|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24745858|NCT03569475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24629323|NCT01104519|Vitamins|vitamins|mesh-ancestor
25085060|NCT03301350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25085061|NCT03301350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25085062|NCT03301350|Tubulin Modulators|tubulin modulators|mesh-ancestor
25085063|NCT03301350|Antimitotic Agents|antimitotic agents|mesh-ancestor
25085064|NCT03301350|Mitosis Modulators|mitosis modulators|mesh-ancestor
25085065|NCT03301350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085066|NCT03301350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24629278|NCT01104038|Chlorhexidine|chlorhexidine|mesh-list
24629279|NCT01104038|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24629280|NCT01104038|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24629281|NCT01104038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24629282|NCT01104038|Disinfectants|disinfectants|mesh-ancestor
24629283|NCT01104038|Dermatologic Agents|dermatologic agents|mesh-ancestor
24629284|NCT01104259|Vinorelbine|vinorelbine|mesh-list
24629286|NCT01104259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629304|NCT01104337|Acetaminophen|acetaminophen|mesh-list
24629305|NCT01104337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24629306|NCT01104337|Analgesics|analgesics|mesh-ancestor
24629307|NCT01104337|Sensory System Agents|sensory system agents|mesh-ancestor
24629308|NCT01104337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24629309|NCT01104337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629310|NCT01104337|Antipyretics|antipyretics|mesh-ancestor
24629321|NCT01104519|Vasodilator Agents|vasodilator agents|mesh-ancestor
24629322|NCT01104519|Vitamin B Complex|vitamin b complex|mesh-ancestor
25085067|NCT03301350|Immunologic Factors|immunologic factors|mesh-ancestor
25085068|NCT03301350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085069|NCT03301350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25085070|NCT03301350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25218927|NCT02666534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25218928|NCT02666534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218929|NCT02666534|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25218930|NCT02666534|Dermatologic Agents|dermatologic agents|mesh-ancestor
25218931|NCT02666534|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25218932|NCT02666170|Thioctic Acid|thioctic acid|mesh-list
25218933|NCT02666170|Antioxidants|antioxidants|mesh-ancestor
25218934|NCT02666170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218935|NCT02666170|Protective Agents|protective agents|mesh-ancestor
25218936|NCT02666170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218937|NCT02666170|Vitamin B Complex|vitamin b complex|mesh-ancestor
25218939|NCT02666170|Micronutrients|micronutrients|mesh-ancestor
25218940|NCT02666209|Dexamethasone|dexamethasone|mesh-list
25218941|NCT02666209|Lenalidomide|lenalidomide|mesh-list
25218942|NCT02666209|Bortezomib|bortezomib|mesh-list
25085071|NCT03301350|Alkylating Agents|alkylating agents|mesh-ancestor
25085072|NCT03301350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25085073|NCT03301350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25085074|NCT03301350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25085075|NCT03301350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25085076|NCT03301350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085077|NCT03301285|Zoledronic Acid|zoledronic acid|mesh-list
25085078|NCT03301285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25085079|NCT03301285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085080|NCT03301233|Sildenafil Citrate|sildenafil citrate|mesh-list
25085084|NCT03301233|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25085085|NCT03301233|Estrogens|estrogens|mesh-ancestor
25085086|NCT03301233|Hormones|hormones|mesh-ancestor
25085087|NCT03301233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25085088|NCT03301233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24668497|NCT04892706|Dermatologic Agents|dermatologic agents|mesh-ancestor
24629327|NCT01104532|Ipragliflozin|ipragliflozin|mesh-list
24629344|NCT01104571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629346|NCT01104597|Vasodilator Agents|vasodilator agents|mesh-ancestor
24629347|NCT01104649|Riluzole|riluzole|mesh-list
24629348|NCT01104649|Anticonvulsants|anticonvulsants|mesh-ancestor
24629349|NCT01104649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24629350|NCT01104649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24629351|NCT01104649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24629352|NCT01104649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629353|NCT01104649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629354|NCT01104649|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24629355|NCT01104649|Protective Agents|protective agents|mesh-ancestor
24629356|NCT01104844|Acetaminophen|acetaminophen|mesh-list
24629357|NCT01104844|Ibuprofen|ibuprofen|mesh-list
24629359|NCT01104844|Analgesics|analgesics|mesh-ancestor
24629360|NCT01104844|Sensory System Agents|sensory system agents|mesh-ancestor
24629361|NCT01104844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24629362|NCT01104844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629364|NCT01104844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24629365|NCT01104844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24629366|NCT01104844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24629367|NCT01104844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24629368|NCT01104844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25218943|NCT02666209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25218944|NCT02666209|Antiemetics|antiemetics|mesh-ancestor
25218945|NCT02666209|Autonomic Agents|autonomic agents|mesh-ancestor
25218946|NCT02666209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25218947|NCT02666209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218948|NCT02666209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25218949|NCT02666209|Glucocorticoids|glucocorticoids|mesh-ancestor
25218950|NCT02666209|Hormones|hormones|mesh-ancestor
25218951|NCT02666209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25218952|NCT02666209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25218953|NCT02666209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218954|NCT02666209|Immunologic Factors|immunologic factors|mesh-ancestor
25218955|NCT02666209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24795436|NCT02679170|Crizotinib|crizotinib|mesh-list
25218956|NCT02666209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24832681|NCT02172001|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
24832682|NCT02172001|Hematinics|hematinics|mesh-ancestor
24832683|NCT02172014|Fentanyl|fentanyl|mesh-list
24832684|NCT02172014|Midazolam|midazolam|mesh-list
25085089|NCT03301233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25085090|NCT03301233|Contraceptive Agents|contraceptive agents|mesh-ancestor
25085095|NCT03301233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25085096|NCT03301233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085097|NCT03301233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679327|NCT01836471|Plant Growth Regulators|plant growth regulators|mesh-ancestor
25085098|NCT03301233|Urological Agents|urological agents|mesh-ancestor
25085101|NCT03301207|Levonorgestrel|levonorgestrel|mesh-list
25085102|NCT03301207|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25085103|NCT03301207|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25085104|NCT03301207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25085105|NCT03301207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25085106|NCT03301207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25085107|NCT03301207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085108|NCT03301207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25085109|NCT03301207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25085111|NCT03301207|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25085112|NCT03301207|Anesthetics, General|anesthetics, general|mesh-ancestor
25085114|NCT03301207|GABA Modulators|gaba modulators|mesh-ancestor
25085115|NCT03301207|GABA Agents|gaba agents|mesh-ancestor
25085116|NCT03301207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25085117|NCT03301207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085118|NCT03301207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25085119|NCT03301207|Antidepressive Agents|antidepressive agents|mesh-ancestor
25085120|NCT03301207|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25085121|NCT03301207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25085122|NCT03301207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25085123|NCT03301207|Dopamine Agents|dopamine agents|mesh-ancestor
25085125|NCT03301207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25085127|NCT03301207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25085128|NCT03301207|Contraceptive Agents|contraceptive agents|mesh-ancestor
25085129|NCT03301207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25085130|NCT03301207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25085131|NCT03301207|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25218957|NCT02666209|Growth Substances|growth substances|mesh-ancestor
25218958|NCT02666209|Growth Inhibitors|growth inhibitors|mesh-ancestor
25218960|NCT02666365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25218961|NCT02666365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25218962|NCT02666443|Dexamethasone|dexamethasone|mesh-list
25218963|NCT02666443|Dexamethasone acetate|dexamethasone acetate|mesh-list
25218964|NCT02666443|BB 1101|bb 1101|mesh-list
25218965|NCT02666443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25218966|NCT02666443|Antiemetics|antiemetics|mesh-ancestor
25218967|NCT02666443|Autonomic Agents|autonomic agents|mesh-ancestor
25218968|NCT02666443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25218969|NCT02666443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218970|NCT02666443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25218971|NCT02666443|Glucocorticoids|glucocorticoids|mesh-ancestor
25218972|NCT02666443|Hormones|hormones|mesh-ancestor
25218973|NCT02666443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25218974|NCT02666443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25218975|NCT02666443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25218976|NCT02666443|Protease Inhibitors|protease inhibitors|mesh-ancestor
24952155|NCT03897062|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
24952156|NCT03897062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24777910|NCT01867775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24777911|NCT01867775|Adrenergic Agents|adrenergic agents|mesh-ancestor
24777912|NCT01867775|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24777913|NCT01867775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24599463|NCT04534023|Idebenone|idebenone|mesh-list
25085132|NCT03301207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25085133|NCT03301207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25085134|NCT03301207|Estrogens|estrogens|mesh-ancestor
25085135|NCT03301207|Hormones|hormones|mesh-ancestor
25085136|NCT03301207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25085137|NCT03301207|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25085138|NCT03301181|Itraconazole|itraconazole|mesh-list
25085139|NCT03301181|Rifampin|rifampin|mesh-list
25085140|NCT03301181|Zanubrutinib|zanubrutinib|mesh-list
25085141|NCT03301181|Antifungal Agents|antifungal agents|mesh-ancestor
25085142|NCT03301181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25085143|NCT03301181|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25085144|NCT03301181|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25085145|NCT03301181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422657|NCT00223418|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25085146|NCT03301181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085147|NCT03301181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25085148|NCT03301181|Hormone Antagonists|hormone antagonists|mesh-ancestor
25085149|NCT03301181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25085150|NCT03301181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085151|NCT03301181|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25085152|NCT03301181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25085153|NCT03301181|Antitubercular Agents|antitubercular agents|mesh-ancestor
25085154|NCT03301181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25085155|NCT03301181|Leprostatic Agents|leprostatic agents|mesh-ancestor
25085156|NCT03301181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25085157|NCT03301181|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25085158|NCT03301181|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24746030|NCT03456700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25085169|NCT03301025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085170|NCT03301025|Anticonvulsants|anticonvulsants|mesh-ancestor
25085171|NCT03301025|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25085172|NCT03301025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25085173|NCT03301025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085174|NCT03301025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25085175|NCT03301025|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25085176|NCT03301025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25085177|NCT03301025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25085178|NCT03301025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25085179|NCT03300960|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25085181|NCT03300960|Hormone Antagonists|hormone antagonists|mesh-ancestor
25218977|NCT02666443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25218978|NCT02666443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218979|NCT02666417|Iron|iron|mesh-list
25218980|NCT02666417|Trace Elements|trace elements|mesh-ancestor
25218981|NCT02666417|Micronutrients|micronutrients|mesh-ancestor
25218982|NCT02666417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218983|NCT02666092|Antibodies|antibodies|mesh-list
25218984|NCT02666092|Immunologic Factors|immunologic factors|mesh-ancestor
25218985|NCT02666092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25218986|NCT02666157|Rivaroxaban|rivaroxaban|mesh-list
25218987|NCT02666157|Apixaban|apixaban|mesh-list
25218988|NCT02666157|Dabigatran|dabigatran|mesh-list
25218989|NCT02666157|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25218990|NCT02666157|Antithrombins|antithrombins|mesh-ancestor
25218991|NCT02666157|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25218992|NCT02666157|Protease Inhibitors|protease inhibitors|mesh-ancestor
25218993|NCT02666157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832685|NCT02172014|Citric Acid|citric acid|mesh-list
24832686|NCT02172014|Sodium Citrate|sodium citrate|mesh-list
24832687|NCT02172014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24832688|NCT02172014|Narcotics|narcotics|mesh-ancestor
24832689|NCT02172014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24832690|NCT02172014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832691|NCT02172014|Analgesics|analgesics|mesh-ancestor
25085182|NCT03300960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25085183|NCT03300960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085184|NCT03300960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25085185|NCT03300960|Contraceptive Agents|contraceptive agents|mesh-ancestor
25085186|NCT03300960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25085187|NCT03300960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25085188|NCT03300960|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25085189|NCT03300960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25085190|NCT03300960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25085191|NCT03300765|Apatinib|apatinib|mesh-list
25085192|NCT03300765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511793|NCT00570934|Vitamin D|vitamin d|mesh-list
25085193|NCT03300765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25085194|NCT03300765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085195|NCT03300765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085196|NCT03300609|Calcium, Dietary|calcium, dietary|mesh-list
25085197|NCT03300609|Leucovorin|leucovorin|mesh-list
25085198|NCT03300609|Folic Acid|folic acid|mesh-list
25085199|NCT03300609|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
25085200|NCT03300609|Tetrahydrofolates|tetrahydrofolates|mesh-list
25085201|NCT03300609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25085202|NCT03300609|Panitumumab|panitumumab|mesh-list
25085203|NCT03300609|Fluorouracil|fluorouracil|mesh-list
25085204|NCT03300609|Capecitabine|capecitabine|mesh-list
25085205|NCT03300609|Oxaliplatin|oxaliplatin|mesh-list
25085206|NCT03300609|Antibodies|antibodies|mesh-list
25085207|NCT03300609|Immunoglobulins|immunoglobulins|mesh-list
25085208|NCT03300609|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25085209|NCT03300609|Calcium|calcium|mesh-list
25085210|NCT03300609|Levoleucovorin|levoleucovorin|mesh-list
25085211|NCT03300609|Immunologic Factors|immunologic factors|mesh-ancestor
25085212|NCT03300609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085213|NCT03300609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25085214|NCT03300609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25085215|NCT03300609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25085216|NCT03300609|Antimetabolites|antimetabolites|mesh-ancestor
25085217|NCT03300609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085218|NCT03300609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25085219|NCT03300609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25218994|NCT02666157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25218995|NCT02666157|Anticoagulants|anticoagulants|mesh-ancestor
25218996|NCT02666053|Fostemsavir|fostemsavir|mesh-list
25218997|NCT02666053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25218998|NCT02666053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25218999|NCT02666053|Antiviral Agents|antiviral agents|mesh-ancestor
25219000|NCT02666053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25219002|NCT02666053|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25219003|NCT02666053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219004|NCT02666040|Anesthetics|anesthetics|mesh-list
25219005|NCT02666040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25219006|NCT02666040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219007|NCT02665806|Fluticasone|fluticasone|mesh-list
25219008|NCT02665806|Ciclesonide|ciclesonide|mesh-list
25219009|NCT02665806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25219010|NCT02665806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25219011|NCT02665806|Autonomic Agents|autonomic agents|mesh-ancestor
25085220|NCT03300609|Antidotes|antidotes|mesh-ancestor
24629369|NCT01104844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629394|NCT01105013|Miconazole|miconazole|mesh-list
24629395|NCT01105013|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24629401|NCT01105013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629402|NCT01105013|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24629403|NCT01105013|Hormone Antagonists|hormone antagonists|mesh-ancestor
24629404|NCT01105013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24629423|NCT01105273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629424|NCT01105273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24629425|NCT01105273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24629426|NCT01105273|Alkylating Agents|alkylating agents|mesh-ancestor
24629427|NCT01105273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085221|NCT03300609|Protective Agents|protective agents|mesh-ancestor
25085222|NCT03300609|Vitamin B Complex|vitamin b complex|mesh-ancestor
25085223|NCT03300609|Vitamins|vitamins|mesh-ancestor
25085224|NCT03300609|Micronutrients|micronutrients|mesh-ancestor
25085225|NCT03300609|Hematinics|hematinics|mesh-ancestor
25085226|NCT03300531|Betamethasone|betamethasone|mesh-list
25085227|NCT03300531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25085228|NCT03300531|Glucocorticoids|glucocorticoids|mesh-ancestor
25085229|NCT03300531|Hormones|hormones|mesh-ancestor
25405116|NCT03630159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25085231|NCT03300531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085232|NCT03300531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25085233|NCT03300531|Respiratory System Agents|respiratory system agents|mesh-ancestor
24760395|NCT01757860|Vitamins|vitamins|mesh-ancestor
25085234|NCT03300440|Vitamins|vitamins|mesh-list
25085236|NCT03300440|Vitamin B Complex|vitamin b complex|mesh-list
25085237|NCT03300440|Micronutrients|micronutrients|mesh-ancestor
25085238|NCT03300440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085241|NCT03300362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085242|NCT03300115|Abivertinib|abivertinib|mesh-list
25085243|NCT03300115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25085244|NCT03300115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085245|NCT03300115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629431|NCT01105286|Calcipotriene|calcipotriene|mesh-list
24629432|NCT01105286|Vitamins|vitamins|mesh-ancestor
24629433|NCT01105286|Micronutrients|micronutrients|mesh-ancestor
24629434|NCT01105286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629435|NCT01105286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24629436|NCT01105286|Dermatologic Agents|dermatologic agents|mesh-ancestor
24629438|NCT01105299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24629439|NCT01105299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629440|NCT01105299|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24629441|NCT01105299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24629442|NCT01105299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423018|NCT00224445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24423108|NCT00224679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423109|NCT00224679|Antipyretics|antipyretics|mesh-ancestor
24629443|NCT01105299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629444|NCT01105299|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24629445|NCT01105299|Hormone Antagonists|hormone antagonists|mesh-ancestor
24629446|NCT01105299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24629447|NCT01105299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629448|NCT01105338|Lycopene|lycopene|mesh-list
24629458|NCT01105351|Vitamin B Complex|vitamin b complex|mesh-list
25085246|NCT03300089|Anesthetics|anesthetics|mesh-list
25085247|NCT03300089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25085248|NCT03300089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085258|NCT03299842|Serotonin Agents|serotonin agents|mesh-ancestor
25085259|NCT03299842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085260|NCT03299829|Trientine|trientine|mesh-list
25085261|NCT03299829|Chelating Agents|chelating agents|mesh-ancestor
25085262|NCT03299829|Sequestering Agents|sequestering agents|mesh-ancestor
25085263|NCT03299829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085264|NCT03299725|Bismuth|bismuth|mesh-list
25085265|NCT03299725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085266|NCT03299725|Antacids|antacids|mesh-ancestor
25085267|NCT03299725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25085268|NCT03299712|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
25085269|NCT03299712|Vasodilator Agents|vasodilator agents|mesh-ancestor
25085270|NCT03299712|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25085271|NCT03299712|Protective Agents|protective agents|mesh-ancestor
25085272|NCT03299712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085273|NCT03299621|Rocuronium|rocuronium|mesh-list
25085274|NCT03299621|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25085275|NCT03299621|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25085276|NCT03299621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25085277|NCT03299621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25085278|NCT03299621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085279|NCT03299517|Lidocaine|lidocaine|mesh-list
25085280|NCT03299517|Amiodarone|amiodarone|mesh-list
25085281|NCT03299517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
24629459|NCT01105351|Hematinics|hematinics|mesh-ancestor
25085282|NCT03299517|Anesthetics, Local|anesthetics, local|mesh-ancestor
25085283|NCT03299517|Anesthetics|anesthetics|mesh-ancestor
25085284|NCT03299517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25085285|NCT03299517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456314|NCT00330824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24456315|NCT00330902|Artesunate|artesunate|mesh-list
24456316|NCT00330902|Pyrimethamine|pyrimethamine|mesh-list
24456317|NCT00330902|Primaquine|primaquine|mesh-list
25085356|NCT03298906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25219017|NCT02665806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25219018|NCT02665806|Glucocorticoids|glucocorticoids|mesh-ancestor
25219019|NCT02665806|Hormones|hormones|mesh-ancestor
25219020|NCT02665806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25085358|NCT03298906|Purinergic Agents|purinergic agents|mesh-ancestor
25085359|NCT03298906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25085360|NCT03298906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085361|NCT03298906|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25085362|NCT03298906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25085363|NCT03298906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085364|NCT03298854|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
25085365|NCT03298854|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25085366|NCT03298854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085370|NCT03298698|Prednisolone|prednisolone|mesh-list
25085371|NCT03298698|Rituximab|rituximab|mesh-list
25085372|NCT03298698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25085373|NCT03298698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25085374|NCT03298698|Immunologic Factors|immunologic factors|mesh-ancestor
25085375|NCT03298698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085376|NCT03298698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25085377|NCT03298698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25085378|NCT03298698|Glucocorticoids|glucocorticoids|mesh-ancestor
25085379|NCT03298698|Hormones|hormones|mesh-ancestor
25085380|NCT03298698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25085381|NCT03298698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25085382|NCT03298646|Diclofenac|diclofenac|mesh-list
25085383|NCT03298646|Lidocaine|lidocaine|mesh-list
25085384|NCT03298646|Anesthetics, Local|anesthetics, local|mesh-ancestor
25085385|NCT03298646|Anesthetics|anesthetics|mesh-ancestor
25085386|NCT03298646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25085387|NCT03298646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085388|NCT03298646|Sensory System Agents|sensory system agents|mesh-ancestor
25085389|NCT03298646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24629460|NCT01105351|Vitamins|vitamins|mesh-ancestor
24629461|NCT01105351|Micronutrients|micronutrients|mesh-ancestor
24979039|NCT01761890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085390|NCT03298646|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25085391|NCT03298646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25085392|NCT03298646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25085393|NCT03298646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25085394|NCT03298646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085395|NCT03298646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25085396|NCT03298646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25085397|NCT03298646|Analgesics|analgesics|mesh-ancestor
25085398|NCT03298646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25085399|NCT03298646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25085400|NCT03298646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25085401|NCT03298646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085402|NCT03298581|Clobetasol|clobetasol|mesh-list
25085403|NCT03298581|Halobetasol|halobetasol|mesh-list
25085404|NCT03298581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25219021|NCT02666001|Fostemsavir|fostemsavir|mesh-list
25219022|NCT02666001|Buprenorphine|buprenorphine|mesh-list
25219023|NCT02666001|Methadone|methadone|mesh-list
25219024|NCT02666001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25219025|NCT02666001|Narcotics|narcotics|mesh-ancestor
25219026|NCT02666001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25219027|NCT02666001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219028|NCT02666001|Analgesics|analgesics|mesh-ancestor
25219029|NCT02666001|Sensory System Agents|sensory system agents|mesh-ancestor
25219030|NCT02666001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25219031|NCT02666001|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25219032|NCT02666001|Antitussive Agents|antitussive agents|mesh-ancestor
25219033|NCT02666001|Respiratory System Agents|respiratory system agents|mesh-ancestor
25085405|NCT03298581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25085406|NCT03298581|Glucocorticoids|glucocorticoids|mesh-ancestor
25085407|NCT03298581|Hormones|hormones|mesh-ancestor
25085408|NCT03298581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25085415|NCT03298542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085416|NCT03298516|Azacitidine|azacitidine|mesh-list
25085417|NCT03298516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25085419|NCT03298516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085420|NCT03298516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25085421|NCT03298516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085427|NCT03298373|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
25085428|NCT03298373|Androgens|androgens|mesh-ancestor
25085429|NCT03298373|Hormones|hormones|mesh-ancestor
25085430|NCT03298373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25085431|NCT03298373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085432|NCT03298373|Anabolic Agents|anabolic agents|mesh-ancestor
25085433|NCT03298373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25085434|NCT03298347|Caffeine|caffeine|mesh-list
25085435|NCT03298347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25085436|NCT03298347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085437|NCT03298347|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25085438|NCT03298347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085439|NCT03298347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085440|NCT03298347|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25085441|NCT03298347|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24760632|NCT01759394|Maleic acid|maleic acid|mesh-list
24423230|NCT00225173|Etoposide|etoposide|mesh-list
25085442|NCT03298347|Purinergic Agents|purinergic agents|mesh-ancestor
25085443|NCT03298347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25085444|NCT03298321|Azacitidine|azacitidine|mesh-list
25085445|NCT03298321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25085446|NCT03298321|Antimetabolites|antimetabolites|mesh-ancestor
25085447|NCT03298321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085448|NCT03298321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25085449|NCT03298321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085450|NCT03298295|Insulin|insulin|mesh-list
25085451|NCT03298295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25085452|NCT03298295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085453|NCT03298191|Magnesium Sulfate|magnesium sulfate|mesh-list
25085454|NCT03298191|Calcium Channel Blockers|calcium channel blockers|mesh-list
25085455|NCT03298191|Ritodrine|ritodrine|mesh-list
25085456|NCT03298191|Calcium|calcium|mesh-list
25085457|NCT03298191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25085466|NCT03298191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25085467|NCT03298191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085468|NCT03298191|Tocolytic Agents|tocolytic agents|mesh-ancestor
25085469|NCT03298191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25085470|NCT03298191|Sympathomimetics|sympathomimetics|mesh-ancestor
25085471|NCT03298191|Autonomic Agents|autonomic agents|mesh-ancestor
25085472|NCT03298191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25085473|NCT03298191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25085474|NCT03298191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25085475|NCT03298191|Adrenergic Agents|adrenergic agents|mesh-ancestor
25085476|NCT03298191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25085478|NCT03298074|Apatinib|apatinib|mesh-list
25085479|NCT03298074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25085480|NCT03298074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25085481|NCT03298074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25085482|NCT03298074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25085483|NCT03298074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085484|NCT03298074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085485|NCT03298074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25085501|NCT03297502|Pimecrolimus|pimecrolimus|mesh-list
25219034|NCT02666001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25219035|NCT02666001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25219036|NCT02666001|Antiviral Agents|antiviral agents|mesh-ancestor
25219037|NCT02666001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25085508|NCT03297502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085509|NCT03297502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25085515|NCT03297502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423331|NCT00225511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662792|NCT01296958|Antinematodal Agents|antinematodal agents|mesh-ancestor
24423332|NCT00225511|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24423333|NCT00225511|Antidepressive Agents|antidepressive agents|mesh-ancestor
24423334|NCT00225511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25085516|NCT03297502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085518|NCT03297463|Interleukin-2|interleukin-2|mesh-list
25085519|NCT03297463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25085520|NCT03297463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25085521|NCT03297463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25085522|NCT03297463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085523|NCT03297463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25085524|NCT03297463|Analgesics|analgesics|mesh-ancestor
25085525|NCT03297463|Sensory System Agents|sensory system agents|mesh-ancestor
25085526|NCT03297463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25085527|NCT03297463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085528|NCT03297359|Dalteparin|dalteparin|mesh-list
25085529|NCT03297359|Tinzaparin|tinzaparin|mesh-list
25085530|NCT03297359|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25085531|NCT03297359|Anticoagulants|anticoagulants|mesh-ancestor
25085532|NCT03297359|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25085533|NCT03297359|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25085534|NCT03297359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085535|NCT03297073|Acetaminophen|acetaminophen|mesh-list
24629462|NCT01105351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629463|NCT01105390|Pemetrexed|pemetrexed|mesh-list
24629477|NCT01105481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24629478|NCT01105481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629479|NCT01105481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24629480|NCT01105481|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24629481|NCT01105481|Dopamine Agents|dopamine agents|mesh-ancestor
24629482|NCT01105481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25085536|NCT03297073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25085537|NCT03297073|Analgesics|analgesics|mesh-ancestor
25085538|NCT03297073|Sensory System Agents|sensory system agents|mesh-ancestor
25085539|NCT03297073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25085540|NCT03297073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085541|NCT03297073|Antipyretics|antipyretics|mesh-ancestor
25085542|NCT03296982|Enoxaparin|enoxaparin|mesh-list
25085543|NCT03296982|Edoxaban|edoxaban|mesh-list
25085544|NCT03296982|Anticoagulants|anticoagulants|mesh-ancestor
24746347|NCT05437575|Narcotics|narcotics|mesh-ancestor
24629490|NCT01105598|Antimetabolites|antimetabolites|mesh-ancestor
24629491|NCT01105598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629492|NCT01105598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24629493|NCT01105598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423610|NCT00226421|Analgesics|analgesics|mesh-ancestor
24423611|NCT00226421|Sensory System Agents|sensory system agents|mesh-ancestor
24832692|NCT02172014|Sensory System Agents|sensory system agents|mesh-ancestor
24832693|NCT02172014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24832694|NCT02172014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24643767|NCT01187212|Sorafenib|sorafenib|mesh-list
24629498|NCT01105611|Raltegravir Potassium|raltegravir potassium|mesh-list
25085556|NCT03296930|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25085557|NCT03296930|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25085558|NCT03296930|Protease Inhibitors|protease inhibitors|mesh-ancestor
25085559|NCT03296930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085573|NCT03296657|Fluorides|fluorides|mesh-list
25085574|NCT03296657|Tin Fluorides|tin fluorides|mesh-list
25085575|NCT03296657|Cariostatic Agents|cariostatic agents|mesh-ancestor
25085576|NCT03296657|Protective Agents|protective agents|mesh-ancestor
25085577|NCT03296657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085578|NCT03296579|Magnesium Sulfate|magnesium sulfate|mesh-list
25085579|NCT03296579|Aminophylline|aminophylline|mesh-list
25085580|NCT03296579|Albuterol|albuterol|mesh-list
25085581|NCT03296579|Ipratropium|ipratropium|mesh-list
25085582|NCT03296579|Analgesics|analgesics|mesh-ancestor
25085583|NCT03296579|Sensory System Agents|sensory system agents|mesh-ancestor
25679328|NCT01836471|Growth Substances|growth substances|mesh-ancestor
25405117|NCT03629613|Antioxidants|antioxidants|mesh-list
25085584|NCT03296579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25085585|NCT03296579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085586|NCT03296579|Anesthetics|anesthetics|mesh-ancestor
25085587|NCT03296579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25085600|NCT03296579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25085601|NCT03296579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25085602|NCT03296579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25219051|NCT02665936|Glucocorticoids|glucocorticoids|mesh-ancestor
25219052|NCT02665936|Hormones|hormones|mesh-ancestor
25219053|NCT02665936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25219054|NCT02665936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25219055|NCT02665936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219056|NCT02665936|Protease Inhibitors|protease inhibitors|mesh-ancestor
25219057|NCT02665936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219058|NCT02665936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219059|NCT02665936|Anesthetics, Local|anesthetics, local|mesh-ancestor
25219060|NCT02665936|Anesthetics|anesthetics|mesh-ancestor
25085604|NCT03296579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25085605|NCT03296579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25085606|NCT03296579|Cholinergic Agents|cholinergic agents|mesh-ancestor
25085607|NCT03296579|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25085608|NCT03296579|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25085609|NCT03296579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085610|NCT03296579|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24531406|NCT00635726|Cisplatin|cisplatin|mesh-list
24629515|NCT01105793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24629518|NCT01105819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24629519|NCT01105819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24629520|NCT01105819|Disinfectants|disinfectants|mesh-ancestor
24629521|NCT01105832|Teriparatide|teriparatide|mesh-list
24629522|NCT01105832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24629523|NCT01105832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629524|NCT01105832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24629525|NCT01105871|Naloxone|naloxone|mesh-list
24629526|NCT01105871|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24629527|NCT01105871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629557|NCT01106118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629559|NCT01106131|Pioglitazone|pioglitazone|mesh-list
24629560|NCT01106131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24629561|NCT01106131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629562|NCT01106235|Aldesleukin|aldesleukin|mesh-list
24629563|NCT01106235|Cyclophosphamide|cyclophosphamide|mesh-list
24629564|NCT01106235|Interleukin-2|interleukin-2|mesh-list
25219132|NCT02665533|Antiemetics|antiemetics|mesh-ancestor
24629565|NCT01106235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24629566|NCT01106235|Immunologic Factors|immunologic factors|mesh-ancestor
24629567|NCT01106235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629568|NCT01106235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24629569|NCT01106235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24629570|NCT01106235|Alkylating Agents|alkylating agents|mesh-ancestor
25219061|NCT02665936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25219062|NCT02665936|Sensory System Agents|sensory system agents|mesh-ancestor
25219064|NCT02665871|Immunologic Factors|immunologic factors|mesh-ancestor
25219065|NCT02665871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219066|NCT02665845|Mesalamine|mesalamine|mesh-list
25219067|NCT02665845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25219068|NCT02665845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25219069|NCT02665845|Analgesics|analgesics|mesh-ancestor
25219070|NCT02665845|Sensory System Agents|sensory system agents|mesh-ancestor
25219071|NCT02665845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25219072|NCT02665845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219073|NCT02665845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25219074|NCT02665845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25219075|NCT02665780|Cetylpyridinium|cetylpyridinium|mesh-list
25219076|NCT02665780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25219077|NCT02665780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25219078|NCT02665832|Amlodipine|amlodipine|mesh-list
24863276|NCT02086552|Lenalidomide|lenalidomide|mesh-list
24629571|NCT01106235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629579|NCT01106235|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24629580|NCT01106235|Antiviral Agents|antiviral agents|mesh-ancestor
24629602|NCT01106547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24629603|NCT01106547|Glucocorticoids|glucocorticoids|mesh-ancestor
24629604|NCT01106547|Hormones|hormones|mesh-ancestor
24629605|NCT01106547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24629606|NCT01106547|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24629607|NCT01106547|Protective Agents|protective agents|mesh-ancestor
24629608|NCT01106547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24629609|NCT01106547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629610|NCT01106716|Lidocaine|lidocaine|mesh-list
25085611|NCT03296579|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25085612|NCT03296579|Purinergic Agents|purinergic agents|mesh-ancestor
25085613|NCT03296579|Protective Agents|protective agents|mesh-ancestor
25085614|NCT03296540|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25085615|NCT03296540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25085616|NCT03296488|Fentanyl|fentanyl|mesh-list
25085617|NCT03296488|Nalbuphine|nalbuphine|mesh-list
25085618|NCT03296488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25085619|NCT03296488|Narcotics|narcotics|mesh-ancestor
25085620|NCT03296488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25085621|NCT03296488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085622|NCT03296488|Analgesics|analgesics|mesh-ancestor
25085623|NCT03296488|Sensory System Agents|sensory system agents|mesh-ancestor
25085624|NCT03296488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25085625|NCT03296488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25085626|NCT03296488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25085627|NCT03296488|Anesthetics, General|anesthetics, general|mesh-ancestor
25085628|NCT03296488|Anesthetics|anesthetics|mesh-ancestor
25085629|NCT03296410|Vaccines|vaccines|mesh-list
25085630|NCT03296410|Immunologic Factors|immunologic factors|mesh-ancestor
25085631|NCT03296410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085633|NCT03296358|Prednisolone|prednisolone|mesh-list
25085634|NCT03296358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25085635|NCT03296358|Antiemetics|antiemetics|mesh-ancestor
25085636|NCT03296358|Autonomic Agents|autonomic agents|mesh-ancestor
25085637|NCT03296358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25085638|NCT03296358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629611|NCT01106716|Anesthetics, Local|anesthetics, local|mesh-ancestor
24629612|NCT01106716|Anesthetics|anesthetics|mesh-ancestor
24629613|NCT01106716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24629614|NCT01106716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629615|NCT01106716|Sensory System Agents|sensory system agents|mesh-ancestor
24629616|NCT01106716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24629617|NCT01106716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24629618|NCT01106716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24629619|NCT01106716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24629620|NCT01106716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24629621|NCT01106716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629622|NCT01106872|Gemcitabine|gemcitabine|mesh-list
24629623|NCT01106872|Bevacizumab|bevacizumab|mesh-list
24629624|NCT01106872|Docetaxel|docetaxel|mesh-list
24629625|NCT01106872|Valproic Acid|valproic acid|mesh-list
24979237|NCT05064332|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24629626|NCT01106872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24629627|NCT01106872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629628|NCT01106872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24629629|NCT01106872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24629630|NCT01106872|Growth Substances|growth substances|mesh-ancestor
24629830|NCT01108055|Antimitotic Agents|antimitotic agents|mesh-ancestor
24629638|NCT01106872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219080|NCT02665832|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25219081|NCT02665832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25219082|NCT02665832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25042462|NCT01437735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25042463|NCT01437735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042464|NCT01437735|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25042465|NCT01437735|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25042466|NCT01437735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042468|NCT01436032|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25042469|NCT01436032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25042470|NCT01436032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25042471|NCT01436032|Analgesics|analgesics|mesh-ancestor
25042472|NCT01436032|Sensory System Agents|sensory system agents|mesh-ancestor
25042473|NCT01436032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25042474|NCT01436032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629639|NCT01106872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24629640|NCT01106872|Immunologic Factors|immunologic factors|mesh-ancestor
24629641|NCT01106872|Tubulin Modulators|tubulin modulators|mesh-ancestor
24629642|NCT01106872|Antimitotic Agents|antimitotic agents|mesh-ancestor
24629643|NCT01106872|Mitosis Modulators|mitosis modulators|mesh-ancestor
24629644|NCT01106872|Anticonvulsants|anticonvulsants|mesh-ancestor
24629645|NCT01106872|GABA Agents|gaba agents|mesh-ancestor
24629646|NCT01106872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24629699|NCT01107145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105963|NCT04718025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24621224|NCT01061112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24629701|NCT01107145|Filaricides|filaricides|mesh-ancestor
24629702|NCT01107145|Antinematodal Agents|antinematodal agents|mesh-ancestor
24629703|NCT01107223|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24629704|NCT01107223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24629705|NCT01107223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24629706|NCT01107223|Antitubercular Agents|antitubercular agents|mesh-ancestor
25085670|NCT03296137|Aldesleukin|aldesleukin|mesh-list
25085671|NCT03296137|Cyclophosphamide|cyclophosphamide|mesh-list
25085672|NCT03296137|Nivolumab|nivolumab|mesh-list
25085673|NCT03296137|Ipilimumab|ipilimumab|mesh-list
25085674|NCT03296137|Fludarabine phosphate|fludarabine phosphate|mesh-list
25085675|NCT03296137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25085676|NCT03296137|Immunologic Factors|immunologic factors|mesh-ancestor
25085677|NCT03296137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085678|NCT03296137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25085679|NCT03296137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25085680|NCT03296137|Alkylating Agents|alkylating agents|mesh-ancestor
25085681|NCT03296137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085682|NCT03296137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25085683|NCT03296137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25085684|NCT03296137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25085685|NCT03296137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25085686|NCT03296137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25219083|NCT02665832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25219084|NCT02665832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219085|NCT02665832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24629831|NCT01108055|Mitosis Modulators|mitosis modulators|mesh-ancestor
25219094|NCT02665832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25219096|NCT02666014|Neostigmine|neostigmine|mesh-list
25219097|NCT02666014|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25042477|NCT01436032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24944296|NCT03961503|Vancomycin|vancomycin|mesh-list
25105964|NCT04718025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24424226|NCT00228358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424227|NCT00228358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24424228|NCT00228358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24424229|NCT00228358|Analgesics|analgesics|mesh-ancestor
24424230|NCT00228358|Sensory System Agents|sensory system agents|mesh-ancestor
24424231|NCT00228358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24424232|NCT00228397|Sirolimus|sirolimus|mesh-list
25085687|NCT03296137|Antimetabolites|antimetabolites|mesh-ancestor
25085688|NCT03296137|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25085689|NCT03296137|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25085690|NCT03296137|Antiviral Agents|antiviral agents|mesh-ancestor
24505125|NCT00540085|Rocuronium|rocuronium|mesh-list
24629730|NCT01107509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24629731|NCT01107509|Immunologic Factors|immunologic factors|mesh-ancestor
24629732|NCT01107509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629733|NCT01107522|Temozolomide|temozolomide|mesh-list
25085691|NCT03296137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25085693|NCT03296098|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25085694|NCT03296098|Contraceptive Agents|contraceptive agents|mesh-ancestor
25085695|NCT03296098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25085696|NCT03296098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085697|NCT03296098|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25085698|NCT03295968|Ibuprofen|ibuprofen|mesh-list
25085699|NCT03295968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25085700|NCT03295968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25085701|NCT03295968|Analgesics|analgesics|mesh-ancestor
25085702|NCT03295968|Sensory System Agents|sensory system agents|mesh-ancestor
25085703|NCT03295968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24760980|NCT01760642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24629734|NCT01107522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24629735|NCT01107522|Alkylating Agents|alkylating agents|mesh-ancestor
24629770|NCT01107782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629772|NCT01107808|Calcium, Dietary|calcium, dietary|mesh-list
24629774|NCT01107808|Ergocalciferols|ergocalciferols|mesh-list
24629775|NCT01107808|Metformin|metformin|mesh-list
24629776|NCT01107808|Calcium|calcium|mesh-list
24629777|NCT01107808|Vitamins|vitamins|mesh-ancestor
24629821|NCT01108042|Antimetabolites|antimetabolites|mesh-ancestor
24629822|NCT01108042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24629823|NCT01108042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24629824|NCT01108042|Immunologic Factors|immunologic factors|mesh-ancestor
24629825|NCT01108042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629826|NCT01108055|Paclitaxel|paclitaxel|mesh-list
24629827|NCT01108055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24629828|NCT01108055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629829|NCT01108055|Tubulin Modulators|tubulin modulators|mesh-ancestor
24456382|NCT00331058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24456383|NCT00331058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456384|NCT00331058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24456387|NCT00331071|Ortho Evra|ortho evra|mesh-list
25085704|NCT03295968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085705|NCT03295968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25085706|NCT03295968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25219098|NCT02666014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219099|NCT02666014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219100|NCT02666014|Cholinergic Agents|cholinergic agents|mesh-ancestor
25219101|NCT02666014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25219102|NCT02666014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219103|NCT02666014|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25219104|NCT02666014|Autonomic Agents|autonomic agents|mesh-ancestor
25219105|NCT02666014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25219106|NCT02665702|Cisplatin|cisplatin|mesh-list
25219107|NCT02665702|Vinorelbine|vinorelbine|mesh-list
25085707|NCT03295968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25085716|NCT03295955|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25085717|NCT03295955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085718|NCT03295955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085720|NCT03295903|Anticonvulsants|anticonvulsants|mesh-ancestor
25085721|NCT03295851|Iron|iron|mesh-list
25085722|NCT03295851|Ferrous fumarate|ferrous fumarate|mesh-list
25085723|NCT03295851|Trace Elements|trace elements|mesh-ancestor
25085724|NCT03295851|Micronutrients|micronutrients|mesh-ancestor
24979263|NCT04938024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979264|NCT04938024|Antioxidants|antioxidants|mesh-ancestor
24979282|NCT04855526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24979283|NCT04855526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979284|NCT04855526|Hormones|hormones|mesh-ancestor
25679329|NCT01836523|Liraglutide|liraglutide|mesh-list
24979285|NCT04855526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24979286|NCT04842552|Hydralazine|hydralazine|mesh-list
25085725|NCT03295851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085726|NCT03295825|Heparin|heparin|mesh-list
25085727|NCT03295825|Anticoagulants|anticoagulants|mesh-ancestor
25085731|NCT03295786|Dopamine|dopamine|mesh-list
25085744|NCT03295760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085745|NCT03295760|Vitamins|vitamins|mesh-ancestor
25085746|NCT03295695|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25085747|NCT03295695|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25085748|NCT03295695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085749|NCT03295487|Estrogens|estrogens|mesh-list
25085750|NCT03295487|Hormones|hormones|mesh-ancestor
25085751|NCT03295487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25085752|NCT03295487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085753|NCT03295461|Chlorhexidine|chlorhexidine|mesh-list
25085754|NCT03295461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25085755|NCT03295461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25085756|NCT03295461|Disinfectants|disinfectants|mesh-ancestor
25085757|NCT03295383|Cyclophosphamide|cyclophosphamide|mesh-list
25085758|NCT03295383|Rituximab|rituximab|mesh-list
25085759|NCT03295383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25085760|NCT03295383|Immunologic Factors|immunologic factors|mesh-ancestor
25085761|NCT03295383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085762|NCT03295383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25085763|NCT03295383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25085764|NCT03295383|Alkylating Agents|alkylating agents|mesh-ancestor
25085765|NCT03295383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085766|NCT03295383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25085767|NCT03295383|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25085768|NCT03295383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25085769|NCT03295227|Pembrolizumab|pembrolizumab|mesh-list
25219108|NCT02665702|Endostar protein|endostar protein|mesh-list
25219109|NCT02665702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219110|NCT02665702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25219111|NCT02665702|Tubulin Modulators|tubulin modulators|mesh-ancestor
25219112|NCT02665702|Antimitotic Agents|antimitotic agents|mesh-ancestor
25219113|NCT02665702|Mitosis Modulators|mitosis modulators|mesh-ancestor
25219114|NCT02665702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219115|NCT02665702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25219116|NCT02665702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25219117|NCT02665702|Growth Substances|growth substances|mesh-ancestor
25219118|NCT02665702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219119|NCT02665702|Growth Inhibitors|growth inhibitors|mesh-ancestor
25272996|NCT02388061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25272997|NCT02388035|Cefotaxime|cefotaxime|mesh-list
25272998|NCT02388035|Cefoxitin|cefoxitin|mesh-list
25272999|NCT02388035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25273000|NCT02388035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25273001|NCT02387892|Vitamin D|vitamin d|mesh-list
25273002|NCT02387892|Cholecalciferol|cholecalciferol|mesh-list
25219133|NCT02665533|Autonomic Agents|autonomic agents|mesh-ancestor
24832702|NCT02172014|GABA Modulators|gaba modulators|mesh-ancestor
24832704|NCT02172014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24832705|NCT02172014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629832|NCT01108055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629833|NCT01108107|Capecitabine|capecitabine|mesh-list
24629834|NCT01108107|Oxaliplatin|oxaliplatin|mesh-list
24629835|NCT01108107|Panitumumab|panitumumab|mesh-list
24629836|NCT01108107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24629837|NCT01108107|Antimetabolites|antimetabolites|mesh-ancestor
24629838|NCT01108107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629887|NCT01108588|Clopidogrel|clopidogrel|mesh-list
24629888|NCT01108588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24629889|NCT01108588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24629890|NCT01108588|Analgesics|analgesics|mesh-ancestor
24629891|NCT01108588|Sensory System Agents|sensory system agents|mesh-ancestor
24629892|NCT01108588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24629893|NCT01108588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629894|NCT01108588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24629895|NCT01108588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24629896|NCT01108588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24629897|NCT01108588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24746788|NCT03537014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085785|NCT03295110|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25085787|NCT03295084|Irinotecan|irinotecan|mesh-list
25085788|NCT03295084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25085789|NCT03295084|Antimetabolites|antimetabolites|mesh-ancestor
25085790|NCT03295084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085791|NCT03295084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25085792|NCT03295084|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25085793|NCT03295084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25085794|NCT03295084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085795|NCT03294967|Vitamin E|vitamin e|mesh-list
25085796|NCT03294967|Caffeine|caffeine|mesh-list
25085797|NCT03294967|Vitamins|vitamins|mesh-ancestor
24424786|NCT00230776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424812|NCT00230867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24424815|NCT00230958|Interferon-alpha|interferon-alpha|mesh-list
24424816|NCT00230958|Interferon alpha-2|interferon alpha-2|mesh-list
24424817|NCT00230958|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24424818|NCT00230958|Taribavirin|taribavirin|mesh-list
24424819|NCT00230958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424820|NCT00230958|Antiviral Agents|antiviral agents|mesh-ancestor
24424821|NCT00230958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25085801|NCT03294967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25085802|NCT03294967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219120|NCT02665650|Pembrolizumab|pembrolizumab|mesh-list
25219121|NCT02665650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25219122|NCT02665650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219123|NCT02665637|Trastuzumab|trastuzumab|mesh-list
25219124|NCT02665637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25219125|NCT02665637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219126|NCT02665533|Dexamethasone|dexamethasone|mesh-list
25219127|NCT02665533|Dexamethasone acetate|dexamethasone acetate|mesh-list
25219128|NCT02665533|Diclofenac|diclofenac|mesh-list
25219129|NCT02665533|Codeine|codeine|mesh-list
25219130|NCT02665533|BB 1101|bb 1101|mesh-list
25219131|NCT02665533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25219134|NCT02665533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24832706|NCT02172014|Anticoagulants|anticoagulants|mesh-ancestor
24832707|NCT02172014|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24832708|NCT02172014|Chelating Agents|chelating agents|mesh-ancestor
24832709|NCT02172014|Sequestering Agents|sequestering agents|mesh-ancestor
25052123|NCT00327743|Antimetabolites|antimetabolites|mesh-ancestor
25085803|NCT03294967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085804|NCT03294967|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25085805|NCT03294967|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25085806|NCT03294967|Purinergic Agents|purinergic agents|mesh-ancestor
25085807|NCT03294967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25085808|NCT03294967|Antioxidants|antioxidants|mesh-ancestor
25085809|NCT03294967|Protective Agents|protective agents|mesh-ancestor
25085810|NCT03294798|Interferons|interferons|mesh-list
24424822|NCT00230958|Antimetabolites|antimetabolites|mesh-ancestor
24424901|NCT00231244|Sirolimus|sirolimus|mesh-list
24425056|NCT00231829|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24425057|NCT00231829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24425058|NCT00231829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085861|NCT03294525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25085862|NCT03294525|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25085863|NCT03294525|Analgesics|analgesics|mesh-ancestor
25085864|NCT03294525|Sensory System Agents|sensory system agents|mesh-ancestor
25085865|NCT03294525|Dopamine Agents|dopamine agents|mesh-ancestor
25085866|NCT03294525|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25085896|NCT03294382|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25085897|NCT03294382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25085898|NCT03294382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085899|NCT03294382|Cholinergic Agents|cholinergic agents|mesh-ancestor
25085900|NCT03294382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25085901|NCT03294382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085902|NCT03294382|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25085903|NCT03294382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25085904|NCT03294252|Leucovorin|leucovorin|mesh-list
25085905|NCT03294252|Folic Acid|folic acid|mesh-list
25085906|NCT03294252|Fluorouracil|fluorouracil|mesh-list
25085907|NCT03294252|Oxaliplatin|oxaliplatin|mesh-list
25085908|NCT03294252|Levoleucovorin|levoleucovorin|mesh-list
25085909|NCT03294252|Antimetabolites|antimetabolites|mesh-ancestor
25085910|NCT03294252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219135|NCT02665533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219136|NCT02665533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25219137|NCT02665533|Glucocorticoids|glucocorticoids|mesh-ancestor
25219138|NCT02665533|Hormones|hormones|mesh-ancestor
25219139|NCT02665533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25219140|NCT02665533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25219141|NCT02665533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219142|NCT02665533|Protease Inhibitors|protease inhibitors|mesh-ancestor
25219143|NCT02665533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219144|NCT02665533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219145|NCT02665533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25219146|NCT02665533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25219147|NCT02665533|Analgesics|analgesics|mesh-ancestor
24425269|NCT00232531|Vitamin B Complex|vitamin b complex|mesh-ancestor
25219148|NCT02665533|Sensory System Agents|sensory system agents|mesh-ancestor
24832711|NCT02172105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24832712|NCT02172105|Autonomic Agents|autonomic agents|mesh-ancestor
25052141|NCT00325650|Hormones|hormones|mesh-ancestor
25219221|NCT02664493|Prednisolone|prednisolone|mesh-list
25085911|NCT03294252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25085912|NCT03294252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25085913|NCT03294252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25085914|NCT03294252|Immunologic Factors|immunologic factors|mesh-ancestor
25085915|NCT03294252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085916|NCT03294252|Antidotes|antidotes|mesh-ancestor
25085917|NCT03294252|Protective Agents|protective agents|mesh-ancestor
24551970|NCT04406727|UB-421|ub-421|mesh-list
24761130|NCT01761201|Isoniazid|isoniazid|mesh-list
25085918|NCT03294252|Vitamin B Complex|vitamin b complex|mesh-ancestor
25085919|NCT03294252|Vitamins|vitamins|mesh-ancestor
25085920|NCT03294252|Micronutrients|micronutrients|mesh-ancestor
25085922|NCT03294174|Ropivacaine|ropivacaine|mesh-list
25085923|NCT03294174|Anesthetics, Local|anesthetics, local|mesh-ancestor
25085924|NCT03294174|Anesthetics|anesthetics|mesh-ancestor
25085925|NCT03294174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25085926|NCT03294174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219149|NCT02665533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25219150|NCT02665533|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25219151|NCT02665533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25219152|NCT02665533|Narcotics|narcotics|mesh-ancestor
25219153|NCT02665533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25219154|NCT02665533|Antitussive Agents|antitussive agents|mesh-ancestor
25219155|NCT02665533|Respiratory System Agents|respiratory system agents|mesh-ancestor
25219156|NCT02665624|Calcium, Dietary|calcium, dietary|mesh-list
25219157|NCT02665624|Sennosides|sennosides|mesh-list
25219158|NCT02665624|Senna Extract|senna extract|mesh-list
25219159|NCT02665624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25219160|NCT02665624|Calcium|calcium|mesh-list
24666477|NCT01319370|Minoxidil|minoxidil|mesh-list
25219161|NCT02665624|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25219162|NCT02665624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219163|NCT02665624|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25219164|NCT02665624|Laxatives|laxatives|mesh-ancestor
25219165|NCT02665624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25219166|NCT02665624|Cathartics|cathartics|mesh-ancestor
25219167|NCT02665351|Peramivir|peramivir|mesh-list
25219168|NCT02665351|Antiviral Agents|antiviral agents|mesh-ancestor
25219169|NCT02665351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25219170|NCT02665351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219171|NCT02665351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219172|NCT02665416|Bevacizumab|bevacizumab|mesh-list
25219173|NCT02665416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25219174|NCT02665416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219175|NCT02665416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25219176|NCT02665416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25219177|NCT02665416|Growth Substances|growth substances|mesh-ancestor
25219178|NCT02665416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219179|NCT02665416|Growth Inhibitors|growth inhibitors|mesh-ancestor
25219181|NCT02665208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25219182|NCT02665208|Autonomic Agents|autonomic agents|mesh-ancestor
25219183|NCT02665208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25219184|NCT02665208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219185|NCT02665208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25219186|NCT02665208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25219187|NCT02665208|Cholinergic Agents|cholinergic agents|mesh-ancestor
25219188|NCT02665208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25219189|NCT02665208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219190|NCT02665039|Gemcitabine|gemcitabine|mesh-list
25219191|NCT02665039|Carboplatin|carboplatin|mesh-list
25219192|NCT02665039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219193|NCT02665039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25219194|NCT02665039|Antimetabolites|antimetabolites|mesh-ancestor
25219195|NCT02665039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219196|NCT02665039|Antiviral Agents|antiviral agents|mesh-ancestor
25219197|NCT02665039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25219198|NCT02665039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219199|NCT02665039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25219200|NCT02665039|Immunologic Factors|immunologic factors|mesh-ancestor
25219201|NCT02665039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219202|NCT02664857|Vitamin D|vitamin d|mesh-list
25219203|NCT02664857|Ergocalciferols|ergocalciferols|mesh-list
25219204|NCT02664857|Cholecalciferol|cholecalciferol|mesh-list
25219205|NCT02664857|Vitamins|vitamins|mesh-list
25219206|NCT02664857|Micronutrients|micronutrients|mesh-ancestor
25219207|NCT02664857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219208|NCT02664857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24425989|NCT00234910|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25219209|NCT02664857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25219210|NCT02664649|Apixaban|apixaban|mesh-list
25219211|NCT02664649|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
25219212|NCT02664649|Anticoagulants|anticoagulants|mesh-list
25219213|NCT02664649|Antithrombins|antithrombins|mesh-ancestor
25219214|NCT02664649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25219215|NCT02664649|Protease Inhibitors|protease inhibitors|mesh-ancestor
25219216|NCT02664649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219217|NCT02664649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219218|NCT02664493|Methylprednisolone|methylprednisolone|mesh-list
25219219|NCT02664493|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24832714|NCT02172105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832715|NCT02172105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24832716|NCT02172105|Respiratory System Agents|respiratory system agents|mesh-ancestor
24832717|NCT02172131|Olodaterol|olodaterol|mesh-list
25219220|NCT02664493|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25219222|NCT02664493|Prednisolone acetate|prednisolone acetate|mesh-list
25219223|NCT02664493|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25219224|NCT02664493|Prednisolone phosphate|prednisolone phosphate|mesh-list
25219225|NCT02664493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25219226|NCT02664493|Antiemetics|antiemetics|mesh-ancestor
25219227|NCT02664493|Autonomic Agents|autonomic agents|mesh-ancestor
25219228|NCT02664493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25219229|NCT02664493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219230|NCT02664493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25219231|NCT02664493|Glucocorticoids|glucocorticoids|mesh-ancestor
25219232|NCT02664493|Hormones|hormones|mesh-ancestor
25219233|NCT02664493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25219234|NCT02664493|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25219235|NCT02664493|Protective Agents|protective agents|mesh-ancestor
25219236|NCT02664493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25219237|NCT02664493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219238|NCT02664116|Diclofenac|diclofenac|mesh-list
25219239|NCT02664116|Ketorolac|ketorolac|mesh-list
25219240|NCT02664116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25219241|NCT02664116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25219242|NCT02664116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25219243|NCT02664116|Analgesics|analgesics|mesh-ancestor
25219244|NCT02664116|Sensory System Agents|sensory system agents|mesh-ancestor
25219245|NCT02664116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25219246|NCT02664116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219247|NCT02664116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25219248|NCT02664116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25219249|NCT02664116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25219250|NCT02664116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219251|NCT02664116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219252|NCT02664051|Cromolyn Sodium|cromolyn sodium|mesh-list
25219253|NCT02664051|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
25219254|NCT02664051|Immunologic Factors|immunologic factors|mesh-ancestor
25219255|NCT02664051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219256|NCT02664051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25219257|NCT02664051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25219258|NCT02664051|Respiratory System Agents|respiratory system agents|mesh-ancestor
25219259|NCT02664142|Anesthetics|anesthetics|mesh-list
25219260|NCT02664142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24449476|NCT00315744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449477|NCT00315744|Tocolytic Agents|tocolytic agents|mesh-ancestor
24449478|NCT00315744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24449479|NCT00315835|Buprenorphine|buprenorphine|mesh-list
24449480|NCT00315835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24449481|NCT00315835|Narcotics|narcotics|mesh-ancestor
24449482|NCT00315835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24449483|NCT00315835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449484|NCT00315835|Analgesics|analgesics|mesh-ancestor
24449485|NCT00315835|Sensory System Agents|sensory system agents|mesh-ancestor
24449495|NCT00315848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24449496|NCT00315848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24449498|NCT00315861|Topotecan|topotecan|mesh-list
24449509|NCT00315874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24449510|NCT00315874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219261|NCT02664142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219263|NCT02664168|Laxatives|laxatives|mesh-ancestor
25266781|NCT02426177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25266782|NCT02426177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266783|NCT02426177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25266784|NCT02426177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266785|NCT02426177|Vasodilator Agents|vasodilator agents|mesh-ancestor
24400081|NCT00149617|Buspirone|buspirone|mesh-list
25219264|NCT02664168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25219265|NCT02663960|Citric Acid|citric acid|mesh-list
25219266|NCT02663960|Sodium Citrate|sodium citrate|mesh-list
25219267|NCT02663960|Anticoagulants|anticoagulants|mesh-ancestor
25219268|NCT02663960|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25219269|NCT02663960|Chelating Agents|chelating agents|mesh-ancestor
25219270|NCT02663960|Sequestering Agents|sequestering agents|mesh-ancestor
25219271|NCT02663960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219272|NCT02664103|Cyclophosphamide|cyclophosphamide|mesh-list
25219273|NCT02664103|Capecitabine|capecitabine|mesh-list
25219274|NCT02664103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25219275|NCT02664103|Immunologic Factors|immunologic factors|mesh-ancestor
25219276|NCT02664103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219277|NCT02664103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25219278|NCT02664103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25219279|NCT02664103|Alkylating Agents|alkylating agents|mesh-ancestor
25219280|NCT02664103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219281|NCT02664103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219282|NCT02664103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25219283|NCT02664103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25219284|NCT02664103|Antimetabolites|antimetabolites|mesh-ancestor
25219285|NCT02663999|Diazepam|diazepam|mesh-list
25219286|NCT02663999|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25219287|NCT02663999|Anticonvulsants|anticonvulsants|mesh-ancestor
25219288|NCT02663999|Antiemetics|antiemetics|mesh-ancestor
25219289|NCT02663999|Autonomic Agents|autonomic agents|mesh-ancestor
25219290|NCT02663999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25219291|NCT02663999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219292|NCT02663999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25219293|NCT02663999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25219294|NCT02663999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25219295|NCT02663999|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25219296|NCT02663999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25219297|NCT02663999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25219298|NCT02663999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25219299|NCT02663999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25219300|NCT02663999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25219301|NCT02663999|Anesthetics, General|anesthetics, general|mesh-ancestor
25219302|NCT02663999|Anesthetics|anesthetics|mesh-ancestor
25219303|NCT02663999|GABA Modulators|gaba modulators|mesh-ancestor
25219304|NCT02663999|GABA Agents|gaba agents|mesh-ancestor
25219305|NCT02663999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25219306|NCT02663999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219307|NCT02664012|Menthol|menthol|mesh-list
25219308|NCT02664012|Nicotine|nicotine|mesh-list
25219309|NCT02664012|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25219310|NCT02664012|Autonomic Agents|autonomic agents|mesh-ancestor
25219311|NCT02664012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25219312|NCT02664012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219313|NCT02664012|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25219314|NCT02664012|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25679330|NCT01836523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25679331|NCT01836523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679332|NCT01836523|Incretins|incretins|mesh-ancestor
25679333|NCT01836523|Hormones|hormones|mesh-ancestor
25679334|NCT01836523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25679335|NCT01836549|Imetelstat|imetelstat|mesh-list
25679336|NCT01836549|Motesanib diphosphate|motesanib diphosphate|mesh-list
25679337|NCT01836549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857365|NCT02291367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24667687|NCT05327296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667688|NCT05327296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24667689|NCT05327296|Anesthetics, General|anesthetics, general|mesh-ancestor
24667691|NCT05327296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24667694|NCT05323214|Analgesics|analgesics|mesh-list
24667695|NCT05323214|Bupivacaine|bupivacaine|mesh-list
24667697|NCT05323214|Anesthetics|anesthetics|mesh-ancestor
24832739|NCT02172157|Olodaterol|olodaterol|mesh-list
24832740|NCT02172157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24832741|NCT02172157|Autonomic Agents|autonomic agents|mesh-ancestor
24832742|NCT02172157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24738700|NCT01676987|Budesonide|budesonide|mesh-list
25219315|NCT02664012|Cholinergic Agents|cholinergic agents|mesh-ancestor
25219316|NCT02664012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25219317|NCT02664012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219318|NCT02664012|Antipruritics|antipruritics|mesh-ancestor
25219319|NCT02664012|Dermatologic Agents|dermatologic agents|mesh-ancestor
25219321|NCT02663713|Ticagrelor|ticagrelor|mesh-list
25219322|NCT02663713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25219323|NCT02663713|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25219324|NCT02663713|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25219325|NCT02663713|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25219326|NCT02663713|Purinergic Agents|purinergic agents|mesh-ancestor
25219327|NCT02663713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25219328|NCT02663713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219329|NCT02663713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219330|NCT02663830|Sildenafil Citrate|sildenafil citrate|mesh-list
25219331|NCT02663830|Clomiphene|clomiphene|mesh-list
25219332|NCT02663830|Enclomiphene|enclomiphene|mesh-list
25219333|NCT02663830|Zuclomiphene|zuclomiphene|mesh-list
25219334|NCT02663830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219335|NCT02663830|Vasodilator Agents|vasodilator agents|mesh-ancestor
25219336|NCT02663830|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25219337|NCT02663830|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25219338|NCT02663830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219339|NCT02663830|Urological Agents|urological agents|mesh-ancestor
25219340|NCT02663830|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25219341|NCT02663830|Hormone Antagonists|hormone antagonists|mesh-ancestor
25219342|NCT02663830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25219343|NCT02663830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679338|NCT01836549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679339|NCT01836549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25679340|NCT01837069|Metoprolol|metoprolol|mesh-list
25679341|NCT01837069|Lisinopril|lisinopril|mesh-list
25679342|NCT01837069|Atorvastatin|atorvastatin|mesh-list
25679343|NCT01837069|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25679344|NCT01837069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25679345|NCT01837069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25679346|NCT01837069|Antimetabolites|antimetabolites|mesh-ancestor
25679347|NCT01837069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679348|NCT01837069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24667967|NCT05200884|Lidocaine|lidocaine|mesh-list
24667968|NCT05200884|Carticaine|carticaine|mesh-list
24667969|NCT05200884|Anesthetics, Local|anesthetics, local|mesh-ancestor
24667970|NCT05200884|Anesthetics|anesthetics|mesh-ancestor
24700625|NCT01453881|Beclomethasone|beclomethasone|mesh-list
25266808|NCT02426164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25219344|NCT02663830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25219345|NCT02663830|Fertility Agents|fertility agents|mesh-ancestor
25679349|NCT01837069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25219346|NCT02663830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25219347|NCT02663830|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25219348|NCT02663830|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25219349|NCT02663700|Artesunate|artesunate|mesh-list
25219350|NCT02663700|Antimalarials|antimalarials|mesh-ancestor
25042478|NCT01436032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25042479|NCT01436032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042480|NCT01435369|Pidilizumab|pidilizumab|mesh-list
25042481|NCT01435369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25042482|NCT01435369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042483|NCT01435226|Ribavirin|ribavirin|mesh-list
25042484|NCT01435226|Ledipasvir|ledipasvir|mesh-list
25042485|NCT01435226|Antimetabolites|antimetabolites|mesh-ancestor
25042486|NCT01435226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042487|NCT01435226|Antiviral Agents|antiviral agents|mesh-ancestor
25042488|NCT01435226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042489|NCT01435044|Sofosbuvir|sofosbuvir|mesh-list
25042490|NCT01435044|Ribavirin|ribavirin|mesh-list
25042491|NCT01435044|Antiviral Agents|antiviral agents|mesh-ancestor
25042492|NCT01435044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042494|NCT01435044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042495|NCT01434498|Ribavirin|ribavirin|mesh-list
25042496|NCT01434498|Ledipasvir|ledipasvir|mesh-list
25042497|NCT01434498|Antimetabolites|antimetabolites|mesh-ancestor
25042498|NCT01434498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042499|NCT01434498|Antiviral Agents|antiviral agents|mesh-ancestor
25042500|NCT01434498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042501|NCT01431820|Luliconazole|luliconazole|mesh-list
25042502|NCT01431820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25042503|NCT01431820|Antifungal Agents|antifungal agents|mesh-ancestor
25042504|NCT01431820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042506|NCT01425970|Ribavirin|ribavirin|mesh-list
25219351|NCT02663700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25219352|NCT02663700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25219353|NCT02663700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25219357|NCT02663700|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25219358|NCT02663700|Anthelmintics|anthelmintics|mesh-ancestor
25273003|NCT02387892|Vitamins|vitamins|mesh-ancestor
25273004|NCT02387892|Micronutrients|micronutrients|mesh-ancestor
25273005|NCT02387892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273006|NCT02387892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25273007|NCT02387892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25273008|NCT02387931|Vitamin D|vitamin d|mesh-list
25273009|NCT02387931|Ergocalciferols|ergocalciferols|mesh-list
25273010|NCT02387931|Cholecalciferol|cholecalciferol|mesh-list
25273011|NCT02387931|Vitamins|vitamins|mesh-list
25273012|NCT02387931|Micronutrients|micronutrients|mesh-ancestor
25273013|NCT02387931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679350|NCT01837069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25679351|NCT01837069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25679352|NCT01837069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25679353|NCT01837069|Sympatholytics|sympatholytics|mesh-ancestor
25679354|NCT01837069|Autonomic Agents|autonomic agents|mesh-ancestor
25679355|NCT01837069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25273014|NCT02387931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25273015|NCT02387931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25273016|NCT02387918|Dexamethasone|dexamethasone|mesh-list
24668152|NCT05070039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24668153|NCT05069896|Mirikizumab|mirikizumab|mesh-list
24921676|NCT04188158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24668267|NCT05010590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24668268|NCT05010590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266824|NCT02426164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266825|NCT02426164|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25273017|NCT02387918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25273018|NCT02387918|Antiemetics|antiemetics|mesh-ancestor
25273019|NCT02387918|Autonomic Agents|autonomic agents|mesh-ancestor
25273020|NCT02387918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25273021|NCT02387918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273022|NCT02387918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25273023|NCT02387918|Glucocorticoids|glucocorticoids|mesh-ancestor
25273025|NCT02387918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25273026|NCT02387918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25273027|NCT02387918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25275623|NCT02370680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25275624|NCT02370680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25275625|NCT02370680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275626|NCT02370680|Antipyretics|antipyretics|mesh-ancestor
25275627|NCT02370745|Insulin|insulin|mesh-list
25275628|NCT02370745|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24427510|NCT00238290|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24427517|NCT00238316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25052366|NCT00299507|Anecortave|anecortave|mesh-list
25085927|NCT03294174|Sensory System Agents|sensory system agents|mesh-ancestor
25085928|NCT03294174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25085929|NCT03294161|Meglumine Antimoniate|meglumine antimoniate|mesh-list
25085937|NCT03294070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25219359|NCT02663596|Vancomycin|vancomycin|mesh-list
25219360|NCT02663596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25219361|NCT02663596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25219362|NCT02663570|Melatonin|melatonin|mesh-list
25219363|NCT02663570|Antioxidants|antioxidants|mesh-ancestor
25679356|NCT01837069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679357|NCT01837069|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25679358|NCT01837069|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25679359|NCT01837069|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25679360|NCT01837069|Adrenergic Agents|adrenergic agents|mesh-ancestor
25679361|NCT01837069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25679362|NCT01837069|Protease Inhibitors|protease inhibitors|mesh-ancestor
25679363|NCT01837069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24533489|NCT00644137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921740|NCT04187469|Isoniazid|isoniazid|mesh-list
24465809|NCT00370760|Colchicine|colchicine|mesh-list
24857373|NCT02291380|Botulinum Toxins|botulinum toxins|mesh-list
24413400|NCT00193726|Estrogens|estrogens|mesh-ancestor
25219364|NCT02663570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219365|NCT02663570|Protective Agents|protective agents|mesh-ancestor
25219366|NCT02663570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219367|NCT02663570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25219368|NCT02663440|Temozolomide|temozolomide|mesh-list
25219369|NCT02663440|Molgramostim|molgramostim|mesh-list
25219370|NCT02663440|Sargramostim|sargramostim|mesh-list
25219371|NCT02663440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25219372|NCT02663440|Alkylating Agents|alkylating agents|mesh-ancestor
25219373|NCT02663440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219374|NCT02663440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219375|NCT02663440|Immunologic Factors|immunologic factors|mesh-ancestor
25219376|NCT02663440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219377|NCT02663323|Sirolimus|sirolimus|mesh-list
25219378|NCT02663323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25219379|NCT02663323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25219380|NCT02663323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25219381|NCT02663323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219382|NCT02663323|Antifungal Agents|antifungal agents|mesh-ancestor
25219383|NCT02663323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25219384|NCT02663323|Immunologic Factors|immunologic factors|mesh-ancestor
24427518|NCT00238316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427663|NCT00238667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25219385|NCT02663323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219386|NCT02663206|Botulinum Toxins|botulinum toxins|mesh-list
25219387|NCT02663206|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25219388|NCT02663206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25219389|NCT02663206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219390|NCT02663206|Cholinergic Agents|cholinergic agents|mesh-ancestor
25219391|NCT02663206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25219392|NCT02663206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832744|NCT02172157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24832745|NCT02172157|Respiratory System Agents|respiratory system agents|mesh-ancestor
24832747|NCT02172170|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24832748|NCT02172170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679364|NCT01837069|Protective Agents|protective agents|mesh-ancestor
25679365|NCT01837680|Insulin|insulin|mesh-list
25679366|NCT01837680|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25679367|NCT01837680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25679368|NCT01837680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679369|NCT01837719|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25679370|NCT01837719|Cobicistat|cobicistat|mesh-list
25679371|NCT01837719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25679372|NCT01837719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25679373|NCT01837719|Protease Inhibitors|protease inhibitors|mesh-ancestor
25679374|NCT01837719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219393|NCT02663258|Pembrolizumab|pembrolizumab|mesh-list
25219394|NCT02663258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25219395|NCT02663258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219396|NCT02663284|Ropivacaine|ropivacaine|mesh-list
25219397|NCT02663284|Anesthetics, Local|anesthetics, local|mesh-ancestor
25219398|NCT02663284|Anesthetics|anesthetics|mesh-ancestor
25086025|NCT03293277|Analgesics|analgesics|mesh-ancestor
25219399|NCT02663284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25219400|NCT02663284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219401|NCT02663284|Sensory System Agents|sensory system agents|mesh-ancestor
25219402|NCT02663284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25219403|NCT02663141|Bevacizumab|bevacizumab|mesh-list
25219404|NCT02663141|Losartan|losartan|mesh-list
25219405|NCT02663141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25219406|NCT02663141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219407|NCT02663141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25219408|NCT02663141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25219409|NCT02663141|Growth Substances|growth substances|mesh-ancestor
25219410|NCT02663141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219411|NCT02663141|Growth Inhibitors|growth inhibitors|mesh-ancestor
25219412|NCT02663141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25219413|NCT02663141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25219414|NCT02663141|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25219415|NCT02663141|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25219416|NCT02663141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219417|NCT02663089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25219418|NCT02663050|Diclofenac|diclofenac|mesh-list
25219419|NCT02663050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25219420|NCT02663050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25219421|NCT02663050|Analgesics|analgesics|mesh-ancestor
25219422|NCT02663050|Sensory System Agents|sensory system agents|mesh-ancestor
25219423|NCT02663050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25219424|NCT02663050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219425|NCT02663050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25219426|NCT02663050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25219427|NCT02663050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25219428|NCT02663050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219429|NCT02663050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219430|NCT02662972|Botulinum Toxins|botulinum toxins|mesh-list
24979399|NCT04499131|Progestins|progestins|mesh-ancestor
24979400|NCT04499131|Hormones|hormones|mesh-ancestor
24979401|NCT04499131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24832754|NCT02172196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832755|NCT02172196|Incretins|incretins|mesh-ancestor
24832756|NCT02172196|Hormones|hormones|mesh-ancestor
24832757|NCT02172196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24832758|NCT02172196|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25085938|NCT03294070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25085939|NCT03294070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24654619|NCT01250561|Gabapentin|gabapentin|mesh-list
25085952|NCT03293927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25085953|NCT03293927|Analgesics|analgesics|mesh-ancestor
25085954|NCT03293927|Sensory System Agents|sensory system agents|mesh-ancestor
25085955|NCT03293927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25085956|NCT03293927|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25085957|NCT03293927|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25085958|NCT03293927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25085959|NCT03293927|Adrenergic Agents|adrenergic agents|mesh-ancestor
25085960|NCT03293927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25085961|NCT03293927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085962|NCT03293927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24629900|NCT01108588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24629901|NCT01108588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085964|NCT03293927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25085965|NCT03293927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25219431|NCT02662972|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25219432|NCT02662972|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25219433|NCT02662972|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25219434|NCT02662972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24979402|NCT04499131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219435|NCT02662972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219436|NCT02662972|Cholinergic Agents|cholinergic agents|mesh-ancestor
25219437|NCT02662972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25219438|NCT02662972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219439|NCT02662972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25219440|NCT02662972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25219441|NCT02662959|Irinotecan|irinotecan|mesh-list
25219442|NCT02662959|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25219443|NCT02662959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25219444|NCT02662959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219445|NCT02662959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219446|NCT02662959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219447|NCT02662894|Valsartan|valsartan|mesh-list
25219448|NCT02662894|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25219449|NCT02662894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25219450|NCT02662894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25219451|NCT02662894|Antimetabolites|antimetabolites|mesh-ancestor
25219452|NCT02662894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219453|NCT02662894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25219454|NCT02662894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25219455|NCT02662894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219456|NCT02662894|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25219457|NCT02662894|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25219774|NCT02660736|Hormones|hormones|mesh-ancestor
25219460|NCT02662855|Antiviral Agents|antiviral agents|mesh-ancestor
25219461|NCT02662855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25219462|NCT02662647|Cytarabine|cytarabine|mesh-list
25219463|NCT02662647|Decitabine|decitabine|mesh-list
25692423|NCT01999335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25692424|NCT01999335|Growth Substances|growth substances|mesh-ancestor
25219465|NCT02662647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25219466|NCT02662647|Antimetabolites|antimetabolites|mesh-ancestor
25219467|NCT02662647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219468|NCT02662647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219469|NCT02662647|Antiviral Agents|antiviral agents|mesh-ancestor
25219470|NCT02662647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25219471|NCT02662647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25219472|NCT02662647|Immunologic Factors|immunologic factors|mesh-ancestor
25219473|NCT02662647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219474|NCT02662647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219475|NCT02662647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25219476|NCT02662647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25219477|NCT02662660|Acetaminophen|acetaminophen|mesh-list
25219478|NCT02662660|Dipyrone|dipyrone|mesh-list
25219479|NCT02662660|Bupivacaine|bupivacaine|mesh-list
25219480|NCT02662660|Levobupivacaine|levobupivacaine|mesh-list
25219481|NCT02662660|Anesthetics, Local|anesthetics, local|mesh-ancestor
25219482|NCT02662660|Anesthetics|anesthetics|mesh-ancestor
25219483|NCT02662660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25219484|NCT02662660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219485|NCT02662660|Sensory System Agents|sensory system agents|mesh-ancestor
25219486|NCT02662660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25219487|NCT02662660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25219488|NCT02662660|Analgesics|analgesics|mesh-ancestor
25219489|NCT02662660|Antipyretics|antipyretics|mesh-ancestor
25219490|NCT02662660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25219491|NCT02662660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25219492|NCT02662660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25219493|NCT02662725|Ipilimumab|ipilimumab|mesh-list
24832759|NCT02172196|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832760|NCT02172196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832761|NCT02172196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060685|NCT03477994|Sympatholytics|sympatholytics|mesh-ancestor
24832764|NCT02172209|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24832765|NCT02172209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832766|NCT02172209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24832767|NCT02172209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052491|NCT00263341|Hormones|hormones|mesh-ancestor
25085966|NCT03293927|Anesthetics, General|anesthetics, general|mesh-ancestor
25085967|NCT03293927|Anesthetics|anesthetics|mesh-ancestor
25085968|NCT03293641|Folic Acid|folic acid|mesh-list
25085969|NCT03293641|Penicillins|penicillins|mesh-list
25085970|NCT03293641|Penicillin V|penicillin v|mesh-list
25085971|NCT03293641|Proguanil|proguanil|mesh-list
25085972|NCT03293641|Hydroxyurea|hydroxyurea|mesh-list
25219816|NCT02660762|Antimetabolites|antimetabolites|mesh-ancestor
25219494|NCT02662725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25219495|NCT02662725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219496|NCT02662725|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25219497|NCT02662725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219498|NCT02662530|Botulinum Toxins|botulinum toxins|mesh-list
25219499|NCT02662530|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25219500|NCT02662530|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25219501|NCT02662530|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25219502|NCT02662530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25219503|NCT02662530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219504|NCT02662530|Cholinergic Agents|cholinergic agents|mesh-ancestor
25219505|NCT02662530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25219506|NCT02662530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219507|NCT02662530|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25219508|NCT02662530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25219509|NCT02662712|JNJ-56136379|jnj-56136379|mesh-list
25219510|NCT02662712|Antiviral Agents|antiviral agents|mesh-ancestor
25219511|NCT02662712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25219512|NCT02662504|Cisplatin|cisplatin|mesh-list
25219513|NCT02662504|Pemetrexed|pemetrexed|mesh-list
25219514|NCT02662504|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
25219515|NCT02662504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219516|NCT02662504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219517|NCT02662504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219518|NCT02662504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25219519|NCT02662504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25219520|NCT02662504|Dermatologic Agents|dermatologic agents|mesh-ancestor
25219521|NCT02662504|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25219522|NCT02662491|Calcium, Dietary|calcium, dietary|mesh-list
25219523|NCT02662491|Vitamin D|vitamin d|mesh-list
25219524|NCT02662491|Ergocalciferols|ergocalciferols|mesh-list
25219525|NCT02662491|Cholecalciferol|cholecalciferol|mesh-list
25219526|NCT02662491|Vitamins|vitamins|mesh-list
25219527|NCT02662491|Calcium|calcium|mesh-list
25219528|NCT02662491|Micronutrients|micronutrients|mesh-ancestor
25085973|NCT03293641|Zinc Sulfate|zinc sulfate|mesh-list
25085974|NCT03293641|Hematinics|hematinics|mesh-ancestor
25085975|NCT03293641|Vitamin B Complex|vitamin b complex|mesh-ancestor
25085976|NCT03293641|Vitamins|vitamins|mesh-ancestor
25085977|NCT03293641|Micronutrients|micronutrients|mesh-ancestor
25085978|NCT03293641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085979|NCT03293641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25085980|NCT03293641|Antisickling Agents|antisickling agents|mesh-ancestor
25085981|NCT03293641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085982|NCT03293641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085983|NCT03293641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25086001|NCT03293472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086002|NCT03293472|Sensory System Agents|sensory system agents|mesh-ancestor
25086004|NCT03293407|Iloprost|iloprost|mesh-list
25086005|NCT03293407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25086006|NCT03293407|Vasodilator Agents|vasodilator agents|mesh-ancestor
25086007|NCT03293368|Triamcinolone|triamcinolone|mesh-list
25086008|NCT03293368|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25086009|NCT03293368|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25086010|NCT03293368|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25086011|NCT03293368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25086012|NCT03293368|Glucocorticoids|glucocorticoids|mesh-ancestor
25679375|NCT01837719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679376|NCT01837719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25679377|NCT01837719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25086013|NCT03293368|Hormones|hormones|mesh-ancestor
25086014|NCT03293368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25086015|NCT03293368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086016|NCT03293368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25086017|NCT03293368|Immunologic Factors|immunologic factors|mesh-ancestor
25086018|NCT03293368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25086019|NCT03293368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086020|NCT03293277|Dexmedetomidine|dexmedetomidine|mesh-list
25086021|NCT03293277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25086022|NCT03293277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25086023|NCT03293277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086024|NCT03293277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25086026|NCT03293277|Sensory System Agents|sensory system agents|mesh-ancestor
25219529|NCT02662491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219530|NCT02662491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25219531|NCT02662491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25219532|NCT02662426|Oseltamivir|oseltamivir|mesh-list
25219533|NCT02662426|Antiviral Agents|antiviral agents|mesh-ancestor
25219534|NCT02662426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25219535|NCT02662426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219536|NCT02662426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219537|NCT02662348|Aldesleukin|aldesleukin|mesh-list
25219538|NCT02662348|Interleukin-2|interleukin-2|mesh-list
25219539|NCT02662348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219540|NCT02662348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25219541|NCT02662348|Analgesics|analgesics|mesh-ancestor
25219542|NCT02662348|Sensory System Agents|sensory system agents|mesh-ancestor
25219543|NCT02662348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25219544|NCT02662348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219545|NCT02662348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25219546|NCT02662348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25219547|NCT02662348|Antiviral Agents|antiviral agents|mesh-ancestor
25273028|NCT02387619|Amlodipine|amlodipine|mesh-list
24449522|NCT00315887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24449523|NCT00315887|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24449524|NCT00315900|Valproic Acid|valproic acid|mesh-list
24449525|NCT00315900|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24449526|NCT00315900|Antidepressive Agents|antidepressive agents|mesh-ancestor
24449527|NCT00315900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24449528|NCT00315900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24449529|NCT00315900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24449530|NCT00315900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25052530|NCT00260078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25086027|NCT03293277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25086028|NCT03293277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25086029|NCT03293277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25086030|NCT03293277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25086031|NCT03293277|Adrenergic Agents|adrenergic agents|mesh-ancestor
25086032|NCT03293277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25086033|NCT03293277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086034|NCT03293108|Vitamin D|vitamin d|mesh-list
25086035|NCT03293108|Denosumab|denosumab|mesh-list
25086046|NCT03293069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086047|NCT03293004|Vitamins|vitamins|mesh-list
25086048|NCT03293004|Ascorbic Acid|ascorbic acid|mesh-list
25086049|NCT03293004|Micronutrients|micronutrients|mesh-ancestor
25086050|NCT03293004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086051|NCT03293004|Antioxidants|antioxidants|mesh-ancestor
25086052|NCT03293004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086053|NCT03293004|Protective Agents|protective agents|mesh-ancestor
25086054|NCT03292965|Neostigmine|neostigmine|mesh-list
25086067|NCT03292848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761309|NCT01762163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761310|NCT01762163|Antipyretics|antipyretics|mesh-ancestor
24761311|NCT01762202|Cyclophosphamide|cyclophosphamide|mesh-list
24761312|NCT01762202|Fludarabine|fludarabine|mesh-list
25086068|NCT03292848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086069|NCT03292848|Dopamine Agonists|dopamine agonists|mesh-ancestor
25086070|NCT03292848|Dopamine Agents|dopamine agents|mesh-ancestor
25086084|NCT03292744|Alfacalcidol|alfacalcidol|mesh-list
25086085|NCT03292744|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
25679378|NCT01837719|Antiviral Agents|antiviral agents|mesh-ancestor
25086086|NCT03292744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25086087|NCT03292744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086089|NCT03292744|Micronutrients|micronutrients|mesh-ancestor
25086090|NCT03292744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25086091|NCT03292731|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
25086092|NCT03292731|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
25086093|NCT03292731|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25086094|NCT03292731|Hormone Antagonists|hormone antagonists|mesh-ancestor
25086095|NCT03292731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25086096|NCT03292731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086097|NCT03292731|Progestins|progestins|mesh-ancestor
25086098|NCT03292731|Hormones|hormones|mesh-ancestor
25086099|NCT03292575|Anticoagulants|anticoagulants|mesh-list
25219549|NCT02662322|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25219550|NCT02662322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25219551|NCT02662322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219552|NCT02662283|Acteoside|acteoside|mesh-list
25219553|NCT02662283|Prednisolone|prednisolone|mesh-list
25219554|NCT02662283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25219555|NCT02662283|Glucocorticoids|glucocorticoids|mesh-ancestor
25219556|NCT02662283|Hormones|hormones|mesh-ancestor
25219557|NCT02662283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25219558|NCT02662283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219559|NCT02662283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25219560|NCT02662283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449535|NCT00315900|GABA Agents|gaba agents|mesh-ancestor
24449536|NCT00315900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24449537|NCT00315900|Antimanic Agents|antimanic agents|mesh-ancestor
24449538|NCT00315913|Propranolol|propranolol|mesh-list
24449539|NCT00315913|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24449540|NCT00315913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24832771|NCT02172222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832772|NCT02172222|Incretins|incretins|mesh-ancestor
24832773|NCT02172222|Hormones|hormones|mesh-ancestor
24832774|NCT02172222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24832775|NCT02172222|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24832776|NCT02172222|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832777|NCT02172222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832778|NCT02172222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738997|NCT01678664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25219561|NCT02662283|Protective Agents|protective agents|mesh-ancestor
25219562|NCT02662283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25219563|NCT02662283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25219564|NCT02662283|Antioxidants|antioxidants|mesh-ancestor
25219565|NCT02662283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219566|NCT02662283|Chelating Agents|chelating agents|mesh-ancestor
25219567|NCT02662283|Sequestering Agents|sequestering agents|mesh-ancestor
25219568|NCT02662283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25219569|NCT02662283|Immunologic Factors|immunologic factors|mesh-ancestor
25219570|NCT02662296|Idelalisib|idelalisib|mesh-list
25219571|NCT02662296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219572|NCT02662296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219573|NCT02662296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219574|NCT02662309|Atezolizumab|atezolizumab|mesh-list
25219575|NCT02662309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219576|NCT02662374|Nystatin|nystatin|mesh-list
25219577|NCT02662374|Calcium|calcium|mesh-list
25219578|NCT02662374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25219579|NCT02662374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219580|NCT02662374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25219581|NCT02662374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25679379|NCT01837719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25692425|NCT01999335|Growth Inhibitors|growth inhibitors|mesh-ancestor
25219585|NCT02662374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273033|NCT02387619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25273034|NCT02387619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25273035|NCT02387619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273036|NCT02387619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25273037|NCT02387619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273038|NCT02387619|Vasodilator Agents|vasodilator agents|mesh-ancestor
25273039|NCT02387619|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25273040|NCT02387619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25273041|NCT02387619|Antimetabolites|antimetabolites|mesh-ancestor
25273042|NCT02387619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25273043|NCT02387619|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25042511|NCT01425970|Antiviral Agents|antiviral agents|mesh-ancestor
24449541|NCT00315913|Adrenergic Agents|adrenergic agents|mesh-ancestor
24449542|NCT00315913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24449543|NCT00315913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052582|NCT00253968|SR 46349B|sr 46349b|mesh-list
24629908|NCT01108601|Ciprofloxacin|ciprofloxacin|mesh-list
24629909|NCT01108601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24629910|NCT01108601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24629922|NCT01108627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629923|NCT01108627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24629932|NCT01108744|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24629934|NCT01108744|Natriuretic Agents|natriuretic agents|mesh-ancestor
24629935|NCT01108744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629936|NCT01108783|Desloratadine|desloratadine|mesh-list
25086101|NCT03292315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25086102|NCT03292315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086103|NCT03292315|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25086104|NCT03292315|Incretins|incretins|mesh-ancestor
25086105|NCT03292315|Hormones|hormones|mesh-ancestor
25086106|NCT03292315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25086107|NCT03292263|Nivolumab|nivolumab|mesh-list
25086108|NCT03292263|Melphalan|melphalan|mesh-list
25086109|NCT03292263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25086110|NCT03292263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105997|NCT04688203|Anticonvulsants|anticonvulsants|mesh-ancestor
24429763|NCT00245024|Sulindac|sulindac|mesh-list
25679380|NCT01837719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25679381|NCT01837719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25679382|NCT01837797|Brexpiprazole|brexpiprazole|mesh-list
25679383|NCT01837797|Serotonin Agents|serotonin agents|mesh-ancestor
25679384|NCT01837797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25679385|NCT01837797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679386|NCT01837797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086111|NCT03292263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25086112|NCT03292263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086113|NCT03292263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25086114|NCT03292263|Alkylating Agents|alkylating agents|mesh-ancestor
25086115|NCT03292263|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24832779|NCT02172222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24449544|NCT00315913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052616|NCT00243867|Paclitaxel|paclitaxel|mesh-list
25086116|NCT03292263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25086117|NCT03292263|Immunologic Factors|immunologic factors|mesh-ancestor
25086118|NCT03292263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086119|NCT03292185|Insulin|insulin|mesh-list
25086120|NCT03292185|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25086121|NCT03292185|Liraglutide|liraglutide|mesh-list
25086122|NCT03292185|Insulin, Long-Acting|insulin, long-acting|mesh-list
25086123|NCT03292185|Xultophy|xultophy|mesh-list
25086124|NCT03292185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25086125|NCT03292185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086126|NCT03292185|Incretins|incretins|mesh-ancestor
25086127|NCT03292185|Hormones|hormones|mesh-ancestor
25086128|NCT03292185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25086129|NCT03292172|Atezolizumab|atezolizumab|mesh-list
24761323|NCT01762306|Folic Acid|folic acid|mesh-list
25086130|NCT03292172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25086131|NCT03291899|Folfirinox|folfirinox|mesh-list
25086132|NCT03291899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25086133|NCT03291821|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25086134|NCT03291821|Cetrorelix|cetrorelix|mesh-list
25086135|NCT03291821|Menotropins|menotropins|mesh-list
25086136|NCT03291821|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25086137|NCT03291821|Ganirelix|ganirelix|mesh-list
24761377|NCT01762436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24761378|NCT01762436|Adrenergic Agents|adrenergic agents|mesh-ancestor
25086146|NCT03291821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25086147|NCT03291821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25086148|NCT03291821|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25086149|NCT03291821|Fertility Agents|fertility agents|mesh-ancestor
25086150|NCT03291821|Hormone Antagonists|hormone antagonists|mesh-ancestor
24761450|NCT01762787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24761451|NCT01762787|Analgesics|analgesics|mesh-ancestor
25086151|NCT03291457|Glucocorticoids|glucocorticoids|mesh-list
25086152|NCT03291457|Hormones|hormones|mesh-ancestor
25086153|NCT03291457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24629937|NCT01108783|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24629938|NCT01108783|Cholinergic Agents|cholinergic agents|mesh-ancestor
24629939|NCT01108783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25679387|NCT01837797|Dopamine Agonists|dopamine agonists|mesh-ancestor
25679388|NCT01837797|Dopamine Agents|dopamine agents|mesh-ancestor
25679389|NCT01837823|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25679390|NCT01837823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25679391|NCT01837823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25679392|NCT01837823|Antimetabolites|antimetabolites|mesh-ancestor
25679393|NCT01837823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679394|NCT01837823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25679395|NCT01837823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24629940|NCT01108783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219604|NCT02661893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219605|NCT02661893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25219607|NCT02661893|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25219608|NCT02661893|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25219609|NCT02661893|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25219610|NCT02661893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25219612|NCT02661711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25219613|NCT02661711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25219615|NCT02661711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219616|NCT02661711|Growth Inhibitors|growth inhibitors|mesh-ancestor
25219617|NCT02661711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219618|NCT02661789|Goserelin|goserelin|mesh-list
25219619|NCT02661789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25219620|NCT02661789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24430349|NCT00247247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24629941|NCT01108783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430350|NCT00247247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979468|NCT04217135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24979469|NCT04217135|Vasodilator Agents|vasodilator agents|mesh-ancestor
24979470|NCT04205838|Vidarabine|vidarabine|mesh-list
24979471|NCT04205838|Cyclophosphamide|cyclophosphamide|mesh-list
24979472|NCT04205838|Fludarabine|fludarabine|mesh-list
24629942|NCT01108783|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24629943|NCT01108783|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24629944|NCT01108783|Histamine Antagonists|histamine antagonists|mesh-ancestor
25219621|NCT02661425|Immunoglobulins|immunoglobulins|mesh-list
25219622|NCT02661425|Immunologic Factors|immunologic factors|mesh-ancestor
25219623|NCT02661425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219624|NCT02661373|Cobicistat|cobicistat|mesh-list
25219625|NCT02661373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25219626|NCT02661373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25219627|NCT02661373|Antiviral Agents|antiviral agents|mesh-ancestor
25219628|NCT02661373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25219629|NCT02661373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25219630|NCT02661373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25219631|NCT02661373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219632|NCT02661373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629945|NCT01108783|Histamine Agents|histamine agents|mesh-ancestor
24629947|NCT01108848|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
24629948|NCT01108848|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
24629949|NCT01108848|Immunologic Factors|immunologic factors|mesh-ancestor
24629950|NCT01108848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629951|NCT01108848|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24629961|NCT01108874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24629962|NCT01108874|Adrenergic Agents|adrenergic agents|mesh-ancestor
24629963|NCT01108874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24629964|NCT01108874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629966|NCT01108900|Vasodilator Agents|vasodilator agents|mesh-ancestor
24629967|NCT01108900|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24629968|NCT01108900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25219673|NCT02661438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24979508|NCT04064411|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
25219674|NCT02661438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25219675|NCT02661438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219676|NCT02661438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219677|NCT02661438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219678|NCT02661438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25219679|NCT02661438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25219681|NCT02661347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25219682|NCT02661347|Serotonin Agents|serotonin agents|mesh-ancestor
25219683|NCT02661347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25042553|NCT01421056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25219684|NCT02661347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219685|NCT02661347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629969|NCT01108900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25245798|NCT03719326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24629970|NCT01108900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629971|NCT01108900|Urological Agents|urological agents|mesh-ancestor
24629972|NCT01108926|Tenofovir|tenofovir|mesh-list
24629973|NCT01108926|Emtricitabine|emtricitabine|mesh-list
24629974|NCT01108926|Efavirenz|efavirenz|mesh-list
24665158|NCT01310478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24629975|NCT01108926|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25086154|NCT03291457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086155|NCT03291418|Naproxen|naproxen|mesh-list
25086156|NCT03291418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25086157|NCT03291418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25086158|NCT03291418|Analgesics|analgesics|mesh-ancestor
24431443|NCT00251732|Rabeprazole|rabeprazole|mesh-list
24431444|NCT00251732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25679396|NCT01837823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25679397|NCT01838044|Celecoxib|celecoxib|mesh-list
25679398|NCT01838044|Pregabalin|pregabalin|mesh-list
25679399|NCT01838044|Analgesics|analgesics|mesh-ancestor
25679400|NCT01838044|Sensory System Agents|sensory system agents|mesh-ancestor
25679401|NCT01838044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25679402|NCT01838044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679403|NCT01838044|Anticonvulsants|anticonvulsants|mesh-ancestor
25679404|NCT01838044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25086159|NCT03291418|Sensory System Agents|sensory system agents|mesh-ancestor
25086160|NCT03291418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25086161|NCT03291418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086162|NCT03291418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25086163|NCT03291418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25086164|NCT03291418|Gout Suppressants|gout suppressants|mesh-ancestor
25086165|NCT03291418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25086166|NCT03291418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25086167|NCT03291418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629979|NCT01108926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24629981|NCT01108926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629982|NCT01108926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24629983|NCT01108926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24629984|NCT01108926|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24629985|NCT01108926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24630002|NCT01109030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24630003|NCT01109030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630004|NCT01109030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24630005|NCT01109030|Serotonin Agents|serotonin agents|mesh-ancestor
24630006|NCT01109030|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25086182|NCT03291249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219717|NCT02661100|Immunologic Factors|immunologic factors|mesh-ancestor
25086183|NCT03291249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086185|NCT03291158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25086186|NCT03291158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25086187|NCT03291145|Spironolactone|spironolactone|mesh-list
25086188|NCT03291145|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25086189|NCT03291145|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25219686|NCT02661347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25219687|NCT02661347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25219688|NCT02661347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25219689|NCT02661347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25219690|NCT02661347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25219691|NCT02661347|Dopamine Agents|dopamine agents|mesh-ancestor
25219692|NCT02661477|Interferons|interferons|mesh-list
25219693|NCT02661477|Interferon-alpha|interferon-alpha|mesh-list
25219694|NCT02661477|Interferon alpha-2|interferon alpha-2|mesh-list
24979515|NCT04057937|Analgesics|analgesics|mesh-ancestor
24431676|NCT00252668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24431677|NCT00252668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25219696|NCT02661477|Antiviral Agents|antiviral agents|mesh-ancestor
25219697|NCT02661477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25219698|NCT02661477|Immunologic Factors|immunologic factors|mesh-ancestor
25219699|NCT02661477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219700|NCT02661152|Nimorazole|nimorazole|mesh-list
25219701|NCT02661152|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
24832786|NCT02172248|Metformin|metformin|mesh-list
24832787|NCT02172248|Empagliflozin|empagliflozin|mesh-list
25679405|NCT01838044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25060847|NCT03475810|Midazolam|midazolam|mesh-list
25219702|NCT02661152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25219703|NCT02661152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25219704|NCT02661152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25219705|NCT02661191|Cholecalciferol|cholecalciferol|mesh-list
25219706|NCT02661191|Vitamin D|vitamin d|mesh-list
25219707|NCT02661191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25219708|NCT02661191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219709|NCT02661191|Vitamins|vitamins|mesh-ancestor
25219710|NCT02661191|Micronutrients|micronutrients|mesh-ancestor
25219711|NCT02661191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25219712|NCT02661100|Pembrolizumab|pembrolizumab|mesh-list
25219713|NCT02661100|Poly ICLC|poly iclc|mesh-list
25219714|NCT02661100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25219715|NCT02661100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219716|NCT02661100|Interferon Inducers|interferon inducers|mesh-ancestor
25219718|NCT02661100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219719|NCT02661035|Mycophenolic Acid|mycophenolic acid|mesh-list
25219720|NCT02661035|Cyclophosphamide|cyclophosphamide|mesh-list
25219722|NCT02661035|Allopurinol|allopurinol|mesh-list
25219723|NCT02661035|Tacrolimus|tacrolimus|mesh-list
25219724|NCT02661035|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25219725|NCT02661035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25219726|NCT02661035|Immunologic Factors|immunologic factors|mesh-ancestor
25219727|NCT02661035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219728|NCT02661035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25219729|NCT02661035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25219730|NCT02661035|Alkylating Agents|alkylating agents|mesh-ancestor
25219731|NCT02661035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219732|NCT02661035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219733|NCT02661035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25219734|NCT02661035|Antimetabolites|antimetabolites|mesh-ancestor
25219735|NCT02661035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25219736|NCT02661035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219737|NCT02661035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25219738|NCT02661035|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25219739|NCT02661035|Antitubercular Agents|antitubercular agents|mesh-ancestor
25219740|NCT02661035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24832789|NCT02172248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832790|NCT02172248|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24832791|NCT02172248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832792|NCT02172261|Glimepiride|glimepiride|mesh-list
24832793|NCT02172261|Empagliflozin|empagliflozin|mesh-list
24832794|NCT02172261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25086190|NCT03291145|Hormone Antagonists|hormone antagonists|mesh-ancestor
25086191|NCT03291145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25086192|NCT03291145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086193|NCT03291145|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24432242|NCT00254046|Etravirine|etravirine|mesh-list
24432518|NCT00255073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25086194|NCT03291145|Diuretics|diuretics|mesh-ancestor
25086195|NCT03291145|Natriuretic Agents|natriuretic agents|mesh-ancestor
25219741|NCT02661035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25219742|NCT02661035|Gout Suppressants|gout suppressants|mesh-ancestor
25219743|NCT02661035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25219744|NCT02661035|Antioxidants|antioxidants|mesh-ancestor
25219745|NCT02661035|Protective Agents|protective agents|mesh-ancestor
25219746|NCT02660840|Flupenthixol|flupenthixol|mesh-list
25219747|NCT02660840|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
25219748|NCT02660840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25219749|NCT02660840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25219750|NCT02660840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25219751|NCT02660840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219752|NCT02660840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25219753|NCT02660840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25219754|NCT02660840|Dopamine Agents|dopamine agents|mesh-ancestor
25219755|NCT02660840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25219756|NCT02660840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219757|NCT02660905|Tenofovir|tenofovir|mesh-list
25219758|NCT02660905|Emtricitabine|emtricitabine|mesh-list
25219759|NCT02660905|Sofosbuvir|sofosbuvir|mesh-list
25219760|NCT02660905|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25219761|NCT02660905|Rilpivirine|rilpivirine|mesh-list
25219762|NCT02660905|Ledipasvir|ledipasvir|mesh-list
25219763|NCT02660905|Antiviral Agents|antiviral agents|mesh-ancestor
25219764|NCT02660905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25219765|NCT02660905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25219766|NCT02660905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25219767|NCT02660905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219768|NCT02660905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219769|NCT02660905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25219770|NCT02660905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25219771|NCT02660736|rGLP-1 protein|rglp-1 protein|mesh-list
25219772|NCT02660736|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25219773|NCT02660736|Incretins|incretins|mesh-ancestor
25219775|NCT02660736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24449545|NCT00315913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24449546|NCT00315913|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24449547|NCT00315913|Vasodilator Agents|vasodilator agents|mesh-ancestor
24449548|NCT00315926|Melatonin|melatonin|mesh-list
24449549|NCT00315926|Antioxidants|antioxidants|mesh-ancestor
24449550|NCT00315926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449551|NCT00315926|Protective Agents|protective agents|mesh-ancestor
24465449|NCT00369603|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24832795|NCT02172261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24832796|NCT02172261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086196|NCT03291145|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25086197|NCT03291145|Adrenergic Agents|adrenergic agents|mesh-ancestor
25679406|NCT01838044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086198|NCT03291145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25086199|NCT03291145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086200|NCT03291093|Flutemetamol|flutemetamol|mesh-list
25086201|NCT03291093|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25086202|NCT03291093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086203|NCT03291054|Pembrolizumab|pembrolizumab|mesh-list
25086204|NCT03291054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25086205|NCT03291054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25086232|NCT03290820|Aspirin|aspirin|mesh-list
25086233|NCT03290820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25086234|NCT03290820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25086235|NCT03290820|Analgesics|analgesics|mesh-ancestor
25086236|NCT03290820|Sensory System Agents|sensory system agents|mesh-ancestor
25219776|NCT02660736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219777|NCT02660866|Vorapaxar|vorapaxar|mesh-list
25219778|NCT02660866|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25219779|NCT02660762|Cytarabine|cytarabine|mesh-list
25219780|NCT02660762|Dexamethasone|dexamethasone|mesh-list
25219781|NCT02660762|Dexamethasone acetate|dexamethasone acetate|mesh-list
25219782|NCT02660762|Prednisone|prednisone|mesh-list
25219783|NCT02660762|Cyclophosphamide|cyclophosphamide|mesh-list
25219784|NCT02660762|Methotrexate|methotrexate|mesh-list
25219785|NCT02660762|Etoposide|etoposide|mesh-list
25219786|NCT02660762|Vincristine|vincristine|mesh-list
25219787|NCT02660762|Daunorubicin|daunorubicin|mesh-list
25219788|NCT02660762|Mercaptopurine|mercaptopurine|mesh-list
25219789|NCT02660762|Pegaspargase|pegaspargase|mesh-list
25219790|NCT02660762|Thioguanine|thioguanine|mesh-list
25219792|NCT02660762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25219793|NCT02660762|Immunologic Factors|immunologic factors|mesh-ancestor
25219794|NCT02660762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219795|NCT02660762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25219796|NCT02660762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25219797|NCT02660762|Alkylating Agents|alkylating agents|mesh-ancestor
25219798|NCT02660762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219799|NCT02660762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219800|NCT02660762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25219801|NCT02660762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25219802|NCT02660762|Antiemetics|antiemetics|mesh-ancestor
25219803|NCT02660762|Autonomic Agents|autonomic agents|mesh-ancestor
25219804|NCT02660762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25219805|NCT02660762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25219806|NCT02660762|Glucocorticoids|glucocorticoids|mesh-ancestor
25219807|NCT02660762|Hormones|hormones|mesh-ancestor
25086388|NCT03289728|Adrenergic Agents|adrenergic agents|mesh-ancestor
25042552|NCT01421056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25052744|NCT00162292|Methotrexate|methotrexate|mesh-list
25086237|NCT03290820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25086238|NCT03290820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086239|NCT03290820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25086240|NCT03290820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25086241|NCT03290820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25086242|NCT03290820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25086243|NCT03290820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086244|NCT03290820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24456460|NCT00331188|Vapreotide|vapreotide|mesh-list
24630007|NCT01109030|Antidepressive Agents|antidepressive agents|mesh-ancestor
24630008|NCT01109030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24432864|NCT00256542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24432865|NCT00256542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24433018|NCT00257270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24433019|NCT00257270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24433020|NCT00257270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24433021|NCT00257270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24433025|NCT00257348|Docetaxel|docetaxel|mesh-list
24630009|NCT01109030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24630010|NCT01109030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24630011|NCT01109030|Parasympatholytics|parasympatholytics|mesh-ancestor
24630012|NCT01109030|Autonomic Agents|autonomic agents|mesh-ancestor
24630013|NCT01109030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24630014|NCT01109030|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24630015|NCT01109030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24630016|NCT01109030|Cholinergic Agents|cholinergic agents|mesh-ancestor
24630017|NCT01109030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24630018|NCT01109030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24630019|NCT01109030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24630020|NCT01109030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24630021|NCT01109030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24630022|NCT01109030|GABA Modulators|gaba modulators|mesh-ancestor
24630023|NCT01109030|GABA Agents|gaba agents|mesh-ancestor
24630024|NCT01109043|Bisoprolol|bisoprolol|mesh-list
24630025|NCT01109043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24630026|NCT01109043|Sympatholytics|sympatholytics|mesh-ancestor
24630027|NCT01109043|Autonomic Agents|autonomic agents|mesh-ancestor
24630028|NCT01109043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24630064|NCT01109264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630065|NCT01109446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24630066|NCT01109485|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
24630067|NCT01109485|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24630068|NCT01109485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24630069|NCT01109485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25086245|NCT03290820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25086246|NCT03290820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25086247|NCT03290820|Antipyretics|antipyretics|mesh-ancestor
25086257|NCT03290625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25086258|NCT03290625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086259|NCT03290625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25086261|NCT03290625|Sensory System Agents|sensory system agents|mesh-ancestor
25086262|NCT03290625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25086263|NCT03290625|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25086264|NCT03290625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25086265|NCT03290625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25086266|NCT03290625|Adrenergic Agents|adrenergic agents|mesh-ancestor
25086267|NCT03290625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25086268|NCT03290625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086269|NCT03290625|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25219808|NCT02660762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25219809|NCT02660762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25219810|NCT02660762|Protease Inhibitors|protease inhibitors|mesh-ancestor
25219811|NCT02660762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219812|NCT02660762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25219813|NCT02660762|Abortifacient Agents|abortifacient agents|mesh-ancestor
25219814|NCT02660762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25219815|NCT02660762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25042554|NCT01421056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25042555|NCT01421056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25042556|NCT01421056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042559|NCT01418222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25042560|NCT01418222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042561|NCT01418222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25042562|NCT01418222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25042563|NCT01418222|Growth Substances|growth substances|mesh-ancestor
25042564|NCT01418222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042565|NCT01418222|Growth Inhibitors|growth inhibitors|mesh-ancestor
25042566|NCT01418222|Antidotes|antidotes|mesh-ancestor
25042567|NCT01418222|Protective Agents|protective agents|mesh-ancestor
25042568|NCT01418222|Vitamin B Complex|vitamin b complex|mesh-ancestor
25042569|NCT01418222|Vitamins|vitamins|mesh-ancestor
25042570|NCT01418222|Micronutrients|micronutrients|mesh-ancestor
25042571|NCT01416402|Colchicine|colchicine|mesh-list
25042572|NCT01416402|Febuxostat|febuxostat|mesh-list
25042573|NCT01416402|Gout Suppressants|gout suppressants|mesh-ancestor
25042574|NCT01416402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25042575|NCT01416402|Tubulin Modulators|tubulin modulators|mesh-ancestor
25042576|NCT01416402|Antimitotic Agents|antimitotic agents|mesh-ancestor
25042577|NCT01416402|Mitosis Modulators|mitosis modulators|mesh-ancestor
25042578|NCT01416402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086270|NCT03290625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25086271|NCT03290625|Anesthetics, General|anesthetics, general|mesh-ancestor
25086272|NCT03290625|Anesthetics|anesthetics|mesh-ancestor
25086273|NCT03290625|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25086274|NCT03290625|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25086275|NCT03290495|Ketamine|ketamine|mesh-list
25086276|NCT03290495|Analgesics|analgesics|mesh-ancestor
25086277|NCT03290495|Sensory System Agents|sensory system agents|mesh-ancestor
25086278|NCT03290495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25086279|NCT03290495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630070|NCT01109485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24630071|NCT01109485|Analgesics|analgesics|mesh-ancestor
25086280|NCT03290495|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25086281|NCT03290495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25086282|NCT03290495|Anesthetics, General|anesthetics, general|mesh-ancestor
25086283|NCT03290495|Anesthetics|anesthetics|mesh-ancestor
25086284|NCT03290495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25086285|NCT03290495|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25086286|NCT03290495|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25086287|NCT03290495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25219817|NCT02660762|Dermatologic Agents|dermatologic agents|mesh-ancestor
25219818|NCT02660762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25219819|NCT02660762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25219820|NCT02660762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25219821|NCT02660762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25219831|NCT02660684|Tacrolimus|tacrolimus|mesh-list
25219832|NCT02660684|Cyclosporins|cyclosporins|mesh-list
25219833|NCT02660684|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25219834|NCT02660684|Abortifacient Agents|abortifacient agents|mesh-ancestor
25219835|NCT02660684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25219836|NCT02660684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219837|NCT02660684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25219838|NCT02660684|Antimetabolites|antimetabolites|mesh-ancestor
25219839|NCT02660684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219840|NCT02660684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219841|NCT02660684|Dermatologic Agents|dermatologic agents|mesh-ancestor
25219842|NCT02660684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219843|NCT02660684|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25086288|NCT03290495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086289|NCT03290456|Prednisone|prednisone|mesh-list
25086290|NCT03290456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25086291|NCT03290456|Glucocorticoids|glucocorticoids|mesh-ancestor
25086292|NCT03290456|Hormones|hormones|mesh-ancestor
25086293|NCT03290456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25086294|NCT03290456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086295|NCT03290456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25086296|NCT03290456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25086297|NCT03290430|Nicotine|nicotine|mesh-list
25086298|NCT03290430|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25086299|NCT03290430|Autonomic Agents|autonomic agents|mesh-ancestor
25086300|NCT03290430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25086301|NCT03290430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086302|NCT03290430|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25086303|NCT03290430|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25086304|NCT03290430|Cholinergic Agents|cholinergic agents|mesh-ancestor
25086305|NCT03290430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25086306|NCT03290430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086307|NCT03290417|Vitamin D|vitamin d|mesh-list
25086308|NCT03290417|Ergocalciferols|ergocalciferols|mesh-list
24979634|NCT03373188|Nivolumab|nivolumab|mesh-list
25086309|NCT03290417|Cholecalciferol|cholecalciferol|mesh-list
25086323|NCT03290417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25086335|NCT03290196|Bupivacaine|bupivacaine|mesh-list
25086336|NCT03290196|Anesthetics, Local|anesthetics, local|mesh-ancestor
25086337|NCT03290196|Anesthetics|anesthetics|mesh-ancestor
25086338|NCT03290196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25086339|NCT03290196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692426|NCT01999348|Timolol|timolol|mesh-list
25086340|NCT03290196|Sensory System Agents|sensory system agents|mesh-ancestor
25086341|NCT03290196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25086369|NCT03289819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086370|NCT03289819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25086371|NCT03289819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25086372|NCT03289819|Alkylating Agents|alkylating agents|mesh-ancestor
25086373|NCT03289819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25219844|NCT02660684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25219845|NCT02660684|Immunologic Factors|immunologic factors|mesh-ancestor
25219846|NCT02660684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25219847|NCT02660684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25219848|NCT02660684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25219849|NCT02660684|Antifungal Agents|antifungal agents|mesh-ancestor
25219850|NCT02660684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25219851|NCT02660658|Dexmedetomidine|dexmedetomidine|mesh-list
25219852|NCT02660658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25219853|NCT02660658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25219854|NCT02660658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219855|NCT02660658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25219856|NCT02660658|Analgesics|analgesics|mesh-ancestor
25219857|NCT02660658|Sensory System Agents|sensory system agents|mesh-ancestor
25086374|NCT03289819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25086375|NCT03289819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25086376|NCT03289819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24979635|NCT03373188|Ipilimumab|ipilimumab|mesh-list
24433465|NCT00258479|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24433466|NCT00258479|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25086377|NCT03289819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25086378|NCT03289819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25086379|NCT03289728|Dobutamine|dobutamine|mesh-list
25086380|NCT03289728|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25086381|NCT03289728|Sympathomimetics|sympathomimetics|mesh-ancestor
25086382|NCT03289728|Autonomic Agents|autonomic agents|mesh-ancestor
25086383|NCT03289728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25086384|NCT03289728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086385|NCT03289728|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25086386|NCT03289728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25086387|NCT03289728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25086389|NCT03289728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25086390|NCT03289728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086391|NCT03289728|Protective Agents|protective agents|mesh-ancestor
25086392|NCT03289637|Vitamin D|vitamin d|mesh-list
25086393|NCT03289637|Vitamins|vitamins|mesh-ancestor
25086394|NCT03289637|Micronutrients|micronutrients|mesh-ancestor
25086395|NCT03289637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086396|NCT03289637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25086397|NCT03289559|Testosterone|testosterone|mesh-list
25086398|NCT03289559|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25086399|NCT03289559|Androgens|androgens|mesh-ancestor
25086400|NCT03289559|Hormones|hormones|mesh-ancestor
25086402|NCT03289559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086410|NCT03289520|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25086411|NCT03289520|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25086412|NCT03289520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25086421|NCT03289429|Antimetabolites|antimetabolites|mesh-ancestor
25086422|NCT03289429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086423|NCT03289429|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25086424|NCT03289429|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25086425|NCT03289429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25086426|NCT03289429|Analgesics|analgesics|mesh-ancestor
25086427|NCT03289429|Sensory System Agents|sensory system agents|mesh-ancestor
25086428|NCT03289429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25086429|NCT03289429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086430|NCT03289429|Anesthetics|anesthetics|mesh-ancestor
25086431|NCT03289429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25086432|NCT03289429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25086433|NCT03289429|Anticonvulsants|anticonvulsants|mesh-ancestor
25086434|NCT03289429|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25086435|NCT03289429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25086436|NCT03289429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25679407|NCT01838044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25679408|NCT01838044|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25679409|NCT01838044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25086437|NCT03289429|Tocolytic Agents|tocolytic agents|mesh-ancestor
25086438|NCT03289429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25086439|NCT03289390|Acetaminophen|acetaminophen|mesh-list
25086440|NCT03289390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25086441|NCT03289390|Analgesics|analgesics|mesh-ancestor
25086444|NCT03289390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086445|NCT03289390|Antipyretics|antipyretics|mesh-ancestor
25086446|NCT03289338|Zoledronic Acid|zoledronic acid|mesh-list
25086447|NCT03289338|Methylprednisolone|methylprednisolone|mesh-list
25086448|NCT03289338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25086449|NCT03289338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25086450|NCT03289338|Prednisolone|prednisolone|mesh-list
25086451|NCT03289338|Prednisolone acetate|prednisolone acetate|mesh-list
25086452|NCT03289338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25086453|NCT03289338|Prednisolone phosphate|prednisolone phosphate|mesh-list
25086454|NCT03289338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25086455|NCT03289338|Antiemetics|antiemetics|mesh-ancestor
25086456|NCT03289338|Autonomic Agents|autonomic agents|mesh-ancestor
25086457|NCT03289338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24630072|NCT01109485|Sensory System Agents|sensory system agents|mesh-ancestor
24630073|NCT01109485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24630074|NCT01109485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219858|NCT02660658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25219859|NCT02660658|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25219860|NCT02660658|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25042579|NCT01416402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630075|NCT01109485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24630076|NCT01109485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24630077|NCT01109485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24630078|NCT01109485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24630085|NCT01109498|Mycophenolic Acid|mycophenolic acid|mesh-list
24630086|NCT01109498|Cyclosporins|cyclosporins|mesh-list
24630087|NCT01109498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24630088|NCT01109498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630089|NCT01109498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24630090|NCT01109498|Immunologic Factors|immunologic factors|mesh-ancestor
24630091|NCT01109498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630092|NCT01109498|Antifungal Agents|antifungal agents|mesh-ancestor
24630093|NCT01109498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24630148|NCT01109693|Histamine Agents|histamine agents|mesh-ancestor
24630149|NCT01109693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24630150|NCT01109693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24630151|NCT01109693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24630152|NCT01109693|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24630153|NCT01109693|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24630154|NCT01109693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24630155|NCT01109693|Adrenergic Agents|adrenergic agents|mesh-ancestor
24630156|NCT01109693|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24630157|NCT01109693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24630158|NCT01109693|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25086458|NCT03289338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086459|NCT03289338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25086460|NCT03289338|Glucocorticoids|glucocorticoids|mesh-ancestor
25086461|NCT03289338|Hormones|hormones|mesh-ancestor
25086462|NCT03289338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25086463|NCT03289338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25086464|NCT03289338|Protective Agents|protective agents|mesh-ancestor
25086465|NCT03289338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24433501|NCT00258622|Anesthetics|anesthetics|mesh-ancestor
25086466|NCT03289338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25086467|NCT03289338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25086468|NCT03289260|Imiquimod|imiquimod|mesh-list
25086469|NCT03289260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25086470|NCT03289260|Immunologic Factors|immunologic factors|mesh-ancestor
25679410|NCT01838044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25679411|NCT01838044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25679412|NCT01838044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25679413|NCT01838044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25679414|NCT01838044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25679415|NCT01838044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25267050|NCT02424695|Gabapentin|gabapentin|mesh-list
25086471|NCT03289260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086472|NCT03289260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25086473|NCT03289260|Interferon Inducers|interferon inducers|mesh-ancestor
25086474|NCT03289182|Rituximab|rituximab|mesh-list
25086475|NCT03289182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25086476|NCT03289182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25086477|NCT03289182|Immunologic Factors|immunologic factors|mesh-ancestor
25086478|NCT03289182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086479|NCT03289182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25086480|NCT03289169|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25086481|NCT03289169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25086482|NCT03289169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25086483|NCT03289169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086484|NCT03289169|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25086485|NCT03289169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25086486|NCT03289169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086487|NCT03289169|Cholinergic Agents|cholinergic agents|mesh-ancestor
25086488|NCT03289169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25086489|NCT03289026|Aripiprazole|aripiprazole|mesh-list
25086490|NCT03289026|Antidepressive Agents|antidepressive agents|mesh-ancestor
25086491|NCT03289026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25086492|NCT03289026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24456486|NCT00331305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25219861|NCT02660658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25219862|NCT02660658|Adrenergic Agents|adrenergic agents|mesh-ancestor
25219863|NCT02660658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25219864|NCT02660658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219865|NCT02660502|Insulin|insulin|mesh-list
25086495|NCT03289026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086504|NCT03289026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25086505|NCT03289026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25086506|NCT03289026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25086508|NCT03288896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25086509|NCT03288896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25086510|NCT03288896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25086511|NCT03288896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433725|NCT00259779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25086512|NCT03288870|Docetaxel|docetaxel|mesh-list
25086513|NCT03288870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25086514|NCT03288870|Tubulin Modulators|tubulin modulators|mesh-ancestor
25086515|NCT03288870|Antimitotic Agents|antimitotic agents|mesh-ancestor
25086516|NCT03288870|Mitosis Modulators|mitosis modulators|mesh-ancestor
25086707|NCT03287011|Protective Agents|protective agents|mesh-ancestor
24630176|NCT01109823|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24630177|NCT01109823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25086519|NCT03288818|Alkylating Agents|alkylating agents|mesh-ancestor
25086520|NCT03288818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086521|NCT03288818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25086522|NCT03288818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25086524|NCT03288675|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25086525|NCT03288675|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25086526|NCT03288675|Serotonin Agents|serotonin agents|mesh-ancestor
25086527|NCT03288675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25086573|NCT03288402|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24630198|NCT01110031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630199|NCT01110226|Cisplatin|cisplatin|mesh-list
24630200|NCT01110226|Sodium arsenite|sodium arsenite|mesh-list
24630201|NCT01110226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630202|NCT01110226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24630203|NCT01110226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630204|NCT01110291|Docetaxel|docetaxel|mesh-list
24630205|NCT01110291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219866|NCT02660502|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25219867|NCT02660502|Insulin Lispro|insulin lispro|mesh-list
25679416|NCT01838044|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25679417|NCT01838044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25679418|NCT01838044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25679419|NCT01838200|Isoniazid|isoniazid|mesh-list
25679420|NCT01838200|Ipilimumab|ipilimumab|mesh-list
25679421|NCT01838200|BCG Vaccine|bcg vaccine|mesh-list
25692427|NCT01999348|Bimatoprost|bimatoprost|mesh-list
25219869|NCT02660502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219870|NCT02660606|Analgesics, Opioid|analgesics, opioid|mesh-list
24832798|NCT02172261|Immunologic Factors|immunologic factors|mesh-ancestor
24832799|NCT02172261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24630206|NCT01110291|Tubulin Modulators|tubulin modulators|mesh-ancestor
24630207|NCT01110291|Antimitotic Agents|antimitotic agents|mesh-ancestor
24630208|NCT01110291|Mitosis Modulators|mitosis modulators|mesh-ancestor
24630209|NCT01110291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630211|NCT01110304|Sensory System Agents|sensory system agents|mesh-ancestor
24630212|NCT01110304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24630213|NCT01110304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630214|NCT01110317|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24630215|NCT01110317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24630216|NCT01110317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24630217|NCT01110317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25086531|NCT03288675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25086533|NCT03288636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25086534|NCT03288636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25086535|NCT03288636|Protease Inhibitors|protease inhibitors|mesh-ancestor
25086536|NCT03288636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25086537|NCT03288636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086539|NCT03288636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25086540|NCT03288636|Antiviral Agents|antiviral agents|mesh-ancestor
25086541|NCT03288636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25086542|NCT03288636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25086543|NCT03288636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25086544|NCT03288610|Vasopressins|vasopressins|mesh-list
25086545|NCT03288610|Hemostatics|hemostatics|mesh-ancestor
25086557|NCT03288532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25086559|NCT03288428|Nalbuphine|nalbuphine|mesh-list
24456491|NCT00331305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25086567|NCT03288402|Caffeine|caffeine|mesh-list
25086568|NCT03288402|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25086569|NCT03288402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086570|NCT03288402|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25086571|NCT03288402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25086572|NCT03288402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086574|NCT03288402|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25086575|NCT03288402|Purinergic Agents|purinergic agents|mesh-ancestor
25086576|NCT03288402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25086577|NCT03288350|Avelumab|avelumab|mesh-list
25086578|NCT03288350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25086579|NCT03288350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25086580|NCT03288259|Anesthetics|anesthetics|mesh-list
25086581|NCT03288259|Anesthetics, Local|anesthetics, local|mesh-list
25086582|NCT03288259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25086583|NCT03288259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086584|NCT03288259|Sensory System Agents|sensory system agents|mesh-ancestor
25086585|NCT03288259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25086586|NCT03288233|Carbon Monoxide|carbon monoxide|mesh-list
25086587|NCT03288233|Antimetabolites|antimetabolites|mesh-ancestor
25219871|NCT02660606|Narcotics|narcotics|mesh-ancestor
25219872|NCT02660606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25219873|NCT02660606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219874|NCT02660606|Analgesics|analgesics|mesh-ancestor
25219875|NCT02660606|Sensory System Agents|sensory system agents|mesh-ancestor
25219876|NCT02660606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25219877|NCT02660346|Vancomycin|vancomycin|mesh-list
24832800|NCT02172261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832801|NCT02172274|Empagliflozin|empagliflozin|mesh-list
24832802|NCT02172274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24832803|NCT02172274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832804|NCT02172274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24432222|NCT00254020|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25267062|NCT02424695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25267063|NCT02424695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267064|NCT02424695|Antimanic Agents|antimanic agents|mesh-ancestor
25267065|NCT02424318|Topiramate|topiramate|mesh-list
25267066|NCT02424318|Anticonvulsants|anticonvulsants|mesh-ancestor
25267067|NCT02424318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25086588|NCT03288233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086589|NCT03288233|Gasotransmitters|gasotransmitters|mesh-ancestor
25086590|NCT03288233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25086591|NCT03288233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761996|NCT01765790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761997|NCT01765829|Droperidol|droperidol|mesh-list
24630218|NCT01110317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630219|NCT01110317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24630220|NCT01110317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24443396|NCT00294775|Candesartan|candesartan|mesh-list
24630221|NCT01110317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24630222|NCT01110317|Serotonin Agents|serotonin agents|mesh-ancestor
24630223|NCT01110317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24630224|NCT01110317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630225|NCT01110317|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24630226|NCT01110317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24630227|NCT01110317|Dopamine Agents|dopamine agents|mesh-ancestor
24630228|NCT01110473|Azacitidine|azacitidine|mesh-list
24630229|NCT01110473|Ilorasertib|ilorasertib|mesh-list
24630230|NCT01110473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24630231|NCT01110473|Antimetabolites|antimetabolites|mesh-ancestor
25086655|NCT03287388|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24630232|NCT01110473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761998|NCT01765829|Haloperidol|haloperidol|mesh-list
24762000|NCT01765829|Olanzapine|olanzapine|mesh-list
25086592|NCT03288077|Tryptophan|tryptophan|mesh-list
25086598|NCT03288051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25086599|NCT03288051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25086600|NCT03288051|Adrenergic Agents|adrenergic agents|mesh-ancestor
25086601|NCT03288051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25086602|NCT03288051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086603|NCT03288051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086604|NCT03288051|Sympathomimetics|sympathomimetics|mesh-ancestor
25086605|NCT03288051|Autonomic Agents|autonomic agents|mesh-ancestor
25086606|NCT03288051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25086607|NCT03288051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25086608|NCT03288051|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25086609|NCT03288051|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25086610|NCT03288051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25086611|NCT03288051|Protective Agents|protective agents|mesh-ancestor
25086612|NCT03288038|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25086613|NCT03288038|Ezetimibe|ezetimibe|mesh-list
25086614|NCT03288038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25086615|NCT03288038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25086616|NCT03288038|Antimetabolites|antimetabolites|mesh-ancestor
25086617|NCT03288038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086618|NCT03288038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25086619|NCT03288038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25086634|NCT03287609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086635|NCT03287609|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25086637|NCT03287505|Antidepressive Agents|antidepressive agents|mesh-ancestor
25086638|NCT03287505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25086639|NCT03287505|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25219878|NCT02660346|Daptomycin|daptomycin|mesh-list
25219879|NCT02660346|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
25219880|NCT02660346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25679422|NCT01838200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25679423|NCT01838200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25679424|NCT01838200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25679425|NCT01838200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679426|NCT01838200|Antitubercular Agents|antitubercular agents|mesh-ancestor
25679427|NCT01838200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25679428|NCT01838200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25219881|NCT02660346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25267081|NCT02424201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25267082|NCT02424201|Oxytocics|oxytocics|mesh-ancestor
25267083|NCT02424201|Antioxidants|antioxidants|mesh-ancestor
25267084|NCT02424201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267085|NCT02424201|Protective Agents|protective agents|mesh-ancestor
25267086|NCT02424461|Ceftriaxone|ceftriaxone|mesh-list
25267087|NCT02424461|Ofloxacin|ofloxacin|mesh-list
25219882|NCT02660255|Cannabidiol|cannabidiol|mesh-list
25219883|NCT02660255|Anticonvulsants|anticonvulsants|mesh-ancestor
25219884|NCT02660177|Dipyrone|dipyrone|mesh-list
25219885|NCT02660177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25219886|NCT02660177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25219887|NCT02660177|Analgesics|analgesics|mesh-ancestor
25219888|NCT02660177|Sensory System Agents|sensory system agents|mesh-ancestor
24451481|NCT00323843|Respiratory System Agents|respiratory system agents|mesh-ancestor
24451482|NCT00323843|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24451483|NCT00323843|Sympathomimetics|sympathomimetics|mesh-ancestor
24451484|NCT00323843|Protective Agents|protective agents|mesh-ancestor
24476633|NCT00415935|Methotrexate|methotrexate|mesh-list
25086640|NCT03287505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25086641|NCT03287505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25086642|NCT03287505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086643|NCT03287505|Dopamine Agonists|dopamine agonists|mesh-ancestor
25086644|NCT03287505|Dopamine Agents|dopamine agents|mesh-ancestor
25086645|NCT03287505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25086646|NCT03287505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086647|NCT03287505|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25086648|NCT03287505|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25086649|NCT03287505|Serotonin Agents|serotonin agents|mesh-ancestor
25086650|NCT03287505|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25086651|NCT03287505|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25086652|NCT03287505|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25086653|NCT03287505|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25086654|NCT03287388|Rocuronium|rocuronium|mesh-list
25086656|NCT03287388|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24762001|NCT01765829|Chlorpromazine|chlorpromazine|mesh-list
25086657|NCT03287388|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25086658|NCT03287388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25086659|NCT03287388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086660|NCT03287375|Cisplatin|cisplatin|mesh-list
24762070|NCT01765881|Abortifacient Agents|abortifacient agents|mesh-ancestor
25086661|NCT03287375|Doxorubicin|doxorubicin|mesh-list
25086662|NCT03287375|Oxaliplatin|oxaliplatin|mesh-list
25086663|NCT03287375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630233|NCT01110473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630234|NCT01110473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24630235|NCT01110473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24630236|NCT01110486|Carboplatin|carboplatin|mesh-list
24630237|NCT01110486|Docetaxel|docetaxel|mesh-list
24630238|NCT01110486|Ilorasertib|ilorasertib|mesh-list
24630239|NCT01110486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630240|NCT01110486|Tubulin Modulators|tubulin modulators|mesh-ancestor
25086664|NCT03287375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25086665|NCT03287375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25679429|NCT01838200|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25679430|NCT01838200|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25679431|NCT01838200|Antimetabolites|antimetabolites|mesh-ancestor
25679432|NCT01838200|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25679433|NCT01838200|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25679434|NCT01838200|Immunologic Factors|immunologic factors|mesh-ancestor
25086666|NCT03287375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25086675|NCT03287271|Paclitaxel|paclitaxel|mesh-list
25086676|NCT03287271|Carboplatin|carboplatin|mesh-list
25086677|NCT03287271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25086678|NCT03287271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25086679|NCT03287271|Tubulin Modulators|tubulin modulators|mesh-ancestor
25219889|NCT02660177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25219890|NCT02660177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219891|NCT02660177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25219892|NCT02660177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25219895|NCT02660008|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25219896|NCT02660008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25219897|NCT02660008|Hormones|hormones|mesh-ancestor
25219898|NCT02660008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25219899|NCT02660008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219900|NCT02660008|Incretins|incretins|mesh-ancestor
25219901|NCT02660060|Pramipexole|pramipexole|mesh-list
25219902|NCT02660060|Antioxidants|antioxidants|mesh-ancestor
25219903|NCT02660060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219904|NCT02660060|Protective Agents|protective agents|mesh-ancestor
25275630|NCT02370745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25086680|NCT03287271|Antimitotic Agents|antimitotic agents|mesh-ancestor
25086681|NCT03287271|Mitosis Modulators|mitosis modulators|mesh-ancestor
25086682|NCT03287271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086683|NCT03287180|Buprenorphine|buprenorphine|mesh-list
25086684|NCT03287180|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25086685|NCT03287180|Naloxone|naloxone|mesh-list
25086686|NCT03287180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25086687|NCT03287180|Narcotics|narcotics|mesh-ancestor
25086688|NCT03287180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25086689|NCT03287180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630241|NCT01110486|Antimitotic Agents|antimitotic agents|mesh-ancestor
24630243|NCT01110486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630257|NCT01110603|Carboplatin|carboplatin|mesh-list
24630258|NCT01110603|Doxorubicin|doxorubicin|mesh-list
24630259|NCT01110603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24630260|NCT01110603|Niraparib|niraparib|mesh-list
24443428|NCT00294918|Hormones|hormones|mesh-list
24630261|NCT01110603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24630262|NCT01110603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630263|NCT01110603|Tubulin Modulators|tubulin modulators|mesh-ancestor
24630264|NCT01110603|Antimitotic Agents|antimitotic agents|mesh-ancestor
24630265|NCT01110603|Mitosis Modulators|mitosis modulators|mesh-ancestor
24630266|NCT01110603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435178|NCT00265408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24630267|NCT01110603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24630268|NCT01110603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24630269|NCT01110603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24630270|NCT01110603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219905|NCT02660060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219907|NCT02660060|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25219908|NCT02660060|Dopamine Agonists|dopamine agonists|mesh-ancestor
25219909|NCT02660060|Dopamine Agents|dopamine agents|mesh-ancestor
25219910|NCT02660060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25219911|NCT02660047|Liraglutide|liraglutide|mesh-list
25219912|NCT02660047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25219913|NCT02660047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219915|NCT02660047|Hormones|hormones|mesh-ancestor
25219916|NCT02660047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25273045|NCT02387619|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25273046|NCT02387619|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25273047|NCT02387307|Interferons|interferons|mesh-list
25273048|NCT02387307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25273049|NCT02387307|Antiviral Agents|antiviral agents|mesh-ancestor
25273050|NCT02387307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25273051|NCT02387567|Lidocaine|lidocaine|mesh-list
25273052|NCT02387567|Anesthetics, Local|anesthetics, local|mesh-ancestor
25273053|NCT02387567|Anesthetics|anesthetics|mesh-ancestor
25273054|NCT02387567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25273055|NCT02387567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832823|NCT02172300|Tiotropium Bromide|tiotropium bromide|mesh-list
24832824|NCT02172300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24832825|NCT02172300|Autonomic Agents|autonomic agents|mesh-ancestor
25052844|NCT00135369|Lamivudine|lamivudine|mesh-list
24630271|NCT01110603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24630272|NCT01110616|Lorazepam|lorazepam|mesh-list
25086690|NCT03287180|Analgesics|analgesics|mesh-ancestor
25086691|NCT03287180|Sensory System Agents|sensory system agents|mesh-ancestor
25086692|NCT03287180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25086693|NCT03287180|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25086694|NCT03287128|Gemtuzumab|gemtuzumab|mesh-list
25086695|NCT03287128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25086696|NCT03287128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25086697|NCT03287076|Exenatide|exenatide|mesh-list
25086698|NCT03287076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25086699|NCT03287076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086700|NCT03287076|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25086701|NCT03287076|Incretins|incretins|mesh-ancestor
25086702|NCT03287076|Hormones|hormones|mesh-ancestor
25086703|NCT03287076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25086704|NCT03287011|Listerine|listerine|mesh-list
25086705|NCT03287011|Sodium Fluoride|sodium fluoride|mesh-list
25086706|NCT03287011|Cariostatic Agents|cariostatic agents|mesh-ancestor
25086708|NCT03287011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630273|NCT01110616|Anticonvulsants|anticonvulsants|mesh-ancestor
24630274|NCT01110616|Antiemetics|antiemetics|mesh-ancestor
24630275|NCT01110616|Autonomic Agents|autonomic agents|mesh-ancestor
24630276|NCT01110616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24630287|NCT01110616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630288|NCT01110642|Lovastatin|lovastatin|mesh-list
24630289|NCT01110642|L 647318|l 647318|mesh-list
24630290|NCT01110642|Dihydromevinolin|dihydromevinolin|mesh-list
24630291|NCT01110642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24630292|NCT01110642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24630293|NCT01110642|Antimetabolites|antimetabolites|mesh-ancestor
24630294|NCT01110642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630295|NCT01110642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24630296|NCT01110642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24630297|NCT01110642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24630298|NCT01110785|Panitumumab|panitumumab|mesh-list
24630302|NCT01110785|Antimetabolites|antimetabolites|mesh-ancestor
24630303|NCT01110785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630304|NCT01110785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25219917|NCT02659683|Esomeprazole|esomeprazole|mesh-list
25219918|NCT02659683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25219919|NCT02659683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25219920|NCT02659683|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25219921|NCT02659683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219922|NCT02659683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219923|NCT02659761|Lamivudine|lamivudine|mesh-list
25219924|NCT02659761|Abacavir|abacavir|mesh-list
25219925|NCT02659761|Dolutegravir|dolutegravir|mesh-list
25219926|NCT02659761|Triumeq|triumeq|mesh-list
25219927|NCT02659761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25219928|NCT02659761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25219929|NCT02659761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25219930|NCT02659761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219931|NCT02659761|Antiviral Agents|antiviral agents|mesh-ancestor
25219932|NCT02659761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24832826|NCT02172300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24832827|NCT02172300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630305|NCT01110785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24630306|NCT01110785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24630307|NCT01110785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24630308|NCT01110785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630309|NCT01110824|Carvedilol|carvedilol|mesh-list
24630310|NCT01110824|Enalapril|enalapril|mesh-list
24630311|NCT01110824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24456502|NCT00331500|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24456503|NCT00331500|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24456504|NCT00331500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24456505|NCT00331500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24456506|NCT00331500|Analgesics|analgesics|mesh-ancestor
24452959|NCT05384691|Luspatercept|luspatercept|mesh-list
24452960|NCT05384691|Hematinics|hematinics|mesh-ancestor
25086709|NCT03287011|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25086710|NCT03287011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25086711|NCT03286959|Calcium|calcium|mesh-list
25086712|NCT03286959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25086713|NCT03286959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086714|NCT03286803|Vaccines|vaccines|mesh-list
25086715|NCT03286803|Immunologic Factors|immunologic factors|mesh-ancestor
25086716|NCT03286803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086717|NCT03286764|Peppermint oil|peppermint oil|mesh-list
25086718|NCT03286764|Antiemetics|antiemetics|mesh-ancestor
25086720|NCT03286764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25086721|NCT03286764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086722|NCT03286764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25086723|NCT03286764|Parasympatholytics|parasympatholytics|mesh-ancestor
25086724|NCT03286673|Calcium, Dietary|calcium, dietary|mesh-list
25086725|NCT03286673|Calcium Carbonate|calcium carbonate|mesh-list
25086726|NCT03286673|Calcium|calcium|mesh-list
25086727|NCT03286673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25086728|NCT03286673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086729|NCT03286673|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24762071|NCT01765881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24762076|NCT01765946|Metformin|metformin|mesh-list
25086730|NCT03286673|Antacids|antacids|mesh-ancestor
25219946|NCT02659917|Adrenergic Agents|adrenergic agents|mesh-ancestor
25219947|NCT02659917|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25219948|NCT02659917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24532840|NCT00641264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24532841|NCT00641264|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25086731|NCT03286673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086732|NCT03286673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24762143|NCT01766375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532842|NCT00641264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532844|NCT00641329|Clonidine|clonidine|mesh-list
24630340|NCT01111019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630341|NCT01111084|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24630342|NCT01111084|Hormones|hormones|mesh-ancestor
25405195|NCT03623321|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24630343|NCT01111084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24630344|NCT01111084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630345|NCT01111188|Bortezomib|bortezomib|mesh-list
24630346|NCT01111188|Palbociclib|palbociclib|mesh-list
24630347|NCT01111188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630348|NCT01111188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24630349|NCT01111188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505126|NCT00540085|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24630350|NCT01111188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630352|NCT01111227|Isoflurane|isoflurane|mesh-list
24630353|NCT01111227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24630354|NCT01111227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24630355|NCT01111227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630356|NCT01111227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24630367|NCT01111253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24630368|NCT01111253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630369|NCT01111383|Tobramycin|tobramycin|mesh-list
24630370|NCT01111383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24630415|NCT01111630|Hematinics|hematinics|mesh-ancestor
24630416|NCT01111656|Interferons|interferons|mesh-list
24630417|NCT01111656|Interferon-beta|interferon-beta|mesh-list
24630418|NCT01111656|Atorvastatin|atorvastatin|mesh-list
24630419|NCT01111656|Interferon beta-1b|interferon beta-1b|mesh-list
24630578|NCT01112462|Adrenergic Agents|adrenergic agents|mesh-ancestor
24832831|NCT02172300|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24832832|NCT02172300|Cholinergic Agents|cholinergic agents|mesh-ancestor
24832833|NCT02172300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24832834|NCT02172300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832836|NCT02172326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24832837|NCT02172326|Autonomic Agents|autonomic agents|mesh-ancestor
24739548|NCT01682408|Histamine Agents|histamine agents|mesh-ancestor
24630420|NCT01111656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630421|NCT01111656|Antiviral Agents|antiviral agents|mesh-ancestor
24630422|NCT01111656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24630423|NCT01111656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24630442|NCT01111682|Natriuretic Agents|natriuretic agents|mesh-ancestor
24630443|NCT01111682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436660|NCT00270777|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24630444|NCT01111734|Acetylcysteine|acetylcysteine|mesh-list
24630445|NCT01111734|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24630446|NCT01111734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630447|NCT01111734|Antiviral Agents|antiviral agents|mesh-ancestor
24630448|NCT01111734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24630466|NCT01111890|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24630467|NCT01111890|Adrenergic Agents|adrenergic agents|mesh-ancestor
24630468|NCT01111890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24630469|NCT01111890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630470|NCT01111890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630471|NCT01111890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24630472|NCT01111890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24630473|NCT01111890|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24630475|NCT01111903|Lenalidomide|lenalidomide|mesh-list
24630486|NCT01111942|Fluorouracil|fluorouracil|mesh-list
24630487|NCT01111942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630488|NCT01111942|Tubulin Modulators|tubulin modulators|mesh-ancestor
24630489|NCT01111942|Antimitotic Agents|antimitotic agents|mesh-ancestor
24630490|NCT01111942|Mitosis Modulators|mitosis modulators|mesh-ancestor
24630491|NCT01111942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630492|NCT01111942|Antimetabolites|antimetabolites|mesh-ancestor
24630493|NCT01111942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24630496|NCT01111942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630498|NCT01111968|Immunologic Factors|immunologic factors|mesh-ancestor
24630499|NCT01111968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630501|NCT01111981|Emollients|emollients|mesh-list
24630502|NCT01111981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24630503|NCT01111981|Glucocorticoids|glucocorticoids|mesh-ancestor
25219953|NCT02659657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25219954|NCT02659657|Analgesics|analgesics|mesh-ancestor
25219955|NCT02659657|Sensory System Agents|sensory system agents|mesh-ancestor
25219956|NCT02659657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25219957|NCT02659657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219958|NCT02659891|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25219959|NCT02659891|Immunologic Factors|immunologic factors|mesh-ancestor
25219960|NCT02659891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219961|NCT02659488|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25219962|NCT02659488|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25219963|NCT02659488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219964|NCT02659488|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24630508|NCT01111994|Clindamycin|clindamycin|mesh-list
24630509|NCT01111994|Clindamycin palmitate|clindamycin palmitate|mesh-list
24630510|NCT01111994|Clindamycin phosphate|clindamycin phosphate|mesh-list
24630511|NCT01111994|Tretinoin|tretinoin|mesh-list
24630512|NCT01111994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24630513|NCT01111994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24630514|NCT01111994|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24630515|NCT01111994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24630516|NCT01111994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630517|NCT01111994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630518|NCT01111994|Keratolytic Agents|keratolytic agents|mesh-ancestor
24630519|NCT01111994|Dermatologic Agents|dermatologic agents|mesh-ancestor
24630527|NCT01112137|Clopidogrel|clopidogrel|mesh-list
24630528|NCT01112137|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24630529|NCT01112137|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24630530|NCT01112137|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24630545|NCT01112215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630546|NCT01112215|Antimetabolites|antimetabolites|mesh-ancestor
25086775|NCT03286582|Clobetasol|clobetasol|mesh-list
25086776|NCT03286582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25086777|NCT03286582|Glucocorticoids|glucocorticoids|mesh-ancestor
25086778|NCT03286582|Hormones|hormones|mesh-ancestor
25086779|NCT03286582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25086780|NCT03286582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630548|NCT01112215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24630549|NCT01112215|Immunologic Factors|immunologic factors|mesh-ancestor
24630550|NCT01112215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630551|NCT01112215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24630552|NCT01112449|Selenium|selenium|mesh-list
25219966|NCT02659488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25219967|NCT02659488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25219968|NCT02659488|Dopamine Agents|dopamine agents|mesh-ancestor
25219969|NCT02659488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25219970|NCT02659384|Aspirin|aspirin|mesh-list
25219971|NCT02659384|Bevacizumab|bevacizumab|mesh-list
25219972|NCT02659384|Atezolizumab|atezolizumab|mesh-list
25219973|NCT02659384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25219974|NCT02659384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219975|NCT02659384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24832842|NCT02172326|Parasympatholytics|parasympatholytics|mesh-ancestor
24630553|NCT01112449|Antioxidants|antioxidants|mesh-ancestor
24630554|NCT01112449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630555|NCT01112449|Protective Agents|protective agents|mesh-ancestor
24630556|NCT01112449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630557|NCT01112449|Trace Elements|trace elements|mesh-ancestor
24630558|NCT01112449|Micronutrients|micronutrients|mesh-ancestor
24630559|NCT01112462|Acetaminophen|acetaminophen|mesh-list
24630560|NCT01112462|Phenylephrine|phenylephrine|mesh-list
24630575|NCT01112462|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24630576|NCT01112462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24630577|NCT01112462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25679435|NCT01838200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679436|NCT01838317|Pioglitazone|pioglitazone|mesh-list
25679437|NCT01838317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25679438|NCT01838317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679439|NCT01838447|Vitamin D|vitamin d|mesh-list
25679440|NCT01838447|Cholecalciferol|cholecalciferol|mesh-list
24436826|NCT00271453|Anesthetics|anesthetics|mesh-ancestor
24630580|NCT01112462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630588|NCT01112540|Sensory System Agents|sensory system agents|mesh-ancestor
24630589|NCT01112540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24630590|NCT01112644|Oxycodone|oxycodone|mesh-list
24630591|NCT01112644|Naloxone|naloxone|mesh-list
24630592|NCT01112644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24630593|NCT01112644|Narcotics|narcotics|mesh-ancestor
24630594|NCT01112644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24630595|NCT01112644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630596|NCT01112644|Analgesics|analgesics|mesh-ancestor
24630597|NCT01112644|Sensory System Agents|sensory system agents|mesh-ancestor
24630598|NCT01112644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25086781|NCT03286452|Anti-Infective Agents|anti-infective agents|mesh-list
25086782|NCT03286452|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25086783|NCT03286296|Antibodies|antibodies|mesh-list
25086784|NCT03286296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25086785|NCT03286296|Immunologic Factors|immunologic factors|mesh-ancestor
25086786|NCT03286296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086787|NCT03286244|Paclitaxel|paclitaxel|mesh-list
25245799|NCT03719326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25086788|NCT03286244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25086789|NCT03286244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25086790|NCT03286244|Tubulin Modulators|tubulin modulators|mesh-ancestor
25086791|NCT03286244|Antimitotic Agents|antimitotic agents|mesh-ancestor
25086792|NCT03286244|Mitosis Modulators|mitosis modulators|mesh-ancestor
25086793|NCT03286244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086794|NCT03286101|Ivermectin|ivermectin|mesh-list
25086795|NCT03286101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25086796|NCT03286101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25086797|NCT03285906|Apatinib|apatinib|mesh-list
25086798|NCT03285906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25086799|NCT03285906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24795513|NCT01968213|Rucaparib|rucaparib|mesh-list
24437248|NCT00273039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24437249|NCT00273039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24437263|NCT00273247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795527|NCT01812252|Azacitidine|azacitidine|mesh-list
24795528|NCT01812252|Decitabine|decitabine|mesh-list
24437264|NCT00273299|Valsartan|valsartan|mesh-list
24630604|NCT01112722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630605|NCT01112722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630606|NCT01112748|Lidocaine|lidocaine|mesh-list
24630607|NCT01112748|Anesthetics, Local|anesthetics, local|mesh-ancestor
24630608|NCT01112748|Anesthetics|anesthetics|mesh-ancestor
24630610|NCT01112748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630611|NCT01112748|Sensory System Agents|sensory system agents|mesh-ancestor
24630612|NCT01112748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24630613|NCT01112748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24630614|NCT01112748|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24630615|NCT01112748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24630616|NCT01112748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24630617|NCT01112748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630618|NCT01112787|Tazarotene|tazarotene|mesh-list
24630619|NCT01112787|Dermatologic Agents|dermatologic agents|mesh-ancestor
24630620|NCT01112787|Keratolytic Agents|keratolytic agents|mesh-ancestor
24630621|NCT01112813|Lithium Carbonate|lithium carbonate|mesh-list
24630622|NCT01112813|Antidepressive Agents|antidepressive agents|mesh-ancestor
25219976|NCT02659384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25219977|NCT02659384|Growth Substances|growth substances|mesh-ancestor
25219978|NCT02659384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219979|NCT02659384|Growth Inhibitors|growth inhibitors|mesh-ancestor
25219980|NCT02659384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24630623|NCT01112813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24630624|NCT01112813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24630627|NCT01112813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24630628|NCT01112813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25086805|NCT03285802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25086806|NCT03285802|Immunologic Factors|immunologic factors|mesh-ancestor
25086807|NCT03285802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762217|NCT01766960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24762218|NCT01766960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267152|NCT02424071|Melatonin|melatonin|mesh-list
24762220|NCT01766960|Sensory System Agents|sensory system agents|mesh-ancestor
24762221|NCT01766960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24762222|NCT01767025|Oxytocin|oxytocin|mesh-list
24762223|NCT01767025|Oxytocics|oxytocics|mesh-ancestor
24762224|NCT01767025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24762225|NCT01767025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762226|NCT01767090|Leuprolide|leuprolide|mesh-list
24762227|NCT01767090|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24762228|NCT01767090|Fertility Agents|fertility agents|mesh-ancestor
24762229|NCT01767090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24762230|NCT01767090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762231|NCT01767090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24762232|NCT01767090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24762233|NCT01767259|Valsartan|valsartan|mesh-list
24762234|NCT01767259|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24762235|NCT01767259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24630629|NCT01112813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630630|NCT01112826|Capecitabine|capecitabine|mesh-list
24630631|NCT01112826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24630697|NCT01113138|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24630698|NCT01113138|Anticonvulsants|anticonvulsants|mesh-ancestor
24630699|NCT01113138|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24630700|NCT01113138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24630701|NCT01113138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630719|NCT01113164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24630720|NCT01113164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24630721|NCT01113164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24630730|NCT01113229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24630731|NCT01113229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630732|NCT01113229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24630733|NCT01113229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24630734|NCT01113229|Oxytocics|oxytocics|mesh-ancestor
24630736|NCT01113281|Immunologic Factors|immunologic factors|mesh-ancestor
24630737|NCT01113281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630738|NCT01113372|Clopidogrel|clopidogrel|mesh-list
24630739|NCT01113372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24630740|NCT01113372|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24762236|NCT01767259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24762237|NCT01767259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25087071|NCT03283020|Naltrexone|naltrexone|mesh-list
25086811|NCT03285802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086812|NCT03285802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25086813|NCT03285802|Hormone Antagonists|hormone antagonists|mesh-ancestor
25086814|NCT03285802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25086815|NCT03285607|Paclitaxel|paclitaxel|mesh-list
25086816|NCT03285607|Cyclophosphamide|cyclophosphamide|mesh-list
25086817|NCT03285607|Doxorubicin|doxorubicin|mesh-list
25086818|NCT03285607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25086819|NCT03285607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25219981|NCT02659384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25219982|NCT02659384|Analgesics|analgesics|mesh-ancestor
25219983|NCT02659384|Sensory System Agents|sensory system agents|mesh-ancestor
25086822|NCT03285607|Mitosis Modulators|mitosis modulators|mesh-ancestor
25086823|NCT03285607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086824|NCT03285607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25086825|NCT03285607|Immunologic Factors|immunologic factors|mesh-ancestor
25086826|NCT03285607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086827|NCT03285607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25086828|NCT03285607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25086829|NCT03285607|Alkylating Agents|alkylating agents|mesh-ancestor
25086830|NCT03285607|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25086831|NCT03285607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25086832|NCT03285607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25086833|NCT03285607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25679441|NCT01838447|Vitamins|vitamins|mesh-ancestor
25086839|NCT03285568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086840|NCT03285503|Aripiprazole|aripiprazole|mesh-list
25086841|NCT03285503|Antidepressive Agents|antidepressive agents|mesh-ancestor
25086848|NCT03285503|Dopamine Agents|dopamine agents|mesh-ancestor
25086849|NCT03285503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25086851|NCT03285503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25086885|NCT03284762|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25086886|NCT03284762|Antithrombins|antithrombins|mesh-ancestor
25086887|NCT03284762|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25086888|NCT03284762|Protease Inhibitors|protease inhibitors|mesh-ancestor
25086889|NCT03284762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25086890|NCT03284762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086891|NCT03284762|Anticoagulants|anticoagulants|mesh-ancestor
25086893|NCT03284749|Trace Elements|trace elements|mesh-ancestor
25086894|NCT03284749|Micronutrients|micronutrients|mesh-ancestor
25086895|NCT03284749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086896|NCT03284645|Tenofovir|tenofovir|mesh-list
25086897|NCT03284645|Lamivudine|lamivudine|mesh-list
25086898|NCT03284645|Zidovudine|zidovudine|mesh-list
25086899|NCT03284645|Efavirenz|efavirenz|mesh-list
25086900|NCT03284645|Abacavir|abacavir|mesh-list
25086901|NCT03284645|Antiviral Agents|antiviral agents|mesh-ancestor
25086902|NCT03284645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25086903|NCT03284645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25086904|NCT03284645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25086905|NCT03284645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25086906|NCT03284645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762260|NCT01767298|Natriuretic Agents|natriuretic agents|mesh-ancestor
24630741|NCT01113372|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24630742|NCT01113372|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24630743|NCT01113372|Purinergic Agents|purinergic agents|mesh-ancestor
24630744|NCT01113372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24630745|NCT01113372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630767|NCT01113489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25219984|NCT02659384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25219985|NCT02659384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25219986|NCT02659384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25219987|NCT02659384|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25219988|NCT02659384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25220039|NCT02659085|Anesthetics, General|anesthetics, general|mesh-ancestor
24437371|NCT00273481|Timolol|timolol|mesh-list
24437390|NCT00273507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24437391|NCT00273507|Tubulin Modulators|tubulin modulators|mesh-ancestor
24979915|NCT04971954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24979916|NCT04971954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979917|NCT04971954|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24437392|NCT00273507|Antimitotic Agents|antimitotic agents|mesh-ancestor
25061106|NCT03473626|Alicaforsen|alicaforsen|mesh-list
24630768|NCT01113489|Respiratory System Agents|respiratory system agents|mesh-ancestor
24630769|NCT01113515|Esmolol|esmolol|mesh-list
24630770|NCT01113515|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24630771|NCT01113515|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24630772|NCT01113515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24630773|NCT01113515|Adrenergic Agents|adrenergic agents|mesh-ancestor
24630774|NCT01113515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24630775|NCT01113515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630776|NCT01113515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630777|NCT01113528|Aspirin|aspirin|mesh-list
25405196|NCT03623321|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24630778|NCT01113528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24630779|NCT01113528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24630780|NCT01113528|Analgesics|analgesics|mesh-ancestor
24630781|NCT01113528|Sensory System Agents|sensory system agents|mesh-ancestor
24630782|NCT01113528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24630783|NCT01113528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630784|NCT01113528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24630785|NCT01113528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24630786|NCT01113528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24630787|NCT01113528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24630788|NCT01113528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086908|NCT03284645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25086909|NCT03284645|Antimetabolites|antimetabolites|mesh-ancestor
25086910|NCT03284645|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25086911|NCT03284645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25086912|NCT03284645|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25086913|NCT03284645|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24437398|NCT00273533|Ramipril|ramipril|mesh-list
24437418|NCT00273611|Vitamin D|vitamin d|mesh-list
25086914|NCT03284645|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24670076|NCT03300947|Lorazepam|lorazepam|mesh-list
24630819|NCT01114048|Immunologic Factors|immunologic factors|mesh-ancestor
24630820|NCT01114048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219994|NCT02659306|Metformin|metformin|mesh-list
25219995|NCT02659306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25219996|NCT02659306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25219997|NCT02659254|Sirolimus|sirolimus|mesh-list
24832850|NCT02172339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24832851|NCT02172339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832852|NCT02172339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24630868|NCT01114191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630869|NCT01114191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24630871|NCT01114282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630872|NCT01114425|Raltegravir Potassium|raltegravir potassium|mesh-list
24630873|NCT01114425|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24630874|NCT01114425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24630875|NCT01114425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24630876|NCT01114425|Antiviral Agents|antiviral agents|mesh-ancestor
24630877|NCT01114425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24630878|NCT01114425|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24630879|NCT01114425|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24630880|NCT01114425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24630881|NCT01114425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630882|NCT01114425|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24630883|NCT01114425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24630884|NCT01114490|Anacetrapib|anacetrapib|mesh-list
24630885|NCT01114490|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24513536|NCT00583258|Alfuzosin|alfuzosin|mesh-list
24630886|NCT01114490|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24630917|NCT01115036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630919|NCT01115049|Hexetidine|hexetidine|mesh-list
24630939|NCT01115127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630940|NCT01115127|Protective Agents|protective agents|mesh-ancestor
24630941|NCT01115127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630942|NCT01115127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24630943|NCT01115127|Vitamin B Complex|vitamin b complex|mesh-ancestor
25220011|NCT02659527|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25220012|NCT02659527|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25052921|NCT00126984|Vaccines|vaccines|mesh-list
24630945|NCT01115127|Micronutrients|micronutrients|mesh-ancestor
24630946|NCT01115140|Folic Acid|folic acid|mesh-list
24630947|NCT01115140|Vitamin B Complex|vitamin b complex|mesh-list
24630948|NCT01115140|Metformin|metformin|mesh-list
24630949|NCT01115140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24630950|NCT01115140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630951|NCT01115140|Hematinics|hematinics|mesh-ancestor
24439385|NCT00278408|Glucocorticoids|glucocorticoids|mesh-ancestor
24630953|NCT01115140|Micronutrients|micronutrients|mesh-ancestor
24630954|NCT01115179|Propofol|propofol|mesh-list
24630955|NCT01115179|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24630956|NCT01115179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24630957|NCT01115179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25086951|NCT03284294|Cholecalciferol|cholecalciferol|mesh-list
25086952|NCT03284294|Vitamin D|vitamin d|mesh-list
25086953|NCT03284294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25086954|NCT03284294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086955|NCT03284294|Vitamins|vitamins|mesh-ancestor
25086956|NCT03284294|Micronutrients|micronutrients|mesh-ancestor
24630958|NCT01115179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630959|NCT01115179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24630960|NCT01115179|Anesthetics, General|anesthetics, general|mesh-ancestor
24630961|NCT01115179|Anesthetics|anesthetics|mesh-ancestor
24630962|NCT01115179|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24630963|NCT01115179|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24630964|NCT01115179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24630965|NCT01115322|Nicotinic Acids|nicotinic acids|mesh-list
24630966|NCT01115322|Tazarotene|tazarotene|mesh-list
24631013|NCT01115543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25086968|NCT03284164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25086969|NCT03284164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25086970|NCT03283943|Durvalumab|durvalumab|mesh-list
25086971|NCT03283943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25086972|NCT03283943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451920|NCT00325286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24670122|NCT03251326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24631014|NCT01115543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631015|NCT01115543|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24631016|NCT01115543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24631017|NCT01115543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631018|NCT01115543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24631020|NCT01115543|Micronutrients|micronutrients|mesh-ancestor
24631021|NCT01115543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24631023|NCT01115712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24631024|NCT01115712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631025|NCT01115725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24631026|NCT01115725|Hormones|hormones|mesh-ancestor
24979962|NCT04851522|Disinfectants|disinfectants|mesh-ancestor
24979963|NCT04851522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24979964|NCT04851522|Emollients|emollients|mesh-ancestor
24631027|NCT01115725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24631028|NCT01115725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631029|NCT01115842|Vitamin D|vitamin d|mesh-list
24631030|NCT01115842|Vitamins|vitamins|mesh-ancestor
24631031|NCT01115842|Micronutrients|micronutrients|mesh-ancestor
24631032|NCT01115842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631033|NCT01115842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24631034|NCT01115894|Naltrexone|naltrexone|mesh-list
24631035|NCT01115894|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24631036|NCT01115894|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24762409|NCT01768260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25086998|NCT03283800|Trace Elements|trace elements|mesh-ancestor
25086999|NCT03283800|Micronutrients|micronutrients|mesh-ancestor
25245800|NCT03705585|Vaccines|vaccines|mesh-list
25087000|NCT03283800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087001|NCT03283410|Propofol|propofol|mesh-list
25087002|NCT03283410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25087003|NCT03283410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25087006|NCT03283410|Anesthetics, General|anesthetics, general|mesh-ancestor
25087007|NCT03283410|Anesthetics|anesthetics|mesh-ancestor
25087009|NCT03283202|Prednisolone|prednisolone|mesh-list
25087010|NCT03283202|Cyclophosphamide|cyclophosphamide|mesh-list
25087011|NCT03283202|Rituximab|rituximab|mesh-list
25087012|NCT03283202|Vincristine|vincristine|mesh-list
25220040|NCT02659085|Anesthetics|anesthetics|mesh-ancestor
25087013|NCT03283202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25087014|NCT03283202|Immunologic Factors|immunologic factors|mesh-ancestor
25087015|NCT03283202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087041|NCT03283059|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25679442|NCT01838447|Micronutrients|micronutrients|mesh-ancestor
25679443|NCT01838447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679444|NCT01838447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25679445|NCT01838447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25679446|NCT01838590|Sofosbuvir|sofosbuvir|mesh-list
24825738|NCT02129985|Metformin|metformin|mesh-list
25087042|NCT03283059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25087043|NCT03283059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087044|NCT03283059|Cholinergic Agents|cholinergic agents|mesh-ancestor
25087045|NCT03283059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25087046|NCT03283059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220026|NCT02659293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25220027|NCT02659293|Immunologic Factors|immunologic factors|mesh-ancestor
25220028|NCT02659293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25220029|NCT02659293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25220030|NCT02659293|Growth Substances|growth substances|mesh-ancestor
25220031|NCT02659293|Growth Inhibitors|growth inhibitors|mesh-ancestor
25220032|NCT02659085|Ketamine|ketamine|mesh-list
25220033|NCT02659085|Analgesics|analgesics|mesh-ancestor
25220034|NCT02659085|Sensory System Agents|sensory system agents|mesh-ancestor
25087047|NCT03283059|Nootropic Agents|nootropic agents|mesh-ancestor
25087048|NCT03283046|Dexamethasone|dexamethasone|mesh-list
25087049|NCT03283046|Nivolumab|nivolumab|mesh-list
25087050|NCT03283046|Lenalidomide|lenalidomide|mesh-list
25087051|NCT03283046|Ipilimumab|ipilimumab|mesh-list
25087052|NCT03283046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25087053|NCT03283046|Antiemetics|antiemetics|mesh-ancestor
25087054|NCT03283046|Autonomic Agents|autonomic agents|mesh-ancestor
25087055|NCT03283046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25087056|NCT03283046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087057|NCT03283046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25087058|NCT03283046|Glucocorticoids|glucocorticoids|mesh-ancestor
25087059|NCT03283046|Hormones|hormones|mesh-ancestor
24631064|NCT01115985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24631065|NCT01115985|Antimetabolites|antimetabolites|mesh-ancestor
24631066|NCT01115985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748925|NCT01976754|Analgesics|analgesics|mesh-ancestor
24631092|NCT01116128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24631094|NCT01116128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24631095|NCT01116128|Alkylating Agents|alkylating agents|mesh-ancestor
24631096|NCT01116128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631097|NCT01116128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24631098|NCT01116128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24631099|NCT01116128|Immunologic Factors|immunologic factors|mesh-ancestor
24631100|NCT01116128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24631101|NCT01116128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631102|NCT01116154|Lenalidomide|lenalidomide|mesh-list
24631103|NCT01116154|Vorinostat|vorinostat|mesh-list
24631104|NCT01116154|Immunologic Factors|immunologic factors|mesh-ancestor
25087060|NCT03283046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25087061|NCT03283046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25087062|NCT03283046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25087063|NCT03283046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25087064|NCT03283046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24437607|NCT00274053|Tiotropium Bromide|tiotropium bromide|mesh-list
25087065|NCT03283046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087066|NCT03283046|Immunologic Factors|immunologic factors|mesh-ancestor
25087067|NCT03283046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25087068|NCT03283046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25087069|NCT03283046|Growth Substances|growth substances|mesh-ancestor
25087070|NCT03283046|Growth Inhibitors|growth inhibitors|mesh-ancestor
25087072|NCT03283020|Remifentanil|remifentanil|mesh-list
25087073|NCT03283020|Methylnaltrexone|methylnaltrexone|mesh-list
24762482|NCT01768364|Renal Agents|renal agents|mesh-ancestor
25087074|NCT03283020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25220035|NCT02659085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25220036|NCT02659085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220037|NCT02659085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25220038|NCT02659085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25220041|NCT02659085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25220042|NCT02659085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25220043|NCT02659085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25679447|NCT01838590|Antiviral Agents|antiviral agents|mesh-ancestor
25087081|NCT03283020|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25087082|NCT03283020|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25087083|NCT03282838|Celecoxib|celecoxib|mesh-list
25087084|NCT03282838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24437707|NCT00274235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25087085|NCT03282838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25087086|NCT03282838|Analgesics|analgesics|mesh-ancestor
25087087|NCT03282838|Sensory System Agents|sensory system agents|mesh-ancestor
25087088|NCT03282838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25087089|NCT03282838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087090|NCT03282838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25087091|NCT03282838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25087100|NCT03282825|Tubulin Modulators|tubulin modulators|mesh-ancestor
25087101|NCT03282825|Antimitotic Agents|antimitotic agents|mesh-ancestor
25087102|NCT03282825|Mitosis Modulators|mitosis modulators|mesh-ancestor
25087103|NCT03282825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087104|NCT03282825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25087105|NCT03282825|Antimetabolites|antimetabolites|mesh-ancestor
25087106|NCT03282825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25087107|NCT03282643|Heparin|heparin|mesh-list
25087116|NCT03282643|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25087117|NCT03282643|Antithrombins|antithrombins|mesh-ancestor
25087118|NCT03282643|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25087119|NCT03282643|Protease Inhibitors|protease inhibitors|mesh-ancestor
25087120|NCT03282643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631105|NCT01116154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631106|NCT01116154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24631107|NCT01116154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24631108|NCT01116154|Growth Substances|growth substances|mesh-ancestor
24631109|NCT01116154|Growth Inhibitors|growth inhibitors|mesh-ancestor
24631110|NCT01116154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24631111|NCT01116154|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24631147|NCT01116193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24631148|NCT01116193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24631149|NCT01116193|Immunologic Factors|immunologic factors|mesh-ancestor
24631181|NCT01116271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631182|NCT01116271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631183|NCT01116271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24631185|NCT01116310|Glycine Agents|glycine agents|mesh-ancestor
24631186|NCT01116310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24631187|NCT01116310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631188|NCT01116310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679448|NCT01838590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25679449|NCT01838616|Oxycodone|oxycodone|mesh-list
25679450|NCT01838616|Tapentadol|tapentadol|mesh-list
25679451|NCT01838616|Naloxone|naloxone|mesh-list
25679452|NCT01838616|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25679453|NCT01838616|Narcotics|narcotics|mesh-ancestor
25679454|NCT01838616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25679455|NCT01838616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679456|NCT01838616|Analgesics|analgesics|mesh-ancestor
25220045|NCT02659085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220046|NCT02659033|Ceftriaxone|ceftriaxone|mesh-list
25220048|NCT02659033|Cefoxitin|cefoxitin|mesh-list
25220049|NCT02659033|Cephalosporins|cephalosporins|mesh-list
25220050|NCT02659033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25220051|NCT02659033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25220052|NCT02658864|Lafutidine|lafutidine|mesh-list
25220053|NCT02658864|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25220054|NCT02658864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25220055|NCT02658864|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25220056|NCT02658864|Histamine Antagonists|histamine antagonists|mesh-ancestor
25220057|NCT02658864|Histamine Agents|histamine agents|mesh-ancestor
24631189|NCT01116336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25252739|NCT02505633|Mydriatics|mydriatics|mesh-ancestor
24631190|NCT01116336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24631191|NCT01116336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24631192|NCT01116336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631193|NCT01116336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631194|NCT01116388|Caseins|caseins|mesh-list
24631195|NCT01116388|Chelating Agents|chelating agents|mesh-ancestor
24443494|NCT00295243|Topotecan|topotecan|mesh-list
24631196|NCT01116388|Sequestering Agents|sequestering agents|mesh-ancestor
24631197|NCT01116388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631198|NCT01116531|Pregabalin|pregabalin|mesh-list
24631199|NCT01116531|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24631200|NCT01116531|Tramadol|tramadol|mesh-list
24631201|NCT01116531|Analgesics|analgesics|mesh-ancestor
24631202|NCT01116531|Sensory System Agents|sensory system agents|mesh-ancestor
25087122|NCT03282513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25087123|NCT03282513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25087124|NCT03282513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087125|NCT03282487|Hydrocortisone|hydrocortisone|mesh-list
25087126|NCT03282487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25087127|NCT03282474|Sofosbuvir|sofosbuvir|mesh-list
25087128|NCT03282474|Antiviral Agents|antiviral agents|mesh-ancestor
25087129|NCT03282474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24620158|NCT01055743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24620163|NCT01055756|Loratadine|loratadine|mesh-list
25087130|NCT03282188|Sargramostim|sargramostim|mesh-list
25087131|NCT03282188|Immunologic Factors|immunologic factors|mesh-ancestor
25087132|NCT03282188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087133|NCT03282162|Oxytocin|oxytocin|mesh-list
25087134|NCT03282162|Oxytocics|oxytocics|mesh-ancestor
25087135|NCT03282162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25087136|NCT03282162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087137|NCT03282136|Incretins|incretins|mesh-list
25087138|NCT03282136|Hormones|hormones|mesh-ancestor
25087139|NCT03282136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25087140|NCT03282136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087141|NCT03282110|Citalopram|citalopram|mesh-list
25087142|NCT03282110|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24749077|NCT01817751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25087150|NCT03282110|Antidepressive Agents|antidepressive agents|mesh-ancestor
25087162|NCT03281941|Sensory System Agents|sensory system agents|mesh-ancestor
25087163|NCT03281941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25087164|NCT03281941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087165|NCT03281928|Potassium Citrate|potassium citrate|mesh-list
25087166|NCT03281928|Diuretics|diuretics|mesh-ancestor
25087167|NCT03281928|Natriuretic Agents|natriuretic agents|mesh-ancestor
25087168|NCT03281928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087169|NCT03281928|Expectorants|expectorants|mesh-ancestor
25087170|NCT03281928|Respiratory System Agents|respiratory system agents|mesh-ancestor
25087171|NCT03281863|Antibodies|antibodies|mesh-list
25087172|NCT03281863|Antistreptolysin|antistreptolysin|mesh-list
25087173|NCT03281863|Immunologic Factors|immunologic factors|mesh-ancestor
25087174|NCT03281863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087175|NCT03281811|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25087176|NCT03281811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25087177|NCT03281811|Dermatologic Agents|dermatologic agents|mesh-ancestor
25087178|NCT03281694|Nicotine|nicotine|mesh-list
25679457|NCT01838616|Sensory System Agents|sensory system agents|mesh-ancestor
25087179|NCT03281694|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25087180|NCT03281694|Autonomic Agents|autonomic agents|mesh-ancestor
25087181|NCT03281694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25087182|NCT03281694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679458|NCT01838616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24940011|NCT04004702|Levetiracetam|levetiracetam|mesh-list
25087183|NCT03281694|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25087184|NCT03281694|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25087185|NCT03281694|Cholinergic Agents|cholinergic agents|mesh-ancestor
25087186|NCT03281694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25087187|NCT03281694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042609|NCT01410695|Immunologic Factors|immunologic factors|mesh-ancestor
24631225|NCT01116583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631226|NCT01116583|Anticonvulsants|anticonvulsants|mesh-ancestor
25220058|NCT02658864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24631227|NCT01116583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24631228|NCT01116583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24631229|NCT01116583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24631230|NCT01116583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24631277|NCT01116700|Analgesics|analgesics|mesh-ancestor
24631278|NCT01116700|Sensory System Agents|sensory system agents|mesh-ancestor
24631279|NCT01116700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24631280|NCT01116700|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24631281|NCT01116700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24631282|NCT01116700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24631283|NCT01116700|Adrenergic Agents|adrenergic agents|mesh-ancestor
25087191|NCT03281681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087192|NCT03281681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25087193|NCT03281187|Methyltestosterone|methyltestosterone|mesh-list
25087195|NCT03281187|Testosterone undecanoate|testosterone undecanoate|mesh-list
25087196|NCT03281187|Testosterone enanthate|testosterone enanthate|mesh-list
25087197|NCT03281187|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25087198|NCT03281187|Androgens|androgens|mesh-ancestor
25087200|NCT03281187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25087201|NCT03281187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087202|NCT03281187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25087215|NCT03280849|Sequestering Agents|sequestering agents|mesh-ancestor
25087216|NCT03280849|Hemostatics|hemostatics|mesh-ancestor
25087217|NCT03280849|Coagulants|coagulants|mesh-ancestor
24762753|NCT01769664|Clindamycin|clindamycin|mesh-list
25087218|NCT03280667|Denosumab|denosumab|mesh-list
25087219|NCT03280667|Pembrolizumab|pembrolizumab|mesh-list
25087220|NCT03280667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25087221|NCT03280667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25087222|NCT03280667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25087223|NCT03280667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087224|NCT03280641|Warfarin|warfarin|mesh-list
24979997|NCT04756765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24979998|NCT04756765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087225|NCT03280641|Dabigatran|dabigatran|mesh-list
24631284|NCT01116700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24631285|NCT01116700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631286|NCT01116713|Dexamethasone|dexamethasone|mesh-list
24631287|NCT01116713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24631288|NCT01116713|Antiemetics|antiemetics|mesh-ancestor
25087226|NCT03280641|Anticoagulants|anticoagulants|mesh-ancestor
25087227|NCT03280641|Antithrombins|antithrombins|mesh-ancestor
25087228|NCT03280641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25087229|NCT03280641|Protease Inhibitors|protease inhibitors|mesh-ancestor
25679459|NCT01838616|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25679460|NCT01838616|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25679461|NCT01838616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25679462|NCT01838616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25679463|NCT01838616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679464|NCT01838616|Adrenergic Agents|adrenergic agents|mesh-ancestor
25679465|NCT01838616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25679466|NCT01838642|Ponatinib|ponatinib|mesh-list
25087230|NCT03280641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25087231|NCT03280641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087232|NCT03280511|Oxaliplatin|oxaliplatin|mesh-list
24631292|NCT01116713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24631293|NCT01116713|Glucocorticoids|glucocorticoids|mesh-ancestor
24631294|NCT01116713|Hormones|hormones|mesh-ancestor
24631370|NCT01117129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25220059|NCT02658864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220060|NCT02658864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220061|NCT02658825|Moxifloxacin|moxifloxacin|mesh-list
25220062|NCT02658825|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25220063|NCT02658825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24832860|NCT02172352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24832861|NCT02172352|Autonomic Agents|autonomic agents|mesh-ancestor
24631295|NCT01116713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24631339|NCT01117116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631340|NCT01117116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24631341|NCT01117116|Respiratory System Agents|respiratory system agents|mesh-ancestor
24631342|NCT01117116|Dermatologic Agents|dermatologic agents|mesh-ancestor
24631343|NCT01117116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24631344|NCT01117116|Glucocorticoids|glucocorticoids|mesh-ancestor
24631355|NCT01117129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24631356|NCT01117129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25087246|NCT03280407|Vitamins|vitamins|mesh-ancestor
25087247|NCT03280407|Micronutrients|micronutrients|mesh-ancestor
25087248|NCT03280342|Topiramate|topiramate|mesh-list
25087249|NCT03280342|Anticonvulsants|anticonvulsants|mesh-ancestor
25087250|NCT03280342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25087251|NCT03280342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087252|NCT03280316|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25087253|NCT03280316|Botulinum Toxins|botulinum toxins|mesh-list
25087254|NCT03280316|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25087255|NCT03280316|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25087256|NCT03280316|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25087257|NCT03280316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25087258|NCT03280316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087259|NCT03280316|Cholinergic Agents|cholinergic agents|mesh-ancestor
25679467|NCT01838642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25679468|NCT01838642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25679469|NCT01838642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25679470|NCT01838642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692428|NCT01999348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25692429|NCT01999348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25679472|NCT01838655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25679473|NCT01838655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825996|NCT02131480|Alkylating Agents|alkylating agents|mesh-ancestor
24825997|NCT02131506|Lapatinib|lapatinib|mesh-list
24706283|NCT01489631|Sufentanil|sufentanil|mesh-list
25087260|NCT03280316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25087261|NCT03280316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087262|NCT03280316|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25087263|NCT03280316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25087264|NCT03280316|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25220064|NCT02658825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25220065|NCT02658825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25220066|NCT02658825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25220067|NCT02658825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25220068|NCT02658825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220069|NCT02658825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25220070|NCT02658825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25220071|NCT02658825|Contraceptive Agents|contraceptive agents|mesh-ancestor
25220072|NCT02658825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25220073|NCT02658825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220074|NCT02658825|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25220075|NCT02658825|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25220076|NCT02658825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25220077|NCT02658838|Heparin|heparin|mesh-list
25220078|NCT02658838|Calcium heparin|calcium heparin|mesh-list
25220079|NCT02658838|Enoxaparin|enoxaparin|mesh-list
25220080|NCT02658838|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25220081|NCT02658838|Tinzaparin|tinzaparin|mesh-list
25220082|NCT02658838|Dalteparin|dalteparin|mesh-list
25220083|NCT02658838|Enoxaparin sodium|enoxaparin sodium|mesh-list
25087266|NCT03280316|Urological Agents|urological agents|mesh-ancestor
24670343|NCT02936622|Paclitaxel|paclitaxel|mesh-list
24631357|NCT01117129|Immunologic Factors|immunologic factors|mesh-ancestor
24631358|NCT01117129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631409|NCT01117610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631410|NCT01117610|Sensory System Agents|sensory system agents|mesh-ancestor
24631411|NCT01117610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24631413|NCT01117636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24631414|NCT01117636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24631415|NCT01117636|Analgesics|analgesics|mesh-ancestor
24631416|NCT01117636|Sensory System Agents|sensory system agents|mesh-ancestor
24631417|NCT01117636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24631418|NCT01117636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087280|NCT03280212|Tranexamic Acid|tranexamic acid|mesh-list
25087281|NCT03280212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25087282|NCT03280212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25087283|NCT03280212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087284|NCT03280212|Hemostatics|hemostatics|mesh-ancestor
25087285|NCT03280212|Coagulants|coagulants|mesh-ancestor
25087288|NCT03280147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25087289|NCT03280147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25087290|NCT03280147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24631474|NCT01118403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438230|NCT00275119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24438231|NCT00275119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25679474|NCT01838681|Brexpiprazole|brexpiprazole|mesh-list
25679475|NCT01838681|Serotonin Agents|serotonin agents|mesh-ancestor
25679476|NCT01838681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25679477|NCT01838681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679478|NCT01838681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679479|NCT01838681|Dopamine Agonists|dopamine agonists|mesh-ancestor
25679480|NCT01838681|Dopamine Agents|dopamine agents|mesh-ancestor
25679481|NCT01838876|Cariprazine|cariprazine|mesh-list
25679482|NCT01838876|Antidepressive Agents|antidepressive agents|mesh-list
25679483|NCT01838876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25679484|NCT01838876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24438233|NCT00275119|Immunologic Factors|immunologic factors|mesh-ancestor
24438234|NCT00275119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438235|NCT00275132|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24438236|NCT00275132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438237|NCT00275132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24438238|NCT00275132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631475|NCT01118429|Oxybutynin|oxybutynin|mesh-list
24631476|NCT01118429|Parasympatholytics|parasympatholytics|mesh-ancestor
24631477|NCT01118429|Autonomic Agents|autonomic agents|mesh-ancestor
24631478|NCT01118429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24631479|NCT01118429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631480|NCT01118429|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24631481|NCT01118429|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24631482|NCT01118429|Cholinergic Agents|cholinergic agents|mesh-ancestor
24631483|NCT01118429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24631484|NCT01118429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631485|NCT01118429|Urological Agents|urological agents|mesh-ancestor
24631486|NCT01118533|Pyrithione zinc|pyrithione zinc|mesh-list
24631487|NCT01118533|Keratolytic Agents|keratolytic agents|mesh-ancestor
24631488|NCT01118533|Dermatologic Agents|dermatologic agents|mesh-ancestor
24631531|NCT01118702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24670385|NCT02842086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25087291|NCT03280147|Antitubercular Agents|antitubercular agents|mesh-ancestor
25087292|NCT03280095|Acetaminophen|acetaminophen|mesh-list
25087294|NCT03280095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24762822|NCT01769833|Antiviral Agents|antiviral agents|mesh-ancestor
25087295|NCT03280095|Analgesics|analgesics|mesh-ancestor
25087296|NCT03280095|Sensory System Agents|sensory system agents|mesh-ancestor
25087297|NCT03280095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25087298|NCT03280095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087299|NCT03280095|Antipyretics|antipyretics|mesh-ancestor
25087300|NCT03280095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25087301|NCT03280095|Narcotics|narcotics|mesh-ancestor
25087302|NCT03280095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24631532|NCT01118702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631533|NCT01118702|Dopamine Agents|dopamine agents|mesh-ancestor
24631534|NCT01118702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24631535|NCT01118793|Clopidogrel|clopidogrel|mesh-list
24665381|NCT01312064|Rituximab|rituximab|mesh-list
25220084|NCT02658838|Ticagrelor|ticagrelor|mesh-list
25220085|NCT02658838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25220086|NCT02658838|Anticoagulants|anticoagulants|mesh-ancestor
25220087|NCT02658838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25042589|NCT01414920|Incretins|incretins|mesh-ancestor
25042590|NCT01414920|Hormones|hormones|mesh-ancestor
24631542|NCT01118793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631543|NCT01118793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631544|NCT01118871|Ritonavir|ritonavir|mesh-list
24631545|NCT01118871|Darunavir|darunavir|mesh-list
24631546|NCT01118871|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24631547|NCT01118871|Etravirine|etravirine|mesh-list
24631548|NCT01118871|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24631549|NCT01118871|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24631550|NCT01118871|Protease Inhibitors|protease inhibitors|mesh-ancestor
24631551|NCT01118871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631552|NCT01118871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631553|NCT01118871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24631554|NCT01118871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24631555|NCT01118871|Antiviral Agents|antiviral agents|mesh-ancestor
25679485|NCT01838876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25679486|NCT01838876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25679487|NCT01838876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679488|NCT01838941|Betaine|betaine|mesh-list
25679489|NCT01838941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25679490|NCT01838941|Lipotropic Agents|lipotropic agents|mesh-ancestor
25679491|NCT01838941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25679492|NCT01838941|Antimetabolites|antimetabolites|mesh-ancestor
24631559|NCT01118871|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24631560|NCT01118871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24631562|NCT01118884|Diphenhydramine|diphenhydramine|mesh-list
25220088|NCT02658838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25220089|NCT02658838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220090|NCT02658838|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24438506|NCT00276068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24438507|NCT00276068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24438508|NCT00276068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25220091|NCT02658838|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25220092|NCT02658838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25220093|NCT02658838|Purinergic Agents|purinergic agents|mesh-ancestor
25220094|NCT02658838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25220095|NCT02658838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220096|NCT02658799|Diclofenac|diclofenac|mesh-list
25220097|NCT02658799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25220098|NCT02658799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25220099|NCT02658799|Analgesics|analgesics|mesh-ancestor
25220100|NCT02658799|Sensory System Agents|sensory system agents|mesh-ancestor
25042598|NCT01410695|Abortifacient Agents|abortifacient agents|mesh-ancestor
25042599|NCT01410695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24952332|NCT03894839|Sodium Hypochlorite|sodium hypochlorite|mesh-list
25087320|NCT03280004|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25087322|NCT03280004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25087323|NCT03280004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25087324|NCT03280004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25087325|NCT03280004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25087326|NCT03280004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087327|NCT03280004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25087328|NCT03280004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25087329|NCT03280004|Contraceptive Agents|contraceptive agents|mesh-ancestor
25087333|NCT03280004|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25087347|NCT03279978|GABA Agents|gaba agents|mesh-ancestor
25087348|NCT03279978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25087349|NCT03279978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087353|NCT03279861|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25087354|NCT03279861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25087355|NCT03279861|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25087356|NCT03279861|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24438509|NCT00276068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25220160|NCT02658721|Narcotics|narcotics|mesh-ancestor
25679493|NCT01838941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679494|NCT01838941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25679495|NCT01839110|Ranolazine|ranolazine|mesh-list
25679496|NCT01839110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25679497|NCT01839110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25679498|NCT01839110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679499|NCT01839188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25679500|NCT01839188|Immunologic Factors|immunologic factors|mesh-ancestor
25679501|NCT01839188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679502|NCT01839279|Moxifloxacin|moxifloxacin|mesh-list
25679503|NCT01839279|Tizanidine|tizanidine|mesh-list
25087363|NCT03279809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24762823|NCT01769833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25087364|NCT03279809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087365|NCT03279809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25087366|NCT03279809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25087367|NCT03279809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25087368|NCT03279809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25087369|NCT03279809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087370|NCT03279809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24670442|NCT02567825|Ofloxacin|ofloxacin|mesh-list
24631572|NCT01118884|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24631573|NCT01118884|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24631574|NCT01118884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24631575|NCT01118884|Anesthetics, Local|anesthetics, local|mesh-ancestor
24631576|NCT01118884|Anesthetics|anesthetics|mesh-ancestor
24631577|NCT01118884|Sensory System Agents|sensory system agents|mesh-ancestor
24631578|NCT01118884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24631579|NCT01118884|Antiemetics|antiemetics|mesh-ancestor
24631580|NCT01118884|Autonomic Agents|autonomic agents|mesh-ancestor
24631581|NCT01118884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24631582|NCT01118923|Magnesium Hydroxide|magnesium hydroxide|mesh-list
24749425|NCT01096368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25087379|NCT03279796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087380|NCT03279796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25087381|NCT03279796|Respiratory System Agents|respiratory system agents|mesh-ancestor
25087382|NCT03279757|Lidocaine|lidocaine|mesh-list
25087383|NCT03279757|Epinephrine|epinephrine|mesh-list
25087384|NCT03279757|Racepinephrine|racepinephrine|mesh-list
25087385|NCT03279757|Tetracaine|tetracaine|mesh-list
25087386|NCT03279757|Carticaine|carticaine|mesh-list
25220101|NCT02658799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25220102|NCT02658799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220103|NCT02658799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25220104|NCT02658799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25042600|NCT01410695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042601|NCT01410695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25042602|NCT01410695|Antimetabolites|antimetabolites|mesh-ancestor
25042603|NCT01410695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042604|NCT01410695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042605|NCT01410695|Dermatologic Agents|dermatologic agents|mesh-ancestor
25042606|NCT01410695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25042607|NCT01410695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25042608|NCT01410695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25042611|NCT01410695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25042612|NCT01410188|Latanoprost|latanoprost|mesh-list
25042613|NCT01410188|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25061179|NCT03473210|Erythromycin|erythromycin|mesh-list
25679504|NCT01839279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25679505|NCT01839279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25679506|NCT01839279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25679507|NCT01839279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25679508|NCT01839279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25679509|NCT01839279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679510|NCT01839279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25220114|NCT02658773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220115|NCT02658773|Sensory System Agents|sensory system agents|mesh-ancestor
25220116|NCT02658773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25220117|NCT02658773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25220118|NCT02658773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25220119|NCT02658773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25220120|NCT02658773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25220121|NCT02658773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220122|NCT02658773|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25220123|NCT02658760|Dexmedetomidine|dexmedetomidine|mesh-list
25220124|NCT02658760|Bupivacaine|bupivacaine|mesh-list
24439276|NCT00278265|Vidarabine|vidarabine|mesh-list
25220125|NCT02658760|Anesthetics, Local|anesthetics, local|mesh-ancestor
25220126|NCT02658760|Anesthetics|anesthetics|mesh-ancestor
25220127|NCT02658760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25220128|NCT02658760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220129|NCT02658760|Sensory System Agents|sensory system agents|mesh-ancestor
25220130|NCT02658760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25220131|NCT02658760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25220132|NCT02658760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25220133|NCT02658760|Analgesics|analgesics|mesh-ancestor
25220134|NCT02658760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25220135|NCT02658760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25220136|NCT02658760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25220137|NCT02658760|Adrenergic Agents|adrenergic agents|mesh-ancestor
25220138|NCT02658760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25220139|NCT02658760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220140|NCT02658721|Diclofenac|diclofenac|mesh-list
24864857|NCT05148910|Copper|copper|mesh-list
25087387|NCT03279757|Epinephryl borate|epinephryl borate|mesh-list
25087388|NCT03279757|Anesthetics, Local|anesthetics, local|mesh-ancestor
25087389|NCT03279757|Anesthetics|anesthetics|mesh-ancestor
25087390|NCT03279757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25087391|NCT03279757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679512|NCT01839279|Analgesics|analgesics|mesh-ancestor
25679513|NCT01839279|Sensory System Agents|sensory system agents|mesh-ancestor
25679514|NCT01839279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25679515|NCT01839279|Anticonvulsants|anticonvulsants|mesh-ancestor
25679516|NCT01839279|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25679517|NCT01839279|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25679518|NCT01839279|Parasympatholytics|parasympatholytics|mesh-ancestor
25679519|NCT01839279|Autonomic Agents|autonomic agents|mesh-ancestor
25245801|NCT03705585|Immunologic Factors|immunologic factors|mesh-ancestor
25087393|NCT03279757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25087395|NCT03279757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25087396|NCT03279757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25087397|NCT03279757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25087398|NCT03279757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087399|NCT03279757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25087400|NCT03279757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25087401|NCT03279757|Adrenergic Agents|adrenergic agents|mesh-ancestor
25087402|NCT03279757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25087408|NCT03279757|Mydriatics|mydriatics|mesh-ancestor
25087415|NCT03279679|Anesthetics, Local|anesthetics, local|mesh-ancestor
25087416|NCT03279679|Anesthetics|anesthetics|mesh-ancestor
25087417|NCT03279679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25087418|NCT03279679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087419|NCT03279679|Sensory System Agents|sensory system agents|mesh-ancestor
24980081|NCT05442008|Analgesics|analgesics|mesh-ancestor
25087420|NCT03279679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25087421|NCT03279601|Capecitabine|capecitabine|mesh-list
25087422|NCT03279601|Temozolomide|temozolomide|mesh-list
25087423|NCT03279601|Dacarbazine|dacarbazine|mesh-list
25087424|NCT03279601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25087425|NCT03279601|Antimetabolites|antimetabolites|mesh-ancestor
25087480|NCT03279146|Antiviral Agents|antiviral agents|mesh-ancestor
25087481|NCT03279146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25087482|NCT03279146|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25087483|NCT03279146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25087484|NCT03279146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25087485|NCT03279146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087486|NCT03279146|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25087487|NCT03279146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25087488|NCT03279133|Ledipasvir|ledipasvir|mesh-list
25087541|NCT03278808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25087542|NCT03278808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25087543|NCT03278808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25087555|NCT03278782|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25087556|NCT03278782|Pembrolizumab|pembrolizumab|mesh-list
25087558|NCT03278782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25087559|NCT03278782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25220141|NCT02658721|Lidocaine|lidocaine|mesh-list
25220142|NCT02658721|Atropine|atropine|mesh-list
25220143|NCT02658721|Ephedrine|ephedrine|mesh-list
25220144|NCT02658721|Fentanyl|fentanyl|mesh-list
25220145|NCT02658721|Midazolam|midazolam|mesh-list
25220146|NCT02658721|Tramadol|tramadol|mesh-list
25220147|NCT02658721|Ondansetron|ondansetron|mesh-list
25220148|NCT02658721|Anesthetics, Local|anesthetics, local|mesh-ancestor
25220149|NCT02658721|Anesthetics|anesthetics|mesh-ancestor
25220150|NCT02658721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25220151|NCT02658721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220152|NCT02658721|Sensory System Agents|sensory system agents|mesh-ancestor
25220153|NCT02658721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25220154|NCT02658721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25220155|NCT02658721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25220156|NCT02658721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25405197|NCT03623321|Serotonin Agents|serotonin agents|mesh-ancestor
25679520|NCT01839279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25679521|NCT01839279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25679522|NCT01839279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25679523|NCT01839279|Adrenergic Agents|adrenergic agents|mesh-ancestor
25679524|NCT01839279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25087566|NCT03278522|Ramosetron|ramosetron|mesh-list
25087567|NCT03278522|Antiemetics|antiemetics|mesh-ancestor
25087587|NCT03278483|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25087588|NCT03278483|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25087589|NCT03278483|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25087590|NCT03278483|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25087591|NCT03278483|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25087592|NCT03278483|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25087593|NCT03278483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25087594|NCT03278483|Antimetabolites|antimetabolites|mesh-ancestor
25087595|NCT03278483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25087596|NCT03278444|Trimetazidine|trimetazidine|mesh-list
25087597|NCT03278444|Vasodilator Agents|vasodilator agents|mesh-ancestor
25087598|NCT03278431|Albendazole|albendazole|mesh-list
25087599|NCT03278431|Mebendazole|mebendazole|mesh-list
25087600|NCT03278431|Piperazine|piperazine|mesh-list
25220157|NCT02658721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25220158|NCT02658721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220159|NCT02658721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25220162|NCT02658721|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25220163|NCT02658721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25220164|NCT02658721|Anesthetics, General|anesthetics, general|mesh-ancestor
25220165|NCT02658721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25220166|NCT02658721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25220167|NCT02658721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24440268|NCT00282126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440270|NCT00282126|Respiratory System Agents|respiratory system agents|mesh-ancestor
24440271|NCT00282139|Aripiprazole|aripiprazole|mesh-list
24440372|NCT00282607|Udenafil|udenafil|mesh-list
25220168|NCT02658721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25220169|NCT02658721|GABA Modulators|gaba modulators|mesh-ancestor
25220170|NCT02658721|GABA Agents|gaba agents|mesh-ancestor
25220171|NCT02658721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25220172|NCT02658721|Antiemetics|antiemetics|mesh-ancestor
25220173|NCT02658721|Autonomic Agents|autonomic agents|mesh-ancestor
25220174|NCT02658721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25220175|NCT02658721|Antipruritics|antipruritics|mesh-ancestor
25220176|NCT02658721|Dermatologic Agents|dermatologic agents|mesh-ancestor
25220177|NCT02658721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25220178|NCT02658721|Serotonin Agents|serotonin agents|mesh-ancestor
25220179|NCT02658721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25220180|NCT02658721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25220181|NCT02658721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25220182|NCT02658721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25220183|NCT02658721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25220184|NCT02658721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25679525|NCT01839487|Gemcitabine|gemcitabine|mesh-list
24832868|NCT02172352|Cholinergic Agents|cholinergic agents|mesh-ancestor
25679526|NCT01839487|Dexamethasone|dexamethasone|mesh-list
25220189|NCT02658721|Mydriatics|mydriatics|mesh-ancestor
25220190|NCT02658721|Parasympatholytics|parasympatholytics|mesh-ancestor
25220191|NCT02658721|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25220192|NCT02658721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25220193|NCT02658721|Cholinergic Agents|cholinergic agents|mesh-ancestor
25220194|NCT02658721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25220195|NCT02658721|Sympathomimetics|sympathomimetics|mesh-ancestor
25220196|NCT02658721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25220197|NCT02658721|Adrenergic Agents|adrenergic agents|mesh-ancestor
25220198|NCT02658422|Montelukast|montelukast|mesh-list
25220199|NCT02658422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25220200|NCT02658422|Respiratory System Agents|respiratory system agents|mesh-ancestor
25220201|NCT02658422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25220202|NCT02658422|Hormone Antagonists|hormone antagonists|mesh-ancestor
25220203|NCT02658422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25220204|NCT02658422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220205|NCT02658422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25220206|NCT02658422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25220207|NCT02658422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220208|NCT02658526|Anesthetics|anesthetics|mesh-list
25220209|NCT02658526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25220210|NCT02658526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220211|NCT02658435|Tafenoquine|tafenoquine|mesh-list
25220212|NCT02658435|Antimalarials|antimalarials|mesh-ancestor
25220213|NCT02658435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25220214|NCT02658435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25220215|NCT02658435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25220216|NCT02658409|Vaccines|vaccines|mesh-list
25220217|NCT02658409|Immunologic Factors|immunologic factors|mesh-ancestor
25220218|NCT02658409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220219|NCT02658188|Gabapentin|gabapentin|mesh-list
25220220|NCT02658188|Analgesics|analgesics|mesh-ancestor
25087646|NCT03278015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25087647|NCT03278015|Tubulin Modulators|tubulin modulators|mesh-ancestor
25087648|NCT03278015|Antimitotic Agents|antimitotic agents|mesh-ancestor
25087649|NCT03278015|Mitosis Modulators|mitosis modulators|mesh-ancestor
25087650|NCT03278015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087651|NCT03278015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25087652|NCT03278015|Antimetabolites|antimetabolites|mesh-ancestor
25087653|NCT03278015|Antiviral Agents|antiviral agents|mesh-ancestor
25087654|NCT03278015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25087655|NCT03278015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25087656|NCT03278015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25087657|NCT03278015|Immunologic Factors|immunologic factors|mesh-ancestor
25087658|NCT03278015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783923|NCT01904786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783924|NCT01904786|Protective Agents|protective agents|mesh-ancestor
24783925|NCT01904786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783927|NCT01904981|Atenolol|atenolol|mesh-list
25087659|NCT03277872|Pyrithione zinc|pyrithione zinc|mesh-list
25087660|NCT03277872|Keratolytic Agents|keratolytic agents|mesh-ancestor
25087661|NCT03277872|Dermatologic Agents|dermatologic agents|mesh-ancestor
25087663|NCT03277755|Antiviral Agents|antiviral agents|mesh-ancestor
25087664|NCT03277755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25087666|NCT03277599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25087667|NCT03277599|Narcotics|narcotics|mesh-ancestor
25087668|NCT03277599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25087669|NCT03277599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087670|NCT03277599|Analgesics|analgesics|mesh-ancestor
25087671|NCT03277599|Sensory System Agents|sensory system agents|mesh-ancestor
25087672|NCT03277599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25087673|NCT03277573|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
25087696|NCT03277391|Narcotics|narcotics|mesh-ancestor
25087697|NCT03277391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25087698|NCT03277391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087699|NCT03277391|Analgesics|analgesics|mesh-ancestor
25087700|NCT03277391|Sensory System Agents|sensory system agents|mesh-ancestor
25087701|NCT03277391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25087702|NCT03277391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25087703|NCT03277391|Antiemetics|antiemetics|mesh-ancestor
25087704|NCT03277391|Autonomic Agents|autonomic agents|mesh-ancestor
25087705|NCT03277391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25087706|NCT03277391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25087707|NCT03277391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25087708|NCT03277391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25087709|NCT03277391|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25087710|NCT03277391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25087711|NCT03277391|Dopamine Agents|dopamine agents|mesh-ancestor
25087712|NCT03277391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25087713|NCT03277391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087715|NCT03277339|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25087716|NCT03277339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25087717|NCT03277339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25087718|NCT03277339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087737|NCT03277209|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25087738|NCT03277209|Antiviral Agents|antiviral agents|mesh-ancestor
25087739|NCT03277209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25087741|NCT03277079|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
25087742|NCT03277079|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25087743|NCT03277079|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25087744|NCT03277079|Antimetabolites|antimetabolites|mesh-ancestor
25087745|NCT03277079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087746|NCT03277079|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25087747|NCT03277079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25087748|NCT03277001|Enoxaparin|enoxaparin|mesh-list
25087749|NCT03277001|Rivaroxaban|rivaroxaban|mesh-list
25087750|NCT03277001|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25087751|NCT03277001|Antithrombins|antithrombins|mesh-ancestor
25087796|NCT03276689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25087797|NCT03276689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25087798|NCT03276689|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25087799|NCT03276689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25087800|NCT03276689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25220221|NCT02658188|Sensory System Agents|sensory system agents|mesh-ancestor
25679527|NCT01839487|Paclitaxel|paclitaxel|mesh-list
25679528|NCT01839487|Enoxaparin|enoxaparin|mesh-list
25087824|NCT03276598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25087825|NCT03276598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25087826|NCT03276598|Adrenergic Agents|adrenergic agents|mesh-ancestor
25087827|NCT03276598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25087828|NCT03276572|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25087829|NCT03276572|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25087833|NCT03276520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25220224|NCT02658188|Anticonvulsants|anticonvulsants|mesh-ancestor
25220225|NCT02658188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25220226|NCT02658188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25220227|NCT02658188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25220228|NCT02658188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25220229|NCT02658188|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25220230|NCT02658188|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25220231|NCT02658188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25220232|NCT02658188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220233|NCT02658188|Antimanic Agents|antimanic agents|mesh-ancestor
25220235|NCT02658396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25220236|NCT02658214|Leucovorin|leucovorin|mesh-list
25679529|NCT01839487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25679530|NCT01839487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25679531|NCT01839487|Tubulin Modulators|tubulin modulators|mesh-ancestor
25679532|NCT01839487|Antimitotic Agents|antimitotic agents|mesh-ancestor
25679533|NCT01839487|Mitosis Modulators|mitosis modulators|mesh-ancestor
25679534|NCT01839487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679535|NCT01839487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25220237|NCT02658214|Folic Acid|folic acid|mesh-list
25220238|NCT02658214|Gemcitabine|gemcitabine|mesh-list
25220239|NCT02658214|Paclitaxel|paclitaxel|mesh-list
25220240|NCT02658214|Etoposide|etoposide|mesh-list
25220241|NCT02658214|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25220242|NCT02658214|Carboplatin|carboplatin|mesh-list
25220243|NCT02658214|Fluorouracil|fluorouracil|mesh-list
25220244|NCT02658214|Oxaliplatin|oxaliplatin|mesh-list
25220245|NCT02658214|Durvalumab|durvalumab|mesh-list
25220246|NCT02658214|Tremelimumab|tremelimumab|mesh-list
25220247|NCT02658214|Levoleucovorin|levoleucovorin|mesh-list
25220248|NCT02658214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25220249|NCT02658214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25220250|NCT02658214|Tubulin Modulators|tubulin modulators|mesh-ancestor
25220251|NCT02658214|Antimitotic Agents|antimitotic agents|mesh-ancestor
25053073|NCT00109681|Iloprost|iloprost|mesh-list
25087836|NCT03276325|Dexamethasone|dexamethasone|mesh-list
25087838|NCT03276325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25087839|NCT03276325|Antiemetics|antiemetics|mesh-ancestor
25087840|NCT03276325|Autonomic Agents|autonomic agents|mesh-ancestor
25087841|NCT03276325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25087842|NCT03276325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087843|NCT03276325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25087844|NCT03276325|Glucocorticoids|glucocorticoids|mesh-ancestor
24442309|NCT00290667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24442310|NCT00290667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442311|NCT00290667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24442312|NCT00290667|Glucocorticoids|glucocorticoids|mesh-ancestor
24442313|NCT00290667|Hormones|hormones|mesh-ancestor
24442314|NCT00290667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25087845|NCT03276325|Hormones|hormones|mesh-ancestor
24631588|NCT01118936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631589|NCT01118936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24631590|NCT01119014|Aripiprazole|aripiprazole|mesh-list
24631591|NCT01119014|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24631592|NCT01119014|Antidepressive Agents|antidepressive agents|mesh-ancestor
24631593|NCT01119014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24631594|NCT01119014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24631595|NCT01119014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24631596|NCT01119014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24631597|NCT01119014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631598|NCT01119014|Dopamine Agonists|dopamine agonists|mesh-ancestor
25220252|NCT02658214|Mitosis Modulators|mitosis modulators|mesh-ancestor
25220253|NCT02658214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220254|NCT02658214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25220255|NCT02658214|Antimetabolites|antimetabolites|mesh-ancestor
25220256|NCT02658214|Antiviral Agents|antiviral agents|mesh-ancestor
25220257|NCT02658214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25220258|NCT02658214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25220259|NCT02658214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25220260|NCT02658214|Immunologic Factors|immunologic factors|mesh-ancestor
25220261|NCT02658214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220262|NCT02658214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25220263|NCT02658214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25220264|NCT02658214|Antidotes|antidotes|mesh-ancestor
25220265|NCT02658214|Protective Agents|protective agents|mesh-ancestor
25220266|NCT02658214|Vitamin B Complex|vitamin b complex|mesh-ancestor
25220267|NCT02658214|Vitamins|vitamins|mesh-ancestor
25220268|NCT02658214|Micronutrients|micronutrients|mesh-ancestor
25220269|NCT02658214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25220270|NCT02658214|Hematinics|hematinics|mesh-ancestor
25220271|NCT02658253|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25220272|NCT02658253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25220273|NCT02658253|Immunologic Factors|immunologic factors|mesh-ancestor
25220274|NCT02658253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220275|NCT02658253|Antacids|antacids|mesh-ancestor
25220276|NCT02658253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220277|NCT02658253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25273056|NCT02387567|Sensory System Agents|sensory system agents|mesh-ancestor
25053102|NCT00106340|Metformin|metformin|mesh-list
24631599|NCT01119014|Dopamine Agents|dopamine agents|mesh-ancestor
24631604|NCT01119014|Serotonin Agents|serotonin agents|mesh-ancestor
24631605|NCT01119014|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24631606|NCT01119014|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24631607|NCT01119014|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24631608|NCT01119014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24618853|NCT01049880|Antimetabolites|antimetabolites|mesh-ancestor
24631664|NCT01119430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631666|NCT01119482|Immunologic Factors|immunologic factors|mesh-ancestor
24631667|NCT01119482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631668|NCT01119521|Isoniazid|isoniazid|mesh-list
24631669|NCT01119521|Antitubercular Agents|antitubercular agents|mesh-ancestor
24631670|NCT01119521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25087846|NCT03276325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25087847|NCT03276325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25087848|NCT03276325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25087849|NCT03276325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25087850|NCT03276325|Narcotics|narcotics|mesh-ancestor
25087851|NCT03276325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25087852|NCT03276325|Analgesics|analgesics|mesh-ancestor
25087853|NCT03276325|Sensory System Agents|sensory system agents|mesh-ancestor
25087854|NCT03276156|Apatinib|apatinib|mesh-list
24670847|NCT01759459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25087855|NCT03276156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25087856|NCT03276156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25087857|NCT03276156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25087906|NCT03275415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25087907|NCT03275415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456608|NCT00331786|Vasodilator Agents|vasodilator agents|mesh-ancestor
24456609|NCT00331786|Gasotransmitters|gasotransmitters|mesh-ancestor
24456610|NCT00331786|Protective Agents|protective agents|mesh-ancestor
25087908|NCT03275415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24456611|NCT00331786|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
24456612|NCT00331786|Protease Inhibitors|protease inhibitors|mesh-ancestor
24514301|NCT00589485|Cobalt|cobalt|mesh-list
25087909|NCT03275415|Respiratory System Agents|respiratory system agents|mesh-ancestor
25087910|NCT03275415|Glucocorticoids|glucocorticoids|mesh-ancestor
25087911|NCT03275415|Hormones|hormones|mesh-ancestor
25087912|NCT03275415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25220281|NCT02658292|Naftifine|naftifine|mesh-list
25220282|NCT02658292|Antifungal Agents|antifungal agents|mesh-ancestor
25220283|NCT02658292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25220284|NCT02657603|Lidocaine|lidocaine|mesh-list
25220285|NCT02657603|Anesthetics, Local|anesthetics, local|mesh-ancestor
25220286|NCT02657603|Anesthetics|anesthetics|mesh-ancestor
25220287|NCT02657603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24442859|NCT00293072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442860|NCT00293072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25220288|NCT02657603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832882|NCT02172378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740298|NCT01687699|Spironolactone|spironolactone|mesh-list
24420889|NCT00217178|Micronutrients|micronutrients|mesh-ancestor
25053114|NCT00103831|Taxane|taxane|mesh-list
25087913|NCT03275376|Atorvastatin|atorvastatin|mesh-list
25087914|NCT03275376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25087957|NCT03275090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25087958|NCT03275012|Morphine|morphine|mesh-list
25087959|NCT03275012|Gabapentin|gabapentin|mesh-list
25087960|NCT03275012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25087961|NCT03275012|Narcotics|narcotics|mesh-ancestor
24763504|NCT01774474|Bromfenac|bromfenac|mesh-list
24620267|NCT01056224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25087962|NCT03275012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25087963|NCT03275012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087964|NCT03275012|Analgesics|analgesics|mesh-ancestor
25087965|NCT03275012|Sensory System Agents|sensory system agents|mesh-ancestor
25087966|NCT03275012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25087967|NCT03275012|Anticonvulsants|anticonvulsants|mesh-ancestor
25087968|NCT03275012|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25087969|NCT03275012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25087970|NCT03275012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25087971|NCT03275012|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25253155|NCT02503319|Oxytocin|oxytocin|mesh-list
25087972|NCT03275012|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25087973|NCT03275012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25087974|NCT03275012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087975|NCT03275012|Antimanic Agents|antimanic agents|mesh-ancestor
25087976|NCT03274895|Biguanides|biguanides|mesh-list
25087977|NCT03274895|Polihexanide|polihexanide|mesh-list
25087978|NCT03274895|Dibrompropamidine|dibrompropamidine|mesh-list
25087979|NCT03274895|Propamidine|propamidine|mesh-list
24631673|NCT01119521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24631674|NCT01119521|Antimetabolites|antimetabolites|mesh-ancestor
24631675|NCT01119521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631676|NCT01119521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24631677|NCT01119534|Camphor|camphor|mesh-list
24631678|NCT01119534|Eucalyptol|eucalyptol|mesh-list
24631679|NCT01119534|Phenylpropanolamine|phenylpropanolamine|mesh-list
24631680|NCT01119534|Menthol|menthol|mesh-list
24631681|NCT01119534|Guaifenesin|guaifenesin|mesh-list
24631682|NCT01119534|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
25087988|NCT03274817|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25087989|NCT03274817|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25087990|NCT03274817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25087991|NCT03274817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25087992|NCT03274817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087993|NCT03274817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25087994|NCT03274817|Serotonin Agents|serotonin agents|mesh-ancestor
25087995|NCT03274817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087996|NCT03274817|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25087997|NCT03274817|Antidepressive Agents|antidepressive agents|mesh-ancestor
25220296|NCT02657616|Vitamin K|vitamin k|mesh-list
25220297|NCT02657616|Anticoagulants|anticoagulants|mesh-list
25220298|NCT02657616|Vitamins|vitamins|mesh-ancestor
25220299|NCT02657616|Micronutrients|micronutrients|mesh-ancestor
25220300|NCT02657616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220301|NCT02657616|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25220302|NCT02657616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25679536|NCT01839487|Antiemetics|antiemetics|mesh-ancestor
25679537|NCT01839487|Autonomic Agents|autonomic agents|mesh-ancestor
25679538|NCT01839487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25679539|NCT01839487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679540|NCT01839487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25088009|NCT03274700|Adrenergic Agents|adrenergic agents|mesh-ancestor
25088010|NCT03274700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25088011|NCT03274700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088012|NCT03274700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088013|NCT03274700|Urological Agents|urological agents|mesh-ancestor
24631713|NCT01119638|Citalopram|citalopram|mesh-list
24631714|NCT01119638|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24631715|NCT01119638|Serotonin Agents|serotonin agents|mesh-ancestor
24631716|NCT01119638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24631717|NCT01119638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631718|NCT01119638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631719|NCT01119638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24631721|NCT01119638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24631722|NCT01119638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24631723|NCT01119638|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24631724|NCT01119638|Dopamine Agents|dopamine agents|mesh-ancestor
24631725|NCT01119638|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24631726|NCT01119638|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24631727|NCT01119638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24631728|NCT01119638|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24631729|NCT01119638|Antidepressive Agents|antidepressive agents|mesh-ancestor
25088015|NCT03274596|Vitamins|vitamins|mesh-ancestor
25088019|NCT03274596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088021|NCT03274427|Trimetazidine|trimetazidine|mesh-list
25088022|NCT03274427|Vasodilator Agents|vasodilator agents|mesh-ancestor
25088024|NCT03274323|Travoprost|travoprost|mesh-list
25088025|NCT03274323|Latanoprost|latanoprost|mesh-list
25088026|NCT03274323|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25088027|NCT03274323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25088028|NCT03274323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25220303|NCT02657616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220304|NCT02657616|Hemostatics|hemostatics|mesh-ancestor
25220305|NCT02657616|Coagulants|coagulants|mesh-ancestor
25220306|NCT02657694|Sofosbuvir|sofosbuvir|mesh-list
25220307|NCT02657694|Ledipasvir|ledipasvir|mesh-list
25220308|NCT02657694|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25220314|NCT02657447|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
25220315|NCT02657447|Chelating Agents|chelating agents|mesh-ancestor
25220316|NCT02657447|Sequestering Agents|sequestering agents|mesh-ancestor
25220317|NCT02657447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088036|NCT03274167|Analgesics|analgesics|mesh-ancestor
25679541|NCT01839487|Glucocorticoids|glucocorticoids|mesh-ancestor
25679542|NCT01839487|Hormones|hormones|mesh-ancestor
25679543|NCT01839487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25679544|NCT01839487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25679545|NCT01839487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25267384|NCT02422966|Acetaminophen|acetaminophen|mesh-list
25088037|NCT03274167|Sensory System Agents|sensory system agents|mesh-ancestor
25088038|NCT03274167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25088039|NCT03274167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088040|NCT03274167|Anticonvulsants|anticonvulsants|mesh-ancestor
25088041|NCT03274167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25088042|NCT03274167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25088043|NCT03274167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25088044|NCT03274167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25088045|NCT03274167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25088046|NCT03274167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25088059|NCT03274024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25088062|NCT03274011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25088063|NCT03274011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25088064|NCT03274011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25088065|NCT03274011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088066|NCT03273881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25088067|NCT03273712|Octreotide|octreotide|mesh-list
25088068|NCT03273712|Edotreotide|edotreotide|mesh-list
25088069|NCT03273712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25088070|NCT03273712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25088071|NCT03273712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25088072|NCT03273712|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25088073|NCT03273712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088074|NCT03273634|Lansoprazole|lansoprazole|mesh-list
25088075|NCT03273634|Dexlansoprazole|dexlansoprazole|mesh-list
25088076|NCT03273634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25088077|NCT03273634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25088078|NCT03273634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25088079|NCT03273634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25088080|NCT03273634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088081|NCT03273595|Paclitaxel|paclitaxel|mesh-list
25220318|NCT02657512|Rivaroxaban|rivaroxaban|mesh-list
25220319|NCT02657512|Charcoal|charcoal|mesh-list
25220320|NCT02657512|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25220321|NCT02657512|Antithrombins|antithrombins|mesh-ancestor
25220322|NCT02657512|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25220323|NCT02657512|Protease Inhibitors|protease inhibitors|mesh-ancestor
25220324|NCT02657512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25220325|NCT02657512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220326|NCT02657512|Anticoagulants|anticoagulants|mesh-ancestor
25220327|NCT02657512|Antidotes|antidotes|mesh-ancestor
25220328|NCT02657512|Protective Agents|protective agents|mesh-ancestor
25220329|NCT02657512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220330|NCT02657486|Infigratinib|infigratinib|mesh-list
25220331|NCT02657486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25220332|NCT02657291|Ropivacaine|ropivacaine|mesh-list
25220333|NCT02657291|Anesthetics, Local|anesthetics, local|mesh-ancestor
25220334|NCT02657291|Anesthetics|anesthetics|mesh-ancestor
25220335|NCT02657291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25220336|NCT02657291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088082|NCT03273595|Cyclophosphamide|cyclophosphamide|mesh-list
25088083|NCT03273595|Trastuzumab|trastuzumab|mesh-list
25088084|NCT03273595|Epirubicin|epirubicin|mesh-list
25088085|NCT03273595|Lapatinib|lapatinib|mesh-list
25088086|NCT03273595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25088087|NCT03273595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25088088|NCT03273595|Tubulin Modulators|tubulin modulators|mesh-ancestor
25088089|NCT03273595|Antimitotic Agents|antimitotic agents|mesh-ancestor
25088090|NCT03273595|Mitosis Modulators|mitosis modulators|mesh-ancestor
25088091|NCT03273595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088092|NCT03273595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25088093|NCT03273595|Immunologic Factors|immunologic factors|mesh-ancestor
25088094|NCT03273595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631730|NCT01119651|Tazarotene|tazarotene|mesh-list
24631731|NCT01119651|Dermatologic Agents|dermatologic agents|mesh-ancestor
24631732|NCT01119651|Keratolytic Agents|keratolytic agents|mesh-ancestor
25088095|NCT03273595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25088096|NCT03273595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25679549|NCT01839487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25088097|NCT03273595|Alkylating Agents|alkylating agents|mesh-ancestor
25088098|NCT03273595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25088108|NCT03273556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25088109|NCT03273556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088110|NCT03273556|Sensory System Agents|sensory system agents|mesh-ancestor
25088111|NCT03273556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25088112|NCT03273556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25088113|NCT03273556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25088114|NCT03273556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25088115|NCT03273556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25088116|NCT03273556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088117|NCT03273296|Amoxicillin|amoxicillin|mesh-list
25088118|NCT03273296|Azithromycin|azithromycin|mesh-list
25088119|NCT03273296|Vancomycin|vancomycin|mesh-list
25088120|NCT03273296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25088121|NCT03273296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25088122|NCT03273231|Ketamine|ketamine|mesh-list
25088123|NCT03273231|Analgesics|analgesics|mesh-ancestor
24631733|NCT01119677|Interferon beta-1a|interferon beta-1a|mesh-list
24631734|NCT01119677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24631735|NCT01119677|Immunologic Factors|immunologic factors|mesh-ancestor
24631736|NCT01119677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665397|NCT01312077|Narcotics|narcotics|mesh-ancestor
24631751|NCT01119885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24631752|NCT01119885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24631753|NCT01119885|Anesthetics, General|anesthetics, general|mesh-ancestor
24631755|NCT01120015|Diacetylrhein|diacetylrhein|mesh-list
24631756|NCT01120015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24631757|NCT01120106|Simendan|simendan|mesh-list
24631758|NCT01120106|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25088124|NCT03273231|Sensory System Agents|sensory system agents|mesh-ancestor
25088125|NCT03273231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25088126|NCT03273231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220337|NCT02657291|Sensory System Agents|sensory system agents|mesh-ancestor
25220338|NCT02657291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25220339|NCT02657473|Tobramycin|tobramycin|mesh-list
25220340|NCT02657473|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25220341|NCT02657473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25220342|NCT02657473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25220343|NCT02657187|Rocuronium|rocuronium|mesh-list
25220344|NCT02657187|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25220345|NCT02657187|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25220346|NCT02657187|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25088127|NCT03273231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25088128|NCT03273231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25088129|NCT03273231|Anesthetics, General|anesthetics, general|mesh-ancestor
25088130|NCT03273231|Anesthetics|anesthetics|mesh-ancestor
25088131|NCT03273231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25088132|NCT03273231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25088133|NCT03273231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25088134|NCT03273231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25088135|NCT03273231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088136|NCT03273192|Adalimumab|adalimumab|mesh-list
25088137|NCT03273192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25088138|NCT03273192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25088139|NCT03273088|Etanercept|etanercept|mesh-list
25088140|NCT03273088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24763681|NCT01775839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24763746|NCT01776515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25088141|NCT03273088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25088143|NCT03273088|Sensory System Agents|sensory system agents|mesh-ancestor
25088145|NCT03273088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088146|NCT03273088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24631764|NCT01120106|Protective Agents|protective agents|mesh-ancestor
24631765|NCT01120106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631767|NCT01120119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24631768|NCT01120119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631769|NCT01120119|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24631773|NCT01120119|Vitamins|vitamins|mesh-ancestor
24631778|NCT01120158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24631779|NCT01120158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24631780|NCT01120158|Tubulin Modulators|tubulin modulators|mesh-ancestor
24631781|NCT01120158|Antimitotic Agents|antimitotic agents|mesh-ancestor
24631782|NCT01120158|Mitosis Modulators|mitosis modulators|mesh-ancestor
24631798|NCT01120171|Alkylating Agents|alkylating agents|mesh-ancestor
25088149|NCT03273088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25088150|NCT03273088|Immunologic Factors|immunologic factors|mesh-ancestor
25088152|NCT03273075|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25088153|NCT03273075|Cangrelor|cangrelor|mesh-list
25088154|NCT03273075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25088155|NCT03273075|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25088156|NCT03273075|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25088157|NCT03273075|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25088158|NCT03273075|Purinergic Agents|purinergic agents|mesh-ancestor
25088159|NCT03273075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25088160|NCT03273075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088161|NCT03273075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088162|NCT03273062|Tolcapone|tolcapone|mesh-list
25088163|NCT03273062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25088164|NCT03273062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25088165|NCT03273062|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25220347|NCT02657187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25220348|NCT02657187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220349|NCT02657213|Insulin|insulin|mesh-list
25220350|NCT02657213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25220351|NCT02657213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25220352|NCT02657213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220353|NCT02657161|Vaccines|vaccines|mesh-list
25220354|NCT02657161|Immunologic Factors|immunologic factors|mesh-ancestor
25220355|NCT02657161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220356|NCT02657148|Contraceptive Agents|contraceptive agents|mesh-list
25220357|NCT02657148|Etonogestrel|etonogestrel|mesh-list
25220358|NCT02657148|Desogestrel|desogestrel|mesh-list
24451951|NCT00325390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053171|NCT00095290|Ramipril|ramipril|mesh-list
25088166|NCT03273062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25088167|NCT03273062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088168|NCT03273036|Triamcinolone|triamcinolone|mesh-list
25088169|NCT03273036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25088170|NCT03273036|Glucocorticoids|glucocorticoids|mesh-ancestor
25088171|NCT03273036|Hormones|hormones|mesh-ancestor
25088172|NCT03273036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25088173|NCT03273036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088174|NCT03272867|Mannitol|mannitol|mesh-list
24631799|NCT01120171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631800|NCT01120171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24631826|NCT01120340|Sensory System Agents|sensory system agents|mesh-ancestor
24635004|NCT01136421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635005|NCT01136421|Anesthetics|anesthetics|mesh-ancestor
24635006|NCT01136421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24631827|NCT01120340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24631828|NCT01120340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631829|NCT01120340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24631830|NCT01120340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24631831|NCT01120366|Methotrexate|methotrexate|mesh-list
24631832|NCT01120366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24631833|NCT01120366|Abortifacient Agents|abortifacient agents|mesh-ancestor
24631834|NCT01120366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24631835|NCT01120366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631836|NCT01120366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24631837|NCT01120366|Antimetabolites|antimetabolites|mesh-ancestor
24631838|NCT01120366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631839|NCT01120366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24631840|NCT01120366|Dermatologic Agents|dermatologic agents|mesh-ancestor
24631841|NCT01120366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631842|NCT01120366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25088184|NCT03272802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25088185|NCT03272802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088186|NCT03272802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088187|NCT03272802|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25088188|NCT03272802|Protective Agents|protective agents|mesh-ancestor
25088189|NCT03272802|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25088191|NCT03272711|Vortioxetine|vortioxetine|mesh-list
25088192|NCT03272711|Antidepressive Agents|antidepressive agents|mesh-ancestor
25088193|NCT03272711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25088194|NCT03272711|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25220359|NCT02657148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25220360|NCT02657148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220361|NCT02657148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25220362|NCT02657148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25220363|NCT02657148|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25220364|NCT02657148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25220365|NCT02657148|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25220366|NCT02657148|Progestins|progestins|mesh-ancestor
25220367|NCT02657148|Hormones|hormones|mesh-ancestor
25220368|NCT02657148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25220369|NCT02657096|Hybenx|hybenx|mesh-list
25220370|NCT02657096|Dental Disinfectants|dental disinfectants|mesh-ancestor
25220371|NCT02657096|Disinfectants|disinfectants|mesh-ancestor
25220372|NCT02657096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25220373|NCT02656901|Anesthetics|anesthetics|mesh-list
25220374|NCT02656901|Sevoflurane|sevoflurane|mesh-list
25220375|NCT02656901|Desflurane|desflurane|mesh-list
25220376|NCT02656901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24451956|NCT00325429|Protease Inhibitors|protease inhibitors|mesh-ancestor
24451977|NCT00325637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24451978|NCT00325637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24451979|NCT00325637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25088195|NCT03272711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25088196|NCT03272711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24631844|NCT01120366|Immunologic Factors|immunologic factors|mesh-ancestor
24631845|NCT01120366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24631846|NCT01120366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24631856|NCT01120444|Insulin|insulin|mesh-list
24631876|NCT01120665|Contraceptive Agents|contraceptive agents|mesh-ancestor
24631877|NCT01120665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24631878|NCT01120665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24631879|NCT01120769|Acetaminophen|acetaminophen|mesh-list
24631880|NCT01120769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24631881|NCT01120769|Analgesics|analgesics|mesh-ancestor
24631882|NCT01120769|Sensory System Agents|sensory system agents|mesh-ancestor
24631883|NCT01120769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25679550|NCT01839487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25679551|NCT01839487|Immunologic Factors|immunologic factors|mesh-ancestor
25679552|NCT01839487|Anticoagulants|anticoagulants|mesh-ancestor
24631884|NCT01120769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631885|NCT01120769|Antipyretics|antipyretics|mesh-ancestor
24631886|NCT01120795|Interferons|interferons|mesh-list
24631887|NCT01120795|Ribavirin|ribavirin|mesh-list
24631888|NCT01120795|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24631889|NCT01120795|Interferon-alpha|interferon-alpha|mesh-list
24631890|NCT01120795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24631891|NCT01120795|Antiviral Agents|antiviral agents|mesh-ancestor
24631892|NCT01120795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24631893|NCT01120795|Antimetabolites|antimetabolites|mesh-ancestor
24631904|NCT01120912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631905|NCT01121016|Montelukast|montelukast|mesh-list
24631906|NCT01121016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24631907|NCT01121016|Respiratory System Agents|respiratory system agents|mesh-ancestor
24631908|NCT01121016|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24631909|NCT01121016|Hormone Antagonists|hormone antagonists|mesh-ancestor
25088197|NCT03272711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088198|NCT03272711|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25088199|NCT03272711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25088200|NCT03272711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25088201|NCT03272711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088203|NCT03272711|Serotonin Agents|serotonin agents|mesh-ancestor
25088204|NCT03272711|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25088205|NCT03272711|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25088206|NCT03272711|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25220377|NCT02656901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220378|NCT02656901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25220379|NCT02656901|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25220380|NCT02656901|Anesthetics, General|anesthetics, general|mesh-ancestor
25220381|NCT02656979|Latanoprost|latanoprost|mesh-list
25220382|NCT02656979|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25220383|NCT02656979|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25220384|NCT02656810|Teriparatide|teriparatide|mesh-list
25220385|NCT02656810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25220386|NCT02656810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220387|NCT02656810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25220388|NCT02656771|Metronidazole|metronidazole|mesh-list
25220389|NCT02656771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25220390|NCT02656771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25220391|NCT02656771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25088207|NCT03272711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25088220|NCT05075512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24631910|NCT01121016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24631911|NCT01121016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631912|NCT01121016|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24631914|NCT01121016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631916|NCT01121042|Antiemetics|antiemetics|mesh-ancestor
24631917|NCT01121042|Autonomic Agents|autonomic agents|mesh-ancestor
24631918|NCT01121042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24631919|NCT01121042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631920|NCT01121042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24631921|NCT01121042|Antipruritics|antipruritics|mesh-ancestor
24631922|NCT01121042|Dermatologic Agents|dermatologic agents|mesh-ancestor
24631923|NCT01121042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24631924|NCT01121042|Serotonin Agents|serotonin agents|mesh-ancestor
24631925|NCT01121042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25088221|NCT05075512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088222|NCT05075265|Methadone|methadone|mesh-list
25088223|NCT05075265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25088224|NCT05075265|Narcotics|narcotics|mesh-ancestor
25088225|NCT05075265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25088231|NCT05075265|Respiratory System Agents|respiratory system agents|mesh-ancestor
25088232|NCT05074875|Carbon Monoxide|carbon monoxide|mesh-list
25088233|NCT05074875|Antimetabolites|antimetabolites|mesh-ancestor
25088234|NCT05074875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088235|NCT05074875|Gasotransmitters|gasotransmitters|mesh-ancestor
25088236|NCT05074875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25088237|NCT05074875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088238|NCT05074966|Cetuximab|cetuximab|mesh-list
25088239|NCT05074966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25088240|NCT05074966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25220392|NCT02656771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25220393|NCT02656563|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25220394|NCT02656563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25220395|NCT02656589|Capecitabine|capecitabine|mesh-list
25220396|NCT02656589|Trastuzumab|trastuzumab|mesh-list
25220397|NCT02656589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25220398|NCT02656589|Antimetabolites|antimetabolites|mesh-ancestor
25220399|NCT02656589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220400|NCT02656589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25220401|NCT02656589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25220402|NCT02656472|Tranexamic Acid|tranexamic acid|mesh-list
25220403|NCT02656472|Aminocaproic Acid|aminocaproic acid|mesh-list
25220404|NCT02656472|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25220405|NCT02656472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24832903|NCT02172404|Cholinergic Agents|cholinergic agents|mesh-ancestor
24832904|NCT02172404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25053212|NCT00084344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24750006|NCT01695460|Vitamins|vitamins|mesh-list
25088285|NCT05074043|Antiviral Agents|antiviral agents|mesh-list
25088286|NCT05074043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24763924|NCT01778192|Cathartics|cathartics|mesh-ancestor
25088287|NCT05073965|Vitamin D|vitamin d|mesh-list
25088288|NCT05073965|Vitamins|vitamins|mesh-ancestor
25088289|NCT05073965|Micronutrients|micronutrients|mesh-ancestor
25088290|NCT05073965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088291|NCT05073965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25088292|NCT05065775|Dexmedetomidine|dexmedetomidine|mesh-list
25088293|NCT05065775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25220433|NCT02656121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25088294|NCT05065775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25088295|NCT05065775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088296|NCT05065775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25088297|NCT05065775|Analgesics|analgesics|mesh-ancestor
25088298|NCT05065775|Sensory System Agents|sensory system agents|mesh-ancestor
25088299|NCT05065775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25088300|NCT05065775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25253364|NCT02501850|Hormones|hormones|mesh-ancestor
24631926|NCT01121042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631927|NCT01121042|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24631928|NCT01121042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24631929|NCT01121042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24631930|NCT01121042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24631931|NCT01121042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24631933|NCT01121055|Anticonvulsants|anticonvulsants|mesh-ancestor
25088301|NCT05065775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25088302|NCT05065775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25679553|NCT01839487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25088309|NCT05045586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220406|NCT02656472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220408|NCT02656472|Coagulants|coagulants|mesh-ancestor
25220409|NCT02656615|Abiraterone Acetate|abiraterone acetate|mesh-list
25220410|NCT02656615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25220411|NCT02656615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25220412|NCT02656615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25220413|NCT02656615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220414|NCT02656615|Hormone Antagonists|hormone antagonists|mesh-ancestor
25220415|NCT02656615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25220416|NCT02656615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220417|NCT02656615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25273057|NCT02387567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25273058|NCT02387567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25273059|NCT02387567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24832905|NCT02172404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832907|NCT02172417|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
24832908|NCT02172417|Cimetidine|cimetidine|mesh-list
24832909|NCT02172417|Tiotropium Bromide|tiotropium bromide|mesh-list
25042614|NCT01410188|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24832910|NCT02172417|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25088310|NCT05045586|Viscosupplements|viscosupplements|mesh-ancestor
25088311|NCT05045586|Protective Agents|protective agents|mesh-ancestor
25088312|NCT04962022|Ritonavir|ritonavir|mesh-list
25088313|NCT04962022|Itraconazole|itraconazole|mesh-list
25088314|NCT04962022|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25088315|NCT04962022|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25088316|NCT04962022|Protease Inhibitors|protease inhibitors|mesh-ancestor
25088323|NCT04962022|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25088324|NCT04962022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25088326|NCT04962022|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25088327|NCT04962022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25088328|NCT04962022|Hormone Antagonists|hormone antagonists|mesh-ancestor
25088349|NCT04889287|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25088350|NCT04889287|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25088351|NCT04889287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25088352|NCT04889287|Antimetabolites|antimetabolites|mesh-ancestor
25088353|NCT04889287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088354|NCT04889287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25088355|NCT04889287|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25088358|NCT04877821|Cyclophosphamide|cyclophosphamide|mesh-list
25088359|NCT04877821|Carboplatin|carboplatin|mesh-list
25088360|NCT04877821|Epirubicin|epirubicin|mesh-list
24764017|NCT01779206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24764019|NCT01779206|Antimitotic Agents|antimitotic agents|mesh-ancestor
25088384|NCT04733560|Bupivacaine|bupivacaine|mesh-list
25088385|NCT04733560|Anesthetics, Local|anesthetics, local|mesh-ancestor
25088386|NCT04733560|Anesthetics|anesthetics|mesh-ancestor
25088387|NCT04733560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25220418|NCT02656251|Ethanol|ethanol|mesh-list
25220419|NCT02656251|Chlorhexidine|chlorhexidine|mesh-list
25220420|NCT02656251|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25220421|NCT02656251|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25220422|NCT02656251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25220423|NCT02656251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25220424|NCT02656251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220425|NCT02656251|Disinfectants|disinfectants|mesh-ancestor
25220426|NCT02656251|Dermatologic Agents|dermatologic agents|mesh-ancestor
25220427|NCT02656121|Vitamin D|vitamin d|mesh-list
25220428|NCT02656121|Clomiphene|clomiphene|mesh-list
25220429|NCT02656121|Vitamins|vitamins|mesh-ancestor
25088394|NCT04647383|Lemborexant|lemborexant|mesh-list
25088395|NCT04647383|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25088396|NCT04647383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25245802|NCT03705585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088397|NCT04647383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088398|NCT04647383|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25088402|NCT04630002|Ritonavir|ritonavir|mesh-list
25088438|NCT04427904|Anesthetics, Local|anesthetics, local|mesh-ancestor
25088439|NCT04427904|Anesthetics|anesthetics|mesh-ancestor
25088440|NCT04427904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25088441|NCT04427904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088442|NCT04427904|Sensory System Agents|sensory system agents|mesh-ancestor
25088443|NCT04427904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24750147|NCT01696799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25088450|NCT04427904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25088451|NCT04427904|Adrenergic Agents|adrenergic agents|mesh-ancestor
25088452|NCT04427904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25088453|NCT04427904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25088454|NCT04427904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25088455|NCT04427904|Autonomic Agents|autonomic agents|mesh-ancestor
25088456|NCT04427904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25088457|NCT04427904|Respiratory System Agents|respiratory system agents|mesh-ancestor
24455549|NCT00327756|Coenzyme Q10|coenzyme q10|mesh-list
25220432|NCT02656121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25220435|NCT02656121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25220437|NCT02656121|Fertility Agents|fertility agents|mesh-ancestor
25220438|NCT02656121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25220439|NCT02656121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25220440|NCT02656121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25220441|NCT02656342|Cycloserine|cycloserine|mesh-list
25220442|NCT02656342|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25220443|NCT02656342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25220444|NCT02656342|Renal Agents|renal agents|mesh-ancestor
25679554|NCT01839487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25679555|NCT01839799|Gemcitabine|gemcitabine|mesh-list
25679556|NCT01839799|Paclitaxel|paclitaxel|mesh-list
25679557|NCT01839799|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25679558|NCT01839799|Folfirinox|folfirinox|mesh-list
25679559|NCT01839799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25220454|NCT02656095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220455|NCT02656082|Etanercept|etanercept|mesh-list
25220456|NCT02656082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25220457|NCT02656082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25220458|NCT02656082|Analgesics|analgesics|mesh-ancestor
25220459|NCT02656082|Sensory System Agents|sensory system agents|mesh-ancestor
25220460|NCT02656082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25220461|NCT02656082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220462|NCT02656082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25220463|NCT02656082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25220464|NCT02656082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25220465|NCT02656082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25220466|NCT02656082|Immunologic Factors|immunologic factors|mesh-ancestor
25220470|NCT02655757|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25220471|NCT02655757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25220472|NCT02655757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220473|NCT02655757|Incretins|incretins|mesh-ancestor
25220474|NCT02655757|Hormones|hormones|mesh-ancestor
25220475|NCT02655757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25220476|NCT02655757|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25220477|NCT02655757|Protease Inhibitors|protease inhibitors|mesh-ancestor
25220478|NCT02655757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25220479|NCT02655757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220480|NCT02655770|Liraglutide|liraglutide|mesh-list
25220481|NCT02655770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25220482|NCT02655770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220483|NCT02655770|Incretins|incretins|mesh-ancestor
25220484|NCT02655770|Hormones|hormones|mesh-ancestor
25405198|NCT03623321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25692430|NCT01999348|Adrenergic Agents|adrenergic agents|mesh-ancestor
25692431|NCT01999348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25220485|NCT02655770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25220487|NCT02655874|Immunologic Factors|immunologic factors|mesh-ancestor
25220488|NCT02655874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220489|NCT02655913|Ascorbic Acid|ascorbic acid|mesh-list
24832920|NCT02172417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832921|NCT02172417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24832922|NCT02172417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24832923|NCT02172417|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24832924|NCT02172417|Histamine Antagonists|histamine antagonists|mesh-ancestor
24832925|NCT02172417|Histamine Agents|histamine agents|mesh-ancestor
24832926|NCT02172417|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24832927|NCT02172417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24452010|NCT00325689|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24452011|NCT00325715|Esomeprazole|esomeprazole|mesh-list
24452012|NCT00325715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24452013|NCT00325715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24452014|NCT00325715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25220491|NCT02655913|Micronutrients|micronutrients|mesh-ancestor
25220492|NCT02655913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220493|NCT02655913|Antioxidants|antioxidants|mesh-ancestor
25220494|NCT02655913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220495|NCT02655913|Protective Agents|protective agents|mesh-ancestor
25220496|NCT02655822|Atezolizumab|atezolizumab|mesh-list
25220497|NCT02655822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25220498|NCT02655965|Clonidine|clonidine|mesh-list
25220499|NCT02655965|Ropivacaine|ropivacaine|mesh-list
25220500|NCT02655965|Anesthetics, Local|anesthetics, local|mesh-ancestor
25220501|NCT02655965|Anesthetics|anesthetics|mesh-ancestor
25220502|NCT02655965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25220503|NCT02655965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220504|NCT02655965|Sensory System Agents|sensory system agents|mesh-ancestor
25220505|NCT02655965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25220506|NCT02655965|Analgesics|analgesics|mesh-ancestor
25220507|NCT02655965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25220508|NCT02655965|Sympatholytics|sympatholytics|mesh-ancestor
25220509|NCT02655965|Autonomic Agents|autonomic agents|mesh-ancestor
25220510|NCT02655965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25220511|NCT02655965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25220512|NCT02655965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25220513|NCT02655965|Adrenergic Agents|adrenergic agents|mesh-ancestor
25220514|NCT02655965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25220515|NCT02655965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220516|NCT02655705|Cyclosporine|cyclosporine|mesh-list
25220517|NCT02655705|Methotrexate|methotrexate|mesh-list
25220518|NCT02655705|Cyclosporins|cyclosporins|mesh-list
25220519|NCT02655705|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25220520|NCT02655705|Abortifacient Agents|abortifacient agents|mesh-ancestor
25220521|NCT02655705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25220522|NCT02655705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220523|NCT02655705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25220524|NCT02655705|Antimetabolites|antimetabolites|mesh-ancestor
25220525|NCT02655705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220526|NCT02655705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25220527|NCT02655705|Dermatologic Agents|dermatologic agents|mesh-ancestor
25220528|NCT02655705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25220529|NCT02655705|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25220530|NCT02655705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25220531|NCT02655705|Immunologic Factors|immunologic factors|mesh-ancestor
25220532|NCT02655705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25220533|NCT02655705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25220534|NCT02655705|Antifungal Agents|antifungal agents|mesh-ancestor
25220535|NCT02655705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25220536|NCT02655705|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25220537|NCT02655614|Midazolam|midazolam|mesh-list
25220543|NCT02655614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220544|NCT02655614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25220545|NCT02655614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25220546|NCT02655614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25220547|NCT02655614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25220548|NCT02655614|Anesthetics, General|anesthetics, general|mesh-ancestor
25220549|NCT02655614|Anesthetics|anesthetics|mesh-ancestor
25220550|NCT02655614|GABA Modulators|gaba modulators|mesh-ancestor
25220551|NCT02655614|GABA Agents|gaba agents|mesh-ancestor
25220552|NCT02655614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25220553|NCT02655614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220554|NCT02655614|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25220555|NCT02655614|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25220556|NCT02655614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25220557|NCT02655614|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25220558|NCT02655614|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25220559|NCT02655614|Purinergic Agents|purinergic agents|mesh-ancestor
25220560|NCT02655614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25220561|NCT02655614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25220562|NCT02655614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25220563|NCT02655536|Bevacizumab|bevacizumab|mesh-list
25220564|NCT02655536|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25220565|NCT02655536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25220566|NCT02655536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25220567|NCT02655536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25220568|NCT02655536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25220569|NCT02655536|Growth Substances|growth substances|mesh-ancestor
25220570|NCT02655536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220571|NCT02655536|Growth Inhibitors|growth inhibitors|mesh-ancestor
25220572|NCT02655536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25220573|NCT02655536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25220574|NCT02655536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220575|NCT02655380|Ketamine|ketamine|mesh-list
25220576|NCT02655380|Remifentanil|remifentanil|mesh-list
25220577|NCT02655380|Analgesics|analgesics|mesh-ancestor
25220578|NCT02655380|Sensory System Agents|sensory system agents|mesh-ancestor
25220579|NCT02655380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25220580|NCT02655380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220581|NCT02655380|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24589322|NCT00906828|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24589324|NCT00906867|Miotics|miotics|mesh-ancestor
24589325|NCT00906867|Autonomic Agents|autonomic agents|mesh-ancestor
24589326|NCT00906867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24589327|NCT00906867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589328|NCT00906867|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24631936|NCT01121055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24631937|NCT01121055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631938|NCT01121055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24631939|NCT01121055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24631940|NCT01121055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24631943|NCT01121055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24631944|NCT01121055|GABA Modulators|gaba modulators|mesh-ancestor
24631945|NCT01121055|GABA Agents|gaba agents|mesh-ancestor
24631946|NCT01121055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24631947|NCT01121055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631948|NCT01121120|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
24631958|NCT01121133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24631959|NCT01121133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631960|NCT01121133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631961|NCT01121133|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24631962|NCT01121133|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24631963|NCT01121133|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24631964|NCT01121133|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25220582|NCT02655380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25220583|NCT02655380|Anesthetics, General|anesthetics, general|mesh-ancestor
25220584|NCT02655380|Anesthetics|anesthetics|mesh-ancestor
25220585|NCT02655380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25220586|NCT02655380|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25220587|NCT02655380|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25220588|NCT02655380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25220589|NCT02655380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220590|NCT02655380|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25220591|NCT02655380|Narcotics|narcotics|mesh-ancestor
25220592|NCT02655458|Lenalidomide|lenalidomide|mesh-list
25220593|NCT02655458|Elotuzumab|elotuzumab|mesh-list
25220594|NCT02655458|Immunologic Factors|immunologic factors|mesh-ancestor
25220595|NCT02655458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220596|NCT02655458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25220597|NCT02655458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25220598|NCT02655458|Growth Substances|growth substances|mesh-ancestor
25220599|NCT02655458|Growth Inhibitors|growth inhibitors|mesh-ancestor
25220600|NCT02655458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25220601|NCT02655471|Zidovudine|zidovudine|mesh-list
25220602|NCT02655471|Raltegravir Potassium|raltegravir potassium|mesh-list
25220603|NCT02655471|Antimetabolites|antimetabolites|mesh-ancestor
25220604|NCT02655471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220605|NCT02655471|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25220606|NCT02655471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25220607|NCT02655471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832952|NCT02172443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24832953|NCT02172443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832954|NCT02172456|Tiotropium Bromide|tiotropium bromide|mesh-list
24832960|NCT02172456|Respiratory System Agents|respiratory system agents|mesh-ancestor
24631965|NCT01121133|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24631966|NCT01121133|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24631967|NCT01121133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25088460|NCT04427904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25088461|NCT04416282|Terlipressin|terlipressin|mesh-list
25088462|NCT04416282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25088463|NCT04416282|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25088464|NCT04341129|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
25088465|NCT04341129|Chelating Agents|chelating agents|mesh-ancestor
25088466|NCT04341129|Sequestering Agents|sequestering agents|mesh-ancestor
25088467|NCT04341129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088468|NCT04239040|Nivolumab|nivolumab|mesh-list
25088469|NCT04239040|Ipilimumab|ipilimumab|mesh-list
25088470|NCT04239040|Vaccines|vaccines|mesh-list
25088471|NCT04239040|Immunologic Factors|immunologic factors|mesh-ancestor
25088472|NCT04239040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088473|NCT04239040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25088474|NCT04239040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25088475|NCT04239040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24980358|NCT05352321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980359|NCT05352321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24980360|NCT05352321|Antimetabolites|antimetabolites|mesh-ancestor
25106068|NCT04542135|Sulindac|sulindac|mesh-list
25106069|NCT04542135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25106070|NCT04542135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25106071|NCT04542135|Analgesics|analgesics|mesh-ancestor
25088476|NCT04239040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088477|NCT04149899|Timolol|timolol|mesh-list
25220608|NCT02655471|Antiviral Agents|antiviral agents|mesh-ancestor
25220609|NCT02655471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25220610|NCT02655471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25220611|NCT02655471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25220612|NCT02655471|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25220613|NCT02655471|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25220614|NCT02655315|Deferiprone|deferiprone|mesh-list
25220615|NCT02655315|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25220616|NCT02655315|Chelating Agents|chelating agents|mesh-ancestor
25220617|NCT02655315|Sequestering Agents|sequestering agents|mesh-ancestor
25220618|NCT02655315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220619|NCT02655276|Glycine|glycine|mesh-list
25220620|NCT02655276|Glycine Agents|glycine agents|mesh-ancestor
25220621|NCT02655276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25220622|NCT02655276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220623|NCT02655276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220624|NCT02655198|Fenfluramine|fenfluramine|mesh-list
25220625|NCT02655198|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25220626|NCT02655198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25220627|NCT02655198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25220628|NCT02655198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220629|NCT02655198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25220630|NCT02655198|Serotonin Agents|serotonin agents|mesh-ancestor
24832961|NCT02172456|Parasympatholytics|parasympatholytics|mesh-ancestor
24741119|NCT01692132|Prucalopride|prucalopride|mesh-list
24639705|NCT01163994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24452019|NCT00325767|Autonomic Agents|autonomic agents|mesh-ancestor
25088478|NCT04149899|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25088479|NCT04149899|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25088529|NCT03854370|Plasma Substitutes|plasma substitutes|mesh-ancestor
25088530|NCT03854370|Blood Substitutes|blood substitutes|mesh-ancestor
25088531|NCT03849651|Cyclophosphamide|cyclophosphamide|mesh-list
25088546|NCT03821883|Aspirin|aspirin|mesh-list
25088547|NCT03821883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25088548|NCT03821883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25088549|NCT03821883|Analgesics|analgesics|mesh-ancestor
25088550|NCT03821883|Sensory System Agents|sensory system agents|mesh-ancestor
25088551|NCT03821883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25088552|NCT03821883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088553|NCT03821883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25088554|NCT03821883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25088555|NCT03821883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25088556|NCT03821883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25088557|NCT03821883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088558|NCT03821883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25245803|NCT03697512|Rituximab|rituximab|mesh-list
25088559|NCT03821883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25088560|NCT03821883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25088561|NCT03821883|Antipyretics|antipyretics|mesh-ancestor
25088565|NCT03545464|Prednisone|prednisone|mesh-list
25088571|NCT03545464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088572|NCT03545464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25088573|NCT03545464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25088574|NCT03545464|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25088575|NCT03545464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25088576|NCT03545464|Histamine Antagonists|histamine antagonists|mesh-ancestor
25088577|NCT03545464|Histamine Agents|histamine agents|mesh-ancestor
25088578|NCT03545464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25088579|NCT03545464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220631|NCT02655198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220632|NCT02655146|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25220633|NCT02655146|Progesterone|progesterone|mesh-list
25220634|NCT02655146|Estradiol|estradiol|mesh-list
25220635|NCT02655146|Progestins|progestins|mesh-ancestor
25220636|NCT02655146|Hormones|hormones|mesh-ancestor
25220637|NCT02655146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25220638|NCT02655146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220639|NCT02655146|Luteolytic Agents|luteolytic agents|mesh-ancestor
25220640|NCT02655146|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24452020|NCT00325767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24452021|NCT00325767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452022|NCT00325767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24452023|NCT00325767|Respiratory System Agents|respiratory system agents|mesh-ancestor
24452024|NCT00325767|Tocolytic Agents|tocolytic agents|mesh-ancestor
24452025|NCT00325767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24452026|NCT00325767|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24452027|NCT00325767|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24452028|NCT00325767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24452029|NCT00325767|Adrenergic Agents|adrenergic agents|mesh-ancestor
24452060|NCT00325910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452061|NCT00325936|Cilnidipine|cilnidipine|mesh-list
25088590|NCT03536520|Acetazolamide|acetazolamide|mesh-list
25088591|NCT03536520|Anticonvulsants|anticonvulsants|mesh-ancestor
25088592|NCT03536520|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25088593|NCT03536520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25088594|NCT03536520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088595|NCT03536520|Diuretics|diuretics|mesh-ancestor
25088596|NCT03536520|Natriuretic Agents|natriuretic agents|mesh-ancestor
25088597|NCT03536520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088598|NCT03536455|Acetazolamide|acetazolamide|mesh-list
25088599|NCT03536455|Anticonvulsants|anticonvulsants|mesh-ancestor
25088600|NCT03536455|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25088601|NCT03536455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25088602|NCT03536455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088603|NCT03536455|Diuretics|diuretics|mesh-ancestor
25088604|NCT03536455|Natriuretic Agents|natriuretic agents|mesh-ancestor
25679560|NCT01839799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011442|NCT05130788|Autonomic Agents|autonomic agents|mesh-ancestor
25088605|NCT03536455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088607|NCT03536429|Anticonvulsants|anticonvulsants|mesh-ancestor
25088608|NCT03536429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25088609|NCT03536429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25088610|NCT03536429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088612|NCT03536429|Natriuretic Agents|natriuretic agents|mesh-ancestor
25088613|NCT03536429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088614|NCT03529825|Rifaximin|rifaximin|mesh-list
25088615|NCT03529825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25088616|NCT03529825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25088617|NCT03529825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25088624|NCT03475134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088625|NCT03475134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25088626|NCT03475134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25088627|NCT03475134|Alkylating Agents|alkylating agents|mesh-ancestor
25088628|NCT03475134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088629|NCT03475134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25220641|NCT02655146|Contraceptive Agents|contraceptive agents|mesh-ancestor
25220642|NCT02655146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25220643|NCT02655146|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25220644|NCT02655146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25220645|NCT02655146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25220646|NCT02655146|Estrogens|estrogens|mesh-ancestor
25220647|NCT02654847|Norepinephrine|norepinephrine|mesh-list
25220648|NCT02654847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25220649|NCT02654847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25220650|NCT02654847|Adrenergic Agents|adrenergic agents|mesh-ancestor
25220651|NCT02654847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25220652|NCT02654847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220653|NCT02654847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220654|NCT02654847|Sympathomimetics|sympathomimetics|mesh-ancestor
25220655|NCT02654847|Autonomic Agents|autonomic agents|mesh-ancestor
25220656|NCT02654847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25220657|NCT02654847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25220658|NCT02655029|Amlodipine|amlodipine|mesh-list
25220659|NCT02655029|Perindopril|perindopril|mesh-list
25061696|NCT03469128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25088630|NCT03475134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25088631|NCT03475134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25088632|NCT03475134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25088633|NCT03475134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25088634|NCT03475134|Analgesics|analgesics|mesh-ancestor
25088635|NCT03475134|Sensory System Agents|sensory system agents|mesh-ancestor
25088636|NCT03475134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25088637|NCT03461120|Anesthetics|anesthetics|mesh-list
25088638|NCT03461120|Anesthetics, Local|anesthetics, local|mesh-list
25088639|NCT03461120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25088640|NCT03461120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631969|NCT01121198|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24631970|NCT01121198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631972|NCT01121198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679561|NCT01839799|Tubulin Modulators|tubulin modulators|mesh-ancestor
25679562|NCT01839799|Antimitotic Agents|antimitotic agents|mesh-ancestor
25679563|NCT01839799|Mitosis Modulators|mitosis modulators|mesh-ancestor
25110287|NCT05464433|Mitoxantrone|mitoxantrone|mesh-list
25110288|NCT05464433|Analgesics|analgesics|mesh-ancestor
25110289|NCT05464433|Sensory System Agents|sensory system agents|mesh-ancestor
25110290|NCT05464433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25110291|NCT05464433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110292|NCT05464433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25110293|NCT05464433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24631973|NCT01121237|Epoetin Alfa|epoetin alfa|mesh-list
24631974|NCT01121237|Hematinics|hematinics|mesh-ancestor
24631976|NCT01121276|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24631977|NCT01121276|Insulin Aspart|insulin aspart|mesh-list
24631978|NCT01121276|Insulin, Long-Acting|insulin, long-acting|mesh-list
24631979|NCT01121276|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24631980|NCT01121276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24631981|NCT01121276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631982|NCT01121289|Insulin Aspart|insulin aspart|mesh-list
24631983|NCT01121289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24631984|NCT01121289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088644|NCT03384212|Fludarabine|fludarabine|mesh-list
25088645|NCT03384212|Busulfan|busulfan|mesh-list
25220660|NCT02655029|Indapamide|indapamide|mesh-list
25220661|NCT02655029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25220662|NCT02655029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25220663|NCT02655029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25220664|NCT02655029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220665|NCT02655029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25220666|NCT02655029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220667|NCT02655029|Vasodilator Agents|vasodilator agents|mesh-ancestor
25220668|NCT02655029|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25220669|NCT02655029|Protease Inhibitors|protease inhibitors|mesh-ancestor
25220670|NCT02655029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25220671|NCT02655029|Diuretics|diuretics|mesh-ancestor
25220672|NCT02655029|Natriuretic Agents|natriuretic agents|mesh-ancestor
25220673|NCT02655029|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25220674|NCT02654834|Nitrous Oxide|nitrous oxide|mesh-list
25220675|NCT02654834|Anesthetics|anesthetics|mesh-list
25220676|NCT02654834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25088648|NCT03384212|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25088649|NCT03384212|Antimetabolites|antimetabolites|mesh-ancestor
25088650|NCT03384212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088651|NCT03384212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25088652|NCT03384212|Immunologic Factors|immunologic factors|mesh-ancestor
25088653|NCT03384212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088654|NCT03384212|Antiviral Agents|antiviral agents|mesh-ancestor
25088655|NCT03384212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25088656|NCT03384212|Alkylating Agents|alkylating agents|mesh-ancestor
25088657|NCT03384212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25088658|NCT03384212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25088659|NCT03384225|Cytarabine|cytarabine|mesh-list
25088660|NCT03384225|Fludarabine|fludarabine|mesh-list
25088661|NCT03384225|Busulfan|busulfan|mesh-list
25088662|NCT03384225|Cladribine|cladribine|mesh-list
25088663|NCT03384225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25679564|NCT01839799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679565|NCT01839799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25679566|NCT01839799|Antimetabolites|antimetabolites|mesh-ancestor
25679567|NCT01839799|Antiviral Agents|antiviral agents|mesh-ancestor
25679568|NCT01839799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25679569|NCT01839799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25679570|NCT01839799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25679571|NCT01839799|Immunologic Factors|immunologic factors|mesh-ancestor
25679572|NCT01839799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679573|NCT01840072|Antihypertensive Agents|antihypertensive agents|mesh-list
25679574|NCT01840228|Progesterone|progesterone|mesh-list
25088664|NCT03384225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25679575|NCT01840228|Progestins|progestins|mesh-ancestor
25011520|NCT04844528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011521|NCT04844528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25011522|NCT04844528|Antimetabolites|antimetabolites|mesh-ancestor
25011523|NCT04844528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011524|NCT04844528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25011525|NCT04844528|Vasodilator Agents|vasodilator agents|mesh-ancestor
25011543|NCT04811118|Docetaxel|docetaxel|mesh-list
25011544|NCT04811118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011545|NCT04811118|Tubulin Modulators|tubulin modulators|mesh-ancestor
25011546|NCT04811118|Antimitotic Agents|antimitotic agents|mesh-ancestor
24443877|NCT00296049|Daptomycin|daptomycin|mesh-list
25011618|NCT04557449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011620|NCT04557449|Hormone Antagonists|hormone antagonists|mesh-ancestor
25011621|NCT04557449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25011622|NCT04557449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583897|NCT00877539|Xhance|xhance|mesh-list
25088665|NCT03384225|Antimetabolites|antimetabolites|mesh-ancestor
25088666|NCT03384225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455718|NCT00328796|Lidocaine|lidocaine|mesh-list
24631987|NCT01121354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24631989|NCT01121458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24631990|NCT01121458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24631991|NCT01121458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631992|NCT01121458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24631993|NCT01121458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631994|NCT01121497|Physostigmine|physostigmine|mesh-list
24631995|NCT01121497|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24631996|NCT01121497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631997|NCT01121497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088667|NCT03384225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25088668|NCT03384225|Immunologic Factors|immunologic factors|mesh-ancestor
25088669|NCT03384225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088670|NCT03384225|Antiviral Agents|antiviral agents|mesh-ancestor
25088671|NCT03384225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25088672|NCT03384225|Alkylating Agents|alkylating agents|mesh-ancestor
25088673|NCT03384225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25088674|NCT03384225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25088675|NCT03272698|Ketamine|ketamine|mesh-list
25088676|NCT03272698|Analgesics|analgesics|mesh-ancestor
25088677|NCT03272698|Sensory System Agents|sensory system agents|mesh-ancestor
25088678|NCT03272698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25088679|NCT03272698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088680|NCT03272698|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25088681|NCT03272698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25088682|NCT03272698|Anesthetics, General|anesthetics, general|mesh-ancestor
25220677|NCT02654834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220678|NCT02654834|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25220679|NCT02654834|Anesthetics, General|anesthetics, general|mesh-ancestor
25220680|NCT02654834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25220681|NCT02654834|Analgesics|analgesics|mesh-ancestor
25220682|NCT02654834|Sensory System Agents|sensory system agents|mesh-ancestor
25220683|NCT02654834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25679576|NCT01840228|Hormones|hormones|mesh-ancestor
25679577|NCT01840228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25679578|NCT01840228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679579|NCT01840345|Acetylcysteine|acetylcysteine|mesh-list
25679580|NCT01840345|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25679581|NCT01840345|Antiviral Agents|antiviral agents|mesh-ancestor
25679582|NCT01840345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25679583|NCT01840345|Expectorants|expectorants|mesh-ancestor
25679584|NCT01840345|Respiratory System Agents|respiratory system agents|mesh-ancestor
25679585|NCT01840345|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25679586|NCT01840345|Antioxidants|antioxidants|mesh-ancestor
25679587|NCT01840345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679588|NCT01840345|Protective Agents|protective agents|mesh-ancestor
25679589|NCT01840345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679590|NCT01840345|Antidotes|antidotes|mesh-ancestor
25679591|NCT01840410|Ranibizumab|ranibizumab|mesh-list
25679592|NCT01840410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24764443|NCT01781702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24764444|NCT01781702|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25088686|NCT03272698|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25088687|NCT03272698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25088688|NCT03272698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088689|NCT03272568|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
25088690|NCT03272568|Immunologic Factors|immunologic factors|mesh-ancestor
25088691|NCT03272568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088692|NCT03272425|Allopurinol|allopurinol|mesh-list
25088693|NCT03272425|Lesinurad|lesinurad|mesh-list
25088694|NCT03272425|Antimetabolites|antimetabolites|mesh-ancestor
25088696|NCT03272425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25088702|NCT03272425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088703|NCT03272425|Uricosuric Agents|uricosuric agents|mesh-ancestor
25088704|NCT03272425|Renal Agents|renal agents|mesh-ancestor
25088705|NCT03272477|Tamoxifen|tamoxifen|mesh-list
25088706|NCT03272477|Paclitaxel|paclitaxel|mesh-list
25088707|NCT03272477|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25088708|NCT03272477|Cyclophosphamide|cyclophosphamide|mesh-list
25088709|NCT03272477|Trastuzumab|trastuzumab|mesh-list
25088715|NCT03272477|Goserelin|goserelin|mesh-list
25088716|NCT03272477|Leuprolide|leuprolide|mesh-list
25088717|NCT03272477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25088750|NCT03272503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25088751|NCT03272503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088753|NCT03272503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25088754|NCT03272503|Dopamine Agents|dopamine agents|mesh-ancestor
25088755|NCT03272503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25088756|NCT03272503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088757|NCT03272503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25088758|NCT03272412|Progesterone|progesterone|mesh-list
25088759|NCT03272412|Progestins|progestins|mesh-ancestor
25088760|NCT03272412|Hormones|hormones|mesh-ancestor
25088761|NCT03272412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25088762|NCT03272412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088763|NCT03272126|Vitamin D|vitamin d|mesh-list
25088764|NCT03272126|Vitamins|vitamins|mesh-ancestor
25088765|NCT03272126|Micronutrients|micronutrients|mesh-ancestor
25088766|NCT03272126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088767|NCT03272126|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25088768|NCT03272321|Oxytocin|oxytocin|mesh-list
25088769|NCT03272321|Oxytocics|oxytocics|mesh-ancestor
25220685|NCT02654743|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25220686|NCT02654743|Protective Agents|protective agents|mesh-ancestor
25220687|NCT02654743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220688|NCT02654743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25220689|NCT02654561|Heparin|heparin|mesh-list
25220690|NCT02654561|Calcium heparin|calcium heparin|mesh-list
25220691|NCT02654561|Anticoagulants|anticoagulants|mesh-ancestor
25220692|NCT02654561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25220693|NCT02654561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25220694|NCT02654561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220695|NCT02654665|Liraglutide|liraglutide|mesh-list
25220696|NCT02654665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24586145|NCT00889356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586146|NCT00889356|Antifungal Agents|antifungal agents|mesh-ancestor
24445543|NCT00301847|Sorafenib|sorafenib|mesh-list
25053506|NCT00013897|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25088770|NCT03272321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25088771|NCT03272321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088772|NCT03272295|Menthol|menthol|mesh-list
25088773|NCT03272295|Sorbitol|sorbitol|mesh-list
25088774|NCT03272295|Glycerol|glycerol|mesh-list
25088775|NCT03272295|Antipruritics|antipruritics|mesh-ancestor
25088776|NCT03272295|Dermatologic Agents|dermatologic agents|mesh-ancestor
25088777|NCT03272295|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25088778|NCT03272295|Protective Agents|protective agents|mesh-ancestor
25088779|NCT03272295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088796|NCT03272009|Interferons|interferons|mesh-list
25088797|NCT03272009|Interferon-alpha|interferon-alpha|mesh-list
25088798|NCT03272009|Interferon alpha-2|interferon alpha-2|mesh-list
25088805|NCT03272009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088807|NCT03271879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25088808|NCT03271879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088809|NCT03271879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25088810|NCT03271879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088811|NCT03271983|Metronidazole|metronidazole|mesh-list
25088812|NCT03271983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25088813|NCT03271983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24632009|NCT01121705|Interferons|interferons|mesh-list
24632010|NCT01121705|Ribavirin|ribavirin|mesh-list
24632011|NCT01121705|Interferon-alpha|interferon-alpha|mesh-list
24632012|NCT01121705|Interferon alpha-2|interferon alpha-2|mesh-list
25220697|NCT02654665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220698|NCT02654665|Incretins|incretins|mesh-ancestor
25220699|NCT02654665|Hormones|hormones|mesh-ancestor
25220700|NCT02654665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25220701|NCT02654730|Piperaquine|piperaquine|mesh-list
25220702|NCT02654730|Primaquine|primaquine|mesh-list
25220703|NCT02654730|Artenimol|artenimol|mesh-list
25220704|NCT02654730|Artemisinins|artemisinins|mesh-list
25220705|NCT02654730|Antimalarials|antimalarials|mesh-ancestor
25220708|NCT02654730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25273060|NCT02387567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25273061|NCT02387567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24443270|NCT00294359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25679593|NCT01840410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25679594|NCT01840410|Growth Substances|growth substances|mesh-ancestor
25679595|NCT01840410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679596|NCT01840410|Growth Inhibitors|growth inhibitors|mesh-ancestor
25679597|NCT01840410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25679598|NCT01840579|Paclitaxel|paclitaxel|mesh-list
25679599|NCT01840579|Etoposide|etoposide|mesh-list
25679600|NCT01840579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25679601|NCT01840579|Cisplatin|cisplatin|mesh-list
25679602|NCT01840579|Carboplatin|carboplatin|mesh-list
25679603|NCT01840579|Pembrolizumab|pembrolizumab|mesh-list
24466880|NCT00375440|Hemostatics|hemostatics|mesh-ancestor
24452074|NCT00325949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24452075|NCT00325949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452077|NCT00325949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24452078|NCT00325949|Narcotics|narcotics|mesh-ancestor
24452079|NCT00325949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24452080|NCT00325949|Antitussive Agents|antitussive agents|mesh-ancestor
24632013|NCT01121705|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24632014|NCT01121705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632025|NCT01121731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25088821|NCT03271905|Autonomic Agents|autonomic agents|mesh-ancestor
25088822|NCT03271905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25088823|NCT03271905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088824|NCT03271905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25088825|NCT03271905|Respiratory System Agents|respiratory system agents|mesh-ancestor
25088826|NCT03271905|Tocolytic Agents|tocolytic agents|mesh-ancestor
25220709|NCT02654678|Enalapril|enalapril|mesh-list
25220710|NCT02654678|Enalaprilat|enalaprilat|mesh-list
25220711|NCT02654678|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25220712|NCT02654678|Protease Inhibitors|protease inhibitors|mesh-ancestor
25220713|NCT02654678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25220714|NCT02654678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220715|NCT02654678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25220716|NCT02654587|Docetaxel|docetaxel|mesh-list
25220717|NCT02654587|Pemetrexed|pemetrexed|mesh-list
25220718|NCT02654587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25220719|NCT02654587|Tubulin Modulators|tubulin modulators|mesh-ancestor
25220720|NCT02654587|Antimitotic Agents|antimitotic agents|mesh-ancestor
25220721|NCT02654587|Mitosis Modulators|mitosis modulators|mesh-ancestor
25405274|NCT03615105|Cyclophosphamide|cyclophosphamide|mesh-list
25679604|NCT01840579|Pemetrexed|pemetrexed|mesh-list
25679605|NCT01840579|Ipilimumab|ipilimumab|mesh-list
25679606|NCT01840579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25679607|NCT01840579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25679608|NCT01840579|Tubulin Modulators|tubulin modulators|mesh-ancestor
25679609|NCT01840579|Antimitotic Agents|antimitotic agents|mesh-ancestor
25679610|NCT01840579|Mitosis Modulators|mitosis modulators|mesh-ancestor
25679611|NCT01840579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220722|NCT02654587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220723|NCT02654587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25220724|NCT02654587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25220725|NCT02654587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25220726|NCT02654405|Butyric Acid|butyric acid|mesh-list
25220727|NCT02654405|Histamine Antagonists|histamine antagonists|mesh-ancestor
25220728|NCT02654405|Histamine Agents|histamine agents|mesh-ancestor
25220729|NCT02654405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25220730|NCT02654405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220731|NCT02654405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220732|NCT02654379|Rituximab|rituximab|mesh-list
25220733|NCT02654379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25220734|NCT02654379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25220735|NCT02654379|Immunologic Factors|immunologic factors|mesh-ancestor
25220736|NCT02654379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832994|NCT02172482|Anticonvulsants|anticonvulsants|mesh-ancestor
24832995|NCT02172495|Bromides|bromides|mesh-list
25053557|NCT00005608|Leucovorin|leucovorin|mesh-list
25088827|NCT03271905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25106085|NCT04509973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25088828|NCT03271905|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25088829|NCT03271905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25088830|NCT03271905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25088831|NCT03271905|Adrenergic Agents|adrenergic agents|mesh-ancestor
25088832|NCT03271905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25088833|NCT03271905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088834|NCT03271905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25088837|NCT03271749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25088838|NCT03271749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088839|NCT03271450|Warfarin|warfarin|mesh-list
24764584|NCT01782781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088840|NCT03271450|Rivaroxaban|rivaroxaban|mesh-list
25088841|NCT03271450|Dabigatran|dabigatran|mesh-list
25088842|NCT03271450|Apixaban|apixaban|mesh-list
25088843|NCT03271450|Edoxaban|edoxaban|mesh-list
25088844|NCT03271450|Anticoagulants|anticoagulants|mesh-ancestor
25088845|NCT03271450|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25088846|NCT03271450|Antithrombins|antithrombins|mesh-ancestor
25088847|NCT03271450|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25088848|NCT03271450|Protease Inhibitors|protease inhibitors|mesh-ancestor
25088849|NCT03271450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25088853|NCT03271502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088855|NCT03271164|Vitamins|vitamins|mesh-ancestor
25088856|NCT03271164|Micronutrients|micronutrients|mesh-ancestor
25088857|NCT03271164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088858|NCT03271164|Antioxidants|antioxidants|mesh-ancestor
25088859|NCT03271164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679612|NCT01840579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25679613|NCT01840579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25679614|NCT01840579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25679615|NCT01840579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25679616|NCT01840579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25679617|NCT01840579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25679618|NCT01840579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25679619|NCT01840605|Ketotifen|ketotifen|mesh-list
25679620|NCT01840605|Bepotastine besilate|bepotastine besilate|mesh-list
25220740|NCT02654093|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25220741|NCT02654093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25220742|NCT02654093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220743|NCT02654093|Vitamins|vitamins|mesh-ancestor
25220744|NCT02654093|Micronutrients|micronutrients|mesh-ancestor
25220745|NCT02654093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25220746|NCT02654093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25220747|NCT02654093|Hormone Antagonists|hormone antagonists|mesh-ancestor
25220748|NCT02654093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25220749|NCT02654093|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25220750|NCT02654093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24832999|NCT02172495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24833000|NCT02172495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088877|NCT03271073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451772|NCT00324766|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25220751|NCT02654106|Temozolomide|temozolomide|mesh-list
25220752|NCT02654106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25220753|NCT02654106|Alkylating Agents|alkylating agents|mesh-ancestor
25220754|NCT02654106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220755|NCT02654106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25220756|NCT02654119|Paclitaxel|paclitaxel|mesh-list
25220757|NCT02654119|Cyclophosphamide|cyclophosphamide|mesh-list
25220758|NCT02654119|Trastuzumab|trastuzumab|mesh-list
25220759|NCT02654119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25220760|NCT02654119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24643557|NCT01186029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643559|NCT01186094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24643560|NCT01186094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24643561|NCT01186094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24643583|NCT01186146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25220761|NCT02654119|Antibodies|antibodies|mesh-list
25220762|NCT02654119|Immunoglobulins|immunoglobulins|mesh-list
25220763|NCT02654119|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25220764|NCT02654119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25220765|NCT02654119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25220766|NCT02654119|Tubulin Modulators|tubulin modulators|mesh-ancestor
25220767|NCT02654119|Antimitotic Agents|antimitotic agents|mesh-ancestor
25220768|NCT02654119|Mitosis Modulators|mitosis modulators|mesh-ancestor
25220769|NCT02654119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220770|NCT02654119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25220771|NCT02654119|Immunologic Factors|immunologic factors|mesh-ancestor
25220772|NCT02654119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220773|NCT02654119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25220774|NCT02654119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25220775|NCT02654119|Alkylating Agents|alkylating agents|mesh-ancestor
25220776|NCT02654119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25220777|NCT02654171|Ziresovir|ziresovir|mesh-list
25220778|NCT02654171|Antiviral Agents|antiviral agents|mesh-ancestor
25220779|NCT02654171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25220780|NCT02654288|Gemcitabine|gemcitabine|mesh-list
25220781|NCT02654288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25220782|NCT02654288|Antimetabolites|antimetabolites|mesh-ancestor
25220783|NCT02654288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833008|NCT02172495|Anticonvulsants|anticonvulsants|mesh-ancestor
24833009|NCT02172508|Tiotropium Bromide|tiotropium bromide|mesh-list
24833010|NCT02172508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24833011|NCT02172508|Autonomic Agents|autonomic agents|mesh-ancestor
25053595|NCT00004915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25053598|NCT00004912|Megestrol|megestrol|mesh-list
25053599|NCT00004912|Megestrol Acetate|megestrol acetate|mesh-list
25053600|NCT00004912|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25053601|NCT00004912|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25053602|NCT00004912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25053603|NCT00004912|Contraceptive Agents|contraceptive agents|mesh-ancestor
25053612|NCT00004908|Cyclophosphamide|cyclophosphamide|mesh-list
25220784|NCT02654288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25220785|NCT02654288|Antiviral Agents|antiviral agents|mesh-ancestor
25220786|NCT02654288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25220787|NCT02654288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25220788|NCT02654288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25220789|NCT02654288|Immunologic Factors|immunologic factors|mesh-ancestor
25220790|NCT02654288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220791|NCT02654041|Methimazole|methimazole|mesh-list
25220792|NCT02654041|Antithyroid Agents|antithyroid agents|mesh-ancestor
25220793|NCT02654041|Hormone Antagonists|hormone antagonists|mesh-ancestor
25220794|NCT02654041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25220795|NCT02654041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220796|NCT02653898|Artesunate|artesunate|mesh-list
25220797|NCT02653898|Piperaquine|piperaquine|mesh-list
25220798|NCT02653898|Primaquine|primaquine|mesh-list
25220799|NCT02653898|Artenimol|artenimol|mesh-list
25220800|NCT02653898|Mefloquine|mefloquine|mesh-list
25220801|NCT02653898|Permethrin|permethrin|mesh-list
25220802|NCT02653898|Antimalarials|antimalarials|mesh-ancestor
25220803|NCT02653898|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25220804|NCT02653898|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25220805|NCT02653898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25220806|NCT02653898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25679621|NCT01840605|Antipruritics|antipruritics|mesh-ancestor
25679622|NCT01840605|Dermatologic Agents|dermatologic agents|mesh-ancestor
25679623|NCT01840605|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25679624|NCT01840605|Histamine Antagonists|histamine antagonists|mesh-ancestor
25679625|NCT01840605|Histamine Agents|histamine agents|mesh-ancestor
25679626|NCT01840605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25679627|NCT01840605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220807|NCT02653898|Antiviral Agents|antiviral agents|mesh-ancestor
25220808|NCT02653898|Schistosomicides|schistosomicides|mesh-ancestor
25220809|NCT02653898|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25220810|NCT02653898|Anthelmintics|anthelmintics|mesh-ancestor
25220811|NCT02653898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25220812|NCT02653898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220813|NCT02653833|Tadalafil|tadalafil|mesh-list
25220814|NCT02653833|Vasodilator Agents|vasodilator agents|mesh-ancestor
25220815|NCT02653833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24833012|NCT02172508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24833013|NCT02172508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833014|NCT02172508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24741644|NCT05290948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25042681|NCT01393639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25042683|NCT01393639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25042684|NCT01393639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042686|NCT01390545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042687|NCT01384383|Ledipasvir|ledipasvir|mesh-list
25042688|NCT01384383|Antiviral Agents|antiviral agents|mesh-ancestor
25042689|NCT01384383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042690|NCT01382654|Azelastine|azelastine|mesh-list
25088879|NCT03270969|Emtricitabine|emtricitabine|mesh-list
25088891|NCT03270839|Antiemetics|antiemetics|mesh-ancestor
25088892|NCT03270839|Autonomic Agents|autonomic agents|mesh-ancestor
25088893|NCT03270839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24980696|NCT05024214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24980697|NCT05024214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980698|NCT05017025|Osimertinib|osimertinib|mesh-list
24980699|NCT05017025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980700|NCT05017025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25088894|NCT03270839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088895|NCT03270839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25088896|NCT03270839|Mydriatics|mydriatics|mesh-ancestor
25088897|NCT03270839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25088898|NCT03270839|Cholinergic Agents|cholinergic agents|mesh-ancestor
25088899|NCT03270839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25088900|NCT03270839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088901|NCT03270839|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25088902|NCT03270839|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25088903|NCT03270839|Histamine Antagonists|histamine antagonists|mesh-ancestor
25088904|NCT03270839|Histamine Agents|histamine agents|mesh-ancestor
25088905|NCT03270839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25088906|NCT03270735|Thrombin|thrombin|mesh-list
25088907|NCT03270735|Hemostatics|hemostatics|mesh-ancestor
25088908|NCT03270735|Coagulants|coagulants|mesh-ancestor
25088909|NCT03270709|Vitamin D|vitamin d|mesh-list
25088910|NCT03270709|Cholecalciferol|cholecalciferol|mesh-list
25088911|NCT03270709|Vitamins|vitamins|mesh-ancestor
25088912|NCT03270709|Micronutrients|micronutrients|mesh-ancestor
25088913|NCT03270709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088914|NCT03270709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25088915|NCT03270709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25088916|NCT03270696|Propofol|propofol|mesh-list
25088917|NCT03270696|Rocuronium|rocuronium|mesh-list
25088918|NCT03270696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25088919|NCT03270696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25088920|NCT03270696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088921|NCT03270696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25088922|NCT03270696|Anesthetics, General|anesthetics, general|mesh-ancestor
25088923|NCT03270696|Anesthetics|anesthetics|mesh-ancestor
24925705|NCT04148846|Ketoprofen|ketoprofen|mesh-list
25088924|NCT03270696|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25088925|NCT03270696|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25088926|NCT03270696|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25088927|NCT03270696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25088928|NCT03270553|Metformin|metformin|mesh-list
25088929|NCT03270553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25220816|NCT02653833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25220817|NCT02653833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25220818|NCT02653833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220819|NCT02653833|Urological Agents|urological agents|mesh-ancestor
25220820|NCT02653703|Ethanol|ethanol|mesh-list
25220821|NCT02653703|Menthol|menthol|mesh-list
25220822|NCT02653703|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25220823|NCT02653703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042696|NCT01382654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25042697|NCT01382654|Respiratory System Agents|respiratory system agents|mesh-ancestor
25042698|NCT01382654|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25042699|NCT01382654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053634|NCT00004907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25088930|NCT03270553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088931|NCT03269929|Midazolam|midazolam|mesh-list
25088932|NCT03269929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25088933|NCT03269929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25088934|NCT03269929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25088935|NCT03269929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088937|NCT03269929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25088938|NCT03269929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25088939|NCT03269929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25088940|NCT03269929|Anesthetics, General|anesthetics, general|mesh-ancestor
25088941|NCT03269929|Anesthetics|anesthetics|mesh-ancestor
25088942|NCT03269929|GABA Modulators|gaba modulators|mesh-ancestor
25088943|NCT03269929|GABA Agents|gaba agents|mesh-ancestor
25088944|NCT03269929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25088945|NCT03269929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088955|NCT03269760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088956|NCT03270007|Vinorelbine|vinorelbine|mesh-list
25088957|NCT03270007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25088958|NCT03270007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25088959|NCT03270007|Tubulin Modulators|tubulin modulators|mesh-ancestor
24632046|NCT01121796|Vitamin D|vitamin d|mesh-list
24632047|NCT01121796|Ergocalciferols|ergocalciferols|mesh-list
24632048|NCT01121796|Cholecalciferol|cholecalciferol|mesh-list
24632049|NCT01121796|Vitamins|vitamins|mesh-list
24632050|NCT01121796|Micronutrients|micronutrients|mesh-ancestor
24632051|NCT01121796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632052|NCT01121796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24632053|NCT01121796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25220834|NCT02653742|Analgesics|analgesics|mesh-ancestor
25220835|NCT02653742|Sensory System Agents|sensory system agents|mesh-ancestor
25220836|NCT02653742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25220837|NCT02653742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25220838|NCT02653742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25220839|NCT02653742|Anesthetics, General|anesthetics, general|mesh-ancestor
25220840|NCT02653742|Anesthetics|anesthetics|mesh-ancestor
24980733|NCT04969705|Analgesics|analgesics|mesh-ancestor
24458944|NCT00343187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443380|NCT00294619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443422|NCT00294892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24443423|NCT00294892|Analgesics|analgesics|mesh-ancestor
25220841|NCT02653742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25220842|NCT02653742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25220843|NCT02653742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25220844|NCT02653742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25220845|NCT02653742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25220846|NCT02653742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25220847|NCT02653742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220848|NCT02653651|Lidocaine|lidocaine|mesh-list
25405275|NCT03615105|Melphalan|melphalan|mesh-list
24644884|NCT01193504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24644885|NCT01193504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644886|NCT01193504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24644888|NCT01193595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24644889|NCT01193595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644890|NCT01193595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24644892|NCT01193595|Growth Substances|growth substances|mesh-ancestor
24644893|NCT01193595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833028|NCT02172521|Respiratory System Agents|respiratory system agents|mesh-ancestor
24833029|NCT02172521|Parasympatholytics|parasympatholytics|mesh-ancestor
24632054|NCT01121809|Raltegravir Potassium|raltegravir potassium|mesh-list
24632055|NCT01121809|Etravirine|etravirine|mesh-list
24632056|NCT01121809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24632057|NCT01121809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24632058|NCT01121809|Antiviral Agents|antiviral agents|mesh-ancestor
24632059|NCT01121809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24632060|NCT01121809|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24632061|NCT01121809|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24632062|NCT01121809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632063|NCT01121809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632064|NCT01121809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24632065|NCT01121809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24451786|NCT00324818|Azithromycin|azithromycin|mesh-list
24632067|NCT01121822|Immunologic Factors|immunologic factors|mesh-ancestor
24632068|NCT01121822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632070|NCT01121835|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24632071|NCT01121835|Insulin Glargine|insulin glargine|mesh-list
25088962|NCT03270007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088963|NCT03269786|Bilirubin|bilirubin|mesh-list
25088964|NCT03269786|Antioxidants|antioxidants|mesh-ancestor
25088965|NCT03269786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088966|NCT03269786|Protective Agents|protective agents|mesh-ancestor
25088967|NCT03269786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088968|NCT03270033|Dexamethasone|dexamethasone|mesh-list
25088969|NCT03270033|Dexamethasone acetate|dexamethasone acetate|mesh-list
25088970|NCT03270033|Dexmedetomidine|dexmedetomidine|mesh-list
25088971|NCT03270033|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25088972|NCT03270033|BB 1101|bb 1101|mesh-list
25088973|NCT03270033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25088974|NCT03270033|Antiemetics|antiemetics|mesh-ancestor
25088975|NCT03270033|Autonomic Agents|autonomic agents|mesh-ancestor
25088976|NCT03270033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25088977|NCT03270033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088978|NCT03270033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25088979|NCT03270033|Glucocorticoids|glucocorticoids|mesh-ancestor
25088980|NCT03270033|Hormones|hormones|mesh-ancestor
25220852|NCT02653651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25220853|NCT02653651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220854|NCT02653651|Sensory System Agents|sensory system agents|mesh-ancestor
25220855|NCT02653651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25220856|NCT02653651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25220857|NCT02653651|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25220858|NCT02653651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25220859|NCT02653651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25220860|NCT02653651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220861|NCT02653651|Analgesics|analgesics|mesh-ancestor
25220862|NCT02653651|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24833030|NCT02172521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24833031|NCT02172521|Cholinergic Agents|cholinergic agents|mesh-ancestor
24833032|NCT02172521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24833033|NCT02172521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833034|NCT02172521|Anticonvulsants|anticonvulsants|mesh-ancestor
24833036|NCT02172534|Tiotropium Bromide|tiotropium bromide|mesh-list
24833037|NCT02172534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25679628|NCT01840605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679629|NCT01840605|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25679630|NCT01840943|Topotecan|topotecan|mesh-list
25679631|NCT01840943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25679632|NCT01840943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25679633|NCT01840943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25679634|NCT01840943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679635|NCT01840943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25012013|NCT02389465|Dexetimide|dexetimide|mesh-list
25012014|NCT02389465|Citalopram|citalopram|mesh-list
25012015|NCT02389465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24584205|NCT00879021|Pregabalin|pregabalin|mesh-list
25012016|NCT02389465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25012017|NCT02389465|Analgesics|analgesics|mesh-ancestor
25012018|NCT02389465|Sensory System Agents|sensory system agents|mesh-ancestor
24833038|NCT02172534|Autonomic Agents|autonomic agents|mesh-ancestor
25053671|NCT00004897|Leucovorin|leucovorin|mesh-list
25088981|NCT03270033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25088982|NCT03270033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25088984|NCT03270033|Protease Inhibitors|protease inhibitors|mesh-ancestor
25088985|NCT03270033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632082|NCT01121848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24632094|NCT01122004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632115|NCT01122121|Fertility Agents|fertility agents|mesh-ancestor
24632116|NCT01122121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24632117|NCT01122121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632118|NCT01122121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24632119|NCT01122121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632120|NCT01122121|Androgen Antagonists|androgen antagonists|mesh-ancestor
24632121|NCT01122121|Hormone Antagonists|hormone antagonists|mesh-ancestor
24632122|NCT01122121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24632123|NCT01122134|Artesunate|artesunate|mesh-list
24632124|NCT01122134|Antimalarials|antimalarials|mesh-ancestor
24632125|NCT01122134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24632126|NCT01122134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24632127|NCT01122134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24632128|NCT01122134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632129|NCT01122134|Antiviral Agents|antiviral agents|mesh-ancestor
24632130|NCT01122134|Schistosomicides|schistosomicides|mesh-ancestor
25088986|NCT03270033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088987|NCT03270033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25088988|NCT03270033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25088989|NCT03270033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25089001|NCT03269916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632131|NCT01122134|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24632132|NCT01122134|Anthelmintics|anthelmintics|mesh-ancestor
24632133|NCT01122199|Everolimus|everolimus|mesh-list
24632134|NCT01122199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632135|NCT01122199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24632136|NCT01122199|Immunologic Factors|immunologic factors|mesh-ancestor
24632137|NCT01122199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632138|NCT01122251|Valsartan|valsartan|mesh-list
24632140|NCT01122251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24632141|NCT01122251|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24632142|NCT01122251|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24632143|NCT01122251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632144|NCT01122251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24632145|NCT01122251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25220863|NCT02653651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25220864|NCT02653651|Anesthetics, General|anesthetics, general|mesh-ancestor
25220865|NCT02653651|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25220866|NCT02653651|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25220867|NCT02653651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25220868|NCT02653638|Indomethacin|indomethacin|mesh-list
25220869|NCT02653638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25220870|NCT02653638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25220871|NCT02653638|Analgesics|analgesics|mesh-ancestor
25679636|NCT01841021|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25679637|NCT01841021|Immunoconjugates|immunoconjugates|mesh-list
25679638|NCT01841021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25679639|NCT01841021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25679640|NCT01841021|Immunologic Factors|immunologic factors|mesh-ancestor
25679641|NCT01841021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679642|NCT01841593|Raltegravir Potassium|raltegravir potassium|mesh-list
24632150|NCT01122342|Testosterone undecanoate|testosterone undecanoate|mesh-list
24632151|NCT01122342|Testosterone enanthate|testosterone enanthate|mesh-list
24632152|NCT01122342|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24632153|NCT01122342|Androgens|androgens|mesh-ancestor
24632154|NCT01122342|Hormones|hormones|mesh-ancestor
24632155|NCT01122342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24632156|NCT01122342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632157|NCT01122342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24632158|NCT01122342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632159|NCT01122342|Anabolic Agents|anabolic agents|mesh-ancestor
24632165|NCT01122407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632167|NCT01122407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24632168|NCT01122407|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
24632169|NCT01122407|Autonomic Agents|autonomic agents|mesh-ancestor
25220875|NCT02653638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25220876|NCT02653638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25220877|NCT02653638|Gout Suppressants|gout suppressants|mesh-ancestor
25220878|NCT02653638|Tocolytic Agents|tocolytic agents|mesh-ancestor
25220879|NCT02653638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25220880|NCT02653638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25220881|NCT02653638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25220882|NCT02653638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220883|NCT02653261|Tranexamic Acid|tranexamic acid|mesh-list
25220884|NCT02653261|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25220885|NCT02653261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25220886|NCT02653261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220887|NCT02653261|Hemostatics|hemostatics|mesh-ancestor
25220888|NCT02653261|Coagulants|coagulants|mesh-ancestor
25220889|NCT02653196|Cyclosporine|cyclosporine|mesh-list
25220890|NCT02653196|Mycophenolic Acid|mycophenolic acid|mesh-list
25220891|NCT02653196|Fludarabine|fludarabine|mesh-list
25220892|NCT02653196|Etoposide|etoposide|mesh-list
25220893|NCT02653196|Melphalan|melphalan|mesh-list
25220894|NCT02653196|Alemtuzumab|alemtuzumab|mesh-list
25220895|NCT02653196|Thiotepa|thiotepa|mesh-list
25220896|NCT02653196|Tacrolimus|tacrolimus|mesh-list
25220897|NCT02653196|Cyclosporins|cyclosporins|mesh-list
25220898|NCT02653196|Mitogens|mitogens|mesh-list
25220899|NCT02653196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25220900|NCT02653196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679643|NCT01841593|Amlodipine|amlodipine|mesh-list
25679644|NCT01841593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25679645|NCT01841593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25679646|NCT01841593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25053707|NCT00004895|Octreotide|octreotide|mesh-list
25089003|NCT03269747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25089004|NCT03269747|Glucocorticoids|glucocorticoids|mesh-ancestor
25089005|NCT03269747|Hormones|hormones|mesh-ancestor
25089006|NCT03269747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25089007|NCT03269747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089008|NCT03269747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25089010|NCT03269721|Carbon Monoxide|carbon monoxide|mesh-list
25089011|NCT03269721|Antimetabolites|antimetabolites|mesh-ancestor
25089012|NCT03269721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089013|NCT03269721|Gasotransmitters|gasotransmitters|mesh-ancestor
25089014|NCT03269721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24632170|NCT01122407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24632171|NCT01122407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632172|NCT01122407|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24632173|NCT01122407|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24632174|NCT01122407|Cholinergic Agents|cholinergic agents|mesh-ancestor
24632175|NCT01122407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24632176|NCT01122407|Vasodilator Agents|vasodilator agents|mesh-ancestor
24632177|NCT01122472|Lenalidomide|lenalidomide|mesh-list
24632178|NCT01122472|Immunologic Factors|immunologic factors|mesh-ancestor
24632179|NCT01122472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632180|NCT01122472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24632181|NCT01122472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24632182|NCT01122472|Growth Substances|growth substances|mesh-ancestor
24632183|NCT01122472|Growth Inhibitors|growth inhibitors|mesh-ancestor
24632184|NCT01122472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632185|NCT01122563|Solifenacin Succinate|solifenacin succinate|mesh-list
24632186|NCT01122563|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24632187|NCT01122563|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24632188|NCT01122563|Cholinergic Agents|cholinergic agents|mesh-ancestor
24632189|NCT01122563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25220901|NCT02653196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25220902|NCT02653196|Immunologic Factors|immunologic factors|mesh-ancestor
25220903|NCT02653196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220904|NCT02653196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25220905|NCT02653196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25220906|NCT02653196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25220907|NCT02653196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25220908|NCT02653196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25220909|NCT02653196|Antifungal Agents|antifungal agents|mesh-ancestor
25220910|NCT02653196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25220911|NCT02653196|Dermatologic Agents|dermatologic agents|mesh-ancestor
25220912|NCT02653196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25220913|NCT02653196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25220914|NCT02653196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25220915|NCT02653196|Antitubercular Agents|antitubercular agents|mesh-ancestor
25220916|NCT02653196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25061878|NCT05390307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25089029|NCT03269799|Protective Agents|protective agents|mesh-ancestor
25089031|NCT03269591|Progesterone|progesterone|mesh-list
25089032|NCT03269591|Progestins|progestins|mesh-ancestor
25089033|NCT03269591|Hormones|hormones|mesh-ancestor
24980787|NCT04945616|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25089048|NCT03269383|Anesthetics|anesthetics|mesh-ancestor
25089049|NCT03269383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25089050|NCT03269383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089051|NCT03269383|Sensory System Agents|sensory system agents|mesh-ancestor
25089052|NCT03269383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25089053|NCT03269357|Contraceptive Agents|contraceptive agents|mesh-list
25089054|NCT03269357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25089055|NCT03269357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089056|NCT03269214|Phenytoin|phenytoin|mesh-list
25220917|NCT02653196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25220918|NCT02653196|Alkylating Agents|alkylating agents|mesh-ancestor
25220919|NCT02653196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25220920|NCT02653196|Mitosis Modulators|mitosis modulators|mesh-ancestor
25220921|NCT02653196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25220922|NCT02653209|Pioglitazone|pioglitazone|mesh-list
25220923|NCT02653209|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25220924|NCT02653209|Canagliflozin|canagliflozin|mesh-list
25220925|NCT02653209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25220926|NCT02653209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220927|NCT02653209|Incretins|incretins|mesh-ancestor
25220928|NCT02653209|Hormones|hormones|mesh-ancestor
25220929|NCT02653209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25220930|NCT02653209|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25220931|NCT02653209|Protease Inhibitors|protease inhibitors|mesh-ancestor
25089057|NCT03269214|Anticonvulsants|anticonvulsants|mesh-ancestor
25089058|NCT03269214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25089059|NCT03269214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25089060|NCT03269214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25089061|NCT03269214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089062|NCT03269214|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24632235|NCT01122667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24632236|NCT01122667|Antimetabolites|antimetabolites|mesh-ancestor
24632237|NCT01122667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632238|NCT01122667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24632239|NCT01122771|Amphotericin B|amphotericin b|mesh-list
24632240|NCT01122771|Paromomycin|paromomycin|mesh-list
24632241|NCT01122771|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24632242|NCT01122771|Miltefosine|miltefosine|mesh-list
24632243|NCT01122771|Amebicides|amebicides|mesh-ancestor
24980802|NCT04904302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24980803|NCT04904302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24646773|NCT01205074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24646774|NCT01205074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24980804|NCT04904302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24980805|NCT04904302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632244|NCT01122771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24632245|NCT01122771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24632246|NCT01122771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24632247|NCT01122771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24632248|NCT01122771|Antifungal Agents|antifungal agents|mesh-ancestor
24632249|NCT01122771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632250|NCT01122914|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24632251|NCT01122914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24632271|NCT01122966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24632272|NCT01122966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24632273|NCT01122966|Growth Substances|growth substances|mesh-ancestor
24632274|NCT01122966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632275|NCT01122966|Growth Inhibitors|growth inhibitors|mesh-ancestor
24632276|NCT01122979|Insulin|insulin|mesh-list
24632277|NCT01122979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24632278|NCT01122979|Insulin Glargine|insulin glargine|mesh-list
24632279|NCT01122979|Insulin glulisine|insulin glulisine|mesh-list
24632280|NCT01122979|Insulin, Isophane|insulin, isophane|mesh-list
24632281|NCT01122979|Isophane Insulin, Human|isophane insulin, human|mesh-list
24632282|NCT01122979|Isophane insulin, beef|isophane insulin, beef|mesh-list
24632283|NCT01122979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24632284|NCT01122979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632285|NCT01123031|Esomeprazole|esomeprazole|mesh-list
24632286|NCT01123031|Lansoprazole|lansoprazole|mesh-list
25089063|NCT03269214|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25089064|NCT03269279|Misoprostol|misoprostol|mesh-list
25089065|NCT03269279|Mifepristone|mifepristone|mesh-list
25089066|NCT03269279|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25089067|NCT03269279|Abortifacient Agents|abortifacient agents|mesh-ancestor
25089068|NCT03269279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25089069|NCT03269279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089070|NCT03269279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25089071|NCT03269279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25089072|NCT03269279|Oxytocics|oxytocics|mesh-ancestor
25089073|NCT03269279|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25089074|NCT03269279|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25089075|NCT03269279|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25220932|NCT02653209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25220933|NCT02653209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220934|NCT02653209|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25220935|NCT02653339|Loratadine|loratadine|mesh-list
25220936|NCT02653339|Antipruritics|antipruritics|mesh-ancestor
25220937|NCT02653339|Dermatologic Agents|dermatologic agents|mesh-ancestor
25220938|NCT02653339|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25220939|NCT02653339|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25220940|NCT02653339|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25220941|NCT02653339|Histamine Antagonists|histamine antagonists|mesh-ancestor
24980810|NCT04902040|Atezolizumab|atezolizumab|mesh-list
24980811|NCT04902040|Immunoglobulins|immunoglobulins|mesh-list
24833071|NCT02172560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24833072|NCT02172560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833074|NCT02172573|Bromocriptine|bromocriptine|mesh-list
24833075|NCT02172573|Antioxidants|antioxidants|mesh-ancestor
24833076|NCT02172573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833077|NCT02172573|Protective Agents|protective agents|mesh-ancestor
24833078|NCT02172573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833079|NCT02172573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24833080|NCT02172573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24833081|NCT02172573|Dopamine Agonists|dopamine agonists|mesh-ancestor
24833082|NCT02172573|Dopamine Agents|dopamine agents|mesh-ancestor
25089076|NCT03269279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25679647|NCT01841593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647443|NCT01208818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24647444|NCT01208818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24647445|NCT01208818|Glucocorticoids|glucocorticoids|mesh-ancestor
24647514|NCT01209208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24647515|NCT01209208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647516|NCT01209208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24740433|NCT01688518|Anesthetics|anesthetics|mesh-ancestor
25089077|NCT03269279|Contraceptive Agents|contraceptive agents|mesh-ancestor
25089078|NCT03269279|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25089079|NCT03269279|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25089080|NCT03269279|Hormone Antagonists|hormone antagonists|mesh-ancestor
25089081|NCT03269279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25089082|NCT03269279|Luteolytic Agents|luteolytic agents|mesh-ancestor
25089083|NCT03269279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25089084|NCT03269279|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25089085|NCT03269058|Dapagliflozin|dapagliflozin|mesh-list
25089086|NCT03269058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25089087|NCT03269058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089088|NCT03269058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24632296|NCT01123057|Micronutrients|micronutrients|mesh-ancestor
24632297|NCT01123057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632298|NCT01123057|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24632299|NCT01123057|Dermatologic Agents|dermatologic agents|mesh-ancestor
25220942|NCT02653339|Histamine Agents|histamine agents|mesh-ancestor
25220943|NCT02653339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25089130|NCT03269162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25220944|NCT02653339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220945|NCT02653339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220946|NCT02653131|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25220947|NCT02653131|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25220948|NCT02653131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25220949|NCT02653131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25220950|NCT02653131|Incretins|incretins|mesh-ancestor
25220951|NCT02653131|Hormones|hormones|mesh-ancestor
25220952|NCT02653131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25220953|NCT02653131|Protease Inhibitors|protease inhibitors|mesh-ancestor
25220954|NCT02653131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25220955|NCT02653131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220956|NCT02653027|Ivacaftor|ivacaftor|mesh-list
25220957|NCT02653027|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25220958|NCT02653027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25220959|NCT02653027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220960|NCT02653014|Mineralocorticoids|mineralocorticoids|mesh-list
25220961|NCT02653014|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
25220962|NCT02653014|Hormones|hormones|mesh-ancestor
25220963|NCT02653014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24833083|NCT02172573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24833084|NCT02172573|Hormone Antagonists|hormone antagonists|mesh-ancestor
24741917|NCT05294822|Insulin|insulin|mesh-list
24452162|NCT00326248|Autonomic Agents|autonomic agents|mesh-ancestor
24452163|NCT00326248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24452164|NCT00326248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452165|NCT00326248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24452166|NCT00326248|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24452167|NCT00326248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24452168|NCT00326248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452169|NCT00326300|Methylphenidate|methylphenidate|mesh-list
24452170|NCT00326300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24833093|NCT02172586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833094|NCT02172586|Diuretics|diuretics|mesh-ancestor
24952358|NCT03894800|Fentanyl|fentanyl|mesh-list
25679648|NCT01841593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25679649|NCT01841593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679650|NCT01841593|Vasodilator Agents|vasodilator agents|mesh-ancestor
25679651|NCT01841593|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25679652|NCT01841593|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25679653|NCT01841593|Antiviral Agents|antiviral agents|mesh-ancestor
25679654|NCT01841593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24647969|NCT01211691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647970|NCT01211704|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24647971|NCT01211704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24647972|NCT01211704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24647973|NCT01211704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24647974|NCT01211704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647975|NCT01211704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24647976|NCT01211704|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24647977|NCT01211704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24647979|NCT01211704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24647980|NCT01211704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647981|NCT01211704|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24647982|NCT01211704|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24647983|NCT01211704|Dopamine Agents|dopamine agents|mesh-ancestor
24647984|NCT01211795|Ketoprofen|ketoprofen|mesh-list
24647985|NCT01211795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24632303|NCT01123265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24632304|NCT01123265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632305|NCT01123265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25089091|NCT03269318|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25089093|NCT03269318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25089094|NCT03269318|Autonomic Agents|autonomic agents|mesh-ancestor
25089095|NCT03269318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25089096|NCT03269318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089097|NCT03269318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25089098|NCT03269318|Respiratory System Agents|respiratory system agents|mesh-ancestor
25089099|NCT03269318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25089100|NCT03269318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25089101|NCT03269318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25089102|NCT03269318|Adrenergic Agents|adrenergic agents|mesh-ancestor
25089103|NCT03269318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25089104|NCT03269318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089105|NCT03269318|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25089106|NCT03269318|Hormone Antagonists|hormone antagonists|mesh-ancestor
25089107|NCT03269318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25089108|NCT03269318|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25089109|NCT03269318|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25089110|NCT03269318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25089111|NCT03269318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25089112|NCT03269318|Vasodilator Agents|vasodilator agents|mesh-ancestor
25089113|NCT03269318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25089114|NCT03269318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25089115|NCT03269318|Purinergic Agents|purinergic agents|mesh-ancestor
25089117|NCT03268733|Hematinics|hematinics|mesh-ancestor
25089118|NCT03268733|Vitamin B Complex|vitamin b complex|mesh-ancestor
25089119|NCT03268733|Vitamins|vitamins|mesh-ancestor
25089120|NCT03268733|Micronutrients|micronutrients|mesh-ancestor
25089121|NCT03268733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089128|NCT03269162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089129|NCT03269162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632419|NCT01123824|Clopidogrel|clopidogrel|mesh-list
25089131|NCT03269162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25089132|NCT03268902|Niacinamide|niacinamide|mesh-list
25089133|NCT03268902|Niacin|niacin|mesh-list
25679655|NCT01841593|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25679656|NCT01841593|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25679657|NCT01841593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25679658|NCT01841606|Ondansetron|ondansetron|mesh-list
25679659|NCT01841606|Antiemetics|antiemetics|mesh-ancestor
25679660|NCT01841606|Autonomic Agents|autonomic agents|mesh-ancestor
25679661|NCT01841606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25679662|NCT01841606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679663|NCT01841606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25679664|NCT01841606|Antipruritics|antipruritics|mesh-ancestor
25679665|NCT01841606|Dermatologic Agents|dermatologic agents|mesh-ancestor
25679666|NCT01841606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25679667|NCT01841606|Serotonin Agents|serotonin agents|mesh-ancestor
25679668|NCT01841606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25679669|NCT01841606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679670|NCT01841606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25679671|NCT01841606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25679672|NCT01841606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25220966|NCT02653014|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25220967|NCT02653014|Diuretics|diuretics|mesh-ancestor
25220968|NCT02653014|Natriuretic Agents|natriuretic agents|mesh-ancestor
25220969|NCT02652793|Lamivudine|lamivudine|mesh-list
25220970|NCT02652793|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25220971|NCT02652793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25220972|NCT02652793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25220973|NCT02652793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25220974|NCT02652793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220975|NCT02652793|Antiviral Agents|antiviral agents|mesh-ancestor
25220976|NCT02652793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25220977|NCT02652793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25220978|NCT02652793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25220979|NCT02652793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24833095|NCT02172586|Natriuretic Agents|natriuretic agents|mesh-ancestor
24833096|NCT02172586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833097|NCT02172586|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24833098|NCT02172586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24833099|NCT02172729|Lidocaine|lidocaine|mesh-list
24980865|NCT04783857|Hormones|hormones|mesh-ancestor
24833100|NCT02172729|Anesthetics, Local|anesthetics, local|mesh-ancestor
24833101|NCT02172729|Anesthetics|anesthetics|mesh-ancestor
24833102|NCT02172729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24591188|NCT00915512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24833118|NCT02172781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24833119|NCT02172781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833120|NCT02172781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24833121|NCT02172781|Respiratory System Agents|respiratory system agents|mesh-ancestor
24952367|NCT03894800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25089138|NCT03268902|Micronutrients|micronutrients|mesh-ancestor
25089139|NCT03268902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089140|NCT03268902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25089141|NCT03268902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25089142|NCT03268902|Vitamin B Complex|vitamin b complex|mesh-ancestor
25089143|NCT03268902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25089144|NCT03268902|Antimetabolites|antimetabolites|mesh-ancestor
25089145|NCT03268902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089146|NCT03268902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25089147|NCT03268902|Vasodilator Agents|vasodilator agents|mesh-ancestor
24632309|NCT01123265|Dermatologic Agents|dermatologic agents|mesh-ancestor
24632310|NCT01123265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632311|NCT01123265|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24632312|NCT01123265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24632313|NCT01123265|Immunologic Factors|immunologic factors|mesh-ancestor
24632314|NCT01123265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24632315|NCT01123265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24632317|NCT01123278|Androgens|androgens|mesh-ancestor
24632318|NCT01123278|Hormones|hormones|mesh-ancestor
24632320|NCT01123278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632361|NCT01123473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24632362|NCT01123473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24632369|NCT01123486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24632370|NCT01123486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632371|NCT01123486|Analgesics|analgesics|mesh-ancestor
24632372|NCT01123486|Sensory System Agents|sensory system agents|mesh-ancestor
24632373|NCT01123486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24632375|NCT01123525|Analgesics|analgesics|mesh-ancestor
24632376|NCT01123525|Sensory System Agents|sensory system agents|mesh-ancestor
24632377|NCT01123525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24632378|NCT01123525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632379|NCT01123525|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24632418|NCT01123811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25220980|NCT02652793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25220981|NCT02652793|Protease Inhibitors|protease inhibitors|mesh-ancestor
25220982|NCT02652884|Betamethasone|betamethasone|mesh-list
25220991|NCT02652871|Cytarabine|cytarabine|mesh-list
25220992|NCT02652871|Idarubicin|idarubicin|mesh-list
25220993|NCT02652871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25220994|NCT02652871|Antimetabolites|antimetabolites|mesh-ancestor
25220995|NCT02652871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25220996|NCT02652871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25220997|NCT02652871|Antiviral Agents|antiviral agents|mesh-ancestor
25220998|NCT02652871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25220999|NCT02652871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25221000|NCT02652871|Immunologic Factors|immunologic factors|mesh-ancestor
24632420|NCT01123824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24632421|NCT01123824|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24632422|NCT01123824|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24632423|NCT01123824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24632424|NCT01123824|Purinergic Agents|purinergic agents|mesh-ancestor
24632425|NCT01123824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25089148|NCT03268902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25089149|NCT03268863|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25089151|NCT03268525|Anesthetics, Local|anesthetics, local|mesh-ancestor
25089152|NCT03268525|Anesthetics|anesthetics|mesh-ancestor
25089153|NCT03268525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25089154|NCT03268525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089155|NCT03268525|Sensory System Agents|sensory system agents|mesh-ancestor
25089156|NCT03268525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25089157|NCT03268278|Lidocaine|lidocaine|mesh-list
25089158|NCT03268278|Epinephrine|epinephrine|mesh-list
25089159|NCT03268278|Buprenorphine|buprenorphine|mesh-list
25089162|NCT03268278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24456138|NCT00330239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24632426|NCT01123824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632427|NCT01123824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632429|NCT01123876|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24632430|NCT01123876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632431|NCT01123876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632432|NCT01123876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632433|NCT01123915|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
24632434|NCT01123915|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25106119|NCT04356638|Midazolam|midazolam|mesh-list
24632435|NCT01123915|Protective Agents|protective agents|mesh-ancestor
24632436|NCT01123915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632437|NCT01123915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24632438|NCT01123915|Antioxidants|antioxidants|mesh-ancestor
24632460|NCT01124058|Calcium heparin|calcium heparin|mesh-list
24632461|NCT01124058|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24632462|NCT01124058|Tinzaparin|tinzaparin|mesh-list
24632464|NCT01124058|Warfarin|warfarin|mesh-list
24632467|NCT01124058|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24632468|NCT01124058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632470|NCT01124227|Dialysis Solutions|dialysis solutions|mesh-ancestor
25221001|NCT02652871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221009|NCT02652650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25221011|NCT02652650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25221012|NCT02652650|Contraceptive Agents|contraceptive agents|mesh-ancestor
25221013|NCT02652650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25221014|NCT02652650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221015|NCT02652650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24808057|NCT02025010|Prednisone|prednisone|mesh-list
24632471|NCT01124227|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24632472|NCT01124240|Temozolomide|temozolomide|mesh-list
24632473|NCT01124240|Procarbazine|procarbazine|mesh-list
24632474|NCT01124240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24632475|NCT01124240|Alkylating Agents|alkylating agents|mesh-ancestor
24632476|NCT01124240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632477|NCT01124240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632478|NCT01124253|Endostatins|endostatins|mesh-list
24632479|NCT01124253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24632480|NCT01124253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24632486|NCT01124318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24632488|NCT01124383|Ephedrine|ephedrine|mesh-list
24632489|NCT01124383|Midazolam|midazolam|mesh-list
24632490|NCT01124383|Sufentanil|sufentanil|mesh-list
24632491|NCT01124383|Dsuvia|dsuvia|mesh-list
24632492|NCT01124383|Anesthetics|anesthetics|mesh-list
24632493|NCT01124383|Propofol|propofol|mesh-list
24632494|NCT01124383|Sevoflurane|sevoflurane|mesh-list
25089169|NCT03268278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25089170|NCT03268278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089219|NCT03267771|Dydrogesterone|dydrogesterone|mesh-list
25089171|NCT03268278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25089172|NCT03268278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25089173|NCT03268278|Adrenergic Agents|adrenergic agents|mesh-ancestor
25089174|NCT03268278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25089175|NCT03268278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25089176|NCT03268278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25089177|NCT03268278|Autonomic Agents|autonomic agents|mesh-ancestor
25089178|NCT03268278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25679673|NCT01841606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25679674|NCT01841606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25679675|NCT01841697|Metformin|metformin|mesh-list
25679676|NCT01841697|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25679677|NCT01841697|Glimepiride|glimepiride|mesh-list
25679678|NCT01841697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25679679|NCT01841697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679680|NCT01841697|Incretins|incretins|mesh-ancestor
25679681|NCT01841697|Hormones|hormones|mesh-ancestor
25089179|NCT03268278|Respiratory System Agents|respiratory system agents|mesh-ancestor
25089180|NCT03268278|Mydriatics|mydriatics|mesh-ancestor
24649095|NCT01218620|R04929097|r04929097|mesh-list
24649096|NCT01218620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24649097|NCT01218620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24649098|NCT01218620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24412685|NCT00191828|Olanzapine|olanzapine|mesh-list
25089181|NCT03268278|Sympathomimetics|sympathomimetics|mesh-ancestor
25089182|NCT03268278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25089183|NCT03268278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25089184|NCT03268278|Narcotics|narcotics|mesh-ancestor
25089185|NCT03268278|Analgesics|analgesics|mesh-ancestor
25089186|NCT03268278|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24456152|NCT00330304|Isoniazid|isoniazid|mesh-list
24456729|NCT00332072|Timolol|timolol|mesh-list
24632495|NCT01124383|Rocuronium|rocuronium|mesh-list
24632496|NCT01124383|Anesthetics, Local|anesthetics, local|mesh-ancestor
25089227|NCT03267628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24632497|NCT01124383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24632498|NCT01124383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632500|NCT01124383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24632501|NCT01124383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24632502|NCT01124383|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24632503|NCT01124383|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24632504|NCT01124383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25089197|NCT03268226|Formoterol Fumarate|formoterol fumarate|mesh-list
25089198|NCT03268226|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25089199|NCT03268226|Autonomic Agents|autonomic agents|mesh-ancestor
25089200|NCT03268226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25089201|NCT03268226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089202|NCT03268226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25221016|NCT02652650|Estrogens|estrogens|mesh-ancestor
25221017|NCT02652650|Hormones|hormones|mesh-ancestor
25221018|NCT02652650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25221019|NCT02652650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25221020|NCT02652806|Epoetin Alfa|epoetin alfa|mesh-list
25221021|NCT02652806|Hematinics|hematinics|mesh-ancestor
25221022|NCT02652585|Naltrexone|naltrexone|mesh-list
25221023|NCT02652585|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25221024|NCT02652585|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25221025|NCT02652585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221026|NCT02652585|Sensory System Agents|sensory system agents|mesh-ancestor
25221027|NCT02652585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24448496|NCT00312000|Antimetabolites|antimetabolites|mesh-ancestor
24448497|NCT00312000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448498|NCT00312000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24833128|NCT02172794|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24833129|NCT02172794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24833130|NCT02172794|Autonomic Agents|autonomic agents|mesh-ancestor
24833131|NCT02172794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24833132|NCT02172794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053770|NCT00004231|Vitamins|vitamins|mesh-ancestor
25089203|NCT03268226|Respiratory System Agents|respiratory system agents|mesh-ancestor
25089204|NCT03268226|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25089205|NCT03268226|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25089206|NCT03268226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25089207|NCT03268226|Adrenergic Agents|adrenergic agents|mesh-ancestor
25089208|NCT03268226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25089209|NCT03268226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089210|NCT03268226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25089211|NCT03268226|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25089212|NCT03268226|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25089213|NCT03268226|Cholinergic Agents|cholinergic agents|mesh-ancestor
25089214|NCT03268226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25089215|NCT03268226|Glucocorticoids|glucocorticoids|mesh-ancestor
25089216|NCT03268226|Hormones|hormones|mesh-ancestor
25089217|NCT03268226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25089218|NCT03267771|Progesterone|progesterone|mesh-list
25679682|NCT01841697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25679683|NCT01841697|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25679684|NCT01841697|Protease Inhibitors|protease inhibitors|mesh-ancestor
25679685|NCT01841697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24751272|NCT01703130|Anesthetics|anesthetics|mesh-ancestor
25089220|NCT03267771|Progestins|progestins|mesh-ancestor
25089221|NCT03267771|Hormones|hormones|mesh-ancestor
25089222|NCT03267771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25089223|NCT03267771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089224|NCT03267628|Morphine|morphine|mesh-list
25089225|NCT03267628|Anesthetics|anesthetics|mesh-list
25089226|NCT03267628|Anesthetics, Local|anesthetics, local|mesh-list
25089228|NCT03267628|Narcotics|narcotics|mesh-ancestor
25089229|NCT03267628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25089230|NCT03267628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089231|NCT03267628|Analgesics|analgesics|mesh-ancestor
25089232|NCT03267628|Sensory System Agents|sensory system agents|mesh-ancestor
25089233|NCT03267628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25089234|NCT03268018|Calcium|calcium|mesh-list
24448521|NCT00312104|Insulin Detemir|insulin detemir|mesh-list
24448522|NCT00312104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24448523|NCT00312104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089235|NCT03268018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25089236|NCT03268018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089237|NCT03267654|Apatinib|apatinib|mesh-list
24632532|NCT01124435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24632533|NCT01124435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25221028|NCT02652637|Metronidazole|metronidazole|mesh-list
25221029|NCT02652637|Neomycin|neomycin|mesh-list
25221030|NCT02652637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25221031|NCT02652637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25221032|NCT02652637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25221033|NCT02652637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25221034|NCT02652637|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25221035|NCT02652637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25221036|NCT02652637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221037|NCT02652728|Enalapril|enalapril|mesh-list
25221038|NCT02652728|Enalaprilat|enalaprilat|mesh-list
24833133|NCT02172794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24833134|NCT02172794|Respiratory System Agents|respiratory system agents|mesh-ancestor
24833135|NCT02172794|Parasympatholytics|parasympatholytics|mesh-ancestor
24833136|NCT02172794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24833137|NCT02172794|Cholinergic Agents|cholinergic agents|mesh-ancestor
24833138|NCT02172794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24833139|NCT02172794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833140|NCT02172794|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24833141|NCT02172794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24833142|NCT02172794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24833148|NCT02172807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24833149|NCT02172807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833150|NCT02172807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24833151|NCT02172807|Respiratory System Agents|respiratory system agents|mesh-ancestor
24833152|NCT02172807|Parasympatholytics|parasympatholytics|mesh-ancestor
24833153|NCT02172807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24632535|NCT01124435|Sensory System Agents|sensory system agents|mesh-ancestor
24632536|NCT01124435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24632537|NCT01124435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632538|NCT01124435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24632539|NCT01124435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24632540|NCT01124435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24632541|NCT01124435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24632542|NCT01124435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632543|NCT01124435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632544|NCT01124487|Insulin|insulin|mesh-list
24632545|NCT01124487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24632546|NCT01124487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632547|NCT01124500|Methylphenidate|methylphenidate|mesh-list
25221041|NCT02652728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25221042|NCT02652728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221043|NCT02652728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25221044|NCT02652598|Tolcapone|tolcapone|mesh-list
25221045|NCT02652598|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25221046|NCT02652598|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25221047|NCT02652598|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25221048|NCT02652598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25221049|NCT02652598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221050|NCT02652741|Enalapril|enalapril|mesh-list
25221051|NCT02652741|Enalaprilat|enalaprilat|mesh-list
25221052|NCT02652741|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25221053|NCT02652741|Protease Inhibitors|protease inhibitors|mesh-ancestor
25221054|NCT02652741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25221055|NCT02652741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221056|NCT02652741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24833154|NCT02172807|Cholinergic Agents|cholinergic agents|mesh-ancestor
24833155|NCT02172807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24833156|NCT02172807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833157|NCT02172846|Paclitaxel|paclitaxel|mesh-list
24833158|NCT02172846|Carboplatin|carboplatin|mesh-list
24833159|NCT02172846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25042733|NCT01379209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25042734|NCT01379209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042735|NCT01379209|Antifungal Agents|antifungal agents|mesh-ancestor
25042736|NCT01379209|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25042737|NCT01378676|Riluzole|riluzole|mesh-list
25042738|NCT01378676|Anticonvulsants|anticonvulsants|mesh-ancestor
25042739|NCT01378676|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24632602|NCT01124760|Ketoconazole|ketoconazole|mesh-list
24632603|NCT01124760|Diltiazem|diltiazem|mesh-list
24632604|NCT01124760|Antifungal Agents|antifungal agents|mesh-ancestor
24632605|NCT01124760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24632606|NCT01124760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24632607|NCT01124760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24632608|NCT01124760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632609|NCT01124760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632610|NCT01124760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24632611|NCT01124760|Hormone Antagonists|hormone antagonists|mesh-ancestor
24632754|NCT01125553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24632618|NCT01124760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24632619|NCT01124760|Vasodilator Agents|vasodilator agents|mesh-ancestor
24632621|NCT01124799|Simeprevir|simeprevir|mesh-list
24632622|NCT01124799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24632623|NCT01124799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24632624|NCT01124799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24632625|NCT01124799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24632626|NCT01124799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632627|NCT01124799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632628|NCT01124799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632629|NCT01124799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24650007|NCT01223131|Isophane Insulin, Human|isophane insulin, human|mesh-list
24650050|NCT01223612|Growth Substances|growth substances|mesh-ancestor
24650100|NCT01223820|Sensory System Agents|sensory system agents|mesh-ancestor
24632630|NCT01124799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24632631|NCT01124799|Antiviral Agents|antiviral agents|mesh-ancestor
24632632|NCT01124799|Protease Inhibitors|protease inhibitors|mesh-ancestor
24632634|NCT01124877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24632635|NCT01124877|Serotonin Agents|serotonin agents|mesh-ancestor
24632636|NCT01124877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25221057|NCT02652507|Dexmedetomidine|dexmedetomidine|mesh-list
25221058|NCT02652507|Ketamine|ketamine|mesh-list
25221059|NCT02652507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25221060|NCT02652507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25221061|NCT02652507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221062|NCT02652507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25221063|NCT02652507|Analgesics|analgesics|mesh-ancestor
25221064|NCT02652507|Sensory System Agents|sensory system agents|mesh-ancestor
25221065|NCT02652507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25221066|NCT02652507|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25221067|NCT02652507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25221068|NCT02652507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25221069|NCT02652507|Adrenergic Agents|adrenergic agents|mesh-ancestor
25221070|NCT02652507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25221071|NCT02652507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221072|NCT02652507|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25221073|NCT02652507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25221074|NCT02652507|Anesthetics, General|anesthetics, general|mesh-ancestor
25221075|NCT02652507|Anesthetics|anesthetics|mesh-ancestor
25221076|NCT02652507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25042742|NCT01378676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042743|NCT01378676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042745|NCT01378676|Protective Agents|protective agents|mesh-ancestor
25042746|NCT01377662|Methylphenidate|methylphenidate|mesh-list
25042747|NCT01377662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25042748|NCT01377662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042749|NCT01377662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25042750|NCT01377662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25042751|NCT01377662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25042752|NCT01377662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042753|NCT01377662|Dopamine Agents|dopamine agents|mesh-ancestor
25042754|NCT01377662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25042755|NCT01373086|Eplerenone|eplerenone|mesh-list
25053814|NCT00004175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24632654|NCT01125020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632655|NCT01125020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24632656|NCT01125020|Immunologic Factors|immunologic factors|mesh-ancestor
24632657|NCT01125020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632663|NCT01125033|Vitamin E|vitamin e|mesh-list
24632664|NCT01125033|Tocopherols|tocopherols|mesh-list
24632665|NCT01125033|Tocotrienols|tocotrienols|mesh-list
24632666|NCT01125033|alpha-Tocopherol|alpha-tocopherol|mesh-list
24632667|NCT01125033|Micronutrients|micronutrients|mesh-ancestor
24632668|NCT01125033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632669|NCT01125033|Antioxidants|antioxidants|mesh-ancestor
24632670|NCT01125033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632671|NCT01125033|Protective Agents|protective agents|mesh-ancestor
24632672|NCT01125059|Methadone|methadone|mesh-list
24632673|NCT01125059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24632674|NCT01125059|Narcotics|narcotics|mesh-ancestor
24981017|NCT04551144|Estrogens|estrogens|mesh-ancestor
24632675|NCT01125059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24632676|NCT01125059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632677|NCT01125059|Analgesics|analgesics|mesh-ancestor
24632678|NCT01125059|Sensory System Agents|sensory system agents|mesh-ancestor
24632679|NCT01125059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24632680|NCT01125059|Antitussive Agents|antitussive agents|mesh-ancestor
24632681|NCT01125059|Respiratory System Agents|respiratory system agents|mesh-ancestor
25679686|NCT01841697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679687|NCT01841697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25679688|NCT01841697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25679689|NCT01841697|Immunologic Factors|immunologic factors|mesh-ancestor
24632683|NCT01125124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25679690|NCT01841762|Macitentan|macitentan|mesh-list
24650417|NCT01225705|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24650418|NCT01225705|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24650420|NCT01225705|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24650421|NCT01225744|Oxaliplatin|oxaliplatin|mesh-list
24650422|NCT01225744|Irinotecan|irinotecan|mesh-list
24650423|NCT01225744|Cetuximab|cetuximab|mesh-list
24650424|NCT01225744|Tegafur|tegafur|mesh-list
24650425|NCT01225744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650426|NCT01225744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24650427|NCT01225744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24650434|NCT01225874|Dexamethasone|dexamethasone|mesh-list
24650464|NCT01225874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24650465|NCT01225874|Antiviral Agents|antiviral agents|mesh-ancestor
24650466|NCT01225874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24650514|NCT01226069|Glycerol|glycerol|mesh-list
24632684|NCT01125124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24632697|NCT01125254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24632698|NCT01125254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632699|NCT01125254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24632700|NCT01125254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632701|NCT01125254|Vasodilator Agents|vasodilator agents|mesh-ancestor
24632703|NCT01125410|Clindamycin palmitate|clindamycin palmitate|mesh-list
24632704|NCT01125410|Clindamycin phosphate|clindamycin phosphate|mesh-list
24632705|NCT01125410|Dequalinium|dequalinium|mesh-list
24632706|NCT01125410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25221077|NCT02652507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25221078|NCT02652273|Abatacept|abatacept|mesh-list
25221079|NCT02652273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25221080|NCT02652273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221081|NCT02652273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221082|NCT02652273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25221083|NCT02652273|Immunologic Factors|immunologic factors|mesh-ancestor
25221084|NCT02652273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221085|NCT02652273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25221086|NCT02652312|Diclofenac|diclofenac|mesh-list
25221087|NCT02652312|Fentanyl|fentanyl|mesh-list
25221088|NCT02652312|Dexmedetomidine|dexmedetomidine|mesh-list
25221089|NCT02652312|Ondansetron|ondansetron|mesh-list
25221090|NCT02652312|Propofol|propofol|mesh-list
25221091|NCT02652312|Desflurane|desflurane|mesh-list
25221092|NCT02652312|Atracurium|atracurium|mesh-list
25221093|NCT02652312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25221094|NCT02652312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25221095|NCT02652312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042756|NCT01373086|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24833168|NCT02172976|Irinotecan|irinotecan|mesh-list
24833169|NCT02172976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24833170|NCT02172976|Antimetabolites|antimetabolites|mesh-ancestor
24833171|NCT02172976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833172|NCT02172976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24833173|NCT02172976|Antiviral Agents|antiviral agents|mesh-ancestor
24833174|NCT02172976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24833175|NCT02172976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25679691|NCT01841762|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25679692|NCT01841762|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25679693|NCT01841762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679694|NCT01841762|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25679695|NCT01842308|Melphalan|melphalan|mesh-list
25679696|NCT01842308|Mechlorethamine|mechlorethamine|mesh-list
25679697|NCT01842308|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25679698|NCT01842308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25679699|NCT01842308|Alkylating Agents|alkylating agents|mesh-ancestor
25679700|NCT01842308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679701|NCT01842308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25679702|NCT01842308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25679703|NCT01842308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25679704|NCT01842308|Immunologic Factors|immunologic factors|mesh-ancestor
24833177|NCT02172976|Immunologic Factors|immunologic factors|mesh-ancestor
24833178|NCT02172976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833179|NCT02172976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24833180|NCT02172976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24833181|NCT02173093|Aldesleukin|aldesleukin|mesh-list
24833182|NCT02173093|Interleukin-2|interleukin-2|mesh-list
24833183|NCT02173093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24833202|NCT02173106|Dermatologic Agents|dermatologic agents|mesh-ancestor
25053832|NCT00004172|Thiotepa|thiotepa|mesh-list
24632707|NCT01125410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25221096|NCT02652312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25221097|NCT02652312|Anesthetics, General|anesthetics, general|mesh-ancestor
25221098|NCT02652312|Anesthetics|anesthetics|mesh-ancestor
25221099|NCT02652312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25221100|NCT02652312|Analgesics|analgesics|mesh-ancestor
25221105|NCT02652312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25221106|NCT02652312|Adrenergic Agents|adrenergic agents|mesh-ancestor
25221107|NCT02652312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25221108|NCT02652312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221109|NCT02652312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25221111|NCT02652312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25221112|NCT02652312|Antiemetics|antiemetics|mesh-ancestor
25221113|NCT02652312|Autonomic Agents|autonomic agents|mesh-ancestor
25221114|NCT02652312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25221115|NCT02652312|Antipruritics|antipruritics|mesh-ancestor
25221116|NCT02652312|Dermatologic Agents|dermatologic agents|mesh-ancestor
25221117|NCT02652312|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25221118|NCT02652312|Serotonin Agents|serotonin agents|mesh-ancestor
25221119|NCT02652312|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25221120|NCT02652312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25221121|NCT02652312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25221122|NCT02652312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25221123|NCT02652312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25221124|NCT02652312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25221125|NCT02652312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25221126|NCT02652312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25221127|NCT02652312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25221128|NCT02652312|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25221129|NCT02652312|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25221130|NCT02652312|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25221131|NCT02652312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25221132|NCT02652312|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24632708|NCT01125410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24632709|NCT01125410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632710|NCT01125410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089269|NCT03267407|Fluconazole|fluconazole|mesh-list
25089270|NCT03267407|Antifungal Agents|antifungal agents|mesh-ancestor
25089271|NCT03267407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25110421|NCT05463601|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25089272|NCT03267407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25089273|NCT03267407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25089274|NCT03267407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25089275|NCT03267407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089276|NCT03267407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25089277|NCT03267407|Hormone Antagonists|hormone antagonists|mesh-ancestor
25089278|NCT03267407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25089279|NCT03267407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089280|NCT03267407|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25089281|NCT03267407|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25089282|NCT03267316|Gemcitabine|gemcitabine|mesh-list
25089283|NCT03267316|Paclitaxel|paclitaxel|mesh-list
24456228|NCT00330746|Antiviral Agents|antiviral agents|mesh-ancestor
24632751|NCT01125527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632753|NCT01125553|Insulin Aspart|insulin aspart|mesh-list
24632757|NCT01125657|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24632758|NCT01125657|Antithrombins|antithrombins|mesh-ancestor
24632759|NCT01125657|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24632760|NCT01125657|Protease Inhibitors|protease inhibitors|mesh-ancestor
24632761|NCT01125657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632762|NCT01125657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632763|NCT01125657|Anticoagulants|anticoagulants|mesh-ancestor
24632764|NCT01125670|Darexaban|darexaban|mesh-list
24632765|NCT01125670|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24632766|NCT01125670|Antithrombins|antithrombins|mesh-ancestor
25221133|NCT02652312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25221134|NCT02652312|Cholinergic Agents|cholinergic agents|mesh-ancestor
25221135|NCT02652325|Iodine|iodine|mesh-list
25221136|NCT02652325|Cadexomer iodine|cadexomer iodine|mesh-list
25221137|NCT02652325|Povidone-Iodine|povidone-iodine|mesh-list
25221138|NCT02652325|Povidone|povidone|mesh-list
25221139|NCT02652325|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25221140|NCT02652325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25221141|NCT02652325|Trace Elements|trace elements|mesh-ancestor
25221142|NCT02652325|Micronutrients|micronutrients|mesh-ancestor
25221143|NCT02652325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221144|NCT02652325|Plasma Substitutes|plasma substitutes|mesh-ancestor
25221145|NCT02652325|Blood Substitutes|blood substitutes|mesh-ancestor
25221146|NCT02652234|Endostar protein|endostar protein|mesh-list
25221147|NCT02652234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24981118|NCT04420195|Tacrolimus|tacrolimus|mesh-list
24981119|NCT04420195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24981120|NCT04420195|Immunologic Factors|immunologic factors|mesh-ancestor
24632767|NCT01125670|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24632768|NCT01125670|Protease Inhibitors|protease inhibitors|mesh-ancestor
24632769|NCT01125670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632799|NCT01125761|Clemastine|clemastine|mesh-list
24632800|NCT01125761|Dexamethasone|dexamethasone|mesh-list
24632801|NCT01125761|Dexamethasone acetate|dexamethasone acetate|mesh-list
24632802|NCT01125761|BB 1101|bb 1101|mesh-list
24632803|NCT01125761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24632804|NCT01125761|Antiemetics|antiemetics|mesh-ancestor
24632805|NCT01125761|Autonomic Agents|autonomic agents|mesh-ancestor
24632806|NCT01125761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24632807|NCT01125761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632808|NCT01125761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24632809|NCT01125761|Glucocorticoids|glucocorticoids|mesh-ancestor
24632810|NCT01125761|Hormones|hormones|mesh-ancestor
24632811|NCT01125761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25679705|NCT01842308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089284|NCT03267316|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25089285|NCT03267316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25679706|NCT01842334|Nicotine|nicotine|mesh-list
24751569|NCT01704794|Proguanil|proguanil|mesh-list
25089300|NCT03267329|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25089301|NCT03267329|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25089302|NCT03267329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221164|NCT02652091|Antiviral Agents|antiviral agents|mesh-ancestor
24632814|NCT01125761|Protease Inhibitors|protease inhibitors|mesh-ancestor
24632815|NCT01125761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632816|NCT01125761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632817|NCT01125761|Antipruritics|antipruritics|mesh-ancestor
25221148|NCT02652234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25221149|NCT02652234|Growth Substances|growth substances|mesh-ancestor
25221150|NCT02652234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221151|NCT02652234|Growth Inhibitors|growth inhibitors|mesh-ancestor
25221152|NCT02652234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221153|NCT02652065|Acetylcholine|acetylcholine|mesh-list
25221154|NCT02652065|Vasodilator Agents|vasodilator agents|mesh-ancestor
25221155|NCT02652065|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25221156|NCT02652065|Cholinergic Agents|cholinergic agents|mesh-ancestor
25221157|NCT02652065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25221158|NCT02652065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221159|NCT02652065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221160|NCT02652091|Interferons|interferons|mesh-list
24946479|NCT03939273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053888|NCT00004096|Carboplatin|carboplatin|mesh-list
24632818|NCT01125761|Dermatologic Agents|dermatologic agents|mesh-ancestor
24632819|NCT01125761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24632820|NCT01125761|Histamine Antagonists|histamine antagonists|mesh-ancestor
24632821|NCT01125761|Histamine Agents|histamine agents|mesh-ancestor
24632822|NCT01125761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24632823|NCT01125761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25679707|NCT01842334|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25679708|NCT01842334|Autonomic Agents|autonomic agents|mesh-ancestor
25679709|NCT01842334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25679710|NCT01842334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679711|NCT01842334|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24632824|NCT01125787|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25221161|NCT02652091|Interferon-beta|interferon-beta|mesh-list
25221162|NCT02652091|Interferon beta-1b|interferon beta-1b|mesh-list
25221163|NCT02652091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221166|NCT02652091|Immunologic Factors|immunologic factors|mesh-ancestor
25221167|NCT02652091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221168|NCT02652091|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25221169|NCT02651870|Amlodipine|amlodipine|mesh-list
25221170|NCT02651870|Candesartan|candesartan|mesh-list
25221171|NCT02651870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25221172|NCT02651870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25221173|NCT02651870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25221174|NCT02651870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221175|NCT02651870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25221176|NCT02651870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221177|NCT02651870|Vasodilator Agents|vasodilator agents|mesh-ancestor
25221178|NCT02651870|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25221179|NCT02651870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25221180|NCT02651792|Meperidine|meperidine|mesh-list
25221181|NCT02651792|Ketamine|ketamine|mesh-list
25221182|NCT02651792|Propofol|propofol|mesh-list
25221183|NCT02651792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25221184|NCT02651792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25221185|NCT02651792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221186|NCT02651792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25221187|NCT02651792|Anesthetics, General|anesthetics, general|mesh-ancestor
25221188|NCT02651792|Anesthetics|anesthetics|mesh-ancestor
25221189|NCT02651792|Analgesics|analgesics|mesh-ancestor
25221190|NCT02651792|Sensory System Agents|sensory system agents|mesh-ancestor
24467463|NCT00377806|Diclofenac|diclofenac|mesh-list
25089321|NCT03266965|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25089322|NCT03266965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25089323|NCT03266926|Bupivacaine|bupivacaine|mesh-list
25089324|NCT03266926|Estrogens|estrogens|mesh-list
25089325|NCT03266926|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25089326|NCT03266926|Anesthetics, Local|anesthetics, local|mesh-ancestor
25089327|NCT03266926|Anesthetics|anesthetics|mesh-ancestor
25089328|NCT03266926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25089329|NCT03266926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089330|NCT03266926|Sensory System Agents|sensory system agents|mesh-ancestor
25089331|NCT03266926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25679712|NCT01842334|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25679713|NCT01842334|Cholinergic Agents|cholinergic agents|mesh-ancestor
24652362|NCT01238029|Capecitabine|capecitabine|mesh-list
24652363|NCT01238029|Vinorelbine|vinorelbine|mesh-list
24652364|NCT01238029|Lapatinib|lapatinib|mesh-list
25089332|NCT03266926|Hormones|hormones|mesh-ancestor
25089333|NCT03266926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25089334|NCT03266991|Isoniazid|isoniazid|mesh-list
25089335|NCT03266991|Rifapentine|rifapentine|mesh-list
25089336|NCT03266991|Antitubercular Agents|antitubercular agents|mesh-ancestor
25089337|NCT03266991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25089338|NCT03266991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25089339|NCT03266991|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25089340|NCT03266991|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25089341|NCT03266991|Antimetabolites|antimetabolites|mesh-ancestor
25089342|NCT03266991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089343|NCT03266991|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25089344|NCT03266991|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25089345|NCT03266991|Leprostatic Agents|leprostatic agents|mesh-ancestor
25221191|NCT02651792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25221192|NCT02651792|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25221193|NCT02651792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25221194|NCT02651792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25221196|NCT02651792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221197|NCT02651792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25221198|NCT02651792|Narcotics|narcotics|mesh-ancestor
25221199|NCT02651792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25221200|NCT02651753|Calcium, Dietary|calcium, dietary|mesh-list
25221201|NCT02651753|Atorvastatin|atorvastatin|mesh-list
25221202|NCT02651753|Fenofibrate|fenofibrate|mesh-list
25221203|NCT02651753|Calcium|calcium|mesh-list
25221204|NCT02651753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25221205|NCT02651753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221206|NCT02651753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25221207|NCT02651753|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25221208|NCT02651753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25221209|NCT02651753|Antimetabolites|antimetabolites|mesh-ancestor
25221210|NCT02651753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221211|NCT02651753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25221212|NCT02651753|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25221213|NCT02651753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632826|NCT01125787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24632827|NCT01125787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24632828|NCT01125787|Alkylating Agents|alkylating agents|mesh-ancestor
25089347|NCT03266731|Clopidogrel|clopidogrel|mesh-list
25089348|NCT03266731|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25089354|NCT03266731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25089355|NCT03266731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25089356|NCT03266731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25089357|NCT03266731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25089358|NCT03266731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089359|NCT03266731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25089360|NCT03266731|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25089361|NCT03266731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25089362|NCT03266731|Antipyretics|antipyretics|mesh-ancestor
25089363|NCT03266731|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25089364|NCT03266731|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25089365|NCT03266731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25089366|NCT03266731|Purinergic Agents|purinergic agents|mesh-ancestor
25089367|NCT03266731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25679714|NCT01842334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25679715|NCT01842334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679716|NCT01842581|Rifaximin|rifaximin|mesh-list
25679717|NCT01842581|Lactulose|lactulose|mesh-list
25679718|NCT01842581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25679719|NCT01842581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25679720|NCT01842581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24632829|NCT01125787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632837|NCT01125891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632839|NCT01125891|Antiviral Agents|antiviral agents|mesh-ancestor
24632840|NCT01125891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24632841|NCT01125891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632842|NCT01125891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24632843|NCT01125891|Immunologic Factors|immunologic factors|mesh-ancestor
24632844|NCT01125891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632845|NCT01125891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24632847|NCT01125904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632849|NCT01125904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632850|NCT01125904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632851|NCT01125943|Bevacizumab|bevacizumab|mesh-list
24632852|NCT01125943|Nitroprusside|nitroprusside|mesh-list
24632853|NCT01125943|Acetylcholine|acetylcholine|mesh-list
24632854|NCT01125943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24443802|NCT00295997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24632863|NCT01125943|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24632864|NCT01125943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089368|NCT03266562|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25089369|NCT03266562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25089370|NCT03266562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089372|NCT03266549|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25089373|NCT03266549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25089374|NCT03266549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089375|NCT03266549|Cholinergic Agents|cholinergic agents|mesh-ancestor
25089376|NCT03266549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25089377|NCT03266549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089378|NCT03266601|Interferons|interferons|mesh-list
25089379|NCT03266601|Ribavirin|ribavirin|mesh-list
25089380|NCT03266601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221214|NCT02651610|Paclitaxel|paclitaxel|mesh-list
25221215|NCT02651610|Docetaxel|docetaxel|mesh-list
25221217|NCT02651610|Bavituximab|bavituximab|mesh-list
25221218|NCT02651610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25221219|NCT02651610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221220|NCT02651610|Tubulin Modulators|tubulin modulators|mesh-ancestor
24446070|NCT00303758|Vitamins|vitamins|mesh-ancestor
25089381|NCT03266601|Antiviral Agents|antiviral agents|mesh-ancestor
25089382|NCT03266601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24632865|NCT01125943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24632910|NCT01126138|Mitosis Modulators|mitosis modulators|mesh-ancestor
24632911|NCT01126138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632912|NCT01126138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24632913|NCT01126138|Antimetabolites|antimetabolites|mesh-ancestor
24751728|NCT01705743|Sensory System Agents|sensory system agents|mesh-ancestor
24632924|NCT01126216|Paclitaxel|paclitaxel|mesh-list
24632925|NCT01126216|Cisplatin|cisplatin|mesh-list
24632926|NCT01126216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24632986|NCT01126684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24632987|NCT01126684|Antimetabolites|antimetabolites|mesh-ancestor
24632988|NCT01126684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632989|NCT01126684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24632990|NCT01126684|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24632993|NCT01126697|Coenzyme Q10|coenzyme q10|mesh-list
24632994|NCT01126697|Lisinopril|lisinopril|mesh-list
24632995|NCT01126697|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24632996|NCT01126697|Protease Inhibitors|protease inhibitors|mesh-ancestor
24632997|NCT01126697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632998|NCT01126697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633012|NCT01126814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25089383|NCT03266601|Antimetabolites|antimetabolites|mesh-ancestor
25405276|NCT03615105|Busulfan|busulfan|mesh-list
25679721|NCT01842594|Sirolimus|sirolimus|mesh-list
24652746|NCT01239940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25089384|NCT03266601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089385|NCT03266393|Tacrolimus|tacrolimus|mesh-list
25089386|NCT03266393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24765266|NCT01787357|Canagliflozin|canagliflozin|mesh-list
25089387|NCT03266393|Immunologic Factors|immunologic factors|mesh-ancestor
25089388|NCT03266393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089389|NCT03266393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25089390|NCT03266393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25089391|NCT03266393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089392|NCT03266159|Trametinib|trametinib|mesh-list
25089393|NCT03266159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633061|NCT01127100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25089394|NCT03266159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25089395|NCT03266159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25089396|NCT03266159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089397|NCT03266250|Anesthetics|anesthetics|mesh-list
25089398|NCT03266250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25089399|NCT03266250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089400|NCT03266146|Methylprednisolone|methylprednisolone|mesh-list
25089401|NCT03266146|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25089402|NCT03266146|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25089403|NCT03266146|Prednisolone|prednisolone|mesh-list
25089404|NCT03266146|Prednisolone acetate|prednisolone acetate|mesh-list
25089405|NCT03266146|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24633035|NCT01127009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633036|NCT01127009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25221221|NCT02651610|Antimitotic Agents|antimitotic agents|mesh-ancestor
25221222|NCT02651610|Mitosis Modulators|mitosis modulators|mesh-ancestor
25221223|NCT02651610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833217|NCT02173262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24833218|NCT02173262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24633037|NCT01127009|Antimetabolites|antimetabolites|mesh-ancestor
24633038|NCT01127009|Antiviral Agents|antiviral agents|mesh-ancestor
24633039|NCT01127009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24633040|NCT01127009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24633041|NCT01127009|Immunologic Factors|immunologic factors|mesh-ancestor
24633042|NCT01127009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633043|NCT01127009|Analgesics|analgesics|mesh-ancestor
24633047|NCT01127009|Dermatologic Agents|dermatologic agents|mesh-ancestor
24633048|NCT01127009|Tubulin Modulators|tubulin modulators|mesh-ancestor
24633049|NCT01127009|Antimitotic Agents|antimitotic agents|mesh-ancestor
25089406|NCT03266146|Prednisolone phosphate|prednisolone phosphate|mesh-list
25089407|NCT03266146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25089408|NCT03266146|Antiemetics|antiemetics|mesh-ancestor
25089409|NCT03266146|Autonomic Agents|autonomic agents|mesh-ancestor
25089410|NCT03266146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25089411|NCT03266146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089412|NCT03266146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25089413|NCT03266146|Glucocorticoids|glucocorticoids|mesh-ancestor
25089414|NCT03266146|Hormones|hormones|mesh-ancestor
25089415|NCT03266146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25089416|NCT03266146|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25089417|NCT03266146|Protective Agents|protective agents|mesh-ancestor
25089418|NCT03266146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25089419|NCT03266146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25089420|NCT03266445|Buprenorphine|buprenorphine|mesh-list
25089421|NCT03266445|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25089422|NCT03266445|Naloxone|naloxone|mesh-list
24633050|NCT01127009|Mitosis Modulators|mitosis modulators|mesh-ancestor
24633051|NCT01127022|Choline|choline|mesh-list
24633052|NCT01127022|Lipotropic Agents|lipotropic agents|mesh-ancestor
24633053|NCT01127022|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24633054|NCT01127022|Antimetabolites|antimetabolites|mesh-ancestor
24633055|NCT01127022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633056|NCT01127022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24633057|NCT01127022|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25679722|NCT01842594|Hydroxychloroquine|hydroxychloroquine|mesh-list
24652952|NCT01241032|Udenafil|udenafil|mesh-list
24633060|NCT01127100|Gabapentin|gabapentin|mesh-list
24633064|NCT01127100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221224|NCT02651610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25221225|NCT02651623|Moxifloxacin|moxifloxacin|mesh-list
25221226|NCT02651623|Sertraline|sertraline|mesh-list
25221227|NCT02651623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25221228|NCT02651623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25221229|NCT02651623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25221230|NCT02651623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25221231|NCT02651623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25221232|NCT02651623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833220|NCT02173262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24833221|NCT02173262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833222|NCT02173262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24833223|NCT02173262|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24833224|NCT02173262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24833225|NCT02173262|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24833226|NCT02173262|Immunologic Factors|immunologic factors|mesh-ancestor
24952381|NCT03894189|Autonomic Agents|autonomic agents|mesh-ancestor
24633065|NCT01127100|Analgesics|analgesics|mesh-ancestor
24633067|NCT01127100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24633077|NCT01127100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25089423|NCT03266445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25089425|NCT03266445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25089426|NCT03266445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089427|NCT03266445|Analgesics|analgesics|mesh-ancestor
25089428|NCT03266445|Sensory System Agents|sensory system agents|mesh-ancestor
25089429|NCT03266445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25089430|NCT03266445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24537443|NCT00654576|GABA Agents|gaba agents|mesh-ancestor
24633078|NCT01127100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24633087|NCT01127204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24633088|NCT01127204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24633091|NCT01127204|Antiviral Agents|antiviral agents|mesh-ancestor
24633092|NCT01127204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24633093|NCT01127204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24633094|NCT01127204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24633095|NCT01127217|Losartan|losartan|mesh-list
24633096|NCT01127217|Amlodipine|amlodipine|mesh-list
24633097|NCT01127217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24633098|NCT01127217|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24633099|NCT01127217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24633100|NCT01127217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633101|NCT01127217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24633102|NCT01127217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633103|NCT01127217|Vasodilator Agents|vasodilator agents|mesh-ancestor
24633104|NCT01127217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24633105|NCT01127217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24633106|NCT01127217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24633107|NCT01127269|Insulin Glargine|insulin glargine|mesh-list
24633108|NCT01127269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24633127|NCT01127295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24633128|NCT01127295|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24633143|NCT01127360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633144|NCT01127360|Growth Inhibitors|growth inhibitors|mesh-ancestor
24633146|NCT01127386|Immunologic Factors|immunologic factors|mesh-ancestor
24633147|NCT01127386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633148|NCT01127386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24633149|NCT01127386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24633150|NCT01127386|Growth Substances|growth substances|mesh-ancestor
24633151|NCT01127386|Growth Inhibitors|growth inhibitors|mesh-ancestor
24633155|NCT01127464|Immunologic Factors|immunologic factors|mesh-ancestor
24633156|NCT01127464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633169|NCT01127490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25405277|NCT03615105|Thiotepa|thiotepa|mesh-list
25221238|NCT02651623|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25221239|NCT02651623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25221240|NCT02651623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25221241|NCT02651623|Serotonin Agents|serotonin agents|mesh-ancestor
24633175|NCT01127529|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24633176|NCT01127529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24633177|NCT01127529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089438|NCT03265886|Bupivacaine|bupivacaine|mesh-list
25089439|NCT03265886|Anesthetics, Local|anesthetics, local|mesh-ancestor
25089440|NCT03265886|Anesthetics|anesthetics|mesh-ancestor
25089441|NCT03265886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25089442|NCT03265886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089443|NCT03265886|Sensory System Agents|sensory system agents|mesh-ancestor
25089444|NCT03265886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25089445|NCT03265834|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25089446|NCT03265834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25089447|NCT03265834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25089448|NCT03265834|Antitubercular Agents|antitubercular agents|mesh-ancestor
25089449|NCT03265782|Acetaminophen|acetaminophen|mesh-list
25089450|NCT03265782|Ibuprofen|ibuprofen|mesh-list
25089451|NCT03265782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25089452|NCT03265782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25089453|NCT03265782|Analgesics|analgesics|mesh-ancestor
25089454|NCT03265782|Sensory System Agents|sensory system agents|mesh-ancestor
25089455|NCT03265782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24633185|NCT01127542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633186|NCT01127555|Leucovorin|leucovorin|mesh-list
24633187|NCT01127555|Fluorouracil|fluorouracil|mesh-list
24633196|NCT01127555|Antidotes|antidotes|mesh-ancestor
24633197|NCT01127555|Protective Agents|protective agents|mesh-ancestor
24633198|NCT01127555|Vitamin B Complex|vitamin b complex|mesh-ancestor
24633199|NCT01127555|Vitamins|vitamins|mesh-ancestor
24633200|NCT01127555|Micronutrients|micronutrients|mesh-ancestor
24633201|NCT01127568|Propranolol|propranolol|mesh-list
24633234|NCT01127672|Anesthetics, Local|anesthetics, local|mesh-ancestor
24633235|NCT01127672|Anesthetics|anesthetics|mesh-ancestor
24633236|NCT01127672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25089456|NCT03265782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089457|NCT03265782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25089458|NCT03265782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25089459|NCT03265782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25089460|NCT03265782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25089461|NCT03265782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089462|NCT03265782|Antipyretics|antipyretics|mesh-ancestor
25089463|NCT03265470|Fentanyl|fentanyl|mesh-list
24981356|NCT03648892|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24981357|NCT03638947|Povidone-Iodine|povidone-iodine|mesh-list
24981358|NCT03638947|Povidone|povidone|mesh-list
24981360|NCT03638947|Blood Substitutes|blood substitutes|mesh-ancestor
25405278|NCT03615105|Rituximab|rituximab|mesh-list
24833236|NCT02173288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24833237|NCT02173288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833238|NCT02173288|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24833239|NCT02173288|Hormone Antagonists|hormone antagonists|mesh-ancestor
24833240|NCT02173288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24833241|NCT02173288|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24833242|NCT02173288|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24833243|NCT02173288|Sympathomimetics|sympathomimetics|mesh-ancestor
24833244|NCT02173288|Autonomic Agents|autonomic agents|mesh-ancestor
24833245|NCT02173288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24633242|NCT01127672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24633243|NCT01127672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633245|NCT01127724|Vitamin B 12|vitamin b 12|mesh-list
24633246|NCT01127724|Hydroxocobalamin|hydroxocobalamin|mesh-list
24633247|NCT01127724|Vitamin B Complex|vitamin b complex|mesh-list
24633248|NCT01127724|Micronutrients|micronutrients|mesh-ancestor
24633266|NCT01127841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633267|NCT01127880|Clindamycin|clindamycin|mesh-list
24633268|NCT01127880|Clindamycin palmitate|clindamycin palmitate|mesh-list
24633269|NCT01127880|Clindamycin phosphate|clindamycin phosphate|mesh-list
24633270|NCT01127880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24633271|NCT01127880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24633272|NCT01127880|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24633273|NCT01127880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633276|NCT01127906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25221250|NCT02651727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221251|NCT02651727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25221252|NCT02651727|Antimetabolites|antimetabolites|mesh-ancestor
25221253|NCT02651727|Antiviral Agents|antiviral agents|mesh-ancestor
25221254|NCT02651727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25221255|NCT02651727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25221256|NCT02651727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25221257|NCT02651727|Immunologic Factors|immunologic factors|mesh-ancestor
25221258|NCT02651727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221259|NCT02651519|Ropivacaine|ropivacaine|mesh-list
25221260|NCT02651519|Anesthetics, Local|anesthetics, local|mesh-ancestor
25221261|NCT02651519|Anesthetics|anesthetics|mesh-ancestor
25221262|NCT02651519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25221263|NCT02651519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221264|NCT02651519|Sensory System Agents|sensory system agents|mesh-ancestor
25221265|NCT02651519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24633301|NCT01128218|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24633309|NCT01128322|Amlodipine|amlodipine|mesh-list
25221271|NCT02651636|Inositol|inositol|mesh-list
25221272|NCT02651636|Hematinics|hematinics|mesh-ancestor
25221273|NCT02651636|Vitamin B Complex|vitamin b complex|mesh-ancestor
25221274|NCT02651636|Vitamins|vitamins|mesh-ancestor
25221275|NCT02651636|Micronutrients|micronutrients|mesh-ancestor
25221276|NCT02651636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221277|NCT02651636|Antioxidants|antioxidants|mesh-ancestor
25221279|NCT02651636|Protective Agents|protective agents|mesh-ancestor
25221280|NCT02651441|Gemcitabine|gemcitabine|mesh-list
25221281|NCT02651441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221282|NCT02651441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25221283|NCT02651441|Antimetabolites|antimetabolites|mesh-ancestor
25221284|NCT02651441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221285|NCT02651441|Antiviral Agents|antiviral agents|mesh-ancestor
25221286|NCT02651441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25221287|NCT02651441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25221288|NCT02651441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25221289|NCT02651441|Immunologic Factors|immunologic factors|mesh-ancestor
25221290|NCT02651441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833270|NCT02173639|Linagliptin|linagliptin|mesh-list
24833271|NCT02173639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24833272|NCT02173639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833273|NCT02173639|Incretins|incretins|mesh-ancestor
24833274|NCT02173639|Hormones|hormones|mesh-ancestor
24981430|NCT03382977|Lomustine|lomustine|mesh-list
24981431|NCT03382977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24467609|NCT00378183|Dopamine Agents|dopamine agents|mesh-ancestor
24833295|NCT02173665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24833297|NCT02173665|Protease Inhibitors|protease inhibitors|mesh-ancestor
24833298|NCT02173665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24833299|NCT02173665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833300|NCT02173691|Tiotropium Bromide|tiotropium bromide|mesh-list
24633310|NCT01128322|Telmisartan|telmisartan|mesh-list
24633311|NCT01128322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24633312|NCT01128322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24633313|NCT01128322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24633314|NCT01128322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633315|NCT01128322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24633316|NCT01128322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633318|NCT01128322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24633319|NCT01128322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24633320|NCT01128322|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24633321|NCT01128322|Antimetabolites|antimetabolites|mesh-ancestor
24633322|NCT01128322|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24633323|NCT01128322|Vitamin B Complex|vitamin b complex|mesh-ancestor
25089487|NCT03265899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25089488|NCT03265899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089489|NCT03265899|Cathartics|cathartics|mesh-ancestor
25089490|NCT03265899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25089491|NCT03265574|Enalapril|enalapril|mesh-list
25089492|NCT03265574|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25221291|NCT02651350|Methylprednisolone|methylprednisolone|mesh-list
25221292|NCT02651350|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25221293|NCT02651350|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25221294|NCT02651350|Prednisolone|prednisolone|mesh-list
25221295|NCT02651350|Prednisolone acetate|prednisolone acetate|mesh-list
25221296|NCT02651350|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25221297|NCT02651350|Prednisolone phosphate|prednisolone phosphate|mesh-list
25221298|NCT02651350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25221299|NCT02651350|Antiemetics|antiemetics|mesh-ancestor
25221300|NCT02651350|Autonomic Agents|autonomic agents|mesh-ancestor
25221301|NCT02651350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25221302|NCT02651350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221303|NCT02651350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25221305|NCT02651350|Hormones|hormones|mesh-ancestor
25221306|NCT02651350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25221307|NCT02651350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25221308|NCT02651350|Protective Agents|protective agents|mesh-ancestor
25221309|NCT02651350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25221310|NCT02651350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221311|NCT02651324|Ketamine|ketamine|mesh-list
25221312|NCT02651324|Analgesics|analgesics|mesh-ancestor
25221313|NCT02651324|Sensory System Agents|sensory system agents|mesh-ancestor
25221314|NCT02651324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25221315|NCT02651324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221316|NCT02651324|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25221317|NCT02651324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24833301|NCT02173691|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24833302|NCT02173691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24833303|NCT02173691|Autonomic Agents|autonomic agents|mesh-ancestor
24833304|NCT02173691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24833305|NCT02173691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833306|NCT02173691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24833307|NCT02173691|Respiratory System Agents|respiratory system agents|mesh-ancestor
24742705|NCT05192629|Anesthetics|anesthetics|mesh-ancestor
25042780|NCT01369095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25042781|NCT01369095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25042782|NCT01369095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042783|NCT01369095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25042785|NCT01369095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042786|NCT01369095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25042787|NCT01369095|Antidepressive Agents|antidepressive agents|mesh-ancestor
25042788|NCT01369095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25042789|NCT01369095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25042794|NCT01366131|Paclitaxel|paclitaxel|mesh-list
25042795|NCT01366131|Bevacizumab|bevacizumab|mesh-list
25042796|NCT01366131|Carboplatin|carboplatin|mesh-list
25089493|NCT03265574|Protease Inhibitors|protease inhibitors|mesh-ancestor
25089494|NCT03265574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25089495|NCT03265574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089496|NCT03265574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25089498|NCT03265795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25089499|NCT03265795|Anesthetics, General|anesthetics, general|mesh-ancestor
25089500|NCT03265795|Anesthetics|anesthetics|mesh-ancestor
25089501|NCT03265795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25089502|NCT03265795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221323|NCT02651324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25221324|NCT02651324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221325|NCT02651311|Ibuprofen|ibuprofen|mesh-list
25221326|NCT02651311|Fentanyl|fentanyl|mesh-list
25221327|NCT02651311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25221328|NCT02651311|Narcotics|narcotics|mesh-ancestor
25221332|NCT02651311|Sensory System Agents|sensory system agents|mesh-ancestor
25221333|NCT02651311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25221334|NCT02651311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25221335|NCT02651311|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25221336|NCT02651311|Anesthetics, General|anesthetics, general|mesh-ancestor
25221337|NCT02651311|Anesthetics|anesthetics|mesh-ancestor
25221338|NCT02651311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25221339|NCT02651311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25221340|NCT02651311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25221341|NCT02651311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25221342|NCT02651311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24633342|NCT01128712|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24633343|NCT01128712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25089506|NCT03265002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25089508|NCT03265288|Fenretinide|fenretinide|mesh-list
25089509|NCT03265288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25089510|NCT03265288|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25089511|NCT03265288|Protective Agents|protective agents|mesh-ancestor
25089512|NCT03265288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089513|NCT03265171|Plasminogen|plasminogen|mesh-list
25089514|NCT03265171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25089515|NCT03265171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25089516|NCT03265171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089517|NCT03265223|Ropivacaine|ropivacaine|mesh-list
25089518|NCT03265223|Anesthetics, Local|anesthetics, local|mesh-ancestor
25089519|NCT03265223|Anesthetics|anesthetics|mesh-ancestor
25089520|NCT03265223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25089521|NCT03265223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089522|NCT03265223|Sensory System Agents|sensory system agents|mesh-ancestor
25089523|NCT03265223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25089525|NCT03265197|Anesthetics, Local|anesthetics, local|mesh-ancestor
24765482|NCT01788774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089526|NCT03265197|Anesthetics|anesthetics|mesh-ancestor
25089527|NCT03265197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25089528|NCT03265197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089529|NCT03265197|Sensory System Agents|sensory system agents|mesh-ancestor
24515630|NCT00598533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24633368|NCT01129063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633370|NCT01129089|Trace Elements|trace elements|mesh-list
24633371|NCT01129089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221344|NCT02651311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221345|NCT02651168|Aflibercept|aflibercept|mesh-list
25221346|NCT02651168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25221347|NCT02651168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25221348|NCT02651168|Growth Substances|growth substances|mesh-ancestor
25221349|NCT02651168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221350|NCT02651168|Growth Inhibitors|growth inhibitors|mesh-ancestor
25221351|NCT02651168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221352|NCT02651207|Lidocaine|lidocaine|mesh-list
24654529|NCT01250236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654530|NCT01250236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654569|NCT01250457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654570|NCT01250457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24654571|NCT01250457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24654573|NCT01250470|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
24654574|NCT01250470|Immunologic Factors|immunologic factors|mesh-ancestor
24654575|NCT01250470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654576|NCT01250470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24654577|NCT01250496|Aminophylline|aminophylline|mesh-list
24654578|NCT01250496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24654579|NCT01250496|Autonomic Agents|autonomic agents|mesh-ancestor
25013116|NCT03603184|Mitosis Modulators|mitosis modulators|mesh-ancestor
24969773|NCT03740243|Narcotics|narcotics|mesh-ancestor
25221353|NCT02651207|Ethyl Chloride|ethyl chloride|mesh-list
25221354|NCT02651207|Contraceptive Agents|contraceptive agents|mesh-list
25221355|NCT02651207|Anesthetics, Local|anesthetics, local|mesh-ancestor
24833318|NCT02173717|Dabigatran|dabigatran|mesh-list
24833319|NCT02173717|Antithrombins|antithrombins|mesh-ancestor
24833320|NCT02173717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24833321|NCT02173717|Protease Inhibitors|protease inhibitors|mesh-ancestor
25089530|NCT03265197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25089531|NCT03265197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24981500|NCT03092817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24981503|NCT03075462|Apatinib|apatinib|mesh-list
25089532|NCT03265197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25089533|NCT03265197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25089534|NCT03265197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25089535|NCT03265197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089536|NCT03264638|Cyproterone Acetate|cyproterone acetate|mesh-list
25089537|NCT03264638|Cyproterone|cyproterone|mesh-list
25089538|NCT03264638|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
25089539|NCT03264638|Androgen Antagonists|androgen antagonists|mesh-ancestor
25089540|NCT03264638|Hormone Antagonists|hormone antagonists|mesh-ancestor
25159910|NCT03504956|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25679724|NCT01842594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25679725|NCT01842594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25679726|NCT01842594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25679727|NCT01842594|Antifungal Agents|antifungal agents|mesh-ancestor
25679728|NCT01842594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25679729|NCT01842594|Immunologic Factors|immunologic factors|mesh-ancestor
25679730|NCT01842594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679731|NCT01842594|Antimalarials|antimalarials|mesh-ancestor
25679732|NCT01842594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25679733|NCT01842594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25679734|NCT01842594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25679735|NCT01842594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679736|NCT01842594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25679737|NCT01842620|Metformin|metformin|mesh-list
25679738|NCT01842620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25679739|NCT01842620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679740|NCT01842633|Acetaminophen|acetaminophen|mesh-list
25679741|NCT01842633|Ibuprofen|ibuprofen|mesh-list
25679742|NCT01842633|Caffeine|caffeine|mesh-list
25679743|NCT01842633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25679744|NCT01842633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25679745|NCT01842633|Analgesics|analgesics|mesh-ancestor
25679746|NCT01842633|Sensory System Agents|sensory system agents|mesh-ancestor
24633374|NCT01129154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633375|NCT01129180|Bortezomib|bortezomib|mesh-list
24633376|NCT01129180|Azacitidine|azacitidine|mesh-list
24633377|NCT01129180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633378|NCT01129180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24633379|NCT01129180|Antimetabolites|antimetabolites|mesh-ancestor
25089550|NCT03264651|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25089551|NCT03264651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25089552|NCT03264651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25089553|NCT03264651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089554|NCT03264651|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25089555|NCT03264651|Hormone Antagonists|hormone antagonists|mesh-ancestor
25089556|NCT03264651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25089557|NCT03264651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089558|NCT03264794|Gefitinib|gefitinib|mesh-list
25089559|NCT03264794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25089560|NCT03264794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25089561|NCT03264794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25089562|NCT03264794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089563|NCT03264781|CycloProvera|cycloprovera|mesh-list
24633385|NCT01129271|Clopidogrel|clopidogrel|mesh-list
24633386|NCT01129271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24633387|NCT01129271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25221357|NCT02651207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25221358|NCT02651207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221359|NCT02651207|Sensory System Agents|sensory system agents|mesh-ancestor
25221360|NCT02651207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25221361|NCT02651207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25221362|NCT02651207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25221363|NCT02651207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25221364|NCT02651207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25221365|NCT02651207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221366|NCT02651207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25221367|NCT02651038|Micafungin|micafungin|mesh-list
24833324|NCT02173717|Anticoagulants|anticoagulants|mesh-ancestor
24833325|NCT02173717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24833326|NCT02173717|Antitubercular Agents|antitubercular agents|mesh-ancestor
24833327|NCT02173717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24833328|NCT02173717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24833329|NCT02173717|Leprostatic Agents|leprostatic agents|mesh-ancestor
24833330|NCT02173717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24833331|NCT02173717|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24833332|NCT02173717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24833333|NCT02173717|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24833334|NCT02173717|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24742820|NCT05150795|Anesthetics, General|anesthetics, general|mesh-ancestor
24833335|NCT02173717|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25405279|NCT03615105|Fludarabine|fludarabine|mesh-list
25679747|NCT01842633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25273070|NCT02387242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273071|NCT02387242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273072|NCT02387242|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25273073|NCT02387242|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25273074|NCT02387242|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25273075|NCT02387242|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25273076|NCT02387242|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25273077|NCT02387242|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25273078|NCT02387450|Sildenafil Citrate|sildenafil citrate|mesh-list
25273079|NCT02387450|Vasodilator Agents|vasodilator agents|mesh-ancestor
25254652|NCT02493335|Hormones|hormones|mesh-ancestor
25273080|NCT02387450|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25273081|NCT02387450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25273082|NCT02387450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273083|NCT02387450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273084|NCT02387450|Urological Agents|urological agents|mesh-ancestor
25273085|NCT02387229|Rivaroxaban|rivaroxaban|mesh-list
25273086|NCT02387229|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25273087|NCT02387229|Antithrombins|antithrombins|mesh-ancestor
25273088|NCT02387229|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25273090|NCT02387229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273091|NCT02387229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273092|NCT02387229|Anticoagulants|anticoagulants|mesh-ancestor
24452235|NCT00326456|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24452236|NCT00326456|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24452237|NCT00326456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24452238|NCT00326469|Lanreotide|lanreotide|mesh-list
24452239|NCT00326469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24452240|NCT00326508|Daclizumab|daclizumab|mesh-list
24452241|NCT00326508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24452242|NCT00326508|Immunologic Factors|immunologic factors|mesh-ancestor
24467701|NCT00378547|BB 1101|bb 1101|mesh-list
25221378|NCT02650791|Tranexamic Acid|tranexamic acid|mesh-list
25221379|NCT02650791|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25221380|NCT02650791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25221381|NCT02650791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013193|NCT03416179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25013194|NCT03416179|Immunologic Factors|immunologic factors|mesh-ancestor
25013195|NCT03416179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655415|NCT01256580|Hormones|hormones|mesh-ancestor
25221382|NCT02650791|Hemostatics|hemostatics|mesh-ancestor
25221383|NCT02650791|Coagulants|coagulants|mesh-ancestor
25221384|NCT02650713|Atezolizumab|atezolizumab|mesh-list
25221385|NCT02650713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221386|NCT02650609|Methylprednisolone|methylprednisolone|mesh-list
25221387|NCT02650609|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25221388|NCT02650609|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25221389|NCT02650609|Prednisolone|prednisolone|mesh-list
25221390|NCT02650609|Prednisolone acetate|prednisolone acetate|mesh-list
25221391|NCT02650609|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25221392|NCT02650609|Prednisolone phosphate|prednisolone phosphate|mesh-list
25221393|NCT02650609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25221394|NCT02650609|Antiemetics|antiemetics|mesh-ancestor
25221395|NCT02650609|Autonomic Agents|autonomic agents|mesh-ancestor
25221396|NCT02650609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25221397|NCT02650609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221398|NCT02650609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25221399|NCT02650609|Glucocorticoids|glucocorticoids|mesh-ancestor
25221400|NCT02650609|Hormones|hormones|mesh-ancestor
25221401|NCT02650609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25221402|NCT02650609|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25221403|NCT02650609|Protective Agents|protective agents|mesh-ancestor
25221404|NCT02650609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25221405|NCT02650609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221406|NCT02650635|Cyclophosphamide|cyclophosphamide|mesh-list
25221407|NCT02650635|Lenograstim|lenograstim|mesh-list
25221408|NCT02650635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25221409|NCT02650635|Immunologic Factors|immunologic factors|mesh-ancestor
25221410|NCT02650635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221411|NCT02650635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25221412|NCT02650635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25221413|NCT02650635|Alkylating Agents|alkylating agents|mesh-ancestor
25221414|NCT02650635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221415|NCT02650635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221416|NCT02650635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24633393|NCT01129271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633394|NCT01129310|Capecitabine|capecitabine|mesh-list
24633395|NCT01129310|Oxaliplatin|oxaliplatin|mesh-list
25221418|NCT02650596|Liraglutide|liraglutide|mesh-list
25221419|NCT02650596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25254847|NCT02492178|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25221420|NCT02650596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221421|NCT02650596|Incretins|incretins|mesh-ancestor
25221422|NCT02650596|Hormones|hormones|mesh-ancestor
25221423|NCT02650596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25221424|NCT02650518|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25221425|NCT02650518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25221426|NCT02650427|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25221427|NCT02650427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25221428|NCT02650427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221429|NCT02650427|Incretins|incretins|mesh-ancestor
25221430|NCT02650427|Hormones|hormones|mesh-ancestor
25221431|NCT02650427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25221432|NCT02650427|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25221433|NCT02650427|Protease Inhibitors|protease inhibitors|mesh-ancestor
25221434|NCT02650427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25221435|NCT02650427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221436|NCT02650479|Exenatide|exenatide|mesh-list
25221437|NCT02650479|Moxifloxacin|moxifloxacin|mesh-list
25221438|NCT02650479|Palonosetron|palonosetron|mesh-list
25221439|NCT02650479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25221440|NCT02650479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25221441|NCT02650479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25221442|NCT02650479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25221443|NCT02650479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25221444|NCT02650479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221445|NCT02650479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221446|NCT02650479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221447|NCT02650479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25679748|NCT01842633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679749|NCT01842633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25679750|NCT01842633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25679751|NCT01842633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24633401|NCT01129310|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25221451|NCT02650479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25221452|NCT02650479|Antiemetics|antiemetics|mesh-ancestor
25221453|NCT02650479|Autonomic Agents|autonomic agents|mesh-ancestor
25221454|NCT02650479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25221455|NCT02650479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25221456|NCT02650479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25221457|NCT02650479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25221458|NCT02650479|Serotonin Agents|serotonin agents|mesh-ancestor
25221459|NCT02650479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25221460|NCT02650544|Mirtazapine|mirtazapine|mesh-list
25221461|NCT02650544|Antidepressive Agents|antidepressive agents|mesh-ancestor
25221462|NCT02650544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25221463|NCT02650544|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25221464|NCT02650544|Histamine Antagonists|histamine antagonists|mesh-ancestor
25221465|NCT02650544|Histamine Agents|histamine agents|mesh-ancestor
25221466|NCT02650544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25221467|NCT02650544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221468|NCT02650544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221469|NCT02650544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25221470|NCT02650544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25221471|NCT02650544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25221472|NCT02650544|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25221473|NCT02650544|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25221474|NCT02650544|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25221475|NCT02650544|Adrenergic Agents|adrenergic agents|mesh-ancestor
25221476|NCT02650544|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25221477|NCT02650544|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25221478|NCT02650544|Serotonin Agents|serotonin agents|mesh-ancestor
25221479|NCT02650544|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25221480|NCT02650388|Chrysarobin|chrysarobin|mesh-list
25221481|NCT02650388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25221482|NCT02650388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25221483|NCT02650388|Analgesics|analgesics|mesh-ancestor
24833382|NCT02173795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833383|NCT02173795|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24833384|NCT02173795|Respiratory System Agents|respiratory system agents|mesh-ancestor
24833385|NCT02173795|Sympathomimetics|sympathomimetics|mesh-ancestor
24833386|NCT02173795|Tocolytic Agents|tocolytic agents|mesh-ancestor
24833388|NCT02173795|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24833389|NCT02173795|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24576160|NCT00837187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24833391|NCT02173795|Adrenergic Agents|adrenergic agents|mesh-ancestor
24833392|NCT02173795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24833502|NCT02174172|Obinutuzumab|obinutuzumab|mesh-list
24833393|NCT02173795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833394|NCT02173795|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24833395|NCT02173795|Cholinergic Agents|cholinergic agents|mesh-ancestor
24833396|NCT02173808|Levonorgestrel|levonorgestrel|mesh-list
24833397|NCT02173808|Levonorgestrel butanoate|levonorgestrel butanoate|mesh-list
24833398|NCT02173808|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24833399|NCT02173808|Contraceptive Agents|contraceptive agents|mesh-ancestor
24833401|NCT02173808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833402|NCT02173808|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24833403|NCT02173808|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24833404|NCT02173808|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24452302|NCT00327093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24452303|NCT00327093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24833428|NCT02173886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24833429|NCT02173886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833430|NCT02173886|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24833431|NCT02173886|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24833432|NCT02173886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24833434|NCT02173912|Candesartan|candesartan|mesh-list
24833435|NCT02173912|Candesartan cilexetil|candesartan cilexetil|mesh-list
24833436|NCT02173912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24833464|NCT02173990|Growth Substances|growth substances|mesh-ancestor
24833465|NCT02173990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633402|NCT01129310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24633403|NCT01129310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25221484|NCT02650388|Sensory System Agents|sensory system agents|mesh-ancestor
25221485|NCT02650388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25221486|NCT02650388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221487|NCT02650388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25221488|NCT02650388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25221489|NCT02650245|Lactulose|lactulose|mesh-list
25221490|NCT02650245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25221491|NCT02650206|Liraglutide|liraglutide|mesh-list
25221492|NCT02650206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25221493|NCT02650206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221494|NCT02650206|Incretins|incretins|mesh-ancestor
25221495|NCT02650206|Hormones|hormones|mesh-ancestor
25221496|NCT02650206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25221497|NCT02650102|Olanzapine|olanzapine|mesh-list
25221498|NCT02650102|Risperidone|risperidone|mesh-list
25221499|NCT02650102|Aripiprazole|aripiprazole|mesh-list
25221500|NCT02650102|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25221501|NCT02650102|Ziprasidone|ziprasidone|mesh-list
25221502|NCT02650102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25221503|NCT02650102|Serotonin Agents|serotonin agents|mesh-ancestor
25221504|NCT02650102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25221505|NCT02650102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576161|NCT00837187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25221506|NCT02650102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221507|NCT02650102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25221508|NCT02650102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25221509|NCT02650102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25221510|NCT02650102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25221511|NCT02650102|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25221512|NCT02650102|Dopamine Agents|dopamine agents|mesh-ancestor
25221513|NCT02650102|Antiemetics|antiemetics|mesh-ancestor
25221514|NCT02650102|Autonomic Agents|autonomic agents|mesh-ancestor
25221515|NCT02650102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25221516|NCT02650102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25221517|NCT02650102|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25221518|NCT02650102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25221519|NCT02650102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24833466|NCT02173990|Growth Inhibitors|growth inhibitors|mesh-ancestor
25679752|NCT01842633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24833490|NCT02174120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24833491|NCT02174120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24833492|NCT02174120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833493|NCT02174120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24833494|NCT02174120|Anesthetics, General|anesthetics, general|mesh-ancestor
24833495|NCT02174120|Anesthetics|anesthetics|mesh-ancestor
24833496|NCT02174172|Interferons|interferons|mesh-list
24833497|NCT02174172|Interferon-alpha|interferon-alpha|mesh-list
24833498|NCT02174172|Interferon alpha-2|interferon alpha-2|mesh-list
24833499|NCT02174172|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24833500|NCT02174172|Bevacizumab|bevacizumab|mesh-list
24833501|NCT02174172|Ipilimumab|ipilimumab|mesh-list
24833503|NCT02174172|Atezolizumab|atezolizumab|mesh-list
24833504|NCT02174172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24833505|NCT02174172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24833506|NCT02174172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24833507|NCT02174172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24833545|NCT02174250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833546|NCT02174263|Immunoglobulins|immunoglobulins|mesh-list
24833547|NCT02174263|Immunoglobulin G|immunoglobulin g|mesh-list
24833548|NCT02174263|Immunologic Factors|immunologic factors|mesh-ancestor
24633404|NCT01129323|Cyclophosphamide|cyclophosphamide|mesh-list
24633405|NCT01129323|Fludarabine|fludarabine|mesh-list
24633427|NCT01129375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24633428|NCT01129375|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24633429|NCT01129375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633432|NCT01129388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24633433|NCT01129388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24633434|NCT01129388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24633435|NCT01129388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24633436|NCT01129388|Purinergic Agents|purinergic agents|mesh-ancestor
24633437|NCT01129388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25089571|NCT03264781|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25089572|NCT03264911|Amoxicillin|amoxicillin|mesh-list
25089573|NCT03264911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25089574|NCT03264911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25089575|NCT03264586|Lidocaine|lidocaine|mesh-list
25089576|NCT03264586|Prilocaine|prilocaine|mesh-list
25089577|NCT03264586|Mepivacaine|mepivacaine|mesh-list
25089578|NCT03264586|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25089579|NCT03264586|Anesthetics, Local|anesthetics, local|mesh-ancestor
24633439|NCT01129388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633440|NCT01129388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24633441|NCT01129388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24633442|NCT01129388|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24633443|NCT01129388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633444|NCT01129414|Omeprazole|omeprazole|mesh-list
24633445|NCT01129414|Clopidogrel|clopidogrel|mesh-list
24633446|NCT01129414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24633447|NCT01129414|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24633448|NCT01129414|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24633449|NCT01129414|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24633450|NCT01129414|Purinergic Agents|purinergic agents|mesh-ancestor
25221520|NCT02650102|Antidepressive Agents|antidepressive agents|mesh-ancestor
25221521|NCT02650102|Dopamine Agonists|dopamine agonists|mesh-ancestor
25221522|NCT02650102|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25221523|NCT02650102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25221524|NCT02650102|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25221525|NCT02650102|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25221526|NCT02649920|Dinoprostone|dinoprostone|mesh-list
25221527|NCT02649920|Oxytocics|oxytocics|mesh-ancestor
25221528|NCT02649920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25221529|NCT02649920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221530|NCT02649998|Furosemide|furosemide|mesh-list
25221531|NCT02649998|Isosorbide|isosorbide|mesh-list
25221532|NCT02649998|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25221533|NCT02649998|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25221534|NCT02649998|Diuretics|diuretics|mesh-ancestor
25221535|NCT02649998|Natriuretic Agents|natriuretic agents|mesh-ancestor
25221536|NCT02649998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221537|NCT02649998|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25221538|NCT02649998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25221539|NCT02649998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221540|NCT02649998|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24833556|NCT02174328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833558|NCT02174328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24833579|NCT02174588|Midazolam|midazolam|mesh-list
24833580|NCT02174588|Propofol|propofol|mesh-list
24833581|NCT02174588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24833582|NCT02174588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24833583|NCT02174588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833584|NCT02174588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24833585|NCT02174588|Anesthetics, General|anesthetics, general|mesh-ancestor
24833586|NCT02174588|Anesthetics|anesthetics|mesh-ancestor
24833587|NCT02174588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24833588|NCT02174588|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24833589|NCT02174588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25221541|NCT02649998|Vasodilator Agents|vasodilator agents|mesh-ancestor
25221542|NCT02649998|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25221543|NCT02649751|Roscovitine|roscovitine|mesh-list
25221544|NCT02649751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221545|NCT02649751|Antiviral Agents|antiviral agents|mesh-ancestor
25221546|NCT02649751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25221547|NCT02649751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25221548|NCT02649751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25221549|NCT02649751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221550|NCT02649686|Trastuzumab|trastuzumab|mesh-list
25221551|NCT02649686|Durvalumab|durvalumab|mesh-list
25221552|NCT02649686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25221553|NCT02649686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221554|NCT02649582|Temozolomide|temozolomide|mesh-list
25221555|NCT02649582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25221556|NCT02649582|Alkylating Agents|alkylating agents|mesh-ancestor
25221557|NCT02649582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221558|NCT02649582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221559|NCT02649530|LGK974|lgk974|mesh-list
25221560|NCT02649530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25221561|NCT02649530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221562|NCT02649621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24833599|NCT02174666|Genistein|genistein|mesh-list
24833600|NCT02174666|Biochanin A|biochanin a|mesh-list
24833601|NCT02174666|Daidzein|daidzein|mesh-list
24833602|NCT02174666|Formononetin|formononetin|mesh-list
24833603|NCT02174666|Micronutrients|micronutrients|mesh-ancestor
25054208|NCT03531281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25089580|NCT03264586|Anesthetics|anesthetics|mesh-ancestor
25089581|NCT03264586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25089582|NCT03264586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089583|NCT03264586|Sensory System Agents|sensory system agents|mesh-ancestor
25089584|NCT03264586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25089585|NCT03264586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24752419|NCT01710228|Hormones|hormones|mesh-ancestor
24765556|NCT01789242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25089596|NCT03264625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25089597|NCT03264625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25089599|NCT03264547|Docetaxel|docetaxel|mesh-list
24633478|NCT01129479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633479|NCT01129479|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24633480|NCT01129479|Autonomic Agents|autonomic agents|mesh-ancestor
24633481|NCT01129479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24633482|NCT01129479|Nootropic Agents|nootropic agents|mesh-ancestor
24633484|NCT01129518|Immunologic Factors|immunologic factors|mesh-ancestor
24633485|NCT01129518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633486|NCT01129570|Silybin|silybin|mesh-list
24633488|NCT01129570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633489|NCT01129570|Protective Agents|protective agents|mesh-ancestor
25089600|NCT03264547|Trastuzumab|trastuzumab|mesh-list
25089601|NCT03264547|Pertuzumab|pertuzumab|mesh-list
25089602|NCT03264547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25089603|NCT03264547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25089604|NCT03264547|Tubulin Modulators|tubulin modulators|mesh-ancestor
25089605|NCT03264547|Antimitotic Agents|antimitotic agents|mesh-ancestor
25089606|NCT03264547|Mitosis Modulators|mitosis modulators|mesh-ancestor
25089607|NCT03264547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089608|NCT03264547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25221563|NCT02649621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25089609|NCT03264430|Ketamine|ketamine|mesh-list
25089610|NCT03264430|Bupivacaine|bupivacaine|mesh-list
25221570|NCT02649504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221571|NCT02649504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25221572|NCT02649504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25221573|NCT02649504|Antiemetics|antiemetics|mesh-ancestor
25221574|NCT02649504|Autonomic Agents|autonomic agents|mesh-ancestor
24833604|NCT02174666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833605|NCT02174666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24833606|NCT02174666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24833607|NCT02174666|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24833608|NCT02174666|Protective Agents|protective agents|mesh-ancestor
24833609|NCT02174666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25089612|NCT03264430|Anesthetics|anesthetics|mesh-ancestor
24633490|NCT01129570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633491|NCT01129596|Donepezil|donepezil|mesh-list
24633492|NCT01129596|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24665608|NCT01313689|Ofatumumab|ofatumumab|mesh-list
24633493|NCT01129596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633494|NCT01129596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633495|NCT01129596|Cholinergic Agents|cholinergic agents|mesh-ancestor
24633502|NCT01129713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24633503|NCT01129713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24633504|NCT01129713|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24633505|NCT01129713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633506|NCT01129713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633508|NCT01129739|Cyclosporins|cyclosporins|mesh-list
24633509|NCT01129739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633511|NCT01129739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24633512|NCT01129739|Immunologic Factors|immunologic factors|mesh-ancestor
24633513|NCT01129739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633514|NCT01129739|Antifungal Agents|antifungal agents|mesh-ancestor
24633515|NCT01129739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24633516|NCT01129739|Dermatologic Agents|dermatologic agents|mesh-ancestor
24633517|NCT01129739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24633518|NCT01129739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24633519|NCT01129830|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24633520|NCT01129830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24633521|NCT01129830|Immunologic Factors|immunologic factors|mesh-ancestor
24633522|NCT01129830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633523|NCT01129856|Dexamethasone|dexamethasone|mesh-list
24633524|NCT01129856|Citric Acid|citric acid|mesh-list
24633535|NCT01129856|Glucocorticoids|glucocorticoids|mesh-ancestor
24633536|NCT01129856|Hormones|hormones|mesh-ancestor
24633537|NCT01129856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24633540|NCT01129856|Anticoagulants|anticoagulants|mesh-ancestor
24633541|NCT01129856|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24633542|NCT01129856|Chelating Agents|chelating agents|mesh-ancestor
24633543|NCT01129856|Sequestering Agents|sequestering agents|mesh-ancestor
24633544|NCT01129856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089614|NCT03264430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089615|NCT03264430|Sensory System Agents|sensory system agents|mesh-ancestor
25089616|NCT03264430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25089617|NCT03264430|Analgesics|analgesics|mesh-ancestor
25089618|NCT03264430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25089619|NCT03264430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25089620|NCT03264430|Anesthetics, General|anesthetics, general|mesh-ancestor
25089621|NCT03264430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25221575|NCT02649504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25221576|NCT02649504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25679753|NCT01842633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221579|NCT02649504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25221580|NCT02649504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25221581|NCT02649504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25221582|NCT02649504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25221583|NCT02649504|Antitubercular Agents|antitubercular agents|mesh-ancestor
25221584|NCT02649504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25221585|NCT02649504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25221586|NCT02649504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25221587|NCT02649504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833610|NCT02174666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24833611|NCT02174666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24833637|NCT02174887|Mitosis Modulators|mitosis modulators|mesh-ancestor
24833638|NCT02174887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833639|NCT02174887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24833640|NCT02174887|Antimetabolites|antimetabolites|mesh-ancestor
24833641|NCT02174887|Antiviral Agents|antiviral agents|mesh-ancestor
24833642|NCT02174887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24833643|NCT02174887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24833644|NCT02174887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24833645|NCT02174887|Immunologic Factors|immunologic factors|mesh-ancestor
24833664|NCT02174939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833665|NCT02174939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24833666|NCT02174939|Vasodilator Agents|vasodilator agents|mesh-ancestor
24833667|NCT02174939|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24833668|NCT02174939|Protective Agents|protective agents|mesh-ancestor
24833669|NCT02174939|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24833670|NCT02174939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24833676|NCT02175017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833677|NCT02175056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24833678|NCT02175056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24833680|NCT02175069|Anesthetics, Local|anesthetics, local|mesh-ancestor
24833681|NCT02175069|Anesthetics|anesthetics|mesh-ancestor
24833682|NCT02175069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24833683|NCT02175069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833684|NCT02175069|Sensory System Agents|sensory system agents|mesh-ancestor
24833685|NCT02175069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24833686|NCT02175342|Tiotropium Bromide|tiotropium bromide|mesh-list
24833687|NCT02175342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25089622|NCT03264430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25089623|NCT03264430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25089624|NCT03264430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089625|NCT03264118|Tolonium Chloride|tolonium chloride|mesh-list
24633545|NCT01129934|Promethazine|promethazine|mesh-list
24633546|NCT01129934|Diphenhydramine|diphenhydramine|mesh-list
24633547|NCT01129934|Morphine|morphine|mesh-list
25221588|NCT02649478|Fluticasone|fluticasone|mesh-list
25221589|NCT02649478|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25221590|NCT02649478|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25221591|NCT02649478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25221592|NCT02649478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25221593|NCT02649478|Autonomic Agents|autonomic agents|mesh-ancestor
25221599|NCT02649478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25221600|NCT02649478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25221601|NCT02649478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25221602|NCT02649478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25221603|NCT02649478|Adrenergic Agents|adrenergic agents|mesh-ancestor
25221604|NCT02649478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25221605|NCT02649478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221606|NCT02649478|Glucocorticoids|glucocorticoids|mesh-ancestor
25221607|NCT02649478|Hormones|hormones|mesh-ancestor
25221608|NCT02649478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25221609|NCT02649478|Sympathomimetics|sympathomimetics|mesh-ancestor
25221610|NCT02649465|Glimepiride|glimepiride|mesh-list
25221611|NCT02649465|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
25221612|NCT02649465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25221613|NCT02649465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25221614|NCT02649465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221615|NCT02649465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24833694|NCT02175342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24833695|NCT02175342|Cholinergic Agents|cholinergic agents|mesh-ancestor
24833696|NCT02175342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24833697|NCT02175342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833698|NCT02175355|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24833700|NCT02175355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24833701|NCT02175355|Diuretics|diuretics|mesh-ancestor
24633548|NCT01129934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24633549|NCT01129934|Narcotics|narcotics|mesh-ancestor
24633550|NCT01129934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24633551|NCT01129934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633552|NCT01129934|Analgesics|analgesics|mesh-ancestor
24633553|NCT01129934|Sensory System Agents|sensory system agents|mesh-ancestor
24633587|NCT01130194|Procarbazine|procarbazine|mesh-list
24633588|NCT01130194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633589|NCT01130246|Varespladib methyl|varespladib methyl|mesh-list
24633590|NCT01130246|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
24633600|NCT01130298|Hormones|hormones|mesh-ancestor
24633601|NCT01130298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24633602|NCT01130298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633603|NCT01130311|Vitamin D|vitamin d|mesh-list
24633604|NCT01130311|Cholecalciferol|cholecalciferol|mesh-list
24633605|NCT01130311|Vitamins|vitamins|mesh-ancestor
24633606|NCT01130311|Micronutrients|micronutrients|mesh-ancestor
24633607|NCT01130311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633608|NCT01130311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24633609|NCT01130311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24633610|NCT01130324|Telavancin|telavancin|mesh-list
25089626|NCT03264118|Hemostatics|hemostatics|mesh-ancestor
25089627|NCT03264118|Coagulants|coagulants|mesh-ancestor
25089628|NCT03264118|Heparin Antagonists|heparin antagonists|mesh-ancestor
25089629|NCT03264118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089630|NCT03264274|Aflibercept|aflibercept|mesh-list
25089631|NCT03264274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25089632|NCT03264274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25221623|NCT02649179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221624|NCT02649179|Sensory System Agents|sensory system agents|mesh-ancestor
25221625|NCT02649179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25221627|NCT02649335|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25221628|NCT02649335|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25221629|NCT02649335|Adrenergic Agents|adrenergic agents|mesh-ancestor
25221630|NCT02649335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24833703|NCT02175355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833704|NCT02175355|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24833705|NCT02175355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24833706|NCT02175355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833722|NCT02175394|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
24833723|NCT02175394|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
24833724|NCT02175394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25054250|NCT03530488|Lidocaine|lidocaine|mesh-list
25089636|NCT03264274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25089637|NCT03264079|Itraconazole|itraconazole|mesh-list
25089638|NCT03264079|Antifungal Agents|antifungal agents|mesh-ancestor
24633611|NCT01130324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25679754|NCT01842633|Antipyretics|antipyretics|mesh-ancestor
25679755|NCT01842633|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25679756|NCT01842633|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24633612|NCT01130324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25679757|NCT01842633|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25679758|NCT01842633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25013325|NCT03006068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657678|NCT01268904|GABA Agents|gaba agents|mesh-ancestor
24657679|NCT01268904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24633613|NCT01130376|Aldesleukin|aldesleukin|mesh-list
24633614|NCT01130376|Interleukin-2|interleukin-2|mesh-list
24633615|NCT01130376|Hormones|hormones|mesh-list
24633616|NCT01130376|Sargramostim|sargramostim|mesh-list
24633617|NCT01130376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24633618|NCT01130376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633619|NCT01130376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633620|NCT01130376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24633621|NCT01130376|Analgesics|analgesics|mesh-ancestor
24633622|NCT01130376|Sensory System Agents|sensory system agents|mesh-ancestor
24633623|NCT01130376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24633634|NCT01130467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24633635|NCT01130467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24633636|NCT01130467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633637|NCT01130467|Dopamine Agents|dopamine agents|mesh-ancestor
24633650|NCT01130506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24633652|NCT01130506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633653|NCT01130506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633679|NCT01130688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633680|NCT01130688|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24633682|NCT01130688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24633683|NCT01130701|Capecitabine|capecitabine|mesh-list
24633684|NCT01130701|Panitumumab|panitumumab|mesh-list
24633685|NCT01130701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24633686|NCT01130701|Antimetabolites|antimetabolites|mesh-ancestor
25089639|NCT03264079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25089640|NCT03264079|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25089641|NCT03264079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25089642|NCT03264079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25089643|NCT03264079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089644|NCT03264079|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25089645|NCT03264079|Hormone Antagonists|hormone antagonists|mesh-ancestor
25089646|NCT03264079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25221657|NCT02648958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25089648|NCT03264079|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25089649|NCT03263741|Paclitaxel|paclitaxel|mesh-list
25089650|NCT03263741|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25089651|NCT03263741|Oxaliplatin|oxaliplatin|mesh-list
25221631|NCT02649335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221632|NCT02649335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221633|NCT02649335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25221634|NCT02649335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25221635|NCT02649335|Vasodilator Agents|vasodilator agents|mesh-ancestor
25221636|NCT02649413|Prednisone|prednisone|mesh-list
25221637|NCT02649413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25221638|NCT02649413|Glucocorticoids|glucocorticoids|mesh-ancestor
25221639|NCT02649413|Hormones|hormones|mesh-ancestor
25221640|NCT02649413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24833725|NCT02175394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405280|NCT03615105|Clofarabine|clofarabine|mesh-list
25679759|NCT01842633|Purinergic Agents|purinergic agents|mesh-ancestor
25679760|NCT01842633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25679761|NCT01843023|Naltrexone|naltrexone|mesh-list
25679762|NCT01843023|Buprenorphine|buprenorphine|mesh-list
25679763|NCT01843023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25679764|NCT01843023|Narcotics|narcotics|mesh-ancestor
25679765|NCT01843023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25679766|NCT01843023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679767|NCT01843023|Analgesics|analgesics|mesh-ancestor
25679768|NCT01843023|Sensory System Agents|sensory system agents|mesh-ancestor
24833729|NCT02175394|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24833731|NCT02175394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25089652|NCT03263741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25089653|NCT03263741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25089654|NCT03263741|Tubulin Modulators|tubulin modulators|mesh-ancestor
24633687|NCT01130701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633688|NCT01130701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633689|NCT01130701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25221641|NCT02649413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221642|NCT02649413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25221643|NCT02649413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221644|NCT02649140|Acetic Acid|acetic acid|mesh-list
25221645|NCT02649140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25221646|NCT02649140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25221647|NCT02648958|Dexmedetomidine|dexmedetomidine|mesh-list
25221648|NCT02648958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25221649|NCT02648958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25221650|NCT02648958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221651|NCT02648958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25221652|NCT02648958|Analgesics|analgesics|mesh-ancestor
25221653|NCT02648958|Sensory System Agents|sensory system agents|mesh-ancestor
25221654|NCT02648958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25221655|NCT02648958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25221656|NCT02648958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24468150|NCT00380224|Olanzapine|olanzapine|mesh-list
25679769|NCT01843023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25679770|NCT01843023|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25679771|NCT01843023|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25679772|NCT01843205|Methamphetamine|methamphetamine|mesh-list
25679773|NCT01843205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25679774|NCT01843205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679775|NCT01843205|Sympathomimetics|sympathomimetics|mesh-ancestor
25679776|NCT01843205|Autonomic Agents|autonomic agents|mesh-ancestor
24657916|NCT01269528|Respiratory System Agents|respiratory system agents|mesh-ancestor
24657917|NCT01269528|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24657919|NCT01269528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657920|NCT01269528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24657926|NCT01269528|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24657927|NCT01269528|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
24657928|NCT01269528|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24658006|NCT01269853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24833764|NCT02175446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24833765|NCT02175446|Growth Substances|growth substances|mesh-ancestor
25089671|NCT03263689|Narcotics|narcotics|mesh-ancestor
24833766|NCT02175446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833768|NCT02175485|Fexofenadine|fexofenadine|mesh-list
24833769|NCT02175485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24833770|NCT02175485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24833771|NCT02175485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24833772|NCT02175485|Histamine Antagonists|histamine antagonists|mesh-ancestor
24833773|NCT02175485|Histamine Agents|histamine agents|mesh-ancestor
24591996|NCT00920088|Ritonavir|ritonavir|mesh-list
24833774|NCT02175485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24833775|NCT02175485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833776|NCT02175485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833777|NCT02175589|Colchicine|colchicine|mesh-list
24833778|NCT02175589|Gout Suppressants|gout suppressants|mesh-ancestor
24833779|NCT02175589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24633690|NCT01130753|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24633691|NCT01130753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633692|NCT01130753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24633693|NCT01130753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633694|NCT01130753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633695|NCT01130779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24633696|NCT01130779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633697|NCT01130779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24633698|NCT01130779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633699|NCT01130779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633701|NCT01130805|Oxaliplatin|oxaliplatin|mesh-list
24633722|NCT01130922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24633723|NCT01130922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24633724|NCT01130922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24633725|NCT01130922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24633726|NCT01130922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633727|NCT01130922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089655|NCT03263741|Antimitotic Agents|antimitotic agents|mesh-ancestor
25089656|NCT03263741|Mitosis Modulators|mitosis modulators|mesh-ancestor
25089657|NCT03263741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089659|NCT03263962|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25089660|NCT03263962|Hormone Antagonists|hormone antagonists|mesh-ancestor
25089661|NCT03263962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25221664|NCT02649075|Immunoglobulins|immunoglobulins|mesh-list
25221665|NCT02649075|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25221666|NCT02649075|Antibodies|antibodies|mesh-list
25221667|NCT02649075|Immunologic Factors|immunologic factors|mesh-ancestor
25221668|NCT02649075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221669|NCT02648906|Choline|choline|mesh-list
25221670|NCT02648906|Lipotropic Agents|lipotropic agents|mesh-ancestor
25221671|NCT02648906|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25221672|NCT02648906|Antimetabolites|antimetabolites|mesh-ancestor
25221673|NCT02648906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221674|NCT02648906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25221675|NCT02648906|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25221676|NCT02648906|Nootropic Agents|nootropic agents|mesh-ancestor
25221683|NCT02649101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25221684|NCT02649101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25679777|NCT01843205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25679778|NCT01843205|Dopamine Agents|dopamine agents|mesh-ancestor
25679779|NCT01843205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25679780|NCT01843205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679781|NCT01843205|Adrenergic Agents|adrenergic agents|mesh-ancestor
25679782|NCT01843205|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25679783|NCT01843205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25679784|NCT01843205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25221685|NCT02649101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25221686|NCT02649101|Growth Substances|growth substances|mesh-ancestor
25221687|NCT02649101|Growth Inhibitors|growth inhibitors|mesh-ancestor
24833781|NCT02175589|Antimitotic Agents|antimitotic agents|mesh-ancestor
24833782|NCT02175589|Mitosis Modulators|mitosis modulators|mesh-ancestor
24833785|NCT02175602|Citalopram|citalopram|mesh-list
24833804|NCT02175680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24833805|NCT02175784|Ipragliflozin|ipragliflozin|mesh-list
24833806|NCT02175784|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24833807|NCT02175784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937526|NCT04027972|Neostigmine|neostigmine|mesh-list
25089662|NCT03263962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089663|NCT03263962|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25089664|NCT03263962|Diuretics|diuretics|mesh-ancestor
25089665|NCT03263962|Natriuretic Agents|natriuretic agents|mesh-ancestor
25089666|NCT03263871|Micronutrients|micronutrients|mesh-list
25089667|NCT03263871|Trace Elements|trace elements|mesh-list
25089668|NCT03263871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089669|NCT03263689|Morphine|morphine|mesh-list
25089670|NCT03263689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25089672|NCT03263689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25089673|NCT03263689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089674|NCT03263689|Analgesics|analgesics|mesh-ancestor
24456765|NCT00332176|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24633728|NCT01130922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633729|NCT01130922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24633730|NCT01130922|Contraceptive Agents|contraceptive agents|mesh-ancestor
24765710|NCT01790022|Prednisolone|prednisolone|mesh-list
25089682|NCT03263650|Carboplatin|carboplatin|mesh-list
25089683|NCT03263650|Olaparib|olaparib|mesh-list
25089684|NCT03263650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25089685|NCT03263650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25089686|NCT03263650|Glucocorticoids|glucocorticoids|mesh-ancestor
25089687|NCT03263650|Hormones|hormones|mesh-ancestor
25089688|NCT03263650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25089689|NCT03263650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089690|NCT03263650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25089691|NCT03263650|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25089692|NCT03263650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25089693|NCT03263650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089694|NCT03263624|Tazarotene|tazarotene|mesh-list
25089695|NCT03263624|Dermatologic Agents|dermatologic agents|mesh-ancestor
25089696|NCT03263624|Keratolytic Agents|keratolytic agents|mesh-ancestor
25089697|NCT03263390|Anti-Obesity Agents|anti-obesity agents|mesh-list
25089703|NCT03263299|Aspirin|aspirin|mesh-list
25089704|NCT03263299|Cabergoline|cabergoline|mesh-list
24394718|NCT00134030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24394719|NCT00134030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24394720|NCT00134030|Immunologic Factors|immunologic factors|mesh-ancestor
24394721|NCT00134030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25221688|NCT02649101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221689|NCT02648776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25221690|NCT02648776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25679785|NCT01843205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25679786|NCT01843348|Cyclosporine|cyclosporine|mesh-list
25679787|NCT01843348|Mycophenolic Acid|mycophenolic acid|mesh-list
25679788|NCT01843348|Everolimus|everolimus|mesh-list
25679789|NCT01843348|Tacrolimus|tacrolimus|mesh-list
25221691|NCT02648776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221693|NCT02648425|Cisplatin|cisplatin|mesh-list
25221694|NCT02648425|Fluorouracil|fluorouracil|mesh-list
25221695|NCT02648425|Capecitabine|capecitabine|mesh-list
25221696|NCT02648425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24833808|NCT02175784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24833809|NCT02175784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833811|NCT02175888|Trace Elements|trace elements|mesh-ancestor
24833812|NCT02175888|Micronutrients|micronutrients|mesh-ancestor
24833813|NCT02175888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833814|NCT02175901|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24833815|NCT02175901|Amoxicillin|amoxicillin|mesh-list
24833816|NCT02175901|Metronidazole|metronidazole|mesh-list
24833817|NCT02175901|Clarithromycin|clarithromycin|mesh-list
24833818|NCT02175901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24833819|NCT02175901|Potassium Citrate|potassium citrate|mesh-list
24833820|NCT02175901|Lansoprazole|lansoprazole|mesh-list
24833822|NCT02175901|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25089709|NCT03263299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25089710|NCT03263299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089711|NCT03263299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25089712|NCT03263299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25089713|NCT03263299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25089714|NCT03263299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25089715|NCT03263299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089716|NCT03263299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25089717|NCT03263299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25089719|NCT03263299|Antipyretics|antipyretics|mesh-ancestor
25089720|NCT03263299|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25089721|NCT03263299|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25089722|NCT03263299|Dopamine Agonists|dopamine agonists|mesh-ancestor
25089723|NCT03263299|Dopamine Agents|dopamine agents|mesh-ancestor
25089724|NCT03263299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25089725|NCT03263533|Vorinostat|vorinostat|mesh-list
24394755|NCT00134095|Antimetabolites|antimetabolites|mesh-ancestor
24394756|NCT00134147|Insulin|insulin|mesh-list
24394757|NCT00134147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24394758|NCT00134147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394759|NCT00134160|Amlodipine|amlodipine|mesh-list
24394760|NCT00134160|Olmesartan|olmesartan|mesh-list
24394792|NCT00134212|Dopexamine|dopexamine|mesh-list
24394793|NCT00134212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24394794|NCT00134212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24394795|NCT00134212|Adrenergic Agents|adrenergic agents|mesh-ancestor
24394796|NCT00134212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24394797|NCT00134212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394798|NCT00134212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394799|NCT00134212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24394800|NCT00134212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24394801|NCT00134212|Autonomic Agents|autonomic agents|mesh-ancestor
24394802|NCT00134212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24394803|NCT00134212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24394804|NCT00134212|Respiratory System Agents|respiratory system agents|mesh-ancestor
24394805|NCT00134212|Mydriatics|mydriatics|mesh-ancestor
24394806|NCT00134212|Sympathomimetics|sympathomimetics|mesh-ancestor
24394807|NCT00134212|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24394808|NCT00134212|Vasodilator Agents|vasodilator agents|mesh-ancestor
24394809|NCT00134212|Dopamine Agonists|dopamine agonists|mesh-ancestor
24394831|NCT00134368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24394832|NCT00134368|Immunologic Factors|immunologic factors|mesh-ancestor
24394833|NCT00134394|Etanercept|etanercept|mesh-list
24394834|NCT00134394|Tacrolimus|tacrolimus|mesh-list
25221697|NCT02648425|Antimetabolites|antimetabolites|mesh-ancestor
25221698|NCT02648425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221699|NCT02648425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25221700|NCT02648425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25221701|NCT02648425|Immunologic Factors|immunologic factors|mesh-ancestor
25221702|NCT02648425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221703|NCT02648425|Antidotes|antidotes|mesh-ancestor
25221704|NCT02648425|Protective Agents|protective agents|mesh-ancestor
25221705|NCT02648425|Vitamin B Complex|vitamin b complex|mesh-ancestor
25221706|NCT02648425|Vitamins|vitamins|mesh-ancestor
25221707|NCT02648425|Micronutrients|micronutrients|mesh-ancestor
25221708|NCT02648711|Leucovorin|leucovorin|mesh-list
25221709|NCT02648711|Bevacizumab|bevacizumab|mesh-list
25221711|NCT02648711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24394835|NCT00134394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24394836|NCT00134394|Immunologic Factors|immunologic factors|mesh-ancestor
25089726|NCT03263533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25089727|NCT03263533|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25089728|NCT03263533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394842|NCT00134394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24394843|NCT00134394|Analgesics|analgesics|mesh-ancestor
24394844|NCT00134394|Sensory System Agents|sensory system agents|mesh-ancestor
24394851|NCT00134420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394852|NCT00134420|Mitosis Modulators|mitosis modulators|mesh-ancestor
24394931|NCT00134680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394932|NCT00134680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24394933|NCT00134680|Hormone Antagonists|hormone antagonists|mesh-ancestor
24394934|NCT00134680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24394935|NCT00134680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394936|NCT00134693|Prednisolone|prednisolone|mesh-list
25221713|NCT02648711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25221714|NCT02648711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25221715|NCT02648711|Growth Substances|growth substances|mesh-ancestor
25221716|NCT02648711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221717|NCT02648711|Growth Inhibitors|growth inhibitors|mesh-ancestor
25221718|NCT02648711|Antidotes|antidotes|mesh-ancestor
25221719|NCT02648711|Protective Agents|protective agents|mesh-ancestor
25221720|NCT02648711|Vitamin B Complex|vitamin b complex|mesh-ancestor
25221721|NCT02648711|Vitamins|vitamins|mesh-ancestor
25221722|NCT02648711|Micronutrients|micronutrients|mesh-ancestor
25221723|NCT02648464|Hydroxychloroquine|hydroxychloroquine|mesh-list
25221724|NCT02648464|Antimalarials|antimalarials|mesh-ancestor
25221725|NCT02648464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25221726|NCT02648464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25221727|NCT02648464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25221728|NCT02648464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25221729|NCT02648464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221730|NCT02648464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25679790|NCT01843348|Cyclosporins|cyclosporins|mesh-list
25679791|NCT01843348|Basiliximab|basiliximab|mesh-list
25679792|NCT01843348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25679793|NCT01843348|Immunologic Factors|immunologic factors|mesh-ancestor
25679794|NCT01843348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679795|NCT01843348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25679796|NCT01843348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25221731|NCT02648503|Atropine|atropine|mesh-list
25679797|NCT01843348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679798|NCT01843348|Antifungal Agents|antifungal agents|mesh-ancestor
25221733|NCT02648503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25221734|NCT02648503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25221735|NCT02648503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25221736|NCT02648503|Autonomic Agents|autonomic agents|mesh-ancestor
25221737|NCT02648503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25221738|NCT02648503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833854|NCT02175927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24833855|NCT02175927|Potassium Citrate|potassium citrate|mesh-list
24833856|NCT02175927|Lansoprazole|lansoprazole|mesh-list
24833881|NCT02176057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24833882|NCT02176122|Meropenem|meropenem|mesh-list
24833902|NCT02176187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833903|NCT02176187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24833904|NCT02176187|Respiratory System Agents|respiratory system agents|mesh-ancestor
24833905|NCT02176187|Sympathomimetics|sympathomimetics|mesh-ancestor
24833906|NCT02176187|Tocolytic Agents|tocolytic agents|mesh-ancestor
24833907|NCT02176187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24833908|NCT02176187|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24833909|NCT02176187|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24833910|NCT02176187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24394937|NCT00134693|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24394938|NCT00134693|Methylprednisolone|methylprednisolone|mesh-list
24394939|NCT00134693|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24394940|NCT00134693|Prednisolone acetate|prednisolone acetate|mesh-list
24394941|NCT00134693|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24394942|NCT00134693|Prednisolone phosphate|prednisolone phosphate|mesh-list
24394944|NCT00134693|Glucocorticoids|glucocorticoids|mesh-ancestor
24394962|NCT00134706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394965|NCT00134745|Hormones|hormones|mesh-ancestor
24394966|NCT00134745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24394967|NCT00134745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395033|NCT00134966|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24395034|NCT00134979|Formoterol Fumarate|formoterol fumarate|mesh-list
24395035|NCT00134979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24395036|NCT00134979|Autonomic Agents|autonomic agents|mesh-ancestor
24395037|NCT00134979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24395038|NCT00134979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395039|NCT00134979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24395040|NCT00134979|Respiratory System Agents|respiratory system agents|mesh-ancestor
24395041|NCT00134979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24395042|NCT00134979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24395043|NCT00134979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24395044|NCT00134979|Adrenergic Agents|adrenergic agents|mesh-ancestor
24395045|NCT00134979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24395046|NCT00134979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395047|NCT00134992|Prednisolone|prednisolone|mesh-list
24395048|NCT00134992|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24395109|NCT00135122|Prednisolone phosphate|prednisolone phosphate|mesh-list
24395110|NCT00135122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24395111|NCT00135122|Glucocorticoids|glucocorticoids|mesh-ancestor
25221739|NCT02648503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25221740|NCT02648503|Respiratory System Agents|respiratory system agents|mesh-ancestor
25221741|NCT02648503|Mydriatics|mydriatics|mesh-ancestor
25221742|NCT02648503|Parasympatholytics|parasympatholytics|mesh-ancestor
25221743|NCT02648503|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25221744|NCT02648503|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25221745|NCT02648503|Cholinergic Agents|cholinergic agents|mesh-ancestor
25221746|NCT02648503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25221747|NCT02648503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221748|NCT02648503|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25221749|NCT02648503|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25221750|NCT02648503|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25679799|NCT01843348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25679800|NCT01843348|Dermatologic Agents|dermatologic agents|mesh-ancestor
25679801|NCT01843348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25679802|NCT01843348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221756|NCT02648490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25221757|NCT02648490|Antiemetics|antiemetics|mesh-ancestor
25221758|NCT02648490|Autonomic Agents|autonomic agents|mesh-ancestor
25221759|NCT02648490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25221760|NCT02648490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833911|NCT02176187|Adrenergic Agents|adrenergic agents|mesh-ancestor
24833912|NCT02176187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25274855|NCT02375100|Antipyretics|antipyretics|mesh-ancestor
24833913|NCT02176187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833914|NCT02176187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24833915|NCT02176187|Cholinergic Agents|cholinergic agents|mesh-ancestor
24833917|NCT02176200|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
24833918|NCT02176200|Ipratropium|ipratropium|mesh-list
24833919|NCT02176200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24833920|NCT02176200|Autonomic Agents|autonomic agents|mesh-ancestor
24833921|NCT02176200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24592146|NCT00920413|Ascorbic Acid|ascorbic acid|mesh-list
24833922|NCT02176200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833923|NCT02176200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24833924|NCT02176200|Respiratory System Agents|respiratory system agents|mesh-ancestor
24833926|NCT02176200|Tocolytic Agents|tocolytic agents|mesh-ancestor
24833927|NCT02176200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24833957|NCT02176213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24833958|NCT02176213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24833959|NCT02176213|Growth Substances|growth substances|mesh-ancestor
24833960|NCT02176213|Growth Inhibitors|growth inhibitors|mesh-ancestor
24833961|NCT02176304|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24833962|NCT02176304|Methylprednisolone|methylprednisolone|mesh-list
24833963|NCT02176304|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24833964|NCT02176304|Prednisolone|prednisolone|mesh-list
24833965|NCT02176304|Prednisolone acetate|prednisolone acetate|mesh-list
24833966|NCT02176304|Lidocaine|lidocaine|mesh-list
25054350|NCT03530176|Listerine|listerine|mesh-list
25089739|NCT03263520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25089740|NCT03263520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395161|NCT00135187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24455324|NCT01785459|Bupivacaine|bupivacaine|mesh-list
24455325|NCT01785459|Anesthetics, Local|anesthetics, local|mesh-ancestor
24455326|NCT01785459|Anesthetics|anesthetics|mesh-ancestor
24455327|NCT01785459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24455328|NCT01785459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455329|NCT01785459|Sensory System Agents|sensory system agents|mesh-ancestor
24455340|NCT01785459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455341|NCT01691833|Vitamin D|vitamin d|mesh-list
24395162|NCT00135304|Vitamin D|vitamin d|mesh-list
24395163|NCT00135304|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
24395164|NCT00135304|Cinacalcet|cinacalcet|mesh-list
24395165|NCT00135304|Vitamins|vitamins|mesh-ancestor
24395166|NCT00135304|Micronutrients|micronutrients|mesh-ancestor
24395167|NCT00135304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221761|NCT02648490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25221762|NCT02648490|Glucocorticoids|glucocorticoids|mesh-ancestor
25221763|NCT02648490|Hormones|hormones|mesh-ancestor
25221764|NCT02648490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25221765|NCT02648490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25221766|NCT02648490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221767|NCT02648490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25221768|NCT02648490|Analgesics|analgesics|mesh-ancestor
25221769|NCT02648490|Sensory System Agents|sensory system agents|mesh-ancestor
25221770|NCT02648490|Antipyretics|antipyretics|mesh-ancestor
25221771|NCT02648490|Antipruritics|antipruritics|mesh-ancestor
25221772|NCT02648490|Dermatologic Agents|dermatologic agents|mesh-ancestor
25221773|NCT02648490|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25221774|NCT02648490|Serotonin Agents|serotonin agents|mesh-ancestor
25221775|NCT02648490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25221776|NCT02648490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221777|NCT02648490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25679803|NCT01843348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25221779|NCT02648490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25221780|NCT02648490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25221781|NCT02648490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25221782|NCT02648490|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25221783|NCT02648490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25221784|NCT02648490|Anesthetics, Local|anesthetics, local|mesh-ancestor
25221785|NCT02648490|Anesthetics|anesthetics|mesh-ancestor
25221786|NCT02648490|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25221787|NCT02648490|Histamine Antagonists|histamine antagonists|mesh-ancestor
24833971|NCT02176304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24833972|NCT02176304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833973|NCT02176304|Sensory System Agents|sensory system agents|mesh-ancestor
24833974|NCT02176304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24833975|NCT02176304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24833976|NCT02176304|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24833977|NCT02176304|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25054373|NCT03530085|Antimetabolites|antimetabolites|mesh-ancestor
24395168|NCT00135304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24395169|NCT00135304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24395170|NCT00135304|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24395171|NCT00135304|Hormone Antagonists|hormone antagonists|mesh-ancestor
24395172|NCT00135304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24395173|NCT00135317|Darbepoetin alfa|darbepoetin alfa|mesh-list
24395174|NCT00135317|Hematinics|hematinics|mesh-ancestor
24395175|NCT00135408|Budesonide|budesonide|mesh-list
24395176|NCT00135408|Ipilimumab|ipilimumab|mesh-list
24395177|NCT00135408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25089757|NCT03263208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089758|NCT03263208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25089759|NCT03263208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24539683|NCT00665041|Quinagolide|quinagolide|mesh-list
24395270|NCT00135551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24395271|NCT00135551|Vasodilator Agents|vasodilator agents|mesh-ancestor
24395272|NCT00135577|Alvimopan|alvimopan|mesh-list
24395273|NCT00135577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24395274|NCT00135603|Amoxicillin|amoxicillin|mesh-list
24395275|NCT00135603|Clavulanic Acid|clavulanic acid|mesh-list
25221788|NCT02648490|Histamine Agents|histamine agents|mesh-ancestor
25221789|NCT02648490|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25221790|NCT02648633|Nivolumab|nivolumab|mesh-list
25221791|NCT02648633|Valproic Acid|valproic acid|mesh-list
25221792|NCT02648633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25221793|NCT02648633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221794|NCT02648633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25221795|NCT02648633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221796|NCT02648633|Anticonvulsants|anticonvulsants|mesh-ancestor
25221797|NCT02648633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25221798|NCT02648633|GABA Agents|gaba agents|mesh-ancestor
25221799|NCT02648633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25221832|NCT02648048|Analgesics|analgesics|mesh-ancestor
24834011|NCT02176512|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24834062|NCT02176850|Telmisartan|telmisartan|mesh-list
24834063|NCT02176850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24834064|NCT02176850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24834065|NCT02176850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24834066|NCT02176850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834067|NCT02176876|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24834068|NCT02176876|Immunologic Factors|immunologic factors|mesh-ancestor
24834069|NCT02176876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042832|NCT01361802|Expectorants|expectorants|mesh-ancestor
25042833|NCT01361802|Respiratory System Agents|respiratory system agents|mesh-ancestor
25042834|NCT01360853|Gemcitabine|gemcitabine|mesh-list
25042835|NCT01360853|ON 01910|on 01910|mesh-list
24395276|NCT00135603|Clavulanic Acids|clavulanic acids|mesh-list
24395283|NCT00135668|Nitroprusside|nitroprusside|mesh-list
24395342|NCT00135785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395343|NCT00135785|Dopamine Agents|dopamine agents|mesh-ancestor
24395344|NCT00135785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24395345|NCT00135785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221806|NCT02648659|Metronidazole|metronidazole|mesh-list
25221807|NCT02648659|Clarithromycin|clarithromycin|mesh-list
25221808|NCT02648659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25221809|NCT02648659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25221810|NCT02648659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25221811|NCT02648659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25221812|NCT02648659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25221813|NCT02648659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25221814|NCT02648659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221815|NCT02648659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25221816|NCT02648659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25221817|NCT02648412|Ketamine|ketamine|mesh-list
25221818|NCT02648412|Analgesics|analgesics|mesh-ancestor
25221819|NCT02648412|Sensory System Agents|sensory system agents|mesh-ancestor
25221820|NCT02648412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25221821|NCT02648412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221822|NCT02648412|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25221823|NCT02648412|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25221824|NCT02648412|Anesthetics, General|anesthetics, general|mesh-ancestor
25221825|NCT02648412|Anesthetics|anesthetics|mesh-ancestor
25221826|NCT02648412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25221827|NCT02648412|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25221828|NCT02648412|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25221829|NCT02648412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25221830|NCT02648412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221831|NCT02648048|Pirfenidone|pirfenidone|mesh-list
24395346|NCT00135785|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24395347|NCT00135785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24395348|NCT00135785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395349|NCT00135811|Cyclosporine|cyclosporine|mesh-list
24395350|NCT00135811|Dexamethasone|dexamethasone|mesh-list
24395351|NCT00135811|Cyclosporins|cyclosporins|mesh-list
24395352|NCT00135811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24395353|NCT00135811|Antiemetics|antiemetics|mesh-ancestor
24395354|NCT00135811|Autonomic Agents|autonomic agents|mesh-ancestor
24395355|NCT00135811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24395356|NCT00135811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395357|NCT00135811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24395358|NCT00135811|Glucocorticoids|glucocorticoids|mesh-ancestor
24395359|NCT00135811|Hormones|hormones|mesh-ancestor
24395360|NCT00135811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24395361|NCT00135811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24395370|NCT00135811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24395371|NCT00135811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24395372|NCT00135824|Povidone|povidone|mesh-list
24395373|NCT00135824|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24395374|NCT00135824|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24395375|NCT00135824|Plasma Substitutes|plasma substitutes|mesh-ancestor
24395376|NCT00135824|Blood Substitutes|blood substitutes|mesh-ancestor
24395377|NCT00135837|Verteporfin|verteporfin|mesh-list
24395378|NCT00135837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24444128|NCT00296777|Imipramine|imipramine|mesh-list
25089760|NCT03263208|Alkylating Agents|alkylating agents|mesh-ancestor
25089761|NCT03263208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089762|NCT03263208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25089763|NCT03263208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25089764|NCT03262857|Lidocaine|lidocaine|mesh-list
25089765|NCT03262857|Magnesium Sulfate|magnesium sulfate|mesh-list
24395399|NCT00135902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24395400|NCT00135902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395401|NCT00135902|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24395402|NCT00135902|Hormone Antagonists|hormone antagonists|mesh-ancestor
24395413|NCT00135954|Prednisolone|prednisolone|mesh-list
24395414|NCT00135954|Cyclophosphamide|cyclophosphamide|mesh-list
24395415|NCT00135954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24395416|NCT00135954|Immunologic Factors|immunologic factors|mesh-ancestor
24395417|NCT00135954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395418|NCT00135954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24395419|NCT00135954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24395420|NCT00135954|Alkylating Agents|alkylating agents|mesh-ancestor
24395482|NCT00136110|GABA Agents|gaba agents|mesh-ancestor
24395483|NCT00136110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25221836|NCT02648048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24660025|NCT01281553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660026|NCT01281566|Cisapride|cisapride|mesh-list
24660027|NCT01281566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24660030|NCT01281566|Serotonin Agents|serotonin agents|mesh-ancestor
25221837|NCT02648048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25221838|NCT02648048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25221839|NCT02648048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25221840|NCT02648048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221841|NCT02647892|Lidocaine|lidocaine|mesh-list
25221842|NCT02647892|Anesthetics, Local|anesthetics, local|mesh-ancestor
25221843|NCT02647892|Anesthetics|anesthetics|mesh-ancestor
25221844|NCT02647892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25221845|NCT02647892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834091|NCT02177253|Albuterol|albuterol|mesh-list
24834092|NCT02177253|Ipratropium|ipratropium|mesh-list
24795713|NCT01042379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24834094|NCT02177253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24834095|NCT02177253|Autonomic Agents|autonomic agents|mesh-ancestor
24834096|NCT02177253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834097|NCT02177253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834098|NCT02177253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24834099|NCT02177253|Respiratory System Agents|respiratory system agents|mesh-ancestor
24834100|NCT02177253|Tocolytic Agents|tocolytic agents|mesh-ancestor
24834101|NCT02177253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24834102|NCT02177253|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24834103|NCT02177253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24834104|NCT02177253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24395484|NCT00136110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395485|NCT00136110|Antimanic Agents|antimanic agents|mesh-ancestor
24395486|NCT00136110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24395487|NCT00136110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24395488|NCT00136110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24395506|NCT00136188|Folic Acid|folic acid|mesh-list
24395558|NCT00136383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24395559|NCT00136383|Antidepressive Agents|antidepressive agents|mesh-ancestor
24395560|NCT00136383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24395561|NCT00136383|Dopamine Agents|dopamine agents|mesh-ancestor
24395562|NCT00136383|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24395563|NCT00136383|Serotonin Agents|serotonin agents|mesh-ancestor
24395564|NCT00136383|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24395565|NCT00136383|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24395566|NCT00136383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24395567|NCT00136383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395568|NCT00136396|Rituximab|rituximab|mesh-list
25089770|NCT03262857|Sensory System Agents|sensory system agents|mesh-ancestor
25089771|NCT03262857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25089772|NCT03262857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25089773|NCT03262857|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25089774|NCT03262857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25089775|NCT03262857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25089776|NCT03262857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395669|NCT00136565|Immunologic Factors|immunologic factors|mesh-ancestor
24395670|NCT00136565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395671|NCT00136565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24395672|NCT00136565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24395673|NCT00136565|Alkylating Agents|alkylating agents|mesh-ancestor
25221846|NCT02647892|Sensory System Agents|sensory system agents|mesh-ancestor
25221847|NCT02647892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25221848|NCT02647892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25221849|NCT02647892|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25221850|NCT02647892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25221851|NCT02647892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25221852|NCT02647892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221853|NCT02647918|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25221854|NCT02647918|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25221855|NCT02647918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221856|NCT02647918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25679804|NCT01843348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25679805|NCT01843348|Antitubercular Agents|antitubercular agents|mesh-ancestor
25679806|NCT01843348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25679807|NCT01843621|Vaccines|vaccines|mesh-list
25221857|NCT02647918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221858|NCT02647671|Calcium Carbonate|calcium carbonate|mesh-list
25221859|NCT02647671|Calcium|calcium|mesh-list
25221860|NCT02647671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25273106|NCT02387086|Aspirin|aspirin|mesh-list
25273107|NCT02387086|Thalidomide|thalidomide|mesh-list
25273108|NCT02387086|Gefitinib|gefitinib|mesh-list
25273109|NCT02387086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24834105|NCT02177253|Adrenergic Agents|adrenergic agents|mesh-ancestor
24834106|NCT02177253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24834107|NCT02177253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834108|NCT02177253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24834109|NCT02177253|Cholinergic Agents|cholinergic agents|mesh-ancestor
24834110|NCT02177305|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24834111|NCT02177305|Tiotropium Bromide|tiotropium bromide|mesh-list
24468450|NCT00381589|Ipratropium|ipratropium|mesh-list
24834180|NCT02177370|Adrenergic Agents|adrenergic agents|mesh-ancestor
24834181|NCT02177370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24834779|NCT02181023|Anticonvulsants|anticonvulsants|mesh-ancestor
24834184|NCT02177396|Telmisartan|telmisartan|mesh-list
24834185|NCT02177396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24395674|NCT00136565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395682|NCT00136565|Glucocorticoids|glucocorticoids|mesh-ancestor
24395722|NCT00136747|Antidepressive Agents|antidepressive agents|mesh-ancestor
24395723|NCT00136747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24395724|NCT00136747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24395725|NCT00136747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24395726|NCT00136747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24395736|NCT00136747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24395738|NCT00136773|Amlodipine|amlodipine|mesh-list
24455344|NCT01691833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455345|NCT01691833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24455346|NCT01640301|Aldesleukin|aldesleukin|mesh-list
24455347|NCT01640301|Cyclophosphamide|cyclophosphamide|mesh-list
24455348|NCT01640301|Fludarabine|fludarabine|mesh-list
24455349|NCT01640301|Fludarabine phosphate|fludarabine phosphate|mesh-list
24455350|NCT01640301|Interleukin-2|interleukin-2|mesh-list
24455351|NCT01640301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24455352|NCT01640301|Immunologic Factors|immunologic factors|mesh-ancestor
24455353|NCT01640301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455354|NCT01640301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24455355|NCT01640301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24455356|NCT01640301|Alkylating Agents|alkylating agents|mesh-ancestor
24455357|NCT01640301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455358|NCT01640301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24455359|NCT01640301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24455360|NCT01640301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24455361|NCT01640301|Antimetabolites|antimetabolites|mesh-ancestor
24455362|NCT01640301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24395786|NCT00136942|Atorvastatin|atorvastatin|mesh-list
24395811|NCT00136981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395816|NCT00136994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24395817|NCT00136994|Serotonin Agents|serotonin agents|mesh-ancestor
25221861|NCT02647671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221862|NCT02647671|Antacids|antacids|mesh-ancestor
25221863|NCT02647671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221864|NCT02647671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25221865|NCT02647567|Caffeine|caffeine|mesh-list
25221866|NCT02647567|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25221867|NCT02647567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221868|NCT02647567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25221869|NCT02647567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25221870|NCT02647567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221871|NCT02647567|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25221872|NCT02647567|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25221873|NCT02647567|Purinergic Agents|purinergic agents|mesh-ancestor
25221874|NCT02647567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24834186|NCT02177396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24834187|NCT02177396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24834188|NCT02177396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834189|NCT02177409|Amlodipine|amlodipine|mesh-list
25679808|NCT01843621|Immunologic Factors|immunologic factors|mesh-ancestor
24395824|NCT00136994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24395825|NCT00136994|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25089777|NCT03262857|Analgesics|analgesics|mesh-ancestor
25089778|NCT03262857|Anticonvulsants|anticonvulsants|mesh-ancestor
25089782|NCT03262857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25089784|NCT03262948|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25089785|NCT03262948|Carboplatin|carboplatin|mesh-list
24395873|NCT00137072|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24395874|NCT00137072|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24395875|NCT00137072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395876|NCT00137072|Urological Agents|urological agents|mesh-ancestor
24395877|NCT00137085|Ketamine|ketamine|mesh-list
24395878|NCT00137085|Analgesics|analgesics|mesh-ancestor
24395898|NCT00137098|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24395899|NCT00137098|Purinergic Agents|purinergic agents|mesh-ancestor
24395900|NCT00137098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24395901|NCT00137202|Diphenhydramine|diphenhydramine|mesh-list
24395902|NCT00137202|Promethazine|promethazine|mesh-list
24395903|NCT00137202|Ondansetron|ondansetron|mesh-list
24395904|NCT00137202|Antiemetics|antiemetics|mesh-ancestor
24395905|NCT00137202|Autonomic Agents|autonomic agents|mesh-ancestor
24395914|NCT00137202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395915|NCT00137202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24395916|NCT00137202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24395917|NCT00137202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24395918|NCT00137202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24395919|NCT00137202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24395920|NCT00137202|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25089797|NCT03263052|Immunologic Factors|immunologic factors|mesh-ancestor
25089798|NCT03263052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089799|NCT03263052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25089800|NCT03263052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25221887|NCT02647515|Ranibizumab|ranibizumab|mesh-list
25221888|NCT02647515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25221889|NCT02647515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25221890|NCT02647515|Growth Substances|growth substances|mesh-ancestor
25221891|NCT02647515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221892|NCT02647515|Growth Inhibitors|growth inhibitors|mesh-ancestor
25221893|NCT02647515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221894|NCT02647424|Letrozole|letrozole|mesh-list
24834293|NCT02177539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24834294|NCT02177539|Adrenergic Agents|adrenergic agents|mesh-ancestor
24834295|NCT02177539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24834296|NCT02177539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834297|NCT02177539|Protective Agents|protective agents|mesh-ancestor
24834298|NCT02177539|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24834299|NCT02177539|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24834302|NCT02177552|Carboplatin|carboplatin|mesh-list
24834303|NCT02177552|Docetaxel|docetaxel|mesh-list
24834304|NCT02177552|Capecitabine|capecitabine|mesh-list
24834305|NCT02177552|Oxaliplatin|oxaliplatin|mesh-list
24834306|NCT02177552|Epirubicin|epirubicin|mesh-list
24834307|NCT02177552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24834308|NCT02177552|Tubulin Modulators|tubulin modulators|mesh-ancestor
24834309|NCT02177552|Antimitotic Agents|antimitotic agents|mesh-ancestor
24834310|NCT02177552|Mitosis Modulators|mitosis modulators|mesh-ancestor
25089801|NCT03263052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089802|NCT03263039|Pembrolizumab|pembrolizumab|mesh-list
25089803|NCT03263039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25089814|NCT03262792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25089815|NCT03262792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25089816|NCT03262792|Analgesics|analgesics|mesh-ancestor
25089817|NCT03262792|Sensory System Agents|sensory system agents|mesh-ancestor
25089818|NCT03262792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25089819|NCT03262792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089820|NCT03262792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25089821|NCT03262792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25089822|NCT03262792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25089823|NCT03262792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25089824|NCT03262792|Antiviral Agents|antiviral agents|mesh-ancestor
25089825|NCT03262792|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25089826|NCT03262545|Apatinib|apatinib|mesh-list
25089827|NCT03262545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25089828|NCT03262545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24765786|NCT01790555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25089829|NCT03262545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539987|NCT00666159|Analgesics|analgesics|mesh-ancestor
24395922|NCT00137202|Anesthetics, Local|anesthetics, local|mesh-ancestor
24395931|NCT00137254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395932|NCT00137345|Sirolimus|sirolimus|mesh-list
25089830|NCT03262545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089831|NCT03262688|Bupivacaine|bupivacaine|mesh-list
25089832|NCT03262688|Anesthetics, Local|anesthetics, local|mesh-ancestor
25089833|NCT03262688|Anesthetics|anesthetics|mesh-ancestor
25089834|NCT03262688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25089835|NCT03262688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089836|NCT03262688|Sensory System Agents|sensory system agents|mesh-ancestor
25089837|NCT03262688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25089839|NCT03262740|Norethindrone|norethindrone|mesh-list
25089840|NCT03262740|Norethindrone Acetate|norethindrone acetate|mesh-list
25089841|NCT03262740|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
25089842|NCT03262740|Estradiol|estradiol|mesh-list
25089843|NCT03262740|Branebrutinib|branebrutinib|mesh-list
25089844|NCT03262740|Estrogens|estrogens|mesh-ancestor
25089845|NCT03262740|Hormones|hormones|mesh-ancestor
25089846|NCT03262740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25089847|NCT03262740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089848|NCT03262740|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25221895|NCT02647424|Clomiphene|clomiphene|mesh-list
25221896|NCT02647424|Enclomiphene|enclomiphene|mesh-list
25221897|NCT02647424|Zuclomiphene|zuclomiphene|mesh-list
25221898|NCT02647424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25221899|NCT02647424|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25221900|NCT02647424|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25221901|NCT02647424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25245804|NCT03697512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25221902|NCT02647424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221903|NCT02647424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25221904|NCT02647424|Hormone Antagonists|hormone antagonists|mesh-ancestor
25221905|NCT02647424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25221906|NCT02647424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221907|NCT02647424|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25221908|NCT02647424|Fertility Agents|fertility agents|mesh-ancestor
25221909|NCT02647424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24834311|NCT02177552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834363|NCT02177955|Antiemetics|antiemetics|mesh-ancestor
24834364|NCT02177955|Autonomic Agents|autonomic agents|mesh-ancestor
24468594|NCT00382356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25042895|NCT01356160|Antimetabolites|antimetabolites|mesh-ancestor
24834391|NCT02178254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24834393|NCT02178293|Ketoprofen lysine|ketoprofen lysine|mesh-list
24834394|NCT02178293|Benzydamine|benzydamine|mesh-list
24834395|NCT02178293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24834396|NCT02178293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24834397|NCT02178293|Analgesics|analgesics|mesh-ancestor
24834398|NCT02178293|Sensory System Agents|sensory system agents|mesh-ancestor
24834399|NCT02178293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834400|NCT02178293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834401|NCT02178293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24660514|NCT01284049|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24660515|NCT01284049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24660517|NCT01284166|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24660518|NCT01284166|Dorzolamide|dorzolamide|mesh-list
24660519|NCT01284166|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24660538|NCT01284309|Mirabegron|mirabegron|mesh-list
24834402|NCT02178293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24834403|NCT02178293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24834404|NCT02178293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24834405|NCT02178293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834406|NCT02178306|Telmisartan|telmisartan|mesh-list
24834407|NCT02178306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25054492|NCT03529331|Morphine|morphine|mesh-list
25089849|NCT03262740|Contraceptive Agents|contraceptive agents|mesh-ancestor
25089850|NCT03262740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25089851|NCT03262740|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25089852|NCT03262740|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25089854|NCT03262740|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25089855|NCT03262740|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24395933|NCT00137345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24395934|NCT00137345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25106279|NCT03573817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395935|NCT00137345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24395995|NCT00137540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
24395996|NCT00137553|Pyrimethamine|pyrimethamine|mesh-list
24395997|NCT00137553|Sulfadoxine|sulfadoxine|mesh-list
24395998|NCT00137553|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24395999|NCT00137553|Antimalarials|antimalarials|mesh-ancestor
24396008|NCT00137566|Acetaminophen|acetaminophen|mesh-list
24396009|NCT00137566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25089856|NCT03262740|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
25089857|NCT03262740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25089858|NCT03262740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25089859|NCT03262740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089860|NCT03262727|BMS-986165|bms-986165|mesh-list
25089861|NCT03262727|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25089862|NCT03262727|Norethindrone|norethindrone|mesh-list
25089863|NCT03262727|Norethindrone Acetate|norethindrone acetate|mesh-list
25089864|NCT03262727|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
25089865|NCT03262727|Estradiol|estradiol|mesh-list
25221910|NCT02647424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25221911|NCT02647424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25221912|NCT02647632|Ribavirin|ribavirin|mesh-list
25221913|NCT02647632|Sofosbuvir|sofosbuvir|mesh-list
25221914|NCT02647632|Grazoprevir|grazoprevir|mesh-list
25221915|NCT02647632|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25221916|NCT02647632|Antimetabolites|antimetabolites|mesh-ancestor
25221917|NCT02647632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221918|NCT02647632|Antiviral Agents|antiviral agents|mesh-ancestor
25221919|NCT02647632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25221920|NCT02647489|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25221921|NCT02647489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25221922|NCT02647489|Immunologic Factors|immunologic factors|mesh-ancestor
25221923|NCT02647489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221924|NCT02647489|Antacids|antacids|mesh-ancestor
25221925|NCT02647489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221926|NCT02647489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25221927|NCT02647554|Urinastatin|urinastatin|mesh-list
25221928|NCT02647554|Trypsin Inhibitors|trypsin inhibitors|mesh-list
25679809|NCT01843621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679810|NCT01843660|Acetaminophen|acetaminophen|mesh-list
25679811|NCT01843660|Tramadol|tramadol|mesh-list
25679812|NCT01843660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25679813|NCT01843660|Analgesics|analgesics|mesh-ancestor
25679814|NCT01843660|Sensory System Agents|sensory system agents|mesh-ancestor
25679815|NCT01843660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25679816|NCT01843660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679817|NCT01843660|Antipyretics|antipyretics|mesh-ancestor
25679818|NCT01843660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25679819|NCT01843660|Narcotics|narcotics|mesh-ancestor
24660712|NCT01285388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24660714|NCT01285388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660715|NCT01285388|Antiviral Agents|antiviral agents|mesh-ancestor
24660716|NCT01285414|Temozolomide|temozolomide|mesh-list
24660721|NCT01285453|Vadimezan|vadimezan|mesh-list
25221929|NCT02647554|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25221930|NCT02647554|Protease Inhibitors|protease inhibitors|mesh-ancestor
25221931|NCT02647554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24834408|NCT02178306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24834409|NCT02178306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24834410|NCT02178306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834411|NCT02178397|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24834412|NCT02178397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24834413|NCT02178397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24834414|NCT02178397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24834415|NCT02178397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834449|NCT02178644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24834450|NCT02178683|Mycophenolic Acid|mycophenolic acid|mesh-list
24834452|NCT02178683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24834560|NCT02179645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24834561|NCT02179645|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24834562|NCT02179645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24834586|NCT02179814|Anesthetics|anesthetics|mesh-ancestor
24834587|NCT02179814|Sensory System Agents|sensory system agents|mesh-ancestor
24834588|NCT02179814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834589|NCT02179814|Antiemetics|antiemetics|mesh-ancestor
24834590|NCT02179814|Autonomic Agents|autonomic agents|mesh-ancestor
24834591|NCT02179814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24834592|NCT02179814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24834593|NCT02179814|Histamine Antagonists|histamine antagonists|mesh-ancestor
24834594|NCT02179814|Histamine Agents|histamine agents|mesh-ancestor
24834623|NCT02180048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24834624|NCT02180048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089866|NCT03262727|Estrogens|estrogens|mesh-ancestor
25089868|NCT03262727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25089869|NCT03262727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089870|NCT03262727|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25089871|NCT03262727|Contraceptive Agents|contraceptive agents|mesh-ancestor
25089872|NCT03262727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24396010|NCT00137566|Analgesics|analgesics|mesh-ancestor
24396011|NCT00137566|Sensory System Agents|sensory system agents|mesh-ancestor
25221932|NCT02647554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221933|NCT02647190|Asparaginase|asparaginase|mesh-list
25221934|NCT02647190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25273110|NCT02387086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25273111|NCT02387086|Analgesics|analgesics|mesh-ancestor
25273112|NCT02387086|Sensory System Agents|sensory system agents|mesh-ancestor
25273113|NCT02387086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25273114|NCT02387086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273115|NCT02387086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25273116|NCT02387086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25273117|NCT02387086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25405281|NCT03615105|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25679820|NCT01843660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25679821|NCT01843751|Buprenorphine|buprenorphine|mesh-list
25679822|NCT01843751|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25679823|NCT01843751|Naloxone|naloxone|mesh-list
25679824|NCT01843751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25679825|NCT01843751|Narcotics|narcotics|mesh-ancestor
25679826|NCT01843751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25679827|NCT01843751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679828|NCT01843751|Analgesics|analgesics|mesh-ancestor
25679829|NCT01843751|Sensory System Agents|sensory system agents|mesh-ancestor
25273121|NCT02387086|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25273122|NCT02387086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273123|NCT02387086|Antipyretics|antipyretics|mesh-ancestor
25273124|NCT02387086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25273125|NCT02387086|Immunologic Factors|immunologic factors|mesh-ancestor
25273126|NCT02387086|Leprostatic Agents|leprostatic agents|mesh-ancestor
25273127|NCT02387086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25273128|NCT02387086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25273129|NCT02387086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25273130|NCT02387086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25273131|NCT02387086|Growth Substances|growth substances|mesh-ancestor
25273132|NCT02387086|Growth Inhibitors|growth inhibitors|mesh-ancestor
25273133|NCT02387086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25273134|NCT02387086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25273135|NCT02387138|Oxaliplatin|oxaliplatin|mesh-list
25273136|NCT02387138|Irinotecan|irinotecan|mesh-list
25273138|NCT02387138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24834625|NCT02180048|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24834626|NCT02180048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24834627|NCT02180048|Purinergic Agents|purinergic agents|mesh-ancestor
24834628|NCT02180048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24834629|NCT02180087|Ketoprofen|ketoprofen|mesh-list
24452315|NCT00327119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468900|NCT00383877|Insulin|insulin|mesh-list
24834716|NCT02180529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24834717|NCT02180529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834740|NCT02180789|Adrenergic Agents|adrenergic agents|mesh-ancestor
24468997|NCT00384280|Rifampin|rifampin|mesh-list
24834766|NCT02180997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24834767|NCT02180997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24834768|NCT02180997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24834769|NCT02180997|Adrenergic Agents|adrenergic agents|mesh-ancestor
24834770|NCT02180997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24834771|NCT02180997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834772|NCT02180997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834773|NCT02180997|Urological Agents|urological agents|mesh-ancestor
24834774|NCT02180997|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24834775|NCT02180997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24834776|NCT02180997|Cholinergic Agents|cholinergic agents|mesh-ancestor
24834777|NCT02181023|Glycopyrrolate|glycopyrrolate|mesh-list
24834784|NCT02181023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25054543|NCT03529175|Gemcitabine|gemcitabine|mesh-list
24396090|NCT00137787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24396091|NCT00137787|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24396092|NCT00137787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24396093|NCT00137787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25221935|NCT02647255|Methylprednisolone|methylprednisolone|mesh-list
25221936|NCT02647255|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25221937|NCT02647255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25221938|NCT02647255|Prednisolone|prednisolone|mesh-list
25221939|NCT02647255|Prednisolone acetate|prednisolone acetate|mesh-list
25221940|NCT02647255|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25221941|NCT02647255|Prednisolone phosphate|prednisolone phosphate|mesh-list
25221942|NCT02647255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25221943|NCT02647255|Antiemetics|antiemetics|mesh-ancestor
25221944|NCT02647255|Autonomic Agents|autonomic agents|mesh-ancestor
25221945|NCT02647255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25221946|NCT02647255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982087|NCT04259749|Dermatologic Agents|dermatologic agents|mesh-ancestor
24982088|NCT04250636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25221947|NCT02647255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25221948|NCT02647255|Glucocorticoids|glucocorticoids|mesh-ancestor
25221949|NCT02647255|Hormones|hormones|mesh-ancestor
25679830|NCT01843751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25221950|NCT02647255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25679831|NCT01843751|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25221964|NCT02647268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25221965|NCT02647268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25221966|NCT02647268|Anticonvulsants|anticonvulsants|mesh-ancestor
25221967|NCT02647268|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25221968|NCT02647268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25221969|NCT02647268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834785|NCT02181023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834786|NCT02181023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834787|NCT02181101|Zoledronic Acid|zoledronic acid|mesh-list
24834788|NCT02181101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24834789|NCT02181101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834790|NCT02181205|Bupivacaine|bupivacaine|mesh-list
24834845|NCT02181322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24834846|NCT02181322|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24834847|NCT02181322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24834848|NCT02181322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24834849|NCT02181322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834851|NCT02181335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24834852|NCT02181335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24834853|NCT02181335|Autonomic Agents|autonomic agents|mesh-ancestor
24834854|NCT02181335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24744573|NCT04224558|Acetaminophen|acetaminophen|mesh-list
24982089|NCT04250636|Antibodies|antibodies|mesh-list
24396103|NCT00137813|Bevacizumab|bevacizumab|mesh-list
24396105|NCT00137813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24396106|NCT00137813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396107|NCT00137813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24396108|NCT00137813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25221970|NCT02647268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25221971|NCT02647268|Tocolytic Agents|tocolytic agents|mesh-ancestor
25221972|NCT02647151|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25221973|NCT02647151|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
25221974|NCT02647151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25221975|NCT02647151|Dermatologic Agents|dermatologic agents|mesh-ancestor
25221976|NCT02647047|Acetaminophen|acetaminophen|mesh-list
25221977|NCT02647047|Ketorolac|ketorolac|mesh-list
25221978|NCT02647047|Sufentanil|sufentanil|mesh-list
25221979|NCT02647047|Ropivacaine|ropivacaine|mesh-list
25221980|NCT02647047|Anesthetics, Local|anesthetics, local|mesh-ancestor
25221981|NCT02647047|Anesthetics|anesthetics|mesh-ancestor
25221982|NCT02647047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25221983|NCT02647047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25221984|NCT02647047|Sensory System Agents|sensory system agents|mesh-ancestor
25221985|NCT02647047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25679832|NCT01843920|Trimethoprim|trimethoprim|mesh-list
25679833|NCT01843920|Polymyxins|polymyxins|mesh-list
25221992|NCT02647047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25221993|NCT02647047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25221994|NCT02647047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25221995|NCT02647047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25221996|NCT02647047|Narcotics|narcotics|mesh-ancestor
25221997|NCT02647047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25221998|NCT02647047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25221999|NCT02647047|Anesthetics, General|anesthetics, general|mesh-ancestor
25222000|NCT02646800|Micafungin|micafungin|mesh-list
25222001|NCT02646800|Antifungal Agents|antifungal agents|mesh-ancestor
25222002|NCT02646800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25222003|NCT02646774|Micafungin|micafungin|mesh-list
25222004|NCT02646774|Antifungal Agents|antifungal agents|mesh-ancestor
25222005|NCT02646774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25222006|NCT02647086|Metoprolol|metoprolol|mesh-list
24834890|NCT02181478|Cyclosporine|cyclosporine|mesh-list
24834915|NCT02181478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24834916|NCT02181543|Clonidine|clonidine|mesh-list
24834917|NCT02181543|Analgesics|analgesics|mesh-ancestor
24834918|NCT02181543|Sensory System Agents|sensory system agents|mesh-ancestor
24834919|NCT02181543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834920|NCT02181543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834921|NCT02181543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24834922|NCT02181543|Sympatholytics|sympatholytics|mesh-ancestor
24834923|NCT02181543|Autonomic Agents|autonomic agents|mesh-ancestor
25089879|NCT03262727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24834925|NCT02181543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24834926|NCT02181543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24396109|NCT00137813|Growth Substances|growth substances|mesh-ancestor
24396110|NCT00137813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396111|NCT00137813|Growth Inhibitors|growth inhibitors|mesh-ancestor
24396112|NCT00137813|Tubulin Modulators|tubulin modulators|mesh-ancestor
24396113|NCT00137813|Antimitotic Agents|antimitotic agents|mesh-ancestor
24396114|NCT00137813|Mitosis Modulators|mitosis modulators|mesh-ancestor
24396353|NCT00138710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396354|NCT00138710|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24396390|NCT00138970|Mycophenolic Acid|mycophenolic acid|mesh-list
24396391|NCT00138970|Cyclosporine|cyclosporine|mesh-list
24396392|NCT00138970|Prednisolone|prednisolone|mesh-list
24396393|NCT00138970|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24396394|NCT00138970|Methylprednisolone|methylprednisolone|mesh-list
25222007|NCT02647086|Midazolam|midazolam|mesh-list
25222008|NCT02647086|Caffeine|caffeine|mesh-list
25679834|NCT01843920|Polymyxin B|polymyxin b|mesh-list
25679835|NCT01843920|Prednisolone|prednisolone|mesh-list
25222009|NCT02647086|Omeprazole|omeprazole|mesh-list
25222010|NCT02647086|Warfarin|warfarin|mesh-list
25222011|NCT02647086|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25222012|NCT02647086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25222013|NCT02647086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25222014|NCT02647086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679836|NCT01843920|Timolol|timolol|mesh-list
25679837|NCT01843920|Dorzolamide|dorzolamide|mesh-list
25679838|NCT01843920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25679839|NCT01843920|Glucocorticoids|glucocorticoids|mesh-ancestor
24661597|NCT01290120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24661598|NCT01290120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25222015|NCT02647086|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25222016|NCT02647086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25222017|NCT02647086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25222018|NCT02647086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24982141|NCT04221997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982142|NCT04221997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24982143|NCT04221997|Serotonin Agents|serotonin agents|mesh-ancestor
24982144|NCT04221997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222019|NCT02647086|Anesthetics, General|anesthetics, general|mesh-ancestor
25222020|NCT02647086|Anesthetics|anesthetics|mesh-ancestor
25222021|NCT02647086|GABA Modulators|gaba modulators|mesh-ancestor
25222022|NCT02647086|GABA Agents|gaba agents|mesh-ancestor
25222023|NCT02647086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25222024|NCT02647086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222025|NCT02647086|Anticoagulants|anticoagulants|mesh-ancestor
25222026|NCT02647086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25222027|NCT02647086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25222028|NCT02647086|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25222029|NCT02647086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25222030|NCT02647086|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25222031|NCT02647086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25222032|NCT02647086|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25222033|NCT02647086|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25222034|NCT02647086|Purinergic Agents|purinergic agents|mesh-ancestor
25222035|NCT02647086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25222036|NCT02647086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25222037|NCT02647086|Sympatholytics|sympatholytics|mesh-ancestor
25222038|NCT02647086|Autonomic Agents|autonomic agents|mesh-ancestor
24834928|NCT02181543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24834929|NCT02181543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834930|NCT02181621|Cadexomer iodine|cadexomer iodine|mesh-list
24834931|NCT02181621|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24834932|NCT02181621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24593400|NCT00928798|Antifungal Agents|antifungal agents|mesh-ancestor
24834933|NCT02181920|Dipyrone|dipyrone|mesh-list
24834934|NCT02181920|Diclofenac|diclofenac|mesh-list
24396440|NCT00139009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396465|NCT00139061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24396466|NCT00139061|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24396467|NCT00139061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396468|NCT00139074|Valproic Acid|valproic acid|mesh-list
24396469|NCT00139074|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24396470|NCT00139074|Antidepressive Agents|antidepressive agents|mesh-ancestor
24396471|NCT00139074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24396472|NCT00139074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25089873|NCT03262727|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25089874|NCT03262727|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25089876|NCT03262727|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25089877|NCT03262727|Dermatologic Agents|dermatologic agents|mesh-ancestor
25089878|NCT03262727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25089880|NCT03262727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089881|NCT03262727|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25089882|NCT03262727|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
25089883|NCT03262142|Ciprofloxacin|ciprofloxacin|mesh-list
25089884|NCT03262142|Tazobactam|tazobactam|mesh-list
25089885|NCT03262142|Piperacillin|piperacillin|mesh-list
25089886|NCT03262142|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25089887|NCT03262142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24396476|NCT00139074|Anticonvulsants|anticonvulsants|mesh-ancestor
24396477|NCT00139074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396478|NCT00139074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396518|NCT00139230|Ciprofloxacin|ciprofloxacin|mesh-list
24396519|NCT00139230|Fluorouracil|fluorouracil|mesh-list
24396521|NCT00139230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396522|NCT00139230|Antimetabolites|antimetabolites|mesh-ancestor
24396523|NCT00139230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679840|NCT01843920|Hormones|hormones|mesh-ancestor
25679841|NCT01843920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24396524|NCT00139230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24396525|NCT00139230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24396526|NCT00139230|Immunologic Factors|immunologic factors|mesh-ancestor
24396527|NCT00139230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396528|NCT00139230|Antidotes|antidotes|mesh-ancestor
24396529|NCT00139230|Protective Agents|protective agents|mesh-ancestor
24396530|NCT00139230|Vitamin B Complex|vitamin b complex|mesh-ancestor
24396531|NCT00139230|Vitamins|vitamins|mesh-ancestor
24396532|NCT00139230|Micronutrients|micronutrients|mesh-ancestor
24396533|NCT00139230|Tubulin Modulators|tubulin modulators|mesh-ancestor
24396534|NCT00139230|Antimitotic Agents|antimitotic agents|mesh-ancestor
24396535|NCT00139230|Mitosis Modulators|mitosis modulators|mesh-ancestor
24396536|NCT00139230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24396537|NCT00139230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24396562|NCT00139256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24396563|NCT00139256|Glucocorticoids|glucocorticoids|mesh-ancestor
24396564|NCT00139256|Hormones|hormones|mesh-ancestor
24396565|NCT00139256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24396566|NCT00139256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396567|NCT00139256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25222039|NCT02647086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222040|NCT02647086|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25222041|NCT02647086|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25222042|NCT02647086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25222043|NCT02647086|Adrenergic Agents|adrenergic agents|mesh-ancestor
25222044|NCT02646904|Beclomethasone|beclomethasone|mesh-list
25222045|NCT02646904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25222046|NCT02646904|Glucocorticoids|glucocorticoids|mesh-ancestor
25222047|NCT02646904|Hormones|hormones|mesh-ancestor
25222048|NCT02646904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24834935|NCT02181920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24834951|NCT02181933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24834952|NCT02181933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24834953|NCT02181933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834954|NCT02181933|Antiviral Agents|antiviral agents|mesh-ancestor
24834955|NCT02181933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24834956|NCT02181933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24834957|NCT02181933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25222180|NCT02646189|Antiviral Agents|antiviral agents|mesh-ancestor
24396568|NCT00139256|Respiratory System Agents|respiratory system agents|mesh-ancestor
24396569|NCT00139269|Docetaxel|docetaxel|mesh-list
24396570|NCT00139269|Fluorouracil|fluorouracil|mesh-list
24396571|NCT00139269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396661|NCT00139620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396662|NCT00139633|Carboplatin|carboplatin|mesh-list
24396663|NCT00139633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396664|NCT00139646|Diclofenac|diclofenac|mesh-list
24396665|NCT00139646|Parecoxib|parecoxib|mesh-list
24396666|NCT00139646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25679842|NCT01843920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679843|NCT01843920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25679844|NCT01843920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396680|NCT00139685|Medroxyprogesterone|medroxyprogesterone|mesh-list
24586384|NCT00890500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24586404|NCT00890539|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24979735|NCT02784704|Meropenem|meropenem|mesh-list
24661918|NCT01291511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24661919|NCT01291524|Pregabalin|pregabalin|mesh-list
24661920|NCT01291524|Analgesics|analgesics|mesh-ancestor
24661921|NCT01291524|Sensory System Agents|sensory system agents|mesh-ancestor
25089888|NCT03262142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25089889|NCT03262142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25089890|NCT03262142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25222049|NCT02646904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222050|NCT02646904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25222051|NCT02646904|Respiratory System Agents|respiratory system agents|mesh-ancestor
25222052|NCT02646709|Ketamine|ketamine|mesh-list
25222053|NCT02646709|Rocuronium|rocuronium|mesh-list
25222054|NCT02646709|Analgesics|analgesics|mesh-ancestor
25222055|NCT02646709|Sensory System Agents|sensory system agents|mesh-ancestor
25222056|NCT02646709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222057|NCT02646709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222058|NCT02646709|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25222059|NCT02646709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25222060|NCT02646709|Anesthetics, General|anesthetics, general|mesh-ancestor
25222061|NCT02646709|Anesthetics|anesthetics|mesh-ancestor
25222062|NCT02646709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25222063|NCT02646709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25222064|NCT02646709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25222065|NCT02646709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25222066|NCT02646709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222067|NCT02646709|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25222068|NCT02646709|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25222069|NCT02646709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25222070|NCT02646735|Fulvestrant|fulvestrant|mesh-list
25222071|NCT02646735|Exemestane|exemestane|mesh-list
25222072|NCT02646735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25222073|NCT02646735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25222074|NCT02646735|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25222075|NCT02646735|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25222076|NCT02646735|Hormone Antagonists|hormone antagonists|mesh-ancestor
25273139|NCT02387138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25273140|NCT02387138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24834959|NCT02181933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24834960|NCT02181933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24834961|NCT02181946|Fluconazole|fluconazole|mesh-list
24834962|NCT02181946|Nevirapine|nevirapine|mesh-list
24834963|NCT02181946|Antifungal Agents|antifungal agents|mesh-ancestor
24834964|NCT02181946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24834965|NCT02181946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24834983|NCT02181985|Enoxaparin|enoxaparin|mesh-list
24834984|NCT02181985|Tenecteplase|tenecteplase|mesh-list
24834985|NCT02181985|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24834986|NCT02181985|Abciximab|abciximab|mesh-list
24834987|NCT02181985|Anticoagulants|anticoagulants|mesh-ancestor
24834988|NCT02181985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24834989|NCT02181985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24834990|NCT02181985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834991|NCT02181985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24834992|NCT02181998|Heparin|heparin|mesh-list
24834993|NCT02181998|Enoxaparin|enoxaparin|mesh-list
24834994|NCT02181998|Tenecteplase|tenecteplase|mesh-list
24834995|NCT02181998|Anticoagulants|anticoagulants|mesh-ancestor
24834996|NCT02181998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24834997|NCT02181998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24834998|NCT02181998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679845|NCT01843920|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25679846|NCT01843920|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25679847|NCT01843920|Adrenergic Agents|adrenergic agents|mesh-ancestor
25679848|NCT01843920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25679849|NCT01843920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679850|NCT01843920|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25679851|NCT01843920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24834999|NCT02182011|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24835000|NCT02182011|Tenecteplase|tenecteplase|mesh-list
24835001|NCT02182011|Streptokinase|streptokinase|mesh-list
24835002|NCT02182011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25222080|NCT02646735|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25222081|NCT02646735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25222082|NCT02646735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222083|NCT02646683|Vedolizumab|vedolizumab|mesh-list
25222084|NCT02646683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25222085|NCT02646501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
25222086|NCT02646397|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25222087|NCT02646397|Fosinopril|fosinopril|mesh-list
25222088|NCT02646397|Benidipine|benidipine|mesh-list
25222089|NCT02646397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25222090|NCT02646397|Diuretics|diuretics|mesh-ancestor
25222091|NCT02646397|Natriuretic Agents|natriuretic agents|mesh-ancestor
25222092|NCT02646397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222093|NCT02646397|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25222094|NCT02646397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25222095|NCT02646397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222096|NCT02646397|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25222097|NCT02646397|Protease Inhibitors|protease inhibitors|mesh-ancestor
25222098|NCT02646397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25222099|NCT02646397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25222100|NCT02646397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25222101|NCT02646397|Vasodilator Agents|vasodilator agents|mesh-ancestor
25222102|NCT02646592|Alfentanil|alfentanil|mesh-list
25222103|NCT02646592|Propofol|propofol|mesh-list
25222104|NCT02646592|Sevoflurane|sevoflurane|mesh-list
25222105|NCT02646592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25222106|NCT02646592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25222107|NCT02646592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222108|NCT02646592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25222109|NCT02646592|Anesthetics, General|anesthetics, general|mesh-ancestor
25222110|NCT02646592|Anesthetics|anesthetics|mesh-ancestor
25222111|NCT02646592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25222112|NCT02646592|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25063006|NCT03237611|Fosaprepitant|fosaprepitant|mesh-list
25063007|NCT03237611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25063008|NCT03237611|Antiemetics|antiemetics|mesh-ancestor
25063009|NCT03237611|Autonomic Agents|autonomic agents|mesh-ancestor
24469396|NCT00385632|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24835047|NCT02182154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24835048|NCT02182154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835049|NCT02182154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835058|NCT02182167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835060|NCT02182167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835061|NCT02182167|Antidotes|antidotes|mesh-ancestor
24835062|NCT02182193|Nintedanib|nintedanib|mesh-list
24835063|NCT02182193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24835064|NCT02182193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24835065|NCT02182193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25089892|NCT03262142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089893|NCT03262142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25089894|NCT03262142|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25089895|NCT03262142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25089896|NCT03262142|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25089897|NCT03262077|Methylene Blue|methylene blue|mesh-list
24396692|NCT00139698|Olmesartan|olmesartan|mesh-list
24982228|NCT03450629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982229|NCT03445858|Pembrolizumab|pembrolizumab|mesh-list
24396695|NCT00139698|Natriuretic Agents|natriuretic agents|mesh-ancestor
24396696|NCT00139698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396697|NCT00139698|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24396698|NCT00139698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24396699|NCT00139698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396700|NCT00139698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24396701|NCT00139698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24396702|NCT00139711|Docetaxel|docetaxel|mesh-list
24396703|NCT00139711|Irinotecan|irinotecan|mesh-list
25222113|NCT02646592|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25222114|NCT02646592|Narcotics|narcotics|mesh-ancestor
25222115|NCT02646592|Analgesics|analgesics|mesh-ancestor
25222116|NCT02646592|Sensory System Agents|sensory system agents|mesh-ancestor
25222117|NCT02646592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222118|NCT02646670|Ranibizumab|ranibizumab|mesh-list
25222119|NCT02646670|Aflibercept|aflibercept|mesh-list
25222120|NCT02646670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25222121|NCT02646670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25222122|NCT02646670|Growth Substances|growth substances|mesh-ancestor
25222123|NCT02646670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222124|NCT02646670|Growth Inhibitors|growth inhibitors|mesh-ancestor
25222125|NCT02646670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25222126|NCT02646657|Vedolizumab|vedolizumab|mesh-list
25222127|NCT02646657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25222128|NCT02646540|Metolazone|metolazone|mesh-list
25222129|NCT02646540|Furosemide|furosemide|mesh-list
25222130|NCT02646540|Tolvaptan|tolvaptan|mesh-list
25222131|NCT02646540|Diuretics|diuretics|mesh-list
25222132|NCT02646540|Natriuretic Agents|natriuretic agents|mesh-ancestor
25222133|NCT02646540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222134|NCT02646540|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25222135|NCT02646540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25222136|NCT02646540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222137|NCT02646540|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25222138|NCT02646540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24396704|NCT00139711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396705|NCT00139711|Tubulin Modulators|tubulin modulators|mesh-ancestor
24396706|NCT00139711|Antimitotic Agents|antimitotic agents|mesh-ancestor
24396707|NCT00139711|Mitosis Modulators|mitosis modulators|mesh-ancestor
24396709|NCT00139711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24396720|NCT00139750|Varenicline|varenicline|mesh-list
24396721|NCT00139750|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24396799|NCT00139971|Gemcitabine|gemcitabine|mesh-list
24396818|NCT00140075|Cyclophosphamide|cyclophosphamide|mesh-list
24396819|NCT00140075|Epirubicin|epirubicin|mesh-list
24396892|NCT00140309|Rifampin|rifampin|mesh-list
24396893|NCT00140309|Isoniazid|isoniazid|mesh-list
24396894|NCT00140309|Pyrazinamide|pyrazinamide|mesh-list
24396895|NCT00140309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24396896|NCT00140309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24546563|NCT00699062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25089900|NCT03262090|Dexmedetomidine|dexmedetomidine|mesh-list
25089901|NCT03262090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25089902|NCT03262090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25089903|NCT03262090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089904|NCT03262090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25089905|NCT03262090|Analgesics|analgesics|mesh-ancestor
25089917|NCT03262116|Insulin Aspart|insulin aspart|mesh-list
25089918|NCT03262116|Pancrelipase|pancrelipase|mesh-list
25089919|NCT03262116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24396998|NCT00140530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24396999|NCT00140530|Antifungal Agents|antifungal agents|mesh-ancestor
24397000|NCT00140530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25222139|NCT02646540|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25222140|NCT02646111|Ribavirin|ribavirin|mesh-list
25222141|NCT02646111|Antimetabolites|antimetabolites|mesh-ancestor
25222142|NCT02646111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222143|NCT02646111|Antiviral Agents|antiviral agents|mesh-ancestor
25222144|NCT02646111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25222145|NCT02646085|Carbon-11 methionine|carbon-11 methionine|mesh-list
25222146|NCT02646085|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25222147|NCT02646085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222148|NCT02646137|Chlorotrianisene|chlorotrianisene|mesh-list
25222149|NCT02646137|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25222150|NCT02646137|Estrogens|estrogens|mesh-ancestor
25222151|NCT02646137|Hormones|hormones|mesh-ancestor
25222152|NCT02646137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24469488|NCT00386061|Rimonabant|rimonabant|mesh-list
24835076|NCT02182219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835077|NCT02182232|Paclitaxel|paclitaxel|mesh-list
24835078|NCT02182232|Carboplatin|carboplatin|mesh-list
24835079|NCT02182232|Nintedanib|nintedanib|mesh-list
24835080|NCT02182232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24593582|NCT00930189|Growth Substances|growth substances|mesh-ancestor
24835081|NCT02182232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24835082|NCT02182232|Tubulin Modulators|tubulin modulators|mesh-ancestor
24397001|NCT00140530|Immunologic Factors|immunologic factors|mesh-ancestor
24397002|NCT00140530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397003|NCT00140543|Mycophenolic Acid|mycophenolic acid|mesh-list
24397004|NCT00140543|Sirolimus|sirolimus|mesh-list
24397005|NCT00140543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24397006|NCT00140543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24397007|NCT00140543|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24397008|NCT00140543|Antitubercular Agents|antitubercular agents|mesh-ancestor
24397009|NCT00140543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24397010|NCT00140543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24397011|NCT00140543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24397012|NCT00140543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397013|NCT00140543|Antifungal Agents|antifungal agents|mesh-ancestor
24397014|NCT00140543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24546807|NCT00700492|Progestins|progestins|mesh-ancestor
25089920|NCT03262116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089921|NCT03262116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25089922|NCT03262363|Curcumin|curcumin|mesh-list
25089923|NCT03262363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25089924|NCT03262363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25089925|NCT03262363|Analgesics|analgesics|mesh-ancestor
25089926|NCT03262363|Sensory System Agents|sensory system agents|mesh-ancestor
25222153|NCT02646137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222154|NCT02646137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25222155|NCT02646137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25222156|NCT02646319|Sirolimus|sirolimus|mesh-list
25222157|NCT02646319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25222158|NCT02646319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25222159|NCT02646319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25222160|NCT02646319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25222166|NCT02646267|Dabigatran|dabigatran|mesh-list
25222167|NCT02646267|Anticoagulants|anticoagulants|mesh-ancestor
25222168|NCT02646267|Antithrombins|antithrombins|mesh-ancestor
25222169|NCT02646267|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25222170|NCT02646267|Protease Inhibitors|protease inhibitors|mesh-ancestor
25222171|NCT02646267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25222172|NCT02646267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222173|NCT02646189|Interferons|interferons|mesh-list
25222174|NCT02646189|Interferon-alpha|interferon-alpha|mesh-list
25222175|NCT02646189|Interferon alpha-2|interferon alpha-2|mesh-list
25222176|NCT02646189|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25222177|NCT02646189|REP 2139|rep 2139|mesh-list
25222178|NCT02646189|Thymalfasin|thymalfasin|mesh-list
24835088|NCT02182245|Paclitaxel|paclitaxel|mesh-list
24835089|NCT02182245|Carboplatin|carboplatin|mesh-list
25089928|NCT03262363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089929|NCT03262363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24397044|NCT00140595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24397046|NCT00140647|Ramipril|ramipril|mesh-list
24397047|NCT00140647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24397048|NCT00140647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397049|NCT00140647|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24397050|NCT00140647|Protease Inhibitors|protease inhibitors|mesh-ancestor
24619291|NCT01051934|Paclitaxel|paclitaxel|mesh-list
24397082|NCT00140725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24397084|NCT00140751|Lopinavir|lopinavir|mesh-list
24397085|NCT00140751|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24397086|NCT00140751|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24397087|NCT00140751|Protease Inhibitors|protease inhibitors|mesh-ancestor
24397088|NCT00140751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24397089|NCT00140751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397090|NCT00140751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24397091|NCT00140751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24397092|NCT00140751|Antiviral Agents|antiviral agents|mesh-ancestor
24397093|NCT00140751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24397094|NCT00140751|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24397095|NCT00140751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24397096|NCT00140764|Metronidazole|metronidazole|mesh-list
24397097|NCT00140764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24397098|NCT00140764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24397099|NCT00140764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24397100|NCT00140764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24397101|NCT00140790|Valsartan|valsartan|mesh-list
24397102|NCT00140790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24397103|NCT00140790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24397104|NCT00140790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24397106|NCT00140803|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25222179|NCT02646189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25222181|NCT02646189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25222182|NCT02646189|Immunologic Factors|immunologic factors|mesh-ancestor
25222183|NCT02646189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222184|NCT02646189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25679852|NCT01843920|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25679853|NCT01843920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25679854|NCT01843920|Renal Agents|renal agents|mesh-ancestor
25679855|NCT01843920|Antimalarials|antimalarials|mesh-ancestor
25679856|NCT01843920|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24575843|NCT00834730|Ketamine|ketamine|mesh-list
25014035|NCT05126264|Analgesics|analgesics|mesh-ancestor
25014036|NCT05126264|Sensory System Agents|sensory system agents|mesh-ancestor
25014037|NCT05126264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222186|NCT02646072|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25222187|NCT02646072|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25222188|NCT02646072|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25222189|NCT02646072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25222190|NCT02646072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25222191|NCT02646072|Analgesics|analgesics|mesh-ancestor
25222192|NCT02646072|Sensory System Agents|sensory system agents|mesh-ancestor
25222193|NCT02646072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222194|NCT02646072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835091|NCT02182245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24835092|NCT02182245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24835093|NCT02182245|Tubulin Modulators|tubulin modulators|mesh-ancestor
24835094|NCT02182245|Antimitotic Agents|antimitotic agents|mesh-ancestor
24835095|NCT02182245|Mitosis Modulators|mitosis modulators|mesh-ancestor
25089933|NCT03262363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089935|NCT03262376|Micronutrients|micronutrients|mesh-ancestor
25089936|NCT03262376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089954|NCT03261635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25089955|NCT03261635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25089956|NCT03261635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25089957|NCT03261635|Analgesics|analgesics|mesh-ancestor
25089958|NCT03261635|Sensory System Agents|sensory system agents|mesh-ancestor
25089959|NCT03261635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25089960|NCT03261635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25089961|NCT03261635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25089962|NCT03261635|Gout Suppressants|gout suppressants|mesh-ancestor
25089963|NCT03261635|Tocolytic Agents|tocolytic agents|mesh-ancestor
25089964|NCT03261635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25089965|NCT03261635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25089966|NCT03261635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25089979|NCT03261921|Dexamethasone|dexamethasone|mesh-list
25089980|NCT03261921|Dexmedetomidine|dexmedetomidine|mesh-list
25089981|NCT03261921|Bupivacaine|bupivacaine|mesh-list
25089982|NCT03261921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25089983|NCT03261921|Antiemetics|antiemetics|mesh-ancestor
25089984|NCT03261921|Autonomic Agents|autonomic agents|mesh-ancestor
25089985|NCT03261921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25089986|NCT03261921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089987|NCT03261921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25089988|NCT03261921|Glucocorticoids|glucocorticoids|mesh-ancestor
25089989|NCT03261921|Hormones|hormones|mesh-ancestor
25089990|NCT03261921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25089991|NCT03261921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25089992|NCT03261921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25089993|NCT03261921|Anesthetics, Local|anesthetics, local|mesh-ancestor
25089994|NCT03261921|Anesthetics|anesthetics|mesh-ancestor
25089995|NCT03261921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25089996|NCT03261921|Sensory System Agents|sensory system agents|mesh-ancestor
25089997|NCT03261921|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25089998|NCT03261921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25089999|NCT03261921|Analgesics|analgesics|mesh-ancestor
24547055|NCT00702130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25222195|NCT02646072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25222196|NCT02646072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25222197|NCT02646072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25222198|NCT02646072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25222199|NCT02646072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222200|NCT02645747|Aflibercept|aflibercept|mesh-list
24835096|NCT02182245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835098|NCT02182245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835099|NCT02182258|Nintedanib|nintedanib|mesh-list
24397121|NCT00140868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397122|NCT00140868|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24397123|NCT00140868|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24397124|NCT00140868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24397125|NCT00140868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679857|NCT01843920|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25679858|NCT01843920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25679859|NCT01843920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25679860|NCT01843920|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25405282|NCT03615105|Thymoglobulin|thymoglobulin|mesh-list
24663016|NCT01297907|Cholinergic Agents|cholinergic agents|mesh-ancestor
24663017|NCT01297907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24663018|NCT01297907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663019|NCT01297946|Hormones|hormones|mesh-list
24663020|NCT01297946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663071|NCT01298180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090000|NCT03261921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25090001|NCT03261921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25090002|NCT03261921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25090003|NCT03261921|Adrenergic Agents|adrenergic agents|mesh-ancestor
25090004|NCT03261921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25090005|NCT03261921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090007|NCT03261596|Piperazine|piperazine|mesh-list
25090008|NCT03261596|Piperazine citrate|piperazine citrate|mesh-list
25090009|NCT03261596|DMP 777|dmp 777|mesh-list
25090010|NCT03261596|Antinematodal Agents|antinematodal agents|mesh-ancestor
25090011|NCT03261596|Anthelmintics|anthelmintics|mesh-ancestor
25090012|NCT03261596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25090013|NCT03261596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25090014|NCT03261596|Tubulin Modulators|tubulin modulators|mesh-ancestor
25090015|NCT03261596|Antimitotic Agents|antimitotic agents|mesh-ancestor
25090016|NCT03261596|Mitosis Modulators|mitosis modulators|mesh-ancestor
25090017|NCT03261596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090018|NCT03261596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24397209|NCT00141089|Serotonin Agents|serotonin agents|mesh-ancestor
24753153|NCT01714037|Tubulin Modulators|tubulin modulators|mesh-ancestor
24397230|NCT00141154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24397231|NCT00141154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24397238|NCT00141167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24397239|NCT00141167|Cholinergic Agents|cholinergic agents|mesh-ancestor
24397246|NCT00141193|Analgesics|analgesics|mesh-ancestor
24397254|NCT00141193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24397255|NCT00141193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397256|NCT00141206|Varenicline|varenicline|mesh-list
24397257|NCT00141206|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24397258|NCT00141206|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24397259|NCT00141206|Cholinergic Agents|cholinergic agents|mesh-ancestor
24397260|NCT00141206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24397261|NCT00141206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397262|NCT00141206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397263|NCT00141232|Atorvastatin|atorvastatin|mesh-list
24397264|NCT00141232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24397279|NCT00141245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397280|NCT00141245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24397281|NCT00141245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24397282|NCT00141245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24397283|NCT00141245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24397284|NCT00141245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24397286|NCT00141258|Analgesics|analgesics|mesh-ancestor
24547890|NCT00706277|Analgesics|analgesics|mesh-ancestor
25090019|NCT03261596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090020|NCT03261791|Apatinib|apatinib|mesh-list
25090021|NCT03261791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25679861|NCT01843920|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25679862|NCT01843920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25679863|NCT01843920|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25679864|NCT01843920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25679865|NCT01844076|Quinacrine|quinacrine|mesh-list
25679866|NCT01844076|Capecitabine|capecitabine|mesh-list
25679867|NCT01844076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25679868|NCT01844076|Antimetabolites|antimetabolites|mesh-ancestor
25679869|NCT01844076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679870|NCT01844076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25679871|NCT01844076|Anticestodal Agents|anticestodal agents|mesh-ancestor
25222204|NCT02645747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222205|NCT02645747|Growth Inhibitors|growth inhibitors|mesh-ancestor
24835100|NCT02182258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24594649|NCT00934817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25090022|NCT03261791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25090023|NCT03261791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090024|NCT03261791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090025|NCT03261284|Warfarin|warfarin|mesh-list
25090026|NCT03261284|Dabigatran|dabigatran|mesh-list
25090027|NCT03261284|Anticoagulants|anticoagulants|mesh-ancestor
25090028|NCT03261284|Antithrombins|antithrombins|mesh-ancestor
25090029|NCT03261284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25090030|NCT03261284|Protease Inhibitors|protease inhibitors|mesh-ancestor
25090031|NCT03261284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090032|NCT03261284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090033|NCT03261427|Pregabalin|pregabalin|mesh-list
25090034|NCT03261427|Analgesics|analgesics|mesh-ancestor
25090035|NCT03261427|Sensory System Agents|sensory system agents|mesh-ancestor
24397350|NCT00141388|Sensory System Agents|sensory system agents|mesh-ancestor
24397351|NCT00141388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24397352|NCT00141388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397353|NCT00141388|Anticonvulsants|anticonvulsants|mesh-ancestor
24397362|NCT00141401|Pregabalin|pregabalin|mesh-list
24397365|NCT00141401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24397395|NCT00141427|Anticonvulsants|anticonvulsants|mesh-ancestor
24397401|NCT00141427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24397402|NCT00141427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24397403|NCT00141427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24397404|NCT00141492|Testosterone|testosterone|mesh-list
24397405|NCT00141492|Androgens|androgens|mesh-ancestor
24455415|NCT01370486|Protective Agents|protective agents|mesh-ancestor
24455416|NCT01370486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455417|NCT01370486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24455418|NCT00945724|Cytarabine|cytarabine|mesh-list
24455419|NCT00945724|Prednisolone|prednisolone|mesh-list
24455420|NCT00945724|Cyclophosphamide|cyclophosphamide|mesh-list
24455421|NCT00945724|Rituximab|rituximab|mesh-list
25090037|NCT03261427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090038|NCT03261427|Anticonvulsants|anticonvulsants|mesh-ancestor
25090039|NCT03261427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25090040|NCT03261427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25090041|NCT03261427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090042|NCT03261427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25090043|NCT03261427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25090044|NCT03261427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25090045|NCT03261427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25090046|NCT03261427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25090047|NCT03261349|Sofosbuvir|sofosbuvir|mesh-list
25090048|NCT03261349|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25090049|NCT03261349|Ledipasvir|ledipasvir|mesh-list
25090050|NCT03261349|Antiviral Agents|antiviral agents|mesh-ancestor
25090051|NCT03261349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25090052|NCT03261375|Antihypertensive Agents|antihypertensive agents|mesh-list
25090053|NCT03261310|Acetaminophen|acetaminophen|mesh-list
24982476|NCT02581215|Ramucirumab|ramucirumab|mesh-list
25090054|NCT03261310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25090055|NCT03261310|Analgesics|analgesics|mesh-ancestor
24766104|NCT01792700|Moxifloxacin|moxifloxacin|mesh-list
25090056|NCT03261310|Sensory System Agents|sensory system agents|mesh-ancestor
25090057|NCT03261310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25090058|NCT03261310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090059|NCT03261310|Antipyretics|antipyretics|mesh-ancestor
25090060|NCT03261102|Adalimumab|adalimumab|mesh-list
25090061|NCT03261102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25090062|NCT03261102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25222206|NCT02645747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25222207|NCT02645864|Irinotecan|irinotecan|mesh-list
25222208|NCT02645864|Apatinib|apatinib|mesh-list
25090063|NCT03260829|Ascorbic Acid|ascorbic acid|mesh-list
25090064|NCT03260829|Vitamins|vitamins|mesh-ancestor
25090065|NCT03260829|Micronutrients|micronutrients|mesh-ancestor
25090066|NCT03260829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090067|NCT03260829|Antioxidants|antioxidants|mesh-ancestor
24664051|NCT01304797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24664052|NCT01304797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25090068|NCT03260829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090069|NCT03260829|Protective Agents|protective agents|mesh-ancestor
25090078|NCT03260920|Oxytocics|oxytocics|mesh-ancestor
25090079|NCT03260920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25090080|NCT03260920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090082|NCT03261024|Trace Elements|trace elements|mesh-ancestor
25090085|NCT03260634|Voriconazole|voriconazole|mesh-list
25090086|NCT03260634|Antifungal Agents|antifungal agents|mesh-ancestor
25090087|NCT03260634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25090088|NCT03260634|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25090089|NCT03260634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25090090|NCT03260634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24397468|NCT00141596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397469|NCT00141596|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24397479|NCT00141648|Vincristine|vincristine|mesh-list
24397480|NCT00141648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24397481|NCT00141648|Immunologic Factors|immunologic factors|mesh-ancestor
25011730|NCT04256629|Protective Agents|protective agents|mesh-ancestor
24397482|NCT00141648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397483|NCT00141648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24397506|NCT00141700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397507|NCT00141700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24397508|NCT00141713|Etanercept|etanercept|mesh-list
24397509|NCT00141713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24397510|NCT00141713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24397511|NCT00141713|Analgesics|analgesics|mesh-ancestor
24397512|NCT00141713|Sensory System Agents|sensory system agents|mesh-ancestor
24397513|NCT00141713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24397514|NCT00141713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397515|NCT00141713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24397516|NCT00141713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24397517|NCT00141713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24397529|NCT00141791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24397530|NCT00141791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24397531|NCT00141791|Immunologic Factors|immunologic factors|mesh-ancestor
24397532|NCT00141804|Sirolimus|sirolimus|mesh-list
24397533|NCT00141804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24397534|NCT00141804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24397535|NCT00141804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24397536|NCT00141804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25090091|NCT03260634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090092|NCT03260634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25090093|NCT03260634|Hormone Antagonists|hormone antagonists|mesh-ancestor
25090094|NCT03260634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25222209|NCT02645864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25222210|NCT02645864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25222211|NCT02645864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25222212|NCT02645864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222213|NCT02645864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25222214|NCT02645864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24835102|NCT02182258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835103|NCT02182258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835104|NCT02182310|Moxifloxacin|moxifloxacin|mesh-list
24835105|NCT02182310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24835106|NCT02182310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24835107|NCT02182310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24835108|NCT02182310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24835109|NCT02182310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25679872|NCT01844076|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25679873|NCT01844076|Anthelmintics|anthelmintics|mesh-ancestor
25679874|NCT01844076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25679875|NCT01844076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25679876|NCT01844076|Antimalarials|antimalarials|mesh-ancestor
25679877|NCT01844076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25679878|NCT01844076|Antinematodal Agents|antinematodal agents|mesh-ancestor
25679879|NCT01844076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25679880|NCT01844115|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
25679881|NCT01844115|Antidepressive Agents|antidepressive agents|mesh-ancestor
25679882|NCT01844115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24664667|NCT01308229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24664668|NCT01308229|Tubulin Modulators|tubulin modulators|mesh-ancestor
24664669|NCT01308229|Antimitotic Agents|antimitotic agents|mesh-ancestor
24664670|NCT01308229|Mitosis Modulators|mitosis modulators|mesh-ancestor
24664671|NCT01308229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664672|NCT01308242|Sevelamer|sevelamer|mesh-list
24664673|NCT01308242|Chelating Agents|chelating agents|mesh-ancestor
24455936|NCT00329394|Anesthetics|anesthetics|mesh-ancestor
24664674|NCT01308242|Sequestering Agents|sequestering agents|mesh-ancestor
24664675|NCT01308242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664676|NCT01308255|Vitamins|vitamins|mesh-list
24664677|NCT01308255|Folic Acid|folic acid|mesh-list
24664678|NCT01308255|Methylprednisolone|methylprednisolone|mesh-list
24664680|NCT01308255|Methotrexate|methotrexate|mesh-list
24664749|NCT01308528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24664750|NCT01308528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24664753|NCT01308541|Fospropofol|fospropofol|mesh-list
24835110|NCT02182310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835111|NCT02182310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24835112|NCT02182336|Vitamin K|vitamin k|mesh-list
24835113|NCT02182336|Digoxin|digoxin|mesh-list
24835114|NCT02182336|Midazolam|midazolam|mesh-list
25054759|NCT03527836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25054760|NCT03527836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25090095|NCT03260634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090098|NCT03261115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25090099|NCT03261115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090102|NCT03260439|Narcotics|narcotics|mesh-ancestor
25090103|NCT03260439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24397548|NCT00141830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397549|NCT00141830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24397551|NCT00141830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24397552|NCT00141830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24397553|NCT00141830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24397596|NCT00141960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397598|NCT00141986|Vitamin D|vitamin d|mesh-list
24397599|NCT00141986|Ergocalciferols|ergocalciferols|mesh-list
24397600|NCT00141986|Cholecalciferol|cholecalciferol|mesh-list
24397601|NCT00141986|Vitamins|vitamins|mesh-list
24397602|NCT00141986|Micronutrients|micronutrients|mesh-ancestor
24397603|NCT00141986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397604|NCT00141986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24397605|NCT00141986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24397606|NCT00142025|Oxcarbazepine|oxcarbazepine|mesh-list
24397607|NCT00142025|Anticonvulsants|anticonvulsants|mesh-ancestor
24397608|NCT00142025|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24397609|NCT00142025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25222215|NCT02645994|Anesthetics|anesthetics|mesh-list
25222216|NCT02645994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25222217|NCT02645994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222218|NCT02645734|Bevacizumab|bevacizumab|mesh-list
25222219|NCT02645734|Aflibercept|aflibercept|mesh-list
25222220|NCT02645734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25222221|NCT02645734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25679883|NCT01844115|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25679884|NCT01844115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25679885|NCT01844115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25679886|NCT01844115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679887|NCT01844115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25679888|NCT01844115|Serotonin Agents|serotonin agents|mesh-ancestor
25679889|NCT01844115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679890|NCT01844115|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25679891|NCT01844115|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25692432|NCT01999348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692433|NCT01999348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692434|NCT01999348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25692435|NCT01999348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25692436|NCT01999400|Mesalamine|mesalamine|mesh-list
25222227|NCT02645565|Methylprednisolone|methylprednisolone|mesh-list
25222228|NCT02645565|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25222229|NCT02645565|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25222230|NCT02645565|Prednisolone|prednisolone|mesh-list
25222231|NCT02645565|Prednisolone acetate|prednisolone acetate|mesh-list
25222232|NCT02645565|Cyclophosphamide|cyclophosphamide|mesh-list
25222233|NCT02645565|Azathioprine|azathioprine|mesh-list
25222234|NCT02645565|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25222235|NCT02645565|Prednisolone phosphate|prednisolone phosphate|mesh-list
24397623|NCT00142051|Nitric Oxide|nitric oxide|mesh-list
24397624|NCT00142051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24397625|NCT00142051|Autonomic Agents|autonomic agents|mesh-ancestor
24397626|NCT00142051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24397627|NCT00142051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397628|NCT00142051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24397629|NCT00142051|Respiratory System Agents|respiratory system agents|mesh-ancestor
24397630|NCT00142051|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24397631|NCT00142051|Antioxidants|antioxidants|mesh-ancestor
24397632|NCT00142051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090104|NCT03260439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222236|NCT02645565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25222237|NCT02645565|Immunologic Factors|immunologic factors|mesh-ancestor
25222238|NCT02645565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222239|NCT02645565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25222240|NCT02645565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25222241|NCT02645565|Alkylating Agents|alkylating agents|mesh-ancestor
25222242|NCT02645565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222243|NCT02645565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25222244|NCT02645565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25222245|NCT02645565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25222246|NCT02645565|Antiemetics|antiemetics|mesh-ancestor
25222247|NCT02645565|Autonomic Agents|autonomic agents|mesh-ancestor
25222248|NCT02645565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222249|NCT02645565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25222250|NCT02645565|Glucocorticoids|glucocorticoids|mesh-ancestor
25222251|NCT02645565|Hormones|hormones|mesh-ancestor
24784282|NCT01907204|Prednisolone|prednisolone|mesh-list
24784284|NCT01907204|Budesonide|budesonide|mesh-list
25159911|NCT03504956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25679894|NCT01844388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25679895|NCT01844388|Laxatives|laxatives|mesh-ancestor
25679896|NCT01844388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25222253|NCT02645565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25222254|NCT02645565|Protective Agents|protective agents|mesh-ancestor
25222255|NCT02645565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25222256|NCT02645565|Antimetabolites|antimetabolites|mesh-ancestor
25222257|NCT02645565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25222258|NCT02645903|Morphine|morphine|mesh-list
25222259|NCT02645903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25222260|NCT02645903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222261|NCT02645903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25222262|NCT02645903|Narcotics|narcotics|mesh-ancestor
25222263|NCT02645903|Analgesics|analgesics|mesh-ancestor
25222264|NCT02645903|Sensory System Agents|sensory system agents|mesh-ancestor
25042898|NCT01356160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042899|NCT01355393|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
25042900|NCT01355393|Sargramostim|sargramostim|mesh-list
25042901|NCT01355393|Immunologic Factors|immunologic factors|mesh-ancestor
25042902|NCT01355393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042903|NCT01355393|Antiviral Agents|antiviral agents|mesh-ancestor
25042904|NCT01355393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042905|NCT01354717|Fluorouracil|fluorouracil|mesh-list
25042906|NCT01354717|Antimetabolites|antimetabolites|mesh-ancestor
25042907|NCT01354717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042908|NCT01354717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25042909|NCT01354717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042910|NCT01354717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25042911|NCT01354717|Immunologic Factors|immunologic factors|mesh-ancestor
25042912|NCT01354717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042913|NCT01353248|Ribavirin|ribavirin|mesh-list
25042914|NCT01353248|Ledipasvir|ledipasvir|mesh-list
25042915|NCT01353248|Antimetabolites|antimetabolites|mesh-ancestor
25042916|NCT01353248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042917|NCT01353248|Antiviral Agents|antiviral agents|mesh-ancestor
25042918|NCT01353248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042919|NCT01349868|Formoterol Fumarate|formoterol fumarate|mesh-list
25042920|NCT01349868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25042921|NCT01349868|Autonomic Agents|autonomic agents|mesh-ancestor
25042922|NCT01349868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25042923|NCT01349868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042924|NCT01349868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25042925|NCT01349868|Respiratory System Agents|respiratory system agents|mesh-ancestor
25042926|NCT01349868|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25042927|NCT01349868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24835145|NCT02182336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25090105|NCT03260439|Analgesics|analgesics|mesh-ancestor
25090106|NCT03260439|Sensory System Agents|sensory system agents|mesh-ancestor
25090107|NCT03260439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25090108|NCT03260569|Nitric Oxide|nitric oxide|mesh-list
25090109|NCT03260569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25222265|NCT02645903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222266|NCT02645981|Sorafenib|sorafenib|mesh-list
25222267|NCT02645981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25222268|NCT02645981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25222269|NCT02645981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25222270|NCT02645981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273141|NCT02387138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273142|NCT02387060|Fentanyl|fentanyl|mesh-list
25273143|NCT02387060|Bupivacaine|bupivacaine|mesh-list
25273144|NCT02387060|Anesthetics, Local|anesthetics, local|mesh-ancestor
25273145|NCT02387060|Anesthetics|anesthetics|mesh-ancestor
25273146|NCT02387060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25273147|NCT02387060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273148|NCT02387060|Sensory System Agents|sensory system agents|mesh-ancestor
25679897|NCT01844531|Metformin|metformin|mesh-list
25679898|NCT01844531|Empagliflozin|empagliflozin|mesh-list
25679899|NCT01844531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25679900|NCT01844531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679901|NCT01844531|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25679902|NCT01844531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273161|NCT02387021|Sensory System Agents|sensory system agents|mesh-ancestor
25273162|NCT02387021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25273163|NCT02386943|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25273164|NCT02386943|Saxagliptin|saxagliptin|mesh-list
25273165|NCT02386943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25273166|NCT02386943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273167|NCT02386943|Incretins|incretins|mesh-ancestor
25273168|NCT02386943|Hormones|hormones|mesh-ancestor
25273169|NCT02386943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24835146|NCT02182336|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24835147|NCT02182336|Protective Agents|protective agents|mesh-ancestor
24835148|NCT02182336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24835149|NCT02182336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24835174|NCT02182401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24835175|NCT02182401|Anesthetics, General|anesthetics, general|mesh-ancestor
24835177|NCT02182401|GABA Modulators|gaba modulators|mesh-ancestor
25090110|NCT03260569|Autonomic Agents|autonomic agents|mesh-ancestor
25090111|NCT03260569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25090112|NCT03260569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090113|NCT03260569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25090114|NCT03260569|Respiratory System Agents|respiratory system agents|mesh-ancestor
24397768|NCT00142493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25090117|NCT03260569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550196|NCT00719602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24550197|NCT00719602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24397633|NCT00142051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24397634|NCT00142051|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24397635|NCT00142051|Vasodilator Agents|vasodilator agents|mesh-ancestor
24397636|NCT00142051|Gasotransmitters|gasotransmitters|mesh-ancestor
24397637|NCT00142051|Protective Agents|protective agents|mesh-ancestor
24397639|NCT00142129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24397640|NCT00142155|Rituximab|rituximab|mesh-list
24397641|NCT00142155|Antibodies|antibodies|mesh-list
24397642|NCT00142155|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25679903|NCT01844583|Rifampin|rifampin|mesh-list
25679904|NCT01844583|Esomeprazole|esomeprazole|mesh-list
25679905|NCT01844583|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25679906|NCT01844583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25679907|NCT01844583|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25679908|NCT01844583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25679909|NCT01844583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679910|NCT01844583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24397643|NCT00142155|Immunologic Factors|immunologic factors|mesh-ancestor
24397644|NCT00142155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397645|NCT00142155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25222271|NCT02646020|Loratadine|loratadine|mesh-list
25222272|NCT02646020|Aprepitant|aprepitant|mesh-list
25222273|NCT02646020|Fosaprepitant|fosaprepitant|mesh-list
25222274|NCT02646020|Desloratadine|desloratadine|mesh-list
25222275|NCT02646020|Antiemetics|antiemetics|mesh-ancestor
25222276|NCT02646020|Autonomic Agents|autonomic agents|mesh-ancestor
25222277|NCT02646020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222278|NCT02646020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222279|NCT02646020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25222280|NCT02646020|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25222281|NCT02646020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25222282|NCT02646020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222283|NCT02646020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25222284|NCT02646020|Cholinergic Agents|cholinergic agents|mesh-ancestor
25222285|NCT02646020|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25222286|NCT02646020|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25222287|NCT02646020|Histamine Antagonists|histamine antagonists|mesh-ancestor
25222288|NCT02646020|Histamine Agents|histamine agents|mesh-ancestor
25222289|NCT02646020|Antipruritics|antipruritics|mesh-ancestor
25222290|NCT02646020|Dermatologic Agents|dermatologic agents|mesh-ancestor
25222291|NCT02646020|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25222292|NCT02645656|Curcumin|curcumin|mesh-list
25245805|NCT03697512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25222293|NCT02645656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25222294|NCT02645656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25222295|NCT02645656|Analgesics|analgesics|mesh-ancestor
25222296|NCT02645656|Sensory System Agents|sensory system agents|mesh-ancestor
24835202|NCT02182479|Adrenergic Agents|adrenergic agents|mesh-ancestor
24835203|NCT02182479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24835205|NCT02182479|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24835206|NCT02182479|Cholinergic Agents|cholinergic agents|mesh-ancestor
24835208|NCT02182505|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
24835209|NCT02182505|Ipratropium|ipratropium|mesh-list
24835210|NCT02182505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24835211|NCT02182505|Autonomic Agents|autonomic agents|mesh-ancestor
24835212|NCT02182505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835213|NCT02182505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569765|NCT00801879|Mupirocin|mupirocin|mesh-list
24397648|NCT00142181|Alemtuzumab|alemtuzumab|mesh-list
25679912|NCT01844583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25679913|NCT01844583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25679914|NCT01844583|Leprostatic Agents|leprostatic agents|mesh-ancestor
25679915|NCT01844583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25679916|NCT01844583|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25679917|NCT01844583|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25679918|NCT01844583|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25679919|NCT01844583|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25679920|NCT01844583|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25679921|NCT01844583|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24397719|NCT00142467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24397720|NCT00142467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24397721|NCT00142467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24397722|NCT00142467|Growth Substances|growth substances|mesh-ancestor
24397723|NCT00142467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397724|NCT00142467|Growth Inhibitors|growth inhibitors|mesh-ancestor
24397726|NCT00142467|Antimetabolites|antimetabolites|mesh-ancestor
25090118|NCT03260569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25090119|NCT03260569|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25090120|NCT03260569|Vasodilator Agents|vasodilator agents|mesh-ancestor
24397778|NCT00142545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24397779|NCT00142545|Dopamine Agonists|dopamine agonists|mesh-ancestor
24397780|NCT00142545|Dopamine Agents|dopamine agents|mesh-ancestor
24397781|NCT00142545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25222297|NCT02645656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222298|NCT02645656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222299|NCT02645656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25222300|NCT02645656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25222301|NCT02645656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25222302|NCT02645656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25222303|NCT02645656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222304|NCT02645552|Tranexamic Acid|tranexamic acid|mesh-list
25222305|NCT02645552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25222306|NCT02645552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25222307|NCT02645552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222308|NCT02645552|Hemostatics|hemostatics|mesh-ancestor
25222309|NCT02645552|Coagulants|coagulants|mesh-ancestor
25222310|NCT02645370|Topiramate|topiramate|mesh-list
25222311|NCT02645370|Anticonvulsants|anticonvulsants|mesh-ancestor
25222312|NCT02645370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25222313|NCT02645370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222314|NCT02645461|Palmidrol|palmidrol|mesh-list
25222315|NCT02645461|Riluzole|riluzole|mesh-list
25222316|NCT02645461|Anticonvulsants|anticonvulsants|mesh-ancestor
25222317|NCT02645461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25222318|NCT02645461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25222319|NCT02645461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25222320|NCT02645461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222321|NCT02645461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835215|NCT02182505|Respiratory System Agents|respiratory system agents|mesh-ancestor
24835234|NCT02182518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24835235|NCT02182518|Respiratory System Agents|respiratory system agents|mesh-ancestor
24835236|NCT02182518|Nasal Decongestants|nasal decongestants|mesh-ancestor
24835237|NCT02182518|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24835238|NCT02182518|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24835239|NCT02182518|Sympathomimetics|sympathomimetics|mesh-ancestor
24952419|NCT03894280|Xhance|xhance|mesh-list
24397782|NCT00142545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397783|NCT00142571|Gemcitabine|gemcitabine|mesh-list
24397785|NCT00142571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24397786|NCT00142571|Antimetabolites|antimetabolites|mesh-ancestor
24397788|NCT00142571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24397798|NCT00142610|Vitamins|vitamins|mesh-list
24397799|NCT00142610|Vitamin E|vitamin e|mesh-list
24397833|NCT00142844|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25679923|NCT01844687|Anticonvulsants|anticonvulsants|mesh-ancestor
25679924|NCT01844700|Risperidone|risperidone|mesh-list
25679925|NCT01844700|Aripiprazole|aripiprazole|mesh-list
25679926|NCT01844700|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25679927|NCT01844700|Ziprasidone|ziprasidone|mesh-list
25679928|NCT01844700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25679929|NCT01844700|Serotonin Agents|serotonin agents|mesh-ancestor
25679930|NCT01844700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24397835|NCT00142844|Sensory System Agents|sensory system agents|mesh-ancestor
24397836|NCT00142844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24397837|NCT00142844|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
24397838|NCT00142844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24397839|NCT00142844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397918|NCT00143026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397919|NCT00143026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397920|NCT00143026|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24397921|NCT00143026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24397922|NCT00143026|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24397923|NCT00143065|Rituximab|rituximab|mesh-list
24397956|NCT00143130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24397957|NCT00143130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24397958|NCT00143143|Pregabalin|pregabalin|mesh-list
24397960|NCT00143143|Sensory System Agents|sensory system agents|mesh-ancestor
24397961|NCT00143143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24397962|NCT00143143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982658|NCT01307033|Losartan|losartan|mesh-list
24397963|NCT00143143|Anticonvulsants|anticonvulsants|mesh-ancestor
24397964|NCT00143143|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24397965|NCT00143143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24397966|NCT00143143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397967|NCT00143143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24397968|NCT00143143|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24397969|NCT00143143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24397970|NCT00143143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24397971|NCT00143143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24397972|NCT00143156|Pregabalin|pregabalin|mesh-list
25222322|NCT02645461|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25222323|NCT02645461|Protective Agents|protective agents|mesh-ancestor
25222324|NCT02645461|Analgesics|analgesics|mesh-ancestor
25222325|NCT02645461|Sensory System Agents|sensory system agents|mesh-ancestor
25222326|NCT02645461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222327|NCT02645461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25222328|NCT02645461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25222329|NCT02645461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25222330|NCT02645461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25222331|NCT02645461|Antiviral Agents|antiviral agents|mesh-ancestor
25222332|NCT02645461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25222333|NCT02645461|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25222334|NCT02645461|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25222335|NCT02645461|Hormones|hormones|mesh-ancestor
24835242|NCT02182518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835243|NCT02182518|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24835244|NCT02182518|Histamine Antagonists|histamine antagonists|mesh-ancestor
24835245|NCT02182518|Histamine Agents|histamine agents|mesh-ancestor
24835246|NCT02182531|Pseudoephedrine|pseudoephedrine|mesh-list
24835249|NCT02182531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24835250|NCT02182531|Autonomic Agents|autonomic agents|mesh-ancestor
25090121|NCT03260569|Gasotransmitters|gasotransmitters|mesh-ancestor
25090122|NCT03260569|Protective Agents|protective agents|mesh-ancestor
25090123|NCT03260556|Pirfenidone|pirfenidone|mesh-list
25090124|NCT03260556|Analgesics|analgesics|mesh-ancestor
25090125|NCT03260556|Sensory System Agents|sensory system agents|mesh-ancestor
24982692|NCT00739674|Diuretics|diuretics|mesh-ancestor
25090126|NCT03260556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25090127|NCT03260556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090128|NCT03260556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25090129|NCT03260556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25090130|NCT03260556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25090131|NCT03260556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25090132|NCT03260556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25090133|NCT03260283|Fentanyl|fentanyl|mesh-list
25090134|NCT03260283|Meperidine|meperidine|mesh-list
25090135|NCT03260283|Ropivacaine|ropivacaine|mesh-list
25090136|NCT03260283|Anesthetics, Local|anesthetics, local|mesh-ancestor
25090137|NCT03260283|Anesthetics|anesthetics|mesh-ancestor
25090138|NCT03260283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25090139|NCT03260283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090140|NCT03260283|Sensory System Agents|sensory system agents|mesh-ancestor
25090141|NCT03260283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25090142|NCT03260283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25090143|NCT03260283|Narcotics|narcotics|mesh-ancestor
25090144|NCT03260283|Analgesics|analgesics|mesh-ancestor
25090145|NCT03260283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24516157|NCT00600691|Urological Agents|urological agents|mesh-ancestor
24397973|NCT00143156|Analgesics|analgesics|mesh-ancestor
24397974|NCT00143156|Sensory System Agents|sensory system agents|mesh-ancestor
24398001|NCT00143195|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24398002|NCT00143195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24398003|NCT00143195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398004|NCT00143195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24398005|NCT00143195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398006|NCT00143195|Vasodilator Agents|vasodilator agents|mesh-ancestor
24455468|NCT00107198|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24455469|NCT00107198|Vincristine|vincristine|mesh-list
24455470|NCT00107198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24455471|NCT00107198|Immunologic Factors|immunologic factors|mesh-ancestor
24455472|NCT00107198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090146|NCT03260283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25090147|NCT03260283|Anesthetics, General|anesthetics, general|mesh-ancestor
25090148|NCT03260166|Niacinamide|niacinamide|mesh-list
25090149|NCT03260166|Niacin|niacin|mesh-list
25222336|NCT02645461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25222337|NCT02645227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25222338|NCT02645227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25222339|NCT02645227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25222340|NCT02645227|Antimetabolites|antimetabolites|mesh-ancestor
25222341|NCT02645227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222342|NCT02645227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25222343|NCT02645227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25222344|NCT02645227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25222345|NCT02645240|Heparin|heparin|mesh-list
25222346|NCT02645240|Calcium heparin|calcium heparin|mesh-list
25222347|NCT02645240|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25222348|NCT02645240|Tinzaparin|tinzaparin|mesh-list
25222349|NCT02645240|Dalteparin|dalteparin|mesh-list
25222350|NCT02645240|Anticoagulants|anticoagulants|mesh-ancestor
25222351|NCT02645240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24835251|NCT02182531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835252|NCT02182531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835253|NCT02182531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24835254|NCT02182531|Respiratory System Agents|respiratory system agents|mesh-ancestor
24835255|NCT02182531|Nasal Decongestants|nasal decongestants|mesh-ancestor
24835256|NCT02182531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24835257|NCT02182531|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24835258|NCT02182531|Sympathomimetics|sympathomimetics|mesh-ancestor
24835259|NCT02182531|Adrenergic Agents|adrenergic agents|mesh-ancestor
24835260|NCT02182531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24835291|NCT02182570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24835292|NCT02182570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835293|NCT02182570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835294|NCT02182583|Oxitropium|oxitropium|mesh-list
24835295|NCT02182583|Parasympatholytics|parasympatholytics|mesh-ancestor
24835296|NCT02182583|Autonomic Agents|autonomic agents|mesh-ancestor
24835301|NCT02182596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24835302|NCT02182622|Prednisone|prednisone|mesh-list
24835303|NCT02182622|Docetaxel|docetaxel|mesh-list
24835304|NCT02182622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24835305|NCT02182622|Tubulin Modulators|tubulin modulators|mesh-ancestor
24835306|NCT02182622|Antimitotic Agents|antimitotic agents|mesh-ancestor
24835307|NCT02182622|Mitosis Modulators|mitosis modulators|mesh-ancestor
24835308|NCT02182622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835309|NCT02182622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25679931|NCT01844700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835311|NCT02182622|Hormones|hormones|mesh-ancestor
24835312|NCT02182622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24835313|NCT02182622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835314|NCT02182622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24835315|NCT02182635|Oxitropium|oxitropium|mesh-list
24835316|NCT02182635|Parasympatholytics|parasympatholytics|mesh-ancestor
24835317|NCT02182635|Autonomic Agents|autonomic agents|mesh-ancestor
25090150|NCT03260166|Nicotinic Acids|nicotinic acids|mesh-list
25222352|NCT02645240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25222353|NCT02645240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222354|NCT02645214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
25222355|NCT02645214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25222356|NCT02645266|Aflibercept|aflibercept|mesh-list
25222357|NCT02645266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25222358|NCT02645266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25222359|NCT02645266|Growth Substances|growth substances|mesh-ancestor
25222360|NCT02645266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222361|NCT02645266|Growth Inhibitors|growth inhibitors|mesh-ancestor
25222362|NCT02645266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25222363|NCT02645279|Midazolam|midazolam|mesh-list
25222364|NCT02645279|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25222365|NCT02645279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25222366|NCT02645279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25222367|NCT02645279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222368|NCT02645279|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25222369|NCT02645279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25222370|NCT02645279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25222371|NCT02645279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25222372|NCT02645279|Anesthetics, General|anesthetics, general|mesh-ancestor
25222373|NCT02645279|Anesthetics|anesthetics|mesh-ancestor
25222374|NCT02645279|GABA Modulators|gaba modulators|mesh-ancestor
25222375|NCT02645279|GABA Agents|gaba agents|mesh-ancestor
25222376|NCT02645279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25222377|NCT02645279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222378|NCT02645058|Analgesics|analgesics|mesh-list
25222379|NCT02645058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222380|NCT02645058|Sensory System Agents|sensory system agents|mesh-ancestor
25222381|NCT02645058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222382|NCT02645032|Vaccines|vaccines|mesh-list
25222383|NCT02645032|Immunologic Factors|immunologic factors|mesh-ancestor
25222384|NCT02645032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835318|NCT02182635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835319|NCT02182635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835320|NCT02182648|Propofol|propofol|mesh-list
24835321|NCT02182648|Etomidate|etomidate|mesh-list
24835322|NCT02182648|Sevoflurane|sevoflurane|mesh-list
24835323|NCT02182648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24835324|NCT02182648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24835325|NCT02182648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835326|NCT02182648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24835327|NCT02182648|Anesthetics, General|anesthetics, general|mesh-ancestor
25090153|NCT03260166|Micronutrients|micronutrients|mesh-ancestor
24766283|NCT01794078|Respiratory System Agents|respiratory system agents|mesh-ancestor
25090154|NCT03260166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090155|NCT03260166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24766357|NCT01794273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25090156|NCT03260166|Antimetabolites|antimetabolites|mesh-ancestor
25090157|NCT03260166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090158|NCT03260166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25090159|NCT03260166|Vasodilator Agents|vasodilator agents|mesh-ancestor
25090160|NCT03260010|Fosfomycin|fosfomycin|mesh-list
25090161|NCT03260010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25245806|NCT03697512|Immunologic Factors|immunologic factors|mesh-ancestor
25090162|NCT03260010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25090163|NCT03260049|Antiviral Agents|antiviral agents|mesh-list
25090164|NCT03260049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25090165|NCT03260088|Immunoglobulins|immunoglobulins|mesh-list
25222391|NCT02644980|Anesthetics|anesthetics|mesh-list
25222392|NCT02644980|Propofol|propofol|mesh-list
25222393|NCT02644980|Etomidate|etomidate|mesh-list
25222394|NCT02644980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25222395|NCT02644980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159912|NCT03504956|Adrenergic Agents|adrenergic agents|mesh-ancestor
25222403|NCT02644954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222404|NCT02644954|Dermatologic Agents|dermatologic agents|mesh-ancestor
25222405|NCT02644954|Keratolytic Agents|keratolytic agents|mesh-ancestor
25222406|NCT02644785|Protamines|protamines|mesh-list
25222407|NCT02644785|Heparin Antagonists|heparin antagonists|mesh-ancestor
25222440|NCT02644720|Hormones|hormones|mesh-ancestor
25222411|NCT02644694|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25222412|NCT02644694|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25222413|NCT02644694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25222414|NCT02644694|Antiemetics|antiemetics|mesh-ancestor
25222415|NCT02644694|Autonomic Agents|autonomic agents|mesh-ancestor
25222416|NCT02644694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222417|NCT02644694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222418|NCT02644694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24835359|NCT02182713|Anticonvulsants|anticonvulsants|mesh-ancestor
24835360|NCT02182713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24835361|NCT02182713|Autonomic Agents|autonomic agents|mesh-ancestor
24835362|NCT02182713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835363|NCT02182713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835364|NCT02182713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24835365|NCT02182713|Respiratory System Agents|respiratory system agents|mesh-ancestor
24835381|NCT02182739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835403|NCT02182765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24835404|NCT02182765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24835405|NCT02182765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835406|NCT02182765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835407|NCT02182765|Antiviral Agents|antiviral agents|mesh-ancestor
24835408|NCT02182765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24835409|NCT02182765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25054903|NCT03526224|Dermatologic Agents|dermatologic agents|mesh-ancestor
25090166|NCT03260088|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25090167|NCT03260088|Antibodies|antibodies|mesh-list
25090168|NCT03260088|Immunoglobulin G|immunoglobulin g|mesh-list
25090169|NCT03260088|Immunologic Factors|immunologic factors|mesh-ancestor
24455473|NCT00107198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24455474|NCT00107198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24398033|NCT00143260|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24398034|NCT00143260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24398035|NCT00143260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398036|NCT00143260|Urological Agents|urological agents|mesh-ancestor
24398037|NCT00143286|Varenicline|varenicline|mesh-list
24398038|NCT00143286|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24398039|NCT00143286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24398049|NCT00143299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398060|NCT00143338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222419|NCT02644694|Glucocorticoids|glucocorticoids|mesh-ancestor
25222420|NCT02644694|Hormones|hormones|mesh-ancestor
25222421|NCT02644694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25222422|NCT02644694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25222423|NCT02644694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25222424|NCT02644694|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25222425|NCT02644707|Selenium|selenium|mesh-list
25222426|NCT02644707|Antioxidants|antioxidants|mesh-ancestor
25222427|NCT02644707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222428|NCT02644707|Protective Agents|protective agents|mesh-ancestor
25222429|NCT02644707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222430|NCT02644707|Trace Elements|trace elements|mesh-ancestor
25679933|NCT01844700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25222431|NCT02644707|Micronutrients|micronutrients|mesh-ancestor
25222432|NCT02644720|Dexamethasone|dexamethasone|mesh-list
25679934|NCT01844700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25222433|NCT02644720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25222434|NCT02644720|Antiemetics|antiemetics|mesh-ancestor
25222435|NCT02644720|Autonomic Agents|autonomic agents|mesh-ancestor
25222436|NCT02644720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222437|NCT02644720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222438|NCT02644720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25222439|NCT02644720|Glucocorticoids|glucocorticoids|mesh-ancestor
25222441|NCT02644720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25222442|NCT02644720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25222443|NCT02644720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25222444|NCT02644863|Paclitaxel|paclitaxel|mesh-list
25222445|NCT02644863|Cisplatin|cisplatin|mesh-list
25222446|NCT02644863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25222447|NCT02644863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24835410|NCT02182765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24835411|NCT02182765|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24835412|NCT02182765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24835413|NCT02182765|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24835414|NCT02182765|Antitubercular Agents|antitubercular agents|mesh-ancestor
24398062|NCT00143351|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24398063|NCT00143351|Serotonin Agents|serotonin agents|mesh-ancestor
24398064|NCT00143351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24398065|NCT00143351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398066|NCT00143351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398067|NCT00143351|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24398068|NCT00143351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25090175|NCT03259958|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25090176|NCT03259958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090177|NCT03259958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090178|NCT03259958|Cholinergic Agents|cholinergic agents|mesh-ancestor
25090179|NCT03259958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25090180|NCT03259958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090181|NCT03259958|Nootropic Agents|nootropic agents|mesh-ancestor
25090182|NCT03259529|Gemcitabine|gemcitabine|mesh-list
25090184|NCT03259529|Nivolumab|nivolumab|mesh-list
24398095|NCT00143442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24398096|NCT00143442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24398097|NCT00143442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398098|NCT00143442|Adrenergic Agents|adrenergic agents|mesh-ancestor
24398099|NCT00143442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24398100|NCT00143442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398101|NCT00143481|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24398102|NCT00143481|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24398103|NCT00143481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24398138|NCT00143624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398139|NCT00143676|Atorvastatin|atorvastatin|mesh-list
24398140|NCT00143676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24398141|NCT00143676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24398142|NCT00143676|Antimetabolites|antimetabolites|mesh-ancestor
24398143|NCT00143676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398144|NCT00143676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24398145|NCT00143676|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24398146|NCT00143676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398147|NCT00143689|Ritonavir|ritonavir|mesh-list
24398148|NCT00143689|Lopinavir|lopinavir|mesh-list
24398189|NCT00143715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398190|NCT00143715|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24398191|NCT00143715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24398192|NCT00143715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398193|NCT00143715|Hemostatics|hemostatics|mesh-ancestor
24398194|NCT00143715|Coagulants|coagulants|mesh-ancestor
24398196|NCT00143728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24398197|NCT00143728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25679935|NCT01844700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25222459|NCT02644629|Anesthetics, General|anesthetics, general|mesh-ancestor
25222460|NCT02644629|Anesthetics|anesthetics|mesh-ancestor
24835418|NCT02182765|Protease Inhibitors|protease inhibitors|mesh-ancestor
24745646|NCT03662919|Adalimumab|adalimumab|mesh-list
24398200|NCT00143728|Antiviral Agents|antiviral agents|mesh-ancestor
24398201|NCT00143728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24398202|NCT00143728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24398203|NCT00143728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24398204|NCT00143741|Atorvastatin|atorvastatin|mesh-list
24398224|NCT00143806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24398225|NCT00143806|Dermatologic Agents|dermatologic agents|mesh-ancestor
25090185|NCT03259529|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24753545|NCT01715922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090193|NCT03259529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090194|NCT03259529|Antiviral Agents|antiviral agents|mesh-ancestor
24398226|NCT00143806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24398227|NCT00143806|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24398229|NCT00143871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24398230|NCT00143871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24398231|NCT00143871|Immunologic Factors|immunologic factors|mesh-ancestor
24398232|NCT00143871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398233|NCT00143871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24398235|NCT00143949|Enalapril|enalapril|mesh-list
24398236|NCT00143949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24398237|NCT00143949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24398238|NCT00143949|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24398239|NCT00143949|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24398240|NCT00143949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398241|NCT00143949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24398242|NCT00143949|Protease Inhibitors|protease inhibitors|mesh-ancestor
24398243|NCT00143949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398244|NCT00143975|Cytarabine|cytarabine|mesh-list
24398245|NCT00143975|Mitoxantrone|mitoxantrone|mesh-list
24398246|NCT00143975|Gemtuzumab|gemtuzumab|mesh-list
24398247|NCT00143975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25222461|NCT02644629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25222462|NCT02644629|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25222463|NCT02644629|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25222464|NCT02644629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25222465|NCT02644629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222466|NCT02644915|Edaravone|edaravone|mesh-list
25222467|NCT02644915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25679936|NCT01844700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25679937|NCT01844700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25679938|NCT01844700|Dopamine Agents|dopamine agents|mesh-ancestor
25679939|NCT01844700|Antidepressive Agents|antidepressive agents|mesh-ancestor
25679940|NCT01844700|Dopamine Agonists|dopamine agonists|mesh-ancestor
25222468|NCT02644915|Antioxidants|antioxidants|mesh-ancestor
25679941|NCT01844700|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25222469|NCT02644915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222470|NCT02644915|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25222471|NCT02644915|Protective Agents|protective agents|mesh-ancestor
25222472|NCT02644915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222473|NCT02644811|Anesthetics|anesthetics|mesh-list
25222474|NCT02644811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25222475|NCT02644811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222476|NCT02644616|Torsemide|torsemide|mesh-list
25222477|NCT02644616|Tolvaptan|tolvaptan|mesh-list
24835440|NCT02182791|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24835441|NCT02182791|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24835443|NCT02182856|Albuterol|albuterol|mesh-list
24835444|NCT02182856|Ipratropium|ipratropium|mesh-list
24835445|NCT02182856|Anticonvulsants|anticonvulsants|mesh-ancestor
24835446|NCT02182856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24835447|NCT02182856|Autonomic Agents|autonomic agents|mesh-ancestor
24835448|NCT02182856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835449|NCT02182856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835450|NCT02182856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24835451|NCT02182856|Respiratory System Agents|respiratory system agents|mesh-ancestor
24835452|NCT02182856|Tocolytic Agents|tocolytic agents|mesh-ancestor
24835453|NCT02182856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24835454|NCT02182856|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24835455|NCT02182856|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24835456|NCT02182856|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24835457|NCT02182856|Adrenergic Agents|adrenergic agents|mesh-ancestor
24835458|NCT02182856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24835463|NCT02182960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24835464|NCT02182960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24835465|NCT02182960|Analgesics|analgesics|mesh-ancestor
24835466|NCT02182960|Sensory System Agents|sensory system agents|mesh-ancestor
24835467|NCT02182960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835468|NCT02182960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835469|NCT02182960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24835470|NCT02182960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24835471|NCT02182960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24835472|NCT02182960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398248|NCT00143975|Antimetabolites|antimetabolites|mesh-ancestor
24398249|NCT00143975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398250|NCT00143975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24398251|NCT00143975|Antiviral Agents|antiviral agents|mesh-ancestor
24398252|NCT00143975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24398261|NCT00143975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398262|NCT00143975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24398263|NCT00144040|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25222478|NCT02644616|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25222479|NCT02644616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222480|NCT02644616|Natriuretic Agents|natriuretic agents|mesh-ancestor
25222481|NCT02644616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222482|NCT02644616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25222483|NCT02644616|Diuretics|diuretics|mesh-ancestor
25222484|NCT02644616|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25222485|NCT02644616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25222486|NCT02644499|Folic Acid|folic acid|mesh-list
25222487|NCT02644499|Hydroxychloroquine|hydroxychloroquine|mesh-list
25222488|NCT02644499|Prednisolone|prednisolone|mesh-list
25222489|NCT02644499|Methotrexate|methotrexate|mesh-list
25222490|NCT02644499|Leflunomide|leflunomide|mesh-list
25222491|NCT02644499|Glucocorticoids|glucocorticoids|mesh-list
25222492|NCT02644499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25222493|NCT02644499|Abortifacient Agents|abortifacient agents|mesh-ancestor
25222494|NCT02644499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25222495|NCT02644499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222496|NCT02644499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25222497|NCT02644499|Antimetabolites|antimetabolites|mesh-ancestor
25222498|NCT02644499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222499|NCT02644499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25222500|NCT02644499|Dermatologic Agents|dermatologic agents|mesh-ancestor
25222501|NCT02644499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25222502|NCT02644499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25222503|NCT02644499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25222504|NCT02644499|Immunologic Factors|immunologic factors|mesh-ancestor
25222505|NCT02644499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25222506|NCT02644499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25222507|NCT02644499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24982892|NCT00378378|Mometasone Furoate|mometasone furoate|mesh-list
24982893|NCT00378378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25273170|NCT02386943|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24835474|NCT02182986|Immunosuppressive Agents|immunosuppressive agents|mesh-list
24835516|NCT02183038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835524|NCT02183051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835525|NCT02183051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835526|NCT02183051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24835527|NCT02183051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24398265|NCT00144040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24398266|NCT00144040|Antitubercular Agents|antitubercular agents|mesh-ancestor
24398279|NCT00144053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398280|NCT00144066|Gefitinib|gefitinib|mesh-list
24398281|NCT00144066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24398282|NCT00144066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24398283|NCT00144066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398284|NCT00144066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398285|NCT00144118|Sevoflurane|sevoflurane|mesh-list
24398286|NCT00144118|Isoflurane|isoflurane|mesh-list
24398287|NCT00144118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24398288|NCT00144118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25090195|NCT03259529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25090196|NCT03259529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090197|NCT03259529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25090198|NCT03259529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25090199|NCT03259529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25090208|NCT03259516|Sildenafil Citrate|sildenafil citrate|mesh-list
25222509|NCT02644499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25222510|NCT02644499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25222511|NCT02644499|Antimalarials|antimalarials|mesh-ancestor
24982894|NCT00378378|Dermatologic Agents|dermatologic agents|mesh-ancestor
25222512|NCT02644499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25222513|NCT02644499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25222514|NCT02644499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25222515|NCT02644499|Hematinics|hematinics|mesh-ancestor
25222516|NCT02644499|Vitamin B Complex|vitamin b complex|mesh-ancestor
25222517|NCT02644499|Vitamins|vitamins|mesh-ancestor
25222518|NCT02644499|Micronutrients|micronutrients|mesh-ancestor
25222519|NCT02644590|Melatonin|melatonin|mesh-list
25222520|NCT02644590|Antioxidants|antioxidants|mesh-ancestor
25222521|NCT02644590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222522|NCT02644590|Protective Agents|protective agents|mesh-ancestor
25222523|NCT02644590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222524|NCT02644590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25222525|NCT02644538|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25222526|NCT02644538|Antiviral Agents|antiviral agents|mesh-ancestor
25222527|NCT02644538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25222528|NCT02644551|Ciclopirox|ciclopirox|mesh-list
25222529|NCT02644551|Antifungal Agents|antifungal agents|mesh-ancestor
25222530|NCT02644551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25222531|NCT02644395|Amlodipine|amlodipine|mesh-list
25222532|NCT02644395|Chlorthalidone|chlorthalidone|mesh-list
24835528|NCT02183051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24835529|NCT02183051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835530|NCT02183051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835532|NCT02183064|Meloxicam|meloxicam|mesh-list
25679942|NCT01844700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25679943|NCT01844700|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24835533|NCT02183064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24835534|NCT02183064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24835535|NCT02183064|Analgesics|analgesics|mesh-ancestor
25679944|NCT01844700|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24835536|NCT02183064|Sensory System Agents|sensory system agents|mesh-ancestor
24835537|NCT02183064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835538|NCT02183064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835539|NCT02183064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24835540|NCT02183064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24835548|NCT02183077|Analgesics|analgesics|mesh-ancestor
25054988|NCT03525730|Antimalarials|antimalarials|mesh-ancestor
25090209|NCT03259516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25090210|NCT03259516|Immunologic Factors|immunologic factors|mesh-ancestor
25090211|NCT03259516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090212|NCT03259516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25090213|NCT03259516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25090214|NCT03259516|Alkylating Agents|alkylating agents|mesh-ancestor
25090215|NCT03259516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090216|NCT03259516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25090217|NCT03259516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25090218|NCT03259516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25090219|NCT03259516|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25090220|NCT03259516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25090221|NCT03259516|Antimetabolites|antimetabolites|mesh-ancestor
25090222|NCT03259516|Antiviral Agents|antiviral agents|mesh-ancestor
25090223|NCT03259516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24398289|NCT00144118|Anesthetics, General|anesthetics, general|mesh-ancestor
24398290|NCT00144118|Anesthetics|anesthetics|mesh-ancestor
24398291|NCT00144118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24398292|NCT00144118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398293|NCT00144131|Darbepoetin alfa|darbepoetin alfa|mesh-list
24398313|NCT00144157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24398314|NCT00144157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24398315|NCT00144157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398316|NCT00144157|Antiviral Agents|antiviral agents|mesh-ancestor
24398317|NCT00144157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24398318|NCT00144157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24398319|NCT00144157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24398320|NCT00144157|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24398321|NCT00144157|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24398322|NCT00144183|Zidovudine|zidovudine|mesh-list
24398323|NCT00144183|Nevirapine|nevirapine|mesh-list
24398324|NCT00144183|Antimetabolites|antimetabolites|mesh-ancestor
25090225|NCT03259516|Vasodilator Agents|vasodilator agents|mesh-ancestor
25090226|NCT03259516|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25090227|NCT03259516|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25090228|NCT03259516|Urological Agents|urological agents|mesh-ancestor
25090229|NCT03259516|Keratolytic Agents|keratolytic agents|mesh-ancestor
24398325|NCT00144183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398326|NCT00144183|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24398327|NCT00144183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24398328|NCT00144183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398329|NCT00144183|Antiviral Agents|antiviral agents|mesh-ancestor
24398330|NCT00144183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25679945|NCT01844778|Tobramycin|tobramycin|mesh-list
25679946|NCT01844778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25679947|NCT01844778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25679948|NCT01844830|Phenylephrine|phenylephrine|mesh-list
25679949|NCT01844830|Oxymetazoline|oxymetazoline|mesh-list
25679950|NCT01844830|Tetracaine|tetracaine|mesh-list
25679951|NCT01844830|Anesthetics, Local|anesthetics, local|mesh-ancestor
25679952|NCT01844830|Anesthetics|anesthetics|mesh-ancestor
25679953|NCT01844830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25679954|NCT01844830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679955|NCT01844830|Sensory System Agents|sensory system agents|mesh-ancestor
25679956|NCT01844830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222533|NCT02644395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25222534|NCT02644395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25222535|NCT02644395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25222536|NCT02644395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222537|NCT02644395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25222538|NCT02644395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222539|NCT02644395|Vasodilator Agents|vasodilator agents|mesh-ancestor
25222540|NCT02644395|Diuretics|diuretics|mesh-ancestor
25222541|NCT02644395|Natriuretic Agents|natriuretic agents|mesh-ancestor
25222542|NCT02644395|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25222543|NCT02644304|Cabergoline|cabergoline|mesh-list
25222544|NCT02644304|Clomiphene|clomiphene|mesh-list
25222545|NCT02644304|Enclomiphene|enclomiphene|mesh-list
25222546|NCT02644304|Zuclomiphene|zuclomiphene|mesh-list
25106493|NCT02642315|Gabapentin|gabapentin|mesh-list
25106494|NCT02642315|Analgesics|analgesics|mesh-ancestor
25106495|NCT02642315|Sensory System Agents|sensory system agents|mesh-ancestor
25222547|NCT02644304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835549|NCT02183077|Sensory System Agents|sensory system agents|mesh-ancestor
24835550|NCT02183077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835551|NCT02183077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835552|NCT02183077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24835553|NCT02183077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24470284|NCT00389506|Cyclophosphamide|cyclophosphamide|mesh-list
24835576|NCT02183103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835577|NCT02183103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835578|NCT02183103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24835579|NCT02183103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24835581|NCT02183103|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24835582|NCT02183103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835583|NCT02183103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835585|NCT02183116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24835586|NCT02183116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24835587|NCT02183116|Analgesics|analgesics|mesh-ancestor
24835588|NCT02183116|Sensory System Agents|sensory system agents|mesh-ancestor
24835589|NCT02183116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835590|NCT02183116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835591|NCT02183116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24835592|NCT02183116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24835593|NCT02183116|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24835594|NCT02183116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24835595|NCT02183116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835596|NCT02183116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835598|NCT02183129|Meloxicam|meloxicam|mesh-list
24398340|NCT00144196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25106496|NCT02642315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25106497|NCT02642315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106498|NCT02642315|Anticonvulsants|anticonvulsants|mesh-ancestor
25106499|NCT02642315|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25106500|NCT02642315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25106501|NCT02642315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25106502|NCT02642315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25106503|NCT02642315|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25106504|NCT02642315|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25106505|NCT02642315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25106508|NCT02631447|Nivolumab|nivolumab|mesh-list
24398341|NCT00144196|Respiratory System Agents|respiratory system agents|mesh-ancestor
24398343|NCT00144196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24398344|NCT00144196|Cholinergic Agents|cholinergic agents|mesh-ancestor
24398345|NCT00144196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24398346|NCT00144196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398347|NCT00144209|Levodopa|levodopa|mesh-list
24398348|NCT00144209|Pramipexole|pramipexole|mesh-list
24398349|NCT00144209|Benserazide|benserazide|mesh-list
24398352|NCT00144209|Dopamine Agents|dopamine agents|mesh-ancestor
24398400|NCT00144287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24398401|NCT00144287|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24398402|NCT00144287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24398403|NCT00144326|Bromides|bromides|mesh-list
24398404|NCT00144326|Tiotropium Bromide|tiotropium bromide|mesh-list
25222548|NCT02644304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25679957|NCT01844830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25679958|NCT01844830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25222549|NCT02644304|Hormone Antagonists|hormone antagonists|mesh-ancestor
25222550|NCT02644304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25222551|NCT02644304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222552|NCT02644304|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25222553|NCT02644304|Fertility Agents|fertility agents|mesh-ancestor
25222554|NCT02644304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25222555|NCT02644304|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25222556|NCT02644304|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25222557|NCT02644304|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25222558|NCT02644304|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25222559|NCT02644304|Dopamine Agonists|dopamine agonists|mesh-ancestor
25222560|NCT02644304|Dopamine Agents|dopamine agents|mesh-ancestor
25222561|NCT02644304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25222562|NCT02644408|Megestrol|megestrol|mesh-list
25222563|NCT02644408|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25222564|NCT02644408|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25222565|NCT02644408|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25222566|NCT02644408|Contraceptive Agents|contraceptive agents|mesh-ancestor
25222567|NCT02644408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25222568|NCT02644408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222569|NCT02644408|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25222570|NCT02644408|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25222571|NCT02644408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25222572|NCT02644408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25222573|NCT02644486|Irbesartan|irbesartan|mesh-list
25222574|NCT02644486|Sevelamer|sevelamer|mesh-list
25222575|NCT02644486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25222576|NCT02644486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24835626|NCT02183155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24835627|NCT02183155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24835628|NCT02183155|Analgesics|analgesics|mesh-ancestor
24835629|NCT02183155|Sensory System Agents|sensory system agents|mesh-ancestor
24835630|NCT02183155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835631|NCT02183155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835632|NCT02183155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24835633|NCT02183155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24835636|NCT02183155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24835637|NCT02183155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24835638|NCT02183155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835657|NCT02183168|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24835659|NCT02183181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24835660|NCT02183181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24835661|NCT02183181|Analgesics|analgesics|mesh-ancestor
24835662|NCT02183181|Sensory System Agents|sensory system agents|mesh-ancestor
24835663|NCT02183181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835664|NCT02183181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835665|NCT02183181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24753616|NCT01716611|Tolvaptan|tolvaptan|mesh-list
24398460|NCT00144417|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24398461|NCT00144417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24398463|NCT00144417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24398465|NCT00144430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24398466|NCT00144430|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
24398467|NCT00144430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398468|NCT00144430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398469|NCT00144456|Alfacalcidol|alfacalcidol|mesh-list
24398470|NCT00144456|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
24398476|NCT00144469|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24398477|NCT00144469|Antiviral Agents|antiviral agents|mesh-ancestor
24398529|NCT00144807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24398530|NCT00144807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398531|NCT00144820|Hyaluronic Acid|hyaluronic acid|mesh-list
24398532|NCT00144820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24398533|NCT00144820|Immunologic Factors|immunologic factors|mesh-ancestor
24398534|NCT00144820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398535|NCT00144820|Viscosupplements|viscosupplements|mesh-ancestor
24398536|NCT00144820|Protective Agents|protective agents|mesh-ancestor
24398537|NCT00144833|Ritonavir|ritonavir|mesh-list
25222577|NCT02644486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25222578|NCT02644486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222579|NCT02644486|Chelating Agents|chelating agents|mesh-ancestor
25222580|NCT02644486|Sequestering Agents|sequestering agents|mesh-ancestor
25222581|NCT02644473|Tranexamic Acid|tranexamic acid|mesh-list
25222582|NCT02644473|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25222583|NCT02644473|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25222584|NCT02644473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222585|NCT02644473|Hemostatics|hemostatics|mesh-ancestor
25222586|NCT02644473|Coagulants|coagulants|mesh-ancestor
25222587|NCT02644577|Metformin|metformin|mesh-list
25222588|NCT02644577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25222589|NCT02644577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222590|NCT02644083|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25222591|NCT02644083|Dermatologic Agents|dermatologic agents|mesh-ancestor
25222592|NCT02644083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25222593|NCT02644083|Immunologic Factors|immunologic factors|mesh-ancestor
25222594|NCT02644083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222595|NCT02644421|Lidocaine|lidocaine|mesh-list
25222596|NCT02644421|Anesthetics, Local|anesthetics, local|mesh-ancestor
25222597|NCT02644421|Anesthetics|anesthetics|mesh-ancestor
24398844|NCT00145938|Vasodilator Agents|vasodilator agents|mesh-ancestor
24835666|NCT02183181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24835667|NCT02183181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24835668|NCT02183181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24835675|NCT02183194|Antimitotic Agents|antimitotic agents|mesh-ancestor
24835676|NCT02183194|Mitosis Modulators|mitosis modulators|mesh-ancestor
24835677|NCT02183194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835679|NCT02183220|Dipyrone|dipyrone|mesh-list
24835680|NCT02183220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24835681|NCT02183220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24835682|NCT02183220|Analgesics|analgesics|mesh-ancestor
24398613|NCT00145002|Immunologic Factors|immunologic factors|mesh-ancestor
24398614|NCT00145002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398616|NCT00145028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24398617|NCT00145093|Chromium|chromium|mesh-list
24398618|NCT00145093|Trace Elements|trace elements|mesh-ancestor
24398619|NCT00145093|Micronutrients|micronutrients|mesh-ancestor
24398620|NCT00145093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090231|NCT03259672|Sevoflurane|sevoflurane|mesh-list
25090232|NCT03259672|Desflurane|desflurane|mesh-list
25090233|NCT03259672|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25090234|NCT03259672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25090235|NCT03259672|Anesthetics, General|anesthetics, general|mesh-ancestor
24983073|NCT00090168|Atorvastatin|atorvastatin|mesh-list
24983139|NCT02118610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24983140|NCT02118610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24983141|NCT02118610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24983142|NCT02118610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090237|NCT03259672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25090238|NCT03259672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090239|NCT03259607|Nicotine|nicotine|mesh-list
25090240|NCT03259607|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25090241|NCT03259607|Autonomic Agents|autonomic agents|mesh-ancestor
25090242|NCT03259607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25090243|NCT03259607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090244|NCT03259607|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25090245|NCT03259607|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25090246|NCT03259607|Cholinergic Agents|cholinergic agents|mesh-ancestor
25090247|NCT03259607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24398621|NCT00145106|Minocycline|minocycline|mesh-list
24398622|NCT00145106|Tazarotene|tazarotene|mesh-list
24398623|NCT00145106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24398624|NCT00145106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24398625|NCT00145106|Dermatologic Agents|dermatologic agents|mesh-ancestor
24398649|NCT00145210|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24398650|NCT00145210|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24398651|NCT00145210|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24398652|NCT00145210|Adrenergic Agents|adrenergic agents|mesh-ancestor
24398653|NCT00145210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24398654|NCT00145210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398841|NCT00145925|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24398842|NCT00145925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24398843|NCT00145938|Sildenafil Citrate|sildenafil citrate|mesh-list
24398846|NCT00145938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24398847|NCT00145938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090248|NCT03259607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222603|NCT02644421|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25222604|NCT02644421|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25222605|NCT02644421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25222606|NCT02644421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222607|NCT02644252|Tocotrienols|tocotrienols|mesh-list
25222608|NCT02644252|Vitamin E|vitamin e|mesh-list
25222609|NCT02644252|Tocopherols|tocopherols|mesh-list
25222610|NCT02644252|Carboplatin|carboplatin|mesh-list
25222611|NCT02644252|Vinorelbine|vinorelbine|mesh-list
25222612|NCT02644252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795821|NCT01946373|Fludarabine phosphate|fludarabine phosphate|mesh-list
25222613|NCT02644252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24835684|NCT02183220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25090250|NCT03259542|Mifepristone|mifepristone|mesh-list
25090251|NCT03259542|Antifungal Agents|antifungal agents|mesh-ancestor
25090252|NCT03259542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25090253|NCT03259542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25090254|NCT03259542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24398848|NCT00145938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398849|NCT00145938|Urological Agents|urological agents|mesh-ancestor
24398858|NCT00145990|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24398859|NCT00145990|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24398860|NCT00145990|Cholinergic Agents|cholinergic agents|mesh-ancestor
24398861|NCT00145990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24398912|NCT00146146|Testosterone|testosterone|mesh-list
24398913|NCT00146146|Testosterone undecanoate|testosterone undecanoate|mesh-list
24398914|NCT00146146|Testosterone enanthate|testosterone enanthate|mesh-list
24398915|NCT00146146|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24398916|NCT00146146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24398917|NCT00146146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24398918|NCT00146146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24398919|NCT00146146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398920|NCT00146146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398921|NCT00146146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24398922|NCT00146146|Hormone Antagonists|hormone antagonists|mesh-ancestor
24398923|NCT00146146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24398999|NCT00146380|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24399000|NCT00146380|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24399001|NCT00146380|Protease Inhibitors|protease inhibitors|mesh-ancestor
24399002|NCT00146458|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24399078|NCT00146575|Mitosis Modulators|mitosis modulators|mesh-ancestor
24399079|NCT00146575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399080|NCT00146575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24399081|NCT00146575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24399082|NCT00146575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24795835|NCT01946373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24795836|NCT01946373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24399083|NCT00146575|Antifungal Agents|antifungal agents|mesh-ancestor
24399084|NCT00146575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24399085|NCT00146575|Immunologic Factors|immunologic factors|mesh-ancestor
24399086|NCT00146575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399087|NCT00146588|Cyclophosphamide|cyclophosphamide|mesh-list
24399088|NCT00146588|Capecitabine|capecitabine|mesh-list
24399089|NCT00146588|Epirubicin|epirubicin|mesh-list
25679959|NCT01844830|Adrenergic Agents|adrenergic agents|mesh-ancestor
25679960|NCT01844830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25679961|NCT01844830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679962|NCT01844830|Sympathomimetics|sympathomimetics|mesh-ancestor
25679963|NCT01844830|Autonomic Agents|autonomic agents|mesh-ancestor
24399092|NCT00146588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399093|NCT00146588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24399105|NCT00146601|Fulvestrant|fulvestrant|mesh-list
24399106|NCT00146601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24399107|NCT00146601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399108|NCT00146601|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25090255|NCT03259542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090256|NCT03259542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090260|NCT03259542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090261|NCT03259542|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25090262|NCT03259542|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24399122|NCT00146614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399124|NCT00146614|Dermatologic Agents|dermatologic agents|mesh-ancestor
24399125|NCT00146614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24399126|NCT00146614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24399127|NCT00146614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24399128|NCT00146614|Immunologic Factors|immunologic factors|mesh-ancestor
24399129|NCT00146614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25222614|NCT02644252|Tubulin Modulators|tubulin modulators|mesh-ancestor
25222615|NCT02644252|Antimitotic Agents|antimitotic agents|mesh-ancestor
25222616|NCT02644252|Mitosis Modulators|mitosis modulators|mesh-ancestor
24835686|NCT02183220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24835688|NCT02183220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24835689|NCT02183220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24835690|NCT02183220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835691|NCT02183220|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24835692|NCT02183220|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24835693|NCT02183220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835694|NCT02183220|Antipyretics|antipyretics|mesh-ancestor
24795844|NCT01946386|Clobetasol|clobetasol|mesh-list
24399130|NCT00146614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24399215|NCT00146926|Anesthetics|anesthetics|mesh-ancestor
24399216|NCT00146926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24399217|NCT00146926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399218|NCT00146926|Sensory System Agents|sensory system agents|mesh-ancestor
24399219|NCT00146926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24399220|NCT00146926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24399221|NCT00146926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24399222|NCT00146926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24399223|NCT00146926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24399224|NCT00146926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399240|NCT00147004|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24399242|NCT00147121|Rituximab|rituximab|mesh-list
24399243|NCT00147121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24399244|NCT00147121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399245|NCT00147121|Immunologic Factors|immunologic factors|mesh-ancestor
24399246|NCT00147121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399247|NCT00147121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24399248|NCT00147160|Temozolomide|temozolomide|mesh-list
24399249|NCT00147160|Cisplatin|cisplatin|mesh-list
24399250|NCT00147160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24399251|NCT00147160|Alkylating Agents|alkylating agents|mesh-ancestor
24399252|NCT00147160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090263|NCT03259542|Abortifacient Agents|abortifacient agents|mesh-ancestor
25090264|NCT03259542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25090265|NCT03259542|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25090266|NCT03259542|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25090267|NCT03259542|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25090268|NCT03259542|Contraceptive Agents|contraceptive agents|mesh-ancestor
25090269|NCT03259542|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25679964|NCT01844830|Nasal Decongestants|nasal decongestants|mesh-ancestor
25014653|NCT04095208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25014655|NCT04095208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25014656|NCT04095208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014657|NCT04067609|Dexamethasone|dexamethasone|mesh-list
25014658|NCT04067609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25014659|NCT04067609|Antiemetics|antiemetics|mesh-ancestor
25014660|NCT04067609|Autonomic Agents|autonomic agents|mesh-ancestor
25014681|NCT04042077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25090270|NCT03259542|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25090271|NCT03259542|Luteolytic Agents|luteolytic agents|mesh-ancestor
25090272|NCT03259542|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25222634|NCT02644187|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24399311|NCT00147381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24399312|NCT00147381|Immunologic Factors|immunologic factors|mesh-ancestor
24399313|NCT00147381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012469|NCT05141305|Aspirin|aspirin|mesh-list
24399424|NCT00147719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24399317|NCT00147381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24399320|NCT00147394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24399321|NCT00147394|Serotonin Agents|serotonin agents|mesh-ancestor
24399322|NCT00147394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24399324|NCT00147394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399334|NCT00147511|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24399335|NCT00147511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24399336|NCT00147511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399337|NCT00147524|Quinapril|quinapril|mesh-list
24399338|NCT00147524|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24399339|NCT00147524|Protease Inhibitors|protease inhibitors|mesh-ancestor
24399340|NCT00147524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24399342|NCT00147524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24983168|NCT02083250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24399387|NCT00147628|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24399388|NCT00147628|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24399389|NCT00147628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24399390|NCT00147628|Urological Agents|urological agents|mesh-ancestor
24399391|NCT00147654|Tamsulosin|tamsulosin|mesh-list
24399392|NCT00147654|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24399393|NCT00147654|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24399394|NCT00147654|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24399395|NCT00147654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24399419|NCT00147680|Antimitotic Agents|antimitotic agents|mesh-ancestor
25090273|NCT03259542|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25090275|NCT03259152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25090276|NCT03259152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090277|NCT03259282|gamma-Globulins|gamma-globulins|mesh-list
25090278|NCT03259282|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25090279|NCT03259282|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25090280|NCT03259282|Immunologic Factors|immunologic factors|mesh-ancestor
25090281|NCT03259282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766432|NCT01794533|Respiratory System Agents|respiratory system agents|mesh-ancestor
25090282|NCT03258931|Cytarabine|cytarabine|mesh-list
25090283|NCT03258931|Midostaurin|midostaurin|mesh-list
25090284|NCT03258931|Crenolanib|crenolanib|mesh-list
25090285|NCT03258931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25090286|NCT03258931|Antimetabolites|antimetabolites|mesh-ancestor
25090287|NCT03258931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090288|NCT03258931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25090289|NCT03258931|Antiviral Agents|antiviral agents|mesh-ancestor
25090290|NCT03258931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25090296|NCT03259243|Bupivacaine|bupivacaine|mesh-list
25090297|NCT03259243|Anesthetics, Local|anesthetics, local|mesh-ancestor
25090298|NCT03259243|Anesthetics|anesthetics|mesh-ancestor
25679965|NCT01844830|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25679966|NCT01844830|Respiratory System Agents|respiratory system agents|mesh-ancestor
25679967|NCT01844830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25679968|NCT01844830|Mydriatics|mydriatics|mesh-ancestor
25679969|NCT01844830|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25679970|NCT01844830|Protective Agents|protective agents|mesh-ancestor
25679971|NCT01844895|Abatacept|abatacept|mesh-list
25679972|NCT01844895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25679973|NCT01844895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090299|NCT03259243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25090300|NCT03259243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399420|NCT00147680|Mitosis Modulators|mitosis modulators|mesh-ancestor
24399421|NCT00147680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399422|NCT00147719|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
24399423|NCT00147719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24399426|NCT00147719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399427|NCT00147719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24399428|NCT00147758|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
24399429|NCT00147758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24399430|NCT00147758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25090314|NCT03258697|Levobupivacaine|levobupivacaine|mesh-list
25090315|NCT03258697|Anesthetics, Local|anesthetics, local|mesh-ancestor
25090316|NCT03258697|Anesthetics|anesthetics|mesh-ancestor
25090317|NCT03258697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25090318|NCT03258697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399436|NCT00147771|Immunologic Factors|immunologic factors|mesh-ancestor
24399480|NCT00147875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24399482|NCT00147875|Hormones|hormones|mesh-ancestor
24399483|NCT00147875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24399484|NCT00147875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24399485|NCT00147875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24399486|NCT00147875|Tubulin Modulators|tubulin modulators|mesh-ancestor
24399487|NCT00147875|Antimitotic Agents|antimitotic agents|mesh-ancestor
24399500|NCT00147901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24399519|NCT00147979|Calcium heparin|calcium heparin|mesh-list
24399520|NCT00147979|Anticoagulants|anticoagulants|mesh-ancestor
24399521|NCT00147979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24399522|NCT00147979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24399523|NCT00147979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399524|NCT00148005|Cholinergic Antagonists|cholinergic antagonists|mesh-list
24399525|NCT00148005|Cholinergic Agents|cholinergic agents|mesh-ancestor
24399526|NCT00148005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24399527|NCT00148005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399528|NCT00148005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399529|NCT00148018|Dexamethasone|dexamethasone|mesh-list
25679974|NCT01844895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25679975|NCT01844895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25679976|NCT01844895|Immunologic Factors|immunologic factors|mesh-ancestor
25679977|NCT01844895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679978|NCT01844895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25679979|NCT01845025|Fluticasone|fluticasone|mesh-list
25679980|NCT01845025|Xhance|xhance|mesh-list
25679981|NCT01845025|Formoterol Fumarate|formoterol fumarate|mesh-list
25679982|NCT01845025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25679983|NCT01845025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25679984|NCT01845025|Autonomic Agents|autonomic agents|mesh-ancestor
25679985|NCT01845025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25679986|NCT01845025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25679987|NCT01845025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25679988|NCT01845025|Respiratory System Agents|respiratory system agents|mesh-ancestor
24399530|NCT00148018|Bortezomib|bortezomib|mesh-list
24399544|NCT00148031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399545|NCT00148031|Antiviral Agents|antiviral agents|mesh-ancestor
24399546|NCT00148031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24399547|NCT00148031|Antimetabolites|antimetabolites|mesh-ancestor
24399548|NCT00148031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399550|NCT00148070|Erythromycin Estolate|erythromycin estolate|mesh-list
25222631|NCT02644226|Anesthetics|anesthetics|mesh-ancestor
25222632|NCT02644226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25222633|NCT02644226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222636|NCT02644187|Dermatologic Agents|dermatologic agents|mesh-ancestor
25222637|NCT02644044|Methotrexate|methotrexate|mesh-list
25222638|NCT02644044|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25222639|NCT02644044|Abortifacient Agents|abortifacient agents|mesh-ancestor
25222640|NCT02644044|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25222641|NCT02644044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042931|NCT01349868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042932|NCT01348919|Dexamethasone|dexamethasone|mesh-list
25042933|NCT01348919|Lenalidomide|lenalidomide|mesh-list
25042934|NCT01348919|Delanzomib|delanzomib|mesh-list
25042935|NCT01348919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25042936|NCT01348919|Antiemetics|antiemetics|mesh-ancestor
24938382|NCT04019652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055046|NCT03524950|Analgesics|analgesics|mesh-ancestor
25055047|NCT03524950|Sensory System Agents|sensory system agents|mesh-ancestor
24399551|NCT00148070|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24399552|NCT00148070|Erythromycin stearate|erythromycin stearate|mesh-list
24399553|NCT00148070|Docetaxel|docetaxel|mesh-list
24399554|NCT00148070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25090319|NCT03258697|Sensory System Agents|sensory system agents|mesh-ancestor
25090320|NCT03258697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25090321|NCT03258866|Rituximab|rituximab|mesh-list
25090322|NCT03258866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25090323|NCT03258866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25090324|NCT03258866|Immunologic Factors|immunologic factors|mesh-ancestor
25090334|NCT03258749|Respiratory System Agents|respiratory system agents|mesh-ancestor
25090335|NCT03258749|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25090336|NCT03258749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25090337|NCT03258749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25090338|NCT03258749|Adrenergic Agents|adrenergic agents|mesh-ancestor
25090339|NCT03258749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25090340|NCT03258749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090341|NCT03258749|Parasympatholytics|parasympatholytics|mesh-ancestor
25090342|NCT03258749|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25090343|NCT03258749|Cholinergic Agents|cholinergic agents|mesh-ancestor
25090344|NCT03258515|Moxifloxacin|moxifloxacin|mesh-list
25090345|NCT03258515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25090346|NCT03258515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25090347|NCT03258515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25090348|NCT03258515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25090349|NCT03258515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090350|NCT03258515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090351|NCT03258515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25090352|NCT03258372|Rifampin|rifampin|mesh-list
25090353|NCT03258372|Mifepristone|mifepristone|mesh-list
24766589|NCT01795599|Contraceptive Agents|contraceptive agents|mesh-ancestor
24766590|NCT01795599|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24766592|NCT01795599|Hormone Antagonists|hormone antagonists|mesh-ancestor
25090357|NCT03258372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25679989|NCT01845025|Dermatologic Agents|dermatologic agents|mesh-ancestor
25679990|NCT01845025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25679991|NCT01845025|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25679992|NCT01845025|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25679993|NCT01845025|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25679994|NCT01845025|Adrenergic Agents|adrenergic agents|mesh-ancestor
25090358|NCT03258372|Leprostatic Agents|leprostatic agents|mesh-ancestor
25014748|NCT03926299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014749|NCT03923374|Buprenorphine|buprenorphine|mesh-list
25014750|NCT03923374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25014754|NCT03923374|Analgesics|analgesics|mesh-ancestor
25014755|NCT03923374|Sensory System Agents|sensory system agents|mesh-ancestor
25014756|NCT03923374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25014757|NCT03923374|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25109576|NCT03123107|Antioxidants|antioxidants|mesh-ancestor
25090359|NCT03258372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25222642|NCT02644044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25222643|NCT02644044|Antimetabolites|antimetabolites|mesh-ancestor
25222644|NCT02644044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222645|NCT02644044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25222646|NCT02644044|Dermatologic Agents|dermatologic agents|mesh-ancestor
25222647|NCT02644044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25222648|NCT02644044|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25222649|NCT02644044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25222650|NCT02644044|Immunologic Factors|immunologic factors|mesh-ancestor
25222651|NCT02644044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25222652|NCT02644044|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25222653|NCT02644161|Antidepressive Agents|antidepressive agents|mesh-list
25222654|NCT02644161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25273171|NCT02386943|Protease Inhibitors|protease inhibitors|mesh-ancestor
25273172|NCT02386943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273173|NCT02386943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273175|NCT02386735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25273176|NCT02386735|Glucocorticoids|glucocorticoids|mesh-ancestor
25042937|NCT01348919|Autonomic Agents|autonomic agents|mesh-ancestor
25042938|NCT01348919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25042939|NCT01348919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042941|NCT01348919|Glucocorticoids|glucocorticoids|mesh-ancestor
25042942|NCT01348919|Hormones|hormones|mesh-ancestor
24983234|NCT01697527|Aldesleukin|aldesleukin|mesh-list
25042943|NCT01348919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25055055|NCT03524937|Melatonin|melatonin|mesh-list
25090360|NCT03258372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090361|NCT03258372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090362|NCT03258372|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25090363|NCT03258372|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25090364|NCT03258372|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25090365|NCT03258372|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25090366|NCT03258372|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25090367|NCT03258372|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24399555|NCT00148070|Tubulin Modulators|tubulin modulators|mesh-ancestor
24399556|NCT00148070|Antimitotic Agents|antimitotic agents|mesh-ancestor
24399557|NCT00148070|Mitosis Modulators|mitosis modulators|mesh-ancestor
24399558|NCT00148070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399559|NCT00148070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24399560|NCT00148070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24399561|NCT00148070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24399562|NCT00148070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24399563|NCT00148070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24399564|NCT00148083|Risperidone|risperidone|mesh-list
24399567|NCT00148083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24399568|NCT00148083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399569|NCT00148083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399570|NCT00148083|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24399571|NCT00148083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24399572|NCT00148083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24399573|NCT00148083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24399574|NCT00148083|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24399627|NCT00148278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24399628|NCT00148278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24399713|NCT00148460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679995|NCT01845025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25679996|NCT01845025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25679997|NCT01845077|Metformin|metformin|mesh-list
25679998|NCT01845077|Linagliptin|linagliptin|mesh-list
25679999|NCT01845077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25680000|NCT01845077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680001|NCT01845077|Incretins|incretins|mesh-ancestor
25680002|NCT01845077|Hormones|hormones|mesh-ancestor
24535420|NCT00649116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24535421|NCT00649116|Sympatholytics|sympatholytics|mesh-ancestor
24535422|NCT00649116|Autonomic Agents|autonomic agents|mesh-ancestor
24399715|NCT00148473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24399716|NCT00148473|Abortifacient Agents|abortifacient agents|mesh-ancestor
24399717|NCT00148473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24399718|NCT00148473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399719|NCT00148473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24399720|NCT00148473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24399721|NCT00148473|Oxytocics|oxytocics|mesh-ancestor
24399724|NCT00148499|Anesthetics, Local|anesthetics, local|mesh-ancestor
24399749|NCT00148564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25090368|NCT03258372|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25090369|NCT03258372|Abortifacient Agents|abortifacient agents|mesh-ancestor
25090370|NCT03258372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25090371|NCT03258372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090372|NCT03258372|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25090373|NCT03258372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24784465|NCT01908114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784466|NCT01908257|Lesinurad|lesinurad|mesh-list
24784467|NCT01908257|Ranitidine|ranitidine|mesh-list
25090374|NCT03258372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25090375|NCT03258372|Contraceptive Agents|contraceptive agents|mesh-ancestor
25090376|NCT03258372|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25090377|NCT03258372|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25090378|NCT03258372|Hormone Antagonists|hormone antagonists|mesh-ancestor
25090379|NCT03258372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25090380|NCT03258372|Luteolytic Agents|luteolytic agents|mesh-ancestor
25090381|NCT03258372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25090382|NCT03258372|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25222655|NCT02644057|Dobutamine|dobutamine|mesh-list
25222656|NCT02644057|Milrinone|milrinone|mesh-list
25222657|NCT02644057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25222658|NCT02644057|Sympathomimetics|sympathomimetics|mesh-ancestor
25222659|NCT02644057|Autonomic Agents|autonomic agents|mesh-ancestor
25222660|NCT02644057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222661|NCT02644057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222662|NCT02644057|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25222663|NCT02644057|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25012890|NCT04143659|Contraceptive Agents|contraceptive agents|mesh-ancestor
25042944|NCT01348919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25042945|NCT01348919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042946|NCT01348919|Immunologic Factors|immunologic factors|mesh-ancestor
25042947|NCT01348919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25042948|NCT01348919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25042949|NCT01348919|Growth Substances|growth substances|mesh-ancestor
25042950|NCT01348919|Growth Inhibitors|growth inhibitors|mesh-ancestor
25042951|NCT01348919|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
25042952|NCT01348919|Protease Inhibitors|protease inhibitors|mesh-ancestor
25042953|NCT01348919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25042954|NCT01348919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042956|NCT01345045|Analgesics|analgesics|mesh-ancestor
25090384|NCT03258385|Hydroxocobalamin|hydroxocobalamin|mesh-list
25090386|NCT03258385|Micronutrients|micronutrients|mesh-ancestor
25090387|NCT03258385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090388|NCT03258385|Vitamin B Complex|vitamin b complex|mesh-ancestor
25090389|NCT03258385|Hematinics|hematinics|mesh-ancestor
25090390|NCT03258476|Guanfacine|guanfacine|mesh-list
25090391|NCT03258476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25090392|NCT03258476|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25090393|NCT03258476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25090394|NCT03258476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25090395|NCT03258476|Adrenergic Agents|adrenergic agents|mesh-ancestor
25090396|NCT03258476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25090397|NCT03258476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402845|NCT00158561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24399750|NCT00148564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399751|NCT00148564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24399752|NCT00148564|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24399753|NCT00148564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24399754|NCT00148564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24399755|NCT00148564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24399756|NCT00148564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25680003|NCT01845077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25680004|NCT01845077|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25014812|NCT03814200|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24980233|NCT05431075|Respiratory System Agents|respiratory system agents|mesh-ancestor
24535449|NCT00649155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931809|NCT04085354|Vitamins|vitamins|mesh-list
24535450|NCT00649155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24535451|NCT00649155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24535452|NCT00649168|Bromocriptine|bromocriptine|mesh-list
24535453|NCT00649168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24535454|NCT00649168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24535455|NCT00649168|Hormone Antagonists|hormone antagonists|mesh-ancestor
24399757|NCT00148564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24399761|NCT00148564|Serotonin Agents|serotonin agents|mesh-ancestor
24399769|NCT00148590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24784468|NCT01908257|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
25106605|NCT02129751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25106606|NCT02129751|Antidepressive Agents|antidepressive agents|mesh-ancestor
25106607|NCT02129751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25106608|NCT02129751|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25106609|NCT02129751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25106610|NCT02129751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25106611|NCT02129751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106612|NCT02129751|Dopamine Agents|dopamine agents|mesh-ancestor
25106613|NCT02129751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24399770|NCT00148590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399771|NCT00148590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090400|NCT03258294|Antioxidants|antioxidants|mesh-ancestor
24754008|NCT01718678|Melatonin|melatonin|mesh-list
24399938|NCT00149084|Dexlansoprazole|dexlansoprazole|mesh-list
24399939|NCT00149084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24399940|NCT00149084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24399941|NCT00149084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24399942|NCT00149084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24399943|NCT00149084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399961|NCT00149110|Dopamine Agents|dopamine agents|mesh-ancestor
24400032|NCT00149292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24400034|NCT00149383|Rosiglitazone|rosiglitazone|mesh-list
24400035|NCT00149383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24400036|NCT00149383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400037|NCT00149539|Buprenorphine|buprenorphine|mesh-list
24400039|NCT00149539|Naloxone|naloxone|mesh-list
24400044|NCT00149539|Analgesics|analgesics|mesh-ancestor
24400045|NCT00149539|Sensory System Agents|sensory system agents|mesh-ancestor
24400046|NCT00149539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24400047|NCT00149539|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24400048|NCT00149565|Interferon alpha-2|interferon alpha-2|mesh-list
24400049|NCT00149565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25222664|NCT02644057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25222665|NCT02644057|Adrenergic Agents|adrenergic agents|mesh-ancestor
25222666|NCT02644057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25222667|NCT02644057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222668|NCT02644057|Protective Agents|protective agents|mesh-ancestor
25222669|NCT02644057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25222670|NCT02644057|Vasodilator Agents|vasodilator agents|mesh-ancestor
25222671|NCT02644057|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25222672|NCT02644057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25222673|NCT02644057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25222674|NCT02643914|Nicotine|nicotine|mesh-list
25222675|NCT02643914|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25222676|NCT02643914|Autonomic Agents|autonomic agents|mesh-ancestor
25042958|NCT01345045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25042959|NCT01345045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680005|NCT01845077|Protease Inhibitors|protease inhibitors|mesh-ancestor
25680006|NCT01845077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25680007|NCT01845077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680008|NCT01845636|Atropine|atropine|mesh-list
25680009|NCT01845636|Donepezil|donepezil|mesh-list
25680010|NCT01845636|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25680011|NCT01845636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25680012|NCT01845636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25680013|NCT01845636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25680014|NCT01845636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400050|NCT00149565|Antiviral Agents|antiviral agents|mesh-ancestor
25014890|NCT03674320|Methyltestosterone|methyltestosterone|mesh-list
25014891|NCT03674320|Testosterone|testosterone|mesh-list
25014924|NCT03639610|Glucocorticoids|glucocorticoids|mesh-ancestor
25014926|NCT03639610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25014927|NCT03639610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24400051|NCT00149565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24400052|NCT00149578|Leucovorin|leucovorin|mesh-list
24400053|NCT00149578|Gemcitabine|gemcitabine|mesh-list
24400054|NCT00149578|Oxaliplatin|oxaliplatin|mesh-list
24400121|NCT00149877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400136|NCT00149916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24400137|NCT00149916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24400138|NCT00149916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400139|NCT00149916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400224|NCT00150085|Dermatologic Agents|dermatologic agents|mesh-ancestor
24400225|NCT00150085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24400230|NCT00150111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24400231|NCT00150111|Immunologic Factors|immunologic factors|mesh-ancestor
24400232|NCT00150111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400233|NCT00150111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25090410|NCT03257930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24400491|NCT00150657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400493|NCT00150657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24400494|NCT00150657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400496|NCT00150657|Immunologic Factors|immunologic factors|mesh-ancestor
24400500|NCT00150696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24400501|NCT00150696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24400502|NCT00150696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400503|NCT00150696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24400504|NCT00150696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400505|NCT00150696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24400506|NCT00150709|Levetiracetam|levetiracetam|mesh-list
24400507|NCT00150709|Anticonvulsants|anticonvulsants|mesh-ancestor
24400508|NCT00150709|Nootropic Agents|nootropic agents|mesh-ancestor
24400509|NCT00150722|Atorvastatin|atorvastatin|mesh-list
24400510|NCT00150722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24400511|NCT00150722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24400550|NCT00150839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400608|NCT00150995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400609|NCT00150995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24400610|NCT00150995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24400632|NCT00151034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24400633|NCT00151034|Immunologic Factors|immunologic factors|mesh-ancestor
25090419|NCT03257683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090420|NCT03257670|Lidocaine|lidocaine|mesh-list
25090421|NCT03257670|Anesthetics, Local|anesthetics, local|mesh-ancestor
25090422|NCT03257670|Anesthetics|anesthetics|mesh-ancestor
25090423|NCT03257670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25090424|NCT03257670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090425|NCT03257670|Sensory System Agents|sensory system agents|mesh-ancestor
25090426|NCT03257670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25090427|NCT03257670|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25090428|NCT03257670|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25090429|NCT03257670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25090430|NCT03257670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25090431|NCT03257670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400717|NCT00151203|Glucocorticoids|glucocorticoids|mesh-ancestor
24400773|NCT00151255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24400775|NCT00151255|Dermatologic Agents|dermatologic agents|mesh-ancestor
24400777|NCT00151294|Citalopram|citalopram|mesh-list
24400778|NCT00151294|Antidepressive Agents|antidepressive agents|mesh-list
24400779|NCT00151294|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25042961|NCT01345045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25042962|NCT01345045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25680015|NCT01845636|Cholinergic Agents|cholinergic agents|mesh-ancestor
25680016|NCT01845636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25680017|NCT01845636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680018|NCT01845636|Nootropic Agents|nootropic agents|mesh-ancestor
25680019|NCT01845636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25680020|NCT01845636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24400781|NCT00151294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24400783|NCT00151294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24400848|NCT00151489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24400849|NCT00151489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24400850|NCT00151489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24400851|NCT00151502|Atorvastatin|atorvastatin|mesh-list
24400852|NCT00151502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24400853|NCT00151502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24400854|NCT00151502|Antimetabolites|antimetabolites|mesh-ancestor
24400855|NCT00151502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400856|NCT00151502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24400857|NCT00151502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25090433|NCT03257722|Idelalisib|idelalisib|mesh-list
25090434|NCT03257722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25090435|NCT03257722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25090436|NCT03257722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090437|NCT03257722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090438|NCT03257852|Methotrexate|methotrexate|mesh-list
25090439|NCT03257852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25090440|NCT03257852|Abortifacient Agents|abortifacient agents|mesh-ancestor
25090441|NCT03257852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24401211|NCT00152425|Immunologic Factors|immunologic factors|mesh-ancestor
24401212|NCT00152425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401265|NCT00152620|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24401266|NCT00152620|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24401268|NCT00152620|Prednisolone acetate|prednisolone acetate|mesh-list
24401270|NCT00152620|Prednisolone phosphate|prednisolone phosphate|mesh-list
24401345|NCT00152724|Tocolytic Agents|tocolytic agents|mesh-ancestor
24401346|NCT00152724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24401347|NCT00152724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24401377|NCT00152828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24401378|NCT00152828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24401379|NCT00152828|Analgesics|analgesics|mesh-ancestor
24401380|NCT00152828|Sensory System Agents|sensory system agents|mesh-ancestor
24401381|NCT00152828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24401382|NCT00152828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401383|NCT00152828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24401384|NCT00152828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24401385|NCT00152828|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24401386|NCT00152828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24401387|NCT00152828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24401388|NCT00152828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401389|NCT00152841|Vitamin E|vitamin e|mesh-list
24401390|NCT00152841|Vitamins|vitamins|mesh-ancestor
24401391|NCT00152841|Micronutrients|micronutrients|mesh-ancestor
24401414|NCT00152867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24401415|NCT00152893|Chromium|chromium|mesh-list
24401417|NCT00152893|Trace Elements|trace elements|mesh-ancestor
24401418|NCT00152893|Micronutrients|micronutrients|mesh-ancestor
24401419|NCT00152893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401420|NCT00152893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24401421|NCT00152893|Antimetabolites|antimetabolites|mesh-ancestor
24401422|NCT00152893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401423|NCT00152893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24401434|NCT00152919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25222681|NCT02643914|Cholinergic Agents|cholinergic agents|mesh-ancestor
25222682|NCT02643914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25273177|NCT02386735|Hormones|hormones|mesh-ancestor
24835762|NCT02183350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835764|NCT02183363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24470575|NCT00390676|Antimetabolites|antimetabolites|mesh-ancestor
24868269|NCT00354835|Dactinomycin|dactinomycin|mesh-list
24401436|NCT00152919|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24401437|NCT00152919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24401438|NCT00152919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090443|NCT03257852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25090444|NCT03257852|Antimetabolites|antimetabolites|mesh-ancestor
25090445|NCT03257852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090446|NCT03257852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25090447|NCT03257852|Dermatologic Agents|dermatologic agents|mesh-ancestor
25090448|NCT03257852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090449|NCT03257852|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25090450|NCT03257852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25090451|NCT03257852|Immunologic Factors|immunologic factors|mesh-ancestor
24401439|NCT00152919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401440|NCT00152932|Dorzolamide|dorzolamide|mesh-list
24401441|NCT00152932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24401442|NCT00152932|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24401458|NCT00152958|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24401459|NCT00152958|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24401516|NCT00153075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24401517|NCT00153075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24401518|NCT00153075|Adrenergic Agents|adrenergic agents|mesh-ancestor
24401519|NCT00153075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24401520|NCT00153075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401521|NCT00153075|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24401522|NCT00153075|Cholinergic Agents|cholinergic agents|mesh-ancestor
24401524|NCT00153088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24401525|NCT00153088|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24401526|NCT00153088|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24401528|NCT00153114|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24401574|NCT00153270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24401575|NCT00153270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24401576|NCT00153270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24401577|NCT00153283|Gabapentin|gabapentin|mesh-list
24401578|NCT00153283|Analgesics|analgesics|mesh-ancestor
24401579|NCT00153283|Sensory System Agents|sensory system agents|mesh-ancestor
24401580|NCT00153283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24401601|NCT00153296|Sensory System Agents|sensory system agents|mesh-ancestor
24401603|NCT00153296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24401626|NCT00153530|Antimetabolites|antimetabolites|mesh-ancestor
24401627|NCT00153530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401628|NCT00153530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24401629|NCT00153530|Dermatologic Agents|dermatologic agents|mesh-ancestor
24983409|NCT00085202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24401630|NCT00153530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24401635|NCT00153530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24401637|NCT00153543|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24401638|NCT00153543|Immunologic Factors|immunologic factors|mesh-ancestor
24401639|NCT00153543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401641|NCT00153556|Immunologic Factors|immunologic factors|mesh-ancestor
25090452|NCT03257852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25090453|NCT03257852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25090454|NCT03257514|Thioctic Acid|thioctic acid|mesh-list
25222683|NCT02643914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222684|NCT02643563|Epinephrine|epinephrine|mesh-list
25222685|NCT02643563|Bupivacaine|bupivacaine|mesh-list
25222686|NCT02643563|Ropivacaine|ropivacaine|mesh-list
25222687|NCT02643563|Anesthetics, Local|anesthetics, local|mesh-ancestor
25222688|NCT02643563|Anesthetics|anesthetics|mesh-ancestor
25222694|NCT02643563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25090456|NCT03257514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090457|NCT03257514|Protective Agents|protective agents|mesh-ancestor
25090458|NCT03257514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090459|NCT03257514|Vitamin B Complex|vitamin b complex|mesh-ancestor
25090461|NCT03257514|Micronutrients|micronutrients|mesh-ancestor
25090462|NCT03257800|Ketamine|ketamine|mesh-list
25090463|NCT03257800|Nitrous Oxide|nitrous oxide|mesh-list
25090464|NCT03257800|Sevoflurane|sevoflurane|mesh-list
25090465|NCT03257800|Analgesics|analgesics|mesh-ancestor
25090466|NCT03257800|Sensory System Agents|sensory system agents|mesh-ancestor
25090467|NCT03257800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25090468|NCT03257800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680021|NCT01845636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24579909|NCT00858676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25090469|NCT03257800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25090470|NCT03257800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25090471|NCT03257800|Anesthetics, General|anesthetics, general|mesh-ancestor
25090472|NCT03257800|Anesthetics|anesthetics|mesh-ancestor
25090473|NCT03257800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24401642|NCT00153556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401643|NCT00153634|Azithromycin|azithromycin|mesh-list
24401644|NCT00153634|Ciprofloxacin|ciprofloxacin|mesh-list
24401646|NCT00153634|Tazobactam|tazobactam|mesh-list
24401647|NCT00153634|Piperacillin|piperacillin|mesh-list
24401648|NCT00153634|Tobramycin|tobramycin|mesh-list
24401649|NCT00153634|Clavulanic Acid|clavulanic acid|mesh-list
24401650|NCT00153634|Amikacin|amikacin|mesh-list
24401651|NCT00153634|Ceftazidime|ceftazidime|mesh-list
24401652|NCT00153634|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24401653|NCT00153634|Ticarcillin|ticarcillin|mesh-list
24401679|NCT00153660|Gout Suppressants|gout suppressants|mesh-ancestor
24401681|NCT00153673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24401682|NCT00153673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24401683|NCT00153673|Analgesics|analgesics|mesh-ancestor
24401684|NCT00153673|Sensory System Agents|sensory system agents|mesh-ancestor
24401685|NCT00153673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24401686|NCT00153673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401687|NCT00153673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24401688|NCT00153673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24401689|NCT00153673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24401747|NCT00153946|Edaravone|edaravone|mesh-list
24401818|NCT00154050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24401819|NCT00154076|Topiramate|topiramate|mesh-list
24401820|NCT00154076|Zonisamide|zonisamide|mesh-list
24401821|NCT00154076|Anticonvulsants|anticonvulsants|mesh-ancestor
24401822|NCT00154076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24401823|NCT00154076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401824|NCT00154076|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24401825|NCT00154076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25090478|NCT03257800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25090479|NCT03257800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25090480|NCT03257800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25090481|NCT03257423|Moxifloxacin|moxifloxacin|mesh-list
25090482|NCT03257423|Metronidazole|metronidazole|mesh-list
25090483|NCT03257423|Levofloxacin|levofloxacin|mesh-list
25090484|NCT03257423|Ofloxacin|ofloxacin|mesh-list
25090485|NCT03257423|Ertapenem|ertapenem|mesh-list
25090486|NCT03257423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25090487|NCT03257423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25090488|NCT03257423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25090489|NCT03257423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24456796|NCT00332306|Lamivudine|lamivudine|mesh-list
24401826|NCT00154076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222691|NCT02643563|Sensory System Agents|sensory system agents|mesh-ancestor
25222692|NCT02643563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222693|NCT02643563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24401828|NCT00154089|Masoprocol|masoprocol|mesh-list
24401829|NCT00154089|Antioxidants|antioxidants|mesh-ancestor
24401830|NCT00154089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401838|NCT00154089|Analgesics|analgesics|mesh-ancestor
24401889|NCT00154193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401891|NCT00154193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24401892|NCT00154193|Dermatologic Agents|dermatologic agents|mesh-ancestor
24401893|NCT00154193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24401894|NCT00154193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24401895|NCT00154206|Mycophenolic Acid|mycophenolic acid|mesh-list
24401896|NCT00154206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24401897|NCT00154206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25680022|NCT01845636|Autonomic Agents|autonomic agents|mesh-ancestor
25680023|NCT01845636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25680024|NCT01845636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24401935|NCT00154258|Clozapine|clozapine|mesh-list
24401936|NCT00154258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24401937|NCT00154258|Serotonin Agents|serotonin agents|mesh-ancestor
24401938|NCT00154258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25015131|NCT03126968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24535805|NCT00649727|Cholinergic Agents|cholinergic agents|mesh-ancestor
24535806|NCT00649727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535807|NCT00649727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535808|NCT00649727|Urological Agents|urological agents|mesh-ancestor
24535810|NCT00649740|Anticonvulsants|anticonvulsants|mesh-ancestor
24401939|NCT00154258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401940|NCT00154258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401941|NCT00154258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24401946|NCT00154258|GABA Agents|gaba agents|mesh-ancestor
24402001|NCT00154401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24402002|NCT00154414|Liraglutide|liraglutide|mesh-list
24402003|NCT00154414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24402004|NCT00154414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402005|NCT00154414|Incretins|incretins|mesh-ancestor
24402008|NCT00154440|Amoxicillin|amoxicillin|mesh-list
24402009|NCT00154440|Metronidazole|metronidazole|mesh-list
24402010|NCT00154440|Clarithromycin|clarithromycin|mesh-list
24402011|NCT00154440|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24402012|NCT00154440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24402013|NCT00154440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402021|NCT00154661|Pentoxifylline|pentoxifylline|mesh-list
25090490|NCT03257423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090491|NCT03257423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090492|NCT03257423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25090493|NCT03257423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25090494|NCT03257423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25090495|NCT03257423|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25090496|NCT03257423|Renal Agents|renal agents|mesh-ancestor
25090497|NCT03257423|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25090498|NCT03257423|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25090500|NCT03257319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25090501|NCT03257319|Narcotics|narcotics|mesh-ancestor
24402137|NCT00155064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24402138|NCT00155064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24402139|NCT00155064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402160|NCT00155246|Vasodilator Agents|vasodilator agents|mesh-ancestor
25222697|NCT02643563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222698|NCT02643563|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25222699|NCT02643563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25222700|NCT02643563|Autonomic Agents|autonomic agents|mesh-ancestor
25222701|NCT02643563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25222702|NCT02643563|Respiratory System Agents|respiratory system agents|mesh-ancestor
25222703|NCT02643563|Mydriatics|mydriatics|mesh-ancestor
25222704|NCT02643563|Sympathomimetics|sympathomimetics|mesh-ancestor
25222705|NCT02643563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24835787|NCT02183389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835788|NCT02183389|Incretins|incretins|mesh-ancestor
24835789|NCT02183389|Hormones|hormones|mesh-ancestor
25245807|NCT03697512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835790|NCT02183389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24835791|NCT02183389|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24402161|NCT00155246|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24402162|NCT00155246|Antioxidants|antioxidants|mesh-ancestor
24402164|NCT00155259|Capecitabine|capecitabine|mesh-list
24402214|NCT00155558|Vitamins|vitamins|mesh-ancestor
24402215|NCT00155558|Micronutrients|micronutrients|mesh-ancestor
24402216|NCT00155714|Sildenafil Citrate|sildenafil citrate|mesh-list
24402217|NCT00155714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
24402218|NCT00155714|Vasodilator Agents|vasodilator agents|mesh-ancestor
24402219|NCT00155714|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24402220|NCT00155714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402221|NCT00155714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680025|NCT01845636|Respiratory System Agents|respiratory system agents|mesh-ancestor
25680026|NCT01845636|Mydriatics|mydriatics|mesh-ancestor
25680027|NCT01845636|Parasympatholytics|parasympatholytics|mesh-ancestor
25680028|NCT01845636|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25680029|NCT01845636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25680030|NCT01845792|Abiraterone Acetate|abiraterone acetate|mesh-list
25680031|NCT01845792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25680032|NCT01845792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25680033|NCT01845792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25015230|NCT02950259|Gout Suppressants|gout suppressants|mesh-ancestor
25015231|NCT02950259|Tocolytic Agents|tocolytic agents|mesh-ancestor
24971839|NCT03722173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402222|NCT00155714|Urological Agents|urological agents|mesh-ancestor
24402223|NCT00155883|Leucovorin|leucovorin|mesh-list
24402224|NCT00155883|Fluorouracil|fluorouracil|mesh-list
24402225|NCT00155883|Antimetabolites|antimetabolites|mesh-ancestor
24402226|NCT00155883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402279|NCT00156299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24402280|NCT00156299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24402282|NCT00156312|Capecitabine|capecitabine|mesh-list
24402283|NCT00156312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402284|NCT00156312|Tubulin Modulators|tubulin modulators|mesh-ancestor
24402285|NCT00156312|Antimitotic Agents|antimitotic agents|mesh-ancestor
24402286|NCT00156312|Mitosis Modulators|mitosis modulators|mesh-ancestor
24402287|NCT00156312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402288|NCT00156312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24402289|NCT00156312|Antimetabolites|antimetabolites|mesh-ancestor
24402290|NCT00156325|Citalopram|citalopram|mesh-list
25090510|NCT03257241|Mitoxantrone|mitoxantrone|mesh-list
25090511|NCT03257241|Idarubicin|idarubicin|mesh-list
25090512|NCT03257241|Cladribine|cladribine|mesh-list
25090513|NCT03257241|Lenograstim|lenograstim|mesh-list
25090514|NCT03257241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25090515|NCT03257241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25090516|NCT03257241|Antimetabolites|antimetabolites|mesh-ancestor
25090517|NCT03257241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090518|NCT03257241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25090519|NCT03257241|Immunologic Factors|immunologic factors|mesh-ancestor
25090520|NCT03257241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090521|NCT03257241|Antiviral Agents|antiviral agents|mesh-ancestor
25090522|NCT03257241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24983490|NCT05185869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090523|NCT03257241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25090524|NCT03257241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25090525|NCT03257241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25090526|NCT03257241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25090527|NCT03257241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090528|NCT03257241|Analgesics|analgesics|mesh-ancestor
25090529|NCT03257241|Sensory System Agents|sensory system agents|mesh-ancestor
25090530|NCT03257241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25090531|NCT03257215|Vitamin D|vitamin d|mesh-list
25090532|NCT03257215|Ergocalciferols|ergocalciferols|mesh-list
25090533|NCT03257215|Cholecalciferol|cholecalciferol|mesh-list
25090534|NCT03257215|Vitamins|vitamins|mesh-list
25090535|NCT03257215|Micronutrients|micronutrients|mesh-ancestor
25090536|NCT03257215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090537|NCT03257215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24754357|NCT01720108|Rivaroxaban|rivaroxaban|mesh-list
24402298|NCT00156325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25090545|NCT03256903|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25090546|NCT03256903|Anesthetics, General|anesthetics, general|mesh-ancestor
25090547|NCT03256903|Anesthetics|anesthetics|mesh-ancestor
25090548|NCT03256903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25245808|NCT03697512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25090549|NCT03256903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090550|NCT03256721|Docetaxel|docetaxel|mesh-list
25222706|NCT02643784|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25222707|NCT02643784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25222708|NCT02643784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25222709|NCT02643784|Antimetabolites|antimetabolites|mesh-ancestor
25222710|NCT02643784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835794|NCT02183389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835796|NCT02183402|Digoxin|digoxin|mesh-list
24835797|NCT02183402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24835798|NCT02183402|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25680034|NCT01845792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680035|NCT01845792|Hormone Antagonists|hormone antagonists|mesh-ancestor
25090551|NCT03256721|Pemetrexed|pemetrexed|mesh-list
25680036|NCT01845792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25680037|NCT01845792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680038|NCT01845792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24980381|NCT05303727|Methotrexate|methotrexate|mesh-list
24980382|NCT05303727|Fludarabine|fludarabine|mesh-list
24980383|NCT05303727|Topotecan|topotecan|mesh-list
24980384|NCT05303727|Tacrolimus|tacrolimus|mesh-list
24980385|NCT05303727|Cyclosporins|cyclosporins|mesh-list
24980403|NCT05303727|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24980447|NCT05263921|Ritonavir|ritonavir|mesh-list
24980448|NCT05263921|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24980449|NCT05263921|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24980450|NCT05263921|Protease Inhibitors|protease inhibitors|mesh-ancestor
25090552|NCT03256721|Apatinib|apatinib|mesh-list
25090553|NCT03256721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25090554|NCT03256721|Tubulin Modulators|tubulin modulators|mesh-ancestor
25090555|NCT03256721|Antimitotic Agents|antimitotic agents|mesh-ancestor
25090556|NCT03256721|Mitosis Modulators|mitosis modulators|mesh-ancestor
24402344|NCT00156650|Hormone Antagonists|hormone antagonists|mesh-ancestor
24402346|NCT00156689|Anticonvulsants|anticonvulsants|mesh-ancestor
24402347|NCT00156689|Nootropic Agents|nootropic agents|mesh-ancestor
24402348|NCT00156858|Busulfan|busulfan|mesh-list
24402349|NCT00156858|Alkylating Agents|alkylating agents|mesh-ancestor
24402350|NCT00156858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402351|NCT00156858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24402360|NCT00156897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402361|NCT00156897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402362|NCT00156897|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24402363|NCT00156897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24402364|NCT00156949|Epoetin Alfa|epoetin alfa|mesh-list
24402365|NCT00156949|Hematinics|hematinics|mesh-ancestor
24402366|NCT00156962|Epoetin Alfa|epoetin alfa|mesh-list
24402367|NCT00156962|Hematinics|hematinics|mesh-ancestor
24402368|NCT00156975|Capecitabine|capecitabine|mesh-list
24402369|NCT00156975|Oxaliplatin|oxaliplatin|mesh-list
24402370|NCT00156975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24402371|NCT00156975|Antimetabolites|antimetabolites|mesh-ancestor
24402372|NCT00156975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402388|NCT00157066|Vitamin D|vitamin d|mesh-list
24402418|NCT00157235|Bromides|bromides|mesh-list
24402419|NCT00157235|Tiotropium Bromide|tiotropium bromide|mesh-list
24402420|NCT00157235|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24402421|NCT00157235|Autonomic Agents|autonomic agents|mesh-ancestor
24402422|NCT00157235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24402423|NCT00157235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402424|NCT00157235|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24402425|NCT00157235|Respiratory System Agents|respiratory system agents|mesh-ancestor
24402426|NCT00157235|Parasympatholytics|parasympatholytics|mesh-ancestor
24402427|NCT00157235|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24402428|NCT00157235|Cholinergic Agents|cholinergic agents|mesh-ancestor
24402429|NCT00157235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24402430|NCT00157235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402431|NCT00157235|Anticonvulsants|anticonvulsants|mesh-ancestor
24402432|NCT00157261|Tenecteplase|tenecteplase|mesh-list
24402433|NCT00157261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24402434|NCT00157261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24402435|NCT00157261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402436|NCT00157274|Alemtuzumab|alemtuzumab|mesh-list
24402446|NCT00157326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090559|NCT03256721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25090560|NCT03256721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25090561|NCT03256721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25090562|NCT03256825|Anti-Infective Agents|anti-infective agents|mesh-list
25090563|NCT03256825|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25090565|NCT03256864|Tacrolimus|tacrolimus|mesh-list
24983501|NCT05185544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402478|NCT00157508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24402479|NCT00157508|Analgesics|analgesics|mesh-ancestor
25222711|NCT02643784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25222712|NCT02643784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25680039|NCT01845831|Metformin|metformin|mesh-list
25680040|NCT01845831|Insulin Glargine|insulin glargine|mesh-list
25680041|NCT01845831|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25680042|NCT01845831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25680043|NCT01845831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680044|NCT01845831|Incretins|incretins|mesh-ancestor
25680045|NCT01845831|Hormones|hormones|mesh-ancestor
25680046|NCT01845831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015373|NCT02516696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25015374|NCT02516696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015375|NCT02516696|Immunologic Factors|immunologic factors|mesh-ancestor
25222713|NCT02643784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25222714|NCT02643680|Chlorhexidine|chlorhexidine|mesh-list
25222715|NCT02643680|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25222716|NCT02643680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25222717|NCT02643680|Disinfectants|disinfectants|mesh-ancestor
25222718|NCT02643823|Methotrexate|methotrexate|mesh-list
25222719|NCT02643823|Antirheumatic Agents|antirheumatic agents|mesh-list
24402483|NCT00157508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24402485|NCT00157508|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24402486|NCT00157508|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24402532|NCT00157677|Fibrin fragment D|fibrin fragment d|mesh-list
24402533|NCT00157677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24402534|NCT00157677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24402535|NCT00157677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402536|NCT00157677|Hemostatics|hemostatics|mesh-ancestor
24402537|NCT00157677|Coagulants|coagulants|mesh-ancestor
24402538|NCT00157690|Alendronate|alendronate|mesh-list
24402539|NCT00157690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24402540|NCT00157690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402541|NCT00157716|Pyridoxal|pyridoxal|mesh-list
24402542|NCT00157716|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
24402543|NCT00157716|Vitamin B Complex|vitamin b complex|mesh-ancestor
24402544|NCT00157716|Vitamins|vitamins|mesh-ancestor
24402545|NCT00157716|Micronutrients|micronutrients|mesh-ancestor
24402546|NCT00157716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402547|NCT00157729|Pyridoxal|pyridoxal|mesh-list
24402548|NCT00157729|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
24402549|NCT00157729|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24402550|NCT00157729|Protease Inhibitors|protease inhibitors|mesh-ancestor
24402551|NCT00157729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402552|NCT00157729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402565|NCT00157859|Antimalarials|antimalarials|mesh-ancestor
24402566|NCT00157859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24402567|NCT00157859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24402568|NCT00157859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402569|NCT00157859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402593|NCT00157885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402594|NCT00157885|Antiviral Agents|antiviral agents|mesh-ancestor
24402595|NCT00157885|Schistosomicides|schistosomicides|mesh-ancestor
24402596|NCT00157885|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24402597|NCT00157885|Anthelmintics|anthelmintics|mesh-ancestor
24402598|NCT00157898|Metronidazole|metronidazole|mesh-list
24402599|NCT00157898|Ceftriaxone|ceftriaxone|mesh-list
24402600|NCT00157898|Ertapenem|ertapenem|mesh-list
24402601|NCT00157898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402604|NCT00157898|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24402605|NCT00157976|Tin etiopurpurin|tin etiopurpurin|mesh-list
24402606|NCT00157976|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24402618|NCT00158028|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24402619|NCT00158028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25090566|NCT03256864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25090567|NCT03256864|Immunologic Factors|immunologic factors|mesh-ancestor
25090568|NCT03256864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090569|NCT03256864|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25090570|NCT03256864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25680047|NCT01845831|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25680048|NCT01845831|Protease Inhibitors|protease inhibitors|mesh-ancestor
25680049|NCT01845831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25014836|NCT03809624|Antibodies|antibodies|mesh-list
25680050|NCT01845831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680051|NCT01846039|Hyaluronic Acid|hyaluronic acid|mesh-list
25680052|NCT01846039|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25680053|NCT01846039|Immunologic Factors|immunologic factors|mesh-ancestor
25090571|NCT03256864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090572|NCT03256864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25090574|NCT03256487|Buprenorphine|buprenorphine|mesh-list
25090575|NCT03256487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25090576|NCT03256487|Narcotics|narcotics|mesh-ancestor
25090577|NCT03256487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25090578|NCT03256487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090579|NCT03256487|Analgesics|analgesics|mesh-ancestor
25090580|NCT03256487|Sensory System Agents|sensory system agents|mesh-ancestor
25222721|NCT02643823|Abortifacient Agents|abortifacient agents|mesh-ancestor
25222722|NCT02643823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25222723|NCT02643823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222724|NCT02643823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25222725|NCT02643823|Antimetabolites|antimetabolites|mesh-ancestor
25222726|NCT02643823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222727|NCT02643823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25222728|NCT02643823|Dermatologic Agents|dermatologic agents|mesh-ancestor
24402630|NCT00158093|Nebivolol|nebivolol|mesh-list
24402631|NCT00158093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24402632|NCT00158093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402633|NCT00158093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24402634|NCT00158093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24402635|NCT00158093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402636|NCT00158093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402637|NCT00158093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402638|NCT00158093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402639|NCT00158093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24402640|NCT00158093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24402641|NCT00158093|Sympatholytics|sympatholytics|mesh-ancestor
24402642|NCT00158093|Autonomic Agents|autonomic agents|mesh-ancestor
24402643|NCT00158093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24402644|NCT00158093|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24402645|NCT00158093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24402646|NCT00158093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24402647|NCT00158093|Adrenergic Agents|adrenergic agents|mesh-ancestor
24402648|NCT00158093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24402649|NCT00158093|Vasodilator Agents|vasodilator agents|mesh-ancestor
24402650|NCT00158093|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25090586|NCT03256149|Autonomic Agents|autonomic agents|mesh-ancestor
24449784|NCT00316927|Antipyretics|antipyretics|mesh-ancestor
24402669|NCT00158132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24402670|NCT00158132|Analgesics|analgesics|mesh-ancestor
24402671|NCT00158132|Sensory System Agents|sensory system agents|mesh-ancestor
24402672|NCT00158132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24402673|NCT00158158|Nicotine|nicotine|mesh-list
24402674|NCT00158158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24402675|NCT00158158|Autonomic Agents|autonomic agents|mesh-ancestor
24402676|NCT00158158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24402677|NCT00158158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402678|NCT00158158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24402679|NCT00158158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24402680|NCT00158158|Cholinergic Agents|cholinergic agents|mesh-ancestor
24402681|NCT00158158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24402682|NCT00158158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402684|NCT00158171|Nicotine|nicotine|mesh-list
24402685|NCT00158171|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24402686|NCT00158171|Autonomic Agents|autonomic agents|mesh-ancestor
24402687|NCT00158171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24402688|NCT00158171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402689|NCT00158171|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24402690|NCT00158171|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24402691|NCT00158171|Cholinergic Agents|cholinergic agents|mesh-ancestor
24402692|NCT00158171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24402693|NCT00158171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222729|NCT02643823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25222730|NCT02643823|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25222731|NCT02643823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24402709|NCT00158236|Naloxone|naloxone|mesh-list
25680054|NCT01846039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680055|NCT01846039|Viscosupplements|viscosupplements|mesh-ancestor
25680056|NCT01846039|Protective Agents|protective agents|mesh-ancestor
25680057|NCT01846104|Vaccines|vaccines|mesh-list
25680058|NCT01846104|Immunologic Factors|immunologic factors|mesh-ancestor
25015486|NCT02245230|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
25015487|NCT02245230|Trimethaphan|trimethaphan|mesh-list
24536162|NCT00650429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24536163|NCT00650429|Serotonin Agents|serotonin agents|mesh-ancestor
24536164|NCT00650429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24536165|NCT00650429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680059|NCT01846104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536166|NCT00650429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536167|NCT00650429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24536181|NCT00650442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24402710|NCT00158236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24402711|NCT00158236|Narcotics|narcotics|mesh-ancestor
24402712|NCT00158236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24402713|NCT00158236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402714|NCT00158236|Analgesics|analgesics|mesh-ancestor
24402783|NCT00158470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402784|NCT00158470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24402785|NCT00158470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24402786|NCT00158470|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24402787|NCT00158470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24402788|NCT00158470|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24402789|NCT00158470|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24402790|NCT00158470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24402791|NCT00158470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24402792|NCT00158470|Antimetabolites|antimetabolites|mesh-ancestor
24402793|NCT00158483|Acyclovir|acyclovir|mesh-list
24402794|NCT00158483|Antiviral Agents|antiviral agents|mesh-ancestor
24402813|NCT00158522|Interferon alpha-2|interferon alpha-2|mesh-list
25090601|NCT03256292|Testosterone|testosterone|mesh-list
24402838|NCT00158561|Dapsone|dapsone|mesh-list
24402839|NCT00158561|Chlorproguanil|chlorproguanil|mesh-list
24402840|NCT00158561|Antimalarials|antimalarials|mesh-ancestor
24402841|NCT00158561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24402842|NCT00158561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24402843|NCT00158561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402844|NCT00158561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24402847|NCT00158561|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24402849|NCT00158561|Leprostatic Agents|leprostatic agents|mesh-ancestor
24402850|NCT00158561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24402889|NCT00158704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402891|NCT00158717|Antiviral Agents|antiviral agents|mesh-ancestor
24402892|NCT00158717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402893|NCT00158717|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24402894|NCT00158717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24402895|NCT00158717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402896|NCT00158717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402897|NCT00158730|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24402898|NCT00158730|Antifungal Agents|antifungal agents|mesh-ancestor
24402899|NCT00158730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402900|NCT00158730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24402901|NCT00158730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24402902|NCT00158782|Lapatinib|lapatinib|mesh-list
24402903|NCT00158782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402904|NCT00158782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24402905|NCT00158782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402910|NCT00158821|Stavudine|stavudine|mesh-list
24402911|NCT00158821|Antiviral Agents|antiviral agents|mesh-ancestor
24402912|NCT00158821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402913|NCT00158821|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24402914|NCT00158821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25222732|NCT02643823|Immunologic Factors|immunologic factors|mesh-ancestor
25222733|NCT02643823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25222734|NCT02643719|Topiramate|topiramate|mesh-list
25680060|NCT01846221|Clonidine|clonidine|mesh-list
25680061|NCT01846221|Fentanyl|fentanyl|mesh-list
25680062|NCT01846221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25680063|NCT01846221|Narcotics|narcotics|mesh-ancestor
25680064|NCT01846221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25680065|NCT01846221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680066|NCT01846221|Analgesics|analgesics|mesh-ancestor
25680067|NCT01846221|Sensory System Agents|sensory system agents|mesh-ancestor
25680068|NCT01846221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25680069|NCT01846221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25680070|NCT01846221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24835816|NCT02183415|Protease Inhibitors|protease inhibitors|mesh-ancestor
24835817|NCT02183415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809410|NCT02033551|Veliparib|veliparib|mesh-list
24548573|NCT00710268|Olaparib|olaparib|mesh-list
25090617|NCT03255642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25090619|NCT03255642|GABA Modulators|gaba modulators|mesh-ancestor
25090620|NCT03255642|GABA Agents|gaba agents|mesh-ancestor
25090621|NCT03255642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24402920|NCT00158821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24402921|NCT00158821|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24402922|NCT00158821|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24402938|NCT00158834|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24402939|NCT00158834|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24402940|NCT00158834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24402944|NCT00158847|Fluticasone|fluticasone|mesh-list
24402946|NCT00158847|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24402947|NCT00158847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24754599|NCT01721707|Brinzolamide|brinzolamide|mesh-list
25090633|NCT03255226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090635|NCT03255330|Gabapentin|gabapentin|mesh-list
25090636|NCT03255330|Tramadol|tramadol|mesh-list
24402951|NCT00158847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402952|NCT00158847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24402953|NCT00158847|Respiratory System Agents|respiratory system agents|mesh-ancestor
24402954|NCT00158847|Dermatologic Agents|dermatologic agents|mesh-ancestor
24402955|NCT00158847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24402956|NCT00158847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24402960|NCT00158847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24402961|NCT00158847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402962|NCT00158873|Fentanyl|fentanyl|mesh-list
24402963|NCT00158873|Midazolam|midazolam|mesh-list
24402964|NCT00158873|Morphine|morphine|mesh-list
24402965|NCT00158873|Remifentanil|remifentanil|mesh-list
24402966|NCT00158873|Lorazepam|lorazepam|mesh-list
24402967|NCT00158873|Propofol|propofol|mesh-list
24402968|NCT00158873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24402969|NCT00158873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25222735|NCT02643719|Naproxen|naproxen|mesh-list
25222736|NCT02643719|Sumatriptan|sumatriptan|mesh-list
25222737|NCT02643719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25222738|NCT02643719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25222739|NCT02643719|Analgesics|analgesics|mesh-ancestor
25222740|NCT02643719|Sensory System Agents|sensory system agents|mesh-ancestor
25222741|NCT02643719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222742|NCT02643719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222743|NCT02643719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25222744|NCT02643719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24835819|NCT02183428|Glyburide|glyburide|mesh-list
24835820|NCT02183428|Linagliptin|linagliptin|mesh-list
24835821|NCT02183428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24835822|NCT02183428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835823|NCT02183428|Incretins|incretins|mesh-ancestor
25055121|NCT03523832|Pregabalin|pregabalin|mesh-list
24402970|NCT00158873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402971|NCT00158873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24402972|NCT00158873|Anesthetics, General|anesthetics, general|mesh-ancestor
24402973|NCT00158873|Anesthetics|anesthetics|mesh-ancestor
24402974|NCT00158873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25680071|NCT01846221|Anesthetics, General|anesthetics, general|mesh-ancestor
25680072|NCT01846221|Anesthetics|anesthetics|mesh-ancestor
25680073|NCT01846221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25680074|NCT01846221|Sympatholytics|sympatholytics|mesh-ancestor
25680075|NCT01846221|Autonomic Agents|autonomic agents|mesh-ancestor
25680076|NCT01846221|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25680077|NCT01846221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25680078|NCT01846221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25680079|NCT01846221|Adrenergic Agents|adrenergic agents|mesh-ancestor
24402993|NCT00158886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24402994|NCT00158886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402995|NCT00158886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402996|NCT00158886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25090645|NCT03255330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24983601|NCT05183841|Respiratory System Agents|respiratory system agents|mesh-ancestor
24983602|NCT05183841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25090646|NCT03255330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25090647|NCT03255330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25090648|NCT03255330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25090649|NCT03255330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090650|NCT03255330|Antimanic Agents|antimanic agents|mesh-ancestor
25090651|NCT03255330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25090652|NCT03255330|Narcotics|narcotics|mesh-ancestor
25090653|NCT03255330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25090654|NCT03255330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25090655|NCT03255330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25090656|NCT03255330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25090658|NCT03255473|Dexamethasone|dexamethasone|mesh-list
25090659|NCT03255473|Dexamethasone acetate|dexamethasone acetate|mesh-list
25090660|NCT03255473|Prednisone|prednisone|mesh-list
25090661|NCT03255473|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25090662|NCT03255473|BB 1101|bb 1101|mesh-list
25222745|NCT02643719|Gout Suppressants|gout suppressants|mesh-ancestor
25222746|NCT02643719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25222747|NCT02643719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25222748|NCT02643719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222749|NCT02643719|Anticonvulsants|anticonvulsants|mesh-ancestor
25222750|NCT02643719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25222751|NCT02643719|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25222752|NCT02643719|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25222753|NCT02643719|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25222754|NCT02643719|Serotonin Agents|serotonin agents|mesh-ancestor
25222755|NCT02643719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25222756|NCT02643732|Methylphenidate|methylphenidate|mesh-list
25222757|NCT02643732|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25222758|NCT02643732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835825|NCT02183428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24835826|NCT02183428|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24835827|NCT02183428|Protease Inhibitors|protease inhibitors|mesh-ancestor
24835828|NCT02183428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835829|NCT02183428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835830|NCT02183441|Linagliptin|linagliptin|mesh-list
24835831|NCT02183441|Ritonavir|ritonavir|mesh-list
24835832|NCT02183441|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24835833|NCT02183441|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24835834|NCT02183441|Protease Inhibitors|protease inhibitors|mesh-ancestor
24835835|NCT02183441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835836|NCT02183441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835837|NCT02183441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24835838|NCT02183441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24835839|NCT02183441|Antiviral Agents|antiviral agents|mesh-ancestor
24835840|NCT02183441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25090663|NCT03255473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25090664|NCT03255473|Antiemetics|antiemetics|mesh-ancestor
25090665|NCT03255473|Autonomic Agents|autonomic agents|mesh-ancestor
25090666|NCT03255473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25090668|NCT03255473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25090669|NCT03255473|Glucocorticoids|glucocorticoids|mesh-ancestor
25015568|NCT01656434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25015569|NCT01656434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090670|NCT03255473|Hormones|hormones|mesh-ancestor
25090671|NCT03255473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25090672|NCT03255473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25090673|NCT03255473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25090674|NCT03255473|Protease Inhibitors|protease inhibitors|mesh-ancestor
25090675|NCT03255473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090676|NCT03255473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090677|NCT03255148|Oxytocin|oxytocin|mesh-list
25090678|NCT03255148|Oxytocics|oxytocics|mesh-ancestor
25090679|NCT03255148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25090680|NCT03255148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222764|NCT02643732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25222766|NCT02643550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25222767|NCT02643550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25222768|NCT02643602|Theophylline|theophylline|mesh-list
25222769|NCT02643602|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25222770|NCT02643602|Autonomic Agents|autonomic agents|mesh-ancestor
25222771|NCT02643602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222772|NCT02643602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222773|NCT02643602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25222774|NCT02643602|Respiratory System Agents|respiratory system agents|mesh-ancestor
25222775|NCT02643602|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25222776|NCT02643602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25222777|NCT02643602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222778|NCT02643602|Vasodilator Agents|vasodilator agents|mesh-ancestor
25222779|NCT02643602|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25222780|NCT02643602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25222781|NCT02643602|Purinergic Agents|purinergic agents|mesh-ancestor
25222782|NCT02643602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25222783|NCT02643433|Vaccines|vaccines|mesh-list
25222784|NCT02643433|Immunologic Factors|immunologic factors|mesh-ancestor
25222785|NCT02643433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835841|NCT02183441|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24835842|NCT02183441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24835843|NCT02183441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24835844|NCT02183441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835845|NCT02183441|Incretins|incretins|mesh-ancestor
24835847|NCT02183441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24835848|NCT02183441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24835849|NCT02183467|Linagliptin|linagliptin|mesh-list
24835850|NCT02183467|Moxifloxacin|moxifloxacin|mesh-list
24835851|NCT02183467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24835876|NCT02183493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24835877|NCT02183493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835878|NCT02183493|Incretins|incretins|mesh-ancestor
24835879|NCT02183493|Hormones|hormones|mesh-ancestor
24835880|NCT02183493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25090683|NCT03254849|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25090684|NCT03254849|Diuretics|diuretics|mesh-ancestor
25090685|NCT03254849|Natriuretic Agents|natriuretic agents|mesh-ancestor
25090686|NCT03254849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090687|NCT03254849|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25090688|NCT03254849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24403000|NCT00158990|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24619475|NCT01052597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403080|NCT00159159|Antifungal Agents|antifungal agents|mesh-ancestor
24403081|NCT00159159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24403082|NCT00159159|Dermatologic Agents|dermatologic agents|mesh-ancestor
24403083|NCT00159159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24403084|NCT00159159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24403085|NCT00159211|Pioglitazone|pioglitazone|mesh-list
24403086|NCT00159211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24403087|NCT00159211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403088|NCT00159224|Ritonavir|ritonavir|mesh-list
24403089|NCT00159224|Lopinavir|lopinavir|mesh-list
24403090|NCT00159224|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24403123|NCT00159445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680080|NCT01846221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25680081|NCT01846221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680082|NCT01846299|Ranibizumab|ranibizumab|mesh-list
24536429|NCT00651287|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24403126|NCT00159445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24403127|NCT00159445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403128|NCT00159445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24403129|NCT00159445|Immunologic Factors|immunologic factors|mesh-ancestor
25222787|NCT02643407|Nedaplatin|nedaplatin|mesh-list
25222788|NCT02643407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25222789|NCT02643407|Tubulin Modulators|tubulin modulators|mesh-ancestor
25222790|NCT02643407|Antimitotic Agents|antimitotic agents|mesh-ancestor
25222791|NCT02643407|Mitosis Modulators|mitosis modulators|mesh-ancestor
25222792|NCT02643407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222793|NCT02643329|Gliclazide|gliclazide|mesh-list
25222794|NCT02643329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25222795|NCT02643329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222796|NCT02643017|Dexmedetomidine|dexmedetomidine|mesh-list
25222797|NCT02643017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25222798|NCT02643017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25222799|NCT02643017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222800|NCT02643017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25222801|NCT02643017|Analgesics|analgesics|mesh-ancestor
25222802|NCT02643017|Sensory System Agents|sensory system agents|mesh-ancestor
25222803|NCT02643017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222804|NCT02643017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25222805|NCT02643017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25222806|NCT02643017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25222807|NCT02643017|Adrenergic Agents|adrenergic agents|mesh-ancestor
25222808|NCT02643017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25222809|NCT02643017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835882|NCT02183493|Protease Inhibitors|protease inhibitors|mesh-ancestor
24835883|NCT02183493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835884|NCT02183493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835885|NCT02183506|Metformin|metformin|mesh-list
24835886|NCT02183506|Linagliptin|linagliptin|mesh-list
24835923|NCT02183584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24835924|NCT02183584|Leprostatic Agents|leprostatic agents|mesh-ancestor
24835925|NCT02183584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24835926|NCT02183584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24835927|NCT02183584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24835928|NCT02183584|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24835929|NCT02183584|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24835930|NCT02183584|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25090689|NCT03254849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090690|NCT03254849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25090692|NCT03254810|Adalimumab|adalimumab|mesh-list
25090693|NCT03254810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24403130|NCT00159445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403132|NCT00159458|Oxaliplatin|oxaliplatin|mesh-list
24403133|NCT00159458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24403143|NCT00159471|Gemcitabine|gemcitabine|mesh-list
24403144|NCT00159471|Capecitabine|capecitabine|mesh-list
24403145|NCT00159471|Docetaxel|docetaxel|mesh-list
24403146|NCT00159471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24403147|NCT00159471|Antimetabolites|antimetabolites|mesh-ancestor
24403148|NCT00159471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403149|NCT00159471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403150|NCT00159471|Antiviral Agents|antiviral agents|mesh-ancestor
24403151|NCT00159471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24403180|NCT00159510|Autonomic Agents|autonomic agents|mesh-ancestor
24403181|NCT00159510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24403182|NCT00159510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403183|NCT00159510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24403184|NCT00159510|Respiratory System Agents|respiratory system agents|mesh-ancestor
24403185|NCT00159510|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24403186|NCT00159510|Antioxidants|antioxidants|mesh-ancestor
24403187|NCT00159510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403188|NCT00159510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24403189|NCT00159510|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24403190|NCT00159510|Vasodilator Agents|vasodilator agents|mesh-ancestor
24403191|NCT00159510|Gasotransmitters|gasotransmitters|mesh-ancestor
24403205|NCT00159627|Diuretics|diuretics|mesh-ancestor
24403206|NCT00159627|Natriuretic Agents|natriuretic agents|mesh-ancestor
25680083|NCT01846299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24403207|NCT00159627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403232|NCT00159666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24403233|NCT00159666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24403234|NCT00159679|Pregabalin|pregabalin|mesh-list
24403248|NCT00159692|Amlodipine|amlodipine|mesh-list
24403249|NCT00159692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24403250|NCT00159692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24403251|NCT00159692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25222810|NCT02643173|Anesthetics|anesthetics|mesh-list
25222811|NCT02643173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
25222812|NCT02643173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25222814|NCT02643173|Anesthetics, General|anesthetics, general|mesh-ancestor
25222815|NCT02643147|Furosemide|furosemide|mesh-list
25222816|NCT02643147|Diuretics|diuretics|mesh-list
25222817|NCT02643147|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
25222818|NCT02643147|Natriuretic Agents|natriuretic agents|mesh-ancestor
25222819|NCT02643147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222820|NCT02643147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25222821|NCT02643147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222822|NCT02643186|Misoprostol|misoprostol|mesh-list
25222823|NCT02643186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25222824|NCT02643186|Abortifacient Agents|abortifacient agents|mesh-ancestor
24835934|NCT02183610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24835935|NCT02183610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835936|NCT02183610|Incretins|incretins|mesh-ancestor
24835938|NCT02183610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24835956|NCT02183623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24835957|NCT02183623|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24835958|NCT02183623|Protease Inhibitors|protease inhibitors|mesh-ancestor
24835959|NCT02183636|Pioglitazone|pioglitazone|mesh-list
24835960|NCT02183636|Linagliptin|linagliptin|mesh-list
24835961|NCT02183636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24835962|NCT02183636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055165|NCT03523741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24403252|NCT00159692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403253|NCT00159692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24403254|NCT00159692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403255|NCT00159692|Vasodilator Agents|vasodilator agents|mesh-ancestor
24403256|NCT00159705|Pregabalin|pregabalin|mesh-list
24403257|NCT00159705|Analgesics|analgesics|mesh-ancestor
24403258|NCT00159705|Sensory System Agents|sensory system agents|mesh-ancestor
24403259|NCT00159705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24403260|NCT00159705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403261|NCT00159705|Anticonvulsants|anticonvulsants|mesh-ancestor
24403262|NCT00159705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24403263|NCT00159705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24403264|NCT00159705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090694|NCT03254810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25090695|NCT03254927|Cetuximab|cetuximab|mesh-list
25090696|NCT03254927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25090697|NCT03254927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25090698|NCT03255044|Atorvastatin|atorvastatin|mesh-list
25090699|NCT03255044|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25090700|NCT03255044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25090701|NCT03255044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25090702|NCT03255044|Antimetabolites|antimetabolites|mesh-ancestor
25090703|NCT03255044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090704|NCT03255044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25090705|NCT03255044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25090706|NCT03255044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090707|NCT03254511|Enoxaparin|enoxaparin|mesh-list
25090708|NCT03254511|Enoxaparin sodium|enoxaparin sodium|mesh-list
25090709|NCT03254511|Anticoagulants|anticoagulants|mesh-ancestor
25090710|NCT03254511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25090711|NCT03254511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25090712|NCT03254511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403265|NCT00159705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24403266|NCT00159705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25680084|NCT01846299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25680085|NCT01846299|Growth Substances|growth substances|mesh-ancestor
24536685|NCT00652041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24536686|NCT00652041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24536687|NCT00652041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24536688|NCT00652041|Growth Substances|growth substances|mesh-ancestor
24536689|NCT00652041|Growth Inhibitors|growth inhibitors|mesh-ancestor
24536690|NCT00652106|Timolol|timolol|mesh-list
25011366|NCT05215730|Copper|copper|mesh-list
25222825|NCT02643186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25222826|NCT02643186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222828|NCT02643186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25222829|NCT02643186|Oxytocics|oxytocics|mesh-ancestor
25222830|NCT02643212|Rivaroxaban|rivaroxaban|mesh-list
25222831|NCT02643212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25222832|NCT02643212|Antithrombins|antithrombins|mesh-ancestor
25222833|NCT02643212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25222834|NCT02643212|Protease Inhibitors|protease inhibitors|mesh-ancestor
24403271|NCT00159718|Atorvastatin|atorvastatin|mesh-list
24403302|NCT00159757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24403305|NCT00159757|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24403306|NCT00159757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24403307|NCT00159757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24403308|NCT00159757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24403309|NCT00159757|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24403310|NCT00159757|Dopamine Agents|dopamine agents|mesh-ancestor
24403311|NCT00159770|Olanzapine|olanzapine|mesh-list
24403312|NCT00159770|Risperidone|risperidone|mesh-list
24403313|NCT00159770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24403314|NCT00159770|Ziprasidone|ziprasidone|mesh-list
24403315|NCT00159770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24403316|NCT00159770|Serotonin Agents|serotonin agents|mesh-ancestor
24403317|NCT00159770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24403318|NCT00159770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403319|NCT00159770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403361|NCT00159900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24403362|NCT00159900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403363|NCT00159900|Urological Agents|urological agents|mesh-ancestor
24403364|NCT00159952|Insulin|insulin|mesh-list
24403365|NCT00159952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25222841|NCT02642900|Antifungal Agents|antifungal agents|mesh-ancestor
25222842|NCT02642900|Ionophores|ionophores|mesh-ancestor
25222843|NCT02642900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25222844|NCT02642900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222845|NCT02642861|Cyclobenzaprine|cyclobenzaprine|mesh-list
25222846|NCT02642861|Calcium Carbonate|calcium carbonate|mesh-list
25222847|NCT02642861|Calcium|calcium|mesh-list
25222848|NCT02642861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25222849|NCT02642861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222850|NCT02642861|Antacids|antacids|mesh-ancestor
25222851|NCT02642861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055181|NCT03523572|Nivolumab|nivolumab|mesh-list
24403366|NCT00159952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403367|NCT00159978|Alovudine|alovudine|mesh-list
24403368|NCT00159978|Antiviral Agents|antiviral agents|mesh-ancestor
24403369|NCT00159978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24403371|NCT00160030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403372|NCT00160043|Vatalanib|vatalanib|mesh-list
24403373|NCT00160043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24403374|NCT00160043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403376|NCT00160069|Sagopilone|sagopilone|mesh-list
24403382|NCT00160069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403464|NCT00160394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24445144|NCT00300573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445172|NCT00300716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445175|NCT00300729|Celecoxib|celecoxib|mesh-list
25680086|NCT01846299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680087|NCT01846299|Growth Inhibitors|growth inhibitors|mesh-ancestor
25680088|NCT01846299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25680089|NCT01846416|Atezolizumab|atezolizumab|mesh-list
25680090|NCT01846416|Antibodies|antibodies|mesh-list
25680091|NCT01846416|Immunologic Factors|immunologic factors|mesh-ancestor
25680092|NCT01846416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680093|NCT01846416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25680094|NCT01846442|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24403465|NCT00160394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090738|NCT03254784|BMS-986165|bms-986165|mesh-list
25090739|NCT03254784|Dermatologic Agents|dermatologic agents|mesh-ancestor
25090740|NCT03254784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25090741|NCT03254784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090742|NCT03254784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090743|NCT03254628|Misoprostol|misoprostol|mesh-list
24403466|NCT00160394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24403467|NCT00160394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24403468|NCT00160394|Dermatologic Agents|dermatologic agents|mesh-ancestor
24403470|NCT00160407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403479|NCT00160498|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24403480|NCT00160498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24403481|NCT00160498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403482|NCT00160498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24403483|NCT00160498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403488|NCT00160537|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24403489|NCT00160537|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24403490|NCT00160537|Histamine Antagonists|histamine antagonists|mesh-ancestor
24403491|NCT00160537|Histamine Agents|histamine agents|mesh-ancestor
24403492|NCT00160537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24403493|NCT00160537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403494|NCT00160537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403511|NCT00160602|Immunologic Factors|immunologic factors|mesh-ancestor
24403512|NCT00160602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403513|NCT00160602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24403514|NCT00160628|Levetiracetam|levetiracetam|mesh-list
24403515|NCT00160628|Anticonvulsants|anticonvulsants|mesh-ancestor
24403516|NCT00160628|Nootropic Agents|nootropic agents|mesh-ancestor
24445298|NCT00301145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445299|NCT00301171|Fluticasone|fluticasone|mesh-list
24445300|NCT00301171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24403519|NCT00160745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24403520|NCT00160745|Antimetabolites|antimetabolites|mesh-ancestor
24403535|NCT00160849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24403536|NCT00160849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24403538|NCT00160875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403539|NCT00160875|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24403540|NCT00160875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24403553|NCT00160888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24403554|NCT00160888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222854|NCT02642861|Antidepressive Agents|antidepressive agents|mesh-ancestor
25222855|NCT02642861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24403555|NCT00160888|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
24403557|NCT00160888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403558|NCT00160927|Nitroprusside|nitroprusside|mesh-list
24403559|NCT00160927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24403560|NCT00160927|Vasodilator Agents|vasodilator agents|mesh-ancestor
24403561|NCT00160927|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25090744|NCT03254628|Oxytocin|oxytocin|mesh-list
25090745|NCT03254628|Oxytocics|oxytocics|mesh-ancestor
25090746|NCT03254628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25090755|NCT03254186|Propranolol|propranolol|mesh-list
25090756|NCT03254186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25090757|NCT03254186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25090758|NCT03254186|Adrenergic Agents|adrenergic agents|mesh-ancestor
25090759|NCT03254186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25090760|NCT03254186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090761|NCT03254186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090762|NCT03254186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25090763|NCT03254186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25090764|NCT03254186|Vasodilator Agents|vasodilator agents|mesh-ancestor
25090765|NCT03254173|Mirtazapine|mirtazapine|mesh-list
24445302|NCT00301171|Autonomic Agents|autonomic agents|mesh-ancestor
24445331|NCT00301236|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
24445387|NCT00301483|HBOC 201|hboc 201|mesh-list
25090766|NCT03254173|Antidepressive Agents|antidepressive agents|mesh-ancestor
24536885|NCT00652808|Sensory System Agents|sensory system agents|mesh-ancestor
25015753|NCT00963469|Montelukast|montelukast|mesh-list
25015754|NCT00963469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25015755|NCT00963469|Respiratory System Agents|respiratory system agents|mesh-ancestor
25015756|NCT00963469|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25015757|NCT00963469|Hormone Antagonists|hormone antagonists|mesh-ancestor
24972398|NCT03718377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972399|NCT03718273|Digoxin|digoxin|mesh-list
24972400|NCT03718273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24972401|NCT03718273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25090767|NCT03254173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25090768|NCT03254173|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25090769|NCT03254173|Histamine Antagonists|histamine antagonists|mesh-ancestor
25090770|NCT03254173|Histamine Agents|histamine agents|mesh-ancestor
25090771|NCT03254173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25090772|NCT03254173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090773|NCT03254173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403562|NCT00160927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403563|NCT00160966|Cyclosporine|cyclosporine|mesh-list
24403564|NCT00160966|Mycophenolic Acid|mycophenolic acid|mesh-list
24403565|NCT00160966|Everolimus|everolimus|mesh-list
24403566|NCT00160966|Tacrolimus|tacrolimus|mesh-list
24403567|NCT00160966|Cyclosporins|cyclosporins|mesh-list
24403568|NCT00160966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24403569|NCT00160966|Immunologic Factors|immunologic factors|mesh-ancestor
24403570|NCT00160966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403571|NCT00160966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24403572|NCT00160966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403573|NCT00160966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403574|NCT00160966|Antifungal Agents|antifungal agents|mesh-ancestor
25090774|NCT03254173|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25090775|NCT03254173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25090776|NCT03254173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25090777|NCT03254173|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25090778|NCT03254173|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25090779|NCT03254173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25090780|NCT03254173|Adrenergic Agents|adrenergic agents|mesh-ancestor
25090781|NCT03254173|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25090782|NCT03254173|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25090783|NCT03254173|Serotonin Agents|serotonin agents|mesh-ancestor
25090784|NCT03254173|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25090785|NCT03254368|ZGN-1061|zgn-1061|mesh-list
25090786|NCT03254368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403575|NCT00160966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24403576|NCT00160966|Dermatologic Agents|dermatologic agents|mesh-ancestor
24403577|NCT00160966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24403578|NCT00160966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403579|NCT00160966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24403580|NCT00160966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24403581|NCT00160966|Antitubercular Agents|antitubercular agents|mesh-ancestor
24445400|NCT00301509|Antiviral Agents|antiviral agents|mesh-ancestor
24445401|NCT00301509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24445414|NCT00301535|Sensory System Agents|sensory system agents|mesh-ancestor
24445415|NCT00301535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24445416|NCT00301535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445417|NCT00301535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24445418|NCT00301535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24445419|NCT00301535|Blood Substitutes|blood substitutes|mesh-ancestor
24445420|NCT00301574|Galantamine|galantamine|mesh-list
24445421|NCT00301574|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24445422|NCT00301574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403582|NCT00160966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24403583|NCT00161018|Risperidone|risperidone|mesh-list
25680095|NCT01846442|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25680096|NCT01846442|Immunologic Factors|immunologic factors|mesh-ancestor
25680097|NCT01846442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680098|NCT01846455|Promethazine|promethazine|mesh-list
25680099|NCT01846455|Diphenhydramine|diphenhydramine|mesh-list
25680100|NCT01846455|Buprenorphine|buprenorphine|mesh-list
25680101|NCT01846455|Naloxone|naloxone|mesh-list
25680102|NCT01846455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25680103|NCT01846455|Narcotics|narcotics|mesh-ancestor
25680104|NCT01846455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24403584|NCT00161018|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24451582|NCT00324324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619538|NCT01052896|Antimanic Agents|antimanic agents|mesh-ancestor
24403599|NCT00161018|Antidepressive Agents|antidepressive agents|mesh-ancestor
24403600|NCT00161031|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24403651|NCT00161200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24403652|NCT00161200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222856|NCT02642861|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25222857|NCT02642861|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24836028|NCT02183805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24836029|NCT02183805|Tubulin Modulators|tubulin modulators|mesh-ancestor
24836030|NCT02183805|Antimitotic Agents|antimitotic agents|mesh-ancestor
24836031|NCT02183805|Mitosis Modulators|mitosis modulators|mesh-ancestor
24836032|NCT02183909|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24836033|NCT02183909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24836034|NCT02183909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24403654|NCT00161226|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24403655|NCT00161226|Contraceptive Agents|contraceptive agents|mesh-ancestor
24403656|NCT00161226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24403657|NCT00161226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403658|NCT00161226|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24403659|NCT00161226|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24403660|NCT00161226|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24403662|NCT00161239|Methotrexate|methotrexate|mesh-list
24403663|NCT00161239|Asparaginase|asparaginase|mesh-list
24403664|NCT00161239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24403665|NCT00161239|Glucocorticoids|glucocorticoids|mesh-ancestor
24403666|NCT00161239|Hormones|hormones|mesh-ancestor
24403667|NCT00161239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24403668|NCT00161239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403684|NCT00161278|Paclitaxel|paclitaxel|mesh-list
24451628|NCT00324467|Alkylating Agents|alkylating agents|mesh-ancestor
25090787|NCT03254368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090788|NCT03254368|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25090789|NCT03254004|Pembrolizumab|pembrolizumab|mesh-list
25090790|NCT03254004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25090791|NCT03254004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25090792|NCT03253913|Sirolimus|sirolimus|mesh-list
25090793|NCT03253913|Resveratrol|resveratrol|mesh-list
25090794|NCT03253913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25090795|NCT03253913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24403686|NCT00161278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24403687|NCT00161278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403688|NCT00161278|Tubulin Modulators|tubulin modulators|mesh-ancestor
24403689|NCT00161278|Antimitotic Agents|antimitotic agents|mesh-ancestor
24403690|NCT00161278|Mitosis Modulators|mitosis modulators|mesh-ancestor
24403691|NCT00161278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403692|NCT00161291|Bevacizumab|bevacizumab|mesh-list
25222858|NCT02642861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222859|NCT02642861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25222860|NCT02642861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25222861|NCT02642913|Sorafenib|sorafenib|mesh-list
25222862|NCT02642913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25222863|NCT02642913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25222864|NCT02642913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25222865|NCT02642913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222866|NCT02642874|Methocarbamol|methocarbamol|mesh-list
25222867|NCT02642874|Calcium Carbonate|calcium carbonate|mesh-list
25222868|NCT02642874|Calcium|calcium|mesh-list
25222869|NCT02642874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25222870|NCT02642874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222871|NCT02642874|Antacids|antacids|mesh-ancestor
24836035|NCT02183909|Antiviral Agents|antiviral agents|mesh-ancestor
24836036|NCT02183909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24836038|NCT02183948|Oxytocics|oxytocics|mesh-ancestor
24836039|NCT02183948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24836040|NCT02183948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836042|NCT02184052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24836043|NCT02184052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24836044|NCT02184052|Analgesics|analgesics|mesh-ancestor
24836045|NCT02184052|Sensory System Agents|sensory system agents|mesh-ancestor
24836046|NCT02184052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24836047|NCT02184052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836048|NCT02184052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24836049|NCT02184052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24836050|NCT02184052|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24836060|NCT02184065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836061|NCT02184065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25055201|NCT03523221|Glucocorticoids|glucocorticoids|mesh-ancestor
24403693|NCT00161291|Letrozole|letrozole|mesh-list
24755012|NCT01724268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24403740|NCT00161421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403741|NCT00161421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24403742|NCT00161421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403743|NCT00161421|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24403744|NCT00161421|Fertility Agents|fertility agents|mesh-ancestor
24403745|NCT00161421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24403762|NCT00161447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24403763|NCT00161447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403764|NCT00161447|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24403765|NCT00161447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24403766|NCT00161447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24403767|NCT00161447|Contraceptive Agents|contraceptive agents|mesh-ancestor
24403768|NCT00161447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24403926|NCT00162188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403927|NCT00162188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403928|NCT00162188|Antiviral Agents|antiviral agents|mesh-ancestor
24403929|NCT00162188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24403930|NCT00162188|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24404003|NCT00162383|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24404004|NCT00162383|Purinergic Agents|purinergic agents|mesh-ancestor
24404005|NCT00162383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24404006|NCT00162383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24404007|NCT00162383|Antimalarials|antimalarials|mesh-ancestor
25090797|NCT03253913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25222872|NCT02642874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222873|NCT02642874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25222874|NCT02642874|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25222875|NCT02642874|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25222876|NCT02642874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222877|NCT02642939|Mifepristone|mifepristone|mesh-list
25222878|NCT02642939|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25222879|NCT02642939|Abortifacient Agents|abortifacient agents|mesh-ancestor
25222880|NCT02642939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25222881|NCT02642939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222882|NCT02642939|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25222883|NCT02642939|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25222884|NCT02642939|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25222885|NCT02642939|Contraceptive Agents|contraceptive agents|mesh-ancestor
25222886|NCT02642939|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25222887|NCT02642939|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25222888|NCT02642939|Hormone Antagonists|hormone antagonists|mesh-ancestor
25222889|NCT02642939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25222890|NCT02642939|Luteolytic Agents|luteolytic agents|mesh-ancestor
25222891|NCT02642939|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24836065|NCT02184065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836066|NCT02184065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836067|NCT02184078|Nevirapine|nevirapine|mesh-list
25106672|NCT00799396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25106673|NCT00799396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25106674|NCT00799396|Antipyretics|antipyretics|mesh-ancestor
24836068|NCT02184078|Rifabutin|rifabutin|mesh-list
24836069|NCT02184078|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24404010|NCT00162383|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24404011|NCT00162383|Leprostatic Agents|leprostatic agents|mesh-ancestor
24404012|NCT00162383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24404013|NCT00162383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24404014|NCT00162383|Sympatholytics|sympatholytics|mesh-ancestor
24404015|NCT00162383|Autonomic Agents|autonomic agents|mesh-ancestor
24404080|NCT00162487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24404081|NCT00162487|Respiratory System Agents|respiratory system agents|mesh-ancestor
24404082|NCT00162487|Tocolytic Agents|tocolytic agents|mesh-ancestor
24404083|NCT00162487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24404168|NCT00162669|Growth Substances|growth substances|mesh-ancestor
24404169|NCT00162669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404170|NCT00162669|Growth Inhibitors|growth inhibitors|mesh-ancestor
24404247|NCT00162864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24404256|NCT00162877|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24404257|NCT00162877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404258|NCT00162877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404259|NCT00162916|Citalopram|citalopram|mesh-list
24404260|NCT00162916|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24404261|NCT00162916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24445581|NCT00301899|Pertuzumab|pertuzumab|mesh-list
25106682|NCT00069238|Doxorubicin|doxorubicin|mesh-list
24404262|NCT00162916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24404305|NCT00163072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24404306|NCT00163072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404307|NCT00163111|Amphotericin B|amphotericin b|mesh-list
24404308|NCT00163111|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25222892|NCT02642939|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25222893|NCT02642718|Ketorolac|ketorolac|mesh-list
25222894|NCT02642718|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25222895|NCT02642718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25222896|NCT02642718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25222897|NCT02642718|Analgesics|analgesics|mesh-ancestor
25222898|NCT02642718|Sensory System Agents|sensory system agents|mesh-ancestor
25222899|NCT02642718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222900|NCT02642718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222901|NCT02642718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25222902|NCT02642718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25222903|NCT02642718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25222904|NCT02642718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25222905|NCT02642718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222906|NCT02642523|Insulin|insulin|mesh-list
25222907|NCT02642523|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25042971|NCT01344187|Vitamin B Complex|vitamin b complex|mesh-ancestor
25042973|NCT01344187|Micronutrients|micronutrients|mesh-ancestor
25042974|NCT01344187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042975|NCT01344187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25042976|NCT01344187|Dermatologic Agents|dermatologic agents|mesh-ancestor
24404309|NCT00163111|Fluconazole|fluconazole|mesh-list
24404310|NCT00163111|Amebicides|amebicides|mesh-ancestor
24404311|NCT00163111|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24404312|NCT00163111|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24404354|NCT00163241|Sensory System Agents|sensory system agents|mesh-ancestor
24404355|NCT00163241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24404359|NCT00163241|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24404360|NCT00163241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25106684|NCT00069238|Vincristine|vincristine|mesh-list
25090809|NCT03253887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25090810|NCT03253887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25090811|NCT03253887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090812|NCT03253328|Acetylcysteine|acetylcysteine|mesh-list
25090813|NCT03253328|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25090814|NCT03253328|Antiviral Agents|antiviral agents|mesh-ancestor
25090815|NCT03253328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25090816|NCT03253328|Expectorants|expectorants|mesh-ancestor
25090817|NCT03253328|Respiratory System Agents|respiratory system agents|mesh-ancestor
25090818|NCT03253328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25090819|NCT03253328|Antioxidants|antioxidants|mesh-ancestor
25090820|NCT03253328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090821|NCT03253328|Protective Agents|protective agents|mesh-ancestor
25090822|NCT03253328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090823|NCT03253328|Antidotes|antidotes|mesh-ancestor
24404362|NCT00163241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404363|NCT00163254|Abciximab|abciximab|mesh-list
24404364|NCT00163254|Anticoagulants|anticoagulants|mesh-ancestor
24404415|NCT00163384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404416|NCT00163384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24404418|NCT00163397|Glucocorticoids|glucocorticoids|mesh-ancestor
24404419|NCT00163397|Hormones|hormones|mesh-ancestor
24404420|NCT00163397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24404421|NCT00163397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404422|NCT00163397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24404423|NCT00163410|Ciclesonide|ciclesonide|mesh-list
24404480|NCT00163553|Sensory System Agents|sensory system agents|mesh-ancestor
24404481|NCT00163553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24404482|NCT00163553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24404601|NCT00164164|Laxatives|laxatives|mesh-ancestor
24404602|NCT00164164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24404603|NCT00164216|Artesunate|artesunate|mesh-list
24404604|NCT00164216|Mefloquine|mefloquine|mesh-list
24404605|NCT00164216|Antimalarials|antimalarials|mesh-ancestor
24404606|NCT00164216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24404607|NCT00164216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25090836|NCT03253276|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
25222908|NCT02642523|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25222909|NCT02642523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25222910|NCT02642523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222911|NCT02642523|Natriuretic Agents|natriuretic agents|mesh-ancestor
25222912|NCT02642497|Ketamine|ketamine|mesh-list
25222913|NCT02642497|Analgesics|analgesics|mesh-ancestor
25222914|NCT02642497|Sensory System Agents|sensory system agents|mesh-ancestor
25222915|NCT02642497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25042984|NCT01339689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042985|NCT01339689|GABA Modulators|gaba modulators|mesh-ancestor
25042986|NCT01339689|GABA Agents|gaba agents|mesh-ancestor
25042987|NCT01338883|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25042988|NCT01338883|Efavirenz|efavirenz|mesh-list
25042989|NCT01338883|Cenicriviroc|cenicriviroc|mesh-list
25063746|NCT03466333|Enalapril|enalapril|mesh-list
25090837|NCT03253276|Cathartics|cathartics|mesh-ancestor
24404718|NCT00164710|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24404719|NCT00164710|Anthelmintics|anthelmintics|mesh-ancestor
24404720|NCT00164710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24404721|NCT00164710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25680105|NCT01846455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404830|NCT00164970|Hematinics|hematinics|mesh-ancestor
24404888|NCT00165139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404890|NCT00165139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24404891|NCT00165139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24404892|NCT00165139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24404893|NCT00165139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24404894|NCT00165139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404895|NCT00165139|Tubulin Modulators|tubulin modulators|mesh-ancestor
24404901|NCT00165178|Cytarabine|cytarabine|mesh-list
24404959|NCT00165191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24405041|NCT00165373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405042|NCT00165373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24983712|NCT05177939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24983713|NCT05177939|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24983715|NCT05177939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24405130|NCT00165516|Chelating Agents|chelating agents|mesh-ancestor
24405131|NCT00165516|Sequestering Agents|sequestering agents|mesh-ancestor
24405132|NCT00165555|Sodium thiosulfate|sodium thiosulfate|mesh-list
24405133|NCT00165555|Antidotes|antidotes|mesh-ancestor
24405281|NCT00166413|Leprostatic Agents|leprostatic agents|mesh-ancestor
25222916|NCT02642497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222917|NCT02642497|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25222918|NCT02642497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25222919|NCT02642497|Anesthetics, General|anesthetics, general|mesh-ancestor
25222920|NCT02642497|Anesthetics|anesthetics|mesh-ancestor
25222921|NCT02642497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25222922|NCT02642497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25222923|NCT02642497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25222924|NCT02642497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25222925|NCT02642497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222926|NCT02642484|Gabapentin|gabapentin|mesh-list
25222927|NCT02642484|Calcium Carbonate|calcium carbonate|mesh-list
25222928|NCT02642484|Calcium|calcium|mesh-list
25055248|NCT03522649|Fluorouracil|fluorouracil|mesh-list
24405337|NCT00166556|Alemtuzumab|alemtuzumab|mesh-list
25090838|NCT03253276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25090839|NCT03253224|Magnesium Sulfate|magnesium sulfate|mesh-list
25090840|NCT03253224|Analgesics|analgesics|mesh-ancestor
25090841|NCT03253224|Sensory System Agents|sensory system agents|mesh-ancestor
25090842|NCT03253224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25090843|NCT03253224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090844|NCT03253224|Anesthetics|anesthetics|mesh-ancestor
25090845|NCT03253224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25090846|NCT03253224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25090847|NCT03253224|Anticonvulsants|anticonvulsants|mesh-ancestor
24405339|NCT00166556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24405340|NCT00166556|Immunologic Factors|immunologic factors|mesh-ancestor
24405341|NCT00166556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405342|NCT00166556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24405343|NCT00166556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405344|NCT00166556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405516|NCT00167492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405517|NCT00167518|Triamcinolone|triamcinolone|mesh-list
24405518|NCT00167518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24405557|NCT00167648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405558|NCT00167648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24405559|NCT00167648|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24405560|NCT00167648|Fertility Agents|fertility agents|mesh-ancestor
24405561|NCT00167648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24405562|NCT00167648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405563|NCT00167674|Zidovudine|zidovudine|mesh-list
24405564|NCT00167674|Nevirapine|nevirapine|mesh-list
25090849|NCT03253224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25090850|NCT03253224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090851|NCT03253224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25222929|NCT02642484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25222930|NCT02642484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222931|NCT02642484|Analgesics|analgesics|mesh-ancestor
25222932|NCT02642484|Sensory System Agents|sensory system agents|mesh-ancestor
25222933|NCT02642484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222934|NCT02642484|Anticonvulsants|anticonvulsants|mesh-ancestor
25222935|NCT02642484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25222936|NCT02642484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25222937|NCT02642484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25222938|NCT02642484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24836126|NCT02184247|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24836127|NCT02184247|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24836128|NCT02184247|Purinergic Agents|purinergic agents|mesh-ancestor
24836129|NCT02184247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24836130|NCT02184260|Dipyrone|dipyrone|mesh-list
24836131|NCT02184260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25063785|NCT03466216|Octreotide|octreotide|mesh-list
25090853|NCT03253224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25090854|NCT03253250|Tenofovir|tenofovir|mesh-list
25090855|NCT03253250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25090856|NCT03253250|Entecavir|entecavir|mesh-list
24405720|NCT00167999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405721|NCT00168012|Immunoglobulins|immunoglobulins|mesh-list
24405722|NCT00168012|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24405723|NCT00168012|Antibodies|antibodies|mesh-list
24405724|NCT00168012|Immunologic Factors|immunologic factors|mesh-ancestor
24405725|NCT00168012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680106|NCT01846455|Analgesics|analgesics|mesh-ancestor
25222945|NCT02642484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25222947|NCT02642419|Rivaroxaban|rivaroxaban|mesh-list
25222948|NCT02642419|Clopidogrel|clopidogrel|mesh-list
25222949|NCT02642419|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25222950|NCT02642419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25222951|NCT02642419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25222952|NCT02642419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25222953|NCT02642419|Analgesics|analgesics|mesh-ancestor
25222954|NCT02642419|Sensory System Agents|sensory system agents|mesh-ancestor
25222955|NCT02642419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222956|NCT02642419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222957|NCT02642419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25222958|NCT02642419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25222959|NCT02642419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25222960|NCT02642419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25222961|NCT02642419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222962|NCT02642419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25222963|NCT02642419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25222964|NCT02642419|Antipyretics|antipyretics|mesh-ancestor
24836139|NCT02184260|Antipyretics|antipyretics|mesh-ancestor
24405726|NCT00168025|Immunoglobulins|immunoglobulins|mesh-list
24405727|NCT00168025|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24405728|NCT00168025|Antibodies|antibodies|mesh-list
24405729|NCT00168025|Immunologic Factors|immunologic factors|mesh-ancestor
24405730|NCT00168025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405731|NCT00168051|Factor VIII|factor viii|mesh-list
24405732|NCT00168051|Coagulants|coagulants|mesh-ancestor
24405733|NCT00168077|Thrombin|thrombin|mesh-list
24405734|NCT00168077|Hemostatics|hemostatics|mesh-ancestor
24405735|NCT00168077|Coagulants|coagulants|mesh-ancestor
24405736|NCT00168090|Factor VIII|factor viii|mesh-list
24405737|NCT00168090|Coagulants|coagulants|mesh-ancestor
24405738|NCT00168168|Lenograstim|lenograstim|mesh-list
24405743|NCT00168181|Miotics|miotics|mesh-ancestor
24405828|NCT00168493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405829|NCT00168493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24405857|NCT00168597|Vitamins|vitamins|mesh-ancestor
24405858|NCT00168597|Micronutrients|micronutrients|mesh-ancestor
24405859|NCT00168597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405860|NCT00168610|Vitamin A|vitamin a|mesh-list
24405861|NCT00168610|Vitamins|vitamins|mesh-ancestor
24405862|NCT00168610|Micronutrients|micronutrients|mesh-ancestor
25090865|NCT03253250|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25090866|NCT03253562|Metformin|metformin|mesh-list
25090867|NCT03253562|Vildagliptin|vildagliptin|mesh-list
25090868|NCT03253562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25090869|NCT03253562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680107|NCT01846455|Sensory System Agents|sensory system agents|mesh-ancestor
25222965|NCT02642419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25222966|NCT02642419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25222967|NCT02642419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25222968|NCT02642419|Purinergic Agents|purinergic agents|mesh-ancestor
25680108|NCT01846455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25680109|NCT01846455|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25680110|NCT01846455|Antipruritics|antipruritics|mesh-ancestor
25680111|NCT01846455|Dermatologic Agents|dermatologic agents|mesh-ancestor
25222972|NCT02642419|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25222973|NCT02642419|Protease Inhibitors|protease inhibitors|mesh-ancestor
25222974|NCT02642419|Anticoagulants|anticoagulants|mesh-ancestor
25222975|NCT02642380|Dexamethasone|dexamethasone|mesh-list
25222976|NCT02642380|Dexamethasone acetate|dexamethasone acetate|mesh-list
25222977|NCT02642380|BB 1101|bb 1101|mesh-list
25222978|NCT02642380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25222979|NCT02642380|Antiemetics|antiemetics|mesh-ancestor
25222980|NCT02642380|Autonomic Agents|autonomic agents|mesh-ancestor
25222981|NCT02642380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222982|NCT02642380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222983|NCT02642380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25222984|NCT02642380|Glucocorticoids|glucocorticoids|mesh-ancestor
25222985|NCT02642380|Hormones|hormones|mesh-ancestor
25275631|NCT02370745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055286|NCT03522207|Trazodone|trazodone|mesh-list
25090870|NCT03253562|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25090871|NCT03253562|Protease Inhibitors|protease inhibitors|mesh-ancestor
25090872|NCT03253562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405913|NCT00168766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24405914|NCT00168766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405915|NCT00168766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24405916|NCT00168766|Glucocorticoids|glucocorticoids|mesh-ancestor
24405917|NCT00168766|Hormones|hormones|mesh-ancestor
24405919|NCT00168766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24405935|NCT00168792|Tenecteplase|tenecteplase|mesh-list
24405936|NCT00168792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24405937|NCT00168792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24405938|NCT00168792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405939|NCT00168857|Losartan|losartan|mesh-list
24405940|NCT00168857|Telmisartan|telmisartan|mesh-list
24405941|NCT00168857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24405942|NCT00168857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24405949|NCT00168870|Antimetabolites|antimetabolites|mesh-ancestor
24405966|NCT00168883|Antimitotic Agents|antimitotic agents|mesh-ancestor
24405967|NCT00168883|Mitosis Modulators|mitosis modulators|mesh-ancestor
24405968|NCT00168883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405970|NCT00168896|Irinotecan|irinotecan|mesh-list
24406045|NCT00169039|GABA Antagonists|gaba antagonists|mesh-ancestor
24406046|NCT00169039|GABA Agents|gaba agents|mesh-ancestor
24406162|NCT00169182|Mitosis Modulators|mitosis modulators|mesh-ancestor
24406163|NCT00169182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406164|NCT00169182|Vitamin B Complex|vitamin b complex|mesh-ancestor
24406165|NCT00169182|Vitamins|vitamins|mesh-ancestor
24406166|NCT00169182|Micronutrients|micronutrients|mesh-ancestor
24406223|NCT00169299|Contraceptive Agents|contraceptive agents|mesh-ancestor
25090873|NCT03253562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090874|NCT03253198|Bupivacaine|bupivacaine|mesh-list
25090875|NCT03253198|Anesthetics, Local|anesthetics, local|mesh-ancestor
25090876|NCT03253198|Anesthetics|anesthetics|mesh-ancestor
25090877|NCT03253198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25090878|NCT03253198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090879|NCT03253198|Sensory System Agents|sensory system agents|mesh-ancestor
25222986|NCT02642380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25222987|NCT02642380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25222988|NCT02642380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25222989|NCT02642380|Protease Inhibitors|protease inhibitors|mesh-ancestor
25222990|NCT02642380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25222991|NCT02642380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25222992|NCT02642601|Indomethacin|indomethacin|mesh-list
25222993|NCT02642601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25090880|NCT03253198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25090883|NCT03253133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25090884|NCT03253133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25090885|NCT03253133|Narcotics|narcotics|mesh-ancestor
24406224|NCT00169299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24406225|NCT00169299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24406226|NCT00169299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24406227|NCT00169299|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24406228|NCT00169299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24406229|NCT00169299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406230|NCT00169416|Valacyclovir|valacyclovir|mesh-list
24406231|NCT00169416|Antiviral Agents|antiviral agents|mesh-ancestor
24406232|NCT00169416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24406233|NCT00169468|Rituximab|rituximab|mesh-list
24406234|NCT00169468|Bortezomib|bortezomib|mesh-list
24406238|NCT00169468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406304|NCT00169585|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24406305|NCT00169585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24406306|NCT00169585|Renal Agents|renal agents|mesh-ancestor
24406307|NCT00169585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24406308|NCT00169585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24406309|NCT00169585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24406310|NCT00169585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24406312|NCT00169585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406352|NCT00169923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406353|NCT00169949|Aripiprazole|aripiprazole|mesh-list
24406354|NCT00169949|Antidepressive Agents|antidepressive agents|mesh-ancestor
24406355|NCT00169949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24406356|NCT00169949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24406357|NCT00169949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25222994|NCT02642601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25222995|NCT02642601|Analgesics|analgesics|mesh-ancestor
25222996|NCT02642601|Sensory System Agents|sensory system agents|mesh-ancestor
25222997|NCT02642601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25222998|NCT02642601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25222999|NCT02642601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25223000|NCT02642601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25223001|NCT02642601|Gout Suppressants|gout suppressants|mesh-ancestor
25223002|NCT02642601|Tocolytic Agents|tocolytic agents|mesh-ancestor
25223003|NCT02642601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25223004|NCT02642601|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25223005|NCT02642601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25223006|NCT02642601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223007|NCT02642367|Rocuronium|rocuronium|mesh-list
25223008|NCT02642367|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25223009|NCT02642367|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25055307|NCT03522194|Anesthetics|anesthetics|mesh-ancestor
24406358|NCT00169949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24406359|NCT00169949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406360|NCT00169949|Dopamine Agonists|dopamine agonists|mesh-ancestor
24406361|NCT00169949|Dopamine Agents|dopamine agents|mesh-ancestor
24406362|NCT00169949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24406366|NCT00169949|Serotonin Agents|serotonin agents|mesh-ancestor
24406412|NCT00170196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24406413|NCT00170196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767244|NCT01799460|Alkylating Agents|alkylating agents|mesh-ancestor
24406417|NCT00170209|Antitubercular Agents|antitubercular agents|mesh-ancestor
24406420|NCT00170209|Leprostatic Agents|leprostatic agents|mesh-ancestor
24537430|NCT00654576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24406490|NCT00170573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406491|NCT00170612|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24406492|NCT00170612|Immunologic Factors|immunologic factors|mesh-ancestor
24406493|NCT00170612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406495|NCT00170664|Carboplatin|carboplatin|mesh-list
24406496|NCT00170664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24406557|NCT00170768|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24406610|NCT00170885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24406611|NCT00170885|Immunologic Factors|immunologic factors|mesh-ancestor
24406612|NCT00170885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406613|NCT00170898|Lumiracoxib|lumiracoxib|mesh-list
24406614|NCT00170898|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24406615|NCT00170898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24406616|NCT00170898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451676|NCT00324480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407238|NCT00173862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24407239|NCT00173862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407242|NCT00173862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407321|NCT00174304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407322|NCT00174304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24407323|NCT00174304|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24407422|NCT00174499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451702|NCT00324558|Anticoagulants|anticoagulants|mesh-ancestor
24451703|NCT00324571|Calcium|calcium|mesh-list
24451704|NCT00324571|Sevelamer|sevelamer|mesh-list
24451705|NCT00324571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24451706|NCT00324571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451707|NCT00324571|Chelating Agents|chelating agents|mesh-ancestor
24451708|NCT00324571|Sequestering Agents|sequestering agents|mesh-ancestor
25223010|NCT02642367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25223011|NCT02642367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25223012|NCT02642367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223013|NCT02642146|Calcium Channel Blockers|calcium channel blockers|mesh-list
25223014|NCT02642146|Vasodilator Agents|vasodilator agents|mesh-list
25223015|NCT02642146|Calcium|calcium|mesh-list
25275632|NCT02370745|Hormones|hormones|mesh-ancestor
25275727|NCT02369939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24407535|NCT00174655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24407536|NCT00174655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090892|NCT03253068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25090893|NCT03253068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25090894|NCT03253107|Trastuzumab|trastuzumab|mesh-list
25090895|NCT03253107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25090896|NCT03253107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407601|NCT00174798|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24407602|NCT00174798|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24407603|NCT00174798|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24407604|NCT00174798|Cholinergic Agents|cholinergic agents|mesh-ancestor
24407678|NCT00175032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24407680|NCT00175032|Analgesics|analgesics|mesh-ancestor
24407765|NCT00175396|Bicalutamide|bicalutamide|mesh-list
24407767|NCT00175396|Buserelin|buserelin|mesh-list
24407777|NCT00175396|Hormone Antagonists|hormone antagonists|mesh-ancestor
24407778|NCT00175396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24407781|NCT00175396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407891|NCT00175812|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24407892|NCT00175812|Vasodilator Agents|vasodilator agents|mesh-ancestor
25680112|NCT01846455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25680113|NCT01846455|Histamine Antagonists|histamine antagonists|mesh-ancestor
25680114|NCT01846455|Histamine Agents|histamine agents|mesh-ancestor
24407898|NCT00175838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24407899|NCT00175838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24407901|NCT00175838|Sensory System Agents|sensory system agents|mesh-ancestor
24407902|NCT00175838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24407903|NCT00175838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407904|NCT00175838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24407912|NCT00175838|Antipyretics|antipyretics|mesh-ancestor
24451736|NCT00324623|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24451737|NCT00324623|Alkylating Agents|alkylating agents|mesh-ancestor
24451738|NCT00324623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407941|NCT00175929|Brivaracetam|brivaracetam|mesh-list
25090903|NCT03252665|Vasodilator Agents|vasodilator agents|mesh-ancestor
25090904|NCT03252665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25090906|NCT03252665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24408145|NCT00176670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408147|NCT00176735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24408148|NCT00176735|Antimetabolites|antimetabolites|mesh-ancestor
25223016|NCT02642146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
25223017|NCT02642146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25223018|NCT02642146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836247|NCT02184819|Vitamin B Complex|vitamin b complex|mesh-ancestor
24836248|NCT02184819|Vitamins|vitamins|mesh-ancestor
24836249|NCT02184819|Micronutrients|micronutrients|mesh-ancestor
24836250|NCT02184819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836251|NCT02184819|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24408149|NCT00176735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408150|NCT00176735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408151|NCT00176761|Interleukin-2|interleukin-2|mesh-list
24408152|NCT00176761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408153|NCT00176761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24408293|NCT00177138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408294|NCT00177138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24408295|NCT00177138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408297|NCT00177242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408298|NCT00177242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24408299|NCT00177242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408358|NCT00177528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24408366|NCT00177567|Valproic Acid|valproic acid|mesh-list
24408367|NCT00177567|Olanzapine|olanzapine|mesh-list
24408368|NCT00177567|Risperidone|risperidone|mesh-list
24408369|NCT00177567|Lithium Carbonate|lithium carbonate|mesh-list
24408370|NCT00177567|Mirtazapine|mirtazapine|mesh-list
24408371|NCT00177567|Tranylcypromine|tranylcypromine|mesh-list
24408372|NCT00177567|Bupropion|bupropion|mesh-list
24408373|NCT00177567|Paroxetine|paroxetine|mesh-list
24408411|NCT00177567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24408412|NCT00177567|Adrenergic Agents|adrenergic agents|mesh-ancestor
24408413|NCT00177567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24408414|NCT00177567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24408415|NCT00177567|GABA Agents|gaba agents|mesh-ancestor
24527724|NCT00618176|Stavudine|stavudine|mesh-list
24408416|NCT00177567|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24408417|NCT00177580|Pravastatin|pravastatin|mesh-list
25090923|NCT03252457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25090924|NCT03252457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25223020|NCT02642146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223021|NCT02642146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25223022|NCT02642250|Metronidazole|metronidazole|mesh-list
25223023|NCT02642250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25223024|NCT02642250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25223025|NCT02642250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25223026|NCT02642250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25223028|NCT02642263|Oxytocics|oxytocics|mesh-ancestor
25223029|NCT02642263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25223030|NCT02642263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273178|NCT02386735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25273179|NCT02386735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273180|NCT02386735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25273181|NCT02386735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25273182|NCT02386358|Benzonidazole|benzonidazole|mesh-list
25273183|NCT02386358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25273184|NCT02386358|Immunologic Factors|immunologic factors|mesh-ancestor
24836281|NCT02184910|Hormones|hormones|mesh-ancestor
24836282|NCT02184910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24747174|NCT01734512|Everolimus|everolimus|mesh-list
24796375|NCT01949571|Serotonin Agents|serotonin agents|mesh-ancestor
25090932|NCT03252496|Bupivacaine|bupivacaine|mesh-list
25090933|NCT03252496|Oxytocin|oxytocin|mesh-list
25090934|NCT03252496|Anesthetics, Local|anesthetics, local|mesh-ancestor
25090935|NCT03252496|Anesthetics|anesthetics|mesh-ancestor
25090936|NCT03252496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25090937|NCT03252496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090938|NCT03252496|Sensory System Agents|sensory system agents|mesh-ancestor
24408463|NCT00177853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408464|NCT00177853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408465|NCT00177853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24408466|NCT00177853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24408467|NCT00177853|Analgesics|analgesics|mesh-ancestor
24408505|NCT00178048|Serotonin Agents|serotonin agents|mesh-ancestor
24408506|NCT00178048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408507|NCT00178048|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24408508|NCT00178048|Antidepressive Agents|antidepressive agents|mesh-ancestor
24408509|NCT00178048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24408510|NCT00178048|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24408511|NCT00178048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24408512|NCT00178048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408524|NCT00178100|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24408608|NCT00178828|Dopamine Agents|dopamine agents|mesh-ancestor
24408609|NCT00178828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24408610|NCT00178828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408611|NCT00178828|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24408612|NCT00178828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24408613|NCT00178828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408614|NCT00178828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24408615|NCT00178828|Serotonin Agents|serotonin agents|mesh-ancestor
25223031|NCT02641990|Exenatide|exenatide|mesh-list
25223032|NCT02641990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25223033|NCT02641990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223034|NCT02641990|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25223050|NCT02641938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25223051|NCT02641938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24784556|NCT01908556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24952470|NCT03894007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24952471|NCT03894007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24952472|NCT03894007|Alkylating Agents|alkylating agents|mesh-ancestor
24952473|NCT03894007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24952474|NCT03894007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24952475|NCT03894007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24952476|NCT03894007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24408691|NCT00179062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24408692|NCT00179062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24408694|NCT00179114|Botulinum Toxins|botulinum toxins|mesh-list
25090943|NCT03252496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25090944|NCT03252496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25090945|NCT03252496|Anesthetics, General|anesthetics, general|mesh-ancestor
25090946|NCT03252496|Oxytocics|oxytocics|mesh-ancestor
25090947|NCT03252496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25090948|NCT03252496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25090949|NCT03252496|Sympathomimetics|sympathomimetics|mesh-ancestor
25090950|NCT03252496|Autonomic Agents|autonomic agents|mesh-ancestor
25090951|NCT03252496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25090952|NCT03252496|Adrenergic Agents|adrenergic agents|mesh-ancestor
25090953|NCT03252496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25090954|NCT03252496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408695|NCT00179114|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24408696|NCT00179114|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24408697|NCT00179114|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24408760|NCT00179283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223052|NCT02641938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25223053|NCT02641938|Adrenergic Agents|adrenergic agents|mesh-ancestor
25680115|NCT01846455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24537644|NCT00655616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24537645|NCT00655616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537646|NCT00655616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24537647|NCT00655616|Respiratory System Agents|respiratory system agents|mesh-ancestor
24537648|NCT00655616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24537649|NCT00655616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24537650|NCT00655616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24537656|NCT00655616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25223054|NCT02641938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25223055|NCT02641938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223056|NCT02641847|Gemcitabine|gemcitabine|mesh-list
25223057|NCT02641847|Cyclophosphamide|cyclophosphamide|mesh-list
25223060|NCT02641847|Epirubicin|epirubicin|mesh-list
25223061|NCT02641847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25223062|NCT02641847|Immunologic Factors|immunologic factors|mesh-ancestor
25223063|NCT02641847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223064|NCT02641847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25223065|NCT02641847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25223066|NCT02641847|Alkylating Agents|alkylating agents|mesh-ancestor
25223067|NCT02641847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223068|NCT02641847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223069|NCT02641847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25223070|NCT02641847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25223071|NCT02641847|Antimetabolites|antimetabolites|mesh-ancestor
25223072|NCT02641847|Antiviral Agents|antiviral agents|mesh-ancestor
25223073|NCT02641847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25223074|NCT02641847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836292|NCT02185066|Antimetabolites|antimetabolites|mesh-ancestor
24836293|NCT02185066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836294|NCT02185066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24409121|NCT00180921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409167|NCT00181142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24409168|NCT00181142|Immunologic Factors|immunologic factors|mesh-ancestor
24409169|NCT00181142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409170|NCT00181181|Atorvastatin|atorvastatin|mesh-list
24409171|NCT00181181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24409250|NCT00181597|Abortifacient Agents|abortifacient agents|mesh-ancestor
24409251|NCT00181597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24409252|NCT00181597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409253|NCT00181597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409254|NCT00181597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409255|NCT00181597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409258|NCT00181636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090955|NCT03252418|Ascorbic Acid|ascorbic acid|mesh-list
25090956|NCT03252418|Antioxidants|antioxidants|mesh-ancestor
25090957|NCT03252418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090959|NCT03252418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090960|NCT03252418|Vitamins|vitamins|mesh-ancestor
25090961|NCT03252418|Micronutrients|micronutrients|mesh-ancestor
25090962|NCT03252561|Anesthetics|anesthetics|mesh-list
25090963|NCT03252561|Anesthetics, Local|anesthetics, local|mesh-list
25090964|NCT03252561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25090965|NCT03252561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090966|NCT03252561|Sensory System Agents|sensory system agents|mesh-ancestor
25090967|NCT03252561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25090968|NCT03252366|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
25090969|NCT03252366|Hemostatics|hemostatics|mesh-ancestor
25090970|NCT03252366|Coagulants|coagulants|mesh-ancestor
25680116|NCT01846455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680117|NCT01846455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25680118|NCT01846455|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25680119|NCT01846455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25680120|NCT01846455|Anesthetics, Local|anesthetics, local|mesh-ancestor
25680121|NCT01846455|Anesthetics|anesthetics|mesh-ancestor
25680122|NCT01846455|Antiemetics|antiemetics|mesh-ancestor
25680123|NCT01846455|Autonomic Agents|autonomic agents|mesh-ancestor
25680124|NCT01846455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25680125|NCT01846507|Tranexamic Acid|tranexamic acid|mesh-list
25090977|NCT03252223|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25090978|NCT03252223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25090979|NCT03252223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767316|NCT01800019|Nicotine|nicotine|mesh-list
24558378|NCT00756873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091018|NCT03251521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25091019|NCT03251521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091020|NCT03251521|Cholinergic Agents|cholinergic agents|mesh-ancestor
25091021|NCT03251521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25091022|NCT03251521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091023|NCT03251599|Nitroglycerin|nitroglycerin|mesh-list
25091024|NCT03251599|Vasodilator Agents|vasodilator agents|mesh-ancestor
25091025|NCT03251469|Tranexamic Acid|tranexamic acid|mesh-list
25091026|NCT03251469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25091027|NCT03251469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25091028|NCT03251469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091029|NCT03251469|Hemostatics|hemostatics|mesh-ancestor
24409285|NCT00181675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409315|NCT00181740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25223075|NCT02641847|Tubulin Modulators|tubulin modulators|mesh-ancestor
25223077|NCT02641847|Mitosis Modulators|mitosis modulators|mesh-ancestor
25223078|NCT02641847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25223079|NCT02641847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24952523|NCT03893630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409790|NCT00183222|Dermatologic Agents|dermatologic agents|mesh-ancestor
24409791|NCT00183222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25091031|NCT03251365|Gemcitabine|gemcitabine|mesh-list
25091032|NCT03251365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25091033|NCT03251365|Antimetabolites|antimetabolites|mesh-ancestor
25091034|NCT03251365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091035|NCT03251365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25091036|NCT03251365|Antiviral Agents|antiviral agents|mesh-ancestor
25091037|NCT03251365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25091038|NCT03251365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091039|NCT03251365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25091040|NCT03251365|Immunologic Factors|immunologic factors|mesh-ancestor
25091041|NCT03251365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091054|NCT03251417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25091055|NCT03251417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091056|NCT03251417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091057|NCT03251417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409792|NCT00183222|Serotonin Agents|serotonin agents|mesh-ancestor
24409793|NCT00183222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24409794|NCT00183222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409795|NCT00183222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24409796|NCT00183222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24409797|NCT00183222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24409798|NCT00183222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24409799|NCT00183222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24409800|NCT00183235|Aripiprazole|aripiprazole|mesh-list
24409801|NCT00183235|Antidepressive Agents|antidepressive agents|mesh-ancestor
24409802|NCT00183235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24409803|NCT00183235|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24409804|NCT00183235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25223080|NCT02641847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25223081|NCT02641899|Acetaminophen|acetaminophen|mesh-list
25223083|NCT02641899|Digoxin|digoxin|mesh-list
25223084|NCT02641899|Lisinopril|lisinopril|mesh-list
25223085|NCT02641899|Warfarin|warfarin|mesh-list
25223086|NCT02641899|Atorvastatin|atorvastatin|mesh-list
25223087|NCT02641899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25223088|NCT02641899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25223089|NCT02641899|Antimetabolites|antimetabolites|mesh-ancestor
25223090|NCT02641899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223093|NCT02641899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25223094|NCT02641899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25223095|NCT02641899|Analgesics|analgesics|mesh-ancestor
25223096|NCT02641899|Sensory System Agents|sensory system agents|mesh-ancestor
25223097|NCT02641899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25223098|NCT02641899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223099|NCT02641899|Antipyretics|antipyretics|mesh-ancestor
25223100|NCT02641899|Anticoagulants|anticoagulants|mesh-ancestor
24836311|NCT02185196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24836312|NCT02185222|Cholecalciferol|cholecalciferol|mesh-list
24836313|NCT02185222|Vitamin D|vitamin d|mesh-list
24836314|NCT02185222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25106700|NCT00069238|Glucocorticoids|glucocorticoids|mesh-ancestor
24836333|NCT02185300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24836334|NCT02185300|Antiviral Agents|antiviral agents|mesh-ancestor
24836335|NCT02185300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24836336|NCT02185326|Hormones|hormones|mesh-list
25042990|NCT01338883|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25042993|NCT01338883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042994|NCT01338883|Antiviral Agents|antiviral agents|mesh-ancestor
25042995|NCT01338883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042996|NCT01338883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25042997|NCT01338883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25042998|NCT01338883|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24409805|NCT00183235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24409806|NCT00183235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451837|NCT00324922|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24451838|NCT00324922|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24451839|NCT00324922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25091058|NCT03251417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25091059|NCT03251443|Apatinib|apatinib|mesh-list
25091060|NCT03251443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25091061|NCT03251443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25091062|NCT03251443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091063|NCT03251443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091064|NCT03251040|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25091065|NCT03251040|Hemostatics|hemostatics|mesh-ancestor
25091066|NCT03251040|Coagulants|coagulants|mesh-ancestor
25091067|NCT03250923|Acemannan|acemannan|mesh-list
25091068|NCT03250923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25091069|NCT03250923|Immunologic Factors|immunologic factors|mesh-ancestor
25091070|NCT03250923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091071|NCT03250923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25091072|NCT03250923|Antiviral Agents|antiviral agents|mesh-ancestor
25091073|NCT03250923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25091074|NCT03250923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25091075|NCT03251170|Fentanyl|fentanyl|mesh-list
25091076|NCT03251170|Midazolam|midazolam|mesh-list
25091077|NCT03251170|Ketamine|ketamine|mesh-list
25223101|NCT02641899|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25223102|NCT02641899|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25223103|NCT02641899|Protective Agents|protective agents|mesh-ancestor
25223104|NCT02641899|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25223105|NCT02641899|Protease Inhibitors|protease inhibitors|mesh-ancestor
25223106|NCT02641899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25223107|NCT02641899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25223108|NCT02641899|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25223109|NCT02641899|Incretins|incretins|mesh-ancestor
25223110|NCT02641899|Hormones|hormones|mesh-ancestor
24983913|NCT05072600|Pembrolizumab|pembrolizumab|mesh-list
25223111|NCT02641899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25223112|NCT02641821|Nifedipine|nifedipine|mesh-list
25223113|NCT02641821|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25223114|NCT02641821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25223115|NCT02641821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223116|NCT02641821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25223117|NCT02641821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223118|NCT02641821|Vasodilator Agents|vasodilator agents|mesh-ancestor
25223119|NCT02641821|Tocolytic Agents|tocolytic agents|mesh-ancestor
25223120|NCT02641821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25223121|NCT02641782|Aldesleukin|aldesleukin|mesh-list
25223122|NCT02641782|Interleukin-2|interleukin-2|mesh-list
25043005|NCT01337752|Dexamethasone|dexamethasone|mesh-list
25043007|NCT01337752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25043008|NCT01337752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25043009|NCT01337752|Antiemetics|antiemetics|mesh-ancestor
25043010|NCT01337752|Autonomic Agents|autonomic agents|mesh-ancestor
24836342|NCT02185352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24836343|NCT02185352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24836344|NCT02185352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24836345|NCT02185352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091078|NCT03251170|Analgesics|analgesics|mesh-ancestor
25091079|NCT03251170|Sensory System Agents|sensory system agents|mesh-ancestor
25223127|NCT02641782|Sargramostim|sargramostim|mesh-list
25223128|NCT02641782|Immunologic Factors|immunologic factors|mesh-ancestor
25223129|NCT02641782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223130|NCT02641782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223131|NCT02641782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25223132|NCT02641782|Analgesics|analgesics|mesh-ancestor
25223133|NCT02641782|Sensory System Agents|sensory system agents|mesh-ancestor
25223134|NCT02641782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25223135|NCT02641782|Keratolytic Agents|keratolytic agents|mesh-ancestor
25223136|NCT02641782|Dermatologic Agents|dermatologic agents|mesh-ancestor
25223137|NCT02641782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25223138|NCT02641782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25223139|NCT02641782|Antiviral Agents|antiviral agents|mesh-ancestor
25223140|NCT02641782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25223141|NCT02641652|Sertraline|sertraline|mesh-list
25223142|NCT02641652|Antidepressive Agents|antidepressive agents|mesh-ancestor
25223143|NCT02641652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25223144|NCT02641652|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25223145|NCT02641652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25223146|NCT02641652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25223147|NCT02641652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223148|NCT02641652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25223149|NCT02641652|Serotonin Agents|serotonin agents|mesh-ancestor
25223150|NCT02641652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223151|NCT02641639|Fosbretabulin|fosbretabulin|mesh-list
25223152|NCT02641639|Combretastatin|combretastatin|mesh-list
25223153|NCT02641639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25223154|NCT02641639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223155|NCT02641639|Tubulin Modulators|tubulin modulators|mesh-ancestor
25223156|NCT02641639|Antimitotic Agents|antimitotic agents|mesh-ancestor
25223157|NCT02641639|Mitosis Modulators|mitosis modulators|mesh-ancestor
25223158|NCT02641639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223159|NCT02641457|Ranibizumab|ranibizumab|mesh-list
25223160|NCT02641457|Aflibercept|aflibercept|mesh-list
25223161|NCT02641457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25223162|NCT02641457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25223163|NCT02641457|Growth Substances|growth substances|mesh-ancestor
25091121|NCT03250910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25091123|NCT03250962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25091124|NCT03250962|Antimetabolites|antimetabolites|mesh-ancestor
25091125|NCT03250962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767453|NCT01800799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25091126|NCT03250962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25091127|NCT03250962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25223164|NCT02641457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223165|NCT02641457|Growth Inhibitors|growth inhibitors|mesh-ancestor
25223166|NCT02641457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223167|NCT02641210|Albendazole|albendazole|mesh-list
25223168|NCT02641210|Anthelmintics|anthelmintics|mesh-ancestor
25223169|NCT02641210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25223170|NCT02641210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25223171|NCT02641210|Anticestodal Agents|anticestodal agents|mesh-ancestor
25223172|NCT02641210|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25223173|NCT02641210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25223174|NCT02641210|Tubulin Modulators|tubulin modulators|mesh-ancestor
25223175|NCT02641210|Antimitotic Agents|antimitotic agents|mesh-ancestor
25223176|NCT02641210|Mitosis Modulators|mitosis modulators|mesh-ancestor
25223177|NCT02641210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223178|NCT02641210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223179|NCT02641431|Ajmaline|ajmaline|mesh-list
25223180|NCT02641431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25223181|NCT02641431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25223182|NCT02641431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25223183|NCT02641431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25223184|NCT02641431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223185|NCT02641301|Morphine|morphine|mesh-list
25223186|NCT02641301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25223187|NCT02641301|Narcotics|narcotics|mesh-ancestor
25223188|NCT02641301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25223189|NCT02641301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223190|NCT02641301|Analgesics|analgesics|mesh-ancestor
25223191|NCT02641301|Sensory System Agents|sensory system agents|mesh-ancestor
24836346|NCT02185352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836348|NCT02185430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24836349|NCT02185430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24836350|NCT02185430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836351|NCT02185430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24836352|NCT02185430|Analgesics|analgesics|mesh-ancestor
24836353|NCT02185430|Sensory System Agents|sensory system agents|mesh-ancestor
24836354|NCT02185430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24836355|NCT02185430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24836356|NCT02185430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24836357|NCT02185430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24836358|NCT02185430|Adrenergic Agents|adrenergic agents|mesh-ancestor
24836359|NCT02185430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25680126|NCT01846507|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25016551|NCT05091294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25110883|NCT05329779|Brexanolone|brexanolone|mesh-list
25110884|NCT05329779|Anesthetics|anesthetics|mesh-ancestor
25110885|NCT05329779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25110886|NCT05329779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110887|NCT05329779|Neurosteroids|neurosteroids|mesh-ancestor
24836360|NCT02185430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836361|NCT02185456|Metronidazole|metronidazole|mesh-list
24836363|NCT02185456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24836364|NCT02185456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24836366|NCT02185456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24836367|NCT02185456|Antifungal Agents|antifungal agents|mesh-ancestor
25091131|NCT03250520|Protective Agents|protective agents|mesh-ancestor
25091132|NCT03250520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451840|NCT00324922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409831|NCT00183404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409833|NCT00183404|Serotonin Agents|serotonin agents|mesh-ancestor
24409834|NCT00183560|Antidepressive Agents|antidepressive agents|mesh-list
24409835|NCT00183560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24409836|NCT00183612|Olanzapine|olanzapine|mesh-list
25223192|NCT02641301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25223193|NCT02641314|Celecoxib|celecoxib|mesh-list
25223194|NCT02641314|Propranolol|propranolol|mesh-list
25223195|NCT02641314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223196|NCT02641314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25223197|NCT02641314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223198|NCT02641314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25223199|NCT02641314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25223200|NCT02641314|Analgesics|analgesics|mesh-ancestor
25223201|NCT02641314|Sensory System Agents|sensory system agents|mesh-ancestor
25223202|NCT02641314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25223203|NCT02641314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24983992|NCT04952389|Hormones|hormones|mesh-ancestor
25223204|NCT02641314|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25223205|NCT02641314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25223206|NCT02641314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25223207|NCT02641314|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25223208|NCT02641314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25223209|NCT02641314|Adrenergic Agents|adrenergic agents|mesh-ancestor
25223210|NCT02641314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25223211|NCT02641314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25223212|NCT02641314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25223213|NCT02641314|Vasodilator Agents|vasodilator agents|mesh-ancestor
25223214|NCT02641288|Ropivacaine|ropivacaine|mesh-list
25223215|NCT02641288|Anesthetics, Local|anesthetics, local|mesh-ancestor
25223216|NCT02641288|Anesthetics|anesthetics|mesh-ancestor
25223217|NCT02641288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25223218|NCT02641288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223219|NCT02641288|Sensory System Agents|sensory system agents|mesh-ancestor
24836376|NCT02185456|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24836377|NCT02185456|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24836379|NCT02185547|Antidepressive Agents|antidepressive agents|mesh-ancestor
24836380|NCT02185547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25680127|NCT01846507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25680128|NCT01846507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680129|NCT01846507|Hemostatics|hemostatics|mesh-ancestor
25680130|NCT01846507|Coagulants|coagulants|mesh-ancestor
25680131|NCT01846611|Dexamethasone|dexamethasone|mesh-list
25680132|NCT01846611|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25680133|NCT01846611|Doxorubicin|doxorubicin|mesh-list
25680134|NCT01846611|Trabectedin|trabectedin|mesh-list
24836381|NCT02185547|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24836382|NCT02185547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24836383|NCT02185547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24836384|NCT02185547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836385|NCT02185547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24836386|NCT02185547|Serotonin Agents|serotonin agents|mesh-ancestor
24836387|NCT02185547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836388|NCT02185638|Appetite Depressants|appetite depressants|mesh-list
24836389|NCT02185638|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24409837|NCT00183612|Antiemetics|antiemetics|mesh-ancestor
24409838|NCT00183612|Autonomic Agents|autonomic agents|mesh-ancestor
24409839|NCT00183612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24409849|NCT00183612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091133|NCT03250520|Dermatologic Agents|dermatologic agents|mesh-ancestor
25091134|NCT03250520|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25091135|NCT03250494|Dexamethasone|dexamethasone|mesh-list
25091136|NCT03250494|Dexamethasone acetate|dexamethasone acetate|mesh-list
25091137|NCT03250494|BB 1101|bb 1101|mesh-list
25223220|NCT02641288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25223221|NCT02641340|Fentanyl|fentanyl|mesh-list
25223222|NCT02641340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25223223|NCT02641340|Narcotics|narcotics|mesh-ancestor
25223224|NCT02641340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25223225|NCT02641340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223226|NCT02641340|Analgesics|analgesics|mesh-ancestor
25223227|NCT02641340|Sensory System Agents|sensory system agents|mesh-ancestor
25223228|NCT02641340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25223229|NCT02641340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25223230|NCT02641340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25223231|NCT02641340|Anesthetics, General|anesthetics, general|mesh-ancestor
25223232|NCT02641340|Anesthetics|anesthetics|mesh-ancestor
25223233|NCT02641132|Mitomycins|mitomycins|mesh-list
25223234|NCT02641132|Mitomycin|mitomycin|mesh-list
25223235|NCT02641132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25223236|NCT02641132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223237|NCT02641132|Alkylating Agents|alkylating agents|mesh-ancestor
25223238|NCT02641132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223239|NCT02641132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25223240|NCT02641132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25223241|NCT02641093|Pembrolizumab|pembrolizumab|mesh-list
25223242|NCT02641093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223243|NCT02641093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25223244|NCT02640989|Vaccines|vaccines|mesh-list
25223245|NCT02640989|Immunologic Factors|immunologic factors|mesh-ancestor
25223246|NCT02640989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223247|NCT02640976|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25223248|NCT02640976|Cetrorelix|cetrorelix|mesh-list
25223249|NCT02640976|Menotropins|menotropins|mesh-list
25223250|NCT02640976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25223251|NCT02640976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055370|NCT03521700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055371|NCT03521700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25091138|NCT03250494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25091140|NCT03250494|Autonomic Agents|autonomic agents|mesh-ancestor
25091141|NCT03250494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25091142|NCT03250494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091143|NCT03250494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25091144|NCT03250494|Glucocorticoids|glucocorticoids|mesh-ancestor
25091145|NCT03250494|Hormones|hormones|mesh-ancestor
25091146|NCT03250494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25091147|NCT03250494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25680135|NCT01846611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24409884|NCT00183820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24410109|NCT00184574|Biphasic Insulins|biphasic insulins|mesh-list
24409886|NCT00183820|Tubulin Modulators|tubulin modulators|mesh-ancestor
24409887|NCT00183820|Antimitotic Agents|antimitotic agents|mesh-ancestor
24409888|NCT00183820|Mitosis Modulators|mitosis modulators|mesh-ancestor
24409919|NCT00183885|Mitomycin|mitomycin|mesh-list
24409920|NCT00183885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409921|NCT00183885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24409922|NCT00183885|Alkylating Agents|alkylating agents|mesh-ancestor
24409923|NCT00183885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409924|NCT00183885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24409926|NCT00183898|Capecitabine|capecitabine|mesh-list
24409927|NCT00183898|Oxaliplatin|oxaliplatin|mesh-list
24409928|NCT00183898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24409929|NCT00183898|Antimetabolites|antimetabolites|mesh-ancestor
24409930|NCT00183898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091150|NCT03250494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091151|NCT03250494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091152|NCT03250507|Bupivacaine|bupivacaine|mesh-list
25091153|NCT03250507|Anesthetics, Local|anesthetics, local|mesh-ancestor
25091154|NCT03250507|Anesthetics|anesthetics|mesh-ancestor
25091155|NCT03250507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25091156|NCT03250507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091157|NCT03250507|Sensory System Agents|sensory system agents|mesh-ancestor
25091158|NCT03250507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25091159|NCT03250481|Oxycodone|oxycodone|mesh-list
25091160|NCT03250481|Propofol|propofol|mesh-list
25091161|NCT03250481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25223252|NCT02640976|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25223253|NCT02640976|Fertility Agents|fertility agents|mesh-ancestor
25223254|NCT02640976|Hormone Antagonists|hormone antagonists|mesh-ancestor
25223255|NCT02640976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25223256|NCT02640846|Simendan|simendan|mesh-list
25223257|NCT02640846|Milrinone|milrinone|mesh-list
25223258|NCT02640846|Norepinephrine|norepinephrine|mesh-list
25223259|NCT02640846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25223260|NCT02640846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25223261|NCT02640846|Adrenergic Agents|adrenergic agents|mesh-ancestor
25223262|NCT02640846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25223263|NCT02640846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275728|NCT02369939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091162|NCT03250481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25091163|NCT03250481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091164|NCT03250481|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25091165|NCT03250481|Anesthetics, General|anesthetics, general|mesh-ancestor
25091166|NCT03250481|Anesthetics|anesthetics|mesh-ancestor
25091167|NCT03250481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25091168|NCT03250481|Narcotics|narcotics|mesh-ancestor
25091169|NCT03250481|Analgesics|analgesics|mesh-ancestor
25091170|NCT03250481|Sensory System Agents|sensory system agents|mesh-ancestor
25091171|NCT03250481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25091172|NCT03250741|Rotigotine|rotigotine|mesh-list
24410111|NCT00184574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410112|NCT00184587|Candesartan|candesartan|mesh-list
24410113|NCT00184587|Candesartan cilexetil|candesartan cilexetil|mesh-list
24410123|NCT00184613|Insulin Aspart|insulin aspart|mesh-list
24410124|NCT00184613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24410125|NCT00184613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410126|NCT00184626|Insulin|insulin|mesh-list
24410167|NCT00184821|Analgesics|analgesics|mesh-ancestor
24410168|NCT00184821|Sensory System Agents|sensory system agents|mesh-ancestor
24410169|NCT00184821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25091173|NCT03250741|Dopamine Agonists|dopamine agonists|mesh-ancestor
25091174|NCT03250741|Dopamine Agents|dopamine agents|mesh-ancestor
25091175|NCT03250741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25223264|NCT02640846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223265|NCT02640846|Sympathomimetics|sympathomimetics|mesh-ancestor
25223266|NCT02640846|Autonomic Agents|autonomic agents|mesh-ancestor
25223267|NCT02640846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25223268|NCT02640846|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25223269|NCT02640846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25223270|NCT02640846|Vasodilator Agents|vasodilator agents|mesh-ancestor
25223271|NCT02640846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25223272|NCT02640846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25223273|NCT02640846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25223274|NCT02640846|Protective Agents|protective agents|mesh-ancestor
25223275|NCT02640846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25223276|NCT02640898|Docetaxel|docetaxel|mesh-list
25223277|NCT02640898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223278|NCT02640898|Tubulin Modulators|tubulin modulators|mesh-ancestor
25223279|NCT02640898|Antimitotic Agents|antimitotic agents|mesh-ancestor
25223280|NCT02640898|Mitosis Modulators|mitosis modulators|mesh-ancestor
25223281|NCT02640898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223282|NCT02641054|Levodopa|levodopa|mesh-list
25223283|NCT02641054|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25223284|NCT02641054|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24836399|NCT02185651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836401|NCT02185690|Pemetrexed|pemetrexed|mesh-list
24836402|NCT02185690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24836403|NCT02185690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836404|NCT02185690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836405|NCT02185690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24836406|NCT02185690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24836407|NCT02185716|Levobupivacaine|levobupivacaine|mesh-list
24836408|NCT02185716|Anesthetics, Local|anesthetics, local|mesh-ancestor
24836409|NCT02185716|Anesthetics|anesthetics|mesh-ancestor
25091176|NCT03250741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091177|NCT03250741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767521|NCT01801423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25091178|NCT03250338|Cytarabine|cytarabine|mesh-list
25091179|NCT03250338|Fludarabine|fludarabine|mesh-list
25091180|NCT03250338|Mitoxantrone|mitoxantrone|mesh-list
25091181|NCT03250338|Idarubicin|idarubicin|mesh-list
25091182|NCT03250338|Crenolanib|crenolanib|mesh-list
25091183|NCT03250338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25091184|NCT03250338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25091185|NCT03250338|Antimetabolites|antimetabolites|mesh-ancestor
25091186|NCT03250338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091187|NCT03250338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25091188|NCT03250338|Immunologic Factors|immunologic factors|mesh-ancestor
25091189|NCT03250338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091190|NCT03250338|Antiviral Agents|antiviral agents|mesh-ancestor
25091191|NCT03250338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25091192|NCT03250338|Analgesics|analgesics|mesh-ancestor
25223285|NCT02641054|Dopamine Agents|dopamine agents|mesh-ancestor
25223286|NCT02641054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25091253|NCT03249506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25223287|NCT02641054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223288|NCT02641054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223290|NCT02640833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223291|NCT02640703|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25223292|NCT02640703|Immunologic Factors|immunologic factors|mesh-ancestor
25223293|NCT02640703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223295|NCT02640794|Clopidogrel|clopidogrel|mesh-list
25223296|NCT02640794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25223297|NCT02640794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25223298|NCT02640794|Analgesics|analgesics|mesh-ancestor
25223299|NCT02640794|Sensory System Agents|sensory system agents|mesh-ancestor
25223300|NCT02640794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25223301|NCT02640794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223302|NCT02640794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25223303|NCT02640794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25223304|NCT02640794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25223305|NCT02640794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25223306|NCT02640794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275729|NCT02369822|Ascorbic Acid|ascorbic acid|mesh-list
25091226|NCT03250052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24410170|NCT00184821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410171|NCT00184821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24410172|NCT00184821|Vasodilator Agents|vasodilator agents|mesh-ancestor
24410173|NCT00184821|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24410188|NCT00184847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451881|NCT00325026|Oxytocics|oxytocics|mesh-ancestor
24410221|NCT00184899|Glycerol|glycerol|mesh-list
25680137|NCT01846611|Autonomic Agents|autonomic agents|mesh-ancestor
25223318|NCT02640417|Micronutrients|micronutrients|mesh-ancestor
24984117|NCT04791176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24984118|NCT04791176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984119|NCT04791176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984121|NCT04787562|Cilastatin|cilastatin|mesh-list
24984122|NCT04787562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25223319|NCT02640417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223320|NCT02640469|Chlorhexidine|chlorhexidine|mesh-list
25223321|NCT02640469|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25223322|NCT02640469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25223323|NCT02640469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25223324|NCT02640469|Disinfectants|disinfectants|mesh-ancestor
25223325|NCT02640469|Dermatologic Agents|dermatologic agents|mesh-ancestor
25223326|NCT02640495|Artesunate|artesunate|mesh-list
25223327|NCT02640495|Antimalarials|antimalarials|mesh-ancestor
25223328|NCT02640495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25223329|NCT02640495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25223330|NCT02640495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25223331|NCT02640495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223332|NCT02640495|Antiviral Agents|antiviral agents|mesh-ancestor
25223333|NCT02640495|Schistosomicides|schistosomicides|mesh-ancestor
25223334|NCT02640495|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24809656|NCT02035709|Narcotics|narcotics|mesh-ancestor
24410228|NCT00184899|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24410229|NCT00184899|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24410230|NCT00184899|Protective Agents|protective agents|mesh-ancestor
24410256|NCT00184951|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24410257|NCT00184951|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24410258|NCT00184951|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24410259|NCT00184951|Antimetabolites|antimetabolites|mesh-ancestor
24410260|NCT00184951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410261|NCT00184951|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25223388|NCT02640144|Viscosupplements|viscosupplements|mesh-ancestor
24410264|NCT00184977|Fluticasone|fluticasone|mesh-list
25091227|NCT03250052|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25091228|NCT03250052|Protease Inhibitors|protease inhibitors|mesh-ancestor
25091229|NCT03250052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091230|NCT03250052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016759|NCT04509115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25016760|NCT04509115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016761|NCT04509115|Analgesics|analgesics|mesh-ancestor
25016762|NCT04509115|Sensory System Agents|sensory system agents|mesh-ancestor
25016764|NCT04497987|Bamlanivimab|bamlanivimab|mesh-list
25223335|NCT02640495|Anthelmintics|anthelmintics|mesh-ancestor
25223336|NCT02640508|Lenvatinib|lenvatinib|mesh-list
25223337|NCT02640508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223338|NCT02640508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25223339|NCT02640508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25223340|NCT02640508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223341|NCT02640443|Sulfamethoxazole|sulfamethoxazole|mesh-list
25223349|NCT02640365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25223350|NCT02640365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25223351|NCT02640365|Growth Substances|growth substances|mesh-ancestor
25223352|NCT02640365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223353|NCT02640365|Growth Inhibitors|growth inhibitors|mesh-ancestor
25223354|NCT02640365|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25223355|NCT02640365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25223356|NCT02640365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25223357|NCT02640365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984146|NCT04768426|Capecitabine|capecitabine|mesh-list
24999560|NCT04013334|Nivolumab|nivolumab|mesh-list
25055415|NCT03521167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25091231|NCT03249870|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25091232|NCT03249870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25091240|NCT03249740|Growth Substances|growth substances|mesh-ancestor
25091241|NCT03249740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091242|NCT03249740|Growth Inhibitors|growth inhibitors|mesh-ancestor
25091243|NCT03249740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25091244|NCT03249740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091245|NCT03249740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091247|NCT03249506|Empagliflozin|empagliflozin|mesh-list
24410266|NCT00184977|Acetylcysteine|acetylcysteine|mesh-list
24410267|NCT00184977|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24410302|NCT00185068|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24410303|NCT00185068|Olmesartan|olmesartan|mesh-list
24410304|NCT00185068|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24410305|NCT00185068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24410306|NCT00185068|Diuretics|diuretics|mesh-ancestor
24410307|NCT00185068|Natriuretic Agents|natriuretic agents|mesh-ancestor
24410366|NCT00185133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410367|NCT00185133|Vasodilator Agents|vasodilator agents|mesh-ancestor
24410368|NCT00185133|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24410369|NCT00185133|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24410371|NCT00185159|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24410372|NCT00185159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24410373|NCT00185159|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24410374|NCT00185159|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25223389|NCT02640144|Protective Agents|protective agents|mesh-ancestor
24410375|NCT00185159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410469|NCT00185445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24410470|NCT00185445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24410471|NCT00185445|Antimetabolites|antimetabolites|mesh-ancestor
24410472|NCT00185445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410502|NCT00185575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24410526|NCT00185835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24410528|NCT00185835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410529|NCT00185861|Arsenic Trioxide|arsenic trioxide|mesh-list
25091248|NCT03249506|Canagliflozin|canagliflozin|mesh-list
25091249|NCT03249506|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
25680138|NCT01846611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25680139|NCT01846611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680140|NCT01846611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25680141|NCT01846611|Glucocorticoids|glucocorticoids|mesh-ancestor
25680142|NCT01846611|Hormones|hormones|mesh-ancestor
25091252|NCT03249506|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24767622|NCT01802593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091256|NCT03249506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223359|NCT02640365|Protective Agents|protective agents|mesh-ancestor
25223360|NCT02640365|Vitamin B Complex|vitamin b complex|mesh-ancestor
25223361|NCT02640365|Vitamins|vitamins|mesh-ancestor
25223362|NCT02640365|Micronutrients|micronutrients|mesh-ancestor
25223363|NCT02640365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25273185|NCT02386358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273186|NCT02386358|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25273187|NCT02386358|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25273188|NCT02386358|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25273189|NCT02386358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25273190|NCT02386397|Gemcitabine|gemcitabine|mesh-list
25273191|NCT02386397|Oxaliplatin|oxaliplatin|mesh-list
24999562|NCT04013334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999563|NCT04013334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24999564|NCT04013334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589381|NCT00907114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589382|NCT00907166|Gemcitabine|gemcitabine|mesh-list
24589383|NCT00907166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24589394|NCT00907179|Panobinostat|panobinostat|mesh-list
24589395|NCT00907179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589396|NCT00907179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589397|NCT00907179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589398|NCT00907179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24589399|NCT00907179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25091257|NCT03249506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25091258|NCT03249506|Hormones|hormones|mesh-ancestor
25091259|NCT03249506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25091260|NCT03249506|Incretins|incretins|mesh-ancestor
25091261|NCT03249506|Protease Inhibitors|protease inhibitors|mesh-ancestor
25091262|NCT03249506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091263|NCT03249402|Levonorgestrel|levonorgestrel|mesh-list
25091264|NCT03249402|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25091265|NCT03249402|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25091266|NCT03249402|Estradiol|estradiol|mesh-list
25091267|NCT03249402|Estrogens|estrogens|mesh-ancestor
25091268|NCT03249402|Hormones|hormones|mesh-ancestor
24795978|NCT01947114|Ketamine|ketamine|mesh-list
24410542|NCT00185887|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24410543|NCT00185887|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24410544|NCT00185887|Adrenergic Agents|adrenergic agents|mesh-ancestor
24410545|NCT00185887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24410546|NCT00185887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091270|NCT03249402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091271|NCT03249402|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25223365|NCT02640313|Lipotropic Agents|lipotropic agents|mesh-ancestor
25223366|NCT02640313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25223367|NCT02640313|Antimetabolites|antimetabolites|mesh-ancestor
25680144|NCT01846611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25680145|NCT01846611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25680146|NCT01846611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25680147|NCT01846611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25680148|NCT01846611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25680149|NCT01846611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25223368|NCT02640313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836488|NCT02186028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24836491|NCT02186106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24836492|NCT02186106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091272|NCT03249402|Contraceptive Agents|contraceptive agents|mesh-ancestor
25091273|NCT03249402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25091274|NCT03249402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25091275|NCT03249402|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25091276|NCT03249402|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25091277|NCT03249402|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25091278|NCT03249402|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24410645|NCT00186849|Cyclophosphamide|cyclophosphamide|mesh-list
24410646|NCT00186849|Ifosfamide|ifosfamide|mesh-list
24410647|NCT00186849|Carboplatin|carboplatin|mesh-list
24410648|NCT00186849|Doxorubicin|doxorubicin|mesh-list
24410666|NCT00186862|Interleukin-2|interleukin-2|mesh-list
24410667|NCT00186862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24410668|NCT00186862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25223381|NCT02640300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25223382|NCT02640300|GABA Antagonists|gaba antagonists|mesh-ancestor
25223383|NCT02640300|GABA Agents|gaba agents|mesh-ancestor
25223384|NCT02640144|Hyaluronic Acid|hyaluronic acid|mesh-list
25223385|NCT02640144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25223386|NCT02640144|Immunologic Factors|immunologic factors|mesh-ancestor
25223387|NCT02640144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223390|NCT02640118|Lixisenatide|lixisenatide|mesh-list
25223391|NCT02640118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25223392|NCT02640118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223393|NCT02639858|Docetaxel|docetaxel|mesh-list
25223394|NCT02639858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223395|NCT02639858|Tubulin Modulators|tubulin modulators|mesh-ancestor
25223396|NCT02639858|Antimitotic Agents|antimitotic agents|mesh-ancestor
25223397|NCT02639858|Mitosis Modulators|mitosis modulators|mesh-ancestor
25223398|NCT02639858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223399|NCT02639767|Pemetrexed|pemetrexed|mesh-list
25223400|NCT02639767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223401|NCT02639767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25223402|NCT02639767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836493|NCT02186106|Vitamins|vitamins|mesh-ancestor
24836494|NCT02186106|Micronutrients|micronutrients|mesh-ancestor
25223406|NCT02639819|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25223407|NCT02639819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25223408|NCT02639819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223409|NCT02639819|Hemostatics|hemostatics|mesh-ancestor
25223410|NCT02639819|Coagulants|coagulants|mesh-ancestor
25223411|NCT02639806|Lidocaine|lidocaine|mesh-list
25223412|NCT02639806|Sevoflurane|sevoflurane|mesh-list
25223413|NCT02639806|Anesthetics, Local|anesthetics, local|mesh-ancestor
25223414|NCT02639806|Anesthetics|anesthetics|mesh-ancestor
25223415|NCT02639806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25223416|NCT02639806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223417|NCT02639806|Sensory System Agents|sensory system agents|mesh-ancestor
25223418|NCT02639806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25223419|NCT02639806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25223420|NCT02639806|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25223421|NCT02639806|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25223422|NCT02639806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25223423|NCT02639806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223424|NCT02639806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25223425|NCT02639806|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25223426|NCT02639806|Anesthetics, General|anesthetics, general|mesh-ancestor
25223427|NCT02639741|Vitamins|vitamins|mesh-list
24836525|NCT02186145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24836526|NCT02186145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836527|NCT02186145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24836528|NCT02186145|Glucocorticoids|glucocorticoids|mesh-ancestor
24836529|NCT02186145|Hormones|hormones|mesh-ancestor
25091296|NCT03249662|Bupivacaine|bupivacaine|mesh-list
25091297|NCT03249662|Anesthetics, Local|anesthetics, local|mesh-ancestor
25091298|NCT03249662|Anesthetics|anesthetics|mesh-ancestor
25091299|NCT03249662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25091300|NCT03249662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091301|NCT03249662|Sensory System Agents|sensory system agents|mesh-ancestor
25106806|NCT03144713|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24984362|NCT04595266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25245809|NCT03685890|Nivolumab|nivolumab|mesh-list
24984363|NCT04595266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24984364|NCT04595266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984365|NCT04595266|Antidotes|antidotes|mesh-ancestor
24984366|NCT04595266|Protective Agents|protective agents|mesh-ancestor
24984367|NCT04595266|Vitamin B Complex|vitamin b complex|mesh-ancestor
25091302|NCT03249662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25091303|NCT03249311|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25091304|NCT03249311|Milnacipran|milnacipran|mesh-list
25091305|NCT03249311|Levomilnacipran|levomilnacipran|mesh-list
25091306|NCT03249311|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25091307|NCT03249311|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25091308|NCT03249311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24410743|NCT00187005|Autonomic Agents|autonomic agents|mesh-ancestor
24410744|NCT00187005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24410745|NCT00187005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24410746|NCT00187005|Glucocorticoids|glucocorticoids|mesh-ancestor
25223442|NCT02639533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223443|NCT02639533|Anticonvulsants|anticonvulsants|mesh-ancestor
25223444|NCT02639533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24836531|NCT02186145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24836532|NCT02186145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25091327|NCT03249285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091328|NCT03249285|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25091329|NCT03249285|Protease Inhibitors|protease inhibitors|mesh-ancestor
25091330|NCT03249285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091332|NCT03249428|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25091333|NCT03249428|Autonomic Agents|autonomic agents|mesh-ancestor
25091334|NCT03249428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25091335|NCT03249428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091336|NCT03249428|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25091337|NCT03249428|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25091338|NCT03249428|Cholinergic Agents|cholinergic agents|mesh-ancestor
25091339|NCT03249428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25091340|NCT03249428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091341|NCT03249519|Cisplatin|cisplatin|mesh-list
25091342|NCT03249519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25091343|NCT03249337|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25091351|NCT03249259|Antimetabolites|antimetabolites|mesh-ancestor
25091352|NCT03249259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091353|NCT03249259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25091354|NCT03249259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25091355|NCT03249259|Nootropic Agents|nootropic agents|mesh-ancestor
25091356|NCT03249194|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25091357|NCT03249194|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25091358|NCT03249194|Antiviral Agents|antiviral agents|mesh-list
25091359|NCT03249194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25091388|NCT03249168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091390|NCT03249168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091391|NCT03249168|Analgesics|analgesics|mesh-ancestor
25091392|NCT03249168|Sensory System Agents|sensory system agents|mesh-ancestor
25091393|NCT03249168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25091394|NCT03249168|Antidepressive Agents|antidepressive agents|mesh-ancestor
25091395|NCT03249168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25091396|NCT03249168|Dopamine Agents|dopamine agents|mesh-ancestor
25091397|NCT03248856|Triamcinolone|triamcinolone|mesh-list
25091398|NCT03248856|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25091399|NCT03248856|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25091400|NCT03248856|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25091401|NCT03248856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25091402|NCT03248856|Glucocorticoids|glucocorticoids|mesh-ancestor
25223449|NCT02639533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25223450|NCT02639533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25223451|NCT02639533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25223452|NCT02639377|Chlorhexidine|chlorhexidine|mesh-list
25223453|NCT02639377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25223454|NCT02639377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25223455|NCT02639377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25680150|NCT01846611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411157|NCT00188045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25091405|NCT03248856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091406|NCT03248856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25091407|NCT03248856|Immunologic Factors|immunologic factors|mesh-ancestor
25091408|NCT03248856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091409|NCT03248856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091410|NCT03249025|Lidocaine|lidocaine|mesh-list
25091411|NCT03249025|Ketamine|ketamine|mesh-list
25091412|NCT03249025|Anesthetics, Local|anesthetics, local|mesh-ancestor
25091413|NCT03249025|Anesthetics|anesthetics|mesh-ancestor
25091414|NCT03249025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25091415|NCT03249025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091416|NCT03249025|Sensory System Agents|sensory system agents|mesh-ancestor
25091417|NCT03249025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25091418|NCT03249025|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25091419|NCT03249025|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25223456|NCT02639377|Disinfectants|disinfectants|mesh-ancestor
25223457|NCT02639377|Dermatologic Agents|dermatologic agents|mesh-ancestor
25223458|NCT02639598|Topiramate|topiramate|mesh-list
25223459|NCT02639598|Flunarizine|flunarizine|mesh-list
25223460|NCT02639598|Anticonvulsants|anticonvulsants|mesh-ancestor
25223461|NCT02639598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25223462|NCT02639598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223463|NCT02639598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25223464|NCT02639598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25223465|NCT02639598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091516|NCT03248791|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24411189|NCT00188227|Midazolam|midazolam|mesh-list
24411190|NCT00188227|Pirinitramide|pirinitramide|mesh-list
24411191|NCT00188227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
24411192|NCT00188227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24411193|NCT00188227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24411194|NCT00188227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680151|NCT01846611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25680152|NCT01846611|Alkylating Agents|alkylating agents|mesh-ancestor
25680153|NCT01846624|Decitabine|decitabine|mesh-list
25680154|NCT01846624|Azacitidine|azacitidine|mesh-list
25680155|NCT01846624|Midostaurin|midostaurin|mesh-list
25680156|NCT01846624|Staurosporine|staurosporine|mesh-list
25680157|NCT01846624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25680158|NCT01846624|Antimetabolites|antimetabolites|mesh-ancestor
24411195|NCT00188227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24411196|NCT00188227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24411197|NCT00188227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25680159|NCT01846624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411205|NCT00188227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24411207|NCT00188227|Analgesics|analgesics|mesh-ancestor
24411208|NCT00188227|Sensory System Agents|sensory system agents|mesh-ancestor
24411209|NCT00188227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24411210|NCT00188240|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24411211|NCT00188240|Antiviral Agents|antiviral agents|mesh-ancestor
24411212|NCT00188240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24411213|NCT00188266|Fluorouracil|fluorouracil|mesh-list
24411214|NCT00188266|Cisplatin|cisplatin|mesh-list
25091421|NCT03249025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25091422|NCT03249025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091423|NCT03249025|Analgesics|analgesics|mesh-ancestor
25091424|NCT03249025|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25091425|NCT03249025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25091426|NCT03249025|Anesthetics, General|anesthetics, general|mesh-ancestor
25091427|NCT03249025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25091428|NCT03249025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25091429|NCT03249025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25091430|NCT03249038|Chrysarobin|chrysarobin|mesh-list
25091431|NCT03249038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25091432|NCT03249038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25091433|NCT03249038|Analgesics|analgesics|mesh-ancestor
25223478|NCT02639143|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25223479|NCT02639143|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25223480|NCT02639143|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25223481|NCT02639143|Purinergic Agents|purinergic agents|mesh-ancestor
25223482|NCT02639143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25223483|NCT02639143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223484|NCT02639143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223485|NCT02639234|Nivolumab|nivolumab|mesh-list
25223486|NCT02639234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25223487|NCT02639234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223488|NCT02639234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25223489|NCT02639234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223490|NCT02639039|Cortisone|cortisone|mesh-list
25223491|NCT02639039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25223492|NCT02639091|Pemetrexed|pemetrexed|mesh-list
25223493|NCT02639091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223494|NCT02639091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25223495|NCT02639091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452450|NCT05458765|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24836577|NCT02186483|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24836578|NCT02186483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25680161|NCT01846624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25680162|NCT01846624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25680163|NCT01846728|Estrogens|estrogens|mesh-list
25680164|NCT01846728|Hormones|hormones|mesh-ancestor
25680165|NCT01846728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25680166|NCT01846728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680167|NCT01847001|Paclitaxel|paclitaxel|mesh-list
25680168|NCT01847001|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25680169|NCT01847001|Cyclophosphamide|cyclophosphamide|mesh-list
25680170|NCT01847001|Doxorubicin|doxorubicin|mesh-list
25680171|NCT01847001|Trastuzumab|trastuzumab|mesh-list
25680172|NCT01847001|Pertuzumab|pertuzumab|mesh-list
25017180|NCT02337686|Pembrolizumab|pembrolizumab|mesh-list
25017181|NCT02337686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25017182|NCT02337686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25017183|NCT02316834|Talazoparib|talazoparib|mesh-list
25017184|NCT02316834|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25017185|NCT02316834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25017186|NCT02316834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017194|NCT02293655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017195|NCT02293655|Dopamine Agents|dopamine agents|mesh-ancestor
25017196|NCT02293655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25017198|NCT02275546|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25017199|NCT02275546|Desogestrel|desogestrel|mesh-list
25017200|NCT02275546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25017205|NCT02275546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25017206|NCT02275546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25680173|NCT01847001|Propranolol|propranolol|mesh-list
25017211|NCT02275546|Progestins|progestins|mesh-ancestor
24836579|NCT02186483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836580|NCT02186483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25091434|NCT03249038|Sensory System Agents|sensory system agents|mesh-ancestor
25091435|NCT03249038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25091436|NCT03249038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091437|NCT03249038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25091438|NCT03249038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25091439|NCT03249142|Durvalumab|durvalumab|mesh-list
25091440|NCT03249142|Tremelimumab|tremelimumab|mesh-list
25091441|NCT03249142|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25091442|NCT03249142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25091443|NCT03249142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25091444|NCT03249142|Immunologic Factors|immunologic factors|mesh-ancestor
25091445|NCT03249142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091446|NCT03248726|Bisacodyl|bisacodyl|mesh-list
25091447|NCT03248726|Cathartics|cathartics|mesh-ancestor
25091448|NCT03248726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25091449|NCT03248726|Laxatives|laxatives|mesh-ancestor
25091450|NCT03248765|Analgesics, Opioid|analgesics, opioid|mesh-list
25091451|NCT03248765|Narcotics|narcotics|mesh-ancestor
25091463|NCT03248817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091464|NCT03248817|Sensory System Agents|sensory system agents|mesh-ancestor
24421071|NCT00217555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25091471|NCT03248817|Nasal Decongestants|nasal decongestants|mesh-ancestor
25091472|NCT03248817|Respiratory System Agents|respiratory system agents|mesh-ancestor
25091473|NCT03248817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25091474|NCT03248817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25091475|NCT03248817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25091476|NCT03248817|Adrenergic Agents|adrenergic agents|mesh-ancestor
25091477|NCT03248817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25091478|NCT03248817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091479|NCT03248817|Protective Agents|protective agents|mesh-ancestor
25091480|NCT03248713|Mifepristone|mifepristone|mesh-list
24796059|NCT01947803|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25091481|NCT03248713|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25091482|NCT03248713|Abortifacient Agents|abortifacient agents|mesh-ancestor
25091483|NCT03248713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25091484|NCT03248713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091485|NCT03248713|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25091486|NCT03248713|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25680174|NCT01847001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25680175|NCT01847001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25680176|NCT01847001|Tubulin Modulators|tubulin modulators|mesh-ancestor
25680177|NCT01847001|Antimitotic Agents|antimitotic agents|mesh-ancestor
25680178|NCT01847001|Mitosis Modulators|mitosis modulators|mesh-ancestor
25680179|NCT01847001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680180|NCT01847001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25680181|NCT01847001|Immunologic Factors|immunologic factors|mesh-ancestor
25680182|NCT01847001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680183|NCT01847001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25680184|NCT01847001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25680185|NCT01847001|Alkylating Agents|alkylating agents|mesh-ancestor
25680186|NCT01847001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25680187|NCT01847001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25680188|NCT01847001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25680189|NCT01847001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24411218|NCT00188266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411219|NCT00188266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24411220|NCT00188266|Immunologic Factors|immunologic factors|mesh-ancestor
24411221|NCT00188266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411222|NCT00188383|Amantadine|amantadine|mesh-list
24411223|NCT00188383|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24411224|NCT00188383|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25223496|NCT02639091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25223497|NCT02639091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25223498|NCT02638922|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25223499|NCT02638922|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25223500|NCT02638922|Trisequens|trisequens|mesh-list
25223501|NCT02638922|Norethindrone|norethindrone|mesh-list
25223502|NCT02638922|Estradiol|estradiol|mesh-list
25223503|NCT02638922|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25223504|NCT02638922|Estrogens|estrogens|mesh-ancestor
25223505|NCT02638922|Hormones|hormones|mesh-ancestor
25223506|NCT02638922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24595231|NCT00937417|Docetaxel|docetaxel|mesh-list
24836581|NCT02186483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24836582|NCT02186483|Antimetabolites|antimetabolites|mesh-ancestor
24836583|NCT02186483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836584|NCT02186483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24836585|NCT02186483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24836586|NCT02186483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836587|NCT02186496|Amlodipine|amlodipine|mesh-list
24836588|NCT02186496|Candesartan|candesartan|mesh-list
24836604|NCT02186535|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24836605|NCT02186574|Tenofovir|tenofovir|mesh-list
24836606|NCT02186574|Antiviral Agents|antiviral agents|mesh-ancestor
24836607|NCT02186574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24836608|NCT02186574|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25055640|NCT03519022|Dopamine Agents|dopamine agents|mesh-ancestor
24836614|NCT02186600|Vitamin D|vitamin d|mesh-list
24836615|NCT02186600|Cholecalciferol|cholecalciferol|mesh-list
24836616|NCT02186600|Risedronic Acid|risedronic acid|mesh-list
24836617|NCT02186600|Calcium Carbonate|calcium carbonate|mesh-list
25223507|NCT02638922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223508|NCT02638922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25223509|NCT02638922|Contraceptive Agents|contraceptive agents|mesh-ancestor
25223510|NCT02638922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25223511|NCT02638922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25223512|NCT02638922|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25223513|NCT02638922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25223514|NCT02638922|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25223515|NCT02638909|Ceritinib|ceritinib|mesh-list
25223516|NCT02638909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223517|NCT02638909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25223518|NCT02638909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25223519|NCT02638909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223520|NCT02638896|Sulfasalazine|sulfasalazine|mesh-list
25223521|NCT02638896|Celecoxib|celecoxib|mesh-list
25223522|NCT02638896|Etanercept|etanercept|mesh-list
25223523|NCT02638896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25223524|NCT02638896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24451452|NCT00323804|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25223525|NCT02638896|Analgesics|analgesics|mesh-ancestor
25223526|NCT02638896|Sensory System Agents|sensory system agents|mesh-ancestor
25223527|NCT02638896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25223528|NCT02638896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223529|NCT02638896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24984634|NCT04296942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24984635|NCT04296942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24984636|NCT04296942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24984637|NCT04296942|Tubulin Modulators|tubulin modulators|mesh-ancestor
24984638|NCT04296942|Antimitotic Agents|antimitotic agents|mesh-ancestor
24984639|NCT04296942|Mitosis Modulators|mitosis modulators|mesh-ancestor
24984640|NCT04296942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223530|NCT02638896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25223531|NCT02638896|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25223532|NCT02638896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25223533|NCT02638896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25223534|NCT02638896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223535|NCT02638896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25223536|NCT02638896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25223537|NCT02638896|Immunologic Factors|immunologic factors|mesh-ancestor
25223538|NCT02638896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25223539|NCT02638870|Amitriptyline|amitriptyline|mesh-list
25223540|NCT02638870|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25223541|NCT02638870|Antidepressive Agents|antidepressive agents|mesh-ancestor
25223542|NCT02638870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25223543|NCT02638870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25223544|NCT02638870|Analgesics|analgesics|mesh-ancestor
25223545|NCT02638870|Sensory System Agents|sensory system agents|mesh-ancestor
24836640|NCT02186769|Dopamine Agents|dopamine agents|mesh-ancestor
24836641|NCT02186782|Citric Acid|citric acid|mesh-list
24836642|NCT02186782|Sodium Citrate|sodium citrate|mesh-list
24836643|NCT02186782|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24748404|NCT02608684|Gemcitabine|gemcitabine|mesh-list
24836652|NCT02186782|Chelating Agents|chelating agents|mesh-ancestor
24836653|NCT02186782|Sequestering Agents|sequestering agents|mesh-ancestor
25091492|NCT03248713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25091493|NCT03248713|Luteolytic Agents|luteolytic agents|mesh-ancestor
25091494|NCT03248713|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25091495|NCT03248713|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25091496|NCT03248544|Vitamin D|vitamin d|mesh-list
25091497|NCT03248544|Cholecalciferol|cholecalciferol|mesh-list
24984641|NCT04296942|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24984642|NCT04296942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984644|NCT04291599|Morphine|morphine|mesh-list
24984645|NCT04291599|Hydromorphone|hydromorphone|mesh-list
24984646|NCT04291599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24984647|NCT04291599|Narcotics|narcotics|mesh-ancestor
24984650|NCT04291599|Analgesics|analgesics|mesh-ancestor
25091498|NCT03248544|Vitamins|vitamins|mesh-ancestor
25091499|NCT03248544|Micronutrients|micronutrients|mesh-ancestor
25091500|NCT03248544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091501|NCT03248544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25091502|NCT03248544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25091503|NCT03248973|Ampicillin|ampicillin|mesh-list
25091504|NCT03248973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25091505|NCT03248973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25091506|NCT03248791|Phenylephrine|phenylephrine|mesh-list
25091507|NCT03248791|Oxymetazoline|oxymetazoline|mesh-list
25091508|NCT03248791|Norepinephrine|norepinephrine|mesh-list
25091509|NCT03248791|Bupivacaine|bupivacaine|mesh-list
25091510|NCT03248791|Anesthetics, Local|anesthetics, local|mesh-ancestor
25680190|NCT01847001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091511|NCT03248791|Anesthetics|anesthetics|mesh-ancestor
24411245|NCT00188396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24411246|NCT00188552|Tocopherols|tocopherols|mesh-list
24411247|NCT00188552|Vitamin E|vitamin e|mesh-list
25680191|NCT01847001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24411253|NCT00188552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411266|NCT00188565|Analgesics|analgesics|mesh-ancestor
24411267|NCT00188565|Sensory System Agents|sensory system agents|mesh-ancestor
24411297|NCT00188630|Antidotes|antidotes|mesh-ancestor
24411298|NCT00188643|Lamotrigine|lamotrigine|mesh-list
24411299|NCT00188643|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24411300|NCT00188643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25223546|NCT02638870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25223547|NCT02638870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223548|NCT02638870|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25223549|NCT02638870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25223550|NCT02638870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25223551|NCT02638870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984655|NCT04291599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24984656|NCT04291599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24984657|NCT04291599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24984658|NCT04291599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984659|NCT04291599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984660|NCT04278872|SJX-653|sjx-653|mesh-list
24984661|NCT04278872|Hormone Antagonists|hormone antagonists|mesh-ancestor
24984662|NCT04278872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24984663|NCT04278872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984664|NCT04270669|RC28-E protein|rc28-e protein|mesh-list
24984665|NCT04270669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24984666|NCT04270669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24859796|NCT02305836|Donepezil|donepezil|mesh-list
25223552|NCT02638870|Adrenergic Agents|adrenergic agents|mesh-ancestor
25223553|NCT02638870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25223555|NCT02638857|Mitomycins|mitomycins|mesh-list
25223556|NCT02638857|Mitomycin|mitomycin|mesh-list
25223557|NCT02638857|Ethiodized Oil|ethiodized oil|mesh-list
25223558|NCT02638857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25223559|NCT02638857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223560|NCT02638857|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24836676|NCT02186899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24836678|NCT02186951|Amoxicillin|amoxicillin|mesh-list
24836679|NCT02186951|Clavulanic Acids|clavulanic acids|mesh-list
24836680|NCT02186951|Clavulanic Acid|clavulanic acid|mesh-list
24836681|NCT02186951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24836682|NCT02186951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24836683|NCT02186951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411301|NCT00188643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24411302|NCT00188643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25091512|NCT03248791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25091513|NCT03248791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091514|NCT03248791|Sensory System Agents|sensory system agents|mesh-ancestor
25091515|NCT03248791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25091517|NCT03248791|Mydriatics|mydriatics|mesh-ancestor
25091518|NCT03248791|Autonomic Agents|autonomic agents|mesh-ancestor
25680192|NCT01847001|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25091519|NCT03248791|Sympathomimetics|sympathomimetics|mesh-ancestor
25680193|NCT01847001|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25680194|NCT01847001|Adrenergic Agents|adrenergic agents|mesh-ancestor
25680195|NCT01847001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25680196|NCT01847001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25091528|NCT03248791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091530|NCT03248700|Vitamins|vitamins|mesh-list
25091531|NCT03248700|Vitamin A|vitamin a|mesh-list
25091532|NCT03248700|Retinol palmitate|retinol palmitate|mesh-list
25091533|NCT03248700|Retinol acetate|retinol acetate|mesh-list
25091534|NCT03248700|Micronutrients|micronutrients|mesh-ancestor
24411352|NCT00188773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25223561|NCT02638857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25223562|NCT02638857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25223563|NCT02638857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223564|NCT02638857|Alkylating Agents|alkylating agents|mesh-ancestor
25223565|NCT02638857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25223566|NCT02638545|Dexmedetomidine|dexmedetomidine|mesh-list
25223567|NCT02638545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25223568|NCT02638545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25223569|NCT02638545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223570|NCT02638545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25223571|NCT02638545|Analgesics|analgesics|mesh-ancestor
25223572|NCT02638545|Sensory System Agents|sensory system agents|mesh-ancestor
25223573|NCT02638545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25223574|NCT02638545|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25223575|NCT02638545|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25223576|NCT02638545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25223577|NCT02638545|Adrenergic Agents|adrenergic agents|mesh-ancestor
25223578|NCT02638545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25223579|NCT02638545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223581|NCT02638831|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25223583|NCT02638831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24836710|NCT02187081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24836711|NCT02187081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836712|NCT02187081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836713|NCT02187107|Darunavir|darunavir|mesh-list
24748654|NCT02283281|Hallucinogens|hallucinogens|mesh-ancestor
25043056|NCT01332812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043058|NCT01332812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043059|NCT01332812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411353|NCT00188812|Donepezil|donepezil|mesh-list
24411354|NCT00188812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24411355|NCT00188812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25159913|NCT03504956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25680197|NCT01847001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25680198|NCT01847001|Vasodilator Agents|vasodilator agents|mesh-ancestor
25680199|NCT01847014|Macitentan|macitentan|mesh-list
24443675|NCT00295776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24443676|NCT00295776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411356|NCT00188812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091540|NCT03248700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25091541|NCT03248700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25091542|NCT03248700|Immunologic Factors|immunologic factors|mesh-ancestor
25091544|NCT03248648|Neostigmine|neostigmine|mesh-list
25091545|NCT03248648|Analgesics|analgesics|mesh-ancestor
25091546|NCT03248648|Sensory System Agents|sensory system agents|mesh-ancestor
25091547|NCT03248648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25223584|NCT02638831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25223585|NCT02638831|Analgesics|analgesics|mesh-ancestor
25223586|NCT02638831|Sensory System Agents|sensory system agents|mesh-ancestor
25223587|NCT02638831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25223588|NCT02638831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223589|NCT02638831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25223590|NCT02638831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25223591|NCT02638831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25223592|NCT02638831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25223593|NCT02638831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223594|NCT02638740|Mechlorethamine|mechlorethamine|mesh-list
25223595|NCT02638740|Alkylating Agents|alkylating agents|mesh-ancestor
25223596|NCT02638740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223597|NCT02638740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25223598|NCT02638740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223599|NCT02638519|Xenon|xenon|mesh-list
25223600|NCT02638519|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25223601|NCT02638519|Anesthetics, General|anesthetics, general|mesh-ancestor
25223602|NCT02638519|Anesthetics|anesthetics|mesh-ancestor
25223603|NCT02638519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25223604|NCT02638519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223605|NCT02638506|Fentanyl|fentanyl|mesh-list
25223606|NCT02638506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25223607|NCT02638506|Narcotics|narcotics|mesh-ancestor
25223608|NCT02638506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25223609|NCT02638506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223610|NCT02638506|Analgesics|analgesics|mesh-ancestor
25091550|NCT03248648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25091551|NCT03248648|Anesthetics, General|anesthetics, general|mesh-ancestor
25091552|NCT03248648|Anesthetics|anesthetics|mesh-ancestor
25091553|NCT03248648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25091554|NCT03248648|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25091555|NCT03248648|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25091556|NCT03248648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25091557|NCT03248648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091558|NCT03248648|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25091559|NCT03248648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091560|NCT03248648|Cholinergic Agents|cholinergic agents|mesh-ancestor
25091561|NCT03248648|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25091562|NCT03248648|Autonomic Agents|autonomic agents|mesh-ancestor
25091564|NCT03248401|Cilostazol|cilostazol|mesh-list
25091565|NCT03248401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25091566|NCT03248401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25091567|NCT03248401|Analgesics|analgesics|mesh-ancestor
25091568|NCT03248401|Sensory System Agents|sensory system agents|mesh-ancestor
25091569|NCT03248401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25091570|NCT03248401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091571|NCT03248401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24411525|NCT00189358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24411527|NCT00189358|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24411529|NCT00189358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25091581|NCT03248401|Autonomic Agents|autonomic agents|mesh-ancestor
25091582|NCT03248401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25091583|NCT03248401|Respiratory System Agents|respiratory system agents|mesh-ancestor
25091584|NCT03248401|Vasodilator Agents|vasodilator agents|mesh-ancestor
25091585|NCT03248401|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25223611|NCT02638506|Sensory System Agents|sensory system agents|mesh-ancestor
25680200|NCT01847014|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25680201|NCT01847014|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25223614|NCT02638506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25223615|NCT02638506|Anesthetics, General|anesthetics, general|mesh-ancestor
25223616|NCT02638506|Anesthetics|anesthetics|mesh-ancestor
25273192|NCT02386397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25273193|NCT02386397|Antimetabolites|antimetabolites|mesh-ancestor
25273194|NCT02386397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273195|NCT02386397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25273196|NCT02386397|Antiviral Agents|antiviral agents|mesh-ancestor
25273197|NCT02386397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25273198|NCT02386397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273199|NCT02386397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25273200|NCT02386397|Immunologic Factors|immunologic factors|mesh-ancestor
25273201|NCT02386397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273202|NCT02386488|Vortioxetine|vortioxetine|mesh-list
25273203|NCT02386488|Antidepressive Agents|antidepressive agents|mesh-ancestor
25273204|NCT02386488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25273205|NCT02386488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25223824|NCT02637193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24836738|NCT02187133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055551|NCT03519776|Progesterone|progesterone|mesh-list
25091586|NCT03248401|Protective Agents|protective agents|mesh-ancestor
25091587|NCT03248401|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25091588|NCT03248401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25091589|NCT03248427|Paclitaxel|paclitaxel|mesh-list
25091590|NCT03248427|Cyclophosphamide|cyclophosphamide|mesh-list
25091591|NCT03248427|Doxorubicin|doxorubicin|mesh-list
25091592|NCT03248427|Letrozole|letrozole|mesh-list
25091593|NCT03248427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25091594|NCT03248427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25091595|NCT03248427|Tubulin Modulators|tubulin modulators|mesh-ancestor
25091596|NCT03248427|Antimitotic Agents|antimitotic agents|mesh-ancestor
25091597|NCT03248427|Mitosis Modulators|mitosis modulators|mesh-ancestor
24411538|NCT00189371|Tubulin Modulators|tubulin modulators|mesh-ancestor
24411539|NCT00189371|Antimitotic Agents|antimitotic agents|mesh-ancestor
24411540|NCT00189371|Mitosis Modulators|mitosis modulators|mesh-ancestor
24411622|NCT00189579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411623|NCT00189618|Aspirin|aspirin|mesh-list
24411624|NCT00189618|Clopidogrel|clopidogrel|mesh-list
24411625|NCT00189618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25223617|NCT02638389|Sirolimus|sirolimus|mesh-list
25223618|NCT02638389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25223619|NCT02638389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25223620|NCT02638389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25223621|NCT02638389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223622|NCT02638389|Antifungal Agents|antifungal agents|mesh-ancestor
25223623|NCT02638389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25223624|NCT02638389|Immunologic Factors|immunologic factors|mesh-ancestor
25223625|NCT02638389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223626|NCT02638428|Cytarabine|cytarabine|mesh-list
25223627|NCT02638428|Carboplatin|carboplatin|mesh-list
25223628|NCT02638428|Trastuzumab|trastuzumab|mesh-list
25223629|NCT02638428|Fludarabine|fludarabine|mesh-list
25223630|NCT02638428|Etoposide|etoposide|mesh-list
25680204|NCT01847131|Phenylephrine|phenylephrine|mesh-list
25680205|NCT01847131|Oxymetazoline|oxymetazoline|mesh-list
25223631|NCT02638428|Everolimus|everolimus|mesh-list
25223632|NCT02638428|Sorafenib|sorafenib|mesh-list
25223633|NCT02638428|Dasatinib|dasatinib|mesh-list
25680206|NCT01847131|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24836782|NCT02187445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24836784|NCT02187484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24836785|NCT02187484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24836786|NCT02187484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24411626|NCT00189618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24411627|NCT00189618|Analgesics|analgesics|mesh-ancestor
24411628|NCT00189618|Sensory System Agents|sensory system agents|mesh-ancestor
25091598|NCT03248427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091599|NCT03248427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25091600|NCT03248427|Immunologic Factors|immunologic factors|mesh-ancestor
25091601|NCT03248427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091602|NCT03248427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25091603|NCT03248427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25091604|NCT03248427|Alkylating Agents|alkylating agents|mesh-ancestor
25091605|NCT03248427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25091606|NCT03248427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25091607|NCT03248427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25223642|NCT02638428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223643|NCT02638428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25223644|NCT02638428|Immunologic Factors|immunologic factors|mesh-ancestor
25223645|NCT02638428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223646|NCT02638428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25223647|NCT02638428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25223648|NCT02638428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25223649|NCT02638428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25223650|NCT02638428|Antiviral Agents|antiviral agents|mesh-ancestor
25223651|NCT02638428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25223652|NCT02638428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25223653|NCT02638428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25223654|NCT02638428|Alkylating Agents|alkylating agents|mesh-ancestor
25223655|NCT02638233|Sofosbuvir|sofosbuvir|mesh-list
25223656|NCT02638233|Ledipasvir|ledipasvir|mesh-list
25223657|NCT02638233|Antiviral Agents|antiviral agents|mesh-ancestor
25223658|NCT02638233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25223659|NCT02638376|Riboflavin|riboflavin|mesh-list
25223660|NCT02638376|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25223661|NCT02638376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25223662|NCT02638376|Vitamin B Complex|vitamin b complex|mesh-ancestor
25223663|NCT02638376|Vitamins|vitamins|mesh-ancestor
25223664|NCT02638376|Micronutrients|micronutrients|mesh-ancestor
25223665|NCT02638376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223666|NCT02638376|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25223667|NCT02638376|Dermatologic Agents|dermatologic agents|mesh-ancestor
25680207|NCT01847131|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24836815|NCT02187536|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24836816|NCT02187562|Aspirin|aspirin|mesh-list
24836817|NCT02187562|Meloxicam|meloxicam|mesh-list
24595555|NCT00939549|(T,G)-A-L|(t,g)-a-l|mesh-list
24836818|NCT02187562|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24836819|NCT02187562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24836821|NCT02187562|Sensory System Agents|sensory system agents|mesh-ancestor
24836822|NCT02187562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24836823|NCT02187562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091608|NCT03248427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25091609|NCT03248427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091610|NCT03248427|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25091611|NCT03248427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25091612|NCT03248427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25091613|NCT03248427|Hormone Antagonists|hormone antagonists|mesh-ancestor
25091628|NCT03247972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411629|NCT00189618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24411630|NCT00189618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411631|NCT00189618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24411632|NCT00189618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24411633|NCT00189618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24411669|NCT00189657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411670|NCT00189657|Antimetabolites|antimetabolites|mesh-ancestor
24411680|NCT00189709|Fluconazole|fluconazole|mesh-list
24411681|NCT00189709|Micafungin|micafungin|mesh-list
25091631|NCT03247998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25091632|NCT03247998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091633|NCT03247998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25091634|NCT03247998|Narcotics|narcotics|mesh-ancestor
25091635|NCT03247998|Analgesics|analgesics|mesh-ancestor
25091636|NCT03247998|Sensory System Agents|sensory system agents|mesh-ancestor
25091637|NCT03247998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25091638|NCT03248076|Fentanyl|fentanyl|mesh-list
25091639|NCT03248076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25091640|NCT03248076|Narcotics|narcotics|mesh-ancestor
25091641|NCT03248076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25091642|NCT03248076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091643|NCT03248076|Analgesics|analgesics|mesh-ancestor
25091644|NCT03248076|Sensory System Agents|sensory system agents|mesh-ancestor
25091645|NCT03248076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25091646|NCT03248076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25223673|NCT02638584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223674|NCT02638415|Carvedilol|carvedilol|mesh-list
25223675|NCT02638415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25223676|NCT02638415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25223677|NCT02638415|Adrenergic Agents|adrenergic agents|mesh-ancestor
25223678|NCT02638415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25223679|NCT02638415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223680|NCT02638415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223681|NCT02638415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25223682|NCT02638415|Antioxidants|antioxidants|mesh-ancestor
25223683|NCT02638415|Protective Agents|protective agents|mesh-ancestor
25223684|NCT02638415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25223685|NCT02638415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25223686|NCT02638415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25680208|NCT01847131|Adrenergic Agents|adrenergic agents|mesh-ancestor
24443721|NCT00295893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017623|NCT00159744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25017624|NCT00159744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25017625|NCT00159744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25017626|NCT00159744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25017630|NCT00159744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25223687|NCT02638415|Vasodilator Agents|vasodilator agents|mesh-ancestor
25223688|NCT02638415|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25223689|NCT02638415|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25223690|NCT02638285|Clomiphene|clomiphene|mesh-list
25223691|NCT02638285|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25223692|NCT02638285|Hormone Antagonists|hormone antagonists|mesh-ancestor
24836824|NCT02187562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24836825|NCT02187562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24836826|NCT02187562|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24836827|NCT02187562|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25223825|NCT02637128|Artesunate|artesunate|mesh-list
24836835|NCT02187588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24836836|NCT02187588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24836837|NCT02187588|Analgesics|analgesics|mesh-ancestor
24836838|NCT02187588|Sensory System Agents|sensory system agents|mesh-ancestor
25091647|NCT03248076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25091648|NCT03248076|Anesthetics, General|anesthetics, general|mesh-ancestor
25091649|NCT03248076|Anesthetics|anesthetics|mesh-ancestor
25091650|NCT03247920|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25091651|NCT03247920|Amoxicillin|amoxicillin|mesh-list
24411682|NCT00189709|Antifungal Agents|antifungal agents|mesh-ancestor
24411683|NCT00189709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24411684|NCT00189709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25223693|NCT02638285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25223694|NCT02638285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223695|NCT02638285|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25680211|NCT01847131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680212|NCT01847131|Sympathomimetics|sympathomimetics|mesh-ancestor
25680213|NCT01847131|Autonomic Agents|autonomic agents|mesh-ancestor
25680214|NCT01847131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25680215|NCT01847131|Nasal Decongestants|nasal decongestants|mesh-ancestor
25680216|NCT01847131|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25680217|NCT01847131|Respiratory System Agents|respiratory system agents|mesh-ancestor
25680218|NCT01847131|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25680219|NCT01847131|Mydriatics|mydriatics|mesh-ancestor
25223696|NCT02638285|Fertility Agents|fertility agents|mesh-ancestor
25223697|NCT02638285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25223706|NCT02638142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223707|NCT02638142|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25223708|NCT02638142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25223709|NCT02638142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223711|NCT02638116|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25223712|NCT02638116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25223713|NCT02638116|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25223714|NCT02638116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25223715|NCT02638116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223716|NCT02637973|Empagliflozin|empagliflozin|mesh-list
25223717|NCT02637973|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25223718|NCT02637973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223719|NCT02637973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25223720|NCT02637973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223721|NCT02637830|Fluorides|fluorides|mesh-list
25223722|NCT02637830|Fluorides, Topical|fluorides, topical|mesh-list
25223723|NCT02637830|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
25223724|NCT02637830|Cariostatic Agents|cariostatic agents|mesh-ancestor
24836896|NCT02187900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444146|NCT00296777|Adrenergic Agents|adrenergic agents|mesh-ancestor
24444147|NCT00296790|Zolpidem|zolpidem|mesh-list
24444148|NCT00296790|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25091655|NCT03247920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25091656|NCT03247920|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25091657|NCT03247920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091658|NCT03247920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091659|NCT03247868|Botulinum Toxins|botulinum toxins|mesh-list
25091660|NCT03247868|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25091661|NCT03247868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25091662|NCT03247868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091663|NCT03247868|Cholinergic Agents|cholinergic agents|mesh-ancestor
25223729|NCT02637648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25223730|NCT02637648|Anesthetics, General|anesthetics, general|mesh-ancestor
25223732|NCT02637648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25223733|NCT02637648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223734|NCT02637726|Remifentanil|remifentanil|mesh-list
25223735|NCT02637726|Propofol|propofol|mesh-list
25223736|NCT02637726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25223737|NCT02637726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25223738|NCT02637726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223739|NCT02637726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25223740|NCT02637726|Anesthetics, General|anesthetics, general|mesh-ancestor
25223741|NCT02637726|Anesthetics|anesthetics|mesh-ancestor
24836897|NCT02187900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680220|NCT01847131|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25680221|NCT01847131|Protective Agents|protective agents|mesh-ancestor
25017714|NCT03704818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017715|NCT03704818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25680225|NCT01847313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25680226|NCT01847313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680227|NCT01847313|Incretins|incretins|mesh-ancestor
25017716|NCT03704818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539427|NCT00663832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539431|NCT00663845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24539432|NCT00663845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527549|NCT00617370|Epirubicin|epirubicin|mesh-list
24539433|NCT00663845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539434|NCT00663845|Urological Agents|urological agents|mesh-ancestor
24539436|NCT00663884|Mitiglinide|mitiglinide|mesh-list
24539437|NCT00663884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24539442|NCT00663897|Lansoprazole|lansoprazole|mesh-list
24836898|NCT02187900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24836899|NCT02187900|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24836900|NCT02187900|Protective Agents|protective agents|mesh-ancestor
24836901|NCT02187900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836921|NCT02188173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24836922|NCT02188173|Glucocorticoids|glucocorticoids|mesh-ancestor
24836923|NCT02188173|Hormones|hormones|mesh-ancestor
24836924|NCT02188173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24836925|NCT02188173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24836926|NCT02188173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24836927|NCT02188186|Metformin|metformin|mesh-list
24836928|NCT02188186|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24836929|NCT02188186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24836930|NCT02188186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055652|NCT03518528|Estradiol|estradiol|mesh-list
25091683|NCT03247452|Protective Agents|protective agents|mesh-ancestor
25091684|NCT03247452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091685|NCT03247452|Vitamins|vitamins|mesh-ancestor
25091686|NCT03247452|Micronutrients|micronutrients|mesh-ancestor
25091687|NCT03247283|Linrodostat|linrodostat|mesh-list
25091689|NCT03247283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091690|NCT03247413|Dexamethasone|dexamethasone|mesh-list
25091691|NCT03247413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25091693|NCT03247413|Autonomic Agents|autonomic agents|mesh-ancestor
25091694|NCT03247413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25223742|NCT02637726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25223743|NCT02637726|Narcotics|narcotics|mesh-ancestor
25223744|NCT02637726|Analgesics|analgesics|mesh-ancestor
25223745|NCT02637726|Sensory System Agents|sensory system agents|mesh-ancestor
25223746|NCT02637726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25680228|NCT01847313|Hormones|hormones|mesh-ancestor
25680229|NCT01847313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25680230|NCT01847313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25680231|NCT01847443|Nicotine|nicotine|mesh-list
25680232|NCT01847443|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25680233|NCT01847443|Autonomic Agents|autonomic agents|mesh-ancestor
25680234|NCT01847443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25680235|NCT01847443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680236|NCT01847443|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25680237|NCT01847443|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25680238|NCT01847443|Cholinergic Agents|cholinergic agents|mesh-ancestor
25680239|NCT01847443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25680240|NCT01847443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680241|NCT01847469|Zonisamide|zonisamide|mesh-list
25680242|NCT01847469|Anticonvulsants|anticonvulsants|mesh-ancestor
25680243|NCT01847469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25680244|NCT01847469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25223761|NCT02637466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25223762|NCT02637466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25223763|NCT02637466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223764|NCT02637466|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25223765|NCT02637466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25223766|NCT02637466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25223767|NCT02637466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223768|NCT02637466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25223769|NCT02637466|Serotonin Agents|serotonin agents|mesh-ancestor
25223770|NCT02637466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24859988|NCT02307045|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25223771|NCT02637466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25223772|NCT02637466|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24836931|NCT02188186|Incretins|incretins|mesh-ancestor
24836932|NCT02188186|Hormones|hormones|mesh-ancestor
24836933|NCT02188186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24836934|NCT02188186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24836935|NCT02188186|Protease Inhibitors|protease inhibitors|mesh-ancestor
24837001|NCT02188394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25223773|NCT02637466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25223774|NCT02637479|Deoxyglucose|deoxyglucose|mesh-list
25223775|NCT02637479|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25223776|NCT02637479|Antimetabolites|antimetabolites|mesh-ancestor
25223777|NCT02637479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223778|NCT02637479|Antiviral Agents|antiviral agents|mesh-ancestor
25223779|NCT02637479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25223780|NCT02637479|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25223781|NCT02637284|BPC 157|bpc 157|mesh-list
25223782|NCT02637284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25223783|NCT02637284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25223784|NCT02637375|Paclitaxel|paclitaxel|mesh-list
25223785|NCT02637375|Cyclophosphamide|cyclophosphamide|mesh-list
25223786|NCT02637375|Doxorubicin|doxorubicin|mesh-list
25680245|NCT01847469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223787|NCT02637375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25223788|NCT02637375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223789|NCT02637375|Tubulin Modulators|tubulin modulators|mesh-ancestor
25223790|NCT02637375|Antimitotic Agents|antimitotic agents|mesh-ancestor
25223791|NCT02637375|Mitosis Modulators|mitosis modulators|mesh-ancestor
25223792|NCT02637375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223801|NCT02637375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25223802|NCT02637375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25223803|NCT02637375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25223804|NCT02637167|Rifaximin|rifaximin|mesh-list
25223805|NCT02637167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25223806|NCT02637167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25223807|NCT02637167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25223808|NCT02637193|Moxifloxacin|moxifloxacin|mesh-list
25223809|NCT02637193|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25223810|NCT02637193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25223811|NCT02637193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25223812|NCT02637193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25223813|NCT02637193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25043065|NCT01332656|Antimitotic Agents|antimitotic agents|mesh-ancestor
25043066|NCT01332656|Mitosis Modulators|mitosis modulators|mesh-ancestor
25043067|NCT01332656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043069|NCT01331850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25043070|NCT01331850|Interferon-alpha|interferon-alpha|mesh-list
25043071|NCT01331850|Ribavirin|ribavirin|mesh-list
25043072|NCT01331850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25043073|NCT01331850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25043074|NCT01331850|Protease Inhibitors|protease inhibitors|mesh-ancestor
25043075|NCT01331850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043076|NCT01331850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043077|NCT01331850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25043078|NCT01331850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25043079|NCT01331850|Antiviral Agents|antiviral agents|mesh-ancestor
25043080|NCT01331850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25043081|NCT01331850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25043082|NCT01331850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25043083|NCT01331850|Immunologic Factors|immunologic factors|mesh-ancestor
25043084|NCT01331850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043085|NCT01331850|Antimetabolites|antimetabolites|mesh-ancestor
25043086|NCT01330979|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25043087|NCT01330979|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25043088|NCT01328808|Acetaminophen|acetaminophen|mesh-list
25091695|NCT03247413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411761|NCT00189878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24411762|NCT00189878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24411763|NCT00189982|Factor VIII|factor viii|mesh-list
25223814|NCT02637193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25223815|NCT02637193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223816|NCT02637193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223817|NCT02637193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223818|NCT02637193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25223819|NCT02637193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25223820|NCT02637193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25223821|NCT02637193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25223822|NCT02637193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25223823|NCT02637193|Antidepressive Agents|antidepressive agents|mesh-ancestor
25223827|NCT02637128|Artemether|artemether|mesh-list
25223828|NCT02637128|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25223829|NCT02637128|Amodiaquine|amodiaquine|mesh-list
25223830|NCT02637128|Antimalarials|antimalarials|mesh-ancestor
25223831|NCT02637128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25223832|NCT02637128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25223833|NCT02637128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25223834|NCT02637128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25680246|NCT01847469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25043094|NCT01328808|Antipyretics|antipyretics|mesh-ancestor
24472804|NCT00400608|Hormones|hormones|mesh-ancestor
24837016|NCT02188472|Penicillins|penicillins|mesh-list
24837017|NCT02188472|Penicillin V|penicillin v|mesh-list
24837018|NCT02188472|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24837019|NCT02188472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24837020|NCT02188472|Renal Agents|renal agents|mesh-ancestor
24837021|NCT02188472|Antimalarials|antimalarials|mesh-ancestor
24837022|NCT02188472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24837023|NCT02188472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24837024|NCT02188472|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24837025|NCT02188472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837026|NCT02188472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837027|NCT02188472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24837028|NCT02188472|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25223839|NCT02636816|Carbetocin|carbetocin|mesh-list
25223840|NCT02636816|Oxytocics|oxytocics|mesh-ancestor
25223841|NCT02636816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25223842|NCT02636816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223843|NCT02636803|Albendazole|albendazole|mesh-list
25223844|NCT02636803|Oxfendazole|oxfendazole|mesh-list
25223845|NCT02636803|Anthelmintics|anthelmintics|mesh-ancestor
25223846|NCT02636803|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25223848|NCT02636803|Anticestodal Agents|anticestodal agents|mesh-ancestor
25223849|NCT02636803|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25223850|NCT02636803|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25223851|NCT02636803|Tubulin Modulators|tubulin modulators|mesh-ancestor
25223852|NCT02636803|Antimitotic Agents|antimitotic agents|mesh-ancestor
25223853|NCT02636803|Mitosis Modulators|mitosis modulators|mesh-ancestor
25223854|NCT02636803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223855|NCT02636803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223856|NCT02636803|Antinematodal Agents|antinematodal agents|mesh-ancestor
25223857|NCT02636829|Calcium|calcium|mesh-list
25223858|NCT02636829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25223859|NCT02636829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223860|NCT02636842|Aripiprazole|aripiprazole|mesh-list
25223861|NCT02636842|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
25223862|NCT02636842|Antidepressive Agents|antidepressive agents|mesh-ancestor
25223863|NCT02636842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25223864|NCT02636842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25223865|NCT02636842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25223866|NCT02636842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25223867|NCT02636842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223868|NCT02636842|Dopamine Agonists|dopamine agonists|mesh-ancestor
25680247|NCT01847469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680248|NCT01847638|Nepafenac|nepafenac|mesh-list
25680249|NCT01847638|Bromfenac|bromfenac|mesh-list
25680250|NCT01847638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25680251|NCT01847638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25680252|NCT01847638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25680253|NCT01847638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25223878|NCT02636842|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25273206|NCT02386488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25273207|NCT02386488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25273208|NCT02386488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273209|NCT02386488|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25273210|NCT02386488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25273211|NCT02386488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25273212|NCT02386488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273213|NCT02386488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25273214|NCT02386488|Serotonin Agents|serotonin agents|mesh-ancestor
25273215|NCT02386488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25273216|NCT02386488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25273217|NCT02386488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25273218|NCT02386488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25273219|NCT02386462|Dexmedetomidine|dexmedetomidine|mesh-list
25273221|NCT02386462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25273222|NCT02386462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25273223|NCT02386462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273224|NCT02386462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24985011|NCT03772951|GABA Antagonists|gaba antagonists|mesh-ancestor
24860123|NCT02307565|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24860124|NCT02307565|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24860125|NCT02307565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24860126|NCT02307565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24860127|NCT02307565|Adrenergic Agents|adrenergic agents|mesh-ancestor
24860130|NCT02307591|Amiodarone|amiodarone|mesh-list
25273225|NCT02386462|Anesthetics, General|anesthetics, general|mesh-ancestor
25273226|NCT02386462|Anesthetics|anesthetics|mesh-ancestor
25273228|NCT02386462|Analgesics|analgesics|mesh-ancestor
25273229|NCT02386462|Sensory System Agents|sensory system agents|mesh-ancestor
25273230|NCT02386462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25273231|NCT02386462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25273232|NCT02386462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25273233|NCT02386462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25680254|NCT01847638|Analgesics|analgesics|mesh-ancestor
25680255|NCT01847638|Sensory System Agents|sensory system agents|mesh-ancestor
25680256|NCT01847638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25680257|NCT01847638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680258|NCT01847638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25680259|NCT01847638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25680260|NCT01848041|Phenylephrine|phenylephrine|mesh-list
25680261|NCT01848041|Oxymetazoline|oxymetazoline|mesh-list
24837065|NCT02188550|Letrozole|letrozole|mesh-list
24837066|NCT02188550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24837067|NCT02188550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24837068|NCT02188550|Immunologic Factors|immunologic factors|mesh-ancestor
24837069|NCT02188550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837070|NCT02188550|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24837071|NCT02188550|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24837072|NCT02188550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837073|NCT02188550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837074|NCT02188550|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24837075|NCT02188550|Hormone Antagonists|hormone antagonists|mesh-ancestor
25223879|NCT02636426|Sorafenib|sorafenib|mesh-list
25223880|NCT02636426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223881|NCT02636426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25223882|NCT02636426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25245810|NCT03685890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25223883|NCT02636426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223884|NCT02636491|Insulin|insulin|mesh-list
25223885|NCT02636491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24453683|NCT04855266|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25223886|NCT02636491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25223887|NCT02636491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223888|NCT02636231|Endostatins|endostatins|mesh-list
24453684|NCT04855266|Hematinics|hematinics|mesh-ancestor
25223889|NCT02636231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25223890|NCT02636231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25223891|NCT02636231|Growth Substances|growth substances|mesh-ancestor
25223892|NCT02636231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223893|NCT02636231|Growth Inhibitors|growth inhibitors|mesh-ancestor
25223894|NCT02636231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223895|NCT02636218|Ketamine|ketamine|mesh-list
25223896|NCT02636218|Analgesics|analgesics|mesh-ancestor
25223897|NCT02636218|Sensory System Agents|sensory system agents|mesh-ancestor
25223898|NCT02636218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25223899|NCT02636218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223900|NCT02636218|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25223901|NCT02636218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25223902|NCT02636218|Anesthetics, General|anesthetics, general|mesh-ancestor
25223903|NCT02636218|Anesthetics|anesthetics|mesh-ancestor
25223904|NCT02636218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25223905|NCT02636218|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25223906|NCT02636218|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25223907|NCT02636218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25223908|NCT02636218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223909|NCT02636348|Vitamin D|vitamin d|mesh-list
25223910|NCT02636348|Calcium|calcium|mesh-list
25223911|NCT02636348|Vitamins|vitamins|mesh-ancestor
25223912|NCT02636348|Micronutrients|micronutrients|mesh-ancestor
25223913|NCT02636348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223914|NCT02636348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25680262|NCT01848041|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25680263|NCT01848041|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25680264|NCT01848041|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25680265|NCT01848041|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25017878|NCT03703089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25017879|NCT03703089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25017880|NCT03703089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25017881|NCT03703089|Immunologic Factors|immunologic factors|mesh-ancestor
25017882|NCT03703089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25111045|NCT05272826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25111047|NCT05265650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25111048|NCT05265650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25111049|NCT05265650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25106271|NCT03573817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106272|NCT03573817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25106273|NCT03573817|Respiratory System Agents|respiratory system agents|mesh-ancestor
25106274|NCT03573817|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25223915|NCT02636348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24837082|NCT02188615|Mitosis Modulators|mitosis modulators|mesh-ancestor
24837083|NCT02188615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837084|NCT02188654|Metformin|metformin|mesh-list
24837085|NCT02188654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24576932|NCT00841061|Trace Elements|trace elements|mesh-ancestor
24576933|NCT00841061|Micronutrients|micronutrients|mesh-ancestor
24576934|NCT00841061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091699|NCT03247413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25091700|NCT03247413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25091701|NCT03247413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25091702|NCT03247140|Amlodipine|amlodipine|mesh-list
25091703|NCT03247140|Telmisartan|telmisartan|mesh-list
25091725|NCT03247400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091726|NCT03247400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25091727|NCT03247400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25091728|NCT03247400|Antimetabolites|antimetabolites|mesh-ancestor
25091729|NCT03247400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091738|NCT03247296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25091739|NCT03247257|Lidocaine|lidocaine|mesh-list
25091740|NCT03247257|Anesthetics|anesthetics|mesh-list
25091741|NCT03247257|Propofol|propofol|mesh-list
25091742|NCT03247257|Anesthetics, Local|anesthetics, local|mesh-ancestor
25091743|NCT03247257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25091744|NCT03247257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680266|NCT01848041|Adrenergic Agents|adrenergic agents|mesh-ancestor
25680267|NCT01848041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25680268|NCT01848041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680269|NCT01848041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680270|NCT01848041|Sympathomimetics|sympathomimetics|mesh-ancestor
25680271|NCT01848041|Autonomic Agents|autonomic agents|mesh-ancestor
25680272|NCT01848041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25680273|NCT01848041|Nasal Decongestants|nasal decongestants|mesh-ancestor
25680274|NCT01848041|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25680275|NCT01848041|Respiratory System Agents|respiratory system agents|mesh-ancestor
25680276|NCT01848041|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25680277|NCT01848041|Mydriatics|mydriatics|mesh-ancestor
25680278|NCT01848041|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25091745|NCT03247257|Sensory System Agents|sensory system agents|mesh-ancestor
25091746|NCT03247257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25091747|NCT03247257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25091748|NCT03247257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24768066|NCT01805570|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25091749|NCT03247257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25091750|NCT03247257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25223916|NCT02636101|Betamethasone|betamethasone|mesh-list
25223917|NCT02636101|Betamethasone Valerate|betamethasone valerate|mesh-list
25223918|NCT02636101|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25223919|NCT02636101|Betamethasone benzoate|betamethasone benzoate|mesh-list
25223920|NCT02636101|Calcipotriene|calcipotriene|mesh-list
25223921|NCT02636101|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25223922|NCT02636101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25223923|NCT02636101|Glucocorticoids|glucocorticoids|mesh-ancestor
25223924|NCT02636101|Hormones|hormones|mesh-ancestor
25223925|NCT02636101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25223926|NCT02636101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223927|NCT02636101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25223928|NCT02636101|Respiratory System Agents|respiratory system agents|mesh-ancestor
25223929|NCT02636101|Dermatologic Agents|dermatologic agents|mesh-ancestor
25223930|NCT02636088|Cetuximab|cetuximab|mesh-list
25223931|NCT02636088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24860176|NCT02307864|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24860177|NCT02307864|Contraceptive Agents|contraceptive agents|mesh-ancestor
24860178|NCT02307864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25223932|NCT02636088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223933|NCT02635841|Deferiprone|deferiprone|mesh-list
25223934|NCT02635841|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25223935|NCT02635841|Chelating Agents|chelating agents|mesh-ancestor
25223936|NCT02635841|Sequestering Agents|sequestering agents|mesh-ancestor
25223937|NCT02635841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223938|NCT02635802|Lidocaine|lidocaine|mesh-list
24837090|NCT02188771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837091|NCT02188771|Viscosupplements|viscosupplements|mesh-ancestor
24837092|NCT02188771|Protective Agents|protective agents|mesh-ancestor
24837093|NCT02188810|Vaccines|vaccines|mesh-list
24411896|NCT00190333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411898|NCT00190333|Serotonin Agents|serotonin agents|mesh-ancestor
24411899|NCT00190333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411900|NCT00190333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24411901|NCT00190333|Antidepressive Agents|antidepressive agents|mesh-ancestor
24411902|NCT00190333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24411903|NCT00190372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
24411905|NCT00190372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411939|NCT00190476|Mitosis Modulators|mitosis modulators|mesh-ancestor
24411940|NCT00190476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411941|NCT00190489|Docetaxel|docetaxel|mesh-list
25091751|NCT03247257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091752|NCT03247257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25091753|NCT03247257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25091755|NCT03247218|Memantine|memantine|mesh-list
25091756|NCT03247218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25091757|NCT03247218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25091758|NCT03247218|Dopamine Agents|dopamine agents|mesh-ancestor
25091759|NCT03247218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25091760|NCT03247218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091761|NCT03247218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680279|NCT01848041|Protective Agents|protective agents|mesh-ancestor
25680280|NCT01848054|Buprenorphine|buprenorphine|mesh-list
25680281|NCT01848054|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25680282|NCT01848054|Naloxone|naloxone|mesh-list
25680283|NCT01848054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25680284|NCT01848054|Narcotics|narcotics|mesh-ancestor
25680285|NCT01848054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25680286|NCT01848054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091772|NCT03246776|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25091773|NCT03246776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25091774|NCT03246776|Antimetabolites|antimetabolites|mesh-ancestor
25091775|NCT03246776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411942|NCT00190489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411943|NCT00190489|Tubulin Modulators|tubulin modulators|mesh-ancestor
24411944|NCT00190489|Antimitotic Agents|antimitotic agents|mesh-ancestor
24411945|NCT00190489|Mitosis Modulators|mitosis modulators|mesh-ancestor
24411946|NCT00190489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411948|NCT00190502|Immunologic Factors|immunologic factors|mesh-ancestor
24756759|NCT01735383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25091776|NCT03246776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25091777|NCT03246776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25091780|NCT03246776|Hormones|hormones|mesh-ancestor
25223939|NCT02635802|Midazolam|midazolam|mesh-list
25223940|NCT02635802|Remifentanil|remifentanil|mesh-list
25223941|NCT02635802|Anesthetics, Local|anesthetics, local|mesh-ancestor
25223942|NCT02635802|Anesthetics|anesthetics|mesh-ancestor
25223943|NCT02635802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25223944|NCT02635802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223945|NCT02635802|Sensory System Agents|sensory system agents|mesh-ancestor
25223946|NCT02635802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25223947|NCT02635802|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25223948|NCT02635802|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25091781|NCT03246776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25091782|NCT03246776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091783|NCT03246880|Tadalafil|tadalafil|mesh-list
25091784|NCT03246880|Tamsulosin|tamsulosin|mesh-list
25091785|NCT03246880|Vasodilator Agents|vasodilator agents|mesh-ancestor
25091786|NCT03246880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25091787|NCT03246880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24411995|NCT00190606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24411996|NCT00190606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412002|NCT00190606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24412003|NCT00190606|Antidepressive Agents|antidepressive agents|mesh-ancestor
24412004|NCT00190606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24412005|NCT00190606|Dopamine Agents|dopamine agents|mesh-ancestor
24412006|NCT00190619|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24412007|NCT00190619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25223949|NCT02635802|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25223950|NCT02635802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25223951|NCT02635802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680287|NCT01848054|Analgesics|analgesics|mesh-ancestor
25680288|NCT01848054|Sensory System Agents|sensory system agents|mesh-ancestor
25680289|NCT01848054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25680290|NCT01848054|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25680291|NCT01848067|Prednisone|prednisone|mesh-list
25680292|NCT01848067|Abiraterone Acetate|abiraterone acetate|mesh-list
25680293|NCT01848067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25680294|NCT01848067|Glucocorticoids|glucocorticoids|mesh-ancestor
25223952|NCT02635802|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25223953|NCT02635802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25223954|NCT02635802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25223955|NCT02635802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25223956|NCT02635802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25223957|NCT02635802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25223958|NCT02635802|Anesthetics, General|anesthetics, general|mesh-ancestor
25223959|NCT02635802|GABA Modulators|gaba modulators|mesh-ancestor
25223960|NCT02635802|GABA Agents|gaba agents|mesh-ancestor
25223961|NCT02635802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25223962|NCT02635802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25223963|NCT02635802|Narcotics|narcotics|mesh-ancestor
25223964|NCT02635802|Analgesics|analgesics|mesh-ancestor
25223965|NCT02635971|Gemcitabine|gemcitabine|mesh-list
25223966|NCT02635971|Oxaliplatin|oxaliplatin|mesh-list
25223967|NCT02635971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25223968|NCT02635971|Antimetabolites|antimetabolites|mesh-ancestor
25223969|NCT02635971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223970|NCT02635971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223971|NCT02635971|Antiviral Agents|antiviral agents|mesh-ancestor
25223972|NCT02635971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25223973|NCT02635971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25223974|NCT02635971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25223975|NCT02635971|Immunologic Factors|immunologic factors|mesh-ancestor
25043113|NCT01324466|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
25043114|NCT01324466|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
25043115|NCT01324466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043116|NCT01324466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043117|NCT01323205|Antipsychotic Agents|antipsychotic agents|mesh-list
24837123|NCT02189304|Respiratory System Agents|respiratory system agents|mesh-ancestor
24837124|NCT02189304|Glucocorticoids|glucocorticoids|mesh-ancestor
25055799|NCT03517930|Antipruritics|antipruritics|mesh-ancestor
24412008|NCT00190619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412010|NCT00190619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412011|NCT00190619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412020|NCT00190632|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24412021|NCT00190632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412051|NCT00190710|Antiviral Agents|antiviral agents|mesh-ancestor
24412052|NCT00190710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24412053|NCT00190710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412054|NCT00190710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24412055|NCT00190710|Immunologic Factors|immunologic factors|mesh-ancestor
24412071|NCT00190788|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
24412072|NCT00190788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24412074|NCT00190801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25091790|NCT03246880|Urological Agents|urological agents|mesh-ancestor
25223976|NCT02635971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223977|NCT02635607|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25223978|NCT02635607|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25223979|NCT02635607|Ganirelix|ganirelix|mesh-list
25223980|NCT02635607|Luteolytic Agents|luteolytic agents|mesh-ancestor
25223981|NCT02635607|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25223982|NCT02635607|Contraceptive Agents|contraceptive agents|mesh-ancestor
25223983|NCT02635607|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25223984|NCT02635607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25223985|NCT02635607|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25223986|NCT02635607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25223987|NCT02635607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25223988|NCT02635607|Hormones|hormones|mesh-ancestor
25680295|NCT01848067|Hormones|hormones|mesh-ancestor
25680296|NCT01848067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25680297|NCT01848067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680298|NCT01848067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25680299|NCT01848067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25680300|NCT01848067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25680301|NCT01848067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25680302|NCT01848067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223996|NCT02635750|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25223997|NCT02635750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25223998|NCT02635750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25223999|NCT02635750|Cholinergic Agents|cholinergic agents|mesh-ancestor
25224000|NCT02635750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25224001|NCT02635750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224003|NCT02635750|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25055810|NCT03517930|Autonomic Agents|autonomic agents|mesh-ancestor
25091791|NCT03246880|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25091792|NCT03246880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25091793|NCT03246880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25091794|NCT03246880|Adrenergic Agents|adrenergic agents|mesh-ancestor
25091795|NCT03246880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25091796|NCT03246880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091797|NCT03246555|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25091798|NCT03246555|Perindopril|perindopril|mesh-list
25091800|NCT03246555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25091801|NCT03246555|Diuretics|diuretics|mesh-ancestor
25091802|NCT03246555|Natriuretic Agents|natriuretic agents|mesh-ancestor
25091803|NCT03246555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091804|NCT03246555|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24412102|NCT00190827|Antidepressive Agents|antidepressive agents|mesh-ancestor
24412103|NCT00190827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24412104|NCT00190827|Dopamine Agents|dopamine agents|mesh-ancestor
24412105|NCT00190840|Pemetrexed|pemetrexed|mesh-list
24412106|NCT00190840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985076|NCT03706898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985077|NCT03706898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24985098|NCT03691727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24985099|NCT03691727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412107|NCT00190840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412108|NCT00190840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412109|NCT00190840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24412110|NCT00190840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24412131|NCT00190866|Analgesics|analgesics|mesh-ancestor
24412132|NCT00190866|Sensory System Agents|sensory system agents|mesh-ancestor
24412133|NCT00190866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24412134|NCT00190866|Antidepressive Agents|antidepressive agents|mesh-ancestor
24412135|NCT00190866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24412136|NCT00190866|Dopamine Agents|dopamine agents|mesh-ancestor
24412137|NCT00190879|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24412138|NCT00190879|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24412139|NCT00190879|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412140|NCT00190879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412141|NCT00190879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412142|NCT00190879|Adrenergic Agents|adrenergic agents|mesh-ancestor
25091807|NCT03246555|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25224010|NCT02635893|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25224011|NCT02635893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25224013|NCT02635893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25224014|NCT02635893|Antitubercular Agents|antitubercular agents|mesh-ancestor
25224015|NCT02635893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25224016|NCT02635893|Antimetabolites|antimetabolites|mesh-ancestor
25224017|NCT02635893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837126|NCT02189304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24837128|NCT02189304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24837129|NCT02189304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24837130|NCT02189304|Adrenergic Agents|adrenergic agents|mesh-ancestor
24837131|NCT02189304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24837132|NCT02189304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985103|NCT03647852|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24985105|NCT03647852|Prednisolone acetate|prednisolone acetate|mesh-list
24985106|NCT03647852|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25064740|NCT03457233|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24412184|NCT00190918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985107|NCT03647852|Prednisolone phosphate|prednisolone phosphate|mesh-list
24796159|NCT01948245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796160|NCT01948245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24796161|NCT01948245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24796162|NCT01948245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24860256|NCT02308553|Nintedanib|nintedanib|mesh-list
25224038|NCT02635243|Glucagon|glucagon|mesh-list
25224039|NCT02635243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224040|NCT02635243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25224041|NCT02635243|Hormones|hormones|mesh-ancestor
24472956|NCT00401219|Progestins|progestins|mesh-list
24837133|NCT02189304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24837134|NCT02189304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24837135|NCT02189304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25224061|NCT02635230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25224062|NCT02635230|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25224063|NCT02635230|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25224064|NCT02635230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224065|NCT02635230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25224066|NCT02635230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25224067|NCT02635230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25224068|NCT02635230|Antipyretics|antipyretics|mesh-ancestor
25224069|NCT02635360|Pembrolizumab|pembrolizumab|mesh-list
25224070|NCT02635360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25224071|NCT02635360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25224072|NCT02635282|Fentanyl|fentanyl|mesh-list
25224073|NCT02635282|Midazolam|midazolam|mesh-list
25224074|NCT02635282|Ketamine|ketamine|mesh-list
25224075|NCT02635282|Analgesics|analgesics|mesh-ancestor
25224076|NCT02635282|Sensory System Agents|sensory system agents|mesh-ancestor
25224077|NCT02635282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25224078|NCT02635282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224079|NCT02635282|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24837171|NCT02189395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837173|NCT02189577|Bromides|bromides|mesh-list
25018135|NCT03701672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018136|NCT03701672|Sensory System Agents|sensory system agents|mesh-ancestor
25018137|NCT03701672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018138|NCT03701581|4-Aminopyridine|4-aminopyridine|mesh-list
25018139|NCT03701581|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25018140|NCT03701581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25055893|NCT03517033|Nebivolol|nebivolol|mesh-list
24412215|NCT00190996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412216|NCT00190996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412217|NCT00190996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412218|NCT00190996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412219|NCT00190996|Analgesics|analgesics|mesh-ancestor
24412220|NCT00190996|Sensory System Agents|sensory system agents|mesh-ancestor
24412221|NCT00190996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24412222|NCT00190996|Antidepressive Agents|antidepressive agents|mesh-ancestor
24412223|NCT00190996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24412224|NCT00190996|Dopamine Agents|dopamine agents|mesh-ancestor
24412225|NCT00191009|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24412226|NCT00191009|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24412227|NCT00191009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412228|NCT00191009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412229|NCT00191009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412230|NCT00191009|Adrenergic Agents|adrenergic agents|mesh-ancestor
24412231|NCT00191009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412232|NCT00191009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412234|NCT00191022|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25091837|NCT03246620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25091838|NCT03246620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25091839|NCT03246620|Anesthetics, General|anesthetics, general|mesh-ancestor
25091841|NCT03246620|GABA Modulators|gaba modulators|mesh-ancestor
25091842|NCT03246620|GABA Agents|gaba agents|mesh-ancestor
25091843|NCT03246659|Polygeline|polygeline|mesh-list
25091844|NCT03246659|Gastrins|gastrins|mesh-list
25091845|NCT03246659|Plasma Substitutes|plasma substitutes|mesh-ancestor
25091846|NCT03246659|Blood Substitutes|blood substitutes|mesh-ancestor
25091847|NCT03246659|Hormones|hormones|mesh-ancestor
25091848|NCT03246659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25091849|NCT03246659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091850|NCT03246685|Pembrolizumab|pembrolizumab|mesh-list
25091851|NCT03246685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25091852|NCT03246685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768196|NCT01806324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224080|NCT02635282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25224081|NCT02635282|Anesthetics, General|anesthetics, general|mesh-ancestor
25224082|NCT02635282|Anesthetics|anesthetics|mesh-ancestor
25224083|NCT02635282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25224084|NCT02635282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25224085|NCT02635282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25224086|NCT02635282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25224087|NCT02635282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224088|NCT02635282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25224089|NCT02635282|Narcotics|narcotics|mesh-ancestor
25224090|NCT02635282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25224091|NCT02635282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25224092|NCT02635282|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25224093|NCT02635282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25224094|NCT02635282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25224095|NCT02635282|GABA Modulators|gaba modulators|mesh-ancestor
25224096|NCT02635282|GABA Agents|gaba agents|mesh-ancestor
25224097|NCT02635074|Cytarabine|cytarabine|mesh-list
25680303|NCT01848067|Hormone Antagonists|hormone antagonists|mesh-ancestor
25680304|NCT01848067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25680305|NCT01848145|Ofatumumab|ofatumumab|mesh-list
25680306|NCT01848145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25680307|NCT01848210|Troxerutin|troxerutin|mesh-list
25680308|NCT01848210|Anticoagulants|anticoagulants|mesh-ancestor
25680309|NCT01848457|Methotrexate|methotrexate|mesh-list
25680310|NCT01848457|Pantoprazole|pantoprazole|mesh-list
25680311|NCT01848457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25680312|NCT01848457|Abortifacient Agents|abortifacient agents|mesh-ancestor
24540131|NCT00666692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24540132|NCT00666692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25091853|NCT03246581|Tiotropium Bromide|tiotropium bromide|mesh-list
25091854|NCT03246581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25091855|NCT03246581|Autonomic Agents|autonomic agents|mesh-ancestor
25091856|NCT03246581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24412278|NCT00191087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412279|NCT00191087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412287|NCT00191087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24412288|NCT00191087|Dopamine Agents|dopamine agents|mesh-ancestor
24412289|NCT00191126|Gemcitabine|gemcitabine|mesh-list
24412290|NCT00191126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25091857|NCT03246581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091858|NCT03246581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25091859|NCT03246581|Respiratory System Agents|respiratory system agents|mesh-ancestor
25091860|NCT03246581|Parasympatholytics|parasympatholytics|mesh-ancestor
25091862|NCT03246581|Cholinergic Agents|cholinergic agents|mesh-ancestor
25091863|NCT03246581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25091864|NCT03246581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091866|NCT03246386|Antifungal Agents|antifungal agents|mesh-ancestor
25091867|NCT03246386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25091868|NCT03246386|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25091869|NCT03246386|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25091870|NCT03246386|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24985149|NCT03629327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25091871|NCT03246386|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25091872|NCT03246386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25091873|NCT03246386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091874|NCT03246386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091875|NCT03246386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25091876|NCT03246386|Hormone Antagonists|hormone antagonists|mesh-ancestor
25091877|NCT03246386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25091878|NCT03246386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091880|NCT03246451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25091881|NCT03246451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091882|NCT03246360|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25091883|NCT03246360|Cloxacillin|cloxacillin|mesh-list
24412339|NCT00191243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412340|NCT00191243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412341|NCT00191243|Antiviral Agents|antiviral agents|mesh-ancestor
24412342|NCT00191243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24412343|NCT00191243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412344|NCT00191243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25224098|NCT02635074|Idarubicin|idarubicin|mesh-list
25680313|NCT01848457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25680314|NCT01848457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680315|NCT01848457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25680316|NCT01848457|Antimetabolites|antimetabolites|mesh-ancestor
25680317|NCT01848457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680318|NCT01848457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25224100|NCT02635074|Antimetabolites|antimetabolites|mesh-ancestor
25224101|NCT02635074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224102|NCT02635074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25055903|NCT03517020|Nebivolol|nebivolol|mesh-list
24412345|NCT00191243|Immunologic Factors|immunologic factors|mesh-ancestor
24412346|NCT00191243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412347|NCT00191243|Tubulin Modulators|tubulin modulators|mesh-ancestor
24412348|NCT00191243|Antimitotic Agents|antimitotic agents|mesh-ancestor
24412349|NCT00191243|Mitosis Modulators|mitosis modulators|mesh-ancestor
24412350|NCT00191256|Gemcitabine|gemcitabine|mesh-list
24412351|NCT00191256|Paclitaxel|paclitaxel|mesh-list
24412352|NCT00191256|Carboplatin|carboplatin|mesh-list
24412353|NCT00191256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24412354|NCT00191256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25091884|NCT03246360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25091885|NCT03246295|Insulin|insulin|mesh-list
25091886|NCT03246295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25091887|NCT03246295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091888|NCT03246009|Lenograstim|lenograstim|mesh-list
25091889|NCT03246009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25091900|NCT03245853|Flavin Mononucleotide|flavin mononucleotide|mesh-list
25091901|NCT03245853|Vitamin B Complex|vitamin b complex|mesh-ancestor
25091902|NCT03245853|Vitamins|vitamins|mesh-ancestor
25091903|NCT03245853|Micronutrients|micronutrients|mesh-ancestor
25091904|NCT03245853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091905|NCT03245853|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25091906|NCT03245853|Dermatologic Agents|dermatologic agents|mesh-ancestor
25091907|NCT03245970|Atenolol|atenolol|mesh-list
25091908|NCT03245970|Labetalol|labetalol|mesh-list
25091909|NCT03245970|Nifedipine|nifedipine|mesh-list
25091914|NCT03245970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091916|NCT03245970|Tocolytic Agents|tocolytic agents|mesh-ancestor
25091917|NCT03245970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25091918|NCT03245970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25091919|NCT03245970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24412382|NCT00191347|Antimetabolites|antimetabolites|mesh-ancestor
24412383|NCT00191347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091920|NCT03245970|Sympatholytics|sympatholytics|mesh-ancestor
25091921|NCT03245970|Autonomic Agents|autonomic agents|mesh-ancestor
25091922|NCT03245970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25091923|NCT03245970|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25091924|NCT03245970|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25091925|NCT03245970|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25091926|NCT03245970|Adrenergic Agents|adrenergic agents|mesh-ancestor
25091927|NCT03245970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25091928|NCT03245970|Sympathomimetics|sympathomimetics|mesh-ancestor
25091929|NCT03245970|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24768269|NCT01806948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25224103|NCT02635074|Antiviral Agents|antiviral agents|mesh-ancestor
25224104|NCT02635074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25224105|NCT02635074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25224106|NCT02635074|Immunologic Factors|immunologic factors|mesh-ancestor
25224107|NCT02635074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224108|NCT02635074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25224109|NCT02635074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25224110|NCT02635074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25224111|NCT02635074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25224112|NCT02635191|Amoxicillin|amoxicillin|mesh-list
25224113|NCT02635191|Metronidazole|metronidazole|mesh-list
25224114|NCT02635191|Clarithromycin|clarithromycin|mesh-list
25224115|NCT02635191|Esomeprazole|esomeprazole|mesh-list
25224116|NCT02635191|Omeprazole|omeprazole|mesh-list
25091939|NCT03245996|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25091940|NCT03245996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25091941|NCT03245996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25091942|NCT03245996|Adrenergic Agents|adrenergic agents|mesh-ancestor
25091943|NCT03245996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25091944|NCT03245996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091945|NCT03245996|Vasodilator Agents|vasodilator agents|mesh-ancestor
24412384|NCT00191347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412385|NCT00191347|Antiviral Agents|antiviral agents|mesh-ancestor
24412386|NCT00191347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24412387|NCT00191347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412394|NCT00191373|Trastuzumab|trastuzumab|mesh-list
25091946|NCT03245996|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25091947|NCT03245996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25091948|NCT03245996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25091950|NCT03245658|Analgesics|analgesics|mesh-ancestor
25091951|NCT03245658|Sensory System Agents|sensory system agents|mesh-ancestor
25091952|NCT03245658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25091953|NCT03245658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091954|NCT03245671|Dexamethasone|dexamethasone|mesh-list
25091962|NCT03245671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25091963|NCT03245671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091964|NCT03245671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25091965|NCT03245671|Glucocorticoids|glucocorticoids|mesh-ancestor
25091966|NCT03245671|Hormones|hormones|mesh-ancestor
25091967|NCT03245671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25091968|NCT03245671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25091969|NCT03245671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25091970|NCT03245671|Protease Inhibitors|protease inhibitors|mesh-ancestor
25091971|NCT03245671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091972|NCT03245671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091973|NCT03245671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25091974|NCT03245671|Immunologic Factors|immunologic factors|mesh-ancestor
25091975|NCT03245515|Branebrutinib|branebrutinib|mesh-list
25091976|NCT03245515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25091977|NCT03245515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091978|NCT03245515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091979|NCT03245528|Angiotensin II|angiotensin ii|mesh-list
25091980|NCT03245528|Giapreza|giapreza|mesh-list
25091981|NCT03245528|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24465797|NCT00370747|Ecabet|ecabet|mesh-list
24412456|NCT00191438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091982|NCT03245424|Ivosidenib|ivosidenib|mesh-list
25091983|NCT03245424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25091984|NCT03245424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25224117|NCT02635191|Rabeprazole|rabeprazole|mesh-list
25224118|NCT02635191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25224119|NCT02635191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25224120|NCT02635191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24837200|NCT02189720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24837201|NCT02189720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837203|NCT02189772|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24837204|NCT02190058|DS-1971a|ds-1971a|mesh-list
24837205|NCT02190058|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24837206|NCT02190058|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24837207|NCT02190058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25091985|NCT03245424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091986|NCT03245554|Propranolol|propranolol|mesh-list
25091987|NCT03245554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25018313|NCT03700229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018315|NCT03700177|Dexamethasone|dexamethasone|mesh-list
25018316|NCT03700177|Ropivacaine|ropivacaine|mesh-list
25018317|NCT03700177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25018318|NCT03700177|Antiemetics|antiemetics|mesh-ancestor
25018319|NCT03700177|Autonomic Agents|autonomic agents|mesh-ancestor
25018320|NCT03700177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018321|NCT03700177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091988|NCT03245554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25091989|NCT03245554|Adrenergic Agents|adrenergic agents|mesh-ancestor
24412461|NCT00191464|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24412463|NCT00191464|Insulin Glargine|insulin glargine|mesh-list
24412464|NCT00191464|Insulin Lispro|insulin lispro|mesh-list
24412465|NCT00191464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24412552|NCT00191594|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24412639|NCT00191698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412640|NCT00191698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412641|NCT00191698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412643|NCT00191698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412644|NCT00191698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412646|NCT00191711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24412647|NCT00191711|Antimetabolites|antimetabolites|mesh-ancestor
24412648|NCT00191711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412649|NCT00191711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412650|NCT00191711|Antiviral Agents|antiviral agents|mesh-ancestor
25091995|NCT03245554|Vasodilator Agents|vasodilator agents|mesh-ancestor
25091999|NCT03245177|Pembrolizumab|pembrolizumab|mesh-list
25092000|NCT03245177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25224121|NCT02635191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25224122|NCT02635191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25224123|NCT02635191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25224124|NCT02635191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25224125|NCT02635191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25224126|NCT02635191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224127|NCT02635191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25224128|NCT02635191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25224129|NCT02635191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24837213|NCT02190305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837214|NCT02190318|Losartan|losartan|mesh-list
24837215|NCT02190318|Spironolactone|spironolactone|mesh-list
24837216|NCT02190318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25023226|NCT03656627|Nivolumab|nivolumab|mesh-list
24837217|NCT02190318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24939318|NCT04011098|Fentanyl|fentanyl|mesh-list
25092001|NCT03245177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25092002|NCT03245229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25092003|NCT03245229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24465934|NCT00371124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24465935|NCT00371124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412684|NCT00191802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24412697|NCT00191828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25092005|NCT03245229|Antimetabolites|antimetabolites|mesh-ancestor
25092006|NCT03245229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092007|NCT03245229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25680319|NCT01848457|Dermatologic Agents|dermatologic agents|mesh-ancestor
25680320|NCT01848457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25680321|NCT01848457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25680322|NCT01848457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25680323|NCT01848457|Immunologic Factors|immunologic factors|mesh-ancestor
25680324|NCT01848457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25680325|NCT01848457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25680326|NCT01848457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25680327|NCT01848457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25018406|NCT03699384|Azacitidine|azacitidine|mesh-list
25092008|NCT03245229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25092009|NCT03245229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092010|NCT03245385|Halobetasol|halobetasol|mesh-list
25092011|NCT03245385|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25092013|NCT03245333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25092014|NCT03245333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092016|NCT03245307|Nifedipine|nifedipine|mesh-list
25092017|NCT03245307|Warfarin|warfarin|mesh-list
25092018|NCT03245307|Anticoagulants|anticoagulants|mesh-ancestor
25273234|NCT02386462|Adrenergic Agents|adrenergic agents|mesh-ancestor
25273235|NCT02386462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25273236|NCT02386462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273237|NCT02386449|Mannitol|mannitol|mesh-list
25273238|NCT02386449|Bisacodyl|bisacodyl|mesh-list
25273239|NCT02386449|Picosulfate sodium|picosulfate sodium|mesh-list
25273240|NCT02386449|Magnesium Oxide|magnesium oxide|mesh-list
24985263|NCT03535688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273241|NCT02386449|Citric Acid|citric acid|mesh-list
25273242|NCT02386449|Sodium Citrate|sodium citrate|mesh-list
25273243|NCT02386449|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25273244|NCT02386449|Diuretics|diuretics|mesh-ancestor
24837218|NCT02190318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24837219|NCT02190318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24837220|NCT02190318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837221|NCT02190318|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24837222|NCT02190318|Hormone Antagonists|hormone antagonists|mesh-ancestor
24837223|NCT02190318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24412698|NCT00191828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412699|NCT00191828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412700|NCT00191828|Serotonin Agents|serotonin agents|mesh-ancestor
24412701|NCT00191841|Gemcitabine|gemcitabine|mesh-list
24412702|NCT00191841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412703|NCT00191841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24412773|NCT00191997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24412810|NCT00192062|Tubulin Modulators|tubulin modulators|mesh-ancestor
24412811|NCT00192062|Antimitotic Agents|antimitotic agents|mesh-ancestor
24412812|NCT00192062|Mitosis Modulators|mitosis modulators|mesh-ancestor
24412813|NCT00192088|Oxaliplatin|oxaliplatin|mesh-list
24412815|NCT00192088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412816|NCT00192088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412817|NCT00192088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412818|NCT00192088|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24412819|NCT00192088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24412820|NCT00192101|Gemcitabine|gemcitabine|mesh-list
24757358|NCT01739439|Immunologic Factors|immunologic factors|mesh-ancestor
24412948|NCT00192673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412949|NCT00192712|Gemcitabine|gemcitabine|mesh-list
24412950|NCT00192712|Irinotecan|irinotecan|mesh-list
24412951|NCT00192712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24412952|NCT00192712|Antimetabolites|antimetabolites|mesh-ancestor
24412953|NCT00192712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412954|NCT00192712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412955|NCT00192712|Antiviral Agents|antiviral agents|mesh-ancestor
24412956|NCT00192712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24412957|NCT00192712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412958|NCT00192712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24412959|NCT00192712|Immunologic Factors|immunologic factors|mesh-ancestor
24412960|NCT00192712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412962|NCT00192712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24412963|NCT00192725|Tryptophan|tryptophan|mesh-list
24412964|NCT00192725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25092019|NCT03245307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25092020|NCT03245307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25092021|NCT03245307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092022|NCT03245307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092023|NCT03245307|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25092024|NCT03245307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25092025|NCT03245307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25092026|NCT03245307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092027|NCT03245307|Vasodilator Agents|vasodilator agents|mesh-ancestor
25092028|NCT03245307|Tocolytic Agents|tocolytic agents|mesh-ancestor
25092029|NCT03245307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24412965|NCT00192725|Antidepressive Agents|antidepressive agents|mesh-ancestor
24413005|NCT00192842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25224135|NCT02634970|Ranibizumab|ranibizumab|mesh-list
25224136|NCT02634970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25224137|NCT02634970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25224138|NCT02634970|Growth Substances|growth substances|mesh-ancestor
25224139|NCT02634970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224140|NCT02634970|Growth Inhibitors|growth inhibitors|mesh-ancestor
25224141|NCT02634970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25224142|NCT02634723|Factor VIII|factor viii|mesh-list
24444536|NCT00298415|Vinorelbine|vinorelbine|mesh-list
24837234|NCT02190526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24837235|NCT02190526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24837236|NCT02190526|Analgesics|analgesics|mesh-ancestor
24837237|NCT02190526|Sensory System Agents|sensory system agents|mesh-ancestor
24837238|NCT02190526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24837239|NCT02190526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837240|NCT02190526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24837241|NCT02190526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24837242|NCT02190526|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24413007|NCT00192855|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24413008|NCT00192855|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24413009|NCT00192855|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24413010|NCT00192855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413011|NCT00192855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413012|NCT00192959|Propofol|propofol|mesh-list
24413013|NCT00192959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24985315|NCT03476642|Anesthetics, Local|anesthetics, local|mesh-ancestor
24413154|NCT00193193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413155|NCT00193193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24413157|NCT00193193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24413159|NCT00193232|Bortezomib|bortezomib|mesh-list
24413160|NCT00193232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413161|NCT00193232|Tubulin Modulators|tubulin modulators|mesh-ancestor
24413162|NCT00193232|Antimitotic Agents|antimitotic agents|mesh-ancestor
24413163|NCT00193232|Mitosis Modulators|mitosis modulators|mesh-ancestor
25092034|NCT03245281|Diuretics|diuretics|mesh-list
25092035|NCT03245281|Natriuretic Agents|natriuretic agents|mesh-ancestor
25092036|NCT03245281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092037|NCT03245190|Chiauranib|chiauranib|mesh-list
25092038|NCT03245190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25092039|NCT03245190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25092040|NCT03245190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092041|NCT03245190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092042|NCT03245346|Anesthetics|anesthetics|mesh-list
25092043|NCT03245346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25092044|NCT03245346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768384|NCT01807611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092054|NCT03244956|Trametinib|trametinib|mesh-list
25092055|NCT03244956|Dabrafenib|dabrafenib|mesh-list
25092056|NCT03244956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25224143|NCT02634723|Coagulants|coagulants|mesh-ancestor
25224144|NCT02634541|Adalimumab|adalimumab|mesh-list
25224153|NCT02634489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25273245|NCT02386449|Natriuretic Agents|natriuretic agents|mesh-ancestor
24413237|NCT00193336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413238|NCT00193336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24413239|NCT00193336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413240|NCT00193336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413241|NCT00193349|Carboplatin|carboplatin|mesh-list
24413242|NCT00193349|Irinotecan|irinotecan|mesh-list
24413263|NCT00193362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25092067|NCT03244774|Antimitotic Agents|antimitotic agents|mesh-ancestor
25092068|NCT03244774|Mitosis Modulators|mitosis modulators|mesh-ancestor
25092069|NCT03244774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092070|NCT03244774|Antimetabolites|antimetabolites|mesh-ancestor
25680328|NCT01848457|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25680329|NCT01848834|Pembrolizumab|pembrolizumab|mesh-list
25680330|NCT01848834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25680331|NCT01848834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25092071|NCT03244774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25092072|NCT03244774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25092073|NCT03244774|Immunologic Factors|immunologic factors|mesh-ancestor
25092074|NCT03244774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092075|NCT03244774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25092076|NCT03244774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092077|NCT03244930|Plerixafor|plerixafor|mesh-list
25092078|NCT03244930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24413264|NCT00193362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413265|NCT00193362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24413266|NCT00193362|Immunologic Factors|immunologic factors|mesh-ancestor
24413267|NCT00193362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413269|NCT00193388|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24413270|NCT00193388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24413271|NCT00193388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413272|NCT00193388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413273|NCT00193388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413274|NCT00193401|Topotecan|topotecan|mesh-list
24985313|NCT03476642|Epinephrine|epinephrine|mesh-list
24985314|NCT03476642|Ropivacaine|ropivacaine|mesh-list
24413275|NCT00193401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24413276|NCT00193401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24413338|NCT00193570|Docetaxel|docetaxel|mesh-list
24413339|NCT00193570|Topotecan|topotecan|mesh-list
24413340|NCT00193570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413341|NCT00193570|Tubulin Modulators|tubulin modulators|mesh-ancestor
25092080|NCT03244930|Antiviral Agents|antiviral agents|mesh-ancestor
25092081|NCT03244930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25092082|NCT03244592|Minocycline|minocycline|mesh-list
25092083|NCT03244592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25092084|NCT03244592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25092085|NCT03244488|Mecamylamine|mecamylamine|mesh-list
25092086|NCT03244488|Scopolamine|scopolamine|mesh-list
25224154|NCT02634489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092100|NCT03244488|Parasympatholytics|parasympatholytics|mesh-ancestor
25092101|NCT03244488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25092102|NCT03244488|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
25092103|NCT03244488|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25092104|NCT03244319|Warfarin|warfarin|mesh-list
25092105|NCT03244319|Edoxaban|edoxaban|mesh-list
25092106|NCT03244319|Anticoagulants|anticoagulants|mesh-list
25092107|NCT03244319|Coagulants|coagulants|mesh-list
25092108|NCT03244319|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25092109|NCT03244319|Antithrombins|antithrombins|mesh-ancestor
25092110|NCT03244319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25092111|NCT03244319|Protease Inhibitors|protease inhibitors|mesh-ancestor
25092126|NCT03244423|Tranexamic Acid|tranexamic acid|mesh-list
25092127|NCT03244423|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24768454|NCT01808300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25092128|NCT03244423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25092129|NCT03244423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768529|NCT01808768|Histamine Agents|histamine agents|mesh-ancestor
25092130|NCT03244423|Hemostatics|hemostatics|mesh-ancestor
25092131|NCT03244423|Coagulants|coagulants|mesh-ancestor
25092132|NCT03244358|Epalrestat|epalrestat|mesh-list
25092133|NCT03244358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092134|NCT03244358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092135|NCT03244462|Methotrexate|methotrexate|mesh-list
25092136|NCT03244462|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25092137|NCT03244462|Abortifacient Agents|abortifacient agents|mesh-ancestor
25092138|NCT03244462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25092139|NCT03244462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680332|NCT01848899|Bivalirudin|bivalirudin|mesh-list
25680333|NCT01848899|Antithrombins|antithrombins|mesh-ancestor
25092140|NCT03244462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25092144|NCT03244462|Dermatologic Agents|dermatologic agents|mesh-ancestor
25092145|NCT03244462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092146|NCT03244462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25092147|NCT03244462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25092148|NCT03244462|Immunologic Factors|immunologic factors|mesh-ancestor
25092149|NCT03244462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25018693|NCT03697746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25018698|NCT03697746|Antipyretics|antipyretics|mesh-ancestor
25092150|NCT03244462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25092151|NCT03244540|Acetaminophen|acetaminophen|mesh-list
25092152|NCT03244540|Dipyrone|dipyrone|mesh-list
25092153|NCT03244540|Ketoprofen|ketoprofen|mesh-list
25092154|NCT03244540|Bupivacaine|bupivacaine|mesh-list
25092155|NCT03244540|Ropivacaine|ropivacaine|mesh-list
25092156|NCT03244540|Anesthetics, Local|anesthetics, local|mesh-ancestor
24413443|NCT00193882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413444|NCT00193882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25092165|NCT03244540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25092166|NCT03244540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25092168|NCT03244540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25092169|NCT03244540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092170|NCT03244540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784833|NCT01910480|Hormone Antagonists|hormone antagonists|mesh-ancestor
24784834|NCT01910480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24784837|NCT01910506|Verinurad|verinurad|mesh-list
25092179|NCT03244241|Insulin|insulin|mesh-list
25092180|NCT03244241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25224156|NCT02634489|Urological Agents|urological agents|mesh-ancestor
25224157|NCT02634489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25224158|NCT02634489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25224159|NCT02634489|Cholinergic Agents|cholinergic agents|mesh-ancestor
25224160|NCT02634476|Ethanol|ethanol|mesh-list
24837256|NCT02190695|Antimetabolites|antimetabolites|mesh-ancestor
24837257|NCT02190695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092181|NCT03244241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092182|NCT03243903|Insulin|insulin|mesh-list
25092183|NCT03243903|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25092184|NCT03243903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25092185|NCT03243903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413446|NCT00193882|Immunologic Factors|immunologic factors|mesh-ancestor
24413447|NCT00193882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092207|NCT03243851|Metformin|metformin|mesh-list
25092208|NCT03243851|Temozolomide|temozolomide|mesh-list
25092209|NCT03243851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25092210|NCT03243851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092211|NCT03243851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25092212|NCT03243851|Alkylating Agents|alkylating agents|mesh-ancestor
25092213|NCT03243851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092214|NCT03243851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25092215|NCT03243552|Levodopa|levodopa|mesh-list
25092216|NCT03243552|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25092249|NCT03243604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25092250|NCT03243604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092251|NCT03243331|Gedatolisib|gedatolisib|mesh-list
25092252|NCT03243331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25092253|NCT03243331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092254|NCT03243331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092255|NCT03243344|Surgiflo|surgiflo|mesh-list
25092256|NCT03243344|Hemostatics|hemostatics|mesh-ancestor
25092257|NCT03243344|Coagulants|coagulants|mesh-ancestor
25092258|NCT03243175|Apixaban|apixaban|mesh-list
25092259|NCT03243175|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25092260|NCT03243175|Antithrombins|antithrombins|mesh-ancestor
25092261|NCT03243175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25092262|NCT03243175|Protease Inhibitors|protease inhibitors|mesh-ancestor
25092263|NCT03243175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413452|NCT00193921|Vinorelbine|vinorelbine|mesh-list
24413453|NCT00193921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413454|NCT00193921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24413455|NCT00193921|Antimetabolites|antimetabolites|mesh-ancestor
24413456|NCT00193921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092276|NCT03243032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25092277|NCT03243032|Anesthetics|anesthetics|mesh-list
25680334|NCT01848899|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25257387|NCT02476799|Narcotics|narcotics|mesh-ancestor
25680335|NCT01848899|Protease Inhibitors|protease inhibitors|mesh-ancestor
25680336|NCT01848899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092278|NCT03243032|Anesthetics, Local|anesthetics, local|mesh-list
25092279|NCT03243032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25680337|NCT01848899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445314|NCT00301210|Analgesics|analgesics|mesh-ancestor
25092280|NCT03243032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224161|NCT02634476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25224162|NCT02634476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25224163|NCT02634476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24837258|NCT02190695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837259|NCT02190708|Midazolam|midazolam|mesh-list
24837260|NCT02190708|Omeprazole|omeprazole|mesh-list
24837261|NCT02190708|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25043118|NCT01323205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25043119|NCT01323205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25043120|NCT01323205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092281|NCT03243032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25092282|NCT03243032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25092283|NCT03243032|Analgesics|analgesics|mesh-ancestor
25092284|NCT03243032|Sensory System Agents|sensory system agents|mesh-ancestor
25092285|NCT03243032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25092286|NCT03243032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25092287|NCT03243032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25092288|NCT03243032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092289|NCT03243032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413497|NCT00194038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413498|NCT00194038|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24413499|NCT00194038|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25092345|NCT03242460|Glucocorticoids|glucocorticoids|mesh-ancestor
24413501|NCT00194038|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24413502|NCT00194038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24413503|NCT00194038|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24413616|NCT00194649|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25092290|NCT03242993|Folic Acid|folic acid|mesh-list
25092291|NCT03242993|Hematinics|hematinics|mesh-ancestor
25092292|NCT03242993|Vitamin B Complex|vitamin b complex|mesh-ancestor
25092293|NCT03242993|Vitamins|vitamins|mesh-ancestor
25092294|NCT03242993|Micronutrients|micronutrients|mesh-ancestor
25092295|NCT03242993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092296|NCT03242967|Darbepoetin alfa|darbepoetin alfa|mesh-list
25092297|NCT03242967|Hematinics|hematinics|mesh-ancestor
25092298|NCT03243006|Acetaminophen|acetaminophen|mesh-list
25092299|NCT03243006|Tramadol|tramadol|mesh-list
25092300|NCT03243006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25092301|NCT03243006|Analgesics|analgesics|mesh-ancestor
25092302|NCT03243006|Sensory System Agents|sensory system agents|mesh-ancestor
25092303|NCT03243006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25092304|NCT03243006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092305|NCT03243006|Antipyretics|antipyretics|mesh-ancestor
25092306|NCT03243006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25092307|NCT03243006|Narcotics|narcotics|mesh-ancestor
25092308|NCT03243006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25092318|NCT03242707|Hyaluronic Acid|hyaluronic acid|mesh-list
25092319|NCT03242707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25092320|NCT03242707|Immunologic Factors|immunologic factors|mesh-ancestor
25092321|NCT03242707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092322|NCT03242707|Viscosupplements|viscosupplements|mesh-ancestor
25092323|NCT03242707|Protective Agents|protective agents|mesh-ancestor
24413617|NCT00194649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24413618|NCT00194649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413619|NCT00194727|Capecitabine|capecitabine|mesh-list
24413620|NCT00194727|Vinorelbine|vinorelbine|mesh-list
24413621|NCT00194727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24413622|NCT00194727|Antimetabolites|antimetabolites|mesh-ancestor
25224164|NCT02634476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224165|NCT02634528|Insulin|insulin|mesh-list
25224166|NCT02634528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25224167|NCT02634528|Insulin, Isophane|insulin, isophane|mesh-list
25224168|NCT02634528|Isophane Insulin, Human|isophane insulin, human|mesh-list
25224169|NCT02634528|Isophane insulin, beef|isophane insulin, beef|mesh-list
25224170|NCT02634528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25043121|NCT01323205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25043122|NCT01321359|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
25680338|NCT01848899|Anticoagulants|anticoagulants|mesh-ancestor
25680339|NCT01848990|Insulin|insulin|mesh-list
25680340|NCT01848990|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25043123|NCT01321359|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
25680341|NCT01848990|Insulin Aspart|insulin aspart|mesh-list
25043124|NCT01321359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055948|NCT03516747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092324|NCT03242629|Chloral Hydrate|chloral hydrate|mesh-list
25092325|NCT03242629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25092326|NCT03242629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25092327|NCT03242629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768754|NCT01810458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25092329|NCT03242460|Cyclophosphamide|cyclophosphamide|mesh-list
25092330|NCT03242460|Pomalidomide|pomalidomide|mesh-list
25092331|NCT03242460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25092340|NCT03242460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25092341|NCT03242460|Antiemetics|antiemetics|mesh-ancestor
25092342|NCT03242460|Autonomic Agents|autonomic agents|mesh-ancestor
25092343|NCT03242460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25092344|NCT03242460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25092346|NCT03242460|Hormones|hormones|mesh-ancestor
25092347|NCT03242460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25092348|NCT03242460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25092349|NCT03242460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25092350|NCT03242460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25092351|NCT03242460|Growth Substances|growth substances|mesh-ancestor
25092352|NCT03242460|Growth Inhibitors|growth inhibitors|mesh-ancestor
25092353|NCT03242499|Lovastatin|lovastatin|mesh-list
25092354|NCT03242499|L 647318|l 647318|mesh-list
25092355|NCT03242499|Dihydromevinolin|dihydromevinolin|mesh-list
25092356|NCT03242499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25092365|NCT03242616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25092366|NCT03242616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092367|NCT03242616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092368|NCT03242616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25092369|NCT03242616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25092370|NCT03242616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25092371|NCT03242616|Tubulin Modulators|tubulin modulators|mesh-ancestor
25092372|NCT03242616|Antimitotic Agents|antimitotic agents|mesh-ancestor
25092373|NCT03242616|Mitosis Modulators|mitosis modulators|mesh-ancestor
25092374|NCT03242317|Mitomycins|mitomycins|mesh-list
25092375|NCT03242317|Mitomycin|mitomycin|mesh-list
25092376|NCT03242317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25092377|NCT03242317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25092378|NCT03242317|Alkylating Agents|alkylating agents|mesh-ancestor
25092379|NCT03242317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092380|NCT03242317|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25092382|NCT03242278|Rivaroxaban|rivaroxaban|mesh-list
25092403|NCT03241875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25092404|NCT03241875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224171|NCT02634528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224172|NCT02634463|Olanzapine|olanzapine|mesh-list
25224173|NCT02634463|Risperidone|risperidone|mesh-list
25224174|NCT02634463|Aripiprazole|aripiprazole|mesh-list
25224175|NCT02634463|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25224176|NCT02634463|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25224177|NCT02634463|Serotonin Agents|serotonin agents|mesh-ancestor
25043125|NCT01321359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043126|NCT01318642|Gemcitabine|gemcitabine|mesh-list
25043127|NCT01318642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25043128|NCT01318642|Antimetabolites|antimetabolites|mesh-ancestor
25043129|NCT01318642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043130|NCT01318642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043131|NCT01318642|Antiviral Agents|antiviral agents|mesh-ancestor
25680342|NCT01848990|Insulin Lispro|insulin lispro|mesh-list
25680343|NCT01848990|Insulin glulisine|insulin glulisine|mesh-list
25680344|NCT01848990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25680345|NCT01848990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680346|NCT01849055|Celecoxib|celecoxib|mesh-list
25680347|NCT01849055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25680348|NCT01849055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25680349|NCT01849055|Analgesics|analgesics|mesh-ancestor
25018898|NCT03695822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018899|NCT03695822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018900|NCT03695822|Urological Agents|urological agents|mesh-ancestor
25018901|NCT03695744|Dexamethasone|dexamethasone|mesh-list
25018902|NCT03695744|Bortezomib|bortezomib|mesh-list
25018903|NCT03695744|Daratumumab|daratumumab|mesh-list
24975343|NCT04080804|Nivolumab|nivolumab|mesh-list
24975344|NCT04080804|Ipilimumab|ipilimumab|mesh-list
25018904|NCT03695744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24975345|NCT04080804|Antibodies|antibodies|mesh-list
25043132|NCT01318642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25043133|NCT01318642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043134|NCT01318642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25092405|NCT03241875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25092406|NCT03241875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25092407|NCT03241875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25092408|NCT03241875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25092409|NCT03241875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25092410|NCT03241875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25092411|NCT03241875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25092412|NCT03241875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25092415|NCT03241901|Artemether|artemether|mesh-list
25092416|NCT03241901|Primaquine|primaquine|mesh-list
24796195|NCT01948401|Hormones|hormones|mesh-ancestor
25092417|NCT03241901|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25092418|NCT03241901|Antimalarials|antimalarials|mesh-ancestor
25092419|NCT03241901|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25092420|NCT03241901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25092421|NCT03241901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25092422|NCT03241914|Megestrol|megestrol|mesh-list
25092423|NCT03241914|Megestrol Acetate|megestrol acetate|mesh-list
25092424|NCT03241914|Levonorgestrel|levonorgestrel|mesh-list
25092425|NCT03241914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25092426|NCT03241914|Contraceptive Agents|contraceptive agents|mesh-ancestor
25092427|NCT03241914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25092428|NCT03241914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092429|NCT03241914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25092430|NCT03241914|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25092431|NCT03241914|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25092432|NCT03241914|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25092433|NCT03241914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25092434|NCT03241914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25092435|NCT03241914|Appetite Stimulants|appetite stimulants|mesh-ancestor
25092436|NCT03241914|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25092437|NCT03241784|Interleukin-2|interleukin-2|mesh-list
25092438|NCT03241784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25092441|NCT03241784|Sensory System Agents|sensory system agents|mesh-ancestor
25092442|NCT03241784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25092443|NCT03241784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092444|NCT03242096|Sirolimus|sirolimus|mesh-list
25092445|NCT03242096|Paclitaxel|paclitaxel|mesh-list
25092446|NCT03242096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25092457|NCT03242096|Immunologic Factors|immunologic factors|mesh-ancestor
25092458|NCT03242096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092460|NCT03241888|Megestrol Acetate|megestrol acetate|mesh-list
25092461|NCT03241888|Levonorgestrel|levonorgestrel|mesh-list
25092462|NCT03241888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25092463|NCT03241888|Contraceptive Agents|contraceptive agents|mesh-ancestor
25092464|NCT03241888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25092465|NCT03241888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092466|NCT03241888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25092467|NCT03241888|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25092468|NCT03241888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25092469|NCT03241888|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25092470|NCT03241888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25092471|NCT03241888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25680350|NCT01849055|Sensory System Agents|sensory system agents|mesh-ancestor
25680351|NCT01849055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25680352|NCT01849055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680353|NCT01849055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25680354|NCT01849055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25680355|NCT01849055|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25680356|NCT01849055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25680357|NCT01849055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092472|NCT03241888|Appetite Stimulants|appetite stimulants|mesh-ancestor
24975469|NCT03593811|Autonomic Agents|autonomic agents|mesh-ancestor
24975473|NCT03593811|Antipruritics|antipruritics|mesh-ancestor
25224178|NCT02634463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25224179|NCT02634463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224180|NCT02634463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224181|NCT02634463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25224182|NCT02634463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25224183|NCT02634463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25224184|NCT02634463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25224185|NCT02634463|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25224186|NCT02634463|Dopamine Agents|dopamine agents|mesh-ancestor
25224187|NCT02634463|Antiemetics|antiemetics|mesh-ancestor
25043135|NCT01318642|Immunologic Factors|immunologic factors|mesh-ancestor
24837262|NCT02190708|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24837263|NCT02190708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25092473|NCT03241888|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25092474|NCT03241472|Letrozole|letrozole|mesh-list
25092475|NCT03241472|Clomiphene|clomiphene|mesh-list
25092476|NCT03241472|Enclomiphene|enclomiphene|mesh-list
25092477|NCT03241472|Zuclomiphene|zuclomiphene|mesh-list
25092478|NCT03241472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092479|NCT03241472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25092480|NCT03241472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25092481|NCT03241472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25092484|NCT03241472|Hormone Antagonists|hormone antagonists|mesh-ancestor
25092485|NCT03241472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25092486|NCT03241472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092487|NCT03241472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25092488|NCT03241472|Fertility Agents|fertility agents|mesh-ancestor
25092489|NCT03241472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25092490|NCT03241472|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25092491|NCT03241472|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25092492|NCT03241563|Triamcinolone|triamcinolone|mesh-list
25092493|NCT03241563|Deoxycholic Acid|deoxycholic acid|mesh-list
25092494|NCT03241563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25092495|NCT03241563|Glucocorticoids|glucocorticoids|mesh-ancestor
25092497|NCT03241563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25092498|NCT03241563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092499|NCT03241563|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25092500|NCT03241563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24768903|NCT01811251|Pregabalin|pregabalin|mesh-list
24768979|NCT01811836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768980|NCT01811849|Insulin|insulin|mesh-list
24768981|NCT01811849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24768982|NCT01811849|Insulin Lispro|insulin lispro|mesh-list
25092514|NCT03241602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25092515|NCT03241602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25092524|NCT03241641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092526|NCT03241641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25092527|NCT03241550|Isavuconazole|isavuconazole|mesh-list
25092528|NCT03241550|Antifungal Agents|antifungal agents|mesh-ancestor
25092529|NCT03241550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25092530|NCT03241407|Triclosan|triclosan|mesh-list
25092531|NCT03241407|Fluorides|fluorides|mesh-list
25092532|NCT03241407|Cariostatic Agents|cariostatic agents|mesh-ancestor
25092533|NCT03241407|Protective Agents|protective agents|mesh-ancestor
25092534|NCT03241407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092535|NCT03241407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25092536|NCT03241407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25092537|NCT03241407|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25092538|NCT03241407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25092539|NCT03241407|Antimetabolites|antimetabolites|mesh-ancestor
25092540|NCT03241407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092541|NCT03241407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25092542|NCT03241706|Glucagon|glucagon|mesh-list
25092543|NCT03241706|Somatostatin|somatostatin|mesh-list
25092544|NCT03241706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092545|NCT03241706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25092546|NCT03241706|Hormones|hormones|mesh-ancestor
25680358|NCT01849055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680359|NCT01849068|Ezetimibe|ezetimibe|mesh-list
25680361|NCT01849068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25680362|NCT01849068|Antimetabolites|antimetabolites|mesh-ancestor
25680363|NCT01849068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587001|NCT00893048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25092548|NCT03241381|Vitamin D|vitamin d|mesh-list
25092549|NCT03241381|Vitamins|vitamins|mesh-ancestor
25092554|NCT03241303|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25092555|NCT03241303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092556|NCT03241303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092557|NCT03241303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25092558|NCT03241303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092559|NCT03241199|Imatinib Mesylate|imatinib mesylate|mesh-list
25092560|NCT03241199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25224188|NCT02634463|Autonomic Agents|autonomic agents|mesh-ancestor
25224189|NCT02634463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25224190|NCT02634463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24837286|NCT02190760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24837287|NCT02190760|Glucocorticoids|glucocorticoids|mesh-ancestor
24837289|NCT02190760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24837290|NCT02190760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24837291|NCT02190760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24837292|NCT02190760|Anesthetics, Local|anesthetics, local|mesh-ancestor
24837293|NCT02190760|Anesthetics|anesthetics|mesh-ancestor
25055965|NCT03516630|Moxifloxacin|moxifloxacin|mesh-list
24985364|NCT03465280|Analgesics|analgesics|mesh-ancestor
25092561|NCT03241199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25092562|NCT03241199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092563|NCT03241199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092564|NCT03241043|Tacrolimus|tacrolimus|mesh-list
25092565|NCT03241043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25092566|NCT03241043|Immunologic Factors|immunologic factors|mesh-ancestor
25092567|NCT03241043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092568|NCT03241043|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25092569|NCT03241043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092570|NCT03241043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769053|NCT01812330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092572|NCT03241017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25092585|NCT03240822|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25092591|NCT03240939|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25092592|NCT03240939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25092593|NCT03240939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092594|NCT03240939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092595|NCT03240939|Urological Agents|urological agents|mesh-ancestor
25092596|NCT03240939|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25092597|NCT03240939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25092598|NCT03240939|Hormone Antagonists|hormone antagonists|mesh-ancestor
25092599|NCT03240939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25092600|NCT03240939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092601|NCT03240783|Dexamethasone|dexamethasone|mesh-list
25092602|NCT03240783|Dexamethasone acetate|dexamethasone acetate|mesh-list
25092603|NCT03240783|Betamethasone|betamethasone|mesh-list
25092604|NCT03240783|BB 1101|bb 1101|mesh-list
25224191|NCT02634463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25224192|NCT02634463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25224193|NCT02634463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25224194|NCT02634463|Antidepressive Agents|antidepressive agents|mesh-ancestor
25224195|NCT02634463|Dopamine Agonists|dopamine agonists|mesh-ancestor
25224196|NCT02634463|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25680364|NCT01849068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25680365|NCT01849276|Metformin|metformin|mesh-list
25680366|NCT01849276|Cytarabine|cytarabine|mesh-list
25680367|NCT01849276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25680368|NCT01849276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25111322|NCT04939909|Botulinum Toxins|botulinum toxins|mesh-list
25111323|NCT04939909|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25111324|NCT04939909|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25019104|NCT03693573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25019105|NCT03693573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019106|NCT03693573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25019107|NCT03693573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25224197|NCT02634463|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25224198|NCT02634463|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25224199|NCT02634463|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25224200|NCT02634437|Ulipristal acetate|ulipristal acetate|mesh-list
25224201|NCT02634437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25224202|NCT02634437|Contraceptive Agents|contraceptive agents|mesh-ancestor
25224203|NCT02634437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25224204|NCT02634437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224205|NCT02634437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25224206|NCT02634294|Interferons|interferons|mesh-list
24985379|NCT03465280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24837306|NCT02190838|Alkylating Agents|alkylating agents|mesh-ancestor
24837307|NCT02190838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24837309|NCT02190994|Hydrocortisone|hydrocortisone|mesh-list
24837310|NCT02190994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24837311|NCT02190994|Glucocorticoids|glucocorticoids|mesh-ancestor
24837312|NCT02190994|Hormones|hormones|mesh-ancestor
24837313|NCT02190994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25064886|NCT03455426|Letrozole|letrozole|mesh-list
25092605|NCT03240783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25092606|NCT03240783|Antiemetics|antiemetics|mesh-ancestor
25092607|NCT03240783|Autonomic Agents|autonomic agents|mesh-ancestor
25092608|NCT03240783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25092609|NCT03240783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092610|NCT03240783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25092611|NCT03240783|Glucocorticoids|glucocorticoids|mesh-ancestor
25092612|NCT03240783|Hormones|hormones|mesh-ancestor
25092613|NCT03240783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25092614|NCT03240783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25092615|NCT03240783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25092616|NCT03240783|Protease Inhibitors|protease inhibitors|mesh-ancestor
25092617|NCT03240783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092630|NCT03240471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092631|NCT03240471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092632|NCT03240549|Bevacizumab|bevacizumab|mesh-list
25092633|NCT03240549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25092634|NCT03240549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25092635|NCT03240549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25092636|NCT03240549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25092637|NCT03240549|Growth Substances|growth substances|mesh-ancestor
25092638|NCT03240549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092639|NCT03240549|Growth Inhibitors|growth inhibitors|mesh-ancestor
25092640|NCT03240120|Tinzaparin|tinzaparin|mesh-list
25092641|NCT03240120|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25092642|NCT03240120|Dalteparin|dalteparin|mesh-list
25092643|NCT03240120|Dabigatran|dabigatran|mesh-list
25092644|NCT03240120|Antithrombins|antithrombins|mesh-ancestor
25092645|NCT03240120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25092646|NCT03240120|Protease Inhibitors|protease inhibitors|mesh-ancestor
24985460|NCT03337594|Chelating Agents|chelating agents|mesh-ancestor
25092662|NCT03239691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224207|NCT02634294|Interferon-alpha|interferon-alpha|mesh-list
25680369|NCT01849276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25680370|NCT01849276|Antimetabolites|antimetabolites|mesh-ancestor
25680371|NCT01849276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680372|NCT01849276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25680373|NCT01849276|Antiviral Agents|antiviral agents|mesh-ancestor
25680374|NCT01849276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25680375|NCT01849276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25680376|NCT01849276|Immunologic Factors|immunologic factors|mesh-ancestor
25019193|NCT03693066|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25106489|NCT02669173|Growth Inhibitors|growth inhibitors|mesh-ancestor
25224208|NCT02634294|Interferon alpha-2|interferon alpha-2|mesh-list
25224209|NCT02634294|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25224210|NCT02634294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25224211|NCT02634294|Antiviral Agents|antiviral agents|mesh-ancestor
25224212|NCT02634294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25224213|NCT02634294|Immunologic Factors|immunologic factors|mesh-ancestor
25224214|NCT02634294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224215|NCT02634515|Insulin|insulin|mesh-list
25224216|NCT02634515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25224217|NCT02634515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25224218|NCT02634515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224219|NCT02634281|Varenicline|varenicline|mesh-list
25224220|NCT02634281|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25224221|NCT02634281|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25224222|NCT02634281|Cholinergic Agents|cholinergic agents|mesh-ancestor
25224223|NCT02634281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25224224|NCT02634281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224225|NCT02634281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837314|NCT02190994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837315|NCT02190994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25092663|NCT03239691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25092664|NCT03239691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092666|NCT03239860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25092667|NCT03239860|Immunologic Factors|immunologic factors|mesh-ancestor
25092668|NCT03239860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092669|NCT03239743|Midazolam|midazolam|mesh-list
25092670|NCT03239743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25092671|NCT03239743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25092672|NCT03239743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25092673|NCT03239743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092674|NCT03239743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25092675|NCT03239743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25092676|NCT03239743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25092677|NCT03239743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25092678|NCT03239743|Anesthetics, General|anesthetics, general|mesh-ancestor
25092679|NCT03239743|Anesthetics|anesthetics|mesh-ancestor
25092680|NCT03239743|GABA Modulators|gaba modulators|mesh-ancestor
25092681|NCT03239743|GABA Agents|gaba agents|mesh-ancestor
25092682|NCT03239743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25092683|NCT03239743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092684|NCT03239821|Codeine|codeine|mesh-list
25092685|NCT03239821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25092686|NCT03239821|Narcotics|narcotics|mesh-ancestor
25092687|NCT03239821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25092688|NCT03239821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092689|NCT03239821|Analgesics|analgesics|mesh-ancestor
25092690|NCT03239821|Sensory System Agents|sensory system agents|mesh-ancestor
25092691|NCT03239821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25092692|NCT03239821|Antitussive Agents|antitussive agents|mesh-ancestor
25092693|NCT03239821|Respiratory System Agents|respiratory system agents|mesh-ancestor
25092694|NCT03239964|Dexamethasone|dexamethasone|mesh-list
25092695|NCT03239964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24985550|NCT03187769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24860636|NCT02311608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25092705|NCT03239964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25092706|NCT03239886|Imatinib Mesylate|imatinib mesylate|mesh-list
25092707|NCT03239886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25092708|NCT03239886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25092709|NCT03239886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092710|NCT03239886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092711|NCT03239600|Methotrexate|methotrexate|mesh-list
25092712|NCT03239600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25092713|NCT03239600|Abortifacient Agents|abortifacient agents|mesh-ancestor
25092730|NCT03239327|Alprostadil|alprostadil|mesh-list
25092731|NCT03239327|Misoprostol|misoprostol|mesh-list
25092733|NCT03239327|Abortifacient Agents|abortifacient agents|mesh-ancestor
24769291|NCT01813617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24769292|NCT01813617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25680377|NCT01849289|Insulin|insulin|mesh-list
25680378|NCT01849289|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25680379|NCT01849289|Insulin Glargine|insulin glargine|mesh-list
25680380|NCT01849289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25092740|NCT03239327|Vasodilator Agents|vasodilator agents|mesh-ancestor
25092741|NCT03239327|Urological Agents|urological agents|mesh-ancestor
25092743|NCT03239314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25092744|NCT03239314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25092745|NCT03239314|Antiemetics|antiemetics|mesh-ancestor
25092746|NCT03239314|Autonomic Agents|autonomic agents|mesh-ancestor
25092747|NCT03239314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25092748|NCT03239314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092749|NCT03239314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25092750|NCT03239314|Glucocorticoids|glucocorticoids|mesh-ancestor
25092752|NCT03239314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25092753|NCT03239314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25092754|NCT03239314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25092755|NCT03239353|Entecavir|entecavir|mesh-list
25092756|NCT03239353|Antiviral Agents|antiviral agents|mesh-ancestor
25092757|NCT03239353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25092758|NCT03239236|Anesthetics|anesthetics|mesh-list
25224226|NCT02634255|Fentanyl|fentanyl|mesh-list
25224227|NCT02634255|Propofol|propofol|mesh-list
25224228|NCT02634255|Rocuronium|rocuronium|mesh-list
25275731|NCT02369822|Micronutrients|micronutrients|mesh-ancestor
24837317|NCT02191007|Calcitriol|calcitriol|mesh-list
25092759|NCT03239236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25092760|NCT03239236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092761|NCT03239457|Mitogens|mitogens|mesh-list
25092762|NCT03239457|Mitosis Modulators|mitosis modulators|mesh-ancestor
25092763|NCT03239457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092792|NCT03238898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092793|NCT03238898|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25092794|NCT03238898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25092798|NCT03238703|Tamoxifen|tamoxifen|mesh-list
25092818|NCT03238703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25092819|NCT03238703|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25092820|NCT03238703|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25092821|NCT03238703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25092833|NCT03238625|Lidocaine|lidocaine|mesh-list
25092834|NCT03238625|Anesthetics, Local|anesthetics, local|mesh-ancestor
25092835|NCT03238625|Anesthetics|anesthetics|mesh-ancestor
25092836|NCT03238625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25092837|NCT03238625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092838|NCT03238625|Sensory System Agents|sensory system agents|mesh-ancestor
25092839|NCT03238625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25092840|NCT03238625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25092865|NCT03238482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25092866|NCT03238482|Respiratory System Agents|respiratory system agents|mesh-ancestor
25092867|NCT03238482|Dermatologic Agents|dermatologic agents|mesh-ancestor
25092868|NCT03238482|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25092869|NCT03238482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25092874|NCT03238482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092875|NCT03238482|Glucocorticoids|glucocorticoids|mesh-ancestor
25092876|NCT03238482|Hormones|hormones|mesh-ancestor
25092877|NCT03238482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25092878|NCT03238482|Sympathomimetics|sympathomimetics|mesh-ancestor
25092879|NCT03238560|Montelukast|montelukast|mesh-list
25224229|NCT02634255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25680381|NCT01849289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680382|NCT01849419|Oxytocin|oxytocin|mesh-list
25680383|NCT01849419|Oxytocics|oxytocics|mesh-ancestor
25680384|NCT01849419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25680385|NCT01849419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680386|NCT01849497|Evolocumab|evolocumab|mesh-list
25680387|NCT01849497|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25680388|NCT01849497|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25680389|NCT01849497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24837318|NCT02191007|Betamethasone|betamethasone|mesh-list
24837319|NCT02191007|Betamethasone Valerate|betamethasone valerate|mesh-list
24837320|NCT02191007|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24837321|NCT02191007|Betamethasone benzoate|betamethasone benzoate|mesh-list
24837322|NCT02191007|Calcipotriene|calcipotriene|mesh-list
25092880|NCT03238560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25092881|NCT03238560|Respiratory System Agents|respiratory system agents|mesh-ancestor
25092882|NCT03238560|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25092883|NCT03238560|Hormone Antagonists|hormone antagonists|mesh-ancestor
25092884|NCT03238560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25092885|NCT03238560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092886|NCT03238560|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25092887|NCT03238560|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25092888|NCT03238560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092912|NCT03238131|Mitosis Modulators|mitosis modulators|mesh-ancestor
25092913|NCT03238131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092914|NCT03238131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25092915|NCT03238079|Immunoglobulins|immunoglobulins|mesh-list
25092916|NCT03238079|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25092917|NCT03238079|Immunologic Factors|immunologic factors|mesh-ancestor
25092918|NCT03238079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092919|NCT03238092|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25092920|NCT03238092|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25092921|NCT03238092|Estradiol|estradiol|mesh-list
25092923|NCT03238092|Testosterone|testosterone|mesh-list
25092924|NCT03238092|Estrogens|estrogens|mesh-ancestor
25092925|NCT03238092|Hormones|hormones|mesh-ancestor
25092926|NCT03238092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25092927|NCT03238092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092928|NCT03238092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25092929|NCT03238092|Contraceptive Agents|contraceptive agents|mesh-ancestor
25092930|NCT03238092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25092931|NCT03238092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25092932|NCT03238092|Androgens|androgens|mesh-ancestor
25092933|NCT03238157|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
25092934|NCT03238157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25092935|NCT03238157|Glucocorticoids|glucocorticoids|mesh-ancestor
25092936|NCT03238157|Hormones|hormones|mesh-ancestor
25092937|NCT03238157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25092958|NCT03237637|Atenolol|atenolol|mesh-list
25092959|NCT03237637|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25092960|NCT03237637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25092962|NCT03237637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25092963|NCT03237637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092964|NCT03237637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092965|NCT03237637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25092966|NCT03237637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25092967|NCT03237637|Vasodilator Agents|vasodilator agents|mesh-ancestor
25092968|NCT03237637|Sympatholytics|sympatholytics|mesh-ancestor
25092969|NCT03237637|Autonomic Agents|autonomic agents|mesh-ancestor
25092970|NCT03237637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25092971|NCT03237637|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25092972|NCT03237715|Bilirubin|bilirubin|mesh-list
25092973|NCT03237715|Antioxidants|antioxidants|mesh-ancestor
25092974|NCT03237715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092975|NCT03237715|Protective Agents|protective agents|mesh-ancestor
25092976|NCT03237715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092977|NCT03237741|Rabeprazole|rabeprazole|mesh-list
25092978|NCT03237741|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25092979|NCT03237741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25092980|NCT03237741|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25092981|NCT03237741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757996|NCT01743235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25093005|NCT03237533|Antipruritics|antipruritics|mesh-ancestor
25093006|NCT03237533|Dermatologic Agents|dermatologic agents|mesh-ancestor
25093007|NCT03237533|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25093008|NCT03237533|Histamine Antagonists|histamine antagonists|mesh-ancestor
25093009|NCT03237533|Histamine Agents|histamine agents|mesh-ancestor
25224230|NCT02634255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25224231|NCT02634255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224232|NCT02634255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25224233|NCT02634255|Anesthetics, General|anesthetics, general|mesh-ancestor
25224234|NCT02634255|Anesthetics|anesthetics|mesh-ancestor
24837323|NCT02191007|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25093025|NCT03237507|Tubulin Modulators|tubulin modulators|mesh-ancestor
25093026|NCT03237507|Antimitotic Agents|antimitotic agents|mesh-ancestor
25093027|NCT03237507|Mitosis Modulators|mitosis modulators|mesh-ancestor
25093028|NCT03237507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093029|NCT03237416|Midazolam|midazolam|mesh-list
25093030|NCT03237416|Dabigatran|dabigatran|mesh-list
25093031|NCT03237416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25093032|NCT03237416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25093048|NCT03237416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25093050|NCT03237546|Anesthetics|anesthetics|mesh-list
25093051|NCT03237546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25093052|NCT03237546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769518|NCT01814501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24769519|NCT01814501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769520|NCT01814501|Antimetabolites|antimetabolites|mesh-ancestor
24769521|NCT01814501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769522|NCT01814501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24769523|NCT01814501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24769524|NCT01814501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24769525|NCT01814501|Immunologic Factors|immunologic factors|mesh-ancestor
24769526|NCT01814501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24769527|NCT01814501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24769528|NCT01814501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24769529|NCT01814501|Antidotes|antidotes|mesh-ancestor
24769530|NCT01814501|Protective Agents|protective agents|mesh-ancestor
25093053|NCT03237624|Chitosan|chitosan|mesh-list
24758026|NCT01743326|Anesthetics|anesthetics|mesh-list
25093080|NCT03236818|Sildenafil Citrate|sildenafil citrate|mesh-list
25093081|NCT03236818|Tadalafil|tadalafil|mesh-list
25093082|NCT03236818|Macitentan|macitentan|mesh-list
25093083|NCT03236818|Vasodilator Agents|vasodilator agents|mesh-ancestor
25093084|NCT03236818|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25093085|NCT03236818|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25093086|NCT03236818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25093087|NCT03236818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093088|NCT03236818|Urological Agents|urological agents|mesh-ancestor
25093089|NCT03236818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25093090|NCT03236818|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25224235|NCT02634255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24837325|NCT02191007|Glucocorticoids|glucocorticoids|mesh-ancestor
24837326|NCT02191007|Hormones|hormones|mesh-ancestor
24837335|NCT02191007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837336|NCT02191007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25093091|NCT03236818|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25093092|NCT03236818|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25093093|NCT03236805|Ketamine|ketamine|mesh-list
25093094|NCT03236805|Morphine|morphine|mesh-list
25093115|NCT03236974|Hormone Antagonists|hormone antagonists|mesh-ancestor
25093116|NCT03236974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25093117|NCT03236974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769593|NCT01814709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25093156|NCT03236961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25093157|NCT03236961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25093158|NCT03236961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25093159|NCT03236961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25093160|NCT03236961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24985679|NCT02924272|Ixazomib|ixazomib|mesh-list
25093161|NCT03236961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093162|NCT03236961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25093163|NCT03236961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25093164|NCT03236961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25093165|NCT03236961|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25093166|NCT03236961|Renal Agents|renal agents|mesh-ancestor
25093167|NCT03236961|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25093168|NCT03236961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25093169|NCT03236610|Tenofovir|tenofovir|mesh-list
25093170|NCT03236610|Entecavir|entecavir|mesh-list
25093171|NCT03236610|Antiviral Agents|antiviral agents|mesh-ancestor
25093172|NCT03236610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25093173|NCT03236610|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25093174|NCT03236610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25093175|NCT03236610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25680390|NCT01849497|Antimetabolites|antimetabolites|mesh-ancestor
25680391|NCT01849497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540859|NCT00669812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540860|NCT00669812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24540861|NCT00669812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25019570|NCT03690414|Parasympatholytics|parasympatholytics|mesh-ancestor
25019585|NCT03690323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25019588|NCT03690323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25019589|NCT03690323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25019590|NCT03690323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25019591|NCT03690323|Immunologic Factors|immunologic factors|mesh-ancestor
25019592|NCT03690323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019594|NCT03690167|Mitosis Modulators|mitosis modulators|mesh-ancestor
25019595|NCT03690167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093176|NCT03236610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093177|NCT03236610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25093178|NCT03236610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25093179|NCT03236649|Sorafenib|sorafenib|mesh-list
25093180|NCT03236649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25093181|NCT03236649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25093182|NCT03236649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25093183|NCT03236649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093184|NCT03236740|Metformin|metformin|mesh-list
25093185|NCT03236740|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25093186|NCT03236740|Estradiol|estradiol|mesh-list
25093189|NCT03236740|Estrogens|estrogens|mesh-ancestor
25224236|NCT02634255|Narcotics|narcotics|mesh-ancestor
25224237|NCT02634255|Analgesics|analgesics|mesh-ancestor
25224238|NCT02634255|Sensory System Agents|sensory system agents|mesh-ancestor
25224239|NCT02634255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25224240|NCT02634255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24837337|NCT02191007|Vitamins|vitamins|mesh-ancestor
24837338|NCT02191007|Micronutrients|micronutrients|mesh-ancestor
24837339|NCT02191007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24837340|NCT02191020|Acitretin|acitretin|mesh-list
25093195|NCT03236740|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25093196|NCT03236740|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25093197|NCT03236740|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25093198|NCT03236727|Dexmedetomidine|dexmedetomidine|mesh-list
25093199|NCT03236727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25093200|NCT03236727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25093201|NCT03236727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093202|NCT03236727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25680392|NCT01849497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25680393|NCT01849497|Immunologic Factors|immunologic factors|mesh-ancestor
25680394|NCT01849497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680395|NCT01849562|Ribavirin|ribavirin|mesh-list
25680396|NCT01849562|Odalasvir|odalasvir|mesh-list
25680397|NCT01849562|Antimetabolites|antimetabolites|mesh-ancestor
25680398|NCT01849562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680399|NCT01849562|Antiviral Agents|antiviral agents|mesh-ancestor
25680400|NCT01849562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25680401|NCT01849588|Sorafenib|sorafenib|mesh-list
25680402|NCT01849588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25680403|NCT01849588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25680404|NCT01849588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25680405|NCT01849588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680406|NCT01849692|Ranibizumab|ranibizumab|mesh-list
25680407|NCT01849692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25680408|NCT01849692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25680409|NCT01849692|Growth Substances|growth substances|mesh-ancestor
25680410|NCT01849692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680411|NCT01849692|Growth Inhibitors|growth inhibitors|mesh-ancestor
25680412|NCT01849692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25680413|NCT01849770|Mexiletine|mexiletine|mesh-list
25680414|NCT01849770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25019659|NCT03689114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25019660|NCT03689114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25019661|NCT03689114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25093204|NCT03236727|Sensory System Agents|sensory system agents|mesh-ancestor
25093205|NCT03236727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25093206|NCT03236727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25093207|NCT03236727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25093208|NCT03236727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25093209|NCT03236727|Adrenergic Agents|adrenergic agents|mesh-ancestor
25093210|NCT03236727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25093211|NCT03236727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093212|NCT03236987|Azithromycin|azithromycin|mesh-list
25093213|NCT03236987|Clarithromycin|clarithromycin|mesh-list
25093215|NCT03236987|Ethambutol|ethambutol|mesh-list
25093216|NCT03236987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25093217|NCT03236987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25093218|NCT03236987|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25093252|NCT03236324|Bupivacaine|bupivacaine|mesh-list
25093253|NCT03236324|Anesthetics, Local|anesthetics, local|mesh-ancestor
25093254|NCT03236324|Anesthetics|anesthetics|mesh-ancestor
24985735|NCT02809131|Ofloxacin|ofloxacin|mesh-list
25093255|NCT03236324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25093256|NCT03236324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093257|NCT03236324|Sensory System Agents|sensory system agents|mesh-ancestor
25093258|NCT03236324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25093259|NCT03236324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25093260|NCT03236324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25093261|NCT03236324|Adrenergic Agents|adrenergic agents|mesh-ancestor
25093262|NCT03236324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25093263|NCT03236324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093272|NCT03236233|PC-786|pc-786|mesh-list
25093283|NCT03236220|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25093284|NCT03236220|Antioxidants|antioxidants|mesh-ancestor
25093285|NCT03236220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093286|NCT03236220|Protective Agents|protective agents|mesh-ancestor
25093287|NCT03236220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093288|NCT03236220|Antidotes|antidotes|mesh-ancestor
25093289|NCT03235947|Trimethoprim|trimethoprim|mesh-list
25093290|NCT03235947|Sulfamethoxazole|sulfamethoxazole|mesh-list
25093291|NCT03235947|Fosfomycin|fosfomycin|mesh-list
25093292|NCT03235947|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25093293|NCT03235947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25093294|NCT03235947|Renal Agents|renal agents|mesh-ancestor
25093295|NCT03235947|Antimalarials|antimalarials|mesh-ancestor
25093296|NCT03235947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25093297|NCT03235947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25093298|NCT03235947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25093307|NCT03236155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25093308|NCT03236155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093309|NCT03236155|Analgesics|analgesics|mesh-ancestor
25093310|NCT03236155|Sensory System Agents|sensory system agents|mesh-ancestor
25093326|NCT03235869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25093327|NCT03235869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25093328|NCT03236012|Botulinum Toxins|botulinum toxins|mesh-list
25093329|NCT03236012|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25093330|NCT03236012|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25093331|NCT03236012|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25093332|NCT03236012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25093333|NCT03236012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093334|NCT03236012|Cholinergic Agents|cholinergic agents|mesh-ancestor
25093335|NCT03236012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25093336|NCT03236012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093337|NCT03236012|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25224241|NCT02634255|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25224242|NCT02634255|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25224243|NCT02634255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24837342|NCT02191020|Dermatologic Agents|dermatologic agents|mesh-ancestor
24837343|NCT02191059|Docetaxel|docetaxel|mesh-list
25680415|NCT01849770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25680416|NCT01849770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25680417|NCT01849770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24837357|NCT02191124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24837358|NCT02191124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093338|NCT03236012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25093340|NCT03235609|Ketamine|ketamine|mesh-list
25093341|NCT03235609|Analgesics|analgesics|mesh-ancestor
25093342|NCT03235609|Sensory System Agents|sensory system agents|mesh-ancestor
25093343|NCT03235609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25093344|NCT03235609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093345|NCT03235609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25093346|NCT03235609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25093347|NCT03235609|Anesthetics, General|anesthetics, general|mesh-ancestor
25093348|NCT03235609|Anesthetics|anesthetics|mesh-ancestor
25093349|NCT03235609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25093350|NCT03235609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25093351|NCT03235609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25093352|NCT03235609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25093353|NCT03235609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093354|NCT03235609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25093355|NCT03235609|Narcotics|narcotics|mesh-ancestor
25093356|NCT03235609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25093357|NCT03235531|Valproic Acid|valproic acid|mesh-list
25093358|NCT03235531|Lorazepam|lorazepam|mesh-list
25093359|NCT03235531|Anticonvulsants|anticonvulsants|mesh-ancestor
25093375|NCT03235531|GABA Modulators|gaba modulators|mesh-ancestor
25093376|NCT03235700|Nicorandil|nicorandil|mesh-list
25093377|NCT03235700|Adenosine|adenosine|mesh-list
25093378|NCT03235700|Analgesics|analgesics|mesh-ancestor
25093379|NCT03235700|Sensory System Agents|sensory system agents|mesh-ancestor
25093380|NCT03235700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25093381|NCT03235700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093382|NCT03235700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24758308|NCT01745081|Diuretics|diuretics|mesh-ancestor
25093395|NCT03235778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25093397|NCT03235778|Sensory System Agents|sensory system agents|mesh-ancestor
25093398|NCT03235778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24769994|NCT01817322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24769995|NCT01817322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093399|NCT03235778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093400|NCT03235778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25093401|NCT03235778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25224244|NCT02634034|Pitavastatin|pitavastatin|mesh-list
25224245|NCT02634034|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25224246|NCT02634034|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25224247|NCT02634034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25224248|NCT02634034|Antimetabolites|antimetabolites|mesh-ancestor
24837361|NCT02191124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026615|NCT03626454|Norepinephrine|norepinephrine|mesh-list
24837362|NCT02191124|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24837363|NCT02191124|Antidepressive Agents|antidepressive agents|mesh-ancestor
24837364|NCT02191124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25056022|NCT03515798|Pembrolizumab|pembrolizumab|mesh-list
25093414|NCT03235245|Nivolumab|nivolumab|mesh-list
25093415|NCT03235245|Ipilimumab|ipilimumab|mesh-list
25093416|NCT03235245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25093417|NCT03235245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25093418|NCT03235245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25093419|NCT03235245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093420|NCT03235037|Levodopa|levodopa|mesh-list
25093421|NCT03235037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25093422|NCT03235037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25093423|NCT03235037|Dopamine Agents|dopamine agents|mesh-ancestor
25093424|NCT03235037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25093425|NCT03235037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093426|NCT03235037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093427|NCT03235141|Azithromycin|azithromycin|mesh-list
25093428|NCT03235141|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25093429|NCT03235141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25093430|NCT03235141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25093431|NCT03235141|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25093432|NCT03234816|Norepinephrine|norepinephrine|mesh-list
25093437|NCT03234816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093438|NCT03234816|Sensory System Agents|sensory system agents|mesh-ancestor
25093439|NCT03234816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25093795|NCT03232021|Pregabalin|pregabalin|mesh-list
25093440|NCT03234816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25093441|NCT03234816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25093442|NCT03234816|Adrenergic Agents|adrenergic agents|mesh-ancestor
25093443|NCT03234816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25405283|NCT03615105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25019910|NCT03686657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25019911|NCT03686657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25019933|NCT03686254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25019934|NCT03686254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25019935|NCT03686254|Growth Substances|growth substances|mesh-ancestor
25019936|NCT03686254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019937|NCT03686254|Growth Inhibitors|growth inhibitors|mesh-ancestor
25019938|NCT03686163|Mitogens|mitogens|mesh-list
25019939|NCT03686163|Mitosis Modulators|mitosis modulators|mesh-ancestor
25093444|NCT03234816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093461|NCT03234673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25093462|NCT03234673|Immunologic Factors|immunologic factors|mesh-ancestor
25093463|NCT03234673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093464|NCT03234673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25093468|NCT03234517|Clindamycin|clindamycin|mesh-list
25093482|NCT03234244|Micronutrients|micronutrients|mesh-ancestor
25093483|NCT03234244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25093484|NCT03234244|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25093485|NCT03234244|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25093486|NCT03234244|Hormone Antagonists|hormone antagonists|mesh-ancestor
25093487|NCT03234244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25093488|NCT03234699|Midazolam|midazolam|mesh-list
25093489|NCT03234699|Cenobamate|cenobamate|mesh-list
25093490|NCT03234699|Bupropion|bupropion|mesh-list
25093491|NCT03234699|Omeprazole|omeprazole|mesh-list
25093492|NCT03234699|Warfarin|warfarin|mesh-list
25093493|NCT03234699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25093494|NCT03234699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25093495|NCT03234699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25093496|NCT03234699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093497|NCT03234699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25093498|NCT03234699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25093499|NCT03234699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25093500|NCT03234699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25093501|NCT03234699|Anesthetics, General|anesthetics, general|mesh-ancestor
25093502|NCT03234699|Anesthetics|anesthetics|mesh-ancestor
25093503|NCT03234699|GABA Modulators|gaba modulators|mesh-ancestor
25093504|NCT03234699|GABA Agents|gaba agents|mesh-ancestor
25093505|NCT03234699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25093506|NCT03234699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093507|NCT03234699|Anticoagulants|anticoagulants|mesh-ancestor
25093508|NCT03234699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25224249|NCT02634034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224250|NCT02634034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25224251|NCT02634034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25224252|NCT02634203|Riociguat|riociguat|mesh-list
25224253|NCT02634203|Enzyme Activators|enzyme activators|mesh-ancestor
25224254|NCT02634203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224255|NCT02634021|Midazolam|midazolam|mesh-list
24837365|NCT02191124|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24837366|NCT02191124|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24837367|NCT02191124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837368|NCT02191124|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24837374|NCT02191124|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24837375|NCT02191124|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25093527|NCT03234413|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25093528|NCT03234413|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25093529|NCT03234413|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25093530|NCT03234413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25093531|NCT03234413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093532|NCT03234413|Cholinergic Agents|cholinergic agents|mesh-ancestor
25093533|NCT03234413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25680418|NCT01849770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680419|NCT01850030|Progesterone|progesterone|mesh-list
25680420|NCT01850030|Dydrogesterone|dydrogesterone|mesh-list
25680421|NCT01850030|Progestins|progestins|mesh-ancestor
25680422|NCT01850030|Hormones|hormones|mesh-ancestor
25680423|NCT01850030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25680424|NCT01850030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680425|NCT01850394|Tranexamic Acid|tranexamic acid|mesh-list
25680426|NCT01850394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25680427|NCT01850394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25093534|NCT03234413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093535|NCT03234413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25093536|NCT03234413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25093580|NCT03234062|Choline|choline|mesh-list
25093581|NCT03234062|Lipotropic Agents|lipotropic agents|mesh-ancestor
25093582|NCT03234062|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25093583|NCT03234062|Antimetabolites|antimetabolites|mesh-ancestor
25093584|NCT03234062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093585|NCT03234062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25093586|NCT03234062|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25093587|NCT03234062|Nootropic Agents|nootropic agents|mesh-ancestor
25093588|NCT03233932|Leuprolide|leuprolide|mesh-list
25093589|NCT03233932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25093590|NCT03233932|Fertility Agents|fertility agents|mesh-ancestor
25093591|NCT03233932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25093592|NCT03233932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093595|NCT03233880|Azithromycin|azithromycin|mesh-list
25093606|NCT03233815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25093612|NCT03233893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25093613|NCT03234153|Durvalumab|durvalumab|mesh-list
25093614|NCT03234153|Tremelimumab|tremelimumab|mesh-list
25093615|NCT03234153|Immunologic Factors|immunologic factors|mesh-list
25093616|NCT03234153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25093617|NCT03234153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25093618|NCT03234153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093630|NCT03233412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25093631|NCT03233412|Immunologic Factors|immunologic factors|mesh-ancestor
25093632|NCT03233412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093633|NCT03233412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25093634|NCT03233412|Interferon Inducers|interferon inducers|mesh-ancestor
25093636|NCT03233295|Cholecalciferol|cholecalciferol|mesh-list
25093637|NCT03233295|Vitamins|vitamins|mesh-ancestor
25093638|NCT03233295|Micronutrients|micronutrients|mesh-ancestor
25093639|NCT03233295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093640|NCT03233295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25093641|NCT03233295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25093642|NCT03233152|Nivolumab|nivolumab|mesh-list
25093643|NCT03233152|Ipilimumab|ipilimumab|mesh-list
24476650|NCT00415961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24476652|NCT00415961|Tubulin Modulators|tubulin modulators|mesh-ancestor
24476653|NCT00415961|Antimitotic Agents|antimitotic agents|mesh-ancestor
25093644|NCT03233152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25093645|NCT03233152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25093646|NCT03233152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25224256|NCT02634021|Dexmedetomidine|dexmedetomidine|mesh-list
25224257|NCT02634021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25026955|NCT03624010|Simendan|simendan|mesh-list
25224258|NCT02634021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25224259|NCT02634021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224260|NCT02634021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25224261|NCT02634021|Analgesics|analgesics|mesh-ancestor
25224262|NCT02634021|Sensory System Agents|sensory system agents|mesh-ancestor
24837378|NCT02191124|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24837379|NCT02191124|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24837380|NCT02191124|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24837381|NCT02191176|Dextromethorphan|dextromethorphan|mesh-list
24837382|NCT02191176|Antitussive Agents|antitussive agents|mesh-ancestor
25093647|NCT03233152|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25093648|NCT03233152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093649|NCT03233035|Ketamine|ketamine|mesh-list
25093650|NCT03233035|Analgesics|analgesics|mesh-ancestor
25093651|NCT03233035|Sensory System Agents|sensory system agents|mesh-ancestor
25093652|NCT03233035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25093653|NCT03233035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093654|NCT03233035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25093655|NCT03233035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25093656|NCT03233035|Anesthetics, General|anesthetics, general|mesh-ancestor
25093657|NCT03233035|Anesthetics|anesthetics|mesh-ancestor
25093658|NCT03233035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25093659|NCT03233035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25020046|NCT03684707|Metformin|metformin|mesh-list
25020047|NCT03684707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25020048|NCT03684707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020049|NCT03684564|Warfarin|warfarin|mesh-list
25020050|NCT03684564|Rivaroxaban|rivaroxaban|mesh-list
25020051|NCT03684564|Anticoagulants|anticoagulants|mesh-ancestor
25020052|NCT03684564|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25020053|NCT03684564|Antithrombins|antithrombins|mesh-ancestor
25020071|NCT03684395|Dabigatran|dabigatran|mesh-list
25093660|NCT03233035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25093680|NCT03232710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25093681|NCT03232710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25093682|NCT03232710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25093683|NCT03232710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093684|NCT03232710|Dopamine Agonists|dopamine agonists|mesh-ancestor
25093685|NCT03232710|Dopamine Agents|dopamine agents|mesh-ancestor
25093686|NCT03232710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25093704|NCT03232450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25093705|NCT03232450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506354|NCT00544804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25093713|NCT03232450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25093714|NCT03232450|Antipyretics|antipyretics|mesh-ancestor
25093715|NCT03232424|Temozolomide|temozolomide|mesh-list
25093716|NCT03232424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25093717|NCT03232424|Alkylating Agents|alkylating agents|mesh-ancestor
25093718|NCT03232424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093719|NCT03232424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25093720|NCT03232398|Warfarin|warfarin|mesh-list
25093721|NCT03232398|Apixaban|apixaban|mesh-list
25093722|NCT03232398|Anticoagulants|anticoagulants|mesh-ancestor
25093723|NCT03232398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25093724|NCT03232398|Antithrombins|antithrombins|mesh-ancestor
25093725|NCT03232398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25093726|NCT03232398|Protease Inhibitors|protease inhibitors|mesh-ancestor
25093727|NCT03232398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25093728|NCT03232398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093729|NCT03232307|Dexamethasone|dexamethasone|mesh-list
25093730|NCT03232307|Dexamethasone acetate|dexamethasone acetate|mesh-list
25093731|NCT03232307|Rituximab|rituximab|mesh-list
25093732|NCT03232307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25093733|NCT03232307|Lenalidomide|lenalidomide|mesh-list
24770243|NCT01819220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25093734|NCT03232307|Antibodies|antibodies|mesh-list
25093735|NCT03232307|Immunoglobulins|immunoglobulins|mesh-list
25093736|NCT03232307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25093737|NCT03232307|BB 1101|bb 1101|mesh-list
25093738|NCT03232307|Immunologic Factors|immunologic factors|mesh-ancestor
24770316|NCT01819701|Vitamins|vitamins|mesh-ancestor
25093739|NCT03232307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224263|NCT02634021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25224264|NCT02634021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25224265|NCT02634021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25224266|NCT02634021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25224267|NCT02634021|Adrenergic Agents|adrenergic agents|mesh-ancestor
25224268|NCT02634021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25273246|NCT02386449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837383|NCT02191176|Respiratory System Agents|respiratory system agents|mesh-ancestor
24837384|NCT02191176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24837385|NCT02191176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25093750|NCT03232307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25093751|NCT03232307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25093752|NCT03232307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25093753|NCT03232307|Growth Substances|growth substances|mesh-ancestor
25093754|NCT03232307|Growth Inhibitors|growth inhibitors|mesh-ancestor
25093755|NCT03232307|Protease Inhibitors|protease inhibitors|mesh-ancestor
25093769|NCT03232320|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25680428|NCT01850394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680429|NCT01850394|Hemostatics|hemostatics|mesh-ancestor
25680430|NCT01850394|Coagulants|coagulants|mesh-ancestor
25680431|NCT01850446|Oseltamivir|oseltamivir|mesh-list
25680432|NCT01850446|Antiviral Agents|antiviral agents|mesh-ancestor
25680433|NCT01850446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25680434|NCT01850446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25111472|NCT04809766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25111473|NCT04809766|Immunologic Factors|immunologic factors|mesh-ancestor
25111474|NCT04809766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25111475|NCT04809766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25111476|NCT04809766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25111477|NCT04809766|Alkylating Agents|alkylating agents|mesh-ancestor
25111478|NCT04809766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25111479|NCT04809766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25111480|NCT04809766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25093770|NCT03232320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25093771|NCT03232320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093772|NCT03232320|Cholinergic Agents|cholinergic agents|mesh-ancestor
25093773|NCT03232320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25093774|NCT03231982|Amlodipine|amlodipine|mesh-list
25093775|NCT03231982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25093776|NCT03231982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25093777|NCT03231982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25093778|NCT03231982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093779|NCT03231982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25093780|NCT03231982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093781|NCT03231982|Vasodilator Agents|vasodilator agents|mesh-ancestor
25093782|NCT03232034|Calcium|calcium|mesh-list
25093784|NCT03232034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476897|NCT00416819|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25093787|NCT03232125|Autonomic Agents|autonomic agents|mesh-ancestor
25093788|NCT03232125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25093789|NCT03232125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093790|NCT03232125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25093791|NCT03232125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25093792|NCT03232125|Serotonin Agents|serotonin agents|mesh-ancestor
25093793|NCT03232125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25093794|NCT03232125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093796|NCT03232021|Analgesics|analgesics|mesh-ancestor
25093797|NCT03232021|Sensory System Agents|sensory system agents|mesh-ancestor
25093798|NCT03232021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25093799|NCT03232021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093800|NCT03232021|Anticonvulsants|anticonvulsants|mesh-ancestor
25093801|NCT03232021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25093802|NCT03232021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25093803|NCT03232021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093804|NCT03232021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25093805|NCT03232021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25093806|NCT03232021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25093807|NCT03232021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25093808|NCT03232021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25093809|NCT03232112|Exenatide|exenatide|mesh-list
25093810|NCT03232112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25093811|NCT03232112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093812|NCT03232112|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25093813|NCT03232112|Incretins|incretins|mesh-ancestor
25093814|NCT03232112|Hormones|hormones|mesh-ancestor
25093816|NCT03231813|Emollients|emollients|mesh-list
24476950|NCT00416858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24476951|NCT00416858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25093839|NCT03231683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25093840|NCT03231436|Bupivacaine|bupivacaine|mesh-list
25093841|NCT03231436|Anesthetics, Local|anesthetics, local|mesh-ancestor
25093842|NCT03231436|Anesthetics|anesthetics|mesh-ancestor
25093843|NCT03231436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25093844|NCT03231436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093845|NCT03231436|Sensory System Agents|sensory system agents|mesh-ancestor
25093846|NCT03231436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24770413|NCT01820325|Paclitaxel|paclitaxel|mesh-list
25680435|NCT01850446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680436|NCT01850602|Sevelamer|sevelamer|mesh-list
25680437|NCT01850602|Chelating Agents|chelating agents|mesh-ancestor
25680438|NCT01850602|Sequestering Agents|sequestering agents|mesh-ancestor
25680439|NCT01850602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680440|NCT01850615|Insulin|insulin|mesh-list
25680441|NCT01850615|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25680442|NCT01850615|Insulin Aspart|insulin aspart|mesh-list
25680443|NCT01850615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25680444|NCT01850615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770421|NCT01820442|Lofexidine|lofexidine|mesh-list
25093847|NCT03231176|Capecitabine|capecitabine|mesh-list
25093848|NCT03231176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25093849|NCT03231176|Antimetabolites|antimetabolites|mesh-ancestor
24837418|NCT02191228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25224269|NCT02634021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224270|NCT02634021|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25224271|NCT02634021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25224272|NCT02634021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24837388|NCT02191176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837412|NCT02191215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24837413|NCT02191215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24837414|NCT02191215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25056047|NCT03515707|Etoposide|etoposide|mesh-list
25093850|NCT03231176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093851|NCT03231176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25093860|NCT03231215|Hormones|hormones|mesh-ancestor
24477131|NCT00417430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25093873|NCT03230825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093874|NCT03230825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25093876|NCT03230851|Indobufen|indobufen|mesh-list
25093877|NCT03230851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24985976|NCT02422368|Methylprednisolone|methylprednisolone|mesh-list
25093878|NCT03230851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25093879|NCT03230851|Analgesics|analgesics|mesh-ancestor
25093880|NCT03230851|Sensory System Agents|sensory system agents|mesh-ancestor
25093881|NCT03230851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25093882|NCT03230851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093883|NCT03230851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25093884|NCT03230851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25093885|NCT03230851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25093886|NCT03230851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25093887|NCT03230851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093888|NCT03230851|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25093889|NCT03230851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25093890|NCT03230851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25093891|NCT03230851|Antipyretics|antipyretics|mesh-ancestor
25093892|NCT03230682|Antidepressive Agents|antidepressive agents|mesh-list
25093893|NCT03230682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25093894|NCT03230630|Melatonin|melatonin|mesh-list
25093895|NCT03230630|Antioxidants|antioxidants|mesh-ancestor
25093896|NCT03230630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093897|NCT03230630|Protective Agents|protective agents|mesh-ancestor
25093898|NCT03230630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477320|NCT00418249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25093918|NCT03230474|Analgesics|analgesics|mesh-ancestor
25093921|NCT03230474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25093922|NCT03230227|Bupivacaine|bupivacaine|mesh-list
25093923|NCT03230227|Anesthetics, Local|anesthetics, local|mesh-ancestor
25093924|NCT03230227|Anesthetics|anesthetics|mesh-ancestor
25093925|NCT03230227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25093926|NCT03230227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093955|NCT03229746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25093956|NCT03229746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25093957|NCT03229746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25093958|NCT03229746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25093959|NCT03229746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25093960|NCT03229746|Antimetabolites|antimetabolites|mesh-ancestor
25093961|NCT03229746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25093962|NCT03229746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25093963|NCT03229746|Immunologic Factors|immunologic factors|mesh-ancestor
25093964|NCT03229746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093965|NCT03229668|Pregabalin|pregabalin|mesh-list
25093966|NCT03229668|Analgesics|analgesics|mesh-ancestor
25093967|NCT03229668|Sensory System Agents|sensory system agents|mesh-ancestor
25093968|NCT03229668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25093969|NCT03229668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093970|NCT03229668|Anticonvulsants|anticonvulsants|mesh-ancestor
25093971|NCT03229668|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25093972|NCT03229668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25224273|NCT02634021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25224274|NCT02634021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25224275|NCT02634021|Anesthetics, General|anesthetics, general|mesh-ancestor
25224276|NCT02634021|Anesthetics|anesthetics|mesh-ancestor
25224277|NCT02634021|GABA Modulators|gaba modulators|mesh-ancestor
25224278|NCT02634021|GABA Agents|gaba agents|mesh-ancestor
25224279|NCT02633969|Indomethacin|indomethacin|mesh-list
25224280|NCT02633969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24837415|NCT02191215|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24837416|NCT02191215|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24837417|NCT02191228|Linagliptin|linagliptin|mesh-list
24837419|NCT02191228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837420|NCT02191228|Incretins|incretins|mesh-ancestor
24837421|NCT02191228|Hormones|hormones|mesh-ancestor
24837422|NCT02191228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25056052|NCT03515707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25093973|NCT03229668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093974|NCT03229668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25093975|NCT03229668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25093976|NCT03229668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25093977|NCT03229668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25093978|NCT03229668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25093979|NCT03229850|Insulin Lispro|insulin lispro|mesh-list
25093980|NCT03229850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25093981|NCT03229850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093982|NCT03230058|Voriconazole|voriconazole|mesh-list
25093983|NCT03230058|Natamycin|natamycin|mesh-list
25093984|NCT03230058|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25093985|NCT03230058|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24477405|NCT00418509|Autonomic Agents|autonomic agents|mesh-ancestor
24477406|NCT00418509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24620026|NCT01055301|Thalidomide|thalidomide|mesh-list
24770656|NCT01821612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24770657|NCT01821612|Antimetabolites|antimetabolites|mesh-ancestor
25093997|NCT03230058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25093998|NCT03230058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25093999|NCT03229694|Bosentan|bosentan|mesh-list
25094000|NCT03229694|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
25094001|NCT03229694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25094002|NCT03229694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094003|NCT03230136|Anesthetics|anesthetics|mesh-list
25094004|NCT03230136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25094005|NCT03230136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094006|NCT03229824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
25094007|NCT03229824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25094033|NCT03229616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25094034|NCT03229616|Immunologic Factors|immunologic factors|mesh-ancestor
25094035|NCT03229616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094036|NCT03229616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25094037|NCT03229616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25094038|NCT03229616|Alkylating Agents|alkylating agents|mesh-ancestor
25027653|NCT03618173|BB 1101|bb 1101|mesh-list
25094039|NCT03229616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094040|NCT03229616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25094041|NCT03229616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25094042|NCT03229616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25094043|NCT03229616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25094044|NCT03229616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25094045|NCT03229616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770658|NCT01821612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094046|NCT03229096|Apatinib|apatinib|mesh-list
25094047|NCT03229096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25094048|NCT03229096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25224281|NCT02633969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25224282|NCT02633969|Analgesics|analgesics|mesh-ancestor
25224283|NCT02633969|Sensory System Agents|sensory system agents|mesh-ancestor
25224284|NCT02633969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25224285|NCT02633969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224286|NCT02633969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25224287|NCT02633969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25224288|NCT02633969|Gout Suppressants|gout suppressants|mesh-ancestor
25224289|NCT02633969|Tocolytic Agents|tocolytic agents|mesh-ancestor
25224290|NCT02633969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24837423|NCT02191228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24837424|NCT02191228|Protease Inhibitors|protease inhibitors|mesh-ancestor
24837425|NCT02191228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837426|NCT02191228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837427|NCT02191280|Quercetin|quercetin|mesh-list
24837428|NCT02191280|Antioxidants|antioxidants|mesh-ancestor
25680445|NCT01850823|Mometasone Furoate|mometasone furoate|mesh-list
25680446|NCT01850823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25680447|NCT01850823|Dermatologic Agents|dermatologic agents|mesh-ancestor
25020296|NCT03681509|Protective Agents|protective agents|mesh-ancestor
25020297|NCT03681509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020298|NCT03681509|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25020299|NCT03681509|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25020300|NCT03681509|Dopamine Agonists|dopamine agonists|mesh-ancestor
25020301|NCT03681509|Dopamine Agents|dopamine agents|mesh-ancestor
25020302|NCT03681509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24837429|NCT02191280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837430|NCT02191280|Protective Agents|protective agents|mesh-ancestor
24837431|NCT02191280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056060|NCT03515707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056061|NCT03515707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25056062|NCT03515707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25056063|NCT03515707|Keratolytic Agents|keratolytic agents|mesh-ancestor
25056064|NCT03515707|Dermatologic Agents|dermatologic agents|mesh-ancestor
25056065|NCT03515707|Tubulin Modulators|tubulin modulators|mesh-ancestor
25056066|NCT03515707|Antimitotic Agents|antimitotic agents|mesh-ancestor
25056067|NCT03515707|Mitosis Modulators|mitosis modulators|mesh-ancestor
25056068|NCT03515668|Methylphenidate|methylphenidate|mesh-list
25094049|NCT03229096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094050|NCT03229096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094054|NCT03229148|Anesthetics|anesthetics|mesh-list
25094055|NCT03229148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24796299|NCT01949129|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25094056|NCT03229148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094057|NCT03229135|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25094058|NCT03229135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25094059|NCT03228992|Ibuprofen|ibuprofen|mesh-list
25094060|NCT03228992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25094061|NCT03228992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25094065|NCT03228992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094066|NCT03228992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25094067|NCT03228992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25094068|NCT03228992|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25094077|NCT03229278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094078|NCT03228901|Oxytocin|oxytocin|mesh-list
25094079|NCT03228901|Oxytocics|oxytocics|mesh-ancestor
25094080|NCT03228901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25094094|NCT03228628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224291|NCT02633969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25224293|NCT02633969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224308|NCT02633930|Amoxicillin|amoxicillin|mesh-list
25224309|NCT02633930|Clarithromycin|clarithromycin|mesh-list
25224310|NCT02633930|Lansoprazole|lansoprazole|mesh-list
24837432|NCT02191293|Nevirapine|nevirapine|mesh-list
24837433|NCT02191293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24837434|NCT02191293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24837435|NCT02191293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837471|NCT02191371|Anesthetics, General|anesthetics, general|mesh-ancestor
24837472|NCT02191371|Anesthetics|anesthetics|mesh-ancestor
24837473|NCT02191371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24837474|NCT02191423|Oxytocin|oxytocin|mesh-list
24837475|NCT02191423|Oxytocics|oxytocics|mesh-ancestor
24837476|NCT02191423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25056069|NCT03515668|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25680448|NCT01850823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25680449|NCT01851330|Sofosbuvir|sofosbuvir|mesh-list
25680450|NCT01851330|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25680451|NCT01851330|Ledipasvir|ledipasvir|mesh-list
25680452|NCT01851330|Antiviral Agents|antiviral agents|mesh-ancestor
25680453|NCT01851330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25680454|NCT01851590|Terbinafine|terbinafine|mesh-list
25680455|NCT01851590|Amorolfine|amorolfine|mesh-list
25680456|NCT01851590|Antifungal Agents|antifungal agents|mesh-ancestor
25680457|NCT01851590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25094096|NCT03228628|Analgesics|analgesics|mesh-ancestor
25094099|NCT03228823|Amiodarone|amiodarone|mesh-list
25094106|NCT03228823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25094107|NCT03228823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25094108|NCT03228823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094109|NCT03228823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25094110|NCT03228823|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25094111|NCT03228823|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24561870|NCT00763347|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24561871|NCT00763347|Protease Inhibitors|protease inhibitors|mesh-ancestor
24561872|NCT00763347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094113|NCT03228732|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25094114|NCT03228732|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25094115|NCT03228732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24770734|NCT01822028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094116|NCT03228732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25094117|NCT03228732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094118|NCT03228732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25094119|NCT03228732|Serotonin Agents|serotonin agents|mesh-ancestor
25094120|NCT03228732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094121|NCT03228732|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25094122|NCT03228732|Antidepressive Agents|antidepressive agents|mesh-ancestor
25094123|NCT03228732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25094124|NCT03228732|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25094126|NCT03228732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094127|NCT03228732|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25094128|NCT03228732|Immunologic Factors|immunologic factors|mesh-ancestor
25094129|NCT03228667|Pembrolizumab|pembrolizumab|mesh-list
25094130|NCT03228667|Nivolumab|nivolumab|mesh-list
25094131|NCT03228667|Durvalumab|durvalumab|mesh-list
25094132|NCT03228667|Avelumab|avelumab|mesh-list
25094133|NCT03228667|Atezolizumab|atezolizumab|mesh-list
24456988|NCT00332891|Amibegron|amibegron|mesh-list
24456989|NCT00332891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24456990|NCT00332891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24456991|NCT00332891|Adrenergic Agents|adrenergic agents|mesh-ancestor
25094140|NCT03228667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094141|NCT03228771|Atorvastatin|atorvastatin|mesh-list
25224311|NCT02633930|Dexlansoprazole|dexlansoprazole|mesh-list
25224312|NCT02633930|Bismuth|bismuth|mesh-list
25224313|NCT02633930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25224314|NCT02633930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25224315|NCT02633930|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25224316|NCT02633930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25224317|NCT02633930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224318|NCT02633930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25224319|NCT02633930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25224320|NCT02633930|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25224321|NCT02633930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25224322|NCT02633930|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25224323|NCT02633930|Antacids|antacids|mesh-ancestor
25224324|NCT02633995|Anesthetics|anesthetics|mesh-list
25224325|NCT02633995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25224326|NCT02633995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224327|NCT02633878|Progesterone|progesterone|mesh-list
25094151|NCT03228576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25094152|NCT03228576|Immunologic Factors|immunologic factors|mesh-ancestor
25094153|NCT03228576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094154|NCT03228576|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25094155|NCT03228576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094156|NCT03228576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094157|NCT03228576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25094158|NCT03228498|Choline|choline|mesh-list
25094159|NCT03228498|Lipotropic Agents|lipotropic agents|mesh-ancestor
25094160|NCT03228498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25094161|NCT03228498|Antimetabolites|antimetabolites|mesh-ancestor
25094162|NCT03228498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094163|NCT03228498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25094164|NCT03228498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25094165|NCT03228498|Nootropic Agents|nootropic agents|mesh-ancestor
25094166|NCT03228368|Atezolizumab|atezolizumab|mesh-list
25094167|NCT03228368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25094169|NCT03228862|Vitamin D|vitamin d|mesh-list
25094178|NCT03228303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25020354|NCT03680716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25020369|NCT03680612|Cefepime|cefepime|mesh-list
25020370|NCT03680612|Enmetazobactam|enmetazobactam|mesh-list
25020371|NCT03680612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25020372|NCT03680612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25020373|NCT03680612|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25020374|NCT03680612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25020375|NCT03680612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020376|NCT03680573|Allopurinol|allopurinol|mesh-list
25020377|NCT03680573|Nitroprusside|nitroprusside|mesh-list
25020378|NCT03680573|Nitroarginine|nitroarginine|mesh-list
24983482|NCT05185869|Tubulin Modulators|tubulin modulators|mesh-ancestor
24542411|NCT00678522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094179|NCT03228303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094180|NCT03228238|Vitamins|vitamins|mesh-list
25094181|NCT03228238|Ascorbic Acid|ascorbic acid|mesh-list
25094182|NCT03228238|Vitamin E|vitamin e|mesh-list
25094183|NCT03228238|Tocopherols|tocopherols|mesh-list
25094184|NCT03228238|Calcium Channel Blockers|calcium channel blockers|mesh-list
25094185|NCT03228238|Atorvastatin|atorvastatin|mesh-list
25094186|NCT03228238|Micronutrients|micronutrients|mesh-ancestor
25094187|NCT03228238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094188|NCT03228238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25094189|NCT03228238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25094190|NCT03228238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25094191|NCT03228238|Antimetabolites|antimetabolites|mesh-ancestor
25094192|NCT03228238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094193|NCT03228238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25094194|NCT03228238|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25094195|NCT03228238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094196|NCT03228238|Antioxidants|antioxidants|mesh-ancestor
25094197|NCT03228238|Protective Agents|protective agents|mesh-ancestor
25094198|NCT03228238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25094199|NCT03228355|Cromakalim|cromakalim|mesh-list
25094200|NCT03228355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25094297|NCT03227705|Hormones|hormones|mesh-ancestor
25094204|NCT03228355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094205|NCT03228355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25094206|NCT03228355|Respiratory System Agents|respiratory system agents|mesh-ancestor
25094207|NCT03228355|Parasympatholytics|parasympatholytics|mesh-ancestor
25094208|NCT03228355|Vasodilator Agents|vasodilator agents|mesh-ancestor
25094209|NCT03228108|Amoxicillin|amoxicillin|mesh-list
25094210|NCT03228108|Ciprofloxacin|ciprofloxacin|mesh-list
25094211|NCT03228108|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25094212|NCT03228108|Clavulanic Acids|clavulanic acids|mesh-list
25094218|NCT03228108|Sulfamethoxazole|sulfamethoxazole|mesh-list
25094219|NCT03228108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25094220|NCT03228108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25094236|NCT03228108|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25094238|NCT03228030|Vitamin B Complex|vitamin b complex|mesh-ancestor
25094239|NCT03228030|Vitamins|vitamins|mesh-ancestor
25094240|NCT03228030|Micronutrients|micronutrients|mesh-ancestor
25094241|NCT03228030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094242|NCT03227731|Tenofovir|tenofovir|mesh-list
25094243|NCT03227731|Emtricitabine|emtricitabine|mesh-list
25094244|NCT03227731|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25224328|NCT02633878|Progestins|progestins|mesh-ancestor
25224329|NCT02633878|Hormones|hormones|mesh-ancestor
25224330|NCT02633878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25224331|NCT02633878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224332|NCT02633696|Silybin|silybin|mesh-list
25405284|NCT03615105|Immunologic Factors|immunologic factors|mesh-ancestor
25680458|NCT01851590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25680459|NCT01851590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680460|NCT01851720|Fentanyl|fentanyl|mesh-list
25680461|NCT01851720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25680462|NCT01851720|Narcotics|narcotics|mesh-ancestor
25680463|NCT01851720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25680464|NCT01851720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680465|NCT01851720|Analgesics|analgesics|mesh-ancestor
25680466|NCT01851720|Sensory System Agents|sensory system agents|mesh-ancestor
25680467|NCT01851720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25680468|NCT01851720|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25680469|NCT01851720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25680470|NCT01851720|Anesthetics, General|anesthetics, general|mesh-ancestor
24837483|NCT02191475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837484|NCT02191527|Chrysarobin|chrysarobin|mesh-list
24837485|NCT02191527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24837486|NCT02191527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25094245|NCT03227731|Antiviral Agents|antiviral agents|mesh-ancestor
25094246|NCT03227731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25094247|NCT03227731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25094249|NCT03227731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094256|NCT03227900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25094257|NCT03227900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094258|NCT03227900|Sensory System Agents|sensory system agents|mesh-ancestor
25094259|NCT03227900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25094260|NCT03227900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25094261|NCT03227900|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24770806|NCT01822509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25094262|NCT03227900|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24770880|NCT01822951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770882|NCT01822951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24770883|NCT01822951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770884|NCT01822951|Nootropic Agents|nootropic agents|mesh-ancestor
24770885|NCT01822951|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24770886|NCT01822951|Protective Agents|protective agents|mesh-ancestor
24770887|NCT01822977|Omeprazole|omeprazole|mesh-list
24770888|NCT01822977|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25094263|NCT03227900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25094264|NCT03227900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770889|NCT01822977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25094265|NCT03228043|Apatinib|apatinib|mesh-list
25094266|NCT03228043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25094267|NCT03228043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25094268|NCT03228043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094269|NCT03228043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094273|NCT03227679|Bupropion|bupropion|mesh-list
25094274|NCT03227679|Nicotine|nicotine|mesh-list
25094292|NCT03227679|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25094293|NCT03227679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25094294|NCT03227679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094296|NCT03227705|Progestins|progestins|mesh-ancestor
25094307|NCT03227653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094308|NCT03227653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094309|NCT03227653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25094310|NCT03227653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25094311|NCT03227653|Antiviral Agents|antiviral agents|mesh-ancestor
25094312|NCT03227653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25094313|NCT03227653|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25094314|NCT03227653|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25094316|NCT03227653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25094317|NCT03227653|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25224334|NCT02633696|Antioxidants|antioxidants|mesh-ancestor
25224335|NCT02633696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224336|NCT02633696|Protective Agents|protective agents|mesh-ancestor
25224337|NCT02633696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224338|NCT02633696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25224339|NCT02633696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25224340|NCT02633683|Gabapentin|gabapentin|mesh-list
24837487|NCT02191527|Analgesics|analgesics|mesh-ancestor
24837488|NCT02191527|Sensory System Agents|sensory system agents|mesh-ancestor
24837489|NCT02191527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25094322|NCT03227484|Empagliflozin|empagliflozin|mesh-list
24478751|NCT00424229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24478752|NCT00424229|Growth Substances|growth substances|mesh-ancestor
25094323|NCT03227484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25405285|NCT03615105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680472|NCT01851863|Flupenthixol|flupenthixol|mesh-list
25680473|NCT01851863|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
25680474|NCT01851863|Omeprazole|omeprazole|mesh-list
25680475|NCT01851863|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24543561|NCT00684216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24543562|NCT00684216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543563|NCT00684216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24543564|NCT00684216|Hormone Antagonists|hormone antagonists|mesh-ancestor
24543565|NCT00684216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25094324|NCT03227484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094325|NCT03227484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25094326|NCT03227484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094327|NCT03227419|Abatacept|abatacept|mesh-list
25094328|NCT03227419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25094329|NCT03227419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094330|NCT03227419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25094331|NCT03227419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25094332|NCT03227419|Immunologic Factors|immunologic factors|mesh-ancestor
25094333|NCT03227419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094334|NCT03227419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24771023|NCT01824238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24478807|NCT00424606|Mitosis Modulators|mitosis modulators|mesh-ancestor
25094361|NCT03227432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25094362|NCT03227432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25094363|NCT03227432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25094364|NCT03227432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094365|NCT03227432|Immunologic Factors|immunologic factors|mesh-ancestor
25094366|NCT03227432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25094367|NCT03227432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25094368|NCT03227432|Growth Substances|growth substances|mesh-ancestor
25094369|NCT03227432|Growth Inhibitors|growth inhibitors|mesh-ancestor
25094370|NCT03227016|Topotecan|topotecan|mesh-list
25094371|NCT03227016|Veliparib|veliparib|mesh-list
25094372|NCT03227016|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25094373|NCT03227016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25094374|NCT03227016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25094375|NCT03227016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094416|NCT03226522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25094417|NCT03226522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24509134|NCT00558662|Sodium Ionophores|sodium ionophores|mesh-ancestor
25094418|NCT03226522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094420|NCT03226522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25224341|NCT02633683|Analgesics|analgesics|mesh-ancestor
25224342|NCT02633683|Sensory System Agents|sensory system agents|mesh-ancestor
25224343|NCT02633683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25094421|NCT03226522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094422|NCT03226522|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25094423|NCT03226522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25094424|NCT03226522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094425|NCT03226340|Niacin|niacin|mesh-list
25094426|NCT03226340|Amlodipine|amlodipine|mesh-list
25094427|NCT03226340|Telmisartan|telmisartan|mesh-list
25094428|NCT03226340|Chlorthalidone|chlorthalidone|mesh-list
25094429|NCT03226340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25094461|NCT03225937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25094463|NCT03225937|Antimitotic Agents|antimitotic agents|mesh-ancestor
25094464|NCT03225937|Mitosis Modulators|mitosis modulators|mesh-ancestor
25094465|NCT03226080|Rocuronium|rocuronium|mesh-list
25094466|NCT03226080|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25094467|NCT03226080|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25094468|NCT03226080|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24429231|NCT00243009|Cyclosporine|cyclosporine|mesh-list
24479042|NCT00425360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24479043|NCT00425360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479044|NCT00425360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25094480|NCT03225924|Vincristine|vincristine|mesh-list
25094481|NCT03225924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25094482|NCT03225924|Immunologic Factors|immunologic factors|mesh-ancestor
25094524|NCT03225950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094525|NCT03225690|Morphine|morphine|mesh-list
25094526|NCT03225690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25094527|NCT03225690|Narcotics|narcotics|mesh-ancestor
25680476|NCT01851863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25680477|NCT01851863|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25680478|NCT01851863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25680479|NCT01851863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680480|NCT01851863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25020431|NCT03680404|Respiratory System Agents|respiratory system agents|mesh-ancestor
25020432|NCT03680404|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25020433|NCT03680404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25020434|NCT03680404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25020435|NCT03680404|Adrenergic Agents|adrenergic agents|mesh-ancestor
25020436|NCT03680404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25020437|NCT03680404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020439|NCT03680404|Antimetabolites|antimetabolites|mesh-ancestor
25094528|NCT03225690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25094529|NCT03225690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094530|NCT03225690|Analgesics|analgesics|mesh-ancestor
25094531|NCT03225690|Sensory System Agents|sensory system agents|mesh-ancestor
25094532|NCT03225690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24509693|NCT00561704|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25094533|NCT03225755|Hormones|hormones|mesh-list
25094534|NCT03225755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25094535|NCT03225755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094536|NCT03225781|Bleomycin|bleomycin|mesh-list
25094537|NCT03225781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25094538|NCT03225781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25094539|NCT03225456|Oxytocin|oxytocin|mesh-list
25094540|NCT03225456|Oxytocics|oxytocics|mesh-ancestor
25094541|NCT03225456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25094542|NCT03225456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094543|NCT03225352|Aspirin|aspirin|mesh-list
25094544|NCT03225352|Ibuprofen|ibuprofen|mesh-list
25094545|NCT03225352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25094546|NCT03225352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25094547|NCT03225352|Analgesics|analgesics|mesh-ancestor
24771139|NCT01825031|Raltegravir Potassium|raltegravir potassium|mesh-list
25094548|NCT03225352|Sensory System Agents|sensory system agents|mesh-ancestor
25094549|NCT03225352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25094550|NCT03225352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771228|NCT01825473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24479149|NCT00425724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479150|NCT00425724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479151|NCT00425724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479152|NCT00425724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24479153|NCT00425724|Immunologic Factors|immunologic factors|mesh-ancestor
24479154|NCT00425724|Antifungal Agents|antifungal agents|mesh-ancestor
25094563|NCT03225326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25094564|NCT03225326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094565|NCT03225326|Sensory System Agents|sensory system agents|mesh-ancestor
25094566|NCT03225326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25224344|NCT02633683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224345|NCT02633683|Anticonvulsants|anticonvulsants|mesh-ancestor
25224346|NCT02633683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25224347|NCT02633683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24837494|NCT02191566|Tegafur|tegafur|mesh-list
24837495|NCT02191566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24837496|NCT02191566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25094567|NCT03224923|Aspirin|aspirin|mesh-list
25094568|NCT03224923|Clopidogrel|clopidogrel|mesh-list
25094569|NCT03224923|Ticagrelor|ticagrelor|mesh-list
25094570|NCT03224923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25094571|NCT03224923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25094572|NCT03224923|Analgesics|analgesics|mesh-ancestor
25094573|NCT03224923|Sensory System Agents|sensory system agents|mesh-ancestor
25094574|NCT03224923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25094575|NCT03224923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094576|NCT03224923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24771229|NCT01825473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25094621|NCT03224871|Antiviral Agents|antiviral agents|mesh-ancestor
25094622|NCT03224871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24771301|NCT01825928|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25094623|NCT03224208|Vemurafenib|vemurafenib|mesh-list
25680481|NCT01851863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25680482|NCT01851863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25680483|NCT01851863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680484|NCT01851863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25680485|NCT01851863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25680486|NCT01851863|Dopamine Agents|dopamine agents|mesh-ancestor
25680487|NCT01851863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25680488|NCT01852019|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25680489|NCT01852019|Cangrelor|cangrelor|mesh-list
24543994|NCT00686322|Mitosis Modulators|mitosis modulators|mesh-ancestor
25094624|NCT03224208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25094625|NCT03224208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25094626|NCT03224208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094627|NCT03224208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094628|NCT03224338|Dolutegravir|dolutegravir|mesh-list
25094629|NCT03224338|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25094630|NCT03224338|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25094631|NCT03224338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094647|NCT03224221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25094649|NCT03224221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094650|NCT03224221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25094651|NCT03224221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094652|NCT03224039|Sufentanil|sufentanil|mesh-list
25094653|NCT03224039|Morphine|morphine|mesh-list
25094654|NCT03224039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25094655|NCT03224039|Narcotics|narcotics|mesh-ancestor
25094656|NCT03224039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25094657|NCT03224039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094658|NCT03224039|Analgesics|analgesics|mesh-ancestor
25094659|NCT03224039|Sensory System Agents|sensory system agents|mesh-ancestor
25094660|NCT03224039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25094661|NCT03224039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25094662|NCT03224039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25094663|NCT03224039|Anesthetics, General|anesthetics, general|mesh-ancestor
25094677|NCT03223844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094679|NCT03223844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25094680|NCT03223844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25094681|NCT03223844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094682|NCT03223844|Dopamine Agents|dopamine agents|mesh-ancestor
25094685|NCT03223961|Hematinics|hematinics|mesh-ancestor
25094686|NCT03223506|Acetaminophen|acetaminophen|mesh-list
25094687|NCT03223506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25094688|NCT03223506|Analgesics|analgesics|mesh-ancestor
25094689|NCT03223506|Sensory System Agents|sensory system agents|mesh-ancestor
25094690|NCT03223506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25094691|NCT03223506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094692|NCT03223506|Antipyretics|antipyretics|mesh-ancestor
25094699|NCT03223519|Ibuprofen|ibuprofen|mesh-list
25094700|NCT03223519|Vitamins|vitamins|mesh-ancestor
25094701|NCT03223519|Micronutrients|micronutrients|mesh-ancestor
25094702|NCT03223519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094703|NCT03223519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25094704|NCT03223519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25094705|NCT03223519|Analgesics|analgesics|mesh-ancestor
25094706|NCT03223519|Sensory System Agents|sensory system agents|mesh-ancestor
25094707|NCT03223519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25094708|NCT03223519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25094709|NCT03223519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25224348|NCT02633683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25224349|NCT02633683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25273247|NCT02386449|Cathartics|cathartics|mesh-ancestor
24837497|NCT02191566|Antimetabolites|antimetabolites|mesh-ancestor
24837498|NCT02191566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837499|NCT02191657|Deferiprone|deferiprone|mesh-list
24837500|NCT02191657|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24837501|NCT02191657|Chelating Agents|chelating agents|mesh-ancestor
24837502|NCT02191657|Sequestering Agents|sequestering agents|mesh-ancestor
24837503|NCT02191657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094710|NCT03223519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25094711|NCT03223519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094712|NCT03223519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094713|NCT03223519|Antioxidants|antioxidants|mesh-ancestor
25094714|NCT03223519|Protective Agents|protective agents|mesh-ancestor
25094715|NCT03223402|Lamivudine|lamivudine|mesh-list
25094716|NCT03223402|Nevirapine|nevirapine|mesh-list
25094719|NCT03223402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094724|NCT03223402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25094725|NCT03223402|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25094726|NCT03223402|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25680490|NCT01852019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25094727|NCT03223220|Midazolam|midazolam|mesh-list
25094728|NCT03223220|Ketamine|ketamine|mesh-list
25680491|NCT01852019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25020565|NCT03679065|Analgesics|analgesics|mesh-ancestor
25094729|NCT03223220|Analgesics|analgesics|mesh-ancestor
25094730|NCT03223220|Sensory System Agents|sensory system agents|mesh-ancestor
25094765|NCT03223025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25094766|NCT03223025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094768|NCT03222960|Fluorides|fluorides|mesh-list
25094769|NCT03222960|Cariostatic Agents|cariostatic agents|mesh-ancestor
25094770|NCT03222960|Protective Agents|protective agents|mesh-ancestor
25094771|NCT03222960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094772|NCT03222960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25094774|NCT03222544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094775|NCT03222544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094776|NCT03222765|Metformin|metformin|mesh-list
25094777|NCT03222765|Linagliptin|linagliptin|mesh-list
25094778|NCT03222765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25094779|NCT03222765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094780|NCT03222765|Incretins|incretins|mesh-ancestor
25094781|NCT03222765|Hormones|hormones|mesh-ancestor
25094782|NCT03222765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25094783|NCT03222765|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25094784|NCT03222765|Protease Inhibitors|protease inhibitors|mesh-ancestor
25094785|NCT03222765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094786|NCT03222765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094787|NCT03222687|Prednisone|prednisone|mesh-list
25094788|NCT03222687|Tacrolimus|tacrolimus|mesh-list
25094789|NCT03222687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25094791|NCT03222687|Hormones|hormones|mesh-ancestor
25094792|NCT03222687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25094793|NCT03222687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094794|NCT03222687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25094823|NCT03222206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25094824|NCT03222323|Dexmedetomidine|dexmedetomidine|mesh-list
25094825|NCT03222323|Ropivacaine|ropivacaine|mesh-list
25094826|NCT03222323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25094827|NCT03222323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25094828|NCT03222323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224350|NCT02633683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25224351|NCT02633683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25224352|NCT02633683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25224353|NCT02633683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224354|NCT02633683|Antimanic Agents|antimanic agents|mesh-ancestor
25224355|NCT02633813|Naftifine|naftifine|mesh-list
25224356|NCT02633813|Antifungal Agents|antifungal agents|mesh-ancestor
25224357|NCT02633813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24837508|NCT02191709|Dextromethorphan|dextromethorphan|mesh-list
24837520|NCT02191748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24837521|NCT02191748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837522|NCT02191826|Tolcapone|tolcapone|mesh-list
24837523|NCT02191826|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25056111|NCT03515200|Cytarabine|cytarabine|mesh-list
25094829|NCT03222323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25094830|NCT03222323|Analgesics|analgesics|mesh-ancestor
25094831|NCT03222323|Sensory System Agents|sensory system agents|mesh-ancestor
25094832|NCT03222323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25094833|NCT03222323|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25094834|NCT03222323|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25094847|NCT03222089|Sargramostim|sargramostim|mesh-list
25094848|NCT03222089|Levoleucovorin|levoleucovorin|mesh-list
25094849|NCT03222089|Antimetabolites|antimetabolites|mesh-ancestor
25094850|NCT03222089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094851|NCT03222089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25094852|NCT03222089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25094853|NCT03222089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25094854|NCT03222089|Immunologic Factors|immunologic factors|mesh-ancestor
25094855|NCT03222089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094856|NCT03222089|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25094857|NCT03222089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25094858|NCT03222089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094859|NCT03222089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25094860|NCT03222089|Analgesics|analgesics|mesh-ancestor
25094861|NCT03222089|Sensory System Agents|sensory system agents|mesh-ancestor
25094862|NCT03222089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24545337|NCT00693069|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24545343|NCT00693108|Testosterone|testosterone|mesh-list
25094863|NCT03222089|Antidotes|antidotes|mesh-ancestor
25094864|NCT03222089|Protective Agents|protective agents|mesh-ancestor
25094865|NCT03222089|Vitamin B Complex|vitamin b complex|mesh-ancestor
25094866|NCT03222089|Vitamins|vitamins|mesh-ancestor
25094867|NCT03222089|Micronutrients|micronutrients|mesh-ancestor
25094868|NCT03222310|Itraconazole|itraconazole|mesh-list
25094891|NCT03221816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094892|NCT03221855|Domperidone|domperidone|mesh-list
25094893|NCT03221855|Antiemetics|antiemetics|mesh-ancestor
25094894|NCT03221855|Autonomic Agents|autonomic agents|mesh-ancestor
25094895|NCT03221855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25094896|NCT03221855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094897|NCT03221855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25094898|NCT03221855|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25094899|NCT03221855|Dopamine Agents|dopamine agents|mesh-ancestor
25094900|NCT03221855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25094901|NCT03221855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094902|NCT03221907|Pregabalin|pregabalin|mesh-list
25094903|NCT03221907|Analgesics|analgesics|mesh-ancestor
25094904|NCT03221907|Sensory System Agents|sensory system agents|mesh-ancestor
25094905|NCT03221907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25094906|NCT03221907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094907|NCT03221907|Anticonvulsants|anticonvulsants|mesh-ancestor
25094908|NCT03221907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25094909|NCT03221907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25094910|NCT03221907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224359|NCT02633852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25224360|NCT02633852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25224361|NCT02633852|Growth Substances|growth substances|mesh-ancestor
25224362|NCT02633852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224363|NCT02633852|Growth Inhibitors|growth inhibitors|mesh-ancestor
24837525|NCT02191826|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24837526|NCT02191826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25056118|NCT03515200|Palbociclib|palbociclib|mesh-list
25094946|NCT03221998|Antipyretics|antipyretics|mesh-ancestor
25094947|NCT03221569|Ketorolac|ketorolac|mesh-list
25094948|NCT03221569|Ketamine|ketamine|mesh-list
25094949|NCT03221569|Analgesics|analgesics|mesh-ancestor
25094950|NCT03221569|Sensory System Agents|sensory system agents|mesh-ancestor
25094951|NCT03221569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25094952|NCT03221569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094953|NCT03221569|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25094954|NCT03221569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25094955|NCT03221569|Anesthetics, General|anesthetics, general|mesh-ancestor
25094956|NCT03221569|Anesthetics|anesthetics|mesh-ancestor
25094957|NCT03221569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25094958|NCT03221569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25094959|NCT03221569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25094960|NCT03221569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25094961|NCT03221569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094962|NCT03221569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25094963|NCT03221569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25094964|NCT03221569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25094965|NCT03221569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25095003|NCT03221582|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25095004|NCT03221582|Antiviral Agents|antiviral agents|mesh-ancestor
25095005|NCT03221582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25095006|NCT03221634|Pembrolizumab|pembrolizumab|mesh-list
25095007|NCT03221634|Daratumumab|daratumumab|mesh-list
25095008|NCT03221634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25095009|NCT03221634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095024|NCT03221166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25095026|NCT03221166|Growth Inhibitors|growth inhibitors|mesh-ancestor
25095027|NCT03221166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095028|NCT03221231|Acetylcysteine|acetylcysteine|mesh-list
25095029|NCT03221231|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25095030|NCT03221231|Antiviral Agents|antiviral agents|mesh-ancestor
25095031|NCT03221231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25095032|NCT03221231|Expectorants|expectorants|mesh-ancestor
25095033|NCT03221231|Respiratory System Agents|respiratory system agents|mesh-ancestor
25095034|NCT03221231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25095035|NCT03221231|Antioxidants|antioxidants|mesh-ancestor
25680492|NCT01852019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25680493|NCT01852019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25095036|NCT03221231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095037|NCT03221231|Protective Agents|protective agents|mesh-ancestor
25095041|NCT03221621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25095042|NCT03221621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25095044|NCT03221023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25095045|NCT03221023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25095047|NCT03220932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25224364|NCT02633852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095048|NCT03220932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095049|NCT03220932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25095050|NCT03220932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25224365|NCT02633774|Propafenone|propafenone|mesh-list
25224366|NCT02633774|Apixaban|apixaban|mesh-list
25224367|NCT02633774|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25224368|NCT02633774|Antithrombins|antithrombins|mesh-ancestor
24837539|NCT02191891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095051|NCT03220932|Growth Substances|growth substances|mesh-ancestor
25095052|NCT03220932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095053|NCT03220932|Growth Inhibitors|growth inhibitors|mesh-ancestor
25095054|NCT03220815|Methamphetamine|methamphetamine|mesh-list
25095055|NCT03220815|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25095078|NCT03220880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25095079|NCT03220880|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25095080|NCT03220880|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25095081|NCT03220880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25095082|NCT03220880|Adrenergic Agents|adrenergic agents|mesh-ancestor
25095083|NCT03220880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25095084|NCT03220880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771839|NCT01830270|Antimitotic Agents|antimitotic agents|mesh-ancestor
24771840|NCT01830270|Mitosis Modulators|mitosis modulators|mesh-ancestor
25095085|NCT03220867|Risperidone|risperidone|mesh-list
25095086|NCT03220867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25095087|NCT03220867|Serotonin Agents|serotonin agents|mesh-ancestor
25095088|NCT03220867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25095089|NCT03220867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095090|NCT03220867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095091|NCT03220867|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25095092|NCT03220867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25095101|NCT03220789|Autonomic Agents|autonomic agents|mesh-ancestor
25095102|NCT03220789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25095103|NCT03220789|Dopamine Agents|dopamine agents|mesh-ancestor
25095104|NCT03220789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25095105|NCT03220789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095106|NCT03220789|Adrenergic Agents|adrenergic agents|mesh-ancestor
25095107|NCT03220789|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25095108|NCT03220789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25095109|NCT03220789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25095110|NCT03220789|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25095111|NCT03220555|Lidocaine|lidocaine|mesh-list
25095112|NCT03220555|Prilocaine|prilocaine|mesh-list
25095113|NCT03220555|Anesthetics, Local|anesthetics, local|mesh-ancestor
25095114|NCT03220555|Anesthetics|anesthetics|mesh-ancestor
25095115|NCT03220555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25095116|NCT03220555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095117|NCT03220555|Sensory System Agents|sensory system agents|mesh-ancestor
25095118|NCT03220555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25095133|NCT03220256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25095134|NCT03220256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25095135|NCT03220256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25095136|NCT03220321|Lithium Carbonate|lithium carbonate|mesh-list
25095137|NCT03220321|Antidepressive Agents|antidepressive agents|mesh-ancestor
25095138|NCT03220321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25095139|NCT03220321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25095140|NCT03220321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095141|NCT03220321|Antimanic Agents|antimanic agents|mesh-ancestor
25095142|NCT03220321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25095143|NCT03220321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25224378|NCT02633709|Itraconazole|itraconazole|mesh-list
25224375|NCT02633774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25224376|NCT02633774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24837560|NCT02191943|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
24837561|NCT02191943|Cariostatic Agents|cariostatic agents|mesh-ancestor
24703846|NCT01475019|Orlistat|orlistat|mesh-list
24447403|NCT00308425|Valsartan|valsartan|mesh-list
25056130|NCT03515200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25095145|NCT03220425|Insulin|insulin|mesh-list
25095146|NCT03220425|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25095147|NCT03220425|Insulin Detemir|insulin detemir|mesh-list
25095148|NCT03220425|Insulin, Isophane|insulin, isophane|mesh-list
25095149|NCT03220425|Isophane Insulin, Human|isophane insulin, human|mesh-list
25095150|NCT03220425|Isophane insulin, beef|isophane insulin, beef|mesh-list
25095151|NCT03220425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25095152|NCT03220425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095153|NCT03220542|Amoxicillin|amoxicillin|mesh-list
25095154|NCT03220542|Clarithromycin|clarithromycin|mesh-list
25095155|NCT03220542|Sulforaphane|sulforaphane|mesh-list
25095180|NCT03220490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25095181|NCT03220490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25095182|NCT03220490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25095183|NCT03220490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25095184|NCT03220152|Tenofovir|tenofovir|mesh-list
25095185|NCT03220152|Emtricitabine|emtricitabine|mesh-list
25095186|NCT03220152|Antiviral Agents|antiviral agents|mesh-ancestor
25095187|NCT03220152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25095188|NCT03220152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25095189|NCT03220152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25095190|NCT03220152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25095191|NCT03220152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095192|NCT03220152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25095219|NCT03220113|Thiamine|thiamine|mesh-list
25095226|NCT03220113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095227|NCT03220113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25095228|NCT03220113|Glucocorticoids|glucocorticoids|mesh-ancestor
25095229|NCT03220113|Hormones|hormones|mesh-ancestor
25095230|NCT03220113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25095231|NCT03220113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25095232|NCT03220113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095233|NCT03220113|Anesthetics, Local|anesthetics, local|mesh-ancestor
25095234|NCT03220113|Anesthetics|anesthetics|mesh-ancestor
25095235|NCT03220113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25095236|NCT03220113|Sensory System Agents|sensory system agents|mesh-ancestor
25095237|NCT03220113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25095238|NCT03220113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25095239|NCT03220113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25095240|NCT03220113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25095241|NCT03220113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095242|NCT03220113|Vitamin B Complex|vitamin b complex|mesh-ancestor
25095243|NCT03220113|Vitamins|vitamins|mesh-ancestor
25095244|NCT03220113|Micronutrients|micronutrients|mesh-ancestor
25095245|NCT03219788|Remifentanil|remifentanil|mesh-list
25095246|NCT03219788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25095247|NCT03219788|Narcotics|narcotics|mesh-ancestor
25095248|NCT03219788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25095249|NCT03219788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095250|NCT03219788|Analgesics|analgesics|mesh-ancestor
25095251|NCT03219788|Sensory System Agents|sensory system agents|mesh-ancestor
25095252|NCT03219788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25095253|NCT03219853|Selenium|selenium|mesh-list
25095254|NCT03219853|Antioxidants|antioxidants|mesh-ancestor
25095255|NCT03219853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224377|NCT02633774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25043139|NCT01318252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25043140|NCT01314222|Pregabalin|pregabalin|mesh-list
25095256|NCT03219853|Protective Agents|protective agents|mesh-ancestor
25095257|NCT03219853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095258|NCT03219853|Trace Elements|trace elements|mesh-ancestor
25095259|NCT03219853|Micronutrients|micronutrients|mesh-ancestor
25095260|NCT03219762|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25095262|NCT03219970|Osimertinib|osimertinib|mesh-list
25095264|NCT03219970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25095265|NCT03219970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25095266|NCT03219970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095268|NCT03220009|Ipilimumab|ipilimumab|mesh-list
25095269|NCT03220009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25095270|NCT03220009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095271|NCT03220009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25680494|NCT01852019|Purinergic Agents|purinergic agents|mesh-ancestor
25680495|NCT01852019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25095272|NCT03220009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095289|NCT03219710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095290|NCT03219710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25095291|NCT03219710|Glucocorticoids|glucocorticoids|mesh-ancestor
25095293|NCT03219710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25095294|NCT03219710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25095295|NCT03219710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095296|NCT03219710|Antipruritics|antipruritics|mesh-ancestor
24771987|NCT01830829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25095297|NCT03219710|Dermatologic Agents|dermatologic agents|mesh-ancestor
25095303|NCT03219710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25095304|NCT03219710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25095305|NCT03219710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25095306|NCT03219710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25095307|NCT03219710|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25095308|NCT03219710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25095309|NCT03219710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25095310|NCT03219710|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25095311|NCT03219554|Palbociclib|palbociclib|mesh-list
25095312|NCT03219554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095313|NCT03219554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25095314|NCT03219554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25095315|NCT03219554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095316|NCT03219593|Apatinib|apatinib|mesh-list
25095317|NCT03219593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095318|NCT03219593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25095319|NCT03219593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25095320|NCT03219593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095321|NCT03219580|Fluorouracil|fluorouracil|mesh-list
25095322|NCT03219580|Antimetabolites|antimetabolites|mesh-ancestor
25095323|NCT03219580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095324|NCT03219580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25095325|NCT03219580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095326|NCT03219580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25095327|NCT03219580|Immunologic Factors|immunologic factors|mesh-ancestor
25095328|NCT03219580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480478|NCT00431119|Antimetabolites|antimetabolites|mesh-ancestor
25224400|NCT02633657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25043147|NCT01314222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25043148|NCT01314222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043149|NCT01314222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25043150|NCT01314222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25043151|NCT01314222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25043152|NCT01314222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25043153|NCT01314222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25043154|NCT01313572|Adenosine|adenosine|mesh-list
25095369|NCT03219671|Nivolumab|nivolumab|mesh-list
25095370|NCT03219671|Ipilimumab|ipilimumab|mesh-list
25095371|NCT03219671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25095372|NCT03219671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772063|NCT01831479|Olmesartan|olmesartan|mesh-list
25095373|NCT03219671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25095374|NCT03219671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511156|NCT00567554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25095387|NCT03219645|Aspirin|aspirin|mesh-list
25095388|NCT03219645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25095389|NCT03219645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25095390|NCT03219645|Analgesics|analgesics|mesh-ancestor
25095391|NCT03219645|Sensory System Agents|sensory system agents|mesh-ancestor
25680496|NCT01852019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680497|NCT01852019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680498|NCT01852045|Botulinum Toxins|botulinum toxins|mesh-list
25680499|NCT01852045|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25680500|NCT01852045|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25680501|NCT01852045|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25095392|NCT03219645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25095393|NCT03219645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095394|NCT03219645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25095395|NCT03219645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25095396|NCT03219645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25095397|NCT03219645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25095398|NCT03219645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095399|NCT03219645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25095400|NCT03219645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25095401|NCT03219645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413678|NCT00194909|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24413679|NCT00194909|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25095413|NCT03218969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25095414|NCT03218969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095415|NCT03218969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25095416|NCT03218969|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25095417|NCT03218969|Dopamine Agents|dopamine agents|mesh-ancestor
25095418|NCT03218969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25095419|NCT03218969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224391|NCT02633709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25224392|NCT02633709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25224393|NCT02633657|Gabapentin|gabapentin|mesh-list
25224394|NCT02633657|Analgesics|analgesics|mesh-ancestor
25224395|NCT02633657|Sensory System Agents|sensory system agents|mesh-ancestor
25224396|NCT02633657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25224397|NCT02633657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224398|NCT02633657|Anticonvulsants|anticonvulsants|mesh-ancestor
25224399|NCT02633657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25224401|NCT02633657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25224402|NCT02633657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25224403|NCT02633657|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25224404|NCT02633657|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25043156|NCT01313572|Sensory System Agents|sensory system agents|mesh-ancestor
25095420|NCT03219008|Lithium Carbonate|lithium carbonate|mesh-list
25095421|NCT03219008|Mirtazapine|mirtazapine|mesh-list
25095422|NCT03219008|Fluvoxamine|fluvoxamine|mesh-list
25095423|NCT03219008|Fluoxetine|fluoxetine|mesh-list
25095424|NCT03219008|Bupropion|bupropion|mesh-list
25095425|NCT03219008|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
25095426|NCT03219008|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25095427|NCT03219008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25095428|NCT03219008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25095429|NCT03219008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095430|NCT03219008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25095431|NCT03219008|Serotonin Agents|serotonin agents|mesh-ancestor
25095432|NCT03219008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095433|NCT03219008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25095434|NCT03219008|Antidepressive Agents|antidepressive agents|mesh-ancestor
25095435|NCT03219008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25095436|NCT03219008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25095437|NCT03219008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25095438|NCT03219008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25095439|NCT03219008|Antimanic Agents|antimanic agents|mesh-ancestor
25095440|NCT03219008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25095441|NCT03219008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25095442|NCT03219008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25095443|NCT03219008|Histamine Antagonists|histamine antagonists|mesh-ancestor
24620634|NCT01058057|Antimetabolites|antimetabolites|mesh-ancestor
25095446|NCT03219008|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25095447|NCT03219008|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25095448|NCT03219008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25095449|NCT03219008|Adrenergic Agents|adrenergic agents|mesh-ancestor
25095450|NCT03219008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25095451|NCT03219008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25095452|NCT03219008|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25095453|NCT03219008|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25095454|NCT03219008|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25095455|NCT03219008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25095456|NCT03219008|Dopamine Agents|dopamine agents|mesh-ancestor
25095457|NCT03218930|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25095458|NCT03218930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24547975|NCT00707083|Vincristine|vincristine|mesh-list
25095459|NCT03218930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25095460|NCT03218930|Antitubercular Agents|antitubercular agents|mesh-ancestor
24772153|NCT01832051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25095473|NCT03218631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095474|NCT03218631|Anabolic Agents|anabolic agents|mesh-ancestor
25095475|NCT03218709|Vitamins|vitamins|mesh-list
25095476|NCT03218709|Micronutrients|micronutrients|mesh-ancestor
25095478|NCT03218657|Cyclosporine|cyclosporine|mesh-list
24986555|NCT00193219|Protective Agents|protective agents|mesh-ancestor
25095486|NCT03218657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095487|NCT03218657|Antifungal Agents|antifungal agents|mesh-ancestor
25095488|NCT03218657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25095489|NCT03218657|Dermatologic Agents|dermatologic agents|mesh-ancestor
25095490|NCT03218657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25095491|NCT03218657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25095492|NCT03218657|Hormones|hormones|mesh-ancestor
25095493|NCT03218657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25095494|NCT03218657|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25095495|NCT03218657|Antinematodal Agents|antinematodal agents|mesh-ancestor
25095496|NCT03218657|Anthelmintics|anthelmintics|mesh-ancestor
25095497|NCT03218657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25095498|NCT03218553|Dexamethasone|dexamethasone|mesh-list
25095499|NCT03218553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25095500|NCT03218553|Antiemetics|antiemetics|mesh-ancestor
25095501|NCT03218553|Autonomic Agents|autonomic agents|mesh-ancestor
25095502|NCT03218553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25095503|NCT03218553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095504|NCT03218553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25095505|NCT03218553|Glucocorticoids|glucocorticoids|mesh-ancestor
25095506|NCT03218553|Hormones|hormones|mesh-ancestor
25095507|NCT03218553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25095509|NCT03218553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25224405|NCT02633657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25043157|NCT01313572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25043158|NCT01313572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043159|NCT01313572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25043160|NCT01313572|Vasodilator Agents|vasodilator agents|mesh-ancestor
25043161|NCT01313572|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25043162|NCT01313572|Purinergic Agonists|purinergic agonists|mesh-ancestor
25043163|NCT01313572|Purinergic Agents|purinergic agents|mesh-ancestor
25095511|NCT03218852|Cyclophosphamide|cyclophosphamide|mesh-list
25095512|NCT03218852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25095513|NCT03218852|Immunologic Factors|immunologic factors|mesh-ancestor
25095514|NCT03218852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095515|NCT03218852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25095516|NCT03218852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25095530|NCT03218722|Hemostatics|hemostatics|mesh-ancestor
25095531|NCT03218722|Coagulants|coagulants|mesh-ancestor
24772232|NCT01832467|Cetuximab|cetuximab|mesh-list
25095532|NCT03218514|Dalteparin|dalteparin|mesh-list
25095533|NCT03218514|Tinzaparin|tinzaparin|mesh-list
25095534|NCT03218514|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25095535|NCT03218514|Anticoagulants|anticoagulants|mesh-ancestor
25095536|NCT03218514|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25095537|NCT03218514|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25095538|NCT03218514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095539|NCT03218254|Methylphenidate|methylphenidate|mesh-list
25095540|NCT03218254|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25095541|NCT03218254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095542|NCT03218254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25680502|NCT01852045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25680503|NCT01852045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680504|NCT01852045|Cholinergic Agents|cholinergic agents|mesh-ancestor
25680505|NCT01852045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25680506|NCT01852045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680507|NCT01852045|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25095543|NCT03218254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25095554|NCT03218280|Protective Agents|protective agents|mesh-ancestor
25095555|NCT03218059|Methotrexate|methotrexate|mesh-list
25005676|NCT02968563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25005677|NCT02968563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24548654|NCT00711204|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24548655|NCT00711204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548656|NCT00711204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095556|NCT03218059|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25095557|NCT03218059|Abortifacient Agents|abortifacient agents|mesh-ancestor
25095569|NCT03218059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25095570|NCT03218059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25095571|NCT03217916|polysaccharide-K|polysaccharide-k|mesh-list
25095572|NCT03217916|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25095573|NCT03217916|Immunologic Factors|immunologic factors|mesh-ancestor
25095574|NCT03217916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095575|NCT03217916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25095576|NCT03217916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095577|NCT03217916|Antiviral Agents|antiviral agents|mesh-ancestor
25095578|NCT03217916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25095579|NCT03217916|Interferon Inducers|interferon inducers|mesh-ancestor
25095580|NCT03217916|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25095581|NCT03217916|Protective Agents|protective agents|mesh-ancestor
25095582|NCT03218124|Remifentanil|remifentanil|mesh-list
25095583|NCT03218124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25095584|NCT03218124|Narcotics|narcotics|mesh-ancestor
25095585|NCT03218124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25095586|NCT03218124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095587|NCT03218124|Analgesics|analgesics|mesh-ancestor
25095588|NCT03218124|Sensory System Agents|sensory system agents|mesh-ancestor
25095589|NCT03218124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25095590|NCT03217838|Azacitidine|azacitidine|mesh-list
25095591|NCT03217838|Venetoclax|venetoclax|mesh-list
25095592|NCT03217838|Pyrazole|pyrazole|mesh-list
25095593|NCT03217838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25095594|NCT03217838|Antimetabolites|antimetabolites|mesh-ancestor
25095595|NCT03217838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095596|NCT03217838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095597|NCT03217838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25095598|NCT03217825|Losartan|losartan|mesh-list
25095599|NCT03217825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25095600|NCT03217825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25095601|NCT03217825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25224406|NCT02633657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224407|NCT02633657|Antimanic Agents|antimanic agents|mesh-ancestor
25224408|NCT02633761|Misoprostol|misoprostol|mesh-list
25224409|NCT02633761|Mifepristone|mifepristone|mesh-list
25224410|NCT02633761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25224411|NCT02633761|Abortifacient Agents|abortifacient agents|mesh-ancestor
25224412|NCT02633761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25043164|NCT01313572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25043165|NCT01313572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043167|NCT01312454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25043168|NCT01312454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25043169|NCT01311713|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25043170|NCT01311713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837563|NCT02191943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095602|NCT03217825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25680508|NCT01852045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25680509|NCT01852058|Botulinum Toxins|botulinum toxins|mesh-list
25680510|NCT01852058|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25680511|NCT01852058|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25680512|NCT01852058|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25680513|NCT01852058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25680514|NCT01852058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680515|NCT01852058|Cholinergic Agents|cholinergic agents|mesh-ancestor
25680516|NCT01852058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25680517|NCT01852058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680518|NCT01852058|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25020659|NCT03678610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020660|NCT03678532|Midazolam|midazolam|mesh-list
24704578|NCT01479023|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24704579|NCT01479023|Immunologic Factors|immunologic factors|mesh-ancestor
25095603|NCT03217825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095608|NCT03217760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25095609|NCT03217409|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25095610|NCT03217409|Ezetimibe|ezetimibe|mesh-list
24772286|NCT01832896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25095611|NCT03217409|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25095612|NCT03217409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25095613|NCT03217409|Antimetabolites|antimetabolites|mesh-ancestor
25095614|NCT03217409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095615|NCT03217409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25095616|NCT03217409|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25095617|NCT03217409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25095618|NCT03217292|Tramadol|tramadol|mesh-list
25095619|NCT03217292|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25095620|NCT03217292|Narcotics|narcotics|mesh-ancestor
25095621|NCT03217292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25095649|NCT03217734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095650|NCT03217734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095651|NCT03217734|Dermatologic Agents|dermatologic agents|mesh-ancestor
25095652|NCT03217734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25095653|NCT03217734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25095654|NCT03217734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25095655|NCT03217734|Immunologic Factors|immunologic factors|mesh-ancestor
25095656|NCT03217734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25095657|NCT03217734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25095658|NCT03217734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25095659|NCT03217227|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
25095660|NCT03217227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095661|NCT03217227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25095662|NCT03217227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095663|NCT03217227|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24772360|NCT01833299|Hormones|hormones|mesh-ancestor
24772435|NCT01833728|Analgesics|analgesics|mesh-ancestor
25095664|NCT03217162|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25095665|NCT03217162|Respiratory System Agents|respiratory system agents|mesh-ancestor
25095666|NCT03216759|Dexmedetomidine|dexmedetomidine|mesh-list
25095667|NCT03216759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25095668|NCT03216759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25095669|NCT03216759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095670|NCT03216759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25095671|NCT03216759|Analgesics|analgesics|mesh-ancestor
25095672|NCT03216759|Sensory System Agents|sensory system agents|mesh-ancestor
25095693|NCT03216915|Immunologic Factors|immunologic factors|mesh-ancestor
25095694|NCT03216915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095695|NCT03216980|Antioxidants|antioxidants|mesh-list
25095696|NCT03216980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095697|NCT03216980|Protective Agents|protective agents|mesh-ancestor
25095698|NCT03216980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095699|NCT03216876|Ursolic acid|ursolic acid|mesh-list
25095700|NCT03216876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25095701|NCT03216876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25095702|NCT03216876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095703|NCT03216876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25095704|NCT03216876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25224413|NCT02633761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224414|NCT02633761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25224415|NCT02633761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25224416|NCT02633761|Oxytocics|oxytocics|mesh-ancestor
25224417|NCT02633761|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25224418|NCT02633761|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25224419|NCT02633761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25224420|NCT02633761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25224421|NCT02633761|Contraceptive Agents|contraceptive agents|mesh-ancestor
24837564|NCT02192060|Triclosan|triclosan|mesh-list
24837565|NCT02192060|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24837566|NCT02192060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25680519|NCT01852058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25680520|NCT01852162|Dabigatran|dabigatran|mesh-list
25680521|NCT01852162|Antithrombins|antithrombins|mesh-ancestor
25680522|NCT01852162|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25680523|NCT01852162|Protease Inhibitors|protease inhibitors|mesh-ancestor
24837567|NCT02192060|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24837569|NCT02192060|Antimetabolites|antimetabolites|mesh-ancestor
25095705|NCT03216876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095706|NCT03216876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25095707|NCT03216876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25095709|NCT03216876|Sensory System Agents|sensory system agents|mesh-ancestor
25095710|NCT03216876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25095748|NCT03216707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25095749|NCT03216707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095750|NCT03216668|Silymarin|silymarin|mesh-list
25095751|NCT03216668|Antioxidants|antioxidants|mesh-ancestor
25095752|NCT03216668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095753|NCT03216668|Protective Agents|protective agents|mesh-ancestor
25095754|NCT03216668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095755|NCT03216642|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25095756|NCT03216642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25095757|NCT03216525|Alvimopan|alvimopan|mesh-list
25095758|NCT03216525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25095759|NCT03216278|Metformin|metformin|mesh-list
25095760|NCT03216278|Dapagliflozin|dapagliflozin|mesh-list
25095761|NCT03216278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25095762|NCT03216278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095763|NCT03216278|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24394949|NCT00134693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095777|NCT03216473|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25095778|NCT03216473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25095779|NCT03216473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095780|NCT03216473|Cholinergic Agents|cholinergic agents|mesh-ancestor
25095781|NCT03216473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25095782|NCT03216473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095783|NCT03216473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25095784|NCT03216473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25095785|NCT03216408|Botulinum Toxins|botulinum toxins|mesh-list
25095786|NCT03216408|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25095787|NCT03216408|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25095788|NCT03216408|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25095789|NCT03216408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25095790|NCT03216408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095791|NCT03216408|Cholinergic Agents|cholinergic agents|mesh-ancestor
25095792|NCT03216408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25095793|NCT03216408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095794|NCT03216408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25095795|NCT03216408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25095796|NCT03216564|Vitamin D|vitamin d|mesh-list
25095797|NCT03216564|Calcitriol|calcitriol|mesh-list
25095798|NCT03216564|Vitamins|vitamins|mesh-ancestor
25095799|NCT03216564|Micronutrients|micronutrients|mesh-ancestor
25095800|NCT03216564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095801|NCT03216564|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25095802|NCT03216564|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25095803|NCT03216564|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25095804|NCT03216564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25095808|NCT03216304|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25095810|NCT03216304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25095811|NCT03216304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095812|NCT03216304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25095813|NCT03216304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25095814|NCT03216304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25095815|NCT03216304|Antimetabolites|antimetabolites|mesh-ancestor
25095816|NCT03216304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095817|NCT03216304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25224422|NCT02633761|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25224423|NCT02633761|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25224424|NCT02633761|Hormone Antagonists|hormone antagonists|mesh-ancestor
25224425|NCT02633761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25224426|NCT02633761|Luteolytic Agents|luteolytic agents|mesh-ancestor
25680524|NCT01852162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837570|NCT02192060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837571|NCT02192060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24837573|NCT02192203|Menthol|menthol|mesh-list
25095818|NCT03216304|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25095819|NCT03216304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25095820|NCT03216395|Epinephrine|epinephrine|mesh-list
25095822|NCT03216395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25095823|NCT03216395|Adrenergic Agents|adrenergic agents|mesh-ancestor
25095824|NCT03216395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25095825|NCT03216395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095826|NCT03216395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095827|NCT03216395|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25095828|NCT03216395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25095829|NCT03216395|Autonomic Agents|autonomic agents|mesh-ancestor
25095830|NCT03216395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25095831|NCT03216395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24395080|NCT00135018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25095859|NCT03215875|Natriuretic Agents|natriuretic agents|mesh-ancestor
25095860|NCT03215875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095861|NCT03215875|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25095862|NCT03215875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25095863|NCT03215875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095864|NCT03215797|Phenylephrine|phenylephrine|mesh-list
25095865|NCT03215797|Oxymetazoline|oxymetazoline|mesh-list
25095866|NCT03215797|Norepinephrine|norepinephrine|mesh-list
25095867|NCT03215797|Adrenergic Agonists|adrenergic agonists|mesh-list
25095868|NCT03215797|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25095869|NCT03215797|Mydriatics|mydriatics|mesh-ancestor
25095870|NCT03215797|Autonomic Agents|autonomic agents|mesh-ancestor
25095871|NCT03215797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25095872|NCT03215797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095873|NCT03215797|Sympathomimetics|sympathomimetics|mesh-ancestor
25095874|NCT03215797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25095875|NCT03215797|Nasal Decongestants|nasal decongestants|mesh-ancestor
25095876|NCT03215797|Respiratory System Agents|respiratory system agents|mesh-ancestor
25095889|NCT03216070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095890|NCT03216070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25095891|NCT03216070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25095892|NCT03216070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095893|NCT03215602|Pyrantel|pyrantel|mesh-list
25095894|NCT03215602|Pyrantel Pamoate|pyrantel pamoate|mesh-list
25095895|NCT03215602|Antinematodal Agents|antinematodal agents|mesh-ancestor
25095896|NCT03215602|Anthelmintics|anthelmintics|mesh-ancestor
25095897|NCT03215602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25095898|NCT03215602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25095899|NCT03215602|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
25095900|NCT03215602|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25095901|NCT03215602|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25095902|NCT03215602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25095903|NCT03215602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095904|NCT03216096|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25095905|NCT03216096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25095906|NCT03215966|Tadalafil|tadalafil|mesh-list
25095907|NCT03215966|Macitentan|macitentan|mesh-list
25095908|NCT03215966|Vasodilator Agents|vasodilator agents|mesh-ancestor
25095909|NCT03215966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25095910|NCT03215966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25095911|NCT03215966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25095912|NCT03215966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095921|NCT03215498|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24481918|NCT00437229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25095923|NCT03215498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095924|NCT03215446|Anesthetics|anesthetics|mesh-list
25095925|NCT03215446|Propofol|propofol|mesh-list
25095926|NCT03215446|Sevoflurane|sevoflurane|mesh-list
25224427|NCT02633761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25224428|NCT02633761|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25224429|NCT02633839|Carbidopa|carbidopa|mesh-list
25224430|NCT02633839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24837575|NCT02192203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24837577|NCT02192203|Sensory System Agents|sensory system agents|mesh-ancestor
24837582|NCT02192203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24837583|NCT02192203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837600|NCT02192320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837602|NCT02192320|Glucocorticoids|glucocorticoids|mesh-ancestor
24837603|NCT02192320|Hormones|hormones|mesh-ancestor
25095927|NCT03215446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25095928|NCT03215446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095929|NCT03215446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25095930|NCT03215446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25095931|NCT03215446|Anesthetics, General|anesthetics, general|mesh-ancestor
25095932|NCT03215446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25095933|NCT03215446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25095934|NCT03215264|Hydroxychloroquine|hydroxychloroquine|mesh-list
25095936|NCT03215264|Antimalarials|antimalarials|mesh-ancestor
25095937|NCT03215264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25095938|NCT03215264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25095939|NCT03215264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25095940|NCT03215264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25095941|NCT03215264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095942|NCT03215264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25095943|NCT03215264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095944|NCT03215264|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25095945|NCT03215407|Betamethasone|betamethasone|mesh-list
25095946|NCT03215407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25095947|NCT03215407|Glucocorticoids|glucocorticoids|mesh-ancestor
25095948|NCT03215407|Hormones|hormones|mesh-ancestor
25095949|NCT03215407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25095950|NCT03215407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095951|NCT03215407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25095952|NCT03215407|Respiratory System Agents|respiratory system agents|mesh-ancestor
25095953|NCT03215069|Empagliflozin|empagliflozin|mesh-list
25095954|NCT03215069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25095955|NCT03215069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095956|NCT03215069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25095962|NCT03215056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25095963|NCT03215056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095969|NCT03214874|Torsemide|torsemide|mesh-list
25095970|NCT03214874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25095971|NCT03214874|Diuretics|diuretics|mesh-ancestor
25095972|NCT03214874|Natriuretic Agents|natriuretic agents|mesh-ancestor
25095973|NCT03214874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095974|NCT03214874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25095975|NCT03214874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25224431|NCT02633839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25224432|NCT02633839|Dopamine Agents|dopamine agents|mesh-ancestor
25224433|NCT02633839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25224434|NCT02633839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224435|NCT02633839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224436|NCT02633839|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25224437|NCT02633839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25224438|NCT02633579|Erythromycin|erythromycin|mesh-list
25224439|NCT02633579|Erythromycin Estolate|erythromycin estolate|mesh-list
25224440|NCT02633579|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25224441|NCT02633579|Erythromycin stearate|erythromycin stearate|mesh-list
25224442|NCT02633579|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
25224443|NCT02633579|Atropine|atropine|mesh-list
25224444|NCT02633579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25224445|NCT02633579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25224446|NCT02633579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24837604|NCT02192320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24837605|NCT02192320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24837606|NCT02192320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24837607|NCT02192320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24837608|NCT02192320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24837609|NCT02192320|Antimetabolites|antimetabolites|mesh-ancestor
24837610|NCT02192320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837612|NCT02192320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24837613|NCT02192320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837614|NCT02192411|Lidocaine|lidocaine|mesh-list
24837615|NCT02192411|Anesthetics, Local|anesthetics, local|mesh-ancestor
24837616|NCT02192411|Anesthetics|anesthetics|mesh-ancestor
24837617|NCT02192411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24837618|NCT02192411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837619|NCT02192411|Sensory System Agents|sensory system agents|mesh-ancestor
25405286|NCT03615105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25095976|NCT03214874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095977|NCT03214848|Contraceptive Agents|contraceptive agents|mesh-list
25095978|NCT03214848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25095979|NCT03214848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224448|NCT02633579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25224449|NCT02633579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224450|NCT02633579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25224451|NCT02633579|Respiratory System Agents|respiratory system agents|mesh-ancestor
25224452|NCT02633579|Mydriatics|mydriatics|mesh-ancestor
25224453|NCT02633579|Parasympatholytics|parasympatholytics|mesh-ancestor
25224454|NCT02633579|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25224455|NCT02633579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25224456|NCT02633579|Cholinergic Agents|cholinergic agents|mesh-ancestor
25224457|NCT02633579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25224458|NCT02633579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224459|NCT02633579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25224460|NCT02633579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25224461|NCT02633579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25224462|NCT02633579|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25224463|NCT02633579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837621|NCT02192411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25096038|NCT03214510|Hydromorphone|hydromorphone|mesh-list
25096039|NCT03214510|Bupivacaine|bupivacaine|mesh-list
25096040|NCT03214510|Anesthetics, Local|anesthetics, local|mesh-ancestor
25096041|NCT03214510|Anesthetics|anesthetics|mesh-ancestor
25096042|NCT03214510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25096043|NCT03214510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096044|NCT03214510|Sensory System Agents|sensory system agents|mesh-ancestor
25096045|NCT03214510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25096046|NCT03214510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25096047|NCT03214510|Narcotics|narcotics|mesh-ancestor
25096048|NCT03214510|Analgesics|analgesics|mesh-ancestor
25096061|NCT03214354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096062|NCT03214354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25096064|NCT03214393|Immunologic Factors|immunologic factors|mesh-ancestor
25096065|NCT03214393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096066|NCT03214172|Rivaroxaban|rivaroxaban|mesh-list
25096067|NCT03214172|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25096068|NCT03214172|Antithrombins|antithrombins|mesh-ancestor
25096069|NCT03214172|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24772835|NCT01836120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25096079|NCT03214003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25096080|NCT03214003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25096081|NCT03214003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25096082|NCT03214003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096083|NCT03214159|Ritonavir|ritonavir|mesh-list
25096084|NCT03214159|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25096085|NCT03214159|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24620703|NCT01058317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620704|NCT01058317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24620705|NCT01058317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24620706|NCT01058317|Vasodilator Agents|vasodilator agents|mesh-ancestor
24620707|NCT01058382|Progesterone|progesterone|mesh-list
24620708|NCT01058382|Progestins|progestins|mesh-ancestor
25096086|NCT03214159|Protease Inhibitors|protease inhibitors|mesh-ancestor
25096087|NCT03214159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413697|NCT00194948|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24413781|NCT00195208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24413782|NCT00195208|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24413825|NCT00195377|Sensory System Agents|sensory system agents|mesh-ancestor
24413826|NCT00195377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24413827|NCT00195377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413828|NCT00195377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24413829|NCT00195377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25224464|NCT02633618|Neurotropin|neurotropin|mesh-list
25224465|NCT02633618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25224466|NCT02633618|Immunologic Factors|immunologic factors|mesh-ancestor
25224467|NCT02633618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837627|NCT02192424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24837628|NCT02192424|Metformin|metformin|mesh-list
24837629|NCT02192424|Insulin Glargine|insulin glargine|mesh-list
24837630|NCT02192424|Insulin Lispro|insulin lispro|mesh-list
24837631|NCT02192424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24837632|NCT02192424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837633|NCT02192450|Insulin|insulin|mesh-list
24837634|NCT02192450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24837635|NCT02192450|Insulin Aspart|insulin aspart|mesh-list
24413830|NCT00195377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24413831|NCT00195377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24413832|NCT00195377|Immunologic Factors|immunologic factors|mesh-ancestor
24413833|NCT00195390|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24413834|NCT00195390|Immunologic Factors|immunologic factors|mesh-ancestor
24413835|NCT00195390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413837|NCT00195416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24413838|NCT00195416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24413891|NCT00195559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24413892|NCT00195559|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25096088|NCT03214159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096089|NCT03214159|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25096090|NCT03214159|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25096091|NCT03214159|Antiviral Agents|antiviral agents|mesh-ancestor
25096092|NCT03214159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25096262|NCT03212716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25096093|NCT03214159|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25096094|NCT03214159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25096095|NCT03214302|Tenofovir|tenofovir|mesh-list
25096096|NCT03214302|Antiviral Agents|antiviral agents|mesh-ancestor
25096097|NCT03214302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25096098|NCT03214302|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25096099|NCT03214302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25096100|NCT03214302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25096101|NCT03214302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096102|NCT03214302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25096103|NCT03214302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25096104|NCT03214055|Mannitol|mannitol|mesh-list
25096105|NCT03214055|Diuretics|diuretics|mesh-list
25096106|NCT03214055|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25096107|NCT03214055|Natriuretic Agents|natriuretic agents|mesh-ancestor
25096108|NCT03214055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096109|NCT03213964|Interleukin-2|interleukin-2|mesh-list
25096110|NCT03213964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25096111|NCT03213964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25096112|NCT03213964|Analgesics|analgesics|mesh-ancestor
25096113|NCT03213964|Sensory System Agents|sensory system agents|mesh-ancestor
25096114|NCT03213964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25096115|NCT03213964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096116|NCT03213977|Prednisone|prednisone|mesh-list
25096117|NCT03213977|Cyclophosphamide|cyclophosphamide|mesh-list
25096118|NCT03213977|Doxorubicin|doxorubicin|mesh-list
25096119|NCT03213977|Etoposide|etoposide|mesh-list
25096120|NCT03213977|Vincristine|vincristine|mesh-list
25096121|NCT03213977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25096122|NCT03213977|Immunologic Factors|immunologic factors|mesh-ancestor
25096123|NCT03213977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096127|NCT03213977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096128|NCT03213977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25096129|NCT03213977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25096130|NCT03213977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25096131|NCT03213977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25096132|NCT03213977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25680525|NCT01852162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680526|NCT01852162|Anticoagulants|anticoagulants|mesh-ancestor
25680527|NCT01852175|Ticagrelor|ticagrelor|mesh-list
25680528|NCT01852175|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25680529|NCT01852175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25680530|NCT01852175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25680531|NCT01852175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25680532|NCT01852175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25680533|NCT01852175|Purinergic Agents|purinergic agents|mesh-ancestor
25096133|NCT03213977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25096134|NCT03213977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24929678|NCT04110028|Vitamin B Complex|vitamin b complex|mesh-ancestor
25096135|NCT03213977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25096136|NCT03213977|Glucocorticoids|glucocorticoids|mesh-ancestor
25096146|NCT03213834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096148|NCT03213886|Calcifediol|calcifediol|mesh-list
25224468|NCT02633618|Analgesics|analgesics|mesh-ancestor
25224469|NCT02633618|Sensory System Agents|sensory system agents|mesh-ancestor
25224470|NCT02633618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25224471|NCT02633618|Anticonvulsants|anticonvulsants|mesh-ancestor
25224473|NCT02633384|SMOFlipid|smoflipid|mesh-list
25224474|NCT02633384|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25224475|NCT02633384|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24837636|NCT02192450|Insulin, Long-Acting|insulin, long-acting|mesh-list
24837637|NCT02192450|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24837638|NCT02192450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24837639|NCT02192450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837640|NCT02192463|Nevirapine|nevirapine|mesh-list
24837641|NCT02192463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24837642|NCT02192463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24837643|NCT02192463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25056201|NCT03514771|Isotretinoin|isotretinoin|mesh-list
25096149|NCT03213886|Vitamins|vitamins|mesh-ancestor
25096150|NCT03213886|Micronutrients|micronutrients|mesh-ancestor
25096151|NCT03213886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096152|NCT03213886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25096153|NCT03213769|Ubiquinone|ubiquinone|mesh-list
25096154|NCT03213769|Coenzyme Q10|coenzyme q10|mesh-list
25096155|NCT03213769|Micronutrients|micronutrients|mesh-ancestor
25096161|NCT03213743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096163|NCT03213743|Analgesics|analgesics|mesh-ancestor
25096164|NCT03213743|Sensory System Agents|sensory system agents|mesh-ancestor
25096165|NCT03213743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25096166|NCT03213743|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24513448|NCT00581685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25096167|NCT03213743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25096168|NCT03213743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25096169|NCT03213743|Adrenergic Agents|adrenergic agents|mesh-ancestor
25096170|NCT03213743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25096171|NCT03213743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096172|NCT03213444|Oxaliplatin|oxaliplatin|mesh-list
25096173|NCT03213444|Fluorouracil|fluorouracil|mesh-list
25096174|NCT03213444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25096175|NCT03213444|Antimetabolites|antimetabolites|mesh-ancestor
25096176|NCT03213444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096177|NCT03213444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25096178|NCT03213444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25096179|NCT03213444|Immunologic Factors|immunologic factors|mesh-ancestor
25096180|NCT03213444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096181|NCT03213639|Esomeprazole|esomeprazole|mesh-list
25096182|NCT03213639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25096183|NCT03213639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25680534|NCT01852175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25680535|NCT01852175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680536|NCT01852175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680537|NCT01852214|Ticagrelor|ticagrelor|mesh-list
25680538|NCT01852214|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25680539|NCT01852214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25680540|NCT01852214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25680541|NCT01852214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25680542|NCT01852214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25680543|NCT01852214|Purinergic Agents|purinergic agents|mesh-ancestor
25096184|NCT03213639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25096185|NCT03213639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25096186|NCT03213639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096188|NCT03213548|Plant Growth Regulators|plant growth regulators|mesh-ancestor
25096189|NCT03213548|Growth Substances|growth substances|mesh-ancestor
25096190|NCT03213548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096191|NCT03213587|Apatinib|apatinib|mesh-list
25096203|NCT03213353|Guaifenesin|guaifenesin|mesh-list
25096204|NCT03213353|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
25096205|NCT03213353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25096206|NCT03213353|Analgesics|analgesics|mesh-ancestor
25096207|NCT03213353|Sensory System Agents|sensory system agents|mesh-ancestor
24396503|NCT00139217|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25096219|NCT03213353|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25096220|NCT03213353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25096221|NCT03213353|Adrenergic Agents|adrenergic agents|mesh-ancestor
25096222|NCT03213353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25096223|NCT03213353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096224|NCT03213353|Protective Agents|protective agents|mesh-ancestor
25096225|NCT03213353|Expectorants|expectorants|mesh-ancestor
25096226|NCT03213353|Appetite Depressants|appetite depressants|mesh-ancestor
25096227|NCT03213353|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25096228|NCT03213249|Gentamicins|gentamicins|mesh-list
25096229|NCT03213249|Cefazolin|cefazolin|mesh-list
25096230|NCT03213249|Bacitracin|bacitracin|mesh-list
25096231|NCT03213249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25224476|NCT02633384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25224477|NCT02633384|Cathartics|cathartics|mesh-ancestor
25224478|NCT02633384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25224479|NCT02633462|Inositol|inositol|mesh-list
25224480|NCT02633462|Vitamin B Complex|vitamin b complex|mesh-ancestor
25224481|NCT02633462|Vitamins|vitamins|mesh-ancestor
25224482|NCT02633462|Micronutrients|micronutrients|mesh-ancestor
25224483|NCT02633462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224484|NCT02633202|Cisplatin|cisplatin|mesh-list
25224485|NCT02633202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25224486|NCT02633176|Docetaxel|docetaxel|mesh-list
24837644|NCT02192463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837645|NCT02192463|Antiviral Agents|antiviral agents|mesh-ancestor
24837646|NCT02192463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24837647|NCT02192463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24837648|NCT02192463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24837649|NCT02192463|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25056213|NCT03514667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25096232|NCT03213249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25096233|NCT03213249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25096234|NCT03213249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25096246|NCT03213145|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25096247|NCT03213145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25096248|NCT03213145|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25096249|NCT03213145|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25096250|NCT03213145|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25096251|NCT03213145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25096252|NCT03213041|Carboplatin|carboplatin|mesh-list
25096253|NCT03213041|Pembrolizumab|pembrolizumab|mesh-list
25096254|NCT03213041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25096255|NCT03213041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25096256|NCT03212729|Anti-Infective Agents|anti-infective agents|mesh-list
25096257|NCT03212729|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25096258|NCT03212716|Oseltamivir|oseltamivir|mesh-list
25096259|NCT03212716|Diltiazem|diltiazem|mesh-list
25096260|NCT03212716|Antiviral Agents|antiviral agents|mesh-ancestor
25096261|NCT03212716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25096263|NCT03212716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096264|NCT03212716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25096265|NCT03212716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25096266|NCT03212716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25096267|NCT03212716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25096268|NCT03212716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096269|NCT03212716|Vasodilator Agents|vasodilator agents|mesh-ancestor
25096270|NCT03212807|Lenalidomide|lenalidomide|mesh-list
25096271|NCT03212807|Durvalumab|durvalumab|mesh-list
25096272|NCT03212807|Immunologic Factors|immunologic factors|mesh-ancestor
25096273|NCT03212807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096274|NCT03212807|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24773074|NCT01837446|Morphine|morphine|mesh-list
25096287|NCT03213002|Alkylating Agents|alkylating agents|mesh-ancestor
25020888|NCT03676374|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25020889|NCT03676374|Serotonin Agents|serotonin agents|mesh-ancestor
25020890|NCT03676374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25020891|NCT03676374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020892|NCT03676374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020893|NCT03676361|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25020894|NCT03676361|Hemostatics|hemostatics|mesh-ancestor
25020895|NCT03676361|Coagulants|coagulants|mesh-ancestor
25020896|NCT03676361|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25020897|NCT03676361|Natriuretic Agents|natriuretic agents|mesh-ancestor
25096288|NCT03212651|Pembrolizumab|pembrolizumab|mesh-list
25096289|NCT03212651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25096290|NCT03212651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25096299|NCT03212820|Methamphetamine|methamphetamine|mesh-list
25096300|NCT03212820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25096301|NCT03212820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096302|NCT03212820|Sympathomimetics|sympathomimetics|mesh-ancestor
25096303|NCT03212820|Autonomic Agents|autonomic agents|mesh-ancestor
25096304|NCT03212820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25096305|NCT03212820|Dopamine Agents|dopamine agents|mesh-ancestor
25224487|NCT02633176|Capecitabine|capecitabine|mesh-list
25224488|NCT02633176|Cetuximab|cetuximab|mesh-list
25224489|NCT02633176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25224490|NCT02633176|Tubulin Modulators|tubulin modulators|mesh-ancestor
25224491|NCT02633176|Antimitotic Agents|antimitotic agents|mesh-ancestor
25224492|NCT02633176|Mitosis Modulators|mitosis modulators|mesh-ancestor
25224493|NCT02633176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224494|NCT02633176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24837650|NCT02192463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24837651|NCT02192632|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
24837652|NCT02192632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24837653|NCT02192632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24837654|NCT02192632|Analgesics|analgesics|mesh-ancestor
24837655|NCT02192632|Sensory System Agents|sensory system agents|mesh-ancestor
24837656|NCT02192632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24837671|NCT02192710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24837672|NCT02192710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24837673|NCT02192710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24837674|NCT02192710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24837675|NCT02192710|Anesthetics, General|anesthetics, general|mesh-ancestor
25096306|NCT03212820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25096308|NCT03212820|Adrenergic Agents|adrenergic agents|mesh-ancestor
25096319|NCT03212677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096320|NCT03212950|Insulin|insulin|mesh-list
25096321|NCT03212950|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25096322|NCT03212950|Insulin Aspart|insulin aspart|mesh-list
25096323|NCT03212950|Insulin, Long-Acting|insulin, long-acting|mesh-list
25096324|NCT03212950|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25096325|NCT03212950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25096326|NCT03212950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096327|NCT03212781|Ferrous fumarate|ferrous fumarate|mesh-list
25096328|NCT03212781|Dextrans|dextrans|mesh-list
25096329|NCT03212781|Iron-Dextran Complex|iron-dextran complex|mesh-list
25096330|NCT03212781|Anticoagulants|anticoagulants|mesh-ancestor
25096331|NCT03212781|Plasma Substitutes|plasma substitutes|mesh-ancestor
25096332|NCT03212781|Blood Substitutes|blood substitutes|mesh-ancestor
25096333|NCT03212781|Trace Elements|trace elements|mesh-ancestor
25096334|NCT03212781|Micronutrients|micronutrients|mesh-ancestor
25096335|NCT03212781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096336|NCT03212781|Hematinics|hematinics|mesh-ancestor
25096337|NCT03212937|Carboplatin|carboplatin|mesh-list
25096338|NCT03212937|Etoposide|etoposide|mesh-list
25680544|NCT01852214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25680545|NCT01852214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680546|NCT01852214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680547|NCT01852292|Paclitaxel|paclitaxel|mesh-list
25680548|NCT01852292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25680549|NCT01852292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25680550|NCT01852292|Tubulin Modulators|tubulin modulators|mesh-ancestor
25680551|NCT01852292|Antimitotic Agents|antimitotic agents|mesh-ancestor
25680552|NCT01852292|Mitosis Modulators|mitosis modulators|mesh-ancestor
25680553|NCT01852292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680554|NCT01852344|Methylphenidate|methylphenidate|mesh-list
25096339|NCT03212937|Ifosfamide|ifosfamide|mesh-list
25096340|NCT03212937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25096341|NCT03212937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25096342|NCT03212937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25096343|NCT03212937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25096344|NCT03212937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25096345|NCT03212937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096346|NCT03212937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25096347|NCT03212937|Alkylating Agents|alkylating agents|mesh-ancestor
25096348|NCT03212755|Immunoglobulins|immunoglobulins|mesh-list
25096357|NCT03212599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773142|NCT01837810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24773143|NCT01837810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25096358|NCT03212599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096360|NCT03212352|Mifepristone|mifepristone|mesh-list
25096361|NCT03212352|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25096362|NCT03212352|Abortifacient Agents|abortifacient agents|mesh-ancestor
25096363|NCT03212352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25096364|NCT03212352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796482|NCT01950195|Ipilimumab|ipilimumab|mesh-list
25096365|NCT03212352|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25096366|NCT03212352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25224495|NCT02633176|Antimetabolites|antimetabolites|mesh-ancestor
25224496|NCT02633176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25224497|NCT02633189|Bevacizumab|bevacizumab|mesh-list
25224498|NCT02633189|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25224499|NCT02633189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25224500|NCT02633189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25224501|NCT02633189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25224502|NCT02633189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25224503|NCT02633189|Growth Substances|growth substances|mesh-ancestor
25224504|NCT02633189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224505|NCT02633189|Growth Inhibitors|growth inhibitors|mesh-ancestor
25224506|NCT02633189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24837676|NCT02192710|Anesthetics|anesthetics|mesh-ancestor
24837677|NCT02192710|GABA Modulators|gaba modulators|mesh-ancestor
24837678|NCT02192710|GABA Agents|gaba agents|mesh-ancestor
24837679|NCT02192710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25056227|NCT03514550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25096367|NCT03212352|Oxytocics|oxytocics|mesh-ancestor
25096368|NCT03212352|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25096369|NCT03212352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25096370|NCT03212352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25096371|NCT03212352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25096374|NCT03212352|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25096375|NCT03212352|Hormone Antagonists|hormone antagonists|mesh-ancestor
25096376|NCT03212352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25096377|NCT03212352|Luteolytic Agents|luteolytic agents|mesh-ancestor
25096378|NCT03212352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25096379|NCT03212352|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25096380|NCT03212456|Analgesics, Opioid|analgesics, opioid|mesh-list
25096381|NCT03212456|Ropivacaine|ropivacaine|mesh-list
25096382|NCT03212456|Anesthetics, Local|anesthetics, local|mesh-ancestor
25096383|NCT03212456|Anesthetics|anesthetics|mesh-ancestor
24482856|NCT00440804|Ibuprofen|ibuprofen|mesh-list
24482918|NCT00440960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25096384|NCT03212456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25096385|NCT03212456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096386|NCT03212456|Sensory System Agents|sensory system agents|mesh-ancestor
25096387|NCT03212456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25096388|NCT03212456|Narcotics|narcotics|mesh-ancestor
25096389|NCT03212456|Analgesics|analgesics|mesh-ancestor
25096390|NCT03212495|Neostigmine|neostigmine|mesh-list
25096391|NCT03212495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096392|NCT03212495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25096393|NCT03212495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25096394|NCT03212495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096395|NCT03212495|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25096396|NCT03212495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25096397|NCT03212495|Cholinergic Agents|cholinergic agents|mesh-ancestor
25096398|NCT03212495|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25096399|NCT03212495|Autonomic Agents|autonomic agents|mesh-ancestor
25096400|NCT03212469|Durvalumab|durvalumab|mesh-list
25096401|NCT03212469|Tremelimumab|tremelimumab|mesh-list
25096402|NCT03212469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25096404|NCT03212053|Hemostatics|hemostatics|mesh-list
25096405|NCT03212053|Coagulants|coagulants|mesh-ancestor
25096442|NCT03211897|GABA Modulators|gaba modulators|mesh-ancestor
25096443|NCT03211897|GABA Agents|gaba agents|mesh-ancestor
25096444|NCT03211897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25096445|NCT03211897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096446|NCT03211897|Antiemetics|antiemetics|mesh-ancestor
25096447|NCT03211897|Autonomic Agents|autonomic agents|mesh-ancestor
25096448|NCT03211897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25096449|NCT03211897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25096450|NCT03211897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25096451|NCT03211897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25096452|NCT03211897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25096453|NCT03211897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25096454|NCT03211897|Serotonin Agents|serotonin agents|mesh-ancestor
25096455|NCT03211897|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25096456|NCT03211897|Dopamine Agents|dopamine agents|mesh-ancestor
25096457|NCT03211897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25224507|NCT02633189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25224508|NCT02633189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224509|NCT02632916|Zoledronic Acid|zoledronic acid|mesh-list
25224510|NCT02632916|Denosumab|denosumab|mesh-list
24837680|NCT02192710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837681|NCT02192723|Olanzapine|olanzapine|mesh-list
24837682|NCT02192723|Risperidone|risperidone|mesh-list
24837683|NCT02192723|Aripiprazole|aripiprazole|mesh-list
24837684|NCT02192723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24837685|NCT02192723|Ziprasidone|ziprasidone|mesh-list
24837686|NCT02192723|Antipsychotic Agents|antipsychotic agents|mesh-list
24837719|NCT02192827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24837720|NCT02192827|Glucocorticoids|glucocorticoids|mesh-ancestor
24837722|NCT02192827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24837723|NCT02192827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24837724|NCT02192827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24837725|NCT02192827|Protease Inhibitors|protease inhibitors|mesh-ancestor
24837726|NCT02192827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837727|NCT02192827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837728|NCT02192853|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24837729|NCT02192853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24837730|NCT02192853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837732|NCT02192853|Hormones|hormones|mesh-ancestor
24837733|NCT02192853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24837734|NCT02192853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25096475|NCT03211728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25096476|NCT03211728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25096477|NCT03211728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25096478|NCT03211741|Bevacizumab|bevacizumab|mesh-list
25096479|NCT03211741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25096480|NCT03211741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25096481|NCT03211741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25096482|NCT03211741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25096483|NCT03211741|Growth Substances|growth substances|mesh-ancestor
24773285|NCT01838928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24773286|NCT01838928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096484|NCT03211741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096485|NCT03211741|Growth Inhibitors|growth inhibitors|mesh-ancestor
25096487|NCT03211572|Anastrozole|anastrozole|mesh-list
25096488|NCT03211572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25096489|NCT03211572|Hormone Antagonists|hormone antagonists|mesh-ancestor
25096490|NCT03211572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25096491|NCT03211572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680556|NCT01852344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680557|NCT01852344|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25680558|NCT01852344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25680559|NCT01852344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25680560|NCT01852344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020973|NCT03675841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977427|NCT00335777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020975|NCT03675815|Darunavir|darunavir|mesh-list
25096492|NCT03211572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25096493|NCT03211572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25096494|NCT03211572|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25096495|NCT03211572|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25096496|NCT03211572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25096497|NCT03211572|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25096498|NCT03211572|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25096499|NCT03211572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25096500|NCT03211572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224511|NCT02632916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25224512|NCT02632916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224513|NCT02633514|Etoposide|etoposide|mesh-list
25224514|NCT02633514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25224515|NCT02633514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25224516|NCT02633514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25224517|NCT02633514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25224518|NCT02633514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25224519|NCT02633514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273248|NCT02386449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25273249|NCT02386449|Laxatives|laxatives|mesh-ancestor
24987074|NCT04393350|Lenvatinib|lenvatinib|mesh-list
25273250|NCT02386449|Anticoagulants|anticoagulants|mesh-ancestor
25273251|NCT02386449|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25273252|NCT02386449|Chelating Agents|chelating agents|mesh-ancestor
25273253|NCT02386449|Sequestering Agents|sequestering agents|mesh-ancestor
25273254|NCT02386449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273255|NCT02386449|Antacids|antacids|mesh-ancestor
25273256|NCT02386566|Natalizumab|natalizumab|mesh-list
25273257|NCT02386566|Immunologic Factors|immunologic factors|mesh-ancestor
25273258|NCT02386566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273259|NCT02386293|Irbesartan|irbesartan|mesh-list
25273260|NCT02386293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25275732|NCT02369822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837735|NCT02192853|Protease Inhibitors|protease inhibitors|mesh-ancestor
24837736|NCT02192853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750758|NCT01700478|Abortifacient Agents|abortifacient agents|mesh-ancestor
25096501|NCT03211650|Hyaluronic Acid|hyaluronic acid|mesh-list
25096523|NCT03211065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096524|NCT03211052|Leuprolide|leuprolide|mesh-list
25096525|NCT03211052|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25096526|NCT03211052|Fertility Agents|fertility agents|mesh-ancestor
25096527|NCT03211052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25096528|NCT03211052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837761|NCT02193256|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25096529|NCT03211052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25096530|NCT03211052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25096531|NCT03211104|Curcumin|curcumin|mesh-list
25096532|NCT03211104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25096533|NCT03211104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25096534|NCT03211104|Analgesics|analgesics|mesh-ancestor
25096535|NCT03211104|Sensory System Agents|sensory system agents|mesh-ancestor
25096536|NCT03211104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25096537|NCT03211104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096538|NCT03211104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25096539|NCT03211104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25096540|NCT03211104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25096541|NCT03211104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25096542|NCT03211104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096543|NCT03211143|Esomeprazole|esomeprazole|mesh-list
25096544|NCT03211143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24413986|NCT00195767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413987|NCT00195767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413988|NCT00195767|GABA Agents|gaba agents|mesh-ancestor
25096545|NCT03211143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25096546|NCT03211143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25096547|NCT03211143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25096548|NCT03211143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096549|NCT03211013|Oxytocin|oxytocin|mesh-list
25096550|NCT03211013|Oxytocics|oxytocics|mesh-ancestor
25680561|NCT01852344|Dopamine Agents|dopamine agents|mesh-ancestor
25680562|NCT01852344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25692437|NCT01999400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25096551|NCT03211013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25096552|NCT03211013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096553|NCT03211351|Dextrans|dextrans|mesh-list
25096554|NCT03211351|Anticoagulants|anticoagulants|mesh-ancestor
25096555|NCT03211351|Plasma Substitutes|plasma substitutes|mesh-ancestor
25096556|NCT03211351|Blood Substitutes|blood substitutes|mesh-ancestor
25096557|NCT03211195|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25096558|NCT03211195|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24483218|NCT00442325|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24483219|NCT00442325|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24483220|NCT00442325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25096589|NCT03210545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25096592|NCT03210558|Androgens|androgens|mesh-ancestor
25096594|NCT03210558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25096595|NCT03210558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096596|NCT03210506|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25096597|NCT03210506|Antiviral Agents|antiviral agents|mesh-ancestor
25096598|NCT03210506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25096599|NCT03210532|Amlodipine|amlodipine|mesh-list
25096600|NCT03210532|Telmisartan|telmisartan|mesh-list
25096601|NCT03210532|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
25096602|NCT03210532|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25096603|NCT03210532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25096604|NCT03210532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25096605|NCT03210532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25096606|NCT03210532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096607|NCT03210532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25096608|NCT03210532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096609|NCT03210532|Vasodilator Agents|vasodilator agents|mesh-ancestor
25224520|NCT02633007|Levodopa|levodopa|mesh-list
25224521|NCT02633007|Carbidopa|carbidopa|mesh-list
25224522|NCT02633007|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25224523|NCT02633007|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24837737|NCT02192853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096610|NCT03210532|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25096611|NCT03210532|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25096612|NCT03210532|Antimetabolites|antimetabolites|mesh-ancestor
25096613|NCT03210532|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25096614|NCT03210532|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25096615|NCT03210532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837762|NCT02193256|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25096616|NCT03210532|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25096624|NCT03210246|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25096625|NCT03210246|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25096626|NCT03210246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25096627|NCT03210246|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25096628|NCT03210246|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25096629|NCT03210246|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
25096630|NCT03210246|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25096631|NCT03210246|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25096632|NCT03210324|Mifepristone|mifepristone|mesh-list
25096633|NCT03210324|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25096634|NCT03210324|Abortifacient Agents|abortifacient agents|mesh-ancestor
25096635|NCT03210324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25096636|NCT03210324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096637|NCT03210324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25096647|NCT03210324|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25096649|NCT03210480|Antidepressive Agents|antidepressive agents|mesh-ancestor
25680563|NCT01852383|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25680564|NCT01852383|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25680565|NCT01852383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25680566|NCT01852383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25692438|NCT01999400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24977513|NCT02965690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24977514|NCT02965690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24977515|NCT02965690|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25021020|NCT03675555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25021021|NCT03675555|Antiemetics|antiemetics|mesh-ancestor
25021025|NCT03675555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25021026|NCT03675555|Glucocorticoids|glucocorticoids|mesh-ancestor
25021027|NCT03675555|Hormones|hormones|mesh-ancestor
25021028|NCT03675555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25096650|NCT03210480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25096651|NCT03210480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25096652|NCT03210480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096653|NCT03210480|Antimanic Agents|antimanic agents|mesh-ancestor
25096654|NCT03210480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24773477|NCT01839864|Sensory System Agents|sensory system agents|mesh-ancestor
25096660|NCT03210064|Fluorouracil|fluorouracil|mesh-list
25096662|NCT03210064|Antimetabolites|antimetabolites|mesh-ancestor
25096663|NCT03210064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096664|NCT03210064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25096665|NCT03210064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25096666|NCT03210064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25096667|NCT03210064|Immunologic Factors|immunologic factors|mesh-ancestor
25096668|NCT03210064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096669|NCT03210064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25096670|NCT03210064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25096671|NCT03210025|Methyldopa|methyldopa|mesh-list
25096672|NCT03210025|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25096673|NCT03210025|Sympatholytics|sympatholytics|mesh-ancestor
25096674|NCT03210025|Autonomic Agents|autonomic agents|mesh-ancestor
25096675|NCT03210025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25096676|NCT03210025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096677|NCT03210025|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25096678|NCT03210025|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25096679|NCT03210025|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25096680|NCT03210025|Adrenergic Agents|adrenergic agents|mesh-ancestor
25096681|NCT03210025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25096682|NCT03210025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096683|NCT03210038|Lidocaine|lidocaine|mesh-list
25096684|NCT03210038|Anesthetics, Local|anesthetics, local|mesh-ancestor
25096685|NCT03210038|Anesthetics|anesthetics|mesh-ancestor
25096686|NCT03210038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25096687|NCT03210038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096688|NCT03210038|Sensory System Agents|sensory system agents|mesh-ancestor
25096689|NCT03210038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25224524|NCT02633007|Dopamine Agents|dopamine agents|mesh-ancestor
25224525|NCT02633007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25224526|NCT02633007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224527|NCT02633007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224528|NCT02633007|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25224529|NCT02633007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837739|NCT02192944|Piperaquine|piperaquine|mesh-list
24837740|NCT02192944|Artenimol|artenimol|mesh-list
24837741|NCT02192944|Amebicides|amebicides|mesh-ancestor
25680567|NCT01852383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680568|NCT01852383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25680569|NCT01852383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680570|NCT01852383|Analgesics|analgesics|mesh-ancestor
25680571|NCT01852383|Sensory System Agents|sensory system agents|mesh-ancestor
25680572|NCT01852383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25680573|NCT01852383|Antidepressive Agents|antidepressive agents|mesh-ancestor
25680574|NCT01852383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25680575|NCT01852383|Dopamine Agents|dopamine agents|mesh-ancestor
25680576|NCT01852591|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25680577|NCT01852591|Immunologic Factors|immunologic factors|mesh-ancestor
25680578|NCT01852591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680579|NCT01852669|Furosemide|furosemide|mesh-list
25680580|NCT01852669|Diuretics|diuretics|mesh-ancestor
25680581|NCT01852669|Natriuretic Agents|natriuretic agents|mesh-ancestor
25096691|NCT03210038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25096692|NCT03210038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25096693|NCT03210038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25096696|NCT03209908|Antiviral Agents|antiviral agents|mesh-ancestor
25096697|NCT03209908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25096698|NCT03209908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25096704|NCT03209856|Vitamin D|vitamin d|mesh-list
25096705|NCT03209856|Calcitriol|calcitriol|mesh-list
25096706|NCT03209856|Vitamins|vitamins|mesh-ancestor
25096718|NCT03209622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25096719|NCT03209622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096720|NCT03209622|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25096721|NCT03209622|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25096722|NCT03209622|Cholinergic Agents|cholinergic agents|mesh-ancestor
25096723|NCT03209622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25096724|NCT03209622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096725|NCT03209466|Chlorhexidine|chlorhexidine|mesh-list
25096726|NCT03209466|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25096731|NCT03209427|Morphine|morphine|mesh-list
24773553|NCT01840384|Micronutrients|micronutrients|mesh-list
24773554|NCT01840384|Trace Elements|trace elements|mesh-list
24773555|NCT01840384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773556|NCT01840423|Levodopa|levodopa|mesh-list
24773557|NCT01840423|Carbidopa|carbidopa|mesh-list
24773558|NCT01840423|Entacapone|entacapone|mesh-list
24773559|NCT01840423|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25096732|NCT03209427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25096733|NCT03209427|Narcotics|narcotics|mesh-ancestor
25096734|NCT03209427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25096735|NCT03209427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096736|NCT03209427|Analgesics|analgesics|mesh-ancestor
25096737|NCT03209427|Sensory System Agents|sensory system agents|mesh-ancestor
24528550|NCT00621478|Anesthetics|anesthetics|mesh-ancestor
25096738|NCT03209427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24987256|NCT03412799|Mitosis Modulators|mitosis modulators|mesh-ancestor
24987257|NCT03412799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987258|NCT03412799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24987260|NCT03412799|Antiviral Agents|antiviral agents|mesh-ancestor
25096739|NCT03209661|Menthol|menthol|mesh-list
25096740|NCT03209661|Nicotine|nicotine|mesh-list
25096741|NCT03209661|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25096742|NCT03209661|Autonomic Agents|autonomic agents|mesh-ancestor
25096743|NCT03209661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25096744|NCT03209661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096745|NCT03209661|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25096746|NCT03209661|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25096747|NCT03209661|Cholinergic Agents|cholinergic agents|mesh-ancestor
25096748|NCT03209661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24773649|NCT01841164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096749|NCT03209661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096750|NCT03209661|Antipruritics|antipruritics|mesh-ancestor
25096751|NCT03209661|Dermatologic Agents|dermatologic agents|mesh-ancestor
25096752|NCT03209648|Itraconazole|itraconazole|mesh-list
25096753|NCT03209648|Antifungal Agents|antifungal agents|mesh-ancestor
25096754|NCT03209648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25096755|NCT03209648|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25096756|NCT03209648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25096757|NCT03209648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25096758|NCT03209648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224530|NCT02632903|Zoledronic Acid|zoledronic acid|mesh-list
25224531|NCT02632903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25680582|NCT01852669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680583|NCT01852669|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25680584|NCT01852669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25680585|NCT01852669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680586|NCT01852942|Losartan|losartan|mesh-list
25224532|NCT02632903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709996|NCT01507974|Clavulanic Acid|clavulanic acid|mesh-list
25224533|NCT02632877|Pirfenidone|pirfenidone|mesh-list
25224534|NCT02632877|Ketanserin|ketanserin|mesh-list
25224535|NCT02632877|Analgesics|analgesics|mesh-ancestor
25224536|NCT02632877|Sensory System Agents|sensory system agents|mesh-ancestor
24837745|NCT02192944|Antimalarials|antimalarials|mesh-ancestor
24837746|NCT02192944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24837747|NCT02193022|Miltefosine|miltefosine|mesh-list
24837748|NCT02193022|Antifungal Agents|antifungal agents|mesh-ancestor
24837749|NCT02193022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24837750|NCT02193022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24837751|NCT02193022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25056257|NCT03514108|Metformin|metformin|mesh-list
25096770|NCT03209037|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25096771|NCT03209037|Antiviral Agents|antiviral agents|mesh-ancestor
25096772|NCT03209037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25096773|NCT03209180|Carvedilol|carvedilol|mesh-list
25096784|NCT03209180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25096785|NCT03209180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25096786|NCT03209180|Vasodilator Agents|vasodilator agents|mesh-ancestor
25096787|NCT03209180|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25096788|NCT03209180|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25096789|NCT03209297|Salicylic Acid|salicylic acid|mesh-list
25096790|NCT03209297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25096791|NCT03209297|Antifungal Agents|antifungal agents|mesh-ancestor
25096792|NCT03209297|Keratolytic Agents|keratolytic agents|mesh-ancestor
25096793|NCT03209297|Dermatologic Agents|dermatologic agents|mesh-ancestor
25096794|NCT03209115|Calcium, Dietary|calcium, dietary|mesh-list
25096795|NCT03209115|Chlorhexidine|chlorhexidine|mesh-list
25096796|NCT03209115|Calcium|calcium|mesh-list
25096803|NCT03209193|Sevoflurane|sevoflurane|mesh-list
25096807|NCT03209193|Anesthetics, General|anesthetics, general|mesh-ancestor
25096808|NCT03209193|Anesthetics|anesthetics|mesh-ancestor
25096809|NCT03209193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25096810|NCT03209193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096811|NCT03209219|Interferons|interferons|mesh-list
25096812|NCT03209219|Interferon-alpha|interferon-alpha|mesh-list
25096813|NCT03209219|Interferon alpha-2|interferon alpha-2|mesh-list
25096814|NCT03209219|Cyclosporine|cyclosporine|mesh-list
25096815|NCT03209219|Cyclosporins|cyclosporins|mesh-list
25096816|NCT03209219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25096817|NCT03209219|Antiviral Agents|antiviral agents|mesh-ancestor
25096818|NCT03209219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25096819|NCT03209219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25096820|NCT03209219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096821|NCT03209219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25096822|NCT03209219|Immunologic Factors|immunologic factors|mesh-ancestor
25096823|NCT03209219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096824|NCT03209219|Antifungal Agents|antifungal agents|mesh-ancestor
25096825|NCT03209219|Dermatologic Agents|dermatologic agents|mesh-ancestor
25096826|NCT03209219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25096827|NCT03209219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25096828|NCT03209102|Hydrocortisone|hydrocortisone|mesh-list
25096829|NCT03209102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25096830|NCT03209011|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25096831|NCT03209011|Antiviral Agents|antiviral agents|mesh-ancestor
25096832|NCT03209011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25096833|NCT03209206|Docetaxel|docetaxel|mesh-list
25096834|NCT03209206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25096835|NCT03209206|Tubulin Modulators|tubulin modulators|mesh-ancestor
25096836|NCT03209206|Antimitotic Agents|antimitotic agents|mesh-ancestor
25096837|NCT03209206|Mitosis Modulators|mitosis modulators|mesh-ancestor
25096838|NCT03209206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096839|NCT03209232|Infliximab|infliximab|mesh-list
25096840|NCT03209232|Dermatologic Agents|dermatologic agents|mesh-ancestor
25096841|NCT03209232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25096842|NCT03209232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25096849|NCT03208764|Nitric Oxide|nitric oxide|mesh-list
25096850|NCT03208764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25096851|NCT03208764|Autonomic Agents|autonomic agents|mesh-ancestor
25096852|NCT03208764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25096853|NCT03208764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096874|NCT03208998|Antiviral Agents|antiviral agents|mesh-ancestor
25096875|NCT03208998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25096876|NCT03208556|Cyclophosphamide|cyclophosphamide|mesh-list
25096877|NCT03208556|Fludarabine|fludarabine|mesh-list
25224537|NCT02632877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25224538|NCT02632877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224539|NCT02632877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25680587|NCT01852942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25680588|NCT01852942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25680589|NCT01852942|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25680590|NCT01852942|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25224540|NCT02632877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25224541|NCT02632877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25224542|NCT02632877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25224543|NCT02632877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24837752|NCT02193022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24837753|NCT02193217|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24837754|NCT02193217|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24837755|NCT02193217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837756|NCT02193217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24837757|NCT02193217|Immunologic Factors|immunologic factors|mesh-ancestor
24837758|NCT02193217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837760|NCT02193256|Varenicline|varenicline|mesh-list
24837764|NCT02193256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25056261|NCT03514108|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25056262|NCT03514108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25056263|NCT03514108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056264|NCT03514108|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25056265|NCT03514108|Diuretics|diuretics|mesh-ancestor
25056266|NCT03514108|Natriuretic Agents|natriuretic agents|mesh-ancestor
25056267|NCT03514108|Vasodilator Agents|vasodilator agents|mesh-ancestor
25056268|NCT03514108|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25056269|NCT03514108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056270|NCT03514108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25056271|NCT03514030|Antibodies|antibodies|mesh-list
25096878|NCT03208556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25096879|NCT03208556|Immunologic Factors|immunologic factors|mesh-ancestor
25096880|NCT03208556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096881|NCT03208556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25096882|NCT03208556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25096883|NCT03208556|Alkylating Agents|alkylating agents|mesh-ancestor
25096884|NCT03208556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096885|NCT03208556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25096886|NCT03208556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25096887|NCT03208582|Risedronic Acid|risedronic acid|mesh-list
25096888|NCT03208582|Diphosphonates|diphosphonates|mesh-list
25096889|NCT03208582|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25096890|NCT03208582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25096891|NCT03208582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096892|NCT03208582|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25096893|NCT03208582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096894|NCT03208582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25096895|NCT03208452|Magnesium Sulfate|magnesium sulfate|mesh-list
25096896|NCT03208452|Analgesics|analgesics|mesh-ancestor
25096897|NCT03208452|Sensory System Agents|sensory system agents|mesh-ancestor
25096898|NCT03208452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25096899|NCT03208452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096900|NCT03208452|Anesthetics|anesthetics|mesh-ancestor
25096901|NCT03208452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25096902|NCT03208452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25224544|NCT02632877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25224545|NCT02632877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25224546|NCT02632877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25224547|NCT02632877|Serotonin Agents|serotonin agents|mesh-ancestor
25224548|NCT02632877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25224549|NCT02632877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224550|NCT02632760|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25224551|NCT02632760|Hematinics|hematinics|mesh-ancestor
25224552|NCT02632565|Lidocaine|lidocaine|mesh-list
25224553|NCT02632565|Anesthetics, Local|anesthetics, local|mesh-ancestor
25224554|NCT02632565|Anesthetics|anesthetics|mesh-ancestor
25224555|NCT02632565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25224556|NCT02632565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224557|NCT02632565|Sensory System Agents|sensory system agents|mesh-ancestor
25224558|NCT02632565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25224559|NCT02632565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25224560|NCT02632565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25224561|NCT02632565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25224562|NCT02632565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25405287|NCT03615105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25021204|NCT03674151|Povidone|povidone|mesh-list
25021205|NCT03674151|Plasma Substitutes|plasma substitutes|mesh-ancestor
25021206|NCT03674151|Blood Substitutes|blood substitutes|mesh-ancestor
25021207|NCT03674099|Methylprednisolone|methylprednisolone|mesh-list
25021208|NCT03674099|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25021209|NCT03674099|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25021210|NCT03674099|Prednisolone|prednisolone|mesh-list
25021211|NCT03674099|Prednisolone acetate|prednisolone acetate|mesh-list
25224563|NCT02632565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224565|NCT02632578|Immunologic Factors|immunologic factors|mesh-ancestor
25224566|NCT02632578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837765|NCT02193256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837766|NCT02193256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837767|NCT02193256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24837768|NCT02193256|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24837769|NCT02193256|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24837770|NCT02193256|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24837780|NCT02193308|Telmisartan|telmisartan|mesh-list
24837781|NCT02193308|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
25096903|NCT03208452|Anticonvulsants|anticonvulsants|mesh-ancestor
25096904|NCT03208452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25096905|NCT03208452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25096948|NCT03208257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096949|NCT03208257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096950|NCT03208270|Antithrombins|antithrombins|mesh-list
25096951|NCT03208270|Antithrombin III|antithrombin iii|mesh-list
25096952|NCT03208270|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25096953|NCT03208270|Protease Inhibitors|protease inhibitors|mesh-ancestor
25096954|NCT03208270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25096955|NCT03208270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096956|NCT03208270|Anticoagulants|anticoagulants|mesh-ancestor
25096957|NCT03208309|Diacetylrhein|diacetylrhein|mesh-list
25096960|NCT03208426|Metronidazole|metronidazole|mesh-list
25096961|NCT03208426|Clarithromycin|clarithromycin|mesh-list
25096962|NCT03208426|Tetracycline|tetracycline|mesh-list
25096963|NCT03208426|Esomeprazole|esomeprazole|mesh-list
25096964|NCT03208426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25096965|NCT03208426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25096966|NCT03208426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25096967|NCT03208426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25096968|NCT03208426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25096969|NCT03208426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25096970|NCT03208426|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25096971|NCT03208426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400091|NCT00149656|Selenium|selenium|mesh-list
25224567|NCT02632474|Tenofovir|tenofovir|mesh-list
25224568|NCT02632474|Lamivudine|lamivudine|mesh-list
25224569|NCT02632474|Efavirenz|efavirenz|mesh-list
25224570|NCT02632474|Antiviral Agents|antiviral agents|mesh-ancestor
25224571|NCT02632474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25224572|NCT02632474|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25224573|NCT02632474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25224574|NCT02632474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25224575|NCT02632474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837782|NCT02193308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24837783|NCT02193308|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24837784|NCT02193308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24837785|NCT02193308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837786|NCT02193308|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25097028|NCT03207334|Midostaurin|midostaurin|mesh-list
25097029|NCT03207334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25097030|NCT03207334|Antimetabolites|antimetabolites|mesh-ancestor
25097031|NCT03207334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097032|NCT03207334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097033|NCT03207334|Antiviral Agents|antiviral agents|mesh-ancestor
25097034|NCT03207334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25097035|NCT03207334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25097036|NCT03207334|Immunologic Factors|immunologic factors|mesh-ancestor
25680591|NCT01852942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680592|NCT01852955|Acetaminophen|acetaminophen|mesh-list
25680593|NCT01852955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25680594|NCT01852955|Analgesics|analgesics|mesh-ancestor
25680595|NCT01852955|Sensory System Agents|sensory system agents|mesh-ancestor
25680596|NCT01852955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25692439|NCT01999400|Analgesics|analgesics|mesh-ancestor
25097038|NCT03207334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24484161|NCT00446862|Losartan|losartan|mesh-list
24413989|NCT00195767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24413990|NCT00195767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413991|NCT00195767|Antimanic Agents|antimanic agents|mesh-ancestor
24413996|NCT00195780|Anticonvulsants|anticonvulsants|mesh-ancestor
24413997|NCT00195780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400294|NCT00150280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25097049|NCT03207165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25097050|NCT03207165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25097051|NCT03207165|Adrenergic Agents|adrenergic agents|mesh-ancestor
25097052|NCT03207165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25097053|NCT03207165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097054|NCT03207165|Protective Agents|protective agents|mesh-ancestor
25097055|NCT03207165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25097056|NCT03207165|Vasodilator Agents|vasodilator agents|mesh-ancestor
25097092|NCT03206944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097093|NCT03206944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25097094|NCT03206944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25097095|NCT03206944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25097096|NCT03206944|Antipyretics|antipyretics|mesh-ancestor
25097097|NCT03206931|Selitrectinib|selitrectinib|mesh-list
25097098|NCT03206931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25097099|NCT03206931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097101|NCT03206671|Dexamethasone|dexamethasone|mesh-list
25097102|NCT03206671|Prednisolone|prednisolone|mesh-list
25097103|NCT03206671|Cyclophosphamide|cyclophosphamide|mesh-list
25097104|NCT03206671|Ifosfamide|ifosfamide|mesh-list
25097105|NCT03206671|Rituximab|rituximab|mesh-list
25097106|NCT03206671|Doxorubicin|doxorubicin|mesh-list
25097107|NCT03206671|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25097108|NCT03206671|Methotrexate|methotrexate|mesh-list
25097109|NCT03206671|Etoposide|etoposide|mesh-list
25097110|NCT03206671|Vincristine|vincristine|mesh-list
25097111|NCT03206671|Vindesine|vindesine|mesh-list
25097112|NCT03206671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25097113|NCT03206671|Immunologic Factors|immunologic factors|mesh-ancestor
25097114|NCT03206671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097115|NCT03206671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25097116|NCT03206671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25097117|NCT03206671|Alkylating Agents|alkylating agents|mesh-ancestor
25097118|NCT03206671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097119|NCT03206671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097120|NCT03206671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25097121|NCT03206671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25097122|NCT03206671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25097123|NCT03206671|Antiemetics|antiemetics|mesh-ancestor
25097124|NCT03206671|Autonomic Agents|autonomic agents|mesh-ancestor
25224576|NCT02632474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25224577|NCT02632474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25224578|NCT02632474|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25224579|NCT02632474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25224580|NCT02632474|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24837787|NCT02193308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837788|NCT02193308|Vasodilator Agents|vasodilator agents|mesh-ancestor
24837802|NCT02193620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24837803|NCT02193620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837804|NCT02193620|Analgesics|analgesics|mesh-ancestor
25097125|NCT03206671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25097126|NCT03206671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24413999|NCT00195780|GABA Agents|gaba agents|mesh-ancestor
24414006|NCT00195793|Atorvastatin|atorvastatin|mesh-list
25097127|NCT03206671|Glucocorticoids|glucocorticoids|mesh-ancestor
25097128|NCT03206671|Hormones|hormones|mesh-ancestor
25097129|NCT03206671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24400570|NCT00150852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25097151|NCT03206723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25097152|NCT03206723|Narcotics|narcotics|mesh-ancestor
25097153|NCT03206723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25097154|NCT03206723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097155|NCT03206723|Analgesics|analgesics|mesh-ancestor
25097156|NCT03206723|Sensory System Agents|sensory system agents|mesh-ancestor
25097157|NCT03206723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25097158|NCT03206723|Antitussive Agents|antitussive agents|mesh-ancestor
25097159|NCT03206723|Respiratory System Agents|respiratory system agents|mesh-ancestor
25097160|NCT03206723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25097163|NCT03206658|Hormone Antagonists|hormone antagonists|mesh-ancestor
25097164|NCT03206658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25097165|NCT03206658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097271|NCT03204929|Micronutrients|micronutrients|mesh-ancestor
25097174|NCT03206554|Sensory System Agents|sensory system agents|mesh-ancestor
25097175|NCT03206554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25097176|NCT03206866|Antibodies|antibodies|mesh-list
25097177|NCT03206866|Immunologic Factors|immunologic factors|mesh-ancestor
25097178|NCT03206866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097179|NCT03206346|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
25097180|NCT03206346|Antiviral Agents|antiviral agents|mesh-ancestor
25097181|NCT03206346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25097182|NCT03206138|Imiquimod|imiquimod|mesh-list
25097189|NCT03206177|Carboplatin|carboplatin|mesh-list
25097190|NCT03206177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25097191|NCT03206177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097192|NCT03206177|Tubulin Modulators|tubulin modulators|mesh-ancestor
25097193|NCT03206177|Antimitotic Agents|antimitotic agents|mesh-ancestor
25097194|NCT03206177|Mitosis Modulators|mitosis modulators|mesh-ancestor
25097206|NCT03206320|Anesthetics, Local|anesthetics, local|mesh-ancestor
25097207|NCT03206320|Anesthetics|anesthetics|mesh-ancestor
25097208|NCT03206320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25097209|NCT03206320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097210|NCT03206320|Sensory System Agents|sensory system agents|mesh-ancestor
25097211|NCT03206320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25097212|NCT03206320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25097213|NCT03206320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25097214|NCT03206320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25097215|NCT03206320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25097216|NCT03206320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097217|NCT03206021|Carboplatin|carboplatin|mesh-list
25097218|NCT03206021|Azacitidine|azacitidine|mesh-list
25097219|NCT03206021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774132|NCT01843868|Hormones|hormones|mesh-ancestor
25097220|NCT03206021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25097221|NCT03206021|Antimetabolites|antimetabolites|mesh-ancestor
25224581|NCT02632474|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25224582|NCT02632474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25224583|NCT02632474|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25224584|NCT02632331|Gabapentin|gabapentin|mesh-list
25224585|NCT02632331|Analgesics|analgesics|mesh-ancestor
25224586|NCT02632331|Sensory System Agents|sensory system agents|mesh-ancestor
25275733|NCT02369822|Antioxidants|antioxidants|mesh-ancestor
24837805|NCT02193620|Sensory System Agents|sensory system agents|mesh-ancestor
24837806|NCT02193620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24837807|NCT02193633|Paclitaxel|paclitaxel|mesh-list
24837808|NCT02193633|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25056299|NCT03513601|Rituximab|rituximab|mesh-list
25097222|NCT03206021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097255|NCT03205228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25097256|NCT03205228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097258|NCT03205228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25097259|NCT03205228|Dopamine Agents|dopamine agents|mesh-ancestor
25097260|NCT03205228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25097261|NCT03205176|Olaparib|olaparib|mesh-list
25097262|NCT03205176|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25097263|NCT03205176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25097264|NCT03205176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097265|NCT03205176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097266|NCT03204955|Plasma-lyte 148|plasma-lyte 148|mesh-list
25097267|NCT03204955|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25097268|NCT03204955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25097270|NCT03204929|Trace Elements|trace elements|mesh-ancestor
25097282|NCT03205033|Antioxidants|antioxidants|mesh-ancestor
25097283|NCT03205033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097284|NCT03205033|Protective Agents|protective agents|mesh-ancestor
25097285|NCT03205033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405288|NCT03615105|Alkylating Agents|alkylating agents|mesh-ancestor
25680597|NCT01852955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680598|NCT01852955|Antipyretics|antipyretics|mesh-ancestor
24514796|NCT00592969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25097311|NCT03204799|Metformin|metformin|mesh-list
25097312|NCT03204799|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25097313|NCT03204799|Ezetimibe|ezetimibe|mesh-list
25097314|NCT03204799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25224587|NCT02632331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25224588|NCT02632331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224589|NCT02632331|Anticonvulsants|anticonvulsants|mesh-ancestor
25224590|NCT02632331|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25224591|NCT02632331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25224592|NCT02632331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25224593|NCT02632331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25224594|NCT02632331|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25224595|NCT02632331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25224596|NCT02632331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25224597|NCT02632331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224598|NCT02632331|Antimanic Agents|antimanic agents|mesh-ancestor
25224599|NCT02632019|Gemcitabine|gemcitabine|mesh-list
24837809|NCT02193633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24837810|NCT02193633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24837811|NCT02193633|Tubulin Modulators|tubulin modulators|mesh-ancestor
24837812|NCT02193633|Antimitotic Agents|antimitotic agents|mesh-ancestor
24837813|NCT02193633|Mitosis Modulators|mitosis modulators|mesh-ancestor
24837814|NCT02193633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837815|NCT02193698|Dexamethasone|dexamethasone|mesh-list
24837816|NCT02193698|Lenalidomide|lenalidomide|mesh-list
24837817|NCT02193698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24987565|NCT00321100|Antimetabolites|antimetabolites|mesh-ancestor
24987566|NCT00321100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837818|NCT02193698|Antiemetics|antiemetics|mesh-ancestor
24837819|NCT02193698|Autonomic Agents|autonomic agents|mesh-ancestor
24837820|NCT02193698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24837821|NCT02193698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837822|NCT02193698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24837823|NCT02193698|Glucocorticoids|glucocorticoids|mesh-ancestor
24837824|NCT02193698|Hormones|hormones|mesh-ancestor
25097315|NCT03204799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097316|NCT03204799|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25097317|NCT03204799|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25097318|NCT03204799|Antimetabolites|antimetabolites|mesh-ancestor
25097319|NCT03204799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097320|NCT03204799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25097321|NCT03204669|Trace Elements|trace elements|mesh-list
25097322|NCT03204669|Micronutrients|micronutrients|mesh-list
24485820|NCT00455130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485821|NCT00455234|Promethazine|promethazine|mesh-list
24485889|NCT00455351|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24414038|NCT00195871|Cytarabine|cytarabine|mesh-list
24414039|NCT00195871|Prednisone|prednisone|mesh-list
24414040|NCT00195871|Cyclophosphamide|cyclophosphamide|mesh-list
24414041|NCT00195871|Methotrexate|methotrexate|mesh-list
24414042|NCT00195871|Etoposide|etoposide|mesh-list
24414043|NCT00195871|Vincristine|vincristine|mesh-list
24414044|NCT00195871|Daunorubicin|daunorubicin|mesh-list
25097323|NCT03204669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097324|NCT03204331|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25097325|NCT03204331|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25097326|NCT03204331|Norethindrone|norethindrone|mesh-list
25097327|NCT03204331|Norethindrone Acetate|norethindrone acetate|mesh-list
25097328|NCT03204331|Estradiol|estradiol|mesh-list
25097329|NCT03204331|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25097330|NCT03204331|Relugolix|relugolix|mesh-list
25680599|NCT01853072|Prednisolone|prednisolone|mesh-list
25097331|NCT03204331|Estrogens|estrogens|mesh-ancestor
25097332|NCT03204331|Hormones|hormones|mesh-ancestor
25097333|NCT03204331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25097334|NCT03204331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097335|NCT03204331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25097336|NCT03204331|Contraceptive Agents|contraceptive agents|mesh-ancestor
25097337|NCT03204331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25097338|NCT03204331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24565481|NCT00780780|Triamcinolone|triamcinolone|mesh-list
25097352|NCT03204578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25224600|NCT02632019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25224601|NCT02632019|Antimetabolites|antimetabolites|mesh-ancestor
25224602|NCT02632019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224603|NCT02632019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25224604|NCT02632019|Antiviral Agents|antiviral agents|mesh-ancestor
25224605|NCT02632019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25224606|NCT02632019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25224607|NCT02632019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25224608|NCT02632019|Immunologic Factors|immunologic factors|mesh-ancestor
25224609|NCT02632019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224610|NCT02632279|Tryptophan|tryptophan|mesh-list
25224611|NCT02632279|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25224612|NCT02632279|Antidepressive Agents|antidepressive agents|mesh-ancestor
25224613|NCT02632279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25224614|NCT02632305|Gemcitabine|gemcitabine|mesh-list
25224615|NCT02632305|Paclitaxel|paclitaxel|mesh-list
25224616|NCT02632305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25224617|NCT02632305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25224618|NCT02632305|Tubulin Modulators|tubulin modulators|mesh-ancestor
25224619|NCT02632305|Antimitotic Agents|antimitotic agents|mesh-ancestor
24837848|NCT02194075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24837849|NCT02194075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837850|NCT02194075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24837851|NCT02194075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24837852|NCT02194075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24837853|NCT02194075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837854|NCT02194075|Dopamine Agents|dopamine agents|mesh-ancestor
24837855|NCT02194075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25097353|NCT03204578|Anesthetics, General|anesthetics, general|mesh-ancestor
25097354|NCT03204578|Anesthetics|anesthetics|mesh-ancestor
25097355|NCT03204578|GABA Modulators|gaba modulators|mesh-ancestor
25097364|NCT03204474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097366|NCT03204565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25097367|NCT03204565|Immunologic Factors|immunologic factors|mesh-ancestor
25097368|NCT03204565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097369|NCT03204565|Viscosupplements|viscosupplements|mesh-ancestor
25097370|NCT03204565|Protective Agents|protective agents|mesh-ancestor
25097371|NCT03204318|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25097372|NCT03204318|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25097373|NCT03204318|Norethindrone|norethindrone|mesh-list
25097374|NCT03204318|Norethindrone Acetate|norethindrone acetate|mesh-list
25097375|NCT03204318|Estradiol|estradiol|mesh-list
25097376|NCT03204318|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25097377|NCT03204318|Relugolix|relugolix|mesh-list
25097378|NCT03204318|Estrogens|estrogens|mesh-ancestor
25097379|NCT03204318|Hormones|hormones|mesh-ancestor
25097380|NCT03204318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25097381|NCT03204318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097382|NCT03204318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25097383|NCT03204318|Contraceptive Agents|contraceptive agents|mesh-ancestor
25097384|NCT03204318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25097385|NCT03204318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25097386|NCT03204318|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25097387|NCT03204318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25097388|NCT03204318|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25097389|NCT03204318|Androgen Antagonists|androgen antagonists|mesh-ancestor
25097390|NCT03204318|Hormone Antagonists|hormone antagonists|mesh-ancestor
25097391|NCT03204097|Alendronate|alendronate|mesh-list
25097392|NCT03204097|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25097393|NCT03204097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097394|NCT03203967|Morphine|morphine|mesh-list
25097395|NCT03203967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25097396|NCT03203967|Narcotics|narcotics|mesh-ancestor
25097397|NCT03203967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25097398|NCT03203967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984108|NCT04801043|Imipenem|imipenem|mesh-list
25097399|NCT03203967|Analgesics|analgesics|mesh-ancestor
24486557|NCT00458419|Naloxone|naloxone|mesh-list
24414045|NCT00195871|Asparaginase|asparaginase|mesh-list
24414046|NCT00195871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25097400|NCT03203967|Sensory System Agents|sensory system agents|mesh-ancestor
25097401|NCT03203967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25097402|NCT03204006|Dexmedetomidine|dexmedetomidine|mesh-list
25097403|NCT03204006|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25097404|NCT03204006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25097405|NCT03204006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097406|NCT03204006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24402146|NCT00155233|Narcotics|narcotics|mesh-ancestor
25097424|NCT03204032|Immunologic Factors|immunologic factors|mesh-ancestor
25097425|NCT03204032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097426|NCT03204032|Leprostatic Agents|leprostatic agents|mesh-ancestor
25097427|NCT03204032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25097428|NCT03204032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25097429|NCT03204032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25097435|NCT03204045|Fentanyl|fentanyl|mesh-list
25097443|NCT03204045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25097444|NCT03204045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25224620|NCT02632305|Mitosis Modulators|mitosis modulators|mesh-ancestor
25224621|NCT02632305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224622|NCT02632305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25224623|NCT02632305|Antimetabolites|antimetabolites|mesh-ancestor
25224624|NCT02632305|Antiviral Agents|antiviral agents|mesh-ancestor
25224625|NCT02632305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25224626|NCT02632305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25224627|NCT02632305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25224628|NCT02632305|Immunologic Factors|immunologic factors|mesh-ancestor
24837856|NCT02194075|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24837857|NCT02194075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24837858|NCT02194075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24837859|NCT02194075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24837860|NCT02194075|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25097445|NCT03204045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25097447|NCT03204045|Anesthetics|anesthetics|mesh-ancestor
25097448|NCT03204058|Metformin|metformin|mesh-list
25097449|NCT03204058|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25097450|NCT03204058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25097451|NCT03204058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097452|NCT03204058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25097453|NCT03204058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25097454|NCT03204058|Antimetabolites|antimetabolites|mesh-ancestor
25097455|NCT03204058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097456|NCT03204058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25097457|NCT03204058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25097458|NCT03204058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25097459|NCT03204071|Metformin|metformin|mesh-list
25097460|NCT03204071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25097461|NCT03204071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097462|NCT03204019|Thalidomide|thalidomide|mesh-list
25097463|NCT03204019|Temozolomide|temozolomide|mesh-list
25097464|NCT03204019|Tegafur|tegafur|mesh-list
25097465|NCT03204019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25097466|NCT03204019|Alkylating Agents|alkylating agents|mesh-ancestor
25097467|NCT03204019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097468|NCT03204019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097469|NCT03204019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25097470|NCT03204019|Immunologic Factors|immunologic factors|mesh-ancestor
25097471|NCT03204019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097472|NCT03204019|Leprostatic Agents|leprostatic agents|mesh-ancestor
25097473|NCT03204019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25097474|NCT03204019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25097475|NCT03204019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25097476|NCT03204019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24414047|NCT00195871|Immunologic Factors|immunologic factors|mesh-ancestor
24414048|NCT00195871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414049|NCT00195871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25097490|NCT03203668|Choline|choline|mesh-list
25097491|NCT03203668|Lipotropic Agents|lipotropic agents|mesh-ancestor
25097492|NCT03203668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25097494|NCT03203668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680600|NCT01853072|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25097495|NCT03203668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25097496|NCT03203668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25097497|NCT03203668|Nootropic Agents|nootropic agents|mesh-ancestor
25097499|NCT03203356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25097500|NCT03203356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097502|NCT03203304|Ipilimumab|ipilimumab|mesh-list
25097503|NCT03203304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25097504|NCT03203304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097505|NCT03203304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25097506|NCT03203304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097507|NCT03203590|Carboplatin|carboplatin|mesh-list
25097508|NCT03203590|Vinorelbine|vinorelbine|mesh-list
25097509|NCT03203590|Gefitinib|gefitinib|mesh-list
25097512|NCT03203590|Tubulin Modulators|tubulin modulators|mesh-ancestor
25097520|NCT03203616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25097521|NCT03203616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097522|NCT03203616|Tubulin Modulators|tubulin modulators|mesh-ancestor
25097523|NCT03203616|Antimitotic Agents|antimitotic agents|mesh-ancestor
25097524|NCT03203616|Mitosis Modulators|mitosis modulators|mesh-ancestor
25097525|NCT03203616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097527|NCT03203408|Viscosupplements|viscosupplements|mesh-ancestor
25097528|NCT03203408|Protective Agents|protective agents|mesh-ancestor
25097529|NCT03203408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097530|NCT03203317|Insulin|insulin|mesh-list
25097531|NCT03203317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25224629|NCT02632305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224630|NCT02632032|Insulin|insulin|mesh-list
25224631|NCT02632032|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25224632|NCT02632032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25224633|NCT02632032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224634|NCT02631993|Furocoumarins|furocoumarins|mesh-list
24837861|NCT02194075|Serotonin Agents|serotonin agents|mesh-ancestor
24837862|NCT02194075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24837863|NCT02194075|Antidepressive Agents|antidepressive agents|mesh-ancestor
24837864|NCT02194075|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24837865|NCT02194075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24837866|NCT02194075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837867|NCT02194075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24837868|NCT02194153|Tenecteplase|tenecteplase|mesh-list
24837869|NCT02194153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24837870|NCT02194153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25097532|NCT03203317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097533|NCT03203421|Heparin Cofactor II|heparin cofactor ii|mesh-list
25097534|NCT03203421|Antithrombins|antithrombins|mesh-ancestor
25097535|NCT03203421|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25097536|NCT03203421|Protease Inhibitors|protease inhibitors|mesh-ancestor
25097537|NCT03203421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25097538|NCT03203421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097539|NCT03203421|Anticoagulants|anticoagulants|mesh-ancestor
25097540|NCT03203174|Botulinum Toxins|botulinum toxins|mesh-list
25097541|NCT03203174|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25097542|NCT03203174|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25097543|NCT03203174|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25097544|NCT03203174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25097545|NCT03203174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097561|NCT03202979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25097562|NCT03202979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097563|NCT03202979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25097564|NCT03202979|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25097565|NCT03202979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25097566|NCT03202979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25097567|NCT03202979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097568|NCT03202979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25097569|NCT03202979|Serotonin Agents|serotonin agents|mesh-ancestor
24774469|NCT01845688|Losartan|losartan|mesh-list
25097570|NCT03202979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25097571|NCT03202979|Antidepressive Agents|antidepressive agents|mesh-ancestor
25097572|NCT03202849|Vitamin D|vitamin d|mesh-list
25097573|NCT03202849|Ergocalciferols|ergocalciferols|mesh-list
25097574|NCT03202849|Cholecalciferol|cholecalciferol|mesh-list
25097575|NCT03202849|Vitamins|vitamins|mesh-list
25097576|NCT03202849|Micronutrients|micronutrients|mesh-ancestor
25097577|NCT03202849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021620|NCT03669757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25021621|NCT03669757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25111714|NCT04677049|Vitamins|vitamins|mesh-ancestor
25097578|NCT03202849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25097579|NCT03202849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25097580|NCT03203031|Anesthetics|anesthetics|mesh-list
25097581|NCT03203031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25097583|NCT03203070|Dipyrone|dipyrone|mesh-list
25097600|NCT03203005|Cyclophosphamide|cyclophosphamide|mesh-list
25097601|NCT03203005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25097602|NCT03203005|Immunologic Factors|immunologic factors|mesh-ancestor
25097603|NCT03203005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097604|NCT03203005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25097605|NCT03203005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25097606|NCT03203005|Alkylating Agents|alkylating agents|mesh-ancestor
25097607|NCT03203005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097608|NCT03203005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097609|NCT03203005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25097610|NCT03202862|Fulvestrant|fulvestrant|mesh-list
25097611|NCT03202862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25097612|NCT03202862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097613|NCT03202862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25097614|NCT03202862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25224635|NCT02631993|Dermatologic Agents|dermatologic agents|mesh-ancestor
25224636|NCT02631993|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25224637|NCT02632136|Bupivacaine|bupivacaine|mesh-list
25224638|NCT02632136|Anesthetics, Local|anesthetics, local|mesh-ancestor
25224639|NCT02632136|Anesthetics|anesthetics|mesh-ancestor
25224640|NCT02632136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25224641|NCT02632136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224642|NCT02632136|Sensory System Agents|sensory system agents|mesh-ancestor
25224643|NCT02632136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25224644|NCT02632071|Paclitaxel|paclitaxel|mesh-list
25224645|NCT02632071|Ricolinostat|ricolinostat|mesh-list
24837871|NCT02194153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837873|NCT02194166|Docetaxel|docetaxel|mesh-list
24837874|NCT02194166|Trastuzumab|trastuzumab|mesh-list
25043175|NCT01309945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24837875|NCT02194166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24837876|NCT02194166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24837887|NCT02194179|Antiviral Agents|antiviral agents|mesh-ancestor
24837900|NCT02194192|Antipruritics|antipruritics|mesh-ancestor
24837901|NCT02194192|Dermatologic Agents|dermatologic agents|mesh-ancestor
24837918|NCT02194218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837902|NCT02194192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24837903|NCT02194192|Serotonin Agents|serotonin agents|mesh-ancestor
24596770|NCT00945360|Letrozole|letrozole|mesh-list
24837904|NCT02194192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24837905|NCT02194192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056337|NCT03513393|Omeprazole|omeprazole|mesh-list
25097615|NCT03202862|Hormone Antagonists|hormone antagonists|mesh-ancestor
25097616|NCT03202862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25097617|NCT03202862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097626|NCT03202563|Dapagliflozin|dapagliflozin|mesh-list
25097627|NCT03202563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25097628|NCT03202563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565808|NCT00782652|Protective Agents|protective agents|mesh-ancestor
25097643|NCT03202459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25097644|NCT03202459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25097645|NCT03202459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25097646|NCT03202459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25097647|NCT03202459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25097648|NCT03202459|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25097649|NCT03202459|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25097650|NCT03202459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25097651|NCT03202459|Antimanic Agents|antimanic agents|mesh-ancestor
25097652|NCT03202719|Vaccines|vaccines|mesh-list
25097653|NCT03202719|Immunologic Factors|immunologic factors|mesh-ancestor
25097654|NCT03202719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097655|NCT03202407|Calcium|calcium|mesh-list
25097656|NCT03202407|Sevelamer|sevelamer|mesh-list
25097657|NCT03202407|Calcium acetate|calcium acetate|mesh-list
25680601|NCT01853072|Methylprednisolone|methylprednisolone|mesh-list
25680602|NCT01853072|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25680603|NCT01853072|Prednisolone acetate|prednisolone acetate|mesh-list
25097658|NCT03202407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25097659|NCT03202407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097660|NCT03202407|Chelating Agents|chelating agents|mesh-ancestor
25097661|NCT03202407|Sequestering Agents|sequestering agents|mesh-ancestor
25097662|NCT03202407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097663|NCT03202446|Cyclophosphamide|cyclophosphamide|mesh-list
25097665|NCT03202446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25097666|NCT03202446|Immunologic Factors|immunologic factors|mesh-ancestor
25097667|NCT03202446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097668|NCT03202446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25097669|NCT03202446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25097670|NCT03202446|Alkylating Agents|alkylating agents|mesh-ancestor
25097671|NCT03202446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097672|NCT03202446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097673|NCT03202446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25097674|NCT03202446|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25097675|NCT03202446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24414053|NCT00195871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24414054|NCT00195871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24414055|NCT00195871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25224646|NCT02632071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25224647|NCT02632071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25224648|NCT02632071|Tubulin Modulators|tubulin modulators|mesh-ancestor
25224649|NCT02632071|Antimitotic Agents|antimitotic agents|mesh-ancestor
25224650|NCT02632071|Mitosis Modulators|mitosis modulators|mesh-ancestor
25224651|NCT02632071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224652|NCT02632071|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25224653|NCT02632071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25224654|NCT02631928|Insulin|insulin|mesh-list
25224655|NCT02631928|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25224656|NCT02631928|Biphasic Insulins|biphasic insulins|mesh-list
25224657|NCT02631928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25224658|NCT02631928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224659|NCT02631694|Propranolol|propranolol|mesh-list
25224660|NCT02631694|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24837906|NCT02194192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24837907|NCT02194192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24837908|NCT02194192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24837909|NCT02194192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24837910|NCT02194192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24837911|NCT02194192|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24837912|NCT02194192|Sympathomimetics|sympathomimetics|mesh-ancestor
24837913|NCT02194192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24837914|NCT02194192|Adrenergic Agents|adrenergic agents|mesh-ancestor
24837916|NCT02194218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24837917|NCT02194218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25056347|NCT03513328|Alkylating Agents|alkylating agents|mesh-ancestor
24414057|NCT00195871|Hormones|hormones|mesh-ancestor
24414058|NCT00195871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25097676|NCT03202446|Antimetabolites|antimetabolites|mesh-ancestor
25097677|NCT03202446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25097678|NCT03202446|Chelating Agents|chelating agents|mesh-ancestor
25097679|NCT03202446|Sequestering Agents|sequestering agents|mesh-ancestor
25097680|NCT03202446|Hemostatics|hemostatics|mesh-ancestor
25097681|NCT03202446|Coagulants|coagulants|mesh-ancestor
25097682|NCT03202186|Progesterone|progesterone|mesh-list
25097683|NCT03202186|Progestins|progestins|mesh-ancestor
25097684|NCT03202186|Hormones|hormones|mesh-ancestor
25097685|NCT03202186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25097686|NCT03202186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097687|NCT03202316|Atezolizumab|atezolizumab|mesh-list
25097688|NCT03202316|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25097689|NCT03202316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097690|NCT03202316|Immunologic Factors|immunologic factors|mesh-ancestor
25097691|NCT03202316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097692|NCT03201861|Paclitaxel|paclitaxel|mesh-list
25097693|NCT03201861|Docetaxel|docetaxel|mesh-list
25097694|NCT03201861|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25097723|NCT03201796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097724|NCT03201796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25097725|NCT03201796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25097726|NCT03201770|Artesunate|artesunate|mesh-list
25097727|NCT03201770|Pyronaridine|pyronaridine|mesh-list
25097728|NCT03201770|Antimalarials|antimalarials|mesh-ancestor
25097729|NCT03201770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25680604|NCT01853072|Nepafenac|nepafenac|mesh-list
25021777|NCT03668470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25021778|NCT03668470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021779|NCT03668418|Gemcitabine|gemcitabine|mesh-list
25021780|NCT03668418|Camptothecin|camptothecin|mesh-list
25021781|NCT03668418|Docetaxel|docetaxel|mesh-list
25021782|NCT03668418|Fluorouracil|fluorouracil|mesh-list
25021783|NCT03668418|Oxaliplatin|oxaliplatin|mesh-list
25021784|NCT03668418|Irinotecan|irinotecan|mesh-list
25021812|NCT03668262|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25097730|NCT03201770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25097731|NCT03201770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25097732|NCT03201770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097738|NCT03201627|Antidepressive Agents|antidepressive agents|mesh-ancestor
25097739|NCT03201627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24987687|NCT05167084|Metyrapone|metyrapone|mesh-list
25097740|NCT03201627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25097741|NCT03201627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097818|NCT03201367|Anticoagulants|anticoagulants|mesh-ancestor
25097846|NCT03200782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25097847|NCT03200782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097848|NCT03200782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24774731|NCT01847599|Capecitabine|capecitabine|mesh-list
25224661|NCT02631694|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25097851|NCT03200847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24774838|NCT01848132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25097852|NCT03200847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097853|NCT03200847|Keratolytic Agents|keratolytic agents|mesh-ancestor
25224662|NCT02631694|Adrenergic Agents|adrenergic agents|mesh-ancestor
25224663|NCT02631694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25224664|NCT02631694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224665|NCT02631694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224666|NCT02631694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25224667|NCT02631694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25224668|NCT02631694|Vasodilator Agents|vasodilator agents|mesh-ancestor
25224669|NCT02631616|Somatostatin|somatostatin|mesh-list
25224670|NCT02631616|Hormones|hormones|mesh-ancestor
25224671|NCT02631616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25224672|NCT02631616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224673|NCT02631668|Ascorbic Acid|ascorbic acid|mesh-list
24837919|NCT02194218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837921|NCT02194218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24837922|NCT02194218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24837923|NCT02194218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24837924|NCT02194218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24815221|NCT02068937|Furosemide|furosemide|mesh-list
25097854|NCT03200847|Dermatologic Agents|dermatologic agents|mesh-ancestor
25097855|NCT03200808|Methylene Blue|methylene blue|mesh-list
25097856|NCT03200808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25097857|NCT03200808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097858|NCT03200691|Antibodies|antibodies|mesh-list
24414178|NCT00196586|Interferons|interferons|mesh-list
24414179|NCT00196586|Ribavirin|ribavirin|mesh-list
24414180|NCT00196586|Interferon-alpha|interferon-alpha|mesh-list
24414181|NCT00196586|Interferon alpha-2|interferon alpha-2|mesh-list
24414182|NCT00196586|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24414183|NCT00196586|Interleukin-2|interleukin-2|mesh-list
25680605|NCT01853072|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25680606|NCT01853072|Prednisolone phosphate|prednisolone phosphate|mesh-list
25680607|NCT01853072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25680608|NCT01853072|Glucocorticoids|glucocorticoids|mesh-ancestor
25680609|NCT01853072|Hormones|hormones|mesh-ancestor
25680610|NCT01853072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25680611|NCT01853072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680612|NCT01853072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25680613|NCT01853072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25680614|NCT01853072|Antiemetics|antiemetics|mesh-ancestor
24414184|NCT00196586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24414185|NCT00196586|Antiviral Agents|antiviral agents|mesh-ancestor
24414186|NCT00196586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24414189|NCT00196586|Immunologic Factors|immunologic factors|mesh-ancestor
24414190|NCT00196586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414191|NCT00196586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24414224|NCT00196612|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24414225|NCT00196612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25097907|NCT03200561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25097909|NCT03200561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25097910|NCT03200561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097911|NCT03200561|Immunologic Factors|immunologic factors|mesh-ancestor
25097914|NCT03200613|Tinzaparin|tinzaparin|mesh-list
25097938|NCT03200210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25097939|NCT03200080|Amphetamine|amphetamine|mesh-list
25097940|NCT03200080|Dextroamphetamine|dextroamphetamine|mesh-list
25098913|NCT03194620|Sequestering Agents|sequestering agents|mesh-ancestor
25097941|NCT03200080|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25097942|NCT03200080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097943|NCT03200080|Sympathomimetics|sympathomimetics|mesh-ancestor
25097944|NCT03200080|Autonomic Agents|autonomic agents|mesh-ancestor
25097945|NCT03200080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25097946|NCT03200080|Dopamine Agents|dopamine agents|mesh-ancestor
25097947|NCT03200080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25097948|NCT03200080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097949|NCT03200080|Adrenergic Agents|adrenergic agents|mesh-ancestor
25097950|NCT03200080|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25097951|NCT03200080|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25097952|NCT03200080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25097953|NCT03200080|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25097954|NCT03200236|Nicotine|nicotine|mesh-list
25097955|NCT03200236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25097956|NCT03200236|Autonomic Agents|autonomic agents|mesh-ancestor
25097957|NCT03200236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25097958|NCT03200236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097959|NCT03200236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25097960|NCT03200236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25097961|NCT03200236|Cholinergic Agents|cholinergic agents|mesh-ancestor
25224674|NCT02631668|Ferrous succinate|ferrous succinate|mesh-list
25224675|NCT02631668|Vitamins|vitamins|mesh-ancestor
25224676|NCT02631668|Micronutrients|micronutrients|mesh-ancestor
25224677|NCT02631668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224678|NCT02631668|Antioxidants|antioxidants|mesh-ancestor
25224679|NCT02631668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224680|NCT02631668|Protective Agents|protective agents|mesh-ancestor
25224681|NCT02631668|Hematinics|hematinics|mesh-ancestor
25224682|NCT02631603|Prednisolone|prednisolone|mesh-list
25224683|NCT02631603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25224684|NCT02631603|Glucocorticoids|glucocorticoids|mesh-ancestor
25224685|NCT02631603|Hormones|hormones|mesh-ancestor
24837925|NCT02194218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24837926|NCT02194231|Trabectedin|trabectedin|mesh-list
24837927|NCT02194231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24837928|NCT02194231|Alkylating Agents|alkylating agents|mesh-ancestor
24837929|NCT02194231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837930|NCT02194231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24837931|NCT02194257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24837933|NCT02194257|Expectorants|expectorants|mesh-ancestor
24837934|NCT02194257|Respiratory System Agents|respiratory system agents|mesh-ancestor
24837935|NCT02194270|Ambroxol|ambroxol|mesh-list
24837936|NCT02194270|Expectorants|expectorants|mesh-ancestor
24837937|NCT02194270|Respiratory System Agents|respiratory system agents|mesh-ancestor
24837938|NCT02194283|Ambroxol|ambroxol|mesh-list
25098061|NCT03199950|Dopamine Agents|dopamine agents|mesh-ancestor
25097984|NCT03200002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097985|NCT03200002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097986|NCT03200002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25097987|NCT03200002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25097988|NCT03200002|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25097989|NCT03200002|Antitubercular Agents|antitubercular agents|mesh-ancestor
25097990|NCT03200002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25097991|NCT03200002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25097992|NCT03200002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25097995|NCT03199976|Fluticasone|fluticasone|mesh-list
25097998|NCT03199976|Albuterol|albuterol|mesh-list
25097999|NCT03199976|Tiotropium Bromide|tiotropium bromide|mesh-list
25098000|NCT03199976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25098001|NCT03199976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25098002|NCT03199976|Autonomic Agents|autonomic agents|mesh-ancestor
25098003|NCT03199976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25098004|NCT03199976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098005|NCT03199976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24774978|NCT01849016|Antidotes|antidotes|mesh-ancestor
25098006|NCT03199976|Respiratory System Agents|respiratory system agents|mesh-ancestor
25098007|NCT03199976|Dermatologic Agents|dermatologic agents|mesh-ancestor
25098008|NCT03199976|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25098009|NCT03199976|Parasympatholytics|parasympatholytics|mesh-ancestor
25098010|NCT03199976|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25098011|NCT03199976|Cholinergic Agents|cholinergic agents|mesh-ancestor
24515526|NCT00598156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25098020|NCT03199976|Adrenergic Agents|adrenergic agents|mesh-ancestor
25098021|NCT03199664|Tacrolimus|tacrolimus|mesh-list
25098022|NCT03199664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25098023|NCT03199664|Immunologic Factors|immunologic factors|mesh-ancestor
25098024|NCT03199664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098025|NCT03199664|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25098026|NCT03199664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25098027|NCT03199664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098028|NCT03199690|Rifampin|rifampin|mesh-list
25098029|NCT03199690|Dolutegravir|dolutegravir|mesh-list
25098030|NCT03199690|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25098031|NCT03199690|Antitubercular Agents|antitubercular agents|mesh-ancestor
25098032|NCT03199690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25098033|NCT03199690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25098034|NCT03199690|Leprostatic Agents|leprostatic agents|mesh-ancestor
25098035|NCT03199690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25098036|NCT03199690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25098037|NCT03199690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098038|NCT03199690|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25098039|NCT03199690|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25098040|NCT03199690|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25098041|NCT03199690|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24405114|NCT00165490|Cetuximab|cetuximab|mesh-list
25224686|NCT02631603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25224687|NCT02631603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224688|NCT02631603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25224689|NCT02631603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25224690|NCT02631499|Epirubicin|epirubicin|mesh-list
25224691|NCT02631499|Ethiodized Oil|ethiodized oil|mesh-list
25224692|NCT02631499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25224693|NCT02631499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25224694|NCT02631499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25224695|NCT02631499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25224696|NCT02631499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25224697|NCT02631499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837940|NCT02194283|Respiratory System Agents|respiratory system agents|mesh-ancestor
24837941|NCT02194296|Ambroxol|ambroxol|mesh-list
24837942|NCT02194296|Expectorants|expectorants|mesh-ancestor
24837943|NCT02194296|Respiratory System Agents|respiratory system agents|mesh-ancestor
24837944|NCT02194309|Amlodipine|amlodipine|mesh-list
24837945|NCT02194309|Telmisartan|telmisartan|mesh-list
24837946|NCT02194309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24837947|NCT02194309|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24837948|NCT02194309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24837949|NCT02194309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837950|NCT02194309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24837951|NCT02194309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098062|NCT03199950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25098063|NCT03199950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098064|NCT03199950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25098065|NCT03199677|Apatinib|apatinib|mesh-list
25098066|NCT03199677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25098067|NCT03199677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25098068|NCT03199677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25098069|NCT03199677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098070|NCT03199729|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25098071|NCT03199729|Luteolytic Agents|luteolytic agents|mesh-ancestor
25098072|NCT03199729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25098073|NCT03199729|Contraceptive Agents|contraceptive agents|mesh-ancestor
25098074|NCT03199729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25098075|NCT03199729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712448|NCT01520467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25022027|NCT03666390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25022028|NCT03666390|Anesthetics, General|anesthetics, general|mesh-ancestor
25022029|NCT03666390|Anesthetics|anesthetics|mesh-ancestor
25022040|NCT03666390|GABA Modulators|gaba modulators|mesh-ancestor
25022058|NCT03666325|Pembrolizumab|pembrolizumab|mesh-list
25022059|NCT03666325|Cetuximab|cetuximab|mesh-list
25022060|NCT03666325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25022061|NCT03666325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463592|NCT00361517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24463593|NCT00361517|Antifungal Agents|antifungal agents|mesh-ancestor
24463594|NCT00361517|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24463595|NCT00361517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24463596|NCT00361543|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
24463597|NCT00361543|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24463598|NCT00361543|Hormone Antagonists|hormone antagonists|mesh-ancestor
25022062|NCT03666299|Lidocaine|lidocaine|mesh-list
25098076|NCT03199729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25098077|NCT03199729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25098078|NCT03199729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25098079|NCT03199625|Antidepressive Agents|antidepressive agents|mesh-list
25098080|NCT03199625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25098141|NCT03199430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25098142|NCT03199430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25098143|NCT03199534|Botulinum Toxins|botulinum toxins|mesh-list
25098144|NCT03199534|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25098145|NCT03199534|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25098146|NCT03199534|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25098147|NCT03199534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25098148|NCT03199534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098149|NCT03199534|Cholinergic Agents|cholinergic agents|mesh-ancestor
25098150|NCT03199534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25098151|NCT03199534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098152|NCT03199534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25098153|NCT03199534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24775152|NCT01850511|Respiratory System Agents|respiratory system agents|mesh-ancestor
24775153|NCT01850511|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25098211|NCT03198585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25098244|NCT03198208|Fentanyl|fentanyl|mesh-list
25098245|NCT03198208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25098246|NCT03198208|Narcotics|narcotics|mesh-ancestor
25098247|NCT03198208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25098248|NCT03198208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098249|NCT03198208|Analgesics|analgesics|mesh-ancestor
25098250|NCT03198208|Sensory System Agents|sensory system agents|mesh-ancestor
25098251|NCT03198208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25098252|NCT03198208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25098253|NCT03198208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25098254|NCT03198208|Anesthetics, General|anesthetics, general|mesh-ancestor
25224698|NCT02631473|Ritonavir|ritonavir|mesh-list
25224699|NCT02631473|Lopinavir|lopinavir|mesh-list
25224700|NCT02631473|Efavirenz|efavirenz|mesh-list
25224701|NCT02631473|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25224702|NCT02631473|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25224703|NCT02631473|Protease Inhibitors|protease inhibitors|mesh-ancestor
25224704|NCT02631473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25224705|NCT02631473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224706|NCT02631473|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25680615|NCT01853072|Autonomic Agents|autonomic agents|mesh-ancestor
25680616|NCT01853072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25680617|NCT01853072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25680618|NCT01853072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25680619|NCT01853072|Protective Agents|protective agents|mesh-ancestor
25680620|NCT01853072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25680621|NCT01853072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25680622|NCT01853072|Analgesics|analgesics|mesh-ancestor
25680623|NCT01853072|Sensory System Agents|sensory system agents|mesh-ancestor
25680624|NCT01853072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25680625|NCT01853085|Bimatoprost|bimatoprost|mesh-list
25680626|NCT01853085|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25680627|NCT01853085|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25680628|NCT01853085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25680629|NCT01853228|Cytarabine|cytarabine|mesh-list
25680630|NCT01853228|Decitabine|decitabine|mesh-list
25680631|NCT01853228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25224707|NCT02631473|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25022138|NCT03665740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022139|NCT03665740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022140|NCT03665740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25022141|NCT03665610|Ozanimod|ozanimod|mesh-list
25022142|NCT03665610|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25022143|NCT03665610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022144|NCT03665610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25022145|NCT03665610|Immunologic Factors|immunologic factors|mesh-ancestor
25022146|NCT03665610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022147|NCT03665545|Poly I-C|poly i-c|mesh-list
25022148|NCT03665545|Pembrolizumab|pembrolizumab|mesh-list
25022149|NCT03665545|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25022150|NCT03665545|Poly ICLC|poly iclc|mesh-list
25022151|NCT03665545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25022152|NCT03665545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25022153|NCT03665545|Interferon Inducers|interferon inducers|mesh-ancestor
25022154|NCT03665545|Immunologic Factors|immunologic factors|mesh-ancestor
25022155|NCT03665545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022156|NCT03665545|Laxatives|laxatives|mesh-ancestor
25022157|NCT03665545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25224708|NCT02631473|Antiviral Agents|antiviral agents|mesh-ancestor
25224709|NCT02631473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25224710|NCT02631473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24837952|NCT02194309|Vasodilator Agents|vasodilator agents|mesh-ancestor
24837953|NCT02194309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24837954|NCT02194309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24837955|NCT02194374|Vidarabine|vidarabine|mesh-list
24837960|NCT02194374|Fludarabine phosphate|fludarabine phosphate|mesh-list
24837961|NCT02194374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25098255|NCT03198208|Anesthetics|anesthetics|mesh-ancestor
25098256|NCT03198338|Bupivacaine|bupivacaine|mesh-list
25098257|NCT03198338|Anesthetics, Local|anesthetics, local|mesh-ancestor
25098258|NCT03198338|Anesthetics|anesthetics|mesh-ancestor
25098259|NCT03198338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25098260|NCT03198338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098261|NCT03198338|Sensory System Agents|sensory system agents|mesh-ancestor
25098262|NCT03198338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25098263|NCT03198195|Cyclophosphamide|cyclophosphamide|mesh-list
25098264|NCT03198195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25098265|NCT03198195|Immunologic Factors|immunologic factors|mesh-ancestor
25098266|NCT03198195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098267|NCT03198195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25098268|NCT03198195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25098269|NCT03198195|Alkylating Agents|alkylating agents|mesh-ancestor
25098318|NCT03197818|Formoterol Fumarate|formoterol fumarate|mesh-list
25098319|NCT03197818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25680632|NCT01853228|Antimetabolites|antimetabolites|mesh-ancestor
25680633|NCT01853228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680634|NCT01853228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25680635|NCT01853228|Antiviral Agents|antiviral agents|mesh-ancestor
25680636|NCT01853228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25680637|NCT01853228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25680638|NCT01853228|Immunologic Factors|immunologic factors|mesh-ancestor
25680639|NCT01853228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680640|NCT01853228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25680641|NCT01853254|Ribavirin|ribavirin|mesh-list
25680642|NCT01853254|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25680643|NCT01853254|Antimetabolites|antimetabolites|mesh-ancestor
25680644|NCT01853254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680645|NCT01853254|Antiviral Agents|antiviral agents|mesh-ancestor
25680646|NCT01853254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25680647|NCT01853280|Methylphenidate|methylphenidate|mesh-list
25680648|NCT01853280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25680649|NCT01853280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680650|NCT01853280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25680651|NCT01853280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25680652|NCT01853280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25680653|NCT01853280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680654|NCT01853280|Dopamine Agents|dopamine agents|mesh-ancestor
25098320|NCT03197818|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25098321|NCT03197818|Autonomic Agents|autonomic agents|mesh-ancestor
25098330|NCT03197818|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25098331|NCT03197818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25098332|NCT03197818|Adrenergic Agents|adrenergic agents|mesh-ancestor
25098333|NCT03197818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25098334|NCT03197818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098335|NCT03198026|Obinutuzumab|obinutuzumab|mesh-list
25098336|NCT03198026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25098337|NCT03198026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25098338|NCT03197636|Pembrolizumab|pembrolizumab|mesh-list
25098339|NCT03197636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25098362|NCT03197571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25098364|NCT03197571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25098365|NCT03197571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25098370|NCT03197571|Antimetabolites|antimetabolites|mesh-ancestor
25098371|NCT03197571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25098372|NCT03197571|Antidotes|antidotes|mesh-ancestor
25098373|NCT03197571|Protective Agents|protective agents|mesh-ancestor
25098374|NCT03197571|Vitamin B Complex|vitamin b complex|mesh-ancestor
25098375|NCT03197571|Vitamins|vitamins|mesh-ancestor
25098376|NCT03197571|Micronutrients|micronutrients|mesh-ancestor
24775443|NCT01852318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098379|NCT03197571|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25098380|NCT03197571|Hormone Antagonists|hormone antagonists|mesh-ancestor
25098381|NCT03197571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25098382|NCT03198013|Prednisolone|prednisolone|mesh-list
25098383|NCT03198013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25098384|NCT03198013|Glucocorticoids|glucocorticoids|mesh-ancestor
25098385|NCT03198013|Hormones|hormones|mesh-ancestor
25098386|NCT03198013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25098387|NCT03198013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098388|NCT03198013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25098389|NCT03198013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25098390|NCT03197584|Leucovorin|leucovorin|mesh-list
25098391|NCT03197584|Cyclophosphamide|cyclophosphamide|mesh-list
25098392|NCT03197584|Bevacizumab|bevacizumab|mesh-list
25098393|NCT03197584|Fluorouracil|fluorouracil|mesh-list
25098394|NCT03197584|Capecitabine|capecitabine|mesh-list
25098395|NCT03197584|Oxaliplatin|oxaliplatin|mesh-list
25098415|NCT03197584|Protective Agents|protective agents|mesh-ancestor
25098416|NCT03197584|Vitamin B Complex|vitamin b complex|mesh-ancestor
25224711|NCT02631473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25224712|NCT02631473|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25224713|NCT02631473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25224714|NCT02631473|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25224715|NCT02631473|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24837962|NCT02194374|Immunologic Factors|immunologic factors|mesh-ancestor
24837963|NCT02194374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837964|NCT02194374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24837965|NCT02194374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25098474|NCT03197207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25098475|NCT03197207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24515852|NCT00599625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098477|NCT03197207|Sensory System Agents|sensory system agents|mesh-ancestor
25098478|NCT03197207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25098479|NCT03197207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098480|NCT03197207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25098481|NCT03197207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25098482|NCT03197207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25098486|NCT03197740|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25098487|NCT03197740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25098488|NCT03197740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098489|NCT03197740|Cholinergic Agents|cholinergic agents|mesh-ancestor
25098490|NCT03197740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25098491|NCT03197740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098492|NCT03197740|Nootropic Agents|nootropic agents|mesh-ancestor
25098495|NCT03197233|Vitamin A|vitamin a|mesh-list
25098496|NCT03197233|Retinol palmitate|retinol palmitate|mesh-list
25098497|NCT03197233|Micronutrients|micronutrients|mesh-ancestor
25098498|NCT03197233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098499|NCT03197233|Antioxidants|antioxidants|mesh-ancestor
25098500|NCT03197233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022361|NCT03663751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25022362|NCT03663751|Antimetabolites|antimetabolites|mesh-ancestor
25022363|NCT03663751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022364|NCT03663751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25022365|NCT03663751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24463618|NCT00361621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25098548|NCT03197012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25098550|NCT03197103|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25098551|NCT03197103|Antiviral Agents|antiviral agents|mesh-ancestor
24459907|NCT00346827|Emetics|emetics|mesh-ancestor
25098640|NCT03196466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25098641|NCT03196466|GABA Agents|gaba agents|mesh-ancestor
25098642|NCT03196466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25098643|NCT03196466|Antimanic Agents|antimanic agents|mesh-ancestor
25098644|NCT03196466|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25098645|NCT03196466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25098646|NCT03196466|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25098647|NCT03196466|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25098648|NCT03196466|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25098649|NCT03196466|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25098650|NCT03196466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25098651|NCT03196466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25098652|NCT03196466|GABA Modulators|gaba modulators|mesh-ancestor
25099161|NCT03193307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25098653|NCT03196466|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25098654|NCT03196466|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25098691|NCT03196362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098693|NCT03196154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25098694|NCT03196154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098695|NCT03195634|Carvedilol|carvedilol|mesh-list
25098696|NCT03195634|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25098697|NCT03195634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25098698|NCT03195634|Adrenergic Agents|adrenergic agents|mesh-ancestor
25098699|NCT03195634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25098700|NCT03195634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098701|NCT03195634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098702|NCT03195634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25098703|NCT03195634|Antioxidants|antioxidants|mesh-ancestor
25098704|NCT03195634|Protective Agents|protective agents|mesh-ancestor
25098705|NCT03195634|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25098706|NCT03195634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25098707|NCT03195634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25098708|NCT03195634|Vasodilator Agents|vasodilator agents|mesh-ancestor
25098709|NCT03195634|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25098710|NCT03195634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25098711|NCT03195582|Chlorhexidine|chlorhexidine|mesh-list
25098712|NCT03195582|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25098713|NCT03195582|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25098714|NCT03195582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25224716|NCT02631473|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25224717|NCT02631473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25224718|NCT02631473|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24837966|NCT02194374|Alkylating Agents|alkylating agents|mesh-ancestor
24837967|NCT02194374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837971|NCT02194374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24837973|NCT02194374|Antiviral Agents|antiviral agents|mesh-ancestor
25098723|NCT03195569|Antimitotic Agents|antimitotic agents|mesh-ancestor
25098724|NCT03195569|Mitosis Modulators|mitosis modulators|mesh-ancestor
25098725|NCT03195569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098726|NCT03195569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25098727|NCT03195569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25098728|NCT03195569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25098729|NCT03195569|Growth Substances|growth substances|mesh-ancestor
25098730|NCT03195569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098731|NCT03195569|Growth Inhibitors|growth inhibitors|mesh-ancestor
25098733|NCT03195946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25680655|NCT01853280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25680656|NCT01853475|Artefenomel|artefenomel|mesh-list
25680657|NCT01853475|Antimalarials|antimalarials|mesh-ancestor
25680658|NCT01853475|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25680659|NCT01853475|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25680660|NCT01853475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25680661|NCT01853553|Spironolactone|spironolactone|mesh-list
25098734|NCT03195946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25098735|NCT03195946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25098736|NCT03195946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098737|NCT03195946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25098738|NCT03195946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25098739|NCT03195946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25098740|NCT03195946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25098741|NCT03195946|Anesthetics, General|anesthetics, general|mesh-ancestor
25098742|NCT03195946|Anesthetics|anesthetics|mesh-ancestor
25098743|NCT03195946|GABA Modulators|gaba modulators|mesh-ancestor
25098744|NCT03195946|GABA Agents|gaba agents|mesh-ancestor
25098745|NCT03195946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25098746|NCT03195946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098747|NCT03195673|Terazosin|terazosin|mesh-list
25098748|NCT03195673|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25098749|NCT03195673|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25098763|NCT03195530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25098764|NCT03195530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098765|NCT03195530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25098766|NCT03195530|Anesthetics, General|anesthetics, general|mesh-ancestor
25098767|NCT03195530|Anesthetics|anesthetics|mesh-ancestor
25098768|NCT03195452|Raltegravir Potassium|raltegravir potassium|mesh-list
25098769|NCT03195452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
25098770|NCT03195452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25098771|NCT03195452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25098772|NCT03195452|Antiviral Agents|antiviral agents|mesh-ancestor
25098773|NCT03195452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25098774|NCT03195452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25098775|NCT03195452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25098776|NCT03195452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25098777|NCT03195452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098778|NCT03195452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25098780|NCT03195491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25098781|NCT03195491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25098782|NCT03195491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25098784|NCT03195413|Lidocaine|lidocaine|mesh-list
24775948|NCT01855711|Serotonin Agents|serotonin agents|mesh-ancestor
25098814|NCT03195205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098815|NCT03195257|Glucagon|glucagon|mesh-list
25098816|NCT03195257|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
25098817|NCT03195257|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25098818|NCT03195257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25098819|NCT03195257|Hormones|hormones|mesh-ancestor
25098820|NCT03195257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25098821|NCT03195257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098822|NCT03195257|Incretins|incretins|mesh-ancestor
25098823|NCT03195049|Bilirubin|bilirubin|mesh-list
25098824|NCT03195049|Antioxidants|antioxidants|mesh-ancestor
25098825|NCT03195049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098826|NCT03195049|Protective Agents|protective agents|mesh-ancestor
25098827|NCT03195049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098828|NCT03195153|Allopurinol|allopurinol|mesh-list
25098829|NCT03195153|Atorvastatin|atorvastatin|mesh-list
25224719|NCT02631252|Hydroxychloroquine|hydroxychloroquine|mesh-list
25224720|NCT02631252|Etoposide|etoposide|mesh-list
25224721|NCT02631252|Mitoxantrone|mitoxantrone|mesh-list
25224722|NCT02631252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25224723|NCT02631252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25224724|NCT02631252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24837974|NCT02194374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24837975|NCT02194452|Octreotide|octreotide|mesh-list
24837976|NCT02194452|Edotreotide|edotreotide|mesh-list
24837977|NCT02194452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24837978|NCT02194452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25258574|NCT02470117|Antacids|antacids|mesh-list
24837979|NCT02194452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24837980|NCT02194452|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24796707|NCT01951599|Osimertinib|osimertinib|mesh-list
24516141|NCT00600639|Tocolytic Agents|tocolytic agents|mesh-ancestor
24516142|NCT00600639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24837981|NCT02194452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837982|NCT02194491|AS2471907|as2471907|mesh-list
24837983|NCT02194491|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24837984|NCT02194491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837985|NCT02194556|Gemcitabine|gemcitabine|mesh-list
25056411|NCT03512873|Histamine Agents|histamine agents|mesh-ancestor
25098830|NCT03195153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25098834|NCT03195153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25098835|NCT03195153|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25098836|NCT03195153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25098837|NCT03195153|Gout Suppressants|gout suppressants|mesh-ancestor
25098838|NCT03195153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25098861|NCT03195309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25098862|NCT03195309|Anesthetics, General|anesthetics, general|mesh-ancestor
25098864|NCT03195023|Lisinopril|lisinopril|mesh-list
25098865|NCT03195023|Lercanidipine|lercanidipine|mesh-list
25098866|NCT03195023|Furosemide|furosemide|mesh-list
25098867|NCT03195023|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25098868|NCT03195023|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25098869|NCT03195023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25098870|NCT03195023|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25098871|NCT03195023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25098872|NCT03195023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098888|NCT03194815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25098890|NCT03194815|Immunologic Factors|immunologic factors|mesh-ancestor
25098891|NCT03194815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098892|NCT03194815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25098906|NCT03194620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25098907|NCT03194620|Protease Inhibitors|protease inhibitors|mesh-ancestor
25098908|NCT03194620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25098909|NCT03194620|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25098910|NCT03194620|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25098911|NCT03194620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25098912|NCT03194620|Chelating Agents|chelating agents|mesh-ancestor
25098915|NCT03194685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25098916|NCT03194685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25098917|NCT03194685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098918|NCT03194724|Vitamin A|vitamin a|mesh-list
25098919|NCT03194724|Vitamins|vitamins|mesh-ancestor
25098920|NCT03194724|Micronutrients|micronutrients|mesh-ancestor
25098921|NCT03194724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098922|NCT03194633|Nifedipine|nifedipine|mesh-list
25098923|NCT03194633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25098924|NCT03194633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25098925|NCT03194633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098926|NCT03194633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25098927|NCT03194633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098928|NCT03194633|Vasodilator Agents|vasodilator agents|mesh-ancestor
25098929|NCT03194633|Tocolytic Agents|tocolytic agents|mesh-ancestor
25098930|NCT03194633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25098931|NCT03194659|Choline|choline|mesh-list
25224725|NCT02631252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25224726|NCT02631252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25224727|NCT02631252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224728|NCT02631252|Antimalarials|antimalarials|mesh-ancestor
25224729|NCT02631252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25224730|NCT02631252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25224731|NCT02631252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25224732|NCT02631252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25224733|NCT02631252|Analgesics|analgesics|mesh-ancestor
25224734|NCT02631252|Sensory System Agents|sensory system agents|mesh-ancestor
25224735|NCT02631252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25224736|NCT02631252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224737|NCT02631460|Carboplatin|carboplatin|mesh-list
24837986|NCT02194556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24837987|NCT02194556|Antimetabolites|antimetabolites|mesh-ancestor
24837988|NCT02194556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837989|NCT02194556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24837990|NCT02194556|Antiviral Agents|antiviral agents|mesh-ancestor
24837991|NCT02194556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24837992|NCT02194556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837993|NCT02194556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24837994|NCT02194556|Immunologic Factors|immunologic factors|mesh-ancestor
24837995|NCT02194556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837996|NCT02194686|Cilostazol|cilostazol|mesh-list
25098956|NCT03194594|Anesthetics, General|anesthetics, general|mesh-ancestor
25098962|NCT03194594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098963|NCT03194555|Acetaminophen|acetaminophen|mesh-list
25098964|NCT03194555|Naltrexone|naltrexone|mesh-list
25098965|NCT03194555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25098966|NCT03194555|Analgesics|analgesics|mesh-ancestor
25098967|NCT03194555|Sensory System Agents|sensory system agents|mesh-ancestor
25099021|NCT03194074|Anesthetics|anesthetics|mesh-ancestor
25099022|NCT03194074|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25099023|NCT03193749|Amiodarone|amiodarone|mesh-list
25099024|NCT03193749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25099069|NCT03193788|Antiemetics|antiemetics|mesh-ancestor
25099070|NCT03193788|Autonomic Agents|autonomic agents|mesh-ancestor
25099071|NCT03193788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25099072|NCT03193788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25099073|NCT03193788|Glucocorticoids|glucocorticoids|mesh-ancestor
25099075|NCT03193788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25099076|NCT03193788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25099077|NCT03193788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099078|NCT03193788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25099079|NCT03193788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099080|NCT03193788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25099081|NCT03193788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24987779|NCT04990323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24987780|NCT04990323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24987781|NCT04990323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24987783|NCT04989829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24987784|NCT04989829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24987785|NCT04989829|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24987786|NCT04989829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24987787|NCT04989829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099082|NCT03193788|Hematinics|hematinics|mesh-ancestor
25099083|NCT03193788|Vitamin B Complex|vitamin b complex|mesh-ancestor
25099084|NCT03193723|Anesthetics|anesthetics|mesh-list
25099085|NCT03193723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25099086|NCT03193723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099087|NCT03193710|Remifentanil|remifentanil|mesh-list
25099088|NCT03193710|Propofol|propofol|mesh-list
25099089|NCT03193710|Sevoflurane|sevoflurane|mesh-list
25099090|NCT03193710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25099091|NCT03193710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25099092|NCT03193710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099093|NCT03193710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25099094|NCT03193710|Anesthetics, General|anesthetics, general|mesh-ancestor
25099095|NCT03193710|Anesthetics|anesthetics|mesh-ancestor
25099096|NCT03193710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25099097|NCT03193710|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25099098|NCT03193710|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25224738|NCT02631460|Pemetrexed|pemetrexed|mesh-list
25224739|NCT02631460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25224740|NCT02631460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25224741|NCT02631460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224742|NCT02631460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25224743|NCT02631460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25224744|NCT02631408|Vancomycin|vancomycin|mesh-list
25224745|NCT02631408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25224746|NCT02631408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25224747|NCT02631239|Dexamethasone|dexamethasone|mesh-list
25224748|NCT02631239|Methotrexate|methotrexate|mesh-list
25224749|NCT02631239|Etoposide|etoposide|mesh-list
25224750|NCT02631239|Pegaspargase|pegaspargase|mesh-list
25224751|NCT02631239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25680662|NCT01853553|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25680663|NCT01853553|Hormone Antagonists|hormone antagonists|mesh-ancestor
25680664|NCT01853553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25224752|NCT02631239|Antiemetics|antiemetics|mesh-ancestor
24837997|NCT02194686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24837998|NCT02194686|Autonomic Agents|autonomic agents|mesh-ancestor
24463972|NCT00362895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24463975|NCT00362895|Glucocorticoids|glucocorticoids|mesh-ancestor
24837999|NCT02194686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838000|NCT02194686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838001|NCT02194686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24838002|NCT02194686|Respiratory System Agents|respiratory system agents|mesh-ancestor
24838003|NCT02194686|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24838004|NCT02194686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24838005|NCT02194686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838006|NCT02194686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24838007|NCT02194686|Vasodilator Agents|vasodilator agents|mesh-ancestor
24987820|NCT04939090|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24838008|NCT02194686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24838009|NCT02194686|Protective Agents|protective agents|mesh-ancestor
25056431|NCT03512834|Antimitotic Agents|antimitotic agents|mesh-ancestor
25099099|NCT03193710|Narcotics|narcotics|mesh-ancestor
25099100|NCT03193710|Analgesics|analgesics|mesh-ancestor
25099101|NCT03193710|Sensory System Agents|sensory system agents|mesh-ancestor
25099102|NCT03193710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25099110|NCT03193918|Mitosis Modulators|mitosis modulators|mesh-ancestor
25099111|NCT03193918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099113|NCT03194009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25099114|NCT03194009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099115|NCT03193372|Azelaic acid|azelaic acid|mesh-list
25099116|NCT03193372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099117|NCT03193372|Dermatologic Agents|dermatologic agents|mesh-ancestor
25099118|NCT03193502|Rivaroxaban|rivaroxaban|mesh-list
25099119|NCT03193502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25099120|NCT03193502|Antithrombins|antithrombins|mesh-ancestor
25099137|NCT03193359|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25099146|NCT03193346|Botulinum Toxins|botulinum toxins|mesh-list
25099155|NCT03193346|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25099156|NCT03193346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25099157|NCT03193307|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25099158|NCT03193307|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
25099159|NCT03193307|BI 409306|bi 409306|mesh-list
25099160|NCT03193307|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25099162|NCT03193307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099163|NCT03193307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25099164|NCT03193307|Contraceptive Agents|contraceptive agents|mesh-ancestor
25099165|NCT03193307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25099166|NCT03193307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099167|NCT03193307|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25099168|NCT03193307|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25099169|NCT03193307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25099170|NCT03193307|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25099171|NCT03193307|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25099172|NCT03193307|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
25099173|NCT03193307|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25099174|NCT03193307|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25099175|NCT03193463|Topotecan|topotecan|mesh-list
25224753|NCT02631239|Autonomic Agents|autonomic agents|mesh-ancestor
25224754|NCT02631239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25224755|NCT02631239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224756|NCT02631239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25224757|NCT02631239|Glucocorticoids|glucocorticoids|mesh-ancestor
25224758|NCT02631239|Hormones|hormones|mesh-ancestor
25224759|NCT02631239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25224760|NCT02631239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25224761|NCT02631239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25224762|NCT02631239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25224763|NCT02631239|Abortifacient Agents|abortifacient agents|mesh-ancestor
25224764|NCT02631239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25224765|NCT02631239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25224766|NCT02631239|Antimetabolites|antimetabolites|mesh-ancestor
25224767|NCT02631239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680665|NCT01853553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680666|NCT01853553|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25099176|NCT03193463|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25099200|NCT03193203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25099201|NCT03193203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25099202|NCT03193203|Immunologic Factors|immunologic factors|mesh-ancestor
25099204|NCT03192878|Dermatologic Agents|dermatologic agents|mesh-ancestor
25099205|NCT03192878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25099206|NCT03192878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25099207|NCT03193086|Alemtuzumab|alemtuzumab|mesh-list
25099208|NCT03193086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25099209|NCT03193086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099211|NCT03193073|Mitosis Modulators|mitosis modulators|mesh-ancestor
25099212|NCT03193073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099214|NCT03192943|Linrodostat|linrodostat|mesh-list
25099215|NCT03192943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25099216|NCT03192943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099217|NCT03192943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24408222|NCT00176982|Antimalarials|antimalarials|mesh-ancestor
25099260|NCT03192579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25099261|NCT03192579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25099262|NCT03192657|Basiliximab|basiliximab|mesh-list
25099263|NCT03192657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
25099264|NCT03192657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25099265|NCT03192657|Immunologic Factors|immunologic factors|mesh-ancestor
25099266|NCT03192657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099267|NCT03192657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25099307|NCT03192449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25099308|NCT03192449|Anticestodal Agents|anticestodal agents|mesh-ancestor
25099309|NCT03192449|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25099310|NCT03192449|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25099311|NCT03192449|Tubulin Modulators|tubulin modulators|mesh-ancestor
25099312|NCT03192449|Antimitotic Agents|antimitotic agents|mesh-ancestor
25099313|NCT03192449|Mitosis Modulators|mitosis modulators|mesh-ancestor
25099341|NCT03192293|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24776556|NCT01858571|Alkylating Agents|alkylating agents|mesh-ancestor
25099342|NCT03192293|Hormone Antagonists|hormone antagonists|mesh-ancestor
25099343|NCT03192293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25099344|NCT03192332|Plasminogen|plasminogen|mesh-list
25099345|NCT03192332|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25099346|NCT03192332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25099347|NCT03192332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25099348|NCT03192332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099349|NCT03192059|Aspirin|aspirin|mesh-list
25099350|NCT03192059|Vitamin D|vitamin d|mesh-list
25099351|NCT03192059|Curcumin|curcumin|mesh-list
25099352|NCT03192059|Cyclophosphamide|cyclophosphamide|mesh-list
25099353|NCT03192059|Pembrolizumab|pembrolizumab|mesh-list
25099354|NCT03192059|Lansoprazole|lansoprazole|mesh-list
25099355|NCT03192059|Dexlansoprazole|dexlansoprazole|mesh-list
25099356|NCT03192059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25099357|NCT03192059|Immunologic Factors|immunologic factors|mesh-ancestor
25099358|NCT03192059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099359|NCT03192059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25099360|NCT03192059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25099361|NCT03192059|Alkylating Agents|alkylating agents|mesh-ancestor
25099362|NCT03192059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099363|NCT03192059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099364|NCT03192059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25224769|NCT02631239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25224770|NCT02631239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25224771|NCT02631239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25224772|NCT02631239|Immunologic Factors|immunologic factors|mesh-ancestor
25224773|NCT02631239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25224774|NCT02631239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25224775|NCT02631239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25224776|NCT02631239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24838028|NCT02194829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838029|NCT02194829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24838030|NCT02194829|Antimetabolites|antimetabolites|mesh-ancestor
24838032|NCT02194829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24838033|NCT02194829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24838034|NCT02194829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24939928|NCT04005469|Treprostinil|treprostinil|mesh-list
24939929|NCT04005469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24939930|NCT04005430|Dexamethasone|dexamethasone|mesh-list
24939931|NCT04005430|Dexamethasone acetate|dexamethasone acetate|mesh-list
24939932|NCT04005430|BB 1101|bb 1101|mesh-list
24939933|NCT04005430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24939934|NCT04005430|Antiemetics|antiemetics|mesh-ancestor
24939935|NCT04005430|Autonomic Agents|autonomic agents|mesh-ancestor
24939936|NCT04005430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24875280|NCT04253964|Paclitaxel|paclitaxel|mesh-list
24875281|NCT04253964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24875282|NCT04253964|Carboplatin|carboplatin|mesh-list
24875284|NCT04253964|Pemetrexed|pemetrexed|mesh-list
24875285|NCT04253964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24875286|NCT04253964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099365|NCT03192059|Vitamins|vitamins|mesh-ancestor
25099366|NCT03192059|Micronutrients|micronutrients|mesh-ancestor
25099367|NCT03192059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25099368|NCT03192059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25099369|NCT03192059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25099370|NCT03192059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25099371|NCT03192059|Analgesics|analgesics|mesh-ancestor
25099372|NCT03192059|Sensory System Agents|sensory system agents|mesh-ancestor
24408933|NCT00180089|Budesonide|budesonide|mesh-list
25099378|NCT03192059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25099379|NCT03192059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25099380|NCT03192059|Antipyretics|antipyretics|mesh-ancestor
25099381|NCT03192059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25099382|NCT03192059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25099383|NCT03192059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25099384|NCT03192033|Hemostatics|hemostatics|mesh-list
25099385|NCT03192033|Coagulants|coagulants|mesh-ancestor
25099386|NCT03191981|Cyclophosphamide|cyclophosphamide|mesh-list
25099387|NCT03191981|Pembrolizumab|pembrolizumab|mesh-list
25099388|NCT03191981|Lenalidomide|lenalidomide|mesh-list
25099389|NCT03191981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25099390|NCT03191981|Immunologic Factors|immunologic factors|mesh-ancestor
25099391|NCT03191981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099392|NCT03191981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25099393|NCT03191981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25099394|NCT03191981|Alkylating Agents|alkylating agents|mesh-ancestor
25099395|NCT03191981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099396|NCT03191981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099397|NCT03191981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25099398|NCT03191981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25099403|NCT03191903|Triamcinolone|triamcinolone|mesh-list
25099427|NCT03191721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25099428|NCT03191539|Apremilast|apremilast|mesh-list
25224777|NCT02631239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25273261|NCT02386293|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25273262|NCT02386293|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25273263|NCT02386293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273264|NCT02386592|Chlorhexidine|chlorhexidine|mesh-list
25273265|NCT02386592|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25273266|NCT02386592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25273267|NCT02386592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25273268|NCT02386592|Disinfectants|disinfectants|mesh-ancestor
25273269|NCT02386592|Dermatologic Agents|dermatologic agents|mesh-ancestor
25273270|NCT02386475|Dexetimide|dexetimide|mesh-list
25273271|NCT02386475|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25273272|NCT02386475|Citalopram|citalopram|mesh-list
25273273|NCT02386475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25273274|NCT02386475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25273275|NCT02386475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25273276|NCT02386475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273277|NCT02386475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25273278|NCT02386475|Serotonin Agents|serotonin agents|mesh-ancestor
25273279|NCT02386475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838035|NCT02194829|Immunologic Factors|immunologic factors|mesh-ancestor
24838036|NCT02194829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838038|NCT02194855|Cisatracurium|cisatracurium|mesh-list
24838039|NCT02194855|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24838040|NCT02194855|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25099429|NCT03191539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25099430|NCT03191539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25099431|NCT03191539|Analgesics|analgesics|mesh-ancestor
25099432|NCT03191539|Sensory System Agents|sensory system agents|mesh-ancestor
25099433|NCT03191539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25099434|NCT03191539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099435|NCT03191539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25099436|NCT03191539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25099437|NCT03191539|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25099438|NCT03191539|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25099439|NCT03191539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25099440|NCT03191539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099441|NCT03191383|Vaccines|vaccines|mesh-list
25099442|NCT03191383|Immunologic Factors|immunologic factors|mesh-ancestor
25099443|NCT03191383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099444|NCT03191370|Anesthetics|anesthetics|mesh-list
25099445|NCT03191370|Anesthetics, Local|anesthetics, local|mesh-list
25099446|NCT03191370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25099447|NCT03191370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099448|NCT03191370|Sensory System Agents|sensory system agents|mesh-ancestor
25099449|NCT03191370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25099450|NCT03191162|Benzonidazole|benzonidazole|mesh-list
25099451|NCT03191162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25099458|NCT03191305|Warfarin|warfarin|mesh-list
25099473|NCT03190681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25099474|NCT03190681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099475|NCT03190681|Dopamine Agents|dopamine agents|mesh-ancestor
25099476|NCT03190681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25099477|NCT03190733|Fludarabine|fludarabine|mesh-list
25099478|NCT03190733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099479|NCT03190785|Benzoic Acid|benzoic acid|mesh-list
25099480|NCT03190785|Antifungal Agents|antifungal agents|mesh-ancestor
25099481|NCT03190785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25099482|NCT03190694|Dapagliflozin|dapagliflozin|mesh-list
25099483|NCT03190694|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24409295|NCT00181688|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25099496|NCT03190603|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25099497|NCT03190603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25099498|NCT03190603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25099499|NCT03190603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099500|NCT03190642|Methylprednisolone|methylprednisolone|mesh-list
25099501|NCT03190642|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25099502|NCT03190642|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25099503|NCT03190642|Prednisolone|prednisolone|mesh-list
25099504|NCT03190642|Prednisolone acetate|prednisolone acetate|mesh-list
25099508|NCT03190642|Antiemetics|antiemetics|mesh-ancestor
24776683|NCT01859377|Ibuprofen|ibuprofen|mesh-list
25099514|NCT03190642|Hormones|hormones|mesh-ancestor
25099515|NCT03190642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25099516|NCT03190642|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25099517|NCT03190642|Protective Agents|protective agents|mesh-ancestor
25099518|NCT03190642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25099519|NCT03190642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099520|NCT03190616|Apatinib|apatinib|mesh-list
25099521|NCT03190616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099522|NCT03190616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25099523|NCT03190616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25099524|NCT03190616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099525|NCT03190447|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25099526|NCT03190447|Laxatives|laxatives|mesh-ancestor
25099527|NCT03190447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25099528|NCT03190304|Enalapril|enalapril|mesh-list
25099529|NCT03190304|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25224778|NCT02631135|Dexmedetomidine|dexmedetomidine|mesh-list
25224779|NCT02631135|Remifentanil|remifentanil|mesh-list
25224780|NCT02631135|Propofol|propofol|mesh-list
25224781|NCT02631135|Rocuronium|rocuronium|mesh-list
25224782|NCT02631135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25224783|NCT02631135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24838041|NCT02194855|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24838042|NCT02194855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838043|NCT02194855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838045|NCT02194881|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25106858|NCT03144401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25106859|NCT03144401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106860|NCT03144401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24838046|NCT02194881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24838047|NCT02194881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838048|NCT02194894|Acetaminophen|acetaminophen|mesh-list
25099530|NCT03190304|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25099531|NCT03190304|Protease Inhibitors|protease inhibitors|mesh-ancestor
25099533|NCT03190304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25099565|NCT03189901|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25099566|NCT03189901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25099567|NCT03189901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25099568|NCT03189901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099569|NCT03189901|Protective Agents|protective agents|mesh-ancestor
25099570|NCT03189901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099571|NCT03189537|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
25099572|NCT03189537|Antiviral Agents|antiviral agents|mesh-ancestor
25099573|NCT03189537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25099574|NCT03189732|Metformin|metformin|mesh-list
25099575|NCT03189732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25099576|NCT03189732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099577|NCT03189043|Anti-Infective Agents|anti-infective agents|mesh-list
25099578|NCT03189043|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25099579|NCT03189186|Pembrolizumab|pembrolizumab|mesh-list
25099580|NCT03189186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25099581|NCT03189186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099582|NCT03189069|Warfarin|warfarin|mesh-list
25099583|NCT03189069|Rivaroxaban|rivaroxaban|mesh-list
25099637|NCT03188471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25099638|NCT03188471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25099669|NCT03188198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099670|NCT03188198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099671|NCT03188198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25099672|NCT03188198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25099673|NCT03188198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25099674|NCT03188198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25099675|NCT03188198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25099676|NCT03188198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25099677|NCT03188198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25099678|NCT03188198|Glucocorticoids|glucocorticoids|mesh-ancestor
25099679|NCT03188198|Hormones|hormones|mesh-ancestor
25099683|NCT03188198|Tubulin Modulators|tubulin modulators|mesh-ancestor
25099729|NCT03187899|Sensory System Agents|sensory system agents|mesh-ancestor
25099730|NCT03187899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25099740|NCT03187795|Urological Agents|urological agents|mesh-ancestor
25099741|NCT03187795|Parasympatholytics|parasympatholytics|mesh-ancestor
25099742|NCT03187795|Autonomic Agents|autonomic agents|mesh-ancestor
25099743|NCT03187795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25099744|NCT03187795|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25099745|NCT03187795|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25099746|NCT03187795|Cholinergic Agents|cholinergic agents|mesh-ancestor
25099760|NCT03187626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224784|NCT02631135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224785|NCT02631135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25224786|NCT02631135|Anesthetics, General|anesthetics, general|mesh-ancestor
25224787|NCT02631135|Anesthetics|anesthetics|mesh-ancestor
25224788|NCT02631135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25224789|NCT02631135|Analgesics|analgesics|mesh-ancestor
25224790|NCT02631135|Sensory System Agents|sensory system agents|mesh-ancestor
25224791|NCT02631135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24473340|NCT00402558|Antimetabolites|antimetabolites|mesh-ancestor
24838077|NCT02195180|Gemcitabine|gemcitabine|mesh-list
24838078|NCT02195180|Fluorouracil|fluorouracil|mesh-list
24838079|NCT02195180|Oxaliplatin|oxaliplatin|mesh-list
24838085|NCT02195180|Antiviral Agents|antiviral agents|mesh-ancestor
24838086|NCT02195180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25680667|NCT01853553|Diuretics|diuretics|mesh-ancestor
25680668|NCT01853553|Natriuretic Agents|natriuretic agents|mesh-ancestor
25680669|NCT01853618|Tremelimumab|tremelimumab|mesh-list
25680670|NCT01853618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25680671|NCT01853696|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25680672|NCT01853696|Prednisolone|prednisolone|mesh-list
25680673|NCT01853696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24465595|NCT00370240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24465596|NCT00370253|Terlipressin|terlipressin|mesh-list
24465597|NCT00370253|Norepinephrine|norepinephrine|mesh-list
24465598|NCT00370253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24465599|NCT00370253|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24465600|NCT00370253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24465601|NCT00370253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24465602|NCT00370253|Adrenergic Agents|adrenergic agents|mesh-ancestor
24465686|NCT00370539|Immunologic Factors|immunologic factors|mesh-ancestor
24465777|NCT00370669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465778|NCT00370721|Bevacizumab|bevacizumab|mesh-list
24465779|NCT00370721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24715002|NCT01533740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715003|NCT01533740|Growth Inhibitors|growth inhibitors|mesh-ancestor
24715004|NCT01533740|Antimetabolites|antimetabolites|mesh-ancestor
24838087|NCT02195180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24838088|NCT02195180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25099761|NCT03187626|Cholinergic Agents|cholinergic agents|mesh-ancestor
25099762|NCT03187626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25099763|NCT03187626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099764|NCT03187626|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24502155|NCT05318794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24502156|NCT05318794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24502157|NCT05318794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24502158|NCT05318794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25099765|NCT03187626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25099766|NCT03187548|Calcium|calcium|mesh-list
25099767|NCT03187548|Caseins|caseins|mesh-list
25099768|NCT03187548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25099769|NCT03187548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099770|NCT03187548|Chelating Agents|chelating agents|mesh-ancestor
25099771|NCT03187548|Sequestering Agents|sequestering agents|mesh-ancestor
25099772|NCT03187548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099812|NCT03187392|Anesthetics, Local|anesthetics, local|mesh-ancestor
25099813|NCT03187392|Anesthetics|anesthetics|mesh-ancestor
25099814|NCT03187392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25099815|NCT03187392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099816|NCT03187392|Sensory System Agents|sensory system agents|mesh-ancestor
25099817|NCT03187392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25099818|NCT03187392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25680674|NCT01853696|Methylprednisolone|methylprednisolone|mesh-list
25680675|NCT01853696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25680676|NCT01853696|Prednisolone acetate|prednisolone acetate|mesh-list
25680677|NCT01853696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25680678|NCT01853696|Prednisolone phosphate|prednisolone phosphate|mesh-list
25680679|NCT01853696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25680680|NCT01853696|Glucocorticoids|glucocorticoids|mesh-ancestor
25680681|NCT01853696|Hormones|hormones|mesh-ancestor
25680682|NCT01853696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25680683|NCT01853696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680684|NCT01853696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25680685|NCT01853696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25680686|NCT01853696|Antiemetics|antiemetics|mesh-ancestor
25680687|NCT01853696|Autonomic Agents|autonomic agents|mesh-ancestor
25680688|NCT01853696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25680689|NCT01853696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25680690|NCT01853696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25680691|NCT01853696|Protective Agents|protective agents|mesh-ancestor
25680692|NCT01853696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25680693|NCT01854047|Albuterol|albuterol|mesh-list
25680694|NCT01854047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25680695|NCT01854047|Autonomic Agents|autonomic agents|mesh-ancestor
25680696|NCT01854047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25680697|NCT01854047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680698|NCT01854047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25022715|NCT03660306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25022716|NCT03660306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022718|NCT03660306|Analgesics|analgesics|mesh-ancestor
25022719|NCT03660306|Sensory System Agents|sensory system agents|mesh-ancestor
25022720|NCT03660306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25022722|NCT03660293|Atorvastatin|atorvastatin|mesh-list
25022723|NCT03660293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25022724|NCT03660293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25022725|NCT03660293|Antimetabolites|antimetabolites|mesh-ancestor
25022739|NCT03660267|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25022740|NCT03660267|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25022741|NCT03660267|Purinergic Agents|purinergic agents|mesh-ancestor
24984831|NCT03982485|Paclitaxel|paclitaxel|mesh-list
25099819|NCT03187392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25099820|NCT03187392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25099821|NCT03187392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25099822|NCT03187392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099829|NCT03187496|Midazolam|midazolam|mesh-list
25099830|NCT03187496|Caffeine|caffeine|mesh-list
25099831|NCT03187496|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24410005|NCT00184041|Cytarabine|cytarabine|mesh-list
25099841|NCT03187496|Anesthetics|anesthetics|mesh-ancestor
25099842|NCT03187496|GABA Modulators|gaba modulators|mesh-ancestor
25099843|NCT03187496|GABA Agents|gaba agents|mesh-ancestor
25099844|NCT03187496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25245811|NCT03685890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099845|NCT03187496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224792|NCT02631135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25224793|NCT02631135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25224794|NCT02631135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25224795|NCT02631135|Adrenergic Agents|adrenergic agents|mesh-ancestor
25224796|NCT02631135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25224797|NCT02631135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224798|NCT02631135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25224799|NCT02631135|Narcotics|narcotics|mesh-ancestor
25224800|NCT02631135|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25224801|NCT02631135|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25224802|NCT02631135|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25224803|NCT02631031|Valsartan|valsartan|mesh-list
25224804|NCT02631031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24838089|NCT02195180|Immunologic Factors|immunologic factors|mesh-ancestor
24838090|NCT02195180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473398|NCT00402623|Protective Agents|protective agents|mesh-ancestor
24473399|NCT00402623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838103|NCT02195336|Bevacizumab|bevacizumab|mesh-list
24838104|NCT02195336|Carboplatin|carboplatin|mesh-list
24838105|NCT02195336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24838106|NCT02195336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099846|NCT03187496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25099847|NCT03187496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25099848|NCT03187496|Antimetabolites|antimetabolites|mesh-ancestor
25099849|NCT03187496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25099850|NCT03187496|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25099851|NCT03187496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25099852|NCT03187496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25099853|NCT03187496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25099854|NCT03187496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25099855|NCT03187496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25099856|NCT03187496|Purinergic Agents|purinergic agents|mesh-ancestor
25680699|NCT01854047|Respiratory System Agents|respiratory system agents|mesh-ancestor
25680700|NCT01854047|Tocolytic Agents|tocolytic agents|mesh-ancestor
25680701|NCT01854047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25680702|NCT01854047|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25680703|NCT01854047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25680704|NCT01854047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25680705|NCT01854047|Adrenergic Agents|adrenergic agents|mesh-ancestor
25680706|NCT01854047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25680707|NCT01854047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680708|NCT01854177|Aprepitant|aprepitant|mesh-list
25680709|NCT01854177|Fosaprepitant|fosaprepitant|mesh-list
25680710|NCT01854177|Antiemetics|antiemetics|mesh-ancestor
25680711|NCT01854177|Autonomic Agents|autonomic agents|mesh-ancestor
25680712|NCT01854177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24465899|NCT00371033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24465900|NCT00371033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099858|NCT03187015|Midazolam|midazolam|mesh-list
25099859|NCT03187015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25099860|NCT03187015|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25099861|NCT03187015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25099862|NCT03187015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099863|NCT03187015|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25099864|NCT03187015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25099865|NCT03187015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25099866|NCT03187015|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25099867|NCT03187015|Anesthetics, General|anesthetics, general|mesh-ancestor
25099868|NCT03187015|Anesthetics|anesthetics|mesh-ancestor
24777118|NCT01862120|Interleukin-2|interleukin-2|mesh-list
25099869|NCT03187015|GABA Modulators|gaba modulators|mesh-ancestor
25099870|NCT03187015|GABA Agents|gaba agents|mesh-ancestor
25099871|NCT03187015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25099872|NCT03187015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099873|NCT03187015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099895|NCT03186755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25099896|NCT03186755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25099897|NCT03186755|Analgesics|analgesics|mesh-ancestor
25099898|NCT03186755|Sensory System Agents|sensory system agents|mesh-ancestor
25099899|NCT03186755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25099900|NCT03186755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25099901|NCT03186755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25099902|NCT03186755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25099903|NCT03186755|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25099904|NCT03186755|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25099905|NCT03186755|Histamine Antagonists|histamine antagonists|mesh-ancestor
25099906|NCT03186755|Histamine Agents|histamine agents|mesh-ancestor
25099907|NCT03186755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25099908|NCT03186755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099909|NCT03186742|Eplerenone|eplerenone|mesh-list
25099910|NCT03186742|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25099911|NCT03186742|Hormone Antagonists|hormone antagonists|mesh-ancestor
25099912|NCT03186742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25099913|NCT03186742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099916|NCT03186742|Natriuretic Agents|natriuretic agents|mesh-ancestor
25099917|NCT03186742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24414251|NCT00196638|Antiviral Agents|antiviral agents|mesh-ancestor
24414252|NCT00196638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24414253|NCT00196638|Immunologic Factors|immunologic factors|mesh-ancestor
24414254|NCT00196638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414255|NCT00196664|Paroxetine|paroxetine|mesh-list
24414256|NCT00196664|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24414257|NCT00196664|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25224805|NCT02631031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25224806|NCT02631031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25224807|NCT02631031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224808|NCT02630862|Aspirin|aspirin|mesh-list
25224809|NCT02630862|Dipyridamole|dipyridamole|mesh-list
25224810|NCT02630862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25224811|NCT02630862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24838107|NCT02195336|Tubulin Modulators|tubulin modulators|mesh-ancestor
24838108|NCT02195336|Antimitotic Agents|antimitotic agents|mesh-ancestor
24414258|NCT00196664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24505485|NCT00541177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25099925|NCT03186586|Contraceptive Agents|contraceptive agents|mesh-ancestor
25099926|NCT03186586|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25099927|NCT03186586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099928|NCT03186586|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25099930|NCT03186547|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25099931|NCT03186547|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25099932|NCT03186547|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25099933|NCT03186547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25680713|NCT01854177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680714|NCT01854177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25680715|NCT01854177|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25680716|NCT01854177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24788967|NCT01934933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788969|NCT01934933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25099934|NCT03186547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099935|NCT03186547|Cholinergic Agents|cholinergic agents|mesh-ancestor
25099936|NCT03186547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25099937|NCT03186547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099938|NCT03186547|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25099939|NCT03186547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25099941|NCT03186482|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25099942|NCT03186482|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25099943|NCT03186482|Antitubercular Agents|antitubercular agents|mesh-ancestor
25099944|NCT03186482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25099945|NCT03186482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25099946|NCT03186482|Leprostatic Agents|leprostatic agents|mesh-ancestor
25099947|NCT03186482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25099948|NCT03186482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25099949|NCT03186482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099950|NCT03186482|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25099951|NCT03186482|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25099952|NCT03186482|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25099953|NCT03186482|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25099954|NCT03186482|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25099955|NCT03186482|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25099956|NCT03186482|Antiviral Agents|antiviral agents|mesh-ancestor
24525325|NCT03655691|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24414294|NCT00196755|Chelating Agents|chelating agents|mesh-ancestor
24414295|NCT00196755|Sequestering Agents|sequestering agents|mesh-ancestor
25099957|NCT03186482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25099958|NCT03186482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25099959|NCT03186482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25099960|NCT03186313|Ribavirin|ribavirin|mesh-list
25099961|NCT03186313|Sofosbuvir|sofosbuvir|mesh-list
25099962|NCT03186313|Antimetabolites|antimetabolites|mesh-ancestor
25099963|NCT03186313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099964|NCT03186313|Antiviral Agents|antiviral agents|mesh-ancestor
25099965|NCT03186313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25099966|NCT03186053|Phosphocreatine|phosphocreatine|mesh-list
25099967|NCT03186053|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25099968|NCT03186053|Protective Agents|protective agents|mesh-ancestor
25100001|NCT03186443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24987940|NCT04631471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24517046|NCT00605683|Protective Agents|protective agents|mesh-ancestor
24517047|NCT00605683|Hormone Antagonists|hormone antagonists|mesh-ancestor
25100002|NCT03186443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25100003|NCT03186443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25100004|NCT03186443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25100005|NCT03186443|Antimanic Agents|antimanic agents|mesh-ancestor
25100015|NCT03186131|Vitamin D|vitamin d|mesh-list
25100062|NCT03185611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25100063|NCT03185611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25100064|NCT03185611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25224812|NCT02630862|Analgesics|analgesics|mesh-ancestor
25224813|NCT02630862|Sensory System Agents|sensory system agents|mesh-ancestor
25224814|NCT02630862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25224815|NCT02630862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224816|NCT02630862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24838111|NCT02195336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24838112|NCT02195336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24838113|NCT02195336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24838114|NCT02195336|Growth Substances|growth substances|mesh-ancestor
24838126|NCT02195375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24838127|NCT02195375|Sympathomimetics|sympathomimetics|mesh-ancestor
24838128|NCT02195466|Ritonavir|ritonavir|mesh-list
24838129|NCT02195466|Tipranavir|tipranavir|mesh-list
25100065|NCT03185611|Immunologic Factors|immunologic factors|mesh-ancestor
25100066|NCT03185611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100067|NCT03185611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25100068|NCT03185624|Rifaximin|rifaximin|mesh-list
25100069|NCT03185624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25100070|NCT03185624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25100071|NCT03185624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25680717|NCT01854177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680718|NCT01854359|Idebenone|idebenone|mesh-list
24466656|NCT00374465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24466657|NCT00374465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022880|NCT03658746|Renal Agents|renal agents|mesh-ancestor
25022881|NCT03658746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25022882|NCT03658746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25022883|NCT03658746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25022884|NCT03658746|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25100072|NCT03185429|Cyclophosphamide|cyclophosphamide|mesh-list
25100073|NCT03185429|Immunologic Factors|immunologic factors|mesh-ancestor
25100074|NCT03185429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100075|NCT03185429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25100076|NCT03185429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25100077|NCT03185429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25100078|NCT03185429|Alkylating Agents|alkylating agents|mesh-ancestor
25100079|NCT03185429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100080|NCT03185429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25100081|NCT03185429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25100128|NCT03185104|Cariostatic Agents|cariostatic agents|mesh-ancestor
25100129|NCT03185104|Protective Agents|protective agents|mesh-ancestor
25100130|NCT03185104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100131|NCT03185156|Propofol|propofol|mesh-list
25100132|NCT03185156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25100133|NCT03185156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25100134|NCT03185156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100135|NCT03185156|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25100136|NCT03185156|Anesthetics, General|anesthetics, general|mesh-ancestor
25100137|NCT03185156|Anesthetics|anesthetics|mesh-ancestor
25100163|NCT03185143|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25100164|NCT03185143|Serotonin Agents|serotonin agents|mesh-ancestor
25100165|NCT03185143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25100166|NCT03185143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100167|NCT03185195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25100168|NCT03184870|Leucovorin|leucovorin|mesh-list
25100169|NCT03184870|Gemcitabine|gemcitabine|mesh-list
25100170|NCT03184870|Paclitaxel|paclitaxel|mesh-list
25100171|NCT03184870|Fluorouracil|fluorouracil|mesh-list
25100172|NCT03184870|Nivolumab|nivolumab|mesh-list
25100173|NCT03184870|Irinotecan|irinotecan|mesh-list
25100174|NCT03184870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25100175|NCT03184870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25100176|NCT03184870|Tubulin Modulators|tubulin modulators|mesh-ancestor
25100177|NCT03184870|Antimitotic Agents|antimitotic agents|mesh-ancestor
25100178|NCT03184870|Mitosis Modulators|mitosis modulators|mesh-ancestor
25100179|NCT03184870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100180|NCT03184870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25100181|NCT03184870|Antimetabolites|antimetabolites|mesh-ancestor
25100182|NCT03184870|Antiviral Agents|antiviral agents|mesh-ancestor
25100183|NCT03184870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25100184|NCT03184870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100185|NCT03184870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25100186|NCT03184870|Immunologic Factors|immunologic factors|mesh-ancestor
25100187|NCT03184870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100188|NCT03184870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25100189|NCT03184870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25100190|NCT03184870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25100211|NCT03185130|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25100212|NCT03185130|Histamine Antagonists|histamine antagonists|mesh-ancestor
25100213|NCT03185130|Histamine Agents|histamine agents|mesh-ancestor
25224817|NCT02630862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25224818|NCT02630862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25224819|NCT02630862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25224820|NCT02630862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224821|NCT02630862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24987996|NCT04479267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25224822|NCT02630862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25224823|NCT02630862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25224824|NCT02630862|Antipyretics|antipyretics|mesh-ancestor
25680719|NCT01854359|Antioxidants|antioxidants|mesh-ancestor
25680720|NCT01854359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680721|NCT01854359|Protective Agents|protective agents|mesh-ancestor
25680722|NCT01854359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680723|NCT01854528|Interferons|interferons|mesh-list
25680724|NCT01854528|Ribavirin|ribavirin|mesh-list
25680725|NCT01854528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25680726|NCT01854528|Antiviral Agents|antiviral agents|mesh-ancestor
24838132|NCT02195466|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24838133|NCT02195466|Protease Inhibitors|protease inhibitors|mesh-ancestor
25100214|NCT03185130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25100215|NCT03185130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100216|NCT03185130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25100217|NCT03185130|Antipruritics|antipruritics|mesh-ancestor
25100218|NCT03185130|Dermatologic Agents|dermatologic agents|mesh-ancestor
25100219|NCT03185130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25100220|NCT03185130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25100221|NCT03185130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25100222|NCT03185130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25100223|NCT03185130|Dopamine Agents|dopamine agents|mesh-ancestor
25100225|NCT03184805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25100226|NCT03184805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25100227|NCT03184805|Analgesics|analgesics|mesh-ancestor
25100228|NCT03184805|Sensory System Agents|sensory system agents|mesh-ancestor
25100229|NCT03184805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100230|NCT03184805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100231|NCT03184805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25100232|NCT03184805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25100233|NCT03184805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25100234|NCT03184805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25100253|NCT03184649|Antipyretics|antipyretics|mesh-ancestor
25100254|NCT03184480|Fluticasone|fluticasone|mesh-list
25100255|NCT03184480|Xhance|xhance|mesh-list
25100256|NCT03184480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25100257|NCT03184480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25100258|NCT03184480|Autonomic Agents|autonomic agents|mesh-ancestor
25100259|NCT03184480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100260|NCT03184480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100261|NCT03184480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25100262|NCT03184480|Respiratory System Agents|respiratory system agents|mesh-ancestor
25100263|NCT03184480|Dermatologic Agents|dermatologic agents|mesh-ancestor
25100264|NCT03184480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25100265|NCT03184493|Metformin|metformin|mesh-list
25100266|NCT03184493|Celecoxib|celecoxib|mesh-list
25100267|NCT03184493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25100268|NCT03184493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100269|NCT03184493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25100270|NCT03184493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25100271|NCT03184493|Analgesics|analgesics|mesh-ancestor
25100272|NCT03184493|Sensory System Agents|sensory system agents|mesh-ancestor
25100273|NCT03184493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100274|NCT03184493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25100275|NCT03184493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25100276|NCT03184493|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25100277|NCT03184493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25100278|NCT03184493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100279|NCT03184493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100280|NCT03184363|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25100281|NCT03184363|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25100282|NCT03184363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25100283|NCT03184363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100284|NCT03184363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100285|NCT03184363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25100286|NCT03184363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25100306|NCT03184766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25100307|NCT03184766|Respiratory System Agents|respiratory system agents|mesh-ancestor
25100308|NCT03184766|Nasal Decongestants|nasal decongestants|mesh-ancestor
25224895|NCT02630485|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25100309|NCT03184766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25100310|NCT03184766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25100311|NCT03184766|Sympathomimetics|sympathomimetics|mesh-ancestor
25100312|NCT03184766|Adrenergic Agents|adrenergic agents|mesh-ancestor
25100313|NCT03184766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25100314|NCT03184324|Esomeprazole|esomeprazole|mesh-list
25224825|NCT02630862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25224826|NCT02630862|Vasodilator Agents|vasodilator agents|mesh-ancestor
25224827|NCT02631174|Antithrombins|antithrombins|mesh-list
25224828|NCT02631174|Antithrombin III|antithrombin iii|mesh-list
25224829|NCT02631174|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25224830|NCT02631174|Protease Inhibitors|protease inhibitors|mesh-ancestor
24838134|NCT02195466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24838135|NCT02195466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838136|NCT02195466|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24838137|NCT02195466|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24838139|NCT02195466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24838140|NCT02195466|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24838141|NCT02195466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24838142|NCT02195466|Antifungal Agents|antifungal agents|mesh-ancestor
24838143|NCT02195466|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24838144|NCT02195466|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24838145|NCT02195466|Hormone Antagonists|hormone antagonists|mesh-ancestor
24838146|NCT02195466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24838147|NCT02195466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838148|NCT02195466|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24838149|NCT02195466|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24838150|NCT02195492|Hylan|hylan|mesh-list
24838151|NCT02195492|Viscosupplements|viscosupplements|mesh-ancestor
24838152|NCT02195492|Protective Agents|protective agents|mesh-ancestor
24838153|NCT02195492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056480|NCT03512496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056481|NCT03512496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25056482|NCT03512496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25056483|NCT03512496|Purinergic Agents|purinergic agents|mesh-ancestor
25056484|NCT03512496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25100315|NCT03184324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25100316|NCT03184324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25100317|NCT03184324|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25100318|NCT03184324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100319|NCT03184324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100320|NCT03184103|Complement System Proteins|complement system proteins|mesh-list
25100321|NCT03184103|Antistreptolysin|antistreptolysin|mesh-list
25100322|NCT03184103|Immunologic Factors|immunologic factors|mesh-ancestor
25100323|NCT03184103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100324|NCT03184194|Cyclophosphamide|cyclophosphamide|mesh-list
25100326|NCT03184194|Daratumumab|daratumumab|mesh-list
25100332|NCT03184194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25100334|NCT03184194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100335|NCT03184194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25100336|NCT03184194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24777614|NCT01865279|Insulin|insulin|mesh-list
25100337|NCT03184194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25100338|NCT03184194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25100339|NCT03183739|ASP8062|asp8062|mesh-list
25100340|NCT03183739|Analgesics|analgesics|mesh-ancestor
25224831|NCT02631174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25224832|NCT02631174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224833|NCT02631174|Anticoagulants|anticoagulants|mesh-ancestor
25224834|NCT02630888|Memantine|memantine|mesh-list
25224835|NCT02630888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25224836|NCT02630888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25224837|NCT02630888|Dopamine Agents|dopamine agents|mesh-ancestor
24862479|NCT02325583|Anesthetics|anesthetics|mesh-ancestor
25224838|NCT02630888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25224839|NCT02630888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224840|NCT02630888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224841|NCT02630888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25224842|NCT02630888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25224843|NCT02631109|Methylprednisolone|methylprednisolone|mesh-list
25224844|NCT02631109|Doxorubicin|doxorubicin|mesh-list
25224845|NCT02631109|Etoposide|etoposide|mesh-list
25224846|NCT02631109|Pegaspargase|pegaspargase|mesh-list
25224847|NCT02631109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25224849|NCT02631109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25224850|NCT02631109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25224851|NCT02631109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25224852|NCT02631109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224853|NCT02631109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25224854|NCT02631109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25224855|NCT02631109|Antiemetics|antiemetics|mesh-ancestor
25224856|NCT02631109|Autonomic Agents|autonomic agents|mesh-ancestor
25224857|NCT02631109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838160|NCT02195557|Protective Agents|protective agents|mesh-ancestor
24838161|NCT02195557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100341|NCT03183739|Sensory System Agents|sensory system agents|mesh-ancestor
25100342|NCT03183739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100343|NCT03183739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100344|NCT03183739|GABA Modulators|gaba modulators|mesh-ancestor
25100345|NCT03183739|GABA Agents|gaba agents|mesh-ancestor
25100346|NCT03183739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25100347|NCT03183739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100348|NCT03183752|Metformin|metformin|mesh-list
25100349|NCT03183752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25100350|NCT03183752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100351|NCT03183843|Warfarin|warfarin|mesh-list
25100352|NCT03183843|Dabigatran|dabigatran|mesh-list
25100353|NCT03183843|Anticoagulants|anticoagulants|mesh-ancestor
25100354|NCT03183843|Antithrombins|antithrombins|mesh-ancestor
25100355|NCT03183843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25100356|NCT03183843|Protease Inhibitors|protease inhibitors|mesh-ancestor
25100357|NCT03183843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100358|NCT03183843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100382|NCT03183557|Alfacalcidol|alfacalcidol|mesh-list
25100383|NCT03183557|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
25100384|NCT03183557|Vitamins|vitamins|mesh-ancestor
25100385|NCT03183557|Micronutrients|micronutrients|mesh-ancestor
25100386|NCT03183557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100387|NCT03183557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25100388|NCT03183375|Hydroxyurea|hydroxyurea|mesh-list
25100389|NCT03183375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25100390|NCT03183375|Antisickling Agents|antisickling agents|mesh-ancestor
25100391|NCT03183375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100392|NCT03183375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100393|NCT03183375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25100394|NCT03183297|Fexofenadine|fexofenadine|mesh-list
25100395|NCT03183297|Naproxen|naproxen|mesh-list
25100396|NCT03183297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25100416|NCT03183544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100417|NCT03183310|Chlorpromazine|chlorpromazine|mesh-list
25100418|NCT03183310|Antiemetics|antiemetics|mesh-ancestor
25100419|NCT03183310|Autonomic Agents|autonomic agents|mesh-ancestor
25100420|NCT03183310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100421|NCT03183310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100422|NCT03183310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25100423|NCT03183310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25100424|NCT03183310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25100425|NCT03183310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25100426|NCT03183310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25100427|NCT03183310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25100428|NCT03183310|Dopamine Agents|dopamine agents|mesh-ancestor
25100429|NCT03183310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25100430|NCT03183310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100431|NCT03183492|Vaccines|vaccines|mesh-list
25100432|NCT03183492|Immunologic Factors|immunologic factors|mesh-ancestor
25100433|NCT03183492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100434|NCT03183115|Lugol's solution|lugol's solution|mesh-list
25100435|NCT03183115|Hemostatics|hemostatics|mesh-ancestor
25100436|NCT03183115|Coagulants|coagulants|mesh-ancestor
24414296|NCT00196755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224858|NCT02631109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224859|NCT02631109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25224860|NCT02631109|Glucocorticoids|glucocorticoids|mesh-ancestor
25224861|NCT02631109|Hormones|hormones|mesh-ancestor
25224862|NCT02631109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25224863|NCT02631109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25224864|NCT02631109|Protective Agents|protective agents|mesh-ancestor
24838163|NCT02195635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24517380|NCT00607581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24838164|NCT02195635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24838196|NCT02195908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24838198|NCT02195973|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24838199|NCT02195973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24838200|NCT02195973|Tubulin Modulators|tubulin modulators|mesh-ancestor
24838201|NCT02195973|Antimitotic Agents|antimitotic agents|mesh-ancestor
24838202|NCT02195973|Mitosis Modulators|mitosis modulators|mesh-ancestor
24838204|NCT02196142|Hydrocortisone|hydrocortisone|mesh-list
24838216|NCT02196155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25405367|NCT03609580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468381|NCT00381251|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24468441|NCT00381537|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25023092|NCT03657550|Amlodipine|amlodipine|mesh-list
24414338|NCT00196885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414339|NCT00196885|Protective Agents|protective agents|mesh-ancestor
24414340|NCT00196885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414341|NCT00196885|Antidotes|antidotes|mesh-ancestor
24414342|NCT00196989|Pioglitazone|pioglitazone|mesh-list
24414343|NCT00196989|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25100443|NCT03182894|Antimetabolites|antimetabolites|mesh-ancestor
25100444|NCT03182894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100445|NCT03182894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100446|NCT03182803|Antibodies|antibodies|mesh-list
25100447|NCT03182803|Immunologic Factors|immunologic factors|mesh-ancestor
25100448|NCT03182803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777758|NCT01866488|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25100449|NCT03183024|Benralizumab|benralizumab|mesh-list
25100450|NCT03183024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25100451|NCT03183024|Respiratory System Agents|respiratory system agents|mesh-ancestor
25100456|NCT03182855|Ticagrelor|ticagrelor|mesh-list
25100457|NCT03182855|Cangrelor|cangrelor|mesh-list
25100458|NCT03182855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25100459|NCT03182855|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25100460|NCT03182855|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25100461|NCT03182855|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25100462|NCT03182855|Purinergic Agents|purinergic agents|mesh-ancestor
25100463|NCT03182855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25100464|NCT03182855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100465|NCT03182855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100466|NCT03182634|Olaparib|olaparib|mesh-list
25100467|NCT03182634|Fulvestrant|fulvestrant|mesh-list
25100468|NCT03182634|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25100469|NCT03182634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517443|NCT00607971|Renzapride|renzapride|mesh-list
24517444|NCT00607971|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24517445|NCT00607971|Serotonin Agents|serotonin agents|mesh-ancestor
25100470|NCT03182634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100471|NCT03182634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25100472|NCT03182634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25100481|NCT03182595|Sensory System Agents|sensory system agents|mesh-ancestor
25100482|NCT03182595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100483|NCT03182595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224865|NCT02630823|Paclitaxel|paclitaxel|mesh-list
25224866|NCT02630823|Carboplatin|carboplatin|mesh-list
25224867|NCT02630823|Pembrolizumab|pembrolizumab|mesh-list
25224868|NCT02630823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25224869|NCT02630823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25224870|NCT02630823|Tubulin Modulators|tubulin modulators|mesh-ancestor
25224871|NCT02630823|Antimitotic Agents|antimitotic agents|mesh-ancestor
25224872|NCT02630823|Mitosis Modulators|mitosis modulators|mesh-ancestor
25224873|NCT02630823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224874|NCT02630823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25224875|NCT02630511|Mannitol|mannitol|mesh-list
25224876|NCT02630511|Methacholine Chloride|methacholine chloride|mesh-list
25224877|NCT02630511|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25224878|NCT02630511|Diuretics|diuretics|mesh-ancestor
24838218|NCT02196155|Cholinergic Agents|cholinergic agents|mesh-ancestor
24838219|NCT02196155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24838220|NCT02196155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838221|NCT02196155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25100484|NCT03182595|Antipyretics|antipyretics|mesh-ancestor
25100485|NCT03182413|Modafinil|modafinil|mesh-list
25100486|NCT03182413|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25100487|NCT03182413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100488|NCT03182413|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24412585|NCT00191620|Antiviral Agents|antiviral agents|mesh-ancestor
25100504|NCT03182218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25680727|NCT01854528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25680728|NCT01854528|Antimetabolites|antimetabolites|mesh-ancestor
25680729|NCT01854528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680730|NCT01854593|Bevacizumab|bevacizumab|mesh-list
25680731|NCT01854593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24468526|NCT00382057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24468528|NCT00382057|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25100505|NCT03182218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100506|NCT03182296|Exenatide|exenatide|mesh-list
25100507|NCT03182296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25100508|NCT03182296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100509|NCT03182296|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25100526|NCT03181919|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25100527|NCT03181919|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25100528|NCT03181919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100529|NCT03181919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100530|NCT03181919|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25100531|NCT03181919|Hormone Antagonists|hormone antagonists|mesh-ancestor
25100532|NCT03181919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25100533|NCT03181919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100535|NCT03182088|Bupivacaine|bupivacaine|mesh-list
25100536|NCT03182088|Anesthetics, Local|anesthetics, local|mesh-ancestor
25100537|NCT03182088|Anesthetics|anesthetics|mesh-ancestor
25100538|NCT03182088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25100539|NCT03182088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100540|NCT03182088|Sensory System Agents|sensory system agents|mesh-ancestor
25100541|NCT03182088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100542|NCT03182088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25100543|NCT03182088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25100544|NCT03182088|Adrenergic Agents|adrenergic agents|mesh-ancestor
25100545|NCT03182088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25100546|NCT03182088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100547|NCT03182088|Sympathomimetics|sympathomimetics|mesh-ancestor
25100548|NCT03182088|Autonomic Agents|autonomic agents|mesh-ancestor
25100549|NCT03182088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25100550|NCT03182140|Levonorgestrel|levonorgestrel|mesh-list
25100551|NCT03182140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25100552|NCT03182140|Contraceptive Agents|contraceptive agents|mesh-ancestor
25100553|NCT03182140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25100554|NCT03182140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100555|NCT03182140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25100556|NCT03182140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25100557|NCT03182140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25100558|NCT03181880|Bromides|bromides|mesh-list
25100559|NCT03181880|Formoterol Fumarate|formoterol fumarate|mesh-list
25100564|NCT03181880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25100565|NCT03181880|Respiratory System Agents|respiratory system agents|mesh-ancestor
25100566|NCT03181880|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25100567|NCT03181880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25100568|NCT03181880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25100569|NCT03181880|Adrenergic Agents|adrenergic agents|mesh-ancestor
25100583|NCT03181763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25100584|NCT03181763|Serotonin Agents|serotonin agents|mesh-ancestor
25100585|NCT03181763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25100586|NCT03181763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100587|NCT03181763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25100588|NCT03181763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25100589|NCT03181763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25100590|NCT03181763|Adrenergic Agents|adrenergic agents|mesh-ancestor
25100591|NCT03181646|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
25100592|NCT03181646|Nootropic Agents|nootropic agents|mesh-ancestor
25100593|NCT03181685|Cetrorelix|cetrorelix|mesh-list
25100594|NCT03181685|Progesterone|progesterone|mesh-list
25100595|NCT03181685|Progestins|progestins|mesh-ancestor
25100596|NCT03181685|Hormones|hormones|mesh-ancestor
25224879|NCT02630511|Natriuretic Agents|natriuretic agents|mesh-ancestor
25224880|NCT02630511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224881|NCT02630511|Miotics|miotics|mesh-ancestor
25224882|NCT02630511|Autonomic Agents|autonomic agents|mesh-ancestor
25224883|NCT02630511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838222|NCT02196155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24838223|NCT02196155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838224|NCT02196194|Tiotropium Bromide|tiotropium bromide|mesh-list
24838225|NCT02196194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24838226|NCT02196194|Autonomic Agents|autonomic agents|mesh-ancestor
25680732|NCT01854593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25680733|NCT01854593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25680734|NCT01854593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25056527|NCT03511833|Ketamine|ketamine|mesh-list
25100604|NCT03181464|Anesthetics, Local|anesthetics, local|mesh-ancestor
25100606|NCT03181464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25100607|NCT03181464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100608|NCT03181464|Sensory System Agents|sensory system agents|mesh-ancestor
25100609|NCT03181464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100610|NCT03181464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25100611|NCT03181464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25100612|NCT03181464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25100613|NCT03181464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25100614|NCT03181464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100615|NCT03181243|Anesthetics|anesthetics|mesh-list
25100616|NCT03181243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25100617|NCT03181243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100618|NCT03181360|Tenecteplase|tenecteplase|mesh-list
25100619|NCT03181360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25100661|NCT03180879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25100662|NCT03180879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25100663|NCT03180879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25100664|NCT03180879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100665|NCT03180879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100666|NCT03180944|Lugol's solution|lugol's solution|mesh-list
25100667|NCT03180944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25100668|NCT03180944|Hemostatics|hemostatics|mesh-ancestor
25100669|NCT03180944|Coagulants|coagulants|mesh-ancestor
25100671|NCT03180775|Glycine Agents|glycine agents|mesh-ancestor
25100672|NCT03180775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25100673|NCT03180775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100674|NCT03180775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100675|NCT03180723|Cyclosporine|cyclosporine|mesh-list
25100676|NCT03180723|Rituximab|rituximab|mesh-list
25100677|NCT03180723|Cyclosporins|cyclosporins|mesh-list
25100678|NCT03180723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25100679|NCT03180723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25100718|NCT03180671|Dermatologic Agents|dermatologic agents|mesh-ancestor
25100719|NCT03180593|Valsartan|valsartan|mesh-list
25100720|NCT03180593|Nebivolol|nebivolol|mesh-list
24778071|NCT01868984|Paclitaxel|paclitaxel|mesh-list
25100721|NCT03180593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25100772|NCT03180281|Incretins|incretins|mesh-ancestor
25100773|NCT03180281|Hormones|hormones|mesh-ancestor
25100774|NCT03180281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25100775|NCT03180281|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25100776|NCT03180281|Protease Inhibitors|protease inhibitors|mesh-ancestor
25100777|NCT03180281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100778|NCT03180281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100779|NCT03180281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25100780|NCT03180281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25100781|NCT03180281|Immunologic Factors|immunologic factors|mesh-ancestor
25100782|NCT03180255|Dexamethasone|dexamethasone|mesh-list
25100783|NCT03180255|Sodium Citrate|sodium citrate|mesh-list
25100784|NCT03180255|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25100785|NCT03180255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25100786|NCT03180255|Antiemetics|antiemetics|mesh-ancestor
25100787|NCT03180255|Autonomic Agents|autonomic agents|mesh-ancestor
25100788|NCT03180255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100789|NCT03180255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100790|NCT03180255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25100791|NCT03180255|Glucocorticoids|glucocorticoids|mesh-ancestor
25100792|NCT03180255|Hormones|hormones|mesh-ancestor
24988072|NCT04251715|Hormones|hormones|mesh-ancestor
25100793|NCT03180255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25100794|NCT03180255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24569772|NCT00801879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100795|NCT03180255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25100797|NCT03180190|Hydroxychloroquine|hydroxychloroquine|mesh-list
25224884|NCT02630511|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25224885|NCT02630511|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
25224886|NCT02630511|Respiratory System Agents|respiratory system agents|mesh-ancestor
25224887|NCT02630511|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25224888|NCT02630511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25224889|NCT02630511|Cholinergic Agents|cholinergic agents|mesh-ancestor
24838227|NCT02196194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838266|NCT02196740|Clindamycin phosphate|clindamycin phosphate|mesh-list
24838267|NCT02196740|Gatifloxacin|gatifloxacin|mesh-list
24838268|NCT02196740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24838269|NCT02196740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24838270|NCT02196740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25100799|NCT03180190|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25100800|NCT03180190|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25100801|NCT03180190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25100802|NCT03180190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100805|NCT03180099|Bupivacaine|bupivacaine|mesh-list
25100815|NCT03179839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25100816|NCT03179839|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25100817|NCT03179839|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25100818|NCT03179839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25100819|NCT03179839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100820|NCT03179839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25100821|NCT03179839|Serotonin Agents|serotonin agents|mesh-ancestor
25100822|NCT03179839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100823|NCT03179839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25100824|NCT03179839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25100825|NCT03179839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25100885|NCT03178708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100886|NCT03178708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100887|NCT03178708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25100888|NCT03178708|Analgesics|analgesics|mesh-ancestor
25100889|NCT03178708|Sensory System Agents|sensory system agents|mesh-ancestor
25100890|NCT03178708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100892|NCT03178955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25100893|NCT03178955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25100894|NCT03178955|Analgesics|analgesics|mesh-ancestor
25100895|NCT03178955|Sensory System Agents|sensory system agents|mesh-ancestor
25100896|NCT03178955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24988146|NCT04198805|Micronutrients|micronutrients|mesh-ancestor
25100897|NCT03178955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100898|NCT03178955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25100903|NCT03178864|Heparin|heparin|mesh-list
25100921|NCT03178721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100922|NCT03178643|Piperaquine|piperaquine|mesh-list
25100923|NCT03178643|Sulfadoxine|sulfadoxine|mesh-list
25100924|NCT03178643|Amodiaquine|amodiaquine|mesh-list
25100925|NCT03178643|Artenimol|artenimol|mesh-list
25100926|NCT03178643|Proguanil|proguanil|mesh-list
25100927|NCT03178643|Antimalarials|antimalarials|mesh-ancestor
25100928|NCT03178643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25100929|NCT03178643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25100930|NCT03178643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25100931|NCT03178643|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25100932|NCT03178643|Renal Agents|renal agents|mesh-ancestor
25100933|NCT03178643|Antimetabolites|antimetabolites|mesh-ancestor
25100934|NCT03178643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100935|NCT03178747|Methylene Blue|methylene blue|mesh-list
25100936|NCT03178747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100937|NCT03178747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100938|NCT03178591|Dapagliflozin|dapagliflozin|mesh-list
25100939|NCT03178591|Vildagliptin|vildagliptin|mesh-list
25100940|NCT03178591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25100941|NCT03178591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100942|NCT03178591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25100943|NCT03178591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100944|NCT03178591|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25100945|NCT03178591|Protease Inhibitors|protease inhibitors|mesh-ancestor
25100946|NCT03178591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100947|NCT03178292|Levofloxacin|levofloxacin|mesh-list
25100948|NCT03178292|Ofloxacin|ofloxacin|mesh-list
25100949|NCT03178292|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24778317|NCT01870219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
25100950|NCT03178292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25224890|NCT02630511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25224891|NCT02630511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224892|NCT02630485|Inositol|inositol|mesh-list
25224893|NCT02630485|Letrozole|letrozole|mesh-list
25224894|NCT02630485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24838286|NCT02196805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100963|NCT03178422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100964|NCT03178422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457722|NCT00335075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469669|NCT00386672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101020|NCT03178123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25101021|NCT03177993|Ivermectin|ivermectin|mesh-list
25101022|NCT03177993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25101023|NCT03177993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25101024|NCT03178084|Lamivudine|lamivudine|mesh-list
25101025|NCT03178084|Zidovudine|zidovudine|mesh-list
25101026|NCT03178084|Efavirenz|efavirenz|mesh-list
25101027|NCT03178084|Maraviroc|maraviroc|mesh-list
24778405|NCT01870648|Ondansetron|ondansetron|mesh-list
25101028|NCT03178084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25101029|NCT03178084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25101030|NCT03178084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25101031|NCT03178084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101032|NCT03178084|Antiviral Agents|antiviral agents|mesh-ancestor
25101033|NCT03178084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25101034|NCT03178084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25101035|NCT03178084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25101036|NCT03178084|Antimetabolites|antimetabolites|mesh-ancestor
25101037|NCT03178084|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25101038|NCT03178084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25101039|NCT03178084|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25101040|NCT03178084|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25101041|NCT03178084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25101042|NCT03178084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25101043|NCT03178084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25101044|NCT03178084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24414363|NCT00197197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24414365|NCT00197249|Immunologic Factors|immunologic factors|mesh-ancestor
24414385|NCT00197353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414386|NCT00197353|Sensory System Agents|sensory system agents|mesh-ancestor
24414387|NCT00197353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24414388|NCT00197379|Roxithromycin|roxithromycin|mesh-list
24414389|NCT00197379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24414390|NCT00197379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24414391|NCT00197418|Amoxicillin|amoxicillin|mesh-list
24414392|NCT00197418|Metronidazole|metronidazole|mesh-list
24414393|NCT00197418|Clarithromycin|clarithromycin|mesh-list
24414394|NCT00197418|Rabeprazole|rabeprazole|mesh-list
24414395|NCT00197418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24414396|NCT00197418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24414426|NCT00197561|Trace Elements|trace elements|mesh-ancestor
24414427|NCT00197561|Micronutrients|micronutrients|mesh-ancestor
24414428|NCT00197587|Nevirapine|nevirapine|mesh-list
24414429|NCT00197587|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25101045|NCT03178084|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25101054|NCT03177837|Anticonvulsants|anticonvulsants|mesh-ancestor
25101055|NCT03177837|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25101056|NCT03177837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25101057|NCT03177837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101058|NCT03177837|Diuretics|diuretics|mesh-ancestor
25101059|NCT03177837|Natriuretic Agents|natriuretic agents|mesh-ancestor
25101060|NCT03177837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101061|NCT03177811|Acetazolamide|acetazolamide|mesh-list
25101062|NCT03177811|Anticonvulsants|anticonvulsants|mesh-ancestor
25101063|NCT03177811|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25101064|NCT03177811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988174|NCT04118387|Anticonvulsants|anticonvulsants|mesh-ancestor
25101065|NCT03177811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101066|NCT03177811|Diuretics|diuretics|mesh-ancestor
25101067|NCT03177811|Natriuretic Agents|natriuretic agents|mesh-ancestor
25101068|NCT03177811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101069|NCT03177980|Clonidine|clonidine|mesh-list
25101070|NCT03177980|Fentanyl|fentanyl|mesh-list
25101071|NCT03177980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25224896|NCT02630485|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25224897|NCT02630485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25224898|NCT02630485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101077|NCT03177980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101078|NCT03177980|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25101079|NCT03177980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25101080|NCT03177980|Anesthetics, General|anesthetics, general|mesh-ancestor
25101082|NCT03177980|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25680735|NCT01854593|Growth Substances|growth substances|mesh-ancestor
25680736|NCT01854593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101083|NCT03177980|Sympatholytics|sympatholytics|mesh-ancestor
25101084|NCT03177980|Autonomic Agents|autonomic agents|mesh-ancestor
25101085|NCT03177980|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25101086|NCT03177980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25101087|NCT03177980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25101088|NCT03177980|Adrenergic Agents|adrenergic agents|mesh-ancestor
25101089|NCT03177980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25101090|NCT03177980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101091|NCT03177850|Acetazolamide|acetazolamide|mesh-list
25101092|NCT03177850|Anticonvulsants|anticonvulsants|mesh-ancestor
25101093|NCT03177850|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25101094|NCT03177850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25101095|NCT03177850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101096|NCT03177850|Diuretics|diuretics|mesh-ancestor
25101097|NCT03177850|Natriuretic Agents|natriuretic agents|mesh-ancestor
25101098|NCT03177850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101099|NCT03177720|Ciprofloxacin|ciprofloxacin|mesh-list
25101101|NCT03177720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25101102|NCT03177720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25101103|NCT03177720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25101104|NCT03177720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25101105|NCT03177720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25101106|NCT03177720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101107|NCT03177720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25101108|NCT03177720|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25101109|NCT03177720|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25101110|NCT03177538|Menotropins|menotropins|mesh-list
25101111|NCT03177538|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25101112|NCT03177538|Hormones|hormones|mesh-ancestor
24413596|NCT00194597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25101131|NCT03177252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101132|NCT03177252|Sensory System Agents|sensory system agents|mesh-ancestor
25101133|NCT03177252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101134|NCT03177252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25101135|NCT03177252|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25101136|NCT03177252|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25101137|NCT03177252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25101139|NCT03177317|Dexamethasone|dexamethasone|mesh-list
25101180|NCT03176966|Dopamine Agonists|dopamine agonists|mesh-ancestor
25101181|NCT03176966|Dopamine Agents|dopamine agents|mesh-ancestor
25101182|NCT03176966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25101183|NCT03177083|Interferons|interferons|mesh-list
25101184|NCT03177083|Interferon-beta|interferon-beta|mesh-list
25101185|NCT03177083|Interferon beta-1a|interferon beta-1a|mesh-list
25101186|NCT03177083|Interferon beta-1b|interferon beta-1b|mesh-list
25101187|NCT03177083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25101188|NCT03177083|Antiviral Agents|antiviral agents|mesh-ancestor
25101189|NCT03177083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25101190|NCT03177083|Immunologic Factors|immunologic factors|mesh-ancestor
25101191|NCT03177083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224899|NCT02630485|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25224900|NCT02630485|Hormone Antagonists|hormone antagonists|mesh-ancestor
25224901|NCT02630485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25224902|NCT02630485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224903|NCT02630485|Vitamin B Complex|vitamin b complex|mesh-ancestor
25224904|NCT02630485|Vitamins|vitamins|mesh-ancestor
25224905|NCT02630485|Micronutrients|micronutrients|mesh-ancestor
25224906|NCT02630420|Cetuximab|cetuximab|mesh-list
24838310|NCT02197143|Ranitidine|ranitidine|mesh-list
24838311|NCT02197143|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
24838314|NCT02197143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25101192|NCT03177083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25101193|NCT03176758|Anesthetics|anesthetics|mesh-list
24512639|NCT00575952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25101242|NCT03176446|Anesthetics|anesthetics|mesh-list
25101243|NCT03176446|Anesthetics, Local|anesthetics, local|mesh-list
25101244|NCT03176446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24988257|NCT03615664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25101245|NCT03176446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101246|NCT03176446|Sensory System Agents|sensory system agents|mesh-ancestor
25101247|NCT03176446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101248|NCT03176537|Testosterone|testosterone|mesh-list
25101249|NCT03176537|Androgens|androgens|mesh-ancestor
25101250|NCT03176537|Hormones|hormones|mesh-ancestor
25101251|NCT03176537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25101252|NCT03176537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023314|NCT03656094|Pembrolizumab|pembrolizumab|mesh-list
25023315|NCT03656094|Pemetrexed|pemetrexed|mesh-list
25023316|NCT03656094|Vinorelbine|vinorelbine|mesh-list
25023326|NCT03656094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25023327|NCT03656042|Lenograstim|lenograstim|mesh-list
25023328|NCT03656042|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25023329|NCT03656042|Immunologic Factors|immunologic factors|mesh-ancestor
25023330|NCT03656042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023332|NCT03655964|Nebivolol|nebivolol|mesh-list
25023337|NCT03655964|Vasodilator Agents|vasodilator agents|mesh-ancestor
25101253|NCT03176212|Milk fat globule|milk fat globule|mesh-list
25101254|NCT03176212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25101255|NCT03176121|Oxycodone|oxycodone|mesh-list
25101256|NCT03176121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25101257|NCT03176121|Narcotics|narcotics|mesh-ancestor
25101258|NCT03176121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25101259|NCT03176121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101260|NCT03176121|Analgesics|analgesics|mesh-ancestor
25101261|NCT03176121|Sensory System Agents|sensory system agents|mesh-ancestor
25101262|NCT03176121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101263|NCT03176199|Oxycodone|oxycodone|mesh-list
25101264|NCT03176199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25101265|NCT03176199|Narcotics|narcotics|mesh-ancestor
25101266|NCT03176199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25101267|NCT03176199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101268|NCT03176199|Analgesics|analgesics|mesh-ancestor
25101269|NCT03176199|Sensory System Agents|sensory system agents|mesh-ancestor
25101270|NCT03176199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101271|NCT03176186|Xenon|xenon|mesh-list
25101272|NCT03176186|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25101284|NCT03175939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101286|NCT03175926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25101287|NCT03175926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25101288|NCT03175926|Autonomic Agents|autonomic agents|mesh-ancestor
25101345|NCT03175705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101346|NCT03175705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101347|NCT03175705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25101348|NCT03175705|Antimetabolites|antimetabolites|mesh-ancestor
25101349|NCT03175705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101350|NCT03175835|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25101351|NCT03175835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25101352|NCT03175835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25101353|NCT03175835|Antimetabolites|antimetabolites|mesh-ancestor
25101354|NCT03175835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101355|NCT03175835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25101356|NCT03175835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25101357|NCT03175835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24778816|NCT01872494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25101359|NCT03175653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25101360|NCT03175653|Narcotics|narcotics|mesh-ancestor
25101361|NCT03175653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25101362|NCT03175653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101363|NCT03175653|Analgesics|analgesics|mesh-ancestor
25101364|NCT03175653|Sensory System Agents|sensory system agents|mesh-ancestor
25101365|NCT03175653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101366|NCT03175341|Ascorbic Acid|ascorbic acid|mesh-list
25101367|NCT03175341|Vitamins|vitamins|mesh-ancestor
25224907|NCT02630420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25224908|NCT02630420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25224909|NCT02630394|Azithromycin|azithromycin|mesh-list
25224910|NCT02630394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25224911|NCT02630394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24796823|NCT01952626|Antiemetics|antiemetics|mesh-ancestor
24838316|NCT02197143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101389|NCT03175380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101390|NCT03175042|Chrysarobin|chrysarobin|mesh-list
25680737|NCT01854593|Growth Inhibitors|growth inhibitors|mesh-ancestor
25680738|NCT01854645|Bromides|bromides|mesh-list
25680739|NCT01854645|Tiotropium Bromide|tiotropium bromide|mesh-list
25680740|NCT01854645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25680741|NCT01854645|Autonomic Agents|autonomic agents|mesh-ancestor
25680742|NCT01854645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25680743|NCT01854645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680744|NCT01854645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25680745|NCT01854645|Respiratory System Agents|respiratory system agents|mesh-ancestor
25101391|NCT03175042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25112073|NCT04491084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112074|NCT04491084|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25112075|NCT04491084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25112076|NCT04491084|Protective Agents|protective agents|mesh-ancestor
24469948|NCT00388089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469949|NCT00388089|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24469950|NCT00388089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25101392|NCT03175042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25101393|NCT03175042|Analgesics|analgesics|mesh-ancestor
25101394|NCT03175042|Sensory System Agents|sensory system agents|mesh-ancestor
25101395|NCT03175042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24414798|NCT00198640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25101406|NCT03174977|Raltegravir Potassium|raltegravir potassium|mesh-list
25101407|NCT03174977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25101408|NCT03174977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25101425|NCT03174860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25101426|NCT03174860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25101427|NCT03174860|Analgesics|analgesics|mesh-ancestor
25101428|NCT03174860|Sensory System Agents|sensory system agents|mesh-ancestor
25101429|NCT03174860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101430|NCT03174860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101431|NCT03174860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25101432|NCT03174860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25101433|NCT03174860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25101434|NCT03174860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25101435|NCT03174860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101437|NCT03174821|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25101438|NCT03174821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25101439|NCT03174821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101440|NCT03174795|Meropenem|meropenem|mesh-list
25101441|NCT03174795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25101442|NCT03174795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25101443|NCT03174548|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25101444|NCT03174548|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25101445|NCT03174548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101446|NCT03174548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25101447|NCT03174548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988389|NCT02887248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24988390|NCT02887248|Antimetabolites|antimetabolites|mesh-ancestor
24988391|NCT02887248|Antiviral Agents|antiviral agents|mesh-ancestor
25101448|NCT03174561|Choline|choline|mesh-list
25101471|NCT03174483|Fluticasone|fluticasone|mesh-list
25101472|NCT03174483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25101473|NCT03174483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25101474|NCT03174483|Autonomic Agents|autonomic agents|mesh-ancestor
25101475|NCT03174483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101476|NCT03174483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101477|NCT03174483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24838323|NCT02197156|Hydrocodone|hydrocodone|mesh-list
24838352|NCT02197260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24838353|NCT02197260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24838354|NCT02197260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24838356|NCT02197286|Ergocalciferols|ergocalciferols|mesh-list
24838357|NCT02197286|Cholecalciferol|cholecalciferol|mesh-list
24838358|NCT02197286|Vitamins|vitamins|mesh-list
24838359|NCT02197286|Micronutrients|micronutrients|mesh-ancestor
24838360|NCT02197286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838361|NCT02197286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25101478|NCT03174483|Respiratory System Agents|respiratory system agents|mesh-ancestor
25101479|NCT03174483|Dermatologic Agents|dermatologic agents|mesh-ancestor
25101480|NCT03174483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25101481|NCT03174457|Micafungin|micafungin|mesh-list
25101482|NCT03174457|Antifungal Agents|antifungal agents|mesh-ancestor
25101483|NCT03174457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25101484|NCT03174678|Dexmedetomidine|dexmedetomidine|mesh-list
25101485|NCT03174678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25101486|NCT03174678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25680746|NCT01854645|Parasympatholytics|parasympatholytics|mesh-ancestor
25680747|NCT01854645|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25680748|NCT01854645|Cholinergic Agents|cholinergic agents|mesh-ancestor
25680749|NCT01854645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25680750|NCT01854645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680751|NCT01854645|Anticonvulsants|anticonvulsants|mesh-ancestor
25680752|NCT01854658|Glycopyrrolate|glycopyrrolate|mesh-list
25680753|NCT01854658|Formoterol Fumarate|formoterol fumarate|mesh-list
24470084|NCT00388739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24470173|NCT00389038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24470174|NCT00389038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24470175|NCT00389038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101487|NCT03174678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101488|NCT03174678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25101489|NCT03174678|Analgesics|analgesics|mesh-ancestor
25101490|NCT03174678|Sensory System Agents|sensory system agents|mesh-ancestor
25101491|NCT03174678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101492|NCT03174678|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25101493|NCT03174678|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25101494|NCT03174678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25101495|NCT03174678|Adrenergic Agents|adrenergic agents|mesh-ancestor
25101496|NCT03174678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25101526|NCT03174288|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25101527|NCT03174288|Diuretics|diuretics|mesh-ancestor
25101528|NCT03174288|Natriuretic Agents|natriuretic agents|mesh-ancestor
25101529|NCT03174067|Clonidine|clonidine|mesh-list
25101530|NCT03174067|Buprenorphine|buprenorphine|mesh-list
25101531|NCT03174067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25101532|NCT03174067|Narcotics|narcotics|mesh-ancestor
24988392|NCT02887248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24988397|NCT02849990|Prednisone|prednisone|mesh-list
24988428|NCT02817347|Dexamethasone|dexamethasone|mesh-list
25101533|NCT03174067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25101534|NCT03174067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101535|NCT03174067|Analgesics|analgesics|mesh-ancestor
25101536|NCT03174067|Sensory System Agents|sensory system agents|mesh-ancestor
25101537|NCT03174067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101538|NCT03174067|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25101539|NCT03174067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25101540|NCT03174067|Sympatholytics|sympatholytics|mesh-ancestor
25101541|NCT03174067|Autonomic Agents|autonomic agents|mesh-ancestor
25101542|NCT03174067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25101543|NCT03174067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25101544|NCT03174067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25101545|NCT03174067|Adrenergic Agents|adrenergic agents|mesh-ancestor
25101546|NCT03174067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25101547|NCT03174067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101548|NCT03174041|Itraconazole|itraconazole|mesh-list
25101549|NCT03174041|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
25101560|NCT03174041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25101561|NCT03174041|Anesthetics, General|anesthetics, general|mesh-ancestor
25101562|NCT03174041|Anesthetics|anesthetics|mesh-ancestor
25101563|NCT03174041|GABA Modulators|gaba modulators|mesh-ancestor
25101564|NCT03174041|GABA Agents|gaba agents|mesh-ancestor
25101565|NCT03174041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25224921|NCT02630303|Coal Tar|coal tar|mesh-list
25224922|NCT02630303|Keratolytic Agents|keratolytic agents|mesh-ancestor
25224923|NCT02630303|Dermatologic Agents|dermatologic agents|mesh-ancestor
25224924|NCT02630264|Paclitaxel|paclitaxel|mesh-list
25224925|NCT02630264|Endostatins|endostatins|mesh-list
25224926|NCT02630264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25224927|NCT02630264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25224928|NCT02630264|Tubulin Modulators|tubulin modulators|mesh-ancestor
25224929|NCT02630264|Antimitotic Agents|antimitotic agents|mesh-ancestor
25224930|NCT02630264|Mitosis Modulators|mitosis modulators|mesh-ancestor
25224931|NCT02630264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838369|NCT02197403|Anesthetics, General|anesthetics, general|mesh-ancestor
24838370|NCT02197403|Anesthetics|anesthetics|mesh-ancestor
24838376|NCT02197403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24838377|NCT02197403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24838378|NCT02197403|Adrenergic Agents|adrenergic agents|mesh-ancestor
24838379|NCT02197403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25101566|NCT03174041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680754|NCT01854658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25680755|NCT01854658|Autonomic Agents|autonomic agents|mesh-ancestor
25680756|NCT01854658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25680757|NCT01854658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680758|NCT01854658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25680759|NCT01854658|Respiratory System Agents|respiratory system agents|mesh-ancestor
25101567|NCT03174041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25101568|NCT03174041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25023433|NCT03654703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25101569|NCT03174041|Antimetabolites|antimetabolites|mesh-ancestor
25101570|NCT03174041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25101571|NCT03174041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25101572|NCT03174041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25101573|NCT03174041|Antifungal Agents|antifungal agents|mesh-ancestor
25101574|NCT03174041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25101575|NCT03174041|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25101576|NCT03174041|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25101577|NCT03174041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25101618|NCT03173417|Cyclophosphamide|cyclophosphamide|mesh-list
25101619|NCT03173417|Fludarabine|fludarabine|mesh-list
25101620|NCT03173417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25101621|NCT03173417|Immunologic Factors|immunologic factors|mesh-ancestor
25101622|NCT03173417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101623|NCT03173417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24415369|NCT00199329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25101671|NCT03172858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25101672|NCT03172858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101673|NCT03172871|Aripiprazole|aripiprazole|mesh-list
25101674|NCT03172871|Antidepressive Agents|antidepressive agents|mesh-ancestor
25101675|NCT03172871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25101676|NCT03172871|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25101677|NCT03172871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25101678|NCT03172871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25101679|NCT03172871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101680|NCT03172871|Dopamine Agonists|dopamine agonists|mesh-ancestor
25101681|NCT03172871|Dopamine Agents|dopamine agents|mesh-ancestor
25101682|NCT03172871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25101683|NCT03172871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101684|NCT03172871|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25101685|NCT03172871|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25101686|NCT03172871|Serotonin Agents|serotonin agents|mesh-ancestor
25101687|NCT03172871|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25101721|NCT03173092|Dexamethasone|dexamethasone|mesh-list
25101722|NCT03173092|Lenalidomide|lenalidomide|mesh-list
25101723|NCT03173092|Ixazomib|ixazomib|mesh-list
25101724|NCT03173092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25101725|NCT03173092|Antiemetics|antiemetics|mesh-ancestor
25224932|NCT02630264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25224933|NCT02630264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25224934|NCT02630264|Growth Substances|growth substances|mesh-ancestor
25224935|NCT02630264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224936|NCT02630264|Growth Inhibitors|growth inhibitors|mesh-ancestor
25224937|NCT02630290|Dexmedetomidine|dexmedetomidine|mesh-list
25224938|NCT02630290|Ropivacaine|ropivacaine|mesh-list
25224939|NCT02630290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25224940|NCT02630290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25224941|NCT02630290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224942|NCT02630290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25224943|NCT02630290|Analgesics|analgesics|mesh-ancestor
25224944|NCT02630290|Sensory System Agents|sensory system agents|mesh-ancestor
24838382|NCT02197442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25101726|NCT03173092|Autonomic Agents|autonomic agents|mesh-ancestor
25101727|NCT03173092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101728|NCT03173092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101729|NCT03173092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25101731|NCT03173092|Hormones|hormones|mesh-ancestor
25101732|NCT03173092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25101733|NCT03173092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25101734|NCT03173092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25101735|NCT03173092|Immunologic Factors|immunologic factors|mesh-ancestor
25101736|NCT03173092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25101737|NCT03173092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25101738|NCT03173092|Growth Substances|growth substances|mesh-ancestor
25101739|NCT03173092|Growth Inhibitors|growth inhibitors|mesh-ancestor
25101740|NCT03173092|Protease Inhibitors|protease inhibitors|mesh-ancestor
25101741|NCT03173092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25101742|NCT03173092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101743|NCT03173131|Analgesics, Opioid|analgesics, opioid|mesh-list
25101744|NCT03173131|Narcotics|narcotics|mesh-ancestor
25101745|NCT03173131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25101746|NCT03173131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101747|NCT03173131|Analgesics|analgesics|mesh-ancestor
25023453|NCT03654144|Contraceptive Agents|contraceptive agents|mesh-list
25023454|NCT03654144|Contraceptives, Oral|contraceptives, oral|mesh-list
25023455|NCT03654144|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25023456|NCT03654144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25023457|NCT03654144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023458|NCT03654144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25023459|NCT03654144|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24470370|NCT00389987|Tazobactam|tazobactam|mesh-list
24470396|NCT00390039|Morphine|morphine|mesh-list
24470406|NCT00390065|Autonomic Agents|autonomic agents|mesh-ancestor
24470407|NCT00390065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023493|NCT03654027|Docetaxel|docetaxel|mesh-list
25023494|NCT03654027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023495|NCT03654027|Tubulin Modulators|tubulin modulators|mesh-ancestor
25023496|NCT03654027|Antimitotic Agents|antimitotic agents|mesh-ancestor
25023497|NCT03654027|Mitosis Modulators|mitosis modulators|mesh-ancestor
25023498|NCT03654027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101748|NCT03173131|Sensory System Agents|sensory system agents|mesh-ancestor
25101749|NCT03173131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101762|NCT03172676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25101764|NCT03172793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25101765|NCT03172793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25101766|NCT03172741|Dronabinol|dronabinol|mesh-list
25101767|NCT03172741|Cannabidiol|cannabidiol|mesh-list
25101768|NCT03172741|Anticonvulsants|anticonvulsants|mesh-ancestor
25101769|NCT03172741|Hallucinogens|hallucinogens|mesh-ancestor
24571003|NCT00807755|Everolimus|everolimus|mesh-list
25101791|NCT03172299|Aflibercept|aflibercept|mesh-list
25101792|NCT03172299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25101793|NCT03172299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25101803|NCT03172533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25101804|NCT03172533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101805|NCT03172533|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25101806|NCT03172533|Contraceptive Agents|contraceptive agents|mesh-ancestor
25101807|NCT03172533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25101808|NCT03172533|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25101809|NCT03172533|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25101810|NCT03172533|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25101811|NCT03172533|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25101812|NCT03172533|Hormone Antagonists|hormone antagonists|mesh-ancestor
25101813|NCT03172533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25101814|NCT03172533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25101816|NCT03172234|Gabapentin|gabapentin|mesh-list
25101817|NCT03172234|Analgesics|analgesics|mesh-ancestor
25101818|NCT03172234|Sensory System Agents|sensory system agents|mesh-ancestor
25101819|NCT03172234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101820|NCT03172234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101821|NCT03172234|Anticonvulsants|anticonvulsants|mesh-ancestor
25101822|NCT03172234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25101823|NCT03172234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25101824|NCT03172234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25101825|NCT03172234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25101826|NCT03172234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25101827|NCT03172234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25101828|NCT03172234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24515283|NCT00596154|Procarbazine|procarbazine|mesh-list
25680760|NCT01854658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25680761|NCT01854658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25680762|NCT01854658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25680763|NCT01854658|Adrenergic Agents|adrenergic agents|mesh-ancestor
25680764|NCT01854658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25680765|NCT01854658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680766|NCT01854658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25680767|NCT01854658|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25680768|NCT01854658|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25680769|NCT01854658|Cholinergic Agents|cholinergic agents|mesh-ancestor
25680770|NCT01854697|Interferons|interferons|mesh-list
25680771|NCT01854697|Ribavirin|ribavirin|mesh-list
25680772|NCT01854697|Interferon-alpha|interferon-alpha|mesh-list
25680773|NCT01854697|Interferon alpha-2|interferon alpha-2|mesh-list
25680774|NCT01854697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25680775|NCT01854697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25680776|NCT01854697|Antiviral Agents|antiviral agents|mesh-ancestor
25680777|NCT01854697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25101855|NCT03171987|Sensory System Agents|sensory system agents|mesh-ancestor
24517607|NCT00608803|Doxorubicin|doxorubicin|mesh-list
25101856|NCT03171987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101857|NCT03171987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25101858|NCT03171987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25224945|NCT02630290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25224946|NCT02630290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25224947|NCT02630290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24838383|NCT02197442|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24838384|NCT02197442|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24838385|NCT02197442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101859|NCT03171987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25101860|NCT03171987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25101861|NCT03171987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101862|NCT03171987|Analgesics|analgesics|mesh-ancestor
25101863|NCT03171987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25101864|NCT03171987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25101865|NCT03171987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25101900|NCT03171831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25101901|NCT03171831|Immunologic Factors|immunologic factors|mesh-ancestor
25101902|NCT03171831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101903|NCT03171831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25101904|NCT03171831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25101905|NCT03171831|Alkylating Agents|alkylating agents|mesh-ancestor
25101906|NCT03171831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101907|NCT03171831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25101908|NCT03171831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25101909|NCT03171831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25101910|NCT03171831|Abortifacient Agents|abortifacient agents|mesh-ancestor
25101911|NCT03171831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25101912|NCT03171831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25101913|NCT03171831|Antimetabolites|antimetabolites|mesh-ancestor
25101914|NCT03171831|Dermatologic Agents|dermatologic agents|mesh-ancestor
25101915|NCT03171831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25101916|NCT03171831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25101917|NCT03171831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25101954|NCT03171740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25101955|NCT03171740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25101956|NCT03171740|Anesthetics, General|anesthetics, general|mesh-ancestor
25101958|NCT03171740|GABA Modulators|gaba modulators|mesh-ancestor
25101959|NCT03171740|GABA Agents|gaba agents|mesh-ancestor
25101960|NCT03171584|Itraconazole|itraconazole|mesh-list
25101961|NCT03171584|Fluconazole|fluconazole|mesh-list
25101962|NCT03171584|Terbinafine|terbinafine|mesh-list
25101963|NCT03171584|Antifungal Agents|antifungal agents|mesh-ancestor
25101964|NCT03171584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25101965|NCT03171584|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25101966|NCT03171584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25101967|NCT03171584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25101968|NCT03171584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101969|NCT03171584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25101970|NCT03171584|Hormone Antagonists|hormone antagonists|mesh-ancestor
25101971|NCT03171584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24988533|NCT02452554|Mitosis Modulators|mitosis modulators|mesh-ancestor
25107232|NCT03141632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101972|NCT03171584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101973|NCT03171584|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25101974|NCT03171584|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25101975|NCT03171584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25101976|NCT03171610|Fentanyl|fentanyl|mesh-list
25101977|NCT03171610|Sufentanil|sufentanil|mesh-list
25101978|NCT03171610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25101979|NCT03171610|Narcotics|narcotics|mesh-ancestor
25101980|NCT03171610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25101981|NCT03171610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101982|NCT03171610|Analgesics|analgesics|mesh-ancestor
24415824|NCT00201305|Antidotes|antidotes|mesh-ancestor
25101996|NCT03171389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101997|NCT03171090|Anesthetics|anesthetics|mesh-list
25101998|NCT03171090|Anesthetics, Local|anesthetics, local|mesh-list
25101999|NCT03171090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25405368|NCT03609580|Urological Agents|urological agents|mesh-ancestor
24471286|NCT00394394|Protease Inhibitors|protease inhibitors|mesh-ancestor
24471287|NCT00394394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24471288|NCT00394394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102000|NCT03171090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102001|NCT03171090|Sensory System Agents|sensory system agents|mesh-ancestor
25102002|NCT03171090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25102004|NCT03170895|Homoharringtonine|homoharringtonine|mesh-list
25224948|NCT02630290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25224949|NCT02630290|Adrenergic Agents|adrenergic agents|mesh-ancestor
25224950|NCT02630290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25224951|NCT02630290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224952|NCT02630290|Anesthetics, Local|anesthetics, local|mesh-ancestor
24838387|NCT02197494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24838388|NCT02197494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25043247|NCT01295060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25102005|NCT03170895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102006|NCT03170895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25102007|NCT03170895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102008|NCT03170895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102009|NCT03170895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25102010|NCT03170895|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25102011|NCT03171220|Cyclophosphamide|cyclophosphamide|mesh-list
24779483|NCT01876355|Sympatholytics|sympatholytics|mesh-ancestor
25102013|NCT03171220|Interleukin-2|interleukin-2|mesh-list
24779556|NCT01876849|Exenatide|exenatide|mesh-list
25102014|NCT03171220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25102015|NCT03171220|Immunologic Factors|immunologic factors|mesh-ancestor
25102016|NCT03171220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102017|NCT03171220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25102019|NCT03171220|Alkylating Agents|alkylating agents|mesh-ancestor
25102038|NCT03170713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102039|NCT03170713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102040|NCT03170596|Tazarotene|tazarotene|mesh-list
25102041|NCT03170596|Dermatologic Agents|dermatologic agents|mesh-ancestor
25102042|NCT03170596|Keratolytic Agents|keratolytic agents|mesh-ancestor
25102043|NCT03170687|Calpastatin|calpastatin|mesh-list
25102044|NCT03170687|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25102045|NCT03170687|Protease Inhibitors|protease inhibitors|mesh-ancestor
25102046|NCT03170687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102047|NCT03170687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102048|NCT03170726|Ibuprofen|ibuprofen|mesh-list
25102049|NCT03170726|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
25102050|NCT03170726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25102051|NCT03170726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25102052|NCT03170726|Analgesics|analgesics|mesh-ancestor
25102053|NCT03170726|Sensory System Agents|sensory system agents|mesh-ancestor
25102054|NCT03170726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25102055|NCT03170726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102056|NCT03170726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25102057|NCT03170726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25102058|NCT03170726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25102059|NCT03170726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102060|NCT03170726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102061|NCT03170739|Dopamine|dopamine|mesh-list
25102062|NCT03170739|Dexmedetomidine|dexmedetomidine|mesh-list
25102063|NCT03170739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25102064|NCT03170739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25102065|NCT03170739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102066|NCT03170739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25102067|NCT03170739|Analgesics|analgesics|mesh-ancestor
25102081|NCT03170310|Apatinib|apatinib|mesh-list
25102082|NCT03170310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102083|NCT03170310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25102084|NCT03170310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416103|NCT00202007|Dopamine Agonists|dopamine agonists|mesh-ancestor
25102096|NCT03170323|Dermatologic Agents|dermatologic agents|mesh-ancestor
24779712|NCT01878357|Primaquine|primaquine|mesh-list
25102135|NCT03170050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25102136|NCT03170050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102137|NCT03170115|Aspirin|aspirin|mesh-list
25102138|NCT03170115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25680778|NCT01854697|Antimetabolites|antimetabolites|mesh-ancestor
25680779|NCT01854697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680780|NCT01854697|Immunologic Factors|immunologic factors|mesh-ancestor
25102142|NCT03170115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25102143|NCT03170115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102145|NCT03170115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25102146|NCT03170115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25102147|NCT03170115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25102148|NCT03170115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102149|NCT03170115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25224953|NCT02630290|Anesthetics|anesthetics|mesh-ancestor
25224954|NCT02630160|Epinephrine|epinephrine|mesh-list
25224955|NCT02630160|Bupivacaine|bupivacaine|mesh-list
25224956|NCT02630160|Anesthetics, Local|anesthetics, local|mesh-ancestor
25043249|NCT01295060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043250|NCT01294202|Imatinib Mesylate|imatinib mesylate|mesh-list
25043251|NCT01294202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043252|NCT01294202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25043253|NCT01294202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043254|NCT01294202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043256|NCT01283594|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25043257|NCT01283594|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25043258|NCT01283594|Dopamine Agents|dopamine agents|mesh-ancestor
25102150|NCT03170115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25102151|NCT03170115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102152|NCT03170115|Antipyretics|antipyretics|mesh-ancestor
25102154|NCT03169959|Dapagliflozin|dapagliflozin|mesh-list
25102155|NCT03169959|Saxagliptin|saxagliptin|mesh-list
25102156|NCT03169959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25102157|NCT03169959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102158|NCT03169959|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25102159|NCT03169959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102182|NCT03169764|Cetuximab|cetuximab|mesh-list
25102183|NCT03169764|Fulvestrant|fulvestrant|mesh-list
25102184|NCT03169764|Avelumab|avelumab|mesh-list
25102185|NCT03169764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102186|NCT03169764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102187|NCT03169764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25102188|NCT03169764|Immunologic Factors|immunologic factors|mesh-ancestor
25102189|NCT03169764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102190|NCT03169764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25102191|NCT03169764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25102192|NCT03169764|Alkylating Agents|alkylating agents|mesh-ancestor
25102193|NCT03169764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25102194|NCT03169764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25102195|NCT03169764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25102196|NCT03169764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25102197|NCT03169764|Growth Substances|growth substances|mesh-ancestor
25102198|NCT03169764|Growth Inhibitors|growth inhibitors|mesh-ancestor
25102199|NCT03169764|Antimetabolites|antimetabolites|mesh-ancestor
25102200|NCT03169764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25102201|NCT03169764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25680781|NCT01854697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680782|NCT01854710|Moxifloxacin|moxifloxacin|mesh-list
25680783|NCT01854710|Loxapine|loxapine|mesh-list
25680784|NCT01854710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25680785|NCT01854710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25680786|NCT01854710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25680787|NCT01854710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25680788|NCT01854710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25680789|NCT01854710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680790|NCT01854710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102202|NCT03169764|Antidotes|antidotes|mesh-ancestor
25102203|NCT03169764|Protective Agents|protective agents|mesh-ancestor
25102204|NCT03169764|Vitamin B Complex|vitamin b complex|mesh-ancestor
25680791|NCT01854710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102206|NCT03169764|Micronutrients|micronutrients|mesh-ancestor
24416291|NCT00202618|Amlodipine|amlodipine|mesh-list
25102236|NCT03169738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25102237|NCT03169738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25102238|NCT03169738|Antidotes|antidotes|mesh-ancestor
25102239|NCT03169738|Protective Agents|protective agents|mesh-ancestor
25102240|NCT03169738|Vitamin B Complex|vitamin b complex|mesh-ancestor
25102241|NCT03169738|Vitamins|vitamins|mesh-ancestor
25102242|NCT03169738|Micronutrients|micronutrients|mesh-ancestor
25102243|NCT03169738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25102244|NCT03169738|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25102245|NCT03169738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25102246|NCT03169738|Hormone Antagonists|hormone antagonists|mesh-ancestor
25102247|NCT03169738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25102248|NCT03169725|Vaccines|vaccines|mesh-list
25102249|NCT03169725|Immunologic Factors|immunologic factors|mesh-ancestor
25102250|NCT03169725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102251|NCT03170479|Vitamin D|vitamin d|mesh-list
25102252|NCT03170479|Vitamins|vitamins|mesh-ancestor
25102253|NCT03170479|Micronutrients|micronutrients|mesh-ancestor
25102254|NCT03170479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102255|NCT03170479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25224957|NCT02630160|Anesthetics|anesthetics|mesh-ancestor
24862801|NCT04364997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24862802|NCT04364997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862803|NCT04364997|Analgesics|analgesics|mesh-ancestor
24862804|NCT04364997|Sensory System Agents|sensory system agents|mesh-ancestor
24988626|NCT02176668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988627|NCT02143063|Cocaine|cocaine|mesh-list
24926375|NCT04142749|Oltipraz|oltipraz|mesh-list
24988641|NCT02073097|Acyclovir|acyclovir|mesh-list
24988650|NCT02073097|Immunologic Factors|immunologic factors|mesh-ancestor
24988651|NCT02073097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988652|NCT02073097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24988653|NCT02073097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24988654|NCT02073097|Alkylating Agents|alkylating agents|mesh-ancestor
24988655|NCT02073097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988656|NCT02073097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988657|NCT02073097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24988658|NCT02073097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24988659|NCT02073097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24517632|NCT00608946|Copper|copper|mesh-list
25224958|NCT02630160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25224959|NCT02630160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224960|NCT02630160|Sensory System Agents|sensory system agents|mesh-ancestor
25224961|NCT02630160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25224962|NCT02630160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25224963|NCT02630160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25224964|NCT02630160|Adrenergic Agents|adrenergic agents|mesh-ancestor
25224965|NCT02630160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25043259|NCT01283594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25043260|NCT01283594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043261|NCT01283594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043262|NCT01281462|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
25043263|NCT01281462|Cephalosporins|cephalosporins|mesh-list
24999682|NCT03516214|Trametinib|trametinib|mesh-list
25043264|NCT01281462|Doripenem|doripenem|mesh-list
25043265|NCT01281462|Avibactam|avibactam|mesh-list
25043266|NCT01281462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25043267|NCT01281462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25102256|NCT03169933|Androgens|androgens|mesh-list
25102257|NCT03169933|Hormones|hormones|mesh-ancestor
25102258|NCT03169933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25102260|NCT03169790|Leucovorin|leucovorin|mesh-list
25102277|NCT03169790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102278|NCT03169790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25102279|NCT03169790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25102280|NCT03169790|Alkylating Agents|alkylating agents|mesh-ancestor
25102281|NCT03169790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25102282|NCT03169790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25102283|NCT03169790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25102284|NCT03169790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25680792|NCT01854710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25102285|NCT03169790|Growth Substances|growth substances|mesh-ancestor
25102286|NCT03169790|Growth Inhibitors|growth inhibitors|mesh-ancestor
25102287|NCT03169790|Antimetabolites|antimetabolites|mesh-ancestor
25102288|NCT03169790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25102289|NCT03169790|Antidotes|antidotes|mesh-ancestor
25102290|NCT03169790|Protective Agents|protective agents|mesh-ancestor
24517633|NCT00608946|Trace Elements|trace elements|mesh-ancestor
24517634|NCT00608946|Micronutrients|micronutrients|mesh-ancestor
25102291|NCT03169790|Vitamin B Complex|vitamin b complex|mesh-ancestor
25102293|NCT03169790|Micronutrients|micronutrients|mesh-ancestor
25102294|NCT03169660|Aflibercept|aflibercept|mesh-list
25102295|NCT03169660|Mitogens|mitogens|mesh-list
25102296|NCT03169660|Endothelial Growth Factors|endothelial growth factors|mesh-list
25102297|NCT03169660|Mitosis Modulators|mitosis modulators|mesh-ancestor
25102298|NCT03169660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102299|NCT03169660|Growth Substances|growth substances|mesh-ancestor
25102300|NCT03169660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102301|NCT03169660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25102302|NCT03169660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25102303|NCT03169660|Growth Inhibitors|growth inhibitors|mesh-ancestor
25102304|NCT03169660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519700|NCT05287360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102324|NCT03169777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24621005|NCT01060293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621006|NCT01060293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24621007|NCT01060293|Sympathomimetics|sympathomimetics|mesh-ancestor
25102336|NCT03169777|Micronutrients|micronutrients|mesh-ancestor
25102337|NCT03169777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25102338|NCT03169777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25102339|NCT03169777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25102340|NCT03169777|Hormone Antagonists|hormone antagonists|mesh-ancestor
25102341|NCT03169777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25102342|NCT03169582|Sildenafil Citrate|sildenafil citrate|mesh-list
25102343|NCT03169582|Vasodilator Agents|vasodilator agents|mesh-ancestor
25102344|NCT03169582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25102368|NCT03169504|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25102371|NCT03169504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102372|NCT03169504|Anticonvulsants|anticonvulsants|mesh-ancestor
25102374|NCT03169426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25102375|NCT03169426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25102376|NCT03169426|Adrenergic Agents|adrenergic agents|mesh-ancestor
25102377|NCT03169426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25224966|NCT02630160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224967|NCT02630160|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25224968|NCT02630160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25224969|NCT02630160|Autonomic Agents|autonomic agents|mesh-ancestor
25224970|NCT02630160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25224971|NCT02630160|Respiratory System Agents|respiratory system agents|mesh-ancestor
25224972|NCT02630160|Mydriatics|mydriatics|mesh-ancestor
25224973|NCT02630160|Sympathomimetics|sympathomimetics|mesh-ancestor
25224974|NCT02630160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25224975|NCT02630277|Aflibercept|aflibercept|mesh-list
25043268|NCT01281462|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25043269|NCT01281462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043270|NCT01281462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931035|NCT04094532|Sensory System Agents|sensory system agents|mesh-ancestor
24838389|NCT02197494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24838390|NCT02197494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838391|NCT02197598|Nalmefene|nalmefene|mesh-list
24838392|NCT02197598|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24838393|NCT02197598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838394|NCT02197598|Sensory System Agents|sensory system agents|mesh-ancestor
24838395|NCT02197598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838396|NCT02197637|Vinorelbine|vinorelbine|mesh-list
24838397|NCT02197637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24838398|NCT02197637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24838399|NCT02197637|Tubulin Modulators|tubulin modulators|mesh-ancestor
24838400|NCT02197637|Antimitotic Agents|antimitotic agents|mesh-ancestor
25102378|NCT03169426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102379|NCT03169426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102380|NCT03169426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25102381|NCT03169426|Antioxidants|antioxidants|mesh-ancestor
25102382|NCT03169426|Protective Agents|protective agents|mesh-ancestor
25102383|NCT03169426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24980401|NCT05303727|Dermatologic Agents|dermatologic agents|mesh-ancestor
24980402|NCT05303727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25023729|NCT03652233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471681|NCT00396513|Antimetabolites|antimetabolites|mesh-ancestor
25102384|NCT03169426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25102385|NCT03169426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25102386|NCT03169426|Vasodilator Agents|vasodilator agents|mesh-ancestor
25102387|NCT03169426|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25102388|NCT03169426|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25102389|NCT03169569|Hemostatics|hemostatics|mesh-list
25102417|NCT03169335|Growth Inhibitors|growth inhibitors|mesh-ancestor
25102418|NCT03169192|Zoledronic Acid|zoledronic acid|mesh-list
25102419|NCT03169192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25102420|NCT03169192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102421|NCT03168997|Memantine|memantine|mesh-list
25102422|NCT03168997|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25102423|NCT03168997|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25102424|NCT03168997|Dopamine Agents|dopamine agents|mesh-ancestor
25102425|NCT03168997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25102426|NCT03168997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102427|NCT03168997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102428|NCT03168997|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25102429|NCT03168997|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25102430|NCT03169114|Amikacin|amikacin|mesh-list
25102431|NCT03169114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25102432|NCT03169114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25102433|NCT03169127|Ibuprofen|ibuprofen|mesh-list
25102434|NCT03169127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25102435|NCT03169127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25102436|NCT03169127|Analgesics|analgesics|mesh-ancestor
24416821|NCT00204191|Immunologic Factors|immunologic factors|mesh-ancestor
25102458|NCT03168828|Trospium chloride|trospium chloride|mesh-list
25102459|NCT03168828|Parasympatholytics|parasympatholytics|mesh-ancestor
25102460|NCT03168828|Autonomic Agents|autonomic agents|mesh-ancestor
25102461|NCT03168828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25102462|NCT03168828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102463|NCT03168828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25102464|NCT03168828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25102465|NCT03168828|Cholinergic Agents|cholinergic agents|mesh-ancestor
25224976|NCT02630277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25224977|NCT02630277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25224978|NCT02630277|Growth Substances|growth substances|mesh-ancestor
25224979|NCT02630277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25224980|NCT02630277|Growth Inhibitors|growth inhibitors|mesh-ancestor
25224981|NCT02630277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25224983|NCT02630108|Ethiodized Oil|ethiodized oil|mesh-list
25224984|NCT02630108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25224985|NCT02630108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25224986|NCT02630108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25224987|NCT02630108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25224988|NCT02630108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25224989|NCT02630108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25224990|NCT02630121|Phenylephrine|phenylephrine|mesh-list
25224991|NCT02630121|Oxymetazoline|oxymetazoline|mesh-list
24838401|NCT02197637|Mitosis Modulators|mitosis modulators|mesh-ancestor
24838429|NCT02197884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24838430|NCT02197884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24838431|NCT02197884|Antifungal Agents|antifungal agents|mesh-ancestor
24838432|NCT02197884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24838433|NCT02197884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24838434|NCT02197884|Hormone Antagonists|hormone antagonists|mesh-ancestor
24838435|NCT02197884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24838436|NCT02197884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838437|NCT02197988|Fentanyl|fentanyl|mesh-list
24838438|NCT02197988|Bupivacaine|bupivacaine|mesh-list
25102466|NCT03168828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25102467|NCT03168828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102468|NCT03168828|Urological Agents|urological agents|mesh-ancestor
25102469|NCT03168698|Oxytocin|oxytocin|mesh-list
25102470|NCT03168698|Carbetocin|carbetocin|mesh-list
25680793|NCT01854710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25680794|NCT01854710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25680795|NCT01854710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25680796|NCT01854710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25023813|NCT03651661|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25023814|NCT03651661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25023815|NCT03651661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023816|NCT03651557|Salicylates|salicylates|mesh-list
25023817|NCT03651557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25023818|NCT03651557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25023819|NCT03651557|Analgesics|analgesics|mesh-ancestor
25102471|NCT03168698|Oxytocics|oxytocics|mesh-ancestor
25102472|NCT03168698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25102473|NCT03168698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102474|NCT03168594|Cisplatin|cisplatin|mesh-list
25102475|NCT03168594|Irinotecan|irinotecan|mesh-list
25102476|NCT03168594|Etoposide|etoposide|mesh-list
25102477|NCT03168594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102478|NCT03168594|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25102479|NCT03168594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25102480|NCT03168594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102481|NCT03168594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102482|NCT03168594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25102483|NCT03168594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25102484|NCT03168568|Valsartan|valsartan|mesh-list
25102485|NCT03168568|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25102486|NCT03168568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25102487|NCT03168568|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25102499|NCT03168191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25102500|NCT03168191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102501|NCT03168191|Antipruritics|antipruritics|mesh-ancestor
25102502|NCT03168191|Dermatologic Agents|dermatologic agents|mesh-ancestor
25102503|NCT03168178|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25102504|NCT03168178|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25102505|NCT03168178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25102506|NCT03168178|Antitubercular Agents|antitubercular agents|mesh-ancestor
25102507|NCT03168412|Vaccines|vaccines|mesh-list
25102508|NCT03168412|Immunologic Factors|immunologic factors|mesh-ancestor
25102509|NCT03168412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102510|NCT03168139|Pembrolizumab|pembrolizumab|mesh-list
25102511|NCT03168139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25102512|NCT03168139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102513|NCT03168074|Lenvatinib|lenvatinib|mesh-list
25102514|NCT03168074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102515|NCT03168074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25102527|NCT03168100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25102528|NCT03168100|Antiemetics|antiemetics|mesh-ancestor
25102529|NCT03168100|Autonomic Agents|autonomic agents|mesh-ancestor
25102530|NCT03168100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25102531|NCT03168100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102532|NCT03168100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25102534|NCT03168100|Hormones|hormones|mesh-ancestor
25225002|NCT02630121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24838439|NCT02197988|Anesthetics, Local|anesthetics, local|mesh-ancestor
24838443|NCT02197988|Sensory System Agents|sensory system agents|mesh-ancestor
24838444|NCT02197988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838445|NCT02197988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24838446|NCT02197988|Narcotics|narcotics|mesh-ancestor
24838447|NCT02197988|Analgesics|analgesics|mesh-ancestor
24838448|NCT02197988|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24838449|NCT02197988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24838450|NCT02197988|Anesthetics, General|anesthetics, general|mesh-ancestor
24838451|NCT02198001|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24838452|NCT02198001|Amoxicillin|amoxicillin|mesh-list
24838501|NCT02198261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24838502|NCT02198261|Vasodilator Agents|vasodilator agents|mesh-ancestor
24838504|NCT02198300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25056629|NCT03510611|Ensartinib|ensartinib|mesh-list
25102536|NCT03168100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25102537|NCT03168100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102538|NCT03168100|Immunologic Factors|immunologic factors|mesh-ancestor
25102539|NCT03168100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25102540|NCT03168100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25680797|NCT01854710|Dopamine Agents|dopamine agents|mesh-ancestor
25680798|NCT01854710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25680799|NCT01854827|Immunoglobulins|immunoglobulins|mesh-list
25680800|NCT01854827|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25680801|NCT01854827|Antibodies|antibodies|mesh-list
25680802|NCT01854827|gamma-Globulins|gamma-globulins|mesh-list
25680803|NCT01854827|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25680804|NCT01854827|Immunologic Factors|immunologic factors|mesh-ancestor
24472076|NCT00398008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25102541|NCT03168100|Growth Substances|growth substances|mesh-ancestor
25102542|NCT03168100|Growth Inhibitors|growth inhibitors|mesh-ancestor
25102543|NCT03167918|Calcium, Dietary|calcium, dietary|mesh-list
25102544|NCT03167918|Metformin|metformin|mesh-list
25102545|NCT03167918|Calcium Dobesilate|calcium dobesilate|mesh-list
25102546|NCT03167918|Calcium|calcium|mesh-list
25102547|NCT03167918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25102548|NCT03167918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102549|NCT03167918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25102550|NCT03167918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25102551|NCT03167918|Hemostatics|hemostatics|mesh-ancestor
25102552|NCT03167918|Coagulants|coagulants|mesh-ancestor
24988756|NCT00867178|Vorinostat|vorinostat|mesh-list
25225003|NCT02630121|Respiratory System Agents|respiratory system agents|mesh-ancestor
25225004|NCT02630121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25225005|NCT02630121|Mydriatics|mydriatics|mesh-ancestor
25102897|NCT03165344|Antacids|antacids|mesh-ancestor
25225008|NCT02630095|Nadroparin|nadroparin|mesh-list
25225009|NCT02630095|Warfarin|warfarin|mesh-list
25225010|NCT02630095|Calcium|calcium|mesh-list
25225011|NCT02630095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25225012|NCT02630095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225013|NCT02630095|Anticoagulants|anticoagulants|mesh-ancestor
25225014|NCT02630095|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25225015|NCT02630095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25225016|NCT02630095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225017|NCT02630004|Melatonin|melatonin|mesh-list
25225018|NCT02630004|Antioxidants|antioxidants|mesh-ancestor
25225019|NCT02630004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225020|NCT02630004|Protective Agents|protective agents|mesh-ancestor
25225021|NCT02630004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225022|NCT02630004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25225023|NCT02629848|Paclitaxel|paclitaxel|mesh-list
24838505|NCT02198300|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24838506|NCT02198300|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24838507|NCT02198300|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24838508|NCT02198300|Purinergic Agents|purinergic agents|mesh-ancestor
24838509|NCT02198300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24838510|NCT02198300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838511|NCT02198300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838512|NCT02198378|Acetaminophen|acetaminophen|mesh-list
24838513|NCT02198378|Morphine|morphine|mesh-list
24838514|NCT02198378|Entonox|entonox|mesh-list
24838515|NCT02198378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24838516|NCT02198378|Narcotics|narcotics|mesh-ancestor
24838517|NCT02198378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24414434|NCT00197587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24414435|NCT00197587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24414436|NCT00197587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25102574|NCT03167957|Amphotericin B|amphotericin b|mesh-list
25102575|NCT03167957|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25102576|NCT03167957|Amebicides|amebicides|mesh-ancestor
25102577|NCT03167957|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25102578|NCT03167957|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25102628|NCT03167216|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
25102630|NCT03167216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25102631|NCT03167216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25102632|NCT03167216|Respiratory System Agents|respiratory system agents|mesh-ancestor
25102633|NCT03166956|Ascorbic Acid|ascorbic acid|mesh-list
25102635|NCT03166956|Micronutrients|micronutrients|mesh-ancestor
25102636|NCT03166956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102637|NCT03166956|Antioxidants|antioxidants|mesh-ancestor
25102638|NCT03166956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102639|NCT03166956|Protective Agents|protective agents|mesh-ancestor
25102640|NCT03167164|Leucovorin|leucovorin|mesh-list
25102641|NCT03167164|Paclitaxel|paclitaxel|mesh-list
25102642|NCT03167164|Cyclophosphamide|cyclophosphamide|mesh-list
25102643|NCT03167164|Bevacizumab|bevacizumab|mesh-list
25102644|NCT03167164|Fluorouracil|fluorouracil|mesh-list
25680805|NCT01854827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680806|NCT01854918|Evolocumab|evolocumab|mesh-list
25102645|NCT03167164|Capecitabine|capecitabine|mesh-list
25102646|NCT03167164|Avelumab|avelumab|mesh-list
25102647|NCT03167164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25102648|NCT03167164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102649|NCT03167164|Tubulin Modulators|tubulin modulators|mesh-ancestor
25102650|NCT03167164|Antimitotic Agents|antimitotic agents|mesh-ancestor
25023997|NCT03649711|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25023998|NCT03649711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25023999|NCT03649711|Antipyretics|antipyretics|mesh-ancestor
25024000|NCT03649711|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25024001|NCT03649711|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25024002|NCT03649711|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25024003|NCT03649711|Purinergic Agents|purinergic agents|mesh-ancestor
25024004|NCT03649711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25024009|NCT03649464|Antineoplastic Agents|antineoplastic agents|mesh-list
25112167|NCT04335201|Defibrotide|defibrotide|mesh-list
25102651|NCT03167164|Mitosis Modulators|mitosis modulators|mesh-ancestor
25102652|NCT03167164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102653|NCT03167164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25102654|NCT03167164|Immunologic Factors|immunologic factors|mesh-ancestor
25102655|NCT03167164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102656|NCT03167164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25102657|NCT03167164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25102675|NCT03166891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102676|NCT03166891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102677|NCT03167112|Leucovorin|leucovorin|mesh-list
25102678|NCT03167112|Fluorouracil|fluorouracil|mesh-list
25102679|NCT03167112|Oxaliplatin|oxaliplatin|mesh-list
25102680|NCT03167112|Irinotecan|irinotecan|mesh-list
25102681|NCT03167112|Antimetabolites|antimetabolites|mesh-ancestor
25102682|NCT03167112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102683|NCT03167112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25102684|NCT03167112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102685|NCT03167112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25225024|NCT02629848|Carboplatin|carboplatin|mesh-list
25225025|NCT02629848|Motesanib diphosphate|motesanib diphosphate|mesh-list
25225026|NCT02629848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25225027|NCT02629848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225028|NCT02629848|Tubulin Modulators|tubulin modulators|mesh-ancestor
25225029|NCT02629848|Antimitotic Agents|antimitotic agents|mesh-ancestor
25225030|NCT02629848|Mitosis Modulators|mitosis modulators|mesh-ancestor
25225031|NCT02629848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225032|NCT02629848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25225033|NCT02629848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225034|NCT02629835|Dexamethasone|dexamethasone|mesh-list
25225035|NCT02629835|Dexamethasone acetate|dexamethasone acetate|mesh-list
25225036|NCT02629835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25225037|NCT02629835|BB 1101|bb 1101|mesh-list
24838518|NCT02198378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838547|NCT02198443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838549|NCT02198443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24838550|NCT02198443|Antiviral Agents|antiviral agents|mesh-ancestor
24838551|NCT02198443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24838552|NCT02198443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25102686|NCT03167112|Immunologic Factors|immunologic factors|mesh-ancestor
25102687|NCT03167112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102688|NCT03167112|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25102689|NCT03167112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25102690|NCT03167112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102691|NCT03167112|Antidotes|antidotes|mesh-ancestor
25102702|NCT03167034|Natriuretic Agents|natriuretic agents|mesh-ancestor
25102703|NCT03167034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102704|NCT03167177|Leucovorin|leucovorin|mesh-list
25102705|NCT03167177|Paclitaxel|paclitaxel|mesh-list
25102706|NCT03167177|Cyclophosphamide|cyclophosphamide|mesh-list
25102707|NCT03167177|Bevacizumab|bevacizumab|mesh-list
25102708|NCT03167177|Fluorouracil|fluorouracil|mesh-list
25102709|NCT03167177|Capecitabine|capecitabine|mesh-list
25102710|NCT03167177|Nivolumab|nivolumab|mesh-list
25102711|NCT03167177|Avelumab|avelumab|mesh-list
25102712|NCT03167177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25680807|NCT01854918|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25680808|NCT01854918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25680809|NCT01854918|Antimetabolites|antimetabolites|mesh-ancestor
25680810|NCT01854918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680811|NCT01854918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25680812|NCT01854944|Brexpiprazole|brexpiprazole|mesh-list
25680813|NCT01854944|Serotonin Agents|serotonin agents|mesh-ancestor
25680814|NCT01854944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25680815|NCT01854944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680816|NCT01854944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102713|NCT03167177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25024067|NCT03649009|Hydrocortisone|hydrocortisone|mesh-list
25024068|NCT03649009|Metoclopramide|metoclopramide|mesh-list
25024069|NCT03649009|Vitamins|vitamins|mesh-ancestor
25024070|NCT03649009|Micronutrients|micronutrients|mesh-ancestor
25024071|NCT03649009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024072|NCT03649009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25024073|NCT03649009|Vitamin B Complex|vitamin b complex|mesh-ancestor
25024074|NCT03649009|Antiemetics|antiemetics|mesh-ancestor
25024075|NCT03649009|Autonomic Agents|autonomic agents|mesh-ancestor
24414437|NCT00197587|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25102714|NCT03167177|Tubulin Modulators|tubulin modulators|mesh-ancestor
25102715|NCT03167177|Antimitotic Agents|antimitotic agents|mesh-ancestor
25102716|NCT03167177|Mitosis Modulators|mitosis modulators|mesh-ancestor
25102717|NCT03167177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102718|NCT03167177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25102719|NCT03167177|Immunologic Factors|immunologic factors|mesh-ancestor
25102720|NCT03167177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102721|NCT03167177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25102722|NCT03167177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25102723|NCT03167177|Alkylating Agents|alkylating agents|mesh-ancestor
25102724|NCT03167177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25102725|NCT03167177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25102726|NCT03167177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25102727|NCT03167177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25102728|NCT03167177|Growth Substances|growth substances|mesh-ancestor
25102729|NCT03167177|Growth Inhibitors|growth inhibitors|mesh-ancestor
25102731|NCT03167177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25102732|NCT03167177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25102733|NCT03167177|Antidotes|antidotes|mesh-ancestor
25102734|NCT03167177|Protective Agents|protective agents|mesh-ancestor
25102735|NCT03167177|Vitamin B Complex|vitamin b complex|mesh-ancestor
25102736|NCT03167177|Vitamins|vitamins|mesh-ancestor
25102737|NCT03167177|Micronutrients|micronutrients|mesh-ancestor
25102766|NCT03166787|Vasodilator Agents|vasodilator agents|mesh-ancestor
25102767|NCT03166787|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25102768|NCT03166787|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25102769|NCT03166787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102770|NCT03166787|Urological Agents|urological agents|mesh-ancestor
25102771|NCT03166787|Antidotes|antidotes|mesh-ancestor
25102772|NCT03166787|Antimetabolites|antimetabolites|mesh-ancestor
25102773|NCT03166787|Gasotransmitters|gasotransmitters|mesh-ancestor
25102774|NCT03166787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25102775|NCT03166254|Pembrolizumab|pembrolizumab|mesh-list
25102777|NCT03166254|Poly ICLC|poly iclc|mesh-list
25102778|NCT03166254|Immunologic Factors|immunologic factors|mesh-ancestor
25103068|NCT03164512|Anticonvulsants|anticonvulsants|mesh-ancestor
25102781|NCT03166254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102782|NCT03166254|Interferon Inducers|interferon inducers|mesh-ancestor
25102783|NCT03166306|Bevacizumab|bevacizumab|mesh-list
25102784|NCT03166306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25102785|NCT03166306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102786|NCT03166306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25225038|NCT02629835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25225039|NCT02629835|Antiemetics|antiemetics|mesh-ancestor
25225040|NCT02629835|Autonomic Agents|autonomic agents|mesh-ancestor
25225041|NCT02629835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25225042|NCT02629835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225043|NCT02629835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25225044|NCT02629835|Glucocorticoids|glucocorticoids|mesh-ancestor
25225045|NCT02629835|Hormones|hormones|mesh-ancestor
24838553|NCT02198443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24838554|NCT02198443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24838555|NCT02198443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24838556|NCT02198443|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24838557|NCT02198469|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
25680817|NCT01854944|Dopamine Agonists|dopamine agonists|mesh-ancestor
25680818|NCT01854944|Dopamine Agents|dopamine agents|mesh-ancestor
25680819|NCT01855074|Risperidone|risperidone|mesh-list
25680820|NCT01855074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25680821|NCT01855074|Serotonin Agents|serotonin agents|mesh-ancestor
25680822|NCT01855074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25680823|NCT01855074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680824|NCT01855074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838558|NCT02198469|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25102787|NCT03166306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24780345|NCT01883882|Analgesics, Opioid|analgesics, opioid|mesh-list
25102788|NCT03166306|Growth Substances|growth substances|mesh-ancestor
25102826|NCT03166111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25102827|NCT03166111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25102828|NCT03166111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25102829|NCT03166111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24988869|NCT05193227|Sensory System Agents|sensory system agents|mesh-ancestor
25102830|NCT03166111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102831|NCT03165890|Acetazolamide|acetazolamide|mesh-list
25102832|NCT03165890|Anticonvulsants|anticonvulsants|mesh-ancestor
25102833|NCT03165890|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25102834|NCT03165890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102835|NCT03165890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102836|NCT03165890|Diuretics|diuretics|mesh-ancestor
25102837|NCT03165890|Natriuretic Agents|natriuretic agents|mesh-ancestor
25102838|NCT03165890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102864|NCT03165825|Autonomic Agents|autonomic agents|mesh-ancestor
25102865|NCT03165825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25102866|NCT03165825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102868|NCT03165825|Glucocorticoids|glucocorticoids|mesh-ancestor
25102869|NCT03165825|Hormones|hormones|mesh-ancestor
25102870|NCT03165825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25102871|NCT03165825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25102872|NCT03165825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102873|NCT03165825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25102874|NCT03165825|Respiratory System Agents|respiratory system agents|mesh-ancestor
25102875|NCT03165344|Prednisone|prednisone|mesh-list
25102876|NCT03165344|Triamcinolone|triamcinolone|mesh-list
25102877|NCT03165344|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25102878|NCT03165344|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25102879|NCT03165344|Hydrocortisone|hydrocortisone|mesh-list
25102880|NCT03165344|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25102881|NCT03165344|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25102882|NCT03165344|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25102883|NCT03165344|Aluminum phosphate|aluminum phosphate|mesh-list
25102884|NCT03165344|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25102885|NCT03165344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25102886|NCT03165344|Glucocorticoids|glucocorticoids|mesh-ancestor
25102887|NCT03165344|Hormones|hormones|mesh-ancestor
25102888|NCT03165344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25102889|NCT03165344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102890|NCT03165344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25102891|NCT03165344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102892|NCT03165344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25102893|NCT03165344|Immunologic Factors|immunologic factors|mesh-ancestor
25102894|NCT03165344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102895|NCT03165344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102896|NCT03165344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25102898|NCT03165344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25102904|NCT03165383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102905|NCT03165383|Sensory System Agents|sensory system agents|mesh-ancestor
25102906|NCT03165383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25102907|NCT03165383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25102908|NCT03165383|Narcotics|narcotics|mesh-ancestor
25102909|NCT03165383|Analgesics|analgesics|mesh-ancestor
25102918|NCT03165500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25225046|NCT02629835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25225047|NCT02629835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25225048|NCT02629835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225049|NCT02629835|Protease Inhibitors|protease inhibitors|mesh-ancestor
25225050|NCT02629835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225051|NCT02629835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838559|NCT02198469|Dermatologic Agents|dermatologic agents|mesh-ancestor
24838560|NCT02198482|Cytarabine|cytarabine|mesh-list
24838561|NCT02198482|Daunorubicin|daunorubicin|mesh-list
24838563|NCT02198482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24838564|NCT02198482|Antimetabolites|antimetabolites|mesh-ancestor
24838567|NCT02198482|Antiviral Agents|antiviral agents|mesh-ancestor
24838582|NCT02198508|Deferiprone|deferiprone|mesh-list
24838583|NCT02198508|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24838584|NCT02198508|Chelating Agents|chelating agents|mesh-ancestor
24838585|NCT02198508|Sequestering Agents|sequestering agents|mesh-ancestor
24838590|NCT02198547|Anesthetics|anesthetics|mesh-ancestor
24838591|NCT02198547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24838592|NCT02198547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024290|NCT03647579|Anesthetics|anesthetics|mesh-ancestor
24838593|NCT02198547|Sensory System Agents|sensory system agents|mesh-ancestor
24838594|NCT02198547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838595|NCT02198547|Analgesics|analgesics|mesh-ancestor
24838596|NCT02198547|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24838597|NCT02198547|Anticonvulsants|anticonvulsants|mesh-ancestor
24838598|NCT02198547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24838599|NCT02198547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24838600|NCT02198547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838601|NCT02198547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25102919|NCT03165500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102921|NCT03165500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25102922|NCT03165500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25102923|NCT03165500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25102924|NCT03165500|Anesthetics, General|anesthetics, general|mesh-ancestor
25102925|NCT03165500|Anesthetics|anesthetics|mesh-ancestor
25102926|NCT03165500|GABA Modulators|gaba modulators|mesh-ancestor
25102927|NCT03165500|GABA Agents|gaba agents|mesh-ancestor
25103061|NCT03164590|Anesthetics, General|anesthetics, general|mesh-ancestor
25102928|NCT03165500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25102929|NCT03165500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102930|NCT03165500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25102931|NCT03165500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25102954|NCT03165253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25102955|NCT03165253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25102956|NCT03165253|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25102957|NCT03165253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25102958|NCT03165253|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25102959|NCT03165253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102960|NCT03165253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102961|NCT03165253|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25102962|NCT03165253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25102963|NCT03165253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25102965|NCT03165123|Dexamethasone|dexamethasone|mesh-list
25102966|NCT03165123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25102967|NCT03165123|Antiemetics|antiemetics|mesh-ancestor
25102968|NCT03165123|Autonomic Agents|autonomic agents|mesh-ancestor
25102969|NCT03165123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25102970|NCT03165123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102971|NCT03165123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25102973|NCT03165123|Hormones|hormones|mesh-ancestor
24988914|NCT05191888|Amoxicillin|amoxicillin|mesh-list
25225052|NCT02629770|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25225053|NCT02629770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25225054|NCT02629744|Etrolizumab|etrolizumab|mesh-list
25225055|NCT02629744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25225056|NCT02629744|Immunologic Factors|immunologic factors|mesh-ancestor
25225057|NCT02629744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225058|NCT02629718|Paclitaxel|paclitaxel|mesh-list
25225059|NCT02629718|Carboplatin|carboplatin|mesh-list
25225071|NCT02629536|Respiratory System Agents|respiratory system agents|mesh-ancestor
25225072|NCT02629536|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25225074|NCT02629536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838602|NCT02198547|Tocolytic Agents|tocolytic agents|mesh-ancestor
24838603|NCT02198547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24838604|NCT02198807|Piperaquine|piperaquine|mesh-list
24838605|NCT02198807|Fosmidomycin|fosmidomycin|mesh-list
24838606|NCT02198807|Antimalarials|antimalarials|mesh-ancestor
24838607|NCT02198807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24838608|NCT02198807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24838609|NCT02198807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24838610|NCT02198807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24838611|NCT02198820|Anesthetics|anesthetics|mesh-list
24838612|NCT02198820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24838613|NCT02198820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838614|NCT02198846|Insulin|insulin|mesh-list
24838615|NCT02198846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25103020|NCT03165409|Nivolumab|nivolumab|mesh-list
25103021|NCT03165409|Ipilimumab|ipilimumab|mesh-list
25103022|NCT03165409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25103023|NCT03165409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25103024|NCT03165409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25405369|NCT03609216|Gemcitabine|gemcitabine|mesh-list
25680825|NCT01855074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25024374|NCT03646526|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25103025|NCT03165409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103027|NCT03164837|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25103028|NCT03164837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103032|NCT03164694|Carboplatin|carboplatin|mesh-list
25103033|NCT03164694|Pemetrexed|pemetrexed|mesh-list
25103034|NCT03164694|Apatinib|apatinib|mesh-list
25103035|NCT03164694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25103052|NCT03164590|Analgesics|analgesics|mesh-ancestor
25103053|NCT03164590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25103054|NCT03164590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25103055|NCT03164590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25103056|NCT03164590|Adrenergic Agents|adrenergic agents|mesh-ancestor
25103057|NCT03164590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24780643|NCT01885481|Dexamethasone|dexamethasone|mesh-list
24780707|NCT01886001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25103058|NCT03164590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103059|NCT03164590|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25103060|NCT03164590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25103063|NCT03164590|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25103065|NCT03164668|Antipruritics|antipruritics|mesh-ancestor
25103066|NCT03164668|Dermatologic Agents|dermatologic agents|mesh-ancestor
25103069|NCT03164421|Acetylcysteine|acetylcysteine|mesh-list
25103070|NCT03164421|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25103071|NCT03164421|Antiviral Agents|antiviral agents|mesh-ancestor
25103072|NCT03164421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25225075|NCT02629536|Protective Agents|protective agents|mesh-ancestor
25225076|NCT02629536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225077|NCT02629536|Antidotes|antidotes|mesh-ancestor
25225078|NCT02629523|Afatinib|afatinib|mesh-list
25225079|NCT02629523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225080|NCT02629523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25225081|NCT02629523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225082|NCT02629523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225083|NCT02629627|Metformin|metformin|mesh-list
25225084|NCT02629627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25225085|NCT02629627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273280|NCT02386475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25273281|NCT02386475|Antidepressive Agents|antidepressive agents|mesh-ancestor
24838616|NCT02198846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838618|NCT02198859|Antidepressive Agents|antidepressive agents|mesh-ancestor
24838619|NCT02198859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24838620|NCT02198859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24838621|NCT02198859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838622|NCT02198859|Antimanic Agents|antimanic agents|mesh-ancestor
25103073|NCT03164421|Expectorants|expectorants|mesh-ancestor
25103074|NCT03164421|Respiratory System Agents|respiratory system agents|mesh-ancestor
25103075|NCT03164421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25103095|NCT03164304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25103096|NCT03164382|Sorafenib|sorafenib|mesh-list
25103097|NCT03164382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25103098|NCT03164382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25103099|NCT03164382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25103100|NCT03164382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103101|NCT03164291|Rifabutin|rifabutin|mesh-list
25103102|NCT03164291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25103103|NCT03164291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25103104|NCT03164291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25103105|NCT03164291|Antitubercular Agents|antitubercular agents|mesh-ancestor
25103106|NCT03164096|Bupivacaine|bupivacaine|mesh-list
25103107|NCT03164096|Anesthetics, Local|anesthetics, local|mesh-ancestor
25103108|NCT03164096|Anesthetics|anesthetics|mesh-ancestor
25103109|NCT03164096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25103110|NCT03164096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103111|NCT03164096|Sensory System Agents|sensory system agents|mesh-ancestor
25103112|NCT03164096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25103113|NCT03164109|Moxifloxacin|moxifloxacin|mesh-list
25103114|NCT03164109|Avasopasem manganese|avasopasem manganese|mesh-list
25103115|NCT03164109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25103116|NCT03164109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25103117|NCT03164109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25680826|NCT01855074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25103118|NCT03164109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24719885|NCT01564680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024437|NCT03646006|Anesthetics, Local|anesthetics, local|mesh-ancestor
25024439|NCT03646006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25024443|NCT03645980|Sorafenib|sorafenib|mesh-list
25103119|NCT03164109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25103120|NCT03164109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103121|NCT03164109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25103122|NCT03164109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103123|NCT03164109|Antioxidants|antioxidants|mesh-ancestor
25103124|NCT03164109|Protective Agents|protective agents|mesh-ancestor
25103125|NCT03164018|4-Aminopyridine|4-aminopyridine|mesh-list
25103126|NCT03164018|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25103127|NCT03164018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24780709|NCT01886001|Disinfectants|disinfectants|mesh-ancestor
24523924|NCT05338502|Histamine Antagonists|histamine antagonists|mesh-ancestor
25103134|NCT03163914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25103135|NCT03163914|Adrenergic Agents|adrenergic agents|mesh-ancestor
25103149|NCT03163914|Nasal Decongestants|nasal decongestants|mesh-ancestor
25103150|NCT03163914|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25103151|NCT03163914|Protective Agents|protective agents|mesh-ancestor
25103152|NCT03163693|Dexmedetomidine|dexmedetomidine|mesh-list
25103153|NCT03163693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25103154|NCT03163693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25103155|NCT03163693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103156|NCT03163693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25103157|NCT03163693|Analgesics|analgesics|mesh-ancestor
24524172|NCT05206110|Analgesics|analgesics|mesh-ancestor
25103182|NCT03164161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103184|NCT03163849|Antiviral Agents|antiviral agents|mesh-ancestor
25103185|NCT03163849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25103186|NCT03163966|Methotrexate|methotrexate|mesh-list
25103187|NCT03163966|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25103188|NCT03163966|Abortifacient Agents|abortifacient agents|mesh-ancestor
25225086|NCT02629575|Sirolimus|sirolimus|mesh-list
25225087|NCT02629575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25225088|NCT02629575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25225089|NCT02629575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25225090|NCT02629575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225091|NCT02629575|Antifungal Agents|antifungal agents|mesh-ancestor
25225092|NCT02629575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25225093|NCT02629575|Immunologic Factors|immunologic factors|mesh-ancestor
24838623|NCT02198859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24838624|NCT02198859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24838625|NCT02198859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103189|NCT03163966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25103190|NCT03163966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103191|NCT03163966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25103192|NCT03163966|Antimetabolites|antimetabolites|mesh-ancestor
25103193|NCT03163966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103194|NCT03163966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25103195|NCT03163966|Dermatologic Agents|dermatologic agents|mesh-ancestor
25103196|NCT03163966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25103197|NCT03163966|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25103198|NCT03163966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25103199|NCT03163966|Immunologic Factors|immunologic factors|mesh-ancestor
25103200|NCT03163966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25103201|NCT03163966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25103202|NCT03163589|Epoetin Alfa|epoetin alfa|mesh-list
25103203|NCT03163589|Hematinics|hematinics|mesh-ancestor
25103204|NCT03163277|Emtricitabine|emtricitabine|mesh-list
25103227|NCT03163238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25103228|NCT03163238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103229|NCT03163238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25103230|NCT03163238|Analgesics|analgesics|mesh-ancestor
25103231|NCT03163238|Sensory System Agents|sensory system agents|mesh-ancestor
25103232|NCT03163238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25103233|NCT03163238|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25103234|NCT03163238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25103235|NCT03163238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25680827|NCT01855074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25680828|NCT01855074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25680829|NCT01855074|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25680830|NCT01855074|Dopamine Agents|dopamine agents|mesh-ancestor
25680831|NCT01855243|Insulin|insulin|mesh-list
25103236|NCT03163238|Adrenergic Agents|adrenergic agents|mesh-ancestor
25103237|NCT03163238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25103238|NCT03163238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103239|NCT03163420|Diclofenac|diclofenac|mesh-list
25103241|NCT03163420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25103284|NCT03163212|Lactoferrin|lactoferrin|mesh-list
25103292|NCT03162861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25103293|NCT03162861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103295|NCT03162861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25103296|NCT03162861|Anesthetics, General|anesthetics, general|mesh-ancestor
25103297|NCT03162861|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25103298|NCT03162861|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25103299|NCT03162653|Allopurinol|allopurinol|mesh-list
25103300|NCT03162653|Mannitol|mannitol|mesh-list
25103301|NCT03162653|Antimetabolites|antimetabolites|mesh-ancestor
25103303|NCT03162653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25103344|NCT03162562|Poly ICLC|poly iclc|mesh-list
25103345|NCT03162562|Interferon Inducers|interferon inducers|mesh-ancestor
25103346|NCT03162562|Immunologic Factors|immunologic factors|mesh-ancestor
25103347|NCT03162562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103348|NCT03162562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25103349|NCT03162562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25103350|NCT03162367|Sulfadiazine|sulfadiazine|mesh-list
25103351|NCT03162367|Silver Sulfadiazine|silver sulfadiazine|mesh-list
25103352|NCT03162367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25103353|NCT03162367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25103354|NCT03162367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25103355|NCT03162367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25103356|NCT03162367|Coccidiostats|coccidiostats|mesh-ancestor
25103364|NCT03162185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25103365|NCT03162185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103366|NCT03162185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25225094|NCT02629575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225095|NCT02629224|Gabapentin|gabapentin|mesh-list
25225096|NCT02629224|Analgesics|analgesics|mesh-ancestor
25225097|NCT02629224|Sensory System Agents|sensory system agents|mesh-ancestor
24838628|NCT02198924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24838629|NCT02198924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24838630|NCT02198924|Analgesics|analgesics|mesh-ancestor
24838631|NCT02198924|Sensory System Agents|sensory system agents|mesh-ancestor
24838632|NCT02198924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838633|NCT02198924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838634|NCT02198924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24838635|NCT02198924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24838636|NCT02198924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24838639|NCT02198924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838640|NCT02199171|Carboplatin|carboplatin|mesh-list
24838641|NCT02199171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24838642|NCT02199223|Panitumumab|panitumumab|mesh-list
24838643|NCT02199223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24838644|NCT02199223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24838645|NCT02199327|Interferons|interferons|mesh-list
25103367|NCT03162185|Serotonin Agents|serotonin agents|mesh-ancestor
25103368|NCT03162185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103369|NCT03162185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25103370|NCT03162185|Antidepressive Agents|antidepressive agents|mesh-ancestor
25103371|NCT03162185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25103372|NCT03162120|Metoprolol|metoprolol|mesh-list
25103373|NCT03162120|Flecainide|flecainide|mesh-list
25103374|NCT03162120|Ranolazine|ranolazine|mesh-list
25103375|NCT03162120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25103376|NCT03162120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25103377|NCT03162120|Sympatholytics|sympatholytics|mesh-ancestor
24414438|NCT00197587|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24528325|NCT00620789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24524522|NCT04771741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25103379|NCT03162120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25103380|NCT03162120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103381|NCT03162120|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25103382|NCT03162120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25103383|NCT03162120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25103384|NCT03162120|Adrenergic Agents|adrenergic agents|mesh-ancestor
25103385|NCT03162120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25103386|NCT03162120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103387|NCT03162120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25024636|NCT03643874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25024637|NCT03643874|Respiratory System Agents|respiratory system agents|mesh-ancestor
25112257|NCT04258631|Hydromorphone|hydromorphone|mesh-list
25112258|NCT04258631|Bupivacaine|bupivacaine|mesh-list
25112259|NCT04258631|Anesthetics, Local|anesthetics, local|mesh-ancestor
25112260|NCT04258631|Anesthetics|anesthetics|mesh-ancestor
25112261|NCT04258631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24473010|NCT00401492|Antiviral Agents|antiviral agents|mesh-ancestor
24444473|NCT00298168|Antiviral Agents|antiviral agents|mesh-ancestor
25103388|NCT03162120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25103389|NCT03162120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25103436|NCT03161509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25103437|NCT03161509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25103438|NCT03161509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25103439|NCT03161509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25103440|NCT03161509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25103441|NCT03161509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25103442|NCT03161509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25103443|NCT03161509|GABA Agents|gaba agents|mesh-ancestor
25103444|NCT03161509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24524762|NCT04403698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25103483|NCT03161574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25103484|NCT03161574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25103485|NCT03161574|Immunologic Factors|immunologic factors|mesh-ancestor
25103486|NCT03161574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103487|NCT03161574|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25225098|NCT02629224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25225099|NCT02629224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225100|NCT02629224|Anticonvulsants|anticonvulsants|mesh-ancestor
25225101|NCT02629224|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25225102|NCT02629224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25225103|NCT02629224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25225104|NCT02629224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25225105|NCT02629224|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25225106|NCT02629224|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25225107|NCT02629224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25225109|NCT02629224|Antimanic Agents|antimanic agents|mesh-ancestor
25225110|NCT02629289|Lenograstim|lenograstim|mesh-list
25225111|NCT02629289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25225112|NCT02629289|Immunologic Factors|immunologic factors|mesh-ancestor
25225113|NCT02629289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838646|NCT02199327|Interferon-alpha|interferon-alpha|mesh-list
24838647|NCT02199327|Interferon alpha-2|interferon alpha-2|mesh-list
24838649|NCT02199327|Mitomycin|mitomycin|mesh-list
24838650|NCT02199327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24838651|NCT02199327|Antiviral Agents|antiviral agents|mesh-ancestor
25103488|NCT03161574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25103489|NCT03161574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25103491|NCT03160872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25103492|NCT03160872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103493|NCT03161080|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25103494|NCT03161080|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25103495|NCT03161132|Doxorubicin|doxorubicin|mesh-list
25103496|NCT03161132|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25103497|NCT03161132|Olaparib|olaparib|mesh-list
25103498|NCT03161132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24781173|NCT01888302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25103499|NCT03161132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25103500|NCT03161132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25103501|NCT03161132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25103502|NCT03161132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25103503|NCT03161132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680832|NCT01855243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25680833|NCT01855243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25680834|NCT01855243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680835|NCT01855360|Doxycycline|doxycycline|mesh-list
25680836|NCT01855360|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
25680837|NCT01855360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25680838|NCT01855360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25680839|NCT01855360|Antimalarials|antimalarials|mesh-ancestor
25680840|NCT01855360|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25680841|NCT01855360|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25680842|NCT01855360|Antiviral Agents|antiviral agents|mesh-ancestor
25024686|NCT03643549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25103504|NCT03161132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25103506|NCT03161041|Oxaliplatin|oxaliplatin|mesh-list
25103507|NCT03161041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25103508|NCT03161041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25103509|NCT03161041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25103510|NCT03161041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25103511|NCT03161041|Growth Substances|growth substances|mesh-ancestor
24781174|NCT01888302|Antifungal Agents|antifungal agents|mesh-ancestor
25103512|NCT03161041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103520|NCT03160807|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25103521|NCT03160807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25103522|NCT03160807|Renal Agents|renal agents|mesh-ancestor
25103523|NCT03160807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25103524|NCT03160807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25103525|NCT03160807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25103526|NCT03160807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25103527|NCT03160807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103528|NCT03160807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24422921|NCT00223925|Antiviral Agents|antiviral agents|mesh-ancestor
24781253|NCT01888744|Cetrorelix|cetrorelix|mesh-list
25103576|NCT03160248|Apremilast|apremilast|mesh-list
25103577|NCT03160248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25103578|NCT03160248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25103579|NCT03160248|Analgesics|analgesics|mesh-ancestor
25103580|NCT03160248|Sensory System Agents|sensory system agents|mesh-ancestor
25103581|NCT03160248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25103582|NCT03160248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103583|NCT03160248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25103584|NCT03160248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25103585|NCT03160248|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25103586|NCT03160248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25103587|NCT03160248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25103588|NCT03160248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103589|NCT03160001|Niclosamide|niclosamide|mesh-list
25103590|NCT03160001|Etanercept|etanercept|mesh-list
25103593|NCT03160001|Analgesics|analgesics|mesh-ancestor
25103594|NCT03160001|Sensory System Agents|sensory system agents|mesh-ancestor
25103595|NCT03160001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25103596|NCT03160001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225114|NCT02629315|Formaldehyde|formaldehyde|mesh-list
25225115|NCT02629315|Disinfectants|disinfectants|mesh-ancestor
25225116|NCT02629315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25225117|NCT02629042|Prednisolone|prednisolone|mesh-list
25225118|NCT02629042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103619|NCT03159988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25103620|NCT03159988|Vasodilator Agents|vasodilator agents|mesh-ancestor
25103622|NCT03159741|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25103623|NCT03159741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25103624|NCT03159741|Hormones|hormones|mesh-ancestor
25103625|NCT03159741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25103626|NCT03159741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103627|NCT03159741|Incretins|incretins|mesh-ancestor
25103628|NCT03159845|Levofloxacin|levofloxacin|mesh-list
25103629|NCT03159845|Ofloxacin|ofloxacin|mesh-list
25103630|NCT03159845|Fluconazole|fluconazole|mesh-list
25103631|NCT03159845|Acyclovir|acyclovir|mesh-list
25103632|NCT03159845|Zinc Sulfate|zinc sulfate|mesh-list
25103633|NCT03159845|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25103634|NCT03159845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25103635|NCT03159845|Renal Agents|renal agents|mesh-ancestor
25103636|NCT03159845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25103637|NCT03159845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25103638|NCT03159845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25103639|NCT03159845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25103645|NCT03159845|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25103646|NCT03159845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25103647|NCT03159845|Hormone Antagonists|hormone antagonists|mesh-ancestor
24414440|NCT00197613|Zidovudine|zidovudine|mesh-list
24414441|NCT00197613|Efavirenz|efavirenz|mesh-list
24989086|NCT04871165|Antibodies|antibodies|mesh-list
24414478|NCT00197730|Hematinics|hematinics|mesh-ancestor
24414479|NCT00197743|Vitamin A|vitamin a|mesh-list
25680843|NCT01855360|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24414480|NCT00197743|Beta Carotene|beta carotene|mesh-list
25680844|NCT01855360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24414554|NCT00198055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25103648|NCT03159845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24781321|NCT01888861|Thioctic Acid|thioctic acid|mesh-list
25103649|NCT03159845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103650|NCT03159845|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25103651|NCT03159845|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25103653|NCT03159845|Astringents|astringents|mesh-ancestor
25103654|NCT03159845|Dermatologic Agents|dermatologic agents|mesh-ancestor
25103655|NCT03159598|Urethane|urethane|mesh-list
25103656|NCT03159598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25103657|NCT03159598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25103658|NCT03159598|Anesthetics, General|anesthetics, general|mesh-ancestor
25103659|NCT03159598|Anesthetics|anesthetics|mesh-ancestor
25103660|NCT03159598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25103661|NCT03159598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103662|NCT03159754|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25103663|NCT03159754|Metronidazole|metronidazole|mesh-list
25103664|NCT03159754|Ciprofloxacin|ciprofloxacin|mesh-list
25103702|NCT03159559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25103703|NCT03159559|Vasodilator Agents|vasodilator agents|mesh-ancestor
25103704|NCT03159559|Urological Agents|urological agents|mesh-ancestor
25103705|NCT03159403|Oritavancin|oritavancin|mesh-list
25103706|NCT03159403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25103707|NCT03159403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25103708|NCT03159390|Phenylacetic acid|phenylacetic acid|mesh-list
25103709|NCT03159390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25103710|NCT03159390|Antimetabolites|antimetabolites|mesh-ancestor
25225122|NCT02629042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25225123|NCT02629042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25225124|NCT02629042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225126|NCT02629146|Midazolam|midazolam|mesh-list
25225133|NCT02629146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25043296|NCT01279590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043297|NCT01279590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25043298|NCT01279590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25103711|NCT03159390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103712|NCT03159390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25103713|NCT03159078|Imipenem|imipenem|mesh-list
25103714|NCT03159078|Polymyxins|polymyxins|mesh-list
25103715|NCT03159078|Polymyxin B|polymyxin b|mesh-list
25103716|NCT03159078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25103717|NCT03159078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25103718|NCT03159234|Epinephrine|epinephrine|mesh-list
24518284|NCT05329454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518285|NCT05327348|Ascorbic Acid|ascorbic acid|mesh-list
24518286|NCT05327348|Antioxidants|antioxidants|mesh-ancestor
24518287|NCT05327348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518288|NCT05327348|Protective Agents|protective agents|mesh-ancestor
24518289|NCT05327348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103719|NCT03159234|Racepinephrine|racepinephrine|mesh-list
25103720|NCT03159234|Epinephryl borate|epinephryl borate|mesh-list
25103721|NCT03159234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25103722|NCT03159234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25103723|NCT03159234|Adrenergic Agents|adrenergic agents|mesh-ancestor
25103724|NCT03159234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24621065|NCT01060566|Ivacaftor|ivacaftor|mesh-list
25103725|NCT03159234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103726|NCT03159234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103727|NCT03159234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25103749|NCT03158935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25103750|NCT03158935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25103751|NCT03158935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25103752|NCT03158935|Analgesics|analgesics|mesh-ancestor
25103753|NCT03158935|Sensory System Agents|sensory system agents|mesh-ancestor
25103754|NCT03158935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25103755|NCT03158935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25103761|NCT03158584|Morphine|morphine|mesh-list
25103805|NCT03158142|Parasympatholytics|parasympatholytics|mesh-ancestor
25103806|NCT03158142|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25103807|NCT03158142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25103808|NCT03158142|Cholinergic Agents|cholinergic agents|mesh-ancestor
25405370|NCT03609216|Cisplatin|cisplatin|mesh-list
25680846|NCT01855750|Cyclophosphamide|cyclophosphamide|mesh-list
24446837|NCT00306176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24446838|NCT00306176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474025|NCT00404781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24474026|NCT00404781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24474027|NCT00404781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24474028|NCT00404781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024847|NCT03642353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024849|NCT03642184|Empagliflozin|empagliflozin|mesh-list
25024850|NCT03642184|Linagliptin|linagliptin|mesh-list
25024851|NCT03642184|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25024852|NCT03642184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024853|NCT03642184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25024854|NCT03642184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103809|NCT03158142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25103810|NCT03158142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103811|NCT03158168|Zinc Sulfate|zinc sulfate|mesh-list
25103812|NCT03158168|Astringents|astringents|mesh-ancestor
25103813|NCT03158168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103814|NCT03158168|Dermatologic Agents|dermatologic agents|mesh-ancestor
25103870|NCT03157791|Antifoaming Agents|antifoaming agents|mesh-ancestor
25103871|NCT03157791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103872|NCT03157791|Emollients|emollients|mesh-ancestor
25103873|NCT03157791|Dermatologic Agents|dermatologic agents|mesh-ancestor
25103874|NCT03157505|Immunologic Factors|immunologic factors|mesh-list
25103875|NCT03157505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103876|NCT03157479|Anesthetics|anesthetics|mesh-list
25103877|NCT03157479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
25103878|NCT03157479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25103879|NCT03157479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103880|NCT03157479|Anesthetics, General|anesthetics, general|mesh-ancestor
25103881|NCT03157401|Tranexamic Acid|tranexamic acid|mesh-list
25103882|NCT03157401|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25103883|NCT03157401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25103884|NCT03157401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103885|NCT03157401|Hemostatics|hemostatics|mesh-ancestor
24518290|NCT05327348|Vitamins|vitamins|mesh-ancestor
25103886|NCT03157401|Coagulants|coagulants|mesh-ancestor
25103887|NCT03157310|Gefitinib|gefitinib|mesh-list
25103888|NCT03157310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25103889|NCT03157310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25103903|NCT03157388|Vancomycin|vancomycin|mesh-list
25103922|NCT03156920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103923|NCT03156842|Amlodipine|amlodipine|mesh-list
25103924|NCT03156842|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25103925|NCT03156842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25103926|NCT03156842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25103927|NCT03156842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25225134|NCT02629146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25103929|NCT03156842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25225127|NCT02629146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25225128|NCT02629146|Narcotics|narcotics|mesh-ancestor
25225129|NCT02629146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25225130|NCT02629146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225131|NCT02629146|Analgesics|analgesics|mesh-ancestor
25043301|NCT01278134|Ribavirin|ribavirin|mesh-list
25043302|NCT01278134|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25043303|NCT01278134|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25043304|NCT01278134|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25680847|NCT01855750|Rituximab|rituximab|mesh-list
25680848|NCT01855750|Doxorubicin|doxorubicin|mesh-list
25680849|NCT01855750|Vincristine|vincristine|mesh-list
25680850|NCT01855750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25680851|NCT01855750|Immunologic Factors|immunologic factors|mesh-ancestor
25680852|NCT01855750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680853|NCT01855750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25680854|NCT01855750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25680855|NCT01855750|Alkylating Agents|alkylating agents|mesh-ancestor
25680856|NCT01855750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680857|NCT01855750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25680858|NCT01855750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25680859|NCT01855750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25680860|NCT01855750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25680861|NCT01855750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25024872|NCT03641950|Cholinergic Agents|cholinergic agents|mesh-ancestor
25043305|NCT01278134|Protease Inhibitors|protease inhibitors|mesh-ancestor
25043306|NCT01278134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043307|NCT01278134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043308|NCT01278134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25103930|NCT03156842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103931|NCT03156842|Vasodilator Agents|vasodilator agents|mesh-ancestor
25103932|NCT03156842|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25103933|NCT03156842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25103934|NCT03156842|Antimetabolites|antimetabolites|mesh-ancestor
25103935|NCT03156842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25103937|NCT03156842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25103979|NCT03156452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24423501|NCT00226109|Spironolactone|spironolactone|mesh-list
25103989|NCT03156296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25103990|NCT03156296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103992|NCT03156296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25103993|NCT03156296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25103994|NCT03156296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25103995|NCT03156296|Analgesics|analgesics|mesh-ancestor
25103996|NCT03156296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25103997|NCT03156296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25103998|NCT03156296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25103999|NCT03156296|Adrenergic Agents|adrenergic agents|mesh-ancestor
25104000|NCT03156296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25104001|NCT03156296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104002|NCT03156322|Fentanyl|fentanyl|mesh-list
25104003|NCT03156322|Bupivacaine|bupivacaine|mesh-list
25104004|NCT03156322|Anesthetics, Local|anesthetics, local|mesh-ancestor
25104005|NCT03156322|Anesthetics|anesthetics|mesh-ancestor
25104006|NCT03156322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25104007|NCT03156322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104008|NCT03156322|Sensory System Agents|sensory system agents|mesh-ancestor
25104009|NCT03156322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25104010|NCT03156322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25104011|NCT03156322|Narcotics|narcotics|mesh-ancestor
25104012|NCT03156322|Analgesics|analgesics|mesh-ancestor
25104020|NCT03156036|Temozolomide|temozolomide|mesh-list
25104027|NCT03156179|Calcium|calcium|mesh-list
25104078|NCT03155893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25104079|NCT03155893|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25104080|NCT03155893|Contraceptive Agents|contraceptive agents|mesh-ancestor
25104081|NCT03155893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25104082|NCT03155893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104083|NCT03155893|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25104084|NCT03155893|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25104085|NCT03155893|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25104086|NCT03155893|Antiviral Agents|antiviral agents|mesh-ancestor
25104088|NCT03155984|Immunologic Factors|immunologic factors|mesh-ancestor
25104089|NCT03155984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104090|NCT03155568|Bupivacaine|bupivacaine|mesh-list
25104091|NCT03155568|Anesthetics, Local|anesthetics, local|mesh-ancestor
25104092|NCT03155568|Anesthetics|anesthetics|mesh-ancestor
25104093|NCT03155568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25104094|NCT03155568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104095|NCT03155568|Sensory System Agents|sensory system agents|mesh-ancestor
25104096|NCT03155568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25104097|NCT03155477|Cholecalciferol|cholecalciferol|mesh-list
25104098|NCT03155477|Vitamin D|vitamin d|mesh-list
25225132|NCT02629146|Sensory System Agents|sensory system agents|mesh-ancestor
25225135|NCT02629146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25225136|NCT02629146|Anesthetics, General|anesthetics, general|mesh-ancestor
25225137|NCT02629146|Anesthetics|anesthetics|mesh-ancestor
25225138|NCT02629146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25225139|NCT02629146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25225140|NCT02629146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25043309|NCT01278134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25043310|NCT01278134|Antiviral Agents|antiviral agents|mesh-ancestor
25043311|NCT01278134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25043312|NCT01278134|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25056705|NCT03510208|Antibodies|antibodies|mesh-list
25680862|NCT01855750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25025017|NCT03640390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25025018|NCT03640390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25025020|NCT03640390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25025021|NCT03640351|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25025022|NCT03640351|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25025023|NCT03640351|Hyaluronic Acid|hyaluronic acid|mesh-list
25025024|NCT03640351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25025025|NCT03640351|Immunologic Factors|immunologic factors|mesh-ancestor
25025026|NCT03640351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025027|NCT03640351|Viscosupplements|viscosupplements|mesh-ancestor
25025028|NCT03640351|Protective Agents|protective agents|mesh-ancestor
25025029|NCT03640273|Loratadine|loratadine|mesh-list
25025030|NCT03640273|Antipruritics|antipruritics|mesh-ancestor
25104099|NCT03155477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25104100|NCT03155477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104101|NCT03155477|Vitamins|vitamins|mesh-ancestor
25104129|NCT03155204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24526348|NCT00611286|Everolimus|everolimus|mesh-list
25104130|NCT03155204|Autonomic Agents|autonomic agents|mesh-ancestor
25104131|NCT03155204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25104132|NCT03155204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104141|NCT03155048|Estrogens|estrogens|mesh-list
25104142|NCT03155048|Hormones|hormones|mesh-ancestor
25104143|NCT03155048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25104144|NCT03155048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104145|NCT03154827|Atezolizumab|atezolizumab|mesh-list
25104146|NCT03154827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25104147|NCT03155035|Vitamin D|vitamin d|mesh-list
25104148|NCT03155035|Albendazole|albendazole|mesh-list
25104149|NCT03155035|Calcium|calcium|mesh-list
25104150|NCT03155035|Vitamins|vitamins|mesh-ancestor
25104151|NCT03155035|Micronutrients|micronutrients|mesh-ancestor
25104152|NCT03155035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104153|NCT03155035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25104154|NCT03155035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25104155|NCT03155035|Anthelmintics|anthelmintics|mesh-ancestor
25104156|NCT03155035|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25104157|NCT03155035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25104158|NCT03155035|Anticestodal Agents|anticestodal agents|mesh-ancestor
25104159|NCT03155035|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25104160|NCT03155035|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25104171|NCT03154814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104172|NCT03154723|Vitamin A|vitamin a|mesh-list
25104173|NCT03154723|Vitamins|vitamins|mesh-ancestor
25104174|NCT03154723|Micronutrients|micronutrients|mesh-ancestor
25104175|NCT03154723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104176|NCT03154918|Gemcitabine|gemcitabine|mesh-list
25104177|NCT03154918|Dexamethasone|dexamethasone|mesh-list
25104178|NCT03154918|Etoposide|etoposide|mesh-list
25104179|NCT03154918|Ifosfamide|ifosfamide|mesh-list
25104180|NCT03154918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25104181|NCT03154918|Antiemetics|antiemetics|mesh-ancestor
25104182|NCT03154918|Autonomic Agents|autonomic agents|mesh-ancestor
25104183|NCT03154918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25104184|NCT03154918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104185|NCT03154918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25104186|NCT03154918|Glucocorticoids|glucocorticoids|mesh-ancestor
25104187|NCT03154918|Hormones|hormones|mesh-ancestor
25104188|NCT03154918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25104189|NCT03154918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25104190|NCT03154918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25104191|NCT03154918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25104192|NCT03154918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104193|NCT03154918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25680863|NCT01855750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25680864|NCT01855750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25680865|NCT01855750|Glucocorticoids|glucocorticoids|mesh-ancestor
25680866|NCT01855750|Hormones|hormones|mesh-ancestor
25680867|NCT01855750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25680868|NCT01855750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25680869|NCT01855750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25680870|NCT01855750|Tubulin Modulators|tubulin modulators|mesh-ancestor
25680871|NCT01855750|Antimitotic Agents|antimitotic agents|mesh-ancestor
25680872|NCT01855750|Mitosis Modulators|mitosis modulators|mesh-ancestor
25680873|NCT01855789|Methotrexate|methotrexate|mesh-list
25680874|NCT01855789|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25104194|NCT03154918|Antimetabolites|antimetabolites|mesh-ancestor
25104195|NCT03154918|Antiviral Agents|antiviral agents|mesh-ancestor
25104196|NCT03154918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25104197|NCT03154918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25104198|NCT03154918|Immunologic Factors|immunologic factors|mesh-ancestor
25104199|NCT03154918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25104200|NCT03154918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25104204|NCT03154983|Docetaxel|docetaxel|mesh-list
25104213|NCT03154983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25104214|NCT03154983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25104215|NCT03154983|Antimetabolites|antimetabolites|mesh-ancestor
25104217|NCT03154567|Mydriatics|mydriatics|mesh-ancestor
25104218|NCT03154567|Autonomic Agents|autonomic agents|mesh-ancestor
25225141|NCT02629146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25104219|NCT03154567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25104220|NCT03154567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104221|NCT03154567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25225142|NCT02629146|GABA Modulators|gaba modulators|mesh-ancestor
25225143|NCT02629146|GABA Agents|gaba agents|mesh-ancestor
25225144|NCT02629146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25225145|NCT02629146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043313|NCT01278134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25104222|NCT03154567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25104232|NCT03154645|Analgesics|analgesics|mesh-ancestor
25104233|NCT03154645|Sensory System Agents|sensory system agents|mesh-ancestor
25104234|NCT03154645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25104235|NCT03154645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104236|NCT03154645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25104237|NCT03154645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25104238|NCT03154645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25104239|NCT03154645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25104240|NCT03154645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104241|NCT03154645|Anticonvulsants|anticonvulsants|mesh-ancestor
25104242|NCT03154645|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25104243|NCT03154645|Diuretics|diuretics|mesh-ancestor
25104244|NCT03154645|Natriuretic Agents|natriuretic agents|mesh-ancestor
25104245|NCT03154385|Rituximab|rituximab|mesh-list
25104246|NCT03154385|Belimumab|belimumab|mesh-list
25104247|NCT03154385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25104248|NCT03154385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25104252|NCT03154385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25104253|NCT03154489|Acenocoumarol|acenocoumarol|mesh-list
25104254|NCT03154489|Anticoagulants|anticoagulants|mesh-ancestor
25104255|NCT03154528|Vitamin D|vitamin d|mesh-list
25104256|NCT03154528|Vitamins|vitamins|mesh-ancestor
25104257|NCT03154528|Micronutrients|micronutrients|mesh-ancestor
25104258|NCT03154528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104259|NCT03154528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25104260|NCT03154515|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
25104261|NCT03154515|Antiviral Agents|antiviral agents|mesh-ancestor
25104262|NCT03154515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25104263|NCT03154372|Metronidazole|metronidazole|mesh-list
25104264|NCT03154372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25104265|NCT03154372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25104266|NCT03154372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25104267|NCT03154372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25104268|NCT03154294|Paclitaxel|paclitaxel|mesh-list
25104269|NCT03154294|Serabelisib|serabelisib|mesh-list
25104270|NCT03154294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25104271|NCT03154294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25104272|NCT03154294|Tubulin Modulators|tubulin modulators|mesh-ancestor
25104273|NCT03154294|Antimitotic Agents|antimitotic agents|mesh-ancestor
25104274|NCT03154294|Mitosis Modulators|mitosis modulators|mesh-ancestor
25104275|NCT03154294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104276|NCT03154294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25104277|NCT03154606|Calcium|calcium|mesh-list
25104278|NCT03154606|Caseins|caseins|mesh-list
25104279|NCT03154606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25104280|NCT03154606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573989|NCT00822848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25104281|NCT03154606|Chelating Agents|chelating agents|mesh-ancestor
25104282|NCT03154606|Sequestering Agents|sequestering agents|mesh-ancestor
25104283|NCT03154606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104285|NCT03154281|Niraparib|niraparib|mesh-list
25104292|NCT03154281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025239|NCT03638960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025240|NCT03638960|Sensory System Agents|sensory system agents|mesh-ancestor
25025241|NCT03638960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25104294|NCT03154125|Medroxyprogesterone|medroxyprogesterone|mesh-list
25104295|NCT03154125|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25104315|NCT03153917|Hydrocortisone|hydrocortisone|mesh-list
25104316|NCT03153917|Melatonin|melatonin|mesh-list
25104317|NCT03153917|Antioxidants|antioxidants|mesh-ancestor
25104318|NCT03153917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104319|NCT03153917|Protective Agents|protective agents|mesh-ancestor
25104320|NCT03153917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104321|NCT03153917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25104334|NCT03153657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25104335|NCT03153657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225146|NCT02629380|Hyaluronic Acid|hyaluronic acid|mesh-list
25225147|NCT02629380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25043314|NCT01278134|Antimetabolites|antimetabolites|mesh-ancestor
25043315|NCT01276587|Vitamin D|vitamin d|mesh-list
25043316|NCT01276587|Ergocalciferols|ergocalciferols|mesh-list
25043317|NCT01276587|Cholecalciferol|cholecalciferol|mesh-list
25043318|NCT01276587|Vitamins|vitamins|mesh-list
25043319|NCT01276587|Micronutrients|micronutrients|mesh-ancestor
25043320|NCT01276587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043321|NCT01276587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25043322|NCT01276587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25043323|NCT01275105|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25056711|NCT03510078|Insulin|insulin|mesh-list
25056712|NCT03510078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25056713|NCT03510078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056714|NCT03510013|Anesthetics|anesthetics|mesh-list
25056715|NCT03510013|Sevoflurane|sevoflurane|mesh-list
25056716|NCT03510013|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
25104336|NCT03153657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104337|NCT03153657|Sequestering Agents|sequestering agents|mesh-ancestor
25104338|NCT03153267|Doxycycline|doxycycline|mesh-list
25104339|NCT03153267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25104340|NCT03153267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25104341|NCT03153267|Antimalarials|antimalarials|mesh-ancestor
25104342|NCT03153267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25104343|NCT03153267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25104344|NCT03153436|Inositol|inositol|mesh-list
25104345|NCT03153436|Vitamin B Complex|vitamin b complex|mesh-ancestor
25104346|NCT03153436|Vitamins|vitamins|mesh-ancestor
25104396|NCT03152981|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25104397|NCT03153163|Trastuzumab|trastuzumab|mesh-list
25104398|NCT03153163|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25104400|NCT03153163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25104401|NCT03153163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25104402|NCT03153163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25104403|NCT03153163|Tubulin Modulators|tubulin modulators|mesh-ancestor
25104404|NCT03153163|Antimitotic Agents|antimitotic agents|mesh-ancestor
25104405|NCT03153163|Mitosis Modulators|mitosis modulators|mesh-ancestor
25104406|NCT03153163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104407|NCT03153085|Ipilimumab|ipilimumab|mesh-list
25104408|NCT03153085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25104409|NCT03153085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25104410|NCT03153085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24782074|NCT01893788|Eplerenone|eplerenone|mesh-list
25104411|NCT03153085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104420|NCT03152955|Sufentanil|sufentanil|mesh-list
25104421|NCT03152955|Ketamine|ketamine|mesh-list
25104422|NCT03152955|Ondansetron|ondansetron|mesh-list
25104423|NCT03152955|Analgesics|analgesics|mesh-ancestor
25104424|NCT03152955|Sensory System Agents|sensory system agents|mesh-ancestor
25104449|NCT03152955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25104451|NCT03152903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25104452|NCT03152903|Immunologic Factors|immunologic factors|mesh-ancestor
25104453|NCT03152903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104454|NCT03152565|Avelumab|avelumab|mesh-list
25680875|NCT01855789|Abortifacient Agents|abortifacient agents|mesh-ancestor
25680876|NCT01855789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25680877|NCT01855789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680878|NCT01855789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25225148|NCT02629380|Immunologic Factors|immunologic factors|mesh-ancestor
25225149|NCT02629380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225150|NCT02629380|Viscosupplements|viscosupplements|mesh-ancestor
25225151|NCT02629380|Protective Agents|protective agents|mesh-ancestor
25225152|NCT02628704|Dexamethasone|dexamethasone|mesh-list
25225153|NCT02628704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25225154|NCT02628704|Antiemetics|antiemetics|mesh-ancestor
25225155|NCT02628704|Autonomic Agents|autonomic agents|mesh-ancestor
25225156|NCT02628704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25225157|NCT02628704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225158|NCT02628704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25225159|NCT02628704|Glucocorticoids|glucocorticoids|mesh-ancestor
25225160|NCT02628704|Hormones|hormones|mesh-ancestor
25225161|NCT02628704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25225162|NCT02628704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25043324|NCT01275105|Phenylephrine|phenylephrine|mesh-list
25043325|NCT01275105|Oxymetazoline|oxymetazoline|mesh-list
25043326|NCT01275105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25065584|NCT05320692|Apatinib|apatinib|mesh-list
24838652|NCT02199327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24838653|NCT02199327|Immunologic Factors|immunologic factors|mesh-ancestor
24838654|NCT02199327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838655|NCT02199327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24838656|NCT02199327|Alkylating Agents|alkylating agents|mesh-ancestor
24838657|NCT02199327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838658|NCT02199327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24838659|NCT02199327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24838660|NCT02199379|Lenvatinib|lenvatinib|mesh-list
24597641|NCT00950417|Nimotuzumab|nimotuzumab|mesh-list
24838661|NCT02199379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24838662|NCT02199379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24838663|NCT02199379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24838664|NCT02199379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104455|NCT03152565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25104456|NCT03152565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25104457|NCT03152890|Insulin|insulin|mesh-list
25104458|NCT03152890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25104459|NCT03152890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104460|NCT03152578|Capsaicin|capsaicin|mesh-list
25104461|NCT03152578|Antipruritics|antipruritics|mesh-ancestor
25104462|NCT03152578|Dermatologic Agents|dermatologic agents|mesh-ancestor
25104463|NCT03152578|Sensory System Agents|sensory system agents|mesh-ancestor
25104464|NCT03152578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25104465|NCT03152578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104466|NCT03152877|Bupivacaine|bupivacaine|mesh-list
25104467|NCT03152877|Anesthetics, Local|anesthetics, local|mesh-ancestor
25104484|NCT03152370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104485|NCT03152370|Vitamin B Complex|vitamin b complex|mesh-ancestor
25104486|NCT03152370|Vitamins|vitamins|mesh-ancestor
25104487|NCT03152370|Micronutrients|micronutrients|mesh-ancestor
25104488|NCT03152370|Hematinics|hematinics|mesh-ancestor
25104489|NCT03152409|Aspirin|aspirin|mesh-list
25104490|NCT03152409|Salicylic Acid|salicylic acid|mesh-list
25104491|NCT03152409|Salicylates|salicylates|mesh-list
25104492|NCT03152409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25104493|NCT03152409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25104494|NCT03152409|Analgesics|analgesics|mesh-ancestor
25104495|NCT03152409|Sensory System Agents|sensory system agents|mesh-ancestor
25104496|NCT03152409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25104497|NCT03152409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104498|NCT03152409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25104499|NCT03152409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25680879|NCT01855789|Antimetabolites|antimetabolites|mesh-ancestor
25680880|NCT01855789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680881|NCT01855789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25680882|NCT01855789|Dermatologic Agents|dermatologic agents|mesh-ancestor
25104500|NCT03152409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25104501|NCT03152409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25104502|NCT03152409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104503|NCT03152409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25104504|NCT03152409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25104505|NCT03152409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25025409|NCT03637400|Trimethoprim|trimethoprim|mesh-list
25225168|NCT02628847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25225169|NCT02628847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225170|NCT02628847|Urological Agents|urological agents|mesh-ancestor
25225171|NCT02628951|Paclitaxel|paclitaxel|mesh-list
25225172|NCT02628951|Ramucirumab|ramucirumab|mesh-list
25225173|NCT02628951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25225174|NCT02628951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225175|NCT02628951|Tubulin Modulators|tubulin modulators|mesh-ancestor
25225176|NCT02628951|Antimitotic Agents|antimitotic agents|mesh-ancestor
25225177|NCT02628951|Mitosis Modulators|mitosis modulators|mesh-ancestor
25225178|NCT02628951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225179|NCT02628886|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25225180|NCT02628886|Immunologic Factors|immunologic factors|mesh-ancestor
25225181|NCT02628886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838665|NCT02199392|Lenvatinib|lenvatinib|mesh-list
24838666|NCT02199392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24838667|NCT02199392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24838668|NCT02199392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24838669|NCT02199392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838670|NCT02199418|Paclitaxel|paclitaxel|mesh-list
24838680|NCT02199431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24838683|NCT02199431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24838692|NCT02199444|Sequestering Agents|sequestering agents|mesh-ancestor
24838693|NCT02199444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838694|NCT02199522|Propofol|propofol|mesh-list
24813592|NCT02059564|Hormones|hormones|mesh-ancestor
25104544|NCT03152175|Propranolol|propranolol|mesh-list
25104545|NCT03152175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25104546|NCT03152175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25104547|NCT03152175|Adrenergic Agents|adrenergic agents|mesh-ancestor
25104548|NCT03152175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25104549|NCT03152175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104550|NCT03152175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104551|NCT03152175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25104552|NCT03152175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25104553|NCT03152175|Vasodilator Agents|vasodilator agents|mesh-ancestor
25104565|NCT03152149|Autonomic Agents|autonomic agents|mesh-ancestor
25104566|NCT03152149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25104567|NCT03152149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104568|NCT03152149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25104569|NCT03152149|Respiratory System Agents|respiratory system agents|mesh-ancestor
25104570|NCT03152149|Dermatologic Agents|dermatologic agents|mesh-ancestor
25104577|NCT03152123|Phentermine|phentermine|mesh-list
25104578|NCT03152123|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25104579|NCT03152123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104580|NCT03152123|Appetite Depressants|appetite depressants|mesh-ancestor
25104581|NCT03152123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25104582|NCT03152123|Sympathomimetics|sympathomimetics|mesh-ancestor
25104583|NCT03152123|Autonomic Agents|autonomic agents|mesh-ancestor
25104584|NCT03152123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25104585|NCT03152123|Adrenergic Agents|adrenergic agents|mesh-ancestor
25104586|NCT03152123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25104587|NCT03152123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104588|NCT03151863|Dexmedetomidine|dexmedetomidine|mesh-list
25104589|NCT03151863|Analgesics, Opioid|analgesics, opioid|mesh-list
25104590|NCT03151863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25104591|NCT03151863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25104592|NCT03151863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104593|NCT03151863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25104594|NCT03151863|Analgesics|analgesics|mesh-ancestor
25104595|NCT03151863|Sensory System Agents|sensory system agents|mesh-ancestor
25104596|NCT03151863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25104597|NCT03151863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25104787|NCT03151161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25104598|NCT03151863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25104599|NCT03151863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25104600|NCT03151863|Adrenergic Agents|adrenergic agents|mesh-ancestor
25104601|NCT03151863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25104602|NCT03151863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104603|NCT03151863|Narcotics|narcotics|mesh-ancestor
25104604|NCT03151993|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25104605|NCT03151993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25104606|NCT03151993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25680883|NCT01855789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25680884|NCT01855789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25680885|NCT01855789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25680886|NCT01855789|Immunologic Factors|immunologic factors|mesh-ancestor
24474620|NCT00406952|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25680887|NCT01855789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25225182|NCT02628860|Ferric Compounds|ferric compounds|mesh-list
25225183|NCT02628860|Hematinics|hematinics|mesh-ancestor
25680888|NCT01855789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25225184|NCT02628665|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
25225185|NCT02628665|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
25225186|NCT02628665|Trioxsalen|trioxsalen|mesh-list
25225187|NCT02628665|Photosensitizing Agents|photosensitizing agents|mesh-list
25225188|NCT02628665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225189|NCT02628665|Dermatologic Agents|dermatologic agents|mesh-ancestor
25225190|NCT02628613|Paclitaxel|paclitaxel|mesh-list
25225191|NCT02628613|Vinorelbine|vinorelbine|mesh-list
25225192|NCT02628613|Epirubicin|epirubicin|mesh-list
25225193|NCT02628613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25225194|NCT02628613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24838695|NCT02199522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24838696|NCT02199522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24838697|NCT02199522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838698|NCT02199522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24838699|NCT02199522|Anesthetics, General|anesthetics, general|mesh-ancestor
24838700|NCT02199522|Anesthetics|anesthetics|mesh-ancestor
24838701|NCT02199613|Darunavir|darunavir|mesh-list
24838702|NCT02199613|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24838703|NCT02199613|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25104607|NCT03151993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104608|NCT03151772|Metformin|metformin|mesh-list
25104609|NCT03151772|Disulfiram|disulfiram|mesh-list
25104610|NCT03151772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25104611|NCT03151772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104612|NCT03151772|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24527336|NCT00616005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25104613|NCT03151772|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25104614|NCT03151772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25104615|NCT03151772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104616|NCT03151876|Gemcitabine|gemcitabine|mesh-list
25104617|NCT03151876|Busulfan|busulfan|mesh-list
25104618|NCT03151876|Cladribine|cladribine|mesh-list
25104619|NCT03151876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25104620|NCT03151876|Antimetabolites|antimetabolites|mesh-ancestor
25104621|NCT03151876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104631|NCT03151876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25104633|NCT03151720|Antipruritics|antipruritics|mesh-ancestor
25104634|NCT03151720|Dermatologic Agents|dermatologic agents|mesh-ancestor
25104635|NCT03151720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25104636|NCT03151720|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25104637|NCT03151720|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25104638|NCT03151720|Histamine Antagonists|histamine antagonists|mesh-ancestor
25104639|NCT03151720|Histamine Agents|histamine agents|mesh-ancestor
25104640|NCT03151720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25104641|NCT03151720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104655|NCT03151668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25104656|NCT03151668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104657|NCT03151668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25104658|NCT03151668|Analgesics|analgesics|mesh-ancestor
25104659|NCT03151668|Sensory System Agents|sensory system agents|mesh-ancestor
25104660|NCT03151668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25104661|NCT03151668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25104662|NCT03151668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25104663|NCT03151668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25104664|NCT03151668|Adrenergic Agents|adrenergic agents|mesh-ancestor
25104665|NCT03151668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25104666|NCT03151668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104667|NCT03151525|Azathioprine|azathioprine|mesh-list
25104668|NCT03151525|Infliximab|infliximab|mesh-list
25104669|NCT03151525|Dermatologic Agents|dermatologic agents|mesh-ancestor
25104670|NCT03151525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25104671|NCT03151525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25104672|NCT03151525|Antimetabolites|antimetabolites|mesh-ancestor
25104673|NCT03151525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104674|NCT03151525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25680889|NCT01855828|Paclitaxel|paclitaxel|mesh-list
25680890|NCT01855828|Cyclophosphamide|cyclophosphamide|mesh-list
25025549|NCT03636308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104675|NCT03151525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25104676|NCT03151525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25104677|NCT03151525|Immunologic Factors|immunologic factors|mesh-ancestor
25104678|NCT03151525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104702|NCT03151460|Dopamine Agents|dopamine agents|mesh-list
25104703|NCT03151460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25104704|NCT03151460|Sympathomimetics|sympathomimetics|mesh-ancestor
25104705|NCT03151460|Autonomic Agents|autonomic agents|mesh-ancestor
25104706|NCT03151460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25104707|NCT03151460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225195|NCT02628613|Tubulin Modulators|tubulin modulators|mesh-ancestor
25225196|NCT02628613|Antimitotic Agents|antimitotic agents|mesh-ancestor
25225197|NCT02628613|Mitosis Modulators|mitosis modulators|mesh-ancestor
25225198|NCT02628613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225199|NCT02628613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25225200|NCT02628613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25225201|NCT02628613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25225202|NCT02628613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225203|NCT02628587|Clopidogrel|clopidogrel|mesh-list
24838704|NCT02199613|Protease Inhibitors|protease inhibitors|mesh-ancestor
24838705|NCT02199613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24838706|NCT02199613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838707|NCT02199613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24838708|NCT02199613|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24838709|NCT02199613|Antiviral Agents|antiviral agents|mesh-ancestor
24838710|NCT02199613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24838711|NCT02199678|Ketamine|ketamine|mesh-list
24838712|NCT02199678|Analgesics|analgesics|mesh-ancestor
24838713|NCT02199678|Sensory System Agents|sensory system agents|mesh-ancestor
25056757|NCT03509740|Sensory System Agents|sensory system agents|mesh-ancestor
25104708|NCT03151460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25104709|NCT03151460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104710|NCT03151460|Protective Agents|protective agents|mesh-ancestor
25104711|NCT03151486|JNJ-55308942|jnj-55308942|mesh-list
25104712|NCT03151486|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
25104713|NCT03151486|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25104714|NCT03151486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25104715|NCT03151486|Purinergic Agents|purinergic agents|mesh-ancestor
25104716|NCT03151486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25104717|NCT03151486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104718|NCT03151486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104719|NCT03151603|Fosfomycin|fosfomycin|mesh-list
25104720|NCT03151603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24460152|NCT00347503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25104769|NCT03151174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104770|NCT03151174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25104771|NCT03151174|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25104773|NCT03151044|Epirubicin|epirubicin|mesh-list
25104774|NCT03151044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25104775|NCT03151044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25104776|NCT03151044|Immunologic Factors|immunologic factors|mesh-ancestor
25104777|NCT03151044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104778|NCT03151044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25104779|NCT03151044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25104780|NCT03151044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25104781|NCT03151044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25104782|NCT03151044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25104783|NCT03151044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414555|NCT00198055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414556|NCT00198055|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24414557|NCT00198055|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24414558|NCT00198055|Serotonin Agents|serotonin agents|mesh-ancestor
24414559|NCT00198055|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24414560|NCT00198055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24414561|NCT00198055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24414562|NCT00198055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24414563|NCT00198094|Alprazolam|alprazolam|mesh-list
24414564|NCT00198094|Sertraline|sertraline|mesh-list
25104784|NCT03151161|Carboplatin|carboplatin|mesh-list
25104785|NCT03151161|Pemetrexed|pemetrexed|mesh-list
25104786|NCT03151161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25680891|NCT01855828|Fluorouracil|fluorouracil|mesh-list
25680892|NCT01855828|Trastuzumab|trastuzumab|mesh-list
25025655|NCT03635125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25025656|NCT03635125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025657|NCT03635125|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25025658|NCT03635125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25025659|NCT03635125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25025660|NCT03635125|Adrenergic Agents|adrenergic agents|mesh-ancestor
25104788|NCT03151161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104789|NCT03151161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25104790|NCT03151161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25104791|NCT03151096|Riboflavin|riboflavin|mesh-list
25104792|NCT03151096|Vitamin B Complex|vitamin b complex|mesh-ancestor
25104793|NCT03151096|Vitamins|vitamins|mesh-ancestor
25104794|NCT03151096|Micronutrients|micronutrients|mesh-ancestor
24425937|NCT00234858|Losartan|losartan|mesh-list
25104804|NCT03151005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225204|NCT02628587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25225205|NCT02628587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25225206|NCT02628587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25225207|NCT02628587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25225208|NCT02628587|Purinergic Agents|purinergic agents|mesh-ancestor
25225209|NCT02628587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25225210|NCT02628587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225211|NCT02628587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225212|NCT02628574|Gemcitabine|gemcitabine|mesh-list
25225213|NCT02628574|Pembrolizumab|pembrolizumab|mesh-list
24838714|NCT02199678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838715|NCT02199678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838716|NCT02199678|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24838717|NCT02199678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24838718|NCT02199678|Anesthetics, General|anesthetics, general|mesh-ancestor
24838720|NCT02199678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24838721|NCT02199678|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24838722|NCT02199678|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24838723|NCT02199678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24838724|NCT02199678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838725|NCT02199925|gamma-Globulins|gamma-globulins|mesh-list
24444811|NCT00299208|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24444820|NCT00299234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24838726|NCT02199925|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24838727|NCT02199925|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24838728|NCT02199925|Immunologic Factors|immunologic factors|mesh-ancestor
24838729|NCT02199925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838731|NCT02199951|Artenimol|artenimol|mesh-list
24838732|NCT02199951|Antimalarials|antimalarials|mesh-ancestor
24838733|NCT02199951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24838734|NCT02199951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25056769|NCT03509714|Vitamins|vitamins|mesh-ancestor
25104805|NCT03151005|Incretins|incretins|mesh-ancestor
25104806|NCT03151005|Hormones|hormones|mesh-ancestor
24782464|NCT01896336|GABA Agonists|gaba agonists|mesh-ancestor
25104807|NCT03151005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25104808|NCT03151005|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25104809|NCT03151005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25104810|NCT03151005|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25104811|NCT03151239|Niacinamide|niacinamide|mesh-list
25104812|NCT03151239|Vitamin B Complex|vitamin b complex|mesh-ancestor
25104813|NCT03151239|Vitamins|vitamins|mesh-ancestor
25104814|NCT03151239|Micronutrients|micronutrients|mesh-ancestor
25104829|NCT03150771|Antidepressive Agents|antidepressive agents|mesh-ancestor
25104830|NCT03150771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25104831|NCT03150771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25104832|NCT03150771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25104833|NCT03150771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25104834|NCT03150771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104835|NCT03150771|Dopamine Agonists|dopamine agonists|mesh-ancestor
25104836|NCT03150771|Dopamine Agents|dopamine agents|mesh-ancestor
25104837|NCT03150771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25680893|NCT01855828|Epirubicin|epirubicin|mesh-list
25680894|NCT01855828|Pertuzumab|pertuzumab|mesh-list
25680895|NCT01855828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25680896|NCT01855828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25680897|NCT01855828|Tubulin Modulators|tubulin modulators|mesh-ancestor
25680898|NCT01855828|Antimitotic Agents|antimitotic agents|mesh-ancestor
25680899|NCT01855828|Mitosis Modulators|mitosis modulators|mesh-ancestor
25692440|NCT01999400|Sensory System Agents|sensory system agents|mesh-ancestor
25104838|NCT03150771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104839|NCT03150771|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25104840|NCT03150771|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25104841|NCT03150771|Serotonin Agents|serotonin agents|mesh-ancestor
25104842|NCT03150771|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25104843|NCT03150771|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25104844|NCT03150771|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25225214|NCT02628574|Nivolumab|nivolumab|mesh-list
25225215|NCT02628574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25225216|NCT02628574|Antimetabolites|antimetabolites|mesh-ancestor
25225217|NCT02628574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225218|NCT02628574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225219|NCT02628574|Antiviral Agents|antiviral agents|mesh-ancestor
25225222|NCT02628574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25225223|NCT02628574|Immunologic Factors|immunologic factors|mesh-ancestor
25225224|NCT02628574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225225|NCT02628574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25225226|NCT02628574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25225229|NCT02628392|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25225230|NCT02628392|Firuglipel|firuglipel|mesh-list
25225231|NCT02628392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25225232|NCT02628392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225233|NCT02628392|Incretins|incretins|mesh-ancestor
25225234|NCT02628392|Hormones|hormones|mesh-ancestor
25225235|NCT02628392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25225236|NCT02628392|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24838735|NCT02199951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24597709|NCT00951106|Pyrimethamine|pyrimethamine|mesh-list
24838737|NCT02200094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24838738|NCT02200094|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24838739|NCT02200094|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24838740|NCT02200094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838741|NCT02200146|Hydroxychloroquine|hydroxychloroquine|mesh-list
24838742|NCT02200146|Prednisone|prednisone|mesh-list
24838743|NCT02200146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24838744|NCT02200146|Glucocorticoids|glucocorticoids|mesh-ancestor
24838745|NCT02200146|Hormones|hormones|mesh-ancestor
24838746|NCT02200146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24838747|NCT02200146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838748|NCT02200146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24838749|NCT02200146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25104845|NCT03150771|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25104847|NCT03150576|Carboplatin|carboplatin|mesh-list
25104848|NCT03150576|Olaparib|olaparib|mesh-list
25104849|NCT03150576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25104850|NCT03150576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25104851|NCT03150576|Tubulin Modulators|tubulin modulators|mesh-ancestor
25104852|NCT03150576|Antimitotic Agents|antimitotic agents|mesh-ancestor
25104853|NCT03150576|Mitosis Modulators|mitosis modulators|mesh-ancestor
25104854|NCT03150576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104855|NCT03150576|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25104856|NCT03150576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25104857|NCT03150667|Clopidogrel|clopidogrel|mesh-list
25104858|NCT03150667|Ticagrelor|ticagrelor|mesh-list
25104859|NCT03150667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24521968|NCT04388683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25104863|NCT03150667|Purinergic Agents|purinergic agents|mesh-ancestor
25104870|NCT03150836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25104874|NCT03150316|CKD-581|ckd-581|mesh-list
25104875|NCT03150316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25104876|NCT03150316|Antiemetics|antiemetics|mesh-ancestor
25104877|NCT03150316|Autonomic Agents|autonomic agents|mesh-ancestor
25104878|NCT03150316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25104879|NCT03150316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104880|NCT03150316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25104881|NCT03150316|Glucocorticoids|glucocorticoids|mesh-ancestor
24782535|NCT01896440|Ondansetron|ondansetron|mesh-list
25104883|NCT03150316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25104884|NCT03150316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25104885|NCT03150316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25104893|NCT03150316|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25104895|NCT03150290|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25104896|NCT03150290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025807|NCT03633994|Anticoagulants|anticoagulants|mesh-ancestor
25025808|NCT03633994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25025809|NCT03633994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25025810|NCT03633994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025811|NCT03633812|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25104897|NCT03150459|Rifaximin|rifaximin|mesh-list
25104898|NCT03150459|Simvastatin|simvastatin|mesh-list
25104914|NCT03150524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104915|NCT03150524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25104916|NCT03150524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104917|NCT03150524|Vasodilator Agents|vasodilator agents|mesh-ancestor
25104918|NCT03150524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25104919|NCT03150420|Sodium thiosulfate|sodium thiosulfate|mesh-list
25104920|NCT03150420|Antidotes|antidotes|mesh-ancestor
25225237|NCT02628392|Protease Inhibitors|protease inhibitors|mesh-ancestor
25225238|NCT02628392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225239|NCT02628392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225240|NCT02628522|Lidocaine|lidocaine|mesh-list
25225241|NCT02628522|Epinephrine|epinephrine|mesh-list
25225242|NCT02628522|Anesthetics, Local|anesthetics, local|mesh-ancestor
25225243|NCT02628522|Anesthetics|anesthetics|mesh-ancestor
25225244|NCT02628522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25225245|NCT02628522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225246|NCT02628522|Sensory System Agents|sensory system agents|mesh-ancestor
25225247|NCT02628522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25225248|NCT02628522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25225249|NCT02628522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25225250|NCT02628522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25225251|NCT02628522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25273283|NCT02386475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24838750|NCT02200146|Antimalarials|antimalarials|mesh-ancestor
24838751|NCT02200146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24838752|NCT02200146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24838753|NCT02200146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24838754|NCT02200146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24838755|NCT02200146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851655|NCT02257697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24522253|NCT04081831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24522263|NCT04081831|Antipyretics|antipyretics|mesh-ancestor
24522337|NCT03961165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24522338|NCT03961165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838756|NCT02200146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24838757|NCT02200159|Dexmedetomidine|dexmedetomidine|mesh-list
24838758|NCT02200159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24838759|NCT02200159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24838760|NCT02200159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838764|NCT02200159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838765|NCT02200159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24838766|NCT02200159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24838767|NCT02200159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24838768|NCT02200159|Adrenergic Agents|adrenergic agents|mesh-ancestor
24838769|NCT02200159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24838770|NCT02200159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838771|NCT02200172|Melatonin|melatonin|mesh-list
24838793|NCT02200315|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24838794|NCT02200354|Bevacizumab|bevacizumab|mesh-list
24838795|NCT02200354|Pemetrexed|pemetrexed|mesh-list
24838805|NCT02200354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24838806|NCT02200354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24838807|NCT02200406|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25104921|NCT03150420|Protective Agents|protective agents|mesh-ancestor
25104922|NCT03150420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104923|NCT03150420|Antioxidants|antioxidants|mesh-ancestor
25104924|NCT03150420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104925|NCT03150420|Antitubercular Agents|antitubercular agents|mesh-ancestor
25104926|NCT03150420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25104927|NCT03150420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25680900|NCT01855828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680901|NCT01855828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25680902|NCT01855828|Immunologic Factors|immunologic factors|mesh-ancestor
25680903|NCT01855828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680904|NCT01855828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24475699|NCT00411190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475700|NCT00411190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24446710|NCT00305734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25104928|NCT03150420|Chelating Agents|chelating agents|mesh-ancestor
25104929|NCT03150420|Sequestering Agents|sequestering agents|mesh-ancestor
25104930|NCT03150134|Cyclosporine|cyclosporine|mesh-list
25104931|NCT03150134|Cyclosporins|cyclosporins|mesh-list
25104932|NCT03150134|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25104933|NCT03150134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25104934|NCT03150134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104935|NCT03150134|Immunologic Factors|immunologic factors|mesh-ancestor
25104936|NCT03150134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104937|NCT03150134|Antifungal Agents|antifungal agents|mesh-ancestor
25104938|NCT03150134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25104939|NCT03150134|Dermatologic Agents|dermatologic agents|mesh-ancestor
25104940|NCT03150134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25104941|NCT03150134|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24782606|NCT01896661|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24522339|NCT03961165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24989427|NCT05261321|Analgesics|analgesics|mesh-ancestor
25225253|NCT02628522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25225254|NCT02628522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25225255|NCT02628522|Adrenergic Agents|adrenergic agents|mesh-ancestor
25225256|NCT02628522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25225257|NCT02628522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25225258|NCT02628522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25225259|NCT02628522|Autonomic Agents|autonomic agents|mesh-ancestor
25225260|NCT02628522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25225261|NCT02628522|Respiratory System Agents|respiratory system agents|mesh-ancestor
25225262|NCT02628522|Mydriatics|mydriatics|mesh-ancestor
25225263|NCT02628522|Sympathomimetics|sympathomimetics|mesh-ancestor
25225264|NCT02628522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25225266|NCT02628197|Calcium|calcium|mesh-list
25225267|NCT02628197|Vitamins|vitamins|mesh-ancestor
25225268|NCT02628197|Micronutrients|micronutrients|mesh-ancestor
25225269|NCT02628197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225270|NCT02628197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25225271|NCT02628197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25225272|NCT02628002|Regadenoson|regadenoson|mesh-list
25225273|NCT02628002|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25225274|NCT02628002|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25225275|NCT02628002|Purinergic Agonists|purinergic agonists|mesh-ancestor
25225276|NCT02628002|Purinergic Agents|purinergic agents|mesh-ancestor
25225277|NCT02628002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24838808|NCT02200406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24838809|NCT02200406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24838810|NCT02200406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24838811|NCT02200406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838812|NCT02200406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24838813|NCT02200406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838814|NCT02200406|Antidepressive Agents|antidepressive agents|mesh-ancestor
24838816|NCT02200562|Ipilimumab|ipilimumab|mesh-list
24838817|NCT02200562|Dabrafenib|dabrafenib|mesh-list
24838818|NCT02200562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24838819|NCT02200562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056834|NCT03509246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25056835|NCT03509246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25056836|NCT03509246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056837|NCT03509168|Misoprostol|misoprostol|mesh-list
24522427|NCT03853044|Glucocorticoids|glucocorticoids|mesh-ancestor
25680905|NCT01855828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25680906|NCT01855828|Alkylating Agents|alkylating agents|mesh-ancestor
25680907|NCT01855828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25680908|NCT01855828|Antimetabolites|antimetabolites|mesh-ancestor
25680909|NCT01855828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25680910|NCT01855828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25680911|NCT01855828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25104949|NCT03149913|Antimitotic Agents|antimitotic agents|mesh-ancestor
25104950|NCT03149913|Mitosis Modulators|mitosis modulators|mesh-ancestor
25104951|NCT03149913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104952|NCT03150030|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25104953|NCT03150030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104955|NCT03149783|Anesthetics, Local|anesthetics, local|mesh-ancestor
25104956|NCT03149783|Anesthetics|anesthetics|mesh-ancestor
25104957|NCT03149783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25104958|NCT03149783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104959|NCT03149783|Sensory System Agents|sensory system agents|mesh-ancestor
25104960|NCT03149783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25104961|NCT03149653|SMOFlipid|smoflipid|mesh-list
25104962|NCT03149653|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25104963|NCT03149653|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25104964|NCT03149653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25104965|NCT03149432|Gabapentin|gabapentin|mesh-list
25104966|NCT03149432|Analgesics|analgesics|mesh-ancestor
25104967|NCT03149432|Sensory System Agents|sensory system agents|mesh-ancestor
25104968|NCT03149432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25105001|NCT03149588|Anesthetics|anesthetics|mesh-ancestor
25105002|NCT03149588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24782769|NCT01898039|Cyclophosphamide|cyclophosphamide|mesh-list
24782770|NCT01898039|Vaccines|vaccines|mesh-list
24782771|NCT01898039|Immunologic Factors|immunologic factors|mesh-ancestor
24782772|NCT01898039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782773|NCT01898039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24782774|NCT01898039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25105011|NCT03149679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25105012|NCT03149679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25225278|NCT02628002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838820|NCT02200562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24838821|NCT02200562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838822|NCT02200562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24838823|NCT02200562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24838824|NCT02200575|Telmisartan|telmisartan|mesh-list
24838825|NCT02200575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24838826|NCT02200575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24838854|NCT02200822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24838856|NCT02200822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24838857|NCT02200822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838858|NCT02200822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838859|NCT02200848|Rituximab|rituximab|mesh-list
24838860|NCT02200848|Lenalidomide|lenalidomide|mesh-list
24838861|NCT02200848|Glutarimide|glutarimide|mesh-list
25056854|NCT03508999|Metronidazole|metronidazole|mesh-list
25105045|NCT03149289|Antiviral Agents|antiviral agents|mesh-list
25105046|NCT03149289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25105047|NCT03148990|Vaccines|vaccines|mesh-list
25105048|NCT03148990|Immunologic Factors|immunologic factors|mesh-ancestor
25105049|NCT03148990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105050|NCT03149159|Nivolumab|nivolumab|mesh-list
25105051|NCT03149159|Ipilimumab|ipilimumab|mesh-list
25105052|NCT03149159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25105053|NCT03149159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105054|NCT03149159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25105055|NCT03149159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105056|NCT03149120|Nivolumab|nivolumab|mesh-list
25105057|NCT03149120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25105058|NCT03149120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105059|NCT03149120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25105060|NCT03149120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105061|NCT03149250|Hemostatics|hemostatics|mesh-list
25105062|NCT03149250|Coagulants|coagulants|mesh-ancestor
25105063|NCT03148717|Misoprostol|misoprostol|mesh-list
25105064|NCT03148717|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25105065|NCT03148717|Abortifacient Agents|abortifacient agents|mesh-ancestor
25105066|NCT03148717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25105067|NCT03148717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105088|NCT03148561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25105089|NCT03148561|Oxytocics|oxytocics|mesh-ancestor
25105090|NCT03148574|Misoprostol|misoprostol|mesh-list
25105091|NCT03148574|Oxytocin|oxytocin|mesh-list
25105092|NCT03148574|Oxytocics|oxytocics|mesh-ancestor
25105093|NCT03148574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25105094|NCT03148574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105095|NCT03148574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25105096|NCT03148574|Abortifacient Agents|abortifacient agents|mesh-ancestor
25105097|NCT03148574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24838864|NCT02200848|Immunologic Factors|immunologic factors|mesh-ancestor
24838865|NCT02200848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838866|NCT02200848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24838867|NCT02200848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25105450|NCT03145649|Insulin|insulin|mesh-list
24838868|NCT02200848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24838869|NCT02200848|Growth Substances|growth substances|mesh-ancestor
24838870|NCT02200848|Growth Inhibitors|growth inhibitors|mesh-ancestor
24838874|NCT02200991|Insulin Glargine|insulin glargine|mesh-list
24838886|NCT02201004|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
24838887|NCT02201004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24838888|NCT02201004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838889|NCT02201004|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25105144|NCT03148522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105145|NCT03148522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25105146|NCT03148522|Antidepressive Agents|antidepressive agents|mesh-ancestor
25105147|NCT03148522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25105148|NCT03148522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24782838|NCT01898377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25105149|NCT03148522|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25105151|NCT03148522|Sensory System Agents|sensory system agents|mesh-ancestor
25105152|NCT03148522|Dopamine Agents|dopamine agents|mesh-ancestor
25105153|NCT03148522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25105154|NCT03148522|Histamine Antagonists|histamine antagonists|mesh-ancestor
25105155|NCT03148522|Histamine Agents|histamine agents|mesh-ancestor
25105156|NCT03148522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25105157|NCT03148522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25105158|NCT03148522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25105167|NCT03148444|Roxithromycin|roxithromycin|mesh-list
25105189|NCT03148288|Micronutrients|micronutrients|mesh-ancestor
25105190|NCT03148288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105191|NCT03148288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25105192|NCT03148002|Lactulose|lactulose|mesh-list
25105193|NCT03148002|Sennosides|sennosides|mesh-list
25105194|NCT03148002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25105195|NCT03148002|Laxatives|laxatives|mesh-ancestor
25105196|NCT03147963|Docetaxel|docetaxel|mesh-list
25105197|NCT03147963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105198|NCT03147963|Tubulin Modulators|tubulin modulators|mesh-ancestor
25105199|NCT03147963|Antimitotic Agents|antimitotic agents|mesh-ancestor
25105200|NCT03147963|Mitosis Modulators|mitosis modulators|mesh-ancestor
25105201|NCT03147963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105202|NCT03147638|Warfarin|warfarin|mesh-list
25105203|NCT03147638|Anticoagulants|anticoagulants|mesh-ancestor
25105204|NCT03147859|Vedolizumab|vedolizumab|mesh-list
25105205|NCT03147859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25105207|NCT03147677|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
25105208|NCT03147677|Irbesartan|irbesartan|mesh-list
25105209|NCT03147677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25105210|NCT03147677|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25105211|NCT03147677|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25105212|NCT03147677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105242|NCT03147066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25105243|NCT03147066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225310|NCT02628132|Paclitaxel|paclitaxel|mesh-list
25225311|NCT02628132|Durvalumab|durvalumab|mesh-list
25225312|NCT02628132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25225313|NCT02628132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225314|NCT02628132|Tubulin Modulators|tubulin modulators|mesh-ancestor
25225315|NCT02628132|Antimitotic Agents|antimitotic agents|mesh-ancestor
25225316|NCT02628132|Mitosis Modulators|mitosis modulators|mesh-ancestor
25225317|NCT02628132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680912|NCT01855828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25680913|NCT01855828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25680914|NCT01855828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25680915|NCT01855919|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25692441|NCT01999400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25006470|NCT05003076|Sympathomimetics|sympathomimetics|mesh-ancestor
24476230|NCT00413608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24476299|NCT00414024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476301|NCT00414037|Eszopiclone|eszopiclone|mesh-list
24476302|NCT00414037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24476303|NCT00414037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24476304|NCT00414037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476305|NCT00414089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24476306|NCT00414089|Immunologic Factors|immunologic factors|mesh-ancestor
24476307|NCT00414089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680916|NCT01855919|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25680917|NCT01855919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25225318|NCT02628132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25225319|NCT02628080|Atovaquone|atovaquone|mesh-list
25225320|NCT02628080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25225321|NCT02628080|Antimalarials|antimalarials|mesh-ancestor
25225322|NCT02628080|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25225323|NCT02628080|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25225324|NCT02628080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225325|NCT02628080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838890|NCT02201004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838891|NCT02201030|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24838892|NCT02201030|Immunologic Factors|immunologic factors|mesh-ancestor
24838893|NCT02201030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838894|NCT02201043|Thalidomide|thalidomide|mesh-list
24838895|NCT02201043|Tolnaftate|tolnaftate|mesh-list
24838896|NCT02201043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24838897|NCT02201043|Immunologic Factors|immunologic factors|mesh-ancestor
25105244|NCT03147066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25105245|NCT03147066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25105246|NCT03147066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25105247|NCT03147066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25105248|NCT03147066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25105249|NCT03147066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25105250|NCT03147066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105251|NCT03147066|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25105252|NCT03147066|Narcotics|narcotics|mesh-ancestor
25105253|NCT03147066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25105254|NCT03147092|Losartan|losartan|mesh-list
25105255|NCT03147092|Atenolol|atenolol|mesh-list
25105256|NCT03147092|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25105257|NCT03147092|Clonidine|clonidine|mesh-list
25105258|NCT03147092|Captopril|captopril|mesh-list
24428403|NCT00240422|Ramipril|ramipril|mesh-list
25105272|NCT03147092|Sympatholytics|sympatholytics|mesh-ancestor
25105282|NCT03147092|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25105283|NCT03147092|Protease Inhibitors|protease inhibitors|mesh-ancestor
25105284|NCT03147092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25105285|NCT03147196|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25105286|NCT03147196|Bicalutamide|bicalutamide|mesh-list
25105287|NCT03147196|Androgen Antagonists|androgen antagonists|mesh-ancestor
25105288|NCT03147196|Hormone Antagonists|hormone antagonists|mesh-ancestor
25680918|NCT01855919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25680919|NCT01855919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680920|NCT01855919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25680921|NCT01855919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680922|NCT01855919|Analgesics|analgesics|mesh-ancestor
25680923|NCT01855919|Sensory System Agents|sensory system agents|mesh-ancestor
25680924|NCT01855919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25680925|NCT01855919|Antidepressive Agents|antidepressive agents|mesh-ancestor
25680926|NCT01855919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25680927|NCT01855919|Dopamine Agents|dopamine agents|mesh-ancestor
25680928|NCT01855997|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25680929|NCT01855997|Interferon alpha-2|interferon alpha-2|mesh-list
25680930|NCT01855997|Antiviral Agents|antiviral agents|mesh-ancestor
25680931|NCT01855997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25680932|NCT01855997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25680933|NCT01856114|Fentanyl|fentanyl|mesh-list
25105289|NCT03147196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25105290|NCT03147196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105291|NCT03147196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105292|NCT03147196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25105293|NCT03147196|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25105294|NCT03147196|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25105295|NCT03147196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25105296|NCT03146858|Enoxaparin|enoxaparin|mesh-list
25105297|NCT03146858|Anticoagulants|anticoagulants|mesh-ancestor
25105298|NCT03146858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25105299|NCT03146858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25105300|NCT03146858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105301|NCT03146793|Sodium thiosulfate|sodium thiosulfate|mesh-list
25105302|NCT03146793|Antidotes|antidotes|mesh-ancestor
25105303|NCT03146793|Protective Agents|protective agents|mesh-ancestor
25105330|NCT03146650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25105331|NCT03146650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105335|NCT03146533|Immunologic Factors|immunologic factors|mesh-ancestor
25105336|NCT03146533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105337|NCT03146533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25105338|NCT03146533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25105339|NCT03146533|Alkylating Agents|alkylating agents|mesh-ancestor
25105340|NCT03146533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105341|NCT03146533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105342|NCT03146533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25105345|NCT03146689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25105346|NCT03146689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25105347|NCT03146689|Analgesics|analgesics|mesh-ancestor
25105348|NCT03146689|Sensory System Agents|sensory system agents|mesh-ancestor
25105349|NCT03146689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25225326|NCT02627989|Diflucortolone|diflucortolone|mesh-list
25225327|NCT02627989|Diflucortolone valerate|diflucortolone valerate|mesh-list
25225328|NCT02627989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25225329|NCT02627989|Glucocorticoids|glucocorticoids|mesh-ancestor
25225330|NCT02627989|Hormones|hormones|mesh-ancestor
25225331|NCT02627989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25225332|NCT02627989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225333|NCT02627950|Metoclopramide|metoclopramide|mesh-list
25225334|NCT02627950|Ticagrelor|ticagrelor|mesh-list
24473550|NCT00403286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24838911|NCT02201121|Phenylephrine|phenylephrine|mesh-list
24838912|NCT02201121|Dopamine|dopamine|mesh-list
24838913|NCT02201121|Oxymetazoline|oxymetazoline|mesh-list
24838914|NCT02201121|Ephedrine|ephedrine|mesh-list
24838915|NCT02201121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24838916|NCT02201121|Mydriatics|mydriatics|mesh-ancestor
24838917|NCT02201121|Autonomic Agents|autonomic agents|mesh-ancestor
24838918|NCT02201121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838919|NCT02201121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751782|NCT01706172|Lidocaine|lidocaine|mesh-list
24838923|NCT02201121|Respiratory System Agents|respiratory system agents|mesh-ancestor
24975520|NCT03520686|Tubulin Modulators|tubulin modulators|mesh-ancestor
25105350|NCT03146689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105351|NCT03146689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25105352|NCT03146689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25105381|NCT03146377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783198|NCT01900587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24783199|NCT01900587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783200|NCT01900587|Adrenergic Agents|adrenergic agents|mesh-ancestor
24783201|NCT01900587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25105383|NCT03146390|Sodium Fluoride|sodium fluoride|mesh-list
25105384|NCT03146390|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25105385|NCT03146390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25105386|NCT03146390|Cariostatic Agents|cariostatic agents|mesh-ancestor
24975024|NCT04818216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975025|NCT04818216|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24975026|NCT04818216|Antimetabolites|antimetabolites|mesh-ancestor
24975027|NCT04818216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975028|NCT04818216|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24975029|NCT04818216|Vasodilator Agents|vasodilator agents|mesh-ancestor
24975033|NCT04788667|Erenumab|erenumab|mesh-list
24975034|NCT04788667|Botulinum Toxins|botulinum toxins|mesh-list
24975035|NCT04788667|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24975036|NCT04788667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24975057|NCT04776499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975058|NCT04776499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24975059|NCT04776499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24975060|NCT04776499|Dopamine Agents|dopamine agents|mesh-ancestor
24975061|NCT04776499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24975062|NCT04776499|Antimetabolites|antimetabolites|mesh-ancestor
24975063|NCT04776499|Antithyroid Agents|antithyroid agents|mesh-ancestor
24975064|NCT04776499|Hormone Antagonists|hormone antagonists|mesh-ancestor
24794925|NCT04146935|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25225336|NCT02627950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25225337|NCT02627950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25225338|NCT02627950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25225339|NCT02627950|Purinergic Agents|purinergic agents|mesh-ancestor
25225340|NCT02627950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25225341|NCT02627950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225342|NCT02627950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225343|NCT02627950|Antiemetics|antiemetics|mesh-ancestor
25225344|NCT02627950|Autonomic Agents|autonomic agents|mesh-ancestor
24838924|NCT02201121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24838925|NCT02201121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24838926|NCT02201121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24838927|NCT02201121|Adrenergic Agents|adrenergic agents|mesh-ancestor
24838928|NCT02201121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24838929|NCT02201121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838930|NCT02201121|Protective Agents|protective agents|mesh-ancestor
24838931|NCT02201121|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24838932|NCT02201121|Dopamine Agents|dopamine agents|mesh-ancestor
24975080|NCT04756427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975081|NCT04753749|Aspirin|aspirin|mesh-list
24975082|NCT04753749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24975084|NCT04753749|Analgesics|analgesics|mesh-ancestor
24913201|NCT04267679|Anticonvulsants|anticonvulsants|mesh-ancestor
24975119|NCT04732910|Ivacaftor|ivacaftor|mesh-list
24975120|NCT04732910|Elexacaftor|elexacaftor|mesh-list
24975121|NCT04732910|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24975122|NCT04732910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24975123|NCT04732910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529237|NCT00625170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989563|NCT05008887|Antimetabolites|antimetabolites|mesh-ancestor
24794908|NCT04222283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24794909|NCT04222283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24794910|NCT04160052|Azacitidine|azacitidine|mesh-list
24794912|NCT04160052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24794913|NCT04160052|Antimetabolites|antimetabolites|mesh-ancestor
24794914|NCT04160052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794915|NCT04160052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24794916|NCT04160052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225352|NCT02627807|Docetaxel|docetaxel|mesh-list
25225353|NCT02627807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225354|NCT02627807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24838933|NCT02201134|Sevoflurane|sevoflurane|mesh-list
24838934|NCT02201134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24838935|NCT02201134|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24838936|NCT02201134|Anesthetics, General|anesthetics, general|mesh-ancestor
24838937|NCT02201134|Anesthetics|anesthetics|mesh-ancestor
24838938|NCT02201134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24838939|NCT02201134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838941|NCT02201199|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24838942|NCT02201199|Insulin Glargine|insulin glargine|mesh-list
24838943|NCT02201199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24838944|NCT02201199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838945|NCT02201225|Micronutrients|micronutrients|mesh-list
24838946|NCT02201225|Trace Elements|trace elements|mesh-list
24838947|NCT02201225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838948|NCT02201238|Diclofenac|diclofenac|mesh-list
24838949|NCT02201238|Menthol|menthol|mesh-list
24838950|NCT02201238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25026177|NCT03631602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026178|NCT03631602|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25026179|NCT03631602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25026180|NCT03631563|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25026181|NCT03631563|Immunologic Factors|immunologic factors|mesh-ancestor
24975147|NCT04698031|Antipyretics|antipyretics|mesh-ancestor
24975148|NCT04698031|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24975149|NCT04698031|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24975150|NCT04698031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24975151|NCT04698031|Purinergic Agents|purinergic agents|mesh-ancestor
24975152|NCT04698031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24975153|NCT04689347|Leucovorin|leucovorin|mesh-list
24975154|NCT04689347|Bevacizumab|bevacizumab|mesh-list
24975155|NCT04689347|Fluorouracil|fluorouracil|mesh-list
24975156|NCT04689347|Irinotecan|irinotecan|mesh-list
24975157|NCT04689347|Temozolomide|temozolomide|mesh-list
24975210|NCT04623684|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24975211|NCT04623684|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24975212|NCT04623684|Adrenergic Agents|adrenergic agents|mesh-ancestor
24975213|NCT04623684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24975214|NCT04623684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975215|NCT04623684|Protective Agents|protective agents|mesh-ancestor
24975216|NCT04623684|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24975217|NCT04623684|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24975218|NCT04623684|Cholinergic Agents|cholinergic agents|mesh-ancestor
24975219|NCT04621981|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24975256|NCT04511702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24975257|NCT04421378|Bevacizumab|bevacizumab|mesh-list
24975258|NCT04421378|Temozolomide|temozolomide|mesh-list
24975259|NCT04421378|Carmustine|carmustine|mesh-list
24975260|NCT04421378|Lomustine|lomustine|mesh-list
25225355|NCT02627807|Antimetabolites|antimetabolites|mesh-ancestor
25225356|NCT02627807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225357|NCT02627807|Antiviral Agents|antiviral agents|mesh-ancestor
25225358|NCT02627807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25225359|NCT02627807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225360|NCT02627807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25225361|NCT02627807|Immunologic Factors|immunologic factors|mesh-ancestor
25225362|NCT02627807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225363|NCT02627807|Tubulin Modulators|tubulin modulators|mesh-ancestor
25225364|NCT02627807|Antimitotic Agents|antimitotic agents|mesh-ancestor
25225365|NCT02627807|Mitosis Modulators|mitosis modulators|mesh-ancestor
25273284|NCT02386475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25273285|NCT02386475|Parasympatholytics|parasympatholytics|mesh-ancestor
25273286|NCT02386475|Autonomic Agents|autonomic agents|mesh-ancestor
25273287|NCT02386475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25273288|NCT02386475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25273289|NCT02386475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25273290|NCT02386475|Cholinergic Agents|cholinergic agents|mesh-ancestor
25273291|NCT02386475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25273292|NCT02386475|Immunologic Factors|immunologic factors|mesh-ancestor
25273293|NCT02386475|Dopamine Agonists|dopamine agonists|mesh-ancestor
24838960|NCT02201238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838962|NCT02201238|Dermatologic Agents|dermatologic agents|mesh-ancestor
24838964|NCT02201316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838965|NCT02201316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24838966|NCT02201316|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24838967|NCT02201316|Serotonin Agents|serotonin agents|mesh-ancestor
24838968|NCT02201316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25680934|NCT01856114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25680935|NCT01856114|Narcotics|narcotics|mesh-ancestor
25680936|NCT01856114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25680937|NCT01856114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680938|NCT01856114|Analgesics|analgesics|mesh-ancestor
25680939|NCT01856114|Sensory System Agents|sensory system agents|mesh-ancestor
25680940|NCT01856114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25680941|NCT01856114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25680942|NCT01856114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25680943|NCT01856114|Anesthetics, General|anesthetics, general|mesh-ancestor
25026290|NCT03630042|Immunologic Factors|immunologic factors|mesh-ancestor
25026294|NCT03630029|Hematinics|hematinics|mesh-ancestor
24838969|NCT02201316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838970|NCT02201342|Udenafil|udenafil|mesh-list
24838971|NCT02201342|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24838972|NCT02201342|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24838973|NCT02201342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24838974|NCT02201342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975278|NCT04401384|Doxylamine|doxylamine|mesh-list
24975279|NCT04401384|Dicyclomine|dicyclomine|mesh-list
24975280|NCT04401384|Antiemetics|antiemetics|mesh-ancestor
24975281|NCT04401384|Autonomic Agents|autonomic agents|mesh-ancestor
24975282|NCT04401384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24975283|NCT04401384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975284|NCT04401384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24975285|NCT04401384|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24975286|NCT04401384|Histamine Antagonists|histamine antagonists|mesh-ancestor
24975287|NCT04401384|Histamine Agents|histamine agents|mesh-ancestor
24975288|NCT04401384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24975289|NCT04401384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975290|NCT04401384|Parasympatholytics|parasympatholytics|mesh-ancestor
24975291|NCT04401384|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24975292|NCT04401384|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24975293|NCT04401384|Cholinergic Agents|cholinergic agents|mesh-ancestor
24975294|NCT04401384|Vitamin B Complex|vitamin b complex|mesh-ancestor
24975296|NCT04401384|Micronutrients|micronutrients|mesh-ancestor
24975297|NCT04276493|Docetaxel|docetaxel|mesh-list
24975298|NCT04276493|Capecitabine|capecitabine|mesh-list
24975299|NCT04276493|Oxaliplatin|oxaliplatin|mesh-list
24975300|NCT04276493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24975301|NCT04276493|Tubulin Modulators|tubulin modulators|mesh-ancestor
24975302|NCT04276493|Antimitotic Agents|antimitotic agents|mesh-ancestor
24975303|NCT04276493|Mitosis Modulators|mitosis modulators|mesh-ancestor
24975361|NCT03968822|Bupivacaine|bupivacaine|mesh-list
24975362|NCT03968822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24975363|NCT03968822|Anesthetics, Local|anesthetics, local|mesh-ancestor
24975364|NCT03968822|Anesthetics|anesthetics|mesh-ancestor
24975365|NCT03968822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24975366|NCT03968822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975367|NCT03968822|Sensory System Agents|sensory system agents|mesh-ancestor
24975368|NCT03968822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24975369|NCT03968822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25225379|NCT02627573|Cyclophosphamide|cyclophosphamide|mesh-list
25225380|NCT02627573|Busulfan|busulfan|mesh-list
25225381|NCT02627573|Fludarabine|fludarabine|mesh-list
25225382|NCT02627573|Fludarabine phosphate|fludarabine phosphate|mesh-list
25225383|NCT02627573|Tacrolimus|tacrolimus|mesh-list
25225384|NCT02627573|Thymoglobulin|thymoglobulin|mesh-list
25225385|NCT02627573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25225386|NCT02627573|Immunologic Factors|immunologic factors|mesh-ancestor
25680944|NCT01856114|Anesthetics|anesthetics|mesh-ancestor
25680945|NCT01856257|Mycophenolic Acid|mycophenolic acid|mesh-list
25680946|NCT01856257|Methylprednisolone|methylprednisolone|mesh-list
25680947|NCT01856257|Abatacept|abatacept|mesh-list
25680948|NCT01856257|Tacrolimus|tacrolimus|mesh-list
25680949|NCT01856257|Thymoglobulin|thymoglobulin|mesh-list
25680950|NCT01856257|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25680951|NCT01856257|Basiliximab|basiliximab|mesh-list
25680952|NCT01856257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25680953|NCT01856257|Immunologic Factors|immunologic factors|mesh-ancestor
25680954|NCT01856257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680955|NCT01856257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25026321|NCT03629600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026322|NCT03629600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25026323|NCT03629600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25026324|NCT03629600|Gout Suppressants|gout suppressants|mesh-ancestor
25026325|NCT03629600|Tocolytic Agents|tocolytic agents|mesh-ancestor
25026326|NCT03629600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25026327|NCT03629600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24838999|NCT02201407|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24839000|NCT02201407|Antiviral Agents|antiviral agents|mesh-ancestor
24839001|NCT02201407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24839003|NCT02201459|Interferon-alpha|interferon-alpha|mesh-list
24839004|NCT02201459|Interferon alpha-2|interferon alpha-2|mesh-list
24975372|NCT03968822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24913460|NCT04264039|Fludarabine|fludarabine|mesh-list
24975409|NCT03822013|Miglustat|miglustat|mesh-list
24975410|NCT03822013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24975411|NCT03822013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975412|NCT03822013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24975413|NCT03822013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24975414|NCT03822013|Antiviral Agents|antiviral agents|mesh-ancestor
24975415|NCT03822013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24975416|NCT03822013|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24975417|NCT03822013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24975418|NCT03822013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975440|NCT03692403|Dopamine Agonists|dopamine agonists|mesh-ancestor
24975441|NCT03692403|Dopamine Agents|dopamine agents|mesh-ancestor
24975442|NCT03692403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24975443|NCT03692403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975444|NCT03692403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975445|NCT03680274|Ascorbic Acid|ascorbic acid|mesh-list
24975446|NCT03680274|Vitamins|vitamins|mesh-ancestor
24794966|NCT04131504|Adalimumab|adalimumab|mesh-list
24794968|NCT04131504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24794969|NCT04131504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24794970|NCT04131504|Dermatologic Agents|dermatologic agents|mesh-ancestor
24975482|NCT03593811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24975483|NCT03593811|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24975484|NCT03593811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24975485|NCT03593811|Histamine Antagonists|histamine antagonists|mesh-ancestor
24975486|NCT03593811|Histamine Agents|histamine agents|mesh-ancestor
25225387|NCT02627573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225388|NCT02627573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25225389|NCT02627573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25225390|NCT02627573|Alkylating Agents|alkylating agents|mesh-ancestor
25225391|NCT02627573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225392|NCT02627573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225393|NCT02627573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25225394|NCT02627573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25225395|NCT02627573|Antimetabolites|antimetabolites|mesh-ancestor
25225396|NCT02627573|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25225397|NCT02627573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225398|NCT02627573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25225399|NCT02627573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24839015|NCT02201576|Immunoglobulins|immunoglobulins|mesh-list
24839016|NCT02201576|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24839017|NCT02201576|Antibodies|antibodies|mesh-list
24839018|NCT02201576|gamma-Globulins|gamma-globulins|mesh-list
24839019|NCT02201576|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24839020|NCT02201576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24839021|NCT02201576|Immunologic Factors|immunologic factors|mesh-ancestor
24839022|NCT02201576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839023|NCT02201602|Gliclazide|gliclazide|mesh-list
24839024|NCT02201602|Glyburide|glyburide|mesh-list
24839025|NCT02201602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24839026|NCT02201602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680956|NCT01856257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25680957|NCT01856257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680958|NCT01856257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25680959|NCT01856257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25680960|NCT01856257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25680961|NCT01856257|Antitubercular Agents|antitubercular agents|mesh-ancestor
25680962|NCT01856257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25680963|NCT01856257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24839027|NCT02201641|Calcium|calcium|mesh-list
25026469|NCT03628430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25026470|NCT03628430|Respiratory System Agents|respiratory system agents|mesh-ancestor
25026472|NCT03628430|Sympathomimetics|sympathomimetics|mesh-ancestor
25026473|NCT03628430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24591465|NCT00916890|Fentanyl|fentanyl|mesh-list
25026491|NCT03628300|Piperacillin|piperacillin|mesh-list
25026492|NCT03628300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25026493|NCT03628300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25026494|NCT03628131|Carboplatin|carboplatin|mesh-list
25026524|NCT03628040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839028|NCT02201641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24597974|NCT00953108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24839029|NCT02201641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598130|NCT00954135|Cyclophosphamide|cyclophosphamide|mesh-list
24839030|NCT02201667|Aspirin|aspirin|mesh-list
24839033|NCT02201667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24839034|NCT02201667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24839035|NCT02201667|Analgesics|analgesics|mesh-ancestor
24839036|NCT02201667|Sensory System Agents|sensory system agents|mesh-ancestor
24839037|NCT02201667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24839038|NCT02201667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839039|NCT02201667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24839040|NCT02201667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24839041|NCT02201667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24839042|NCT02201667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24940492|NCT04001348|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24975487|NCT03593811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24975488|NCT03572764|Cytarabine|cytarabine|mesh-list
24975489|NCT03572764|Daunorubicin|daunorubicin|mesh-list
24975490|NCT03572764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24975491|NCT03572764|Antimetabolites|antimetabolites|mesh-ancestor
24975492|NCT03572764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975493|NCT03572764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24975494|NCT03572764|Antiviral Agents|antiviral agents|mesh-ancestor
24975495|NCT03572764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24975496|NCT03572764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24975497|NCT03572764|Immunologic Factors|immunologic factors|mesh-ancestor
24975498|NCT03572764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975499|NCT03572764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24975500|NCT03572764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25225400|NCT02627573|Antitubercular Agents|antitubercular agents|mesh-ancestor
25225401|NCT02627573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25225402|NCT02627573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25225403|NCT02627560|Tranexamic Acid|tranexamic acid|mesh-list
25225404|NCT02627560|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25225405|NCT02627560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25225406|NCT02627560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225407|NCT02627560|Hemostatics|hemostatics|mesh-ancestor
25225408|NCT02627560|Coagulants|coagulants|mesh-ancestor
25225409|NCT02627521|Ticagrelor|ticagrelor|mesh-list
25225410|NCT02627521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25225411|NCT02627521|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25225412|NCT02627521|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25225413|NCT02627521|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25225414|NCT02627521|Purinergic Agents|purinergic agents|mesh-ancestor
25225415|NCT02627521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25225416|NCT02627521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25680964|NCT01856257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25680965|NCT01856257|Antiemetics|antiemetics|mesh-ancestor
25680966|NCT01856257|Autonomic Agents|autonomic agents|mesh-ancestor
25680967|NCT01856257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25680968|NCT01856257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25680969|NCT01856257|Glucocorticoids|glucocorticoids|mesh-ancestor
25680970|NCT01856257|Hormones|hormones|mesh-ancestor
25680971|NCT01856257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25680972|NCT01856257|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25680973|NCT01856257|Protective Agents|protective agents|mesh-ancestor
25680974|NCT01856257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25680975|NCT01856257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25680976|NCT01856309|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25026597|NCT03626519|Dermatologic Agents|dermatologic agents|mesh-ancestor
25225417|NCT02627521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225418|NCT02627534|Anti-Infective Agents|anti-infective agents|mesh-list
25225419|NCT02627534|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25225420|NCT02627456|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25225422|NCT02627456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25225423|NCT02627456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25225424|NCT02627456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25225425|NCT02627469|Listerine|listerine|mesh-list
25225426|NCT02627469|Fluorides|fluorides|mesh-list
25225427|NCT02627469|Sodium Fluoride|sodium fluoride|mesh-list
25225428|NCT02627469|Cariostatic Agents|cariostatic agents|mesh-ancestor
25225429|NCT02627469|Protective Agents|protective agents|mesh-ancestor
24839043|NCT02201667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839044|NCT02201667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24839045|NCT02201667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24839046|NCT02201667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24839051|NCT02201667|Purinergic Agents|purinergic agents|mesh-ancestor
24839052|NCT02201667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24839053|NCT02201849|Dimethyl Fumarate|dimethyl fumarate|mesh-list
24778448|NCT01870895|Serotonin Agents|serotonin agents|mesh-ancestor
24975501|NCT03572764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24975502|NCT03572764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24975503|NCT03559010|Norgestrel|norgestrel|mesh-list
24975504|NCT03559010|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24975505|NCT03559010|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24975506|NCT03559010|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25105391|NCT03146247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25105392|NCT03146247|Analgesics|analgesics|mesh-ancestor
25105393|NCT03146247|Sensory System Agents|sensory system agents|mesh-ancestor
25105394|NCT03146247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25105395|NCT03146247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105396|NCT03146247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25105397|NCT03146247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25105398|NCT03146247|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25105399|NCT03146247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25105400|NCT03146247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25105401|NCT03146247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105402|NCT03146000|Meloxicam|meloxicam|mesh-list
25105403|NCT03146000|Lidocaine|lidocaine|mesh-list
25105404|NCT03146000|Prilocaine|prilocaine|mesh-list
25105405|NCT03146000|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25105406|NCT03146000|Anesthetics, Local|anesthetics, local|mesh-ancestor
25105407|NCT03146000|Anesthetics|anesthetics|mesh-ancestor
25105408|NCT03146000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25105409|NCT03146000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105437|NCT03146325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25105438|NCT03146325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105439|NCT03146325|Antacids|antacids|mesh-ancestor
25105440|NCT03146325|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25105441|NCT03146052|Simethicone|simethicone|mesh-list
25105442|NCT03146052|Bisacodyl|bisacodyl|mesh-list
24863700|NCT03749616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25105443|NCT03146052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105444|NCT03146052|Cathartics|cathartics|mesh-ancestor
25105445|NCT03146052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25105446|NCT03146052|Laxatives|laxatives|mesh-ancestor
25105447|NCT03146052|Antifoaming Agents|antifoaming agents|mesh-ancestor
25105448|NCT03146052|Emollients|emollients|mesh-ancestor
25105449|NCT03146052|Dermatologic Agents|dermatologic agents|mesh-ancestor
24975524|NCT03520686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24975525|NCT03520686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24975526|NCT03520686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24975545|NCT03476603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24975546|NCT03476603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24975547|NCT03476603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24975569|NCT03476538|Gabapentin|gabapentin|mesh-list
24975570|NCT03476538|Analgesics|analgesics|mesh-ancestor
24975571|NCT03476538|Sensory System Agents|sensory system agents|mesh-ancestor
24975572|NCT03476538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24975573|NCT03476538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975574|NCT03476538|Anticonvulsants|anticonvulsants|mesh-ancestor
24975575|NCT03476538|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24975576|NCT03476538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24975577|NCT03476538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25225431|NCT02627469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25225432|NCT02627469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25225433|NCT02627417|Dapsone|dapsone|mesh-list
25225434|NCT02627417|Prednisone|prednisone|mesh-list
25225435|NCT02627417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25225436|NCT02627417|Glucocorticoids|glucocorticoids|mesh-ancestor
25225437|NCT02627417|Hormones|hormones|mesh-ancestor
25273294|NCT02386475|Dopamine Agents|dopamine agents|mesh-ancestor
24839054|NCT02201849|Dermatologic Agents|dermatologic agents|mesh-ancestor
24839055|NCT02201849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24839056|NCT02201849|Immunologic Factors|immunologic factors|mesh-ancestor
24839057|NCT02201849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839058|NCT02201914|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24839059|NCT02201914|Clomiphene|clomiphene|mesh-list
24839060|NCT02201914|Enclomiphene|enclomiphene|mesh-list
24839061|NCT02201914|Zuclomiphene|zuclomiphene|mesh-list
24839062|NCT02201914|Cetrorelix|cetrorelix|mesh-list
24839063|NCT02201914|Luteolytic Agents|luteolytic agents|mesh-ancestor
24975579|NCT03476538|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24975580|NCT03476538|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24975581|NCT03476538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24975582|NCT03476538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975583|NCT03476538|Antimanic Agents|antimanic agents|mesh-ancestor
24975584|NCT03476525|Fluoxetine|fluoxetine|mesh-list
24975585|NCT03476525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24975586|NCT03476525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24975587|NCT03476525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24975588|NCT03476525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975589|NCT03476525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24975590|NCT03476525|Serotonin Agents|serotonin agents|mesh-ancestor
24975591|NCT03476525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526328|NCT00611169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24975592|NCT03476525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24975593|NCT03476525|Antidepressive Agents|antidepressive agents|mesh-ancestor
24975594|NCT03476525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24975595|NCT03476525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24975596|NCT03476525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24975597|NCT03476525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24975598|NCT03440112|Clarithromycin|clarithromycin|mesh-list
24431125|NCT00250393|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24975623|NCT03434262|Immunologic Factors|immunologic factors|mesh-ancestor
24975624|NCT03434262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975625|NCT03434262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24975626|NCT03425838|Letrozole|letrozole|mesh-list
24975627|NCT03425838|Fulvestrant|fulvestrant|mesh-list
24975628|NCT03425838|Palbociclib|palbociclib|mesh-list
24975629|NCT03425838|Anastrozole|anastrozole|mesh-list
24975630|NCT03425838|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24975631|NCT03425838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24975632|NCT03425838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24975633|NCT03425838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24975637|NCT03425838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25225440|NCT02627417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25225441|NCT02627417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225442|NCT02627417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25225443|NCT02627417|Antimalarials|antimalarials|mesh-ancestor
25225444|NCT02627417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25225445|NCT02627417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25225446|NCT02627417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25225447|NCT02627417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225448|NCT02627417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225449|NCT02627417|Leprostatic Agents|leprostatic agents|mesh-ancestor
25225450|NCT02627417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25225451|NCT02627430|Talazoparib|talazoparib|mesh-list
24839064|NCT02201914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24839066|NCT02201914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24839067|NCT02201914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839068|NCT02201914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24839069|NCT02201914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24839070|NCT02201914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24839071|NCT02201914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24839072|NCT02201914|Hormone Antagonists|hormone antagonists|mesh-ancestor
24839073|NCT02201914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24839074|NCT02201914|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24839075|NCT02201914|Fertility Agents|fertility agents|mesh-ancestor
24975656|NCT03364244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989759|NCT04820205|Chloral Hydrate|chloral hydrate|mesh-list
24975657|NCT03364244|Urological Agents|urological agents|mesh-ancestor
24975668|NCT03323151|Ixazomib|ixazomib|mesh-list
24975669|NCT03323151|Glycine|glycine|mesh-list
24975670|NCT03323151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24975671|NCT03323151|Protease Inhibitors|protease inhibitors|mesh-ancestor
24975672|NCT03323151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24975673|NCT03323151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975674|NCT03323151|Glycine Agents|glycine agents|mesh-ancestor
24975675|NCT03323151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24975676|NCT03323151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975677|NCT03286114|Pembrolizumab|pembrolizumab|mesh-list
24975679|NCT03286114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795018|NCT03915405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24795019|NCT03915405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795043|NCT03831113|Buprenorphine|buprenorphine|mesh-list
24795044|NCT03831113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24795045|NCT03831113|Narcotics|narcotics|mesh-ancestor
24795046|NCT03831113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24795048|NCT03831113|Analgesics|analgesics|mesh-ancestor
24795063|NCT03783013|Antioxidants|antioxidants|mesh-ancestor
24795064|NCT03783013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795070|NCT03781414|Tacrolimus|tacrolimus|mesh-list
24795071|NCT03781414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24795072|NCT03781414|Immunologic Factors|immunologic factors|mesh-ancestor
25225452|NCT02627430|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25225453|NCT02627430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225454|NCT02627430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225455|NCT02627430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225456|NCT02627053|Rivaroxaban|rivaroxaban|mesh-list
25225457|NCT02627053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25225458|NCT02627053|Antithrombins|antithrombins|mesh-ancestor
25225459|NCT02627053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25225460|NCT02627053|Protease Inhibitors|protease inhibitors|mesh-ancestor
25225461|NCT02627053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225462|NCT02627053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225463|NCT02627053|Anticoagulants|anticoagulants|mesh-ancestor
25225464|NCT02627222|Vitamin A|vitamin a|mesh-list
25225465|NCT02627222|Provitamins|provitamins|mesh-list
25225466|NCT02627222|Vitamins|vitamins|mesh-ancestor
25225467|NCT02627222|Micronutrients|micronutrients|mesh-ancestor
24839076|NCT02201914|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24839077|NCT02201914|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24839079|NCT02202005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24839080|NCT02202005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24839081|NCT02202005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24839082|NCT02202005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056957|NCT03508635|Prednisone|prednisone|mesh-list
24795073|NCT03781414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795074|NCT03781414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24795075|NCT03781414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795076|NCT03781414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795077|NCT03773237|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24795079|NCT03773237|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24588369|NCT00902395|GABA Modulators|gaba modulators|mesh-ancestor
24795080|NCT03773237|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24795081|NCT03773237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24795082|NCT03762473|Tacrolimus|tacrolimus|mesh-list
24975691|NCT03239145|Trebananib|trebananib|mesh-list
24975739|NCT03063749|Sirolimus|sirolimus|mesh-list
24975740|NCT03063749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24975741|NCT03063749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24975742|NCT03063749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24975743|NCT03063749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24975744|NCT03063749|Antifungal Agents|antifungal agents|mesh-ancestor
25105455|NCT03145714|Propofol|propofol|mesh-list
25105456|NCT03145714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25105457|NCT03145714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105458|NCT03145714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25105459|NCT03145714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25680977|NCT01856309|Immunologic Factors|immunologic factors|mesh-ancestor
25680978|NCT01856309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680979|NCT01856530|Oxytocin|oxytocin|mesh-list
25680980|NCT01856530|Oxytocics|oxytocics|mesh-ancestor
25680981|NCT01856530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25105460|NCT03145714|Anesthetics, General|anesthetics, general|mesh-ancestor
25105461|NCT03145714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25105462|NCT03145714|Analgesics|analgesics|mesh-ancestor
25105463|NCT03145714|Sensory System Agents|sensory system agents|mesh-ancestor
25105464|NCT03145714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25105465|NCT03145714|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25105466|NCT03145714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25105467|NCT03145714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25105468|NCT03145714|Adrenergic Agents|adrenergic agents|mesh-ancestor
25105469|NCT03145714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25105470|NCT03145714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105471|NCT03145610|Triclosan|triclosan|mesh-list
25105472|NCT03145610|Fluorides|fluorides|mesh-list
25105473|NCT03145610|Cariostatic Agents|cariostatic agents|mesh-ancestor
25105474|NCT03145610|Protective Agents|protective agents|mesh-ancestor
25105475|NCT03145610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105485|NCT03146104|Propofol|propofol|mesh-list
25105507|NCT03145675|Enoxaparin sodium|enoxaparin sodium|mesh-list
25105508|NCT03145675|Anticoagulants|anticoagulants|mesh-ancestor
25105509|NCT03145675|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25105510|NCT03145675|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25105511|NCT03145675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105512|NCT03145558|Doxorubicin|doxorubicin|mesh-list
25105513|NCT03145558|Tirapazamine|tirapazamine|mesh-list
25105514|NCT03145558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25105515|NCT03145558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105516|NCT03145558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25105517|NCT03145558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25105518|NCT03145558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225468|NCT02627222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225469|NCT02627027|Metformin|metformin|mesh-list
25225470|NCT02627027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25225471|NCT02627027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225472|NCT02627248|Cyclophosphamide|cyclophosphamide|mesh-list
25225473|NCT02627248|Docetaxel|docetaxel|mesh-list
25225474|NCT02627248|Epirubicin|epirubicin|mesh-list
25225475|NCT02627248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25225476|NCT02627248|Immunologic Factors|immunologic factors|mesh-ancestor
25225477|NCT02627248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043327|NCT01275105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25043328|NCT01275105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25043329|NCT01275105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25043330|NCT01275105|Adrenergic Agents|adrenergic agents|mesh-ancestor
25043331|NCT01275105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25043332|NCT01275105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043334|NCT01275105|Sympathomimetics|sympathomimetics|mesh-ancestor
24839083|NCT02202005|Antiviral Agents|antiviral agents|mesh-ancestor
24473621|NCT00403533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25105519|NCT03145558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105520|NCT03145480|Obinutuzumab|obinutuzumab|mesh-list
25105521|NCT03145480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24975758|NCT03013998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24975759|NCT03013998|Antiviral Agents|antiviral agents|mesh-ancestor
24975777|NCT03011671|Diuretics|diuretics|mesh-ancestor
24975778|NCT03011671|Natriuretic Agents|natriuretic agents|mesh-ancestor
24975779|NCT03011671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975781|NCT03008616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24975782|NCT03008616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25680982|NCT01856530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680983|NCT01856543|Mometasone Furoate|mometasone furoate|mesh-list
25680984|NCT01856543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25680985|NCT01856543|Dermatologic Agents|dermatologic agents|mesh-ancestor
25680986|NCT01856543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25680987|NCT01856712|Naltrexone|naltrexone|mesh-list
25680988|NCT01856712|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24975785|NCT03008616|Protective Agents|protective agents|mesh-ancestor
24975786|NCT03008616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975787|NCT02947087|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
24975788|NCT02947087|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24975789|NCT02947087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24975790|NCT02947087|Protease Inhibitors|protease inhibitors|mesh-ancestor
24975791|NCT02947087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24975792|NCT02947087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975793|NCT02931695|Hormones|hormones|mesh-list
24975794|NCT02931695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24975795|NCT02931695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975796|NCT02921035|Interferons|interferons|mesh-list
24975797|NCT02921035|Interferon-beta|interferon-beta|mesh-list
24975798|NCT02921035|Interferon beta-1a|interferon beta-1a|mesh-list
24975799|NCT02921035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24975800|NCT02921035|Antiviral Agents|antiviral agents|mesh-ancestor
24975801|NCT02921035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24975802|NCT02921035|Immunologic Factors|immunologic factors|mesh-ancestor
24975803|NCT02921035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975804|NCT02921035|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24975805|NCT02885753|Leucovorin|leucovorin|mesh-list
24975806|NCT02885753|Folic Acid|folic acid|mesh-list
24975807|NCT02885753|Bevacizumab|bevacizumab|mesh-list
24975808|NCT02885753|Panitumumab|panitumumab|mesh-list
24975809|NCT02885753|Oxaliplatin|oxaliplatin|mesh-list
24975810|NCT02885753|Irinotecan|irinotecan|mesh-list
24975811|NCT02885753|Fluorouracil|fluorouracil|mesh-list
24975826|NCT02885753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24975827|NCT02885753|Immunologic Factors|immunologic factors|mesh-ancestor
24975828|NCT02885753|Antidotes|antidotes|mesh-ancestor
24975829|NCT02885753|Protective Agents|protective agents|mesh-ancestor
24975830|NCT02885753|Vitamin B Complex|vitamin b complex|mesh-ancestor
24975831|NCT02885753|Vitamins|vitamins|mesh-ancestor
24975832|NCT02885753|Micronutrients|micronutrients|mesh-ancestor
24975833|NCT02885753|Hematinics|hematinics|mesh-ancestor
24975834|NCT02836899|Nitric Oxide|nitric oxide|mesh-list
24975844|NCT02836899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25225478|NCT02627248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25225479|NCT02627248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25225480|NCT02627248|Alkylating Agents|alkylating agents|mesh-ancestor
25225481|NCT02627248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225482|NCT02627248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225483|NCT02627248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25225484|NCT02627248|Tubulin Modulators|tubulin modulators|mesh-ancestor
25225485|NCT02627248|Antimitotic Agents|antimitotic agents|mesh-ancestor
25225486|NCT02627248|Mitosis Modulators|mitosis modulators|mesh-ancestor
25225487|NCT02627248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25225488|NCT02627248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25225489|NCT02627248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25225490|NCT02627248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225491|NCT02626936|Insulin|insulin|mesh-list
24839094|NCT02202070|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24839095|NCT02202070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24839096|NCT02202070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975845|NCT02836899|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24975846|NCT02836899|Vasodilator Agents|vasodilator agents|mesh-ancestor
24975847|NCT02836899|Gasotransmitters|gasotransmitters|mesh-ancestor
24975851|NCT02824575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24975853|NCT02824575|Tubulin Modulators|tubulin modulators|mesh-ancestor
24975854|NCT02824575|Antimitotic Agents|antimitotic agents|mesh-ancestor
24975855|NCT02824575|Mitosis Modulators|mitosis modulators|mesh-ancestor
24975856|NCT02824575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975857|NCT02824575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24975858|NCT02824575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24975869|NCT02807181|Gemcitabine|gemcitabine|mesh-list
24975870|NCT02807181|Cisplatin|cisplatin|mesh-list
24975871|NCT02807181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24975872|NCT02807181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24975873|NCT02807181|Antimetabolites|antimetabolites|mesh-ancestor
25245812|NCT03685890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24975874|NCT02807181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975875|NCT02807181|Antiviral Agents|antiviral agents|mesh-ancestor
24975876|NCT02807181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24975877|NCT02807181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24975878|NCT02807181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24975879|NCT02807181|Immunologic Factors|immunologic factors|mesh-ancestor
24975880|NCT02807181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975881|NCT02749968|Bupivacaine|bupivacaine|mesh-list
24975882|NCT02749968|Anesthetics, Local|anesthetics, local|mesh-ancestor
24975883|NCT02749968|Anesthetics|anesthetics|mesh-ancestor
24975884|NCT02749968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24975885|NCT02749968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975886|NCT02749968|Sensory System Agents|sensory system agents|mesh-ancestor
24975887|NCT02749968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24975888|NCT02713776|Pasireotide|pasireotide|mesh-list
24975889|NCT02713776|Somatostatin|somatostatin|mesh-list
24975890|NCT02713776|Hormones|hormones|mesh-ancestor
24975891|NCT02713776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24975892|NCT02713776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975893|NCT02702414|Pembrolizumab|pembrolizumab|mesh-list
24975894|NCT02702414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24975895|NCT02702414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24975896|NCT02637531|Nivolumab|nivolumab|mesh-list
24975897|NCT02637531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24975898|NCT02637531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24975914|NCT02573233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24975915|NCT02573233|Respiratory System Agents|respiratory system agents|mesh-ancestor
24975916|NCT02573233|Dermatologic Agents|dermatologic agents|mesh-ancestor
24975917|NCT02573233|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24975939|NCT02439658|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24975940|NCT02439658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25225492|NCT02626936|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25225493|NCT02626936|Glucagon|glucagon|mesh-list
25225494|NCT02626936|Hormones|hormones|mesh-list
25225495|NCT02626936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25225496|NCT02626936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225497|NCT02626936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24839097|NCT02202070|Cholinergic Agents|cholinergic agents|mesh-ancestor
24975957|NCT02367846|Contraceptives, Oral|contraceptives, oral|mesh-list
24975958|NCT02367846|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
24975959|NCT02367846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24975960|NCT02367846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975961|NCT02367846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24975962|NCT02367846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24975963|NCT02274662|Cyclosporine|cyclosporine|mesh-list
24975964|NCT02274662|Tacrolimus|tacrolimus|mesh-list
24975965|NCT02274662|Cyclosporins|cyclosporins|mesh-list
24975966|NCT02274662|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24975967|NCT02274662|Thymoglobulin|thymoglobulin|mesh-list
24975968|NCT02274662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24975969|NCT02274662|Immunologic Factors|immunologic factors|mesh-ancestor
24975970|NCT02274662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975971|NCT02274662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24795083|NCT03762473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24795084|NCT03762473|Immunologic Factors|immunologic factors|mesh-ancestor
24795085|NCT03762473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795086|NCT03762473|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24795087|NCT03762473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795088|NCT03762473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975998|NCT02199665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24975999|NCT02199665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976000|NCT02143726|Everolimus|everolimus|mesh-list
24976001|NCT02143726|Sorafenib|sorafenib|mesh-list
24976002|NCT02143726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976003|NCT02143726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24976004|NCT02143726|Immunologic Factors|immunologic factors|mesh-ancestor
24976005|NCT02143726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976006|NCT02143726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24976007|NCT02143726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24976008|NCT02143726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432453|NCT00254800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25105523|NCT03145272|Oxycodone|oxycodone|mesh-list
24783406|NCT01901640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783407|NCT01901666|Hormones|hormones|mesh-list
24783408|NCT01901666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24783409|NCT01901666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783410|NCT01901692|Sorafenib|sorafenib|mesh-list
24783411|NCT01901692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783413|NCT01901692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783414|NCT01901692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783415|NCT01901861|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24783416|NCT01901861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24783417|NCT01901861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783418|NCT01901861|Incretins|incretins|mesh-ancestor
24783419|NCT01901861|Hormones|hormones|mesh-ancestor
24783420|NCT01901861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24783421|NCT01901861|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24783422|NCT01901861|Protease Inhibitors|protease inhibitors|mesh-ancestor
24783423|NCT01901861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783424|NCT01901861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783425|NCT01902017|Ketotifen|ketotifen|mesh-list
24783426|NCT01902017|Antipruritics|antipruritics|mesh-ancestor
24626054|NCT01085422|Veliparib|veliparib|mesh-list
24783427|NCT01902017|Dermatologic Agents|dermatologic agents|mesh-ancestor
24783428|NCT01902017|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24976047|NCT01842035|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24976048|NCT01842035|Purinergic Agonists|purinergic agonists|mesh-ancestor
24414572|NCT00198094|Serotonin Agents|serotonin agents|mesh-ancestor
25273295|NCT02386150|Vaccines|vaccines|mesh-list
24839098|NCT02202070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24839099|NCT02202200|Palbociclib|palbociclib|mesh-list
24839100|NCT02202200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24839101|NCT02202200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24839102|NCT02202200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25056980|NCT03508440|Prednisone|prednisone|mesh-list
24414579|NCT00198094|GABA Agents|gaba agents|mesh-ancestor
24414580|NCT00198120|Cycloserine|cycloserine|mesh-list
24414581|NCT00198120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24414582|NCT00198120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24414583|NCT00198120|Renal Agents|renal agents|mesh-ancestor
24414584|NCT00198120|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24414585|NCT00198120|Antitubercular Agents|antitubercular agents|mesh-ancestor
24414586|NCT00198120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24414587|NCT00198120|Antimetabolites|antimetabolites|mesh-ancestor
24976049|NCT01842035|Purinergic Agents|purinergic agents|mesh-ancestor
24976050|NCT01842035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24976051|NCT01842035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976052|NCT01842035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976053|NCT01751984|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
24976054|NCT01751984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24976055|NCT01751984|Antimetabolites|antimetabolites|mesh-ancestor
24976056|NCT01751984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976057|NCT01751984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24976058|NCT01751984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24976059|NCT01751984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24976060|NCT01751984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976061|NCT01732627|Vaccines|vaccines|mesh-list
24976062|NCT01732627|Immunologic Factors|immunologic factors|mesh-ancestor
24976071|NCT01702571|Antimitotic Agents|antimitotic agents|mesh-ancestor
24976077|NCT01578239|Octreotide|octreotide|mesh-list
24976082|NCT01578239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24976083|NCT01578239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976084|NCT01411267|Cytarabine|cytarabine|mesh-list
24976085|NCT01411267|Methotrexate|methotrexate|mesh-list
24976086|NCT01411267|Etoposide|etoposide|mesh-list
24976087|NCT01411267|Etoposide phosphate|etoposide phosphate|mesh-list
24976088|NCT01411267|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24976089|NCT01411267|Abortifacient Agents|abortifacient agents|mesh-ancestor
24976090|NCT01411267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24976091|NCT01411267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976092|NCT01411267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24976093|NCT01411267|Antimetabolites|antimetabolites|mesh-ancestor
24976094|NCT01411267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976095|NCT01411267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976096|NCT01411267|Dermatologic Agents|dermatologic agents|mesh-ancestor
24976097|NCT01411267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24976098|NCT01411267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24976099|NCT01411267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24976100|NCT01411267|Immunologic Factors|immunologic factors|mesh-ancestor
24976101|NCT01411267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24976102|NCT01411267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25680989|NCT01856712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25027506|NCT03619785|Hydrocodone|hydrocodone|mesh-list
25027507|NCT03619785|Bupivacaine|bupivacaine|mesh-list
25027508|NCT03619785|Anesthetics, Local|anesthetics, local|mesh-ancestor
25027509|NCT03619785|Anesthetics|anesthetics|mesh-ancestor
25027510|NCT03619785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25027564|NCT03619005|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25027565|NCT03619005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25027566|NCT03619005|Immunologic Factors|immunologic factors|mesh-ancestor
25027567|NCT03619005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027568|NCT03618953|Atezolizumab|atezolizumab|mesh-list
25027569|NCT03618953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25027570|NCT03618797|Fenofibrate|fenofibrate|mesh-list
25027571|NCT03618797|Pitavastatin|pitavastatin|mesh-list
25027572|NCT03618797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25027573|NCT03618797|Antimetabolites|antimetabolites|mesh-ancestor
25027574|NCT03618797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027575|NCT03618797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24976103|NCT01411267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24976104|NCT01411267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24914148|NCT04257812|Tazobactam|tazobactam|mesh-list
24976106|NCT01411267|Antiviral Agents|antiviral agents|mesh-ancestor
24976127|NCT01220531|Cyclosporine|cyclosporine|mesh-list
25225498|NCT02626936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25225499|NCT02626754|Sunitinib|sunitinib|mesh-list
25225500|NCT02626754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225501|NCT02626754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25225502|NCT02626754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25225503|NCT02626754|Growth Substances|growth substances|mesh-ancestor
24839103|NCT02202200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839104|NCT02202239|Fentanyl|fentanyl|mesh-list
24839105|NCT02202239|Midazolam|midazolam|mesh-list
24976128|NCT01220531|Mycophenolic Acid|mycophenolic acid|mesh-list
24976129|NCT01220531|Methylprednisolone|methylprednisolone|mesh-list
24976130|NCT01220531|Prednisolone|prednisolone|mesh-list
24976149|NCT01220531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24976150|NCT01220531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24976151|NCT01220531|Antiemetics|antiemetics|mesh-ancestor
24976152|NCT01220531|Autonomic Agents|autonomic agents|mesh-ancestor
24976153|NCT01220531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24976154|NCT01220531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24976155|NCT01220531|Glucocorticoids|glucocorticoids|mesh-ancestor
24976156|NCT01220531|Hormones|hormones|mesh-ancestor
24976162|NCT01155375|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24976164|NCT01155375|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24976165|NCT01155375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24976166|NCT01155375|Trace Elements|trace elements|mesh-ancestor
24976167|NCT01155375|Micronutrients|micronutrients|mesh-ancestor
24976168|NCT01155375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976169|NCT00785798|Doxorubicin|doxorubicin|mesh-list
24976170|NCT00785798|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24976171|NCT00785798|Vorinostat|vorinostat|mesh-list
24976172|NCT00785798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24976173|NCT00785798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976174|NCT00785798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24976175|NCT00785798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24976176|NCT00785798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24976177|NCT00785798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976178|NCT00785798|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24976180|NCT00673010|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24976181|NCT00673010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24976182|NCT00673010|Trace Elements|trace elements|mesh-ancestor
25680990|NCT01856712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680991|NCT01856712|Sensory System Agents|sensory system agents|mesh-ancestor
25680992|NCT01856712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25680993|NCT01856790|Liraglutide|liraglutide|mesh-list
25680994|NCT01856790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25680995|NCT01856790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25680996|NCT01856790|Incretins|incretins|mesh-ancestor
25680997|NCT01856790|Hormones|hormones|mesh-ancestor
25680998|NCT01856790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25680999|NCT01856907|Metformin|metformin|mesh-list
25681000|NCT01856907|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25681001|NCT01856907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25681002|NCT01856907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681003|NCT01856907|Incretins|incretins|mesh-ancestor
25681004|NCT01856907|Hormones|hormones|mesh-ancestor
25681005|NCT01856907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24976183|NCT00673010|Micronutrients|micronutrients|mesh-ancestor
24976184|NCT00673010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976185|NCT00566488|Parathyroid Hormone|parathyroid hormone|mesh-list
24976186|NCT00566488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24976187|NCT00566488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976189|NCT00360425|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24976190|NCT00360425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24976191|NCT00360425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24976192|NCT00360425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24976193|NCT00360425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24976207|NCT00346125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24976208|NCT00346125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24976209|NCT00346125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976210|NCT00346125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24976211|NCT00346125|Alkylating Agents|alkylating agents|mesh-ancestor
24976212|NCT00346125|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24976213|NCT00233597|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24976215|NCT00233597|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24976216|NCT00233597|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24976217|NCT04335669|Paclitaxel|paclitaxel|mesh-list
24976218|NCT04335669|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24976219|NCT04335669|Cyclophosphamide|cyclophosphamide|mesh-list
24976220|NCT04335669|Carboplatin|carboplatin|mesh-list
24976224|NCT04335669|Antimetabolites|antimetabolites|mesh-list
24976225|NCT04335669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24976226|NCT04335669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976227|NCT04335669|Tubulin Modulators|tubulin modulators|mesh-ancestor
24976228|NCT04335669|Antimitotic Agents|antimitotic agents|mesh-ancestor
24976229|NCT04335669|Mitosis Modulators|mitosis modulators|mesh-ancestor
24976230|NCT04335669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976231|NCT04335669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24976232|NCT04335669|Immunologic Factors|immunologic factors|mesh-ancestor
24976233|NCT04335669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976234|NCT04335669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24976235|NCT04335669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24795117|NCT03626922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225504|NCT02626754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225505|NCT02626754|Growth Inhibitors|growth inhibitors|mesh-ancestor
25225506|NCT02626754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24839108|NCT02202239|Etomidate|etomidate|mesh-list
24839109|NCT02202239|Sevoflurane|sevoflurane|mesh-list
24839110|NCT02202239|Cisatracurium|cisatracurium|mesh-list
24795118|NCT03626922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795119|NCT03626922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24795120|NCT03626922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24795121|NCT03626922|Hematinics|hematinics|mesh-ancestor
24795122|NCT03626922|Vitamin B Complex|vitamin b complex|mesh-ancestor
24976236|NCT04335669|Alkylating Agents|alkylating agents|mesh-ancestor
24976237|NCT04335669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24976239|NCT04335669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24976240|NCT04335669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24976241|NCT04335669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24976242|NCT04335669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24976243|NCT04327999|Lubricant Eye Drops|lubricant eye drops|mesh-list
24976244|NCT04327999|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24976245|NCT04327999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24976246|NCT04323189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24976247|NCT04323189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24976248|NCT04323189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976249|NCT04323189|Incretins|incretins|mesh-ancestor
24976250|NCT04323189|Hormones|hormones|mesh-ancestor
24976251|NCT04323189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24976252|NCT04323189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24976253|NCT04323189|Protease Inhibitors|protease inhibitors|mesh-ancestor
24976254|NCT04323189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24976255|NCT04323189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976256|NCT04282811|Venetoclax|venetoclax|mesh-list
24976257|NCT04282811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976258|NCT04279197|Ascorbic Acid|ascorbic acid|mesh-list
24976259|NCT04279197|Vitamins|vitamins|mesh-ancestor
24976260|NCT04279197|Micronutrients|micronutrients|mesh-ancestor
24976261|NCT04279197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976262|NCT04279197|Antioxidants|antioxidants|mesh-ancestor
24783429|NCT01902017|Histamine Antagonists|histamine antagonists|mesh-ancestor
24783431|NCT01902017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24783432|NCT01902017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783433|NCT01902017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783434|NCT01902017|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24783435|NCT01902108|Clonidine|clonidine|mesh-list
24783436|NCT01902108|Bupivacaine|bupivacaine|mesh-list
24783437|NCT01902108|Anesthetics, Local|anesthetics, local|mesh-ancestor
24783438|NCT01902108|Anesthetics|anesthetics|mesh-ancestor
24783439|NCT01902108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24783440|NCT01902108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783441|NCT01902108|Sensory System Agents|sensory system agents|mesh-ancestor
24976663|NCT05275777|Antimitotic Agents|antimitotic agents|mesh-ancestor
24783442|NCT01902108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24783443|NCT01902108|Analgesics|analgesics|mesh-ancestor
24783444|NCT01902108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24783445|NCT01902108|Sympatholytics|sympatholytics|mesh-ancestor
24783446|NCT01902108|Autonomic Agents|autonomic agents|mesh-ancestor
24783447|NCT01902108|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24976297|NCT04188028|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24976298|NCT04188028|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24976305|NCT04188028|Antidepressive Agents|antidepressive agents|mesh-ancestor
24976306|NCT04188028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24976307|NCT04188028|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24976308|NCT04188028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24976309|NCT04188028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225507|NCT02626754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225508|NCT02626754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839111|NCT02202239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24839112|NCT02202239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24976310|NCT04188028|Antitussive Agents|antitussive agents|mesh-ancestor
25105532|NCT05255575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24976311|NCT04188028|Respiratory System Agents|respiratory system agents|mesh-ancestor
25105533|NCT05255575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25105534|NCT05255523|Capecitabine|capecitabine|mesh-list
25105535|NCT05255523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25105536|NCT05255523|Antimetabolites|antimetabolites|mesh-ancestor
25105537|NCT05255523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105538|NCT05255523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24414588|NCT00198120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414589|NCT00198146|Daclizumab|daclizumab|mesh-list
24414590|NCT00198146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24976331|NCT04154800|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24976332|NCT04154800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24976333|NCT04154800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24976334|NCT04154800|Vasodilator Agents|vasodilator agents|mesh-ancestor
24976336|NCT04127968|Vitamins|vitamins|mesh-ancestor
24976337|NCT04127968|Micronutrients|micronutrients|mesh-ancestor
24976338|NCT04127968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976339|NCT04071626|Ertugliflozin|ertugliflozin|mesh-list
24976340|NCT04071626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24976341|NCT04071626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976342|NCT04071626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24976343|NCT04071626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976344|NCT04056962|Tacrolimus|tacrolimus|mesh-list
24976345|NCT04056962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24976346|NCT04056962|Immunologic Factors|immunologic factors|mesh-ancestor
24976347|NCT04056962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976348|NCT04056962|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24976349|NCT04056962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24976350|NCT04056962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976351|NCT04051268|Vaccines|vaccines|mesh-list
24976358|NCT04017832|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24976359|NCT04017832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24976360|NCT04017832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976361|NCT04017832|Incretins|incretins|mesh-ancestor
24976362|NCT04017832|Hormones|hormones|mesh-ancestor
24976363|NCT04017832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24976364|NCT04017832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24976365|NCT04017832|Protease Inhibitors|protease inhibitors|mesh-ancestor
24976366|NCT04017832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24976367|NCT04017832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976371|NCT03945825|Immunologic Factors|immunologic factors|mesh-ancestor
24976372|NCT03945825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976373|NCT03942419|Atropine|atropine|mesh-list
24976374|NCT03942419|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24976375|NCT03942419|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24976376|NCT03942419|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24976377|NCT03942419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24976378|NCT03942419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24976379|NCT03942419|Autonomic Agents|autonomic agents|mesh-ancestor
24976380|NCT03942419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24976381|NCT03942419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976382|NCT03942419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24976383|NCT03942419|Respiratory System Agents|respiratory system agents|mesh-ancestor
24976384|NCT03942419|Mydriatics|mydriatics|mesh-ancestor
24976385|NCT03942419|Parasympatholytics|parasympatholytics|mesh-ancestor
24976386|NCT03942419|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24976387|NCT03942419|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24976388|NCT03942419|Cholinergic Agents|cholinergic agents|mesh-ancestor
24976389|NCT03942419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25225510|NCT02626845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25225511|NCT02626845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225512|NCT02626845|Immunologic Factors|immunologic factors|mesh-ancestor
24839113|NCT02202239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839114|NCT02202239|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24839115|NCT02202239|Anesthetics, General|anesthetics, general|mesh-ancestor
24839116|NCT02202239|Anesthetics|anesthetics|mesh-ancestor
24839117|NCT02202239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24839118|NCT02202239|Narcotics|narcotics|mesh-ancestor
24839119|NCT02202239|Analgesics|analgesics|mesh-ancestor
24839120|NCT02202239|Sensory System Agents|sensory system agents|mesh-ancestor
24976391|NCT03877354|Anesthetics|anesthetics|mesh-list
24976400|NCT03659578|Thymalfasin|thymalfasin|mesh-list
24434064|NCT00261352|Metformin|metformin|mesh-list
24976409|NCT03629873|Immunologic Factors|immunologic factors|mesh-ancestor
24976410|NCT03629873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976411|NCT03629873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24976412|NCT03629873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24976413|NCT03629873|Alkylating Agents|alkylating agents|mesh-ancestor
24976414|NCT03629873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976415|NCT03629873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976416|NCT03629873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24976417|NCT03629873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24976418|NCT03629873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24976419|NCT03629873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24976420|NCT03629873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24989977|NCT04442022|Immunologic Factors|immunologic factors|mesh-ancestor
24976421|NCT03629873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24976422|NCT03629873|Antimetabolites|antimetabolites|mesh-ancestor
24976423|NCT03629873|Antiviral Agents|antiviral agents|mesh-ancestor
24976424|NCT03629873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24976425|NCT03610438|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
24976426|NCT03610438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24976427|NCT03610438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976448|NCT03560193|Ethanol|ethanol|mesh-list
24976449|NCT03560193|Povidone-Iodine|povidone-iodine|mesh-list
24976450|NCT03560193|Povidone|povidone|mesh-list
24976451|NCT03560193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24976452|NCT03560193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24976453|NCT03560193|Disinfectants|disinfectants|mesh-ancestor
24976454|NCT03560193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24976455|NCT03560193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976456|NCT03560193|Plasma Substitutes|plasma substitutes|mesh-ancestor
24976457|NCT03560193|Blood Substitutes|blood substitutes|mesh-ancestor
24976458|NCT03557281|GSK656|gsk656|mesh-list
24976459|NCT03557281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24976460|NCT03557281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24976461|NCT03557242|Aspirin|aspirin|mesh-list
24976462|NCT03557242|Warfarin|warfarin|mesh-list
24976463|NCT03557242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24976464|NCT03557242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24976465|NCT03557242|Analgesics|analgesics|mesh-ancestor
24976466|NCT03557242|Sensory System Agents|sensory system agents|mesh-ancestor
24976467|NCT03557242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24976468|NCT03557242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976469|NCT03557242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24976470|NCT03557242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24976471|NCT03557242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24976474|NCT03557242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24976475|NCT03557242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24821604|NCT02106767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24976477|NCT03557242|Antipyretics|antipyretics|mesh-ancestor
25225518|NCT02626559|Anesthetics, Local|anesthetics, local|mesh-ancestor
25225519|NCT02626559|Anesthetics|anesthetics|mesh-ancestor
25225520|NCT02626559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24976664|NCT05275777|Mitosis Modulators|mitosis modulators|mesh-ancestor
24976498|NCT03473561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976499|NCT03455517|Rituximab|rituximab|mesh-list
24976500|NCT03455517|Venetoclax|venetoclax|mesh-list
24976509|NCT03419234|Methyltestosterone|methyltestosterone|mesh-list
24976510|NCT03419234|Abiraterone Acetate|abiraterone acetate|mesh-list
24976512|NCT03419234|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24976513|NCT03419234|Androgens|androgens|mesh-list
24976514|NCT03419234|Androgen Antagonists|androgen antagonists|mesh-list
24976515|NCT03419234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24976516|NCT03419234|Glucocorticoids|glucocorticoids|mesh-ancestor
24531298|NCT00634959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24976517|NCT03419234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24976518|NCT03419234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976519|NCT03419234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24976520|NCT03419234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976521|NCT03419234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24976522|NCT03419234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24976529|NCT03419234|Micronutrients|micronutrients|mesh-ancestor
24976530|NCT03419234|Estrogens|estrogens|mesh-ancestor
24976531|NCT03419234|Anabolic Agents|anabolic agents|mesh-ancestor
24976532|NCT03383679|Capecitabine|capecitabine|mesh-list
24976533|NCT03383679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24976534|NCT03383679|Antimetabolites|antimetabolites|mesh-ancestor
24783448|NCT01902108|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24783449|NCT01902108|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24783450|NCT01902108|Adrenergic Agents|adrenergic agents|mesh-ancestor
24783451|NCT01902108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24783452|NCT01902108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783454|NCT01902121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24783455|NCT01902121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24783456|NCT01902121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783457|NCT01902160|Sirolimus|sirolimus|mesh-list
24783481|NCT01902186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783482|NCT01902186|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24783483|NCT01902186|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24783484|NCT01902186|Antiviral Agents|antiviral agents|mesh-ancestor
24783485|NCT01902186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783486|NCT01902186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25105573|NCT05255211|Propofol|propofol|mesh-list
25105574|NCT05255211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25105575|NCT05255211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25105576|NCT05255211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105577|NCT05255211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25105578|NCT05255211|Anesthetics, General|anesthetics, general|mesh-ancestor
25105587|NCT05254899|Gemcitabine|gemcitabine|mesh-list
25105588|NCT05254899|Oxaliplatin|oxaliplatin|mesh-list
25105589|NCT05254899|Pegaspargase|pegaspargase|mesh-list
25105590|NCT05254899|Antibodies|antibodies|mesh-list
25105591|NCT05254899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25105592|NCT05254899|Immunologic Factors|immunologic factors|mesh-ancestor
25105593|NCT05254899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105594|NCT05254899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25105595|NCT05254899|Antimetabolites|antimetabolites|mesh-ancestor
25105596|NCT05254899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105597|NCT05254899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105598|NCT05254899|Antiviral Agents|antiviral agents|mesh-ancestor
25105599|NCT05254899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24976535|NCT03383679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976536|NCT03383679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976537|NCT03367299|Blinatumomab|blinatumomab|mesh-list
24853863|NCT02270788|Leucovorin|leucovorin|mesh-list
24976538|NCT03367299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976539|NCT03341806|Avelumab|avelumab|mesh-list
24976540|NCT03341806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24976541|NCT03341806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976542|NCT03316872|Pembrolizumab|pembrolizumab|mesh-list
24976543|NCT03316872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24976544|NCT03316872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976545|NCT03271047|Nivolumab|nivolumab|mesh-list
24976546|NCT03271047|Ipilimumab|ipilimumab|mesh-list
24976547|NCT03271047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24976548|NCT03271047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976549|NCT03271047|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24976552|NCT03171480|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24976553|NCT03171480|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
24976554|NCT03171480|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24976555|NCT03171480|Diuretics|diuretics|mesh-ancestor
24976556|NCT03171480|Natriuretic Agents|natriuretic agents|mesh-ancestor
24839132|NCT02202239|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24839135|NCT02202304|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24839137|NCT02202304|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24839138|NCT02202304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24839139|NCT02202304|Disinfectants|disinfectants|mesh-ancestor
24839140|NCT02202304|Dermatologic Agents|dermatologic agents|mesh-ancestor
24839141|NCT02202304|Antifungal Agents|antifungal agents|mesh-ancestor
24839142|NCT02202473|Lamivudine|lamivudine|mesh-list
24976572|NCT03164655|Growth Substances|growth substances|mesh-ancestor
24976573|NCT03164655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976574|NCT03164655|Growth Inhibitors|growth inhibitors|mesh-ancestor
24976576|NCT03164655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976577|NCT03164655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24976578|NCT03164655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24976579|NCT03164655|Immunologic Factors|immunologic factors|mesh-ancestor
24976580|NCT03164655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24976581|NCT03164655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24976582|NCT03164655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24976583|NCT03164655|Antidotes|antidotes|mesh-ancestor
24914594|NCT04254081|Narcotics|narcotics|mesh-ancestor
24976599|NCT03074240|Anesthetics|anesthetics|mesh-list
24976600|NCT03074240|Anesthetics, General|anesthetics, general|mesh-list
24976601|NCT03074240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24976602|NCT03074240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785337|NCT01913834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24976617|NCT05276687|Vancomycin|vancomycin|mesh-list
24976618|NCT05276687|Povidone-Iodine|povidone-iodine|mesh-list
24976619|NCT05276687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24976620|NCT05276687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24976621|NCT05276687|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24976622|NCT05276596|Norepinephrine|norepinephrine|mesh-list
24976623|NCT05276596|Ephedrine|ephedrine|mesh-list
24976624|NCT05276596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24976625|NCT05276596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24976626|NCT05276596|Adrenergic Agents|adrenergic agents|mesh-ancestor
24976627|NCT05276596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24976628|NCT05276596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976629|NCT05276596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976630|NCT05276596|Sympathomimetics|sympathomimetics|mesh-ancestor
24976631|NCT05276596|Autonomic Agents|autonomic agents|mesh-ancestor
24976632|NCT05276596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24976633|NCT05276596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24976634|NCT05276596|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24976640|NCT05276492|Prednisone|prednisone|mesh-list
25225537|NCT02626169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225538|NCT02626208|ST 1435|st 1435|mesh-list
25225539|NCT02626208|Contraceptive Agents|contraceptive agents|mesh-list
25225540|NCT02626208|Estradiol|estradiol|mesh-list
25225541|NCT02626208|Estrogens|estrogens|mesh-ancestor
25225542|NCT02626208|Hormones|hormones|mesh-ancestor
25273297|NCT02386150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839144|NCT02202473|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24839145|NCT02202473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24839146|NCT02202473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24839147|NCT02202473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839148|NCT02202473|Antiviral Agents|antiviral agents|mesh-ancestor
24839149|NCT02202473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24976645|NCT05276492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434759|NCT00263458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24976654|NCT05276258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976656|NCT05276258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24976657|NCT05275777|Paclitaxel|paclitaxel|mesh-list
24976658|NCT05275777|Cyclophosphamide|cyclophosphamide|mesh-list
24976659|NCT05275777|Doxorubicin|doxorubicin|mesh-list
24976660|NCT05275777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24976661|NCT05275777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976662|NCT05275777|Tubulin Modulators|tubulin modulators|mesh-ancestor
24976696|NCT05275179|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24976697|NCT05275179|Hormone Antagonists|hormone antagonists|mesh-ancestor
24976746|NCT05232396|Immunologic Factors|immunologic factors|mesh-ancestor
24976747|NCT05232396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976748|NCT05232396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976749|NCT05222724|Ibuprofen|ibuprofen|mesh-list
24976750|NCT05222724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24976751|NCT05222724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24976752|NCT05222724|Analgesics|analgesics|mesh-ancestor
24976753|NCT05222724|Sensory System Agents|sensory system agents|mesh-ancestor
24976754|NCT05222724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24795150|NCT03600818|Prednisone|prednisone|mesh-list
24795151|NCT03600818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24795152|NCT03600818|Glucocorticoids|glucocorticoids|mesh-ancestor
24795153|NCT03600818|Hormones|hormones|mesh-ancestor
24795154|NCT03600818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24795155|NCT03600818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588450|NCT00902772|Lorazepam|lorazepam|mesh-list
24588518|NCT00902954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783512|NCT01902342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783514|NCT01902446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24783515|NCT01902446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24783516|NCT01902446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783518|NCT01902446|Dermatologic Agents|dermatologic agents|mesh-ancestor
25225543|NCT02626208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25225544|NCT02626208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225545|NCT02626208|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25225546|NCT02626208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25225547|NCT02626208|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25225548|NCT02626234|Digoxin|digoxin|mesh-list
25225549|NCT02626234|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24839150|NCT02202473|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24839151|NCT02202473|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24839152|NCT02202473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24839153|NCT02202512|Naproxen|naproxen|mesh-list
24839154|NCT02202512|Cimetidine|cimetidine|mesh-list
24839155|NCT02202512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24839156|NCT02202512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24839157|NCT02202512|Analgesics|analgesics|mesh-ancestor
24435096|NCT00265031|Immunologic Factors|immunologic factors|mesh-ancestor
24783520|NCT01902485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24783521|NCT01902485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575531|NCT00832234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24575532|NCT00832286|Ciprofloxacin|ciprofloxacin|mesh-list
24783523|NCT01902498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24783524|NCT01902498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24783525|NCT01902498|Analgesics|analgesics|mesh-ancestor
24783526|NCT01902498|Sensory System Agents|sensory system agents|mesh-ancestor
24783527|NCT01902498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24783528|NCT01902498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783529|NCT01902498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24783530|NCT01902498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24783531|NCT01902498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24783532|NCT01902498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24821923|NCT02108795|Remifentanil|remifentanil|mesh-list
24588519|NCT00902954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588521|NCT00902954|Hormone Antagonists|hormone antagonists|mesh-ancestor
24588522|NCT00902954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24588523|NCT00902954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414625|NCT00198237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24414626|NCT00198237|Tubulin Modulators|tubulin modulators|mesh-ancestor
24414627|NCT00198237|Antimitotic Agents|antimitotic agents|mesh-ancestor
24414628|NCT00198237|Mitosis Modulators|mitosis modulators|mesh-ancestor
24414629|NCT00198237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414637|NCT00198250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24414638|NCT00198250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414639|NCT00198250|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24414640|NCT00198250|Antidepressive Agents|antidepressive agents|mesh-ancestor
24414641|NCT00198250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24414643|NCT00198354|Paclitaxel|paclitaxel|mesh-list
24414644|NCT00198354|Carboplatin|carboplatin|mesh-list
24414645|NCT00198354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24414646|NCT00198354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24414647|NCT00198354|Tubulin Modulators|tubulin modulators|mesh-ancestor
24414648|NCT00198354|Antimitotic Agents|antimitotic agents|mesh-ancestor
24414649|NCT00198354|Mitosis Modulators|mitosis modulators|mesh-ancestor
24414650|NCT00198354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414651|NCT00198354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24414652|NCT00198354|Antimetabolites|antimetabolites|mesh-ancestor
24414653|NCT00198354|Antiviral Agents|antiviral agents|mesh-ancestor
24414679|NCT00198393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24414680|NCT00198393|Antiviral Agents|antiviral agents|mesh-ancestor
24414681|NCT00198393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24414682|NCT00198393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414683|NCT00198393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24414697|NCT00198432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414698|NCT00198445|Bromfenac|bromfenac|mesh-list
25225550|NCT02626234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25225551|NCT02626234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25225553|NCT02626234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225554|NCT02626234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25225555|NCT02626234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25225556|NCT02626234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24839158|NCT02202512|Sensory System Agents|sensory system agents|mesh-ancestor
25043399|NCT01265901|Molgramostim|molgramostim|mesh-list
25043400|NCT01265901|Sargramostim|sargramostim|mesh-list
25043401|NCT01265901|Immunologic Factors|immunologic factors|mesh-ancestor
24621976|NCT01065116|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24621977|NCT01065116|Antimalarials|antimalarials|mesh-ancestor
24621978|NCT01065116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24621979|NCT01065116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24621980|NCT01065116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24621982|NCT01065129|Azacitidine|azacitidine|mesh-list
24621983|NCT01065129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24621984|NCT01065129|Antimetabolites|antimetabolites|mesh-ancestor
24621985|NCT01065129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621986|NCT01065129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105601|NCT05254899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25105602|NCT05254665|Docetaxel|docetaxel|mesh-list
25105603|NCT05254665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105604|NCT05254665|Tubulin Modulators|tubulin modulators|mesh-ancestor
25105605|NCT05254665|Antimitotic Agents|antimitotic agents|mesh-ancestor
25105606|NCT05254665|Mitosis Modulators|mitosis modulators|mesh-ancestor
25105607|NCT05254665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105608|NCT05254652|Pregabalin|pregabalin|mesh-list
25105609|NCT05254652|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25105610|NCT05254652|Analgesics|analgesics|mesh-ancestor
25105611|NCT05254652|Sensory System Agents|sensory system agents|mesh-ancestor
25105612|NCT05254652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24414699|NCT00198445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24414700|NCT00198445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24414701|NCT00198445|Analgesics|analgesics|mesh-ancestor
25105613|NCT05254652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105614|NCT05254652|Anticonvulsants|anticonvulsants|mesh-ancestor
25105615|NCT05254652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25105616|NCT05254652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25105617|NCT05254652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105618|NCT05254652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25105619|NCT05254652|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25105620|NCT05254652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25105621|NCT05254652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24621987|NCT01065129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621988|NCT01065129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24976791|NCT05200312|Zanubrutinib|zanubrutinib|mesh-list
24976792|NCT05200312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24976793|NCT05200312|Immunologic Factors|immunologic factors|mesh-ancestor
24976794|NCT05200312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976795|NCT05200312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24976796|NCT05200312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24976797|NCT05200312|Alkylating Agents|alkylating agents|mesh-ancestor
24976798|NCT05200312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681006|NCT01856907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25028144|NCT03613545|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24976799|NCT05200312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976800|NCT05200312|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24976801|NCT05200312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24976802|NCT05200312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24976803|NCT05200312|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24976813|NCT05200312|Antimitotic Agents|antimitotic agents|mesh-ancestor
24976814|NCT05200312|Mitosis Modulators|mitosis modulators|mesh-ancestor
24976815|NCT05200312|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24976816|NCT05200312|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24976817|NCT05200312|Growth Substances|growth substances|mesh-ancestor
24976818|NCT05200312|Growth Inhibitors|growth inhibitors|mesh-ancestor
24976819|NCT05200312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25043405|NCT01265901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24976827|NCT05040984|Solifenacin Succinate|solifenacin succinate|mesh-list
24976829|NCT05040984|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24976830|NCT05040984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24976831|NCT05040984|Cholinergic Agents|cholinergic agents|mesh-ancestor
24976832|NCT05040984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24976833|NCT05040984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976834|NCT05040984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976835|NCT05040984|Urological Agents|urological agents|mesh-ancestor
24976836|NCT05040984|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24976837|NCT05040984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24976838|NCT05040984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24976839|NCT05040984|Adrenergic Agents|adrenergic agents|mesh-ancestor
24976840|NCT05039489|Antipsychotic Agents|antipsychotic agents|mesh-list
24976841|NCT05039489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24976842|NCT05039489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24976843|NCT05039489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976844|NCT05039489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24976851|NCT04977375|Pembrolizumab|pembrolizumab|mesh-list
24976852|NCT04977375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24976853|NCT04977375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976854|NCT04973254|Rilpivirine|rilpivirine|mesh-list
24976855|NCT04973254|Cabotegravir|cabotegravir|mesh-list
24976856|NCT04973254|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24976857|NCT04973254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24976858|NCT04973254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414702|NCT00198445|Sensory System Agents|sensory system agents|mesh-ancestor
24976859|NCT04973254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976860|NCT04973254|Antiviral Agents|antiviral agents|mesh-ancestor
24976861|NCT04973254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24976862|NCT04973254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24976863|NCT04973254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24976864|NCT04973254|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24976879|NCT04943302|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24976880|NCT04943302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24976881|NCT04943302|Alkylating Agents|alkylating agents|mesh-ancestor
25105623|NCT05254652|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24976882|NCT04943302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976883|NCT04943302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976887|NCT04914793|Anti-Infective Agents|anti-infective agents|mesh-list
24976888|NCT04914793|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24976889|NCT04893915|Cyclophosphamide|cyclophosphamide|mesh-list
24976890|NCT04893915|Fludarabine|fludarabine|mesh-list
24976898|NCT04893915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976899|NCT04893915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976900|NCT04893915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24445880|NCT00302835|Analgesics|analgesics|mesh-list
24976901|NCT04893915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24976902|NCT04893915|Analgesics|analgesics|mesh-ancestor
24976903|NCT04893915|Sensory System Agents|sensory system agents|mesh-ancestor
24622004|NCT01065220|Estradiol|estradiol|mesh-list
24976921|NCT04817189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976923|NCT04817189|Dermatologic Agents|dermatologic agents|mesh-ancestor
25225565|NCT02626481|Autonomic Agents|autonomic agents|mesh-ancestor
25273298|NCT02386111|Sunitinib|sunitinib|mesh-list
25043407|NCT01265901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043409|NCT01265901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25043410|NCT01265901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25043411|NCT01265901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25043412|NCT01265901|Growth Substances|growth substances|mesh-ancestor
25681007|NCT01856907|Protease Inhibitors|protease inhibitors|mesh-ancestor
25028208|NCT03612817|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25028209|NCT03612817|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24976930|NCT04817189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24976931|NCT04817189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24976932|NCT04817189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24976933|NCT04817189|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24976934|NCT04782830|Midodrine|midodrine|mesh-list
24976935|NCT04782830|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24976936|NCT04782830|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24976937|NCT04782830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24976938|NCT04782830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24976939|NCT04782830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976940|NCT04782830|Adrenergic Agents|adrenergic agents|mesh-ancestor
24976941|NCT04782830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24976942|NCT04782830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976943|NCT04782830|Sympathomimetics|sympathomimetics|mesh-ancestor
24976958|NCT04781426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24976959|NCT04781426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24976960|NCT04774666|Antibodies|antibodies|mesh-list
24976961|NCT04774666|Immunologic Factors|immunologic factors|mesh-ancestor
24976974|NCT04707534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24976975|NCT04707534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976976|NCT04707534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24976978|NCT04707534|Hormones|hormones|mesh-ancestor
24976979|NCT04707534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24976980|NCT04707534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24976981|NCT04707534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976982|NCT04697823|Hyaluronic Acid|hyaluronic acid|mesh-list
24976983|NCT04697823|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24976984|NCT04697823|Immunologic Factors|immunologic factors|mesh-ancestor
24976985|NCT04697823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976986|NCT04697823|Viscosupplements|viscosupplements|mesh-ancestor
24976987|NCT04697823|Protective Agents|protective agents|mesh-ancestor
24976988|NCT04691856|Acetaminophen|acetaminophen|mesh-list
24976989|NCT04691856|Ibuprofen|ibuprofen|mesh-list
24976990|NCT04691856|Morphine|morphine|mesh-list
24622005|NCT01065220|Cyproterone|cyproterone|mesh-list
24622006|NCT01065220|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
24622007|NCT01065220|Estrogens|estrogens|mesh-ancestor
24622008|NCT01065220|Hormones|hormones|mesh-ancestor
24532213|NCT00638638|Anticoagulants|anticoagulants|mesh-ancestor
24414703|NCT00198445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24414704|NCT00198445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622009|NCT01065220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24622010|NCT01065220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622011|NCT01065220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24622012|NCT01065220|Contraceptive Agents|contraceptive agents|mesh-ancestor
24622013|NCT01065220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24795156|NCT03600818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24795157|NCT03600818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225566|NCT02626481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25225567|NCT02626481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414712|NCT00198523|Prednisolone acetate|prednisolone acetate|mesh-list
24414713|NCT00198523|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24414714|NCT00198523|Prednisolone phosphate|prednisolone phosphate|mesh-list
24414715|NCT00198523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24414716|NCT00198523|Glucocorticoids|glucocorticoids|mesh-ancestor
24914972|NCT05252325|Lidocaine|lidocaine|mesh-list
24976991|NCT04691856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24976992|NCT04691856|Narcotics|narcotics|mesh-ancestor
24976993|NCT04691856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24976994|NCT04691856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976996|NCT04691856|Sensory System Agents|sensory system agents|mesh-ancestor
24976997|NCT04691856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24976998|NCT04691856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24976999|NCT04691856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24977000|NCT04691856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25225574|NCT02626065|Nivolumab|nivolumab|mesh-list
25225575|NCT02626065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25225576|NCT02626065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225577|NCT02626065|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25225578|NCT02626065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681008|NCT01856907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692442|NCT01999400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273299|NCT02386111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25273300|NCT02386111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25273301|NCT02386111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25273302|NCT02386111|Growth Substances|growth substances|mesh-ancestor
25273303|NCT02386111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273304|NCT02386111|Growth Inhibitors|growth inhibitors|mesh-ancestor
25273305|NCT02386111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25273306|NCT02386111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24839203|NCT02202707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839205|NCT02202707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24839206|NCT02202707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24783533|NCT01902498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783534|NCT01902498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24783535|NCT01902498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24783538|NCT01902511|Epoetin Alfa|epoetin alfa|mesh-list
24977010|NCT04671966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24977011|NCT04671966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977012|NCT04671966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24977013|NCT04671966|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24977014|NCT04671966|Fertility Agents|fertility agents|mesh-ancestor
24977015|NCT04671966|Hormone Antagonists|hormone antagonists|mesh-ancestor
24977016|NCT04666688|Gemcitabine|gemcitabine|mesh-list
24977018|NCT04666688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24977019|NCT04666688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977020|NCT04666688|Tubulin Modulators|tubulin modulators|mesh-ancestor
24977021|NCT04666688|Antimitotic Agents|antimitotic agents|mesh-ancestor
24977022|NCT04666688|Mitosis Modulators|mitosis modulators|mesh-ancestor
24977023|NCT04666688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977024|NCT04666688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24977025|NCT04666688|Antimetabolites|antimetabolites|mesh-ancestor
24977026|NCT04666688|Antiviral Agents|antiviral agents|mesh-ancestor
24977035|NCT04632459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977036|NCT04509791|Immunoglobulins|immunoglobulins|mesh-list
24977037|NCT04509791|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24977038|NCT04509791|Antibodies|antibodies|mesh-list
24977039|NCT04509791|Thymoglobulin|thymoglobulin|mesh-list
24977040|NCT04509791|Immunologic Factors|immunologic factors|mesh-ancestor
24977041|NCT04509791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977042|NCT04509791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24977043|NCT04301765|Testosterone|testosterone|mesh-list
24977044|NCT04301765|Androgens|androgens|mesh-ancestor
24977045|NCT04301765|Hormones|hormones|mesh-ancestor
24414717|NCT00198523|Hormones|hormones|mesh-ancestor
24414718|NCT00198523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24458049|NCT00336375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24458050|NCT00336375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24458051|NCT00336401|Propofol|propofol|mesh-list
24458052|NCT00336401|Sevoflurane|sevoflurane|mesh-list
24402519|NCT00157586|Manidipine|manidipine|mesh-list
24977046|NCT04301765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24977047|NCT04301765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977048|NCT04296799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24977049|NCT04280328|Daratumumab|daratumumab|mesh-list
24977050|NCT04280328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977051|NCT04251884|Ropivacaine|ropivacaine|mesh-list
24977052|NCT04251884|Anesthetics, Local|anesthetics, local|mesh-list
24977053|NCT04251884|Anesthetics|anesthetics|mesh-list
24977054|NCT04251884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24977055|NCT04251884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977056|NCT04251884|Sensory System Agents|sensory system agents|mesh-ancestor
24977057|NCT04251884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24977058|NCT04196283|Paclitaxel|paclitaxel|mesh-list
24977059|NCT04196283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24977060|NCT04196283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105624|NCT05254652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25105625|NCT05254652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25105626|NCT05254652|Antidepressive Agents|antidepressive agents|mesh-ancestor
25105627|NCT05254652|Dopamine Agents|dopamine agents|mesh-ancestor
25105628|NCT05254574|Diclofenac|diclofenac|mesh-list
25105629|NCT05254574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25105630|NCT05254574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25225579|NCT02626104|Lactoferrin|lactoferrin|mesh-list
25225580|NCT02626104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25225581|NCT02625948|Tranexamic Acid|tranexamic acid|mesh-list
25225582|NCT02625948|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25057070|NCT03507556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977077|NCT03783286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977079|NCT03708003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977092|NCT03648489|Paclitaxel|paclitaxel|mesh-list
24977093|NCT03648489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24977094|NCT03648489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977095|NCT03648489|Tubulin Modulators|tubulin modulators|mesh-ancestor
24977096|NCT03648489|Antimitotic Agents|antimitotic agents|mesh-ancestor
24977097|NCT03648489|Mitosis Modulators|mitosis modulators|mesh-ancestor
24977098|NCT03648489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977129|NCT03448978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977130|NCT03448978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24977131|NCT03448978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24977132|NCT03448978|Alkylating Agents|alkylating agents|mesh-ancestor
24977133|NCT03448978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105632|NCT05254574|Sensory System Agents|sensory system agents|mesh-ancestor
24977134|NCT03448978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977135|NCT03448978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24977136|NCT03439033|Edetic Acid|edetic acid|mesh-list
24795196|NCT03578276|Gatifloxacin|gatifloxacin|mesh-list
24795197|NCT03578276|Prednisolone|prednisolone|mesh-list
24795198|NCT03578276|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24795199|NCT03578276|Methylprednisolone|methylprednisolone|mesh-list
24977170|NCT03340896|Docetaxel|docetaxel|mesh-list
24977171|NCT03340896|Fluorouracil|fluorouracil|mesh-list
24977172|NCT03340896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977173|NCT03340896|Tubulin Modulators|tubulin modulators|mesh-ancestor
24977174|NCT03340896|Antimitotic Agents|antimitotic agents|mesh-ancestor
24977175|NCT03340896|Mitosis Modulators|mitosis modulators|mesh-ancestor
24977177|NCT03340896|Antimetabolites|antimetabolites|mesh-ancestor
24977195|NCT03304379|Analgesics|analgesics|mesh-ancestor
24977196|NCT03304379|Sensory System Agents|sensory system agents|mesh-ancestor
24977197|NCT03304379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24977198|NCT03304379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977199|NCT03304379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24977200|NCT03304379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24977201|NCT03304379|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24977202|NCT03304379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24977203|NCT03304379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24977204|NCT03304379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977205|NCT03268499|Cisplatin|cisplatin|mesh-list
24977206|NCT03268499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977207|NCT03255070|Immunoconjugates|immunoconjugates|mesh-list
24977208|NCT03255070|Immunologic Factors|immunologic factors|mesh-ancestor
24977209|NCT03255070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977210|NCT03122522|Nivolumab|nivolumab|mesh-list
24977211|NCT03122522|Ipilimumab|ipilimumab|mesh-list
24977212|NCT03122522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24977213|NCT03122522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977214|NCT03122522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24977215|NCT03122522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977216|NCT03110978|Nivolumab|nivolumab|mesh-list
24915214|NCT03899857|Pembrolizumab|pembrolizumab|mesh-list
25225585|NCT02625948|Hemostatics|hemostatics|mesh-ancestor
25225586|NCT02625948|Coagulants|coagulants|mesh-ancestor
25225587|NCT02625753|Acetaminophen|acetaminophen|mesh-list
25225588|NCT02625753|Codeine|codeine|mesh-list
25225589|NCT02625753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25225590|NCT02625753|Analgesics|analgesics|mesh-ancestor
25225591|NCT02625753|Sensory System Agents|sensory system agents|mesh-ancestor
24839223|NCT02202889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839237|NCT02202993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24839238|NCT02202993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839239|NCT02202993|Vasodilator Agents|vasodilator agents|mesh-ancestor
24839241|NCT02202993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24977217|NCT03110978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24977218|NCT03110978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977219|NCT03110978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24977220|NCT03110978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977222|NCT03085056|Trametinib|trametinib|mesh-list
24532231|NCT00638729|GABA Agents|gaba agents|mesh-ancestor
24977223|NCT03085056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24977229|NCT03085056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24977230|NCT03085056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24977231|NCT03055026|Rivaroxaban|rivaroxaban|mesh-list
25681009|NCT01856907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482871|NCT00440843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24482872|NCT00440843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482873|NCT00440843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24482874|NCT00440843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24482875|NCT00440843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24482876|NCT00440843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24482877|NCT00440843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24482878|NCT00440843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24482879|NCT00440843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24482880|NCT00440843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24977232|NCT03055026|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24977233|NCT03055026|Antithrombins|antithrombins|mesh-ancestor
24977234|NCT03055026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24977235|NCT03055026|Protease Inhibitors|protease inhibitors|mesh-ancestor
24977236|NCT03055026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25105633|NCT05254574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24977237|NCT03055026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977238|NCT03055026|Anticoagulants|anticoagulants|mesh-ancestor
24977239|NCT03025269|Ocrelizumab|ocrelizumab|mesh-list
24977240|NCT03025269|Immunologic Factors|immunologic factors|mesh-ancestor
24977241|NCT03025269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977242|NCT02999087|Cetuximab|cetuximab|mesh-list
24977243|NCT02999087|Avelumab|avelumab|mesh-list
24977244|NCT02999087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977245|NCT02999087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24977246|NCT02998385|Cisplatin|cisplatin|mesh-list
24977247|NCT02998385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977248|NCT02958150|Dexmedetomidine|dexmedetomidine|mesh-list
24977249|NCT02958150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24977250|NCT02958150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24977251|NCT02958150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977252|NCT02958150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24977253|NCT02958150|Analgesics|analgesics|mesh-ancestor
24977254|NCT02958150|Sensory System Agents|sensory system agents|mesh-ancestor
24977255|NCT02958150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24977256|NCT02958150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24977257|NCT02958150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24977258|NCT02958150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24977259|NCT02958150|Adrenergic Agents|adrenergic agents|mesh-ancestor
24977260|NCT02958150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24977261|NCT02958150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977262|NCT02955134|Hydrotalcite|hydrotalcite|mesh-list
24977263|NCT02955134|Antacids|antacids|mesh-ancestor
24977264|NCT02955134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977265|NCT02955134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24977266|NCT02861183|Hyaluronic Acid|hyaluronic acid|mesh-list
24977267|NCT02861183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24977268|NCT02861183|Immunologic Factors|immunologic factors|mesh-ancestor
24977269|NCT02861183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977270|NCT02861183|Viscosupplements|viscosupplements|mesh-ancestor
24977279|NCT02807805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24977281|NCT02807805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24977282|NCT02807805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977283|NCT02807805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24977310|NCT02553473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25225592|NCT02625753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25681011|NCT01857206|Immunologic Factors|immunologic factors|mesh-ancestor
25681012|NCT01857206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681013|NCT01857232|Dexamethasone|dexamethasone|mesh-list
25681014|NCT01857232|Ondansetron|ondansetron|mesh-list
25681015|NCT01857232|Fosaprepitant|fosaprepitant|mesh-list
25681016|NCT01857232|Aprepitant|aprepitant|mesh-list
25681017|NCT01857232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25681018|NCT01857232|Antiemetics|antiemetics|mesh-ancestor
25681019|NCT01857232|Autonomic Agents|autonomic agents|mesh-ancestor
25681020|NCT01857232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25681021|NCT01857232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681022|NCT01857232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25681023|NCT01857232|Glucocorticoids|glucocorticoids|mesh-ancestor
25681024|NCT01857232|Hormones|hormones|mesh-ancestor
25225593|NCT02625753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225594|NCT02625753|Antipyretics|antipyretics|mesh-ancestor
25225595|NCT02625753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25225596|NCT02625753|Narcotics|narcotics|mesh-ancestor
25225597|NCT02625753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25225598|NCT02625753|Antitussive Agents|antitussive agents|mesh-ancestor
24839245|NCT02203097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24839246|NCT02203097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839247|NCT02203097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24839248|NCT02203097|Anesthetics, General|anesthetics, general|mesh-ancestor
24839249|NCT02203097|Anesthetics|anesthetics|mesh-ancestor
24839250|NCT02203175|Fentanyl|fentanyl|mesh-list
24977312|NCT02472912|Adalimumab|adalimumab|mesh-list
24783542|NCT01902511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783543|NCT01902511|Hematinics|hematinics|mesh-ancestor
24783544|NCT01902524|Fentanyl|fentanyl|mesh-list
24783545|NCT01902524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24783546|NCT01902524|Narcotics|narcotics|mesh-ancestor
24783547|NCT01902524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24783548|NCT01902524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783549|NCT01902524|Analgesics|analgesics|mesh-ancestor
24783550|NCT01902524|Sensory System Agents|sensory system agents|mesh-ancestor
24783551|NCT01902524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24783552|NCT01902524|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24783553|NCT01902524|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24783554|NCT01902524|Anesthetics, General|anesthetics, general|mesh-ancestor
24783555|NCT01902524|Anesthetics|anesthetics|mesh-ancestor
24783556|NCT01902537|Prucalopride|prucalopride|mesh-list
24783557|NCT01902537|Laxatives|laxatives|mesh-ancestor
24783558|NCT01902537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24783559|NCT01902537|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24783560|NCT01902537|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24783561|NCT01902537|Serotonin Agents|serotonin agents|mesh-ancestor
24783562|NCT01902537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24783563|NCT01902537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783564|NCT01902537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977313|NCT02472912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24977314|NCT02472912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24977315|NCT02467582|Aspirin|aspirin|mesh-list
24977316|NCT02467582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24977317|NCT02467582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24977318|NCT02467582|Analgesics|analgesics|mesh-ancestor
24977319|NCT02467582|Sensory System Agents|sensory system agents|mesh-ancestor
24977320|NCT02467582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24977321|NCT02467582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414819|NCT00198978|Cytarabine|cytarabine|mesh-list
24414820|NCT00198978|Dexamethasone|dexamethasone|mesh-list
24977322|NCT02467582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24977323|NCT02467582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24977324|NCT02467582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24977325|NCT02467582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24977326|NCT02467582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977327|NCT02467582|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24977328|NCT02467582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24977329|NCT02467582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24977331|NCT02356458|Bortezomib|bortezomib|mesh-list
24977332|NCT02356458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977335|NCT01974609|Acetaminophen|acetaminophen|mesh-list
24977336|NCT01974609|Ibuprofen|ibuprofen|mesh-list
24977337|NCT01974609|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
24977338|NCT01974609|Hydrocodone|hydrocodone|mesh-list
24977346|NCT01974609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24977347|NCT01974609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25225600|NCT02625779|Valproic Acid|valproic acid|mesh-list
25225601|NCT02625779|Anticonvulsants|anticonvulsants|mesh-ancestor
25225602|NCT02625779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225603|NCT02625779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225604|NCT02625779|GABA Agents|gaba agents|mesh-ancestor
25225605|NCT02625779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25225606|NCT02625779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225607|NCT02625779|Antimanic Agents|antimanic agents|mesh-ancestor
25225608|NCT02625779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24977349|NCT01974609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24977350|NCT01974609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692443|NCT01999400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24977351|NCT01974609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977352|NCT01974609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24977353|NCT01974609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24977354|NCT01974609|Antitussive Agents|antitussive agents|mesh-ancestor
24977355|NCT01974609|Respiratory System Agents|respiratory system agents|mesh-ancestor
24977356|NCT01758081|Vitamin D|vitamin d|mesh-list
24977357|NCT01758081|Ergocalciferols|ergocalciferols|mesh-list
24977358|NCT01758081|Cholecalciferol|cholecalciferol|mesh-list
24977359|NCT01758081|Vitamins|vitamins|mesh-list
24977377|NCT01182727|Sensory System Agents|sensory system agents|mesh-ancestor
24977378|NCT01182727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24977379|NCT01182727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977380|NCT01182727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24414821|NCT00198978|Prednisolone|prednisolone|mesh-list
24977381|NCT01182727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24977382|NCT01059188|Docetaxel|docetaxel|mesh-list
24977383|NCT01059188|Cetuximab|cetuximab|mesh-list
24977384|NCT01059188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977385|NCT01059188|Tubulin Modulators|tubulin modulators|mesh-ancestor
24977386|NCT01059188|Antimitotic Agents|antimitotic agents|mesh-ancestor
24977387|NCT01059188|Mitosis Modulators|mitosis modulators|mesh-ancestor
24977388|NCT01059188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977389|NCT01059188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24977421|NCT00335777|Dihydroergotamine|dihydroergotamine|mesh-list
24977422|NCT00335777|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24977423|NCT00335777|Dopamine Agonists|dopamine agonists|mesh-ancestor
24977424|NCT00335777|Dopamine Agents|dopamine agents|mesh-ancestor
24977425|NCT00335777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24977426|NCT00335777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225609|NCT02625779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25225610|NCT02625779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25225611|NCT02625805|Methylphenidate|methylphenidate|mesh-list
24795202|NCT03578276|Bromfenac|bromfenac|mesh-list
24795203|NCT03578276|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24795204|NCT03578276|Prednisolone phosphate|prednisolone phosphate|mesh-list
24795205|NCT03578276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24795206|NCT03578276|Glucocorticoids|glucocorticoids|mesh-ancestor
24795207|NCT03578276|Hormones|hormones|mesh-ancestor
24795208|NCT03578276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24795209|NCT03578276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795210|NCT03578276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24795211|NCT03578276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795212|NCT03578276|Antiemetics|antiemetics|mesh-ancestor
24795213|NCT03578276|Autonomic Agents|autonomic agents|mesh-ancestor
24795214|NCT03578276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24795215|NCT03578276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24795216|NCT03578276|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24795217|NCT03578276|Protective Agents|protective agents|mesh-ancestor
24795218|NCT03578276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24795221|NCT03578276|Sensory System Agents|sensory system agents|mesh-ancestor
24795222|NCT03578276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24795223|NCT03578276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24795224|NCT03578276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24414822|NCT00198978|Cyclophosphamide|cyclophosphamide|mesh-list
24414823|NCT00198978|Rituximab|rituximab|mesh-list
24414839|NCT00198978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24414840|NCT00198978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24414841|NCT00198978|Antiemetics|antiemetics|mesh-ancestor
24414862|NCT00198978|Antimitotic Agents|antimitotic agents|mesh-ancestor
24414863|NCT00198978|Mitosis Modulators|mitosis modulators|mesh-ancestor
24414864|NCT00198978|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24414865|NCT00198978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24414866|NCT00198978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24414867|NCT00198978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24458139|NCT00336791|Fluorouracil|fluorouracil|mesh-list
24458140|NCT00336791|Epirubicin|epirubicin|mesh-list
24795225|NCT03578276|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24795234|NCT03532477|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24795235|NCT03532477|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24795236|NCT03532477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24795237|NCT03532477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24795238|NCT03532477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795239|NCT03532477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24795240|NCT03532477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795241|NCT03532477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25028363|NCT03611244|Benzocaine|benzocaine|mesh-list
24977428|NCT00335777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24977429|NCT00335777|Analgesics|analgesics|mesh-ancestor
24977430|NCT00335777|Sensory System Agents|sensory system agents|mesh-ancestor
24977431|NCT00335777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24977432|NCT00159588|Angiotensin II|angiotensin ii|mesh-list
24977433|NCT00159588|Gabapentin|gabapentin|mesh-list
24977434|NCT00159588|Valproic Acid|valproic acid|mesh-list
24977435|NCT00159588|Antidepressive Agents|antidepressive agents|mesh-list
24977436|NCT00159588|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
24977450|NCT00159588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977452|NCT00159588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24977453|NCT00159588|GABA Agents|gaba agents|mesh-ancestor
24977454|NCT00159588|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24977455|NCT00159588|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24977456|NCT00159588|Adrenergic Agents|adrenergic agents|mesh-ancestor
25225612|NCT02625805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25225613|NCT02625805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225614|NCT02625805|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24839259|NCT02203175|Narcotics|narcotics|mesh-ancestor
24839260|NCT02203175|Analgesics|analgesics|mesh-ancestor
24839261|NCT02203175|Sensory System Agents|sensory system agents|mesh-ancestor
24977474|NCT03051217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24977492|NCT02987530|Emtricitabine|emtricitabine|mesh-list
24977493|NCT02987530|Darunavir|darunavir|mesh-list
24977494|NCT02987530|Dolutegravir|dolutegravir|mesh-list
24977495|NCT02987530|Cobicistat|cobicistat|mesh-list
24977496|NCT02987530|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
24977497|NCT02987530|Antiviral Agents|antiviral agents|mesh-ancestor
24977498|NCT02987530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24977499|NCT02987530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24977500|NCT02987530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24977501|NCT02987530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24977534|NCT02889809|Fluticasone|fluticasone|mesh-list
24977536|NCT02889809|Montelukast|montelukast|mesh-list
24977537|NCT02889809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24977538|NCT02889809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24977539|NCT02889809|Autonomic Agents|autonomic agents|mesh-ancestor
24977540|NCT02889809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24977541|NCT02889809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225615|NCT02625805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25225616|NCT02625805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25225617|NCT02625805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225618|NCT02625805|Dopamine Agents|dopamine agents|mesh-ancestor
25225619|NCT02625805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24839284|NCT02203253|Immunologic Factors|immunologic factors|mesh-ancestor
24839285|NCT02203253|Leprostatic Agents|leprostatic agents|mesh-ancestor
24839287|NCT02203253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24839294|NCT02203253|Serotonin Agents|serotonin agents|mesh-ancestor
24977542|NCT02889809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24977543|NCT02889809|Respiratory System Agents|respiratory system agents|mesh-ancestor
24977544|NCT02889809|Dermatologic Agents|dermatologic agents|mesh-ancestor
24977545|NCT02889809|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24977546|NCT02889809|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24977547|NCT02889809|Hormone Antagonists|hormone antagonists|mesh-ancestor
24977548|NCT02889809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24977549|NCT02889809|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24977550|NCT02889809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24977551|NCT02889809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977552|NCT02884648|Bevacizumab|bevacizumab|mesh-list
24977553|NCT02884648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24977554|NCT02884648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977583|NCT02785224|Autonomic Agents|autonomic agents|mesh-ancestor
24977584|NCT02785224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24977585|NCT02785224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24977586|NCT02785224|Respiratory System Agents|respiratory system agents|mesh-ancestor
24977590|NCT02785224|Hemostatics|hemostatics|mesh-ancestor
24977591|NCT02785224|Coagulants|coagulants|mesh-ancestor
24977592|NCT02785224|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24977593|NCT02785224|Natriuretic Agents|natriuretic agents|mesh-ancestor
24977600|NCT02780583|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24977601|NCT02780583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24977602|NCT02778204|Maraviroc|maraviroc|mesh-list
24977603|NCT02778204|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25692444|NCT01999400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24977604|NCT02778204|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24483743|NCT00444756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483744|NCT00444808|Calcitonin|calcitonin|mesh-list
24483754|NCT00444834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24483755|NCT00444834|Adrenergic Agents|adrenergic agents|mesh-ancestor
24483756|NCT00444834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24483757|NCT00444834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483794|NCT00445055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483795|NCT00445055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24483796|NCT00445055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24483797|NCT00445055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24483798|NCT00445055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24483799|NCT00445055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25028428|NCT03610893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028429|NCT03610893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24977605|NCT02778204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977606|NCT02778204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24977607|NCT02778204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24977608|NCT02778204|Antiviral Agents|antiviral agents|mesh-ancestor
24977609|NCT02778204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24977610|NCT02778204|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24977611|NCT02743364|Simvastatin|simvastatin|mesh-list
24977612|NCT02743364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24783566|NCT01902550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24783567|NCT01902550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24783568|NCT01902550|Sympatholytics|sympatholytics|mesh-ancestor
24783569|NCT01902550|Autonomic Agents|autonomic agents|mesh-ancestor
24783570|NCT01902550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24783574|NCT01902550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24783575|NCT01902550|Adrenergic Agents|adrenergic agents|mesh-ancestor
24783576|NCT01902550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24783577|NCT01902550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783579|NCT01902641|Succinylcholine|succinylcholine|mesh-list
24783580|NCT01902641|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25225620|NCT02625740|Paclitaxel|paclitaxel|mesh-list
25225621|NCT02625740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25225622|NCT02625740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225623|NCT02625740|Tubulin Modulators|tubulin modulators|mesh-ancestor
25225624|NCT02625740|Antimitotic Agents|antimitotic agents|mesh-ancestor
25225625|NCT02625740|Mitosis Modulators|mitosis modulators|mesh-ancestor
25225626|NCT02625740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225627|NCT02625519|Hormones|hormones|mesh-list
25225628|NCT02625519|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25225629|NCT02625519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24839300|NCT02203396|Thymoglobulin|thymoglobulin|mesh-list
24839301|NCT02203396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24839302|NCT02203396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839303|NCT02203396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24575602|NCT00832689|Gemcitabine|gemcitabine|mesh-list
24575604|NCT00832689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24575605|NCT00832689|Antimetabolites|antimetabolites|mesh-ancestor
24575606|NCT00832689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575607|NCT00832689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977613|NCT02743364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24977614|NCT02743364|Antimetabolites|antimetabolites|mesh-ancestor
24977615|NCT02743364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977616|NCT02743364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24977617|NCT02743364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25681025|NCT01857232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25681026|NCT01857232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25681027|NCT01857232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25681028|NCT01857232|Antipruritics|antipruritics|mesh-ancestor
25681029|NCT01857232|Dermatologic Agents|dermatologic agents|mesh-ancestor
25681030|NCT01857232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25681031|NCT01857232|Serotonin Agents|serotonin agents|mesh-ancestor
25681032|NCT01857232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25681033|NCT01857232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681034|NCT01857232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25681035|NCT01857232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25681036|NCT01857232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25681037|NCT01857232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25681038|NCT01857232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25028485|NCT03610282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25028487|NCT03610230|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24987876|NCT04770272|Paclitaxel|paclitaxel|mesh-list
24483874|NCT00445523|Interferon-alpha|interferon-alpha|mesh-list
24483875|NCT00445523|Vaccines|vaccines|mesh-list
24483876|NCT00445523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977618|NCT02743364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24977620|NCT02670044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977621|NCT02648997|Nivolumab|nivolumab|mesh-list
24977622|NCT02648997|Ipilimumab|ipilimumab|mesh-list
24977623|NCT02648997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24977624|NCT02648997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977625|NCT02648997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24414958|NCT00199004|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25105667|NCT05253781|Aspirin|aspirin|mesh-list
25105668|NCT05253781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25105670|NCT05253781|Analgesics|analgesics|mesh-ancestor
24977654|NCT02547493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977655|NCT02547493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24977656|NCT02547493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24977660|NCT02496611|Exenatide|exenatide|mesh-list
24977661|NCT02496611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24977662|NCT02496611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977663|NCT02496611|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24977664|NCT02496611|Incretins|incretins|mesh-ancestor
25225630|NCT02625519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225631|NCT02625636|Glucagon|glucagon|mesh-list
25225632|NCT02625636|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25225633|NCT02625636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25225634|NCT02625636|Hormones|hormones|mesh-ancestor
25225635|NCT02625636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25225636|NCT02625636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225637|NCT02625636|Incretins|incretins|mesh-ancestor
25225638|NCT02625727|Hyaluronic Acid|hyaluronic acid|mesh-list
25225639|NCT02625727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25225640|NCT02625727|Immunologic Factors|immunologic factors|mesh-ancestor
24839310|NCT02203396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24977666|NCT02496611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24977667|NCT02476097|Esomeprazole|esomeprazole|mesh-list
24977668|NCT02476097|Omeprazole|omeprazole|mesh-list
24977669|NCT02476097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24977670|NCT02476097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24977671|NCT02476097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24977672|NCT02476097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24977673|NCT02476097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977674|NCT02459392|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24977675|NCT02459392|Methylprednisolone|methylprednisolone|mesh-list
24977676|NCT02459392|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24977677|NCT02459392|Prednisolone|prednisolone|mesh-list
24977683|NCT02459392|Immunologic Factors|immunologic factors|mesh-ancestor
24977684|NCT02459392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977685|NCT02459392|Viscosupplements|viscosupplements|mesh-ancestor
24977686|NCT02459392|Protective Agents|protective agents|mesh-ancestor
24977687|NCT02459392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24977696|NCT02459392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24977697|NCT02459392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795242|NCT03532477|Antidepressive Agents|antidepressive agents|mesh-ancestor
24795243|NCT03532477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24795244|NCT03491267|Tretinoin|tretinoin|mesh-list
25681039|NCT01857232|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25681040|NCT01857297|Vaccines|vaccines|mesh-list
25681041|NCT01857297|Immunologic Factors|immunologic factors|mesh-ancestor
25681042|NCT01857297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681043|NCT01857310|Folic Acid|folic acid|mesh-list
25681044|NCT01857310|Hematinics|hematinics|mesh-ancestor
25681045|NCT01857310|Vitamin B Complex|vitamin b complex|mesh-ancestor
25681046|NCT01857310|Vitamins|vitamins|mesh-ancestor
25681047|NCT01857310|Micronutrients|micronutrients|mesh-ancestor
25105685|NCT05253768|Protective Agents|protective agents|mesh-ancestor
24795245|NCT03491267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795246|NCT03491267|Keratolytic Agents|keratolytic agents|mesh-ancestor
24977710|NCT02361125|Dopamine Agents|dopamine agents|mesh-ancestor
25692445|NCT01999517|Nitroglycerin|nitroglycerin|mesh-list
25681048|NCT01857310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977711|NCT02361125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24977713|NCT02338921|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24977714|NCT02338921|Dapagliflozin|dapagliflozin|mesh-list
24977715|NCT02338921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24977716|NCT02338921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977717|NCT02338921|Incretins|incretins|mesh-ancestor
24977718|NCT02338921|Hormones|hormones|mesh-ancestor
24415049|NCT00199056|Thioguanine|thioguanine|mesh-list
24415050|NCT00199056|Vindesine|vindesine|mesh-list
24415099|NCT00199069|Thioguanine|thioguanine|mesh-list
24415100|NCT00199069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24415119|NCT00199069|Abortifacient Agents|abortifacient agents|mesh-ancestor
24415120|NCT00199069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24415121|NCT00199069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24415122|NCT00199069|Antimetabolites|antimetabolites|mesh-ancestor
24977719|NCT02338921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24977720|NCT02338921|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24977721|NCT02338921|Protease Inhibitors|protease inhibitors|mesh-ancestor
24977723|NCT02338921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977724|NCT02338921|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24977725|NCT02245308|Bupropion|bupropion|mesh-list
24977726|NCT02245308|Nicotine|nicotine|mesh-list
24977727|NCT02245308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25225641|NCT02625727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225642|NCT02625727|Viscosupplements|viscosupplements|mesh-ancestor
25225643|NCT02625727|Protective Agents|protective agents|mesh-ancestor
25225644|NCT02625506|Tramadol|tramadol|mesh-list
25225645|NCT02625506|Levobupivacaine|levobupivacaine|mesh-list
25225646|NCT02625506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24839312|NCT02203396|Antinematodal Agents|antinematodal agents|mesh-ancestor
24839313|NCT02203396|Anthelmintics|anthelmintics|mesh-ancestor
24839314|NCT02203396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24839317|NCT02203422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24839336|NCT02203461|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24839338|NCT02203461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057126|NCT03507387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24977728|NCT02245308|Autonomic Agents|autonomic agents|mesh-ancestor
24977729|NCT02245308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24977730|NCT02245308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977731|NCT02245308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24977732|NCT02245308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24977733|NCT02245308|Cholinergic Agents|cholinergic agents|mesh-ancestor
24977734|NCT02245308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24977735|NCT02245308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977736|NCT02245308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24977737|NCT02245308|Antidepressive Agents|antidepressive agents|mesh-ancestor
24977738|NCT02245308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24977739|NCT02245308|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24977740|NCT02245308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24415123|NCT00199069|Dermatologic Agents|dermatologic agents|mesh-ancestor
24415124|NCT00199069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24977741|NCT02245308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24977743|NCT02245308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24977744|NCT02245308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24977745|NCT02245308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24977746|NCT02177695|Gemcitabine|gemcitabine|mesh-list
24977747|NCT02177695|Doxorubicin|doxorubicin|mesh-list
24977748|NCT02177695|Methotrexate|methotrexate|mesh-list
24977749|NCT02177695|Vinblastine|vinblastine|mesh-list
24977750|NCT02177695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977751|NCT02177695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24977752|NCT02177695|Antimetabolites|antimetabolites|mesh-ancestor
24977753|NCT02177695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977754|NCT02177695|Antiviral Agents|antiviral agents|mesh-ancestor
24977755|NCT02177695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24977756|NCT02177695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24977757|NCT02177695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24977758|NCT02177695|Immunologic Factors|immunologic factors|mesh-ancestor
24977759|NCT02177695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681049|NCT01857323|Albuterol|albuterol|mesh-list
25681050|NCT01857323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24977760|NCT02177695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24977761|NCT02177695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24977762|NCT02177695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24977763|NCT02177695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24977764|NCT02177695|Abortifacient Agents|abortifacient agents|mesh-ancestor
24977765|NCT02177695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25225647|NCT02625506|Narcotics|narcotics|mesh-ancestor
25225648|NCT02625506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25225649|NCT02625506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225650|NCT02625506|Analgesics|analgesics|mesh-ancestor
25225651|NCT02625506|Sensory System Agents|sensory system agents|mesh-ancestor
25225652|NCT02625506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25225653|NCT02625506|Anesthetics, Local|anesthetics, local|mesh-ancestor
25225654|NCT02625506|Anesthetics|anesthetics|mesh-ancestor
25225655|NCT02625558|Riociguat|riociguat|mesh-list
24839339|NCT02203461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977790|NCT02105636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24977791|NCT02105636|Abortifacient Agents|abortifacient agents|mesh-ancestor
24977792|NCT02105636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24977793|NCT02105636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533247|NCT00642733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977799|NCT02105636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24977800|NCT02105636|Immunologic Factors|immunologic factors|mesh-ancestor
24977801|NCT02105636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24977802|NCT02105636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24977803|NCT02105636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24977804|NCT02105636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24977805|NCT02038946|Nivolumab|nivolumab|mesh-list
24977806|NCT02038946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24977807|NCT02038946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977808|NCT02038946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24977809|NCT02038946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977842|NCT01863550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24977844|NCT01863550|Autonomic Agents|autonomic agents|mesh-ancestor
24977862|NCT01824875|Capecitabine|capecitabine|mesh-list
24977863|NCT01824875|Temozolomide|temozolomide|mesh-list
24977864|NCT01824875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24977865|NCT01824875|Antimetabolites|antimetabolites|mesh-ancestor
24977866|NCT01824875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977869|NCT01824875|Alkylating Agents|alkylating agents|mesh-ancestor
24977891|NCT01670409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977892|NCT01670409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24977893|NCT01670409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24977894|NCT01670409|Immunologic Factors|immunologic factors|mesh-ancestor
24977895|NCT01670409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977896|NCT01526135|Gemcitabine|gemcitabine|mesh-list
24977897|NCT01526135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24977898|NCT01526135|Antimetabolites|antimetabolites|mesh-ancestor
24977899|NCT01526135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977900|NCT01526135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977901|NCT01526135|Antiviral Agents|antiviral agents|mesh-ancestor
24977902|NCT01526135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24977903|NCT01526135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24977904|NCT01526135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24977905|NCT01526135|Immunologic Factors|immunologic factors|mesh-ancestor
24977906|NCT01526135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977907|NCT01475110|Imatinib Mesylate|imatinib mesylate|mesh-list
24977908|NCT01475110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977909|NCT01475110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24977910|NCT01475110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24977911|NCT01475110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415186|NCT00199095|Dexamethasone|dexamethasone|mesh-list
24415187|NCT00199095|Cyclophosphamide|cyclophosphamide|mesh-list
25225656|NCT02625558|Enzyme Activators|enzyme activators|mesh-ancestor
25225657|NCT02625558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225658|NCT02625415|Vitamins|vitamins|mesh-list
24839342|NCT02203461|Antiviral Agents|antiviral agents|mesh-ancestor
24839343|NCT02203461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24839344|NCT02203461|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24839345|NCT02203461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24415189|NCT00199095|Methotrexate|methotrexate|mesh-list
24415190|NCT00199095|Vincristine|vincristine|mesh-list
24415191|NCT00199095|Doxorubicin|doxorubicin|mesh-list
24415192|NCT00199095|Mercaptopurine|mercaptopurine|mesh-list
24415193|NCT00199095|Idarubicin|idarubicin|mesh-list
24415194|NCT00199095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24415195|NCT00199095|Immunologic Factors|immunologic factors|mesh-ancestor
24415196|NCT00199095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415197|NCT00199095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24415199|NCT00199095|Alkylating Agents|alkylating agents|mesh-ancestor
24415200|NCT00199095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783588|NCT01902771|Immunologic Factors|immunologic factors|mesh-ancestor
24415205|NCT00199095|Autonomic Agents|autonomic agents|mesh-ancestor
24415206|NCT00199095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24415242|NCT00199121|Zidovudine|zidovudine|mesh-list
24415243|NCT00199121|Antimetabolites|antimetabolites|mesh-ancestor
24415244|NCT00199121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415245|NCT00199121|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24415246|NCT00199121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24415247|NCT00199121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24415248|NCT00199121|Antiviral Agents|antiviral agents|mesh-ancestor
24415249|NCT00199121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24415250|NCT00199121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24415251|NCT00199121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24415252|NCT00199134|Letrozole|letrozole|mesh-list
25225659|NCT02625415|Vitamin B 6|vitamin b 6|mesh-list
25225660|NCT02625415|Pyridoxal|pyridoxal|mesh-list
25225661|NCT02625415|Pyridoxine|pyridoxine|mesh-list
25225662|NCT02625415|Vitamin B Complex|vitamin b complex|mesh-list
25225663|NCT02625415|Micronutrients|micronutrients|mesh-ancestor
25225664|NCT02625415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415253|NCT00199134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415254|NCT00199134|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24415255|NCT00199134|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24415256|NCT00199134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783590|NCT01902771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24783591|NCT01902771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783592|NCT01902771|Interferon Inducers|interferon inducers|mesh-ancestor
24783594|NCT01902810|Metoprolol|metoprolol|mesh-list
24783595|NCT01902810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24783596|NCT01902810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24783597|NCT01902810|Adrenergic Agents|adrenergic agents|mesh-ancestor
24783598|NCT01902810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24783599|NCT01902810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783600|NCT01902810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783601|NCT01902810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24783602|NCT01902810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24783603|NCT01902810|Vasodilator Agents|vasodilator agents|mesh-ancestor
24783604|NCT01902810|Sympatholytics|sympatholytics|mesh-ancestor
24783605|NCT01902810|Autonomic Agents|autonomic agents|mesh-ancestor
24783606|NCT01902810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24783607|NCT01902810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24783611|NCT01902862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783612|NCT01902862|Immunologic Factors|immunologic factors|mesh-ancestor
24783615|NCT01902875|Paclitaxel|paclitaxel|mesh-list
25105687|NCT05227677|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25105688|NCT05227677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105689|NCT05178823|Chlorhexidine|chlorhexidine|mesh-list
25105690|NCT05178823|Chlorine dioxide|chlorine dioxide|mesh-list
25105691|NCT05178823|Fluorides|fluorides|mesh-list
25105692|NCT05178823|Sodium Fluoride|sodium fluoride|mesh-list
25105701|NCT05166304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25105702|NCT05166304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25105703|NCT05166304|Antioxidants|antioxidants|mesh-ancestor
25105704|NCT05166304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105705|NCT05166304|Protective Agents|protective agents|mesh-ancestor
25105706|NCT05166304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105707|NCT05166304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24415308|NCT00199186|Glucocorticoids|glucocorticoids|mesh-ancestor
24415309|NCT00199186|Hormones|hormones|mesh-ancestor
24415310|NCT00199186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24415311|NCT00199186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24415312|NCT00199186|Protease Inhibitors|protease inhibitors|mesh-ancestor
24415449|NCT00199563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24415450|NCT00199563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415451|NCT00199563|Urological Agents|urological agents|mesh-ancestor
24415452|NCT00199576|Methylprednisolone|methylprednisolone|mesh-list
25681051|NCT01857323|Autonomic Agents|autonomic agents|mesh-ancestor
25681052|NCT01857323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24485488|NCT00453167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24485489|NCT00453167|Immunologic Factors|immunologic factors|mesh-ancestor
24485490|NCT00453167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485493|NCT00453232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485494|NCT00453232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24485495|NCT00453232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24485496|NCT00453232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24839347|NCT02203461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24839349|NCT02203500|Telmisartan|telmisartan|mesh-list
24839351|NCT02203500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24839352|NCT02203500|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24415453|NCT00199576|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24415454|NCT00199576|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25105711|NCT05149638|Cosyntropin|cosyntropin|mesh-list
24415469|NCT00199576|Protective Agents|protective agents|mesh-ancestor
24415470|NCT00199576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24415471|NCT00199576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415472|NCT00199602|Heparin|heparin|mesh-list
24415473|NCT00199602|Anticoagulants|anticoagulants|mesh-ancestor
24415493|NCT00199745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24415521|NCT00199784|Sympathomimetics|sympathomimetics|mesh-ancestor
24415522|NCT00199784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24415523|NCT00199784|Nasal Decongestants|nasal decongestants|mesh-ancestor
24415524|NCT00199784|Respiratory System Agents|respiratory system agents|mesh-ancestor
24415525|NCT00199784|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24415526|NCT00199784|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24415581|NCT00200174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24415612|NCT00200395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24415613|NCT00200395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415615|NCT00200421|Nebivolol|nebivolol|mesh-list
24415616|NCT00200421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24415617|NCT00200421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24415618|NCT00200421|Sympatholytics|sympatholytics|mesh-ancestor
24415619|NCT00200421|Autonomic Agents|autonomic agents|mesh-ancestor
24415620|NCT00200421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24415621|NCT00200421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415672|NCT00200473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24415673|NCT00200473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415674|NCT00200473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415676|NCT00200499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24415678|NCT00200499|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24415679|NCT00200499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24415680|NCT00200499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24415681|NCT00200499|Adrenergic Agents|adrenergic agents|mesh-ancestor
24415682|NCT00200499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24415683|NCT00200499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415684|NCT00200499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105713|NCT05149638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25105714|NCT05149638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105715|NCT05143970|Trastuzumab|trastuzumab|mesh-list
25105716|NCT05143970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24415688|NCT00200512|Autonomic Agents|autonomic agents|mesh-ancestor
25225665|NCT02625389|Ethiodized Oil|ethiodized oil|mesh-list
25225666|NCT02625389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225667|NCT02625454|Acetaminophen|acetaminophen|mesh-list
25225668|NCT02625454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25225669|NCT02625454|Analgesics|analgesics|mesh-ancestor
25681053|NCT01857323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681054|NCT01857323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25681055|NCT01857323|Respiratory System Agents|respiratory system agents|mesh-ancestor
25681056|NCT01857323|Tocolytic Agents|tocolytic agents|mesh-ancestor
25681057|NCT01857323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25681058|NCT01857323|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25681059|NCT01857323|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25681060|NCT01857323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25681061|NCT01857323|Adrenergic Agents|adrenergic agents|mesh-ancestor
25028607|NCT03609424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25028608|NCT03609359|Pembrolizumab|pembrolizumab|mesh-list
25028609|NCT03609359|Lenvatinib|lenvatinib|mesh-list
25028636|NCT03609294|Hormones|hormones|mesh-ancestor
25028639|NCT03609294|Protease Inhibitors|protease inhibitors|mesh-ancestor
25225670|NCT02625454|Sensory System Agents|sensory system agents|mesh-ancestor
24839356|NCT02203500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24839357|NCT02203500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24839358|NCT02203500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839359|NCT02203552|Minocycline|minocycline|mesh-list
24839360|NCT02203552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24839361|NCT02203552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24839362|NCT02203604|Aldesleukin|aldesleukin|mesh-list
24839363|NCT02203604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24839365|NCT02203604|Interleukin-2|interleukin-2|mesh-list
24839366|NCT02203604|Antibodies|antibodies|mesh-list
24415689|NCT00200512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24415690|NCT00200512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24415691|NCT00200512|Dopamine Agonists|dopamine agonists|mesh-ancestor
24415697|NCT00200525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415698|NCT00200525|Autonomic Agents|autonomic agents|mesh-ancestor
24415700|NCT00200525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24415709|NCT00200538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24415710|NCT00200538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415711|NCT00200538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415712|NCT00200538|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24415713|NCT00200538|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24415714|NCT00200551|Cyclosporine|cyclosporine|mesh-list
24415715|NCT00200551|Mycophenolic Acid|mycophenolic acid|mesh-list
24415716|NCT00200551|Cyclosporins|cyclosporins|mesh-list
24415717|NCT00200551|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24415718|NCT00200551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24415719|NCT00200551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415720|NCT00200551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24415721|NCT00200551|Immunologic Factors|immunologic factors|mesh-ancestor
24415760|NCT00200603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24415761|NCT00200603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415762|NCT00200616|Anti-Infective Agents|anti-infective agents|mesh-list
24415763|NCT00200616|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24415766|NCT00200629|Sensory System Agents|sensory system agents|mesh-ancestor
24415767|NCT00200629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24415768|NCT00200629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415769|NCT00200629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24415770|NCT00200629|Vasodilator Agents|vasodilator agents|mesh-ancestor
24415771|NCT00200629|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24415772|NCT00200629|Purinergic Agonists|purinergic agonists|mesh-ancestor
24415773|NCT00200629|Purinergic Agents|purinergic agents|mesh-ancestor
24415774|NCT00200629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24415775|NCT00200629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415776|NCT00200655|Pravastatin|pravastatin|mesh-list
24415777|NCT00200655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24977929|NCT01332266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25225671|NCT02625454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25225672|NCT02625454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225673|NCT02625454|Antipyretics|antipyretics|mesh-ancestor
25225674|NCT02625103|Clozapine|clozapine|mesh-list
25225675|NCT02625103|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25225679|NCT02625103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225680|NCT02625103|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25225681|NCT02625103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25225682|NCT02625103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25225683|NCT02625103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24839369|NCT02203604|Immunologic Factors|immunologic factors|mesh-ancestor
24839370|NCT02203604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839371|NCT02203604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977930|NCT01332266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977931|NCT01261728|Gemcitabine|gemcitabine|mesh-list
24977932|NCT01261728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449974|NCT00317512|Chrysarobin|chrysarobin|mesh-list
24415778|NCT00200655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25681062|NCT01857323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25681063|NCT01857323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681064|NCT01857362|Nitisinone|nitisinone|mesh-list
25681065|NCT01857362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24415779|NCT00200655|Antimetabolites|antimetabolites|mesh-ancestor
24415901|NCT00201396|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24415902|NCT00201396|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24415910|NCT00201422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24415918|NCT00201422|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24415919|NCT00201422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24415922|NCT00201435|Capecitabine|capecitabine|mesh-list
24415923|NCT00201435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24415924|NCT00201435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415925|NCT00201435|Tubulin Modulators|tubulin modulators|mesh-ancestor
24415926|NCT00201435|Antimitotic Agents|antimitotic agents|mesh-ancestor
24415927|NCT00201435|Mitosis Modulators|mitosis modulators|mesh-ancestor
24440901|NCT00285298|Vasodilator Agents|vasodilator agents|mesh-ancestor
24415949|NCT00201669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24415950|NCT00201669|Antimetabolites|antimetabolites|mesh-ancestor
24415956|NCT00201682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415957|NCT00201682|Immunologic Factors|immunologic factors|mesh-ancestor
24415958|NCT00201682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415959|NCT00201682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24415960|NCT00201682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24415961|NCT00201682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24415963|NCT00201682|Sensory System Agents|sensory system agents|mesh-ancestor
24415964|NCT00201682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24415965|NCT00201682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24415966|NCT00201682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24415967|NCT00201682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24415968|NCT00201695|Dexamethasone|dexamethasone|mesh-list
24415969|NCT00201695|Doxorubicin|doxorubicin|mesh-list
24415970|NCT00201695|Vincristine|vincristine|mesh-list
24415971|NCT00201695|Arsenic Trioxide|arsenic trioxide|mesh-list
24416017|NCT00201721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24416018|NCT00201721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24416019|NCT00201721|Alkylating Agents|alkylating agents|mesh-ancestor
24416020|NCT00201721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416021|NCT00201721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24416022|NCT00201721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24416023|NCT00201721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24416024|NCT00201721|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
24416025|NCT00201721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416091|NCT00202007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24416093|NCT00202007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24416094|NCT00202007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416095|NCT00202007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416096|NCT00202007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24416097|NCT00202007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24416098|NCT00202007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24416099|NCT00202007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24416100|NCT00202007|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24416101|NCT00202007|Dopamine Agents|dopamine agents|mesh-ancestor
24416125|NCT00202020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24416126|NCT00202020|Autonomic Agents|autonomic agents|mesh-ancestor
24839372|NCT02203604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24778466|NCT01871129|Analgesics|analgesics|mesh-ancestor
24977938|NCT01261728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24977939|NCT01261728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24977940|NCT01261728|Immunologic Factors|immunologic factors|mesh-ancestor
24977941|NCT01261728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977942|NCT01222754|Lenalidomide|lenalidomide|mesh-list
24977943|NCT01222754|Immunologic Factors|immunologic factors|mesh-ancestor
24977944|NCT01222754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416144|NCT00202163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24416145|NCT00202163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416148|NCT00202176|Anticonvulsants|anticonvulsants|mesh-ancestor
24416149|NCT00202176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24416150|NCT00202176|Autonomic Agents|autonomic agents|mesh-ancestor
24416151|NCT00202176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24416152|NCT00202176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416153|NCT00202176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24416154|NCT00202176|Respiratory System Agents|respiratory system agents|mesh-ancestor
24416155|NCT00202176|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24416169|NCT00202189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24416170|NCT00202228|Riboflavin|riboflavin|mesh-list
24416171|NCT00202228|Thiamine|thiamine|mesh-list
24416172|NCT00202228|Vitamin B Complex|vitamin b complex|mesh-ancestor
24416173|NCT00202228|Vitamins|vitamins|mesh-ancestor
24416174|NCT00202228|Micronutrients|micronutrients|mesh-ancestor
24416175|NCT00202228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441158|NCT00286260|Levetiracetam|levetiracetam|mesh-list
24977945|NCT01222754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24977946|NCT01222754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24795251|NCT03464292|Sensory System Agents|sensory system agents|mesh-ancestor
24795252|NCT03464292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24795267|NCT03390686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416353|NCT00202852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24416354|NCT00202852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24416356|NCT00202865|Dermatologic Agents|dermatologic agents|mesh-ancestor
24416357|NCT00202865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24416358|NCT00202865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24416359|NCT00202891|Sisomicin|sisomicin|mesh-list
24416360|NCT00202891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24416361|NCT00202891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24416362|NCT00202891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24416363|NCT00202891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416364|NCT00202891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416365|NCT00202917|Fludarabine|fludarabine|mesh-list
24416366|NCT00202917|Melphalan|melphalan|mesh-list
24416367|NCT00202917|Thiotepa|thiotepa|mesh-list
24416368|NCT00202917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24416369|NCT00202917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416370|NCT00202917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24416371|NCT00202917|Immunologic Factors|immunologic factors|mesh-ancestor
24416372|NCT00202917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225689|NCT02625376|Protective Agents|protective agents|mesh-ancestor
25225690|NCT02625376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839404|NCT02203643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24416384|NCT00202982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24416385|NCT00202995|Glatiramer Acetate|glatiramer acetate|mesh-list
24416386|NCT00202995|Interferon beta-1b|interferon beta-1b|mesh-list
24416387|NCT00202995|(T,G)-A-L|(t,g)-a-l|mesh-list
24795268|NCT03390686|Growth Inhibitors|growth inhibitors|mesh-ancestor
24795273|NCT03264131|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24795274|NCT03264131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24795275|NCT03264131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795276|NCT03229538|Methylprednisolone|methylprednisolone|mesh-list
24795277|NCT03229538|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24795278|NCT03229538|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24795279|NCT03229538|Prednisolone|prednisolone|mesh-list
24795280|NCT03229538|Prednisolone acetate|prednisolone acetate|mesh-list
24416388|NCT00202995|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24416389|NCT00202995|Immunologic Factors|immunologic factors|mesh-ancestor
24416390|NCT00202995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416391|NCT00202995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24416445|NCT00203112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24416446|NCT00203112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24416447|NCT00203112|Immunologic Factors|immunologic factors|mesh-ancestor
24416448|NCT00203112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416449|NCT00203112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24416450|NCT00203112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24416451|NCT00203125|Rasagiline|rasagiline|mesh-list
24416452|NCT00203125|Tyramine|tyramine|mesh-list
24416453|NCT00203125|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24416454|NCT00203125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416455|NCT00203125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795281|NCT03229538|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24795282|NCT03229538|Prednisolone phosphate|prednisolone phosphate|mesh-list
24795283|NCT03229538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24416573|NCT00203450|Anticonvulsants|anticonvulsants|mesh-ancestor
24977957|NCT01143779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977958|NCT01140867|Zonisamide|zonisamide|mesh-list
25225691|NCT02625376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225692|NCT02625376|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25225693|NCT02625168|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25225694|NCT02625168|Afatinib|afatinib|mesh-list
25225695|NCT02625168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225696|NCT02625168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25225697|NCT02625168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225698|NCT02625168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225699|NCT02625337|Pembrolizumab|pembrolizumab|mesh-list
25225700|NCT02625337|Trametinib|trametinib|mesh-list
25225701|NCT02625337|Dabrafenib|dabrafenib|mesh-list
24839412|NCT02203656|Androgens|androgens|mesh-ancestor
24839413|NCT02203656|Hormones|hormones|mesh-ancestor
24839414|NCT02203656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24839415|NCT02203656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839416|NCT02203656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24977959|NCT01140867|Anticonvulsants|anticonvulsants|mesh-ancestor
24977960|NCT01140867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24977961|NCT01140867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24977962|NCT01140867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417185|NCT00205751|Alkylating Agents|alkylating agents|mesh-ancestor
24416694|NCT00203775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977966|NCT01137773|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24977967|NCT01137773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24977968|NCT01137773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977969|NCT01127256|Carbamazepine|carbamazepine|mesh-list
24977971|NCT01127256|Anticonvulsants|anticonvulsants|mesh-ancestor
24977972|NCT01127256|Antimanic Agents|antimanic agents|mesh-ancestor
24977973|NCT01127256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24977974|NCT01127256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24450003|NCT00317577|Adrenergic Agents|adrenergic agents|mesh-ancestor
24416695|NCT00203775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864868|NCT05148767|Irinotecan|irinotecan|mesh-list
24416696|NCT00203775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24416697|NCT00203775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24416698|NCT00203775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24416799|NCT00204061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416800|NCT00204061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24416801|NCT00204061|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24416802|NCT00204061|Dopamine Agents|dopamine agents|mesh-ancestor
24416803|NCT00204061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24416804|NCT00204061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416805|NCT00204061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24416806|NCT00204061|Antidepressive Agents|antidepressive agents|mesh-ancestor
24416807|NCT00204074|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24416808|NCT00204074|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24416809|NCT00204074|Estradiol|estradiol|mesh-list
24416810|NCT00204074|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24416811|NCT00204074|Estrogens|estrogens|mesh-ancestor
24416812|NCT00204074|Hormones|hormones|mesh-ancestor
24416834|NCT00204230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416835|NCT00204243|Naltrexone|naltrexone|mesh-list
24416836|NCT00204243|Methadone|methadone|mesh-list
24416837|NCT00204243|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24416838|NCT00204243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24416839|NCT00204243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416840|NCT00204243|Sensory System Agents|sensory system agents|mesh-ancestor
24416841|NCT00204243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24416842|NCT00204243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24416843|NCT00204243|Narcotics|narcotics|mesh-ancestor
25225718|NCT02624856|Hormones|hormones|mesh-ancestor
24416863|NCT00204308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24416864|NCT00204308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24416865|NCT00204321|Sirolimus|sirolimus|mesh-list
24416866|NCT00204321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24416876|NCT00204347|Serotonin Agents|serotonin agents|mesh-ancestor
24416877|NCT00204347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24416887|NCT00204386|Anticonvulsants|anticonvulsants|mesh-ancestor
24416888|NCT00204386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24416889|NCT00204386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416890|NCT00204438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25692446|NCT01999517|Vasodilator Agents|vasodilator agents|mesh-ancestor
24486901|NCT00460499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24486902|NCT00460499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487061|NCT00461396|Interferons|interferons|mesh-list
24416918|NCT00204451|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24977975|NCT01127256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977976|NCT01127256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24977977|NCT01127256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24977978|NCT01127256|Analgesics|analgesics|mesh-ancestor
24977979|NCT01127256|Sensory System Agents|sensory system agents|mesh-ancestor
24977980|NCT01127256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24977981|NCT01127256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25225702|NCT02625337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25225703|NCT02625337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225704|NCT02625337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25225705|NCT02625337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225706|NCT02625337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977983|NCT01127256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416938|NCT00204529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416940|NCT00204542|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24416949|NCT00204542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416950|NCT00204542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416951|NCT00204555|Imiquimod|imiquimod|mesh-list
24416952|NCT00204555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24416953|NCT00204555|Immunologic Factors|immunologic factors|mesh-ancestor
24416954|NCT00204555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416955|NCT00204555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24416956|NCT00204555|Interferon Inducers|interferon inducers|mesh-ancestor
24416957|NCT00204568|Doxorubicin|doxorubicin|mesh-list
24416958|NCT00204568|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24417026|NCT00204776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24417027|NCT00204776|Antimetabolites|antimetabolites|mesh-ancestor
24417031|NCT00204789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417032|NCT00204789|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24417033|NCT00204789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24417034|NCT00204789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24417053|NCT00204919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24417054|NCT00204945|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24417055|NCT00204945|Natriuretic Agents|natriuretic agents|mesh-ancestor
24417056|NCT00204945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417058|NCT00204984|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24417059|NCT00204984|Natriuretic Agents|natriuretic agents|mesh-ancestor
24417060|NCT00204984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417061|NCT00204984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24417138|NCT00205725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24417139|NCT00205725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24417140|NCT00205725|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24417141|NCT00205725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24417142|NCT00205725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24417143|NCT00205725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417144|NCT00205725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24417145|NCT00205725|Serotonin Agents|serotonin agents|mesh-ancestor
24417146|NCT00205725|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24417147|NCT00205725|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24417148|NCT00205725|Dopamine Agents|dopamine agents|mesh-ancestor
24417149|NCT00205738|Olanzapine|olanzapine|mesh-list
24417150|NCT00205738|Risperidone|risperidone|mesh-list
24417151|NCT00205738|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24417152|NCT00205738|Serotonin Agents|serotonin agents|mesh-ancestor
24417153|NCT00205738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24417154|NCT00205738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225707|NCT02624999|Cisplatin|cisplatin|mesh-list
25225708|NCT02624999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225709|NCT02624856|Dexamethasone|dexamethasone|mesh-list
25225710|NCT02624856|Bupivacaine|bupivacaine|mesh-list
25225711|NCT02624856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25225712|NCT02624856|Antiemetics|antiemetics|mesh-ancestor
25225713|NCT02624856|Autonomic Agents|autonomic agents|mesh-ancestor
25225714|NCT02624856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25681066|NCT01857362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681067|NCT01857531|Nicotine|nicotine|mesh-list
25681068|NCT01857531|Ganaxolone|ganaxolone|mesh-list
25028844|NCT03607643|Antidotes|antidotes|mesh-ancestor
24839435|NCT02204020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839436|NCT02204020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417155|NCT00205738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417156|NCT00205738|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24417157|NCT00205738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24417158|NCT00205738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24417159|NCT00205738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24417160|NCT00205738|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24417161|NCT00205738|Dopamine Agents|dopamine agents|mesh-ancestor
24417162|NCT00205738|Antiemetics|antiemetics|mesh-ancestor
24417163|NCT00205738|Autonomic Agents|autonomic agents|mesh-ancestor
24417164|NCT00205738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24417165|NCT00205738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24417166|NCT00205738|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24417172|NCT00205751|Melphalan|melphalan|mesh-list
24417173|NCT00205751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24417174|NCT00205751|Antiemetics|antiemetics|mesh-ancestor
24417175|NCT00205751|Autonomic Agents|autonomic agents|mesh-ancestor
24417176|NCT00205751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24417177|NCT00205751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417178|NCT00205751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24417179|NCT00205751|Glucocorticoids|glucocorticoids|mesh-ancestor
24417180|NCT00205751|Hormones|hormones|mesh-ancestor
24417181|NCT00205751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24417182|NCT00205751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24417183|NCT00205751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417184|NCT00205751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24417188|NCT00205751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24417189|NCT00205751|Immunologic Factors|immunologic factors|mesh-ancestor
24417194|NCT00205751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24417195|NCT00205751|Growth Substances|growth substances|mesh-ancestor
24417196|NCT00205751|Growth Inhibitors|growth inhibitors|mesh-ancestor
24417198|NCT00205764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24417199|NCT00205764|Alkylating Agents|alkylating agents|mesh-ancestor
24417200|NCT00205764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417201|NCT00205764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417202|NCT00205764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24417203|NCT00205764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24417204|NCT00205764|Immunologic Factors|immunologic factors|mesh-ancestor
24417205|NCT00205764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417207|NCT00205816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24417208|NCT00205816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24417209|NCT00205816|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24417210|NCT00205816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417211|NCT00205816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417212|NCT00205842|Alvimopan|alvimopan|mesh-list
24417213|NCT00205842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24417214|NCT00205946|Bupropion|bupropion|mesh-list
24417215|NCT00205946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25225715|NCT02624856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225716|NCT02624856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25225717|NCT02624856|Glucocorticoids|glucocorticoids|mesh-ancestor
25225719|NCT02624856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25225720|NCT02624856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24417220|NCT00205946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24417221|NCT00205946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417241|NCT00206063|Ximelagatran|ximelagatran|mesh-list
24417242|NCT00206063|Antithrombins|antithrombins|mesh-ancestor
24417243|NCT00206063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24417244|NCT00206063|Protease Inhibitors|protease inhibitors|mesh-ancestor
24417245|NCT00206063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417246|NCT00206063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417247|NCT00206063|Anticoagulants|anticoagulants|mesh-ancestor
24978006|NCT00482833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978007|NCT00482833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24978008|NCT00482833|Antimetabolites|antimetabolites|mesh-ancestor
24978009|NCT00482833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978010|NCT00482833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978011|NCT00482833|Dermatologic Agents|dermatologic agents|mesh-ancestor
24978012|NCT00482833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692447|NCT01999530|Prazosin|prazosin|mesh-list
25681069|NCT01857531|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25681070|NCT01857531|Autonomic Agents|autonomic agents|mesh-ancestor
24487353|NCT00462787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24487354|NCT00462787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24487355|NCT00462787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487356|NCT00462787|Immunologic Factors|immunologic factors|mesh-ancestor
24487357|NCT00462787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24487358|NCT00462787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24417255|NCT00206089|Anticoagulants|anticoagulants|mesh-ancestor
24417256|NCT00206115|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24417257|NCT00206115|Antidepressive Agents|antidepressive agents|mesh-ancestor
24417258|NCT00206115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24417259|NCT00206115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24417260|NCT00206115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24417261|NCT00206115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24417265|NCT00206128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25225729|NCT02624973|Trastuzumab|trastuzumab|mesh-list
25225730|NCT02624973|Letrozole|letrozole|mesh-list
24417276|NCT00206141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417277|NCT00206154|Budesonide|budesonide|mesh-list
24978015|NCT00482833|Immunologic Factors|immunologic factors|mesh-ancestor
24978016|NCT00482833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24978017|NCT00482833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24978018|NCT00482833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24978019|NCT00482833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24978020|NCT00482833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24978021|NCT00482833|Keratolytic Agents|keratolytic agents|mesh-ancestor
24978022|NCT00381381|Donepezil|donepezil|mesh-list
24442386|NCT00290836|Coagulants|coagulants|mesh-ancestor
24417292|NCT00206154|Adrenergic Agents|adrenergic agents|mesh-ancestor
24417293|NCT00206154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24417296|NCT00206167|Formoterol Fumarate|formoterol fumarate|mesh-list
24417314|NCT00206180|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24417315|NCT00206180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24417316|NCT00206180|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24417317|NCT00206180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417318|NCT00206180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417319|NCT00206193|Misoprostol|misoprostol|mesh-list
24417320|NCT00206193|Sulprostone|sulprostone|mesh-list
24417321|NCT00206193|Mifepristone|mifepristone|mesh-list
24417322|NCT00206193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24417323|NCT00206193|Abortifacient Agents|abortifacient agents|mesh-ancestor
24417324|NCT00206193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24417325|NCT00206193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417326|NCT00206193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24417329|NCT00206193|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24417330|NCT00206193|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24417331|NCT00206193|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24417332|NCT00206193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24417333|NCT00206193|Contraceptive Agents|contraceptive agents|mesh-ancestor
24417334|NCT00206193|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24978043|NCT05179525|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24978044|NCT05179525|Serotonin Agents|serotonin agents|mesh-ancestor
24442609|NCT00291785|Leucovorin|leucovorin|mesh-list
24978052|NCT05179525|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24978053|NCT05179525|Dopamine Agents|dopamine agents|mesh-ancestor
25225731|NCT02624973|Epirubicin|epirubicin|mesh-list
25225732|NCT02624973|Olaparib|olaparib|mesh-list
25225733|NCT02624973|Palbociclib|palbociclib|mesh-list
25681071|NCT01857531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25681072|NCT01857531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681073|NCT01857531|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25681074|NCT01857531|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25681075|NCT01857531|Cholinergic Agents|cholinergic agents|mesh-ancestor
25681076|NCT01857531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25681077|NCT01857531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681078|NCT01857531|Neurosteroids|neurosteroids|mesh-ancestor
25681079|NCT01857531|GABA Modulators|gaba modulators|mesh-ancestor
25681080|NCT01857531|GABA Agents|gaba agents|mesh-ancestor
25225734|NCT02624973|Pertuzumab|pertuzumab|mesh-list
24839453|NCT02204501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24978055|NCT05179512|Tiotropium Bromide|tiotropium bromide|mesh-list
24978056|NCT05179512|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24978057|NCT05179512|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24978058|NCT05179512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24978059|NCT05179512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24978060|NCT05179512|Autonomic Agents|autonomic agents|mesh-ancestor
24978061|NCT05179512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24978062|NCT05179512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978063|NCT05179512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24978064|NCT05179512|Respiratory System Agents|respiratory system agents|mesh-ancestor
24978065|NCT05179512|Dermatologic Agents|dermatologic agents|mesh-ancestor
24978066|NCT05179512|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24978067|NCT05179512|Parasympatholytics|parasympatholytics|mesh-ancestor
24417335|NCT00206193|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24417336|NCT00206193|Hormone Antagonists|hormone antagonists|mesh-ancestor
24417337|NCT00206193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24417349|NCT00206219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417350|NCT00206219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417351|NCT00206219|Dermatologic Agents|dermatologic agents|mesh-ancestor
24417352|NCT00206219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417353|NCT00206219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24417354|NCT00206219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24417355|NCT00206219|Immunologic Factors|immunologic factors|mesh-ancestor
24417356|NCT00206219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24978068|NCT05179512|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24978069|NCT05179512|Cholinergic Agents|cholinergic agents|mesh-ancestor
24978070|NCT05179512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24978071|NCT05179512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978072|NCT05179512|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24978073|NCT05179512|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24978074|NCT05179512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24978075|NCT05179512|Adrenergic Agents|adrenergic agents|mesh-ancestor
24978076|NCT05179512|Glucocorticoids|glucocorticoids|mesh-ancestor
24978077|NCT05179512|Hormones|hormones|mesh-ancestor
24978078|NCT05179512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24978079|NCT05179512|Sympathomimetics|sympathomimetics|mesh-ancestor
24978080|NCT05179213|Azacitidine|azacitidine|mesh-list
24978081|NCT05179213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24978082|NCT05179213|Antimetabolites|antimetabolites|mesh-ancestor
24978083|NCT05179213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978084|NCT05179213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417367|NCT00206258|Pramlintide|pramlintide|mesh-list
24417369|NCT00206258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24417371|NCT00206258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24417372|NCT00206258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417373|NCT00206258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24417374|NCT00206297|Pramlintide|pramlintide|mesh-list
24417375|NCT00206297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25225740|NCT02624973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25225741|NCT02624973|Alkylating Agents|alkylating agents|mesh-ancestor
25225742|NCT02624973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225743|NCT02624973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225744|NCT02624973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24417376|NCT00206297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417377|NCT00206310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24417378|NCT00206310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24417379|NCT00206310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24417380|NCT00206310|Antimetabolites|antimetabolites|mesh-ancestor
24417381|NCT00206310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417382|NCT00206310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24978085|NCT05179213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978086|NCT05179070|Carvedilol|carvedilol|mesh-list
24978087|NCT05179070|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24978088|NCT05179070|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24978089|NCT05179070|Adrenergic Agents|adrenergic agents|mesh-ancestor
24978090|NCT05179070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24978091|NCT05179070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029008|NCT03606369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25029009|NCT03606369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029010|NCT03606369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25029011|NCT03606369|Antipruritics|antipruritics|mesh-ancestor
25029012|NCT03606369|Dermatologic Agents|dermatologic agents|mesh-ancestor
25029013|NCT03606369|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25029014|NCT03606369|Serotonin Agents|serotonin agents|mesh-ancestor
25029015|NCT03606369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25029016|NCT03606369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029017|NCT03606369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25029018|NCT03606369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25029019|NCT03606369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25029020|NCT03606369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25029021|NCT03606369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25029022|NCT03606369|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25029024|NCT03606174|Nivolumab|nivolumab|mesh-list
25029025|NCT03606174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24978092|NCT05179070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978093|NCT05179070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24978095|NCT05179070|Protective Agents|protective agents|mesh-ancestor
24978096|NCT05179070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24978097|NCT05179070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24978098|NCT05179070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24978099|NCT05179070|Vasodilator Agents|vasodilator agents|mesh-ancestor
24978100|NCT05179070|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24978101|NCT05179070|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24978102|NCT05179018|Autoantibodies|autoantibodies|mesh-list
24978103|NCT05179018|Immunologic Factors|immunologic factors|mesh-ancestor
24978104|NCT05179018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533389|NCT00643643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225745|NCT02624973|Tubulin Modulators|tubulin modulators|mesh-ancestor
25225746|NCT02624973|Antimitotic Agents|antimitotic agents|mesh-ancestor
25225747|NCT02624973|Mitosis Modulators|mitosis modulators|mesh-ancestor
25225748|NCT02624973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25225749|NCT02624973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25225750|NCT02624973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25225751|NCT02624973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225752|NCT02624973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25225753|NCT02624973|Hormone Antagonists|hormone antagonists|mesh-ancestor
24839496|NCT02204839|Insulin|insulin|mesh-list
24839497|NCT02204839|Insulin Glargine|insulin glargine|mesh-list
24839498|NCT02204839|Insulin Detemir|insulin detemir|mesh-list
24839499|NCT02204839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24417406|NCT00206414|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24417407|NCT00206414|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24978105|NCT05179005|Imidacloprid|imidacloprid|mesh-list
24978106|NCT05179005|Cholinergic Agents|cholinergic agents|mesh-ancestor
24978107|NCT05179005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24978108|NCT05179005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978109|NCT05179005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978111|NCT05178953|Pentoxifylline|pentoxifylline|mesh-list
24978112|NCT05178953|Zinc Sulfate|zinc sulfate|mesh-list
24978113|NCT05178953|Trace Elements|trace elements|mesh-ancestor
25681081|NCT01857583|PENTA|penta|mesh-list
25681082|NCT01857583|Edoxaban|edoxaban|mesh-list
25681083|NCT01857583|Fondaparinux|fondaparinux|mesh-list
25681084|NCT01857583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25681085|NCT01857583|Antithrombins|antithrombins|mesh-ancestor
25681086|NCT01857583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25681087|NCT01857583|Protease Inhibitors|protease inhibitors|mesh-ancestor
25681088|NCT01857583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25681089|NCT01857583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681090|NCT01857583|Anticoagulants|anticoagulants|mesh-ancestor
25681091|NCT01857583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25681092|NCT01857583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25681093|NCT01857622|Edoxaban|edoxaban|mesh-list
25681094|NCT01857622|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25681095|NCT01857622|Antithrombins|antithrombins|mesh-ancestor
25681096|NCT01857622|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25681097|NCT01857622|Protease Inhibitors|protease inhibitors|mesh-ancestor
25681098|NCT01857622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25681099|NCT01857622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681100|NCT01857622|Anticoagulants|anticoagulants|mesh-ancestor
25681101|NCT01858363|Paclitaxel|paclitaxel|mesh-list
24487741|NCT00464893|Antibodies, Bispecific|antibodies, bispecific|mesh-list
24487742|NCT00464893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24487743|NCT00464893|Immunologic Factors|immunologic factors|mesh-ancestor
24487744|NCT00464893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487745|NCT00464919|Sorafenib|sorafenib|mesh-list
24487746|NCT00464919|Tegafur|tegafur|mesh-list
24823497|NCT02117622|Insulin|insulin|mesh-list
24978114|NCT05178953|Micronutrients|micronutrients|mesh-ancestor
24978115|NCT05178953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978116|NCT05178953|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24978117|NCT05178953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978118|NCT05178953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978119|NCT05178953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24978120|NCT05178953|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24978121|NCT05178953|Protective Agents|protective agents|mesh-ancestor
24978122|NCT05178953|Vasodilator Agents|vasodilator agents|mesh-ancestor
24978123|NCT05178953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24991191|NCT01442194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797298|NCT01955135|Sevoflurane|sevoflurane|mesh-list
24417408|NCT00206414|Hormone Antagonists|hormone antagonists|mesh-ancestor
24417409|NCT00206414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24417410|NCT00206414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225754|NCT02624973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25225755|NCT02624973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25225756|NCT02624973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25225757|NCT02624973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25225758|NCT02624973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25225759|NCT02624973|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25225760|NCT02624973|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25225761|NCT02624973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25225762|NCT02624973|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24417416|NCT00206453|Antimitotic Agents|antimitotic agents|mesh-ancestor
24417428|NCT00206466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24417429|NCT00206466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24417430|NCT00206466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24417431|NCT00206466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417432|NCT00206466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24417433|NCT00206466|Immunologic Factors|immunologic factors|mesh-ancestor
24417434|NCT00206466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417435|NCT00206466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24417436|NCT00206466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24417437|NCT00206466|Alkylating Agents|alkylating agents|mesh-ancestor
24417438|NCT00206466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24417440|NCT00206492|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24417441|NCT00206492|Hormone Antagonists|hormone antagonists|mesh-ancestor
24417442|NCT00206492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24417443|NCT00206492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417444|NCT00206492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24417473|NCT00206557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417474|NCT00206557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24417475|NCT00206557|Hormone Antagonists|hormone antagonists|mesh-ancestor
25681102|NCT01858363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25681103|NCT01858363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25681104|NCT01858363|Tubulin Modulators|tubulin modulators|mesh-ancestor
25681105|NCT01858363|Antimitotic Agents|antimitotic agents|mesh-ancestor
25681106|NCT01858363|Mitosis Modulators|mitosis modulators|mesh-ancestor
25681107|NCT01858363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692448|NCT01999530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25692449|NCT01999530|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25692450|NCT01999530|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25692451|NCT01999530|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25692452|NCT01999530|Adrenergic Agents|adrenergic agents|mesh-ancestor
25692453|NCT01999530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25692454|NCT01999530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692455|NCT01999530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25113113|NCT03511625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25113114|NCT03511625|Antiemetics|antiemetics|mesh-ancestor
24733369|NCT01645449|Calcium|calcium|mesh-list
25113115|NCT03511625|Autonomic Agents|autonomic agents|mesh-ancestor
25113116|NCT03511625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25113117|NCT03511625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25113118|NCT03511625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25113119|NCT03511625|Glucocorticoids|glucocorticoids|mesh-ancestor
25019699|NCT03688958|Iodine|iodine|mesh-list
24417476|NCT00206557|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24417477|NCT00206557|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24417478|NCT00206557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24417479|NCT00206570|Estradiol|estradiol|mesh-list
24417480|NCT00206570|Estrogens|estrogens|mesh-ancestor
24417481|NCT00206570|Hormones|hormones|mesh-ancestor
24417496|NCT00206622|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24417497|NCT00206622|Contraceptive Agents|contraceptive agents|mesh-ancestor
24978131|NCT05178745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978132|NCT05178745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24978133|NCT05178745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978134|NCT05178745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24978135|NCT05178745|Immunologic Factors|immunologic factors|mesh-ancestor
24978136|NCT05178745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978137|NCT05178745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25225763|NCT02624973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25225764|NCT02624817|Glyburide|glyburide|mesh-list
25225765|NCT02624817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25225766|NCT02624817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839514|NCT02204878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24417498|NCT00206622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24417499|NCT00206622|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24417500|NCT00206622|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24417501|NCT00206622|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24417503|NCT00206635|Interferon-beta|interferon-beta|mesh-list
24417504|NCT00206635|Interferon beta-1b|interferon beta-1b|mesh-list
24417505|NCT00206635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417506|NCT00206635|Antiviral Agents|antiviral agents|mesh-ancestor
24417507|NCT00206635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24417508|NCT00206635|Immunologic Factors|immunologic factors|mesh-ancestor
24417524|NCT00206700|Immunologic Factors|immunologic factors|mesh-ancestor
24417525|NCT00206700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417526|NCT00206713|Sargramostim|sargramostim|mesh-list
24417527|NCT00206713|Immunologic Factors|immunologic factors|mesh-ancestor
24417528|NCT00206713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417529|NCT00206739|Pyrimethamine|pyrimethamine|mesh-list
24417530|NCT00206739|Sulfadoxine|sulfadoxine|mesh-list
24417531|NCT00206739|Antimalarials|antimalarials|mesh-ancestor
24417543|NCT00206765|Serotonin Agents|serotonin agents|mesh-ancestor
24978139|NCT05178745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795299|NCT03174184|Amoxicillin|amoxicillin|mesh-list
24795300|NCT03174184|Rifampin|rifampin|mesh-list
24795301|NCT03174184|Meropenem|meropenem|mesh-list
24795302|NCT03174184|Clavulanic Acid|clavulanic acid|mesh-list
24795303|NCT03174184|Clavulanic Acids|clavulanic acids|mesh-list
24795304|NCT03174184|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24795305|NCT03174184|Rifamycins|rifamycins|mesh-list
24795307|NCT03174184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24417581|NCT00206934|Dexetimide|dexetimide|mesh-list
24417591|NCT00206934|Antidepressive Agents|antidepressive agents|mesh-ancestor
24417592|NCT00206934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24417593|NCT00206934|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24417594|NCT00206934|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24417595|NCT00206934|Parasympatholytics|parasympatholytics|mesh-ancestor
24417596|NCT00206934|Autonomic Agents|autonomic agents|mesh-ancestor
24417597|NCT00206934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25681108|NCT01858428|Paclitaxel|paclitaxel|mesh-list
25681109|NCT01858428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25681110|NCT01858428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25681111|NCT01858428|Tubulin Modulators|tubulin modulators|mesh-ancestor
25681112|NCT01858428|Antimitotic Agents|antimitotic agents|mesh-ancestor
25681113|NCT01858428|Mitosis Modulators|mitosis modulators|mesh-ancestor
25681114|NCT01858428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681115|NCT01858532|Atrasentan|atrasentan|mesh-list
24417598|NCT00206934|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24417599|NCT00206934|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25681116|NCT01858532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417600|NCT00206934|Cholinergic Agents|cholinergic agents|mesh-ancestor
24417601|NCT00206947|Ziprasidone|ziprasidone|mesh-list
24417602|NCT00206947|Donepezil|donepezil|mesh-list
24417603|NCT00206947|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24417604|NCT00206947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417605|NCT00206947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417637|NCT00206986|Analgesics|analgesics|mesh-ancestor
24417638|NCT00206986|Sensory System Agents|sensory system agents|mesh-ancestor
24417639|NCT00206986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24417644|NCT00206986|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24417646|NCT00206986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24417647|NCT00206986|Adrenergic Agents|adrenergic agents|mesh-ancestor
24417650|NCT00206999|Imipramine|imipramine|mesh-list
24417705|NCT00207363|Interferon-alpha|interferon-alpha|mesh-list
24417706|NCT00207363|Interferon alpha-2|interferon alpha-2|mesh-list
24417707|NCT00207363|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24417708|NCT00207363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417709|NCT00207363|Antiviral Agents|antiviral agents|mesh-ancestor
24417710|NCT00207363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24417711|NCT00207363|Antimetabolites|antimetabolites|mesh-ancestor
24417716|NCT00207402|Interferons|interferons|mesh-list
24795308|NCT03174184|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24795309|NCT03174184|Antitubercular Agents|antitubercular agents|mesh-ancestor
24795310|NCT03174184|Leprostatic Agents|leprostatic agents|mesh-ancestor
24795311|NCT03174184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24795312|NCT03174184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795313|NCT03174184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795314|NCT03174184|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24795315|NCT03174184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24795316|NCT03174184|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24795317|NCT03174184|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24795318|NCT03174184|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24795319|NCT03174184|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24588609|NCT00903227|Dermatologic Agents|dermatologic agents|mesh-ancestor
24795320|NCT03174184|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24417717|NCT00207402|Ribavirin|ribavirin|mesh-list
24417754|NCT00207584|Doxycycline|doxycycline|mesh-list
24417755|NCT00207584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25225773|NCT02624726|Fluorouracil|fluorouracil|mesh-list
25225775|NCT02624726|Aflibercept|aflibercept|mesh-list
25225776|NCT02624726|Levoleucovorin|levoleucovorin|mesh-list
25225777|NCT02624726|Antimetabolites|antimetabolites|mesh-ancestor
25225778|NCT02624726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225779|NCT02624726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25225780|NCT02624726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225781|NCT02624726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25225782|NCT02624726|Immunologic Factors|immunologic factors|mesh-ancestor
25225783|NCT02624726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225784|NCT02624726|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24417758|NCT00207584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24417759|NCT00207584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24417760|NCT00207662|Infliximab|infliximab|mesh-list
24417761|NCT00207662|Dermatologic Agents|dermatologic agents|mesh-ancestor
24417806|NCT00207831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417808|NCT00207844|Selenious Acid|selenious acid|mesh-list
24417809|NCT00207844|Sodium Selenite|sodium selenite|mesh-list
24417810|NCT00207844|Antioxidants|antioxidants|mesh-ancestor
24417811|NCT00207844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417812|NCT00207844|Protective Agents|protective agents|mesh-ancestor
24417813|NCT00207844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417814|NCT00207844|Trace Elements|trace elements|mesh-ancestor
24417815|NCT00207844|Micronutrients|micronutrients|mesh-ancestor
24417816|NCT00207948|Ritonavir|ritonavir|mesh-list
24417817|NCT00207948|Lopinavir|lopinavir|mesh-list
24417818|NCT00207948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24417819|NCT00207948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24417820|NCT00207948|Protease Inhibitors|protease inhibitors|mesh-ancestor
24417821|NCT00207948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417822|NCT00207948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417823|NCT00207948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24417824|NCT00207948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24417825|NCT00207948|Antiviral Agents|antiviral agents|mesh-ancestor
24417826|NCT00207948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24417827|NCT00207948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24417828|NCT00207948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24417829|NCT00208039|Calfactant|calfactant|mesh-list
25029316|NCT03603366|Sensory System Agents|sensory system agents|mesh-ancestor
25029317|NCT03603366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25029318|NCT03603366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029319|NCT03603366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25029320|NCT03603366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25029321|NCT03603366|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25029322|NCT03603366|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25029323|NCT03603366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029324|NCT03603366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25029325|NCT03603366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25029326|NCT03603366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25029327|NCT03603366|Antipyretics|antipyretics|mesh-ancestor
25029328|NCT03603327|Antiviral Agents|antiviral agents|mesh-list
25029329|NCT03603327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25029330|NCT03603249|Trimetazidine|trimetazidine|mesh-list
25029331|NCT03603249|Vasodilator Agents|vasodilator agents|mesh-ancestor
24417830|NCT00208039|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
24417831|NCT00208039|Respiratory System Agents|respiratory system agents|mesh-ancestor
24417832|NCT00208065|Pseudoephedrine|pseudoephedrine|mesh-list
24795337|NCT02999230|Fluorides|fluorides|mesh-list
24795338|NCT02999230|Sodium Fluoride|sodium fluoride|mesh-list
24795339|NCT02999230|Cariostatic Agents|cariostatic agents|mesh-ancestor
24795340|NCT02999230|Protective Agents|protective agents|mesh-ancestor
24795341|NCT02999230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795342|NCT02999230|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24795343|NCT02999230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24795344|NCT02971761|Pembrolizumab|pembrolizumab|mesh-list
24417842|NCT00208065|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24417843|NCT00208065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24417844|NCT00208065|Sympathomimetics|sympathomimetics|mesh-ancestor
24417845|NCT00208065|Adrenergic Agents|adrenergic agents|mesh-ancestor
24417846|NCT00208065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24417847|NCT00208065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417848|NCT00208065|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24417961|NCT00208221|Protease Inhibitors|protease inhibitors|mesh-ancestor
24417962|NCT00208221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417963|NCT00208234|Omalizumab|omalizumab|mesh-list
24417964|NCT00208234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25225785|NCT02624726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25225786|NCT02624726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225787|NCT02624726|Antidotes|antidotes|mesh-ancestor
25225788|NCT02624726|Protective Agents|protective agents|mesh-ancestor
24417969|NCT00208234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417970|NCT00208260|Leucovorin|leucovorin|mesh-list
24417971|NCT00208260|Fluorouracil|fluorouracil|mesh-list
24417972|NCT00208260|Oxaliplatin|oxaliplatin|mesh-list
24417973|NCT00208260|Folfirinox|folfirinox|mesh-list
24417974|NCT00208260|Antimetabolites|antimetabolites|mesh-ancestor
24417975|NCT00208260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417984|NCT00208260|Vitamins|vitamins|mesh-ancestor
24417991|NCT00208273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417992|NCT00208273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24417993|NCT00208273|Hormone Antagonists|hormone antagonists|mesh-ancestor
24795351|NCT02959697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795352|NCT02959697|Sensory System Agents|sensory system agents|mesh-ancestor
24678728|NCT01363752|Sirolimus|sirolimus|mesh-list
24795353|NCT02959697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24795354|NCT02959697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24795355|NCT02959697|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25105719|NCT05096442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25681117|NCT01858532|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25681118|NCT01858532|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25681119|NCT01858532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681120|NCT01858766|Ribavirin|ribavirin|mesh-list
25681121|NCT01858766|Antiviral Agents|antiviral agents|mesh-ancestor
25681122|NCT01858766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25681123|NCT01858766|Antimetabolites|antimetabolites|mesh-ancestor
25681124|NCT01858766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681125|NCT01859013|Topiramate|topiramate|mesh-list
25681126|NCT01859013|Anticonvulsants|anticonvulsants|mesh-ancestor
25681127|NCT01859013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25681128|NCT01859013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681129|NCT01859078|Digoxin|digoxin|mesh-list
25681130|NCT01859078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25681131|NCT01859078|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25681132|NCT01859078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692456|NCT01999868|Abatacept|abatacept|mesh-list
25681133|NCT01859078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986301|NCT01978938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24986302|NCT01978938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24986303|NCT01978938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986304|NCT01978938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986305|NCT01978938|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24487956|NCT00466063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487957|NCT00466076|Glatiramer Acetate|glatiramer acetate|mesh-list
24487958|NCT00466076|(T,G)-A-L|(t,g)-a-l|mesh-list
24439106|NCT00277589|Iodine|iodine|mesh-list
24783638|NCT01903057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783639|NCT01903057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783641|NCT01903070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24458285|NCT00337376|Mitosis Modulators|mitosis modulators|mesh-ancestor
24418013|NCT00208312|Sensory System Agents|sensory system agents|mesh-ancestor
24783642|NCT01903070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783643|NCT01903070|Incretins|incretins|mesh-ancestor
24783644|NCT01903070|Hormones|hormones|mesh-ancestor
24418075|NCT00208533|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24418076|NCT00208546|Bevacizumab|bevacizumab|mesh-list
24418078|NCT00208546|Capecitabine|capecitabine|mesh-list
24418079|NCT00208546|Oxaliplatin|oxaliplatin|mesh-list
24418090|NCT00208559|Ziprasidone|ziprasidone|mesh-list
24418091|NCT00208559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24418092|NCT00208559|Serotonin Agents|serotonin agents|mesh-ancestor
24418093|NCT00208559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24418104|NCT00208572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24418105|NCT00208572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24418106|NCT00208572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418107|NCT00208572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24418108|NCT00208572|Serotonin Agents|serotonin agents|mesh-ancestor
24418109|NCT00208572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418110|NCT00208572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24418111|NCT00208572|Antidepressive Agents|antidepressive agents|mesh-ancestor
24418112|NCT00208572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24418114|NCT00208585|Antidepressive Agents|antidepressive agents|mesh-ancestor
24418115|NCT00208585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24418116|NCT00208585|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24418117|NCT00208585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24418118|NCT00208585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24418119|NCT00208585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418120|NCT00208585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24783651|NCT01903083|Tadalafil|tadalafil|mesh-list
24783652|NCT01903083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24418126|NCT00208611|Vitamin B Complex|vitamin b complex|mesh-list
24418127|NCT00208611|Micronutrients|micronutrients|mesh-ancestor
24418128|NCT00208611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418129|NCT00208611|Hematinics|hematinics|mesh-ancestor
24418130|NCT00208702|Sertraline|sertraline|mesh-list
24418139|NCT00208702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418141|NCT00208715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24418142|NCT00208715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418143|NCT00208715|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24418144|NCT00208715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24418145|NCT00208715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24418146|NCT00208715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418147|NCT00208741|Tiagabine|tiagabine|mesh-list
24418148|NCT00208741|Anticonvulsants|anticonvulsants|mesh-ancestor
25681134|NCT01859078|Protective Agents|protective agents|mesh-ancestor
25681135|NCT01859078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681136|NCT01859312|Hydrocortisone|hydrocortisone|mesh-list
25681137|NCT01859312|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25681138|NCT01859312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25681139|NCT01859390|Antioxidants|antioxidants|mesh-list
25681140|NCT01859390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681141|NCT01859390|Protective Agents|protective agents|mesh-ancestor
25681142|NCT01859390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029402|NCT03602898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25029403|NCT03602898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25029404|NCT03602898|Antifungal Agents|antifungal agents|mesh-ancestor
25029405|NCT03602898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25029406|NCT03602846|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25029407|NCT03602846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029423|NCT03602690|Ritonavir|ritonavir|mesh-list
25029424|NCT03602690|Darunavir|darunavir|mesh-list
25029425|NCT03602690|Dolutegravir|dolutegravir|mesh-list
25029431|NCT03602690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24418149|NCT00208741|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
25225793|NCT02624726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25225794|NCT02624726|Growth Substances|growth substances|mesh-ancestor
25225795|NCT02624726|Growth Inhibitors|growth inhibitors|mesh-ancestor
25225796|NCT02624830|Glyburide|glyburide|mesh-list
25225797|NCT02624830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25225798|NCT02624830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225799|NCT02624661|Glycerol|glycerol|mesh-list
25225800|NCT02624661|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25225801|NCT02624661|Protective Agents|protective agents|mesh-ancestor
25105723|NCT05096442|Antimitotic Agents|antimitotic agents|mesh-ancestor
25105724|NCT05096442|Mitosis Modulators|mitosis modulators|mesh-ancestor
25105725|NCT05096442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418199|NCT00208897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24418200|NCT00208897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24418201|NCT00208897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418202|NCT00208897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24418203|NCT00208897|Serotonin Agents|serotonin agents|mesh-ancestor
24418204|NCT00208897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418205|NCT00208897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25225802|NCT02624661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225803|NCT02624622|Chlorhexidine|chlorhexidine|mesh-list
25225804|NCT02624622|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25225805|NCT02624622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25225806|NCT02624622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25225807|NCT02624622|Disinfectants|disinfectants|mesh-ancestor
25225808|NCT02624622|Dermatologic Agents|dermatologic agents|mesh-ancestor
25057189|NCT03506828|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
24418216|NCT00208923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418217|NCT00208923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24418245|NCT00209079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24418246|NCT00209079|Tubulin Modulators|tubulin modulators|mesh-ancestor
24418247|NCT00209079|Antimitotic Agents|antimitotic agents|mesh-ancestor
24418248|NCT00209079|Mitosis Modulators|mitosis modulators|mesh-ancestor
24418249|NCT00209079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418250|NCT00209079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24418251|NCT00209079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24418252|NCT00209118|Paroxetine|paroxetine|mesh-list
24418253|NCT00209118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24418254|NCT00209118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25105737|NCT05017610|Lomustine|lomustine|mesh-list
25105738|NCT05017610|Methimazole|methimazole|mesh-list
25105739|NCT05017610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25105740|NCT05017610|Alkylating Agents|alkylating agents|mesh-ancestor
24418273|NCT00209209|Cyclophosphamide|cyclophosphamide|mesh-list
24418293|NCT00209209|Glucocorticoids|glucocorticoids|mesh-ancestor
24418294|NCT00209209|Hormones|hormones|mesh-ancestor
24418296|NCT00209209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24418297|NCT00209209|Antiviral Agents|antiviral agents|mesh-ancestor
24418298|NCT00209209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24418299|NCT00209209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24418300|NCT00209209|Tubulin Modulators|tubulin modulators|mesh-ancestor
24418301|NCT00209209|Antimitotic Agents|antimitotic agents|mesh-ancestor
24418302|NCT00209209|Mitosis Modulators|mitosis modulators|mesh-ancestor
25681143|NCT01859637|Lenograstim|lenograstim|mesh-list
25681144|NCT01859637|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25681145|NCT01859637|Immunologic Factors|immunologic factors|mesh-ancestor
25681146|NCT01859637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681147|NCT01859702|Moxifloxacin|moxifloxacin|mesh-list
25681148|NCT01859702|Dexamethasone|dexamethasone|mesh-list
25681149|NCT01859702|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25681150|NCT01859702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25681151|NCT01859702|Antiemetics|antiemetics|mesh-ancestor
25681152|NCT01859702|Autonomic Agents|autonomic agents|mesh-ancestor
24418303|NCT00209222|Cytarabine|cytarabine|mesh-list
25681153|NCT01859702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24418304|NCT00209222|Dexamethasone|dexamethasone|mesh-list
24418305|NCT00209222|Prednisone|prednisone|mesh-list
24418306|NCT00209222|Cyclophosphamide|cyclophosphamide|mesh-list
24418307|NCT00209222|Melphalan|melphalan|mesh-list
24418308|NCT00209222|Rituximab|rituximab|mesh-list
24418309|NCT00209222|Doxorubicin|doxorubicin|mesh-list
24418336|NCT00209222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24418338|NCT00209222|Antimitotic Agents|antimitotic agents|mesh-ancestor
24418339|NCT00209222|Mitosis Modulators|mitosis modulators|mesh-ancestor
24418340|NCT00209222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24418341|NCT00209222|Antimetabolites|antimetabolites|mesh-ancestor
24418342|NCT00209222|Antiviral Agents|antiviral agents|mesh-ancestor
24418343|NCT00209222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24418344|NCT00209261|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24418345|NCT00209261|Hemostatics|hemostatics|mesh-ancestor
24418346|NCT00209261|Coagulants|coagulants|mesh-ancestor
24418347|NCT00209261|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24418348|NCT00209261|Natriuretic Agents|natriuretic agents|mesh-ancestor
24418349|NCT00209261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418350|NCT00209300|Mesalamine|mesalamine|mesh-list
25225809|NCT02624505|Albuterol|albuterol|mesh-list
24418351|NCT00209300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24418352|NCT00209300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25225810|NCT02624505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25225811|NCT02624505|Autonomic Agents|autonomic agents|mesh-ancestor
25225812|NCT02624505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25225813|NCT02624505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839539|NCT02205151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839540|NCT02205151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24839541|NCT02205151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839543|NCT02205164|Aprepitant|aprepitant|mesh-list
24839544|NCT02205164|Palonosetron|palonosetron|mesh-list
24839545|NCT02205164|Antiemetics|antiemetics|mesh-ancestor
24675641|NCT01344291|Curcumin|curcumin|mesh-list
24418353|NCT00209300|Analgesics|analgesics|mesh-ancestor
24418354|NCT00209300|Sensory System Agents|sensory system agents|mesh-ancestor
24418355|NCT00209300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24418356|NCT00209300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105741|NCT05017610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105743|NCT05017610|Antithyroid Agents|antithyroid agents|mesh-ancestor
25105744|NCT05017610|Hormone Antagonists|hormone antagonists|mesh-ancestor
25105745|NCT05017610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25105746|NCT05017610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105747|NCT05013801|Hydroquinone|hydroquinone|mesh-list
25105748|NCT05013801|Antioxidants|antioxidants|mesh-ancestor
25105749|NCT05013801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105750|NCT05013801|Protective Agents|protective agents|mesh-ancestor
25105751|NCT05013801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105752|NCT05013801|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25105753|NCT05012865|Avelumab|avelumab|mesh-list
25105754|NCT05012865|Axitinib|axitinib|mesh-list
25105755|NCT05012865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25105756|NCT05012865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783655|NCT01903083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105757|NCT05012865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25105758|NCT05012865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24418389|NCT00209495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418390|NCT00209495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24418391|NCT00209495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24418392|NCT00209495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24418393|NCT00209495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24418394|NCT00209495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24418398|NCT00209521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24418399|NCT00209521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418400|NCT00209521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24418401|NCT00209521|Anesthetics, General|anesthetics, general|mesh-ancestor
24418402|NCT00209521|Anesthetics|anesthetics|mesh-ancestor
24418403|NCT00209534|Fospropofol|fospropofol|mesh-list
24418404|NCT00209534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24418405|NCT00209534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24418406|NCT00209534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418407|NCT00209547|Fospropofol|fospropofol|mesh-list
24418408|NCT00209547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24418409|NCT00209547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24418410|NCT00209547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225814|NCT02624505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25225815|NCT02624505|Respiratory System Agents|respiratory system agents|mesh-ancestor
25225817|NCT02624505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25225818|NCT02624505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25225819|NCT02624505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24839548|NCT02205164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839555|NCT02205164|Serotonin Agents|serotonin agents|mesh-ancestor
24839556|NCT02205190|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24839557|NCT02205190|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24839558|NCT02205190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24839559|NCT02205190|Antimetabolites|antimetabolites|mesh-ancestor
24839560|NCT02205190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839561|NCT02205190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25057198|NCT03506815|Anticoagulants|anticoagulants|mesh-ancestor
25057199|NCT03506802|Aldesleukin|aldesleukin|mesh-list
25057200|NCT03506802|Plerixafor|plerixafor|mesh-list
25057201|NCT03506802|Lenalidomide|lenalidomide|mesh-list
25057202|NCT03506802|Melphalan|melphalan|mesh-list
25057203|NCT03506802|Interleukin-2|interleukin-2|mesh-list
25057204|NCT03506802|Mechlorethamine|mechlorethamine|mesh-list
25057205|NCT03506802|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25057206|NCT03506802|Lenograstim|lenograstim|mesh-list
25057207|NCT03506802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25057208|NCT03506802|Immunologic Factors|immunologic factors|mesh-ancestor
25057209|NCT03506802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057210|NCT03506802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24882495|NCT05170061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24882496|NCT05170061|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24882497|NCT05170061|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24505327|NCT00540943|Irinotecan|irinotecan|mesh-list
24443105|NCT00293657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24533788|NCT00645151|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24533791|NCT00645190|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25225820|NCT02624505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25225821|NCT02624505|Adrenergic Agents|adrenergic agents|mesh-ancestor
25225822|NCT02624505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25225823|NCT02624505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225824|NCT02624479|Sodium thiosulfate|sodium thiosulfate|mesh-list
25225825|NCT02624479|Antidotes|antidotes|mesh-ancestor
25225826|NCT02624479|Protective Agents|protective agents|mesh-ancestor
25225827|NCT02624479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225828|NCT02624479|Antioxidants|antioxidants|mesh-ancestor
24533816|NCT00645242|Fluconazole|fluconazole|mesh-list
24839566|NCT02205242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24839568|NCT02205255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24839569|NCT02205255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24598684|NCT00957320|Pegaspargase|pegaspargase|mesh-list
24459904|NCT00346801|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24533808|NCT00645229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533809|NCT00645229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533810|NCT00645229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24533811|NCT00645229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24488294|NCT00467571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24488295|NCT00467571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24488296|NCT00467571|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24488297|NCT00467571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488298|NCT00467571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488299|NCT00467571|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24488300|NCT00467571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25225849|NCT02624453|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25225850|NCT02624453|Antifungal Agents|antifungal agents|mesh-ancestor
25225851|NCT02624453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25225852|NCT02624453|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25225853|NCT02624453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25225854|NCT02624453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225855|NCT02624453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225856|NCT02624453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25225857|NCT02624453|Hormone Antagonists|hormone antagonists|mesh-ancestor
24839577|NCT02205489|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25043413|NCT01265901|Growth Inhibitors|growth inhibitors|mesh-ancestor
24533812|NCT00645229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24533813|NCT00645229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24533814|NCT00645229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24533815|NCT00645229|Dopamine Agents|dopamine agents|mesh-ancestor
24533817|NCT00645242|Antifungal Agents|antifungal agents|mesh-ancestor
24533828|NCT00645242|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25681154|NCT01859702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681155|NCT01859702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25681156|NCT01859702|Glucocorticoids|glucocorticoids|mesh-ancestor
25681157|NCT01859702|Hormones|hormones|mesh-ancestor
25681158|NCT01859702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25681159|NCT01859702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25681160|NCT01859702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029693|NCT03601091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25029694|NCT03601091|Anesthetics, General|anesthetics, general|mesh-ancestor
25029695|NCT03601091|Anesthetics|anesthetics|mesh-ancestor
25029696|NCT03601091|GABA Modulators|gaba modulators|mesh-ancestor
25029697|NCT03601091|GABA Agents|gaba agents|mesh-ancestor
24701688|NCT01460420|Lenalidomide|lenalidomide|mesh-list
25225858|NCT02624453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25107464|NCT03139708|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25107465|NCT03139708|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25107467|NCT03140033|Misoprostol|misoprostol|mesh-list
25225859|NCT02624453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225860|NCT02624453|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25225861|NCT02624453|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25225862|NCT02624453|Antiviral Agents|antiviral agents|mesh-ancestor
25225863|NCT02624388|Genistein|genistein|mesh-list
25225864|NCT02624388|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25225865|NCT02624388|Protective Agents|protective agents|mesh-ancestor
24533841|NCT00645281|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24533842|NCT00645281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24533860|NCT00645307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24533861|NCT00645307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533862|NCT00645307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24533863|NCT00645307|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24533864|NCT00645307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24533865|NCT00645307|Serotonin Agents|serotonin agents|mesh-ancestor
24533866|NCT00645307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24533867|NCT00645307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533868|NCT00645307|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24533869|NCT00645307|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25225866|NCT02624388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225867|NCT02624388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225868|NCT02624388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25225870|NCT02624388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839584|NCT02205489|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24839585|NCT02205489|Prednisolone phosphate|prednisolone phosphate|mesh-list
24839586|NCT02205489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24839587|NCT02205489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25681161|NCT01859702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25681162|NCT01859702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25681163|NCT01859702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25681164|NCT01859702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25681165|NCT01859702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25681166|NCT01859702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25681167|NCT01859702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681168|NCT01859715|Oxycodone|oxycodone|mesh-list
25029767|NCT03600831|Antimitotic Agents|antimitotic agents|mesh-ancestor
25029768|NCT03600831|Mitosis Modulators|mitosis modulators|mesh-ancestor
25029769|NCT03600831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029770|NCT03600766|Mirabegron|mirabegron|mesh-list
25029786|NCT03600727|Anesthetics|anesthetics|mesh-ancestor
25225871|NCT02624388|Phytoestrogens|phytoestrogens|mesh-ancestor
25225872|NCT02624388|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25225873|NCT02624388|Estrogens|estrogens|mesh-ancestor
25225874|NCT02624388|Hormones|hormones|mesh-ancestor
25225875|NCT02624388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25225876|NCT02624531|Cisplatin|cisplatin|mesh-list
25225878|NCT02624531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225879|NCT02624401|Dexmedetomidine|dexmedetomidine|mesh-list
25225880|NCT02624401|Ketamine|ketamine|mesh-list
25225881|NCT02624401|Propofol|propofol|mesh-list
25225882|NCT02624401|Sevoflurane|sevoflurane|mesh-list
25225883|NCT02624401|Esketamine|esketamine|mesh-list
25225884|NCT02624401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24533988|NCT00645606|Immunologic Factors|immunologic factors|mesh-ancestor
24533989|NCT00645606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857404|NCT02291536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24857405|NCT02291562|Dronabinol|dronabinol|mesh-list
24857406|NCT02291562|Cannabidiol|cannabidiol|mesh-list
24857407|NCT02291562|Anticonvulsants|anticonvulsants|mesh-ancestor
24408270|NCT00177086|Alfuzosin|alfuzosin|mesh-list
24534037|NCT00645866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534039|NCT00645866|Antimetabolites|antimetabolites|mesh-ancestor
25681169|NCT01859715|Hydrocodone|hydrocodone|mesh-list
25681170|NCT01859715|Ondansetron|ondansetron|mesh-list
25681171|NCT01859715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25681172|NCT01859715|Narcotics|narcotics|mesh-ancestor
25681173|NCT01859715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25681174|NCT01859715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681175|NCT01859715|Analgesics|analgesics|mesh-ancestor
25681176|NCT01859715|Sensory System Agents|sensory system agents|mesh-ancestor
25681177|NCT01859715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25681178|NCT01859715|Antiemetics|antiemetics|mesh-ancestor
25681179|NCT01859715|Autonomic Agents|autonomic agents|mesh-ancestor
25692457|NCT01999868|Ustekinumab|ustekinumab|mesh-list
24488562|NCT00469404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24488563|NCT00469404|Narcotics|narcotics|mesh-ancestor
24488564|NCT00469404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24488566|NCT00469404|Analgesics|analgesics|mesh-ancestor
25029826|NCT03600506|Analgesics|analgesics|mesh-ancestor
24534040|NCT00645866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24534041|NCT00645866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24534042|NCT00645866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24534043|NCT00645866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534044|NCT00645879|Citric Acid|citric acid|mesh-list
24534045|NCT00645879|Sodium Citrate|sodium citrate|mesh-list
24534046|NCT00645879|Anticoagulants|anticoagulants|mesh-ancestor
24534047|NCT00645879|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24534048|NCT00645879|Chelating Agents|chelating agents|mesh-ancestor
24534049|NCT00645879|Sequestering Agents|sequestering agents|mesh-ancestor
25225888|NCT02624401|Anesthetics, General|anesthetics, general|mesh-ancestor
25225889|NCT02624401|Anesthetics|anesthetics|mesh-ancestor
25225890|NCT02624401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25225891|NCT02624401|Analgesics|analgesics|mesh-ancestor
25225892|NCT02624401|Sensory System Agents|sensory system agents|mesh-ancestor
25225893|NCT02624401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24839599|NCT02205489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24839601|NCT02205489|Hormones|hormones|mesh-ancestor
25057250|NCT03506763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534050|NCT00645879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534056|NCT00645905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24534067|NCT00645931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24534068|NCT00645931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534069|NCT00646009|Fluticasone|fluticasone|mesh-list
24534070|NCT00646009|Budesonide|budesonide|mesh-list
24534071|NCT00646009|Albuterol|albuterol|mesh-list
24534072|NCT00646009|Formoterol Fumarate|formoterol fumarate|mesh-list
24534073|NCT00646009|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24534074|NCT00646009|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24534075|NCT00646009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24534076|NCT00646009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24534077|NCT00646009|Autonomic Agents|autonomic agents|mesh-ancestor
24534078|NCT00646009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24534079|NCT00646009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534080|NCT00646009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24534081|NCT00646009|Respiratory System Agents|respiratory system agents|mesh-ancestor
24534082|NCT00646009|Dermatologic Agents|dermatologic agents|mesh-ancestor
24534083|NCT00646009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24534084|NCT00646009|Glucocorticoids|glucocorticoids|mesh-ancestor
24534085|NCT00646009|Hormones|hormones|mesh-ancestor
24857408|NCT02291562|Hallucinogens|hallucinogens|mesh-ancestor
24414781|NCT00198614|Antioxidants|antioxidants|mesh-ancestor
24534096|NCT00646035|Ergocalciferols|ergocalciferols|mesh-list
24534097|NCT00646035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24534111|NCT00646061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534112|NCT00646087|Ketamine|ketamine|mesh-list
24534113|NCT00646087|Analgesics|analgesics|mesh-ancestor
24444639|NCT00298675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25681180|NCT01859715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25681181|NCT01859715|Antipruritics|antipruritics|mesh-ancestor
25681182|NCT01859715|Dermatologic Agents|dermatologic agents|mesh-ancestor
25681183|NCT01859715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24991552|NCT05139875|Respiratory System Agents|respiratory system agents|mesh-ancestor
24991553|NCT05137860|Bortezomib|bortezomib|mesh-list
24991554|NCT05137860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029911|NCT03599726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029912|NCT03599726|Cholinergic Agents|cholinergic agents|mesh-ancestor
25029913|NCT03599726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25029914|NCT03599726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029915|NCT03599726|Nootropic Agents|nootropic agents|mesh-ancestor
24488604|NCT00469443|Micronutrients|micronutrients|mesh-ancestor
24488605|NCT00469469|Bevacizumab|bevacizumab|mesh-list
25225894|NCT02624401|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25225895|NCT02624401|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25225896|NCT02624401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25225897|NCT02624401|Adrenergic Agents|adrenergic agents|mesh-ancestor
24839605|NCT02205489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24839606|NCT02205489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24839607|NCT02205489|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24839608|NCT02205489|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24839609|NCT02205489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24534135|NCT00646126|Schistosomicides|schistosomicides|mesh-ancestor
24534136|NCT00646126|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24534137|NCT00646126|Anthelmintics|anthelmintics|mesh-ancestor
24534138|NCT00646126|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24534139|NCT00646126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487673|NCT00464373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857415|NCT02291562|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24857416|NCT02291562|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24857417|NCT02291562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24459916|NCT00346840|Misoprostol|misoprostol|mesh-list
25681184|NCT01859715|Serotonin Agents|serotonin agents|mesh-ancestor
25681185|NCT01859715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25681186|NCT01859715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681187|NCT01859715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25681188|NCT01859715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25681189|NCT01859715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25681190|NCT01859715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25681191|NCT01859715|Antitussive Agents|antitussive agents|mesh-ancestor
25681192|NCT01859715|Respiratory System Agents|respiratory system agents|mesh-ancestor
25029979|NCT03599427|Lidocaine|lidocaine|mesh-list
25029980|NCT03599427|Anesthetics, Local|anesthetics, local|mesh-ancestor
25029981|NCT03599427|Anesthetics|anesthetics|mesh-ancestor
25029982|NCT03599427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25029983|NCT03599427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029984|NCT03599427|Sensory System Agents|sensory system agents|mesh-ancestor
25029985|NCT03599427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25225898|NCT02624401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25225899|NCT02624401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225900|NCT02624401|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25225901|NCT02624401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25225902|NCT02624401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25225903|NCT02624401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25225904|NCT02624401|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25225905|NCT02624401|Antidepressive Agents|antidepressive agents|mesh-ancestor
24857418|NCT02291562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857419|NCT02291562|Hormones|hormones|mesh-ancestor
24857421|NCT02291666|Tolbutamide|tolbutamide|mesh-list
24534161|NCT00646204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534162|NCT00646204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534178|NCT00646321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24534179|NCT00646321|Respiratory System Agents|respiratory system agents|mesh-ancestor
24702199|NCT01464528|Hyaluronic Acid|hyaluronic acid|mesh-list
24702200|NCT01464528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25225906|NCT02624401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25225907|NCT02624362|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
25225908|NCT02624362|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25225909|NCT02624362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25681193|NCT01859741|Cisplatin|cisplatin|mesh-list
25681194|NCT01859741|Carboplatin|carboplatin|mesh-list
25681195|NCT01859741|Etoposide|etoposide|mesh-list
25681196|NCT01859741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25681197|NCT01859741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25681198|NCT01859741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25681199|NCT01859741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25681200|NCT01859741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225910|NCT02624362|Disinfectants|disinfectants|mesh-ancestor
25225912|NCT02624310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25225913|NCT02624310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25225914|NCT02624440|Clarithromycin|clarithromycin|mesh-list
25225915|NCT02624440|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24857428|NCT02291666|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24857429|NCT02291666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24857430|NCT02291666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24857431|NCT02291666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225916|NCT02624440|Trimethoprim|trimethoprim|mesh-list
25225917|NCT02624440|Sulfamethoxazole|sulfamethoxazole|mesh-list
25225918|NCT02624440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25225919|NCT02624440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25225920|NCT02624440|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25225921|NCT02624440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225922|NCT02624440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534211|NCT00646516|Respiratory System Agents|respiratory system agents|mesh-ancestor
24534214|NCT00646516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24534215|NCT00646516|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24857437|NCT02291666|Anesthetics|anesthetics|mesh-ancestor
24857438|NCT02291666|GABA Modulators|gaba modulators|mesh-ancestor
24857439|NCT02291666|GABA Agents|gaba agents|mesh-ancestor
24857440|NCT02291666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24857441|NCT02291666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857446|NCT02291666|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24857447|NCT02291666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24857448|NCT02291666|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24797402|NCT01955460|Aldesleukin|aldesleukin|mesh-list
25692458|NCT01999868|Immunoglobulins|immunoglobulins|mesh-list
25692459|NCT01999868|Immunologic Factors|immunologic factors|mesh-ancestor
25681201|NCT01859741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225923|NCT02624440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25225924|NCT02624440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25225925|NCT02624440|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25225927|NCT02624440|Antimalarials|antimalarials|mesh-ancestor
24702384|NCT01465685|Methylphenidate|methylphenidate|mesh-list
24702404|NCT01465828|Clopidogrel|clopidogrel|mesh-list
24991615|NCT05105750|Aspirin|aspirin|mesh-list
24991616|NCT05105750|Indobufen|indobufen|mesh-list
24991617|NCT05105750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24991618|NCT05105750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24991619|NCT05105750|Analgesics|analgesics|mesh-ancestor
24991620|NCT05105750|Sensory System Agents|sensory system agents|mesh-ancestor
24534240|NCT00646568|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24534241|NCT00646568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24534242|NCT00646568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534243|NCT00646594|Fluticasone|fluticasone|mesh-list
24857449|NCT02291666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24857450|NCT02291666|Purinergic Agents|purinergic agents|mesh-ancestor
24857451|NCT02291666|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24857452|NCT02291666|Antidepressive Agents|antidepressive agents|mesh-ancestor
25225928|NCT02624440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25225929|NCT02624440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25225930|NCT02624440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25225931|NCT02624440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25225932|NCT02624440|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25273307|NCT02386111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273308|NCT02386033|Atorvastatin|atorvastatin|mesh-list
25273309|NCT02386033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25681202|NCT01859793|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25681203|NCT01859793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25681204|NCT01859793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488908|NCT00470522|Antimetabolites|antimetabolites|mesh-ancestor
24587919|NCT00898794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25273310|NCT02386033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24785508|NCT01914822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24534293|NCT00646620|Autonomic Agents|autonomic agents|mesh-ancestor
24534294|NCT00646620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24702448|NCT01465919|Antidepressive Agents|antidepressive agents|mesh-ancestor
24450924|NCT00320983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24450925|NCT00320983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450926|NCT00320983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450928|NCT00321009|Anticoagulants|anticoagulants|mesh-ancestor
24450929|NCT00321009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24450930|NCT00321009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24450931|NCT00321009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450932|NCT00321074|Tacrolimus|tacrolimus|mesh-list
24450933|NCT00321074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24450934|NCT00321074|Immunologic Factors|immunologic factors|mesh-ancestor
24450935|NCT00321074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450936|NCT00321074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24450937|NCT00321074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450938|NCT00321074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450939|NCT00321113|Mycophenolic Acid|mycophenolic acid|mesh-list
24450940|NCT00321113|Tacrolimus|tacrolimus|mesh-list
24450941|NCT00321113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24450942|NCT00321113|Immunologic Factors|immunologic factors|mesh-ancestor
24450943|NCT00321113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450944|NCT00321113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24450945|NCT00321113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857453|NCT02291666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25225933|NCT02624063|Sofosbuvir|sofosbuvir|mesh-list
25225934|NCT02624063|Simeprevir|simeprevir|mesh-list
25225935|NCT02624063|Antiviral Agents|antiviral agents|mesh-ancestor
25225936|NCT02624063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25225937|NCT02624063|Protease Inhibitors|protease inhibitors|mesh-ancestor
25225938|NCT02624063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225939|NCT02624063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991639|NCT05081089|Amodiaquine|amodiaquine|mesh-list
24991640|NCT05081089|Tafenoquine|tafenoquine|mesh-list
24991641|NCT05081089|Antimalarials|antimalarials|mesh-ancestor
24991650|NCT05068661|Fentanyl|fentanyl|mesh-list
25681205|NCT01859793|Incretins|incretins|mesh-ancestor
25681206|NCT01859793|Hormones|hormones|mesh-ancestor
25681207|NCT01859793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25681208|NCT01859793|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25681209|NCT01859793|Protease Inhibitors|protease inhibitors|mesh-ancestor
25681210|NCT01859793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813061|NCT02056249|Autonomic Agents|autonomic agents|mesh-ancestor
24813062|NCT02056249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24813064|NCT02056353|Insulin|insulin|mesh-list
24813065|NCT02056353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24813066|NCT02056353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813067|NCT02056366|Thioctic Acid|thioctic acid|mesh-list
24813068|NCT02056366|Antioxidants|antioxidants|mesh-ancestor
24813069|NCT02056366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813070|NCT02056366|Protective Agents|protective agents|mesh-ancestor
24813071|NCT02056366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813072|NCT02056366|Vitamin B Complex|vitamin b complex|mesh-ancestor
24813073|NCT02056366|Vitamins|vitamins|mesh-ancestor
24813074|NCT02056366|Micronutrients|micronutrients|mesh-ancestor
25225940|NCT02624141|Epoetin Alfa|epoetin alfa|mesh-list
25225941|NCT02624141|Hematinics|hematinics|mesh-ancestor
25225942|NCT02623881|Progesterone|progesterone|mesh-list
25225944|NCT02623881|Hormones|hormones|mesh-ancestor
25225945|NCT02623881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25225946|NCT02623881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225947|NCT02624089|Ropivacaine|ropivacaine|mesh-list
25225948|NCT02624089|Anesthetics, Local|anesthetics, local|mesh-ancestor
25225949|NCT02624089|Anesthetics|anesthetics|mesh-ancestor
24534329|NCT00646711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460562|NCT00348894|Reboxetine|reboxetine|mesh-list
24702663|NCT01467115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702664|NCT01467115|Antidotes|antidotes|mesh-ancestor
24702665|NCT01467115|Protective Agents|protective agents|mesh-ancestor
24702666|NCT01467115|Vitamin B Complex|vitamin b complex|mesh-ancestor
24702667|NCT01467115|Vitamins|vitamins|mesh-ancestor
24702668|NCT01467115|Micronutrients|micronutrients|mesh-ancestor
24702669|NCT01467115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24702670|NCT01467115|Hematinics|hematinics|mesh-ancestor
24702671|NCT01467141|Insulin|insulin|mesh-list
24702672|NCT01467141|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24449880|NCT00317408|Carboplatin|carboplatin|mesh-list
24449881|NCT00317408|Methotrexate|methotrexate|mesh-list
24449882|NCT00317408|Etoposide|etoposide|mesh-list
24449883|NCT00317408|Melphalan|melphalan|mesh-list
24449884|NCT00317408|Busulfan|busulfan|mesh-list
24449885|NCT00317408|Ifosfamide|ifosfamide|mesh-list
24449886|NCT00317408|Mitoxantrone|mitoxantrone|mesh-list
24449887|NCT00317408|Idarubicin|idarubicin|mesh-list
24449888|NCT00317408|Thiotepa|thiotepa|mesh-list
24449889|NCT00317408|Carmustine|carmustine|mesh-list
25225950|NCT02624089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25225951|NCT02624089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225952|NCT02624089|Sensory System Agents|sensory system agents|mesh-ancestor
25225953|NCT02624089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25692460|NCT01999868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692461|NCT01999868|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25692462|NCT01999868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692463|NCT01999868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25692464|NCT01999868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25692465|NCT01999868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24489466|NCT00473486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225955|NCT02623816|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25225956|NCT02623816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24813077|NCT02056379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24813078|NCT02056379|Antiemetics|antiemetics|mesh-ancestor
24813079|NCT02056379|Autonomic Agents|autonomic agents|mesh-ancestor
24702673|NCT01467141|Insulin Aspart|insulin aspart|mesh-list
24702674|NCT01467141|Isophane Insulin, Human|isophane insulin, human|mesh-list
24702675|NCT01467141|Insulin, Isophane|insulin, isophane|mesh-list
24702676|NCT01467141|Isophane insulin, beef|isophane insulin, beef|mesh-list
24534380|NCT00646854|Vincristine|vincristine|mesh-list
24534381|NCT00646854|Lenograstim|lenograstim|mesh-list
24813080|NCT02056379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24813081|NCT02056379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813082|NCT02056379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24449890|NCT00317408|Vinblastine|vinblastine|mesh-list
24449891|NCT00317408|Lomustine|lomustine|mesh-list
24449892|NCT00317408|Etoposide phosphate|etoposide phosphate|mesh-list
24449893|NCT00317408|Vindesine|vindesine|mesh-list
24449902|NCT00317408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24813084|NCT02056379|Hormones|hormones|mesh-ancestor
24459967|NCT00346970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25225957|NCT02623816|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25225958|NCT02623816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25225959|NCT02623816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225960|NCT02623920|Rituximab|rituximab|mesh-list
25225961|NCT02623920|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25225962|NCT02623920|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25225963|NCT02623920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25225964|NCT02623920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225965|NCT02623920|Immunologic Factors|immunologic factors|mesh-ancestor
25225966|NCT02623920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225967|NCT02623920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25225968|NCT02623920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25225969|NCT02623920|Alkylating Agents|alkylating agents|mesh-ancestor
24839665|NCT02205619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839666|NCT02205619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057307|NCT03506178|Menthol|menthol|mesh-list
24534382|NCT00646854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24534384|NCT00646854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534385|NCT00646854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24534386|NCT00646854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24534387|NCT00646854|Alkylating Agents|alkylating agents|mesh-ancestor
24534388|NCT00646854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534389|NCT00646854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24534390|NCT00646854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24534391|NCT00646854|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24534392|NCT00646854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24702764|NCT01467531|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25681211|NCT01859793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681212|NCT01860170|Cyclophosphamide|cyclophosphamide|mesh-list
25681213|NCT01860170|Bortezomib|bortezomib|mesh-list
25681214|NCT01860170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25681215|NCT01860170|Immunologic Factors|immunologic factors|mesh-ancestor
24489880|NCT00475800|Sensory System Agents|sensory system agents|mesh-ancestor
24489881|NCT00475800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489882|NCT00475800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489883|NCT00475800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24489884|NCT00475800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24489887|NCT00475813|Formoterol Fumarate|formoterol fumarate|mesh-list
24489888|NCT00475813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25030105|NCT03598582|Hematinics|hematinics|mesh-ancestor
25030106|NCT03598556|Vitamin D|vitamin d|mesh-list
25030107|NCT03598556|Cholecalciferol|cholecalciferol|mesh-list
25030108|NCT03598556|Vitamins|vitamins|mesh-ancestor
25225970|NCT02623920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225971|NCT02623621|Bevacizumab|bevacizumab|mesh-list
25225972|NCT02623621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25225973|NCT02623621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225974|NCT02623621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25225975|NCT02623621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25225976|NCT02623621|Growth Substances|growth substances|mesh-ancestor
25225977|NCT02623621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225978|NCT02623621|Growth Inhibitors|growth inhibitors|mesh-ancestor
24839683|NCT02205879|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24839684|NCT02205879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24839685|NCT02205879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681216|NCT01860170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681217|NCT01860170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25681218|NCT01860170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25681219|NCT01860170|Alkylating Agents|alkylating agents|mesh-ancestor
25681220|NCT01860170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681221|NCT01860170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25681222|NCT01860170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25681223|NCT01860287|Buprenorphine|buprenorphine|mesh-list
25681224|NCT01860287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25681225|NCT01860287|Narcotics|narcotics|mesh-ancestor
25681226|NCT01860287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24534431|NCT00646984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24534433|NCT00647023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24991742|NCT05032950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991743|NCT05032950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24991744|NCT05032950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24991745|NCT05032950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24929531|NCT04111159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24534434|NCT00647023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534436|NCT00647049|Rituximab|rituximab|mesh-list
24534437|NCT00647049|Methotrexate|methotrexate|mesh-list
24534438|NCT00647049|Thiotepa|thiotepa|mesh-list
24451000|NCT00321347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451002|NCT00321360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24534451|NCT00647049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534452|NCT00647049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24534453|NCT00647049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24534454|NCT00647049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24534455|NCT00647049|Antiviral Agents|antiviral agents|mesh-ancestor
24534456|NCT00647049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24991746|NCT05032950|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24702934|NCT01468571|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24702935|NCT01468571|Diuretics|diuretics|mesh-ancestor
25225979|NCT02623738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25225980|NCT02623738|Latanoprost|latanoprost|mesh-list
25225981|NCT02623738|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25225982|NCT02623582|Cyclophosphamide|cyclophosphamide|mesh-list
25225983|NCT02623582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25225984|NCT02623582|Immunologic Factors|immunologic factors|mesh-ancestor
25225985|NCT02623582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25225986|NCT02623582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24839695|NCT02205931|Zonisamide|zonisamide|mesh-list
25681227|NCT01860287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534478|NCT00647140|Dopamine Agents|dopamine agents|mesh-ancestor
24534479|NCT00647140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24534493|NCT00647192|Eplerenone|eplerenone|mesh-list
24839702|NCT02205931|Vigabatrin|vigabatrin|mesh-list
25225987|NCT02623582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25225988|NCT02623582|Alkylating Agents|alkylating agents|mesh-ancestor
25225989|NCT02623582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25225990|NCT02623582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225991|NCT02623582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25225993|NCT02623673|Bevacizumab|bevacizumab|mesh-list
25225994|NCT02623673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24534514|NCT00647244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24534515|NCT00647244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534516|NCT00647244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534517|NCT00647244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24534518|NCT00647244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24857462|NCT02291666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24534533|NCT00647530|Antimetabolites|antimetabolites|mesh-ancestor
24534534|NCT00647530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534535|NCT00647530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24534536|NCT00647530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24534538|NCT00647530|Immunologic Factors|immunologic factors|mesh-ancestor
24534539|NCT00647530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534540|NCT00647530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24534541|NCT00647543|Atorvastatin|atorvastatin|mesh-list
24534542|NCT00647543|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24534543|NCT00647543|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24534544|NCT00647543|Antimetabolites|antimetabolites|mesh-ancestor
24534545|NCT00647543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534550|NCT00647608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25681228|NCT01860287|Analgesics|analgesics|mesh-ancestor
25681229|NCT01860287|Sensory System Agents|sensory system agents|mesh-ancestor
25692466|NCT01999868|Dermatologic Agents|dermatologic agents|mesh-ancestor
25113276|NCT03176472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25113277|NCT03176472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25113278|NCT03176472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25113279|NCT03176472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113280|NCT03147040|Carboplatin|carboplatin|mesh-list
25113281|NCT03147040|Atezolizumab|atezolizumab|mesh-list
25113282|NCT03147040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25113283|NCT03112590|Interferons|interferons|mesh-list
25113284|NCT03112590|Interferon-gamma|interferon-gamma|mesh-list
25113287|NCT03112590|Pertuzumab|pertuzumab|mesh-list
24857466|NCT02291666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857468|NCT02291705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24857469|NCT02291705|Narcotics|narcotics|mesh-ancestor
25225995|NCT02623673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25225996|NCT02623673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25225997|NCT02623673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25225998|NCT02623673|Growth Substances|growth substances|mesh-ancestor
24839703|NCT02205931|Anticonvulsants|anticonvulsants|mesh-list
24839705|NCT02205931|Ethosuximide|ethosuximide|mesh-list
24839706|NCT02205931|Stiripentol|stiripentol|mesh-list
24839707|NCT02205931|Nitrazepam|nitrazepam|mesh-list
24839708|NCT02205931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24839709|NCT02205931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839710|NCT02205931|Nootropic Agents|nootropic agents|mesh-ancestor
24839711|NCT02205931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24839712|NCT02205931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24839713|NCT02205931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839714|NCT02205931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24839715|NCT02205931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24839716|NCT02205931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24839717|NCT02205931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24839718|NCT02205931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25681230|NCT01860287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25681231|NCT01860287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25681232|NCT01860521|Sufentanil|sufentanil|mesh-list
25681233|NCT01860521|Levobupivacaine|levobupivacaine|mesh-list
25681234|NCT01860521|Gemeprost|gemeprost|mesh-list
25681235|NCT01860521|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25681236|NCT01860521|Narcotics|narcotics|mesh-ancestor
25681237|NCT01860521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25681238|NCT01860521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681239|NCT01860521|Analgesics|analgesics|mesh-ancestor
25226001|NCT02623673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25226002|NCT02623673|Antiemetics|antiemetics|mesh-ancestor
25226003|NCT02623673|Autonomic Agents|autonomic agents|mesh-ancestor
25226004|NCT02623673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25226005|NCT02623673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25226006|NCT02623673|Glucocorticoids|glucocorticoids|mesh-ancestor
25226007|NCT02623673|Hormones|hormones|mesh-ancestor
25226008|NCT02623673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25226009|NCT02623673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25226010|NCT02623569|Atenolol|atenolol|mesh-list
25226011|NCT02623569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25226012|NCT02623569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25226013|NCT02623569|Sympatholytics|sympatholytics|mesh-ancestor
25226014|NCT02623569|Autonomic Agents|autonomic agents|mesh-ancestor
25226015|NCT02623569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25226016|NCT02623569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226017|NCT02623569|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25226018|NCT02623569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25226019|NCT02623569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24839723|NCT02205931|Antimanic Agents|antimanic agents|mesh-ancestor
24839724|NCT02205931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24839725|NCT02205931|Analgesics|analgesics|mesh-ancestor
24839726|NCT02205931|Sensory System Agents|sensory system agents|mesh-ancestor
24857477|NCT02291796|Bezafibrate|bezafibrate|mesh-list
24534584|NCT00647660|Bendroflumethiazide|bendroflumethiazide|mesh-list
24534585|NCT00647660|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25681240|NCT01860521|Sensory System Agents|sensory system agents|mesh-ancestor
25681241|NCT01860521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25681242|NCT01860521|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24991842|NCT04885257|Dopamine Agents|dopamine agents|mesh-ancestor
24588043|NCT00900445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857478|NCT02291796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24534591|NCT00647660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25226020|NCT02623569|Adrenergic Agents|adrenergic agents|mesh-ancestor
25226021|NCT02623569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25226022|NCT02623569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226023|NCT02623595|Molgramostim|molgramostim|mesh-list
25226024|NCT02623595|Sargramostim|sargramostim|mesh-list
25226025|NCT02623595|Immunologic Factors|immunologic factors|mesh-ancestor
25226026|NCT02623595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226027|NCT02623595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25226028|NCT02623465|Insulin Lispro|insulin lispro|mesh-list
24534593|NCT00647660|Sympatholytics|sympatholytics|mesh-ancestor
24534594|NCT00647660|Autonomic Agents|autonomic agents|mesh-ancestor
24534595|NCT00647660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24534597|NCT00647660|Natriuretic Agents|natriuretic agents|mesh-ancestor
24534598|NCT00647660|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24534599|NCT00647660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24534600|NCT00647673|Verapamil|verapamil|mesh-list
24534601|NCT00647673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24534602|NCT00647673|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24534603|NCT00647673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24534617|NCT00647686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24534618|NCT00647686|Anesthetics, General|anesthetics, general|mesh-ancestor
24534619|NCT00647686|Anesthetics|anesthetics|mesh-ancestor
24534620|NCT00647712|Valproic Acid|valproic acid|mesh-list
24797442|NCT01955642|Clopidogrel|clopidogrel|mesh-list
24534622|NCT00647712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534623|NCT00647712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857479|NCT02291796|Antimetabolites|antimetabolites|mesh-ancestor
24857480|NCT02291796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857481|NCT02291796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24857482|NCT02291874|Ipragliflozin|ipragliflozin|mesh-list
24534624|NCT00647712|GABA Agents|gaba agents|mesh-ancestor
24534625|NCT00647712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25226029|NCT02623465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25226030|NCT02623465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226031|NCT02623452|Insulin Lispro|insulin lispro|mesh-list
25681243|NCT01860521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25226032|NCT02623452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25681244|NCT01860521|Anesthetics, General|anesthetics, general|mesh-ancestor
25681245|NCT01860521|Anesthetics|anesthetics|mesh-ancestor
25681246|NCT01860521|Anesthetics, Local|anesthetics, local|mesh-ancestor
25692467|NCT01999894|Memantine|memantine|mesh-list
25226033|NCT02623452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226034|NCT02623504|Carbamazepine|carbamazepine|mesh-list
25226035|NCT02623504|Anticonvulsants|anticonvulsants|mesh-ancestor
25226036|NCT02623504|Antimanic Agents|antimanic agents|mesh-ancestor
24534630|NCT00647712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24534632|NCT00647738|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24534633|NCT00647738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534634|NCT00647738|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25226037|NCT02623504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25226038|NCT02623504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25226039|NCT02623504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226040|NCT02623504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25226041|NCT02623504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25226042|NCT02623504|Analgesics|analgesics|mesh-ancestor
25226043|NCT02623504|Sensory System Agents|sensory system agents|mesh-ancestor
25226044|NCT02623504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24839761|NCT02206035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24839762|NCT02206035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24839763|NCT02206035|Immunologic Factors|immunologic factors|mesh-ancestor
24839764|NCT02206035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24839765|NCT02206035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24534637|NCT00647738|GABA Agonists|gaba agonists|mesh-ancestor
24534638|NCT00647738|GABA Agents|gaba agents|mesh-ancestor
24534647|NCT00647751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107538|NCT03139591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24534648|NCT00647751|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24534649|NCT00647751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24534650|NCT00647751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24534651|NCT00647751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24534652|NCT00647751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24534653|NCT00647777|Olanzapine|olanzapine|mesh-list
24534654|NCT00647777|Antiemetics|antiemetics|mesh-ancestor
25226047|NCT02623504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226048|NCT02623504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25226049|NCT02623504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25226050|NCT02623478|Insulin Lispro|insulin lispro|mesh-list
25226051|NCT02623478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25226052|NCT02623478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159914|NCT03504956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226053|NCT02623062|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
24839787|NCT02206178|Sensory System Agents|sensory system agents|mesh-ancestor
24839788|NCT02206178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24534656|NCT00647777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24534657|NCT00647777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534658|NCT00647777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24534659|NCT00647777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24534660|NCT00647777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24534661|NCT00647777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24534662|NCT00647777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24534663|NCT00647777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24534664|NCT00647777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24857483|NCT02291874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24857484|NCT02291874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444166|NCT00296868|Ascorbic Acid|ascorbic acid|mesh-list
25107548|NCT03139409|Chlorhexidine|chlorhexidine|mesh-list
25107549|NCT03139409|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24534680|NCT00647829|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24534681|NCT00647829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24534683|NCT00647829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534684|NCT00647829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24534685|NCT00647829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24534686|NCT00647829|Analgesics|analgesics|mesh-ancestor
24534687|NCT00647829|Sensory System Agents|sensory system agents|mesh-ancestor
24857486|NCT02291874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857487|NCT02291887|Ranibizumab|ranibizumab|mesh-list
24857488|NCT02291887|Aflibercept|aflibercept|mesh-list
24857489|NCT02291887|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24857490|NCT02291887|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24857491|NCT02291887|Growth Substances|growth substances|mesh-ancestor
24460005|NCT00347100|Metformin|metformin|mesh-list
24534688|NCT00647829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25226055|NCT02623062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226056|NCT02623062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25226057|NCT02623127|Sunitinib|sunitinib|mesh-list
25226058|NCT02623127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25226059|NCT02623127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25226060|NCT02623127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25226061|NCT02623127|Growth Substances|growth substances|mesh-ancestor
25226062|NCT02623127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226063|NCT02623127|Growth Inhibitors|growth inhibitors|mesh-ancestor
25226064|NCT02623127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24839789|NCT02206178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839790|NCT02206178|Antipyretics|antipyretics|mesh-ancestor
24839791|NCT02206178|Antiviral Agents|antiviral agents|mesh-ancestor
24839792|NCT02206178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24839793|NCT02206178|Expectorants|expectorants|mesh-ancestor
24839794|NCT02206178|Respiratory System Agents|respiratory system agents|mesh-ancestor
24681779|NCT01382017|Lacosamide|lacosamide|mesh-list
24839795|NCT02206178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24839796|NCT02206178|Antioxidants|antioxidants|mesh-ancestor
24839797|NCT02206178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839798|NCT02206178|Protective Agents|protective agents|mesh-ancestor
24839799|NCT02206178|Antidotes|antidotes|mesh-ancestor
24839800|NCT02206204|Moxifloxacin|moxifloxacin|mesh-list
24839801|NCT02206204|Selexipag|selexipag|mesh-list
25057386|NCT03505502|Tranexamic Acid|tranexamic acid|mesh-list
24534700|NCT00647842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24534701|NCT00647842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24534702|NCT00647842|Anesthetics, General|anesthetics, general|mesh-ancestor
24534706|NCT00647868|Hormones|hormones|mesh-ancestor
24703608|NCT01472783|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24703609|NCT01472783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703610|NCT01472783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857492|NCT02291887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857493|NCT02291887|Growth Inhibitors|growth inhibitors|mesh-ancestor
24857494|NCT02291887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24857495|NCT02292069|Amlodipine|amlodipine|mesh-list
25226072|NCT02623036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226073|NCT02623036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25226074|NCT02623036|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25226075|NCT02623036|Protective Agents|protective agents|mesh-ancestor
25226076|NCT02623036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226077|NCT02623049|Anticoagulants|anticoagulants|mesh-list
24460013|NCT00347113|Praziquantel|praziquantel|mesh-list
25681247|NCT01860521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25681248|NCT01860521|Abortifacient Agents|abortifacient agents|mesh-ancestor
25681249|NCT01860521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25681250|NCT01860586|Bevacizumab|bevacizumab|mesh-list
25681251|NCT01860586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24534716|NCT00647881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534717|NCT00647881|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24534719|NCT00647881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24534720|NCT00647881|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24703636|NCT01473043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24534721|NCT00647881|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24534722|NCT00647881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534723|NCT00647894|Alprazolam|alprazolam|mesh-list
24534724|NCT00647894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24534725|NCT00647894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24534726|NCT00647894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534727|NCT00647894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24534728|NCT00647894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24534729|NCT00647894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24534730|NCT00647894|GABA Modulators|gaba modulators|mesh-ancestor
24534731|NCT00647894|GABA Agents|gaba agents|mesh-ancestor
24534732|NCT00647894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24534733|NCT00647894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534734|NCT00647907|Voriconazole|voriconazole|mesh-list
24534735|NCT00647907|Antifungal Agents|antifungal agents|mesh-ancestor
24534736|NCT00647907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24534737|NCT00647907|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24534738|NCT00647907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24534739|NCT00647907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857500|NCT02292069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24857501|NCT02292069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24857502|NCT02292069|Antimetabolites|antimetabolites|mesh-ancestor
24857503|NCT02292069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857504|NCT02292069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24409968|NCT00183976|Rituximab|rituximab|mesh-list
24703726|NCT01473472|Tenofovir|tenofovir|mesh-list
25226080|NCT02623231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25226081|NCT02623231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25226082|NCT02623231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839825|NCT02206425|Dexamethasone|dexamethasone|mesh-list
24839826|NCT02206425|Dexamethasone acetate|dexamethasone acetate|mesh-list
24839827|NCT02206425|Prednisone|prednisone|mesh-list
24839828|NCT02206425|Cyclophosphamide|cyclophosphamide|mesh-list
24839829|NCT02206425|Melphalan|melphalan|mesh-list
24419702|NCT00213512|Rituximab|rituximab|mesh-list
24613472|NCT01019265|Sensory System Agents|sensory system agents|mesh-ancestor
24613473|NCT01019265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24613474|NCT01019265|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24613475|NCT01019278|Cisplatin|cisplatin|mesh-list
24619206|NCT01051388|Gefarnate|gefarnate|mesh-list
24534773|NCT00647972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24534774|NCT00647972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24534775|NCT00647972|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24534776|NCT00647972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24534777|NCT00647972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24534778|NCT00647972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534779|NCT00647972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24534780|NCT00647972|Serotonin Agents|serotonin agents|mesh-ancestor
24534781|NCT00647985|Fexofenadine|fexofenadine|mesh-list
24534782|NCT00647985|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24857512|NCT02292121|Lactitol|lactitol|mesh-list
24857513|NCT02292121|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24857514|NCT02292121|Diuretics|diuretics|mesh-ancestor
25226083|NCT02623231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25226084|NCT02623231|Serotonin Agents|serotonin agents|mesh-ancestor
25226085|NCT02623231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226086|NCT02623231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25226087|NCT02623231|Antidepressive Agents|antidepressive agents|mesh-ancestor
25226088|NCT02623231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25226089|NCT02623153|Docetaxel|docetaxel|mesh-list
25226090|NCT02623153|Capecitabine|capecitabine|mesh-list
24839835|NCT02206425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24839836|NCT02206425|Immunologic Factors|immunologic factors|mesh-ancestor
24839837|NCT02206425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839838|NCT02206425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24839839|NCT02206425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24951370|NCT03905564|Vitamins|vitamins|mesh-ancestor
24839840|NCT02206425|Alkylating Agents|alkylating agents|mesh-ancestor
25057396|NCT03505489|Natriuretic Agents|natriuretic agents|mesh-ancestor
24534820|NCT00648063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534821|NCT00648063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24857520|NCT02292173|Trametinib|trametinib|mesh-list
24534822|NCT00648063|Hormone Antagonists|hormone antagonists|mesh-ancestor
25226091|NCT02623153|Oxaliplatin|oxaliplatin|mesh-list
25226092|NCT02623153|Tegafur|tegafur|mesh-list
25226093|NCT02623153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25226094|NCT02623153|Tubulin Modulators|tubulin modulators|mesh-ancestor
25226095|NCT02623153|Antimitotic Agents|antimitotic agents|mesh-ancestor
25226096|NCT02623153|Mitosis Modulators|mitosis modulators|mesh-ancestor
25226097|NCT02623153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226098|NCT02623153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25226099|NCT02623153|Antimetabolites|antimetabolites|mesh-ancestor
25226100|NCT02623114|Methylphenidate|methylphenidate|mesh-list
25226101|NCT02623114|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25226102|NCT02623114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24839842|NCT02206425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24839843|NCT02206425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24839844|NCT02206425|Vitamins|vitamins|mesh-ancestor
24839845|NCT02206425|Micronutrients|micronutrients|mesh-ancestor
24839846|NCT02206425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24839847|NCT02206425|Antiemetics|antiemetics|mesh-ancestor
24839848|NCT02206425|Autonomic Agents|autonomic agents|mesh-ancestor
24444255|NCT00297206|Valacyclovir|valacyclovir|mesh-list
24857521|NCT02292173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24857522|NCT02292173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24857523|NCT02292173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857524|NCT02292173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226103|NCT02623114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226104|NCT02623114|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25226105|NCT02623114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25226106|NCT02623114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25226107|NCT02623114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226108|NCT02623114|Dopamine Agents|dopamine agents|mesh-ancestor
25226109|NCT02623114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24839869|NCT02206477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839870|NCT02206477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24839872|NCT02206477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534831|NCT00648076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534832|NCT00648076|Antimanic Agents|antimanic agents|mesh-ancestor
24534833|NCT00648076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25226115|NCT02623023|Adrenergic Agents|adrenergic agents|mesh-ancestor
25226116|NCT02623023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25226117|NCT02623023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226118|NCT02623023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857526|NCT02292225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25226120|NCT02623023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25226121|NCT02623023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25226122|NCT02622906|Pasireotide|pasireotide|mesh-list
25226123|NCT02622906|Hormones|hormones|mesh-ancestor
25226124|NCT02622906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25226125|NCT02622906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226126|NCT02622854|Insulin|insulin|mesh-list
25226127|NCT02622854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25226128|NCT02622854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226129|NCT02622503|Rituximab|rituximab|mesh-list
25226130|NCT02622503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25226131|NCT02622503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25226132|NCT02622503|Immunologic Factors|immunologic factors|mesh-ancestor
24839896|NCT02206503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24839897|NCT02206503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24839898|NCT02206503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24839921|NCT02206555|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24839922|NCT02206568|Insulin Lispro|insulin lispro|mesh-list
24495491|NCT00500422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24495526|NCT00500721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495527|NCT00500721|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24495528|NCT00500721|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24495529|NCT00500721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24495530|NCT00500721|Adrenergic Agents|adrenergic agents|mesh-ancestor
24495533|NCT00500864|Magnesium Sulfate|magnesium sulfate|mesh-list
25113383|NCT02888743|Immunoglobulins|immunoglobulins|mesh-list
25113384|NCT02888743|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25113385|NCT02888743|Immunoglobulin G|immunoglobulin g|mesh-list
24857527|NCT02292225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24857528|NCT02292277|Ticagrelor|ticagrelor|mesh-list
24857529|NCT02292277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24857530|NCT02292277|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25226133|NCT02622503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226134|NCT02622503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25226135|NCT02622594|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25226136|NCT02622594|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25226137|NCT02622594|Dermatologic Agents|dermatologic agents|mesh-ancestor
25226138|NCT02622555|Mirabegron|mirabegron|mesh-list
25226139|NCT02622555|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25226140|NCT02622555|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25226141|NCT02622555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25226142|NCT02622555|Adrenergic Agents|adrenergic agents|mesh-ancestor
25226143|NCT02622555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25226144|NCT02622555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279174|NCT02346110|Glucocorticoids|glucocorticoids|mesh-ancestor
25681252|NCT01860586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25681253|NCT01860586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25681254|NCT01860586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25681255|NCT01860586|Growth Substances|growth substances|mesh-ancestor
25681256|NCT01860586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681257|NCT01860586|Growth Inhibitors|growth inhibitors|mesh-ancestor
25681258|NCT01860703|Moxifloxacin|moxifloxacin|mesh-list
25681259|NCT01860703|Deferiprone|deferiprone|mesh-list
25681260|NCT01860703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25681261|NCT01860703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25681262|NCT01860703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25681263|NCT01860703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25681264|NCT01860703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692468|NCT01999894|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24495760|NCT00501878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24495761|NCT00501878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495762|NCT00501878|Sympathomimetics|sympathomimetics|mesh-ancestor
24495763|NCT00501878|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24495764|NCT00501878|Nasal Decongestants|nasal decongestants|mesh-ancestor
24495765|NCT00501878|Respiratory System Agents|respiratory system agents|mesh-ancestor
24495766|NCT00501878|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24495808|NCT00502073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25057472|NCT03504865|Bupivacaine|bupivacaine|mesh-list
24813094|NCT02056405|Serotonin Agents|serotonin agents|mesh-ancestor
24857531|NCT02292277|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24857532|NCT02292277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24857533|NCT02292277|Purinergic Agents|purinergic agents|mesh-ancestor
24857534|NCT02292277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24857535|NCT02292277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857536|NCT02292277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857537|NCT02292290|Pioglitazone|pioglitazone|mesh-list
24857538|NCT02292290|Liraglutide|liraglutide|mesh-list
24857539|NCT02292290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24857540|NCT02292290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857541|NCT02292290|Incretins|incretins|mesh-ancestor
24857542|NCT02292290|Hormones|hormones|mesh-ancestor
24857543|NCT02292290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24857544|NCT02292303|Zinc|zinc|mesh-list
24857545|NCT02292303|Zinc Oxide|zinc oxide|mesh-list
24534881|NCT00648193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550862|NCT00722956|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25226145|NCT02622555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226146|NCT02622555|Urological Agents|urological agents|mesh-ancestor
25226147|NCT02622672|Coenzyme Q10|coenzyme q10|mesh-list
25226148|NCT02622672|Micronutrients|micronutrients|mesh-ancestor
25226149|NCT02622672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226150|NCT02622672|Vitamins|vitamins|mesh-ancestor
24992036|NCT04583592|Anticoagulants|anticoagulants|mesh-ancestor
25681265|NCT01860703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681266|NCT01860703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25681267|NCT01860703|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25681268|NCT01860703|Chelating Agents|chelating agents|mesh-ancestor
25681269|NCT01860703|Sequestering Agents|sequestering agents|mesh-ancestor
25681270|NCT01860807|Ibudilast|ibudilast|mesh-list
25681271|NCT01860807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25681272|NCT01860807|Autonomic Agents|autonomic agents|mesh-ancestor
25681273|NCT01860807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25681274|NCT01860807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273314|NCT02386033|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25057450|NCT03505008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25057451|NCT03504982|Moxifloxacin|moxifloxacin|mesh-list
25057452|NCT03504982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24940953|NCT03996564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25057453|NCT03504982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25057454|NCT03504982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25057455|NCT03504982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25057457|NCT03504982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057458|NCT03504982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25226151|NCT02622802|Acetaminophen|acetaminophen|mesh-list
25226152|NCT02622802|Azithromycin|azithromycin|mesh-list
25226153|NCT02622802|Erythromycin|erythromycin|mesh-list
25226154|NCT02622802|Erythromycin Estolate|erythromycin estolate|mesh-list
25226155|NCT02622802|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25226156|NCT02622802|Erythromycin stearate|erythromycin stearate|mesh-list
25226157|NCT02622802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25226158|NCT02622802|Analgesics|analgesics|mesh-ancestor
25226159|NCT02622802|Sensory System Agents|sensory system agents|mesh-ancestor
25226160|NCT02622802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25226161|NCT02622802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226162|NCT02622802|Antipyretics|antipyretics|mesh-ancestor
25226163|NCT02622802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24839924|NCT02206568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24839925|NCT02206568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839926|NCT02206646|Tenecteplase|tenecteplase|mesh-list
24839927|NCT02206646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24839928|NCT02206646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24839929|NCT02206646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839930|NCT02206659|Telmisartan|telmisartan|mesh-list
24839931|NCT02206659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24839932|NCT02206659|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24839933|NCT02206659|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24839934|NCT02206659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839935|NCT02206711|BMS-955176|bms-955176|mesh-list
24839936|NCT02206711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24839937|NCT02206711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24839938|NCT02206711|Antiviral Agents|antiviral agents|mesh-ancestor
24839939|NCT02206711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24839952|NCT02206763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24839956|NCT02206789|Cyclosporine|cyclosporine|mesh-list
24839966|NCT02206789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226170|NCT02622477|Analgesics|analgesics|mesh-ancestor
25226171|NCT02622477|Sensory System Agents|sensory system agents|mesh-ancestor
25226172|NCT02622477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25226173|NCT02622477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226174|NCT02622477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25226175|NCT02622477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25226176|NCT02622477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25226177|NCT02622477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25226178|NCT02622477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25226179|NCT02622685|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25226180|NCT02622685|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25226181|NCT02622685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25226182|NCT02622607|Zoledronic Acid|zoledronic acid|mesh-list
25226183|NCT02622607|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25226184|NCT02622607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226185|NCT02622334|Latanoprost|latanoprost|mesh-list
25226186|NCT02622334|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25226187|NCT02622334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24839979|NCT02206789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24839980|NCT02206789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24839981|NCT02206789|Antiemetics|antiemetics|mesh-ancestor
24839982|NCT02206789|Autonomic Agents|autonomic agents|mesh-ancestor
24839983|NCT02206789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24839984|NCT02206789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24839985|NCT02206789|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24839986|NCT02206789|Protective Agents|protective agents|mesh-ancestor
24839987|NCT02206802|Minoxidil|minoxidil|mesh-list
25226203|NCT02622126|Sensory System Agents|sensory system agents|mesh-ancestor
25226204|NCT02622126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25226205|NCT02622126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25226206|NCT02622126|Narcotics|narcotics|mesh-ancestor
25226208|NCT02622126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25226209|NCT02622126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25226210|NCT02622126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24992109|NCT04409665|Anesthetics, General|anesthetics, general|mesh-ancestor
24992110|NCT04409665|Anesthetics|anesthetics|mesh-ancestor
25057492|NCT03504566|Empagliflozin|empagliflozin|mesh-list
25681275|NCT01860807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25681276|NCT01860807|Respiratory System Agents|respiratory system agents|mesh-ancestor
25681277|NCT01860807|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25681278|NCT01860807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25681279|NCT01860807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681280|NCT01860807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25681281|NCT01860807|Vasodilator Agents|vasodilator agents|mesh-ancestor
25681282|NCT01861002|Vidarabine|vidarabine|mesh-list
25681283|NCT01861002|Cytarabine|cytarabine|mesh-list
25113409|NCT02832544|Warfarin|warfarin|mesh-list
25113410|NCT02832544|Rivaroxaban|rivaroxaban|mesh-list
25113411|NCT02832544|Vitamins|vitamins|mesh-ancestor
25113412|NCT02832544|Micronutrients|micronutrients|mesh-ancestor
25113413|NCT02832544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25113414|NCT02832544|Anticoagulants|anticoagulants|mesh-ancestor
25113415|NCT02832544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25113416|NCT02832544|Antithrombins|antithrombins|mesh-ancestor
25113417|NCT02832544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25113418|NCT02832544|Protease Inhibitors|protease inhibitors|mesh-ancestor
24857554|NCT02292459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24857555|NCT02292459|Laxatives|laxatives|mesh-ancestor
24857556|NCT02292459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24857557|NCT02292472|Botulinum Toxins|botulinum toxins|mesh-list
25226211|NCT02622126|Autonomic Agents|autonomic agents|mesh-ancestor
25226212|NCT02622126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25226213|NCT02622126|Respiratory System Agents|respiratory system agents|mesh-ancestor
25226214|NCT02622126|Mydriatics|mydriatics|mesh-ancestor
25226215|NCT02622126|Parasympatholytics|parasympatholytics|mesh-ancestor
25226216|NCT02622126|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25226217|NCT02622126|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25226218|NCT02622126|Cholinergic Agents|cholinergic agents|mesh-ancestor
25226219|NCT02622126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25226220|NCT02622126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226221|NCT02622126|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25226222|NCT02622126|Sympathomimetics|sympathomimetics|mesh-ancestor
25226223|NCT02622126|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25226224|NCT02622126|Adrenergic Agents|adrenergic agents|mesh-ancestor
25226225|NCT02622243|Glycopyrrolate|glycopyrrolate|mesh-list
25226226|NCT02622243|Tiotropium Bromide|tiotropium bromide|mesh-list
25226227|NCT02622243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25226228|NCT02622243|Autonomic Agents|autonomic agents|mesh-ancestor
25226229|NCT02622243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25226230|NCT02622243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226231|NCT02622243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25226232|NCT02622243|Respiratory System Agents|respiratory system agents|mesh-ancestor
24933116|NCT04073680|Canagliflozin|canagliflozin|mesh-list
25226233|NCT02622243|Parasympatholytics|parasympatholytics|mesh-ancestor
25226234|NCT02622243|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25226235|NCT02622243|Cholinergic Agents|cholinergic agents|mesh-ancestor
24840020|NCT02206854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24840021|NCT02206854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24840022|NCT02206854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24840023|NCT02206854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24840024|NCT02206854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24840032|NCT02206932|Antiviral Agents|antiviral agents|mesh-ancestor
24840033|NCT02206932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24840034|NCT02206932|Protease Inhibitors|protease inhibitors|mesh-ancestor
24840035|NCT02206932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840036|NCT02206932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840037|NCT02207010|Adavosertib|adavosertib|mesh-list
24840038|NCT02207010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473854|NCT00404378|Casopitant|casopitant|mesh-list
24840072|NCT02207361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840074|NCT02207387|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24840075|NCT02207387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840076|NCT02207387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840077|NCT02207387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25681284|NCT01861002|Methotrexate|methotrexate|mesh-list
25681285|NCT01861002|Fludarabine phosphate|fludarabine phosphate|mesh-list
25681286|NCT01861002|Azacitidine|azacitidine|mesh-list
25681287|NCT01861002|Fludarabine|fludarabine|mesh-list
25681288|NCT01861002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25681289|NCT01861002|Abortifacient Agents|abortifacient agents|mesh-ancestor
25681290|NCT01861002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25681291|NCT01861002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681292|NCT01861002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25681293|NCT01861002|Antimetabolites|antimetabolites|mesh-ancestor
24840078|NCT02207387|Protective Agents|protective agents|mesh-ancestor
24840079|NCT02207387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840081|NCT02207426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24840082|NCT02207426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24840083|NCT02207439|Nelfinavir|nelfinavir|mesh-list
24840084|NCT02207439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24840085|NCT02207439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24840086|NCT02207439|Protease Inhibitors|protease inhibitors|mesh-ancestor
24840087|NCT02207439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840110|NCT02207452|Cholinergic Agents|cholinergic agents|mesh-ancestor
24840111|NCT02207660|Fluorouracil|fluorouracil|mesh-list
24840112|NCT02207660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24857558|NCT02292472|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24857559|NCT02292472|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25226236|NCT02622243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25226237|NCT02622243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226238|NCT02622243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25226239|NCT02622243|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25226240|NCT02622022|Morphine|morphine|mesh-list
25226241|NCT02622022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25226242|NCT02622022|Narcotics|narcotics|mesh-ancestor
25226243|NCT02622022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25226244|NCT02622022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226245|NCT02622022|Analgesics|analgesics|mesh-ancestor
25226246|NCT02622022|Sensory System Agents|sensory system agents|mesh-ancestor
25226247|NCT02622022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25226248|NCT02621957|Pravastatin|pravastatin|mesh-list
25226249|NCT02621957|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25226250|NCT02621957|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25226251|NCT02621957|Antimetabolites|antimetabolites|mesh-ancestor
25226252|NCT02621957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226253|NCT02621957|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25226254|NCT02621957|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25226255|NCT02621957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25226262|NCT02621970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226264|NCT02621905|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
25226265|NCT02621905|Antifungal Agents|antifungal agents|mesh-ancestor
25226266|NCT02621905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25226267|NCT02621905|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24840120|NCT02207699|Benzonatate|benzonatate|mesh-list
24534913|NCT00648271|Sympatholytics|sympatholytics|mesh-ancestor
24534914|NCT00648271|Autonomic Agents|autonomic agents|mesh-ancestor
24534915|NCT00648271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24530109|NCT00629148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24534916|NCT00648271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534917|NCT00648271|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24534918|NCT00648271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24534919|NCT00648271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24534920|NCT00648271|Adrenergic Agents|adrenergic agents|mesh-ancestor
24534921|NCT00648271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24857563|NCT02292472|Cholinergic Agents|cholinergic agents|mesh-ancestor
24857564|NCT02292472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24857565|NCT02292472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857566|NCT02292472|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24857567|NCT02292472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857568|NCT02292550|Ceritinib|ceritinib|mesh-list
24857569|NCT02292550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24857570|NCT02292550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24857571|NCT02292550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857572|NCT02292550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857573|NCT02292667|Acetaminophen|acetaminophen|mesh-list
24857574|NCT02292667|Morphine|morphine|mesh-list
24857589|NCT02292732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857590|NCT02292732|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24857591|NCT02292732|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25030963|NCT03591549|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24857592|NCT02292732|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24857593|NCT02292732|Contraceptive Agents|contraceptive agents|mesh-ancestor
24857594|NCT02292732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24857595|NCT02292732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857596|NCT02292732|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24857597|NCT02292732|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24857599|NCT02292966|Protease Inhibitors|protease inhibitors|mesh-ancestor
24857600|NCT02292966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857601|NCT02292966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226268|NCT02621905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25226269|NCT02621905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25226270|NCT02621905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226271|NCT02621905|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25226272|NCT02621905|Hormone Antagonists|hormone antagonists|mesh-ancestor
25226273|NCT02621905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25226274|NCT02621905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226275|NCT02621905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25226276|NCT02621827|Calcifediol|calcifediol|mesh-list
25226277|NCT02621827|Vitamins|vitamins|mesh-ancestor
25226278|NCT02621827|Micronutrients|micronutrients|mesh-ancestor
25226279|NCT02621827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840127|NCT02207699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24840128|NCT02207699|Antitussive Agents|antitussive agents|mesh-ancestor
24840129|NCT02207699|Respiratory System Agents|respiratory system agents|mesh-ancestor
24840131|NCT02207855|Anesthetics, Local|anesthetics, local|mesh-ancestor
24840132|NCT02207855|Anesthetics|anesthetics|mesh-ancestor
24840133|NCT02207855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24840134|NCT02207855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857620|NCT02293148|Moxifloxacin|moxifloxacin|mesh-list
24797536|NCT01956201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24857621|NCT02293148|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24857623|NCT02293148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24857624|NCT02293148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24857625|NCT02293148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25226280|NCT02621827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25226281|NCT02621554|Resveratrol|resveratrol|mesh-list
25226282|NCT02621554|Antioxidants|antioxidants|mesh-ancestor
25226283|NCT02621554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226284|NCT02621554|Protective Agents|protective agents|mesh-ancestor
25226285|NCT02621554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226286|NCT02621554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25226287|NCT02621554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25226288|NCT02621515|Nivolumab|nivolumab|mesh-list
25273315|NCT02386033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840154|NCT02208128|Immunologic Factors|immunologic factors|mesh-ancestor
24534932|NCT00648297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25681294|NCT01861002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501310|NCT00528008|Blood Substitutes|blood substitutes|mesh-ancestor
24534933|NCT00648297|Sympatholytics|sympatholytics|mesh-ancestor
24534934|NCT00648297|Autonomic Agents|autonomic agents|mesh-ancestor
24534935|NCT00648297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24534936|NCT00648297|Diuretics|diuretics|mesh-ancestor
24534937|NCT00648297|Natriuretic Agents|natriuretic agents|mesh-ancestor
24534938|NCT00648297|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24534939|NCT00648297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25226300|NCT02621385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24534973|NCT00648349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24534974|NCT00648349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25226289|NCT02621515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25226290|NCT02621515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25226291|NCT02621515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25226292|NCT02621515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226293|NCT02621385|Midazolam|midazolam|mesh-list
25226294|NCT02621385|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25226295|NCT02621385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25226296|NCT02621385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25226297|NCT02621385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840158|NCT02208154|Chlorhexidine|chlorhexidine|mesh-list
24840159|NCT02208154|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24840160|NCT02208154|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24840161|NCT02208154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24840162|NCT02208154|Disinfectants|disinfectants|mesh-ancestor
24840163|NCT02208154|Dermatologic Agents|dermatologic agents|mesh-ancestor
24840164|NCT02208245|Ropivacaine|ropivacaine|mesh-list
25107586|NCT03139500|Anesthetics, General|anesthetics, general|mesh-ancestor
24857628|NCT02293148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681295|NCT01861002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25681296|NCT01861002|Dermatologic Agents|dermatologic agents|mesh-ancestor
25681297|NCT01861002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25681298|NCT01861002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25226298|NCT02621385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25226299|NCT02621385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25226307|NCT02621385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534979|NCT00648362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534980|NCT00648362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24534981|NCT00648362|Immunologic Factors|immunologic factors|mesh-ancestor
24534983|NCT00648388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25226308|NCT02621489|Metformin|metformin|mesh-list
25226309|NCT02621489|Insulin Aspart|insulin aspart|mesh-list
25226310|NCT02621489|Exenatide|exenatide|mesh-list
25226311|NCT02621489|Biguanides|biguanides|mesh-list
25226312|NCT02621489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25226313|NCT02621489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226314|NCT02621489|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25226315|NCT02621489|Incretins|incretins|mesh-ancestor
24502017|NCT00531999|Ritonavir|ritonavir|mesh-list
24502018|NCT00531999|Lopinavir|lopinavir|mesh-list
24502019|NCT00531999|Raltegravir Potassium|raltegravir potassium|mesh-list
24502020|NCT00531999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25226316|NCT02621489|Hormones|hormones|mesh-ancestor
25226317|NCT02621489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25226318|NCT02621359|Doxycycline|doxycycline|mesh-list
24534997|NCT00648388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24534998|NCT00648388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534999|NCT00648401|Verapamil|verapamil|mesh-list
24535000|NCT00648401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24535001|NCT00648401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24535002|NCT00648401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24535003|NCT00648401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535004|NCT00648401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24704682|NCT01479751|Magnesium Sulfate|magnesium sulfate|mesh-list
24704699|NCT01479751|Anticonvulsants|anticonvulsants|mesh-ancestor
24535013|NCT00648414|Sensory System Agents|sensory system agents|mesh-ancestor
24535014|NCT00648414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24535015|NCT00648414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25226319|NCT02621359|Levofloxacin|levofloxacin|mesh-list
25226323|NCT02621359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25226324|NCT02621359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25226325|NCT02621359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25681302|NCT01861002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25681303|NCT01861002|Antiviral Agents|antiviral agents|mesh-ancestor
25681304|NCT01861002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25681305|NCT01861457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
25681306|NCT01861457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25681307|NCT01861522|Bepotastine besilate|bepotastine besilate|mesh-list
25681308|NCT01861522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25681309|NCT01861665|Bupivacaine|bupivacaine|mesh-list
25681310|NCT01861665|Anesthetics, Local|anesthetics, local|mesh-ancestor
25681311|NCT01861665|Anesthetics|anesthetics|mesh-ancestor
25681312|NCT01861665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25681313|NCT01861665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681314|NCT01861665|Sensory System Agents|sensory system agents|mesh-ancestor
25681315|NCT01861665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25226326|NCT02621359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25226327|NCT02621359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226328|NCT02621359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25226329|NCT02621359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25226330|NCT02621359|Antimalarials|antimalarials|mesh-ancestor
25226331|NCT02621359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25226332|NCT02621359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25226333|NCT02621359|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25226334|NCT02621359|Renal Agents|renal agents|mesh-ancestor
25226335|NCT02621359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24535017|NCT00648414|Anesthetics, General|anesthetics, general|mesh-ancestor
24535018|NCT00648414|Anesthetics|anesthetics|mesh-ancestor
24535020|NCT00648427|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24535021|NCT00648427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24535022|NCT00648427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24535023|NCT00648427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681317|NCT01862250|Analgesics|analgesics|mesh-ancestor
25681318|NCT01862250|Sensory System Agents|sensory system agents|mesh-ancestor
25681319|NCT01862250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25681320|NCT01862250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681321|NCT01862250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25681322|NCT01862250|Sympatholytics|sympatholytics|mesh-ancestor
25681323|NCT01862250|Autonomic Agents|autonomic agents|mesh-ancestor
24535024|NCT00648427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25681324|NCT01862250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25681325|NCT01862250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25681326|NCT01862250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24444567|NCT00298506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535025|NCT00648427|Serotonin Agents|serotonin agents|mesh-ancestor
24535026|NCT00648427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535027|NCT00648427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24857636|NCT02293148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24857637|NCT02293148|Glycine Agents|glycine agents|mesh-ancestor
24857638|NCT02293148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535028|NCT00648427|Antidepressive Agents|antidepressive agents|mesh-ancestor
24535029|NCT00648427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25226336|NCT02621359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25226337|NCT02621359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25226338|NCT02621359|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25226339|NCT02621359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24840213|NCT02208583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25043426|NCT01262001|Immunologic Factors|immunologic factors|mesh-ancestor
24857640|NCT02293187|Cholecalciferol|cholecalciferol|mesh-list
24857641|NCT02293187|Vitamins|vitamins|mesh-ancestor
24535069|NCT00648518|Metformin|metformin|mesh-list
24535078|NCT00648531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535079|NCT00648531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24535080|NCT00648531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24535081|NCT00648531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24535082|NCT00648544|Pravastatin|pravastatin|mesh-list
24535083|NCT00648544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24535084|NCT00648544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25681327|NCT01862250|Adrenergic Agents|adrenergic agents|mesh-ancestor
24535085|NCT00648544|Antimetabolites|antimetabolites|mesh-ancestor
25226342|NCT02621242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25226343|NCT02621242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25226344|NCT02621242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840216|NCT02208583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24840218|NCT02208583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24840219|NCT02208583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24840236|NCT02208596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24840237|NCT02208596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24840238|NCT02208596|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24840240|NCT02208778|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24840241|NCT02208778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24840242|NCT02208778|Narcotics|narcotics|mesh-ancestor
24840243|NCT02208778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24840244|NCT02208778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840246|NCT02208778|Sensory System Agents|sensory system agents|mesh-ancestor
24840247|NCT02208778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24840248|NCT02208778|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24840249|NCT02208778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24840250|NCT02208778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24840251|NCT02208778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840252|NCT02208778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24552430|NCT03149211|UB-421|ub-421|mesh-list
25226345|NCT02621242|Antiviral Agents|antiviral agents|mesh-ancestor
25226346|NCT02621242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25226347|NCT02621242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25681328|NCT01862250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25681329|NCT01862250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681330|NCT01862328|Gemcitabine|gemcitabine|mesh-list
25681331|NCT01862328|Paclitaxel|paclitaxel|mesh-list
25681332|NCT01862328|Docetaxel|docetaxel|mesh-list
25681333|NCT01862328|Carboplatin|carboplatin|mesh-list
25031235|NCT03589040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031237|NCT03589040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25031238|NCT03589040|Antiviral Agents|antiviral agents|mesh-ancestor
25031239|NCT03589040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25226348|NCT02621242|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25226349|NCT02621320|Vitamin D|vitamin d|mesh-list
25226350|NCT02621320|Vitamins|vitamins|mesh-ancestor
25226351|NCT02621320|Micronutrients|micronutrients|mesh-ancestor
25226352|NCT02621320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226353|NCT02621320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25226354|NCT02621255|Bupivacaine|bupivacaine|mesh-list
25226355|NCT02621255|Anesthetics|anesthetics|mesh-list
25226356|NCT02621255|Sevoflurane|sevoflurane|mesh-list
25226357|NCT02621255|Anesthetics, Local|anesthetics, local|mesh-ancestor
25226358|NCT02621255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25226359|NCT02621255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226360|NCT02621255|Sensory System Agents|sensory system agents|mesh-ancestor
25226361|NCT02621255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25226362|NCT02621255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25226363|NCT02621255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25226364|NCT02621255|Anesthetics, General|anesthetics, general|mesh-ancestor
25226365|NCT02621112|Imiquimod|imiquimod|mesh-list
25226366|NCT02621112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25226367|NCT02621112|Immunologic Factors|immunologic factors|mesh-ancestor
25226368|NCT02621112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226369|NCT02621112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25226370|NCT02621112|Interferon Inducers|interferon inducers|mesh-ancestor
25226371|NCT02620995|Sildenafil Citrate|sildenafil citrate|mesh-list
25226372|NCT02620995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226373|NCT02620995|Vasodilator Agents|vasodilator agents|mesh-ancestor
25226374|NCT02620995|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24840261|NCT02208791|Antifungal Agents|antifungal agents|mesh-ancestor
24840262|NCT02208791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24535151|NCT00648661|Citalopram|citalopram|mesh-list
24535152|NCT00648661|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24535153|NCT00648661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24535154|NCT00648661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24535155|NCT00648661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535156|NCT00648661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535161|NCT00648661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24535162|NCT00648661|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25681334|NCT01862328|Pevonedistat|pevonedistat|mesh-list
25681335|NCT01862328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25681336|NCT01862328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25681337|NCT01862328|Tubulin Modulators|tubulin modulators|mesh-ancestor
25681338|NCT01862328|Antimitotic Agents|antimitotic agents|mesh-ancestor
25681339|NCT01862328|Mitosis Modulators|mitosis modulators|mesh-ancestor
24451126|NCT00322114|Protective Agents|protective agents|mesh-ancestor
24451127|NCT00322114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451128|NCT00322114|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25226375|NCT02620995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25226376|NCT02620995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25226377|NCT02620995|Urological Agents|urological agents|mesh-ancestor
25273316|NCT02386059|Dexamethasone|dexamethasone|mesh-list
25273317|NCT02386059|Dexamethasone acetate|dexamethasone acetate|mesh-list
25273318|NCT02386059|Ondansetron|ondansetron|mesh-list
25273319|NCT02386059|BB 1101|bb 1101|mesh-list
25273320|NCT02386059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25273321|NCT02386059|Antiemetics|antiemetics|mesh-ancestor
25273322|NCT02386059|Autonomic Agents|autonomic agents|mesh-ancestor
24840263|NCT02208791|Immunologic Factors|immunologic factors|mesh-ancestor
24840279|NCT02208882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24840280|NCT02208882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840281|NCT02208882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24840282|NCT02208986|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24840283|NCT02208986|Luteolytic Agents|luteolytic agents|mesh-ancestor
24840284|NCT02208986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24840285|NCT02208986|Contraceptive Agents|contraceptive agents|mesh-ancestor
24840286|NCT02208986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24840287|NCT02208986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840288|NCT02208986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24840289|NCT02208986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24840290|NCT02208986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24840291|NCT02209012|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24840292|NCT02209012|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24840293|NCT02209012|Dermatologic Agents|dermatologic agents|mesh-ancestor
24840294|NCT02209025|Theobromine|theobromine|mesh-list
24840295|NCT02209025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24840296|NCT02209025|Autonomic Agents|autonomic agents|mesh-ancestor
24840297|NCT02209025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24840298|NCT02209025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840299|NCT02209025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24992463|NCT03631446|Magnesium Oxide|magnesium oxide|mesh-list
24840300|NCT02209025|Respiratory System Agents|respiratory system agents|mesh-ancestor
24840301|NCT02209025|Vasodilator Agents|vasodilator agents|mesh-ancestor
24451129|NCT00322114|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24451130|NCT00322114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451131|NCT00322127|Plerixafor|plerixafor|mesh-list
24451132|NCT00322127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24451133|NCT00322127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24451134|NCT00322127|Antiviral Agents|antiviral agents|mesh-ancestor
24451135|NCT00322127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24451136|NCT00322166|Calcium|calcium|mesh-list
24444587|NCT00298571|Bupivacaine|bupivacaine|mesh-list
24444588|NCT00298571|Anesthetics, Local|anesthetics, local|mesh-ancestor
24535209|NCT00648791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24535210|NCT00648791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535231|NCT00648817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24535232|NCT00648817|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24535233|NCT00648817|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25226378|NCT02620969|Dialysis Solutions|dialysis solutions|mesh-list
25226379|NCT02620969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25226380|NCT02620800|Leucovorin|leucovorin|mesh-list
25226381|NCT02620800|Paclitaxel|paclitaxel|mesh-list
25226382|NCT02620800|Bevacizumab|bevacizumab|mesh-list
25226383|NCT02620800|Oxaliplatin|oxaliplatin|mesh-list
25113520|NCT02723955|Antiviral Agents|antiviral agents|mesh-ancestor
25226385|NCT02620800|Levoleucovorin|levoleucovorin|mesh-list
25226386|NCT02620800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25226387|NCT02620800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25226388|NCT02620800|Tubulin Modulators|tubulin modulators|mesh-ancestor
25226389|NCT02620800|Antimitotic Agents|antimitotic agents|mesh-ancestor
25226390|NCT02620800|Mitosis Modulators|mitosis modulators|mesh-ancestor
25226391|NCT02620800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226392|NCT02620800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25226393|NCT02620800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25226394|NCT02620800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25226395|NCT02620800|Growth Substances|growth substances|mesh-ancestor
25226396|NCT02620800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226397|NCT02620800|Growth Inhibitors|growth inhibitors|mesh-ancestor
25226398|NCT02620800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25226399|NCT02620800|Antidotes|antidotes|mesh-ancestor
25226400|NCT02620800|Protective Agents|protective agents|mesh-ancestor
25226401|NCT02620800|Vitamin B Complex|vitamin b complex|mesh-ancestor
25226402|NCT02620800|Vitamins|vitamins|mesh-ancestor
25226403|NCT02620800|Micronutrients|micronutrients|mesh-ancestor
25226404|NCT02620813|Tretinoin|tretinoin|mesh-list
25226405|NCT02620813|Isotretinoin|isotretinoin|mesh-list
24535315|NCT00648973|Anesthetics, Local|anesthetics, local|mesh-ancestor
25107642|NCT03138785|Hormone Antagonists|hormone antagonists|mesh-ancestor
24857648|NCT02293291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24857649|NCT02293291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535274|NCT00648921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535275|NCT00648921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24535276|NCT00648921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24535298|NCT00648947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535300|NCT00648960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24535301|NCT00648960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24535302|NCT00648960|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24535303|NCT00648960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25226406|NCT02620813|Dermatologic Agents|dermatologic agents|mesh-ancestor
25226407|NCT02620813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25226408|NCT02620813|Keratolytic Agents|keratolytic agents|mesh-ancestor
25226409|NCT02620748|Tranexamic Acid|tranexamic acid|mesh-list
25226410|NCT02620748|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25226411|NCT02620748|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25226412|NCT02620748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226413|NCT02620748|Hemostatics|hemostatics|mesh-ancestor
25226414|NCT02620748|Coagulants|coagulants|mesh-ancestor
25226415|NCT02620839|Cisplatin|cisplatin|mesh-list
25226416|NCT02620839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992479|NCT03625388|Dasatinib|dasatinib|mesh-list
24992480|NCT03625388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866299|NCT01067521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866300|NCT01067521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25226429|NCT02620605|Dopamine Agents|dopamine agents|mesh-ancestor
25226430|NCT02620605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24840383|NCT02209909|Sensory System Agents|sensory system agents|mesh-ancestor
24840384|NCT02209909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24840385|NCT02209909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840386|NCT02209909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24840387|NCT02209909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24840388|NCT02209909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24840389|NCT02209909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25057633|NCT03503604|Protective Agents|protective agents|mesh-ancestor
24535317|NCT00648973|Sensory System Agents|sensory system agents|mesh-ancestor
25681340|NCT01862328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681341|NCT01862328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25279175|NCT02346110|Hormones|hormones|mesh-ancestor
25113549|NCT02657434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24535318|NCT00648973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25681342|NCT01862328|Antimetabolites|antimetabolites|mesh-ancestor
25681343|NCT01862328|Antiviral Agents|antiviral agents|mesh-ancestor
25681344|NCT01862328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25681345|NCT01862328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25681346|NCT01862328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25681347|NCT01862328|Immunologic Factors|immunologic factors|mesh-ancestor
25681348|NCT01862328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681349|NCT01862536|Tadalafil|tadalafil|mesh-list
24535319|NCT00648973|Antiemetics|antiemetics|mesh-ancestor
24535320|NCT00648973|Autonomic Agents|autonomic agents|mesh-ancestor
24535321|NCT00648973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24535322|NCT00648973|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24535323|NCT00648973|Histamine Antagonists|histamine antagonists|mesh-ancestor
24535324|NCT00648973|Histamine Agents|histamine agents|mesh-ancestor
24857650|NCT02293291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535347|NCT00648999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535349|NCT00648999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24535350|NCT00648999|Antiviral Agents|antiviral agents|mesh-ancestor
24535351|NCT00648999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24535352|NCT00648999|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24535368|NCT00649038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535369|NCT00649051|Metolazone|metolazone|mesh-list
25226431|NCT02620605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226432|NCT02620605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226433|NCT02620618|Infliximab|infliximab|mesh-list
25226434|NCT02620618|Dermatologic Agents|dermatologic agents|mesh-ancestor
25226435|NCT02620618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25226436|NCT02620618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25226437|NCT02620566|Bupivacaine|bupivacaine|mesh-list
25226438|NCT02620566|Anesthetics, Local|anesthetics, local|mesh-ancestor
25226439|NCT02620566|Anesthetics|anesthetics|mesh-ancestor
25226440|NCT02620566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25226441|NCT02620566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226442|NCT02620566|Sensory System Agents|sensory system agents|mesh-ancestor
25226443|NCT02620566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25226444|NCT02620501|Lidocaine|lidocaine|mesh-list
25226445|NCT02620501|Anesthetics, Local|anesthetics, local|mesh-ancestor
25226446|NCT02620501|Anesthetics|anesthetics|mesh-ancestor
25226447|NCT02620501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24840459|NCT02210260|Narcotics|narcotics|mesh-ancestor
24840460|NCT02210260|Analgesics|analgesics|mesh-ancestor
24840461|NCT02210325|Azithromycin|azithromycin|mesh-list
24840462|NCT02210325|Ceftriaxone|ceftriaxone|mesh-list
24840463|NCT02210325|Solithromycin|solithromycin|mesh-list
24840464|NCT02210325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24840506|NCT02210715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840507|NCT02210728|Methylphenidate|methylphenidate|mesh-list
24840508|NCT02210728|Amphetamine|amphetamine|mesh-list
24840509|NCT02210728|Adderall|adderall|mesh-list
24840510|NCT02210728|Dextroamphetamine|dextroamphetamine|mesh-list
24840511|NCT02210728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24840517|NCT02210728|Dopamine Agents|dopamine agents|mesh-ancestor
24840530|NCT02210754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840531|NCT02210754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24840532|NCT02210754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24840533|NCT02210754|Cholinergic Agents|cholinergic agents|mesh-ancestor
24840534|NCT02210754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24840535|NCT02210754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840557|NCT02210884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24840559|NCT02210949|Hematinics|hematinics|mesh-ancestor
24840560|NCT02211066|Clopidogrel|clopidogrel|mesh-list
24840561|NCT02211066|Ticagrelor|ticagrelor|mesh-list
24840566|NCT02211066|Purinergic Agents|purinergic agents|mesh-ancestor
25681350|NCT01862536|Vasodilator Agents|vasodilator agents|mesh-ancestor
25681351|NCT01862536|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24840573|NCT02211079|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24840574|NCT02211079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24840575|NCT02211079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24840576|NCT02211079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840577|NCT02211079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24840578|NCT02211079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24840579|NCT02211079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25226448|NCT02620501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226449|NCT02620501|Sensory System Agents|sensory system agents|mesh-ancestor
25226450|NCT02620501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25226451|NCT02620501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25226452|NCT02620501|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25226453|NCT02620501|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25226454|NCT02620501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25226455|NCT02620501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226456|NCT02620631|Morphine|morphine|mesh-list
25226457|NCT02620631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25226458|NCT02620631|Narcotics|narcotics|mesh-ancestor
25226459|NCT02620631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25226460|NCT02620631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226461|NCT02620631|Analgesics|analgesics|mesh-ancestor
25226462|NCT02620631|Sensory System Agents|sensory system agents|mesh-ancestor
25226463|NCT02620631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25226464|NCT02620423|Leucovorin|leucovorin|mesh-list
25226465|NCT02620423|Gemcitabine|gemcitabine|mesh-list
25226466|NCT02620423|Fluorouracil|fluorouracil|mesh-list
25226467|NCT02620423|Pembrolizumab|pembrolizumab|mesh-list
25226468|NCT02620423|Irinotecan|irinotecan|mesh-list
25226469|NCT02620423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25226470|NCT02620423|Antimetabolites|antimetabolites|mesh-ancestor
25226471|NCT02620423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226472|NCT02620423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25226473|NCT02620423|Antiviral Agents|antiviral agents|mesh-ancestor
25226474|NCT02620423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25226475|NCT02620423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25226476|NCT02620423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25226477|NCT02620423|Immunologic Factors|immunologic factors|mesh-ancestor
25226478|NCT02620423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226479|NCT02620423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24840587|NCT02211079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24998407|NCT02960646|Antimetabolites|antimetabolites|mesh-ancestor
24840588|NCT02211079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24840589|NCT02211079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840590|NCT02211079|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24840591|NCT02211079|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24840592|NCT02211079|Purinergic Agents|purinergic agents|mesh-ancestor
24840593|NCT02211079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24840594|NCT02211118|Dexmedetomidine|dexmedetomidine|mesh-list
24840595|NCT02211118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24840596|NCT02211118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24840597|NCT02211118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840598|NCT02211118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24840599|NCT02211118|Analgesics|analgesics|mesh-ancestor
24840600|NCT02211118|Sensory System Agents|sensory system agents|mesh-ancestor
24840601|NCT02211118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24840612|NCT02211222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840613|NCT02211326|Warfarin|warfarin|mesh-list
24840614|NCT02211326|Anticoagulants|anticoagulants|mesh-ancestor
24552995|NCT00728715|Hormones|hormones|mesh-ancestor
24930388|NCT04101474|Ketamine|ketamine|mesh-list
25226480|NCT02620423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25226481|NCT02620423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25226482|NCT02620423|Antidotes|antidotes|mesh-ancestor
25226483|NCT02620423|Protective Agents|protective agents|mesh-ancestor
25226484|NCT02620423|Vitamin B Complex|vitamin b complex|mesh-ancestor
25031358|NCT03588429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25031359|NCT03588429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031360|NCT03588351|Chlorhexidine|chlorhexidine|mesh-list
25031361|NCT03588351|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25031362|NCT03588351|Chitosan|chitosan|mesh-list
25031363|NCT03588351|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25031364|NCT03588351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25031400|NCT03588039|Paclitaxel|paclitaxel|mesh-list
25226485|NCT02620423|Vitamins|vitamins|mesh-ancestor
25226486|NCT02620423|Micronutrients|micronutrients|mesh-ancestor
25226487|NCT02620163|Amlodipine|amlodipine|mesh-list
25226488|NCT02620163|Telmisartan|telmisartan|mesh-list
25226489|NCT02620163|Chlorthalidone|chlorthalidone|mesh-list
25226502|NCT02620163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24840615|NCT02211391|Caseins|caseins|mesh-list
24840616|NCT02211391|Chelating Agents|chelating agents|mesh-ancestor
24840617|NCT02211391|Sequestering Agents|sequestering agents|mesh-ancestor
24840618|NCT02211391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840619|NCT02211417|Mineral Oil|mineral oil|mesh-list
24840620|NCT02211417|Dermatologic Agents|dermatologic agents|mesh-ancestor
24840621|NCT02211417|Emollients|emollients|mesh-ancestor
24840622|NCT02211443|Antibodies|antibodies|mesh-list
24840623|NCT02211443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24840624|NCT02211443|Immunologic Factors|immunologic factors|mesh-ancestor
24840625|NCT02211443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840626|NCT02211482|Lamivudine|lamivudine|mesh-list
24840627|NCT02211482|Dolutegravir|dolutegravir|mesh-list
24840628|NCT02211482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24840629|NCT02211482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24840630|NCT02211482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24992534|NCT03496610|Bupivacaine|bupivacaine|mesh-list
24992540|NCT03496610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24840631|NCT02211482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840632|NCT02211482|Antiviral Agents|antiviral agents|mesh-ancestor
24840633|NCT02211482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24840634|NCT02211482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24840635|NCT02211482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24840636|NCT02211482|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24840637|NCT02211482|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24840638|NCT02211521|Hyaluronic Acid|hyaluronic acid|mesh-list
24840639|NCT02211521|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24840640|NCT02211521|Immunologic Factors|immunologic factors|mesh-ancestor
24840641|NCT02211521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840642|NCT02211521|Viscosupplements|viscosupplements|mesh-ancestor
24840643|NCT02211521|Protective Agents|protective agents|mesh-ancestor
24840644|NCT02211625|Oxycodone|oxycodone|mesh-list
24840645|NCT02211625|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24840646|NCT02211625|Narcotics|narcotics|mesh-ancestor
24840655|NCT02211690|Antiviral Agents|antiviral agents|mesh-ancestor
25226517|NCT02620124|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25226518|NCT02620124|Hormones|hormones|mesh-list
25226519|NCT02620124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25226520|NCT02620124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226521|NCT02620124|Luteolytic Agents|luteolytic agents|mesh-ancestor
25226522|NCT02620124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25226523|NCT02620124|Contraceptive Agents|contraceptive agents|mesh-ancestor
25226524|NCT02620124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25226525|NCT02620124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25226526|NCT02620124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25226527|NCT02620124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25226528|NCT02620215|Dinoprostone|dinoprostone|mesh-list
25226529|NCT02620215|Oxytocics|oxytocics|mesh-ancestor
25226530|NCT02620215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25226536|NCT02620345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226538|NCT02620293|Dermatologic Agents|dermatologic agents|mesh-ancestor
25226539|NCT02619981|Lidocaine|lidocaine|mesh-list
25226540|NCT02619981|Anesthetics, Local|anesthetics, local|mesh-ancestor
25681352|NCT01862536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25681353|NCT01862536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25681354|NCT01862536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681355|NCT01862536|Urological Agents|urological agents|mesh-ancestor
25681356|NCT01862614|Epinephrine|epinephrine|mesh-list
25681357|NCT01862614|Racepinephrine|racepinephrine|mesh-list
25681358|NCT01862614|Carticaine|carticaine|mesh-list
25226541|NCT02619981|Anesthetics|anesthetics|mesh-ancestor
25226542|NCT02619981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25681359|NCT01862614|Epinephryl borate|epinephryl borate|mesh-list
25681360|NCT01862614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25031431|NCT03587662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031432|NCT03587662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031451|NCT03587558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226543|NCT02619981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226544|NCT02619981|Sensory System Agents|sensory system agents|mesh-ancestor
24535549|NCT00649350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24840732|NCT02212210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24705266|NCT01483508|Protective Agents|protective agents|mesh-ancestor
25226550|NCT02619981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840740|NCT02212210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24840744|NCT02212223|Vitamins|vitamins|mesh-ancestor
24840745|NCT02212223|Micronutrients|micronutrients|mesh-ancestor
24840746|NCT02212223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840747|NCT02212223|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24840748|NCT02212223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24840749|NCT02212340|Remifentanil|remifentanil|mesh-list
24840750|NCT02212340|Desflurane|desflurane|mesh-list
24840751|NCT02212340|Propofol|propofol|mesh-list
25681361|NCT01862614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25681362|NCT01862614|Adrenergic Agents|adrenergic agents|mesh-ancestor
25681363|NCT01862614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25681364|NCT01862614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681365|NCT01862614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681366|NCT01862614|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25681367|NCT01862614|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25681368|NCT01862614|Autonomic Agents|autonomic agents|mesh-ancestor
24426699|NCT00236522|Levofloxacin|levofloxacin|mesh-list
25226561|NCT02619929|Vinorelbine|vinorelbine|mesh-list
25226562|NCT02619929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25226563|NCT02619929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25226564|NCT02619929|Tubulin Modulators|tubulin modulators|mesh-ancestor
25226565|NCT02619929|Antimitotic Agents|antimitotic agents|mesh-ancestor
25226566|NCT02619929|Mitosis Modulators|mitosis modulators|mesh-ancestor
25226567|NCT02619929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226568|NCT02619994|Levofloxacin|levofloxacin|mesh-list
25226569|NCT02619994|Ofloxacin|ofloxacin|mesh-list
25226570|NCT02619994|Linezolid|linezolid|mesh-list
25226571|NCT02619994|Pyrazinamide|pyrazinamide|mesh-list
25226572|NCT02619994|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25226573|NCT02619994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25226574|NCT02619994|Renal Agents|renal agents|mesh-ancestor
25226575|NCT02619994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25226576|NCT02619994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24535482|NCT00649233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24535483|NCT00649233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24535484|NCT00649233|Diuretics|diuretics|mesh-ancestor
24535485|NCT00649233|Natriuretic Agents|natriuretic agents|mesh-ancestor
24613628|NCT01020162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613629|NCT01020162|Anticonvulsants|anticonvulsants|mesh-ancestor
24613630|NCT01020162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24613631|NCT01020162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24613632|NCT01020162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24535486|NCT00649233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535487|NCT00649233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24535488|NCT00649233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24535489|NCT00649233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226577|NCT02619994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25226578|NCT02619994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25681370|NCT01862614|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25681371|NCT01862614|Respiratory System Agents|respiratory system agents|mesh-ancestor
25681372|NCT01862614|Mydriatics|mydriatics|mesh-ancestor
25681373|NCT01862614|Sympathomimetics|sympathomimetics|mesh-ancestor
24705376|NCT01484717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857661|NCT02293330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857663|NCT02293356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24857664|NCT02293356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24857665|NCT02293447|Lidocaine|lidocaine|mesh-list
24857666|NCT02293447|Anesthetics, Local|anesthetics, local|mesh-list
24857667|NCT02293447|Anesthetics|anesthetics|mesh-list
24857668|NCT02293447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24992692|NCT03150173|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24857669|NCT02293447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226584|NCT02619994|Antitubercular Agents|antitubercular agents|mesh-ancestor
25226585|NCT02620072|Insulin|insulin|mesh-list
25226586|NCT02620072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25226587|NCT02620072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226588|NCT02620007|Ciprofloxacin|ciprofloxacin|mesh-list
25226589|NCT02620007|Rifaximin|rifaximin|mesh-list
25226590|NCT02620007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24840821|NCT02212756|Metformin|metformin|mesh-list
24840822|NCT02212756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24840823|NCT02212756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840824|NCT02212769|Losartan|losartan|mesh-list
24840825|NCT02212769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24840826|NCT02212769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24840827|NCT02212769|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24840828|NCT02212769|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24840829|NCT02212769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840830|NCT02212782|Linagliptin|linagliptin|mesh-list
24840831|NCT02212782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24840832|NCT02212782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840833|NCT02212782|Incretins|incretins|mesh-ancestor
24840834|NCT02212782|Hormones|hormones|mesh-ancestor
24840835|NCT02212782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24840836|NCT02212782|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24840837|NCT02212782|Protease Inhibitors|protease inhibitors|mesh-ancestor
24840838|NCT02212782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840839|NCT02212782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840840|NCT02212795|Levofloxacin|levofloxacin|mesh-list
24840841|NCT02212795|Ofloxacin|ofloxacin|mesh-list
24840842|NCT02212795|Fluoroquinolones|fluoroquinolones|mesh-list
24840843|NCT02212795|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24840861|NCT02212821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24840862|NCT02212821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24992747|NCT03022279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24840863|NCT02212821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24840864|NCT02212821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24840865|NCT02212821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840866|NCT02212821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840867|NCT02212990|Acetaminophen|acetaminophen|mesh-list
25226591|NCT02620007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25226592|NCT02620007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25226593|NCT02620007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25226594|NCT02620007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25226595|NCT02620007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681374|NCT01862614|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25681375|NCT01862614|Anesthetics, Local|anesthetics, local|mesh-ancestor
25681376|NCT01862614|Anesthetics|anesthetics|mesh-ancestor
25681377|NCT01862614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25681378|NCT01862614|Sensory System Agents|sensory system agents|mesh-ancestor
25681379|NCT01862640|Brexpiprazole|brexpiprazole|mesh-list
25031597|NCT03586934|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25031598|NCT03586934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25031599|NCT03586934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25031600|NCT03586934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031601|NCT03586934|Antitussive Agents|antitussive agents|mesh-ancestor
25031602|NCT03586934|Respiratory System Agents|respiratory system agents|mesh-ancestor
25031603|NCT03586908|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25031604|NCT03586908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25031605|NCT03586869|Leucovorin|leucovorin|mesh-list
25031606|NCT03586869|Paclitaxel|paclitaxel|mesh-list
25031607|NCT03586869|Cyclophosphamide|cyclophosphamide|mesh-list
25031608|NCT03586869|Bevacizumab|bevacizumab|mesh-list
25031609|NCT03586869|Fluorouracil|fluorouracil|mesh-list
25031610|NCT03586869|Capecitabine|capecitabine|mesh-list
25226596|NCT02620007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25226597|NCT02620007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25226598|NCT02620007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25226599|NCT02620007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25226600|NCT02619773|Mupirocin|mupirocin|mesh-list
25226601|NCT02619773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25226602|NCT02619773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25226603|NCT02619773|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25226604|NCT02619773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25226605|NCT02619773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226606|NCT02619786|Colistin|colistin|mesh-list
25226607|NCT02619786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25226608|NCT02619786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25226609|NCT02619669|Letrozole|letrozole|mesh-list
25226610|NCT02619669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25226611|NCT02619669|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25226612|NCT02619669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25226613|NCT02619669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25226614|NCT02619669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226615|NCT02619669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25226616|NCT02619669|Hormone Antagonists|hormone antagonists|mesh-ancestor
25226617|NCT02619669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25226618|NCT02619669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226619|NCT02619513|Dexmedetomidine|dexmedetomidine|mesh-list
25226620|NCT02619513|Ropivacaine|ropivacaine|mesh-list
25226621|NCT02619513|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25226622|NCT02619513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25226623|NCT02619513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226624|NCT02619513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25226625|NCT02619513|Analgesics|analgesics|mesh-ancestor
25226626|NCT02619513|Sensory System Agents|sensory system agents|mesh-ancestor
25226627|NCT02619513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25226628|NCT02619513|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24840869|NCT02212990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24840870|NCT02212990|Analgesics|analgesics|mesh-ancestor
24840871|NCT02212990|Sensory System Agents|sensory system agents|mesh-ancestor
24840872|NCT02212990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857670|NCT02293447|Sensory System Agents|sensory system agents|mesh-ancestor
24857671|NCT02293447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857672|NCT02293447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24857673|NCT02293447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24857674|NCT02293447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24857675|NCT02293447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24857676|NCT02293447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857677|NCT02293525|Morphine|morphine|mesh-list
24857678|NCT02293525|Oxycodone|oxycodone|mesh-list
24857679|NCT02293525|Ropivacaine|ropivacaine|mesh-list
25681380|NCT01862640|Serotonin Agents|serotonin agents|mesh-ancestor
25681381|NCT01862640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25681382|NCT01862640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681383|NCT01862640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681384|NCT01862640|Dopamine Agonists|dopamine agonists|mesh-ancestor
25681385|NCT01862640|Dopamine Agents|dopamine agents|mesh-ancestor
25681386|NCT01862874|Vaccines|vaccines|mesh-list
25681387|NCT01862874|Immunologic Factors|immunologic factors|mesh-ancestor
25681388|NCT01862874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681389|NCT01862991|Digoxin|digoxin|mesh-list
25681390|NCT01862991|Misoprostol|misoprostol|mesh-list
25681391|NCT01862991|Mifepristone|mifepristone|mesh-list
25681392|NCT01862991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25681393|NCT01862991|Abortifacient Agents|abortifacient agents|mesh-ancestor
25031643|NCT03586817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25031644|NCT03586817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031645|NCT03586817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25031659|NCT03586674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031660|NCT03586674|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25031661|NCT03586674|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25031662|NCT03586674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25031668|NCT03586466|Buprenorphine|buprenorphine|mesh-list
25031670|NCT03586466|Naloxone|naloxone|mesh-list
24857680|NCT02293525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24857681|NCT02293525|Narcotics|narcotics|mesh-ancestor
24460167|NCT00347555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24705405|NCT01485003|Natalizumab|natalizumab|mesh-list
24535537|NCT00649311|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24535538|NCT00649311|Diuretics|diuretics|mesh-ancestor
24535539|NCT00649311|Natriuretic Agents|natriuretic agents|mesh-ancestor
24535540|NCT00649324|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24535541|NCT00649324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24535542|NCT00649324|Diuretics|diuretics|mesh-ancestor
24535543|NCT00649324|Natriuretic Agents|natriuretic agents|mesh-ancestor
24535544|NCT00649324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535545|NCT00649324|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25226629|NCT02619513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25226630|NCT02619513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25226631|NCT02619513|Adrenergic Agents|adrenergic agents|mesh-ancestor
25226632|NCT02619513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25226633|NCT02619513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226634|NCT02619513|Anesthetics, Local|anesthetics, local|mesh-ancestor
25226635|NCT02619513|Anesthetics|anesthetics|mesh-ancestor
25226636|NCT02619747|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
25226637|NCT02619747|Antacids|antacids|mesh-ancestor
25226638|NCT02619747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226639|NCT02619747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25226640|NCT02619448|Paclitaxel|paclitaxel|mesh-list
25043500|NCT01253603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25043501|NCT01253603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25043502|NCT01253603|Autonomic Agents|autonomic agents|mesh-ancestor
25043503|NCT01253603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25043504|NCT01253603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043505|NCT01253603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25043506|NCT01253603|Respiratory System Agents|respiratory system agents|mesh-ancestor
25043507|NCT01253603|Dermatologic Agents|dermatologic agents|mesh-ancestor
24840874|NCT02212990|Antipyretics|antipyretics|mesh-ancestor
24840875|NCT02212990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24840876|NCT02212990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24535546|NCT00649324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24857682|NCT02293525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24857683|NCT02293525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535547|NCT00649324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681394|NCT01862991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25681395|NCT01862991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681396|NCT01862991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25681397|NCT01862991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25681398|NCT01862991|Oxytocics|oxytocics|mesh-ancestor
25681399|NCT01862991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25681400|NCT01862991|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25681401|NCT01862991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25681402|NCT01862991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535596|NCT00649415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24535598|NCT00649415|Sensory System Agents|sensory system agents|mesh-ancestor
24535599|NCT00649415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24705511|NCT01485562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25226641|NCT02619448|Carboplatin|carboplatin|mesh-list
25226642|NCT02619448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25226648|NCT02619578|Remifentanil|remifentanil|mesh-list
25226649|NCT02619578|Propofol|propofol|mesh-list
25226650|NCT02619578|Vecuronium Bromide|vecuronium bromide|mesh-list
25226651|NCT02619578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25226652|NCT02619578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24840878|NCT02212990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24840879|NCT02212990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840880|NCT02212990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840881|NCT02213029|Oxytocin|oxytocin|mesh-list
24840882|NCT02213029|Oxytocics|oxytocics|mesh-ancestor
24840899|NCT02213146|Insulin|insulin|mesh-list
24840900|NCT02213146|Insulin Lispro|insulin lispro|mesh-list
24840901|NCT02213146|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24840902|NCT02213146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24840903|NCT02213146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840904|NCT02213159|Dexmedetomidine|dexmedetomidine|mesh-list
24840905|NCT02213159|Morphine|morphine|mesh-list
24840923|NCT02213211|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24840924|NCT02213211|Artemisinins|artemisinins|mesh-list
24535600|NCT00649415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535602|NCT00649415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24535603|NCT00649441|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24535604|NCT00649441|Quinapril|quinapril|mesh-list
25226660|NCT02619578|Sensory System Agents|sensory system agents|mesh-ancestor
25226661|NCT02619578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25226662|NCT02619578|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25226663|NCT02619578|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25226664|NCT02619578|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25226665|NCT02619578|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25226666|NCT02619578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25226667|NCT02619578|Cholinergic Agents|cholinergic agents|mesh-ancestor
25226668|NCT02619578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25226669|NCT02619578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226670|NCT02619526|Carvedilol|carvedilol|mesh-list
25226671|NCT02619526|Nebivolol|nebivolol|mesh-list
25226672|NCT02619526|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25226673|NCT02619526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25226674|NCT02619526|Adrenergic Agents|adrenergic agents|mesh-ancestor
25226675|NCT02619526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25226676|NCT02619526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226677|NCT02619526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226678|NCT02619526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25226679|NCT02619526|Antioxidants|antioxidants|mesh-ancestor
25226680|NCT02619526|Protective Agents|protective agents|mesh-ancestor
25226681|NCT02619526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24840925|NCT02213211|Artemisinin|artemisinin|mesh-list
24840926|NCT02213211|Antimalarials|antimalarials|mesh-ancestor
24840927|NCT02213211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24840928|NCT02213211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24840929|NCT02213211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24840930|NCT02213224|Amlodipine|amlodipine|mesh-list
24840931|NCT02213224|Telmisartan|telmisartan|mesh-list
24840932|NCT02213224|Perindopril|perindopril|mesh-list
24840933|NCT02213224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24840934|NCT02213224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24535606|NCT00649441|Diuretics|diuretics|mesh-ancestor
24535607|NCT00649441|Natriuretic Agents|natriuretic agents|mesh-ancestor
24535608|NCT00649441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535609|NCT00649441|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24535610|NCT00649441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24535611|NCT00649441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681403|NCT01862991|Protective Agents|protective agents|mesh-ancestor
25031873|NCT03585413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031875|NCT03585374|Ketoprofen|ketoprofen|mesh-list
25031876|NCT03585374|Morphine|morphine|mesh-list
24857688|NCT02293525|Anesthetics|anesthetics|mesh-ancestor
24857689|NCT02293551|Insulin Lispro|insulin lispro|mesh-list
24857690|NCT02293551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24857691|NCT02293551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857692|NCT02293590|Sulfasalazine|sulfasalazine|mesh-list
24857693|NCT02293590|Certolizumab Pegol|certolizumab pegol|mesh-list
24857694|NCT02293590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24857695|NCT02293590|Immunologic Factors|immunologic factors|mesh-ancestor
24857696|NCT02293590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226682|NCT02619526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25226683|NCT02619526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25226684|NCT02619526|Vasodilator Agents|vasodilator agents|mesh-ancestor
25226685|NCT02619526|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25226686|NCT02619526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25226687|NCT02619526|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25226688|NCT02619526|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25226689|NCT02619526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25273323|NCT02386059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25273324|NCT02386059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273325|NCT02386059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25273326|NCT02386059|Glucocorticoids|glucocorticoids|mesh-ancestor
25273327|NCT02386059|Hormones|hormones|mesh-ancestor
25273328|NCT02386059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25273329|NCT02386059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25273330|NCT02386059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25273331|NCT02386059|Protease Inhibitors|protease inhibitors|mesh-ancestor
24840937|NCT02213224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24840938|NCT02213224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840939|NCT02213224|Vasodilator Agents|vasodilator agents|mesh-ancestor
24840940|NCT02213224|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24840941|NCT02213224|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24840942|NCT02213224|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24840943|NCT02213224|Protease Inhibitors|protease inhibitors|mesh-ancestor
24840944|NCT02213224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840946|NCT02213302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24840947|NCT02213302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24841021|NCT02213718|Anesthetics|anesthetics|mesh-ancestor
24841022|NCT02213718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24535649|NCT00649519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535685|NCT00649584|Gemcitabine|gemcitabine|mesh-list
24535686|NCT00649584|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24535687|NCT00649584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24535688|NCT00649584|Antimetabolites|antimetabolites|mesh-ancestor
24535689|NCT00649584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681404|NCT01862991|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25681405|NCT01862991|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25681406|NCT01862991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25113571|NCT02568566|Immunologic Factors|immunologic factors|mesh-ancestor
25113572|NCT02568566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25113576|NCT02535312|Cisplatin|cisplatin|mesh-list
25113577|NCT02535312|Pemetrexed|pemetrexed|mesh-list
25113578|NCT02535312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25113579|NCT02535312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25113580|NCT02535312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535690|NCT00649584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24535728|NCT00649623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24535729|NCT00649623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535730|NCT00649636|Fluoxetine|fluoxetine|mesh-list
24535731|NCT00649636|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24535732|NCT00649636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24535733|NCT00649636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24535734|NCT00649636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535735|NCT00649636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535736|NCT00649636|Serotonin Agents|serotonin agents|mesh-ancestor
24535737|NCT00649636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535738|NCT00649636|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25226690|NCT02619201|Ondansetron|ondansetron|mesh-list
25226691|NCT02619201|Metoclopramide|metoclopramide|mesh-list
25226692|NCT02619201|Antiemetics|antiemetics|mesh-ancestor
25226693|NCT02619201|Autonomic Agents|autonomic agents|mesh-ancestor
25226694|NCT02619201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25226695|NCT02619201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226696|NCT02619201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25226697|NCT02619201|Antipruritics|antipruritics|mesh-ancestor
25226698|NCT02619201|Dermatologic Agents|dermatologic agents|mesh-ancestor
25226699|NCT02619201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25226700|NCT02619201|Serotonin Agents|serotonin agents|mesh-ancestor
25226701|NCT02619201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25226702|NCT02619201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226703|NCT02619201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25226704|NCT02619201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25226705|NCT02619201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25226706|NCT02619201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24841025|NCT02213718|Sensory System Agents|sensory system agents|mesh-ancestor
24841026|NCT02213718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24841027|NCT02213718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24841028|NCT02213718|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24841029|NCT02213744|Gemcitabine|gemcitabine|mesh-list
24841030|NCT02213744|Capecitabine|capecitabine|mesh-list
24841031|NCT02213744|Trastuzumab|trastuzumab|mesh-list
24841032|NCT02213744|Vinorelbine|vinorelbine|mesh-list
24446295|NCT00304369|Metronidazole|metronidazole|mesh-list
24993003|NCT01881048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24841087|NCT02213913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24841088|NCT02213913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24841089|NCT02213913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24841130|NCT02214381|Antimitotic Agents|antimitotic agents|mesh-ancestor
24841131|NCT02214381|Mitosis Modulators|mitosis modulators|mesh-ancestor
24705623|NCT01485848|Paclitaxel|paclitaxel|mesh-list
24535739|NCT00649636|Antidepressive Agents|antidepressive agents|mesh-ancestor
24535740|NCT00649636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24535741|NCT00649636|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24857698|NCT02293590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24857699|NCT02293590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24857700|NCT02293590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24857701|NCT02293590|Analgesics|analgesics|mesh-ancestor
24857702|NCT02293590|Sensory System Agents|sensory system agents|mesh-ancestor
24857703|NCT02293590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857704|NCT02293590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24857705|NCT02293590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24535742|NCT00649636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24535743|NCT00649636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535744|NCT00649649|Quinapril|quinapril|mesh-list
25681407|NCT01862991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25681408|NCT01862991|Contraceptive Agents|contraceptive agents|mesh-ancestor
25681409|NCT01862991|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25681410|NCT01862991|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25681411|NCT01862991|Hormone Antagonists|hormone antagonists|mesh-ancestor
25681412|NCT01862991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25681413|NCT01862991|Luteolytic Agents|luteolytic agents|mesh-ancestor
24504049|NCT00533923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504050|NCT00533923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24504052|NCT00533923|Antifungal Agents|antifungal agents|mesh-ancestor
24504057|NCT00533936|Paclitaxel|paclitaxel|mesh-list
24504144|NCT00534287|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24504145|NCT00534287|Contraceptive Agents|contraceptive agents|mesh-ancestor
24504146|NCT00534287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24504147|NCT00534287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504148|NCT00534287|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24504149|NCT00534287|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24504150|NCT00534287|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24504152|NCT00534378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24504153|NCT00534378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24504154|NCT00534378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25031976|NCT03584841|Pilocarpine|pilocarpine|mesh-list
24535745|NCT00649649|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24535746|NCT00649649|Protease Inhibitors|protease inhibitors|mesh-ancestor
24535758|NCT00649662|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24535759|NCT00649662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24535760|NCT00649675|Meloxicam|meloxicam|mesh-list
24535761|NCT00649675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24535762|NCT00649675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24535772|NCT00649675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535774|NCT00649688|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24535775|NCT00649688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24535777|NCT00649688|Natriuretic Agents|natriuretic agents|mesh-ancestor
24535778|NCT00649688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535779|NCT00649688|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24535780|NCT00649688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24535781|NCT00649688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535782|NCT00649688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24535783|NCT00649688|Sympatholytics|sympatholytics|mesh-ancestor
24535784|NCT00649688|Autonomic Agents|autonomic agents|mesh-ancestor
24535785|NCT00649688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25226707|NCT02619201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25226708|NCT02619201|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25226709|NCT02619201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25226710|NCT02619201|Dopamine Agents|dopamine agents|mesh-ancestor
25226711|NCT02619162|Letrozole|letrozole|mesh-list
25226712|NCT02619162|Nintedanib|nintedanib|mesh-list
25226713|NCT02619162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25226714|NCT02619162|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25226715|NCT02619162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25226716|NCT02619162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25226717|NCT02619162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226718|NCT02619162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25226719|NCT02619162|Hormone Antagonists|hormone antagonists|mesh-ancestor
25226720|NCT02619162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25226721|NCT02619162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841137|NCT02214381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24841138|NCT02214381|Alkylating Agents|alkylating agents|mesh-ancestor
25681414|NCT01862991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25681415|NCT01862991|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25681416|NCT01863134|Eptifibatide|eptifibatide|mesh-list
25681417|NCT01863134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25681418|NCT01863368|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25681419|NCT01863368|Lubricant Eye Drops|lubricant eye drops|mesh-list
25681420|NCT01863368|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25681421|NCT01863667|Glimepiride|glimepiride|mesh-list
25681422|NCT01863667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25681423|NCT01863667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25681424|NCT01863667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681425|NCT01863667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25681426|NCT01863667|Immunologic Factors|immunologic factors|mesh-ancestor
25681427|NCT01863680|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25681428|NCT01863680|Hormones|hormones|mesh-list
25681429|NCT01863680|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24857709|NCT02293668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25226722|NCT02619162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25226723|NCT02619266|Megestrol|megestrol|mesh-list
25226724|NCT02619266|Megestrol Acetate|megestrol acetate|mesh-list
25226725|NCT02619266|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25226726|NCT02619266|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25226727|NCT02619266|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25226728|NCT02619266|Contraceptive Agents|contraceptive agents|mesh-ancestor
25226729|NCT02619266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25226730|NCT02619266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226731|NCT02619266|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25226732|NCT02619266|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25226733|NCT02619266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25226734|NCT02619266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25226735|NCT02619266|Appetite Stimulants|appetite stimulants|mesh-ancestor
25226736|NCT02619266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25226737|NCT02619149|Tazobactam|tazobactam|mesh-list
25226738|NCT02619149|Piperacillin|piperacillin|mesh-list
25273332|NCT02386059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273333|NCT02386059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273334|NCT02386059|Antipruritics|antipruritics|mesh-ancestor
25273335|NCT02386059|Dermatologic Agents|dermatologic agents|mesh-ancestor
25273336|NCT02386059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25273337|NCT02386059|Serotonin Agents|serotonin agents|mesh-ancestor
24452520|NCT05458401|Trastuzumab|trastuzumab|mesh-list
24452521|NCT05458401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24452522|NCT05458401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841168|NCT02214563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057913|NCT03500848|Antifungal Agents|antifungal agents|mesh-ancestor
24535814|NCT00649779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24535815|NCT00649779|Autonomic Agents|autonomic agents|mesh-ancestor
24535816|NCT00649779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24535817|NCT00649779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535818|NCT00649779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24535819|NCT00649779|Respiratory System Agents|respiratory system agents|mesh-ancestor
24535821|NCT00649779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24535822|NCT00649779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24535823|NCT00649779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24535824|NCT00649779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24535825|NCT00649779|Adrenergic Agents|adrenergic agents|mesh-ancestor
24535826|NCT00649779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535894|NCT00649935|Azithromycin|azithromycin|mesh-list
24535895|NCT00649935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24535896|NCT00649935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24535900|NCT00649974|Valacyclovir|valacyclovir|mesh-list
24535901|NCT00649974|Antiviral Agents|antiviral agents|mesh-ancestor
24535912|NCT00649987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24535913|NCT00649987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24857714|NCT02293668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24857717|NCT02293681|Dermatologic Agents|dermatologic agents|mesh-ancestor
24857718|NCT02293681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24857719|NCT02293681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24857720|NCT02293694|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24460215|NCT00347750|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24460216|NCT00347750|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24460217|NCT00347750|Protease Inhibitors|protease inhibitors|mesh-ancestor
24460220|NCT00347750|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24535914|NCT00649987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24535915|NCT00649987|Adrenergic Agents|adrenergic agents|mesh-ancestor
24535916|NCT00649987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535917|NCT00649987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535918|NCT00650000|Modafinil|modafinil|mesh-list
24535919|NCT00650000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24535920|NCT00650000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535921|NCT00650000|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25226739|NCT02619149|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25226740|NCT02619149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25226741|NCT02619149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25226742|NCT02619149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25226743|NCT02619149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25226744|NCT02619149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226745|NCT02619019|Dexamethasone|dexamethasone|mesh-list
25226746|NCT02619019|Meperidine|meperidine|mesh-list
25226747|NCT02619019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25226748|NCT02619019|Antiemetics|antiemetics|mesh-ancestor
25226749|NCT02619019|Autonomic Agents|autonomic agents|mesh-ancestor
24452535|NCT05458180|Prednisone|prednisone|mesh-list
24535922|NCT00650000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25043580|NCT01235754|Hormones|hormones|mesh-ancestor
24613663|NCT01020253|Vitamins|vitamins|mesh-ancestor
25226756|NCT02619019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25226757|NCT02619019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25226758|NCT02619019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24452537|NCT05458180|Etoposide|etoposide|mesh-list
24452538|NCT05458180|Vincristine|vincristine|mesh-list
24452539|NCT05458180|Mitoxantrone|mitoxantrone|mesh-list
24452540|NCT05458180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24452541|NCT05458180|Immunologic Factors|immunologic factors|mesh-ancestor
24452542|NCT05458180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452555|NCT05458180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24841196|NCT02214706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24841197|NCT02214706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841198|NCT02214706|Antifungal Agents|antifungal agents|mesh-ancestor
24841199|NCT02214706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24841200|NCT02214706|Immunologic Factors|immunologic factors|mesh-ancestor
24841201|NCT02214706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841203|NCT02214771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24841204|NCT02214771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24841205|NCT02214810|Bupivacaine|bupivacaine|mesh-list
24841206|NCT02214810|Anesthetics, Local|anesthetics, local|mesh-ancestor
24841207|NCT02214810|Anesthetics|anesthetics|mesh-ancestor
24993198|NCT05200299|Antimetabolites|antimetabolites|mesh-ancestor
24993224|NCT05200156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24993225|NCT05200156|Nootropic Agents|nootropic agents|mesh-ancestor
24993226|NCT05199727|Tadalafil|tadalafil|mesh-list
24504642|NCT00537550|Methotrexate|methotrexate|mesh-list
24504643|NCT00537550|Vincristine|vincristine|mesh-list
24504644|NCT00537550|Asparaginase|asparaginase|mesh-list
24504670|NCT00537563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24504671|NCT00537602|Miglustat|miglustat|mesh-list
24504672|NCT00537602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504673|NCT00537602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504674|NCT00537602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24993227|NCT05199727|Vasodilator Agents|vasodilator agents|mesh-ancestor
24993228|NCT05199727|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24993229|NCT05199727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24535950|NCT00650039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535951|NCT00650039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24535952|NCT00650039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24535954|NCT00650052|Anticonvulsants|anticonvulsants|mesh-ancestor
24535955|NCT00650052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24535978|NCT00650117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24535979|NCT00650117|Anesthetics, General|anesthetics, general|mesh-ancestor
24535980|NCT00650117|Anesthetics|anesthetics|mesh-ancestor
24857721|NCT02293694|Medroxyprogesterone|medroxyprogesterone|mesh-list
24857722|NCT02293694|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24857723|NCT02293694|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24857724|NCT02293694|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24705800|NCT01486901|Insulin|insulin|mesh-list
25226760|NCT02619019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25226761|NCT02619019|Analgesics|analgesics|mesh-ancestor
24536348|NCT00650897|Serotonin Agents|serotonin agents|mesh-ancestor
25226768|NCT02619032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25226769|NCT02619032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226770|NCT02619032|Analgesics|analgesics|mesh-ancestor
24993230|NCT05199727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25226777|NCT02618876|Nalbuphine|nalbuphine|mesh-list
25226778|NCT02618876|Bupivacaine|bupivacaine|mesh-list
24841213|NCT02214966|Ramipril|ramipril|mesh-list
24841214|NCT02214966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24841215|NCT02214966|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24841216|NCT02214966|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24841251|NCT02215044|Antimetabolites|antimetabolites|mesh-ancestor
25043559|NCT01241214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043560|NCT01240759|Metformin|metformin|mesh-list
25043561|NCT01240759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25043562|NCT01240759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043563|NCT01240512|Vitamin D|vitamin d|mesh-list
25043564|NCT01240512|Cholecalciferol|cholecalciferol|mesh-list
25043565|NCT01240512|Vitamins|vitamins|mesh-ancestor
25043566|NCT01240512|Micronutrients|micronutrients|mesh-ancestor
25043567|NCT01240512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043568|NCT01240512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25043569|NCT01240512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24536034|NCT00650208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24536035|NCT00650208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536036|NCT00650208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24536037|NCT00650208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24536038|NCT00650208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25681430|NCT01863680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25681431|NCT01863680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681432|NCT01863680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25681433|NCT01863771|Golimumab|golimumab|mesh-list
25681434|NCT01863771|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25681435|NCT01863771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25681436|NCT01863771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25226779|NCT02618876|Anesthetics, Local|anesthetics, local|mesh-ancestor
25226780|NCT02618876|Anesthetics|anesthetics|mesh-ancestor
25226781|NCT02618876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25226782|NCT02618876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226783|NCT02618876|Sensory System Agents|sensory system agents|mesh-ancestor
25226784|NCT02618876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25226785|NCT02618876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25226786|NCT02618876|Narcotics|narcotics|mesh-ancestor
25226787|NCT02618876|Analgesics|analgesics|mesh-ancestor
25226788|NCT02618824|Tryptophan|tryptophan|mesh-list
25226789|NCT02618824|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25226790|NCT02618824|Antidepressive Agents|antidepressive agents|mesh-ancestor
25226791|NCT02618824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25226792|NCT02618668|Ketamine|ketamine|mesh-list
25226793|NCT02618668|Propofol|propofol|mesh-list
25226794|NCT02618668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25226795|NCT02618668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25226796|NCT02618668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226797|NCT02618668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25226798|NCT02618668|Anesthetics, General|anesthetics, general|mesh-ancestor
25226799|NCT02618668|Anesthetics|anesthetics|mesh-ancestor
25226800|NCT02618668|Analgesics|analgesics|mesh-ancestor
25226801|NCT02618668|Sensory System Agents|sensory system agents|mesh-ancestor
25226802|NCT02618668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25043571|NCT01236638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25043572|NCT01236638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043573|NCT01236638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043574|NCT01235754|Methyltestosterone|methyltestosterone|mesh-list
25043575|NCT01235754|Testosterone|testosterone|mesh-list
25043576|NCT01235754|Testosterone undecanoate|testosterone undecanoate|mesh-list
25043577|NCT01235754|Testosterone enanthate|testosterone enanthate|mesh-list
25043578|NCT01235754|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25043579|NCT01235754|Androgens|androgens|mesh-ancestor
25043581|NCT01235754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25043582|NCT01235754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057969|NCT03500432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24536044|NCT00650221|Antimetabolites|antimetabolites|mesh-ancestor
24536045|NCT00650221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536046|NCT00650221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24536047|NCT00650221|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24536048|NCT00650221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25681437|NCT01863771|Immunologic Factors|immunologic factors|mesh-ancestor
25681438|NCT01863771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505083|NCT00539669|Tubulin Modulators|tubulin modulators|mesh-ancestor
25032229|NCT03583021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032230|NCT03583021|Cholinergic Agents|cholinergic agents|mesh-ancestor
25032231|NCT03583021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25032232|NCT03583021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032233|NCT03583021|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25032234|NCT03583021|Autonomic Agents|autonomic agents|mesh-ancestor
25032235|NCT03583021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25226803|NCT02618668|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25226804|NCT02618668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25226805|NCT02618668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25226806|NCT02618668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25226807|NCT02618668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226808|NCT02618395|Hydrocodone|hydrocodone|mesh-list
25226809|NCT02618395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25226810|NCT02618395|Narcotics|narcotics|mesh-ancestor
25226811|NCT02618395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25226812|NCT02618395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226813|NCT02618395|Analgesics|analgesics|mesh-ancestor
25226814|NCT02618395|Sensory System Agents|sensory system agents|mesh-ancestor
25226815|NCT02618395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25226816|NCT02618395|Antitussive Agents|antitussive agents|mesh-ancestor
24841253|NCT02215044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841254|NCT02215044|Antiviral Agents|antiviral agents|mesh-ancestor
24841255|NCT02215044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24841256|NCT02215044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841257|NCT02215044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24841258|NCT02215044|Immunologic Factors|immunologic factors|mesh-ancestor
24841259|NCT02215044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841260|NCT02215057|Lidocaine|lidocaine|mesh-list
24841261|NCT02215057|Anesthetics|anesthetics|mesh-list
24841280|NCT02215148|Natriuretic Agents|natriuretic agents|mesh-ancestor
24841281|NCT02215148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841282|NCT02215174|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24841283|NCT02215174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24841284|NCT02215174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24841285|NCT02215174|Antimetabolites|antimetabolites|mesh-ancestor
24841287|NCT02215174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24841288|NCT02215174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24536085|NCT00650325|Antidepressive Agents|antidepressive agents|mesh-ancestor
24536086|NCT00650325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24536087|NCT00650325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24536088|NCT00650325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24857737|NCT02293785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24451173|NCT00322569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24451174|NCT00322569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451175|NCT00322569|Tubulin Modulators|tubulin modulators|mesh-ancestor
24451176|NCT00322569|Antimitotic Agents|antimitotic agents|mesh-ancestor
24536130|NCT00650390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24536131|NCT00650403|Paroxetine|paroxetine|mesh-list
24536132|NCT00650403|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24536133|NCT00650403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24536134|NCT00650403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24451177|NCT00322569|Mitosis Modulators|mitosis modulators|mesh-ancestor
24451178|NCT00322569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451179|NCT00322569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24451180|NCT00322569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25681439|NCT01863953|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25681440|NCT01863953|Bimatoprost|bimatoprost|mesh-list
25681441|NCT01863953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25681442|NCT01863953|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25681443|NCT01863953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25681444|NCT01863953|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25681445|NCT01863953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25681446|NCT01863953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25681447|NCT01863953|Adrenergic Agents|adrenergic agents|mesh-ancestor
24926800|NCT04138472|Lidocaine|lidocaine|mesh-list
24588220|NCT00901550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25032266|NCT03582332|Indomethacin|indomethacin|mesh-list
25032267|NCT03582332|Etoricoxib|etoricoxib|mesh-list
25032268|NCT03582332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25032269|NCT03582332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25032270|NCT03582332|Analgesics|analgesics|mesh-ancestor
25032271|NCT03582332|Sensory System Agents|sensory system agents|mesh-ancestor
24451181|NCT00322569|Analgesics|analgesics|mesh-ancestor
24451182|NCT00322569|Sensory System Agents|sensory system agents|mesh-ancestor
24451183|NCT00322569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24451184|NCT00322569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226817|NCT02618395|Respiratory System Agents|respiratory system agents|mesh-ancestor
25226818|NCT02618564|Sennosides|sennosides|mesh-list
25226819|NCT02618564|Laxatives|laxatives|mesh-ancestor
25226820|NCT02618564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25226821|NCT02618603|Triamcinolone|triamcinolone|mesh-list
25226822|NCT02618603|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25226823|NCT02618603|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25226824|NCT02618603|Botulinum Toxins|botulinum toxins|mesh-list
25226825|NCT02618603|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25226826|NCT02618603|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25226827|NCT02618603|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25226828|NCT02618603|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25226829|NCT02618603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25226830|NCT02618603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226831|NCT02618603|Cholinergic Agents|cholinergic agents|mesh-ancestor
25226832|NCT02618603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25226833|NCT02618603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226834|NCT02618603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25226835|NCT02618603|Glucocorticoids|glucocorticoids|mesh-ancestor
25226836|NCT02618603|Hormones|hormones|mesh-ancestor
24841291|NCT02215213|Ergocalciferols|ergocalciferols|mesh-list
24841292|NCT02215213|Cholecalciferol|cholecalciferol|mesh-list
24841293|NCT02215213|Vitamins|vitamins|mesh-list
24841294|NCT02215213|Micronutrients|micronutrients|mesh-ancestor
24841298|NCT02215330|Eplerenone|eplerenone|mesh-list
24841323|NCT02215382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841324|NCT02215382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24841325|NCT02215382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841326|NCT02215382|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24536258|NCT00650598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24536259|NCT00650598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24536260|NCT00650598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24536261|NCT00650598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536262|NCT00650598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536263|NCT00650598|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24536264|NCT00650611|Ziprasidone|ziprasidone|mesh-list
24857738|NCT02293785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857739|NCT02293785|Analgesics|analgesics|mesh-ancestor
24857740|NCT02293785|Sensory System Agents|sensory system agents|mesh-ancestor
24460238|NCT00347815|Sensory System Agents|sensory system agents|mesh-ancestor
24536265|NCT00650611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24536266|NCT00650611|Serotonin Agents|serotonin agents|mesh-ancestor
24536267|NCT00650611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25681448|NCT01863953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25681449|NCT01863953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681450|NCT01863953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681451|NCT01864005|Clopidogrel|clopidogrel|mesh-list
25681452|NCT01864005|Ticagrelor|ticagrelor|mesh-list
25681453|NCT01864005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25681454|NCT01864005|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25113633|NCT02428192|Ipilimumab|ipilimumab|mesh-list
24536336|NCT00650871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25226837|NCT02618603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25226838|NCT02618603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25226839|NCT02618603|Immunologic Factors|immunologic factors|mesh-ancestor
25226840|NCT02618603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25226841|NCT02618603|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25226842|NCT02618603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25226843|NCT02618356|Raltitrexed|raltitrexed|mesh-list
25226844|NCT02618356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25226845|NCT02618356|Antimetabolites|antimetabolites|mesh-ancestor
25273338|NCT02386059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24841327|NCT02215395|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24841328|NCT02215395|Contraceptive Agents|contraceptive agents|mesh-list
24841330|NCT02215395|Estrogens|estrogens|mesh-ancestor
24841332|NCT02215395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24841333|NCT02215395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841334|NCT02215395|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24841335|NCT02215395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24841336|NCT02215395|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24841337|NCT02215395|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24841338|NCT02215395|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24841339|NCT02215434|Methyltestosterone|methyltestosterone|mesh-list
24841340|NCT02215434|Testosterone|testosterone|mesh-list
24536337|NCT00650871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536338|NCT00650871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24536339|NCT00650871|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24536340|NCT00650871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24536341|NCT00650871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536343|NCT00650897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24536344|NCT00650897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24536345|NCT00650897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24536346|NCT00650897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536347|NCT00650897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24857741|NCT02293785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857742|NCT02293785|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25681455|NCT01864005|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25032427|NCT03580889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989216|NCT04249167|Immunologic Factors|immunologic factors|mesh-ancestor
24989217|NCT04249167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989218|NCT04245423|Analgesics, Opioid|analgesics, opioid|mesh-list
24989220|NCT04245423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25032428|NCT03580876|Azathioprine|azathioprine|mesh-list
25032473|NCT03580590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25032474|NCT03580590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032475|NCT03580590|Vasodilator Agents|vasodilator agents|mesh-ancestor
25032476|NCT03580499|Vitamins|vitamins|mesh-list
25032477|NCT03580499|Vitamin B 6|vitamin b 6|mesh-list
25032478|NCT03580499|Pyridoxal|pyridoxal|mesh-list
24536368|NCT00650923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536369|NCT00650923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24536370|NCT00650923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24536371|NCT00650923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24536372|NCT00650923|Growth Substances|growth substances|mesh-ancestor
24536373|NCT00650923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706116|NCT01488656|Vitamin D|vitamin d|mesh-list
25226846|NCT02618356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226847|NCT02618356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25226848|NCT02618356|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25226849|NCT02618356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25226850|NCT02618499|Oxytocin|oxytocin|mesh-list
25226851|NCT02618499|Oxytocics|oxytocics|mesh-ancestor
25226852|NCT02618499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25226853|NCT02618499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226854|NCT02618317|Minocycline|minocycline|mesh-list
25226855|NCT02618317|Heparin|heparin|mesh-list
25226856|NCT02618317|Anticoagulants|anticoagulants|mesh-ancestor
25226857|NCT02618317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226858|NCT02618317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24841347|NCT02215434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841348|NCT02215434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24841371|NCT02215473|Disinfectants|disinfectants|mesh-ancestor
24841372|NCT02215473|Dermatologic Agents|dermatologic agents|mesh-ancestor
24841373|NCT02215499|Sodium Oxybate|sodium oxybate|mesh-list
24841374|NCT02215499|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24841375|NCT02215499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24841376|NCT02215499|Anesthetics, General|anesthetics, general|mesh-ancestor
24841377|NCT02215499|Anesthetics|anesthetics|mesh-ancestor
24444725|NCT00299013|Methylprednisolone|methylprednisolone|mesh-list
24536407|NCT00651209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536408|NCT00651209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536409|NCT00651209|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25681456|NCT01864005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25681457|NCT01864005|Purinergic Agents|purinergic agents|mesh-ancestor
25681458|NCT01864005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25681459|NCT01864005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681460|NCT01864005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681461|NCT01864148|Interferons|interferons|mesh-list
25681462|NCT01864148|Interferon-beta|interferon-beta|mesh-list
25681463|NCT01864148|Interferon beta-1a|interferon beta-1a|mesh-list
25681464|NCT01864148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25681465|NCT01864148|Antiviral Agents|antiviral agents|mesh-ancestor
25681466|NCT01864148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25681467|NCT01864148|Immunologic Factors|immunologic factors|mesh-ancestor
25681468|NCT01864148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032553|NCT03579927|Antibodies|antibodies|mesh-list
24536410|NCT00651209|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24536412|NCT00651235|Propranolol|propranolol|mesh-list
24857743|NCT02293824|Caffeine|caffeine|mesh-list
24857744|NCT02293824|Caffeine citrate|caffeine citrate|mesh-list
24813095|NCT02056405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24813096|NCT02056405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554698|NCT00737724|Antiviral Agents|antiviral agents|mesh-ancestor
25226859|NCT02618317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25226860|NCT02618317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24797770|NCT01957852|Thrombin|thrombin|mesh-list
25226861|NCT02618317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25226862|NCT02618096|Oxytocin|oxytocin|mesh-list
25226863|NCT02618096|Dinoprostone|dinoprostone|mesh-list
25226864|NCT02618096|Oxytocics|oxytocics|mesh-ancestor
25226865|NCT02618096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25226866|NCT02618096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226867|NCT02618733|Clopidogrel|clopidogrel|mesh-list
25226868|NCT02618733|Ticagrelor|ticagrelor|mesh-list
25226869|NCT02618733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25226870|NCT02618733|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25226871|NCT02618733|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25226872|NCT02618733|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25226873|NCT02618733|Purinergic Agents|purinergic agents|mesh-ancestor
25226874|NCT02618733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24841379|NCT02215499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601003|NCT00961857|Metformin|metformin|mesh-list
24841381|NCT02215538|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24841382|NCT02215538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841383|NCT02215538|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24841426|NCT02215863|Immunologic Factors|immunologic factors|mesh-ancestor
24841427|NCT02215863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841428|NCT02215876|Cyclophosphamide|cyclophosphamide|mesh-list
24536434|NCT00651287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536435|NCT00651287|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24536436|NCT00651287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24536437|NCT00651287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536438|NCT00651287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24536441|NCT00651300|Parecoxib|parecoxib|mesh-list
24536454|NCT00651300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24536455|NCT00651326|Docetaxel|docetaxel|mesh-list
24536456|NCT00651326|Leuprolide|leuprolide|mesh-list
24536457|NCT00651326|Goserelin|goserelin|mesh-list
24536458|NCT00651326|Bicalutamide|bicalutamide|mesh-list
24536459|NCT00651326|Flutamide|flutamide|mesh-list
24536460|NCT00651326|Buserelin|buserelin|mesh-list
24536461|NCT00651326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24536462|NCT00651326|Tubulin Modulators|tubulin modulators|mesh-ancestor
24536463|NCT00651326|Antimitotic Agents|antimitotic agents|mesh-ancestor
24536464|NCT00651326|Mitosis Modulators|mitosis modulators|mesh-ancestor
24536465|NCT00651326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536466|NCT00651326|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24536467|NCT00651326|Fertility Agents|fertility agents|mesh-ancestor
24536468|NCT00651326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24536469|NCT00651326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706174|NCT01489072|Remifentanil|remifentanil|mesh-list
24536470|NCT00651326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24536471|NCT00651326|Androgen Antagonists|androgen antagonists|mesh-ancestor
24536472|NCT00651326|Hormone Antagonists|hormone antagonists|mesh-ancestor
24444782|NCT00299065|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24536478|NCT00651352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681469|NCT01864148|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25032652|NCT03579771|Antimetabolites|antimetabolites|mesh-ancestor
25032653|NCT03579771|Antiviral Agents|antiviral agents|mesh-ancestor
25032654|NCT03579771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24536479|NCT00651352|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25226875|NCT02618733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226876|NCT02618733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226877|NCT02618057|Levofloxacin|levofloxacin|mesh-list
25226878|NCT02618057|Ofloxacin|ofloxacin|mesh-list
25226879|NCT02618057|Prednisolone|prednisolone|mesh-list
25226880|NCT02618057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25226881|NCT02618057|Glucocorticoids|glucocorticoids|mesh-ancestor
25226882|NCT02618057|Hormones|hormones|mesh-ancestor
25226883|NCT02618057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25226884|NCT02618057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841434|NCT02215876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24841435|NCT02215876|Alkylating Agents|alkylating agents|mesh-ancestor
24841436|NCT02215876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841437|NCT02215876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841438|NCT02215876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24841439|NCT02215876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24841440|NCT02215876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24841441|NCT02215876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24536481|NCT00651352|Cholinergic Agents|cholinergic agents|mesh-ancestor
24536482|NCT00651352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24857745|NCT02293824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857746|NCT02293824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24536483|NCT00651352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536484|NCT00651443|Galiximab|galiximab|mesh-list
24536485|NCT00651443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24536486|NCT00651443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24536487|NCT00651456|Bevacizumab|bevacizumab|mesh-list
24536488|NCT00651456|Cisplatin|cisplatin|mesh-list
24536489|NCT00651456|Pemetrexed|pemetrexed|mesh-list
24554843|NCT00738556|Sirolimus|sirolimus|mesh-list
24536497|NCT00651456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536498|NCT00651456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536499|NCT00651456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24536500|NCT00651456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24536501|NCT00651547|Budesonide|budesonide|mesh-list
24536502|NCT00651547|Formoterol Fumarate|formoterol fumarate|mesh-list
24536503|NCT00651547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24536504|NCT00651547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24536505|NCT00651547|Autonomic Agents|autonomic agents|mesh-ancestor
24536507|NCT00651547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536508|NCT00651547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25226885|NCT02618057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25226886|NCT02618057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25226887|NCT02618057|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25226888|NCT02618057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25226890|NCT02618057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25226891|NCT02618057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25226892|NCT02618057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25226893|NCT02618057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25226894|NCT02618057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226895|NCT02618057|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25226896|NCT02618057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24841442|NCT02215876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841457|NCT02216045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841475|NCT02216149|Antimetabolites|antimetabolites|mesh-ancestor
24841476|NCT02216149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681470|NCT01864174|Metformin|metformin|mesh-list
25681471|NCT01864174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25681472|NCT01864174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841477|NCT02216149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841479|NCT02216227|Chlorhexidine|chlorhexidine|mesh-list
24841480|NCT02216227|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24841481|NCT02216227|Povidone-Iodine|povidone-iodine|mesh-list
24841482|NCT02216227|Vancomycin|vancomycin|mesh-list
24841483|NCT02216227|Cefazolin|cefazolin|mesh-list
24841484|NCT02216227|Mupirocin|mupirocin|mesh-list
24841485|NCT02216227|Povidone|povidone|mesh-list
24841486|NCT02216227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24841487|NCT02216227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24536545|NCT00651612|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24536546|NCT00651612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24857747|NCT02293824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431152|NCT00250575|Serotonin Agents|serotonin agents|mesh-ancestor
24536571|NCT00651651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24536572|NCT00651651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24536600|NCT00651729|Cholinergic Agents|cholinergic agents|mesh-ancestor
24536601|NCT00651729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24536602|NCT00651729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536604|NCT00651729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24536605|NCT00651768|Budesonide|budesonide|mesh-list
24536606|NCT00651768|Formoterol Fumarate|formoterol fumarate|mesh-list
24536623|NCT00651768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536625|NCT00651781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706284|NCT01489631|Gabapentin|gabapentin|mesh-list
24554961|NCT00738842|Ticagrelor|ticagrelor|mesh-list
25226898|NCT02617862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25226899|NCT02617862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226900|NCT02617849|Paclitaxel|paclitaxel|mesh-list
25226901|NCT02617849|Carboplatin|carboplatin|mesh-list
25226902|NCT02617849|Pembrolizumab|pembrolizumab|mesh-list
25226903|NCT02617849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25226904|NCT02617849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25226908|NCT02617849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226909|NCT02617849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25226910|NCT02617680|Nitric Oxide|nitric oxide|mesh-list
24536672|NCT00652002|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24536674|NCT00652002|Adrenergic Agents|adrenergic agents|mesh-ancestor
24536675|NCT00652002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24706341|NCT01489709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24462238|NCT00355589|Natriuretic Agents|natriuretic agents|mesh-ancestor
24706367|NCT01489865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25226911|NCT02617680|Desflurane|desflurane|mesh-list
25226912|NCT02617680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25226913|NCT02617680|Autonomic Agents|autonomic agents|mesh-ancestor
25226914|NCT02617680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24841493|NCT02216227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452557|NCT05458180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24452558|NCT05458180|Tubulin Modulators|tubulin modulators|mesh-ancestor
24841494|NCT02216227|Plasma Substitutes|plasma substitutes|mesh-ancestor
24841495|NCT02216227|Blood Substitutes|blood substitutes|mesh-ancestor
24841496|NCT02216227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24841497|NCT02216227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841498|NCT02216227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841499|NCT02216266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24841500|NCT02216266|Physostigmine|physostigmine|mesh-list
24841501|NCT02216266|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24841502|NCT02216266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841503|NCT02216266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841504|NCT02216266|Cholinergic Agents|cholinergic agents|mesh-ancestor
24841505|NCT02216266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24841506|NCT02216266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841507|NCT02216266|Miotics|miotics|mesh-ancestor
24841508|NCT02216266|Autonomic Agents|autonomic agents|mesh-ancestor
24841509|NCT02216266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24841510|NCT02216331|Rifampin|rifampin|mesh-list
24841511|NCT02216331|Rifapentine|rifapentine|mesh-list
24841512|NCT02216331|Bedaquiline|bedaquiline|mesh-list
25058058|NCT03499743|Mydriatics|mydriatics|mesh-ancestor
24536727|NCT00652132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24536728|NCT00652132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25681473|NCT01865084|Tadalafil|tadalafil|mesh-list
24536867|NCT00652730|Serotonin Agents|serotonin agents|mesh-ancestor
24536868|NCT00652730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24536869|NCT00652730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226915|NCT02617680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226916|NCT02617680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25226917|NCT02617680|Respiratory System Agents|respiratory system agents|mesh-ancestor
25226918|NCT02617680|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25226919|NCT02617680|Antioxidants|antioxidants|mesh-ancestor
25226920|NCT02617680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226921|NCT02617680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25226922|NCT02617680|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25226923|NCT02617680|Vasodilator Agents|vasodilator agents|mesh-ancestor
25226924|NCT02617680|Gasotransmitters|gasotransmitters|mesh-ancestor
25226925|NCT02617680|Protective Agents|protective agents|mesh-ancestor
25226926|NCT02617680|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25226927|NCT02617680|Anesthetics, General|anesthetics, general|mesh-ancestor
25226928|NCT02617680|Anesthetics|anesthetics|mesh-ancestor
25226929|NCT02617680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25226930|NCT02617810|Midazolam|midazolam|mesh-list
25226931|NCT02617810|Warfarin|warfarin|mesh-list
25226932|NCT02617810|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25226933|NCT02617810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25226934|NCT02617810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25226935|NCT02617810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226936|NCT02617810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25226937|NCT02617810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25226938|NCT02617810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24841513|NCT02216331|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24841514|NCT02216331|Antitubercular Agents|antitubercular agents|mesh-ancestor
24841515|NCT02216331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24841539|NCT02216487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24841540|NCT02216487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841541|NCT02216487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841542|NCT02216487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841543|NCT02216513|Deferoxamine|deferoxamine|mesh-list
24841544|NCT02216513|Siderophores|siderophores|mesh-ancestor
24841545|NCT02216513|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24841546|NCT02216513|Chelating Agents|chelating agents|mesh-ancestor
24841547|NCT02216513|Sequestering Agents|sequestering agents|mesh-ancestor
24841548|NCT02216513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841549|NCT02216552|Resveratrol|resveratrol|mesh-list
24841550|NCT02216552|Antioxidants|antioxidants|mesh-ancestor
24841551|NCT02216552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058079|NCT03499639|Ritonavir|ritonavir|mesh-list
24536870|NCT00652782|Rolofylline|rolofylline|mesh-list
24536871|NCT00652782|Diuretics|diuretics|mesh-ancestor
24536872|NCT00652782|Natriuretic Agents|natriuretic agents|mesh-ancestor
24706438|NCT01490047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24536873|NCT00652782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857750|NCT02293824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24857751|NCT02293824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24857752|NCT02293824|Purinergic Agents|purinergic agents|mesh-ancestor
24857753|NCT02293824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24857754|NCT02293876|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24857755|NCT02293876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24993618|NCT05415917|Gemcitabine|gemcitabine|mesh-list
24628890|NCT01101789|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24536904|NCT00652860|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24536905|NCT00652860|Ifosfamide|ifosfamide|mesh-list
24536906|NCT00652860|Molgramostim|molgramostim|mesh-list
24536907|NCT00652860|Mitomycins|mitomycins|mesh-list
25226939|NCT02617810|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25226940|NCT02617810|Anesthetics, General|anesthetics, general|mesh-ancestor
25226941|NCT02617810|Anesthetics|anesthetics|mesh-ancestor
25226942|NCT02617810|GABA Modulators|gaba modulators|mesh-ancestor
25226943|NCT02617810|GABA Agents|gaba agents|mesh-ancestor
25226944|NCT02617810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25226945|NCT02617810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226946|NCT02617810|Anticoagulants|anticoagulants|mesh-ancestor
25273339|NCT02386059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25273340|NCT02386059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25273341|NCT02386059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25273342|NCT02386059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25273343|NCT02386059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25273344|NCT02386072|Mirabegron|mirabegron|mesh-list
25273345|NCT02386072|Oxybutynin|oxybutynin|mesh-list
25273346|NCT02386072|Muscarinic Antagonists|muscarinic antagonists|mesh-list
25273347|NCT02386072|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25273348|NCT02386072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24841553|NCT02216552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841554|NCT02216552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841555|NCT02216552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24841556|NCT02216565|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24841557|NCT02216565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24841558|NCT02216565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24536908|NCT00652860|Mitomycin|mitomycin|mesh-list
24536909|NCT00652860|Sargramostim|sargramostim|mesh-list
24536910|NCT00652860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24536911|NCT00652860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24857774|NCT02294006|Everolimus|everolimus|mesh-list
25681474|NCT01865084|Vasodilator Agents|vasodilator agents|mesh-ancestor
25032840|NCT03577899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25032841|NCT03577899|Growth Substances|growth substances|mesh-ancestor
25032842|NCT03577899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032843|NCT03577899|Growth Inhibitors|growth inhibitors|mesh-ancestor
25032844|NCT03577899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24536969|NCT00653016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536970|NCT00653016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24536971|NCT00653016|Contraceptive Agents|contraceptive agents|mesh-ancestor
24536972|NCT00653016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24536973|NCT00653016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24444878|NCT00299559|Camphor|camphor|mesh-list
25226947|NCT02617771|Vitamin D|vitamin d|mesh-list
25226948|NCT02617771|Cholecalciferol|cholecalciferol|mesh-list
25226949|NCT02617771|Vitamins|vitamins|mesh-ancestor
25226950|NCT02617771|Micronutrients|micronutrients|mesh-ancestor
25226951|NCT02617771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226952|NCT02617771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25226953|NCT02617771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25226954|NCT02617459|Betaxolol|betaxolol|mesh-list
24841559|NCT02216565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841561|NCT02216617|Afatinib|afatinib|mesh-list
24841562|NCT02216617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841563|NCT02216617|Tubulin Modulators|tubulin modulators|mesh-ancestor
24841564|NCT02216617|Antimitotic Agents|antimitotic agents|mesh-ancestor
24841565|NCT02216617|Mitosis Modulators|mitosis modulators|mesh-ancestor
24753945|NCT01718379|Lenalidomide|lenalidomide|mesh-list
24452559|NCT05458180|Antimitotic Agents|antimitotic agents|mesh-ancestor
24452560|NCT05458180|Mitosis Modulators|mitosis modulators|mesh-ancestor
24857775|NCT02294006|Octreotide|octreotide|mesh-list
24857763|NCT02293889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24460261|NCT00347854|Laxatives|laxatives|mesh-ancestor
25681475|NCT01865084|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25681476|NCT01865084|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25681477|NCT01865084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25681478|NCT01865084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681479|NCT01865084|Urological Agents|urological agents|mesh-ancestor
25681480|NCT01865552|Etanercept|etanercept|mesh-list
24629601|NCT01106547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629647|NCT01106872|Antimanic Agents|antimanic agents|mesh-ancestor
24629648|NCT01106872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24629649|NCT01106872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24629650|NCT01106872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24629652|NCT01107054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24629653|NCT01107054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25113744|NCT02278315|Dexamethasone|dexamethasone|mesh-list
25113745|NCT02278315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25113746|NCT02278315|Antiemetics|antiemetics|mesh-ancestor
25113747|NCT02278315|Autonomic Agents|autonomic agents|mesh-ancestor
24989589|NCT05007522|Tocolytic Agents|tocolytic agents|mesh-ancestor
25032865|NCT03577652|Ticagrelor|ticagrelor|mesh-list
25032866|NCT03577652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25226955|NCT02617459|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25226956|NCT02617459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25226957|NCT02617459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25226958|NCT02617459|Sympatholytics|sympatholytics|mesh-ancestor
25226959|NCT02617459|Autonomic Agents|autonomic agents|mesh-ancestor
25226960|NCT02617459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25226961|NCT02617459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226962|NCT02617459|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25226963|NCT02617459|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24841583|NCT02216747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841584|NCT02216747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24841585|NCT02216747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841586|NCT02216786|Everolimus|everolimus|mesh-list
24841587|NCT02216786|Fulvestrant|fulvestrant|mesh-list
24841588|NCT02216786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841589|NCT02216786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24841590|NCT02216786|Immunologic Factors|immunologic factors|mesh-ancestor
24941775|NCT03988075|Ibuprofen|ibuprofen|mesh-list
24857773|NCT02294006|Metformin|metformin|mesh-list
24857776|NCT02294006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25681481|NCT01865552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25681482|NCT01865552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25681483|NCT01865552|Analgesics|analgesics|mesh-ancestor
25681484|NCT01865552|Sensory System Agents|sensory system agents|mesh-ancestor
25681485|NCT01865552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25681486|NCT01865552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681487|NCT01865552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25681488|NCT01865552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25681489|NCT01865552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25681490|NCT01865552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25681491|NCT01865552|Immunologic Factors|immunologic factors|mesh-ancestor
25681492|NCT01865708|Ethanol|ethanol|mesh-list
25681493|NCT01865708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25681494|NCT01865708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25226966|NCT02617459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25226967|NCT02617459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226968|NCT02617758|Fentanyl|fentanyl|mesh-list
25226969|NCT02617758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25226970|NCT02617758|Narcotics|narcotics|mesh-ancestor
25226971|NCT02617758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25226972|NCT02617758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226973|NCT02617758|Analgesics|analgesics|mesh-ancestor
24841591|NCT02216786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841592|NCT02216786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24841593|NCT02216786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24841594|NCT02216786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24841595|NCT02216786|Hormone Antagonists|hormone antagonists|mesh-ancestor
24841596|NCT02216786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24841597|NCT02216799|Insulin|insulin|mesh-list
24613707|NCT01020357|Purinergic Agents|purinergic agents|mesh-ancestor
24613708|NCT01020357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24613710|NCT01020383|Anticoagulants|anticoagulants|mesh-ancestor
24613712|NCT01020396|Metronidazole|metronidazole|mesh-list
24857777|NCT02294006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419943|NCT00214630|Atorvastatin|atorvastatin|mesh-list
24537101|NCT00653458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537102|NCT00653458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24537103|NCT00653458|Antipruritics|antipruritics|mesh-ancestor
24537104|NCT00653458|Dermatologic Agents|dermatologic agents|mesh-ancestor
24537105|NCT00653458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24537106|NCT00653458|Serotonin Agents|serotonin agents|mesh-ancestor
24537107|NCT00653458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24394242|NCT00132652|Telbivudine|telbivudine|mesh-list
24445334|NCT00301236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24630323|NCT01110824|Vasodilator Agents|vasodilator agents|mesh-ancestor
24630324|NCT01110824|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24630325|NCT01110824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25032928|NCT03576963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24613742|NCT01020630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613743|NCT01020643|Propofol|propofol|mesh-list
24613744|NCT01020643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25226987|NCT02617485|Cyclophosphamide|cyclophosphamide|mesh-list
25226974|NCT02617758|Sensory System Agents|sensory system agents|mesh-ancestor
25226975|NCT02617758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25226976|NCT02617758|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25226977|NCT02617758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25226978|NCT02617758|Anesthetics, General|anesthetics, general|mesh-ancestor
25226979|NCT02617758|Anesthetics|anesthetics|mesh-ancestor
25226980|NCT02617654|Liraglutide|liraglutide|mesh-list
25226981|NCT02617654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25226982|NCT02617654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226983|NCT02617654|Incretins|incretins|mesh-ancestor
25043583|NCT01235754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25043585|NCT01235754|Anabolic Agents|anabolic agents|mesh-ancestor
25043587|NCT01235039|Insulin Lispro|insulin lispro|mesh-list
25043588|NCT01235039|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25043589|NCT01235039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25043590|NCT01235039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043591|NCT01234779|Olanzapine|olanzapine|mesh-list
25043592|NCT01234779|Antiemetics|antiemetics|mesh-ancestor
25043593|NCT01234779|Autonomic Agents|autonomic agents|mesh-ancestor
25043594|NCT01234779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25043595|NCT01234779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043607|NCT01234519|Doxorubicin|doxorubicin|mesh-list
24841598|NCT02216799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24841599|NCT02216799|Insulin Glargine|insulin glargine|mesh-list
24841611|NCT02217007|Calcium, Dietary|calcium, dietary|mesh-list
24841612|NCT02217007|Acamprosate|acamprosate|mesh-list
24841614|NCT02217007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24841615|NCT02217007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681495|NCT01865708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25681496|NCT01865708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681497|NCT01865747|Everolimus|everolimus|mesh-list
25681498|NCT01865747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25681499|NCT01865747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25681500|NCT01865747|Immunologic Factors|immunologic factors|mesh-ancestor
25681501|NCT01865747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681502|NCT01866098|Naltrexone|naltrexone|mesh-list
25681503|NCT01866098|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24537261|NCT00654108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537262|NCT00654108|Vitamins|vitamins|mesh-ancestor
24537263|NCT00654108|Micronutrients|micronutrients|mesh-ancestor
24537267|NCT00654121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537268|NCT00654160|Leucovorin|leucovorin|mesh-list
24537269|NCT00654160|Fluorouracil|fluorouracil|mesh-list
24537270|NCT00654160|Irinotecan|irinotecan|mesh-list
25226984|NCT02617654|Hormones|hormones|mesh-ancestor
25226985|NCT02617654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25226986|NCT02617485|Prednisone|prednisone|mesh-list
25226991|NCT02617485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25226993|NCT02617485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25226994|NCT02617485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25226995|NCT02617485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25226996|NCT02617485|Alkylating Agents|alkylating agents|mesh-ancestor
25226997|NCT02617485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25226998|NCT02617485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25226999|NCT02617485|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25227000|NCT02617485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25227001|NCT02617485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25227002|NCT02617485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25227003|NCT02617485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25227004|NCT02617485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227005|NCT02617485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25227006|NCT02617485|Glucocorticoids|glucocorticoids|mesh-ancestor
25227007|NCT02617485|Hormones|hormones|mesh-ancestor
25227008|NCT02617485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24754022|NCT01718808|Capecitabine|capecitabine|mesh-list
24537271|NCT00654160|Calcium|calcium|mesh-list
24537272|NCT00654160|Levoleucovorin|levoleucovorin|mesh-list
24857778|NCT02294006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24857779|NCT02294006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24857780|NCT02294006|Immunologic Factors|immunologic factors|mesh-ancestor
24857781|NCT02294006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24857782|NCT02294006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24537273|NCT00654160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24537274|NCT00654160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537407|NCT00654537|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24537408|NCT00654537|Simvastatin|simvastatin|mesh-list
24537409|NCT00654537|Pravastatin|pravastatin|mesh-list
24537410|NCT00654537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24537411|NCT00654537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24537412|NCT00654537|Antimetabolites|antimetabolites|mesh-ancestor
24537413|NCT00654537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537414|NCT00654537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25681504|NCT01866098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25681505|NCT01866098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681506|NCT01866098|Sensory System Agents|sensory system agents|mesh-ancestor
24989796|NCT04776408|Protective Agents|protective agents|mesh-ancestor
24927544|NCT04132115|Vancomycin|vancomycin|mesh-list
24588236|NCT00901654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588237|NCT00901719|Nitroprusside|nitroprusside|mesh-list
24588238|NCT00901719|Acetylcholine|acetylcholine|mesh-list
24588239|NCT00901719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24588240|NCT00901719|Vasodilator Agents|vasodilator agents|mesh-ancestor
24588241|NCT00901719|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24588242|NCT00901719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588243|NCT00901719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24588244|NCT00901719|Cholinergic Agents|cholinergic agents|mesh-ancestor
24588245|NCT00901719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24588246|NCT00901719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588247|NCT00901732|Calcium|calcium|mesh-list
25033011|NCT03576638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422176|NCT00221520|Midazolam|midazolam|mesh-list
25033012|NCT03576638|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25033013|NCT03576638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991006|NCT03263559|Antisickling Agents|antisickling agents|mesh-ancestor
24630675|NCT01112891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24630677|NCT01113047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24537602|NCT00655408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537603|NCT00655421|Tolonium Chloride|tolonium chloride|mesh-list
24537604|NCT00655421|Hemostatics|hemostatics|mesh-ancestor
24537605|NCT00655421|Coagulants|coagulants|mesh-ancestor
24537606|NCT00655421|Heparin Antagonists|heparin antagonists|mesh-ancestor
24537695|NCT00655837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24537696|NCT00655837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24537698|NCT00655837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537769|NCT00656110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25227009|NCT02617485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25681507|NCT01866098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25692469|NCT01999894|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25692470|NCT01999894|Dopamine Agents|dopamine agents|mesh-ancestor
25692471|NCT01999894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25692472|NCT01999894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692473|NCT01999894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692474|NCT01999894|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25692475|NCT01999894|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25692476|NCT01999920|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
25692477|NCT01999920|Antidepressive Agents|antidepressive agents|mesh-ancestor
25692478|NCT01999920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25692479|NCT01999920|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25692480|NCT01999920|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25692481|NCT01999920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25692482|NCT01999920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692483|NCT01999920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25692484|NCT01999920|Serotonin Agents|serotonin agents|mesh-ancestor
25692485|NCT01999920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692486|NCT01999920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24857787|NCT02294071|Sensory System Agents|sensory system agents|mesh-ancestor
24857788|NCT02294071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857789|NCT02294071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857790|NCT02294071|Antipyretics|antipyretics|mesh-ancestor
24857791|NCT02294071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24857792|NCT02294071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24857793|NCT02294071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24857794|NCT02294071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24857795|NCT02294071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857796|NCT02294071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537780|NCT00656123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24537781|NCT00656123|Alkylating Agents|alkylating agents|mesh-ancestor
24537782|NCT00656123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537822|NCT00656331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537824|NCT00656331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537825|NCT00656331|Vasodilator Agents|vasodilator agents|mesh-ancestor
24537826|NCT00656409|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24537827|NCT00656409|Immunologic Factors|immunologic factors|mesh-ancestor
25227019|NCT02617121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227020|NCT02617121|Anticonvulsants|anticonvulsants|mesh-ancestor
25227021|NCT02617121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25227022|NCT02617121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25227027|NCT02617121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25227028|NCT02617121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227029|NCT02617121|Antimanic Agents|antimanic agents|mesh-ancestor
24537828|NCT00656409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537829|NCT00656422|Insulin|insulin|mesh-list
24537830|NCT00656422|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24537831|NCT00656422|Insulin Detemir|insulin detemir|mesh-list
24537832|NCT00656422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24537833|NCT00656422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537834|NCT00656435|Bevacizumab|bevacizumab|mesh-list
24537961|NCT00656929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24537963|NCT00657007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24537964|NCT00657007|Immunologic Factors|immunologic factors|mesh-ancestor
24537965|NCT00657007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537966|NCT00657033|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24537967|NCT00657033|Vasodilator Agents|vasodilator agents|mesh-ancestor
24537988|NCT00657059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24537990|NCT00657059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227030|NCT02617121|Antiemetics|antiemetics|mesh-ancestor
25227031|NCT02617121|Autonomic Agents|autonomic agents|mesh-ancestor
25227032|NCT02617121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25227033|NCT02617121|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25227034|NCT02617121|Serotonin Agents|serotonin agents|mesh-ancestor
25227035|NCT02617199|Fentanyl|fentanyl|mesh-list
25227036|NCT02617199|Analgesics|analgesics|mesh-list
25227037|NCT02617199|Ropivacaine|ropivacaine|mesh-list
25227038|NCT02617199|Anesthetics|anesthetics|mesh-ancestor
25227039|NCT02617199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25227040|NCT02617199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227041|NCT02617199|Anesthetics, Local|anesthetics, local|mesh-ancestor
24841633|NCT02217163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841635|NCT02217163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24841636|NCT02217163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24841637|NCT02217163|Antiemetics|antiemetics|mesh-ancestor
24841638|NCT02217163|Autonomic Agents|autonomic agents|mesh-ancestor
24841639|NCT02217163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24841640|NCT02217163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24460297|NCT00348023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24538020|NCT00657163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24538021|NCT00657163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538022|NCT00657202|Ranibizumab|ranibizumab|mesh-list
24538044|NCT00657319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24538045|NCT00657319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538046|NCT00657384|Tranexamic Acid|tranexamic acid|mesh-list
24538047|NCT00657384|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24538048|NCT00657384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25227042|NCT02617199|Sensory System Agents|sensory system agents|mesh-ancestor
25227043|NCT02617199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25227044|NCT02617199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25227045|NCT02617199|Narcotics|narcotics|mesh-ancestor
25227046|NCT02617199|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25227047|NCT02617199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25227048|NCT02617199|Anesthetics, General|anesthetics, general|mesh-ancestor
25227049|NCT02617290|Clopidogrel|clopidogrel|mesh-list
25227050|NCT02617290|Ticagrelor|ticagrelor|mesh-list
25227051|NCT02617290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25227052|NCT02617290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25227053|NCT02617290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25227054|NCT02617290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25227055|NCT02617290|Purinergic Agents|purinergic agents|mesh-ancestor
25227063|NCT02617069|Cholinergic Agents|cholinergic agents|mesh-ancestor
25227056|NCT02617290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25227057|NCT02617290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227058|NCT02617290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227059|NCT02617069|Botulinum Toxins|botulinum toxins|mesh-list
25227060|NCT02617069|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25227061|NCT02617069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25273349|NCT02386072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25273350|NCT02386072|Adrenergic Agents|adrenergic agents|mesh-ancestor
24841641|NCT02217163|Glucocorticoids|glucocorticoids|mesh-ancestor
24841642|NCT02217163|Hormones|hormones|mesh-ancestor
24394683|NCT00133887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841643|NCT02217163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24841644|NCT02217163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24841645|NCT02217189|Zinc Sulfate|zinc sulfate|mesh-list
24841646|NCT02217189|Astringents|astringents|mesh-ancestor
24841647|NCT02217189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841648|NCT02217189|Dermatologic Agents|dermatologic agents|mesh-ancestor
24841658|NCT02217267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24841659|NCT02217267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24841660|NCT02217267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24841661|NCT02217267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24841662|NCT02217267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24538049|NCT00657384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538050|NCT00657384|Hemostatics|hemostatics|mesh-ancestor
24538141|NCT00657644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24451257|NCT00322907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24451258|NCT00322907|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24451259|NCT00322907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451260|NCT00322907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24631362|NCT01117129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24631366|NCT01117129|Dermatologic Agents|dermatologic agents|mesh-ancestor
24538277|NCT00658255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24555882|NCT00744081|Analgesics|analgesics|mesh-ancestor
24538322|NCT00658840|Capecitabine|capecitabine|mesh-list
24538323|NCT00658840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24857802|NCT02294084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24857803|NCT02294084|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24857804|NCT02294084|Protease Inhibitors|protease inhibitors|mesh-ancestor
24857805|NCT02294084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538324|NCT00658840|Antimetabolites|antimetabolites|mesh-ancestor
24994207|NCT04771520|Mebendazole|mebendazole|mesh-list
25227062|NCT02617069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227064|NCT02617069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25227065|NCT02617069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227066|NCT02617017|Buspirone|buspirone|mesh-list
25227067|NCT02617017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25227068|NCT02617017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25227069|NCT02617017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25227070|NCT02617017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227071|NCT02617017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25227072|NCT02617017|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25227073|NCT02617017|Serotonin Agents|serotonin agents|mesh-ancestor
25227074|NCT02617017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25227075|NCT02617017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841663|NCT02217267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841665|NCT02217319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24841666|NCT02217319|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24841667|NCT02217319|Anesthetics, General|anesthetics, general|mesh-ancestor
24841668|NCT02217319|Anesthetics|anesthetics|mesh-ancestor
24841669|NCT02217319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24841670|NCT02217319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841671|NCT02217514|Midazolam|midazolam|mesh-list
24841672|NCT02217514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24841673|NCT02217514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24841674|NCT02217514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24841675|NCT02217514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841676|NCT02217514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24841677|NCT02217514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24841709|NCT02217631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24841711|NCT02217631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24841712|NCT02217631|Protective Agents|protective agents|mesh-ancestor
24841713|NCT02217670|Metformin|metformin|mesh-list
24841714|NCT02217670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24841715|NCT02217670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841716|NCT02217683|Nitric Oxide|nitric oxide|mesh-list
25681508|NCT01866319|Pembrolizumab|pembrolizumab|mesh-list
25681509|NCT01866319|Ipilimumab|ipilimumab|mesh-list
25681510|NCT01866319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24538331|NCT00658918|Glucocorticoids|glucocorticoids|mesh-ancestor
24538332|NCT00658918|Hormones|hormones|mesh-ancestor
24538435|NCT00659321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24538436|NCT00659321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538567|NCT00659958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24538568|NCT00659958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555990|NCT00744549|Selenium|selenium|mesh-list
24538639|NCT00660231|Gemcitabine|gemcitabine|mesh-list
24538641|NCT00660231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24538642|NCT00660231|Antimetabolites|antimetabolites|mesh-ancestor
24538643|NCT00660231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538644|NCT00660231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538645|NCT00660231|Antiviral Agents|antiviral agents|mesh-ancestor
25227076|NCT02616913|Moxifloxacin|moxifloxacin|mesh-list
25227077|NCT02616913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25227078|NCT02616913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25227079|NCT02616913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25227080|NCT02616913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25227081|NCT02616913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227082|NCT02616913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227083|NCT02616913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25227084|NCT02616770|Perflubron|perflubron|mesh-list
25227085|NCT02616770|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25227086|NCT02616692|Sorafenib|sorafenib|mesh-list
25227087|NCT02616692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25227088|NCT02616692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25227089|NCT02616692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227090|NCT02616692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227091|NCT02616744|Ibandronic Acid|ibandronic acid|mesh-list
25227092|NCT02616744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25227093|NCT02616744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227094|NCT02616822|Resveratrol|resveratrol|mesh-list
25227095|NCT02616822|Antioxidants|antioxidants|mesh-ancestor
25227096|NCT02616822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227097|NCT02616822|Protective Agents|protective agents|mesh-ancestor
24841717|NCT02217683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24841718|NCT02217683|Autonomic Agents|autonomic agents|mesh-ancestor
24841719|NCT02217683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24841720|NCT02217683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841721|NCT02217683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24841722|NCT02217683|Respiratory System Agents|respiratory system agents|mesh-ancestor
24841724|NCT02217683|Antioxidants|antioxidants|mesh-ancestor
24859036|NCT02301286|Sensory System Agents|sensory system agents|mesh-ancestor
24841758|NCT02217839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841759|NCT02217852|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24841761|NCT02217852|Antihypertensive Agents|antihypertensive agents|mesh-list
24841762|NCT02217852|Nitrendipine|nitrendipine|mesh-list
24841763|NCT02217852|Diuretics|diuretics|mesh-ancestor
24841764|NCT02217852|Natriuretic Agents|natriuretic agents|mesh-ancestor
24841765|NCT02217852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841766|NCT02217852|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24841767|NCT02217852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25058194|NCT03498534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24538677|NCT00660270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24538678|NCT00660270|Immunologic Factors|immunologic factors|mesh-ancestor
24538680|NCT00660283|Temozolomide|temozolomide|mesh-list
24538681|NCT00660283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25033232|NCT03575078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033233|NCT03575078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797296|NCT01955135|Ketamine|ketamine|mesh-list
24632597|NCT01124656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24632598|NCT01124656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632599|NCT01124656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24462837|NCT00357669|Brivaracetam|brivaracetam|mesh-list
24538702|NCT00660426|Antiviral Agents|antiviral agents|mesh-ancestor
24538703|NCT00660426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24538704|NCT00660426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538705|NCT00660426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24538706|NCT00660426|Immunologic Factors|immunologic factors|mesh-ancestor
24538707|NCT00660426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451275|NCT00322985|Immunologic Factors|immunologic factors|mesh-ancestor
24451340|NCT00323219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451342|NCT00323323|Prednisone|prednisone|mesh-list
24451343|NCT00323323|Cyclophosphamide|cyclophosphamide|mesh-list
24451344|NCT00323323|Doxorubicin|doxorubicin|mesh-list
24451345|NCT00323323|Vincristine|vincristine|mesh-list
24451346|NCT00323323|Alemtuzumab|alemtuzumab|mesh-list
24451347|NCT00323323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24451348|NCT00323323|Immunologic Factors|immunologic factors|mesh-ancestor
24451349|NCT00323323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451350|NCT00323323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24451351|NCT00323323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24451352|NCT00323323|Alkylating Agents|alkylating agents|mesh-ancestor
25227098|NCT02616822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227099|NCT02616822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227100|NCT02616822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25227101|NCT02616731|Tranexamic Acid|tranexamic acid|mesh-list
25227102|NCT02616731|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25227103|NCT02616731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25227104|NCT02616731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227105|NCT02616731|Hemostatics|hemostatics|mesh-ancestor
25227106|NCT02616731|Coagulants|coagulants|mesh-ancestor
25227107|NCT02616874|Romidepsin|romidepsin|mesh-list
25227108|NCT02616874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25227109|NCT02616874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25227110|NCT02616861|Praliciguat|praliciguat|mesh-list
25227111|NCT02616861|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25227112|NCT02616861|Enzyme Activators|enzyme activators|mesh-ancestor
25227113|NCT02616861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227114|NCT02616861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25227115|NCT02616848|Everolimus|everolimus|mesh-list
25227116|NCT02616848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25227117|NCT02616848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24841769|NCT02217852|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24841770|NCT02217852|Protease Inhibitors|protease inhibitors|mesh-ancestor
24841771|NCT02217852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841772|NCT02217852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24841773|NCT02217852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24841774|NCT02217852|Vasodilator Agents|vasodilator agents|mesh-ancestor
24841775|NCT02217930|Moxifloxacin|moxifloxacin|mesh-list
24841776|NCT02217930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24841777|NCT02217930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24841778|NCT02217930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24841779|NCT02217930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24841780|NCT02217930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841781|NCT02217930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681511|NCT01866319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25681512|NCT01866319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25681513|NCT01866319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681514|NCT01866410|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25681515|NCT01866410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25681516|NCT01866410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25033310|NCT03574402|Maleic acid|maleic acid|mesh-list
24841782|NCT02217930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841784|NCT02217956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24841785|NCT02217956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25058212|NCT03498417|Antibodies|antibodies|mesh-list
24538737|NCT00660621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24538738|NCT00660621|Alkylating Agents|alkylating agents|mesh-ancestor
24538739|NCT00660621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538752|NCT00660725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24538753|NCT00660725|Immunologic Factors|immunologic factors|mesh-ancestor
24538754|NCT00660725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538755|NCT00660751|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24538756|NCT00660751|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24538757|NCT00660751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24538758|NCT00660751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24538759|NCT00660751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227118|NCT02616848|Immunologic Factors|immunologic factors|mesh-ancestor
25227119|NCT02616848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227120|NCT02616640|Dexamethasone|dexamethasone|mesh-list
25227121|NCT02616640|Durvalumab|durvalumab|mesh-list
25227122|NCT02616640|Pomalidomide|pomalidomide|mesh-list
25227123|NCT02616640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25227124|NCT02616640|Antiemetics|antiemetics|mesh-ancestor
25227125|NCT02616640|Autonomic Agents|autonomic agents|mesh-ancestor
25227126|NCT02616640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25227127|NCT02616640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227128|NCT02616640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25227129|NCT02616640|Glucocorticoids|glucocorticoids|mesh-ancestor
25227130|NCT02616640|Hormones|hormones|mesh-ancestor
25227131|NCT02616640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25227132|NCT02616640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25227133|NCT02616640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25227134|NCT02616640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25227135|NCT02616640|Immunologic Factors|immunologic factors|mesh-ancestor
25227136|NCT02616640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24841798|NCT02218021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24841800|NCT02218034|Tazarotene|tazarotene|mesh-list
24841801|NCT02218034|Dermatologic Agents|dermatologic agents|mesh-ancestor
24841802|NCT02218034|Keratolytic Agents|keratolytic agents|mesh-ancestor
24841803|NCT02218034|Vitamin B Complex|vitamin b complex|mesh-ancestor
24841804|NCT02218034|Vitamins|vitamins|mesh-ancestor
24841805|NCT02218034|Micronutrients|micronutrients|mesh-ancestor
24841806|NCT02218034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841807|NCT02218047|Interferons|interferons|mesh-list
24994305|NCT04664829|Capecitabine|capecitabine|mesh-list
24841808|NCT02218047|Interferon-alpha|interferon-alpha|mesh-list
24841809|NCT02218047|Interferon alpha-2|interferon alpha-2|mesh-list
25681517|NCT01866410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24665577|NCT01313429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633230|NCT01127672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24451409|NCT00323583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451410|NCT00323583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24451411|NCT00323583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451412|NCT00323583|Antimetabolites|antimetabolites|mesh-ancestor
24857810|NCT02294162|Ketamine|ketamine|mesh-list
24857811|NCT02294162|Analgesics|analgesics|mesh-ancestor
24857812|NCT02294162|Sensory System Agents|sensory system agents|mesh-ancestor
24857813|NCT02294162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857814|NCT02294162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857815|NCT02294162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24857816|NCT02294162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24460309|NCT00348101|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25227137|NCT02616640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25227138|NCT02616640|Growth Substances|growth substances|mesh-ancestor
25227139|NCT02616640|Growth Inhibitors|growth inhibitors|mesh-ancestor
25227140|NCT02616354|Imipenem|imipenem|mesh-list
25227141|NCT02616354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25227142|NCT02616354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25227143|NCT02616367|Bupivacaine|bupivacaine|mesh-list
25227144|NCT02616367|Ropivacaine|ropivacaine|mesh-list
25227145|NCT02616367|Anesthetics, Local|anesthetics, local|mesh-ancestor
25227146|NCT02616367|Anesthetics|anesthetics|mesh-ancestor
25227147|NCT02616367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25227148|NCT02616367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227149|NCT02616367|Sensory System Agents|sensory system agents|mesh-ancestor
25227150|NCT02616367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25227151|NCT02616289|Emollients|emollients|mesh-list
25227152|NCT02616289|Dermatologic Agents|dermatologic agents|mesh-ancestor
25227153|NCT02616497|Aspirin|aspirin|mesh-list
25227154|NCT02616497|Triflusal|triflusal|mesh-list
25227155|NCT02616497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25043650|NCT01231347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043651|NCT01231347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25043652|NCT01231347|Immunologic Factors|immunologic factors|mesh-ancestor
25043653|NCT01231347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043655|NCT01230957|Immunologic Factors|immunologic factors|mesh-ancestor
25067373|NCT03443999|Sirolimus|sirolimus|mesh-list
24841812|NCT02218047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24841813|NCT02218047|Immunologic Factors|immunologic factors|mesh-ancestor
24841814|NCT02218047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841815|NCT02218177|Ranibizumab|ranibizumab|mesh-list
24841816|NCT02218177|Aflibercept|aflibercept|mesh-list
24841817|NCT02218177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24841818|NCT02218177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24841819|NCT02218177|Growth Substances|growth substances|mesh-ancestor
24841843|NCT02218476|Coenzyme Q10|coenzyme q10|mesh-list
24841844|NCT02218476|Vitamins|vitamins|mesh-ancestor
24841845|NCT02218476|Micronutrients|micronutrients|mesh-ancestor
25058250|NCT03498261|Antimanic Agents|antimanic agents|mesh-ancestor
24538899|NCT00661115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24538900|NCT00661115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25681518|NCT01866410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681519|NCT01866592|Adalimumab|adalimumab|mesh-list
25681520|NCT01866592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24633460|NCT01129427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24633461|NCT01129427|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24633466|NCT01129427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633467|NCT01129427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633468|NCT01129427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24633469|NCT01129427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24633470|NCT01129427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24538906|NCT00661154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538907|NCT00661154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24538908|NCT00661154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24538909|NCT00661154|Growth Substances|growth substances|mesh-ancestor
24538910|NCT00661154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227156|NCT02616497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25227157|NCT02616497|Analgesics|analgesics|mesh-ancestor
25227158|NCT02616497|Sensory System Agents|sensory system agents|mesh-ancestor
25227159|NCT02616497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25227160|NCT02616497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227161|NCT02616497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25227162|NCT02616497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25227163|NCT02616497|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25227164|NCT02616497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25227165|NCT02616497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227166|NCT02616497|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25227167|NCT02616497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25227168|NCT02616497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227169|NCT02616497|Antipyretics|antipyretics|mesh-ancestor
25227170|NCT02616419|Lidocaine|lidocaine|mesh-list
25227171|NCT02616419|Anesthetics, Local|anesthetics, local|mesh-ancestor
25227172|NCT02616419|Anesthetics|anesthetics|mesh-ancestor
25227173|NCT02616419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25227174|NCT02616419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227175|NCT02616419|Sensory System Agents|sensory system agents|mesh-ancestor
24841847|NCT02218619|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
24841848|NCT02218619|Antiviral Agents|antiviral agents|mesh-ancestor
24841849|NCT02218619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24841850|NCT02218619|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24841851|NCT02218619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24841852|NCT02218645|Brotizolam|brotizolam|mesh-list
24841853|NCT02218645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24841883|NCT02218762|Autonomic Agents|autonomic agents|mesh-ancestor
24841884|NCT02218762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24538911|NCT00661154|Growth Inhibitors|growth inhibitors|mesh-ancestor
24538912|NCT00661167|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24538913|NCT00661167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538915|NCT00661180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538916|NCT00661180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24538918|NCT00661180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681521|NCT01866592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25681522|NCT01866826|Rifaximin|rifaximin|mesh-list
25681523|NCT01866826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25681524|NCT01866826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25681525|NCT01866826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25681526|NCT01866917|Ropivacaine|ropivacaine|mesh-list
25681527|NCT01866917|Anesthetics, Local|anesthetics, local|mesh-ancestor
25681528|NCT01866917|Anesthetics|anesthetics|mesh-ancestor
25681529|NCT01866917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24539026|NCT00661856|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24556330|NCT00747110|Budesonide|budesonide|mesh-list
24707309|NCT01495169|Iloperidone|iloperidone|mesh-list
25227176|NCT02616419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25227177|NCT02616419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25227178|NCT02616419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25227179|NCT02616419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25227180|NCT02616419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25227181|NCT02616419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227182|NCT02616315|Naltrexone|naltrexone|mesh-list
25227183|NCT02616315|Bupropion|bupropion|mesh-list
25227184|NCT02616315|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24841885|NCT02218762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841886|NCT02218762|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24841916|NCT02218879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24841917|NCT02218879|Immunologic Factors|immunologic factors|mesh-ancestor
24841918|NCT02218879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841919|NCT02219100|Mifepristone|mifepristone|mesh-list
24841922|NCT02219100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24841923|NCT02219100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841927|NCT02219100|Contraceptive Agents|contraceptive agents|mesh-ancestor
24841928|NCT02219100|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24841929|NCT02219100|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24841930|NCT02219100|Hormone Antagonists|hormone antagonists|mesh-ancestor
24841972|NCT02219191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24841974|NCT02219191|Vasodilator Agents|vasodilator agents|mesh-ancestor
24841975|NCT02219217|Dolutegravir|dolutegravir|mesh-list
24841976|NCT02219217|Cobicistat|cobicistat|mesh-list
24841977|NCT02219217|Elvitegravir|elvitegravir|mesh-list
24841978|NCT02219217|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24841979|NCT02219217|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24841980|NCT02219217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058287|NCT03498118|Bupivacaine|bupivacaine|mesh-list
24539027|NCT00661856|Protective Agents|protective agents|mesh-ancestor
24539028|NCT00661856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539029|NCT00661856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24539030|NCT00661856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24539051|NCT00662077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227185|NCT02616315|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25227186|NCT02616315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227187|NCT02616315|Sensory System Agents|sensory system agents|mesh-ancestor
25227188|NCT02616315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25227189|NCT02616315|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25227190|NCT02616315|Antidepressive Agents|antidepressive agents|mesh-ancestor
25227191|NCT02616315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25227192|NCT02616315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25227193|NCT02616315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25227194|NCT02616315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25227195|NCT02616315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227196|NCT02616315|Dopamine Agents|dopamine agents|mesh-ancestor
25227197|NCT02616315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25227198|NCT02616315|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25227199|NCT02616315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25227200|NCT02616315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227201|NCT02616003|Liraglutide|liraglutide|mesh-list
25227202|NCT02616003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25227203|NCT02616003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227204|NCT02616003|Incretins|incretins|mesh-ancestor
25227205|NCT02616003|Hormones|hormones|mesh-ancestor
25227206|NCT02616003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24842047|NCT02219659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24842048|NCT02219659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842049|NCT02219659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24842052|NCT02219659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24842053|NCT02219659|Narcotics|narcotics|mesh-ancestor
24842054|NCT02219659|Analgesics|analgesics|mesh-ancestor
24842055|NCT02219659|Sensory System Agents|sensory system agents|mesh-ancestor
24842056|NCT02219659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24842057|NCT02219659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24842059|NCT02219659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24842060|NCT02219659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24556369|NCT00747383|Glimepiride|glimepiride|mesh-list
24539053|NCT00662220|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24539054|NCT00662220|Interferon-alpha|interferon-alpha|mesh-list
24539055|NCT00662220|Antimetabolites|antimetabolites|mesh-ancestor
24539056|NCT00662220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539057|NCT00662220|Antiviral Agents|antiviral agents|mesh-ancestor
24539058|NCT00662220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24539059|NCT00662220|Immunologic Factors|immunologic factors|mesh-ancestor
25227207|NCT02615938|Hydroxychloroquine|hydroxychloroquine|mesh-list
25227208|NCT02615938|Antimalarials|antimalarials|mesh-ancestor
25227209|NCT02615938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25227210|NCT02615938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25227211|NCT02615938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25227212|NCT02615938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227213|NCT02615938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227216|NCT02615977|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25227217|NCT02615977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25227218|NCT02615977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25227219|NCT02615977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227220|NCT02616068|Loxoprofen|loxoprofen|mesh-list
25227221|NCT02616068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25227222|NCT02616068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25227223|NCT02616068|Analgesics|analgesics|mesh-ancestor
25227224|NCT02616068|Sensory System Agents|sensory system agents|mesh-ancestor
25227225|NCT02616068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25227226|NCT02616068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842061|NCT02219659|GABA Modulators|gaba modulators|mesh-ancestor
24842062|NCT02219659|GABA Agents|gaba agents|mesh-ancestor
24842063|NCT02219659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24842093|NCT02219672|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24842095|NCT02219672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24842096|NCT02219698|Acetaminophen|acetaminophen|mesh-list
24842097|NCT02219698|Ibuprofen|ibuprofen|mesh-list
24842101|NCT02219698|Sensory System Agents|sensory system agents|mesh-ancestor
24842102|NCT02219698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24842103|NCT02219698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842104|NCT02219698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24842105|NCT02219698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24842106|NCT02219698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24842107|NCT02219698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058314|NCT03497988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539095|NCT00662337|Sensory System Agents|sensory system agents|mesh-ancestor
24539096|NCT00662337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24539098|NCT00662337|Autonomic Agents|autonomic agents|mesh-ancestor
24539099|NCT00662337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24539100|NCT00662337|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24613832|NCT01021163|Protective Agents|protective agents|mesh-ancestor
25227227|NCT02616068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25227228|NCT02616068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25273351|NCT02386072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25273352|NCT02386072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273353|NCT02386072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273354|NCT02386072|Urological Agents|urological agents|mesh-ancestor
25273355|NCT02386072|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25273356|NCT02386072|Cholinergic Agents|cholinergic agents|mesh-ancestor
25273357|NCT02386072|Parasympatholytics|parasympatholytics|mesh-ancestor
25273358|NCT02386072|Autonomic Agents|autonomic agents|mesh-ancestor
25273359|NCT02386072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25273360|NCT02385825|Vaccines|vaccines|mesh-list
25273361|NCT02385825|Immunologic Factors|immunologic factors|mesh-ancestor
25273362|NCT02385825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273363|NCT02385656|Modafinil|modafinil|mesh-list
25273364|NCT02385656|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25273365|NCT02385656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273366|NCT02385656|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25273367|NCT02385656|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25273368|NCT02385656|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24842240|NCT02220296|Insulin Glargine|insulin glargine|mesh-list
25681530|NCT01866917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681531|NCT01866917|Sensory System Agents|sensory system agents|mesh-ancestor
25681532|NCT01866917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25033499|NCT03572829|Dexamethasone|dexamethasone|mesh-list
25033500|NCT03572829|Ondansetron|ondansetron|mesh-list
25033501|NCT03572829|Aprepitant|aprepitant|mesh-list
25033502|NCT03572829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25033503|NCT03572829|Antiemetics|antiemetics|mesh-ancestor
25033504|NCT03572829|Autonomic Agents|autonomic agents|mesh-ancestor
25033505|NCT03572829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25033506|NCT03572829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033507|NCT03572829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25033509|NCT03572829|Hormones|hormones|mesh-ancestor
24707367|NCT01495338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24539171|NCT00662610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227231|NCT02615873|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25227232|NCT02615873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25227233|NCT02615873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25227234|NCT02615873|Dopamine Agents|dopamine agents|mesh-ancestor
25227235|NCT02615873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25227236|NCT02615873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227237|NCT02615873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227238|NCT02615873|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25227239|NCT02615873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227240|NCT02615873|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25227241|NCT02615873|Immunologic Factors|immunologic factors|mesh-ancestor
25227242|NCT02615873|Dopamine Agonists|dopamine agonists|mesh-ancestor
25227243|NCT02615847|Memantine|memantine|mesh-list
24842148|NCT02219789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24842149|NCT02219789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24842150|NCT02219789|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24842151|NCT02219789|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24842152|NCT02219789|Hormone Antagonists|hormone antagonists|mesh-ancestor
24842153|NCT02219789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24842154|NCT02219789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842155|NCT02219828|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25058350|NCT03497702|Letrozole|letrozole|mesh-list
24539206|NCT00662805|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24539265|NCT00662948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24539266|NCT00662948|Immunologic Factors|immunologic factors|mesh-ancestor
24539267|NCT00662948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539268|NCT00662948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25681533|NCT01866943|Tranexamic Acid|tranexamic acid|mesh-list
25681534|NCT01866943|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25681535|NCT01866943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25681536|NCT01866943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681537|NCT01866943|Hemostatics|hemostatics|mesh-ancestor
25681538|NCT01866943|Coagulants|coagulants|mesh-ancestor
25681539|NCT01867021|Vaccines|vaccines|mesh-list
25681540|NCT01867021|Immunologic Factors|immunologic factors|mesh-ancestor
25681541|NCT01867021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556639|NCT00748527|Decitabine|decitabine|mesh-list
24443745|NCT00295919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444963|NCT00299884|Ezetimibe|ezetimibe|mesh-list
24444964|NCT00299884|Fenofibrate|fenofibrate|mesh-list
24444982|NCT00299923|Ribavirin|ribavirin|mesh-list
24445067|NCT00300287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445068|NCT00300287|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25227244|NCT02615847|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25227245|NCT02615847|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25227246|NCT02615847|Dopamine Agents|dopamine agents|mesh-ancestor
25227247|NCT02615847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25227248|NCT02615847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227249|NCT02615847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227250|NCT02615847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25227251|NCT02615847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25227252|NCT02615912|Castor Oil|castor oil|mesh-list
25227253|NCT02615912|Cathartics|cathartics|mesh-ancestor
24445071|NCT00300287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857826|NCT02294240|Vitamin B Complex|vitamin b complex|mesh-ancestor
24857827|NCT02294240|Vitamins|vitamins|mesh-ancestor
24857828|NCT02294240|Micronutrients|micronutrients|mesh-ancestor
24540278|NCT00667147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24540280|NCT00667147|Antimitotic Agents|antimitotic agents|mesh-ancestor
24540281|NCT00667147|Mitosis Modulators|mitosis modulators|mesh-ancestor
24556689|NCT00749099|Pancreatin|pancreatin|mesh-list
24444107|NCT00296712|Dopamine Agents|dopamine agents|mesh-ancestor
24444108|NCT00296712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24444109|NCT00296712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24540420|NCT00667927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24540421|NCT00667927|Alkylating Agents|alkylating agents|mesh-ancestor
24540422|NCT00667927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540423|NCT00667927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445549|NCT00301860|Methotrexate|methotrexate|mesh-list
24540808|NCT00669695|Atorvastatin|atorvastatin|mesh-list
24540809|NCT00669695|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24540810|NCT00669695|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24540811|NCT00669695|Antimetabolites|antimetabolites|mesh-ancestor
24540812|NCT00669695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540813|NCT00669695|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24842241|NCT02220296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24540815|NCT00669695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540816|NCT00669721|Heparin|heparin|mesh-list
24540817|NCT00669721|Calcium heparin|calcium heparin|mesh-list
24540818|NCT00669721|Nadroparin|nadroparin|mesh-list
24398277|NCT00144053|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24398278|NCT00144053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25033586|NCT03572400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25033588|NCT03572257|Antidepressive Agents|antidepressive agents|mesh-ancestor
25033589|NCT03572257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25033590|NCT03572257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25227254|NCT02615912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25227255|NCT02615639|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25227256|NCT02615639|Interferon-alpha|interferon-alpha|mesh-list
25227257|NCT02615639|Entecavir|entecavir|mesh-list
25227258|NCT02615639|Telbivudine|telbivudine|mesh-list
25227259|NCT02615639|Interferon alpha-2|interferon alpha-2|mesh-list
25227260|NCT02615639|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
25227261|NCT02615639|Vaccines|vaccines|mesh-list
25227262|NCT02615639|Immunologic Factors|immunologic factors|mesh-ancestor
25227263|NCT02615639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842190|NCT02220023|Antioxidants|antioxidants|mesh-ancestor
24842191|NCT02220023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842192|NCT02220023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24859037|NCT02301286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25058366|NCT03497702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24541137|NCT00671151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541138|NCT00671151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24857839|NCT02294266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857840|NCT02294266|Dopamine Agents|dopamine agents|mesh-ancestor
24857841|NCT02294266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24541139|NCT00671151|Respiratory System Agents|respiratory system agents|mesh-ancestor
24541140|NCT00671151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24541141|NCT00671151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541150|NCT00671203|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24541152|NCT00671203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24541153|NCT00671203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24541154|NCT00671203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24541155|NCT00671203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24541156|NCT00671203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541157|NCT00671203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541179|NCT00671359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24541180|NCT00671359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24541181|NCT00671372|Bevacizumab|bevacizumab|mesh-list
24541184|NCT00671372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24541185|NCT00671372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541186|NCT00671372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24541187|NCT00671372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24541210|NCT00671476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24541211|NCT00671476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25107931|NCT03135795|Propofol|propofol|mesh-list
24541212|NCT00671476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24541213|NCT00671476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25227264|NCT02615639|Antiviral Agents|antiviral agents|mesh-ancestor
25227265|NCT02615639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25227266|NCT02615639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25227267|NCT02615639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227268|NCT02615639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227269|NCT02615639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25227270|NCT02615730|Paclitaxel|paclitaxel|mesh-list
25227271|NCT02615730|GSK2636771|gsk2636771|mesh-list
25227272|NCT02615730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25227273|NCT02615730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25227274|NCT02615730|Tubulin Modulators|tubulin modulators|mesh-ancestor
25227275|NCT02615730|Antimitotic Agents|antimitotic agents|mesh-ancestor
25227276|NCT02615730|Mitosis Modulators|mitosis modulators|mesh-ancestor
25681542|NCT01867047|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25681543|NCT01867047|Protease Inhibitors|protease inhibitors|mesh-ancestor
25681544|NCT01867047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25681545|NCT01867047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681546|NCT01867086|Carboplatin|carboplatin|mesh-list
25681547|NCT01867086|Vaccines|vaccines|mesh-list
25681548|NCT01867086|Immunologic Factors|immunologic factors|mesh-ancestor
24399027|NCT00146523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399028|NCT00146523|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24399029|NCT00146523|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24399030|NCT00146523|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24399031|NCT00146523|Contraceptive Agents|contraceptive agents|mesh-ancestor
25033616|NCT03572088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25033617|NCT03572088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24399032|NCT00146523|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24399033|NCT00146523|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24399034|NCT00146523|Hormone Antagonists|hormone antagonists|mesh-ancestor
24399035|NCT00146523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24399068|NCT00146562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24399069|NCT00146562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24399131|NCT00146614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25227277|NCT02615730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227278|NCT02615730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25227279|NCT02615730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227280|NCT02615782|Tadalafil|tadalafil|mesh-list
25227281|NCT02615782|Tamsulosin|tamsulosin|mesh-list
24541214|NCT00671476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541215|NCT00671476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541216|NCT00671541|Gentamicins|gentamicins|mesh-list
24541217|NCT00671541|Bacitracin|bacitracin|mesh-list
24541218|NCT00671541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24541219|NCT00671541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24541220|NCT00671541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24541221|NCT00671541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25681549|NCT01867086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681550|NCT01867086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25681551|NCT01867294|Doxycycline|doxycycline|mesh-list
25681552|NCT01867294|Hydrocortisone|hydrocortisone|mesh-list
25681553|NCT01867294|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25681554|NCT01867294|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25681555|NCT01867294|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25681556|NCT01867294|Spironolactone|spironolactone|mesh-list
25681557|NCT01867294|Sunscreening Agents|sunscreening agents|mesh-list
25681558|NCT01867294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25681559|NCT01867294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25681560|NCT01867294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25681561|NCT01867294|Antimalarials|antimalarials|mesh-ancestor
25681562|NCT01867294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25681563|NCT01867294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25681564|NCT01867294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25681565|NCT01867294|Hormone Antagonists|hormone antagonists|mesh-ancestor
25681566|NCT01867294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25681567|NCT01867294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681568|NCT01867294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25681569|NCT01867294|Diuretics|diuretics|mesh-ancestor
25681570|NCT01867294|Natriuretic Agents|natriuretic agents|mesh-ancestor
25681571|NCT01867294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25227296|NCT02615496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25227297|NCT02615496|Growth Substances|growth substances|mesh-ancestor
25227298|NCT02615496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227299|NCT02615496|Growth Inhibitors|growth inhibitors|mesh-ancestor
25227300|NCT02615496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25227301|NCT02615561|Pantothenic Acid|pantothenic acid|mesh-list
24842193|NCT02220023|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24842194|NCT02220023|Vasodilator Agents|vasodilator agents|mesh-ancestor
24842195|NCT02220023|Gasotransmitters|gasotransmitters|mesh-ancestor
24842196|NCT02220023|Protective Agents|protective agents|mesh-ancestor
24842242|NCT02220296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541313|NCT00672282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541314|NCT00672282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541316|NCT00672295|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24541317|NCT00672295|Carboplatin|carboplatin|mesh-list
24541318|NCT00672295|Dasatinib|dasatinib|mesh-list
25262780|NCT02446431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541319|NCT00672295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24541320|NCT00672295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541321|NCT00672295|Tubulin Modulators|tubulin modulators|mesh-ancestor
24541322|NCT00672295|Antimitotic Agents|antimitotic agents|mesh-ancestor
24541323|NCT00672295|Mitosis Modulators|mitosis modulators|mesh-ancestor
24541324|NCT00672295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541325|NCT00672295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25227302|NCT02615561|Vitamin B Complex|vitamin b complex|mesh-ancestor
25227303|NCT02615561|Vitamins|vitamins|mesh-ancestor
25227304|NCT02615561|Micronutrients|micronutrients|mesh-ancestor
25227305|NCT02615561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227310|NCT02615574|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
25227312|NCT02615574|Vaccines|vaccines|mesh-list
25227313|NCT02615574|Immunologic Factors|immunologic factors|mesh-ancestor
25227314|NCT02615574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227315|NCT02615574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25227316|NCT02615574|Antiviral Agents|antiviral agents|mesh-ancestor
25227317|NCT02615574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25227318|NCT02615574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25227319|NCT02615574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25227320|NCT02615574|Analgesics|analgesics|mesh-ancestor
25227321|NCT02615574|Sensory System Agents|sensory system agents|mesh-ancestor
25227323|NCT02615574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25227324|NCT02615574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25227325|NCT02615574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25227326|NCT02615574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25227327|NCT02615574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227328|NCT02615574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227329|NCT02615366|Tranexamic Acid|tranexamic acid|mesh-list
25227330|NCT02615366|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25227331|NCT02615366|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25227332|NCT02615366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227333|NCT02615366|Hemostatics|hemostatics|mesh-ancestor
24842266|NCT02220361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842267|NCT02220361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24842268|NCT02220361|Analgesics|analgesics|mesh-ancestor
24857845|NCT02294266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24541547|NCT00673621|Respiratory System Agents|respiratory system agents|mesh-ancestor
24541568|NCT00673829|Analgesics|analgesics|mesh-ancestor
24541569|NCT00673829|Sensory System Agents|sensory system agents|mesh-ancestor
24541570|NCT00673829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24541571|NCT00673829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541572|NCT00674011|Bevacizumab|bevacizumab|mesh-list
24541573|NCT00674011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24541958|NCT00676117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227334|NCT02615366|Coagulants|coagulants|mesh-ancestor
25227335|NCT02615223|Bicalutamide|bicalutamide|mesh-list
25227337|NCT02615223|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25227338|NCT02615223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25227339|NCT02615223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227340|NCT02615223|Androgen Antagonists|androgen antagonists|mesh-ancestor
25227341|NCT02615223|Hormone Antagonists|hormone antagonists|mesh-ancestor
25227342|NCT02615223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25227343|NCT02615288|Vitamin D|vitamin d|mesh-list
25227344|NCT02615288|Cholecalciferol|cholecalciferol|mesh-list
24842269|NCT02220361|Sensory System Agents|sensory system agents|mesh-ancestor
24842270|NCT02220361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24842271|NCT02220361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24842272|NCT02220361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24842273|NCT02220361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24842274|NCT02220361|Adrenergic Agents|adrenergic agents|mesh-ancestor
24842275|NCT02220361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25043656|NCT01230957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043657|NCT01229982|Latanoprost|latanoprost|mesh-list
25043658|NCT01229982|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25043659|NCT01229982|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25043661|NCT01229644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043662|NCT01228383|Vaccines|vaccines|mesh-list
25043663|NCT01228383|Antibodies|antibodies|mesh-list
25043664|NCT01228383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25043665|NCT01228383|Immunoglobulins|immunoglobulins|mesh-list
25043666|NCT01228383|gamma-Globulins|gamma-globulins|mesh-list
25043667|NCT01228383|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25043668|NCT01228383|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25043669|NCT01228383|Immunologic Factors|immunologic factors|mesh-ancestor
25043670|NCT01228383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842276|NCT02220361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602037|NCT00967057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24842277|NCT02220400|Ketamine|ketamine|mesh-list
24842278|NCT02220400|Analgesics|analgesics|mesh-ancestor
24842279|NCT02220400|Sensory System Agents|sensory system agents|mesh-ancestor
24842280|NCT02220400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24942224|NCT03982862|Triamcinolone|triamcinolone|mesh-list
24542083|NCT00676741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24542084|NCT00676741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542085|NCT00676819|Insulin|insulin|mesh-list
24542086|NCT00676819|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25227345|NCT02615288|Vitamins|vitamins|mesh-ancestor
25227346|NCT02615288|Micronutrients|micronutrients|mesh-ancestor
25227347|NCT02615288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227348|NCT02615288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25227349|NCT02615288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25227350|NCT02615041|Meropenem|meropenem|mesh-list
25227351|NCT02615041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25227352|NCT02615041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25227353|NCT02615340|Melatonin|melatonin|mesh-list
25227354|NCT02615340|Antioxidants|antioxidants|mesh-ancestor
25227355|NCT02615340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227356|NCT02615340|Protective Agents|protective agents|mesh-ancestor
25227357|NCT02615340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227358|NCT02615340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25227359|NCT02615301|Vitamin D|vitamin d|mesh-list
25227361|NCT02615301|Cholecalciferol|cholecalciferol|mesh-list
25227363|NCT02615301|Micronutrients|micronutrients|mesh-ancestor
25227364|NCT02615301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227365|NCT02615301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25227366|NCT02615301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25227367|NCT02615080|Pemirolast|pemirolast|mesh-list
25227368|NCT02615080|Histamine Antagonists|histamine antagonists|mesh-ancestor
25227369|NCT02615080|Histamine Agents|histamine agents|mesh-ancestor
25227370|NCT02615080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25227371|NCT02615080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227372|NCT02615080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227373|NCT02615106|Endostar protein|endostar protein|mesh-list
25227374|NCT02615106|Endostatins|endostatins|mesh-list
24842281|NCT02220400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842311|NCT02220530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24842312|NCT02220530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24842314|NCT02220530|GABA Agents|gaba agents|mesh-ancestor
24842315|NCT02220530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24842316|NCT02220530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842317|NCT02220608|Bortezomib|bortezomib|mesh-list
24842318|NCT02220608|Lenograstim|lenograstim|mesh-list
24842319|NCT02220608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24842320|NCT02220608|Immunologic Factors|immunologic factors|mesh-ancestor
24842321|NCT02220608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842322|NCT02220608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24842323|NCT02220621|Hyaluronic Acid|hyaluronic acid|mesh-list
24842324|NCT02220621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24842325|NCT02220621|Immunologic Factors|immunologic factors|mesh-ancestor
24842326|NCT02220621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842332|NCT02220634|Purinergic Agonists|purinergic agonists|mesh-ancestor
24842333|NCT02220634|Purinergic Agents|purinergic agents|mesh-ancestor
24842334|NCT02220634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24842335|NCT02220634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842336|NCT02220634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842338|NCT02220647|Linagliptin|linagliptin|mesh-list
24842339|NCT02220647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24542270|NCT00678132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542271|NCT00678132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24542272|NCT00678145|Epinephrine|epinephrine|mesh-list
24542273|NCT00678145|Morphine|morphine|mesh-list
25227375|NCT02615106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25227376|NCT02615106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25227377|NCT02615106|Growth Substances|growth substances|mesh-ancestor
25227378|NCT02615106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227379|NCT02615106|Growth Inhibitors|growth inhibitors|mesh-ancestor
25227380|NCT02615106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25227381|NCT02615262|Dexamethasone|dexamethasone|mesh-list
25227382|NCT02615262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25227383|NCT02615262|Antiemetics|antiemetics|mesh-ancestor
25227384|NCT02615262|Autonomic Agents|autonomic agents|mesh-ancestor
25227385|NCT02615262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25227386|NCT02615262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227387|NCT02615262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25227388|NCT02615262|Glucocorticoids|glucocorticoids|mesh-ancestor
25227389|NCT02615262|Hormones|hormones|mesh-ancestor
25227390|NCT02615262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25227391|NCT02615262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25227392|NCT02615262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25227393|NCT02614937|Squalamine|squalamine|mesh-list
25227394|NCT02614937|Ranibizumab|ranibizumab|mesh-list
25227395|NCT02614937|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25227396|NCT02614937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25227397|NCT02614937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25227398|NCT02614937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25227399|NCT02614937|Growth Substances|growth substances|mesh-ancestor
25227400|NCT02614937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227401|NCT02614937|Growth Inhibitors|growth inhibitors|mesh-ancestor
25227402|NCT02614937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25227403|NCT02614937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25227404|NCT02614937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24842354|NCT02220660|Respiratory System Agents|respiratory system agents|mesh-ancestor
24842355|NCT02220673|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
24842356|NCT02220673|Antioxidants|antioxidants|mesh-ancestor
24842357|NCT02220673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842358|NCT02220673|Protective Agents|protective agents|mesh-ancestor
24842359|NCT02220673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842360|NCT02220751|Doxycycline|doxycycline|mesh-list
24842361|NCT02220751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24842362|NCT02220751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24842363|NCT02220751|Antimalarials|antimalarials|mesh-ancestor
24842364|NCT02220751|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24842365|NCT02220751|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24842366|NCT02220777|Omeprazole|omeprazole|mesh-list
25033889|NCT03570346|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25033890|NCT03570346|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25033891|NCT03570346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25033892|NCT03570346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033893|NCT03570320|Analgesics, Opioid|analgesics, opioid|mesh-list
25033908|NCT03570281|Anticoagulants|anticoagulants|mesh-ancestor
25033909|NCT03570281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25033910|NCT03570281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25033911|NCT03570281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842367|NCT02220777|ASP8477|asp8477|mesh-list
24842368|NCT02220777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24842369|NCT02220777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24842370|NCT02220777|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24842371|NCT02220777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842372|NCT02220777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842373|NCT02220803|Acetazolamide|acetazolamide|mesh-list
24842374|NCT02220803|Anticonvulsants|anticonvulsants|mesh-ancestor
24842379|NCT02220803|Natriuretic Agents|natriuretic agents|mesh-ancestor
24842380|NCT02220803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842381|NCT02220829|Silodosin|silodosin|mesh-list
24842382|NCT02220829|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24842383|NCT02220829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24842384|NCT02220829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24842385|NCT02220829|Adrenergic Agents|adrenergic agents|mesh-ancestor
24842386|NCT02220829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25058452|NCT03496779|Antimetabolites|antimetabolites|mesh-ancestor
24542284|NCT00678145|Adrenergic Agents|adrenergic agents|mesh-ancestor
25227405|NCT02614937|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25227406|NCT02614937|Protective Agents|protective agents|mesh-ancestor
25227407|NCT02614872|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25227408|NCT02614872|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25227409|NCT02614872|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25227410|NCT02614872|Protease Inhibitors|protease inhibitors|mesh-ancestor
25227411|NCT02614872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227412|NCT02614872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227413|NCT02614612|Prednisone|prednisone|mesh-list
25227414|NCT02614612|Methylprednisolone|methylprednisolone|mesh-list
25227415|NCT02614612|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25227416|NCT02614612|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25227417|NCT02614612|Prednisolone|prednisolone|mesh-list
25227418|NCT02614612|Prednisolone acetate|prednisolone acetate|mesh-list
25227419|NCT02614612|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25227420|NCT02614612|Prednisolone phosphate|prednisolone phosphate|mesh-list
25227421|NCT02614612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25227422|NCT02614612|Glucocorticoids|glucocorticoids|mesh-ancestor
25227423|NCT02614612|Hormones|hormones|mesh-ancestor
25227424|NCT02614612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25227425|NCT02614612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227426|NCT02614612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25227448|NCT02614482|Urological Agents|urological agents|mesh-ancestor
25227429|NCT02614612|Autonomic Agents|autonomic agents|mesh-ancestor
25227430|NCT02614612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25227431|NCT02614612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25227432|NCT02614612|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25227433|NCT02614612|Protective Agents|protective agents|mesh-ancestor
24451285|NCT00323011|Fluorouracil|fluorouracil|mesh-list
25227434|NCT02614833|Paclitaxel|paclitaxel|mesh-list
25227435|NCT02614833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25227436|NCT02614833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25227437|NCT02614833|Tubulin Modulators|tubulin modulators|mesh-ancestor
25227438|NCT02614833|Antimitotic Agents|antimitotic agents|mesh-ancestor
25681572|NCT01867294|Protective Agents|protective agents|mesh-ancestor
25681573|NCT01867294|Dermatologic Agents|dermatologic agents|mesh-ancestor
25681574|NCT01867307|Empagliflozin|empagliflozin|mesh-list
25681575|NCT01867307|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25681576|NCT01867307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681577|NCT01867307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25681578|NCT01867307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681579|NCT01867671|Immunologic Factors|immunologic factors|mesh-list
25681580|NCT01867671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681581|NCT01867710|Dexamethasone|dexamethasone|mesh-list
24402087|NCT00154791|Gemcitabine|gemcitabine|mesh-list
24402088|NCT00154791|Oxaliplatin|oxaliplatin|mesh-list
24402089|NCT00154791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24402090|NCT00154791|Antimetabolites|antimetabolites|mesh-ancestor
24402092|NCT00154791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402131|NCT00154895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24402132|NCT00154895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25227439|NCT02614833|Mitosis Modulators|mitosis modulators|mesh-ancestor
24474347|NCT00405730|Analgesics|analgesics|mesh-ancestor
24842387|NCT02220829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842389|NCT02220829|Urological Agents|urological agents|mesh-ancestor
24842390|NCT02220842|Atezolizumab|atezolizumab|mesh-list
24842391|NCT02220842|Obinutuzumab|obinutuzumab|mesh-list
24842392|NCT02220842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24842393|NCT02220842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24842394|NCT02220868|Ribavirin|ribavirin|mesh-list
24842395|NCT02220868|Sofosbuvir|sofosbuvir|mesh-list
24842396|NCT02220868|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24842397|NCT02220868|Antimetabolites|antimetabolites|mesh-ancestor
24842420|NCT02221102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24842421|NCT02221102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842422|NCT02221102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24842423|NCT02221102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24842424|NCT02221102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842425|NCT02221102|Antipyretics|antipyretics|mesh-ancestor
24842426|NCT02221102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24842428|NCT02221102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24842429|NCT02221102|Protease Inhibitors|protease inhibitors|mesh-ancestor
24842430|NCT02221102|Anticoagulants|anticoagulants|mesh-ancestor
24842431|NCT02221154|Folic Acid|folic acid|mesh-list
24557086|NCT00751205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24542306|NCT00678236|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24394684|NCT00133887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25227440|NCT02614833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227441|NCT02614482|Fesoterodine|fesoterodine|mesh-list
25227442|NCT02614482|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25227443|NCT02614482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25227444|NCT02614482|Cholinergic Agents|cholinergic agents|mesh-ancestor
25227445|NCT02614482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25227446|NCT02614482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227447|NCT02614482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227456|NCT02614456|Antiviral Agents|antiviral agents|mesh-ancestor
25227457|NCT02614456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25681582|NCT01867710|Prednisone|prednisone|mesh-list
25275284|NCT02373163|Amlodipine|amlodipine|mesh-list
25681583|NCT01867710|Abiraterone Acetate|abiraterone acetate|mesh-list
25681584|NCT01867710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25681585|NCT01867710|Antiemetics|antiemetics|mesh-ancestor
25681586|NCT01867710|Autonomic Agents|autonomic agents|mesh-ancestor
25681587|NCT01867710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25681588|NCT01867710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681589|NCT01867710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25681590|NCT01867710|Glucocorticoids|glucocorticoids|mesh-ancestor
24402937|NCT00158834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25033925|NCT03570112|Sofosbuvir|sofosbuvir|mesh-list
25227458|NCT02614352|Candesartan|candesartan|mesh-list
25227459|NCT02614352|Atorvastatin|atorvastatin|mesh-list
25227460|NCT02614352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25227461|NCT02614352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25227462|NCT02614352|Antimetabolites|antimetabolites|mesh-ancestor
24842433|NCT02221154|Vitamin B Complex|vitamin b complex|mesh-ancestor
24842434|NCT02221154|Vitamins|vitamins|mesh-ancestor
24842451|NCT02221375|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24842452|NCT02221401|Metformin|metformin|mesh-list
24842453|NCT02221401|Linagliptin|linagliptin|mesh-list
24842454|NCT02221401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24842455|NCT02221401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842456|NCT02221401|Incretins|incretins|mesh-ancestor
24842457|NCT02221401|Hormones|hormones|mesh-ancestor
24842458|NCT02221401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24842459|NCT02221401|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24842460|NCT02221401|Protease Inhibitors|protease inhibitors|mesh-ancestor
24842482|NCT02221453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542307|NCT00678236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24707960|NCT01499004|Tofacitinib|tofacitinib|mesh-list
24542525|NCT00679146|Sensory System Agents|sensory system agents|mesh-ancestor
24542526|NCT00679146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24542527|NCT00679146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542528|NCT00679146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24542529|NCT00679146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24542530|NCT00679146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24542531|NCT00679146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227463|NCT02614352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227464|NCT02614352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25227465|NCT02614352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25227466|NCT02614352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227467|NCT02614352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25227468|NCT02614352|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25681591|NCT01867710|Hormones|hormones|mesh-ancestor
25681592|NCT01867710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25681593|NCT01867710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25681594|NCT01867710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25681595|NCT01867710|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25681596|NCT01867710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25681597|NCT01867710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681598|NCT01867710|Hormone Antagonists|hormone antagonists|mesh-ancestor
25681599|NCT01867710|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25681600|NCT01868022|Paclitaxel|paclitaxel|mesh-list
25681601|NCT01868022|Docetaxel|docetaxel|mesh-list
25681602|NCT01868022|Cisplatin|cisplatin|mesh-list
25681603|NCT01868022|Carboplatin|carboplatin|mesh-list
25681604|NCT01868022|Pemetrexed|pemetrexed|mesh-list
25681605|NCT01868022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24403839|NCT00161681|Hormones|hormones|mesh-ancestor
24403840|NCT00161681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24403856|NCT00161720|Protein C|protein c|mesh-list
25227469|NCT02614352|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25227470|NCT02614339|Metformin|metformin|mesh-list
25227471|NCT02614339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25227472|NCT02614339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227481|NCT02614404|Piperaquine|piperaquine|mesh-list
25227482|NCT02614404|Artenimol|artenimol|mesh-list
25227483|NCT02614404|Imatinib Mesylate|imatinib mesylate|mesh-list
25227484|NCT02614404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24842484|NCT02221453|Immunologic Factors|immunologic factors|mesh-ancestor
24842485|NCT02221453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842541|NCT02221635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842542|NCT02221635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24842543|NCT02221635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24842544|NCT02221635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24684972|NCT03121534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24842564|NCT02221960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24842565|NCT02221960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24842568|NCT02221999|Hormones|hormones|mesh-list
24842569|NCT02221999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24842570|NCT02221999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24842571|NCT02221999|Tubulin Modulators|tubulin modulators|mesh-ancestor
24542595|NCT00679510|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24542596|NCT00679510|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24542597|NCT00679510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24542598|NCT00679510|Antimetabolites|antimetabolites|mesh-ancestor
24542599|NCT00679510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542600|NCT00679510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24542601|NCT00679510|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24542602|NCT00679510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227485|NCT02614404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25227486|NCT02614404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227487|NCT02614404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227488|NCT02614404|Antimalarials|antimalarials|mesh-ancestor
25227489|NCT02614404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25227490|NCT02614404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25227491|NCT02614404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25227492|NCT02614118|Acetaminophen|acetaminophen|mesh-list
25227493|NCT02614118|Ketorolac|ketorolac|mesh-list
25227494|NCT02614118|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25227495|NCT02614118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25227496|NCT02614118|Analgesics|analgesics|mesh-ancestor
25227497|NCT02614118|Sensory System Agents|sensory system agents|mesh-ancestor
25227498|NCT02614118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25227499|NCT02614118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227500|NCT02614118|Antipyretics|antipyretics|mesh-ancestor
25227501|NCT02614118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25227502|NCT02614118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25227503|NCT02614118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25227504|NCT02614118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25227505|NCT02614118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227506|NCT02614118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273371|NCT02385617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25273372|NCT02385617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25273373|NCT02385617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25273374|NCT02385734|Mitogens|mitogens|mesh-list
25273375|NCT02385734|Mitosis Modulators|mitosis modulators|mesh-ancestor
25681606|NCT01868022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25681607|NCT01868022|Tubulin Modulators|tubulin modulators|mesh-ancestor
25681608|NCT01868022|Antimitotic Agents|antimitotic agents|mesh-ancestor
25681609|NCT01868022|Mitosis Modulators|mitosis modulators|mesh-ancestor
25681610|NCT01868022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681611|NCT01868022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24602291|NCT00967967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842572|NCT02221999|Antimitotic Agents|antimitotic agents|mesh-ancestor
24842573|NCT02221999|Mitosis Modulators|mitosis modulators|mesh-ancestor
24842574|NCT02221999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842575|NCT02221999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24842576|NCT02221999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842577|NCT02221999|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24842578|NCT02221999|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24842579|NCT02221999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043719|NCT01222702|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25043720|NCT01222702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043721|NCT01222702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043722|NCT01221077|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25043723|NCT01221077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043724|NCT01221077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25043725|NCT01221077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043726|NCT01221077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043728|NCT01220947|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25043729|NCT01220947|Lactams|lactams|mesh-list
25043730|NCT01220947|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24842580|NCT02221999|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24842581|NCT02221999|Hormone Antagonists|hormone antagonists|mesh-ancestor
24842582|NCT02222142|Anesthetics|anesthetics|mesh-list
24842583|NCT02222142|Isoflurane|isoflurane|mesh-list
24842584|NCT02222142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24842585|NCT02222142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842586|NCT02222142|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24842587|NCT02222142|Anesthetics, General|anesthetics, general|mesh-ancestor
24842588|NCT02222168|BI 409306|bi 409306|mesh-list
24842589|NCT02222168|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24842590|NCT02222168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058555|NCT03495609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227507|NCT02614248|Protective Agents|protective agents|mesh-list
25227508|NCT02614248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227509|NCT02614508|Ofatumumab|ofatumumab|mesh-list
25227510|NCT02614508|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25227511|NCT02614508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25227512|NCT02614508|Immunologic Factors|immunologic factors|mesh-ancestor
25227513|NCT02614508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227514|NCT02614040|Plasma-lyte 148|plasma-lyte 148|mesh-list
25227515|NCT02614040|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25227516|NCT02614040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25227517|NCT02613715|Ethanol|ethanol|mesh-list
25227518|NCT02613715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25227519|NCT02613715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25227520|NCT02613715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25227521|NCT02613715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227522|NCT02613585|Permethrin|permethrin|mesh-list
25227523|NCT02613585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227524|NCT02613585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227525|NCT02613676|Bilirubin|bilirubin|mesh-list
25227526|NCT02613676|Antioxidants|antioxidants|mesh-ancestor
25227527|NCT02613676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227528|NCT02613676|Protective Agents|protective agents|mesh-ancestor
25227529|NCT02613676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227530|NCT02613494|Glycopyrrolate|glycopyrrolate|mesh-list
25227531|NCT02613494|Scopolamine|scopolamine|mesh-list
25227532|NCT02613494|Bromides|bromides|mesh-list
25227533|NCT02613494|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25227534|NCT02613494|Anticonvulsants|anticonvulsants|mesh-ancestor
25227535|NCT02613494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25227536|NCT02613494|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25227537|NCT02613494|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25227538|NCT02613494|Cholinergic Agents|cholinergic agents|mesh-ancestor
25227539|NCT02613494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25227540|NCT02613494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227541|NCT02613494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842592|NCT02222220|Metoclopramide|metoclopramide|mesh-list
24842593|NCT02222220|Antiemetics|antiemetics|mesh-ancestor
24405908|NCT00168766|Antiviral Agents|antiviral agents|mesh-ancestor
24405909|NCT00168766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24405910|NCT00168766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24407528|NCT00174655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407529|NCT00174655|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24842594|NCT02222220|Autonomic Agents|autonomic agents|mesh-ancestor
24842665|NCT02222636|Anesthetics|anesthetics|mesh-list
24842666|NCT02222636|Sevoflurane|sevoflurane|mesh-list
24842667|NCT02222636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24842668|NCT02222636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842669|NCT02222636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24842670|NCT02222636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24842671|NCT02222636|Analgesics|analgesics|mesh-ancestor
24842672|NCT02222636|Sensory System Agents|sensory system agents|mesh-ancestor
24842698|NCT02222727|Cholinergic Agents|cholinergic agents|mesh-ancestor
24842683|NCT02222636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25058588|NCT03495024|Varenicline|varenicline|mesh-list
24542638|NCT00679640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542663|NCT00679653|Vasodilator Agents|vasodilator agents|mesh-ancestor
24542664|NCT00679653|Antidepressive Agents|antidepressive agents|mesh-ancestor
24542665|NCT00679653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24542723|NCT00679965|Antifungal Agents|antifungal agents|mesh-ancestor
24542724|NCT00679965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24542726|NCT00680095|Antifungal Agents|antifungal agents|mesh-ancestor
24542727|NCT00680095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24542728|NCT00680108|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24708027|NCT01499485|Acetazolamide|acetazolamide|mesh-list
24542729|NCT00680108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24542731|NCT00680134|Antifungal Agents|antifungal agents|mesh-ancestor
24542732|NCT00680134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24542733|NCT00680160|Tavaborole|tavaborole|mesh-list
24542734|NCT00680160|Antifungal Agents|antifungal agents|mesh-ancestor
24542735|NCT00680160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24542736|NCT00680173|Interferons|interferons|mesh-list
24542737|NCT00680173|Ribavirin|ribavirin|mesh-list
24542738|NCT00680173|Interferon-alpha|interferon-alpha|mesh-list
24542739|NCT00680173|Interferon alpha-2|interferon alpha-2|mesh-list
24542740|NCT00680173|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24542741|NCT00680173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542742|NCT00680173|Antiviral Agents|antiviral agents|mesh-ancestor
24542784|NCT00680394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542785|NCT00680394|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24542786|NCT00680394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24542787|NCT00680394|Oxytocics|oxytocics|mesh-ancestor
24542788|NCT00680394|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24542789|NCT00680394|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24542790|NCT00680394|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24542798|NCT00680394|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24542799|NCT00680394|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24542800|NCT00680433|Ketamine|ketamine|mesh-list
24542801|NCT00680433|Analgesics|analgesics|mesh-ancestor
25227542|NCT02613494|Antiemetics|antiemetics|mesh-ancestor
25227543|NCT02613494|Autonomic Agents|autonomic agents|mesh-ancestor
25227544|NCT02613494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25227545|NCT02613494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25227546|NCT02613494|Mydriatics|mydriatics|mesh-ancestor
25227547|NCT02613494|Parasympatholytics|parasympatholytics|mesh-ancestor
25681612|NCT01868022|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25681613|NCT01868022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25681614|NCT01868035|Tositumomab I-131|tositumomab i-131|mesh-list
25681615|NCT01868035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25681616|NCT01868243|Warfarin|warfarin|mesh-list
25681617|NCT01868243|Dabigatran|dabigatran|mesh-list
25681618|NCT01868243|Anticoagulants|anticoagulants|mesh-ancestor
25227548|NCT02613455|Triamcinolone|triamcinolone|mesh-list
25227549|NCT02613455|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25227550|NCT02613455|Lidocaine|lidocaine|mesh-list
25681619|NCT01868243|Antithrombins|antithrombins|mesh-ancestor
25681620|NCT01868243|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25227553|NCT02613455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25227554|NCT02613455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227555|NCT02613455|Sensory System Agents|sensory system agents|mesh-ancestor
25227556|NCT02613455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24842685|NCT02222636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24842686|NCT02222636|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24842687|NCT02222649|Vitamin D|vitamin d|mesh-list
24842688|NCT02222649|Cholecalciferol|cholecalciferol|mesh-list
24842689|NCT02222649|Vitamins|vitamins|mesh-ancestor
24842690|NCT02222649|Micronutrients|micronutrients|mesh-ancestor
24842691|NCT02222649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842692|NCT02222649|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24842693|NCT02222649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24842694|NCT02222727|Donepezil|donepezil|mesh-list
24842695|NCT02222727|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24842696|NCT02222727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842697|NCT02222727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842736|NCT02223052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842737|NCT02223052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24842738|NCT02223052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842739|NCT02223299|Tryptophan|tryptophan|mesh-list
24842740|NCT02223299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24842741|NCT02223299|Antidepressive Agents|antidepressive agents|mesh-ancestor
24842742|NCT02223299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24842743|NCT02223377|Morphine|morphine|mesh-list
24842744|NCT02223377|Hydromorphone|hydromorphone|mesh-list
24842745|NCT02223377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24842746|NCT02223377|Narcotics|narcotics|mesh-ancestor
24842747|NCT02223377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24842748|NCT02223377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842749|NCT02223377|Analgesics|analgesics|mesh-ancestor
24542802|NCT00680433|Sensory System Agents|sensory system agents|mesh-ancestor
24542803|NCT00680433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24542805|NCT00680433|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24542811|NCT00680433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24542812|NCT00680433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24542813|NCT00680433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542814|NCT00680446|Immunoglobulins|immunoglobulins|mesh-list
24542815|NCT00680446|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24542816|NCT00680446|Antibodies|antibodies|mesh-list
24542817|NCT00680446|Immunoglobulin G|immunoglobulin g|mesh-list
24542818|NCT00680446|Immunologic Factors|immunologic factors|mesh-ancestor
24542819|NCT00680446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227557|NCT02613455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25227558|NCT02613455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25227559|NCT02613455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25227560|NCT02613455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25227561|NCT02613455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227562|NCT02613455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25227563|NCT02613455|Glucocorticoids|glucocorticoids|mesh-ancestor
25227564|NCT02613455|Hormones|hormones|mesh-ancestor
25227565|NCT02613455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25227566|NCT02613455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25227567|NCT02613455|Immunologic Factors|immunologic factors|mesh-ancestor
25227568|NCT02613195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25227569|NCT02613247|Hylan|hylan|mesh-list
25227570|NCT02613247|Viscosupplements|viscosupplements|mesh-ancestor
25227571|NCT02613247|Protective Agents|protective agents|mesh-ancestor
25227572|NCT02613247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227573|NCT02613130|Fluorides|fluorides|mesh-list
25227574|NCT02613130|Tin Fluorides|tin fluorides|mesh-list
25227575|NCT02613130|Cariostatic Agents|cariostatic agents|mesh-ancestor
25227576|NCT02613130|Protective Agents|protective agents|mesh-ancestor
24409872|NCT00183807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25227577|NCT02613130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227578|NCT02613091|Clemastine|clemastine|mesh-list
25227579|NCT02613091|Antipruritics|antipruritics|mesh-ancestor
25227580|NCT02613091|Dermatologic Agents|dermatologic agents|mesh-ancestor
25227581|NCT02613091|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25227582|NCT02613091|Histamine Antagonists|histamine antagonists|mesh-ancestor
25227583|NCT02613091|Histamine Agents|histamine agents|mesh-ancestor
25227584|NCT02613091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24842750|NCT02223377|Sensory System Agents|sensory system agents|mesh-ancestor
24842751|NCT02223377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24842752|NCT02223416|Teriparatide|teriparatide|mesh-list
24842753|NCT02223416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24842754|NCT02223416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842755|NCT02223416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24842756|NCT02223533|Morphine|morphine|mesh-list
24842757|NCT02223533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24842758|NCT02223533|Narcotics|narcotics|mesh-ancestor
24842759|NCT02223533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25227767|NCT02612181|Analgesics|analgesics|mesh-ancestor
24842760|NCT02223533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557259|NCT00752037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24542899|NCT00680732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542900|NCT00680732|Amebicides|amebicides|mesh-ancestor
24542901|NCT00680732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24542902|NCT00680732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24542903|NCT00680732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24857934|NCT02294539|Amlodipine|amlodipine|mesh-list
24440948|NCT00285389|Hormones|hormones|mesh-ancestor
24542904|NCT00680732|Antimalarials|antimalarials|mesh-ancestor
24542905|NCT00680732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24542906|NCT00680732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24542907|NCT00680732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542908|NCT00680732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542909|NCT00680758|Paclitaxel|paclitaxel|mesh-list
24542910|NCT00680758|Everolimus|everolimus|mesh-list
24542911|NCT00680758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24542912|NCT00680758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542913|NCT00680758|Tubulin Modulators|tubulin modulators|mesh-ancestor
24542914|NCT00680758|Antimitotic Agents|antimitotic agents|mesh-ancestor
24542915|NCT00680758|Mitosis Modulators|mitosis modulators|mesh-ancestor
24542916|NCT00680758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542917|NCT00680758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24542918|NCT00680758|Immunologic Factors|immunologic factors|mesh-ancestor
25227585|NCT02613091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681621|NCT01868243|Protease Inhibitors|protease inhibitors|mesh-ancestor
25681622|NCT01868243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25681623|NCT01868243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681624|NCT01868425|Acetaminophen|acetaminophen|mesh-list
25681625|NCT01868425|Ketamine|ketamine|mesh-list
25681626|NCT01868425|Gabapentin|gabapentin|mesh-list
25681627|NCT01868425|Bupivacaine|bupivacaine|mesh-list
25681628|NCT01868425|Anesthetics, Local|anesthetics, local|mesh-ancestor
25681629|NCT01868425|Anesthetics|anesthetics|mesh-ancestor
25034138|NCT03567434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25034139|NCT03567434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25034140|NCT03567434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034141|NCT03567408|Bivalirudin|bivalirudin|mesh-list
25034142|NCT03567408|Antithrombins|antithrombins|mesh-ancestor
24806078|NCT02013492|Adrenergic Agents|adrenergic agents|mesh-ancestor
24991777|NCT05008276|Dextrans|dextrans|mesh-list
24410325|NCT00185094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24410326|NCT00185094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227586|NCT02613091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994956|NCT00089245|Iodine|iodine|mesh-list
25227587|NCT02613091|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25227588|NCT02612948|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25227589|NCT02612948|Antidepressive Agents|antidepressive agents|mesh-ancestor
25227590|NCT02612948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25227591|NCT02612948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25227592|NCT02612948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25227593|NCT02612948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25227594|NCT02612948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227595|NCT02612844|Insulin Aspart|insulin aspart|mesh-list
24842781|NCT02223611|Antimitotic Agents|antimitotic agents|mesh-ancestor
24842782|NCT02223611|Mitosis Modulators|mitosis modulators|mesh-ancestor
24842783|NCT02223611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842784|NCT02223819|Crizotinib|crizotinib|mesh-list
24842785|NCT02223819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24842786|NCT02223819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24842787|NCT02223819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842788|NCT02223819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227814|NCT02611973|Aspirin|aspirin|mesh-list
25043782|NCT01205048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25043783|NCT01205048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043784|NCT01204762|Entecavir|entecavir|mesh-list
25043785|NCT01204762|Antiviral Agents|antiviral agents|mesh-ancestor
25043786|NCT01204762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24857935|NCT02294539|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24857936|NCT02294539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24857937|NCT02294539|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24857938|NCT02294539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24440999|NCT00285662|Schistosomicides|schistosomicides|mesh-ancestor
25227596|NCT02612844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25227597|NCT02612844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227598|NCT02613052|Propofol|propofol|mesh-list
25227599|NCT02613052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25227600|NCT02613052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25227601|NCT02613052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227602|NCT02613052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25227603|NCT02613052|Anesthetics, General|anesthetics, general|mesh-ancestor
25227604|NCT02613052|Anesthetics|anesthetics|mesh-ancestor
25227605|NCT02613013|Proxymetacaine|proxymetacaine|mesh-list
25227606|NCT02613013|Pilocarpine|pilocarpine|mesh-list
25227607|NCT02613013|Miotics|miotics|mesh-ancestor
25681630|NCT01868425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25681631|NCT01868425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681632|NCT01868425|Sensory System Agents|sensory system agents|mesh-ancestor
25681633|NCT01868425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25681634|NCT01868425|Analgesics|analgesics|mesh-ancestor
25681635|NCT01868425|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25681636|NCT01868425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25681637|NCT01868425|Anesthetics, General|anesthetics, general|mesh-ancestor
25681638|NCT01868425|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25681639|NCT01868425|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25681640|NCT01868425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25227608|NCT02613013|Autonomic Agents|autonomic agents|mesh-ancestor
25113994|NCT01552434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25113996|NCT01552434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25113997|NCT01552434|Growth Inhibitors|growth inhibitors|mesh-ancestor
25113998|NCT01552434|Immunologic Factors|immunologic factors|mesh-ancestor
25113999|NCT01552434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25114000|NCT01552434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25114002|NCT01552434|Antifungal Agents|antifungal agents|mesh-ancestor
25227609|NCT02613013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25227610|NCT02613013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227611|NCT02613013|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25227612|NCT02613013|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25227613|NCT02613013|Cholinergic Agents|cholinergic agents|mesh-ancestor
25227614|NCT02613013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25227615|NCT02613013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227616|NCT02613013|Anesthetics, Local|anesthetics, local|mesh-ancestor
25227617|NCT02613013|Anesthetics|anesthetics|mesh-ancestor
25043788|NCT01204749|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25043790|NCT01204749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
25043791|NCT01204749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25043792|NCT01204749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043793|NCT01204749|Tubulin Modulators|tubulin modulators|mesh-ancestor
25043794|NCT01204749|Antimitotic Agents|antimitotic agents|mesh-ancestor
25043795|NCT01204749|Mitosis Modulators|mitosis modulators|mesh-ancestor
25043796|NCT01204749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043797|NCT01204749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24602594|NCT00969631|Metformin|metformin|mesh-list
24842789|NCT02223832|Ponesimod|ponesimod|mesh-list
24542938|NCT00681135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542939|NCT00681148|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24857940|NCT02294539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24995066|NCT05418244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24995067|NCT05418244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995068|NCT05418244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24995069|NCT05418244|Antipruritics|antipruritics|mesh-ancestor
25227618|NCT02613013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25681641|NCT01868425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681642|NCT01868425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25681643|NCT01868425|Antipyretics|antipyretics|mesh-ancestor
25681644|NCT01868425|Anticonvulsants|anticonvulsants|mesh-ancestor
25681645|NCT01868425|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25681646|NCT01868425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25681647|NCT01868425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25681648|NCT01868425|Antimanic Agents|antimanic agents|mesh-ancestor
25681649|NCT01868477|Epoetin Alfa|epoetin alfa|mesh-list
25681650|NCT01868477|Deferasirox|deferasirox|mesh-list
25227631|NCT02613026|Pirarubicin|pirarubicin|mesh-list
24542975|NCT00681213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24542979|NCT00681226|Ramipril|ramipril|mesh-list
24542980|NCT00681226|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24542981|NCT00681226|Protease Inhibitors|protease inhibitors|mesh-ancestor
24542995|NCT00681395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24542996|NCT00681395|Antimetabolites|antimetabolites|mesh-ancestor
24542997|NCT00681395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708261|NCT01500850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24995096|NCT05418114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24995099|NCT05418114|Tocolytic Agents|tocolytic agents|mesh-ancestor
24542998|NCT00681395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24542999|NCT00681395|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24543000|NCT00681395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543002|NCT00681460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24543007|NCT00681525|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24543008|NCT00681525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24543009|NCT00681525|Antimetabolites|antimetabolites|mesh-ancestor
24543010|NCT00681525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446971|NCT00306774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543027|NCT00681720|GABA Agents|gaba agents|mesh-ancestor
24543028|NCT00681720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25227632|NCT02613026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25227633|NCT02613026|Immunologic Factors|immunologic factors|mesh-ancestor
25227634|NCT02613026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227635|NCT02613026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25227636|NCT02613026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25227637|NCT02613026|Alkylating Agents|alkylating agents|mesh-ancestor
25227638|NCT02613026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227639|NCT02613026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24995135|NCT05417997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25227640|NCT02613026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25227641|NCT02613026|Tubulin Modulators|tubulin modulators|mesh-ancestor
25681651|NCT01868477|Hematinics|hematinics|mesh-ancestor
25681652|NCT01868477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25681653|NCT01868477|Chelating Agents|chelating agents|mesh-ancestor
25681654|NCT01868477|Sequestering Agents|sequestering agents|mesh-ancestor
25681655|NCT01868477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681656|NCT01868503|Lapatinib|lapatinib|mesh-list
25681657|NCT01868503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25681658|NCT01868503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25681659|NCT01868503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25681660|NCT01868503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681661|NCT01868542|Insulin Detemir|insulin detemir|mesh-list
24995154|NCT05417893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24995155|NCT05417893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24995156|NCT05417893|Immunologic Factors|immunologic factors|mesh-ancestor
25227646|NCT02612896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25227647|NCT02612896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25227648|NCT02612792|Atorvastatin|atorvastatin|mesh-list
25227649|NCT02612792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25227650|NCT02612792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25227651|NCT02612792|Antimetabolites|antimetabolites|mesh-ancestor
25227652|NCT02612792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227653|NCT02612792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25227654|NCT02612792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25227655|NCT02612792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227656|NCT02612545|Piperaquine|piperaquine|mesh-list
25227657|NCT02612545|Artenimol|artenimol|mesh-list
25227658|NCT02612545|Mefloquine|mefloquine|mesh-list
25227659|NCT02612545|Antimalarials|antimalarials|mesh-ancestor
25227660|NCT02612545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25227661|NCT02612545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25227662|NCT02612545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25227663|NCT02612480|Aspirin|aspirin|mesh-list
24842834|NCT02224066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24842835|NCT02224066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24842837|NCT02224066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24842838|NCT02224105|Prednisolone|prednisolone|mesh-list
24842839|NCT02224105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25681662|NCT01868542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25681663|NCT01868542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681664|NCT01868633|Dexamethasone|dexamethasone|mesh-list
25681665|NCT01868633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25681666|NCT01868633|Antiemetics|antiemetics|mesh-ancestor
25681667|NCT01868633|Autonomic Agents|autonomic agents|mesh-ancestor
25681668|NCT01868633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25681669|NCT01868633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227667|NCT02612480|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25227668|NCT02612480|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25227669|NCT02612480|Analgesics|analgesics|mesh-ancestor
25227670|NCT02612480|Sensory System Agents|sensory system agents|mesh-ancestor
25227671|NCT02612480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25227672|NCT02612480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227673|NCT02612480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25227674|NCT02612480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25227675|NCT02612480|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25227676|NCT02612480|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25227677|NCT02612480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227678|NCT02612480|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25227679|NCT02612480|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25227680|NCT02612480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227681|NCT02612480|Antipyretics|antipyretics|mesh-ancestor
25227682|NCT02612480|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25227683|NCT02612480|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25227684|NCT02612480|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25227685|NCT02612480|Purinergic Agents|purinergic agents|mesh-ancestor
25227686|NCT02612480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25227687|NCT02612701|Nicotine|nicotine|mesh-list
25227688|NCT02612701|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25227689|NCT02612701|Autonomic Agents|autonomic agents|mesh-ancestor
25227690|NCT02612701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25227691|NCT02612701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227692|NCT02612701|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25227693|NCT02612701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25227694|NCT02612701|Cholinergic Agents|cholinergic agents|mesh-ancestor
25227695|NCT02612701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25227696|NCT02612701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227697|NCT02612649|Ramosetron|ramosetron|mesh-list
25227698|NCT02612649|Antiemetics|antiemetics|mesh-ancestor
25227699|NCT02612649|Autonomic Agents|autonomic agents|mesh-ancestor
25227700|NCT02612649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24842875|NCT02224131|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24842883|NCT02224170|Antiemetics|antiemetics|mesh-ancestor
24842884|NCT02224170|Autonomic Agents|autonomic agents|mesh-ancestor
24842885|NCT02224170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24842886|NCT02224170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842887|NCT02224170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24842888|NCT02224170|Glucocorticoids|glucocorticoids|mesh-ancestor
24842889|NCT02224170|Hormones|hormones|mesh-ancestor
24842923|NCT02224443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842925|NCT02224443|Anesthetics, General|anesthetics, general|mesh-ancestor
24842926|NCT02224443|Anesthetics|anesthetics|mesh-ancestor
24842927|NCT02224443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25681670|NCT01868633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25681671|NCT01868633|Glucocorticoids|glucocorticoids|mesh-ancestor
24842928|NCT02224443|Analgesics|analgesics|mesh-ancestor
25058679|NCT03493841|Thioctic Acid|thioctic acid|mesh-list
25681672|NCT01868633|Hormones|hormones|mesh-ancestor
25681673|NCT01868633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24857943|NCT02294539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24857944|NCT02294539|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24857945|NCT02294539|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24857946|NCT02294539|Diuretics|diuretics|mesh-ancestor
24857947|NCT02294539|Natriuretic Agents|natriuretic agents|mesh-ancestor
24543100|NCT00681928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543101|NCT00681928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24543104|NCT00681941|Sequestering Agents|sequestering agents|mesh-ancestor
24543105|NCT00681941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543106|NCT00681967|Gefitinib|gefitinib|mesh-list
24543107|NCT00681967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543108|NCT00681967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25227701|NCT02612649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227702|NCT02612649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25227703|NCT02612649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25227704|NCT02612649|Serotonin Agents|serotonin agents|mesh-ancestor
25227705|NCT02612649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25227706|NCT02612649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227707|NCT02612714|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25227708|NCT02612714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25227709|NCT02612714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25227710|NCT02612714|Antimetabolites|antimetabolites|mesh-ancestor
25227711|NCT02612714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227712|NCT02612714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25227713|NCT02612714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25227714|NCT02612714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273376|NCT02385734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842930|NCT02224443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24842931|NCT02224443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24842932|NCT02224443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24842935|NCT02224443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24995241|NCT05417087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24842936|NCT02224443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842937|NCT02224443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24842938|NCT02224443|Narcotics|narcotics|mesh-ancestor
24842939|NCT02224443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24842940|NCT02224443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24842941|NCT02224443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24842942|NCT02224443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24842945|NCT02224443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24842946|NCT02224443|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24842947|NCT02224443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24842948|NCT02224443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24842949|NCT02224443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24842950|NCT02224443|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24842951|NCT02224443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24842952|NCT02224443|Cholinergic Agents|cholinergic agents|mesh-ancestor
24842953|NCT02224456|Tenofovir|tenofovir|mesh-list
24842954|NCT02224456|Antiviral Agents|antiviral agents|mesh-ancestor
24842955|NCT02224456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24842956|NCT02224456|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24842965|NCT02224534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24842966|NCT02224534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24842988|NCT02224950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842989|NCT02224950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24543109|NCT00681967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543110|NCT00681967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543111|NCT00681980|Valproic Acid|valproic acid|mesh-list
24543112|NCT00681980|Anticonvulsants|anticonvulsants|mesh-ancestor
24543113|NCT00681980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227715|NCT02612363|Dexmedetomidine|dexmedetomidine|mesh-list
24412505|NCT00191542|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25227716|NCT02612363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25227717|NCT02612363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25227718|NCT02612363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227719|NCT02612363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25227720|NCT02612363|Analgesics|analgesics|mesh-ancestor
25227721|NCT02612363|Sensory System Agents|sensory system agents|mesh-ancestor
25227722|NCT02612363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25227723|NCT02612363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25227724|NCT02612363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25227725|NCT02612363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25227726|NCT02612363|Adrenergic Agents|adrenergic agents|mesh-ancestor
25227727|NCT02612363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25227729|NCT02612272|Ketorolac|ketorolac|mesh-list
25227730|NCT02612272|Betamethasone|betamethasone|mesh-list
25227731|NCT02612272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25227732|NCT02612272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25227733|NCT02612272|Analgesics|analgesics|mesh-ancestor
25227734|NCT02612272|Sensory System Agents|sensory system agents|mesh-ancestor
25227735|NCT02612272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25227736|NCT02612272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227737|NCT02612272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25227738|NCT02612272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25227739|NCT02612272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25227740|NCT02612272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227813|NCT02612116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227741|NCT02612272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227742|NCT02612272|Glucocorticoids|glucocorticoids|mesh-ancestor
25227744|NCT02612272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24842991|NCT02224950|Sequestering Agents|sequestering agents|mesh-ancestor
24842992|NCT02224950|Hemostatics|hemostatics|mesh-ancestor
24842993|NCT02224950|Coagulants|coagulants|mesh-ancestor
24842994|NCT02224950|Dermatologic Agents|dermatologic agents|mesh-ancestor
24842995|NCT02225054|Dexmedetomidine|dexmedetomidine|mesh-list
24619547|NCT01052961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24842998|NCT02225054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24842999|NCT02225054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843000|NCT02225054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24843001|NCT02225054|Analgesics|analgesics|mesh-ancestor
24843002|NCT02225054|Sensory System Agents|sensory system agents|mesh-ancestor
24843003|NCT02225054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24843004|NCT02225054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25058724|NCT03493412|Verapamil|verapamil|mesh-list
24543142|NCT00681993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24543147|NCT00682006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24543148|NCT00682006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24543150|NCT00682006|Dermatologic Agents|dermatologic agents|mesh-ancestor
24543151|NCT00682019|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24543152|NCT00682019|Vasodilator Agents|vasodilator agents|mesh-ancestor
24543153|NCT00682019|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24543154|NCT00682019|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25681674|NCT01868633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25681675|NCT01868633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25681676|NCT01868776|Lidocaine|lidocaine|mesh-list
25681677|NCT01868776|Anesthetics, Local|anesthetics, local|mesh-ancestor
25681678|NCT01868776|Anesthetics|anesthetics|mesh-ancestor
25681679|NCT01868776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25681680|NCT01868776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681681|NCT01868776|Sensory System Agents|sensory system agents|mesh-ancestor
25681682|NCT01868776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25681683|NCT01868776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25681684|NCT01868776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24991284|NCT05196256|Sensory System Agents|sensory system agents|mesh-ancestor
24991285|NCT05196256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24991286|NCT05196256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24991287|NCT05196256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25227745|NCT02612272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25227746|NCT02612272|Respiratory System Agents|respiratory system agents|mesh-ancestor
25227748|NCT02612298|Arotinolol|arotinolol|mesh-list
25227749|NCT02612298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25227750|NCT02612298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25227751|NCT02612298|Sympatholytics|sympatholytics|mesh-ancestor
25227752|NCT02612298|Autonomic Agents|autonomic agents|mesh-ancestor
25227753|NCT02612298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25227754|NCT02612298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227755|NCT02612298|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25227756|NCT02612298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25227757|NCT02612298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25227758|NCT02612298|Adrenergic Agents|adrenergic agents|mesh-ancestor
25227759|NCT02612298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25227760|NCT02612298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227761|NCT02612298|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25227762|NCT02612181|Dexmedetomidine|dexmedetomidine|mesh-list
25227763|NCT02612181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25227764|NCT02612181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25227765|NCT02612181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227766|NCT02612181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24995242|NCT05417087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843006|NCT02225054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24843007|NCT02225054|Adrenergic Agents|adrenergic agents|mesh-ancestor
24843008|NCT02225054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24843009|NCT02225054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843010|NCT02225054|Anesthetics, Local|anesthetics, local|mesh-ancestor
24543177|NCT00682214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24543178|NCT00682214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24543179|NCT00682279|Topotecan|topotecan|mesh-list
24543180|NCT00682279|Lapatinib|lapatinib|mesh-list
24543181|NCT00682279|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24543182|NCT00682279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24543183|NCT00682279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446608|NCT00305461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24446609|NCT00305461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446610|NCT00305461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24446611|NCT00305474|Risperidone|risperidone|mesh-list
24995243|NCT05417087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24543190|NCT00682292|Immunologic Factors|immunologic factors|mesh-ancestor
24543191|NCT00682292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543192|NCT00682292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25681685|NCT01868776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25681686|NCT01868776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25681687|NCT01868776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681688|NCT01868893|Obinutuzumab|obinutuzumab|mesh-list
25681689|NCT01868893|Chlorambucil|chlorambucil|mesh-list
25681690|NCT01868893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25681691|NCT01868893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413336|NCT00193557|Bortezomib|bortezomib|mesh-list
24413337|NCT00193557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413367|NCT00193635|Mycophenolic Acid|mycophenolic acid|mesh-list
24413368|NCT00193635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24413369|NCT00193635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25681692|NCT01868893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24543193|NCT00682344|Levobupivacaine|levobupivacaine|mesh-list
24543194|NCT00682344|Anesthetics, Local|anesthetics, local|mesh-ancestor
24543195|NCT00682344|Anesthetics|anesthetics|mesh-ancestor
24543197|NCT00682344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543198|NCT00682344|Sensory System Agents|sensory system agents|mesh-ancestor
24543199|NCT00682344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24543200|NCT00682383|Docetaxel|docetaxel|mesh-list
24543201|NCT00682383|Etoposide|etoposide|mesh-list
24543202|NCT00682383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543203|NCT00682383|Tubulin Modulators|tubulin modulators|mesh-ancestor
24708540|NCT01501591|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25227769|NCT02612181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25227770|NCT02612181|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25227771|NCT02612181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25227772|NCT02612181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25227773|NCT02612181|Adrenergic Agents|adrenergic agents|mesh-ancestor
25227774|NCT02612181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25227775|NCT02612181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227776|NCT02612259|Tryptophan|tryptophan|mesh-list
24843024|NCT02225093|Purinergic Agents|purinergic agents|mesh-ancestor
24843025|NCT02225093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24843026|NCT02225093|Antitussive Agents|antitussive agents|mesh-ancestor
24843027|NCT02225093|Respiratory System Agents|respiratory system agents|mesh-ancestor
24843028|NCT02225093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24843029|NCT02225093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24843030|NCT02225210|Fentanyl|fentanyl|mesh-list
24843031|NCT02225210|Midazolam|midazolam|mesh-list
24843032|NCT02225210|Dexmedetomidine|dexmedetomidine|mesh-list
24843033|NCT02225210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24995248|NCT05417087|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24843034|NCT02225210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24843035|NCT02225210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843036|NCT02225210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24843037|NCT02225210|Analgesics|analgesics|mesh-ancestor
24843038|NCT02225210|Sensory System Agents|sensory system agents|mesh-ancestor
24843039|NCT02225210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953205|NCT03887871|Tamsulosin|tamsulosin|mesh-list
24843040|NCT02225210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24843041|NCT02225210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24843042|NCT02225210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24843043|NCT02225210|Adrenergic Agents|adrenergic agents|mesh-ancestor
24843044|NCT02225210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25058762|NCT03493061|Irinotecan|irinotecan|mesh-list
24543252|NCT00682656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24543253|NCT00682656|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24543254|NCT00682656|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25681693|NCT01868893|Alkylating Agents|alkylating agents|mesh-ancestor
25681694|NCT01868893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681695|NCT01869192|Cyclophosphamide|cyclophosphamide|mesh-list
25681696|NCT01869192|Docetaxel|docetaxel|mesh-list
25681697|NCT01869192|Capecitabine|capecitabine|mesh-list
24543255|NCT00682721|Valacyclovir|valacyclovir|mesh-list
25681698|NCT01869192|Epirubicin|epirubicin|mesh-list
25681699|NCT01869192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25681700|NCT01869192|Immunologic Factors|immunologic factors|mesh-ancestor
25681701|NCT01869192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681702|NCT01869192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24543256|NCT00682721|Antiviral Agents|antiviral agents|mesh-ancestor
24543257|NCT00682721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24543258|NCT00682760|Botulinum Toxins|botulinum toxins|mesh-list
25227778|NCT02612259|Antidepressive Agents|antidepressive agents|mesh-ancestor
25227779|NCT02612259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25227780|NCT02612233|Pregabalin|pregabalin|mesh-list
25227781|NCT02612233|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25227782|NCT02612233|Analgesics|analgesics|mesh-ancestor
25227783|NCT02612233|Sensory System Agents|sensory system agents|mesh-ancestor
25227784|NCT02612233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25227785|NCT02612233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227786|NCT02612233|Anticonvulsants|anticonvulsants|mesh-ancestor
25227787|NCT02612233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25227788|NCT02612233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25227789|NCT02612233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227790|NCT02612233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24798016|NCT01959477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24798017|NCT01959477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227791|NCT02612233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25227792|NCT02612233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25227793|NCT02612233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25227794|NCT02612233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25227795|NCT02612233|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25227796|NCT02612233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25227797|NCT02612233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25227798|NCT02612233|Antidepressive Agents|antidepressive agents|mesh-ancestor
25227801|NCT02612207|Antioxidants|antioxidants|mesh-ancestor
25227802|NCT02612207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227803|NCT02612207|Protective Agents|protective agents|mesh-ancestor
24843045|NCT02225210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843046|NCT02225210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24843047|NCT02225210|Narcotics|narcotics|mesh-ancestor
24843072|NCT02225418|Sensory System Agents|sensory system agents|mesh-ancestor
24843073|NCT02225418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24843074|NCT02225470|Vinorelbine|vinorelbine|mesh-list
24843075|NCT02225470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24843076|NCT02225470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843077|NCT02225470|Tubulin Modulators|tubulin modulators|mesh-ancestor
24843078|NCT02225470|Antimitotic Agents|antimitotic agents|mesh-ancestor
24843079|NCT02225470|Mitosis Modulators|mitosis modulators|mesh-ancestor
24843080|NCT02225470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843082|NCT02225548|Selegiline|selegiline|mesh-list
24843083|NCT02225548|Vasodilator Agents|vasodilator agents|mesh-ancestor
24843084|NCT02225548|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24843085|NCT02225548|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24843086|NCT02225548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24843087|NCT02225548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602908|NCT00971659|Hormones|hormones|mesh-ancestor
24843089|NCT02225548|Antidepressive Agents|antidepressive agents|mesh-ancestor
24843090|NCT02225548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24843091|NCT02225548|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24843092|NCT02225548|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24843093|NCT02225548|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24843094|NCT02225548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24843095|NCT02225548|Protective Agents|protective agents|mesh-ancestor
24843096|NCT02225548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843098|NCT02225652|Cyclophosphamide|cyclophosphamide|mesh-list
24843099|NCT02225652|Fluorouracil|fluorouracil|mesh-list
24543325|NCT00683137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24543326|NCT00683137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24543327|NCT00683176|Choline|choline|mesh-list
24995298|NCT05366192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24995299|NCT05366192|Protease Inhibitors|protease inhibitors|mesh-ancestor
24995300|NCT05366192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24995301|NCT05366192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543328|NCT00683176|Fenofibrate|fenofibrate|mesh-list
24543329|NCT00683176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25227804|NCT02612207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227805|NCT02612116|Ticagrelor|ticagrelor|mesh-list
25227806|NCT02612116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25227807|NCT02612116|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25227808|NCT02612116|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25227809|NCT02612116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25227810|NCT02612116|Purinergic Agents|purinergic agents|mesh-ancestor
25227811|NCT02612116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25227812|NCT02612116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227815|NCT02611973|Hydroxyurea|hydroxyurea|mesh-list
25227816|NCT02611973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25227817|NCT02611973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25227818|NCT02611973|Analgesics|analgesics|mesh-ancestor
25227819|NCT02611973|Sensory System Agents|sensory system agents|mesh-ancestor
25227820|NCT02611973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25227821|NCT02611973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227822|NCT02611973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25227823|NCT02611973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25227824|NCT02611973|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25227825|NCT02611973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25227826|NCT02611973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227827|NCT02611973|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25227828|NCT02611973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25227829|NCT02611973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227830|NCT02611973|Antipyretics|antipyretics|mesh-ancestor
25227831|NCT02611973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843101|NCT02225652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24843102|NCT02225652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843103|NCT02225652|Tubulin Modulators|tubulin modulators|mesh-ancestor
24843104|NCT02225652|Antimitotic Agents|antimitotic agents|mesh-ancestor
24843105|NCT02225652|Mitosis Modulators|mitosis modulators|mesh-ancestor
24843106|NCT02225652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843128|NCT02225756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24843129|NCT02225756|Dermatologic Agents|dermatologic agents|mesh-ancestor
24843130|NCT02225756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24843143|NCT02225795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24843144|NCT02225795|Alkylating Agents|alkylating agents|mesh-ancestor
24543330|NCT00683176|Antimetabolites|antimetabolites|mesh-ancestor
24543331|NCT00683176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681703|NCT01869192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25681704|NCT01869192|Alkylating Agents|alkylating agents|mesh-ancestor
25681705|NCT01869192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681706|NCT01869192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24414726|NCT00198523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24414727|NCT00198523|Protective Agents|protective agents|mesh-ancestor
24414728|NCT00198523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24414731|NCT00198536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24414732|NCT00198536|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24414733|NCT00198536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24543374|NCT00683319|Alkylating Agents|alkylating agents|mesh-ancestor
24543375|NCT00683319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543376|NCT00683319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543377|NCT00683319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24543378|NCT00683319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24543379|NCT00683319|Abortifacient Agents|abortifacient agents|mesh-ancestor
24543380|NCT00683319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24543381|NCT00683319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24543382|NCT00683319|Antimetabolites|antimetabolites|mesh-ancestor
24543383|NCT00683319|Dermatologic Agents|dermatologic agents|mesh-ancestor
24543385|NCT00683319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24543395|NCT00683358|Immunologic Factors|immunologic factors|mesh-ancestor
24543453|NCT00683865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24543454|NCT00683865|Renal Agents|renal agents|mesh-ancestor
25227832|NCT02611973|Antisickling Agents|antisickling agents|mesh-ancestor
25227833|NCT02611973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25227837|NCT02611908|Obinutuzumab|obinutuzumab|mesh-list
25227838|NCT02611908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25227842|NCT02611921|Sensory System Agents|sensory system agents|mesh-ancestor
25227843|NCT02611921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25227844|NCT02611921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227845|NCT02611921|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25227846|NCT02611921|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25227847|NCT02611921|Anesthetics, General|anesthetics, general|mesh-ancestor
25227848|NCT02611921|Anesthetics|anesthetics|mesh-ancestor
25227849|NCT02611921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25227850|NCT02611921|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24843147|NCT02225795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24843149|NCT02225834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24843150|NCT02225834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24843151|NCT02225834|Antimetabolites|antimetabolites|mesh-ancestor
24843152|NCT02225834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843153|NCT02225834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24843154|NCT02225834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24843155|NCT02225834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058832|NCT03492736|Melatonin|melatonin|mesh-list
24543455|NCT00683865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24543456|NCT00683865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24543457|NCT00683891|Clozapine|clozapine|mesh-list
24543458|NCT00683891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24543459|NCT00683891|Serotonin Agents|serotonin agents|mesh-ancestor
24543460|NCT00683891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24543461|NCT00683891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543462|NCT00683891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681707|NCT01869192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25681708|NCT01869192|Tubulin Modulators|tubulin modulators|mesh-ancestor
25681709|NCT01869192|Antimitotic Agents|antimitotic agents|mesh-ancestor
25681710|NCT01869192|Mitosis Modulators|mitosis modulators|mesh-ancestor
25681711|NCT01869192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25681712|NCT01869192|Antimetabolites|antimetabolites|mesh-ancestor
24992015|NCT04625946|Metformin|metformin|mesh-list
24414748|NCT00198562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414749|NCT00198562|Vasodilator Agents|vasodilator agents|mesh-ancestor
24414750|NCT00198562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24414751|NCT00198562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24414752|NCT00198562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24414753|NCT00198588|Argatroban|argatroban|mesh-list
24414754|NCT00198588|Antithrombins|antithrombins|mesh-ancestor
24414755|NCT00198588|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24543470|NCT00683943|Antidepressive Agents|antidepressive agents|mesh-ancestor
24543472|NCT00683943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543473|NCT00683943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543474|NCT00683943|Antimanic Agents|antimanic agents|mesh-ancestor
24543475|NCT00683943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24543476|NCT00683943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24543480|NCT00683956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24543487|NCT00683969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543488|NCT00683969|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24543489|NCT00683969|Antitubercular Agents|antitubercular agents|mesh-ancestor
24543490|NCT00683969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25227851|NCT02611921|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25227852|NCT02611921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25227853|NCT02611921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227854|NCT02611700|Paclitaxel|paclitaxel|mesh-list
25227855|NCT02611700|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24843158|NCT02225886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843159|NCT02225886|Protective Agents|protective agents|mesh-ancestor
24843160|NCT02225886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843161|NCT02225886|Vitamins|vitamins|mesh-ancestor
25068041|NCT03437057|Antipyretics|antipyretics|mesh-ancestor
25681713|NCT01869192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25681714|NCT01869192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25681715|NCT01869192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25681716|NCT01869192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25681717|NCT01869634|Ritonavir|ritonavir|mesh-list
25681718|NCT01869634|Darunavir|darunavir|mesh-list
25681719|NCT01869634|Emtricitabine|emtricitabine|mesh-list
25681720|NCT01869634|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25681721|NCT01869634|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25681722|NCT01869634|Protease Inhibitors|protease inhibitors|mesh-ancestor
24414830|NCT00198978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24414831|NCT00198978|Immunologic Factors|immunologic factors|mesh-ancestor
24414832|NCT00198978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414833|NCT00198978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24414834|NCT00198978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24843172|NCT02226068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843212|NCT02226328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843213|NCT02226328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24843214|NCT02226328|Anesthetics, General|anesthetics, general|mesh-ancestor
24843230|NCT02226341|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24843231|NCT02226341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24843232|NCT02226341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843233|NCT02226341|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24843234|NCT02226341|Antitubercular Agents|antitubercular agents|mesh-ancestor
24843235|NCT02226341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24843236|NCT02226341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24843237|NCT02226341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24843238|NCT02226341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843239|NCT02226341|Hormones|hormones|mesh-ancestor
25058835|NCT03492736|Protective Agents|protective agents|mesh-ancestor
24543500|NCT00683995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24543501|NCT00683995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227863|NCT02611700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543502|NCT00683995|Analgesics|analgesics|mesh-ancestor
25227864|NCT02611700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25227865|NCT02611596|Ranolazine|ranolazine|mesh-list
25227866|NCT02611596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25227867|NCT02611596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25227868|NCT02611596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227869|NCT02611635|Warfarin|warfarin|mesh-list
25227870|NCT02611635|Rivaroxaban|rivaroxaban|mesh-list
25227871|NCT02611635|Dabigatran|dabigatran|mesh-list
25227872|NCT02611635|Apixaban|apixaban|mesh-list
25227873|NCT02611635|Edoxaban|edoxaban|mesh-list
25227874|NCT02611635|Anticoagulants|anticoagulants|mesh-ancestor
25227875|NCT02611635|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25227876|NCT02611635|Antithrombins|antithrombins|mesh-ancestor
25227877|NCT02611635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25227878|NCT02611635|Protease Inhibitors|protease inhibitors|mesh-ancestor
25227879|NCT02611635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227880|NCT02611635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227881|NCT02611804|Diclofenac|diclofenac|mesh-list
25227886|NCT02611804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25227887|NCT02611804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227888|NCT02611804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25227889|NCT02611804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25227890|NCT02611804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25227891|NCT02611804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227892|NCT02611804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227894|NCT02611492|Dexamethasone|dexamethasone|mesh-list
25227895|NCT02611492|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25227896|NCT02611492|Methotrexate|methotrexate|mesh-list
24843240|NCT02226341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24843241|NCT02226341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843243|NCT02226367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24843244|NCT02226367|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24843245|NCT02226367|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24843246|NCT02226367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24843247|NCT02226367|Adrenergic Agents|adrenergic agents|mesh-ancestor
25681723|NCT01869634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25681724|NCT01869634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681725|NCT01869634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25681726|NCT01869634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25681727|NCT01869634|Antiviral Agents|antiviral agents|mesh-ancestor
25681728|NCT01869634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25681729|NCT01869634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25681730|NCT01869634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25681731|NCT01869634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24843251|NCT02226484|Quercetin|quercetin|mesh-list
24843252|NCT02226484|Antioxidants|antioxidants|mesh-ancestor
24843253|NCT02226484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843254|NCT02226484|Protective Agents|protective agents|mesh-ancestor
24843255|NCT02226484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843256|NCT02226510|Metformin|metformin|mesh-list
24843291|NCT02226913|Anesthetics, Local|anesthetics, local|mesh-ancestor
24843292|NCT02226913|Anesthetics|anesthetics|mesh-ancestor
24843294|NCT02226913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843308|NCT02226913|Autonomic Agents|autonomic agents|mesh-ancestor
24843309|NCT02226913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24843310|NCT02226913|Respiratory System Agents|respiratory system agents|mesh-ancestor
25058868|NCT03492593|Antioxidants|antioxidants|mesh-ancestor
24995413|NCT05212025|Gemcitabine|gemcitabine|mesh-list
24995415|NCT05212025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24995416|NCT05212025|Antimetabolites|antimetabolites|mesh-ancestor
24543511|NCT00684099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543512|NCT00684099|Tubulin Modulators|tubulin modulators|mesh-ancestor
24543513|NCT00684099|Antimitotic Agents|antimitotic agents|mesh-ancestor
24543514|NCT00684099|Mitosis Modulators|mitosis modulators|mesh-ancestor
25227897|NCT02611492|Vincristine|vincristine|mesh-list
25227898|NCT02611492|Mercaptopurine|mercaptopurine|mesh-list
25227899|NCT02611492|Lenograstim|lenograstim|mesh-list
25227900|NCT02611492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25227901|NCT02611492|Antiemetics|antiemetics|mesh-ancestor
25227902|NCT02611492|Autonomic Agents|autonomic agents|mesh-ancestor
25227903|NCT02611492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25227904|NCT02611492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227905|NCT02611492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25227906|NCT02611492|Glucocorticoids|glucocorticoids|mesh-ancestor
25227907|NCT02611492|Hormones|hormones|mesh-ancestor
25227911|NCT02611492|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25227915|NCT02611492|Antimetabolites|antimetabolites|mesh-ancestor
25227916|NCT02611492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227917|NCT02611492|Dermatologic Agents|dermatologic agents|mesh-ancestor
25227918|NCT02611492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227919|NCT02611492|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25227920|NCT02611492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25227921|NCT02611492|Immunologic Factors|immunologic factors|mesh-ancestor
24843341|NCT02226978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843344|NCT02226978|Antiviral Agents|antiviral agents|mesh-ancestor
24843345|NCT02226978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24843346|NCT02226978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24843347|NCT02226978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24843348|NCT02226991|Ritonavir|ritonavir|mesh-list
24843349|NCT02226991|Tipranavir|tipranavir|mesh-list
24843350|NCT02226991|Efavirenz|efavirenz|mesh-list
24843351|NCT02226991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24843352|NCT02226991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24843366|NCT02226991|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24843367|NCT02226991|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24843368|NCT02226991|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24843369|NCT02227017|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24843370|NCT02227030|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25035029|NCT03560349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25035030|NCT03560349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24416143|NCT00202163|Hormones|hormones|mesh-ancestor
24843371|NCT02227056|Methylphenidate|methylphenidate|mesh-list
24843372|NCT02227056|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24843373|NCT02227056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543515|NCT00684099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543516|NCT00684099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543517|NCT00684099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24621301|NCT01061437|Lansoprazole|lansoprazole|mesh-list
24621302|NCT01061437|Dexlansoprazole|dexlansoprazole|mesh-list
24621303|NCT01061437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24621304|NCT01061437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24621305|NCT01061437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25227922|NCT02611492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25227923|NCT02611492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25227924|NCT02611492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25227925|NCT02611492|Tubulin Modulators|tubulin modulators|mesh-ancestor
25227926|NCT02611492|Antimitotic Agents|antimitotic agents|mesh-ancestor
25227927|NCT02611492|Mitosis Modulators|mitosis modulators|mesh-ancestor
25227928|NCT02611492|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25227929|NCT02611492|Antiviral Agents|antiviral agents|mesh-ancestor
25227930|NCT02611492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25227931|NCT02611518|Metformin|metformin|mesh-list
25227932|NCT02611518|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25227933|NCT02611518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25227934|NCT02611518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227935|NCT02611518|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25227936|NCT02611518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25227937|NCT02611518|Antimetabolites|antimetabolites|mesh-ancestor
25227938|NCT02611518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227939|NCT02611518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25227940|NCT02611518|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25227941|NCT02611518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227942|NCT02611505|Esketamine|esketamine|mesh-list
25108079|NCT03134547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25108080|NCT03134547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227943|NCT02611505|Antidepressive Agents|antidepressive agents|mesh-ancestor
25227944|NCT02611505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25227945|NCT02611336|Tadalafil|tadalafil|mesh-list
24843374|NCT02227056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24843375|NCT02227056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24843376|NCT02227056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25043798|NCT01204749|Growth Substances|growth substances|mesh-ancestor
25043799|NCT01204749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043800|NCT01204749|Growth Inhibitors|growth inhibitors|mesh-ancestor
25043801|NCT01204099|Docetaxel|docetaxel|mesh-list
25043802|NCT01204099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043803|NCT01204099|Tubulin Modulators|tubulin modulators|mesh-ancestor
25043804|NCT01204099|Antimitotic Agents|antimitotic agents|mesh-ancestor
25043805|NCT01204099|Mitosis Modulators|mitosis modulators|mesh-ancestor
25681732|NCT01869634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25681733|NCT01869686|Denosumab|denosumab|mesh-list
25681734|NCT01869686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25681735|NCT01869686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681736|NCT01869699|Acetaminophen|acetaminophen|mesh-list
25681737|NCT01869699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25681738|NCT01869699|Analgesics|analgesics|mesh-ancestor
25681739|NCT01869699|Sensory System Agents|sensory system agents|mesh-ancestor
25035179|NCT03559049|Rucaparib|rucaparib|mesh-list
25035180|NCT03559049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25035181|NCT03559049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25035182|NCT03559049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25035183|NCT03559049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035184|NCT03559049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25035185|NCT03559049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25035186|NCT03559049|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25035187|NCT03558971|Hydrocortisone|hydrocortisone|mesh-list
25043806|NCT01204099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043807|NCT01198834|Etodolac|etodolac|mesh-list
25043808|NCT01198834|Lidocaine|lidocaine|mesh-list
25043809|NCT01198834|Anesthetics, Local|anesthetics, local|mesh-ancestor
25043810|NCT01198834|Anesthetics|anesthetics|mesh-ancestor
25043811|NCT01198834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25043812|NCT01198834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043813|NCT01198834|Sensory System Agents|sensory system agents|mesh-ancestor
24843381|NCT02227082|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24843382|NCT02227082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24843383|NCT02227082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843384|NCT02227082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843385|NCT02227173|Flurbiprofen|flurbiprofen|mesh-list
24843387|NCT02227173|Montelukast|montelukast|mesh-list
24843388|NCT02227173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25058919|NCT03492255|Prednisone|prednisone|mesh-list
24543538|NCT00684164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543540|NCT00684190|Lesogaberan|lesogaberan|mesh-list
24543541|NCT00684190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24543542|NCT00684190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24543543|NCT00684190|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24543544|NCT00684190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543545|NCT00684190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543546|NCT00684190|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24543547|NCT00684190|GABA Agonists|gaba agonists|mesh-ancestor
24543548|NCT00684190|GABA Agents|gaba agents|mesh-ancestor
24543549|NCT00684190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24543550|NCT00684190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543551|NCT00684216|Tamoxifen|tamoxifen|mesh-list
24543552|NCT00684216|Capecitabine|capecitabine|mesh-list
24543553|NCT00684216|Letrozole|letrozole|mesh-list
24543554|NCT00684216|Anastrozole|anastrozole|mesh-list
24543555|NCT00684216|Exemestane|exemestane|mesh-list
25227946|NCT02611336|Vasodilator Agents|vasodilator agents|mesh-ancestor
24543616|NCT00684606|Oxytocics|oxytocics|mesh-ancestor
25227947|NCT02611336|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25227948|NCT02611336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25227949|NCT02611336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227950|NCT02611336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227951|NCT02611336|Urological Agents|urological agents|mesh-ancestor
25227952|NCT02611271|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25227953|NCT02611271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25227954|NCT02611258|Tadalafil|tadalafil|mesh-list
25227959|NCT02611258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227960|NCT02611258|Urological Agents|urological agents|mesh-ancestor
25227961|NCT02611466|Naproxen|naproxen|mesh-list
25227962|NCT02611466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25227963|NCT02611466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25227964|NCT02611466|Analgesics|analgesics|mesh-ancestor
25227965|NCT02611466|Sensory System Agents|sensory system agents|mesh-ancestor
25681740|NCT01869699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25681741|NCT01869699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681742|NCT01869699|Antipyretics|antipyretics|mesh-ancestor
25681743|NCT01869725|Octreotide|octreotide|mesh-list
25681744|NCT01869725|Edotreotide|edotreotide|mesh-list
25681745|NCT01869725|Indium-111-octreotide|indium-111-octreotide|mesh-list
25681746|NCT01869725|Somatostatin|somatostatin|mesh-list
25681747|NCT01869725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25681748|NCT01869725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25681749|NCT01869725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25227971|NCT02611466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24843389|NCT02227173|Respiratory System Agents|respiratory system agents|mesh-ancestor
24843390|NCT02227173|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24843391|NCT02227173|Hormone Antagonists|hormone antagonists|mesh-ancestor
24843392|NCT02227173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24843393|NCT02227173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843394|NCT02227173|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24843395|NCT02227173|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25108131|NCT03134456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25058942|NCT03492255|Antiemetics|antiemetics|mesh-ancestor
25227972|NCT02611466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25227973|NCT02611466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25227974|NCT02610920|Iron|iron|mesh-list
25227975|NCT02610920|Trace Elements|trace elements|mesh-ancestor
25681753|NCT01869725|Hormones|hormones|mesh-ancestor
25681754|NCT01869725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25681755|NCT01870297|Liraglutide|liraglutide|mesh-list
25681756|NCT01870297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25681757|NCT01870297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681758|NCT01870297|Incretins|incretins|mesh-ancestor
25681759|NCT01870297|Hormones|hormones|mesh-ancestor
25681760|NCT01870297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25681761|NCT01870583|Iodine|iodine|mesh-list
25681762|NCT01870583|Chlorhexidine|chlorhexidine|mesh-list
25227980|NCT02610933|Rivaroxaban|rivaroxaban|mesh-list
25227982|NCT02610933|Micronutrients|micronutrients|mesh-ancestor
25227983|NCT02610933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25227984|NCT02610933|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25227985|NCT02610933|Antithrombins|antithrombins|mesh-ancestor
25227993|NCT02610933|Hemostatics|hemostatics|mesh-ancestor
25227994|NCT02610933|Coagulants|coagulants|mesh-ancestor
25227995|NCT02610881|Iron|iron|mesh-list
25227996|NCT02610881|Trace Elements|trace elements|mesh-list
25227997|NCT02610881|Folic Acid|folic acid|mesh-list
25227998|NCT02610881|Micronutrients|micronutrients|mesh-list
25227999|NCT02610881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228000|NCT02610881|Hematinics|hematinics|mesh-ancestor
25228001|NCT02610881|Vitamin B Complex|vitamin b complex|mesh-ancestor
25228002|NCT02610881|Vitamins|vitamins|mesh-ancestor
25228003|NCT02610712|Ketamine|ketamine|mesh-list
25228004|NCT02610712|Analgesics|analgesics|mesh-ancestor
24843396|NCT02227173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843397|NCT02227173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24843398|NCT02227173|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24843399|NCT02227173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058969|NCT03492047|Paclitaxel|paclitaxel|mesh-list
24543599|NCT00684463|Autonomic Agents|autonomic agents|mesh-ancestor
24543600|NCT00684463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24543601|NCT00684463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543602|NCT00684463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24543603|NCT00684463|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24543604|NCT00684463|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24543605|NCT00684463|Serotonin Agents|serotonin agents|mesh-ancestor
24543606|NCT00684463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24543607|NCT00684463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543608|NCT00684489|Antihypertensive Agents|antihypertensive agents|mesh-list
24543609|NCT00684489|Coal Tar|coal tar|mesh-list
24543610|NCT00684489|Keratolytic Agents|keratolytic agents|mesh-ancestor
24543611|NCT00684489|Dermatologic Agents|dermatologic agents|mesh-ancestor
24543612|NCT00684528|Metformin|metformin|mesh-list
24543613|NCT00684528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24543614|NCT00684528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543615|NCT00684606|Oxytocin|oxytocin|mesh-list
24543649|NCT00684853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24543650|NCT00684853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24543651|NCT00684853|Growth Substances|growth substances|mesh-ancestor
25681763|NCT01870583|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25681764|NCT01870583|Cadexomer iodine|cadexomer iodine|mesh-list
25681765|NCT01870583|Povidone|povidone|mesh-list
25681766|NCT01870583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24417958|NCT00208221|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24417959|NCT00208221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543671|NCT00684905|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24543672|NCT00684905|Fertility Agents|fertility agents|mesh-ancestor
24543673|NCT00684905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25228005|NCT02610712|Sensory System Agents|sensory system agents|mesh-ancestor
25228006|NCT02610712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25228007|NCT02610712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228008|NCT02610712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25228009|NCT02610712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25228010|NCT02610712|Anesthetics, General|anesthetics, general|mesh-ancestor
25228011|NCT02610712|Anesthetics|anesthetics|mesh-ancestor
25228012|NCT02610712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25228013|NCT02610712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24843400|NCT02227173|Protective Agents|protective agents|mesh-ancestor
24843402|NCT02227173|Sensory System Agents|sensory system agents|mesh-ancestor
24843403|NCT02227173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24843404|NCT02227173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24843405|NCT02227173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24843406|NCT02227173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24843407|NCT02227173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24843408|NCT02227173|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24543674|NCT00684905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543675|NCT00684905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24543676|NCT00684905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543677|NCT00684905|Androgen Antagonists|androgen antagonists|mesh-ancestor
24543678|NCT00684905|Hormone Antagonists|hormone antagonists|mesh-ancestor
24543679|NCT00684905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24543682|NCT00684957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543683|NCT00685009|Hormones|hormones|mesh-list
24543684|NCT00685009|Progesterone|progesterone|mesh-list
24543685|NCT00685009|Estrogens|estrogens|mesh-list
24557820|NCT00754351|Growth Substances|growth substances|mesh-ancestor
24543707|NCT00685061|Immunologic Factors|immunologic factors|mesh-ancestor
24543708|NCT00685061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543709|NCT00685061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24543710|NCT00685061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24543711|NCT00685061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543712|NCT00685100|Triamcinolone|triamcinolone|mesh-list
24543713|NCT00685100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25681767|NCT01870583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25681768|NCT01870583|Disinfectants|disinfectants|mesh-ancestor
25681769|NCT01870583|Dermatologic Agents|dermatologic agents|mesh-ancestor
25681770|NCT01870583|Trace Elements|trace elements|mesh-ancestor
25681771|NCT01870583|Micronutrients|micronutrients|mesh-ancestor
25035494|NCT03555188|Autonomic Agents|autonomic agents|mesh-ancestor
25035495|NCT03555188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25035496|NCT03555188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035497|NCT03555188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25035498|NCT03555188|Antipruritics|antipruritics|mesh-ancestor
25035499|NCT03555188|Dermatologic Agents|dermatologic agents|mesh-ancestor
25035500|NCT03555188|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25035501|NCT03555188|Serotonin Agents|serotonin agents|mesh-ancestor
25035502|NCT03555188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25035504|NCT03555188|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25035529|NCT03555032|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
24543732|NCT00685126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24505101|NCT00539799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24543758|NCT00685347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24543759|NCT00685347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24543760|NCT00685347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24543761|NCT00685347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25228014|NCT02610712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25228015|NCT02610712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25228016|NCT02610712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228017|NCT02610829|Vitamin E|vitamin e|mesh-list
25228018|NCT02610829|Tocopherols|tocopherols|mesh-list
25228019|NCT02610829|Tocotrienols|tocotrienols|mesh-list
25228020|NCT02610829|alpha-Tocopherol|alpha-tocopherol|mesh-list
25228021|NCT02610829|gamma-Tocopherol|gamma-tocopherol|mesh-list
25228022|NCT02610829|Vitamins|vitamins|mesh-ancestor
25228023|NCT02610829|Micronutrients|micronutrients|mesh-ancestor
24843411|NCT02227212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24843412|NCT02227212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843413|NCT02227264|Parathyroid Hormone|parathyroid hormone|mesh-list
24843414|NCT02227264|Cinacalcet|cinacalcet|mesh-list
24843415|NCT02227264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24843416|NCT02227264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843417|NCT02227264|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24843418|NCT02227264|Hormone Antagonists|hormone antagonists|mesh-ancestor
24843419|NCT02227264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24843420|NCT02227277|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24843421|NCT02227277|Interferon alpha-2|interferon alpha-2|mesh-list
24843422|NCT02227277|Antiviral Agents|antiviral agents|mesh-ancestor
24843423|NCT02227277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24843424|NCT02227277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843446|NCT02227550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24843448|NCT02227550|Coagulants|coagulants|mesh-ancestor
24843449|NCT02227745|Dorzolamide|dorzolamide|mesh-list
24843450|NCT02227745|Hyaluronic Acid|hyaluronic acid|mesh-list
24843451|NCT02227745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24843452|NCT02227745|Immunologic Factors|immunologic factors|mesh-ancestor
24474701|NCT00407056|Difluprednate|difluprednate|mesh-list
24843484|NCT02227901|Alkylating Agents|alkylating agents|mesh-ancestor
24843485|NCT02227901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843486|NCT02227901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843487|NCT02227914|Sorafenib|sorafenib|mesh-list
24843488|NCT02227914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843489|NCT02227914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24843490|NCT02227914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24843491|NCT02227914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543762|NCT00685347|Adrenergic Agents|adrenergic agents|mesh-ancestor
25228024|NCT02610829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681772|NCT01870583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681773|NCT01870583|Plasma Substitutes|plasma substitutes|mesh-ancestor
25681774|NCT01870583|Blood Substitutes|blood substitutes|mesh-ancestor
25681775|NCT01870596|Cytarabine|cytarabine|mesh-list
25681776|NCT01870596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25681777|NCT01870596|Antimetabolites|antimetabolites|mesh-ancestor
25681778|NCT01870596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681779|NCT01870596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25681780|NCT01870596|Antiviral Agents|antiviral agents|mesh-ancestor
25681781|NCT01870596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25681782|NCT01870596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25228033|NCT02610686|Antimalarials|antimalarials|mesh-ancestor
25228034|NCT02610686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25228035|NCT02610647|Anesthetics|anesthetics|mesh-list
25228036|NCT02610647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25228037|NCT02610647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228038|NCT02610530|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25228039|NCT02610530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273385|NCT02385539|Sensory System Agents|sensory system agents|mesh-ancestor
25273386|NCT02385539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25273387|NCT02385500|Fesoterodine|fesoterodine|mesh-list
25273388|NCT02385500|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25273389|NCT02385500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25273390|NCT02385500|Cholinergic Agents|cholinergic agents|mesh-ancestor
25273398|NCT02385474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273400|NCT02385461|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25273402|NCT02385461|Dalteparin|dalteparin|mesh-list
25273403|NCT02385461|Anticoagulants|anticoagulants|mesh-ancestor
25273404|NCT02385461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25273405|NCT02385461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24543763|NCT00685347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24543764|NCT00685347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543766|NCT00685425|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24543767|NCT00685425|Autonomic Agents|autonomic agents|mesh-ancestor
24543768|NCT00685425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24543769|NCT00685425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543770|NCT00685425|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24543771|NCT00685425|Respiratory System Agents|respiratory system agents|mesh-ancestor
24543793|NCT00685529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857978|NCT02294591|Respiratory System Agents|respiratory system agents|mesh-ancestor
24857979|NCT02294591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24857980|NCT02294591|Antioxidants|antioxidants|mesh-ancestor
25681783|NCT01870596|Immunologic Factors|immunologic factors|mesh-ancestor
25681784|NCT01870596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681785|NCT01870739|Amlodipine|amlodipine|mesh-list
25681786|NCT01870739|Valsartan|valsartan|mesh-list
25681787|NCT01870739|Olmesartan|olmesartan|mesh-list
25681788|NCT01870739|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25681789|NCT01870739|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25681790|NCT01870739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25681791|NCT01870739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25681792|NCT01870739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25228042|NCT02610556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25228043|NCT02610556|Tubulin Modulators|tubulin modulators|mesh-ancestor
25228044|NCT02610556|Antimitotic Agents|antimitotic agents|mesh-ancestor
25228045|NCT02610556|Mitosis Modulators|mitosis modulators|mesh-ancestor
25228046|NCT02610556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228047|NCT02610504|Hyaluronic Acid|hyaluronic acid|mesh-list
25228048|NCT02610504|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25228049|NCT02610504|Immunologic Factors|immunologic factors|mesh-ancestor
24843525|NCT02228031|Oxytocin|oxytocin|mesh-list
24843526|NCT02228031|Oxytocics|oxytocics|mesh-ancestor
24843527|NCT02228031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24843528|NCT02228031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843529|NCT02228083|Lidocaine|lidocaine|mesh-list
24843530|NCT02228083|Epinephrine|epinephrine|mesh-list
24843531|NCT02228083|Anesthetics, Local|anesthetics, local|mesh-ancestor
24843532|NCT02228083|Anesthetics|anesthetics|mesh-ancestor
24843533|NCT02228083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24843534|NCT02228083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843535|NCT02228083|Sensory System Agents|sensory system agents|mesh-ancestor
24843536|NCT02228083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24843537|NCT02228083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24843538|NCT02228083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24843539|NCT02228083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24843540|NCT02228083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24843541|NCT02228083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843542|NCT02228083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24843543|NCT02228083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24995565|NCT05053503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24995566|NCT05053503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995567|NCT05053503|Sensory System Agents|sensory system agents|mesh-ancestor
24995568|NCT05053503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24995569|NCT05053503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24995570|NCT05053503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24995571|NCT05053503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24995572|NCT05053503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24995573|NCT05053503|Adrenergic Agents|adrenergic agents|mesh-ancestor
24995574|NCT05053503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24995583|NCT05026905|Gemcitabine|gemcitabine|mesh-list
24995584|NCT05026905|Paclitaxel|paclitaxel|mesh-list
24623265|NCT01070732|Antipyretics|antipyretics|mesh-ancestor
24843544|NCT02228083|Adrenergic Agents|adrenergic agents|mesh-ancestor
24843568|NCT02228135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843569|NCT02228239|Mirtazapine|mirtazapine|mesh-list
24843570|NCT02228239|Esketamine|esketamine|mesh-list
24843571|NCT02228239|Antidepressive Agents|antidepressive agents|mesh-ancestor
25681793|NCT01870739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681794|NCT01870739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25681795|NCT01870739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681796|NCT01870739|Vasodilator Agents|vasodilator agents|mesh-ancestor
25681797|NCT01870739|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25681798|NCT01870739|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25681799|NCT01870843|Citalopram|citalopram|mesh-list
25681800|NCT01870843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25035717|NCT03553537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25035718|NCT03553537|Tubulin Modulators|tubulin modulators|mesh-ancestor
25035719|NCT03553537|Antimitotic Agents|antimitotic agents|mesh-ancestor
25035720|NCT03553537|Mitosis Modulators|mitosis modulators|mesh-ancestor
25114155|NCT01236547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228050|NCT02610504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228051|NCT02610504|Viscosupplements|viscosupplements|mesh-ancestor
25228052|NCT02610504|Protective Agents|protective agents|mesh-ancestor
25228053|NCT02610348|Vaccines|vaccines|mesh-list
25228054|NCT02610348|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25228055|NCT02610348|Immunologic Factors|immunologic factors|mesh-ancestor
25228056|NCT02610348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228057|NCT02610153|Vitamin K|vitamin k|mesh-list
25228058|NCT02610153|Vitamins|vitamins|mesh-ancestor
25228059|NCT02610153|Micronutrients|micronutrients|mesh-ancestor
25228060|NCT02610153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228061|NCT02610153|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25228062|NCT02610153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25228063|NCT02610153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228064|NCT02610153|Hemostatics|hemostatics|mesh-ancestor
25228065|NCT02610153|Coagulants|coagulants|mesh-ancestor
25228066|NCT02610010|Cisplatin|cisplatin|mesh-list
24995587|NCT05026905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25228067|NCT02610010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25228068|NCT02610088|Dapagliflozin|dapagliflozin|mesh-list
25228069|NCT02610088|Gliclazide|gliclazide|mesh-list
25228070|NCT02610088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25228071|NCT02610088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228072|NCT02610088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25228073|NCT02610088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228074|NCT02610127|Factor VIII|factor viii|mesh-list
25228075|NCT02610127|Coagulants|coagulants|mesh-ancestor
25228076|NCT02610075|Adavosertib|adavosertib|mesh-list
25228077|NCT02610075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25228078|NCT02610075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228079|NCT02609932|Interferons|interferons|mesh-list
25228080|NCT02609932|Interferon-gamma|interferon-gamma|mesh-list
25228081|NCT02609932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25228082|NCT02609932|Antiviral Agents|antiviral agents|mesh-ancestor
24843581|NCT02228239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24452586|NCT05458089|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24843582|NCT02228239|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24756069|NCT01731132|Copper|copper|mesh-list
25058996|NCT03491904|Analgesics|analgesics|mesh-ancestor
25681801|NCT01870843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25681802|NCT01870843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25681803|NCT01870843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681804|NCT01870843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25681805|NCT01870843|Serotonin Agents|serotonin agents|mesh-ancestor
25681806|NCT01870843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681807|NCT01870843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25681808|NCT01870843|Antidepressive Agents|antidepressive agents|mesh-ancestor
24543850|NCT00685672|Adrenergic Agents|adrenergic agents|mesh-ancestor
24543851|NCT00685672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24543852|NCT00685672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543853|NCT00685672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543854|NCT00685672|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24543855|NCT00685672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24543856|NCT00685672|Autonomic Agents|autonomic agents|mesh-ancestor
24543857|NCT00685672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24543861|NCT00685672|Sympathomimetics|sympathomimetics|mesh-ancestor
25228083|NCT02609932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25228084|NCT02609945|Oxazolidinones|oxazolidinones|mesh-list
25228085|NCT02609945|Zolmitriptan|zolmitriptan|mesh-list
25228086|NCT02609945|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25228087|NCT02609945|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25228088|NCT02609945|Serotonin Agents|serotonin agents|mesh-ancestor
25228089|NCT02609945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25228090|NCT02609945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228091|NCT02609945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228092|NCT02609945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25228093|NCT02609945|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25228094|NCT02609945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25228095|NCT02609997|Dexamethasone|dexamethasone|mesh-list
25228096|NCT02609997|Proxymetacaine|proxymetacaine|mesh-list
25228097|NCT02609997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25228098|NCT02609997|Antiemetics|antiemetics|mesh-ancestor
25228099|NCT02609997|Autonomic Agents|autonomic agents|mesh-ancestor
25228100|NCT02609997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25059017|NCT03491696|Metyrapone|metyrapone|mesh-list
24857983|NCT02294591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857985|NCT02294617|Nicotine|nicotine|mesh-list
24857986|NCT02294617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24857987|NCT02294617|Autonomic Agents|autonomic agents|mesh-ancestor
25681809|NCT01870843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25681810|NCT01870921|Ticagrelor|ticagrelor|mesh-list
25681811|NCT01870921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25681812|NCT01870921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25681813|NCT01870921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25681814|NCT01870921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25681815|NCT01870921|Purinergic Agents|purinergic agents|mesh-ancestor
24421415|NCT00218569|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24421416|NCT00218569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421417|NCT00218569|Sensory System Agents|sensory system agents|mesh-ancestor
24421418|NCT00218569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24554281|NCT00735241|Immunologic Factors|immunologic factors|mesh-ancestor
24857988|NCT02294617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857989|NCT02294617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857990|NCT02294617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24543904|NCT00685906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24543905|NCT00685906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543906|NCT00685906|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24543907|NCT00685906|Contraceptive Agents|contraceptive agents|mesh-ancestor
24543914|NCT00685906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24543915|NCT00685906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24543916|NCT00685906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24543917|NCT00685906|Purinergic Agents|purinergic agents|mesh-ancestor
24543918|NCT00685906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24447010|NCT00307099|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24447013|NCT00307138|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24447015|NCT00307138|Blood Substitutes|blood substitutes|mesh-ancestor
24447016|NCT00307177|Vaccines|vaccines|mesh-list
24447017|NCT00307177|Immunologic Factors|immunologic factors|mesh-ancestor
25228101|NCT02609997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228102|NCT02609997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25228103|NCT02609997|Glucocorticoids|glucocorticoids|mesh-ancestor
25228104|NCT02609997|Hormones|hormones|mesh-ancestor
25228105|NCT02609997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25228106|NCT02609997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25228107|NCT02609997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25228108|NCT02609997|Anesthetics, Local|anesthetics, local|mesh-ancestor
25228109|NCT02609997|Anesthetics|anesthetics|mesh-ancestor
25228110|NCT02609997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24843594|NCT02228369|Osimertinib|osimertinib|mesh-list
24843595|NCT02228369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843596|NCT02228369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24843597|NCT02228369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24843598|NCT02228369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843599|NCT02228473|Atropine|atropine|mesh-list
24843600|NCT02228473|Glycopyrrolate|glycopyrrolate|mesh-list
25043814|NCT01198834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25043815|NCT01198834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25043816|NCT01198834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25043817|NCT01198834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25043818|NCT01198834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25043820|NCT01198834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25228114|NCT02609919|Sequestering Agents|sequestering agents|mesh-ancestor
25228115|NCT02609919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228116|NCT02609802|Sevoflurane|sevoflurane|mesh-list
25228117|NCT02609802|Desflurane|desflurane|mesh-list
25228118|NCT02609802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25228119|NCT02609802|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25228120|NCT02609802|Anesthetics, General|anesthetics, general|mesh-ancestor
25681816|NCT01870921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25681817|NCT01870921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681818|NCT01870921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681819|NCT01870973|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25681820|NCT01870973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25228121|NCT02609802|Anesthetics|anesthetics|mesh-ancestor
25228122|NCT02609802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25228123|NCT02609802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228124|NCT02609646|Vancomycin|vancomycin|mesh-list
25228125|NCT02609646|Meropenem|meropenem|mesh-list
25228126|NCT02609646|Tazobactam|tazobactam|mesh-list
25228141|NCT02609490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25228142|NCT02609490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25228143|NCT02609490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25228144|NCT02609490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228146|NCT02609711|Candesartan cilexetil|candesartan cilexetil|mesh-list
25228147|NCT02609711|Atorvastatin|atorvastatin|mesh-list
25228148|NCT02609711|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25228149|NCT02609711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25228150|NCT02609711|Antimetabolites|antimetabolites|mesh-ancestor
25228151|NCT02609711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228152|NCT02609711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25043823|NCT01198834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25043824|NCT01198834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25043825|NCT01198834|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24843601|NCT02228473|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24869744|NCT05160623|Povidone-Iodine|povidone-iodine|mesh-list
24869745|NCT05160623|Povidone|povidone|mesh-list
24869746|NCT05160623|Plasma Substitutes|plasma substitutes|mesh-ancestor
24995658|NCT04961580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24995665|NCT04943900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24995666|NCT04943900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24995667|NCT04943900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24843602|NCT02228473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24843603|NCT02228473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24843604|NCT02228473|Autonomic Agents|autonomic agents|mesh-ancestor
24843605|NCT02228473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24843606|NCT02228473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843607|NCT02228473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24843608|NCT02228473|Respiratory System Agents|respiratory system agents|mesh-ancestor
24843609|NCT02228473|Mydriatics|mydriatics|mesh-ancestor
24843610|NCT02228473|Parasympatholytics|parasympatholytics|mesh-ancestor
24843611|NCT02228473|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24843612|NCT02228473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24756109|NCT01731184|Anesthetics|anesthetics|mesh-ancestor
24452585|NCT05458089|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24798051|NCT01960153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798052|NCT01960153|Urological Agents|urological agents|mesh-ancestor
24798053|NCT01960179|Lixisenatide|lixisenatide|mesh-list
24798054|NCT01960179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24798055|NCT01960179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798056|NCT01960205|Metformin|metformin|mesh-list
24798057|NCT01960205|Saxagliptin|saxagliptin|mesh-list
24798058|NCT01960205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25228155|NCT02609711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25228156|NCT02609711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25228157|NCT02609711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25228159|NCT02609698|Clopidogrel|clopidogrel|mesh-list
25228160|NCT02609698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25228161|NCT02609698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25228162|NCT02609698|Analgesics|analgesics|mesh-ancestor
25228163|NCT02609698|Sensory System Agents|sensory system agents|mesh-ancestor
25228164|NCT02609698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25228165|NCT02609698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228166|NCT02609698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25228167|NCT02609698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25228168|NCT02609698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25228169|NCT02609698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25228170|NCT02609698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228171|NCT02609698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25228172|NCT02609698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24423299|NCT00225342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24423300|NCT00225342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423301|NCT00225355|Rosiglitazone|rosiglitazone|mesh-list
25035940|NCT03551873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035941|NCT03551873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25035942|NCT03551847|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25035943|NCT03551847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25228173|NCT02609698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25228174|NCT02609698|Antipyretics|antipyretics|mesh-ancestor
25228175|NCT02609698|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25228176|NCT02609698|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25228177|NCT02609698|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25228178|NCT02609698|Purinergic Agents|purinergic agents|mesh-ancestor
25228179|NCT02609698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25228180|NCT02609477|Phentermine|phentermine|mesh-list
25228181|NCT02609477|Istradefylline|istradefylline|mesh-list
25228182|NCT02609477|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24843615|NCT02228473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843617|NCT02228512|Cyclophosphamide|cyclophosphamide|mesh-list
24452595|NCT05458076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24452596|NCT05458076|Antiviral Agents|antiviral agents|mesh-ancestor
24452597|NCT05458076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24798078|NCT01960283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24798079|NCT01960283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24798080|NCT01960283|Immunologic Factors|immunologic factors|mesh-ancestor
24452598|NCT05458076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24452599|NCT05458076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24843637|NCT02228512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25068356|NCT03434197|Diclofenac|diclofenac|mesh-list
24843679|NCT02228772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543938|NCT00686010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24543939|NCT00686010|Antimetabolites|antimetabolites|mesh-ancestor
24543940|NCT00686010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543941|NCT00686010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24543942|NCT00686114|Paclitaxel|paclitaxel|mesh-list
24543943|NCT00686114|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24543944|NCT00686114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24558180|NCT00755664|Vitamin B Complex|vitamin b complex|mesh-list
24543979|NCT00686192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24543981|NCT00686218|Panobinostat|panobinostat|mesh-list
24543982|NCT00686218|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
24543983|NCT00686218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543984|NCT00686218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24543985|NCT00686218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543986|NCT00686218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857997|NCT02294643|Clopidogrel|clopidogrel|mesh-list
24460459|NCT00348439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24543987|NCT00686322|Paclitaxel|paclitaxel|mesh-list
24543988|NCT00686322|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24798089|NCT01960543|Fentanyl|fentanyl|mesh-list
24543989|NCT00686322|Cisplatin|cisplatin|mesh-list
24543990|NCT00686322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25228183|NCT02609477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228184|NCT02609477|Appetite Depressants|appetite depressants|mesh-ancestor
25228185|NCT02609477|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25228186|NCT02609477|Sympathomimetics|sympathomimetics|mesh-ancestor
25228187|NCT02609477|Autonomic Agents|autonomic agents|mesh-ancestor
25228188|NCT02609477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25228189|NCT02609477|Adrenergic Agents|adrenergic agents|mesh-ancestor
25681821|NCT01870973|Analgesics|analgesics|mesh-list
25681822|NCT01870973|Anesthetics|anesthetics|mesh-list
25263907|NCT02444013|Folic Acid|folic acid|mesh-list
25681823|NCT01870973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25681824|NCT01870973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681825|NCT01870973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25681826|NCT01870973|Antitubercular Agents|antitubercular agents|mesh-ancestor
25681827|NCT01870973|Sensory System Agents|sensory system agents|mesh-ancestor
25228190|NCT02609477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25228191|NCT02609477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228192|NCT02609477|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
25681828|NCT01870973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25228201|NCT02609386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25228202|NCT02609386|Immunologic Factors|immunologic factors|mesh-ancestor
25228203|NCT02609386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228204|NCT02609386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25228205|NCT02609386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25228206|NCT02609386|Alkylating Agents|alkylating agents|mesh-ancestor
24843680|NCT02228772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24843681|NCT02228772|Abortifacient Agents|abortifacient agents|mesh-ancestor
24843682|NCT02228772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24843683|NCT02228772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24843684|NCT02228772|Antimetabolites|antimetabolites|mesh-ancestor
24843685|NCT02228772|Dermatologic Agents|dermatologic agents|mesh-ancestor
24843686|NCT02228772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24843687|NCT02228772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24843688|NCT02228772|Antiviral Agents|antiviral agents|mesh-ancestor
24843704|NCT02228863|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25059111|NCT03491072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24544016|NCT00686478|Immunologic Factors|immunologic factors|mesh-ancestor
24544017|NCT00686478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544018|NCT00686556|Cyclosporine|cyclosporine|mesh-list
24544019|NCT00686556|Mycophenolic Acid|mycophenolic acid|mesh-list
24544020|NCT00686556|Cyclophosphamide|cyclophosphamide|mesh-list
24544021|NCT00686556|Fludarabine|fludarabine|mesh-list
25681829|NCT01870999|Aripiprazole|aripiprazole|mesh-list
25681830|NCT01870999|Antidepressive Agents|antidepressive agents|mesh-ancestor
25681831|NCT01870999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25681832|NCT01870999|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25681833|NCT01870999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25681834|NCT01870999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25681835|NCT01870999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797666|NCT01957189|Urological Agents|urological agents|mesh-ancestor
24797667|NCT01957189|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24797668|NCT01957189|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24797669|NCT01957189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24797670|NCT01957189|Hormone Antagonists|hormone antagonists|mesh-ancestor
24588813|NCT00904397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24588815|NCT00904397|Analgesics|analgesics|mesh-ancestor
24588816|NCT00904397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24544022|NCT00686556|Cyclosporins|cyclosporins|mesh-list
24544023|NCT00686556|Lenograstim|lenograstim|mesh-list
24544024|NCT00686556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24544025|NCT00686556|Immunologic Factors|immunologic factors|mesh-ancestor
24544026|NCT00686556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544027|NCT00686556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25228207|NCT02609386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228208|NCT02609386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25228209|NCT02609386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25228210|NCT02609386|Micronutrients|micronutrients|mesh-ancestor
25228211|NCT02609386|Trace Elements|trace elements|mesh-ancestor
25228212|NCT02609386|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25228213|NCT02609386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25228214|NCT02609386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25228215|NCT02609386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25228216|NCT02609386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25228217|NCT02609386|Analgesics|analgesics|mesh-ancestor
25228218|NCT02609386|Sensory System Agents|sensory system agents|mesh-ancestor
25228219|NCT02609386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25228220|NCT02609386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25228221|NCT02609386|Gout Suppressants|gout suppressants|mesh-ancestor
25228222|NCT02609386|Tocolytic Agents|tocolytic agents|mesh-ancestor
25228223|NCT02609386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25228224|NCT02609386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25228225|NCT02609230|TIC10 compound|tic10 compound|mesh-list
25228226|NCT02609230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25228227|NCT02609087|Propofol|propofol|mesh-list
25228228|NCT02609087|Sevoflurane|sevoflurane|mesh-list
24843705|NCT02228863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24843706|NCT02228863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843707|NCT02228863|Cholinergic Agents|cholinergic agents|mesh-ancestor
24843708|NCT02228863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24843709|NCT02228902|Ferrous fumarate|ferrous fumarate|mesh-list
24843710|NCT02228902|Ferrous gluconate|ferrous gluconate|mesh-list
24843711|NCT02228902|Trace Elements|trace elements|mesh-ancestor
24843712|NCT02228902|Micronutrients|micronutrients|mesh-ancestor
24843713|NCT02228902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995727|NCT04793646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995728|NCT04793646|Protective Agents|protective agents|mesh-ancestor
24995729|NCT04793646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549798|NCT00717561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24843737|NCT02229123|Levetiracetam|levetiracetam|mesh-list
24843738|NCT02229123|Anticonvulsants|anticonvulsants|mesh-ancestor
24843739|NCT02229123|Nootropic Agents|nootropic agents|mesh-ancestor
24843740|NCT02229175|Bevacizumab|bevacizumab|mesh-list
25059132|NCT03490825|Antioxidants|antioxidants|mesh-ancestor
24544028|NCT00686556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24544029|NCT00686556|Alkylating Agents|alkylating agents|mesh-ancestor
24558251|NCT00755885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681836|NCT01870999|Dopamine Agonists|dopamine agonists|mesh-ancestor
25681837|NCT01870999|Dopamine Agents|dopamine agents|mesh-ancestor
25681838|NCT01870999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25681839|NCT01870999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681840|NCT01870999|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25681841|NCT01870999|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25681842|NCT01870999|Serotonin Agents|serotonin agents|mesh-ancestor
25228242|NCT02608944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228244|NCT02608944|Vasodilator Agents|vasodilator agents|mesh-ancestor
25228245|NCT02608944|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25228246|NCT02608944|Purinergic Agonists|purinergic agonists|mesh-ancestor
25228247|NCT02608944|Purinergic Agents|purinergic agents|mesh-ancestor
25228248|NCT02608944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25228249|NCT02608944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228250|NCT02608944|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25228251|NCT02609152|Esmolol|esmolol|mesh-list
25228252|NCT02609152|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25228253|NCT02609152|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25228254|NCT02609152|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25228255|NCT02609152|Adrenergic Agents|adrenergic agents|mesh-ancestor
24843741|NCT02229175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24843742|NCT02229175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843743|NCT02229175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24474914|NCT00408148|Hormones|hormones|mesh-ancestor
24843802|NCT02229721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24843803|NCT02229721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843804|NCT02229734|Androgens|androgens|mesh-list
24843805|NCT02229734|Hormones|hormones|mesh-ancestor
24843806|NCT02229734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24843811|NCT02229747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24843812|NCT02229747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24843813|NCT02229747|Analgesics|analgesics|mesh-ancestor
24843814|NCT02229747|Sensory System Agents|sensory system agents|mesh-ancestor
24843815|NCT02229747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25681843|NCT01870999|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25681844|NCT01870999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25681845|NCT01870999|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25681846|NCT01870999|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25681847|NCT01871077|Ketorolac|ketorolac|mesh-list
25681848|NCT01871077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25681849|NCT01871077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25681850|NCT01871077|Analgesics|analgesics|mesh-ancestor
25681851|NCT01871077|Sensory System Agents|sensory system agents|mesh-ancestor
25228258|NCT02609152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228260|NCT02608918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25228261|NCT02608918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25228262|NCT02608918|Antiviral Agents|antiviral agents|mesh-ancestor
25228263|NCT02608918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25228264|NCT02609061|Alendronate|alendronate|mesh-list
25228265|NCT02609061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25228266|NCT02609061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228267|NCT02608996|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25228268|NCT02608996|Natriuretic Agents|natriuretic agents|mesh-ancestor
25228269|NCT02608996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228270|NCT02609334|Pemirolast|pemirolast|mesh-list
25228271|NCT02609334|Histamine Antagonists|histamine antagonists|mesh-ancestor
25228272|NCT02609334|Histamine Agents|histamine agents|mesh-ancestor
25228273|NCT02609334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25228274|NCT02609334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228275|NCT02609334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228276|NCT02608931|Dronabinol|dronabinol|mesh-list
25228277|NCT02608931|Hallucinogens|hallucinogens|mesh-ancestor
25228278|NCT02608931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228279|NCT02608931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25228280|NCT02608931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25228281|NCT02608931|Analgesics|analgesics|mesh-ancestor
25228282|NCT02608931|Sensory System Agents|sensory system agents|mesh-ancestor
25228283|NCT02608931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25228284|NCT02608931|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24995756|NCT04780581|Dexamethasone|dexamethasone|mesh-list
24995757|NCT04780581|Methylprednisolone|methylprednisolone|mesh-list
24995758|NCT04780581|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25228285|NCT02608931|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25228286|NCT02608931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25228287|NCT02608931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228288|NCT02608931|Hormones|hormones|mesh-ancestor
25228289|NCT02608931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25228290|NCT02609165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24843835|NCT02229760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24843837|NCT02229773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24843838|NCT02229773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24843839|NCT02229773|Antimetabolites|antimetabolites|mesh-ancestor
24869850|NCT05142098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24544090|NCT00687037|Cetylpyridinium|cetylpyridinium|mesh-list
24544091|NCT00687037|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24544092|NCT00687037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25036440|NCT03547505|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
25036441|NCT03547505|Vasodilator Agents|vasodilator agents|mesh-ancestor
25036442|NCT03547505|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25036443|NCT03547505|Protective Agents|protective agents|mesh-ancestor
24604039|NCT00976976|Antimitotic Agents|antimitotic agents|mesh-ancestor
24604040|NCT00976976|Mitosis Modulators|mitosis modulators|mesh-ancestor
24604043|NCT00976976|Antimetabolites|antimetabolites|mesh-ancestor
25036471|NCT03547219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25036472|NCT03547219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25036474|NCT03547219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24544093|NCT00687063|Insulin Detemir|insulin detemir|mesh-list
24544094|NCT00687063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24544095|NCT00687063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544096|NCT00687206|Valsartan|valsartan|mesh-list
24544097|NCT00687206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24544098|NCT00687206|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24858000|NCT02294643|Analgesics|analgesics|mesh-ancestor
24558322|NCT00756184|Travoprost|travoprost|mesh-list
24544111|NCT00687258|Antioxidants|antioxidants|mesh-ancestor
24544112|NCT00687258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544113|NCT00687258|Protective Agents|protective agents|mesh-ancestor
24544114|NCT00687284|Insulin Detemir|insulin detemir|mesh-list
24544115|NCT00687284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25228291|NCT02609165|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25273406|NCT02385461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273407|NCT02385448|Dienogest|dienogest|mesh-list
25273408|NCT02385448|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
25273409|NCT02385448|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25273410|NCT02385448|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25273411|NCT02385448|Contraceptive Agents|contraceptive agents|mesh-ancestor
25273412|NCT02385448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25681852|NCT01871077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25681853|NCT01871077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681854|NCT01871077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25681855|NCT01871077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25681856|NCT01871077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25681857|NCT01871077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25681858|NCT01871077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681859|NCT01871285|Morphine|morphine|mesh-list
25681860|NCT01871285|Oxycodone|oxycodone|mesh-list
25681861|NCT01871285|Buprenorphine|buprenorphine|mesh-list
25273413|NCT02385448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273414|NCT02385448|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25273415|NCT02385448|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25273416|NCT02385448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24858001|NCT02294643|Sensory System Agents|sensory system agents|mesh-ancestor
24858002|NCT02294643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858003|NCT02294643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447043|NCT00307255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24544136|NCT00687388|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24447044|NCT00307255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447045|NCT00307255|Tubulin Modulators|tubulin modulators|mesh-ancestor
24447046|NCT00307255|Antimitotic Agents|antimitotic agents|mesh-ancestor
24447047|NCT00307255|Mitosis Modulators|mitosis modulators|mesh-ancestor
24447048|NCT00307255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447064|NCT00307307|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24447066|NCT00307307|Vasodilator Agents|vasodilator agents|mesh-ancestor
24447067|NCT00307307|Vitamin B Complex|vitamin b complex|mesh-ancestor
24447068|NCT00307307|Vitamins|vitamins|mesh-ancestor
24447069|NCT00307307|Micronutrients|micronutrients|mesh-ancestor
25228292|NCT02608710|Verinurad|verinurad|mesh-list
25228293|NCT02608710|Gout Suppressants|gout suppressants|mesh-ancestor
24858007|NCT02294643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24858008|NCT02294643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460465|NCT00348452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24544218|NCT00687843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24544219|NCT00687843|Antimetabolites|antimetabolites|mesh-ancestor
24544220|NCT00687843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544221|NCT00687843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544222|NCT00687843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24544223|NCT00687843|Immunologic Factors|immunologic factors|mesh-ancestor
24544224|NCT00687843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228296|NCT02608736|Anticonvulsants|anticonvulsants|mesh-ancestor
25228297|NCT02608736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25228298|NCT02608736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228299|NCT02608736|GABA Agents|gaba agents|mesh-ancestor
24843842|NCT02229773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24843843|NCT02229773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24843844|NCT02229786|Acetaminophen|acetaminophen|mesh-list
24843845|NCT02229786|Scopolamine|scopolamine|mesh-list
24843846|NCT02229786|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24843847|NCT02229786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24843848|NCT02229786|Analgesics|analgesics|mesh-ancestor
24843849|NCT02229786|Sensory System Agents|sensory system agents|mesh-ancestor
24843850|NCT02229786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24843851|NCT02229786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843852|NCT02229786|Antipyretics|antipyretics|mesh-ancestor
24843853|NCT02229786|Parasympatholytics|parasympatholytics|mesh-ancestor
24843854|NCT02229786|Autonomic Agents|autonomic agents|mesh-ancestor
24843855|NCT02229786|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24756524|NCT01733979|Iron|iron|mesh-list
24843880|NCT02229825|Sensory System Agents|sensory system agents|mesh-ancestor
24843881|NCT02229825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24843882|NCT02229825|Antidepressive Agents|antidepressive agents|mesh-ancestor
24843883|NCT02229825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24843884|NCT02229825|Dopamine Agents|dopamine agents|mesh-ancestor
25228301|NCT02608736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228304|NCT02608736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25228306|NCT02608788|Ketorolac|ketorolac|mesh-list
25228307|NCT02608788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25228308|NCT02608788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25228309|NCT02608788|Analgesics|analgesics|mesh-ancestor
25228310|NCT02608788|Sensory System Agents|sensory system agents|mesh-ancestor
25228311|NCT02608788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25228312|NCT02608788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228313|NCT02608788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25681862|NCT01871285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25681863|NCT01871285|Narcotics|narcotics|mesh-ancestor
25681864|NCT01871285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25228314|NCT02608788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25681865|NCT01871285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228333|NCT02608606|Immunologic Factors|immunologic factors|mesh-ancestor
25228334|NCT02608606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228335|NCT02608606|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24544234|NCT00687999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544242|NCT00688077|Salmon calcitonin|salmon calcitonin|mesh-list
24544243|NCT00688077|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
24544245|NCT00688077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24858013|NCT02294643|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25228336|NCT02608606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25228337|NCT02608606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228338|NCT02608437|Ipilimumab|ipilimumab|mesh-list
25228339|NCT02608437|Guadecitabine|guadecitabine|mesh-list
25228340|NCT02608437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25036903|NCT03542331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25036904|NCT03542279|Glucocorticoids|glucocorticoids|mesh-list
25036905|NCT03542279|Hormones|hormones|mesh-ancestor
25228341|NCT02608437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25228342|NCT02608437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25228343|NCT02608437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228344|NCT02608242|Amlodipine|amlodipine|mesh-list
25228345|NCT02608242|Telmisartan|telmisartan|mesh-list
25228346|NCT02608242|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
25228347|NCT02608242|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25228348|NCT02608242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25228349|NCT02608242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24843913|NCT02229955|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24843914|NCT02229955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24843915|NCT02230033|Itraconazole|itraconazole|mesh-list
24843916|NCT02230033|Gemfibrozil|gemfibrozil|mesh-list
24843917|NCT02230033|Antifungal Agents|antifungal agents|mesh-ancestor
24843942|NCT02230163|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24843944|NCT02230163|Immunologic Factors|immunologic factors|mesh-ancestor
24843951|NCT02230176|Growth Substances|growth substances|mesh-ancestor
24843952|NCT02230176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843953|NCT02230176|Growth Inhibitors|growth inhibitors|mesh-ancestor
24843954|NCT02230176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24843955|NCT02230176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24843956|NCT02230176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843957|NCT02230176|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24843958|NCT02230228|Vitamin A|vitamin a|mesh-list
24843959|NCT02230228|Retinol acetate|retinol acetate|mesh-list
24843960|NCT02230228|Vitamins|vitamins|mesh-ancestor
24843961|NCT02230228|Micronutrients|micronutrients|mesh-ancestor
24843962|NCT02230228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843963|NCT02230228|Protective Agents|protective agents|mesh-ancestor
24843964|NCT02230228|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24843965|NCT02230228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843966|NCT02230228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24843967|NCT02230228|Immunologic Factors|immunologic factors|mesh-ancestor
24843968|NCT02230319|Paclitaxel|paclitaxel|mesh-list
24844002|NCT02230735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24544254|NCT00688194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544255|NCT00688194|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24544256|NCT00688194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25228354|NCT02608242|Vasodilator Agents|vasodilator agents|mesh-ancestor
24544316|NCT00688428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25228355|NCT02608242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25228356|NCT02608242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25228357|NCT02608242|Antimetabolites|antimetabolites|mesh-ancestor
25228358|NCT02608242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25228359|NCT02608242|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25228360|NCT02608242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25228361|NCT02608242|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25228362|NCT02608242|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25228363|NCT02608320|Fentanyl|fentanyl|mesh-list
25228364|NCT02608320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25228365|NCT02608320|Narcotics|narcotics|mesh-ancestor
25228366|NCT02608320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25228367|NCT02608320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228368|NCT02608320|Analgesics|analgesics|mesh-ancestor
25228369|NCT02608320|Sensory System Agents|sensory system agents|mesh-ancestor
25228370|NCT02608320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25681866|NCT01871285|Analgesics|analgesics|mesh-ancestor
25681867|NCT01871285|Sensory System Agents|sensory system agents|mesh-ancestor
25681868|NCT01871285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25228371|NCT02608320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25228372|NCT02608320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24588876|NCT00904540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588877|NCT00904605|Celecoxib|celecoxib|mesh-list
24588878|NCT00904605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24588879|NCT00904605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24588880|NCT00904605|Analgesics|analgesics|mesh-ancestor
25037033|NCT03541564|BMS-986165|bms-986165|mesh-list
25228373|NCT02608320|Anesthetics, General|anesthetics, general|mesh-ancestor
25228374|NCT02608320|Anesthetics|anesthetics|mesh-ancestor
24844004|NCT02230735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24844005|NCT02230735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844006|NCT02230735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844007|NCT02230735|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24844008|NCT02230735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24844009|NCT02230735|Autonomic Agents|autonomic agents|mesh-ancestor
24844010|NCT02230735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24844011|NCT02230735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24844012|NCT02230735|Respiratory System Agents|respiratory system agents|mesh-ancestor
24844013|NCT02230735|Mydriatics|mydriatics|mesh-ancestor
24844014|NCT02230735|Sympathomimetics|sympathomimetics|mesh-ancestor
24844050|NCT02231021|Pioglitazone|pioglitazone|mesh-list
24844051|NCT02231021|Alogliptin|alogliptin|mesh-list
24544257|NCT00688194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544258|NCT00688194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544259|NCT00688194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24544260|NCT00688194|Hormone Antagonists|hormone antagonists|mesh-ancestor
24544261|NCT00688194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24544262|NCT00688194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544263|NCT00688194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24544264|NCT00688194|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24544265|NCT00688194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24996022|NCT04397354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858016|NCT02294643|Purinergic Agents|purinergic agents|mesh-ancestor
24447116|NCT00307528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447117|NCT00307580|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24447118|NCT00307580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24447119|NCT00307580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24544267|NCT00688207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24544268|NCT00688207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544270|NCT00688272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24544271|NCT00688272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24447126|NCT00307593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447127|NCT00307593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24447128|NCT00307593|Dermatologic Agents|dermatologic agents|mesh-ancestor
24447129|NCT00307593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24447130|NCT00307606|Methylprednisolone|methylprednisolone|mesh-list
24996023|NCT04397354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996025|NCT04397354|Glucocorticoids|glucocorticoids|mesh-ancestor
24996026|NCT04397354|Hormones|hormones|mesh-ancestor
24996027|NCT04397354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25681869|NCT01871285|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25681870|NCT01871441|Mycophenolic Acid|mycophenolic acid|mesh-list
25681871|NCT01871441|Cyclophosphamide|cyclophosphamide|mesh-list
25681872|NCT01871441|Tacrolimus|tacrolimus|mesh-list
25681873|NCT01871441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25681874|NCT01871441|Immunologic Factors|immunologic factors|mesh-ancestor
25681875|NCT01871441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681876|NCT01871441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25681877|NCT01871441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25681878|NCT01871441|Alkylating Agents|alkylating agents|mesh-ancestor
25681879|NCT01871441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681880|NCT01871441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447136|NCT00307606|Prednisolone phosphate|prednisolone phosphate|mesh-list
24447137|NCT00307606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24447138|NCT00307606|Antiemetics|antiemetics|mesh-ancestor
24447139|NCT00307606|Autonomic Agents|autonomic agents|mesh-ancestor
24447140|NCT00307606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24447141|NCT00307606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447142|NCT00307606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24544289|NCT00688363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25228384|NCT02608164|Vitamins|vitamins|mesh-ancestor
25228385|NCT02608164|Micronutrients|micronutrients|mesh-ancestor
25228386|NCT02608164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228387|NCT02608164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25228388|NCT02608164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25228389|NCT02608112|Methotrexate|methotrexate|mesh-list
25228390|NCT02608112|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25228391|NCT02608112|Abortifacient Agents|abortifacient agents|mesh-ancestor
25228392|NCT02608112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25228393|NCT02608112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228394|NCT02608112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25228395|NCT02608112|Antimetabolites|antimetabolites|mesh-ancestor
25228396|NCT02608112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844052|NCT02231021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24844053|NCT02231021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844055|NCT02231021|Hormones|hormones|mesh-ancestor
24844056|NCT02231021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24844057|NCT02231021|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24844058|NCT02231021|Protease Inhibitors|protease inhibitors|mesh-ancestor
24996031|NCT04397354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24844059|NCT02231021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24844060|NCT02231021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844061|NCT02231125|Losartan|losartan|mesh-list
24844062|NCT02231125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24844063|NCT02231125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25068532|NCT03432793|Itraconazole|itraconazole|mesh-list
24844064|NCT02231125|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24544290|NCT00688363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544291|NCT00688363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24544292|NCT00688363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24544293|NCT00688402|Lesogaberan|lesogaberan|mesh-list
24544294|NCT00688402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24544295|NCT00688402|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24447156|NCT00307632|Estrogens|estrogens|mesh-ancestor
24447157|NCT00307632|Hormones|hormones|mesh-ancestor
24447158|NCT00307632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24447175|NCT00307645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25405371|NCT03609216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993860|NCT05335655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24993861|NCT05335655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24993862|NCT05335655|Adrenergic Agents|adrenergic agents|mesh-ancestor
24588931|NCT00904709|Coagulants|coagulants|mesh-ancestor
24426496|NCT00236223|Autonomic Agents|autonomic agents|mesh-ancestor
24588945|NCT00904852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24588946|NCT00904852|Growth Substances|growth substances|mesh-ancestor
24588947|NCT00904852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588948|NCT00904852|Growth Inhibitors|growth inhibitors|mesh-ancestor
24588949|NCT00904852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24588950|NCT00904852|Alkylating Agents|alkylating agents|mesh-ancestor
24588951|NCT00904852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588952|NCT00904904|Ketorolac|ketorolac|mesh-list
24588953|NCT00904904|Indomethacin|indomethacin|mesh-list
25037201|NCT03539562|Antiemetics|antiemetics|mesh-ancestor
25037202|NCT03539562|Autonomic Agents|autonomic agents|mesh-ancestor
25037203|NCT03539562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24544305|NCT00688428|Analgesics|analgesics|mesh-ancestor
24544306|NCT00688428|Sensory System Agents|sensory system agents|mesh-ancestor
24798124|NCT01960595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24798125|NCT01960595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24798126|NCT01960595|Anesthetics, General|anesthetics, general|mesh-ancestor
24798127|NCT01960647|Paclitaxel|paclitaxel|mesh-list
24798128|NCT01960647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24798129|NCT01960647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544307|NCT00688428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25228397|NCT02608112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25228398|NCT02608112|Dermatologic Agents|dermatologic agents|mesh-ancestor
25228399|NCT02608112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25228400|NCT02608112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25228401|NCT02608112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25228402|NCT02608112|Immunologic Factors|immunologic factors|mesh-ancestor
25228403|NCT02608112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25228404|NCT02608112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25228405|NCT02607904|Cannabidiol|cannabidiol|mesh-list
25228406|NCT02607904|Anticonvulsants|anticonvulsants|mesh-ancestor
25228407|NCT02607943|Insulin|insulin|mesh-list
25228408|NCT02607943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25228409|NCT02607943|Insulin Glargine|insulin glargine|mesh-list
25228410|NCT02607943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25228411|NCT02607943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228412|NCT02607891|Cannabidiol|cannabidiol|mesh-list
25228413|NCT02607891|Anticonvulsants|anticonvulsants|mesh-ancestor
25228414|NCT02607982|Paclitaxel|paclitaxel|mesh-list
25228415|NCT02607982|Oxaliplatin|oxaliplatin|mesh-list
25228416|NCT02607982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25228417|NCT02607982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25228418|NCT02607982|Tubulin Modulators|tubulin modulators|mesh-ancestor
25228419|NCT02607982|Antimitotic Agents|antimitotic agents|mesh-ancestor
25681881|NCT01871441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25681882|NCT01871441|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25681883|NCT01871441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25681884|NCT01871441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25681885|NCT01871441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25681886|NCT01871441|Antitubercular Agents|antitubercular agents|mesh-ancestor
25681887|NCT01871441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25681888|NCT01871441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25681889|NCT01871532|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25681890|NCT01871532|Hormones|hormones|mesh-ancestor
25681891|NCT01871532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25681892|NCT01871532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681893|NCT01871558|Metformin|metformin|mesh-list
25681894|NCT01871558|Vildagliptin|vildagliptin|mesh-list
25681895|NCT01871558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25681896|NCT01871558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681897|NCT01871558|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25681898|NCT01871558|Protease Inhibitors|protease inhibitors|mesh-ancestor
25681899|NCT01871558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25681900|NCT01871558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426726|NCT00236548|Risperidone|risperidone|mesh-list
24426914|NCT00236821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24426915|NCT00236821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24426916|NCT00236821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24426917|NCT00236821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24426918|NCT00236821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024888|NCT03641456|Bortezomib|bortezomib|mesh-list
25037240|NCT03539224|Lamivudine|lamivudine|mesh-list
25037241|NCT03539224|Dolutegravir|dolutegravir|mesh-list
25037242|NCT03539224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25037243|NCT03539224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25037244|NCT03539224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037245|NCT03539224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844065|NCT02231125|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24844066|NCT02231125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844067|NCT02231203|Tocopherols|tocopherols|mesh-list
24844068|NCT02231203|Antioxidants|antioxidants|mesh-list
24798143|NCT01961154|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24844069|NCT02231203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844070|NCT02231203|Protective Agents|protective agents|mesh-ancestor
24844071|NCT02231203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844072|NCT02231203|Vitamins|vitamins|mesh-ancestor
24544308|NCT00688428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544309|NCT00688428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24544310|NCT00688428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24544311|NCT00688428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24544312|NCT00688428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24544313|NCT00688428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544314|NCT00688428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24544315|NCT00688428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24544317|NCT00688428|Antipyretics|antipyretics|mesh-ancestor
24544318|NCT00688428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24544319|NCT00688428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24544320|NCT00688428|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24544321|NCT00688480|Allopurinol|allopurinol|mesh-list
24544322|NCT00688480|Antimetabolites|antimetabolites|mesh-ancestor
24544326|NCT00688480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24544327|NCT00688480|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24544328|NCT00688480|Antioxidants|antioxidants|mesh-ancestor
24544329|NCT00688480|Protective Agents|protective agents|mesh-ancestor
24544330|NCT00688480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544331|NCT00688493|Dapagliflozin|dapagliflozin|mesh-list
25228420|NCT02607982|Mitosis Modulators|mitosis modulators|mesh-ancestor
25228421|NCT02607982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228422|NCT02608034|Itraconazole|itraconazole|mesh-list
25228423|NCT02608034|Rifampin|rifampin|mesh-list
25228424|NCT02608034|Vemurafenib|vemurafenib|mesh-list
25228425|NCT02608034|Antifungal Agents|antifungal agents|mesh-ancestor
25228426|NCT02608034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25228427|NCT02608034|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25228428|NCT02608034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25228429|NCT02608034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25228430|NCT02608034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228431|NCT02608034|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25228432|NCT02608034|Hormone Antagonists|hormone antagonists|mesh-ancestor
25228433|NCT02608034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25228434|NCT02608034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681901|NCT01871870|Pancrelipase|pancrelipase|mesh-list
25681902|NCT01871870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25681903|NCT01872611|Prednisolone|prednisolone|mesh-list
25681904|NCT01872611|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25681905|NCT01872611|Methylprednisolone|methylprednisolone|mesh-list
25681906|NCT01872611|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25681907|NCT01872611|Prednisolone acetate|prednisolone acetate|mesh-list
25681908|NCT01872611|Nepafenac|nepafenac|mesh-list
25681909|NCT01872611|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25681910|NCT01872611|Prednisolone phosphate|prednisolone phosphate|mesh-list
25681911|NCT01872611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25681912|NCT01872611|Glucocorticoids|glucocorticoids|mesh-ancestor
25681913|NCT01872611|Hormones|hormones|mesh-ancestor
25681914|NCT01872611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24426953|NCT00236912|Levofloxacin|levofloxacin|mesh-list
24427175|NCT00237588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24427176|NCT00237588|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24427177|NCT00237588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24427178|NCT00237588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427224|NCT00237731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427225|NCT00237731|Analgesics|analgesics|mesh-ancestor
24427226|NCT00237731|Sensory System Agents|sensory system agents|mesh-ancestor
24427227|NCT00237731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25228435|NCT02608034|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25228436|NCT02608034|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25228437|NCT02608034|Antitubercular Agents|antitubercular agents|mesh-ancestor
25228438|NCT02608034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25228439|NCT02608034|Leprostatic Agents|leprostatic agents|mesh-ancestor
25228440|NCT02608034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25228441|NCT02608034|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25228442|NCT02608034|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24844073|NCT02231203|Micronutrients|micronutrients|mesh-ancestor
24996189|NCT04162873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24844074|NCT02231255|Pramipexole|pramipexole|mesh-list
24844075|NCT02231255|Antioxidants|antioxidants|mesh-ancestor
24844076|NCT02231255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844077|NCT02231255|Protective Agents|protective agents|mesh-ancestor
24844078|NCT02231255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475191|NCT00409357|Alfuzosin|alfuzosin|mesh-list
24844096|NCT02231281|Antiviral Agents|antiviral agents|mesh-ancestor
24844097|NCT02231281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24844098|NCT02231281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24844099|NCT02231281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24844100|NCT02231281|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24844105|NCT02231294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844106|NCT02231294|Protective Agents|protective agents|mesh-ancestor
24844107|NCT02231294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844108|NCT02231294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24844109|NCT02231294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24844110|NCT02231294|Dopamine Agonists|dopamine agonists|mesh-ancestor
24844111|NCT02231294|Dopamine Agents|dopamine agents|mesh-ancestor
24844112|NCT02231294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24844113|NCT02231320|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
25059348|NCT03489005|Zamicastat|zamicastat|mesh-list
24544346|NCT00688493|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24544355|NCT00688558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544357|NCT00688558|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24544358|NCT00688558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544359|NCT00688805|Propranolol|propranolol|mesh-list
24544360|NCT00688805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24544361|NCT00688805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24544362|NCT00688805|Adrenergic Agents|adrenergic agents|mesh-ancestor
24544363|NCT00688805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24544364|NCT00688805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544365|NCT00688805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858022|NCT02294656|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24544368|NCT00688805|Vasodilator Agents|vasodilator agents|mesh-ancestor
24544369|NCT00688818|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24544370|NCT00688818|Antidepressive Agents|antidepressive agents|mesh-ancestor
24544371|NCT00688818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24544372|NCT00688818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25681915|NCT01872611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681916|NCT01872611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25681917|NCT01872611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25681918|NCT01872611|Antiemetics|antiemetics|mesh-ancestor
25681919|NCT01872611|Autonomic Agents|autonomic agents|mesh-ancestor
25681920|NCT01872611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25681921|NCT01872611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25681922|NCT01872611|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25681923|NCT01872611|Protective Agents|protective agents|mesh-ancestor
25681924|NCT01872611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25681925|NCT01872611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25228453|NCT02608073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228455|NCT02608060|Hematinics|hematinics|mesh-ancestor
25228456|NCT02607631|Pembrolizumab|pembrolizumab|mesh-list
25228457|NCT02607631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25228458|NCT02607631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25228459|NCT02607657|Eplerenone|eplerenone|mesh-list
25228460|NCT02607657|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25228461|NCT02607657|Hormone Antagonists|hormone antagonists|mesh-ancestor
25228462|NCT02607657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25228463|NCT02607657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844116|NCT02231320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24844117|NCT02231320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043826|NCT01198834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25043827|NCT01198834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043828|NCT01198626|Moxifloxacin|moxifloxacin|mesh-list
25043829|NCT01198626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25043830|NCT01198626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25043831|NCT01198626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25043832|NCT01198626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24558848|NCT05428293|Ibuprofen|ibuprofen|mesh-list
25228464|NCT02607657|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25228465|NCT02607657|Diuretics|diuretics|mesh-ancestor
25228466|NCT02607657|Natriuretic Agents|natriuretic agents|mesh-ancestor
25228467|NCT02607657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25228468|NCT02607696|Zolpidem|zolpidem|mesh-list
25228469|NCT02607696|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25228470|NCT02607696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25228471|NCT02607696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25228481|NCT02607774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25228482|NCT02607774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228484|NCT02607774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25228485|NCT02607774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25228486|NCT02607774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25228487|NCT02607774|Anesthetics, General|anesthetics, general|mesh-ancestor
25228488|NCT02607774|Anesthetics|anesthetics|mesh-ancestor
24844122|NCT02231333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24844123|NCT02231333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844124|NCT02231333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24844125|NCT02231333|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24756849|NCT01736033|Tamsulosin|tamsulosin|mesh-list
24996261|NCT03941964|Venetoclax|venetoclax|mesh-list
25228492|NCT02607774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228493|NCT02607579|Ropivacaine|ropivacaine|mesh-list
25228494|NCT02607579|Anesthetics, Local|anesthetics, local|mesh-ancestor
25228495|NCT02607579|Anesthetics|anesthetics|mesh-ancestor
25228496|NCT02607579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25228497|NCT02607579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228498|NCT02607579|Sensory System Agents|sensory system agents|mesh-ancestor
25228617|NCT02607072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25228499|NCT02607579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25228500|NCT02607540|Cisplatin|cisplatin|mesh-list
25228501|NCT02607540|Fluorouracil|fluorouracil|mesh-list
25228502|NCT02607540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25228503|NCT02607540|Antimetabolites|antimetabolites|mesh-ancestor
25228504|NCT02607540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228505|NCT02607540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25681929|NCT01872689|Pirfenidone|pirfenidone|mesh-list
25681930|NCT01872689|Analgesics|analgesics|mesh-ancestor
25681931|NCT01872689|Sensory System Agents|sensory system agents|mesh-ancestor
25681932|NCT01872689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25681933|NCT01872689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681934|NCT01872689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25681935|NCT01872689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25681936|NCT01872689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25228506|NCT02607540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25228521|NCT02607410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25228522|NCT02607410|Protease Inhibitors|protease inhibitors|mesh-ancestor
25228523|NCT02607410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25228524|NCT02607410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228525|NCT02607436|Aspirin|aspirin|mesh-list
25228526|NCT02607436|Sarpogrelate|sarpogrelate|mesh-list
25228527|NCT02607436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25228528|NCT02607436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25228529|NCT02607436|Analgesics|analgesics|mesh-ancestor
25228530|NCT02607436|Sensory System Agents|sensory system agents|mesh-ancestor
24394685|NCT00133887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24844132|NCT02231346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24844133|NCT02231346|Autonomic Agents|autonomic agents|mesh-ancestor
24844134|NCT02231346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24844135|NCT02231346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844136|NCT02231346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24844137|NCT02231346|Respiratory System Agents|respiratory system agents|mesh-ancestor
24844138|NCT02231359|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
24844139|NCT02231359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24844140|NCT02231359|Autonomic Agents|autonomic agents|mesh-ancestor
24844141|NCT02231359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24844142|NCT02231359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544409|NCT00688922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544411|NCT00688922|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24544412|NCT00688922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544414|NCT00688948|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25228531|NCT02607436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25681937|NCT01872689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25681938|NCT01872689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25681939|NCT01872819|Antineoplastic Agents|antineoplastic agents|mesh-list
25681940|NCT01872910|Celecoxib|celecoxib|mesh-list
25037551|NCT03536598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25037552|NCT03536598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107795|NCT03137004|Docetaxel|docetaxel|mesh-list
24428808|NCT00241241|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24428809|NCT00241241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25037553|NCT03536598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25037554|NCT03536598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037555|NCT03536598|Vasodilator Agents|vasodilator agents|mesh-ancestor
25037556|NCT03536598|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25037557|NCT03536598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25037559|NCT03536598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25037560|NCT03536598|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25037561|NCT03536598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037562|NCT03536598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25037563|NCT03536598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25228532|NCT02607436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228533|NCT02607436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25228534|NCT02607436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25228535|NCT02607436|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25228536|NCT02607436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25228537|NCT02607436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228538|NCT02607436|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25228539|NCT02607436|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25228540|NCT02607436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25228541|NCT02607436|Antipyretics|antipyretics|mesh-ancestor
25228542|NCT02607436|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25228543|NCT02607436|Serotonin Agents|serotonin agents|mesh-ancestor
25228544|NCT02607436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25228545|NCT02607592|Pemetrexed|pemetrexed|mesh-list
25228546|NCT02607592|Nedaplatin|nedaplatin|mesh-list
25228547|NCT02607592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25228548|NCT02607592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25228549|NCT02607592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228550|NCT02607592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25228551|NCT02607592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25228552|NCT02607488|Lidocaine|lidocaine|mesh-list
25228553|NCT02607488|Anesthetics, Local|anesthetics, local|mesh-ancestor
25228554|NCT02607488|Anesthetics|anesthetics|mesh-ancestor
25228555|NCT02607488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25228556|NCT02607488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228557|NCT02607488|Sensory System Agents|sensory system agents|mesh-ancestor
25228558|NCT02607488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25228559|NCT02607488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25228560|NCT02607488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25228561|NCT02607488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25228562|NCT02607488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25228563|NCT02607488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844143|NCT02231359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24844144|NCT02231359|Respiratory System Agents|respiratory system agents|mesh-ancestor
24844145|NCT02231372|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
24844146|NCT02231372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24844147|NCT02231372|Autonomic Agents|autonomic agents|mesh-ancestor
25681941|NCT01872910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25681942|NCT01872910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25681943|NCT01872910|Analgesics|analgesics|mesh-ancestor
25681944|NCT01872910|Sensory System Agents|sensory system agents|mesh-ancestor
25681945|NCT01872910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25681946|NCT01872910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681947|NCT01872910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25681948|NCT01872910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25681949|NCT01872910|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25681950|NCT01872910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25681951|NCT01872910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25681952|NCT01872910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681953|NCT01873417|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25681954|NCT01873417|Dermatologic Agents|dermatologic agents|mesh-ancestor
25681955|NCT01873417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25681956|NCT01873417|Immunologic Factors|immunologic factors|mesh-ancestor
24844149|NCT02231372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844151|NCT02231372|Respiratory System Agents|respiratory system agents|mesh-ancestor
24844153|NCT02231385|Retinol acetate|retinol acetate|mesh-list
24844154|NCT02231385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24844155|NCT02231385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24943236|NCT03973203|Niacin|niacin|mesh-list
24544415|NCT00688948|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24544416|NCT00688948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24544417|NCT00688948|Adrenergic Agents|adrenergic agents|mesh-ancestor
24544418|NCT00688948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24544491|NCT00689195|Curcumin|curcumin|mesh-list
24544492|NCT00689195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25228564|NCT02607423|Gemcitabine|gemcitabine|mesh-list
25228565|NCT02607423|Deoxyglucose|deoxyglucose|mesh-list
25228566|NCT02607423|Cisplatin|cisplatin|mesh-list
25228567|NCT02607423|Docetaxel|docetaxel|mesh-list
25228568|NCT02607423|Pemetrexed|pemetrexed|mesh-list
25228569|NCT02607423|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25228570|NCT02607423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25228571|NCT02607423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25228572|NCT02607423|Antimetabolites|antimetabolites|mesh-ancestor
25228573|NCT02607423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228574|NCT02607423|Antiviral Agents|antiviral agents|mesh-ancestor
25228575|NCT02607423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25228576|NCT02607423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25228578|NCT02607423|Immunologic Factors|immunologic factors|mesh-ancestor
25228579|NCT02607423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228580|NCT02607423|Tubulin Modulators|tubulin modulators|mesh-ancestor
25228581|NCT02607423|Antimitotic Agents|antimitotic agents|mesh-ancestor
25228582|NCT02607423|Mitosis Modulators|mitosis modulators|mesh-ancestor
25228583|NCT02607423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25228584|NCT02607423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25228585|NCT02607423|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25228586|NCT02607293|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25228587|NCT02607293|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25228588|NCT02607293|Hormones|hormones|mesh-ancestor
24844156|NCT02231385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24844157|NCT02231385|Immunologic Factors|immunologic factors|mesh-ancestor
24844158|NCT02231385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844159|NCT02231385|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24844160|NCT02231385|Protective Agents|protective agents|mesh-ancestor
24786154|NCT01918176|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24786157|NCT01918241|Lenograstim|lenograstim|mesh-list
24844161|NCT02231385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24844162|NCT02231424|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
24844163|NCT02231424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24844164|NCT02231424|Autonomic Agents|autonomic agents|mesh-ancestor
24844165|NCT02231424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24844166|NCT02231424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844167|NCT02231424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24844168|NCT02231424|Respiratory System Agents|respiratory system agents|mesh-ancestor
24844169|NCT02231437|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
24844170|NCT02231437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25681957|NCT01873417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681958|NCT01873495|Homoharringtonine|homoharringtonine|mesh-list
25681959|NCT01873495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25681960|NCT01873495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25681961|NCT01873495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25681962|NCT01873495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515150|NCT00594867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24844171|NCT02231437|Autonomic Agents|autonomic agents|mesh-ancestor
24844172|NCT02231437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24844173|NCT02231437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844174|NCT02231437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24844175|NCT02231437|Respiratory System Agents|respiratory system agents|mesh-ancestor
24544493|NCT00689195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24544517|NCT00689208|Cholinergic Agents|cholinergic agents|mesh-ancestor
24544518|NCT00689208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24544519|NCT00689208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544520|NCT00689208|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24544521|NCT00689208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544523|NCT00689416|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24544524|NCT00689416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24544525|NCT00689416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24544526|NCT00689416|Antimetabolites|antimetabolites|mesh-ancestor
24544527|NCT00689416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858024|NCT02294656|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24858025|NCT02294656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24786175|NCT01918358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108168|NCT03133975|Vitamins|vitamins|mesh-ancestor
25108169|NCT03133975|Micronutrients|micronutrients|mesh-ancestor
25108170|NCT03133975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108171|NCT03133975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25108172|NCT03133975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25108173|NCT03133832|Praziquantel|praziquantel|mesh-list
24858026|NCT02294656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24858027|NCT02294656|Growth Substances|growth substances|mesh-ancestor
24544555|NCT00689520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544556|NCT00689520|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24544557|NCT00689520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24544559|NCT00689520|Hemostatics|hemostatics|mesh-ancestor
24544573|NCT00689559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544574|NCT00689559|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24544575|NCT00689559|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24544576|NCT00689559|Serotonin Agents|serotonin agents|mesh-ancestor
25228618|NCT02607072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25228589|NCT02607293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25228590|NCT02607293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228591|NCT02607371|Rivaroxaban|rivaroxaban|mesh-list
25228592|NCT02607371|Apixaban|apixaban|mesh-list
25228593|NCT02607371|Edoxaban|edoxaban|mesh-list
25228594|NCT02607371|Dabigatran|dabigatran|mesh-list
25228595|NCT02607371|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25228596|NCT02607371|Antithrombins|antithrombins|mesh-ancestor
25228597|NCT02607371|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25228598|NCT02607371|Protease Inhibitors|protease inhibitors|mesh-ancestor
25228599|NCT02607371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25228600|NCT02607371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228601|NCT02607371|Anticoagulants|anticoagulants|mesh-ancestor
25228602|NCT02607332|Paclitaxel|paclitaxel|mesh-list
25228603|NCT02607332|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25228604|NCT02607332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25228605|NCT02607332|Tubulin Modulators|tubulin modulators|mesh-ancestor
25228606|NCT02607332|Antimitotic Agents|antimitotic agents|mesh-ancestor
25228607|NCT02607332|Mitosis Modulators|mitosis modulators|mesh-ancestor
25228608|NCT02607332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228609|NCT02607072|Aspirin|aspirin|mesh-list
25228610|NCT02607072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24394686|NCT00133887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25108174|NCT03133832|Anthelmintics|anthelmintics|mesh-ancestor
25108177|NCT03133845|Fentanyl|fentanyl|mesh-list
24844199|NCT02231658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24844202|NCT02231762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25681963|NCT01873495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681964|NCT01873729|Naltrexone|naltrexone|mesh-list
25681965|NCT01873729|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25681966|NCT01873729|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25228628|NCT02607202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25228629|NCT02607202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25228630|NCT02607202|Tubulin Modulators|tubulin modulators|mesh-ancestor
25228631|NCT02607202|Antimitotic Agents|antimitotic agents|mesh-ancestor
25228632|NCT02607202|Mitosis Modulators|mitosis modulators|mesh-ancestor
25228633|NCT02607202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228634|NCT02607202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25228635|NCT02607202|Antimetabolites|antimetabolites|mesh-ancestor
25228636|NCT02607202|Antiviral Agents|antiviral agents|mesh-ancestor
25228637|NCT02607202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25681967|NCT01873729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681968|NCT01873729|Sensory System Agents|sensory system agents|mesh-ancestor
25681969|NCT01873729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24432500|NCT00254930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24432638|NCT00255554|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24432639|NCT00255554|Antidepressive Agents|antidepressive agents|mesh-ancestor
24432640|NCT00255554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24432674|NCT00255658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432675|NCT00255658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24993514|NCT04512079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24844224|NCT02231905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844225|NCT02231905|Protective Agents|protective agents|mesh-ancestor
24844226|NCT02231905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844227|NCT02231905|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24844228|NCT02231905|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24858028|NCT02294656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858030|NCT02294656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858031|NCT02294656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25228638|NCT02607202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25228639|NCT02607202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25228640|NCT02607202|Immunologic Factors|immunologic factors|mesh-ancestor
25228641|NCT02607202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228642|NCT02607111|Dalteparin|dalteparin|mesh-list
25228643|NCT02607111|Tinzaparin|tinzaparin|mesh-list
25228644|NCT02607111|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25228645|NCT02607111|Anticoagulants|anticoagulants|mesh-ancestor
25228646|NCT02607111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24996448|NCT03463265|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24996449|NCT03463265|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25228647|NCT02607111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25228648|NCT02607111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228649|NCT02607163|Dexmedetomidine|dexmedetomidine|mesh-list
25228650|NCT02607163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25228651|NCT02607163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25228652|NCT02607163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844229|NCT02231905|Dopamine Agonists|dopamine agonists|mesh-ancestor
24844230|NCT02231905|Dopamine Agents|dopamine agents|mesh-ancestor
24844231|NCT02231905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25681971|NCT01873859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25681972|NCT01873859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681973|NCT01873950|Quinidine|quinidine|mesh-list
25681974|NCT01873950|Quinidine gluconate|quinidine gluconate|mesh-list
25681975|NCT01873950|Verapamil|verapamil|mesh-list
25681976|NCT01873950|Dofetilide|dofetilide|mesh-list
25681977|NCT01873950|Ranolazine|ranolazine|mesh-list
25681978|NCT01873950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25681979|NCT01873950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25681980|NCT01873950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25681981|NCT01873950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25681982|NCT01873950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25038017|NCT03533387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25038018|NCT03533387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038019|NCT03533387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25038020|NCT03533387|Respiratory System Agents|respiratory system agents|mesh-ancestor
25038022|NCT03533387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24844236|NCT02231931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24604308|NCT00978393|Incretins|incretins|mesh-ancestor
24844237|NCT02231931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844238|NCT02231931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24844239|NCT02231931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25059504|NCT03487406|Aspirin|aspirin|mesh-list
25228653|NCT02607163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25228654|NCT02607163|Analgesics|analgesics|mesh-ancestor
25228655|NCT02607163|Sensory System Agents|sensory system agents|mesh-ancestor
25228656|NCT02607163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25228657|NCT02607163|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25228658|NCT02607163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25228659|NCT02607163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25228660|NCT02607163|Adrenergic Agents|adrenergic agents|mesh-ancestor
25228661|NCT02607163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25228662|NCT02607163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273419|NCT02385448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25273420|NCT02385448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25273421|NCT02385448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25273422|NCT02385448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25273423|NCT02385448|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25273424|NCT02385448|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
25273425|NCT02385448|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25273426|NCT02385448|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25273427|NCT02385422|Propranolol|propranolol|mesh-list
25273428|NCT02385422|Carvedilol|carvedilol|mesh-list
25273429|NCT02385422|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25273430|NCT02385422|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25273431|NCT02385422|Adrenergic Agents|adrenergic agents|mesh-ancestor
25273432|NCT02385422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25273433|NCT02385422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25273434|NCT02385422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25273435|NCT02385422|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25681983|NCT01873950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25681984|NCT01873950|Vasodilator Agents|vasodilator agents|mesh-ancestor
25681985|NCT01873950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25681986|NCT01873950|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25681987|NCT01873950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25681988|NCT01873950|Adrenergic Agents|adrenergic agents|mesh-ancestor
25681989|NCT01873950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25681990|NCT01873950|Antimalarials|antimalarials|mesh-ancestor
25681991|NCT01873950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25681992|NCT01873950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25681993|NCT01873950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25681994|NCT01873950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273436|NCT02385422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24844243|NCT02231931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24544637|NCT00689780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24544646|NCT00689780|GABA Agents|gaba agents|mesh-ancestor
24544647|NCT00689780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24544648|NCT00689780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544649|NCT00689806|Lovastatin|lovastatin|mesh-list
24544650|NCT00689806|L 647318|l 647318|mesh-list
24544651|NCT00689806|Dihydromevinolin|dihydromevinolin|mesh-list
24544652|NCT00689806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24544653|NCT00689806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24544654|NCT00689806|Antimetabolites|antimetabolites|mesh-ancestor
24544655|NCT00689806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544656|NCT00689806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25228663|NCT02606773|Ascorbic Acid|ascorbic acid|mesh-list
25228664|NCT02606773|Antioxidants|antioxidants|mesh-ancestor
25228665|NCT02606773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228666|NCT02606773|Protective Agents|protective agents|mesh-ancestor
25228667|NCT02606773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228668|NCT02606773|Vitamins|vitamins|mesh-ancestor
25228669|NCT02606773|Micronutrients|micronutrients|mesh-ancestor
25228670|NCT02606864|Nifurtimox|nifurtimox|mesh-list
25228671|NCT02606864|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25228672|NCT02606864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25228673|NCT02606864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25228674|NCT02606864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25228675|NCT02606994|Diphenhydramine|diphenhydramine|mesh-list
25228676|NCT02606994|Lidocaine|lidocaine|mesh-list
25228677|NCT02606994|Anesthetics, Local|anesthetics, local|mesh-ancestor
25681995|NCT01873950|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25681996|NCT01873950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25681997|NCT01873950|Cholinergic Agents|cholinergic agents|mesh-ancestor
25681998|NCT01873950|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25681999|NCT01873950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25682000|NCT01873950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25682001|NCT01873950|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25228678|NCT02606994|Anesthetics|anesthetics|mesh-ancestor
24844261|NCT02232035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844262|NCT02232035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24844263|NCT02232035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24844264|NCT02232035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24844265|NCT02232035|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24844266|NCT02232035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24544657|NCT00689806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24544658|NCT00689806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544659|NCT00689832|Fluticasone|fluticasone|mesh-list
24544660|NCT00689832|Tacrolimus|tacrolimus|mesh-list
24544661|NCT00689832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24544662|NCT00689832|Immunologic Factors|immunologic factors|mesh-ancestor
24544685|NCT00689845|Vincristine|vincristine|mesh-list
24544686|NCT00689845|Bleomycin|bleomycin|mesh-list
24544687|NCT00689845|Etoposide phosphate|etoposide phosphate|mesh-list
24544688|NCT00689845|Vindesine|vindesine|mesh-list
24544689|NCT00689845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25228685|NCT02606994|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25228686|NCT02606994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25228687|NCT02606994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228688|NCT02606994|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25228689|NCT02606994|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25228690|NCT02606994|Antiemetics|antiemetics|mesh-ancestor
25228691|NCT02606994|Autonomic Agents|autonomic agents|mesh-ancestor
25228692|NCT02606994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25228693|NCT02606994|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25228694|NCT02606994|Histamine Antagonists|histamine antagonists|mesh-ancestor
25228695|NCT02606994|Histamine Agents|histamine agents|mesh-ancestor
25228696|NCT02606994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25228697|NCT02606994|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25228698|NCT02606981|Vitamins|vitamins|mesh-list
25228699|NCT02606981|Ascorbic Acid|ascorbic acid|mesh-list
25228700|NCT02606981|Micronutrients|micronutrients|mesh-ancestor
25228701|NCT02606981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228703|NCT02606981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228705|NCT02606617|Mosapride|mosapride|mesh-list
25228706|NCT02606617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25228707|NCT02606617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25228708|NCT02606617|Serotonin Agents|serotonin agents|mesh-ancestor
25228709|NCT02606617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24996784|NCT01966471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996785|NCT01966471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24996786|NCT01966471|Immunologic Factors|immunologic factors|mesh-ancestor
24996787|NCT01966471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996788|NCT01966471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24996789|NCT01966471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24996805|NCT01926197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996806|NCT01926197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996807|NCT01926197|Antidotes|antidotes|mesh-ancestor
24996808|NCT01926197|Protective Agents|protective agents|mesh-ancestor
24693196|NCT01418625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25228710|NCT02606617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228711|NCT02606617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228712|NCT02606565|Chlorhexidine|chlorhexidine|mesh-list
25228713|NCT02606565|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25228714|NCT02606565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25228715|NCT02606565|Disinfectants|disinfectants|mesh-ancestor
25228716|NCT02606409|Dexmedetomidine|dexmedetomidine|mesh-list
25228717|NCT02606409|Propofol|propofol|mesh-list
25228718|NCT02606409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25228719|NCT02606409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25228720|NCT02606409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228721|NCT02606409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25228722|NCT02606409|Anesthetics, General|anesthetics, general|mesh-ancestor
25228723|NCT02606409|Anesthetics|anesthetics|mesh-ancestor
25059564|NCT03487133|Bortezomib|bortezomib|mesh-list
24544729|NCT00689858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24544730|NCT00689858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24544731|NCT00689858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544732|NCT00689858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24996817|NCT01672762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996818|NCT01536964|Morphine|morphine|mesh-list
24996819|NCT01536964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24996820|NCT01536964|Narcotics|narcotics|mesh-ancestor
24996821|NCT01536964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24996822|NCT01536964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996823|NCT01536964|Analgesics|analgesics|mesh-ancestor
24996824|NCT01536964|Sensory System Agents|sensory system agents|mesh-ancestor
24996825|NCT01536964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24996826|NCT01508312|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24996827|NCT01508312|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24996828|NCT01508312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24996829|NCT01508312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996830|NCT01508312|Immunologic Factors|immunologic factors|mesh-ancestor
24996831|NCT01508312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870851|NCT03296033|Enoxaparin|enoxaparin|mesh-list
25228729|NCT02606409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25228730|NCT02606409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25228731|NCT02606409|Adrenergic Agents|adrenergic agents|mesh-ancestor
25228732|NCT02606409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25228733|NCT02606409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228734|NCT02606448|Bupivacaine|bupivacaine|mesh-list
25228735|NCT02606448|Anesthetics, Local|anesthetics, local|mesh-ancestor
25228736|NCT02606448|Anesthetics|anesthetics|mesh-ancestor
25228737|NCT02606448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25228738|NCT02606448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228739|NCT02606448|Sensory System Agents|sensory system agents|mesh-ancestor
25228740|NCT02606448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25228741|NCT02606552|Aspirin|aspirin|mesh-list
25228742|NCT02606552|Clopidogrel|clopidogrel|mesh-list
25228743|NCT02606552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25228744|NCT02606552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25228752|NCT02606552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25228753|NCT02606552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228754|NCT02606552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25228755|NCT02606552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25228756|NCT02606552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25228757|NCT02606552|Antipyretics|antipyretics|mesh-ancestor
25228758|NCT02606552|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25228759|NCT02606552|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25228760|NCT02606552|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25228761|NCT02606552|Purinergic Agents|purinergic agents|mesh-ancestor
25228762|NCT02606552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25228763|NCT02606539|Leucovorin|leucovorin|mesh-list
25228764|NCT02606539|Folic Acid|folic acid|mesh-list
25228765|NCT02606539|Methotrexate|methotrexate|mesh-list
25228766|NCT02606539|Levoleucovorin|levoleucovorin|mesh-list
25228767|NCT02606539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25228768|NCT02606539|Abortifacient Agents|abortifacient agents|mesh-ancestor
25228769|NCT02606539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25228770|NCT02606539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228771|NCT02606539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24757232|NCT01738724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25275844|NCT02368795|Isosorbide|isosorbide|mesh-list
25275845|NCT02368795|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25275846|NCT02368795|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25038258|NCT05262166|Sensory System Agents|sensory system agents|mesh-ancestor
25038259|NCT05262166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25038260|NCT05262166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25038261|NCT05262166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25038262|NCT05262166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25038263|NCT05262166|Adrenergic Agents|adrenergic agents|mesh-ancestor
25038264|NCT05262166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25038265|NCT05262166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038266|NCT05261997|Metformin|metformin|mesh-list
25038267|NCT05261997|Acarbose|acarbose|mesh-list
25038268|NCT05261997|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25682002|NCT01873989|Testosterone|testosterone|mesh-list
25682003|NCT01873989|Androgens|androgens|mesh-ancestor
25038269|NCT05261997|Pancreatin|pancreatin|mesh-list
25038270|NCT05261997|Pancrelipase|pancrelipase|mesh-list
24844273|NCT02232035|GABA Modulators|gaba modulators|mesh-ancestor
24844274|NCT02232035|GABA Agents|gaba agents|mesh-ancestor
24844275|NCT02232035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24844276|NCT02232035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844278|NCT02232139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24844279|NCT02232139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24844280|NCT02232139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24844281|NCT02232139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844296|NCT02232269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24544743|NCT00689949|Micronutrients|micronutrients|mesh-ancestor
24544744|NCT00689949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544745|NCT00690014|Probenecid|probenecid|mesh-list
24544746|NCT00690014|Uricosuric Agents|uricosuric agents|mesh-ancestor
24544747|NCT00690014|Gout Suppressants|gout suppressants|mesh-ancestor
24544748|NCT00690014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24544749|NCT00690014|Renal Agents|renal agents|mesh-ancestor
24544750|NCT00690105|Fluticasone|fluticasone|mesh-list
24544751|NCT00690105|Tacrolimus|tacrolimus|mesh-list
24544752|NCT00690105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24858050|NCT02294955|Propafenone|propafenone|mesh-list
24858051|NCT02294955|Disopyramide|disopyramide|mesh-list
24858052|NCT02294955|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24858053|NCT02294955|Vasodilator Agents|vasodilator agents|mesh-ancestor
24858054|NCT02294955|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24858055|NCT02294955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24460492|NCT00348504|Simendan|simendan|mesh-list
24544761|NCT00690105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24544762|NCT00690105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24544763|NCT00690105|Respiratory System Agents|respiratory system agents|mesh-ancestor
24544764|NCT00690105|Dermatologic Agents|dermatologic agents|mesh-ancestor
25228772|NCT02606539|Antimetabolites|antimetabolites|mesh-ancestor
25228773|NCT02606539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228774|NCT02606539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25228775|NCT02606539|Dermatologic Agents|dermatologic agents|mesh-ancestor
25682004|NCT01873989|Hormones|hormones|mesh-ancestor
25682005|NCT01873989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25682006|NCT01873989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692487|NCT01999920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25692488|NCT01999946|Naltrexone|naltrexone|mesh-list
25692489|NCT01999946|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25692490|NCT01999946|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25692491|NCT01999946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692492|NCT01999946|Sensory System Agents|sensory system agents|mesh-ancestor
25692493|NCT01999946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25692494|NCT01999972|Axitinib|axitinib|mesh-list
25692495|NCT01999972|Crizotinib|crizotinib|mesh-list
25692496|NCT01999972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25692497|NCT01999972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25692498|NCT01999972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692499|NCT01999972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692500|NCT01999985|Dasatinib|dasatinib|mesh-list
25228776|NCT02606539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996919|NCT00655876|Mitosis Modulators|mitosis modulators|mesh-ancestor
24996920|NCT00655876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996921|NCT00655876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25228778|NCT02606539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25228779|NCT02606539|Immunologic Factors|immunologic factors|mesh-ancestor
25228780|NCT02606539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25228781|NCT02606539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25228782|NCT02606539|Antidotes|antidotes|mesh-ancestor
25228783|NCT02606539|Protective Agents|protective agents|mesh-ancestor
25228784|NCT02606539|Vitamin B Complex|vitamin b complex|mesh-ancestor
25228785|NCT02606539|Vitamins|vitamins|mesh-ancestor
25228786|NCT02606539|Micronutrients|micronutrients|mesh-ancestor
25228787|NCT02606539|Hematinics|hematinics|mesh-ancestor
25228788|NCT02606383|Ketoconazole|ketoconazole|mesh-list
25228789|NCT02606383|Antifungal Agents|antifungal agents|mesh-ancestor
25228790|NCT02606383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25228791|NCT02606383|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25228792|NCT02606383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25228793|NCT02606383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25228794|NCT02606383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228795|NCT02606383|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25228796|NCT02606383|Hormone Antagonists|hormone antagonists|mesh-ancestor
24844299|NCT02232269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844300|NCT02232269|Vasodilator Agents|vasodilator agents|mesh-ancestor
24844302|NCT02232308|Nizatidine|nizatidine|mesh-list
24844303|NCT02232308|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24844304|NCT02232308|Protease Inhibitors|protease inhibitors|mesh-ancestor
24844306|NCT02232308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059625|NCT03486925|Oxytocin|oxytocin|mesh-list
24544765|NCT00690105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24544767|NCT00690118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24544768|NCT00690118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544769|NCT00690170|Ketamine|ketamine|mesh-list
24544770|NCT00690170|Nicotine|nicotine|mesh-list
24996954|NCT05420922|Lenvatinib|lenvatinib|mesh-list
24997010|NCT05419921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24997016|NCT05419674|Amoxicillin|amoxicillin|mesh-list
24544771|NCT00690170|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24544772|NCT00690170|Autonomic Agents|autonomic agents|mesh-ancestor
24544773|NCT00690170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24544774|NCT00690170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544775|NCT00690170|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24544776|NCT00690170|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24544777|NCT00690170|Cholinergic Agents|cholinergic agents|mesh-ancestor
24544778|NCT00690170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25682007|NCT01874054|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25682008|NCT01874054|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25682009|NCT01874054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25682010|NCT01874054|Alkylating Agents|alkylating agents|mesh-ancestor
25692501|NCT01999985|Afatinib|afatinib|mesh-list
25275924|NCT02368288|Antiviral Agents|antiviral agents|mesh-ancestor
25275925|NCT02368288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25275926|NCT02368171|Nitric Oxide|nitric oxide|mesh-list
25228797|NCT02606383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25228798|NCT02606383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228799|NCT02606383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25228800|NCT02606357|Insulin Glargine|insulin glargine|mesh-list
25228801|NCT02606357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24997036|NCT05419466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25228802|NCT02606357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228803|NCT02606266|Valganciclovir|valganciclovir|mesh-list
25228804|NCT02606266|Antiviral Agents|antiviral agents|mesh-ancestor
25228805|NCT02606266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25228806|NCT02606084|Esketamine|esketamine|mesh-list
25228807|NCT02606084|Antidepressive Agents|antidepressive agents|mesh-ancestor
25228808|NCT02606084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25228809|NCT02605915|Cyclophosphamide|cyclophosphamide|mesh-list
25228810|NCT02605915|Carboplatin|carboplatin|mesh-list
25228811|NCT02605915|Docetaxel|docetaxel|mesh-list
25228812|NCT02605915|Doxorubicin|doxorubicin|mesh-list
25228813|NCT02605915|Trastuzumab|trastuzumab|mesh-list
25228814|NCT02605915|Atezolizumab|atezolizumab|mesh-list
25228815|NCT02605915|Pertuzumab|pertuzumab|mesh-list
24844307|NCT02232308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24844308|NCT02232308|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24844309|NCT02232308|Protective Agents|protective agents|mesh-ancestor
24844310|NCT02232308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844311|NCT02232308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24844312|NCT02232308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24844313|NCT02232308|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24844314|NCT02232308|Histamine Antagonists|histamine antagonists|mesh-ancestor
24844315|NCT02232308|Histamine Agents|histamine agents|mesh-ancestor
24844316|NCT02232308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24844317|NCT02232347|Sufentanil|sufentanil|mesh-list
24844318|NCT02232347|Ketamine|ketamine|mesh-list
24844319|NCT02232347|Analgesics|analgesics|mesh-ancestor
24844320|NCT02232347|Sensory System Agents|sensory system agents|mesh-ancestor
24844321|NCT02232347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24844322|NCT02232347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844323|NCT02232347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25043834|NCT01198626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043835|NCT01198626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043837|NCT01194960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043838|NCT01194960|Tubulin Modulators|tubulin modulators|mesh-ancestor
24844324|NCT02232347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24844325|NCT02232347|Anesthetics, General|anesthetics, general|mesh-ancestor
24844326|NCT02232347|Anesthetics|anesthetics|mesh-ancestor
24844327|NCT02232347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24844328|NCT02232347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24844329|NCT02232347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24844330|NCT02232347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24844331|NCT02232347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844332|NCT02232347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24997040|NCT05419297|Buprenorphine|buprenorphine|mesh-list
24544795|NCT00690300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544796|NCT00690300|Tubulin Modulators|tubulin modulators|mesh-ancestor
25682011|NCT01874054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682012|NCT01874054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682013|NCT01874054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24544797|NCT00690300|Antimitotic Agents|antimitotic agents|mesh-ancestor
24544798|NCT00690300|Mitosis Modulators|mitosis modulators|mesh-ancestor
25682014|NCT01874119|Fosaprepitant|fosaprepitant|mesh-list
25682015|NCT01874119|Aprepitant|aprepitant|mesh-list
25682016|NCT01874119|Antiemetics|antiemetics|mesh-ancestor
25275956|NCT02368054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25038436|NCT05162976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038444|NCT05151484|Alendronate|alendronate|mesh-list
25038445|NCT05151484|Teriparatide|teriparatide|mesh-list
25038446|NCT05151484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25038447|NCT05151484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038448|NCT05151484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25038449|NCT05140148|Amantadine|amantadine|mesh-list
25038450|NCT05140148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25038451|NCT05140148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25038452|NCT05140148|Antiviral Agents|antiviral agents|mesh-ancestor
25038453|NCT05140148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25038454|NCT05140148|Dopamine Agents|dopamine agents|mesh-ancestor
25038474|NCT05092841|GABA Agents|gaba agents|mesh-ancestor
25038475|NCT05092841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25275957|NCT02368054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275966|NCT02368379|Metyrapone|metyrapone|mesh-list
24544799|NCT00690300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544800|NCT00690313|Moxifloxacin|moxifloxacin|mesh-list
24544801|NCT00690313|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25228816|NCT02605915|Maytansine|maytansine|mesh-list
25228817|NCT02605915|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25228818|NCT02605915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25228819|NCT02605915|Immunologic Factors|immunologic factors|mesh-ancestor
25228820|NCT02605915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228821|NCT02605915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25228822|NCT02605915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25228823|NCT02605915|Alkylating Agents|alkylating agents|mesh-ancestor
25228824|NCT02605915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228825|NCT02605915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25228826|NCT02605915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25228827|NCT02605915|Tubulin Modulators|tubulin modulators|mesh-ancestor
25228828|NCT02605915|Antimitotic Agents|antimitotic agents|mesh-ancestor
25228829|NCT02605915|Mitosis Modulators|mitosis modulators|mesh-ancestor
25228830|NCT02605915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25228831|NCT02605915|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25228832|NCT02605915|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25228833|NCT02605915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25228834|NCT02605915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25228835|NCT02605915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25228836|NCT02606032|Metronidazole|metronidazole|mesh-list
25228837|NCT02606032|Doxycycline|doxycycline|mesh-list
25228838|NCT02606032|Terbinafine|terbinafine|mesh-list
25228839|NCT02606032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25228840|NCT02606032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25228841|NCT02606032|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25228842|NCT02606032|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25228843|NCT02606032|Antimalarials|antimalarials|mesh-ancestor
25228844|NCT02606032|Antifungal Agents|antifungal agents|mesh-ancestor
25228845|NCT02606032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25228846|NCT02606032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228847|NCT02605798|Sofosbuvir|sofosbuvir|mesh-list
24844333|NCT02232347|Narcotics|narcotics|mesh-ancestor
24475516|NCT00410644|Analgesics|analgesics|mesh-ancestor
24844342|NCT02232360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24844343|NCT02232360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24844344|NCT02232386|Rituximab|rituximab|mesh-list
24844345|NCT02232386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24844346|NCT02232386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682017|NCT01874119|Autonomic Agents|autonomic agents|mesh-ancestor
25682018|NCT01874119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682019|NCT01874119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682020|NCT01874119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25682021|NCT01874119|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25682022|NCT01874119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25682023|NCT01874119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682024|NCT01874145|Glatiramer Acetate|glatiramer acetate|mesh-list
25682025|NCT01874145|(T,G)-A-L|(t,g)-a-l|mesh-list
25682026|NCT01874145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25682027|NCT01874145|Immunologic Factors|immunologic factors|mesh-ancestor
25682028|NCT01874145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682029|NCT01874145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25682030|NCT01874145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25682031|NCT01874392|Insulin|insulin|mesh-list
25682032|NCT01874392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24544812|NCT00690313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544813|NCT00690313|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24544815|NCT00690313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24544816|NCT00690417|Vitamin D|vitamin d|mesh-list
24544817|NCT00690417|Cholecalciferol|cholecalciferol|mesh-list
24544818|NCT00690417|Vitamins|vitamins|mesh-ancestor
24544819|NCT00690417|Micronutrients|micronutrients|mesh-ancestor
24544820|NCT00690417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858056|NCT02294955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858057|NCT02294955|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24858058|NCT02294955|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24544821|NCT00690417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24544822|NCT00690417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25228848|NCT02605798|Antiviral Agents|antiviral agents|mesh-ancestor
25228849|NCT02605798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25228850|NCT02605746|Ceritinib|ceritinib|mesh-list
25228851|NCT02605746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25228852|NCT02605746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25228853|NCT02605746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25228854|NCT02605746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228855|NCT02605772|Metformin|metformin|mesh-list
25228856|NCT02605772|Saxagliptin|saxagliptin|mesh-list
25228857|NCT02605772|Acarbose|acarbose|mesh-list
25228858|NCT02605772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25228859|NCT02605772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228860|NCT02605772|Incretins|incretins|mesh-ancestor
25228861|NCT02605772|Hormones|hormones|mesh-ancestor
25228862|NCT02605772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25228863|NCT02605772|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25228864|NCT02605772|Protease Inhibitors|protease inhibitors|mesh-ancestor
25228865|NCT02605772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25273438|NCT02385422|Antioxidants|antioxidants|mesh-ancestor
24452626|NCT05457959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25682033|NCT01874392|Pancrelipase|pancrelipase|mesh-list
25682034|NCT01874392|Pancreatin|pancreatin|mesh-list
24844365|NCT02232516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24447209|NCT00307671|Methylprednisolone|methylprednisolone|mesh-list
24447210|NCT00307671|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24544829|NCT00690521|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24544830|NCT00690521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24544837|NCT00690534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24544838|NCT00690534|Vasodilator Agents|vasodilator agents|mesh-ancestor
24544839|NCT00690534|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25228866|NCT02605772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228867|NCT02605772|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25228868|NCT02605811|Temozolomide|temozolomide|mesh-list
25228869|NCT02605811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25228870|NCT02605811|Alkylating Agents|alkylating agents|mesh-ancestor
25228871|NCT02605811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228872|NCT02605811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25228873|NCT02605460|Plerixafor|plerixafor|mesh-list
25228874|NCT02605460|Cyclophosphamide|cyclophosphamide|mesh-list
25228875|NCT02605460|Busulfan|busulfan|mesh-list
25228876|NCT02605460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25228877|NCT02605460|Immunologic Factors|immunologic factors|mesh-ancestor
25228878|NCT02605460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228879|NCT02605460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25228880|NCT02605460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25228881|NCT02605460|Alkylating Agents|alkylating agents|mesh-ancestor
25228882|NCT02605460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228883|NCT02605460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25228884|NCT02605460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25228885|NCT02605460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25228886|NCT02605460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25228887|NCT02605460|Antiviral Agents|antiviral agents|mesh-ancestor
25228888|NCT02605460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25228889|NCT02605720|Piperaquine|piperaquine|mesh-list
25228890|NCT02605720|Artenimol|artenimol|mesh-list
25228891|NCT02605720|Antimalarials|antimalarials|mesh-ancestor
25228892|NCT02605720|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25228893|NCT02605720|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25228894|NCT02605720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25228895|NCT02605421|Cyclophosphamide|cyclophosphamide|mesh-list
24844367|NCT02232516|Growth Substances|growth substances|mesh-ancestor
24844368|NCT02232516|Growth Inhibitors|growth inhibitors|mesh-ancestor
24844369|NCT02232516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24844370|NCT02232516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24844371|NCT02232542|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24844374|NCT02232542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24844375|NCT02232542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844395|NCT02232555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24544840|NCT00690534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589110|NCT00905905|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
24589111|NCT00905905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24589112|NCT00905905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24589113|NCT00905905|Antimetabolites|antimetabolites|mesh-ancestor
25038535|NCT04983589|Miotics|miotics|mesh-ancestor
24544841|NCT00690560|Prednisone|prednisone|mesh-list
24544842|NCT00690560|Cyclophosphamide|cyclophosphamide|mesh-list
24544843|NCT00690560|Rituximab|rituximab|mesh-list
24544878|NCT00690768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24544879|NCT00690768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24544880|NCT00690768|Growth Substances|growth substances|mesh-ancestor
24544881|NCT00690768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544882|NCT00690768|Growth Inhibitors|growth inhibitors|mesh-ancestor
24544883|NCT00690781|Caseins|caseins|mesh-list
25228896|NCT02605421|Melphalan|melphalan|mesh-list
25228897|NCT02605421|Thiotepa|thiotepa|mesh-list
25228898|NCT02605421|Carboplatin|carboplatin|mesh-list
25228899|NCT02605421|Etoposide|etoposide|mesh-list
25228900|NCT02605421|Lenograstim|lenograstim|mesh-list
25228901|NCT02605421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25228902|NCT02605421|Immunologic Factors|immunologic factors|mesh-ancestor
25228903|NCT02605421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228904|NCT02605421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25228905|NCT02605421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25228906|NCT02605421|Alkylating Agents|alkylating agents|mesh-ancestor
25228907|NCT02605421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228908|NCT02605421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25228909|NCT02605421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24786189|NCT01918488|Triamterene|triamterene|mesh-list
24845743|NCT02238704|Iron|iron|mesh-list
24844399|NCT02232581|Antiviral Agents|antiviral agents|mesh-ancestor
24858061|NCT02294955|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24858062|NCT02294955|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24858063|NCT02294955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24858064|NCT02294955|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25682035|NCT01874392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25682036|NCT01874392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682037|NCT01874392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25682038|NCT01874535|Esomeprazole|esomeprazole|mesh-list
25682039|NCT01874535|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25682040|NCT01874535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25682041|NCT01874535|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25038565|NCT04943445|Mitosis Modulators|mitosis modulators|mesh-ancestor
25038566|NCT04943445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038567|NCT04943445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25038568|NCT04943445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038569|NCT04929808|Emollients|emollients|mesh-list
25038570|NCT04929808|Dermatologic Agents|dermatologic agents|mesh-ancestor
25038587|NCT04907214|Empagliflozin|empagliflozin|mesh-list
25038588|NCT04907214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25038592|NCT04907071|Coal Tar|coal tar|mesh-list
24710653|NCT01511302|Respiratory System Agents|respiratory system agents|mesh-ancestor
24710654|NCT01511302|Glucocorticoids|glucocorticoids|mesh-ancestor
24710655|NCT01511302|Hormones|hormones|mesh-ancestor
24710658|NCT01511302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24544897|NCT00690872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24544898|NCT00690872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24858066|NCT02294955|Adrenergic Agents|adrenergic agents|mesh-ancestor
24858069|NCT02294955|Sympatholytics|sympatholytics|mesh-ancestor
24858070|NCT02294955|Autonomic Agents|autonomic agents|mesh-ancestor
24858071|NCT02294955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25241764|NCT05299931|Dermatologic Agents|dermatologic agents|mesh-ancestor
24857146|NCT02289482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24858072|NCT02294955|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24858073|NCT02294994|Tirofiban|tirofiban|mesh-list
24858074|NCT02294994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24447281|NCT00307827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447282|NCT00307944|Pantoprazole|pantoprazole|mesh-list
24447283|NCT00307944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24447284|NCT00307944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24447285|NCT00307944|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24544953|NCT00691145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544965|NCT00691184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24858075|NCT02294994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24858076|NCT02294994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858077|NCT02294994|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25682042|NCT01874535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25682043|NCT01874535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682044|NCT01874665|Ponatinib|ponatinib|mesh-list
25682045|NCT01874665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682046|NCT01874665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25682047|NCT01874665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25682048|NCT01874665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682049|NCT01874951|Naltrexone|naltrexone|mesh-list
25682050|NCT01874951|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25038697|NCT04634799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25038698|NCT04634799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038702|NCT04624776|Methylprednisolone|methylprednisolone|mesh-list
25276086|NCT02367404|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24649446|NCT01219920|Leucovorin|leucovorin|mesh-list
24447286|NCT00307944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25228910|NCT02605421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25228911|NCT02605421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24844400|NCT02232581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24844401|NCT02232581|Antimetabolites|antimetabolites|mesh-ancestor
24844402|NCT02232581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844403|NCT02232581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24844404|NCT02232581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24844405|NCT02232581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24844406|NCT02232594|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
24844407|NCT02232594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24844408|NCT02232594|Autonomic Agents|autonomic agents|mesh-ancestor
24844409|NCT02232594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24844410|NCT02232594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844411|NCT02232594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24844412|NCT02232594|Respiratory System Agents|respiratory system agents|mesh-ancestor
24844413|NCT02232607|Lacidipine|lacidipine|mesh-list
24844414|NCT02232607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24844415|NCT02232607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25059731|NCT03485625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25059732|NCT03485625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447287|NCT00307944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447288|NCT00307996|Ubiquinone|ubiquinone|mesh-list
24447289|NCT00307996|Coenzyme Q10|coenzyme q10|mesh-list
24544968|NCT00691236|Doxorubicin|doxorubicin|mesh-list
24544969|NCT00691236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24544970|NCT00691236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544971|NCT00691236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24544972|NCT00691236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24544973|NCT00691236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544974|NCT00691236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544975|NCT00691236|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24544976|NCT00691236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228912|NCT02605421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25228913|NCT02605421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25228914|NCT02605421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25228915|NCT02605694|Prednisone|prednisone|mesh-list
25228916|NCT02605694|Rituximab|rituximab|mesh-list
25228917|NCT02605694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25228918|NCT02605694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858171|NCT02295722|Gemcitabine|gemcitabine|mesh-list
24858262|NCT02296047|Respiratory System Agents|respiratory system agents|mesh-ancestor
24858263|NCT02296047|Tocolytic Agents|tocolytic agents|mesh-ancestor
25682051|NCT01874951|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25682052|NCT01874951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682053|NCT01874951|Sensory System Agents|sensory system agents|mesh-ancestor
25682054|NCT01874951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682055|NCT01875159|Caffeine|caffeine|mesh-list
25682056|NCT01875159|Caffeine citrate|caffeine citrate|mesh-list
25682057|NCT01875159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858264|NCT02296047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24858265|NCT02296047|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25228919|NCT02605694|Immunologic Factors|immunologic factors|mesh-ancestor
25228920|NCT02605694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228921|NCT02605694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25228922|NCT02605694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25228923|NCT02605694|Glucocorticoids|glucocorticoids|mesh-ancestor
25228924|NCT02605694|Hormones|hormones|mesh-ancestor
25228925|NCT02605694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25228926|NCT02605694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25228927|NCT02605434|Levodopa|levodopa|mesh-list
25228928|NCT02605434|Carbidopa|carbidopa|mesh-list
25228929|NCT02605434|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25228930|NCT02605434|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25228931|NCT02605434|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24844416|NCT02232607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24844417|NCT02232607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544983|NCT00691262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544985|NCT00691275|Antiemetics|antiemetics|mesh-ancestor
24544986|NCT00691275|Autonomic Agents|autonomic agents|mesh-ancestor
24544987|NCT00691275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24544988|NCT00691275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544989|NCT00691275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24544990|NCT00691275|Antipruritics|antipruritics|mesh-ancestor
24544991|NCT00691275|Dermatologic Agents|dermatologic agents|mesh-ancestor
24858294|NCT02296073|Anesthetics|anesthetics|mesh-ancestor
24544992|NCT00691275|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24544993|NCT00691275|Serotonin Agents|serotonin agents|mesh-ancestor
24858078|NCT02295046|Amlodipine|amlodipine|mesh-list
24858079|NCT02295046|Atorvastatin|atorvastatin|mesh-list
25228932|NCT02605434|Dopamine Agents|dopamine agents|mesh-ancestor
25228933|NCT02605434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25228934|NCT02605434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228935|NCT02605434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228936|NCT02605434|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25228937|NCT02605434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25228938|NCT02605434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25228939|NCT02605434|Immunologic Factors|immunologic factors|mesh-ancestor
24844424|NCT02232672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844425|NCT02232672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24844446|NCT02232737|Autonomic Agents|autonomic agents|mesh-ancestor
24844447|NCT02232737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24844448|NCT02232737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844449|NCT02232737|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24844450|NCT02232737|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24844451|NCT02232737|Cholinergic Agents|cholinergic agents|mesh-ancestor
24844452|NCT02232737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24844453|NCT02232737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844454|NCT02232763|Losartan|losartan|mesh-list
24545030|NCT00691405|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24545031|NCT00691405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24545032|NCT00691405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24545033|NCT00691405|Adrenergic Agents|adrenergic agents|mesh-ancestor
24545034|NCT00691405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24545035|NCT00691405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545036|NCT00691457|Contact Lens Solutions|contact lens solutions|mesh-list
24545037|NCT00691457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24534896|NCT00648258|Valdecoxib|valdecoxib|mesh-list
24545038|NCT00691457|Disinfectants|disinfectants|mesh-ancestor
25228940|NCT02605434|Dopamine Agonists|dopamine agonists|mesh-ancestor
25228941|NCT02605382|Chlorhexidine|chlorhexidine|mesh-list
25228942|NCT02605382|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25228943|NCT02605382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25228944|NCT02605382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25228945|NCT02605382|Disinfectants|disinfectants|mesh-ancestor
25228946|NCT02605382|Dermatologic Agents|dermatologic agents|mesh-ancestor
25228947|NCT02605356|Dexamethasone|dexamethasone|mesh-list
25228948|NCT02605356|Bortezomib|bortezomib|mesh-list
25228949|NCT02605356|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25228950|NCT02605356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25228951|NCT02605356|Antiemetics|antiemetics|mesh-ancestor
25228952|NCT02605356|Autonomic Agents|autonomic agents|mesh-ancestor
25228953|NCT02605356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25228954|NCT02605356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228955|NCT02605356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25228956|NCT02605356|Glucocorticoids|glucocorticoids|mesh-ancestor
25228957|NCT02605356|Hormones|hormones|mesh-ancestor
24844455|NCT02232763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24844456|NCT02232763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24844458|NCT02232763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24844459|NCT02232763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844460|NCT02232776|Losartan|losartan|mesh-list
24545039|NCT00691457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24545042|NCT00691548|Cetuximab|cetuximab|mesh-list
24545043|NCT00691548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24545044|NCT00691548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24594666|NCT00934973|Mebeverine|mebeverine|mesh-list
24545070|NCT00691873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24545071|NCT00691873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24545072|NCT00691873|Respiratory System Agents|respiratory system agents|mesh-ancestor
24545082|NCT00691886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24545083|NCT00691886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24545084|NCT00691886|Adrenergic Agents|adrenergic agents|mesh-ancestor
24545085|NCT00691886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25228958|NCT02605356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25228959|NCT02605356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25228960|NCT02605356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25228961|NCT02605213|Vancomycin|vancomycin|mesh-list
25228962|NCT02605213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25228963|NCT02605213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25273439|NCT02385422|Protective Agents|protective agents|mesh-ancestor
25273440|NCT02385422|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25273441|NCT02385422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25273442|NCT02385422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25273443|NCT02385422|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25273444|NCT02385422|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24844461|NCT02232776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24844462|NCT02232776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24844463|NCT02232776|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24844464|NCT02232776|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24844488|NCT02232945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844489|NCT02232971|Glucagon|glucagon|mesh-list
24844490|NCT02232971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24844491|NCT02232971|Hormones|hormones|mesh-ancestor
24844492|NCT02232971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24844493|NCT02232971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844494|NCT02233023|Dopamine|dopamine|mesh-list
24844495|NCT02233023|Pramipexole|pramipexole|mesh-list
24844496|NCT02233023|Bromocriptine|bromocriptine|mesh-list
24844497|NCT02233023|Dopamine Agonists|dopamine agonists|mesh-list
25043901|NCT01189396|Adrenergic Agents|adrenergic agents|mesh-ancestor
24844498|NCT02233023|Antioxidants|antioxidants|mesh-ancestor
24844499|NCT02233023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844500|NCT02233023|Protective Agents|protective agents|mesh-ancestor
24844501|NCT02233023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858091|NCT02295046|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24813098|NCT02056418|Prednisone|prednisone|mesh-list
24813099|NCT02056418|Hydrocortisone|hydrocortisone|mesh-list
24813100|NCT02056418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24813101|NCT02056418|Glucocorticoids|glucocorticoids|mesh-ancestor
24813102|NCT02056418|Hormones|hormones|mesh-ancestor
25228964|NCT02605226|Bicalutamide|bicalutamide|mesh-list
25228965|NCT02605226|Hormones|hormones|mesh-list
25228966|NCT02605226|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25228967|NCT02605226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25228968|NCT02605226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228969|NCT02605226|Androgen Antagonists|androgen antagonists|mesh-ancestor
25228970|NCT02605226|Hormone Antagonists|hormone antagonists|mesh-ancestor
25228971|NCT02605226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25228972|NCT02604992|Dronabinol|dronabinol|mesh-list
25228973|NCT02604992|Hallucinogens|hallucinogens|mesh-ancestor
24800945|NCT01979679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25228974|NCT02604992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25228975|NCT02604992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25228976|NCT02604992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25228978|NCT02604992|Sensory System Agents|sensory system agents|mesh-ancestor
25228979|NCT02604992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25228980|NCT02604992|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25228981|NCT02604992|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25228982|NCT02604992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25228983|NCT02604992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25228984|NCT02604992|Hormones|hormones|mesh-ancestor
25228985|NCT02604992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25228986|NCT02605252|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25228987|NCT02605252|Antiviral Agents|antiviral agents|mesh-ancestor
25228988|NCT02605252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25228989|NCT02604966|Artesunate|artesunate|mesh-list
25228990|NCT02604966|Antimalarials|antimalarials|mesh-ancestor
25228991|NCT02604966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25228992|NCT02604966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25228993|NCT02604966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25228994|NCT02604966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24844509|NCT02233023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24844510|NCT02233023|Hormone Antagonists|hormone antagonists|mesh-ancestor
24803023|NCT01993810|Keratolytic Agents|keratolytic agents|mesh-ancestor
24803024|NCT01993810|Dermatologic Agents|dermatologic agents|mesh-ancestor
24952922|NCT03891043|Selenium|selenium|mesh-list
24858098|NCT02295124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24858099|NCT02295124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858100|NCT02295124|Analgesics|analgesics|mesh-ancestor
24858101|NCT02295124|Sensory System Agents|sensory system agents|mesh-ancestor
24858102|NCT02295124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858104|NCT02295150|Anticoagulants|anticoagulants|mesh-ancestor
24858105|NCT02295150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24803202|NCT01995019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24803203|NCT01995019|Protective Agents|protective agents|mesh-ancestor
24803204|NCT01995019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24803206|NCT01995032|Metformin|metformin|mesh-list
24858106|NCT02295150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24858108|NCT02295189|Triamcinolone|triamcinolone|mesh-list
24858110|NCT02295189|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24858111|NCT02295189|Ketorolac|ketorolac|mesh-list
24858112|NCT02295189|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25228995|NCT02604966|Antiviral Agents|antiviral agents|mesh-ancestor
25228996|NCT02604966|Schistosomicides|schistosomicides|mesh-ancestor
25228997|NCT02604966|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25228998|NCT02604966|Anthelmintics|anthelmintics|mesh-ancestor
25228999|NCT02605265|Capecitabine|capecitabine|mesh-list
25229000|NCT02605265|Oxaliplatin|oxaliplatin|mesh-list
25229001|NCT02605265|Irinotecan|irinotecan|mesh-list
25229002|NCT02605265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25229003|NCT02605265|Antimetabolites|antimetabolites|mesh-ancestor
25229004|NCT02605265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229005|NCT02605265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25229006|NCT02605265|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25229007|NCT02605265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25229008|NCT02605265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229009|NCT02604914|Levodopa|levodopa|mesh-list
25229010|NCT02604914|Carbidopa|carbidopa|mesh-list
25229011|NCT02604914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25229012|NCT02604914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25229013|NCT02604914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25229014|NCT02604914|Dopamine Agents|dopamine agents|mesh-ancestor
25229015|NCT02604914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25229016|NCT02604914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229017|NCT02604914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229018|NCT02604914|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24844511|NCT02233023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25682058|NCT01875159|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25682059|NCT01875159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682060|NCT01875159|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25682061|NCT01875159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25682062|NCT01875159|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24844513|NCT02233049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25682063|NCT01875159|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25682064|NCT01875159|Purinergic Agents|purinergic agents|mesh-ancestor
25682065|NCT01875159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25276272|NCT02365935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25276273|NCT02365935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24565731|NCT00782106|gamma-Globulins|gamma-globulins|mesh-list
25276274|NCT02365935|Tubulin Modulators|tubulin modulators|mesh-ancestor
25276275|NCT02365935|Antimitotic Agents|antimitotic agents|mesh-ancestor
25276276|NCT02365935|Mitosis Modulators|mitosis modulators|mesh-ancestor
25276277|NCT02365935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276278|NCT02365675|Petrolatum|petrolatum|mesh-list
25276280|NCT02365675|Laxatives|laxatives|mesh-ancestor
24844515|NCT02233049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24844516|NCT02233049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24844517|NCT02233049|Immunologic Factors|immunologic factors|mesh-ancestor
24858113|NCT02295189|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24858114|NCT02295189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24858115|NCT02295189|Glucocorticoids|glucocorticoids|mesh-ancestor
24858116|NCT02295189|Hormones|hormones|mesh-ancestor
24460537|NCT00348634|Tegaserod|tegaserod|mesh-list
24545120|NCT00692016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24545121|NCT00692016|Analgesics|analgesics|mesh-ancestor
24545122|NCT00692016|Sensory System Agents|sensory system agents|mesh-ancestor
24545123|NCT00692016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24545124|NCT00692016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545125|NCT00692016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24545126|NCT00692016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24545127|NCT00692016|Gout Suppressants|gout suppressants|mesh-ancestor
24545128|NCT00692016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24545129|NCT00692016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24803649|NCT01997762|Resveratrol|resveratrol|mesh-list
25229019|NCT02604914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229020|NCT02604914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25229021|NCT02604914|Immunologic Factors|immunologic factors|mesh-ancestor
25682066|NCT01875237|Methylprednisolone|methylprednisolone|mesh-list
25682067|NCT01875237|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25682068|NCT01875237|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25682069|NCT01875237|Prednisolone|prednisolone|mesh-list
25682070|NCT01875237|Prednisolone acetate|prednisolone acetate|mesh-list
25682071|NCT01875237|Methotrexate|methotrexate|mesh-list
25682072|NCT01875237|Fludarabine phosphate|fludarabine phosphate|mesh-list
25682073|NCT01875237|Fludarabine|fludarabine|mesh-list
25682074|NCT01875237|Melphalan|melphalan|mesh-list
25682075|NCT01875237|Alemtuzumab|alemtuzumab|mesh-list
25682076|NCT01875237|Tacrolimus|tacrolimus|mesh-list
25682077|NCT01875237|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25682078|NCT01875237|Prednisolone phosphate|prednisolone phosphate|mesh-list
25682079|NCT01875237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24449935|NCT00317408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25276297|NCT02365740|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25276298|NCT02365740|Hormones|hormones|mesh-list
25276299|NCT02365740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25276300|NCT02365740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276301|NCT02365740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25276302|NCT02365948|Certolizumab Pegol|certolizumab pegol|mesh-list
25276303|NCT02365948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25276304|NCT02365948|Immunologic Factors|immunologic factors|mesh-ancestor
25229022|NCT02604914|Dopamine Agonists|dopamine agonists|mesh-ancestor
25229023|NCT02604849|Gentamicins|gentamicins|mesh-list
25229024|NCT02604849|Neomycin|neomycin|mesh-list
25229025|NCT02604849|Streptomycin|streptomycin|mesh-list
25229026|NCT02604849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25229027|NCT02604849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25229028|NCT02604849|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25229029|NCT02604849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229030|NCT02604849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229031|NCT02604940|Dexmedetomidine|dexmedetomidine|mesh-list
25229032|NCT02604940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25229033|NCT02604940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25229034|NCT02604940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844518|NCT02233049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844519|NCT02233049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24844520|NCT02233049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24844521|NCT02233049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844522|NCT02233075|Interferons|interferons|mesh-list
24844523|NCT02233075|Interferon-alpha|interferon-alpha|mesh-list
24844524|NCT02233075|Interferon alpha-2|interferon alpha-2|mesh-list
24844525|NCT02233075|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24844526|NCT02233075|REP 2139|rep 2139|mesh-list
24844527|NCT02233075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24844528|NCT02233075|Antiviral Agents|antiviral agents|mesh-ancestor
25059793|NCT03485092|Empagliflozin|empagliflozin|mesh-list
24598410|NCT00956098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24598411|NCT00956098|Schistosomicides|schistosomicides|mesh-ancestor
24545130|NCT00692016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545131|NCT00692055|Naproxen|naproxen|mesh-list
24545132|NCT00692055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24545133|NCT00692055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24545134|NCT00692055|Analgesics|analgesics|mesh-ancestor
24545135|NCT00692055|Sensory System Agents|sensory system agents|mesh-ancestor
24545136|NCT00692055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24545137|NCT00692055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545138|NCT00692055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24545139|NCT00692055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25682080|NCT01875237|Abortifacient Agents|abortifacient agents|mesh-ancestor
25682081|NCT01875237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25682082|NCT01875237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682083|NCT01875237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25682084|NCT01875237|Antimetabolites|antimetabolites|mesh-ancestor
25682085|NCT01875237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682086|NCT01875237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682087|NCT01875237|Dermatologic Agents|dermatologic agents|mesh-ancestor
25682088|NCT01875237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24545148|NCT00692120|Micronutrients|micronutrients|mesh-ancestor
24545154|NCT00692159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24545155|NCT00692159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108230|NCT03133780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25108231|NCT03133780|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24545156|NCT00692159|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24545176|NCT00692263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545177|NCT00692263|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24545178|NCT00692263|Antidepressive Agents|antidepressive agents|mesh-ancestor
24545179|NCT00692263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24545180|NCT00692263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24545181|NCT00692263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24545182|NCT00692263|Narcotics|narcotics|mesh-ancestor
24545183|NCT00692263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24545184|NCT00692263|Analgesics|analgesics|mesh-ancestor
25229035|NCT02604940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25229036|NCT02604940|Analgesics|analgesics|mesh-ancestor
25229037|NCT02604940|Sensory System Agents|sensory system agents|mesh-ancestor
25229038|NCT02604940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229039|NCT02604940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25229040|NCT02604940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25229041|NCT02604940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25229042|NCT02604940|Adrenergic Agents|adrenergic agents|mesh-ancestor
25229043|NCT02604940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25229044|NCT02604940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229045|NCT02604628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24844529|NCT02233075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24844530|NCT02233075|Immunologic Factors|immunologic factors|mesh-ancestor
25059800|NCT03484962|Immunologic Factors|immunologic factors|mesh-ancestor
24447308|NCT00308126|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
25682089|NCT01875237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25682090|NCT01875237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25682091|NCT01875237|Immunologic Factors|immunologic factors|mesh-ancestor
25682092|NCT01875237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25682093|NCT01875237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25682094|NCT01875237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25682095|NCT01875237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25682096|NCT01875237|Antiemetics|antiemetics|mesh-ancestor
24447309|NCT00308126|Plasma Substitutes|plasma substitutes|mesh-ancestor
25276376|NCT02365532|Dofetilide|dofetilide|mesh-list
25276377|NCT02365532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25276378|NCT02365532|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25276379|NCT02365532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25276380|NCT02365532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276381|NCT02365155|Vitamin D|vitamin d|mesh-list
25276382|NCT02365155|Vitamins|vitamins|mesh-list
25276383|NCT02365155|Micronutrients|micronutrients|mesh-ancestor
25276384|NCT02365155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276385|NCT02365155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25276386|NCT02365272|Amikacin|amikacin|mesh-list
25276387|NCT02365272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25276388|NCT02365272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25039013|NCT04222712|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24447310|NCT00308126|Blood Substitutes|blood substitutes|mesh-ancestor
24447312|NCT00308165|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24858117|NCT02295189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24858118|NCT02295189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858119|NCT02295189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24858120|NCT02295189|Immunologic Factors|immunologic factors|mesh-ancestor
24858121|NCT02295189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24858122|NCT02295189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858123|NCT02295189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24858124|NCT02295189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24858125|NCT02295189|Analgesics|analgesics|mesh-ancestor
24858126|NCT02295189|Sensory System Agents|sensory system agents|mesh-ancestor
24858127|NCT02295189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858128|NCT02295189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24858129|NCT02295189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24858130|NCT02295475|Warfarin|warfarin|mesh-list
24858131|NCT02295475|Apixaban|apixaban|mesh-list
24858132|NCT02295475|Anticoagulants|anticoagulants|mesh-ancestor
24858139|NCT02295566|Nitric Oxide|nitric oxide|mesh-list
24545218|NCT00692510|GABA Agents|gaba agents|mesh-ancestor
24545219|NCT00692510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24545220|NCT00692510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229046|NCT02604628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25229047|NCT02604719|Tranexamic Acid|tranexamic acid|mesh-list
25229048|NCT02604719|Ethamsylate|ethamsylate|mesh-list
25229049|NCT02604719|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25229050|NCT02604719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25229051|NCT02604719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229052|NCT02604719|Hemostatics|hemostatics|mesh-ancestor
25229053|NCT02604719|Coagulants|coagulants|mesh-ancestor
25229054|NCT02604797|Flurbiprofen|flurbiprofen|mesh-list
25229055|NCT02604797|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
25229056|NCT02604797|Sufentanil|sufentanil|mesh-list
25229057|NCT02604797|Dsuvia|dsuvia|mesh-list
25229058|NCT02604797|Nalbuphine|nalbuphine|mesh-list
25229059|NCT02604797|Ramosetron|ramosetron|mesh-list
25682097|NCT01875237|Autonomic Agents|autonomic agents|mesh-ancestor
25682098|NCT01875237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682099|NCT01875237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25682100|NCT01875237|Glucocorticoids|glucocorticoids|mesh-ancestor
25682101|NCT01875237|Hormones|hormones|mesh-ancestor
25682102|NCT01875237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25682103|NCT01875237|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25682104|NCT01875237|Protective Agents|protective agents|mesh-ancestor
25682105|NCT01875237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25682106|NCT01875237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25682107|NCT01875237|Alkylating Agents|alkylating agents|mesh-ancestor
25682108|NCT01875237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25229060|NCT02604797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25229061|NCT02604797|Narcotics|narcotics|mesh-ancestor
25229062|NCT02604797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25276397|NCT02365415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039062|NCT04163185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24599122|NCT05194969|Emollients|emollients|mesh-ancestor
25229063|NCT02604797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043902|NCT01189396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25043903|NCT01189396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043906|NCT01188187|Docetaxel|docetaxel|mesh-list
24510163|NCT00563641|Pulmonary Surfactants|pulmonary surfactants|mesh-list
24545230|NCT00692510|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24545231|NCT00692510|Antidepressive Agents|antidepressive agents|mesh-ancestor
24545232|NCT00692510|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24545233|NCT00692510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24545234|NCT00692510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24545235|NCT00692510|Dopamine Agents|dopamine agents|mesh-ancestor
24545236|NCT00692510|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24545237|NCT00692510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24545238|NCT00692510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24545245|NCT00692601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24545246|NCT00692601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545248|NCT00692614|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24545249|NCT00692614|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24545250|NCT00692614|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24545251|NCT00692614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24545252|NCT00692614|Glucocorticoids|glucocorticoids|mesh-ancestor
24545253|NCT00692614|Hormones|hormones|mesh-ancestor
24545254|NCT00692614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24545255|NCT00692614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545256|NCT00692614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24545257|NCT00692614|Immunologic Factors|immunologic factors|mesh-ancestor
24545258|NCT00692614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24545259|NCT00692614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545260|NCT00692640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24545261|NCT00692640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24545262|NCT00692640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24872108|NCT05398770|Micronutrients|micronutrients|mesh-ancestor
24806461|NCT02016001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545263|NCT00692640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24545264|NCT00692640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545265|NCT00692731|Caffeine|caffeine|mesh-list
24545266|NCT00692731|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24545288|NCT00692952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24545289|NCT00692952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545290|NCT00692952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24545291|NCT00692952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24545292|NCT00692952|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
24858140|NCT02295566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24858142|NCT02295566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858143|NCT02295566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858144|NCT02295566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24858145|NCT02295566|Respiratory System Agents|respiratory system agents|mesh-ancestor
24858146|NCT02295566|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24858153|NCT02295566|Protective Agents|protective agents|mesh-ancestor
24858154|NCT02295709|Dexamethasone|dexamethasone|mesh-list
24858199|NCT02295787|Anesthetics|anesthetics|mesh-ancestor
24858200|NCT02295787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24545293|NCT00692952|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
24545294|NCT00692952|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24545295|NCT00692952|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24545296|NCT00693004|Donepezil|donepezil|mesh-list
24545297|NCT00693004|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25274025|NCT02381470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25682109|NCT01875237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25682110|NCT01875250|Metronidazole|metronidazole|mesh-list
24589169|NCT00906048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589170|NCT00906048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589171|NCT00906048|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24589172|NCT00906048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24589173|NCT00906048|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25039104|NCT04129086|Ketamine|ketamine|mesh-list
25039105|NCT04129086|Analgesics|analgesics|mesh-ancestor
24806462|NCT02016157|Moxifloxacin|moxifloxacin|mesh-list
24806463|NCT02016157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24806464|NCT02016157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24806465|NCT02016157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24806466|NCT02016157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25229064|NCT02604797|Analgesics|analgesics|mesh-ancestor
25229065|NCT02604797|Sensory System Agents|sensory system agents|mesh-ancestor
25229066|NCT02604797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229067|NCT02604797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25229068|NCT02604797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25043908|NCT01188187|Antiemetics|antiemetics|mesh-ancestor
25043909|NCT01188187|Autonomic Agents|autonomic agents|mesh-ancestor
25043910|NCT01188187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25043968|NCT01175785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24844532|NCT02233179|Calpastatin|calpastatin|mesh-list
24844533|NCT02233179|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
24844534|NCT02233179|Protease Inhibitors|protease inhibitors|mesh-ancestor
24844535|NCT02233179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24844536|NCT02233179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844537|NCT02233205|Gemcitabine|gemcitabine|mesh-list
24844538|NCT02233205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24844539|NCT02233205|Antimetabolites|antimetabolites|mesh-ancestor
24844540|NCT02233205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844541|NCT02233205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24844542|NCT02233205|Antiviral Agents|antiviral agents|mesh-ancestor
24844543|NCT02233205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24844544|NCT02233205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24844545|NCT02233205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24844546|NCT02233205|Immunologic Factors|immunologic factors|mesh-ancestor
25059824|NCT03484650|Lidocaine|lidocaine|mesh-list
24560601|NCT02218164|Interferons|interferons|mesh-list
25682111|NCT01875250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25682112|NCT01875250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25682113|NCT01875250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25682114|NCT01875250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25682115|NCT01875367|Trastuzumab|trastuzumab|mesh-list
25682116|NCT01875367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25682117|NCT01875367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682118|NCT01875445|Inositol|inositol|mesh-list
25682119|NCT01875445|Vitamin B Complex|vitamin b complex|mesh-ancestor
25682120|NCT01875445|Vitamins|vitamins|mesh-ancestor
25682121|NCT01875445|Micronutrients|micronutrients|mesh-ancestor
25682122|NCT01875445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039107|NCT04129086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039108|NCT04129086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545317|NCT00693030|Immunologic Factors|immunologic factors|mesh-ancestor
24858201|NCT02295787|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24858202|NCT02295787|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24858203|NCT02295787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24858204|NCT02295787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858207|NCT02295826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25229069|NCT02604797|Anesthetics, General|anesthetics, general|mesh-ancestor
25229070|NCT02604797|Anesthetics|anesthetics|mesh-ancestor
25229071|NCT02604797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25229072|NCT02604797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25229073|NCT02604797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25229074|NCT02604797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25229075|NCT02604797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25229076|NCT02604797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229077|NCT02604797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229078|NCT02604797|Antiemetics|antiemetics|mesh-ancestor
25229079|NCT02604797|Autonomic Agents|autonomic agents|mesh-ancestor
25229080|NCT02604797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25229081|NCT02604797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25229082|NCT02604797|Serotonin Agents|serotonin agents|mesh-ancestor
25229083|NCT02604797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25229084|NCT02604784|Cisplatin|cisplatin|mesh-list
25229085|NCT02604784|Doxorubicin|doxorubicin|mesh-list
25229086|NCT02604784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25229088|NCT02604784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25229089|NCT02604784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25229090|NCT02604784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24844547|NCT02233205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807664|NCT02023021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623008|NCT01069770|Growth Inhibitors|growth inhibitors|mesh-ancestor
24623009|NCT01069770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24623010|NCT01069770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24844548|NCT02233218|Amlodipine|amlodipine|mesh-list
24844549|NCT02233218|Telmisartan|telmisartan|mesh-list
24844587|NCT02233244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844589|NCT02233322|Hematinics|hematinics|mesh-ancestor
24858208|NCT02295826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24858209|NCT02295826|Analgesics|analgesics|mesh-ancestor
24858210|NCT02295826|Sensory System Agents|sensory system agents|mesh-ancestor
24858211|NCT02295826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858215|NCT02295826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24858216|NCT02295826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24858217|NCT02295826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858218|NCT02295826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24858219|NCT02295826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24858220|NCT02295826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24858222|NCT02295826|Antithrombins|antithrombins|mesh-ancestor
24858223|NCT02295826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24858224|NCT02295826|Protease Inhibitors|protease inhibitors|mesh-ancestor
24858225|NCT02295826|Anticoagulants|anticoagulants|mesh-ancestor
24858226|NCT02295852|Calcium|calcium|mesh-list
24858227|NCT02295852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24858228|NCT02295852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858229|NCT02295930|Bevacizumab|bevacizumab|mesh-list
24822834|NCT02113735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24822835|NCT02113735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823555|NCT02117752|Leprostatic Agents|leprostatic agents|mesh-ancestor
24823556|NCT02117752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24823557|NCT02117765|Ustekinumab|ustekinumab|mesh-list
24858230|NCT02295930|Cetuximab|cetuximab|mesh-list
24858231|NCT02295930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24858232|NCT02295930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24545318|NCT00693030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682123|NCT01875510|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25682124|NCT01875510|SMOFlipid|smoflipid|mesh-list
25682125|NCT01875510|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25682126|NCT01875510|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25682127|NCT01875510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25682128|NCT01875848|Buprenorphine|buprenorphine|mesh-list
24545351|NCT00693121|Antiviral Agents|antiviral agents|mesh-ancestor
25682129|NCT01875848|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25682131|NCT01875848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25682132|NCT01875848|Narcotics|narcotics|mesh-ancestor
25682133|NCT01875848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25682134|NCT01875848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545354|NCT00693121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24545355|NCT00693121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274026|NCT02381470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229091|NCT02604784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25229092|NCT02604784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229093|NCT02604784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229094|NCT02604823|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25229095|NCT02604823|Antiviral Agents|antiviral agents|mesh-ancestor
24844591|NCT02233387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24844608|NCT02233452|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24844639|NCT02233582|Sensory System Agents|sensory system agents|mesh-ancestor
24844640|NCT02233582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24844641|NCT02233582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844642|NCT02233582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24844643|NCT02233582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24844644|NCT02233582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24844645|NCT02233582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24844646|NCT02233582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844647|NCT02233621|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24844648|NCT02233621|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24823683|NCT02118467|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24824601|NCT02124200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682135|NCT01875848|Analgesics|analgesics|mesh-ancestor
25682136|NCT01875848|Sensory System Agents|sensory system agents|mesh-ancestor
25682137|NCT01875848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682138|NCT01875848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25039132|NCT04104685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25039134|NCT04104685|Analgesics|analgesics|mesh-ancestor
25039135|NCT04104685|Sensory System Agents|sensory system agents|mesh-ancestor
25039136|NCT04104685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039137|NCT04104685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039138|NCT04104685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25039139|NCT04104685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25039140|NCT04104685|Dermatologic Agents|dermatologic agents|mesh-ancestor
24458203|NCT00336960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24824602|NCT02124226|Methotrexate|methotrexate|mesh-list
24824603|NCT02124226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24824604|NCT02124226|Abortifacient Agents|abortifacient agents|mesh-ancestor
24824698|NCT02124954|Digoxin|digoxin|mesh-list
24824699|NCT02124954|Midazolam|midazolam|mesh-list
24824700|NCT02124954|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24824701|NCT02124954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24824702|NCT02124954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24824703|NCT02124954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824705|NCT02124954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24858305|NCT02296203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858306|NCT02296203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858307|NCT02296203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24858308|NCT02296281|Pirfenidone|pirfenidone|mesh-list
24858313|NCT02296281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24447327|NCT00308191|Respiratory System Agents|respiratory system agents|mesh-ancestor
24447328|NCT00308191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24447329|NCT00308191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24447330|NCT00308191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24447331|NCT00308191|Adrenergic Agents|adrenergic agents|mesh-ancestor
24447332|NCT00308191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24824706|NCT02124954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24824707|NCT02124954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24824708|NCT02124954|Anesthetics, General|anesthetics, general|mesh-ancestor
24447333|NCT00308191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447334|NCT00308191|Parasympatholytics|parasympatholytics|mesh-ancestor
24545374|NCT00693199|Adrenergic Agents|adrenergic agents|mesh-ancestor
24545375|NCT00693199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24545376|NCT00693199|Urological Agents|urological agents|mesh-ancestor
24545377|NCT00693212|Methylphenidate|methylphenidate|mesh-list
25229096|NCT02604823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25229097|NCT02604836|Ibandronic Acid|ibandronic acid|mesh-list
25229098|NCT02604836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25229099|NCT02604836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229100|NCT02604615|Capecitabine|capecitabine|mesh-list
25682139|NCT01875991|Etanercept|etanercept|mesh-list
25682140|NCT01875991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25682141|NCT01875991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25682142|NCT01875991|Analgesics|analgesics|mesh-ancestor
25682143|NCT01875991|Sensory System Agents|sensory system agents|mesh-ancestor
25682144|NCT01875991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682145|NCT01875991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682146|NCT01875991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25682147|NCT01875991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25682148|NCT01875991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25682149|NCT01875991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25682150|NCT01875991|Immunologic Factors|immunologic factors|mesh-ancestor
25682151|NCT01876082|Methotrexate|methotrexate|mesh-list
25682152|NCT01876082|Vinblastine|vinblastine|mesh-list
24827952|NCT02142556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24844649|NCT02233621|Estradiol|estradiol|mesh-list
24711610|NCT01516255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24711611|NCT01516255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24711612|NCT01516255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711613|NCT01516255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229114|NCT02604576|Autonomic Agents|autonomic agents|mesh-ancestor
25229115|NCT02604576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229116|NCT02604576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229117|NCT02604576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25229118|NCT02604576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25229119|NCT02604576|Dopamine Agents|dopamine agents|mesh-ancestor
25229120|NCT02604576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25229121|NCT02604576|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25229122|NCT02604420|Eculizumab|eculizumab|mesh-list
25229123|NCT02604420|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25682153|NCT01876082|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25682154|NCT01876082|Abortifacient Agents|abortifacient agents|mesh-ancestor
25682155|NCT01876082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25682156|NCT01876082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682157|NCT01876082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24607729|NCT03859687|Vitamins|vitamins|mesh-list
25229124|NCT02604420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25229125|NCT02604420|Immunologic Factors|immunologic factors|mesh-ancestor
25229126|NCT02604420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229127|NCT02604459|Fentanyl|fentanyl|mesh-list
24828091|NCT02143362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24828092|NCT02143362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828155|NCT02143570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828160|NCT02143687|Sevoflurane|sevoflurane|mesh-list
25229128|NCT02604459|Anesthetics|anesthetics|mesh-list
25229129|NCT02604459|Propofol|propofol|mesh-list
25229130|NCT02604459|Sevoflurane|sevoflurane|mesh-list
25229131|NCT02604459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25229132|NCT02604459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229133|NCT02604459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25229134|NCT02604459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25229135|NCT02604459|Anesthetics, General|anesthetics, general|mesh-ancestor
25229136|NCT02604459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25229137|NCT02604459|Narcotics|narcotics|mesh-ancestor
25229138|NCT02604459|Analgesics|analgesics|mesh-ancestor
25229139|NCT02604459|Sensory System Agents|sensory system agents|mesh-ancestor
25229140|NCT02604459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25229141|NCT02604459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25229142|NCT02604459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25229143|NCT02604459|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25229144|NCT02604225|Methoxyflurane|methoxyflurane|mesh-list
25229145|NCT02604225|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25229146|NCT02604225|Anesthetics, General|anesthetics, general|mesh-ancestor
25229147|NCT02604225|Anesthetics|anesthetics|mesh-ancestor
25229148|NCT02604225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25273445|NCT02385435|Dexmedetomidine|dexmedetomidine|mesh-list
24844650|NCT02233621|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24844651|NCT02233621|Estrogens|estrogens|mesh-ancestor
24844652|NCT02233621|Hormones|hormones|mesh-ancestor
24844653|NCT02233621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24844654|NCT02233621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844655|NCT02233621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24844656|NCT02233621|Contraceptive Agents|contraceptive agents|mesh-ancestor
24844657|NCT02233621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24844658|NCT02233621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24844659|NCT02233777|Pregabalin|pregabalin|mesh-list
24844660|NCT02233777|Analgesics|analgesics|mesh-ancestor
24844661|NCT02233777|Sensory System Agents|sensory system agents|mesh-ancestor
24844662|NCT02233777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24844663|NCT02233777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844664|NCT02233777|Anticonvulsants|anticonvulsants|mesh-ancestor
24844665|NCT02233777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24844666|NCT02233777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24844671|NCT02233777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24844672|NCT02233777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24844673|NCT02233790|Clopidogrel|clopidogrel|mesh-list
24844674|NCT02233790|Ticagrelor|ticagrelor|mesh-list
24844675|NCT02233790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24844683|NCT02233816|Vaccines|vaccines|mesh-list
24844694|NCT02233881|Cholinergic Agents|cholinergic agents|mesh-ancestor
24844695|NCT02233881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24844696|NCT02233881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844697|NCT02233894|Ipratropium|ipratropium|mesh-list
24844698|NCT02233894|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24844699|NCT02233894|Autonomic Agents|autonomic agents|mesh-ancestor
24844700|NCT02233894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24844701|NCT02233894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711618|NCT01516255|Hormones|hormones|mesh-ancestor
25229149|NCT02604225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229150|NCT02604238|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25229151|NCT02604238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25229152|NCT02604238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25229153|NCT02604238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229154|NCT02604186|Botulinum Toxins|botulinum toxins|mesh-list
25229155|NCT02604186|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25229156|NCT02604186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25229157|NCT02604186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229158|NCT02604186|Cholinergic Agents|cholinergic agents|mesh-ancestor
25229159|NCT02604186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25682158|NCT01876082|Antimetabolites|antimetabolites|mesh-ancestor
25229160|NCT02604186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229161|NCT02604134|Silver Nitrate|silver nitrate|mesh-list
25229162|NCT02604134|Fluorides|fluorides|mesh-list
25229163|NCT02604134|Fluorides, Topical|fluorides, topical|mesh-list
25229164|NCT02604134|Cariostatic Agents|cariostatic agents|mesh-ancestor
25229165|NCT02604134|Protective Agents|protective agents|mesh-ancestor
25229166|NCT02604134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229167|NCT02604134|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25229168|NCT02604134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25229169|NCT02604095|Melatonin|melatonin|mesh-list
25229170|NCT02604095|Antioxidants|antioxidants|mesh-ancestor
25229171|NCT02604095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229172|NCT02604095|Protective Agents|protective agents|mesh-ancestor
25229173|NCT02604095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25229174|NCT02604095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25229175|NCT02604004|Lamivudine|lamivudine|mesh-list
25229176|NCT02604004|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25229177|NCT02604004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25229178|NCT02604004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25229179|NCT02604004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25229180|NCT02604004|Antiviral Agents|antiviral agents|mesh-ancestor
25229181|NCT02604004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25229182|NCT02604004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25229183|NCT02604004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25229184|NCT02603965|Copper|copper|mesh-list
25229185|NCT02603965|Trace Elements|trace elements|mesh-ancestor
24844775|NCT02234466|Ondansetron|ondansetron|mesh-list
24844776|NCT02234466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24829131|NCT02150031|Lidocaine|lidocaine|mesh-list
24829140|NCT02150031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24829141|NCT02150031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24414805|NCT00198718|Vitamins|vitamins|mesh-ancestor
24414806|NCT00198718|Micronutrients|micronutrients|mesh-ancestor
25125666|NCT03067688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125667|NCT03067688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25125668|NCT03067688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125669|NCT03067688|Vasodilator Agents|vasodilator agents|mesh-ancestor
25125670|NCT03067688|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25125671|NCT03067688|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25125672|NCT03067688|Antimetabolites|antimetabolites|mesh-ancestor
25125673|NCT03067688|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25125674|NCT03067688|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25125675|NCT03067688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414807|NCT00198718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414808|NCT00198718|Antioxidants|antioxidants|mesh-ancestor
24414810|NCT00198718|Protective Agents|protective agents|mesh-ancestor
24414994|NCT00199017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24414995|NCT00199017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24414996|NCT00199017|Glucocorticoids|glucocorticoids|mesh-ancestor
24415033|NCT00199043|Antioxidants|antioxidants|mesh-ancestor
24415370|NCT00199329|Serotonin Agents|serotonin agents|mesh-ancestor
24415371|NCT00199329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24415372|NCT00199329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415373|NCT00199329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24415374|NCT00199329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24415375|NCT00199329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24415376|NCT00199329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24415377|NCT00199329|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24415378|NCT00199342|Ecromeximab|ecromeximab|mesh-list
24415566|NCT00199979|Antiviral Agents|antiviral agents|mesh-ancestor
24415707|NCT00200538|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24415817|NCT00201305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415818|NCT00201305|Antiviral Agents|antiviral agents|mesh-ancestor
25125676|NCT03067688|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25125677|NCT03067688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25125678|NCT03067727|Dinoprostone|dinoprostone|mesh-list
25039215|NCT03957590|Paclitaxel|paclitaxel|mesh-list
25039216|NCT03957590|Cisplatin|cisplatin|mesh-list
25125679|NCT03067727|Oxytocics|oxytocics|mesh-ancestor
25125680|NCT03067727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25125681|NCT03067727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125682|NCT03067155|Antiviral Agents|antiviral agents|mesh-list
25125683|NCT03067155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25125684|NCT03067103|Ketamine|ketamine|mesh-list
25125685|NCT03067103|Tramadol|tramadol|mesh-list
25125686|NCT03067103|Analgesics|analgesics|mesh-ancestor
25125687|NCT03067103|Sensory System Agents|sensory system agents|mesh-ancestor
25125688|NCT03067103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125689|NCT03067103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125690|NCT03067103|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24415819|NCT00201305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24415820|NCT00201305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24415821|NCT00201305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24415822|NCT00201305|Immunologic Factors|immunologic factors|mesh-ancestor
24415823|NCT00201305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416102|NCT00202007|Antidepressive Agents|antidepressive agents|mesh-ancestor
24416104|NCT00202007|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24416105|NCT00202007|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24416110|NCT00202020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24416111|NCT00202020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24416286|NCT00202605|Adrenergic Agents|adrenergic agents|mesh-ancestor
24416287|NCT00202605|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24416288|NCT00202605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24416289|NCT00202605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24416290|NCT00202605|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24416292|NCT00202618|Valsartan|valsartan|mesh-list
24416314|NCT00202774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24416315|NCT00202774|Immunologic Factors|immunologic factors|mesh-ancestor
24416316|NCT00202774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416317|NCT00202787|Leucovorin|leucovorin|mesh-list
24416318|NCT00202787|Cetuximab|cetuximab|mesh-list
24416493|NCT00203281|Tacrolimus|tacrolimus|mesh-list
24416494|NCT00203281|Daclizumab|daclizumab|mesh-list
24416516|NCT00203320|Sensory System Agents|sensory system agents|mesh-ancestor
24416517|NCT00203320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24416518|NCT00203320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416519|NCT00203320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24416521|NCT00203320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24416522|NCT00203320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24416523|NCT00203320|Immunologic Factors|immunologic factors|mesh-ancestor
24416524|NCT00203359|Etanercept|etanercept|mesh-list
24416820|NCT00204191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24416822|NCT00204191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417933|NCT00208195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24418987|NCT00210769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24460014|NCT00347113|Anthelmintics|anthelmintics|mesh-ancestor
24460015|NCT00347113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24460016|NCT00347113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24460017|NCT00347113|Anticestodal Agents|anticestodal agents|mesh-ancestor
24460018|NCT00347113|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24418988|NCT00210769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24418989|NCT00210769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418990|NCT00210769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25125691|NCT03067103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25125692|NCT03067103|Anesthetics, General|anesthetics, general|mesh-ancestor
25125693|NCT03067103|Anesthetics|anesthetics|mesh-ancestor
25125694|NCT03067103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25125695|NCT03067103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25125696|NCT03067103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25125697|NCT03067103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25125698|NCT03067103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125699|NCT03067103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25125700|NCT03067103|Narcotics|narcotics|mesh-ancestor
25125701|NCT03067168|Bupivacaine|bupivacaine|mesh-list
25125702|NCT03067168|Anesthetics, Local|anesthetics, local|mesh-ancestor
25125703|NCT03067168|Anesthetics|anesthetics|mesh-ancestor
25125704|NCT03067168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25125705|NCT03067168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125706|NCT03067168|Sensory System Agents|sensory system agents|mesh-ancestor
25682159|NCT01876082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682160|NCT01876082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25039231|NCT03949673|Analgesics|analgesics|mesh-ancestor
25039232|NCT03949673|Sensory System Agents|sensory system agents|mesh-ancestor
25125707|NCT03067168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125708|NCT03067194|Celecoxib|celecoxib|mesh-list
25125709|NCT03067194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25125710|NCT03067194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25125711|NCT03067194|Analgesics|analgesics|mesh-ancestor
24955695|NCT03862404|Sensory System Agents|sensory system agents|mesh-ancestor
24460020|NCT00347113|Tubulin Modulators|tubulin modulators|mesh-ancestor
24460021|NCT00347113|Antimitotic Agents|antimitotic agents|mesh-ancestor
24460022|NCT00347113|Mitosis Modulators|mitosis modulators|mesh-ancestor
24419698|NCT00213486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24419699|NCT00213486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419700|NCT00213486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419701|NCT00213486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419703|NCT00213512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24419704|NCT00213512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419705|NCT00213512|Immunologic Factors|immunologic factors|mesh-ancestor
24419706|NCT00213512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419707|NCT00213512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24419708|NCT00213538|Methotrexate|methotrexate|mesh-list
24419709|NCT00213538|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24419711|NCT00213538|Abortifacient Agents|abortifacient agents|mesh-ancestor
24420089|NCT00215163|Antidepressive Agents|antidepressive agents|mesh-ancestor
24420090|NCT00215163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24420175|NCT00215345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24420176|NCT00215345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420177|NCT00215345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24420178|NCT00215345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24420179|NCT00215345|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24421567|NCT00219700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24421568|NCT00219700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24429787|NCT00245089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24429206|NCT00242944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24421815|NCT00220233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25125717|NCT03067194|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25125718|NCT03067194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25125719|NCT03067194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125720|NCT03067194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125724|NCT03067415|Latanoprost|latanoprost|mesh-list
25125725|NCT03067415|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25125726|NCT03067415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25125727|NCT03066635|Botulinum Toxins|botulinum toxins|mesh-list
25125728|NCT03066635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25125729|NCT03066635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25125730|NCT03066635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25125731|NCT03066635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25125732|NCT03066635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125733|NCT03066635|Cholinergic Agents|cholinergic agents|mesh-ancestor
25125736|NCT03066635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25125737|NCT03066635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24781507|NCT01889992|Antifungal Agents|antifungal agents|mesh-ancestor
24421816|NCT00220233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24421817|NCT00220233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24421818|NCT00220259|Fluticasone|fluticasone|mesh-list
24421819|NCT00220259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24421820|NCT00220259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24421821|NCT00220259|Autonomic Agents|autonomic agents|mesh-ancestor
24421822|NCT00220259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24421823|NCT00220259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421824|NCT00220259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24421825|NCT00220259|Respiratory System Agents|respiratory system agents|mesh-ancestor
24460058|NCT00347204|Nepafenac|nepafenac|mesh-list
24460059|NCT00347204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24460060|NCT00347204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24460061|NCT00347204|Analgesics|analgesics|mesh-ancestor
24460062|NCT00347204|Sensory System Agents|sensory system agents|mesh-ancestor
24417237|NCT00206050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24422922|NCT00223925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24422923|NCT00223938|Ferric gluconate|ferric gluconate|mesh-list
24422924|NCT00223938|Ferric Compounds|ferric compounds|mesh-list
24422925|NCT00223938|Hematinics|hematinics|mesh-ancestor
25682161|NCT01876082|Dermatologic Agents|dermatologic agents|mesh-ancestor
25682162|NCT01876082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039274|NCT03935958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039276|NCT03928184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24422926|NCT00223964|Ferric gluconate|ferric gluconate|mesh-list
25125741|NCT03066791|Analgesics|analgesics|mesh-ancestor
25125742|NCT03066791|Sensory System Agents|sensory system agents|mesh-ancestor
25125743|NCT03066791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125744|NCT03066791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125745|NCT03066791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25125746|NCT03066791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25125747|NCT03066791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125748|NCT03066791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125749|NCT03066791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125750|NCT03066817|Ergocalciferols|ergocalciferols|mesh-list
25125751|NCT03066817|Vitamin D|vitamin d|mesh-list
25125752|NCT03066817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25125753|NCT03066817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422927|NCT00223964|Hematinics|hematinics|mesh-ancestor
24422928|NCT00224068|Ferric gluconate|ferric gluconate|mesh-list
24422929|NCT00224068|Hematinics|hematinics|mesh-ancestor
24423986|NCT00227656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423987|NCT00227669|Gemcitabine|gemcitabine|mesh-list
24423988|NCT00227669|Docetaxel|docetaxel|mesh-list
24423989|NCT00227669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24423990|NCT00227669|Antimetabolites|antimetabolites|mesh-ancestor
24423991|NCT00227669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423992|NCT00227669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424468|NCT00229515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424469|NCT00229515|Antifungal Agents|antifungal agents|mesh-ancestor
24424470|NCT00229515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24424471|NCT00229515|Immunologic Factors|immunologic factors|mesh-ancestor
24424472|NCT00229515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424473|NCT00229515|Anticoagulants|anticoagulants|mesh-ancestor
24425415|NCT00232934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24425416|NCT00232934|Immunologic Factors|immunologic factors|mesh-ancestor
24425417|NCT00232934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425418|NCT00232934|Leprostatic Agents|leprostatic agents|mesh-ancestor
24425419|NCT00232934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24460146|NCT00347503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24425420|NCT00232934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24425421|NCT00232934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24425486|NCT00233532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24425492|NCT00233532|Vasodilator Agents|vasodilator agents|mesh-ancestor
24425500|NCT00233545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24425501|NCT00233545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24425502|NCT00233545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24425504|NCT00233558|Methotrexate|methotrexate|mesh-list
24425505|NCT00233558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24425506|NCT00233558|Abortifacient Agents|abortifacient agents|mesh-ancestor
24425507|NCT00233558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24425508|NCT00233558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425509|NCT00233558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24425625|NCT00233792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425627|NCT00233805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24425628|NCT00233805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24425629|NCT00233805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24425630|NCT00233805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125754|NCT03066817|Vitamins|vitamins|mesh-ancestor
25125755|NCT03066817|Micronutrients|micronutrients|mesh-ancestor
25125756|NCT03066817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25125757|NCT03066661|Entrectinib|entrectinib|mesh-list
25125758|NCT03066661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25125759|NCT03066661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125760|NCT03066661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125761|NCT03066700|Hemostatics|hemostatics|mesh-list
25125762|NCT03066700|Coagulants|coagulants|mesh-ancestor
25125763|NCT03066557|Apatinib|apatinib|mesh-list
25125764|NCT03066557|Chlorotrianisene|chlorotrianisene|mesh-list
25125765|NCT03066557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125766|NCT03066557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25125767|NCT03066557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25682163|NCT01876082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25682164|NCT01876082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25682165|NCT01876082|Immunologic Factors|immunologic factors|mesh-ancestor
25405372|NCT03609216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25276610|NCT02363452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276611|NCT02363452|Antiviral Agents|antiviral agents|mesh-ancestor
25276612|NCT02363452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25276613|NCT02363452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25276614|NCT02363452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25276615|NCT02363452|Antimetabolites|antimetabolites|mesh-ancestor
25276634|NCT02363400|Cisplatin|cisplatin|mesh-list
25276635|NCT02363400|Epirubicin|epirubicin|mesh-list
25276636|NCT02363400|Mitomycins|mitomycins|mesh-list
25276637|NCT02363400|Mitomycin|mitomycin|mesh-list
25039340|NCT03881852|Reboxetine|reboxetine|mesh-list
25039341|NCT03881852|Antidepressive Agents|antidepressive agents|mesh-ancestor
25039342|NCT03881852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25039343|NCT03881852|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25039344|NCT03881852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25039345|NCT03881852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25125768|NCT03066557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125769|NCT03066557|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25125770|NCT03066557|Estrogens|estrogens|mesh-ancestor
25125771|NCT03066557|Hormones|hormones|mesh-ancestor
25125772|NCT03066557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25125773|NCT03066557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955710|NCT03862391|Analgesics|analgesics|mesh-list
24425631|NCT00233805|Antifungal Agents|antifungal agents|mesh-ancestor
24425632|NCT00233805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24425633|NCT00233805|Immunologic Factors|immunologic factors|mesh-ancestor
24425635|NCT00233818|Sirolimus|sirolimus|mesh-list
25264678|NCT02439125|Eltoprazine|eltoprazine|mesh-list
24425935|NCT00234845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24425936|NCT00234845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24426264|NCT00235300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24460176|NCT00347581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460177|NCT00347581|Adrenergic Agents|adrenergic agents|mesh-ancestor
24460178|NCT00347581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24460182|NCT00347646|Fibrinolysin|fibrinolysin|mesh-list
24427135|NCT00237510|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24427137|NCT00237510|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24427138|NCT00237510|Adrenergic Agents|adrenergic agents|mesh-ancestor
24427143|NCT00237523|Iodine|iodine|mesh-list
24427438|NCT00238173|Sequestering Agents|sequestering agents|mesh-ancestor
24427440|NCT00238199|Docetaxel|docetaxel|mesh-list
24427441|NCT00238199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427442|NCT00238199|Tubulin Modulators|tubulin modulators|mesh-ancestor
24427443|NCT00238199|Antimitotic Agents|antimitotic agents|mesh-ancestor
24427447|NCT00238199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427448|NCT00238199|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24427451|NCT00238199|Vitamins|vitamins|mesh-ancestor
24428065|NCT00239473|Parasympatholytics|parasympatholytics|mesh-ancestor
24428094|NCT00239499|Cholinergic Agents|cholinergic agents|mesh-ancestor
24428095|NCT00239499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24428096|NCT00239499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428097|NCT00239499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24458374|NCT00337649|Desoxyepothilone B|desoxyepothilone b|mesh-list
24428098|NCT00239499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24429170|NCT00242853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24429207|NCT00242944|Antimetabolites|antimetabolites|mesh-ancestor
24429237|NCT00243009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24429238|NCT00243009|Antimetabolites|antimetabolites|mesh-ancestor
25125774|NCT03066557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25125775|NCT03066544|Dexamethasone|dexamethasone|mesh-list
25682166|NCT01876082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25682167|NCT01876082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25682168|NCT01876082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25682169|NCT01876082|Tubulin Modulators|tubulin modulators|mesh-ancestor
25682170|NCT01876082|Antimitotic Agents|antimitotic agents|mesh-ancestor
25682171|NCT01876082|Mitosis Modulators|mitosis modulators|mesh-ancestor
25682172|NCT01876212|Dasatinib|dasatinib|mesh-list
25682173|NCT01876212|Vaccines|vaccines|mesh-list
25682174|NCT01876212|Immunologic Factors|immunologic factors|mesh-ancestor
25682175|NCT01876212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682176|NCT01876212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682177|NCT01876212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25682178|NCT01876212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25682179|NCT01876212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682180|NCT01876251|Docetaxel|docetaxel|mesh-list
25125776|NCT03066544|Ketorolac|ketorolac|mesh-list
25125777|NCT03066544|Naratriptan|naratriptan|mesh-list
25125778|NCT03066544|Bupivacaine|bupivacaine|mesh-list
25125779|NCT03066544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25125780|NCT03066544|Antiemetics|antiemetics|mesh-ancestor
25125781|NCT03066544|Autonomic Agents|autonomic agents|mesh-ancestor
25125782|NCT03066544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125783|NCT03066544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125784|NCT03066544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25125785|NCT03066544|Glucocorticoids|glucocorticoids|mesh-ancestor
25125786|NCT03066544|Hormones|hormones|mesh-ancestor
24784558|NCT01908621|Cytarabine|cytarabine|mesh-list
25125787|NCT03066544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25125788|NCT03066544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25125789|NCT03066544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125791|NCT03066544|Anesthetics|anesthetics|mesh-ancestor
24955730|NCT03862053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24429239|NCT00243009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430003|NCT00245791|Levofloxacin|levofloxacin|mesh-list
24430004|NCT00245791|Ofloxacin|ofloxacin|mesh-list
24430005|NCT00245791|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24430042|NCT00245934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24430098|NCT00246155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24430099|NCT00246168|Acetaminophen|acetaminophen|mesh-list
24430100|NCT00246168|Tramadol|tramadol|mesh-list
24430101|NCT00246168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24430102|NCT00246168|Analgesics|analgesics|mesh-ancestor
24430103|NCT00246168|Sensory System Agents|sensory system agents|mesh-ancestor
24430104|NCT00246168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24456128|NCT00330239|Paroxetine|paroxetine|mesh-list
24430105|NCT00246168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430106|NCT00246168|Antipyretics|antipyretics|mesh-ancestor
24430107|NCT00246168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24430108|NCT00246168|Narcotics|narcotics|mesh-ancestor
24430109|NCT00246168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24430113|NCT00246194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430114|NCT00246194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430397|NCT00247559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430398|NCT00247559|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24430399|NCT00247559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24430400|NCT00247572|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
24430401|NCT00247572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24430402|NCT00247572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430403|NCT00247572|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24430404|NCT00247572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24430405|NCT00247572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24430409|NCT00247585|Ethanol|ethanol|mesh-list
24430625|NCT00248456|Glucocorticoids|glucocorticoids|mesh-ancestor
24430626|NCT00248456|Hormones|hormones|mesh-ancestor
24430627|NCT00248456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24430628|NCT00248456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430629|NCT00248456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24430630|NCT00248456|Respiratory System Agents|respiratory system agents|mesh-ancestor
24430631|NCT00248456|Dermatologic Agents|dermatologic agents|mesh-ancestor
25125801|NCT03066544|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24430666|NCT00248963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25125792|NCT03066544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25125793|NCT03066544|Sensory System Agents|sensory system agents|mesh-ancestor
25125794|NCT03066544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25125795|NCT03066544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24430667|NCT00248963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430668|NCT00248963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24430669|NCT00248963|Contraceptive Agents|contraceptive agents|mesh-ancestor
24430670|NCT00248963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24430967|NCT00249886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430968|NCT00249886|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24430969|NCT00249886|Antidepressive Agents|antidepressive agents|mesh-ancestor
24430970|NCT00249886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24430972|NCT00249899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24430974|NCT00249899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
25682181|NCT01876251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682182|NCT01876251|Tubulin Modulators|tubulin modulators|mesh-ancestor
25276659|NCT02363361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276660|NCT02363075|Dextroamphetamine|dextroamphetamine|mesh-list
25276661|NCT02363075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25276662|NCT02363075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276663|NCT02363075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25276664|NCT02363075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24430975|NCT00249899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24431460|NCT00251784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431461|NCT00251784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431465|NCT00251797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24431466|NCT00251797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24431467|NCT00251797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431468|NCT00251797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431469|NCT00251797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431470|NCT00251797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24431471|NCT00251797|Immunologic Factors|immunologic factors|mesh-ancestor
24431502|NCT00251914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24431503|NCT00251914|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24431504|NCT00251914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431505|NCT00251914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431791|NCT00252863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24431980|NCT00253344|Tubulin Modulators|tubulin modulators|mesh-ancestor
24431981|NCT00253344|Antimitotic Agents|antimitotic agents|mesh-ancestor
24432196|NCT00253955|Piperacillin|piperacillin|mesh-list
24432197|NCT00253955|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24432199|NCT00253955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24432205|NCT00253955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432206|NCT00253955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432207|NCT00253955|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24432208|NCT00253955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24432209|NCT00253955|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24432210|NCT00254007|Citalopram|citalopram|mesh-list
24432454|NCT00254800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24432455|NCT00254800|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24432457|NCT00254800|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24432458|NCT00254800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24432758|NCT00255918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432759|NCT00255918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432789|NCT00256178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460290|NCT00348023|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24460291|NCT00348023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24460292|NCT00348023|Adrenergic Agents|adrenergic agents|mesh-ancestor
24460293|NCT00348023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24460294|NCT00348023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420078|NCT00215124|Immunologic Factors|immunologic factors|mesh-ancestor
24433195|NCT00257855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24433260|NCT00258050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24433261|NCT00258050|Anesthetics, General|anesthetics, general|mesh-ancestor
24433262|NCT00258050|Anesthetics|anesthetics|mesh-ancestor
24433263|NCT00258050|GABA Modulators|gaba modulators|mesh-ancestor
24433264|NCT00258050|GABA Agents|gaba agents|mesh-ancestor
24433265|NCT00258050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24433285|NCT00258076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125797|NCT03066544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25125798|NCT03066544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25125799|NCT03066544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125800|NCT03066544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125806|NCT03066466|Methotrexate|methotrexate|mesh-list
25125807|NCT03066466|Atorvastatin|atorvastatin|mesh-list
25125809|NCT03066466|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25682183|NCT01876251|Antimitotic Agents|antimitotic agents|mesh-ancestor
25682184|NCT01876251|Mitosis Modulators|mitosis modulators|mesh-ancestor
25682185|NCT01876251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682186|NCT01876368|Olmesartan|olmesartan|mesh-list
25682187|NCT01876368|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25682188|NCT01876368|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25682189|NCT01876368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25692502|NCT01999985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25276704|NCT02362711|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24433287|NCT00258089|Ofloxacin|ofloxacin|mesh-list
24433290|NCT00258089|Renal Agents|renal agents|mesh-ancestor
24433382|NCT00258245|Antioxidants|antioxidants|mesh-ancestor
24433383|NCT00258245|Protective Agents|protective agents|mesh-ancestor
24433384|NCT00258245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24433385|NCT00258245|Immunologic Factors|immunologic factors|mesh-ancestor
24433386|NCT00258245|Leprostatic Agents|leprostatic agents|mesh-ancestor
24433387|NCT00258245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24433388|NCT00258245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24433389|NCT00258245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24433390|NCT00258245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24433391|NCT00258245|Growth Substances|growth substances|mesh-ancestor
24433392|NCT00258245|Growth Inhibitors|growth inhibitors|mesh-ancestor
24433424|NCT00258323|Fluorouracil|fluorouracil|mesh-list
24433767|NCT00259883|Paroxetine|paroxetine|mesh-list
24433768|NCT00259883|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24433769|NCT00259883|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24433770|NCT00259883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24433771|NCT00259883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433772|NCT00259883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24433951|NCT00261027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433952|NCT00261027|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24433953|NCT00261027|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24433954|NCT00261027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434070|NCT00261352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434071|NCT00261352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24434073|NCT00261365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24434074|NCT00261365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24434217|NCT00261729|Prazosin|prazosin|mesh-list
24434218|NCT00261729|Paroxetine|paroxetine|mesh-list
24434219|NCT00261729|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24434220|NCT00261729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24434221|NCT00261729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24434224|NCT00261729|Serotonin Agents|serotonin agents|mesh-ancestor
24420414|NCT00215995|Cisplatin|cisplatin|mesh-list
24434361|NCT00262275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24434362|NCT00262275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434363|NCT00262275|Antipyretics|antipyretics|mesh-ancestor
24434364|NCT00262275|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24434365|NCT00262275|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24433010|NCT00257270|Gabapentin|gabapentin|mesh-list
25125810|NCT03066466|Abortifacient Agents|abortifacient agents|mesh-ancestor
25125811|NCT03066466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25125812|NCT03066466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125813|NCT03066466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25125814|NCT03066466|Antimetabolites|antimetabolites|mesh-ancestor
25125815|NCT03066466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434568|NCT00262808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434569|NCT00262808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24434570|NCT00262808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24434571|NCT00262808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24434572|NCT00262808|Immunologic Factors|immunologic factors|mesh-ancestor
24434574|NCT00262808|Protective Agents|protective agents|mesh-ancestor
24434757|NCT00263406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434760|NCT00263458|Narcotics|narcotics|mesh-ancestor
24434761|NCT00263458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24434762|NCT00263458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434763|NCT00263458|Analgesics|analgesics|mesh-ancestor
24435097|NCT00265031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435098|NCT00265031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24435099|NCT00265031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24435100|NCT00265031|Alkylating Agents|alkylating agents|mesh-ancestor
24435107|NCT00265031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25682190|NCT01876368|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25682191|NCT01876368|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25682192|NCT01876368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682193|NCT01876381|Tolvaptan|tolvaptan|mesh-list
25682194|NCT01876381|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25682195|NCT01876381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435354|NCT00266097|Gemcitabine|gemcitabine|mesh-list
24435765|NCT00268177|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24436190|NCT00269334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436191|NCT00269334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24436192|NCT00269334|Serotonin Agents|serotonin agents|mesh-ancestor
24436193|NCT00269334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433548|NCT00258804|Insulin Glargine|insulin glargine|mesh-list
24436381|NCT00269815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436382|NCT00269815|Dopamine Agents|dopamine agents|mesh-ancestor
24436383|NCT00269815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24436384|NCT00269828|Paclitaxel|paclitaxel|mesh-list
24436385|NCT00269828|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24436387|NCT00269828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24436388|NCT00269828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24436389|NCT00269828|Tubulin Modulators|tubulin modulators|mesh-ancestor
24436420|NCT00269867|Immunologic Factors|immunologic factors|mesh-ancestor
24436882|NCT00271791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24436883|NCT00271791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24437130|NCT00272753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24437131|NCT00272753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24437132|NCT00272753|Autonomic Agents|autonomic agents|mesh-ancestor
24437133|NCT00272753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24437134|NCT00272753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437135|NCT00272753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24437136|NCT00272753|Respiratory System Agents|respiratory system agents|mesh-ancestor
24437161|NCT00272805|Vasodilator Agents|vasodilator agents|mesh-ancestor
24437162|NCT00272805|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24437163|NCT00272805|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24437164|NCT00272831|Cilostazol|cilostazol|mesh-list
25125822|NCT03066466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25125823|NCT03066466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25125824|NCT03066466|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25125825|NCT03066466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25125826|NCT03066466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25125827|NCT03066466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25125828|NCT03066466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25125829|NCT03066518|Melatonin|melatonin|mesh-list
25125830|NCT03066518|Antioxidants|antioxidants|mesh-ancestor
25125831|NCT03066518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125832|NCT03066518|Protective Agents|protective agents|mesh-ancestor
25125833|NCT03066518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125834|NCT03066518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25125835|NCT03066427|Sunitinib|sunitinib|mesh-list
25125836|NCT03066427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125837|NCT03066427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25125838|NCT03066427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25125839|NCT03066427|Growth Substances|growth substances|mesh-ancestor
25125840|NCT03066427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125841|NCT03066427|Growth Inhibitors|growth inhibitors|mesh-ancestor
24437166|NCT00272831|Autonomic Agents|autonomic agents|mesh-ancestor
24437363|NCT00273468|Autonomic Agents|autonomic agents|mesh-ancestor
24437364|NCT00273468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24437365|NCT00273468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437366|NCT00273468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24437396|NCT00273520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24437412|NCT00273559|Glucocorticoids|glucocorticoids|mesh-ancestor
24438052|NCT00274950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24438053|NCT00274950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24438054|NCT00274950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438055|NCT00274950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438056|NCT00274950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24438057|NCT00274950|Alkylating Agents|alkylating agents|mesh-ancestor
25125842|NCT03066427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25125843|NCT03066427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125844|NCT03066427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125845|NCT03066076|Propylthiouracil|propylthiouracil|mesh-list
25125846|NCT03066076|Antithyroid Agents|antithyroid agents|mesh-list
25125847|NCT03066076|Antimetabolites|antimetabolites|mesh-ancestor
25682197|NCT01876381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682198|NCT01876446|Irinotecan|irinotecan|mesh-list
25682199|NCT01876446|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25682200|NCT01876446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25276776|NCT02362256|Anticonvulsants|anticonvulsants|mesh-ancestor
25276777|NCT02362256|Antiemetics|antiemetics|mesh-ancestor
25276778|NCT02362256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25276779|NCT02362256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25276780|NCT02362256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25276785|NCT02362256|GABA Agents|gaba agents|mesh-ancestor
25125851|NCT03066076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125852|NCT03066115|Ascorbic Acid|ascorbic acid|mesh-list
24438058|NCT00274950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24438412|NCT00275756|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24438413|NCT00275756|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24438414|NCT00275756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438415|NCT00275912|Oxcarbazepine|oxcarbazepine|mesh-list
24438484|NCT00276055|Growth Substances|growth substances|mesh-ancestor
24460357|NCT00348244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24438816|NCT00276783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24438817|NCT00276783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24438818|NCT00276796|Paclitaxel|paclitaxel|mesh-list
24438819|NCT00276796|Topotecan|topotecan|mesh-list
24438884|NCT00276835|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24438885|NCT00276835|Estrogens|estrogens|mesh-ancestor
24438886|NCT00276835|Hormones|hormones|mesh-ancestor
24438887|NCT00276835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24438888|NCT00276848|Vidarabine|vidarabine|mesh-list
24438972|NCT00277017|Thalidomide|thalidomide|mesh-list
24438973|NCT00277017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438974|NCT00277017|Antiviral Agents|antiviral agents|mesh-ancestor
24438975|NCT00277017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24438976|NCT00277017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24439072|NCT00277498|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24439073|NCT00277498|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24439074|NCT00277498|Adrenergic Agents|adrenergic agents|mesh-ancestor
24439406|NCT00278421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439407|NCT00278421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24439408|NCT00278421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24439409|NCT00278421|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24439410|NCT00278421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24439411|NCT00278421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24439412|NCT00278421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24439413|NCT00278421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24439421|NCT00278421|Mitosis Modulators|mitosis modulators|mesh-ancestor
24439423|NCT00278434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24439425|NCT00278460|Gemcitabine|gemcitabine|mesh-list
24439505|NCT00279084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439506|NCT00279084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24439507|NCT00279084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24439508|NCT00279110|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24439509|NCT00279110|Antiviral Agents|antiviral agents|mesh-ancestor
24439510|NCT00279110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24439511|NCT00279123|Pantoprazole|pantoprazole|mesh-list
24439514|NCT00279123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25125854|NCT03066115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25125855|NCT03066115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25125856|NCT03066115|Analgesics|analgesics|mesh-ancestor
25125857|NCT03066115|Sensory System Agents|sensory system agents|mesh-ancestor
25125858|NCT03066115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125859|NCT03066115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125860|NCT03066115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25125861|NCT03066115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25125862|NCT03066115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24439599|NCT00279487|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24439600|NCT00279487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24439601|NCT00279487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25682201|NCT01876446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25682202|NCT01876446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682203|NCT01876446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682204|NCT01876511|Pembrolizumab|pembrolizumab|mesh-list
25682205|NCT01876511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24439602|NCT00279487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25682206|NCT01876511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682207|NCT01876732|Vitamin B 12|vitamin b 12|mesh-list
25682208|NCT01876732|Hydroxocobalamin|hydroxocobalamin|mesh-list
25276819|NCT02362165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24439603|NCT00279487|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24440049|NCT00281567|Respiratory System Agents|respiratory system agents|mesh-ancestor
24440050|NCT00281567|Parasympatholytics|parasympatholytics|mesh-ancestor
24440197|NCT00281944|Micronutrients|micronutrients|mesh-ancestor
24440198|NCT00281970|Docetaxel|docetaxel|mesh-list
24440199|NCT00281970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440200|NCT00281970|Tubulin Modulators|tubulin modulators|mesh-ancestor
24440201|NCT00281970|Antimitotic Agents|antimitotic agents|mesh-ancestor
24440202|NCT00281970|Mitosis Modulators|mitosis modulators|mesh-ancestor
24440203|NCT00281970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440211|NCT00281983|Fludarabine phosphate|fludarabine phosphate|mesh-list
24440492|NCT00283335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440493|NCT00283335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24440518|NCT00283543|Alkylating Agents|alkylating agents|mesh-ancestor
24440519|NCT00283543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440520|NCT00283543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440521|NCT00283556|Irinotecan|irinotecan|mesh-list
24440522|NCT00283556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24440523|NCT00283556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24440524|NCT00283556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24440525|NCT00283556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440526|NCT00283556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440527|NCT00283621|Doxorubicin|doxorubicin|mesh-list
24440528|NCT00283621|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24440529|NCT00283621|Ifosfamide|ifosfamide|mesh-list
24440530|NCT00283621|Darbepoetin alfa|darbepoetin alfa|mesh-list
24440531|NCT00283621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24440532|NCT00283621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440533|NCT00283621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24440534|NCT00283621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24440535|NCT00283621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24440536|NCT00283621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440537|NCT00283621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24440538|NCT00283621|Alkylating Agents|alkylating agents|mesh-ancestor
24440539|NCT00283621|Hematinics|hematinics|mesh-ancestor
24440540|NCT00283634|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24440541|NCT00283634|Bortezomib|bortezomib|mesh-list
24440549|NCT00283660|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24448964|NCT00313690|Docetaxel|docetaxel|mesh-list
24440804|NCT00284791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24440805|NCT00284791|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24440806|NCT00284791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24440825|NCT00284947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24440826|NCT00284947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440827|NCT00284947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24440828|NCT00284947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440829|NCT00284947|Antiemetics|antiemetics|mesh-ancestor
25125863|NCT03066115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125864|NCT03066115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125865|NCT03066115|Antioxidants|antioxidants|mesh-ancestor
25125866|NCT03066115|Protective Agents|protective agents|mesh-ancestor
25125867|NCT03066115|Vitamins|vitamins|mesh-ancestor
25125868|NCT03066115|Micronutrients|micronutrients|mesh-ancestor
25125869|NCT03066154|Ritonavir|ritonavir|mesh-list
25125870|NCT03066154|Docetaxel|docetaxel|mesh-list
25125871|NCT03066154|Androgens|androgens|mesh-list
25125872|NCT03066154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125873|NCT03066154|Tubulin Modulators|tubulin modulators|mesh-ancestor
25125874|NCT03066154|Antimitotic Agents|antimitotic agents|mesh-ancestor
25125875|NCT03066154|Mitosis Modulators|mitosis modulators|mesh-ancestor
25125876|NCT03066154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125877|NCT03066154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25125878|NCT03066154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25125879|NCT03066154|Protease Inhibitors|protease inhibitors|mesh-ancestor
25125880|NCT03066154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125882|NCT03066154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25125883|NCT03066154|Antiviral Agents|antiviral agents|mesh-ancestor
25125884|NCT03066154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25125885|NCT03066154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25125886|NCT03066154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25125887|NCT03066154|Hormones|hormones|mesh-ancestor
25125888|NCT03066154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25682209|NCT01876732|Vitamins|vitamins|mesh-ancestor
25125889|NCT03066154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440902|NCT00285298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24440903|NCT00285298|Antioxidants|antioxidants|mesh-ancestor
24440904|NCT00285350|Mycophenolic Acid|mycophenolic acid|mesh-list
24441266|NCT00286871|Immunologic Factors|immunologic factors|mesh-ancestor
24440905|NCT00285350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24440906|NCT00285350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440907|NCT00285350|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24440908|NCT00285350|Antitubercular Agents|antitubercular agents|mesh-ancestor
24440909|NCT00285350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24440910|NCT00285350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24440911|NCT00285350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24440912|NCT00285350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440913|NCT00285376|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
24440914|NCT00285376|Antidepressive Agents|antidepressive agents|mesh-ancestor
24440915|NCT00285376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24440916|NCT00285376|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24440917|NCT00285376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24440918|NCT00285376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24440919|NCT00285376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440944|NCT00285389|Autonomic Agents|autonomic agents|mesh-ancestor
24440950|NCT00285389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24440951|NCT00285389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25125899|NCT03065868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25125900|NCT03065868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25125902|NCT03066011|Posaconazole|posaconazole|mesh-list
25125903|NCT03066011|Isavuconazole|isavuconazole|mesh-list
25125904|NCT03066011|Antifungal Agents|antifungal agents|mesh-ancestor
25125905|NCT03066011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25125906|NCT03066011|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25125907|NCT03066011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25125908|NCT03066011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125909|NCT03066011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125910|NCT03066011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24440952|NCT00285389|Tubulin Modulators|tubulin modulators|mesh-ancestor
24440953|NCT00285389|Antimitotic Agents|antimitotic agents|mesh-ancestor
24440954|NCT00285389|Mitosis Modulators|mitosis modulators|mesh-ancestor
24440955|NCT00285389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24440956|NCT00285389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24441021|NCT00285727|Dopamine Agents|dopamine agents|mesh-ancestor
24441022|NCT00285727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24441180|NCT00286312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24441181|NCT00286312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24441182|NCT00286312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441183|NCT00286351|Goserelin|goserelin|mesh-list
24441184|NCT00286351|Anastrozole|anastrozole|mesh-list
24441185|NCT00286351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24441186|NCT00286351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125914|NCT03066011|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25125916|NCT03066011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25125917|NCT03066011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25125918|NCT03065998|Baclofen|baclofen|mesh-list
25125919|NCT03065998|Opipramol|opipramol|mesh-list
25125920|NCT03065998|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25125921|NCT03065998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441207|NCT00286403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24441208|NCT00286403|Vasodilator Agents|vasodilator agents|mesh-ancestor
24441209|NCT00286403|Dopamine Agonists|dopamine agonists|mesh-ancestor
24441210|NCT00286403|Dopamine Agents|dopamine agents|mesh-ancestor
24441211|NCT00286403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24441212|NCT00286403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441213|NCT00286416|Omalizumab|omalizumab|mesh-list
24441214|NCT00286416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24441215|NCT00286416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24441216|NCT00286416|Respiratory System Agents|respiratory system agents|mesh-ancestor
24441217|NCT00286481|Simvastatin|simvastatin|mesh-list
24441218|NCT00286481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24441219|NCT00286481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24441220|NCT00286481|Antimetabolites|antimetabolites|mesh-ancestor
24441260|NCT00286780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441261|NCT00286780|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
24441262|NCT00286780|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
24441263|NCT00286780|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24441264|NCT00286871|Tacrolimus|tacrolimus|mesh-list
24441265|NCT00286871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24441267|NCT00286871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441278|NCT00286936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24441279|NCT00286936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441280|NCT00286936|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24441281|NCT00286936|GABA Agonists|gaba agonists|mesh-ancestor
24441282|NCT00286936|GABA Agents|gaba agents|mesh-ancestor
24441283|NCT00286936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24441284|NCT00286936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441285|NCT00286962|Insulin|insulin|mesh-list
24441319|NCT00287157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24441320|NCT00287157|Adrenergic Agents|adrenergic agents|mesh-ancestor
24441321|NCT00287157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24441322|NCT00287157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441323|NCT00287170|Calcitriol|calcitriol|mesh-list
24441324|NCT00287170|Mercaptopurine|mercaptopurine|mesh-list
24441325|NCT00287170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24441326|NCT00287170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441331|NCT00287170|Vitamins|vitamins|mesh-ancestor
24441350|NCT00287209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441359|NCT00287300|Pyrimethamine|pyrimethamine|mesh-list
24441360|NCT00287300|Sulfadoxine|sulfadoxine|mesh-list
24441361|NCT00287300|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24441362|NCT00287300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24441363|NCT00287300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24441364|NCT00287300|Antimalarials|antimalarials|mesh-ancestor
25125923|NCT03065998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125924|NCT03065998|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25125926|NCT03065998|GABA Agents|gaba agents|mesh-ancestor
25125927|NCT03065998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25125928|NCT03065998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125929|NCT03065998|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24394040|NCT00131768|Hylan|hylan|mesh-list
24441365|NCT00287300|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24441366|NCT00287300|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24441367|NCT00287300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441368|NCT00287300|Antiviral Agents|antiviral agents|mesh-ancestor
24441377|NCT00287313|Vitamin K|vitamin k|mesh-list
24460427|NCT00348413|Prednisolone phosphate|prednisolone phosphate|mesh-list
24460428|NCT00348413|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24460429|NCT00348413|Abortifacient Agents|abortifacient agents|mesh-ancestor
24460430|NCT00348413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24441379|NCT00287313|Micronutrients|micronutrients|mesh-ancestor
24441380|NCT00287313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441431|NCT00287352|Sensory System Agents|sensory system agents|mesh-ancestor
24441433|NCT00287378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24441451|NCT00287456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441452|NCT00287495|Sorafenib|sorafenib|mesh-list
24441453|NCT00287495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441454|NCT00287495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24441455|NCT00287495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441456|NCT00287495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441457|NCT00287521|Timolol|timolol|mesh-list
24441463|NCT00287521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441464|NCT00287521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441465|NCT00287521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24441466|NCT00287521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24441467|NCT00287521|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24441468|NCT00287521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24441469|NCT00287534|Tamoxifen|tamoxifen|mesh-list
24441470|NCT00287534|Anastrozole|anastrozole|mesh-list
24441471|NCT00287534|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24441472|NCT00287534|Hormone Antagonists|hormone antagonists|mesh-ancestor
24441473|NCT00287534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24441474|NCT00287534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441475|NCT00287534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24441476|NCT00287534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441558|NCT00287820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24441559|NCT00287820|Serotonin Agents|serotonin agents|mesh-ancestor
24441563|NCT00287820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25682210|NCT01876732|Micronutrients|micronutrients|mesh-ancestor
24441564|NCT00287820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24441637|NCT00287950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441638|NCT00287950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24441639|NCT00287950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24441683|NCT00288002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24441684|NCT00288002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24441717|NCT00288171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24441718|NCT00288171|Antioxidants|antioxidants|mesh-ancestor
25125930|NCT03065998|Antidepressive Agents|antidepressive agents|mesh-ancestor
25125931|NCT03065998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25125932|NCT03065998|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25125933|NCT03065998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25078233|NCT03358017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441719|NCT00288171|Protective Agents|protective agents|mesh-ancestor
24441721|NCT00288184|Allopurinol|allopurinol|mesh-list
24441730|NCT00288184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441731|NCT00288197|Voriconazole|voriconazole|mesh-list
24441794|NCT00288379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24441795|NCT00288379|Respiratory System Agents|respiratory system agents|mesh-ancestor
24441796|NCT00288379|Glucocorticoids|glucocorticoids|mesh-ancestor
24441797|NCT00288379|Hormones|hormones|mesh-ancestor
24441798|NCT00288379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24441799|NCT00288379|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24441800|NCT00288379|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24441801|NCT00288379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24441802|NCT00288379|Adrenergic Agents|adrenergic agents|mesh-ancestor
24441905|NCT00288782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441906|NCT00288782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441907|NCT00288782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24441908|NCT00288782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24441909|NCT00288782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24441910|NCT00288782|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24441912|NCT00288782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24441913|NCT00288782|Adrenergic Agents|adrenergic agents|mesh-ancestor
24441914|NCT00288782|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24441915|NCT00288782|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24441916|NCT00288782|Serotonin Agents|serotonin agents|mesh-ancestor
24441917|NCT00288782|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24441918|NCT00288873|Cholecalciferol|cholecalciferol|mesh-list
24442040|NCT00289601|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24442041|NCT00289627|Ipilimumab|ipilimumab|mesh-list
24442042|NCT00289627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24442043|NCT00289627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442044|NCT00289627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24442045|NCT00289627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442046|NCT00289809|Ifosfamide|ifosfamide|mesh-list
24442047|NCT00289809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24442048|NCT00289809|Alkylating Agents|alkylating agents|mesh-ancestor
24442049|NCT00289809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442050|NCT00289809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442051|NCT00289835|Paclitaxel|paclitaxel|mesh-list
24442052|NCT00289835|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24460435|NCT00348413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442053|NCT00289835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24442054|NCT00289835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442055|NCT00289835|Tubulin Modulators|tubulin modulators|mesh-ancestor
24442056|NCT00289835|Antimitotic Agents|antimitotic agents|mesh-ancestor
24442098|NCT00290030|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24442099|NCT00290030|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24442100|NCT00290030|Adrenergic Agents|adrenergic agents|mesh-ancestor
24442453|NCT00291109|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24460445|NCT00348413|Autonomic Agents|autonomic agents|mesh-ancestor
24442610|NCT00291785|Folic Acid|folic acid|mesh-list
24442611|NCT00291785|Fluorouracil|fluorouracil|mesh-list
24442612|NCT00291785|Levoleucovorin|levoleucovorin|mesh-list
25125936|NCT03065816|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
25125938|NCT03065816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125940|NCT03065764|Pembrolizumab|pembrolizumab|mesh-list
25125941|NCT03065764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25125942|NCT03065764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125943|NCT03065504|Turmeric extract|turmeric extract|mesh-list
25682211|NCT01876732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682213|NCT01876732|Hematinics|hematinics|mesh-ancestor
25125944|NCT03065504|Antioxidants|antioxidants|mesh-ancestor
25125945|NCT03065504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125946|NCT03065504|Protective Agents|protective agents|mesh-ancestor
25125947|NCT03065504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442613|NCT00291785|Antimetabolites|antimetabolites|mesh-ancestor
24442614|NCT00291785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442615|NCT00291785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24442616|NCT00291785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442647|NCT00291915|Adalimumab|adalimumab|mesh-list
24442648|NCT00291915|Methotrexate|methotrexate|mesh-list
24442649|NCT00291915|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24442650|NCT00291915|Abortifacient Agents|abortifacient agents|mesh-ancestor
24442651|NCT00291915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24442652|NCT00291915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442653|NCT00291915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24442654|NCT00291915|Antimetabolites|antimetabolites|mesh-ancestor
24442656|NCT00291915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442772|NCT00292695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442773|NCT00292708|Cefmetazole|cefmetazole|mesh-list
24442774|NCT00292708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24442775|NCT00292708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24442776|NCT00292721|Celecoxib|celecoxib|mesh-list
24442777|NCT00292721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24442843|NCT00292929|Antimalarials|antimalarials|mesh-ancestor
24442844|NCT00292929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25125980|NCT03065660|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25125981|NCT03065309|Remifentanil|remifentanil|mesh-list
25125982|NCT03065309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25125983|NCT03065309|Narcotics|narcotics|mesh-ancestor
25125984|NCT03065309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25125985|NCT03065309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125986|NCT03065309|Analgesics|analgesics|mesh-ancestor
25125987|NCT03065309|Sensory System Agents|sensory system agents|mesh-ancestor
25125988|NCT03065309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125989|NCT03064984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25682214|NCT01876810|Gemfibrozil|gemfibrozil|mesh-list
25682215|NCT01876810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25682216|NCT01876810|Antimetabolites|antimetabolites|mesh-ancestor
25682217|NCT01876810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682218|NCT01876810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25682219|NCT01876810|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24460461|NCT00348439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460463|NCT00348452|Tramadol|tramadol|mesh-list
25125993|NCT03064633|Dexamethasone|dexamethasone|mesh-list
25125994|NCT03064633|Dexamethasone acetate|dexamethasone acetate|mesh-list
25125995|NCT03064633|Dexmedetomidine|dexmedetomidine|mesh-list
25125996|NCT03064633|Bupivacaine|bupivacaine|mesh-list
25125997|NCT03064633|BB 1101|bb 1101|mesh-list
25125998|NCT03064633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25125999|NCT03064633|Antiemetics|antiemetics|mesh-ancestor
25126000|NCT03064633|Autonomic Agents|autonomic agents|mesh-ancestor
25126001|NCT03064633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25126002|NCT03064633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126003|NCT03064633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24443104|NCT00293657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24443106|NCT00293657|Analgesics|analgesics|mesh-ancestor
24437844|NCT00274560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25126004|NCT03064633|Glucocorticoids|glucocorticoids|mesh-ancestor
25126005|NCT03064633|Hormones|hormones|mesh-ancestor
25126006|NCT03064633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25126007|NCT03064633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25126008|NCT03064633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25126009|NCT03064633|Protease Inhibitors|protease inhibitors|mesh-ancestor
25126010|NCT03064633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126011|NCT03064633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126012|NCT03064633|Anesthetics, Local|anesthetics, local|mesh-ancestor
25126013|NCT03064633|Anesthetics|anesthetics|mesh-ancestor
25126014|NCT03064633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25126015|NCT03064633|Sensory System Agents|sensory system agents|mesh-ancestor
25126018|NCT03064633|Analgesics|analgesics|mesh-ancestor
25126019|NCT03064633|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25126020|NCT03064633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25126021|NCT03064633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24955915|NCT03859921|Hormones|hormones|mesh-ancestor
24460483|NCT00348491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126038|NCT03064282|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25126039|NCT03064282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126040|NCT03064282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955922|NCT03859583|Antipruritics|antipruritics|mesh-ancestor
24460486|NCT00348491|Analgesics|analgesics|mesh-ancestor
24460487|NCT00348491|Sensory System Agents|sensory system agents|mesh-ancestor
24425919|NCT00234845|Adalimumab|adalimumab|mesh-list
24438189|NCT00275106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24438190|NCT00275106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24460489|NCT00348491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460490|NCT00348491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24460491|NCT00348491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25126041|NCT03064282|Vasodilator Agents|vasodilator agents|mesh-ancestor
25126042|NCT03064282|Urological Agents|urological agents|mesh-ancestor
25126043|NCT03064191|Calcium, Dietary|calcium, dietary|mesh-list
25126044|NCT03064191|Chlorhexidine|chlorhexidine|mesh-list
25126046|NCT03064191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25126047|NCT03064191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126048|NCT03064191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25126049|NCT03064191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25126050|NCT03064191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25126051|NCT03064191|Disinfectants|disinfectants|mesh-ancestor
25126052|NCT03064165|Epinephrine|epinephrine|mesh-list
25126053|NCT03064165|Bupivacaine|bupivacaine|mesh-list
25126054|NCT03064165|Anesthetics, Local|anesthetics, local|mesh-ancestor
24552198|NCT04042935|Vitamins|vitamins|mesh-ancestor
24460503|NCT00348504|Autonomic Agents|autonomic agents|mesh-ancestor
24460504|NCT00348504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24426347|NCT00235885|Adalimumab|adalimumab|mesh-list
25126064|NCT03064165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126065|NCT03064165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25126066|NCT03064165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24791427|NCT04411953|Haloperidol|haloperidol|mesh-list
25126067|NCT03064165|Autonomic Agents|autonomic agents|mesh-ancestor
25126068|NCT03064165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24443309|NCT00294463|Hormones|hormones|mesh-ancestor
24460559|NCT00348764|Polidocanol|polidocanol|mesh-list
24460560|NCT00348764|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
24460561|NCT00348764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24460563|NCT00348894|Antidepressive Agents|antidepressive agents|mesh-ancestor
24460564|NCT00348894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24460565|NCT00348894|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24409383|NCT00181896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460566|NCT00348894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25405373|NCT03609216|Antimetabolites|antimetabolites|mesh-ancestor
24552434|NCT03068624|Aldesleukin|aldesleukin|mesh-list
24443502|NCT00295282|Immunologic Factors|immunologic factors|mesh-ancestor
25126069|NCT03064165|Respiratory System Agents|respiratory system agents|mesh-ancestor
25126070|NCT03064165|Mydriatics|mydriatics|mesh-ancestor
25126071|NCT03064165|Sympathomimetics|sympathomimetics|mesh-ancestor
25126072|NCT03064165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25126074|NCT03064295|Regadenoson|regadenoson|mesh-list
25126075|NCT03064295|Analgesics|analgesics|mesh-ancestor
25126076|NCT03064295|Sensory System Agents|sensory system agents|mesh-ancestor
25126077|NCT03064295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25126078|NCT03064295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126079|NCT03064295|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25126080|NCT03064295|Vasodilator Agents|vasodilator agents|mesh-ancestor
25126081|NCT03064295|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25126082|NCT03064295|Purinergic Agonists|purinergic agonists|mesh-ancestor
25126083|NCT03064295|Purinergic Agents|purinergic agents|mesh-ancestor
25126084|NCT03064295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25126085|NCT03064295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126086|NCT03064295|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
24460816|NCT00349583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460818|NCT00349583|Immunologic Factors|immunologic factors|mesh-ancestor
24460819|NCT00349583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460825|NCT00349596|Decitabine|decitabine|mesh-list
24460826|NCT00349596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24460827|NCT00349596|Antimetabolites|antimetabolites|mesh-ancestor
24460828|NCT00349596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460831|NCT00349635|Metformin|metformin|mesh-list
24460850|NCT00349674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460851|NCT00349674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24460852|NCT00349674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24460853|NCT00349674|Immunologic Factors|immunologic factors|mesh-ancestor
24460854|NCT00349674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25277074|NCT02360644|Vitamins|vitamins|mesh-ancestor
25277075|NCT02360644|Micronutrients|micronutrients|mesh-ancestor
25277076|NCT02360644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277077|NCT02360644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25277078|NCT02360644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25277079|NCT02360501|Docetaxel|docetaxel|mesh-list
25277080|NCT02360501|Capecitabine|capecitabine|mesh-list
25277081|NCT02360501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25277082|NCT02360501|Tubulin Modulators|tubulin modulators|mesh-ancestor
25277083|NCT02360501|Antimitotic Agents|antimitotic agents|mesh-ancestor
25277084|NCT02360501|Mitosis Modulators|mitosis modulators|mesh-ancestor
25277087|NCT02360501|Antimetabolites|antimetabolites|mesh-ancestor
25126087|NCT03064243|Apatinib|apatinib|mesh-list
25126088|NCT03064243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25126089|NCT03064243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25126090|NCT03064243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126093|NCT03063983|Methotrexate|methotrexate|mesh-list
25126094|NCT03063983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25126095|NCT03063983|Immunologic Factors|immunologic factors|mesh-ancestor
25126096|NCT03063983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126097|NCT03063983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25126098|NCT03063983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25126099|NCT03063983|Alkylating Agents|alkylating agents|mesh-ancestor
24460927|NCT00350168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24460962|NCT00350311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24460963|NCT00350311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460964|NCT00350311|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24460965|NCT00350311|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24460966|NCT00350311|Cholinergic Agents|cholinergic agents|mesh-ancestor
24460967|NCT00350311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24460968|NCT00350311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460969|NCT00350415|Mesalamine|mesalamine|mesh-list
24461024|NCT00350480|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24461025|NCT00350480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24461026|NCT00350480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461027|NCT00350597|Molgramostim|molgramostim|mesh-list
24461028|NCT00350597|Sargramostim|sargramostim|mesh-list
24461029|NCT00350597|Immunologic Factors|immunologic factors|mesh-ancestor
25682220|NCT01876810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25682221|NCT01876810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25682222|NCT01876823|Memantine|memantine|mesh-list
25682223|NCT01876823|Citalopram|citalopram|mesh-list
25682224|NCT01876823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25682225|NCT01876823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25682226|NCT01876823|Dopamine Agents|dopamine agents|mesh-ancestor
25682227|NCT01876823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25682228|NCT01876823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682229|NCT01876823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682230|NCT01876823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25277117|NCT02360592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277118|NCT02360592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25277120|NCT02360592|Sensory System Agents|sensory system agents|mesh-ancestor
25277121|NCT02360592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25277122|NCT02360384|Linaclotide|linaclotide|mesh-list
25277123|NCT02360384|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25277124|NCT02360384|Enzyme Activators|enzyme activators|mesh-ancestor
25158104|NCT04497142|Levetiracetam|levetiracetam|mesh-list
24461074|NCT00350948|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25126100|NCT03063983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126101|NCT03063983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25126103|NCT03063983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25126104|NCT03063983|Abortifacient Agents|abortifacient agents|mesh-ancestor
25126105|NCT03063983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25126106|NCT03063983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25126107|NCT03063983|Antimetabolites|antimetabolites|mesh-ancestor
25126108|NCT03063983|Dermatologic Agents|dermatologic agents|mesh-ancestor
25126109|NCT03063983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126110|NCT03063983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25126111|NCT03063983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25126112|NCT03064035|Thrombin|thrombin|mesh-list
25126113|NCT03064035|Hemostatics|hemostatics|mesh-ancestor
25126114|NCT03064035|Coagulants|coagulants|mesh-ancestor
24461093|NCT00350961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461095|NCT00351026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24461096|NCT00351026|Narcotics|narcotics|mesh-ancestor
24461097|NCT00351026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24461147|NCT00351130|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24461148|NCT00351130|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24461149|NCT00351143|Fluticasone|fluticasone|mesh-list
24461151|NCT00351143|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24461152|NCT00351143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24461153|NCT00351143|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24461154|NCT00351143|Autonomic Agents|autonomic agents|mesh-ancestor
25682231|NCT01876823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25682232|NCT01876823|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25682233|NCT01876823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25682234|NCT01876823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25682235|NCT01876823|Serotonin Agents|serotonin agents|mesh-ancestor
25682236|NCT01876823|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25682237|NCT01876823|Antidepressive Agents|antidepressive agents|mesh-ancestor
25682238|NCT01876823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25682239|NCT01876992|Metformin|metformin|mesh-list
25682240|NCT01876992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25126115|NCT03063762|Bevacizumab|bevacizumab|mesh-list
25126116|NCT03063762|Atezolizumab|atezolizumab|mesh-list
25126117|NCT03063762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25126118|NCT03063762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25126119|NCT03063762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25126120|NCT03063762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25126121|NCT03063762|Growth Substances|growth substances|mesh-ancestor
25126122|NCT03063762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126123|NCT03063762|Growth Inhibitors|growth inhibitors|mesh-ancestor
25126124|NCT03063892|Tranexamic Acid|tranexamic acid|mesh-list
25126125|NCT03063892|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25126126|NCT03063892|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25126127|NCT03063892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126128|NCT03063892|Hemostatics|hemostatics|mesh-ancestor
25126129|NCT03063892|Coagulants|coagulants|mesh-ancestor
25126130|NCT03063905|Buprenorphine|buprenorphine|mesh-list
25126131|NCT03063905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25126132|NCT03063905|Narcotics|narcotics|mesh-ancestor
25126133|NCT03063905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25126134|NCT03063905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126135|NCT03063905|Analgesics|analgesics|mesh-ancestor
25126136|NCT03063905|Sensory System Agents|sensory system agents|mesh-ancestor
24461197|NCT00351195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24461198|NCT00351195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24461199|NCT00351195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461200|NCT00351286|Simvastatin|simvastatin|mesh-list
24461225|NCT00351507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24639359|NCT01161186|Paclitaxel|paclitaxel|mesh-list
24461226|NCT00351507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461227|NCT00351507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25126137|NCT03063905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25126138|NCT03063905|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25126139|NCT03063710|Olaparib|olaparib|mesh-list
25045747|NCT00917826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25126140|NCT03063710|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25126141|NCT03063710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126142|NCT03063710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126143|NCT03063710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25126144|NCT03063775|Fibrin Foam|fibrin foam|mesh-list
25126145|NCT03063775|Hemostatics|hemostatics|mesh-ancestor
25126146|NCT03063775|Coagulants|coagulants|mesh-ancestor
25126147|NCT03063879|Sofosbuvir|sofosbuvir|mesh-list
25126148|NCT03063879|Antiviral Agents|antiviral agents|mesh-ancestor
25126149|NCT03063879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24900723|NCT04391621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25277180|NCT02359721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25277181|NCT02359721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25277182|NCT02359721|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25277183|NCT02359721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277184|NCT02359721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277185|NCT02359721|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25277186|NCT02359721|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25126150|NCT03063580|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25126151|NCT03063580|Rifampin|rifampin|mesh-list
25126152|NCT03063580|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25126153|NCT03063580|Antitubercular Agents|antitubercular agents|mesh-ancestor
25126154|NCT03063580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25126155|NCT03063580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25126156|NCT03063580|Leprostatic Agents|leprostatic agents|mesh-ancestor
25126157|NCT03063580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25126158|NCT03063580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126159|NCT03063580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550800|NCT00722488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550801|NCT00722488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126160|NCT03063580|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25126161|NCT03063580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25126162|NCT03063580|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25126163|NCT03063580|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25126164|NCT03063580|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25126165|NCT03063580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25126166|NCT03063580|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25126168|NCT03063580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126170|NCT03063541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25126171|NCT03063541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25126172|NCT03063541|Analgesics|analgesics|mesh-ancestor
25126173|NCT03063541|Sensory System Agents|sensory system agents|mesh-ancestor
24956015|NCT03858465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24550803|NCT00722579|Chromium|chromium|mesh-list
24550804|NCT00722579|Trace Elements|trace elements|mesh-ancestor
24550805|NCT00722579|Micronutrients|micronutrients|mesh-ancestor
24550806|NCT00722579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550807|NCT00722631|Pioglitazone|pioglitazone|mesh-list
24550810|NCT00722631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682241|NCT01876992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682242|NCT01877083|Lenvatinib|lenvatinib|mesh-list
25682243|NCT01877083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682244|NCT01877083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25682245|NCT01877083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25682246|NCT01877083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682247|NCT01877187|Ethiodized Oil|ethiodized oil|mesh-list
25682248|NCT01877187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682249|NCT01877538|Donepezil|donepezil|mesh-list
24550937|NCT00723268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550938|NCT00723307|Metformin|metformin|mesh-list
24550939|NCT00723307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24550940|NCT00723307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550941|NCT00723320|Atorvastatin|atorvastatin|mesh-list
24551017|NCT00723658|Immunologic Factors|immunologic factors|mesh-ancestor
24551018|NCT00723658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551019|NCT00723658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24551020|NCT00723658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24551021|NCT00723658|Alkylating Agents|alkylating agents|mesh-ancestor
24551022|NCT00723658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551023|NCT00723658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24551024|NCT00723658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24551025|NCT00723658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24551030|NCT00723658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24551102|NCT00724022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24551103|NCT00724022|Glucocorticoids|glucocorticoids|mesh-ancestor
24551104|NCT00724022|Hormones|hormones|mesh-ancestor
24551105|NCT00724022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24551106|NCT00724022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24551107|NCT00724022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24551108|NCT00724022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24551109|NCT00724022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24551110|NCT00724022|Antitubercular Agents|antitubercular agents|mesh-ancestor
24551111|NCT00724022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24551112|NCT00724022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24551113|NCT00724035|Fentanyl|fentanyl|mesh-list
24551114|NCT00724035|Midazolam|midazolam|mesh-list
24551115|NCT00724035|Analgesics|analgesics|mesh-list
24551116|NCT00724035|Anesthetics|anesthetics|mesh-list
25126174|NCT03063541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25126175|NCT03063541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126176|NCT03063541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25126177|NCT03063541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25126178|NCT03063541|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25126179|NCT03063541|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25126180|NCT03063541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126181|NCT03063541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25126182|NCT03063541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25126183|NCT03063541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126184|NCT03063541|Antipyretics|antipyretics|mesh-ancestor
25126185|NCT03063723|Sofosbuvir|sofosbuvir|mesh-list
24552349|NCT03504241|Antifungal Agents|antifungal agents|mesh-ancestor
25126186|NCT03063723|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25126187|NCT03063723|Ledipasvir|ledipasvir|mesh-list
25126188|NCT03063723|Antiviral Agents|antiviral agents|mesh-ancestor
25126189|NCT03063723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25126190|NCT03063671|Dexmedetomidine|dexmedetomidine|mesh-list
25126191|NCT03063671|Ketamine|ketamine|mesh-list
25126192|NCT03063671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25126193|NCT03063671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25126194|NCT03063671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126195|NCT03063671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25126196|NCT03063671|Analgesics|analgesics|mesh-ancestor
25126197|NCT03063671|Sensory System Agents|sensory system agents|mesh-ancestor
25126229|NCT03063658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126230|NCT03063658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25126231|NCT03063658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25126232|NCT03063658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25126233|NCT03063658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126234|NCT03063658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551117|NCT00724035|Ropivacaine|ropivacaine|mesh-list
24551118|NCT00724035|Anesthetics, Local|anesthetics, local|mesh-list
24551280|NCT00724880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24551281|NCT00724880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551282|NCT00724880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551284|NCT00725036|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24551285|NCT00725036|Insulin Aspart|insulin aspart|mesh-list
24551286|NCT00725036|Isophane Insulin, Human|isophane insulin, human|mesh-list
24551460|NCT00726700|Glucocorticoids|glucocorticoids|mesh-ancestor
24551461|NCT00726700|Hormones|hormones|mesh-ancestor
24551462|NCT00726700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24551463|NCT00726700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25277219|NCT02359370|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25277220|NCT02359448|Melatonin|melatonin|mesh-list
25158148|NCT04453839|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
25158149|NCT04453839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25158150|NCT04453839|Vasodilator Agents|vasodilator agents|mesh-ancestor
24843097|NCT02225652|Paclitaxel|paclitaxel|mesh-list
24437914|NCT00274690|Casopitant|casopitant|mesh-list
24551464|NCT00726700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24551465|NCT00726700|Tubulin Modulators|tubulin modulators|mesh-ancestor
24551466|NCT00726700|Antimitotic Agents|antimitotic agents|mesh-ancestor
24551757|NCT05065567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24551758|NCT05065567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551759|NCT05065567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24551760|NCT05065567|Antipruritics|antipruritics|mesh-ancestor
24551761|NCT05065567|Dermatologic Agents|dermatologic agents|mesh-ancestor
24551762|NCT05065567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24551763|NCT05065567|Serotonin Agents|serotonin agents|mesh-ancestor
24551764|NCT05065567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24551765|NCT05065567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551766|NCT05065567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24551767|NCT05065567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24551768|NCT05065567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24551769|NCT05065567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24551770|NCT05065567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24551771|NCT05065567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24551772|NCT05065567|Dopamine Agents|dopamine agents|mesh-ancestor
24551773|NCT05065567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24551797|NCT04984811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24551798|NCT04961528|Terlipressin|terlipressin|mesh-list
24900724|NCT04391621|Glucocorticoids|glucocorticoids|mesh-ancestor
24551799|NCT04961528|Tranexamic Acid|tranexamic acid|mesh-list
24551800|NCT04961528|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24551801|NCT04961528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24551802|NCT04961528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551803|NCT04961528|Hemostatics|hemostatics|mesh-ancestor
24551804|NCT04961528|Coagulants|coagulants|mesh-ancestor
24551805|NCT04961528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24551806|NCT04961528|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24551870|NCT04800224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24551872|NCT04781972|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24551873|NCT04781972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551874|NCT04781972|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24551875|NCT04781972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24551876|NCT04781972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24551877|NCT04781972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552007|NCT04254627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552008|NCT04254627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24552009|NCT04254627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24552010|NCT04254627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24552017|NCT04254627|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24552020|NCT04254627|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24552022|NCT04254627|Hormone Antagonists|hormone antagonists|mesh-ancestor
24552023|NCT04254627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24552024|NCT04254627|Luteolytic Agents|luteolytic agents|mesh-ancestor
24552088|NCT04183062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552089|NCT04183062|Tubulin Modulators|tubulin modulators|mesh-ancestor
24552090|NCT04183062|Antimitotic Agents|antimitotic agents|mesh-ancestor
24552091|NCT04183062|Mitosis Modulators|mitosis modulators|mesh-ancestor
24552092|NCT04176419|Acetaminophen|acetaminophen|mesh-list
24552093|NCT04176419|Celecoxib|celecoxib|mesh-list
24552094|NCT04176419|Lidocaine|lidocaine|mesh-list
24552095|NCT04176419|Ketamine|ketamine|mesh-list
24552096|NCT04176419|Gabapentin|gabapentin|mesh-list
24552099|NCT04176419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24458517|NCT00338247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458518|NCT00338273|Aripiprazole|aripiprazole|mesh-list
24458519|NCT00338273|Antidepressive Agents|antidepressive agents|mesh-ancestor
24458520|NCT00338273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24458521|NCT00338273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25682250|NCT01877538|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25682251|NCT01877538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25682252|NCT01877538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682253|NCT01877538|Cholinergic Agents|cholinergic agents|mesh-ancestor
25682254|NCT01877538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25158158|NCT04445025|Leuprolide|leuprolide|mesh-list
25158159|NCT04445025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25158160|NCT04445025|Fertility Agents|fertility agents|mesh-ancestor
25158161|NCT04445025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25158162|NCT04445025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25158163|NCT04445025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25158164|NCT04445025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25158177|NCT04432974|Anesthetics|anesthetics|mesh-list
25158178|NCT04432974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24639915|NCT01164826|Nabumetone|nabumetone|mesh-list
25158179|NCT04432974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25158180|NCT04431258|Folfirinox|folfirinox|mesh-list
25158181|NCT04431258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458522|NCT00338273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24552100|NCT04176419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552101|NCT04176419|Sensory System Agents|sensory system agents|mesh-ancestor
24552102|NCT04176419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24552103|NCT04176419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24552105|NCT04176419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24552192|NCT04042935|Thioctic Acid|thioctic acid|mesh-list
24552193|NCT04042935|Antioxidants|antioxidants|mesh-ancestor
24552194|NCT04042935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552195|NCT04042935|Protective Agents|protective agents|mesh-ancestor
24552196|NCT04042935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126247|NCT03063827|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25126248|NCT03063827|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25126249|NCT03063827|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25126250|NCT03063827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25126251|NCT03063827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126252|NCT03063827|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25126253|NCT03063827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25126254|NCT03063827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126255|NCT03063827|Cholinergic Agents|cholinergic agents|mesh-ancestor
25126256|NCT03063827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25126257|NCT03063866|Fentanyl|fentanyl|mesh-list
25126258|NCT03063866|Midazolam|midazolam|mesh-list
25126259|NCT03063866|Propofol|propofol|mesh-list
25126260|NCT03063866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25126261|NCT03063866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25126262|NCT03063866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126263|NCT03063866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25126264|NCT03063866|Anesthetics, General|anesthetics, general|mesh-ancestor
25126265|NCT03063866|Anesthetics|anesthetics|mesh-ancestor
25126266|NCT03063866|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25126267|NCT03063866|Narcotics|narcotics|mesh-ancestor
24552197|NCT04042935|Vitamin B Complex|vitamin b complex|mesh-ancestor
24552256|NCT03728478|Etanercept|etanercept|mesh-list
24552257|NCT03728478|Methotrexate|methotrexate|mesh-list
24552258|NCT03728478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24552259|NCT03728478|Abortifacient Agents|abortifacient agents|mesh-ancestor
24552260|NCT03728478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24458523|NCT00338273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24552338|NCT03504241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24552339|NCT03504241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552340|NCT03504241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24552342|NCT03504241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24552343|NCT03504241|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24552344|NCT03504241|Antitubercular Agents|antitubercular agents|mesh-ancestor
24552345|NCT03504241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24552346|NCT03504241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25682255|NCT01877538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682256|NCT01877538|Nootropic Agents|nootropic agents|mesh-ancestor
25682257|NCT01877551|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
25682258|NCT01877551|Antiviral Agents|antiviral agents|mesh-ancestor
25682259|NCT01877551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25682260|NCT01877551|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25682261|NCT01877551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25682262|NCT01877642|Lorazepam|lorazepam|mesh-list
25682263|NCT01877642|Loxapine|loxapine|mesh-list
25682264|NCT01877642|Anticonvulsants|anticonvulsants|mesh-ancestor
25682265|NCT01877642|Antiemetics|antiemetics|mesh-ancestor
25682266|NCT01877642|Autonomic Agents|autonomic agents|mesh-ancestor
25682267|NCT01877642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25158216|NCT04396496|Daratumumab|daratumumab|mesh-list
25158217|NCT04396496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552347|NCT03504241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462016|NCT00354549|Antimetabolites|antimetabolites|mesh-ancestor
24552348|NCT03504241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552351|NCT03504241|Immunologic Factors|immunologic factors|mesh-ancestor
24552352|NCT03504241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24552353|NCT03504241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24552354|NCT03504241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24552388|NCT03491540|Amebicides|amebicides|mesh-ancestor
24552389|NCT03491540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24552390|NCT03491540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25126269|NCT03063866|Sensory System Agents|sensory system agents|mesh-ancestor
25126270|NCT03063866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25126271|NCT03063866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25126272|NCT03063866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25126273|NCT03063866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25126274|NCT03063866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25126275|NCT03063866|GABA Modulators|gaba modulators|mesh-ancestor
25126276|NCT03063866|GABA Agents|gaba agents|mesh-ancestor
25126277|NCT03063866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25126278|NCT03063866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126279|NCT03063515|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
25126280|NCT03063515|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25126281|NCT03063515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126282|NCT03063515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126283|NCT03063515|Cholinergic Agents|cholinergic agents|mesh-ancestor
25126284|NCT03063515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25126285|NCT03063515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803559|NCT01997099|Anesthetics|anesthetics|mesh-ancestor
24552391|NCT03491540|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
24552405|NCT03448666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24552406|NCT03448666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552407|NCT03401918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24552408|NCT03401918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24552409|NCT03355976|Nivolumab|nivolumab|mesh-list
24552410|NCT03355976|Ipilimumab|ipilimumab|mesh-list
24552420|NCT03222492|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24552421|NCT03222492|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24552422|NCT03222492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24552423|NCT03222492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552424|NCT03222492|Immunologic Factors|immunologic factors|mesh-ancestor
25682268|NCT01877642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682269|NCT01877642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25682270|NCT01877642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25682271|NCT01877642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25682272|NCT01877642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25682273|NCT01877642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25682274|NCT01877642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25682275|NCT01877642|GABA Modulators|gaba modulators|mesh-ancestor
25682276|NCT01877642|GABA Agents|gaba agents|mesh-ancestor
25682277|NCT01877642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25682278|NCT01877642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682279|NCT01877642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25682280|NCT01877642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25682281|NCT01877642|Dopamine Agents|dopamine agents|mesh-ancestor
25682282|NCT01877668|Adalimumab|adalimumab|mesh-list
24569662|NCT00801450|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25277298|NCT02358850|Acetaminophen|acetaminophen|mesh-list
25277299|NCT02358850|Oxycodone|oxycodone|mesh-list
25277300|NCT02358850|Hydromorphone|hydromorphone|mesh-list
25277301|NCT02358850|Hydrocodone|hydrocodone|mesh-list
25277302|NCT02358850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25277303|NCT02358850|Analgesics|analgesics|mesh-ancestor
25277304|NCT02358850|Sensory System Agents|sensory system agents|mesh-ancestor
24552425|NCT03222492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552427|NCT03164447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24552429|NCT03164447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24552431|NCT03149211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25126332|NCT03062800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25126333|NCT03062800|Immunologic Factors|immunologic factors|mesh-ancestor
25126334|NCT03062800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126335|NCT03062800|Leprostatic Agents|leprostatic agents|mesh-ancestor
25126336|NCT03062800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25126337|NCT03062800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25126338|NCT03062800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25126339|NCT03062800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25126340|NCT03062800|Growth Substances|growth substances|mesh-ancestor
25126341|NCT03062800|Growth Inhibitors|growth inhibitors|mesh-ancestor
25126342|NCT03062813|Entecavir|entecavir|mesh-list
25126343|NCT03062813|Tacrolimus|tacrolimus|mesh-list
25126344|NCT03062813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25126345|NCT03062813|Immunologic Factors|immunologic factors|mesh-ancestor
25126346|NCT03062813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126347|NCT03062813|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25126348|NCT03062813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126349|NCT03062813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126350|NCT03062813|Antiviral Agents|antiviral agents|mesh-ancestor
25126351|NCT03062813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25126352|NCT03062904|Methacholine Chloride|methacholine chloride|mesh-list
25126353|NCT03062904|Bronchodilator Agents|bronchodilator agents|mesh-list
25126354|NCT03062904|Miotics|miotics|mesh-ancestor
25126355|NCT03062904|Autonomic Agents|autonomic agents|mesh-ancestor
25126356|NCT03062904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25126366|NCT03062904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25682283|NCT01877668|Tofacitinib|tofacitinib|mesh-list
25682284|NCT01877668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25682285|NCT01877668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25682286|NCT01877668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25682287|NCT01877668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25682288|NCT01877668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682289|NCT01877915|Rivaroxaban|rivaroxaban|mesh-list
25682290|NCT01877915|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25682291|NCT01877915|Antithrombins|antithrombins|mesh-ancestor
25682292|NCT01877915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25682293|NCT01877915|Protease Inhibitors|protease inhibitors|mesh-ancestor
25682294|NCT01877915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25682295|NCT01877915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682296|NCT01877915|Anticoagulants|anticoagulants|mesh-ancestor
25682297|NCT01878006|Morphine|morphine|mesh-list
25682298|NCT01878006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25682299|NCT01878006|Narcotics|narcotics|mesh-ancestor
25682300|NCT01878006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25682301|NCT01878006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682302|NCT01878006|Analgesics|analgesics|mesh-ancestor
25682303|NCT01878006|Sensory System Agents|sensory system agents|mesh-ancestor
25682304|NCT01878006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682305|NCT01878292|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
25117214|NCT05374356|Anesthetics, Local|anesthetics, local|mesh-ancestor
25117215|NCT05374356|Anesthetics|anesthetics|mesh-ancestor
25117216|NCT05374356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25117217|NCT05374356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117218|NCT05374356|Sensory System Agents|sensory system agents|mesh-ancestor
25117219|NCT05374356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25117220|NCT05374356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25126367|NCT03062787|Triamcinolone|triamcinolone|mesh-list
25126368|NCT03062787|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25126369|NCT03062787|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25126370|NCT03062787|Hyaluronic Acid|hyaluronic acid|mesh-list
25126371|NCT03062787|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25126372|NCT03062787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25126373|NCT03062787|Glucocorticoids|glucocorticoids|mesh-ancestor
25126374|NCT03062787|Hormones|hormones|mesh-ancestor
25126375|NCT03062787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25126376|NCT03062787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126377|NCT03062787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25126378|NCT03062787|Immunologic Factors|immunologic factors|mesh-ancestor
25126379|NCT03062787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126380|NCT03062787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126381|NCT03062787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25126382|NCT03062787|Viscosupplements|viscosupplements|mesh-ancestor
25126383|NCT03062787|Protective Agents|protective agents|mesh-ancestor
25126384|NCT03063073|Dexmedetomidine|dexmedetomidine|mesh-list
25126385|NCT03063073|Bupivacaine|bupivacaine|mesh-list
25126386|NCT03063073|Anesthetics, Local|anesthetics, local|mesh-ancestor
25126387|NCT03063073|Anesthetics|anesthetics|mesh-ancestor
25126388|NCT03063073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25126389|NCT03063073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126390|NCT03063073|Sensory System Agents|sensory system agents|mesh-ancestor
25126391|NCT03063073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25126392|NCT03063073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24956194|NCT03856502|Hormones|hormones|mesh-ancestor
25126397|NCT03063073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25126398|NCT03063073|Adrenergic Agents|adrenergic agents|mesh-ancestor
25126399|NCT03063073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25126400|NCT03063073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126402|NCT03063112|Lidocaine|lidocaine|mesh-list
25126403|NCT03063112|Anesthetics, Local|anesthetics, local|mesh-ancestor
25126404|NCT03063112|Anesthetics|anesthetics|mesh-ancestor
25126405|NCT03063112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25126406|NCT03063112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126407|NCT03063112|Sensory System Agents|sensory system agents|mesh-ancestor
25126408|NCT03063112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25126409|NCT03063112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25126410|NCT03063112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25126411|NCT03063112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25126412|NCT03063112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25126413|NCT03063112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126414|NCT03063112|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25126415|NCT03063112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25126416|NCT03063060|Vitamin D|vitamin d|mesh-list
25126417|NCT03063060|Calcium|calcium|mesh-list
25126418|NCT03063060|Vitamins|vitamins|mesh-ancestor
25126419|NCT03063060|Micronutrients|micronutrients|mesh-ancestor
25126420|NCT03063060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126421|NCT03063060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25126422|NCT03063060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25126423|NCT03062644|Celecoxib|celecoxib|mesh-list
25126424|NCT03062644|Tramadol|tramadol|mesh-list
25126425|NCT03062644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25126426|NCT03062644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25126427|NCT03062644|Analgesics|analgesics|mesh-ancestor
25126428|NCT03062644|Sensory System Agents|sensory system agents|mesh-ancestor
25126429|NCT03062644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682306|NCT01878292|Antidepressive Agents|antidepressive agents|mesh-ancestor
25682307|NCT01878292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25682308|NCT01878292|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25682309|NCT01878292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25682310|NCT01878292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25682311|NCT01878292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529394|NCT00625898|Bevacizumab|bevacizumab|mesh-list
24529395|NCT00625898|Carboplatin|carboplatin|mesh-list
24529396|NCT00625898|Docetaxel|docetaxel|mesh-list
24529397|NCT00625898|Fluorouracil|fluorouracil|mesh-list
24529398|NCT00625898|Trastuzumab|trastuzumab|mesh-list
24529399|NCT00625898|Epirubicin|epirubicin|mesh-list
24529400|NCT00625898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24529401|NCT00625898|Immunologic Factors|immunologic factors|mesh-ancestor
24529402|NCT00625898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529403|NCT00625898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24529404|NCT00625898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24529419|NCT00625898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25126430|NCT03062644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126431|NCT03062644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25126432|NCT03062644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25126433|NCT03062644|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25126434|NCT03062644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25126435|NCT03062644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126436|NCT03062644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126437|NCT03062644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25126438|NCT03062644|Narcotics|narcotics|mesh-ancestor
25126439|NCT03062644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25126440|NCT03062436|Tin Fluorides|tin fluorides|mesh-list
25126441|NCT03062436|Cariostatic Agents|cariostatic agents|mesh-ancestor
25126442|NCT03062436|Protective Agents|protective agents|mesh-ancestor
25126443|NCT03062436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126444|NCT03062423|Sofosbuvir|sofosbuvir|mesh-list
25126445|NCT03062423|Antiviral Agents|antiviral agents|mesh-ancestor
25126446|NCT03062423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25126447|NCT03062631|Amifampridine|amifampridine|mesh-list
25126448|NCT03062631|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25126449|NCT03062631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25126450|NCT03062631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126451|NCT03062631|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25126452|NCT03062631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25126453|NCT03062631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126454|NCT03062501|Hydroxyurea|hydroxyurea|mesh-list
25126455|NCT03062501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25126456|NCT03062501|Antisickling Agents|antisickling agents|mesh-ancestor
25126457|NCT03062501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126458|NCT03062501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126459|NCT03062501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25126460|NCT03062462|Clopidogrel|clopidogrel|mesh-list
25682312|NCT01878292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25682313|NCT01878292|Serotonin Agents|serotonin agents|mesh-ancestor
25682314|NCT01878292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682315|NCT01878292|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25682316|NCT01878292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25682317|NCT01878526|Domperidone|domperidone|mesh-list
25682318|NCT01878526|Antiemetics|antiemetics|mesh-ancestor
25682319|NCT01878526|Autonomic Agents|autonomic agents|mesh-ancestor
25682320|NCT01878526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682321|NCT01878526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682322|NCT01878526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25682323|NCT01878526|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25682324|NCT01878526|Dopamine Agents|dopamine agents|mesh-ancestor
25682325|NCT01878526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25682326|NCT01878526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682327|NCT01878604|Hypolipidemic Agents|hypolipidemic agents|mesh-list
25682328|NCT01878604|Antimetabolites|antimetabolites|mesh-ancestor
25682329|NCT01878604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682330|NCT01878604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25682331|NCT01878656|Sevoflurane|sevoflurane|mesh-list
25682332|NCT01878656|Desflurane|desflurane|mesh-list
25158275|NCT04378933|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25158276|NCT04378933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25158277|NCT04378933|Sympathomimetics|sympathomimetics|mesh-ancestor
25158278|NCT04378933|Autonomic Agents|autonomic agents|mesh-ancestor
25158279|NCT04378933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25158280|NCT04378933|Dopamine Agents|dopamine agents|mesh-ancestor
25158281|NCT04378933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25158282|NCT04378933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25158283|NCT04378933|Adrenergic Agents|adrenergic agents|mesh-ancestor
25126461|NCT03062462|Ticagrelor|ticagrelor|mesh-list
25126462|NCT03062462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25126463|NCT03062462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24574004|NCT00823004|Letrozole|letrozole|mesh-list
24552658|NCT00522145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24552683|NCT00726804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24552684|NCT00726804|Immunologic Factors|immunologic factors|mesh-ancestor
25126464|NCT03062462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25126465|NCT03062462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25126466|NCT03062462|Purinergic Agents|purinergic agents|mesh-ancestor
25126467|NCT03062462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25126468|NCT03062462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126469|NCT03062462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126470|NCT03062319|Anticoagulants|anticoagulants|mesh-list
25126471|NCT03062319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25126472|NCT03062176|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25126473|NCT03062176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25126474|NCT03062072|Antineoplastic Agents|antineoplastic agents|mesh-list
25126475|NCT03061838|Rituximab|rituximab|mesh-list
25126476|NCT03061838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25126477|NCT03061838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25126478|NCT03061838|Immunologic Factors|immunologic factors|mesh-ancestor
25126479|NCT03061838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126480|NCT03061838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25126481|NCT03061981|Metformin|metformin|mesh-list
25126482|NCT03061981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25126483|NCT03061981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126484|NCT03062254|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25126485|NCT03062254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25126486|NCT03062163|Thioctic Acid|thioctic acid|mesh-list
25126487|NCT03062163|Resveratrol|resveratrol|mesh-list
25126488|NCT03062163|Antioxidants|antioxidants|mesh-ancestor
25126489|NCT03062163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126490|NCT03062163|Protective Agents|protective agents|mesh-ancestor
25126491|NCT03062163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126492|NCT03062163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126493|NCT03062163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24552685|NCT00726869|Elotuzumab|elotuzumab|mesh-list
24552686|NCT00726869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552687|NCT00726960|Buprenorphine|buprenorphine|mesh-list
24552688|NCT00726960|Aprepitant|aprepitant|mesh-list
24552689|NCT00726960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24552691|NCT00726960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24552692|NCT00726960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552693|NCT00726960|Analgesics|analgesics|mesh-ancestor
24552694|NCT00726960|Sensory System Agents|sensory system agents|mesh-ancestor
24552696|NCT00726960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24552748|NCT00727207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552752|NCT00727233|Sorafenib|sorafenib|mesh-list
24552880|NCT00728013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552881|NCT00728013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25126494|NCT03062163|Vitamin B Complex|vitamin b complex|mesh-ancestor
25126496|NCT03062163|Micronutrients|micronutrients|mesh-ancestor
25682333|NCT01878656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25682334|NCT01878656|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25682335|NCT01878656|Anesthetics, General|anesthetics, general|mesh-ancestor
25682336|NCT01878656|Anesthetics|anesthetics|mesh-ancestor
25682337|NCT01878656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25682338|NCT01878656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682339|NCT01878799|Sofosbuvir|sofosbuvir|mesh-list
25682340|NCT01878799|Ledipasvir|ledipasvir|mesh-list
25682341|NCT01878799|Antiviral Agents|antiviral agents|mesh-ancestor
25682342|NCT01878799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25126497|NCT03061734|Acetaminophen|acetaminophen|mesh-list
25126498|NCT03061734|Naltrexone|naltrexone|mesh-list
25682343|NCT01878890|Efavirenz|efavirenz|mesh-list
24701595|NCT01459627|Purinergic Agents|purinergic agents|mesh-ancestor
24437991|NCT00274859|Antiviral Agents|antiviral agents|mesh-ancestor
25126499|NCT03061734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25126500|NCT03061734|Analgesics|analgesics|mesh-ancestor
25126501|NCT03061734|Sensory System Agents|sensory system agents|mesh-ancestor
25126502|NCT03061734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25126503|NCT03061734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126504|NCT03061734|Antipyretics|antipyretics|mesh-ancestor
25126505|NCT03061734|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25126506|NCT03061734|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25126507|NCT03062150|Cycloserine|cycloserine|mesh-list
25126508|NCT03062150|Fludrocortisone|fludrocortisone|mesh-list
25126509|NCT03062150|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25126510|NCT03062150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25126511|NCT03062150|Renal Agents|renal agents|mesh-ancestor
25126512|NCT03062150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25126513|NCT03062150|Antitubercular Agents|antitubercular agents|mesh-ancestor
25126514|NCT03062150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25126515|NCT03062150|Antimetabolites|antimetabolites|mesh-ancestor
25126516|NCT03062150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126517|NCT03062150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25126518|NCT03061656|Cyclophosphamide|cyclophosphamide|mesh-list
25126520|NCT03061656|Thiotepa|thiotepa|mesh-list
25126521|NCT03061656|Carboplatin|carboplatin|mesh-list
25126522|NCT03061656|Etoposide|etoposide|mesh-list
25126523|NCT03061656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25126524|NCT03061656|Immunologic Factors|immunologic factors|mesh-ancestor
25126525|NCT03061656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126526|NCT03061656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25126527|NCT03061656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25126528|NCT03061656|Alkylating Agents|alkylating agents|mesh-ancestor
25126529|NCT03061656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126536|NCT03061916|Chlorhexidine|chlorhexidine|mesh-list
25126537|NCT03061916|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25126538|NCT03061916|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25126539|NCT03061916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25126540|NCT03061916|Disinfectants|disinfectants|mesh-ancestor
25126541|NCT03061916|Dermatologic Agents|dermatologic agents|mesh-ancestor
25126542|NCT03061604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25126543|NCT03061604|Ceftriaxone|ceftriaxone|mesh-list
25126544|NCT03061604|Octreotide|octreotide|mesh-list
25126545|NCT03061604|Hemostatics|hemostatics|mesh-list
25126546|NCT03061604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25126547|NCT03061604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25126548|NCT03061604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25126554|NCT03061253|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25126555|NCT03061253|Autonomic Agents|autonomic agents|mesh-ancestor
25126556|NCT03061253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25126557|NCT03061253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126558|NCT03061253|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25126559|NCT03061253|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25126560|NCT03061253|Cholinergic Agents|cholinergic agents|mesh-ancestor
25126561|NCT03061253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25126562|NCT03061253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126563|NCT03061058|Docetaxel|docetaxel|mesh-list
25126564|NCT03061058|Oxaliplatin|oxaliplatin|mesh-list
25126565|NCT03061058|Irinotecan|irinotecan|mesh-list
25126566|NCT03061058|Pemetrexed|pemetrexed|mesh-list
25126567|NCT03061058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25126568|NCT03061058|Tubulin Modulators|tubulin modulators|mesh-ancestor
25126569|NCT03061058|Antimitotic Agents|antimitotic agents|mesh-ancestor
25126570|NCT03061058|Mitosis Modulators|mitosis modulators|mesh-ancestor
25126571|NCT03061058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126572|NCT03061058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25126573|NCT03061058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25126574|NCT03061058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126575|NCT03061058|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25682344|NCT01878890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25682345|NCT01878890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25682346|NCT01878890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692503|NCT01999985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25126576|NCT03061058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24701673|NCT01460212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24701674|NCT01460212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24701675|NCT01460212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24701676|NCT01460212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24701677|NCT01460355|Botulinum Toxins|botulinum toxins|mesh-list
24701678|NCT01460355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25126577|NCT03061006|Warfarin|warfarin|mesh-list
24393156|NCT00128934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553029|NCT00729118|Growth Inhibitors|growth inhibitors|mesh-ancestor
24553030|NCT00729118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25126580|NCT03061006|Antithrombins|antithrombins|mesh-ancestor
25126581|NCT03061006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25126582|NCT03061006|Protease Inhibitors|protease inhibitors|mesh-ancestor
25126583|NCT03061006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126584|NCT03061006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126585|NCT03061227|Glucagon|glucagon|mesh-list
25126586|NCT03061227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25126587|NCT03061227|Hormones|hormones|mesh-ancestor
25126633|NCT03060798|Anesthetics, General|anesthetics, general|mesh-ancestor
25126589|NCT03061227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126590|NCT03061136|Clonazepam|clonazepam|mesh-list
25126591|NCT03061136|Anticonvulsants|anticonvulsants|mesh-ancestor
25126592|NCT03061136|GABA Modulators|gaba modulators|mesh-ancestor
25126593|NCT03061136|GABA Agents|gaba agents|mesh-ancestor
25126594|NCT03061136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25126595|NCT03061136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126596|NCT03061136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126597|NCT03061032|Ribavirin|ribavirin|mesh-list
25126598|NCT03061032|Sofosbuvir|sofosbuvir|mesh-list
25126599|NCT03061032|Ledipasvir|ledipasvir|mesh-list
25126600|NCT03061032|Antimetabolites|antimetabolites|mesh-ancestor
25126601|NCT03061032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126602|NCT03061032|Antiviral Agents|antiviral agents|mesh-ancestor
24553031|NCT00729118|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24553032|NCT00729118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553033|NCT00729118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553034|NCT00729131|Etanercept|etanercept|mesh-list
24553087|NCT00729404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24553088|NCT00729404|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24553089|NCT00729404|Progestins|progestins|mesh-ancestor
24553090|NCT00729404|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24553091|NCT00729495|Celecoxib|celecoxib|mesh-list
24553092|NCT00729495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24553093|NCT00729495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24553094|NCT00729495|Analgesics|analgesics|mesh-ancestor
24553095|NCT00729495|Sensory System Agents|sensory system agents|mesh-ancestor
24553239|NCT00730054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24553299|NCT00730223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24553387|NCT00730821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24553388|NCT00730821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24553389|NCT00730821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553390|NCT00730821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553391|NCT00730938|Cefuroxime|cefuroxime|mesh-list
24553392|NCT00730938|Cefuroxime axetil|cefuroxime axetil|mesh-list
24462235|NCT00355589|Ramipril|ramipril|mesh-list
25126604|NCT03060889|Tranexamic Acid|tranexamic acid|mesh-list
25126605|NCT03060889|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25126606|NCT03060889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25126607|NCT03060889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126608|NCT03060889|Hemostatics|hemostatics|mesh-ancestor
25126609|NCT03060889|Coagulants|coagulants|mesh-ancestor
25126610|NCT03060603|Epoetin Alfa|epoetin alfa|mesh-list
25126611|NCT03060603|Hematinics|hematinics|mesh-ancestor
25126612|NCT03060707|Bromides|bromides|mesh-list
25126613|NCT03060707|Rocuronium|rocuronium|mesh-list
25126614|NCT03060707|Anticonvulsants|anticonvulsants|mesh-ancestor
25682347|NCT01878890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682348|NCT01878890|Antiviral Agents|antiviral agents|mesh-ancestor
25682349|NCT01878890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25682350|NCT01878890|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25682351|NCT01878890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25277459|NCT02358161|Gemcitabine|gemcitabine|mesh-list
25277461|NCT02358161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25277462|NCT02358161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25277463|NCT02358161|Tubulin Modulators|tubulin modulators|mesh-ancestor
24534870|NCT00648180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25126615|NCT03060707|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25126616|NCT03060707|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25126617|NCT03060707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25126618|NCT03060707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25126619|NCT03060707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126620|NCT03060681|Bupivacaine|bupivacaine|mesh-list
25126621|NCT03060681|Anesthetics, Local|anesthetics, local|mesh-ancestor
25126622|NCT03060681|Anesthetics|anesthetics|mesh-ancestor
25126623|NCT03060681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25126624|NCT03060681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126625|NCT03060681|Sensory System Agents|sensory system agents|mesh-ancestor
25126626|NCT03060681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25126627|NCT03060850|Abivertinib|abivertinib|mesh-list
25126628|NCT03060850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25126629|NCT03060850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126630|NCT03060850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126632|NCT03060798|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25126636|NCT03060798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553396|NCT00730977|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24553397|NCT00730977|Diuretics|diuretics|mesh-ancestor
24553398|NCT00730977|Natriuretic Agents|natriuretic agents|mesh-ancestor
24553399|NCT00730977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553400|NCT00731003|Tryptophan|tryptophan|mesh-list
24553401|NCT00731003|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
24553402|NCT00731003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25126639|NCT03060785|Antiviral Agents|antiviral agents|mesh-ancestor
25126640|NCT03060785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25126641|NCT03060785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25126642|NCT03060785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25126643|NCT03060785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126644|NCT03060785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126645|NCT03060785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25126646|NCT03060785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25126647|NCT03060278|Nicotine|nicotine|mesh-list
25126648|NCT03060278|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25126649|NCT03060278|Autonomic Agents|autonomic agents|mesh-ancestor
25126650|NCT03060278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25126651|NCT03060278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682352|NCT01878890|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25682353|NCT01878890|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25682354|NCT01878890|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25682355|NCT01878890|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25682356|NCT01879319|Evolocumab|evolocumab|mesh-list
25682357|NCT01879319|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25682358|NCT01879319|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25682359|NCT01879319|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25682360|NCT01879319|Antimetabolites|antimetabolites|mesh-ancestor
25682361|NCT01879319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682362|NCT01879319|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25682363|NCT01879319|Immunologic Factors|immunologic factors|mesh-ancestor
25682364|NCT01879319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682365|NCT01879332|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25682366|NCT01879332|Anticonvulsants|anticonvulsants|mesh-ancestor
24701765|NCT01460693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701767|NCT01460706|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25277486|NCT02358200|Tubulin Modulators|tubulin modulators|mesh-ancestor
25277487|NCT02358200|Antimitotic Agents|antimitotic agents|mesh-ancestor
25277488|NCT02358200|Mitosis Modulators|mitosis modulators|mesh-ancestor
25277491|NCT02358200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126652|NCT03060278|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25126653|NCT03060278|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25126654|NCT03060278|Cholinergic Agents|cholinergic agents|mesh-ancestor
25126655|NCT03060278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25126656|NCT03060278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126657|NCT03060304|Tamoxifen|tamoxifen|mesh-list
25126658|NCT03060304|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25126659|NCT03060304|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25126660|NCT03060304|Estradiol|estradiol|mesh-list
25126661|NCT03060304|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25126662|NCT03060304|Estrogens|estrogens|mesh-ancestor
25126663|NCT03060304|Hormones|hormones|mesh-ancestor
25126664|NCT03060304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25126665|NCT03060304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126666|NCT03060304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24553550|NCT00731926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553557|NCT00731952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553558|NCT00732082|Gemcitabine|gemcitabine|mesh-list
24553559|NCT00732082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24553560|NCT00732082|Antimetabolites|antimetabolites|mesh-ancestor
24553561|NCT00732082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553562|NCT00732082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24553563|NCT00732082|Antiviral Agents|antiviral agents|mesh-ancestor
24553564|NCT00732082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24553565|NCT00732082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553566|NCT00732082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24553567|NCT00732082|Immunologic Factors|immunologic factors|mesh-ancestor
24553568|NCT00732082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553606|NCT00732290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126667|NCT03060304|Contraceptive Agents|contraceptive agents|mesh-ancestor
25126668|NCT03060304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25126669|NCT03060304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25126670|NCT03060304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25126671|NCT03060304|Hormone Antagonists|hormone antagonists|mesh-ancestor
25126672|NCT03060304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25126673|NCT03060304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25126674|NCT03060304|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25126675|NCT03060304|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25126676|NCT03060304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25126677|NCT03060265|Acetaminophen|acetaminophen|mesh-list
25126678|NCT03060265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25126679|NCT03060265|Analgesics|analgesics|mesh-ancestor
25126680|NCT03060265|Sensory System Agents|sensory system agents|mesh-ancestor
25126681|NCT03060265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25126682|NCT03060265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126683|NCT03060265|Antipyretics|antipyretics|mesh-ancestor
24956384|NCT03854812|Fentanyl|fentanyl|mesh-list
24553607|NCT00732290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553608|NCT00732290|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24553632|NCT00732446|Dexamethasone acetate|dexamethasone acetate|mesh-list
24553633|NCT00732446|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24553636|NCT00732446|Antiemetics|antiemetics|mesh-ancestor
24553637|NCT00732446|Autonomic Agents|autonomic agents|mesh-ancestor
24553725|NCT00732589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24553726|NCT00732589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24553727|NCT00732589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24553728|NCT00732589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24553752|NCT00732745|Mitosis Modulators|mitosis modulators|mesh-ancestor
25682367|NCT01879332|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25682368|NCT01879332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25682369|NCT01879332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25682370|NCT01879332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682371|NCT01879345|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25682372|NCT01879345|Anticonvulsants|anticonvulsants|mesh-ancestor
24644102|NCT01189006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24701821|NCT01461174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24701823|NCT01461460|Tedizolid phosphate|tedizolid phosphate|mesh-list
25277517|NCT02357849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25277518|NCT02357849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25277519|NCT02357849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277520|NCT02357849|Dopamine Agonists|dopamine agonists|mesh-ancestor
25277538|NCT02357693|Aprepitant|aprepitant|mesh-list
24553801|NCT00732927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24553802|NCT00732927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24553803|NCT00732927|Analgesics|analgesics|mesh-ancestor
24553804|NCT00732927|Sensory System Agents|sensory system agents|mesh-ancestor
24553805|NCT00732927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24553806|NCT00732927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553807|NCT00732927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24553808|NCT00732927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24553809|NCT00732927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24553810|NCT00732927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24553812|NCT00732927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24553881|NCT00733239|Sensory System Agents|sensory system agents|mesh-ancestor
24553882|NCT00733239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24553883|NCT00733239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553884|NCT00733239|Anticonvulsants|anticonvulsants|mesh-ancestor
24553885|NCT00733239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25126694|NCT03060070|Dexmedetomidine|dexmedetomidine|mesh-list
25126696|NCT03060070|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25126697|NCT03060070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25126698|NCT03060070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126699|NCT03060070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25126700|NCT03060070|Analgesics|analgesics|mesh-ancestor
25126701|NCT03060070|Sensory System Agents|sensory system agents|mesh-ancestor
25126702|NCT03060070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25126703|NCT03060070|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25126704|NCT03060070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25126705|NCT03060070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25126706|NCT03060070|Adrenergic Agents|adrenergic agents|mesh-ancestor
25126707|NCT03060070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25126708|NCT03060070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126709|NCT03060070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25126710|NCT03060070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25126711|NCT03060070|Anesthetics, General|anesthetics, general|mesh-ancestor
24553886|NCT00733239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24553887|NCT00733239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24553888|NCT00733239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24553889|NCT00733239|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24553938|NCT00733473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24553939|NCT00733473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553969|NCT00733564|Sensory System Agents|sensory system agents|mesh-ancestor
24553970|NCT00733564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24553971|NCT00733564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24553972|NCT00733564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24553973|NCT00733564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25126712|NCT03060070|Anesthetics|anesthetics|mesh-ancestor
25126713|NCT03060070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25126722|NCT03059888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25126723|NCT03059849|Adalimumab|adalimumab|mesh-list
25126724|NCT03059849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25126725|NCT03059849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25126726|NCT03060018|Oxitropium|oxitropium|mesh-list
25682373|NCT01879345|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25682374|NCT01879345|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25682375|NCT01879345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25682376|NCT01879345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682377|NCT01879371|Ibuprofen|ibuprofen|mesh-list
25682378|NCT01879371|Caffeine|caffeine|mesh-list
25682379|NCT01879371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25682380|NCT01879371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25682381|NCT01879371|Analgesics|analgesics|mesh-ancestor
25126742|NCT03059979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126743|NCT03059979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25126744|NCT03059979|Glucocorticoids|glucocorticoids|mesh-ancestor
25126752|NCT03060044|Xhance|xhance|mesh-list
25126754|NCT03060044|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25126755|NCT03060044|Charcoal|charcoal|mesh-list
25126756|NCT03060044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25126757|NCT03060044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25126758|NCT03060044|Autonomic Agents|autonomic agents|mesh-ancestor
25126759|NCT03060044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25126760|NCT03060044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126761|NCT03060044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25126762|NCT03060044|Respiratory System Agents|respiratory system agents|mesh-ancestor
25126763|NCT03060044|Dermatologic Agents|dermatologic agents|mesh-ancestor
25126764|NCT03060044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25126765|NCT03060044|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25126766|NCT03060044|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25126767|NCT03060044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25126768|NCT03060044|Adrenergic Agents|adrenergic agents|mesh-ancestor
25126769|NCT03060044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25126770|NCT03060044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126771|NCT03060044|Glucocorticoids|glucocorticoids|mesh-ancestor
25126772|NCT03060044|Hormones|hormones|mesh-ancestor
25126773|NCT03060044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25126774|NCT03060044|Sympathomimetics|sympathomimetics|mesh-ancestor
25126775|NCT03060044|Antidotes|antidotes|mesh-ancestor
25126776|NCT03060044|Protective Agents|protective agents|mesh-ancestor
25126777|NCT03059719|Exenatide|exenatide|mesh-list
25126784|NCT03059862|Tryptophan|tryptophan|mesh-list
25682382|NCT01879371|Sensory System Agents|sensory system agents|mesh-ancestor
25682383|NCT01879371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682384|NCT01879371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682385|NCT01879371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25682386|NCT01879371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25682387|NCT01879371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25682388|NCT01879371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25682389|NCT01879371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682390|NCT01879371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25682391|NCT01879371|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25682392|NCT01879371|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25682393|NCT01879371|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25682394|NCT01879371|Purinergic Agents|purinergic agents|mesh-ancestor
25682395|NCT01879371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25126785|NCT03059862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25126786|NCT03059862|Antidepressive Agents|antidepressive agents|mesh-ancestor
25158446|NCT04297267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25158447|NCT04297267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25158448|NCT04297267|Antimetabolites|antimetabolites|mesh-ancestor
25158449|NCT04297267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701976|NCT01463215|Ambroxol|ambroxol|mesh-list
24701977|NCT01463215|Expectorants|expectorants|mesh-ancestor
24701978|NCT01463215|Respiratory System Agents|respiratory system agents|mesh-ancestor
24701979|NCT01463228|Metformin|metformin|mesh-list
24701980|NCT01463228|Canagliflozin|canagliflozin|mesh-list
24701981|NCT01463228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24701982|NCT01463228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701983|NCT01463228|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24701985|NCT01463280|Lidocaine|lidocaine|mesh-list
25126787|NCT03059862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25126788|NCT03060031|Oxytocin|oxytocin|mesh-list
25126789|NCT03060031|Oxytocics|oxytocics|mesh-ancestor
25126790|NCT03060031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25126791|NCT03060031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126792|NCT03060005|Dextrans|dextrans|mesh-list
25126793|NCT03060005|Anticoagulants|anticoagulants|mesh-ancestor
25126794|NCT03060005|Plasma Substitutes|plasma substitutes|mesh-ancestor
25126795|NCT03060005|Blood Substitutes|blood substitutes|mesh-ancestor
25126810|NCT03059667|Etoposide|etoposide|mesh-list
25126811|NCT03059667|Atezolizumab|atezolizumab|mesh-list
25126812|NCT03059667|Topotecan|topotecan|mesh-list
25126813|NCT03059667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25126814|NCT03059667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25126815|NCT03059667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25126816|NCT03059667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25126817|NCT03059667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126818|NCT03059667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126819|NCT03059667|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25126820|NCT03059563|Varenicline|varenicline|mesh-list
25126821|NCT03059563|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25126822|NCT03059563|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25126823|NCT03059563|Cholinergic Agents|cholinergic agents|mesh-ancestor
25126824|NCT03059563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25126825|NCT03059563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126826|NCT03059563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126827|NCT03059615|Doxorubicin|doxorubicin|mesh-list
25126828|NCT03059615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25126829|NCT03059615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25126830|NCT03059615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24553974|NCT00733564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24553975|NCT00733564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554078|NCT00734123|Antimetabolites|antimetabolites|mesh-ancestor
24554079|NCT00734123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24554080|NCT00734123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24554081|NCT00734123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24554112|NCT00734318|Respiratory System Agents|respiratory system agents|mesh-ancestor
24554113|NCT00734318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24554114|NCT00734318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24554115|NCT00734318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24554116|NCT00734318|Adrenergic Agents|adrenergic agents|mesh-ancestor
25126831|NCT03059615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25126832|NCT03059615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126833|NCT03059615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126834|NCT03059277|Aflibercept|aflibercept|mesh-list
25126835|NCT03059277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25126836|NCT03059277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25682396|NCT01879579|Insulin|insulin|mesh-list
25682397|NCT01879579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25682398|NCT01879579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682399|NCT01879618|Dalteparin|dalteparin|mesh-list
25682400|NCT01879618|Anticoagulants|anticoagulants|mesh-ancestor
25682401|NCT01879618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25682402|NCT01879618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25682403|NCT01879618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682404|NCT05329116|Lidocaine|lidocaine|mesh-list
25682405|NCT05329116|Pentoxifylline|pentoxifylline|mesh-list
25682406|NCT05329116|Anesthetics, Local|anesthetics, local|mesh-ancestor
25682407|NCT05329116|Anesthetics|anesthetics|mesh-ancestor
25682408|NCT05329116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25682409|NCT05329116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25158472|NCT04283513|Antiviral Agents|antiviral agents|mesh-ancestor
25158473|NCT04283513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24702006|NCT01463332|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24702007|NCT01463332|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24702008|NCT01463332|Adrenergic Agents|adrenergic agents|mesh-ancestor
24613375|NCT01018615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613376|NCT01018758|Palonosetron|palonosetron|mesh-list
24613377|NCT01018758|Antiemetics|antiemetics|mesh-ancestor
24613378|NCT01018758|Autonomic Agents|autonomic agents|mesh-ancestor
24613379|NCT01018758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24613380|NCT01018758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613381|NCT01018758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24613382|NCT01018758|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24613383|NCT01018758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24613384|NCT01018758|Serotonin Agents|serotonin agents|mesh-ancestor
24613385|NCT01018758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24613386|NCT01018758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126837|NCT03059277|Growth Substances|growth substances|mesh-ancestor
25126838|NCT03059277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126839|NCT03059277|Growth Inhibitors|growth inhibitors|mesh-ancestor
25126840|NCT03059277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25126841|NCT03059316|Labetalol|labetalol|mesh-list
25126842|NCT03059316|Nitroglycerin|nitroglycerin|mesh-list
25126843|NCT03059316|Vasodilator Agents|vasodilator agents|mesh-ancestor
25126844|NCT03059316|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25126845|NCT03059316|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25126846|NCT03059316|Adrenergic Agents|adrenergic agents|mesh-ancestor
25126847|NCT03059316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25126848|NCT03059316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126849|NCT03059316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126850|NCT03059316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25126851|NCT03059316|Sympathomimetics|sympathomimetics|mesh-ancestor
25126852|NCT03059316|Autonomic Agents|autonomic agents|mesh-ancestor
25126853|NCT03059316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25126854|NCT03059316|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25126855|NCT03059316|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25126856|NCT03059303|Simeprevir|simeprevir|mesh-list
25126857|NCT03059303|Odalasvir|odalasvir|mesh-list
25126858|NCT03059303|Omeprazole|omeprazole|mesh-list
25126859|NCT03059303|Lansoprazole|lansoprazole|mesh-list
25126860|NCT03059303|Dexlansoprazole|dexlansoprazole|mesh-list
25126861|NCT03059303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25126862|NCT03059303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25126863|NCT03059303|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25126864|NCT03059303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126865|NCT03059303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126866|NCT03059303|Antiviral Agents|antiviral agents|mesh-ancestor
25126867|NCT03059303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25126868|NCT03059303|Protease Inhibitors|protease inhibitors|mesh-ancestor
25126869|NCT03059537|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
25126870|NCT03059537|Cathartics|cathartics|mesh-ancestor
25126871|NCT03059537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25126872|NCT03059238|Celecoxib|celecoxib|mesh-list
25126883|NCT03059238|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25126884|NCT03059238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25126885|NCT03059238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126886|NCT03059238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126887|NCT03059238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25682410|NCT05329116|Sensory System Agents|sensory system agents|mesh-ancestor
25682411|NCT05329116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682412|NCT05329116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25682413|NCT05329116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25682414|NCT05329116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25682415|NCT05329116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25682416|NCT05329116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682417|NCT05329116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25682418|NCT05329116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25682419|NCT05329116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25682420|NCT05329116|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25682421|NCT05329116|Protective Agents|protective agents|mesh-ancestor
25682422|NCT05329116|Vasodilator Agents|vasodilator agents|mesh-ancestor
25682423|NCT05329116|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25682424|NCT05329116|Antioxidants|antioxidants|mesh-ancestor
25682425|NCT05329090|Rituximab|rituximab|mesh-list
25682426|NCT05329090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25158502|NCT04265755|Erenumab|erenumab|mesh-list
25158503|NCT04265755|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25158504|NCT04265755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25158505|NCT04265755|Analgesics|analgesics|mesh-ancestor
25158506|NCT04265755|Sensory System Agents|sensory system agents|mesh-ancestor
25158507|NCT04265755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25158508|NCT04265755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277641|NCT02357225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277642|NCT02357212|Adenosine|adenosine|mesh-list
25277643|NCT02357212|Analgesics|analgesics|mesh-ancestor
25277644|NCT02357212|Sensory System Agents|sensory system agents|mesh-ancestor
25277645|NCT02357212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25277646|NCT02357212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277654|NCT02357004|Carvedilol|carvedilol|mesh-list
25126889|NCT03059238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25126891|NCT03059134|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25126892|NCT03059134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25126893|NCT03059134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25126894|NCT03059134|Adrenergic Agents|adrenergic agents|mesh-ancestor
25126895|NCT03059134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25126896|NCT03059134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126897|NCT03059134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126898|NCT03059134|Urological Agents|urological agents|mesh-ancestor
25126899|NCT03058939|Tamoxifen|tamoxifen|mesh-list
25126900|NCT03058939|Paclitaxel|paclitaxel|mesh-list
25126901|NCT03058939|Carboplatin|carboplatin|mesh-list
24554117|NCT00734318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24554118|NCT00734318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554119|NCT00734318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24554120|NCT00734318|Dermatologic Agents|dermatologic agents|mesh-ancestor
24554121|NCT00734318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24554174|NCT00734773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554175|NCT00734773|Dermatologic Agents|dermatologic agents|mesh-ancestor
25126902|NCT03058939|Trastuzumab|trastuzumab|mesh-list
25126903|NCT03058939|Letrozole|letrozole|mesh-list
25126904|NCT03058939|Pertuzumab|pertuzumab|mesh-list
25126905|NCT03058939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25126906|NCT03058939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25126907|NCT03058939|Tubulin Modulators|tubulin modulators|mesh-ancestor
25126909|NCT03058939|Mitosis Modulators|mitosis modulators|mesh-ancestor
25126910|NCT03058939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126911|NCT03058939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25126912|NCT03058939|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25126913|NCT03058939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25126914|NCT03058939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126915|NCT03058939|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25126916|NCT03058939|Hormone Antagonists|hormone antagonists|mesh-ancestor
25126917|NCT03058939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25126918|NCT03058939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126919|NCT03058939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25126920|NCT03058939|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25126921|NCT03058939|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25126922|NCT03058939|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25126928|NCT03058900|Methotrexate|methotrexate|mesh-list
25126929|NCT03058900|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25126930|NCT03058900|Abortifacient Agents|abortifacient agents|mesh-ancestor
25126931|NCT03058900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25126932|NCT03058900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682427|NCT05329090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682428|NCT05329090|Immunologic Factors|immunologic factors|mesh-ancestor
25682429|NCT05329090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682430|NCT05329090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25692504|NCT01999985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692505|NCT01999985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692506|NCT02000531|Gemcitabine|gemcitabine|mesh-list
25692507|NCT02000531|Cisplatin|cisplatin|mesh-list
25692508|NCT02000531|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25692509|NCT02000531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25692510|NCT02000531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25692511|NCT02000531|Antimetabolites|antimetabolites|mesh-ancestor
25692512|NCT02000531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692513|NCT02000531|Antiviral Agents|antiviral agents|mesh-ancestor
25126933|NCT03058900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25126934|NCT03058900|Antimetabolites|antimetabolites|mesh-ancestor
25126946|NCT03058835|Antiviral Agents|antiviral agents|mesh-ancestor
25126947|NCT03058835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25126948|NCT03058835|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25126949|NCT03058835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25126950|NCT03058835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25126951|NCT03058835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126952|NCT03058835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25126953|NCT03058835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25126954|NCT03059017|Albuterol|albuterol|mesh-list
24554250|NCT00735124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554251|NCT00735124|Anticonvulsants|anticonvulsants|mesh-ancestor
24554327|NCT00735748|Sensory System Agents|sensory system agents|mesh-ancestor
24554328|NCT00735748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24554329|NCT00735761|Acyclovir|acyclovir|mesh-list
24554330|NCT00735761|Hydrocortisone|hydrocortisone|mesh-list
24554331|NCT00735761|Antiviral Agents|antiviral agents|mesh-ancestor
24554332|NCT00735761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24554335|NCT00735813|Anticoagulants|anticoagulants|mesh-ancestor
24554336|NCT00735813|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24554337|NCT00735813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24554338|NCT00735813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554339|NCT00735852|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24554511|NCT00736866|Antioxidants|antioxidants|mesh-ancestor
24554512|NCT00736866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554513|NCT00736866|Protective Agents|protective agents|mesh-ancestor
24554514|NCT00736866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554515|NCT00736866|Antidotes|antidotes|mesh-ancestor
25126955|NCT03059017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25126956|NCT03059017|Autonomic Agents|autonomic agents|mesh-ancestor
25126957|NCT03059017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25126958|NCT03059017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126959|NCT03059017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25126960|NCT03059017|Respiratory System Agents|respiratory system agents|mesh-ancestor
25126961|NCT03059017|Tocolytic Agents|tocolytic agents|mesh-ancestor
25126962|NCT03059017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25126963|NCT03059017|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25126964|NCT03059017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25126965|NCT03059017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25126966|NCT03059017|Adrenergic Agents|adrenergic agents|mesh-ancestor
25126967|NCT03059017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25126968|NCT03059017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126969|NCT03058744|Clobetasol|clobetasol|mesh-list
25126970|NCT03058744|Halobetasol|halobetasol|mesh-list
25126971|NCT03058744|Tazarotene|tazarotene|mesh-list
25126972|NCT03058744|Dermatologic Agents|dermatologic agents|mesh-ancestor
25126973|NCT03058744|Keratolytic Agents|keratolytic agents|mesh-ancestor
25126974|NCT03058744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25126975|NCT03058744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25126976|NCT03058744|Glucocorticoids|glucocorticoids|mesh-ancestor
25126977|NCT03058744|Hormones|hormones|mesh-ancestor
25126978|NCT03058744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25126979|NCT03058744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126980|NCT03059251|Obinutuzumab|obinutuzumab|mesh-list
25126981|NCT03059251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25126982|NCT03059251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25126983|NCT03059056|Empagliflozin|empagliflozin|mesh-list
25126984|NCT03059056|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25126985|NCT03059056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126986|NCT03059056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25126987|NCT03059056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554582|NCT00737139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24554583|NCT00737139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554584|NCT00737139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554585|NCT00737139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25126988|NCT03058666|Calfactant|calfactant|mesh-list
25126989|NCT03058666|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
25126990|NCT03058666|Respiratory System Agents|respiratory system agents|mesh-ancestor
25126991|NCT03058354|Propofol|propofol|mesh-list
25126993|NCT03058354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25126994|NCT03058354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126995|NCT03058354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25126996|NCT03058354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25126997|NCT03058354|Anesthetics, General|anesthetics, general|mesh-ancestor
25126998|NCT03058419|Midazolam|midazolam|mesh-list
25126999|NCT03058419|Dextromethorphan|dextromethorphan|mesh-list
25127000|NCT03058419|Caffeine|caffeine|mesh-list
25127001|NCT03058419|Bupropion|bupropion|mesh-list
25127002|NCT03058419|Omeprazole|omeprazole|mesh-list
25127003|NCT03058419|Warfarin|warfarin|mesh-list
25127004|NCT03058419|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25127005|NCT03058419|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25127006|NCT03058419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25127007|NCT03058419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127008|NCT03058419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25127009|NCT03058419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25127010|NCT03058419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25127011|NCT03058419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25127012|NCT03058419|Anesthetics, General|anesthetics, general|mesh-ancestor
25127013|NCT03058419|Anesthetics|anesthetics|mesh-ancestor
25127014|NCT03058419|GABA Modulators|gaba modulators|mesh-ancestor
25127015|NCT03058419|GABA Agents|gaba agents|mesh-ancestor
25127016|NCT03058419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25127017|NCT03058419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127018|NCT03058419|Anticoagulants|anticoagulants|mesh-ancestor
25127019|NCT03058419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25127020|NCT03058419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25127021|NCT03058419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25127022|NCT03058419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048517|NCT00692445|Mecamylamine|mecamylamine|mesh-list
25127032|NCT03058419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25127033|NCT03058419|Dopamine Agents|dopamine agents|mesh-ancestor
25127034|NCT03058419|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25127035|NCT03058419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25127036|NCT03058419|Antitussive Agents|antitussive agents|mesh-ancestor
25127037|NCT03058419|Respiratory System Agents|respiratory system agents|mesh-ancestor
25127038|NCT03058419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25127039|NCT03058419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25127040|NCT03058536|Progesterone|progesterone|mesh-list
25127041|NCT03058536|Progestins|progestins|mesh-ancestor
25127043|NCT03058536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25127044|NCT03058536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127045|NCT03058341|Propofol|propofol|mesh-list
25127046|NCT03058341|Sevoflurane|sevoflurane|mesh-list
25127047|NCT03058341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25127048|NCT03058341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25127049|NCT03058341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127050|NCT03058341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25127051|NCT03058341|Anesthetics, General|anesthetics, general|mesh-ancestor
25127052|NCT03058341|Anesthetics|anesthetics|mesh-ancestor
25127053|NCT03058341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25127054|NCT03058341|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25127056|NCT03058471|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25127057|NCT03058471|Abortifacient Agents|abortifacient agents|mesh-ancestor
25127058|NCT03058471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25127059|NCT03058471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554697|NCT00737724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554699|NCT00737724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25127060|NCT03058471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25127061|NCT03058471|Antimetabolites|antimetabolites|mesh-ancestor
25127062|NCT03058471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127063|NCT03058471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25127064|NCT03058471|Dermatologic Agents|dermatologic agents|mesh-ancestor
25127065|NCT03058471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25127066|NCT03058471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25127067|NCT03058471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25127068|NCT03058471|Immunologic Factors|immunologic factors|mesh-ancestor
25127069|NCT03058471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25127070|NCT03058471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25127071|NCT03058263|Neostigmine|neostigmine|mesh-list
25127072|NCT03058263|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25127073|NCT03058263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702314|NCT01465074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25277731|NCT02356445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277732|NCT02356445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25277733|NCT02356445|Antimetabolites|antimetabolites|mesh-ancestor
25277734|NCT02356445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277735|NCT02356445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25277736|NCT02356445|Dermatologic Agents|dermatologic agents|mesh-ancestor
25277737|NCT02356445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277738|NCT02356445|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25127074|NCT03058263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127075|NCT03058263|Cholinergic Agents|cholinergic agents|mesh-ancestor
25127076|NCT03058263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25127077|NCT03058263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127078|NCT03058263|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25127079|NCT03058263|Autonomic Agents|autonomic agents|mesh-ancestor
25127080|NCT03058263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25127081|NCT03058224|Acetaminophen|acetaminophen|mesh-list
25127082|NCT03058224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25127100|NCT03058094|Abivertinib|abivertinib|mesh-list
25127101|NCT03058094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25127102|NCT03058094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25127103|NCT03058094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127104|NCT03058094|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25127105|NCT03058094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25127106|NCT03058094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25127107|NCT03057990|Pyrimethamine|pyrimethamine|mesh-list
25127108|NCT03057990|Antimalarials|antimalarials|mesh-ancestor
25127109|NCT03057990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25127110|NCT03057990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25127111|NCT03057990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24554700|NCT00737724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25265179|NCT02435537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25265180|NCT02435537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393268|NCT00129363|Carvedilol|carvedilol|mesh-list
24554815|NCT00738296|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25127112|NCT03057990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25127113|NCT03057990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25127114|NCT03057990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127120|NCT03057769|Indomethacin|indomethacin|mesh-list
25127121|NCT03057769|Epinephrine|epinephrine|mesh-list
25127122|NCT03057769|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25127123|NCT03057769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25127124|NCT03057769|Adrenergic Agents|adrenergic agents|mesh-ancestor
25127125|NCT03057769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25127126|NCT03057769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127127|NCT03057769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127128|NCT03057769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25127129|NCT03057769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25127130|NCT03057769|Autonomic Agents|autonomic agents|mesh-ancestor
25127131|NCT03057769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25127132|NCT03057769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25127133|NCT03057769|Respiratory System Agents|respiratory system agents|mesh-ancestor
25127134|NCT03057769|Mydriatics|mydriatics|mesh-ancestor
25127135|NCT03057769|Sympathomimetics|sympathomimetics|mesh-ancestor
25127136|NCT03057769|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25127137|NCT03057769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25127138|NCT03057769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25127139|NCT03057769|Analgesics|analgesics|mesh-ancestor
25127140|NCT03057769|Sensory System Agents|sensory system agents|mesh-ancestor
25127141|NCT03057769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25127142|NCT03057769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25127143|NCT03057769|Gout Suppressants|gout suppressants|mesh-ancestor
25127144|NCT03057769|Tocolytic Agents|tocolytic agents|mesh-ancestor
25127145|NCT03057769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25127146|NCT03057769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24956828|NCT03850561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682431|NCT05328921|Antihypertensive Agents|antihypertensive agents|mesh-list
25682432|NCT05328817|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25682433|NCT05328817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25682434|NCT05328817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25682435|NCT05328817|Antitubercular Agents|antitubercular agents|mesh-ancestor
25682436|NCT05328674|Mitogens|mitogens|mesh-list
25682437|NCT05328674|Mitosis Modulators|mitosis modulators|mesh-ancestor
25682438|NCT05328674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682439|NCT05328635|Candesartan|candesartan|mesh-list
25682440|NCT05328635|Gabapentin|gabapentin|mesh-list
25682441|NCT05328635|Analgesics|analgesics|mesh-ancestor
24702315|NCT01465074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702316|NCT01465074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24702317|NCT01465074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24702318|NCT01465074|Cholinergic Agents|cholinergic agents|mesh-ancestor
24702319|NCT01465074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24702320|NCT01465074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702322|NCT01465113|Ergocalciferols|ergocalciferols|mesh-list
24702323|NCT01465113|Cholecalciferol|cholecalciferol|mesh-list
24702324|NCT01465113|Vitamins|vitamins|mesh-list
24702325|NCT01465113|Metformin|metformin|mesh-list
24702326|NCT01465113|Omeprazole|omeprazole|mesh-list
24702327|NCT01465113|Micronutrients|micronutrients|mesh-ancestor
24702328|NCT01465113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702342|NCT01465256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24702343|NCT01465256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24702344|NCT01465256|Analgesics|analgesics|mesh-ancestor
24702345|NCT01465256|Sensory System Agents|sensory system agents|mesh-ancestor
24702348|NCT01465256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24464934|NCT00367315|Sensory System Agents|sensory system agents|mesh-ancestor
25127147|NCT03057769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25127149|NCT03057821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25127150|NCT03057821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25127151|NCT03057691|Antidepressive Agents|antidepressive agents|mesh-list
25127152|NCT03057691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25127153|NCT03057509|Octreotide|octreotide|mesh-list
25127154|NCT03057509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25127155|NCT03057509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25127156|NCT03057509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25127157|NCT03057483|Vaccines|vaccines|mesh-list
25127158|NCT03057483|Immunologic Factors|immunologic factors|mesh-ancestor
25127159|NCT03057483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127160|NCT03057470|Insulin|insulin|mesh-list
25127161|NCT03057470|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25127162|NCT03057470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25127163|NCT03057470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127164|NCT03057314|Calcium Carbonate|calcium carbonate|mesh-list
25127165|NCT03057314|Calcium|calcium|mesh-list
25127166|NCT03057314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25127167|NCT03057314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127168|NCT03057314|Antacids|antacids|mesh-ancestor
25127169|NCT03057314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127170|NCT03057314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25127171|NCT03057574|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25127172|NCT03057574|Hormones|hormones|mesh-ancestor
25127173|NCT03057574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25127174|NCT03057574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127175|NCT03057561|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
25127176|NCT03057561|Chelating Agents|chelating agents|mesh-ancestor
25127177|NCT03057561|Sequestering Agents|sequestering agents|mesh-ancestor
25127190|NCT03057041|Sensory System Agents|sensory system agents|mesh-ancestor
25127191|NCT03057041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25127192|NCT03057041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25127193|NCT03057041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25127194|NCT03057041|Anesthetics, General|anesthetics, general|mesh-ancestor
25127195|NCT03057041|Anesthetics|anesthetics|mesh-ancestor
25127196|NCT03056846|Sulfalene|sulfalene|mesh-list
25682442|NCT05328635|Sensory System Agents|sensory system agents|mesh-ancestor
25682443|NCT05328635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682444|NCT05328635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682445|NCT05328635|Anticonvulsants|anticonvulsants|mesh-ancestor
25682446|NCT05328635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25682447|NCT05328635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25682448|NCT05328635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25682449|NCT05328635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25682450|NCT05328635|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25682451|NCT05328635|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25682452|NCT05328635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25682453|NCT05328635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682454|NCT05328635|Antimanic Agents|antimanic agents|mesh-ancestor
25682455|NCT05328635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25682456|NCT05328635|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25682457|NCT05328635|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25682458|NCT05328427|Tin Fluorides|tin fluorides|mesh-list
24702389|NCT01465685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24702390|NCT01465685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24702391|NCT01465685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702392|NCT01465685|Dopamine Agents|dopamine agents|mesh-ancestor
24702416|NCT01465867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702417|NCT01465867|Protective Agents|protective agents|mesh-ancestor
25127197|NCT03056846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25127198|NCT03056846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25127199|NCT03056846|Renal Agents|renal agents|mesh-ancestor
25127200|NCT03056846|Antimalarials|antimalarials|mesh-ancestor
25127201|NCT03056846|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25127202|NCT03056846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25127203|NCT03057015|Dexamethasone|dexamethasone|mesh-list
25127204|NCT03057015|Clonidine|clonidine|mesh-list
25127205|NCT03057015|Epinephrine|epinephrine|mesh-list
25127206|NCT03057015|Ropivacaine|ropivacaine|mesh-list
25127207|NCT03057015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25127208|NCT03057015|Antiemetics|antiemetics|mesh-ancestor
25127209|NCT03057015|Autonomic Agents|autonomic agents|mesh-ancestor
25127210|NCT03057015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25127211|NCT03057015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127212|NCT03057015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25127213|NCT03057015|Glucocorticoids|glucocorticoids|mesh-ancestor
25127214|NCT03057015|Hormones|hormones|mesh-ancestor
25127215|NCT03057015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25127216|NCT03057015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25127217|NCT03057015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25127218|NCT03057015|Anesthetics, Local|anesthetics, local|mesh-ancestor
25127219|NCT03057015|Anesthetics|anesthetics|mesh-ancestor
24956859|NCT03850028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24956861|NCT03849833|Cholecalciferol|cholecalciferol|mesh-list
24956863|NCT03849833|Micronutrients|micronutrients|mesh-ancestor
24554816|NCT00738296|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24554845|NCT00738556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24554846|NCT00738556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24554847|NCT00738556|Tubulin Modulators|tubulin modulators|mesh-ancestor
24554848|NCT00738556|Antimitotic Agents|antimitotic agents|mesh-ancestor
25127220|NCT03057015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25127221|NCT03057015|Sensory System Agents|sensory system agents|mesh-ancestor
25127222|NCT03057015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25127225|NCT03057015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25127226|NCT03057015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127227|NCT03057015|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25127228|NCT03057015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25127229|NCT03057015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25127230|NCT03057015|Respiratory System Agents|respiratory system agents|mesh-ancestor
25127231|NCT03057015|Mydriatics|mydriatics|mesh-ancestor
25127232|NCT03057015|Sympathomimetics|sympathomimetics|mesh-ancestor
25127233|NCT03057015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25127234|NCT03057015|Analgesics|analgesics|mesh-ancestor
25127235|NCT03057015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25127236|NCT03057015|Sympatholytics|sympatholytics|mesh-ancestor
25127237|NCT03057015|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25127238|NCT03056924|Vaccines|vaccines|mesh-list
25127239|NCT03056924|Immunologic Factors|immunologic factors|mesh-ancestor
25127240|NCT03056924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127249|NCT03057028|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25127250|NCT03057028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25127252|NCT03056495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25127263|NCT03056703|Analgesics|analgesics|mesh-ancestor
25127264|NCT03056703|Sensory System Agents|sensory system agents|mesh-ancestor
25127265|NCT03056703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25127266|NCT03056703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127267|NCT03056703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25127268|NCT03056703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25127269|NCT03056703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25127270|NCT03056703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25127271|NCT03056703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682459|NCT05328427|Cariostatic Agents|cariostatic agents|mesh-ancestor
25682460|NCT05328427|Protective Agents|protective agents|mesh-ancestor
25682461|NCT05328427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682462|NCT05328310|Nebivolol|nebivolol|mesh-list
25682463|NCT05328310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25682464|NCT05328310|Vasodilator Agents|vasodilator agents|mesh-ancestor
25682465|NCT05328310|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25682466|NCT05328310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24702539|NCT01466465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25127272|NCT03056703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25127273|NCT03056703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25127274|NCT03056703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25127275|NCT03056703|Antipyretics|antipyretics|mesh-ancestor
25127276|NCT03056482|Haloperidol|haloperidol|mesh-list
25127277|NCT03056482|Ondansetron|ondansetron|mesh-list
25127278|NCT03056482|Haloperidol decanoate|haloperidol decanoate|mesh-list
25127279|NCT03056482|Antiemetics|antiemetics|mesh-ancestor
25127280|NCT03056482|Autonomic Agents|autonomic agents|mesh-ancestor
25127281|NCT03056482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25127282|NCT03056482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127283|NCT03056482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25127284|NCT03056482|Antipruritics|antipruritics|mesh-ancestor
25127285|NCT03056482|Dermatologic Agents|dermatologic agents|mesh-ancestor
25127286|NCT03056482|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25127287|NCT03056482|Serotonin Agents|serotonin agents|mesh-ancestor
25127288|NCT03056482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25127289|NCT03056482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127290|NCT03056482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25127296|NCT03056482|Dopamine Agents|dopamine agents|mesh-ancestor
25127313|NCT03056599|Trabectedin|trabectedin|mesh-list
25127314|NCT03056599|Olaratumab|olaratumab|mesh-list
25127315|NCT03056599|Entrectinib|entrectinib|mesh-list
25127316|NCT03056599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25127317|NCT03056599|Antimetabolites|antimetabolites|mesh-ancestor
25127318|NCT03056599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127319|NCT03056599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25127320|NCT03056599|Antiviral Agents|antiviral agents|mesh-ancestor
25127321|NCT03056599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25127322|NCT03056599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25127323|NCT03056599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25127324|NCT03056599|Immunologic Factors|immunologic factors|mesh-ancestor
25127325|NCT03056599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127326|NCT03056599|Tubulin Modulators|tubulin modulators|mesh-ancestor
25127327|NCT03056599|Antimitotic Agents|antimitotic agents|mesh-ancestor
25127347|NCT03056274|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25127348|NCT03056274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25127349|NCT03056274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957016|NCT03847792|Antiemetics|antiemetics|mesh-ancestor
24554855|NCT00738556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24554856|NCT00738556|Immunologic Factors|immunologic factors|mesh-ancestor
24554857|NCT00738556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554858|NCT00738569|Raltegravir Potassium|raltegravir potassium|mesh-list
24554859|NCT00738569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24554860|NCT00738569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24554861|NCT00738569|Antiviral Agents|antiviral agents|mesh-ancestor
24554862|NCT00738569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24554891|NCT00738621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24554892|NCT00738621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24554893|NCT00738621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24554894|NCT00738621|Protease Inhibitors|protease inhibitors|mesh-ancestor
24554895|NCT00738621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24554896|NCT00738621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554897|NCT00738621|Antipruritics|antipruritics|mesh-ancestor
24554907|NCT00738621|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24554909|NCT00738660|Ramipril|ramipril|mesh-list
24554910|NCT00738660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24554911|NCT00738660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24554912|NCT00738660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24554915|NCT00738660|Protease Inhibitors|protease inhibitors|mesh-ancestor
24554958|NCT00738829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24554959|NCT00738829|Growth Substances|growth substances|mesh-ancestor
24554960|NCT00738829|Growth Inhibitors|growth inhibitors|mesh-ancestor
24554962|NCT00738842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24554963|NCT00738842|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25127353|NCT03056118|Clopidogrel|clopidogrel|mesh-list
25127354|NCT03056118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25127355|NCT03056118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25682467|NCT05328310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25682468|NCT05328310|Adrenergic Agents|adrenergic agents|mesh-ancestor
25682469|NCT05328310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25682470|NCT05328310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702706|NCT01467297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24702766|NCT01467531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24702767|NCT01467596|Lidocaine|lidocaine|mesh-list
24702768|NCT01467596|Levobupivacaine|levobupivacaine|mesh-list
24702769|NCT01467596|Anesthetics, Local|anesthetics, local|mesh-ancestor
24702770|NCT01467596|Anesthetics|anesthetics|mesh-ancestor
24702771|NCT01467596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24702807|NCT01467986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24702809|NCT01467986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277811|NCT02355431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25277812|NCT02355431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277814|NCT02355522|Lidocaine|lidocaine|mesh-list
24554964|NCT00738842|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24554965|NCT00738842|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24554966|NCT00738842|Purinergic Agents|purinergic agents|mesh-ancestor
24554967|NCT00738842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24555034|NCT00739531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24555035|NCT00739531|Autonomic Agents|autonomic agents|mesh-ancestor
24555036|NCT00739531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24555037|NCT00739531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555040|NCT00739531|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24555042|NCT00739531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555043|NCT00739531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24555044|NCT00739531|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24555045|NCT00739531|Vasodilator Agents|vasodilator agents|mesh-ancestor
24555046|NCT00739531|Gasotransmitters|gasotransmitters|mesh-ancestor
24555047|NCT00739531|Protective Agents|protective agents|mesh-ancestor
24555048|NCT00739609|Tryptophan|tryptophan|mesh-list
24555049|NCT00739609|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24555050|NCT00739609|Antidepressive Agents|antidepressive agents|mesh-ancestor
24555051|NCT00739609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24555052|NCT00739622|Rilpivirine|rilpivirine|mesh-list
24759010|NCT01749072|Gefitinib|gefitinib|mesh-list
25127363|NCT03056118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25127364|NCT03056118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127365|NCT03056118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25127366|NCT03056118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25127367|NCT03056118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25127368|NCT03056118|Antipyretics|antipyretics|mesh-ancestor
25127369|NCT03056118|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25127370|NCT03056118|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25127371|NCT03056118|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25127372|NCT03056118|Purinergic Agents|purinergic agents|mesh-ancestor
25127373|NCT03056118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25127374|NCT03056079|Aflibercept|aflibercept|mesh-list
25127375|NCT03056079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25127376|NCT03056079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25127377|NCT03056079|Growth Substances|growth substances|mesh-ancestor
25127378|NCT03056079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127379|NCT03056079|Growth Inhibitors|growth inhibitors|mesh-ancestor
25682471|NCT05328310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682472|NCT05328258|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25682473|NCT05328258|Luteolytic Agents|luteolytic agents|mesh-ancestor
25682474|NCT05328258|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25682475|NCT05328258|Contraceptive Agents|contraceptive agents|mesh-ancestor
25682476|NCT05328258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25682477|NCT05328258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682478|NCT05328258|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25682479|NCT05328258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25682480|NCT05328258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682481|NCT05328102|Lenalidomide|lenalidomide|mesh-list
25277828|NCT02355639|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25277829|NCT02355639|Betamethasone benzoate|betamethasone benzoate|mesh-list
25277830|NCT02355639|Clobetasol|clobetasol|mesh-list
25277831|NCT02355639|Petrolatum|petrolatum|mesh-list
25277832|NCT02355639|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25277833|NCT02355639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25277834|NCT02355639|Glucocorticoids|glucocorticoids|mesh-ancestor
25277835|NCT02355639|Hormones|hormones|mesh-ancestor
25277836|NCT02355639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25277837|NCT02355639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277838|NCT02355639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25277839|NCT02355639|Respiratory System Agents|respiratory system agents|mesh-ancestor
25277840|NCT02355639|Emollients|emollients|mesh-ancestor
25277841|NCT02355639|Dermatologic Agents|dermatologic agents|mesh-ancestor
25277842|NCT02355509|Acarbose|acarbose|mesh-list
25277843|NCT02355509|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25277844|NCT02355509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277845|NCT02355509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277846|NCT02355509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25277847|NCT02355509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127380|NCT03056079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25127381|NCT03056053|Zolpidem|zolpidem|mesh-list
25127382|NCT03056053|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24555087|NCT00739986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24555088|NCT00739986|Analgesics|analgesics|mesh-ancestor
24555089|NCT00739986|Sensory System Agents|sensory system agents|mesh-ancestor
24555090|NCT00739986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24555091|NCT00739986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555092|NCT00739986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24555093|NCT00739986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24555094|NCT00739986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24555095|NCT00739986|Immunologic Factors|immunologic factors|mesh-ancestor
24555096|NCT00740064|Lamivudine|lamivudine|mesh-list
24555097|NCT00740064|Abacavir|abacavir|mesh-list
24555098|NCT00740064|Raltegravir Potassium|raltegravir potassium|mesh-list
24555099|NCT00740064|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24555104|NCT00740064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24555106|NCT00740064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24555107|NCT00740064|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24555108|NCT00740064|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24555109|NCT00740090|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24555110|NCT00740090|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24555111|NCT00740090|Immunologic Factors|immunologic factors|mesh-ancestor
25127384|NCT03056053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25127385|NCT03056053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127386|NCT03056053|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25127387|NCT03056053|GABA Agonists|gaba agonists|mesh-ancestor
25127388|NCT03056053|GABA Agents|gaba agents|mesh-ancestor
25127389|NCT03056053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25127390|NCT03056053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127391|NCT03056261|Anesthetics|anesthetics|mesh-list
24555112|NCT00740090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682482|NCT05328102|Immunologic Factors|immunologic factors|mesh-ancestor
25682483|NCT05328102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682484|NCT05328102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25682485|NCT05328102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25682486|NCT05328102|Growth Substances|growth substances|mesh-ancestor
25682487|NCT05328102|Growth Inhibitors|growth inhibitors|mesh-ancestor
25682488|NCT05328102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682489|NCT05327894|Blinatumomab|blinatumomab|mesh-list
25682490|NCT05327894|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25682491|NCT05327894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682492|NCT05327894|Immunologic Factors|immunologic factors|mesh-ancestor
25682493|NCT05327894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682494|NCT05327777|Oxycodone|oxycodone|mesh-list
25682495|NCT05327777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25682496|NCT05327777|Narcotics|narcotics|mesh-ancestor
25682497|NCT05327777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25682498|NCT05327777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682499|NCT05327777|Analgesics|analgesics|mesh-ancestor
25682500|NCT05327777|Sensory System Agents|sensory system agents|mesh-ancestor
25682501|NCT05327777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682502|NCT05327751|Celecoxib|celecoxib|mesh-list
25277851|NCT02355184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277852|NCT02355184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25277853|NCT02355184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25277854|NCT02355184|Antiviral Agents|antiviral agents|mesh-ancestor
25277855|NCT02355184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25277856|NCT02355236|Celecoxib|celecoxib|mesh-list
25277857|NCT02355236|Naproxen|naproxen|mesh-list
25277858|NCT02355236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25277859|NCT02355236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25277860|NCT02355236|Analgesics|analgesics|mesh-ancestor
25277861|NCT02355236|Sensory System Agents|sensory system agents|mesh-ancestor
25277862|NCT02355236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24555134|NCT00740142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555135|NCT00740168|Bevacizumab|bevacizumab|mesh-list
24555236|NCT00740467|Antitubercular Agents|antitubercular agents|mesh-ancestor
24555237|NCT00740467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24555239|NCT00740493|Anticoagulants|anticoagulants|mesh-ancestor
24555240|NCT00740519|Insulin Detemir|insulin detemir|mesh-list
24555241|NCT00740519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24555242|NCT00740519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555243|NCT00740545|Enoxaparin|enoxaparin|mesh-list
24555244|NCT00740545|Anticoagulants|anticoagulants|mesh-ancestor
24555245|NCT00740545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24555246|NCT00740545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24555247|NCT00740545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555248|NCT00740571|Pregabalin|pregabalin|mesh-list
24555277|NCT00740922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555279|NCT00740948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24555280|NCT00740948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24555281|NCT00740948|Immunologic Factors|immunologic factors|mesh-ancestor
24555282|NCT00740948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555283|NCT00740948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24555284|NCT00741052|Azithromycin|azithromycin|mesh-list
24555363|NCT00741234|Antimetabolites|antimetabolites|mesh-ancestor
24555364|NCT00741234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555365|NCT00741234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24555502|NCT00741780|Immunologic Factors|immunologic factors|mesh-ancestor
24555503|NCT00741780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555504|NCT00741780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24555505|NCT00741780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24555529|NCT00741910|Semapimod|semapimod|mesh-list
24555604|NCT00742287|Protective Agents|protective agents|mesh-ancestor
24555605|NCT00742287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555606|NCT00742287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24555607|NCT00742287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25127392|NCT03056261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25127393|NCT03056261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127394|NCT03056092|Ranibizumab|ranibizumab|mesh-list
25127395|NCT03056092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25127396|NCT03056092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25127397|NCT03056092|Growth Substances|growth substances|mesh-ancestor
25127398|NCT03056092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127399|NCT03056092|Growth Inhibitors|growth inhibitors|mesh-ancestor
25127400|NCT03056092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25127401|NCT03056248|Lithium Carbonate|lithium carbonate|mesh-list
25127402|NCT03056248|Antidepressive Agents|antidepressive agents|mesh-ancestor
25127403|NCT03056248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25127404|NCT03056248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25127405|NCT03056248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127406|NCT03056248|Antimanic Agents|antimanic agents|mesh-ancestor
25127407|NCT03056248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25682503|NCT05327751|Capecitabine|capecitabine|mesh-list
25682504|NCT05327751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25682505|NCT05327751|Antimetabolites|antimetabolites|mesh-ancestor
25682506|NCT05327751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682507|NCT05327751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682508|NCT05327751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25682509|NCT05327751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25682510|NCT05327751|Analgesics|analgesics|mesh-ancestor
25682511|NCT05327751|Sensory System Agents|sensory system agents|mesh-ancestor
25682512|NCT05327751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682513|NCT05327751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127408|NCT03056248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25277882|NCT02355119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25277884|NCT02355119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25277885|NCT02355119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277886|NCT02355119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25277887|NCT02355119|Immunologic Factors|immunologic factors|mesh-ancestor
25127409|NCT03056248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127411|NCT03055663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25127412|NCT03055663|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25127413|NCT03055663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25127414|NCT03055663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127415|NCT03055663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25127416|NCT03055663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24555617|NCT00742300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24555618|NCT00742300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24555647|NCT00742404|Glucocorticoids|glucocorticoids|mesh-ancestor
24555649|NCT00742404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24555650|NCT00742404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24555651|NCT00742404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24555652|NCT00742404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24555653|NCT00742404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24555654|NCT00742404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24555655|NCT00742404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24555658|NCT00742638|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24555715|NCT00742846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24555716|NCT00742846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24555717|NCT00742846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24555718|NCT00742846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25127417|NCT03055663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25127418|NCT03055663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25127419|NCT03055663|Anesthetics, General|anesthetics, general|mesh-ancestor
25127420|NCT03055663|Anesthetics|anesthetics|mesh-ancestor
25127421|NCT03055663|GABA Modulators|gaba modulators|mesh-ancestor
25127422|NCT03055663|GABA Agents|gaba agents|mesh-ancestor
25127423|NCT03055663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24957097|NCT03847558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555719|NCT00742846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555720|NCT00742846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24555723|NCT00742846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24555724|NCT00742846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24555725|NCT00742846|Immunologic Factors|immunologic factors|mesh-ancestor
24555727|NCT00742911|Copper|copper|mesh-list
24555728|NCT00742911|Disulfiram|disulfiram|mesh-list
24555729|NCT00742911|Trace Elements|trace elements|mesh-ancestor
24555730|NCT00742911|Micronutrients|micronutrients|mesh-ancestor
24555731|NCT00742911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555732|NCT00742911|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24555733|NCT00742911|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
24555879|NCT00744081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556068|NCT00744809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24556069|NCT00744887|Darunavir|darunavir|mesh-list
24556070|NCT00744887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24556085|NCT00744913|Nicotine|nicotine|mesh-list
24556164|NCT00745433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24556165|NCT00745433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556166|NCT00745485|Zoledronic Acid|zoledronic acid|mesh-list
24556167|NCT00745485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24556248|NCT00746499|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24556249|NCT00746499|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24556250|NCT00746499|Antiviral Agents|antiviral agents|mesh-ancestor
24556254|NCT00746499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556255|NCT00746499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556256|NCT00746655|Cisplatin|cisplatin|mesh-list
24556257|NCT00746655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556258|NCT00746681|Pregabalin|pregabalin|mesh-list
25682514|NCT05327751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25682515|NCT05327751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25682516|NCT05327751|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25682517|NCT05327751|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25682518|NCT05327751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25682519|NCT05327738|Atezolizumab|atezolizumab|mesh-list
25682520|NCT05327738|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24703100|NCT01469624|Pentoxifylline|pentoxifylline|mesh-list
24561793|NCT00762775|Micronutrients|micronutrients|mesh-ancestor
24561794|NCT00762775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573228|NCT00818610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24703101|NCT01469624|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24556259|NCT00746681|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24556260|NCT00746681|Analgesics|analgesics|mesh-ancestor
24556261|NCT00746681|Sensory System Agents|sensory system agents|mesh-ancestor
24556262|NCT00746681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24556263|NCT00746681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556264|NCT00746681|Anticonvulsants|anticonvulsants|mesh-ancestor
24556265|NCT00746681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24556266|NCT00746681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24556336|NCT00747110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556337|NCT00747110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24556338|NCT00747110|Respiratory System Agents|respiratory system agents|mesh-ancestor
24556368|NCT00747383|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24556370|NCT00747383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24556371|NCT00747383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556473|NCT00747877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556474|NCT00747877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25127426|NCT03055741|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25127427|NCT03055741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25127428|NCT03055741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127429|NCT03055741|Cholinergic Agents|cholinergic agents|mesh-ancestor
25127430|NCT03055741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25127431|NCT03055741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127432|NCT03055741|Nootropic Agents|nootropic agents|mesh-ancestor
25127433|NCT03055767|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25127434|NCT03055767|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25127435|NCT03055767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24957102|NCT03847207|Pasireotide|pasireotide|mesh-list
24556475|NCT00747877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24556476|NCT00747903|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24556477|NCT00747903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24556478|NCT00747903|Dermatologic Agents|dermatologic agents|mesh-ancestor
24556565|NCT00748163|Antimitotic Agents|antimitotic agents|mesh-ancestor
24556566|NCT00748163|Mitosis Modulators|mitosis modulators|mesh-ancestor
24556567|NCT00748163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556599|NCT00748358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556600|NCT00748371|Aspirin|aspirin|mesh-list
24556601|NCT00748371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24556602|NCT00748371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24556603|NCT00748371|Analgesics|analgesics|mesh-ancestor
24556604|NCT00748371|Sensory System Agents|sensory system agents|mesh-ancestor
24556605|NCT00748371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24556606|NCT00748371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556607|NCT00748371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24556608|NCT00748371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24556609|NCT00748371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24556610|NCT00748371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24556611|NCT00748371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556633|NCT00748436|Histamine Agonists|histamine agonists|mesh-ancestor
24556634|NCT00748436|Histamine Agents|histamine agents|mesh-ancestor
24556635|NCT00748436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24556636|NCT00748436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556637|NCT00748436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556638|NCT00748527|Carboplatin|carboplatin|mesh-list
24556640|NCT00748527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556641|NCT00748527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24556642|NCT00748527|Antimetabolites|antimetabolites|mesh-ancestor
24556643|NCT00748527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556688|NCT00749099|Pancrelipase|pancrelipase|mesh-list
24556690|NCT00749099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25682521|NCT05327738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682522|NCT05327738|Immunologic Factors|immunologic factors|mesh-ancestor
25682523|NCT05327738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682524|NCT05327660|Carbon Monoxide|carbon monoxide|mesh-list
25682525|NCT05327660|Antimetabolites|antimetabolites|mesh-ancestor
24556691|NCT00749112|Rituximab|rituximab|mesh-list
24556692|NCT00749112|Alemtuzumab|alemtuzumab|mesh-list
24556693|NCT00749112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25127438|NCT03055767|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25127439|NCT03055767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25127440|NCT03055767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127441|NCT03055767|Cholinergic Agents|cholinergic agents|mesh-ancestor
25127442|NCT03055767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25127444|NCT03055793|Formoterol Fumarate|formoterol fumarate|mesh-list
25127445|NCT03055793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24556702|NCT00749138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556704|NCT00749138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556748|NCT00749450|Antimetabolites|antimetabolites|mesh-ancestor
24556749|NCT00749450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556750|NCT00749450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24556751|NCT00749450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450318|NCT00318760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24450319|NCT00318760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556770|NCT00749567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556771|NCT00749567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556772|NCT00749619|Taurolidine|taurolidine|mesh-list
24556773|NCT00749619|Heparin|heparin|mesh-list
24556810|NCT00749723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24556811|NCT00749723|Alkylating Agents|alkylating agents|mesh-ancestor
24556812|NCT00749723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24556813|NCT00749723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25127456|NCT03055793|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25127457|NCT03055793|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24556814|NCT00749723|Immunologic Factors|immunologic factors|mesh-ancestor
24556815|NCT00749723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556816|NCT00749723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24556817|NCT00749736|Cholecalciferol|cholecalciferol|mesh-list
24556818|NCT00749736|Vitamin D|vitamin d|mesh-list
24556841|NCT00749866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24556842|NCT00749866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24556843|NCT00749866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556844|NCT00749866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556871|NCT00750113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24556872|NCT00750113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24556873|NCT00750113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556874|NCT00750113|Vasodilator Agents|vasodilator agents|mesh-ancestor
24556875|NCT00750113|Tocolytic Agents|tocolytic agents|mesh-ancestor
24556876|NCT00750113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24556877|NCT00750126|Fludarabine|fludarabine|mesh-list
24556878|NCT00750126|Busulfan|busulfan|mesh-list
24556879|NCT00750126|Thymoglobulin|thymoglobulin|mesh-list
25127458|NCT03055793|Adrenergic Agents|adrenergic agents|mesh-ancestor
25127459|NCT03055793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25127460|NCT03055793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127461|NCT03055546|Oxytocin|oxytocin|mesh-list
25127462|NCT03055546|Oxytocics|oxytocics|mesh-ancestor
25127463|NCT03055546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25127464|NCT03055546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127465|NCT03055507|Acetaminophen|acetaminophen|mesh-list
25127466|NCT03055507|Ibuprofen|ibuprofen|mesh-list
25127467|NCT03055507|Oxycodone|oxycodone|mesh-list
25127468|NCT03055507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25127469|NCT03055507|Analgesics|analgesics|mesh-ancestor
25078340|NCT03357627|Venetoclax|venetoclax|mesh-list
25277950|NCT02354872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25277951|NCT02354872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277952|NCT02354638|Nicotine|nicotine|mesh-list
25277953|NCT02354638|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24556880|NCT00750126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556886|NCT00750126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24556887|NCT00750126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24556889|NCT00750178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556890|NCT00750178|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24556977|NCT00750581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556978|NCT00750581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556979|NCT00750620|Mirabegron|mirabegron|mesh-list
24556980|NCT00750620|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24556981|NCT00750620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24556982|NCT00750620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24556983|NCT00750620|Adrenergic Agents|adrenergic agents|mesh-ancestor
24556984|NCT00750620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24556985|NCT00750620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556986|NCT00750620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556987|NCT00750620|Urological Agents|urological agents|mesh-ancestor
24556988|NCT00750724|Hyaluronic Acid|hyaluronic acid|mesh-list
24556989|NCT00750724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24556990|NCT00750724|Immunologic Factors|immunologic factors|mesh-ancestor
24556991|NCT00750724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556992|NCT00750724|Viscosupplements|viscosupplements|mesh-ancestor
24556993|NCT00750724|Protective Agents|protective agents|mesh-ancestor
24556994|NCT00750763|Picosulfate sodium|picosulfate sodium|mesh-list
24556995|NCT00750763|Cathartics|cathartics|mesh-ancestor
24556996|NCT00750763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24556997|NCT00750802|Lorazepam|lorazepam|mesh-list
24556998|NCT00750802|Anticonvulsants|anticonvulsants|mesh-ancestor
24556999|NCT00750802|Antiemetics|antiemetics|mesh-ancestor
24557001|NCT00750802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24557002|NCT00750802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557003|NCT00750802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24557015|NCT00750997|Plasma Substitutes|plasma substitutes|mesh-ancestor
24557016|NCT00750997|Blood Substitutes|blood substitutes|mesh-ancestor
24557018|NCT00751049|Latanoprost|latanoprost|mesh-list
24557019|NCT00751049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24557021|NCT00751049|Adrenergic Agents|adrenergic agents|mesh-ancestor
24557026|NCT00751049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24557087|NCT00751205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24557088|NCT00751205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24557089|NCT00751205|Protective Agents|protective agents|mesh-ancestor
24557090|NCT00751205|Vitamin B Complex|vitamin b complex|mesh-ancestor
24557092|NCT00751205|Micronutrients|micronutrients|mesh-ancestor
24557093|NCT00751205|Nootropic Agents|nootropic agents|mesh-ancestor
24557094|NCT00751205|Tubulin Modulators|tubulin modulators|mesh-ancestor
24557098|NCT00751257|Acetylcysteine|acetylcysteine|mesh-list
24557138|NCT00751491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557139|NCT00751491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557140|NCT00751504|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25127472|NCT03055507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127473|NCT03055507|Antipyretics|antipyretics|mesh-ancestor
25127474|NCT03055507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25127475|NCT03055507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25127476|NCT03055507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25127477|NCT03055507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25127478|NCT03055507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25127479|NCT03055507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127480|NCT03055507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25127481|NCT03055507|Narcotics|narcotics|mesh-ancestor
25127482|NCT03055507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24535431|NCT00649129|Oxybutynin|oxybutynin|mesh-list
25682526|NCT05327660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682527|NCT05327660|Gasotransmitters|gasotransmitters|mesh-ancestor
25682528|NCT05327660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25682529|NCT05327660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643440|NCT01185743|Ziprasidone|ziprasidone|mesh-list
25277989|NCT02354547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25277990|NCT02354547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277991|NCT02354313|Lenalidomide|lenalidomide|mesh-list
25277992|NCT02354313|Immunologic Factors|immunologic factors|mesh-ancestor
25277993|NCT02354313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277994|NCT02354313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25277995|NCT02354313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25277996|NCT02354313|Growth Substances|growth substances|mesh-ancestor
25277997|NCT02354313|Growth Inhibitors|growth inhibitors|mesh-ancestor
25277998|NCT02354313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24671087|NCT01323465|Hormone Antagonists|hormone antagonists|mesh-ancestor
24573691|NCT00821535|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24995520|NCT05101564|Tamoxifen|tamoxifen|mesh-list
24703252|NCT01470443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703253|NCT01470456|Rituximab|rituximab|mesh-list
24703254|NCT01470456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24703318|NCT01471067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24703319|NCT01471067|Antimetabolites|antimetabolites|mesh-ancestor
24703324|NCT01471067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25127483|NCT03055234|Treprostinil|treprostinil|mesh-list
25127484|NCT03055234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25127485|NCT03055312|Bicalutamide|bicalutamide|mesh-list
25127486|NCT03055312|Androgen Antagonists|androgen antagonists|mesh-ancestor
25127487|NCT03055312|Hormone Antagonists|hormone antagonists|mesh-ancestor
25127488|NCT03055312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24557141|NCT00751504|Antidepressive Agents|antidepressive agents|mesh-ancestor
24557142|NCT00751504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24557143|NCT00751504|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24557144|NCT00751504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24557145|NCT00751504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24557146|NCT00751504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557147|NCT00751517|Cyclophosphamide|cyclophosphamide|mesh-list
24557148|NCT00751517|Methotrexate|methotrexate|mesh-list
24557149|NCT00751517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24557150|NCT00751517|Immunologic Factors|immunologic factors|mesh-ancestor
24462600|NCT00357084|Prednisolone|prednisolone|mesh-list
24557154|NCT00751517|Alkylating Agents|alkylating agents|mesh-ancestor
24557155|NCT00751517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557159|NCT00751517|Abortifacient Agents|abortifacient agents|mesh-ancestor
24557174|NCT00751556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24557175|NCT00751556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24557180|NCT00751699|Mesalamine|mesalamine|mesh-list
24557202|NCT00751751|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24557203|NCT00751751|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24557204|NCT00751751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557205|NCT00751751|Diuretics|diuretics|mesh-ancestor
24557317|NCT00752180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557318|NCT00752310|Darunavir|darunavir|mesh-list
24557319|NCT00752310|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25127500|NCT03055247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25127501|NCT03055247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25682530|NCT05327582|Paclitaxel|paclitaxel|mesh-list
25682531|NCT05327582|Durvalumab|durvalumab|mesh-list
25682532|NCT05327582|Lenvatinib|lenvatinib|mesh-list
25682533|NCT05327582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25682534|NCT05327582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682535|NCT05327582|Tubulin Modulators|tubulin modulators|mesh-ancestor
25682536|NCT05327582|Antimitotic Agents|antimitotic agents|mesh-ancestor
25682537|NCT05327582|Mitosis Modulators|mitosis modulators|mesh-ancestor
25682538|NCT05327582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682539|NCT05327582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25682540|NCT05327582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25682541|NCT05327582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25682542|NCT05327439|Nicotine|nicotine|mesh-list
25682543|NCT05327439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25682544|NCT05327439|Autonomic Agents|autonomic agents|mesh-ancestor
25682545|NCT05327439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682546|NCT05327439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682547|NCT05327439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25682548|NCT05327439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25278013|NCT02354261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25278014|NCT02354261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25278015|NCT02354261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278016|NCT02354261|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25278017|NCT02354261|Hormone Antagonists|hormone antagonists|mesh-ancestor
25127502|NCT03055247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127504|NCT03055442|Vitamin B Complex|vitamin b complex|mesh-ancestor
24557482|NCT00752648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24557483|NCT00752648|Protease Inhibitors|protease inhibitors|mesh-ancestor
24557484|NCT00752648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557485|NCT00752648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557486|NCT00752661|Tramadol|tramadol|mesh-list
24557487|NCT00752661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24557488|NCT00752661|Narcotics|narcotics|mesh-ancestor
24557489|NCT00752661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24557490|NCT00752661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557491|NCT00752661|Analgesics|analgesics|mesh-ancestor
24557524|NCT00752869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557525|NCT00752882|Ceftazidime|ceftazidime|mesh-list
24557526|NCT00752882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24557527|NCT00752882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24557587|NCT00753051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24557588|NCT00753051|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24557589|NCT00753051|Dopamine Agents|dopamine agents|mesh-ancestor
24557590|NCT00753051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24557599|NCT00753064|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24557661|NCT00753246|Nimotuzumab|nimotuzumab|mesh-list
24557662|NCT00753246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24557663|NCT00753246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24557664|NCT00753311|Rizatriptan|rizatriptan|mesh-list
24557665|NCT00753311|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24557666|NCT00753311|Serotonin Agents|serotonin agents|mesh-ancestor
24557667|NCT00753311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24557668|NCT00753311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557669|NCT00753311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557670|NCT00753324|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24557671|NCT00753324|Antiviral Agents|antiviral agents|mesh-ancestor
24557672|NCT00753324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24557673|NCT00753389|Anesthetics|anesthetics|mesh-list
24557716|NCT00753571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24557717|NCT00753571|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24557763|NCT00753792|Autonomic Agents|autonomic agents|mesh-ancestor
24557764|NCT00753792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25127526|NCT03054948|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25127535|NCT03054766|Ranibizumab|ranibizumab|mesh-list
24557765|NCT00753792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557766|NCT00753792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24557767|NCT00753792|Glucocorticoids|glucocorticoids|mesh-ancestor
24557768|NCT00753792|Hormones|hormones|mesh-ancestor
24557769|NCT00753792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24557770|NCT00753792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24557771|NCT00753792|Protective Agents|protective agents|mesh-ancestor
24557772|NCT00753792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24557819|NCT00754351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24557878|NCT00754689|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24557902|NCT00754780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24557903|NCT00754780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24557904|NCT00754780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24557905|NCT00754819|Colchicine|colchicine|mesh-list
24557906|NCT00754819|Gout Suppressants|gout suppressants|mesh-ancestor
24557907|NCT00754819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24557908|NCT00754819|Tubulin Modulators|tubulin modulators|mesh-ancestor
25682549|NCT05327439|Cholinergic Agents|cholinergic agents|mesh-ancestor
25682550|NCT05327439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25682551|NCT05327439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682552|NCT05327309|Bleomycin|bleomycin|mesh-list
25682553|NCT05327309|Propranolol|propranolol|mesh-list
24557909|NCT00754819|Antimitotic Agents|antimitotic agents|mesh-ancestor
24557910|NCT00754819|Mitosis Modulators|mitosis modulators|mesh-ancestor
25682554|NCT05327309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25682555|NCT05327309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24703535|NCT01472055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278023|NCT02354170|Abortifacient Agents|abortifacient agents|mesh-ancestor
25278024|NCT02354170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25278025|NCT02354170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278026|NCT02354170|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25278027|NCT02354170|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25278028|NCT02354170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25278029|NCT02354170|Contraceptive Agents|contraceptive agents|mesh-ancestor
25278030|NCT02354170|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25278031|NCT02354170|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24995552|NCT05071703|Carboplatin|carboplatin|mesh-list
24703536|NCT01472146|Doxorubicin|doxorubicin|mesh-list
24557911|NCT00754819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558017|NCT00755118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24558018|NCT00755118|Immunologic Factors|immunologic factors|mesh-ancestor
24558054|NCT00755209|Tranexamic Acid|tranexamic acid|mesh-list
24558258|NCT00755898|Dopamine Agents|dopamine agents|mesh-ancestor
24558259|NCT00755898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24558260|NCT00755898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558261|NCT00755898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127536|NCT03054766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25127537|NCT03054766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25127538|NCT03054766|Growth Substances|growth substances|mesh-ancestor
25127539|NCT03054766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127540|NCT03054766|Growth Inhibitors|growth inhibitors|mesh-ancestor
25127541|NCT03054766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25127542|NCT03054662|Hemostatics|hemostatics|mesh-list
25127543|NCT03054662|Coagulants|coagulants|mesh-ancestor
25127544|NCT03054610|Betamethasone|betamethasone|mesh-list
25127545|NCT03054610|Betamethasone Valerate|betamethasone valerate|mesh-list
25127546|NCT03054610|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25127547|NCT03054610|Betamethasone benzoate|betamethasone benzoate|mesh-list
25127548|NCT03054610|Ropivacaine|ropivacaine|mesh-list
25127549|NCT03054610|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
25127550|NCT03054610|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25127551|NCT03054610|Botulinum Toxins|botulinum toxins|mesh-list
25127552|NCT03054610|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25127553|NCT03054610|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24558262|NCT00755898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24558263|NCT00755898|Analgesics|analgesics|mesh-ancestor
24558323|NCT00756184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24558325|NCT00756301|Anesthetics, Local|anesthetics, local|mesh-ancestor
24558489|NCT00757458|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24558490|NCT00757458|Chelating Agents|chelating agents|mesh-ancestor
24558491|NCT00757458|Sequestering Agents|sequestering agents|mesh-ancestor
24558508|NCT00757549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24558509|NCT00757549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24558510|NCT00757549|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24558511|NCT00757549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558512|NCT00757679|Milnacipran|milnacipran|mesh-list
24558513|NCT00757679|Levomilnacipran|levomilnacipran|mesh-list
24558514|NCT00757679|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24558521|NCT00757679|Analgesics|analgesics|mesh-ancestor
24558578|NCT00757978|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25682556|NCT05327309|Adrenergic Agents|adrenergic agents|mesh-ancestor
25682557|NCT05327309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25682558|NCT05327309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682559|NCT05327309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682560|NCT05327309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25682561|NCT05327309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25682562|NCT05327309|Vasodilator Agents|vasodilator agents|mesh-ancestor
25682563|NCT05327309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25682564|NCT05327309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682565|NCT05327088|Dexmedetomidine|dexmedetomidine|mesh-list
25682566|NCT05327088|Nalbuphine|nalbuphine|mesh-list
25682567|NCT05327088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25278039|NCT02353949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278040|NCT02354027|Metformin|metformin|mesh-list
25278041|NCT02354027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25278042|NCT02354027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278043|NCT02354001|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25278044|NCT02354001|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24558709|NCT05435729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24558710|NCT05435729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127554|NCT03054610|Anesthetics, Local|anesthetics, local|mesh-ancestor
25127555|NCT03054610|Anesthetics|anesthetics|mesh-ancestor
25127556|NCT03054610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25127557|NCT03054610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127558|NCT03054610|Sensory System Agents|sensory system agents|mesh-ancestor
25127559|NCT03054610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25265451|NCT02433418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25127560|NCT03054610|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25127561|NCT03054610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25127562|NCT03054610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127563|NCT03054610|Cholinergic Agents|cholinergic agents|mesh-ancestor
25127564|NCT03054610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25127565|NCT03054610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25127566|NCT03054610|Glucocorticoids|glucocorticoids|mesh-ancestor
24804628|NCT02004067|Dermatologic Agents|dermatologic agents|mesh-ancestor
25127577|NCT03054480|Botulinum Toxins|botulinum toxins|mesh-list
25127578|NCT03054480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25127579|NCT03054480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25127580|NCT03054480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25127581|NCT03054480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25127582|NCT03054480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127583|NCT03054480|Cholinergic Agents|cholinergic agents|mesh-ancestor
25127584|NCT03054480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25127585|NCT03054480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127586|NCT03054480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25127587|NCT03054480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25127588|NCT03054207|Clopidogrel|clopidogrel|mesh-list
25127589|NCT03054207|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25127590|NCT03054207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25127591|NCT03054207|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25127593|NCT03054207|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25127605|NCT03054467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127606|NCT03054467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25127607|NCT03054467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127608|NCT03054467|Vasodilator Agents|vasodilator agents|mesh-ancestor
25127609|NCT03054168|Goserelin|goserelin|mesh-list
25127610|NCT03054168|Testosterone|testosterone|mesh-list
25127611|NCT03054168|Hormones|hormones|mesh-ancestor
25127684|NCT03053856|Tubulin Modulators|tubulin modulators|mesh-ancestor
25127612|NCT03054168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25127613|NCT03054168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127614|NCT03054168|Androgens|androgens|mesh-ancestor
25127615|NCT03054168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25127616|NCT03054168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25127617|NCT03054220|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25127618|NCT03054220|Tramadol|tramadol|mesh-list
25127619|NCT03054220|Dextromethorphan|dextromethorphan|mesh-list
25127620|NCT03054220|Paroxetine|paroxetine|mesh-list
25127621|NCT03054220|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25127622|NCT03054220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25127623|NCT03054220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25127636|NCT03054220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25127637|NCT03054220|Serotonin Agents|serotonin agents|mesh-ancestor
24957175|NCT03846765|Nasal Decongestants|nasal decongestants|mesh-ancestor
24558711|NCT05435729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558713|NCT05435677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25682568|NCT05327088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25682569|NCT05327088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682570|NCT05327088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25682571|NCT05327088|Analgesics|analgesics|mesh-ancestor
25682572|NCT05327088|Sensory System Agents|sensory system agents|mesh-ancestor
25682573|NCT05327088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24440795|NCT00284791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24440796|NCT00284791|Serotonin Agents|serotonin agents|mesh-ancestor
24440797|NCT00284791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440798|NCT00284791|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24440799|NCT00284791|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24440801|NCT00284791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703786|NCT01474304|Acetaminophen|acetaminophen|mesh-list
24703787|NCT01474304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24703788|NCT01474304|Analgesics|analgesics|mesh-ancestor
24703789|NCT01474304|Sensory System Agents|sensory system agents|mesh-ancestor
24703790|NCT01474304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24703791|NCT01474304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558714|NCT05435677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127639|NCT03054220|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25127640|NCT03054220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25127642|NCT03054220|Antitussive Agents|antitussive agents|mesh-ancestor
25127643|NCT03054220|Respiratory System Agents|respiratory system agents|mesh-ancestor
25127644|NCT03054220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25127645|NCT03054220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25127646|NCT03054259|Methylprednisolone|methylprednisolone|mesh-list
25127647|NCT03054259|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25127648|NCT03054259|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25127649|NCT03054259|Prednisolone|prednisolone|mesh-list
25127650|NCT03054259|Prednisolone acetate|prednisolone acetate|mesh-list
25127651|NCT03054259|Rituximab|rituximab|mesh-list
24458983|NCT00343369|Dexamethasone|dexamethasone|mesh-list
24459026|NCT00343369|Antiviral Agents|antiviral agents|mesh-ancestor
25127652|NCT03054259|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25127653|NCT03054259|Prednisolone phosphate|prednisolone phosphate|mesh-list
25127654|NCT03054259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25127655|NCT03054259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25127656|NCT03054259|Immunologic Factors|immunologic factors|mesh-ancestor
25127657|NCT03054259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127658|NCT03054259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25127659|NCT03054259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25127660|NCT03054259|Antiemetics|antiemetics|mesh-ancestor
25127661|NCT03054259|Autonomic Agents|autonomic agents|mesh-ancestor
25127662|NCT03054259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24558844|NCT05428306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24558845|NCT05428306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24558846|NCT05428306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558847|NCT05428293|Acetaminophen|acetaminophen|mesh-list
24558850|NCT05428293|Analgesics|analgesics|mesh-ancestor
24671006|NCT01323218|Vitamins|vitamins|mesh-ancestor
24559090|NCT05291364|Ethanol|ethanol|mesh-list
24559091|NCT05291364|Dexmedetomidine|dexmedetomidine|mesh-list
24559092|NCT05291364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24559093|NCT05291364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24559094|NCT05291364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127663|NCT03054259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25127664|NCT03054259|Glucocorticoids|glucocorticoids|mesh-ancestor
25127665|NCT03054259|Hormones|hormones|mesh-ancestor
25127666|NCT03054259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25127667|NCT03054259|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25127668|NCT03054259|Protective Agents|protective agents|mesh-ancestor
25127669|NCT03054259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25127670|NCT03053739|Bosentan|bosentan|mesh-list
25127672|NCT03053739|Vasodilator Agents|vasodilator agents|mesh-ancestor
25127673|NCT03053739|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25127674|NCT03053739|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25127675|NCT03053739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25682574|NCT05327088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25682575|NCT05327088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25682576|NCT05327088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25682577|NCT05327088|Adrenergic Agents|adrenergic agents|mesh-ancestor
25682578|NCT05327088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25682579|NCT05327088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682580|NCT05327088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25682581|NCT05327088|Narcotics|narcotics|mesh-ancestor
25682582|NCT05326997|Tranexamic Acid|tranexamic acid|mesh-list
25682583|NCT05326997|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25682584|NCT05326997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25682585|NCT05326997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25158893|NCT04109066|Paclitaxel|paclitaxel|mesh-list
25158894|NCT04109066|Cyclophosphamide|cyclophosphamide|mesh-list
25158895|NCT04109066|Nivolumab|nivolumab|mesh-list
25127676|NCT03053739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127677|NCT03053739|Urological Agents|urological agents|mesh-ancestor
25127678|NCT03053739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25127679|NCT03053739|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25127680|NCT03053856|Paclitaxel|paclitaxel|mesh-list
25127681|NCT03053856|Pembrolizumab|pembrolizumab|mesh-list
25127682|NCT03053856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25127683|NCT03053856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25127687|NCT03053856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127688|NCT03053856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25127690|NCT03053869|Lorazepam|lorazepam|mesh-list
25127691|NCT03053869|Alprazolam|alprazolam|mesh-list
25127692|NCT03053869|Anticonvulsants|anticonvulsants|mesh-ancestor
25127693|NCT03053869|Antiemetics|antiemetics|mesh-ancestor
25127694|NCT03053869|Autonomic Agents|autonomic agents|mesh-ancestor
25127695|NCT03053869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25127696|NCT03053869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957268|NCT03845881|Oxycodone|oxycodone|mesh-list
24559095|NCT05291364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24559096|NCT05291364|Analgesics|analgesics|mesh-ancestor
24559097|NCT05291364|Sensory System Agents|sensory system agents|mesh-ancestor
24559098|NCT05291364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25127697|NCT03053869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25127698|NCT03053869|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25127699|NCT03053869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25127700|NCT03053869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25127701|NCT03053869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25127702|NCT03053869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25127703|NCT03053869|GABA Modulators|gaba modulators|mesh-ancestor
25127704|NCT03053869|GABA Agents|gaba agents|mesh-ancestor
25127705|NCT03053869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25127706|NCT03053869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127707|NCT03053869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25127708|NCT03053869|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25127709|NCT03053869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25127710|NCT03053869|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25127711|NCT03053869|Anesthetics, General|anesthetics, general|mesh-ancestor
25127712|NCT03053869|Anesthetics|anesthetics|mesh-ancestor
25127713|NCT03053947|Ketamine|ketamine|mesh-list
25127714|NCT03053947|Analgesics|analgesics|mesh-ancestor
25127715|NCT03053947|Sensory System Agents|sensory system agents|mesh-ancestor
25127716|NCT03053947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25127717|NCT03053947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127718|NCT03053947|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25127719|NCT03053947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24598772|NCT00958100|Tenofovir|tenofovir|mesh-list
25127748|NCT03053388|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25127749|NCT03053388|Antioxidants|antioxidants|mesh-ancestor
25127750|NCT03053388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127751|NCT03053388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25127752|NCT03053388|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25127753|NCT03053388|Vasodilator Agents|vasodilator agents|mesh-ancestor
25127754|NCT03053388|Gasotransmitters|gasotransmitters|mesh-ancestor
25127755|NCT03053388|Protective Agents|protective agents|mesh-ancestor
25127756|NCT03053544|Metformin|metformin|mesh-list
25127757|NCT03053544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25127758|NCT03053544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127759|NCT03053622|Mirikizumab|mirikizumab|mesh-list
25127760|NCT03053622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25127761|NCT03053622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25127762|NCT03053622|Analgesics|analgesics|mesh-ancestor
25127763|NCT03053622|Sensory System Agents|sensory system agents|mesh-ancestor
25127764|NCT03053622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25127765|NCT03053622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127766|NCT03053622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25127767|NCT03053622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25127773|NCT03053414|Vitamin D|vitamin d|mesh-list
25127774|NCT03053414|Cholecalciferol|cholecalciferol|mesh-list
25682586|NCT05326997|Hemostatics|hemostatics|mesh-ancestor
25682587|NCT05326997|Coagulants|coagulants|mesh-ancestor
25682588|NCT05326984|Metformin|metformin|mesh-list
25127775|NCT03053414|Ergocalciferols|ergocalciferols|mesh-list
25127776|NCT03053414|Vitamins|vitamins|mesh-ancestor
25127777|NCT03053414|Micronutrients|micronutrients|mesh-ancestor
24459062|NCT00343447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25682589|NCT05326984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24704091|NCT01476488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441128|NCT00286143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24704100|NCT01476592|Antioxidants|antioxidants|mesh-ancestor
24613515|NCT01019447|Triclosan|triclosan|mesh-list
24613516|NCT01019447|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24613517|NCT01019447|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24613518|NCT01019447|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24613519|NCT01019447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24613520|NCT01019447|Antimetabolites|antimetabolites|mesh-ancestor
24574434|NCT00825188|Amlodipine|amlodipine|mesh-list
25127778|NCT03053414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127779|NCT03053414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25127780|NCT03053414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25127781|NCT03053505|Vancomycin|vancomycin|mesh-list
25127782|NCT03053505|Fidaxomicin|fidaxomicin|mesh-list
25127783|NCT03053505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25265518|NCT02433184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25045749|NCT00917826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045750|NCT00917826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045751|NCT00917293|Pyridoxal|pyridoxal|mesh-list
25045752|NCT00917293|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
25045753|NCT00917293|Vitamin B Complex|vitamin b complex|mesh-ancestor
25045754|NCT00917293|Vitamins|vitamins|mesh-ancestor
25045755|NCT00917293|Micronutrients|micronutrients|mesh-ancestor
25045756|NCT00917293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045757|NCT00914602|Levodopa|levodopa|mesh-list
25045758|NCT00914602|Carbidopa|carbidopa|mesh-list
25045759|NCT00914602|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25045760|NCT00914602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25045761|NCT00914602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25045762|NCT00914602|Dopamine Agents|dopamine agents|mesh-ancestor
25045763|NCT00914602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24804933|NCT02005783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25127798|NCT03053167|Irinotecan|irinotecan|mesh-list
25127799|NCT03053167|Raltitrexed|raltitrexed|mesh-list
25127800|NCT03053167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25127801|NCT03053167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25127802|NCT03053167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25127803|NCT03053167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127804|NCT03053167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25127805|NCT03053167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25127806|NCT03053167|Antimetabolites|antimetabolites|mesh-ancestor
25127807|NCT03053167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25127808|NCT03052673|Fentanyl|fentanyl|mesh-list
25127809|NCT03052673|Ketamine|ketamine|mesh-list
25127810|NCT03052673|Analgesics|analgesics|mesh-ancestor
25127811|NCT03052673|Sensory System Agents|sensory system agents|mesh-ancestor
25127827|NCT03052569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25127828|NCT03052569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25127829|NCT03052569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127830|NCT03052660|Midazolam|midazolam|mesh-list
25127831|NCT03052660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25127832|NCT03052660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25127833|NCT03052660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25127834|NCT03052660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127835|NCT03052660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25127836|NCT03052660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25127837|NCT03052660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25127838|NCT03052660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25127839|NCT03052660|Anesthetics, General|anesthetics, general|mesh-ancestor
25682590|NCT05326984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682591|NCT05326867|Lidocaine|lidocaine|mesh-list
25682592|NCT05326867|Anesthetics, Local|anesthetics, local|mesh-ancestor
25682593|NCT05326867|Anesthetics|anesthetics|mesh-ancestor
25682594|NCT05326867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25682595|NCT05326867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682596|NCT05326867|Sensory System Agents|sensory system agents|mesh-ancestor
25682597|NCT05326867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682598|NCT05326867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25682599|NCT05326867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25682600|NCT05326867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25682601|NCT05326867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25682602|NCT05326867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278116|NCT02353325|Vitamins|vitamins|mesh-ancestor
25278117|NCT02353325|Micronutrients|micronutrients|mesh-ancestor
25278118|NCT02353325|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25278119|NCT02353325|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25278120|NCT02353325|Cholinergic Agents|cholinergic agents|mesh-ancestor
25278121|NCT02353325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25278122|NCT02353325|Urological Agents|urological agents|mesh-ancestor
25278123|NCT02353260|Docetaxel|docetaxel|mesh-list
25278124|NCT02353260|Fluorouracil|fluorouracil|mesh-list
25278125|NCT02353260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278126|NCT02353260|Tubulin Modulators|tubulin modulators|mesh-ancestor
25278127|NCT02353260|Antimitotic Agents|antimitotic agents|mesh-ancestor
25278128|NCT02353260|Mitosis Modulators|mitosis modulators|mesh-ancestor
25278129|NCT02353260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278130|NCT02353260|Antimetabolites|antimetabolites|mesh-ancestor
25127840|NCT03052660|Anesthetics|anesthetics|mesh-ancestor
25127841|NCT03052660|GABA Modulators|gaba modulators|mesh-ancestor
25127842|NCT03052660|GABA Agents|gaba agents|mesh-ancestor
25127843|NCT03052660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25127844|NCT03052660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127845|NCT03052348|Fusidic Acid|fusidic acid|mesh-list
25127846|NCT03052348|Betamethasone|betamethasone|mesh-list
25127847|NCT03052348|Betamethasone Valerate|betamethasone valerate|mesh-list
25127848|NCT03052348|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25127849|NCT03052348|Betamethasone benzoate|betamethasone benzoate|mesh-list
25127850|NCT03052348|Ether|ether|mesh-list
24626698|NCT01088373|Antimetabolites|antimetabolites|mesh-ancestor
24559492|NCT04757584|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24559493|NCT04757584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24559494|NCT04757584|Adrenergic Agents|adrenergic agents|mesh-ancestor
24559495|NCT04757584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24559496|NCT04757584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24559497|NCT04757584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24559498|NCT04757584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25127851|NCT03052348|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25127852|NCT03052348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25127853|NCT03052348|Glucocorticoids|glucocorticoids|mesh-ancestor
25127855|NCT03052348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25127856|NCT03052348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127857|NCT03052348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25127858|NCT03052348|Respiratory System Agents|respiratory system agents|mesh-ancestor
25127859|NCT03052348|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25127860|NCT03052348|Anesthetics, General|anesthetics, general|mesh-ancestor
25127861|NCT03052348|Anesthetics|anesthetics|mesh-ancestor
25127862|NCT03052348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25127863|NCT03052348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25127864|NCT03052348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25127865|NCT03052348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25127866|NCT03052348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25127867|NCT03052348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127868|NCT03052400|Mifepristone|mifepristone|mesh-list
25127869|NCT03052400|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25127870|NCT03052400|Abortifacient Agents|abortifacient agents|mesh-ancestor
25127871|NCT03052400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25127872|NCT03052400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127873|NCT03052400|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25127874|NCT03052400|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25127875|NCT03052400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25127876|NCT03052400|Contraceptive Agents|contraceptive agents|mesh-ancestor
25127877|NCT03052400|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25682603|NCT05326841|Vitamin D|vitamin d|mesh-list
25682604|NCT05326841|Cholecalciferol|cholecalciferol|mesh-list
25682605|NCT05326841|Vitamins|vitamins|mesh-ancestor
25682606|NCT05326841|Micronutrients|micronutrients|mesh-ancestor
25682607|NCT05326841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682608|NCT05326841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25682609|NCT05326841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25682610|NCT05326776|Oxytocin|oxytocin|mesh-list
25682611|NCT05326776|Oxytocics|oxytocics|mesh-ancestor
25682612|NCT05326776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25682613|NCT05326776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682614|NCT05324995|Celecoxib|celecoxib|mesh-list
25682615|NCT05324995|Epinephrine|epinephrine|mesh-list
25682616|NCT05324995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25682617|NCT05324995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24704123|NCT01476774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24704124|NCT01476774|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24704126|NCT01476787|Lenalidomide|lenalidomide|mesh-list
24704127|NCT01476787|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24704128|NCT01476787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24704129|NCT01476787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24704130|NCT01476787|Immunologic Factors|immunologic factors|mesh-ancestor
24704131|NCT01476787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704132|NCT01476787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24704133|NCT01476787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24704134|NCT01476787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24704136|NCT01476787|Growth Inhibitors|growth inhibitors|mesh-ancestor
24704137|NCT01476787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25278154|NCT02353182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25127878|NCT03052400|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25127879|NCT03052400|Hormone Antagonists|hormone antagonists|mesh-ancestor
24443241|NCT00294190|Topotecan|topotecan|mesh-list
24671009|NCT01323218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25127886|NCT03052361|Autonomic Agents|autonomic agents|mesh-ancestor
25127887|NCT03052361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25127888|NCT03052361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127889|NCT03052361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25127890|NCT03052361|Antipruritics|antipruritics|mesh-ancestor
25127891|NCT03052361|Dermatologic Agents|dermatologic agents|mesh-ancestor
25127892|NCT03052361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25127893|NCT03052361|Serotonin Agents|serotonin agents|mesh-ancestor
25127894|NCT03052361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25127895|NCT03052361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127896|NCT03052361|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25127897|NCT03052361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25127898|NCT03052361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24560243|NCT03086369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24560244|NCT03086369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25127911|NCT03051945|Analgesics|analgesics|mesh-ancestor
25127912|NCT03051945|Sensory System Agents|sensory system agents|mesh-ancestor
25127913|NCT03051945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24957448|NCT03844776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24560317|NCT02927847|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24560500|NCT02471833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24560540|NCT02369458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24560541|NCT02312245|Gemcitabine|gemcitabine|mesh-list
24560542|NCT02312245|Paclitaxel|paclitaxel|mesh-list
24560543|NCT02312245|Bevacizumab|bevacizumab|mesh-list
24560544|NCT02312245|Doxorubicin|doxorubicin|mesh-list
24560545|NCT02312245|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24560546|NCT02312245|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24560547|NCT02312245|Topotecan|topotecan|mesh-list
24560548|NCT02312245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24560549|NCT02312245|Endothelial Growth Factors|endothelial growth factors|mesh-list
24560550|NCT02312245|Antibodies|antibodies|mesh-list
24560551|NCT02312245|Immunoglobulins|immunoglobulins|mesh-list
24560552|NCT02312245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24560600|NCT02255097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682618|NCT05324995|Adrenergic Agents|adrenergic agents|mesh-ancestor
25682619|NCT05324995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25682620|NCT05324995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682621|NCT05324995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682622|NCT05324995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25682623|NCT05324995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25682624|NCT05324995|Autonomic Agents|autonomic agents|mesh-ancestor
25682625|NCT05324995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682626|NCT05324995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25682627|NCT05324995|Respiratory System Agents|respiratory system agents|mesh-ancestor
25682628|NCT05324995|Mydriatics|mydriatics|mesh-ancestor
25682629|NCT05324995|Sympathomimetics|sympathomimetics|mesh-ancestor
25682630|NCT05324995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25682631|NCT05324995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24560602|NCT02218164|Interferon-alpha|interferon-alpha|mesh-list
24560603|NCT02218164|Interferon alpha-2|interferon alpha-2|mesh-list
25158993|NCT04082650|Vitamin D|vitamin d|mesh-list
25158994|NCT04082650|Vitamins|vitamins|mesh-ancestor
25158995|NCT04082650|Micronutrients|micronutrients|mesh-ancestor
25158996|NCT04082650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25158997|NCT04082650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24704138|NCT01476787|Alkylating Agents|alkylating agents|mesh-ancestor
24704139|NCT01476787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704180|NCT01477034|Vitamins|vitamins|mesh-list
24704181|NCT01477034|Micronutrients|micronutrients|mesh-ancestor
24704182|NCT01477034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704183|NCT01477034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24704184|NCT01477034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24704185|NCT01477060|Metformin|metformin|mesh-list
24560604|NCT02218164|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24560605|NCT02218164|Fluorouracil|fluorouracil|mesh-list
24560606|NCT02218164|Capecitabine|capecitabine|mesh-list
24560683|NCT01737502|Sirolimus|sirolimus|mesh-list
24560684|NCT01737502|Auranofin|auranofin|mesh-list
24560685|NCT01737502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24560686|NCT01737502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24560694|NCT01721759|Nivolumab|nivolumab|mesh-list
25127914|NCT03051945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127915|NCT03051945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25127916|NCT03051945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25127917|NCT03051945|Anesthetics, General|anesthetics, general|mesh-ancestor
24968048|NCT03754959|Midazolam|midazolam|mesh-list
25127918|NCT03051945|Anesthetics|anesthetics|mesh-ancestor
25127919|NCT03051945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25127920|NCT03051945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25127921|NCT03051945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25127922|NCT03051945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25127923|NCT03051945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127926|NCT03051906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25127927|NCT03051906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25127929|NCT03051841|Bortezomib|bortezomib|mesh-list
25127930|NCT03051841|CKD-581|ckd-581|mesh-list
25127931|NCT03051841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25127932|NCT03051841|Antiemetics|antiemetics|mesh-ancestor
25127933|NCT03051841|Autonomic Agents|autonomic agents|mesh-ancestor
25127934|NCT03051841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25127935|NCT03051841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127936|NCT03051841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25127937|NCT03051841|Glucocorticoids|glucocorticoids|mesh-ancestor
25127938|NCT03051841|Hormones|hormones|mesh-ancestor
25127939|NCT03051841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25127940|NCT03051841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25127941|NCT03051841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25127942|NCT03051841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25127943|NCT03051841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127944|NCT03051841|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25127945|NCT03051542|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25127946|NCT03051542|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25127947|NCT03051542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560766|NCT01451515|Prednisolone|prednisolone|mesh-list
24560767|NCT01451515|Hydrocortisone|hydrocortisone|mesh-list
24560768|NCT01451515|Cyclophosphamide|cyclophosphamide|mesh-list
24560769|NCT01451515|Doxorubicin|doxorubicin|mesh-list
24560770|NCT01451515|Methotrexate|methotrexate|mesh-list
25127948|NCT03051555|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25127949|NCT03051555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25127950|NCT03051555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127951|NCT03051711|Pyrazole|pyrazole|mesh-list
25682632|NCT05324995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25682633|NCT05324995|Analgesics|analgesics|mesh-ancestor
25682634|NCT05324995|Sensory System Agents|sensory system agents|mesh-ancestor
25682635|NCT05324995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25682636|NCT05324995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25682637|NCT05324995|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25682638|NCT05324995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25682639|NCT05324995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25682640|NCT05318521|Ibuprofen|ibuprofen|mesh-list
25682641|NCT05318521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25682642|NCT05318521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25682643|NCT05318521|Analgesics|analgesics|mesh-ancestor
25682644|NCT05318521|Sensory System Agents|sensory system agents|mesh-ancestor
24704297|NCT01477606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24704298|NCT01477606|Immunologic Factors|immunologic factors|mesh-ancestor
24704299|NCT01477606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644380|NCT01190683|Calcium, Dietary|calcium, dietary|mesh-list
24574714|NCT00826969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24704300|NCT01477606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25278190|NCT02352987|Salicylic Acid|salicylic acid|mesh-list
25278191|NCT02352987|Salicylates|salicylates|mesh-list
25278192|NCT02352987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25278193|NCT02352987|Antifungal Agents|antifungal agents|mesh-ancestor
25278194|NCT02352987|Keratolytic Agents|keratolytic agents|mesh-ancestor
25127952|NCT03051711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25127953|NCT03051711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127954|NCT03051568|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25127955|NCT03051568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25127956|NCT03051568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127957|NCT03051581|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25127958|NCT03051581|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25127959|NCT03051581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127960|NCT03051529|Anesthetics|anesthetics|mesh-list
25127961|NCT03051529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25127962|NCT03051529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127963|NCT03051698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25127964|NCT03051698|Metronidazole|metronidazole|mesh-list
25127965|NCT03051698|Vancomycin|vancomycin|mesh-list
25127966|NCT03051698|Ciprofloxacin|ciprofloxacin|mesh-list
25127967|NCT03051698|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25127968|NCT03051698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25127969|NCT03051698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25127970|NCT03051698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25127971|NCT03051698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25127972|NCT03051698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25127973|NCT03051698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25127974|NCT03051698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127975|NCT03051698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25127976|NCT03051698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25127977|NCT03051698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25127978|NCT03051698|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25127989|NCT03051503|Sensory System Agents|sensory system agents|mesh-ancestor
25127990|NCT03051503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25127991|NCT03051503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25127992|NCT03051503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25127993|NCT03051503|Anesthetics, General|anesthetics, general|mesh-ancestor
25127994|NCT03051503|Anesthetics|anesthetics|mesh-ancestor
25127995|NCT03051451|Metformin|metformin|mesh-list
25127996|NCT03051451|Fluoxetine|fluoxetine|mesh-list
25127997|NCT03051451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25127998|NCT03051451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127999|NCT03051451|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25128000|NCT03051451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25128001|NCT03051451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25128002|NCT03051451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957536|NCT03844178|Anesthetics|anesthetics|mesh-ancestor
24560799|NCT01451515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24560800|NCT01451515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24560802|NCT01451515|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24561203|NCT00759005|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24561204|NCT00759005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24561205|NCT00759005|Adrenergic Agents|adrenergic agents|mesh-ancestor
24561206|NCT00759005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24561207|NCT00759005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561211|NCT00759005|Vasodilator Agents|vasodilator agents|mesh-ancestor
24561286|NCT00759239|Timolol|timolol|mesh-list
24561287|NCT00759239|Travoprost|travoprost|mesh-list
25682645|NCT05318521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682646|NCT05318521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682647|NCT05318521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25682648|NCT05318521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25682649|NCT05318521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25682650|NCT05318521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25682651|NCT05318521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682652|NCT05304364|Naltrexone|naltrexone|mesh-list
25682653|NCT05304364|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25682654|NCT05304364|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24704424|NCT01478165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24704425|NCT01478165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704426|NCT01478230|Nicotine|nicotine|mesh-list
24704427|NCT01478230|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25278209|NCT02352714|Anesthetics|anesthetics|mesh-ancestor
25278210|NCT02352714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25278211|NCT02352714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278212|NCT02352714|Sensory System Agents|sensory system agents|mesh-ancestor
25278213|NCT02352714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25278214|NCT02352714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25278215|NCT02352714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25278216|NCT02352714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25278217|NCT02352714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24561288|NCT00759239|Maleic acid|maleic acid|mesh-list
24561289|NCT00759239|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24561290|NCT00759239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24561322|NCT00759421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24561377|NCT00759824|Anticonvulsants|anticonvulsants|mesh-ancestor
24561378|NCT00759824|GABA Agents|gaba agents|mesh-ancestor
24561379|NCT00759824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24561380|NCT00759824|Antimanic Agents|antimanic agents|mesh-ancestor
24561381|NCT00759824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24561382|NCT00759824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24561477|NCT00760864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24561478|NCT00760864|Immunologic Factors|immunologic factors|mesh-ancestor
24561479|NCT00760864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24561480|NCT00760864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24561481|NCT00760916|Treprostinil|treprostinil|mesh-list
24561482|NCT00760916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24561483|NCT00760968|Methotrexate|methotrexate|mesh-list
24561484|NCT00760968|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24561485|NCT00760968|Abortifacient Agents|abortifacient agents|mesh-ancestor
24561486|NCT00760968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24561487|NCT00760968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561488|NCT00760968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24561489|NCT00760968|Antimetabolites|antimetabolites|mesh-ancestor
24561490|NCT00760968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128003|NCT03051451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25128004|NCT03051451|Serotonin Agents|serotonin agents|mesh-ancestor
25128005|NCT03051451|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25128006|NCT03051451|Antidepressive Agents|antidepressive agents|mesh-ancestor
25128007|NCT03051451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25128008|NCT03051451|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25128009|NCT03051451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25128010|NCT03051451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128012|NCT03051373|Paclitaxel|paclitaxel|mesh-list
25128013|NCT03051373|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25128014|NCT03051373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25682655|NCT05304364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682656|NCT05304364|Sensory System Agents|sensory system agents|mesh-ancestor
25682657|NCT05304364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682658|NCT05302336|Cyclophosphamide|cyclophosphamide|mesh-list
25682659|NCT05302336|Docetaxel|docetaxel|mesh-list
25682660|NCT05302336|Doxorubicin|doxorubicin|mesh-list
25682661|NCT05302336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25682662|NCT05302336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25682663|NCT05302336|Immunologic Factors|immunologic factors|mesh-ancestor
25682664|NCT05302336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682665|NCT05302336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25682666|NCT05302336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25682667|NCT05302336|Alkylating Agents|alkylating agents|mesh-ancestor
25682668|NCT05302336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278241|NCT02352597|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25278242|NCT02352597|Contraceptive Agents|contraceptive agents|mesh-ancestor
25278243|NCT02352597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25278244|NCT02352597|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25128015|NCT03051373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25128016|NCT03051373|Tubulin Modulators|tubulin modulators|mesh-ancestor
25128017|NCT03051373|Antimitotic Agents|antimitotic agents|mesh-ancestor
25128018|NCT03051373|Mitosis Modulators|mitosis modulators|mesh-ancestor
25128019|NCT03051373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128020|NCT03051373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25128021|NCT03051373|Antimetabolites|antimetabolites|mesh-ancestor
25128022|NCT03051373|Antiviral Agents|antiviral agents|mesh-ancestor
25128023|NCT03051373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25128024|NCT03051373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128025|NCT03051373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25128026|NCT03051373|Immunologic Factors|immunologic factors|mesh-ancestor
25128027|NCT03051373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128028|NCT03051087|Ganirelix|ganirelix|mesh-list
25128052|NCT03050866|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25128053|NCT03050866|Histamine Agonists|histamine agonists|mesh-ancestor
25128054|NCT03050866|Histamine Agents|histamine agents|mesh-ancestor
25128055|NCT03050866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25128056|NCT03050866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128057|NCT03050866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128058|NCT03050866|Autonomic Agents|autonomic agents|mesh-ancestor
25128059|NCT03050866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25128060|NCT03050866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25128061|NCT03050905|Ritonavir|ritonavir|mesh-list
25128062|NCT03050905|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25128063|NCT03050905|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25128064|NCT03050905|Protease Inhibitors|protease inhibitors|mesh-ancestor
25128092|NCT03051009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128094|NCT03051022|Morphine|morphine|mesh-list
25128095|NCT03051022|Bupivacaine|bupivacaine|mesh-list
25128096|NCT03051022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25128097|NCT03051022|Antiemetics|antiemetics|mesh-ancestor
25128098|NCT03051022|Autonomic Agents|autonomic agents|mesh-ancestor
25128099|NCT03051022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25128100|NCT03051022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128101|NCT03051022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25128103|NCT03051022|Hormones|hormones|mesh-ancestor
25128131|NCT03050437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25128132|NCT03050411|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25128133|NCT03050411|Apatinib|apatinib|mesh-list
25128134|NCT03050411|Gefitinib|gefitinib|mesh-list
25128135|NCT03050411|Osimertinib|osimertinib|mesh-list
25128136|NCT03050411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25128137|NCT03050411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25128138|NCT03050411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128139|NCT03050411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128140|NCT03050554|Avelumab|avelumab|mesh-list
25128141|NCT03050554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25128142|NCT03050554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25128143|NCT03050086|Minocycline|minocycline|mesh-list
25128144|NCT03050086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25128145|NCT03050086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25128146|NCT03050242|Glycopyrrolate|glycopyrrolate|mesh-list
25128147|NCT03050242|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25128148|NCT03050242|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25128149|NCT03050242|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25128150|NCT03050242|Cholinergic Agents|cholinergic agents|mesh-ancestor
25128151|NCT03050242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25128152|NCT03050242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783472|NCT01902186|Ritonavir|ritonavir|mesh-list
24561491|NCT00760968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24561492|NCT00760968|Dermatologic Agents|dermatologic agents|mesh-ancestor
24561493|NCT00760968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24561494|NCT00760968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24671024|NCT01323257|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24561495|NCT00760968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24561496|NCT00760968|Immunologic Factors|immunologic factors|mesh-ancestor
24561497|NCT00760968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25682669|NCT05302336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682670|NCT05302336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25682671|NCT05302336|Tubulin Modulators|tubulin modulators|mesh-ancestor
25682672|NCT05302336|Antimitotic Agents|antimitotic agents|mesh-ancestor
25682673|NCT05302336|Mitosis Modulators|mitosis modulators|mesh-ancestor
25682674|NCT05302336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24704661|NCT01479556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24704677|NCT01479634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24704678|NCT01479634|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24704679|NCT01479634|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24704680|NCT01479634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24704681|NCT01479634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24704683|NCT01479751|Ketamine|ketamine|mesh-list
24704684|NCT01479751|Rocuronium|rocuronium|mesh-list
24704685|NCT01479751|Analgesics|analgesics|mesh-ancestor
24442421|NCT00290914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24561498|NCT00760968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24561499|NCT00760981|Imatinib Mesylate|imatinib mesylate|mesh-list
24561500|NCT00760981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24561549|NCT00761332|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
24561550|NCT00761332|Diphosphonates|diphosphonates|mesh-list
24561551|NCT00761332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24561552|NCT00761332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561553|NCT00761332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24561554|NCT00761332|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24561555|NCT00761332|Hormone Antagonists|hormone antagonists|mesh-ancestor
24561556|NCT00761332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24561557|NCT00761332|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24561606|NCT00761644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24561607|NCT00761644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24561608|NCT00761644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24561609|NCT00761644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561610|NCT00761644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24561611|NCT00761644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24561612|NCT00761644|Antifungal Agents|antifungal agents|mesh-ancestor
25128153|NCT03050242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128154|NCT03050177|Gefitinib|gefitinib|mesh-list
25128155|NCT03050177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25128156|NCT03050177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25128157|NCT03050177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128158|NCT03050177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128159|NCT03050229|Empagliflozin|empagliflozin|mesh-list
25128302|NCT03048942|Tubulin Modulators|tubulin modulators|mesh-ancestor
25128160|NCT03050229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25128161|NCT03050229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128162|NCT03050229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25128163|NCT03050229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128164|NCT03050164|Gefitinib|gefitinib|mesh-list
25128165|NCT03050164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25128166|NCT03050164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25128167|NCT03050164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128168|NCT03050164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128169|NCT03049930|Ketamine|ketamine|mesh-list
25128170|NCT03049930|Analgesics|analgesics|mesh-ancestor
25128171|NCT03049930|Sensory System Agents|sensory system agents|mesh-ancestor
25128172|NCT03049930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25128173|NCT03049930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128174|NCT03049930|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24561613|NCT00761644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24643284|NCT01185015|Nicorandil|nicorandil|mesh-list
24561614|NCT00761644|Immunologic Factors|immunologic factors|mesh-ancestor
25682675|NCT05302336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25682676|NCT05302336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25682677|NCT05302336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25682678|NCT05301712|Naloxone|naloxone|mesh-list
25682679|NCT05301712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25682680|NCT05301712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682681|NCT05301712|Sensory System Agents|sensory system agents|mesh-ancestor
25682682|NCT05301712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682683|NCT05300841|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25682684|NCT05300841|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25682685|NCT05300841|Estradiol|estradiol|mesh-list
25682686|NCT05300841|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25682687|NCT05300841|Dydrogesterone|dydrogesterone|mesh-list
25682688|NCT05300841|Estrogens|estrogens|mesh-ancestor
25682690|NCT05300841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25682691|NCT05300841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704756|NCT01480050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278271|NCT02352402|Ticagrelor|ticagrelor|mesh-list
24575114|NCT00829634|Sympathomimetics|sympathomimetics|mesh-ancestor
25278272|NCT02352402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25278273|NCT02352402|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25278280|NCT02352285|Tolvaptan|tolvaptan|mesh-list
24561615|NCT00761670|Risperidone|risperidone|mesh-list
24561616|NCT00761670|Amisulpride|amisulpride|mesh-list
24561617|NCT00761670|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24561684|NCT00762255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24561685|NCT00762255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24561686|NCT00762255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24561687|NCT00762255|Growth Substances|growth substances|mesh-ancestor
24561688|NCT00762255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561689|NCT00762255|Growth Inhibitors|growth inhibitors|mesh-ancestor
24561690|NCT00762255|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24561691|NCT00762255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24561692|NCT00762255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24561693|NCT00762255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561694|NCT00762255|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24561695|NCT00762346|Zoledronic Acid|zoledronic acid|mesh-list
24561696|NCT00762346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24561697|NCT00762346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561698|NCT00762398|Chrysarobin|chrysarobin|mesh-list
24561701|NCT00762398|Analgesics|analgesics|mesh-ancestor
24561713|NCT00762567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24561714|NCT00762567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561715|NCT00762567|Sympathomimetics|sympathomimetics|mesh-ancestor
24561716|NCT00762567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24561717|NCT00762567|Respiratory System Agents|respiratory system agents|mesh-ancestor
24561720|NCT00762567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24393868|NCT00131053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128175|NCT03049930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25128176|NCT03049930|Anesthetics, General|anesthetics, general|mesh-ancestor
25128177|NCT03049930|Anesthetics|anesthetics|mesh-ancestor
25128178|NCT03049930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25128179|NCT03049930|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25128180|NCT03049930|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25128181|NCT03049930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25128182|NCT03049930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128183|NCT03049878|Acetaminophen|acetaminophen|mesh-list
25128184|NCT03049878|Codeine|codeine|mesh-list
25128185|NCT03049878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25128186|NCT03049878|Analgesics|analgesics|mesh-ancestor
25128187|NCT03049878|Sensory System Agents|sensory system agents|mesh-ancestor
25128188|NCT03049878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25128189|NCT03049878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128190|NCT03049878|Antipyretics|antipyretics|mesh-ancestor
25128191|NCT03049878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25128192|NCT03049878|Narcotics|narcotics|mesh-ancestor
25128193|NCT03049878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25128194|NCT03049878|Antitussive Agents|antitussive agents|mesh-ancestor
25128195|NCT03049878|Respiratory System Agents|respiratory system agents|mesh-ancestor
25128196|NCT03049163|Proxymetacaine|proxymetacaine|mesh-list
25128197|NCT03049163|Propoxycaine|propoxycaine|mesh-list
25128198|NCT03049163|Anesthetics|anesthetics|mesh-ancestor
25128199|NCT03049163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25128200|NCT03049163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128201|NCT03049163|Anesthetics, Local|anesthetics, local|mesh-ancestor
25128202|NCT03049163|Sensory System Agents|sensory system agents|mesh-ancestor
25128203|NCT03049163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25128204|NCT03049176|Tenofovir|tenofovir|mesh-list
25128205|NCT03049176|Emtricitabine|emtricitabine|mesh-list
25682692|NCT05300841|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25682693|NCT05300841|Contraceptive Agents|contraceptive agents|mesh-ancestor
25682694|NCT05300841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25682695|NCT05300841|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25682696|NCT05300841|Progestins|progestins|mesh-ancestor
25692514|NCT02000531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25692515|NCT02000531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704832|NCT01480752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24704834|NCT01480752|Sensory System Agents|sensory system agents|mesh-ancestor
24704835|NCT01480752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25128206|NCT03049176|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25128207|NCT03049176|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25128210|NCT03049176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25128211|NCT03049176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25128212|NCT03049176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128213|NCT03049176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128214|NCT03049176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25128215|NCT03049059|Hydroquinone|hydroquinone|mesh-list
25128216|NCT03049059|Antioxidants|antioxidants|mesh-ancestor
25128217|NCT03049059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128218|NCT03049059|Protective Agents|protective agents|mesh-ancestor
25128219|NCT03049059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128220|NCT03049059|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25128221|NCT03049293|Midazolam|midazolam|mesh-list
25128222|NCT03049293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25128223|NCT03049293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25128224|NCT03049293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25128225|NCT03049293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128226|NCT03049293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25128227|NCT03049293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25128228|NCT03049293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25128229|NCT03049293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25128230|NCT03049293|Anesthetics, General|anesthetics, general|mesh-ancestor
25128231|NCT03049293|Anesthetics|anesthetics|mesh-ancestor
25128232|NCT03049293|GABA Modulators|gaba modulators|mesh-ancestor
25128233|NCT03049293|GABA Agents|gaba agents|mesh-ancestor
25128234|NCT03049293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25128235|NCT03049293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128236|NCT03049267|Apremilast|apremilast|mesh-list
25128237|NCT03049267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24561833|NCT00763165|Protective Agents|protective agents|mesh-ancestor
24561834|NCT00763165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561835|NCT00763165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24561920|NCT00763763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24561921|NCT00763763|Interferon-alpha|interferon-alpha|mesh-list
24561922|NCT00763763|Dexamethasone|dexamethasone|mesh-list
24561923|NCT00763763|Vincristine|vincristine|mesh-list
24561924|NCT00763763|Imatinib Mesylate|imatinib mesylate|mesh-list
24561925|NCT00763763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24561926|NCT00763763|Antiemetics|antiemetics|mesh-ancestor
24561927|NCT00763763|Autonomic Agents|autonomic agents|mesh-ancestor
24443304|NCT00294463|Medroxyprogesterone|medroxyprogesterone|mesh-list
24562006|NCT00764036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25128238|NCT03049267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25128240|NCT03049267|Sensory System Agents|sensory system agents|mesh-ancestor
25128241|NCT03049267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25128242|NCT03049267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128243|NCT03049267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25128244|NCT03049267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25128245|NCT03049267|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25128246|NCT03049267|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24450699|NCT00320060|Vitamins|vitamins|mesh-ancestor
25128247|NCT03049267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128248|NCT03049267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128249|NCT03049046|Caffeic acid|caffeic acid|mesh-list
25128250|NCT03049046|Antioxidants|antioxidants|mesh-ancestor
25128251|NCT03049046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128252|NCT03049046|Protective Agents|protective agents|mesh-ancestor
25128253|NCT03049046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682697|NCT05290194|Capecitabine|capecitabine|mesh-list
25682698|NCT05290194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25682699|NCT05290194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25682700|NCT05290194|Antimetabolites|antimetabolites|mesh-ancestor
25128254|NCT03049085|Aspirin|aspirin|mesh-list
25278310|NCT02351973|Natriuretic Agents|natriuretic agents|mesh-ancestor
25278311|NCT02351973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278312|NCT02351973|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
25278313|NCT02351973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25278314|NCT02351973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25278315|NCT02351973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278318|NCT02352155|Epinephrine|epinephrine|mesh-list
25128256|NCT03049085|Vitamins|vitamins|mesh-ancestor
25128257|NCT03049085|Micronutrients|micronutrients|mesh-ancestor
25128258|NCT03049085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128259|NCT03049085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25128278|NCT03048877|Apatinib|apatinib|mesh-list
25128279|NCT03048877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25128280|NCT03048877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25128300|NCT03048942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25128307|NCT03048643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25128308|NCT03048474|Nivolumab|nivolumab|mesh-list
25128309|NCT03048474|Ipilimumab|ipilimumab|mesh-list
25128310|NCT03048474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25128311|NCT03048474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25128312|NCT03048474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25128313|NCT03048474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128314|NCT03048214|Anesthetics|anesthetics|mesh-list
25128315|NCT03048214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25128316|NCT03048214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128317|NCT03048110|Itraconazole|itraconazole|mesh-list
25128318|NCT03048110|Rifampin|rifampin|mesh-list
25128319|NCT03048110|Antifungal Agents|antifungal agents|mesh-ancestor
25128320|NCT03048110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25128321|NCT03048110|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25128322|NCT03048110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25128323|NCT03048110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128324|NCT03048110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128325|NCT03048110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25128326|NCT03048110|Hormone Antagonists|hormone antagonists|mesh-ancestor
25128327|NCT03048110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25128328|NCT03048110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128329|NCT03048110|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25128330|NCT03048110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25128331|NCT03048110|Antitubercular Agents|antitubercular agents|mesh-ancestor
25128332|NCT03048110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25128333|NCT03048110|Leprostatic Agents|leprostatic agents|mesh-ancestor
25128339|NCT03048110|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25128340|NCT03048110|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25128341|NCT03048097|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25128342|NCT03048097|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25128343|NCT03048097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128345|NCT03047837|Metformin|metformin|mesh-list
25128346|NCT03047837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25128347|NCT03047837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128348|NCT03047837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24968524|NCT03750669|Paclitaxel|paclitaxel|mesh-list
25128350|NCT03047837|Analgesics|analgesics|mesh-ancestor
25128351|NCT03047837|Sensory System Agents|sensory system agents|mesh-ancestor
25128352|NCT03047837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25128353|NCT03047837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25128354|NCT03047837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25128355|NCT03047837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24562007|NCT00764036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562008|NCT00764036|Antiviral Agents|antiviral agents|mesh-ancestor
24562009|NCT00764036|Schistosomicides|schistosomicides|mesh-ancestor
24562010|NCT00764036|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24562014|NCT00764062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24562015|NCT00764114|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25682701|NCT05290194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682702|NCT05290194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682703|NCT05287893|Pyronaridine|pyronaridine|mesh-list
25682704|NCT05287893|Antimalarials|antimalarials|mesh-ancestor
25682705|NCT05287893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25682706|NCT05287893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25682707|NCT05287893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25682708|NCT05251129|Atorvastatin|atorvastatin|mesh-list
25278350|NCT02352311|Vasodilator Agents|vasodilator agents|mesh-ancestor
25278351|NCT02352311|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25278352|NCT02352311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25278353|NCT02352311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25278354|NCT02352311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562016|NCT00764114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24562017|NCT00764140|Mitogens|mitogens|mesh-list
24562018|NCT00764140|Mitosis Modulators|mitosis modulators|mesh-ancestor
24562020|NCT00764166|Docetaxel|docetaxel|mesh-list
24443308|NCT00294463|Estrogens|estrogens|mesh-ancestor
25128357|NCT03047837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128358|NCT03047837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25128359|NCT03047837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25128360|NCT03047837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128361|NCT03047837|Antipyretics|antipyretics|mesh-ancestor
25128362|NCT03048084|Levetiracetam|levetiracetam|mesh-list
25128363|NCT03048084|Valproic Acid|valproic acid|mesh-list
25128364|NCT03048084|Anticonvulsants|anticonvulsants|mesh-ancestor
25128365|NCT03048084|Nootropic Agents|nootropic agents|mesh-ancestor
25128366|NCT03048084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128367|NCT03048084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128368|NCT03048084|GABA Agents|gaba agents|mesh-ancestor
25128369|NCT03048084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25128370|NCT03048084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128371|NCT03048084|Antimanic Agents|antimanic agents|mesh-ancestor
25128372|NCT03048084|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25128373|NCT03048084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25128374|NCT03048084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25128376|NCT03048136|Ipilimumab|ipilimumab|mesh-list
25128377|NCT03048136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25128378|NCT03048136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25128379|NCT03048136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25128380|NCT03048136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128381|NCT03047954|Broncho-Vaxom|broncho-vaxom|mesh-list
25128382|NCT03047954|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25128383|NCT03047954|Immunologic Factors|immunologic factors|mesh-ancestor
25128384|NCT03047954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128385|NCT03048019|Tirofiban|tirofiban|mesh-list
25128386|NCT03048019|Cangrelor|cangrelor|mesh-list
25128387|NCT03048019|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25128388|NCT03048019|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24562228|NCT00765024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24562229|NCT00765024|Tubulin Modulators|tubulin modulators|mesh-ancestor
24562230|NCT00765024|Antimitotic Agents|antimitotic agents|mesh-ancestor
24562231|NCT00765024|Mitosis Modulators|mitosis modulators|mesh-ancestor
24562232|NCT00765024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562233|NCT00765024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562235|NCT00765154|Darunavir|darunavir|mesh-list
24562236|NCT00765154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24562237|NCT00765154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25128389|NCT03048019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128390|NCT03048019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25128391|NCT03048019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25128392|NCT03048019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25128393|NCT03048019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25128394|NCT03048019|Purinergic Agents|purinergic agents|mesh-ancestor
25128395|NCT03048019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25128396|NCT03048019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128398|NCT03047772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25128399|NCT03047772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25128400|NCT03047772|Antimetabolites|antimetabolites|mesh-ancestor
25128401|NCT03047772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128402|NCT03047772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25128403|NCT03047772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25682709|NCT05251129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25682710|NCT05251129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25682711|NCT05251129|Antimetabolites|antimetabolites|mesh-ancestor
25682712|NCT05251129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682713|NCT05251129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25278384|NCT02351908|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25278385|NCT02351908|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25278386|NCT02351908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25278387|NCT02352064|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25278388|NCT02352064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25128404|NCT03047772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128405|NCT03047538|Amlodipine|amlodipine|mesh-list
25128406|NCT03047538|Perindopril|perindopril|mesh-list
25128407|NCT03047538|Atorvastatin|atorvastatin|mesh-list
25128408|NCT03047538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25128409|NCT03047538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25128410|NCT03047538|Antimetabolites|antimetabolites|mesh-ancestor
25128411|NCT03047538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128412|NCT03047538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25128413|NCT03047538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25128414|NCT03047538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128415|NCT03047538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25128416|NCT03047538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25128417|NCT03047538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25128418|NCT03047538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25128419|NCT03047538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128420|NCT03047538|Vasodilator Agents|vasodilator agents|mesh-ancestor
24968583|NCT03750383|Immunologic Factors|immunologic factors|mesh-ancestor
25128449|NCT03047278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128450|NCT03047278|Anticonvulsants|anticonvulsants|mesh-ancestor
25128451|NCT03047278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25128452|NCT03047278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25128453|NCT03047278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25128454|NCT03047278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25128455|NCT03047278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25128456|NCT03047278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25128457|NCT03047278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25128458|NCT03047278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128459|NCT03047278|Antimanic Agents|antimanic agents|mesh-ancestor
25128460|NCT03047278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25128461|NCT03047278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25128462|NCT03047278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25128463|NCT03047278|Histamine Antagonists|histamine antagonists|mesh-ancestor
25128464|NCT03047278|Histamine Agents|histamine agents|mesh-ancestor
25128465|NCT03047096|Hyaluronic Acid|hyaluronic acid|mesh-list
25128466|NCT03047096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25128467|NCT03047096|Immunologic Factors|immunologic factors|mesh-ancestor
25128468|NCT03047096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128469|NCT03047096|Viscosupplements|viscosupplements|mesh-ancestor
25128470|NCT03047096|Protective Agents|protective agents|mesh-ancestor
24459315|NCT00344253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24459319|NCT00344383|Norgestimate|norgestimate|mesh-list
25128472|NCT03046953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25128473|NCT03046953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25128474|NCT03046979|Apatinib|apatinib|mesh-list
25128475|NCT03046979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25128476|NCT03046979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25128477|NCT03046979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128478|NCT03046979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128479|NCT03047057|Lidocaine|lidocaine|mesh-list
25128490|NCT03047057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128492|NCT03047109|Oxymetazoline|oxymetazoline|mesh-list
25128493|NCT03047109|Ephedrine|ephedrine|mesh-list
25128494|NCT03047109|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25128495|NCT03047109|Mydriatics|mydriatics|mesh-ancestor
25128496|NCT03047109|Autonomic Agents|autonomic agents|mesh-ancestor
25128497|NCT03047109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25128498|NCT03047109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128499|NCT03047109|Sympathomimetics|sympathomimetics|mesh-ancestor
25128500|NCT03047109|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25128501|NCT03047109|Nasal Decongestants|nasal decongestants|mesh-ancestor
25128502|NCT03047109|Respiratory System Agents|respiratory system agents|mesh-ancestor
25128503|NCT03047109|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25128504|NCT03047109|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25682714|NCT05251129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25682715|NCT05251129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25682716|NCT05244226|Fentanyl|fentanyl|mesh-list
25682717|NCT05244226|Methadone|methadone|mesh-list
25682718|NCT05244226|Hydromorphone|hydromorphone|mesh-list
25682719|NCT05244226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25278413|NCT02351687|Pyrimethamine|pyrimethamine|mesh-list
25128505|NCT03047109|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25128506|NCT03047109|Adrenergic Agents|adrenergic agents|mesh-ancestor
25128507|NCT03047109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25128508|NCT03047109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128509|NCT03047109|Protective Agents|protective agents|mesh-ancestor
25128510|NCT03047109|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25128511|NCT03047265|Paclitaxel|paclitaxel|mesh-list
25128512|NCT03047265|Cisplatin|cisplatin|mesh-list
25128513|NCT03047265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25128514|NCT03047265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25128516|NCT03047265|Antimitotic Agents|antimitotic agents|mesh-ancestor
25128517|NCT03047265|Mitosis Modulators|mitosis modulators|mesh-ancestor
25128518|NCT03047265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128519|NCT03046901|Vancomycin|vancomycin|mesh-list
25128537|NCT03046719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128538|NCT03046719|Sensory System Agents|sensory system agents|mesh-ancestor
25128539|NCT03046719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25128540|NCT03046082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25128541|NCT03046082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25128542|NCT03046173|Mitogens|mitogens|mesh-list
25128543|NCT03046173|Mitosis Modulators|mitosis modulators|mesh-ancestor
25128544|NCT03046173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128545|NCT03046017|Lidocaine|lidocaine|mesh-list
25128549|NCT03046017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128550|NCT03046017|Sensory System Agents|sensory system agents|mesh-ancestor
25128551|NCT03046017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25128552|NCT03046017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25128553|NCT03046017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25128554|NCT03046017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25128555|NCT03046017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24856450|NCT02284412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128556|NCT03046017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562238|NCT00765154|Protease Inhibitors|protease inhibitors|mesh-ancestor
24562239|NCT00765154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562240|NCT00765154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562272|NCT00765271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24562317|NCT00765973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562318|NCT00765986|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24562319|NCT00765986|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
24562320|NCT00765986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24562321|NCT00765986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562322|NCT00766025|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24562323|NCT00766025|Calcium|calcium|mesh-list
24562324|NCT00766025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24562325|NCT00766025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562326|NCT00766025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24562327|NCT00766025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24562328|NCT00766025|Antimetabolites|antimetabolites|mesh-ancestor
24562329|NCT00766025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562330|NCT00766025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24562387|NCT00766285|Vaccines|vaccines|mesh-list
24562408|NCT00766350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24562409|NCT00766350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24562410|NCT00766350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24562411|NCT00766350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562413|NCT00766350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24562530|NCT00766870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24562636|NCT00767494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128560|NCT03046108|Triamcinolone|triamcinolone|mesh-list
25128561|NCT03046108|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25128562|NCT03046108|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25128563|NCT03046108|Mepivacaine|mepivacaine|mesh-list
25128564|NCT03046108|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25128565|NCT03046108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25128566|NCT03046108|Glucocorticoids|glucocorticoids|mesh-ancestor
25128568|NCT03046108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25128569|NCT03046108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128570|NCT03046108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25128571|NCT03046108|Immunologic Factors|immunologic factors|mesh-ancestor
25128572|NCT03046108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25682720|NCT05244226|Narcotics|narcotics|mesh-ancestor
25278445|NCT02351622|Autonomic Agents|autonomic agents|mesh-ancestor
25278446|NCT02351622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25278447|NCT02351622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278448|NCT02351622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25278449|NCT02351622|Glucocorticoids|glucocorticoids|mesh-ancestor
25278450|NCT02351622|Hormones|hormones|mesh-ancestor
25278451|NCT02351622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25278454|NCT02351622|Antioxidants|antioxidants|mesh-ancestor
25128573|NCT03046108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128574|NCT03046108|Anesthetics, Local|anesthetics, local|mesh-ancestor
25128575|NCT03046108|Anesthetics|anesthetics|mesh-ancestor
25128576|NCT03046108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25128577|NCT03046108|Sensory System Agents|sensory system agents|mesh-ancestor
25128578|NCT03046108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25128579|NCT03046290|Lidocaine|lidocaine|mesh-list
25128580|NCT03046290|Ropivacaine|ropivacaine|mesh-list
25128581|NCT03046290|Anesthetics, Local|anesthetics, local|mesh-ancestor
25128582|NCT03046290|Anesthetics|anesthetics|mesh-ancestor
25128583|NCT03046290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25128584|NCT03046290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128585|NCT03046290|Sensory System Agents|sensory system agents|mesh-ancestor
25128586|NCT03046290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25128587|NCT03046290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25128588|NCT03046290|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25128589|NCT03046290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25128590|NCT03046290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25128592|NCT03046238|Dexmedetomidine|dexmedetomidine|mesh-list
25128600|NCT03046238|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25128601|NCT03046238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25128602|NCT03046238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25128603|NCT03046238|Adrenergic Agents|adrenergic agents|mesh-ancestor
25128604|NCT03046238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24818032|NCT02086656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128605|NCT03046238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128606|NCT03045783|Cefotiam|cefotiam|mesh-list
25128607|NCT03045783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25128608|NCT03045783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25128609|NCT03045770|Leucovorin|leucovorin|mesh-list
25128610|NCT03045770|Paclitaxel|paclitaxel|mesh-list
25128611|NCT03045770|Fluorouracil|fluorouracil|mesh-list
25128612|NCT03045770|Oxaliplatin|oxaliplatin|mesh-list
25128613|NCT03045770|Irinotecan|irinotecan|mesh-list
25128614|NCT03045770|Calcium|calcium|mesh-list
25128615|NCT03045770|Levoleucovorin|levoleucovorin|mesh-list
25128616|NCT03045770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25128617|NCT03045770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25128618|NCT03045770|Tubulin Modulators|tubulin modulators|mesh-ancestor
25128619|NCT03045770|Antimitotic Agents|antimitotic agents|mesh-ancestor
25128654|NCT03045484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25128655|NCT03045484|Narcotics|narcotics|mesh-ancestor
25128656|NCT03045484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25128657|NCT03045484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128658|NCT03045484|Analgesics|analgesics|mesh-ancestor
25128659|NCT03045484|Sensory System Agents|sensory system agents|mesh-ancestor
25128660|NCT03045484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25128661|NCT03045471|Prednisolone|prednisolone|mesh-list
25128662|NCT03045471|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25128663|NCT03045471|Methylprednisolone|methylprednisolone|mesh-list
25128664|NCT03045471|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25128665|NCT03045471|Prednisolone acetate|prednisolone acetate|mesh-list
25128680|NCT03045471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25128681|NCT03045471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25128682|NCT03045471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25128683|NCT03045471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25128684|NCT03045471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25682721|NCT05244226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25682722|NCT05244226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682723|NCT05244226|Analgesics|analgesics|mesh-ancestor
25682724|NCT05244226|Sensory System Agents|sensory system agents|mesh-ancestor
25682725|NCT05244226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682726|NCT05244226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25682727|NCT05244226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25682728|NCT05244226|Anesthetics, General|anesthetics, general|mesh-ancestor
25278475|NCT02351297|Chelating Agents|chelating agents|mesh-ancestor
25278476|NCT02351297|Sequestering Agents|sequestering agents|mesh-ancestor
25278477|NCT02351297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278479|NCT02351232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25278480|NCT02351232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278481|NCT02351232|Incretins|incretins|mesh-ancestor
25278482|NCT02351232|Hormones|hormones|mesh-ancestor
25278483|NCT02351232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25278484|NCT02351427|Bortezomib|bortezomib|mesh-list
25278485|NCT02351427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278486|NCT02351310|Betamethasone|betamethasone|mesh-list
25278487|NCT02351310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25278488|NCT02351310|Glucocorticoids|glucocorticoids|mesh-ancestor
25278489|NCT02351310|Hormones|hormones|mesh-ancestor
25278490|NCT02351310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25278491|NCT02351310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278492|NCT02351310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25278493|NCT02351310|Respiratory System Agents|respiratory system agents|mesh-ancestor
25278494|NCT02351440|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24705146|NCT01482377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705147|NCT01482377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24705148|NCT01482377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705149|NCT01482377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705150|NCT01482416|Estrogens|estrogens|mesh-list
24705151|NCT01482416|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25128685|NCT03045471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128686|NCT03045471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25128687|NCT03045471|Glucocorticoids|glucocorticoids|mesh-ancestor
25128689|NCT03045471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25128690|NCT03045471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25128691|NCT03045471|Antiemetics|antiemetics|mesh-ancestor
25128692|NCT03045471|Autonomic Agents|autonomic agents|mesh-ancestor
25128693|NCT03045471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25128694|NCT03045471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25128695|NCT03045471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25128696|NCT03045471|Protective Agents|protective agents|mesh-ancestor
25128698|NCT03045471|Antimitotic Agents|antimitotic agents|mesh-ancestor
25128699|NCT03045471|Mitosis Modulators|mitosis modulators|mesh-ancestor
25128700|NCT03045510|Decitabine|decitabine|mesh-list
25128701|NCT03045510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25128702|NCT03045510|Antimetabolites|antimetabolites|mesh-ancestor
25128703|NCT03045510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128704|NCT03045510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25128705|NCT03045510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128706|NCT03045406|Dalteparin|dalteparin|mesh-list
25128707|NCT03045406|Tinzaparin|tinzaparin|mesh-list
24958112|NCT03836833|Lamivudine|lamivudine|mesh-list
25682729|NCT05244226|Anesthetics|anesthetics|mesh-ancestor
25682730|NCT05244226|Antitussive Agents|antitussive agents|mesh-ancestor
25682731|NCT05244226|Respiratory System Agents|respiratory system agents|mesh-ancestor
25682732|NCT05229653|Ketamine|ketamine|mesh-list
25682733|NCT05229653|Analgesics|analgesics|mesh-ancestor
25682734|NCT05229653|Sensory System Agents|sensory system agents|mesh-ancestor
25682735|NCT05229653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682736|NCT05229653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682737|NCT05229653|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25682738|NCT05229653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25682739|NCT05229653|Anesthetics, General|anesthetics, general|mesh-ancestor
25682740|NCT05229653|Anesthetics|anesthetics|mesh-ancestor
25682741|NCT05229653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25682742|NCT05229653|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25682743|NCT05229653|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25682744|NCT05229653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25682745|NCT05229653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682746|NCT05228574|Amiloride|amiloride|mesh-list
25682747|NCT05228574|Diuretics|diuretics|mesh-ancestor
25682748|NCT05228574|Natriuretic Agents|natriuretic agents|mesh-ancestor
25682749|NCT05228574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682750|NCT05228574|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
25682751|NCT05228574|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25682752|NCT05228574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25682753|NCT05228574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562645|NCT00767559|Warfarin|warfarin|mesh-list
25159279|NCT03918252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25159280|NCT03918252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25159281|NCT03918252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25159282|NCT03918252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278507|NCT02351128|Lanreotide|lanreotide|mesh-list
25278508|NCT02351128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278509|NCT02351102|Valacyclovir|valacyclovir|mesh-list
25278510|NCT02351102|Antiviral Agents|antiviral agents|mesh-ancestor
25278511|NCT02351102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25278512|NCT02350751|MEDI8852|medi8852|mesh-list
24562646|NCT00767559|Fondaparinux|fondaparinux|mesh-list
24562647|NCT00767559|Anticoagulants|anticoagulants|mesh-ancestor
24562648|NCT00767559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24562706|NCT00767728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24562707|NCT00767728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24562708|NCT00767754|Paroxetine|paroxetine|mesh-list
24562776|NCT00768183|Narcotics|narcotics|mesh-ancestor
24562847|NCT00768612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24562848|NCT00768612|Serotonin Agents|serotonin agents|mesh-ancestor
24562849|NCT00768612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24562850|NCT00768612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562851|NCT00768612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562852|NCT00768612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24562853|NCT00768612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24818033|NCT02086656|Growth Inhibitors|growth inhibitors|mesh-ancestor
25128708|NCT03045406|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25128709|NCT03045406|Apixaban|apixaban|mesh-list
25128710|NCT03045406|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25128711|NCT03045406|Antithrombins|antithrombins|mesh-ancestor
25128712|NCT03045406|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25128713|NCT03045406|Protease Inhibitors|protease inhibitors|mesh-ancestor
25128714|NCT03045406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128715|NCT03045406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128716|NCT03045406|Anticoagulants|anticoagulants|mesh-ancestor
25128717|NCT03045406|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25128718|NCT03045406|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25128719|NCT03045185|Metronidazole|metronidazole|mesh-list
25128720|NCT03045185|Ciprofloxacin|ciprofloxacin|mesh-list
25128721|NCT03045185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25128722|NCT03045185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25128723|NCT03045185|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25128724|NCT03045185|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25128725|NCT03045185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25128726|NCT03045185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25128727|NCT03045185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128728|NCT03045185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128729|NCT03045185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25128730|NCT03045185|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25128731|NCT03045185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25128732|NCT03045198|Azithromycin|azithromycin|mesh-list
25128733|NCT03045198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25128734|NCT03045198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25128736|NCT03045393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25128737|NCT03045393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25128738|NCT03045393|Tubulin Modulators|tubulin modulators|mesh-ancestor
25128739|NCT03045393|Antimitotic Agents|antimitotic agents|mesh-ancestor
25128740|NCT03045393|Mitosis Modulators|mitosis modulators|mesh-ancestor
25128742|NCT03045133|Morphine|morphine|mesh-list
25128751|NCT03045133|Antitussive Agents|antitussive agents|mesh-ancestor
25128752|NCT03045133|Respiratory System Agents|respiratory system agents|mesh-ancestor
25682754|NCT05228574|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
25682755|NCT05228574|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25682756|NCT05131919|Pembrolizumab|pembrolizumab|mesh-list
25682757|NCT05131919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25682758|NCT05131919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682759|NCT05058287|Methylprednisolone|methylprednisolone|mesh-list
25682760|NCT05058287|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25682761|NCT05058287|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25682762|NCT05058287|Prednisolone|prednisolone|mesh-list
25682763|NCT05058287|Prednisolone acetate|prednisolone acetate|mesh-list
25682764|NCT05058287|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25128753|NCT03045016|Prazosin|prazosin|mesh-list
24705157|NCT01482442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24705170|NCT01482468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705171|NCT01482559|Dopamine|dopamine|mesh-list
24705172|NCT01482559|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24705173|NCT01482559|Sympathomimetics|sympathomimetics|mesh-ancestor
24705174|NCT01482559|Autonomic Agents|autonomic agents|mesh-ancestor
24705222|NCT01482936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705223|NCT01482936|Analgesics|analgesics|mesh-ancestor
24705226|NCT01483014|Imatinib Mesylate|imatinib mesylate|mesh-list
24705227|NCT01483014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705228|NCT01483014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25128754|NCT03045016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25128755|NCT03045016|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25128756|NCT03045016|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25128757|NCT03045016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25128758|NCT03045016|Adrenergic Agents|adrenergic agents|mesh-ancestor
25128759|NCT03045016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25128760|NCT03045016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128761|NCT03045016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128764|NCT03044912|Mirabegron|mirabegron|mesh-list
25128765|NCT03044912|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25128766|NCT03044912|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25128767|NCT03044912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25128768|NCT03044912|Adrenergic Agents|adrenergic agents|mesh-ancestor
25128769|NCT03044912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25128770|NCT03044912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128771|NCT03044912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128772|NCT03044912|Urological Agents|urological agents|mesh-ancestor
25128773|NCT03044964|Ranolazine|ranolazine|mesh-list
25128774|NCT03044964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25128777|NCT03044873|BMS-986165|bms-986165|mesh-list
25128798|NCT03044743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128799|NCT03044743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25128800|NCT03044743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25128801|NCT03044743|Alkylating Agents|alkylating agents|mesh-ancestor
24968935|NCT03746821|Vitamins|vitamins|mesh-ancestor
25128802|NCT03044743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128803|NCT03044743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25128804|NCT03044743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25128805|NCT03044743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25128806|NCT03044743|Analgesics|analgesics|mesh-ancestor
25128807|NCT03044743|Sensory System Agents|sensory system agents|mesh-ancestor
25128808|NCT03044743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25128809|NCT03044795|Veliparib|veliparib|mesh-list
25128810|NCT03044795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25128811|NCT03044795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128812|NCT03044795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128813|NCT03044795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25128814|NCT03044665|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25128815|NCT03044665|Ezetimibe|ezetimibe|mesh-list
25128816|NCT03044665|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25128817|NCT03044665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25128818|NCT03044665|Antimetabolites|antimetabolites|mesh-ancestor
25128819|NCT03044665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128820|NCT03044665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25128821|NCT03044665|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25128822|NCT03044665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128823|NCT03044587|Leucovorin|leucovorin|mesh-list
25128824|NCT03044587|Gemcitabine|gemcitabine|mesh-list
24784863|NCT01910610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25682765|NCT05058287|Prednisolone phosphate|prednisolone phosphate|mesh-list
25682766|NCT05058287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25682767|NCT05058287|Antiemetics|antiemetics|mesh-ancestor
25682768|NCT05058287|Autonomic Agents|autonomic agents|mesh-ancestor
25682769|NCT05058287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682770|NCT05058287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682771|NCT05058287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25682772|NCT05058287|Glucocorticoids|glucocorticoids|mesh-ancestor
25682773|NCT05058287|Hormones|hormones|mesh-ancestor
25682774|NCT05058287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25682775|NCT05058287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25682776|NCT05058287|Protective Agents|protective agents|mesh-ancestor
25159350|NCT03887377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25159351|NCT03887377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25159352|NCT03887377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159353|NCT03887377|Cholinergic Agents|cholinergic agents|mesh-ancestor
25159354|NCT03887377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25159355|NCT03887377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118250|NCT04299113|Vinorelbine|vinorelbine|mesh-list
25128825|NCT03044587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25128826|NCT03044587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25128827|NCT03044587|Antimetabolites|antimetabolites|mesh-ancestor
25128828|NCT03044587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128829|NCT03044587|Antiviral Agents|antiviral agents|mesh-ancestor
25128830|NCT03044587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24958260|NCT03834935|Pimecrolimus|pimecrolimus|mesh-list
25128831|NCT03044587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128832|NCT03044587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25128833|NCT03044587|Immunologic Factors|immunologic factors|mesh-ancestor
25128834|NCT03044587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128835|NCT03044587|Antidotes|antidotes|mesh-ancestor
25128836|NCT03044587|Protective Agents|protective agents|mesh-ancestor
25128837|NCT03044587|Vitamin B Complex|vitamin b complex|mesh-ancestor
25128838|NCT03044587|Vitamins|vitamins|mesh-ancestor
25128839|NCT03044587|Micronutrients|micronutrients|mesh-ancestor
25128840|NCT03044808|Lidocaine|lidocaine|mesh-list
25128841|NCT03044808|Anesthetics, Local|anesthetics, local|mesh-ancestor
25128842|NCT03044808|Anesthetics|anesthetics|mesh-ancestor
25128843|NCT03044808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25128844|NCT03044808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128845|NCT03044808|Sensory System Agents|sensory system agents|mesh-ancestor
25128846|NCT03044808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25128847|NCT03044808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25128848|NCT03044808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25128849|NCT03044808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25128850|NCT03044808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25128851|NCT03044808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128852|NCT03044561|Sildenafil Citrate|sildenafil citrate|mesh-list
25128853|NCT03044561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128881|NCT03044639|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
25128882|NCT03044639|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25128883|NCT03044639|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25128885|NCT03044366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25128886|NCT03044366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128887|NCT03044379|Dapivirine|dapivirine|mesh-list
25128888|NCT03044379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25128889|NCT03044379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25128890|NCT03044379|Antiviral Agents|antiviral agents|mesh-ancestor
25128891|NCT03044379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25128892|NCT03044171|Listerine|listerine|mesh-list
25128893|NCT03044171|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25128894|NCT03044171|Fluorides|fluorides|mesh-list
25128895|NCT03044171|Sodium Fluoride|sodium fluoride|mesh-list
25128896|NCT03044171|Cariostatic Agents|cariostatic agents|mesh-ancestor
25128897|NCT03044171|Protective Agents|protective agents|mesh-ancestor
25129020|NCT03043430|Anesthetics|anesthetics|mesh-ancestor
25128904|NCT03044184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25265783|NCT02431728|Antioxidants|antioxidants|mesh-ancestor
25128905|NCT03044184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682777|NCT05058287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25682778|NCT05058287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682779|NCT04986072|Nitroprusside|nitroprusside|mesh-list
25682780|NCT04986072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25682781|NCT04986072|Vasodilator Agents|vasodilator agents|mesh-ancestor
25682782|NCT04986072|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25682783|NCT04986072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682784|NCT04981678|Buprenorphine|buprenorphine|mesh-list
25159382|NCT03851588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25159383|NCT03851588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128906|NCT03044184|Hemostatics|hemostatics|mesh-ancestor
25128907|NCT03044184|Coagulants|coagulants|mesh-ancestor
25128908|NCT03044184|Antidepressive Agents|antidepressive agents|mesh-ancestor
25128909|NCT03044184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25128910|NCT03044184|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25128911|NCT03044184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128912|NCT03044184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25128926|NCT03044093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25128927|NCT03044093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128928|NCT03044093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25128929|NCT03044093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25128930|NCT03044093|Oxytocics|oxytocics|mesh-ancestor
25128931|NCT03044093|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25128932|NCT03044093|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25128933|NCT03044093|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25128934|NCT03044093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25128935|NCT03044093|Contraceptive Agents|contraceptive agents|mesh-ancestor
25128936|NCT03044093|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25128937|NCT03044093|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25128938|NCT03044093|Hormone Antagonists|hormone antagonists|mesh-ancestor
25129170|NCT03042871|Ranibizumab|ranibizumab|mesh-list
25128939|NCT03044093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25128940|NCT03044093|Luteolytic Agents|luteolytic agents|mesh-ancestor
25128941|NCT03044093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25128942|NCT03044093|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25128943|NCT03044080|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25128944|NCT03044080|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25128945|NCT03044080|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25128946|NCT03044080|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25128947|NCT03044080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25128948|NCT03044080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128949|NCT03044080|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25128954|NCT03043677|Adalimumab|adalimumab|mesh-list
25128955|NCT03043677|Golimumab|golimumab|mesh-list
25128956|NCT03043677|Infliximab|infliximab|mesh-list
25128957|NCT03043677|Ustekinumab|ustekinumab|mesh-list
25128974|NCT03043820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25128975|NCT03043989|Clarithromycin|clarithromycin|mesh-list
25128976|NCT03043989|Docetaxel|docetaxel|mesh-list
25128977|NCT03043989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25128978|NCT03043989|Tubulin Modulators|tubulin modulators|mesh-ancestor
25128979|NCT03043989|Antimitotic Agents|antimitotic agents|mesh-ancestor
25128980|NCT03043989|Mitosis Modulators|mitosis modulators|mesh-ancestor
25128981|NCT03043989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128982|NCT03043989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25128983|NCT03043989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25128984|NCT03043989|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25128985|NCT03043989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128986|NCT03043989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25128987|NCT03043989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25128995|NCT03043612|Doxazosin|doxazosin|mesh-list
25128996|NCT03043612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25128997|NCT03043612|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25128998|NCT03043612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25128999|NCT03043612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25129000|NCT03043612|Adrenergic Agents|adrenergic agents|mesh-ancestor
25129001|NCT03043612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25129002|NCT03043612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129011|NCT03043430|Midazolam|midazolam|mesh-list
25129019|NCT03043430|Anesthetics, General|anesthetics, general|mesh-ancestor
25129021|NCT03043430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25129022|NCT03043430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24647019|NCT01205997|Fentanyl|fentanyl|mesh-list
25129023|NCT03043430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25129024|NCT03043430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25129025|NCT03043430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129026|NCT03043430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25129027|NCT03043430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25129028|NCT03043430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25682785|NCT04981678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25682786|NCT04981678|Narcotics|narcotics|mesh-ancestor
25682787|NCT04981678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25159422|NCT03828006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25159423|NCT03828006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25159424|NCT03818685|Capecitabine|capecitabine|mesh-list
25159425|NCT03818685|Nivolumab|nivolumab|mesh-list
25159426|NCT03818685|Ipilimumab|ipilimumab|mesh-list
25159427|NCT03818685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25159428|NCT03818685|Antimetabolites|antimetabolites|mesh-ancestor
25159429|NCT03818685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159430|NCT03818685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25159431|NCT03818685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25159432|NCT03818685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25129029|NCT03043430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25129030|NCT03043430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25129031|NCT03043430|GABA Modulators|gaba modulators|mesh-ancestor
25129032|NCT03043430|GABA Agents|gaba agents|mesh-ancestor
25129034|NCT03043248|Midazolam|midazolam|mesh-list
25129035|NCT03043248|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25129036|NCT03043248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25129037|NCT03043248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25129038|NCT03043248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129039|NCT03043248|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25129040|NCT03043248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25129041|NCT03043248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25129042|NCT03043248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25129043|NCT03043248|Anesthetics, General|anesthetics, general|mesh-ancestor
25129044|NCT03043248|Anesthetics|anesthetics|mesh-ancestor
25129045|NCT03043248|GABA Modulators|gaba modulators|mesh-ancestor
25129046|NCT03043248|GABA Agents|gaba agents|mesh-ancestor
25129047|NCT03043248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25129048|NCT03043248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129049|NCT03043248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25129050|NCT03043248|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25129051|NCT03043248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25129061|NCT03043326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25129062|NCT03043326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25129063|NCT03043482|Calcitriol|calcitriol|mesh-list
25129064|NCT03043482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25129065|NCT03043482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129066|NCT03043482|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25129067|NCT03043482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25129068|NCT03043482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129069|NCT03043482|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25129070|NCT03043482|Vitamins|vitamins|mesh-ancestor
25129071|NCT03043482|Micronutrients|micronutrients|mesh-ancestor
25129072|NCT03043482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25129073|NCT03043287|Botulinum Toxins|botulinum toxins|mesh-list
25129074|NCT03043287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25129075|NCT03043287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25682788|NCT04981678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682789|NCT04981678|Analgesics|analgesics|mesh-ancestor
25682790|NCT04981678|Sensory System Agents|sensory system agents|mesh-ancestor
25682791|NCT04981678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682792|NCT04981678|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25682793|NCT04969627|Metformin|metformin|mesh-list
25682794|NCT04969627|Exenatide|exenatide|mesh-list
25682795|NCT04969627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25682796|NCT04969627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682797|NCT04969627|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25682798|NCT04969627|Incretins|incretins|mesh-ancestor
25682799|NCT04969627|Hormones|hormones|mesh-ancestor
25682800|NCT04969627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25682801|NCT04956575|Vaccines|vaccines|mesh-list
25682802|NCT04956575|Immunologic Factors|immunologic factors|mesh-ancestor
25682803|NCT04956575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682804|NCT04953325|Vaccines|vaccines|mesh-list
25682805|NCT04953325|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25682806|NCT04953325|Immunologic Factors|immunologic factors|mesh-ancestor
25159458|NCT03798405|Analgesics|analgesics|mesh-list
25159459|NCT03798405|Narcotics|narcotics|mesh-list
25159460|NCT03798405|Sensory System Agents|sensory system agents|mesh-ancestor
25159461|NCT03798405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25159462|NCT03798405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159463|NCT03798405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25159470|NCT03789916|Aspirin|aspirin|mesh-list
25129076|NCT03043287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25129077|NCT03043287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25129078|NCT03043287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129079|NCT03043287|Cholinergic Agents|cholinergic agents|mesh-ancestor
25129080|NCT03043287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25129081|NCT03043287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129082|NCT03043287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25129083|NCT03043287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25129084|NCT03043443|Melatonin|melatonin|mesh-list
25129085|NCT03043443|Antioxidants|antioxidants|mesh-ancestor
25129086|NCT03043443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129087|NCT03043443|Protective Agents|protective agents|mesh-ancestor
25129105|NCT03043157|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25129106|NCT03043157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25129107|NCT03043157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129108|NCT03043196|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25129109|NCT03043196|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25129110|NCT03043196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25129112|NCT03043196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129113|NCT03043196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25129114|NCT03043196|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25129115|NCT03043196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25129116|NCT03043131|Plasma-lyte 148|plasma-lyte 148|mesh-list
25129117|NCT03043131|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25129118|NCT03043131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25129119|NCT03042936|Insulin|insulin|mesh-list
25129120|NCT03042936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25129121|NCT03042936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129123|NCT03042923|Lactulose|lactulose|mesh-list
25129124|NCT03042923|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25129125|NCT03042923|Diuretics|diuretics|mesh-ancestor
25129126|NCT03042923|Natriuretic Agents|natriuretic agents|mesh-ancestor
25129127|NCT03042923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129128|NCT03042923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25129129|NCT03043001|Memantine|memantine|mesh-list
25129130|NCT03043001|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25129131|NCT03043001|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25129132|NCT03043001|Dopamine Agents|dopamine agents|mesh-ancestor
25129133|NCT03043001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25129134|NCT03043001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129135|NCT03043001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129136|NCT03043001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25129137|NCT03043001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25129150|NCT03043014|Mifepristone|mifepristone|mesh-list
25129151|NCT03043014|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25129152|NCT03043014|Abortifacient Agents|abortifacient agents|mesh-ancestor
25129153|NCT03043014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25129154|NCT03043014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129155|NCT03043014|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25129156|NCT03043014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25129157|NCT03043014|Oxytocics|oxytocics|mesh-ancestor
25129158|NCT03043014|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25129159|NCT03043014|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25129160|NCT03043014|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25129161|NCT03043014|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25129162|NCT03043014|Contraceptive Agents|contraceptive agents|mesh-ancestor
25129163|NCT03043014|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25129164|NCT03043014|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25129165|NCT03043014|Hormone Antagonists|hormone antagonists|mesh-ancestor
25129166|NCT03043014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25682807|NCT04953325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682808|NCT04923776|Carboplatin|carboplatin|mesh-list
25682809|NCT04923776|Etoposide|etoposide|mesh-list
25682810|NCT04923776|Atezolizumab|atezolizumab|mesh-list
25682811|NCT04923776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682812|NCT04923776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25129167|NCT03043014|Luteolytic Agents|luteolytic agents|mesh-ancestor
25129168|NCT03043014|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25129169|NCT03043014|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25129175|NCT03042871|Growth Inhibitors|growth inhibitors|mesh-ancestor
25129176|NCT03042871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25129178|NCT03042546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25129179|NCT03042546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562880|NCT00768690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129181|NCT03042637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25129182|NCT03042637|Immunologic Factors|immunologic factors|mesh-ancestor
25129183|NCT03042637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129184|NCT03042637|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25129185|NCT03042637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25129186|NCT03042637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129187|NCT03042429|Cyclophosphamide|cyclophosphamide|mesh-list
25129189|NCT03042429|Cisplatin|cisplatin|mesh-list
25129190|NCT03042429|Doxorubicin|doxorubicin|mesh-list
25129191|NCT03042429|Etoposide|etoposide|mesh-list
25129193|NCT03042429|Vindesine|vindesine|mesh-list
25129194|NCT03042429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25129195|NCT03042429|Immunologic Factors|immunologic factors|mesh-ancestor
25129196|NCT03042429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129197|NCT03042429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25129198|NCT03042429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25129199|NCT03042429|Alkylating Agents|alkylating agents|mesh-ancestor
25129200|NCT03042429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129201|NCT03042429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25129202|NCT03042429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25129203|NCT03042429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25129204|NCT03042429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25129205|NCT03042429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25129206|NCT03042429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25129207|NCT03042429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25129208|NCT03042429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25129209|NCT03042429|Tubulin Modulators|tubulin modulators|mesh-ancestor
25129210|NCT03042429|Antimitotic Agents|antimitotic agents|mesh-ancestor
25129211|NCT03042429|Mitosis Modulators|mitosis modulators|mesh-ancestor
25129212|NCT03042377|Calcium, Dietary|calcium, dietary|mesh-list
25129213|NCT03042377|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25129226|NCT03042325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25129227|NCT03042325|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25129228|NCT03042325|Protease Inhibitors|protease inhibitors|mesh-ancestor
25129229|NCT03042325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25129230|NCT03042325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129231|NCT03042260|Trimethoprim|trimethoprim|mesh-list
25129232|NCT03042260|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25129233|NCT03042260|Sulfamethoxazole|sulfamethoxazole|mesh-list
25129234|NCT03042260|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25129235|NCT03042260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25129236|NCT03042260|Renal Agents|renal agents|mesh-ancestor
25129237|NCT03042260|Antimalarials|antimalarials|mesh-ancestor
25129238|NCT03042260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25129239|NCT03042260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25129240|NCT03042260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25129241|NCT03042260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25129242|NCT03042260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129243|NCT03042260|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25129244|NCT03042260|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25129245|NCT03042260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25129246|NCT03042260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25129247|NCT03042234|Insulin|insulin|mesh-list
25129248|NCT03042234|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25129249|NCT03042234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25129250|NCT03042234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129251|NCT03041935|Acetaminophen|acetaminophen|mesh-list
25129252|NCT03041935|Dexamethasone|dexamethasone|mesh-list
25129253|NCT03041935|Ketorolac|ketorolac|mesh-list
25129254|NCT03041935|Morphine|morphine|mesh-list
25129255|NCT03041935|Remifentanil|remifentanil|mesh-list
25129270|NCT03041935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25129271|NCT03041935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25129272|NCT03041935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25129273|NCT03041935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25129274|NCT03041935|Anesthetics, General|anesthetics, general|mesh-ancestor
25129276|NCT03041935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25129277|NCT03041935|Narcotics|narcotics|mesh-ancestor
25129278|NCT03041935|Analgesics|analgesics|mesh-ancestor
25129279|NCT03041935|Sensory System Agents|sensory system agents|mesh-ancestor
25129280|NCT03041935|Anesthetics, Local|anesthetics, local|mesh-ancestor
25129281|NCT03041935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25129282|NCT03041935|Antipyretics|antipyretics|mesh-ancestor
25129283|NCT03041935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25129284|NCT03041935|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25129285|NCT03041935|Antipruritics|antipruritics|mesh-ancestor
25129286|NCT03041935|Dermatologic Agents|dermatologic agents|mesh-ancestor
25129287|NCT03041935|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25129288|NCT03041935|Serotonin Agents|serotonin agents|mesh-ancestor
25129289|NCT03041935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25129290|NCT03041935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129291|NCT03041935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25129292|NCT03041935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25129293|NCT03041935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25129294|NCT03041935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25129295|NCT03041935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25129296|NCT03041935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25129297|NCT03041935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25129298|NCT03041935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25129300|NCT03042013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25129301|NCT03042013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24562881|NCT00768690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24562883|NCT00768729|Azathioprine|azathioprine|mesh-list
24562884|NCT00768729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24562885|NCT00768729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24562886|NCT00768729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24562887|NCT00768729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562920|NCT00768937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562921|NCT00768963|Ranibizumab|ranibizumab|mesh-list
24562922|NCT00768963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24562923|NCT00768963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24562924|NCT00768963|Growth Substances|growth substances|mesh-ancestor
25129302|NCT03042013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25129303|NCT03042013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129304|NCT03042000|Capecitabine|capecitabine|mesh-list
25129305|NCT03042000|Oxaliplatin|oxaliplatin|mesh-list
25129306|NCT03042000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25129307|NCT03042000|Antimetabolites|antimetabolites|mesh-ancestor
24856712|NCT02286544|Antimetabolites|antimetabolites|mesh-ancestor
25129308|NCT03042000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129309|NCT03042000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25129310|NCT03041948|Acetaminophen|acetaminophen|mesh-list
25129311|NCT03041948|Dexamethasone|dexamethasone|mesh-list
25129312|NCT03041948|Ketorolac|ketorolac|mesh-list
25129313|NCT03041948|Morphine|morphine|mesh-list
25129314|NCT03041948|Remifentanil|remifentanil|mesh-list
25129315|NCT03041948|Ondansetron|ondansetron|mesh-list
25129316|NCT03041948|Propofol|propofol|mesh-list
25129317|NCT03041948|Sevoflurane|sevoflurane|mesh-list
25129318|NCT03041948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25129319|NCT03041948|Antiemetics|antiemetics|mesh-ancestor
25129320|NCT03041948|Autonomic Agents|autonomic agents|mesh-ancestor
25129321|NCT03041948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25129322|NCT03041948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129323|NCT03041948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25129325|NCT03041948|Hormones|hormones|mesh-ancestor
25129358|NCT03042182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129360|NCT03042091|Ethanol|ethanol|mesh-list
25129361|NCT03042091|Neomycin|neomycin|mesh-list
25129362|NCT03042091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25129363|NCT03042091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25129364|NCT03042091|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25129365|NCT03042091|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25129366|NCT03042091|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25129367|NCT03042091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25129368|NCT03042091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129370|NCT03042091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25129371|NCT03042091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129372|NCT03042052|Botulinum Toxins|botulinum toxins|mesh-list
25129373|NCT03042052|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25129374|NCT03042052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25405451|NCT03606967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24613594|NCT01019850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613601|NCT01019876|Cyclophosphamide|cyclophosphamide|mesh-list
24613616|NCT01019941|Mitosis Modulators|mitosis modulators|mesh-ancestor
24613617|NCT01019941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613618|NCT01020136|Axitinib|axitinib|mesh-list
24613619|NCT01020136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613620|NCT01020136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24613621|NCT01020136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613622|NCT01020136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613623|NCT01020162|Gabapentin|gabapentin|mesh-list
24613624|NCT01020162|Amitriptyline|amitriptyline|mesh-list
24613625|NCT01020162|Analgesics|analgesics|mesh-ancestor
25129375|NCT03042052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129376|NCT03042052|Cholinergic Agents|cholinergic agents|mesh-ancestor
25129377|NCT03042052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25129378|NCT03042052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129379|NCT03041779|Acetaminophen|acetaminophen|mesh-list
25129380|NCT03041779|Diclofenac|diclofenac|mesh-list
25129381|NCT03041779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25129382|NCT03041779|Analgesics|analgesics|mesh-ancestor
25129383|NCT03041779|Sensory System Agents|sensory system agents|mesh-ancestor
25129384|NCT03041779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25129385|NCT03041779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129386|NCT03041779|Antipyretics|antipyretics|mesh-ancestor
25129387|NCT03041779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25129388|NCT03041779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25129389|NCT03041779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25129390|NCT03041779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25129391|NCT03041779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25129392|NCT03041779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129400|NCT03041506|Sensory System Agents|sensory system agents|mesh-ancestor
25129401|NCT03041506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25129402|NCT03041506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25129403|NCT03041506|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25129404|NCT03041506|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25129405|NCT03041506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25129406|NCT03041506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129408|NCT03041506|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25129409|NCT03041506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25129410|NCT03041506|Anesthetics, General|anesthetics, general|mesh-ancestor
25129411|NCT03041506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25129412|NCT03041506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25129413|NCT03041506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24562925|NCT00768963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562926|NCT00768963|Growth Inhibitors|growth inhibitors|mesh-ancestor
24562927|NCT00768963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562928|NCT00769041|Moxifloxacin|moxifloxacin|mesh-list
24562929|NCT00769041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24562930|NCT00769041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24563010|NCT00769405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24563011|NCT00769405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24563012|NCT00769405|Immunologic Factors|immunologic factors|mesh-ancestor
24563014|NCT00769405|Protective Agents|protective agents|mesh-ancestor
24563015|NCT00769405|Vitamin B Complex|vitamin b complex|mesh-ancestor
24563016|NCT00769405|Vitamins|vitamins|mesh-ancestor
24563017|NCT00769405|Micronutrients|micronutrients|mesh-ancestor
24563018|NCT00769470|Carboplatin|carboplatin|mesh-list
24563019|NCT00769470|Docetaxel|docetaxel|mesh-list
24563092|NCT00770042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563094|NCT00770042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25682813|NCT04923776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25682814|NCT04923776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25682815|NCT04923776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25682816|NCT04923776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682817|NCT04885712|Metformin|metformin|mesh-list
25682818|NCT04885712|Pioglitazone|pioglitazone|mesh-list
25682819|NCT04885712|Dapagliflozin|dapagliflozin|mesh-list
25682820|NCT04885712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25682821|NCT04885712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682822|NCT04885712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25682823|NCT04885712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692516|NCT02000531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24563095|NCT00770042|Antiviral Agents|antiviral agents|mesh-ancestor
25682824|NCT04871061|Fentanyl|fentanyl|mesh-list
25682825|NCT04871061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24705377|NCT01484717|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24705399|NCT01484990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705400|NCT01484990|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25278802|NCT02349581|Bupivacaine|bupivacaine|mesh-list
25278803|NCT02349581|Anesthetics, Local|anesthetics, local|mesh-ancestor
25278804|NCT02349581|Anesthetics|anesthetics|mesh-ancestor
25278805|NCT02349581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25278806|NCT02349581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278809|NCT02349607|Ibuprofen|ibuprofen|mesh-list
24563096|NCT00770042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24563097|NCT00770042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24563411|NCT00771433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24563412|NCT00771433|Immunologic Factors|immunologic factors|mesh-ancestor
24563413|NCT00771433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563415|NCT00771459|Anesthetics, Local|anesthetics, local|mesh-ancestor
24563416|NCT00771459|Anesthetics|anesthetics|mesh-ancestor
24459532|NCT00344981|Tenofovir|tenofovir|mesh-list
24563417|NCT00771459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24563418|NCT00771459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563437|NCT00771511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25129414|NCT03041506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25129415|NCT03041506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25129416|NCT03041506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25129417|NCT03041506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25129418|NCT03041506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25129420|NCT03041506|GABA Agents|gaba agents|mesh-ancestor
24647381|NCT01208480|Growth Inhibitors|growth inhibitors|mesh-ancestor
25129421|NCT03041259|Ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium D-pantothenate drug combination|ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium d-pantothenate drug combination|mesh-list
25129422|NCT03041259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25129423|NCT03041259|Antioxidants|antioxidants|mesh-ancestor
25129424|NCT03041259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129425|NCT03041259|Protective Agents|protective agents|mesh-ancestor
25129426|NCT03041259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129427|NCT03041207|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25129428|NCT03041207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25129429|NCT03041012|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25129430|NCT03041012|Romidepsin|romidepsin|mesh-list
25129431|NCT03041012|Antibodies, Blocking|antibodies, blocking|mesh-list
25129432|NCT03041012|Antiviral Agents|antiviral agents|mesh-ancestor
25129433|NCT03041012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25129434|NCT03041012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25129435|NCT03041012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25129436|NCT03041012|Immunologic Factors|immunologic factors|mesh-ancestor
25129437|NCT03041012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129438|NCT03040934|Sirolimus|sirolimus|mesh-list
25129439|NCT03040934|Everolimus|everolimus|mesh-list
25129440|NCT03040934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25129441|NCT03040934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25129442|NCT03040934|Immunologic Factors|immunologic factors|mesh-ancestor
25129443|NCT03040934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563438|NCT00771511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563439|NCT00771524|Ceftobiprole|ceftobiprole|mesh-list
24563440|NCT00771524|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
24563441|NCT00771524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24563442|NCT00771524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24563585|NCT00772499|Diuretics|diuretics|mesh-ancestor
24563586|NCT00772499|Natriuretic Agents|natriuretic agents|mesh-ancestor
24563587|NCT00772499|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24563627|NCT00772616|Analgesics|analgesics|mesh-ancestor
24563731|NCT00773149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682826|NCT04871061|Narcotics|narcotics|mesh-ancestor
25682827|NCT04871061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25682828|NCT04871061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682829|NCT04871061|Analgesics|analgesics|mesh-ancestor
25682830|NCT04871061|Sensory System Agents|sensory system agents|mesh-ancestor
25682831|NCT04871061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682832|NCT04871061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25682833|NCT04871061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25682834|NCT04871061|Anesthetics, General|anesthetics, general|mesh-ancestor
25682835|NCT04871061|Anesthetics|anesthetics|mesh-ancestor
24705447|NCT01485185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705448|NCT01485185|Cholinergic Agents|cholinergic agents|mesh-ancestor
24705449|NCT01485185|Nootropic Agents|nootropic agents|mesh-ancestor
25278824|NCT02349607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25102796|NCT03166553|Oxaliplatin|oxaliplatin|mesh-list
25278825|NCT02349607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25278826|NCT02349607|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25278827|NCT02349607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25129444|NCT03040934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25129445|NCT03040934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25129446|NCT03040934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25129447|NCT03040934|Antifungal Agents|antifungal agents|mesh-ancestor
25129449|NCT03040791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25129450|NCT03040791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25129451|NCT03040791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25129452|NCT03040791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129453|NCT03040830|Progesterone|progesterone|mesh-list
25129454|NCT03040830|Progestins|progestins|mesh-ancestor
25129456|NCT03040830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25129457|NCT03040830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129458|NCT03040752|Nifedipine|nifedipine|mesh-list
25129459|NCT03040752|Ritodrine|ritodrine|mesh-list
25129460|NCT03040752|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25129461|NCT03040752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25129462|NCT03040752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129463|NCT03040752|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25129464|NCT03040752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129465|NCT03040752|Vasodilator Agents|vasodilator agents|mesh-ancestor
25129466|NCT03040752|Tocolytic Agents|tocolytic agents|mesh-ancestor
25129467|NCT03040752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25129468|NCT03040752|Sympathomimetics|sympathomimetics|mesh-ancestor
25129469|NCT03040752|Autonomic Agents|autonomic agents|mesh-ancestor
25129470|NCT03040752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25129471|NCT03040752|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25129472|NCT03040752|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25129497|NCT03040531|Alendronate|alendronate|mesh-list
25129498|NCT03040531|Genistein|genistein|mesh-list
25129499|NCT03040531|Calcium|calcium|mesh-list
25129501|NCT03040531|Micronutrients|micronutrients|mesh-ancestor
25129502|NCT03040531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129503|NCT03040531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25129504|NCT03040531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25129505|NCT03040531|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25129506|NCT03040531|Protective Agents|protective agents|mesh-ancestor
25129507|NCT03040531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25129508|NCT03040531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25129509|NCT03040531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25129510|NCT03040531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129512|NCT03040531|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25129513|NCT03040531|Estrogens|estrogens|mesh-ancestor
25129514|NCT03040531|Hormones|hormones|mesh-ancestor
25129515|NCT03040531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25129516|NCT03040219|Folic Acid|folic acid|mesh-list
25129517|NCT03040219|Hematinics|hematinics|mesh-ancestor
25129518|NCT03040219|Vitamin B Complex|vitamin b complex|mesh-ancestor
25129519|NCT03040219|Vitamins|vitamins|mesh-ancestor
25129520|NCT03040219|Micronutrients|micronutrients|mesh-ancestor
25129521|NCT03040219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129522|NCT03040141|Oseltamivir|oseltamivir|mesh-list
25129523|NCT03040141|Antiviral Agents|antiviral agents|mesh-ancestor
25129524|NCT03040141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25129525|NCT03040141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25129526|NCT03040141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129527|NCT03040401|Aldesleukin|aldesleukin|mesh-list
25129528|NCT03040401|Interleukin-2|interleukin-2|mesh-list
24563732|NCT00773162|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24563733|NCT00773162|Antidepressive Agents|antidepressive agents|mesh-ancestor
25682836|NCT04838054|Chlorine dioxide|chlorine dioxide|mesh-list
25682837|NCT04838054|Dental Disinfectants|dental disinfectants|mesh-ancestor
25682838|NCT04838054|Disinfectants|disinfectants|mesh-ancestor
25682839|NCT04838054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25682840|NCT04837209|Niraparib|niraparib|mesh-list
25682841|NCT04837209|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25682842|NCT04837209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25682843|NCT04837209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278859|NCT02349165|Dermatologic Agents|dermatologic agents|mesh-ancestor
25278860|NCT02348905|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25278862|NCT02348905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25278863|NCT02348905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278864|NCT02349113|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25278865|NCT02349113|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25278866|NCT02349113|Estrogens|estrogens|mesh-list
25278867|NCT02349113|Estradiol|estradiol|mesh-list
25278868|NCT02349113|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25278869|NCT02349113|Hormones|hormones|mesh-ancestor
25278870|NCT02349113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25278871|NCT02349113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278872|NCT02349113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25278873|NCT02349113|Contraceptive Agents|contraceptive agents|mesh-ancestor
25278874|NCT02349113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25278875|NCT02349113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25278876|NCT02348788|Chloroquine|chloroquine|mesh-list
25278877|NCT02348788|Lumefantrine|lumefantrine|mesh-list
25278878|NCT02348788|Artemether|artemether|mesh-list
24563734|NCT00773162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24563735|NCT00773162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24563736|NCT00773162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24563737|NCT00773162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24563738|NCT00773162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563842|NCT00773916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24563843|NCT00773916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563844|NCT00773916|Dopamine Agents|dopamine agents|mesh-ancestor
24563858|NCT00774072|Tobramycin|tobramycin|mesh-list
24563882|NCT00774241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24563883|NCT00774241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24563884|NCT00774241|Growth Substances|growth substances|mesh-ancestor
25129530|NCT03040401|Histamine phosphate|histamine phosphate|mesh-list
25129531|NCT03040401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25129532|NCT03040401|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25129533|NCT03040401|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25129534|NCT03040401|Antiviral Agents|antiviral agents|mesh-ancestor
25129535|NCT03040401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25129536|NCT03040401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25129537|NCT03040401|Analgesics|analgesics|mesh-ancestor
25129538|NCT03040401|Sensory System Agents|sensory system agents|mesh-ancestor
25129539|NCT03040401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25129540|NCT03040401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129541|NCT03040401|Histamine Agonists|histamine agonists|mesh-ancestor
25129542|NCT03040401|Histamine Agents|histamine agents|mesh-ancestor
25129543|NCT03040401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25129544|NCT03040401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563885|NCT00774241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563886|NCT00774241|Growth Inhibitors|growth inhibitors|mesh-ancestor
24564069|NCT00775047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564070|NCT00775047|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24564071|NCT00775047|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24564072|NCT00775047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24564073|NCT00775047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682844|NCT04837209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682845|NCT04837066|Imidacloprid|imidacloprid|mesh-list
25682846|NCT04837066|Cholinergic Agents|cholinergic agents|mesh-ancestor
25682847|NCT04837066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25682848|NCT04837066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682849|NCT04837066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682850|NCT04827537|Metronidazole|metronidazole|mesh-list
25682851|NCT04827537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25682852|NCT04827537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25682853|NCT04827537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25682854|NCT04827537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25682855|NCT04814927|Copper|copper|mesh-list
25682856|NCT04814927|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25682857|NCT04814927|Levonorgestrel|levonorgestrel|mesh-list
25682858|NCT04814927|Medroxyprogesterone|medroxyprogesterone|mesh-list
25682859|NCT04814927|Etonogestrel|etonogestrel|mesh-list
25682860|NCT04814927|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25682861|NCT04814927|Contraceptive Agents|contraceptive agents|mesh-ancestor
25682862|NCT04814927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25682863|NCT04814927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278898|NCT02348528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25278899|NCT02348528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278900|NCT02348528|Immunologic Factors|immunologic factors|mesh-ancestor
25278901|NCT02348528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25278902|NCT02348528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24564074|NCT00775047|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24564075|NCT00775047|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24564076|NCT00775047|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24564086|NCT00775073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24564087|NCT00775073|Immunologic Factors|immunologic factors|mesh-ancestor
24647551|NCT01209403|Insulin|insulin|mesh-list
24647552|NCT01209403|Insulin Aspart|insulin aspart|mesh-list
24564089|NCT00775086|Norelgestromin|norelgestromin|mesh-list
24564090|NCT00775086|Contraceptive Agents|contraceptive agents|mesh-list
24564285|NCT00775762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564287|NCT00775762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24564333|NCT00775918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24564334|NCT00775918|Antimalarials|antimalarials|mesh-ancestor
24564335|NCT00775918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24564336|NCT00775918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24564337|NCT00775996|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
24564338|NCT00775996|Anticonvulsants|anticonvulsants|mesh-ancestor
24564499|NCT00776620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24564500|NCT00776620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564501|NCT00776620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24564502|NCT00776620|Immunologic Factors|immunologic factors|mesh-ancestor
24564504|NCT00776633|Clopidogrel|clopidogrel|mesh-list
24564505|NCT00776633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24564869|NCT00778063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24565199|NCT00779220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565200|NCT00779220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24565201|NCT00779220|Antimetabolites|antimetabolites|mesh-ancestor
24565203|NCT00779220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24565377|NCT00779935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24565378|NCT00780013|Metformin|metformin|mesh-list
24565379|NCT00780013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24565380|NCT00780013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565381|NCT00780039|Carboplatin|carboplatin|mesh-list
24565382|NCT00780039|Doxorubicin|doxorubicin|mesh-list
24565383|NCT00780039|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24565384|NCT00780039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25129546|NCT03040180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25129547|NCT03040180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25129548|NCT03040167|Epinephrine|epinephrine|mesh-list
25129549|NCT03040167|Bupivacaine|bupivacaine|mesh-list
25129550|NCT03040167|Anesthetics, Local|anesthetics, local|mesh-ancestor
25129551|NCT03040167|Anesthetics|anesthetics|mesh-ancestor
25129552|NCT03040167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25129553|NCT03040167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129554|NCT03040167|Sensory System Agents|sensory system agents|mesh-ancestor
25129555|NCT03040167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25129556|NCT03040167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25129557|NCT03040167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25129558|NCT03040167|Adrenergic Agents|adrenergic agents|mesh-ancestor
24459556|NCT00345059|Docetaxel|docetaxel|mesh-list
25129559|NCT03040167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25129560|NCT03040167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129561|NCT03040167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25129562|NCT03040167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25129563|NCT03040167|Autonomic Agents|autonomic agents|mesh-ancestor
25129564|NCT03040167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25129565|NCT03040167|Respiratory System Agents|respiratory system agents|mesh-ancestor
25129566|NCT03040167|Mydriatics|mydriatics|mesh-ancestor
25129567|NCT03040167|Sympathomimetics|sympathomimetics|mesh-ancestor
25129568|NCT03040167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25129569|NCT03040193|Lidocaine|lidocaine|mesh-list
25129570|NCT03040193|Anesthetics, Local|anesthetics, local|mesh-ancestor
25129571|NCT03040193|Anesthetics|anesthetics|mesh-ancestor
25129572|NCT03040193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25129573|NCT03040193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129574|NCT03040193|Sensory System Agents|sensory system agents|mesh-ancestor
25129575|NCT03040193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682864|NCT04814927|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25682865|NCT04814927|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25682866|NCT04814927|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25682867|NCT04814927|Trace Elements|trace elements|mesh-ancestor
25682868|NCT04814927|Micronutrients|micronutrients|mesh-ancestor
25129576|NCT03040193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25129577|NCT03040193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25129579|NCT03040193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24565385|NCT00780039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24565386|NCT00780039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24565387|NCT00780039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24565388|NCT00780039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565389|NCT00780039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565637|NCT00781521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24565638|NCT00781521|Renal Agents|renal agents|mesh-ancestor
25129580|NCT03040193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129581|NCT03040128|Minocycline|minocycline|mesh-list
25129582|NCT03040128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25129583|NCT03040128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25129584|NCT03039985|Lithium Carbonate|lithium carbonate|mesh-list
25129585|NCT03039985|Antidepressive Agents|antidepressive agents|mesh-ancestor
25129586|NCT03039985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25129587|NCT03039985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25129588|NCT03039985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129589|NCT03039985|Antimanic Agents|antimanic agents|mesh-ancestor
25129590|NCT03039985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25129591|NCT03039985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25129592|NCT03039985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129593|NCT03039842|Valproic Acid|valproic acid|mesh-list
25129594|NCT03039842|Memantine|memantine|mesh-list
25129595|NCT03039842|Dextromethorphan|dextromethorphan|mesh-list
25129596|NCT03039842|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25129597|NCT03039842|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25129598|NCT03039842|Dopamine Agents|dopamine agents|mesh-ancestor
25129599|NCT03039842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25129600|NCT03039842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129601|NCT03039842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129602|NCT03039842|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25129603|NCT03039842|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25129604|NCT03039842|Antitussive Agents|antitussive agents|mesh-ancestor
25129605|NCT03039842|Respiratory System Agents|respiratory system agents|mesh-ancestor
25129606|NCT03039842|Anticonvulsants|anticonvulsants|mesh-ancestor
25129607|NCT03039842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25129608|NCT03039842|GABA Agents|gaba agents|mesh-ancestor
25129609|NCT03039842|Antimanic Agents|antimanic agents|mesh-ancestor
25129610|NCT03039842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25129611|NCT03039842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25129612|NCT03039842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25129613|NCT03039608|Prednisone|prednisone|mesh-list
25129614|NCT03039608|Triamcinolone|triamcinolone|mesh-list
25129615|NCT03039608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25129618|NCT03039608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25129619|NCT03039608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129620|NCT03039608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25129621|NCT03039608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25129622|NCT03039413|Copper|copper|mesh-list
25129623|NCT03039413|Trace Elements|trace elements|mesh-ancestor
25129624|NCT03039413|Micronutrients|micronutrients|mesh-ancestor
25129625|NCT03039413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129626|NCT03039491|Vaccines|vaccines|mesh-list
25129627|NCT03039491|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25129628|NCT03039491|Immunologic Factors|immunologic factors|mesh-ancestor
25129629|NCT03039491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129630|NCT03039426|Diclofenac|diclofenac|mesh-list
25129631|NCT03039426|Bupivacaine|bupivacaine|mesh-list
25129632|NCT03039426|Anesthetics, Local|anesthetics, local|mesh-ancestor
25129633|NCT03039426|Anesthetics|anesthetics|mesh-ancestor
25129634|NCT03039426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25129635|NCT03039426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129636|NCT03039426|Sensory System Agents|sensory system agents|mesh-ancestor
25129637|NCT03039426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24958968|NCT03828682|Autonomic Agents|autonomic agents|mesh-ancestor
25129671|NCT03038919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25129672|NCT03038919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25129673|NCT03038919|Anabolic Agents|anabolic agents|mesh-ancestor
25129674|NCT03039101|Montelukast|montelukast|mesh-list
25129675|NCT03039101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25129676|NCT03039101|Respiratory System Agents|respiratory system agents|mesh-ancestor
25278956|NCT02348450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25278957|NCT02348450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25278958|NCT02348372|Glycine|glycine|mesh-list
25278959|NCT02348372|Glycine Agents|glycine agents|mesh-ancestor
25278960|NCT02348372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25278961|NCT02348372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278962|NCT02348372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278963|NCT02348281|Bicalutamide|bicalutamide|mesh-list
25278964|NCT02348281|Androgen Antagonists|androgen antagonists|mesh-ancestor
25278965|NCT02348281|Hormone Antagonists|hormone antagonists|mesh-ancestor
25278966|NCT02348281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25278967|NCT02348281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278968|NCT02348281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278969|NCT02348398|Topotecan|topotecan|mesh-list
25129677|NCT03039101|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25129678|NCT03039101|Hormone Antagonists|hormone antagonists|mesh-ancestor
25129679|NCT03039101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25129680|NCT03039101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129681|NCT03039101|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25129682|NCT03039101|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25129683|NCT03039101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129684|NCT03038958|Prilocaine|prilocaine|mesh-list
25129685|NCT03038958|Chloroprocaine|chloroprocaine|mesh-list
25129686|NCT03038958|Anesthetics, Local|anesthetics, local|mesh-ancestor
25129687|NCT03038958|Anesthetics|anesthetics|mesh-ancestor
25129688|NCT03038958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25129689|NCT03038958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129690|NCT03038958|Sensory System Agents|sensory system agents|mesh-ancestor
25129691|NCT03038958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25129728|NCT03038516|Vitamins|vitamins|mesh-ancestor
25129729|NCT03038516|Micronutrients|micronutrients|mesh-ancestor
25129730|NCT03038516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25129731|NCT03038477|Durvalumab|durvalumab|mesh-list
25129732|NCT03038477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25129733|NCT03038477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25129734|NCT03038503|Terlipressin|terlipressin|mesh-list
25129735|NCT03038503|Methylene Blue|methylene blue|mesh-list
25129736|NCT03038503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25129737|NCT03038503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129738|NCT03038503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25129739|NCT03038503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25129740|NCT03038451|Amlodipine|amlodipine|mesh-list
24959010|NCT03828032|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24959011|NCT03828032|Diuretics|diuretics|mesh-ancestor
24959012|NCT03828032|Natriuretic Agents|natriuretic agents|mesh-ancestor
24959013|NCT03828032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959014|NCT03827876|Calcitriol|calcitriol|mesh-list
24959015|NCT03827876|Betamethasone|betamethasone|mesh-list
24959016|NCT03827876|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25129744|NCT03038451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129745|NCT03038451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25129746|NCT03038451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129747|NCT03038451|Vasodilator Agents|vasodilator agents|mesh-ancestor
25129748|NCT03038243|Vaccines|vaccines|mesh-list
25129749|NCT03038243|Immunologic Factors|immunologic factors|mesh-ancestor
25129750|NCT03038243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129751|NCT03038295|Propranolol|propranolol|mesh-list
25129752|NCT03038295|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25682869|NCT04814927|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25682870|NCT04814927|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25682871|NCT04814927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25682872|NCT04814927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682873|NCT04810949|Vitamin D|vitamin d|mesh-list
25682874|NCT04810949|Cholecalciferol|cholecalciferol|mesh-list
25682875|NCT04810949|Vitamins|vitamins|mesh-ancestor
25682876|NCT04810949|Micronutrients|micronutrients|mesh-ancestor
25682877|NCT04810949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682878|NCT04810949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25682879|NCT04810949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25682880|NCT04807894|Testosterone|testosterone|mesh-list
25682881|NCT04807894|Androgens|androgens|mesh-ancestor
25682882|NCT04807894|Hormones|hormones|mesh-ancestor
25682883|NCT04807894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24705624|NCT01485848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24705625|NCT01485848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278980|NCT02348190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25278981|NCT02348190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25278982|NCT02348190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278983|NCT02348177|Ritonavir|ritonavir|mesh-list
25278984|NCT02348177|Lopinavir|lopinavir|mesh-list
25278985|NCT02348177|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25278986|NCT02348177|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25278987|NCT02348177|Protease Inhibitors|protease inhibitors|mesh-ancestor
25278988|NCT02348177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25278989|NCT02348177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278990|NCT02348177|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25278991|NCT02348177|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25129753|NCT03038295|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25129754|NCT03038295|Adrenergic Agents|adrenergic agents|mesh-ancestor
25129755|NCT03038295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25129756|NCT03038295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129757|NCT03038295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129758|NCT03038295|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25129759|NCT03038295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25129760|NCT03038295|Vasodilator Agents|vasodilator agents|mesh-ancestor
25129761|NCT03038321|Levofloxacin|levofloxacin|mesh-list
25129762|NCT03038321|Lornoxicam|lornoxicam|mesh-list
25129763|NCT03038321|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25129764|NCT03038321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25129765|NCT03038321|Renal Agents|renal agents|mesh-ancestor
25129779|NCT03038321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129780|NCT03038321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25129781|NCT03038321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25129782|NCT03038282|Chromium|chromium|mesh-list
25129783|NCT03038282|Chromous chloride|chromous chloride|mesh-list
25129784|NCT03038282|Trace Elements|trace elements|mesh-ancestor
25129785|NCT03038282|Micronutrients|micronutrients|mesh-ancestor
25129817|NCT03038334|Anesthetics|anesthetics|mesh-ancestor
25129818|NCT03038334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25129819|NCT03038334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25129820|NCT03038334|Anticonvulsants|anticonvulsants|mesh-ancestor
25129821|NCT03038334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25129822|NCT03038334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25129823|NCT03038334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129824|NCT03038334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25129825|NCT03038334|Tocolytic Agents|tocolytic agents|mesh-ancestor
25129826|NCT03038334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25129827|NCT03037970|Becaplermin|becaplermin|mesh-list
25129828|NCT03037970|Anticoagulants|anticoagulants|mesh-ancestor
25129829|NCT03037970|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
25129830|NCT03037970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25129831|NCT03037970|Growth Substances|growth substances|mesh-ancestor
25129832|NCT03037970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129833|NCT03037944|Drospirenone|drospirenone|mesh-list
25129834|NCT03037944|Levonorgestrel|levonorgestrel|mesh-list
25129835|NCT03037944|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25129836|NCT03037944|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
25129837|NCT03037944|Estradiol|estradiol|mesh-list
25129838|NCT03037944|Estrogens|estrogens|mesh-ancestor
25129839|NCT03037944|Hormones|hormones|mesh-ancestor
25129840|NCT03037944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25129841|NCT03037944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129842|NCT03037944|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25129843|NCT03037944|Contraceptive Agents|contraceptive agents|mesh-ancestor
25682884|NCT04807894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682885|NCT04795583|Prednisone|prednisone|mesh-list
25682886|NCT04795583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25682887|NCT04795583|Glucocorticoids|glucocorticoids|mesh-ancestor
25682888|NCT04795583|Hormones|hormones|mesh-ancestor
25682889|NCT04795583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25682890|NCT04795583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682891|NCT04795583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25682892|NCT04795583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682893|NCT04775173|Sirolimus|sirolimus|mesh-list
25682894|NCT04775173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25682895|NCT04775173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25682896|NCT04775173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25682897|NCT04775173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25279018|NCT02347891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279019|NCT02347865|Denosumab|denosumab|mesh-list
25279020|NCT02347865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25279021|NCT02347865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118721|NCT03906721|Oxycodone|oxycodone|mesh-list
25118722|NCT03906721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25118723|NCT03906721|Narcotics|narcotics|mesh-ancestor
25118724|NCT03906721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25118725|NCT03906721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118726|NCT03906721|Analgesics|analgesics|mesh-ancestor
25118727|NCT03906721|Sensory System Agents|sensory system agents|mesh-ancestor
25118728|NCT03906721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25118729|NCT03905811|Terazosin|terazosin|mesh-list
25129844|NCT03037944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25129845|NCT03037944|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25129846|NCT03037944|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25129847|NCT03037944|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25129848|NCT03037944|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25129852|NCT03037944|Diuretics|diuretics|mesh-ancestor
25129853|NCT03037944|Natriuretic Agents|natriuretic agents|mesh-ancestor
25129854|NCT03038048|Ranibizumab|ranibizumab|mesh-list
25129855|NCT03038048|Aflibercept|aflibercept|mesh-list
25129856|NCT03038048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25129857|NCT03038048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25129858|NCT03038048|Growth Substances|growth substances|mesh-ancestor
25129863|NCT03037775|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25129864|NCT03037775|Autonomic Agents|autonomic agents|mesh-ancestor
25129865|NCT03037775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24806351|NCT02015312|Trace Elements|trace elements|mesh-ancestor
25129866|NCT03037775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129867|NCT03037775|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25129868|NCT03037775|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25129869|NCT03037775|Cholinergic Agents|cholinergic agents|mesh-ancestor
25129916|NCT03037606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25129917|NCT03037606|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25129918|NCT03037606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25129919|NCT03037606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129921|NCT03037593|Cholecalciferol|cholecalciferol|mesh-list
25129922|NCT03037593|Vitamins|vitamins|mesh-ancestor
25129923|NCT03037593|Micronutrients|micronutrients|mesh-ancestor
25129924|NCT03037593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129925|NCT03037593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25129926|NCT03037593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25129927|NCT03037515|Tranexamic Acid|tranexamic acid|mesh-list
25129928|NCT03037515|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25129929|NCT03037515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25129930|NCT03037515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129931|NCT03037515|Hemostatics|hemostatics|mesh-ancestor
25129932|NCT03037515|Coagulants|coagulants|mesh-ancestor
24565639|NCT00781521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24565686|NCT00781820|Bifonazole|bifonazole|mesh-list
24565687|NCT00781820|Antifungal Agents|antifungal agents|mesh-ancestor
24565688|NCT00781820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24565689|NCT00781846|Sirolimus|sirolimus|mesh-list
24565690|NCT00781846|Bevacizumab|bevacizumab|mesh-list
24566375|NCT00785421|Protective Agents|protective agents|mesh-ancestor
25682898|NCT04775173|Antifungal Agents|antifungal agents|mesh-ancestor
25266031|NCT02429973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682899|NCT04775173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25682900|NCT04775173|Immunologic Factors|immunologic factors|mesh-ancestor
25682901|NCT04775173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682902|NCT04774068|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25682903|NCT04774068|Romidepsin|romidepsin|mesh-list
25682904|NCT04774068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25682905|NCT04774068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25682906|NCT04774068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682907|NCT04767191|Lumefantrine|lumefantrine|mesh-list
25682908|NCT04767191|Artemether|artemether|mesh-list
25682909|NCT04767191|Piperaquine|piperaquine|mesh-list
25682910|NCT04767191|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25682911|NCT04767191|Artenimol|artenimol|mesh-list
25682912|NCT04767191|Antimalarials|antimalarials|mesh-ancestor
24566376|NCT00785421|Vitamin B Complex|vitamin b complex|mesh-ancestor
24566420|NCT00785551|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24566566|NCT00786370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25279059|NCT02347059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25279060|NCT02347059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25279061|NCT02347059|Dopamine Agents|dopamine agents|mesh-ancestor
25279062|NCT02347059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25159780|NCT03642132|Growth Substances|growth substances|mesh-ancestor
25159781|NCT03642132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159782|NCT03642132|Growth Inhibitors|growth inhibitors|mesh-ancestor
25159783|NCT03642132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25159784|NCT03642132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25159785|NCT03642132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159801|NCT03615326|Pembrolizumab|pembrolizumab|mesh-list
25159802|NCT03615326|Capecitabine|capecitabine|mesh-list
25159803|NCT03615326|Oxaliplatin|oxaliplatin|mesh-list
25159804|NCT03615326|Trastuzumab|trastuzumab|mesh-list
25159805|NCT03615326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566567|NCT00786370|Adrenergic Agents|adrenergic agents|mesh-ancestor
24566568|NCT00786370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24566569|NCT00786370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566570|NCT00786383|Ramucirumab|ramucirumab|mesh-list
24566571|NCT00786383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566572|NCT00786396|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25129933|NCT03037372|Atorvastatin|atorvastatin|mesh-list
25129934|NCT03037372|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25129935|NCT03037372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
25129936|NCT03037372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25129937|NCT03037372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25129938|NCT03037372|Antimetabolites|antimetabolites|mesh-ancestor
25129939|NCT03037372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129940|NCT03037372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25129941|NCT03037372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25129954|NCT03036995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25129955|NCT03036995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25129956|NCT03036995|Analgesics|analgesics|mesh-ancestor
25129957|NCT03036995|Sensory System Agents|sensory system agents|mesh-ancestor
25129958|NCT03036995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25129959|NCT03036995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129960|NCT03036995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25129961|NCT03036995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25129962|NCT03036995|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25129963|NCT03036995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25129980|NCT03037073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25129981|NCT03037073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129983|NCT03037073|Sensory System Agents|sensory system agents|mesh-ancestor
25129984|NCT03037073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25129985|NCT03037073|Antidepressive Agents|antidepressive agents|mesh-ancestor
25129986|NCT03037073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25129987|NCT03037073|Dopamine Agents|dopamine agents|mesh-ancestor
25129988|NCT03036891|Naloxegol|naloxegol|mesh-list
25129989|NCT03036891|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25129990|NCT03036891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129991|NCT03036891|Sensory System Agents|sensory system agents|mesh-ancestor
25129992|NCT03036891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25129993|NCT03036800|Liraglutide|liraglutide|mesh-list
25129994|NCT03036800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25129995|NCT03036800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129996|NCT03036800|Incretins|incretins|mesh-ancestor
25129997|NCT03036800|Hormones|hormones|mesh-ancestor
25129998|NCT03036800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24628345|NCT01098357|Becaplermin|becaplermin|mesh-list
25682913|NCT04767191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25682914|NCT04767191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25682915|NCT04767191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25682916|NCT04728087|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
25682917|NCT04728087|Hemostatics|hemostatics|mesh-ancestor
25682918|NCT04728087|Coagulants|coagulants|mesh-ancestor
25682919|NCT04663347|Gemcitabine|gemcitabine|mesh-list
25682920|NCT04663347|Cytarabine|cytarabine|mesh-list
25682921|NCT04663347|Dexamethasone|dexamethasone|mesh-list
25682922|NCT04663347|Prednisone|prednisone|mesh-list
25682923|NCT04663347|Cyclophosphamide|cyclophosphamide|mesh-list
25682924|NCT04663347|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25682925|NCT04663347|Rituximab|rituximab|mesh-list
25682926|NCT04663347|Carboplatin|carboplatin|mesh-list
25682927|NCT04663347|Doxorubicin|doxorubicin|mesh-list
25130040|NCT03036605|Dexamethasone|dexamethasone|mesh-list
25682928|NCT04663347|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25682929|NCT04663347|Oxaliplatin|oxaliplatin|mesh-list
25682930|NCT04663347|Vincristine|vincristine|mesh-list
25279093|NCT02346682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279094|NCT02346682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25159812|NCT03610412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159813|NCT03610412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25159829|NCT03599323|Clotrimazole|clotrimazole|mesh-list
25159830|NCT03599323|Miconazole|miconazole|mesh-list
25159831|NCT03599323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25159832|NCT03599323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25159833|NCT03599323|Antifungal Agents|antifungal agents|mesh-ancestor
25159834|NCT03599323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25159835|NCT03599323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25130041|NCT03036605|Dexamethasone acetate|dexamethasone acetate|mesh-list
25130042|NCT03036605|Bupivacaine|bupivacaine|mesh-list
25130043|NCT03036605|BB 1101|bb 1101|mesh-list
25130044|NCT03036605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25130045|NCT03036605|Antiemetics|antiemetics|mesh-ancestor
25130046|NCT03036605|Autonomic Agents|autonomic agents|mesh-ancestor
25130047|NCT03036605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130048|NCT03036605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130049|NCT03036605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25130050|NCT03036605|Glucocorticoids|glucocorticoids|mesh-ancestor
25130051|NCT03036605|Hormones|hormones|mesh-ancestor
25130052|NCT03036605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25130053|NCT03036605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25130054|NCT03036605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25130055|NCT03036605|Protease Inhibitors|protease inhibitors|mesh-ancestor
25130056|NCT03036605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25130088|NCT03036644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25130089|NCT03036644|Autonomic Agents|autonomic agents|mesh-ancestor
25130090|NCT03036644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130091|NCT03036644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130092|NCT03036644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25130093|NCT03036644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25130094|NCT03036644|Cholinergic Agents|cholinergic agents|mesh-ancestor
25130095|NCT03036644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25130096|NCT03036644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130097|NCT03036046|Fluconazole|fluconazole|mesh-list
25130098|NCT03036046|Posaconazole|posaconazole|mesh-list
25130099|NCT03036046|Olorofim|olorofim|mesh-list
25130100|NCT03036046|Antifungal Agents|antifungal agents|mesh-ancestor
25130101|NCT03036046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25130102|NCT03036046|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25130103|NCT03036046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25130104|NCT03036046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25130105|NCT03036046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130106|NCT03036046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24648235|NCT01213238|Capecitabine|capecitabine|mesh-list
25130107|NCT03036046|Hormone Antagonists|hormone antagonists|mesh-ancestor
25130108|NCT03036046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25130109|NCT03036046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130110|NCT03036046|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25130111|NCT03036046|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25130112|NCT03036046|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25130113|NCT03036046|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25682931|NCT04663347|Lenalidomide|lenalidomide|mesh-list
25682932|NCT04663347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25682933|NCT04663347|Immunologic Factors|immunologic factors|mesh-ancestor
25682934|NCT04663347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682935|NCT04663347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25682936|NCT04663347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25682937|NCT04663347|Alkylating Agents|alkylating agents|mesh-ancestor
25682938|NCT04663347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682939|NCT04663347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682940|NCT04663347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25682941|NCT04663347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25279133|NCT02346357|Sensory System Agents|sensory system agents|mesh-ancestor
25159854|NCT03579966|Amifampridine|amifampridine|mesh-list
25159855|NCT03579966|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25159856|NCT03579966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25159857|NCT03579966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159858|NCT03579966|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25159859|NCT03579966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25159860|NCT03579966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159871|NCT03575195|Rifaximin|rifaximin|mesh-list
25159872|NCT03575195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25159873|NCT03575195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25159875|NCT03546361|Pembrolizumab|pembrolizumab|mesh-list
25130114|NCT03036046|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25130115|NCT03036202|Epinephrine|epinephrine|mesh-list
25130116|NCT03036202|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25130117|NCT03036202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25130118|NCT03036202|Adrenergic Agents|adrenergic agents|mesh-ancestor
25130119|NCT03036202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25130123|NCT03036202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25130124|NCT03036202|Autonomic Agents|autonomic agents|mesh-ancestor
25130125|NCT03036202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130126|NCT03036202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25130127|NCT03036202|Respiratory System Agents|respiratory system agents|mesh-ancestor
25130129|NCT03036202|Sympathomimetics|sympathomimetics|mesh-ancestor
25130130|NCT03036202|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25130132|NCT03036059|Albendazole|albendazole|mesh-list
25130133|NCT03036059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25130134|NCT03036059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25130135|NCT03036059|Anthelmintics|anthelmintics|mesh-ancestor
25130136|NCT03036059|Anticestodal Agents|anticestodal agents|mesh-ancestor
25130137|NCT03036059|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25130138|NCT03036059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25130139|NCT03036059|Tubulin Modulators|tubulin modulators|mesh-ancestor
25130140|NCT03036059|Antimitotic Agents|antimitotic agents|mesh-ancestor
25130141|NCT03036059|Mitosis Modulators|mitosis modulators|mesh-ancestor
25130142|NCT03036059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130143|NCT03036059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25130144|NCT03036111|Trimebutine|trimebutine|mesh-list
25130145|NCT03036111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25130146|NCT03036111|Parasympatholytics|parasympatholytics|mesh-ancestor
25130147|NCT03036111|Autonomic Agents|autonomic agents|mesh-ancestor
25130148|NCT03036111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130149|NCT03036111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130150|NCT03036085|Epinephrine|epinephrine|mesh-list
25130151|NCT03036085|Bupivacaine|bupivacaine|mesh-list
25130152|NCT03036085|Anesthetics, Local|anesthetics, local|mesh-ancestor
25130153|NCT03036085|Anesthetics|anesthetics|mesh-ancestor
25130154|NCT03036085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25130167|NCT03036085|Respiratory System Agents|respiratory system agents|mesh-ancestor
25130168|NCT03036085|Mydriatics|mydriatics|mesh-ancestor
25130169|NCT03036085|Sympathomimetics|sympathomimetics|mesh-ancestor
25130170|NCT03036085|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25130171|NCT03035838|Fosaprepitant|fosaprepitant|mesh-list
25130172|NCT03035838|Aprepitant|aprepitant|mesh-list
25130173|NCT03035838|Antiemetics|antiemetics|mesh-ancestor
25130174|NCT03035838|Autonomic Agents|autonomic agents|mesh-ancestor
25130175|NCT03035838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130176|NCT03035838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130177|NCT03035838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25130178|NCT03035838|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25130179|NCT03035838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25130180|NCT03035838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130181|NCT03035656|Ropivacaine|ropivacaine|mesh-list
25130182|NCT03035656|Anesthetics, Local|anesthetics, local|mesh-ancestor
25682942|NCT04663347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25682943|NCT04663347|Antiemetics|antiemetics|mesh-ancestor
25682944|NCT04663347|Autonomic Agents|autonomic agents|mesh-ancestor
25682945|NCT04663347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682946|NCT04663347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25682947|NCT04663347|Glucocorticoids|glucocorticoids|mesh-ancestor
25682948|NCT04663347|Hormones|hormones|mesh-ancestor
25682949|NCT04663347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25682950|NCT04663347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25682951|NCT04663347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25682952|NCT04663347|Antimetabolites|antimetabolites|mesh-ancestor
25682953|NCT04663347|Antiviral Agents|antiviral agents|mesh-ancestor
25692517|NCT02000531|Immunologic Factors|immunologic factors|mesh-ancestor
25279173|NCT02346110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25159890|NCT03539744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25159891|NCT03539744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25159892|NCT03539744|Immunologic Factors|immunologic factors|mesh-ancestor
25159893|NCT03539744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25159895|NCT03539744|Growth Substances|growth substances|mesh-ancestor
25130183|NCT03035656|Anesthetics|anesthetics|mesh-ancestor
25130184|NCT03035656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25130185|NCT03035656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130186|NCT03035656|Sensory System Agents|sensory system agents|mesh-ancestor
25130187|NCT03035656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130188|NCT03035695|Hemostatics|hemostatics|mesh-list
25130189|NCT03035695|Coagulants|coagulants|mesh-ancestor
25130190|NCT03035578|Morphine|morphine|mesh-list
25130191|NCT03035578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25130192|NCT03035578|Narcotics|narcotics|mesh-ancestor
25130193|NCT03035578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25130194|NCT03035578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130216|NCT03035305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25130217|NCT03035305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25130218|NCT03035305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130219|NCT03035305|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25130220|NCT03035305|Renal Agents|renal agents|mesh-ancestor
25130221|NCT03035214|Dexamethasone|dexamethasone|mesh-list
25130222|NCT03035214|Dexamethasone acetate|dexamethasone acetate|mesh-list
25130223|NCT03035214|BB 1101|bb 1101|mesh-list
25130224|NCT03035214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25130225|NCT03035214|Antiemetics|antiemetics|mesh-ancestor
25130226|NCT03035214|Autonomic Agents|autonomic agents|mesh-ancestor
25130227|NCT03035214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130228|NCT03035214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130229|NCT03035214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25130230|NCT03035214|Glucocorticoids|glucocorticoids|mesh-ancestor
25130231|NCT03035214|Hormones|hormones|mesh-ancestor
25130232|NCT03035214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25130233|NCT03035214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24566574|NCT00786396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24566575|NCT00786448|Darifenacin|darifenacin|mesh-list
24856919|NCT02287857|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24566576|NCT00786448|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24566577|NCT00786448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24566578|NCT00786448|Cholinergic Agents|cholinergic agents|mesh-ancestor
24566579|NCT00786448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24566580|NCT00786448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566581|NCT00786448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566582|NCT00786448|Urological Agents|urological agents|mesh-ancestor
24566593|NCT00786552|Antimitotic Agents|antimitotic agents|mesh-ancestor
24566594|NCT00786552|Mitosis Modulators|mitosis modulators|mesh-ancestor
24566699|NCT00787436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24566700|NCT00787436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24566701|NCT00787436|Adrenergic Agents|adrenergic agents|mesh-ancestor
24566917|NCT00788567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566918|NCT00788567|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24566919|NCT00788567|Antitubercular Agents|antitubercular agents|mesh-ancestor
24566920|NCT00788567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24566921|NCT00788567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24567513|NCT00791401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24567514|NCT00791401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567515|NCT00791401|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24567516|NCT00791401|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24567517|NCT00791401|Dopamine Agents|dopamine agents|mesh-ancestor
24567518|NCT00791427|Ranibizumab|ranibizumab|mesh-list
24567519|NCT00791427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24567520|NCT00791427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24567521|NCT00791427|Growth Substances|growth substances|mesh-ancestor
24567522|NCT00791427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567647|NCT00791856|Anabolic Agents|anabolic agents|mesh-ancestor
24567648|NCT00791895|Insulin Aspart|insulin aspart|mesh-list
25682954|NCT04663347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25682955|NCT04663347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25682956|NCT04663347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25682957|NCT04663347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25682958|NCT04663347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25682959|NCT04663347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25159951|NCT03428945|Hydroxychloroquine|hydroxychloroquine|mesh-list
25159952|NCT03428945|Antimalarials|antimalarials|mesh-ancestor
25159953|NCT03428945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25159954|NCT03428945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25159955|NCT03428945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25159956|NCT03428945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25159957|NCT03428945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159958|NCT03428945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25159960|NCT03421639|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25159961|NCT03421639|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25159962|NCT03421639|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25159963|NCT03421639|Fertility Agents|fertility agents|mesh-ancestor
25159964|NCT03421639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25159965|NCT03421639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159966|NCT03421639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25159967|NCT03421639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24567649|NCT00791895|Biphasic Insulins|biphasic insulins|mesh-list
24567650|NCT00791895|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24567651|NCT00791895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24567652|NCT00791895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567653|NCT00791960|Dimenhydrinate|dimenhydrinate|mesh-list
24567654|NCT00791960|Antiemetics|antiemetics|mesh-ancestor
24567697|NCT00792181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25130234|NCT03035214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25130235|NCT03035214|Protease Inhibitors|protease inhibitors|mesh-ancestor
25130236|NCT03035214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25130237|NCT03035214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130250|NCT03035084|Vitamins|vitamins|mesh-list
25130251|NCT03035084|Micronutrients|micronutrients|mesh-ancestor
25130252|NCT03035084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130253|NCT03035084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25130254|NCT03035084|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25130255|NCT03034941|Metformin|metformin|mesh-list
25130256|NCT03034941|Liraglutide|liraglutide|mesh-list
25130257|NCT03034941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25130258|NCT03034941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130259|NCT03034941|Incretins|incretins|mesh-ancestor
25130260|NCT03034941|Hormones|hormones|mesh-ancestor
25130261|NCT03034941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25130262|NCT03034850|Doxorubicin|doxorubicin|mesh-list
25130263|NCT03034850|Fluorouracil|fluorouracil|mesh-list
25130264|NCT03034850|Ifosfamide|ifosfamide|mesh-list
25130265|NCT03034850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25130266|NCT03034850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25130267|NCT03034850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25130268|NCT03034850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25130291|NCT03034733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25130292|NCT03034733|Antiemetics|antiemetics|mesh-ancestor
25130293|NCT03034733|Autonomic Agents|autonomic agents|mesh-ancestor
25130295|NCT03034733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130296|NCT03034733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25130297|NCT03034733|Glucocorticoids|glucocorticoids|mesh-ancestor
25130298|NCT03034733|Hormones|hormones|mesh-ancestor
25130299|NCT03034733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25130300|NCT03034733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25130301|NCT03034733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682960|NCT04663347|Tubulin Modulators|tubulin modulators|mesh-ancestor
25682961|NCT04663347|Antimitotic Agents|antimitotic agents|mesh-ancestor
25682962|NCT04663347|Mitosis Modulators|mitosis modulators|mesh-ancestor
25682963|NCT04663347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25682964|NCT04663347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25682965|NCT04663347|Growth Substances|growth substances|mesh-ancestor
25682966|NCT04663347|Growth Inhibitors|growth inhibitors|mesh-ancestor
25682967|NCT04654507|Dexamethasone|dexamethasone|mesh-list
25682968|NCT04654507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25682969|NCT04654507|Antiemetics|antiemetics|mesh-ancestor
25682970|NCT04654507|Autonomic Agents|autonomic agents|mesh-ancestor
25682971|NCT04654507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682972|NCT04654507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682973|NCT04654507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25682974|NCT04654507|Glucocorticoids|glucocorticoids|mesh-ancestor
25682975|NCT04654507|Hormones|hormones|mesh-ancestor
25682976|NCT04654507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25130303|NCT03034707|Vitamin B Complex|vitamin b complex|mesh-ancestor
24996630|NCT03104413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279254|NCT02345993|Glucocorticoids|glucocorticoids|mesh-ancestor
25279255|NCT02345993|Hormones|hormones|mesh-ancestor
25279256|NCT02345993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25279257|NCT02345980|Sildenafil Citrate|sildenafil citrate|mesh-list
25279258|NCT02345980|Vasodilator Agents|vasodilator agents|mesh-ancestor
25279259|NCT02345980|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24996637|NCT03091491|Nivolumab|nivolumab|mesh-list
24996638|NCT03091491|Ipilimumab|ipilimumab|mesh-list
24996639|NCT03091491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25130304|NCT03034707|Vitamins|vitamins|mesh-ancestor
25130305|NCT03034707|Micronutrients|micronutrients|mesh-ancestor
25130306|NCT03034707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130307|NCT03034408|Mannitol|mannitol|mesh-list
25130308|NCT03034408|Baclofen|baclofen|mesh-list
25130309|NCT03034408|Nalmefene|nalmefene|mesh-list
25130310|NCT03034408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25130311|NCT03034408|Diuretics|diuretics|mesh-ancestor
25130312|NCT03034408|Natriuretic Agents|natriuretic agents|mesh-ancestor
25130313|NCT03034408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130314|NCT03034408|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25130315|NCT03034408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25130316|NCT03034408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130317|NCT03034408|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25130318|NCT03034408|GABA Agonists|gaba agonists|mesh-ancestor
25130319|NCT03034408|GABA Agents|gaba agents|mesh-ancestor
25130320|NCT03034408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25130321|NCT03034408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130322|NCT03034408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25130323|NCT03034408|Sensory System Agents|sensory system agents|mesh-ancestor
25130324|NCT03034382|Lidocaine|lidocaine|mesh-list
25130325|NCT03034382|Epinephrine|epinephrine|mesh-list
25130326|NCT03034382|Morphine|morphine|mesh-list
25130327|NCT03034382|Nalbuphine|nalbuphine|mesh-list
25130328|NCT03034382|Bupivacaine|bupivacaine|mesh-list
25130329|NCT03034382|Anesthetics, Local|anesthetics, local|mesh-ancestor
25130330|NCT03034382|Anesthetics|anesthetics|mesh-ancestor
25130331|NCT03034382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25130332|NCT03034382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130333|NCT03034382|Sensory System Agents|sensory system agents|mesh-ancestor
25130335|NCT03034382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25130336|NCT03034382|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25130337|NCT03034382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25130338|NCT03034382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25130339|NCT03034382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130340|NCT03034382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25130341|NCT03034382|Narcotics|narcotics|mesh-ancestor
25130353|NCT03034382|Sympathomimetics|sympathomimetics|mesh-ancestor
25130354|NCT03034382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25130356|NCT03034304|Antibodies|antibodies|mesh-list
25130357|NCT03034304|Immunologic Factors|immunologic factors|mesh-ancestor
25130358|NCT03034304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130359|NCT03034304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25130360|NCT03034304|Alkylating Agents|alkylating agents|mesh-ancestor
25130361|NCT03034304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130362|NCT03034304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25130363|NCT03034005|Budesonide|budesonide|mesh-list
25130364|NCT03034005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25130365|NCT03034005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25130366|NCT03034005|Autonomic Agents|autonomic agents|mesh-ancestor
25130367|NCT03034005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130368|NCT03034005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130369|NCT03034005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24567698|NCT00792181|Anesthetics, General|anesthetics, general|mesh-ancestor
24567700|NCT00792181|GABA Modulators|gaba modulators|mesh-ancestor
24567701|NCT00792181|GABA Agents|gaba agents|mesh-ancestor
24567702|NCT00792181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25682977|NCT04654507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25682978|NCT04654507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682979|NCT04630834|Acetaminophen|acetaminophen|mesh-list
25682980|NCT04630834|Ibuprofen|ibuprofen|mesh-list
25682981|NCT04630834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25682982|NCT04630834|Analgesics|analgesics|mesh-ancestor
25682983|NCT04630834|Sensory System Agents|sensory system agents|mesh-ancestor
25682984|NCT04630834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682985|NCT04630834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25682986|NCT04630834|Antipyretics|antipyretics|mesh-ancestor
25279270|NCT02345746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279271|NCT02345746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25279272|NCT02345746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25279273|NCT02345746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25279274|NCT02345746|Immunologic Factors|immunologic factors|mesh-ancestor
25279275|NCT02345746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279277|NCT02345746|Protective Agents|protective agents|mesh-ancestor
25279278|NCT02345746|Vitamin B Complex|vitamin b complex|mesh-ancestor
25279279|NCT02345746|Vitamins|vitamins|mesh-ancestor
25279280|NCT02345746|Micronutrients|micronutrients|mesh-ancestor
25279281|NCT02345746|Hematinics|hematinics|mesh-ancestor
25279282|NCT02345707|Cabotegravir|cabotegravir|mesh-list
25279283|NCT02345707|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25279284|NCT02345707|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25279285|NCT02345707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279291|NCT02345616|Nitric Oxide|nitric oxide|mesh-list
25130370|NCT03034005|Respiratory System Agents|respiratory system agents|mesh-ancestor
25130371|NCT03034005|Glucocorticoids|glucocorticoids|mesh-ancestor
25130372|NCT03034005|Hormones|hormones|mesh-ancestor
25130373|NCT03034005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25130374|NCT03033589|Bupivacaine|bupivacaine|mesh-list
25130375|NCT03033589|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25130376|NCT03033589|Anesthetics, Local|anesthetics, local|mesh-ancestor
25130377|NCT03033589|Anesthetics|anesthetics|mesh-ancestor
25130378|NCT03033589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25130379|NCT03033589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130380|NCT03033589|Sensory System Agents|sensory system agents|mesh-ancestor
25130381|NCT03033589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130382|NCT03033537|Verapamil|verapamil|mesh-list
25130383|NCT03033537|Calcium Channel Blockers|calcium channel blockers|mesh-list
25130384|NCT03033537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25130385|NCT03033537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130386|NCT03033537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25130387|NCT03033537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25130388|NCT03033537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130389|NCT03033537|Vasodilator Agents|vasodilator agents|mesh-ancestor
25130411|NCT03033654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130412|NCT03033654|Dermatologic Agents|dermatologic agents|mesh-ancestor
25130413|NCT03033732|Buprenorphine|buprenorphine|mesh-list
25130414|NCT03033732|Methadone|methadone|mesh-list
25130415|NCT03033732|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25130416|NCT03033732|Naloxone|naloxone|mesh-list
25130417|NCT03033732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25130418|NCT03033732|Narcotics|narcotics|mesh-ancestor
25130419|NCT03033732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25682987|NCT04630834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25682988|NCT04630834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25682989|NCT04630834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25682990|NCT04630834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25682991|NCT04630834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25682992|NCT04630834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25682993|NCT04630769|Interleukin-2|interleukin-2|mesh-list
25682994|NCT04630769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25682995|NCT04630769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25682996|NCT04630769|Analgesics|analgesics|mesh-ancestor
25682997|NCT04630769|Sensory System Agents|sensory system agents|mesh-ancestor
25682998|NCT04630769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25682999|NCT04630769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683000|NCT04619680|Nintedanib|nintedanib|mesh-list
25683001|NCT04619680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683002|NCT04619680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25130420|NCT03033732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279313|NCT02345304|Digoxin|digoxin|mesh-list
25130421|NCT03033732|Analgesics|analgesics|mesh-ancestor
25130422|NCT03033732|Sensory System Agents|sensory system agents|mesh-ancestor
25130423|NCT03033732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130424|NCT03033732|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25130425|NCT03033732|Antitussive Agents|antitussive agents|mesh-ancestor
25130426|NCT03033732|Respiratory System Agents|respiratory system agents|mesh-ancestor
25130427|NCT03033472|Clindamycin|clindamycin|mesh-list
25130428|NCT03033472|Clindamycin palmitate|clindamycin palmitate|mesh-list
25130429|NCT03033472|Clindamycin phosphate|clindamycin phosphate|mesh-list
25130430|NCT03033472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25130431|NCT03033472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25130432|NCT03033472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25130433|NCT03033472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25130434|NCT03033472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130435|NCT03033836|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25130436|NCT03033836|Dolutegravir|dolutegravir|mesh-list
25130437|NCT03033836|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25130438|NCT03033836|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25130439|NCT03033836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25130447|NCT03033355|Botulinum Toxins|botulinum toxins|mesh-list
25130448|NCT03033355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25130449|NCT03033355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25130450|NCT03033355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25130451|NCT03033355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25130452|NCT03033355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130455|NCT03033355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130456|NCT03033355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25130457|NCT03033355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130458|NCT03033121|Hormones|hormones|mesh-list
24459676|NCT00345761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24459677|NCT00345761|Antimetabolites|antimetabolites|mesh-ancestor
24459678|NCT00345761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459679|NCT00345787|Buprenorphine|buprenorphine|mesh-list
24459680|NCT00345787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25130459|NCT03033121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25130460|NCT03033121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130461|NCT03033264|Dinoprostone|dinoprostone|mesh-list
25130462|NCT03033264|Oxytocics|oxytocics|mesh-ancestor
25130463|NCT03033264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25130464|NCT03033264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130465|NCT03033199|Dexamethasone|dexamethasone|mesh-list
25130466|NCT03033199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25130467|NCT03033199|Antiemetics|antiemetics|mesh-ancestor
25130468|NCT03033199|Autonomic Agents|autonomic agents|mesh-ancestor
25130469|NCT03033199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130470|NCT03033199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130471|NCT03033199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25130472|NCT03033199|Glucocorticoids|glucocorticoids|mesh-ancestor
25130473|NCT03033199|Hormones|hormones|mesh-ancestor
25130474|NCT03033199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25130476|NCT03033199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25130477|NCT03033368|Rilpivirine|rilpivirine|mesh-list
25130478|NCT03033368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25130479|NCT03033368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25130504|NCT03032978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130505|NCT03032978|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25130506|NCT03033160|Estradiol|estradiol|mesh-list
25130507|NCT03033160|Estrogens|estrogens|mesh-ancestor
25130508|NCT03033160|Hormones|hormones|mesh-ancestor
25130751|NCT03031353|Abortifacient Agents|abortifacient agents|mesh-ancestor
25130509|NCT03033160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25130510|NCT03033160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130512|NCT03033316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25130513|NCT03033316|Antiemetics|antiemetics|mesh-ancestor
25130514|NCT03033316|Autonomic Agents|autonomic agents|mesh-ancestor
25130548|NCT03032666|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25130549|NCT03032666|Velpatasvir|velpatasvir|mesh-list
25130550|NCT03032666|Antiviral Agents|antiviral agents|mesh-ancestor
25130551|NCT03032666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25130552|NCT03032536|Tenofovir|tenofovir|mesh-list
25130553|NCT03032536|Entecavir|entecavir|mesh-list
25130554|NCT03032536|Antiviral Agents|antiviral agents|mesh-ancestor
25130555|NCT03032536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25683003|NCT04619680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279366|NCT02345044|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25279367|NCT02345044|Hormone Antagonists|hormone antagonists|mesh-ancestor
25279368|NCT02345044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25279369|NCT02345044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279370|NCT02345044|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25279371|NCT02345044|Diuretics|diuretics|mesh-ancestor
25130556|NCT03032536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25130557|NCT03032536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25130558|NCT03032536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25130559|NCT03032536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130560|NCT03032536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25130561|NCT03032536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25130562|NCT03032484|Bevacizumab|bevacizumab|mesh-list
25130563|NCT03032484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25130564|NCT03032484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25130565|NCT03032484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25130566|NCT03032484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25130567|NCT03032484|Growth Substances|growth substances|mesh-ancestor
25130568|NCT03032484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130569|NCT03032484|Growth Inhibitors|growth inhibitors|mesh-ancestor
25130570|NCT03032614|Carboplatin|carboplatin|mesh-list
25130571|NCT03032614|Veliparib|veliparib|mesh-list
25130572|NCT03032614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25130573|NCT03032614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25130574|NCT03032614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25130575|NCT03032614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130581|NCT03032458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25130582|NCT03032458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130583|NCT03032458|Sensory System Agents|sensory system agents|mesh-ancestor
25130584|NCT03032458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130585|NCT03032458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25130586|NCT03032458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25130587|NCT03032458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25130588|NCT03032458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25130589|NCT03032458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130590|NCT03032458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25130591|NCT03032458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25130592|NCT03032458|Analgesics|analgesics|mesh-ancestor
25130602|NCT03032367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25130631|NCT03032315|Vasodilator Agents|vasodilator agents|mesh-ancestor
25130632|NCT03032315|Diuretics|diuretics|mesh-ancestor
25130633|NCT03032315|Natriuretic Agents|natriuretic agents|mesh-ancestor
25130634|NCT03032315|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25130635|NCT03032315|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25130636|NCT03032315|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25130646|NCT03031834|Quinapril|quinapril|mesh-list
25130647|NCT03031834|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25130648|NCT03031834|Protease Inhibitors|protease inhibitors|mesh-ancestor
25130649|NCT03031834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25130650|NCT03031834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130651|NCT03031834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25130652|NCT03031691|Trifluridine|trifluridine|mesh-list
25130653|NCT03031691|Antimetabolites|antimetabolites|mesh-ancestor
25130654|NCT03031691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130655|NCT03031691|Antiviral Agents|antiviral agents|mesh-ancestor
25130656|NCT03031691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25130657|NCT03031808|Lidocaine|lidocaine|mesh-list
25130658|NCT03031808|Rocuronium|rocuronium|mesh-list
25130659|NCT03031808|Anesthetics, Local|anesthetics, local|mesh-ancestor
25130660|NCT03031808|Anesthetics|anesthetics|mesh-ancestor
25130661|NCT03031808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25130662|NCT03031808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130663|NCT03031808|Sensory System Agents|sensory system agents|mesh-ancestor
25130664|NCT03031808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130665|NCT03031808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25683004|NCT04619680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683005|NCT04550377|Cannabidiol|cannabidiol|mesh-list
25683006|NCT04550377|Anticonvulsants|anticonvulsants|mesh-ancestor
25683007|NCT04476212|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25683008|NCT04476212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25683009|NCT04457219|Hemostatics|hemostatics|mesh-list
25683010|NCT04457219|Coagulants|coagulants|mesh-ancestor
25279397|NCT02344940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25279398|NCT02344940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25279399|NCT02344888|Folic Acid|folic acid|mesh-list
25279400|NCT02344888|Vitamin B Complex|vitamin b complex|mesh-list
25130669|NCT03031808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130670|NCT03031808|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25130671|NCT03031808|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25130672|NCT03031808|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25130673|NCT03031756|Glycine|glycine|mesh-list
25130674|NCT03031756|Glycine Agents|glycine agents|mesh-ancestor
25130675|NCT03031756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25130676|NCT03031756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130677|NCT03031756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130678|NCT03031535|Octreotide|octreotide|mesh-list
25130679|NCT03031535|Hormones|hormones|mesh-list
24648926|NCT01217398|Alkylating Agents|alkylating agents|mesh-ancestor
24648929|NCT01217450|Cetuximab|cetuximab|mesh-list
25130680|NCT03031535|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
25130681|NCT03031535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25130682|NCT03031535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130683|NCT03031535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25130684|NCT03031535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25130685|NCT03031535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25130686|NCT03031405|Oxytocin|oxytocin|mesh-list
25130687|NCT03031405|Oxytocics|oxytocics|mesh-ancestor
25130688|NCT03031405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25130689|NCT03031405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130690|NCT03031444|Leucovorin|leucovorin|mesh-list
25130691|NCT03031444|Cetuximab|cetuximab|mesh-list
25130692|NCT03031444|Fluorouracil|fluorouracil|mesh-list
25130693|NCT03031444|Oxaliplatin|oxaliplatin|mesh-list
25130694|NCT03031444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25130696|NCT03031444|Antimetabolites|antimetabolites|mesh-ancestor
25130697|NCT03031444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130698|NCT03031444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25130699|NCT03031444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25130700|NCT03031444|Immunologic Factors|immunologic factors|mesh-ancestor
25130701|NCT03031444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130702|NCT03031444|Antidotes|antidotes|mesh-ancestor
24567703|NCT00792181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567704|NCT00792246|Voriconazole|voriconazole|mesh-list
24567705|NCT00792246|Antifungal Agents|antifungal agents|mesh-ancestor
24567706|NCT00792246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24567707|NCT00792246|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24567708|NCT00792246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25130703|NCT03031444|Protective Agents|protective agents|mesh-ancestor
25130704|NCT03031444|Vitamin B Complex|vitamin b complex|mesh-ancestor
25130705|NCT03031444|Vitamins|vitamins|mesh-ancestor
25130706|NCT03031444|Micronutrients|micronutrients|mesh-ancestor
25130707|NCT03031249|Cytarabine|cytarabine|mesh-list
25130708|NCT03031249|Tretinoin|tretinoin|mesh-list
25130709|NCT03031249|Arsenic Trioxide|arsenic trioxide|mesh-list
25130710|NCT03031249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25130711|NCT03031249|Antimetabolites|antimetabolites|mesh-ancestor
25130712|NCT03031249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130713|NCT03031249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25130714|NCT03031249|Antiviral Agents|antiviral agents|mesh-ancestor
25130715|NCT03031249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25130716|NCT03031249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25130717|NCT03031249|Immunologic Factors|immunologic factors|mesh-ancestor
25130718|NCT03031249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130719|NCT03031249|Keratolytic Agents|keratolytic agents|mesh-ancestor
25130720|NCT03031249|Dermatologic Agents|dermatologic agents|mesh-ancestor
25130721|NCT03031184|Mirtazapine|mirtazapine|mesh-list
25130722|NCT03031184|Antidepressive Agents|antidepressive agents|mesh-ancestor
25683011|NCT04443010|Temozolomide|temozolomide|mesh-list
25683012|NCT04443010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25683013|NCT04443010|Alkylating Agents|alkylating agents|mesh-ancestor
25683014|NCT04443010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683015|NCT04443010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683016|NCT04272333|Nivolumab|nivolumab|mesh-list
25683017|NCT04272333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25279430|NCT02344862|Uricosuric Agents|uricosuric agents|mesh-ancestor
25279431|NCT02344862|Gout Suppressants|gout suppressants|mesh-ancestor
25279432|NCT02344862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25279434|NCT02344875|Dotinurad|dotinurad|mesh-list
25279438|NCT02344875|Renal Agents|renal agents|mesh-ancestor
25130723|NCT03031184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25130724|NCT03031184|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25130725|NCT03031184|Histamine Antagonists|histamine antagonists|mesh-ancestor
25130726|NCT03031184|Histamine Agents|histamine agents|mesh-ancestor
25130727|NCT03031184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25130728|NCT03031184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130729|NCT03031184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130741|NCT03031327|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25130742|NCT03031327|Hyaluronic Acid|hyaluronic acid|mesh-list
25130743|NCT03031327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25130744|NCT03031327|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25130745|NCT03031327|Immunologic Factors|immunologic factors|mesh-ancestor
25130746|NCT03031327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130747|NCT03031327|Viscosupplements|viscosupplements|mesh-ancestor
25130748|NCT03031327|Protective Agents|protective agents|mesh-ancestor
25130749|NCT03031353|Misoprostol|misoprostol|mesh-list
25130753|NCT03031353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130754|NCT03031353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25130755|NCT03031353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25130757|NCT03031054|Hyaluronic Acid|hyaluronic acid|mesh-list
25130758|NCT03031054|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25130759|NCT03031054|Immunologic Factors|immunologic factors|mesh-ancestor
25130760|NCT03031054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130761|NCT03031054|Viscosupplements|viscosupplements|mesh-ancestor
25130762|NCT03031054|Protective Agents|protective agents|mesh-ancestor
25130763|NCT03030911|Fentanyl|fentanyl|mesh-list
25130764|NCT03030911|Midazolam|midazolam|mesh-list
25130765|NCT03030911|Dexmedetomidine|dexmedetomidine|mesh-list
25130766|NCT03030911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25130767|NCT03030911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25130768|NCT03030911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130769|NCT03030911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25130770|NCT03030911|Analgesics|analgesics|mesh-ancestor
25130771|NCT03030911|Sensory System Agents|sensory system agents|mesh-ancestor
25130772|NCT03030911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130773|NCT03030911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25130774|NCT03030911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25130775|NCT03030911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25130776|NCT03030911|Adrenergic Agents|adrenergic agents|mesh-ancestor
25130777|NCT03030911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25130778|NCT03030911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567709|NCT00792246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567710|NCT00792246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567716|NCT00792324|Efavirenz|efavirenz|mesh-list
24567833|NCT00793052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24567834|NCT00793052|Antiemetics|antiemetics|mesh-ancestor
24567835|NCT00793052|Autonomic Agents|autonomic agents|mesh-ancestor
24567836|NCT00793052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24567837|NCT00793052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567838|NCT00793052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24567839|NCT00793052|Glucocorticoids|glucocorticoids|mesh-ancestor
24567865|NCT00793221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567866|NCT00793221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24567867|NCT00793221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24567868|NCT00793221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24567869|NCT00793221|Antifungal Agents|antifungal agents|mesh-ancestor
24567870|NCT00793234|Enoxaparin|enoxaparin|mesh-list
24567871|NCT00793234|Anticoagulants|anticoagulants|mesh-ancestor
24567872|NCT00793234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24568449|NCT00796029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568451|NCT00796029|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24629134|NCT01103388|Rituximab|rituximab|mesh-list
24568460|NCT00796081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24568461|NCT00796081|Serotonin Agents|serotonin agents|mesh-ancestor
25130779|NCT03030911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25130780|NCT03030911|Narcotics|narcotics|mesh-ancestor
25683018|NCT04272333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683019|NCT04272333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25683020|NCT04272333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692518|NCT02000531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279489|NCT02344784|Methylphenidate|methylphenidate|mesh-list
25279490|NCT02344784|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25279491|NCT02344784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279492|NCT02344784|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25279493|NCT02344784|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25130781|NCT03030911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25130783|NCT03030911|Anesthetics, General|anesthetics, general|mesh-ancestor
25130784|NCT03030911|Anesthetics|anesthetics|mesh-ancestor
25130785|NCT03030911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24649144|NCT01218711|Losartan|losartan|mesh-list
25266242|NCT02429440|Molgramostim|molgramostim|mesh-list
25130786|NCT03030911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25130787|NCT03030911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25130788|NCT03030911|GABA Modulators|gaba modulators|mesh-ancestor
25130789|NCT03030911|GABA Agents|gaba agents|mesh-ancestor
25130790|NCT03030950|Dexmedetomidine|dexmedetomidine|mesh-list
25130791|NCT03030950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25130792|NCT03030950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25130793|NCT03030950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130794|NCT03030950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25130795|NCT03030950|Analgesics|analgesics|mesh-ancestor
25130796|NCT03030950|Sensory System Agents|sensory system agents|mesh-ancestor
25130797|NCT03030950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130798|NCT03030950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24959882|NCT03821480|Antifungal Agents|antifungal agents|mesh-ancestor
24568462|NCT00796081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24568464|NCT00796081|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24568548|NCT00796276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24568549|NCT00796276|Serotonin Agents|serotonin agents|mesh-ancestor
24568550|NCT00796276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24568551|NCT00796276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568552|NCT00796276|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24568553|NCT00796276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24568554|NCT00796276|Dopamine Agents|dopamine agents|mesh-ancestor
24568555|NCT00796432|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24568556|NCT00796432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24568557|NCT00796432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24568560|NCT00796432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24568744|NCT00797303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24568745|NCT00797303|Growth Substances|growth substances|mesh-ancestor
24568746|NCT00797303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568747|NCT00797303|Growth Inhibitors|growth inhibitors|mesh-ancestor
24568748|NCT00797394|Saw palmetto extract|saw palmetto extract|mesh-list
24568749|NCT00797394|Urological Agents|urological agents|mesh-ancestor
24568750|NCT00797420|Fluconazole|fluconazole|mesh-list
24568751|NCT00797420|Antifungal Agents|antifungal agents|mesh-ancestor
24568752|NCT00797420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24568753|NCT00797420|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24568754|NCT00797420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24568755|NCT00797420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24568756|NCT00797420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568894|NCT00798070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24568895|NCT00798070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24568896|NCT00798070|Alkylating Agents|alkylating agents|mesh-ancestor
24568897|NCT00798070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568898|NCT00798070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24569090|NCT00798993|Vitamin D|vitamin d|mesh-list
24569091|NCT00798993|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
24569092|NCT00798993|Calcifediol|calcifediol|mesh-list
24569093|NCT00798993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25130799|NCT03030950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25130800|NCT03030950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25130801|NCT03030950|Adrenergic Agents|adrenergic agents|mesh-ancestor
25130802|NCT03030950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25130803|NCT03030950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130804|NCT03030768|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25130805|NCT03030768|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25130806|NCT03030768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25130807|NCT03030768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683021|NCT04226495|Sufentanil|sufentanil|mesh-list
25683022|NCT04226495|Dsuvia|dsuvia|mesh-list
25683023|NCT04226495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25683024|NCT04226495|Narcotics|narcotics|mesh-ancestor
25683025|NCT04226495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25683026|NCT04226495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683027|NCT04226495|Analgesics|analgesics|mesh-ancestor
25279519|NCT02344641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25279520|NCT02344732|Polymyxins|polymyxins|mesh-list
25279521|NCT02344732|Neomycin|neomycin|mesh-list
25279522|NCT02344732|Polymyxin B|polymyxin b|mesh-list
25279523|NCT02344732|Dexamethasone|dexamethasone|mesh-list
25279524|NCT02344732|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25279525|NCT02344732|Homatropine|homatropine|mesh-list
25279526|NCT02344732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25279527|NCT02344732|Antiemetics|antiemetics|mesh-ancestor
25279533|NCT02344732|Hormones|hormones|mesh-ancestor
25130808|NCT03030768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130809|NCT03030768|Antiviral Agents|antiviral agents|mesh-ancestor
25130810|NCT03030768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25130811|NCT03030768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25130812|NCT03030768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25130814|NCT03030937|Apatinib|apatinib|mesh-list
25130815|NCT03030937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25130816|NCT03030937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25130817|NCT03030937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25130818|NCT03030937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130819|NCT03030937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25130820|NCT03030937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25130821|NCT03030976|Cyclophosphamide|cyclophosphamide|mesh-list
25130822|NCT03030976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25130823|NCT03030976|Immunologic Factors|immunologic factors|mesh-ancestor
25130824|NCT03030976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130825|NCT03030976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25130826|NCT03030976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25130827|NCT03030976|Alkylating Agents|alkylating agents|mesh-ancestor
25130828|NCT03030976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130829|NCT03030976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25130838|NCT03030690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25130839|NCT03030690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130840|NCT03030690|Adrenergic Agents|adrenergic agents|mesh-ancestor
25130841|NCT03030690|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25130842|NCT03030690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25130843|NCT03030690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25130844|NCT03030690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25130845|NCT03030716|Proanthocyanidin|proanthocyanidin|mesh-list
25130846|NCT03030716|Grape Seed Extract|grape seed extract|mesh-list
25130847|NCT03030716|Procyanidin|procyanidin|mesh-list
25130848|NCT03030716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25130849|NCT03030716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25130850|NCT03030716|Antioxidants|antioxidants|mesh-ancestor
25130851|NCT03030716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130852|NCT03030716|Protective Agents|protective agents|mesh-ancestor
25130853|NCT03030716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130854|NCT03030716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25130855|NCT03030716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25130856|NCT03030716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25130858|NCT03031119|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25130859|NCT03031119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25130860|NCT03031119|Antimetabolites|antimetabolites|mesh-ancestor
25130861|NCT03031119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130862|NCT03031119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25130863|NCT03031119|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25130864|NCT03031119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25130865|NCT03030430|Bevacizumab|bevacizumab|mesh-list
25130866|NCT03030430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25130867|NCT03030430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25130868|NCT03030430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25130869|NCT03030430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25130870|NCT03030430|Growth Substances|growth substances|mesh-ancestor
24569094|NCT00798993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569095|NCT00798993|Vitamins|vitamins|mesh-ancestor
25683028|NCT04226495|Sensory System Agents|sensory system agents|mesh-ancestor
25683029|NCT04226495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25683030|NCT04226495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25683031|NCT04226495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25683032|NCT04226495|Anesthetics, General|anesthetics, general|mesh-ancestor
25683033|NCT04226495|Anesthetics|anesthetics|mesh-ancestor
25683034|NCT04172246|Zanubrutinib|zanubrutinib|mesh-list
25683035|NCT04172246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683036|NCT04172246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25160307|NCT03026062|Immunologic Factors|immunologic factors|mesh-ancestor
25160308|NCT03026062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160309|NCT03026062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24649696|NCT01221402|Vitamin B Complex|vitamin b complex|mesh-ancestor
25160310|NCT03026062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160312|NCT03020589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25160313|NCT03020589|Immunologic Factors|immunologic factors|mesh-ancestor
25160314|NCT03020589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160315|NCT03020589|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25160316|NCT03020589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25160317|NCT03020589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160318|NCT03020199|Betamethasone|betamethasone|mesh-list
25160319|NCT03020199|Calcipotriene|calcipotriene|mesh-list
25160320|NCT03020199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25160321|NCT03020199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25160322|NCT03020199|Glucocorticoids|glucocorticoids|mesh-ancestor
25160323|NCT03020199|Hormones|hormones|mesh-ancestor
25160324|NCT03020199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25160325|NCT03020199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584889|NCT00882076|Etoposide|etoposide|mesh-list
24569096|NCT00798993|Micronutrients|micronutrients|mesh-ancestor
24569112|NCT00799071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24569113|NCT00799071|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24569114|NCT00799071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24569115|NCT00799071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25130871|NCT03030430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130872|NCT03030430|Growth Inhibitors|growth inhibitors|mesh-ancestor
25130874|NCT03030703|Vitamin B Complex|vitamin b complex|mesh-ancestor
25130875|NCT03030703|Vitamins|vitamins|mesh-ancestor
25130877|NCT03030703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130879|NCT03030469|Analgesics|analgesics|mesh-list
25130880|NCT03030469|Narcotics|narcotics|mesh-ancestor
25130881|NCT03030469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25130882|NCT03030469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130883|NCT03030469|Sensory System Agents|sensory system agents|mesh-ancestor
25130884|NCT03030469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130885|NCT03030560|Lidocaine|lidocaine|mesh-list
25130886|NCT03030560|Anesthetics, Local|anesthetics, local|mesh-ancestor
25130887|NCT03030560|Anesthetics|anesthetics|mesh-ancestor
25130888|NCT03030560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25130889|NCT03030560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569117|NCT00799071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24569218|NCT00799448|Isophane Insulin, Human|isophane insulin, human|mesh-list
24569220|NCT00799448|Isophane insulin, beef|isophane insulin, beef|mesh-list
24569221|NCT00799448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24569222|NCT00799448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569223|NCT00799513|Lenalidomide|lenalidomide|mesh-list
24569224|NCT00799513|Immunologic Factors|immunologic factors|mesh-ancestor
24569225|NCT00799513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569226|NCT00799513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24569227|NCT00799513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24569228|NCT00799513|Growth Substances|growth substances|mesh-ancestor
24569229|NCT00799513|Growth Inhibitors|growth inhibitors|mesh-ancestor
25683037|NCT04172246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683038|NCT04172246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683039|NCT04130516|Pembrolizumab|pembrolizumab|mesh-list
25683040|NCT04130516|Antibodies|antibodies|mesh-list
25683041|NCT04130516|Immunologic Factors|immunologic factors|mesh-ancestor
25683042|NCT04130516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683043|NCT04130516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25683044|NCT04130516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683045|NCT04103034|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25683046|NCT04103034|Hemostatics|hemostatics|mesh-ancestor
25683047|NCT04103034|Coagulants|coagulants|mesh-ancestor
25683048|NCT04103034|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25683049|NCT04103034|Natriuretic Agents|natriuretic agents|mesh-ancestor
25683050|NCT04103034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683051|NCT04060108|Methamphetamine|methamphetamine|mesh-list
25683052|NCT04060108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25683053|NCT04060108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683054|NCT04060108|Sympathomimetics|sympathomimetics|mesh-ancestor
25683055|NCT04060108|Autonomic Agents|autonomic agents|mesh-ancestor
25683056|NCT04060108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25279599|NCT02344095|Paclitaxel|paclitaxel|mesh-list
25279600|NCT02344095|Cisplatin|cisplatin|mesh-list
25279601|NCT02344095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25279602|NCT02344095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25279603|NCT02344095|Tubulin Modulators|tubulin modulators|mesh-ancestor
25279604|NCT02344095|Antimitotic Agents|antimitotic agents|mesh-ancestor
25279605|NCT02344095|Mitosis Modulators|mitosis modulators|mesh-ancestor
25279606|NCT02344095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279607|NCT02343926|Metformin|metformin|mesh-list
25279608|NCT02343926|Vildagliptin|vildagliptin|mesh-list
25279609|NCT02343926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25279610|NCT02343926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279611|NCT02343926|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25279612|NCT02343926|Protease Inhibitors|protease inhibitors|mesh-ancestor
25279613|NCT02343926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279614|NCT02343926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279615|NCT02344030|Pyrithione zinc|pyrithione zinc|mesh-list
25160352|NCT03013218|Paclitaxel|paclitaxel|mesh-list
24569230|NCT00799513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24569232|NCT00799539|Bortezomib|bortezomib|mesh-list
24569233|NCT00799539|Melphalan|melphalan|mesh-list
24569234|NCT00799539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24569235|NCT00799539|Glucocorticoids|glucocorticoids|mesh-ancestor
24569287|NCT00799968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569288|NCT00800137|Heparin|heparin|mesh-list
24569289|NCT00800137|Calcium heparin|calcium heparin|mesh-list
24569290|NCT00800137|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24569291|NCT00800137|Tinzaparin|tinzaparin|mesh-list
24569292|NCT00800137|Dalteparin|dalteparin|mesh-list
24569293|NCT00800137|Warfarin|warfarin|mesh-list
24569294|NCT00800137|Anticoagulants|anticoagulants|mesh-ancestor
24569295|NCT00800137|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24569296|NCT00800137|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24569408|NCT00800462|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24569410|NCT00800462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24569411|NCT00800462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569412|NCT00800462|Urological Agents|urological agents|mesh-ancestor
24569413|NCT00800475|Gemfibrozil|gemfibrozil|mesh-list
24569414|NCT00800475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24569415|NCT00800475|Antimetabolites|antimetabolites|mesh-ancestor
24671050|NCT01323374|Droxidopa|droxidopa|mesh-list
24569416|NCT00800475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130890|NCT03030560|Sensory System Agents|sensory system agents|mesh-ancestor
25130891|NCT03030560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130892|NCT03030560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25130893|NCT03030560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25130894|NCT03030560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25130895|NCT03030560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25130896|NCT03030560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130897|NCT03030677|Lidocaine|lidocaine|mesh-list
25130898|NCT03030677|Anesthetics, Local|anesthetics, local|mesh-ancestor
25130899|NCT03030677|Anesthetics|anesthetics|mesh-ancestor
25130900|NCT03030677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25130901|NCT03030677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130902|NCT03030677|Sensory System Agents|sensory system agents|mesh-ancestor
25130903|NCT03030677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130904|NCT03030677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25130905|NCT03030677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25683057|NCT04060108|Dopamine Agents|dopamine agents|mesh-ancestor
25683058|NCT04060108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25683059|NCT04060108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683060|NCT04060108|Adrenergic Agents|adrenergic agents|mesh-ancestor
25683061|NCT04060108|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25683062|NCT04060108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25683063|NCT04060108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25683064|NCT04060108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25683065|NCT04058470|Prednisone|prednisone|mesh-list
25683066|NCT04058470|Cyclophosphamide|cyclophosphamide|mesh-list
25683067|NCT04058470|Rituximab|rituximab|mesh-list
25683068|NCT04058470|Doxorubicin|doxorubicin|mesh-list
25683069|NCT04058470|Vincristine|vincristine|mesh-list
25683070|NCT04058470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25683071|NCT04058470|Immunologic Factors|immunologic factors|mesh-ancestor
25683072|NCT04058470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683073|NCT04058470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25683074|NCT04058470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25279626|NCT02343861|Emollients|emollients|mesh-list
25279627|NCT02343861|Dermatologic Agents|dermatologic agents|mesh-ancestor
25279628|NCT02343718|Sirolimus|sirolimus|mesh-list
25279629|NCT02343718|Vinblastine|vinblastine|mesh-list
24904646|NCT04354350|Telmisartan|telmisartan|mesh-list
25130906|NCT03030677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25130907|NCT03030677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25130908|NCT03030677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130909|NCT03031262|Cytarabine|cytarabine|mesh-list
25130910|NCT03031262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25130911|NCT03031262|Antimetabolites|antimetabolites|mesh-ancestor
25130933|NCT03030300|Pioglitazone|pioglitazone|mesh-list
25130934|NCT03030300|Insulin|insulin|mesh-list
25130935|NCT03030300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25130936|NCT03030300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130937|NCT03030001|Antibodies|antibodies|mesh-list
25130938|NCT03030001|Immunologic Factors|immunologic factors|mesh-ancestor
25130939|NCT03030001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130940|NCT03030196|Denosumab|denosumab|mesh-list
25130941|NCT03030196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25130942|NCT03030196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130943|NCT03030105|Scopolamine|scopolamine|mesh-list
25130944|NCT03030105|Donepezil|donepezil|mesh-list
25130945|NCT03030105|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25130946|NCT03030105|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25130947|NCT03030105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25130948|NCT03030105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130949|NCT03030105|Cholinergic Agents|cholinergic agents|mesh-ancestor
25130950|NCT03030105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25130951|NCT03030105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130952|NCT03030105|Nootropic Agents|nootropic agents|mesh-ancestor
25130953|NCT03030105|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25130954|NCT03030105|Antiemetics|antiemetics|mesh-ancestor
25131017|NCT03029845|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25131018|NCT03029845|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25131019|NCT03029845|Adrenergic Agents|adrenergic agents|mesh-ancestor
25131020|NCT03029845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25131021|NCT03029845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131022|NCT03029845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131023|NCT03029845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25131024|NCT03029845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25131025|NCT03029845|Vasodilator Agents|vasodilator agents|mesh-ancestor
25131026|NCT03029442|Denosumab|denosumab|mesh-list
25131027|NCT03029442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25131028|NCT03029442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131044|NCT03029351|Exenatide|exenatide|mesh-list
25131045|NCT03029351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25131046|NCT03029351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131047|NCT03029351|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25131048|NCT03029351|Incretins|incretins|mesh-ancestor
25131049|NCT03029351|Hormones|hormones|mesh-ancestor
24960004|NCT03820193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24569461|NCT00800592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569817|NCT00801957|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
24569818|NCT00801957|Tacrolimus|tacrolimus|mesh-list
24569819|NCT00801957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25131051|NCT03029273|Cyclophosphamide|cyclophosphamide|mesh-list
25131053|NCT03029273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25131054|NCT03029273|Immunologic Factors|immunologic factors|mesh-ancestor
25131055|NCT03029273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131056|NCT03029273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25683075|NCT04058470|Alkylating Agents|alkylating agents|mesh-ancestor
25683076|NCT04058470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683077|NCT04058470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683078|NCT04058470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25683079|NCT04058470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25683080|NCT04058470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25683081|NCT04058470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25683082|NCT04058470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25683083|NCT04058470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705825|NCT01486953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25279658|NCT02343666|Antiviral Agents|antiviral agents|mesh-ancestor
25279659|NCT02343666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25279660|NCT02343666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279661|NCT02343679|Ceritinib|ceritinib|mesh-list
25279662|NCT02343679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25279663|NCT02343679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25279664|NCT02343679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279665|NCT02343679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279666|NCT02343432|Triamcinolone|triamcinolone|mesh-list
25279667|NCT02343432|Bupivacaine|bupivacaine|mesh-list
25279668|NCT02343432|Anesthetics, Local|anesthetics, local|mesh-ancestor
25279669|NCT02343432|Anesthetics|anesthetics|mesh-ancestor
25279670|NCT02343432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25279676|NCT02343432|Hormones|hormones|mesh-ancestor
25131057|NCT03029273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25131058|NCT03029273|Alkylating Agents|alkylating agents|mesh-ancestor
25131059|NCT03029273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131060|NCT03029273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131061|NCT03029273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25131062|NCT03029013|Apatinib|apatinib|mesh-list
25131063|NCT03029013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131064|NCT03029013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25131065|NCT03029013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131066|NCT03029013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131067|NCT03028883|Buprenorphine|buprenorphine|mesh-list
25131068|NCT03028883|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25131069|NCT03028883|Narcotics|narcotics|mesh-ancestor
25131070|NCT03028883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25131071|NCT03028883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131072|NCT03028883|Analgesics|analgesics|mesh-ancestor
25131073|NCT03028883|Sensory System Agents|sensory system agents|mesh-ancestor
25131074|NCT03028883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25131075|NCT03028883|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24970791|NCT03730766|Bismuth|bismuth|mesh-list
25131092|NCT03028701|Formoterol Fumarate|formoterol fumarate|mesh-list
25131093|NCT03028701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25131094|NCT03028701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25131095|NCT03028701|Autonomic Agents|autonomic agents|mesh-ancestor
25131096|NCT03028701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25131097|NCT03028701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131098|NCT03028701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25131099|NCT03028701|Respiratory System Agents|respiratory system agents|mesh-ancestor
25131100|NCT03028701|Glucocorticoids|glucocorticoids|mesh-ancestor
25131101|NCT03028701|Hormones|hormones|mesh-ancestor
24394713|NCT00134030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25131102|NCT03028701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25131103|NCT03028701|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25131104|NCT03028701|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25131105|NCT03028701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25131106|NCT03028701|Adrenergic Agents|adrenergic agents|mesh-ancestor
25131107|NCT03028701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25131108|NCT03028701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131109|NCT03028766|Adavosertib|adavosertib|mesh-list
25131110|NCT03028766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131111|NCT03028766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131112|NCT03028909|Oseltamivir|oseltamivir|mesh-list
25131113|NCT03028909|MEDI8852|medi8852|mesh-list
25131114|NCT03028909|Antiviral Agents|antiviral agents|mesh-ancestor
25131115|NCT03028909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25683084|NCT04058470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25683085|NCT04058470|Glucocorticoids|glucocorticoids|mesh-ancestor
25683086|NCT04058470|Hormones|hormones|mesh-ancestor
25683087|NCT04058470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25683088|NCT04058470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25683089|NCT04058470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25683090|NCT04058470|Tubulin Modulators|tubulin modulators|mesh-ancestor
25683091|NCT04058470|Antimitotic Agents|antimitotic agents|mesh-ancestor
25683092|NCT04058470|Mitosis Modulators|mitosis modulators|mesh-ancestor
25683093|NCT04046887|Gemcitabine|gemcitabine|mesh-list
25683094|NCT04046887|Paclitaxel|paclitaxel|mesh-list
25683095|NCT04046887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25683096|NCT04046887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683097|NCT04046887|Tubulin Modulators|tubulin modulators|mesh-ancestor
25683098|NCT04046887|Antimitotic Agents|antimitotic agents|mesh-ancestor
25279703|NCT02343536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25279704|NCT02343536|Tubulin Modulators|tubulin modulators|mesh-ancestor
25279705|NCT02343536|Antimitotic Agents|antimitotic agents|mesh-ancestor
25279706|NCT02343536|Mitosis Modulators|mitosis modulators|mesh-ancestor
25279707|NCT02343536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25279708|NCT02343536|Antimetabolites|antimetabolites|mesh-ancestor
25279709|NCT02343536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279710|NCT02343419|Methacholine Chloride|methacholine chloride|mesh-list
25279712|NCT02343419|Autonomic Agents|autonomic agents|mesh-ancestor
25279713|NCT02343419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25279714|NCT02343419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279715|NCT02343419|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25279716|NCT02343419|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
25279717|NCT02343419|Respiratory System Agents|respiratory system agents|mesh-ancestor
25279718|NCT02343419|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25279719|NCT02343419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25279720|NCT02343419|Cholinergic Agents|cholinergic agents|mesh-ancestor
25279721|NCT02343419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25279722|NCT02343419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160485|NCT02917083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131116|NCT03028909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131117|NCT03028909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131118|NCT03028298|Sildenafil Citrate|sildenafil citrate|mesh-list
24569820|NCT00801957|Immunologic Factors|immunologic factors|mesh-ancestor
24569862|NCT00802087|Hydrocodone|hydrocodone|mesh-list
24569863|NCT00802087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24569864|NCT00802087|Analgesics|analgesics|mesh-ancestor
24569865|NCT00802087|Sensory System Agents|sensory system agents|mesh-ancestor
24569866|NCT00802087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24569867|NCT00802087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569868|NCT00802087|Antipyretics|antipyretics|mesh-ancestor
24569869|NCT00802087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24569870|NCT00802087|Narcotics|narcotics|mesh-ancestor
24569871|NCT00802087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24569872|NCT00802087|Antitussive Agents|antitussive agents|mesh-ancestor
24569873|NCT00802087|Respiratory System Agents|respiratory system agents|mesh-ancestor
24569874|NCT00802139|Iron|iron|mesh-list
24569875|NCT00802139|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24671052|NCT01323374|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24569876|NCT00802139|Trace Elements|trace elements|mesh-ancestor
25131119|NCT03028298|Citric Acid|citric acid|mesh-list
25131120|NCT03028298|Sodium Citrate|sodium citrate|mesh-list
25131121|NCT03028298|Anticoagulants|anticoagulants|mesh-ancestor
25131122|NCT03028298|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25131123|NCT03028298|Chelating Agents|chelating agents|mesh-ancestor
25131124|NCT03028298|Sequestering Agents|sequestering agents|mesh-ancestor
25131125|NCT03028298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131126|NCT03028298|Vasodilator Agents|vasodilator agents|mesh-ancestor
25131127|NCT03028298|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24570277|NCT00804115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25131128|NCT03028298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25131129|NCT03028298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683099|NCT04046887|Mitosis Modulators|mitosis modulators|mesh-ancestor
25683100|NCT04046887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683101|NCT04046887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25683102|NCT04046887|Antimetabolites|antimetabolites|mesh-ancestor
25683103|NCT04046887|Antiviral Agents|antiviral agents|mesh-ancestor
25683104|NCT04046887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25683105|NCT04046887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683106|NCT04046887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25683107|NCT04046887|Immunologic Factors|immunologic factors|mesh-ancestor
25683108|NCT04046887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683109|NCT03921060|Denosumab|denosumab|mesh-list
25683110|NCT03921060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25683111|NCT03921060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683112|NCT03868657|Moxifloxacin|moxifloxacin|mesh-list
25683113|NCT03868657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25683114|NCT03868657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25683115|NCT03868657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25683116|NCT03868657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25683117|NCT03868657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683118|NCT03868657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683119|NCT03868657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131131|NCT03028428|Hyaluronic Acid|hyaluronic acid|mesh-list
25131132|NCT03028428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25131133|NCT03028428|Immunologic Factors|immunologic factors|mesh-ancestor
25131134|NCT03028428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131135|NCT03028428|Viscosupplements|viscosupplements|mesh-ancestor
25131136|NCT03028428|Protective Agents|protective agents|mesh-ancestor
25131137|NCT03028571|Trimethaphan|trimethaphan|mesh-list
25131138|NCT03028571|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
25131139|NCT03028571|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25131140|NCT03028571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25131141|NCT03028571|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
25131142|NCT03028571|Autonomic Agents|autonomic agents|mesh-ancestor
25131143|NCT03028571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25131144|NCT03028571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131145|NCT03028571|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25131146|NCT03028571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25131147|NCT03028571|Cholinergic Agents|cholinergic agents|mesh-ancestor
25131148|NCT03028571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24569964|NCT00802568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24569965|NCT00802568|Antimetabolites|antimetabolites|mesh-ancestor
24569966|NCT00802568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569976|NCT00802581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569977|NCT00802581|Sensory System Agents|sensory system agents|mesh-ancestor
24569978|NCT00802581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24570062|NCT00802958|Clobetasol|clobetasol|mesh-list
24570063|NCT00802958|Halobetasol|halobetasol|mesh-list
24570064|NCT00802958|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24570065|NCT00802958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24570066|NCT00802958|Glucocorticoids|glucocorticoids|mesh-ancestor
24570067|NCT00802958|Hormones|hormones|mesh-ancestor
24570070|NCT00803166|Clobetasol|clobetasol|mesh-list
24570101|NCT00803309|Interferon alpha-2|interferon alpha-2|mesh-list
24570102|NCT00803309|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24570103|NCT00803309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131149|NCT03028571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131150|NCT03028571|Vasodilator Agents|vasodilator agents|mesh-ancestor
25131176|NCT03027934|Purinergic Agents|purinergic agents|mesh-ancestor
25131177|NCT03027934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25131178|NCT03027934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131179|NCT03027934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131180|NCT03027973|Tranexamic Acid|tranexamic acid|mesh-list
25131181|NCT03027973|Ulipristal acetate|ulipristal acetate|mesh-list
25131182|NCT03027973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25131183|NCT03027973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25131184|NCT03027973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131185|NCT03027973|Hemostatics|hemostatics|mesh-ancestor
24459715|NCT00346099|Capecitabine|capecitabine|mesh-list
25131186|NCT03027973|Coagulants|coagulants|mesh-ancestor
25131187|NCT03027973|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25131188|NCT03027973|Contraceptive Agents|contraceptive agents|mesh-ancestor
25131189|NCT03027973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25131190|NCT03027973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131191|NCT03027973|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25131192|NCT03027908|Fluorides|fluorides|mesh-list
25131193|NCT03027908|Cariostatic Agents|cariostatic agents|mesh-ancestor
25131194|NCT03027908|Protective Agents|protective agents|mesh-ancestor
25131195|NCT03027908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131196|NCT03027843|Hormones|hormones|mesh-list
24570104|NCT00803309|Antiviral Agents|antiviral agents|mesh-ancestor
24570105|NCT00803309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24570238|NCT00803933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24570239|NCT00803933|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24570240|NCT00803946|Ibuprofen|ibuprofen|mesh-list
24570241|NCT00803946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24570242|NCT00803946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24570243|NCT00803946|Analgesics|analgesics|mesh-ancestor
24570244|NCT00803946|Sensory System Agents|sensory system agents|mesh-ancestor
24570245|NCT00803946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24570246|NCT00803946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570252|NCT00803972|Insulin|insulin|mesh-list
24570276|NCT00804115|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24570280|NCT00804206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24570281|NCT00804206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25279778|NCT02343250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25279779|NCT02343250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279780|NCT02342925|Metformin|metformin|mesh-list
25279781|NCT02342925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25279782|NCT02342925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279783|NCT02342769|Abacavir|abacavir|mesh-list
25279784|NCT02342769|Dolutegravir|dolutegravir|mesh-list
25279785|NCT02342769|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25279786|NCT02342769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24570282|NCT00804206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24570283|NCT00804206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24570284|NCT00804206|Growth Substances|growth substances|mesh-ancestor
24570285|NCT00804206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570287|NCT00804245|Choline|choline|mesh-list
25131197|NCT03027843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25131198|NCT03027843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131199|NCT03027635|Ciprofloxacin|ciprofloxacin|mesh-list
25131200|NCT03027635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25131201|NCT03027635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25131202|NCT03027635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25131203|NCT03027635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25131204|NCT03027635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131205|NCT03027635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131206|NCT03027635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131207|NCT03027635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24537792|NCT00656214|Lycopene|lycopene|mesh-list
25131208|NCT03027635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25131210|NCT03027674|Sildenafil Citrate|sildenafil citrate|mesh-list
25131211|NCT03027674|Vasodilator Agents|vasodilator agents|mesh-ancestor
25131212|NCT03027674|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25131213|NCT03027674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25131214|NCT03027674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131215|NCT03027674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131216|NCT03027674|Urological Agents|urological agents|mesh-ancestor
25131217|NCT03027674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25131218|NCT03027674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25131219|NCT03027674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25131220|NCT03027674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131243|NCT03027167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25131244|NCT03027167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25131245|NCT03027167|Analgesics|analgesics|mesh-ancestor
25131246|NCT03027167|Sensory System Agents|sensory system agents|mesh-ancestor
25131247|NCT03027167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25131248|NCT03027167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131249|NCT03027167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25131250|NCT03027167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25131251|NCT03027167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25131252|NCT03027167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25131253|NCT03027167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131254|NCT03027167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25131255|NCT03027167|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25131256|NCT03027167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131257|NCT03027167|Antipyretics|antipyretics|mesh-ancestor
25131258|NCT03027219|Alprostadil|alprostadil|mesh-list
25131259|NCT03027219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25131260|NCT03027219|Vasodilator Agents|vasodilator agents|mesh-ancestor
25131261|NCT03027219|Urological Agents|urological agents|mesh-ancestor
25683120|NCT03867500|Niacin|niacin|mesh-list
25683121|NCT03867500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25683122|NCT03867500|Antimetabolites|antimetabolites|mesh-ancestor
25683123|NCT03867500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683124|NCT03867500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25683125|NCT03867500|Vasodilator Agents|vasodilator agents|mesh-ancestor
25683126|NCT03867500|Vitamin B Complex|vitamin b complex|mesh-ancestor
25683127|NCT03867500|Vitamins|vitamins|mesh-ancestor
25683128|NCT03867500|Micronutrients|micronutrients|mesh-ancestor
25683129|NCT03867500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683130|NCT03861052|Dulaglutide|dulaglutide|mesh-list
25279800|NCT02342717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25279803|NCT02342717|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25131262|NCT03026933|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25131263|NCT03026933|Calcium|calcium|mesh-list
25131264|NCT03026933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25131265|NCT03026933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131266|NCT03026933|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25131267|NCT03026933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25131268|NCT03026933|Antimetabolites|antimetabolites|mesh-ancestor
25131269|NCT03026933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808110|NCT02025192|Tucatinib|tucatinib|mesh-list
25131289|NCT03026842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25131290|NCT03026842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25131292|NCT03026842|Sensory System Agents|sensory system agents|mesh-ancestor
25131293|NCT03026842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25131294|NCT03026842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25131295|NCT03026894|Salicylic Acid|salicylic acid|mesh-list
25131296|NCT03026894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25131297|NCT03026894|Antifungal Agents|antifungal agents|mesh-ancestor
25131298|NCT03026894|Keratolytic Agents|keratolytic agents|mesh-ancestor
25131299|NCT03026894|Dermatologic Agents|dermatologic agents|mesh-ancestor
25131301|NCT03027115|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25131302|NCT03027115|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25131303|NCT03027115|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25131304|NCT03027115|Adrenergic Agents|adrenergic agents|mesh-ancestor
25131305|NCT03027115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25131306|NCT03027115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131307|NCT03027115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131308|NCT03027115|Urological Agents|urological agents|mesh-ancestor
25131309|NCT03026881|Paclitaxel|paclitaxel|mesh-list
25131310|NCT03026881|Apatinib|apatinib|mesh-list
25131311|NCT03026881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25131312|NCT03026881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131313|NCT03026881|Tubulin Modulators|tubulin modulators|mesh-ancestor
25131314|NCT03026881|Antimitotic Agents|antimitotic agents|mesh-ancestor
25131315|NCT03026881|Mitosis Modulators|mitosis modulators|mesh-ancestor
25131316|NCT03026881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131317|NCT03026881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25131318|NCT03026881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131319|NCT03026946|Cyclosporine|cyclosporine|mesh-list
25131320|NCT03026946|Alitretinoin|alitretinoin|mesh-list
25131321|NCT03026946|Cyclosporins|cyclosporins|mesh-list
25131322|NCT03026946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131323|NCT03026946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131331|NCT03026946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25131332|NCT03026946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131333|NCT03026907|Azathioprine|azathioprine|mesh-list
25131334|NCT03026907|Alitretinoin|alitretinoin|mesh-list
25131335|NCT03026907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131336|NCT03026907|Dermatologic Agents|dermatologic agents|mesh-ancestor
25131337|NCT03026907|Antimetabolites|antimetabolites|mesh-ancestor
25131338|NCT03026907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131339|NCT03026907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25131340|NCT03026907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25131341|NCT03026907|Immunologic Factors|immunologic factors|mesh-ancestor
24647080|NCT01206075|Plerixafor|plerixafor|mesh-list
25131342|NCT03026907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131343|NCT03026907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25131344|NCT03026725|Calcium|calcium|mesh-list
25131345|NCT03026725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25131376|NCT03026140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131377|NCT03026140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25131378|NCT03026140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131379|NCT03026140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25131380|NCT03026140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25131381|NCT03026140|Analgesics|analgesics|mesh-ancestor
25131382|NCT03026140|Sensory System Agents|sensory system agents|mesh-ancestor
25131383|NCT03026140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24786342|NCT01919255|Sequestering Agents|sequestering agents|mesh-ancestor
25683131|NCT03861052|Tirzepatide|tirzepatide|mesh-list
25683132|NCT03861052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25683133|NCT03861052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683134|NCT03861052|Incretins|incretins|mesh-ancestor
25279844|NCT02342366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25279845|NCT02342366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25279846|NCT02342366|Anesthetics, General|anesthetics, general|mesh-ancestor
25279847|NCT02342366|Anesthetics|anesthetics|mesh-ancestor
25279848|NCT02342366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25279849|NCT02342366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279850|NCT02342184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25279851|NCT02342184|Immunologic Factors|immunologic factors|mesh-ancestor
25279852|NCT02342184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279853|NCT02342145|Cyclosporine|cyclosporine|mesh-list
25279854|NCT02342145|Mycophenolic Acid|mycophenolic acid|mesh-list
25279855|NCT02342145|Methotrexate|methotrexate|mesh-list
25279856|NCT02342145|Cyclosporins|cyclosporins|mesh-list
25279857|NCT02342145|Basiliximab|basiliximab|mesh-list
24570340|NCT00804401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570374|NCT00804622|Telbivudine|telbivudine|mesh-list
24570375|NCT00804622|Antiviral Agents|antiviral agents|mesh-ancestor
24570376|NCT00804622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24570377|NCT00804622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24570378|NCT00804622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24570379|NCT00804622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24570499|NCT00805064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24570500|NCT00805064|Glucocorticoids|glucocorticoids|mesh-ancestor
24570501|NCT00805064|Hormones|hormones|mesh-ancestor
24570523|NCT00805090|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24570524|NCT00805116|Cod Liver Oil|cod liver oil|mesh-list
24570526|NCT00805116|Micronutrients|micronutrients|mesh-ancestor
24570527|NCT00805116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570528|NCT00805155|Mometasone Furoate|mometasone furoate|mesh-list
24570529|NCT00805155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24570724|NCT00806247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24570725|NCT00806247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570726|NCT00806247|Analgesics|analgesics|mesh-ancestor
24572621|NCT00815893|Anesthetics, General|anesthetics, general|mesh-ancestor
24570727|NCT00806247|Sensory System Agents|sensory system agents|mesh-ancestor
25131385|NCT03026140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25131386|NCT03026140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25131387|NCT03026140|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25131388|NCT03026140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25131389|NCT03026140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131391|NCT03026101|Vasodilator Agents|vasodilator agents|mesh-ancestor
25131393|NCT03026036|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25131394|NCT03026036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25131395|NCT03026036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25131396|NCT03026036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131397|NCT03026036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25131398|NCT03026036|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25131399|NCT03026036|Dopamine Agents|dopamine agents|mesh-ancestor
25131400|NCT03026036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25131401|NCT03026036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131402|NCT03026023|Ribavirin|ribavirin|mesh-list
25131403|NCT03026023|Grazoprevir|grazoprevir|mesh-list
25131404|NCT03026023|Antimetabolites|antimetabolites|mesh-ancestor
25131405|NCT03026023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131406|NCT03026023|Antiviral Agents|antiviral agents|mesh-ancestor
25131407|NCT03026023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25131408|NCT03025841|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
25131409|NCT03025841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25131410|NCT03025841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25683135|NCT03861052|Hormones|hormones|mesh-ancestor
25683136|NCT03861052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25683137|NCT03858231|Acetaminophen|acetaminophen|mesh-list
25683138|NCT03858231|Ibuprofen|ibuprofen|mesh-list
25683139|NCT03858231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25683140|NCT03858231|Analgesics|analgesics|mesh-ancestor
25683141|NCT03858231|Sensory System Agents|sensory system agents|mesh-ancestor
25683142|NCT03858231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25683143|NCT03858231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683144|NCT03858231|Antipyretics|antipyretics|mesh-ancestor
25683145|NCT03858231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25683146|NCT03858231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25683147|NCT03858231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25131411|NCT03025750|Vaccines|vaccines|mesh-list
24960355|NCT03817541|Propofol|propofol|mesh-list
25279886|NCT02342093|Diuretics|diuretics|mesh-ancestor
24570888|NCT00807079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24570889|NCT00807079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24570890|NCT00807079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570891|NCT00807118|Fesoterodine|fesoterodine|mesh-list
25266310|NCT02428777|Analgesics|analgesics|mesh-ancestor
24570892|NCT00807118|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24570893|NCT00807118|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24570894|NCT00807118|Cholinergic Agents|cholinergic agents|mesh-ancestor
24570895|NCT00807118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24570896|NCT00807118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570897|NCT00807118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570898|NCT00807118|Urological Agents|urological agents|mesh-ancestor
24570899|NCT00807196|Cyclophosphamide|cyclophosphamide|mesh-list
24570901|NCT00807196|Fludarabine|fludarabine|mesh-list
24570921|NCT00807261|Gemcitabine|gemcitabine|mesh-list
25131412|NCT03025750|Immunologic Factors|immunologic factors|mesh-ancestor
25131413|NCT03025750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131414|NCT03025867|Niraparib|niraparib|mesh-list
25131415|NCT03025867|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25131416|NCT03025867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131417|NCT03025867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131418|NCT03025867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131419|NCT03025724|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25131420|NCT03025724|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25131421|NCT03025724|Dermatologic Agents|dermatologic agents|mesh-ancestor
25131422|NCT03025880|Gemcitabine|gemcitabine|mesh-list
25131423|NCT03025880|Pembrolizumab|pembrolizumab|mesh-list
25131424|NCT03025880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25131425|NCT03025880|Antimetabolites|antimetabolites|mesh-ancestor
25131426|NCT03025880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131427|NCT03025880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131428|NCT03025880|Antiviral Agents|antiviral agents|mesh-ancestor
25131429|NCT03025880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25131430|NCT03025880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131431|NCT03025880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25131432|NCT03025880|Immunologic Factors|immunologic factors|mesh-ancestor
25131442|NCT03025893|Sunitinib|sunitinib|mesh-list
25131443|NCT03025893|Lomustine|lomustine|mesh-list
25131444|NCT03025893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131445|NCT03025893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25131446|NCT03025893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25131447|NCT03025893|Growth Substances|growth substances|mesh-ancestor
25131448|NCT03025893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131449|NCT03025893|Growth Inhibitors|growth inhibitors|mesh-ancestor
25131450|NCT03025893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25131451|NCT03025893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131452|NCT03025893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131453|NCT03025893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25131454|NCT03025893|Alkylating Agents|alkylating agents|mesh-ancestor
25131455|NCT03025906|Valproic Acid|valproic acid|mesh-list
25131456|NCT03025906|Phenobarbital|phenobarbital|mesh-list
25131457|NCT03025906|Anticonvulsants|anticonvulsants|mesh-ancestor
25131458|NCT03025906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131459|NCT03025906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131460|NCT03025906|GABA Agents|gaba agents|mesh-ancestor
25131461|NCT03025906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25131462|NCT03025906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131463|NCT03025906|Antimanic Agents|antimanic agents|mesh-ancestor
24807952|NCT02024555|Renal Agents|renal agents|mesh-ancestor
25131465|NCT03025906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25131466|NCT03025906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25131467|NCT03025906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25131468|NCT03025906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25131469|NCT03025906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25131470|NCT03025906|GABA Modulators|gaba modulators|mesh-ancestor
25131471|NCT03025906|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25131472|NCT03025906|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25131496|NCT03025594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131497|NCT03025594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131498|NCT03025594|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25279921|NCT02342002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25279922|NCT02342002|Luteolytic Agents|luteolytic agents|mesh-ancestor
25279923|NCT02342002|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25279924|NCT02342002|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25279925|NCT02341833|Sevoflurane|sevoflurane|mesh-list
25119601|NCT05403229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25119602|NCT05403229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119603|NCT05403138|Daratumumab|daratumumab|mesh-list
25119604|NCT05403138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119605|NCT05403125|Listerine|listerine|mesh-list
25119606|NCT05403125|Fluorides|fluorides|mesh-list
25119607|NCT05403125|Sodium Fluoride|sodium fluoride|mesh-list
25119608|NCT05403125|Cariostatic Agents|cariostatic agents|mesh-ancestor
25119609|NCT05403125|Protective Agents|protective agents|mesh-ancestor
25119613|NCT05403099|Hyaluronic Acid|hyaluronic acid|mesh-list
25131499|NCT03025594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25131500|NCT03025594|Autonomic Agents|autonomic agents|mesh-ancestor
25131501|NCT03025594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25131502|NCT03025594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25131503|NCT03025594|Respiratory System Agents|respiratory system agents|mesh-ancestor
25131504|NCT03025594|Mydriatics|mydriatics|mesh-ancestor
25131505|NCT03025594|Sympathomimetics|sympathomimetics|mesh-ancestor
25131506|NCT03025594|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25131507|NCT03025594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25131508|NCT03025594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25131509|NCT03025594|Analgesics|analgesics|mesh-ancestor
25131510|NCT03025594|Sensory System Agents|sensory system agents|mesh-ancestor
25131511|NCT03025594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25131512|NCT03025594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25131513|NCT03025594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25131514|NCT03025594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131515|NCT03025594|Anesthetics, Local|anesthetics, local|mesh-ancestor
25131516|NCT03025594|Anesthetics|anesthetics|mesh-ancestor
25131517|NCT03025594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25131518|NCT03025282|Betamethasone|betamethasone|mesh-list
25131519|NCT03025282|Betamethasone Valerate|betamethasone valerate|mesh-list
25131520|NCT03025282|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25131521|NCT03025282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25131522|NCT03025282|Glucocorticoids|glucocorticoids|mesh-ancestor
25131523|NCT03025282|Hormones|hormones|mesh-ancestor
25131524|NCT03025282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25131525|NCT03025282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131526|NCT03025282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25131527|NCT03025282|Respiratory System Agents|respiratory system agents|mesh-ancestor
25131632|NCT03024814|Antipyretics|antipyretics|mesh-ancestor
25131536|NCT03025295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131537|NCT03025295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25131539|NCT03025295|Sensory System Agents|sensory system agents|mesh-ancestor
25131540|NCT03025295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25131541|NCT03025295|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25131542|NCT03025295|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25131543|NCT03025295|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25131544|NCT03025295|Adrenergic Agents|adrenergic agents|mesh-ancestor
25131545|NCT03025295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25131546|NCT03025295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131547|NCT03025009|Insulin|insulin|mesh-list
25131548|NCT03025009|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25131549|NCT03025009|Insulin Glargine|insulin glargine|mesh-list
25131550|NCT03025009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25131551|NCT03025009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683148|NCT03858231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25683149|NCT03858231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683150|NCT03858231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683151|NCT03846453|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25683152|NCT03846453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25683153|NCT03818178|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25683154|NCT03818178|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25683155|NCT03818178|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25683156|NCT03818178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25683157|NCT03799731|Trifluridine|trifluridine|mesh-list
25683158|NCT03799731|Antimetabolites|antimetabolites|mesh-ancestor
25683159|NCT03799731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683160|NCT03799731|Antiviral Agents|antiviral agents|mesh-ancestor
25683161|NCT03799731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25160734|NCT02607748|Fluorides|fluorides|mesh-list
25160735|NCT02607748|Sodium Fluoride|sodium fluoride|mesh-list
25160736|NCT02607748|Cariostatic Agents|cariostatic agents|mesh-ancestor
25160737|NCT02607748|Protective Agents|protective agents|mesh-ancestor
25160738|NCT02607748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652925|NCT01240941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25160739|NCT02607748|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25160740|NCT02607748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24705935|NCT01487629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131552|NCT03024879|Erythromycin|erythromycin|mesh-list
25131553|NCT03024879|Erythromycin Estolate|erythromycin estolate|mesh-list
25131554|NCT03024879|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25131555|NCT03024879|Erythromycin stearate|erythromycin stearate|mesh-list
24444502|NCT00298324|Cyclosporine|cyclosporine|mesh-list
25131556|NCT03024879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25131557|NCT03024879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25131558|NCT03024879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25131559|NCT03024879|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25131560|NCT03024879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131561|NCT03024879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131562|NCT03024905|Misoprostol|misoprostol|mesh-list
25131563|NCT03024905|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25131564|NCT03024905|Abortifacient Agents|abortifacient agents|mesh-ancestor
25131578|NCT03024957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25131579|NCT03024957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25131580|NCT03024957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25131581|NCT03024957|Analgesics|analgesics|mesh-ancestor
25131582|NCT03024957|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25131583|NCT03024957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25131584|NCT03024957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25131585|NCT03024957|Adrenergic Agents|adrenergic agents|mesh-ancestor
25131586|NCT03024957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25131587|NCT03024957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131588|NCT03024957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25131589|NCT03024957|Narcotics|narcotics|mesh-ancestor
25131590|NCT03025113|Ketoprofen|ketoprofen|mesh-list
25131591|NCT03025113|Amitriptyline|amitriptyline|mesh-list
25131592|NCT03025113|Cyclobenzaprine|cyclobenzaprine|mesh-list
25131593|NCT03025113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25131594|NCT03025113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25131595|NCT03025113|Analgesics|analgesics|mesh-ancestor
25131596|NCT03025113|Sensory System Agents|sensory system agents|mesh-ancestor
25131597|NCT03025113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25131598|NCT03025113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131599|NCT03025113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25131600|NCT03025113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25131601|NCT03025113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25131602|NCT03025113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131603|NCT03025113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131604|NCT03025113|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25131605|NCT03025113|Antidepressive Agents|antidepressive agents|mesh-ancestor
25131606|NCT03025113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25131616|NCT03024840|Propofol|propofol|mesh-list
25131621|NCT03024840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25131622|NCT03024840|Anesthetics, General|anesthetics, general|mesh-ancestor
25131623|NCT03024840|Anesthetics|anesthetics|mesh-ancestor
25131624|NCT03024840|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25131625|NCT03024840|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25131626|NCT03024814|Acetaminophen|acetaminophen|mesh-list
25131627|NCT03024814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25131628|NCT03024814|Analgesics|analgesics|mesh-ancestor
25131629|NCT03024814|Sensory System Agents|sensory system agents|mesh-ancestor
25131630|NCT03024814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25131631|NCT03024814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131633|NCT03024502|Clotrimazole|clotrimazole|mesh-list
25683162|NCT03776760|Sofosbuvir|sofosbuvir|mesh-list
25683163|NCT03776760|Antiviral Agents|antiviral agents|mesh-ancestor
25683164|NCT03776760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25683165|NCT03643796|Dexmedetomidine|dexmedetomidine|mesh-list
25683166|NCT03643796|Ketamine|ketamine|mesh-list
25683167|NCT03643796|Remifentanil|remifentanil|mesh-list
25683168|NCT03643796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25683169|NCT03643796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25683170|NCT03643796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131634|NCT03024502|Miconazole|miconazole|mesh-list
25683171|NCT03643796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25160748|NCT02546583|Chlorothiazide|chlorothiazide|mesh-list
25160749|NCT02546583|Furosemide|furosemide|mesh-list
25160750|NCT02546583|Bumetanide|bumetanide|mesh-list
25160751|NCT02546583|Diuretics|diuretics|mesh-list
25160752|NCT02546583|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
24653194|NCT01242332|Analgesics|analgesics|mesh-ancestor
25160753|NCT02546583|Natriuretic Agents|natriuretic agents|mesh-ancestor
25160754|NCT02546583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160755|NCT02546583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25131635|NCT03024502|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25131636|NCT03024502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25131637|NCT03024502|Antifungal Agents|antifungal agents|mesh-ancestor
25131638|NCT03024502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25131639|NCT03024502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25131640|NCT03024502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131641|NCT03024502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131642|NCT03024502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25131643|NCT03024502|Hormone Antagonists|hormone antagonists|mesh-ancestor
25131644|NCT03024502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25131645|NCT03024502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131646|NCT03024502|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25131647|NCT03024502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25131648|NCT03024580|Tamoxifen|tamoxifen|mesh-list
25131649|NCT03024580|Letrozole|letrozole|mesh-list
25131650|NCT03024580|Fulvestrant|fulvestrant|mesh-list
25131651|NCT03024580|Anastrozole|anastrozole|mesh-list
24570977|NCT00807534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570979|NCT00807625|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24570980|NCT00807625|Medroxyprogesterone|medroxyprogesterone|mesh-list
24570981|NCT00807625|Trace Elements|trace elements|mesh-ancestor
24570982|NCT00807625|Micronutrients|micronutrients|mesh-ancestor
24570983|NCT00807625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570984|NCT00807625|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24571150|NCT00808275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571151|NCT00808275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24571154|NCT00808314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24571155|NCT00808314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131653|NCT03024580|Megestrol|megestrol|mesh-list
25131654|NCT03024580|Megestrol Acetate|megestrol acetate|mesh-list
25131655|NCT03024580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131656|NCT03024580|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25131657|NCT03024580|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25131658|NCT03024580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131659|NCT03024580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131660|NCT03024580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25131661|NCT03024580|Hormone Antagonists|hormone antagonists|mesh-ancestor
25131662|NCT03024580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25131663|NCT03024580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131664|NCT03024580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24571156|NCT00808314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571157|NCT00808314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24571158|NCT00808314|Vasodilator Agents|vasodilator agents|mesh-ancestor
24571159|NCT00808314|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
24571160|NCT00808314|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24571161|NCT00808314|Purinergic Agonists|purinergic agonists|mesh-ancestor
24571302|NCT00809068|Androgen Antagonists|androgen antagonists|mesh-ancestor
24571303|NCT00809068|Hormone Antagonists|hormone antagonists|mesh-ancestor
24571304|NCT00809068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24571498|NCT00810381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571499|NCT00810381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25683172|NCT03643796|Analgesics|analgesics|mesh-ancestor
25683173|NCT03643796|Sensory System Agents|sensory system agents|mesh-ancestor
25683174|NCT03643796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25683175|NCT03643796|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25683176|NCT03643796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25683177|NCT03643796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25683178|NCT03643796|Adrenergic Agents|adrenergic agents|mesh-ancestor
25683179|NCT03643796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25160804|NCT02502253|Resveratrol|resveratrol|mesh-list
25160805|NCT02502253|Antioxidants|antioxidants|mesh-ancestor
25160806|NCT02502253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160807|NCT02502253|Protective Agents|protective agents|mesh-ancestor
25160808|NCT02502253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160809|NCT02502253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25160810|NCT02502253|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25160811|NCT02499354|Iron|iron|mesh-list
25160812|NCT02499354|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24571592|NCT00810940|Natriuretic Agents|natriuretic agents|mesh-ancestor
24571593|NCT00810940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571594|NCT00810953|Pentamidine|pentamidine|mesh-list
24572045|NCT00812786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572046|NCT00812786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24572047|NCT00812786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24572048|NCT00812786|Antitubercular Agents|antitubercular agents|mesh-ancestor
24572049|NCT00812786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24572051|NCT00812825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24572300|NCT00814125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24572301|NCT00814125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24572302|NCT00814125|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24572303|NCT00814125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24572304|NCT00814125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24572305|NCT00814125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572306|NCT00814216|Fluticasone|fluticasone|mesh-list
24572307|NCT00814216|Xhance|xhance|mesh-list
24572308|NCT00814216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24572309|NCT00814216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25131666|NCT03024580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25131667|NCT03024580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25131668|NCT03024580|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25131669|NCT03024580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25131670|NCT03024580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25131671|NCT03024580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25131672|NCT03024580|Contraceptive Agents|contraceptive agents|mesh-ancestor
25131673|NCT03024580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25131674|NCT03024580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25131675|NCT03024580|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25131676|NCT03024580|Appetite Stimulants|appetite stimulants|mesh-ancestor
25131677|NCT03024580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24572310|NCT00814216|Autonomic Agents|autonomic agents|mesh-ancestor
24444503|NCT00298324|Mycophenolic Acid|mycophenolic acid|mesh-list
24444505|NCT00298324|Cyclosporins|cyclosporins|mesh-list
24444506|NCT00298324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24572733|NCT00816426|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24572734|NCT00816426|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24572735|NCT00816426|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24572736|NCT00816426|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24572737|NCT00816426|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24572738|NCT00816426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24572739|NCT00816426|Antimetabolites|antimetabolites|mesh-ancestor
24572740|NCT00816426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24572741|NCT00816426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24572816|NCT00816855|Tubulin Modulators|tubulin modulators|mesh-ancestor
24572817|NCT00816855|Antimitotic Agents|antimitotic agents|mesh-ancestor
24572818|NCT00816855|Mitosis Modulators|mitosis modulators|mesh-ancestor
25683180|NCT03643796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683181|NCT03643796|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25683182|NCT03643796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25683183|NCT03643796|Anesthetics, General|anesthetics, general|mesh-ancestor
25683184|NCT03643796|Anesthetics|anesthetics|mesh-ancestor
25683185|NCT03643796|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25683186|NCT03643796|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25683187|NCT03643796|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24572819|NCT00816855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160829|NCT02483585|Sensory System Agents|sensory system agents|mesh-ancestor
25160830|NCT02483585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25160831|NCT02483585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011973|NCT02721069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25011982|NCT02721069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706058|NCT01488266|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24706059|NCT01488266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25280071|NCT02340910|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25280072|NCT02340910|Adrenergic Agents|adrenergic agents|mesh-ancestor
25280073|NCT02340910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25280074|NCT02340910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280075|NCT02340910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280076|NCT02340910|Sympathomimetics|sympathomimetics|mesh-ancestor
25280077|NCT02340910|Autonomic Agents|autonomic agents|mesh-ancestor
25280078|NCT02340910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25280079|NCT02340910|Nasal Decongestants|nasal decongestants|mesh-ancestor
25280080|NCT02340910|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25280081|NCT02340910|Respiratory System Agents|respiratory system agents|mesh-ancestor
25280082|NCT02340936|Lenalidomide|lenalidomide|mesh-list
25280083|NCT02340936|Immunologic Factors|immunologic factors|mesh-ancestor
25280084|NCT02340936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280085|NCT02340936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25280086|NCT02340936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25280087|NCT02340936|Growth Substances|growth substances|mesh-ancestor
25280088|NCT02340936|Growth Inhibitors|growth inhibitors|mesh-ancestor
25280089|NCT02340936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572820|NCT00816855|Antimetabolites|antimetabolites|mesh-ancestor
24572998|NCT00817466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572999|NCT00817466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573000|NCT00817466|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24573001|NCT00817466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24573002|NCT00817466|Autonomic Agents|autonomic agents|mesh-ancestor
24573003|NCT00817466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24573004|NCT00817466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24573005|NCT00817466|Respiratory System Agents|respiratory system agents|mesh-ancestor
24573062|NCT00817713|Anthelmintics|anthelmintics|mesh-ancestor
24573063|NCT00817713|Anticestodal Agents|anticestodal agents|mesh-ancestor
24573064|NCT00817713|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24573065|NCT00817713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24573066|NCT00817713|Tubulin Modulators|tubulin modulators|mesh-ancestor
25131685|NCT03024515|Analgesics, Opioid|analgesics, opioid|mesh-list
24971328|NCT03726580|Propofol|propofol|mesh-list
25131701|NCT03024476|Olmesartan|olmesartan|mesh-list
25131702|NCT03024476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25131703|NCT03024476|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25683188|NCT03643796|Narcotics|narcotics|mesh-ancestor
25683189|NCT03605862|Nitazoxanide|nitazoxanide|mesh-list
25683190|NCT03605862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25683191|NCT03605862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25683192|NCT03605342|Buprenorphine|buprenorphine|mesh-list
25683193|NCT03605342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25683194|NCT03605342|Narcotics|narcotics|mesh-ancestor
25683195|NCT03605342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25683196|NCT03605342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683197|NCT03605342|Analgesics|analgesics|mesh-ancestor
25683198|NCT03605342|Sensory System Agents|sensory system agents|mesh-ancestor
25683199|NCT03605342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25683200|NCT03605342|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25683201|NCT03550391|Memantine|memantine|mesh-list
25683202|NCT03550391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25683203|NCT03550391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25683204|NCT03550391|Dopamine Agents|dopamine agents|mesh-ancestor
25683205|NCT03550391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25683206|NCT03550391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683207|NCT03550391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683208|NCT03550391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25683209|NCT03550391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25683210|NCT03541252|Cisplatin|cisplatin|mesh-list
25683211|NCT03541252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683212|NCT03471364|Ketoconazole|ketoconazole|mesh-list
25683213|NCT03471364|Antifungal Agents|antifungal agents|mesh-ancestor
25683214|NCT03471364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25683215|NCT03471364|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25280105|NCT02340455|Sensory System Agents|sensory system agents|mesh-ancestor
25280106|NCT02340455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25160878|NCT02443831|Cyclophosphamide|cyclophosphamide|mesh-list
25160879|NCT02443831|Fludarabine|fludarabine|mesh-list
25160880|NCT02443831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25160881|NCT02443831|Immunologic Factors|immunologic factors|mesh-ancestor
25160882|NCT02443831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160883|NCT02443831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25160884|NCT02443831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25160885|NCT02443831|Alkylating Agents|alkylating agents|mesh-ancestor
25160886|NCT02443831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160887|NCT02443831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25160888|NCT02443831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25280107|NCT02340455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280108|NCT02340455|Anticonvulsants|anticonvulsants|mesh-ancestor
25280109|NCT02340455|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25280110|NCT02340455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25280111|NCT02340455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280112|NCT02340455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25280113|NCT02340455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25131704|NCT03024476|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25131705|NCT03024476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131706|NCT03024060|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25131707|NCT03024060|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25131708|NCT03024060|Dermatologic Agents|dermatologic agents|mesh-ancestor
25131709|NCT03024216|Atezolizumab|atezolizumab|mesh-list
25131710|NCT03024216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131711|NCT03023982|Morphine|morphine|mesh-list
25131712|NCT03023982|Bupivacaine|bupivacaine|mesh-list
25131713|NCT03023982|Anesthetics, Local|anesthetics, local|mesh-ancestor
25131714|NCT03023982|Anesthetics|anesthetics|mesh-ancestor
25131715|NCT03023982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25131716|NCT03023982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131717|NCT03023982|Sensory System Agents|sensory system agents|mesh-ancestor
25131718|NCT03023982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25131719|NCT03023982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25131720|NCT03023982|Narcotics|narcotics|mesh-ancestor
25131721|NCT03023982|Analgesics|analgesics|mesh-ancestor
25131722|NCT03023852|Oseltamivir|oseltamivir|mesh-list
25131723|NCT03023852|Antiviral Agents|antiviral agents|mesh-ancestor
25131724|NCT03023852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25131725|NCT03023852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131726|NCT03023852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131727|NCT03023774|Lenograstim|lenograstim|mesh-list
25131728|NCT03023774|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24960618|NCT03815279|Dexamethasone|dexamethasone|mesh-list
24573067|NCT00817713|Antimitotic Agents|antimitotic agents|mesh-ancestor
24573068|NCT00817713|Mitosis Modulators|mitosis modulators|mesh-ancestor
24573071|NCT00817739|Leuprolide|leuprolide|mesh-list
24573125|NCT00817960|Dopamine Agents|dopamine agents|mesh-ancestor
24573126|NCT00817960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24573128|NCT00817973|Chelating Agents|chelating agents|mesh-ancestor
24573129|NCT00817973|Sequestering Agents|sequestering agents|mesh-ancestor
25405452|NCT03606967|Interferon Inducers|interferon inducers|mesh-ancestor
25683216|NCT03471364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25683217|NCT03471364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683218|NCT03471364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683219|NCT03471364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25683220|NCT03471364|Hormone Antagonists|hormone antagonists|mesh-ancestor
25683221|NCT03471364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25683222|NCT03471364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683223|NCT03471364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25683224|NCT03440450|Gemcitabine|gemcitabine|mesh-list
25683225|NCT03440450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25683226|NCT03440450|Antimetabolites|antimetabolites|mesh-ancestor
25683227|NCT03440450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683228|NCT03440450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683229|NCT03440450|Antiviral Agents|antiviral agents|mesh-ancestor
25683230|NCT03440450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25683231|NCT03440450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683232|NCT03440450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25683233|NCT03440450|Immunologic Factors|immunologic factors|mesh-ancestor
25683234|NCT03440450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683235|NCT03420014|Doxorubicin|doxorubicin|mesh-list
25160922|NCT02399215|Nintedanib|nintedanib|mesh-list
24654109|NCT01247701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25160923|NCT02399215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25160924|NCT02399215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25160925|NCT02399215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25160926|NCT02399215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119802|NCT05147090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280138|NCT02340273|Oxymetazoline|oxymetazoline|mesh-list
25280140|NCT02340273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24573130|NCT00817973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573131|NCT00818038|Natalizumab|natalizumab|mesh-list
24573132|NCT00818038|Immunologic Factors|immunologic factors|mesh-ancestor
24573133|NCT00818038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573134|NCT00818090|Paclitaxel|paclitaxel|mesh-list
24573135|NCT00818090|Cisplatin|cisplatin|mesh-list
25131730|NCT03023774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131732|NCT03023904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25131733|NCT03023904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131734|NCT03023904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25131735|NCT03023904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131736|NCT03023527|Dexamethasone|dexamethasone|mesh-list
25131737|NCT03023527|Nivolumab|nivolumab|mesh-list
25131738|NCT03023527|Pomalidomide|pomalidomide|mesh-list
25131739|NCT03023527|Elotuzumab|elotuzumab|mesh-list
25131740|NCT03023527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25131741|NCT03023527|Antiemetics|antiemetics|mesh-ancestor
25131742|NCT03023527|Autonomic Agents|autonomic agents|mesh-ancestor
25131743|NCT03023527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25131744|NCT03023527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131745|NCT03023527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25131746|NCT03023527|Glucocorticoids|glucocorticoids|mesh-ancestor
25131747|NCT03023527|Hormones|hormones|mesh-ancestor
25131748|NCT03023527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25131749|NCT03023527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25131750|NCT03023527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131751|NCT03023527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25131752|NCT03023527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24573136|NCT00818090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24573137|NCT00818090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24573138|NCT00818090|Tubulin Modulators|tubulin modulators|mesh-ancestor
24573139|NCT00818090|Antimitotic Agents|antimitotic agents|mesh-ancestor
24573140|NCT00818090|Mitosis Modulators|mitosis modulators|mesh-ancestor
24573141|NCT00818090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573142|NCT00818103|Interferons|interferons|mesh-list
24573149|NCT00818103|Antimetabolites|antimetabolites|mesh-ancestor
24573150|NCT00818103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573151|NCT00818103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24573152|NCT00818103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24573153|NCT00818103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573154|NCT00818155|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24573155|NCT00818155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24573159|NCT00818155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24573160|NCT00818155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573161|NCT00818155|Antidepressive Agents|antidepressive agents|mesh-ancestor
24573163|NCT00818194|Cyclosporine|cyclosporine|mesh-list
24573168|NCT00818194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573169|NCT00818194|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24573170|NCT00818194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573190|NCT00818350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131753|NCT03023527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131755|NCT03023527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25131756|NCT03023527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25131757|NCT03023527|Growth Substances|growth substances|mesh-ancestor
25131758|NCT03023527|Growth Inhibitors|growth inhibitors|mesh-ancestor
25683236|NCT03420014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25683237|NCT03420014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25683238|NCT03420014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683239|NCT03420014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25683240|NCT03420014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25683241|NCT03420014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683242|NCT03420014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683243|NCT03360890|Docetaxel|docetaxel|mesh-list
25160972|NCT02335944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25280179|NCT02340182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25280180|NCT02340182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25280181|NCT02340182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25280182|NCT02340182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280183|NCT02340182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280184|NCT02340182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25280185|NCT02340182|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25280186|NCT02340182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25131759|NCT03023514|Thioctic Acid|thioctic acid|mesh-list
25131760|NCT03023514|Progesterone|progesterone|mesh-list
25131761|NCT03023514|Progestins|progestins|mesh-ancestor
25131762|NCT03023514|Hormones|hormones|mesh-ancestor
25131763|NCT03023514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25131764|NCT03023514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131765|NCT03023514|Antioxidants|antioxidants|mesh-ancestor
25131766|NCT03023514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131767|NCT03023514|Protective Agents|protective agents|mesh-ancestor
25131768|NCT03023514|Vitamin B Complex|vitamin b complex|mesh-ancestor
25131769|NCT03023514|Vitamins|vitamins|mesh-ancestor
25131770|NCT03023514|Micronutrients|micronutrients|mesh-ancestor
25131771|NCT03023501|Gabapentin|gabapentin|mesh-list
25131772|NCT03023501|Analgesics|analgesics|mesh-ancestor
25131774|NCT03023501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24971439|NCT03725995|Midazolam|midazolam|mesh-list
25131775|NCT03023501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131776|NCT03023501|Anticonvulsants|anticonvulsants|mesh-ancestor
25131777|NCT03023501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25131778|NCT03023501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25131779|NCT03023501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25131780|NCT03023501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25131781|NCT03023501|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25131782|NCT03023501|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25131783|NCT03023501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25131798|NCT03023306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131799|NCT03023306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25131800|NCT03023189|Tranexamic Acid|tranexamic acid|mesh-list
25131801|NCT03023189|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25131802|NCT03023189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25131803|NCT03023189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131804|NCT03023189|Hemostatics|hemostatics|mesh-ancestor
25131805|NCT03023189|Coagulants|coagulants|mesh-ancestor
25131806|NCT03023111|Miltefosine|miltefosine|mesh-list
25131807|NCT03023111|Meglumine Antimoniate|meglumine antimoniate|mesh-list
25131808|NCT03023111|Molgramostim|molgramostim|mesh-list
25131809|NCT03023111|Sargramostim|sargramostim|mesh-list
25131810|NCT03023111|Immunologic Factors|immunologic factors|mesh-ancestor
25131811|NCT03023111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131812|NCT03023111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131813|NCT03023111|Antifungal Agents|antifungal agents|mesh-ancestor
25131814|NCT03023111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25131815|NCT03023111|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25131816|NCT03023111|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25131818|NCT03023358|Cyclophosphamide|cyclophosphamide|mesh-list
25131819|NCT03023358|Doxorubicin|doxorubicin|mesh-list
25131820|NCT03023358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25131821|NCT03023358|Vincristine|vincristine|mesh-list
25131822|NCT03023358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25131823|NCT03023358|Immunologic Factors|immunologic factors|mesh-ancestor
25131824|NCT03023358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131825|NCT03023358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25131826|NCT03023358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25131827|NCT03023358|Alkylating Agents|alkylating agents|mesh-ancestor
25683244|NCT03360890|Pembrolizumab|pembrolizumab|mesh-list
25683245|NCT03360890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683246|NCT03360890|Tubulin Modulators|tubulin modulators|mesh-ancestor
25683247|NCT03360890|Antimitotic Agents|antimitotic agents|mesh-ancestor
25683248|NCT03360890|Mitosis Modulators|mitosis modulators|mesh-ancestor
25683249|NCT03360890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683250|NCT03360890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25683251|NCT03252600|Dexamethasone|dexamethasone|mesh-list
25683252|NCT03252600|Dexamethasone acetate|dexamethasone acetate|mesh-list
25131828|NCT03023358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573191|NCT00818350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25683253|NCT03252600|Cyclophosphamide|cyclophosphamide|mesh-list
25161004|NCT02229877|Omeprazole|omeprazole|mesh-list
25161005|NCT02229877|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25161006|NCT02229877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25161007|NCT02229877|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25161008|NCT02229877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25161009|NCT02229877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161010|NCT02202577|Chlorhexidine|chlorhexidine|mesh-list
25161011|NCT02202577|Povidone-Iodine|povidone-iodine|mesh-list
25161012|NCT02202577|Povidone|povidone|mesh-list
25161013|NCT02202577|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24573192|NCT00818350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24573193|NCT00818350|Growth Substances|growth substances|mesh-ancestor
24573194|NCT00818350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573195|NCT00818350|Growth Inhibitors|growth inhibitors|mesh-ancestor
24573196|NCT00818350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24573197|NCT00818350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573198|NCT00818350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573200|NCT00818415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25131829|NCT03023358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131830|NCT03023358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25131831|NCT03023358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25131832|NCT03023358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25131833|NCT03023358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25131834|NCT03023358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131835|NCT03023358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25131836|NCT03023358|Glucocorticoids|glucocorticoids|mesh-ancestor
25131837|NCT03023358|Hormones|hormones|mesh-ancestor
25131838|NCT03023358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25131839|NCT03023358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25131840|NCT03023358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25131841|NCT03023358|Tubulin Modulators|tubulin modulators|mesh-ancestor
25131842|NCT03023358|Antimitotic Agents|antimitotic agents|mesh-ancestor
25131843|NCT03023358|Mitosis Modulators|mitosis modulators|mesh-ancestor
25131844|NCT03023059|Levodopa|levodopa|mesh-list
25131845|NCT03023059|Carbidopa|carbidopa|mesh-list
25131846|NCT03023059|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25131847|NCT03023059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25131893|NCT03022877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131894|NCT03022877|Protective Agents|protective agents|mesh-ancestor
25131895|NCT03022877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131896|NCT03022773|Carotenoids|carotenoids|mesh-list
25131897|NCT03022773|Antioxidants|antioxidants|mesh-ancestor
25131898|NCT03022773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131899|NCT03022773|Protective Agents|protective agents|mesh-ancestor
25131900|NCT03022773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131901|NCT03022929|Anti-Infective Agents|anti-infective agents|mesh-list
25131902|NCT03022929|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25131903|NCT03022747|Allopurinol|allopurinol|mesh-list
25131904|NCT03022747|Antimetabolites|antimetabolites|mesh-ancestor
25131905|NCT03022747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131906|NCT03022747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131907|NCT03022747|Gout Suppressants|gout suppressants|mesh-ancestor
25131908|NCT03022747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25131909|NCT03022747|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25131910|NCT03022747|Antioxidants|antioxidants|mesh-ancestor
25131911|NCT03022747|Protective Agents|protective agents|mesh-ancestor
25131912|NCT03022747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131913|NCT03022565|Vorinostat|vorinostat|mesh-list
25131914|NCT03022565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131915|NCT03022565|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25131916|NCT03022565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131917|NCT03022565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131918|NCT03022318|Levodopa|levodopa|mesh-list
25683254|NCT03252600|Lenalidomide|lenalidomide|mesh-list
25683255|NCT03252600|Elotuzumab|elotuzumab|mesh-list
25683256|NCT03252600|Ichthammol|ichthammol|mesh-list
25683257|NCT03252600|BB 1101|bb 1101|mesh-list
25683258|NCT03252600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25683259|NCT03252600|Immunologic Factors|immunologic factors|mesh-ancestor
25683260|NCT03252600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683261|NCT03252600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25683262|NCT03252600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25683263|NCT03252600|Alkylating Agents|alkylating agents|mesh-ancestor
25161058|NCT02178410|Vitamin D|vitamin d|mesh-list
25280258|NCT02339844|Serotonin Agents|serotonin agents|mesh-ancestor
25161059|NCT02178410|Ergocalciferols|ergocalciferols|mesh-list
25161060|NCT02178410|Cholecalciferol|cholecalciferol|mesh-list
25161061|NCT02178410|Vitamins|vitamins|mesh-list
25280259|NCT02339844|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25280260|NCT02339844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25012604|NCT04724252|Anticonvulsants|anticonvulsants|mesh-ancestor
25280261|NCT02339844|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25280262|NCT02339844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25280263|NCT02339350|Methotrexate|methotrexate|mesh-list
25280264|NCT02339350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25280265|NCT02339350|Abortifacient Agents|abortifacient agents|mesh-ancestor
25280266|NCT02339350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25280267|NCT02339350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280268|NCT02339350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25280269|NCT02339350|Antimetabolites|antimetabolites|mesh-ancestor
25280271|NCT02339350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131940|NCT03022240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25131941|NCT03022240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25131942|NCT03022240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131943|NCT03022240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25131944|NCT03022240|Anesthetics, General|anesthetics, general|mesh-ancestor
25131945|NCT03022240|Anesthetics|anesthetics|mesh-ancestor
25131946|NCT03022240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25131947|NCT03022240|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25131948|NCT03022240|Antiemetics|antiemetics|mesh-ancestor
25131949|NCT03022240|Autonomic Agents|autonomic agents|mesh-ancestor
25131950|NCT03022240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25131951|NCT03022240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25131952|NCT03022240|Antipruritics|antipruritics|mesh-ancestor
25131953|NCT03022240|Dermatologic Agents|dermatologic agents|mesh-ancestor
25131954|NCT03022240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25131955|NCT03022240|Serotonin Agents|serotonin agents|mesh-ancestor
25131956|NCT03022240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25131957|NCT03022240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131958|NCT03022240|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25131994|NCT03021772|Autonomic Agents|autonomic agents|mesh-ancestor
25131995|NCT03021772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25131996|NCT03021772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131997|NCT03021772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25131998|NCT03021772|Glucocorticoids|glucocorticoids|mesh-ancestor
25132000|NCT03021772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25132001|NCT03021772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25132002|NCT03021772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25132003|NCT03021772|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25132004|NCT03021772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25132005|NCT03021772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132006|NCT03021772|Cholinergic Agents|cholinergic agents|mesh-ancestor
25132007|NCT03021772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25132008|NCT03021772|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25132010|NCT03022123|Cyclophosphamide|cyclophosphamide|mesh-list
25132011|NCT03022123|Doxorubicin|doxorubicin|mesh-list
25132012|NCT03022123|Vincristine|vincristine|mesh-list
25132013|NCT03022123|Epirubicin|epirubicin|mesh-list
25132014|NCT03022123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25132015|NCT03022123|Immunologic Factors|immunologic factors|mesh-ancestor
25683264|NCT03252600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683265|NCT03252600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683266|NCT03252600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25683267|NCT03252600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25683268|NCT03252600|Antiemetics|antiemetics|mesh-ancestor
25683269|NCT03252600|Autonomic Agents|autonomic agents|mesh-ancestor
25683270|NCT03252600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25683271|NCT03252600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25683272|NCT03252600|Glucocorticoids|glucocorticoids|mesh-ancestor
25683273|NCT03252600|Hormones|hormones|mesh-ancestor
25683274|NCT03252600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25683275|NCT03252600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25683276|NCT03252600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25683277|NCT03252600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25683278|NCT03252600|Growth Substances|growth substances|mesh-ancestor
25683279|NCT03252600|Growth Inhibitors|growth inhibitors|mesh-ancestor
25683280|NCT03252600|Protease Inhibitors|protease inhibitors|mesh-ancestor
25132016|NCT03022123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161080|NCT02047513|Gemcitabine|gemcitabine|mesh-list
25132017|NCT03022123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25132018|NCT03022123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25132019|NCT03022123|Alkylating Agents|alkylating agents|mesh-ancestor
25132020|NCT03022123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132028|NCT03022123|Glucocorticoids|glucocorticoids|mesh-ancestor
25132030|NCT03022123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25132031|NCT03022123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25132032|NCT03022123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25132033|NCT03022123|Tubulin Modulators|tubulin modulators|mesh-ancestor
25132034|NCT03022123|Antimitotic Agents|antimitotic agents|mesh-ancestor
25132035|NCT03022123|Mitosis Modulators|mitosis modulators|mesh-ancestor
25132037|NCT03022006|Antiviral Agents|antiviral agents|mesh-ancestor
25132038|NCT03022006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25132039|NCT03021616|Moxifloxacin|moxifloxacin|mesh-list
25132040|NCT03021616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25132041|NCT03021616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25132042|NCT03021616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25132043|NCT03021616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25132044|NCT03021616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25132045|NCT03021616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132046|NCT03021616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24573235|NCT00818675|Antifungal Agents|antifungal agents|mesh-ancestor
24573236|NCT00818675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24573237|NCT00818675|Immunologic Factors|immunologic factors|mesh-ancestor
24573240|NCT00818701|Sildenafil Citrate|sildenafil citrate|mesh-list
25132064|NCT03021629|Vitamin D|vitamin d|mesh-list
25132065|NCT03021629|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
25132066|NCT03021629|Vitamins|vitamins|mesh-ancestor
25132067|NCT03021629|Micronutrients|micronutrients|mesh-ancestor
25132068|NCT03021629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132069|NCT03021629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25132070|NCT03021590|Amoxicillin|amoxicillin|mesh-list
25132071|NCT03021590|Clarithromycin|clarithromycin|mesh-list
25132072|NCT03021590|Levofloxacin|levofloxacin|mesh-list
25132073|NCT03021590|Ofloxacin|ofloxacin|mesh-list
25132074|NCT03021590|Tinidazole|tinidazole|mesh-list
25132075|NCT03021590|Esomeprazole|esomeprazole|mesh-list
25132076|NCT03021590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25132077|NCT03021590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25132078|NCT03021590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25132079|NCT03021590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25132080|NCT03021590|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25132081|NCT03021590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25132082|NCT03021590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132083|NCT03021590|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25132091|NCT03021590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25132092|NCT03021590|Alkylating Agents|alkylating agents|mesh-ancestor
25132093|NCT03021590|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25132094|NCT03021590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25132095|NCT03021590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25132096|NCT03021694|Caseins|caseins|mesh-list
25132097|NCT03021694|Chelating Agents|chelating agents|mesh-ancestor
25132098|NCT03021694|Sequestering Agents|sequestering agents|mesh-ancestor
25132099|NCT03021694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132100|NCT03021395|Decitabine|decitabine|mesh-list
25132101|NCT03021395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25132102|NCT03021395|Antimetabolites|antimetabolites|mesh-ancestor
25132103|NCT03021395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132104|NCT03021395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25132105|NCT03021395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573272|NCT00819065|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24573273|NCT00819065|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24573274|NCT00819065|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24573275|NCT00819065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25132106|NCT03021317|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25132107|NCT03021317|Hormones|hormones|mesh-ancestor
25132108|NCT03021317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25132109|NCT03021317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132110|NCT03021330|Cytarabine|cytarabine|mesh-list
25132111|NCT03021330|Daunorubicin|daunorubicin|mesh-list
25132112|NCT03021330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25132113|NCT03021330|Antimetabolites|antimetabolites|mesh-ancestor
25132114|NCT03021330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161116|NCT01959698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161117|NCT01959698|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25161118|NCT01959698|Alkylating Agents|alkylating agents|mesh-ancestor
25161119|NCT01959698|Keratolytic Agents|keratolytic agents|mesh-ancestor
25161120|NCT01959698|Dermatologic Agents|dermatologic agents|mesh-ancestor
25161121|NCT01959698|Tubulin Modulators|tubulin modulators|mesh-ancestor
25161122|NCT01959698|Antimitotic Agents|antimitotic agents|mesh-ancestor
25161123|NCT01959698|Mitosis Modulators|mitosis modulators|mesh-ancestor
25280331|NCT02339142|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25280332|NCT02339142|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25132115|NCT03021330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25132116|NCT03021330|Antiviral Agents|antiviral agents|mesh-ancestor
25132117|NCT03021330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25132118|NCT03021330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25132119|NCT03021330|Immunologic Factors|immunologic factors|mesh-ancestor
25132120|NCT03021330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132121|NCT03021330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25132122|NCT03021330|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25132123|NCT03021330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25132124|NCT03021330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25132125|NCT03021421|Bupivacaine|bupivacaine|mesh-list
25132126|NCT03021421|Anesthetics, Local|anesthetics, local|mesh-ancestor
25132127|NCT03021421|Anesthetics|anesthetics|mesh-ancestor
25132128|NCT03021421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25132129|NCT03021421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132130|NCT03021421|Sensory System Agents|sensory system agents|mesh-ancestor
25132131|NCT03021421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25132132|NCT03021057|Pembrolizumab|pembrolizumab|mesh-list
25132133|NCT03021057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24573276|NCT00819065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573277|NCT00819065|Cholinergic Agents|cholinergic agents|mesh-ancestor
24573278|NCT00819065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24573279|NCT00819065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573280|NCT00819065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24573281|NCT00819065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24671072|NCT01323465|Antitubercular Agents|antitubercular agents|mesh-ancestor
24671073|NCT01323465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24671074|NCT01323465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24671075|NCT01323465|Leprostatic Agents|leprostatic agents|mesh-ancestor
24671076|NCT01323465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24573353|NCT00819572|Immunoglobulin Fragments|immunoglobulin fragments|mesh-list
24573354|NCT00819572|Immunologic Factors|immunologic factors|mesh-ancestor
25132135|NCT03020979|Apatinib|apatinib|mesh-list
25132136|NCT03020979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25132137|NCT03020979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24971714|NCT03723109|Anesthetics|anesthetics|mesh-list
25132174|NCT03020706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132175|NCT03020706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25132176|NCT03020706|Tocolytic Agents|tocolytic agents|mesh-ancestor
25132177|NCT03020706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24971791|NCT03722498|Antidotes|antidotes|mesh-ancestor
25132179|NCT03020602|Coenzyme Q10|coenzyme q10|mesh-list
25132180|NCT03020602|Micronutrients|micronutrients|mesh-ancestor
25132181|NCT03020602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132182|NCT03020602|Vitamins|vitamins|mesh-ancestor
25132190|NCT03020368|Diclofenac|diclofenac|mesh-list
25132191|NCT03020368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24796840|NCT01952652|Naproxen|naproxen|mesh-list
25132192|NCT03020368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25132193|NCT03020368|Analgesics|analgesics|mesh-ancestor
25132194|NCT03020368|Sensory System Agents|sensory system agents|mesh-ancestor
25132195|NCT03020368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25132196|NCT03020368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132197|NCT03020368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25683281|NCT03252600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683282|NCT03252600|Dermatologic Agents|dermatologic agents|mesh-ancestor
24449721|NCT00316745|Vitamins|vitamins|mesh-ancestor
25692519|NCT02000531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25692520|NCT02000921|Nicotine|nicotine|mesh-list
25692521|NCT02000921|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25692522|NCT02000921|Autonomic Agents|autonomic agents|mesh-ancestor
25692523|NCT02000921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25692524|NCT02000921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692525|NCT02000921|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25692526|NCT02000921|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25692527|NCT02000921|Cholinergic Agents|cholinergic agents|mesh-ancestor
25120098|NCT04695704|Montelukast|montelukast|mesh-list
25120099|NCT04695704|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25120100|NCT04695704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25120101|NCT04695704|Respiratory System Agents|respiratory system agents|mesh-ancestor
25120102|NCT04695704|Hormone Antagonists|hormone antagonists|mesh-ancestor
25120103|NCT04695704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25280379|NCT02338934|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25132198|NCT03020368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25132199|NCT03020368|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24960981|NCT03813030|Lidocaine|lidocaine|mesh-list
24573355|NCT00819572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573356|NCT00819676|Nitric Oxide|nitric oxide|mesh-list
24573357|NCT00819676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24573358|NCT00819676|Autonomic Agents|autonomic agents|mesh-ancestor
24573364|NCT00819676|Antioxidants|antioxidants|mesh-ancestor
24573390|NCT00819754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573391|NCT00819754|Growth Inhibitors|growth inhibitors|mesh-ancestor
24573392|NCT00819754|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24573393|NCT00819754|Antimetabolites|antimetabolites|mesh-ancestor
24573424|NCT00819845|Vasodilator Agents|vasodilator agents|mesh-ancestor
24573473|NCT00820118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24573474|NCT00820118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24573475|NCT00820118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24573476|NCT00820118|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24573477|NCT00820118|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24573478|NCT00820118|Protease Inhibitors|protease inhibitors|mesh-ancestor
24573479|NCT00820326|Dolasetron|dolasetron|mesh-list
25132200|NCT03020368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25132201|NCT03020368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132203|NCT03020329|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25132205|NCT03020329|Fluorouracil|fluorouracil|mesh-list
25132206|NCT03020329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25132207|NCT03020329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25132208|NCT03020329|Tubulin Modulators|tubulin modulators|mesh-ancestor
25132209|NCT03020329|Antimitotic Agents|antimitotic agents|mesh-ancestor
25132210|NCT03020329|Mitosis Modulators|mitosis modulators|mesh-ancestor
25132211|NCT03020329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132230|NCT03020134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132232|NCT03020134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25132233|NCT03020134|Antiviral Agents|antiviral agents|mesh-ancestor
25132234|NCT03020134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24961003|NCT03812731|Fentanyl|fentanyl|mesh-list
24573480|NCT00820326|Antiemetics|antiemetics|mesh-ancestor
24573481|NCT00820326|Autonomic Agents|autonomic agents|mesh-ancestor
24573482|NCT00820326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25132235|NCT03020134|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25132236|NCT03020134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25132237|NCT03020056|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25132238|NCT03020056|Antioxidants|antioxidants|mesh-list
25132239|NCT03020056|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25132240|NCT03020056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132241|NCT03020056|Protective Agents|protective agents|mesh-ancestor
25132242|NCT03020056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132243|NCT03019822|Amphetamine|amphetamine|mesh-list
25132244|NCT03019822|Dextroamphetamine|dextroamphetamine|mesh-list
25132245|NCT03019822|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25132246|NCT03019822|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
25683283|NCT03222570|Serotonin|serotonin|mesh-list
25683284|NCT03222570|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25683285|NCT03222570|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25683286|NCT03222570|Serotonin Agents|serotonin agents|mesh-ancestor
25683287|NCT03222570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25683288|NCT03222570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683289|NCT03222570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25405453|NCT03606967|Laxatives|laxatives|mesh-ancestor
24529852|NCT00628056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24529898|NCT00628225|Dopamine Agents|dopamine agents|mesh-ancestor
24529899|NCT00628225|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24529900|NCT00628225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24529901|NCT00628225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280415|NCT02338518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280416|NCT02338518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25280417|NCT02338635|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25280418|NCT02338635|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25280419|NCT02338635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25280421|NCT02338544|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25280422|NCT02338544|Dermatologic Agents|dermatologic agents|mesh-ancestor
25280423|NCT02338544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25280424|NCT02338544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25280425|NCT02338544|Analgesics|analgesics|mesh-ancestor
25280426|NCT02338544|Sensory System Agents|sensory system agents|mesh-ancestor
25280427|NCT02338544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25280428|NCT02338544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280429|NCT02338544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25132247|NCT03019822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25132248|NCT03019822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132249|NCT03019822|Sympathomimetics|sympathomimetics|mesh-ancestor
25132250|NCT03019822|Autonomic Agents|autonomic agents|mesh-ancestor
25132251|NCT03019822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25132252|NCT03019822|Dopamine Agents|dopamine agents|mesh-ancestor
25132253|NCT03019822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25132254|NCT03019822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132255|NCT03019822|Adrenergic Agents|adrenergic agents|mesh-ancestor
25132256|NCT03019822|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25132257|NCT03019822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25132258|NCT03019822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25132259|NCT03019822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25132260|NCT03019822|Hallucinogens|hallucinogens|mesh-ancestor
25132261|NCT03019822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25132262|NCT03019822|Serotonin Agents|serotonin agents|mesh-ancestor
25132263|NCT03019822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25132264|NCT03019822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25132266|NCT03019991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25132267|NCT03019991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24573483|NCT00820326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573484|NCT00820326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24573530|NCT00820547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24573638|NCT00821301|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
24573639|NCT00821301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24573640|NCT00821301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25132268|NCT03019991|Protease Inhibitors|protease inhibitors|mesh-ancestor
25132269|NCT03019991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25132270|NCT03019991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132271|NCT03019991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25132272|NCT03019991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25683290|NCT03222570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25683291|NCT03222570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25683292|NCT03191526|Mogamulizumab|mogamulizumab|mesh-list
25683293|NCT03191526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683294|NCT03169361|Ixazomib|ixazomib|mesh-list
25683295|NCT03169361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683296|NCT03169361|Protease Inhibitors|protease inhibitors|mesh-ancestor
25683297|NCT03169361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683298|NCT03169361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683299|NCT03093155|Bevacizumab|bevacizumab|mesh-list
25683300|NCT03093155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25683301|NCT03093155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683302|NCT03093155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25683303|NCT03093155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25683304|NCT03093155|Growth Substances|growth substances|mesh-ancestor
25683305|NCT03093155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683306|NCT03093155|Growth Inhibitors|growth inhibitors|mesh-ancestor
25683307|NCT03062059|Gemcitabine|gemcitabine|mesh-list
25683308|NCT03062059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25683309|NCT03062059|Antimetabolites|antimetabolites|mesh-ancestor
25280455|NCT02338310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102800|NCT03166280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25280456|NCT02338310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280457|NCT02338310|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25280458|NCT02338310|Hormone Antagonists|hormone antagonists|mesh-ancestor
25280459|NCT02338310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25280460|NCT02338310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280461|NCT02338024|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25132273|NCT03019991|Antiviral Agents|antiviral agents|mesh-ancestor
25132274|NCT03019991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25132275|NCT03019991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25132276|NCT03019991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25132277|NCT03019926|Hydroxychloroquine|hydroxychloroquine|mesh-list
25132278|NCT03019926|Antimalarials|antimalarials|mesh-ancestor
25132279|NCT03019926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25132280|NCT03019926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25132281|NCT03019926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25132282|NCT03019926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25132283|NCT03019926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132284|NCT03019926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25132285|NCT03019835|Neostigmine|neostigmine|mesh-list
25132286|NCT03019835|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25132287|NCT03019835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25132288|NCT03019835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132289|NCT03019835|Cholinergic Agents|cholinergic agents|mesh-ancestor
25132290|NCT03019835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25132291|NCT03019835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132292|NCT03019835|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25132294|NCT03019835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25132295|NCT03019848|Curcumin|curcumin|mesh-list
25132296|NCT03019848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25132297|NCT03019848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24573641|NCT00821301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24573642|NCT00821301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573643|NCT00821301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24573656|NCT00821444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573657|NCT00821444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573658|NCT00821444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24573659|NCT00821444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24573660|NCT00821444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24573661|NCT00821444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24573662|NCT00821444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24573663|NCT00821444|Dopamine Agents|dopamine agents|mesh-ancestor
24573664|NCT00821457|Mitogens|mitogens|mesh-list
25132298|NCT03019848|Analgesics|analgesics|mesh-ancestor
25132299|NCT03019848|Sensory System Agents|sensory system agents|mesh-ancestor
25132300|NCT03019848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24657166|NCT01266031|Growth Substances|growth substances|mesh-ancestor
25132301|NCT03019848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132302|NCT03019848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25132303|NCT03019848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25132304|NCT03019848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25132305|NCT03019848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25132306|NCT03019848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132307|NCT03019809|Plerixafor|plerixafor|mesh-list
25132308|NCT03019809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25132309|NCT03019809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25132310|NCT03019809|Antiviral Agents|antiviral agents|mesh-ancestor
25132311|NCT03019809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25132312|NCT03019614|Hydrocortisone|hydrocortisone|mesh-list
25132313|NCT03019614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25132314|NCT03019666|Niacinamide|niacinamide|mesh-list
25132315|NCT03019666|Niacin|niacin|mesh-list
25132316|NCT03019666|Nicotinic Acids|nicotinic acids|mesh-list
25132317|NCT03019666|Vitamin B Complex|vitamin b complex|mesh-ancestor
25132318|NCT03019666|Vitamins|vitamins|mesh-ancestor
25132319|NCT03019666|Micronutrients|micronutrients|mesh-ancestor
25683310|NCT03062059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683311|NCT03062059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683312|NCT03062059|Antiviral Agents|antiviral agents|mesh-ancestor
25683313|NCT03062059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25683314|NCT03062059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683315|NCT03062059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25683316|NCT03062059|Immunologic Factors|immunologic factors|mesh-ancestor
25683317|NCT03062059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683318|NCT03054038|Afatinib|afatinib|mesh-list
25280494|NCT02338115|Mitosis Modulators|mitosis modulators|mesh-ancestor
25280495|NCT02338115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280496|NCT02338050|Immunotoxin HA22|immunotoxin ha22|mesh-list
25280497|NCT02338050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25132320|NCT03019666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132321|NCT03019666|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24573665|NCT00821457|Mitosis Modulators|mitosis modulators|mesh-ancestor
24573666|NCT00821457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573667|NCT00821483|Frovatriptan|frovatriptan|mesh-list
24573668|NCT00821483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24573669|NCT00821483|Serotonin Agents|serotonin agents|mesh-ancestor
24573670|NCT00821483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24573671|NCT00821483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573672|NCT00821483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573673|NCT00821496|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24573674|NCT00821496|Norethindrone|norethindrone|mesh-list
24573675|NCT00821496|Norethindrone Acetate|norethindrone acetate|mesh-list
24573676|NCT00821496|Norinyl|norinyl|mesh-list
24573677|NCT00821496|Estradiol|estradiol|mesh-list
24573678|NCT00821496|Estrogens|estrogens|mesh-ancestor
24573679|NCT00821496|Hormones|hormones|mesh-ancestor
24573680|NCT00821496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24573681|NCT00821496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629661|NCT01107067|Hormones|hormones|mesh-ancestor
24573698|NCT00821535|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24573700|NCT00821574|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24573704|NCT00821574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573705|NCT00821574|Diuretics|diuretics|mesh-ancestor
24573706|NCT00821574|Natriuretic Agents|natriuretic agents|mesh-ancestor
24573707|NCT00821574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573708|NCT00821574|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24573709|NCT00821574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24573710|NCT00821600|Risperidone|risperidone|mesh-list
25132322|NCT03019666|Antimetabolites|antimetabolites|mesh-ancestor
24603968|NCT00976326|Insulin|insulin|mesh-list
25132323|NCT03019666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132324|NCT03019666|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25132325|NCT03019666|Vasodilator Agents|vasodilator agents|mesh-ancestor
25132326|NCT03019536|Flutemetamol|flutemetamol|mesh-list
25132327|NCT03019536|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25266477|NCT02428283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25266478|NCT02428283|Narcotics|narcotics|mesh-ancestor
25266479|NCT02428283|Analgesics|analgesics|mesh-ancestor
25266480|NCT02428218|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25132328|NCT03019536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132329|NCT03019523|Caffeine|caffeine|mesh-list
25132330|NCT03019523|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25132331|NCT03019523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132332|NCT03019523|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25132333|NCT03019523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25132334|NCT03019523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132335|NCT03019523|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25132336|NCT03019523|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25132337|NCT03019523|Purinergic Agents|purinergic agents|mesh-ancestor
25132338|NCT03019523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25132340|NCT03019562|Oxycodone|oxycodone|mesh-list
24573792|NCT00822081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24573793|NCT00822081|Adrenergic Agents|adrenergic agents|mesh-ancestor
24573794|NCT00822081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24573795|NCT00822081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573832|NCT00822263|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24573834|NCT00822263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24573941|NCT00822614|Analgesics|analgesics|mesh-ancestor
24573942|NCT00822614|Sensory System Agents|sensory system agents|mesh-ancestor
24573943|NCT00822614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24573944|NCT00822614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24573945|NCT00822614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24573946|NCT00822614|Anesthetics, General|anesthetics, general|mesh-ancestor
24573947|NCT00822614|Anesthetics|anesthetics|mesh-ancestor
24573948|NCT00822666|Clopidogrel|clopidogrel|mesh-list
24573949|NCT00822666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24573950|NCT00822666|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25683319|NCT03054038|Necitumumab|necitumumab|mesh-list
25683320|NCT03054038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683321|NCT03054038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25683322|NCT03054038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683323|NCT03054038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280534|NCT02337426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280535|NCT02337413|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25280536|NCT02337413|Laxatives|laxatives|mesh-ancestor
25280537|NCT02337413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25280538|NCT02337283|BI 425809|bi 425809|mesh-list
25280539|NCT02337283|Nootropic Agents|nootropic agents|mesh-ancestor
25280540|NCT02337257|Vitamin D|vitamin d|mesh-list
25280541|NCT02337257|Cholecalciferol|cholecalciferol|mesh-list
25280542|NCT02337257|Vitamins|vitamins|mesh-ancestor
25280543|NCT02337257|Micronutrients|micronutrients|mesh-ancestor
25280544|NCT02337257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280545|NCT02337257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25280546|NCT02337257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25280547|NCT02337231|Borage oil|borage oil|mesh-list
25280548|NCT02337231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25280549|NCT02337322|Ritonavir|ritonavir|mesh-list
25280550|NCT02337322|Darunavir|darunavir|mesh-list
25280551|NCT02337322|Dolutegravir|dolutegravir|mesh-list
25280554|NCT02337322|Protease Inhibitors|protease inhibitors|mesh-ancestor
24573951|NCT00822666|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24573952|NCT00822666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24573953|NCT00822666|Purinergic Agents|purinergic agents|mesh-ancestor
24573954|NCT00822666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24573955|NCT00822666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573956|NCT00822666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573957|NCT00822744|Citalopram|citalopram|mesh-list
24573958|NCT00822744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24573959|NCT00822744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24574026|NCT00823030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574027|NCT00823030|Sensory System Agents|sensory system agents|mesh-ancestor
24574028|NCT00823030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24574029|NCT00823030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24759019|NCT01749072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24574030|NCT00823030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24574031|NCT00823030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24574032|NCT00823030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25132341|NCT03019562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25132342|NCT03019562|Narcotics|narcotics|mesh-ancestor
24657584|NCT01268384|Antiviral Agents|antiviral agents|mesh-ancestor
25132343|NCT03019562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25132344|NCT03019562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132345|NCT03019562|Analgesics|analgesics|mesh-ancestor
25132346|NCT03019562|Sensory System Agents|sensory system agents|mesh-ancestor
25132347|NCT03019562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25132348|NCT03019562|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25132349|NCT03019562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25132350|NCT03019562|Anesthetics, General|anesthetics, general|mesh-ancestor
25132351|NCT03019562|Anesthetics|anesthetics|mesh-ancestor
25132352|NCT03019237|Omalizumab|omalizumab|mesh-list
25132353|NCT03019237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25132354|NCT03019237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25132355|NCT03019237|Respiratory System Agents|respiratory system agents|mesh-ancestor
25132356|NCT03019224|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25132357|NCT03019224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25132358|NCT03019224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25132359|NCT03019081|Isoproterenol|isoproterenol|mesh-list
25132360|NCT03019081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25132361|NCT03019081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25132362|NCT03019081|Adrenergic Agents|adrenergic agents|mesh-ancestor
25683324|NCT03054038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25683325|NCT03041701|Dasatinib|dasatinib|mesh-list
25683326|NCT03041701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683327|NCT03041701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683328|NCT03041701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25683329|NCT03041701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683330|NCT03021083|Fentanyl|fentanyl|mesh-list
25683331|NCT03021083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25683332|NCT03021083|Narcotics|narcotics|mesh-ancestor
25683333|NCT03021083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25683334|NCT03021083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683335|NCT03021083|Analgesics|analgesics|mesh-ancestor
25683336|NCT03021083|Sensory System Agents|sensory system agents|mesh-ancestor
25683337|NCT03021083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25683338|NCT03021083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25683339|NCT03021083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25683340|NCT03021083|Anesthetics, General|anesthetics, general|mesh-ancestor
25280577|NCT02337192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25280578|NCT02337192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280579|NCT02337192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25280580|NCT02337192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25280581|NCT02337192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25280582|NCT02337192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280583|NCT02337192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280584|NCT02337192|Respiratory System Agents|respiratory system agents|mesh-ancestor
25280585|NCT02337127|Lamivudine|lamivudine|mesh-list
25280588|NCT02337127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25132363|NCT03019081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25132364|NCT03019081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132365|NCT03019081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132366|NCT03019081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25132367|NCT03019081|Autonomic Agents|autonomic agents|mesh-ancestor
25132368|NCT03019081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24648854|NCT01217099|Hormones|hormones|mesh-ancestor
25132369|NCT03019081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25132370|NCT03019081|Respiratory System Agents|respiratory system agents|mesh-ancestor
25132371|NCT03019081|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25132372|NCT03019081|Sympathomimetics|sympathomimetics|mesh-ancestor
25132373|NCT03019081|Protective Agents|protective agents|mesh-ancestor
25132374|NCT03019120|Vitamin D|vitamin d|mesh-list
25132375|NCT03019120|Vitamins|vitamins|mesh-ancestor
25132376|NCT03019120|Micronutrients|micronutrients|mesh-ancestor
25132377|NCT03019120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132378|NCT03019120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25132379|NCT03018899|Anesthetics|anesthetics|mesh-list
25132380|NCT03018899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25132381|NCT03018899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132382|NCT03018990|Ethanol|ethanol|mesh-list
24516304|NCT00601432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25132383|NCT03018990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25132384|NCT03018990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25132385|NCT03018990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25132386|NCT03018990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132387|NCT03018977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25132388|NCT03018977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25132389|NCT03018977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132390|NCT03019198|Tranexamic Acid|tranexamic acid|mesh-list
25132391|NCT03019198|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25132392|NCT03019198|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25132393|NCT03019198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132394|NCT03019198|Hemostatics|hemostatics|mesh-ancestor
25132395|NCT03019198|Coagulants|coagulants|mesh-ancestor
25132396|NCT03018821|Tenofovir|tenofovir|mesh-list
25132397|NCT03018821|Entecavir|entecavir|mesh-list
25132398|NCT03018821|Antiviral Agents|antiviral agents|mesh-ancestor
25132399|NCT03018821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24574122|NCT00823849|Protective Agents|protective agents|mesh-ancestor
24574123|NCT00823849|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24574124|NCT00823849|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24574125|NCT00823849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574126|NCT00823849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24574127|NCT00823849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24574128|NCT00823849|Antimetabolites|antimetabolites|mesh-ancestor
24574129|NCT00823849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24574130|NCT00823849|Antioxidants|antioxidants|mesh-ancestor
24574131|NCT00823862|Ribavirin|ribavirin|mesh-list
24574132|NCT00823862|Antimetabolites|antimetabolites|mesh-ancestor
24574133|NCT00823862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574134|NCT00823862|Antiviral Agents|antiviral agents|mesh-ancestor
24574135|NCT00823862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24574184|NCT00824057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683341|NCT03021083|Anesthetics|anesthetics|mesh-ancestor
25683342|NCT03000257|Venetoclax|venetoclax|mesh-list
25683343|NCT03000257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683344|NCT03000179|Avelumab|avelumab|mesh-list
25683345|NCT03000179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25683346|NCT03000179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683347|NCT02990533|Methyltestosterone|methyltestosterone|mesh-list
25683348|NCT02990533|Testosterone|testosterone|mesh-list
25683349|NCT02990533|Testosterone undecanoate|testosterone undecanoate|mesh-list
25683350|NCT02990533|Testosterone enanthate|testosterone enanthate|mesh-list
25683351|NCT02990533|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25683352|NCT02990533|Androgens|androgens|mesh-ancestor
25280616|NCT02336984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25280617|NCT02336984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25280618|NCT02336906|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25280619|NCT02336906|Laxatives|laxatives|mesh-ancestor
25280620|NCT02336906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25280621|NCT02336854|Tacrolimus|tacrolimus|mesh-list
25280622|NCT02336854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25280623|NCT02336854|Immunologic Factors|immunologic factors|mesh-ancestor
25280624|NCT02336854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280625|NCT02336854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25280626|NCT02336854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280627|NCT02336854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280628|NCT02336659|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24574185|NCT00824057|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24574186|NCT00824057|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24574187|NCT00824057|Purinergic Agents|purinergic agents|mesh-ancestor
24574188|NCT00824109|Anti-Infective Agents|anti-infective agents|mesh-list
24574212|NCT00824135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24574213|NCT00824135|Antimetabolites|antimetabolites|mesh-ancestor
24574214|NCT00824200|Tamsulosin|tamsulosin|mesh-list
24574215|NCT00824200|Adrenergic Agents|adrenergic agents|mesh-list
24574216|NCT00824200|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
24574217|NCT00824200|Adrenergic Antagonists|adrenergic antagonists|mesh-list
24574218|NCT00824200|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24574221|NCT00824200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574223|NCT00824239|Fentanyl|fentanyl|mesh-list
24574224|NCT00824239|Midazolam|midazolam|mesh-list
24574225|NCT00824239|Propofol|propofol|mesh-list
25132400|NCT03018821|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25132415|NCT03018626|Cyclophosphamide|cyclophosphamide|mesh-list
25132416|NCT03018626|Rituximab|rituximab|mesh-list
25132417|NCT03018626|Doxorubicin|doxorubicin|mesh-list
25132418|NCT03018626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25132419|NCT03018626|Etoposide|etoposide|mesh-list
25132420|NCT03018626|Vincristine|vincristine|mesh-list
25132421|NCT03018626|Bleomycin|bleomycin|mesh-list
25132422|NCT03018626|Vindesine|vindesine|mesh-list
25132423|NCT03018626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25132424|NCT03018626|Immunologic Factors|immunologic factors|mesh-ancestor
25132425|NCT03018626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132426|NCT03018626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25132427|NCT03018626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25132428|NCT03018626|Alkylating Agents|alkylating agents|mesh-ancestor
25132429|NCT03018626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132430|NCT03018626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25132431|NCT03018626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25132432|NCT03018626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25132433|NCT03018626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25132434|NCT03018626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25132435|NCT03018626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25132436|NCT03018626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25132437|NCT03018626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25132438|NCT03018626|Glucocorticoids|glucocorticoids|mesh-ancestor
25132440|NCT03018626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25132441|NCT03018626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25132442|NCT03018626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25132460|NCT03018535|Alkylating Agents|alkylating agents|mesh-ancestor
25132461|NCT03018535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132462|NCT03018535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25132463|NCT03018535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25132464|NCT03018535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25132465|NCT03018535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25683353|NCT02990533|Hormones|hormones|mesh-ancestor
25683354|NCT02990533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25683355|NCT02990533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683356|NCT02990533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25683357|NCT02990533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683358|NCT02990533|Anabolic Agents|anabolic agents|mesh-ancestor
25683359|NCT02979327|Adderall|adderall|mesh-list
25683360|NCT02979327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25683361|NCT02979327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683362|NCT02945813|Metformin|metformin|mesh-list
25683363|NCT02945813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25683364|NCT02945813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683365|NCT02909322|Hydromorphone|hydromorphone|mesh-list
25120349|NCT04006925|Sodium Oxybate|sodium oxybate|mesh-list
25120350|NCT04006925|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25120351|NCT04006925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25120352|NCT04006925|Anesthetics, General|anesthetics, general|mesh-ancestor
25120353|NCT04006925|Anesthetics|anesthetics|mesh-ancestor
25120354|NCT04006925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25120355|NCT04006925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120356|NCT03995004|Dexamethasone|dexamethasone|mesh-list
25120357|NCT03995004|Melatonin|melatonin|mesh-list
25120358|NCT03995004|Sodium sulfate|sodium sulfate|mesh-list
25120359|NCT03995004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25120360|NCT03995004|Antiemetics|antiemetics|mesh-ancestor
25120361|NCT03995004|Autonomic Agents|autonomic agents|mesh-ancestor
25120362|NCT03995004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25120363|NCT03995004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132466|NCT03018535|Antiemetics|antiemetics|mesh-ancestor
25132467|NCT03018535|Autonomic Agents|autonomic agents|mesh-ancestor
25132468|NCT03018535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25132469|NCT03018535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25132470|NCT03018535|Glucocorticoids|glucocorticoids|mesh-ancestor
25132471|NCT03018535|Hormones|hormones|mesh-ancestor
25132472|NCT03018535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25132473|NCT03018535|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25132474|NCT03018535|Protective Agents|protective agents|mesh-ancestor
25132475|NCT03018535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25132476|NCT03018652|Immunoglobulins|immunoglobulins|mesh-list
25132477|NCT03018652|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25132479|NCT03018652|gamma-Globulins|gamma-globulins|mesh-list
25132480|NCT03018652|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25132481|NCT03018652|Immunologic Factors|immunologic factors|mesh-ancestor
25132482|NCT03018652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132487|NCT03018756|Fentanyl|fentanyl|mesh-list
25132488|NCT03018756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25132489|NCT03018756|Narcotics|narcotics|mesh-ancestor
24961244|NCT03809897|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24574226|NCT00824239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24574227|NCT00824239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24574228|NCT00824239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574229|NCT00824239|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24574278|NCT00824785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24574279|NCT00824811|Fluorometholone|fluorometholone|mesh-list
24574280|NCT00824811|Cyclosporine|cyclosporine|mesh-list
24574281|NCT00824811|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24574314|NCT00825019|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24574315|NCT00825019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24574316|NCT00825019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24574317|NCT00825019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671092|NCT01323465|Sensory System Agents|sensory system agents|mesh-ancestor
24574318|NCT00825019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25132490|NCT03018756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25132491|NCT03018756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132492|NCT03018756|Analgesics|analgesics|mesh-ancestor
25132493|NCT03018756|Sensory System Agents|sensory system agents|mesh-ancestor
25132494|NCT03018756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25132495|NCT03018756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25132496|NCT03018756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25132497|NCT03018756|Anesthetics, General|anesthetics, general|mesh-ancestor
25132498|NCT03018756|Anesthetics|anesthetics|mesh-ancestor
25132499|NCT03018444|Atorvastatin|atorvastatin|mesh-list
25132500|NCT03018444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25132501|NCT03018444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25683366|NCT02909322|Bupivacaine|bupivacaine|mesh-list
25683367|NCT02909322|Ropivacaine|ropivacaine|mesh-list
25683368|NCT02909322|Anesthetics, Local|anesthetics, local|mesh-ancestor
25683369|NCT02909322|Anesthetics|anesthetics|mesh-ancestor
25683370|NCT02909322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25683371|NCT02909322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683372|NCT02909322|Sensory System Agents|sensory system agents|mesh-ancestor
25683373|NCT02909322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25683374|NCT02909322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25683375|NCT02909322|Narcotics|narcotics|mesh-ancestor
25683376|NCT02909322|Analgesics|analgesics|mesh-ancestor
25683377|NCT02891447|Cisplatin|cisplatin|mesh-list
25683378|NCT02891447|Mitomycins|mitomycins|mesh-list
25683379|NCT02891447|Mitomycin|mitomycin|mesh-list
25683380|NCT02891447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25132502|NCT03018444|Antimetabolites|antimetabolites|mesh-ancestor
25161481|NCT00746590|Tretazicar|tretazicar|mesh-list
25280684|NCT02336386|Immunologic Factors|immunologic factors|mesh-ancestor
25280685|NCT02336386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280686|NCT02336386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25280687|NCT02336386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25280688|NCT02336386|Alkylating Agents|alkylating agents|mesh-ancestor
25280689|NCT02336386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280690|NCT02336386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25280691|NCT02336386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25280692|NCT02336386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25280693|NCT02336386|Antiemetics|antiemetics|mesh-ancestor
25280694|NCT02336386|Autonomic Agents|autonomic agents|mesh-ancestor
25280695|NCT02336386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25280696|NCT02336386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25280697|NCT02336386|Glucocorticoids|glucocorticoids|mesh-ancestor
25132503|NCT03018444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132504|NCT03018444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25132505|NCT03018444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25132506|NCT03018444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25132507|NCT03018418|Mitomycins|mitomycins|mesh-list
25132508|NCT03018418|Mitomycin|mitomycin|mesh-list
25132509|NCT03018418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25132510|NCT03018418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25132511|NCT03018418|Alkylating Agents|alkylating agents|mesh-ancestor
25132512|NCT03018418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132513|NCT03018418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25132514|NCT03018418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25132515|NCT03018171|Clonidine|clonidine|mesh-list
25132516|NCT03018171|Sufentanil|sufentanil|mesh-list
25132517|NCT03018171|Analgesics|analgesics|mesh-ancestor
25132518|NCT03018171|Sensory System Agents|sensory system agents|mesh-ancestor
24574319|NCT00825019|Serotonin Agents|serotonin agents|mesh-ancestor
24574320|NCT00825019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574355|NCT00825058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24574356|NCT00825058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574357|NCT00825058|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24574358|NCT00825058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24574360|NCT00825071|Dexamethasone|dexamethasone|mesh-list
24574410|NCT00825149|Obinutuzumab|obinutuzumab|mesh-list
24574411|NCT00825149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24574412|NCT00825149|Immunologic Factors|immunologic factors|mesh-ancestor
24574413|NCT00825149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574414|NCT00825149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24574415|NCT00825149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24574416|NCT00825149|Alkylating Agents|alkylating agents|mesh-ancestor
24574417|NCT00825149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574418|NCT00825149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24574419|NCT00825149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25132519|NCT03018171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25132520|NCT03018171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132521|NCT03018171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25132522|NCT03018171|Sympatholytics|sympatholytics|mesh-ancestor
25132523|NCT03018171|Autonomic Agents|autonomic agents|mesh-ancestor
25132524|NCT03018171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25132525|NCT03018171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25132526|NCT03018171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25132527|NCT03018171|Adrenergic Agents|adrenergic agents|mesh-ancestor
25132528|NCT03018171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25132529|NCT03018171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683381|NCT02891447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25683382|NCT02891447|Alkylating Agents|alkylating agents|mesh-ancestor
25683383|NCT02891447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683384|NCT02891447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25683385|NCT02891447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683386|NCT02876835|Darbepoetin alfa|darbepoetin alfa|mesh-list
25683387|NCT02876835|Hematinics|hematinics|mesh-ancestor
25683388|NCT02841748|Pembrolizumab|pembrolizumab|mesh-list
25683389|NCT02841748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25683390|NCT02841748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683391|NCT02815033|Choline|choline|mesh-list
25683392|NCT02815033|Lipotropic Agents|lipotropic agents|mesh-ancestor
25683393|NCT02815033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25683394|NCT02815033|Antimetabolites|antimetabolites|mesh-ancestor
25683395|NCT02815033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161527|NCT00490035|Brivaracetam|brivaracetam|mesh-list
25161528|NCT00490035|Anticonvulsants|anticonvulsants|mesh-ancestor
25161529|NCT00464269|Brivaracetam|brivaracetam|mesh-list
25161530|NCT00464269|Anticonvulsants|anticonvulsants|mesh-ancestor
25161531|NCT00334815|Bevacizumab|bevacizumab|mesh-list
25161532|NCT00334815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25161534|NCT00334815|Docetaxel|docetaxel|mesh-list
25161535|NCT00334815|Etoposide|etoposide|mesh-list
25161536|NCT00334815|Etoposide phosphate|etoposide phosphate|mesh-list
25132530|NCT03018171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25132531|NCT03018171|Narcotics|narcotics|mesh-ancestor
25132532|NCT03018171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25132533|NCT03018171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25132534|NCT03018171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25132535|NCT03018171|Anesthetics, General|anesthetics, general|mesh-ancestor
25132536|NCT03018171|Anesthetics|anesthetics|mesh-ancestor
25132538|NCT03018301|Analgesics|analgesics|mesh-ancestor
25132539|NCT03018301|Sensory System Agents|sensory system agents|mesh-ancestor
25132540|NCT03018301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25132541|NCT03018301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132542|NCT03018301|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25132543|NCT03018301|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25132544|NCT03018301|Anesthetics, General|anesthetics, general|mesh-ancestor
25132545|NCT03018301|Anesthetics|anesthetics|mesh-ancestor
24574683|NCT00826839|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24574684|NCT00826839|Hormone Antagonists|hormone antagonists|mesh-ancestor
24574685|NCT00826839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25132551|NCT03018236|Ethanol|ethanol|mesh-list
25132552|NCT03018236|Acetylcysteine|acetylcysteine|mesh-list
25132553|NCT03018236|Cocaine|cocaine|mesh-list
25132554|NCT03018236|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25132555|NCT03018236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25132556|NCT03018236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25132557|NCT03018236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25132558|NCT03018236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132559|NCT03018236|Antiviral Agents|antiviral agents|mesh-ancestor
25132560|NCT03018236|Expectorants|expectorants|mesh-ancestor
25132561|NCT03018236|Respiratory System Agents|respiratory system agents|mesh-ancestor
25132562|NCT03018236|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25132563|NCT03018236|Antioxidants|antioxidants|mesh-ancestor
25132564|NCT03018236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132565|NCT03018236|Protective Agents|protective agents|mesh-ancestor
25132566|NCT03018236|Antidotes|antidotes|mesh-ancestor
25132567|NCT03018236|Anesthetics, Local|anesthetics, local|mesh-ancestor
25132568|NCT03018236|Anesthetics|anesthetics|mesh-ancestor
25132569|NCT03018236|Sensory System Agents|sensory system agents|mesh-ancestor
25132570|NCT03018236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25132571|NCT03018236|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25132572|NCT03018236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25132573|NCT03018236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25132574|NCT03018236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25132575|NCT03018236|Dopamine Agents|dopamine agents|mesh-ancestor
25132576|NCT03018236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25132578|NCT03018015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25132579|NCT03018015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25132580|NCT03018015|Analgesics|analgesics|mesh-ancestor
25132581|NCT03018015|Sensory System Agents|sensory system agents|mesh-ancestor
25132582|NCT03018015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25132583|NCT03018015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132584|NCT03018015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25132585|NCT03018015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25132586|NCT03018015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25132587|NCT03018015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24961345|NCT03809260|Metformin|metformin|mesh-list
25132589|NCT03017963|Sodium thiosulfate|sodium thiosulfate|mesh-list
25132590|NCT03017963|Antidotes|antidotes|mesh-ancestor
25683396|NCT02815033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25683397|NCT02815033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25683398|NCT02815033|Nootropic Agents|nootropic agents|mesh-ancestor
25683399|NCT02814968|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25683400|NCT02814968|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25683401|NCT02814968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683402|NCT02813642|Mitogens|mitogens|mesh-list
25683403|NCT02813642|Mitosis Modulators|mitosis modulators|mesh-ancestor
25683404|NCT02813642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132591|NCT03017963|Protective Agents|protective agents|mesh-ancestor
25161558|NCT00334815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25161559|NCT00334815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25161560|NCT00334815|Keratolytic Agents|keratolytic agents|mesh-ancestor
25161561|NCT00334815|Dermatologic Agents|dermatologic agents|mesh-ancestor
25280770|NCT02335684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25280771|NCT02335684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25280772|NCT02335684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25280773|NCT02335684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25280781|NCT02335372|Acetic Acid|acetic acid|mesh-list
25280782|NCT02335372|Proflavine|proflavine|mesh-list
25280783|NCT02335372|Retinol acetate|retinol acetate|mesh-list
25280784|NCT02335372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25280785|NCT02335372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25280786|NCT02335372|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25280787|NCT02335372|Immunologic Factors|immunologic factors|mesh-ancestor
25280788|NCT02335372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280789|NCT02335372|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25280790|NCT02335372|Protective Agents|protective agents|mesh-ancestor
25280791|NCT02335372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25280792|NCT02335372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25280793|NCT02335255|Naftifine|naftifine|mesh-list
25280794|NCT02335255|Antifungal Agents|antifungal agents|mesh-ancestor
25280795|NCT02335255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25280796|NCT02335151|Desflurane|desflurane|mesh-list
25280797|NCT02335151|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25280798|NCT02335151|Anesthetics, General|anesthetics, general|mesh-ancestor
25280799|NCT02335151|Anesthetics|anesthetics|mesh-ancestor
25280800|NCT02335151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25280801|NCT02335151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280802|NCT02335281|Mesalamine|mesalamine|mesh-list
25280803|NCT02335281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25280804|NCT02335281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25280805|NCT02335281|Analgesics|analgesics|mesh-ancestor
25280806|NCT02335281|Sensory System Agents|sensory system agents|mesh-ancestor
25280807|NCT02335281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25280808|NCT02335281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132592|NCT03017963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132593|NCT03017963|Antioxidants|antioxidants|mesh-ancestor
25132594|NCT03017963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683405|NCT02766582|Paclitaxel|paclitaxel|mesh-list
25683406|NCT02766582|Carboplatin|carboplatin|mesh-list
25683407|NCT02766582|Pembrolizumab|pembrolizumab|mesh-list
25683408|NCT02766582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25683409|NCT02766582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683410|NCT02766582|Tubulin Modulators|tubulin modulators|mesh-ancestor
25683411|NCT02766582|Antimitotic Agents|antimitotic agents|mesh-ancestor
25683412|NCT02766582|Mitosis Modulators|mitosis modulators|mesh-ancestor
25683413|NCT02766582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683414|NCT02766582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25683415|NCT02734602|Ketamine|ketamine|mesh-list
25683416|NCT02734602|Analgesics|analgesics|mesh-ancestor
25683417|NCT02734602|Sensory System Agents|sensory system agents|mesh-ancestor
25683418|NCT02734602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25683419|NCT02734602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683420|NCT02734602|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25683421|NCT02734602|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25683422|NCT02734602|Anesthetics, General|anesthetics, general|mesh-ancestor
25683423|NCT02734602|Anesthetics|anesthetics|mesh-ancestor
25683424|NCT02734602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25683425|NCT02734602|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25683426|NCT02734602|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25683427|NCT02734602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25683428|NCT02734602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683429|NCT02647099|Aspirin|aspirin|mesh-list
25683430|NCT02647099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25683431|NCT02647099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25683432|NCT02647099|Analgesics|analgesics|mesh-ancestor
25683433|NCT02647099|Sensory System Agents|sensory system agents|mesh-ancestor
25683434|NCT02647099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25683435|NCT02647099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683436|NCT02647099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25683437|NCT02647099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25683438|NCT02647099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25683439|NCT02647099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25161608|NCT00042289|Lopinavir|lopinavir|mesh-list
25161609|NCT00042289|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25161610|NCT00042289|Darunavir|darunavir|mesh-list
25161611|NCT00042289|Nelfinavir|nelfinavir|mesh-list
25161612|NCT00042289|Indinavir|indinavir|mesh-list
25161613|NCT00042289|Fosamprenavir|fosamprenavir|mesh-list
25161614|NCT00042289|Amprenavir|amprenavir|mesh-list
25161615|NCT00042289|Tenofovir|tenofovir|mesh-list
25132595|NCT03017963|Antitubercular Agents|antitubercular agents|mesh-ancestor
25132596|NCT03017963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25132597|NCT03017963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25132598|NCT03017963|Chelating Agents|chelating agents|mesh-ancestor
25132599|NCT03017963|Sequestering Agents|sequestering agents|mesh-ancestor
25132600|NCT03018353|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25132601|NCT03018353|Antiviral Agents|antiviral agents|mesh-ancestor
25132602|NCT03018353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25132638|NCT03017729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25132639|NCT03017729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25132640|NCT03017729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132641|NCT03017729|Cholinergic Agents|cholinergic agents|mesh-ancestor
25132642|NCT03017729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25132643|NCT03017729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132644|NCT03017729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25132645|NCT03017729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25132647|NCT03017495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25132648|NCT03017495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25132649|NCT03017495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25132650|NCT03017495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132651|NCT03017495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25132652|NCT03017495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24574687|NCT00826852|Docetaxel|docetaxel|mesh-list
24574688|NCT00826852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24574689|NCT00826852|Tubulin Modulators|tubulin modulators|mesh-ancestor
24574690|NCT00826852|Antimitotic Agents|antimitotic agents|mesh-ancestor
24574860|NCT00827996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24574881|NCT00828230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24574883|NCT00828282|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24574884|NCT00828282|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24574885|NCT00828282|Antimetabolites|antimetabolites|mesh-ancestor
24574886|NCT00828282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574887|NCT00828282|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24574894|NCT00828373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574895|NCT00828373|Sensory System Agents|sensory system agents|mesh-ancestor
24574896|NCT00828373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24574897|NCT00828373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24574898|NCT00828373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24574899|NCT00828373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24574900|NCT00828373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24574901|NCT00828373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574902|NCT00828477|Nepafenac|nepafenac|mesh-list
24574903|NCT00828477|Bromfenac|bromfenac|mesh-list
24574904|NCT00828477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24574905|NCT00828477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24574906|NCT00828477|Analgesics|analgesics|mesh-ancestor
24576971|NCT00841256|Protective Agents|protective agents|mesh-ancestor
24574939|NCT00828763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24574941|NCT00828763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24574943|NCT00828776|Calcium heparin|calcium heparin|mesh-list
25132653|NCT03017495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25132654|NCT03017495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25132655|NCT03017495|Anesthetics, General|anesthetics, general|mesh-ancestor
25132656|NCT03017495|Anesthetics|anesthetics|mesh-ancestor
25132657|NCT03017495|GABA Modulators|gaba modulators|mesh-ancestor
25683440|NCT02647099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683441|NCT02647099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25683442|NCT02647099|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25683443|NCT02647099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683444|NCT02647099|Antipyretics|antipyretics|mesh-ancestor
25683445|NCT02506192|Prednisone|prednisone|mesh-list
25683446|NCT02506192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25683447|NCT02506192|Glucocorticoids|glucocorticoids|mesh-ancestor
25132658|NCT03017495|GABA Agents|gaba agents|mesh-ancestor
25132659|NCT03017495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25132660|NCT03017495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132661|NCT03017222|Ondansetron|ondansetron|mesh-list
25132662|NCT03017222|Ramosetron|ramosetron|mesh-list
25132663|NCT03017222|Antiemetics|antiemetics|mesh-ancestor
25132664|NCT03017222|Autonomic Agents|autonomic agents|mesh-ancestor
25132665|NCT03017222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25132666|NCT03017222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132667|NCT03017222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25132668|NCT03017222|Antipruritics|antipruritics|mesh-ancestor
25132669|NCT03017222|Dermatologic Agents|dermatologic agents|mesh-ancestor
25132670|NCT03017222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25132671|NCT03017222|Serotonin Agents|serotonin agents|mesh-ancestor
25132672|NCT03017222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25132673|NCT03017222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132674|NCT03017222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25132675|NCT03017222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25132676|NCT03017222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25132677|NCT03017222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25132678|NCT03017222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25132679|NCT03017248|Ketamine|ketamine|mesh-list
25132680|NCT03017248|Morphine|morphine|mesh-list
25132681|NCT03017248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25132701|NCT03017391|Antiemetics|antiemetics|mesh-ancestor
25132702|NCT03017391|Autonomic Agents|autonomic agents|mesh-ancestor
25132703|NCT03017391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25132704|NCT03017391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132705|NCT03017391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25132706|NCT03017391|Glucocorticoids|glucocorticoids|mesh-ancestor
25132707|NCT03017391|Hormones|hormones|mesh-ancestor
25132708|NCT03017391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25132709|NCT03017391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25132710|NCT03017391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25132711|NCT03017391|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25132712|NCT03017391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25132713|NCT03017391|Dopamine Agents|dopamine agents|mesh-ancestor
25132714|NCT03017391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25132715|NCT03017391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809200|NCT02031939|Capecitabine|capecitabine|mesh-list
25132716|NCT03017391|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25132717|NCT03017391|Serotonin Agents|serotonin agents|mesh-ancestor
25132718|NCT03017430|Ketorolac|ketorolac|mesh-list
25132719|NCT03017430|Phenazepam|phenazepam|mesh-list
25132720|NCT03017430|Clonidine|clonidine|mesh-list
25132721|NCT03017430|Pregabalin|pregabalin|mesh-list
25132722|NCT03017430|Metoclopramide|metoclopramide|mesh-list
25132723|NCT03017430|Loperamide|loperamide|mesh-list
25132724|NCT03017430|Antidiarrheals|antidiarrheals|mesh-list
25132725|NCT03017430|Analgesics|analgesics|mesh-ancestor
25132726|NCT03017430|Sensory System Agents|sensory system agents|mesh-ancestor
25132727|NCT03017430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25132728|NCT03017430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132729|NCT03017430|Anticonvulsants|anticonvulsants|mesh-ancestor
25132730|NCT03017430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25132731|NCT03017430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25132732|NCT03017430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132733|NCT03017430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25132734|NCT03017430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24574944|NCT00828776|Anticoagulants|anticoagulants|mesh-ancestor
24574945|NCT00828776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24574946|NCT00828776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24574947|NCT00828776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574948|NCT00828789|Tenofovir|tenofovir|mesh-list
24574949|NCT00828789|Efavirenz|efavirenz|mesh-list
25132735|NCT03017430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25132736|NCT03017430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25132737|NCT03017430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25132738|NCT03017430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25132739|NCT03017430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25132740|NCT03017430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25132741|NCT03017430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25132742|NCT03017430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25132743|NCT03017430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25132744|NCT03017430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25132745|NCT03017430|Sympatholytics|sympatholytics|mesh-ancestor
25132746|NCT03017430|Autonomic Agents|autonomic agents|mesh-ancestor
25683448|NCT02506192|Hormones|hormones|mesh-ancestor
24822251|NCT02110719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24706117|NCT01488656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24706118|NCT01488656|Antioxidants|antioxidants|mesh-list
24706119|NCT01488656|Vitamins|vitamins|mesh-ancestor
24706120|NCT01488656|Micronutrients|micronutrients|mesh-ancestor
24659641|NCT01279096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706121|NCT01488656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706122|NCT01488656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24706123|NCT01488656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706124|NCT01488656|Protective Agents|protective agents|mesh-ancestor
24706125|NCT01488734|Vitamin D|vitamin d|mesh-list
25132747|NCT03017430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25132748|NCT03017430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25132749|NCT03017430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25132750|NCT03017430|Adrenergic Agents|adrenergic agents|mesh-ancestor
25132751|NCT03017430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25132752|NCT03017430|Antiemetics|antiemetics|mesh-ancestor
25132753|NCT03017430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25132792|NCT03016988|Fludarabine|fludarabine|mesh-list
25132804|NCT03017066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25132805|NCT03017066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132806|NCT03016832|Irbesartan|irbesartan|mesh-list
25132807|NCT03016832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25132808|NCT03016832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25132809|NCT03016832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25132810|NCT03016832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132811|NCT03016871|Carboplatin|carboplatin|mesh-list
25132812|NCT03016871|Nivolumab|nivolumab|mesh-list
25132813|NCT03016871|Etoposide|etoposide|mesh-list
25132814|NCT03016871|Etoposide phosphate|etoposide phosphate|mesh-list
25132815|NCT03016871|Ifosfamide|ifosfamide|mesh-list
25132816|NCT03016871|Isophosphamide mustard|isophosphamide mustard|mesh-list
25132817|NCT03016871|Podophyllotoxin|podophyllotoxin|mesh-list
25132818|NCT03016871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25132819|NCT03016871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25132820|NCT03016871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25132822|NCT03016871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25132860|NCT03016741|Abiraterone Acetate|abiraterone acetate|mesh-list
25132861|NCT03016741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25132862|NCT03016741|Glucocorticoids|glucocorticoids|mesh-ancestor
25132863|NCT03016741|Hormones|hormones|mesh-ancestor
25132864|NCT03016741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25132865|NCT03016741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132866|NCT03016741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25132867|NCT03016741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25132868|NCT03016741|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25132869|NCT03016741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25132870|NCT03016741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132871|NCT03016741|Hormone Antagonists|hormone antagonists|mesh-ancestor
25132872|NCT03016741|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25132873|NCT03016650|Acetaminophen|acetaminophen|mesh-list
25132874|NCT03016650|Ibuprofen|ibuprofen|mesh-list
25132875|NCT03016650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25132876|NCT03016650|Analgesics|analgesics|mesh-ancestor
25132877|NCT03016650|Sensory System Agents|sensory system agents|mesh-ancestor
24809429|NCT02033707|Nicotine|nicotine|mesh-list
25132879|NCT03016650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132880|NCT03016650|Antipyretics|antipyretics|mesh-ancestor
24574950|NCT00828789|Antiviral Agents|antiviral agents|mesh-ancestor
24574951|NCT00828789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24574952|NCT00828789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24574953|NCT00828789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24574955|NCT00828789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683449|NCT02506192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25683450|NCT02506192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683451|NCT02506192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25683452|NCT02506192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683453|NCT02281838|Enalapril|enalapril|mesh-list
25683454|NCT02281838|Hydralazine|hydralazine|mesh-list
25683455|NCT02281838|Labetalol|labetalol|mesh-list
25683456|NCT02281838|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25683457|NCT02281838|Protease Inhibitors|protease inhibitors|mesh-ancestor
25683458|NCT02281838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574957|NCT00828789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24574958|NCT00828789|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24659777|NCT01279694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24574959|NCT00828789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24574960|NCT00828789|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24574961|NCT00828789|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24575002|NCT00828971|Amoxicillin|amoxicillin|mesh-list
24575003|NCT00828971|Moxifloxacin|moxifloxacin|mesh-list
24630870|NCT01114282|Bortezomib|bortezomib|mesh-list
24575040|NCT00829114|Estrogens|estrogens|mesh-ancestor
24575041|NCT00829114|Hormones|hormones|mesh-ancestor
24575042|NCT00829114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24575043|NCT00829114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575044|NCT00829114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24575045|NCT00829114|Contraceptive Agents|contraceptive agents|mesh-ancestor
24575046|NCT00829114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24575047|NCT00829114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24575048|NCT00829114|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24575049|NCT00829114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24575051|NCT00829192|Dermatologic Agents|dermatologic agents|mesh-ancestor
24671105|NCT01323569|Dronabinol|dronabinol|mesh-list
24575052|NCT00829205|Rituximab|rituximab|mesh-list
24575146|NCT00829699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24575147|NCT00829777|Naloxone|naloxone|mesh-list
24575148|NCT00829777|Lactulose|lactulose|mesh-list
24575149|NCT00829777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24575150|NCT00829777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132881|NCT03016650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25132882|NCT03016650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25132883|NCT03016650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25132884|NCT03016650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25132885|NCT03016650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25132886|NCT03016650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132887|NCT03016611|Ticagrelor|ticagrelor|mesh-list
25132888|NCT03016611|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25132889|NCT03016611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25132890|NCT03016611|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25132891|NCT03016611|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25132892|NCT03016611|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25132893|NCT03016611|Purinergic Agents|purinergic agents|mesh-ancestor
25132894|NCT03016611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25132895|NCT03016611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132896|NCT03016611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132897|NCT03016442|Dinoprostone|dinoprostone|mesh-list
25132898|NCT03016442|Oxytocics|oxytocics|mesh-ancestor
25132899|NCT03016442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25132900|NCT03016442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132901|NCT03016260|Adalimumab|adalimumab|mesh-list
25132902|NCT03016260|Etanercept|etanercept|mesh-list
25132903|NCT03016260|Golimumab|golimumab|mesh-list
25132904|NCT03016260|Infliximab|infliximab|mesh-list
25132905|NCT03016260|Certolizumab Pegol|certolizumab pegol|mesh-list
25132906|NCT03016260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25132907|NCT03016260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25132908|NCT03016260|Dermatologic Agents|dermatologic agents|mesh-ancestor
25132909|NCT03016260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25132910|NCT03016260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25132911|NCT03016260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25132912|NCT03016260|Analgesics|analgesics|mesh-ancestor
25132913|NCT03016260|Sensory System Agents|sensory system agents|mesh-ancestor
25132914|NCT03016260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25132915|NCT03016260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132916|NCT03016260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25132918|NCT03016260|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25132919|NCT03016234|Propofol|propofol|mesh-list
25132920|NCT03016234|Desflurane|desflurane|mesh-list
25132921|NCT03016234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25132922|NCT03016234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25132923|NCT03016234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132924|NCT03016234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25132925|NCT03016234|Anesthetics, General|anesthetics, general|mesh-ancestor
25132926|NCT03016234|Anesthetics|anesthetics|mesh-ancestor
25132927|NCT03016234|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25132928|NCT03016468|Treprostinil|treprostinil|mesh-list
25132929|NCT03016468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25132930|NCT03016208|Misoprostol|misoprostol|mesh-list
25132931|NCT03016208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25132932|NCT03016208|Abortifacient Agents|abortifacient agents|mesh-ancestor
25132933|NCT03016208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25132934|NCT03016208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132935|NCT03016208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25132936|NCT03016208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25132937|NCT03016208|Oxytocics|oxytocics|mesh-ancestor
25132938|NCT03016000|Thalidomide|thalidomide|mesh-list
25132939|NCT03016000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25132940|NCT03016000|Immunologic Factors|immunologic factors|mesh-ancestor
25132941|NCT03016000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132942|NCT03016000|Leprostatic Agents|leprostatic agents|mesh-ancestor
25132943|NCT03016000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24787627|NCT01926132|Vitamins|vitamins|mesh-ancestor
24575151|NCT00829777|Sensory System Agents|sensory system agents|mesh-ancestor
24575152|NCT00829777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24575153|NCT00829777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24575154|NCT00829881|Betahistine|betahistine|mesh-list
24575155|NCT00829881|Vasodilator Agents|vasodilator agents|mesh-ancestor
24575156|NCT00829881|Histamine Agonists|histamine agonists|mesh-ancestor
24575157|NCT00829881|Histamine Agents|histamine agents|mesh-ancestor
24575158|NCT00829881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24575159|NCT00829881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575160|NCT00829881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575161|NCT00829894|Risperidone|risperidone|mesh-list
24575162|NCT00829894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24575163|NCT00829894|Serotonin Agents|serotonin agents|mesh-ancestor
24575164|NCT00829894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24575165|NCT00829894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575330|NCT00830830|Viscosupplements|viscosupplements|mesh-ancestor
24575331|NCT00830830|Protective Agents|protective agents|mesh-ancestor
24575332|NCT00830843|Propofol|propofol|mesh-list
24575333|NCT00830843|Isoflurane|isoflurane|mesh-list
24575334|NCT00830843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24575392|NCT00831155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24575393|NCT00831155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132944|NCT03016000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25132945|NCT03016000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25132946|NCT03016000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25132947|NCT03016000|Growth Substances|growth substances|mesh-ancestor
25132948|NCT03016000|Growth Inhibitors|growth inhibitors|mesh-ancestor
25132949|NCT03016000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25132950|NCT03015844|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
25132951|NCT03015844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25132952|NCT03015844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25132953|NCT03015844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132954|NCT03015844|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25132956|NCT03016039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25132957|NCT03016039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25132958|NCT03016039|Analgesics|analgesics|mesh-ancestor
25132959|NCT03016039|Sensory System Agents|sensory system agents|mesh-ancestor
25132960|NCT03016039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25132961|NCT03016039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132962|NCT03016039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25132963|NCT03016039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25132964|NCT03016039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25132965|NCT03016039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25132966|NCT03016039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132967|NCT03015818|Calcium|calcium|mesh-list
25132968|NCT03015818|Fluorides|fluorides|mesh-list
25132969|NCT03015818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25132970|NCT03015818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132971|NCT03015818|Cariostatic Agents|cariostatic agents|mesh-ancestor
25132972|NCT03015818|Protective Agents|protective agents|mesh-ancestor
25132973|NCT03015857|Phenylephrine|phenylephrine|mesh-list
25132974|NCT03015857|Oxymetazoline|oxymetazoline|mesh-list
25132975|NCT03015857|Norepinephrine|norepinephrine|mesh-list
25132976|NCT03015857|Fentanyl|fentanyl|mesh-list
25132977|NCT03015857|Bupivacaine|bupivacaine|mesh-list
25132978|NCT03015857|Anesthetics, Local|anesthetics, local|mesh-ancestor
25132979|NCT03015857|Anesthetics|anesthetics|mesh-ancestor
25132986|NCT03015857|Analgesics|analgesics|mesh-ancestor
25132987|NCT03015857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25132988|NCT03015857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25132989|NCT03015857|Anesthetics, General|anesthetics, general|mesh-ancestor
25132990|NCT03015857|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25132991|NCT03015857|Mydriatics|mydriatics|mesh-ancestor
25132992|NCT03015857|Autonomic Agents|autonomic agents|mesh-ancestor
25132993|NCT03015857|Sympathomimetics|sympathomimetics|mesh-ancestor
25132994|NCT03015857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25132995|NCT03015857|Nasal Decongestants|nasal decongestants|mesh-ancestor
25132996|NCT03015857|Respiratory System Agents|respiratory system agents|mesh-ancestor
25132997|NCT03015857|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25132998|NCT03015857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25132999|NCT03015857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25133000|NCT03015857|Adrenergic Agents|adrenergic agents|mesh-ancestor
25133001|NCT03015857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25133002|NCT03015857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133003|NCT03015857|Protective Agents|protective agents|mesh-ancestor
25133005|NCT03016091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25133006|NCT03016091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25133007|NCT03015922|Lenalidomide|lenalidomide|mesh-list
25133008|NCT03015922|Pomalidomide|pomalidomide|mesh-list
25133009|NCT03015922|Immunologic Factors|immunologic factors|mesh-ancestor
25133010|NCT03015922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133011|NCT03015922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25133012|NCT03015922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25133013|NCT03015922|Growth Substances|growth substances|mesh-ancestor
25133014|NCT03015922|Growth Inhibitors|growth inhibitors|mesh-ancestor
25133015|NCT03015922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25133016|NCT03015727|Docetaxel|docetaxel|mesh-list
25133017|NCT03015727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25133018|NCT03015727|Tubulin Modulators|tubulin modulators|mesh-ancestor
25133019|NCT03015727|Antimitotic Agents|antimitotic agents|mesh-ancestor
25133020|NCT03015727|Mitosis Modulators|mitosis modulators|mesh-ancestor
24575394|NCT00831155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24575395|NCT00831155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24575396|NCT00831155|Cholinergic Agents|cholinergic agents|mesh-ancestor
24575397|NCT00831155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24575398|NCT00831155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133021|NCT03015727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133022|NCT03015831|Colchicine|colchicine|mesh-list
25133023|NCT03015831|Gout Suppressants|gout suppressants|mesh-ancestor
25133024|NCT03015831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25133025|NCT03015831|Tubulin Modulators|tubulin modulators|mesh-ancestor
25133026|NCT03015831|Antimitotic Agents|antimitotic agents|mesh-ancestor
25133027|NCT03015831|Mitosis Modulators|mitosis modulators|mesh-ancestor
25133028|NCT03015831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133058|NCT03015350|Sevoflurane|sevoflurane|mesh-list
25133059|NCT03015350|Desflurane|desflurane|mesh-list
25133060|NCT03015350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25133061|NCT03015350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25133062|NCT03015350|Anesthetics, General|anesthetics, general|mesh-ancestor
25133063|NCT03015350|Anesthetics|anesthetics|mesh-ancestor
25133064|NCT03015350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25133065|NCT03015350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133066|NCT03015246|Morphine|morphine|mesh-list
25133067|NCT03015246|Buprenorphine|buprenorphine|mesh-list
25133068|NCT03015246|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25133069|NCT03015246|Naloxone|naloxone|mesh-list
25133070|NCT03015246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25133071|NCT03015246|Narcotics|narcotics|mesh-ancestor
25133072|NCT03015246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25133073|NCT03015246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133074|NCT03015246|Analgesics|analgesics|mesh-ancestor
25133075|NCT03015246|Sensory System Agents|sensory system agents|mesh-ancestor
25133076|NCT03015246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25133077|NCT03015246|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25133100|NCT03014882|Expectorants|expectorants|mesh-ancestor
25133101|NCT03014882|Respiratory System Agents|respiratory system agents|mesh-ancestor
25133102|NCT03014882|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25133103|NCT03014882|Antioxidants|antioxidants|mesh-ancestor
25133104|NCT03014882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133105|NCT03014882|Protective Agents|protective agents|mesh-ancestor
25133106|NCT03014882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133107|NCT03014882|Antidotes|antidotes|mesh-ancestor
25133108|NCT03014713|Flurbiprofen|flurbiprofen|mesh-list
25133109|NCT03014713|Dexmedetomidine|dexmedetomidine|mesh-list
25133110|NCT03014713|Dezocine|dezocine|mesh-list
25133111|NCT03014713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25133112|NCT03014713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25133113|NCT03014713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133114|NCT03014713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25133115|NCT03014713|Analgesics|analgesics|mesh-ancestor
25133116|NCT03014713|Sensory System Agents|sensory system agents|mesh-ancestor
25133117|NCT03014713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25133118|NCT03014713|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25133119|NCT03014713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25133120|NCT03014713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25133121|NCT03014713|Adrenergic Agents|adrenergic agents|mesh-ancestor
25133122|NCT03014713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25133123|NCT03014713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133124|NCT03014713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25133126|NCT03014713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25133127|NCT03014713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25133128|NCT03014713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25133129|NCT03014713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25133130|NCT03014713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25133131|NCT03014687|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25133132|NCT03014687|Cefdinir|cefdinir|mesh-list
25133141|NCT03014687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25133142|NCT03014687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25133143|NCT03014687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25133144|NCT03014687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133145|NCT03014687|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25133146|NCT03014687|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25133147|NCT03014687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25133148|NCT03014804|Nivolumab|nivolumab|mesh-list
25133149|NCT03014804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25133150|NCT03014804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25133151|NCT03014804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25133152|NCT03014804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133153|NCT03014778|Chlorhexidine|chlorhexidine|mesh-list
25133154|NCT03014778|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25133155|NCT03014778|Povidone-Iodine|povidone-iodine|mesh-list
25133156|NCT03014778|Povidone|povidone|mesh-list
25133157|NCT03014778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25133158|NCT03014778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25133159|NCT03014778|Disinfectants|disinfectants|mesh-ancestor
25133160|NCT03014778|Dermatologic Agents|dermatologic agents|mesh-ancestor
25133161|NCT03014778|Plasma Substitutes|plasma substitutes|mesh-ancestor
25133162|NCT03014778|Blood Substitutes|blood substitutes|mesh-ancestor
25133163|NCT03014440|Cannabidiol|cannabidiol|mesh-list
25133164|NCT03014440|Anticonvulsants|anticonvulsants|mesh-ancestor
25133165|NCT03014323|Galantamine|galantamine|mesh-list
25133166|NCT03014323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25133167|NCT03014323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575407|NCT00831376|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24575408|NCT00831376|Autonomic Agents|autonomic agents|mesh-ancestor
24575409|NCT00831376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24575410|NCT00831376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575411|NCT00831376|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24575412|NCT00831376|Respiratory System Agents|respiratory system agents|mesh-ancestor
24575413|NCT00831376|Tocolytic Agents|tocolytic agents|mesh-ancestor
24575427|NCT00831506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575429|NCT00831545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24575430|NCT00831545|Alkylating Agents|alkylating agents|mesh-ancestor
24575431|NCT00831545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575432|NCT00831545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24575434|NCT00831597|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24575435|NCT00831597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24575436|NCT00831597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24575437|NCT00831597|Immunologic Factors|immunologic factors|mesh-ancestor
24575438|NCT00831597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575439|NCT00831597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24575440|NCT00831597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25133168|NCT03014323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133169|NCT03014323|Cholinergic Agents|cholinergic agents|mesh-ancestor
25133170|NCT03014323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25133171|NCT03014323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133172|NCT03014323|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25133173|NCT03014323|Autonomic Agents|autonomic agents|mesh-ancestor
25133174|NCT03014323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25133175|NCT03014323|Nootropic Agents|nootropic agents|mesh-ancestor
25133176|NCT03014297|Everolimus|everolimus|mesh-list
25133177|NCT03014297|Fosbretabulin|fosbretabulin|mesh-list
25133178|NCT03014297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25133179|NCT03014297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25133180|NCT03014297|Immunologic Factors|immunologic factors|mesh-ancestor
25133181|NCT03014297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133715|NCT03010995|Adrenergic Agents|adrenergic agents|mesh-ancestor
25133182|NCT03014297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25133183|NCT03014167|Albendazole|albendazole|mesh-list
25133184|NCT03014167|Anthelmintics|anthelmintics|mesh-ancestor
25133185|NCT03014167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25133186|NCT03014167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25133187|NCT03014167|Anticestodal Agents|anticestodal agents|mesh-ancestor
25133188|NCT03014167|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25133189|NCT03014167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25133190|NCT03014167|Tubulin Modulators|tubulin modulators|mesh-ancestor
25133191|NCT03014167|Antimitotic Agents|antimitotic agents|mesh-ancestor
25133192|NCT03014167|Mitosis Modulators|mitosis modulators|mesh-ancestor
25133193|NCT03014167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133194|NCT03014167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25133195|NCT03014076|Trastuzumab|trastuzumab|mesh-list
25133196|NCT03014076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25133197|NCT03014076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25133198|NCT03013959|Pyranoprofen|pyranoprofen|mesh-list
25133199|NCT03013959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25133200|NCT03013959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25133201|NCT03013959|Analgesics|analgesics|mesh-ancestor
25133202|NCT03013959|Sensory System Agents|sensory system agents|mesh-ancestor
25133203|NCT03013959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961871|NCT03804840|Analgesics|analgesics|mesh-ancestor
24575441|NCT00831597|Alkylating Agents|alkylating agents|mesh-ancestor
25133204|NCT03013959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133205|NCT03013959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25133206|NCT03013959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25133207|NCT03013959|Gout Suppressants|gout suppressants|mesh-ancestor
25133208|NCT03013881|Trastuzumab|trastuzumab|mesh-list
25133209|NCT03013881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25133210|NCT03013881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25133220|NCT03013790|Melatonin|melatonin|mesh-list
25133221|NCT03013790|Antioxidants|antioxidants|mesh-ancestor
25133222|NCT03013790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133223|NCT03013790|Protective Agents|protective agents|mesh-ancestor
25133224|NCT03013790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133225|NCT03013790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25133226|NCT03013335|Nivolumab|nivolumab|mesh-list
25133227|NCT03013335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25133228|NCT03013335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25133229|NCT03013335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25133230|NCT03013335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133231|NCT03013439|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25133232|NCT03013439|Hematinics|hematinics|mesh-ancestor
25133279|NCT03013205|Immunologic Factors|immunologic factors|mesh-ancestor
25133280|NCT03013205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25133281|NCT03013205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133282|NCT03013205|Anesthetics, Local|anesthetics, local|mesh-ancestor
25133283|NCT03013205|Anesthetics|anesthetics|mesh-ancestor
25133284|NCT03013205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25133285|NCT03013205|Sensory System Agents|sensory system agents|mesh-ancestor
25133286|NCT03013205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25133287|NCT03013205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25133288|NCT03013205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25133289|NCT03013205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25133290|NCT03013205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25133291|NCT03013400|Ebselen|ebselen|mesh-list
25133292|NCT03013400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24973036|NCT03712735|Fentanyl|fentanyl|mesh-list
25133293|NCT03013400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25133294|NCT03013400|Analgesics|analgesics|mesh-ancestor
25133295|NCT03013400|Sensory System Agents|sensory system agents|mesh-ancestor
25133296|NCT03013400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25133297|NCT03013400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133298|NCT03013400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25133299|NCT03013400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25133300|NCT03013400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25133301|NCT03013400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25078725|NCT03354117|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25078726|NCT03354117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25078727|NCT03354117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25133325|NCT03013322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133326|NCT03013322|Cholinergic Agents|cholinergic agents|mesh-ancestor
25133334|NCT03013361|Anesthetics, Local|anesthetics, local|mesh-ancestor
25133335|NCT03013361|Anesthetics|anesthetics|mesh-ancestor
25133336|NCT03013361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25133337|NCT03013361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133338|NCT03013361|Sensory System Agents|sensory system agents|mesh-ancestor
25133339|NCT03013361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25133340|NCT03013036|Fentanyl|fentanyl|mesh-list
25133341|NCT03013036|Midazolam|midazolam|mesh-list
25133342|NCT03013036|Propofol|propofol|mesh-list
25133378|NCT03013140|Anesthetics|anesthetics|mesh-list
25133379|NCT03013140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25133380|NCT03013140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133381|NCT03013075|Morphine|morphine|mesh-list
25133382|NCT03013075|Bupivacaine|bupivacaine|mesh-list
25133383|NCT03013075|Anesthetics|anesthetics|mesh-list
25133384|NCT03013075|Anesthetics, General|anesthetics, general|mesh-list
24575715|NCT00833404|Cholinergic Agents|cholinergic agents|mesh-ancestor
24575987|NCT00836043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24575988|NCT00836043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24575990|NCT00836134|Anesthetics, Local|anesthetics, local|mesh-list
24575991|NCT00836134|Anesthetics|anesthetics|mesh-list
24575992|NCT00836134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24575993|NCT00836134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575994|NCT00836134|Sensory System Agents|sensory system agents|mesh-ancestor
24575995|NCT00836134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24575997|NCT00836199|Immunologic Factors|immunologic factors|mesh-ancestor
24575998|NCT00836199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576115|NCT00836849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576116|NCT00836849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576117|NCT00836849|Serotonin Agents|serotonin agents|mesh-ancestor
24576143|NCT00837135|Immunologic Factors|immunologic factors|mesh-ancestor
24576144|NCT00837135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576145|NCT00837174|Bortezomib|bortezomib|mesh-list
24576146|NCT00837174|Vorinostat|vorinostat|mesh-list
24576147|NCT00837174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24576178|NCT00837317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24576179|NCT00837317|Disinfectants|disinfectants|mesh-ancestor
24576282|NCT00837915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24576283|NCT00837915|Respiratory System Agents|respiratory system agents|mesh-ancestor
24576284|NCT00837915|Nasal Decongestants|nasal decongestants|mesh-ancestor
24576285|NCT00837915|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24576286|NCT00837915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24576287|NCT00837915|Sympathomimetics|sympathomimetics|mesh-ancestor
24576288|NCT00837915|Adrenergic Agents|adrenergic agents|mesh-ancestor
24576616|NCT00839397|Antidepressive Agents|antidepressive agents|mesh-ancestor
24576718|NCT00840125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24576719|NCT00840125|Tubulin Modulators|tubulin modulators|mesh-ancestor
25133432|NCT03012646|Treprostinil|treprostinil|mesh-list
25133433|NCT03012646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25133434|NCT03012763|Acetaminophen|acetaminophen|mesh-list
25133435|NCT03012763|Fexofenadine|fexofenadine|mesh-list
25133436|NCT03012763|Sulfasalazine|sulfasalazine|mesh-list
25133437|NCT03012763|Valsartan|valsartan|mesh-list
25133438|NCT03012763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25133439|NCT03012763|Analgesics|analgesics|mesh-ancestor
25133440|NCT03012763|Sensory System Agents|sensory system agents|mesh-ancestor
25133441|NCT03012763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25133442|NCT03012763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133443|NCT03012763|Antipyretics|antipyretics|mesh-ancestor
25133444|NCT03012763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25133445|NCT03012763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25133446|NCT03012763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25133952|NCT03009526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25133447|NCT03012763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133449|NCT03012763|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25133450|NCT03012763|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25133451|NCT03012763|Histamine Antagonists|histamine antagonists|mesh-ancestor
25133452|NCT03012763|Histamine Agents|histamine agents|mesh-ancestor
25133453|NCT03012763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25133454|NCT03012763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25133455|NCT03012763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25133456|NCT03012763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25133457|NCT03012763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25133458|NCT03012763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25133459|NCT03012607|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25133460|NCT03012607|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25133461|NCT03012607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25133462|NCT03012607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25133463|NCT03012607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133464|NCT03012607|Antiviral Agents|antiviral agents|mesh-ancestor
25133466|NCT03012607|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25133472|NCT03012230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25133473|NCT03012230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25133474|NCT03012386|Sildenafil Citrate|sildenafil citrate|mesh-list
25133475|NCT03012386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133476|NCT03012386|Vasodilator Agents|vasodilator agents|mesh-ancestor
25133477|NCT03012386|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25133478|NCT03012386|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25133479|NCT03012386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25133480|NCT03012386|Urological Agents|urological agents|mesh-ancestor
25133481|NCT03012321|Prednisone|prednisone|mesh-list
25133482|NCT03012321|Olaparib|olaparib|mesh-list
25133483|NCT03012321|Abiraterone Acetate|abiraterone acetate|mesh-list
25133484|NCT03012321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25133485|NCT03012321|Glucocorticoids|glucocorticoids|mesh-ancestor
25133486|NCT03012321|Hormones|hormones|mesh-ancestor
25133487|NCT03012321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25133488|NCT03012321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133489|NCT03012321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25133490|NCT03012321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25133491|NCT03012321|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25133492|NCT03012321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25133496|NCT03012321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25133497|NCT03012347|Sunscreening Agents|sunscreening agents|mesh-list
25133498|NCT03012347|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25133499|NCT03012347|Protective Agents|protective agents|mesh-ancestor
25133500|NCT03012347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133501|NCT03012347|Dermatologic Agents|dermatologic agents|mesh-ancestor
25133516|NCT03011970|Oxytocin|oxytocin|mesh-list
25133517|NCT03011970|Oxytocics|oxytocics|mesh-ancestor
24973260|NCT03710395|Nifedipine|nifedipine|mesh-list
25133520|NCT03011905|Acetaminophen|acetaminophen|mesh-list
25133521|NCT03011905|Dexamethasone|dexamethasone|mesh-list
25133522|NCT03011905|Etoricoxib|etoricoxib|mesh-list
25133523|NCT03011905|Oxycodone|oxycodone|mesh-list
25133524|NCT03011905|Ropivacaine|ropivacaine|mesh-list
25133525|NCT03011905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25133526|NCT03011905|Antiemetics|antiemetics|mesh-ancestor
25133527|NCT03011905|Autonomic Agents|autonomic agents|mesh-ancestor
25133528|NCT03011905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25133529|NCT03011905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133530|NCT03011905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25133531|NCT03011905|Glucocorticoids|glucocorticoids|mesh-ancestor
25133532|NCT03011905|Hormones|hormones|mesh-ancestor
25133533|NCT03011905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25133534|NCT03011905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25133535|NCT03011905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25133536|NCT03011905|Anesthetics, Local|anesthetics, local|mesh-ancestor
25133537|NCT03011905|Anesthetics|anesthetics|mesh-ancestor
25133538|NCT03011905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25133539|NCT03011905|Sensory System Agents|sensory system agents|mesh-ancestor
25133540|NCT03011905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25133541|NCT03011905|Analgesics|analgesics|mesh-ancestor
25133542|NCT03011905|Antipyretics|antipyretics|mesh-ancestor
25133543|NCT03011905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25133544|NCT03011905|Narcotics|narcotics|mesh-ancestor
25133545|NCT03011905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25133546|NCT03011905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25133547|NCT03011905|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25133548|NCT03011905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25133549|NCT03011905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25133555|NCT03011918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25133556|NCT03012009|Lidocaine|lidocaine|mesh-list
25133557|NCT03012009|Epinephrine|epinephrine|mesh-list
25133558|NCT03012009|Racepinephrine|racepinephrine|mesh-list
25133559|NCT03012009|Anesthetics, Local|anesthetics, local|mesh-list
25133560|NCT03012009|Anesthetics|anesthetics|mesh-list
25133561|NCT03012009|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
25133562|NCT03012009|Epinephryl borate|epinephryl borate|mesh-list
24661337|NCT01288950|Vitamin D|vitamin d|mesh-list
25133563|NCT03012009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25133564|NCT03012009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133565|NCT03012009|Sensory System Agents|sensory system agents|mesh-ancestor
25133566|NCT03012009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25133567|NCT03012009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25133568|NCT03012009|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25133569|NCT03012009|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25133570|NCT03012009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25133571|NCT03012009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133572|NCT03012009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25133573|NCT03012009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25133574|NCT03012009|Adrenergic Agents|adrenergic agents|mesh-ancestor
25133575|NCT03012009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25133576|NCT03012009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25133577|NCT03012009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25133578|NCT03012009|Autonomic Agents|autonomic agents|mesh-ancestor
25133579|NCT03012009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25133580|NCT03012009|Respiratory System Agents|respiratory system agents|mesh-ancestor
25133581|NCT03012009|Mydriatics|mydriatics|mesh-ancestor
25133582|NCT03012009|Sympathomimetics|sympathomimetics|mesh-ancestor
25133583|NCT03012009|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25133584|NCT03012009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25133585|NCT03012009|Dermatologic Agents|dermatologic agents|mesh-ancestor
24576720|NCT00840125|Antimitotic Agents|antimitotic agents|mesh-ancestor
25133587|NCT03012113|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25133589|NCT03012113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25133590|NCT03012113|Adrenergic Agents|adrenergic agents|mesh-ancestor
25133591|NCT03012113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25133592|NCT03012113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133593|NCT03012113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133594|NCT03012113|Urological Agents|urological agents|mesh-ancestor
25133595|NCT03011931|Simvastatin|simvastatin|mesh-list
25133596|NCT03011931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25133597|NCT03011931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25133598|NCT03011931|Antimetabolites|antimetabolites|mesh-ancestor
25133599|NCT03011931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133600|NCT03011931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25133601|NCT03011931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25133602|NCT03011931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25133603|NCT03011996|Amoxicillin|amoxicillin|mesh-list
25133604|NCT03011996|Clarithromycin|clarithromycin|mesh-list
25133605|NCT03011996|Pantoprazole|pantoprazole|mesh-list
25133606|NCT03011996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25133607|NCT03011996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25133608|NCT03011996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25133609|NCT03011996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25133610|NCT03011996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133611|NCT03011996|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25133612|NCT03011996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25133613|NCT03011996|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25133614|NCT03011996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25133615|NCT03011996|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24576965|NCT00841191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24576966|NCT00841191|Immunologic Factors|immunologic factors|mesh-ancestor
24576967|NCT00841191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539164|NCT00662610|Naproxen|naproxen|mesh-list
24576968|NCT00841191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24576969|NCT00841256|Glycerol|glycerol|mesh-list
25133617|NCT03011476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25133618|NCT03011476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25133619|NCT03011476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133620|NCT03011476|Cholinergic Agents|cholinergic agents|mesh-ancestor
25133621|NCT03011476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25133622|NCT03011476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133623|NCT03011476|Nootropic Agents|nootropic agents|mesh-ancestor
25133624|NCT03011463|Clarithromycin|clarithromycin|mesh-list
25133625|NCT03011463|Ranitidine|ranitidine|mesh-list
25133626|NCT03011463|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
25133627|NCT03011463|Trospium chloride|trospium chloride|mesh-list
25133628|NCT03011463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25133629|NCT03011463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25133630|NCT03011463|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25133631|NCT03011463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25133632|NCT03011463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133633|NCT03011463|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25133634|NCT03011463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25133635|NCT03011463|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25133636|NCT03011463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25133637|NCT03011463|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25133638|NCT03011463|Histamine Antagonists|histamine antagonists|mesh-ancestor
25133639|NCT03011463|Histamine Agents|histamine agents|mesh-ancestor
25133640|NCT03011463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25133641|NCT03011463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133642|NCT03011463|Parasympatholytics|parasympatholytics|mesh-ancestor
25133643|NCT03011463|Autonomic Agents|autonomic agents|mesh-ancestor
25133644|NCT03011463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25133645|NCT03011463|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25133646|NCT03011463|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25133647|NCT03011463|Cholinergic Agents|cholinergic agents|mesh-ancestor
25133648|NCT03011463|Urological Agents|urological agents|mesh-ancestor
24576973|NCT00841373|Ranibizumab|ranibizumab|mesh-list
24576974|NCT00841373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24576975|NCT00841373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24576976|NCT00841373|Growth Substances|growth substances|mesh-ancestor
24444659|NCT00298779|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24577044|NCT00841802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25133649|NCT03011645|Ziprasidone|ziprasidone|mesh-list
25133650|NCT03011645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25133651|NCT03011645|Serotonin Agents|serotonin agents|mesh-ancestor
25133652|NCT03011645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25133653|NCT03011645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133654|NCT03011645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133655|NCT03011645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25133656|NCT03011645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25133657|NCT03011645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25133658|NCT03011645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25133660|NCT03011645|Dopamine Agents|dopamine agents|mesh-ancestor
25133661|NCT03011632|Mometasone Furoate|mometasone furoate|mesh-list
25133662|NCT03011632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25133663|NCT03011632|Dermatologic Agents|dermatologic agents|mesh-ancestor
25133664|NCT03011632|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25133665|NCT03011567|Acetaminophen|acetaminophen|mesh-list
24577047|NCT00841841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24577048|NCT00841841|Analgesics|analgesics|mesh-ancestor
24577049|NCT00841841|Sensory System Agents|sensory system agents|mesh-ancestor
24577050|NCT00841841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24577051|NCT00841841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577052|NCT00841841|Antipyretics|antipyretics|mesh-ancestor
24577053|NCT00841841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24577054|NCT00841841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24577055|NCT00841841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24577056|NCT00841854|Metronidazole|metronidazole|mesh-list
24577057|NCT00841854|Tetracycline|tetracycline|mesh-list
24577058|NCT00841854|Pantoprazole|pantoprazole|mesh-list
24577059|NCT00841854|Bismuth|bismuth|mesh-list
24577060|NCT00841854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24577061|NCT00841854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24577062|NCT00841854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24577063|NCT00841854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24577064|NCT00841854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24577065|NCT00841854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24577066|NCT00841854|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24577069|NCT00841854|Antacids|antacids|mesh-ancestor
24577131|NCT00842114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577132|NCT00842114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577133|NCT00842114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24577134|NCT00842114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24577135|NCT00842114|Glucocorticoids|glucocorticoids|mesh-ancestor
24577137|NCT00842114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24577138|NCT00842114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24577139|NCT00842114|Antiviral Agents|antiviral agents|mesh-ancestor
24577140|NCT00842114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24577141|NCT00842114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25133667|NCT03011567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25133668|NCT03011567|Analgesics|analgesics|mesh-ancestor
25133669|NCT03011567|Sensory System Agents|sensory system agents|mesh-ancestor
25133670|NCT03011567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25133672|NCT03011567|Antipyretics|antipyretics|mesh-ancestor
25133673|NCT03011567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25133674|NCT03011567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25133675|NCT03011567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25133676|NCT03011567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25133677|NCT03011567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25133678|NCT03011567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133679|NCT03011281|Tofacitinib|tofacitinib|mesh-list
25133680|NCT03011281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25133681|NCT03011281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25133682|NCT03011281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133683|NCT03011177|Linagliptin|linagliptin|mesh-list
25133684|NCT03011177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25133685|NCT03011177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133686|NCT03011177|Incretins|incretins|mesh-ancestor
25133688|NCT03011177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25133689|NCT03011177|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25133690|NCT03011177|Protease Inhibitors|protease inhibitors|mesh-ancestor
25133691|NCT03011177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25133692|NCT03011177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962285|NCT03800667|Protective Agents|protective agents|mesh-ancestor
24577174|NCT00842205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24577175|NCT00842400|Metformin|metformin|mesh-list
24577176|NCT00842400|Probenecid|probenecid|mesh-list
24577249|NCT00842595|Sensory System Agents|sensory system agents|mesh-ancestor
24577250|NCT00842595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25133698|NCT03010865|Butyric Acid|butyric acid|mesh-list
25133699|NCT03010865|Histamine Antagonists|histamine antagonists|mesh-ancestor
25133700|NCT03010865|Histamine Agents|histamine agents|mesh-ancestor
25133701|NCT03010865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25133702|NCT03010865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133703|NCT03010865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133704|NCT03011008|Liraglutide|liraglutide|mesh-list
25133705|NCT03011008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25133706|NCT03011008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133707|NCT03011008|Incretins|incretins|mesh-ancestor
25133708|NCT03011008|Hormones|hormones|mesh-ancestor
25133709|NCT03011008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25133710|NCT03010995|Prazosin|prazosin|mesh-list
25133711|NCT03010995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25133712|NCT03010995|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25133713|NCT03010995|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25133714|NCT03010995|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25133716|NCT03010995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25133717|NCT03010995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133718|NCT03010995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133719|NCT03011125|Dexlansoprazole|dexlansoprazole|mesh-list
25133720|NCT03011125|Lansoprazole|lansoprazole|mesh-list
25133721|NCT03011125|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25133722|NCT03011125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25133723|NCT03011125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25281261|NCT02332629|Glucocorticoids|glucocorticoids|mesh-ancestor
25133724|NCT03011125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25133725|NCT03011125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133726|NCT03011060|Capecitabine|capecitabine|mesh-list
25133727|NCT03011060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25133728|NCT03011060|Antimetabolites|antimetabolites|mesh-ancestor
25133729|NCT03011060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133730|NCT03011060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25133733|NCT03010670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25133734|NCT03010670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133735|NCT03010579|Epoetin Alfa|epoetin alfa|mesh-list
25133736|NCT03010579|Ferrous succinate|ferrous succinate|mesh-list
25133738|NCT03010761|Citalopram|citalopram|mesh-list
25133739|NCT03010761|Moclobemide|moclobemide|mesh-list
25133740|NCT03010761|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25133741|NCT03010761|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25133742|NCT03010761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25133769|NCT03010540|Anesthetics, General|anesthetics, general|mesh-ancestor
25133770|NCT03010540|Anesthetics|anesthetics|mesh-ancestor
25133771|NCT03010475|Furosemide|furosemide|mesh-list
25133772|NCT03010475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25133773|NCT03010475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25133774|NCT03010475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24662428|NCT01294878|Omalizumab|omalizumab|mesh-list
25133775|NCT03010475|Antimetabolites|antimetabolites|mesh-ancestor
25133776|NCT03010475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133777|NCT03010475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25133778|NCT03010475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25133779|NCT03010475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25133780|NCT03010475|Diuretics|diuretics|mesh-ancestor
25133781|NCT03010475|Natriuretic Agents|natriuretic agents|mesh-ancestor
25133782|NCT03010475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133808|NCT03010202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133809|NCT03010202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25133810|NCT03010202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25133811|NCT03010202|Antiemetics|antiemetics|mesh-ancestor
25133812|NCT03010202|Autonomic Agents|autonomic agents|mesh-ancestor
25133813|NCT03010202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25133814|NCT03010202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25133815|NCT03010202|Glucocorticoids|glucocorticoids|mesh-ancestor
25133816|NCT03010202|Hormones|hormones|mesh-ancestor
25133817|NCT03010202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25133818|NCT03010202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25133819|NCT03010098|Remifentanil|remifentanil|mesh-list
25133820|NCT03010098|Propofol|propofol|mesh-list
25133821|NCT03010098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25133822|NCT03010098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25133823|NCT03010098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133824|NCT03010098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25133825|NCT03010098|Anesthetics, General|anesthetics, general|mesh-ancestor
25078777|NCT03353857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25078778|NCT03353857|Contraceptive Agents|contraceptive agents|mesh-ancestor
25078779|NCT03353857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25078780|NCT03353857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25078781|NCT03353857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25133868|NCT03009643|Autonomic Agents|autonomic agents|mesh-ancestor
25133869|NCT03009643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25133870|NCT03009643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133871|NCT03009643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25133872|NCT03009643|Respiratory System Agents|respiratory system agents|mesh-ancestor
25133873|NCT03009643|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25133874|NCT03009643|Antioxidants|antioxidants|mesh-ancestor
25133875|NCT03009643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133876|NCT03009643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25133878|NCT03009643|Vasodilator Agents|vasodilator agents|mesh-ancestor
25133879|NCT03009643|Gasotransmitters|gasotransmitters|mesh-ancestor
25133880|NCT03009643|Protective Agents|protective agents|mesh-ancestor
25133881|NCT03009604|Simethicone|simethicone|mesh-list
25133882|NCT03009604|Antifoaming Agents|antifoaming agents|mesh-ancestor
25133883|NCT03009604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133885|NCT03009604|Dermatologic Agents|dermatologic agents|mesh-ancestor
25133886|NCT03009682|Olaparib|olaparib|mesh-list
25692528|NCT02000921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25133887|NCT03009682|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25133888|NCT03009682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25133889|NCT03009682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133890|NCT03009682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25133891|NCT03009799|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25133892|NCT03009799|Laxatives|laxatives|mesh-ancestor
25133893|NCT03009799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25133894|NCT03009461|Sorafenib|sorafenib|mesh-list
25133902|NCT03009500|Prednisolone|prednisolone|mesh-list
25133903|NCT03009500|Prednisolone acetate|prednisolone acetate|mesh-list
25133904|NCT03009500|Lidocaine|lidocaine|mesh-list
25133905|NCT03009500|Bupivacaine|bupivacaine|mesh-list
25133906|NCT03009500|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25133907|NCT03009500|Prednisolone phosphate|prednisolone phosphate|mesh-list
25133908|NCT03009500|Anesthetics, Local|anesthetics, local|mesh-ancestor
25133909|NCT03009500|Anesthetics|anesthetics|mesh-ancestor
25133910|NCT03009500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25133911|NCT03009500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133912|NCT03009500|Sensory System Agents|sensory system agents|mesh-ancestor
25133913|NCT03009500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25133914|NCT03009500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25133915|NCT03009500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25133916|NCT03009500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25133917|NCT03009500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25133918|NCT03009500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133919|NCT03009500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25133921|NCT03009500|Autonomic Agents|autonomic agents|mesh-ancestor
25133922|NCT03009500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25133923|NCT03009500|Glucocorticoids|glucocorticoids|mesh-ancestor
25133924|NCT03009500|Hormones|hormones|mesh-ancestor
25133925|NCT03009500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25133926|NCT03009500|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25133927|NCT03009500|Protective Agents|protective agents|mesh-ancestor
25133928|NCT03009500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25133929|NCT03009500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25133930|NCT03009513|Glimepiride|glimepiride|mesh-list
25133931|NCT03009513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25133932|NCT03009513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25133933|NCT03009513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133934|NCT03009513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24577251|NCT00842595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24577252|NCT00842595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24577253|NCT00842595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577254|NCT00842660|Gemcitabine|gemcitabine|mesh-list
24577255|NCT00842660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24577256|NCT00842660|Antimetabolites|antimetabolites|mesh-ancestor
24577257|NCT00842660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577285|NCT00842907|Tretinoin|tretinoin|mesh-list
25133935|NCT03009513|Immunologic Factors|immunologic factors|mesh-ancestor
25133936|NCT03009474|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
25133937|NCT03009474|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25133938|NCT03009474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25133939|NCT03009474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25133940|NCT03009474|Antimetabolites|antimetabolites|mesh-ancestor
25133941|NCT03009474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133942|NCT03009474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25133943|NCT03009474|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25133944|NCT03009474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25133945|NCT03009474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25133946|NCT03009526|Pyrimethamine|pyrimethamine|mesh-list
25133947|NCT03009526|Piperaquine|piperaquine|mesh-list
25133948|NCT03009526|Sulfadoxine|sulfadoxine|mesh-list
25133949|NCT03009526|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25133950|NCT03009526|Artenimol|artenimol|mesh-list
25133951|NCT03009526|Antimalarials|antimalarials|mesh-ancestor
25133953|NCT03009526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25133954|NCT03009526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25133955|NCT03009526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25133956|NCT03009526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25133957|NCT03009526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133958|NCT03009526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25133959|NCT03009526|Renal Agents|renal agents|mesh-ancestor
25133960|NCT03009422|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
25133961|NCT03009422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25133962|NCT03009422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25133963|NCT03009422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25133964|NCT03009422|Schistosomicides|schistosomicides|mesh-ancestor
25133965|NCT03009422|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25133966|NCT03009422|Anthelmintics|anthelmintics|mesh-ancestor
24577313|NCT00842933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24577314|NCT00842933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24577527|NCT00844454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577528|NCT00844480|Zoledronic Acid|zoledronic acid|mesh-list
24577529|NCT00844480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24577530|NCT00844480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577531|NCT00844506|Cyclophosphamide|cyclophosphamide|mesh-list
24577532|NCT00844506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24577533|NCT00844506|Immunologic Factors|immunologic factors|mesh-ancestor
24577534|NCT00844506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133968|NCT03009292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25133969|NCT03009292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25133970|NCT03009292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25133971|NCT03009292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133972|NCT03009578|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25133973|NCT03009578|Hematinics|hematinics|mesh-ancestor
25133974|NCT03009097|Atorvastatin|atorvastatin|mesh-list
25133975|NCT03009097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25133976|NCT03009097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25133977|NCT03009097|Antimetabolites|antimetabolites|mesh-ancestor
25133978|NCT03009097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133979|NCT03009097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25133980|NCT03009097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25133981|NCT03009097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25133982|NCT03009045|Tedizolid|tedizolid|mesh-list
25133983|NCT03009045|Tedizolid phosphate|tedizolid phosphate|mesh-list
25133985|NCT03009045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25133986|NCT03009045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25133987|NCT03009045|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25133988|NCT03009045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25133989|NCT03009045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133990|NCT03009058|Leucovorin|leucovorin|mesh-list
25133991|NCT03009058|Folic Acid|folic acid|mesh-list
25133992|NCT03009058|Gemcitabine|gemcitabine|mesh-list
25133993|NCT03009058|Cyclophosphamide|cyclophosphamide|mesh-list
25133994|NCT03009058|Pembrolizumab|pembrolizumab|mesh-list
25133995|NCT03009058|Fluorouracil|fluorouracil|mesh-list
25133996|NCT03009058|Capecitabine|capecitabine|mesh-list
25133997|NCT03009058|Oxaliplatin|oxaliplatin|mesh-list
25133998|NCT03009058|Nivolumab|nivolumab|mesh-list
25133999|NCT03009058|Irinotecan|irinotecan|mesh-list
25134000|NCT03009058|Cetuximab|cetuximab|mesh-list
25134001|NCT03009058|Ipilimumab|ipilimumab|mesh-list
25134002|NCT03009058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25134003|NCT03009058|Levoleucovorin|levoleucovorin|mesh-list
25134004|NCT03009058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25134005|NCT03009058|Immunologic Factors|immunologic factors|mesh-ancestor
25134010|NCT03009058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134011|NCT03009058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25134012|NCT03009058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25134013|NCT03009058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25134014|NCT03009058|Antimetabolites|antimetabolites|mesh-ancestor
24606014|NCT00988663|Dopamine Agents|dopamine agents|mesh-ancestor
25134015|NCT03009058|Antiviral Agents|antiviral agents|mesh-ancestor
25134016|NCT03009058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25134017|NCT03009058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25134051|NCT03008876|Acetaminophen|acetaminophen|mesh-list
25134052|NCT03008876|Ibuprofen|ibuprofen|mesh-list
25134053|NCT03008876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25134054|NCT03008876|Analgesics|analgesics|mesh-ancestor
25134055|NCT03008876|Sensory System Agents|sensory system agents|mesh-ancestor
25134056|NCT03008876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25134057|NCT03008876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134058|NCT03008876|Antipyretics|antipyretics|mesh-ancestor
25134059|NCT03008876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25134060|NCT03008876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25134061|NCT03008876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25134062|NCT03008876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25134074|NCT03008512|Tubulin Modulators|tubulin modulators|mesh-ancestor
25134075|NCT03008512|Antimitotic Agents|antimitotic agents|mesh-ancestor
25134076|NCT03008512|Mitosis Modulators|mitosis modulators|mesh-ancestor
25134078|NCT03008551|Metformin|metformin|mesh-list
25134081|NCT03008551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134082|NCT03008551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25134083|NCT03008551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134097|NCT03008317|Chromium|chromium|mesh-list
25134098|NCT03008317|Trace Elements|trace elements|mesh-ancestor
25134099|NCT03008317|Micronutrients|micronutrients|mesh-ancestor
25134100|NCT03008317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134101|NCT03008252|Caseins|caseins|mesh-list
25134102|NCT03008252|Chelating Agents|chelating agents|mesh-ancestor
25134103|NCT03008252|Sequestering Agents|sequestering agents|mesh-ancestor
25134104|NCT03008252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134105|NCT03008148|Temozolomide|temozolomide|mesh-list
25134106|NCT03008148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25134107|NCT03008148|Alkylating Agents|alkylating agents|mesh-ancestor
25134109|NCT03008148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25134125|NCT03007927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25134126|NCT03007927|Sensory System Agents|sensory system agents|mesh-ancestor
25134141|NCT03008109|Endostatins|endostatins|mesh-list
25134142|NCT03008109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25134143|NCT03008109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25134144|NCT03008109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25134145|NCT03008109|Growth Substances|growth substances|mesh-ancestor
25134146|NCT03008109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134147|NCT03008109|Growth Inhibitors|growth inhibitors|mesh-ancestor
25134175|NCT03007810|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25134176|NCT03007810|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25134177|NCT03007810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25134178|NCT03007810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134179|NCT03007446|Oxaliplatin|oxaliplatin|mesh-list
25134180|NCT03007446|Apatinib|apatinib|mesh-list
25134181|NCT03007446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25134182|NCT03007446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25134183|NCT03007446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25134184|NCT03007446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134221|NCT03007303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25134222|NCT03007303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25134223|NCT03007303|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25134224|NCT03007303|Dopamine Agents|dopamine agents|mesh-ancestor
25134225|NCT03007303|Antiemetics|antiemetics|mesh-ancestor
25134226|NCT03007303|Autonomic Agents|autonomic agents|mesh-ancestor
25134227|NCT03007303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25134228|NCT03007303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25134229|NCT03007303|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25134230|NCT03007303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25134231|NCT03007303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25134232|NCT03007303|Antidepressive Agents|antidepressive agents|mesh-ancestor
25134233|NCT03007589|Sunscreening Agents|sunscreening agents|mesh-list
25134234|NCT03007589|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25134235|NCT03007589|Protective Agents|protective agents|mesh-ancestor
25134236|NCT03007589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134238|NCT03007342|Amoxicillin|amoxicillin|mesh-list
25134239|NCT03007342|Clavulanic Acid|clavulanic acid|mesh-list
25134240|NCT03007342|Clavulanic Acids|clavulanic acids|mesh-list
25134241|NCT03007342|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25134242|NCT03007342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25134243|NCT03007342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24962763|NCT03795805|Lidocaine|lidocaine|mesh-list
24577535|NCT00844506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24577536|NCT00844506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24577537|NCT00844506|Alkylating Agents|alkylating agents|mesh-ancestor
24577538|NCT00844506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577539|NCT00844506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577540|NCT00844506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24577541|NCT00844662|Sevelamer|sevelamer|mesh-list
24577542|NCT00844662|Chelating Agents|chelating agents|mesh-ancestor
24577543|NCT00844662|Sequestering Agents|sequestering agents|mesh-ancestor
24577544|NCT00844662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577545|NCT00844675|Rabeprazole|rabeprazole|mesh-list
24577546|NCT00844675|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24577567|NCT00844727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577571|NCT00844727|Analgesics|analgesics|mesh-ancestor
24577590|NCT00844792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577636|NCT00845338|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24577637|NCT00845338|Cholinergic Agents|cholinergic agents|mesh-ancestor
25134244|NCT03007342|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25134245|NCT03007342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25281408|NCT02331706|Interferon-alpha|interferon-alpha|mesh-list
25281409|NCT02331706|Interferon alpha-2|interferon alpha-2|mesh-list
25281410|NCT02331706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281411|NCT02331706|Antiviral Agents|antiviral agents|mesh-ancestor
25281412|NCT02331706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25281413|NCT02331706|Immunologic Factors|immunologic factors|mesh-ancestor
25281414|NCT02331706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134246|NCT03007342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134247|NCT03007537|Epoetin Alfa|epoetin alfa|mesh-list
25134248|NCT03007537|Hematinics|hematinics|mesh-ancestor
25134249|NCT03007563|Bilirubin|bilirubin|mesh-list
25134250|NCT03007563|Antioxidants|antioxidants|mesh-ancestor
25134251|NCT03007563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134252|NCT03007563|Protective Agents|protective agents|mesh-ancestor
25134253|NCT03007563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134254|NCT03007407|Durvalumab|durvalumab|mesh-list
25134255|NCT03007407|Tremelimumab|tremelimumab|mesh-list
25134256|NCT03007407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25134257|NCT03007407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25134258|NCT03007524|Calcium, Dietary|calcium, dietary|mesh-list
25134259|NCT03007524|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25134260|NCT03007524|Calcium|calcium|mesh-list
25134261|NCT03007524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25134262|NCT03007524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134263|NCT03007524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25134264|NCT03007524|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25134265|NCT03007524|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25134266|NCT03007524|Antimetabolites|antimetabolites|mesh-ancestor
24818034|NCT02086656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25134267|NCT03007524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606446|NCT00990444|Blood Substitutes|blood substitutes|mesh-ancestor
25134268|NCT03007524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25134269|NCT03007524|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25134270|NCT03007524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25134309|NCT03007121|Sufentanil|sufentanil|mesh-list
25134310|NCT03007121|Morphine|morphine|mesh-list
25134311|NCT03007121|Dsuvia|dsuvia|mesh-list
25134312|NCT03007121|Bupivacaine|bupivacaine|mesh-list
25134313|NCT03007121|Anesthetics, Local|anesthetics, local|mesh-ancestor
25134314|NCT03007121|Anesthetics|anesthetics|mesh-ancestor
25134315|NCT03007121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25134319|NCT03007121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25134321|NCT03007121|Analgesics|analgesics|mesh-ancestor
25134322|NCT03007121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25134323|NCT03007121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25134324|NCT03007121|Anesthetics, General|anesthetics, general|mesh-ancestor
25134325|NCT03006835|Clopidogrel|clopidogrel|mesh-list
25134326|NCT03006835|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25134327|NCT03006835|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25134328|NCT03006835|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25134329|NCT03006835|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25134330|NCT03006835|Purinergic Agents|purinergic agents|mesh-ancestor
25134331|NCT03006835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25134332|NCT03006835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134333|NCT03006835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134334|NCT03006809|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25134335|NCT03006809|Metronidazole|metronidazole|mesh-list
25134336|NCT03006809|Vancomycin|vancomycin|mesh-list
25134337|NCT03006809|Neomycin|neomycin|mesh-list
25134338|NCT03006809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25134339|NCT03006809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25134340|NCT03006809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25134341|NCT03006809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25134342|NCT03006809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405454|NCT03606967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25683459|NCT02281838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683460|NCT02281838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25683461|NCT02281838|Vasodilator Agents|vasodilator agents|mesh-ancestor
25683462|NCT02281838|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25683463|NCT02281838|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25683464|NCT02281838|Adrenergic Agents|adrenergic agents|mesh-ancestor
25134343|NCT03006809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134344|NCT03006952|Losartan|losartan|mesh-list
25134345|NCT03006952|Pentoxifylline|pentoxifylline|mesh-list
25134346|NCT03006952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25134452|NCT03006211|Vasodilator Agents|vasodilator agents|mesh-ancestor
25134347|NCT03006952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25134348|NCT03006952|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25134349|NCT03006952|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25134350|NCT03006952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134351|NCT03006952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25134352|NCT03006952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25134353|NCT03006952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25134354|NCT03006952|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25134355|NCT03006952|Protective Agents|protective agents|mesh-ancestor
25134356|NCT03006952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134357|NCT03006952|Vasodilator Agents|vasodilator agents|mesh-ancestor
25134358|NCT03006952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25134360|NCT03006757|Titanium dioxide|titanium dioxide|mesh-list
25134361|NCT03006757|Sunscreening Agents|sunscreening agents|mesh-ancestor
25134362|NCT03006757|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25134363|NCT03006757|Protective Agents|protective agents|mesh-ancestor
25134364|NCT03006757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134365|NCT03006757|Dermatologic Agents|dermatologic agents|mesh-ancestor
25134366|NCT03006757|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25134367|NCT03006679|Meropenem|meropenem|mesh-list
25134368|NCT03006679|Tazobactam|tazobactam|mesh-list
25134369|NCT03006679|Piperacillin|piperacillin|mesh-list
25134370|NCT03006679|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25134371|NCT03006679|Vaborbactam|vaborbactam|mesh-list
25134372|NCT03006679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25134373|NCT03006679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25134374|NCT03006679|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25134375|NCT03006679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25134376|NCT03006679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134377|NCT03006614|Gemcitabine|gemcitabine|mesh-list
25134378|NCT03006614|Cisplatin|cisplatin|mesh-list
25134379|NCT03006614|Docetaxel|docetaxel|mesh-list
25134380|NCT03006614|Capecitabine|capecitabine|mesh-list
25134381|NCT03006614|Trastuzumab|trastuzumab|mesh-list
25134382|NCT03006614|Vinorelbine|vinorelbine|mesh-list
25134383|NCT03006614|Epirubicin|epirubicin|mesh-list
24811119|NCT02044978|Zoledronic Acid|zoledronic acid|mesh-list
25134384|NCT03006614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25134385|NCT03006614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25134386|NCT03006614|Antimetabolites|antimetabolites|mesh-ancestor
25134387|NCT03006614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134403|NCT03006380|Oxytocics|oxytocics|mesh-ancestor
25134404|NCT03006380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25134405|NCT03006380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134406|NCT03006445|Dotinurad|dotinurad|mesh-list
25134407|NCT03006445|Uricosuric Agents|uricosuric agents|mesh-ancestor
25134408|NCT03006445|Gout Suppressants|gout suppressants|mesh-ancestor
25134409|NCT03006445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25134410|NCT03006445|Renal Agents|renal agents|mesh-ancestor
25134411|NCT03006627|Morphine|morphine|mesh-list
25134412|NCT03006627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25134413|NCT03006627|Narcotics|narcotics|mesh-ancestor
25134414|NCT03006627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25134415|NCT03006627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134416|NCT03006627|Analgesics|analgesics|mesh-ancestor
25134417|NCT03006627|Sensory System Agents|sensory system agents|mesh-ancestor
25134418|NCT03006627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25134419|NCT03006250|Sevoflurane|sevoflurane|mesh-list
25134420|NCT03006250|Desflurane|desflurane|mesh-list
25134421|NCT03006250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25134422|NCT03006250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25134423|NCT03006250|Anesthetics, General|anesthetics, general|mesh-ancestor
25134424|NCT03006250|Anesthetics|anesthetics|mesh-ancestor
25134425|NCT03006250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25134426|NCT03006250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134427|NCT03006419|Thymoglobulin|thymoglobulin|mesh-list
25134428|NCT03006419|Basiliximab|basiliximab|mesh-list
25134429|NCT03006419|Immunologic Factors|immunologic factors|mesh-ancestor
25134430|NCT03006419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281483|NCT02330952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25134431|NCT03006419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25134432|NCT03006211|Nitric Oxide|nitric oxide|mesh-list
25134450|NCT03006211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25134451|NCT03006211|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25134453|NCT03006211|Gasotransmitters|gasotransmitters|mesh-ancestor
25134454|NCT03006211|Protective Agents|protective agents|mesh-ancestor
25134455|NCT03006146|Molgramostim|molgramostim|mesh-list
25134456|NCT03006146|Sargramostim|sargramostim|mesh-list
25134457|NCT03006146|Immunologic Factors|immunologic factors|mesh-ancestor
24794686|NCT04776850|Glucocorticoids|glucocorticoids|mesh-ancestor
25134458|NCT03006146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134459|NCT03006146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25134460|NCT03006003|Alendronate|alendronate|mesh-list
25134461|NCT03006003|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25134462|NCT03006003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25134463|NCT03006003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134465|NCT03006003|Hormone Antagonists|hormone antagonists|mesh-ancestor
25134466|NCT03006003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25134467|NCT03006003|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25134468|NCT03006003|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25134469|NCT03006107|Piroxicam|piroxicam|mesh-list
25134562|NCT03005496|Provitamins|provitamins|mesh-ancestor
25134470|NCT03006107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25134471|NCT03006107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25134472|NCT03006107|Analgesics|analgesics|mesh-ancestor
25134473|NCT03006107|Sensory System Agents|sensory system agents|mesh-ancestor
25134474|NCT03006107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25134475|NCT03006107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134476|NCT03006107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25134477|NCT03006107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25134478|NCT03006107|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25134479|NCT03006107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25134494|NCT03005860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25134495|NCT03005860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134496|NCT03005860|Analgesics|analgesics|mesh-ancestor
25134497|NCT03005860|Sensory System Agents|sensory system agents|mesh-ancestor
25134498|NCT03005860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25134499|NCT03005860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25134500|NCT03005860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25134502|NCT03005860|Anesthetics|anesthetics|mesh-ancestor
25134503|NCT03005860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134504|NCT03005860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25134505|NCT03005860|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25134506|NCT03005860|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25134507|NCT03005860|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25134508|NCT03005860|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25134509|NCT03005860|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25134510|NCT03005860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25134511|NCT03005860|Cholinergic Agents|cholinergic agents|mesh-ancestor
25134512|NCT03005860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25134513|NCT03005860|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25134514|NCT03006042|Bupivacaine|bupivacaine|mesh-list
25134515|NCT03006042|Anesthetics, Local|anesthetics, local|mesh-ancestor
25134516|NCT03006042|Anesthetics|anesthetics|mesh-ancestor
25134517|NCT03006042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25134518|NCT03006042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134519|NCT03006042|Sensory System Agents|sensory system agents|mesh-ancestor
25134520|NCT03006042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25134521|NCT03005639|Vemurafenib|vemurafenib|mesh-list
25134522|NCT03005639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25134523|NCT03005639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25134524|NCT03005639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25134525|NCT03005639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134526|NCT03005496|Vitamin D|vitamin d|mesh-list
25134527|NCT03005496|Cholecalciferol|cholecalciferol|mesh-list
25134528|NCT03005496|Beta Carotene|beta carotene|mesh-list
25134529|NCT03005496|Zinc|zinc|mesh-list
25134530|NCT03005496|Dexamethasone|dexamethasone|mesh-list
25134532|NCT03005496|Nifedipine|nifedipine|mesh-list
25134533|NCT03005496|BB 1101|bb 1101|mesh-list
25134534|NCT03005496|Carotenoids|carotenoids|mesh-list
25683465|NCT02281838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25134535|NCT03005496|Picolinic acid|picolinic acid|mesh-list
25134536|NCT03005496|Vitamins|vitamins|mesh-ancestor
25281522|NCT02331251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25281523|NCT02331251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25281524|NCT02331251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25134537|NCT03005496|Micronutrients|micronutrients|mesh-ancestor
25134538|NCT03005496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134539|NCT03005496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25134540|NCT03005496|Antiemetics|antiemetics|mesh-ancestor
25134541|NCT03005496|Autonomic Agents|autonomic agents|mesh-ancestor
25134542|NCT03005496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25134543|NCT03005496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25134547|NCT03005496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25134548|NCT03005496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25134549|NCT03005496|Protease Inhibitors|protease inhibitors|mesh-ancestor
25134550|NCT03005496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25134551|NCT03005496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134552|NCT03005496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25134553|NCT03005496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25134554|NCT03005496|Trace Elements|trace elements|mesh-ancestor
25134555|NCT03005496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25134556|NCT03005496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25134557|NCT03005496|Vasodilator Agents|vasodilator agents|mesh-ancestor
25134558|NCT03005496|Tocolytic Agents|tocolytic agents|mesh-ancestor
25134559|NCT03005496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25134560|NCT03005496|Antioxidants|antioxidants|mesh-ancestor
25134561|NCT03005496|Protective Agents|protective agents|mesh-ancestor
25134563|NCT03005496|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25134564|NCT03005496|Chelating Agents|chelating agents|mesh-ancestor
25134565|NCT03005496|Sequestering Agents|sequestering agents|mesh-ancestor
25134566|NCT03005808|Ropivacaine|ropivacaine|mesh-list
25134567|NCT03005808|Anesthetics, Local|anesthetics, local|mesh-ancestor
24577638|NCT00845338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24577725|NCT00845689|Sensory System Agents|sensory system agents|mesh-ancestor
25134568|NCT03005808|Anesthetics|anesthetics|mesh-ancestor
25134569|NCT03005808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25134570|NCT03005808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134571|NCT03005808|Sensory System Agents|sensory system agents|mesh-ancestor
25134572|NCT03005808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25134573|NCT03005665|Acetazolamide|acetazolamide|mesh-list
25134574|NCT03005665|Anticonvulsants|anticonvulsants|mesh-ancestor
25134575|NCT03005665|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25134576|NCT03005665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25134577|NCT03005665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134578|NCT03005665|Diuretics|diuretics|mesh-ancestor
25134579|NCT03005665|Natriuretic Agents|natriuretic agents|mesh-ancestor
25134580|NCT03005665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134581|NCT03005405|Methamphetamine|methamphetamine|mesh-list
25134582|NCT03005405|Fluorides|fluorides|mesh-list
25134583|NCT03005405|Cariostatic Agents|cariostatic agents|mesh-ancestor
25134584|NCT03005405|Protective Agents|protective agents|mesh-ancestor
25134585|NCT03005405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134586|NCT03005405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25134587|NCT03005405|Sympathomimetics|sympathomimetics|mesh-ancestor
25134588|NCT03005405|Autonomic Agents|autonomic agents|mesh-ancestor
25134589|NCT03005405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25134590|NCT03005405|Dopamine Agents|dopamine agents|mesh-ancestor
25134591|NCT03005405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25134592|NCT03005405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134593|NCT03005405|Adrenergic Agents|adrenergic agents|mesh-ancestor
25134594|NCT03005405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25134595|NCT03005405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25134596|NCT03005405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25134597|NCT03005405|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25134598|NCT03005444|Enoxaparin|enoxaparin|mesh-list
25134599|NCT03005444|Nadroparin|nadroparin|mesh-list
25134600|NCT03005444|Rivaroxaban|rivaroxaban|mesh-list
25134601|NCT03005444|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25134602|NCT03005444|Antithrombins|antithrombins|mesh-ancestor
25134603|NCT03005444|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25134606|NCT03005444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683466|NCT02281838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683467|NCT02281838|Sympathomimetics|sympathomimetics|mesh-ancestor
25683468|NCT02281838|Autonomic Agents|autonomic agents|mesh-ancestor
25134607|NCT03005444|Anticoagulants|anticoagulants|mesh-ancestor
25683469|NCT02281838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25134608|NCT03005444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25134609|NCT03005444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25134610|NCT03005704|Aspirin|aspirin|mesh-list
24974424|NCT04682860|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25134611|NCT03005704|Ticagrelor|ticagrelor|mesh-list
25134612|NCT03005704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25134626|NCT03005704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25134627|NCT03005704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25134628|NCT03005704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25134629|NCT03005704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25134630|NCT03005704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25134632|NCT03005717|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25134633|NCT03005717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25134634|NCT03005717|Autonomic Agents|autonomic agents|mesh-ancestor
25134635|NCT03005717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25134636|NCT03005717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134637|NCT03005717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25134638|NCT03005717|Respiratory System Agents|respiratory system agents|mesh-ancestor
25134639|NCT03005717|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25134640|NCT03005717|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25134641|NCT03005717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25134642|NCT03005717|Adrenergic Agents|adrenergic agents|mesh-ancestor
25134643|NCT03005717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25134669|NCT03005483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25134670|NCT03005483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134677|NCT03005522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134678|NCT03005522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25134679|NCT03005522|Glucocorticoids|glucocorticoids|mesh-ancestor
25134680|NCT03005522|Hormones|hormones|mesh-ancestor
25134681|NCT03005522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25134682|NCT03005522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25134683|NCT03005522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25134684|NCT03005210|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25134685|NCT03005210|Antiviral Agents|antiviral agents|mesh-ancestor
25134686|NCT03005210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25134687|NCT03005353|Clotrimazole|clotrimazole|mesh-list
25134688|NCT03005353|Miconazole|miconazole|mesh-list
25134689|NCT03005353|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25134690|NCT03005353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25134691|NCT03005353|Antifungal Agents|antifungal agents|mesh-ancestor
25134692|NCT03005353|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25134693|NCT03005353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25134694|NCT03005353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25134695|NCT03005353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134696|NCT03005353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25134697|NCT03005353|Hormone Antagonists|hormone antagonists|mesh-ancestor
25134698|NCT03005353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25134699|NCT03005353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134700|NCT03005353|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25134701|NCT03005353|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25134704|NCT03005015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25134705|NCT03005015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25134706|NCT03005015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25134707|NCT03005015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25134708|NCT03005015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25134709|NCT03005015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134710|NCT03005015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25134711|NCT03005340|Cholecalciferol|cholecalciferol|mesh-list
25134712|NCT03005340|Vitamin D|vitamin d|mesh-list
25134713|NCT03005340|Bazedoxifene|bazedoxifene|mesh-list
25134714|NCT03005340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25134715|NCT03005340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134716|NCT03005340|Vitamins|vitamins|mesh-ancestor
25134717|NCT03005340|Micronutrients|micronutrients|mesh-ancestor
25134718|NCT03005340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25134719|NCT03005340|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25134720|NCT03005340|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25134721|NCT03005340|Hormone Antagonists|hormone antagonists|mesh-ancestor
25134722|NCT03005340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25134723|NCT03005171|Lidocaine|lidocaine|mesh-list
25134724|NCT03005171|Bupivacaine|bupivacaine|mesh-list
25134725|NCT03005171|Anesthetics, Local|anesthetics, local|mesh-ancestor
25134726|NCT03005171|Anesthetics|anesthetics|mesh-ancestor
25134727|NCT03005171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25134728|NCT03005171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134729|NCT03005171|Sensory System Agents|sensory system agents|mesh-ancestor
25134730|NCT03005171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25134731|NCT03005171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25134732|NCT03005171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25134733|NCT03005171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25134734|NCT03005171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25134735|NCT03005171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134742|NCT03005184|Icatibant|icatibant|mesh-list
25134743|NCT03005184|Valsartan|valsartan|mesh-list
25134744|NCT03005184|Enalapril|enalapril|mesh-list
24577989|NCT00846625|Triamcinolone|triamcinolone|mesh-list
25134758|NCT03005184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134760|NCT03005184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25134761|NCT03005184|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
25134762|NCT03005184|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
25134763|NCT03005184|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25134764|NCT03005184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25134765|NCT03005184|Immunologic Factors|immunologic factors|mesh-ancestor
25134766|NCT03005002|Durvalumab|durvalumab|mesh-list
25134767|NCT03005002|Ipilimumab|ipilimumab|mesh-list
25134768|NCT03005002|Tremelimumab|tremelimumab|mesh-list
25134769|NCT03005002|Immunoglobulins|immunoglobulins|mesh-list
25134797|NCT03004768|BMS-986165|bms-986165|mesh-list
25134798|NCT03004768|Dermatologic Agents|dermatologic agents|mesh-ancestor
25134799|NCT03004768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25134800|NCT03004768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25134801|NCT03004768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134802|NCT03005236|Tacrolimus|tacrolimus|mesh-list
25134803|NCT03005236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25134804|NCT03005236|Immunologic Factors|immunologic factors|mesh-ancestor
25134805|NCT03005236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134806|NCT03005236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25134831|NCT03004612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134832|NCT03004521|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25134833|NCT03004521|Antidepressive Agents|antidepressive agents|mesh-ancestor
25134834|NCT03004521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25134835|NCT03004521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25134836|NCT03004521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25134837|NCT03004521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25134838|NCT03004521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134889|NCT03004339|Hormones|hormones|mesh-ancestor
25134906|NCT03004222|Sensory System Agents|sensory system agents|mesh-ancestor
25134907|NCT03004222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25134908|NCT03004196|Chlorhexidine|chlorhexidine|mesh-list
25134909|NCT03004196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25134910|NCT03004196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25134911|NCT03004196|Disinfectants|disinfectants|mesh-ancestor
25134912|NCT03004209|Epoetin Alfa|epoetin alfa|mesh-list
25134913|NCT03004209|Hematinics|hematinics|mesh-ancestor
25134914|NCT03004261|Ganciclovir|ganciclovir|mesh-list
25134915|NCT03004261|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25134916|NCT03004261|Foscarnet|foscarnet|mesh-list
25134917|NCT03004261|Antiviral Agents|antiviral agents|mesh-ancestor
25134918|NCT03004261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25134919|NCT03004261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25134920|NCT03004261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25134921|NCT03004261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134922|NCT03004261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25134923|NCT03004014|Propofol|propofol|mesh-list
25134924|NCT03004014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24859160|NCT02302326|Folic Acid|folic acid|mesh-list
25134964|NCT03003728|Alkylating Agents|alkylating agents|mesh-ancestor
25134965|NCT03003728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134966|NCT03003728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25134967|NCT03003728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25134968|NCT03003728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25134969|NCT03003728|Immunologic Factors|immunologic factors|mesh-ancestor
25134970|NCT03003728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134971|NCT03003637|Nivolumab|nivolumab|mesh-list
25134972|NCT03003637|Ipilimumab|ipilimumab|mesh-list
25134973|NCT03003637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25134976|NCT03003637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134978|NCT03003611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25134979|NCT03003611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134980|NCT03003273|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25134981|NCT03003273|Amoxicillin|amoxicillin|mesh-list
25134982|NCT03003273|Levofloxacin|levofloxacin|mesh-list
25134983|NCT03003273|Ofloxacin|ofloxacin|mesh-list
25134984|NCT03003273|Clavulanic Acids|clavulanic acids|mesh-list
25134985|NCT03003273|Clavulanic Acid|clavulanic acid|mesh-list
25134986|NCT03003273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24577847|NCT00846079|Purinergic Agents|purinergic agents|mesh-ancestor
24577848|NCT00846079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24577849|NCT00846079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577850|NCT00846079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577851|NCT00846118|Pitavastatin|pitavastatin|mesh-list
24577956|NCT00846430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24577957|NCT00846430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24577959|NCT00846430|Sensory System Agents|sensory system agents|mesh-ancestor
24577960|NCT00846430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24577961|NCT00846430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24577962|NCT00846430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24577963|NCT00846430|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24577964|NCT00846430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24577965|NCT00846430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577979|NCT00846612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24577980|NCT00846612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24577981|NCT00846612|Growth Substances|growth substances|mesh-ancestor
24577982|NCT00846612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577983|NCT00846612|Growth Inhibitors|growth inhibitors|mesh-ancestor
24577984|NCT00846612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24577985|NCT00846612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25134987|NCT03003273|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25134988|NCT03003273|Renal Agents|renal agents|mesh-ancestor
25134989|NCT03003273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25134990|NCT03003273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25134991|NCT03003273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25134992|NCT03003273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134993|NCT03003273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25134994|NCT03003273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25134995|NCT03003273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25134996|NCT03003273|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25134997|NCT03003416|Dexamethasone|dexamethasone|mesh-list
25134998|NCT03003416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25134999|NCT03003416|Antiemetics|antiemetics|mesh-ancestor
25135000|NCT03003416|Autonomic Agents|autonomic agents|mesh-ancestor
25135001|NCT03003416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25135002|NCT03003416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135003|NCT03003416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25135004|NCT03003416|Glucocorticoids|glucocorticoids|mesh-ancestor
25135005|NCT03003416|Hormones|hormones|mesh-ancestor
25135006|NCT03003416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25135007|NCT03003416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25135008|NCT03003416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135012|NCT03003195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25135013|NCT03003195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25135014|NCT03003195|Immunologic Factors|immunologic factors|mesh-ancestor
25135015|NCT03003195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135016|NCT03003143|Vigabatrin|vigabatrin|mesh-list
25135017|NCT03003143|Anticonvulsants|anticonvulsants|mesh-ancestor
24577986|NCT00846612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24577987|NCT00846612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577988|NCT00846612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577990|NCT00846625|Ranibizumab|ranibizumab|mesh-list
24577991|NCT00846625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24577992|NCT00846625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24577993|NCT00846625|Growth Substances|growth substances|mesh-ancestor
24578054|NCT00846703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24578055|NCT00846703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24578056|NCT00846703|Antimetabolites|antimetabolites|mesh-ancestor
25135018|NCT03003143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25135019|NCT03003143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135020|NCT03003143|GABA Agents|gaba agents|mesh-ancestor
25135021|NCT03003143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25135022|NCT03003143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135024|NCT03003039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25135025|NCT03003039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135026|NCT03003039|Immunologic Factors|immunologic factors|mesh-ancestor
25135027|NCT03003039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135028|NCT03003039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25135029|NCT03002844|Gemcitabine|gemcitabine|mesh-list
25135030|NCT03002844|Carboplatin|carboplatin|mesh-list
25135031|NCT03002844|Pemetrexed|pemetrexed|mesh-list
25135032|NCT03002844|Gefitinib|gefitinib|mesh-list
25135033|NCT03002844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135034|NCT03002844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25135035|NCT03002844|Antimetabolites|antimetabolites|mesh-ancestor
25135036|NCT03002844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135037|NCT03002844|Antiviral Agents|antiviral agents|mesh-ancestor
25135038|NCT03002844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25135039|NCT03002844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25135040|NCT03002844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25135041|NCT03002844|Immunologic Factors|immunologic factors|mesh-ancestor
25135042|NCT03002844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135043|NCT03002844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25135044|NCT03002844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25135045|NCT03002844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25135046|NCT03002831|Tegafur|tegafur|mesh-list
25135047|NCT03002831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25135048|NCT03002831|Antimetabolites|antimetabolites|mesh-ancestor
25135049|NCT03002831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135059|NCT03002961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25135060|NCT03002961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25135061|NCT03002805|Doxorubicin|doxorubicin|mesh-list
25135062|NCT03002805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25135063|NCT03002805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135064|NCT03002805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25135065|NCT03002805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25135066|NCT03002805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25135067|NCT03002805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135068|NCT03002935|Coenzyme Q10|coenzyme q10|mesh-list
25135069|NCT03002935|Micronutrients|micronutrients|mesh-ancestor
25135070|NCT03002935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135071|NCT03002935|Vitamins|vitamins|mesh-ancestor
25135072|NCT03002792|Anesthetics|anesthetics|mesh-list
25135073|NCT03002792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25135074|NCT03002792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135075|NCT03002675|Exenatide|exenatide|mesh-list
25135076|NCT03002675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25135077|NCT03002675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135078|NCT03002675|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25135079|NCT03002675|Incretins|incretins|mesh-ancestor
25135080|NCT03002675|Hormones|hormones|mesh-ancestor
25135081|NCT03002675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25135082|NCT03002493|Rifampin|rifampin|mesh-list
25135083|NCT03002493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25135084|NCT03002493|Antitubercular Agents|antitubercular agents|mesh-ancestor
25135085|NCT03002493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25135086|NCT03002493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25135087|NCT03002493|Leprostatic Agents|leprostatic agents|mesh-ancestor
25135088|NCT03002493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25135101|NCT03002545|Magnesium citrate|magnesium citrate|mesh-list
25135102|NCT03002545|Cathartics|cathartics|mesh-ancestor
25135103|NCT03002545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25135104|NCT03002649|Tofacitinib|tofacitinib|mesh-list
25135105|NCT03002649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135106|NCT03002649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25135107|NCT03002649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25135142|NCT03001869|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25135143|NCT03001869|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25135144|NCT03001869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135145|NCT03001960|Clopidogrel|clopidogrel|mesh-list
25135146|NCT03001960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25135147|NCT03001960|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25281688|NCT02330120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25135148|NCT03001960|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25135149|NCT03001960|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25135150|NCT03001960|Purinergic Agents|purinergic agents|mesh-ancestor
25135151|NCT03001960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25135152|NCT03001960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135153|NCT03001960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135154|NCT03001687|Vitamin D|vitamin d|mesh-list
25135155|NCT03001687|Vitamins|vitamins|mesh-ancestor
25135156|NCT03001687|Micronutrients|micronutrients|mesh-ancestor
25135157|NCT03001687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135158|NCT03001687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25135159|NCT03001739|Urapidil|urapidil|mesh-list
25135160|NCT03001739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25135161|NCT03001739|Vasodilator Agents|vasodilator agents|mesh-ancestor
25135162|NCT03001739|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25135163|NCT03001739|Serotonin Agents|serotonin agents|mesh-ancestor
25135164|NCT03001739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25135165|NCT03001739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135166|NCT03001739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135167|NCT03001739|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25135168|NCT03001739|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25135169|NCT03001739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25135170|NCT03001739|Adrenergic Agents|adrenergic agents|mesh-ancestor
25135171|NCT03001609|Abivertinib|abivertinib|mesh-list
25135172|NCT03001609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25135173|NCT03001609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25135174|NCT03001609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135175|NCT03001661|Dinoprostone|dinoprostone|mesh-list
25135176|NCT03001661|Oxytocics|oxytocics|mesh-ancestor
25135177|NCT03001661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25135178|NCT03001661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135180|NCT03001635|Oxytocics|oxytocics|mesh-ancestor
25135181|NCT03001635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25135182|NCT03001635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135183|NCT03001570|Cetuximab|cetuximab|mesh-list
25135184|NCT03001570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25135185|NCT03001570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135186|NCT03001466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25135187|NCT03001466|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25266800|NCT02426164|Morphine|morphine|mesh-list
25135188|NCT03001271|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
25135189|NCT03001271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25135190|NCT03001271|Vasodilator Agents|vasodilator agents|mesh-ancestor
25135191|NCT03001349|Octreotide|octreotide|mesh-list
25135192|NCT03001349|Edotreotide|edotreotide|mesh-list
25135227|NCT03000660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25135228|NCT03000660|Antiemetics|antiemetics|mesh-ancestor
25135229|NCT03000660|Autonomic Agents|autonomic agents|mesh-ancestor
25135230|NCT03000660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25135231|NCT03000660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135232|NCT03000660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25135233|NCT03000660|Glucocorticoids|glucocorticoids|mesh-ancestor
25135234|NCT03000660|Hormones|hormones|mesh-ancestor
25135235|NCT03000660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25135236|NCT03000660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25135237|NCT03000660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135238|NCT03000413|Fentanyl|fentanyl|mesh-list
25135239|NCT03000413|Ketamine|ketamine|mesh-list
25135240|NCT03000413|Analgesics|analgesics|mesh-ancestor
25135241|NCT03000413|Sensory System Agents|sensory system agents|mesh-ancestor
25135242|NCT03000413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25135243|NCT03000413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135244|NCT03000413|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25135245|NCT03000413|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25135246|NCT03000413|Anesthetics, General|anesthetics, general|mesh-ancestor
25135247|NCT03000413|Anesthetics|anesthetics|mesh-ancestor
25135248|NCT03000413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25135249|NCT03000413|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25135250|NCT03000413|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25135251|NCT03000413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25135252|NCT03000413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135253|NCT03000413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25135254|NCT03000413|Narcotics|narcotics|mesh-ancestor
25135255|NCT03000413|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24578057|NCT00846703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578058|NCT00846703|Dermatologic Agents|dermatologic agents|mesh-ancestor
24578151|NCT00847080|Protease Inhibitors|protease inhibitors|mesh-ancestor
24578152|NCT00847080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24578191|NCT00847262|Vasodilator Agents|vasodilator agents|mesh-ancestor
24578153|NCT00847080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578157|NCT00847093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24578158|NCT00847093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578159|NCT00847093|Sensory System Agents|sensory system agents|mesh-ancestor
24578160|NCT00847093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25135257|NCT03000777|Antioxidants|antioxidants|mesh-ancestor
25135258|NCT03000777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135259|NCT03000777|Protective Agents|protective agents|mesh-ancestor
25135260|NCT03000777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135261|NCT03000777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25135262|NCT03000634|Dexamethasone|dexamethasone|mesh-list
25135263|NCT03000634|Lenalidomide|lenalidomide|mesh-list
25135264|NCT03000634|Bortezomib|bortezomib|mesh-list
25135265|NCT03000634|Elotuzumab|elotuzumab|mesh-list
25135266|NCT03000634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25135267|NCT03000634|Antiemetics|antiemetics|mesh-ancestor
25135268|NCT03000634|Autonomic Agents|autonomic agents|mesh-ancestor
25135269|NCT03000634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24859443|NCT02303639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25135270|NCT03000634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135271|NCT03000634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25135272|NCT03000634|Glucocorticoids|glucocorticoids|mesh-ancestor
25135273|NCT03000634|Hormones|hormones|mesh-ancestor
25135274|NCT03000634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25135275|NCT03000634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25135276|NCT03000634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135277|NCT03000634|Immunologic Factors|immunologic factors|mesh-ancestor
25135278|NCT03000634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25135279|NCT03000634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25135280|NCT03000634|Growth Substances|growth substances|mesh-ancestor
25135281|NCT03000634|Growth Inhibitors|growth inhibitors|mesh-ancestor
25135283|NCT03000556|Hyaluronic Acid|hyaluronic acid|mesh-list
25135284|NCT03000556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25135285|NCT03000556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25135286|NCT03000556|Immunologic Factors|immunologic factors|mesh-ancestor
25135287|NCT03000556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135288|NCT03000556|Viscosupplements|viscosupplements|mesh-ancestor
25135289|NCT03000556|Protective Agents|protective agents|mesh-ancestor
25135315|NCT03000205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135316|NCT03000205|Sensory System Agents|sensory system agents|mesh-ancestor
25135317|NCT03000205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25135318|NCT03000205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25135319|NCT03000205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25135320|NCT03000205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25135321|NCT03000205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25135322|NCT03000205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135324|NCT03000036|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
25135325|NCT03000036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25135326|NCT03000036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135327|NCT03000036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25135328|NCT03000036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25135329|NCT03000036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25135330|NCT03000036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135331|NCT03000036|Chelating Agents|chelating agents|mesh-ancestor
25135332|NCT03000036|Sequestering Agents|sequestering agents|mesh-ancestor
25135333|NCT02999958|Thioctic Acid|thioctic acid|mesh-list
25135334|NCT02999958|Acetylcarnitine|acetylcarnitine|mesh-list
25135335|NCT02999958|Acetylcysteine|acetylcysteine|mesh-list
25135336|NCT02999958|Antioxidants|antioxidants|mesh-list
25135337|NCT02999958|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25135338|NCT02999958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135339|NCT02999958|Protective Agents|protective agents|mesh-ancestor
25135340|NCT02999958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578161|NCT00847093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24578162|NCT00847093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24578163|NCT00847093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24578164|NCT00847093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24578165|NCT00847093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578166|NCT00847106|Daclizumab|daclizumab|mesh-list
24578167|NCT00847106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24578168|NCT00847106|Immunologic Factors|immunologic factors|mesh-ancestor
24963590|NCT03790085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963591|NCT03790085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963592|NCT03790085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24963593|NCT03790085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24963594|NCT03790085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24963595|NCT03790085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24963596|NCT03790085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25135341|NCT02999958|Vitamin B Complex|vitamin b complex|mesh-ancestor
25135343|NCT02999958|Micronutrients|micronutrients|mesh-ancestor
25135344|NCT02999958|Nootropic Agents|nootropic agents|mesh-ancestor
25135345|NCT02999958|Antiviral Agents|antiviral agents|mesh-ancestor
25135346|NCT02999958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25135347|NCT02999958|Expectorants|expectorants|mesh-ancestor
25135348|NCT02999958|Respiratory System Agents|respiratory system agents|mesh-ancestor
25135349|NCT02999958|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25135350|NCT02999958|Antidotes|antidotes|mesh-ancestor
25135351|NCT02999776|Etanercept|etanercept|mesh-list
25135352|NCT02999776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25135353|NCT02999776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25135354|NCT02999776|Analgesics|analgesics|mesh-ancestor
25135355|NCT02999776|Sensory System Agents|sensory system agents|mesh-ancestor
25135356|NCT02999776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25135357|NCT02999776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135386|NCT02999724|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25135387|NCT02999724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25135388|NCT02999724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25135389|NCT02999724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25135390|NCT02999724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25135391|NCT02999724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25135392|NCT02999724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25135393|NCT02999724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135394|NCT02999724|Antimanic Agents|antimanic agents|mesh-ancestor
25135395|NCT02999919|Bupivacaine|bupivacaine|mesh-list
25135396|NCT02999919|Anesthetics, Local|anesthetics, local|mesh-ancestor
25135397|NCT02999919|Anesthetics|anesthetics|mesh-ancestor
25135398|NCT02999919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25135399|NCT02999919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135400|NCT02999919|Sensory System Agents|sensory system agents|mesh-ancestor
25135401|NCT02999919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25135402|NCT02999594|Tramadol|tramadol|mesh-list
25135403|NCT02999594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25135404|NCT02999594|Narcotics|narcotics|mesh-ancestor
25135405|NCT02999594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25045793|NCT00911443|Dacarbazine|dacarbazine|mesh-list
25045794|NCT00911443|Thymalfasin|thymalfasin|mesh-list
25045795|NCT00911443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045797|NCT00911443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25045798|NCT00911443|Immunologic Factors|immunologic factors|mesh-ancestor
25045799|NCT00911443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045800|NCT00911443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25045801|NCT00911443|Alkylating Agents|alkylating agents|mesh-ancestor
25045802|NCT00911443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045803|NCT00911443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25045804|NCT00911274|Mycophenolic Acid|mycophenolic acid|mesh-list
25045805|NCT00911274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25045806|NCT00911274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045807|NCT00911274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25045808|NCT00911274|Antitubercular Agents|antitubercular agents|mesh-ancestor
25135413|NCT02999295|Nivolumab|nivolumab|mesh-list
25135414|NCT02999295|Ramucirumab|ramucirumab|mesh-list
25135415|NCT02999295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25135416|NCT02999295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135417|NCT02999295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25135418|NCT02999295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135419|NCT02999204|Vitamin D|vitamin d|mesh-list
25135420|NCT02999204|Cholecalciferol|cholecalciferol|mesh-list
25135421|NCT02999204|Vitamins|vitamins|mesh-ancestor
25135422|NCT02999204|Micronutrients|micronutrients|mesh-ancestor
25135423|NCT02999204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135424|NCT02999204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25135425|NCT02999204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25135426|NCT02999217|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25135427|NCT02999217|Hematinics|hematinics|mesh-ancestor
25135428|NCT02999126|Remifentanil|remifentanil|mesh-list
24578190|NCT00847262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578193|NCT00847314|Testosterone|testosterone|mesh-list
24578194|NCT00847314|Testosterone undecanoate|testosterone undecanoate|mesh-list
24578195|NCT00847314|Testosterone enanthate|testosterone enanthate|mesh-list
24578196|NCT00847314|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24578197|NCT00847314|Androgens|androgens|mesh-ancestor
24578199|NCT00847314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25135429|NCT02999126|Propofol|propofol|mesh-list
25135430|NCT02999126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25135431|NCT02999126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25135432|NCT02999126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135433|NCT02999126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25135434|NCT02999126|Anesthetics, General|anesthetics, general|mesh-ancestor
25135435|NCT02999126|Anesthetics|anesthetics|mesh-ancestor
25135436|NCT02999126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25135437|NCT02999126|Narcotics|narcotics|mesh-ancestor
25135438|NCT02999126|Analgesics|analgesics|mesh-ancestor
25135439|NCT02999126|Sensory System Agents|sensory system agents|mesh-ancestor
25135440|NCT02999126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25135441|NCT02998970|Empagliflozin|empagliflozin|mesh-list
25135442|NCT02998970|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25135443|NCT02998970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135444|NCT02998970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25135445|NCT02998970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135446|NCT02998918|Curcumin|curcumin|mesh-list
25135447|NCT02998918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25135448|NCT02998918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25135449|NCT02998918|Analgesics|analgesics|mesh-ancestor
25135450|NCT02998918|Sensory System Agents|sensory system agents|mesh-ancestor
25135451|NCT02998918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25135452|NCT02998918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135453|NCT02998918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25135454|NCT02998918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25135455|NCT02998918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135456|NCT02998918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25135457|NCT02998918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135458|NCT02998827|Thalidomide|thalidomide|mesh-list
25135473|NCT02998827|Growth Inhibitors|growth inhibitors|mesh-ancestor
25135474|NCT02998827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135475|NCT02998827|Antimetabolites|antimetabolites|mesh-ancestor
25135476|NCT02998827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135477|NCT02998827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25135478|NCT02998905|Aspirin|aspirin|mesh-list
25135479|NCT02998905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25135480|NCT02998905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25135481|NCT02998905|Analgesics|analgesics|mesh-ancestor
25135482|NCT02998905|Sensory System Agents|sensory system agents|mesh-ancestor
25135483|NCT02998905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25135484|NCT02998905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135485|NCT02998905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25135486|NCT02998905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25083600|NCT03314636|Hormones|hormones|mesh-ancestor
25135487|NCT02998905|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25135522|NCT02998242|Apatinib|apatinib|mesh-list
25135523|NCT02998242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135524|NCT02998242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25135525|NCT02998242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25135526|NCT02998242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135527|NCT02998398|Infliximab|infliximab|mesh-list
25135528|NCT02998398|Dermatologic Agents|dermatologic agents|mesh-ancestor
25135529|NCT02998398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25135530|NCT02998398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25135531|NCT02998320|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25135532|NCT02998320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25135533|NCT02998320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25135534|NCT02998320|Antiviral Agents|antiviral agents|mesh-ancestor
25135535|NCT02998320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25135536|NCT02997969|Vaccines|vaccines|mesh-list
25135537|NCT02997969|MF59 oil emulsion|mf59 oil emulsion|mesh-list
25135538|NCT02997969|Immunologic Factors|immunologic factors|mesh-ancestor
25135539|NCT02997969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135540|NCT02997969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25135544|NCT02997995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135545|NCT02997800|Labetalol|labetalol|mesh-list
25135546|NCT02997800|Fentanyl|fentanyl|mesh-list
25135547|NCT02997800|Esmolol|esmolol|mesh-list
25135548|NCT02997800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25135549|NCT02997800|Narcotics|narcotics|mesh-ancestor
25135550|NCT02997800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25135551|NCT02997800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135552|NCT02997800|Analgesics|analgesics|mesh-ancestor
25135553|NCT02997800|Sensory System Agents|sensory system agents|mesh-ancestor
25045809|NCT00911274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25045810|NCT00911274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25045811|NCT00911274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045812|NCT00911274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045813|NCT00909753|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25045814|NCT00909753|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25045815|NCT00909753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25045816|NCT00909649|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25045817|NCT00909649|Hemostatics|hemostatics|mesh-ancestor
25045818|NCT00909649|Coagulants|coagulants|mesh-ancestor
25045819|NCT00909610|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25045820|NCT00909610|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25045821|NCT00909610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25045822|NCT00909597|Pioglitazone|pioglitazone|mesh-list
25045823|NCT00909597|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25045824|NCT00909597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25045825|NCT00909597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045826|NCT00909597|Incretins|incretins|mesh-ancestor
25045827|NCT00909597|Hormones|hormones|mesh-ancestor
25045828|NCT00909597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25045829|NCT00908128|Mycophenolic Acid|mycophenolic acid|mesh-list
25045830|NCT00908128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25045831|NCT00908128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045832|NCT00908128|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25045833|NCT00908128|Antitubercular Agents|antitubercular agents|mesh-ancestor
25045834|NCT00908128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24578200|NCT00847314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578201|NCT00847314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24578202|NCT00847314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578203|NCT00847314|Anabolic Agents|anabolic agents|mesh-ancestor
24578204|NCT00847418|Esketamine|esketamine|mesh-list
25045835|NCT00908128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25045836|NCT00908128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045837|NCT00908128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045839|NCT00907907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25045840|NCT00907907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045841|NCT00907907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25045842|NCT00907907|Antitubercular Agents|antitubercular agents|mesh-ancestor
25045843|NCT00907907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25045844|NCT00907907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25045845|NCT00907907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045846|NCT00907907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045847|NCT00906334|ON 01910|on 01910|mesh-list
25045848|NCT00906334|Glycine|glycine|mesh-list
25045849|NCT00906334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045850|NCT00906334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25045851|NCT00906334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045852|NCT00906334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045853|NCT00906334|Glycine Agents|glycine agents|mesh-ancestor
25045854|NCT00906334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25045855|NCT00906334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135554|NCT02997800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25135555|NCT02997800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25135557|NCT02997800|Anesthetics, General|anesthetics, general|mesh-ancestor
25135559|NCT02997800|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25135560|NCT02997800|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25135561|NCT02997800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25135562|NCT02997800|Adrenergic Agents|adrenergic agents|mesh-ancestor
24578205|NCT00847418|Antidepressive Agents|antidepressive agents|mesh-ancestor
24578206|NCT00847418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24578207|NCT00847483|Bimatoprost|bimatoprost|mesh-list
24578208|NCT00847483|Travoprost|travoprost|mesh-list
24578288|NCT00848302|Autonomic Agents|autonomic agents|mesh-ancestor
24578289|NCT00848302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24578290|NCT00848302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578291|NCT00848302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24578292|NCT00848302|Respiratory System Agents|respiratory system agents|mesh-ancestor
24578293|NCT00848302|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24578294|NCT00848302|Antioxidants|antioxidants|mesh-ancestor
24578295|NCT00848302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578296|NCT00848302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24578297|NCT00848302|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24578298|NCT00848302|Vasodilator Agents|vasodilator agents|mesh-ancestor
24578299|NCT00848302|Gasotransmitters|gasotransmitters|mesh-ancestor
25135563|NCT02997800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25135564|NCT02997800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135565|NCT02997800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25135567|NCT02997800|Autonomic Agents|autonomic agents|mesh-ancestor
25135568|NCT02997800|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25135569|NCT02997800|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25135570|NCT02997982|Valacyclovir|valacyclovir|mesh-list
25135571|NCT02997982|Antiviral Agents|antiviral agents|mesh-ancestor
25135572|NCT02997982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25135573|NCT02997514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25135574|NCT02997371|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25135575|NCT02997371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25135576|NCT02997410|Salicylic Acid|salicylic acid|mesh-list
25135577|NCT02997410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25135578|NCT02997410|Antifungal Agents|antifungal agents|mesh-ancestor
25135579|NCT02997410|Keratolytic Agents|keratolytic agents|mesh-ancestor
25135580|NCT02997410|Dermatologic Agents|dermatologic agents|mesh-ancestor
25135581|NCT02997332|Docetaxel|docetaxel|mesh-list
25135582|NCT02997332|Fluorouracil|fluorouracil|mesh-list
25135583|NCT02997332|Durvalumab|durvalumab|mesh-list
25135584|NCT02997332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135585|NCT02997332|Tubulin Modulators|tubulin modulators|mesh-ancestor
25135586|NCT02997332|Antimitotic Agents|antimitotic agents|mesh-ancestor
25135587|NCT02997332|Mitosis Modulators|mitosis modulators|mesh-ancestor
25135588|NCT02997332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135589|NCT02997332|Antimetabolites|antimetabolites|mesh-ancestor
25135590|NCT02997332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25135591|NCT02997332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25135592|NCT02997332|Immunologic Factors|immunologic factors|mesh-ancestor
25135593|NCT02997332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135594|NCT02997332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25135595|NCT02997215|Lidocaine|lidocaine|mesh-list
25135596|NCT02997215|Anesthetics, Local|anesthetics, local|mesh-ancestor
25135597|NCT02997215|Anesthetics|anesthetics|mesh-ancestor
25135598|NCT02997215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24578300|NCT00848302|Protective Agents|protective agents|mesh-ancestor
24578301|NCT00848432|Risperidone|risperidone|mesh-list
24578302|NCT00848432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24578303|NCT00848432|Serotonin Agents|serotonin agents|mesh-ancestor
25135599|NCT02997215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135600|NCT02997215|Sensory System Agents|sensory system agents|mesh-ancestor
25135601|NCT02997215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25135602|NCT02997215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25135603|NCT02997215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25135604|NCT02997215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25135605|NCT02997215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25135606|NCT02997215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135607|NCT02996916|Amlodipine|amlodipine|mesh-list
25135608|NCT02996916|Olmesartan|olmesartan|mesh-list
25135609|NCT02996916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25135610|NCT02996916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25135611|NCT02996916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25135612|NCT02996916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135613|NCT02996916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25135614|NCT02996916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135615|NCT02996916|Vasodilator Agents|vasodilator agents|mesh-ancestor
25135616|NCT02996916|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25135617|NCT02996916|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25135618|NCT02996942|Factor VIII|factor viii|mesh-list
25135619|NCT02996942|Coagulants|coagulants|mesh-ancestor
25281873|NCT02328469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25281874|NCT02328469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25281875|NCT02328469|Antiviral Agents|antiviral agents|mesh-ancestor
25281876|NCT02328456|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25281877|NCT02328456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25135620|NCT02997059|Fluconazole|fluconazole|mesh-list
25135621|NCT02997059|Antifungal Agents|antifungal agents|mesh-ancestor
25135622|NCT02997059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25135623|NCT02997059|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25135624|NCT02997059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25135661|NCT02996487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25135662|NCT02996487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25135664|NCT02996409|Anesthetics, Local|anesthetics, local|mesh-ancestor
25135665|NCT02996409|Anesthetics|anesthetics|mesh-ancestor
25135666|NCT02996409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25135667|NCT02996409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135668|NCT02996409|Sensory System Agents|sensory system agents|mesh-ancestor
25135669|NCT02996409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25135670|NCT02996409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25135671|NCT02996409|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25135672|NCT02996409|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25135673|NCT02996409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25135674|NCT02996409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135676|NCT02996318|Paclitaxel|paclitaxel|mesh-list
25135677|NCT02996318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25135678|NCT02996318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135679|NCT02996318|Tubulin Modulators|tubulin modulators|mesh-ancestor
25135680|NCT02996318|Antimitotic Agents|antimitotic agents|mesh-ancestor
25135681|NCT02996318|Mitosis Modulators|mitosis modulators|mesh-ancestor
25135682|NCT02996318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135683|NCT02996318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25135684|NCT02996318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25135685|NCT02996318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25135686|NCT02996318|Antifungal Agents|antifungal agents|mesh-ancestor
25135687|NCT02996318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25135688|NCT02996318|Immunologic Factors|immunologic factors|mesh-ancestor
25135689|NCT02996318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135690|NCT02996227|Bupivacaine|bupivacaine|mesh-list
24578313|NCT00848458|Azelaic acid|azelaic acid|mesh-list
25266882|NCT02425852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24578314|NCT00848458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578315|NCT00848458|Dermatologic Agents|dermatologic agents|mesh-ancestor
24578317|NCT00848523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578318|NCT00848523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24578319|NCT00848523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24578329|NCT00848640|Sorafenib|sorafenib|mesh-list
25135692|NCT02996227|Anesthetics|anesthetics|mesh-ancestor
25135693|NCT02996227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25135694|NCT02996227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135695|NCT02996227|Sensory System Agents|sensory system agents|mesh-ancestor
25135696|NCT02996227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25135697|NCT02996214|Gemcitabine|gemcitabine|mesh-list
25135698|NCT02996214|Paclitaxel|paclitaxel|mesh-list
25135699|NCT02996214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25135700|NCT02996214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135701|NCT02996214|Tubulin Modulators|tubulin modulators|mesh-ancestor
25135702|NCT02996214|Antimitotic Agents|antimitotic agents|mesh-ancestor
25135703|NCT02996214|Mitosis Modulators|mitosis modulators|mesh-ancestor
24900896|NCT04390334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25135704|NCT02996214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135705|NCT02996214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25135706|NCT02996214|Antimetabolites|antimetabolites|mesh-ancestor
25135707|NCT02996214|Antiviral Agents|antiviral agents|mesh-ancestor
25135708|NCT02996214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25135709|NCT02996214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25135710|NCT02996214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25135711|NCT02996214|Immunologic Factors|immunologic factors|mesh-ancestor
25135712|NCT02996214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135714|NCT02995954|Perindopril|perindopril|mesh-list
25683470|NCT02281838|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25683471|NCT02281838|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25683472|NCT02270632|Methotrexate|methotrexate|mesh-list
25683473|NCT02270632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25683474|NCT02270632|Abortifacient Agents|abortifacient agents|mesh-ancestor
25135715|NCT02995954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25135716|NCT02995954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25135717|NCT02995954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25045856|NCT00905606|Topiramate|topiramate|mesh-list
25135718|NCT02995954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135719|NCT02995954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25135721|NCT02995954|Vasodilator Agents|vasodilator agents|mesh-ancestor
25045870|NCT00905164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25045871|NCT00905164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045872|NCT00904943|Topiramate|topiramate|mesh-list
25045873|NCT00904943|Anticonvulsants|anticonvulsants|mesh-ancestor
25045878|NCT00902928|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25045879|NCT00902928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25045880|NCT00902928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045882|NCT00902291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25045883|NCT00902291|Antimetabolites|antimetabolites|mesh-ancestor
25045884|NCT00902291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045885|NCT00902291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045886|NCT00902291|Antiviral Agents|antiviral agents|mesh-ancestor
25045887|NCT00902291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25045888|NCT00902291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045889|NCT00902291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25045890|NCT00902291|Immunologic Factors|immunologic factors|mesh-ancestor
25045891|NCT00902291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045892|NCT00901979|Metformin|metformin|mesh-list
25045893|NCT00901979|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25045894|NCT00901979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25045895|NCT00901979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045896|NCT00901979|Incretins|incretins|mesh-ancestor
25045897|NCT00901979|Hormones|hormones|mesh-ancestor
25045898|NCT00901979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25045899|NCT00901979|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25045900|NCT00901979|Protease Inhibitors|protease inhibitors|mesh-ancestor
25045901|NCT00901979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045902|NCT00901979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045903|NCT00901693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25045908|NCT00900900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045909|NCT00900783|Valacyclovir|valacyclovir|mesh-list
25045910|NCT00900783|Antiviral Agents|antiviral agents|mesh-ancestor
25045911|NCT00900783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25045912|NCT00894868|Vildagliptin|vildagliptin|mesh-list
25045913|NCT00894868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25045914|NCT00894868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045915|NCT00894868|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25045916|NCT00894868|Protease Inhibitors|protease inhibitors|mesh-ancestor
25045917|NCT00894868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045918|NCT00894868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045919|NCT00894530|Azithromycin|azithromycin|mesh-list
25045920|NCT00894530|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25045921|NCT00894530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25045922|NCT00894530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25045923|NCT00894530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25045924|NCT00893139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25045925|NCT00893139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25045926|NCT00892970|Azithromycin|azithromycin|mesh-list
25045927|NCT00892970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25045928|NCT00892970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25135722|NCT02995954|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25135724|NCT02995954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25135725|NCT02996058|Dexmedetomidine|dexmedetomidine|mesh-list
25135726|NCT02996058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25135727|NCT02996058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25135728|NCT02996058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135729|NCT02996058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25135730|NCT02996058|Analgesics|analgesics|mesh-ancestor
24578333|NCT00848640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578335|NCT00848679|Anesthetics, Local|anesthetics, local|mesh-ancestor
24578337|NCT00848679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24578338|NCT00848679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578339|NCT00848679|Sensory System Agents|sensory system agents|mesh-ancestor
24578340|NCT00848679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24578341|NCT00848679|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24578342|NCT00848679|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25281938|NCT02328118|Triamcinolone|triamcinolone|mesh-list
24578343|NCT00848679|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24578360|NCT00848770|Sympathomimetics|sympathomimetics|mesh-ancestor
24578361|NCT00848770|Autonomic Agents|autonomic agents|mesh-ancestor
25135734|NCT02996058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25135735|NCT02996058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25135736|NCT02996058|Adrenergic Agents|adrenergic agents|mesh-ancestor
25135737|NCT02996058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25135738|NCT02996058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135739|NCT02996019|Etrolizumab|etrolizumab|mesh-list
25135740|NCT02996019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25135741|NCT02996019|Immunologic Factors|immunologic factors|mesh-ancestor
25135742|NCT02996019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135743|NCT02995772|Tamoxifen|tamoxifen|mesh-list
25135744|NCT02995772|Fluorouracil|fluorouracil|mesh-list
25135745|NCT02995772|Letrozole|letrozole|mesh-list
25135747|NCT02995772|Exemestane|exemestane|mesh-list
25135748|NCT02995772|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25135749|NCT02995772|Antimetabolites|antimetabolites|mesh-ancestor
25135750|NCT02995772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135751|NCT02995772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25135752|NCT02995772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135753|NCT02995772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25135754|NCT02995772|Immunologic Factors|immunologic factors|mesh-ancestor
25135755|NCT02995772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135756|NCT02995772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25135757|NCT02995772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25135758|NCT02995772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25135759|NCT02995772|Hormone Antagonists|hormone antagonists|mesh-ancestor
25135760|NCT02995772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24578362|NCT00848770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24578660|NCT00850382|Antimetabolites|antimetabolites|mesh-ancestor
24578661|NCT00850382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578662|NCT00850382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578663|NCT00850382|Antiviral Agents|antiviral agents|mesh-ancestor
24578664|NCT00850382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24578665|NCT00850382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24578666|NCT00850382|Immunologic Factors|immunologic factors|mesh-ancestor
24578667|NCT00850382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578668|NCT00850382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24578669|NCT00850382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24578670|NCT00850382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24578671|NCT00850382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24578672|NCT00850382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24578816|NCT00852059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25135761|NCT02995772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25135762|NCT02995772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25135763|NCT02995772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25135764|NCT02995772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25135765|NCT02995824|Raltegravir Potassium|raltegravir potassium|mesh-list
25135766|NCT02995824|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25135767|NCT02995824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25135768|NCT02995824|Antiviral Agents|antiviral agents|mesh-ancestor
25135769|NCT02995824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25135770|NCT02995824|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25135771|NCT02995824|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25135772|NCT02995824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25135773|NCT02995824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135774|NCT02995720|Amlodipine|amlodipine|mesh-list
25135775|NCT02995720|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25135776|NCT02995720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25135777|NCT02995720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25135778|NCT02995720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25135779|NCT02995720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135780|NCT02995720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25135781|NCT02995720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135782|NCT02995720|Vasodilator Agents|vasodilator agents|mesh-ancestor
25135783|NCT02995720|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25135784|NCT02995720|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25135785|NCT02995720|Antimetabolites|antimetabolites|mesh-ancestor
25135786|NCT02995720|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25135787|NCT02995720|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25135788|NCT02995720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683475|NCT02270632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25135790|NCT02995707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25135791|NCT02995707|Immunologic Factors|immunologic factors|mesh-ancestor
25135792|NCT02995707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135793|NCT02995707|Leprostatic Agents|leprostatic agents|mesh-ancestor
24578817|NCT00852163|Busulfan|busulfan|mesh-list
24578818|NCT00852163|Clofarabine|clofarabine|mesh-list
24578819|NCT00852163|Alkylating Agents|alkylating agents|mesh-ancestor
24578820|NCT00852163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578821|NCT00852163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24578829|NCT00852189|Folic Acid|folic acid|mesh-list
25135794|NCT02995707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25135796|NCT02995707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25135797|NCT02995707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25135798|NCT02995707|Growth Substances|growth substances|mesh-ancestor
25135799|NCT02995707|Growth Inhibitors|growth inhibitors|mesh-ancestor
25135800|NCT02995707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135801|NCT02995746|Dexamethasone|dexamethasone|mesh-list
25135802|NCT02995746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25135803|NCT02995746|Antiemetics|antiemetics|mesh-ancestor
25135804|NCT02995746|Autonomic Agents|autonomic agents|mesh-ancestor
25135805|NCT02995746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25135806|NCT02995746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135807|NCT02995746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25135808|NCT02995746|Glucocorticoids|glucocorticoids|mesh-ancestor
25135810|NCT02995746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25135811|NCT02995746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25135812|NCT02995746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135813|NCT02995512|Colchicine|colchicine|mesh-list
25135814|NCT02995512|Gout Suppressants|gout suppressants|mesh-ancestor
25135815|NCT02995512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25135816|NCT02995512|Tubulin Modulators|tubulin modulators|mesh-ancestor
25135817|NCT02995512|Antimitotic Agents|antimitotic agents|mesh-ancestor
25135818|NCT02995512|Mitosis Modulators|mitosis modulators|mesh-ancestor
25135819|NCT02995512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135820|NCT02995512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045947|NCT00890968|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25045948|NCT00890968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25045949|NCT00890968|Glucocorticoids|glucocorticoids|mesh-ancestor
25045950|NCT00890968|Hormones|hormones|mesh-ancestor
25045951|NCT00890968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25045952|NCT00890968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045953|NCT00890968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25045954|NCT00890968|Immunologic Factors|immunologic factors|mesh-ancestor
25045955|NCT00890968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045956|NCT00890968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045957|NCT00890591|Amlodipine|amlodipine|mesh-list
25045958|NCT00890591|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25045959|NCT00890591|Olmesartan|olmesartan|mesh-list
25045960|NCT00890591|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25045961|NCT00890591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25045962|NCT00890591|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25045963|NCT00890591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25045964|NCT00890591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045965|NCT00890591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25045966|NCT00890591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045967|NCT00890591|Vasodilator Agents|vasodilator agents|mesh-ancestor
25045968|NCT00890591|Diuretics|diuretics|mesh-ancestor
25045969|NCT00890591|Natriuretic Agents|natriuretic agents|mesh-ancestor
25084065|NCT03310047|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24579016|NCT00853008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24579017|NCT00853008|Glucocorticoids|glucocorticoids|mesh-ancestor
24579018|NCT00853008|Hormones|hormones|mesh-ancestor
24579050|NCT00853177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579051|NCT00853177|Sensory System Agents|sensory system agents|mesh-ancestor
24579052|NCT00853177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24579053|NCT00853177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24579054|NCT00853177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24579055|NCT00853177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24579421|NCT00855049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24579478|NCT00855283|Cholinergic Agents|cholinergic agents|mesh-ancestor
24579546|NCT00856037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579547|NCT00856037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24579588|NCT00856362|Anesthetics|anesthetics|mesh-ancestor
24579590|NCT00856362|GABA Agents|gaba agents|mesh-ancestor
24579716|NCT00857142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24579751|NCT00857428|Sensory System Agents|sensory system agents|mesh-ancestor
24579752|NCT00857428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24579753|NCT00857428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24579754|NCT00857519|Carboplatin|carboplatin|mesh-list
24579755|NCT00857519|Melphalan|melphalan|mesh-list
24579756|NCT00857519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135827|NCT02995655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135828|NCT02995655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135829|NCT02995655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25135830|NCT02995655|Anticoagulants|anticoagulants|mesh-ancestor
25135831|NCT02995655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25135832|NCT02995655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25135834|NCT02995291|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25135835|NCT02995291|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25135836|NCT02995291|Adrenergic Agents|adrenergic agents|mesh-ancestor
25135837|NCT02995291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25135838|NCT02995291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135839|NCT02995291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135840|NCT02995291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25135841|NCT02995330|Cyclophosphamide|cyclophosphamide|mesh-list
25135842|NCT02995330|Methyltestosterone|methyltestosterone|mesh-list
25135843|NCT02995330|Testosterone|testosterone|mesh-list
25135844|NCT02995330|Testosterone undecanoate|testosterone undecanoate|mesh-list
25135845|NCT02995330|Testosterone enanthate|testosterone enanthate|mesh-list
25135846|NCT02995330|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25135847|NCT02995330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25135848|NCT02995330|Immunologic Factors|immunologic factors|mesh-ancestor
25135849|NCT02995330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135850|NCT02995330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25135851|NCT02995330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25135852|NCT02995330|Alkylating Agents|alkylating agents|mesh-ancestor
25135853|NCT02995330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135855|NCT02995330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25135856|NCT02995330|Androgens|androgens|mesh-ancestor
25135857|NCT02995330|Hormones|hormones|mesh-ancestor
25135858|NCT02995330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25135859|NCT02995330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25135860|NCT02995330|Anabolic Agents|anabolic agents|mesh-ancestor
25135861|NCT02995187|Apatinib|apatinib|mesh-list
25135862|NCT02995187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135863|NCT02995187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25135864|NCT02995187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25135865|NCT02995187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135867|NCT02995057|Trace Elements|trace elements|mesh-ancestor
25135868|NCT02995057|Micronutrients|micronutrients|mesh-ancestor
25135869|NCT02995057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135870|NCT02995304|Midazolam|midazolam|mesh-list
25135871|NCT02995304|Morphine|morphine|mesh-list
25135872|NCT02995304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25135873|NCT02995304|Narcotics|narcotics|mesh-ancestor
25135874|NCT02995304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25135875|NCT02995304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135876|NCT02995304|Analgesics|analgesics|mesh-ancestor
25135877|NCT02995304|Sensory System Agents|sensory system agents|mesh-ancestor
25135885|NCT02995304|Anesthetics, General|anesthetics, general|mesh-ancestor
25135886|NCT02995304|Anesthetics|anesthetics|mesh-ancestor
25135887|NCT02995304|GABA Modulators|gaba modulators|mesh-ancestor
25135888|NCT02995304|GABA Agents|gaba agents|mesh-ancestor
25135889|NCT02995304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25135890|NCT02995304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135926|NCT02995083|Anesthetics, Local|anesthetics, local|mesh-ancestor
25135927|NCT02995083|Anesthetics|anesthetics|mesh-ancestor
25135928|NCT02995083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25135929|NCT02995083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135930|NCT02995083|Sensory System Agents|sensory system agents|mesh-ancestor
25135931|NCT02995083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25135932|NCT02995083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25135933|NCT02995083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25135934|NCT02995083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25135935|NCT02995083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25135936|NCT02995083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135937|NCT02995083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25135938|NCT02995083|Antiemetics|antiemetics|mesh-ancestor
25135939|NCT02995083|Autonomic Agents|autonomic agents|mesh-ancestor
25282068|NCT02327689|Emtricitabine|emtricitabine|mesh-list
25135940|NCT02995083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25135941|NCT02995083|Glucocorticoids|glucocorticoids|mesh-ancestor
25135943|NCT02995083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25135944|NCT02995083|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25135945|NCT02995083|Protective Agents|protective agents|mesh-ancestor
25135946|NCT02995083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25135947|NCT02995083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135948|NCT02994745|Atorvastatin|atorvastatin|mesh-list
25135949|NCT02994745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25135950|NCT02994745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25135974|NCT02994719|Pramipexole|pramipexole|mesh-list
25135976|NCT02994719|Entacapone|entacapone|mesh-list
25135977|NCT02994719|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25135978|NCT02994719|Tolcapone|tolcapone|mesh-list
25135979|NCT02994719|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25135980|NCT02994719|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25135981|NCT02994719|Dopamine Agents|dopamine agents|mesh-ancestor
25135982|NCT02994719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25135983|NCT02994719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135984|NCT02994719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135985|NCT02994719|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25135986|NCT02994719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25135987|NCT02994719|Antioxidants|antioxidants|mesh-ancestor
25135988|NCT02994719|Protective Agents|protective agents|mesh-ancestor
25135989|NCT02994719|Dopamine Agonists|dopamine agonists|mesh-ancestor
25135990|NCT02994719|Antiviral Agents|antiviral agents|mesh-ancestor
25135991|NCT02994719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25135992|NCT02994719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25135993|NCT02994719|Analgesics|analgesics|mesh-ancestor
25135994|NCT02994719|Sensory System Agents|sensory system agents|mesh-ancestor
25135995|NCT02994719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25135996|NCT02994719|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25135997|NCT02994719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25135998|NCT02994719|Immunologic Factors|immunologic factors|mesh-ancestor
25135999|NCT02995005|Tenofovir|tenofovir|mesh-list
25136000|NCT02995005|Antiviral Agents|antiviral agents|mesh-ancestor
25136001|NCT02995005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25136002|NCT02995005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25136003|NCT02995005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25136019|NCT02994602|Hormones|hormones|mesh-ancestor
24450001|NCT00317577|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25136020|NCT02994602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25136021|NCT02994602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136022|NCT02994602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25136023|NCT02994602|Contraceptive Agents|contraceptive agents|mesh-ancestor
25136024|NCT02994602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25136025|NCT02994602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25136026|NCT02994433|Nitrous Oxide|nitrous oxide|mesh-list
25136027|NCT02994433|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25136028|NCT02994433|Anesthetics, General|anesthetics, general|mesh-ancestor
25136029|NCT02994433|Anesthetics|anesthetics|mesh-ancestor
25136030|NCT02994433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25136031|NCT02994433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136032|NCT02994433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25136033|NCT02994433|Analgesics|analgesics|mesh-ancestor
25136034|NCT02994433|Sensory System Agents|sensory system agents|mesh-ancestor
25136035|NCT02994433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25136036|NCT02994485|Simvastatin|simvastatin|mesh-list
25136037|NCT02994485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25136038|NCT02994485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25136039|NCT02994485|Antimetabolites|antimetabolites|mesh-ancestor
25136040|NCT02994485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136041|NCT02994485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25136042|NCT02994485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25136043|NCT02994485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136044|NCT02994173|Ketamine|ketamine|mesh-list
25136045|NCT02994173|Oxycodone|oxycodone|mesh-list
25136046|NCT02994173|Esketamine|esketamine|mesh-list
25136047|NCT02994173|Analgesics|analgesics|mesh-ancestor
25136048|NCT02994173|Sensory System Agents|sensory system agents|mesh-ancestor
25136049|NCT02994173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25136050|NCT02994173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136051|NCT02994173|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25683476|NCT02270632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282112|NCT02327923|Antiemetics|antiemetics|mesh-ancestor
25136052|NCT02994173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25136053|NCT02994173|Anesthetics, General|anesthetics, general|mesh-ancestor
24579757|NCT00857519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25136054|NCT02994173|Anesthetics|anesthetics|mesh-ancestor
25136055|NCT02994173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25136056|NCT02994173|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25136057|NCT02994173|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25136058|NCT02994173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25136059|NCT02994173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136060|NCT02994173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25136061|NCT02994173|Narcotics|narcotics|mesh-ancestor
25136062|NCT02994173|Antidepressive Agents|antidepressive agents|mesh-ancestor
25136063|NCT02994173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25136064|NCT02994082|Bupropion|bupropion|mesh-list
25136065|NCT02994082|Nicotine|nicotine|mesh-list
25136066|NCT02994082|Varenicline|varenicline|mesh-list
25045970|NCT00890591|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25045971|NCT00890591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25045972|NCT00890591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25045973|NCT00890305|Pidilizumab|pidilizumab|mesh-list
25045974|NCT00890305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25045975|NCT00890305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045976|NCT00890149|Ondansetron|ondansetron|mesh-list
25045977|NCT00890149|Antiemetics|antiemetics|mesh-ancestor
25045978|NCT00890149|Autonomic Agents|autonomic agents|mesh-ancestor
25045979|NCT00890149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045980|NCT00890149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045981|NCT00890149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25045982|NCT00890149|Antipruritics|antipruritics|mesh-ancestor
25045983|NCT00890149|Dermatologic Agents|dermatologic agents|mesh-ancestor
25045984|NCT00890149|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25045985|NCT00890149|Serotonin Agents|serotonin agents|mesh-ancestor
25045986|NCT00890149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25045987|NCT00890149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045988|NCT00890149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25045989|NCT00890149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25045990|NCT00890149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25045991|NCT00890149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25045996|NCT00889967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25045997|NCT00889967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25045998|NCT00889967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136169|NCT02993094|Protease Inhibitors|protease inhibitors|mesh-ancestor
25045999|NCT00889967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046000|NCT00889967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25046001|NCT00889967|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25046002|NCT00889967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25046003|NCT00889382|Paclitaxel|paclitaxel|mesh-list
25046004|NCT00889382|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25046005|NCT00889382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25046006|NCT00889382|Tubulin Modulators|tubulin modulators|mesh-ancestor
25046007|NCT00889382|Antimitotic Agents|antimitotic agents|mesh-ancestor
25046008|NCT00889382|Mitosis Modulators|mitosis modulators|mesh-ancestor
25046009|NCT00889382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046010|NCT00888355|Losartan|losartan|mesh-list
25046011|NCT00888355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25084318|NCT03308084|Prednisolone|prednisolone|mesh-list
25136067|NCT02994082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25136068|NCT02994082|Autonomic Agents|autonomic agents|mesh-ancestor
25136069|NCT02994082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25136070|NCT02994082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136101|NCT02993991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136102|NCT02993835|Iron|iron|mesh-list
25136103|NCT02993835|Trace Elements|trace elements|mesh-ancestor
25136104|NCT02993835|Micronutrients|micronutrients|mesh-ancestor
25136105|NCT02993835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136106|NCT02993861|Anticonvulsants|anticonvulsants|mesh-list
25136107|NCT02993718|Dexmedetomidine|dexmedetomidine|mesh-list
25136108|NCT02993718|Propofol|propofol|mesh-list
25136109|NCT02993718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25136110|NCT02993718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25136111|NCT02993718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136112|NCT02993718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25136113|NCT02993718|Anesthetics, General|anesthetics, general|mesh-ancestor
25683477|NCT02270632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25136114|NCT02993718|Anesthetics|anesthetics|mesh-ancestor
25136115|NCT02993718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25136116|NCT02993718|Analgesics|analgesics|mesh-ancestor
25136117|NCT02993718|Sensory System Agents|sensory system agents|mesh-ancestor
25136118|NCT02993718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25136119|NCT02993718|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25136120|NCT02993718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25136121|NCT02993718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25136122|NCT02993718|Adrenergic Agents|adrenergic agents|mesh-ancestor
25136123|NCT02993718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25136124|NCT02993718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136125|NCT02993575|Floxacillin|floxacillin|mesh-list
25136126|NCT02993575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25136127|NCT02993575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25136128|NCT02993640|Vasopressins|vasopressins|mesh-list
25136129|NCT02993640|Arginine Vasopressin|arginine vasopressin|mesh-list
25136130|NCT02993640|Hemostatics|hemostatics|mesh-ancestor
25136131|NCT02993640|Coagulants|coagulants|mesh-ancestor
25136132|NCT02993640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25136133|NCT02993640|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25136134|NCT02993640|Natriuretic Agents|natriuretic agents|mesh-ancestor
25136135|NCT02993640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136150|NCT02993588|Antioxidants|antioxidants|mesh-ancestor
25136151|NCT02993588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136152|NCT02993588|Protective Agents|protective agents|mesh-ancestor
25136153|NCT02993588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136154|NCT02993588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24860048|NCT02307305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860049|NCT02307305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24860050|NCT02307305|Narcotics|narcotics|mesh-ancestor
24860051|NCT02307305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25136155|NCT02993705|Trabectedin|trabectedin|mesh-list
25136156|NCT02993705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25136157|NCT02993705|Alkylating Agents|alkylating agents|mesh-ancestor
25136158|NCT02993705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136159|NCT02993705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136160|NCT02993341|Tranexamic Acid|tranexamic acid|mesh-list
25136161|NCT02993341|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25136162|NCT02993341|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25136163|NCT02993341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136164|NCT02993341|Hemostatics|hemostatics|mesh-ancestor
25136165|NCT02993341|Coagulants|coagulants|mesh-ancestor
25136166|NCT02993094|Carboplatin|carboplatin|mesh-list
25136168|NCT02993094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136173|NCT02993159|Afimoxifene|afimoxifene|mesh-list
25136174|NCT02993159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25136175|NCT02993159|Hormone Antagonists|hormone antagonists|mesh-ancestor
25136176|NCT02993159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25136177|NCT02993159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136178|NCT02993159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25136179|NCT02993159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136180|NCT02993159|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25136181|NCT02993159|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25136183|NCT02993029|Celecoxib|celecoxib|mesh-list
25136189|NCT02993029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136190|NCT02993029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25136191|NCT02993029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25136192|NCT02993029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25136193|NCT02993029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25136194|NCT02993029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136195|NCT02993029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136196|NCT02993133|Mycophenolic Acid|mycophenolic acid|mesh-list
25136197|NCT02993133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25136198|NCT02993133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136199|NCT02993133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25136200|NCT02993133|Antitubercular Agents|antitubercular agents|mesh-ancestor
25136201|NCT02993133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25136202|NCT02993133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25136203|NCT02993133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136204|NCT02993133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136205|NCT02992808|Menotropins|menotropins|mesh-list
25136206|NCT02992808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25136207|NCT02992808|Fertility Agents|fertility agents|mesh-ancestor
25136208|NCT02992808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25136209|NCT02992808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136213|NCT02992938|Acetazolamide|acetazolamide|mesh-list
25136214|NCT02992938|Anticonvulsants|anticonvulsants|mesh-ancestor
25136215|NCT02992938|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25136216|NCT02992938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136217|NCT02992938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136218|NCT02992938|Diuretics|diuretics|mesh-ancestor
24579758|NCT00857519|Alkylating Agents|alkylating agents|mesh-ancestor
24579759|NCT00857519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579760|NCT00857519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24579761|NCT00857519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24579762|NCT00857519|Immunologic Factors|immunologic factors|mesh-ancestor
24579763|NCT00857519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579764|NCT00857558|Saxagliptin|saxagliptin|mesh-list
24579765|NCT00857558|Incretins|incretins|mesh-ancestor
24579766|NCT00857558|Hormones|hormones|mesh-ancestor
24579767|NCT00857558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24579768|NCT00857558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136219|NCT02992938|Natriuretic Agents|natriuretic agents|mesh-ancestor
25136220|NCT02992938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136221|NCT02992886|Raltitrexed|raltitrexed|mesh-list
25136222|NCT02992886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25136223|NCT02992886|Antimetabolites|antimetabolites|mesh-ancestor
25136224|NCT02992886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136225|NCT02992886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136226|NCT02992886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25136227|NCT02992886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136228|NCT02992925|Vaccines|vaccines|mesh-list
25136229|NCT02992925|Immunologic Factors|immunologic factors|mesh-ancestor
25136230|NCT02992925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136231|NCT02992678|Pentoxifylline|pentoxifylline|mesh-list
25136232|NCT02992678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25136233|NCT02992678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136234|NCT02992678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136235|NCT02992678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25136236|NCT02992678|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25136237|NCT02992678|Protective Agents|protective agents|mesh-ancestor
25136238|NCT02992678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136239|NCT02992678|Vasodilator Agents|vasodilator agents|mesh-ancestor
25136240|NCT02992678|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25136241|NCT02992678|Antioxidants|antioxidants|mesh-ancestor
25136242|NCT02992912|Atezolizumab|atezolizumab|mesh-list
25136243|NCT02992912|Antibodies|antibodies|mesh-list
25136244|NCT02992912|Immunologic Factors|immunologic factors|mesh-ancestor
25136245|NCT02992912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136246|NCT02992912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136247|NCT02992704|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25136248|NCT02992704|Antiviral Agents|antiviral agents|mesh-ancestor
25136249|NCT02992704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25136250|NCT02992496|Midazolam|midazolam|mesh-list
25136251|NCT02992496|Ketamine|ketamine|mesh-list
25136252|NCT02992496|Analgesics|analgesics|mesh-ancestor
25136253|NCT02992496|Sensory System Agents|sensory system agents|mesh-ancestor
25136254|NCT02992496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25136255|NCT02992496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136256|NCT02992496|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25136257|NCT02992496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25136258|NCT02992496|Anesthetics, General|anesthetics, general|mesh-ancestor
25136259|NCT02992496|Anesthetics|anesthetics|mesh-ancestor
25136260|NCT02992496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25136261|NCT02992496|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25136262|NCT02992496|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25046012|NCT00888355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25046013|NCT00888355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25046014|NCT00888355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25046015|NCT00888355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046016|NCT00887250|Losartan|losartan|mesh-list
25046017|NCT00887250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25046018|NCT00887250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25046019|NCT00887250|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25046020|NCT00887250|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25046021|NCT00887250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046022|NCT00886600|Losartan|losartan|mesh-list
25046023|NCT00886600|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25046024|NCT00886600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25046025|NCT00886600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25136263|NCT02992496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25136264|NCT02992496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136265|NCT02992496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25136266|NCT02992496|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25136267|NCT02992496|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25136268|NCT02992496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25136269|NCT02992496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25136270|NCT02992496|GABA Modulators|gaba modulators|mesh-ancestor
25136271|NCT02992496|GABA Agents|gaba agents|mesh-ancestor
25136272|NCT02992665|Ionophores|ionophores|mesh-list
25136273|NCT02992665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25136274|NCT02992665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136275|NCT02992548|Pravastatin|pravastatin|mesh-list
24579769|NCT00857558|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24579770|NCT00857558|Protease Inhibitors|protease inhibitors|mesh-ancestor
24579771|NCT00857558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579772|NCT00857558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579773|NCT00857558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25136276|NCT02992548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25136277|NCT02992548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25136278|NCT02992548|Antimetabolites|antimetabolites|mesh-ancestor
24428982|NCT00242190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25136279|NCT02992548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136280|NCT02992548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25136281|NCT02992548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25136282|NCT02992548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136284|NCT02992652|Antimetabolites|antimetabolites|mesh-ancestor
25136285|NCT02992652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136286|NCT02992652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136287|NCT02992652|Gout Suppressants|gout suppressants|mesh-ancestor
25136288|NCT02992652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25136289|NCT02992652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25136290|NCT02992652|Antioxidants|antioxidants|mesh-ancestor
25136291|NCT02992652|Protective Agents|protective agents|mesh-ancestor
25136292|NCT02992652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136293|NCT02992457|Interferons|interferons|mesh-list
25136294|NCT02992457|Ribavirin|ribavirin|mesh-list
25136295|NCT02992457|Interferon-alpha|interferon-alpha|mesh-list
25136296|NCT02992457|Interferon alpha-2|interferon alpha-2|mesh-list
25136297|NCT02992457|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25136298|NCT02992457|Sofosbuvir|sofosbuvir|mesh-list
25136299|NCT02992457|Ledipasvir|ledipasvir|mesh-list
25136328|NCT02992028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136329|NCT02991950|Parnaparin|parnaparin|mesh-list
25136330|NCT02991950|Anticoagulants|anticoagulants|mesh-ancestor
25136331|NCT02991950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25136332|NCT02991950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25136333|NCT02991950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136334|NCT02991781|Varenicline|varenicline|mesh-list
25136335|NCT02991781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25136336|NCT02991781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25136337|NCT02991781|Cholinergic Agents|cholinergic agents|mesh-ancestor
25136338|NCT02991781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25136339|NCT02991781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136340|NCT02991781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136341|NCT02991768|Budesonide|budesonide|mesh-list
25084555|NCT03305978|Ivermectin|ivermectin|mesh-list
25136355|NCT02991612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25136357|NCT02991339|Dexamethasone acetate|dexamethasone acetate|mesh-list
25136358|NCT02991339|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25136359|NCT02991339|BB 1101|bb 1101|mesh-list
25136360|NCT02991339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25136361|NCT02991339|Antiemetics|antiemetics|mesh-ancestor
25136362|NCT02991339|Autonomic Agents|autonomic agents|mesh-ancestor
25136363|NCT02991339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25136364|NCT02991339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136365|NCT02991339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25136366|NCT02991339|Glucocorticoids|glucocorticoids|mesh-ancestor
25136367|NCT02991339|Hormones|hormones|mesh-ancestor
25136368|NCT02991339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25136369|NCT02991339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25136370|NCT02991339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136371|NCT02991339|Protease Inhibitors|protease inhibitors|mesh-ancestor
25136372|NCT02991339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136554|NCT02990507|Testosterone|testosterone|mesh-list
25136373|NCT02991339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136374|NCT02991209|Testosterone|testosterone|mesh-list
25136375|NCT02991209|Androgens|androgens|mesh-ancestor
25136376|NCT02991209|Hormones|hormones|mesh-ancestor
25136378|NCT02991209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046026|NCT00886600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25046027|NCT00886600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25046028|NCT00886600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046030|NCT00886600|Natriuretic Agents|natriuretic agents|mesh-ancestor
25046031|NCT00886600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046032|NCT00886600|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25046033|NCT00886600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25046034|NCT00884715|Octreotide|octreotide|mesh-list
25046035|NCT00884715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25046036|NCT00884715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25046037|NCT00884715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25046038|NCT00884234|Botulinum Toxins|botulinum toxins|mesh-list
25046039|NCT00884234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25046040|NCT00884234|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25046041|NCT00884234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25046042|NCT00884234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25046043|NCT00884234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046044|NCT00884234|Cholinergic Agents|cholinergic agents|mesh-ancestor
25046045|NCT00884234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25046046|NCT00884234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046047|NCT00884234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25084636|NCT03304457|Serotonin Agents|serotonin agents|mesh-ancestor
25136380|NCT02991196|DS-8273a|ds-8273a|mesh-list
25136381|NCT02991196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25136382|NCT02991196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136383|NCT02991196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25136384|NCT02991196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136399|NCT02991157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136400|NCT02991157|Vasodilator Agents|vasodilator agents|mesh-ancestor
25136402|NCT02990975|Analgesics|analgesics|mesh-ancestor
25136403|NCT02990975|Sensory System Agents|sensory system agents|mesh-ancestor
25136404|NCT02990975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25136405|NCT02990975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136406|NCT02990975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25136407|NCT02990975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25136408|NCT02990975|Anesthetics, General|anesthetics, general|mesh-ancestor
25136410|NCT02990975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25136411|NCT02990975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25136412|NCT02990975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25136413|NCT02990975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25136414|NCT02990975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136415|NCT02991053|Ketamine|ketamine|mesh-list
25136416|NCT02991053|Analgesics|analgesics|mesh-ancestor
25136417|NCT02991053|Sensory System Agents|sensory system agents|mesh-ancestor
25136418|NCT02991053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25136419|NCT02991053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136420|NCT02991053|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25136421|NCT02991053|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25136422|NCT02991053|Anesthetics, General|anesthetics, general|mesh-ancestor
25136423|NCT02991053|Anesthetics|anesthetics|mesh-ancestor
25136424|NCT02991053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25136425|NCT02991053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25136446|NCT02990962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25136447|NCT02990962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25136448|NCT02990962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25136449|NCT02990702|Bupivacaine|bupivacaine|mesh-list
25136450|NCT02990702|Anesthetics, Local|anesthetics, local|mesh-ancestor
25136451|NCT02990702|Anesthetics|anesthetics|mesh-ancestor
25136452|NCT02990702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25136453|NCT02990702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136454|NCT02990702|Sensory System Agents|sensory system agents|mesh-ancestor
25136455|NCT02990702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25136456|NCT02990845|Pembrolizumab|pembrolizumab|mesh-list
25136457|NCT02990845|Leuprolide|leuprolide|mesh-list
25136458|NCT02990845|Exemestane|exemestane|mesh-list
25136459|NCT02990845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25136460|NCT02990845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136752|NCT02989311|Iron|iron|mesh-list
25136461|NCT02990845|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25136462|NCT02990845|Fertility Agents|fertility agents|mesh-ancestor
25136463|NCT02990845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25136464|NCT02990845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136465|NCT02990845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25136466|NCT02990845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25136467|NCT02990845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25136468|NCT02990845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136469|NCT02990845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136470|NCT02990845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25136471|NCT02990845|Hormone Antagonists|hormone antagonists|mesh-ancestor
25136472|NCT02990845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25136473|NCT02990884|Ketamine|ketamine|mesh-list
25136474|NCT02990884|Analgesics|analgesics|mesh-ancestor
25136480|NCT02990884|Anesthetics, General|anesthetics, general|mesh-ancestor
25136486|NCT02990884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136487|NCT02990858|Leronlimab|leronlimab|mesh-list
25136488|NCT02990858|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25136489|NCT02990858|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25136490|NCT02990858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136491|NCT02990858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25136492|NCT02990858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25136493|NCT02990858|Antiviral Agents|antiviral agents|mesh-ancestor
25136494|NCT02990858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25136495|NCT02990403|Aspirin|aspirin|mesh-list
25136496|NCT02990403|Prednisone|prednisone|mesh-list
25136497|NCT02990403|Heparin|heparin|mesh-list
25136498|NCT02990403|Dydrogesterone|dydrogesterone|mesh-list
25136499|NCT02990403|Immunoglobulins|immunoglobulins|mesh-list
25136500|NCT02990403|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25136501|NCT02990403|Antibodies|antibodies|mesh-list
25136502|NCT02990403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25136503|NCT02990403|Glucocorticoids|glucocorticoids|mesh-ancestor
25136504|NCT02990403|Hormones|hormones|mesh-ancestor
25136505|NCT02990403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25136506|NCT02990403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136507|NCT02990403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25136508|NCT02990403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136509|NCT02990403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25136510|NCT02990403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25136511|NCT02990403|Analgesics|analgesics|mesh-ancestor
25136512|NCT02990403|Sensory System Agents|sensory system agents|mesh-ancestor
25136513|NCT02990403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25136514|NCT02990403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25136515|NCT02990403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25136516|NCT02990403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25136517|NCT02990403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136518|NCT02990403|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25136528|NCT02990455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25136529|NCT02990455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136530|NCT02990455|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25136531|NCT02990455|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25136532|NCT02990455|Cholinergic Agents|cholinergic agents|mesh-ancestor
25136533|NCT02990455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25136534|NCT02990455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136536|NCT02990364|Anesthetics, Local|anesthetics, local|mesh-list
25136537|NCT02990364|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25136538|NCT02990364|Anesthetics|anesthetics|mesh-list
25136539|NCT02990364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25136540|NCT02990364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136541|NCT02990364|Sensory System Agents|sensory system agents|mesh-ancestor
25136542|NCT02990364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25136543|NCT02990364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25136544|NCT02990364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25136545|NCT02990364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25136546|NCT02990364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25136547|NCT02990364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136548|NCT02990364|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25136549|NCT02990416|Pembrolizumab|pembrolizumab|mesh-list
25136550|NCT02990416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25136551|NCT02990416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136553|NCT02990507|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25136555|NCT02990507|Testosterone undecanoate|testosterone undecanoate|mesh-list
25136556|NCT02990507|Testosterone enanthate|testosterone enanthate|mesh-list
25136557|NCT02990507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25136558|NCT02990507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136559|NCT02990507|Anabolic Agents|anabolic agents|mesh-ancestor
25136570|NCT02990546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136571|NCT02990546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25046048|NCT00884234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25046049|NCT00883896|Fezakinumab|fezakinumab|mesh-list
25046050|NCT00883896|Dermatologic Agents|dermatologic agents|mesh-ancestor
25046051|NCT00882440|Losartan|losartan|mesh-list
25046052|NCT00882440|Enalapril|enalapril|mesh-list
25046053|NCT00882440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25046054|NCT00882440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25046055|NCT00882440|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25046056|NCT00882440|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25046057|NCT00882440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046058|NCT00882440|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25046059|NCT00882440|Protease Inhibitors|protease inhibitors|mesh-ancestor
25046060|NCT00882440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046061|NCT00881452|Citric Acid|citric acid|mesh-list
25046062|NCT00881452|Anticoagulants|anticoagulants|mesh-ancestor
25046063|NCT00881452|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25046064|NCT00881452|Chelating Agents|chelating agents|mesh-ancestor
25046065|NCT00881452|Sequestering Agents|sequestering agents|mesh-ancestor
25046066|NCT00881452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046067|NCT00880490|Formoterol Fumarate|formoterol fumarate|mesh-list
25046068|NCT00880490|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25046069|NCT00880490|Autonomic Agents|autonomic agents|mesh-ancestor
25046070|NCT00880490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25046071|NCT00880490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046072|NCT00880490|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25046073|NCT00880490|Respiratory System Agents|respiratory system agents|mesh-ancestor
25046074|NCT00880490|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25136586|NCT02990286|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25136601|NCT02990312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136602|NCT02990312|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25136603|NCT02990312|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25136604|NCT02990312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136605|NCT02990312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25136606|NCT02990312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25136607|NCT02990312|Antiviral Agents|antiviral agents|mesh-ancestor
25136608|NCT02990312|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25136609|NCT02990078|Sildenafil Citrate|sildenafil citrate|mesh-list
25136610|NCT02990078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136611|NCT02990078|Vasodilator Agents|vasodilator agents|mesh-ancestor
25136612|NCT02990078|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25136613|NCT02990078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25136614|NCT02990078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136615|NCT02990078|Urological Agents|urological agents|mesh-ancestor
25136616|NCT02989870|Sorafenib|sorafenib|mesh-list
25136617|NCT02989870|Bavituximab|bavituximab|mesh-list
25136618|NCT02989870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136639|NCT02990013|Chlorhexidine|chlorhexidine|mesh-list
25136640|NCT02990013|Povidone-Iodine|povidone-iodine|mesh-list
25136641|NCT02990013|Povidone|povidone|mesh-list
25136642|NCT02990013|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25136643|NCT02990013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24760108|NCT01756430|Antioxidants|antioxidants|mesh-ancestor
25136664|NCT02989519|Progesterone|progesterone|mesh-list
25136665|NCT02989519|Dydrogesterone|dydrogesterone|mesh-list
25136666|NCT02989519|Progestins|progestins|mesh-ancestor
25136667|NCT02989519|Hormones|hormones|mesh-ancestor
25136668|NCT02989519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25136669|NCT02989519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136670|NCT02989623|Copper|copper|mesh-list
25136671|NCT02989623|Trace Elements|trace elements|mesh-ancestor
25136684|NCT02989558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25136685|NCT02989558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25136686|NCT02989558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25136687|NCT02989558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136688|NCT02989558|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25136689|NCT02989558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25136690|NCT02989558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136691|NCT02989558|Antipyretics|antipyretics|mesh-ancestor
25136692|NCT02989558|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25136693|NCT02989558|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25136694|NCT02989558|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25136695|NCT02989558|Purinergic Agents|purinergic agents|mesh-ancestor
25136696|NCT02989558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25136697|NCT02989467|Aprepitant|aprepitant|mesh-list
25136698|NCT02989467|Antiemetics|antiemetics|mesh-ancestor
25136699|NCT02989467|Autonomic Agents|autonomic agents|mesh-ancestor
25136700|NCT02989467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25136701|NCT02989467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136702|NCT02989467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25136703|NCT02989467|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25136704|NCT02989467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25136705|NCT02989467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136706|NCT02989324|Misoprostol|misoprostol|mesh-list
25136707|NCT02989324|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25136708|NCT02989324|Abortifacient Agents|abortifacient agents|mesh-ancestor
25136709|NCT02989324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25136710|NCT02989324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136711|NCT02989324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25136712|NCT02989324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25136713|NCT02989324|Oxytocics|oxytocics|mesh-ancestor
24579801|NCT00857831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24579803|NCT00857870|Insulin Glargine|insulin glargine|mesh-list
24579804|NCT00857870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24579807|NCT00857909|Spironolactone|spironolactone|mesh-list
24579874|NCT00858429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579875|NCT00858429|Appetite Stimulants|appetite stimulants|mesh-ancestor
24579876|NCT00858429|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24579878|NCT00858455|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24579879|NCT00858455|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24579880|NCT00858455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579881|NCT00858455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579882|NCT00858455|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25136714|NCT02989259|Apatinib|apatinib|mesh-list
25136715|NCT02989259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136716|NCT02989259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25136717|NCT02989259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136718|NCT02989259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136719|NCT02989272|Magnesium Sulfate|magnesium sulfate|mesh-list
25136720|NCT02989272|Analgesics|analgesics|mesh-ancestor
25136721|NCT02989272|Sensory System Agents|sensory system agents|mesh-ancestor
25136722|NCT02989272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25136723|NCT02989272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136724|NCT02989272|Anesthetics|anesthetics|mesh-ancestor
25136725|NCT02989272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25136726|NCT02989272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25136727|NCT02989272|Anticonvulsants|anticonvulsants|mesh-ancestor
25136728|NCT02989272|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25136729|NCT02989272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25136730|NCT02989272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136731|NCT02989272|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25136732|NCT02989272|Tocolytic Agents|tocolytic agents|mesh-ancestor
25136733|NCT02989272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25136734|NCT02989038|Nicotine|nicotine|mesh-list
25136735|NCT02989038|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25136736|NCT02989038|Autonomic Agents|autonomic agents|mesh-ancestor
25136737|NCT02989038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25136738|NCT02989038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136739|NCT02989038|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25136740|NCT02989038|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25136741|NCT02989038|Cholinergic Agents|cholinergic agents|mesh-ancestor
25136742|NCT02989038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25136743|NCT02989038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136744|NCT02989207|Mitomycins|mitomycins|mesh-list
25136745|NCT02989207|Mitomycin|mitomycin|mesh-list
25136746|NCT02989207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25136747|NCT02989207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136748|NCT02989207|Alkylating Agents|alkylating agents|mesh-ancestor
25078992|NCT03351517|Narcotics|narcotics|mesh-ancestor
25683478|NCT02270632|Antimetabolites|antimetabolites|mesh-ancestor
24444124|NCT00296751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25136749|NCT02989207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136750|NCT02989207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25136751|NCT02989207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136753|NCT02989311|Trace Elements|trace elements|mesh-ancestor
25136754|NCT02989311|Micronutrients|micronutrients|mesh-ancestor
25136755|NCT02989311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136756|NCT02989129|Quercetin|quercetin|mesh-list
25136763|NCT02989012|Oseltamivir|oseltamivir|mesh-list
25136764|NCT02989012|Antiviral Agents|antiviral agents|mesh-ancestor
25136765|NCT02989012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25136766|NCT02989012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136767|NCT02989012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136768|NCT02988869|Formoterol Fumarate|formoterol fumarate|mesh-list
25136769|NCT02988869|Tiotropium Bromide|tiotropium bromide|mesh-list
25136770|NCT02988869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25136771|NCT02988869|Autonomic Agents|autonomic agents|mesh-ancestor
25136785|NCT02988921|Paclitaxel|paclitaxel|mesh-list
25136802|NCT02988700|Anesthetics|anesthetics|mesh-ancestor
25136803|NCT02988700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25136804|NCT02988700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136805|NCT02988700|Sensory System Agents|sensory system agents|mesh-ancestor
25136806|NCT02988700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25136807|NCT02988362|Amlodipine|amlodipine|mesh-list
25136808|NCT02988362|Candesartan|candesartan|mesh-list
25136809|NCT02988362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25136810|NCT02988362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25136811|NCT02988362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25136812|NCT02988362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136813|NCT02988362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25136814|NCT02988362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136815|NCT02988362|Vasodilator Agents|vasodilator agents|mesh-ancestor
25136816|NCT02988362|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25136817|NCT02988362|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25136818|NCT02988024|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25136819|NCT02988024|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25136820|NCT02988024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25136821|NCT02988024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25136822|NCT02988024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136823|NCT02988024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25136824|NCT02988024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136825|NCT02988024|Antidepressive Agents|antidepressive agents|mesh-ancestor
25136826|NCT02988024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25136841|NCT02988440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136842|NCT02988440|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25136844|NCT02988089|Amoxicillin|amoxicillin|mesh-list
25136845|NCT02988089|Metronidazole|metronidazole|mesh-list
25136846|NCT02988089|Clarithromycin|clarithromycin|mesh-list
25136847|NCT02988089|Levofloxacin|levofloxacin|mesh-list
25136848|NCT02988089|Ofloxacin|ofloxacin|mesh-list
25136849|NCT02988089|Tetracycline|tetracycline|mesh-list
25136850|NCT02988089|Tinidazole|tinidazole|mesh-list
25136851|NCT02988089|Furazolidone|furazolidone|mesh-list
25085099|NCT03301207|Midazolam|midazolam|mesh-list
25136852|NCT02988089|Bismuth|bismuth|mesh-list
25136853|NCT02988089|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25136854|NCT02988089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25136856|NCT02988089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25136857|NCT02988089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25136858|NCT02988089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25136859|NCT02988089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136860|NCT02988089|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25136861|NCT02988089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25136862|NCT02988089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25136863|NCT02988089|Renal Agents|renal agents|mesh-ancestor
25136864|NCT02988089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25136865|NCT02988089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25136866|NCT02988089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136867|NCT02988089|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25136868|NCT02988089|Antacids|antacids|mesh-ancestor
25136869|NCT02988089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25136870|NCT02988089|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24579923|NCT00858715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579924|NCT00858715|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25282412|NCT02325986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282413|NCT02326038|Methylphenidate|methylphenidate|mesh-list
25282414|NCT02326038|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25282415|NCT02326038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282416|NCT02326038|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25282417|NCT02326038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25282418|NCT02326038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25282419|NCT02326038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282420|NCT02326038|Dopamine Agents|dopamine agents|mesh-ancestor
25129724|NCT03038516|Cholecalciferol|cholecalciferol|mesh-list
25129725|NCT03038516|Vitamin D|vitamin d|mesh-list
25129726|NCT03038516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24579925|NCT00858715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25136871|NCT02988089|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25136872|NCT02988089|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25136873|NCT02988089|Alkylating Agents|alkylating agents|mesh-ancestor
25136875|NCT02988063|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25136876|NCT02988063|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25136877|NCT02987985|Acetaminophen|acetaminophen|mesh-list
25136878|NCT02987985|Dexamethasone|dexamethasone|mesh-list
25136879|NCT02987985|Lidocaine|lidocaine|mesh-list
25136880|NCT02987985|Fentanyl|fentanyl|mesh-list
25136881|NCT02987985|Dexmedetomidine|dexmedetomidine|mesh-list
25136882|NCT02987985|Ketamine|ketamine|mesh-list
25136883|NCT02987985|Gabapentin|gabapentin|mesh-list
25136884|NCT02987985|Analgesics, Opioid|analgesics, opioid|mesh-list
25136885|NCT02987985|Ondansetron|ondansetron|mesh-list
25136886|NCT02987985|Sevoflurane|sevoflurane|mesh-list
25136887|NCT02987985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25136888|NCT02987985|Antiemetics|antiemetics|mesh-ancestor
25136889|NCT02987985|Autonomic Agents|autonomic agents|mesh-ancestor
25136890|NCT02987985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25136891|NCT02987985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136892|NCT02987985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25136893|NCT02987985|Glucocorticoids|glucocorticoids|mesh-ancestor
25136894|NCT02987985|Hormones|hormones|mesh-ancestor
25136895|NCT02987985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25136896|NCT02987985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25136897|NCT02987985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136921|NCT02987985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25136922|NCT02987985|Antipyretics|antipyretics|mesh-ancestor
25136923|NCT02987985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25046075|NCT00880490|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25046076|NCT00880490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25046077|NCT00880490|Adrenergic Agents|adrenergic agents|mesh-ancestor
25046078|NCT00880490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25046079|NCT00880490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25136924|NCT02987985|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25136925|NCT02987985|Anticonvulsants|anticonvulsants|mesh-ancestor
25136926|NCT02987985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25136927|NCT02987985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25136928|NCT02987985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25136929|NCT02987985|Antimanic Agents|antimanic agents|mesh-ancestor
25136930|NCT02987985|Antipruritics|antipruritics|mesh-ancestor
25136931|NCT02987985|Dermatologic Agents|dermatologic agents|mesh-ancestor
25683479|NCT02270632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683480|NCT02270632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683481|NCT02270632|Dermatologic Agents|dermatologic agents|mesh-ancestor
25683482|NCT02270632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683483|NCT02270632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25683484|NCT02270632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25683485|NCT02270632|Immunologic Factors|immunologic factors|mesh-ancestor
25683486|NCT02270632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25683487|NCT02270632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25683488|NCT02261883|Treprostinil|treprostinil|mesh-list
25683489|NCT02261883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25683490|NCT02076646|Interleukin-2|interleukin-2|mesh-list
25683491|NCT02076646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136978|NCT02987907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25136980|NCT02987907|Hormones|hormones|mesh-ancestor
25683492|NCT02076646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25683493|NCT02076646|Analgesics|analgesics|mesh-ancestor
25136981|NCT02987907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25136982|NCT02987907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25136983|NCT02987907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136985|NCT02987751|Insulin Glargine|insulin glargine|mesh-list
25136986|NCT02987751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25136987|NCT02987751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136988|NCT02987699|Leucovorin|leucovorin|mesh-list
25136989|NCT02987699|Oxaliplatin|oxaliplatin|mesh-list
25136990|NCT02987699|Fluorouracil|fluorouracil|mesh-list
25136991|NCT02987699|Levoleucovorin|levoleucovorin|mesh-list
25136992|NCT02987699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25136993|NCT02987699|Antidotes|antidotes|mesh-ancestor
25136994|NCT02987699|Protective Agents|protective agents|mesh-ancestor
25136995|NCT02987699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136996|NCT02987699|Vitamin B Complex|vitamin b complex|mesh-ancestor
25085235|NCT03300440|Biotin|biotin|mesh-list
25136997|NCT02987699|Vitamins|vitamins|mesh-ancestor
25136998|NCT02987699|Micronutrients|micronutrients|mesh-ancestor
25136999|NCT02987699|Antimetabolites|antimetabolites|mesh-ancestor
25137000|NCT02987699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137001|NCT02987699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25137009|NCT02987556|Insulin|insulin|mesh-list
25137010|NCT02987556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25137011|NCT02987556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137012|NCT02987465|Norepinephrine|norepinephrine|mesh-list
25137013|NCT02987465|Acetylcholine|acetylcholine|mesh-list
25137014|NCT02987465|Darbepoetin alfa|darbepoetin alfa|mesh-list
25137029|NCT02987400|Venetoclax|venetoclax|mesh-list
25137033|NCT02987218|Propofol|propofol|mesh-list
25137034|NCT02987218|Desflurane|desflurane|mesh-list
25137035|NCT02987218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25137036|NCT02987218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25137037|NCT02987218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137038|NCT02987218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25137039|NCT02987218|Anesthetics, General|anesthetics, general|mesh-ancestor
25137040|NCT02987218|Anesthetics|anesthetics|mesh-ancestor
25137041|NCT02987218|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25137042|NCT02987270|Piperaquine|piperaquine|mesh-list
25137043|NCT02987270|Artenimol|artenimol|mesh-list
25137044|NCT02987270|Antimalarials|antimalarials|mesh-ancestor
25137045|NCT02987270|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25137046|NCT02987270|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25137047|NCT02987270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25137048|NCT02987244|Prednisone|prednisone|mesh-list
25137049|NCT02987244|Cyclophosphamide|cyclophosphamide|mesh-list
25137050|NCT02987244|Etoposide|etoposide|mesh-list
25137051|NCT02987244|Epirubicin|epirubicin|mesh-list
25137052|NCT02987244|Vindesine|vindesine|mesh-list
25137053|NCT02987244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25137054|NCT02987244|Immunologic Factors|immunologic factors|mesh-ancestor
25137055|NCT02987244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137056|NCT02987244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25137057|NCT02987244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25137058|NCT02987244|Alkylating Agents|alkylating agents|mesh-ancestor
25137059|NCT02987244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137060|NCT02987244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25137061|NCT02987244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25137082|NCT02987348|Glucagon|glucagon|mesh-list
25137083|NCT02987348|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25137084|NCT02987348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25137085|NCT02987348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137086|NCT02987348|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25137087|NCT02987348|Incretins|incretins|mesh-ancestor
25137088|NCT02987348|Hormones|hormones|mesh-ancestor
25137089|NCT02987348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25137090|NCT02987348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25137091|NCT02986685|Rabeprazole|rabeprazole|mesh-list
25137092|NCT02986685|Trimebutine|trimebutine|mesh-list
25137093|NCT02986685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25137094|NCT02986685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137095|NCT02986685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25137096|NCT02986685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25137097|NCT02986685|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25137098|NCT02986685|Parasympatholytics|parasympatholytics|mesh-ancestor
25137099|NCT02986685|Autonomic Agents|autonomic agents|mesh-ancestor
25137100|NCT02986685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25137101|NCT02986685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137102|NCT02986750|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25137103|NCT02986750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25137104|NCT02986880|Botulinum Toxins|botulinum toxins|mesh-list
25282475|NCT05076695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137105|NCT02986880|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25137106|NCT02986880|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25137107|NCT02986880|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25137108|NCT02986880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25137109|NCT02986880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137110|NCT02986880|Cholinergic Agents|cholinergic agents|mesh-ancestor
25137111|NCT02986880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25137112|NCT02986880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137113|NCT02986880|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25137114|NCT02986880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25137115|NCT02986906|Triamcinolone|triamcinolone|mesh-list
25137116|NCT02986906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25137121|NCT02986347|Epinephrine|epinephrine|mesh-list
25137122|NCT02986347|Racepinephrine|racepinephrine|mesh-list
25137123|NCT02986347|Anesthetics|anesthetics|mesh-list
25137124|NCT02986347|Epinephryl borate|epinephryl borate|mesh-list
25137125|NCT02986347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25137126|NCT02986347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137127|NCT02986347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25137128|NCT02986347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25137129|NCT02986347|Adrenergic Agents|adrenergic agents|mesh-ancestor
25137130|NCT02986347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25137131|NCT02986347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860313|NCT02309177|Antimetabolites|antimetabolites|mesh-ancestor
25137133|NCT02986347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25137134|NCT02986347|Autonomic Agents|autonomic agents|mesh-ancestor
25137135|NCT02986347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25137136|NCT02986347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25137137|NCT02986347|Respiratory System Agents|respiratory system agents|mesh-ancestor
25137138|NCT02986347|Mydriatics|mydriatics|mesh-ancestor
25137139|NCT02986347|Sympathomimetics|sympathomimetics|mesh-ancestor
25137140|NCT02986347|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24580514|NCT00862095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580515|NCT00862095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580516|NCT00862095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24580517|NCT00862095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24580518|NCT00862095|Vasodilator Agents|vasodilator agents|mesh-ancestor
24632633|NCT01124877|Ziprasidone|ziprasidone|mesh-list
24580519|NCT00862095|Anticonvulsants|anticonvulsants|mesh-ancestor
24580520|NCT00862095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24580621|NCT00862628|Antioxidants|antioxidants|mesh-ancestor
24580622|NCT00862628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580623|NCT00862628|Protective Agents|protective agents|mesh-ancestor
24580624|NCT00862628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580625|NCT00862628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580627|NCT00862693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24580628|NCT00862693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580629|NCT00862693|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24580633|NCT00862693|Vitamins|vitamins|mesh-ancestor
24580675|NCT00863161|Lesogaberan|lesogaberan|mesh-list
24580676|NCT00863161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24580677|NCT00863161|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24580679|NCT00863161|GABA Agents|gaba agents|mesh-ancestor
24580680|NCT00863161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24580683|NCT00863187|Rituximab|rituximab|mesh-list
25137153|NCT02986503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25137155|NCT02986503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25137156|NCT02986503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137157|NCT02986503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25137158|NCT02986503|Antimetabolites|antimetabolites|mesh-ancestor
25137159|NCT02986503|Dermatologic Agents|dermatologic agents|mesh-ancestor
25137160|NCT02986503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25137161|NCT02986503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24580783|NCT00863668|Emtricitabine|emtricitabine|mesh-list
24580841|NCT00863889|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24580842|NCT00863889|Prednisolone phosphate|prednisolone phosphate|mesh-list
24580843|NCT00863889|Anesthetics, Local|anesthetics, local|mesh-ancestor
25683494|NCT02076646|Sensory System Agents|sensory system agents|mesh-ancestor
25683495|NCT02076646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25683496|NCT02076646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683497|NCT02007122|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
25683498|NCT02007122|Cephalosporins|cephalosporins|mesh-list
24707487|NCT01496105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24580844|NCT00863889|Anesthetics|anesthetics|mesh-ancestor
24580845|NCT00863889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24580846|NCT00863889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580847|NCT00863889|Sensory System Agents|sensory system agents|mesh-ancestor
24580848|NCT00863889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24580849|NCT00863889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24580851|NCT00863889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24580940|NCT00864058|Analgesics|analgesics|mesh-ancestor
24580941|NCT00864058|Sensory System Agents|sensory system agents|mesh-ancestor
24580942|NCT00864058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24580943|NCT00864058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580944|NCT00864058|Anticonvulsants|anticonvulsants|mesh-ancestor
24860340|NCT02309385|Dexamethasone|dexamethasone|mesh-list
24580945|NCT00864058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24580946|NCT00864058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24580987|NCT00864149|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25137164|NCT02986503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25137165|NCT02986503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25137167|NCT02986451|Clarithromycin|clarithromycin|mesh-list
25137168|NCT02986451|Dexamethasone|dexamethasone|mesh-list
25137169|NCT02986451|Lenalidomide|lenalidomide|mesh-list
25137170|NCT02986451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25137171|NCT02986451|Antiemetics|antiemetics|mesh-ancestor
25137172|NCT02986451|Autonomic Agents|autonomic agents|mesh-ancestor
25137173|NCT02986451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25137174|NCT02986451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137175|NCT02986451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25137176|NCT02986451|Glucocorticoids|glucocorticoids|mesh-ancestor
25137178|NCT02986451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25137179|NCT02986451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25137180|NCT02986451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25137181|NCT02986451|Immunologic Factors|immunologic factors|mesh-ancestor
25137182|NCT02986451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25137183|NCT02986451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25137184|NCT02986451|Growth Substances|growth substances|mesh-ancestor
25137185|NCT02986451|Growth Inhibitors|growth inhibitors|mesh-ancestor
25137186|NCT02986451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25137187|NCT02986451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25137188|NCT02986451|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25137189|NCT02986451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25137190|NCT02986451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137191|NCT02986451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25137192|NCT02986451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25137193|NCT02986607|Parathyroid Hormone|parathyroid hormone|mesh-list
25137194|NCT02986607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24650641|NCT01227148|Insulin|insulin|mesh-list
24581023|NCT00864279|Histamine Agents|histamine agents|mesh-ancestor
24581024|NCT00864279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581025|NCT00864279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046089|NCT00880217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25046090|NCT00880217|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25046091|NCT00880217|Adrenergic Agents|adrenergic agents|mesh-ancestor
25046092|NCT00877903|Remestemcel-l|remestemcel-l|mesh-list
25046093|NCT00877903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25046094|NCT00877903|Antiviral Agents|antiviral agents|mesh-ancestor
25046095|NCT00877903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25046097|NCT00875459|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25046098|NCT00875459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25046099|NCT00875459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046100|NCT00875108|Insulin|insulin|mesh-list
25046101|NCT00875108|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25046102|NCT00875108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25046103|NCT00875108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683499|NCT02007122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25683500|NCT02007122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25683501|NCT01919086|Dexamethasone|dexamethasone|mesh-list
25683502|NCT01919086|Lenalidomide|lenalidomide|mesh-list
25683503|NCT01919086|Bortezomib|bortezomib|mesh-list
25683504|NCT01919086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25046104|NCT00872885|Morphine|morphine|mesh-list
25046105|NCT00872885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25046106|NCT00872885|Narcotics|narcotics|mesh-ancestor
25046107|NCT00872885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25046108|NCT00872885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046109|NCT00872885|Analgesics|analgesics|mesh-ancestor
25046110|NCT00872885|Sensory System Agents|sensory system agents|mesh-ancestor
25046111|NCT00872885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25046112|NCT00872430|Laxatives|laxatives|mesh-list
25046113|NCT00872430|Cathartics|cathartics|mesh-list
25046114|NCT00872430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25046115|NCT00872014|Sorafenib|sorafenib|mesh-list
25046116|NCT00872014|Trebananib|trebananib|mesh-list
25046117|NCT00872014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25046118|NCT00872014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25046119|NCT00872014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046120|NCT00872014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046121|NCT00872014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25046122|NCT00872014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25046123|NCT00872014|Growth Substances|growth substances|mesh-ancestor
25046124|NCT00872014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965202|NCT03778567|Lamivudine|lamivudine|mesh-list
24581026|NCT00864279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581027|NCT00864305|Gabapentin|gabapentin|mesh-list
24581028|NCT00864305|Analgesics|analgesics|mesh-ancestor
24581029|NCT00864305|Sensory System Agents|sensory system agents|mesh-ancestor
25046126|NCT00871936|Metformin|metformin|mesh-list
25046127|NCT00871936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25046128|NCT00871936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046129|NCT00871481|Aldesleukin|aldesleukin|mesh-list
25046130|NCT00871481|Cyclophosphamide|cyclophosphamide|mesh-list
25046131|NCT00871481|Ipilimumab|ipilimumab|mesh-list
25046132|NCT00871481|Interleukin-2|interleukin-2|mesh-list
25137218|NCT02986321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137219|NCT02986321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25137220|NCT02986321|Respiratory System Agents|respiratory system agents|mesh-ancestor
25137221|NCT02986321|Glucocorticoids|glucocorticoids|mesh-ancestor
25137222|NCT02986321|Hormones|hormones|mesh-ancestor
25137223|NCT02986321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25137224|NCT02986594|Aspirin|aspirin|mesh-list
25137225|NCT02986594|Heparin|heparin|mesh-list
25137226|NCT02986594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24581030|NCT00864305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24581032|NCT00864305|Anticonvulsants|anticonvulsants|mesh-ancestor
24581131|NCT00864500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24444726|NCT00299013|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24581132|NCT00864500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463033|NCT00358371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24463034|NCT00358384|Betamethasone|betamethasone|mesh-list
24444727|NCT00299013|Prednisolone acetate|prednisolone acetate|mesh-list
24444728|NCT00299013|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24444729|NCT00299013|Prednisolone phosphate|prednisolone phosphate|mesh-list
24581133|NCT00864526|Ibuprofen|ibuprofen|mesh-list
24581134|NCT00864526|Oxycodone|oxycodone|mesh-list
24444730|NCT00299013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24581135|NCT00864526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24581136|NCT00864526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24581276|NCT00864825|Antimetabolites|antimetabolites|mesh-ancestor
24581277|NCT00864825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581278|NCT00864825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581279|NCT00864825|Gout Suppressants|gout suppressants|mesh-ancestor
24581280|NCT00864825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24581281|NCT00864825|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24463035|NCT00358384|Betamethasone Valerate|betamethasone valerate|mesh-list
24446946|NCT00306696|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24581484|NCT00865371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24581485|NCT00865371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24581590|NCT00865540|Glucocorticoids|glucocorticoids|mesh-ancestor
24581592|NCT00865540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24581593|NCT00865540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581594|NCT00865540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25137229|NCT02986594|Sensory System Agents|sensory system agents|mesh-ancestor
25137230|NCT02986594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25137231|NCT02986594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137232|NCT02986594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25137234|NCT02986594|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25137235|NCT02986594|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25137236|NCT02986594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137237|NCT02986594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25137238|NCT02986594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25137239|NCT02986594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25137240|NCT02986594|Antipyretics|antipyretics|mesh-ancestor
25137241|NCT02986594|Anticoagulants|anticoagulants|mesh-ancestor
25137242|NCT02986100|Rucaparib|rucaparib|mesh-list
25137243|NCT02986100|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25137244|NCT02986100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25137245|NCT02986100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137246|NCT02986100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24581595|NCT00865540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24581597|NCT00865540|Autonomic Agents|autonomic agents|mesh-ancestor
24581598|NCT00865540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24581599|NCT00865540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24581601|NCT00865540|Protective Agents|protective agents|mesh-ancestor
24581610|NCT00865605|Clobetasol|clobetasol|mesh-list
24581626|NCT00865618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24581627|NCT00865631|Gabapentin|gabapentin|mesh-list
24581628|NCT00865631|Analgesics|analgesics|mesh-ancestor
24581629|NCT00865631|Sensory System Agents|sensory system agents|mesh-ancestor
24581630|NCT00865631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24581631|NCT00865631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581633|NCT00865631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24581634|NCT00865631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24581635|NCT00865631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24581636|NCT00865631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24581755|NCT00865982|Antimetabolites|antimetabolites|mesh-ancestor
24581756|NCT00866008|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24581960|NCT00866853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581961|NCT00866853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581962|NCT00866866|Acetylcysteine|acetylcysteine|mesh-list
24581963|NCT00866866|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24581964|NCT00866866|Antiviral Agents|antiviral agents|mesh-ancestor
24581965|NCT00866866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24581966|NCT00866866|Expectorants|expectorants|mesh-ancestor
24581967|NCT00866866|Respiratory System Agents|respiratory system agents|mesh-ancestor
24581968|NCT00866866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24581969|NCT00866866|Antioxidants|antioxidants|mesh-ancestor
24581970|NCT00866866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137254|NCT02985697|Dexmedetomidine|dexmedetomidine|mesh-list
25137255|NCT02985697|Nitrous Oxide|nitrous oxide|mesh-list
25137256|NCT02985697|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25137257|NCT02985697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25137258|NCT02985697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581971|NCT00866866|Protective Agents|protective agents|mesh-ancestor
24581972|NCT00866866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581973|NCT00866866|Antidotes|antidotes|mesh-ancestor
24581974|NCT00866944|Leucovorin|leucovorin|mesh-list
24581975|NCT00866944|Fluorouracil|fluorouracil|mesh-list
24581976|NCT00866944|Oxaliplatin|oxaliplatin|mesh-list
24581977|NCT00866944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24581978|NCT00866944|Antimetabolites|antimetabolites|mesh-ancestor
24582057|NCT00867672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24582058|NCT00867737|Fluticasone|fluticasone|mesh-list
24582059|NCT00867737|Budesonide|budesonide|mesh-list
24582060|NCT00867737|Formoterol Fumarate|formoterol fumarate|mesh-list
24582061|NCT00867737|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24582062|NCT00867737|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24582064|NCT00867737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24582112|NCT00868153|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24582173|NCT00868465|Antimalarials|antimalarials|mesh-ancestor
24582174|NCT00868465|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24582175|NCT00868465|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24582176|NCT00868465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24582177|NCT00868491|Cisplatin|cisplatin|mesh-list
24582178|NCT00868491|Docetaxel|docetaxel|mesh-list
24582179|NCT00868491|Fluorouracil|fluorouracil|mesh-list
24582180|NCT00868491|Cetuximab|cetuximab|mesh-list
24582181|NCT00868491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582192|NCT00868569|Leucovorin|leucovorin|mesh-list
24582211|NCT00868634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582212|NCT00868634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24582213|NCT00868634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24582214|NCT00868634|Growth Substances|growth substances|mesh-ancestor
24582215|NCT00868634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582216|NCT00868634|Growth Inhibitors|growth inhibitors|mesh-ancestor
24582217|NCT00868634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24582218|NCT00868634|Antimetabolites|antimetabolites|mesh-ancestor
24582219|NCT00868634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582220|NCT00868634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24582221|NCT00868634|Tubulin Modulators|tubulin modulators|mesh-ancestor
24582222|NCT00868634|Antimitotic Agents|antimitotic agents|mesh-ancestor
24582223|NCT00868634|Mitosis Modulators|mitosis modulators|mesh-ancestor
24582225|NCT00868738|Vitamins|vitamins|mesh-ancestor
24582226|NCT00868738|Micronutrients|micronutrients|mesh-ancestor
24582227|NCT00868738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582228|NCT00868738|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24582229|NCT00868764|Granisetron|granisetron|mesh-list
24582230|NCT00868764|Antiemetics|antiemetics|mesh-ancestor
24582309|NCT00869193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582310|NCT00869219|Nepafenac|nepafenac|mesh-list
25137261|NCT02985697|Sensory System Agents|sensory system agents|mesh-ancestor
25137262|NCT02985697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25137263|NCT02985697|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25137264|NCT02985697|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25137271|NCT02985697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25137273|NCT02985697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25137274|NCT02985697|Anesthetics, General|anesthetics, general|mesh-ancestor
25137276|NCT02985697|GABA Modulators|gaba modulators|mesh-ancestor
25137277|NCT02985697|GABA Agents|gaba agents|mesh-ancestor
25137278|NCT02985697|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25137279|NCT02985866|Pancrelipase|pancrelipase|mesh-list
25137280|NCT02985866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25137281|NCT02985983|Brodalumab|brodalumab|mesh-list
25137282|NCT02985983|Dermatologic Agents|dermatologic agents|mesh-ancestor
25137287|NCT02985905|Zinc Sulfate|zinc sulfate|mesh-list
25137288|NCT02985905|Astringents|astringents|mesh-ancestor
25137289|NCT02985905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137290|NCT02985905|Dermatologic Agents|dermatologic agents|mesh-ancestor
25137292|NCT02985658|Vinorelbine|vinorelbine|mesh-list
24582311|NCT00869219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24582312|NCT00869219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24582313|NCT00869219|Analgesics|analgesics|mesh-ancestor
24582314|NCT00869219|Sensory System Agents|sensory system agents|mesh-ancestor
24582315|NCT00869219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24582316|NCT00869219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582317|NCT00869219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24582318|NCT00869219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24965368|NCT03777644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965370|NCT03777644|Sensory System Agents|sensory system agents|mesh-ancestor
24965371|NCT03777644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24965372|NCT03777644|Anesthetics, Local|anesthetics, local|mesh-ancestor
24965373|NCT03777644|Anesthetics|anesthetics|mesh-ancestor
25137293|NCT02985658|Veliparib|veliparib|mesh-list
25137294|NCT02985658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25137295|NCT02985658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25137296|NCT02985658|Tubulin Modulators|tubulin modulators|mesh-ancestor
25137297|NCT02985658|Antimitotic Agents|antimitotic agents|mesh-ancestor
25137298|NCT02985658|Mitosis Modulators|mitosis modulators|mesh-ancestor
25137299|NCT02985658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137300|NCT02985658|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25137301|NCT02985658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25137302|NCT02985671|Acetaminophen|acetaminophen|mesh-list
25137303|NCT02985671|Diclofenac|diclofenac|mesh-list
25137304|NCT02985671|Orphenadrine|orphenadrine|mesh-list
25137305|NCT02985671|Caffeine|caffeine|mesh-list
25137306|NCT02985671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25137307|NCT02985671|Analgesics|analgesics|mesh-ancestor
25137308|NCT02985671|Sensory System Agents|sensory system agents|mesh-ancestor
25137309|NCT02985671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25137310|NCT02985671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137311|NCT02985671|Antipyretics|antipyretics|mesh-ancestor
25137312|NCT02985671|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25137313|NCT02985671|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24708280|NCT01500863|Contraceptive Agents|contraceptive agents|mesh-ancestor
25137314|NCT02985671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25137315|NCT02985671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137316|NCT02985671|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25137317|NCT02985671|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25137318|NCT02985671|Purinergic Agents|purinergic agents|mesh-ancestor
25137326|NCT02985671|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25137327|NCT02985671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25137328|NCT02985671|Parasympatholytics|parasympatholytics|mesh-ancestor
25137329|NCT02985671|Autonomic Agents|autonomic agents|mesh-ancestor
25137330|NCT02985671|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25137331|NCT02985671|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25137332|NCT02985671|Cholinergic Agents|cholinergic agents|mesh-ancestor
25137333|NCT02985671|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
25137337|NCT02985606|Caffeine|caffeine|mesh-list
25137338|NCT02985606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25137339|NCT02985606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137340|NCT02985606|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25137341|NCT02985606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25137342|NCT02985606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137343|NCT02985606|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25137344|NCT02985606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25137345|NCT02985606|Purinergic Agents|purinergic agents|mesh-ancestor
25137346|NCT02985606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25137348|NCT02985229|Mifepristone|mifepristone|mesh-list
25137349|NCT02985229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25137350|NCT02985229|Abortifacient Agents|abortifacient agents|mesh-ancestor
25137351|NCT02985229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25137352|NCT02985229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137374|NCT02985372|Antiviral Agents|antiviral agents|mesh-ancestor
25137375|NCT02985372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25137376|NCT02985372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25137377|NCT02985372|Immunologic Factors|immunologic factors|mesh-ancestor
25137378|NCT02985372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137379|NCT02985372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25137380|NCT02985216|Pregabalin|pregabalin|mesh-list
25137381|NCT02985216|Analgesics|analgesics|mesh-ancestor
25137382|NCT02985216|Sensory System Agents|sensory system agents|mesh-ancestor
25137383|NCT02985216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25137384|NCT02985216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137386|NCT02985216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25137387|NCT02985216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25137388|NCT02985216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046133|NCT00871481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25046134|NCT00871481|Antibodies|antibodies|mesh-list
25046135|NCT00871481|Immunoglobulins|immunoglobulins|mesh-list
25046136|NCT00871481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25046137|NCT00871481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25046138|NCT00871481|Immunologic Factors|immunologic factors|mesh-ancestor
25046139|NCT00871481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137389|NCT02985216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25137390|NCT02985216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25137391|NCT02985216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25137392|NCT02985216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25137393|NCT02985216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25137394|NCT02985333|Dexamethasone|dexamethasone|mesh-list
25137395|NCT02985333|Paclitaxel|paclitaxel|mesh-list
25137396|NCT02985333|Cyclophosphamide|cyclophosphamide|mesh-list
25137397|NCT02985333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25137398|NCT02985333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582497|NCT00870038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24582499|NCT00870038|Tubulin Modulators|tubulin modulators|mesh-ancestor
24582500|NCT00870038|Antimitotic Agents|antimitotic agents|mesh-ancestor
24582501|NCT00870038|Mitosis Modulators|mitosis modulators|mesh-ancestor
25137403|NCT02985333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25137404|NCT02985333|Immunologic Factors|immunologic factors|mesh-ancestor
25137405|NCT02985333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137406|NCT02985333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25137407|NCT02985333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25137408|NCT02985333|Alkylating Agents|alkylating agents|mesh-ancestor
25137409|NCT02985333|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25137410|NCT02985333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25137412|NCT02985333|Autonomic Agents|autonomic agents|mesh-ancestor
25683505|NCT01919086|Antiemetics|antiemetics|mesh-ancestor
25137413|NCT02985333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25137414|NCT02985333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25137415|NCT02985333|Glucocorticoids|glucocorticoids|mesh-ancestor
25137416|NCT02985333|Hormones|hormones|mesh-ancestor
25137417|NCT02985333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25137418|NCT02985333|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25137419|NCT02985437|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25137420|NCT02985437|Respiratory System Agents|respiratory system agents|mesh-ancestor
25137421|NCT02985190|Azacitidine|azacitidine|mesh-list
25137422|NCT02985190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25137423|NCT02985190|Antimetabolites|antimetabolites|mesh-ancestor
25137424|NCT02985190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137425|NCT02985190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25137426|NCT02985190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25137427|NCT02985177|Ibuprofen|ibuprofen|mesh-list
25137428|NCT02985177|Fentanyl|fentanyl|mesh-list
25137429|NCT02985177|Hydromorphone|hydromorphone|mesh-list
25137430|NCT02985177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25137431|NCT02985177|Narcotics|narcotics|mesh-ancestor
24582502|NCT00870038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582503|NCT00870142|Amlodipine|amlodipine|mesh-list
24632889|NCT01126073|Vitamin B Complex|vitamin b complex|mesh-ancestor
24632890|NCT01126073|Vitamins|vitamins|mesh-ancestor
24582539|NCT00870298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25137432|NCT02985177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25137433|NCT02985177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137434|NCT02985177|Analgesics|analgesics|mesh-ancestor
25137435|NCT02985177|Sensory System Agents|sensory system agents|mesh-ancestor
25137436|NCT02985177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25137437|NCT02985177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25137438|NCT02985177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25137439|NCT02985177|Anesthetics, General|anesthetics, general|mesh-ancestor
25137440|NCT02985177|Anesthetics|anesthetics|mesh-ancestor
25137441|NCT02985177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25137442|NCT02985177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25137443|NCT02985177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25137444|NCT02985177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25137445|NCT02985177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25137446|NCT02985177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25137447|NCT02985177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137449|NCT02985424|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25137450|NCT02985424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137451|NCT02985255|Docetaxel|docetaxel|mesh-list
25137452|NCT02985255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25137453|NCT02985255|Tubulin Modulators|tubulin modulators|mesh-ancestor
25137454|NCT02985255|Antimitotic Agents|antimitotic agents|mesh-ancestor
25137455|NCT02985255|Mitosis Modulators|mitosis modulators|mesh-ancestor
25137456|NCT02985255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137457|NCT02985203|Vinorelbine|vinorelbine|mesh-list
25137458|NCT02985203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25137459|NCT02985203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582580|NCT00870480|Urological Agents|urological agents|mesh-ancestor
24582637|NCT00870883|Antioxidants|antioxidants|mesh-ancestor
24582638|NCT00870883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582639|NCT00870883|Protective Agents|protective agents|mesh-ancestor
24582640|NCT00870883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582641|NCT00870883|Antidotes|antidotes|mesh-ancestor
24582642|NCT00870883|Siderophores|siderophores|mesh-ancestor
24582643|NCT00870883|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24582644|NCT00870883|Chelating Agents|chelating agents|mesh-ancestor
24582645|NCT00870883|Sequestering Agents|sequestering agents|mesh-ancestor
24582646|NCT00870961|Cholecalciferol|cholecalciferol|mesh-list
24582802|NCT00871910|Ondansetron|ondansetron|mesh-list
24582803|NCT00871910|Aprepitant|aprepitant|mesh-list
24582804|NCT00871910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24582805|NCT00871910|Antiemetics|antiemetics|mesh-ancestor
24582806|NCT00871910|Autonomic Agents|autonomic agents|mesh-ancestor
24582807|NCT00871910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25137460|NCT02985203|Tubulin Modulators|tubulin modulators|mesh-ancestor
25137461|NCT02985203|Antimitotic Agents|antimitotic agents|mesh-ancestor
25137462|NCT02985203|Mitosis Modulators|mitosis modulators|mesh-ancestor
25137463|NCT02985203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137465|NCT02985554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25137466|NCT02985554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25137467|NCT02985554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25683506|NCT01919086|Autonomic Agents|autonomic agents|mesh-ancestor
25131152|NCT03028532|Enclomiphene|enclomiphene|mesh-list
25282609|NCT04498741|Midazolam|midazolam|mesh-list
25137468|NCT02985554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137471|NCT02985242|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25137472|NCT02985242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267158|NCT02423954|Sirolimus|sirolimus|mesh-list
25137473|NCT02985242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25137474|NCT02985242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137475|NCT02985242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25137476|NCT02985242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25137477|NCT02985242|Immunologic Factors|immunologic factors|mesh-ancestor
25137480|NCT02985281|Antimetabolites|antimetabolites|mesh-ancestor
25137481|NCT02985281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137482|NCT02985281|Antiviral Agents|antiviral agents|mesh-ancestor
25137483|NCT02985281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25137484|NCT02985125|Everolimus|everolimus|mesh-list
25137485|NCT02985125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25137486|NCT02985125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25137487|NCT02985125|Immunologic Factors|immunologic factors|mesh-ancestor
25137488|NCT02985125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137489|NCT02985099|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25137490|NCT02985099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25137491|NCT02985099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25137492|NCT02985099|Antimetabolites|antimetabolites|mesh-ancestor
24582808|NCT00871910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582809|NCT00871910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24582810|NCT00871910|Glucocorticoids|glucocorticoids|mesh-ancestor
24582811|NCT00871910|Hormones|hormones|mesh-ancestor
24582812|NCT00871910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24582813|NCT00871910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24582814|NCT00871910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582815|NCT00871910|Antipruritics|antipruritics|mesh-ancestor
25137493|NCT02985099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137494|NCT02985099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25137495|NCT02985099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25137496|NCT02985099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25137497|NCT02984930|Esomeprazole|esomeprazole|mesh-list
25137498|NCT02984930|Mosapride|mosapride|mesh-list
25137499|NCT02984930|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25137500|NCT02984930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25137501|NCT02984930|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25137502|NCT02984930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25137503|NCT02984930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137504|NCT02984930|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25137505|NCT02984930|Serotonin Agents|serotonin agents|mesh-ancestor
25137506|NCT02984930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25137507|NCT02984930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137508|NCT02985086|Cefoxitin|cefoxitin|mesh-list
25137509|NCT02985086|Misoprostol|misoprostol|mesh-list
25137510|NCT02985086|Oxytocin|oxytocin|mesh-list
25137511|NCT02985086|Oxytocics|oxytocics|mesh-ancestor
25137512|NCT02985086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25137513|NCT02985086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137514|NCT02985086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25137515|NCT02985086|Abortifacient Agents|abortifacient agents|mesh-ancestor
25137516|NCT02985086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25137517|NCT02985086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25137518|NCT02985086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25137519|NCT02985086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25137520|NCT02984865|Flurbiprofen|flurbiprofen|mesh-list
25137521|NCT02984865|Sufentanil|sufentanil|mesh-list
25137522|NCT02984865|Nalbuphine|nalbuphine|mesh-list
25137523|NCT02984865|Dsuvia|dsuvia|mesh-list
25137524|NCT02984865|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25137525|NCT02984865|Narcotics|narcotics|mesh-ancestor
25137526|NCT02984865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25137527|NCT02984865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137528|NCT02984865|Analgesics|analgesics|mesh-ancestor
25137534|NCT02984865|Anesthetics|anesthetics|mesh-ancestor
25137535|NCT02984865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25137536|NCT02984865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25137537|NCT02984865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25137553|NCT02984852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25137554|NCT02984852|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25683507|NCT01919086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25683508|NCT01919086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137555|NCT02984852|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25137557|NCT02984852|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25137558|NCT02984852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25137560|NCT02984722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25137561|NCT02984722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137562|NCT02984696|Estradiol|estradiol|mesh-list
25137563|NCT02984696|Estrogens|estrogens|mesh-ancestor
25137564|NCT02984696|Hormones|hormones|mesh-ancestor
25137565|NCT02984696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25137568|NCT02984657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25137569|NCT02984657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137570|NCT02984345|Caseins|caseins|mesh-list
25137571|NCT02984345|Chelating Agents|chelating agents|mesh-ancestor
25137572|NCT02984345|Sequestering Agents|sequestering agents|mesh-ancestor
25137573|NCT02984345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137574|NCT02984475|Metformin|metformin|mesh-list
25137575|NCT02984475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25137576|NCT02984475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046144|NCT00871481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25085921|NCT03294252|Hematinics|hematinics|mesh-ancestor
25137592|NCT02984293|Atorvastatin|atorvastatin|mesh-list
25137593|NCT02984293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25137594|NCT02984293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25137595|NCT02984293|Antimetabolites|antimetabolites|mesh-ancestor
25137596|NCT02984293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137597|NCT02984293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25137598|NCT02984293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25137599|NCT02984293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25137600|NCT02984176|Simethicone|simethicone|mesh-list
25137601|NCT02984176|Antifoaming Agents|antifoaming agents|mesh-ancestor
25137602|NCT02984176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137603|NCT02984176|Emollients|emollients|mesh-ancestor
25137604|NCT02984176|Dermatologic Agents|dermatologic agents|mesh-ancestor
25137605|NCT02984111|Epoetin Alfa|epoetin alfa|mesh-list
25137606|NCT02984111|Hematinics|hematinics|mesh-ancestor
25137647|NCT02983734|Antitubercular Agents|antitubercular agents|mesh-ancestor
25137648|NCT02983734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25137649|NCT02983734|Antimetabolites|antimetabolites|mesh-ancestor
25137650|NCT02983734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137652|NCT02983630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25137658|NCT02983214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25137659|NCT02983214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25137660|NCT02983214|Purinergic Agents|purinergic agents|mesh-ancestor
25137661|NCT02983214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25137662|NCT02983214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137663|NCT02983214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137664|NCT02983214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25085992|NCT03293511|Oxytocin|oxytocin|mesh-list
25137666|NCT02983214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25137668|NCT02983214|Respiratory System Agents|respiratory system agents|mesh-ancestor
25137669|NCT02983214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25137670|NCT02983214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25137671|NCT02983214|Vasodilator Agents|vasodilator agents|mesh-ancestor
25137672|NCT02983214|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25137673|NCT02983214|Protective Agents|protective agents|mesh-ancestor
25137695|NCT02983344|Anesthetics, General|anesthetics, general|mesh-ancestor
25137696|NCT02983084|Copper|copper|mesh-list
25137697|NCT02983084|Nickel|nickel|mesh-list
25137698|NCT02983084|Trace Elements|trace elements|mesh-ancestor
25137699|NCT02983084|Micronutrients|micronutrients|mesh-ancestor
25137700|NCT02983084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137701|NCT02983422|Aminophylline|aminophylline|mesh-list
25137702|NCT02983422|Furosemide|furosemide|mesh-list
25137703|NCT02983422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25137704|NCT02983422|Autonomic Agents|autonomic agents|mesh-ancestor
25137705|NCT02983422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25137706|NCT02983422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137707|NCT02983422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25137708|NCT02983422|Respiratory System Agents|respiratory system agents|mesh-ancestor
25137709|NCT02983422|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25137710|NCT02983422|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25137711|NCT02983422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25137712|NCT02983422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137713|NCT02983422|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25282682|NCT04026945|Anesthetics, Local|anesthetics, local|mesh-ancestor
25282683|NCT04026945|Anesthetics|anesthetics|mesh-ancestor
25282684|NCT04026945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25282685|NCT04026945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282686|NCT04026945|Sensory System Agents|sensory system agents|mesh-ancestor
25267175|NCT02423954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25282687|NCT04026945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25282688|NCT04026945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25282689|NCT04026945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25282690|NCT04026945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25282691|NCT04026945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25137714|NCT02983422|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25137715|NCT02983422|Purinergic Agents|purinergic agents|mesh-ancestor
25137716|NCT02983422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25137717|NCT02983422|Protective Agents|protective agents|mesh-ancestor
25137718|NCT02983422|Diuretics|diuretics|mesh-ancestor
25137719|NCT02983422|Natriuretic Agents|natriuretic agents|mesh-ancestor
25137720|NCT02983422|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25137721|NCT02983422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25137722|NCT02983097|Cytarabine|cytarabine|mesh-list
25137723|NCT02983097|Dexamethasone|dexamethasone|mesh-list
25137724|NCT02983097|Rituximab|rituximab|mesh-list
25137725|NCT02983097|Carboplatin|carboplatin|mesh-list
25137726|NCT02983097|Lenalidomide|lenalidomide|mesh-list
25137727|NCT02983097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25137728|NCT02983097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25137729|NCT02983097|Immunologic Factors|immunologic factors|mesh-ancestor
25137730|NCT02983097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137731|NCT02983097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25137732|NCT02983097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25137733|NCT02983097|Antiemetics|antiemetics|mesh-ancestor
25137734|NCT02983097|Autonomic Agents|autonomic agents|mesh-ancestor
25137735|NCT02983097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25137736|NCT02983097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25137737|NCT02983097|Glucocorticoids|glucocorticoids|mesh-ancestor
25137738|NCT02983097|Hormones|hormones|mesh-ancestor
25137739|NCT02983097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25137740|NCT02983097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25137743|NCT02983097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137744|NCT02983097|Antiviral Agents|antiviral agents|mesh-ancestor
25137745|NCT02983097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25137746|NCT02983097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25137747|NCT02983097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25137748|NCT02983097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25137749|NCT02983097|Growth Substances|growth substances|mesh-ancestor
25137750|NCT02983097|Growth Inhibitors|growth inhibitors|mesh-ancestor
25137751|NCT02983383|Anesthetics|anesthetics|mesh-list
24451316|NCT00323154|Nalbuphine|nalbuphine|mesh-list
25137752|NCT02983383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25137753|NCT02983383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137754|NCT02982798|Metformin|metformin|mesh-list
24582937|NCT00872625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24583127|NCT00873379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24583129|NCT00873392|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24583198|NCT00873639|Insulin Detemir|insulin detemir|mesh-list
24583221|NCT00873769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583223|NCT00873795|Sertraline|sertraline|mesh-list
24583224|NCT00873795|Antidepressive Agents|antidepressive agents|mesh-ancestor
25683509|NCT01919086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25683510|NCT01919086|Glucocorticoids|glucocorticoids|mesh-ancestor
25683511|NCT01919086|Hormones|hormones|mesh-ancestor
25683512|NCT01919086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25683513|NCT01919086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25683514|NCT01919086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683515|NCT01919086|Immunologic Factors|immunologic factors|mesh-ancestor
25683516|NCT01919086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25683517|NCT01919086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25683518|NCT01919086|Growth Substances|growth substances|mesh-ancestor
25683519|NCT01919086|Growth Inhibitors|growth inhibitors|mesh-ancestor
25132150|NCT03020901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25132151|NCT03020680|Ubiquinone|ubiquinone|mesh-list
25132152|NCT03020680|Coenzyme Q10|coenzyme q10|mesh-list
25132153|NCT03020680|Micronutrients|micronutrients|mesh-ancestor
25267187|NCT02423915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267188|NCT02423915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25132154|NCT03020680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132155|NCT03020680|Vitamins|vitamins|mesh-ancestor
25132156|NCT03020563|Bupivacaine|bupivacaine|mesh-list
25132157|NCT03020563|Anesthetics, Local|anesthetics, local|mesh-ancestor
25132158|NCT03020563|Anesthetics|anesthetics|mesh-ancestor
25132159|NCT03020563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25132160|NCT03020563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132161|NCT03020563|Sensory System Agents|sensory system agents|mesh-ancestor
25132162|NCT03020563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25132163|NCT03020706|Magnesium Sulfate|magnesium sulfate|mesh-list
24583225|NCT00873795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24583226|NCT00873795|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24583227|NCT00873795|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24583228|NCT00873795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24583229|NCT00873795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583230|NCT00873795|Dopamine Agonists|dopamine agonists|mesh-ancestor
24583231|NCT00873795|Dopamine Agents|dopamine agents|mesh-ancestor
24583232|NCT00873795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24583233|NCT00873795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046146|NCT00871481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25046147|NCT00871481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25046148|NCT00871481|Analgesics|analgesics|mesh-ancestor
25046149|NCT00871481|Sensory System Agents|sensory system agents|mesh-ancestor
25046150|NCT00871481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25046151|NCT00871481|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24586492|NCT00890955|Immunologic Factors|immunologic factors|mesh-ancestor
24583269|NCT00873834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24583271|NCT00873886|Antiviral Agents|antiviral agents|mesh-ancestor
24583272|NCT00873886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24583317|NCT00874068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583318|NCT00874107|Paclitaxel|paclitaxel|mesh-list
24583319|NCT00874107|Bevacizumab|bevacizumab|mesh-list
24583320|NCT00874107|Carboplatin|carboplatin|mesh-list
24583321|NCT00874107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24583322|NCT00874107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583369|NCT00874315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24633111|NCT01127282|Vitamin A|vitamin a|mesh-list
24633112|NCT01127282|Micronutrients|micronutrients|mesh-ancestor
24633113|NCT01127282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633114|NCT01127295|Tamoxifen|tamoxifen|mesh-list
24633115|NCT01127295|Letrozole|letrozole|mesh-list
24633116|NCT01127295|Anastrozole|anastrozole|mesh-list
24633117|NCT01127295|Exemestane|exemestane|mesh-list
24633118|NCT01127295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633119|NCT01127295|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25046171|NCT00870688|GABA Agents|gaba agents|mesh-ancestor
25046172|NCT00870688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25046173|NCT00870688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046174|NCT00870688|Antimanic Agents|antimanic agents|mesh-ancestor
25046175|NCT00870688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24584330|NCT00879918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24584331|NCT00879918|Cholinergic Agents|cholinergic agents|mesh-ancestor
24584332|NCT00879918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24584333|NCT00879918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584444|NCT00880373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24584448|NCT00880386|Losartan|losartan|mesh-list
24584484|NCT00880529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25683520|NCT01794143|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25683521|NCT01794143|Liraglutide|liraglutide|mesh-list
25683522|NCT01794143|Glimepiride|glimepiride|mesh-list
25683523|NCT01794143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25683524|NCT01794143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25683525|NCT01794143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683526|NCT01794143|Incretins|incretins|mesh-ancestor
25683527|NCT01794143|Hormones|hormones|mesh-ancestor
25683528|NCT01794143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25683529|NCT01794143|Protease Inhibitors|protease inhibitors|mesh-ancestor
25683530|NCT01794143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683531|NCT01794143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683532|NCT01794143|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24584485|NCT00880529|Narcotics|narcotics|mesh-ancestor
25683534|NCT01794143|Immunologic Factors|immunologic factors|mesh-ancestor
24607798|NCT03612466|Plerixafor|plerixafor|mesh-list
25683535|NCT01766128|Zonisamide|zonisamide|mesh-list
25683536|NCT01766128|Anticonvulsants|anticonvulsants|mesh-ancestor
25683537|NCT01766128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24458060|NCT00336401|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24458061|NCT00336414|Prednisone|prednisone|mesh-list
24588349|NCT00902395|Midazolam|midazolam|mesh-list
24584486|NCT00880529|Analgesics|analgesics|mesh-ancestor
24584587|NCT00881114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584588|NCT00881114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24585002|NCT00882635|Calcium heparin|calcium heparin|mesh-list
24585003|NCT00882635|Anticoagulants|anticoagulants|mesh-ancestor
24585004|NCT00882635|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24585005|NCT00882635|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24585006|NCT00882635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046185|NCT00870454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25046186|NCT00870454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046187|NCT00870454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25046188|NCT00870454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25046189|NCT00870454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25046190|NCT00870454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25046191|NCT00870454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25046192|NCT00869661|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25046193|NCT00869661|Interferon-alpha|interferon-alpha|mesh-list
25046194|NCT00869661|Ribavirin|ribavirin|mesh-list
25046195|NCT00869661|Antiviral Agents|antiviral agents|mesh-ancestor
25046196|NCT00869661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25046197|NCT00869661|Immunologic Factors|immunologic factors|mesh-ancestor
25046198|NCT00869661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046199|NCT00869661|Antimetabolites|antimetabolites|mesh-ancestor
25046200|NCT00869661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046201|NCT00869336|Luliconazole|luliconazole|mesh-list
25046202|NCT00869336|Antifungal Agents|antifungal agents|mesh-ancestor
24585007|NCT00882700|Cefdinir|cefdinir|mesh-list
24585008|NCT00882700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24585009|NCT00882700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24585010|NCT00882739|Clopidogrel|clopidogrel|mesh-list
24585097|NCT00883259|Metformin|metformin|mesh-list
24585098|NCT00883259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24585099|NCT00883259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137765|NCT02982889|Bupivacaine|bupivacaine|mesh-list
25137766|NCT02982889|Hyaluronic Acid|hyaluronic acid|mesh-list
25137767|NCT02982889|Anesthetics, Local|anesthetics, local|mesh-ancestor
25137768|NCT02982889|Anesthetics|anesthetics|mesh-ancestor
25137769|NCT02982889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25137770|NCT02982889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137771|NCT02982889|Sensory System Agents|sensory system agents|mesh-ancestor
25137772|NCT02982889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25137773|NCT02982889|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25137774|NCT02982889|Immunologic Factors|immunologic factors|mesh-ancestor
25137775|NCT02982889|Viscosupplements|viscosupplements|mesh-ancestor
25137776|NCT02982889|Protective Agents|protective agents|mesh-ancestor
25137777|NCT02982694|Bevacizumab|bevacizumab|mesh-list
25137778|NCT02982694|Atezolizumab|atezolizumab|mesh-list
25137779|NCT02982694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25137780|NCT02982694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25137781|NCT02982694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25683538|NCT01766128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25683539|NCT01766128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683540|NCT01766128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25683541|NCT01766128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683542|NCT01728259|Dexamethasone|dexamethasone|mesh-list
25683543|NCT01728259|Bortezomib|bortezomib|mesh-list
25683544|NCT01728259|Pomalidomide|pomalidomide|mesh-list
25683545|NCT01728259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25137782|NCT02982694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25132798|NCT03016988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25132799|NCT03016988|Immunologic Factors|immunologic factors|mesh-ancestor
25132800|NCT03016988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132801|NCT03016988|Antiviral Agents|antiviral agents|mesh-ancestor
25137783|NCT02982694|Growth Substances|growth substances|mesh-ancestor
25137784|NCT02982694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137785|NCT02982694|Growth Inhibitors|growth inhibitors|mesh-ancestor
25137787|NCT02982850|Warfarin|warfarin|mesh-list
25137788|NCT02982850|Dabigatran|dabigatran|mesh-list
25137789|NCT02982850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25137790|NCT02982850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25137791|NCT02982850|Analgesics|analgesics|mesh-ancestor
25137820|NCT02982577|Autonomic Agents|autonomic agents|mesh-ancestor
25137821|NCT02982577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25137822|NCT02982577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137823|NCT02982577|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25137824|NCT02982577|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25137825|NCT02982577|Cholinergic Agents|cholinergic agents|mesh-ancestor
25137826|NCT02982577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25137827|NCT02982577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137828|NCT02982512|Dexmedetomidine|dexmedetomidine|mesh-list
25137830|NCT02982512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25137831|NCT02982512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137832|NCT02982512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25137833|NCT02982512|Analgesics|analgesics|mesh-ancestor
25137834|NCT02982512|Sensory System Agents|sensory system agents|mesh-ancestor
25137835|NCT02982512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25137836|NCT02982512|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25137837|NCT02982512|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24585279|NCT00884676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24585280|NCT00884676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585281|NCT00884676|Tubulin Modulators|tubulin modulators|mesh-ancestor
24585282|NCT00884676|Antimitotic Agents|antimitotic agents|mesh-ancestor
24585283|NCT00884676|Mitosis Modulators|mitosis modulators|mesh-ancestor
24585585|NCT00886132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24585586|NCT00886132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24585588|NCT00886275|Midazolam|midazolam|mesh-list
24585705|NCT00886873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585706|NCT00886873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24463119|NCT00358930|Beta-lapachone|beta-lapachone|mesh-list
24585847|NCT00887276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585849|NCT00887328|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24585850|NCT00887328|Plasminogen|plasminogen|mesh-list
24633734|NCT01130922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24585851|NCT00887328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24585852|NCT00887328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24585898|NCT00887770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25137839|NCT02982512|Adrenergic Agents|adrenergic agents|mesh-ancestor
25137840|NCT02982512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25137841|NCT02982512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137842|NCT02982434|Botulinum Toxins|botulinum toxins|mesh-list
25137843|NCT02982434|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25137844|NCT02982434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25137845|NCT02982434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137846|NCT02982434|Cholinergic Agents|cholinergic agents|mesh-ancestor
25137847|NCT02982434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25137848|NCT02982434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137850|NCT02982161|Tramadol|tramadol|mesh-list
25137851|NCT02982161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25137852|NCT02982161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25137853|NCT02982161|Analgesics|analgesics|mesh-ancestor
25137854|NCT02982161|Sensory System Agents|sensory system agents|mesh-ancestor
25137855|NCT02982161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24585899|NCT00887770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24585968|NCT00888732|Insulin, Long-Acting|insulin, long-acting|mesh-list
25683546|NCT01728259|Antiemetics|antiemetics|mesh-ancestor
25683547|NCT01728259|Autonomic Agents|autonomic agents|mesh-ancestor
25683548|NCT01728259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25683549|NCT01728259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683550|NCT01728259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24585969|NCT00888732|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24585970|NCT00888732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24585971|NCT00888732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585973|NCT00888758|Umirolimus|umirolimus|mesh-list
24585974|NCT00888758|Everolimus|everolimus|mesh-list
24586151|NCT00889356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24586153|NCT00889356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24586154|NCT00889356|Amebicides|amebicides|mesh-ancestor
24586155|NCT00889356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24586156|NCT00889356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24586157|NCT00889369|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24860576|NCT02311101|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24586158|NCT00889369|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24586159|NCT00889369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24586160|NCT00889369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24452276|NCT00326833|Vitamin B 12|vitamin b 12|mesh-list
24586302|NCT00890188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24586303|NCT00890188|Immunologic Factors|immunologic factors|mesh-ancestor
24586304|NCT00890188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586305|NCT00890188|Leprostatic Agents|leprostatic agents|mesh-ancestor
24586306|NCT00890188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24586307|NCT00890188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24586308|NCT00890188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24586386|NCT00890500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586491|NCT00890955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25137856|NCT02982161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137857|NCT02982161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25137858|NCT02982161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25137859|NCT02982161|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25137860|NCT02982161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25137861|NCT02982161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25137862|NCT02982161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137863|NCT02982161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25137864|NCT02982161|Narcotics|narcotics|mesh-ancestor
25137865|NCT02982161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25137866|NCT02982395|Ethanol|ethanol|mesh-list
25137867|NCT02982395|Docetaxel|docetaxel|mesh-list
25137868|NCT02982395|Mitomycins|mitomycins|mesh-list
25137869|NCT02982395|Mitomycin|mitomycin|mesh-list
25137870|NCT02982395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25137871|NCT02982395|Tubulin Modulators|tubulin modulators|mesh-ancestor
24860579|NCT02311179|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24860580|NCT02311179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24860581|NCT02311179|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24860582|NCT02311179|Histamine Antagonists|histamine antagonists|mesh-ancestor
24860583|NCT02311179|Histamine Agents|histamine agents|mesh-ancestor
25137872|NCT02982395|Antimitotic Agents|antimitotic agents|mesh-ancestor
25137873|NCT02982395|Mitosis Modulators|mitosis modulators|mesh-ancestor
25137874|NCT02982395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137875|NCT02982395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24586642|NCT00891540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24586643|NCT00891540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586644|NCT00891540|Sensory System Agents|sensory system agents|mesh-ancestor
24586645|NCT00891540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24586647|NCT00891579|Gefitinib|gefitinib|mesh-list
24586648|NCT00891579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586649|NCT00891579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24586650|NCT00891579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586651|NCT00891579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24586652|NCT00891579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24586716|NCT00891761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24586717|NCT00891761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586718|NCT00891761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24586719|NCT00891761|Glucocorticoids|glucocorticoids|mesh-ancestor
24586720|NCT00891761|Hormones|hormones|mesh-ancestor
24586721|NCT00891761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24586722|NCT00891761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25683551|NCT01728259|Glucocorticoids|glucocorticoids|mesh-ancestor
25683552|NCT01728259|Hormones|hormones|mesh-ancestor
25683553|NCT01728259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25282881|NCT02427126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25282882|NCT02427126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25282883|NCT02427126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24586723|NCT00891761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586724|NCT00891761|Protease Inhibitors|protease inhibitors|mesh-ancestor
24586725|NCT00891761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24586726|NCT00891761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267214|NCT02424045|Glucocorticoids|glucocorticoids|mesh-ancestor
24586871|NCT00892450|Urological Agents|urological agents|mesh-ancestor
24586872|NCT00892463|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24586873|NCT00892463|Antidepressive Agents|antidepressive agents|mesh-ancestor
24586874|NCT00892463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24586884|NCT00892489|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24586885|NCT00892489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24586886|NCT00892489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24586888|NCT00892489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586912|NCT00892541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137876|NCT02982395|Alkylating Agents|alkylating agents|mesh-ancestor
25137877|NCT02982395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25137878|NCT02982395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25137879|NCT02982395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25137880|NCT02982395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25137881|NCT02982395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25137882|NCT02982395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137883|NCT02982005|Brodalumab|brodalumab|mesh-list
25137884|NCT02982005|Dermatologic Agents|dermatologic agents|mesh-ancestor
25137885|NCT02982148|Methylene Blue|methylene blue|mesh-list
25137886|NCT02982148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25137887|NCT02982148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137888|NCT02982122|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
24586915|NCT00892541|Dopamine Agents|dopamine agents|mesh-ancestor
24586921|NCT00892736|Veliparib|veliparib|mesh-list
24586961|NCT00892918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24586962|NCT00892918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24586963|NCT00892918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586964|NCT00892918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586965|NCT00892996|Dexamethasone|dexamethasone|mesh-list
24586966|NCT00892996|Dexamethasone acetate|dexamethasone acetate|mesh-list
24586967|NCT00892996|BB 1101|bb 1101|mesh-list
24586968|NCT00892996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24586969|NCT00892996|Antiemetics|antiemetics|mesh-ancestor
24586970|NCT00892996|Autonomic Agents|autonomic agents|mesh-ancestor
24586971|NCT00892996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24587050|NCT00893256|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24587051|NCT00893256|Dopamine Agents|dopamine agents|mesh-ancestor
24587081|NCT00893412|Analgesics|analgesics|mesh-ancestor
24587082|NCT00893412|Sensory System Agents|sensory system agents|mesh-ancestor
24587083|NCT00893412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24587084|NCT00893425|Ramipril|ramipril|mesh-list
24587085|NCT00893425|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24587086|NCT00893425|Protease Inhibitors|protease inhibitors|mesh-ancestor
24587087|NCT00893425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634084|NCT01131975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24634086|NCT01131988|Tacrolimus|tacrolimus|mesh-list
24587088|NCT00893425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587089|NCT00893425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24587090|NCT00893451|Vitamin D|vitamin d|mesh-list
24587091|NCT00893451|Cholecalciferol|cholecalciferol|mesh-list
24587092|NCT00893451|Vitamins|vitamins|mesh-ancestor
25137897|NCT02981784|Ponatinib|ponatinib|mesh-list
25137898|NCT02981784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25137899|NCT02981784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25137900|NCT02981784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25086226|NCT03290859|Anesthetics|anesthetics|mesh-ancestor
25137901|NCT02981784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137903|NCT02981914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25137904|NCT02981914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25137905|NCT02981719|Gemcitabine|gemcitabine|mesh-list
25137906|NCT02981719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25137907|NCT02981719|Antimetabolites|antimetabolites|mesh-ancestor
25683554|NCT01728259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25683555|NCT01728259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683556|NCT01728259|Immunologic Factors|immunologic factors|mesh-ancestor
25137908|NCT02981719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137909|NCT02981719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25137911|NCT02981719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25137912|NCT02981719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25137913|NCT02981719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25137914|NCT02981719|Immunologic Factors|immunologic factors|mesh-ancestor
25137915|NCT02981719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137916|NCT02981615|Levofloxacin|levofloxacin|mesh-list
25137917|NCT02981615|Ofloxacin|ofloxacin|mesh-list
25137918|NCT02981615|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25137919|NCT02981615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25137920|NCT02981615|Renal Agents|renal agents|mesh-ancestor
25137921|NCT02981615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24966356|NCT03768908|Schistosomicides|schistosomicides|mesh-ancestor
24966357|NCT03768908|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24966358|NCT03768908|Anthelmintics|anthelmintics|mesh-ancestor
24966359|NCT03768882|Acetaminophen|acetaminophen|mesh-list
24966360|NCT03768882|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
24587093|NCT00893451|Micronutrients|micronutrients|mesh-ancestor
24587094|NCT00893451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587095|NCT00893451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24587096|NCT00893451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24587097|NCT00893477|Rituximab|rituximab|mesh-list
24587098|NCT00893477|Sargramostim|sargramostim|mesh-list
24587099|NCT00893477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24587100|NCT00893477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587101|NCT00893477|Immunologic Factors|immunologic factors|mesh-ancestor
24587102|NCT00893477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587103|NCT00893477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24587142|NCT00893594|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25137923|NCT02981615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25137924|NCT02981615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25137925|NCT02981615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137926|NCT02981615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25137927|NCT02981615|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25137928|NCT02981615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25137929|NCT02981446|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25137930|NCT02981446|Latanoprost|latanoprost|mesh-list
25137931|NCT02981446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25137932|NCT02981329|Metformin|metformin|mesh-list
24966407|NCT03768518|Hormones|hormones|mesh-ancestor
24966408|NCT03768518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24587143|NCT00893594|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24587144|NCT00893594|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24587145|NCT00893594|Serotonin Agents|serotonin agents|mesh-ancestor
24587146|NCT00893594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24463137|NCT00359112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587361|NCT00894608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587362|NCT00894608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24587363|NCT00894608|Hormone Antagonists|hormone antagonists|mesh-ancestor
24587364|NCT00894608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24587365|NCT00894608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587366|NCT00894621|Norepinephrine|norepinephrine|mesh-list
24634114|NCT01132157|Anesthetics|anesthetics|mesh-ancestor
24587367|NCT00894621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24587390|NCT00894673|Heparin|heparin|mesh-list
24587410|NCT00894751|Analgesics|analgesics|mesh-ancestor
24587411|NCT00894751|Sensory System Agents|sensory system agents|mesh-ancestor
24587412|NCT00894751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24587413|NCT00894751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24587471|NCT00895089|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24587472|NCT00895089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24587473|NCT00895089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24587680|NCT00896402|Disinfectants|disinfectants|mesh-ancestor
24587681|NCT00896402|Dermatologic Agents|dermatologic agents|mesh-ancestor
25282941|NCT05080010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587682|NCT00896402|Trace Elements|trace elements|mesh-ancestor
24587683|NCT00896402|Micronutrients|micronutrients|mesh-ancestor
24587684|NCT00896402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587685|NCT00896402|Plasma Substitutes|plasma substitutes|mesh-ancestor
24587686|NCT00896402|Blood Substitutes|blood substitutes|mesh-ancestor
24587687|NCT00896428|Gallopamil|gallopamil|mesh-list
24587688|NCT00896428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24587689|NCT00896428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24587690|NCT00896428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587691|NCT00896428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24587692|NCT00896428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587693|NCT00896519|Prednisone|prednisone|mesh-list
24587694|NCT00896519|Cyclophosphamide|cyclophosphamide|mesh-list
25137934|NCT02981329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137935|NCT02981290|Mycophenolic Acid|mycophenolic acid|mesh-list
25137936|NCT02981290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25137937|NCT02981290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25137938|NCT02981290|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25137939|NCT02981290|Antitubercular Agents|antitubercular agents|mesh-ancestor
25137940|NCT02981290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25137941|NCT02981290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24860657|NCT02311777|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25137943|NCT02981290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137944|NCT02981212|Mycophenolic Acid|mycophenolic acid|mesh-list
24588309|NCT00901888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25137946|NCT02981212|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25046203|NCT00869336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25046204|NCT00869128|Melatonin|melatonin|mesh-list
25046205|NCT00869128|Antioxidants|antioxidants|mesh-ancestor
25046206|NCT00869128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046207|NCT00869128|Protective Agents|protective agents|mesh-ancestor
25046208|NCT00869128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587695|NCT00896519|Rituximab|rituximab|mesh-list
24587696|NCT00896519|Doxorubicin|doxorubicin|mesh-list
24587728|NCT00896558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24587784|NCT00897026|Paclitaxel|paclitaxel|mesh-list
24587785|NCT00897026|Cyclophosphamide|cyclophosphamide|mesh-list
24587786|NCT00897026|Doxorubicin|doxorubicin|mesh-list
24587787|NCT00897026|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24587788|NCT00897026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24587789|NCT00897026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587790|NCT00897026|Tubulin Modulators|tubulin modulators|mesh-ancestor
24587791|NCT00897026|Antimitotic Agents|antimitotic agents|mesh-ancestor
24587792|NCT00897026|Mitosis Modulators|mitosis modulators|mesh-ancestor
24588055|NCT00900510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24588056|NCT00900510|Renal Agents|renal agents|mesh-ancestor
24588058|NCT00900510|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24588059|NCT00900510|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24588060|NCT00900510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24588061|NCT00900510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588062|NCT00900510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588063|NCT00900510|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24588064|NCT00900510|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24588065|NCT00900510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24588194|NCT00901524|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24588195|NCT00901524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588196|NCT00901524|Antiviral Agents|antiviral agents|mesh-ancestor
24588197|NCT00901524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24588302|NCT00901875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25046209|NCT00869128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25046210|NCT00864175|Docetaxel|docetaxel|mesh-list
25046211|NCT00864175|Trastuzumab|trastuzumab|mesh-list
25683557|NCT01728259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25046212|NCT00864175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25046213|NCT00864175|Tubulin Modulators|tubulin modulators|mesh-ancestor
25046214|NCT00864175|Antimitotic Agents|antimitotic agents|mesh-ancestor
25683558|NCT01728259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25683559|NCT01728259|Growth Substances|growth substances|mesh-ancestor
25683560|NCT01728259|Growth Inhibitors|growth inhibitors|mesh-ancestor
25683561|NCT01727193|Azathioprine|azathioprine|mesh-list
25683562|NCT01727193|Leflunomide|leflunomide|mesh-list
25683563|NCT01727193|Antimetabolites|antimetabolites|mesh-ancestor
24458121|NCT00336674|Insulin|insulin|mesh-list
24860682|NCT02312037|Gemtuzumab|gemtuzumab|mesh-list
25046215|NCT00864175|Mitosis Modulators|mitosis modulators|mesh-ancestor
25046216|NCT00864175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046217|NCT00864175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25046218|NCT00863369|Gemcitabine|gemcitabine|mesh-list
25046219|NCT00863369|Rituximab|rituximab|mesh-list
25046220|NCT00863369|Bortezomib|bortezomib|mesh-list
25046221|NCT00863369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25046222|NCT00863369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25046223|NCT00863369|Immunologic Factors|immunologic factors|mesh-ancestor
25046224|NCT00863369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046225|NCT00863369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25046226|NCT00863369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25046227|NCT00863369|Antimetabolites|antimetabolites|mesh-ancestor
25046228|NCT00863369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046229|NCT00863369|Antiviral Agents|antiviral agents|mesh-ancestor
25137947|NCT02981212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25137948|NCT02981212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25137949|NCT02981212|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25137950|NCT02981212|Antitubercular Agents|antitubercular agents|mesh-ancestor
25137951|NCT02981212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25137952|NCT02981212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25137953|NCT02981212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588303|NCT00901875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588304|NCT00901875|Analgesics|analgesics|mesh-ancestor
24588305|NCT00901875|Sensory System Agents|sensory system agents|mesh-ancestor
24588306|NCT00901875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588307|NCT00901875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24588308|NCT00901888|Nitroprusside|nitroprusside|mesh-list
24588310|NCT00901888|Vasodilator Agents|vasodilator agents|mesh-ancestor
24588311|NCT00901888|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24588312|NCT00901888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588388|NCT00902460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588390|NCT00902460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24588391|NCT00902460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24588392|NCT00902460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24588393|NCT00902460|Anesthetics, General|anesthetics, general|mesh-ancestor
25137956|NCT02981212|Glucocorticoids|glucocorticoids|mesh-ancestor
25137957|NCT02981212|Hormones|hormones|mesh-ancestor
24900897|NCT04390334|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25137958|NCT02981212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25137959|NCT02981212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137960|NCT02981212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25137961|NCT02981212|Protease Inhibitors|protease inhibitors|mesh-ancestor
25137962|NCT02981303|Pembrolizumab|pembrolizumab|mesh-list
25137963|NCT02981303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25137964|NCT02981303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25137965|NCT02981264|Lidocaine|lidocaine|mesh-list
25137966|NCT02981264|Anesthetics, Local|anesthetics, local|mesh-ancestor
25137967|NCT02981264|Anesthetics|anesthetics|mesh-ancestor
25137968|NCT02981264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25137969|NCT02981264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588394|NCT00902460|Anesthetics|anesthetics|mesh-ancestor
24588395|NCT00902460|GABA Modulators|gaba modulators|mesh-ancestor
24588396|NCT00902460|GABA Agents|gaba agents|mesh-ancestor
24588397|NCT00902460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24588398|NCT00902460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588399|NCT00902460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24588400|NCT00902460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588401|NCT00902473|Topiramate|topiramate|mesh-list
24588402|NCT00902473|Anticonvulsants|anticonvulsants|mesh-ancestor
24588491|NCT00902915|Autonomic Agents|autonomic agents|mesh-ancestor
24588492|NCT00902915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588493|NCT00902915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588494|NCT00902915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25683564|NCT01727193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683565|NCT01727193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25683566|NCT01727193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683567|NCT01727193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24588571|NCT00903188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24588612|NCT00903279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24588686|NCT00903942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588687|NCT00903942|Tubulin Modulators|tubulin modulators|mesh-ancestor
24588688|NCT00903942|Antimitotic Agents|antimitotic agents|mesh-ancestor
24588699|NCT00903994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24588700|NCT00903994|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24588701|NCT00903994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588774|NCT00904202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24588775|NCT00904202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24588776|NCT00904202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24588777|NCT00904202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24588778|NCT00904202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24588779|NCT00904202|Antimanic Agents|antimanic agents|mesh-ancestor
24588780|NCT00904280|Oxymorphone|oxymorphone|mesh-list
24588781|NCT00904280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24588782|NCT00904280|Narcotics|narcotics|mesh-ancestor
24588783|NCT00904280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24588828|NCT00904436|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24588829|NCT00904436|Cholinergic Agents|cholinergic agents|mesh-ancestor
24588830|NCT00904436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24588831|NCT00904436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588833|NCT00904449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25137971|NCT02981264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25137972|NCT02981264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24860728|NCT02312232|Carbidopa|carbidopa|mesh-list
25137973|NCT02981264|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25137976|NCT02981264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137978|NCT02981459|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25137979|NCT02981459|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25137980|NCT02981459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25137981|NCT02981459|Adrenergic Agents|adrenergic agents|mesh-ancestor
25137982|NCT02981459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25137983|NCT02981459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137984|NCT02981459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137985|NCT02981459|Urological Agents|urological agents|mesh-ancestor
24627254|NCT01091571|Dipyridamole|dipyridamole|mesh-list
24588834|NCT00904449|Narcotics|narcotics|mesh-ancestor
24588835|NCT00904449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24588836|NCT00904449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588837|NCT00904449|Analgesics|analgesics|mesh-ancestor
24588838|NCT00904449|Sensory System Agents|sensory system agents|mesh-ancestor
24588888|NCT00904605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588889|NCT00904605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588890|NCT00904631|Salicylic Acid|salicylic acid|mesh-list
24588891|NCT00904631|Salicylates|salicylates|mesh-list
24588892|NCT00904631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24588893|NCT00904631|Antifungal Agents|antifungal agents|mesh-ancestor
24588912|NCT00904644|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24588913|NCT00904644|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24588916|NCT00904657|Sunitinib|sunitinib|mesh-list
24588932|NCT00904735|Imatinib Mesylate|imatinib mesylate|mesh-list
25683568|NCT01727193|Immunologic Factors|immunologic factors|mesh-ancestor
25683569|NCT01727193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683570|NCT01727193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25683571|NCT01727193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683572|NCT01643460|Ethanol|ethanol|mesh-list
25683573|NCT01643460|Paclitaxel|paclitaxel|mesh-list
25683574|NCT01643460|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25683575|NCT01643460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25683576|NCT01643460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588933|NCT00904735|Hydroxyurea|hydroxyurea|mesh-list
24588934|NCT00904735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588935|NCT00904735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24588936|NCT00904735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588937|NCT00904735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588938|NCT00904735|Antisickling Agents|antisickling agents|mesh-ancestor
24588939|NCT00904735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24588941|NCT00904852|Temozolomide|temozolomide|mesh-list
24589142|NCT00905983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634430|NCT01133470|Ephedrine|ephedrine|mesh-list
24589143|NCT00905983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24589145|NCT00905983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589146|NCT00905983|Tubulin Modulators|tubulin modulators|mesh-ancestor
24589147|NCT00905983|Antimitotic Agents|antimitotic agents|mesh-ancestor
25137990|NCT02981121|Metformin|metformin|mesh-list
25137992|NCT02981121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137993|NCT02981095|Bupivacaine|bupivacaine|mesh-list
24860750|NCT02312427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25137994|NCT02981095|Anesthetics, Local|anesthetics, local|mesh-ancestor
25137995|NCT02981095|Anesthetics|anesthetics|mesh-ancestor
25137996|NCT02981095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25137997|NCT02981095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25137998|NCT02981095|Sensory System Agents|sensory system agents|mesh-ancestor
25137999|NCT02981095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25138000|NCT02980991|Pemetrexed|pemetrexed|mesh-list
25138001|NCT02980991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138002|NCT02980991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25138003|NCT02980991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138004|NCT02980991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25138005|NCT02980991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25138006|NCT02981030|Misoprostol|misoprostol|mesh-list
25138007|NCT02981030|Mifepristone|mifepristone|mesh-list
25138008|NCT02981030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25138009|NCT02981030|Abortifacient Agents|abortifacient agents|mesh-ancestor
25138010|NCT02981030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25138011|NCT02981030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138012|NCT02981030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25138013|NCT02981030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25138014|NCT02981030|Oxytocics|oxytocics|mesh-ancestor
25138015|NCT02981030|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25138016|NCT02981030|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24589180|NCT00906048|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24589181|NCT00906048|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24589182|NCT00906048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24589183|NCT00906061|Gemcitabine|gemcitabine|mesh-list
24589184|NCT00906061|Docetaxel|docetaxel|mesh-list
24589185|NCT00906061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24589186|NCT00906061|Antimetabolites|antimetabolites|mesh-ancestor
24634439|NCT01133470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24634440|NCT01133470|Sympathomimetics|sympathomimetics|mesh-ancestor
24634441|NCT01133470|Adrenergic Agents|adrenergic agents|mesh-ancestor
24634442|NCT01133470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24541112|NCT00670878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541114|NCT00670878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24541115|NCT00670878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541116|NCT00670878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24541117|NCT00670878|Immunologic Factors|immunologic factors|mesh-ancestor
25138032|NCT02980809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138033|NCT02980809|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25138034|NCT02980809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25138035|NCT02980926|Bupivacaine|bupivacaine|mesh-list
25138036|NCT02980926|Mepivacaine|mepivacaine|mesh-list
25138037|NCT02980926|Anesthetics, Local|anesthetics, local|mesh-ancestor
25138038|NCT02980926|Anesthetics|anesthetics|mesh-ancestor
25138039|NCT02980926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25138040|NCT02980926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138041|NCT02980926|Sensory System Agents|sensory system agents|mesh-ancestor
25138042|NCT02980926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25138043|NCT02980913|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25138044|NCT02980913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25283066|NCT05077592|Povidone|povidone|mesh-list
24634443|NCT01133470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634444|NCT01133470|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24634446|NCT01133470|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24589303|NCT00906685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24589304|NCT00906685|Growth Substances|growth substances|mesh-ancestor
24589305|NCT00906685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589306|NCT00906685|Growth Inhibitors|growth inhibitors|mesh-ancestor
24589308|NCT00906724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24589309|NCT00906724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589311|NCT00906828|Carbidopa|carbidopa|mesh-list
24589312|NCT00906828|Entacapone|entacapone|mesh-list
24589313|NCT00906828|Tolcapone|tolcapone|mesh-list
24589314|NCT00906828|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24589315|NCT00906828|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24589316|NCT00906828|Dopamine Agents|dopamine agents|mesh-ancestor
24589323|NCT00906867|Methacholine Chloride|methacholine chloride|mesh-list
24589330|NCT00906867|Respiratory System Agents|respiratory system agents|mesh-ancestor
24589331|NCT00906867|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24589332|NCT00906867|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24589333|NCT00906867|Cholinergic Agents|cholinergic agents|mesh-ancestor
24589334|NCT00906867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24589335|NCT00906867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589336|NCT00906880|Eflornithine|eflornithine|mesh-list
24589337|NCT00906880|Nifurtimox|nifurtimox|mesh-list
24589338|NCT00906880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589604|NCT00908180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25138084|NCT02980965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25138085|NCT02980965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25138086|NCT02980965|Alkylating Agents|alkylating agents|mesh-ancestor
25138087|NCT02980965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138088|NCT02980965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138089|NCT02980965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25138090|NCT02980965|Tubulin Modulators|tubulin modulators|mesh-ancestor
25138091|NCT02980965|Antimitotic Agents|antimitotic agents|mesh-ancestor
25138092|NCT02980965|Mitosis Modulators|mitosis modulators|mesh-ancestor
25138093|NCT02980965|Antimetabolites|antimetabolites|mesh-ancestor
25138094|NCT02980965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25138095|NCT02980965|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25138096|NCT02980965|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25138097|NCT02980965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25138098|NCT02980965|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25138099|NCT02980965|Hormone Antagonists|hormone antagonists|mesh-ancestor
25138100|NCT02980965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25138101|NCT02980965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25138102|NCT02980965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25138103|NCT02980965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25138104|NCT02980965|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25138105|NCT02980965|Fertility Agents|fertility agents|mesh-ancestor
25138106|NCT02980965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25138107|NCT02980965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25138108|NCT02980757|Gliclazide|gliclazide|mesh-list
25138109|NCT02980757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25138110|NCT02980757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138111|NCT02980653|Megestrol|megestrol|mesh-list
25138112|NCT02980653|Megestrol Acetate|megestrol acetate|mesh-list
25138113|NCT02980653|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25138114|NCT02980653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25138115|NCT02980653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25138116|NCT02980653|Contraceptive Agents|contraceptive agents|mesh-ancestor
24860862|NCT02313272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25138117|NCT02980653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25138118|NCT02980653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683577|NCT01643460|Tubulin Modulators|tubulin modulators|mesh-ancestor
25079127|NCT03350295|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24589605|NCT00908180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25138119|NCT02980653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25138120|NCT02980653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25138121|NCT02980653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25138122|NCT02980653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138123|NCT02980653|Appetite Stimulants|appetite stimulants|mesh-ancestor
25138124|NCT02980653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25138125|NCT02980562|Bisacodyl|bisacodyl|mesh-list
25138126|NCT02980562|Cathartics|cathartics|mesh-ancestor
25138127|NCT02980562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25138128|NCT02980562|Laxatives|laxatives|mesh-ancestor
25138129|NCT02980497|Ethanol|ethanol|mesh-list
25138130|NCT02980497|Listerine|listerine|mesh-list
25138131|NCT02980497|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
25138132|NCT02980497|Sodium Fluoride|sodium fluoride|mesh-list
25138133|NCT02980497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25138134|NCT02980497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25046231|NCT00863369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046232|NCT00863369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25046234|NCT00862524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25046235|NCT00862524|Antimetabolites|antimetabolites|mesh-ancestor
25046236|NCT00862524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046237|NCT00862524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25046238|NCT00862524|Antiviral Agents|antiviral agents|mesh-ancestor
25046239|NCT00862524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25046240|NCT00862524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046241|NCT00862524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25046242|NCT00862524|Immunologic Factors|immunologic factors|mesh-ancestor
25046243|NCT00862524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138164|NCT02980458|Chelating Agents|chelating agents|mesh-ancestor
25138165|NCT02980458|Sequestering Agents|sequestering agents|mesh-ancestor
25138166|NCT02980458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138167|NCT02980250|Domperidone|domperidone|mesh-list
25138168|NCT02980250|Antiemetics|antiemetics|mesh-ancestor
25138169|NCT02980250|Autonomic Agents|autonomic agents|mesh-ancestor
25079164|NCT03349840|Insulin Glargine|insulin glargine|mesh-list
24589606|NCT00908180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589607|NCT00908180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589608|NCT00908180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24589609|NCT00908180|Antimetabolites|antimetabolites|mesh-ancestor
24589610|NCT00908180|Antiviral Agents|antiviral agents|mesh-ancestor
25138170|NCT02980250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25138171|NCT02980250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138172|NCT02980250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25138173|NCT02980250|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25138174|NCT02980250|Dopamine Agents|dopamine agents|mesh-ancestor
25138175|NCT02980250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25138176|NCT02980250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138179|NCT02980094|Tocopherols|tocopherols|mesh-list
25138180|NCT02980094|Tocotrienols|tocotrienols|mesh-list
25138181|NCT02980094|alpha-Tocopherol|alpha-tocopherol|mesh-list
25138182|NCT02980094|Selenium|selenium|mesh-list
25138183|NCT02980094|Antioxidants|antioxidants|mesh-list
25138184|NCT02980094|Micronutrients|micronutrients|mesh-ancestor
25138185|NCT02980094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138186|NCT02980094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138187|NCT02980094|Protective Agents|protective agents|mesh-ancestor
25138188|NCT02980094|Trace Elements|trace elements|mesh-ancestor
25138189|NCT02979886|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25138190|NCT02979886|Menotropins|menotropins|mesh-list
25138191|NCT02979886|Luteolytic Agents|luteolytic agents|mesh-ancestor
25138192|NCT02979886|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25138193|NCT02979886|Contraceptive Agents|contraceptive agents|mesh-ancestor
25138194|NCT02979886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25138195|NCT02979886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138196|NCT02979886|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25138197|NCT02979886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25138198|NCT02979886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138199|NCT02979886|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25138200|NCT02979886|Fertility Agents|fertility agents|mesh-ancestor
25138201|NCT02980016|Isoniazid|isoniazid|mesh-list
25138202|NCT02980016|Rifapentine|rifapentine|mesh-list
25138203|NCT02980016|Rifampin|rifampin|mesh-list
25138204|NCT02980016|Antitubercular Agents|antitubercular agents|mesh-ancestor
25683578|NCT01643460|Antimitotic Agents|antimitotic agents|mesh-ancestor
25135118|NCT03002259|Glucocorticoids|glucocorticoids|mesh-ancestor
25283123|NCT05068037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25138205|NCT02980016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25138206|NCT02980016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25138208|NCT02980016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25138211|NCT02980016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25138212|NCT02980016|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25138213|NCT02980016|Leprostatic Agents|leprostatic agents|mesh-ancestor
25138214|NCT02980016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25138215|NCT02980016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25138216|NCT02980016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25138217|NCT02980016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25138218|NCT02980016|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25138219|NCT02980016|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25138220|NCT02980016|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25138221|NCT02980016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25138223|NCT02979665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25138224|NCT02979665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25138225|NCT02979665|Growth Substances|growth substances|mesh-ancestor
25138226|NCT02979665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138227|NCT02979665|Growth Inhibitors|growth inhibitors|mesh-ancestor
25138228|NCT02979665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138230|NCT02979704|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25138231|NCT02979704|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24589611|NCT00908180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24589612|NCT00908180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24589613|NCT00908180|Immunologic Factors|immunologic factors|mesh-ancestor
24589614|NCT00908180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589615|NCT00908180|Antifungal Agents|antifungal agents|mesh-ancestor
24589739|NCT00908817|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24589740|NCT00908817|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24589741|NCT00908817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24589742|NCT00908817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24589743|NCT00908817|Disinfectants|disinfectants|mesh-ancestor
24589744|NCT00908817|Dermatologic Agents|dermatologic agents|mesh-ancestor
24589745|NCT00908817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24589746|NCT00908817|Glucocorticoids|glucocorticoids|mesh-ancestor
24589747|NCT00908817|Hormones|hormones|mesh-ancestor
24589748|NCT00908817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24589749|NCT00908817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589750|NCT00908817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24589751|NCT00908817|Immunologic Factors|immunologic factors|mesh-ancestor
24444832|NCT00299247|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24589890|NCT00909571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24589891|NCT00909571|Immunologic Factors|immunologic factors|mesh-ancestor
24589996|NCT00910195|Antipyretics|antipyretics|mesh-ancestor
24589997|NCT00910221|Atorvastatin|atorvastatin|mesh-list
24589998|NCT00910221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24589999|NCT00910221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24590012|NCT00910351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590013|NCT00910351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138234|NCT02979704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138235|NCT02979704|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24860931|NCT02313922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25138236|NCT02979704|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25138237|NCT02979704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25138238|NCT02979548|Ondansetron|ondansetron|mesh-list
25138239|NCT02979548|Aprepitant|aprepitant|mesh-list
25138240|NCT02979548|Metoclopramide|metoclopramide|mesh-list
25138241|NCT02979548|Antiemetics|antiemetics|mesh-ancestor
25138242|NCT02979548|Autonomic Agents|autonomic agents|mesh-ancestor
25138243|NCT02979548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25138244|NCT02979548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138245|NCT02979548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25138246|NCT02979548|Antipruritics|antipruritics|mesh-ancestor
25138247|NCT02979548|Dermatologic Agents|dermatologic agents|mesh-ancestor
25683579|NCT01643460|Mitosis Modulators|mitosis modulators|mesh-ancestor
25683580|NCT01643460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025664|NCT03635125|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25138248|NCT02979548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25138249|NCT02979548|Serotonin Agents|serotonin agents|mesh-ancestor
25138250|NCT02979548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25138251|NCT02979548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138252|NCT02979548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25138253|NCT02979548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25138254|NCT02979548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25138255|NCT02979548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25138256|NCT02979548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25138257|NCT02979548|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24590014|NCT00910351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24590015|NCT00910351|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24590016|NCT00910351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24590017|NCT00910390|Ethylene|ethylene|mesh-list
24590018|NCT00910390|Plant Growth Regulators|plant growth regulators|mesh-ancestor
24590019|NCT00910390|Growth Substances|growth substances|mesh-ancestor
24590020|NCT00910390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590021|NCT00910416|Remifentanil|remifentanil|mesh-list
24590078|NCT00910637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24590079|NCT00910637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590210|NCT00911235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24590211|NCT00911235|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24590212|NCT00911235|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24590213|NCT00911235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590214|NCT00911235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590215|NCT00911235|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24590216|NCT00911235|Hormone Antagonists|hormone antagonists|mesh-ancestor
24590217|NCT00911235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24590218|NCT00911235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138258|NCT02979548|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25138260|NCT02979548|Dopamine Agents|dopamine agents|mesh-ancestor
25138261|NCT02979561|Warfarin|warfarin|mesh-list
25138262|NCT02979561|Dabigatran|dabigatran|mesh-list
25138263|NCT02979561|Anticoagulants|anticoagulants|mesh-ancestor
25138264|NCT02979561|Antithrombins|antithrombins|mesh-ancestor
25138265|NCT02979561|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25138266|NCT02979561|Protease Inhibitors|protease inhibitors|mesh-ancestor
25138267|NCT02979561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25138268|NCT02979561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138269|NCT02979405|Phenylephrine|phenylephrine|mesh-list
25138270|NCT02979405|Oxymetazoline|oxymetazoline|mesh-list
25138271|NCT02979405|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25138272|NCT02979405|Mydriatics|mydriatics|mesh-ancestor
25138273|NCT02979405|Autonomic Agents|autonomic agents|mesh-ancestor
25138274|NCT02979405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25138275|NCT02979405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138276|NCT02979405|Sympathomimetics|sympathomimetics|mesh-ancestor
25138277|NCT02979405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25138278|NCT02979405|Nasal Decongestants|nasal decongestants|mesh-ancestor
25138279|NCT02979405|Respiratory System Agents|respiratory system agents|mesh-ancestor
24966688|NCT03766425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590219|NCT00911235|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24590220|NCT00911235|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24590221|NCT00911235|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24590222|NCT00911235|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24590223|NCT00911235|Cholinergic Agents|cholinergic agents|mesh-ancestor
24590244|NCT00911313|Metformin|metformin|mesh-list
24590245|NCT00911313|Letrozole|letrozole|mesh-list
24590246|NCT00911313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24590248|NCT00911313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24590296|NCT00911664|Cholecalciferol|cholecalciferol|mesh-list
24590297|NCT00911664|Vitamins|vitamins|mesh-list
24590298|NCT00911664|Micronutrients|micronutrients|mesh-ancestor
24590299|NCT00911664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590300|NCT00911664|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24590301|NCT00911664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24590302|NCT00911716|Cyclophosphamide|cyclophosphamide|mesh-list
24590303|NCT00911716|Bevacizumab|bevacizumab|mesh-list
24590304|NCT00911716|Docetaxel|docetaxel|mesh-list
24590305|NCT00911716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24590306|NCT00911716|Immunologic Factors|immunologic factors|mesh-ancestor
24590765|NCT00913809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683581|NCT01643460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24590766|NCT00913822|Desipramine|desipramine|mesh-list
24590768|NCT00913822|Antidepressive Agents|antidepressive agents|mesh-ancestor
24590769|NCT00913822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24590770|NCT00913822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590771|NCT00913822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590772|NCT00913822|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24590773|NCT00913822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24590774|NCT00913822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24590775|NCT00913822|Adrenergic Agents|adrenergic agents|mesh-ancestor
24590776|NCT00913822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25138280|NCT02979405|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25138281|NCT02979405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25138282|NCT02979405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25138283|NCT02979405|Adrenergic Agents|adrenergic agents|mesh-ancestor
25138284|NCT02979405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25138285|NCT02979405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138286|NCT02979405|Protective Agents|protective agents|mesh-ancestor
25138287|NCT02979392|Paclitaxel|paclitaxel|mesh-list
25138288|NCT02979392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25046290|NCT00859521|Levetiracetam|levetiracetam|mesh-list
25046291|NCT00859521|Anticonvulsants|anticonvulsants|mesh-ancestor
25046292|NCT00859521|Nootropic Agents|nootropic agents|mesh-ancestor
25046293|NCT00859430|Levetiracetam|levetiracetam|mesh-list
25046294|NCT00859430|Anticonvulsants|anticonvulsants|mesh-ancestor
25046295|NCT00859430|Nootropic Agents|nootropic agents|mesh-ancestor
25046296|NCT00858871|Sorafenib|sorafenib|mesh-list
25046297|NCT00858871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138310|NCT02978976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25138311|NCT02978976|Glucocorticoids|glucocorticoids|mesh-ancestor
25138312|NCT02978976|Hormones|hormones|mesh-ancestor
25138313|NCT02978976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24590777|NCT00913822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590779|NCT00913848|Anticonvulsants|anticonvulsants|mesh-ancestor
24590780|NCT00913848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590781|NCT00913848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590782|NCT00913848|GABA Agents|gaba agents|mesh-ancestor
24590783|NCT00913848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24590784|NCT00913848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590785|NCT00913848|Antimanic Agents|antimanic agents|mesh-ancestor
24590819|NCT00913887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24590820|NCT00913887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590851|NCT00914004|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24590852|NCT00914004|Antidepressive Agents|antidepressive agents|mesh-ancestor
24590853|NCT00914004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24590854|NCT00914004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590888|NCT00914121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24590890|NCT00914134|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24451404|NCT00323583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24860966|NCT02314195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860967|NCT02314195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24860968|NCT02314195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24860970|NCT02314208|Resveratrol|resveratrol|mesh-list
24590891|NCT00914134|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24590892|NCT00914134|Dopamine Agents|dopamine agents|mesh-ancestor
24590893|NCT00914134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24590894|NCT00914134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590895|NCT00914134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590986|NCT00914563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24590987|NCT00914563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590988|NCT00914576|Vitamins|vitamins|mesh-list
24590989|NCT00914576|Micronutrients|micronutrients|mesh-ancestor
24590990|NCT00914576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590991|NCT00914641|Apixaban|apixaban|mesh-list
24591027|NCT00914693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24591029|NCT00914693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25138326|NCT02978482|Immunologic Factors|immunologic factors|mesh-ancestor
25138327|NCT02978482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138328|NCT02978313|Cetuximab|cetuximab|mesh-list
25138329|NCT02978313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25138330|NCT02978313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138336|NCT02978495|Paclitaxel|paclitaxel|mesh-list
25138337|NCT02978495|Cyclophosphamide|cyclophosphamide|mesh-list
25138338|NCT02978495|Carboplatin|carboplatin|mesh-list
25138339|NCT02978495|Doxorubicin|doxorubicin|mesh-list
25283254|NCT04925427|Naloxone|naloxone|mesh-list
25283255|NCT04925427|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25283256|NCT04925427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283257|NCT04925427|Sensory System Agents|sensory system agents|mesh-ancestor
25283258|NCT04925427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25283275|NCT04833764|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25283276|NCT04833764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25283277|NCT04833764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25283278|NCT04833764|Antimetabolites|antimetabolites|mesh-ancestor
25283279|NCT04833764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283280|NCT04833764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25283281|NCT04833764|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25283282|NCT04833764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25283283|NCT04824131|Tenofovir|tenofovir|mesh-list
25283284|NCT04824131|Emtricitabine|emtricitabine|mesh-list
25283285|NCT04824131|Cabotegravir|cabotegravir|mesh-list
24591059|NCT00914836|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24591060|NCT00914836|Betamethasone benzoate|betamethasone benzoate|mesh-list
24591061|NCT00914836|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
24591062|NCT00914836|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24591063|NCT00914836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24591064|NCT00914836|Glucocorticoids|glucocorticoids|mesh-ancestor
24591079|NCT00914888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591080|NCT00914888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591171|NCT00915408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24591172|NCT00915408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24591173|NCT00915408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24591174|NCT00915408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24591175|NCT00915408|Growth Substances|growth substances|mesh-ancestor
24591176|NCT00915408|Growth Inhibitors|growth inhibitors|mesh-ancestor
25138343|NCT02978495|Antimitotic Agents|antimitotic agents|mesh-ancestor
24541282|NCT00671814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24541283|NCT00671814|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24541284|NCT00671814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25138344|NCT02978495|Mitosis Modulators|mitosis modulators|mesh-ancestor
25138345|NCT02978495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138346|NCT02978495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25138347|NCT02978495|Immunologic Factors|immunologic factors|mesh-ancestor
25138348|NCT02978495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138349|NCT02978495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25138350|NCT02978495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25138351|NCT02978495|Alkylating Agents|alkylating agents|mesh-ancestor
25138352|NCT02978495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25138353|NCT02978495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25138354|NCT02978495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24591177|NCT00915460|Interferons|interferons|mesh-list
24591178|NCT00915460|Interferon-beta|interferon-beta|mesh-list
24591179|NCT00915460|Interferon beta-1a|interferon beta-1a|mesh-list
24591180|NCT00915460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591273|NCT00915733|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24591274|NCT00915733|Protective Agents|protective agents|mesh-ancestor
24591318|NCT00915837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591319|NCT00915837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591321|NCT00915850|Docetaxel|docetaxel|mesh-list
24591322|NCT00915850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591323|NCT00915850|Tubulin Modulators|tubulin modulators|mesh-ancestor
25683582|NCT01643460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25683583|NCT01643460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25683584|NCT01643460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683585|NCT01547741|Paclitaxel|paclitaxel|mesh-list
25683586|NCT01547741|Docetaxel|docetaxel|mesh-list
25683587|NCT01547741|Cyclophosphamide|cyclophosphamide|mesh-list
25683588|NCT01547741|Doxorubicin|doxorubicin|mesh-list
25683589|NCT01547741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25683590|NCT01547741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683591|NCT01547741|Tubulin Modulators|tubulin modulators|mesh-ancestor
25683592|NCT01547741|Antimitotic Agents|antimitotic agents|mesh-ancestor
25683593|NCT01547741|Mitosis Modulators|mitosis modulators|mesh-ancestor
25683594|NCT01547741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683595|NCT01547741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25683596|NCT01547741|Immunologic Factors|immunologic factors|mesh-ancestor
25683597|NCT01547741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283295|NCT04824131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24591609|NCT00917839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24591610|NCT00917839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591611|NCT00917839|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24591612|NCT00917839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24591613|NCT00917839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24591614|NCT00917839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24591615|NCT00917839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24591616|NCT00917878|Calcium|calcium|mesh-list
24591617|NCT00917878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24591618|NCT00917878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591619|NCT00917891|Dapivirine|dapivirine|mesh-list
24591778|NCT00918554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24591779|NCT00918554|Immunologic Factors|immunologic factors|mesh-ancestor
24591781|NCT00918554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25138355|NCT02978495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25138356|NCT02978495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860992|NCT02314286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24541298|NCT00672113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24541299|NCT00672113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541300|NCT00672113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24541301|NCT00672113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541302|NCT00672113|Vasodilator Agents|vasodilator agents|mesh-ancestor
24541303|NCT00672113|Tocolytic Agents|tocolytic agents|mesh-ancestor
24541304|NCT00672113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24541305|NCT00672165|Antibodies|antibodies|mesh-list
25138358|NCT02978547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25138359|NCT02978547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138360|NCT02978222|Molgramostim|molgramostim|mesh-list
25138361|NCT02978222|Sargramostim|sargramostim|mesh-list
25138362|NCT02978222|Immunologic Factors|immunologic factors|mesh-ancestor
25138363|NCT02978222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138364|NCT02978222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138372|NCT02978443|Nivolumab|nivolumab|mesh-list
24591783|NCT00918593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24591784|NCT00918593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591785|NCT00918632|Axitinib|axitinib|mesh-list
24591786|NCT00918632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591787|NCT00918632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24591822|NCT00919243|Antimetabolites|antimetabolites|mesh-ancestor
24591823|NCT00919243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683598|NCT01547741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25683599|NCT01547741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25683600|NCT01547741|Alkylating Agents|alkylating agents|mesh-ancestor
25683601|NCT01547741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25683602|NCT01547741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25683603|NCT01547741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25683604|NCT01547741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25683605|NCT01547741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683606|NCT01492361|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
25683607|NCT01492361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25683608|NCT01492361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25683609|NCT00954876|Capecitabine|capecitabine|mesh-list
25683610|NCT00954876|Cetuximab|cetuximab|mesh-list
25683611|NCT00954876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25283333|NCT04797312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25135916|NCT02994953|Immunologic Factors|immunologic factors|mesh-ancestor
25135917|NCT02994953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135923|NCT02995083|Lidocaine|lidocaine|mesh-list
25136144|NCT02993367|3-n-butylphthalide|3-n-butylphthalide|mesh-list
25136145|NCT02993367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25136146|NCT02993367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24591824|NCT00919243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591825|NCT00919243|Gout Suppressants|gout suppressants|mesh-ancestor
24591831|NCT00919282|Folic Acid|folic acid|mesh-list
24591868|NCT00919295|Serotonin Agents|serotonin agents|mesh-ancestor
24591869|NCT00919295|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24591870|NCT00919321|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24591873|NCT00919399|Tamoxifen|tamoxifen|mesh-list
24591916|NCT00919542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24591918|NCT00919542|Hormones|hormones|mesh-ancestor
24591919|NCT00919542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24861004|NCT02314312|Antifungal Agents|antifungal agents|mesh-ancestor
24591920|NCT00919542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24591921|NCT00919542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591922|NCT00919555|Pioglitazone|pioglitazone|mesh-list
24591923|NCT00919555|Tretinoin|tretinoin|mesh-list
24592004|NCT00920088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24592005|NCT00920088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592006|NCT00920088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24592007|NCT00920088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24592008|NCT00920088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24592090|NCT00920153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24592091|NCT00920153|Alkylating Agents|alkylating agents|mesh-ancestor
24592092|NCT00920153|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24592093|NCT00920244|Atropine|atropine|mesh-list
24592094|NCT00920244|Amiodarone|amiodarone|mesh-list
24592095|NCT00920244|Epinephrine|epinephrine|mesh-list
24635282|NCT01138085|Trametinib|trametinib|mesh-list
24592096|NCT00920244|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24592097|NCT00920244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25138373|NCT02978443|Ipilimumab|ipilimumab|mesh-list
25138374|NCT02978443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25138375|NCT02978443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138376|NCT02978443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25138377|NCT02978443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138378|NCT02977897|Octreotide|octreotide|mesh-list
25138379|NCT02977897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25138380|NCT02977897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25138381|NCT02977897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138382|NCT02977949|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25138383|NCT02977949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25138393|NCT02978040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25138395|NCT02978040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25138396|NCT02978040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138397|NCT02978040|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25138398|NCT02978040|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25138399|NCT02978040|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25138400|NCT02978040|Purinergic Agents|purinergic agents|mesh-ancestor
25138401|NCT02978040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25138402|NCT02978040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138403|NCT02977832|Alfuzosin|alfuzosin|mesh-list
25138404|NCT02977832|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25138405|NCT02977832|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25138406|NCT02977832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25138407|NCT02977832|Adrenergic Agents|adrenergic agents|mesh-ancestor
25138408|NCT02977832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24592098|NCT00920244|Adrenergic Agents|adrenergic agents|mesh-ancestor
25683612|NCT00954876|Antimetabolites|antimetabolites|mesh-ancestor
25683613|NCT00954876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683614|NCT00954876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683615|NCT00954876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25683616|NCT00181701|Paclitaxel|paclitaxel|mesh-list
25683617|NCT00181701|Carboplatin|carboplatin|mesh-list
25683618|NCT00181701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25283365|NCT04662723|Prednisolone acetate|prednisolone acetate|mesh-list
25283366|NCT04662723|Losartan|losartan|mesh-list
25283367|NCT04662723|Ramipril|ramipril|mesh-list
25283368|NCT04662723|Lisinopril|lisinopril|mesh-list
25136782|NCT02988869|Parasympatholytics|parasympatholytics|mesh-ancestor
25136855|NCT02988089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25137002|NCT02987699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25137004|NCT02987738|Dapagliflozin|dapagliflozin|mesh-list
24592099|NCT00920244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24592100|NCT00920244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592101|NCT00920244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861006|NCT02314312|Dermatologic Agents|dermatologic agents|mesh-ancestor
24592221|NCT00920868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24592222|NCT00920868|Antimetabolites|antimetabolites|mesh-ancestor
24592223|NCT00920868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592224|NCT00920868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24592225|NCT00920868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592226|NCT00920933|Prednisolone|prednisolone|mesh-list
24592227|NCT00920933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24592228|NCT00920933|Glucocorticoids|glucocorticoids|mesh-ancestor
24592229|NCT00920933|Hormones|hormones|mesh-ancestor
24592230|NCT00920933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24592231|NCT00920933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592232|NCT00920933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24592233|NCT00920933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24592234|NCT00920998|Z 338|z 338|mesh-list
25138410|NCT02977832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138411|NCT02977832|Urological Agents|urological agents|mesh-ancestor
25138412|NCT02978066|Anesthetics|anesthetics|mesh-list
25138413|NCT02978066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25138414|NCT02978066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138415|NCT02978001|Glycerol|glycerol|mesh-list
25138416|NCT02978001|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25138417|NCT02978001|Protective Agents|protective agents|mesh-ancestor
25138418|NCT02978001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138419|NCT02977468|Pembrolizumab|pembrolizumab|mesh-list
25138420|NCT02977468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25138421|NCT02977468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138422|NCT02977637|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25138423|NCT02977637|Hematinics|hematinics|mesh-ancestor
25138424|NCT02977637|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25138425|NCT02977637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25138426|NCT02977741|Olanzapine|olanzapine|mesh-list
25138427|NCT02977741|Antiemetics|antiemetics|mesh-ancestor
25138428|NCT02977741|Autonomic Agents|autonomic agents|mesh-ancestor
25138429|NCT02977741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25138430|NCT02977741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138431|NCT02977741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25138432|NCT02977741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25138433|NCT02977741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25138434|NCT02977741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25138435|NCT02977741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25138436|NCT02977741|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25138437|NCT02977741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25138438|NCT02977741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25138439|NCT02977741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138440|NCT02977741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25138441|NCT02977741|Serotonin Agents|serotonin agents|mesh-ancestor
25138442|NCT02977533|Acyclovir|acyclovir|mesh-list
25138443|NCT02977533|Antiviral Agents|antiviral agents|mesh-ancestor
24592235|NCT00920998|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24592236|NCT00920998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592263|NCT00921102|Narcotics|narcotics|mesh-ancestor
25138444|NCT02977533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25138445|NCT02977611|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25138446|NCT02977611|Hematinics|hematinics|mesh-ancestor
25138447|NCT02977208|Gabapentin|gabapentin|mesh-list
25683619|NCT00181701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683620|NCT00181701|Tubulin Modulators|tubulin modulators|mesh-ancestor
25683621|NCT00181701|Antimitotic Agents|antimitotic agents|mesh-ancestor
25683622|NCT00181701|Mitosis Modulators|mitosis modulators|mesh-ancestor
25683623|NCT00181701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692529|NCT02000921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138448|NCT02977208|Analgesics|analgesics|mesh-ancestor
25138449|NCT02977208|Sensory System Agents|sensory system agents|mesh-ancestor
24435524|NCT00266643|Analgesics|analgesics|mesh-ancestor
25138450|NCT02977208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25138451|NCT02977208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138452|NCT02977208|Anticonvulsants|anticonvulsants|mesh-ancestor
25138453|NCT02977208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25138454|NCT02977208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25138455|NCT02977208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25138456|NCT02977208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25138457|NCT02977208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25138458|NCT02977208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25138459|NCT02977208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25138460|NCT02977208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046298|NCT00858871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25046299|NCT00858871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046300|NCT00858871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046301|NCT00858702|Olmesartan|olmesartan|mesh-list
25046302|NCT00858702|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25046303|NCT00858702|Diuretics|diuretics|mesh-list
25046304|NCT00858702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25002586|NCT04490057|Bupropion|bupropion|mesh-list
25046331|NCT00854945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046332|NCT00851045|Leucovorin|leucovorin|mesh-list
25046333|NCT00851045|Bevacizumab|bevacizumab|mesh-list
25046334|NCT00851045|Fluorouracil|fluorouracil|mesh-list
25046335|NCT00851045|Irinotecan|irinotecan|mesh-list
25046336|NCT00851045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25046337|NCT00851045|Calcium|calcium|mesh-list
25046338|NCT00851045|Levoleucovorin|levoleucovorin|mesh-list
25046339|NCT00851045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25046340|NCT00851045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25046341|NCT00851045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25046342|NCT00851045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25046343|NCT00851045|Growth Substances|growth substances|mesh-ancestor
25046344|NCT00851045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046345|NCT00851045|Growth Inhibitors|growth inhibitors|mesh-ancestor
25046346|NCT00851045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25046347|NCT00851045|Antimetabolites|antimetabolites|mesh-ancestor
25046348|NCT00851045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046349|NCT00851045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25046350|NCT00851045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25046351|NCT00851045|Immunologic Factors|immunologic factors|mesh-ancestor
25046352|NCT00851045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25046353|NCT00851045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25046354|NCT00851045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25138461|NCT02977208|Antimanic Agents|antimanic agents|mesh-ancestor
25138462|NCT02977169|Cisplatin|cisplatin|mesh-list
25138463|NCT02977169|Carboplatin|carboplatin|mesh-list
25138464|NCT02977169|Pemetrexed|pemetrexed|mesh-list
25138465|NCT02977169|Vinorelbine|vinorelbine|mesh-list
25138466|NCT02977169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138467|NCT02977169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25138468|NCT02977169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079244|NCT03349177|Docetaxel|docetaxel|mesh-list
24592307|NCT00921180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592308|NCT00921219|Ivermectin|ivermectin|mesh-list
24592571|NCT00922844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592573|NCT00922896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25138474|NCT02977169|Mitosis Modulators|mitosis modulators|mesh-ancestor
25138475|NCT02977117|Dialysis Solutions|dialysis solutions|mesh-list
25138476|NCT02977117|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25138477|NCT02977312|Imatinib Mesylate|imatinib mesylate|mesh-list
25683624|NCT00084656|Ipilimumab|ipilimumab|mesh-list
25683625|NCT00084656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25683626|NCT00084656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683627|NCT00084656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25683628|NCT00084656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683629|NCT01879735|Cholylsarcosine|cholylsarcosine|mesh-list
25683630|NCT01879735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25683631|NCT01880086|Clomiphene|clomiphene|mesh-list
25137763|NCT02982798|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25137764|NCT02982798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25137902|NCT02981914|Pembrolizumab|pembrolizumab|mesh-list
25138019|NCT02981030|Contraceptive Agents|contraceptive agents|mesh-ancestor
25138020|NCT02981030|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25138021|NCT02981030|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25138022|NCT02981030|Hormone Antagonists|hormone antagonists|mesh-ancestor
25138023|NCT02981030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25283447|NCT04428203|Cannabidiol|cannabidiol|mesh-list
25283448|NCT04428203|Anticonvulsants|anticonvulsants|mesh-ancestor
25283449|NCT04427956|Riboflavin|riboflavin|mesh-list
25138478|NCT02977312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138479|NCT02977312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25138480|NCT02977312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25138481|NCT02977312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138482|NCT02977286|Methylnaltrexone|methylnaltrexone|mesh-list
25138484|NCT02977286|Bisacodyl|bisacodyl|mesh-list
25138485|NCT02977286|Magnesium citrate|magnesium citrate|mesh-list
25138486|NCT02977286|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
25138487|NCT02977286|Cathartics|cathartics|mesh-ancestor
25138488|NCT02977286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25138489|NCT02977286|Laxatives|laxatives|mesh-ancestor
25138490|NCT02977286|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25138491|NCT02977286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138492|NCT02977286|Sensory System Agents|sensory system agents|mesh-ancestor
25138493|NCT02977286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25138494|NCT02977286|Antidiarrheals|antidiarrheals|mesh-ancestor
25138495|NCT02977065|Atorvastatin|atorvastatin|mesh-list
25138496|NCT02977065|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25138497|NCT02977065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25138498|NCT02977065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24592574|NCT00922896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24592575|NCT00922896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24592576|NCT00922896|Antimetabolites|antimetabolites|mesh-ancestor
24592577|NCT00922896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592728|NCT00924222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24592729|NCT00924222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24592730|NCT00924430|Simvastatin|simvastatin|mesh-list
24592731|NCT00924430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24592732|NCT00924430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24592733|NCT00924430|Antimetabolites|antimetabolites|mesh-ancestor
25138501|NCT02977065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25138502|NCT02977065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25138503|NCT02977065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25138504|NCT02977013|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25138505|NCT02977013|Dalteparin|dalteparin|mesh-list
25138506|NCT02977013|Anticoagulants|anticoagulants|mesh-ancestor
25138507|NCT02977013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25138508|NCT02977013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25138509|NCT02977013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138510|NCT02977000|Propranolol|propranolol|mesh-list
25138511|NCT02977000|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25138512|NCT02977000|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25138513|NCT02977000|Adrenergic Agents|adrenergic agents|mesh-ancestor
25138514|NCT02977000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25138515|NCT02977000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138516|NCT02977000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138517|NCT02977000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25138518|NCT02977000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25138519|NCT02977000|Vasodilator Agents|vasodilator agents|mesh-ancestor
25138520|NCT02976987|Cidofovir|cidofovir|mesh-list
25138521|NCT02976987|Antiviral Agents|antiviral agents|mesh-ancestor
25138522|NCT02976987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25683632|NCT01880086|Enclomiphene|enclomiphene|mesh-list
25683633|NCT01880086|Zuclomiphene|zuclomiphene|mesh-list
25683634|NCT01880086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25683635|NCT01880086|Hormone Antagonists|hormone antagonists|mesh-ancestor
25683636|NCT01880086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25683637|NCT01880086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683638|NCT01880086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25683639|NCT01880086|Fertility Agents|fertility agents|mesh-ancestor
25683640|NCT01880086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25683641|NCT01880086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25692530|NCT02000973|Lidocaine|lidocaine|mesh-list
25683642|NCT01880086|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25283496|NCT04380142|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25283497|NCT04380142|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25283498|NCT04380142|Dopamine Agents|dopamine agents|mesh-ancestor
25283499|NCT04380142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25283501|NCT04380142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138523|NCT02976987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25138524|NCT02976987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138525|NCT02976805|Bisacodyl|bisacodyl|mesh-list
25138526|NCT02976805|Cathartics|cathartics|mesh-ancestor
24592734|NCT00924430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592735|NCT00924430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24592736|NCT00924430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24592737|NCT00924430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592797|NCT00925106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24592798|NCT00925106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592799|NCT00925106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24592813|NCT00925392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24592814|NCT00925392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24592815|NCT00925457|Domperidone|domperidone|mesh-list
24592842|NCT00925847|Lithium Carbonate|lithium carbonate|mesh-list
24592843|NCT00925847|Antidepressive Agents|antidepressive agents|mesh-ancestor
24592844|NCT00925847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24592845|NCT00925847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25138527|NCT02976805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25138528|NCT02976805|Laxatives|laxatives|mesh-ancestor
25138529|NCT02976909|Paclitaxel|paclitaxel|mesh-list
25138530|NCT02976909|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25138531|NCT02976909|Cisplatin|cisplatin|mesh-list
25138532|NCT02976909|Fluorouracil|fluorouracil|mesh-list
25138533|NCT02976909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25138534|NCT02976909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138535|NCT02976909|Tubulin Modulators|tubulin modulators|mesh-ancestor
25138536|NCT02976909|Antimitotic Agents|antimitotic agents|mesh-ancestor
25138537|NCT02976909|Mitosis Modulators|mitosis modulators|mesh-ancestor
25138538|NCT02976909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138539|NCT02976909|Antimetabolites|antimetabolites|mesh-ancestor
25138540|NCT02976909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25138541|NCT02976909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25138542|NCT02976909|Immunologic Factors|immunologic factors|mesh-ancestor
25138543|NCT02976909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138544|NCT02976727|Vitamin D|vitamin d|mesh-list
25138545|NCT02976727|Lidocaine|lidocaine|mesh-list
25138546|NCT02976727|Prilocaine|prilocaine|mesh-list
25138547|NCT02976727|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25138548|NCT02976727|Calcipotriene|calcipotriene|mesh-list
25138549|NCT02976727|Vitamins|vitamins|mesh-ancestor
25138550|NCT02976727|Micronutrients|micronutrients|mesh-ancestor
25138551|NCT02976727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138552|NCT02976727|Anesthetics, Local|anesthetics, local|mesh-ancestor
25138553|NCT02976727|Anesthetics|anesthetics|mesh-ancestor
25138554|NCT02976727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25138555|NCT02976727|Sensory System Agents|sensory system agents|mesh-ancestor
25138556|NCT02976727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25138557|NCT02976727|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25138558|NCT02976727|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25138559|NCT02976727|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25138560|NCT02976727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25138561|NCT02976727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967199|NCT03761511|Niacin|niacin|mesh-list
24592846|NCT00925847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592847|NCT00925847|Antimanic Agents|antimanic agents|mesh-ancestor
24592935|NCT00926354|Protective Agents|protective agents|mesh-ancestor
24592936|NCT00926354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25138562|NCT02976727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25138563|NCT02976727|Dermatologic Agents|dermatologic agents|mesh-ancestor
25138564|NCT02976727|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25138565|NCT02976740|Immunologic Factors|immunologic factors|mesh-list
25138566|NCT02976740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138567|NCT02976571|Bupivacaine|bupivacaine|mesh-list
25683643|NCT01880099|Galantamine|galantamine|mesh-list
25683644|NCT01880099|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
25683645|NCT01880099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683646|NCT01880099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138387|NCT02977949|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25138388|NCT02977949|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25138389|NCT02977949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25138390|NCT02978040|Tirofiban|tirofiban|mesh-list
25138391|NCT02978040|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25138392|NCT02978040|Cangrelor|cangrelor|mesh-list
25138394|NCT02978040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25138669|NCT02975843|Hormones|hormones|mesh-ancestor
25138670|NCT02975843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25138671|NCT02975986|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
25138672|NCT02975986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25283549|NCT04192955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25283550|NCT04192955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283556|NCT04162756|Cyclophosphamide|cyclophosphamide|mesh-list
25283557|NCT04162756|Fludarabine|fludarabine|mesh-list
25283558|NCT04162756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25283559|NCT04162756|Immunologic Factors|immunologic factors|mesh-ancestor
25283560|NCT04162756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283561|NCT04162756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25283562|NCT04162756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25138682|NCT02976012|Aflibercept|aflibercept|mesh-list
25138568|NCT02976571|Anesthetics, Local|anesthetics, local|mesh-ancestor
25138569|NCT02976571|Anesthetics|anesthetics|mesh-ancestor
25138570|NCT02976571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25138571|NCT02976571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138572|NCT02976571|Sensory System Agents|sensory system agents|mesh-ancestor
25138573|NCT02976571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25138574|NCT02976935|Xenon|xenon|mesh-list
25138575|NCT02976935|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25138576|NCT02976935|Anesthetics, General|anesthetics, general|mesh-ancestor
25138577|NCT02976935|Anesthetics|anesthetics|mesh-ancestor
25138578|NCT02976935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25138579|NCT02976935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138580|NCT02976623|Metronidazole|metronidazole|mesh-list
25138581|NCT02976623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25138582|NCT02976623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25138583|NCT02976623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25138584|NCT02976623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25138585|NCT02976896|Apatinib|apatinib|mesh-list
25138586|NCT02976896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138587|NCT02976896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25138588|NCT02976896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25138589|NCT02976896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138590|NCT02976272|Bortezomib|bortezomib|mesh-list
25138591|NCT02976272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138592|NCT02976259|Dolutegravir|dolutegravir|mesh-list
25138593|NCT02976259|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25138594|NCT02976259|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25138595|NCT02976259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592937|NCT00926354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24592938|NCT00926354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592939|NCT00926354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592941|NCT00926354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24592943|NCT00926419|Immunologic Factors|immunologic factors|mesh-ancestor
25683647|NCT01880099|Cholinergic Agents|cholinergic agents|mesh-ancestor
25683648|NCT01880099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25683649|NCT01880099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683650|NCT01880099|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25683651|NCT01880099|Autonomic Agents|autonomic agents|mesh-ancestor
25683652|NCT01880099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25683653|NCT01880099|Nootropic Agents|nootropic agents|mesh-ancestor
25683654|NCT01880424|Linaclotide|linaclotide|mesh-list
25683655|NCT01880424|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25683656|NCT01880424|Enzyme Activators|enzyme activators|mesh-ancestor
25683657|NCT01880424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683658|NCT01880424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25683659|NCT01880437|Cytarabine|cytarabine|mesh-list
25683660|NCT01880437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25683661|NCT01880437|Antimetabolites|antimetabolites|mesh-ancestor
25683662|NCT01880437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683663|NCT01880437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683664|NCT01880437|Antiviral Agents|antiviral agents|mesh-ancestor
25683665|NCT01880437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25683666|NCT01880437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25683667|NCT01880437|Immunologic Factors|immunologic factors|mesh-ancestor
24458212|NCT00337051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24592944|NCT00926419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592947|NCT00926614|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25138602|NCT02976597|Bupivacaine|bupivacaine|mesh-list
25138603|NCT02976597|Anesthetics, Local|anesthetics, local|mesh-ancestor
25138604|NCT02976597|Anesthetics|anesthetics|mesh-ancestor
25138605|NCT02976597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25138606|NCT02976597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138607|NCT02976597|Sensory System Agents|sensory system agents|mesh-ancestor
25138608|NCT02976597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25138609|NCT02976597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25138610|NCT02976597|Narcotics|narcotics|mesh-ancestor
24592948|NCT00926614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24592949|NCT00926614|Antimetabolites|antimetabolites|mesh-ancestor
24592950|NCT00926614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592982|NCT00926666|Anesthetics|anesthetics|mesh-ancestor
24593084|NCT00926835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24593085|NCT00926835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24593087|NCT00926835|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24593088|NCT00926835|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24593089|NCT00926835|Anticonvulsants|anticonvulsants|mesh-ancestor
24593090|NCT00926835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24593091|NCT00926835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24593092|NCT00926835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24593093|NCT00926835|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24593094|NCT00926835|Histamine Antagonists|histamine antagonists|mesh-ancestor
24593095|NCT00926835|Histamine Agents|histamine agents|mesh-ancestor
24593111|NCT00926926|Oxybutynin|oxybutynin|mesh-list
24593112|NCT00926926|Parasympatholytics|parasympatholytics|mesh-ancestor
24593113|NCT00926926|Autonomic Agents|autonomic agents|mesh-ancestor
24593114|NCT00926926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24593115|NCT00926926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593116|NCT00926926|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24593117|NCT00926926|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24593118|NCT00926926|Cholinergic Agents|cholinergic agents|mesh-ancestor
24593119|NCT00926926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24593125|NCT00926965|Antiemetics|antiemetics|mesh-ancestor
24593126|NCT00926965|Autonomic Agents|autonomic agents|mesh-ancestor
24593129|NCT00926965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24593155|NCT00927004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593156|NCT00927030|Melatonin|melatonin|mesh-list
24593157|NCT00927030|Antioxidants|antioxidants|mesh-ancestor
24593158|NCT00927030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138611|NCT02976597|Analgesics|analgesics|mesh-ancestor
25138612|NCT02976194|Ranibizumab|ranibizumab|mesh-list
25138613|NCT02976194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25138614|NCT02976194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25138615|NCT02976194|Growth Substances|growth substances|mesh-ancestor
25138616|NCT02976194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138617|NCT02976194|Growth Inhibitors|growth inhibitors|mesh-ancestor
25138618|NCT02976194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138619|NCT02976467|Fulacimstat|fulacimstat|mesh-list
25138620|NCT02976467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25138621|NCT02976467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138622|NCT02976441|Temozolomide|temozolomide|mesh-list
25138623|NCT02976441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25138624|NCT02976441|Alkylating Agents|alkylating agents|mesh-ancestor
25138625|NCT02976441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138626|NCT02976441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138628|NCT02976246|Vitamin K 2|vitamin k 2|mesh-list
25138630|NCT02976246|Micronutrients|micronutrients|mesh-ancestor
25138631|NCT02976246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138632|NCT02976246|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25138633|NCT02976246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25138634|NCT02976246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138635|NCT02976246|Hemostatics|hemostatics|mesh-ancestor
25683668|NCT01880437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138636|NCT02976246|Coagulants|coagulants|mesh-ancestor
25138637|NCT02976116|Gefitinib|gefitinib|mesh-list
25138638|NCT02976116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138639|NCT02976116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25138640|NCT02976116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25138641|NCT02976116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138642|NCT02975921|Povidone-Iodine|povidone-iodine|mesh-list
25138643|NCT02975921|Povidone|povidone|mesh-list
25138644|NCT02975921|Plasma Substitutes|plasma substitutes|mesh-ancestor
25138645|NCT02975921|Blood Substitutes|blood substitutes|mesh-ancestor
25138646|NCT02975921|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24593159|NCT00927030|Protective Agents|protective agents|mesh-ancestor
24593160|NCT00927030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593161|NCT00927030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24593163|NCT00927147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25138648|NCT02975843|Beclomethasone|beclomethasone|mesh-list
25138649|NCT02975843|Glycopyrrolate|glycopyrrolate|mesh-list
25138650|NCT02975843|Formoterol Fumarate|formoterol fumarate|mesh-list
25138651|NCT02975843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25138652|NCT02975843|Autonomic Agents|autonomic agents|mesh-ancestor
25138653|NCT02975843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25138654|NCT02975843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138655|NCT02975843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25138656|NCT02975843|Respiratory System Agents|respiratory system agents|mesh-ancestor
25138657|NCT02975843|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25138658|NCT02975843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25138659|NCT02975843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25138660|NCT02975843|Adrenergic Agents|adrenergic agents|mesh-ancestor
25138661|NCT02975843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25138662|NCT02975843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138663|NCT02975843|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25138664|NCT02975843|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25138665|NCT02975843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24627433|NCT01092806|Tacrolimus|tacrolimus|mesh-list
24593164|NCT00927147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24593165|NCT00927212|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
24593166|NCT00927212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24593167|NCT00927212|Immunologic Factors|immunologic factors|mesh-ancestor
24593168|NCT00927212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593169|NCT00927212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24593170|NCT00927212|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24593171|NCT00927212|Protective Agents|protective agents|mesh-ancestor
24593172|NCT00927212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24463300|NCT00359879|Exenatide|exenatide|mesh-list
24593331|NCT00927979|Ropivacaine|ropivacaine|mesh-list
24593332|NCT00927979|Anesthetics, Local|anesthetics, local|mesh-ancestor
24593333|NCT00927979|Anesthetics|anesthetics|mesh-ancestor
24593341|NCT00928148|Sympathomimetics|sympathomimetics|mesh-ancestor
24593349|NCT00928148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24593350|NCT00928148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24593359|NCT00928213|Heparin|heparin|mesh-list
24593523|NCT00929955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593524|NCT00929955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24593665|NCT00930488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593666|NCT00930488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593667|NCT00930488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24593668|NCT00930488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24593669|NCT00930488|Contraceptive Agents|contraceptive agents|mesh-ancestor
25138666|NCT02975843|Cholinergic Agents|cholinergic agents|mesh-ancestor
25138667|NCT02975843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25138668|NCT02975843|Glucocorticoids|glucocorticoids|mesh-ancestor
25046356|NCT00851045|Protective Agents|protective agents|mesh-ancestor
25046357|NCT00851045|Vitamin B Complex|vitamin b complex|mesh-ancestor
25046358|NCT00851045|Vitamins|vitamins|mesh-ancestor
25046359|NCT00851045|Micronutrients|micronutrients|mesh-ancestor
25046360|NCT00850577|Paclitaxel|paclitaxel|mesh-list
25046361|NCT00850577|Bevacizumab|bevacizumab|mesh-list
25046362|NCT00850577|Carboplatin|carboplatin|mesh-list
25046363|NCT00850577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25046364|NCT00850577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25046365|NCT00850577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25046366|NCT00850577|Tubulin Modulators|tubulin modulators|mesh-ancestor
25046367|NCT00850577|Antimitotic Agents|antimitotic agents|mesh-ancestor
25046368|NCT00850577|Mitosis Modulators|mitosis modulators|mesh-ancestor
25046369|NCT00850577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046370|NCT00850577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25046371|NCT00850577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25046372|NCT00850577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25046373|NCT00850577|Growth Substances|growth substances|mesh-ancestor
25046374|NCT00850577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046375|NCT00850577|Growth Inhibitors|growth inhibitors|mesh-ancestor
25046376|NCT00850174|Oxcarbazepine|oxcarbazepine|mesh-list
25046377|NCT00850174|Anticonvulsants|anticonvulsants|mesh-ancestor
24593670|NCT00930488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24593671|NCT00930488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593834|NCT00931138|Daunorubicin|daunorubicin|mesh-list
24593835|NCT00931138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24593865|NCT00931281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24541440|NCT00672776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24541442|NCT00672776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541443|NCT00672776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24541444|NCT00672776|Antidepressive Agents|antidepressive agents|mesh-ancestor
24541445|NCT00672776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24541446|NCT00672776|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24541447|NCT00672776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24861146|NCT02315196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24861147|NCT02315196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593866|NCT00931281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24593867|NCT00931281|Protease Inhibitors|protease inhibitors|mesh-ancestor
24593868|NCT00931281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594037|NCT00931957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24671125|NCT01323608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24594038|NCT00931957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24594039|NCT00931957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24594041|NCT00931957|Sensory System Agents|sensory system agents|mesh-ancestor
24594042|NCT00932048|Atorvastatin|atorvastatin|mesh-list
24594043|NCT00932048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24594044|NCT00932048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24594114|NCT00932555|Coagulants|coagulants|mesh-ancestor
24594116|NCT00932685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24594117|NCT00932685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24594286|NCT00933374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138689|NCT02975453|Rivaroxaban|rivaroxaban|mesh-list
25138690|NCT02975453|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25138691|NCT02975453|Antithrombins|antithrombins|mesh-ancestor
25138692|NCT02975453|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25138693|NCT02975453|Protease Inhibitors|protease inhibitors|mesh-ancestor
25138694|NCT02975453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25138695|NCT02975453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138696|NCT02975453|Anticoagulants|anticoagulants|mesh-ancestor
25138697|NCT02975440|Rifampin|rifampin|mesh-list
25138698|NCT02975440|Midazolam|midazolam|mesh-list
25138699|NCT02975440|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24627465|NCT01092962|Antitubercular Agents|antitubercular agents|mesh-ancestor
24594287|NCT00933374|Tubulin Modulators|tubulin modulators|mesh-ancestor
24594288|NCT00933374|Antimitotic Agents|antimitotic agents|mesh-ancestor
24671126|NCT01323712|Vitamin D|vitamin d|mesh-list
24594289|NCT00933374|Mitosis Modulators|mitosis modulators|mesh-ancestor
24594290|NCT00933374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594291|NCT00933374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24594292|NCT00933374|Immunologic Factors|immunologic factors|mesh-ancestor
24594293|NCT00933374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594296|NCT00933387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24594297|NCT00933387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24594429|NCT00933894|Serotonin Agents|serotonin agents|mesh-ancestor
24594430|NCT00933894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683669|NCT01880515|Tetracycline|tetracycline|mesh-list
25139792|NCT02968693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25139793|NCT02968693|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
24594431|NCT00933894|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24594432|NCT00933894|Antidepressive Agents|antidepressive agents|mesh-ancestor
24861162|NCT02315495|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24861163|NCT02315495|Protease Inhibitors|protease inhibitors|mesh-ancestor
24594783|NCT00935506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24594784|NCT00935506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24594785|NCT00935506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24594786|NCT00935506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594940|NCT00936195|Emtricitabine|emtricitabine|mesh-list
24594941|NCT00936195|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
24594942|NCT00936195|Efavirenz|efavirenz|mesh-list
24594943|NCT00936195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24594944|NCT00936195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24595218|NCT00937300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24595220|NCT00937300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595315|NCT00937924|Anesthetics|anesthetics|mesh-ancestor
24595702|NCT00940303|Bevacizumab|bevacizumab|mesh-list
24595703|NCT00940303|Oxaliplatin|oxaliplatin|mesh-list
24595704|NCT00940303|Irinotecan|irinotecan|mesh-list
24595705|NCT00940303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24595706|NCT00940303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24595707|NCT00940303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24595708|NCT00940303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24595709|NCT00940303|Growth Substances|growth substances|mesh-ancestor
24595710|NCT00940303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595711|NCT00940303|Growth Inhibitors|growth inhibitors|mesh-ancestor
24595712|NCT00940303|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24595713|NCT00940303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25138700|NCT02975440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25138701|NCT02975440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25138702|NCT02975440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861164|NCT02315495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046379|NCT00850174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25046380|NCT00850174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25046381|NCT00850174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046382|NCT00850174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25046383|NCT00850174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25046384|NCT00849862|Levetiracetam|levetiracetam|mesh-list
25046385|NCT00849862|Anticonvulsants|anticonvulsants|mesh-ancestor
25046386|NCT00849862|Nootropic Agents|nootropic agents|mesh-ancestor
25046387|NCT00849797|Oxcarbazepine|oxcarbazepine|mesh-list
25046388|NCT00849797|Anticonvulsants|anticonvulsants|mesh-ancestor
25046389|NCT00849797|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25046390|NCT00849797|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25046391|NCT00849797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24627543|NCT01093274|Cathartics|cathartics|mesh-ancestor
24595714|NCT00940303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595715|NCT00940303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595716|NCT00940303|Antidotes|antidotes|mesh-ancestor
24595719|NCT00940303|Vitamins|vitamins|mesh-ancestor
24595800|NCT00940550|GABA Modulators|gaba modulators|mesh-ancestor
24595801|NCT00940563|Imatinib Mesylate|imatinib mesylate|mesh-list
24595802|NCT00940563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24595803|NCT00940563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24595804|NCT00940563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595805|NCT00940563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595807|NCT00940628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595808|NCT00940628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683670|NCT01880515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25683671|NCT01880515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25683672|NCT01880515|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25683673|NCT01880515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683674|NCT01880515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683675|NCT01880528|Lisinopril|lisinopril|mesh-list
25683676|NCT01880528|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25683677|NCT01880528|Protease Inhibitors|protease inhibitors|mesh-ancestor
24595809|NCT00940628|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24595861|NCT00940719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24595862|NCT00940719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24595864|NCT00940784|Clopidogrel|clopidogrel|mesh-list
24595865|NCT00940784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24595866|NCT00940784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24595867|NCT00940784|Analgesics|analgesics|mesh-ancestor
24595868|NCT00940784|Sensory System Agents|sensory system agents|mesh-ancestor
24595869|NCT00940784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24595870|NCT00940784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595871|NCT00940784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24595872|NCT00940784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24595873|NCT00940784|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24596025|NCT00941239|Metformin|metformin|mesh-list
24596026|NCT00941239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24596027|NCT00941239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596028|NCT00941252|Imiquimod|imiquimod|mesh-list
24596029|NCT00941252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24596030|NCT00941252|Immunologic Factors|immunologic factors|mesh-ancestor
24596031|NCT00941252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541478|NCT00673218|Omalizumab|omalizumab|mesh-list
24596087|NCT00941499|Immunoglobulins|immunoglobulins|mesh-list
24596088|NCT00941499|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24596089|NCT00941499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596443|NCT00943566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046392|NCT00849797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046393|NCT00849797|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25046394|NCT00849797|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25046395|NCT00849667|Farletuzumab|farletuzumab|mesh-list
25046396|NCT00849667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25046397|NCT00849576|Insulin|insulin|mesh-list
25046398|NCT00849576|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25046399|NCT00849576|Insulin Lispro|insulin lispro|mesh-list
25046400|NCT00849576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25046401|NCT00849576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046402|NCT00849485|Levetiracetam|levetiracetam|mesh-list
25046403|NCT00849485|Anticonvulsants|anticonvulsants|mesh-ancestor
25046404|NCT00849485|Nootropic Agents|nootropic agents|mesh-ancestor
25046405|NCT00847405|Sumatriptan|sumatriptan|mesh-list
25046406|NCT00847405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25046407|NCT00847405|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25046408|NCT00847405|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25046409|NCT00847405|Serotonin Agents|serotonin agents|mesh-ancestor
25046410|NCT00847405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25046411|NCT00847405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046412|NCT00847405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046413|NCT00847366|Tamoxifen|tamoxifen|mesh-list
25046414|NCT00847366|Trastuzumab|trastuzumab|mesh-list
25046415|NCT00847366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25046416|NCT00847366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25046417|NCT00847366|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25046418|NCT00847366|Hormone Antagonists|hormone antagonists|mesh-ancestor
25046419|NCT00847366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25046420|NCT00847366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046421|NCT00847366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25046422|NCT00847366|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24596880|NCT00946374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24596881|NCT00946374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24596882|NCT00946374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596883|NCT00946374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596884|NCT00946374|Immunologic Factors|immunologic factors|mesh-ancestor
24596885|NCT00946374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596886|NCT00946374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24596928|NCT00946491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24596929|NCT00946491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046423|NCT00847366|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25046424|NCT00847366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25046425|NCT00846989|Latanoprost|latanoprost|mesh-list
25046427|NCT00846989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25046428|NCT00846885|Sumatriptan|sumatriptan|mesh-list
25046429|NCT00846885|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25046430|NCT00846885|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25046431|NCT00846885|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25046432|NCT00846885|Serotonin Agents|serotonin agents|mesh-ancestor
25046433|NCT00846885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25046434|NCT00846885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046435|NCT00846885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046436|NCT00845299|Benzalkonium Compounds|benzalkonium compounds|mesh-list
25046437|NCT00845299|Latanoprost|latanoprost|mesh-list
25138703|NCT02975440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25138704|NCT02975440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25138705|NCT02975440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25138706|NCT02975440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25138707|NCT02975440|Anesthetics, General|anesthetics, general|mesh-ancestor
25138708|NCT02975440|Anesthetics|anesthetics|mesh-ancestor
25138709|NCT02975440|GABA Modulators|gaba modulators|mesh-ancestor
24596930|NCT00946491|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24596932|NCT00946504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24596933|NCT00946504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596934|NCT00946556|Valacyclovir|valacyclovir|mesh-list
24596935|NCT00946556|Antiviral Agents|antiviral agents|mesh-ancestor
24596936|NCT00946556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24597082|NCT00947063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24597083|NCT00947076|Fluoxetine|fluoxetine|mesh-list
24597084|NCT00947076|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24597086|NCT00947076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24597087|NCT00947076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597088|NCT00947076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24597229|NCT00947843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597230|NCT00947843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24597231|NCT00947843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24597232|NCT00947843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24597233|NCT00947843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24597234|NCT00947843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597289|NCT00948220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597291|NCT00948220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24597292|NCT00948272|Vaccines|vaccines|mesh-list
24597293|NCT00948272|Immunologic Factors|immunologic factors|mesh-ancestor
24597310|NCT00948584|Insulin|insulin|mesh-list
24597311|NCT00948584|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24597312|NCT00948584|Insulin Glargine|insulin glargine|mesh-list
24597313|NCT00948584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24597314|NCT00948584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597315|NCT00948649|Varenicline|varenicline|mesh-list
24597316|NCT00948649|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25138710|NCT02975440|GABA Agents|gaba agents|mesh-ancestor
25138711|NCT02975440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25138712|NCT02975440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138713|NCT02975440|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25138714|NCT02975440|Antitubercular Agents|antitubercular agents|mesh-ancestor
25138715|NCT02975440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25138716|NCT02975440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25138717|NCT02975440|Leprostatic Agents|leprostatic agents|mesh-ancestor
25138718|NCT02975440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25138719|NCT02975440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25138720|NCT02975440|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25138721|NCT02975440|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25138722|NCT02975440|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25138723|NCT02975440|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25138724|NCT02975440|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24597317|NCT00948649|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24597318|NCT00948649|Cholinergic Agents|cholinergic agents|mesh-ancestor
24597319|NCT00948649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24597320|NCT00948649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597321|NCT00948649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597356|NCT00948779|Antitubercular Agents|antitubercular agents|mesh-ancestor
24597357|NCT00948805|Goserelin|goserelin|mesh-list
24597358|NCT00948805|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24597359|NCT00948805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24597360|NCT00948805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597361|NCT00948805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24597362|NCT00948805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597428|NCT00949247|Mitosis Modulators|mitosis modulators|mesh-ancestor
24597429|NCT00949247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597430|NCT00949299|Buprenorphine|buprenorphine|mesh-list
25683678|NCT01880528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683679|NCT01880528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683680|NCT01880528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24708665|NCT01501942|Glycine|glycine|mesh-list
24708666|NCT01501942|Glycine Agents|glycine agents|mesh-ancestor
24708667|NCT01501942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24708670|NCT01501968|Ascorbic Acid|ascorbic acid|mesh-list
24597431|NCT00949299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24597432|NCT00949299|Narcotics|narcotics|mesh-ancestor
24861202|NCT02315651|Vitamins|vitamins|mesh-ancestor
24541507|NCT00673504|Antiviral Agents|antiviral agents|mesh-ancestor
24541508|NCT00673504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24597433|NCT00949299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24597434|NCT00949299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597435|NCT00949299|Analgesics|analgesics|mesh-ancestor
24597436|NCT00949299|Sensory System Agents|sensory system agents|mesh-ancestor
24597437|NCT00949299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24597438|NCT00949299|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24597439|NCT00949364|Pomalidomide|pomalidomide|mesh-list
24597478|NCT00949546|Analgesics|analgesics|mesh-ancestor
24597479|NCT00949546|Sensory System Agents|sensory system agents|mesh-ancestor
24597480|NCT00949546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24597481|NCT00949546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597482|NCT00949546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24597483|NCT00949546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24597484|NCT00949546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24597574|NCT00950066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24597575|NCT00950066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597682|NCT00950794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138731|NCT02975570|Pyrazinamide|pyrazinamide|mesh-list
25138732|NCT02975570|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25138733|NCT02975570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25138734|NCT02975570|Renal Agents|renal agents|mesh-ancestor
25138735|NCT02975570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25138736|NCT02975570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25138737|NCT02975570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25138738|NCT02975570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25138739|NCT02975570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138740|NCT02975570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138741|NCT02975570|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25138742|NCT02975570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25138743|NCT02975570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25138744|NCT02975570|Antitubercular Agents|antitubercular agents|mesh-ancestor
25138745|NCT02975258|Nitric Oxide|nitric oxide|mesh-list
25138746|NCT02975258|Methacholine Chloride|methacholine chloride|mesh-list
24597745|NCT00951444|Antiviral Agents|antiviral agents|mesh-ancestor
24597746|NCT00951444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24597747|NCT00951444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597748|NCT00951444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24597749|NCT00951444|Immunologic Factors|immunologic factors|mesh-ancestor
24861226|NCT02316249|Estradiol|estradiol|mesh-list
24597750|NCT00951444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597860|NCT00952185|Antibodies|antibodies|mesh-list
24597968|NCT00953108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597969|NCT00953108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24597970|NCT00953108|Serotonin Agents|serotonin agents|mesh-ancestor
24597971|NCT00953108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597972|NCT00953108|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24597973|NCT00953108|Antidepressive Agents|antidepressive agents|mesh-ancestor
24597975|NCT00953108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24597976|NCT00953108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24597977|NCT00953108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24597978|NCT00953134|Folic Acid|folic acid|mesh-list
24597979|NCT00953134|Micronutrients|micronutrients|mesh-list
25138747|NCT02975258|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25138748|NCT02975258|Autonomic Agents|autonomic agents|mesh-ancestor
25138749|NCT02975258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25138750|NCT02975258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138751|NCT02975258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25683681|NCT01880528|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25683682|NCT01880528|Protective Agents|protective agents|mesh-ancestor
25692531|NCT02000973|Bupivacaine|bupivacaine|mesh-list
25283837|NCT03757130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25283838|NCT03733418|Vitamin D|vitamin d|mesh-list
25283839|NCT03733418|Cholecalciferol|cholecalciferol|mesh-list
25283840|NCT03733418|Vitamins|vitamins|mesh-ancestor
25283841|NCT03733418|Micronutrients|micronutrients|mesh-ancestor
25283842|NCT03733418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283843|NCT03733418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25138752|NCT02975258|Respiratory System Agents|respiratory system agents|mesh-ancestor
25138753|NCT02975258|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25138754|NCT02975258|Antioxidants|antioxidants|mesh-ancestor
25138755|NCT02975258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138756|NCT02975258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25138757|NCT02975258|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25138758|NCT02975258|Vasodilator Agents|vasodilator agents|mesh-ancestor
25138759|NCT02975258|Gasotransmitters|gasotransmitters|mesh-ancestor
25138760|NCT02975258|Protective Agents|protective agents|mesh-ancestor
25138761|NCT02975258|Miotics|miotics|mesh-ancestor
25138762|NCT02975258|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25138763|NCT02975258|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
25138764|NCT02975258|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25138765|NCT02975258|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25138766|NCT02975258|Cholinergic Agents|cholinergic agents|mesh-ancestor
25138767|NCT02975102|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25138768|NCT02975102|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24597980|NCT00953134|Ferrous fumarate|ferrous fumarate|mesh-list
24597981|NCT00953134|Trace Elements|trace elements|mesh-list
24597982|NCT00953134|Hematinics|hematinics|mesh-ancestor
24597983|NCT00953134|Vitamin B Complex|vitamin b complex|mesh-ancestor
24597984|NCT00953134|Vitamins|vitamins|mesh-ancestor
24598017|NCT00953303|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24598019|NCT00953303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24598083|NCT00953628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24598084|NCT00953628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598085|NCT00953641|Misoprostol|misoprostol|mesh-list
24598086|NCT00953641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24598094|NCT00953771|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24598105|NCT00954005|Gemcitabine|gemcitabine|mesh-list
24598145|NCT00954200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24598147|NCT00954200|Sensory System Agents|sensory system agents|mesh-ancestor
24598148|NCT00954200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24598149|NCT00954200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598150|NCT00954200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24598151|NCT00954200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24598152|NCT00954200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24598153|NCT00954200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598154|NCT00954200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598155|NCT00954252|Flurbiprofen|flurbiprofen|mesh-list
24598219|NCT00954603|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25138769|NCT02975076|Aspirin|aspirin|mesh-list
25138770|NCT02975076|Clopidogrel|clopidogrel|mesh-list
25138771|NCT02975076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25138772|NCT02975076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25138773|NCT02975076|Analgesics|analgesics|mesh-ancestor
25138774|NCT02975076|Sensory System Agents|sensory system agents|mesh-ancestor
25138775|NCT02975076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25138776|NCT02975076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138777|NCT02975076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25138778|NCT02975076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25138779|NCT02975076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25138780|NCT02975076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25138781|NCT02975076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683683|NCT01880528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683684|NCT01880593|Ketamine|ketamine|mesh-list
25683685|NCT01880593|Lithium Carbonate|lithium carbonate|mesh-list
25683686|NCT01880593|Analgesics|analgesics|mesh-ancestor
25683687|NCT01880593|Sensory System Agents|sensory system agents|mesh-ancestor
25683688|NCT01880593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25683689|NCT01880593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683690|NCT01880593|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25283865|NCT03618225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283866|NCT03618225|Analgesics|analgesics|mesh-ancestor
25138782|NCT02975076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25138783|NCT02975076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25138784|NCT02975076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25138785|NCT02975076|Antipyretics|antipyretics|mesh-ancestor
25138786|NCT02975076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25138787|NCT02975076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24598220|NCT00954603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24598221|NCT00954603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24598285|NCT00955045|Purinergic Agents|purinergic agents|mesh-ancestor
24598286|NCT00955045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24598287|NCT00955045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640225|NCT01166932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598288|NCT00955045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598289|NCT00955149|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24598290|NCT00955149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598617|NCT00957060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24598619|NCT00957060|Protease Inhibitors|protease inhibitors|mesh-ancestor
24598662|NCT00957190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24598663|NCT00957190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598664|NCT00957190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138788|NCT02975076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25138789|NCT02975076|Purinergic Agents|purinergic agents|mesh-ancestor
25138790|NCT02975076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25138791|NCT02975037|Itraconazole|itraconazole|mesh-list
25138792|NCT02975037|Erythromycin|erythromycin|mesh-list
25138793|NCT02975037|Erythromycin Estolate|erythromycin estolate|mesh-list
25138794|NCT02975037|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25138795|NCT02975037|Erythromycin stearate|erythromycin stearate|mesh-list
25138796|NCT02975037|Sildenafil Citrate|sildenafil citrate|mesh-list
25138797|NCT02975037|Vasodilator Agents|vasodilator agents|mesh-ancestor
25138798|NCT02975037|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25138799|NCT02975037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25138800|NCT02975037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25138801|NCT02975037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138802|NCT02975037|Urological Agents|urological agents|mesh-ancestor
25138803|NCT02975037|Antifungal Agents|antifungal agents|mesh-ancestor
25138804|NCT02975037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25138805|NCT02975037|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25138806|NCT02975037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25138807|NCT02975037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24598669|NCT00957203|Istradefylline|istradefylline|mesh-list
24599181|NCT05014061|Adenosine|adenosine|mesh-list
24599230|NCT04966663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24599231|NCT04966663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24599232|NCT04966663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24599233|NCT04966663|Immunologic Factors|immunologic factors|mesh-ancestor
24599234|NCT04966663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599235|NCT04966663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25138813|NCT02975037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25138814|NCT02975037|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25138815|NCT02975219|Bevacizumab|bevacizumab|mesh-list
25138816|NCT02975219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25138817|NCT02975219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138818|NCT02975219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25138819|NCT02975219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25138820|NCT02975219|Growth Substances|growth substances|mesh-ancestor
25138821|NCT02975219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138822|NCT02975219|Growth Inhibitors|growth inhibitors|mesh-ancestor
25138823|NCT02975323|Carvedilol|carvedilol|mesh-list
25138824|NCT02975323|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25138825|NCT02975323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25138826|NCT02975323|Adrenergic Agents|adrenergic agents|mesh-ancestor
24599317|NCT04770493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24599319|NCT04768686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24599376|NCT04687800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599378|NCT04678089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599430|NCT04588948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599431|NCT04577014|Gemcitabine|gemcitabine|mesh-list
24599432|NCT04577014|Docetaxel|docetaxel|mesh-list
25683691|NCT01880593|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25683692|NCT01880593|Anesthetics, General|anesthetics, general|mesh-ancestor
25683693|NCT01880593|Anesthetics|anesthetics|mesh-ancestor
24599610|NCT04206163|Edotreotide|edotreotide|mesh-list
24599674|NCT04079452|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
24599675|NCT04079452|Antiviral Agents|antiviral agents|mesh-ancestor
24599676|NCT04079452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24599739|NCT03913559|Methylprednisolone|methylprednisolone|mesh-list
24599740|NCT03913559|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24599741|NCT03913559|Hydrocortisone|hydrocortisone|mesh-list
24599742|NCT03913559|Methotrexate|methotrexate|mesh-list
24599743|NCT03913559|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
24599749|NCT03913559|Antimetabolites|antimetabolites|mesh-ancestor
24599819|NCT03741101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24599820|NCT03741101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24599821|NCT03741101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599822|NCT03678636|Anti-Infective Agents|anti-infective agents|mesh-list
25011518|NCT04844528|Vitamins|vitamins|mesh-ancestor
25138827|NCT02975323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25138828|NCT02975323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138829|NCT02975323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813350|NCT02058173|Chloroquine|chloroquine|mesh-list
25138830|NCT02975323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24599823|NCT03678636|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24599824|NCT03641547|Capecitabine|capecitabine|mesh-list
24599825|NCT03641547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599826|NCT03641547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24599827|NCT03641547|Antimetabolites|antimetabolites|mesh-ancestor
24599828|NCT03641547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599829|NCT03581240|Eflornithine|eflornithine|mesh-list
24599968|NCT02940522|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24599969|NCT02940522|Hormone Antagonists|hormone antagonists|mesh-ancestor
24599970|NCT02940522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24599971|NCT02940522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599974|NCT02923739|Paclitaxel|paclitaxel|mesh-list
24599975|NCT02923739|Bevacizumab|bevacizumab|mesh-list
24599979|NCT02923739|Antibodies|antibodies|mesh-list
24600074|NCT02711137|Antiviral Agents|antiviral agents|mesh-ancestor
24600075|NCT02711137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24863081|NCT03594162|Alkylating Agents|alkylating agents|mesh-ancestor
24863082|NCT03594162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863083|NCT03594162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863084|NCT03594162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24542867|NCT00680602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542868|NCT00680602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24542869|NCT00680602|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24542870|NCT00680602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25138833|NCT02975323|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25138834|NCT02975323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25138835|NCT02975323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25138836|NCT02975323|Vasodilator Agents|vasodilator agents|mesh-ancestor
25138837|NCT02975323|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25683694|NCT01880593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25683695|NCT01880593|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25683696|NCT01880593|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25683697|NCT01880593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25138844|NCT02975141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138845|NCT02975141|Tubulin Modulators|tubulin modulators|mesh-ancestor
25138846|NCT02975141|Antimitotic Agents|antimitotic agents|mesh-ancestor
25138847|NCT02975141|Mitosis Modulators|mitosis modulators|mesh-ancestor
25138848|NCT02975141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138849|NCT02975141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25138850|NCT02975141|Antimetabolites|antimetabolites|mesh-ancestor
25138851|NCT02975141|Antiviral Agents|antiviral agents|mesh-ancestor
24813375|NCT02058199|Antithrombins|antithrombins|mesh-ancestor
25138852|NCT02975141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25138853|NCT02975141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25138854|NCT02975141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25138855|NCT02975141|Immunologic Factors|immunologic factors|mesh-ancestor
25138856|NCT02975141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138857|NCT02975141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25138858|NCT02974985|Hyaluronic Acid|hyaluronic acid|mesh-list
24627660|NCT01094275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627708|NCT01094457|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24813608|NCT02059616|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24451887|NCT00325104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24451888|NCT00325117|Vildagliptin|vildagliptin|mesh-list
24451889|NCT00325117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24813618|NCT02059694|Epinephrine|epinephrine|mesh-list
24813619|NCT02059694|Racepinephrine|racepinephrine|mesh-list
24813620|NCT02059694|Epinephryl borate|epinephryl borate|mesh-list
24813621|NCT02059694|Anesthetics, Local|anesthetics, local|mesh-ancestor
24813622|NCT02059694|Anesthetics|anesthetics|mesh-ancestor
24813623|NCT02059694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25138860|NCT02974985|Immunologic Factors|immunologic factors|mesh-ancestor
25138861|NCT02974985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138862|NCT02974985|Viscosupplements|viscosupplements|mesh-ancestor
25138863|NCT02974985|Protective Agents|protective agents|mesh-ancestor
25138865|NCT02974920|Rivaroxaban|rivaroxaban|mesh-list
25138866|NCT02974920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25138867|NCT02974920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25138868|NCT02974920|Analgesics|analgesics|mesh-ancestor
25138869|NCT02974920|Sensory System Agents|sensory system agents|mesh-ancestor
25138870|NCT02974920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25138871|NCT02974920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138872|NCT02974920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24813399|NCT02058303|Bupivacaine|bupivacaine|mesh-list
25683698|NCT01880593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683699|NCT01880593|Antidepressive Agents|antidepressive agents|mesh-ancestor
25683700|NCT01880593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25683701|NCT01880593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683702|NCT01880593|Antimanic Agents|antimanic agents|mesh-ancestor
25683703|NCT01880593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25683704|NCT01880723|Albuterol|albuterol|mesh-list
25283994|NCT03237377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25283995|NCT03237377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138879|NCT02974920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25138880|NCT02974920|Antipyretics|antipyretics|mesh-ancestor
24863365|NCT05145543|Glucocorticoids|glucocorticoids|mesh-ancestor
24863366|NCT05145543|Hormones|hormones|mesh-ancestor
24863377|NCT05145543|Anesthetics, General|anesthetics, general|mesh-ancestor
24863378|NCT05145543|Anesthetics|anesthetics|mesh-ancestor
24863379|NCT05145543|Anesthetics, Local|anesthetics, local|mesh-ancestor
24863380|NCT05145270|Sulforaphane|sulforaphane|mesh-list
24863381|NCT05145270|Dexetimide|dexetimide|mesh-list
24863382|NCT05145270|Citalopram|citalopram|mesh-list
24863383|NCT05145270|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25138884|NCT02974920|Protease Inhibitors|protease inhibitors|mesh-ancestor
25138885|NCT02974920|Anticoagulants|anticoagulants|mesh-ancestor
25138887|NCT02974933|Apatinib|apatinib|mesh-list
25138888|NCT02974933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138889|NCT02974933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25138890|NCT02974933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138891|NCT02974933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25138892|NCT02974933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25138893|NCT02974933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25138894|NCT02974712|Fentanyl|fentanyl|mesh-list
25138895|NCT02974712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25138896|NCT02974712|Narcotics|narcotics|mesh-ancestor
24863403|NCT05145270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863405|NCT05131386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24863406|NCT05131386|Alkylating Agents|alkylating agents|mesh-ancestor
24863407|NCT05131386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863408|NCT05131386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863409|NCT05100134|Ceritinib|ceritinib|mesh-list
24863410|NCT05100134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863411|NCT05100134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24863412|NCT05100134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24863413|NCT05100134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863414|NCT05079620|Amoxicillin|amoxicillin|mesh-list
24863415|NCT05079620|Vancomycin|vancomycin|mesh-list
25683705|NCT01880723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25683706|NCT01880723|Autonomic Agents|autonomic agents|mesh-ancestor
25683707|NCT01880723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25683708|NCT01880723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683709|NCT01880723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25683710|NCT01880723|Respiratory System Agents|respiratory system agents|mesh-ancestor
25683711|NCT01880723|Tocolytic Agents|tocolytic agents|mesh-ancestor
25683712|NCT01880723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25683713|NCT01880723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25683714|NCT01880723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24863439|NCT05043805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24863440|NCT05043805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24863441|NCT05043805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863442|NCT05043805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863443|NCT04987294|Rasburicase|rasburicase|mesh-list
24863444|NCT04987294|Gout Suppressants|gout suppressants|mesh-ancestor
24863445|NCT04987294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24863446|NCT04956302|Dexamethasone|dexamethasone|mesh-list
24863452|NCT04956302|BB 1101|bb 1101|mesh-list
25138897|NCT02974712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25138898|NCT02974712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138899|NCT02974712|Analgesics|analgesics|mesh-ancestor
25138900|NCT02974712|Sensory System Agents|sensory system agents|mesh-ancestor
24861286|NCT02316626|Progesterone|progesterone|mesh-list
25138901|NCT02974712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25138902|NCT02974712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25138903|NCT02974712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25138904|NCT02974712|Anesthetics, General|anesthetics, general|mesh-ancestor
25138905|NCT02974712|Anesthetics|anesthetics|mesh-ancestor
25138906|NCT02974556|Capecitabine|capecitabine|mesh-list
25138907|NCT02974556|Oxaliplatin|oxaliplatin|mesh-list
25138908|NCT02974556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25138909|NCT02974556|Antimetabolites|antimetabolites|mesh-ancestor
25138910|NCT02974556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138911|NCT02974556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138912|NCT02974660|Protamines|protamines|mesh-list
25138913|NCT02974660|Heparin Antagonists|heparin antagonists|mesh-ancestor
25138914|NCT02974660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138915|NCT02974660|Coagulants|coagulants|mesh-ancestor
25138916|NCT02974439|Amlodipine|amlodipine|mesh-list
25138917|NCT02974439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25138918|NCT02974439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25138919|NCT02974439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25138920|NCT02974439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138921|NCT02974439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25138922|NCT02974439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138923|NCT02974439|Vasodilator Agents|vasodilator agents|mesh-ancestor
25138924|NCT02974387|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25138925|NCT02974387|Fluorometholone|fluorometholone|mesh-list
25138926|NCT02974387|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24863453|NCT04956302|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25138932|NCT02974504|Linagliptin|linagliptin|mesh-list
25138933|NCT02974504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25138934|NCT02974504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138935|NCT02974504|Incretins|incretins|mesh-ancestor
25138936|NCT02974504|Hormones|hormones|mesh-ancestor
25138937|NCT02974504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25138938|NCT02974504|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25138939|NCT02974504|Protease Inhibitors|protease inhibitors|mesh-ancestor
25138940|NCT02974504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25138941|NCT02974504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138942|NCT02974426|Cisplatin|cisplatin|mesh-list
25138943|NCT02974426|Carboplatin|carboplatin|mesh-list
25138944|NCT02974426|Pemetrexed|pemetrexed|mesh-list
25138945|NCT02974426|Vinorelbine|vinorelbine|mesh-list
25138946|NCT02974426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25138947|NCT02974426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841702|NCT02217631|Hormones|hormones|mesh-ancestor
25138948|NCT02974426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138949|NCT02974426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25138950|NCT02974426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25138951|NCT02974426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24863454|NCT04956302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24863455|NCT04956302|Antiemetics|antiemetics|mesh-ancestor
24863456|NCT04956302|Autonomic Agents|autonomic agents|mesh-ancestor
24863457|NCT04956302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24863458|NCT04956302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863459|NCT04956302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24863460|NCT04956302|Glucocorticoids|glucocorticoids|mesh-ancestor
24863461|NCT04956302|Hormones|hormones|mesh-ancestor
24863462|NCT04956302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24863463|NCT04956302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25138952|NCT02974426|Tubulin Modulators|tubulin modulators|mesh-ancestor
25138953|NCT02974426|Antimitotic Agents|antimitotic agents|mesh-ancestor
25138954|NCT02974426|Mitosis Modulators|mitosis modulators|mesh-ancestor
25138956|NCT02974244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25138957|NCT02974244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138958|NCT02974244|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25138959|NCT02974244|Incretins|incretins|mesh-ancestor
25138960|NCT02974244|Hormones|hormones|mesh-ancestor
25138961|NCT02974244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25138962|NCT02974361|Ibuprofen|ibuprofen|mesh-list
25138963|NCT02974361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25138964|NCT02974361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25138965|NCT02974361|Analgesics|analgesics|mesh-ancestor
25138966|NCT02974361|Sensory System Agents|sensory system agents|mesh-ancestor
25138967|NCT02974361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25138968|NCT02974361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541607|NCT00674102|Vadimezan|vadimezan|mesh-list
25138969|NCT02974361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25138970|NCT02974361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25138971|NCT02974361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25138972|NCT02974361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25138973|NCT02974361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138975|NCT02974348|Amoxicillin|amoxicillin|mesh-list
25138976|NCT02974348|Artesunate|artesunate|mesh-list
25683715|NCT01880723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25683716|NCT01880723|Adrenergic Agents|adrenergic agents|mesh-ancestor
25683717|NCT01880723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25683718|NCT01880723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683719|NCT01880736|Insulin|insulin|mesh-list
25683720|NCT01880736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25683721|NCT01880736|Insulin, Long-Acting|insulin, long-acting|mesh-list
25683722|NCT01880736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25138987|NCT02974348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25138988|NCT02974348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046439|NCT00845299|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25046440|NCT00845299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25046441|NCT00845299|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25046442|NCT00845299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25138994|NCT02974348|Antiviral Agents|antiviral agents|mesh-ancestor
25138995|NCT02974348|Schistosomicides|schistosomicides|mesh-ancestor
25139029|NCT02973958|Acetaminophen|acetaminophen|mesh-list
25139030|NCT02973958|Ibuprofen|ibuprofen|mesh-list
25139031|NCT02973958|Ketorolac|ketorolac|mesh-list
25139032|NCT02973958|Bupivacaine|bupivacaine|mesh-list
25139033|NCT02973958|Sevoflurane|sevoflurane|mesh-list
24541628|NCT00674167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25139034|NCT02973958|Anesthetics, Local|anesthetics, local|mesh-ancestor
25139035|NCT02973958|Anesthetics|anesthetics|mesh-ancestor
25139036|NCT02973958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25139037|NCT02973958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139038|NCT02973958|Sensory System Agents|sensory system agents|mesh-ancestor
25139039|NCT02973958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24863464|NCT04956302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863465|NCT04956302|Protease Inhibitors|protease inhibitors|mesh-ancestor
24863466|NCT04956302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24863467|NCT04956302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863468|NCT04956302|Immunologic Factors|immunologic factors|mesh-ancestor
24863469|NCT04956302|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24863470|NCT04956302|Dermatologic Agents|dermatologic agents|mesh-ancestor
24863472|NCT04907032|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24863473|NCT04907032|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24863474|NCT04907032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24863475|NCT04907032|Adrenergic Agents|adrenergic agents|mesh-ancestor
24863476|NCT04907032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24863477|NCT04907032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139046|NCT02973958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25139047|NCT02973958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25139048|NCT02973958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139049|NCT02973958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25139050|NCT02973958|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25139051|NCT02973958|Anesthetics, General|anesthetics, general|mesh-ancestor
25139052|NCT02973737|Capecitabine|capecitabine|mesh-list
25139053|NCT02973737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25139054|NCT02973737|Antimetabolites|antimetabolites|mesh-ancestor
25139055|NCT02973737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139056|NCT02973737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25139057|NCT02973763|Aflutinib|aflutinib|mesh-list
25692532|NCT02000973|Ropivacaine|ropivacaine|mesh-list
25139066|NCT02973724|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25139067|NCT02973724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25139068|NCT02973724|Anesthetics, General|anesthetics, general|mesh-ancestor
25139069|NCT02973724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25139071|NCT02973724|Analgesics|analgesics|mesh-ancestor
25139072|NCT02973724|Sensory System Agents|sensory system agents|mesh-ancestor
25139073|NCT02973724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25139074|NCT02973776|Clobetasol|clobetasol|mesh-list
25139075|NCT02973776|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25139076|NCT02973776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25139077|NCT02973776|Glucocorticoids|glucocorticoids|mesh-ancestor
25139078|NCT02973776|Hormones|hormones|mesh-ancestor
25139079|NCT02973776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25139080|NCT02973776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139081|NCT02973646|Tenofovir|tenofovir|mesh-list
25139082|NCT02973646|Entecavir|entecavir|mesh-list
24586205|NCT00889616|Antacids|antacids|mesh-ancestor
25139083|NCT02973646|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25139084|NCT02973646|Antiviral Agents|antiviral agents|mesh-ancestor
25139085|NCT02973646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25139086|NCT02973646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25139087|NCT02973646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25139088|NCT02973646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25139089|NCT02973646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139090|NCT02973646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24802697|NCT01991678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25139171|NCT02973204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24813682|NCT02059876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813683|NCT02059876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24813684|NCT02059889|Deoxyglucose|deoxyglucose|mesh-list
24813685|NCT02059889|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24813686|NCT02059889|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25139102|NCT02973659|Urological Agents|urological agents|mesh-ancestor
25139104|NCT02973620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25139105|NCT02973620|Vasodilator Agents|vasodilator agents|mesh-ancestor
25139106|NCT02973620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25139107|NCT02973620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25139108|NCT02973620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628109|NCT01096654|Autonomic Agents|autonomic agents|mesh-ancestor
24813687|NCT02059889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813688|NCT02059889|Antimetabolites|antimetabolites|mesh-ancestor
24813689|NCT02059889|Antiviral Agents|antiviral agents|mesh-ancestor
24813690|NCT02059889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24813691|NCT02059915|Oxycodone|oxycodone|mesh-list
25139111|NCT02973620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139114|NCT02973451|Anesthetics|anesthetics|mesh-ancestor
25139115|NCT02973451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25139116|NCT02973451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139117|NCT02973451|Sensory System Agents|sensory system agents|mesh-ancestor
25139118|NCT02973451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25139119|NCT02973464|Valganciclovir|valganciclovir|mesh-list
25139120|NCT02973464|Ganciclovir|ganciclovir|mesh-list
25139121|NCT02973464|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25139122|NCT02973464|Antiviral Agents|antiviral agents|mesh-ancestor
25139123|NCT02973464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25139124|NCT02973464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25139125|NCT02973464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25139126|NCT02973464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139128|NCT02973295|Antioxidants|antioxidants|mesh-ancestor
25139129|NCT02973295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139130|NCT02973295|Protective Agents|protective agents|mesh-ancestor
25139131|NCT02973295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139132|NCT02973581|Acetaminophen|acetaminophen|mesh-list
25139133|NCT02973581|Dipyrone|dipyrone|mesh-list
25139134|NCT02973581|Lidocaine|lidocaine|mesh-list
25139135|NCT02973581|Bupivacaine|bupivacaine|mesh-list
25139136|NCT02973581|Proxymetacaine|proxymetacaine|mesh-list
24861439|NCT02317770|Lidocaine|lidocaine|mesh-list
24543350|NCT00683202|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24543351|NCT00683202|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24543352|NCT00683202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543353|NCT00683202|Antipyretics|antipyretics|mesh-ancestor
24543354|NCT00683267|Capsaicin|capsaicin|mesh-list
24543355|NCT00683267|Antipruritics|antipruritics|mesh-ancestor
25139140|NCT02973581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139142|NCT02973581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25139143|NCT02973581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25139144|NCT02973581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25139145|NCT02973581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25139146|NCT02973581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25139147|NCT02973581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139148|NCT02973581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25139149|NCT02973581|Analgesics|analgesics|mesh-ancestor
25139150|NCT02973581|Antipyretics|antipyretics|mesh-ancestor
25139151|NCT02973581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25139152|NCT02973581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25139153|NCT02973581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25139154|NCT02973113|Nivolumab|nivolumab|mesh-list
25139164|NCT02973204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25139165|NCT02973204|Immunologic Factors|immunologic factors|mesh-ancestor
25139166|NCT02973204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139167|NCT02973204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25139168|NCT02973204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25139169|NCT02973204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139170|NCT02973204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24863563|NCT04425447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24863564|NCT04425447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863565|NCT04355728|Heparin|heparin|mesh-list
24543388|NCT00683319|Tubulin Modulators|tubulin modulators|mesh-ancestor
24543389|NCT00683319|Antimitotic Agents|antimitotic agents|mesh-ancestor
24863597|NCT04223024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24861463|NCT02318017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24863600|NCT04194554|Abiraterone Acetate|abiraterone acetate|mesh-list
24863601|NCT04194554|Niraparib|niraparib|mesh-list
24863602|NCT04194554|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24863603|NCT04194554|Fertility Agents|fertility agents|mesh-ancestor
24863604|NCT04194554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24863605|NCT04194554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863606|NCT04194554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24863607|NCT04194554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863628|NCT04137354|Vitamin A|vitamin a|mesh-list
24863629|NCT04137354|Iron|iron|mesh-list
25683723|NCT01880736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683724|NCT01880840|Azelastine|azelastine|mesh-list
25683725|NCT01880840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25683726|NCT01880840|Autonomic Agents|autonomic agents|mesh-ancestor
25683727|NCT01880840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25683728|NCT01880840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863630|NCT04137354|Retinol palmitate|retinol palmitate|mesh-list
24863631|NCT04137354|Micronutrients|micronutrients|mesh-ancestor
24863632|NCT04137354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543442|NCT00683865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25087665|NCT03277599|Tramadol|tramadol|mesh-list
25139178|NCT02973035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25139179|NCT02973035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139180|NCT02973035|Vasodilator Agents|vasodilator agents|mesh-ancestor
25139187|NCT02972918|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25139188|NCT02972918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25139189|NCT02972918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139190|NCT02972918|Protective Agents|protective agents|mesh-ancestor
25139191|NCT02972918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139192|NCT02972957|Azithromycin|azithromycin|mesh-list
25139193|NCT02972957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25139194|NCT02972957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25139195|NCT02972983|Daptomycin|daptomycin|mesh-list
25139196|NCT02972983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25139197|NCT02972983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25139198|NCT02972905|Nemiralisib|nemiralisib|mesh-list
25139199|NCT02972905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25139200|NCT02972905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543463|NCT00683891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24863662|NCT04002037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863663|NCT04002037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24863664|NCT04002037|Glucocorticoids|glucocorticoids|mesh-ancestor
24543491|NCT00683969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24543492|NCT00683969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543493|NCT00683969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543494|NCT00683982|Nitazoxanide|nitazoxanide|mesh-list
24543495|NCT00683982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25139201|NCT02972905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139202|NCT02972866|Budesonide|budesonide|mesh-list
25139203|NCT02972866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25139204|NCT02972866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25139205|NCT02972866|Autonomic Agents|autonomic agents|mesh-ancestor
25139217|NCT02972762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25139218|NCT02972762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25139219|NCT02972762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139220|NCT02972762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25139221|NCT02972762|Anesthetics, General|anesthetics, general|mesh-ancestor
25139223|NCT02972463|Immunoglobulins|immunoglobulins|mesh-list
25139224|NCT02972463|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25139225|NCT02972463|Antibodies|antibodies|mesh-list
25139226|NCT02972463|Immunologic Factors|immunologic factors|mesh-ancestor
25139227|NCT02972463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139228|NCT02972450|Vedolizumab|vedolizumab|mesh-list
25139229|NCT02972450|Vaccines|vaccines|mesh-list
25139230|NCT02972450|Immunologic Factors|immunologic factors|mesh-ancestor
25139231|NCT02972450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139232|NCT02972450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25139233|NCT02972476|Fluticasone|fluticasone|mesh-list
25139235|NCT02972476|Budesonide|budesonide|mesh-list
25139236|NCT02972476|Bromides|bromides|mesh-list
25139246|NCT02972476|Respiratory System Agents|respiratory system agents|mesh-ancestor
25139247|NCT02972476|Dermatologic Agents|dermatologic agents|mesh-ancestor
25139248|NCT02972476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25139249|NCT02972476|Glucocorticoids|glucocorticoids|mesh-ancestor
25139250|NCT02972476|Hormones|hormones|mesh-ancestor
25139251|NCT02972476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25139252|NCT02972476|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25139253|NCT02972476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25139265|NCT02972333|Osimertinib|osimertinib|mesh-list
25139266|NCT02972333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25139267|NCT02972333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25139268|NCT02972333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25139269|NCT02972333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543496|NCT00683982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24543497|NCT00683995|Fentanyl|fentanyl|mesh-list
24543498|NCT00683995|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24543499|NCT00683995|Narcotics|narcotics|mesh-ancestor
24863667|NCT04002037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24863677|NCT03954938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863678|NCT03954938|Sensory System Agents|sensory system agents|mesh-ancestor
25139283|NCT02972346|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25683729|NCT01880840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25284239|NCT05055830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25284240|NCT05055830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139288|NCT02972346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139289|NCT02972346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25139290|NCT02972346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139291|NCT02972411|Acetazolamide|acetazolamide|mesh-list
25139292|NCT02972411|Anticonvulsants|anticonvulsants|mesh-ancestor
25139293|NCT02972411|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25139294|NCT02972411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25139295|NCT02972411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139296|NCT02972411|Diuretics|diuretics|mesh-ancestor
25139297|NCT02972411|Natriuretic Agents|natriuretic agents|mesh-ancestor
25139298|NCT02972411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139304|NCT02972268|Solifenacin Succinate|solifenacin succinate|mesh-list
25139305|NCT02972268|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25139306|NCT02972268|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25139307|NCT02972268|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25139308|NCT02972268|Adrenergic Agents|adrenergic agents|mesh-ancestor
25139309|NCT02972268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25139310|NCT02972268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139311|NCT02972268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543503|NCT00683995|Sensory System Agents|sensory system agents|mesh-ancestor
24543504|NCT00683995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24543505|NCT00683995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24543506|NCT00683995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25139312|NCT02972268|Urological Agents|urological agents|mesh-ancestor
25139313|NCT02972268|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25139314|NCT02972268|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25139315|NCT02972268|Cholinergic Agents|cholinergic agents|mesh-ancestor
25139317|NCT02972216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25139318|NCT02972216|Tubulin Modulators|tubulin modulators|mesh-ancestor
25139319|NCT02972216|Antimitotic Agents|antimitotic agents|mesh-ancestor
25139320|NCT02972216|Mitosis Modulators|mitosis modulators|mesh-ancestor
25139321|NCT02972216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863689|NCT03749616|Acetaminophen|acetaminophen|mesh-list
24863691|NCT03749616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24863692|NCT03749616|Analgesics|analgesics|mesh-ancestor
24863693|NCT03749616|Sensory System Agents|sensory system agents|mesh-ancestor
24863694|NCT03749616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24863695|NCT03749616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863696|NCT03749616|Antipyretics|antipyretics|mesh-ancestor
24644249|NCT01189864|Glucocorticoids|glucocorticoids|mesh-ancestor
24863697|NCT03749616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24863698|NCT03749616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24863699|NCT03749616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25046476|NCT00843687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25046477|NCT00843687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25046478|NCT00843687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25046479|NCT00843687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25046480|NCT00843687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24863774|NCT03350984|Insulin|insulin|mesh-list
24863775|NCT03350984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24863776|NCT03350984|Insulin Glargine|insulin glargine|mesh-list
24863777|NCT03350984|Insulin Lispro|insulin lispro|mesh-list
24863778|NCT03350984|Insulin, Isophane|insulin, isophane|mesh-list
25046481|NCT00843687|Dopamine Agents|dopamine agents|mesh-ancestor
25046482|NCT00841815|Amlodipine|amlodipine|mesh-list
25046483|NCT00841815|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25683730|NCT01880840|Respiratory System Agents|respiratory system agents|mesh-ancestor
25683731|NCT01880840|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25683732|NCT01880840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683733|NCT01880840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683734|NCT01880840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25683735|NCT01880840|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25683736|NCT01880840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25683737|NCT01880840|Histamine Antagonists|histamine antagonists|mesh-ancestor
25284279|NCT04976387|Sensory System Agents|sensory system agents|mesh-ancestor
25284280|NCT04976387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25284281|NCT04976387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284282|NCT04976387|Antipyretics|antipyretics|mesh-ancestor
25284283|NCT04976387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25046484|NCT00841815|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25046486|NCT00841815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046487|NCT00841815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25046489|NCT00841815|Vasodilator Agents|vasodilator agents|mesh-ancestor
25046490|NCT00841698|Paroxetine|paroxetine|mesh-list
25046491|NCT00841698|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25046492|NCT00841698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25046493|NCT00841698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25046494|NCT00841698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046495|NCT00841698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25046496|NCT00841698|Serotonin Agents|serotonin agents|mesh-ancestor
25046497|NCT00841698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046498|NCT00841698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25046499|NCT00841698|Antidepressive Agents|antidepressive agents|mesh-ancestor
25046500|NCT00841698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25046501|NCT00841698|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25046502|NCT00841698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25046503|NCT00841698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046504|NCT00841659|Paroxetine|paroxetine|mesh-list
25046505|NCT00841659|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25046506|NCT00841659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25046507|NCT00841659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25046508|NCT00841659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046509|NCT00841659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25046510|NCT00841659|Serotonin Agents|serotonin agents|mesh-ancestor
25139323|NCT02972255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25139324|NCT02972255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24863779|NCT03350984|Isophane Insulin, Human|isophane insulin, human|mesh-list
24863780|NCT03350984|Isophane insulin, beef|isophane insulin, beef|mesh-list
24863781|NCT03350984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25139326|NCT02971930|Coagulants|coagulants|mesh-ancestor
25139327|NCT02971982|Dexamethasone|dexamethasone|mesh-list
25139328|NCT02971982|Dexamethasone acetate|dexamethasone acetate|mesh-list
25139329|NCT02971982|Cyclophosphamide|cyclophosphamide|mesh-list
25139330|NCT02971982|Rituximab|rituximab|mesh-list
25139331|NCT02971982|Bortezomib|bortezomib|mesh-list
25139332|NCT02971982|BB 1101|bb 1101|mesh-list
25139333|NCT02971982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25139334|NCT02971982|Immunologic Factors|immunologic factors|mesh-ancestor
25139335|NCT02971982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139336|NCT02971982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24813734|NCT02060032|Antimetabolites|antimetabolites|mesh-ancestor
24813735|NCT02060032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813736|NCT02060032|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24644963|NCT01194336|Galantamine|galantamine|mesh-list
24813737|NCT02060032|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24813738|NCT02060032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813739|NCT02060149|Minocycline|minocycline|mesh-list
24813741|NCT02060149|Cefoperazone|cefoperazone|mesh-list
24813742|NCT02060149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24543652|NCT00684853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813763|NCT02060253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24813764|NCT02060253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813765|NCT02060253|Tubulin Modulators|tubulin modulators|mesh-ancestor
24813766|NCT02060253|Antimitotic Agents|antimitotic agents|mesh-ancestor
24813767|NCT02060253|Mitosis Modulators|mitosis modulators|mesh-ancestor
24863805|NCT03284047|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24863806|NCT03284047|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24863807|NCT03284047|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25683738|NCT01880840|Histamine Agents|histamine agents|mesh-ancestor
25683739|NCT01880840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25683740|NCT01881087|Levobupivacaine|levobupivacaine|mesh-list
25683741|NCT01881087|Anesthetics, Local|anesthetics, local|mesh-ancestor
25683742|NCT01881087|Anesthetics|anesthetics|mesh-ancestor
25683743|NCT01881087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25284320|NCT04800692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25284321|NCT04800692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284322|NCT04800692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25284323|NCT04800692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284325|NCT04585724|Palbociclib|palbociclib|mesh-list
25284326|NCT04585724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25284327|NCT04585724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25284328|NCT04585724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25284329|NCT04585724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284330|NCT04571697|Methotrexate|methotrexate|mesh-list
25284331|NCT04571697|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24863860|NCT03190174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24863861|NCT03190174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24863862|NCT03190174|Antifungal Agents|antifungal agents|mesh-ancestor
24543730|NCT00685126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24863875|NCT03148899|Oxytocin|oxytocin|mesh-list
24863876|NCT03148899|Oxytocics|oxytocics|mesh-ancestor
24863877|NCT03148899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25139337|NCT02971982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25139339|NCT02971982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139340|NCT02971982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25139341|NCT02971982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25139342|NCT02971982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25139343|NCT02971982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25139344|NCT02971982|Antiemetics|antiemetics|mesh-ancestor
25139345|NCT02971982|Autonomic Agents|autonomic agents|mesh-ancestor
25139346|NCT02971982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25139347|NCT02971982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25139348|NCT02971982|Glucocorticoids|glucocorticoids|mesh-ancestor
25139349|NCT02971982|Hormones|hormones|mesh-ancestor
25139350|NCT02971982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25139351|NCT02971982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25139352|NCT02971982|Protease Inhibitors|protease inhibitors|mesh-ancestor
25139353|NCT02971982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25139357|NCT02972125|Lacosamide|lacosamide|mesh-list
25139358|NCT02972125|Anticonvulsants|anticonvulsants|mesh-ancestor
25139359|NCT02972125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25139360|NCT02972125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25139361|NCT02972125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25139362|NCT02972125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139363|NCT02971878|Thioctic Acid|thioctic acid|mesh-list
25139364|NCT02971878|Acetylcarnitine|acetylcarnitine|mesh-list
25139365|NCT02971878|Acetylcysteine|acetylcysteine|mesh-list
25139366|NCT02971878|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24861800|NCT02320240|Serotonin Agents|serotonin agents|mesh-ancestor
25139367|NCT02971878|Antioxidants|antioxidants|mesh-ancestor
24861801|NCT02320240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861802|NCT02320240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24861803|NCT02320240|Antidepressive Agents|antidepressive agents|mesh-ancestor
25139388|NCT02971475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139389|NCT02971696|Sorafenib|sorafenib|mesh-list
25139390|NCT02971696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24645169|NCT01196455|Alkylating Agents|alkylating agents|mesh-ancestor
25139391|NCT02971696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25139392|NCT02971696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25139393|NCT02971696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139394|NCT02971423|Imipenem|imipenem|mesh-list
25139395|NCT02971423|Sulbactam|sulbactam|mesh-list
25139396|NCT02971423|Cilastatin|cilastatin|mesh-list
25683744|NCT01881087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683745|NCT01881087|Sensory System Agents|sensory system agents|mesh-ancestor
25683746|NCT01881087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25683747|NCT01881113|Cetirizine|cetirizine|mesh-list
25683748|NCT01881113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25683749|NCT01881113|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25683750|NCT01881113|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25683751|NCT01881113|Histamine Antagonists|histamine antagonists|mesh-ancestor
25683752|NCT01881113|Histamine Agents|histamine agents|mesh-ancestor
25683753|NCT01881113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25683754|NCT01881113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683755|NCT01881113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683756|NCT01881126|Timolol|timolol|mesh-list
25284362|NCT04455100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25284363|NCT04455100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25139397|NCT02971423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25139398|NCT02971423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24543794|NCT00685529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139404|NCT02971410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25139406|NCT02971410|Antimetabolites|antimetabolites|mesh-ancestor
25139407|NCT02971410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139408|NCT02971410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25139409|NCT02971410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25139410|NCT02971410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25139411|NCT02971540|Dipyrone|dipyrone|mesh-list
25139412|NCT02971540|Tramadol|tramadol|mesh-list
25139413|NCT02971540|Bupivacaine|bupivacaine|mesh-list
25139414|NCT02971540|Ropivacaine|ropivacaine|mesh-list
25139415|NCT02971540|Anesthetics, Local|anesthetics, local|mesh-ancestor
25139416|NCT02971540|Anesthetics|anesthetics|mesh-ancestor
25139417|NCT02971540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25139418|NCT02971540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139419|NCT02971540|Sensory System Agents|sensory system agents|mesh-ancestor
25139420|NCT02971540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25139421|NCT02971540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25139422|NCT02971540|Narcotics|narcotics|mesh-ancestor
24863940|NCT02837783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863941|NCT02837783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25139425|NCT02971540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25139434|NCT02971397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25139435|NCT02971397|Antiviral Agents|antiviral agents|mesh-ancestor
25139436|NCT02971397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25139437|NCT02971397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25139438|NCT02971397|Immunologic Factors|immunologic factors|mesh-ancestor
25139439|NCT02971397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139440|NCT02971397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24863967|NCT02786537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24863968|NCT02786537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863969|NCT02786537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24863970|NCT02786537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24863971|NCT02786537|Antiviral Agents|antiviral agents|mesh-ancestor
24863972|NCT02786537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24863973|NCT02786537|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24863974|NCT02786537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25139445|NCT02971306|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25139446|NCT02971306|Antiviral Agents|antiviral agents|mesh-ancestor
25139447|NCT02971306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24864019|NCT02229149|Tubulin Modulators|tubulin modulators|mesh-ancestor
24864020|NCT02229149|Antimitotic Agents|antimitotic agents|mesh-ancestor
24864021|NCT02229149|Mitosis Modulators|mitosis modulators|mesh-ancestor
24864022|NCT02229149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864023|NCT02229149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24813768|NCT02060253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813769|NCT02060253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24813770|NCT02060279|Carotenoids|carotenoids|mesh-list
24813771|NCT02060279|Antioxidants|antioxidants|mesh-ancestor
25012073|NCT02297438|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24813772|NCT02060279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813786|NCT02060318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25683757|NCT01881126|Bimatoprost|bimatoprost|mesh-list
25683758|NCT01881126|Travoprost|travoprost|mesh-list
24813788|NCT02060396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24864026|NCT02182687|Doxorubicin|doxorubicin|mesh-list
25683759|NCT01881126|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25683760|NCT01881126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25683761|NCT01881126|Adrenergic Agents|adrenergic agents|mesh-ancestor
25683762|NCT01881126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25683763|NCT01881126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683764|NCT01881126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692533|NCT02000973|Anesthetics, Local|anesthetics, local|mesh-ancestor
25145781|NCT02927444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145782|NCT02927509|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
25145783|NCT02927509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25145784|NCT02927509|Adrenergic Agents|adrenergic agents|mesh-ancestor
25145785|NCT02927509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25145786|NCT02927509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031004|NCT03591341|Melatonin|melatonin|mesh-list
25145787|NCT02927509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145788|NCT02927522|Donepezil|donepezil|mesh-list
25145789|NCT02927522|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25145790|NCT02927522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864027|NCT02182687|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24444889|NCT00299611|Levetiracetam|levetiracetam|mesh-list
24444890|NCT00299611|Sertraline|sertraline|mesh-list
24444891|NCT00299611|Antidepressive Agents|antidepressive agents|mesh-ancestor
24444892|NCT00299611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24444893|NCT00299611|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24444895|NCT00299611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24861942|NCT02321384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25139452|NCT02971306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139453|NCT02971306|Protective Agents|protective agents|mesh-ancestor
25139454|NCT02971306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139455|NCT02971306|Antidotes|antidotes|mesh-ancestor
25139456|NCT02971254|Sevoflurane|sevoflurane|mesh-list
24468383|NCT00381251|Hormones|hormones|mesh-ancestor
24444949|NCT00299858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24444950|NCT00299858|Respiratory System Agents|respiratory system agents|mesh-ancestor
24444951|NCT00299858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24444952|NCT00299858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444953|NCT00299858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864192|NCT05147857|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24864193|NCT05147857|Abortifacient Agents|abortifacient agents|mesh-ancestor
24864194|NCT05147857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24864195|NCT05147857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864196|NCT05147857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24864210|NCT05147727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24864216|NCT05146895|Imiquimod|imiquimod|mesh-list
24864217|NCT05146895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24864218|NCT05146895|Immunologic Factors|immunologic factors|mesh-ancestor
24864219|NCT05146895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444980|NCT00299910|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24444981|NCT00299910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444983|NCT00299923|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24444984|NCT00299923|Amantadine|amantadine|mesh-list
24864220|NCT05146895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813843|NCT02060656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544130|NCT00687388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24544131|NCT00687388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24544134|NCT00687388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544135|NCT00687388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544137|NCT00687388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24444985|NCT00299923|Antimetabolites|antimetabolites|mesh-ancestor
24445019|NCT00300040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24445020|NCT00300040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24813850|NCT02060656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813852|NCT02060656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24864249|NCT05116800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864250|NCT05116800|Antiviral Agents|antiviral agents|mesh-ancestor
25683765|NCT01881126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25683766|NCT01881126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25683767|NCT01881230|Gemcitabine|gemcitabine|mesh-list
25683768|NCT01881230|Paclitaxel|paclitaxel|mesh-list
25683769|NCT01881230|Carboplatin|carboplatin|mesh-list
25683770|NCT01881230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25683771|NCT01881230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683772|NCT01881230|Tubulin Modulators|tubulin modulators|mesh-ancestor
25683773|NCT01881230|Antimitotic Agents|antimitotic agents|mesh-ancestor
25683774|NCT01881230|Mitosis Modulators|mitosis modulators|mesh-ancestor
25683775|NCT01881230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145927|NCT02925351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145928|NCT02925351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145930|NCT02925299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24864265|NCT05112861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446660|NCT00305552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24864330|NCT04874311|Doxorubicin|doxorubicin|mesh-list
25139470|NCT02971345|Trace Elements|trace elements|mesh-ancestor
25139471|NCT02971345|Micronutrients|micronutrients|mesh-ancestor
25139472|NCT02971345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139473|NCT02971345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25139474|NCT02971345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25139475|NCT02971345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24620266|NCT01056224|Narcotics|narcotics|mesh-ancestor
25139476|NCT02971345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25139477|NCT02971345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25139478|NCT02971345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139479|NCT02971319|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
25139480|NCT02971319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24864744|NCT02741388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25139481|NCT02971319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139483|NCT02970773|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25139485|NCT02970773|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25139486|NCT02970773|Protease Inhibitors|protease inhibitors|mesh-ancestor
25139487|NCT02970773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445167|NCT00300716|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24445168|NCT00300716|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24445169|NCT00300716|Dopamine Agents|dopamine agents|mesh-ancestor
24445189|NCT00300768|Moxidectin|moxidectin|mesh-list
24864389|NCT04715230|Autonomic Agents|autonomic agents|mesh-ancestor
24864390|NCT04715230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24864393|NCT04715230|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24864394|NCT04715230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24864395|NCT04715230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24864396|NCT04715230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24864397|NCT04715230|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24864398|NCT04715230|Dopamine Agents|dopamine agents|mesh-ancestor
24864399|NCT04715230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24864526|NCT03589976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24864527|NCT03589976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864528|NCT03589976|Antifungal Agents|antifungal agents|mesh-ancestor
24864529|NCT03589976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24544462|NCT00689156|Tubulin Modulators|tubulin modulators|mesh-ancestor
24864673|NCT02802566|Micronutrients|micronutrients|mesh-ancestor
24864674|NCT02802566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864676|NCT02799641|Diazepam|diazepam|mesh-list
24864703|NCT02799641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24864713|NCT02755844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24864714|NCT02755844|Immunologic Factors|immunologic factors|mesh-ancestor
24544592|NCT00689624|Fluorouracil|fluorouracil|mesh-list
24544593|NCT00689624|Oxaliplatin|oxaliplatin|mesh-list
24544594|NCT00689624|Irinotecan|irinotecan|mesh-list
24864716|NCT02755844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24864717|NCT02755844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24864718|NCT02755844|Alkylating Agents|alkylating agents|mesh-ancestor
24864719|NCT02755844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864720|NCT02755844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683776|NCT01881230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25683777|NCT01881230|Antimetabolites|antimetabolites|mesh-ancestor
25683778|NCT01881230|Antiviral Agents|antiviral agents|mesh-ancestor
24864721|NCT02755844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24864722|NCT02755844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25683779|NCT01881230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25683780|NCT01881230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683781|NCT01881230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25683782|NCT01881230|Immunologic Factors|immunologic factors|mesh-ancestor
25683783|NCT01881230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683784|NCT01881412|Fluticasone|fluticasone|mesh-list
24864723|NCT02755844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24864724|NCT02755844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864726|NCT02741388|Cytarabine|cytarabine|mesh-list
24864731|NCT02741388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24864732|NCT02741388|Immunologic Factors|immunologic factors|mesh-ancestor
24864734|NCT02741388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24864745|NCT02741388|Antimetabolites|antimetabolites|mesh-ancestor
24864746|NCT02741388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864747|NCT02741388|Antiviral Agents|antiviral agents|mesh-ancestor
24864748|NCT02741388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24864749|NCT02741388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864750|NCT02741388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24864751|NCT02686346|Etoposide|etoposide|mesh-list
24544708|NCT00689845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24864825|NCT00943618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864827|NCT00943618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24864828|NCT00943618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864829|NCT00943618|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24864830|NCT00943618|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24864831|NCT00943618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813963|NCT02061631|Dexamethasone|dexamethasone|mesh-list
25046513|NCT00841659|Antidepressive Agents|antidepressive agents|mesh-ancestor
25046514|NCT00841659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25046515|NCT00841659|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25046516|NCT00841659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25046524|NCT00841542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046525|NCT00841542|Vasodilator Agents|vasodilator agents|mesh-ancestor
25046526|NCT00840879|Meloxicam|meloxicam|mesh-list
25046527|NCT00840879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25046528|NCT00840879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25046529|NCT00840879|Analgesics|analgesics|mesh-ancestor
25046530|NCT00840879|Sensory System Agents|sensory system agents|mesh-ancestor
24544737|NCT00689858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24544738|NCT00689858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864879|NCT05148715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864880|NCT05148715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864881|NCT05148689|Phenylephrine|phenylephrine|mesh-list
24864882|NCT05148689|Oxymetazoline|oxymetazoline|mesh-list
24864883|NCT05148689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24864884|NCT05148689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24544766|NCT00690118|Pioglitazone|pioglitazone|mesh-list
24445718|NCT00302354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544779|NCT00690170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544780|NCT00690170|Analgesics|analgesics|mesh-ancestor
25046534|NCT00840879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25046535|NCT00840879|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25046536|NCT00840879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25046537|NCT00840879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046538|NCT00840879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046539|NCT00840866|Cefprozil|cefprozil|mesh-list
25046540|NCT00840866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25046541|NCT00840866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25046542|NCT00840840|Amoxicillin|amoxicillin|mesh-list
25046543|NCT00840840|Clavulanic Acid|clavulanic acid|mesh-list
25046544|NCT00840840|Clavulanic Acids|clavulanic acids|mesh-list
25046545|NCT00840840|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25046546|NCT00840840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25046547|NCT00840840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25046548|NCT00840840|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25046549|NCT00840840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25088035|NCT03274167|Gabapentin|gabapentin|mesh-list
25139536|NCT02970539|Antimitotic Agents|antimitotic agents|mesh-ancestor
25139537|NCT02970539|Mitosis Modulators|mitosis modulators|mesh-ancestor
25139538|NCT02970539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139540|NCT02970604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24628447|NCT01099059|Analgesics|analgesics|mesh-ancestor
24544781|NCT00690170|Sensory System Agents|sensory system agents|mesh-ancestor
24544782|NCT00690170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24544783|NCT00690170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24544784|NCT00690170|Anesthetics, General|anesthetics, general|mesh-ancestor
24544785|NCT00690170|Anesthetics|anesthetics|mesh-ancestor
25146353|NCT02922426|Serotonin Agents|serotonin agents|mesh-ancestor
25146421|NCT02921984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25146422|NCT02921984|Tubulin Modulators|tubulin modulators|mesh-ancestor
25146423|NCT02921984|Antimitotic Agents|antimitotic agents|mesh-ancestor
25146424|NCT02921984|Mitosis Modulators|mitosis modulators|mesh-ancestor
25146425|NCT02921984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146426|NCT02921984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146427|NCT02921984|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25146428|NCT02921984|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25146429|NCT02921906|Acetaminophen|acetaminophen|mesh-list
25146430|NCT02921906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25146431|NCT02921906|Analgesics|analgesics|mesh-ancestor
25146432|NCT02921906|Sensory System Agents|sensory system agents|mesh-ancestor
25146433|NCT02921906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25146434|NCT02921906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146435|NCT02921906|Antipyretics|antipyretics|mesh-ancestor
25146436|NCT02921659|Niacinamide|niacinamide|mesh-list
25146437|NCT02921659|Vitamin B Complex|vitamin b complex|mesh-ancestor
25146438|NCT02921659|Vitamins|vitamins|mesh-ancestor
24544786|NCT00690170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24864905|NCT05148442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864906|NCT05148403|Glyburide|glyburide|mesh-list
24864907|NCT05148403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24864908|NCT05148403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864909|NCT05148208|Dialysis Solutions|dialysis solutions|mesh-list
24544787|NCT00690170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24544788|NCT00690170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24544789|NCT00690222|Mydriatics|mydriatics|mesh-list
24544790|NCT00690222|Autonomic Agents|autonomic agents|mesh-ancestor
25139541|NCT02970604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25139542|NCT02970604|Analgesics|analgesics|mesh-ancestor
25139543|NCT02970604|Sensory System Agents|sensory system agents|mesh-ancestor
25139544|NCT02970604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25139553|NCT02970604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25139556|NCT02970682|Fulvestrant|fulvestrant|mesh-list
25139557|NCT02970682|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25139558|NCT02970682|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25139559|NCT02970682|Hormone Antagonists|hormone antagonists|mesh-ancestor
25139560|NCT02970682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24544791|NCT00690222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24544792|NCT00690222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544793|NCT00690300|Docetaxel|docetaxel|mesh-list
24544794|NCT00690300|Oxaliplatin|oxaliplatin|mesh-list
24864928|NCT05148026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24864929|NCT05148026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864930|NCT05148026|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24864968|NCT05100264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864969|NCT05084521|Famotidine|famotidine|mesh-list
24864970|NCT05084521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24864971|NCT05084521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24864972|NCT05084521|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24864973|NCT05084521|Histamine Antagonists|histamine antagonists|mesh-ancestor
24864974|NCT05084521|Histamine Agents|histamine agents|mesh-ancestor
25683785|NCT01881412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25683786|NCT01881412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25683787|NCT01881412|Autonomic Agents|autonomic agents|mesh-ancestor
25683788|NCT01881412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25683789|NCT01881412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683790|NCT01881412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25683791|NCT01881412|Respiratory System Agents|respiratory system agents|mesh-ancestor
25683792|NCT01881412|Dermatologic Agents|dermatologic agents|mesh-ancestor
25683793|NCT01881412|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25683794|NCT01881789|Dexamethasone|dexamethasone|mesh-list
25683795|NCT01881789|Cyclophosphamide|cyclophosphamide|mesh-list
25683796|NCT01881789|Lenalidomide|lenalidomide|mesh-list
25683797|NCT01881789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25683798|NCT01881789|Immunologic Factors|immunologic factors|mesh-ancestor
25683799|NCT01881789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683800|NCT01881789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25683801|NCT01881789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25683802|NCT01881789|Alkylating Agents|alkylating agents|mesh-ancestor
25683803|NCT01881789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683804|NCT01881789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25146667|NCT02920060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25146668|NCT02920060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25146669|NCT02919878|Gemcitabine|gemcitabine|mesh-list
25146670|NCT02919878|Capecitabine|capecitabine|mesh-list
25146671|NCT02919878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25146672|NCT02919878|Antimetabolites|antimetabolites|mesh-ancestor
25146673|NCT02919878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146674|NCT02919878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25146675|NCT02919878|Antiviral Agents|antiviral agents|mesh-ancestor
25146676|NCT02919878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25146677|NCT02919878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146678|NCT02919878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25146679|NCT02919878|Immunologic Factors|immunologic factors|mesh-ancestor
25146680|NCT02919878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146681|NCT02919605|Pentamidine|pentamidine|mesh-list
24864975|NCT05084521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24864976|NCT05084521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864977|NCT05084521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864978|NCT05078931|Pembrolizumab|pembrolizumab|mesh-list
24864979|NCT05078931|Lenvatinib|lenvatinib|mesh-list
24544851|NCT00690560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24544852|NCT00690560|Alkylating Agents|alkylating agents|mesh-ancestor
24544853|NCT00690560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544854|NCT00690560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544855|NCT00690560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24544856|NCT00690560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24544857|NCT00690560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24544858|NCT00690560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25139561|NCT02970682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139562|NCT02970682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25139563|NCT02970682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25139564|NCT02970682|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25139565|NCT02970682|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25139566|NCT02970682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25139567|NCT02970682|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25139568|NCT02970682|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25139569|NCT02970682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25139570|NCT02970682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139571|NCT02970526|Oxaliplatin|oxaliplatin|mesh-list
25139572|NCT02970526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24628460|NCT01099085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24600306|NCT01095003|Antimetabolites|antimetabolites|mesh-ancestor
24865001|NCT04989322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865002|NCT04989322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24865003|NCT04989322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544872|NCT00690677|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24544873|NCT00690677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446684|NCT00305630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25405455|NCT03606538|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25683805|NCT01881789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25683806|NCT01881789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25683807|NCT01881789|Antiemetics|antiemetics|mesh-ancestor
25683808|NCT01881789|Autonomic Agents|autonomic agents|mesh-ancestor
25683809|NCT01881789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25683810|NCT01881789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25683811|NCT01881789|Glucocorticoids|glucocorticoids|mesh-ancestor
25683812|NCT01881789|Hormones|hormones|mesh-ancestor
25683813|NCT01881789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25683814|NCT01881789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25683815|NCT01881789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25683816|NCT01881789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25683817|NCT01881789|Growth Substances|growth substances|mesh-ancestor
25683818|NCT01881789|Growth Inhibitors|growth inhibitors|mesh-ancestor
25683819|NCT01881828|Metformin|metformin|mesh-list
25683821|NCT01881828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683822|NCT01882088|Psyllium|psyllium|mesh-list
25683823|NCT01882088|Cathartics|cathartics|mesh-ancestor
25683824|NCT01882088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25284577|NCT03304821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146899|NCT02918708|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25146900|NCT02918708|Immunologic Factors|immunologic factors|mesh-ancestor
25284598|NCT03136731|Antibodies|antibodies|mesh-list
24445819|NCT00302666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25012189|NCT01491893|Immunologic Factors|immunologic factors|mesh-ancestor
24445820|NCT00302666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24445822|NCT00302666|Androgens|androgens|mesh-ancestor
24865026|NCT04931511|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24865027|NCT04931511|Betamethasone benzoate|betamethasone benzoate|mesh-list
24865028|NCT04931511|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24865029|NCT04931511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24544912|NCT00690911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24544913|NCT00690911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24544914|NCT00690937|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
24544924|NCT00690950|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25139593|NCT02970097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139595|NCT02970097|Sensory System Agents|sensory system agents|mesh-ancestor
25139596|NCT02970097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25139597|NCT02970097|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25139598|NCT02970097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25139599|NCT02970097|Anesthetics, General|anesthetics, general|mesh-ancestor
25139600|NCT02970097|Anesthetics|anesthetics|mesh-ancestor
25139601|NCT02970097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25139602|NCT02970097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25139603|NCT02970097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25139604|NCT02970097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25139605|NCT02970097|GABA Modulators|gaba modulators|mesh-ancestor
25139606|NCT02970097|GABA Agents|gaba agents|mesh-ancestor
25139607|NCT02970097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25139608|NCT02970097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139609|NCT02970097|Anesthetics, Local|anesthetics, local|mesh-ancestor
25139610|NCT02970084|Vitamin K|vitamin k|mesh-list
24544930|NCT00690950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865052|NCT04804709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865053|NCT04694781|Pembrolizumab|pembrolizumab|mesh-list
24865054|NCT04694781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24865055|NCT04694781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683825|NCT01882439|Tofacitinib|tofacitinib|mesh-list
25683826|NCT01882439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25683827|NCT01882439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683828|NCT01882439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683829|NCT01882829|Quinidine|quinidine|mesh-list
25683830|NCT01882829|Dextromethorphan|dextromethorphan|mesh-list
25683831|NCT01882829|Antitussive Agents|antitussive agents|mesh-ancestor
25683832|NCT01882829|Respiratory System Agents|respiratory system agents|mesh-ancestor
25683833|NCT01882829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25683834|NCT01882829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25683835|NCT01882829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25683836|NCT01882829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683837|NCT01882829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146919|NCT02918331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25146920|NCT02918331|Glucocorticoids|glucocorticoids|mesh-ancestor
25147084|NCT02916485|Antifungal Agents|antifungal agents|mesh-ancestor
25147085|NCT02916485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25147086|NCT02916485|Immunologic Factors|immunologic factors|mesh-ancestor
25147087|NCT02916485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147088|NCT02916602|Losartan|losartan|mesh-list
25147089|NCT02916602|Amlodipine|amlodipine|mesh-list
25147090|NCT02916602|Chlorthalidone|chlorthalidone|mesh-list
25147091|NCT02916602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25147092|NCT02916602|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25147093|NCT02916602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25147094|NCT02916602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147095|NCT02916602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25147096|NCT02916602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147097|NCT02916602|Vasodilator Agents|vasodilator agents|mesh-ancestor
25284631|NCT02659813|Nickel|nickel|mesh-list
25284632|NCT02659813|Trace Elements|trace elements|mesh-ancestor
25284633|NCT02659813|Micronutrients|micronutrients|mesh-ancestor
25284635|NCT02566863|Dexmedetomidine|dexmedetomidine|mesh-list
24865056|NCT04690673|Acetaminophen|acetaminophen|mesh-list
24544950|NCT00691145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545000|NCT00691275|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25139616|NCT02970084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25139617|NCT02970084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139618|NCT02970084|Hemostatics|hemostatics|mesh-ancestor
25139619|NCT02970084|Coagulants|coagulants|mesh-ancestor
25139620|NCT02969980|Cyclophosphamide|cyclophosphamide|mesh-list
25139621|NCT02969980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25139622|NCT02969980|Immunologic Factors|immunologic factors|mesh-ancestor
25139623|NCT02969980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139624|NCT02969980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25139625|NCT02969980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25139626|NCT02969980|Alkylating Agents|alkylating agents|mesh-ancestor
25139627|NCT02969980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088142|NCT03273088|Analgesics|analgesics|mesh-ancestor
25139628|NCT02969980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25139629|NCT02969980|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25139630|NCT02969720|Titanium dioxide|titanium dioxide|mesh-list
25139631|NCT02969720|Sunscreening Agents|sunscreening agents|mesh-ancestor
25139632|NCT02969720|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25139633|NCT02969720|Protective Agents|protective agents|mesh-ancestor
25139634|NCT02969720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139635|NCT02969720|Dermatologic Agents|dermatologic agents|mesh-ancestor
25139636|NCT02969720|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25139637|NCT02969746|Charcoal|charcoal|mesh-list
25139638|NCT02969746|Antidotes|antidotes|mesh-ancestor
25139639|NCT02969746|Protective Agents|protective agents|mesh-ancestor
25139640|NCT02969746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139641|NCT02969733|Lidocaine|lidocaine|mesh-list
25139642|NCT02969733|Ketamine|ketamine|mesh-list
25139651|NCT02969733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25139652|NCT02969733|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25683838|NCT01882829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25683839|NCT01882829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25683840|NCT01882829|Adrenergic Agents|adrenergic agents|mesh-ancestor
25683841|NCT01882829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25683842|NCT01882829|Antimalarials|antimalarials|mesh-ancestor
25683843|NCT01882829|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25683844|NCT01882829|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25683845|NCT01882829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25683846|NCT01882829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683847|NCT01882829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25683848|NCT01882829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25683849|NCT01882829|Cholinergic Agents|cholinergic agents|mesh-ancestor
25683850|NCT01882829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25683851|NCT01882829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25683852|NCT01882829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25683853|NCT01882829|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25683854|NCT01882829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25683855|NCT01882868|Leucovorin|leucovorin|mesh-list
25683856|NCT01882868|Irinotecan|irinotecan|mesh-list
25139653|NCT02969733|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25139654|NCT02969733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24545081|NCT00691886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24445956|NCT00303290|Interferon alpha-2|interferon alpha-2|mesh-list
24445957|NCT00303290|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24445958|NCT00303290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445959|NCT00303290|Antiviral Agents|antiviral agents|mesh-ancestor
24445960|NCT00303290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24814091|NCT02062281|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24814092|NCT02062281|Immunologic Factors|immunologic factors|mesh-ancestor
24814093|NCT02062281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865181|NCT04298034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24865182|NCT04298034|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24865183|NCT04298034|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24865184|NCT04298034|Adrenergic Agents|adrenergic agents|mesh-ancestor
24865185|NCT04298034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24865192|NCT04254549|Rifaximin|rifaximin|mesh-list
25139660|NCT02969733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24865279|NCT04006769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865280|NCT04006769|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24865281|NCT04006769|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24865282|NCT04006769|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24445971|NCT00303381|Antiviral Agents|antiviral agents|mesh-ancestor
24865378|NCT03317795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24865379|NCT03317795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24545299|NCT00693004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545301|NCT00693004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24545314|NCT00693030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24545316|NCT00693030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24545319|NCT00693043|Lidocaine|lidocaine|mesh-list
24814105|NCT02062333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24814106|NCT02062333|Adrenergic Agents|adrenergic agents|mesh-ancestor
24814107|NCT02062333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24814108|NCT02062333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814109|NCT02062333|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24814110|NCT02062333|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24814111|NCT02062333|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24814112|NCT02062346|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
24814113|NCT02062346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24814114|NCT02062346|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24814115|NCT02062346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814118|NCT02062892|Sirolimus|sirolimus|mesh-list
24814122|NCT02062892|Immunologic Factors|immunologic factors|mesh-ancestor
24814123|NCT02062892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814124|NCT02062892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24814125|NCT02062892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24814126|NCT02062892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24814127|NCT02062892|Antifungal Agents|antifungal agents|mesh-ancestor
24814128|NCT02062983|Trastuzumab|trastuzumab|mesh-list
24814129|NCT02062983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24814130|NCT02062983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865542|NCT00805961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24865543|NCT00805961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24865544|NCT00805961|Growth Substances|growth substances|mesh-ancestor
24865545|NCT00805961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865546|NCT00805961|Growth Inhibitors|growth inhibitors|mesh-ancestor
24865547|NCT00805961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24865548|NCT00805961|Immunologic Factors|immunologic factors|mesh-ancestor
24865575|NCT05152420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24865576|NCT05152420|Antithrombins|antithrombins|mesh-ancestor
24865577|NCT05152420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24865578|NCT05152420|Protease Inhibitors|protease inhibitors|mesh-ancestor
24865579|NCT05152420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24865580|NCT05152420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865581|NCT05152420|Anticoagulants|anticoagulants|mesh-ancestor
24865583|NCT05152355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24865601|NCT05152264|Sensory System Agents|sensory system agents|mesh-ancestor
25139704|NCT02969473|Antimitotic Agents|antimitotic agents|mesh-ancestor
25139705|NCT02969473|Mitosis Modulators|mitosis modulators|mesh-ancestor
25139706|NCT02969473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046550|NCT00840840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046551|NCT00840632|Trandolapril|trandolapril|mesh-list
25046552|NCT00840632|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25046553|NCT00840632|Protease Inhibitors|protease inhibitors|mesh-ancestor
25046554|NCT00840632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046555|NCT00840632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865636|NCT05151679|Micronutrients|micronutrients|mesh-ancestor
25046559|NCT00840476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25046560|NCT00840476|Analgesics|analgesics|mesh-ancestor
25079401|NCT03347968|Esmolol|esmolol|mesh-list
24446052|NCT00303758|Gemcitabine|gemcitabine|mesh-list
24865797|NCT04933058|Analgesics|analgesics|mesh-ancestor
24865798|NCT04933058|Sensory System Agents|sensory system agents|mesh-ancestor
24865799|NCT04933058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24446089|NCT00303771|Protective Agents|protective agents|mesh-ancestor
24865841|NCT04777851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865842|NCT04777851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24865843|NCT04777851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865844|NCT04761887|Ropivacaine|ropivacaine|mesh-list
24865879|NCT04597372|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24865880|NCT04597372|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24865881|NCT04597372|Adrenergic Agents|adrenergic agents|mesh-ancestor
24865882|NCT04597372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25046566|NCT00840476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25046567|NCT00840476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24865883|NCT04597372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814145|NCT02062996|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24814146|NCT02062996|Mydriatics|mydriatics|mesh-ancestor
24814147|NCT02062996|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24814148|NCT02062996|Protective Agents|protective agents|mesh-ancestor
24446092|NCT00303771|Micronutrients|micronutrients|mesh-ancestor
24446093|NCT00303784|Goserelin|goserelin|mesh-list
24446117|NCT00303810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814232|NCT02063360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24814233|NCT02063360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24814234|NCT02063360|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24814235|NCT02063360|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24814236|NCT02063373|Hyaluronic Acid|hyaluronic acid|mesh-list
24814237|NCT02063373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24814238|NCT02063373|Immunologic Factors|immunologic factors|mesh-ancestor
24865989|NCT04056182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464667|NCT00365755|Mitosis Modulators|mitosis modulators|mesh-ancestor
24413736|NCT00195000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24464669|NCT00365820|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24464676|NCT00365898|Narcotics|narcotics|mesh-ancestor
24464677|NCT00365898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24865996|NCT03966625|Autoantibodies|autoantibodies|mesh-list
24865997|NCT03966625|Immunologic Factors|immunologic factors|mesh-ancestor
24865998|NCT03966625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865999|NCT03961568|Cenobamate|cenobamate|mesh-list
25046572|NCT00840411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25046573|NCT00840411|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25046574|NCT00840411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046575|NCT00840411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046579|NCT00840281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25046580|NCT00840281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25046581|NCT00840216|Clarithromycin|clarithromycin|mesh-list
25046582|NCT00840216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24605468|NCT00985348|Levetiracetam|levetiracetam|mesh-list
24866000|NCT03961568|Anticonvulsants|anticonvulsants|mesh-ancestor
24866001|NCT03959358|Lenalidomide|lenalidomide|mesh-list
24866002|NCT03959358|Pomalidomide|pomalidomide|mesh-list
24866003|NCT03959358|Immunologic Factors|immunologic factors|mesh-ancestor
24866004|NCT03959358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866005|NCT03959358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24866006|NCT03959358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24446178|NCT00303940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446179|NCT00303940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24446180|NCT00303940|Alkylating Agents|alkylating agents|mesh-ancestor
24446181|NCT00303940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866090|NCT03593252|Neomycin|neomycin|mesh-list
24866091|NCT03593252|Picosulfate sodium|picosulfate sodium|mesh-list
24866092|NCT03593252|Magnesium Oxide|magnesium oxide|mesh-list
24866093|NCT03593252|Citric Acid|citric acid|mesh-list
24866094|NCT03593252|Sodium Citrate|sodium citrate|mesh-list
24866095|NCT03593252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24866096|NCT03593252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25046583|NCT00840216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25046584|NCT00840216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25046586|NCT00840216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046587|NCT00840216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25046588|NCT00840216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25046589|NCT00840203|Mesalamine|mesalamine|mesh-list
25046590|NCT00840203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25046591|NCT00840203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25046592|NCT00840203|Analgesics|analgesics|mesh-ancestor
25046593|NCT00840203|Sensory System Agents|sensory system agents|mesh-ancestor
25046594|NCT00840203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25046595|NCT00840203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046596|NCT00840203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25046597|NCT00840203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25046598|NCT00840099|Amoxicillin|amoxicillin|mesh-list
24814266|NCT02063529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24814267|NCT02063529|Immunologic Factors|immunologic factors|mesh-ancestor
24814268|NCT02063529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814269|NCT02063529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24814270|NCT02063529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24814271|NCT02063529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24814272|NCT02063529|Antidotes|antidotes|mesh-ancestor
24814273|NCT02063529|Protective Agents|protective agents|mesh-ancestor
24814274|NCT02063529|Vitamin B Complex|vitamin b complex|mesh-ancestor
24814275|NCT02063529|Vitamins|vitamins|mesh-ancestor
24814276|NCT02063529|Micronutrients|micronutrients|mesh-ancestor
24866184|NCT03219437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24866185|NCT03219437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24866186|NCT03219437|Immunologic Factors|immunologic factors|mesh-ancestor
24866187|NCT03219437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24866188|NCT03219437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24866189|NCT03202537|Dexlansoprazole|dexlansoprazole|mesh-list
24866190|NCT03202537|Lansoprazole|lansoprazole|mesh-list
24866191|NCT03202537|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24866192|NCT03202537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24866193|NCT03202537|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24866194|NCT03202537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866195|NCT03202537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866196|NCT03150511|Tesamorelin|tesamorelin|mesh-list
24866197|NCT03150511|Growth Substances|growth substances|mesh-ancestor
24866198|NCT03150511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688283|NCT03180294|Bupropion|bupropion|mesh-list
24866199|NCT03042819|Doxorubicin|doxorubicin|mesh-list
24866200|NCT03042819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24446230|NCT00304200|Temozolomide|temozolomide|mesh-list
25046608|NCT00840073|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25046609|NCT00840073|Protease Inhibitors|protease inhibitors|mesh-ancestor
25046610|NCT00840073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046611|NCT00840073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046612|NCT00840073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25046613|NCT00839930|Cilostazol|cilostazol|mesh-list
25046614|NCT00839930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25046615|NCT00839930|Autonomic Agents|autonomic agents|mesh-ancestor
25046616|NCT00839930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25046617|NCT00839930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046618|NCT00839930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25139707|NCT02969473|Antimetabolites|antimetabolites|mesh-ancestor
25139708|NCT02969473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25139709|NCT02969473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25139710|NCT02969473|Immunologic Factors|immunologic factors|mesh-ancestor
25139711|NCT02969473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139712|NCT02969304|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25139713|NCT02969304|Dermatologic Agents|dermatologic agents|mesh-ancestor
24810517|NCT02040597|Hormones|hormones|mesh-ancestor
24866233|NCT02703220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24866234|NCT02703220|Hormone Antagonists|hormone antagonists|mesh-ancestor
24866235|NCT02703220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24866236|NCT02703220|Urological Agents|urological agents|mesh-ancestor
24866238|NCT02568449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866239|NCT02568449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24866240|NCT02568449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866241|NCT02568449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866242|NCT02546622|Factor VIII|factor viii|mesh-list
24866243|NCT02546622|Coagulants|coagulants|mesh-ancestor
24866332|NCT05153785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24546331|NCT00697671|Analgesics|analgesics|mesh-ancestor
25139714|NCT02969304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25139715|NCT02969304|Immunologic Factors|immunologic factors|mesh-ancestor
25139716|NCT02969304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139717|NCT02969278|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25139718|NCT02969278|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25139719|NCT02969278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139720|NCT02969265|Amlodipine|amlodipine|mesh-list
25139721|NCT02969265|Candesartan cilexetil|candesartan cilexetil|mesh-list
25139722|NCT02969265|Candesartan|candesartan|mesh-list
25139723|NCT02969265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25139724|NCT02969265|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25139725|NCT02969265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25139726|NCT02969265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139727|NCT02969265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25139728|NCT02969265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139729|NCT02969265|Vasodilator Agents|vasodilator agents|mesh-ancestor
25139730|NCT02969265|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25139731|NCT02969265|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25139732|NCT02969252|Rifamycins|rifamycins|mesh-list
25139733|NCT02969252|Rifamycin SV|rifamycin sv|mesh-list
25139734|NCT02969252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25139735|NCT02969252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25139737|NCT02969239|Phenylephrine|phenylephrine|mesh-list
25139738|NCT02969239|Oxymetazoline|oxymetazoline|mesh-list
25139739|NCT02969239|Norepinephrine|norepinephrine|mesh-list
25139758|NCT02968901|Vasodilator Agents|vasodilator agents|mesh-ancestor
25139759|NCT02968901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24866375|NCT05153070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24866376|NCT05153070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24866378|NCT05152940|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24866379|NCT05152940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284795|NCT05082896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25284796|NCT05082896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284797|NCT05082753|Ivermectin|ivermectin|mesh-list
25284800|NCT05082662|Diclofenac|diclofenac|mesh-list
24866380|NCT05152940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24866381|NCT05152940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866382|NCT05152901|Epinephrine|epinephrine|mesh-list
25139775|NCT02968927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139776|NCT02968927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25139777|NCT02968927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25139778|NCT02968927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25139779|NCT02968927|Immunologic Factors|immunologic factors|mesh-ancestor
25139780|NCT02968927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25139781|NCT02968927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25139782|NCT02968927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25139817|NCT02968641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24866434|NCT05132985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24814286|NCT02063620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814287|NCT02063620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24814288|NCT02063620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24814289|NCT02063620|Anesthetics, General|anesthetics, general|mesh-ancestor
24814290|NCT02063620|Anesthetics|anesthetics|mesh-ancestor
24814291|NCT02063620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24814292|NCT02063620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24814293|NCT02063620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24814294|NCT02063620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24437270|NCT00273299|Diuretics|diuretics|mesh-ancestor
25139818|NCT02968641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25139819|NCT02968641|Antiviral Agents|antiviral agents|mesh-ancestor
25139830|NCT02968498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25139831|NCT02968498|Dopamine Agents|dopamine agents|mesh-ancestor
25139832|NCT02968498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25139833|NCT02968498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139834|NCT02968498|Adrenergic Agents|adrenergic agents|mesh-ancestor
25139835|NCT02968498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25139836|NCT02968498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25139837|NCT02968498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25139838|NCT02968498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25139839|NCT02968394|Omalizumab|omalizumab|mesh-list
25139840|NCT02968394|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25139841|NCT02968394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25139842|NCT02968394|Respiratory System Agents|respiratory system agents|mesh-ancestor
25139843|NCT02968342|Progesterone|progesterone|mesh-list
25139844|NCT02968342|Progestins|progestins|mesh-ancestor
25139845|NCT02968342|Hormones|hormones|mesh-ancestor
25139846|NCT02968342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25139847|NCT02968342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139848|NCT02968303|Vemurafenib|vemurafenib|mesh-list
25139849|NCT02968303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25139850|NCT02968303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25139851|NCT02968303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046619|NCT00839930|Respiratory System Agents|respiratory system agents|mesh-ancestor
25046620|NCT00839930|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25046623|NCT00839930|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25046624|NCT00839930|Vasodilator Agents|vasodilator agents|mesh-ancestor
25046625|NCT00839930|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25046626|NCT00839930|Protective Agents|protective agents|mesh-ancestor
25046627|NCT00839930|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24814295|NCT02063620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814297|NCT02063789|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24814298|NCT02063789|Antibodies|antibodies|mesh-list
24814299|NCT02063789|Immunologic Factors|immunologic factors|mesh-ancestor
24814308|NCT02063945|Risperidone|risperidone|mesh-list
24814309|NCT02063945|Methylphenidate|methylphenidate|mesh-list
24814310|NCT02063945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24814311|NCT02063945|Serotonin Agents|serotonin agents|mesh-ancestor
24814312|NCT02063945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25683857|NCT01882868|Aflibercept|aflibercept|mesh-list
25683858|NCT01882868|Levoleucovorin|levoleucovorin|mesh-list
25683859|NCT01882868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25683860|NCT01882868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25683861|NCT01882868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683862|NCT01882868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284831|NCT05049902|Amoxicillin|amoxicillin|mesh-list
25284832|NCT05049902|Metronidazole|metronidazole|mesh-list
25284833|NCT05049902|Clarithromycin|clarithromycin|mesh-list
25284834|NCT05049902|Tetracycline|tetracycline|mesh-list
25284835|NCT05049902|Potassium Citrate|potassium citrate|mesh-list
25284836|NCT05049902|Bismuth|bismuth|mesh-list
25284837|NCT05049902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284838|NCT05049902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25284839|NCT05049902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25284840|NCT05049902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25284841|NCT05049902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25284842|NCT05049902|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24458256|NCT00337259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458257|NCT00337259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458258|NCT00337259|Antiviral Agents|antiviral agents|mesh-ancestor
24458259|NCT00337259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24458260|NCT00337259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458261|NCT00337259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24458262|NCT00337259|Immunologic Factors|immunologic factors|mesh-ancestor
24458263|NCT00337259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533298|NCT00642967|Hematinics|hematinics|mesh-ancestor
24533299|NCT00642980|Clindamycin|clindamycin|mesh-list
24436416|NCT00269867|Infliximab|infliximab|mesh-list
24814313|NCT02063945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814314|NCT02063945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814315|NCT02063945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24814316|NCT02063945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24866441|NCT05118399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24866477|NCT04884893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24866479|NCT04884893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24866480|NCT04884893|Analgesics|analgesics|mesh-ancestor
24866481|NCT04884893|Sensory System Agents|sensory system agents|mesh-ancestor
24866482|NCT04884893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24866483|NCT04778267|Dexamethasone|dexamethasone|mesh-list
24866484|NCT04778267|Bupivacaine|bupivacaine|mesh-list
24866485|NCT04778267|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24866486|NCT04778267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24446142|NCT00303836|Fludarabine phosphate|fludarabine phosphate|mesh-list
24446143|NCT00303836|Interleukin-2|interleukin-2|mesh-list
24900899|NCT04390334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24866631|NCT05258474|Micronutrients|micronutrients|mesh-ancestor
24866632|NCT05258474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866634|NCT05258474|Antimetabolites|antimetabolites|mesh-ancestor
24866635|NCT05258474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683863|NCT01882868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683864|NCT01882868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25683865|NCT01882868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25683866|NCT01882868|Growth Substances|growth substances|mesh-ancestor
25683867|NCT01882868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683868|NCT01882868|Growth Inhibitors|growth inhibitors|mesh-ancestor
25683869|NCT01882868|Antidotes|antidotes|mesh-ancestor
25683870|NCT01882868|Protective Agents|protective agents|mesh-ancestor
25683871|NCT01882868|Vitamin B Complex|vitamin b complex|mesh-ancestor
25683872|NCT01882868|Vitamins|vitamins|mesh-ancestor
25683873|NCT01882868|Micronutrients|micronutrients|mesh-ancestor
25683874|NCT01882907|Pioglitazone|pioglitazone|mesh-list
25683875|NCT01882907|Vildagliptin|vildagliptin|mesh-list
25683876|NCT01882907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25683877|NCT01882907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683878|NCT01882907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25683879|NCT01882907|Protease Inhibitors|protease inhibitors|mesh-ancestor
25683880|NCT01882907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683881|NCT01882907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683882|NCT01882985|Lycopene|lycopene|mesh-list
25683883|NCT01882985|Docetaxel|docetaxel|mesh-list
25683884|NCT01882985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683885|NCT01882985|Tubulin Modulators|tubulin modulators|mesh-ancestor
25683886|NCT01882985|Antimitotic Agents|antimitotic agents|mesh-ancestor
25683887|NCT01882985|Mitosis Modulators|mitosis modulators|mesh-ancestor
25012516|NCT05052970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683888|NCT01882985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683889|NCT01882985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24866636|NCT05258474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24866637|NCT05258474|Vasodilator Agents|vasodilator agents|mesh-ancestor
25046634|NCT00838799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046635|NCT00838799|Anticonvulsants|anticonvulsants|mesh-ancestor
25046636|NCT00838799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25046637|NCT00838799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25046638|NCT00838799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046639|NCT00838799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25046640|NCT00838799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25046641|NCT00838799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25046642|NCT00838799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25046643|NCT00838799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25046644|NCT00838630|Cilostazol|cilostazol|mesh-list
25046645|NCT00838630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25046646|NCT00838630|Autonomic Agents|autonomic agents|mesh-ancestor
25046647|NCT00838630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25046648|NCT00838630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046649|NCT00838630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24446307|NCT00304421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24446308|NCT00304421|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24446309|NCT00304421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866699|NCT05189197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866700|NCT05189197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24866701|NCT05189197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866702|NCT05189197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866704|NCT05137626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24866705|NCT05137626|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24866706|NCT05137626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866707|NCT05137626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866708|NCT05137626|Protective Agents|protective agents|mesh-ancestor
24866709|NCT05137626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866772|NCT04827953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24866773|NCT04827953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866774|NCT04827953|Tubulin Modulators|tubulin modulators|mesh-ancestor
24866775|NCT04827953|Antimitotic Agents|antimitotic agents|mesh-ancestor
24866776|NCT04827953|Mitosis Modulators|mitosis modulators|mesh-ancestor
24866777|NCT04827953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866778|NCT04827953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25046654|NCT00838630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25046655|NCT00838630|Vasodilator Agents|vasodilator agents|mesh-ancestor
25046656|NCT00838630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25046657|NCT00838630|Protective Agents|protective agents|mesh-ancestor
25046658|NCT00838630|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25046659|NCT00838630|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25046660|NCT00838630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25139852|NCT02968303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139853|NCT02968121|Brexpiprazole|brexpiprazole|mesh-list
25139854|NCT02968121|Serotonin Agents|serotonin agents|mesh-ancestor
25139855|NCT02968121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25139856|NCT02968121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139857|NCT02968121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139858|NCT02968121|Dopamine Agonists|dopamine agonists|mesh-ancestor
25139859|NCT02968121|Dopamine Agents|dopamine agents|mesh-ancestor
25139860|NCT02968160|Telmisartan|telmisartan|mesh-list
25139861|NCT02968160|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25139862|NCT02968160|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25139863|NCT02968160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25139864|NCT02968160|Antimetabolites|antimetabolites|mesh-ancestor
24866779|NCT04827953|Antimetabolites|antimetabolites|mesh-ancestor
24866780|NCT04827953|Antiviral Agents|antiviral agents|mesh-ancestor
24866781|NCT04827953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24866782|NCT04827953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866783|NCT04827953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24866784|NCT04827953|Immunologic Factors|immunologic factors|mesh-ancestor
24866819|NCT04660747|Anticoagulants|anticoagulants|mesh-list
24866891|NCT04107038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24866892|NCT04107038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866894|NCT03993717|Immunologic Factors|immunologic factors|mesh-ancestor
24866895|NCT03993717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866948|NCT03865940|Lidocaine|lidocaine|mesh-list
24866949|NCT03865940|Guanfacine|guanfacine|mesh-list
24866950|NCT03865940|Anesthetics, Local|anesthetics, local|mesh-ancestor
24866951|NCT03865940|Anesthetics|anesthetics|mesh-ancestor
24866953|NCT03865940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866954|NCT03865940|Sensory System Agents|sensory system agents|mesh-ancestor
24866955|NCT03865940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24866956|NCT03865940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24866967|NCT03792750|Nivolumab|nivolumab|mesh-list
24814358|NCT02064088|Sensory System Agents|sensory system agents|mesh-ancestor
24814359|NCT02064088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24814360|NCT02064140|Rocuronium|rocuronium|mesh-list
24862424|NCT02325180|Lumefantrine|lumefantrine|mesh-list
24814361|NCT02064140|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24814362|NCT02064140|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24814363|NCT02064140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24814364|NCT02064140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24814366|NCT02064153|Dialysis Solutions|dialysis solutions|mesh-list
24814370|NCT02064348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24814371|NCT02064348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24814372|NCT02064348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24814373|NCT02064348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24814374|NCT02064348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24814375|NCT02064348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814376|NCT02064348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24814378|NCT02064374|Dolutegravir|dolutegravir|mesh-list
24814379|NCT02064374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24814380|NCT02064374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814381|NCT02064374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24814382|NCT02064374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24867003|NCT03765619|Aspirin|aspirin|mesh-list
24867004|NCT03765619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24867005|NCT03765619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24867006|NCT03765619|Analgesics|analgesics|mesh-ancestor
24867007|NCT03765619|Sensory System Agents|sensory system agents|mesh-ancestor
25139886|NCT02968082|Parasympatholytics|parasympatholytics|mesh-ancestor
25139887|NCT02967939|Tenofovir|tenofovir|mesh-list
25139888|NCT02967939|Antiviral Agents|antiviral agents|mesh-ancestor
25139889|NCT02967939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25139890|NCT02967939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25139891|NCT02967939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24812265|NCT02050958|Ibuprofen|ibuprofen|mesh-list
24867094|NCT03520842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24867095|NCT03520842|Dermatologic Agents|dermatologic agents|mesh-ancestor
24867096|NCT03520842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24867097|NCT03520842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24867098|NCT03520842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24867099|NCT03520842|Immunologic Factors|immunologic factors|mesh-ancestor
24867100|NCT03520842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24867101|NCT03520842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24867145|NCT03347123|Nivolumab|nivolumab|mesh-list
24867146|NCT03347123|Ipilimumab|ipilimumab|mesh-list
24867198|NCT03177460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24867199|NCT03150732|Nalbuphine|nalbuphine|mesh-list
24867200|NCT03150732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24867201|NCT03150732|Narcotics|narcotics|mesh-ancestor
25139899|NCT02967874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139900|NCT02967874|Viscosupplements|viscosupplements|mesh-ancestor
25139901|NCT02967874|Protective Agents|protective agents|mesh-ancestor
25139902|NCT02967848|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
25139903|NCT02967848|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25139904|NCT02967848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139905|NCT02967757|Liraglutide|liraglutide|mesh-list
25139906|NCT02967757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25139907|NCT02967757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139908|NCT02967757|Incretins|incretins|mesh-ancestor
25139909|NCT02967757|Hormones|hormones|mesh-ancestor
24867255|NCT02549092|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24867257|NCT02549092|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24867258|NCT02549092|Dopamine Agents|dopamine agents|mesh-ancestor
24867259|NCT02549092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24867260|NCT02549092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867261|NCT02549092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867262|NCT02549092|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24867263|NCT02549092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978980|NCT02013167|Blinatumomab|blinatumomab|mesh-list
24867274|NCT02478788|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24867275|NCT02478788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867277|NCT02478788|Autonomic Agents|autonomic agents|mesh-ancestor
25284986|NCT04858711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25284987|NCT04858711|Adrenergic Agents|adrenergic agents|mesh-ancestor
25284988|NCT04858711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25284989|NCT04858711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25040664|NCT02973633|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
25040665|NCT02973633|Chelating Agents|chelating agents|mesh-ancestor
25040666|NCT02973633|Sequestering Agents|sequestering agents|mesh-ancestor
25040667|NCT02973633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040668|NCT02971891|Furosemide|furosemide|mesh-list
25040669|NCT02971891|Diuretics|diuretics|mesh-ancestor
25040670|NCT02971891|Natriuretic Agents|natriuretic agents|mesh-ancestor
24867278|NCT02478788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24867279|NCT02478788|Dopamine Agents|dopamine agents|mesh-ancestor
24867292|NCT02335242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867293|NCT02335242|Urological Agents|urological agents|mesh-ancestor
24867295|NCT02323126|Nazartinib|nazartinib|mesh-list
24867296|NCT02323126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24867297|NCT02323126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25139911|NCT02967887|Fluorouracil|fluorouracil|mesh-list
25139912|NCT02967887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25139913|NCT02967887|Antimetabolites|antimetabolites|mesh-ancestor
25139914|NCT02967887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139915|NCT02967887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25139916|NCT02967887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25139917|NCT02967887|Immunologic Factors|immunologic factors|mesh-ancestor
25139918|NCT02967887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139919|NCT02967731|Mometasone Furoate|mometasone furoate|mesh-list
25139920|NCT02967731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25139921|NCT02967731|Dermatologic Agents|dermatologic agents|mesh-ancestor
25139922|NCT02967731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25139923|NCT02967302|Triamcinolone|triamcinolone|mesh-list
25139924|NCT02967302|Morphine|morphine|mesh-list
25139925|NCT02967302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25139926|NCT02967302|Narcotics|narcotics|mesh-ancestor
25139927|NCT02967302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25139928|NCT02967302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139929|NCT02967302|Analgesics|analgesics|mesh-ancestor
25139930|NCT02967302|Sensory System Agents|sensory system agents|mesh-ancestor
25139931|NCT02967302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25139932|NCT02967302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25139933|NCT02967302|Glucocorticoids|glucocorticoids|mesh-ancestor
25139934|NCT02967302|Hormones|hormones|mesh-ancestor
24867298|NCT02323126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24867299|NCT02323126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867302|NCT01712763|Goserelin|goserelin|mesh-list
24867303|NCT01712763|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24867304|NCT01712763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24867305|NCT01712763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24867306|NCT01712763|Luteolytic Agents|luteolytic agents|mesh-ancestor
24867307|NCT01712763|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24446245|NCT00304213|Hormones|hormones|mesh-ancestor
24513179|NCT00579644|Minocycline|minocycline|mesh-list
24867355|NCT01064245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867357|NCT01059448|Dermatologic Agents|dermatologic agents|mesh-ancestor
24867358|NCT00821587|Cyclosporine|cyclosporine|mesh-list
24867359|NCT00821587|Tacrolimus|tacrolimus|mesh-list
24867360|NCT00821587|Cyclosporins|cyclosporins|mesh-list
25139940|NCT02967653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139941|NCT02967653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25139942|NCT02967653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25683890|NCT01882985|Antioxidants|antioxidants|mesh-ancestor
25683891|NCT01882985|Protective Agents|protective agents|mesh-ancestor
25683892|NCT01882985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683893|NCT01882985|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25683894|NCT01882985|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25683895|NCT01883362|Midostaurin|midostaurin|mesh-list
25683896|NCT01883362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683897|NCT01883362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25683898|NCT01883362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683899|NCT01883362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683900|NCT01884337|Apixaban|apixaban|mesh-list
25285028|NCT04810793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25285029|NCT04810793|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25285030|NCT04756687|Dimethyl Fumarate|dimethyl fumarate|mesh-list
24589210|NCT00906126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24589211|NCT00906126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589212|NCT00906126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24589213|NCT00906126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24589214|NCT00906126|Oxytocics|oxytocics|mesh-ancestor
24589215|NCT00906139|Fentanyl|fentanyl|mesh-list
24589216|NCT00906139|Midazolam|midazolam|mesh-list
24589217|NCT00906139|Propofol|propofol|mesh-list
24589218|NCT00906139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24589219|NCT00906139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24589220|NCT00906139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589221|NCT00906139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25040771|NCT02866227|TOL-463|tol-463|mesh-list
25139943|NCT02967653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25139944|NCT02967341|Ciprofloxacin|ciprofloxacin|mesh-list
25139945|NCT02967341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24867499|NCT04312971|Autonomic Agents|autonomic agents|mesh-ancestor
24867370|NCT00821587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24867372|NCT00585195|Rifampin|rifampin|mesh-list
24867373|NCT00585195|Crizotinib|crizotinib|mesh-list
24547418|NCT00703807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24547419|NCT00703807|Immunologic Factors|immunologic factors|mesh-ancestor
24547420|NCT00703807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547421|NCT00703807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24867420|NCT04527003|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24867421|NCT04527003|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24867422|NCT04527003|Contraceptive Agents|contraceptive agents|mesh-ancestor
24867428|NCT04457323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24867450|NCT04448431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24867451|NCT04448431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867452|NCT04448431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24867453|NCT04448431|Serotonin Agents|serotonin agents|mesh-ancestor
24867454|NCT04448431|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24867455|NCT04448431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25102806|NCT03166397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24867456|NCT04448431|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24867457|NCT04448431|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24867458|NCT04448431|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24867460|NCT04372017|Hydroxychloroquine|hydroxychloroquine|mesh-list
24867461|NCT04372017|Vitamins|vitamins|mesh-ancestor
24867462|NCT04372017|Micronutrients|micronutrients|mesh-ancestor
24867484|NCT04339049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867485|NCT04339049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24867486|NCT04339049|Abortifacient Agents|abortifacient agents|mesh-ancestor
24867487|NCT04339049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24867488|NCT04339049|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24867489|NCT04339049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24867490|NCT04339049|Oxytocics|oxytocics|mesh-ancestor
24867491|NCT04312971|Norepinephrine|norepinephrine|mesh-list
24867492|NCT04312971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24867493|NCT04312971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24867494|NCT04312971|Adrenergic Agents|adrenergic agents|mesh-ancestor
24867495|NCT04312971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24547497|NCT00704301|Rivastigmine|rivastigmine|mesh-list
24446379|NCT00304616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25139947|NCT02967341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25139948|NCT02967341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25683901|NCT01884337|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25683902|NCT01884337|Antithrombins|antithrombins|mesh-ancestor
25683903|NCT01884337|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25683904|NCT01884337|Protease Inhibitors|protease inhibitors|mesh-ancestor
25683905|NCT01884337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683906|NCT01884337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683907|NCT01884337|Anticoagulants|anticoagulants|mesh-ancestor
25683908|NCT01884350|Apixaban|apixaban|mesh-list
25683909|NCT01884350|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25683910|NCT01884350|Antithrombins|antithrombins|mesh-ancestor
25683911|NCT01884350|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25683912|NCT01884350|Protease Inhibitors|protease inhibitors|mesh-ancestor
25683913|NCT01884350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683914|NCT01884350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683915|NCT01884350|Anticoagulants|anticoagulants|mesh-ancestor
25139949|NCT02967341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25139950|NCT02967341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139951|NCT02967341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25139952|NCT02967341|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25139953|NCT02967341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25139955|NCT02967614|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25139956|NCT02967614|Dorzolamide|dorzolamide|mesh-list
25139957|NCT02967614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25139958|NCT02967614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25139959|NCT02967614|Adrenergic Agents|adrenergic agents|mesh-ancestor
25139960|NCT02967614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25139961|NCT02967614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139962|NCT02967614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139963|NCT02967614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25139964|NCT02967614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25139965|NCT02967614|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25139966|NCT02967614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24446380|NCT00304616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24446381|NCT00304616|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24446382|NCT00304616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24446383|NCT00304616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24446384|NCT00304616|Antidepressive Agents|antidepressive agents|mesh-ancestor
24867497|NCT04312971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867498|NCT04312971|Sympathomimetics|sympathomimetics|mesh-ancestor
24867505|NCT04282278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24867506|NCT04282278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867507|NCT04243629|Pramlintide|pramlintide|mesh-list
24867508|NCT04243629|Insulin, Short-Acting|insulin, short-acting|mesh-list
24867509|NCT04243629|Pancrelipase|pancrelipase|mesh-list
24446399|NCT00304629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24437290|NCT00273338|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25139967|NCT02967614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25139968|NCT02967614|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25139969|NCT02967614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25139976|NCT02967380|Pentetic Acid|pentetic acid|mesh-list
25139977|NCT02967380|Antidotes|antidotes|mesh-ancestor
25139978|NCT02967380|Protective Agents|protective agents|mesh-ancestor
25139979|NCT02967380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139980|NCT02967380|Chelating Agents|chelating agents|mesh-ancestor
25139981|NCT02967380|Sequestering Agents|sequestering agents|mesh-ancestor
25139982|NCT02967380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139983|NCT02967380|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25139984|NCT02967276|Metformin|metformin|mesh-list
25139985|NCT02967276|Dexamethasone|dexamethasone|mesh-list
25139986|NCT02967276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25139987|NCT02967276|Antiemetics|antiemetics|mesh-ancestor
24965432|NCT03777280|Chromium|chromium|mesh-list
24867521|NCT04194528|Antipyretics|antipyretics|mesh-ancestor
24867522|NCT04194528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24867523|NCT04194528|Narcotics|narcotics|mesh-ancestor
24867524|NCT04194528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25405456|NCT03606538|Hallucinogens|hallucinogens|mesh-ancestor
24708781|NCT01502904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708782|NCT01502904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24708783|NCT01502904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24708785|NCT01502904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708786|NCT01502904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24708787|NCT01502904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24708788|NCT01502904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24867525|NCT04194528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24867526|NCT04194528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24867527|NCT04194528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24867529|NCT04170998|Dapagliflozin|dapagliflozin|mesh-list
24867530|NCT04170998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24867531|NCT04170998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867532|NCT04170998|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24867533|NCT04170998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867534|NCT04147650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24867535|NCT04147650|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24867536|NCT04070573|Aspirin|aspirin|mesh-list
24867537|NCT04070573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24867538|NCT04070573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24867539|NCT04070573|Analgesics|analgesics|mesh-ancestor
24867540|NCT04070573|Sensory System Agents|sensory system agents|mesh-ancestor
25139995|NCT02967276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25139996|NCT02967276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25139997|NCT02967276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25140000|NCT02967432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25140001|NCT02967432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25140002|NCT02967432|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25140003|NCT02967432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25140004|NCT02967432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140005|NCT02967432|Emollients|emollients|mesh-ancestor
25140006|NCT02967432|Dermatologic Agents|dermatologic agents|mesh-ancestor
25140007|NCT02967172|Epinephrine|epinephrine|mesh-list
25140008|NCT02967172|Morphine|morphine|mesh-list
25140009|NCT02967172|Ropivacaine|ropivacaine|mesh-list
25140010|NCT02967172|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24867609|NCT03729258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24867610|NCT03729258|Dopamine Agents|dopamine agents|mesh-ancestor
24867611|NCT03729258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24446289|NCT00304317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24867612|NCT03729258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867613|NCT03729258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140011|NCT02967172|Narcotics|narcotics|mesh-ancestor
25140012|NCT02967172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25140013|NCT02967172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140014|NCT02967172|Analgesics|analgesics|mesh-ancestor
25140015|NCT02967172|Sensory System Agents|sensory system agents|mesh-ancestor
25140016|NCT02967172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24867614|NCT03729258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24867615|NCT03729258|Analgesics|analgesics|mesh-ancestor
24867698|NCT03132129|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24867699|NCT03132129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867700|NCT03132129|Trace Elements|trace elements|mesh-ancestor
24867701|NCT03132129|Micronutrients|micronutrients|mesh-ancestor
24867703|NCT02898207|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
24867704|NCT02898207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683916|NCT01884571|Mycophenolic Acid|mycophenolic acid|mesh-list
25683917|NCT01884571|Prednisone|prednisone|mesh-list
25683918|NCT01884571|Methylprednisolone|methylprednisolone|mesh-list
25683919|NCT01884571|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25683920|NCT01884571|Tacrolimus|tacrolimus|mesh-list
25683921|NCT01884571|Basiliximab|basiliximab|mesh-list
25683922|NCT01884571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25683923|NCT01884571|Glucocorticoids|glucocorticoids|mesh-ancestor
25683924|NCT01884571|Hormones|hormones|mesh-ancestor
25692534|NCT02000973|Anesthetics|anesthetics|mesh-ancestor
25041032|NCT02677298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285108|NCT05392933|Lidocaine|lidocaine|mesh-list
25285109|NCT05392933|Anesthetics, Local|anesthetics, local|mesh-ancestor
25285110|NCT05392933|Anesthetics|anesthetics|mesh-ancestor
25285111|NCT05392933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25285112|NCT05392933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285113|NCT05392933|Sensory System Agents|sensory system agents|mesh-ancestor
25285114|NCT05392933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25285115|NCT05392933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25285116|NCT05392933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25285117|NCT05392933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25285118|NCT05392933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25285119|NCT05392933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285120|NCT05392790|Calcium|calcium|mesh-list
25285121|NCT05392790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24547705|NCT00705315|Antimitotic Agents|antimitotic agents|mesh-ancestor
24446475|NCT00304811|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24446476|NCT00304811|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24867742|NCT02555657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24867743|NCT02555657|Immunologic Factors|immunologic factors|mesh-ancestor
24867744|NCT02555657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867747|NCT02555657|Tubulin Modulators|tubulin modulators|mesh-ancestor
24610166|NCT01000233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623236|NCT01070680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623237|NCT01070706|Gemcitabine|gemcitabine|mesh-list
24547757|NCT00705549|Antiviral Agents|antiviral agents|mesh-ancestor
24547758|NCT00705549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24623238|NCT01070706|Paclitaxel|paclitaxel|mesh-list
24623239|NCT01070706|Sunitinib|sunitinib|mesh-list
24623240|NCT01070706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24547779|NCT00705640|Freund's Adjuvant|freund's adjuvant|mesh-list
24547780|NCT00705640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24547781|NCT00705640|Immunologic Factors|immunologic factors|mesh-ancestor
24547782|NCT00705640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623241|NCT01070706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446506|NCT00304980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446507|NCT00304980|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24446510|NCT00304993|Rosiglitazone|rosiglitazone|mesh-list
24547790|NCT00705692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24547791|NCT00705692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24814414|NCT02064491|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24814415|NCT02064491|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24814416|NCT02064491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25683925|NCT01884571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25683926|NCT01884571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683927|NCT01884571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25683928|NCT01884571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683929|NCT01884571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25683930|NCT01884571|Immunologic Factors|immunologic factors|mesh-ancestor
25683931|NCT01884571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25683932|NCT01884571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25683933|NCT01884571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683934|NCT01884571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25683935|NCT01884571|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25683936|NCT01884571|Antitubercular Agents|antitubercular agents|mesh-ancestor
25683937|NCT01884571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25683938|NCT01884571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25683939|NCT01884571|Antiemetics|antiemetics|mesh-ancestor
24814417|NCT02064504|Fluticasone|fluticasone|mesh-list
24708862|NCT01503242|Antitubercular Agents|antitubercular agents|mesh-ancestor
24708863|NCT01503242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24708864|NCT01503359|Glycine|glycine|mesh-list
24708865|NCT01503359|Glycine Agents|glycine agents|mesh-ancestor
24708866|NCT01503359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24708867|NCT01503359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708868|NCT01503359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708869|NCT01503372|Leucovorin|leucovorin|mesh-list
24708870|NCT01503372|Oxaliplatin|oxaliplatin|mesh-list
25285133|NCT05392673|Bilirubin|bilirubin|mesh-list
24814418|NCT02064504|Xhance|xhance|mesh-list
24814419|NCT02064504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24814420|NCT02064504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24814421|NCT02064504|Autonomic Agents|autonomic agents|mesh-ancestor
24814422|NCT02064504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25140017|NCT02967172|Anesthetics, Local|anesthetics, local|mesh-ancestor
25140019|NCT02967172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25140020|NCT02967172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25140021|NCT02967172|Adrenergic Agents|adrenergic agents|mesh-ancestor
24998218|NCT03409198|Ipilimumab|ipilimumab|mesh-list
25140022|NCT02967172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25140023|NCT02967172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140024|NCT02967172|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25140025|NCT02967172|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25140027|NCT02967172|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25140028|NCT02967172|Respiratory System Agents|respiratory system agents|mesh-ancestor
25140029|NCT02967172|Mydriatics|mydriatics|mesh-ancestor
25140030|NCT02967172|Sympathomimetics|sympathomimetics|mesh-ancestor
25140031|NCT02967172|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25140032|NCT02967237|Insulin Glargine|insulin glargine|mesh-list
25140033|NCT02967237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25140034|NCT02967237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140035|NCT02967211|Insulin|insulin|mesh-list
24814423|NCT02064504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814424|NCT02064504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24814425|NCT02064504|Respiratory System Agents|respiratory system agents|mesh-ancestor
24814426|NCT02064504|Dermatologic Agents|dermatologic agents|mesh-ancestor
24814427|NCT02064504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24814428|NCT02064517|Calcium|calcium|mesh-list
24814429|NCT02064517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24547833|NCT00705835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867823|NCT05155215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24867824|NCT05155215|Alkylating Agents|alkylating agents|mesh-ancestor
24867825|NCT05155215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867826|NCT05155215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24867827|NCT05155215|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24867828|NCT05155202|Antihypertensive Agents|antihypertensive agents|mesh-list
24867832|NCT05154747|Rilpivirine|rilpivirine|mesh-list
24867833|NCT05154747|Cabotegravir|cabotegravir|mesh-list
24867837|NCT05154747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24867880|NCT05154370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867881|NCT05136443|Loteprednol Etabonate|loteprednol etabonate|mesh-list
24867882|NCT05136443|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24867883|NCT05134584|Lactulose|lactulose|mesh-list
24867884|NCT05134584|Linaclotide|linaclotide|mesh-list
24867885|NCT05134584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24867886|NCT05134584|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
24867887|NCT05134584|Enzyme Activators|enzyme activators|mesh-ancestor
24867888|NCT05134584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867889|NCT05134415|Menthol|menthol|mesh-list
24867890|NCT05134415|Antipruritics|antipruritics|mesh-ancestor
24867891|NCT05134415|Dermatologic Agents|dermatologic agents|mesh-ancestor
24867892|NCT05052710|Midazolam|midazolam|mesh-list
24867893|NCT05052710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24867894|NCT05052710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25140065|NCT02967224|Insulin|insulin|mesh-list
25140039|NCT02967211|Insulin, Isophane|insulin, isophane|mesh-list
25683940|NCT01884571|Autonomic Agents|autonomic agents|mesh-ancestor
25683941|NCT01884571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25683942|NCT01884571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25683943|NCT01884571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25683944|NCT01884571|Protective Agents|protective agents|mesh-ancestor
25683945|NCT01884597|Ranibizumab|ranibizumab|mesh-list
25683946|NCT01884597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25683947|NCT01884597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25683948|NCT01884597|Growth Substances|growth substances|mesh-ancestor
25140040|NCT02967211|Isophane Insulin, Human|isophane insulin, human|mesh-list
25683949|NCT01884597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285159|NCT05392257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285160|NCT05392166|Calcium|calcium|mesh-list
25285161|NCT05392166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25285162|NCT05392166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683950|NCT01884597|Growth Inhibitors|growth inhibitors|mesh-ancestor
25683951|NCT01884597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25285163|NCT05392101|Deferasirox|deferasirox|mesh-list
25285164|NCT05392101|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25285165|NCT05392101|Chelating Agents|chelating agents|mesh-ancestor
25285166|NCT05392101|Sequestering Agents|sequestering agents|mesh-ancestor
25285167|NCT05392101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041112|NCT02650804|Micronutrients|micronutrients|mesh-ancestor
25140041|NCT02967211|Isophane insulin, beef|isophane insulin, beef|mesh-list
25140042|NCT02967211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25140043|NCT02967211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140044|NCT02966912|Magnesium Oxide|magnesium oxide|mesh-list
25140045|NCT02966912|Antacids|antacids|mesh-ancestor
25140046|NCT02966912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140047|NCT02966912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25140048|NCT02967029|Remifentanil|remifentanil|mesh-list
25140049|NCT02967029|Esmolol|esmolol|mesh-list
24867896|NCT05052710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867897|NCT05052710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24867898|NCT05052710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24867899|NCT05052710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24867900|NCT05052710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24867901|NCT05052710|Anesthetics, General|anesthetics, general|mesh-ancestor
24867902|NCT05052710|Anesthetics|anesthetics|mesh-ancestor
24867903|NCT05052710|GABA Modulators|gaba modulators|mesh-ancestor
24867904|NCT05052710|GABA Agents|gaba agents|mesh-ancestor
24867905|NCT05052710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24867906|NCT05052710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867907|NCT05051293|Testosterone|testosterone|mesh-list
24867915|NCT05005897|Vitamins|vitamins|mesh-ancestor
24867916|NCT05005897|Micronutrients|micronutrients|mesh-ancestor
24867918|NCT05005897|Vitamin B Complex|vitamin b complex|mesh-ancestor
24867920|NCT04849650|Amisulpride|amisulpride|mesh-list
24547946|NCT00706927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24867921|NCT04849650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24867922|NCT04849650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24867923|NCT04849650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24867924|NCT04849650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867925|NCT04849650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24867926|NCT04849650|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24867927|NCT04849650|Dopamine Agents|dopamine agents|mesh-ancestor
24867928|NCT04849650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24867929|NCT04849650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867930|NCT04849650|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24446527|NCT00305201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24547984|NCT00707083|Hormones|hormones|mesh-ancestor
24547985|NCT00707083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24547986|NCT00707083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24547987|NCT00707083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547988|NCT00707083|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24547989|NCT00707083|Abortifacient Agents|abortifacient agents|mesh-ancestor
24547990|NCT00707083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24547991|NCT00707083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25683952|NCT01884675|Ambrisentan|ambrisentan|mesh-list
25683953|NCT01884675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25683954|NCT01884844|Vitamin D|vitamin d|mesh-list
25683955|NCT01884844|Cholecalciferol|cholecalciferol|mesh-list
25683956|NCT01884844|Vitamins|vitamins|mesh-ancestor
25683957|NCT01884844|Micronutrients|micronutrients|mesh-ancestor
25683958|NCT01884844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683959|NCT01884844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25683960|NCT01884844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25683961|NCT01885000|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25140050|NCT02967029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25140051|NCT02967029|Narcotics|narcotics|mesh-ancestor
25285209|NCT05391724|Brincidofovir|brincidofovir|mesh-list
25285210|NCT05391724|Antiviral Agents|antiviral agents|mesh-ancestor
25285211|NCT05391724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25041228|NCT02598960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25041229|NCT02598960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041447|NCT02521285|Aspirin|aspirin|mesh-list
25140052|NCT02967029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25140053|NCT02967029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140054|NCT02967029|Analgesics|analgesics|mesh-ancestor
25140055|NCT02967029|Sensory System Agents|sensory system agents|mesh-ancestor
25140056|NCT02967029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25140057|NCT02967029|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25140058|NCT02967029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25140059|NCT02967029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25140060|NCT02967029|Adrenergic Agents|adrenergic agents|mesh-ancestor
25140061|NCT02967029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25140062|NCT02967029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140063|NCT02967094|Expectorants|expectorants|mesh-list
25140064|NCT02967094|Respiratory System Agents|respiratory system agents|mesh-ancestor
25046669|NCT00838279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25046670|NCT00838279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046671|NCT00838279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25046672|NCT00838279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25046673|NCT00838279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25046674|NCT00838279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25046675|NCT00838279|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25046677|NCT00838136|Anticonvulsants|anticonvulsants|mesh-ancestor
25046678|NCT00838136|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25046679|NCT00838136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25046680|NCT00838136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046681|NCT00838136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25046682|NCT00838136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046683|NCT00838136|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25046684|NCT00838136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25046685|NCT00838136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25046686|NCT00838136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25046687|NCT00838136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25046688|NCT00837265|Docetaxel|docetaxel|mesh-list
25046689|NCT00837265|Doxorubicin|doxorubicin|mesh-list
25046690|NCT00837265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25046691|NCT00837265|Tubulin Modulators|tubulin modulators|mesh-ancestor
25046692|NCT00837265|Antimitotic Agents|antimitotic agents|mesh-ancestor
25046693|NCT00837265|Mitosis Modulators|mitosis modulators|mesh-ancestor
24862638|NCT04881955|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25046694|NCT00837265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046695|NCT00837265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25046696|NCT00837265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25046697|NCT00837265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24465713|NCT00370617|Metformin|metformin|mesh-list
24868028|NCT04013555|Acetylcysteine|acetylcysteine|mesh-list
24868029|NCT04013555|Tryptophan|tryptophan|mesh-list
24868030|NCT04013555|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24868031|NCT04013555|Antiviral Agents|antiviral agents|mesh-ancestor
24868032|NCT04013555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24868033|NCT04013555|Expectorants|expectorants|mesh-ancestor
24868034|NCT04013555|Respiratory System Agents|respiratory system agents|mesh-ancestor
24868042|NCT04013555|Antidepressive Agents|antidepressive agents|mesh-ancestor
24868043|NCT04013555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24868044|NCT03994172|Calcium, Dietary|calcium, dietary|mesh-list
24868045|NCT03994172|Vitamin D|vitamin d|mesh-list
24868046|NCT03994172|Cholecalciferol|cholecalciferol|mesh-list
24868051|NCT03994172|Parathyroid Hormone|parathyroid hormone|mesh-list
24868053|NCT03994172|Hormones|hormones|mesh-list
24868054|NCT03994172|Vitamins|vitamins|mesh-ancestor
24868055|NCT03994172|Micronutrients|micronutrients|mesh-ancestor
24868056|NCT03994172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868057|NCT03994172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24868058|NCT03994172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24868059|NCT03994172|Anticoagulants|anticoagulants|mesh-ancestor
25683962|NCT01885000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25683963|NCT01885000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25683964|NCT01885000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25683965|NCT01885000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25683966|NCT01885000|Adrenergic Agents|adrenergic agents|mesh-ancestor
24868067|NCT03887936|Testosterone|testosterone|mesh-list
24868068|NCT03887936|Androgens|androgens|mesh-ancestor
25285242|NCT05386524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25285243|NCT05386524|Growth Substances|growth substances|mesh-ancestor
25285244|NCT05386524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285245|NCT05386524|Growth Inhibitors|growth inhibitors|mesh-ancestor
25285246|NCT05386524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25285247|NCT05386524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25285248|NCT05386524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25041461|NCT02521285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24868108|NCT03643965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868109|NCT03643965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24868110|NCT03643965|Respiratory System Agents|respiratory system agents|mesh-ancestor
24868111|NCT03643965|Glucocorticoids|glucocorticoids|mesh-ancestor
24868113|NCT03643965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24868115|NCT03595566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24868116|NCT03595566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24868117|NCT03595553|Vancomycin|vancomycin|mesh-list
24868118|NCT03595553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24868119|NCT03595553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24868142|NCT03336541|Anesthetics, General|anesthetics, general|mesh-ancestor
25046709|NCT00836706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25046710|NCT00836706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25046711|NCT00836706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25046712|NCT00836706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046713|NCT00836706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046714|NCT00836706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25046715|NCT00836706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25046716|NCT00836472|Metformin|metformin|mesh-list
25046717|NCT00836472|Glyburide|glyburide|mesh-list
25046718|NCT00836472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25046719|NCT00836472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046720|NCT00836069|Paroxetine|paroxetine|mesh-list
25046721|NCT00836069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25046722|NCT00836069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25046723|NCT00836069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25046724|NCT00836069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046725|NCT00836069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25140077|NCT02966717|Rituximab|rituximab|mesh-list
25140078|NCT02966717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25140079|NCT02966717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25140080|NCT02966717|Immunologic Factors|immunologic factors|mesh-ancestor
25140081|NCT02966717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140082|NCT02966717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25140083|NCT02966522|Thalidomide|thalidomide|mesh-list
25140084|NCT02966522|Dexamethasone|dexamethasone|mesh-list
25140085|NCT02966522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25140086|NCT02966522|Antiemetics|antiemetics|mesh-ancestor
25140087|NCT02966522|Autonomic Agents|autonomic agents|mesh-ancestor
24813427|NCT02058485|Midazolam|midazolam|mesh-list
25140090|NCT02966522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25140092|NCT02966522|Hormones|hormones|mesh-ancestor
25140093|NCT02966522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25140094|NCT02966522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25140095|NCT02966522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24862636|NCT04881955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862637|NCT04881955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25140102|NCT02966522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25683967|NCT01885000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25683968|NCT01885000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683969|NCT01885000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683970|NCT01885104|Bisacodyl|bisacodyl|mesh-list
25683971|NCT01885104|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25683972|NCT01885104|Laxatives|laxatives|mesh-list
25683973|NCT01885104|Cathartics|cathartics|mesh-ancestor
25683974|NCT01885104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25683975|NCT01885182|Oxycodone|oxycodone|mesh-list
25041607|NCT01616524|Interferon-alpha|interferon-alpha|mesh-list
25041608|NCT01616524|Interferon alpha-2|interferon alpha-2|mesh-list
25041609|NCT01616524|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25041610|NCT01616524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041611|NCT01616524|Antiviral Agents|antiviral agents|mesh-ancestor
25041612|NCT01616524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25041613|NCT01616524|Antimetabolites|antimetabolites|mesh-ancestor
25041614|NCT01616524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041615|NCT01616524|Immunologic Factors|immunologic factors|mesh-ancestor
25041616|NCT01616524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041618|NCT01616303|Carboplatin|carboplatin|mesh-list
25140114|NCT02966457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25140115|NCT02966457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25140117|NCT02966665|Vitamin E|vitamin e|mesh-list
25140118|NCT02966665|Thioctic Acid|thioctic acid|mesh-list
25140119|NCT02966665|Fexofenadine|fexofenadine|mesh-list
25140120|NCT02966665|Valsartan|valsartan|mesh-list
25140121|NCT02966665|Nitroprusside|nitroprusside|mesh-list
25140122|NCT02966665|Phentolamine|phentolamine|mesh-list
25140123|NCT02966665|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
25140124|NCT02966665|Norepinephrine|norepinephrine|mesh-list
25140125|NCT02966665|Angiotensin II|angiotensin ii|mesh-list
25140126|NCT02966665|Giapreza|giapreza|mesh-list
25140127|NCT02966665|Acetylcholine|acetylcholine|mesh-list
24868179|NCT02782702|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24868180|NCT02782702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24868181|NCT02782702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868182|NCT02782702|Cholinergic Agents|cholinergic agents|mesh-ancestor
24868183|NCT02782702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24446599|NCT00305422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24868195|NCT02673567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24868196|NCT02673567|Antibodies|antibodies|mesh-list
24868197|NCT02673567|Immunoglobulins|immunoglobulins|mesh-list
24868198|NCT02673567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24868199|NCT02673567|Immunologic Factors|immunologic factors|mesh-ancestor
24868200|NCT02673567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868201|NCT02673567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24868202|NCT02536183|Doxorubicin|doxorubicin|mesh-list
24868203|NCT02536183|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24868204|NCT02536183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25140129|NCT02966665|Angiotensinogen|angiotensinogen|mesh-list
25140130|NCT02966665|Micronutrients|micronutrients|mesh-ancestor
25140131|NCT02966665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140139|NCT02966665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25140140|NCT02966665|Adrenergic Agents|adrenergic agents|mesh-ancestor
25140141|NCT02966665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25140142|NCT02966665|Sympathomimetics|sympathomimetics|mesh-ancestor
25140143|NCT02966665|Autonomic Agents|autonomic agents|mesh-ancestor
25140144|NCT02966665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24868205|NCT02536183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25683976|NCT01885182|Naloxone|naloxone|mesh-list
25683977|NCT01885182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25683978|NCT01885182|Narcotics|narcotics|mesh-ancestor
25683979|NCT01885182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25683980|NCT01885182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25683981|NCT01885182|Analgesics|analgesics|mesh-ancestor
25683982|NCT01885182|Sensory System Agents|sensory system agents|mesh-ancestor
25683983|NCT01885182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25683984|NCT01885182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25683985|NCT01885208|Exenatide|exenatide|mesh-list
25683986|NCT01885208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25683987|NCT01885208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868206|NCT02536183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24868207|NCT02536183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25285327|NCT05325502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285328|NCT05325502|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25285329|NCT05325502|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25285330|NCT05325502|Purinergic Agents|purinergic agents|mesh-ancestor
25285331|NCT05325502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25041645|NCT01607294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25041646|NCT01607294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041648|NCT01606566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25041649|NCT01606566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041650|NCT01605162|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2h)-one|mesh-list
25041651|NCT01605162|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24868208|NCT02536183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24868249|NCT01489813|Protective Agents|protective agents|mesh-ancestor
24868250|NCT01489813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868251|NCT01489813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24868252|NCT01489813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24548241|NCT00708565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24868301|NCT05156970|Docetaxel|docetaxel|mesh-list
24868302|NCT05156970|Apatinib|apatinib|mesh-list
24868303|NCT05156970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24868304|NCT05156970|Tubulin Modulators|tubulin modulators|mesh-ancestor
24868305|NCT05156970|Antimitotic Agents|antimitotic agents|mesh-ancestor
24868306|NCT05156970|Mitosis Modulators|mitosis modulators|mesh-ancestor
24466117|NCT00372099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24868307|NCT05156970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868308|NCT05156970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24466121|NCT00372138|Thrombin|thrombin|mesh-list
25140164|NCT02966665|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25140167|NCT02966743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25140168|NCT02966743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25140169|NCT02966743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140170|NCT02966743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24862762|NCT04496908|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25140171|NCT02966743|Analgesics|analgesics|mesh-ancestor
25140172|NCT02966743|Sensory System Agents|sensory system agents|mesh-ancestor
25140173|NCT02966743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25140174|NCT02966743|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25140175|NCT02966743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25683988|NCT01885208|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25683989|NCT01885208|Incretins|incretins|mesh-ancestor
25683990|NCT01885208|Hormones|hormones|mesh-ancestor
25683991|NCT01885208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25683992|NCT01885559|Telmisartan|telmisartan|mesh-list
25683993|NCT01885559|Lisinopril|lisinopril|mesh-list
25683994|NCT01885559|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25683995|NCT01885559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25683996|NCT01885559|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25683997|NCT01885559|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25683998|NCT01885559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25683999|NCT01885559|Protease Inhibitors|protease inhibitors|mesh-ancestor
25041784|NCT01582347|Sensory System Agents|sensory system agents|mesh-ancestor
25041785|NCT01582347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25041786|NCT01582347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25041787|NCT01582269|Lomustine|lomustine|mesh-list
25041788|NCT01582269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25041789|NCT01582269|Alkylating Agents|alkylating agents|mesh-ancestor
25041790|NCT01582269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041791|NCT01582269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041792|NCT01581203|Interferons|interferons|mesh-list
25140176|NCT02966743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25140177|NCT02966743|Adrenergic Agents|adrenergic agents|mesh-ancestor
24814511|NCT02064842|Antiviral Agents|antiviral agents|mesh-ancestor
24868375|NCT05155969|Analgesics|analgesics|mesh-ancestor
24868376|NCT05155969|Sensory System Agents|sensory system agents|mesh-ancestor
24868377|NCT05155969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24868378|NCT05155969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868379|NCT05155969|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24868380|NCT05155969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24868381|NCT05155969|Anesthetics, General|anesthetics, general|mesh-ancestor
24868382|NCT05155969|Anesthetics|anesthetics|mesh-ancestor
24868383|NCT05155969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24868384|NCT05155969|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24868385|NCT05155969|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25140179|NCT02966743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140181|NCT02966743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25140182|NCT02966743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25140183|NCT02966743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25140184|NCT02966743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25140185|NCT02966743|Anesthetics, General|anesthetics, general|mesh-ancestor
25140186|NCT02966743|Anesthetics|anesthetics|mesh-ancestor
25140187|NCT02966743|GABA Modulators|gaba modulators|mesh-ancestor
25140188|NCT02966743|GABA Agents|gaba agents|mesh-ancestor
25140189|NCT02966652|Methyltestosterone|methyltestosterone|mesh-list
25140190|NCT02966652|Testosterone|testosterone|mesh-list
25140191|NCT02966652|Testosterone undecanoate|testosterone undecanoate|mesh-list
25140192|NCT02966652|Testosterone enanthate|testosterone enanthate|mesh-list
25140193|NCT02966652|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25140195|NCT02966652|Hormones|hormones|mesh-ancestor
25140196|NCT02966652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25140197|NCT02966652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140198|NCT02966652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25140199|NCT02966652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25140200|NCT02966652|Anabolic Agents|anabolic agents|mesh-ancestor
25140201|NCT02966288|Ibuprofen|ibuprofen|mesh-list
25140202|NCT02966288|Ketorolac|ketorolac|mesh-list
25140203|NCT02966288|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25140204|NCT02966288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25140205|NCT02966288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25140206|NCT02966288|Analgesics|analgesics|mesh-ancestor
25140207|NCT02966288|Sensory System Agents|sensory system agents|mesh-ancestor
25140208|NCT02966288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25140209|NCT02966288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684631|NCT04941937|Hormones|hormones|mesh-ancestor
25140210|NCT02966288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25140248|NCT02966041|Serotonin Agents|serotonin agents|mesh-ancestor
25140249|NCT02966041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25140250|NCT02966041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140251|NCT02966041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25140252|NCT02966041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25140253|NCT02966041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25140254|NCT02966041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25140255|NCT02966041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25140256|NCT02965911|Fenofibrate|fenofibrate|mesh-list
25684000|NCT01885559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25684001|NCT01885559|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25684002|NCT01885559|Protective Agents|protective agents|mesh-ancestor
25684003|NCT01885559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684004|NCT01885910|Doxycycline|doxycycline|mesh-list
25684005|NCT01885910|Dapsone|dapsone|mesh-list
25684006|NCT01885910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25684007|NCT01885910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25684008|NCT01885910|Antimalarials|antimalarials|mesh-ancestor
25684009|NCT01885910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25684010|NCT01885910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25041867|NCT01573351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285382|NCT05275205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25285383|NCT05275205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25285384|NCT05275205|Growth Substances|growth substances|mesh-ancestor
25285385|NCT05275205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285386|NCT05275205|Growth Inhibitors|growth inhibitors|mesh-ancestor
25285387|NCT05275205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25285416|NCT05208983|Vaccines|vaccines|mesh-list
25285417|NCT05208983|Immunologic Factors|immunologic factors|mesh-ancestor
25285418|NCT05208983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285419|NCT05204836|Zoledronic Acid|zoledronic acid|mesh-list
25285420|NCT05204836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25041883|NCT01567059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041885|NCT01567059|Antiviral Agents|antiviral agents|mesh-ancestor
25041886|NCT01567059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25041887|NCT01567059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25041888|NCT01567059|Immunologic Factors|immunologic factors|mesh-ancestor
25041889|NCT01567059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140257|NCT02965911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25140258|NCT02965911|Antimetabolites|antimetabolites|mesh-ancestor
25140259|NCT02965911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140260|NCT02965911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25140261|NCT02966249|Levobupivacaine|levobupivacaine|mesh-list
25140262|NCT02966249|Anesthetics, Local|anesthetics, local|mesh-ancestor
25140263|NCT02966249|Anesthetics|anesthetics|mesh-ancestor
25140264|NCT02966249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25046726|NCT00836069|Serotonin Agents|serotonin agents|mesh-ancestor
25046727|NCT00836069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046728|NCT00836069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25046729|NCT00836069|Antidepressive Agents|antidepressive agents|mesh-ancestor
24868441|NCT04774250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24868442|NCT04774250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868444|NCT04768569|Anticonvulsants|anticonvulsants|mesh-ancestor
24868445|NCT04768569|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24868446|NCT04768569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24868447|NCT04768569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868449|NCT04768569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868495|NCT04506138|Paclitaxel|paclitaxel|mesh-list
24868496|NCT04506138|Carboplatin|carboplatin|mesh-list
24868497|NCT04506138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24868498|NCT04506138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24868499|NCT04506138|Tubulin Modulators|tubulin modulators|mesh-ancestor
24868500|NCT04506138|Antimitotic Agents|antimitotic agents|mesh-ancestor
24868501|NCT04506138|Mitosis Modulators|mitosis modulators|mesh-ancestor
24868502|NCT04506138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868503|NCT04503707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24868505|NCT04503707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24868506|NCT04503707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684011|NCT01885910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25684012|NCT01885910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25684013|NCT01885910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684014|NCT01885910|Leprostatic Agents|leprostatic agents|mesh-ancestor
25684015|NCT01885936|Albuterol|albuterol|mesh-list
25684016|NCT01885936|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25684017|NCT01885936|Autonomic Agents|autonomic agents|mesh-ancestor
25684018|NCT01885936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25684019|NCT01885936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684020|NCT01885936|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25684021|NCT01885936|Respiratory System Agents|respiratory system agents|mesh-ancestor
25684022|NCT01885936|Tocolytic Agents|tocolytic agents|mesh-ancestor
25684023|NCT01885936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25684024|NCT01885936|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25684025|NCT01885936|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25684026|NCT01885936|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25684027|NCT01885936|Adrenergic Agents|adrenergic agents|mesh-ancestor
25684028|NCT01885936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25692535|NCT02000973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25285424|NCT05199753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285425|NCT05199597|Atropine|atropine|mesh-list
25285429|NCT05199597|Autonomic Agents|autonomic agents|mesh-ancestor
24868507|NCT04479241|Pembrolizumab|pembrolizumab|mesh-list
24868508|NCT04479241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24868509|NCT04479241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24868510|NCT04456153|Atovaquone|atovaquone|mesh-list
25046740|NCT00836056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046741|NCT00836056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046742|NCT00836004|Clindamycin|clindamycin|mesh-list
25046743|NCT00836004|Clindamycin palmitate|clindamycin palmitate|mesh-list
25046744|NCT00836004|Clindamycin phosphate|clindamycin phosphate|mesh-list
25046745|NCT00836004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25046746|NCT00836004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25046747|NCT00836004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25046748|NCT00836004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046749|NCT00836004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046750|NCT00835991|Metformin|metformin|mesh-list
25046751|NCT00835991|Glyburide|glyburide|mesh-list
24472830|NCT00400738|Lopinavir|lopinavir|mesh-list
24548473|NCT00709644|Vitamins|vitamins|mesh-ancestor
24548474|NCT00709644|Micronutrients|micronutrients|mesh-ancestor
24548475|NCT00709644|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24548476|NCT00709644|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24868516|NCT04456153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868517|NCT04455464|Midodrine|midodrine|mesh-list
24868518|NCT04455464|Sympathomimetics|sympathomimetics|mesh-ancestor
24814496|NCT02064829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24814497|NCT02064829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24814499|NCT02064829|Antimitotic Agents|antimitotic agents|mesh-ancestor
24814500|NCT02064829|Mitosis Modulators|mitosis modulators|mesh-ancestor
24814501|NCT02064829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814502|NCT02064842|Ritonavir|ritonavir|mesh-list
24814503|NCT02064842|Simeprevir|simeprevir|mesh-list
24814504|NCT02064842|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24868620|NCT04093752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24868621|NCT04093752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868622|NCT04093752|Incretins|incretins|mesh-ancestor
24868623|NCT04093752|Hormones|hormones|mesh-ancestor
24542696|NCT00679744|Pyrimethamine|pyrimethamine|mesh-list
24868624|NCT04093752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24466488|NCT00373646|Thalidomide|thalidomide|mesh-list
24868699|NCT03474640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24868700|NCT03474640|Immunologic Factors|immunologic factors|mesh-ancestor
24868701|NCT03474640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868702|NCT03448939|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24868703|NCT03448939|Dermatologic Agents|dermatologic agents|mesh-ancestor
24868712|NCT03393741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24868713|NCT03393741|Tubulin Modulators|tubulin modulators|mesh-ancestor
24868714|NCT03393741|Antimitotic Agents|antimitotic agents|mesh-ancestor
24868715|NCT03393741|Mitosis Modulators|mitosis modulators|mesh-ancestor
24868716|NCT03393741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868717|NCT03379389|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24868718|NCT03379389|Methenamine hippurate|methenamine hippurate|mesh-list
24868719|NCT03379389|Methenamine mandelate|methenamine mandelate|mesh-list
24868720|NCT03379389|Methenamine|methenamine|mesh-list
24868721|NCT03379389|Acriflavine|acriflavine|mesh-list
24868722|NCT03379389|Methylene Blue|methylene blue|mesh-list
24868723|NCT03379389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24868724|NCT03379389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466549|NCT00373815|Everolimus|everolimus|mesh-list
25046752|NCT00835991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25046753|NCT00835991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046754|NCT00835796|Finasteride|finasteride|mesh-list
25046762|NCT00835796|Urological Agents|urological agents|mesh-ancestor
25140269|NCT02966080|Anticoagulants|anticoagulants|mesh-ancestor
25140270|NCT02966080|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25140271|NCT02966080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25140272|NCT02966080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079466|NCT03347708|Viscosupplements|viscosupplements|mesh-ancestor
24868884|NCT05158699|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24868886|NCT05158699|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24868887|NCT05158699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25684029|NCT01885936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684030|NCT01886105|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
24868888|NCT05158699|Antiemetics|antiemetics|mesh-ancestor
24868889|NCT05158699|Autonomic Agents|autonomic agents|mesh-ancestor
24868890|NCT05158699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25285475|NCT05046184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25285476|NCT05046184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285477|NCT05046184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25285478|NCT05046184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25285479|NCT05046184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25285480|NCT05046184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25285481|NCT05046184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25285482|NCT05046184|GABA Modulators|gaba modulators|mesh-ancestor
25285483|NCT05046184|GABA Agents|gaba agents|mesh-ancestor
24868891|NCT05158699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868892|NCT05158699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24548805|NCT00712205|Calcitriol|calcitriol|mesh-list
25140291|NCT02965859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25140292|NCT02965859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140293|NCT02965404|Vaccines|vaccines|mesh-list
25140294|NCT02965404|Immunologic Factors|immunologic factors|mesh-ancestor
24868894|NCT05158699|Hormones|hormones|mesh-ancestor
24466649|NCT00374426|Serotonin Agents|serotonin agents|mesh-ancestor
24814617|NCT02065843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24814618|NCT02065843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814619|NCT02065843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24814620|NCT02065843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24814621|NCT02065843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24868947|NCT05158348|Anesthetics, Local|anesthetics, local|mesh-ancestor
24868948|NCT05158348|Anesthetics|anesthetics|mesh-ancestor
24868949|NCT05158348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24868950|NCT05158348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868951|NCT05158348|Sensory System Agents|sensory system agents|mesh-ancestor
24868952|NCT05158348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24868953|NCT05158348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24862970|NCT03823534|Morphine|morphine|mesh-list
24862971|NCT03823534|Oxycodone|oxycodone|mesh-list
24868954|NCT05158348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25140295|NCT02965404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140296|NCT02965677|Paclitaxel|paclitaxel|mesh-list
25140297|NCT02965677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25140298|NCT02965677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25140299|NCT02965677|Tubulin Modulators|tubulin modulators|mesh-ancestor
25140300|NCT02965677|Antimitotic Agents|antimitotic agents|mesh-ancestor
25140307|NCT02965443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24815794|NCT02072083|Dexmedetomidine|dexmedetomidine|mesh-list
24868955|NCT05158348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24868957|NCT05158348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868960|NCT05158348|Analgesics|analgesics|mesh-ancestor
24868990|NCT05157295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24868991|NCT05157295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24868992|NCT05157295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24868993|NCT05157295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24868994|NCT05157295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868995|NCT05157295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24868996|NCT05157295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25684031|NCT01886105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25684032|NCT01886105|Analgesics|analgesics|mesh-ancestor
25684033|NCT01886105|Sensory System Agents|sensory system agents|mesh-ancestor
25684034|NCT01886105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25684035|NCT01886105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684036|NCT01886287|Octreotide|octreotide|mesh-list
25684037|NCT01886287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25684038|NCT01886287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25684039|NCT01886287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24868997|NCT05157295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285526|NCT05005728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25285527|NCT05005728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285528|NCT04985266|Tamoxifen|tamoxifen|mesh-list
25285529|NCT04985266|Letrozole|letrozole|mesh-list
25285530|NCT04985266|Fulvestrant|fulvestrant|mesh-list
25285531|NCT04985266|Palbociclib|palbociclib|mesh-list
25285532|NCT04985266|Anastrozole|anastrozole|mesh-list
25285533|NCT04985266|Exemestane|exemestane|mesh-list
25285534|NCT04985266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25285535|NCT04985266|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25285536|NCT04985266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25285537|NCT04985266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25285538|NCT04985266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285539|NCT04985266|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25285540|NCT04985266|Hormone Antagonists|hormone antagonists|mesh-ancestor
25285541|NCT04985266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24868998|NCT05157295|Cholinergic Agents|cholinergic agents|mesh-ancestor
24868999|NCT05157295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24869000|NCT05080946|Aspirin|aspirin|mesh-list
24869094|NCT04761614|Riluzole|riluzole|mesh-list
24869095|NCT04761614|Endothelial Growth Factors|endothelial growth factors|mesh-list
24869137|NCT04694248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869139|NCT04694248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24869140|NCT04694248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24862972|NCT03823534|Hydrocodone|hydrocodone|mesh-list
24869141|NCT04694248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24869142|NCT04694248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869143|NCT04694248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25140308|NCT02965443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140310|NCT02965443|Hormones|hormones|mesh-ancestor
25140311|NCT02965443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25140312|NCT02965443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25140313|NCT02965443|Protease Inhibitors|protease inhibitors|mesh-ancestor
25140314|NCT02965443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25140321|NCT02965053|Sevelamer|sevelamer|mesh-list
25140322|NCT02965053|Chelating Agents|chelating agents|mesh-ancestor
25140323|NCT02965053|Sequestering Agents|sequestering agents|mesh-ancestor
25405457|NCT03606538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684040|NCT01886690|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25684041|NCT01886690|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25684042|NCT01886690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25684043|NCT01886690|Laxatives|laxatives|mesh-ancestor
25684044|NCT01886690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25684045|NCT01886937|Phentermine|phentermine|mesh-list
25684046|NCT01886937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25684047|NCT01886937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684048|NCT01886937|Appetite Depressants|appetite depressants|mesh-ancestor
25684049|NCT01886937|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25684050|NCT01886937|Sympathomimetics|sympathomimetics|mesh-ancestor
25684051|NCT01886937|Autonomic Agents|autonomic agents|mesh-ancestor
25684052|NCT01886937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25684053|NCT01886937|Adrenergic Agents|adrenergic agents|mesh-ancestor
25684054|NCT01886937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25684055|NCT01886937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684056|NCT01887132|Donepezil|donepezil|mesh-list
25042243|NCT01482390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042244|NCT01482390|Antiviral Agents|antiviral agents|mesh-ancestor
25042289|NCT01476904|Mydriatics|mydriatics|mesh-ancestor
25042290|NCT01476904|Sympathomimetics|sympathomimetics|mesh-ancestor
25042291|NCT01476904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25042293|NCT01474135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25042294|NCT01472198|Gemcitabine|gemcitabine|mesh-list
25042295|NCT01472198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25042296|NCT01472198|Antimetabolites|antimetabolites|mesh-ancestor
25042298|NCT01472198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25140324|NCT02965053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140325|NCT02965196|Dexamethasone|dexamethasone|mesh-list
25140326|NCT02965196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25140327|NCT02965196|Antiemetics|antiemetics|mesh-ancestor
25140328|NCT02965196|Autonomic Agents|autonomic agents|mesh-ancestor
24870850|NCT03376763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25140329|NCT02965196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25140330|NCT02965196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869144|NCT04694248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24869145|NCT04694248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24869147|NCT04694248|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24869148|NCT04694248|Antithrombins|antithrombins|mesh-ancestor
24869149|NCT04694248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24869150|NCT04694248|Protease Inhibitors|protease inhibitors|mesh-ancestor
24869151|NCT04650152|Fenofibrate|fenofibrate|mesh-list
24869152|NCT04650152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24869153|NCT04650152|Antimetabolites|antimetabolites|mesh-ancestor
24549084|NCT00713336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25140334|NCT02965196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25140335|NCT02965196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25140336|NCT02965196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25140337|NCT02965248|Calcium, Dietary|calcium, dietary|mesh-list
25088878|NCT03270969|Tenofovir|tenofovir|mesh-list
25140355|NCT02965248|Micronutrients|micronutrients|mesh-ancestor
25140356|NCT02965248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25140357|NCT02965248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25140358|NCT02965274|Fluoxetine|fluoxetine|mesh-list
25140359|NCT02965274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25140360|NCT02965274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25140361|NCT02965274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24869197|NCT04345861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869198|NCT04345861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24869200|NCT04278404|Interferons|interferons|mesh-list
24869201|NCT04278404|Ritonavir|ritonavir|mesh-list
24869202|NCT04278404|Ribavirin|ribavirin|mesh-list
24869203|NCT04278404|Lopinavir|lopinavir|mesh-list
24869204|NCT04278404|Oseltamivir|oseltamivir|mesh-list
24869205|NCT04278404|Remdesivir|remdesivir|mesh-list
24869206|NCT04278404|Azithromycin|azithromycin|mesh-list
24869207|NCT04278404|Clindamycin|clindamycin|mesh-list
24869208|NCT04278404|Meropenem|meropenem|mesh-list
25684057|NCT01887132|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25684058|NCT01887132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25684059|NCT01887132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684060|NCT01887132|Cholinergic Agents|cholinergic agents|mesh-ancestor
25684061|NCT01887132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25684062|NCT01887132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684063|NCT01887132|Nootropic Agents|nootropic agents|mesh-ancestor
25684064|NCT01887171|Tacrolimus|tacrolimus|mesh-list
25684065|NCT01887171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25285633|NCT04722809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285634|NCT04680936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25285635|NCT04655586|Heparin|heparin|mesh-list
25285636|NCT04655586|Protein C|protein c|mesh-list
25042339|NCT01460511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25042340|NCT01460511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25042341|NCT01460511|Adrenergic Agents|adrenergic agents|mesh-ancestor
24869291|NCT04278404|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24869292|NCT04278404|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24869313|NCT04278404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24869314|NCT04278404|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24869315|NCT04278404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24869316|NCT04278404|Vasodilator Agents|vasodilator agents|mesh-ancestor
24869317|NCT04278404|Tocolytic Agents|tocolytic agents|mesh-ancestor
25140363|NCT02965274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25140364|NCT02965274|Serotonin Agents|serotonin agents|mesh-ancestor
25140365|NCT02965274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140366|NCT02965274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25140367|NCT02965274|Antidepressive Agents|antidepressive agents|mesh-ancestor
25140368|NCT02965274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25140369|NCT02965274|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25140370|NCT02965274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25140371|NCT02965274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25140373|NCT02965261|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25140374|NCT02965261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25140375|NCT02965261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25140376|NCT02965261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140377|NCT02965261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25140378|NCT02965261|Serotonin Agents|serotonin agents|mesh-ancestor
25140379|NCT02965261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140380|NCT02965261|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25140383|NCT02965261|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25140384|NCT02965261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25140385|NCT02965261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24869328|NCT04278404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24869329|NCT04278404|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24869330|NCT04278404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24869409|NCT04046614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24869410|NCT04046614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24869412|NCT03916185|Immunologic Factors|immunologic factors|mesh-ancestor
24869413|NCT03916185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869415|NCT03915860|Dermatologic Agents|dermatologic agents|mesh-ancestor
25140395|NCT02964715|Empagliflozin|empagliflozin|mesh-list
25140396|NCT02964715|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25140397|NCT02964715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140398|NCT02964715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25140399|NCT02964715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140400|NCT02964949|Edoxaban|edoxaban|mesh-list
25140401|NCT02964949|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25140402|NCT02964949|Antithrombins|antithrombins|mesh-ancestor
25140403|NCT02964949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25140404|NCT02964949|Protease Inhibitors|protease inhibitors|mesh-ancestor
24869455|NCT03476369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24869456|NCT03476369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869457|NCT03476369|Analgesics|analgesics|mesh-ancestor
25684066|NCT01887171|Immunologic Factors|immunologic factors|mesh-ancestor
25684067|NCT01887171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684068|NCT01887171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25684069|NCT01887171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25684070|NCT01887171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684071|NCT01887327|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
25684072|NCT01887327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25285671|NCT04572217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25285672|NCT04572217|Appetite Depressants|appetite depressants|mesh-ancestor
25285673|NCT04572217|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25285674|NCT04572217|Sympathomimetics|sympathomimetics|mesh-ancestor
24998940|NCT05421858|Antifungal Agents|antifungal agents|mesh-ancestor
24998941|NCT05421858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24998942|NCT05421858|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24998943|NCT05421858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25042374|NCT01455870|Incretins|incretins|mesh-ancestor
24869458|NCT03476369|Sensory System Agents|sensory system agents|mesh-ancestor
24869459|NCT03476369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24869460|NCT03476369|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24869461|NCT03476369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24869462|NCT03476369|Anesthetics, General|anesthetics, general|mesh-ancestor
24869463|NCT03476369|Anesthetics|anesthetics|mesh-ancestor
24869464|NCT03476369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24869465|NCT03476369|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24806094|NCT02013570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24474771|NCT00407277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24474772|NCT00407277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474790|NCT00407407|Carboplatin|carboplatin|mesh-list
24869466|NCT03476369|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24869467|NCT03476369|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24869468|NCT03476369|Purinergic Agents|purinergic agents|mesh-ancestor
24869469|NCT03476369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24869470|NCT03476369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869471|NCT03423355|Dapagliflozin|dapagliflozin|mesh-list
24869472|NCT03423355|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24869496|NCT03238534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24869497|NCT03238534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24814668|NCT02065947|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24814669|NCT02065947|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24814670|NCT02065947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24549440|NCT00715273|Antimetabolites|antimetabolites|mesh-ancestor
24446732|NCT00305812|Lenalidomide|lenalidomide|mesh-list
24446733|NCT00305812|Melphalan|melphalan|mesh-list
24446734|NCT00305812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24446735|NCT00305812|Antiemetics|antiemetics|mesh-ancestor
24446736|NCT00305812|Autonomic Agents|autonomic agents|mesh-ancestor
24446737|NCT00305812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25140405|NCT02964949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25140406|NCT02964949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140407|NCT02964949|Anticoagulants|anticoagulants|mesh-ancestor
25140408|NCT02964728|Botulinum Toxins|botulinum toxins|mesh-list
25140409|NCT02964728|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25140410|NCT02964728|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25140411|NCT02964728|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24869609|NCT02643381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869610|NCT02643381|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24869611|NCT02643381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24869612|NCT02643381|Anesthetics, General|anesthetics, general|mesh-ancestor
24670407|NCT02663622|Dermatologic Agents|dermatologic agents|mesh-ancestor
24670408|NCT02663622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24670409|NCT02663622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24474822|NCT00407459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474823|NCT00407459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474824|NCT00407459|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24869613|NCT02643381|Anesthetics|anesthetics|mesh-ancestor
25684073|NCT01887327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692536|NCT02000973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692537|NCT02000973|Sensory System Agents|sensory system agents|mesh-ancestor
25692538|NCT02000973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25692539|NCT02000973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25692540|NCT02000973|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25692541|NCT02000973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25692542|NCT02000973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25042388|NCT01455857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25042390|NCT01455090|Asunaprevir|asunaprevir|mesh-list
25042391|NCT01455090|Antimetabolites|antimetabolites|mesh-ancestor
25042422|NCT01449071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25042424|NCT01445899|Ranibizumab|ranibizumab|mesh-list
25042425|NCT01445899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25042426|NCT01445899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24869614|NCT02643381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24869615|NCT02643381|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24869616|NCT02643381|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24869617|NCT02643381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24869618|NCT02643381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869619|NCT02643381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24869620|NCT02603900|Bupivacaine|bupivacaine|mesh-list
24869621|NCT02603900|Ropivacaine|ropivacaine|mesh-list
24869622|NCT02603900|Anesthetics, Local|anesthetics, local|mesh-ancestor
24869623|NCT02603900|Anesthetics|anesthetics|mesh-ancestor
24869624|NCT02603900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24869625|NCT02603900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869626|NCT02603900|Sensory System Agents|sensory system agents|mesh-ancestor
24869627|NCT02603900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24869628|NCT02595372|Omeprazole|omeprazole|mesh-list
24869629|NCT02595372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24869634|NCT02334722|Levetiracetam|levetiracetam|mesh-list
24623271|NCT01070745|Sensory System Agents|sensory system agents|mesh-ancestor
24474934|NCT00408187|Antifungal Agents|antifungal agents|mesh-ancestor
24474935|NCT00408187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24474936|NCT00408187|Dermatologic Agents|dermatologic agents|mesh-ancestor
24474937|NCT00408187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24623272|NCT01070745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24623273|NCT01070745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623274|NCT01070745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24623275|NCT01070745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24623276|NCT01070745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24623282|NCT01070758|Lanreotide|lanreotide|mesh-list
25046778|NCT00835692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25046779|NCT00835692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25046780|NCT00835666|Finasteride|finasteride|mesh-list
25046781|NCT00835666|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25046782|NCT00835666|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25046783|NCT00835666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24869773|NCT05159882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869774|NCT05159882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24869775|NCT05159882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869776|NCT05159674|Dexmedetomidine|dexmedetomidine|mesh-list
24869777|NCT05159674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24869812|NCT05157087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24869813|NCT05157087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24869814|NCT05157087|Respiratory System Agents|respiratory system agents|mesh-ancestor
24869815|NCT05150431|Parecoxib|parecoxib|mesh-list
24869826|NCT05150431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24869827|NCT05150431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25684074|NCT01887353|Ranolazine|ranolazine|mesh-list
25684075|NCT01887353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25684076|NCT01887353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25684077|NCT01887353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684078|NCT01887418|Methyltestosterone|methyltestosterone|mesh-list
25684079|NCT01887418|Testosterone|testosterone|mesh-list
25684080|NCT01887418|Testosterone undecanoate|testosterone undecanoate|mesh-list
25684081|NCT01887418|Testosterone enanthate|testosterone enanthate|mesh-list
24869828|NCT05146687|Bevacizumab|bevacizumab|mesh-list
24869829|NCT05146687|Ranibizumab|ranibizumab|mesh-list
24869830|NCT05146687|Aflibercept|aflibercept|mesh-list
24869832|NCT05146687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24869833|NCT05146687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24869834|NCT05146687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24869835|NCT05146687|Growth Substances|growth substances|mesh-ancestor
24869838|NCT05142098|Dexamethasone|dexamethasone|mesh-list
24869839|NCT05142098|Etoricoxib|etoricoxib|mesh-list
24869840|NCT05142098|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
24869841|NCT05142098|Glucocorticoids|glucocorticoids|mesh-list
24869842|NCT05142098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24869843|NCT05142098|Antiemetics|antiemetics|mesh-ancestor
24869844|NCT05142098|Autonomic Agents|autonomic agents|mesh-ancestor
25046793|NCT00835640|Histamine Antagonists|histamine antagonists|mesh-ancestor
25046794|NCT00835640|Histamine Agents|histamine agents|mesh-ancestor
25046795|NCT00835640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25046796|NCT00835640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046797|NCT00835640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046799|NCT00835614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25046800|NCT00835614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25046801|NCT00835588|Pantoprazole|pantoprazole|mesh-list
25046802|NCT00835588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24456566|NCT00331708|Antiviral Agents|antiviral agents|mesh-ancestor
24456567|NCT00331708|Schistosomicides|schistosomicides|mesh-ancestor
24456568|NCT00331708|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24456569|NCT00331708|Anthelmintics|anthelmintics|mesh-ancestor
24454312|NCT04109482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24454313|NCT04109482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25046804|NCT00835588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25046805|NCT00835588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24869845|NCT05142098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24869846|NCT05142098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869847|NCT05142098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24467537|NCT00378027|PENTA|penta|mesh-list
24869849|NCT05142098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24869851|NCT05142098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24869854|NCT05142098|Analgesics|analgesics|mesh-ancestor
24869894|NCT05116930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24869895|NCT05116930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24869896|NCT05116930|Autonomic Agents|autonomic agents|mesh-ancestor
24869897|NCT05116930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24869898|NCT05116930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869899|NCT05116930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24869900|NCT05116930|Respiratory System Agents|respiratory system agents|mesh-ancestor
24869901|NCT05116930|Mydriatics|mydriatics|mesh-ancestor
25046808|NCT00835575|Antidepressive Agents|antidepressive agents|mesh-ancestor
25089027|NCT03269799|Antioxidants|antioxidants|mesh-ancestor
25140423|NCT02964689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25140424|NCT02964689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25140425|NCT02964455|Docetaxel|docetaxel|mesh-list
25140426|NCT02964455|Nedaplatin|nedaplatin|mesh-list
25140427|NCT02964455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25140428|NCT02964455|Tubulin Modulators|tubulin modulators|mesh-ancestor
25140429|NCT02964455|Antimitotic Agents|antimitotic agents|mesh-ancestor
25140430|NCT02964455|Mitosis Modulators|mitosis modulators|mesh-ancestor
25140431|NCT02964455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140432|NCT02964572|Empagliflozin|empagliflozin|mesh-list
25140433|NCT02964572|Glimepiride|glimepiride|mesh-list
25140434|NCT02964572|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25140435|NCT02964572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140436|NCT02964572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25140437|NCT02964572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869902|NCT05116930|Parasympatholytics|parasympatholytics|mesh-ancestor
24869903|NCT05116930|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24869904|NCT05116930|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24869905|NCT05116930|Cholinergic Agents|cholinergic agents|mesh-ancestor
24549850|NCT00717730|Hematinics|hematinics|mesh-ancestor
24869936|NCT05070650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25042636|NCT01407003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24869941|NCT05070650|Antipyretics|antipyretics|mesh-ancestor
24869943|NCT05070650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24869944|NCT05070650|Expectorants|expectorants|mesh-ancestor
24869945|NCT05070650|Respiratory System Agents|respiratory system agents|mesh-ancestor
24869946|NCT05070650|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24869947|NCT05070650|Antioxidants|antioxidants|mesh-ancestor
24869948|NCT05070650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869949|NCT05070650|Protective Agents|protective agents|mesh-ancestor
24869950|NCT05070650|Antidotes|antidotes|mesh-ancestor
24869951|NCT05070650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24869952|NCT05070650|Mydriatics|mydriatics|mesh-ancestor
24869953|NCT05070650|Autonomic Agents|autonomic agents|mesh-ancestor
24814714|NCT02066103|Antimitotic Agents|antimitotic agents|mesh-ancestor
24814715|NCT02066103|Mitosis Modulators|mitosis modulators|mesh-ancestor
24814716|NCT02066103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814717|NCT02066207|Atorvastatin|atorvastatin|mesh-list
24814718|NCT02066207|Fenofibrate|fenofibrate|mesh-list
24814719|NCT02066207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24814720|NCT02066207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24814721|NCT02066207|Antimetabolites|antimetabolites|mesh-ancestor
24692300|NCT01412658|Caseins|caseins|mesh-list
24869958|NCT05070650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24870023|NCT04328961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24870024|NCT04328961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24870025|NCT04328961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24870026|NCT04328961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870027|NCT04328961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24870028|NCT04328961|Antioxidants|antioxidants|mesh-ancestor
25140438|NCT02964572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25140439|NCT02964572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25140440|NCT02964572|Immunologic Factors|immunologic factors|mesh-ancestor
25140441|NCT02964195|Rifaximin|rifaximin|mesh-list
25140442|NCT02964195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24475008|NCT00408525|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24806171|NCT02014337|Abortifacient Agents|abortifacient agents|mesh-ancestor
24806172|NCT02014337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24806173|NCT02014337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806174|NCT02014337|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24806175|NCT02014337|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24806176|NCT02014337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24806177|NCT02014337|Contraceptive Agents|contraceptive agents|mesh-ancestor
24806178|NCT02014337|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24584244|NCT00879099|Serotonin Agents|serotonin agents|mesh-ancestor
25140443|NCT02964195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25140444|NCT02964195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25140445|NCT02964104|Insulin|insulin|mesh-list
25140446|NCT02964104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25140447|NCT02964104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25140448|NCT02964104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140449|NCT02964403|Indomethacin|indomethacin|mesh-list
25140450|NCT02964403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25140451|NCT02964403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25140452|NCT02964403|Analgesics|analgesics|mesh-ancestor
25140453|NCT02964403|Sensory System Agents|sensory system agents|mesh-ancestor
25140454|NCT02964403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25140455|NCT02964403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140456|NCT02964403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25140457|NCT02964403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25140458|NCT02964403|Gout Suppressants|gout suppressants|mesh-ancestor
25140459|NCT02964403|Tocolytic Agents|tocolytic agents|mesh-ancestor
25140460|NCT02964403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25140461|NCT02964403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25140462|NCT02964403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25140463|NCT02964403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140464|NCT02964091|Sofosbuvir|sofosbuvir|mesh-list
25140465|NCT02964091|Ledipasvir|ledipasvir|mesh-list
24870029|NCT04328961|Protective Agents|protective agents|mesh-ancestor
24870030|NCT04328961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684082|NCT01887418|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24870031|NCT04328961|Vitamins|vitamins|mesh-ancestor
24870032|NCT04328961|Micronutrients|micronutrients|mesh-ancestor
25684083|NCT01887418|Androgens|androgens|mesh-ancestor
25684084|NCT01887418|Hormones|hormones|mesh-ancestor
25684085|NCT01887418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25684086|NCT01887418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999270|NCT04795869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589355|NCT00907036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589356|NCT00907036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24589357|NCT00907036|Immunologic Factors|immunologic factors|mesh-ancestor
24589358|NCT00907036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589359|NCT00907036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589360|NCT00907036|Antifungal Agents|antifungal agents|mesh-ancestor
24589362|NCT00907036|Dermatologic Agents|dermatologic agents|mesh-ancestor
24870034|NCT04274361|Analgesics|analgesics|mesh-ancestor
24870067|NCT04142983|Immunologic Factors|immunologic factors|mesh-ancestor
24870068|NCT04142983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692392|NCT01413477|Vitamins|vitamins|mesh-ancestor
24870069|NCT04076579|Olaparib|olaparib|mesh-list
24870070|NCT04076579|Trabectedin|trabectedin|mesh-list
24870071|NCT04076579|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24870072|NCT04076579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24870073|NCT04076579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870081|NCT04028362|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24870082|NCT04028362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24870083|NCT04028362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870084|NCT03945448|Fluconazole|fluconazole|mesh-list
24870085|NCT03945448|Amphotericin B|amphotericin b|mesh-list
24814729|NCT02066454|Anticoagulants|anticoagulants|mesh-list
24814730|NCT02066454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25140469|NCT02963779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24475111|NCT00408941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24475113|NCT00408941|Anesthetics|anesthetics|mesh-ancestor
24475114|NCT00408941|Anesthetics, Local|anesthetics, local|mesh-ancestor
25140480|NCT02963779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140482|NCT02963896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25140483|NCT02963896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24628819|NCT01101581|Veltuzumab|veltuzumab|mesh-list
24814731|NCT02066454|Antithrombins|antithrombins|mesh-ancestor
24814732|NCT02066454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24814733|NCT02066454|Protease Inhibitors|protease inhibitors|mesh-ancestor
24814736|NCT02066532|Trastuzumab|trastuzumab|mesh-list
24870148|NCT03703778|Protective Agents|protective agents|mesh-ancestor
24870149|NCT03703778|Vitamins|vitamins|mesh-ancestor
24870150|NCT03703778|Micronutrients|micronutrients|mesh-ancestor
24870151|NCT03703778|Estrogens|estrogens|mesh-ancestor
24870152|NCT03703778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24870153|NCT03703778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870154|NCT03703778|Anabolic Agents|anabolic agents|mesh-ancestor
24870342|NCT01510184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24870343|NCT01471444|Vidarabine|vidarabine|mesh-list
24870344|NCT01471444|Methotrexate|methotrexate|mesh-list
24870345|NCT01471444|Fludarabine phosphate|fludarabine phosphate|mesh-list
24870346|NCT01471444|Clofarabine|clofarabine|mesh-list
24870347|NCT01471444|Fludarabine|fludarabine|mesh-list
24870348|NCT01471444|Busulfan|busulfan|mesh-list
24870349|NCT01471444|Tacrolimus|tacrolimus|mesh-list
24814777|NCT02066662|Antithrombins|antithrombins|mesh-ancestor
24814778|NCT02066662|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25140492|NCT02963454|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25140493|NCT02963454|Vasodilator Agents|vasodilator agents|mesh-ancestor
25140494|NCT02963454|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25140495|NCT02963454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25140496|NCT02963454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25140497|NCT02963454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610475|NCT01002690|Etoricoxib|etoricoxib|mesh-list
24814816|NCT02066844|Lidocaine|lidocaine|mesh-list
24814817|NCT02066844|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25684087|NCT01887418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25684088|NCT01887418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25684089|NCT01887418|Anabolic Agents|anabolic agents|mesh-ancestor
25684090|NCT01887587|Dexamethasone|dexamethasone|mesh-list
25684091|NCT01887587|Doxorubicin|doxorubicin|mesh-list
25684092|NCT01887587|Vincristine|vincristine|mesh-list
25684093|NCT01887587|Ixazomib|ixazomib|mesh-list
25684094|NCT01887587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24814818|NCT02066844|Anesthetics, Local|anesthetics, local|mesh-ancestor
24814819|NCT02066844|Anesthetics|anesthetics|mesh-ancestor
24814820|NCT02066844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24814821|NCT02066844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042709|NCT01381666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25042710|NCT01379209|Mycophenolic Acid|mycophenolic acid|mesh-list
25285875|NCT04128956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042712|NCT01379209|Methotrexate|methotrexate|mesh-list
25042713|NCT01379209|KRN 7000|krn 7000|mesh-list
25042714|NCT01379209|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
25042715|NCT01379209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25042716|NCT01379209|Abortifacient Agents|abortifacient agents|mesh-ancestor
25042717|NCT01379209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25042720|NCT01379209|Antimetabolites|antimetabolites|mesh-ancestor
24814822|NCT02066844|Sensory System Agents|sensory system agents|mesh-ancestor
24814823|NCT02066844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24814824|NCT02066844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24814825|NCT02066844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24814826|NCT02066844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24870379|NCT05162625|Ciprofloxacin|ciprofloxacin|mesh-list
24870380|NCT05162625|Cefazolin|cefazolin|mesh-list
24870381|NCT05162625|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24870382|NCT05162625|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24870383|NCT05162625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24870384|NCT05162625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24870385|NCT05162625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24870386|NCT05162625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24870387|NCT05162625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24970052|NCT03737201|Disinfectants|disinfectants|mesh-ancestor
24870388|NCT05162625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870389|NCT05162625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870390|NCT05162625|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24870391|NCT05162625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24870392|NCT05162456|Antibodies|antibodies|mesh-list
24870393|NCT05162456|Immunoglobulins|immunoglobulins|mesh-list
24870443|NCT05161403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24870444|NCT05161403|Immunologic Factors|immunologic factors|mesh-ancestor
25140498|NCT02963454|Protective Agents|protective agents|mesh-ancestor
25140499|NCT02963454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140500|NCT02963454|Sympathomimetics|sympathomimetics|mesh-ancestor
25140501|NCT02963454|Autonomic Agents|autonomic agents|mesh-ancestor
25140502|NCT02963454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25140503|NCT02963454|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25140504|NCT02963454|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25140505|NCT02963454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25140506|NCT02963454|Adrenergic Agents|adrenergic agents|mesh-ancestor
25140507|NCT02963454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25140508|NCT02963051|Copper|copper|mesh-list
25140509|NCT02963051|Disulfiram|disulfiram|mesh-list
25140510|NCT02963051|Trace Elements|trace elements|mesh-ancestor
25140511|NCT02963051|Micronutrients|micronutrients|mesh-ancestor
25140512|NCT02963051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140513|NCT02963051|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25140514|NCT02963051|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25140515|NCT02963051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25140516|NCT02963051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140517|NCT02963194|Oxytocin|oxytocin|mesh-list
25140518|NCT02963194|Oxytocics|oxytocics|mesh-ancestor
25140519|NCT02963194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25140520|NCT02963194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140521|NCT02963129|Mupirocin|mupirocin|mesh-list
25140522|NCT02963129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25140523|NCT02963129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25140524|NCT02963129|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25140525|NCT02963129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405458|NCT03606538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25684095|NCT01887587|Antiemetics|antiemetics|mesh-ancestor
25684096|NCT01887587|Autonomic Agents|autonomic agents|mesh-ancestor
25684097|NCT01887587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25684098|NCT01887587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684099|NCT01887587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25684100|NCT01887587|Glucocorticoids|glucocorticoids|mesh-ancestor
25684101|NCT01887587|Hormones|hormones|mesh-ancestor
25684102|NCT01887587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25684103|NCT01887587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25042807|NCT01366131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042808|NCT01366131|Growth Inhibitors|growth inhibitors|mesh-ancestor
25042809|NCT01366014|Oxycodone|oxycodone|mesh-list
25042810|NCT01366014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25042811|NCT01366014|Narcotics|narcotics|mesh-ancestor
25042812|NCT01366014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25042813|NCT01366014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042814|NCT01366014|Analgesics|analgesics|mesh-ancestor
25042815|NCT01366014|Sensory System Agents|sensory system agents|mesh-ancestor
25042816|NCT01366014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25285924|NCT04065113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25285927|NCT04052776|Levodopa|levodopa|mesh-list
25140526|NCT02963129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870445|NCT05161403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870447|NCT05161403|Protective Agents|protective agents|mesh-ancestor
24870448|NCT05161221|Acetaminophen|acetaminophen|mesh-list
24870449|NCT05161221|Naproxen|naproxen|mesh-list
24870450|NCT05161221|Oxycodone|oxycodone|mesh-list
24870451|NCT05161221|Bupivacaine|bupivacaine|mesh-list
24870452|NCT05161221|Anesthetics, Local|anesthetics, local|mesh-ancestor
24870453|NCT05161221|Anesthetics|anesthetics|mesh-ancestor
24692788|NCT01416480|Theobromine|theobromine|mesh-list
24870454|NCT05161221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24870532|NCT05046522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24870533|NCT05046522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870535|NCT05046522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24870558|NCT04998786|Protease Inhibitors|protease inhibitors|mesh-ancestor
24870559|NCT04998786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25140527|NCT02963077|Cholestyramine Resin|cholestyramine resin|mesh-list
25140528|NCT02963077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25140529|NCT02963077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25140530|NCT02963077|Antimetabolites|antimetabolites|mesh-ancestor
25140531|NCT02963077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140532|NCT02963077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24870560|NCT04998786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870561|NCT04991974|Buprenorphine|buprenorphine|mesh-list
24870562|NCT04991974|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
24870563|NCT04991974|Naloxone|naloxone|mesh-list
24870564|NCT04991974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24870565|NCT04991974|Narcotics|narcotics|mesh-ancestor
24870566|NCT04991974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24870567|NCT04991974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870568|NCT04991974|Analgesics|analgesics|mesh-ancestor
24870569|NCT04991974|Sensory System Agents|sensory system agents|mesh-ancestor
24692946|NCT01417429|Galantamine|galantamine|mesh-list
24870572|NCT04976192|Omalizumab|omalizumab|mesh-list
24870573|NCT04976192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24870574|NCT04976192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24870575|NCT04976192|Respiratory System Agents|respiratory system agents|mesh-ancestor
24870616|NCT04821284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24870617|NCT04821284|Antimetabolites|antimetabolites|mesh-ancestor
24870618|NCT04821284|Antiviral Agents|antiviral agents|mesh-ancestor
24870619|NCT04821284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24870620|NCT04821284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24870621|NCT04821284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24870622|NCT04821284|Immunologic Factors|immunologic factors|mesh-ancestor
24870623|NCT04821284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870624|NCT04821284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24870657|NCT04577690|Racepinephrine|racepinephrine|mesh-list
24870658|NCT04577690|Bupivacaine|bupivacaine|mesh-list
24870659|NCT04577690|Epinephryl borate|epinephryl borate|mesh-list
24870660|NCT04577690|Anesthetics, Local|anesthetics, local|mesh-ancestor
24814829|NCT02066844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25684104|NCT01887587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25684105|NCT01887587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25684106|NCT01887587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25684107|NCT01887587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25684108|NCT01887587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25684109|NCT01887587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684110|NCT01887587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25684111|NCT01887587|Tubulin Modulators|tubulin modulators|mesh-ancestor
25684112|NCT01887587|Antimitotic Agents|antimitotic agents|mesh-ancestor
25684113|NCT01887587|Mitosis Modulators|mitosis modulators|mesh-ancestor
25684114|NCT01887587|Protease Inhibitors|protease inhibitors|mesh-ancestor
24814830|NCT02066844|Glucocorticoids|glucocorticoids|mesh-ancestor
25042861|NCT01358695|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25042862|NCT01358695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25042863|NCT01358695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042864|NCT01358695|Cholinergic Agents|cholinergic agents|mesh-ancestor
25042865|NCT01358695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25042866|NCT01358695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042867|NCT01358695|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25285998|NCT03909074|Vaccines|vaccines|mesh-list
24814831|NCT02066844|Hormones|hormones|mesh-ancestor
24814832|NCT02066844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24814833|NCT02066844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24814834|NCT02066844|Respiratory System Agents|respiratory system agents|mesh-ancestor
24870681|NCT04574856|Alkylating Agents|alkylating agents|mesh-ancestor
24870682|NCT04574856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870683|NCT04574856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870684|NCT04523922|Oxytocin|oxytocin|mesh-list
24870685|NCT04523922|Oxytocics|oxytocics|mesh-ancestor
25140551|NCT02963181|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25140552|NCT02963181|Adrenergic Agents|adrenergic agents|mesh-ancestor
25140553|NCT02963181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25140554|NCT02963181|Urological Agents|urological agents|mesh-ancestor
25140555|NCT02963337|Remifentanil|remifentanil|mesh-list
25140556|NCT02963337|Bupivacaine|bupivacaine|mesh-list
25140557|NCT02963337|Anesthetics, Local|anesthetics, local|mesh-ancestor
25140558|NCT02963337|Anesthetics|anesthetics|mesh-ancestor
25140559|NCT02963337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25140560|NCT02963337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140561|NCT02963337|Sensory System Agents|sensory system agents|mesh-ancestor
25140562|NCT02963337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25140563|NCT02963337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25140564|NCT02963337|Narcotics|narcotics|mesh-ancestor
25140565|NCT02963337|Analgesics|analgesics|mesh-ancestor
24870686|NCT04523922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24870847|NCT03376763|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24870849|NCT03376763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24870874|NCT03155061|Nivolumab|nivolumab|mesh-list
25140583|NCT02963103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25140584|NCT02963103|Immunologic Factors|immunologic factors|mesh-ancestor
25140585|NCT02963103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140586|NCT02963103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25140587|NCT02963103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25140588|NCT02963103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140589|NCT02962999|Ketamine|ketamine|mesh-list
25140590|NCT02962999|Analgesics|analgesics|mesh-ancestor
25140591|NCT02962999|Sensory System Agents|sensory system agents|mesh-ancestor
25140592|NCT02962999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25140593|NCT02962999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140594|NCT02962999|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25140595|NCT02962999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25140596|NCT02962999|Anesthetics, General|anesthetics, general|mesh-ancestor
25140597|NCT02962999|Anesthetics|anesthetics|mesh-ancestor
25140598|NCT02962999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25140599|NCT02962999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25140600|NCT02962999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25140601|NCT02962999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25140602|NCT02962999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046809|NCT00835575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25046810|NCT00835575|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24870875|NCT03155061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24870876|NCT03155061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870877|NCT03155061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24870997|NCT05164198|Golimumab|golimumab|mesh-list
24870998|NCT05164198|Infliximab|infliximab|mesh-list
24870999|NCT05164198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25684115|NCT01887717|Sorafenib|sorafenib|mesh-list
25684116|NCT01887717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25684117|NCT01887717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25684118|NCT01887717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25684119|NCT01887717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684120|NCT01887990|Ketamine|ketamine|mesh-list
25684121|NCT01887990|Analgesics|analgesics|mesh-ancestor
25684122|NCT01887990|Sensory System Agents|sensory system agents|mesh-ancestor
25684123|NCT01887990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24999544|NCT04052334|Cyclophosphamide|cyclophosphamide|mesh-list
24999545|NCT04052334|Fludarabine|fludarabine|mesh-list
24999547|NCT04052334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24999548|NCT04052334|Immunologic Factors|immunologic factors|mesh-ancestor
24999549|NCT04052334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999550|NCT04052334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25286020|NCT03880539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25286021|NCT03869892|Trifluridine|trifluridine|mesh-list
25286022|NCT03869892|Bevacizumab|bevacizumab|mesh-list
24871000|NCT05164198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24871001|NCT05164198|Dermatologic Agents|dermatologic agents|mesh-ancestor
24871002|NCT05164198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24871003|NCT05164198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24871004|NCT05164198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24871005|NCT05164198|Analgesics|analgesics|mesh-ancestor
24871084|NCT05160727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24871085|NCT05160727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24871086|NCT05160727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24871087|NCT05160727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871088|NCT05160727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871092|NCT05141422|Efavirenz|efavirenz|mesh-list
24871093|NCT05141422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24871094|NCT05141422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24871095|NCT05141422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24871096|NCT05141422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871097|NCT05141422|Antiviral Agents|antiviral agents|mesh-ancestor
24871098|NCT05141422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24871099|NCT05141422|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24871100|NCT05141422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24871147|NCT04698603|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24871149|NCT04698603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24871150|NCT04698603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871151|NCT04698603|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24871152|NCT04658173|Alfentanil|alfentanil|mesh-list
24871153|NCT04658173|Propofol|propofol|mesh-list
24871154|NCT04658173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24871320|NCT03765632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24871321|NCT03765632|Immunologic Factors|immunologic factors|mesh-ancestor
24871322|NCT03765632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871323|NCT03765632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24871324|NCT03765632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871325|NCT03765632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24871329|NCT03695250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871330|NCT03695250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24871331|NCT03695250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871332|NCT03695250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24871333|NCT03632941|Pembrolizumab|pembrolizumab|mesh-list
24871334|NCT03632941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24871335|NCT03632941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871336|NCT03603912|Metformin|metformin|mesh-list
24871337|NCT03603912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24871338|NCT03603912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871446|NCT02595320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871447|NCT02595320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871512|NCT01633541|Mitosis Modulators|mitosis modulators|mesh-ancestor
24871736|NCT04952857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871737|NCT04952857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24871738|NCT04952857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25405459|NCT03606538|Serotonin Agents|serotonin agents|mesh-ancestor
25684124|NCT01887990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684125|NCT01887990|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25684126|NCT01887990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25684127|NCT01887990|Anesthetics, General|anesthetics, general|mesh-ancestor
25684128|NCT01887990|Anesthetics|anesthetics|mesh-ancestor
25684129|NCT01887990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25684130|NCT01887990|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25286053|NCT03782818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25286054|NCT03782818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286055|NCT03782818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286056|NCT03772028|Cisplatin|cisplatin|mesh-list
25286057|NCT03772028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286069|NCT03712345|Vilobelimab|vilobelimab|mesh-list
25286070|NCT03712345|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25286071|NCT03712345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25286072|NCT03712345|Immunologic Factors|immunologic factors|mesh-ancestor
25043180|NCT01309945|Analgesics|analgesics|mesh-ancestor
24871910|NCT03651518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872144|NCT05398679|Rifampin|rifampin|mesh-list
24872339|NCT05396859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25046827|NCT00835549|Cefdinir|cefdinir|mesh-list
25046828|NCT00835549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25046829|NCT00835549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25046830|NCT00835536|Ribavirin|ribavirin|mesh-list
25046831|NCT00835536|Antimetabolites|antimetabolites|mesh-ancestor
25046832|NCT00835536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046833|NCT00835536|Antiviral Agents|antiviral agents|mesh-ancestor
25046834|NCT00835536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25046835|NCT00835497|Metformin|metformin|mesh-list
25046836|NCT00835497|Glipizide|glipizide|mesh-list
25046839|NCT00835484|Cefdinir|cefdinir|mesh-list
25046840|NCT00835484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25046841|NCT00835484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25046842|NCT00835406|Alendronate|alendronate|mesh-list
24872376|NCT05396144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24872377|NCT05396118|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24872420|NCT05387200|Alendronate|alendronate|mesh-list
24872421|NCT05387200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24872422|NCT05387200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872424|NCT05386810|Immunologic Factors|immunologic factors|mesh-ancestor
24872425|NCT05386810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815016|NCT02067949|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24872646|NCT05293548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872647|NCT05293249|Methylprednisolone|methylprednisolone|mesh-list
24872648|NCT05293249|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24872649|NCT05293249|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24872650|NCT05293249|Prednisolone|prednisolone|mesh-list
24872651|NCT05293249|Prednisolone acetate|prednisolone acetate|mesh-list
24872652|NCT05293249|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24872653|NCT05293249|Prednisolone phosphate|prednisolone phosphate|mesh-list
24872654|NCT05293249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25140609|NCT02962986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25140610|NCT02962986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140611|NCT02962986|Sympathomimetics|sympathomimetics|mesh-ancestor
25140612|NCT02962986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25140613|NCT02962986|Nasal Decongestants|nasal decongestants|mesh-ancestor
25140614|NCT02962986|Respiratory System Agents|respiratory system agents|mesh-ancestor
25140615|NCT02962986|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25684131|NCT01887990|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25684132|NCT01887990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25684133|NCT01887990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684134|NCT01888003|Epoetin Alfa|epoetin alfa|mesh-list
25684135|NCT01888003|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25684136|NCT01888003|Hematinics|hematinics|mesh-ancestor
25684137|NCT01888367|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25684138|NCT01888367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25684139|NCT01888432|Everolimus|everolimus|mesh-list
25684140|NCT01888432|Tacrolimus|tacrolimus|mesh-list
25684141|NCT01888432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25684142|NCT01888432|Immunologic Factors|immunologic factors|mesh-ancestor
25140617|NCT02962986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25140618|NCT02962986|Adrenergic Agents|adrenergic agents|mesh-ancestor
25140619|NCT02962986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25140620|NCT02962986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140621|NCT02962986|Protective Agents|protective agents|mesh-ancestor
25140623|NCT02963324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24873066|NCT05426174|Immunologic Factors|immunologic factors|mesh-ancestor
24873067|NCT05426174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24873068|NCT05424315|Dapagliflozin|dapagliflozin|mesh-list
24873069|NCT05424315|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24873071|NCT05424315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24873146|NCT05382715|Ozanimod|ozanimod|mesh-list
25140624|NCT02963324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25140625|NCT02962947|Propranolol|propranolol|mesh-list
25140626|NCT02962947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25140627|NCT02962947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25140628|NCT02962947|Adrenergic Agents|adrenergic agents|mesh-ancestor
25140629|NCT02962947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25140630|NCT02962947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140631|NCT02962947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140632|NCT02962947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25140634|NCT02962947|Vasodilator Agents|vasodilator agents|mesh-ancestor
25140635|NCT02962804|Nivolumab|nivolumab|mesh-list
25140636|NCT02962804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25140637|NCT02962804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25140638|NCT02962804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25140639|NCT02962804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140640|NCT02962830|Sufentanil|sufentanil|mesh-list
25140641|NCT02962830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25140642|NCT02962830|Narcotics|narcotics|mesh-ancestor
25140643|NCT02962830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25140644|NCT02962830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140645|NCT02962830|Analgesics|analgesics|mesh-ancestor
24873513|NCT05181124|Naproxen|naproxen|mesh-list
24468596|NCT00382356|Hormone Antagonists|hormone antagonists|mesh-ancestor
24873825|NCT04996719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24873826|NCT04996719|Immunologic Factors|immunologic factors|mesh-ancestor
25140649|NCT02962830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25140650|NCT02962830|Anesthetics, General|anesthetics, general|mesh-ancestor
25140651|NCT02962830|Anesthetics|anesthetics|mesh-ancestor
25140652|NCT02962921|Insulin|insulin|mesh-list
25140653|NCT02962921|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25140654|NCT02962921|Insulin Lispro|insulin lispro|mesh-list
25140655|NCT02962921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25140656|NCT02962921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140657|NCT02962232|Paclitaxel|paclitaxel|mesh-list
25140658|NCT02962232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25140659|NCT02962232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25140660|NCT02962232|Tubulin Modulators|tubulin modulators|mesh-ancestor
25140661|NCT02962232|Antimitotic Agents|antimitotic agents|mesh-ancestor
25140662|NCT02962232|Mitosis Modulators|mitosis modulators|mesh-ancestor
25140663|NCT02962232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140664|NCT02962388|Anagrelide|anagrelide|mesh-list
25140665|NCT02962388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25140666|NCT02962388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25140667|NCT02962388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140668|NCT02962388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25286140|NCT03418922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286142|NCT03418922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25286143|NCT03410654|Tacrolimus|tacrolimus|mesh-list
25286144|NCT03410654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25286145|NCT03410654|Immunologic Factors|immunologic factors|mesh-ancestor
25286146|NCT03410654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286147|NCT03410654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25286148|NCT03410654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25286149|NCT03410654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24877058|NCT02974621|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24877059|NCT02974621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043276|NCT01281254|Growth Inhibitors|growth inhibitors|mesh-ancestor
25140675|NCT02962258|Amlodipine|amlodipine|mesh-list
25140676|NCT02962258|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25140677|NCT02962258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25140678|NCT02962258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25140679|NCT02962258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25140680|NCT02962258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140681|NCT02962258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25140682|NCT02962258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140683|NCT02962258|Vasodilator Agents|vasodilator agents|mesh-ancestor
24773741|NCT01841658|Folic Acid|folic acid|mesh-list
25140690|NCT02962492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140691|NCT02962492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25140692|NCT02962492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140693|NCT02962492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25140694|NCT02962492|Incretins|incretins|mesh-ancestor
25140695|NCT02962492|Hormones|hormones|mesh-ancestor
25140696|NCT02962492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25140697|NCT02962518|Triamcinolone|triamcinolone|mesh-list
25140707|NCT02962336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25140708|NCT02962336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25140709|NCT02962336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25140710|NCT02962336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140711|NCT02962336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25140886|NCT02961816|Micronutrients|micronutrients|mesh-ancestor
24468708|NCT00382889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25140719|NCT02962310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25140720|NCT02962310|Calcium|calcium|mesh-list
25140721|NCT02962310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25140722|NCT02962310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140723|NCT02962310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25140724|NCT02962310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25140725|NCT02962310|Antimetabolites|antimetabolites|mesh-ancestor
25140726|NCT02962310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140727|NCT02962310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25684143|NCT01888432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684144|NCT01888432|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25684145|NCT01888432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25684146|NCT01888432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684147|NCT01888432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25684148|NCT01888497|Diphenhydramine|diphenhydramine|mesh-list
25684149|NCT01888497|Promethazine|promethazine|mesh-list
25684150|NCT01888497|Triazolam|triazolam|mesh-list
25684151|NCT01888497|Gabapentin|gabapentin|mesh-list
25684152|NCT01888497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684153|NCT01888497|Analgesics|analgesics|mesh-ancestor
25684154|NCT01888497|Sensory System Agents|sensory system agents|mesh-ancestor
25684155|NCT01888497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25286179|NCT03355534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25286180|NCT03355534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286181|NCT03334461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
24550618|NCT00721487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24468736|NCT00383032|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25140728|NCT02962310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25140729|NCT02962310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25140730|NCT02962323|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25140731|NCT02962323|Calcium|calcium|mesh-list
25140732|NCT02962323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25140733|NCT02962323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140734|NCT02962323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24874962|NCT04492033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24874963|NCT04492033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24874964|NCT04492033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24874965|NCT04492033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24874968|NCT04491032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24875062|NCT04456946|Salicylic Acid|salicylic acid|mesh-list
24875063|NCT04456946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24875064|NCT04456946|Antifungal Agents|antifungal agents|mesh-ancestor
24475799|NCT00411372|Glucocorticoids|glucocorticoids|mesh-ancestor
24875065|NCT04456946|Keratolytic Agents|keratolytic agents|mesh-ancestor
24875066|NCT04456946|Dermatologic Agents|dermatologic agents|mesh-ancestor
24468871|NCT00383812|Bevacizumab|bevacizumab|mesh-list
24875210|NCT04329325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24875211|NCT04329325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24875212|NCT04329325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24875213|NCT04329325|Glucocorticoids|glucocorticoids|mesh-ancestor
24875214|NCT04329325|Hormones|hormones|mesh-ancestor
24437291|NCT00273338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25140747|NCT02962141|Paclitaxel|paclitaxel|mesh-list
25140748|NCT02962141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25140749|NCT02962141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25140750|NCT02962141|Tubulin Modulators|tubulin modulators|mesh-ancestor
25140751|NCT02962141|Antimitotic Agents|antimitotic agents|mesh-ancestor
25140752|NCT02962141|Mitosis Modulators|mitosis modulators|mesh-ancestor
25140753|NCT02962141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140755|NCT02961855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25140756|NCT02961855|Lidocaine|lidocaine|mesh-list
25140757|NCT02961855|Anesthetics, Local|anesthetics, local|mesh-ancestor
25140758|NCT02961855|Anesthetics|anesthetics|mesh-ancestor
25140759|NCT02961855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25140760|NCT02961855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140761|NCT02961855|Sensory System Agents|sensory system agents|mesh-ancestor
25140762|NCT02961855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25140763|NCT02961855|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25140764|NCT02961855|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25140765|NCT02961855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25140766|NCT02961855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25140767|NCT02961855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875215|NCT04329325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24875293|NCT04253964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24875294|NCT04253964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24875576|NCT04021108|Nivolumab|nivolumab|mesh-list
25140768|NCT02961855|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25684156|NCT01888497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684157|NCT01888497|Anticonvulsants|anticonvulsants|mesh-ancestor
25684158|NCT01888497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25684159|NCT01888497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25684160|NCT01888497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25684161|NCT01888497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25684162|NCT01888497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25684163|NCT01888497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25684164|NCT01888497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25286231|NCT03073980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25286232|NCT03073980|Analgesics|analgesics|mesh-ancestor
25286233|NCT03073980|Sensory System Agents|sensory system agents|mesh-ancestor
25286234|NCT03073980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25286235|NCT03073980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286236|NCT03073980|Antipyretics|antipyretics|mesh-ancestor
25286237|NCT03033446|Nivolumab|nivolumab|mesh-list
25140769|NCT02961855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25140770|NCT02961855|Analgesics|analgesics|mesh-ancestor
25140771|NCT02961855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25140772|NCT02961855|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25140773|NCT02961855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25140775|NCT02961998|Sorafenib|sorafenib|mesh-list
25140776|NCT02961998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25140777|NCT02961998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25140778|NCT02961998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25140779|NCT02961998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140780|NCT02961998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25140781|NCT02961998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25140782|NCT02961998|Analgesics|analgesics|mesh-ancestor
25140783|NCT02961998|Sensory System Agents|sensory system agents|mesh-ancestor
25140784|NCT02961998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25140785|NCT02961998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140786|NCT02961998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25140787|NCT02961998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25140788|NCT02961998|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25140789|NCT02961998|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25140790|NCT02961829|Niacinamide|niacinamide|mesh-list
25140791|NCT02961829|Maraviroc|maraviroc|mesh-list
25140792|NCT02961829|Dolutegravir|dolutegravir|mesh-list
25140793|NCT02961829|Auranofin|auranofin|mesh-list
25140794|NCT02961829|Vaccines|vaccines|mesh-list
25140795|NCT02961829|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25140796|NCT02961829|Immunologic Factors|immunologic factors|mesh-ancestor
25140797|NCT02961829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140798|NCT02961829|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25140799|NCT02961829|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25140800|NCT02961829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140801|NCT02961829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25140802|NCT02961829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25140803|NCT02961829|Antiviral Agents|antiviral agents|mesh-ancestor
25140809|NCT02961829|Vitamin B Complex|vitamin b complex|mesh-ancestor
25140810|NCT02961829|Vitamins|vitamins|mesh-ancestor
25140811|NCT02961829|Micronutrients|micronutrients|mesh-ancestor
25046845|NCT00835367|Amlodipine|amlodipine|mesh-list
25046846|NCT00835367|Benazepril|benazepril|mesh-list
25046847|NCT00835367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25046848|NCT00835367|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25046849|NCT00835367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25046850|NCT00835367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046851|NCT00835367|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25046852|NCT00835367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046853|NCT00835367|Vasodilator Agents|vasodilator agents|mesh-ancestor
25046854|NCT00835367|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24875651|NCT03977194|Antimitotic Agents|antimitotic agents|mesh-ancestor
24875652|NCT03977194|Mitosis Modulators|mitosis modulators|mesh-ancestor
24875653|NCT03977194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875713|NCT03907475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24875714|NCT03907475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24875715|NCT03907475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24875716|NCT03907475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24875717|NCT03905603|Cosyntropin|cosyntropin|mesh-list
24875719|NCT03905603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24875843|NCT03819465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24875844|NCT03819465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24875845|NCT03819465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24875846|NCT03819465|Immunologic Factors|immunologic factors|mesh-ancestor
24468967|NCT00384072|Bazedoxifene|bazedoxifene|mesh-list
25684165|NCT01888497|Antimanic Agents|antimanic agents|mesh-ancestor
25684166|NCT01888497|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25684167|NCT01888497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25684168|NCT01888497|Anesthetics, Local|anesthetics, local|mesh-ancestor
25684169|NCT01888497|Anesthetics|anesthetics|mesh-ancestor
25684170|NCT01888497|Antiemetics|antiemetics|mesh-ancestor
25684171|NCT01888497|Autonomic Agents|autonomic agents|mesh-ancestor
25684172|NCT01888497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25043486|NCT01254370|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25043487|NCT01254370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25043488|NCT01254136|Trastuzumab|trastuzumab|mesh-list
25043489|NCT01254136|Vinorelbine|vinorelbine|mesh-list
24970333|NCT03734302|Dopamine Agents|dopamine agents|mesh-ancestor
25043490|NCT01254136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25043491|NCT01254136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043492|NCT01254136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25043493|NCT01254136|Tubulin Modulators|tubulin modulators|mesh-ancestor
25043494|NCT01254136|Antimitotic Agents|antimitotic agents|mesh-ancestor
25286301|NCT02624596|Midazolam|midazolam|mesh-list
25286302|NCT02624596|Ketamine|ketamine|mesh-list
25286303|NCT02624596|Analgesics|analgesics|mesh-ancestor
25286304|NCT02624596|Sensory System Agents|sensory system agents|mesh-ancestor
25286305|NCT02624596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25286306|NCT02624596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286307|NCT02624596|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24876058|NCT03745352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25140818|NCT02961842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25140819|NCT02961842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140820|NCT02961842|Sensory System Agents|sensory system agents|mesh-ancestor
25140821|NCT02961842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25140822|NCT02961842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25140823|NCT02961842|Narcotics|narcotics|mesh-ancestor
25140824|NCT02961842|Analgesics|analgesics|mesh-ancestor
25140825|NCT02961842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25140826|NCT02961842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25140827|NCT02961842|Anesthetics, General|anesthetics, general|mesh-ancestor
25140828|NCT02961842|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25140829|NCT02961842|Sympathomimetics|sympathomimetics|mesh-ancestor
25140830|NCT02961842|Autonomic Agents|autonomic agents|mesh-ancestor
25140831|NCT02961842|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25140832|NCT02961842|Adrenergic Agents|adrenergic agents|mesh-ancestor
25140833|NCT02961842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25140834|NCT02961842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140835|NCT02962024|Morphine|morphine|mesh-list
25140836|NCT02962024|Bupivacaine|bupivacaine|mesh-list
25140837|NCT02962024|Anesthetics, Local|anesthetics, local|mesh-ancestor
25140838|NCT02962024|Anesthetics|anesthetics|mesh-ancestor
25140839|NCT02962024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25140840|NCT02962024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140841|NCT02962024|Sensory System Agents|sensory system agents|mesh-ancestor
25140842|NCT02962024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25140843|NCT02962024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25140844|NCT02962024|Narcotics|narcotics|mesh-ancestor
25140845|NCT02962024|Analgesics|analgesics|mesh-ancestor
25140846|NCT02962037|Melatonin|melatonin|mesh-list
25140847|NCT02962037|Antioxidants|antioxidants|mesh-ancestor
25140848|NCT02962037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140849|NCT02962037|Protective Agents|protective agents|mesh-ancestor
25140850|NCT02962037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102808|NCT03166397|Alkylating Agents|alkylating agents|mesh-ancestor
24469010|NCT00384280|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24876341|NCT03594123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24876342|NCT03594123|Dopamine Agonists|dopamine agonists|mesh-ancestor
25140852|NCT02961816|Pyridoxine|pyridoxine|mesh-list
25140853|NCT02961816|Gemcitabine|gemcitabine|mesh-list
25140854|NCT02961816|Dexamethasone|dexamethasone|mesh-list
25140855|NCT02961816|Rituximab|rituximab|mesh-list
25684173|NCT01888497|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25684174|NCT01888497|Histamine Antagonists|histamine antagonists|mesh-ancestor
25684175|NCT01888497|Histamine Agents|histamine agents|mesh-ancestor
25684176|NCT01888497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25684177|NCT01888497|Antipruritics|antipruritics|mesh-ancestor
25684178|NCT01888497|Dermatologic Agents|dermatologic agents|mesh-ancestor
25684179|NCT01888497|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25684180|NCT01888497|GABA Modulators|gaba modulators|mesh-ancestor
25684181|NCT01888497|GABA Agents|gaba agents|mesh-ancestor
25684182|NCT01888952|Prednisone|prednisone|mesh-list
25684183|NCT01888952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25684184|NCT01888952|Glucocorticoids|glucocorticoids|mesh-ancestor
25684185|NCT01888952|Hormones|hormones|mesh-ancestor
25684186|NCT01888952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25684187|NCT01888952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684188|NCT01888952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25140856|NCT02961816|Melphalan|melphalan|mesh-list
25140857|NCT02961816|Busulfan|busulfan|mesh-list
25140858|NCT02961816|Panobinostat|panobinostat|mesh-list
25140859|NCT02961816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25140860|NCT02961816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25140861|NCT02961816|Immunologic Factors|immunologic factors|mesh-ancestor
25140862|NCT02961816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140863|NCT02961816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25140864|NCT02961816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25140865|NCT02961816|Antiemetics|antiemetics|mesh-ancestor
25140866|NCT02961816|Autonomic Agents|autonomic agents|mesh-ancestor
25140867|NCT02961816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25140868|NCT02961816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25140870|NCT02961816|Hormones|hormones|mesh-ancestor
25140871|NCT02961816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25140872|NCT02961816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25140873|NCT02961816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25140874|NCT02961816|Antimetabolites|antimetabolites|mesh-ancestor
24455667|NCT00328458|Mitosis Modulators|mitosis modulators|mesh-ancestor
24806549|NCT02016417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24806550|NCT02016417|Immunologic Factors|immunologic factors|mesh-ancestor
24806551|NCT02016417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140875|NCT02961816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140876|NCT02961816|Antiviral Agents|antiviral agents|mesh-ancestor
25140877|NCT02961816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25140878|NCT02961816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25140879|NCT02961816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25140880|NCT02961816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25140881|NCT02961816|Alkylating Agents|alkylating agents|mesh-ancestor
25140882|NCT02961816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25140883|NCT02961816|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25140884|NCT02961816|Vitamin B Complex|vitamin b complex|mesh-ancestor
25140885|NCT02961816|Vitamins|vitamins|mesh-ancestor
25140888|NCT02961803|Vitamin B Complex|vitamin b complex|mesh-ancestor
24454570|NCT03878524|Trastuzumab|trastuzumab|mesh-list
25140890|NCT02961803|Micronutrients|micronutrients|mesh-ancestor
25140923|NCT02961361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25140924|NCT02961361|Analgesics|analgesics|mesh-ancestor
25140925|NCT02961361|Sensory System Agents|sensory system agents|mesh-ancestor
25140926|NCT02961361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25140927|NCT02961361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25140928|NCT02961361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25140929|NCT02961361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25140930|NCT02961361|Adrenergic Agents|adrenergic agents|mesh-ancestor
25140931|NCT02961361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25140932|NCT02961361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140933|NCT02961361|Anesthetics, Local|anesthetics, local|mesh-ancestor
25140934|NCT02961361|Anesthetics|anesthetics|mesh-ancestor
25140935|NCT02961101|Decitabine|decitabine|mesh-list
25140936|NCT02961101|Antibodies|antibodies|mesh-list
25140937|NCT02961101|Immunologic Factors|immunologic factors|mesh-ancestor
25140938|NCT02961101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140939|NCT02961101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25140940|NCT02961101|Antimetabolites|antimetabolites|mesh-ancestor
25140941|NCT02961101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140942|NCT02961101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25140943|NCT02961101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25140944|NCT02961075|Anesthetics|anesthetics|mesh-list
25140945|NCT02961075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24806607|NCT02016807|Sucralfate|sucralfate|mesh-list
24806654|NCT02017314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24806655|NCT02017340|Nilvadipine|nilvadipine|mesh-list
24806656|NCT02017340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24806657|NCT02017340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25140946|NCT02961075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140947|NCT02960880|Rivaroxaban|rivaroxaban|mesh-list
25140948|NCT02960880|Phenprocoumon|phenprocoumon|mesh-list
25140949|NCT02960880|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25046862|NCT00835276|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25046863|NCT00835276|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25046864|NCT00835276|Histamine Antagonists|histamine antagonists|mesh-ancestor
25046865|NCT00835276|Histamine Agents|histamine agents|mesh-ancestor
25046866|NCT00835276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25046867|NCT00835276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046868|NCT00835276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046869|NCT00835263|Lamotrigine|lamotrigine|mesh-list
25046870|NCT00835263|Anticonvulsants|anticonvulsants|mesh-ancestor
25046871|NCT00835263|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25043675|NCT01225640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25043676|NCT01225640|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25046872|NCT00835263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25046873|NCT00835263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046874|NCT00835263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25046875|NCT00835263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046876|NCT00835263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25046877|NCT00835263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25046878|NCT00835263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25046879|NCT00835263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25046880|NCT00835263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25046881|NCT00835211|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25046883|NCT00835211|Coagulants|coagulants|mesh-ancestor
25046884|NCT00835211|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25046885|NCT00835211|Natriuretic Agents|natriuretic agents|mesh-ancestor
25046886|NCT00835211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046887|NCT00835172|Glimepiride|glimepiride|mesh-list
25046888|NCT00835172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25046889|NCT00835172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25046890|NCT00835172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046891|NCT00835172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25046892|NCT00835172|Immunologic Factors|immunologic factors|mesh-ancestor
25046893|NCT00835146|Ribavirin|ribavirin|mesh-list
25046894|NCT00835146|Antimetabolites|antimetabolites|mesh-ancestor
25046895|NCT00835146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046896|NCT00835146|Antiviral Agents|antiviral agents|mesh-ancestor
24815414|NCT02070159|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24815415|NCT02070159|Purinergic Agents|purinergic agents|mesh-ancestor
24815416|NCT02070159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24815417|NCT02070159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815418|NCT02070159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815419|NCT02070198|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24815420|NCT02070198|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24815421|NCT02070198|Hormones|hormones|mesh-ancestor
24815422|NCT02070198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25046897|NCT00835146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25046898|NCT00835081|Cefadroxil|cefadroxil|mesh-list
25046899|NCT00835081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25046900|NCT00835081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25046901|NCT00835042|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25046902|NCT00835042|Moexipril|moexipril|mesh-list
25046903|NCT00835042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25046904|NCT00835042|Diuretics|diuretics|mesh-ancestor
25046905|NCT00835042|Natriuretic Agents|natriuretic agents|mesh-ancestor
25046906|NCT00835042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046907|NCT00835042|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25046908|NCT00835042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25046909|NCT00835042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046910|NCT00835042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25046911|NCT00835042|Protease Inhibitors|protease inhibitors|mesh-ancestor
25046912|NCT00835042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046913|NCT00834990|Valproic Acid|valproic acid|mesh-list
25046914|NCT00834990|Anticonvulsants|anticonvulsants|mesh-ancestor
25046915|NCT00834990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046916|NCT00834990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140950|NCT02960880|Antithrombins|antithrombins|mesh-ancestor
25140951|NCT02960880|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25140952|NCT02960880|Protease Inhibitors|protease inhibitors|mesh-ancestor
25140962|NCT02960906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815423|NCT02070198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815424|NCT02070198|Luteolytic Agents|luteolytic agents|mesh-ancestor
24815425|NCT02070198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25140964|NCT02960906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25140965|NCT02960906|Growth Substances|growth substances|mesh-ancestor
25140966|NCT02960906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140967|NCT02960906|Growth Inhibitors|growth inhibitors|mesh-ancestor
25140968|NCT02960906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25140969|NCT02960906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25140970|NCT02960919|Amoxicillin|amoxicillin|mesh-list
25684189|NCT01888952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25684190|NCT01889069|Prednisone|prednisone|mesh-list
25684191|NCT01889069|Cyclophosphamide|cyclophosphamide|mesh-list
25043731|NCT01220947|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25043733|NCT01220947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043734|NCT01220947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043735|NCT01220947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25140971|NCT02960919|Gentamicins|gentamicins|mesh-list
25140972|NCT02960919|Penicillins|penicillins|mesh-list
25140973|NCT02960919|Ampicillin|ampicillin|mesh-list
25140974|NCT02960919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25140975|NCT02960919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25140976|NCT02960919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25140977|NCT02960919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25140978|NCT02960919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140979|NCT02960815|Imiquimod|imiquimod|mesh-list
25140980|NCT02960815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25140981|NCT02960815|Immunologic Factors|immunologic factors|mesh-ancestor
25140982|NCT02960815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140983|NCT02960815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25140984|NCT02960815|Interferon Inducers|interferon inducers|mesh-ancestor
25140985|NCT02960503|Azithromycin|azithromycin|mesh-list
25140986|NCT02960503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25140987|NCT02960503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25140988|NCT02960412|Furosemide|furosemide|mesh-list
25140989|NCT02960412|Diuretics|diuretics|mesh-ancestor
25140991|NCT02960412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140992|NCT02960412|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25140993|NCT02960412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25140994|NCT02960412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140995|NCT02960711|Metformin|metformin|mesh-list
25140996|NCT02960711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25140997|NCT02960711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24876510|NCT03484819|Nivolumab|nivolumab|mesh-list
24876521|NCT03463876|Apatinib|apatinib|mesh-list
24876547|NCT03413202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140998|NCT02960048|Salicylic Acid|salicylic acid|mesh-list
25140999|NCT02960048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25141000|NCT02960048|Antifungal Agents|antifungal agents|mesh-ancestor
25141001|NCT02960048|Keratolytic Agents|keratolytic agents|mesh-ancestor
25141002|NCT02960048|Dermatologic Agents|dermatologic agents|mesh-ancestor
25141003|NCT02960126|Aspirin|aspirin|mesh-list
25141004|NCT02960126|Clopidogrel|clopidogrel|mesh-list
25141005|NCT02960126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25141006|NCT02960126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25141007|NCT02960126|Analgesics|analgesics|mesh-ancestor
25141009|NCT02960126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25141010|NCT02960126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141012|NCT02960126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25141013|NCT02960126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25141014|NCT02960126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25141022|NCT02960126|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25141023|NCT02960126|Purinergic Agents|purinergic agents|mesh-ancestor
25141024|NCT02960126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25141025|NCT02960113|Scopolamine|scopolamine|mesh-list
25141026|NCT02960113|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25141027|NCT02960113|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25141029|NCT02960113|Autonomic Agents|autonomic agents|mesh-ancestor
25141030|NCT02960113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25141031|NCT02960113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141032|NCT02960113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25141033|NCT02960113|Mydriatics|mydriatics|mesh-ancestor
24806767|NCT02018094|Povidone|povidone|mesh-list
25141034|NCT02960113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25141036|NCT02960113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25141037|NCT02960113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141038|NCT02960113|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25141039|NCT02960113|Parasympatholytics|parasympatholytics|mesh-ancestor
25141040|NCT02959957|Cefotaxime|cefotaxime|mesh-list
25141041|NCT02959957|Cefoxitin|cefoxitin|mesh-list
25141042|NCT02959957|Temocillin|temocillin|mesh-list
25141043|NCT02959957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25684192|NCT01889069|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25684193|NCT01889069|Rituximab|rituximab|mesh-list
25684194|NCT01889069|Doxorubicin|doxorubicin|mesh-list
25684195|NCT01889069|Vincristine|vincristine|mesh-list
25684196|NCT01889069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25141044|NCT02959957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25141045|NCT02960035|Etanercept|etanercept|mesh-list
25684197|NCT01889069|Immunologic Factors|immunologic factors|mesh-ancestor
25141046|NCT02960035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25141047|NCT02960035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25141049|NCT02960035|Sensory System Agents|sensory system agents|mesh-ancestor
25141050|NCT02960035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25141051|NCT02960035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141052|NCT02960035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25141053|NCT02960035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25141054|NCT02960035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24876857|NCT03148275|Trametinib|trametinib|mesh-list
24876858|NCT03148275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24876860|NCT03148275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24876926|NCT03057613|Pembrolizumab|pembrolizumab|mesh-list
24876927|NCT03057613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24876928|NCT03057613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24877080|NCT02965716|Pembrolizumab|pembrolizumab|mesh-list
25141069|NCT02959905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141070|NCT02959905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25141071|NCT02959905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25141072|NCT02959905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25141073|NCT02959905|Antimetabolites|antimetabolites|mesh-ancestor
25141074|NCT02959905|Antiviral Agents|antiviral agents|mesh-ancestor
25141075|NCT02959905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25141076|NCT02959580|Hydrocortisone|hydrocortisone|mesh-list
25141077|NCT02959580|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
24759757|NCT01754649|Oxytocics|oxytocics|mesh-ancestor
24877082|NCT02965716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24469194|NCT00384878|Cetuximab|cetuximab|mesh-list
24877103|NCT02954510|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24815508|NCT02070653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815509|NCT02070653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815510|NCT02070679|Vitamin E|vitamin e|mesh-list
24815511|NCT02070679|Tocopherols|tocopherols|mesh-list
24815512|NCT02070679|alpha-Tocopherol|alpha-tocopherol|mesh-list
24815513|NCT02070679|Vitamins|vitamins|mesh-ancestor
24815514|NCT02070679|Micronutrients|micronutrients|mesh-ancestor
24877326|NCT02830594|Pembrolizumab|pembrolizumab|mesh-list
24877327|NCT02830594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24877328|NCT02830594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24877329|NCT02819635|Upadacitinib|upadacitinib|mesh-list
24877330|NCT02819635|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25141078|NCT02959580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25141082|NCT02959762|Vitamin K 2|vitamin k 2|mesh-list
25141083|NCT02959762|Vitamin MK 7|vitamin mk 7|mesh-list
25141084|NCT02959762|Micronutrients|micronutrients|mesh-ancestor
25141085|NCT02959762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141086|NCT02959762|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25141087|NCT02959762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25141088|NCT02959762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141089|NCT02959762|Hemostatics|hemostatics|mesh-ancestor
25141090|NCT02959762|Coagulants|coagulants|mesh-ancestor
25141091|NCT02959749|Bevacizumab|bevacizumab|mesh-list
25141092|NCT02959749|Docetaxel|docetaxel|mesh-list
25141093|NCT02959749|Osimertinib|osimertinib|mesh-list
25141094|NCT02959749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25141095|NCT02959749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25141096|NCT02959749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25141097|NCT02959749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25141098|NCT02959749|Growth Substances|growth substances|mesh-ancestor
25141099|NCT02959749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141130|NCT02959606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25141131|NCT02959606|Purinergic Agents|purinergic agents|mesh-ancestor
25141132|NCT02959606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25141133|NCT02959606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141134|NCT02959606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141135|NCT02959606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25141136|NCT02959606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24877331|NCT02819635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24877332|NCT02819635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24877334|NCT02819635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25141137|NCT02959606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25043878|NCT01192035|Antiviral Agents|antiviral agents|mesh-ancestor
25286521|NCT04562324|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
25286522|NCT04562324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25286523|NCT04562324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25286524|NCT04562324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25286526|NCT04537923|Insulin|insulin|mesh-list
25141140|NCT02959476|Anesthetics, Local|anesthetics, local|mesh-ancestor
25141141|NCT02959476|Anesthetics|anesthetics|mesh-ancestor
25141142|NCT02959476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25141143|NCT02959476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141144|NCT02959476|Sensory System Agents|sensory system agents|mesh-ancestor
25141145|NCT02959476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25141146|NCT02959255|Esomeprazole|esomeprazole|mesh-list
25141147|NCT02959255|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25141148|NCT02959255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25141149|NCT02959255|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25141150|NCT02959255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25141151|NCT02959255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141152|NCT02959229|Lactoferrin|lactoferrin|mesh-list
25141153|NCT02959229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25141154|NCT02959359|Ribavirin|ribavirin|mesh-list
25141155|NCT02959359|Sofosbuvir|sofosbuvir|mesh-list
25141156|NCT02959359|Ledipasvir|ledipasvir|mesh-list
25141157|NCT02959359|Antimetabolites|antimetabolites|mesh-ancestor
25141158|NCT02959359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141159|NCT02959359|Antiviral Agents|antiviral agents|mesh-ancestor
25079534|NCT03347344|Riluzole|riluzole|mesh-list
24877357|NCT02798471|Heparin|heparin|mesh-list
24877358|NCT02798471|Enoxaparin|enoxaparin|mesh-list
24877359|NCT02798471|Warfarin|warfarin|mesh-list
24877360|NCT02798471|Edoxaban|edoxaban|mesh-list
24815571|NCT02071069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24815572|NCT02071160|Melatonin|melatonin|mesh-list
24815573|NCT02071160|Antioxidants|antioxidants|mesh-ancestor
24815574|NCT02071160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815575|NCT02071160|Protective Agents|protective agents|mesh-ancestor
24815576|NCT02071160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815577|NCT02071160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24815578|NCT02071212|Ticagrelor|ticagrelor|mesh-list
24877766|NCT02460588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24877767|NCT02460588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25141160|NCT02959359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25141161|NCT02959411|Tolvaptan|tolvaptan|mesh-list
25046917|NCT00834990|GABA Agents|gaba agents|mesh-ancestor
25046918|NCT00834990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25046919|NCT00834990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046920|NCT00834990|Antimanic Agents|antimanic agents|mesh-ancestor
25046921|NCT00834990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25046922|NCT00834990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25046923|NCT00834990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25046925|NCT00834977|Benazepril|benazepril|mesh-list
25046926|NCT00834977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25046927|NCT00834977|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25046928|NCT00834977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25046929|NCT00834977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046930|NCT00834977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25046931|NCT00834977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046932|NCT00834977|Vasodilator Agents|vasodilator agents|mesh-ancestor
25046933|NCT00834977|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25046934|NCT00834977|Protease Inhibitors|protease inhibitors|mesh-ancestor
25046935|NCT00834977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046936|NCT00834964|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25046937|NCT00834964|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25046938|NCT00834964|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25684198|NCT01889069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684199|NCT01889069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25684200|NCT01889069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25684201|NCT01889069|Alkylating Agents|alkylating agents|mesh-ancestor
25684202|NCT01889069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684203|NCT01889069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25684204|NCT01889069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25684205|NCT01889069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25043945|NCT01181622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25043946|NCT01180634|Levofloxacin|levofloxacin|mesh-list
25043947|NCT01180634|Ofloxacin|ofloxacin|mesh-list
25043948|NCT01180634|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25043949|NCT01180634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25043950|NCT01180634|Renal Agents|renal agents|mesh-ancestor
25043951|NCT01180634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25043952|NCT01180634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25043953|NCT01180634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25043954|NCT01180634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043955|NCT01180634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043956|NCT01180634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043957|NCT01180634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25043958|NCT01180634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25043959|NCT01175785|Cyclosporine|cyclosporine|mesh-list
25043960|NCT01175785|Mycophenolic Acid|mycophenolic acid|mesh-list
25286575|NCT04406415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25286577|NCT04406415|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25046939|NCT00834964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25046940|NCT00834964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046941|NCT00834964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25046942|NCT00834964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046943|NCT00834964|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25046944|NCT00834964|Antidepressive Agents|antidepressive agents|mesh-ancestor
25046945|NCT00834964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25046947|NCT00834873|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25046948|NCT00834873|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25046949|NCT00834873|Adrenergic Agents|adrenergic agents|mesh-ancestor
25046950|NCT00834873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24815601|NCT02071303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24815602|NCT02071303|Narcotics|narcotics|mesh-ancestor
25046951|NCT00834873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046952|NCT00834873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046954|NCT00834873|Antioxidants|antioxidants|mesh-ancestor
25046955|NCT00834873|Protective Agents|protective agents|mesh-ancestor
25046956|NCT00834873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25046957|NCT00834873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25046958|NCT00834873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25046959|NCT00834873|Vasodilator Agents|vasodilator agents|mesh-ancestor
25046960|NCT00834873|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25046961|NCT00834873|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25046962|NCT00834795|Carvedilol|carvedilol|mesh-list
25046963|NCT00834795|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25046964|NCT00834795|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25046965|NCT00834795|Adrenergic Agents|adrenergic agents|mesh-ancestor
25046966|NCT00834795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25046967|NCT00834795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046968|NCT00834795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046969|NCT00834795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25046970|NCT00834795|Antioxidants|antioxidants|mesh-ancestor
25046971|NCT00834795|Protective Agents|protective agents|mesh-ancestor
25046972|NCT00834795|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25046973|NCT00834795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25046974|NCT00834795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25046975|NCT00834795|Vasodilator Agents|vasodilator agents|mesh-ancestor
25684206|NCT01889069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25684207|NCT01889069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25684208|NCT01889069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25684209|NCT01889069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25684210|NCT01889069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25684211|NCT01889069|Glucocorticoids|glucocorticoids|mesh-ancestor
25684212|NCT01889069|Hormones|hormones|mesh-ancestor
25684213|NCT01889069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25684214|NCT01889069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25684215|NCT01889069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25684216|NCT01889069|Tubulin Modulators|tubulin modulators|mesh-ancestor
25684217|NCT01889069|Antimitotic Agents|antimitotic agents|mesh-ancestor
25684218|NCT01889069|Mitosis Modulators|mitosis modulators|mesh-ancestor
25684219|NCT01889602|Topiramate|topiramate|mesh-list
25684220|NCT01889602|Lorazepam|lorazepam|mesh-list
25684221|NCT01889602|Anticonvulsants|anticonvulsants|mesh-ancestor
25684222|NCT01889602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25684223|NCT01889602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046976|NCT00834795|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25046977|NCT00834795|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24759808|NCT01754883|Lithium Carbonate|lithium carbonate|mesh-list
24815603|NCT02071303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24815604|NCT02071316|Esomeprazole|esomeprazole|mesh-list
24815605|NCT02071316|Tranexamic Acid|tranexamic acid|mesh-list
24806976|NCT02019095|Chelating Agents|chelating agents|mesh-ancestor
24815606|NCT02071316|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24815607|NCT02071316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24815608|NCT02071316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24877791|NCT02417103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24877792|NCT02401035|Pantoprazole|pantoprazole|mesh-list
24877793|NCT02401035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24877794|NCT02401035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24877795|NCT02401035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24877796|NCT02401035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25141167|NCT02959125|Micronutrients|micronutrients|mesh-list
25141168|NCT02959125|Trace Elements|trace elements|mesh-list
25141169|NCT02959125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141170|NCT02959112|Indomethacin|indomethacin|mesh-list
25141171|NCT02959112|Epinephrine|epinephrine|mesh-list
25141172|NCT02959112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25141173|NCT02959112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25141174|NCT02959112|Adrenergic Agents|adrenergic agents|mesh-ancestor
25141175|NCT02959112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25141176|NCT02959112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141177|NCT02959112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141178|NCT02959112|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25141179|NCT02959112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25141180|NCT02959112|Autonomic Agents|autonomic agents|mesh-ancestor
25141181|NCT02959112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25141182|NCT02959112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25141183|NCT02959112|Respiratory System Agents|respiratory system agents|mesh-ancestor
25141184|NCT02959112|Mydriatics|mydriatics|mesh-ancestor
25141185|NCT02959112|Sympathomimetics|sympathomimetics|mesh-ancestor
25141186|NCT02959112|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24759825|NCT01754974|Ribavirin|ribavirin|mesh-list
24877797|NCT02401035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24877809|NCT02382549|Vaccines|vaccines|mesh-list
24877810|NCT02382549|Immunologic Factors|immunologic factors|mesh-ancestor
24877811|NCT02382549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806977|NCT02019095|Sequestering Agents|sequestering agents|mesh-ancestor
25141187|NCT02959112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25141188|NCT02959112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25141190|NCT02959112|Sensory System Agents|sensory system agents|mesh-ancestor
25141191|NCT02959112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25141192|NCT02959112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25141193|NCT02959112|Gout Suppressants|gout suppressants|mesh-ancestor
25141194|NCT02959112|Tocolytic Agents|tocolytic agents|mesh-ancestor
25141195|NCT02959112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25141196|NCT02959112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25141197|NCT02959112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25141199|NCT02959060|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25141200|NCT02959060|Antitubercular Agents|antitubercular agents|mesh-ancestor
25141201|NCT02959060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25141202|NCT02959060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25141203|NCT02959060|Leprostatic Agents|leprostatic agents|mesh-ancestor
25141204|NCT02959060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25141205|NCT02959060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25141206|NCT02959060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141207|NCT02959060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25141208|NCT02959060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25141209|NCT02959060|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25141210|NCT02959060|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25141211|NCT02959060|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25141216|NCT02958917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25141217|NCT02958917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684224|NCT01889602|Antiemetics|antiemetics|mesh-ancestor
25286659|NCT03789097|Poly ICLC|poly iclc|mesh-list
25286660|NCT03789097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25286661|NCT03789097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286662|NCT03789097|Interferon Inducers|interferon inducers|mesh-ancestor
25286663|NCT03789097|Immunologic Factors|immunologic factors|mesh-ancestor
25286664|NCT03789097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286675|NCT03718793|Nitric Oxide|nitric oxide|mesh-list
25286676|NCT03718793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25286677|NCT03718793|Autonomic Agents|autonomic agents|mesh-ancestor
25286678|NCT03718793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25141218|NCT02958917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25141219|NCT02958917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25141220|NCT02958917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25141221|NCT02958917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25141222|NCT02958917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25141223|NCT02958852|Letrozole|letrozole|mesh-list
25141224|NCT02958852|Fulvestrant|fulvestrant|mesh-list
25141225|NCT02958852|Atorvastatin|atorvastatin|mesh-list
25141226|NCT02958852|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25141227|NCT02958852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25141228|NCT02958852|Antimetabolites|antimetabolites|mesh-ancestor
25141229|NCT02958852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141230|NCT02958852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25141231|NCT02958852|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25141232|NCT02958852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25141233|NCT02958852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25141235|NCT02958852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25141236|NCT02958852|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25141238|NCT02958852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25141239|NCT02958852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141240|NCT02958852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25141241|NCT02958852|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25141242|NCT02958878|Tamsulosin|tamsulosin|mesh-list
24878335|NCT01915810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815658|NCT02071433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141243|NCT02958878|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25141244|NCT02958878|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25141245|NCT02958878|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25141247|NCT02958878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25141248|NCT02958878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141249|NCT02958878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141250|NCT02958878|Urological Agents|urological agents|mesh-ancestor
25141251|NCT02958800|Olanzapine|olanzapine|mesh-list
25141252|NCT02958800|Risperidone|risperidone|mesh-list
25141253|NCT02958800|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25141254|NCT02958800|Antipsychotic Agents|antipsychotic agents|mesh-list
25141255|NCT02958800|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25141260|NCT02958800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25141261|NCT02958800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25141262|NCT02958800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25141263|NCT02958800|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25141264|NCT02958800|Dopamine Agents|dopamine agents|mesh-ancestor
25141265|NCT02958800|Antiemetics|antiemetics|mesh-ancestor
25684225|NCT01889602|Autonomic Agents|autonomic agents|mesh-ancestor
25684226|NCT01889602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25684227|NCT01889602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25684228|NCT01889602|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25684229|NCT01889602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25684230|NCT01889602|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25684231|NCT01889602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25684232|NCT01889602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25684233|NCT01889602|GABA Modulators|gaba modulators|mesh-ancestor
25684234|NCT01889602|GABA Agents|gaba agents|mesh-ancestor
25286710|NCT03512223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25286711|NCT03512223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286712|NCT03512223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25286713|NCT03512223|Glucocorticoids|glucocorticoids|mesh-ancestor
25286714|NCT03512223|Hormones|hormones|mesh-ancestor
25286715|NCT03512223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25286716|NCT03512223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25286717|NCT03512223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286718|NCT03441139|Analgesics|analgesics|mesh-list
25286719|NCT03441139|Sensory System Agents|sensory system agents|mesh-ancestor
25286720|NCT03441139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25286721|NCT03441139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469456|NCT00385957|Lamivudine|lamivudine|mesh-list
24878659|NCT01301807|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24878660|NCT01301807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24878661|NCT01301807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878662|NCT01283997|Minocycline|minocycline|mesh-list
24878663|NCT01283997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24878664|NCT01283997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24878666|NCT01281176|Carboplatin|carboplatin|mesh-list
24878687|NCT01160211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24878688|NCT01160211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25141266|NCT02958800|Autonomic Agents|autonomic agents|mesh-ancestor
25141267|NCT02958800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25141268|NCT02958800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25141269|NCT02958800|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25141270|NCT02958800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25141271|NCT02958800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25141272|NCT02958800|Antidepressive Agents|antidepressive agents|mesh-ancestor
25141273|NCT02958761|Hyaluronic Acid|hyaluronic acid|mesh-list
24807092|NCT02019797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807093|NCT02019810|Dobutamine|dobutamine|mesh-list
24807094|NCT02019810|Norepinephrine|norepinephrine|mesh-list
25141274|NCT02958761|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25141275|NCT02958761|Immunologic Factors|immunologic factors|mesh-ancestor
25141276|NCT02958761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141277|NCT02958761|Viscosupplements|viscosupplements|mesh-ancestor
25141278|NCT02958761|Protective Agents|protective agents|mesh-ancestor
25141279|NCT02958566|Acetaminophen|acetaminophen|mesh-list
25141281|NCT02958566|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25141285|NCT02958566|Morphine|morphine|mesh-list
25141286|NCT02958566|Gabapentin|gabapentin|mesh-list
25141287|NCT02958566|Tramadol|tramadol|mesh-list
25141288|NCT02958566|Methadone|methadone|mesh-list
25141289|NCT02958566|Hydrocodone|hydrocodone|mesh-list
25141290|NCT02958566|Hydromorphone|hydromorphone|mesh-list
25141291|NCT02958566|Orphenadrine|orphenadrine|mesh-list
25141292|NCT02958566|Bupivacaine|bupivacaine|mesh-list
25141293|NCT02958566|Anesthetics, Local|anesthetics, local|mesh-ancestor
25141294|NCT02958566|Anesthetics|anesthetics|mesh-ancestor
25141295|NCT02958566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25141296|NCT02958566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141297|NCT02958566|Sensory System Agents|sensory system agents|mesh-ancestor
25141298|NCT02958566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25141299|NCT02958566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25141300|NCT02958566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25141301|NCT02958566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25141302|NCT02958566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25684235|NCT01889602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25684236|NCT01889602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684237|NCT01889667|Insulin|insulin|mesh-list
25684238|NCT01889667|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25684239|NCT01889667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25684240|NCT01889667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684241|NCT01889797|Rituximab|rituximab|mesh-list
25684242|NCT01889797|Obinutuzumab|obinutuzumab|mesh-list
25684243|NCT01889797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25684244|NCT01889797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25684245|NCT01889797|Immunologic Factors|immunologic factors|mesh-ancestor
25684246|NCT01889797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759971|NCT01755572|Hormones|hormones|mesh-ancestor
25141316|NCT02958566|Anticonvulsants|anticonvulsants|mesh-ancestor
25044481|NCT01089790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25044483|NCT01089790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044484|NCT01089790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044485|NCT01087151|Rituximab|rituximab|mesh-list
25044486|NCT01087151|Navitoclax|navitoclax|mesh-list
25044487|NCT01087151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25286755|NCT03150368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286756|NCT03147378|Docetaxel|docetaxel|mesh-list
25286757|NCT03147378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286762|NCT03136640|Docetaxel|docetaxel|mesh-list
25141317|NCT02958566|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25141318|NCT02958566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25141319|NCT02958566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25141320|NCT02958566|Antimanic Agents|antimanic agents|mesh-ancestor
25141321|NCT02958566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25141322|NCT02958566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25141323|NCT02958566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25141324|NCT02958566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25141325|NCT02958566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25141326|NCT02958566|Antitussive Agents|antitussive agents|mesh-ancestor
25141327|NCT02958566|Respiratory System Agents|respiratory system agents|mesh-ancestor
25141328|NCT02958566|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25141329|NCT02958566|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24663945|NCT01304212|Mydriatics|mydriatics|mesh-ancestor
24476364|NCT00414336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426317|NCT00235794|Sirolimus|sirolimus|mesh-list
25141331|NCT02958566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25141332|NCT02958566|Parasympatholytics|parasympatholytics|mesh-ancestor
25141333|NCT02958566|Autonomic Agents|autonomic agents|mesh-ancestor
25141334|NCT02958566|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25141335|NCT02958566|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25141336|NCT02958566|Cholinergic Agents|cholinergic agents|mesh-ancestor
25141337|NCT02958566|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
25141338|NCT02958566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25141339|NCT02958501|Cholecalciferol|cholecalciferol|mesh-list
25141340|NCT02958501|Vitamin D|vitamin d|mesh-list
25141341|NCT02958501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25141342|NCT02958501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24878984|NCT05183984|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24878985|NCT05183984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24878986|NCT05183984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878987|NCT05183880|Vitamins|vitamins|mesh-list
24878988|NCT05183880|Ascorbic Acid|ascorbic acid|mesh-list
24878989|NCT05183880|Micronutrients|micronutrients|mesh-ancestor
24878990|NCT05183880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879176|NCT04969861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24476408|NCT00414921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476410|NCT00414921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24476412|NCT00414921|Sensory System Agents|sensory system agents|mesh-ancestor
24664019|NCT01304784|Paclitaxel|paclitaxel|mesh-list
24476453|NCT00415090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24476454|NCT00415090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24476455|NCT00415090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24476456|NCT00415090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24476457|NCT00415103|Aprepitant|aprepitant|mesh-list
24476458|NCT00415103|Palonosetron|palonosetron|mesh-list
24476459|NCT00415103|Granisetron|granisetron|mesh-list
25684247|NCT01889797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25684248|NCT01889862|Dextrans|dextrans|mesh-list
25684249|NCT01889862|Anticoagulants|anticoagulants|mesh-ancestor
25684250|NCT01889862|Plasma Substitutes|plasma substitutes|mesh-ancestor
25684251|NCT01889862|Blood Substitutes|blood substitutes|mesh-ancestor
25684252|NCT01890109|Erenumab|erenumab|mesh-list
25684253|NCT01890109|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25684254|NCT01890109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684255|NCT01890109|Analgesics|analgesics|mesh-ancestor
25684256|NCT01890109|Sensory System Agents|sensory system agents|mesh-ancestor
25684257|NCT01890109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25286808|NCT02484716|Timolol|timolol|mesh-list
24879184|NCT04963530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24879185|NCT04963530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24879272|NCT04921943|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24879273|NCT04921943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24879275|NCT04920032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24879276|NCT04920032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24879277|NCT04920032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24879278|NCT04920032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141348|NCT02958631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25141349|NCT02958631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25141350|NCT02958631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25141351|NCT02958631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141352|NCT02958423|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
25141353|NCT02958423|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25141354|NCT02958423|Serotonin Agents|serotonin agents|mesh-ancestor
25141355|NCT02958423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25141356|NCT02958423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141357|NCT02958423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141358|NCT02958059|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25141359|NCT02958059|Cefoxitin|cefoxitin|mesh-list
25141360|NCT02958059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25141361|NCT02958046|Domperidone|domperidone|mesh-list
25141362|NCT02958046|Lansoprazole|lansoprazole|mesh-list
24879368|NCT04796454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24879369|NCT04796454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24879370|NCT04796454|Antimetabolites|antimetabolites|mesh-ancestor
24879371|NCT04796454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879372|NCT04796454|Antiviral Agents|antiviral agents|mesh-ancestor
24879373|NCT04796454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24879374|NCT04796454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24807101|NCT02019810|Sympathomimetics|sympathomimetics|mesh-ancestor
24807102|NCT02019810|Autonomic Agents|autonomic agents|mesh-ancestor
24807105|NCT02019810|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24807106|NCT02019810|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24664088|NCT01304901|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24664089|NCT01304901|Hormone Antagonists|hormone antagonists|mesh-ancestor
24664090|NCT01304901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24664091|NCT01304901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664092|NCT01304901|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24879375|NCT04796454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24815825|NCT02072213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24815826|NCT02072213|Adrenergic Agents|adrenergic agents|mesh-ancestor
24815827|NCT02072213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24701786|NCT01460979|Antifungal Agents|antifungal agents|mesh-ancestor
24879546|NCT04670068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879547|NCT04670068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24879548|NCT04670068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24879549|NCT04670068|Alkylating Agents|alkylating agents|mesh-ancestor
24879550|NCT04670068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879551|NCT04670068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24879552|NCT04670068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24879564|NCT04664361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879565|NCT04664361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24879566|NCT04664361|Vasodilator Agents|vasodilator agents|mesh-ancestor
25141363|NCT02958046|Dexlansoprazole|dexlansoprazole|mesh-list
25141364|NCT02958046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25141367|NCT02958046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25141368|NCT02958046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141369|NCT02958046|Antiemetics|antiemetics|mesh-ancestor
25684258|NCT01890109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684259|NCT01890122|Metformin|metformin|mesh-list
25684260|NCT01890122|Alogliptin|alogliptin|mesh-list
25684261|NCT01890122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25684262|NCT01890122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684263|NCT01890122|Incretins|incretins|mesh-ancestor
25684264|NCT01890122|Hormones|hormones|mesh-ancestor
25141371|NCT02958046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25141372|NCT02958046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141373|NCT02958046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25141374|NCT02958046|Dopamine Agents|dopamine agents|mesh-ancestor
25141375|NCT02958046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25141376|NCT02957994|Tenofovir|tenofovir|mesh-list
25141377|NCT02957994|Antiviral Agents|antiviral agents|mesh-ancestor
25141378|NCT02957994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25141379|NCT02957994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25141380|NCT02957994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25141381|NCT02957994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25141382|NCT02957994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141383|NCT02957994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25141384|NCT02957994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24476527|NCT00415402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25141385|NCT02958111|Capecitabine|capecitabine|mesh-list
24965576|NCT03775707|Antibodies|antibodies|mesh-list
24879567|NCT04660240|Sirolimus|sirolimus|mesh-list
24879568|NCT04660240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24879569|NCT04660240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24879570|NCT04660240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24879571|NCT04660240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24879597|NCT04640376|Analgesics|analgesics|mesh-ancestor
24879691|NCT04530656|Vaccines|vaccines|mesh-list
24815846|NCT02072278|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24815847|NCT02072278|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25141386|NCT02958111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25141388|NCT02958111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141389|NCT02958111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25141390|NCT02958163|Doxorubicin|doxorubicin|mesh-list
25141391|NCT02958163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25141392|NCT02958163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25141393|NCT02958163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25141394|NCT02958163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25141395|NCT02958163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25141396|NCT02958163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141397|NCT02958215|Phenylephrine|phenylephrine|mesh-list
25141398|NCT02958215|Oxymetazoline|oxymetazoline|mesh-list
25141399|NCT02958215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25141400|NCT02958215|Mydriatics|mydriatics|mesh-ancestor
25141401|NCT02958215|Autonomic Agents|autonomic agents|mesh-ancestor
24760049|NCT01756118|Dactolisib|dactolisib|mesh-list
24807114|NCT02019875|Clarithromycin|clarithromycin|mesh-list
24807115|NCT02019875|Rifampin|rifampin|mesh-list
24586778|NCT00892190|Dasatinib|dasatinib|mesh-list
24476544|NCT00415701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24664151|NCT01305395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24879775|NCT04439799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24879776|NCT04439799|Anabolic Agents|anabolic agents|mesh-ancestor
24879780|NCT04422652|Bupropion|bupropion|mesh-list
24879853|NCT04360629|Hemostatics|hemostatics|mesh-ancestor
24879854|NCT04360629|Coagulants|coagulants|mesh-ancestor
24879855|NCT04360421|Bupivacaine|bupivacaine|mesh-list
24879856|NCT04360421|Anesthetics, Local|anesthetics, local|mesh-ancestor
24879857|NCT04360421|Anesthetics|anesthetics|mesh-ancestor
24879858|NCT04360421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24879859|NCT04360421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879860|NCT04360421|Sensory System Agents|sensory system agents|mesh-ancestor
24879861|NCT04360421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24702117|NCT01464099|Insulin|insulin|mesh-list
24879862|NCT04339270|Azithromycin|azithromycin|mesh-list
24879863|NCT04339270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24879864|NCT04339270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24815901|NCT02072512|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24611713|NCT01010425|Hormones|hormones|mesh-list
24815902|NCT02072512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24815903|NCT02072512|Hormone Antagonists|hormone antagonists|mesh-ancestor
24815904|NCT02072512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24815905|NCT02072512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880059|NCT04145518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24880105|NCT04100135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24880106|NCT04100135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880107|NCT04100135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141402|NCT02958215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25141403|NCT02958215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141404|NCT02958215|Sympathomimetics|sympathomimetics|mesh-ancestor
25141405|NCT02958215|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25141406|NCT02958215|Nasal Decongestants|nasal decongestants|mesh-ancestor
25141407|NCT02958215|Respiratory System Agents|respiratory system agents|mesh-ancestor
25046980|NCT00834756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25046982|NCT00834743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25046983|NCT00834743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046984|NCT00834717|Granisetron|granisetron|mesh-list
25046985|NCT00834717|Antiemetics|antiemetics|mesh-ancestor
25046986|NCT00834717|Autonomic Agents|autonomic agents|mesh-ancestor
25046987|NCT00834717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25046988|NCT00834717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046989|NCT00834717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25046990|NCT00834717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25046991|NCT00834717|Serotonin Agents|serotonin agents|mesh-ancestor
25046992|NCT00834717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25046993|NCT00834717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046994|NCT00834639|Valproic Acid|valproic acid|mesh-list
25046995|NCT00834639|Anticonvulsants|anticonvulsants|mesh-ancestor
25046996|NCT00834639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046997|NCT00834639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25046998|NCT00834639|GABA Agents|gaba agents|mesh-ancestor
25046999|NCT00834639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25047000|NCT00834639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047001|NCT00834639|Antimanic Agents|antimanic agents|mesh-ancestor
25047002|NCT00834639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25047003|NCT00834639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25047004|NCT00834639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25047018|NCT00834561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25047019|NCT00834561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141630|NCT02955810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25047021|NCT00834561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047022|NCT00834561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25047023|NCT00834561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25047024|NCT00834561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25013941|NCT05219669|Nalmefene|nalmefene|mesh-list
25047025|NCT00834561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25047026|NCT00834561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25047027|NCT00834535|Cefdinir|cefdinir|mesh-list
25047028|NCT00834535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25047029|NCT00834535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25047030|NCT00834522|Granisetron|granisetron|mesh-list
25047031|NCT00834522|Antiemetics|antiemetics|mesh-ancestor
25047032|NCT00834522|Autonomic Agents|autonomic agents|mesh-ancestor
25141416|NCT02957903|Anesthetics, Local|anesthetics, local|mesh-ancestor
25141417|NCT02957903|Anesthetics|anesthetics|mesh-ancestor
25141418|NCT02957903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25141419|NCT02957903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141420|NCT02957903|Sensory System Agents|sensory system agents|mesh-ancestor
25286916|NCT05086848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286917|NCT05086848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25286918|NCT05086848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286919|NCT05086848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25141421|NCT02957903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25141422|NCT02957864|Tenofovir|tenofovir|mesh-list
25141423|NCT02957864|Abacavir|abacavir|mesh-list
24476752|NCT00416390|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24476753|NCT00416390|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24664267|NCT01305733|Anesthetics, Local|anesthetics, local|mesh-ancestor
25141427|NCT02957864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25141428|NCT02957864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25141429|NCT02957864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880364|NCT03829371|Alkylating Agents|alkylating agents|mesh-ancestor
24880365|NCT03829371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880366|NCT03829371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24880367|NCT03829371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24880369|NCT03827889|Fluorides, Topical|fluorides, topical|mesh-list
25141431|NCT02957864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25141432|NCT02957760|Hydroxyurea|hydroxyurea|mesh-list
25141433|NCT02957760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25141434|NCT02957760|Antisickling Agents|antisickling agents|mesh-ancestor
25141435|NCT02957760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25141436|NCT02957760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141437|NCT02957760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25141438|NCT02957786|Varenicline|varenicline|mesh-list
25141439|NCT02957786|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25141440|NCT02957786|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25141441|NCT02957786|Cholinergic Agents|cholinergic agents|mesh-ancestor
25141442|NCT02957786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25141443|NCT02957786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141444|NCT02957786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141445|NCT02957877|Heparin|heparin|mesh-list
25141446|NCT02957877|Calcium heparin|calcium heparin|mesh-list
25141447|NCT02957877|Nadroparin|nadroparin|mesh-list
25141448|NCT02957877|Anticoagulants|anticoagulants|mesh-ancestor
25141449|NCT02957877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25141450|NCT02957877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24664271|NCT01305733|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24476783|NCT00416507|Fluorouracil|fluorouracil|mesh-list
24476784|NCT00416507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476785|NCT00416507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24476786|NCT00416507|Antimetabolites|antimetabolites|mesh-ancestor
24476787|NCT00416507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476788|NCT00416507|Antiviral Agents|antiviral agents|mesh-ancestor
25141451|NCT02957877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141452|NCT02957890|Vaccines|vaccines|mesh-list
25141453|NCT02957890|Immunologic Factors|immunologic factors|mesh-ancestor
25141454|NCT02957890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141455|NCT02957851|Nitrous Oxide|nitrous oxide|mesh-list
25141456|NCT02957851|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25141457|NCT02957851|Anesthetics, General|anesthetics, general|mesh-ancestor
25141458|NCT02957851|Anesthetics|anesthetics|mesh-ancestor
25141459|NCT02957851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25141460|NCT02957851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141461|NCT02957851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25141473|NCT02957604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141474|NCT02957604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25141476|NCT02957435|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25684265|NCT01890122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25684266|NCT01890122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25684267|NCT01890122|Protease Inhibitors|protease inhibitors|mesh-ancestor
25684268|NCT01890122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25684269|NCT01890122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286957|NCT05085912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25286958|NCT05085912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25141477|NCT02957435|Hormone Antagonists|hormone antagonists|mesh-ancestor
25141478|NCT02957435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25141479|NCT02957435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141480|NCT02957435|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25141481|NCT02957435|Diuretics|diuretics|mesh-ancestor
25141482|NCT02957435|Natriuretic Agents|natriuretic agents|mesh-ancestor
25141483|NCT02957435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25141484|NCT02957448|Rifampin|rifampin|mesh-list
25141485|NCT02957448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25141487|NCT02957448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25141488|NCT02957448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25141489|NCT02957448|Leprostatic Agents|leprostatic agents|mesh-ancestor
25141490|NCT02957448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25141491|NCT02957448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25141492|NCT02957448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141493|NCT02957448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25141494|NCT02957448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25141495|NCT02957448|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25141496|NCT02957448|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25141497|NCT02957448|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25141498|NCT02957448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25141499|NCT02957656|Vaccines|vaccines|mesh-list
25141500|NCT02957656|Immunologic Factors|immunologic factors|mesh-ancestor
25141501|NCT02957656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141502|NCT02957630|Drospirenone|drospirenone|mesh-list
25141503|NCT02957630|Levonorgestrel|levonorgestrel|mesh-list
25141504|NCT02957630|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25141505|NCT02957630|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25141511|NCT02957630|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25141512|NCT02957630|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25141513|NCT02957630|Estrogens|estrogens|mesh-ancestor
25141514|NCT02957630|Hormones|hormones|mesh-ancestor
25141515|NCT02957630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25141516|NCT02957630|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25141517|NCT02957630|Hormone Antagonists|hormone antagonists|mesh-ancestor
25141518|NCT02957630|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25141519|NCT02957630|Diuretics|diuretics|mesh-ancestor
25141520|NCT02957630|Natriuretic Agents|natriuretic agents|mesh-ancestor
25141521|NCT02957474|Omeprazole|omeprazole|mesh-list
25141522|NCT02957474|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25141523|NCT02957474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25141524|NCT02957474|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25141525|NCT02957474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25141526|NCT02957474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141527|NCT02957266|Gemcitabine|gemcitabine|mesh-list
25141528|NCT02957266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25141529|NCT02957266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25141530|NCT02957266|Antimetabolites|antimetabolites|mesh-ancestor
25141531|NCT02957266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141532|NCT02957266|Antiviral Agents|antiviral agents|mesh-ancestor
25141533|NCT02957266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25141534|NCT02957266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25141535|NCT02957266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25141536|NCT02957266|Immunologic Factors|immunologic factors|mesh-ancestor
25141537|NCT02957266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141538|NCT02957162|Atorvastatin|atorvastatin|mesh-list
25141539|NCT02957162|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25141540|NCT02957162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25141541|NCT02957162|Antimetabolites|antimetabolites|mesh-ancestor
25141543|NCT02957162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25141553|NCT02957097|Anticonvulsants|anticonvulsants|mesh-ancestor
25141554|NCT02957097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25141555|NCT02957097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25141556|NCT02957097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25141557|NCT02957097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25141558|NCT02957097|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25141559|NCT02957097|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25141560|NCT02957097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25684270|NCT01890265|Pirfenidone|pirfenidone|mesh-list
25684271|NCT01890265|Nintedanib|nintedanib|mesh-list
25684272|NCT01890265|Immunoglobulins|immunoglobulins|mesh-list
25684273|NCT01890265|Antibodies|antibodies|mesh-list
25287004|NCT05084872|Hydroxychloroquine|hydroxychloroquine|mesh-list
25287005|NCT05084872|Antimalarials|antimalarials|mesh-ancestor
25141561|NCT02957097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141562|NCT02957097|Antimanic Agents|antimanic agents|mesh-ancestor
25141563|NCT02956772|Arsenic Trioxide|arsenic trioxide|mesh-list
25141564|NCT02956772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25141566|NCT02956811|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25141567|NCT02956811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141568|NCT02956811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25141569|NCT02956811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141570|NCT02956655|Insulin|insulin|mesh-list
25141571|NCT02956655|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25141572|NCT02956655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25141573|NCT02956655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141578|NCT02956538|Leprostatic Agents|leprostatic agents|mesh-ancestor
25141579|NCT02956538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25141580|NCT02956538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25141581|NCT02956538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25141582|NCT02956538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25141583|NCT02956538|Growth Substances|growth substances|mesh-ancestor
25141584|NCT02956538|Growth Inhibitors|growth inhibitors|mesh-ancestor
25141585|NCT02956538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25141586|NCT02956785|Dinoprostone|dinoprostone|mesh-list
24880370|NCT03827889|Cariostatic Agents|cariostatic agents|mesh-ancestor
24880371|NCT03827889|Protective Agents|protective agents|mesh-ancestor
24880372|NCT03827889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880376|NCT03811886|Natalizumab|natalizumab|mesh-list
25141587|NCT02956785|Oxytocics|oxytocics|mesh-ancestor
25141588|NCT02956785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25141589|NCT02956785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141590|NCT02957409|Valsartan|valsartan|mesh-list
25141591|NCT02957409|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25141592|NCT02957409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25141593|NCT02957409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25141594|NCT02957409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25141595|NCT02957409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047033|NCT00834522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25047034|NCT00834522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047035|NCT00834522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25047036|NCT00834522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25047037|NCT00834522|Serotonin Agents|serotonin agents|mesh-ancestor
25047038|NCT00834522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25047039|NCT00834522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047040|NCT00834444|Famciclovir|famciclovir|mesh-list
25047041|NCT00834444|Antiviral Agents|antiviral agents|mesh-ancestor
25047042|NCT00834444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25047043|NCT00834444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25047044|NCT00834444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047045|NCT00834444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047046|NCT00834431|Famciclovir|famciclovir|mesh-list
25047047|NCT00834431|Antiviral Agents|antiviral agents|mesh-ancestor
25047048|NCT00834431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25047049|NCT00834431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25047050|NCT00834431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047051|NCT00834431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047052|NCT00834418|Leflunomide|leflunomide|mesh-list
25141609|NCT02956408|Vitamins|vitamins|mesh-ancestor
25141615|NCT02956421|Immunologic Factors|immunologic factors|mesh-ancestor
25141616|NCT02956421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141617|NCT02956200|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25141618|NCT02956200|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25141619|NCT02956200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141620|NCT02956200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25141621|NCT02956200|Immunologic Factors|immunologic factors|mesh-ancestor
25141622|NCT02956200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141623|NCT02955810|Dexamethasone|dexamethasone|mesh-list
25141624|NCT02955810|Cyclophosphamide|cyclophosphamide|mesh-list
25141625|NCT02955810|Bortezomib|bortezomib|mesh-list
25141626|NCT02955810|Daratumumab|daratumumab|mesh-list
25141627|NCT02955810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25141628|NCT02955810|Immunologic Factors|immunologic factors|mesh-ancestor
25141629|NCT02955810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684274|NCT01890265|Immunoglobulin G|immunoglobulin g|mesh-list
25684275|NCT01890265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25141631|NCT02955810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25141632|NCT02955810|Alkylating Agents|alkylating agents|mesh-ancestor
25141633|NCT02955810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141634|NCT02955810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25141635|NCT02955810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25141636|NCT02955810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25141638|NCT02955810|Autonomic Agents|autonomic agents|mesh-ancestor
25141639|NCT02955810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25141640|NCT02955810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25141641|NCT02955810|Glucocorticoids|glucocorticoids|mesh-ancestor
25141642|NCT02955810|Hormones|hormones|mesh-ancestor
25141643|NCT02955810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25141644|NCT02955810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25141645|NCT02956083|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25141646|NCT02956083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25141652|NCT02955732|Analgesics|analgesics|mesh-ancestor
25141654|NCT02955732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25141655|NCT02955732|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25141656|NCT02955732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25141657|NCT02955732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25141658|NCT02955732|Adrenergic Agents|adrenergic agents|mesh-ancestor
25141659|NCT02955732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25141660|NCT02955732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141661|NCT02955719|Sertraline|sertraline|mesh-list
25141662|NCT02955719|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25141663|NCT02955719|Antidepressive Agents|antidepressive agents|mesh-ancestor
25141664|NCT02955719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25141665|NCT02955719|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25141666|NCT02955719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25141667|NCT02955719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25141668|NCT02955719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141669|NCT02955719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25141670|NCT02955719|Serotonin Agents|serotonin agents|mesh-ancestor
25141671|NCT02955719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141672|NCT02955719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25141673|NCT02955719|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25141674|NCT02955524|Lidocaine|lidocaine|mesh-list
25141675|NCT02955524|Tetracaine|tetracaine|mesh-list
25141676|NCT02955524|Anesthetics, Local|anesthetics, local|mesh-ancestor
25141677|NCT02955524|Anesthetics|anesthetics|mesh-ancestor
25141678|NCT02955524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25141679|NCT02955524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141680|NCT02955524|Sensory System Agents|sensory system agents|mesh-ancestor
25141681|NCT02955524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25141682|NCT02955524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25141683|NCT02955524|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24477301|NCT00418171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24477302|NCT00418171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25141693|NCT02955706|Vitamin B Complex|vitamin b complex|mesh-ancestor
25141694|NCT02955706|Vitamins|vitamins|mesh-ancestor
25141695|NCT02955706|Micronutrients|micronutrients|mesh-ancestor
25141696|NCT02955706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141697|NCT02955706|Nootropic Agents|nootropic agents|mesh-ancestor
25141698|NCT02955641|Dexamethasone|dexamethasone|mesh-list
25141699|NCT02955641|Nepafenac|nepafenac|mesh-list
25141700|NCT02955641|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25141701|NCT02955641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25141702|NCT02955641|Antiemetics|antiemetics|mesh-ancestor
25141703|NCT02955641|Autonomic Agents|autonomic agents|mesh-ancestor
25141704|NCT02955641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25141705|NCT02955641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141706|NCT02955641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25141707|NCT02955641|Glucocorticoids|glucocorticoids|mesh-ancestor
25141708|NCT02955641|Hormones|hormones|mesh-ancestor
25141709|NCT02955641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25141710|NCT02955641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25141711|NCT02955641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25141712|NCT02955641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25141713|NCT02955641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25141714|NCT02955641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25141715|NCT02955641|Analgesics|analgesics|mesh-ancestor
25141716|NCT02955641|Sensory System Agents|sensory system agents|mesh-ancestor
25141717|NCT02955641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25141718|NCT02955927|Atropine|atropine|mesh-list
25141719|NCT02955927|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25141720|NCT02955927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25141721|NCT02955927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25141722|NCT02955927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25141723|NCT02955927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25141724|NCT02955927|Autonomic Agents|autonomic agents|mesh-ancestor
25141918|NCT02953457|Ipilimumab|ipilimumab|mesh-list
25141735|NCT02955927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141754|NCT02955056|Teriparatide|teriparatide|mesh-list
25141755|NCT02955056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141756|NCT02955056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25141757|NCT02955056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25141758|NCT02954939|Prednisone|prednisone|mesh-list
25141759|NCT02954939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25141760|NCT02954939|Glucocorticoids|glucocorticoids|mesh-ancestor
25141761|NCT02954939|Hormones|hormones|mesh-ancestor
25141762|NCT02954939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25141763|NCT02954939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141765|NCT02954939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25141766|NCT02955251|Nivolumab|nivolumab|mesh-list
25141767|NCT02955251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25141768|NCT02955251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25141769|NCT02955251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25141770|NCT02955251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141771|NCT02954913|Liver Extracts|liver extracts|mesh-list
25141772|NCT02954913|Hematinics|hematinics|mesh-ancestor
25141773|NCT02954692|Metformin|metformin|mesh-list
25141774|NCT02954692|Insulin Glargine|insulin glargine|mesh-list
25141775|NCT02954692|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
25141776|NCT02954692|Meglitinide|meglitinide|mesh-list
25141777|NCT02954692|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
25141778|NCT02954692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25141779|NCT02954692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141780|NCT02954692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477367|NCT00418366|Hormones|hormones|mesh-ancestor
25141919|NCT02953457|Olaparib|olaparib|mesh-list
25141786|NCT02954822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25141787|NCT02954822|Immunologic Factors|immunologic factors|mesh-ancestor
25141788|NCT02954588|Pyridoxamine|pyridoxamine|mesh-list
25141789|NCT02954588|Vitamin B Complex|vitamin b complex|mesh-ancestor
25141790|NCT02954588|Vitamins|vitamins|mesh-ancestor
25141791|NCT02954588|Micronutrients|micronutrients|mesh-ancestor
25141792|NCT02954588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141793|NCT02954549|Vitamin D|vitamin d|mesh-list
25141794|NCT02954549|Cholecalciferol|cholecalciferol|mesh-list
25141795|NCT02954549|Vitamins|vitamins|mesh-ancestor
25141796|NCT02954549|Micronutrients|micronutrients|mesh-ancestor
25141797|NCT02954549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141798|NCT02954549|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25047053|NCT00834418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047054|NCT00834418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047055|NCT00834418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25047056|NCT00834418|Immunologic Factors|immunologic factors|mesh-ancestor
25047057|NCT00834418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047058|NCT00834405|Leflunomide|leflunomide|mesh-list
25047059|NCT00834405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047060|NCT00834405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047061|NCT00834405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25047062|NCT00834405|Immunologic Factors|immunologic factors|mesh-ancestor
25047063|NCT00834405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047064|NCT00834340|Glimepiride|glimepiride|mesh-list
25047065|NCT00834340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25047066|NCT00834340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25047067|NCT00834340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047068|NCT00834340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25047069|NCT00834340|Immunologic Factors|immunologic factors|mesh-ancestor
25047070|NCT00834275|Cefadroxil|cefadroxil|mesh-list
25047071|NCT00834275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25047072|NCT00834275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25287139|NCT05013242|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25287140|NCT05013242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25287141|NCT05013242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25287142|NCT05013242|Hormone Antagonists|hormone antagonists|mesh-ancestor
25287143|NCT05013242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25287144|NCT05008510|Camptothecin|camptothecin|mesh-list
25287145|NCT05008510|Immunoconjugates|immunoconjugates|mesh-list
25287146|NCT05008510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25287147|NCT05008510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25287148|NCT05008510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25047073|NCT00834249|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24477480|NCT00418782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047074|NCT00834249|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25047075|NCT00834249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25047076|NCT00834249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25047077|NCT00834249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760419|NCT01758029|Methyltestosterone|methyltestosterone|mesh-list
24880432|NCT03784066|Durvalumab|durvalumab|mesh-list
24880433|NCT03784066|Tremelimumab|tremelimumab|mesh-list
24880434|NCT03784066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24880436|NCT03784066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880437|NCT03784066|Immunologic Factors|immunologic factors|mesh-ancestor
24880438|NCT03784066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880439|NCT03757897|Dexmedetomidine|dexmedetomidine|mesh-list
24880440|NCT03757897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25047078|NCT00834249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25047079|NCT00834249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047080|NCT00834249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25047081|NCT00834249|Antidepressive Agents|antidepressive agents|mesh-ancestor
25047082|NCT00834249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25047084|NCT00834197|Antidepressive Agents|antidepressive agents|mesh-ancestor
25047085|NCT00834197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25047086|NCT00834197|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25047087|NCT00834197|Histamine Antagonists|histamine antagonists|mesh-ancestor
25047088|NCT00834197|Histamine Agents|histamine agents|mesh-ancestor
25047089|NCT00834197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25047090|NCT00834197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047091|NCT00834197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047092|NCT00834197|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25047093|NCT00834197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25047094|NCT00834197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25047099|NCT00834197|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25047100|NCT00834197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25047102|NCT00834197|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25047103|NCT00834132|Azithromycin|azithromycin|mesh-list
25047104|NCT00834132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24477487|NCT00418847|Miglustat|miglustat|mesh-list
25047105|NCT00834132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25047106|NCT00834067|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25047107|NCT00834067|Moexipril|moexipril|mesh-list
25047108|NCT00834067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25047109|NCT00834067|Diuretics|diuretics|mesh-ancestor
25047110|NCT00834067|Natriuretic Agents|natriuretic agents|mesh-ancestor
25047111|NCT00834067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880441|NCT03757897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24880442|NCT03757897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880495|NCT03625648|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24880496|NCT03625648|Protective Agents|protective agents|mesh-ancestor
24880497|NCT03625648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047112|NCT00834067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25047113|NCT00834067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25405460|NCT03606538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25684276|NCT01890265|Immunologic Factors|immunologic factors|mesh-ancestor
25684277|NCT01890265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684278|NCT01890265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25684279|NCT01890265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25684280|NCT01890265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25684281|NCT01890265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684282|NCT01890265|Analgesics|analgesics|mesh-ancestor
25684283|NCT01890265|Sensory System Agents|sensory system agents|mesh-ancestor
25684284|NCT01890265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25684285|NCT01890265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25045467|NCT00948753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045469|NCT00948753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25045470|NCT00948753|Antiviral Agents|antiviral agents|mesh-ancestor
25045471|NCT00948753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25045472|NCT00948753|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25045473|NCT00948142|Linezolid|linezolid|mesh-list
25045474|NCT00948142|Fusidic Acid|fusidic acid|mesh-list
25045475|NCT00948142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25045476|NCT00948142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25045477|NCT00948142|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25045478|NCT00948142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045479|NCT00948142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045480|NCT00947518|Chlorhexidine|chlorhexidine|mesh-list
25045481|NCT00947518|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25045482|NCT00947518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25045483|NCT00947518|Disinfectants|disinfectants|mesh-ancestor
25045484|NCT00945802|Ciprofloxacin|ciprofloxacin|mesh-list
25045485|NCT00945802|Dexamethasone|dexamethasone|mesh-list
25045486|NCT00945802|Dexamethasone acetate|dexamethasone acetate|mesh-list
25045487|NCT00945802|BB 1101|bb 1101|mesh-list
25045488|NCT00945802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25047114|NCT00834067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047115|NCT00834067|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25047116|NCT00834067|Protease Inhibitors|protease inhibitors|mesh-ancestor
25047117|NCT00834067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047118|NCT00833937|Zolpidem|zolpidem|mesh-list
25047119|NCT00833937|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25047120|NCT00833937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24766731|NCT01796444|Hormones|hormones|mesh-list
25141846|NCT02954484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141847|NCT02954484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25141848|NCT02954484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25141849|NCT02954484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25141850|NCT02954484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25141851|NCT02954484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25141852|NCT02954484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25141853|NCT02954484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25141854|NCT02954484|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25141855|NCT02954484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25141856|NCT02954484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25141857|NCT02954068|Oxytocin|oxytocin|mesh-list
25141858|NCT02954068|Oxytocics|oxytocics|mesh-ancestor
25141859|NCT02954068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25141860|NCT02954068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880498|NCT03625648|Vasodilator Agents|vasodilator agents|mesh-ancestor
24880499|NCT03625648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24880500|NCT03625648|Antioxidants|antioxidants|mesh-ancestor
24880502|NCT03621553|Ergocalciferols|ergocalciferols|mesh-list
24880503|NCT03621553|Cholecalciferol|cholecalciferol|mesh-list
24880504|NCT03621553|Vitamins|vitamins|mesh-list
24880902|NCT03213158|Protease Inhibitors|protease inhibitors|mesh-ancestor
24880958|NCT03177291|Sensory System Agents|sensory system agents|mesh-ancestor
25684286|NCT01890265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25684287|NCT01890265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25684288|NCT01890265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25684289|NCT01890343|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25684290|NCT01890343|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25684291|NCT01890343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684292|NCT01890473|Abatacept|abatacept|mesh-list
24665940|NCT01316068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25684293|NCT01890473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25684294|NCT01890473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684295|NCT01890473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25684296|NCT01890473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25684297|NCT01890473|Immunologic Factors|immunologic factors|mesh-ancestor
25684298|NCT01890473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684299|NCT01890473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25684300|NCT01890642|Lidocaine|lidocaine|mesh-list
25684301|NCT01890642|Anesthetics, Local|anesthetics, local|mesh-ancestor
25684302|NCT01890642|Anesthetics|anesthetics|mesh-ancestor
25684303|NCT01890642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25684304|NCT01890642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684305|NCT01890642|Sensory System Agents|sensory system agents|mesh-ancestor
25141916|NCT02953535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24807162|NCT02020122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24881148|NCT02977494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24881149|NCT02977494|Antiemetics|antiemetics|mesh-ancestor
24881150|NCT02977494|Autonomic Agents|autonomic agents|mesh-ancestor
24881151|NCT02977494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24881152|NCT02977494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881153|NCT02977494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24881154|NCT02977494|Glucocorticoids|glucocorticoids|mesh-ancestor
25141883|NCT02953847|Rifampin|rifampin|mesh-list
25141884|NCT02953847|Isoniazid|isoniazid|mesh-list
25141885|NCT02953847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25141886|NCT02953847|Antitubercular Agents|antitubercular agents|mesh-ancestor
25141887|NCT02953847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25141888|NCT02953847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25141889|NCT02953847|Leprostatic Agents|leprostatic agents|mesh-ancestor
25141890|NCT02953847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25141891|NCT02953847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25141892|NCT02953847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141893|NCT02953847|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25141894|NCT02953847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25141895|NCT02953847|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25141896|NCT02953847|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25141897|NCT02953847|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25141898|NCT02953847|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25141899|NCT02953847|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25141900|NCT02953847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25141901|NCT02953847|Antimetabolites|antimetabolites|mesh-ancestor
25141902|NCT02953847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25141903|NCT02953743|Lenvatinib|lenvatinib|mesh-list
25141904|NCT02953743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25141905|NCT02953743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25141906|NCT02953743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25141907|NCT02953743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141908|NCT02953522|Folic Acid|folic acid|mesh-list
25141909|NCT02953522|Vitamin B Complex|vitamin b complex|mesh-list
25141910|NCT02953522|Hematinics|hematinics|mesh-ancestor
25141911|NCT02953522|Vitamins|vitamins|mesh-ancestor
25141912|NCT02953522|Micronutrients|micronutrients|mesh-ancestor
25141913|NCT02953522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047121|NCT00833937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25047125|NCT00833937|GABA Agents|gaba agents|mesh-ancestor
25047126|NCT00833937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25047127|NCT00833937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047128|NCT00833664|Terbinafine|terbinafine|mesh-list
25047129|NCT00833664|Antifungal Agents|antifungal agents|mesh-ancestor
25047130|NCT00833664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25047131|NCT00833664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047132|NCT00833664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047133|NCT00833586|Terbinafine|terbinafine|mesh-list
25047134|NCT00833586|Antifungal Agents|antifungal agents|mesh-ancestor
24666782|NCT01321021|Diphenhydramine|diphenhydramine|mesh-list
25047135|NCT00833586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25047136|NCT00833586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047137|NCT00833586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141922|NCT02953457|Immunoglobulins|immunoglobulins|mesh-list
25141923|NCT02953457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25141924|NCT02953457|Immunoglobulin G|immunoglobulin g|mesh-list
25141925|NCT02953457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25141926|NCT02953457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25141927|NCT02953457|Immunologic Factors|immunologic factors|mesh-ancestor
25141928|NCT02953457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141929|NCT02953457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25141930|NCT02953457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141931|NCT02953457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25141933|NCT02953405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25141934|NCT02953405|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25141935|NCT02953405|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25405538|NCT03604315|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24477740|NCT00419796|Analgesics|analgesics|mesh-ancestor
24760567|NCT01758666|Antimetabolites|antimetabolites|mesh-ancestor
25141937|NCT02953405|Purinergic Agents|purinergic agents|mesh-ancestor
25141938|NCT02953405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25141939|NCT02953405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141940|NCT02953405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141941|NCT02953379|Mometasone Furoate|mometasone furoate|mesh-list
25141942|NCT02953379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25141943|NCT02953379|Dermatologic Agents|dermatologic agents|mesh-ancestor
25141944|NCT02953379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25141945|NCT02953366|Mometasone Furoate|mometasone furoate|mesh-list
25141946|NCT02953366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25141947|NCT02953366|Dermatologic Agents|dermatologic agents|mesh-ancestor
25141948|NCT02953366|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25141949|NCT02953275|Pentoxifylline|pentoxifylline|mesh-list
25141950|NCT02953275|Vedolizumab|vedolizumab|mesh-list
25141951|NCT02953275|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25141952|NCT02953275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25141953|NCT02953275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141954|NCT02953275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25141955|NCT02953275|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25141956|NCT02953275|Protective Agents|protective agents|mesh-ancestor
25141957|NCT02953275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141958|NCT02953275|Vasodilator Agents|vasodilator agents|mesh-ancestor
25141959|NCT02953275|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25141960|NCT02953275|Antioxidants|antioxidants|mesh-ancestor
25141961|NCT02953275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25141962|NCT02953210|Dexamethasone|dexamethasone|mesh-list
25141964|NCT02953210|Lidocaine|lidocaine|mesh-list
25141965|NCT02953210|Clonidine|clonidine|mesh-list
25141966|NCT02953210|Fentanyl|fentanyl|mesh-list
24807175|NCT02020161|Antimetabolites|antimetabolites|mesh-ancestor
25141967|NCT02953210|Midazolam|midazolam|mesh-list
25141968|NCT02953210|Ketamine|ketamine|mesh-list
25141969|NCT02953210|Ondansetron|ondansetron|mesh-list
25141970|NCT02953210|Bupivacaine|bupivacaine|mesh-list
25141971|NCT02953210|Propofol|propofol|mesh-list
25141972|NCT02953210|Isoflurane|isoflurane|mesh-list
25141973|NCT02953210|Ranitidine|ranitidine|mesh-list
25141974|NCT02953210|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
25141975|NCT02953210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25141976|NCT02953210|Rocuronium|rocuronium|mesh-list
25141977|NCT02953210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25141978|NCT02953210|Antiemetics|antiemetics|mesh-ancestor
25141979|NCT02953210|Autonomic Agents|autonomic agents|mesh-ancestor
25141982|NCT02953210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25141983|NCT02953210|Glucocorticoids|glucocorticoids|mesh-ancestor
25141984|NCT02953210|Hormones|hormones|mesh-ancestor
25141985|NCT02953210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25141986|NCT02953210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25141987|NCT02953210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25141988|NCT02953210|Anesthetics, Local|anesthetics, local|mesh-ancestor
25141989|NCT02953210|Anesthetics|anesthetics|mesh-ancestor
25141990|NCT02953210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25141991|NCT02953210|Sensory System Agents|sensory system agents|mesh-ancestor
25141992|NCT02953210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25141993|NCT02953210|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25141994|NCT02953210|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25141995|NCT02953210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25141996|NCT02953210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141997|NCT02953210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25141998|NCT02953210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25141999|NCT02953210|Anesthetics, General|anesthetics, general|mesh-ancestor
25142001|NCT02953210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25142002|NCT02953210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25142009|NCT02953210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25142010|NCT02953210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25142011|NCT02953210|GABA Modulators|gaba modulators|mesh-ancestor
25142012|NCT02953210|GABA Agents|gaba agents|mesh-ancestor
25142013|NCT02953210|Antipruritics|antipruritics|mesh-ancestor
25142014|NCT02953210|Dermatologic Agents|dermatologic agents|mesh-ancestor
25142015|NCT02953210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25142016|NCT02953210|Serotonin Agents|serotonin agents|mesh-ancestor
25142017|NCT02953210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25142018|NCT02953210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25142019|NCT02953210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25142020|NCT02953210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25142021|NCT02953210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25142022|NCT02953210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25142023|NCT02953210|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25142024|NCT02953210|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25142025|NCT02953210|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25142026|NCT02953210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25142027|NCT02953210|Sympatholytics|sympatholytics|mesh-ancestor
25142028|NCT02953210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25142029|NCT02953210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25142030|NCT02953210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25142031|NCT02953210|Adrenergic Agents|adrenergic agents|mesh-ancestor
25142032|NCT02953210|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25142033|NCT02953210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25142034|NCT02953210|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25142035|NCT02953210|Histamine Antagonists|histamine antagonists|mesh-ancestor
25142036|NCT02953210|Histamine Agents|histamine agents|mesh-ancestor
25142037|NCT02953106|Fluticasone|fluticasone|mesh-list
24470388|NCT00390026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142045|NCT02953106|Respiratory System Agents|respiratory system agents|mesh-ancestor
25142046|NCT02953106|Dermatologic Agents|dermatologic agents|mesh-ancestor
25142047|NCT02953106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25142048|NCT02953106|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25142049|NCT02953106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25142050|NCT02953106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142051|NCT02953106|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25142052|NCT02953106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25142053|NCT02953106|Histamine Antagonists|histamine antagonists|mesh-ancestor
25142054|NCT02953106|Histamine Agents|histamine agents|mesh-ancestor
25142055|NCT02953106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25142056|NCT02952989|Pembrolizumab|pembrolizumab|mesh-list
24760697|NCT01759706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24470499|NCT00390260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881287|NCT02780609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24881288|NCT02780609|Immunologic Factors|immunologic factors|mesh-ancestor
24881289|NCT02780609|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24881290|NCT02780609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24881291|NCT02774239|Immunoglobulins|immunoglobulins|mesh-list
24881292|NCT02774239|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25142057|NCT02952989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25142058|NCT02952989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142059|NCT02953041|Glycopyrrolate|glycopyrrolate|mesh-list
25142061|NCT02953041|Anticonvulsants|anticonvulsants|mesh-ancestor
25045584|NCT00939276|Analgesics|analgesics|mesh-ancestor
25045585|NCT00939276|Sensory System Agents|sensory system agents|mesh-ancestor
25045586|NCT00939276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045587|NCT00939276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045588|NCT00939276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25045589|NCT00939276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25045590|NCT00938652|Gemcitabine|gemcitabine|mesh-list
25045591|NCT00938652|Carboplatin|carboplatin|mesh-list
25045592|NCT00938652|Iniparib|iniparib|mesh-list
25045593|NCT00938652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142062|NCT02953041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25142063|NCT02953041|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25142064|NCT02953041|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25142065|NCT02953041|Cholinergic Agents|cholinergic agents|mesh-ancestor
25142066|NCT02953041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25142067|NCT02953041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142068|NCT02953041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142070|NCT02953015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25142071|NCT02953015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25142072|NCT02953015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25142073|NCT02953015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142074|NCT02953015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25142075|NCT02953015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25142076|NCT02953015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142077|NCT02953015|Cholinergic Agents|cholinergic agents|mesh-ancestor
25142078|NCT02953015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25142079|NCT02953184|Vitamins|vitamins|mesh-list
25142080|NCT02953184|Vitamin B Complex|vitamin b complex|mesh-list
25142081|NCT02953184|Cyclophosphamide|cyclophosphamide|mesh-list
25142082|NCT02953184|Docetaxel|docetaxel|mesh-list
25142083|NCT02953184|Doxorubicin|doxorubicin|mesh-list
25142084|NCT02953184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25142085|NCT02953184|Dexrazoxane|dexrazoxane|mesh-list
25142086|NCT02953184|Razoxane|razoxane|mesh-list
25142087|NCT02953184|Pirarubicin|pirarubicin|mesh-list
25142088|NCT02953184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25142089|NCT02953184|Immunologic Factors|immunologic factors|mesh-ancestor
25142090|NCT02953184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142091|NCT02953184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25142092|NCT02953184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25142093|NCT02953184|Alkylating Agents|alkylating agents|mesh-ancestor
25142094|NCT02953184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142095|NCT02953184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142096|NCT02953184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25142097|NCT02953184|Micronutrients|micronutrients|mesh-ancestor
25047138|NCT00833521|Zolpidem|zolpidem|mesh-list
25047139|NCT00833521|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25047140|NCT00833521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25047141|NCT00833521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25047145|NCT00833521|GABA Agents|gaba agents|mesh-ancestor
25047146|NCT00833521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25047147|NCT00833521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047149|NCT00833495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25047150|NCT00833495|Methylprednisolone|methylprednisolone|mesh-list
25047151|NCT00833495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25047152|NCT00833495|Prednisolone acetate|prednisolone acetate|mesh-list
25047154|NCT00833495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25047155|NCT00833495|Prednisolone phosphate|prednisolone phosphate|mesh-list
25047156|NCT00833495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25047157|NCT00833495|Glucocorticoids|glucocorticoids|mesh-ancestor
25047158|NCT00833495|Hormones|hormones|mesh-ancestor
25047159|NCT00833495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25047160|NCT00833495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684306|NCT01890642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25684307|NCT01890642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25684308|NCT01890642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25684309|NCT01890642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25684310|NCT01890642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25684311|NCT01890642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684312|NCT01890707|Anesthetics|anesthetics|mesh-list
25684313|NCT01890707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25114974|NCT03119038|Clonidine|clonidine|mesh-list
25114975|NCT03119038|Epinephrine|epinephrine|mesh-list
25114976|NCT03119038|Bupivacaine|bupivacaine|mesh-list
25114977|NCT03119038|Ropivacaine|ropivacaine|mesh-list
25114978|NCT03119038|Anesthetics, Local|anesthetics, local|mesh-ancestor
25114979|NCT03119038|Anesthetics|anesthetics|mesh-ancestor
25114980|NCT03119038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25114981|NCT03119038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25114982|NCT03119038|Sensory System Agents|sensory system agents|mesh-ancestor
25114983|NCT03119038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25114984|NCT03119038|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25114985|NCT03119038|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25114986|NCT03119038|Adrenergic Agents|adrenergic agents|mesh-ancestor
25047161|NCT00833495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25047162|NCT00833495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25047163|NCT00833495|Antiemetics|antiemetics|mesh-ancestor
25047164|NCT00833495|Autonomic Agents|autonomic agents|mesh-ancestor
25047165|NCT00833495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24881295|NCT02774239|Immunologic Factors|immunologic factors|mesh-ancestor
24881296|NCT02774239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881298|NCT02696564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24881299|NCT02696564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24881300|NCT02696564|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24881301|NCT02696564|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24881302|NCT02696564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047166|NCT00833495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25047167|NCT00833495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25047168|NCT00833495|Protective Agents|protective agents|mesh-ancestor
25047169|NCT00832507|Cicletanine|cicletanine|mesh-list
25047170|NCT00832507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25047171|NCT00832507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25047172|NCT00832507|Diuretics|diuretics|mesh-ancestor
25047173|NCT00832507|Natriuretic Agents|natriuretic agents|mesh-ancestor
25047174|NCT00832507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047175|NCT00831662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25047176|NCT00831662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25047177|NCT00831051|Morphine|morphine|mesh-list
25047178|NCT00831051|Oxycodone|oxycodone|mesh-list
25047179|NCT00831051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25047180|NCT00831051|Narcotics|narcotics|mesh-ancestor
25047181|NCT00831051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25047182|NCT00831051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047183|NCT00831051|Analgesics|analgesics|mesh-ancestor
25142098|NCT02953184|Tubulin Modulators|tubulin modulators|mesh-ancestor
25142115|NCT02952963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25142117|NCT02952573|Dexamethasone acetate|dexamethasone acetate|mesh-list
25142118|NCT02952573|BB 1101|bb 1101|mesh-list
25142119|NCT02952573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25142120|NCT02952573|Antiemetics|antiemetics|mesh-ancestor
25142121|NCT02952573|Autonomic Agents|autonomic agents|mesh-ancestor
25142122|NCT02952573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25142123|NCT02952573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142124|NCT02952573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25142125|NCT02952573|Glucocorticoids|glucocorticoids|mesh-ancestor
25142126|NCT02952573|Hormones|hormones|mesh-ancestor
25142127|NCT02952573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25142128|NCT02952573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25142129|NCT02952573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142130|NCT02952573|Protease Inhibitors|protease inhibitors|mesh-ancestor
25684314|NCT01890707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684315|NCT01890746|Cytarabine|cytarabine|mesh-list
25684316|NCT01890746|Daunorubicin|daunorubicin|mesh-list
25684317|NCT01890746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25684318|NCT01890746|Antimetabolites|antimetabolites|mesh-ancestor
25684319|NCT01890746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684320|NCT01890746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25684321|NCT01890746|Antiviral Agents|antiviral agents|mesh-ancestor
25684322|NCT01890746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25684323|NCT01890746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25684324|NCT01890746|Immunologic Factors|immunologic factors|mesh-ancestor
25684325|NCT01890746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142131|NCT02952573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25115018|NCT03119324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115019|NCT03118830|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25115020|NCT03118830|Cetrorelix|cetrorelix|mesh-list
25115021|NCT03118830|Hormones|hormones|mesh-list
25115022|NCT03118830|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25115023|NCT03118830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25115024|NCT03118830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115025|NCT03118830|Luteolytic Agents|luteolytic agents|mesh-ancestor
25115026|NCT03118830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24791499|NCT04150614|Antipruritics|antipruritics|mesh-ancestor
25115068|NCT03118479|Anastrozole|anastrozole|mesh-list
25142132|NCT02952573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142133|NCT02952599|Edoxaban|edoxaban|mesh-list
25079723|NCT03345992|Clarithromycin|clarithromycin|mesh-list
25142134|NCT02952599|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25142135|NCT02952599|Antithrombins|antithrombins|mesh-ancestor
25142136|NCT02952599|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25142137|NCT02952599|Protease Inhibitors|protease inhibitors|mesh-ancestor
25142138|NCT02952599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25142139|NCT02952599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142140|NCT02952599|Anticoagulants|anticoagulants|mesh-ancestor
25142141|NCT02952807|Misoprostol|misoprostol|mesh-list
25142142|NCT02952807|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25142150|NCT02952235|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25142151|NCT02952235|Protective Agents|protective agents|mesh-ancestor
25142152|NCT02952235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142153|NCT02952235|Dermatologic Agents|dermatologic agents|mesh-ancestor
25142154|NCT02952469|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25142155|NCT02952469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142156|NCT02952469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24767167|NCT01799109|Magnesium Sulfate|magnesium sulfate|mesh-list
25142159|NCT02952157|Lidocaine|lidocaine|mesh-list
25142160|NCT02952157|Anesthetics, Local|anesthetics, local|mesh-ancestor
25142161|NCT02952157|Anesthetics|anesthetics|mesh-ancestor
25142162|NCT02952157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25142163|NCT02952157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142164|NCT02952157|Sensory System Agents|sensory system agents|mesh-ancestor
25142165|NCT02952157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25142166|NCT02952157|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25142167|NCT02952157|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25142168|NCT02952157|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25142169|NCT02952157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25142170|NCT02952157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142171|NCT02951754|Methylphenidate|methylphenidate|mesh-list
25142172|NCT02951754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25142173|NCT02951754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142174|NCT02951754|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25142175|NCT02951754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25142176|NCT02951754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25142177|NCT02951754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142178|NCT02951754|Dopamine Agents|dopamine agents|mesh-ancestor
25142179|NCT02951754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25142180|NCT02951728|Prednisone|prednisone|mesh-list
25142181|NCT02951728|Cyclophosphamide|cyclophosphamide|mesh-list
25142182|NCT02951728|Rituximab|rituximab|mesh-list
25142183|NCT02951728|Doxorubicin|doxorubicin|mesh-list
25142184|NCT02951728|Vincristine|vincristine|mesh-list
25142185|NCT02951728|Decitabine|decitabine|mesh-list
25142186|NCT02951728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25142187|NCT02951728|Immunologic Factors|immunologic factors|mesh-ancestor
25684326|NCT01890746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25684327|NCT01890746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25684328|NCT01890746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25684329|NCT01890746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25684330|NCT01890785|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25684331|NCT01890785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25684332|NCT01890785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684333|NCT01890785|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25684334|NCT01890785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25684335|NCT01890785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25684336|NCT01890785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115095|NCT03118037|Anticonvulsants|anticonvulsants|mesh-ancestor
25115096|NCT03118037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25115097|NCT03118037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25115098|NCT03118037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115099|NCT03118037|GABA Modulators|gaba modulators|mesh-ancestor
25142188|NCT02951728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142189|NCT02951728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25142190|NCT02951728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25142191|NCT02951728|Alkylating Agents|alkylating agents|mesh-ancestor
25142192|NCT02951728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142193|NCT02951728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142194|NCT02951728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25142195|NCT02951728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25142196|NCT02951728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25142197|NCT02951728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25142198|NCT02951728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25142199|NCT02951728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25142200|NCT02951728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25142201|NCT02951728|Glucocorticoids|glucocorticoids|mesh-ancestor
25142203|NCT02951728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25142204|NCT02951728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25142205|NCT02951728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25142206|NCT02951728|Tubulin Modulators|tubulin modulators|mesh-ancestor
25142207|NCT02951728|Antimitotic Agents|antimitotic agents|mesh-ancestor
25142208|NCT02951728|Mitosis Modulators|mitosis modulators|mesh-ancestor
25142209|NCT02951728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25142210|NCT02951728|Antimetabolites|antimetabolites|mesh-ancestor
25142221|NCT02951975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25142222|NCT02951975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142223|NCT02951806|Fentanyl|fentanyl|mesh-list
25142224|NCT02951806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25142225|NCT02951806|Narcotics|narcotics|mesh-ancestor
25142226|NCT02951806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25142227|NCT02951806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142228|NCT02951806|Analgesics|analgesics|mesh-ancestor
25047184|NCT00831051|Sensory System Agents|sensory system agents|mesh-ancestor
25142229|NCT02951806|Sensory System Agents|sensory system agents|mesh-ancestor
25142230|NCT02951806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25142231|NCT02951806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25142232|NCT02951806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25142233|NCT02951806|Anesthetics, General|anesthetics, general|mesh-ancestor
25142234|NCT02951806|Anesthetics|anesthetics|mesh-ancestor
25142237|NCT02951962|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
25142238|NCT02951962|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25142239|NCT02951962|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25142240|NCT02951962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25142241|NCT02951962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25142242|NCT02951962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142243|NCT02951962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25142244|NCT02951962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142245|NCT02951962|Vasodilator Agents|vasodilator agents|mesh-ancestor
25142246|NCT02951962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25142247|NCT02951962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25142248|NCT02951962|Antimetabolites|antimetabolites|mesh-ancestor
25142249|NCT02951962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25142250|NCT02951962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25142251|NCT02951962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047185|NCT00831051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25047186|NCT00830336|Azithromycin|azithromycin|mesh-list
25047187|NCT00830336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25047188|NCT00830336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25047189|NCT00830258|Pravastatin|pravastatin|mesh-list
25047190|NCT00830258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25047191|NCT00830258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25047192|NCT00830258|Antimetabolites|antimetabolites|mesh-ancestor
25047193|NCT00830258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047194|NCT00830258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25684337|NCT01890785|Dopamine Agents|dopamine agents|mesh-ancestor
25684338|NCT01890785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25684339|NCT01890967|Atorvastatin|atorvastatin|mesh-list
25684340|NCT01890967|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25684341|NCT01890967|Simvastatin|simvastatin|mesh-list
25684342|NCT01890967|Ezetimibe|ezetimibe|mesh-list
25684343|NCT01890967|Pravastatin|pravastatin|mesh-list
25287481|NCT04122196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287482|NCT04122196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25287483|NCT04122196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25287484|NCT04122196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25287485|NCT04122196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25287486|NCT04122196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25047195|NCT00830258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25047196|NCT00830258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047198|NCT00830219|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25047199|NCT00830219|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25047200|NCT00830219|Dopamine Agonists|dopamine agonists|mesh-ancestor
25047201|NCT00830219|Dopamine Agents|dopamine agents|mesh-ancestor
25047202|NCT00830219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25047203|NCT00830219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047204|NCT00830219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047205|NCT00830206|Azithromycin|azithromycin|mesh-list
25047206|NCT00830206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25014449|NCT04517435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25014450|NCT04517435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25047215|NCT00830102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047216|NCT00830102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25047217|NCT00830102|Respiratory System Agents|respiratory system agents|mesh-ancestor
25047218|NCT00830102|Dermatologic Agents|dermatologic agents|mesh-ancestor
25047219|NCT00830102|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25047220|NCT00830102|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25047221|NCT00830102|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25047222|NCT00830102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25047223|NCT00830102|Adrenergic Agents|adrenergic agents|mesh-ancestor
25047224|NCT00830102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25142260|NCT02951897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25142262|NCT02951637|Pemetrexed|pemetrexed|mesh-list
25142263|NCT02951637|Gefitinib|gefitinib|mesh-list
25142264|NCT02951637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142265|NCT02951637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25142266|NCT02951637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142267|NCT02951637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25142268|NCT02951637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25142269|NCT02951637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25142270|NCT02951234|Aspirin|aspirin|mesh-list
25142271|NCT02951234|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25142272|NCT02951234|gamma-Globulins|gamma-globulins|mesh-list
25142273|NCT02951234|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25142274|NCT02951234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25142275|NCT02951234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25142276|NCT02951234|Analgesics|analgesics|mesh-ancestor
25142277|NCT02951234|Sensory System Agents|sensory system agents|mesh-ancestor
25142278|NCT02951234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25142279|NCT02951234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142280|NCT02951234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25142281|NCT02951234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25142282|NCT02951234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25142283|NCT02951234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25142284|NCT02951234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142285|NCT02951234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24760932|NCT01760564|Miglustat|miglustat|mesh-list
24881355|NCT02636387|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24881356|NCT02636387|Hemostatics|hemostatics|mesh-ancestor
24881357|NCT02636387|Coagulants|coagulants|mesh-ancestor
24881358|NCT02636387|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24881362|NCT02576574|Paclitaxel|paclitaxel|mesh-list
24881363|NCT02576574|Carboplatin|carboplatin|mesh-list
24881364|NCT02576574|Pemetrexed|pemetrexed|mesh-list
25142290|NCT02951260|Metformin|metformin|mesh-list
25142291|NCT02951260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25142292|NCT02951260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142293|NCT02951299|Pentoxifylline|pentoxifylline|mesh-list
25142294|NCT02951299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25142295|NCT02951299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25684344|NCT01890967|Pitavastatin|pitavastatin|mesh-list
25684345|NCT01890967|Lovastatin|lovastatin|mesh-list
25684346|NCT01890967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25684347|NCT01890967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25684348|NCT01890967|Antimetabolites|antimetabolites|mesh-ancestor
25684349|NCT01890967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684350|NCT01890967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25287529|NCT03966053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25287530|NCT03966053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287531|NCT03943511|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25287532|NCT03943511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25287540|NCT03898154|Dexamethasone|dexamethasone|mesh-list
25287541|NCT03898154|Methylprednisolone|methylprednisolone|mesh-list
25287542|NCT03898154|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25142296|NCT02951299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142297|NCT02951299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24478432|NCT00422773|Cetuximab|cetuximab|mesh-list
25142298|NCT02951299|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25142299|NCT02951299|Protective Agents|protective agents|mesh-ancestor
25142300|NCT02951299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142301|NCT02951299|Vasodilator Agents|vasodilator agents|mesh-ancestor
25142302|NCT02951299|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25142303|NCT02951299|Antioxidants|antioxidants|mesh-ancestor
25142304|NCT02950948|Progesterone|progesterone|mesh-list
25142305|NCT02950948|Progestins|progestins|mesh-ancestor
25142306|NCT02950948|Hormones|hormones|mesh-ancestor
25142307|NCT02950948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25142312|NCT02951039|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25142313|NCT02951039|Protease Inhibitors|protease inhibitors|mesh-ancestor
25142314|NCT02951039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450002|NCT00317577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25142315|NCT02951039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142316|NCT02951039|Anticoagulants|anticoagulants|mesh-ancestor
25142317|NCT02951117|Dexamethasone|dexamethasone|mesh-list
25142318|NCT02951117|Venetoclax|venetoclax|mesh-list
25142319|NCT02951117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25142320|NCT02951117|Antiemetics|antiemetics|mesh-ancestor
25142321|NCT02951117|Autonomic Agents|autonomic agents|mesh-ancestor
25142322|NCT02951117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25142323|NCT02951117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142324|NCT02951117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25142325|NCT02951117|Glucocorticoids|glucocorticoids|mesh-ancestor
25142326|NCT02951117|Hormones|hormones|mesh-ancestor
25142354|NCT02950623|Dermatologic Agents|dermatologic agents|mesh-ancestor
25142355|NCT02950623|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25142356|NCT02950584|Titanium dioxide|titanium dioxide|mesh-list
24807284|NCT02021097|Levonorgestrel|levonorgestrel|mesh-list
25142357|NCT02950584|Sunscreening Agents|sunscreening agents|mesh-ancestor
25142358|NCT02950584|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25142359|NCT02950584|Protective Agents|protective agents|mesh-ancestor
25142360|NCT02950584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142361|NCT02950584|Dermatologic Agents|dermatologic agents|mesh-ancestor
25142362|NCT02950584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25142363|NCT02950441|Niacinamide|niacinamide|mesh-list
25142364|NCT02950441|Niacin|niacin|mesh-list
25142365|NCT02950441|Nicotinic Acids|nicotinic acids|mesh-list
25142366|NCT02950441|Vitamin B Complex|vitamin b complex|mesh-ancestor
25142367|NCT02950441|Vitamins|vitamins|mesh-ancestor
25142368|NCT02950441|Micronutrients|micronutrients|mesh-ancestor
25142369|NCT02950441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142370|NCT02950441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25142371|NCT02950441|Antimetabolites|antimetabolites|mesh-ancestor
24760958|NCT01760642|Rifampin|rifampin|mesh-list
25142374|NCT02950441|Vasodilator Agents|vasodilator agents|mesh-ancestor
25142376|NCT02950246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25142377|NCT02950246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25142378|NCT02950246|Disinfectants|disinfectants|mesh-ancestor
25142379|NCT02950220|Pembrolizumab|pembrolizumab|mesh-list
25142380|NCT02950220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25142381|NCT02950220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142382|NCT02950168|Edoxaban|edoxaban|mesh-list
25142383|NCT02950168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25142384|NCT02950168|Antithrombins|antithrombins|mesh-ancestor
25142385|NCT02950168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25142386|NCT02950168|Protease Inhibitors|protease inhibitors|mesh-ancestor
25142387|NCT02950168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25142388|NCT02950168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684351|NCT01890967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25684352|NCT01890967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25684353|NCT01891331|Fluconazole|fluconazole|mesh-list
25684354|NCT01891331|Antifungal Agents|antifungal agents|mesh-ancestor
25684355|NCT01891331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25684356|NCT01891331|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25684357|NCT01891331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25142389|NCT02950168|Anticoagulants|anticoagulants|mesh-ancestor
25287573|NCT03827447|Vancomycin|vancomycin|mesh-list
25142390|NCT02950233|N-Methylaspartate|n-methylaspartate|mesh-list
25142400|NCT02950155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142401|NCT02950155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25142402|NCT02950038|Nivolumab|nivolumab|mesh-list
25142403|NCT02950038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25142404|NCT02950038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142405|NCT02950038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25142406|NCT02950038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142407|NCT02950051|Cyclophosphamide|cyclophosphamide|mesh-list
24881568|NCT02101853|Vitamins|vitamins|mesh-ancestor
24881569|NCT02101853|Micronutrients|micronutrients|mesh-ancestor
24807302|NCT02021123|Anidulafungin|anidulafungin|mesh-list
24881570|NCT02101853|Tubulin Modulators|tubulin modulators|mesh-ancestor
24881571|NCT02101853|Antimitotic Agents|antimitotic agents|mesh-ancestor
24881572|NCT02101853|Mitosis Modulators|mitosis modulators|mesh-ancestor
24881573|NCT02101853|Hematinics|hematinics|mesh-ancestor
25142408|NCT02950051|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25142409|NCT02950051|Rituximab|rituximab|mesh-list
25142410|NCT02950051|Fludarabine|fludarabine|mesh-list
25142411|NCT02950051|Venetoclax|venetoclax|mesh-list
25142412|NCT02950051|Obinutuzumab|obinutuzumab|mesh-list
25142413|NCT02950051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25142414|NCT02950051|Immunologic Factors|immunologic factors|mesh-ancestor
25142415|NCT02950051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142416|NCT02950051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25142417|NCT02950051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25142418|NCT02950051|Alkylating Agents|alkylating agents|mesh-ancestor
25142419|NCT02950051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142420|NCT02950051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142421|NCT02950051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25142422|NCT02950051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25142423|NCT02949752|Aripiprazole|aripiprazole|mesh-list
25142424|NCT02949752|Antidepressive Agents|antidepressive agents|mesh-ancestor
25142425|NCT02949752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25142426|NCT02949752|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25047236|NCT00830024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047237|NCT00829998|Zaleplon|zaleplon|mesh-list
25047238|NCT00829998|Anticonvulsants|anticonvulsants|mesh-ancestor
25047239|NCT00829998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25047240|NCT00829998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25047241|NCT00829998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047245|NCT00829998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881574|NCT02101853|Analgesics|analgesics|mesh-ancestor
24881575|NCT02101853|Sensory System Agents|sensory system agents|mesh-ancestor
24478581|NCT00423696|Leucovorin|leucovorin|mesh-list
24881636|NCT01918644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24881637|NCT01918644|Antimetabolites|antimetabolites|mesh-ancestor
25047247|NCT00829868|Anticonvulsants|anticonvulsants|mesh-ancestor
25047248|NCT00829868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25047249|NCT00829868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25047250|NCT00829868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047251|NCT00829868|GABA Modulators|gaba modulators|mesh-ancestor
25047252|NCT00829868|GABA Agents|gaba agents|mesh-ancestor
25047253|NCT00829868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25047254|NCT00829868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047255|NCT00829790|Doxycycline|doxycycline|mesh-list
25047256|NCT00829790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25142911|NCT02946294|Epinephryl borate|epinephryl borate|mesh-list
25142430|NCT02949752|Dopamine Agonists|dopamine agonists|mesh-ancestor
25142431|NCT02949752|Dopamine Agents|dopamine agents|mesh-ancestor
25142432|NCT02949752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25142433|NCT02949752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142434|NCT02949752|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25142435|NCT02949752|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25142436|NCT02949752|Serotonin Agents|serotonin agents|mesh-ancestor
25142437|NCT02949752|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25142438|NCT02949752|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25142439|NCT02949752|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25142440|NCT02949752|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25142442|NCT02949895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142443|NCT02949895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25142444|NCT02949895|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25142445|NCT02949895|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25684358|NCT01891331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25142447|NCT02949895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142452|NCT02949648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142453|NCT02949648|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25142454|NCT02949648|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25142455|NCT02949648|Cholinergic Agents|cholinergic agents|mesh-ancestor
25142456|NCT02949648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25142457|NCT02949648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142459|NCT02949583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25142460|NCT02949583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25142461|NCT02949583|Disinfectants|disinfectants|mesh-ancestor
25142463|NCT02949765|Trace Elements|trace elements|mesh-ancestor
25142464|NCT02949765|Micronutrients|micronutrients|mesh-ancestor
25142465|NCT02949765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142466|NCT02949843|Pembrolizumab|pembrolizumab|mesh-list
25142467|NCT02949843|Nivolumab|nivolumab|mesh-list
25142468|NCT02949843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25142469|NCT02949843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142470|NCT02949843|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25142471|NCT02949843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142473|NCT02949778|Anesthetics, Local|anesthetics, local|mesh-ancestor
25142474|NCT02949778|Anesthetics|anesthetics|mesh-ancestor
25142475|NCT02949778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25142476|NCT02949778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142477|NCT02949778|Sensory System Agents|sensory system agents|mesh-ancestor
25142478|NCT02949778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25142479|NCT02949492|Interleukin-2|interleukin-2|mesh-list
25142480|NCT02949492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142481|NCT02949492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25142482|NCT02949492|Analgesics|analgesics|mesh-ancestor
24965778|NCT03774836|Narcotics|narcotics|mesh-ancestor
24881638|NCT01918644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881639|NCT01918644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816084|NCT02074150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24816085|NCT02074150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816087|NCT02074150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24816088|NCT02074163|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24816089|NCT02074163|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24816090|NCT02074163|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25142483|NCT02949492|Sensory System Agents|sensory system agents|mesh-ancestor
25142484|NCT02949492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25142485|NCT02949492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142486|NCT02949232|Prednisolone|prednisolone|mesh-list
25142487|NCT02949232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25142488|NCT02949232|Glucocorticoids|glucocorticoids|mesh-ancestor
25142489|NCT02949232|Hormones|hormones|mesh-ancestor
25142912|NCT02946294|Anesthetics, Local|anesthetics, local|mesh-ancestor
25142491|NCT02949232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142492|NCT02949232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25142493|NCT02949232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142494|NCT02949466|Triamcinolone|triamcinolone|mesh-list
25142495|NCT02949466|Hyaluronic Acid|hyaluronic acid|mesh-list
25142496|NCT02949466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25142497|NCT02949466|Glucocorticoids|glucocorticoids|mesh-ancestor
25142498|NCT02949466|Hormones|hormones|mesh-ancestor
25142499|NCT02949466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25142500|NCT02949466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142501|NCT02949466|Immunologic Factors|immunologic factors|mesh-ancestor
24478771|NCT00424281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24478772|NCT00424333|Insulin|insulin|mesh-list
24478773|NCT00424333|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25142502|NCT02949466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25142503|NCT02949466|Viscosupplements|viscosupplements|mesh-ancestor
25142504|NCT02949466|Protective Agents|protective agents|mesh-ancestor
25142505|NCT02949310|Nefopam|nefopam|mesh-list
25142506|NCT02949310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25142507|NCT02949310|Analgesics|analgesics|mesh-ancestor
25142508|NCT02949310|Sensory System Agents|sensory system agents|mesh-ancestor
25142509|NCT02949310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25142510|NCT02949310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142511|NCT02949349|Mycophenolic Acid|mycophenolic acid|mesh-list
25142512|NCT02949349|Prednisolone|prednisolone|mesh-list
25142513|NCT02949349|Azathioprine|azathioprine|mesh-list
25142514|NCT02949349|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25142515|NCT02949349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142516|NCT02949349|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25142517|NCT02949349|Antitubercular Agents|antitubercular agents|mesh-ancestor
25142518|NCT02949349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25142519|NCT02949349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25142520|NCT02949349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25142521|NCT02949349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142522|NCT02949349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25142523|NCT02949349|Glucocorticoids|glucocorticoids|mesh-ancestor
25142524|NCT02949349|Hormones|hormones|mesh-ancestor
25142525|NCT02949349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25142526|NCT02949349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142527|NCT02949349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25142528|NCT02949349|Antimetabolites|antimetabolites|mesh-ancestor
25142529|NCT02949349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25142530|NCT02949349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25142531|NCT02949349|Immunologic Factors|immunologic factors|mesh-ancestor
25142532|NCT02949349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25142533|NCT02949206|Thrombin|thrombin|mesh-list
25142534|NCT02949206|Hemostatics|hemostatics|mesh-ancestor
25142535|NCT02949206|Coagulants|coagulants|mesh-ancestor
25142536|NCT02949258|Oxaliplatin|oxaliplatin|mesh-list
25142537|NCT02949258|Etoposide|etoposide|mesh-list
25142538|NCT02949258|Epirubicin|epirubicin|mesh-list
25142539|NCT02949258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142540|NCT02949258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25142541|NCT02949258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25142542|NCT02949258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25142543|NCT02949258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25142544|NCT02949258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142545|NCT02949258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25142546|NCT02949193|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25142547|NCT02949193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25142548|NCT02949193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142549|NCT02949193|Incretins|incretins|mesh-ancestor
25142550|NCT02949193|Hormones|hormones|mesh-ancestor
25142552|NCT02949193|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25142569|NCT02948920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142570|NCT02948920|Sympathomimetics|sympathomimetics|mesh-ancestor
25142571|NCT02948920|Autonomic Agents|autonomic agents|mesh-ancestor
25047259|NCT00829790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25142572|NCT02948920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25142573|NCT02948920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25142574|NCT02948920|Adrenergic Agents|adrenergic agents|mesh-ancestor
25142588|NCT02948348|Capecitabine|capecitabine|mesh-list
25142590|NCT02948348|Ipilimumab|ipilimumab|mesh-list
25142599|NCT02948283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25142600|NCT02948283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142601|NCT02948283|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25142602|NCT02948283|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25142603|NCT02948283|Protease Inhibitors|protease inhibitors|mesh-ancestor
25142604|NCT02948283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25142605|NCT02948283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142606|NCT02948283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24478909|NCT00424931|Modafinil|modafinil|mesh-list
25142607|NCT02948283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25142608|NCT02948283|Antiviral Agents|antiviral agents|mesh-ancestor
25142609|NCT02948283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25142610|NCT02948283|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25142611|NCT02948283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25142612|NCT02947945|Reslizumab|reslizumab|mesh-list
25142613|NCT02947945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25142614|NCT02947945|Respiratory System Agents|respiratory system agents|mesh-ancestor
25142615|NCT02948101|Cyclophosphamide|cyclophosphamide|mesh-list
25142616|NCT02948101|Antibodies|antibodies|mesh-list
25142617|NCT02948101|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25142618|NCT02948101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25142619|NCT02948101|Immunologic Factors|immunologic factors|mesh-ancestor
25142620|NCT02948101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142621|NCT02948101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25142622|NCT02948101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25142623|NCT02948101|Alkylating Agents|alkylating agents|mesh-ancestor
25142624|NCT02948101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142625|NCT02948101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142626|NCT02948101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25142628|NCT02948075|Carboplatin|carboplatin|mesh-list
25142629|NCT02948075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25142630|NCT02948075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142631|NCT02948075|Tubulin Modulators|tubulin modulators|mesh-ancestor
25142632|NCT02948075|Antimitotic Agents|antimitotic agents|mesh-ancestor
25142633|NCT02948075|Mitosis Modulators|mitosis modulators|mesh-ancestor
25142644|NCT02947932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25142645|NCT02947932|Analgesics|analgesics|mesh-ancestor
25142646|NCT02947932|Sensory System Agents|sensory system agents|mesh-ancestor
25142647|NCT02947932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25142648|NCT02947932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25142649|NCT02947932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25142650|NCT02947932|Gout Suppressants|gout suppressants|mesh-ancestor
25142651|NCT02947932|Tocolytic Agents|tocolytic agents|mesh-ancestor
25142652|NCT02947932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25142653|NCT02947932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25142654|NCT02947880|Bumetanide|bumetanide|mesh-list
25142655|NCT02947880|Diuretics|diuretics|mesh-ancestor
25142656|NCT02947880|Natriuretic Agents|natriuretic agents|mesh-ancestor
25142657|NCT02947880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142658|NCT02947880|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25142659|NCT02947880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25142660|NCT02947880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142661|NCT02947711|Diltiazem|diltiazem|mesh-list
25142662|NCT02947711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25142667|NCT02947711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142670|NCT02947620|Atorvastatin|atorvastatin|mesh-list
25142671|NCT02947620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25142672|NCT02947620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142673|NCT02947620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25142674|NCT02947620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25142675|NCT02947620|Antimetabolites|antimetabolites|mesh-ancestor
25142676|NCT02947620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142677|NCT02947620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25142678|NCT02947620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25142682|NCT02947854|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
25142683|NCT02947854|Interferon Inducers|interferon inducers|mesh-ancestor
25142684|NCT02947854|Immunologic Factors|immunologic factors|mesh-ancestor
25142685|NCT02947854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142686|NCT02947854|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25142687|NCT02947854|Dermatologic Agents|dermatologic agents|mesh-ancestor
25142688|NCT02947763|Metronidazole|metronidazole|mesh-list
25142689|NCT02947763|Ciprofloxacin|ciprofloxacin|mesh-list
25142690|NCT02947763|Minocycline|minocycline|mesh-list
25142691|NCT02947763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25142692|NCT02947763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25142693|NCT02947763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25142694|NCT02947763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25142695|NCT02947763|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25142696|NCT02947763|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25142697|NCT02947763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25142698|NCT02947763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142699|NCT02947763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142700|NCT02947763|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25142701|NCT02947763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25142702|NCT02947815|Botulinum Toxins|botulinum toxins|mesh-list
25142703|NCT02947815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25142704|NCT02947815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25142705|NCT02947815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25142706|NCT02947815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25142707|NCT02947815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142708|NCT02947815|Cholinergic Agents|cholinergic agents|mesh-ancestor
25142709|NCT02947815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25047268|NCT00829712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25047270|NCT00829712|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25047271|NCT00829712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25047272|NCT00829712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25047273|NCT00829712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047274|NCT00829712|Dopamine Agents|dopamine agents|mesh-ancestor
25047275|NCT00829712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25047276|NCT00829686|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25142718|NCT02947737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142720|NCT02947529|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25142721|NCT02947529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25142722|NCT02947529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142723|NCT02947529|Hemostatics|hemostatics|mesh-ancestor
25142724|NCT02947529|Coagulants|coagulants|mesh-ancestor
25142725|NCT02947672|Dexamethasone|dexamethasone|mesh-list
25142726|NCT02947672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25142727|NCT02947672|Antiemetics|antiemetics|mesh-ancestor
25142728|NCT02947672|Autonomic Agents|autonomic agents|mesh-ancestor
25142729|NCT02947672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25142730|NCT02947672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142731|NCT02947672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25142732|NCT02947672|Glucocorticoids|glucocorticoids|mesh-ancestor
24881774|NCT01358877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24881776|NCT01358877|Tubulin Modulators|tubulin modulators|mesh-ancestor
24881777|NCT01358877|Antimitotic Agents|antimitotic agents|mesh-ancestor
24881778|NCT01358877|Mitosis Modulators|mitosis modulators|mesh-ancestor
24881779|NCT01358877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881864|NCT01004029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24602527|NCT00969176|Sensory System Agents|sensory system agents|mesh-ancestor
24602528|NCT00969176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24881865|NCT01004029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881973|NCT00006455|Hydrocortisone|hydrocortisone|mesh-list
24881975|NCT00006455|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24881976|NCT00006455|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24881977|NCT00006455|Cyclophosphamide|cyclophosphamide|mesh-list
24881978|NCT00006455|Ifosfamide|ifosfamide|mesh-list
24881979|NCT00006455|Doxorubicin|doxorubicin|mesh-list
24881980|NCT00006455|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25142734|NCT02947672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25142735|NCT02947672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25142737|NCT02947178|Bupivacaine|bupivacaine|mesh-list
25142738|NCT02947178|Anesthetics, Local|anesthetics, local|mesh-ancestor
25142739|NCT02947178|Anesthetics|anesthetics|mesh-ancestor
25142740|NCT02947178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25142741|NCT02947178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142742|NCT02947178|Sensory System Agents|sensory system agents|mesh-ancestor
25142743|NCT02947178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25142744|NCT02947438|Epoetin Alfa|epoetin alfa|mesh-list
25142745|NCT02947438|Hematinics|hematinics|mesh-ancestor
25142752|NCT02947113|Etoposide|etoposide|mesh-list
25142753|NCT02947113|Pemetrexed|pemetrexed|mesh-list
25142754|NCT02947113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761321|NCT01762202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761322|NCT01762202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24761324|NCT01762306|Diclofenac|diclofenac|mesh-list
24882034|NCT02983617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882036|NCT02979977|Afatinib|afatinib|mesh-list
24882037|NCT02979977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24882052|NCT02866682|Immunologic Factors|immunologic factors|mesh-ancestor
24882053|NCT02866682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882054|NCT02866682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24882055|NCT02866682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24882056|NCT02866682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882081|NCT02827526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24882082|NCT02827526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24882083|NCT02827526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24882084|NCT02827526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602530|NCT00969176|Antipyretics|antipyretics|mesh-ancestor
25142755|NCT02947113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25142756|NCT02947113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25142757|NCT02947113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25142758|NCT02947113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25142759|NCT02947113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142760|NCT02947113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25142761|NCT02947113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25142762|NCT02947334|Bococizumab|bococizumab|mesh-list
25142763|NCT02947334|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25142764|NCT02947334|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25142765|NCT02947334|Antimetabolites|antimetabolites|mesh-ancestor
25142766|NCT02947334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142767|NCT02947334|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25142768|NCT02947269|Prucalopride|prucalopride|mesh-list
25142769|NCT02947269|Laxatives|laxatives|mesh-ancestor
25142770|NCT02947269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25142771|NCT02947269|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
25142772|NCT02947269|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25142773|NCT02947269|Serotonin Agents|serotonin agents|mesh-ancestor
25142774|NCT02947269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25142775|NCT02947269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142913|NCT02946294|Anesthetics|anesthetics|mesh-ancestor
24882356|NCT01111565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24882357|NCT01111565|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25142783|NCT02947243|Sensory System Agents|sensory system agents|mesh-ancestor
25047465|NCT00810732|Vasodilator Agents|vasodilator agents|mesh-ancestor
25142826|NCT02947061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142827|NCT02947061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25142828|NCT02947061|Antimetabolites|antimetabolites|mesh-ancestor
25142830|NCT02946671|Mogamulizumab|mogamulizumab|mesh-list
25142831|NCT02946671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25142832|NCT02946671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142833|NCT02946671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24816126|NCT02074267|Anticonvulsants|anticonvulsants|mesh-ancestor
24816127|NCT02074267|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24882443|NCT05170828|Fludarabine|fludarabine|mesh-list
24882444|NCT05170828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24882445|NCT05170828|Immunologic Factors|immunologic factors|mesh-ancestor
24882446|NCT05170828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882447|NCT05170828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24882448|NCT05170828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24882449|NCT05170828|Alkylating Agents|alkylating agents|mesh-ancestor
24882450|NCT05170828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882523|NCT05169593|Infliximab|infliximab|mesh-list
24882524|NCT05169593|Ustekinumab|ustekinumab|mesh-list
24882525|NCT05169593|Vedolizumab|vedolizumab|mesh-list
24882526|NCT05169593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24882527|NCT05169593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24882528|NCT05169593|Dermatologic Agents|dermatologic agents|mesh-ancestor
24882624|NCT05168007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882625|NCT05168007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24882627|NCT05167851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24882628|NCT05167851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24882629|NCT05167851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142834|NCT02946671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142835|NCT02946684|Letrozole|letrozole|mesh-list
25142836|NCT02946684|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25142837|NCT02946684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142838|NCT02946684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25142839|NCT02946684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25142847|NCT02946801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25142848|NCT02946801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25142850|NCT02946801|Protective Agents|protective agents|mesh-ancestor
25142851|NCT02946801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142852|NCT02946359|Bevacizumab|bevacizumab|mesh-list
25142853|NCT02946359|Crizotinib|crizotinib|mesh-list
25142854|NCT02946359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25142855|NCT02946359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142856|NCT02946359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25142857|NCT02946359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25142859|NCT02946359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142864|NCT02946437|Midazolam|midazolam|mesh-list
25142884|NCT02946814|Sodium Fluoride|sodium fluoride|mesh-list
25142885|NCT02946814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25142886|NCT02946814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25142887|NCT02946814|Cariostatic Agents|cariostatic agents|mesh-ancestor
25142888|NCT02946814|Protective Agents|protective agents|mesh-ancestor
25142889|NCT02946814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142890|NCT02946632|Metformin|metformin|mesh-list
25142891|NCT02946632|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25142892|NCT02946632|Dapagliflozin|dapagliflozin|mesh-list
25142893|NCT02946632|Glimepiride|glimepiride|mesh-list
25142894|NCT02946632|Saxagliptin|saxagliptin|mesh-list
25142895|NCT02946632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25142896|NCT02946632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115538|NCT03115307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25115539|NCT03115307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25115540|NCT03115307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25115541|NCT03115320|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25115542|NCT03115320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25115543|NCT03115320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115544|NCT03115619|Pirfenidone|pirfenidone|mesh-list
25115545|NCT03115619|Analgesics|analgesics|mesh-ancestor
25115546|NCT03115619|Sensory System Agents|sensory system agents|mesh-ancestor
25115547|NCT03115619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25142897|NCT02946632|Incretins|incretins|mesh-ancestor
25142899|NCT02946632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25142900|NCT02946632|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24882630|NCT05167175|Prednisone|prednisone|mesh-list
24882631|NCT05167175|Olaparib|olaparib|mesh-list
24479656|NCT00427713|Capecitabine|capecitabine|mesh-list
24882632|NCT05167175|Abiraterone Acetate|abiraterone acetate|mesh-list
24882633|NCT05167175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24882647|NCT05167123|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24816139|NCT02074280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24704959|NCT01481389|Theobromine|theobromine|mesh-list
24455175|NCT02448771|Palbociclib|palbociclib|mesh-list
25142907|NCT02946632|Immunologic Factors|immunologic factors|mesh-ancestor
25142908|NCT02946294|Epinephrine|epinephrine|mesh-list
25142909|NCT02946294|Racepinephrine|racepinephrine|mesh-list
25142918|NCT02946294|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25142920|NCT02946294|Adrenergic Agents|adrenergic agents|mesh-ancestor
25142921|NCT02946294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25142922|NCT02946294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142923|NCT02946294|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25142924|NCT02946294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25142925|NCT02946294|Autonomic Agents|autonomic agents|mesh-ancestor
25142926|NCT02946294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25142927|NCT02946294|Respiratory System Agents|respiratory system agents|mesh-ancestor
25142928|NCT02946294|Mydriatics|mydriatics|mesh-ancestor
25142929|NCT02946294|Sympathomimetics|sympathomimetics|mesh-ancestor
25142930|NCT02946294|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25142931|NCT02946268|Ropivacaine|ropivacaine|mesh-list
25142932|NCT02946268|Anesthetics, Local|anesthetics, local|mesh-ancestor
24479787|NCT00428428|Isoproterenol|isoproterenol|mesh-list
24882795|NCT04957368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24882796|NCT04957368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24882797|NCT04957368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882798|NCT04957368|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24882799|NCT04957368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24882800|NCT04957368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24882801|NCT04957368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24882802|NCT04957368|Anesthetics, General|anesthetics, general|mesh-ancestor
24882803|NCT04957368|Anesthetics|anesthetics|mesh-ancestor
24882813|NCT04933682|Rifampin|rifampin|mesh-list
24506282|NCT00544570|Immunologic Factors|immunologic factors|mesh-ancestor
25142935|NCT02946268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142937|NCT02946268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25142940|NCT02946060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142941|NCT02946060|Protective Agents|protective agents|mesh-ancestor
25142942|NCT02946060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047277|NCT00829686|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25047278|NCT00829686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24479858|NCT00428558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24882849|NCT04929600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25684359|NCT01891331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684360|NCT01891331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25684361|NCT01891331|Hormone Antagonists|hormone antagonists|mesh-ancestor
25684362|NCT01891331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25684363|NCT01891331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684364|NCT01891331|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25684365|NCT01891331|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25684366|NCT01891357|Paclitaxel|paclitaxel|mesh-list
25684367|NCT01891357|Trastuzumab|trastuzumab|mesh-list
24882854|NCT04928521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882997|NCT04673617|Analgesics|analgesics|mesh-ancestor
24882998|NCT04673617|Sensory System Agents|sensory system agents|mesh-ancestor
24807688|NCT02023164|Promethazine|promethazine|mesh-list
25047301|NCT00829504|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25047302|NCT00829504|Dopamine Agonists|dopamine agonists|mesh-ancestor
25047303|NCT00829504|Dopamine Agents|dopamine agents|mesh-ancestor
25047304|NCT00829504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24761432|NCT01762657|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25047305|NCT00829504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047306|NCT00829504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047308|NCT00829452|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25047309|NCT00829452|Protease Inhibitors|protease inhibitors|mesh-ancestor
25047310|NCT00829452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047311|NCT00829452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047312|NCT00829452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25047314|NCT00829426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25047315|NCT00829426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25047316|NCT00829426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142944|NCT02945982|Carvedilol|carvedilol|mesh-list
25142945|NCT02945982|Antiviral Agents|antiviral agents|mesh-ancestor
25142946|NCT02945982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25142948|NCT02945982|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25142949|NCT02945982|Adrenergic Agents|adrenergic agents|mesh-ancestor
25142950|NCT02945982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25142951|NCT02945982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142952|NCT02945982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142953|NCT02945982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25142954|NCT02945982|Antioxidants|antioxidants|mesh-ancestor
25142955|NCT02945982|Protective Agents|protective agents|mesh-ancestor
25142956|NCT02945982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25142957|NCT02945982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25142958|NCT02945982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25142959|NCT02945982|Vasodilator Agents|vasodilator agents|mesh-ancestor
24883156|NCT04363840|Aspirin|aspirin|mesh-list
24883157|NCT04363840|Vitamin D|vitamin d|mesh-list
24883158|NCT04363840|Vitamins|vitamins|mesh-ancestor
24883159|NCT04363840|Micronutrients|micronutrients|mesh-ancestor
24883160|NCT04363840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883161|NCT04363840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24883162|NCT04363840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24883163|NCT04363840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24883164|NCT04363840|Analgesics|analgesics|mesh-ancestor
24883166|NCT04363840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24883167|NCT04363840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24883183|NCT04337060|Sensory System Agents|sensory system agents|mesh-ancestor
24883184|NCT04337060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24883185|NCT04337060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24883186|NCT04337060|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24883187|NCT04337060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24883188|NCT04337060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24883189|NCT04337060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883190|NCT04337060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24883191|NCT04337060|Narcotics|narcotics|mesh-ancestor
24883192|NCT04337060|Analgesics|analgesics|mesh-ancestor
24883193|NCT04330183|Ketamine|ketamine|mesh-list
24883211|NCT04300595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24507414|NCT00550342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507415|NCT00550342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24507416|NCT00550433|Bazedoxifene|bazedoxifene|mesh-list
24507417|NCT00550433|Estrogens|estrogens|mesh-list
24883212|NCT04300595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883213|NCT04297293|Ramosetron|ramosetron|mesh-list
24883214|NCT04297293|Antiemetics|antiemetics|mesh-ancestor
24883273|NCT04060758|Latanoprost|latanoprost|mesh-list
24883274|NCT04060758|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24807728|NCT02023450|Ritonavir|ritonavir|mesh-list
24883275|NCT04060758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24883277|NCT04058990|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25142960|NCT02945982|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25142961|NCT02945982|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25142962|NCT02945956|Entecavir|entecavir|mesh-list
25142963|NCT02945956|Antiviral Agents|antiviral agents|mesh-ancestor
25142964|NCT02945956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25142965|NCT02945696|Ropivacaine|ropivacaine|mesh-list
25142966|NCT02945696|Anesthetics, Local|anesthetics, local|mesh-ancestor
25142967|NCT02945696|Anesthetics|anesthetics|mesh-ancestor
25142968|NCT02945696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25142969|NCT02945696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142970|NCT02945696|Sensory System Agents|sensory system agents|mesh-ancestor
25142971|NCT02945696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25142972|NCT02945839|Topiramate|topiramate|mesh-list
25142973|NCT02945839|Anticonvulsants|anticonvulsants|mesh-ancestor
25142974|NCT02945839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25142975|NCT02945839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142976|NCT02945644|Trazodone|trazodone|mesh-list
25142977|NCT02945644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25142978|NCT02945644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25142979|NCT02945644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25142980|NCT02945644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142981|NCT02945644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25142982|NCT02945644|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25142983|NCT02945644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25142984|NCT02945644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25142985|NCT02945644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142986|NCT02945644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25142999|NCT02945527|Hormones|hormones|mesh-ancestor
25143006|NCT02945527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143007|NCT02945527|Diuretics|diuretics|mesh-ancestor
25143008|NCT02945527|Natriuretic Agents|natriuretic agents|mesh-ancestor
25143009|NCT02945293|Oxycodone|oxycodone|mesh-list
24807753|NCT02023554|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25143010|NCT02945293|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25143011|NCT02945293|Narcotics|narcotics|mesh-ancestor
25143012|NCT02945293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25143013|NCT02945293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143014|NCT02945293|Analgesics|analgesics|mesh-ancestor
25143015|NCT02945293|Sensory System Agents|sensory system agents|mesh-ancestor
25143016|NCT02945293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25047317|NCT00829426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25143046|NCT02945163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25143047|NCT02945163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143048|NCT02945163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143049|NCT02945163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25143050|NCT02945163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25143051|NCT02945163|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25143052|NCT02945163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25143053|NCT02945163|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25143054|NCT02945163|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25143055|NCT02945163|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25143056|NCT02945163|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25143058|NCT02945215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25143059|NCT02945215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143060|NCT02945215|Immunologic Factors|immunologic factors|mesh-ancestor
25143061|NCT02945215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143078|NCT02945020|Protease Inhibitors|protease inhibitors|mesh-ancestor
25143079|NCT02945020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143080|NCT02945020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143081|NCT02945020|Anticoagulants|anticoagulants|mesh-ancestor
25143082|NCT02945020|Antiviral Agents|antiviral agents|mesh-ancestor
25143083|NCT02945020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25143084|NCT02944981|Gabapentin|gabapentin|mesh-list
25143085|NCT02944981|Analgesics|analgesics|mesh-ancestor
25143086|NCT02944981|Sensory System Agents|sensory system agents|mesh-ancestor
25143087|NCT02944981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25143088|NCT02944981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143089|NCT02944981|Anticonvulsants|anticonvulsants|mesh-ancestor
25143090|NCT02944981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25143091|NCT02944981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25143092|NCT02944981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25143093|NCT02944981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25143094|NCT02944981|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25143095|NCT02944981|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25143096|NCT02944981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25143097|NCT02944981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143098|NCT02944981|Antimanic Agents|antimanic agents|mesh-ancestor
25143099|NCT02945033|Aspirin|aspirin|mesh-list
25143100|NCT02945033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25143101|NCT02945033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25143102|NCT02945033|Analgesics|analgesics|mesh-ancestor
25143103|NCT02945033|Sensory System Agents|sensory system agents|mesh-ancestor
25143104|NCT02945033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25143105|NCT02945033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143106|NCT02945033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25143107|NCT02945033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25143108|NCT02945033|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25143109|NCT02945033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25143110|NCT02945033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143111|NCT02945033|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25143112|NCT02945033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24761589|NCT01763463|Xhance|xhance|mesh-list
24393711|NCT00130819|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25143113|NCT02945033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143114|NCT02945033|Antipyretics|antipyretics|mesh-ancestor
25143115|NCT02944825|Ciprofloxacin|ciprofloxacin|mesh-list
25143116|NCT02944825|Trimethoprim|trimethoprim|mesh-list
25143117|NCT02944825|Sulfamethoxazole|sulfamethoxazole|mesh-list
25143118|NCT02944825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25143119|NCT02944825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25143120|NCT02944825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25143121|NCT02944825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25143122|NCT02944825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143123|NCT02944825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143124|NCT02944825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143125|NCT02944825|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25143126|NCT02944825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25143127|NCT02944825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25143128|NCT02944825|Renal Agents|renal agents|mesh-ancestor
25143129|NCT02944825|Antimalarials|antimalarials|mesh-ancestor
25143130|NCT02944825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25143131|NCT02944825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25143132|NCT02944825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25143133|NCT02944825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25143134|NCT02944825|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25143135|NCT02944734|Amlodipine|amlodipine|mesh-list
25143136|NCT02944734|Candesartan|candesartan|mesh-list
25143137|NCT02944734|Candesartan cilexetil|candesartan cilexetil|mesh-list
25143138|NCT02944734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25143139|NCT02944734|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25143140|NCT02944734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25143141|NCT02944734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480339|NCT00430651|Mitosis Modulators|mitosis modulators|mesh-ancestor
24807776|NCT02023593|Leucovorin|leucovorin|mesh-list
24807777|NCT02023593|Fluorouracil|fluorouracil|mesh-list
24480458|NCT00431106|Antiviral Agents|antiviral agents|mesh-ancestor
24480460|NCT00431106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143142|NCT02944734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25143157|NCT02944292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143158|NCT02944292|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25143159|NCT02944292|Anesthetics, General|anesthetics, general|mesh-ancestor
25143160|NCT02944292|Anesthetics|anesthetics|mesh-ancestor
25143161|NCT02944357|Gemcitabine|gemcitabine|mesh-list
25143162|NCT02944357|Cisplatin|cisplatin|mesh-list
25143163|NCT02944357|Vaccines|vaccines|mesh-list
25143164|NCT02944357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143165|NCT02944357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25143166|NCT02944357|Antimetabolites|antimetabolites|mesh-ancestor
25143167|NCT02944357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143168|NCT02944357|Antiviral Agents|antiviral agents|mesh-ancestor
25143169|NCT02944357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25143170|NCT02944357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143172|NCT02944357|Immunologic Factors|immunologic factors|mesh-ancestor
25143173|NCT02944357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143174|NCT02944214|Febuxostat|febuxostat|mesh-list
25143175|NCT02944214|Benzbromarone|benzbromarone|mesh-list
25143176|NCT02944214|Gout Suppressants|gout suppressants|mesh-ancestor
25143177|NCT02944214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25143178|NCT02944214|Uricosuric Agents|uricosuric agents|mesh-ancestor
25143179|NCT02944214|Renal Agents|renal agents|mesh-ancestor
25143180|NCT02944396|Paclitaxel|paclitaxel|mesh-list
25143181|NCT02944396|Carboplatin|carboplatin|mesh-list
25143182|NCT02944396|Nivolumab|nivolumab|mesh-list
25143183|NCT02944396|Pemetrexed|pemetrexed|mesh-list
25143184|NCT02944396|Veliparib|veliparib|mesh-list
24883289|NCT04035837|Immunologic Factors|immunologic factors|mesh-ancestor
25143185|NCT02944396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25143186|NCT02944396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143187|NCT02944396|Tubulin Modulators|tubulin modulators|mesh-ancestor
25047318|NCT00829426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25047319|NCT00829426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25047320|NCT00829426|GABA Modulators|gaba modulators|mesh-ancestor
25047321|NCT00829426|GABA Agents|gaba agents|mesh-ancestor
25047322|NCT00829426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25047323|NCT00829426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047324|NCT00829309|Pravastatin|pravastatin|mesh-list
25047325|NCT00829309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25047326|NCT00829309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25047327|NCT00829309|Antimetabolites|antimetabolites|mesh-ancestor
25047328|NCT00829309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047329|NCT00829309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25047330|NCT00829309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25047331|NCT00829309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047332|NCT00828321|Ramipril|ramipril|mesh-list
25047333|NCT00828321|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25047334|NCT00828321|Protease Inhibitors|protease inhibitors|mesh-ancestor
25047335|NCT00828321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047336|NCT00828321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047337|NCT00828321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25047338|NCT00821977|Vildagliptin|vildagliptin|mesh-list
25047339|NCT00821977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25143188|NCT02944396|Antimitotic Agents|antimitotic agents|mesh-ancestor
25143189|NCT02944396|Mitosis Modulators|mitosis modulators|mesh-ancestor
25143190|NCT02944396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143191|NCT02944396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25143192|NCT02944396|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25143193|NCT02944396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143194|NCT02944396|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25143195|NCT02944396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25143196|NCT02944396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25143197|NCT02944552|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
25143198|NCT02944552|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25143199|NCT02944552|Antimetabolites|antimetabolites|mesh-ancestor
25143200|NCT02944552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143201|NCT02944552|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25143202|NCT02944526|Ropivacaine|ropivacaine|mesh-list
25143203|NCT02944526|Anesthetics, Local|anesthetics, local|mesh-ancestor
25143204|NCT02944526|Anesthetics|anesthetics|mesh-ancestor
25143205|NCT02944526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25143206|NCT02944526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143208|NCT02944526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25143210|NCT02944500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25143211|NCT02944500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143212|NCT02944500|Incretins|incretins|mesh-ancestor
25143213|NCT02944500|Hormones|hormones|mesh-ancestor
25143214|NCT02944500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25143215|NCT02944201|Carvedilol|carvedilol|mesh-list
24480569|NCT00431275|Ipilimumab|ipilimumab|mesh-list
24480610|NCT00431392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143216|NCT02944201|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25143217|NCT02944201|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25143218|NCT02944201|Adrenergic Agents|adrenergic agents|mesh-ancestor
25143223|NCT02944201|Antioxidants|antioxidants|mesh-ancestor
25143224|NCT02944201|Protective Agents|protective agents|mesh-ancestor
25143225|NCT02944201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24883278|NCT04058990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24883280|NCT04058990|Tubulin Modulators|tubulin modulators|mesh-ancestor
24883281|NCT04058990|Antimitotic Agents|antimitotic agents|mesh-ancestor
24883282|NCT04058990|Mitosis Modulators|mitosis modulators|mesh-ancestor
24883283|NCT04058990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883284|NCT04035837|Interferons|interferons|mesh-list
24883285|NCT04035837|Interferon-alpha|interferon-alpha|mesh-list
24883286|NCT04035837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24883287|NCT04035837|Antiviral Agents|antiviral agents|mesh-ancestor
24883288|NCT04035837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24816247|NCT02075294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143226|NCT02944201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25143227|NCT02944201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25143228|NCT02944201|Vasodilator Agents|vasodilator agents|mesh-ancestor
25143229|NCT02944201|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25143230|NCT02944201|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25143231|NCT02944123|Clopidogrel|clopidogrel|mesh-list
25143232|NCT02944123|Ticagrelor|ticagrelor|mesh-list
25143233|NCT02944123|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25143234|NCT02944123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25143235|NCT02944123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25143236|NCT02944123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25143237|NCT02944123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25143238|NCT02944123|Purinergic Agents|purinergic agents|mesh-ancestor
25143239|NCT02944123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25143240|NCT02944123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143241|NCT02944123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143242|NCT02944175|Neostigmine|neostigmine|mesh-list
25143243|NCT02944175|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25143244|NCT02944175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143245|NCT02944175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143246|NCT02944175|Cholinergic Agents|cholinergic agents|mesh-ancestor
25143247|NCT02944175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25143248|NCT02944175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143249|NCT02944175|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25143250|NCT02944175|Autonomic Agents|autonomic agents|mesh-ancestor
25143251|NCT02944175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25143252|NCT02944045|Methylprednisolone|methylprednisolone|mesh-list
25143253|NCT02944045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25143254|NCT02944045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25143255|NCT02944045|Prednisolone|prednisolone|mesh-list
25143256|NCT02944045|Prednisolone acetate|prednisolone acetate|mesh-list
25143257|NCT02944045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25143258|NCT02944045|Prednisolone phosphate|prednisolone phosphate|mesh-list
25288061|NCT04750291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25288062|NCT04750291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288063|NCT04750291|Cholinergic Agents|cholinergic agents|mesh-ancestor
25288064|NCT04750291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25288065|NCT04750291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288066|NCT04750291|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25288067|NCT04750291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25288080|NCT04713319|Calcium|calcium|mesh-list
25288081|NCT04713319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25288084|NCT04691986|Niacin|niacin|mesh-list
24807807|NCT02023710|Paclitaxel|paclitaxel|mesh-list
25143259|NCT02944045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25143260|NCT02944045|Antiemetics|antiemetics|mesh-ancestor
25143261|NCT02944045|Autonomic Agents|autonomic agents|mesh-ancestor
25143262|NCT02944045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25143263|NCT02944045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143264|NCT02944045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25143265|NCT02944045|Glucocorticoids|glucocorticoids|mesh-ancestor
25143266|NCT02944045|Hormones|hormones|mesh-ancestor
25143267|NCT02944045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25143268|NCT02944045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25143269|NCT02944045|Protective Agents|protective agents|mesh-ancestor
25143270|NCT02944045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25143271|NCT02944045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143272|NCT02943759|Chlorhexidine|chlorhexidine|mesh-list
25143273|NCT02943759|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25143274|NCT02943759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25143276|NCT02943759|Disinfectants|disinfectants|mesh-ancestor
25143277|NCT02943759|Dermatologic Agents|dermatologic agents|mesh-ancestor
25143278|NCT02943707|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25143279|NCT02943707|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25143280|NCT02943707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25143281|NCT02944110|Glucagon|glucagon|mesh-list
25143282|NCT02944110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25143283|NCT02944110|Hormones|hormones|mesh-ancestor
25143284|NCT02944110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25143285|NCT02944110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143286|NCT02943798|Paclitaxel|paclitaxel|mesh-list
25143287|NCT02943798|Etoposide|etoposide|mesh-list
25143288|NCT02943798|Carboplatin|carboplatin|mesh-list
25143289|NCT02943798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25143290|NCT02943798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143291|NCT02943798|Tubulin Modulators|tubulin modulators|mesh-ancestor
25143301|NCT02943902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143303|NCT02943655|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25143304|NCT02943655|Contraceptive Agents|contraceptive agents|mesh-list
25143305|NCT02943655|Medroxyprogesterone|medroxyprogesterone|mesh-list
25143306|NCT02943655|Progesterone|progesterone|mesh-list
25143307|NCT02943655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25143308|NCT02943655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143309|NCT02943655|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25143310|NCT02943655|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25143311|NCT02943655|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25143312|NCT02943655|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25143313|NCT02943655|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25143314|NCT02943655|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25143315|NCT02943655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24480678|NCT00431665|Hormones|hormones|mesh-ancestor
25143316|NCT02943655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143317|NCT02943655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25684368|NCT01891357|Lapatinib|lapatinib|mesh-list
25684369|NCT01891357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25684370|NCT01891357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25684371|NCT01891357|Tubulin Modulators|tubulin modulators|mesh-ancestor
25684372|NCT01891357|Antimitotic Agents|antimitotic agents|mesh-ancestor
25684373|NCT01891357|Mitosis Modulators|mitosis modulators|mesh-ancestor
25684374|NCT01891357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684375|NCT01891357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25684376|NCT01891357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25684377|NCT01891357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25288108|NCT04565483|Benralizumab|benralizumab|mesh-list
25288109|NCT04565483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25288110|NCT04565483|Respiratory System Agents|respiratory system agents|mesh-ancestor
25115868|NCT03112187|Iron|iron|mesh-list
25143318|NCT02943655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25143319|NCT02943655|Analgesics|analgesics|mesh-ancestor
25143320|NCT02943655|Sensory System Agents|sensory system agents|mesh-ancestor
25143321|NCT02943655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25143322|NCT02943655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25143323|NCT02943655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25143324|NCT02943655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25143325|NCT02943655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143326|NCT02943655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143327|NCT02943655|Progestins|progestins|mesh-ancestor
25143328|NCT02943655|Hormones|hormones|mesh-ancestor
25143329|NCT02943655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25143330|NCT02943603|Pembrolizumab|pembrolizumab|mesh-list
25143347|NCT02943642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143348|NCT02943642|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25143349|NCT02943642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143350|NCT02943642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143352|NCT02943356|Vasodilator Agents|vasodilator agents|mesh-ancestor
25143353|NCT02943356|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25143354|NCT02943356|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25143355|NCT02943356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143356|NCT02943356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761773|NCT01764555|Acetaminophen|acetaminophen|mesh-list
24883621|NCT05237323|Antimetabolites|antimetabolites|mesh-ancestor
24883624|NCT05237323|Immunologic Factors|immunologic factors|mesh-ancestor
25684378|NCT01891669|PF-06263507|pf-06263507|mesh-list
25684379|NCT01891669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25684380|NCT01891669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25684381|NCT01891669|Antimitotic Agents|antimitotic agents|mesh-ancestor
25684382|NCT01891669|Mitosis Modulators|mitosis modulators|mesh-ancestor
25684383|NCT01891669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684384|NCT01891864|Etanercept|etanercept|mesh-list
25684385|NCT01891864|GP2015|gp2015|mesh-list
25288134|NCT04263896|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25288135|NCT04263896|Laxatives|laxatives|mesh-ancestor
25288136|NCT04263896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25143357|NCT02943356|Urological Agents|urological agents|mesh-ancestor
25143360|NCT02943252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143361|NCT02943252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25143362|NCT02943252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143363|NCT02943252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143364|NCT02943252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25143365|NCT02943252|Antimetabolites|antimetabolites|mesh-ancestor
25143366|NCT02942914|Insulin Glargine|insulin glargine|mesh-list
25143367|NCT02942914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25143368|NCT02942914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143369|NCT02943135|Lidocaine|lidocaine|mesh-list
25143370|NCT02943135|Anesthetics, Local|anesthetics, local|mesh-ancestor
25143371|NCT02943135|Anesthetics|anesthetics|mesh-ancestor
25143372|NCT02943135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25143373|NCT02943135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143374|NCT02943135|Sensory System Agents|sensory system agents|mesh-ancestor
25143375|NCT02943135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25143376|NCT02943135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25143377|NCT02943135|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25143378|NCT02943135|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25143379|NCT02943135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25143380|NCT02943135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143381|NCT02943057|Ganciclovir|ganciclovir|mesh-list
25143382|NCT02943057|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25143383|NCT02943057|Antiviral Agents|antiviral agents|mesh-ancestor
25143384|NCT02943057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24899378|NCT04404439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24883702|NCT05097768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24883703|NCT05097768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883704|NCT05097768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24883705|NCT05097768|Glucocorticoids|glucocorticoids|mesh-ancestor
25143385|NCT02943057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25143386|NCT02943057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143387|NCT02943057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143388|NCT02942888|Niacinamide|niacinamide|mesh-list
25143389|NCT02942888|Niacin|niacin|mesh-list
25143390|NCT02942888|Nicotinic Acids|nicotinic acids|mesh-list
25143391|NCT02942888|Vitamin B Complex|vitamin b complex|mesh-ancestor
25143392|NCT02942888|Vitamins|vitamins|mesh-ancestor
25143393|NCT02942888|Micronutrients|micronutrients|mesh-ancestor
25143394|NCT02942888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143395|NCT02942888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25143396|NCT02942888|Antimetabolites|antimetabolites|mesh-ancestor
25143397|NCT02942888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143398|NCT02942888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25143399|NCT02942888|Vasodilator Agents|vasodilator agents|mesh-ancestor
25143400|NCT02942810|Cefepime|cefepime|mesh-list
25143401|NCT02942810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25143402|NCT02942810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25143403|NCT02942680|Aspirin|aspirin|mesh-list
25143404|NCT02942680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25143405|NCT02942680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25143406|NCT02942680|Analgesics|analgesics|mesh-ancestor
25143407|NCT02942680|Sensory System Agents|sensory system agents|mesh-ancestor
25143408|NCT02942680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25143409|NCT02942680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684386|NCT01891864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25684387|NCT01891864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25684388|NCT01891864|Analgesics|analgesics|mesh-ancestor
25684389|NCT01891864|Sensory System Agents|sensory system agents|mesh-ancestor
25684390|NCT01891864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25684391|NCT01891864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684392|NCT01891864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25684393|NCT01891864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25288179|NCT04089150|Vitamins|vitamins|mesh-ancestor
25288180|NCT04089150|Micronutrients|micronutrients|mesh-ancestor
25288181|NCT04082780|Rifamycins|rifamycins|mesh-list
25288182|NCT04082780|Rifamycin SV|rifamycin sv|mesh-list
25288183|NCT04082780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25288184|NCT04082780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25143410|NCT02942680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25143411|NCT02942680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25143412|NCT02942680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25143413|NCT02942680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25143414|NCT02942680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143415|NCT02942680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25143416|NCT02942680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25143417|NCT02942680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143418|NCT02942680|Antipyretics|antipyretics|mesh-ancestor
25143419|NCT02942693|Apatinib|apatinib|mesh-list
25143420|NCT02942693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143423|NCT02942693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143424|NCT02942732|Cholecalciferol|cholecalciferol|mesh-list
25143425|NCT02942732|Vitamin D|vitamin d|mesh-list
25143426|NCT02942732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25143427|NCT02942732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143428|NCT02942732|Vitamins|vitamins|mesh-ancestor
25143429|NCT02942732|Micronutrients|micronutrients|mesh-ancestor
25143430|NCT02942732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25143431|NCT02942758|Pioglitazone|pioglitazone|mesh-list
25143432|NCT02942758|Azacitidine|azacitidine|mesh-list
25143433|NCT02942758|Tretinoin|tretinoin|mesh-list
25143435|NCT02942758|Antimetabolites|antimetabolites|mesh-ancestor
24535713|NCT00649610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25143436|NCT02942758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143437|NCT02942758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143438|NCT02942758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143439|NCT02942758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25143440|NCT02942758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143441|NCT02942758|Keratolytic Agents|keratolytic agents|mesh-ancestor
25143442|NCT02942758|Dermatologic Agents|dermatologic agents|mesh-ancestor
25143443|NCT02942563|Capecitabine|capecitabine|mesh-list
25143444|NCT02942563|Oxaliplatin|oxaliplatin|mesh-list
25143445|NCT02942563|Irinotecan|irinotecan|mesh-list
25143446|NCT02942563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25143447|NCT02942563|Antimetabolites|antimetabolites|mesh-ancestor
25143448|NCT02942563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143449|NCT02942563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143450|NCT02942563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25143451|NCT02942563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25143452|NCT02942563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143453|NCT02942420|Bucillamine|bucillamine|mesh-list
25143454|NCT02942420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24481106|NCT00433316|Ropivacaine|ropivacaine|mesh-list
24481217|NCT00433732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25143455|NCT02942420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25143456|NCT02942420|Analgesics|analgesics|mesh-ancestor
25143458|NCT02942420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25143459|NCT02942420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143461|NCT02942420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25143462|NCT02942420|Antioxidants|antioxidants|mesh-ancestor
25143463|NCT02942420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143464|NCT02942420|Protective Agents|protective agents|mesh-ancestor
25143465|NCT02942706|Cetuximab|cetuximab|mesh-list
25143466|NCT02942706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25143467|NCT02942706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143476|NCT02942381|Hydroxychloroquine|hydroxychloroquine|mesh-list
25143477|NCT02942381|Antimalarials|antimalarials|mesh-ancestor
25143478|NCT02942381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25143479|NCT02942381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25143480|NCT02942381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25143481|NCT02942381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143482|NCT02942381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684394|NCT01891864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25684395|NCT01891864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25684396|NCT01891864|Immunologic Factors|immunologic factors|mesh-ancestor
25684397|NCT01891864|Dermatologic Agents|dermatologic agents|mesh-ancestor
25684398|NCT01891890|Lamotrigine|lamotrigine|mesh-list
25143483|NCT02942381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25143484|NCT02942550|Bromides|bromides|mesh-list
25143485|NCT02942550|Methylnaltrexone|methylnaltrexone|mesh-list
25143486|NCT02942550|Anticonvulsants|anticonvulsants|mesh-ancestor
25115997|NCT03111511|Drospirenone|drospirenone|mesh-list
25115998|NCT03111511|Midazolam|midazolam|mesh-list
25115999|NCT03111511|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25116000|NCT03111511|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
25116001|NCT03111511|Betadex|betadex|mesh-list
25116002|NCT03111511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25116003|NCT03111511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25116004|NCT03111511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25116005|NCT03111511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116006|NCT03111511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25116012|NCT03111511|GABA Modulators|gaba modulators|mesh-ancestor
25143487|NCT02942550|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25143488|NCT02942550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143489|NCT02942550|Sensory System Agents|sensory system agents|mesh-ancestor
25143490|NCT02942550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25143491|NCT02942602|Atorvastatin|atorvastatin|mesh-list
25143492|NCT02942602|Ezetimibe|ezetimibe|mesh-list
25143493|NCT02942602|Cholestyramine Resin|cholestyramine resin|mesh-list
25143494|NCT02942602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25143495|NCT02942602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25143497|NCT02942602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143498|NCT02942602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25143499|NCT02942602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24481218|NCT00433732|Gout Suppressants|gout suppressants|mesh-ancestor
24481219|NCT00433732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24481220|NCT00433732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481362|NCT00434135|Gemcitabine|gemcitabine|mesh-list
24883707|NCT05097768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24883708|NCT05097768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24883709|NCT05097768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24883710|NCT05097768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24455242|NCT02244125|Glucocorticoids|glucocorticoids|mesh-ancestor
24455243|NCT02244125|Hormones|hormones|mesh-ancestor
24455244|NCT02244125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24455245|NCT02244125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24455246|NCT02244125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24883736|NCT05040282|Etonogestrel|etonogestrel|mesh-list
24883737|NCT05040282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25143508|NCT02942303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25143509|NCT02942303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143511|NCT02942303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25143512|NCT02942303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143513|NCT02942212|Nicotine|nicotine|mesh-list
25143514|NCT02942212|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25143515|NCT02942212|Autonomic Agents|autonomic agents|mesh-ancestor
25143516|NCT02942212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25143517|NCT02942212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143518|NCT02942212|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25143519|NCT02942212|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25143520|NCT02942212|Cholinergic Agents|cholinergic agents|mesh-ancestor
25143521|NCT02942212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25143522|NCT02942212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883773|NCT04861584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24883774|NCT04861584|Immunologic Factors|immunologic factors|mesh-ancestor
24883775|NCT04861584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684399|NCT01891890|Oxcarbazepine|oxcarbazepine|mesh-list
25684400|NCT01891890|Levetiracetam|levetiracetam|mesh-list
25684401|NCT01891890|Anticonvulsants|anticonvulsants|mesh-ancestor
25684402|NCT01891890|Nootropic Agents|nootropic agents|mesh-ancestor
25684403|NCT01891890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25684404|NCT01891890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25684405|NCT01891890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684406|NCT01891890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25684407|NCT01891890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684408|NCT01891890|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25116045|NCT03111342|Anesthetics, Local|anesthetics, local|mesh-ancestor
25116046|NCT03111342|Anesthetics|anesthetics|mesh-ancestor
25116047|NCT03111342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25116048|NCT03111342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116049|NCT03111342|Sensory System Agents|sensory system agents|mesh-ancestor
25116050|NCT03111342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116051|NCT03111342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25116052|NCT03111342|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25116053|NCT03111342|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25116054|NCT03111342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25116055|NCT03111342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116056|NCT03111420|Clopidogrel|clopidogrel|mesh-list
25116057|NCT03111420|Ticagrelor|ticagrelor|mesh-list
25116058|NCT03111420|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25116059|NCT03111420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24777672|NCT01865669|Oxytocin|oxytocin|mesh-list
25143523|NCT02942043|Bevacizumab|bevacizumab|mesh-list
25143524|NCT02942043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25143525|NCT02942043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143526|NCT02942043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25143527|NCT02942043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25143528|NCT02942043|Growth Substances|growth substances|mesh-ancestor
24481386|NCT00434174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25143529|NCT02942043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143530|NCT02942043|Growth Inhibitors|growth inhibitors|mesh-ancestor
25143531|NCT02941913|Palonosetron|palonosetron|mesh-list
25143532|NCT02941913|Antiemetics|antiemetics|mesh-ancestor
25143533|NCT02941913|Autonomic Agents|autonomic agents|mesh-ancestor
25143534|NCT02941913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25015225|NCT02950259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25143535|NCT02941913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143536|NCT02941913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25143537|NCT02941913|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25143538|NCT02941913|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25143539|NCT02941913|Serotonin Agents|serotonin agents|mesh-ancestor
25143540|NCT02941913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25143541|NCT02941913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143542|NCT02941575|Methamphetamine|methamphetamine|mesh-list
25143543|NCT02941575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25143544|NCT02941575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143545|NCT02941575|Sympathomimetics|sympathomimetics|mesh-ancestor
25143546|NCT02941575|Autonomic Agents|autonomic agents|mesh-ancestor
25143547|NCT02941575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25143548|NCT02941575|Dopamine Agents|dopamine agents|mesh-ancestor
25143549|NCT02941575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25143550|NCT02941575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684409|NCT01891890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25684410|NCT01891890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25684411|NCT01891890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25684412|NCT01891890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25684413|NCT01891890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25684414|NCT01891890|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25684415|NCT01891890|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25684416|NCT01891968|Bortezomib|bortezomib|mesh-list
25684417|NCT01891968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25684418|NCT01892020|Insulin|insulin|mesh-list
25684419|NCT01892020|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25684420|NCT01892020|Insulin Aspart|insulin aspart|mesh-list
25684421|NCT01892020|Biphasic Insulins|biphasic insulins|mesh-list
25684422|NCT01892020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25684423|NCT01892020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684424|NCT01892163|Dexamethasone|dexamethasone|mesh-list
25684425|NCT01892163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25684426|NCT01892163|Antiemetics|antiemetics|mesh-ancestor
25143551|NCT02941575|Adrenergic Agents|adrenergic agents|mesh-ancestor
25143552|NCT02941575|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25143553|NCT02941575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25143554|NCT02941575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25143555|NCT02941575|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25143557|NCT02941562|Fluorouracil|fluorouracil|mesh-list
25143558|NCT02941562|Oxaliplatin|oxaliplatin|mesh-list
25143560|NCT02941562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143561|NCT02941562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25143567|NCT02941562|Protective Agents|protective agents|mesh-ancestor
25143568|NCT02941562|Vitamin B Complex|vitamin b complex|mesh-ancestor
25143569|NCT02941562|Vitamins|vitamins|mesh-ancestor
25143570|NCT02941562|Micronutrients|micronutrients|mesh-ancestor
25143571|NCT02941731|Oseltamivir|oseltamivir|mesh-list
25143572|NCT02941731|Antiviral Agents|antiviral agents|mesh-ancestor
25143573|NCT02941731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25143574|NCT02941731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143575|NCT02941731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143725|NCT02941016|Evolocumab|evolocumab|mesh-list
25143726|NCT02941016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25143727|NCT02941016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25143728|NCT02941016|Antimetabolites|antimetabolites|mesh-ancestor
25143729|NCT02941016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143730|NCT02941016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25143731|NCT02940912|Apomorphine|apomorphine|mesh-list
25143732|NCT02940912|Emetics|emetics|mesh-ancestor
25143733|NCT02940912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481557|NCT00435448|Contraceptive Agents|contraceptive agents|mesh-ancestor
25143734|NCT02940912|Autonomic Agents|autonomic agents|mesh-ancestor
25143735|NCT02940912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25143736|NCT02940912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25143737|NCT02940912|Dopamine Agonists|dopamine agonists|mesh-ancestor
25143738|NCT02940912|Dopamine Agents|dopamine agents|mesh-ancestor
25047366|NCT00821002|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25047367|NCT00820924|Lapatinib|lapatinib|mesh-list
25047368|NCT00820924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25047370|NCT00820924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761977|NCT01765738|Minocycline|minocycline|mesh-list
25047371|NCT00820924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047375|NCT00820300|Latanoprost|latanoprost|mesh-list
25047376|NCT00820300|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25047377|NCT00820300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25047378|NCT00819169|Conatumumab|conatumumab|mesh-list
25047379|NCT00819169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25047380|NCT00819169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25047381|NCT00818844|Nepafenac|nepafenac|mesh-list
25047382|NCT00818844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25047383|NCT00818844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25047384|NCT00818844|Analgesics|analgesics|mesh-ancestor
25047385|NCT00818844|Sensory System Agents|sensory system agents|mesh-ancestor
25047386|NCT00818844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25047387|NCT00818844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047388|NCT00818844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25047389|NCT00818844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25047390|NCT00818571|Vildagliptin|vildagliptin|mesh-list
25047391|NCT00818571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25047392|NCT00818571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047393|NCT00818571|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25047394|NCT00818571|Protease Inhibitors|protease inhibitors|mesh-ancestor
25047395|NCT00818571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047396|NCT00818571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047397|NCT00818493|Acetaminophen|acetaminophen|mesh-list
25047398|NCT00818493|Morphine|morphine|mesh-list
25047399|NCT00818493|Oxycodone|oxycodone|mesh-list
25047400|NCT00818493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25047401|NCT00818493|Narcotics|narcotics|mesh-ancestor
25047402|NCT00818493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25047403|NCT00818493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047404|NCT00818493|Analgesics|analgesics|mesh-ancestor
25047405|NCT00818493|Sensory System Agents|sensory system agents|mesh-ancestor
25047406|NCT00818493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25047407|NCT00818493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25047408|NCT00818493|Antipyretics|antipyretics|mesh-ancestor
25047409|NCT00817986|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
25047411|NCT00817986|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25047412|NCT00817986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047413|NCT00817986|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25047414|NCT00817986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25047415|NCT00817986|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25092496|NCT03241563|Hormones|hormones|mesh-ancestor
25143739|NCT02940912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25143576|NCT02941744|Nivolumab|nivolumab|mesh-list
25143577|NCT02941744|Ipilimumab|ipilimumab|mesh-list
25143578|NCT02941744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25143579|NCT02941744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143580|NCT02941744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25143581|NCT02941744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143583|NCT02941822|Expectorants|expectorants|mesh-ancestor
25143584|NCT02941822|Respiratory System Agents|respiratory system agents|mesh-ancestor
25143585|NCT02941445|Metformin|metformin|mesh-list
25143586|NCT02941445|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25143587|NCT02941445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25143588|NCT02941445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143589|NCT02941445|Incretins|incretins|mesh-ancestor
25143590|NCT02941445|Hormones|hormones|mesh-ancestor
25143591|NCT02941445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25143592|NCT02941445|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25143593|NCT02941445|Protease Inhibitors|protease inhibitors|mesh-ancestor
25143594|NCT02941445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143595|NCT02941445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143596|NCT02941510|Budesonide|budesonide|mesh-list
25143598|NCT02941510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25143599|NCT02941510|Autonomic Agents|autonomic agents|mesh-ancestor
25143600|NCT02941510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25143601|NCT02941510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143602|NCT02941510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25143603|NCT02941510|Respiratory System Agents|respiratory system agents|mesh-ancestor
25143604|NCT02941510|Glucocorticoids|glucocorticoids|mesh-ancestor
25143605|NCT02941510|Hormones|hormones|mesh-ancestor
25143606|NCT02941510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25143607|NCT02941601|Gemcitabine|gemcitabine|mesh-list
25143608|NCT02941601|Carboplatin|carboplatin|mesh-list
25143609|NCT02941601|Necitumumab|necitumumab|mesh-list
25143610|NCT02941601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143611|NCT02941601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25143612|NCT02941601|Antimetabolites|antimetabolites|mesh-ancestor
25143613|NCT02941601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143614|NCT02941601|Antiviral Agents|antiviral agents|mesh-ancestor
25143615|NCT02941601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25143616|NCT02941601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143617|NCT02941601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25143618|NCT02941601|Immunologic Factors|immunologic factors|mesh-ancestor
25143619|NCT02941601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143620|NCT02941601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25143621|NCT02941367|Metformin|metformin|mesh-list
25143622|NCT02941367|Lixisenatide|lixisenatide|mesh-list
25143623|NCT02941367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25143624|NCT02941367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143625|NCT02941328|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
25143626|NCT02941328|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25143642|NCT02941315|Natriuretic Agents|natriuretic agents|mesh-ancestor
25143643|NCT02941315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25143644|NCT02941315|Adrenergic Agents|adrenergic agents|mesh-ancestor
25143645|NCT02941315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25143646|NCT02941315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684427|NCT01892163|Autonomic Agents|autonomic agents|mesh-ancestor
25143647|NCT02941315|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25143648|NCT02941315|Protease Inhibitors|protease inhibitors|mesh-ancestor
24808052|NCT02024984|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24808054|NCT02024984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24808055|NCT02024984|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24808056|NCT02024984|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25143649|NCT02941315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143650|NCT02941315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25143651|NCT02941315|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25143652|NCT02941315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25143653|NCT02941224|Sirolimus|sirolimus|mesh-list
25143655|NCT02941224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25143656|NCT02941224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25143657|NCT02941224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143658|NCT02941224|Antifungal Agents|antifungal agents|mesh-ancestor
25143659|NCT02941224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25143660|NCT02941224|Immunologic Factors|immunologic factors|mesh-ancestor
25143661|NCT02941224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143662|NCT02941198|Copper|copper|mesh-list
25143663|NCT02941198|Trace Elements|trace elements|mesh-ancestor
25143664|NCT02941198|Micronutrients|micronutrients|mesh-ancestor
25143665|NCT02941198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143666|NCT02940990|Gemcitabine|gemcitabine|mesh-list
25143667|NCT02940990|Paclitaxel|paclitaxel|mesh-list
25143668|NCT02940990|Etoposide|etoposide|mesh-list
25143669|NCT02940990|Vinorelbine|vinorelbine|mesh-list
25143670|NCT02940990|Docetaxel|docetaxel|mesh-list
25143671|NCT02940990|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25143672|NCT02940990|Carboplatin|carboplatin|mesh-list
25143679|NCT02940990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143683|NCT02940990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25143684|NCT02940990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143685|NCT02940990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25143686|NCT02940990|Immunologic Factors|immunologic factors|mesh-ancestor
25143687|NCT02940990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143688|NCT02940990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25143689|NCT02940990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25143690|NCT02940990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25143691|NCT02940990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25143692|NCT02940925|Cisplatin|cisplatin|mesh-list
25143693|NCT02940925|Fluorouracil|fluorouracil|mesh-list
25143694|NCT02940925|Capecitabine|capecitabine|mesh-list
25143695|NCT02940925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143696|NCT02940925|Antimetabolites|antimetabolites|mesh-ancestor
25143697|NCT02940925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143698|NCT02940925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25143699|NCT02940925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25143700|NCT02940925|Immunologic Factors|immunologic factors|mesh-ancestor
25143701|NCT02940925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143740|NCT02940912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143741|NCT02940821|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25143742|NCT02940821|Fluorides|fluorides|mesh-list
25143743|NCT02940821|Tin Fluorides|tin fluorides|mesh-list
25143744|NCT02940821|Fluorophosphate|fluorophosphate|mesh-list
25143745|NCT02940821|Cariostatic Agents|cariostatic agents|mesh-ancestor
25015457|NCT02372630|Incretins|incretins|mesh-ancestor
24808063|NCT02025010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143746|NCT02940821|Protective Agents|protective agents|mesh-ancestor
25143747|NCT02940821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143748|NCT02940821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24762159|NCT01766414|Complement C1s|complement c1s|mesh-list
24883869|NCT04631536|Folic Acid|folic acid|mesh-list
24883870|NCT04631536|Vitamin B Complex|vitamin b complex|mesh-list
25143749|NCT02940821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25143750|NCT02940808|Caffeine|caffeine|mesh-list
25143751|NCT02940808|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25143752|NCT02940808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143753|NCT02940808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25143754|NCT02940808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143755|NCT02940808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143756|NCT02940808|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25143757|NCT02940808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25143758|NCT02940808|Purinergic Agents|purinergic agents|mesh-ancestor
25143759|NCT02940808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25143760|NCT02940717|Lithium Carbonate|lithium carbonate|mesh-list
25143761|NCT02940717|Antidepressive Agents|antidepressive agents|mesh-ancestor
25143762|NCT02940717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25143763|NCT02940717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143764|NCT02940717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143765|NCT02940717|Antimanic Agents|antimanic agents|mesh-ancestor
25143766|NCT02940717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25143767|NCT02940717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25143768|NCT02940717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143769|NCT02940756|Artesunate|artesunate|mesh-list
25143770|NCT02940756|Lumefantrine|lumefantrine|mesh-list
25143772|NCT02940756|Piperaquine|piperaquine|mesh-list
25143773|NCT02940756|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25143774|NCT02940756|Amodiaquine|amodiaquine|mesh-list
25143775|NCT02940756|Artenimol|artenimol|mesh-list
24482338|NCT00438737|Immunologic Factors|immunologic factors|mesh-ancestor
24482339|NCT00438737|Antidotes|antidotes|mesh-ancestor
25143776|NCT02940756|Antimalarials|antimalarials|mesh-ancestor
25143777|NCT02940756|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25143778|NCT02940756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25143779|NCT02940756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25047424|NCT00814372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25047425|NCT00814372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047426|NCT00814294|Insulin|insulin|mesh-list
25047427|NCT00814294|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25047428|NCT00814294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25047429|NCT00814294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047430|NCT00813956|Gemcitabine|gemcitabine|mesh-list
25047431|NCT00813956|Carboplatin|carboplatin|mesh-list
25047432|NCT00813956|Iniparib|iniparib|mesh-list
25047433|NCT00813956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25047434|NCT00813956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25047435|NCT00813956|Antimetabolites|antimetabolites|mesh-ancestor
25047436|NCT00813956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047437|NCT00813956|Antiviral Agents|antiviral agents|mesh-ancestor
25047438|NCT00813956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25047439|NCT00813956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047440|NCT00813956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25047441|NCT00813956|Immunologic Factors|immunologic factors|mesh-ancestor
25047442|NCT00813956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047443|NCT00813956|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25047444|NCT00813605|Conatumumab|conatumumab|mesh-list
25047445|NCT00813605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25047446|NCT00813605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25047447|NCT00813163|Irinotecan|irinotecan|mesh-list
25047448|NCT00813163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25047449|NCT00813163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25047450|NCT00813163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047451|NCT00813163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047452|NCT00813163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25047453|NCT00812240|Imatinib Mesylate|imatinib mesylate|mesh-list
25047454|NCT00812240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25047455|NCT00812240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25047456|NCT00812240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047466|NCT00810732|Tocolytic Agents|tocolytic agents|mesh-ancestor
25047467|NCT00810732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25047468|NCT00810732|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25143784|NCT02940756|Anthelmintics|anthelmintics|mesh-ancestor
25143785|NCT02941068|Fluconazole|fluconazole|mesh-list
25143786|NCT02941068|Caspofungin|caspofungin|mesh-list
25143787|NCT02941068|Antifungal Agents|antifungal agents|mesh-ancestor
25143788|NCT02941068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25143789|NCT02941068|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25143790|NCT02941068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25143791|NCT02941068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143792|NCT02941068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143793|NCT02941068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25143794|NCT02941068|Hormone Antagonists|hormone antagonists|mesh-ancestor
25288446|NCT05077839|Antiviral Agents|antiviral agents|mesh-ancestor
25288447|NCT05077839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25288448|NCT05077683|Rivaroxaban|rivaroxaban|mesh-list
25288449|NCT05077683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25288450|NCT05077683|Antithrombins|antithrombins|mesh-ancestor
25288451|NCT05077683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25288452|NCT05077683|Protease Inhibitors|protease inhibitors|mesh-ancestor
25288455|NCT05077683|Anticoagulants|anticoagulants|mesh-ancestor
25143795|NCT02941068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25143796|NCT02941068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143797|NCT02941068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25143798|NCT02941068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25143800|NCT02940301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25143801|NCT02940301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143802|NCT02940301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25143803|NCT02940301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143804|NCT02940379|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25143805|NCT02940379|Metoprolol|metoprolol|mesh-list
25143806|NCT02940379|Midazolam|midazolam|mesh-list
25143807|NCT02940379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25143808|NCT02940379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25143809|NCT02940379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25143816|NCT02940379|Anesthetics|anesthetics|mesh-ancestor
25143828|NCT02940379|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25143829|NCT02940379|Adrenergic Agents|adrenergic agents|mesh-ancestor
25143830|NCT02940379|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25143831|NCT02940379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25143832|NCT02940535|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25143833|NCT02940535|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25143835|NCT02940535|Luteolytic Agents|luteolytic agents|mesh-ancestor
25143836|NCT02940535|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25143837|NCT02940535|Contraceptive Agents|contraceptive agents|mesh-ancestor
25143838|NCT02940535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24482639|NCT00440128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482640|NCT00440128|Antiemetics|antiemetics|mesh-ancestor
24482641|NCT00440128|Autonomic Agents|autonomic agents|mesh-ancestor
25143839|NCT02940535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143840|NCT02940535|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25143841|NCT02940535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25143842|NCT02940535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143843|NCT02940535|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25143844|NCT02940535|Fertility Agents|fertility agents|mesh-ancestor
25143845|NCT02940561|Methotrexate|methotrexate|mesh-list
25143846|NCT02940561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25143847|NCT02940561|Abortifacient Agents|abortifacient agents|mesh-ancestor
25143848|NCT02940561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24553195|NCT00729898|Insulin Aspart|insulin aspart|mesh-list
24883927|NCT04435808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25143852|NCT02940561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143853|NCT02940561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143854|NCT02940561|Dermatologic Agents|dermatologic agents|mesh-ancestor
25143855|NCT02940561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143856|NCT02940561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25143857|NCT02940561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25143858|NCT02940561|Immunologic Factors|immunologic factors|mesh-ancestor
25143859|NCT02940561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25143860|NCT02940561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25143861|NCT02940314|Solifenacin Succinate|solifenacin succinate|mesh-list
25143862|NCT02940314|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25684428|NCT01892163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25684429|NCT01892163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684430|NCT01892163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25684431|NCT01892163|Glucocorticoids|glucocorticoids|mesh-ancestor
25684432|NCT01892163|Hormones|hormones|mesh-ancestor
25684433|NCT01892163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24709001|NCT01503671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25288481|NCT04952350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25288492|NCT04866017|Durvalumab|durvalumab|mesh-list
25288493|NCT04866017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25288494|NCT04866017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25288495|NCT04850144|Bromides|bromides|mesh-list
25288496|NCT04850144|Tiotropium Bromide|tiotropium bromide|mesh-list
25288497|NCT04850144|Charcoal|charcoal|mesh-list
25288498|NCT04850144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25288499|NCT04850144|Autonomic Agents|autonomic agents|mesh-ancestor
25288504|NCT04850144|Parasympatholytics|parasympatholytics|mesh-ancestor
25143863|NCT02940314|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25143864|NCT02940314|Cholinergic Agents|cholinergic agents|mesh-ancestor
25143865|NCT02940314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25143866|NCT02940314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143867|NCT02940314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143868|NCT02940314|Urological Agents|urological agents|mesh-ancestor
25143869|NCT02940366|Atorvastatin|atorvastatin|mesh-list
24762345|NCT01767714|Plerixafor|plerixafor|mesh-list
25143872|NCT02940366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25143873|NCT02940366|Antimetabolites|antimetabolites|mesh-ancestor
25143874|NCT02940366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143875|NCT02940366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25143876|NCT02940366|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25143877|NCT02940366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143879|NCT02940405|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25143880|NCT02940405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25143881|NCT02940405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25143882|NCT02940405|Analgesics|analgesics|mesh-ancestor
25143883|NCT02940405|Sensory System Agents|sensory system agents|mesh-ancestor
25143884|NCT02940405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25143885|NCT02940405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143886|NCT02940405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25143887|NCT02940405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25143888|NCT02940405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25143889|NCT02940405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143890|NCT02940405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143891|NCT02940444|Heparin|heparin|mesh-list
25143892|NCT02940444|Anticoagulants|anticoagulants|mesh-ancestor
24762368|NCT01768078|Glucocorticoids|glucocorticoids|mesh-ancestor
25684434|NCT01892163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25684435|NCT01892163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25684436|NCT01892189|Ketamine|ketamine|mesh-list
25684437|NCT01892189|Analgesics|analgesics|mesh-ancestor
25684438|NCT01892189|Sensory System Agents|sensory system agents|mesh-ancestor
25684439|NCT01892189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25684440|NCT01892189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684441|NCT01892189|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25684442|NCT01892189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25684443|NCT01892189|Anesthetics, General|anesthetics, general|mesh-ancestor
25684444|NCT01892189|Anesthetics|anesthetics|mesh-ancestor
25288517|NCT04812808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288518|NCT04812808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25288520|NCT04710199|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24816317|NCT02076386|Antiviral Agents|antiviral agents|mesh-ancestor
24816318|NCT02076386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24816320|NCT02076451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24706443|NCT01490047|Analgesics|analgesics|mesh-ancestor
25143894|NCT02940444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25143895|NCT02940444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143896|NCT02940483|Azacitidine|azacitidine|mesh-list
25143897|NCT02940483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25143898|NCT02940483|Antimetabolites|antimetabolites|mesh-ancestor
25143899|NCT02940483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143900|NCT02940483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143901|NCT02940483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143902|NCT02940262|Edetic Acid|edetic acid|mesh-list
25143903|NCT02940262|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25143904|NCT02940262|Chelating Agents|chelating agents|mesh-ancestor
25143905|NCT02940262|Sequestering Agents|sequestering agents|mesh-ancestor
25143906|NCT02940262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143907|NCT02940262|Anticoagulants|anticoagulants|mesh-ancestor
25143908|NCT02940262|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25143909|NCT02940262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25143910|NCT02940184|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25143911|NCT02940184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25143912|NCT02940184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143913|NCT02940184|Incretins|incretins|mesh-ancestor
25143914|NCT02940184|Hormones|hormones|mesh-ancestor
25143915|NCT02940184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25143916|NCT02940184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25143917|NCT02940184|Protease Inhibitors|protease inhibitors|mesh-ancestor
25143918|NCT02940184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143919|NCT02940184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143920|NCT02940002|Betamethasone|betamethasone|mesh-list
25143921|NCT02940002|Clobetasol|clobetasol|mesh-list
25143938|NCT02939898|Letrozole|letrozole|mesh-list
25143939|NCT02939898|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25143940|NCT02939898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143941|NCT02939898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25143942|NCT02939898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143943|NCT02939898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143944|NCT02939898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25143945|NCT02939898|Hormone Antagonists|hormone antagonists|mesh-ancestor
25143946|NCT02939898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25143947|NCT02939898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25143948|NCT02939846|Trametinib|trametinib|mesh-list
25143949|NCT02939846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143950|NCT02939846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25143951|NCT02939846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143952|NCT02939846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143953|NCT02939495|Sildenafil Citrate|sildenafil citrate|mesh-list
25143954|NCT02939495|Vasodilator Agents|vasodilator agents|mesh-ancestor
25143955|NCT02939495|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25143956|NCT02939495|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25143957|NCT02939495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143958|NCT02939495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143959|NCT02939495|Urological Agents|urological agents|mesh-ancestor
25143960|NCT02939482|Triamcinolone|triamcinolone|mesh-list
25143961|NCT02939482|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25143962|NCT02939482|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25143985|NCT02939430|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25143986|NCT02939430|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25143987|NCT02939430|Cholinergic Agents|cholinergic agents|mesh-ancestor
25143988|NCT02939430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25143989|NCT02939430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684445|NCT01892189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25684446|NCT01892189|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25684447|NCT01892189|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25143990|NCT02939430|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25143991|NCT02939430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143992|NCT02939430|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25143993|NCT02939365|Abatacept|abatacept|mesh-list
25143994|NCT02939365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25143995|NCT02939365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143996|NCT02939365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143997|NCT02939365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25143998|NCT02939365|Immunologic Factors|immunologic factors|mesh-ancestor
25143999|NCT02939365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144000|NCT02939365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25144001|NCT02939547|Betadex|betadex|mesh-list
25144002|NCT02939547|Sequestering Agents|sequestering agents|mesh-ancestor
25144003|NCT02939547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144004|NCT02939417|Grape Seed Extract|grape seed extract|mesh-list
24847024|NCT02244710|Clopidogrel|clopidogrel|mesh-list
25144005|NCT02939417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25144006|NCT02939417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25144007|NCT02939417|Antioxidants|antioxidants|mesh-ancestor
25144008|NCT02939417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144009|NCT02939417|Protective Agents|protective agents|mesh-ancestor
24536385|NCT00651066|Antiviral Agents|antiviral agents|mesh-ancestor
25144010|NCT02939417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144011|NCT02939274|Verteporfin|verteporfin|mesh-list
25144012|NCT02939274|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25144013|NCT02939274|Dermatologic Agents|dermatologic agents|mesh-ancestor
25144014|NCT02939287|Olanzapine|olanzapine|mesh-list
25144015|NCT02939287|Aprepitant|aprepitant|mesh-list
25144016|NCT02939287|Fosaprepitant|fosaprepitant|mesh-list
25144017|NCT02939287|Antiemetics|antiemetics|mesh-ancestor
25144018|NCT02939287|Autonomic Agents|autonomic agents|mesh-ancestor
25144024|NCT02939287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25144025|NCT02939287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25144026|NCT02939287|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25144027|NCT02939287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25144028|NCT02939287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25144029|NCT02939287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144030|NCT02939287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25144031|NCT02939287|Serotonin Agents|serotonin agents|mesh-ancestor
25144032|NCT02939287|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25144033|NCT02939300|Nivolumab|nivolumab|mesh-list
25144034|NCT02939300|Ipilimumab|ipilimumab|mesh-list
25144035|NCT02939300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25144036|NCT02939300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25144037|NCT02939300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25047469|NCT00808288|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25047470|NCT00808288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25047471|NCT00808288|Autonomic Agents|autonomic agents|mesh-ancestor
25047472|NCT00808288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25047473|NCT00808288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047474|NCT00808288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25047475|NCT00808288|Respiratory System Agents|respiratory system agents|mesh-ancestor
25047476|NCT00808288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25047477|NCT00808288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25047503|NCT00805805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25047504|NCT00805805|Growth Substances|growth substances|mesh-ancestor
25047505|NCT00805805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047506|NCT00805805|Growth Inhibitors|growth inhibitors|mesh-ancestor
25047507|NCT00805805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25047509|NCT00805350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25092902|NCT03238131|Ivermectin|ivermectin|mesh-list
25144039|NCT02939248|Morphine|morphine|mesh-list
25144040|NCT02939248|Naloxone|naloxone|mesh-list
25144041|NCT02939248|Ticagrelor|ticagrelor|mesh-list
25144042|NCT02939248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25144043|NCT02939248|Narcotics|narcotics|mesh-ancestor
25144044|NCT02939248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25144045|NCT02939248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144046|NCT02939248|Analgesics|analgesics|mesh-ancestor
25144047|NCT02939248|Sensory System Agents|sensory system agents|mesh-ancestor
25144048|NCT02939248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25144049|NCT02939248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25144050|NCT02939248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25144685|NCT02935101|Antiemetics|antiemetics|mesh-ancestor
25144051|NCT02939248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25144052|NCT02939248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25144053|NCT02939248|Purinergic Agents|purinergic agents|mesh-ancestor
25144054|NCT02939248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25405689|NCT03598595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25144055|NCT02939248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144056|NCT02939248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25144057|NCT02938988|Anti-Infective Agents|anti-infective agents|mesh-list
25144058|NCT02938988|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25144060|NCT02938988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25144077|NCT02939235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25144078|NCT02939235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144080|NCT02939235|Autonomic Agents|autonomic agents|mesh-ancestor
25144081|NCT02939235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25144082|NCT02939235|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25144083|NCT02939235|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25144084|NCT02939235|Dopamine Agents|dopamine agents|mesh-ancestor
25144085|NCT02938962|Tranexamic Acid|tranexamic acid|mesh-list
25144086|NCT02938962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25144087|NCT02938962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25144088|NCT02938962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144089|NCT02938962|Hemostatics|hemostatics|mesh-ancestor
25144090|NCT02938962|Coagulants|coagulants|mesh-ancestor
25144091|NCT02938975|Permethrin|permethrin|mesh-list
25144092|NCT02938975|Insect Repellents|insect repellents|mesh-list
25144093|NCT02938975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25144094|NCT02938975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144095|NCT02938975|Protective Agents|protective agents|mesh-ancestor
25144096|NCT02938975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144097|NCT02939209|Hydromorphone|hydromorphone|mesh-list
25144098|NCT02939209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25144099|NCT02939209|Narcotics|narcotics|mesh-ancestor
25144100|NCT02939209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25144101|NCT02939209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144102|NCT02939209|Analgesics|analgesics|mesh-ancestor
25144103|NCT02939209|Sensory System Agents|sensory system agents|mesh-ancestor
25144104|NCT02939209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25144105|NCT02939092|Chlorhexidine|chlorhexidine|mesh-list
25144107|NCT02939092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25144124|NCT02938468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144125|NCT02938468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25144126|NCT02938468|Glucocorticoids|glucocorticoids|mesh-ancestor
25144127|NCT02938468|Hormones|hormones|mesh-ancestor
25144128|NCT02938468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25144129|NCT02938468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25144130|NCT02938468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25144131|NCT02938507|Solabegron|solabegron|mesh-list
25144132|NCT02938507|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25144133|NCT02938507|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25144134|NCT02938507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25144135|NCT02938507|Adrenergic Agents|adrenergic agents|mesh-ancestor
25144136|NCT02938507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25144137|NCT02938507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144138|NCT02938507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144139|NCT02938260|Metoprolol|metoprolol|mesh-list
25144140|NCT02938260|Diltiazem|diltiazem|mesh-list
25144141|NCT02938260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25144142|NCT02938260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25144143|NCT02938260|Sympatholytics|sympatholytics|mesh-ancestor
25144144|NCT02938260|Autonomic Agents|autonomic agents|mesh-ancestor
25144145|NCT02938260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25144146|NCT02938260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144147|NCT02938260|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25144148|NCT02938260|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25144149|NCT02938260|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25144150|NCT02938260|Adrenergic Agents|adrenergic agents|mesh-ancestor
25144151|NCT02938260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25144152|NCT02938260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762608|NCT01768884|Antioxidants|antioxidants|mesh-ancestor
24884002|NCT03717623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884003|NCT03717623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24884004|NCT03717623|Hormone Antagonists|hormone antagonists|mesh-ancestor
25144686|NCT02935101|Autonomic Agents|autonomic agents|mesh-ancestor
24884024|NCT03571633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24884025|NCT03537833|Pemetrexed|pemetrexed|mesh-list
25288635|NCT04255277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288636|NCT04255277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25288637|NCT04255277|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25288638|NCT04255277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25288639|NCT04255277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288640|NCT04255277|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24884026|NCT03537833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24884027|NCT03537833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24884028|NCT03537833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144153|NCT02938260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25144154|NCT02938260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25144155|NCT02938260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25144156|NCT02938260|Vasodilator Agents|vasodilator agents|mesh-ancestor
25144158|NCT02938273|Avelumab|avelumab|mesh-list
25144159|NCT02938273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25144160|NCT02938273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25144161|NCT02938286|Epinephrine|epinephrine|mesh-list
25144162|NCT02938286|Carticaine|carticaine|mesh-list
25144163|NCT02938286|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25144164|NCT02938286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25144165|NCT02938286|Adrenergic Agents|adrenergic agents|mesh-ancestor
25144166|NCT02938286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25144167|NCT02938286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144168|NCT02938286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144169|NCT02938286|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25144170|NCT02938286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25144171|NCT02938286|Autonomic Agents|autonomic agents|mesh-ancestor
25144172|NCT02938286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25144173|NCT02938286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25144174|NCT02938286|Respiratory System Agents|respiratory system agents|mesh-ancestor
25144175|NCT02938286|Mydriatics|mydriatics|mesh-ancestor
25144176|NCT02938286|Sympathomimetics|sympathomimetics|mesh-ancestor
25144177|NCT02938286|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25144178|NCT02938286|Anesthetics, Local|anesthetics, local|mesh-ancestor
25144179|NCT02938286|Anesthetics|anesthetics|mesh-ancestor
24483512|NCT00443794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25144180|NCT02938286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25144181|NCT02938286|Sensory System Agents|sensory system agents|mesh-ancestor
25144182|NCT02938182|Clopidogrel|clopidogrel|mesh-list
25144183|NCT02938182|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25144184|NCT02938182|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25144186|NCT02938182|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25144195|NCT02937662|Immunologic Factors|immunologic factors|mesh-ancestor
25144196|NCT02937662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144197|NCT02937662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25144198|NCT02937662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25144199|NCT02937662|Alkylating Agents|alkylating agents|mesh-ancestor
25144200|NCT02937662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144201|NCT02937662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25144202|NCT02937662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25144203|NCT02937662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25144204|NCT02937662|Antimetabolites|antimetabolites|mesh-ancestor
25144205|NCT02937662|Antiviral Agents|antiviral agents|mesh-ancestor
25144206|NCT02937662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25144207|NCT02937662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25144208|NCT02937662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25144209|NCT02937662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25144210|NCT02937662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25144211|NCT02937857|Antipyretics|antipyretics|mesh-list
25144212|NCT02937857|Expectorants|expectorants|mesh-list
25144213|NCT02937857|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-list
25144214|NCT02937857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144215|NCT02937857|Respiratory System Agents|respiratory system agents|mesh-ancestor
25144216|NCT02937844|Cyclophosphamide|cyclophosphamide|mesh-list
25144217|NCT02937844|Fludarabine|fludarabine|mesh-list
25144218|NCT02937844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25144219|NCT02937844|Immunologic Factors|immunologic factors|mesh-ancestor
25684448|NCT01892189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25684449|NCT01892189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684450|NCT01892345|Eculizumab|eculizumab|mesh-list
25684451|NCT01892345|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25684452|NCT01892345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25684453|NCT01892345|Immunologic Factors|immunologic factors|mesh-ancestor
25116545|NCT03108274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25116546|NCT03108274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116547|NCT03108274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25116548|NCT03108274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25116549|NCT03108274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25116550|NCT03108274|Antitubercular Agents|antitubercular agents|mesh-ancestor
25116551|NCT03108274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25116552|NCT03108274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25116553|NCT03108274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25116554|NCT03108274|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25116555|NCT03108274|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25116556|NCT03108274|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25116557|NCT03108274|Histamine Antagonists|histamine antagonists|mesh-ancestor
25116558|NCT03108274|Histamine Agents|histamine agents|mesh-ancestor
25116559|NCT03107858|Dopamine|dopamine|mesh-list
25116560|NCT03107858|Norepinephrine|norepinephrine|mesh-list
25116561|NCT03107858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25116562|NCT03107858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25116563|NCT03107858|Adrenergic Agents|adrenergic agents|mesh-ancestor
25116564|NCT03107858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25116567|NCT03107858|Sympathomimetics|sympathomimetics|mesh-ancestor
25144220|NCT02937844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144221|NCT02937844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25144222|NCT02937844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25144223|NCT02937844|Alkylating Agents|alkylating agents|mesh-ancestor
25144224|NCT02937844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144225|NCT02937844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25144226|NCT02937844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25144227|NCT02937896|Ketorolac|ketorolac|mesh-list
25144228|NCT02937896|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25144231|NCT02937896|Analgesics|analgesics|mesh-ancestor
24483767|NCT00444834|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24592104|NCT00920244|Autonomic Agents|autonomic agents|mesh-ancestor
24483926|NCT00445900|Alkylating Agents|alkylating agents|mesh-ancestor
24483927|NCT00445900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483928|NCT00445900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24483929|NCT00445900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24483930|NCT00445900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24483931|NCT00445900|Glucocorticoids|glucocorticoids|mesh-ancestor
24483932|NCT00445900|Hormones|hormones|mesh-ancestor
24483933|NCT00445900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24483934|NCT00445900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24483935|NCT00445900|Leprostatic Agents|leprostatic agents|mesh-ancestor
24483936|NCT00445900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25144233|NCT02937896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25144234|NCT02937896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144235|NCT02937896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25144236|NCT02937896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25144237|NCT02937896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25144238|NCT02937896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25144239|NCT02937896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144240|NCT02937896|Hemostatics|hemostatics|mesh-ancestor
25144241|NCT02937896|Coagulants|coagulants|mesh-ancestor
25684454|NCT01892345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684455|NCT01892709|Hydromorphone|hydromorphone|mesh-list
25684456|NCT01892709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25684457|NCT01892709|Narcotics|narcotics|mesh-ancestor
25684458|NCT01892709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25684459|NCT01892709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684460|NCT01892709|Analgesics|analgesics|mesh-ancestor
25684461|NCT01892709|Sensory System Agents|sensory system agents|mesh-ancestor
25684462|NCT01892709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25684463|NCT01893203|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25684464|NCT01893203|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25684465|NCT01893203|Dermatologic Agents|dermatologic agents|mesh-ancestor
25684466|NCT01893281|Methyltestosterone|methyltestosterone|mesh-list
25684467|NCT01893281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25684468|NCT01893281|Testosterone|testosterone|mesh-list
25684469|NCT01893281|Testosterone undecanoate|testosterone undecanoate|mesh-list
25684470|NCT01893281|Testosterone enanthate|testosterone enanthate|mesh-list
25684471|NCT01893281|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25684472|NCT01893281|Androgens|androgens|mesh-ancestor
25684473|NCT01893281|Hormones|hormones|mesh-ancestor
25684474|NCT01893281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25288724|NCT03593915|Decitabine|decitabine|mesh-list
25288725|NCT03593915|Alvocidib|alvocidib|mesh-list
25288726|NCT03593915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25288727|NCT03593915|Antimetabolites|antimetabolites|mesh-ancestor
25116579|NCT03107962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25116580|NCT03107962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25116582|NCT03107884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25116583|NCT03107884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116584|NCT03107923|Dobutamine|dobutamine|mesh-list
25116585|NCT03107923|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25116586|NCT03107923|Sympathomimetics|sympathomimetics|mesh-ancestor
25116587|NCT03107923|Autonomic Agents|autonomic agents|mesh-ancestor
25144242|NCT02937896|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25144243|NCT02937896|Natriuretic Agents|natriuretic agents|mesh-ancestor
25144244|NCT02937792|Bupivacaine|bupivacaine|mesh-list
25144245|NCT02937792|Anesthetics, Local|anesthetics, local|mesh-ancestor
25144246|NCT02937792|Anesthetics|anesthetics|mesh-ancestor
25144247|NCT02937792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25144248|NCT02937792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144249|NCT02937792|Sensory System Agents|sensory system agents|mesh-ancestor
25144250|NCT02937792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25144251|NCT02937779|Tenofovir|tenofovir|mesh-list
25144252|NCT02937779|Antiviral Agents|antiviral agents|mesh-ancestor
25144253|NCT02937779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25144254|NCT02937779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25144255|NCT02937779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25144256|NCT02937779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25144257|NCT02937779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144258|NCT02937779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25144259|NCT02937779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25144260|NCT02937519|Cisplatin|cisplatin|mesh-list
25144266|NCT02937415|Antioxidants|antioxidants|mesh-list
25144267|NCT02937415|Carbon Monoxide|carbon monoxide|mesh-list
25144284|NCT02937285|Interferon beta-1a|interferon beta-1a|mesh-list
25144285|NCT02937285|Mitoxantrone|mitoxantrone|mesh-list
25144286|NCT02937285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25144287|NCT02937285|Antiviral Agents|antiviral agents|mesh-ancestor
24762696|NCT01769183|Squalamine|squalamine|mesh-list
24884029|NCT03537833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24884030|NCT03537833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24884031|NCT03521570|Nivolumab|nivolumab|mesh-list
24884032|NCT03521570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25144288|NCT02937285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25144289|NCT02937285|Analgesics|analgesics|mesh-ancestor
25144290|NCT02937285|Sensory System Agents|sensory system agents|mesh-ancestor
25144291|NCT02937285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25144292|NCT02937285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144293|NCT02937285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25144294|NCT02937285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25144295|NCT02937285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25144296|NCT02937285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144297|NCT02937285|Immunologic Factors|immunologic factors|mesh-ancestor
25144298|NCT02937285|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24484037|NCT00446316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484038|NCT00446316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25144315|NCT02936934|Morphine|morphine|mesh-list
25144316|NCT02936934|Oxycodone|oxycodone|mesh-list
25144317|NCT02936934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25144318|NCT02936934|Narcotics|narcotics|mesh-ancestor
25144319|NCT02936934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25684475|NCT01893281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684476|NCT01893281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25684477|NCT01893281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25684478|NCT01893281|Anabolic Agents|anabolic agents|mesh-ancestor
25684479|NCT01893411|Botulinum Toxins|botulinum toxins|mesh-list
25684480|NCT01893411|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25684481|NCT01893411|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25684482|NCT01893411|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25684483|NCT01893411|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25684484|NCT01893411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25684485|NCT01893411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144320|NCT02936934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144321|NCT02936934|Analgesics|analgesics|mesh-ancestor
25144322|NCT02936934|Sensory System Agents|sensory system agents|mesh-ancestor
25144323|NCT02936934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25288742|NCT03425565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25288743|NCT03425565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25288744|NCT03423680|Aripiprazole|aripiprazole|mesh-list
25288745|NCT03423680|Antidepressive Agents|antidepressive agents|mesh-ancestor
25288746|NCT03423680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25288747|NCT03423680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25288748|NCT03423680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25288749|NCT03423680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25288750|NCT03423680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144324|NCT02937181|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
25144325|NCT02937181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25144327|NCT02937012|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25144328|NCT02937012|Bezafibrate|bezafibrate|mesh-list
25144329|NCT02937012|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25144330|NCT02937012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25144331|NCT02937012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25144352|NCT02936830|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25144353|NCT02936661|Tranexamic Acid|tranexamic acid|mesh-list
25144354|NCT02936661|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25144355|NCT02936661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25144356|NCT02936661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144357|NCT02936661|Hemostatics|hemostatics|mesh-ancestor
25144358|NCT02936661|Coagulants|coagulants|mesh-ancestor
25144359|NCT02936492|Clobetasol|clobetasol|mesh-list
25144360|NCT02936492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25144361|NCT02936492|Glucocorticoids|glucocorticoids|mesh-ancestor
25144362|NCT02936492|Hormones|hormones|mesh-ancestor
25144363|NCT02936492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25144364|NCT02936492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144365|NCT02936505|Cyclosporine|cyclosporine|mesh-list
25144366|NCT02936505|Mycophenolic Acid|mycophenolic acid|mesh-list
25144367|NCT02936505|Tacrolimus|tacrolimus|mesh-list
25144368|NCT02936505|Cyclosporins|cyclosporins|mesh-list
25144369|NCT02936505|Thymoglobulin|thymoglobulin|mesh-list
24484039|NCT00446329|Cinacalcet|cinacalcet|mesh-list
24484040|NCT00446329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24484041|NCT00446329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484042|NCT00446329|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24484043|NCT00446329|Hormone Antagonists|hormone antagonists|mesh-ancestor
24484047|NCT00446368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24484048|NCT00446368|Immunologic Factors|immunologic factors|mesh-ancestor
25144370|NCT02936505|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25144371|NCT02936505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25144372|NCT02936505|Immunologic Factors|immunologic factors|mesh-ancestor
25144373|NCT02936505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144374|NCT02936505|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25144375|NCT02936505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25144376|NCT02936505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144377|NCT02936505|Antifungal Agents|antifungal agents|mesh-ancestor
25144378|NCT02936505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25144401|NCT02936427|Protease Inhibitors|protease inhibitors|mesh-ancestor
25144402|NCT02936427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25144403|NCT02936427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144404|NCT02936375|Cyclophosphamide|cyclophosphamide|mesh-list
25144405|NCT02936375|Azathioprine|azathioprine|mesh-list
25144406|NCT02936375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25144407|NCT02936375|Immunologic Factors|immunologic factors|mesh-ancestor
25144408|NCT02936375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144409|NCT02936375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25144410|NCT02936375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25144411|NCT02936375|Alkylating Agents|alkylating agents|mesh-ancestor
25144412|NCT02936375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144413|NCT02936375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25144414|NCT02936375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25144415|NCT02936375|Antimetabolites|antimetabolites|mesh-ancestor
25684486|NCT01893411|Cholinergic Agents|cholinergic agents|mesh-ancestor
25684487|NCT01893411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25684488|NCT01893411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684489|NCT01893411|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25684490|NCT01893411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25684491|NCT01893632|Gabapentin|gabapentin|mesh-list
25684492|NCT01893632|Analgesics|analgesics|mesh-ancestor
25684493|NCT01893632|Sensory System Agents|sensory system agents|mesh-ancestor
25684494|NCT01893632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25144416|NCT02936375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25144417|NCT02936167|Plasma-lyte 148|plasma-lyte 148|mesh-list
25116638|NCT03107338|Sensory System Agents|sensory system agents|mesh-ancestor
25116639|NCT03107338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116640|NCT03107338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116641|NCT03107338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25116642|NCT03107338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25116643|NCT03107507|Levetiracetam|levetiracetam|mesh-list
25116644|NCT03107507|Phenobarbital|phenobarbital|mesh-list
25116645|NCT03107507|Anticonvulsants|anticonvulsants|mesh-ancestor
25116646|NCT03107507|Nootropic Agents|nootropic agents|mesh-ancestor
25116647|NCT03107507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25116648|NCT03107507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25116649|NCT03107507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116650|NCT03107507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25116651|NCT03107507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25116652|NCT03107507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25116653|NCT03107507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116654|NCT03107507|GABA Modulators|gaba modulators|mesh-ancestor
25116655|NCT03107507|GABA Agents|gaba agents|mesh-ancestor
25116656|NCT03107507|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25116657|NCT03107507|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25116658|NCT03107507|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25116659|NCT03107078|Methylprednisolone|methylprednisolone|mesh-list
25116660|NCT03107078|Glucocorticoids|glucocorticoids|mesh-list
25116661|NCT03107078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25116662|NCT03107078|Antiemetics|antiemetics|mesh-ancestor
24611139|NCT01007500|Hormones|hormones|mesh-ancestor
25116663|NCT03107078|Autonomic Agents|autonomic agents|mesh-ancestor
25116664|NCT03107078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25144418|NCT02936167|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25144419|NCT02936167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24847399|NCT02246816|Analgesics|analgesics|mesh-ancestor
25144421|NCT02935933|Morphine|morphine|mesh-list
25144422|NCT02935933|Bupivacaine|bupivacaine|mesh-list
25144423|NCT02935933|Anesthetics, Local|anesthetics, local|mesh-ancestor
25144424|NCT02935933|Anesthetics|anesthetics|mesh-ancestor
25144425|NCT02935933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25144426|NCT02935933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144427|NCT02935933|Sensory System Agents|sensory system agents|mesh-ancestor
25144428|NCT02935933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25144429|NCT02935933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25144430|NCT02935933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25144431|NCT02935933|Analgesics|analgesics|mesh-ancestor
24808444|NCT02027220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24808459|NCT02027324|Disinfectants|disinfectants|mesh-ancestor
24808460|NCT02027324|Plasma Substitutes|plasma substitutes|mesh-ancestor
24808461|NCT02027324|Blood Substitutes|blood substitutes|mesh-ancestor
25144793|NCT02934035|Fluoxetine|fluoxetine|mesh-list
25684495|NCT01893632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684496|NCT01893632|Anticonvulsants|anticonvulsants|mesh-ancestor
25684497|NCT01893632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25684498|NCT01893632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25684499|NCT01893632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25684500|NCT01893632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25684501|NCT01893632|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25684502|NCT01893632|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25684503|NCT01893632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25684504|NCT01893632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684505|NCT01893632|Antimanic Agents|antimanic agents|mesh-ancestor
25684506|NCT01893801|Gemcitabine|gemcitabine|mesh-list
25684507|NCT01893801|Paclitaxel|paclitaxel|mesh-list
25684508|NCT01893801|Cisplatin|cisplatin|mesh-list
25684509|NCT01893801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25684510|NCT01893801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25684511|NCT01893801|Tubulin Modulators|tubulin modulators|mesh-ancestor
25684512|NCT01893801|Antimitotic Agents|antimitotic agents|mesh-ancestor
25684513|NCT01893801|Mitosis Modulators|mitosis modulators|mesh-ancestor
25684514|NCT01893801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684515|NCT01893801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25684516|NCT01893801|Antimetabolites|antimetabolites|mesh-ancestor
25684517|NCT01893801|Antiviral Agents|antiviral agents|mesh-ancestor
25684518|NCT01893801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25684519|NCT01893801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25684520|NCT01893801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25684521|NCT01893801|Immunologic Factors|immunologic factors|mesh-ancestor
25684522|NCT01893801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288822|NCT03121001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25288823|NCT03121001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25288824|NCT03121001|Antitubercular Agents|antitubercular agents|mesh-ancestor
25288825|NCT03121001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25288826|NCT03121001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25288827|NCT03121001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25288828|NCT03121001|Antifungal Agents|antifungal agents|mesh-ancestor
25288829|NCT03073525|Atezolizumab|atezolizumab|mesh-list
25288830|NCT03073525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25288831|NCT02965898|Vitamin D|vitamin d|mesh-list
25288832|NCT02965898|Ergocalciferols|ergocalciferols|mesh-list
25116682|NCT03106948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25116684|NCT03107169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25116685|NCT03107169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25116686|NCT03106831|Norepinephrine|norepinephrine|mesh-list
25116687|NCT03106831|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25116688|NCT03106831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25116689|NCT03106831|Adrenergic Agents|adrenergic agents|mesh-ancestor
25116690|NCT03106831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25116691|NCT03106831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116692|NCT03106831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116693|NCT03106831|Sympathomimetics|sympathomimetics|mesh-ancestor
25116694|NCT03106831|Autonomic Agents|autonomic agents|mesh-ancestor
25144432|NCT02935933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25144433|NCT02935933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25144434|NCT02935933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25144435|NCT02935933|Adrenergic Agents|adrenergic agents|mesh-ancestor
25144436|NCT02935933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25144438|NCT02935933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25144440|NCT02935725|Ketamine|ketamine|mesh-list
25144441|NCT02935725|Analgesics|analgesics|mesh-ancestor
25144442|NCT02935725|Sensory System Agents|sensory system agents|mesh-ancestor
25144443|NCT02935725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25144444|NCT02935725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144445|NCT02935725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25144446|NCT02935725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25144447|NCT02935725|Anesthetics, General|anesthetics, general|mesh-ancestor
25144448|NCT02935725|Anesthetics|anesthetics|mesh-ancestor
25144449|NCT02935725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25144450|NCT02935725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25144451|NCT02935725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25144452|NCT02935725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25144453|NCT02935725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144454|NCT02935764|Leucovorin|leucovorin|mesh-list
25144455|NCT02935764|Fluorouracil|fluorouracil|mesh-list
25144456|NCT02935764|Irinotecan|irinotecan|mesh-list
25144457|NCT02935764|Antimetabolites|antimetabolites|mesh-ancestor
25144458|NCT02935764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144459|NCT02935764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25144460|NCT02935764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25144461|NCT02935764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25144462|NCT02935764|Immunologic Factors|immunologic factors|mesh-ancestor
25405690|NCT03598595|Immunologic Factors|immunologic factors|mesh-ancestor
25684523|NCT01893827|Naltrexone|naltrexone|mesh-list
25684524|NCT01893827|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25684525|NCT01893827|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25684526|NCT01893827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684527|NCT01893827|Sensory System Agents|sensory system agents|mesh-ancestor
25684528|NCT01893827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25684529|NCT01893879|Ketoprofen|ketoprofen|mesh-list
25684530|NCT01893879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25684531|NCT01893879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25684532|NCT01893879|Analgesics|analgesics|mesh-ancestor
25684533|NCT01893879|Sensory System Agents|sensory system agents|mesh-ancestor
25684534|NCT01893879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25684535|NCT01893879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684536|NCT01893879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25684537|NCT01893879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25684538|NCT01893879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25684539|NCT01893879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25684540|NCT01893879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684541|NCT01894022|Ambrisentan|ambrisentan|mesh-list
25684542|NCT01894022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25684543|NCT01894152|Everolimus|everolimus|mesh-list
25684544|NCT01894152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25116720|NCT03106818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25116721|NCT03106818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25116722|NCT03106818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25116723|NCT03106818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25116724|NCT03106818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25116725|NCT03106818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116726|NCT03106818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25116727|NCT03106818|Anticonvulsants|anticonvulsants|mesh-ancestor
25116728|NCT03106818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25144463|NCT02935764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144464|NCT02935764|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25144465|NCT02935764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25144466|NCT02935764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25144468|NCT02935764|Protective Agents|protective agents|mesh-ancestor
25144469|NCT02935764|Vitamin B Complex|vitamin b complex|mesh-ancestor
24808463|NCT02027337|Drospirenone|drospirenone|mesh-list
25144471|NCT02935764|Micronutrients|micronutrients|mesh-ancestor
25144480|NCT02935998|Ziprasidone|ziprasidone|mesh-list
25144481|NCT02935998|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25144482|NCT02935998|Serotonin Agents|serotonin agents|mesh-ancestor
25144483|NCT02935998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25144484|NCT02935998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144485|NCT02935998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047540|NCT00796289|Anticoagulants|anticoagulants|mesh-ancestor
25047541|NCT00796289|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25047542|NCT00796289|Chelating Agents|chelating agents|mesh-ancestor
25047543|NCT00796289|Sequestering Agents|sequestering agents|mesh-ancestor
25047544|NCT00796289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047546|NCT00796289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144533|NCT02935972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25144534|NCT02935972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144535|NCT02935972|Sensory System Agents|sensory system agents|mesh-ancestor
25144536|NCT02935972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25144537|NCT02935972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25144538|NCT02935972|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25144539|NCT02935972|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25144540|NCT02935972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25144541|NCT02935972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144542|NCT02935972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25144543|NCT02935972|Anticonvulsants|anticonvulsants|mesh-ancestor
25144544|NCT02935972|Antiemetics|antiemetics|mesh-ancestor
25144545|NCT02935972|Autonomic Agents|autonomic agents|mesh-ancestor
25144546|NCT02935972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25144547|NCT02935972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25144548|NCT02935972|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25144549|NCT02935972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25144550|NCT02935972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25144608|NCT02935530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25144609|NCT02935530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25144610|NCT02935114|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25144611|NCT02935114|Carbamide Peroxide|carbamide peroxide|mesh-list
25144612|NCT02935114|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25144613|NCT02935114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25144622|NCT02935231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25144623|NCT02935231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622853|NCT01068847|Anticonvulsants|anticonvulsants|mesh-ancestor
25047549|NCT00796289|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25047550|NCT00796289|Fertility Agents|fertility agents|mesh-ancestor
25047551|NCT00796289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25047552|NCT00796289|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25047553|NCT00796289|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25047554|NCT00794677|Ezetimibe|ezetimibe|mesh-list
25047555|NCT00794677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25684545|NCT01894152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25684546|NCT01894152|Immunologic Factors|immunologic factors|mesh-ancestor
25684547|NCT01894152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684548|NCT01894243|Olaparib|olaparib|mesh-list
25684549|NCT01894243|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25684550|NCT01894243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25684551|NCT01894243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684552|NCT01894243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25684553|NCT01894256|Olaparib|olaparib|mesh-list
25047556|NCT00794677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25047557|NCT00794677|Antimetabolites|antimetabolites|mesh-ancestor
25047558|NCT00794677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144649|NCT02935335|Menotropins|menotropins|mesh-list
25144650|NCT02935335|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25144651|NCT02935335|Fertility Agents|fertility agents|mesh-ancestor
25144652|NCT02935335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25144653|NCT02935335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144655|NCT02935075|Lamivudine|lamivudine|mesh-list
25144656|NCT02935075|Efavirenz|efavirenz|mesh-list
25144657|NCT02935075|Antiviral Agents|antiviral agents|mesh-ancestor
25144658|NCT02935075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25144659|NCT02935075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25144660|NCT02935075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25144661|NCT02935075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25144662|NCT02935075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144663|NCT02935075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25144664|NCT02935075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25144665|NCT02935075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25144666|NCT02935075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25144667|NCT02935075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25144668|NCT02935075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25144669|NCT02935075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24484383|NCT00448097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24484384|NCT00448110|Diclofenac|diclofenac|mesh-list
24484385|NCT00448110|Ketorolac|ketorolac|mesh-list
25144670|NCT02935075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25144671|NCT02935101|Prednisolone|prednisolone|mesh-list
25144672|NCT02935101|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25144673|NCT02935101|Methylprednisolone|methylprednisolone|mesh-list
25144674|NCT02935101|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25144677|NCT02935101|Prednisolone phosphate|prednisolone phosphate|mesh-list
25144678|NCT02935101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25144679|NCT02935101|Glucocorticoids|glucocorticoids|mesh-ancestor
25144680|NCT02935101|Hormones|hormones|mesh-ancestor
25144681|NCT02935101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25144682|NCT02935101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144683|NCT02935101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25144684|NCT02935101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25144687|NCT02935101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25144688|NCT02935101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25144689|NCT02935101|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25144690|NCT02935101|Protective Agents|protective agents|mesh-ancestor
25144691|NCT02934945|Budesonide|budesonide|mesh-list
25144692|NCT02934945|Formoterol Fumarate|formoterol fumarate|mesh-list
25144693|NCT02934945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25144694|NCT02934945|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25144695|NCT02934945|Autonomic Agents|autonomic agents|mesh-ancestor
25144696|NCT02934945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25144697|NCT02934945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144698|NCT02934945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25144699|NCT02934945|Respiratory System Agents|respiratory system agents|mesh-ancestor
25144700|NCT02934945|Glucocorticoids|glucocorticoids|mesh-ancestor
25144701|NCT02934945|Hormones|hormones|mesh-ancestor
25144702|NCT02934945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25144703|NCT02934945|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25144704|NCT02934945|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25144705|NCT02934945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25144706|NCT02934945|Adrenergic Agents|adrenergic agents|mesh-ancestor
25144707|NCT02934945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25144708|NCT02934945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144709|NCT02934919|Nalmefene|nalmefene|mesh-list
25144710|NCT02934919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25144711|NCT02934919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144714|NCT02934789|Contraceptive Agents|contraceptive agents|mesh-list
25144715|NCT02934789|Contraceptives, Oral|contraceptives, oral|mesh-list
25144716|NCT02934789|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25144717|NCT02934789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25144718|NCT02934789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144719|NCT02934789|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24484387|NCT00448110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25144720|NCT02934906|Immunoglobulins|immunoglobulins|mesh-list
25144721|NCT02934906|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25144722|NCT02934906|Antibodies|antibodies|mesh-list
25144724|NCT02934906|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25144725|NCT02934906|Immunologic Factors|immunologic factors|mesh-ancestor
25144726|NCT02934906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144728|NCT02935010|Metronidazole|metronidazole|mesh-list
25144729|NCT02935010|Clarithromycin|clarithromycin|mesh-list
25144730|NCT02935010|Levofloxacin|levofloxacin|mesh-list
25144731|NCT02935010|Ofloxacin|ofloxacin|mesh-list
25144732|NCT02935010|Potassium Citrate|potassium citrate|mesh-list
25144733|NCT02935010|Esomeprazole|esomeprazole|mesh-list
25144734|NCT02935010|Bismuth|bismuth|mesh-list
25144735|NCT02935010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144736|NCT02935010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25144737|NCT02935010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25144738|NCT02935010|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25144739|NCT02935010|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25144748|NCT02935010|Renal Agents|renal agents|mesh-ancestor
25144766|NCT02934763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25144767|NCT02934763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25144768|NCT02934763|Vasodilator Agents|vasodilator agents|mesh-ancestor
25144770|NCT02934464|Paclitaxel|paclitaxel|mesh-list
25144771|NCT02934464|Ramucirumab|ramucirumab|mesh-list
25144772|NCT02934464|Oxaliplatin|oxaliplatin|mesh-list
25144773|NCT02934464|Levoleucovorin|levoleucovorin|mesh-list
25144839|NCT02934204|Methotrexate|methotrexate|mesh-list
25144774|NCT02934464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25144775|NCT02934464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25144776|NCT02934464|Tubulin Modulators|tubulin modulators|mesh-ancestor
25144777|NCT02934464|Antimitotic Agents|antimitotic agents|mesh-ancestor
25144778|NCT02934464|Mitosis Modulators|mitosis modulators|mesh-ancestor
25144779|NCT02934464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144780|NCT02934464|Antidotes|antidotes|mesh-ancestor
25144781|NCT02934464|Protective Agents|protective agents|mesh-ancestor
25144782|NCT02934464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144783|NCT02934464|Vitamin B Complex|vitamin b complex|mesh-ancestor
25144784|NCT02934464|Vitamins|vitamins|mesh-ancestor
25144785|NCT02934464|Micronutrients|micronutrients|mesh-ancestor
25144786|NCT02934607|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25144787|NCT02934607|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25144788|NCT02934607|Respiratory System Agents|respiratory system agents|mesh-ancestor
25144789|NCT02934321|Erythritol|erythritol|mesh-list
25144790|NCT02934321|Vasodilator Agents|vasodilator agents|mesh-ancestor
25144791|NCT02934035|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25144792|NCT02934035|Citalopram|citalopram|mesh-list
25144797|NCT02934035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25144798|NCT02934035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25144799|NCT02934035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25144800|NCT02934035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144802|NCT02934035|Serotonin Agents|serotonin agents|mesh-ancestor
25144808|NCT02934035|Analgesics|analgesics|mesh-ancestor
25144809|NCT02934035|Sensory System Agents|sensory system agents|mesh-ancestor
25144810|NCT02934035|Dopamine Agents|dopamine agents|mesh-ancestor
25144811|NCT02934035|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25144812|NCT02934035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25144813|NCT02934035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25144814|NCT02934152|Amoxicillin|amoxicillin|mesh-list
25144815|NCT02934152|Clarithromycin|clarithromycin|mesh-list
25144816|NCT02934152|Rabeprazole|rabeprazole|mesh-list
25144817|NCT02934152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25144818|NCT02934152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25144819|NCT02934152|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25144820|NCT02934152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25144821|NCT02934152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144822|NCT02934152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25144823|NCT02934152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25144824|NCT02934152|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25144825|NCT02934152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25144826|NCT02934152|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25144827|NCT02934295|Antibodies|antibodies|mesh-list
25144828|NCT02934295|Immunologic Factors|immunologic factors|mesh-ancestor
25144829|NCT02934295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144830|NCT02934022|Maraviroc|maraviroc|mesh-list
25144831|NCT02934022|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25144832|NCT02934022|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25144833|NCT02934022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047563|NCT00792727|Analgesics|analgesics|mesh-ancestor
25047580|NCT00791154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116868|NCT03105661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25116869|NCT03105661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25116870|NCT03105661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116871|NCT03105661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25116872|NCT03105661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116873|NCT03105661|Vasodilator Agents|vasodilator agents|mesh-ancestor
24893967|NCT04445467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25047581|NCT00791154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25047582|NCT00790660|Ipragliflozin|ipragliflozin|mesh-list
25047583|NCT00790660|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25047584|NCT00790660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047585|NCT00790660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25047586|NCT00790660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047587|NCT00789633|Gemcitabine|gemcitabine|mesh-list
25047588|NCT00789633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25047589|NCT00789633|Antimetabolites|antimetabolites|mesh-ancestor
24484672|NCT00449527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24484673|NCT00449527|Autonomic Agents|autonomic agents|mesh-ancestor
24484677|NCT00449527|Respiratory System Agents|respiratory system agents|mesh-ancestor
24484678|NCT00449527|Glucocorticoids|glucocorticoids|mesh-ancestor
24484679|NCT00449527|Hormones|hormones|mesh-ancestor
24484703|NCT00449618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25047590|NCT00789633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047591|NCT00789633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25047592|NCT00789633|Antiviral Agents|antiviral agents|mesh-ancestor
25047593|NCT00789633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25047594|NCT00789633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047595|NCT00789633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25047596|NCT00789633|Immunologic Factors|immunologic factors|mesh-ancestor
25144841|NCT02934204|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25144842|NCT02934204|Abortifacient Agents|abortifacient agents|mesh-ancestor
25144843|NCT02934204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25144844|NCT02934204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144845|NCT02934204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25144846|NCT02934204|Antimetabolites|antimetabolites|mesh-ancestor
25144847|NCT02934204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144848|NCT02934204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25144849|NCT02934204|Dermatologic Agents|dermatologic agents|mesh-ancestor
25144850|NCT02934204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25144851|NCT02934204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25144864|NCT02934061|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25144865|NCT02934061|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25144866|NCT02934061|Parasympatholytics|parasympatholytics|mesh-ancestor
25144867|NCT02934061|Autonomic Agents|autonomic agents|mesh-ancestor
25144868|NCT02934061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25144869|NCT02934061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25144870|NCT02934061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25144871|NCT02934061|Adrenergic Agents|adrenergic agents|mesh-ancestor
25144872|NCT02934061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25144873|NCT02934061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144874|NCT02934217|Cyclosporine|cyclosporine|mesh-list
25144875|NCT02934217|Cyclosporins|cyclosporins|mesh-list
25144876|NCT02934217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25144877|NCT02934217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144878|NCT02934217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25144879|NCT02934217|Immunologic Factors|immunologic factors|mesh-ancestor
25144880|NCT02934217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144881|NCT02934217|Antifungal Agents|antifungal agents|mesh-ancestor
25144882|NCT02934217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25144883|NCT02934217|Dermatologic Agents|dermatologic agents|mesh-ancestor
25144884|NCT02934217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25144885|NCT02934217|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25144886|NCT02933905|Ranibizumab|ranibizumab|mesh-list
25144887|NCT02933905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25144888|NCT02933905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25684554|NCT01894256|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25684555|NCT01894256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25684556|NCT01894256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684557|NCT01894256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25684558|NCT01894477|Fludarabine|fludarabine|mesh-list
25684559|NCT01894477|Fludarabine phosphate|fludarabine phosphate|mesh-list
25684560|NCT01894477|Treosulfan|treosulfan|mesh-list
25684561|NCT01894477|Busulfan|busulfan|mesh-list
25144889|NCT02933905|Growth Substances|growth substances|mesh-ancestor
25144890|NCT02933905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144891|NCT02933905|Growth Inhibitors|growth inhibitors|mesh-ancestor
25144892|NCT02933905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484787|NCT00450086|Budesonide|budesonide|mesh-list
25144902|NCT02933814|Bupivacaine|bupivacaine|mesh-list
25144903|NCT02933814|Anesthetics, Local|anesthetics, local|mesh-ancestor
25144904|NCT02933814|Anesthetics|anesthetics|mesh-ancestor
25144905|NCT02933814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25144906|NCT02933814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144907|NCT02933814|Sensory System Agents|sensory system agents|mesh-ancestor
25144908|NCT02933814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25144909|NCT02933775|Cyclophosphamide|cyclophosphamide|mesh-list
25144910|NCT02933775|Fludarabine|fludarabine|mesh-list
25144911|NCT02933775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25144912|NCT02933775|Immunologic Factors|immunologic factors|mesh-ancestor
25144913|NCT02933775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144914|NCT02933775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25144915|NCT02933775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25144916|NCT02933775|Alkylating Agents|alkylating agents|mesh-ancestor
25144917|NCT02933775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144918|NCT02933775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25144919|NCT02933775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25144920|NCT02933788|Aspirin|aspirin|mesh-list
25144921|NCT02933788|Cilostazol|cilostazol|mesh-list
25144922|NCT02933788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25144923|NCT02933788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25144924|NCT02933788|Analgesics|analgesics|mesh-ancestor
25144925|NCT02933788|Sensory System Agents|sensory system agents|mesh-ancestor
25144926|NCT02933788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25144927|NCT02933788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144928|NCT02933788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25144929|NCT02933788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25144930|NCT02933788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25144931|NCT02933788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25144933|NCT02933788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25144945|NCT02933788|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25144946|NCT02933580|JNJ-56136379|jnj-56136379|mesh-list
25144947|NCT02933580|Antiviral Agents|antiviral agents|mesh-ancestor
25144948|NCT02933580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25144949|NCT02933658|Amlodipine|amlodipine|mesh-list
25144950|NCT02933658|Telmisartan|telmisartan|mesh-list
25144951|NCT02933658|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25144952|NCT02933658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25144953|NCT02933658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25144958|NCT02933658|Vasodilator Agents|vasodilator agents|mesh-ancestor
25144959|NCT02933658|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25144960|NCT02933658|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25144961|NCT02933658|Antimetabolites|antimetabolites|mesh-ancestor
25144962|NCT02933658|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25144963|NCT02933658|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25144964|NCT02933658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25144965|NCT02933658|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25144966|NCT02933658|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25144967|NCT02933593|Labetalol|labetalol|mesh-list
25144968|NCT02933593|Hydralazine|hydralazine|mesh-list
25144969|NCT02933593|Nifedipine|nifedipine|mesh-list
25144970|NCT02933593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25144971|NCT02933593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25047597|NCT00789633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047598|NCT00788541|Hydrocortisone|hydrocortisone|mesh-list
25144973|NCT02933593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25144974|NCT02933593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144976|NCT02933593|Tocolytic Agents|tocolytic agents|mesh-ancestor
25144977|NCT02933593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25144978|NCT02933593|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25144979|NCT02933593|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25144980|NCT02933593|Adrenergic Agents|adrenergic agents|mesh-ancestor
25144981|NCT02933593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25144982|NCT02933593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25144983|NCT02933593|Sympathomimetics|sympathomimetics|mesh-ancestor
25144984|NCT02933593|Autonomic Agents|autonomic agents|mesh-ancestor
25144985|NCT02933593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25144986|NCT02933593|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25144987|NCT02933593|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24614118|NCT01022541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24614119|NCT01022541|Growth Substances|growth substances|mesh-ancestor
24614120|NCT01022541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614121|NCT01022541|Growth Inhibitors|growth inhibitors|mesh-ancestor
24614122|NCT01022541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25289013|NCT05089526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25289014|NCT05089526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25144989|NCT02933853|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25144990|NCT02933853|Insulin Aspart|insulin aspart|mesh-list
25144991|NCT02933853|Insulin, Long-Acting|insulin, long-acting|mesh-list
25144992|NCT02933853|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25144993|NCT02933853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25144994|NCT02933853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144995|NCT02933645|Insulin|insulin|mesh-list
25144996|NCT02933645|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25144997|NCT02933645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25144998|NCT02933645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144999|NCT02933684|Cycloserine|cycloserine|mesh-list
25145000|NCT02933684|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25145001|NCT02933684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25145002|NCT02933684|Renal Agents|renal agents|mesh-ancestor
25145003|NCT02933684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25145004|NCT02933684|Antitubercular Agents|antitubercular agents|mesh-ancestor
24884033|NCT03521570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24884034|NCT03521570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24808588|NCT02028026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24808589|NCT02028026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24808592|NCT02028078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24808593|NCT02028078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485062|NCT00451373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25145005|NCT02933684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25145006|NCT02933684|Antimetabolites|antimetabolites|mesh-ancestor
25145007|NCT02933684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145008|NCT02933333|Molgramostim|molgramostim|mesh-list
25145009|NCT02933333|Lenograstim|lenograstim|mesh-list
25145010|NCT02933333|Sargramostim|sargramostim|mesh-list
25145011|NCT02933333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25145012|NCT02933333|Immunologic Factors|immunologic factors|mesh-ancestor
25145013|NCT02933333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145014|NCT02933333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145015|NCT02933437|Ajmaline|ajmaline|mesh-list
25145020|NCT02933437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145021|NCT02932930|Ropivacaine|ropivacaine|mesh-list
25145022|NCT02932930|Anesthetics, Local|anesthetics, local|mesh-ancestor
25145023|NCT02932930|Anesthetics|anesthetics|mesh-ancestor
25145024|NCT02932930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25145025|NCT02932930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505249|NCT00540748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24505250|NCT00540748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505252|NCT00540787|Amiodarone|amiodarone|mesh-list
24505253|NCT00540787|Sotalol|sotalol|mesh-list
24485102|NCT00451620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24485103|NCT00451620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808606|NCT02028260|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24808607|NCT02028260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808608|NCT02028299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24505265|NCT00540787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505341|NCT00540956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25684562|NCT01894477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25684563|NCT01894477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25684564|NCT01894477|Antimetabolites|antimetabolites|mesh-ancestor
25684565|NCT01894477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684566|NCT01894477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25684567|NCT01894477|Immunologic Factors|immunologic factors|mesh-ancestor
25684568|NCT01894477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684569|NCT01894477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24505342|NCT00540956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24505343|NCT00540956|Immunologic Factors|immunologic factors|mesh-ancestor
24505344|NCT00540956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505345|NCT00541008|Sunitinib|sunitinib|mesh-list
24505346|NCT00541008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505347|NCT00541008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24505348|NCT00541008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24505349|NCT00541008|Growth Substances|growth substances|mesh-ancestor
24505350|NCT00541008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505351|NCT00541008|Growth Inhibitors|growth inhibitors|mesh-ancestor
24505631|NCT00541723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24505632|NCT00541723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24884162|NCT02817789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24884163|NCT02817789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25145026|NCT02932930|Sensory System Agents|sensory system agents|mesh-ancestor
25145027|NCT02932930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25145028|NCT02932826|Insulin|insulin|mesh-list
24537513|NCT00655044|Insulin Detemir|insulin detemir|mesh-list
25145029|NCT02932826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25145030|NCT02932826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145031|NCT02933099|Dexamethasone|dexamethasone|mesh-list
25145032|NCT02933099|Dexamethasone acetate|dexamethasone acetate|mesh-list
25145033|NCT02933099|Aprepitant|aprepitant|mesh-list
25145034|NCT02933099|Palonosetron|palonosetron|mesh-list
25145035|NCT02933099|BB 1101|bb 1101|mesh-list
25145036|NCT02933099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25145037|NCT02933099|Antiemetics|antiemetics|mesh-ancestor
25145038|NCT02933099|Autonomic Agents|autonomic agents|mesh-ancestor
25145039|NCT02933099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25145040|NCT02933099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145041|NCT02933099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25145042|NCT02933099|Glucocorticoids|glucocorticoids|mesh-ancestor
25145043|NCT02933099|Hormones|hormones|mesh-ancestor
25145044|NCT02933099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25145045|NCT02933099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25145046|NCT02933099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145047|NCT02933099|Protease Inhibitors|protease inhibitors|mesh-ancestor
25145048|NCT02933099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25145050|NCT02933099|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25145077|NCT02932774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145078|NCT02932774|Antipruritics|antipruritics|mesh-ancestor
25145079|NCT02932774|Dermatologic Agents|dermatologic agents|mesh-ancestor
25145080|NCT02932605|Cannabidiol|cannabidiol|mesh-list
25145081|NCT02932605|Anticonvulsants|anticonvulsants|mesh-ancestor
25145082|NCT02932488|Sumatriptan|sumatriptan|mesh-list
25145083|NCT02932488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25145084|NCT02932488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25145086|NCT02932488|Serotonin Agents|serotonin agents|mesh-ancestor
25145087|NCT02932488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25145088|NCT02932488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145089|NCT02932488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145091|NCT02932397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25145092|NCT02932397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25145093|NCT02932397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145094|NCT02932397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25145095|NCT02932397|Anesthetics, General|anesthetics, general|mesh-ancestor
25145096|NCT02932397|Anesthetics|anesthetics|mesh-ancestor
25145097|NCT02932566|Pirfenidone|pirfenidone|mesh-list
25145098|NCT02932566|Analgesics|analgesics|mesh-ancestor
25145099|NCT02932566|Sensory System Agents|sensory system agents|mesh-ancestor
25145100|NCT02932566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25145101|NCT02932566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145102|NCT02932566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25145103|NCT02932566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25145104|NCT02932566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25145105|NCT02932566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25145106|NCT02932566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145158|NCT02932020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25145159|NCT02932020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25145160|NCT02932020|Protective Agents|protective agents|mesh-ancestor
25145161|NCT02932020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25145162|NCT02932020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145163|NCT02932137|Interleukin-2|interleukin-2|mesh-list
25289078|NCT04947085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25289079|NCT04947085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25289080|NCT04947085|Anesthetics, General|anesthetics, general|mesh-ancestor
25289081|NCT04947085|Anesthetics|anesthetics|mesh-ancestor
25289082|NCT04947085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25289083|NCT04947085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25289084|NCT04947085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25289085|NCT04947085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25289086|NCT04947085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116994|NCT03105245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116995|NCT03105375|Omeprazole|omeprazole|mesh-list
25116996|NCT03105375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25116997|NCT03105375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25145164|NCT02932137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145165|NCT02932137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25145166|NCT02932137|Analgesics|analgesics|mesh-ancestor
25145167|NCT02932137|Sensory System Agents|sensory system agents|mesh-ancestor
25145168|NCT02932137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24537555|NCT00655174|Antidepressive Agents|antidepressive agents|mesh-ancestor
25145169|NCT02932137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145170|NCT02932254|Magnesium Sulfate|magnesium sulfate|mesh-list
25145171|NCT02932254|Analgesics|analgesics|mesh-ancestor
25145172|NCT02932254|Sensory System Agents|sensory system agents|mesh-ancestor
25145173|NCT02932254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25145174|NCT02932254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047614|NCT00785226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047615|NCT00782431|Vaccines|vaccines|mesh-list
25047616|NCT00782431|Immunologic Factors|immunologic factors|mesh-ancestor
25047617|NCT00782431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808639|NCT02028507|Exemestane|exemestane|mesh-list
25047618|NCT00777309|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25047619|NCT00777309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25047620|NCT00777309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25047621|NCT00777309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047622|NCT00777309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047623|NCT00776373|Cytarabine|cytarabine|mesh-list
25047624|NCT00776373|Sirolimus|sirolimus|mesh-list
25047625|NCT00776373|Etoposide|etoposide|mesh-list
25047626|NCT00776373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25047627|NCT00776373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25047634|NCT00776373|Antiviral Agents|antiviral agents|mesh-ancestor
25047640|NCT00776373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25047641|NCT00776373|Antifungal Agents|antifungal agents|mesh-ancestor
25047642|NCT00774761|Fluticasone|fluticasone|mesh-list
25047644|NCT00774761|Formoterol Fumarate|formoterol fumarate|mesh-list
25047645|NCT00774761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25047646|NCT00774761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25047647|NCT00774761|Autonomic Agents|autonomic agents|mesh-ancestor
25047648|NCT00774761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25047649|NCT00774761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047650|NCT00774761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25047651|NCT00774761|Respiratory System Agents|respiratory system agents|mesh-ancestor
25047652|NCT00774761|Dermatologic Agents|dermatologic agents|mesh-ancestor
25047653|NCT00774761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25047654|NCT00774761|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25047655|NCT00774761|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25047656|NCT00774761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25047657|NCT00774761|Adrenergic Agents|adrenergic agents|mesh-ancestor
25047658|NCT00774761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25145436|NCT02929706|Immunologic Factors|immunologic factors|mesh-ancestor
25047660|NCT00772785|Buprenorphine|buprenorphine|mesh-list
25047661|NCT00772785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25684570|NCT01894477|Alkylating Agents|alkylating agents|mesh-ancestor
25684571|NCT01894477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25684572|NCT01894503|Mometasone Furoate|mometasone furoate|mesh-list
25684573|NCT01894503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25684574|NCT01894503|Dermatologic Agents|dermatologic agents|mesh-ancestor
25684575|NCT01894503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25684576|NCT01894555|Aspirin|aspirin|mesh-list
25684577|NCT01894555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25684578|NCT01894555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25684579|NCT01894555|Analgesics|analgesics|mesh-ancestor
25684580|NCT01894555|Sensory System Agents|sensory system agents|mesh-ancestor
25684581|NCT01894555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25684582|NCT01894555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684583|NCT01894555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25047662|NCT00772785|Narcotics|narcotics|mesh-ancestor
24884164|NCT02817789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24884165|NCT02817789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24884166|NCT02817789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24884167|NCT02817789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24485438|NCT00452985|Tubulin Modulators|tubulin modulators|mesh-ancestor
24485439|NCT00452985|Antimitotic Agents|antimitotic agents|mesh-ancestor
24505828|NCT00542711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505829|NCT00542711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505830|NCT00542763|Mycophenolic Acid|mycophenolic acid|mesh-list
24505831|NCT00542763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24505832|NCT00542763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505833|NCT00542763|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24505834|NCT00542763|Antitubercular Agents|antitubercular agents|mesh-ancestor
24505835|NCT00542763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24505836|NCT00542763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24505837|NCT00542763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505838|NCT00542763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505840|NCT00542802|Levetiracetam|levetiracetam|mesh-list
24505841|NCT00542802|Anticonvulsants|anticonvulsants|mesh-ancestor
24884216|NCT02678143|Fludarabine|fludarabine|mesh-list
24884217|NCT02678143|Alemtuzumab|alemtuzumab|mesh-list
24884218|NCT02678143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24884219|NCT02678143|Immunologic Factors|immunologic factors|mesh-ancestor
24884220|NCT02678143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884221|NCT02678143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25047663|NCT00772785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25047664|NCT00772785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047665|NCT00772785|Analgesics|analgesics|mesh-ancestor
25047666|NCT00772785|Sensory System Agents|sensory system agents|mesh-ancestor
25047667|NCT00772785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25047668|NCT00772785|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25047669|NCT00772343|Vaccines|vaccines|mesh-list
25047670|NCT00772343|Immunologic Factors|immunologic factors|mesh-ancestor
25047671|NCT00772343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047672|NCT00771134|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25047673|NCT00771134|Antidepressive Agents|antidepressive agents|mesh-ancestor
25047674|NCT00771134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25047675|NCT00771134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25047676|NCT00771134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25047677|NCT00771134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25145176|NCT02932254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25145177|NCT02932254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25145178|NCT02932254|Anticonvulsants|anticonvulsants|mesh-ancestor
25145179|NCT02932254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25145180|NCT02932254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25145181|NCT02932254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145182|NCT02932254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24485440|NCT00452985|Mitosis Modulators|mitosis modulators|mesh-ancestor
25145183|NCT02932254|Tocolytic Agents|tocolytic agents|mesh-ancestor
25145184|NCT02932254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25145185|NCT02931903|Lithium Carbonate|lithium carbonate|mesh-list
25145186|NCT02931903|Antidepressive Agents|antidepressive agents|mesh-ancestor
25145187|NCT02931903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25145190|NCT02931903|Antimanic Agents|antimanic agents|mesh-ancestor
25145206|NCT02931786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25145207|NCT02931786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25145208|NCT02931786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25145209|NCT02931786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145212|NCT02931877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25145213|NCT02931877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25145214|NCT02931877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145215|NCT02931877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25145216|NCT02931877|Anesthetics, General|anesthetics, general|mesh-ancestor
25145217|NCT02931877|Anesthetics|anesthetics|mesh-ancestor
25146611|NCT02920489|Dsuvia|dsuvia|mesh-list
25145218|NCT02931877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25145219|NCT02931877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25145220|NCT02931591|Metformin|metformin|mesh-list
25145221|NCT02931591|Hormones|hormones|mesh-list
25145222|NCT02931591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25145223|NCT02931591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289165|NCT04504240|Famotidine|famotidine|mesh-list
25289166|NCT04504240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24786772|NCT01921790|Gemcitabine|gemcitabine|mesh-list
25117159|NCT05375240|Propranolol|propranolol|mesh-list
25117160|NCT05375240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25117161|NCT05375240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25117162|NCT05375240|Adrenergic Agents|adrenergic agents|mesh-ancestor
25117163|NCT05375240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25117164|NCT05375240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117165|NCT05375240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117166|NCT05375240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25117167|NCT05375240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25117168|NCT05375240|Vasodilator Agents|vasodilator agents|mesh-ancestor
25117171|NCT05375188|Dexmedetomidine|dexmedetomidine|mesh-list
25145224|NCT02931591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25145225|NCT02931383|Liraglutide|liraglutide|mesh-list
25145226|NCT02931383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25145227|NCT02931383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145228|NCT02931383|Incretins|incretins|mesh-ancestor
25145229|NCT02931383|Hormones|hormones|mesh-ancestor
25145230|NCT02931383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25145231|NCT02931474|Tesamorelin|tesamorelin|mesh-list
25145232|NCT02931474|Growth Substances|growth substances|mesh-ancestor
25145233|NCT02931474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145234|NCT02931357|Cetylpyridinium|cetylpyridinium|mesh-list
25145235|NCT02931357|Lidocaine|lidocaine|mesh-list
25145251|NCT02931357|Protective Agents|protective agents|mesh-ancestor
25145252|NCT02931357|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25145253|NCT02931357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25145254|NCT02931526|Tigecycline|tigecycline|mesh-list
25145255|NCT02931526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25145256|NCT02931526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25145257|NCT02931526|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25145258|NCT02931526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25145259|NCT02931526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145261|NCT02931123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25145262|NCT02931123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25145263|NCT02931123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25145264|NCT02931136|Huperzine A|huperzine a|mesh-list
25145265|NCT02931136|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25145266|NCT02931136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25145267|NCT02931136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145268|NCT02931136|Cholinergic Agents|cholinergic agents|mesh-ancestor
25145269|NCT02931136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25145270|NCT02931136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145271|NCT02931136|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25145272|NCT02931136|Protective Agents|protective agents|mesh-ancestor
25145273|NCT02931188|Anacetrapib|anacetrapib|mesh-list
25145274|NCT02931188|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25145275|NCT02931188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25145276|NCT02931188|Antimetabolites|antimetabolites|mesh-ancestor
25145277|NCT02931188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145278|NCT02931188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25145279|NCT02931175|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25145280|NCT02931175|Hormones|hormones|mesh-ancestor
25145281|NCT02931175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25145282|NCT02931175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145292|NCT02930733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145293|NCT02930733|Sensory System Agents|sensory system agents|mesh-ancestor
25145294|NCT02930733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25684584|NCT01894555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25684585|NCT01894555|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25684586|NCT01894555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25684587|NCT01894555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684588|NCT01894555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25684589|NCT01894555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25684590|NCT01894555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25684591|NCT01894555|Antipyretics|antipyretics|mesh-ancestor
25684592|NCT01894568|Insulin|insulin|mesh-list
25684593|NCT01894568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25684594|NCT01894568|Insulin Glargine|insulin glargine|mesh-list
25684595|NCT01894568|Pioglitazone|pioglitazone|mesh-list
25684596|NCT01894568|Biguanides|biguanides|mesh-list
25684597|NCT01894568|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25684598|NCT01894568|Meglitinide|meglitinide|mesh-list
25289197|NCT04429802|Prucalopride|prucalopride|mesh-list
25289198|NCT04429802|Laxatives|laxatives|mesh-ancestor
25289199|NCT04429802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25145295|NCT02930811|Sildenafil Citrate|sildenafil citrate|mesh-list
25145296|NCT02930811|Vasodilator Agents|vasodilator agents|mesh-ancestor
25145297|NCT02930811|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25145298|NCT02930811|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25145299|NCT02930811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25145300|NCT02930811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145301|NCT02930811|Urological Agents|urological agents|mesh-ancestor
25145302|NCT02930954|Gemcitabine|gemcitabine|mesh-list
25145303|NCT02930954|Bevacizumab|bevacizumab|mesh-list
25145304|NCT02930954|Carboplatin|carboplatin|mesh-list
25145305|NCT02930954|Pemetrexed|pemetrexed|mesh-list
25145306|NCT02930954|Gefitinib|gefitinib|mesh-list
25145307|NCT02930954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25145308|NCT02930954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145309|NCT02930954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25145310|NCT02930954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25145311|NCT02930954|Growth Substances|growth substances|mesh-ancestor
25145312|NCT02930954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145313|NCT02930954|Growth Inhibitors|growth inhibitors|mesh-ancestor
25145314|NCT02930954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25145315|NCT02930954|Antimetabolites|antimetabolites|mesh-ancestor
25145316|NCT02930954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145317|NCT02930954|Antiviral Agents|antiviral agents|mesh-ancestor
25145319|NCT02930954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25145320|NCT02930954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25145321|NCT02930954|Immunologic Factors|immunologic factors|mesh-ancestor
25145341|NCT02930707|Bupivacaine|bupivacaine|mesh-list
25145342|NCT02930707|Anesthetics, Local|anesthetics, local|mesh-ancestor
25145343|NCT02930707|Anesthetics|anesthetics|mesh-ancestor
25145344|NCT02930707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25145350|NCT02930707|Anticonvulsants|anticonvulsants|mesh-ancestor
25145351|NCT02930707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25145352|NCT02930707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25145353|NCT02930707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145354|NCT02930707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25145355|NCT02930707|Tocolytic Agents|tocolytic agents|mesh-ancestor
25145356|NCT02930707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25145357|NCT02930473|Psychotropic Drugs|psychotropic drugs|mesh-list
25145358|NCT02930434|Vitamin D|vitamin d|mesh-list
25145359|NCT02930434|Cholecalciferol|cholecalciferol|mesh-list
25145360|NCT02930434|Vitamins|vitamins|mesh-ancestor
25145361|NCT02930434|Micronutrients|micronutrients|mesh-ancestor
25145362|NCT02930434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145363|NCT02930434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25145364|NCT02930434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25145365|NCT02930317|Factor VIII|factor viii|mesh-list
25145366|NCT02930317|Coagulants|coagulants|mesh-ancestor
25145367|NCT02930057|Betamethasone|betamethasone|mesh-list
25145368|NCT02930057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25145369|NCT02930057|Glucocorticoids|glucocorticoids|mesh-ancestor
25145370|NCT02930057|Hormones|hormones|mesh-ancestor
25145371|NCT02930057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25145372|NCT02930057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145373|NCT02930057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25145374|NCT02930057|Respiratory System Agents|respiratory system agents|mesh-ancestor
25145376|NCT02930109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25145377|NCT02930109|Antimetabolites|antimetabolites|mesh-ancestor
25145378|NCT02930109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145379|NCT02930109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145380|NCT02930109|Antiviral Agents|antiviral agents|mesh-ancestor
25145381|NCT02930109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25145393|NCT02930031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145395|NCT02930031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145396|NCT02930031|Antidotes|antidotes|mesh-ancestor
25145397|NCT02930265|Liraglutide|liraglutide|mesh-list
25145398|NCT02930265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25145399|NCT02930265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145400|NCT02930265|Incretins|incretins|mesh-ancestor
25145401|NCT02930265|Hormones|hormones|mesh-ancestor
25145402|NCT02930265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25684599|NCT01894568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684600|NCT01894581|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25684601|NCT01894581|Hormones|hormones|mesh-ancestor
25289223|NCT04300244|Ipilimumab|ipilimumab|mesh-list
25289224|NCT04300244|Sargramostim|sargramostim|mesh-list
25289225|NCT04300244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25289226|NCT04300244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289227|NCT04300244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25117248|NCT05371600|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25117249|NCT05371600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25117250|NCT05371600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25145403|NCT02929927|Sodium Hypochlorite|sodium hypochlorite|mesh-list
25145404|NCT02929927|Eusol|eusol|mesh-list
25145405|NCT02929927|Disinfectants|disinfectants|mesh-ancestor
25145406|NCT02929927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25145407|NCT02929797|Gemcitabine|gemcitabine|mesh-list
25145408|NCT02929797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25145409|NCT02929797|Antimetabolites|antimetabolites|mesh-ancestor
25145410|NCT02929797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145411|NCT02929797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145412|NCT02929797|Antiviral Agents|antiviral agents|mesh-ancestor
25145413|NCT02929797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25145414|NCT02929797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25145415|NCT02929797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25145416|NCT02929797|Immunologic Factors|immunologic factors|mesh-ancestor
25145417|NCT02929797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145418|NCT02929901|Caffeine|caffeine|mesh-list
25145419|NCT02929901|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25145420|NCT02929901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145421|NCT02929901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25145422|NCT02929901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25145423|NCT02929901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145424|NCT02929901|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25145425|NCT02929901|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25145430|NCT02929706|Azathioprine|azathioprine|mesh-list
25145432|NCT02929706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145433|NCT02929706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25145434|NCT02929706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145435|NCT02929706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25145437|NCT02929706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145438|NCT02929706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25145439|NCT02929693|Gefitinib|gefitinib|mesh-list
25145440|NCT02929693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145441|NCT02929693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25145442|NCT02929693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25145443|NCT02929693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145444|NCT02929719|Dapsone|dapsone|mesh-list
25145445|NCT02929719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25145446|NCT02929719|Antimalarials|antimalarials|mesh-ancestor
25145447|NCT02929719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25145448|NCT02929719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25145449|NCT02929719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25145450|NCT02929719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25145451|NCT02929719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145452|NCT02929719|Leprostatic Agents|leprostatic agents|mesh-ancestor
25145453|NCT02929719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25145454|NCT02929524|Ketamine|ketamine|mesh-list
25145455|NCT02929524|Analgesics|analgesics|mesh-ancestor
25145456|NCT02929524|Sensory System Agents|sensory system agents|mesh-ancestor
25145457|NCT02929524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25145458|NCT02929524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145459|NCT02929524|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25145460|NCT02929524|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25145461|NCT02929524|Anesthetics, General|anesthetics, general|mesh-ancestor
25145462|NCT02929524|Anesthetics|anesthetics|mesh-ancestor
25145463|NCT02929524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25145464|NCT02929524|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25145465|NCT02929524|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25684602|NCT01894581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25684603|NCT01894581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684604|NCT01894776|Maraviroc|maraviroc|mesh-list
25684605|NCT01894776|Rifabutin|rifabutin|mesh-list
25684606|NCT01894776|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25684607|NCT01894776|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25684608|NCT01894776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684609|NCT01894776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25117287|NCT05363059|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25117288|NCT05363059|Antihypertensive Agents|antihypertensive agents|mesh-list
25117289|NCT05363059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117291|NCT05361330|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25117292|NCT05361330|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25117293|NCT05361330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25117294|NCT05361330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117295|NCT05361330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25117296|NCT05361330|Serotonin Agents|serotonin agents|mesh-ancestor
25289268|NCT04182672|Triamcinolone|triamcinolone|mesh-list
25145466|NCT02929524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25145467|NCT02929524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145468|NCT02929888|Aspirin|aspirin|mesh-list
25145469|NCT02929888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25145470|NCT02929888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25145471|NCT02929888|Analgesics|analgesics|mesh-ancestor
25145472|NCT02929888|Sensory System Agents|sensory system agents|mesh-ancestor
25145473|NCT02929888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25145474|NCT02929888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145475|NCT02929888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25145476|NCT02929888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25145477|NCT02929888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25145478|NCT02929888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25145479|NCT02929888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145480|NCT02929888|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25145481|NCT02929888|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25145482|NCT02929888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25145483|NCT02929888|Antipyretics|antipyretics|mesh-ancestor
25145484|NCT02929563|Pantoprazole|pantoprazole|mesh-list
25145485|NCT02929563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25145486|NCT02929563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25094559|NCT03225352|Antipyretics|antipyretics|mesh-ancestor
25145487|NCT02929563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25145488|NCT02929563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25145489|NCT02929563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145491|NCT02929459|Riboflavin|riboflavin|mesh-list
25145492|NCT02929459|Vitamin B Complex|vitamin b complex|mesh-list
25145493|NCT02929459|Micronutrients|micronutrients|mesh-ancestor
25145494|NCT02929459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145495|NCT02929459|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25145496|NCT02929459|Dermatologic Agents|dermatologic agents|mesh-ancestor
25145497|NCT02929576|Paclitaxel|paclitaxel|mesh-list
25145498|NCT02929576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25145499|NCT02929576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145500|NCT02929576|Tubulin Modulators|tubulin modulators|mesh-ancestor
24706614|NCT01490944|Vitamins|vitamins|mesh-ancestor
24884222|NCT02678143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24884223|NCT02678143|Alkylating Agents|alkylating agents|mesh-ancestor
24884224|NCT02678143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884225|NCT02678143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24884226|NCT02678143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24884227|NCT02678143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24884228|NCT02678143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25145501|NCT02929576|Antimitotic Agents|antimitotic agents|mesh-ancestor
25145502|NCT02929576|Mitosis Modulators|mitosis modulators|mesh-ancestor
25145578|NCT02928965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25145506|NCT02929121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25145507|NCT02929121|Antimalarials|antimalarials|mesh-ancestor
25145508|NCT02929121|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25145509|NCT02929121|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25145510|NCT02929134|Doxycycline|doxycycline|mesh-list
25145511|NCT02929134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25684610|NCT01894776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25684611|NCT01894776|Antiviral Agents|antiviral agents|mesh-ancestor
25684612|NCT01894776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25684613|NCT01894776|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25684614|NCT01894776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25684615|NCT01894776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25684616|NCT01894776|Antitubercular Agents|antitubercular agents|mesh-ancestor
25684617|NCT01894919|Vaccines|vaccines|mesh-list
25684618|NCT01894919|Immunologic Factors|immunologic factors|mesh-ancestor
25684619|NCT01894919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684620|NCT01894984|Risperidone|risperidone|mesh-list
25684621|NCT01894984|Antipsychotic Agents|antipsychotic agents|mesh-list
25117336|NCT05331807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25117337|NCT05326906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25117338|NCT05326906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117339|NCT05326906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25117340|NCT05314127|Fluorouracil|fluorouracil|mesh-list
25117341|NCT05314127|Imiquimod|imiquimod|mesh-list
25117342|NCT05314127|Tazarotene|tazarotene|mesh-list
25117343|NCT05314127|Petrolatum|petrolatum|mesh-list
25117344|NCT05314127|Antimetabolites|antimetabolites|mesh-ancestor
25117347|NCT05314127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145512|NCT02929134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25145513|NCT02929134|Antimalarials|antimalarials|mesh-ancestor
25145514|NCT02929134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25145515|NCT02929134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25145516|NCT02929147|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
25145518|NCT02929147|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25145519|NCT02929147|Narcotics|narcotics|mesh-ancestor
25145520|NCT02929147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25145521|NCT02929147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145522|NCT02929147|Analgesics|analgesics|mesh-ancestor
25145523|NCT02929147|Sensory System Agents|sensory system agents|mesh-ancestor
25145524|NCT02929147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25145525|NCT02929147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25145526|NCT02929147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25145527|NCT02929147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25145528|NCT02929147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25145529|NCT02929212|Acetaminophen|acetaminophen|mesh-list
25145530|NCT02929212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25145531|NCT02929212|Analgesics|analgesics|mesh-ancestor
24884229|NCT02678143|Antitubercular Agents|antitubercular agents|mesh-ancestor
24884230|NCT02678143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24505994|NCT00543686|Montelukast|montelukast|mesh-list
24505995|NCT00543686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24505996|NCT00543686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24505997|NCT00543686|Autonomic Agents|autonomic agents|mesh-ancestor
24505998|NCT00543686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24505999|NCT00543686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506000|NCT00543686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24506028|NCT00543829|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24506029|NCT00543829|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25145532|NCT02929212|Sensory System Agents|sensory system agents|mesh-ancestor
25145533|NCT02929212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25145534|NCT02929212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145535|NCT02929212|Antipyretics|antipyretics|mesh-ancestor
25145536|NCT02929251|Adalimumab|adalimumab|mesh-list
25145537|NCT02929251|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25145538|NCT02929251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25145539|NCT02929251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25145540|NCT02929394|Trabectedin|trabectedin|mesh-list
25145541|NCT02929394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25145542|NCT02929394|Alkylating Agents|alkylating agents|mesh-ancestor
25145543|NCT02929394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145544|NCT02929394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145545|NCT02929316|Vedolizumab|vedolizumab|mesh-list
24808841|NCT02029534|Antimetabolites|antimetabolites|mesh-ancestor
24808879|NCT02029599|Immunologic Factors|immunologic factors|mesh-ancestor
25145546|NCT02929316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25145547|NCT02929095|Midazolam|midazolam|mesh-list
25145548|NCT02929095|Dexmedetomidine|dexmedetomidine|mesh-list
25145549|NCT02929095|Remifentanil|remifentanil|mesh-list
25145550|NCT02929095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25145551|NCT02929095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25145552|NCT02929095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145553|NCT02929095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25145554|NCT02929095|Analgesics|analgesics|mesh-ancestor
25145555|NCT02929095|Sensory System Agents|sensory system agents|mesh-ancestor
25684622|NCT01894984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25684623|NCT01894984|Serotonin Agents|serotonin agents|mesh-ancestor
25684624|NCT01894984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25684625|NCT01894984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684626|NCT01894984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684627|NCT01894984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25684628|NCT01894984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25684629|NCT01894984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25684630|NCT01894984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25684631|NCT01894984|Dopamine Agents|dopamine agents|mesh-ancestor
25145556|NCT02929095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25145557|NCT02929095|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25145558|NCT02929095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25145559|NCT02929095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25145560|NCT02929095|Adrenergic Agents|adrenergic agents|mesh-ancestor
25145561|NCT02929095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25145562|NCT02929095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145582|NCT02928692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25145583|NCT02928991|Vidarabine|vidarabine|mesh-list
25145584|NCT02928991|Fludarabine|fludarabine|mesh-list
25145585|NCT02928991|Fludarabine phosphate|fludarabine phosphate|mesh-list
25145586|NCT02928991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145587|NCT02928991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25145588|NCT02928991|Antimetabolites|antimetabolites|mesh-ancestor
25145589|NCT02928991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145590|NCT02928991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25145591|NCT02928991|Immunologic Factors|immunologic factors|mesh-ancestor
25145592|NCT02928991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145593|NCT02928991|Antiviral Agents|antiviral agents|mesh-ancestor
25145594|NCT02928991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25145595|NCT02928679|Liraglutide|liraglutide|mesh-list
25145596|NCT02928679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25145597|NCT02928679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145598|NCT02928679|Incretins|incretins|mesh-ancestor
25145599|NCT02928679|Hormones|hormones|mesh-ancestor
25145600|NCT02928679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25145601|NCT02928510|Idelalisib|idelalisib|mesh-list
25145602|NCT02928510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145603|NCT02928510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25145604|NCT02928510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145605|NCT02928419|Lenalidomide|lenalidomide|mesh-list
25145606|NCT02928419|Immunologic Factors|immunologic factors|mesh-ancestor
25145607|NCT02928419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145608|NCT02928419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25145609|NCT02928419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25145610|NCT02928419|Growth Substances|growth substances|mesh-ancestor
25145611|NCT02928419|Growth Inhibitors|growth inhibitors|mesh-ancestor
24506160|NCT00544219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24506161|NCT00544219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24506162|NCT00544219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24506163|NCT00544219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506164|NCT00544219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24506165|NCT00544219|Glucocorticoids|glucocorticoids|mesh-ancestor
24506167|NCT00544219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24506168|NCT00544219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25145612|NCT02928419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145613|NCT02928614|Liraglutide|liraglutide|mesh-list
25145614|NCT02928614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25145615|NCT02928614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145616|NCT02928614|Incretins|incretins|mesh-ancestor
25145617|NCT02928614|Hormones|hormones|mesh-ancestor
25145618|NCT02928614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25145619|NCT02928601|Ondansetron|ondansetron|mesh-list
25047688|NCT00770848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25047689|NCT00770848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25047690|NCT00770848|Analgesics|analgesics|mesh-ancestor
25047691|NCT00770848|Sensory System Agents|sensory system agents|mesh-ancestor
25047692|NCT00770848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25047693|NCT00770848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25047694|NCT00770848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25047695|NCT00770848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047696|NCT00770848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047697|NCT00770848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25047698|NCT00770848|Immunologic Factors|immunologic factors|mesh-ancestor
25047699|NCT00770081|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25047700|NCT00770081|Vildagliptin|vildagliptin|mesh-list
25047701|NCT00770081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25047702|NCT00770081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047704|NCT00770081|Hormones|hormones|mesh-ancestor
24506169|NCT00544219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24506170|NCT00544219|Tubulin Modulators|tubulin modulators|mesh-ancestor
24506171|NCT00544219|Antimitotic Agents|antimitotic agents|mesh-ancestor
24506210|NCT00544284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25117470|NCT05135845|Spartalizumab|spartalizumab|mesh-list
25117473|NCT05135845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506226|NCT00544349|Protective Agents|protective agents|mesh-ancestor
24808931|NCT02029950|Etoposide|etoposide|mesh-list
24506227|NCT00544349|Vitamin B Complex|vitamin b complex|mesh-ancestor
24506358|NCT00544986|Anastrozole|anastrozole|mesh-list
24506364|NCT00544986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506365|NCT00544986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24506366|NCT00544986|Hormone Antagonists|hormone antagonists|mesh-ancestor
24506367|NCT00544986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24506368|NCT00544986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506369|NCT00544999|Cytarabine|cytarabine|mesh-list
24506370|NCT00544999|Everolimus|everolimus|mesh-list
24506371|NCT00544999|Daunorubicin|daunorubicin|mesh-list
24506372|NCT00544999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24506373|NCT00544999|Antimetabolites|antimetabolites|mesh-ancestor
24506374|NCT00544999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506375|NCT00544999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506376|NCT00544999|Antiviral Agents|antiviral agents|mesh-ancestor
24506377|NCT00544999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24506492|NCT00545558|Efavirenz|efavirenz|mesh-list
24437292|NCT00273338|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25047705|NCT00770081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25047706|NCT00770081|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25003916|NCT02923128|Dsuvia|dsuvia|mesh-list
25047707|NCT00770081|Protease Inhibitors|protease inhibitors|mesh-ancestor
25047708|NCT00770081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047709|NCT00770081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047710|NCT00769795|Goserelin|goserelin|mesh-list
25047711|NCT00769795|Bicalutamide|bicalutamide|mesh-list
25047712|NCT00769795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25047713|NCT00769795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25047714|NCT00769795|Androgen Antagonists|androgen antagonists|mesh-ancestor
25047715|NCT00769795|Hormone Antagonists|hormone antagonists|mesh-ancestor
25145620|NCT02928601|Antiemetics|antiemetics|mesh-ancestor
25094773|NCT03222544|Methylene Blue|methylene blue|mesh-list
25145621|NCT02928601|Autonomic Agents|autonomic agents|mesh-ancestor
25145622|NCT02928601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25145623|NCT02928601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145624|NCT02928601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25145625|NCT02928601|Antipruritics|antipruritics|mesh-ancestor
25145626|NCT02928601|Dermatologic Agents|dermatologic agents|mesh-ancestor
25145627|NCT02928601|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25145628|NCT02928601|Serotonin Agents|serotonin agents|mesh-ancestor
25145629|NCT02928601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25145630|NCT02928601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145631|NCT02928601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25145632|NCT02928601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25145633|NCT02928601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25145634|NCT02928601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25145635|NCT02928601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25145636|NCT02928575|Temozolomide|temozolomide|mesh-list
25145637|NCT02928575|Sunitinib|sunitinib|mesh-list
25145638|NCT02928575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25145639|NCT02928575|Alkylating Agents|alkylating agents|mesh-ancestor
25145640|NCT02928575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145641|NCT02928575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145642|NCT02928575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24437293|NCT00273338|Vitamins|vitamins|mesh-ancestor
25145644|NCT02928575|Growth Substances|growth substances|mesh-ancestor
25145645|NCT02928575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145646|NCT02928575|Growth Inhibitors|growth inhibitors|mesh-ancestor
25145647|NCT02928575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25145648|NCT02928575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25145649|NCT02928328|Lidocaine|lidocaine|mesh-list
25145650|NCT02928328|Lorazepam|lorazepam|mesh-list
25145651|NCT02928328|Capsaicin|capsaicin|mesh-list
25145652|NCT02928328|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
25145653|NCT02928328|Butyric Acid|butyric acid|mesh-list
25145654|NCT02928328|Anesthetics, Local|anesthetics, local|mesh-ancestor
25145655|NCT02928328|Anesthetics|anesthetics|mesh-ancestor
25145656|NCT02928328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25684632|NCT01895036|Naltrexone|naltrexone|mesh-list
25684633|NCT01895036|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25684634|NCT01895036|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25145657|NCT02928328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145658|NCT02928328|Sensory System Agents|sensory system agents|mesh-ancestor
25145659|NCT02928328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25145660|NCT02928328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25145664|NCT02928328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145666|NCT02928328|Dermatologic Agents|dermatologic agents|mesh-ancestor
25145667|NCT02928328|Anticonvulsants|anticonvulsants|mesh-ancestor
25145668|NCT02928328|Antiemetics|antiemetics|mesh-ancestor
25145669|NCT02928328|Autonomic Agents|autonomic agents|mesh-ancestor
25145670|NCT02928328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25145671|NCT02928328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25145672|NCT02928328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25145673|NCT02928328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25145674|NCT02928328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25145675|NCT02928328|GABA Modulators|gaba modulators|mesh-ancestor
25145676|NCT02928328|GABA Agents|gaba agents|mesh-ancestor
25145677|NCT02928328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25145678|NCT02928328|Histamine Antagonists|histamine antagonists|mesh-ancestor
25145679|NCT02928328|Histamine Agents|histamine agents|mesh-ancestor
25145680|NCT02928315|Magnesium Sulfate|magnesium sulfate|mesh-list
25145681|NCT02928315|Analgesics|analgesics|mesh-ancestor
24486296|NCT00457093|Insulin Glargine|insulin glargine|mesh-list
25145682|NCT02928315|Sensory System Agents|sensory system agents|mesh-ancestor
25145684|NCT02928315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145685|NCT02928315|Anesthetics|anesthetics|mesh-ancestor
25145686|NCT02928315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25145687|NCT02928315|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25145688|NCT02928315|Anticonvulsants|anticonvulsants|mesh-ancestor
25145689|NCT02928315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25145690|NCT02928315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25145691|NCT02928315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145692|NCT02928315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25145693|NCT02928315|Tocolytic Agents|tocolytic agents|mesh-ancestor
25145694|NCT02928315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25094815|NCT03222206|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
25145696|NCT02927951|Analgesics|analgesics|mesh-ancestor
25145697|NCT02927951|Sensory System Agents|sensory system agents|mesh-ancestor
25145698|NCT02927951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25145699|NCT02927951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145700|NCT02927951|Anticonvulsants|anticonvulsants|mesh-ancestor
25145701|NCT02927951|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25145702|NCT02927951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25145703|NCT02927951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763901|NCT01778101|Dexlansoprazole|dexlansoprazole|mesh-list
24506493|NCT00545558|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24506494|NCT00545558|Antiviral Agents|antiviral agents|mesh-ancestor
24506495|NCT00545558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24506496|NCT00545558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24506510|NCT00545675|Antidepressive Agents|antidepressive agents|mesh-ancestor
24506724|NCT00546559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506725|NCT00546559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24506726|NCT00546559|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24506727|NCT00546559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506728|NCT00546650|Sumatriptan|sumatriptan|mesh-list
24506729|NCT00546650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24506732|NCT00546650|Serotonin Agents|serotonin agents|mesh-ancestor
24506772|NCT00546936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24506773|NCT00546936|Growth Substances|growth substances|mesh-ancestor
24506775|NCT00546936|Growth Inhibitors|growth inhibitors|mesh-ancestor
24437302|NCT00273377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25145704|NCT02927951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25145705|NCT02927951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25145706|NCT02927951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25145707|NCT02927951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25145708|NCT02927951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25145710|NCT02927886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25117597|NCT05012566|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25117598|NCT05012566|Immunologic Factors|immunologic factors|mesh-ancestor
25117600|NCT05012566|Protective Agents|protective agents|mesh-ancestor
25117601|NCT05012566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25117602|NCT05012566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25117603|NCT04994535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25289482|NCT02843074|Hormones|hormones|mesh-ancestor
25145711|NCT02927886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25145712|NCT02927886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145713|NCT02927886|Cholinergic Agents|cholinergic agents|mesh-ancestor
25145714|NCT02927886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25145715|NCT02927886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145716|NCT02927587|Propofol|propofol|mesh-list
25145717|NCT02927587|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25145718|NCT02927587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25145719|NCT02927587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145720|NCT02927587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24763926|NCT01778218|Deoxyglucose|deoxyglucose|mesh-list
24884486|NCT00462748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884487|NCT00462748|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24884488|NCT00462748|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24884489|NCT00462748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24884491|NCT00446186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973315|NCT03710304|Coagulants|coagulants|mesh-ancestor
24884492|NCT00446186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884493|NCT00446186|Respiratory System Agents|respiratory system agents|mesh-ancestor
24463518|NCT00361309|Growth Substances|growth substances|mesh-ancestor
24506965|NCT00547664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24506974|NCT00547768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506975|NCT00547885|Dihydrocodeine|dihydrocodeine|mesh-list
24506976|NCT00547885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24506977|NCT00547885|Narcotics|narcotics|mesh-ancestor
24506978|NCT00547885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24506979|NCT00547885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506980|NCT00547885|Analgesics|analgesics|mesh-ancestor
24506981|NCT00547885|Sensory System Agents|sensory system agents|mesh-ancestor
24506982|NCT00547885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24506983|NCT00547989|Bupivacaine|bupivacaine|mesh-list
24506984|NCT00547989|Ropivacaine|ropivacaine|mesh-list
24506985|NCT00547989|Anesthetics, Local|anesthetics, local|mesh-ancestor
24506986|NCT00547989|Anesthetics|anesthetics|mesh-ancestor
24506987|NCT00547989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24506988|NCT00547989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506989|NCT00547989|Sensory System Agents|sensory system agents|mesh-ancestor
24506990|NCT00547989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24506991|NCT00548002|Levofloxacin|levofloxacin|mesh-list
24506992|NCT00548002|Ofloxacin|ofloxacin|mesh-list
24506993|NCT00548002|Trovafloxacin|trovafloxacin|mesh-list
24506994|NCT00548002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24506995|NCT00548002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24506996|NCT00548002|Renal Agents|renal agents|mesh-ancestor
24506997|NCT00548002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24506999|NCT00548002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24507000|NCT00548002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507001|NCT00548002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145721|NCT02927587|Anesthetics, General|anesthetics, general|mesh-ancestor
25145722|NCT02927587|Anesthetics|anesthetics|mesh-ancestor
25145723|NCT02927392|Leuprolide|leuprolide|mesh-list
25145724|NCT02927392|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25145725|NCT02927392|Fertility Agents|fertility agents|mesh-ancestor
25145726|NCT02927392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25145727|NCT02927392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145728|NCT02927392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25145729|NCT02927392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145730|NCT02927405|Gabapentin|gabapentin|mesh-list
25145731|NCT02927405|Analgesics|analgesics|mesh-ancestor
25684635|NCT01895036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684636|NCT01895036|Sensory System Agents|sensory system agents|mesh-ancestor
25684637|NCT01895036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25692543|NCT02000973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692544|NCT02001181|Tofacitinib|tofacitinib|mesh-list
25692545|NCT02001181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25692546|NCT02001181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25145732|NCT02927405|Sensory System Agents|sensory system agents|mesh-ancestor
25117664|NCT04917588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25117665|NCT04917588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117666|NCT04917588|Sensory System Agents|sensory system agents|mesh-ancestor
25117667|NCT04917588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25117699|NCT04859296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117700|NCT04859296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25117701|NCT04859296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25117702|NCT04859296|Analgesics|analgesics|mesh-ancestor
25117703|NCT04859296|Sensory System Agents|sensory system agents|mesh-ancestor
25117704|NCT04859296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25117705|NCT04859296|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25117706|NCT04859296|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25117707|NCT04859296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25145733|NCT02927405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25145734|NCT02927405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145735|NCT02927405|Anticonvulsants|anticonvulsants|mesh-ancestor
25145736|NCT02927405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25145737|NCT02927405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25145738|NCT02927405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25145739|NCT02927405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25145740|NCT02927405|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25145741|NCT02927405|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25145742|NCT02927405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25145743|NCT02927405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145744|NCT02927405|Antimanic Agents|antimanic agents|mesh-ancestor
25145745|NCT02927379|Dexmedetomidine|dexmedetomidine|mesh-list
25145746|NCT02927379|Ketamine|ketamine|mesh-list
25145747|NCT02927379|Bupivacaine|bupivacaine|mesh-list
25145748|NCT02927379|Anesthetics, Local|anesthetics, local|mesh-ancestor
25145749|NCT02927379|Anesthetics|anesthetics|mesh-ancestor
25145750|NCT02927379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25145751|NCT02927379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145752|NCT02927379|Sensory System Agents|sensory system agents|mesh-ancestor
24507096|NCT00548678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24884505|NCT00445107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24884506|NCT00445107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884507|NCT00445107|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24507151|NCT00548964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507152|NCT00548964|Antidepressive Agents|antidepressive agents|mesh-ancestor
24507153|NCT00548964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25145753|NCT02927379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25145754|NCT02927379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25145755|NCT02927379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25145757|NCT02927379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25145758|NCT02927379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25145759|NCT02927379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25145760|NCT02927379|Adrenergic Agents|adrenergic agents|mesh-ancestor
25145761|NCT02927379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25145762|NCT02927379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145763|NCT02927379|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25145764|NCT02927379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25145765|NCT02927379|Anesthetics, General|anesthetics, general|mesh-ancestor
25145766|NCT02927379|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25145767|NCT02927379|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25684638|NCT01895101|Tranexamic Acid|tranexamic acid|mesh-list
25684639|NCT01895101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25684640|NCT01895101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25684641|NCT01895101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684642|NCT01895101|Hemostatics|hemostatics|mesh-ancestor
25684643|NCT01895101|Coagulants|coagulants|mesh-ancestor
25684644|NCT01895127|Immunoglobulins|immunoglobulins|mesh-list
25684645|NCT01895127|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25684646|NCT01895127|Antibodies|antibodies|mesh-list
25684647|NCT01895127|Eculizumab|eculizumab|mesh-list
25684648|NCT01895127|Immunologic Factors|immunologic factors|mesh-ancestor
25684649|NCT01895127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684650|NCT01895127|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25684651|NCT01895127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25684652|NCT01895270|Isradipine|isradipine|mesh-list
25289543|NCT05096520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25289544|NCT05096520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25289545|NCT05096520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25289546|NCT05096520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289554|NCT05096312|Zinc|zinc|mesh-list
25289555|NCT05096312|Adapalene|adapalene|mesh-list
25289557|NCT05096312|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25145768|NCT02927496|Doxycycline|doxycycline|mesh-list
25145769|NCT02927496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25145796|NCT02926976|Valproic Acid|valproic acid|mesh-list
25145797|NCT02926976|Risperidone|risperidone|mesh-list
25145798|NCT02926976|Aripiprazole|aripiprazole|mesh-list
25145799|NCT02926976|Clozapine|clozapine|mesh-list
25145800|NCT02926976|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25145801|NCT02926976|Serotonin Agents|serotonin agents|mesh-ancestor
25145802|NCT02926976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25145803|NCT02926976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145804|NCT02926976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145805|NCT02926976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25145806|NCT02926976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25145807|NCT02926976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25145808|NCT02926976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25145809|NCT02926976|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25145810|NCT02926976|Dopamine Agents|dopamine agents|mesh-ancestor
25145811|NCT02926976|Antidepressive Agents|antidepressive agents|mesh-ancestor
25145812|NCT02926976|Dopamine Agonists|dopamine agonists|mesh-ancestor
25145817|NCT02926976|Anticonvulsants|anticonvulsants|mesh-ancestor
25145818|NCT02926976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25145819|NCT02926976|GABA Agents|gaba agents|mesh-ancestor
25145820|NCT02926976|Antimanic Agents|antimanic agents|mesh-ancestor
25145821|NCT02926976|GABA Antagonists|gaba antagonists|mesh-ancestor
25145822|NCT02926989|Plasma-lyte 148|plasma-lyte 148|mesh-list
25145823|NCT02926989|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25145824|NCT02926989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25145825|NCT02926885|Liver Extracts|liver extracts|mesh-list
25145826|NCT02926885|Hematinics|hematinics|mesh-ancestor
25145828|NCT02926859|Anticonvulsants|anticonvulsants|mesh-ancestor
25145829|NCT02927015|Iproplatin|iproplatin|mesh-list
25145830|NCT02927015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145831|NCT02926846|Vancomycin|vancomycin|mesh-list
25145832|NCT02926846|Gentamicins|gentamicins|mesh-list
25145833|NCT02926846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25145834|NCT02926846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25145835|NCT02926846|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25145836|NCT02926846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047718|NCT00768482|Buprenorphine|buprenorphine|mesh-list
25047719|NCT00768482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25047720|NCT00768482|Narcotics|narcotics|mesh-ancestor
25047721|NCT00768482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25047722|NCT00768482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047723|NCT00768482|Analgesics|analgesics|mesh-ancestor
25047724|NCT00768482|Sensory System Agents|sensory system agents|mesh-ancestor
25047725|NCT00768482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25003945|NCT02921022|Antimetabolites|antimetabolites|mesh-ancestor
25047727|NCT00765830|Vildagliptin|vildagliptin|mesh-list
25047728|NCT00765830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25047729|NCT00765830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047730|NCT00765830|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25047731|NCT00765830|Protease Inhibitors|protease inhibitors|mesh-ancestor
25047732|NCT00765830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763961|NCT01778413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047733|NCT00765830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047735|NCT00765804|Citric Acid|citric acid|mesh-list
25047736|NCT00765804|Sodium Citrate|sodium citrate|mesh-list
25047737|NCT00765804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25047738|NCT00765804|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25047739|NCT00765804|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25047740|NCT00765804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25047741|NCT00765804|Antiemetics|antiemetics|mesh-ancestor
25684653|NCT01895270|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25684654|NCT01895270|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25684655|NCT01895270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25684656|NCT01895270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684657|NCT01895270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25684658|NCT01895270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047742|NCT00765804|Autonomic Agents|autonomic agents|mesh-ancestor
25047743|NCT00765804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25047744|NCT00765804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047745|NCT00765804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25145843|NCT02926248|Gout Suppressants|gout suppressants|mesh-ancestor
24507195|NCT00549120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24507196|NCT00549120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24507197|NCT00549120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24507198|NCT00549120|Cholinergic Agents|cholinergic agents|mesh-ancestor
24507199|NCT00549133|Irbesartan|irbesartan|mesh-list
24507200|NCT00549133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24507201|NCT00549133|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24507202|NCT00549133|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24507204|NCT00549146|Fluticasone|fluticasone|mesh-list
24884518|NCT00418834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24884519|NCT00409773|Atorvastatin|atorvastatin|mesh-list
24884520|NCT00409773|Simvastatin|simvastatin|mesh-list
24884521|NCT00409773|Ezetimibe|ezetimibe|mesh-list
24884522|NCT00409773|Calcium|calcium|mesh-list
24507346|NCT00550004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24507347|NCT00550004|Antimetabolites|antimetabolites|mesh-ancestor
24507348|NCT00550004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507349|NCT00550004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507350|NCT00550004|Antiviral Agents|antiviral agents|mesh-ancestor
24507351|NCT00550004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24507352|NCT00550004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507353|NCT00550004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24507354|NCT00550004|Immunologic Factors|immunologic factors|mesh-ancestor
24507355|NCT00550004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507356|NCT00550095|Valsartan|valsartan|mesh-list
24507382|NCT00550160|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24507383|NCT00550160|Anthelmintics|anthelmintics|mesh-ancestor
24507384|NCT00550199|Gemcitabine|gemcitabine|mesh-list
24507385|NCT00550199|Panobinostat|panobinostat|mesh-list
24507386|NCT00550199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24507400|NCT00550303|Hormones|hormones|mesh-ancestor
24884534|NCT00398151|Respiratory System Agents|respiratory system agents|mesh-ancestor
24884535|NCT00398151|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25145844|NCT02926248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25145845|NCT02926248|Tubulin Modulators|tubulin modulators|mesh-ancestor
25145846|NCT02926248|Antimitotic Agents|antimitotic agents|mesh-ancestor
25145847|NCT02926248|Mitosis Modulators|mitosis modulators|mesh-ancestor
25145848|NCT02926248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145849|NCT02926248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145852|NCT02926326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25145853|NCT02926326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25145854|NCT02926326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25145855|NCT02926326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25145856|NCT02926326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145857|NCT02926183|Gemcitabine|gemcitabine|mesh-list
25145858|NCT02926183|Paclitaxel|paclitaxel|mesh-list
25145859|NCT02926183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25145860|NCT02926183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145861|NCT02926183|Tubulin Modulators|tubulin modulators|mesh-ancestor
25145862|NCT02926183|Antimitotic Agents|antimitotic agents|mesh-ancestor
25145863|NCT02926183|Mitosis Modulators|mitosis modulators|mesh-ancestor
25145864|NCT02926183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884537|NCT00398151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24884538|NCT00398151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884539|NCT00398151|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24884540|NCT00398151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24884541|NCT00398151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884542|NCT00394160|Montelukast|montelukast|mesh-list
24884543|NCT00394160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24884544|NCT00394160|Respiratory System Agents|respiratory system agents|mesh-ancestor
24884545|NCT00394160|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25289616|NCT05095259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25289617|NCT05095259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289618|NCT05095259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25289619|NCT05095259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25289620|NCT05095259|Autonomic Agents|autonomic agents|mesh-ancestor
25289621|NCT05095259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25289622|NCT05095259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25289623|NCT05095259|Respiratory System Agents|respiratory system agents|mesh-ancestor
25289624|NCT05095259|Mydriatics|mydriatics|mesh-ancestor
24507402|NCT00550303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507403|NCT00550303|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24507404|NCT00550303|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24507405|NCT00550303|Hormone Antagonists|hormone antagonists|mesh-ancestor
24507408|NCT00550329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24884557|NCT00380705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24884558|NCT00380705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884559|NCT00380705|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24507470|NCT00550784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25145865|NCT02926183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25145866|NCT02926183|Antimetabolites|antimetabolites|mesh-ancestor
25145867|NCT02926183|Antiviral Agents|antiviral agents|mesh-ancestor
25145868|NCT02926183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25145869|NCT02926183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25145870|NCT02926183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25145871|NCT02926183|Immunologic Factors|immunologic factors|mesh-ancestor
25145872|NCT02926183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145874|NCT02926170|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25145875|NCT02926170|Antithrombins|antithrombins|mesh-ancestor
25145876|NCT02926170|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25145877|NCT02926170|Protease Inhibitors|protease inhibitors|mesh-ancestor
25145878|NCT02926170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809075|NCT02031016|Analgesics|analgesics|mesh-ancestor
25145879|NCT02926170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145880|NCT02926170|Anticoagulants|anticoagulants|mesh-ancestor
25145881|NCT02926053|Cyclophosphamide|cyclophosphamide|mesh-list
25145883|NCT02926053|Interleukin-2|interleukin-2|mesh-list
25145884|NCT02926053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25145885|NCT02926053|Immunologic Factors|immunologic factors|mesh-ancestor
25145886|NCT02926053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145887|NCT02926053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25145888|NCT02926053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25145889|NCT02926053|Alkylating Agents|alkylating agents|mesh-ancestor
25145890|NCT02926053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145891|NCT02926053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145892|NCT02926053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25145893|NCT02926053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25145894|NCT02926053|Analgesics|analgesics|mesh-ancestor
25145895|NCT02926053|Sensory System Agents|sensory system agents|mesh-ancestor
25145896|NCT02926053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25145897|NCT02925832|Bupivacaine|bupivacaine|mesh-list
25145898|NCT02925832|Ropivacaine|ropivacaine|mesh-list
25145899|NCT02925832|Anesthetics, Local|anesthetics, local|mesh-list
25145900|NCT02925832|Proxymetacaine|proxymetacaine|mesh-list
25145901|NCT02925832|Anesthetics|anesthetics|mesh-list
24764034|NCT01779232|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24507471|NCT00550810|Sunitinib|sunitinib|mesh-list
24507472|NCT00550810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25684659|NCT01895270|Vasodilator Agents|vasodilator agents|mesh-ancestor
25684660|NCT01895309|Etanercept|etanercept|mesh-list
25684661|NCT01895309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25684662|NCT01895309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25684663|NCT01895309|Analgesics|analgesics|mesh-ancestor
25684664|NCT01895309|Sensory System Agents|sensory system agents|mesh-ancestor
25684665|NCT01895309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25684666|NCT01895309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684667|NCT01895309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25684668|NCT01895309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25684669|NCT01895309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25289660|NCT05084027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289661|NCT05084027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25289662|NCT05084027|Alkylating Agents|alkylating agents|mesh-ancestor
25289663|NCT05084027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25289664|NCT05083286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25289665|NCT05083286|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25289666|NCT05083286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25289672|NCT05083286|Cholinergic Agents|cholinergic agents|mesh-ancestor
25145902|NCT02925832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25145903|NCT02925832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145904|NCT02925832|Sensory System Agents|sensory system agents|mesh-ancestor
25145905|NCT02925832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25145907|NCT02925975|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25145908|NCT02925975|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25145909|NCT02925975|Adrenergic Agents|adrenergic agents|mesh-ancestor
25145910|NCT02925975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25145911|NCT02925975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145912|NCT02925975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145913|NCT02925975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25145914|NCT02925975|Antioxidants|antioxidants|mesh-ancestor
25145915|NCT02925975|Protective Agents|protective agents|mesh-ancestor
25145916|NCT02925975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25145917|NCT02925975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25145940|NCT02925416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25145941|NCT02925416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25145942|NCT02925533|Pembrolizumab|pembrolizumab|mesh-list
25145943|NCT02925533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25145944|NCT02925533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145945|NCT02924922|Mannitol|mannitol|mesh-list
25145946|NCT02924922|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25145947|NCT02924922|Diuretics|diuretics|mesh-ancestor
25145948|NCT02924922|Natriuretic Agents|natriuretic agents|mesh-ancestor
25145949|NCT02924922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145950|NCT02925026|Lactoferrin|lactoferrin|mesh-list
25145951|NCT02925026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25145952|NCT02925130|Albuterol|albuterol|mesh-list
25145953|NCT02925130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25145954|NCT02925130|Autonomic Agents|autonomic agents|mesh-ancestor
24764071|NCT01779362|Liraglutide|liraglutide|mesh-list
24507473|NCT00550810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24507474|NCT00550810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24507475|NCT00550810|Growth Substances|growth substances|mesh-ancestor
24884565|NCT00276484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24884566|NCT00276484|Antimetabolites|antimetabolites|mesh-ancestor
24884567|NCT00276484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884568|NCT00276484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24884569|NCT00276484|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24884570|NCT00276484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24884571|NCT00276458|Atorvastatin|atorvastatin|mesh-list
24884572|NCT00276458|Ezetimibe|ezetimibe|mesh-list
25145955|NCT02925130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25145956|NCT02925130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145957|NCT02925130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25145958|NCT02925130|Respiratory System Agents|respiratory system agents|mesh-ancestor
25145959|NCT02925130|Tocolytic Agents|tocolytic agents|mesh-ancestor
25145960|NCT02925130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25145961|NCT02925130|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25145962|NCT02925130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25145963|NCT02925130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25145964|NCT02925130|Adrenergic Agents|adrenergic agents|mesh-ancestor
25145965|NCT02925130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25145966|NCT02925130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145967|NCT02925000|Vinorelbine|vinorelbine|mesh-list
25145968|NCT02925000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25145969|NCT02925000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145970|NCT02925000|Tubulin Modulators|tubulin modulators|mesh-ancestor
25684670|NCT01895309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25684671|NCT01895309|Immunologic Factors|immunologic factors|mesh-ancestor
25684672|NCT01895322|Tolvaptan|tolvaptan|mesh-list
25684673|NCT01895322|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25684674|NCT01895322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684675|NCT01895322|Natriuretic Agents|natriuretic agents|mesh-ancestor
25684676|NCT01895322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684677|NCT01895335|Teriflunomide|teriflunomide|mesh-list
25289690|NCT05001360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25145971|NCT02925000|Antimitotic Agents|antimitotic agents|mesh-ancestor
25145972|NCT02925000|Mitosis Modulators|mitosis modulators|mesh-ancestor
25145973|NCT02925000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145975|NCT02924987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25145976|NCT02924987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25145977|NCT02924987|Growth Substances|growth substances|mesh-ancestor
25145978|NCT02924987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145979|NCT02924987|Growth Inhibitors|growth inhibitors|mesh-ancestor
25145980|NCT02924987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145981|NCT02924974|Lidocaine|lidocaine|mesh-list
25145982|NCT02924974|Morphine|morphine|mesh-list
25145983|NCT02924974|Anesthetics, Local|anesthetics, local|mesh-ancestor
25145984|NCT02924974|Anesthetics|anesthetics|mesh-ancestor
25145985|NCT02924974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25145986|NCT02924974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145987|NCT02924974|Sensory System Agents|sensory system agents|mesh-ancestor
25145988|NCT02924974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25145993|NCT02924974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145994|NCT02924974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25145995|NCT02924974|Narcotics|narcotics|mesh-ancestor
25145996|NCT02924974|Analgesics|analgesics|mesh-ancestor
25145997|NCT02924909|Paclitaxel|paclitaxel|mesh-list
25145998|NCT02924909|Carboplatin|carboplatin|mesh-list
25145999|NCT02924909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25146000|NCT02924909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25146001|NCT02924909|Tubulin Modulators|tubulin modulators|mesh-ancestor
25146002|NCT02924909|Antimitotic Agents|antimitotic agents|mesh-ancestor
25146003|NCT02924909|Mitosis Modulators|mitosis modulators|mesh-ancestor
24487525|NCT00463710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25146004|NCT02924909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146005|NCT02924857|Paclitaxel|paclitaxel|mesh-list
25146006|NCT02924857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25146007|NCT02924857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25146008|NCT02924857|Tubulin Modulators|tubulin modulators|mesh-ancestor
25146009|NCT02924857|Antimitotic Agents|antimitotic agents|mesh-ancestor
25146010|NCT02924857|Mitosis Modulators|mitosis modulators|mesh-ancestor
25146011|NCT02924857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146012|NCT02924753|Cyclophosphamide|cyclophosphamide|mesh-list
25146013|NCT02924753|Fludarabine|fludarabine|mesh-list
25146014|NCT02924753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25146015|NCT02924753|Immunologic Factors|immunologic factors|mesh-ancestor
25146016|NCT02924753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146017|NCT02924753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25146018|NCT02924753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25146019|NCT02924753|Alkylating Agents|alkylating agents|mesh-ancestor
25146020|NCT02924753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146021|NCT02924753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25146022|NCT02924753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25146023|NCT02924766|Prednisone|prednisone|mesh-list
25146024|NCT02924766|Abiraterone Acetate|abiraterone acetate|mesh-list
25146025|NCT02924766|Niraparib|niraparib|mesh-list
25146026|NCT02924766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25146027|NCT02924766|Glucocorticoids|glucocorticoids|mesh-ancestor
25146028|NCT02924766|Hormones|hormones|mesh-ancestor
24764177|NCT01779843|Antiviral Agents|antiviral agents|mesh-ancestor
24884573|NCT00276458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24884574|NCT00276458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25146029|NCT02924766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25146030|NCT02924766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146031|NCT02924766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25146033|NCT02924766|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25146034|NCT02924766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146035|NCT02924766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146036|NCT02924766|Hormone Antagonists|hormone antagonists|mesh-ancestor
25146037|NCT02924766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25146038|NCT02924766|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25146039|NCT02924675|Pregabalin|pregabalin|mesh-list
25146040|NCT02924675|Analgesics|analgesics|mesh-ancestor
25146041|NCT02924675|Sensory System Agents|sensory system agents|mesh-ancestor
25146042|NCT02924675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25684678|NCT01895335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25684679|NCT01895335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25289722|NCT04895761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25289723|NCT04895761|Alkylating Agents|alkylating agents|mesh-ancestor
25289724|NCT04895761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289725|NCT04895761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25146043|NCT02924675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146044|NCT02924675|Anticonvulsants|anticonvulsants|mesh-ancestor
25146045|NCT02924675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25146046|NCT02924675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25146047|NCT02924675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146048|NCT02924675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25146049|NCT02924675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24884575|NCT00276458|Antimetabolites|antimetabolites|mesh-ancestor
24487526|NCT00463710|Antiviral Agents|antiviral agents|mesh-ancestor
24884576|NCT00276458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884577|NCT00276458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24884578|NCT00276458|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24507488|NCT00550901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507493|NCT00550927|Bevacizumab|bevacizumab|mesh-list
24512287|NCT00573950|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24884581|NCT00271817|Niacinamide|niacinamide|mesh-list
24884582|NCT00271817|Nicotinic Acids|nicotinic acids|mesh-list
24884583|NCT00271817|Simvastatin|simvastatin|mesh-list
24884584|NCT00271817|Ezetimibe|ezetimibe|mesh-list
24507710|NCT00551564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24884585|NCT00271817|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
24884586|NCT00271817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24884587|NCT00271817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24507598|NCT00551044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24507600|NCT00551044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507627|NCT00551122|Antiviral Agents|antiviral agents|mesh-ancestor
24507628|NCT00551122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24507629|NCT00551122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507630|NCT00551122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24507631|NCT00551122|Immunologic Factors|immunologic factors|mesh-ancestor
24507632|NCT00551122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507633|NCT00551122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24507634|NCT00551122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25146050|NCT02924675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25146051|NCT02924675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25146052|NCT02924675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25146054|NCT02924532|Parathyroid Hormone|parathyroid hormone|mesh-list
25146055|NCT02924532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25146056|NCT02924532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146057|NCT02924532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25146058|NCT02924506|Meloxicam|meloxicam|mesh-list
25146059|NCT02924506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25146060|NCT02924506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25146061|NCT02924506|Analgesics|analgesics|mesh-ancestor
25146062|NCT02924506|Sensory System Agents|sensory system agents|mesh-ancestor
25146063|NCT02924506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25146064|NCT02924506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146065|NCT02924506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25146066|NCT02924506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25146067|NCT02924506|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25146068|NCT02924506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25146069|NCT02924506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146070|NCT02924506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146071|NCT02924727|Valsartan|valsartan|mesh-list
25146072|NCT02924727|Ramipril|ramipril|mesh-list
25146073|NCT02924727|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25146074|NCT02924727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25146075|NCT02924727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25146076|NCT02924727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25684680|NCT01895335|Analgesics|analgesics|mesh-ancestor
25684681|NCT01895335|Sensory System Agents|sensory system agents|mesh-ancestor
25684682|NCT01895335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25684683|NCT01895335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684684|NCT01895335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25118023|NCT04542837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118024|NCT04542837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25118025|NCT04542837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25118026|NCT04542837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118027|NCT04520048|Acetylcholine|acetylcholine|mesh-list
25118028|NCT04520048|Vasodilator Agents|vasodilator agents|mesh-ancestor
25118029|NCT04520048|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25118030|NCT04520048|Cholinergic Agents|cholinergic agents|mesh-ancestor
25118031|NCT04520048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25146077|NCT02924727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146078|NCT02924727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25146079|NCT02924727|Protease Inhibitors|protease inhibitors|mesh-ancestor
25146080|NCT02924727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146081|NCT02924311|Aflibercept|aflibercept|mesh-list
25146082|NCT02924311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25146083|NCT02924311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24507635|NCT00551122|Alkylating Agents|alkylating agents|mesh-ancestor
25047746|NCT00765804|Glucocorticoids|glucocorticoids|mesh-ancestor
25146084|NCT02924311|Growth Substances|growth substances|mesh-ancestor
25146085|NCT02924311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146086|NCT02924311|Growth Inhibitors|growth inhibitors|mesh-ancestor
25146087|NCT02924311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25146088|NCT02924285|Amiodarone|amiodarone|mesh-list
25146089|NCT02924285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25146090|NCT02924285|Vasodilator Agents|vasodilator agents|mesh-ancestor
25146091|NCT02924285|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25146092|NCT02924285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25146093|NCT02924285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146094|NCT02924285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25146095|NCT02924285|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25146096|NCT02924285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25146097|NCT02924285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146098|NCT02924285|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25146099|NCT02924285|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25146100|NCT02924285|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25146101|NCT02924454|Metoprolol|metoprolol|mesh-list
25146102|NCT02924454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25146103|NCT02924454|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25146104|NCT02924454|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
25146105|NCT02924454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25146106|NCT02924454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25146107|NCT02924454|Sympatholytics|sympatholytics|mesh-ancestor
25146108|NCT02924454|Autonomic Agents|autonomic agents|mesh-ancestor
25146109|NCT02924454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25146110|NCT02924454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809228|NCT02032043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25146111|NCT02924454|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25146113|NCT02924454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25146114|NCT02924454|Adrenergic Agents|adrenergic agents|mesh-ancestor
25146115|NCT02924454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25146116|NCT02924454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146117|NCT02924454|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25146118|NCT02924337|Moxifloxacin|moxifloxacin|mesh-list
25146119|NCT02924337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25146120|NCT02924337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25146121|NCT02924337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25146122|NCT02924337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25146123|NCT02924337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146124|NCT02924337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146125|NCT02924337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25146126|NCT02924233|Nivolumab|nivolumab|mesh-list
25146127|NCT02924233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25146128|NCT02924233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25684685|NCT01895335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25684686|NCT01895335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25684687|NCT01895335|Immunologic Factors|immunologic factors|mesh-ancestor
25684688|NCT01895777|Dabigatran|dabigatran|mesh-list
25684689|NCT01895777|Antithrombins|antithrombins|mesh-ancestor
25684690|NCT01895777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25684691|NCT01895777|Protease Inhibitors|protease inhibitors|mesh-ancestor
25684692|NCT01895777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25684693|NCT01895777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684694|NCT01895777|Anticoagulants|anticoagulants|mesh-ancestor
25118058|NCT04495868|Anesthetics|anesthetics|mesh-ancestor
25118059|NCT04495868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25146129|NCT02924233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25146130|NCT02924233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146131|NCT02923986|Dasatinib|dasatinib|mesh-list
25146132|NCT02923986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25146133|NCT02923986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25146134|NCT02923986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146135|NCT02923986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146136|NCT02923934|Nivolumab|nivolumab|mesh-list
25146172|NCT02923856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25146174|NCT02923869|Levobupivacaine|levobupivacaine|mesh-list
25146175|NCT02923869|Anesthetics, Local|anesthetics, local|mesh-ancestor
25146176|NCT02923869|Anesthetics|anesthetics|mesh-ancestor
25146177|NCT02923869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25047748|NCT00765804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25047749|NCT00765804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25047750|NCT00765804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25047751|NCT00765804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047752|NCT00765804|Anticoagulants|anticoagulants|mesh-ancestor
25047754|NCT00765804|Chelating Agents|chelating agents|mesh-ancestor
25047755|NCT00765804|Sequestering Agents|sequestering agents|mesh-ancestor
25047756|NCT00765700|Ketoprofen|ketoprofen|mesh-list
25047757|NCT00765700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25047758|NCT00765700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25047759|NCT00765700|Analgesics|analgesics|mesh-ancestor
25047760|NCT00765700|Sensory System Agents|sensory system agents|mesh-ancestor
25047761|NCT00765700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25047762|NCT00765700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047763|NCT00765700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25047764|NCT00765700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25047765|NCT00765700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25047774|NCT00765323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25047775|NCT00765323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047789|NCT00763503|Calcitriol|calcitriol|mesh-list
25047790|NCT00763503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25047791|NCT00763503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047792|NCT00763503|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25047793|NCT00763503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25047794|NCT00763503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047795|NCT00763503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25146215|NCT02923258|Docetaxel|docetaxel|mesh-list
25146216|NCT02923258|Cisplatin|cisplatin|mesh-list
25146217|NCT02923258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25146218|NCT02923258|Tubulin Modulators|tubulin modulators|mesh-ancestor
25146219|NCT02923258|Antimitotic Agents|antimitotic agents|mesh-ancestor
25146220|NCT02923258|Mitosis Modulators|mitosis modulators|mesh-ancestor
25146221|NCT02923258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146222|NCT02923336|Propranolol|propranolol|mesh-list
25146223|NCT02923336|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25146224|NCT02923336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25146247|NCT02922933|Omeprazole|omeprazole|mesh-list
25146248|NCT02922933|Famotidine|famotidine|mesh-list
25146249|NCT02922933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25146250|NCT02922933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25146251|NCT02922933|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25146252|NCT02922933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146253|NCT02922933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146254|NCT02922933|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25146255|NCT02922933|Histamine Antagonists|histamine antagonists|mesh-ancestor
25146256|NCT02922933|Histamine Agents|histamine agents|mesh-ancestor
25146257|NCT02922933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25146258|NCT02922933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146259|NCT02922933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25146260|NCT02922933|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25146261|NCT02922946|Entinostat|entinostat|mesh-list
25146262|NCT02922946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25146263|NCT02922946|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25146264|NCT02922946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146265|NCT02922946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146267|NCT02922803|Vitamin D|vitamin d|mesh-list
25684695|NCT01896050|Tamoxifen|tamoxifen|mesh-list
25684696|NCT01896050|Letrozole|letrozole|mesh-list
25684697|NCT01896050|Anastrozole|anastrozole|mesh-list
25118094|NCT04472611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118095|NCT04463693|Etonogestrel|etonogestrel|mesh-list
25118096|NCT04463693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25118097|NCT04463693|Contraceptive Agents|contraceptive agents|mesh-ancestor
25118098|NCT04463693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25118099|NCT04463693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118100|NCT04463693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25118104|NCT04438213|Ertugliflozin|ertugliflozin|mesh-list
25118105|NCT04438213|Metolazone|metolazone|mesh-list
24709745|NCT01506804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24709746|NCT01506804|Antiemetics|antiemetics|mesh-ancestor
24709747|NCT01506804|Autonomic Agents|autonomic agents|mesh-ancestor
24709748|NCT01506804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25289838|NCT04182360|Carbetocin|carbetocin|mesh-list
25289839|NCT04182360|Oxytocics|oxytocics|mesh-ancestor
25289840|NCT04182360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25289841|NCT04182360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146300|NCT02922673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25146301|NCT02922673|Analgesics|analgesics|mesh-ancestor
25146302|NCT02922673|Sensory System Agents|sensory system agents|mesh-ancestor
25146303|NCT02922673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25146304|NCT02922673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146305|NCT02922673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25146306|NCT02922673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25146307|NCT02922673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25146308|NCT02922673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25146309|NCT02922673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146310|NCT02922673|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25146311|NCT02922673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25146312|NCT02922673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146313|NCT02922673|Antipyretics|antipyretics|mesh-ancestor
25146314|NCT02922660|Remifentanil|remifentanil|mesh-list
25146315|NCT02922660|Anesthetics|anesthetics|mesh-list
25146316|NCT02922660|Propofol|propofol|mesh-list
25146317|NCT02922660|Desflurane|desflurane|mesh-list
25146318|NCT02922660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25146319|NCT02922660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146320|NCT02922660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25146321|NCT02922660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25017249|NCT02027935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25146323|NCT02922660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25146325|NCT02922660|Analgesics|analgesics|mesh-ancestor
25146326|NCT02922660|Sensory System Agents|sensory system agents|mesh-ancestor
25146327|NCT02922660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25146328|NCT02922660|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25146329|NCT02922465|Clopidogrel|clopidogrel|mesh-list
25146330|NCT02922465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25146331|NCT02922465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25146332|NCT02922465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25146333|NCT02922465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25146334|NCT02922465|Purinergic Agents|purinergic agents|mesh-ancestor
25146335|NCT02922465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25146338|NCT02922426|Olanzapine|olanzapine|mesh-list
25146340|NCT02922426|Autonomic Agents|autonomic agents|mesh-ancestor
25146341|NCT02922426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25146342|NCT02922426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146343|NCT02922426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25684698|NCT01896050|Exemestane|exemestane|mesh-list
25684699|NCT01896050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25684700|NCT01896050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25684701|NCT01896050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25684702|NCT01896050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25684703|NCT01896050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684704|NCT01896050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25684705|NCT01896050|Hormone Antagonists|hormone antagonists|mesh-ancestor
25684706|NCT01896050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25684707|NCT01896050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684708|NCT01896050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25684709|NCT01896050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25684710|NCT01896050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25684711|NCT01896050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25684712|NCT01896128|Modafinil|modafinil|mesh-list
25684713|NCT01896128|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25146344|NCT02922426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25146345|NCT02922426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25289855|NCT04064814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25118133|NCT04433494|Tamoxifen|tamoxifen|mesh-list
25118134|NCT04433494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25118135|NCT04433494|Hormone Antagonists|hormone antagonists|mesh-ancestor
25118136|NCT04433494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25118137|NCT04433494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899737|NCT04400916|Coagulants|coagulants|mesh-ancestor
24709749|NCT01506804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709750|NCT01506804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24709751|NCT01506804|Glucocorticoids|glucocorticoids|mesh-ancestor
25289856|NCT04064814|Histamine Antagonists|histamine antagonists|mesh-ancestor
25289857|NCT04064814|Histamine Agents|histamine agents|mesh-ancestor
25289858|NCT04064814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25289865|NCT03998735|Lobeline|lobeline|mesh-list
25047796|NCT00763503|Vitamins|vitamins|mesh-ancestor
25047797|NCT00763503|Micronutrients|micronutrients|mesh-ancestor
25047798|NCT00763503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25047799|NCT00761709|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25047800|NCT00761709|Latanoprost|latanoprost|mesh-list
25047801|NCT00761709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25047802|NCT00760539|Timolol|timolol|mesh-list
25047803|NCT00760539|Travoprost|travoprost|mesh-list
25047804|NCT00760539|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25047805|NCT00760539|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25047806|NCT00760539|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25146354|NCT02922491|Vitamin E|vitamin e|mesh-list
25146380|NCT02922166|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25146510|NCT02921165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25146381|NCT02922166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146382|NCT02922166|Natriuretic Agents|natriuretic agents|mesh-ancestor
25146383|NCT02922166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146384|NCT02922348|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25146385|NCT02922348|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25146386|NCT02922348|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25146387|NCT02922348|Medroxyprogesterone|medroxyprogesterone|mesh-list
25146388|NCT02922348|Norgestimate|norgestimate|mesh-list
25146389|NCT02922348|Contraceptive Agents|contraceptive agents|mesh-list
25146390|NCT02922348|Contraceptives, Oral|contraceptives, oral|mesh-list
25146391|NCT02922348|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25146392|NCT02922348|Hormones|hormones|mesh-list
25146393|NCT02922348|Estradiol|estradiol|mesh-list
25146394|NCT02922348|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25146395|NCT02922348|Progestins|progestins|mesh-list
25146396|NCT02922348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25146397|NCT02922348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146398|NCT02922348|Estrogens|estrogens|mesh-ancestor
25146399|NCT02922348|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25146400|NCT02922348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25146401|NCT02922348|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25146402|NCT02922348|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25146403|NCT02922348|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25146404|NCT02922387|Varenicline|varenicline|mesh-list
25146405|NCT02922387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25146406|NCT02922387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25146407|NCT02922387|Cholinergic Agents|cholinergic agents|mesh-ancestor
25146408|NCT02922387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24507637|NCT00551239|Fludarabine|fludarabine|mesh-list
24507638|NCT00551239|Fludarabine phosphate|fludarabine phosphate|mesh-list
24507639|NCT00551239|Pixantrone|pixantrone|mesh-list
25684714|NCT01896128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684715|NCT01896128|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25684716|NCT01896128|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25684717|NCT01896128|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25684718|NCT01896128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684719|NCT01896193|Sofosbuvir|sofosbuvir|mesh-list
25684720|NCT01896193|Antiviral Agents|antiviral agents|mesh-ancestor
25684721|NCT01896193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25684722|NCT01896232|Cinacalcet|cinacalcet|mesh-list
25684723|NCT01896232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25684724|NCT01896232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684725|NCT01896232|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25684726|NCT01896232|Hormone Antagonists|hormone antagonists|mesh-ancestor
24507640|NCT00551239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25118190|NCT04323566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25118191|NCT04323566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118192|NCT04323566|Immunologic Factors|immunologic factors|mesh-ancestor
25118193|NCT04323566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118194|NCT04323566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25118195|NCT04319328|Ciprofloxacin|ciprofloxacin|mesh-list
25118196|NCT04319328|Cefazolin|cefazolin|mesh-list
25118197|NCT04319328|Ceftazidime|ceftazidime|mesh-list
24899767|NCT04400045|Treosulfan|treosulfan|mesh-list
24709752|NCT01506804|Hormones|hormones|mesh-ancestor
25289891|NCT03968939|Sensory System Agents|sensory system agents|mesh-ancestor
25289892|NCT03968939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25289893|NCT03968939|Antiemetics|antiemetics|mesh-ancestor
24507641|NCT00551239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507642|NCT00551239|Immunologic Factors|immunologic factors|mesh-ancestor
24507643|NCT00551239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884588|NCT00271817|Antimetabolites|antimetabolites|mesh-ancestor
24884589|NCT00271817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816325|NCT02076477|Tubulin Modulators|tubulin modulators|mesh-ancestor
24816326|NCT02076477|Antimitotic Agents|antimitotic agents|mesh-ancestor
24816327|NCT02076477|Mitosis Modulators|mitosis modulators|mesh-ancestor
24816328|NCT02076477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507644|NCT00551239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24507645|NCT00551239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25146409|NCT02922387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146410|NCT02922387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146411|NCT02922127|Contraceptive Agents|contraceptive agents|mesh-list
25146412|NCT02922127|Ulipristal acetate|ulipristal acetate|mesh-list
25146413|NCT02922127|Contraceptives, Oral|contraceptives, oral|mesh-list
25146414|NCT02922127|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25146415|NCT02922127|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25146416|NCT02922127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146417|NCT02922127|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25146418|NCT02922127|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25146420|NCT02921984|Pemetrexed|pemetrexed|mesh-list
25146456|NCT02921269|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25146457|NCT02921269|Growth Substances|growth substances|mesh-ancestor
25146458|NCT02921269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146459|NCT02921269|Growth Inhibitors|growth inhibitors|mesh-ancestor
25146460|NCT02921269|Immunologic Factors|immunologic factors|mesh-ancestor
25146461|NCT02921282|Dopamine|dopamine|mesh-list
25146462|NCT02921282|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25146463|NCT02921282|Sympathomimetics|sympathomimetics|mesh-ancestor
25146464|NCT02921282|Autonomic Agents|autonomic agents|mesh-ancestor
25146465|NCT02921282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25146466|NCT02921282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507705|NCT00551512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507706|NCT00551538|Insulin Glargine|insulin glargine|mesh-list
24507707|NCT00551538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24507708|NCT00551538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507724|NCT00551590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24507775|NCT00551954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507776|NCT00551954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24507777|NCT00551954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507778|NCT00552149|Cetuximab|cetuximab|mesh-list
24507779|NCT00552149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24507780|NCT00552149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507781|NCT00552201|Tacrolimus|tacrolimus|mesh-list
24507782|NCT00552201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25684727|NCT01896232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25684728|NCT01896297|Dabigatran|dabigatran|mesh-list
25684729|NCT01896297|Antithrombins|antithrombins|mesh-ancestor
25684730|NCT01896297|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25684731|NCT01896297|Protease Inhibitors|protease inhibitors|mesh-ancestor
25684732|NCT01896297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25684733|NCT01896297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684734|NCT01896297|Anticoagulants|anticoagulants|mesh-ancestor
25684735|NCT01896544|Cholecalciferol|cholecalciferol|mesh-list
25684736|NCT01896544|Vitamin D|vitamin d|mesh-list
25684737|NCT01896544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25684738|NCT01896544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118223|NCT04303000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25118224|NCT04303000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118226|NCT04303000|Sensory System Agents|sensory system agents|mesh-ancestor
25118227|NCT04303000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24709753|NCT01506804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24709754|NCT01506804|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24709755|NCT01506804|Protective Agents|protective agents|mesh-ancestor
24709756|NCT01506804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24690445|NCT01402024|Aprepitant|aprepitant|mesh-list
24507783|NCT00552201|Immunologic Factors|immunologic factors|mesh-ancestor
24507784|NCT00552201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507785|NCT00552201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24507786|NCT00552201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507787|NCT00552201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507833|NCT00552656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507835|NCT00552656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24507836|NCT00552656|Immunologic Factors|immunologic factors|mesh-ancestor
24508011|NCT00553878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508012|NCT00553878|Hormone Antagonists|hormone antagonists|mesh-ancestor
25146468|NCT02921282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25146469|NCT02921282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146470|NCT02921282|Protective Agents|protective agents|mesh-ancestor
25146471|NCT02921360|Aspirin|aspirin|mesh-list
25146472|NCT02921360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25146473|NCT02921360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25146474|NCT02921360|Analgesics|analgesics|mesh-ancestor
25146475|NCT02921360|Sensory System Agents|sensory system agents|mesh-ancestor
25146476|NCT02921360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25146477|NCT02921360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146478|NCT02921360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25146479|NCT02921360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25146480|NCT02921360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25146481|NCT02921360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25146482|NCT02921360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146483|NCT02921360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25146484|NCT02921360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25146485|NCT02921360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146486|NCT02921360|Antipyretics|antipyretics|mesh-ancestor
25146487|NCT02921204|Vitamin D|vitamin d|mesh-list
25146488|NCT02921204|Vitamins|vitamins|mesh-ancestor
25146489|NCT02921204|Micronutrients|micronutrients|mesh-ancestor
25146490|NCT02921204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146491|NCT02921204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25146492|NCT02921191|Lenograstim|lenograstim|mesh-list
25146493|NCT02921191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25146494|NCT02921191|Immunologic Factors|immunologic factors|mesh-ancestor
25146495|NCT02921191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146496|NCT02921178|Omalizumab|omalizumab|mesh-list
25146497|NCT02921178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24508013|NCT00553878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24508014|NCT00553878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508015|NCT00553930|Interferons|interferons|mesh-list
24508016|NCT00553930|Ribavirin|ribavirin|mesh-list
24508017|NCT00553930|Interferon-alpha|interferon-alpha|mesh-list
24508018|NCT00553930|Interferon alpha-2|interferon alpha-2|mesh-list
24508019|NCT00553930|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24508020|NCT00553930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508021|NCT00553930|Antiviral Agents|antiviral agents|mesh-ancestor
24508022|NCT00553930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24508023|NCT00553930|Antimetabolites|antimetabolites|mesh-ancestor
25146498|NCT02921178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25684739|NCT01896544|Vitamins|vitamins|mesh-ancestor
25684740|NCT01896544|Micronutrients|micronutrients|mesh-ancestor
25684741|NCT01896544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25684742|NCT01896557|Omeprazole|omeprazole|mesh-list
25684743|NCT01896557|Ranitidine|ranitidine|mesh-list
25684744|NCT01896557|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
25684745|NCT01896557|Clopidogrel|clopidogrel|mesh-list
25684746|NCT01896557|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
25684747|NCT01896557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25684748|NCT01896557|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25684749|NCT01896557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25146499|NCT02921178|Respiratory System Agents|respiratory system agents|mesh-ancestor
25146501|NCT02921165|Analgesics|analgesics|mesh-list
25146502|NCT02921165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25146503|NCT02921165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25146504|NCT02921165|Sensory System Agents|sensory system agents|mesh-ancestor
25146505|NCT02921165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25146506|NCT02921165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146507|NCT02921165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25146508|NCT02921165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25146509|NCT02921165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25146511|NCT02921165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146512|NCT02921165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25146513|NCT02921165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25146514|NCT02921165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146515|NCT02921165|Antipyretics|antipyretics|mesh-ancestor
25146517|NCT02920931|Antiviral Agents|antiviral agents|mesh-ancestor
25146518|NCT02920931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25146519|NCT02920931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25146520|NCT02920931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25146521|NCT02920931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146522|NCT02920931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146523|NCT02920931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25146524|NCT02920931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25146525|NCT02920827|Dapivirine|dapivirine|mesh-list
25146526|NCT02920827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25146527|NCT02920827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25146528|NCT02920827|Antiviral Agents|antiviral agents|mesh-ancestor
25146529|NCT02920827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24508024|NCT00553930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508025|NCT00553930|Immunologic Factors|immunologic factors|mesh-ancestor
24508027|NCT00553943|Cytarabine|cytarabine|mesh-list
24508056|NCT00554125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24508057|NCT00554125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24508058|NCT00554125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24508059|NCT00554125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508061|NCT00554125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24508062|NCT00554125|Immunologic Factors|immunologic factors|mesh-ancestor
24508063|NCT00554125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146530|NCT02920801|Metformin|metformin|mesh-list
25146531|NCT02920801|Saxagliptin|saxagliptin|mesh-list
25146532|NCT02920801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25146533|NCT02920801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146534|NCT02920801|Incretins|incretins|mesh-ancestor
25095809|NCT03216304|Calcium|calcium|mesh-list
25146535|NCT02920801|Hormones|hormones|mesh-ancestor
25146536|NCT02920801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25146537|NCT02920801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24489351|NCT00472550|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25146539|NCT02920801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146540|NCT02920801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146541|NCT02920905|Lidocaine|lidocaine|mesh-list
25146542|NCT02920905|Atracurium|atracurium|mesh-list
25146543|NCT02920905|Anesthetics, Local|anesthetics, local|mesh-ancestor
25146544|NCT02920905|Anesthetics|anesthetics|mesh-ancestor
25146545|NCT02920905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25146546|NCT02920905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146547|NCT02920905|Sensory System Agents|sensory system agents|mesh-ancestor
25146548|NCT02920905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25146549|NCT02920905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25146550|NCT02920905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25146551|NCT02920905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25146552|NCT02920905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25146553|NCT02920905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146554|NCT02920905|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25146555|NCT02920905|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25146556|NCT02920905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25146557|NCT02920905|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25146558|NCT02920905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25146559|NCT02920905|Cholinergic Agents|cholinergic agents|mesh-ancestor
25146573|NCT02920710|Hormones|hormones|mesh-ancestor
25146574|NCT02920710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25146575|NCT02920710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146576|NCT02920502|Cholecalciferol|cholecalciferol|mesh-list
25146577|NCT02920502|Vitamin D|vitamin d|mesh-list
25118283|NCT04274426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25118284|NCT04274426|Antimetabolites|antimetabolites|mesh-ancestor
25118285|NCT04274426|Antiviral Agents|antiviral agents|mesh-ancestor
25118286|NCT04274426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25289990|NCT03636165|Antiemetics|antiemetics|mesh-ancestor
25289991|NCT03636165|Autonomic Agents|autonomic agents|mesh-ancestor
25289992|NCT03636165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25289993|NCT03636165|Glucocorticoids|glucocorticoids|mesh-ancestor
25289994|NCT03636165|Hormones|hormones|mesh-ancestor
25289995|NCT03636165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25146578|NCT02920502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25146579|NCT02920502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146580|NCT02920502|Vitamins|vitamins|mesh-ancestor
25146581|NCT02920502|Micronutrients|micronutrients|mesh-ancestor
25146582|NCT02920502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25146583|NCT02920593|Vitamin D|vitamin d|mesh-list
25146584|NCT02920593|Ergocalciferols|ergocalciferols|mesh-list
25146585|NCT02920593|Cholecalciferol|cholecalciferol|mesh-list
25146586|NCT02920593|Vitamins|vitamins|mesh-list
25146587|NCT02920593|Micronutrients|micronutrients|mesh-ancestor
25146590|NCT02920593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25146591|NCT02920658|Betamethasone|betamethasone|mesh-list
25146592|NCT02920658|Betamethasone Valerate|betamethasone valerate|mesh-list
25047816|NCT00760344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047817|NCT00760344|Incretins|incretins|mesh-ancestor
25047818|NCT00760344|Hormones|hormones|mesh-ancestor
25047819|NCT00760344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25047820|NCT00760344|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25047821|NCT00760344|Protease Inhibitors|protease inhibitors|mesh-ancestor
25047822|NCT00760344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047823|NCT00760344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047824|NCT00759135|Finasteride|finasteride|mesh-list
24489352|NCT00472550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047825|NCT00759135|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25047826|NCT00759135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25047827|NCT00759135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047828|NCT00759135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047829|NCT00759135|Hormone Antagonists|hormone antagonists|mesh-ancestor
25047830|NCT00759135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25146594|NCT02920658|Betamethasone benzoate|betamethasone benzoate|mesh-list
25146595|NCT02920658|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25146596|NCT02920658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25146598|NCT02920658|Hormones|hormones|mesh-ancestor
25146599|NCT02920658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25146600|NCT02920658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146601|NCT02920658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25146602|NCT02920658|Respiratory System Agents|respiratory system agents|mesh-ancestor
25146603|NCT02920359|Leuprolide|leuprolide|mesh-list
25146604|NCT02920359|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25146605|NCT02920359|Fertility Agents|fertility agents|mesh-ancestor
25146606|NCT02920359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25146607|NCT02920359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146608|NCT02920359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25146609|NCT02920359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25146610|NCT02920489|Sufentanil|sufentanil|mesh-list
25146617|NCT02920489|Sensory System Agents|sensory system agents|mesh-ancestor
25146618|NCT02920489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25146619|NCT02920489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25146620|NCT02920489|Narcotics|narcotics|mesh-ancestor
25146621|NCT02920489|Analgesics|analgesics|mesh-ancestor
25146622|NCT02920489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25146623|NCT02920489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25146624|NCT02920489|Anesthetics, General|anesthetics, general|mesh-ancestor
25146625|NCT02920372|Epoetin Alfa|epoetin alfa|mesh-list
25146626|NCT02920372|Hematinics|hematinics|mesh-ancestor
25146627|NCT02920229|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25684750|NCT01896557|Purinergic Agents|purinergic agents|mesh-ancestor
25684751|NCT01896557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25684752|NCT01896557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684753|NCT01896557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684754|NCT01896557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25684755|NCT01896557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25684756|NCT01896557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25684757|NCT01896557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25684758|NCT01896557|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25118332|NCT04221880|Bupivacaine|bupivacaine|mesh-list
25118333|NCT04221880|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25118334|NCT04221880|Anesthetics, Local|anesthetics, local|mesh-ancestor
25118335|NCT04221880|Anesthetics|anesthetics|mesh-ancestor
25118336|NCT04221880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24817919|NCT02086019|Antipyretics|antipyretics|mesh-ancestor
24709841|NCT01507337|Hormones|hormones|mesh-ancestor
24709842|NCT01507337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24709843|NCT01507363|Gabapentin|gabapentin|mesh-list
24709844|NCT01507363|Analgesics|analgesics|mesh-ancestor
24709884|NCT01507428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24709886|NCT01507454|Estrogens|estrogens|mesh-ancestor
24709887|NCT01507454|Hormones|hormones|mesh-ancestor
24709888|NCT01507454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25290043|NCT03311555|Docetaxel|docetaxel|mesh-list
25290044|NCT03311555|Androgens|androgens|mesh-list
25290045|NCT03311555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290046|NCT03311555|Tubulin Modulators|tubulin modulators|mesh-ancestor
24508108|NCT00554177|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25146629|NCT02920229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146630|NCT02919917|Midodrine|midodrine|mesh-list
25146631|NCT02919917|Sympathomimetics|sympathomimetics|mesh-ancestor
25146632|NCT02919917|Autonomic Agents|autonomic agents|mesh-ancestor
25146633|NCT02919917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25146634|NCT02919917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146635|NCT02919917|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25146636|NCT02919917|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25146637|NCT02919917|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25146638|NCT02919917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24489529|NCT00473980|Celecoxib|celecoxib|mesh-list
25146639|NCT02919917|Adrenergic Agents|adrenergic agents|mesh-ancestor
25146640|NCT02919917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25146641|NCT02919917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146642|NCT02920047|Amlodipine|amlodipine|mesh-list
25146643|NCT02920047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25146644|NCT02920047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25146645|NCT02920047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25146646|NCT02920047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146647|NCT02920047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25146648|NCT02920047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146649|NCT02920047|Vasodilator Agents|vasodilator agents|mesh-ancestor
25146650|NCT02920190|Liraglutide|liraglutide|mesh-list
25146651|NCT02920190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25146652|NCT02920190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146653|NCT02920190|Incretins|incretins|mesh-ancestor
25146654|NCT02920190|Hormones|hormones|mesh-ancestor
25146655|NCT02920190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25146656|NCT02920060|Levetiracetam|levetiracetam|mesh-list
25146657|NCT02920060|Valproic Acid|valproic acid|mesh-list
25146658|NCT02920060|Anticonvulsants|anticonvulsants|mesh-ancestor
25146659|NCT02920060|Nootropic Agents|nootropic agents|mesh-ancestor
25146660|NCT02920060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764677|NCT01783106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508123|NCT00554203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25684759|NCT01896557|Histamine Antagonists|histamine antagonists|mesh-ancestor
25684760|NCT01896557|Histamine Agents|histamine agents|mesh-ancestor
25684761|NCT01896700|Methylphenidate|methylphenidate|mesh-list
25684762|NCT01896700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25684763|NCT01896700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684764|NCT01896700|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25684765|NCT01896700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25684766|NCT01896700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25684767|NCT01896700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684768|NCT01896700|Dopamine Agents|dopamine agents|mesh-ancestor
25684769|NCT01896700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25684770|NCT01896726|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25684771|NCT01896726|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
25684772|NCT01896726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25684773|NCT01896726|Contraceptive Agents|contraceptive agents|mesh-ancestor
24508124|NCT00554203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24508126|NCT00554242|Grape Seed Extract|grape seed extract|mesh-list
24508127|NCT00554242|Antioxidants|antioxidants|mesh-ancestor
24884643|NCT00092144|Respiratory System Agents|respiratory system agents|mesh-ancestor
25146661|NCT02920060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146662|NCT02920060|GABA Agents|gaba agents|mesh-ancestor
25146663|NCT02920060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25146664|NCT02920060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146665|NCT02920060|Antimanic Agents|antimanic agents|mesh-ancestor
25146666|NCT02920060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25095935|NCT03215264|Entinostat|entinostat|mesh-list
25146687|NCT02919735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25146706|NCT02919501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25146707|NCT02919501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146708|NCT02919501|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25146709|NCT02919501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25146710|NCT02919501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25146711|NCT02919501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146719|NCT02919579|Antidepressive Agents|antidepressive agents|mesh-ancestor
25146720|NCT02919579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25146722|NCT02919462|Pemetrexed|pemetrexed|mesh-list
25146723|NCT02919462|Vinorelbine|vinorelbine|mesh-list
25146724|NCT02919462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25146725|NCT02919462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146726|NCT02919462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146727|NCT02919462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25146728|NCT02919462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25146729|NCT02919462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25146730|NCT02919462|Tubulin Modulators|tubulin modulators|mesh-ancestor
25146731|NCT02919462|Antimitotic Agents|antimitotic agents|mesh-ancestor
25146732|NCT02919462|Mitosis Modulators|mitosis modulators|mesh-ancestor
25146733|NCT02919332|Deoxyglucose|deoxyglucose|mesh-list
25146734|NCT02919332|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25146735|NCT02919332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25146736|NCT02919332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146737|NCT02919332|Antimetabolites|antimetabolites|mesh-ancestor
25146738|NCT02919332|Antiviral Agents|antiviral agents|mesh-ancestor
25146739|NCT02919332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25146740|NCT02919293|Vaccines|vaccines|mesh-list
25146741|NCT02919293|Immunologic Factors|immunologic factors|mesh-ancestor
25146742|NCT02919293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146743|NCT02919371|Bevacizumab|bevacizumab|mesh-list
25146744|NCT02919371|Sunitinib|sunitinib|mesh-list
25146759|NCT02919202|Cariostatic Agents|cariostatic agents|mesh-ancestor
25146760|NCT02919202|Protective Agents|protective agents|mesh-ancestor
25146761|NCT02919202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786464|NCT01920113|Analgesics|analgesics|mesh-ancestor
25146762|NCT02919202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25146763|NCT02919202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25146764|NCT02919345|Dapagliflozin|dapagliflozin|mesh-list
25146766|NCT02919345|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25146767|NCT02919345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146768|NCT02919345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25146769|NCT02919345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146770|NCT02919449|Atezolizumab|atezolizumab|mesh-list
25146771|NCT02919449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25146772|NCT02919176|Pioglitazone|pioglitazone|mesh-list
25146773|NCT02919176|Mirabegron|mirabegron|mesh-list
25146774|NCT02919176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25146775|NCT02919176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146776|NCT02919176|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25146777|NCT02919176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25146778|NCT02919176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25146779|NCT02919176|Adrenergic Agents|adrenergic agents|mesh-ancestor
25146780|NCT02919176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25146781|NCT02919176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146782|NCT02919176|Urological Agents|urological agents|mesh-ancestor
25146784|NCT02919072|Chloroprocaine|chloroprocaine|mesh-list
25146785|NCT02919072|Anesthetics, Local|anesthetics, local|mesh-ancestor
24884644|NCT00092144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24463703|NCT00361907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24508151|NCT00554398|Antiviral Agents|antiviral agents|mesh-ancestor
24508159|NCT00554424|Anesthetics|anesthetics|mesh-ancestor
24508183|NCT00554476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508463|NCT00555776|Anticonvulsants|anticonvulsants|mesh-ancestor
24508184|NCT00554476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24709978|NCT01507792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24709979|NCT01507792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24709980|NCT01507792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24709981|NCT01507792|Histamine Antagonists|histamine antagonists|mesh-ancestor
24614142|NCT01022632|Analgesics|analgesics|mesh-ancestor
24614143|NCT01022632|Sensory System Agents|sensory system agents|mesh-ancestor
25290084|NCT03046862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290085|NCT03046862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25290086|NCT02936596|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25290087|NCT02936596|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25290088|NCT02936596|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25290089|NCT02936596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25290090|NCT02936596|Immunologic Factors|immunologic factors|mesh-ancestor
25290091|NCT02936596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118395|NCT04189588|Histamine Agents|histamine agents|mesh-ancestor
25118396|NCT04189588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25118397|NCT04189588|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25118399|NCT04189588|Dermatologic Agents|dermatologic agents|mesh-ancestor
25118400|NCT04189588|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25118405|NCT04181008|Diuretics|diuretics|mesh-ancestor
25118406|NCT04181008|Natriuretic Agents|natriuretic agents|mesh-ancestor
25118407|NCT04181008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118408|NCT04181008|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
25118409|NCT04181008|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25118410|NCT04181008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25118412|NCT04181008|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24508185|NCT00554476|Immunologic Factors|immunologic factors|mesh-ancestor
24508186|NCT00554476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508187|NCT00554476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508188|NCT00554476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24508189|NCT00554476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24508190|NCT00554476|Analgesics|analgesics|mesh-ancestor
24508191|NCT00554476|Sensory System Agents|sensory system agents|mesh-ancestor
24508193|NCT00554476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24512782|NCT00576602|Epoetin Alfa|epoetin alfa|mesh-list
24508397|NCT00555347|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24508398|NCT00555347|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24884722|NCT03686813|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24884723|NCT03686813|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24884724|NCT03686813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146786|NCT02919072|Anesthetics|anesthetics|mesh-ancestor
25146787|NCT02919072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25146788|NCT02919072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146789|NCT02919072|Sensory System Agents|sensory system agents|mesh-ancestor
25146790|NCT02919072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25146791|NCT02919059|Dapagliflozin|dapagliflozin|mesh-list
25684774|NCT01896726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25684775|NCT01896726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684776|NCT01896726|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25684777|NCT01896726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25684778|NCT01896726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25684779|NCT01896726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25684780|NCT01896726|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25684781|NCT01896726|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
25684782|NCT01896726|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25684783|NCT01896726|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25684784|NCT01896856|Trifluridine|trifluridine|mesh-list
25684785|NCT01896856|Irinotecan|irinotecan|mesh-list
25684786|NCT01896856|Guadecitabine|guadecitabine|mesh-list
25684787|NCT01896856|Azacitidine|azacitidine|mesh-list
25684788|NCT01896856|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25684789|NCT01896856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25684790|NCT01896856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25684791|NCT01896856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684792|NCT01896856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25684793|NCT01896856|Antimetabolites|antimetabolites|mesh-ancestor
25684794|NCT01896856|Antiviral Agents|antiviral agents|mesh-ancestor
25684795|NCT01896856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25684796|NCT01896856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25684797|NCT01896869|Ipilimumab|ipilimumab|mesh-list
25684798|NCT01896869|Folfirinox|folfirinox|mesh-list
25684799|NCT01896869|Vaccines|vaccines|mesh-list
25684800|NCT01896869|Immunologic Factors|immunologic factors|mesh-ancestor
25290126|NCT02758431|Methyltestosterone|methyltestosterone|mesh-list
25290127|NCT02758431|Anastrozole|anastrozole|mesh-list
25290128|NCT02758431|Testosterone|testosterone|mesh-list
25290129|NCT02758431|Testosterone undecanoate|testosterone undecanoate|mesh-list
25290130|NCT02758431|Testosterone enanthate|testosterone enanthate|mesh-list
25290131|NCT02758431|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25290132|NCT02758431|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25290133|NCT02758431|Acyline|acyline|mesh-list
25290134|NCT02758431|Hormone Antagonists|hormone antagonists|mesh-list
25290135|NCT02758431|Hormones|hormones|mesh-ancestor
25290136|NCT02758431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25290137|NCT02758431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290138|NCT02758431|Androgens|androgens|mesh-ancestor
25290139|NCT02758431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25146792|NCT02919059|Glimepiride|glimepiride|mesh-list
25146793|NCT02919059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25146794|NCT02919059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146795|NCT02919059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25146796|NCT02919059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146797|NCT02919059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25146798|NCT02919059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25146799|NCT02919059|Immunologic Factors|immunologic factors|mesh-ancestor
25146800|NCT02918812|Diclofenac|diclofenac|mesh-list
25146801|NCT02918812|Lidocaine|lidocaine|mesh-list
24490161|NCT00476918|Triamcinolone|triamcinolone|mesh-list
25146802|NCT02918812|Anesthetics, Local|anesthetics, local|mesh-ancestor
25146803|NCT02918812|Anesthetics|anesthetics|mesh-ancestor
25146804|NCT02918812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25146805|NCT02918812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146806|NCT02918812|Sensory System Agents|sensory system agents|mesh-ancestor
25146807|NCT02918812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25146808|NCT02918812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25146809|NCT02918812|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25146835|NCT02918825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25146836|NCT02918825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25146837|NCT02918825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25146838|NCT02918825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146839|NCT02918825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25146841|NCT02918825|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25146842|NCT02918825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25146843|NCT02918825|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25146844|NCT02918825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25146845|NCT02918825|Dopamine Agents|dopamine agents|mesh-ancestor
25146846|NCT02918760|Gabapentin|gabapentin|mesh-list
25146847|NCT02918760|Analgesics|analgesics|mesh-ancestor
25146848|NCT02918760|Sensory System Agents|sensory system agents|mesh-ancestor
25146849|NCT02918760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25146850|NCT02918760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146851|NCT02918760|Anticonvulsants|anticonvulsants|mesh-ancestor
25146852|NCT02918760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25146853|NCT02918760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25146854|NCT02918760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25146855|NCT02918760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25146856|NCT02918760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25146857|NCT02918760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25146858|NCT02918760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25146859|NCT02918760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146860|NCT02918760|Antimanic Agents|antimanic agents|mesh-ancestor
25146861|NCT02918747|Gemcitabine|gemcitabine|mesh-list
25146862|NCT02918747|Dexamethasone|dexamethasone|mesh-list
25684801|NCT01896869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684802|NCT01896869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25684803|NCT01896869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25684804|NCT01896869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25684805|NCT01896869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684806|NCT01896895|Botulinum Toxins|botulinum toxins|mesh-list
25684807|NCT01896895|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25684808|NCT01896895|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25684809|NCT01896895|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25684810|NCT01896895|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25684811|NCT01896895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25684812|NCT01896895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290180|NCT05098574|Drospirenone|drospirenone|mesh-list
25290181|NCT05098574|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25290182|NCT05098574|Estradiol|estradiol|mesh-list
25290183|NCT05098574|Estrogens|estrogens|mesh-ancestor
25290184|NCT05098574|Hormones|hormones|mesh-ancestor
25290185|NCT05098574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25290186|NCT05098574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290187|NCT05098574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25290188|NCT05098574|Contraceptive Agents|contraceptive agents|mesh-ancestor
25290189|NCT05098574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25290190|NCT05098574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25290192|NCT05098574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24513101|NCT00578760|Aspirin|aspirin|mesh-list
24508464|NCT00555776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24508465|NCT00555776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24508466|NCT00555776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24508467|NCT00555776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24508468|NCT00555776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24508469|NCT00555776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24508470|NCT00555776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25146864|NCT02918747|Cyclophosphamide|cyclophosphamide|mesh-list
25146865|NCT02918747|Doxorubicin|doxorubicin|mesh-list
25146866|NCT02918747|Oxaliplatin|oxaliplatin|mesh-list
25146867|NCT02918747|Vincristine|vincristine|mesh-list
25146868|NCT02918747|Pegaspargase|pegaspargase|mesh-list
25146869|NCT02918747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25146870|NCT02918747|Immunologic Factors|immunologic factors|mesh-ancestor
25146871|NCT02918747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146872|NCT02918747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25146873|NCT02918747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25146874|NCT02918747|Alkylating Agents|alkylating agents|mesh-ancestor
25146875|NCT02918747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146876|NCT02918747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25146877|NCT02918747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25146878|NCT02918747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25146879|NCT02918747|Antiemetics|antiemetics|mesh-ancestor
25146880|NCT02918747|Autonomic Agents|autonomic agents|mesh-ancestor
25146881|NCT02918747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25146882|NCT02918747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25146883|NCT02918747|Glucocorticoids|glucocorticoids|mesh-ancestor
25146884|NCT02918747|Hormones|hormones|mesh-ancestor
25146885|NCT02918747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25146886|NCT02918747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25146887|NCT02918747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25146888|NCT02918747|Antimetabolites|antimetabolites|mesh-ancestor
25146889|NCT02918747|Antiviral Agents|antiviral agents|mesh-ancestor
25146890|NCT02918747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25146891|NCT02918747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146892|NCT02918747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25146893|NCT02918747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25146894|NCT02918747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25146929|NCT02918331|Growth Inhibitors|growth inhibitors|mesh-ancestor
25146930|NCT02918045|Cellulose, Oxidized|cellulose, oxidized|mesh-list
25146931|NCT02918045|Hemostatics|hemostatics|mesh-ancestor
25146932|NCT02918045|Coagulants|coagulants|mesh-ancestor
25146933|NCT02918136|Cortisone|cortisone|mesh-list
25146934|NCT02918136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25146935|NCT02918110|Misoprostol|misoprostol|mesh-list
25684813|NCT01896895|Cholinergic Agents|cholinergic agents|mesh-ancestor
25684814|NCT01896895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25684815|NCT01896895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684816|NCT01896895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25684817|NCT01896895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25684818|NCT01896921|Raltegravir Potassium|raltegravir potassium|mesh-list
25684819|NCT01896921|Maraviroc|maraviroc|mesh-list
25684820|NCT01896921|Dolutegravir|dolutegravir|mesh-list
25684821|NCT01896921|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25684822|NCT01896921|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25684823|NCT01896921|Antiviral Agents|antiviral agents|mesh-ancestor
25146936|NCT02918110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25146937|NCT02918110|Abortifacient Agents|abortifacient agents|mesh-ancestor
25684824|NCT01896921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25684825|NCT01896921|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25146938|NCT02918110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25146939|NCT02918110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146940|NCT02918110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25146941|NCT02918110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25146943|NCT02917889|Caffeine|caffeine|mesh-list
25146944|NCT02917889|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25146945|NCT02917889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146946|NCT02917889|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25146947|NCT02917889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146948|NCT02917889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146949|NCT02917889|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25146950|NCT02917889|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25146951|NCT02917889|Purinergic Agents|purinergic agents|mesh-ancestor
25146952|NCT02917889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25146953|NCT02917967|Botulinum Toxins|botulinum toxins|mesh-list
25146954|NCT02917967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25146955|NCT02917967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25017831|NCT03703596|Mitosis Modulators|mitosis modulators|mesh-ancestor
25146956|NCT02917967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146957|NCT02917967|Cholinergic Agents|cholinergic agents|mesh-ancestor
25146958|NCT02917967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25146959|NCT02917967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146960|NCT02917772|Nivolumab|nivolumab|mesh-list
25146961|NCT02917772|Ipilimumab|ipilimumab|mesh-list
25146962|NCT02917772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25146963|NCT02917772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508471|NCT00555776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508472|NCT00555776|Antimanic Agents|antimanic agents|mesh-ancestor
25146965|NCT02917772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146966|NCT02917746|Imiquimod|imiquimod|mesh-list
25146967|NCT02917746|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25146968|NCT02917746|Immunologic Factors|immunologic factors|mesh-ancestor
25146969|NCT02917746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146970|NCT02917746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25146971|NCT02917746|Interferon Inducers|interferon inducers|mesh-ancestor
25146972|NCT02917551|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25146973|NCT02917551|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25146974|NCT02917551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25146975|NCT02917551|Antitubercular Agents|antitubercular agents|mesh-ancestor
25146976|NCT02917512|Cyclosporine|cyclosporine|mesh-list
25146977|NCT02917512|Cyclosporins|cyclosporins|mesh-list
25146978|NCT02917512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146979|NCT02917512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146980|NCT02917512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25146981|NCT02917512|Immunologic Factors|immunologic factors|mesh-ancestor
25146982|NCT02917512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146983|NCT02917512|Antifungal Agents|antifungal agents|mesh-ancestor
25146984|NCT02917512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25146985|NCT02917512|Dermatologic Agents|dermatologic agents|mesh-ancestor
25146986|NCT02917512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25146987|NCT02917512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25146988|NCT02917525|Vitamin K|vitamin k|mesh-list
25146989|NCT02917525|Vitamin K 2|vitamin k 2|mesh-list
25146990|NCT02917525|Vitamins|vitamins|mesh-ancestor
25047843|NCT00758966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047844|NCT00758966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25047845|NCT00758966|Serotonin Agents|serotonin agents|mesh-ancestor
25047846|NCT00758966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25047847|NCT00758966|Antidepressive Agents|antidepressive agents|mesh-ancestor
25047848|NCT00758966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25047849|NCT00758966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25047850|NCT00758966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25047851|NCT00758966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047852|NCT00758953|Danazol|danazol|mesh-list
25047853|NCT00758953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25047854|NCT00758953|Hormone Antagonists|hormone antagonists|mesh-ancestor
25047855|NCT00758953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25047856|NCT00758953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047857|NCT00758563|Triclosan|triclosan|mesh-list
25147012|NCT02917005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147013|NCT02917005|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25147014|NCT02917005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25147015|NCT02917005|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25290259|NCT05097911|Growth Substances|growth substances|mesh-ancestor
25290260|NCT05097911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290261|NCT05097911|Growth Inhibitors|growth inhibitors|mesh-ancestor
25290262|NCT05097781|Antibodies|antibodies|mesh-list
25290263|NCT05097781|Antibodies, Blocking|antibodies, blocking|mesh-list
25290264|NCT05097781|Immunologic Factors|immunologic factors|mesh-ancestor
25290265|NCT05097781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290266|NCT05097508|Bromides|bromides|mesh-list
25290267|NCT05097508|Rocuronium|rocuronium|mesh-list
25290268|NCT05097508|Atracurium|atracurium|mesh-list
25147016|NCT02917005|Hormone Antagonists|hormone antagonists|mesh-ancestor
25147017|NCT02917005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25147018|NCT02917005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147019|NCT02917005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25147020|NCT02917018|Dexmedetomidine|dexmedetomidine|mesh-list
25147021|NCT02917018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25147022|NCT02917018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25147023|NCT02917018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147024|NCT02917018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25147025|NCT02917018|Analgesics|analgesics|mesh-ancestor
25147026|NCT02917018|Sensory System Agents|sensory system agents|mesh-ancestor
25147027|NCT02917018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25147028|NCT02917018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25147029|NCT02917018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24508473|NCT00555854|Benzocaine|benzocaine|mesh-list
24508474|NCT00555854|Anesthetics, Local|anesthetics, local|mesh-ancestor
24508475|NCT00555854|Anesthetics|anesthetics|mesh-ancestor
25147030|NCT02917018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25147031|NCT02917018|Adrenergic Agents|adrenergic agents|mesh-ancestor
25147032|NCT02917018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24490865|NCT00480363|Dexamethasone|dexamethasone|mesh-list
25147033|NCT02917018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147034|NCT02917057|Exenatide|exenatide|mesh-list
25147035|NCT02917057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25147036|NCT02917057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147037|NCT02917057|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25147038|NCT02917057|Incretins|incretins|mesh-ancestor
25147039|NCT02917057|Hormones|hormones|mesh-ancestor
25047883|NCT00755287|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25147040|NCT02917057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25147041|NCT02916940|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
25147042|NCT02916940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25147043|NCT02916940|Glucocorticoids|glucocorticoids|mesh-ancestor
25147044|NCT02916940|Hormones|hormones|mesh-ancestor
25147045|NCT02916940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25147046|NCT02916940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147048|NCT02916654|Trace Elements|trace elements|mesh-ancestor
25147049|NCT02916654|Micronutrients|micronutrients|mesh-ancestor
25147050|NCT02916654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147051|NCT02916355|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25147052|NCT02916355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25147053|NCT02916420|Dexamethasone|dexamethasone|mesh-list
25147054|NCT02916420|Pomalidomide|pomalidomide|mesh-list
25147055|NCT02916420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25147056|NCT02916420|Antiemetics|antiemetics|mesh-ancestor
25147057|NCT02916420|Autonomic Agents|autonomic agents|mesh-ancestor
25147058|NCT02916420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25147059|NCT02916420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147060|NCT02916420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25147061|NCT02916420|Glucocorticoids|glucocorticoids|mesh-ancestor
25147062|NCT02916420|Hormones|hormones|mesh-ancestor
25147063|NCT02916420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24508476|NCT00555854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24884746|NCT03636451|Anesthetics|anesthetics|mesh-ancestor
24884747|NCT03636451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25684826|NCT01896921|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25684827|NCT01896921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25684828|NCT01896921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684829|NCT01896921|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25684830|NCT01896921|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25684831|NCT01896921|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25684832|NCT01896934|Sertraline|sertraline|mesh-list
25684833|NCT01896934|Antidepressive Agents|antidepressive agents|mesh-ancestor
25290302|NCT05097248|Doxorubicin|doxorubicin|mesh-list
25290303|NCT05097248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25290305|NCT05097248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25290306|NCT05097248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290307|NCT05097248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25290308|NCT05097248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25290309|NCT05097248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25290310|NCT05097248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290311|NCT05097248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25290312|NCT05097248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25290313|NCT05097248|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24884748|NCT03636451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147064|NCT02916420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25147065|NCT02916420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25147066|NCT02916420|Immunologic Factors|immunologic factors|mesh-ancestor
25147067|NCT02916420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25147068|NCT02916420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25147069|NCT02916420|Growth Substances|growth substances|mesh-ancestor
25147070|NCT02916420|Growth Inhibitors|growth inhibitors|mesh-ancestor
25147071|NCT02916511|Paclitaxel|paclitaxel|mesh-list
25147072|NCT02916511|Carboplatin|carboplatin|mesh-list
25147073|NCT02916511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25147074|NCT02916511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25147075|NCT02916511|Tubulin Modulators|tubulin modulators|mesh-ancestor
25147076|NCT02916511|Antimitotic Agents|antimitotic agents|mesh-ancestor
25147077|NCT02916511|Mitosis Modulators|mitosis modulators|mesh-ancestor
25147078|NCT02916511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147079|NCT02916485|Sirolimus|sirolimus|mesh-list
25147080|NCT02916485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25147081|NCT02916485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25147082|NCT02916485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25147083|NCT02916485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25147105|NCT02916381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25147106|NCT02916381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147107|NCT02916251|Glucagon|glucagon|mesh-list
25147108|NCT02916251|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24491078|NCT00481169|Bazedoxifene|bazedoxifene|mesh-list
25147109|NCT02916251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25147110|NCT02916251|Hormones|hormones|mesh-ancestor
25147131|NCT02916238|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25147132|NCT02916238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25147133|NCT02916134|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25147134|NCT02916134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25096486|NCT03211572|Tamoxifen|tamoxifen|mesh-list
25147136|NCT02916160|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25147137|NCT02916160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25147138|NCT02916160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25147139|NCT02916160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25147140|NCT02916160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147141|NCT02916121|Folic Acid|folic acid|mesh-list
25147142|NCT02916121|Vitamin B 12|vitamin b 12|mesh-list
25147143|NCT02916121|Vitamins|vitamins|mesh-ancestor
25147144|NCT02916121|Micronutrients|micronutrients|mesh-ancestor
25147145|NCT02916121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047879|NCT00758290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047880|NCT00758290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25047881|NCT00755287|Metformin|metformin|mesh-list
25047882|NCT00755287|Insulin Glargine|insulin glargine|mesh-list
25047889|NCT00754988|Metformin|metformin|mesh-list
25047890|NCT00754988|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25047891|NCT00754988|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25684834|NCT01896934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25684835|NCT01896934|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25684836|NCT01896934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25684837|NCT01896934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25684838|NCT01896934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684839|NCT01896934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25684840|NCT01896934|Serotonin Agents|serotonin agents|mesh-ancestor
25684841|NCT01896934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684842|NCT01897233|Ivacaftor|ivacaftor|mesh-list
25684843|NCT01897233|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25684844|NCT01897233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25047892|NCT00754988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25047893|NCT00754988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047894|NCT00754988|Incretins|incretins|mesh-ancestor
25147171|NCT02915666|Protective Agents|protective agents|mesh-ancestor
25147172|NCT02915666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147173|NCT02915809|Vaccines|vaccines|mesh-list
25147174|NCT02915809|Immunologic Factors|immunologic factors|mesh-ancestor
25147175|NCT02915809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147204|NCT02915354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25147205|NCT02915354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25147206|NCT02915354|Analgesics|analgesics|mesh-ancestor
25147207|NCT02915354|Sensory System Agents|sensory system agents|mesh-ancestor
25147208|NCT02915354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25147209|NCT02915354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147210|NCT02915354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25147211|NCT02915354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25147212|NCT02915354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25147213|NCT02915354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25147214|NCT02915354|Immunologic Factors|immunologic factors|mesh-ancestor
25147215|NCT02915094|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25147216|NCT02915094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25147217|NCT02915172|Capecitabine|capecitabine|mesh-list
25147218|NCT02915172|Lenvatinib|lenvatinib|mesh-list
24491327|NCT00482183|Pioglitazone|pioglitazone|mesh-list
25147219|NCT02915172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25147220|NCT02915172|Antimetabolites|antimetabolites|mesh-ancestor
25147221|NCT02915172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147222|NCT02915172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25147223|NCT02915172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25147224|NCT02915172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25147225|NCT02915055|Acetaminophen|acetaminophen|mesh-list
25147226|NCT02915055|Ibuprofen|ibuprofen|mesh-list
25147228|NCT02915055|Oxycodone|oxycodone|mesh-list
25147259|NCT02914886|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25147260|NCT02914886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25147261|NCT02914886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147262|NCT02914652|Albuterol|albuterol|mesh-list
25147263|NCT02914652|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25147264|NCT02914652|Autonomic Agents|autonomic agents|mesh-ancestor
25147265|NCT02914652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25147266|NCT02914652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147267|NCT02914652|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25147268|NCT02914652|Respiratory System Agents|respiratory system agents|mesh-ancestor
25147269|NCT02914652|Tocolytic Agents|tocolytic agents|mesh-ancestor
25147270|NCT02914652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25147271|NCT02914652|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25147272|NCT02914652|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25147273|NCT02914652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25147274|NCT02914652|Adrenergic Agents|adrenergic agents|mesh-ancestor
25147275|NCT02914652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25147276|NCT02914652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147277|NCT02914678|Fentanyl|fentanyl|mesh-list
25147278|NCT02914678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25147279|NCT02914678|Narcotics|narcotics|mesh-ancestor
25147280|NCT02914678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25147281|NCT02914678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147282|NCT02914678|Analgesics|analgesics|mesh-ancestor
25147283|NCT02914678|Sensory System Agents|sensory system agents|mesh-ancestor
25147504|NCT02912663|Anesthetics|anesthetics|mesh-ancestor
25147308|NCT02914158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25147309|NCT02914158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147310|NCT02914158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25147311|NCT02914158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25147315|NCT02914158|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25147316|NCT02914158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25147317|NCT02914158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147319|NCT02914015|Ropivacaine|ropivacaine|mesh-list
25147320|NCT02914015|Anesthetics, Local|anesthetics, local|mesh-list
25147321|NCT02914015|Anesthetics|anesthetics|mesh-list
25147322|NCT02914015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25147323|NCT02914015|Narcotics|narcotics|mesh-ancestor
25147324|NCT02914015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25147325|NCT02914015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147363|NCT02914028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25147365|NCT02913859|Hormone Antagonists|hormone antagonists|mesh-ancestor
25147366|NCT02913859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25290379|NCT05026801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25290380|NCT05026801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290381|NCT05026801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25118696|NCT03915665|Chlorhexidine|chlorhexidine|mesh-list
25118697|NCT03915665|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25118698|NCT03915665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25118699|NCT03915665|Disinfectants|disinfectants|mesh-ancestor
25118741|NCT03878368|Sulforaphane|sulforaphane|mesh-list
25118742|NCT03878368|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25118743|NCT03878368|Protective Agents|protective agents|mesh-ancestor
25118744|NCT03878368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118745|NCT03878368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118746|NCT03870399|Tamoxifen|tamoxifen|mesh-list
25118747|NCT03870399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25147367|NCT02913859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147368|NCT02913768|Ondansetron|ondansetron|mesh-list
25147369|NCT02913768|Antiemetics|antiemetics|mesh-ancestor
25147370|NCT02913768|Autonomic Agents|autonomic agents|mesh-ancestor
25147371|NCT02913768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25147372|NCT02913768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147373|NCT02913768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25147374|NCT02913768|Antipruritics|antipruritics|mesh-ancestor
25147375|NCT02913768|Dermatologic Agents|dermatologic agents|mesh-ancestor
25147376|NCT02913768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25147377|NCT02913768|Serotonin Agents|serotonin agents|mesh-ancestor
25147378|NCT02913768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25147379|NCT02913768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147380|NCT02913768|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25147381|NCT02913768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25147382|NCT02913768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25147383|NCT02913768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25147384|NCT02913768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25147385|NCT02913417|Nivolumab|nivolumab|mesh-list
25147386|NCT02913417|Ipilimumab|ipilimumab|mesh-list
25147387|NCT02913417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25147388|NCT02913417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25147389|NCT02913417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25147390|NCT02913417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147391|NCT02913573|Bupivacaine|bupivacaine|mesh-list
25147407|NCT02913430|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25147408|NCT02913430|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25147409|NCT02913430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25147410|NCT02913430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25147411|NCT02913430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25147412|NCT02913430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25147413|NCT02913430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147415|NCT02913469|Metoclopramide|metoclopramide|mesh-list
25147416|NCT02913469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25147417|NCT02913469|Narcotics|narcotics|mesh-ancestor
25147418|NCT02913469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25147419|NCT02913469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147420|NCT02913469|Analgesics|analgesics|mesh-ancestor
25147421|NCT02913469|Sensory System Agents|sensory system agents|mesh-ancestor
25147422|NCT02913469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25147423|NCT02913469|Antiemetics|antiemetics|mesh-ancestor
25147431|NCT02913508|Vedolizumab|vedolizumab|mesh-list
25047908|NCT00754221|Adrenergic Agents|adrenergic agents|mesh-ancestor
25047909|NCT00754221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25047910|NCT00754221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047911|NCT00752570|Trebananib|trebananib|mesh-list
25684845|NCT01897233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684846|NCT01897285|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25684847|NCT01897285|Laxatives|laxatives|mesh-ancestor
25684848|NCT01897285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25684849|NCT01897402|Vaccines|vaccines|mesh-list
25684850|NCT01897402|Immunologic Factors|immunologic factors|mesh-ancestor
25684851|NCT01897402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684852|NCT01897493|Digoxin|digoxin|mesh-list
25684853|NCT01897493|Evacetrapib|evacetrapib|mesh-list
25684854|NCT01897493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25684855|NCT01897493|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25684856|NCT01897493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25684857|NCT01897493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047912|NCT00752570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25047913|NCT00752570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25290419|NCT04912791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25290420|NCT04912791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290421|NCT04908293|Listerine|listerine|mesh-list
25290422|NCT04908293|Sodium Fluoride|sodium fluoride|mesh-list
25290423|NCT04908293|Cariostatic Agents|cariostatic agents|mesh-ancestor
25290424|NCT04908293|Protective Agents|protective agents|mesh-ancestor
25290425|NCT04908293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047914|NCT00752570|Growth Substances|growth substances|mesh-ancestor
25047915|NCT00752570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147448|NCT02913690|Micronutrients|micronutrients|mesh-ancestor
25147449|NCT02913690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147451|NCT02913690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147452|NCT02913690|Protective Agents|protective agents|mesh-ancestor
25147502|NCT02912663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25147503|NCT02912663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147505|NCT02912663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25147507|NCT02912663|Anticonvulsants|anticonvulsants|mesh-ancestor
25147508|NCT02912663|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25147509|NCT02912663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25147510|NCT02912663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147511|NCT02912663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25147512|NCT02912663|Tocolytic Agents|tocolytic agents|mesh-ancestor
25147513|NCT02912663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25147514|NCT02912663|Vasodilator Agents|vasodilator agents|mesh-ancestor
25147516|NCT02912637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25147517|NCT02912637|Anesthetics, General|anesthetics, general|mesh-ancestor
25147518|NCT02912637|Anesthetics|anesthetics|mesh-ancestor
25147519|NCT02912637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25047916|NCT00752570|Growth Inhibitors|growth inhibitors|mesh-ancestor
25147520|NCT02912637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147547|NCT02912910|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25147563|NCT02912702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25147564|NCT02912702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25147565|NCT02912702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25147566|NCT02912702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25147567|NCT02912702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25147568|NCT02912702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25147569|NCT02912702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25147570|NCT02912702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147571|NCT02912702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25147572|NCT02912702|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25147573|NCT02912702|Protective Agents|protective agents|mesh-ancestor
25147574|NCT02912676|Methotrexate|methotrexate|mesh-list
25147575|NCT02912676|Mercaptopurine|mercaptopurine|mesh-list
25147576|NCT02912676|Thioguanine|thioguanine|mesh-list
25147577|NCT02912676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24491939|NCT00484640|Warfarin|warfarin|mesh-list
24492042|NCT00485030|Everolimus|everolimus|mesh-list
25147578|NCT02912676|Abortifacient Agents|abortifacient agents|mesh-ancestor
25147579|NCT02912676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25147580|NCT02912676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147581|NCT02912676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25147614|NCT02912182|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25147615|NCT02912182|Prednisolone acetate|prednisolone acetate|mesh-list
25147616|NCT02912182|Betamethasone|betamethasone|mesh-list
25147617|NCT02912182|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25147618|NCT02912182|Prednisolone phosphate|prednisolone phosphate|mesh-list
25147619|NCT02912182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25147620|NCT02912182|Glucocorticoids|glucocorticoids|mesh-ancestor
25147621|NCT02912182|Hormones|hormones|mesh-ancestor
25147622|NCT02912182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25684858|NCT01897493|Protective Agents|protective agents|mesh-ancestor
25684859|NCT01897493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684860|NCT01897493|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25684861|NCT01897493|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25684862|NCT01897493|Antimetabolites|antimetabolites|mesh-ancestor
25684863|NCT01897493|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25684864|NCT01897532|Linagliptin|linagliptin|mesh-list
25684865|NCT01897532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25684866|NCT01897532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290459|NCT04718636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25290460|NCT04718636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290461|NCT04718636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25290462|NCT04718636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25290463|NCT04718636|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25290464|NCT04718636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25290465|NCT04718636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25290466|NCT04718636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25290467|NCT04718636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25147623|NCT02912182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147624|NCT02912182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25147625|NCT02912182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25147627|NCT02912182|Autonomic Agents|autonomic agents|mesh-ancestor
25147628|NCT02912182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25147629|NCT02912182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25147630|NCT02912182|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25147631|NCT02912182|Protective Agents|protective agents|mesh-ancestor
25147632|NCT02912182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25147633|NCT02912182|Respiratory System Agents|respiratory system agents|mesh-ancestor
25047934|NCT00752258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047935|NCT00752258|Cholinergic Agents|cholinergic agents|mesh-ancestor
25047936|NCT00752258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25047937|NCT00752258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047938|NCT00752258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25047939|NCT00752258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25047940|NCT00752050|Botulinum Toxins|botulinum toxins|mesh-list
25047941|NCT00752050|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25047942|NCT00752050|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25047943|NCT00752050|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25047944|NCT00752050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25147752|NCT02910882|Antimetabolites|antimetabolites|mesh-ancestor
25047945|NCT00752050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047946|NCT00752050|Cholinergic Agents|cholinergic agents|mesh-ancestor
25047947|NCT00752050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25047948|NCT00752050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047949|NCT00752050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25047950|NCT00752050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25047952|NCT00751803|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25047953|NCT00751803|Serotonin Agents|serotonin agents|mesh-ancestor
25047954|NCT00751803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25047955|NCT00751803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047956|NCT00751803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047957|NCT00751231|Clopidogrel|clopidogrel|mesh-list
25047958|NCT00751231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25047959|NCT00751231|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25047960|NCT00751231|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25047961|NCT00751231|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25047978|NCT00750633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25047979|NCT00750633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25047980|NCT00750633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25047981|NCT00750633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25047982|NCT00750633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25047983|NCT00750633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25047984|NCT00750633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25047985|NCT00750633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047986|NCT00750633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147650|NCT02912234|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25147651|NCT02912234|Antithrombins|antithrombins|mesh-ancestor
25147652|NCT02912234|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25684867|NCT01897532|Incretins|incretins|mesh-ancestor
25684868|NCT01897532|Hormones|hormones|mesh-ancestor
25684869|NCT01897532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25684870|NCT01897532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25684871|NCT01897532|Protease Inhibitors|protease inhibitors|mesh-ancestor
25684872|NCT01897532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25684873|NCT01897532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684874|NCT01897714|Dexamethasone|dexamethasone|mesh-list
25684875|NCT01897714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25290505|NCT04616274|Venetoclax|venetoclax|mesh-list
25290506|NCT04616274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290507|NCT04613622|Venetoclax|venetoclax|mesh-list
25290508|NCT04613622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290509|NCT04546620|Prednisolone|prednisolone|mesh-list
25290510|NCT04546620|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25290511|NCT04546620|Methylprednisolone|methylprednisolone|mesh-list
25290512|NCT04546620|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25290513|NCT04546620|Prednisolone acetate|prednisolone acetate|mesh-list
25147653|NCT02912234|Protease Inhibitors|protease inhibitors|mesh-ancestor
25147654|NCT02912234|Anticoagulants|anticoagulants|mesh-ancestor
25147655|NCT02912026|Olorofim|olorofim|mesh-list
25147656|NCT02912026|Antifungal Agents|antifungal agents|mesh-ancestor
25147657|NCT02912026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25147658|NCT02911961|Acetaminophen|acetaminophen|mesh-list
25147659|NCT02911961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25147660|NCT02911961|Analgesics|analgesics|mesh-ancestor
25147661|NCT02911961|Sensory System Agents|sensory system agents|mesh-ancestor
25147662|NCT02911961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25147663|NCT02911961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147664|NCT02911961|Antipyretics|antipyretics|mesh-ancestor
25147665|NCT02911870|Moxifloxacin|moxifloxacin|mesh-list
25147666|NCT02911870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25147667|NCT02911870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25147668|NCT02911870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25147669|NCT02911870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25147670|NCT02911870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25147673|NCT02911766|Chlorhexidine|chlorhexidine|mesh-list
25147686|NCT02911662|Nitrofurantoin|nitrofurantoin|mesh-list
25147687|NCT02911662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25147688|NCT02911662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25147689|NCT02911662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25147690|NCT02911662|Renal Agents|renal agents|mesh-ancestor
25147691|NCT02911701|Acetaminophen|acetaminophen|mesh-list
25147692|NCT02911701|Ibuprofen|ibuprofen|mesh-list
25147693|NCT02911701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25147694|NCT02911701|Analgesics|analgesics|mesh-ancestor
25147695|NCT02911701|Sensory System Agents|sensory system agents|mesh-ancestor
25147702|NCT02911701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25147703|NCT02911701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25147704|NCT02911701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147706|NCT02911597|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25147707|NCT02911597|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25147708|NCT02911597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147709|NCT02911597|Sensory System Agents|sensory system agents|mesh-ancestor
25147710|NCT02911597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25147711|NCT02911298|Metronidazole|metronidazole|mesh-list
25147712|NCT02911298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25147746|NCT02910778|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25147747|NCT02910778|Purinergic Agents|purinergic agents|mesh-ancestor
25147748|NCT02910778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25147749|NCT02910778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147750|NCT02910882|Gemcitabine|gemcitabine|mesh-list
25147751|NCT02910882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25147753|NCT02910882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147754|NCT02910882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25147755|NCT02910882|Antiviral Agents|antiviral agents|mesh-ancestor
25147756|NCT02910882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25147757|NCT02910882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25147758|NCT02910882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25147759|NCT02910882|Immunologic Factors|immunologic factors|mesh-ancestor
25147760|NCT02910882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147761|NCT02910817|Metformin|metformin|mesh-list
25147762|NCT02910817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25147763|NCT02910817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147764|NCT02910765|Methylene Blue|methylene blue|mesh-list
25147765|NCT02910765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25147766|NCT02910765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147767|NCT02910518|Insulin|insulin|mesh-list
25684876|NCT01897714|Antiemetics|antiemetics|mesh-ancestor
25684877|NCT01897714|Autonomic Agents|autonomic agents|mesh-ancestor
25684878|NCT01897714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25684879|NCT01897714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684880|NCT01897714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25684881|NCT01897714|Glucocorticoids|glucocorticoids|mesh-ancestor
25684882|NCT01897714|Hormones|hormones|mesh-ancestor
25684883|NCT01897714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25147768|NCT02910518|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25290544|NCT04546620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25290545|NCT04546620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25290546|NCT04546620|Antiemetics|antiemetics|mesh-ancestor
25290547|NCT04546620|Autonomic Agents|autonomic agents|mesh-ancestor
25290548|NCT04546620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25290549|NCT04546620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24700812|NCT01455246|Meropenem|meropenem|mesh-list
25290550|NCT04546620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25290551|NCT04546620|Protective Agents|protective agents|mesh-ancestor
25290552|NCT04523935|Topiramate|topiramate|mesh-list
25290553|NCT04523935|Lamotrigine|lamotrigine|mesh-list
25290554|NCT04523935|Diazepam|diazepam|mesh-list
25290555|NCT04523935|Gabapentin|gabapentin|mesh-list
25290556|NCT04523935|Amitriptyline|amitriptyline|mesh-list
25290557|NCT04523935|Anticonvulsants|anticonvulsants|mesh-list
25290558|NCT04523935|Clonazepam|clonazepam|mesh-list
25290559|NCT04523935|Trihexyphenidyl|trihexyphenidyl|mesh-list
25290560|NCT04523935|Baclofen|baclofen|mesh-list
25290561|NCT04523935|Tetrabenazine|tetrabenazine|mesh-list
25290562|NCT04523935|Analgesics|analgesics|mesh-ancestor
25290563|NCT04523935|Sensory System Agents|sensory system agents|mesh-ancestor
25290564|NCT04523935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25290565|NCT04523935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147769|NCT02910518|Insulin Aspart|insulin aspart|mesh-list
25147770|NCT02910518|Insulin glulisine|insulin glulisine|mesh-list
25147797|NCT02910570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25147798|NCT02910570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147799|NCT02910570|Incretins|incretins|mesh-ancestor
25147800|NCT02910570|Hormones|hormones|mesh-ancestor
25147801|NCT02910570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25147810|NCT02910076|Hydroxychloroquine|hydroxychloroquine|mesh-list
25147811|NCT02910076|Antimalarials|antimalarials|mesh-ancestor
25147812|NCT02910076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25147813|NCT02910076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25147814|NCT02910076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25147815|NCT02910076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25147816|NCT02910076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147817|NCT02910076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25147818|NCT02910141|Insulin|insulin|mesh-list
25147819|NCT02910141|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25147820|NCT02910141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25147821|NCT02910141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147822|NCT02910115|Oxytocin|oxytocin|mesh-list
25147823|NCT02910115|Oxytocics|oxytocics|mesh-ancestor
25147824|NCT02910115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25147825|NCT02910115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147826|NCT02910206|Sufentanil|sufentanil|mesh-list
25147827|NCT02910206|Propofol|propofol|mesh-list
25147828|NCT02910206|Etomidate|etomidate|mesh-list
25147829|NCT02910206|Cisatracurium|cisatracurium|mesh-list
25147830|NCT02910206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25147831|NCT02910206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25147832|NCT02910206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047988|NCT00750295|Hematinics|hematinics|mesh-ancestor
24508630|NCT00556296|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25684884|NCT01897714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25684885|NCT01897714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25684886|NCT01897727|Spironolactone|spironolactone|mesh-list
25684887|NCT01897727|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25684888|NCT01897727|Hormone Antagonists|hormone antagonists|mesh-ancestor
25684889|NCT01897727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25684890|NCT01897727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684891|NCT01897727|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25684892|NCT01897727|Diuretics|diuretics|mesh-ancestor
25684893|NCT01897727|Natriuretic Agents|natriuretic agents|mesh-ancestor
25684894|NCT01897792|Vitamins|vitamins|mesh-list
25684895|NCT01897792|Ascorbic Acid|ascorbic acid|mesh-list
25684896|NCT01897792|Vitamin E|vitamin e|mesh-list
25684897|NCT01897792|Tocopherols|tocopherols|mesh-list
25684898|NCT01897792|Tocotrienols|tocotrienols|mesh-list
25684899|NCT01897792|alpha-Tocopherol|alpha-tocopherol|mesh-list
25684900|NCT01897792|Micronutrients|micronutrients|mesh-ancestor
25684901|NCT01897792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684902|NCT01897792|Antioxidants|antioxidants|mesh-ancestor
25684903|NCT01897792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684904|NCT01897792|Protective Agents|protective agents|mesh-ancestor
25684905|NCT01898091|Ascorbic Acid|ascorbic acid|mesh-list
25684906|NCT01898091|Glycerol|glycerol|mesh-list
24508631|NCT00556296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25047989|NCT00750243|Naproxen|naproxen|mesh-list
25290592|NCT04523935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25290593|NCT04523935|Antiemetics|antiemetics|mesh-ancestor
25290594|NCT04523935|Autonomic Agents|autonomic agents|mesh-ancestor
25290595|NCT04523935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25290596|NCT04523935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25290597|NCT04523935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25290598|NCT04523935|Anesthetics, General|anesthetics, general|mesh-ancestor
25290599|NCT04523935|Anesthetics|anesthetics|mesh-ancestor
25290600|NCT04523935|GABA Modulators|gaba modulators|mesh-ancestor
25290601|NCT04523935|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25290602|NCT04523935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25290603|NCT04523935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25290604|NCT04523935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25118943|NCT03436862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118944|NCT03406715|Nivolumab|nivolumab|mesh-list
25118945|NCT03406715|Ipilimumab|ipilimumab|mesh-list
25118946|NCT03406715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25047990|NCT00750243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25047991|NCT00750243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25047992|NCT00750243|Analgesics|analgesics|mesh-ancestor
25047993|NCT00750243|Sensory System Agents|sensory system agents|mesh-ancestor
25047994|NCT00750243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25047995|NCT00750243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047996|NCT00750243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25047997|NCT00750243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25047998|NCT00750243|Gout Suppressants|gout suppressants|mesh-ancestor
25047999|NCT00750243|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25048000|NCT00750243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048001|NCT00750243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048002|NCT00749632|Mandelic Acids|mandelic acids|mesh-list
25048003|NCT00749632|Oxybutynin|oxybutynin|mesh-list
25048004|NCT00749632|Parasympatholytics|parasympatholytics|mesh-ancestor
25048005|NCT00749632|Autonomic Agents|autonomic agents|mesh-ancestor
25048006|NCT00749632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25048007|NCT00749632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048008|NCT00749632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25048009|NCT00749632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25048010|NCT00749632|Cholinergic Agents|cholinergic agents|mesh-ancestor
25048011|NCT00749632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25048012|NCT00749632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048013|NCT00749632|Urological Agents|urological agents|mesh-ancestor
25147833|NCT02910206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25147834|NCT02910206|Anesthetics, General|anesthetics, general|mesh-ancestor
25147835|NCT02910206|Anesthetics|anesthetics|mesh-ancestor
25147836|NCT02910206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25147837|NCT02910206|Narcotics|narcotics|mesh-ancestor
25147838|NCT02910206|Analgesics|analgesics|mesh-ancestor
25147839|NCT02910206|Sensory System Agents|sensory system agents|mesh-ancestor
25147840|NCT02910206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25147841|NCT02910206|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24508632|NCT00556296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508633|NCT00556296|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24508634|NCT00556296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24508635|NCT00556296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24508636|NCT00556296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472945|NCT00401206|Analgesics|analgesics|mesh-ancestor
25147842|NCT02910206|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25684907|NCT01898091|Antioxidants|antioxidants|mesh-ancestor
25684908|NCT01898091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684909|NCT01898091|Protective Agents|protective agents|mesh-ancestor
25684910|NCT01898091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684911|NCT01898091|Vitamins|vitamins|mesh-ancestor
25684912|NCT01898091|Micronutrients|micronutrients|mesh-ancestor
25684913|NCT01898091|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25684914|NCT01898130|Bevacizumab|bevacizumab|mesh-list
25684915|NCT01898130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25684916|NCT01898130|Antibodies|antibodies|mesh-list
25684917|NCT01898130|Immunoglobulins|immunoglobulins|mesh-list
25684918|NCT01898130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25684919|NCT01898130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25684920|NCT01898130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25684921|NCT01898130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25684922|NCT01898130|Growth Substances|growth substances|mesh-ancestor
25684923|NCT01898130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290639|NCT04389775|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25290640|NCT04389775|Incretins|incretins|mesh-ancestor
25290641|NCT04389775|Hormones|hormones|mesh-ancestor
25290642|NCT04389775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25118983|NCT03177746|Vasodilator Agents|vasodilator agents|mesh-ancestor
25118984|NCT03177746|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25118985|NCT03177746|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25147843|NCT02910206|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25147844|NCT02909972|Cytarabine|cytarabine|mesh-list
25147845|NCT02909972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25147846|NCT02909972|Antimetabolites|antimetabolites|mesh-ancestor
25147847|NCT02909972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147848|NCT02909972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25147849|NCT02909972|Antiviral Agents|antiviral agents|mesh-ancestor
25147850|NCT02909972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25147851|NCT02909972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25147852|NCT02909972|Immunologic Factors|immunologic factors|mesh-ancestor
25147853|NCT02909972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147854|NCT02910050|Letrozole|letrozole|mesh-list
25147855|NCT02910050|Anastrozole|anastrozole|mesh-list
25147856|NCT02910050|Exemestane|exemestane|mesh-list
25147857|NCT02910050|Bicalutamide|bicalutamide|mesh-list
25147858|NCT02910050|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25147859|NCT02910050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25147860|NCT02910050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25147861|NCT02910050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25147862|NCT02910050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147863|NCT02910050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25147864|NCT02910050|Hormone Antagonists|hormone antagonists|mesh-ancestor
25147865|NCT02910050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25147866|NCT02910050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147867|NCT02910050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25147868|NCT02910050|Androgen Antagonists|androgen antagonists|mesh-ancestor
25147869|NCT02909933|Metformin|metformin|mesh-list
25147870|NCT02909933|Liraglutide|liraglutide|mesh-list
24493023|NCT00489099|Vaccines|vaccines|mesh-list
25147871|NCT02909933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25147872|NCT02909933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147886|NCT02910245|Antimetabolites|antimetabolites|mesh-ancestor
25147887|NCT02910245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147888|NCT02910245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25147889|NCT02910245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25147890|NCT02910245|Immunologic Factors|immunologic factors|mesh-ancestor
25147891|NCT02910245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25147892|NCT02910245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25147893|NCT02910245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25147894|NCT02910245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25147895|NCT02910245|Analgesics|analgesics|mesh-ancestor
25147896|NCT02910245|Sensory System Agents|sensory system agents|mesh-ancestor
25147897|NCT02910245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25147898|NCT02910245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25147899|NCT02909751|Tocotrienols|tocotrienols|mesh-list
25147900|NCT02909751|Vitamin E|vitamin e|mesh-list
25147901|NCT02909751|Tocopherols|tocopherols|mesh-list
25147902|NCT02909751|Docetaxel|docetaxel|mesh-list
25147903|NCT02909751|Cyclophosphamide|cyclophosphamide|mesh-list
25147904|NCT02909751|Trastuzumab|trastuzumab|mesh-list
25147905|NCT02909751|Epirubicin|epirubicin|mesh-list
25147906|NCT02909751|Pertuzumab|pertuzumab|mesh-list
25147907|NCT02909751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25147908|NCT02909751|Tubulin Modulators|tubulin modulators|mesh-ancestor
25147909|NCT02909751|Antimitotic Agents|antimitotic agents|mesh-ancestor
25147910|NCT02909751|Mitosis Modulators|mitosis modulators|mesh-ancestor
25147911|NCT02909751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684924|NCT01898130|Growth Inhibitors|growth inhibitors|mesh-ancestor
25684925|NCT01898130|Immunologic Factors|immunologic factors|mesh-ancestor
25684926|NCT01898195|Varenicline|varenicline|mesh-list
25684927|NCT01898195|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25684928|NCT01898195|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25684929|NCT01898195|Cholinergic Agents|cholinergic agents|mesh-ancestor
25684930|NCT01898195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25684931|NCT01898195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147912|NCT02909751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25147913|NCT02909751|Immunologic Factors|immunologic factors|mesh-ancestor
25147926|NCT02909751|Vitamins|vitamins|mesh-ancestor
25147936|NCT02909712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25290669|NCT04316169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25290670|NCT04316169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25290671|NCT04316169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25290672|NCT04316169|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25290673|NCT04305145|Prednisone|prednisone|mesh-list
25290674|NCT04305145|Methylprednisolone|methylprednisolone|mesh-list
25290675|NCT04305145|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25290676|NCT04305145|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25290677|NCT04305145|Prednisolone|prednisolone|mesh-list
25290678|NCT04305145|Prednisolone acetate|prednisolone acetate|mesh-list
25290679|NCT04305145|Infliximab|infliximab|mesh-list
25119026|NCT03077620|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25119027|NCT03077620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25119028|NCT03077620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25119029|NCT03077620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119030|NCT03077620|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25119031|NCT03077620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25119032|NCT03077620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147937|NCT02909712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25147938|NCT02909712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25148065|NCT05312645|Petrolatum|petrolatum|mesh-list
25147939|NCT02909712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147940|NCT02909712|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25147941|NCT02909712|Renal Agents|renal agents|mesh-ancestor
25147942|NCT02909465|Midazolam|midazolam|mesh-list
25147943|NCT02909465|Ketamine|ketamine|mesh-list
25147944|NCT02909465|Haloperidol|haloperidol|mesh-list
25147945|NCT02909465|Haloperidol decanoate|haloperidol decanoate|mesh-list
25147946|NCT02909465|Analgesics|analgesics|mesh-ancestor
25147947|NCT02909465|Sensory System Agents|sensory system agents|mesh-ancestor
25147948|NCT02909465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25147949|NCT02909465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147950|NCT02909465|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25147951|NCT02909465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25147952|NCT02909465|Anesthetics, General|anesthetics, general|mesh-ancestor
25147953|NCT02909465|Anesthetics|anesthetics|mesh-ancestor
25147954|NCT02909465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25147955|NCT02909465|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25147956|NCT02909465|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25147957|NCT02909465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25147958|NCT02909465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147959|NCT02909465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25147987|NCT02909257|Anesthetics, Local|anesthetics, local|mesh-ancestor
25147988|NCT02909257|Anesthetics|anesthetics|mesh-ancestor
25147989|NCT02909257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25147991|NCT02909257|Sensory System Agents|sensory system agents|mesh-ancestor
25147992|NCT02909257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25147993|NCT02909478|Dexamethasone|dexamethasone|mesh-list
25147994|NCT02909478|Aprepitant|aprepitant|mesh-list
25147995|NCT02909478|Tropisetron|tropisetron|mesh-list
25147996|NCT02909478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25147997|NCT02909478|Antiemetics|antiemetics|mesh-ancestor
25147998|NCT02909478|Autonomic Agents|autonomic agents|mesh-ancestor
25147999|NCT02909478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25148000|NCT02909478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148001|NCT02909478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25148002|NCT02909478|Glucocorticoids|glucocorticoids|mesh-ancestor
25684932|NCT01898195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684933|NCT01898208|Anti-Infective Agents|anti-infective agents|mesh-list
25684934|NCT01898208|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25684935|NCT01898403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25684936|NCT01898442|Ticagrelor|ticagrelor|mesh-list
25684937|NCT01898442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25684938|NCT01898442|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25684939|NCT01898442|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25684940|NCT01898442|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25684941|NCT01898442|Purinergic Agents|purinergic agents|mesh-ancestor
25684942|NCT01898442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25684943|NCT01898442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684944|NCT01898442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684945|NCT01898689|Ropivacaine|ropivacaine|mesh-list
25684946|NCT01898689|Anesthetics, Local|anesthetics, local|mesh-ancestor
25684947|NCT01898689|Anesthetics|anesthetics|mesh-ancestor
25684948|NCT01898689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25290703|NCT04188145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290704|NCT04188145|Growth Inhibitors|growth inhibitors|mesh-ancestor
25290705|NCT04181606|Esmolol|esmolol|mesh-list
25290706|NCT04181606|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25290707|NCT04181606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25119071|NCT02871843|Temozolomide|temozolomide|mesh-list
25148003|NCT02909478|Hormones|hormones|mesh-ancestor
25148004|NCT02909478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25148005|NCT02909478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25148006|NCT02909478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148007|NCT02909478|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25148008|NCT02909478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25048076|NCT00743925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25148009|NCT02909478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148010|NCT02909478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25148011|NCT02909478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25148036|NCT02909335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25148037|NCT02909335|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25148039|NCT02909335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25148040|NCT02909335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25148041|NCT02909335|Antiemetics|antiemetics|mesh-ancestor
25148042|NCT02909335|Autonomic Agents|autonomic agents|mesh-ancestor
25148043|NCT02909335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25148044|NCT02909335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25148045|NCT02909335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25148046|NCT02909335|Protective Agents|protective agents|mesh-ancestor
25148047|NCT02909348|Pembrolizumab|pembrolizumab|mesh-list
25148048|NCT02909348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25148049|NCT02909348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148050|NCT02908945|Ketamine|ketamine|mesh-list
25148051|NCT02908945|Analgesics|analgesics|mesh-ancestor
25148052|NCT02908945|Sensory System Agents|sensory system agents|mesh-ancestor
25148053|NCT02908945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25148054|NCT02908945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148055|NCT02908945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25148056|NCT02908945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25148057|NCT02908945|Anesthetics, General|anesthetics, general|mesh-ancestor
25148058|NCT02908945|Anesthetics|anesthetics|mesh-ancestor
25148059|NCT02908945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25148060|NCT02908945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25148061|NCT02908945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25148062|NCT02908945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25097418|NCT03204032|Tegafur|tegafur|mesh-list
25148063|NCT02908945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148064|NCT05312645|Diclofenac|diclofenac|mesh-list
25148066|NCT05312645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25048014|NCT00749632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25048023|NCT00747318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25048024|NCT00747318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048025|NCT00747318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25048026|NCT00747318|Respiratory System Agents|respiratory system agents|mesh-ancestor
25048027|NCT00747318|Dermatologic Agents|dermatologic agents|mesh-ancestor
25048028|NCT00747318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25048029|NCT00747318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25048030|NCT00747318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25048031|NCT00747318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25048032|NCT00747318|Adrenergic Agents|adrenergic agents|mesh-ancestor
25048033|NCT00747318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25048034|NCT00747318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048035|NCT00745316|Adenosine|adenosine|mesh-list
25048036|NCT00745316|Adenosine A1 Receptor Antagonists|adenosine a1 receptor antagonists|mesh-list
25048037|NCT00745316|Analgesics|analgesics|mesh-ancestor
25048038|NCT00745316|Sensory System Agents|sensory system agents|mesh-ancestor
25048039|NCT00745316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25048040|NCT00745316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048041|NCT00745316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25684949|NCT01898689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684950|NCT01898689|Sensory System Agents|sensory system agents|mesh-ancestor
25684951|NCT01898689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25684952|NCT01898806|Triamcinolone|triamcinolone|mesh-list
25684953|NCT01898806|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25684954|NCT01898806|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25290742|NCT03945721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290743|NCT03945721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119124|NCT02724410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25119125|NCT02724410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25119126|NCT02724410|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25119127|NCT02724410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25119128|NCT02724410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119141|NCT02708706|Hyaluronic Acid|hyaluronic acid|mesh-list
25119142|NCT02708706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25119143|NCT02708706|Immunologic Factors|immunologic factors|mesh-ancestor
25119144|NCT02708706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119145|NCT02708706|Viscosupplements|viscosupplements|mesh-ancestor
25119146|NCT02708706|Protective Agents|protective agents|mesh-ancestor
25119147|NCT02708680|Atezolizumab|atezolizumab|mesh-list
25119148|NCT02708680|Entinostat|entinostat|mesh-list
25119149|NCT02708680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119150|NCT02708680|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25048042|NCT00745316|Vasodilator Agents|vasodilator agents|mesh-ancestor
25048043|NCT00745316|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25048044|NCT00745316|Purinergic Agonists|purinergic agonists|mesh-ancestor
25048045|NCT00745316|Purinergic Agents|purinergic agents|mesh-ancestor
25048046|NCT00745316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25048047|NCT00745316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048048|NCT00745316|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25048049|NCT00745316|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25048050|NCT00744926|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25048066|NCT00744276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25048067|NCT00744276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048068|NCT00743938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25048069|NCT00743938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048070|NCT00743938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25048071|NCT00743938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048072|NCT00743938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048074|NCT00743925|Varespladib methyl|varespladib methyl|mesh-list
25048075|NCT00743925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25148115|NCT05312242|Vitamin B Complex|vitamin b complex|mesh-ancestor
25148116|NCT05312242|Vitamins|vitamins|mesh-ancestor
25148117|NCT05312242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148118|NCT05312216|Durvalumab|durvalumab|mesh-list
25148119|NCT05312216|Lenvatinib|lenvatinib|mesh-list
25148120|NCT05312216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25148121|NCT05312216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148122|NCT05312216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25148123|NCT05312216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25148124|NCT05312216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148125|NCT05312190|Progesterone|progesterone|mesh-list
25148126|NCT05312190|Progestins|progestins|mesh-ancestor
25148127|NCT05312190|Hormones|hormones|mesh-ancestor
25148128|NCT05312190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25148129|NCT05312190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148130|NCT05312112|Venetoclax|venetoclax|mesh-list
25148131|NCT05312112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148132|NCT05312034|Anti-Infective Agents|anti-infective agents|mesh-list
25148133|NCT05312034|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25148134|NCT05312008|Oxytocin|oxytocin|mesh-list
25148135|NCT05312008|Oxytocics|oxytocics|mesh-ancestor
25684955|NCT01898806|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25684956|NCT01898806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25684957|NCT01898806|Glucocorticoids|glucocorticoids|mesh-ancestor
25684958|NCT01898806|Hormones|hormones|mesh-ancestor
25684959|NCT01898806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25684960|NCT01898806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684961|NCT01898806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25684962|NCT01898806|Immunologic Factors|immunologic factors|mesh-ancestor
25684963|NCT01898806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25684964|NCT01898806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684965|NCT01898923|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25684966|NCT01898923|Laxatives|laxatives|mesh-ancestor
25684967|NCT01898923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25684968|NCT01899053|Serabelisib|serabelisib|mesh-list
25684969|NCT01899053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25684970|NCT01899053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684971|NCT01899742|Tiotropium Bromide|tiotropium bromide|mesh-list
25119160|NCT02672475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119184|NCT02620046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25119185|NCT02598583|Ravulizumab|ravulizumab|mesh-list
25290784|NCT03753204|Furosemide|furosemide|mesh-list
25290785|NCT03753204|Diuretics|diuretics|mesh-ancestor
25290786|NCT03753204|Natriuretic Agents|natriuretic agents|mesh-ancestor
25290787|NCT03753204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290788|NCT03753204|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25290789|NCT03753204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25290790|NCT03753204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290791|NCT03679611|Neostigmine|neostigmine|mesh-list
25290792|NCT03679611|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25290793|NCT03679611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25290794|NCT03679611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290795|NCT03679611|Cholinergic Agents|cholinergic agents|mesh-ancestor
25290796|NCT03679611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25290797|NCT03679611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290798|NCT03679611|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25290799|NCT03679611|Autonomic Agents|autonomic agents|mesh-ancestor
25290800|NCT03679611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25290801|NCT03608436|Bromides|bromides|mesh-list
25290802|NCT03608436|Rocuronium|rocuronium|mesh-list
25290803|NCT03608436|Anticonvulsants|anticonvulsants|mesh-ancestor
25148136|NCT05312008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25148137|NCT05312008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494188|NCT00494208|Testosterone|testosterone|mesh-list
24472946|NCT00401206|Sensory System Agents|sensory system agents|mesh-ancestor
24472947|NCT00401206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24472948|NCT00401206|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25148157|NCT05311774|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25148158|NCT05311774|Tramadol|tramadol|mesh-list
25148159|NCT05311774|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25148160|NCT05311774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25148161|NCT05311774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25148162|NCT05311774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148163|NCT05311774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25148164|NCT05311774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148165|NCT05311774|Analgesics|analgesics|mesh-ancestor
25148166|NCT05311774|Sensory System Agents|sensory system agents|mesh-ancestor
25148167|NCT05311774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25148168|NCT05311774|Antidepressive Agents|antidepressive agents|mesh-ancestor
25148169|NCT05311774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25148170|NCT05311774|Dopamine Agents|dopamine agents|mesh-ancestor
25148171|NCT05311774|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25148173|NCT05311774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25148174|NCT05311722|Dexmedetomidine|dexmedetomidine|mesh-list
25148195|NCT05311722|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25684972|NCT01899742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25684973|NCT01899742|Autonomic Agents|autonomic agents|mesh-ancestor
25684974|NCT01899742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25684975|NCT01899742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25684976|NCT01899742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25684977|NCT01899742|Respiratory System Agents|respiratory system agents|mesh-ancestor
25684978|NCT01899742|Parasympatholytics|parasympatholytics|mesh-ancestor
25684979|NCT01899742|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25684980|NCT01899742|Cholinergic Agents|cholinergic agents|mesh-ancestor
25684981|NCT01899742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25684982|NCT01899742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25684983|NCT01900054|Bepotastine besilate|bepotastine besilate|mesh-list
25684984|NCT01900054|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25684985|NCT01900249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25684986|NCT01900249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25684987|NCT01900431|Leucovorin|leucovorin|mesh-list
25684988|NCT01900431|Folic Acid|folic acid|mesh-list
25684989|NCT01900431|Prednisone|prednisone|mesh-list
25684990|NCT01900431|Methotrexate|methotrexate|mesh-list
25684991|NCT01900431|Levoleucovorin|levoleucovorin|mesh-list
25684992|NCT01900431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25684993|NCT01900431|Glucocorticoids|glucocorticoids|mesh-ancestor
25684994|NCT01900431|Hormones|hormones|mesh-ancestor
25684995|NCT01900431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25684996|NCT01900431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119216|NCT02489903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25119217|NCT02489903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119218|NCT02489903|Tubulin Modulators|tubulin modulators|mesh-ancestor
25148196|NCT05311722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25148198|NCT05311540|Zinc Sulfate|zinc sulfate|mesh-list
25148199|NCT05311540|Astringents|astringents|mesh-ancestor
25148200|NCT05311540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148201|NCT05311540|Dermatologic Agents|dermatologic agents|mesh-ancestor
25148202|NCT05311514|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25148203|NCT05311514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25148204|NCT05311254|Fosfomycin|fosfomycin|mesh-list
25148205|NCT05311254|Calcium|calcium|mesh-list
25148206|NCT05311254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25148207|NCT05311254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148208|NCT05311254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25148209|NCT05311254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25148210|NCT05311228|Azithromycin|azithromycin|mesh-list
25148211|NCT05311228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25148212|NCT05311228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25148213|NCT05311189|Trastuzumab|trastuzumab|mesh-list
25148214|NCT05311189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25148215|NCT05311189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148216|NCT05311085|Nicotine|nicotine|mesh-list
25148217|NCT05311085|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25148218|NCT05311085|Autonomic Agents|autonomic agents|mesh-ancestor
25148219|NCT05311085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25148256|NCT05296213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25148257|NCT05296213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148258|NCT05296213|Cariostatic Agents|cariostatic agents|mesh-ancestor
25148259|NCT05296213|Protective Agents|protective agents|mesh-ancestor
25148260|NCT05296213|Chelating Agents|chelating agents|mesh-ancestor
25148261|NCT05296213|Sequestering Agents|sequestering agents|mesh-ancestor
25148262|NCT05296213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148263|NCT05287568|Venetoclax|venetoclax|mesh-list
25148264|NCT05287568|Cc-486|cc-486|mesh-list
25148265|NCT05287568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148266|NCT05282875|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25148267|NCT05282875|Immunologic Factors|immunologic factors|mesh-ancestor
25148268|NCT05282875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148269|NCT05277623|Mannitol|mannitol|mesh-list
25148270|NCT05277623|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25148271|NCT05277623|Diuretics|diuretics|mesh-ancestor
25148272|NCT05277623|Natriuretic Agents|natriuretic agents|mesh-ancestor
25148273|NCT05277623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148274|NCT05276206|Anesthetics|anesthetics|mesh-list
25148275|NCT05276206|Anesthetics, Local|anesthetics, local|mesh-list
25148276|NCT05276206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25148277|NCT05276206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148278|NCT05276206|Sensory System Agents|sensory system agents|mesh-ancestor
25148279|NCT05276206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25148285|NCT05259631|Propofol|propofol|mesh-list
25148306|NCT05247268|Hormone Antagonists|hormone antagonists|mesh-ancestor
25148307|NCT05247268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25148308|NCT05247268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148309|NCT05247268|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25148310|NCT05247268|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25148311|NCT05247268|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25148312|NCT05247268|Contraceptive Agents|contraceptive agents|mesh-ancestor
25148313|NCT05247268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25148314|NCT05247268|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25148315|NCT05247268|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25148319|NCT05247268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25097783|NCT03201250|Hormones|hormones|mesh-ancestor
25148320|NCT05246293|Tofacitinib|tofacitinib|mesh-list
25148321|NCT05246293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25148322|NCT05246293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25148323|NCT05246293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018682|NCT03697811|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25148325|NCT05214976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25148363|NCT05148195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148364|NCT05148195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25684997|NCT01900431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25684998|NCT01900431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25684999|NCT01900431|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25148365|NCT05148195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148366|NCT05148195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25148367|NCT05148195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25148368|NCT05148195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25148369|NCT05148195|Antidotes|antidotes|mesh-ancestor
25148370|NCT05148195|Protective Agents|protective agents|mesh-ancestor
25148371|NCT05148195|Vitamin B Complex|vitamin b complex|mesh-ancestor
25148372|NCT05148195|Vitamins|vitamins|mesh-ancestor
25148373|NCT05148195|Micronutrients|micronutrients|mesh-ancestor
25048102|NCT00739349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048103|NCT00739349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048104|NCT00739349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25048105|NCT00739349|Immunologic Factors|immunologic factors|mesh-ancestor
25048106|NCT00739349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048107|NCT00739349|Antifungal Agents|antifungal agents|mesh-ancestor
25048108|NCT00739349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25048109|NCT00739349|Dermatologic Agents|dermatologic agents|mesh-ancestor
25048110|NCT00739349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25048111|NCT00739349|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24495245|NCT00499018|Doxorubicin|doxorubicin|mesh-list
24495246|NCT00499018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25048118|NCT00738387|Docetaxel|docetaxel|mesh-list
25048119|NCT00738387|Vadimezan|vadimezan|mesh-list
25048120|NCT00738387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048121|NCT00738387|Tubulin Modulators|tubulin modulators|mesh-ancestor
25048122|NCT00738387|Antimitotic Agents|antimitotic agents|mesh-ancestor
25048123|NCT00738387|Mitosis Modulators|mitosis modulators|mesh-ancestor
25048124|NCT00738387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048125|NCT00734461|Naltrexone|naltrexone|mesh-list
25048126|NCT00734461|Oxycodone|oxycodone|mesh-list
25048127|NCT00734461|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25048128|NCT00734461|Narcotics|narcotics|mesh-ancestor
25048129|NCT00734461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25048130|NCT00734461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048131|NCT00734461|Analgesics|analgesics|mesh-ancestor
25048132|NCT00734461|Sensory System Agents|sensory system agents|mesh-ancestor
25048134|NCT00734461|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25048147|NCT00734435|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25048148|NCT00734435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25048149|NCT00734435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25048150|NCT00734435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048151|NCT00734435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25048160|NCT00734292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25048162|NCT00734292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25048166|NCT00734292|Dermatologic Agents|dermatologic agents|mesh-ancestor
25048167|NCT00734292|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25048168|NCT00734292|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25048169|NCT00734292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25048170|NCT00734292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25148432|NCT05123040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25148433|NCT05123040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148434|NCT05123040|Antiemetics|antiemetics|mesh-ancestor
25148435|NCT05123040|Autonomic Agents|autonomic agents|mesh-ancestor
25148436|NCT05123040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25148440|NCT05117736|Valsartan|valsartan|mesh-list
25148454|NCT05105061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148455|NCT05105061|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25148456|NCT05105061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25148457|NCT05105061|Anesthetics, General|anesthetics, general|mesh-ancestor
25148458|NCT05105061|Anesthetics|anesthetics|mesh-ancestor
25148459|NCT05105061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25148460|NCT05105061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25148461|NCT05105061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25148462|NCT05105061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25148463|NCT05105061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148476|NCT05056584|Glucagon|glucagon|mesh-list
25148477|NCT05056584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25148478|NCT05056584|Hormones|hormones|mesh-ancestor
25148479|NCT05056584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25148480|NCT05056584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148487|NCT05046535|Nicotine|nicotine|mesh-list
25148505|NCT05011214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25148506|NCT05011214|Anesthetics, General|anesthetics, general|mesh-ancestor
25148507|NCT05011214|Anesthetics|anesthetics|mesh-ancestor
25148508|NCT05011214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25148509|NCT05011214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25119299|NCT02375295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25119301|NCT02375295|Antimalarials|antimalarials|mesh-ancestor
25119302|NCT02375295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25119303|NCT02375295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25119304|NCT02375295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25119305|NCT02375295|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25119306|NCT02375295|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25119320|NCT02263508|Pembrolizumab|pembrolizumab|mesh-list
25119321|NCT02263508|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25119322|NCT02263508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25119323|NCT02263508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119324|NCT02124187|Nicotine|nicotine|mesh-list
25119326|NCT02124187|Autonomic Agents|autonomic agents|mesh-ancestor
25148510|NCT05011214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25148511|NCT05011214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25148512|NCT05011214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148513|NCT05011214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25148514|NCT05011214|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25148515|NCT05011214|Antidepressive Agents|antidepressive agents|mesh-ancestor
25148516|NCT05011214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25148517|NCT04980040|Alogliptin|alogliptin|mesh-list
25148518|NCT04980040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25148519|NCT04980040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148520|NCT04980040|Incretins|incretins|mesh-ancestor
25148521|NCT04980040|Hormones|hormones|mesh-ancestor
25148522|NCT04980040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25148523|NCT04980040|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25148524|NCT04980040|Protease Inhibitors|protease inhibitors|mesh-ancestor
25148525|NCT04980040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25148526|NCT04980040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148527|NCT04965155|Dexamethasone|dexamethasone|mesh-list
25148528|NCT04965155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25148529|NCT04965155|Antiemetics|antiemetics|mesh-ancestor
25148530|NCT04965155|Autonomic Agents|autonomic agents|mesh-ancestor
25148531|NCT04965155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25148556|NCT04932083|Anesthetics, Local|anesthetics, local|mesh-ancestor
25148557|NCT04932083|Anesthetics|anesthetics|mesh-ancestor
25148558|NCT04932083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25148559|NCT04932083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148560|NCT04932083|Sensory System Agents|sensory system agents|mesh-ancestor
25148561|NCT04932083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25148562|NCT04932083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25148563|NCT04932083|Narcotics|narcotics|mesh-ancestor
25148564|NCT04932083|Analgesics|analgesics|mesh-ancestor
25148565|NCT04932083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25148567|NCT04932083|Anesthetics, General|anesthetics, general|mesh-ancestor
25148621|NCT04858490|Anticonvulsants|anticonvulsants|mesh-ancestor
25148622|NCT04858490|Antiemetics|antiemetics|mesh-ancestor
25148623|NCT04858490|Autonomic Agents|autonomic agents|mesh-ancestor
25148624|NCT04858490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25148625|NCT04858490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148626|NCT04858490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25148627|NCT04858490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25148628|NCT04858490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25148629|NCT04858490|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25148630|NCT04858490|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25148631|NCT04858490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25148632|NCT04858490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25148633|NCT04858490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25148634|NCT04858490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25148635|NCT04858490|Anesthetics, General|anesthetics, general|mesh-ancestor
25148636|NCT04858490|Anesthetics|anesthetics|mesh-ancestor
25148637|NCT04858490|GABA Modulators|gaba modulators|mesh-ancestor
25685000|NCT01900431|Abortifacient Agents|abortifacient agents|mesh-ancestor
25685001|NCT01900431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25685002|NCT01900431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25685003|NCT01900431|Antimetabolites|antimetabolites|mesh-ancestor
25685004|NCT01900431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685005|NCT01900431|Dermatologic Agents|dermatologic agents|mesh-ancestor
25685006|NCT01900431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25685007|NCT01900431|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25685008|NCT01900431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25685009|NCT01900431|Immunologic Factors|immunologic factors|mesh-ancestor
25685010|NCT01900431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25685011|NCT01900431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25119339|NCT02096354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290949|NCT02632396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290950|NCT02632396|Protease Inhibitors|protease inhibitors|mesh-ancestor
25290951|NCT02632396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25290952|NCT02595060|Molgramostim|molgramostim|mesh-list
25290953|NCT02595060|Sargramostim|sargramostim|mesh-list
25290954|NCT02595060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290955|NCT02595060|Immunologic Factors|immunologic factors|mesh-ancestor
25290956|NCT02595060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290957|NCT02404155|Clozapine|clozapine|mesh-list
25290958|NCT02404155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25290959|NCT02404155|Serotonin Agents|serotonin agents|mesh-ancestor
25290960|NCT02404155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25290961|NCT02404155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290962|NCT02404155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290963|NCT02404155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25290964|NCT02404155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25290965|NCT02404155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25290966|NCT02404155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25290967|NCT02404155|GABA Antagonists|gaba antagonists|mesh-ancestor
25290968|NCT02404155|GABA Agents|gaba agents|mesh-ancestor
25290969|NCT05101005|Sirolimus|sirolimus|mesh-list
25290970|NCT05101005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25290971|NCT05101005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25290978|NCT05100719|Mebeverine|mebeverine|mesh-list
25148638|NCT04858490|GABA Agents|gaba agents|mesh-ancestor
25148639|NCT04858490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25148640|NCT04858490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148648|NCT04844957|Vitamin D|vitamin d|mesh-list
25048180|NCT00730665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25048181|NCT00730665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25048182|NCT00730665|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25048183|NCT00730665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048184|NCT00730665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048185|NCT00728351|Metformin|metformin|mesh-list
25048186|NCT00728351|Vildagliptin|vildagliptin|mesh-list
25048187|NCT00728351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25048188|NCT00728351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048189|NCT00728351|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25048190|NCT00728351|Protease Inhibitors|protease inhibitors|mesh-ancestor
25048191|NCT00728351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048192|NCT00728351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048193|NCT00728091|Satavaptan|satavaptan|mesh-list
25148822|NCT04567160|Anesthetics|anesthetics|mesh-ancestor
25048194|NCT00728091|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25048195|NCT00728091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048196|NCT00728091|Natriuretic Agents|natriuretic agents|mesh-ancestor
25048197|NCT00728091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048198|NCT00726336|Tenofovir|tenofovir|mesh-list
25048199|NCT00726336|Dolutegravir|dolutegravir|mesh-list
25685012|NCT01900431|Antidotes|antidotes|mesh-ancestor
25685013|NCT01900431|Protective Agents|protective agents|mesh-ancestor
25685014|NCT01900431|Vitamin B Complex|vitamin b complex|mesh-ancestor
25685015|NCT01900431|Vitamins|vitamins|mesh-ancestor
25685016|NCT01900431|Micronutrients|micronutrients|mesh-ancestor
25685017|NCT01900431|Hematinics|hematinics|mesh-ancestor
25685018|NCT01900652|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25685019|NCT01900652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25685020|NCT01900652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25685021|NCT01900652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25685022|NCT01900652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685023|NCT01901146|Paclitaxel|paclitaxel|mesh-list
25685024|NCT01901146|Trastuzumab|trastuzumab|mesh-list
25685025|NCT01901146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25685026|NCT01901146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25685027|NCT01901146|Tubulin Modulators|tubulin modulators|mesh-ancestor
25685028|NCT01901146|Antimitotic Agents|antimitotic agents|mesh-ancestor
25685029|NCT01901146|Mitosis Modulators|mitosis modulators|mesh-ancestor
25685030|NCT01901146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685031|NCT01901146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25685032|NCT01901185|Etanercept|etanercept|mesh-list
25685033|NCT01901185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25685034|NCT01901185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25685035|NCT01901185|Analgesics|analgesics|mesh-ancestor
25685036|NCT01901185|Sensory System Agents|sensory system agents|mesh-ancestor
25048200|NCT00726336|Antiviral Agents|antiviral agents|mesh-ancestor
25048229|NCT00724698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048230|NCT00724698|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25048231|NCT00724698|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25048232|NCT00724698|Histamine Antagonists|histamine antagonists|mesh-ancestor
25048233|NCT00724698|Histamine Agents|histamine agents|mesh-ancestor
25048235|NCT00722917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25048236|NCT00722917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048237|NCT00722592|Doxorubicin|doxorubicin|mesh-list
25148662|NCT04823845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148679|NCT04758975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148680|NCT04758975|Immunologic Factors|immunologic factors|mesh-ancestor
25148681|NCT04758975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148682|NCT04758975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25148709|NCT04669210|Mycophenolic Acid|mycophenolic acid|mesh-list
25148710|NCT04669210|Tacrolimus|tacrolimus|mesh-list
25148711|NCT04669210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25148712|NCT04669210|Immunologic Factors|immunologic factors|mesh-ancestor
25148713|NCT04669210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148714|NCT04669210|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25148715|NCT04669210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25148716|NCT04669210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148717|NCT04669210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25148718|NCT04669210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148719|NCT04669210|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25148720|NCT04669210|Antitubercular Agents|antitubercular agents|mesh-ancestor
25148721|NCT04669210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25148722|NCT04669210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25148749|NCT04640779|Lipotropic Agents|lipotropic agents|mesh-ancestor
25148750|NCT04640779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25148751|NCT04640779|Antimetabolites|antimetabolites|mesh-ancestor
25148752|NCT04640779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148753|NCT04640779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25148754|NCT04640779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25148755|NCT04640779|Nootropic Agents|nootropic agents|mesh-ancestor
25148756|NCT04640779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25148757|NCT04640779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25148758|NCT04640779|Analgesics|analgesics|mesh-ancestor
25148759|NCT04640779|Sensory System Agents|sensory system agents|mesh-ancestor
25148760|NCT04640779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25148761|NCT04640779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148762|NCT04640779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25148763|NCT04640779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25148764|NCT04640779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25148765|NCT04640779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25148767|NCT04630964|Psilocybin|psilocybin|mesh-list
25148768|NCT04630964|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25148769|NCT04630964|Antimetabolites|antimetabolites|mesh-ancestor
25148770|NCT04630964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148771|NCT04630964|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25148800|NCT04607252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25148801|NCT04607252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25148802|NCT04607252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25148803|NCT04607252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25148804|NCT04607252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148805|NCT04607252|Appetite Stimulants|appetite stimulants|mesh-ancestor
25148810|NCT04573556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148812|NCT04573556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25148813|NCT04573556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25148814|NCT04573556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148816|NCT04567160|Sevoflurane|sevoflurane|mesh-list
25148817|NCT04567160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25148818|NCT04567160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25148819|NCT04567160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148820|NCT04567160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25148821|NCT04567160|Anesthetics, General|anesthetics, general|mesh-ancestor
25148823|NCT04567160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25148824|NCT04567160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25148825|NCT04566250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
25148826|NCT04566250|Analgesics|analgesics|mesh-ancestor
25148827|NCT04566250|Sensory System Agents|sensory system agents|mesh-ancestor
25148828|NCT04566250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25148829|NCT04566250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148845|NCT04545866|Respiratory System Agents|respiratory system agents|mesh-ancestor
25148846|NCT04545866|Glucocorticoids|glucocorticoids|mesh-ancestor
25148847|NCT04545866|Hormones|hormones|mesh-ancestor
25148848|NCT04545866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25148849|NCT04543994|Remestemcel-l|remestemcel-l|mesh-list
25148850|NCT04543994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25148851|NCT04543994|Antiviral Agents|antiviral agents|mesh-ancestor
25148852|NCT04543994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25148853|NCT04541355|Sodium thiosulfate|sodium thiosulfate|mesh-list
25148854|NCT04541355|Cisplatin|cisplatin|mesh-list
25148855|NCT04541355|Antidotes|antidotes|mesh-list
25148856|NCT04541355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148857|NCT04541355|Protective Agents|protective agents|mesh-ancestor
25148858|NCT04541355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148859|NCT04541355|Antioxidants|antioxidants|mesh-ancestor
25148860|NCT04541355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148861|NCT04541355|Antitubercular Agents|antitubercular agents|mesh-ancestor
25148862|NCT04541355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25148863|NCT04541355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25148864|NCT04541355|Chelating Agents|chelating agents|mesh-ancestor
25148865|NCT04541355|Sequestering Agents|sequestering agents|mesh-ancestor
25148866|NCT04531059|Metronidazole|metronidazole|mesh-list
25148867|NCT04531059|Minocycline|minocycline|mesh-list
25148868|NCT04531059|Tetracycline|tetracycline|mesh-list
25148869|NCT04531059|Potassium Citrate|potassium citrate|mesh-list
25148870|NCT04531059|Esomeprazole|esomeprazole|mesh-list
25148871|NCT04531059|Bismuth|bismuth|mesh-list
25148872|NCT04531059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148873|NCT04531059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25148874|NCT04531059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25148892|NCT04460560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25148893|NCT04460560|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25148895|NCT04414475|Bortezomib|bortezomib|mesh-list
25148896|NCT04414475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25148897|NCT04414475|Antiemetics|antiemetics|mesh-ancestor
25148898|NCT04414475|Autonomic Agents|autonomic agents|mesh-ancestor
25148899|NCT04414475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25148900|NCT04414475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148901|NCT04414475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25148902|NCT04414475|Glucocorticoids|glucocorticoids|mesh-ancestor
25148903|NCT04414475|Hormones|hormones|mesh-ancestor
25148904|NCT04414475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25148905|NCT04414475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25148906|NCT04414475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148912|NCT04390698|Analgesics, Opioid|analgesics, opioid|mesh-list
25148913|NCT04390698|Anesthetics|anesthetics|mesh-list
25148914|NCT04390698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25148937|NCT04356326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25148938|NCT04356326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25148939|NCT04356326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148940|NCT04356326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25148941|NCT04356326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25148942|NCT04356326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25148944|NCT04322123|Azithromycin|azithromycin|mesh-list
25148945|NCT04322123|Hydroxychloroquine|hydroxychloroquine|mesh-list
25148946|NCT04322123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25148947|NCT04322123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25148948|NCT04322123|Antimalarials|antimalarials|mesh-ancestor
25148949|NCT04322123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25148950|NCT04322123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25148951|NCT04322123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25148952|NCT04322123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148953|NCT04322123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25148954|NCT04299880|Leucovorin|leucovorin|mesh-list
25148955|NCT04299880|Gemcitabine|gemcitabine|mesh-list
25148956|NCT04299880|Paclitaxel|paclitaxel|mesh-list
25148957|NCT04299880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25148958|NCT04299880|Bevacizumab|bevacizumab|mesh-list
25148959|NCT04299880|Fluorouracil|fluorouracil|mesh-list
25148960|NCT04299880|Nivolumab|nivolumab|mesh-list
25148989|NCT04273139|Venetoclax|venetoclax|mesh-list
25148990|NCT04273139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148991|NCT04268706|Fludarabine|fludarabine|mesh-list
25148992|NCT04268706|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25148993|NCT04268706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25685037|NCT01901185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25291039|NCT05100186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25291040|NCT05100186|Antiemetics|antiemetics|mesh-ancestor
25291041|NCT05100186|Autonomic Agents|autonomic agents|mesh-ancestor
25291042|NCT05100186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25291043|NCT05100186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291044|NCT05100186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25291045|NCT05100186|Glucocorticoids|glucocorticoids|mesh-ancestor
25291046|NCT05100186|Hormones|hormones|mesh-ancestor
25291049|NCT05100186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148994|NCT04268706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148995|NCT04268706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25148996|NCT04268706|Alkylating Agents|alkylating agents|mesh-ancestor
25148997|NCT04259138|Vedolizumab|vedolizumab|mesh-list
25148998|NCT04259138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25149007|NCT04244630|Antioxidants|antioxidants|mesh-list
25149008|NCT04244630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149009|NCT04244630|Protective Agents|protective agents|mesh-ancestor
25149010|NCT04244630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149021|NCT04243616|Paclitaxel|paclitaxel|mesh-list
24557976|NCT00755053|Miconazole|miconazole|mesh-list
24884822|NCT03459859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24884823|NCT03459859|Immunologic Factors|immunologic factors|mesh-ancestor
24472957|NCT00401219|Hormones|hormones|mesh-ancestor
24884824|NCT03459859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884825|NCT03459859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24884826|NCT03401710|Epoetin Alfa|epoetin alfa|mesh-list
24884827|NCT03401710|Hematinics|hematinics|mesh-ancestor
25149022|NCT04243616|Cyclophosphamide|cyclophosphamide|mesh-list
25048238|NCT00722592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25048239|NCT00722592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25048240|NCT00722592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048241|NCT00722592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25149186|NCT03777904|Trace Elements|trace elements|mesh-ancestor
25048250|NCT00721760|Semuloparin|semuloparin|mesh-list
25048251|NCT00721760|Enoxaparin sodium|enoxaparin sodium|mesh-list
25048252|NCT00721760|Anticoagulants|anticoagulants|mesh-ancestor
25048253|NCT00721760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25048254|NCT00721760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25048255|NCT00721760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048256|NCT00721695|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25048257|NCT00721695|Mydriatics|mydriatics|mesh-list
25149024|NCT04243616|Doxorubicin|doxorubicin|mesh-list
25149025|NCT04243616|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25149026|NCT04243616|Cemiplimab|cemiplimab|mesh-list
25149027|NCT04243616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25149028|NCT04243616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25149029|NCT04243616|Tubulin Modulators|tubulin modulators|mesh-ancestor
25149051|NCT04239053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25149052|NCT04237623|Sargramostim|sargramostim|mesh-list
25149053|NCT04237623|Immunologic Factors|immunologic factors|mesh-ancestor
25149054|NCT04237623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149055|NCT04235036|Rituximab|rituximab|mesh-list
25149056|NCT04235036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25149057|NCT04235036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25149058|NCT04235036|Immunologic Factors|immunologic factors|mesh-ancestor
25149059|NCT04235036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149060|NCT04235036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25149123|NCT04000009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25149124|NCT04000009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149125|NCT04000009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25149126|NCT04000009|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25149127|NCT04000009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25149128|NCT04000009|Serotonin Agents|serotonin agents|mesh-ancestor
25149129|NCT04000009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25149130|NCT04000009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149136|NCT03984565|Cannabidiol|cannabidiol|mesh-list
25149137|NCT03984565|Anticonvulsants|anticonvulsants|mesh-ancestor
25685038|NCT01901185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685039|NCT01901185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25685040|NCT01901185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25685041|NCT01901185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25685042|NCT01901185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25685043|NCT01901185|Immunologic Factors|immunologic factors|mesh-ancestor
25685044|NCT01901250|Fluorides|fluorides|mesh-list
25685045|NCT01901250|Fluorides, Topical|fluorides, topical|mesh-list
25685046|NCT01901250|Cariostatic Agents|cariostatic agents|mesh-ancestor
24710148|NCT01508611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291077|NCT05099848|Vitamin B Complex|vitamin b complex|mesh-ancestor
25291078|NCT05099848|Vitamins|vitamins|mesh-ancestor
25291079|NCT05099848|Micronutrients|micronutrients|mesh-ancestor
25291080|NCT05099848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25291081|NCT05099848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291082|NCT05099718|Hyaluronic Acid|hyaluronic acid|mesh-list
25291083|NCT05099718|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25291084|NCT05099718|Immunologic Factors|immunologic factors|mesh-ancestor
25291085|NCT05099718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291086|NCT05099718|Viscosupplements|viscosupplements|mesh-ancestor
25149138|NCT03974139|Metformin|metformin|mesh-list
25149139|NCT03974139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25149140|NCT03974139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149141|NCT03936998|Vancomycin|vancomycin|mesh-list
25149142|NCT03936998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25149143|NCT03936998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25149144|NCT03910998|Rocuronium|rocuronium|mesh-list
25149173|NCT03782740|Melatonin|melatonin|mesh-list
25149174|NCT03782740|Antioxidants|antioxidants|mesh-ancestor
25149175|NCT03782740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149176|NCT03782740|Protective Agents|protective agents|mesh-ancestor
25149177|NCT03782740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149178|NCT03782740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25149179|NCT03778424|Rufinamide|rufinamide|mesh-list
25149180|NCT03778424|Anticonvulsants|anticonvulsants|mesh-ancestor
25149181|NCT03778424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25149182|NCT03778424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25149183|NCT03778424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25149184|NCT03778424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149185|NCT03777904|Iron|iron|mesh-list
25149191|NCT03766581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25149192|NCT03766581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25149193|NCT03766581|Analgesics|analgesics|mesh-ancestor
25149226|NCT03719092|Vitamin A|vitamin a|mesh-list
25149227|NCT03719092|Retinol palmitate|retinol palmitate|mesh-list
25149228|NCT03719092|Micronutrients|micronutrients|mesh-ancestor
25149229|NCT03719092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149230|NCT03719092|Antioxidants|antioxidants|mesh-ancestor
25149231|NCT03719092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149232|NCT03719092|Protective Agents|protective agents|mesh-ancestor
25149233|NCT03719092|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25149234|NCT03719092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048258|NCT00721695|Autonomic Agents|autonomic agents|mesh-ancestor
25048259|NCT00721695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25048260|NCT00721695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048261|NCT00719550|Capecitabine|capecitabine|mesh-list
25048262|NCT00719550|Epirubicin|epirubicin|mesh-list
25048263|NCT00719550|Rilotumumab|rilotumumab|mesh-list
25048264|NCT00719550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048265|NCT00719550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25048266|NCT00719550|Antimetabolites|antimetabolites|mesh-ancestor
25048267|NCT00719550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048268|NCT00719550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25048269|NCT00719550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25048270|NCT00719550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25048271|NCT00719550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048272|NCT00719550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25048273|NCT00718224|Enoxaparin|enoxaparin|mesh-list
25048274|NCT00718224|Semuloparin|semuloparin|mesh-list
25048275|NCT00718224|Anticoagulants|anticoagulants|mesh-ancestor
25048276|NCT00718224|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25048277|NCT00718224|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25048278|NCT00718224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048279|NCT00717457|Exenatide|exenatide|mesh-list
25685047|NCT01901250|Protective Agents|protective agents|mesh-ancestor
25685048|NCT01901250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685049|NCT01901393|Ibuprofen|ibuprofen|mesh-list
25685050|NCT01901393|Ketorolac|ketorolac|mesh-list
25685051|NCT01901393|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25685052|NCT01901393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25685053|NCT01901393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25685054|NCT01901393|Analgesics|analgesics|mesh-ancestor
25685055|NCT01901393|Sensory System Agents|sensory system agents|mesh-ancestor
25685056|NCT01901393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25685057|NCT01901393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149246|NCT03694262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291115|NCT05099198|Immunologic Factors|immunologic factors|mesh-ancestor
25291116|NCT05099081|Ethanolamine oleate|ethanolamine oleate|mesh-list
25149247|NCT03694262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149249|NCT03686150|Cholecalciferol|cholecalciferol|mesh-list
25149250|NCT03686150|Vitamins|vitamins|mesh-ancestor
25149251|NCT03686150|Micronutrients|micronutrients|mesh-ancestor
25149252|NCT03686150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149253|NCT03686150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24496653|NCT00505817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25149254|NCT03686150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25149255|NCT03685253|Niacinamide|niacinamide|mesh-list
25149256|NCT03685253|Vitamin B Complex|vitamin b complex|mesh-ancestor
25149257|NCT03685253|Vitamins|vitamins|mesh-ancestor
25149258|NCT03685253|Micronutrients|micronutrients|mesh-ancestor
25149259|NCT03685253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149264|NCT03669367|Abatacept|abatacept|mesh-list
25149265|NCT03669367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25149266|NCT03669367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149267|NCT03669367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25149268|NCT03669367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25149269|NCT03669367|Immunologic Factors|immunologic factors|mesh-ancestor
25149270|NCT03669367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149271|NCT03669367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25149272|NCT03640754|Lenograstim|lenograstim|mesh-list
25149273|NCT03640754|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25149274|NCT03640754|Immunologic Factors|immunologic factors|mesh-ancestor
25149293|NCT03165721|Azacitidine|azacitidine|mesh-list
25149294|NCT03165721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25149295|NCT03165721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25149296|NCT03165721|Antimetabolites|antimetabolites|mesh-ancestor
25149297|NCT03165721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149298|NCT03165721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25149299|NCT03138733|Daptomycin|daptomycin|mesh-list
25149300|NCT03138733|Ceftobiprole|ceftobiprole|mesh-list
25149301|NCT03138733|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
25149302|NCT03138733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25149343|NCT02842866|Immunologic Factors|immunologic factors|mesh-ancestor
25149345|NCT02842853|Vaccines|vaccines|mesh-list
25149357|NCT02834559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25149358|NCT02834559|Immunologic Factors|immunologic factors|mesh-ancestor
25149359|NCT02834559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149360|NCT02834559|Anticoagulants|anticoagulants|mesh-ancestor
25149361|NCT02834559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25149362|NCT02834559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25149363|NCT02828592|Cyclophosphamide|cyclophosphamide|mesh-list
25149364|NCT02828592|Fludarabine|fludarabine|mesh-list
25149365|NCT02828592|Thymoglobulin|thymoglobulin|mesh-list
25149366|NCT02828592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25149367|NCT02828592|Immunologic Factors|immunologic factors|mesh-ancestor
25149368|NCT02828592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149369|NCT02828592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25149370|NCT02828592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25149371|NCT02828592|Alkylating Agents|alkylating agents|mesh-ancestor
25149372|NCT02828592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149373|NCT02828592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019300|NCT03692026|Protective Agents|protective agents|mesh-ancestor
25149374|NCT02828592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25149375|NCT02817451|Vaccines|vaccines|mesh-list
25149376|NCT02817451|Immunologic Factors|immunologic factors|mesh-ancestor
25149377|NCT02817451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149405|NCT05467709|Midazolam|midazolam|mesh-list
25149406|NCT05467709|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25149407|NCT05467709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25149408|NCT05467709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25149409|NCT05467709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149410|NCT05467709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25149411|NCT05467709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25149412|NCT05467709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25149413|NCT05467709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25149414|NCT05467709|Anesthetics, General|anesthetics, general|mesh-ancestor
25149415|NCT05467709|Anesthetics|anesthetics|mesh-ancestor
25149416|NCT05467709|GABA Modulators|gaba modulators|mesh-ancestor
25149417|NCT05467709|GABA Agents|gaba agents|mesh-ancestor
25149418|NCT05467709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25149419|NCT05467709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149420|NCT05467670|Doxorubicin|doxorubicin|mesh-list
25685058|NCT01901393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25291159|NCT05087615|Metoclopramide|metoclopramide|mesh-list
25291160|NCT05087615|Granisetron|granisetron|mesh-list
25291161|NCT05087615|Antiemetics|antiemetics|mesh-ancestor
25291162|NCT05087615|Autonomic Agents|autonomic agents|mesh-ancestor
25291163|NCT05087615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25291164|NCT05087615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291165|NCT05087615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25291166|NCT05087615|Antipruritics|antipruritics|mesh-ancestor
25149421|NCT05467670|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25149422|NCT05467670|Pembrolizumab|pembrolizumab|mesh-list
25149423|NCT05467670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25149424|NCT05467670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25149425|NCT05467670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24508697|NCT00556413|Micronutrients|micronutrients|mesh-ancestor
24508698|NCT00556413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24508699|NCT00556465|Acetylcysteine|acetylcysteine|mesh-list
24508700|NCT00556465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25149435|NCT05467553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25149436|NCT05467553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25149437|NCT05467553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149438|NCT05467553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25149439|NCT05467553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25149440|NCT05467553|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25149441|NCT05467553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25149442|NCT05467514|Liraglutide|liraglutide|mesh-list
25149443|NCT05467514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25149444|NCT05467514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149445|NCT05467514|Incretins|incretins|mesh-ancestor
25149446|NCT05467514|Hormones|hormones|mesh-ancestor
25149447|NCT05467514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25149465|NCT05467436|Analgesics|analgesics|mesh-list
25149466|NCT05467436|Anesthetics|anesthetics|mesh-list
25149467|NCT05467436|Anesthetics, Local|anesthetics, local|mesh-list
25149468|NCT05467436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25149470|NCT05467436|Sensory System Agents|sensory system agents|mesh-ancestor
25149476|NCT05467384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149477|NCT05467384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25149478|NCT05467384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149479|NCT05467384|Vasodilator Agents|vasodilator agents|mesh-ancestor
25149480|NCT05467319|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25149481|NCT05467319|Hematinics|hematinics|mesh-ancestor
25149482|NCT05467293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25149483|NCT05467293|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25149485|NCT05467189|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25149486|NCT05467189|Busulfan|busulfan|mesh-list
25149487|NCT05467189|Lapatinib|lapatinib|mesh-list
25149488|NCT05467189|Afatinib|afatinib|mesh-list
25149489|NCT05467189|Crizotinib|crizotinib|mesh-list
25149490|NCT05467189|Ceritinib|ceritinib|mesh-list
25149491|NCT05467189|Antineoplastic Agents|antineoplastic agents|mesh-list
25149492|NCT05467189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25149493|NCT05467189|Tubulin Modulators|tubulin modulators|mesh-ancestor
25149494|NCT05467189|Antimitotic Agents|antimitotic agents|mesh-ancestor
25149495|NCT05467189|Mitosis Modulators|mitosis modulators|mesh-ancestor
25149496|NCT05467189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149497|NCT05467189|Alkylating Agents|alkylating agents|mesh-ancestor
24497017|NCT00507832|Pimecrolimus|pimecrolimus|mesh-list
25048307|NCT00713518|Growth Inhibitors|growth inhibitors|mesh-ancestor
25048308|NCT00713518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048310|NCT00713401|Tecadenoson|tecadenoson|mesh-list
25685059|NCT01901393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25685060|NCT01901393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25685061|NCT01901393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25685062|NCT01901393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685063|NCT01901419|Nitroglycerin|nitroglycerin|mesh-list
25685064|NCT01901419|Vasodilator Agents|vasodilator agents|mesh-ancestor
25685065|NCT01901575|Remifentanil|remifentanil|mesh-list
25685066|NCT01901575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25048311|NCT00713401|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25048312|NCT00713401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25048313|NCT00713401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25685067|NCT01901575|Narcotics|narcotics|mesh-ancestor
25685068|NCT01901575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25048316|NCT00713401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048317|NCT00713401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048318|NCT00713401|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25048319|NCT00713401|Purinergic Agonists|purinergic agonists|mesh-ancestor
25048320|NCT00713401|Purinergic Agents|purinergic agents|mesh-ancestor
25048322|NCT00712699|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25048323|NCT00712699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149547|NCT05466708|Dexmedetomidine|dexmedetomidine|mesh-list
25149548|NCT05466708|Ketamine|ketamine|mesh-list
25149549|NCT05466708|Esketamine|esketamine|mesh-list
25149550|NCT05466708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25149551|NCT05466708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25149552|NCT05466708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149553|NCT05466708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25149554|NCT05466708|Analgesics|analgesics|mesh-ancestor
25149555|NCT05466708|Sensory System Agents|sensory system agents|mesh-ancestor
24627242|NCT01091376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080445|NCT03338426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25080446|NCT03338426|Antimetabolites|antimetabolites|mesh-ancestor
25080447|NCT03338426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080448|NCT03338426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25149556|NCT05466708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25149557|NCT05466708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25149558|NCT05466708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25149559|NCT05466708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25149672|NCT05466279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25149673|NCT05466279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149674|NCT05466149|Aflutinib|aflutinib|mesh-list
25149675|NCT05466149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25149676|NCT05466149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25149677|NCT05466149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149681|NCT05466019|Leucovorin|leucovorin|mesh-list
25149682|NCT05466019|Docetaxel|docetaxel|mesh-list
25149683|NCT05466019|Oxaliplatin|oxaliplatin|mesh-list
25149684|NCT05466019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25149685|NCT05466019|Tubulin Modulators|tubulin modulators|mesh-ancestor
25149686|NCT05466019|Antimitotic Agents|antimitotic agents|mesh-ancestor
25149687|NCT05466019|Mitosis Modulators|mitosis modulators|mesh-ancestor
25149688|NCT05466019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149689|NCT05466019|Antidotes|antidotes|mesh-ancestor
25149690|NCT05466019|Protective Agents|protective agents|mesh-ancestor
25149704|NCT05465902|Vaccines|vaccines|mesh-list
25149705|NCT05465902|Immunologic Factors|immunologic factors|mesh-ancestor
25149706|NCT05465902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149722|NCT05465733|Pemetrexed|pemetrexed|mesh-list
25149723|NCT05465733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25149724|NCT05465733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24997294|NCT05207644|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25149744|NCT05464654|Estrogens|estrogens|mesh-list
25149745|NCT05464654|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25149746|NCT05464654|Hormones|hormones|mesh-ancestor
25149747|NCT05464654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25149748|NCT05464654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048324|NCT00711555|Dexamethasone|dexamethasone|mesh-list
25048325|NCT00711555|Ondansetron|ondansetron|mesh-list
25048327|NCT00711555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25048328|NCT00711555|Antiemetics|antiemetics|mesh-ancestor
25048329|NCT00711555|Autonomic Agents|autonomic agents|mesh-ancestor
25019559|NCT03690414|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25048330|NCT00711555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24508704|NCT00556465|Respiratory System Agents|respiratory system agents|mesh-ancestor
25685069|NCT01901575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685070|NCT01901575|Analgesics|analgesics|mesh-ancestor
25685071|NCT01901575|Sensory System Agents|sensory system agents|mesh-ancestor
25291239|NCT04602117|Paclitaxel|paclitaxel|mesh-list
25291240|NCT04602117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25291241|NCT04602117|Trastuzumab|trastuzumab|mesh-list
25291242|NCT04602117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25291243|NCT04602117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291244|NCT04602117|Tubulin Modulators|tubulin modulators|mesh-ancestor
25291245|NCT04602117|Antimitotic Agents|antimitotic agents|mesh-ancestor
25291246|NCT04602117|Mitosis Modulators|mitosis modulators|mesh-ancestor
25291247|NCT04602117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291248|NCT04602117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25291249|NCT04540848|Bupivacaine|bupivacaine|mesh-list
24463916|NCT00362726|Antiviral Agents|antiviral agents|mesh-ancestor
24508750|NCT00556959|Analgesics|analgesics|mesh-ancestor
24508751|NCT00556959|Sensory System Agents|sensory system agents|mesh-ancestor
24508752|NCT00556959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24508753|NCT00556959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508765|NCT00557011|Adderall|adderall|mesh-list
24884863|NCT03339284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24884864|NCT03339284|Antiemetics|antiemetics|mesh-ancestor
24884865|NCT03339284|Autonomic Agents|autonomic agents|mesh-ancestor
24508792|NCT00557102|Immunologic Factors|immunologic factors|mesh-ancestor
24508793|NCT00557102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24508967|NCT00557921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24508968|NCT00557921|Purinergic Agents|purinergic agents|mesh-ancestor
25048331|NCT00711555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048332|NCT00711555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25048333|NCT00711555|Glucocorticoids|glucocorticoids|mesh-ancestor
25048334|NCT00711555|Hormones|hormones|mesh-ancestor
25048335|NCT00711555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25048336|NCT00711555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25048337|NCT00711555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048338|NCT00711555|Antipruritics|antipruritics|mesh-ancestor
25048339|NCT00711555|Dermatologic Agents|dermatologic agents|mesh-ancestor
25048340|NCT00711555|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25048341|NCT00711555|Serotonin Agents|serotonin agents|mesh-ancestor
25048342|NCT00711555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25048343|NCT00711555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048344|NCT00711555|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25048345|NCT00711555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25048346|NCT00711555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25048347|NCT00711555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25048348|NCT00711555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25048359|NCT00710580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24508969|NCT00557921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24508970|NCT00557921|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24508971|NCT00557921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24508972|NCT00557921|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24508973|NCT00557934|Dobutamine|dobutamine|mesh-list
24508974|NCT00557934|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24508975|NCT00557934|Sympathomimetics|sympathomimetics|mesh-ancestor
24508976|NCT00557934|Autonomic Agents|autonomic agents|mesh-ancestor
24508977|NCT00557934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24508978|NCT00557934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508979|NCT00557934|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24508980|NCT00557934|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24508981|NCT00557934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24508982|NCT00557934|Adrenergic Agents|adrenergic agents|mesh-ancestor
24508983|NCT00557934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25048360|NCT00710580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25048361|NCT00710580|Immunologic Factors|immunologic factors|mesh-ancestor
25048362|NCT00709904|Semuloparin|semuloparin|mesh-list
25685072|NCT01901575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25685073|NCT01901588|Dexmedetomidine|dexmedetomidine|mesh-list
25685074|NCT01901588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25685075|NCT01901588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25685076|NCT01901588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685077|NCT01901588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25685078|NCT01901588|Analgesics|analgesics|mesh-ancestor
25685079|NCT01901588|Sensory System Agents|sensory system agents|mesh-ancestor
25685080|NCT01901588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25685081|NCT01901588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25685082|NCT01901588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25685083|NCT01901588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25291280|NCT04517357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291281|NCT04517357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25291282|NCT04517357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291283|NCT04517357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119706|NCT05323175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25119707|NCT05323175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119708|NCT05323175|Sensory System Agents|sensory system agents|mesh-ancestor
25119709|NCT05323175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25119716|NCT05301517|Epoetin Alfa|epoetin alfa|mesh-list
25119717|NCT05301517|Hematinics|hematinics|mesh-ancestor
25119732|NCT05279963|Amitriptyline|amitriptyline|mesh-list
25119733|NCT05279963|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25291284|NCT04510584|Bevacizumab|bevacizumab|mesh-list
25291285|NCT04510584|Atezolizumab|atezolizumab|mesh-list
25291286|NCT04510584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25291287|NCT04510584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291288|NCT04510584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25291289|NCT04510584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25291290|NCT04510584|Growth Substances|growth substances|mesh-ancestor
25291291|NCT04510584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048363|NCT00709904|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25048364|NCT00709904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25048365|NCT00709904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25048366|NCT00709904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048367|NCT00709904|Anticoagulants|anticoagulants|mesh-ancestor
25048368|NCT00709865|1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine|1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine|mesh-list
25048369|NCT00709865|Adenosine A1 Receptor Antagonists|adenosine a1 receptor antagonists|mesh-ancestor
25048370|NCT00709865|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25048371|NCT00709865|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25048372|NCT00709865|Purinergic Agents|purinergic agents|mesh-ancestor
25149772|NCT05459792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149773|NCT05459792|Sensory System Agents|sensory system agents|mesh-ancestor
25149774|NCT05459792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25149775|NCT05459792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25149776|NCT05459792|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25149777|NCT05459792|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25149778|NCT05459792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25149779|NCT05459792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149821|NCT05442268|Acetaminophen|acetaminophen|mesh-list
25149822|NCT05442268|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25149823|NCT05442268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25149824|NCT05442268|Analgesics|analgesics|mesh-ancestor
25149825|NCT05442268|Sensory System Agents|sensory system agents|mesh-ancestor
25149826|NCT05442268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25149827|NCT05442268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25149828|NCT05442268|Antipyretics|antipyretics|mesh-ancestor
25048382|NCT00709371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25048383|NCT00709371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25048392|NCT00709371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25048393|NCT00709371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25048396|NCT00708292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25685084|NCT01901588|Adrenergic Agents|adrenergic agents|mesh-ancestor
25685085|NCT01901588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25685086|NCT01901588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685087|NCT01901614|Anesthetics|anesthetics|mesh-list
25685088|NCT01901614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25685089|NCT01901614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685090|NCT01901809|Dopamine|dopamine|mesh-list
25685091|NCT01901809|Furosemide|furosemide|mesh-list
25685092|NCT01901809|Diuretics|diuretics|mesh-ancestor
25685093|NCT01901809|Natriuretic Agents|natriuretic agents|mesh-ancestor
25685094|NCT01901809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685095|NCT01901809|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25685096|NCT01901809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25685097|NCT01901809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685098|NCT01901809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25685099|NCT01901809|Sympathomimetics|sympathomimetics|mesh-ancestor
25685100|NCT01901809|Autonomic Agents|autonomic agents|mesh-ancestor
25685101|NCT01901809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25685102|NCT01901809|Dopamine Agents|dopamine agents|mesh-ancestor
25685103|NCT01901809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25291325|NCT04272008|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25291326|NCT04272008|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25291327|NCT04176718|Dexamethasone|dexamethasone|mesh-list
24783849|NCT01904500|Cefazolin|cefazolin|mesh-list
25119770|NCT05258110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25119771|NCT05258110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119773|NCT05258110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25119774|NCT05258110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25048397|NCT00708292|Antiemetics|antiemetics|mesh-ancestor
25048398|NCT00708292|Autonomic Agents|autonomic agents|mesh-ancestor
25048399|NCT00708292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25048400|NCT00708292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048401|NCT00708292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25048402|NCT00708292|Glucocorticoids|glucocorticoids|mesh-ancestor
24497869|NCT00512291|Autonomic Agents|autonomic agents|mesh-ancestor
24497870|NCT00512291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24497872|NCT00512291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24497954|NCT00512811|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24497955|NCT00512811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24497956|NCT00512811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497957|NCT00512824|Calcium Carbonate|calcium carbonate|mesh-list
25048404|NCT00708292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24997262|NCT05227456|Etonogestrel|etonogestrel|mesh-list
24997263|NCT05227456|Desogestrel|desogestrel|mesh-list
24997264|NCT05227456|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24997265|NCT05227456|Contraceptive Agents|contraceptive agents|mesh-ancestor
24997266|NCT05227456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24997267|NCT05227456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997268|NCT05227456|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24997269|NCT05227456|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24997270|NCT05227456|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24997271|NCT05227456|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24997272|NCT05227456|Progestins|progestins|mesh-ancestor
24997273|NCT05227456|Hormones|hormones|mesh-ancestor
24997274|NCT05227456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24997275|NCT05213312|Paclitaxel|paclitaxel|mesh-list
24997276|NCT05213312|Fluorouracil|fluorouracil|mesh-list
24997282|NCT05213312|Mitosis Modulators|mitosis modulators|mesh-ancestor
24997283|NCT05213312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997284|NCT05213312|Antimetabolites|antimetabolites|mesh-ancestor
24997285|NCT05213312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24997286|NCT05213312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24997287|NCT05213312|Immunologic Factors|immunologic factors|mesh-ancestor
24997288|NCT05213312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997289|NCT05213312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24997290|NCT05213312|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24997291|NCT05207644|Letrozole|letrozole|mesh-list
24997292|NCT05207644|Misoprostol|misoprostol|mesh-list
24997293|NCT05207644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25150084|NCT05341167|Autonomic Agents|autonomic agents|mesh-ancestor
25150085|NCT05341167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25150086|NCT05341167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498316|NCT00513968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25150087|NCT05341167|Sympathomimetics|sympathomimetics|mesh-ancestor
25150088|NCT05341167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25150089|NCT05341167|Nasal Decongestants|nasal decongestants|mesh-ancestor
25150090|NCT05341167|Respiratory System Agents|respiratory system agents|mesh-ancestor
25150091|NCT05341167|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25150092|NCT05341167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25150093|NCT05341167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25150094|NCT05341167|Adrenergic Agents|adrenergic agents|mesh-ancestor
25150095|NCT05341167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25150096|NCT05341167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685104|NCT01901809|Protective Agents|protective agents|mesh-ancestor
25685105|NCT01901848|Bupropion|bupropion|mesh-list
25685106|NCT01901848|Nicotine|nicotine|mesh-list
25685107|NCT01901848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25685108|NCT01901848|Autonomic Agents|autonomic agents|mesh-ancestor
25685109|NCT01901848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25685110|NCT01901848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685111|NCT01901848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25119816|NCT05137262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25119818|NCT05137262|Durvalumab|durvalumab|mesh-list
24638915|NCT01159145|Omeprazole|omeprazole|mesh-list
25119819|NCT05137262|Abiraterone Acetate|abiraterone acetate|mesh-list
25119820|NCT05137262|Vinblastine|vinblastine|mesh-list
25119821|NCT05137262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119822|NCT05137262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25150097|NCT05341167|Protective Agents|protective agents|mesh-ancestor
25150099|NCT05324761|Gabapentin|gabapentin|mesh-list
25150100|NCT05324761|Analgesics|analgesics|mesh-ancestor
25150101|NCT05324761|Sensory System Agents|sensory system agents|mesh-ancestor
25150102|NCT05324761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25150103|NCT05324761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25150104|NCT05324761|Anticonvulsants|anticonvulsants|mesh-ancestor
25150105|NCT05324761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25150106|NCT05324761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25150107|NCT05324761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150108|NCT05324761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25150109|NCT05324761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25150110|NCT05324761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25150188|NCT05314569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25150189|NCT05314569|Adrenergic Agents|adrenergic agents|mesh-ancestor
25150190|NCT05314569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25150191|NCT05314569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150192|NCT05314569|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25150193|NCT05314569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25150194|NCT05314569|Anesthetics, General|anesthetics, general|mesh-ancestor
25150196|NCT05314569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25150197|NCT05314569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25150198|NCT05314569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25150200|NCT05314569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25150204|NCT05314569|GABA Modulators|gaba modulators|mesh-ancestor
25150234|NCT05311618|Pembrolizumab|pembrolizumab|mesh-list
25150235|NCT05311618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25150236|NCT05311618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25150248|NCT05308420|Morphine|morphine|mesh-list
25150249|NCT05308420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25150250|NCT05308420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25150251|NCT05308420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25150252|NCT05308420|Narcotics|narcotics|mesh-ancestor
25150253|NCT05308420|Analgesics|analgesics|mesh-ancestor
25150254|NCT05308420|Sensory System Agents|sensory system agents|mesh-ancestor
25150256|NCT05308030|Aspirin|aspirin|mesh-list
25150277|NCT05308030|Anticoagulants|anticoagulants|mesh-ancestor
25150278|NCT05306301|Ponatinib|ponatinib|mesh-list
25150279|NCT05306301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25150280|NCT05306301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25150281|NCT05306301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25150282|NCT05306301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509013|NCT00558077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24997317|NCT05192850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24997318|NCT05192850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935243|NCT04053491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24935244|NCT04053491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591966|NCT00919815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24591967|NCT00919815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24591968|NCT00919815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25150310|NCT05293600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24591969|NCT00919815|Glucocorticoids|glucocorticoids|mesh-ancestor
24591970|NCT00919815|Hormones|hormones|mesh-ancestor
24591971|NCT00919815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25080542|NCT03337581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25080555|NCT03337529|Vitamins|vitamins|mesh-ancestor
24509014|NCT00558077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24509015|NCT00558077|Fertility Agents|fertility agents|mesh-ancestor
24509016|NCT00558077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24509017|NCT00558077|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24591972|NCT00919815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25685112|NCT01901848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25685113|NCT01901848|Cholinergic Agents|cholinergic agents|mesh-ancestor
25685114|NCT01901848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25685115|NCT01901848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685116|NCT01901848|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25685117|NCT01901848|Antidepressive Agents|antidepressive agents|mesh-ancestor
25119876|NCT05080790|Sensory System Agents|sensory system agents|mesh-ancestor
25119877|NCT05080790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25119878|NCT05080790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119879|NCT05080790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25119900|NCT05059587|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25119901|NCT05059587|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25119902|NCT05059587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25119903|NCT05059587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119904|NCT05059587|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25150311|NCT05293600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25099985|NCT03186365|Antiviral Agents|antiviral agents|mesh-ancestor
25150386|NCT05280106|Sequestering Agents|sequestering agents|mesh-ancestor
25150387|NCT05280106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150402|NCT05272202|Propofol|propofol|mesh-list
25150403|NCT05272202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25150451|NCT05242081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25150452|NCT05242081|Narcotics|narcotics|mesh-ancestor
25150453|NCT05242081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25150457|NCT05240274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25150458|NCT05240274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25150460|NCT05238207|Cathartics|cathartics|mesh-ancestor
25150461|NCT05238207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25100060|NCT03185611|Antimetabolites|antimetabolites|mesh-ancestor
25150462|NCT05231980|Thioctic Acid|thioctic acid|mesh-list
25150463|NCT05231980|Pentoxifylline|pentoxifylline|mesh-list
25150464|NCT05231980|Clomiphene|clomiphene|mesh-list
25150465|NCT05231980|Enclomiphene|enclomiphene|mesh-list
25150466|NCT05231980|Zuclomiphene|zuclomiphene|mesh-list
25150467|NCT05231980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150468|NCT05231980|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25150469|NCT05231980|Hormone Antagonists|hormone antagonists|mesh-ancestor
25150470|NCT05231980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25150471|NCT05231980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25150472|NCT05231980|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25150473|NCT05231980|Fertility Agents|fertility agents|mesh-ancestor
25150474|NCT05231980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25150475|NCT05231980|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25150476|NCT05231980|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25150477|NCT05231980|Antioxidants|antioxidants|mesh-ancestor
25150478|NCT05231980|Protective Agents|protective agents|mesh-ancestor
25150479|NCT05231980|Vitamin B Complex|vitamin b complex|mesh-ancestor
25150480|NCT05231980|Vitamins|vitamins|mesh-ancestor
25150481|NCT05231980|Micronutrients|micronutrients|mesh-ancestor
25150482|NCT05231980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25150483|NCT05231980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25150484|NCT05231980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25150486|NCT05231980|Vasodilator Agents|vasodilator agents|mesh-ancestor
25150492|NCT05209035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25150493|NCT05209035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25150494|NCT05209035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25150495|NCT05209035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25150496|NCT05209035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25150497|NCT05209035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150498|NCT05209035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25150499|NCT05209035|Serotonin Agents|serotonin agents|mesh-ancestor
25150500|NCT05209035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25150501|NCT05209035|Antidepressive Agents|antidepressive agents|mesh-ancestor
25150502|NCT05201300|Propofol|propofol|mesh-list
25020218|NCT03682198|Phenylephrine|phenylephrine|mesh-list
25150503|NCT05201300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25150504|NCT05201300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25150505|NCT05201300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25150506|NCT05201300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25685118|NCT01901848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25685119|NCT01901848|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25685120|NCT01901848|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25685121|NCT01901848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25685122|NCT01901848|Dopamine Agents|dopamine agents|mesh-ancestor
25685123|NCT01901848|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25685124|NCT01901848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25685125|NCT01901848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692547|NCT02001181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119931|NCT05012254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25119932|NCT05012254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25119933|NCT05012254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25119934|NCT05012254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25119935|NCT05012254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25119937|NCT05011812|Midazolam|midazolam|mesh-list
25119938|NCT05011812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25119939|NCT05011812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25119940|NCT05011812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25119941|NCT05011812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119942|NCT05011812|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25119943|NCT05011812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25119944|NCT05011812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25119945|NCT05011812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25119946|NCT05011812|Anesthetics, General|anesthetics, general|mesh-ancestor
25119947|NCT05011812|Anesthetics|anesthetics|mesh-ancestor
25119948|NCT05011812|GABA Modulators|gaba modulators|mesh-ancestor
25119949|NCT05011812|GABA Agents|gaba agents|mesh-ancestor
25119950|NCT05011812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25119956|NCT05011812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25150507|NCT05201300|Anesthetics, General|anesthetics, general|mesh-ancestor
25150508|NCT05201300|Anesthetics|anesthetics|mesh-ancestor
25150509|NCT05191667|Paclitaxel|paclitaxel|mesh-list
25150510|NCT05191667|Carboplatin|carboplatin|mesh-list
25150511|NCT05191667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25150512|NCT05191667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25150513|NCT05191667|Tubulin Modulators|tubulin modulators|mesh-ancestor
25150514|NCT05191667|Antimitotic Agents|antimitotic agents|mesh-ancestor
25150515|NCT05191667|Mitosis Modulators|mitosis modulators|mesh-ancestor
25150516|NCT05191667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150517|NCT05188820|Cortisone|cortisone|mesh-list
25150518|NCT05188820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25150547|NCT05177146|Anesthetics|anesthetics|mesh-ancestor
25150548|NCT05177146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25150549|NCT05177146|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25150550|NCT05177146|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25150551|NCT05177146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25150552|NCT05177146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150553|NCT05171075|Dalteparin|dalteparin|mesh-list
25150554|NCT05171075|Tinzaparin|tinzaparin|mesh-list
25150555|NCT05171075|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25150556|NCT05171075|Anticoagulants|anticoagulants|mesh-ancestor
25150557|NCT05171075|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24591982|NCT00919880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591983|NCT00919919|Progesterone|progesterone|mesh-list
24591984|NCT00919919|Progestins|progestins|mesh-ancestor
24591985|NCT00919919|Hormones|hormones|mesh-ancestor
24591986|NCT00919919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24798224|NCT01961752|Triamcinolone|triamcinolone|mesh-list
24591987|NCT00919919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798225|NCT01961752|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24798226|NCT01961752|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25150609|NCT05152004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25150610|NCT05152004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25685126|NCT01902004|Memantine|memantine|mesh-list
25685127|NCT01902004|Citalopram|citalopram|mesh-list
25685128|NCT01902004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25685129|NCT01902004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25685130|NCT01902004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25685131|NCT01902004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685132|NCT01902004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25685133|NCT01902004|Serotonin Agents|serotonin agents|mesh-ancestor
25685134|NCT01902004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685135|NCT01902004|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25685136|NCT01902004|Antidepressive Agents|antidepressive agents|mesh-ancestor
25685137|NCT01902004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25685138|NCT01902004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25685139|NCT01902004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25685140|NCT01902004|Dopamine Agents|dopamine agents|mesh-ancestor
25685141|NCT01902004|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25685142|NCT01902004|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25685143|NCT01902134|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
25685144|NCT01902134|Tramadol|tramadol|mesh-list
25150611|NCT05152004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25119982|NCT04949113|Nivolumab|nivolumab|mesh-list
25119983|NCT04949113|Ipilimumab|ipilimumab|mesh-list
25119984|NCT04949113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25119985|NCT04949113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119986|NCT04949113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25119987|NCT04949113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710176|NCT01508845|Vitamin D|vitamin d|mesh-list
24710177|NCT01508845|Ergocalciferols|ergocalciferols|mesh-list
24496352|NCT00504413|Digoxin|digoxin|mesh-list
24710232|NCT01509131|Bisacodyl|bisacodyl|mesh-list
24710233|NCT01509131|Cathartics|cathartics|mesh-ancestor
24710234|NCT01509131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24710235|NCT01509131|Laxatives|laxatives|mesh-ancestor
24710236|NCT01509144|Vaccines|vaccines|mesh-list
24710237|NCT01509144|Immunologic Factors|immunologic factors|mesh-ancestor
24710238|NCT01509144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710239|NCT01509209|Pseudoephedrine|pseudoephedrine|mesh-list
24710240|NCT01509209|Ephedrine|ephedrine|mesh-list
24710241|NCT01509209|Levocetirizine|levocetirizine|mesh-list
24710242|NCT01509209|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24710243|NCT01509209|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24710245|NCT01509209|Histamine Agents|histamine agents|mesh-ancestor
25150612|NCT05152004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150613|NCT05152004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25150615|NCT05152004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25150650|NCT05136066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25150651|NCT05136066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25150652|NCT05136066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25150653|NCT05136066|Parasympatholytics|parasympatholytics|mesh-ancestor
25150657|NCT05132153|Milrinone|milrinone|mesh-list
25150658|NCT05132153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25150659|NCT05132153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25150660|NCT05132153|Vasodilator Agents|vasodilator agents|mesh-ancestor
25150661|NCT05132153|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25150662|NCT05132153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25150663|NCT05132153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25150674|NCT05131997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25150675|NCT05131997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25150692|NCT05104229|Aspirin|aspirin|mesh-list
25150693|NCT05104229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24509018|NCT00558077|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24509020|NCT00558090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24509021|NCT00558090|Narcotics|narcotics|mesh-ancestor
25150697|NCT05104229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25150698|NCT05104229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25150699|NCT05104229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25150700|NCT05104229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25150701|NCT05104229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25150702|NCT05104229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25150703|NCT05104229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150704|NCT05104229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25150705|NCT05104229|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25150706|NCT05104229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25150707|NCT05104229|Antipyretics|antipyretics|mesh-ancestor
25685145|NCT01902134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25685146|NCT01902134|Narcotics|narcotics|mesh-ancestor
25685147|NCT01902134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25685148|NCT01902134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685149|NCT01902134|Analgesics|analgesics|mesh-ancestor
25685150|NCT01902134|Sensory System Agents|sensory system agents|mesh-ancestor
24541841|NCT00675688|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25685151|NCT01902134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25685152|NCT01902134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25685153|NCT01902134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25685154|NCT01902134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25685155|NCT01902134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25685156|NCT01902459|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25685157|NCT01902459|Hemostatics|hemostatics|mesh-ancestor
25685158|NCT01902459|Coagulants|coagulants|mesh-ancestor
25685159|NCT01902758|Ambrisentan|ambrisentan|mesh-list
25685160|NCT01902758|Theophylline|theophylline|mesh-list
25685161|NCT01902758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25685162|NCT01902758|Autonomic Agents|autonomic agents|mesh-ancestor
25685163|NCT01902758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25685164|NCT01902758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692548|NCT02001987|Methotrexate|methotrexate|mesh-list
25120022|NCT04913610|Ivermectin|ivermectin|mesh-list
25120023|NCT04913610|Albendazole|albendazole|mesh-list
25120024|NCT04913610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25120025|NCT04913610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25120026|NCT04913610|Anthelmintics|anthelmintics|mesh-ancestor
25120027|NCT04913610|Anticestodal Agents|anticestodal agents|mesh-ancestor
25120028|NCT04913610|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25120029|NCT04913610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25120030|NCT04913610|Tubulin Modulators|tubulin modulators|mesh-ancestor
25120031|NCT04913610|Antimitotic Agents|antimitotic agents|mesh-ancestor
25150708|NCT05103306|Empagliflozin|empagliflozin|mesh-list
25150709|NCT05103306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25150710|NCT05103306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25150711|NCT05103306|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25150712|NCT05103306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150722|NCT05080959|Ropivacaine|ropivacaine|mesh-list
25150723|NCT05080959|Anesthetics, Local|anesthetics, local|mesh-ancestor
25150724|NCT05080959|Anesthetics|anesthetics|mesh-ancestor
25150725|NCT05080959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25150726|NCT05080959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25150727|NCT05080959|Sensory System Agents|sensory system agents|mesh-ancestor
25150728|NCT05080959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25150729|NCT05073237|Bazedoxifene|bazedoxifene|mesh-list
25150730|NCT05073237|Estrogens|estrogens|mesh-list
25150731|NCT05073237|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25150732|NCT05073237|Hormones|hormones|mesh-ancestor
25150758|NCT05060068|Anesthetics|anesthetics|mesh-ancestor
25150759|NCT05060068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25150760|NCT05060068|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25150761|NCT05060068|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25150762|NCT05060068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25150763|NCT05060068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150764|NCT05060068|Antidepressive Agents|antidepressive agents|mesh-ancestor
25150765|NCT05060068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25150766|NCT05059470|Pembrolizumab|pembrolizumab|mesh-list
25150767|NCT05059470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25150768|NCT05059470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24798228|NCT01961752|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25048408|NCT00707889|Folic Acid|folic acid|mesh-list
25048409|NCT00707889|Bevacizumab|bevacizumab|mesh-list
25048410|NCT00707889|Fluorouracil|fluorouracil|mesh-list
25048411|NCT00707889|Oxaliplatin|oxaliplatin|mesh-list
25048412|NCT00707889|Levoleucovorin|levoleucovorin|mesh-list
25048413|NCT00707889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25048414|NCT00707889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048415|NCT00707889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25048416|NCT00707889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25048417|NCT00707889|Growth Substances|growth substances|mesh-ancestor
25048418|NCT00707889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048419|NCT00707889|Growth Inhibitors|growth inhibitors|mesh-ancestor
25048420|NCT00707889|Antimetabolites|antimetabolites|mesh-ancestor
25048421|NCT00707889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048422|NCT00707889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25048423|NCT00707889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25048424|NCT00707889|Immunologic Factors|immunologic factors|mesh-ancestor
25048428|NCT00707889|Vitamins|vitamins|mesh-ancestor
24798233|NCT01961752|Sensory System Agents|sensory system agents|mesh-ancestor
24798234|NCT01961752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24798235|NCT01961752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24798236|NCT01961752|Glucocorticoids|glucocorticoids|mesh-ancestor
24798237|NCT01961752|Hormones|hormones|mesh-ancestor
24798238|NCT01961752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24798239|NCT01961752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24798240|NCT01961752|Immunologic Factors|immunologic factors|mesh-ancestor
25685165|NCT01902758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25685166|NCT01902758|Respiratory System Agents|respiratory system agents|mesh-ancestor
25685167|NCT01902758|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25685168|NCT01902758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25685169|NCT01902758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685170|NCT01902758|Vasodilator Agents|vasodilator agents|mesh-ancestor
25685171|NCT01902758|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25685172|NCT01902758|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25150822|NCT05039593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25150823|NCT05039593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25150824|NCT05039593|Disinfectants|disinfectants|mesh-ancestor
25120061|NCT04812002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120066|NCT04779216|Alendronate|alendronate|mesh-list
25120067|NCT04779216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25120068|NCT04779216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120069|NCT04760730|Vaccines|vaccines|mesh-list
25120070|NCT04760730|Immunologic Factors|immunologic factors|mesh-ancestor
25120071|NCT04760730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120072|NCT04745351|Remdesivir|remdesivir|mesh-list
25120092|NCT04712734|Iloperidone|iloperidone|mesh-list
25120093|NCT04712734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25120094|NCT04712734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25120123|NCT04592159|Analgesics|analgesics|mesh-ancestor
25120124|NCT04592159|Sensory System Agents|sensory system agents|mesh-ancestor
25120125|NCT04592159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25120126|NCT04592159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120136|NCT04585776|Insulin|insulin|mesh-list
25150903|NCT04992065|Evolocumab|evolocumab|mesh-list
25150906|NCT04992065|Antimetabolites|antimetabolites|mesh-ancestor
25150907|NCT04992065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150908|NCT04992065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25150934|NCT04953910|Antimetabolites|antimetabolites|mesh-ancestor
25150935|NCT04953910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150936|NCT04953910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25150937|NCT04953910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25150946|NCT04942730|Mycophenolic Acid|mycophenolic acid|mesh-list
25150947|NCT04942730|Cyclophosphamide|cyclophosphamide|mesh-list
25150948|NCT04942730|Busulfan|busulfan|mesh-list
25150949|NCT04942730|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25150950|NCT04942730|Fludarabine|fludarabine|mesh-list
25150951|NCT04942730|Tacrolimus|tacrolimus|mesh-list
25150952|NCT04942730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25150953|NCT04942730|Immunologic Factors|immunologic factors|mesh-ancestor
25150954|NCT04942730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25150955|NCT04942730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25150956|NCT04942730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25150957|NCT04942730|Alkylating Agents|alkylating agents|mesh-ancestor
25150958|NCT04942730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25150959|NCT04942730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25150960|NCT04942730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25150961|NCT04942730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25150962|NCT04942730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25150963|NCT04942730|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25150964|NCT04942730|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25150965|NCT04942730|Antitubercular Agents|antitubercular agents|mesh-ancestor
25150966|NCT04942730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25150967|NCT04942730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25150968|NCT04941664|Levobupivacaine|levobupivacaine|mesh-list
25150969|NCT04941664|Anesthetics, Local|anesthetics, local|mesh-ancestor
25150970|NCT04941664|Anesthetics|anesthetics|mesh-ancestor
25150971|NCT04941664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25150972|NCT04941664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25150973|NCT04941664|Sensory System Agents|sensory system agents|mesh-ancestor
25150974|NCT04941664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24798255|NCT01961843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24509022|NCT00558090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24509024|NCT00558090|Analgesics|analgesics|mesh-ancestor
24612383|NCT01013584|Vitamin D|vitamin d|mesh-list
24612384|NCT01013584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24472967|NCT00401323|Antimetabolites|antimetabolites|mesh-ancestor
24509096|NCT00558480|Retinol palmitate|retinol palmitate|mesh-list
25685173|NCT01902758|Purinergic Agents|purinergic agents|mesh-ancestor
25685174|NCT01902758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25685175|NCT01902758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25685176|NCT01903005|Buprenorphine|buprenorphine|mesh-list
25685177|NCT01903005|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25685178|NCT01903005|Naloxone|naloxone|mesh-list
25685179|NCT01903005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25685180|NCT01903005|Narcotics|narcotics|mesh-ancestor
25685181|NCT01903005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25685182|NCT01903005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685183|NCT01903005|Analgesics|analgesics|mesh-ancestor
25685184|NCT01903005|Sensory System Agents|sensory system agents|mesh-ancestor
25685185|NCT01903005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25685186|NCT01903005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25685187|NCT01903031|Ritonavir|ritonavir|mesh-list
25685188|NCT01903031|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25685189|NCT01903031|Tenofovir|tenofovir|mesh-list
24509097|NCT00558480|Micronutrients|micronutrients|mesh-ancestor
24509098|NCT00558480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509100|NCT00558480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25151056|NCT04908371|Epinephrine|epinephrine|mesh-list
25151057|NCT04908371|Racepinephrine|racepinephrine|mesh-list
25151058|NCT04908371|Levobupivacaine|levobupivacaine|mesh-list
25151059|NCT04908371|Epinephryl borate|epinephryl borate|mesh-list
25151060|NCT04908371|Anesthetics, Local|anesthetics, local|mesh-ancestor
25151061|NCT04908371|Anesthetics|anesthetics|mesh-ancestor
25151062|NCT04908371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25151063|NCT04908371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151064|NCT04908371|Sensory System Agents|sensory system agents|mesh-ancestor
25151065|NCT04908371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25151066|NCT04908371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25151067|NCT04908371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25151068|NCT04908371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25151069|NCT04908371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25151070|NCT04908371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25151071|NCT04908371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25151072|NCT04908371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25151073|NCT04908371|Adrenergic Agents|adrenergic agents|mesh-ancestor
25151074|NCT04908371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25151075|NCT04908371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25151076|NCT04908371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25151077|NCT04908371|Autonomic Agents|autonomic agents|mesh-ancestor
25151078|NCT04908371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25151079|NCT04908371|Respiratory System Agents|respiratory system agents|mesh-ancestor
25151080|NCT04908371|Mydriatics|mydriatics|mesh-ancestor
25151081|NCT04908371|Sympathomimetics|sympathomimetics|mesh-ancestor
25151082|NCT04908371|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24768467|NCT01808469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25151104|NCT04899206|Antidepressive Agents|antidepressive agents|mesh-list
25151105|NCT04899206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25151106|NCT04893382|Plasma-lyte 148|plasma-lyte 148|mesh-list
25151107|NCT04893382|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25151108|NCT04893382|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25151109|NCT04893148|Insulin Glargine|insulin glargine|mesh-list
25151110|NCT04893148|Dulaglutide|dulaglutide|mesh-list
25151111|NCT04893148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25151112|NCT04893148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151123|NCT04885686|Formaldehyde|formaldehyde|mesh-list
25151125|NCT04885686|Dexamethasone|dexamethasone|mesh-list
25151126|NCT04885686|Hydrocortisone|hydrocortisone|mesh-list
25151127|NCT04885686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25151137|NCT04885686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25151138|NCT04885686|Disinfectants|disinfectants|mesh-ancestor
25151139|NCT04885686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25151140|NCT04885686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25151141|NCT04885686|Antifungal Agents|antifungal agents|mesh-ancestor
25151142|NCT04883632|Lidocaine|lidocaine|mesh-list
25151143|NCT04883632|Anesthetics, Local|anesthetics, local|mesh-ancestor
25151144|NCT04883632|Anesthetics|anesthetics|mesh-ancestor
25151145|NCT04883632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25151146|NCT04883632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151147|NCT04883632|Sensory System Agents|sensory system agents|mesh-ancestor
25151148|NCT04883632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25151149|NCT04883632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25151150|NCT04883632|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25151151|NCT04883632|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25151152|NCT04883632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25151153|NCT04883632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25151157|NCT04865029|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25151158|NCT04865029|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25151159|NCT04865029|Estradiol|estradiol|mesh-list
25151160|NCT04865029|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25151161|NCT04865029|Progesterone|progesterone|mesh-list
25151162|NCT04865029|Estrogens|estrogens|mesh-ancestor
25151163|NCT04865029|Hormones|hormones|mesh-ancestor
25151345|NCT04736901|Antithrombins|antithrombins|mesh-ancestor
25151164|NCT04865029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24499822|NCT00521222|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25151196|NCT04846478|Talazoparib|talazoparib|mesh-list
25151197|NCT04846478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25151198|NCT04846478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25151199|NCT04846478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100796|NCT03180255|Anticoagulants|anticoagulants|mesh-ancestor
24710413|NCT01510366|Immunologic Factors|immunologic factors|mesh-ancestor
24710414|NCT01510366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710415|NCT01510431|Remestemcel-l|remestemcel-l|mesh-list
24710416|NCT01510431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24710417|NCT01510431|Antiviral Agents|antiviral agents|mesh-ancestor
24710418|NCT01510431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24710419|NCT01510509|Everolimus|everolimus|mesh-list
24710481|NCT01510795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24710482|NCT01510795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710483|NCT01510795|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25151200|NCT04846478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25151201|NCT04842071|Listerine|listerine|mesh-list
25151202|NCT04842071|Fluorides|fluorides|mesh-list
25151203|NCT04842071|Sodium Fluoride|sodium fluoride|mesh-list
25151204|NCT04842071|Cariostatic Agents|cariostatic agents|mesh-ancestor
25151205|NCT04842071|Protective Agents|protective agents|mesh-ancestor
25151206|NCT04842071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151207|NCT04842071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24997346|NCT05133687|Anesthetics, Local|anesthetics, local|mesh-ancestor
24997347|NCT05133687|Anesthetics|anesthetics|mesh-ancestor
24997348|NCT05133687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24997349|NCT05133687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997350|NCT05133687|Sensory System Agents|sensory system agents|mesh-ancestor
24997356|NCT05131828|Antipruritics|antipruritics|mesh-ancestor
24997357|NCT05131828|Dermatologic Agents|dermatologic agents|mesh-ancestor
24997358|NCT05131828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24997359|NCT05131828|Histamine Antagonists|histamine antagonists|mesh-ancestor
24997368|NCT05101551|Antimetabolites|antimetabolites|mesh-ancestor
24997369|NCT05101551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997370|NCT05101551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24997371|NCT05101551|Antiviral Agents|antiviral agents|mesh-ancestor
24997372|NCT05101551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24997373|NCT05101551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24997374|NCT05101551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24997375|NCT05101551|Immunologic Factors|immunologic factors|mesh-ancestor
24997376|NCT05101551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997377|NCT05101551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25151210|NCT04828694|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25151211|NCT04828694|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25151212|NCT04828694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151213|NCT04828694|Sensory System Agents|sensory system agents|mesh-ancestor
25151214|NCT04828694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25151215|NCT04820036|Insulin|insulin|mesh-list
25151216|NCT04820036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25151217|NCT04820036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151218|NCT04808414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25151219|NCT04808414|Polymyxins|polymyxins|mesh-list
25151220|NCT04808414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25151221|NCT04808323|Capecitabine|capecitabine|mesh-list
25151222|NCT04808323|Oxaliplatin|oxaliplatin|mesh-list
25151223|NCT04808323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25151224|NCT04808323|Antimetabolites|antimetabolites|mesh-ancestor
25151225|NCT04808323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25151226|NCT04808323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25151274|NCT04788823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25151276|NCT04788823|Hormones|hormones|mesh-ancestor
25151277|NCT04788823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25151278|NCT04788823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151279|NCT04788823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25151280|NCT04788823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25151281|NCT04752033|Morphine|morphine|mesh-list
25151282|NCT04752033|Hydromorphone|hydromorphone|mesh-list
25685190|NCT01903031|Efavirenz|efavirenz|mesh-list
25685191|NCT01903031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
25685192|NCT01903031|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25685193|NCT01903031|Etonogestrel|etonogestrel|mesh-list
25685194|NCT01903031|NuvaRing|nuvaring|mesh-list
25685195|NCT01903031|Estradiol|estradiol|mesh-list
25685196|NCT01903031|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25685197|NCT01903031|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25685198|NCT01903031|Protease Inhibitors|protease inhibitors|mesh-ancestor
25685199|NCT01903031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25685200|NCT01903031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25151283|NCT04752033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25685201|NCT01903031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24710521|NCT01511029|Protective Agents|protective agents|mesh-ancestor
24691129|NCT01405157|Antiemetics|antiemetics|mesh-ancestor
25685202|NCT01903031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25151284|NCT04752033|Narcotics|narcotics|mesh-ancestor
25100878|NCT03178708|Amantadine|amantadine|mesh-list
25151285|NCT04752033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25151286|NCT04752033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151287|NCT04752033|Analgesics|analgesics|mesh-ancestor
25151288|NCT04752033|Sensory System Agents|sensory system agents|mesh-ancestor
25151289|NCT04752033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25151304|NCT04749641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151333|NCT04739761|Trastuzumab|trastuzumab|mesh-list
25151334|NCT04739761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25151335|NCT04739761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25151340|NCT04736901|Enoxaparin|enoxaparin|mesh-list
25151341|NCT04736901|Rivaroxaban|rivaroxaban|mesh-list
25151342|NCT04736901|Apixaban|apixaban|mesh-list
25151343|NCT04736901|Enoxaparin sodium|enoxaparin sodium|mesh-list
25151344|NCT04736901|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25151346|NCT04736901|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25151347|NCT04736901|Protease Inhibitors|protease inhibitors|mesh-ancestor
25151348|NCT04736901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25151349|NCT04736901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25151350|NCT04736901|Anticoagulants|anticoagulants|mesh-ancestor
25151351|NCT04736901|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25151352|NCT04736901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25151403|NCT04691817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25151405|NCT04672382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25151406|NCT04672382|Narcotics|narcotics|mesh-ancestor
25151407|NCT04672382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25151408|NCT04672382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151409|NCT04672382|Analgesics|analgesics|mesh-ancestor
25151490|NCT04622813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25151491|NCT04622813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151492|NCT04622813|Antipyretics|antipyretics|mesh-ancestor
25151493|NCT04622813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25151494|NCT04622813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25151495|NCT04622813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25151496|NCT04622813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25151497|NCT04622813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25151498|NCT04622813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25151499|NCT04614610|Lidocaine|lidocaine|mesh-list
25151500|NCT04614610|Anesthetics, Local|anesthetics, local|mesh-ancestor
25151501|NCT04614610|Anesthetics|anesthetics|mesh-ancestor
25151502|NCT04614610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25151503|NCT04614610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151504|NCT04614610|Sensory System Agents|sensory system agents|mesh-ancestor
25151505|NCT04614610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25151506|NCT04614610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25020448|NCT03680378|Cefepime|cefepime|mesh-list
25151507|NCT04614610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25151508|NCT04614610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25151509|NCT04614610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25151510|NCT04614610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25151554|NCT04598321|Talazoparib|talazoparib|mesh-list
25151555|NCT04598321|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25151556|NCT04598321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25151557|NCT04598321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25151558|NCT04598321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25151603|NCT04554888|Histamine Agents|histamine agents|mesh-ancestor
25151604|NCT04554888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25151605|NCT04554888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25151606|NCT04554888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151607|NCT04554888|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25151608|NCT04554888|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25151609|NCT04554888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25151610|NCT04554888|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25151611|NCT04554888|Antidepressive Agents|antidepressive agents|mesh-ancestor
25151612|NCT04554888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25151613|NCT04554888|Histamine Antagonists|histamine antagonists|mesh-ancestor
25151614|NCT04551963|Clarithromycin|clarithromycin|mesh-list
25151615|NCT04551963|Fluconazole|fluconazole|mesh-list
25685203|NCT01903031|Antiviral Agents|antiviral agents|mesh-ancestor
25685204|NCT01903031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24614253|NCT01023243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24614254|NCT01023243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614255|NCT01023243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24614257|NCT01023243|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24614258|NCT01023243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24710715|NCT01511692|Hormones|hormones|mesh-ancestor
24710716|NCT01511692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24710717|NCT01511692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25120378|NCT03957876|Cytarabine|cytarabine|mesh-list
25151616|NCT04551963|Voriconazole|voriconazole|mesh-list
25151617|NCT04551963|Zanubrutinib|zanubrutinib|mesh-list
25151618|NCT04551963|Diltiazem|diltiazem|mesh-list
25151619|NCT04551963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25151654|NCT04547153|Fluorouracil|fluorouracil|mesh-list
25151655|NCT04547153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25151656|NCT04547153|Tubulin Modulators|tubulin modulators|mesh-ancestor
25151657|NCT04547153|Antimitotic Agents|antimitotic agents|mesh-ancestor
24500106|NCT00522743|Hormones|hormones|mesh-list
24500206|NCT00523185|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24935400|NCT04051099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24935401|NCT04051099|Anesthetics, General|anesthetics, general|mesh-ancestor
24935402|NCT04051099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24935403|NCT04051099|Analgesics|analgesics|mesh-ancestor
24759889|NCT01755338|Hormones|hormones|mesh-ancestor
24759906|NCT01755403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759911|NCT01755468|Insulin|insulin|mesh-list
24997502|NCT04687631|Bevacizumab|bevacizumab|mesh-list
24997503|NCT04687631|Cetuximab|cetuximab|mesh-list
24997504|NCT04687631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25151761|NCT04508023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25151762|NCT04508023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25151844|NCT04397484|Levobupivacaine|levobupivacaine|mesh-list
25151845|NCT04397484|Epinephryl borate|epinephryl borate|mesh-list
25151846|NCT04397484|Anesthetics, Local|anesthetics, local|mesh-ancestor
25151847|NCT04397484|Anesthetics|anesthetics|mesh-ancestor
25151848|NCT04397484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25151849|NCT04397484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151850|NCT04397484|Sensory System Agents|sensory system agents|mesh-ancestor
25151923|NCT04322565|Colchicine|colchicine|mesh-list
25151924|NCT04322565|Gout Suppressants|gout suppressants|mesh-ancestor
25151925|NCT04322565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25151926|NCT04322565|Tubulin Modulators|tubulin modulators|mesh-ancestor
25151927|NCT04322565|Antimitotic Agents|antimitotic agents|mesh-ancestor
25151928|NCT04322565|Mitosis Modulators|mitosis modulators|mesh-ancestor
25151929|NCT04322565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25151930|NCT04322565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25151931|NCT04312503|Olanzapine|olanzapine|mesh-list
25151932|NCT04312503|Risperidone|risperidone|mesh-list
25151933|NCT04312503|Aripiprazole|aripiprazole|mesh-list
25151934|NCT04312503|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25151935|NCT04312503|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25151936|NCT04312503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25151937|NCT04312503|Serotonin Agents|serotonin agents|mesh-ancestor
25151938|NCT04312503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25151939|NCT04312503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25151940|NCT04312503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25151941|NCT04312503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25151942|NCT04312503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25151943|NCT04312503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25151944|NCT04312503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25151945|NCT04312503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25151946|NCT04312503|Dopamine Agents|dopamine agents|mesh-ancestor
25151947|NCT04312503|Antiemetics|antiemetics|mesh-ancestor
25151951|NCT04312503|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25685205|NCT01903031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25685206|NCT01903031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25685207|NCT01903031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25685208|NCT01903031|Estrogens|estrogens|mesh-ancestor
25685209|NCT01903031|Hormones|hormones|mesh-ancestor
25685210|NCT01903031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25685211|NCT01903031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685212|NCT01903031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25685213|NCT01903031|Contraceptive Agents|contraceptive agents|mesh-ancestor
25151952|NCT04312503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25151953|NCT04312503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25151954|NCT04312503|Antidepressive Agents|antidepressive agents|mesh-ancestor
25151955|NCT04312503|Dopamine Agonists|dopamine agonists|mesh-ancestor
24997533|NCT04630210|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24997534|NCT04630210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24997535|NCT04630210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997536|NCT04630210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24997537|NCT04630210|Hormone Antagonists|hormone antagonists|mesh-ancestor
24997538|NCT04630210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24997539|NCT04630210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101730|NCT03173092|Glucocorticoids|glucocorticoids|mesh-ancestor
25152253|NCT04167085|Antimalarials|antimalarials|mesh-ancestor
25152267|NCT04166396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25152268|NCT04166396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25152282|NCT04156828|Gemcitabine|gemcitabine|mesh-list
24779386|NCT01875952|Isoniazid|isoniazid|mesh-list
25152283|NCT04156828|Dexamethasone|dexamethasone|mesh-list
25152284|NCT04156828|Dexamethasone acetate|dexamethasone acetate|mesh-list
25152285|NCT04156828|Rituximab|rituximab|mesh-list
25152286|NCT04156828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25152287|NCT04156828|Carboplatin|carboplatin|mesh-list
25152288|NCT04156828|Antibodies|antibodies|mesh-list
25152289|NCT04156828|Immunoglobulins|immunoglobulins|mesh-list
25152290|NCT04156828|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25152291|NCT04156828|Lenograstim|lenograstim|mesh-list
25152292|NCT04156828|BB 1101|bb 1101|mesh-list
25152293|NCT04156828|Immunologic Factors|immunologic factors|mesh-ancestor
25152294|NCT04156828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25152306|NCT04156828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25152307|NCT04156828|Antimetabolites|antimetabolites|mesh-ancestor
25152308|NCT04156828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25152309|NCT04156828|Antiviral Agents|antiviral agents|mesh-ancestor
25152310|NCT04156828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25152311|NCT04156828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25152312|NCT04156828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25152313|NCT04156828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25152314|NCT04156828|Protease Inhibitors|protease inhibitors|mesh-ancestor
25152315|NCT04153032|Diltiazem|diltiazem|mesh-list
25152316|NCT04153032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25152317|NCT04153032|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25152318|NCT04153032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25152319|NCT04153032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25152329|NCT04121455|Bevacizumab|bevacizumab|mesh-list
25152330|NCT04121455|Pembrolizumab|pembrolizumab|mesh-list
25152331|NCT04121455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25152332|NCT04121455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25152333|NCT04121455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25152334|NCT04121455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25152335|NCT04121455|Growth Substances|growth substances|mesh-ancestor
25152336|NCT04121455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25152337|NCT04121455|Growth Inhibitors|growth inhibitors|mesh-ancestor
25152338|NCT04108858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25152339|NCT04108858|Trastuzumab|trastuzumab|mesh-list
25152340|NCT04108858|Pertuzumab|pertuzumab|mesh-list
25152341|NCT04108858|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
25152342|NCT04108858|Antibodies|antibodies|mesh-list
25048456|NCT00698230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25048457|NCT00698230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048458|NCT00697099|Enoxaparin|enoxaparin|mesh-list
25048459|NCT00697099|Semuloparin|semuloparin|mesh-list
25048460|NCT00697099|Enoxaparin sodium|enoxaparin sodium|mesh-list
25048461|NCT00697099|Anticoagulants|anticoagulants|mesh-ancestor
25048462|NCT00697099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25048463|NCT00697099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25048464|NCT00697099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048465|NCT00696332|alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid|mesh-list
25048466|NCT00696332|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
25048467|NCT00696332|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25048468|NCT00696332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24997564|NCT04592744|Sympathomimetics|sympathomimetics|mesh-ancestor
24997565|NCT04592744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24997566|NCT04592744|Hemostatics|hemostatics|mesh-ancestor
24997567|NCT04592744|Coagulants|coagulants|mesh-ancestor
24997568|NCT04592744|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24997569|NCT04592744|Natriuretic Agents|natriuretic agents|mesh-ancestor
24997570|NCT04592744|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24997571|NCT04592744|Protease Inhibitors|protease inhibitors|mesh-ancestor
24711087|NCT01513200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24711088|NCT01513200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685214|NCT01903031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25685215|NCT01903031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24711162|NCT01513772|Sensory System Agents|sensory system agents|mesh-ancestor
24711163|NCT01513772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25120419|NCT03919435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25120420|NCT03919435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25120422|NCT03892044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25120423|NCT03892044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120424|NCT03892044|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25120425|NCT03892044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120426|NCT03882060|Epoetin Alfa|epoetin alfa|mesh-list
24547024|NCT00701961|Mefloquine|mefloquine|mesh-list
25152380|NCT04101227|Ondansetron|ondansetron|mesh-list
25152381|NCT04101227|Antiemetics|antiemetics|mesh-ancestor
25152382|NCT04101227|Autonomic Agents|autonomic agents|mesh-ancestor
25152423|NCT04083365|Antimetabolites|antimetabolites|mesh-ancestor
25152424|NCT04083365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25152425|NCT04083365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25152426|NCT04083365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25152429|NCT04061161|Bromides|bromides|mesh-list
25152430|NCT04061161|Tiotropium Bromide|tiotropium bromide|mesh-list
25152431|NCT04061161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25152432|NCT04061161|Autonomic Agents|autonomic agents|mesh-ancestor
25152433|NCT04061161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25152434|NCT04061161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25152435|NCT04061161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25152436|NCT04061161|Respiratory System Agents|respiratory system agents|mesh-ancestor
25152437|NCT04061161|Parasympatholytics|parasympatholytics|mesh-ancestor
25152438|NCT04061161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25152439|NCT04061161|Cholinergic Agents|cholinergic agents|mesh-ancestor
25152440|NCT04061161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25152441|NCT04061161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25152442|NCT04061161|Anticonvulsants|anticonvulsants|mesh-ancestor
25152446|NCT04052139|Naltrexone|naltrexone|mesh-list
25152447|NCT04052139|Gabapentin|gabapentin|mesh-list
25152448|NCT04052139|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25152449|NCT04052139|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25152450|NCT04052139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25152451|NCT04052139|Sensory System Agents|sensory system agents|mesh-ancestor
25152452|NCT04052139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25152453|NCT04052139|Analgesics|analgesics|mesh-ancestor
25152454|NCT04052139|Anticonvulsants|anticonvulsants|mesh-ancestor
25152455|NCT04052139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25152456|NCT04052139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25152457|NCT04052139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25152458|NCT04052139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25152459|NCT04052139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25152460|NCT04052139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25152461|NCT04052139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24769381|NCT01814059|Antifungal Agents|antifungal agents|mesh-ancestor
25152463|NCT04052139|Antimanic Agents|antimanic agents|mesh-ancestor
25152464|NCT04034251|Paclitaxel|paclitaxel|mesh-list
25152465|NCT04034251|Capecitabine|capecitabine|mesh-list
25153186|NCT03382938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25152467|NCT04034251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25152468|NCT04034251|Tubulin Modulators|tubulin modulators|mesh-ancestor
25685216|NCT01903031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25685217|NCT01903031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25685218|NCT01903031|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25685219|NCT01903031|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25685220|NCT01903031|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25685221|NCT01903031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25685222|NCT01903031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25685223|NCT01903252|Mesalamine|mesalamine|mesh-list
25685224|NCT01903252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25685225|NCT01903252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25685226|NCT01903252|Analgesics|analgesics|mesh-ancestor
25685227|NCT01903252|Sensory System Agents|sensory system agents|mesh-ancestor
25685228|NCT01903252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25152469|NCT04034251|Antimitotic Agents|antimitotic agents|mesh-ancestor
25152470|NCT04034251|Mitosis Modulators|mitosis modulators|mesh-ancestor
25152471|NCT04034251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25152472|NCT04034251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25152473|NCT04034251|Antimetabolites|antimetabolites|mesh-ancestor
25152474|NCT04028765|Misoprostol|misoprostol|mesh-list
25152475|NCT04028765|Oxytocin|oxytocin|mesh-list
25152476|NCT04028765|Oxytocics|oxytocics|mesh-ancestor
25152477|NCT04028765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25152478|NCT04028765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25152479|NCT04028765|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25152480|NCT04028765|Abortifacient Agents|abortifacient agents|mesh-ancestor
25152481|NCT04028765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25152482|NCT04028765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25152483|NCT04026880|Methyltestosterone|methyltestosterone|mesh-list
25152484|NCT04026880|Testosterone|testosterone|mesh-list
24509117|NCT00558623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24509119|NCT00558623|Antacids|antacids|mesh-ancestor
24509120|NCT00558623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884902|NCT03277066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24884905|NCT03268811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25152485|NCT04026880|Testosterone undecanoate|testosterone undecanoate|mesh-list
25152486|NCT04026880|Testosterone enanthate|testosterone enanthate|mesh-list
25152487|NCT04026880|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25152490|NCT04026880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25152491|NCT04026880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25152492|NCT04026880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25152493|NCT04026880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25152494|NCT04026880|Anabolic Agents|anabolic agents|mesh-ancestor
25152506|NCT03994874|Furosemide|furosemide|mesh-list
25152507|NCT03994874|Dialysis Solutions|dialysis solutions|mesh-list
25152508|NCT03994874|Diuretics|diuretics|mesh-list
25152509|NCT03994874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
25152510|NCT03994874|Natriuretic Agents|natriuretic agents|mesh-ancestor
25152511|NCT03994874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25152512|NCT03994874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25152513|NCT03994874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25152554|NCT03982407|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25152555|NCT03982407|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25152556|NCT03982407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25152561|NCT03958877|Interferons|interferons|mesh-list
25152587|NCT03933215|Cladribine|cladribine|mesh-list
25152588|NCT03933215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25152589|NCT03933215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25152590|NCT03933215|Immunologic Factors|immunologic factors|mesh-ancestor
25152591|NCT03933215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25152719|NCT03813875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25152731|NCT03813875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25152732|NCT03813875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25152733|NCT03813875|GABA Modulators|gaba modulators|mesh-ancestor
25152734|NCT03813875|GABA Agents|gaba agents|mesh-ancestor
25152735|NCT03813875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25152736|NCT03813875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25152737|NCT03813875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25152738|NCT03813875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25152745|NCT03809481|Danaparoid|danaparoid|mesh-list
25152746|NCT03809481|Argatroban|argatroban|mesh-list
25152747|NCT03809481|Antithrombins|antithrombins|mesh-ancestor
25152748|NCT03809481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25152749|NCT03809481|Protease Inhibitors|protease inhibitors|mesh-ancestor
25152750|NCT03809481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25152751|NCT03809481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25152752|NCT03809481|Anticoagulants|anticoagulants|mesh-ancestor
25152753|NCT03809481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25152755|NCT03809481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25152756|NCT03809442|Dexamethasone|dexamethasone|mesh-list
25152757|NCT03809442|Midazolam|midazolam|mesh-list
25152758|NCT03809442|Dexmedetomidine|dexmedetomidine|mesh-list
25152759|NCT03809442|Ketamine|ketamine|mesh-list
25152760|NCT03809442|Tramadol|tramadol|mesh-list
25152784|NCT03809442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25152785|NCT03809442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25152786|NCT03809442|Anesthetics, General|anesthetics, general|mesh-ancestor
25152788|NCT03809442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25152789|NCT03809442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25152790|NCT03809442|Anesthetics, Local|anesthetics, local|mesh-ancestor
25152791|NCT03809442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25152792|NCT03809442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25152793|NCT03809442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25152794|NCT03809442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25152795|NCT03809442|GABA Modulators|gaba modulators|mesh-ancestor
25152796|NCT03809442|GABA Agents|gaba agents|mesh-ancestor
25152797|NCT03809442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25152798|NCT03809442|Narcotics|narcotics|mesh-ancestor
25153206|NCT03377543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25152956|NCT03646058|Analgesics|analgesics|mesh-ancestor
25152957|NCT03646058|Sensory System Agents|sensory system agents|mesh-ancestor
25152958|NCT03646058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25152959|NCT03646058|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25102533|NCT03168100|Glucocorticoids|glucocorticoids|mesh-ancestor
25152971|NCT03600701|Atezolizumab|atezolizumab|mesh-list
25152972|NCT03600701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25152973|NCT03600701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942282|NCT03982784|Morphine|morphine|mesh-list
24997635|NCT04546828|Antimetabolites|antimetabolites|mesh-ancestor
25153007|NCT03580902|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25153008|NCT03580902|Naloxone|naloxone|mesh-list
25153009|NCT03580902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25153010|NCT03580902|Narcotics|narcotics|mesh-ancestor
25153011|NCT03580902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25153012|NCT03580902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153013|NCT03580902|Analgesics|analgesics|mesh-ancestor
25153014|NCT03580902|Sensory System Agents|sensory system agents|mesh-ancestor
25153015|NCT03580902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25153016|NCT03580902|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25153017|NCT03580148|Cortisone|cortisone|mesh-list
25153018|NCT03580148|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25153019|NCT03580148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25153020|NCT03554174|Psilocybin|psilocybin|mesh-list
25153021|NCT03554174|Hallucinogens|hallucinogens|mesh-ancestor
25153022|NCT03554174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153023|NCT03554174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25153028|NCT03532139|Enoxaparin|enoxaparin|mesh-list
25153029|NCT03532139|Enoxaparin sodium|enoxaparin sodium|mesh-list
25153030|NCT03532139|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25153031|NCT03532139|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25153032|NCT03532139|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25153033|NCT03532139|Antimetabolites|antimetabolites|mesh-ancestor
25153076|NCT03522961|Nitrofurantoin|nitrofurantoin|mesh-list
25153077|NCT03522961|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25153078|NCT03522961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25153079|NCT03522961|Renal Agents|renal agents|mesh-ancestor
25153080|NCT03522961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25153238|NCT03374956|Sympathomimetics|sympathomimetics|mesh-ancestor
25153156|NCT03436992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153157|NCT03436992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25153158|NCT03436992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25153159|NCT03429946|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25153161|NCT03429946|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25153162|NCT03429946|Hormone Antagonists|hormone antagonists|mesh-ancestor
25153163|NCT03429946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25153164|NCT03429946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153165|NCT03429946|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25153166|NCT03429946|Diuretics|diuretics|mesh-ancestor
25153167|NCT03429946|Natriuretic Agents|natriuretic agents|mesh-ancestor
25153168|NCT03422471|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25153169|NCT03422471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153175|NCT03382938|Dexmedetomidine|dexmedetomidine|mesh-list
25153185|NCT03382938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25153187|NCT03382938|Adrenergic Agents|adrenergic agents|mesh-ancestor
25153188|NCT03382938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25153189|NCT03382938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153190|NCT03382938|Anesthetics, Local|anesthetics, local|mesh-ancestor
25153191|NCT03382938|Anesthetics|anesthetics|mesh-ancestor
25685229|NCT01903252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614406|NCT01024179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24614407|NCT01024179|Immunologic Factors|immunologic factors|mesh-ancestor
24614408|NCT01024179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614409|NCT01024192|Zolpidem|zolpidem|mesh-list
24614410|NCT01024192|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24614411|NCT01024192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24614412|NCT01024192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24614418|NCT01024192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614419|NCT01024205|Sunitinib|sunitinib|mesh-list
24547318|NCT00703378|Docetaxel|docetaxel|mesh-list
25153192|NCT03377543|Aspirin|aspirin|mesh-list
25153193|NCT03377543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25153194|NCT03377543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25153195|NCT03377543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25153196|NCT03377543|Analgesics|analgesics|mesh-ancestor
25153197|NCT03377543|Sensory System Agents|sensory system agents|mesh-ancestor
25153198|NCT03377543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25153199|NCT03377543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153200|NCT03377543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25153201|NCT03377543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24623052|NCT01069913|Dermatologic Agents|dermatologic agents|mesh-ancestor
25153202|NCT03377543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25153203|NCT03377543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153204|NCT03377543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25153205|NCT03377543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24935571|NCT04048889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24935572|NCT04049110|Dapagliflozin|dapagliflozin|mesh-list
24935573|NCT04049110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24935574|NCT04049110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935575|NCT04049110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24935576|NCT04049110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935577|NCT04049227|Letrozole|letrozole|mesh-list
24935578|NCT04049227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935579|NCT04049227|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24935580|NCT04049227|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24935581|NCT04049227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24769893|NCT01816789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24509282|NCT00559546|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24935582|NCT04049227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935583|NCT04049227|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24935584|NCT04049227|Hormone Antagonists|hormone antagonists|mesh-ancestor
25048469|NCT00696332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048470|NCT00696332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048472|NCT00694928|Clindamycin palmitate|clindamycin palmitate|mesh-list
25102867|NCT03165825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25153261|NCT03358693|Ustekinumab|ustekinumab|mesh-list
25153262|NCT03358693|Ixekizumab|ixekizumab|mesh-list
25153263|NCT03358693|Brodalumab|brodalumab|mesh-list
25153264|NCT03358693|Abrocitinib|abrocitinib|mesh-list
25153265|NCT03358693|Dermatologic Agents|dermatologic agents|mesh-ancestor
25153266|NCT03358693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25153267|NCT03358693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25153268|NCT03358693|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25153269|NCT03358693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24621397|NCT01062139|Histamine Agents|histamine agents|mesh-ancestor
25153270|NCT03358693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25153271|NCT03358693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153387|NCT03173924|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25153388|NCT03173924|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25153389|NCT03173924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884914|NCT03267433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25685230|NCT01903252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25685231|NCT01903252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25685232|NCT01903265|Cyclobenzaprine|cyclobenzaprine|mesh-list
25685233|NCT01903265|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25685234|NCT01903265|Antidepressive Agents|antidepressive agents|mesh-ancestor
25685235|NCT01903265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25685236|NCT01903265|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25685237|NCT01903265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685238|NCT01903265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25685239|NCT01903265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25120530|NCT03472573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25120531|NCT03472573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120532|NCT03472573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25120533|NCT03472573|Glucocorticoids|glucocorticoids|mesh-ancestor
25120534|NCT03472573|Hormones|hormones|mesh-ancestor
25120535|NCT03472573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25120536|NCT03472573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25120537|NCT03472573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120538|NCT03472573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25120539|NCT03472573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25120540|NCT03472573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711734|NCT01516723|Sirolimus|sirolimus|mesh-list
24884915|NCT03231085|Ferrous fumarate|ferrous fumarate|mesh-list
24884916|NCT03231085|Trace Elements|trace elements|mesh-ancestor
24884917|NCT03231085|Micronutrients|micronutrients|mesh-ancestor
24884918|NCT03231085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884919|NCT03207347|Niraparib|niraparib|mesh-list
24884921|NCT03207347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25153403|NCT03126591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25153404|NCT03126591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102984|NCT03165240|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25153435|NCT03090165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153437|NCT03088410|Zidovudine|zidovudine|mesh-list
25153438|NCT03088410|Nevirapine|nevirapine|mesh-list
25153439|NCT03088410|Antimetabolites|antimetabolites|mesh-ancestor
25153440|NCT03088410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153441|NCT03088410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25153442|NCT03088410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25153443|NCT03088410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25153444|NCT03088410|Antiviral Agents|antiviral agents|mesh-ancestor
25153445|NCT03088410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24997734|NCT04454684|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
24997736|NCT04454684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997737|NCT04454684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24997738|NCT04454684|Serotonin Agents|serotonin agents|mesh-ancestor
24997739|NCT04454684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24997740|NCT04454684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997741|NCT04454684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24997742|NCT04454684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24997743|NCT04454684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24997744|NCT04454684|Adrenergic Agents|adrenergic agents|mesh-ancestor
25048473|NCT00694928|Clindamycin phosphate|clindamycin phosphate|mesh-list
25048474|NCT00694928|Butoconazole|butoconazole|mesh-list
25048475|NCT00694928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25048476|NCT00694928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25048477|NCT00694928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25048478|NCT00694928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048479|NCT00694928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048480|NCT00694928|Antifungal Agents|antifungal agents|mesh-ancestor
25153557|NCT02849080|Incretins|incretins|mesh-ancestor
25153558|NCT02849080|Hormones|hormones|mesh-ancestor
25153559|NCT02849080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25153560|NCT02849080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25153561|NCT02849080|Protease Inhibitors|protease inhibitors|mesh-ancestor
25153562|NCT02849080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25153563|NCT02849080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153570|NCT02815995|Durvalumab|durvalumab|mesh-list
25153571|NCT02815995|Tremelimumab|tremelimumab|mesh-list
25153572|NCT02815995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25153573|NCT02815995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25685240|NCT01903265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25685241|NCT01903265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25685242|NCT01903356|Linagliptin|linagliptin|mesh-list
25685243|NCT01903356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25685244|NCT01903356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685245|NCT01903356|Incretins|incretins|mesh-ancestor
25685246|NCT01903356|Hormones|hormones|mesh-ancestor
25685247|NCT01903356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25685248|NCT01903356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25685249|NCT01903356|Protease Inhibitors|protease inhibitors|mesh-ancestor
25685250|NCT01903356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25685251|NCT01903356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685252|NCT01903434|Evacetrapib|evacetrapib|mesh-list
24711742|NCT01516723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24711743|NCT01516723|Antifungal Agents|antifungal agents|mesh-ancestor
24711744|NCT01516762|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
24711779|NCT01516866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24711780|NCT01516944|Capecitabine|capecitabine|mesh-list
24711781|NCT01516944|Tegafur|tegafur|mesh-list
24711782|NCT01516944|Oxaliplatin|oxaliplatin|mesh-list
24711783|NCT01516944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24711784|NCT01516944|Antimetabolites|antimetabolites|mesh-ancestor
24711785|NCT01516944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153574|NCT02764762|Adalimumab|adalimumab|mesh-list
25153575|NCT02764762|Methotrexate|methotrexate|mesh-list
25153576|NCT02764762|Vedolizumab|vedolizumab|mesh-list
25153577|NCT02764762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25153578|NCT02764762|Abortifacient Agents|abortifacient agents|mesh-ancestor
25153579|NCT02764762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25153580|NCT02764762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153581|NCT02764762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25153607|NCT02690064|Vitamins|vitamins|mesh-list
25153608|NCT02690064|Ascorbic Acid|ascorbic acid|mesh-list
25153609|NCT02690064|Vitamin E|vitamin e|mesh-list
25153610|NCT02690064|Tocopherols|tocopherols|mesh-list
25153611|NCT02690064|Tocotrienols|tocotrienols|mesh-list
25153612|NCT02690064|alpha-Tocopherol|alpha-tocopherol|mesh-list
25153613|NCT02690064|Thioctic Acid|thioctic acid|mesh-list
25153614|NCT02690064|Ubiquinone|ubiquinone|mesh-list
25153615|NCT02690064|Resveratrol|resveratrol|mesh-list
25153616|NCT02690064|Antioxidants|antioxidants|mesh-list
25153617|NCT02690064|Micronutrients|micronutrients|mesh-ancestor
25153618|NCT02690064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153619|NCT02690064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153620|NCT02690064|Protective Agents|protective agents|mesh-ancestor
25153621|NCT02690064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25153622|NCT02690064|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25153623|NCT02690064|Vitamin B Complex|vitamin b complex|mesh-ancestor
25153674|NCT02569645|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25153675|NCT02569645|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24997762|NCT04429685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24997763|NCT04429685|Anesthetics, General|anesthetics, general|mesh-ancestor
24997800|NCT04354129|Immunoglobulins|immunoglobulins|mesh-list
24997801|NCT04354129|Immunologic Factors|immunologic factors|mesh-ancestor
24997802|NCT04354129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997804|NCT04326439|Etoposide|etoposide|mesh-list
24997805|NCT04326439|Daunorubicin|daunorubicin|mesh-list
24997806|NCT04326439|Sorafenib|sorafenib|mesh-list
24997807|NCT04326439|Asparaginase|asparaginase|mesh-list
24997808|NCT04326439|Gemtuzumab|gemtuzumab|mesh-list
25153761|NCT02374021|Hydroxychloroquine|hydroxychloroquine|mesh-list
25153762|NCT02374021|Sulfasalazine|sulfasalazine|mesh-list
25153763|NCT02374021|Adalimumab|adalimumab|mesh-list
25153764|NCT02374021|Etanercept|etanercept|mesh-list
25153765|NCT02374021|Methotrexate|methotrexate|mesh-list
25153766|NCT02374021|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25153767|NCT02374021|Abortifacient Agents|abortifacient agents|mesh-ancestor
25153768|NCT02374021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25153769|NCT02374021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153770|NCT02374021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25153800|NCT02226276|Copper|copper|mesh-list
25153801|NCT02226276|Trastuzumab|trastuzumab|mesh-list
25153802|NCT02226276|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25153804|NCT02226276|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25153805|NCT02226276|Immunoconjugates|immunoconjugates|mesh-list
25153806|NCT02226276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25153807|NCT02226276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25153808|NCT02226276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153809|NCT02226276|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25153810|NCT02226276|Trace Elements|trace elements|mesh-ancestor
25153811|NCT02226276|Micronutrients|micronutrients|mesh-ancestor
25153812|NCT02226276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685253|NCT01903434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25685254|NCT01903434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25685255|NCT01903434|Antimetabolites|antimetabolites|mesh-ancestor
25685256|NCT01903434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685257|NCT01903434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25685258|NCT01903720|Dexamethasone|dexamethasone|mesh-list
25685259|NCT01903720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25685260|NCT01903720|Antiemetics|antiemetics|mesh-ancestor
25685261|NCT01903720|Autonomic Agents|autonomic agents|mesh-ancestor
25685262|NCT01903720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24711943|NCT01517828|Ketamine|ketamine|mesh-list
24711944|NCT01517828|Analgesics|analgesics|mesh-ancestor
25153813|NCT02226276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25153814|NCT02226276|Tubulin Modulators|tubulin modulators|mesh-ancestor
25153815|NCT02226276|Antimitotic Agents|antimitotic agents|mesh-ancestor
25153816|NCT02226276|Mitosis Modulators|mitosis modulators|mesh-ancestor
25153817|NCT02226276|Immunologic Factors|immunologic factors|mesh-ancestor
25153818|NCT02213068|Mycophenolic Acid|mycophenolic acid|mesh-list
25153819|NCT02213068|Abatacept|abatacept|mesh-list
25153820|NCT02213068|Tacrolimus|tacrolimus|mesh-list
25153821|NCT02213068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25153875|NCT02116335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25153879|NCT02115724|Vitamin E|vitamin e|mesh-list
25153909|NCT02081755|Mycophenolic Acid|mycophenolic acid|mesh-list
25153910|NCT02081755|Everolimus|everolimus|mesh-list
25153911|NCT02081755|Azathioprine|azathioprine|mesh-list
25153912|NCT02081755|Tacrolimus|tacrolimus|mesh-list
25153913|NCT02081755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25153914|NCT02081755|Immunologic Factors|immunologic factors|mesh-ancestor
25153915|NCT02081755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153916|NCT02081755|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25153917|NCT02081755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25153918|NCT02081755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25153919|NCT02081755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25153920|NCT02081755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25153921|NCT02081755|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25153922|NCT02081755|Antitubercular Agents|antitubercular agents|mesh-ancestor
25153923|NCT02081755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24997819|NCT04326439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24997820|NCT04326439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24997821|NCT04326439|Immunologic Factors|immunologic factors|mesh-ancestor
24997822|NCT04326439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153948|NCT02021474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25153949|NCT02021474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25153950|NCT02021474|Disinfectants|disinfectants|mesh-ancestor
25153951|NCT02021474|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25153952|NCT02021474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25153953|NCT01964430|Gemcitabine|gemcitabine|mesh-list
25153954|NCT01964430|Paclitaxel|paclitaxel|mesh-list
25153955|NCT01964430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25153956|NCT01964430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25153957|NCT01964430|Tubulin Modulators|tubulin modulators|mesh-ancestor
24501983|NCT00531895|Analgesics|analgesics|mesh-ancestor
25153958|NCT01964430|Antimitotic Agents|antimitotic agents|mesh-ancestor
25153972|NCT01933815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25153973|NCT01933815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25153974|NCT01933815|Growth Substances|growth substances|mesh-ancestor
25153975|NCT01933815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25153976|NCT01933815|Growth Inhibitors|growth inhibitors|mesh-ancestor
25154003|NCT01880957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154004|NCT01880957|Antimanic Agents|antimanic agents|mesh-ancestor
25154005|NCT01880957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25020691|NCT03678428|Vitamins|vitamins|mesh-ancestor
25154006|NCT01880957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25154007|NCT01880957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154008|NCT01880957|Anticonvulsants|anticonvulsants|mesh-ancestor
25154009|NCT01880957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25154010|NCT01880957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25154011|NCT01880957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25154012|NCT01880957|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25154013|NCT01880957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25154029|NCT01808820|Imiquimod|imiquimod|mesh-list
25154030|NCT01808820|Vaccines|vaccines|mesh-list
25154031|NCT01808820|Immunologic Factors|immunologic factors|mesh-ancestor
25154032|NCT01808820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154033|NCT01808820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25154034|NCT01808820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25154035|NCT01808820|Interferon Inducers|interferon inducers|mesh-ancestor
25154036|NCT01803152|Gemcitabine|gemcitabine|mesh-list
25154037|NCT01803152|Imiquimod|imiquimod|mesh-list
25154038|NCT01803152|Vaccines|vaccines|mesh-list
25154039|NCT01803152|Immunologic Factors|immunologic factors|mesh-ancestor
25154040|NCT01803152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154041|NCT01803152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25154042|NCT01803152|Antimetabolites|antimetabolites|mesh-ancestor
25685263|NCT01903720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154043|NCT01803152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712007|NCT01518101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154044|NCT01803152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25154045|NCT01803152|Antiviral Agents|antiviral agents|mesh-ancestor
25154046|NCT01803152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25154047|NCT01803152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25154048|NCT01803152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25154049|NCT01803152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25154062|NCT01703949|Immunoconjugates|immunoconjugates|mesh-list
25154063|NCT01703949|Immunologic Factors|immunologic factors|mesh-ancestor
25154064|NCT01703949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154065|NCT01703949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25154066|NCT01703949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25154067|NCT01703949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154068|NCT01651403|Tenofovir|tenofovir|mesh-list
25154069|NCT01651403|Antiviral Agents|antiviral agents|mesh-ancestor
25154074|NCT01651403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154076|NCT01651403|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25154120|NCT01462890|Antimitotic Agents|antimitotic agents|mesh-ancestor
25154121|NCT01462890|Mitosis Modulators|mitosis modulators|mesh-ancestor
25154122|NCT01462890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154123|NCT01462890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25154124|NCT01462890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25154125|NCT01462890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25154126|NCT01462890|Growth Substances|growth substances|mesh-ancestor
25154127|NCT01462890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154128|NCT01462890|Growth Inhibitors|growth inhibitors|mesh-ancestor
25154136|NCT01413100|Mycophenolic Acid|mycophenolic acid|mesh-list
25154149|NCT01413100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25154150|NCT01413100|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25154151|NCT01413100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25154152|NCT01413100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25154153|NCT01413100|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25154154|NCT01413100|Antitubercular Agents|antitubercular agents|mesh-ancestor
25154155|NCT01413100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25154156|NCT01413100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25154157|NCT01413100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25154158|NCT01413100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25154159|NCT01413100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25154160|NCT01413100|Antiviral Agents|antiviral agents|mesh-ancestor
25154193|NCT01351909|Cyclophosphamide|cyclophosphamide|mesh-list
25154194|NCT01351909|Veliparib|veliparib|mesh-list
25154195|NCT01351909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25154196|NCT01351909|Immunologic Factors|immunologic factors|mesh-ancestor
25154197|NCT01351909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25154198|NCT01351909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25154199|NCT01351909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25154200|NCT01351909|Alkylating Agents|alkylating agents|mesh-ancestor
24550274|NCT00720018|Serotonin Agents|serotonin agents|mesh-ancestor
25154201|NCT01351909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154202|NCT01351909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25154203|NCT01351909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25154204|NCT01351909|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25154205|NCT01351909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25154245|NCT01241786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25154246|NCT01241786|Growth Substances|growth substances|mesh-ancestor
25154247|NCT01241786|Growth Inhibitors|growth inhibitors|mesh-ancestor
25154248|NCT01241786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25154249|NCT01241786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25154251|NCT01241786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25154252|NCT01241786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24502388|NCT05165212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24502491|NCT05035316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24502492|NCT05035316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24502494|NCT05034536|Pembrolizumab|pembrolizumab|mesh-list
25104284|NCT03154281|Everolimus|everolimus|mesh-list
24997902|NCT04188730|Sensory System Agents|sensory system agents|mesh-ancestor
24997903|NCT04188730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25685264|NCT01903720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25120658|NCT03020030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24997922|NCT04146298|Alkylating Agents|alkylating agents|mesh-ancestor
24997923|NCT04146298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997924|NCT04146298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24997925|NCT04146298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24997930|NCT04113083|Dehydrocholesterols|dehydrocholesterols|mesh-list
24997932|NCT04113083|Vitamins|vitamins|mesh-ancestor
24997933|NCT04113083|Micronutrients|micronutrients|mesh-ancestor
24997934|NCT04113083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104882|NCT03150316|Hormones|hormones|mesh-ancestor
24935870|NCT04046874|Sensory System Agents|sensory system agents|mesh-ancestor
24935871|NCT04046874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24935872|NCT04046874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105166|NCT03148444|Cephalexin|cephalexin|mesh-list
24935887|NCT04047186|Nivolumab|nivolumab|mesh-list
24935888|NCT04047186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24935889|NCT04047186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935890|NCT04047186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24997996|NCT04038255|Autonomic Agents|autonomic agents|mesh-ancestor
24998020|NCT03944512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24998021|NCT03944512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24998022|NCT03944512|Antimetabolites|antimetabolites|mesh-ancestor
24998023|NCT03944512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998024|NCT03944512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24998025|NCT03944512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24998026|NCT03944512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998027|NCT03909607|Ketamine|ketamine|mesh-list
24998028|NCT03909607|Analgesics|analgesics|mesh-ancestor
24998029|NCT03909607|Sensory System Agents|sensory system agents|mesh-ancestor
24998030|NCT03909607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24998031|NCT03909607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998032|NCT03909607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24998033|NCT03909607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24998035|NCT03909607|Anesthetics|anesthetics|mesh-ancestor
24998036|NCT03909607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24998037|NCT03909607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24998038|NCT03909607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24998039|NCT03909607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24998040|NCT03909607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998041|NCT03902509|Pirfenidone|pirfenidone|mesh-list
24998042|NCT03902509|Analgesics|analgesics|mesh-ancestor
24998043|NCT03902509|Sensory System Agents|sensory system agents|mesh-ancestor
24998044|NCT03902509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24783130|NCT01900301|Parasympatholytics|parasympatholytics|mesh-ancestor
25105319|NCT03146871|Azacitidine|azacitidine|mesh-list
24975295|NCT04401384|Vitamins|vitamins|mesh-ancestor
24998045|NCT03902509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795078|NCT03773237|SMOFlipid|smoflipid|mesh-list
24975780|NCT03008616|Digoxin|digoxin|mesh-list
24998046|NCT03902509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24998047|NCT03902509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24998048|NCT03902509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24998049|NCT03902509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24998050|NCT03902509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998054|NCT03841565|Dexamethasone|dexamethasone|mesh-list
24998055|NCT03841565|Dexamethasone acetate|dexamethasone acetate|mesh-list
24998056|NCT03841565|Daratumumab|daratumumab|mesh-list
24998057|NCT03841565|Pomalidomide|pomalidomide|mesh-list
24998058|NCT03841565|Ichthammol|ichthammol|mesh-list
24998059|NCT03841565|BB 1101|bb 1101|mesh-list
24998060|NCT03841565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24998061|NCT03841565|Antiemetics|antiemetics|mesh-ancestor
24998062|NCT03841565|Autonomic Agents|autonomic agents|mesh-ancestor
24998068|NCT03841565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24998070|NCT03841565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998071|NCT03841565|Protease Inhibitors|protease inhibitors|mesh-ancestor
24998072|NCT03841565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998073|NCT03841565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998074|NCT03841565|Immunologic Factors|immunologic factors|mesh-ancestor
24998075|NCT03841565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24795391|NCT02807454|Pomalidomide|pomalidomide|mesh-list
24795392|NCT02807454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25685265|NCT01903720|Glucocorticoids|glucocorticoids|mesh-ancestor
25685266|NCT01903720|Hormones|hormones|mesh-ancestor
24795393|NCT02807454|Antiemetics|antiemetics|mesh-ancestor
24795394|NCT02807454|Autonomic Agents|autonomic agents|mesh-ancestor
24795395|NCT02807454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24795396|NCT02807454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795397|NCT02807454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24795398|NCT02807454|Glucocorticoids|glucocorticoids|mesh-ancestor
24795399|NCT02807454|Hormones|hormones|mesh-ancestor
24795400|NCT02807454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24795409|NCT02775812|Pembrolizumab|pembrolizumab|mesh-list
24824179|NCT02122055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24978715|NCT03125642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978856|NCT02652468|Rituximab|rituximab|mesh-list
24824474|NCT02123589|Analgesics|analgesics|mesh-ancestor
24998089|NCT03722849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998090|NCT03722849|Analgesics|analgesics|mesh-ancestor
24998091|NCT03722849|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24998092|NCT03722849|Vasodilator Agents|vasodilator agents|mesh-ancestor
24998093|NCT03722849|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24998094|NCT03722849|Purinergic Agonists|purinergic agonists|mesh-ancestor
25048482|NCT00694382|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25048483|NCT00694382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25048484|NCT00694382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25048485|NCT00694382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048486|NCT00694382|Anticoagulants|anticoagulants|mesh-ancestor
25048487|NCT00694135|Dexamethasone|dexamethasone|mesh-list
25048488|NCT00694135|Dexamethasone acetate|dexamethasone acetate|mesh-list
25048489|NCT00694135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25048490|NCT00694135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25048491|NCT00694135|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25048492|NCT00694135|BB 1101|bb 1101|mesh-list
25048493|NCT00694135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25048494|NCT00694135|Antiemetics|antiemetics|mesh-ancestor
24980113|NCT05441761|Antimetabolites|antimetabolites|mesh-ancestor
24825887|NCT02130830|Lidocaine|lidocaine|mesh-list
24980362|NCT05352321|Antiviral Agents|antiviral agents|mesh-ancestor
25048496|NCT00694135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24826232|NCT02133469|Vaccines|vaccines|mesh-list
24826383|NCT02134262|Cyclophosphamide|cyclophosphamide|mesh-list
24622045|NCT01065272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24826966|NCT02136979|Propofol|propofol|mesh-list
24981392|NCT03564470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24981393|NCT03564470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24981394|NCT03564470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981404|NCT03502681|Avelumab|avelumab|mesh-list
24784092|NCT01905904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795678|NCT01042379|Trastuzumab|trastuzumab|mesh-list
24784122|NCT01906294|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25048498|NCT00694135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25048499|NCT00694135|Glucocorticoids|glucocorticoids|mesh-ancestor
25048500|NCT00694135|Hormones|hormones|mesh-ancestor
25048501|NCT00694135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25048502|NCT00694135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25048503|NCT00694135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24982314|NCT03132675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24982315|NCT03132675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24982317|NCT03117309|Ipilimumab|ipilimumab|mesh-list
24982318|NCT03117309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24982319|NCT03117309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24982320|NCT03117309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24982321|NCT03117309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982322|NCT03073785|Zoledronic Acid|zoledronic acid|mesh-list
24982343|NCT03035630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24982429|NCT02668770|Ipilimumab|ipilimumab|mesh-list
24585520|NCT00885872|Antimetabolites|antimetabolites|mesh-ancestor
24503183|NCT02978391|Coagulants|coagulants|mesh-ancestor
24784270|NCT01907165|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
24784271|NCT01907165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24784279|NCT01907204|Methylprednisolone|methylprednisolone|mesh-list
24784280|NCT01907204|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24784281|NCT01907204|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25106390|NCT02812667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106391|NCT02812667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25106393|NCT02797275|Albuterol|albuterol|mesh-list
24828470|NCT02145715|Thalidomide|thalidomide|mesh-list
24982889|NCT00379288|Hormones|hormones|mesh-ancestor
24784403|NCT01907867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25048507|NCT00692484|Chlorhexidine|chlorhexidine|mesh-list
25048526|NCT00692445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985177|NCT03589105|Ocrelizumab|ocrelizumab|mesh-list
24831620|NCT02167425|Narcotics|narcotics|mesh-ancestor
25048527|NCT00692445|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25048528|NCT00692445|Antidepressive Agents|antidepressive agents|mesh-ancestor
25048529|NCT00692445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25048530|NCT00692445|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25048531|NCT00692445|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24998095|NCT03722849|Purinergic Agents|purinergic agents|mesh-ancestor
24998096|NCT03722849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24998097|NCT03722849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784877|NCT01910766|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24986126|NCT02303821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24986127|NCT02303821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24986128|NCT02303821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24986129|NCT02303821|Abortifacient Agents|abortifacient agents|mesh-ancestor
24986130|NCT02303821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24986131|NCT02303821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24986132|NCT02303821|Antimetabolites|antimetabolites|mesh-ancestor
24986133|NCT02303821|Dermatologic Agents|dermatologic agents|mesh-ancestor
24986134|NCT02303821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24986135|NCT02303821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24986137|NCT02303821|Antiviral Agents|antiviral agents|mesh-ancestor
24833111|NCT02172768|Micafungin|micafungin|mesh-list
24784917|NCT01910987|BB 1101|bb 1101|mesh-list
24986599|NCT00070018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24833631|NCT02174887|Gemcitabine|gemcitabine|mesh-list
24987057|NCT04416048|Rivaroxaban|rivaroxaban|mesh-list
24834028|NCT02176681|Vildagliptin|vildagliptin|mesh-list
24590113|NCT00910767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24590141|NCT00910806|Nevirapine|nevirapine|mesh-list
24834837|NCT02181322|Meloxicam|meloxicam|mesh-list
24785093|NCT01911975|Lacosamide|lacosamide|mesh-list
24988049|NCT04297592|Doxycycline|doxycycline|mesh-list
24988438|NCT02817347|Hormones|hormones|mesh-ancestor
24998142|NCT03612713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24990251|NCT03357939|Adalimumab|adalimumab|mesh-list
24990330|NCT03228693|Triamcinolone|triamcinolone|mesh-list
24837759|NCT02193256|Prazosin|prazosin|mesh-list
24785350|NCT01913964|Vitamin B Complex|vitamin b complex|mesh-ancestor
24785351|NCT01913964|Vitamins|vitamins|mesh-ancestor
24785352|NCT01913964|Micronutrients|micronutrients|mesh-ancestor
24785353|NCT01913964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785354|NCT01913964|Nootropic Agents|nootropic agents|mesh-ancestor
24785355|NCT01913990|Dexamethasone|dexamethasone|mesh-list
24990570|NCT02681237|Olaparib|olaparib|mesh-list
24990571|NCT02681237|Cediranib|cediranib|mesh-list
24990572|NCT02681237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24990573|NCT02681237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24990577|NCT02674529|Citalopram|citalopram|mesh-list
24998143|NCT03612713|Narcotics|narcotics|mesh-ancestor
24998144|NCT03612713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24998145|NCT03612713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998146|NCT03612713|Analgesics|analgesics|mesh-ancestor
24998147|NCT03612713|Sensory System Agents|sensory system agents|mesh-ancestor
24998148|NCT03612713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24998149|NCT03590821|Aspirin|aspirin|mesh-list
24998150|NCT03590821|Celecoxib|celecoxib|mesh-list
24936085|NCT04044417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24983767|NCT05166291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936086|NCT04044417|Analgesics|analgesics|mesh-ancestor
24936087|NCT04044417|Sensory System Agents|sensory system agents|mesh-ancestor
24936088|NCT04044417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24936089|NCT04044417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936090|NCT04044417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24936091|NCT04044417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24936092|NCT04044417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24936093|NCT04044547|Rotigotine|rotigotine|mesh-list
24936094|NCT04044547|Dopamine Agonists|dopamine agonists|mesh-ancestor
24936095|NCT04044547|Dopamine Agents|dopamine agents|mesh-ancestor
24936096|NCT04044547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24936097|NCT04044547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936098|NCT04044547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936099|NCT04044313|Lenvatinib|lenvatinib|mesh-list
24884936|NCT03193333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24936100|NCT04044313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24936101|NCT04044313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24936102|NCT04044313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405691|NCT03598595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712429|NCT01520415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612170|NCT01012284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24612171|NCT01012349|Aspirin|aspirin|mesh-list
24712430|NCT01520441|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24712432|NCT01520441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24712433|NCT01520441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712434|NCT01520441|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24712435|NCT01520441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24712436|NCT01520441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712437|NCT01520441|Cholinergic Agents|cholinergic agents|mesh-ancestor
24712438|NCT01520441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24712439|NCT01520467|Anastrozole|anastrozole|mesh-list
24936103|NCT04044313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936104|NCT04044287|Misoprostol|misoprostol|mesh-list
24936105|NCT04044287|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24936106|NCT04044287|Abortifacient Agents|abortifacient agents|mesh-ancestor
24936107|NCT04044287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24936108|NCT04044287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785366|NCT01913990|Hormones|hormones|mesh-ancestor
24797283|NCT01955070|Analgesics|analgesics|mesh-ancestor
24991259|NCT05197101|Oxytocin|oxytocin|mesh-list
24936109|NCT04044287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24797561|NCT01956591|Autonomic Agents|autonomic agents|mesh-ancestor
24992362|NCT03882970|Incretins|incretins|mesh-ancestor
24936110|NCT04044287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24936111|NCT04044287|Oxytocics|oxytocics|mesh-ancestor
24798261|NCT01961856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24798262|NCT01961856|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24798263|NCT01961856|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24798264|NCT01961856|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24798265|NCT01961856|Purinergic Agents|purinergic agents|mesh-ancestor
24503386|NCT01655225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24503387|NCT01655225|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24798266|NCT01961856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24798267|NCT01961856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798268|NCT01961856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798269|NCT01961947|Vaccines|vaccines|mesh-list
24798270|NCT01961947|Immunologic Factors|immunologic factors|mesh-ancestor
24798271|NCT01961947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798272|NCT01962116|Heparin|heparin|mesh-list
24798273|NCT01962116|Calcium heparin|calcium heparin|mesh-list
24798274|NCT01962116|Anticoagulants|anticoagulants|mesh-ancestor
24798275|NCT01962116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798276|NCT01962116|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24798277|NCT01962116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24798278|NCT01962181|Methylphenidate|methylphenidate|mesh-list
24998204|NCT03430531|Anesthetics|anesthetics|mesh-ancestor
24998205|NCT03430531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24998206|NCT03430531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998207|NCT03430531|Sensory System Agents|sensory system agents|mesh-ancestor
24998208|NCT03430531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24998214|NCT03409198|Cyclophosphamide|cyclophosphamide|mesh-list
24797895|NCT01959022|Doxazosin|doxazosin|mesh-list
24998217|NCT03409198|Nivolumab|nivolumab|mesh-list
24998219|NCT03409198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24998220|NCT03409198|Immunologic Factors|immunologic factors|mesh-ancestor
24998221|NCT03409198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685267|NCT01903720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25685268|NCT01903720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25685269|NCT01903720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25685270|NCT01903798|Mycophenolic Acid|mycophenolic acid|mesh-list
25685271|NCT01903798|Prednisolone|prednisolone|mesh-list
25685272|NCT01903798|Rilonacept|rilonacept|mesh-list
25685273|NCT01903798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25685274|NCT01903798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25685275|NCT01903798|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25685276|NCT01903798|Antitubercular Agents|antitubercular agents|mesh-ancestor
25685277|NCT01903798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25685278|NCT01903798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25685279|NCT01903798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692549|NCT02001987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24712460|NCT01520753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712461|NCT01520766|Methamphetamine|methamphetamine|mesh-list
24712482|NCT01520818|Insulin|insulin|mesh-list
24998222|NCT03409198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24998223|NCT03409198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24998224|NCT03409198|Alkylating Agents|alkylating agents|mesh-ancestor
24998225|NCT03409198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998226|NCT03409198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998227|NCT03409198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24998228|NCT03409198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24998229|NCT03409198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24998230|NCT03409198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24998231|NCT03409198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998232|NCT03409198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24998233|NCT03409198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24998234|NCT03402841|Olaparib|olaparib|mesh-list
24998235|NCT03402841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24998236|NCT03402841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998237|NCT03402841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998238|NCT03402841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24997143|NCT05395494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24997144|NCT05395494|Antimetabolites|antimetabolites|mesh-ancestor
24997145|NCT05395494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997146|NCT05351151|Lidocaine|lidocaine|mesh-list
24997147|NCT05351151|Anesthetics, Local|anesthetics, local|mesh-ancestor
24997148|NCT05351151|Anesthetics|anesthetics|mesh-ancestor
24997149|NCT05351151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24997158|NCT05344495|Midazolam|midazolam|mesh-list
24845656|NCT02238392|Adenosine|adenosine|mesh-list
24786183|NCT01918384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24574933|NCT00828763|Dolutegravir|dolutegravir|mesh-list
24804137|NCT02001259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24598736|NCT00957866|Interferons|interferons|mesh-list
24622702|NCT01068067|Tacrolimus|tacrolimus|mesh-list
24806470|NCT02016196|Rifaximin|rifaximin|mesh-list
24847166|NCT02245438|Norinyl|norinyl|mesh-list
24998270|NCT03243058|Sensory System Agents|sensory system agents|mesh-ancestor
24998271|NCT03243058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24998272|NCT03243058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843794|NCT02229617|Anabolic Agents|anabolic agents|mesh-ancestor
24848589|NCT03910387|Gemcitabine|gemcitabine|mesh-list
24845178|NCT02236741|Antioxidants|antioxidants|mesh-ancestor
24786449|NCT01920022|Luteolytic Agents|luteolytic agents|mesh-ancestor
24540978|NCT00670410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540980|NCT00670410|Immunologic Factors|immunologic factors|mesh-ancestor
24540982|NCT00670410|Alkylating Agents|alkylating agents|mesh-ancestor
24540983|NCT00670410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24861358|NCT02317237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861359|NCT02317263|Testosterone|testosterone|mesh-list
24861360|NCT02317263|Androgens|androgens|mesh-ancestor
24861361|NCT02317263|Hormones|hormones|mesh-ancestor
24450812|NCT00320658|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24861371|NCT02317341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24861372|NCT02317341|Anesthetics, General|anesthetics, general|mesh-ancestor
24861511|NCT02318121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24861512|NCT02318121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861513|NCT02318199|Anesthetics|anesthetics|mesh-list
24861721|NCT02319616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24861841|NCT02320448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24861842|NCT02320448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861843|NCT02320474|Aflibercept|aflibercept|mesh-list
24861844|NCT02320474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24861845|NCT02320474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24861846|NCT02320474|Growth Substances|growth substances|mesh-ancestor
24861847|NCT02320474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685280|NCT01903798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685281|NCT01903798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25685282|NCT01903798|Glucocorticoids|glucocorticoids|mesh-ancestor
25685283|NCT01903798|Hormones|hormones|mesh-ancestor
24884977|NCT03030235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25685284|NCT01903798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25120831|NCT02514031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120832|NCT02514031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25120833|NCT02514031|Antimetabolites|antimetabolites|mesh-ancestor
25120834|NCT02514031|Antiviral Agents|antiviral agents|mesh-ancestor
25120835|NCT02514031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25120836|NCT02514031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25120838|NCT02514031|Immunologic Factors|immunologic factors|mesh-ancestor
25120840|NCT02514031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25120870|NCT01868451|Doxorubicin|doxorubicin|mesh-list
25120871|NCT01868451|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25120872|NCT01868451|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25120873|NCT01868451|Dacarbazine|dacarbazine|mesh-list
24884978|NCT03030235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884979|NCT03030235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24884980|NCT03030235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509388|NCT00560092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24509389|NCT00560092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509390|NCT00560092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24509391|NCT00560092|Tocolytic Agents|tocolytic agents|mesh-ancestor
24861848|NCT02320474|Growth Inhibitors|growth inhibitors|mesh-ancestor
24813405|NCT02058303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24849906|NCT02251119|Ritonavir|ritonavir|mesh-list
24862039|NCT02322502|Propofol|propofol|mesh-list
24862040|NCT02322502|Sevoflurane|sevoflurane|mesh-list
24862041|NCT02322502|Desflurane|desflurane|mesh-list
24862067|NCT02322619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24862068|NCT02322619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862069|NCT02322619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24862088|NCT02322853|Tamoxifen|tamoxifen|mesh-list
24866501|NCT04760717|Spironolactone|spironolactone|mesh-list
24850207|NCT02252328|Simvastatin|simvastatin|mesh-list
24850283|NCT02252614|Acetaminophen|acetaminophen|mesh-list
24998306|NCT03164993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814868|NCT02067078|Hormones|hormones|mesh-ancestor
24786616|NCT01920945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24786617|NCT01920984|Bevacizumab|bevacizumab|mesh-list
24786618|NCT01920984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24786619|NCT01920984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24786620|NCT01920984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24786622|NCT01920984|Growth Substances|growth substances|mesh-ancestor
24875803|NCT03839823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24578919|NCT00852423|Artenimol|artenimol|mesh-list
24998307|NCT03164993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24998308|NCT03164993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24998309|NCT03164993|Alkylating Agents|alkylating agents|mesh-ancestor
24945302|NCT03951636|Chlorhexidine|chlorhexidine|mesh-list
24998313|NCT03164993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24889881|NCT04488926|Analgesics|analgesics|mesh-ancestor
24889882|NCT04488926|Sensory System Agents|sensory system agents|mesh-ancestor
24998314|NCT03164993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24853053|NCT02265770|Methotrexate|methotrexate|mesh-list
24893189|NCT04453332|Hormones|hormones|mesh-list
24998315|NCT03164993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24998316|NCT03164993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998317|NCT03110510|Leucovorin|leucovorin|mesh-list
24998318|NCT03110510|Fluorouracil|fluorouracil|mesh-list
24998319|NCT03110510|Irinotecan|irinotecan|mesh-list
24998320|NCT03110510|Calcium|calcium|mesh-list
24998321|NCT03110510|Levoleucovorin|levoleucovorin|mesh-list
25048532|NCT00692445|Parasympatholytics|parasympatholytics|mesh-ancestor
25048533|NCT00692445|Autonomic Agents|autonomic agents|mesh-ancestor
25048534|NCT00692445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25685285|NCT01903798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685286|NCT01903798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24454571|NCT03878524|Everolimus|everolimus|mesh-list
25685287|NCT01903811|Dexamethasone|dexamethasone|mesh-list
25685288|NCT01903811|Dexamethasone acetate|dexamethasone acetate|mesh-list
25685289|NCT01903811|Ichthammol|ichthammol|mesh-list
25685290|NCT01903811|BB 1101|bb 1101|mesh-list
25685291|NCT01903811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25685292|NCT01903811|Antiemetics|antiemetics|mesh-ancestor
25685293|NCT01903811|Autonomic Agents|autonomic agents|mesh-ancestor
25685294|NCT01903811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25685295|NCT01903811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685296|NCT01903811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25048535|NCT00692445|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25048536|NCT00692445|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25048537|NCT00692445|Cholinergic Agents|cholinergic agents|mesh-ancestor
25048538|NCT00692445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25685297|NCT01903811|Glucocorticoids|glucocorticoids|mesh-ancestor
25120925|NCT01554046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25048539|NCT00692445|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
25048540|NCT00692445|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25048541|NCT00691964|Etanercept|etanercept|mesh-list
25048542|NCT00691964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25048543|NCT00691964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25048544|NCT00691964|Analgesics|analgesics|mesh-ancestor
25048545|NCT00691964|Sensory System Agents|sensory system agents|mesh-ancestor
25048546|NCT00691964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24902458|NCT04373967|Metformin|metformin|mesh-list
25048568|NCT00690456|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25048569|NCT00690456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25048570|NCT00690456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048571|NCT00690456|Hormones|hormones|mesh-ancestor
25048572|NCT00690456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25048573|NCT00690066|Remestemcel-l|remestemcel-l|mesh-list
25048574|NCT00690066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25048575|NCT00690066|Antiviral Agents|antiviral agents|mesh-ancestor
25048576|NCT00690066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25048577|NCT00687882|Anticoagulants|anticoagulants|mesh-list
25048578|NCT00687687|Paclitaxel|paclitaxel|mesh-list
25048579|NCT00687687|Carboplatin|carboplatin|mesh-list
25048580|NCT00687687|Iniparib|iniparib|mesh-list
25048581|NCT00687687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25048582|NCT00687687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048583|NCT00687687|Tubulin Modulators|tubulin modulators|mesh-ancestor
25048584|NCT00687687|Antimitotic Agents|antimitotic agents|mesh-ancestor
25048585|NCT00687687|Mitosis Modulators|mitosis modulators|mesh-ancestor
25048586|NCT00687687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786937|NCT01922713|Antioxidants|antioxidants|mesh-ancestor
24854903|NCT02276014|Vitamins|vitamins|mesh-ancestor
24787004|NCT01923012|Coagulants|coagulants|mesh-ancestor
24855013|NCT02276911|Ibuprofen|ibuprofen|mesh-list
24503612|NCT00532389|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24503613|NCT00532389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903701|NCT04361513|Hormones|hormones|mesh-ancestor
24904333|NCT04356833|Plasminogen|plasminogen|mesh-list
24906664|NCT04338191|Leucovorin|leucovorin|mesh-list
24936269|NCT04042441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936271|NCT04042688|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24936272|NCT04042688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24936273|NCT04042688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936274|NCT04042688|Hemostatics|hemostatics|mesh-ancestor
24936275|NCT04042688|Coagulants|coagulants|mesh-ancestor
24936276|NCT04042558|Bevacizumab|bevacizumab|mesh-list
24936277|NCT04042558|Carboplatin|carboplatin|mesh-list
24936278|NCT04042558|Pemetrexed|pemetrexed|mesh-list
24936279|NCT04042558|Atezolizumab|atezolizumab|mesh-list
24936280|NCT04042558|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24936281|NCT04042558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24936282|NCT04042558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24936283|NCT04042558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24936284|NCT04042558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24936285|NCT04042558|Growth Substances|growth substances|mesh-ancestor
24936286|NCT04042558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936287|NCT04042558|Growth Inhibitors|growth inhibitors|mesh-ancestor
24936288|NCT04042558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24941590|NCT03989310|Antibodies|antibodies|mesh-list
24941592|NCT03989310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24941593|NCT03989310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941594|NCT03989310|Tubulin Modulators|tubulin modulators|mesh-ancestor
24941595|NCT03989310|Antimitotic Agents|antimitotic agents|mesh-ancestor
24942729|NCT03978494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24942730|NCT03978494|Immunologic Factors|immunologic factors|mesh-ancestor
24942731|NCT03978494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942732|NCT03978494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24942733|NCT03978494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24942734|NCT03978494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942736|NCT03978559|Caspofungin|caspofungin|mesh-list
24625792|NCT01083537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24625793|NCT01083537|Tubulin Modulators|tubulin modulators|mesh-ancestor
24625794|NCT01083537|Antimitotic Agents|antimitotic agents|mesh-ancestor
24625799|NCT01083589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24625801|NCT01083589|Antimitotic Agents|antimitotic agents|mesh-ancestor
24625802|NCT01083589|Mitosis Modulators|mitosis modulators|mesh-ancestor
24625803|NCT01083589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685298|NCT01903811|Hormones|hormones|mesh-ancestor
25405692|NCT03598595|Tubulin Modulators|tubulin modulators|mesh-ancestor
25692550|NCT02001987|Abortifacient Agents|abortifacient agents|mesh-ancestor
24625804|NCT01083589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24625805|NCT01083589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625806|NCT01083784|Valproic Acid|valproic acid|mesh-list
24625807|NCT01083784|Clonazepam|clonazepam|mesh-list
24625842|NCT01083953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24625843|NCT01083953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625845|NCT01083966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24625846|NCT01083966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24625847|NCT01083966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24625848|NCT01083966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24625849|NCT01083966|Growth Substances|growth substances|mesh-ancestor
24942934|NCT03976544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942943|NCT03976102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24942944|NCT03976102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943554|NCT03969758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24943555|NCT03969017|Interferons|interferons|mesh-list
24943556|NCT03969017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943557|NCT03969017|Antiviral Agents|antiviral agents|mesh-ancestor
24943558|NCT03969017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24943560|NCT03968835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24943561|NCT03968835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24943562|NCT03968835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24943563|NCT03968640|Coenzyme Q10|coenzyme q10|mesh-list
24943564|NCT03968640|Vitamins|vitamins|mesh-ancestor
24943565|NCT03968640|Micronutrients|micronutrients|mesh-ancestor
24943566|NCT03968640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943567|NCT03968588|Mycophenolic Acid|mycophenolic acid|mesh-list
24943568|NCT03968588|Tacrolimus|tacrolimus|mesh-list
24943569|NCT03968588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24943570|NCT03968588|Immunologic Factors|immunologic factors|mesh-ancestor
24943571|NCT03968588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943572|NCT03968588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24812913|NCT02055183|Antitoxins|antitoxins|mesh-list
24959677|NCT03823274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24959678|NCT03823274|Purinergic Agents|purinergic agents|mesh-ancestor
24959679|NCT03823274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24959680|NCT03823482|Lidocaine|lidocaine|mesh-list
24959681|NCT03823482|Anesthetics, Local|anesthetics, local|mesh-ancestor
24959682|NCT03823482|Anesthetics|anesthetics|mesh-ancestor
24959683|NCT03823482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24959684|NCT03823482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943831|NCT03966547|Anesthetics, Local|anesthetics, local|mesh-list
24943837|NCT03966378|Calcium|calcium|mesh-list
25051243|NCT00430092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943871|NCT03966326|Narcotics|narcotics|mesh-ancestor
24542505|NCT00679068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24542506|NCT00679068|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24542706|NCT00679770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24542709|NCT00679835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24542711|NCT00679900|Lormetazepam|lormetazepam|mesh-list
24542712|NCT00679900|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24542713|NCT00679900|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24543303|NCT00683124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24543304|NCT00683124|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24543305|NCT00683124|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24543306|NCT00683124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543307|NCT00683124|Vasodilator Agents|vasodilator agents|mesh-ancestor
24543308|NCT00683124|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24945240|NCT03952572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24945241|NCT03952572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24945242|NCT03952572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24945243|NCT03952572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24945244|NCT03952572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24945245|NCT03952572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24945246|NCT03952572|Glucocorticoids|glucocorticoids|mesh-ancestor
24945247|NCT03952572|Hormones|hormones|mesh-ancestor
24945248|NCT03952572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25692551|NCT02001987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25692552|NCT02001987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692553|NCT02001987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25692554|NCT02001987|Antimetabolites|antimetabolites|mesh-ancestor
24945249|NCT03952572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24945250|NCT03952572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24945252|NCT03952572|Antimitotic Agents|antimitotic agents|mesh-ancestor
24945253|NCT03952572|Mitosis Modulators|mitosis modulators|mesh-ancestor
24945254|NCT03952481|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24945255|NCT03952481|Lifitegrast|lifitegrast|mesh-list
24945256|NCT03952481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24945257|NCT03952325|Pembrolizumab|pembrolizumab|mesh-list
24945258|NCT03952325|Nivolumab|nivolumab|mesh-list
24945259|NCT03952325|Atezolizumab|atezolizumab|mesh-list
24945260|NCT03952325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24945261|NCT03952325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24945262|NCT03952325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24945263|NCT03952325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945264|NCT03952273|Sirolimus|sirolimus|mesh-list
24945265|NCT03952273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24945266|NCT03952273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24945267|NCT03952273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24945268|NCT03952273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24945269|NCT03952273|Antifungal Agents|antifungal agents|mesh-ancestor
24945270|NCT03952273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24945271|NCT03952273|Immunologic Factors|immunologic factors|mesh-ancestor
24945272|NCT03952273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770443|NCT01820455|Dermatologic Agents|dermatologic agents|mesh-ancestor
24819041|NCT02092766|Artesunate|artesunate|mesh-list
24945273|NCT03952260|Anesthetics|anesthetics|mesh-list
24945274|NCT03952260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24945275|NCT03952260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945276|NCT03951987|Charcoal|charcoal|mesh-list
24945277|NCT03951987|Antidotes|antidotes|mesh-ancestor
24945278|NCT03951987|Protective Agents|protective agents|mesh-ancestor
24945279|NCT03951987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945280|NCT03951558|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24858141|NCT02295566|Autonomic Agents|autonomic agents|mesh-ancestor
25051373|NCT00411528|Prednisone|prednisone|mesh-list
25051374|NCT00411528|Docetaxel|docetaxel|mesh-list
25051375|NCT00411528|Epothilone B|epothilone b|mesh-list
25051376|NCT00411528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051377|NCT00411528|Tubulin Modulators|tubulin modulators|mesh-ancestor
25051381|NCT00411528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25051382|NCT00411528|Glucocorticoids|glucocorticoids|mesh-ancestor
25051383|NCT00411528|Hormones|hormones|mesh-ancestor
24945288|NCT03951831|Docetaxel|docetaxel|mesh-list
24945289|NCT03951831|Leuprolide|leuprolide|mesh-list
24945290|NCT03951831|Cemiplimab|cemiplimab|mesh-list
24945291|NCT03951831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24945292|NCT03951831|Tubulin Modulators|tubulin modulators|mesh-ancestor
24945293|NCT03951831|Antimitotic Agents|antimitotic agents|mesh-ancestor
24945294|NCT03951831|Mitosis Modulators|mitosis modulators|mesh-ancestor
24503751|NCT00532727|Docetaxel|docetaxel|mesh-list
24945295|NCT03951831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945296|NCT03951831|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24945297|NCT03951831|Fertility Agents|fertility agents|mesh-ancestor
24945298|NCT03951831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24945299|NCT03951831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945300|NCT03951831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24945301|NCT03951831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24945303|NCT03951636|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24945304|NCT03951636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24945305|NCT03951636|Disinfectants|disinfectants|mesh-ancestor
24945306|NCT03951753|Tirzepatide|tirzepatide|mesh-list
24945307|NCT03951753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24945308|NCT03951753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945309|NCT03951753|Incretins|incretins|mesh-ancestor
25021012|NCT03675594|Cobalt|cobalt|mesh-list
25051384|NCT00411528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25051385|NCT00411528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945311|NCT03951753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24945312|NCT03951597|Gemcitabine|gemcitabine|mesh-list
24945313|NCT03951597|Oxaliplatin|oxaliplatin|mesh-list
24945314|NCT03951597|Lenvatinib|lenvatinib|mesh-list
24945315|NCT03951597|Antibodies|antibodies|mesh-list
24945316|NCT03951597|Immunologic Factors|immunologic factors|mesh-ancestor
24945317|NCT03951597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945318|NCT03951597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24945319|NCT03951597|Antimetabolites|antimetabolites|mesh-ancestor
24771789|NCT01829841|Sunitinib|sunitinib|mesh-list
24945321|NCT03951597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24945322|NCT03951597|Antiviral Agents|antiviral agents|mesh-ancestor
24945323|NCT03951597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24945324|NCT03951597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24945325|NCT03951597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24945326|NCT03951597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24945328|NCT03951415|Olaparib|olaparib|mesh-list
24945329|NCT03951415|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
24945330|NCT03951415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24945331|NCT03951415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24945332|NCT03951415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24945333|NCT03951415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945334|NCT03951402|Moxifloxacin|moxifloxacin|mesh-list
24945335|NCT03951402|Tapentadol|tapentadol|mesh-list
24945336|NCT03951402|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24945337|NCT03951402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24945666|NCT03948620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24946020|NCT03943459|Antioxidants|antioxidants|mesh-ancestor
24946021|NCT03943459|Protective Agents|protective agents|mesh-ancestor
24946022|NCT03943459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946023|NCT03943784|Propranolol|propranolol|mesh-list
24946024|NCT03943784|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24946025|NCT03943784|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24946026|NCT03943784|Adrenergic Agents|adrenergic agents|mesh-ancestor
24946027|NCT03943784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24946028|NCT03943784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946029|NCT03943784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946030|NCT03943784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24946031|NCT03943784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24946032|NCT03943784|Vasodilator Agents|vasodilator agents|mesh-ancestor
24946033|NCT03943823|Estrogens|estrogens|mesh-list
24946034|NCT03943823|Hormones|hormones|mesh-ancestor
24946035|NCT03943823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24946042|NCT03943472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24946043|NCT03943472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24946044|NCT03943472|Alkylating Agents|alkylating agents|mesh-ancestor
24946045|NCT03943472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946046|NCT03943472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24946047|NCT03943472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24946048|NCT03943186|Hyaluronic Acid|hyaluronic acid|mesh-list
24946049|NCT03943186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24946050|NCT03943186|Immunologic Factors|immunologic factors|mesh-ancestor
24946051|NCT03943186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946052|NCT03943186|Viscosupplements|viscosupplements|mesh-ancestor
24946053|NCT03943186|Protective Agents|protective agents|mesh-ancestor
24946054|NCT03943407|Imiquimod|imiquimod|mesh-list
24946055|NCT03943407|Cinnamaldehyde|cinnamaldehyde|mesh-list
24946056|NCT03943407|Doxepin|doxepin|mesh-list
24946057|NCT03943407|Menthol|menthol|mesh-list
24946058|NCT03943407|Histamine|histamine|mesh-list
24946059|NCT03943407|Antipruritics|antipruritics|mesh-ancestor
25051439|NCT00403416|Mycophenolic Acid|mycophenolic acid|mesh-list
24961839|NCT03805152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946060|NCT03943407|Dermatologic Agents|dermatologic agents|mesh-ancestor
24946061|NCT03943407|Histamine Agonists|histamine agonists|mesh-ancestor
24946063|NCT03943407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24946064|NCT03943407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946065|NCT03943407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961916|NCT03804359|Rituximab|rituximab|mesh-list
24961925|NCT03804034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961926|NCT03804177|Ascorbic Acid|ascorbic acid|mesh-list
24961927|NCT03804177|Melatonin|melatonin|mesh-list
25051441|NCT00403416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051442|NCT00403416|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25051443|NCT00403416|Antitubercular Agents|antitubercular agents|mesh-ancestor
24911359|NCT04289207|Danazol|danazol|mesh-list
25051444|NCT00403416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25051445|NCT00403416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24858941|NCT02300623|Analgesics|analgesics|mesh-ancestor
24946144|NCT03942796|Anticonvulsants|anticonvulsants|mesh-ancestor
24946145|NCT03942796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24946146|NCT03942796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24946297|NCT03941535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946299|NCT03941535|Coagulants|coagulants|mesh-ancestor
24946300|NCT03941340|Aflutinib|aflutinib|mesh-list
24946301|NCT03941340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24946303|NCT03941340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946304|NCT03940976|Afatinib|afatinib|mesh-list
24946305|NCT03940976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121089|NCT00583778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946306|NCT03940976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24946307|NCT03940976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24946308|NCT03940976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946338|NCT03940235|Hormones|hormones|mesh-ancestor
24946339|NCT03940235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24946340|NCT03940235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946341|NCT03940391|Chlorpheniramine|chlorpheniramine|mesh-list
24946342|NCT03940391|Midazolam|midazolam|mesh-list
24800540|NCT01976182|Dermatologic Agents|dermatologic agents|mesh-ancestor
24946367|NCT03940469|Dexmedetomidine|dexmedetomidine|mesh-list
24946368|NCT03940469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24946370|NCT03940469|Autonomic Agents|autonomic agents|mesh-ancestor
24946371|NCT03940469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24946372|NCT03940469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946373|NCT03940469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24946374|NCT03940469|Glucocorticoids|glucocorticoids|mesh-ancestor
24946375|NCT03940469|Hormones|hormones|mesh-ancestor
24946376|NCT03940469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24946377|NCT03940469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24946378|NCT03940469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24946379|NCT03940469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24946380|NCT03940469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24946381|NCT03940469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24946382|NCT03940469|Analgesics|analgesics|mesh-ancestor
24946383|NCT03940469|Sensory System Agents|sensory system agents|mesh-ancestor
24946384|NCT03940469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24946385|NCT03940469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24946386|NCT03940469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24946387|NCT03940469|Adrenergic Agents|adrenergic agents|mesh-ancestor
24946388|NCT03940469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24946389|NCT03940469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946391|NCT03939663|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24946397|NCT03939663|Oxytocics|oxytocics|mesh-ancestor
24946404|NCT03939884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946405|NCT03939884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24946406|NCT03939884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24946407|NCT03939884|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24946408|NCT03939884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24946409|NCT03939884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946410|NCT03939923|Glycopyrrolate|glycopyrrolate|mesh-list
24946412|NCT03939923|Neostigmine|neostigmine|mesh-list
24946413|NCT03939923|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24946414|NCT03939923|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24946415|NCT03939923|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24946416|NCT03939923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24946421|NCT03939923|Cholinergic Agents|cholinergic agents|mesh-ancestor
24946422|NCT03939923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24946423|NCT03939923|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24946424|NCT03939923|Autonomic Agents|autonomic agents|mesh-ancestor
24946425|NCT03939923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25021103|NCT03674606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24946426|NCT03939923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24946427|NCT03939923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24946428|NCT03939637|Immunoglobulins|immunoglobulins|mesh-list
24946429|NCT03939637|Antibodies|antibodies|mesh-list
24946430|NCT03939637|gamma-Globulins|gamma-globulins|mesh-list
24946431|NCT03939637|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24946432|NCT03939637|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24946433|NCT03939637|Immunologic Factors|immunologic factors|mesh-ancestor
24946434|NCT03939637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946435|NCT03939975|Pembrolizumab|pembrolizumab|mesh-list
24946436|NCT03939975|Nivolumab|nivolumab|mesh-list
24946609|NCT03936517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24946610|NCT03936491|Methylphenidate|methylphenidate|mesh-list
24946611|NCT03936491|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24946612|NCT03936491|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24946613|NCT03936491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946614|NCT03936491|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24946615|NCT03936491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24946616|NCT03936491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25692555|NCT02001987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946617|NCT03936491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946618|NCT03936491|Dopamine Agents|dopamine agents|mesh-ancestor
24946619|NCT03936491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24946620|NCT03936491|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24946621|NCT03936491|Adrenergic Agents|adrenergic agents|mesh-ancestor
24800916|NCT01979653|Midazolam|midazolam|mesh-list
24948806|NCT05402319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24948807|NCT05402319|Antitubercular Agents|antitubercular agents|mesh-ancestor
24964353|NCT03783728|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24964354|NCT03783728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24964355|NCT03783728|Antimetabolites|antimetabolites|mesh-ancestor
24964357|NCT03783728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24949014|NCT05382871|Vaccines|vaccines|mesh-list
24949015|NCT05382871|Immunologic Factors|immunologic factors|mesh-ancestor
24949016|NCT05382871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949069|NCT05327556|Sympathomimetics|sympathomimetics|mesh-ancestor
24949070|NCT05327556|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24964620|NCT03781596|Dermatologic Agents|dermatologic agents|mesh-ancestor
24949086|NCT05282940|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
24949087|NCT05282940|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
24949089|NCT05282940|Estrogens|estrogens|mesh-ancestor
24949090|NCT05282940|Hormones|hormones|mesh-ancestor
24949091|NCT05282940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24949092|NCT05282940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949093|NCT05282940|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24949094|NCT05282940|Contraceptive Agents|contraceptive agents|mesh-ancestor
24949095|NCT05282940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24949096|NCT05282940|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24949097|NCT05282940|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24949098|NCT05282940|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24949099|NCT05282940|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24949100|NCT05282940|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24802981|NCT01993680|Bromides|bromides|mesh-list
24772048|NCT01831323|Mesalamine|mesalamine|mesh-list
24509392|NCT00560092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24509393|NCT00560118|Fotemustine|fotemustine|mesh-list
24509394|NCT00560118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509395|NCT00560144|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24509396|NCT00560144|Immunologic Factors|immunologic factors|mesh-ancestor
24509397|NCT00560144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885000|NCT02969928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24509495|NCT00560586|Budesonide|budesonide|mesh-list
24509496|NCT00560586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24509497|NCT00560586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24949243|NCT05086939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24949244|NCT05086939|Immunologic Factors|immunologic factors|mesh-ancestor
24949245|NCT05086939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949246|NCT05086939|Viscosupplements|viscosupplements|mesh-ancestor
24949247|NCT05086939|Protective Agents|protective agents|mesh-ancestor
25021148|NCT03674385|Enclomiphene|enclomiphene|mesh-list
24964723|NCT03781115|Serotonin Agents|serotonin agents|mesh-ancestor
24949279|NCT05039073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24949281|NCT05039073|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24949282|NCT05039073|Antibodies|antibodies|mesh-list
24949283|NCT05039073|Immunoglobulins|immunoglobulins|mesh-list
24949284|NCT05039073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24949285|NCT05039073|Immunoconjugates|immunoconjugates|mesh-list
24949286|NCT05039073|Immunologic Factors|immunologic factors|mesh-ancestor
24949287|NCT05039073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949289|NCT05039073|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24885040|NCT02907996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24885042|NCT02857426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24885043|NCT02857426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885044|NCT02857426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24949290|NCT05039073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949292|NCT05028725|Hemostatics|hemostatics|mesh-ancestor
24949293|NCT05028725|Coagulants|coagulants|mesh-ancestor
24949294|NCT05026125|Remifentanil|remifentanil|mesh-list
24949295|NCT05026125|Anesthetics|anesthetics|mesh-list
24949296|NCT05026125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24949297|NCT05026125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713001|NCT01523548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713002|NCT01523548|Gasotransmitters|gasotransmitters|mesh-ancestor
24713003|NCT01523548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24713004|NCT01523548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644447|NCT01191021|Propofol|propofol|mesh-list
24949298|NCT05026125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24949299|NCT05026125|Narcotics|narcotics|mesh-ancestor
24949300|NCT05026125|Analgesics|analgesics|mesh-ancestor
24504135|NCT00534287|Meropenem|meropenem|mesh-list
24803167|NCT01994980|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24949332|NCT04971746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24803212|NCT01995058|Glucocorticoids|glucocorticoids|mesh-ancestor
24949522|NCT04603911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24949523|NCT04603911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803403|NCT01996306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775019|NCT01849640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24885045|NCT02857426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775021|NCT01849666|Phenprocoumon|phenprocoumon|mesh-list
24775022|NCT01849666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24775023|NCT01849666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24775024|NCT01849666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775025|NCT01849666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775026|NCT01849666|Anticoagulants|anticoagulants|mesh-ancestor
24775027|NCT01849757|Plasma-lyte 148|plasma-lyte 148|mesh-list
24775028|NCT01849757|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24775029|NCT01849757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24949555|NCT04564157|Tubulin Modulators|tubulin modulators|mesh-ancestor
24949556|NCT04564157|Antimitotic Agents|antimitotic agents|mesh-ancestor
24949557|NCT04564157|Mitosis Modulators|mitosis modulators|mesh-ancestor
24949558|NCT04564157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949559|NCT04564157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24949560|NCT04564157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25051826|NCT00372437|Mocetinostat|mocetinostat|mesh-list
25051827|NCT00372437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25051828|NCT00372437|Antimetabolites|antimetabolites|mesh-ancestor
24803529|NCT01996735|Purinergic Agents|purinergic agents|mesh-ancestor
24965033|NCT03779178|Adrenergic Agents|adrenergic agents|mesh-ancestor
24965034|NCT03779178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24965035|NCT03779178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504342|NCT00535418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965036|NCT03779178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965037|NCT03779178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24790969|NCT05409339|Purinergic Agents|purinergic agents|mesh-ancestor
24949579|NCT04460183|Autonomic Agents|autonomic agents|mesh-ancestor
24949580|NCT04460183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24949581|NCT04460183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949582|NCT04460183|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24627293|NCT01091753|Vasodilator Agents|vasodilator agents|mesh-ancestor
24949583|NCT04460183|Respiratory System Agents|respiratory system agents|mesh-ancestor
24949584|NCT04460183|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24949585|NCT04460183|Antioxidants|antioxidants|mesh-ancestor
24949586|NCT04460183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949587|NCT04460183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24949588|NCT04460183|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24949589|NCT04460183|Vasodilator Agents|vasodilator agents|mesh-ancestor
24949590|NCT04460183|Gasotransmitters|gasotransmitters|mesh-ancestor
24949591|NCT04460183|Protective Agents|protective agents|mesh-ancestor
24949592|NCT04375033|Buprenorphine|buprenorphine|mesh-list
24949593|NCT04375033|Naloxone|naloxone|mesh-list
24949594|NCT04375033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24949595|NCT04375033|Narcotics|narcotics|mesh-ancestor
24949601|NCT04375033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24949689|NCT03813836|Pembrolizumab|pembrolizumab|mesh-list
24949690|NCT03813836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25051864|NCT00369070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24949691|NCT03813836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24949833|NCT03530800|Dronabinol|dronabinol|mesh-list
24949834|NCT03530800|Hallucinogens|hallucinogens|mesh-ancestor
24803781|NCT01998503|Autonomic Agents|autonomic agents|mesh-ancestor
25685299|NCT01903811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25685300|NCT01903811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25685301|NCT01903811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25685302|NCT01903811|Protease Inhibitors|protease inhibitors|mesh-ancestor
25405693|NCT03598595|Antimitotic Agents|antimitotic agents|mesh-ancestor
24949862|NCT03477175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949865|NCT03439891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24949866|NCT03439891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24949867|NCT03439891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24949868|NCT03439891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949869|NCT03439891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24949870|NCT03439891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24949871|NCT03431584|Hyaluronic Acid|hyaluronic acid|mesh-list
24949872|NCT03431584|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24949873|NCT03431584|Immunologic Factors|immunologic factors|mesh-ancestor
24949874|NCT03431584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949875|NCT03431584|Viscosupplements|viscosupplements|mesh-ancestor
24949876|NCT03431584|Protective Agents|protective agents|mesh-ancestor
24949906|NCT03412643|Alkylating Agents|alkylating agents|mesh-ancestor
24949907|NCT03412643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24949908|NCT03412643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24949909|NCT03412643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24949910|NCT03412643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24949911|NCT03412643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24949912|NCT03412643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24949913|NCT03380455|Cimetidine|cimetidine|mesh-list
24949914|NCT03380455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24949915|NCT03380455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24509532|NCT00560820|Sequestering Agents|sequestering agents|mesh-ancestor
24949916|NCT03380455|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24949917|NCT03380455|Histamine Antagonists|histamine antagonists|mesh-ancestor
24949918|NCT03380455|Histamine Agents|histamine agents|mesh-ancestor
24949919|NCT03380455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24949920|NCT03380455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949921|NCT03380455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949922|NCT03380455|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24949923|NCT03380455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24949924|NCT03380455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598423|NCT00956111|Vaccines|vaccines|mesh-list
25051904|NCT00364546|Sensory System Agents|sensory system agents|mesh-ancestor
25051905|NCT00364546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25051906|NCT00364546|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25051907|NCT00364546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25051908|NCT00364546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24950163|NCT02348203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24950164|NCT02348203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950166|NCT02348203|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24950167|NCT02348203|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24950254|NCT01864109|Ifosfamide|ifosfamide|mesh-list
24950255|NCT01864109|Doxorubicin|doxorubicin|mesh-list
24950256|NCT01864109|Irinotecan|irinotecan|mesh-list
24950257|NCT01864109|Etoposide|etoposide|mesh-list
24950258|NCT01864109|Vincristine|vincristine|mesh-list
24950260|NCT01864109|Razoxane|razoxane|mesh-list
24950261|NCT01864109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24950262|NCT01864109|Immunologic Factors|immunologic factors|mesh-ancestor
24950263|NCT01864109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950264|NCT01864109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24950265|NCT01864109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24950266|NCT01864109|Alkylating Agents|alkylating agents|mesh-ancestor
24950267|NCT01864109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950268|NCT01864109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950269|NCT01864109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24950300|NCT01862315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24950302|NCT01862315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24950303|NCT01862315|Immunologic Factors|immunologic factors|mesh-ancestor
24914023|NCT04258644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914025|NCT04258644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950402|NCT03916328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24950403|NCT03916328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950404|NCT03916510|Capecitabine|capecitabine|mesh-list
24950405|NCT03916510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24775808|NCT01855009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775809|NCT01855009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24775810|NCT01855061|Midazolam|midazolam|mesh-list
24775811|NCT01855061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24775812|NCT01855061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24713488|NCT01526174|Immunologic Factors|immunologic factors|mesh-ancestor
24713489|NCT01526174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713501|NCT01526278|Micronutrients|micronutrients|mesh-ancestor
24713502|NCT01526317|Metformin|metformin|mesh-list
24713553|NCT01526499|Antimitotic Agents|antimitotic agents|mesh-ancestor
24713554|NCT01526499|Mitosis Modulators|mitosis modulators|mesh-ancestor
24775813|NCT01855061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24509533|NCT00560820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509534|NCT00560898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24509535|NCT00560924|Estradiol|estradiol|mesh-list
24509536|NCT00560924|Estrogens|estrogens|mesh-ancestor
24775814|NCT01855061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775815|NCT01855061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24775816|NCT01855061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24775817|NCT01855061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24775818|NCT01855061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24775819|NCT01855061|Anesthetics, General|anesthetics, general|mesh-ancestor
24775820|NCT01855061|Anesthetics|anesthetics|mesh-ancestor
24775821|NCT01855061|GABA Modulators|gaba modulators|mesh-ancestor
24775822|NCT01855061|GABA Agents|gaba agents|mesh-ancestor
24950472|NCT03915444|Mitosis Modulators|mitosis modulators|mesh-ancestor
24950473|NCT03915444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950474|NCT03915444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24950475|NCT03915444|Antimetabolites|antimetabolites|mesh-ancestor
24950476|NCT03915444|Antiviral Agents|antiviral agents|mesh-ancestor
24950477|NCT03915444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24950478|NCT03915444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950479|NCT03915444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24950480|NCT03915444|Immunologic Factors|immunologic factors|mesh-ancestor
24950481|NCT03915444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950483|NCT03915561|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24950484|NCT03915561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24950485|NCT03915561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950486|NCT03915561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509547|NCT00560976|Hematinics|hematinics|mesh-ancestor
24950488|NCT03915561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24950489|NCT03915561|Analgesics|analgesics|mesh-ancestor
24950490|NCT03915561|Sensory System Agents|sensory system agents|mesh-ancestor
24950491|NCT03915561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24950492|NCT03915561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950493|NCT03915561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24775867|NCT01855386|Liver Extracts|liver extracts|mesh-list
24950501|NCT03914963|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24950502|NCT03914963|Hemostatics|hemostatics|mesh-ancestor
24950503|NCT03914963|Coagulants|coagulants|mesh-ancestor
24950504|NCT03915132|Nimotuzumab|nimotuzumab|mesh-list
24950505|NCT03915132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24950543|NCT03914677|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24950544|NCT03914677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24950545|NCT03914677|Cholinergic Agents|cholinergic agents|mesh-ancestor
24950546|NCT03914677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24804462|NCT02002663|Prednisolone|prednisolone|mesh-list
24950609|NCT03913702|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24950611|NCT03913702|Prednisolone acetate|prednisolone acetate|mesh-list
24950612|NCT03913702|Ketorolac|ketorolac|mesh-list
24950613|NCT03913702|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24950614|NCT03913702|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24950615|NCT03913702|Prednisolone phosphate|prednisolone phosphate|mesh-list
24950616|NCT03913702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24950617|NCT03913702|Antiemetics|antiemetics|mesh-ancestor
24950618|NCT03913702|Autonomic Agents|autonomic agents|mesh-ancestor
24950619|NCT03913702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24950620|NCT03913702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950621|NCT03913702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24950622|NCT03913702|Glucocorticoids|glucocorticoids|mesh-ancestor
24950623|NCT03913702|Hormones|hormones|mesh-ancestor
24950624|NCT03913702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24950625|NCT03913702|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24950626|NCT03913702|Protective Agents|protective agents|mesh-ancestor
24950627|NCT03913702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24950628|NCT03913702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25685303|NCT01903811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25685304|NCT01903811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685305|NCT01903811|Dermatologic Agents|dermatologic agents|mesh-ancestor
25685306|NCT01903837|Naltrexone|naltrexone|mesh-list
25685307|NCT01903837|Olanzapine|olanzapine|mesh-list
25685308|NCT01903837|ALKS-33|alks-33|mesh-list
25685309|NCT01903837|Antiemetics|antiemetics|mesh-ancestor
24614686|NCT01025882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24614687|NCT01025882|Antimetabolites|antimetabolites|mesh-ancestor
24804499|NCT02002741|Acetaminophen|acetaminophen|mesh-list
24965882|NCT03773588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965883|NCT03773588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24965884|NCT03773588|Anesthetics, General|anesthetics, general|mesh-ancestor
24965885|NCT03773588|Anesthetics|anesthetics|mesh-ancestor
24965886|NCT03773510|Trabectedin|trabectedin|mesh-list
24965887|NCT03773510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24965888|NCT03773510|Alkylating Agents|alkylating agents|mesh-ancestor
24965889|NCT03773510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965890|NCT03773510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950715|NCT03912727|Micronutrients|micronutrients|mesh-ancestor
24950718|NCT03912740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24950719|NCT03912740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24950720|NCT03912740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950722|NCT03912740|Analgesics|analgesics|mesh-ancestor
24950723|NCT03912740|Sensory System Agents|sensory system agents|mesh-ancestor
24950724|NCT03912740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24950725|NCT03912740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24950726|NCT03912740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24950727|NCT03912740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24950728|NCT03912740|Adrenergic Agents|adrenergic agents|mesh-ancestor
24804679|NCT02004314|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24950844|NCT03910803|Brodalumab|brodalumab|mesh-list
24950845|NCT03910803|Dermatologic Agents|dermatologic agents|mesh-ancestor
24950846|NCT03910647|Pantoprazole|pantoprazole|mesh-list
24950847|NCT03910647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24950848|NCT03910647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24950849|NCT03910647|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24776319|NCT01857609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950850|NCT03910647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950877|NCT03910556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24966062|NCT03771729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24966063|NCT03771729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24966064|NCT03771729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24966065|NCT03771729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966067|NCT03772067|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24509548|NCT00561028|Antibodies|antibodies|mesh-list
24950884|NCT03910543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24950885|NCT03910543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473165|NCT00402207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24473169|NCT00402259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24473170|NCT00402259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24473358|NCT00402558|Sensory System Agents|sensory system agents|mesh-ancestor
24473360|NCT00402558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25052202|NCT00318656|Glimepiride|glimepiride|mesh-list
25052203|NCT00318656|Rosiglitazone|rosiglitazone|mesh-list
25052238|NCT00315640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052239|NCT00315640|Growth Inhibitors|growth inhibitors|mesh-ancestor
25052240|NCT00315640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052241|NCT00315640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25052242|NCT00313794|Tremelimumab|tremelimumab|mesh-list
24504621|NCT00537420|Sibutramine|sibutramine|mesh-list
25052243|NCT00313794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052244|NCT00313768|Paclitaxel|paclitaxel|mesh-list
25052245|NCT00313768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25052246|NCT00313768|Bevacizumab|bevacizumab|mesh-list
25052247|NCT00313768|Carboplatin|carboplatin|mesh-list
25052268|NCT00313222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25052269|NCT00313222|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24935327|NCT04051853|GABA Modulators|gaba modulators|mesh-ancestor
24935328|NCT04051853|GABA Agents|gaba agents|mesh-ancestor
24935329|NCT04051853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24935330|NCT04051853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935331|NCT04051853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935332|NCT04051853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24935333|NCT04051853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935334|NCT04051827|Midazolam|midazolam|mesh-list
24935335|NCT04051827|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24935336|NCT04051827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24935337|NCT04051827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25685310|NCT01903837|Autonomic Agents|autonomic agents|mesh-ancestor
25685311|NCT01903837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24935338|NCT04051827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935339|NCT04051827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24935340|NCT04051827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24935341|NCT04051827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24935342|NCT04051827|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24935343|NCT04051827|Anesthetics, General|anesthetics, general|mesh-ancestor
24509538|NCT00560924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24509539|NCT00560924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509540|NCT00560963|Everolimus|everolimus|mesh-list
24509541|NCT00560963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509542|NCT00560963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24509543|NCT00560963|Immunologic Factors|immunologic factors|mesh-ancestor
24509544|NCT00560963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509545|NCT00560976|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24509546|NCT00560976|Ferric gluconate|ferric gluconate|mesh-list
24509549|NCT00561028|Immunologic Factors|immunologic factors|mesh-ancestor
24509550|NCT00561028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509629|NCT00561197|Contraceptive Agents|contraceptive agents|mesh-ancestor
24509630|NCT00561197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24935344|NCT04051827|Anesthetics|anesthetics|mesh-ancestor
24935345|NCT04051827|GABA Modulators|gaba modulators|mesh-ancestor
24935346|NCT04051827|GABA Agents|gaba agents|mesh-ancestor
24935347|NCT04051827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24935348|NCT04051827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935349|NCT04051970|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24935350|NCT04051970|Antiviral Agents|antiviral agents|mesh-ancestor
24935351|NCT04051970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24935353|NCT04051632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24935354|NCT04051632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935355|NCT04051580|Plasma-lyte 148|plasma-lyte 148|mesh-list
24935356|NCT04051580|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24806458|NCT02016001|Fluorides|fluorides|mesh-list
25052342|NCT00303498|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25052343|NCT00303498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052412|NCT00289640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052413|NCT00287547|Abatacept|abatacept|mesh-list
25052414|NCT00287547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25052415|NCT00287547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914652|NCT04253132|Serotonin Agents|serotonin agents|mesh-ancestor
25052463|NCT00273650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052464|NCT00273650|Vitamin B Complex|vitamin b complex|mesh-ancestor
25052465|NCT00267592|Temozolomide|temozolomide|mesh-list
25052466|NCT00267592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25052467|NCT00267592|Alkylating Agents|alkylating agents|mesh-ancestor
25052468|NCT00267592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052469|NCT00267592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053323|NCT00065728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25053324|NCT00065728|Growth Substances|growth substances|mesh-ancestor
25053325|NCT00065728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053326|NCT00065728|Growth Inhibitors|growth inhibitors|mesh-ancestor
25053327|NCT00065728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053328|NCT00064714|Exenatide|exenatide|mesh-list
25053329|NCT00064714|Daclizumab|daclizumab|mesh-list
25053330|NCT00064714|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25053331|NCT00064714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25053332|NCT00064714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053333|NCT00064714|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25053334|NCT00064714|Incretins|incretins|mesh-ancestor
25053335|NCT00064714|Hormones|hormones|mesh-ancestor
25053336|NCT00064714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25053337|NCT00064714|Immunologic Factors|immunologic factors|mesh-ancestor
25053338|NCT00058266|Genistein|genistein|mesh-list
25053339|NCT00058266|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25053340|NCT00058266|Protective Agents|protective agents|mesh-ancestor
25053341|NCT00058266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053342|NCT00058266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053343|NCT00058266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25053344|NCT00058266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053345|NCT00058266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053346|NCT00058266|Phytoestrogens|phytoestrogens|mesh-ancestor
25053347|NCT00058266|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25053348|NCT00058266|Estrogens|estrogens|mesh-ancestor
25053349|NCT00058266|Hormones|hormones|mesh-ancestor
24807575|NCT02022644|Irinotecan|irinotecan|mesh-list
25053381|NCT00057473|Carboplatin|carboplatin|mesh-list
25053382|NCT00057473|Irinotecan|irinotecan|mesh-list
25053383|NCT00057473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053384|NCT00057473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25053385|NCT00057473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25053386|NCT00057473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053387|NCT00057473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081067|NCT03333278|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24509631|NCT00561197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509632|NCT00561197|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
24509633|NCT00561197|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
24509634|NCT00561197|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24808364|NCT02026778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24808394|NCT02026921|Mitosis Modulators|mitosis modulators|mesh-ancestor
24808395|NCT02026921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808396|NCT02026947|Sodium Benzoate|sodium benzoate|mesh-list
24809896|NCT02036554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24809897|NCT02036554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24809898|NCT02036554|Antitubercular Agents|antitubercular agents|mesh-ancestor
24809899|NCT02036554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24809957|NCT02036879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24809960|NCT02036983|Anesthetics|anesthetics|mesh-list
25055877|NCT03517176|Gemcitabine|gemcitabine|mesh-list
25055878|NCT03517176|Paclitaxel|paclitaxel|mesh-list
25055879|NCT03517176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25055880|NCT03517176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25055881|NCT03517176|Tubulin Modulators|tubulin modulators|mesh-ancestor
25057737|NCT03502421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057738|NCT03502421|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25057739|NCT03502421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25057740|NCT03502421|Anesthetics, General|anesthetics, general|mesh-ancestor
24810713|NCT02042170|Hormones|hormones|mesh-list
25057741|NCT03502421|Anesthetics|anesthetics|mesh-ancestor
25057742|NCT03502421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25057743|NCT03502421|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25057744|NCT03502421|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25057745|NCT03502421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24552030|NCT04250883|Iodine|iodine|mesh-list
24941458|NCT03990922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24941460|NCT03990922|Anesthetics|anesthetics|mesh-ancestor
24941461|NCT03990480|Amlodipine|amlodipine|mesh-list
24941462|NCT03990480|Valsartan|valsartan|mesh-list
24941463|NCT03990480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24941464|NCT03990480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24941465|NCT03990480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25058669|NCT03494257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24952883|NCT03891316|Anesthetics|anesthetics|mesh-ancestor
25059061|NCT03491410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25059062|NCT03491410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25059063|NCT03491410|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25059411|NCT03488173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25059412|NCT03488173|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25059413|NCT03488173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059414|NCT03488173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059924|NCT03484195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25059925|NCT03484195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24952942|NCT03890341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822347|NCT02111161|Immunoglobulins|immunoglobulins|mesh-list
25060414|NCT03480165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25060416|NCT03480165|Analgesics|analgesics|mesh-ancestor
25060417|NCT03480165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25061075|NCT03474198|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25061076|NCT03474198|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25061078|NCT03474198|Antimetabolites|antimetabolites|mesh-ancestor
25061079|NCT03474198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25061116|NCT03473613|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25061164|NCT03473314|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25061165|NCT03473314|Autonomic Agents|autonomic agents|mesh-ancestor
25061166|NCT03473314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24772429|NCT01833715|Antitussive Agents|antitussive agents|mesh-ancestor
24509698|NCT00561717|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24509699|NCT00561717|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25061170|NCT03473314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25061172|NCT03473314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061173|NCT03473314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25061174|NCT03473314|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24504739|NCT00537966|Cobicistat|cobicistat|mesh-list
25061175|NCT03473314|Vasodilator Agents|vasodilator agents|mesh-ancestor
25061176|NCT03473314|Gasotransmitters|gasotransmitters|mesh-ancestor
25061177|NCT03473314|Protective Agents|protective agents|mesh-ancestor
25061178|NCT03473210|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25061180|NCT03473210|Ampicillin|ampicillin|mesh-list
25061181|NCT03473210|Dexamethasone|dexamethasone|mesh-list
25061182|NCT03473210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25061183|NCT03473210|Antiemetics|antiemetics|mesh-ancestor
25061184|NCT03473210|Autonomic Agents|autonomic agents|mesh-ancestor
25061185|NCT03473210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25061186|NCT03473210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061187|NCT03473210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25061188|NCT03473210|Glucocorticoids|glucocorticoids|mesh-ancestor
25061189|NCT03473210|Hormones|hormones|mesh-ancestor
25061190|NCT03473210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25061191|NCT03473210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25061192|NCT03473210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25061193|NCT03473210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048587|NCT00687687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25048588|NCT00687687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048589|NCT00684918|Obatoclax|obatoclax|mesh-list
25048590|NCT00684918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25048591|NCT00684918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048592|NCT00683722|Remestemcel-l|remestemcel-l|mesh-list
25048593|NCT00683722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24787178|NCT01923948|Pregabalin|pregabalin|mesh-list
24885101|NCT02678533|Plerixafor|plerixafor|mesh-list
24885102|NCT02678533|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24885103|NCT02678533|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24885104|NCT02678533|Antiviral Agents|antiviral agents|mesh-ancestor
24885105|NCT02678533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24885142|NCT02346630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048594|NCT00683722|Antiviral Agents|antiviral agents|mesh-ancestor
25048595|NCT00683722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25048596|NCT00682981|Carboplatin|carboplatin|mesh-list
25048597|NCT00682981|Etoposide|etoposide|mesh-list
25048598|NCT00682981|Obatoclax|obatoclax|mesh-list
25048599|NCT00682981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048600|NCT00682981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24998322|NCT03110510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24998323|NCT03110510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998324|NCT03110510|Antimetabolites|antimetabolites|mesh-ancestor
24998325|NCT03110510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998326|NCT03110510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24998327|NCT03110510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25061194|NCT03473210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061195|NCT03473210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25061196|NCT03473210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25061197|NCT03473132|Thrombin|thrombin|mesh-list
25061198|NCT03473132|Hemostatics|hemostatics|mesh-ancestor
25061199|NCT03473132|Coagulants|coagulants|mesh-ancestor
25061200|NCT03473093|Pregabalin|pregabalin|mesh-list
25061201|NCT03473093|Morphine|morphine|mesh-list
25061202|NCT03473093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25061203|NCT03473093|Narcotics|narcotics|mesh-ancestor
25061204|NCT03473093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25061205|NCT03473093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061206|NCT03473093|Analgesics|analgesics|mesh-ancestor
25061207|NCT03473093|Sensory System Agents|sensory system agents|mesh-ancestor
25061208|NCT03473093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25061209|NCT03473093|Anticonvulsants|anticonvulsants|mesh-ancestor
25061210|NCT03473093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25061890|NCT05390255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824385|NCT02123069|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24824386|NCT02123069|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25081092|NCT03333018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772560|NCT01834235|Immunologic Factors|immunologic factors|mesh-ancestor
24772580|NCT01834508|Antiviral Agents|antiviral agents|mesh-ancestor
24772581|NCT01834508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24563764|NCT00773331|Epoetin Alfa|epoetin alfa|mesh-list
24772582|NCT01834508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24772584|NCT01834508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25065544|NCT05321121|Analgesics|analgesics|mesh-ancestor
25065545|NCT05321121|Sensory System Agents|sensory system agents|mesh-ancestor
25065546|NCT05321121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25065547|NCT05321121|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25065548|NCT05321121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25065591|NCT05320692|Estrogens|estrogens|mesh-ancestor
25065592|NCT05320692|Hormones|hormones|mesh-ancestor
25065593|NCT05320692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25065594|NCT05320692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065595|NCT05320692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25065596|NCT05320640|Decitabine|decitabine|mesh-list
25065597|NCT05320640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25065598|NCT05320640|Antibodies|antibodies|mesh-list
25065599|NCT05320640|Immunologic Factors|immunologic factors|mesh-ancestor
25065600|NCT05320640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953456|NCT03884491|Vortioxetine|vortioxetine|mesh-list
24953457|NCT03884491|Antidepressive Agents|antidepressive agents|mesh-ancestor
24953458|NCT03884491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24953459|NCT03884491|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24828127|NCT02143531|Haloperidol|haloperidol|mesh-list
25065797|NCT05202145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25065798|NCT05202145|Immunologic Factors|immunologic factors|mesh-ancestor
25065799|NCT05202145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065800|NCT05202145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25065801|NCT05202145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25065802|NCT05202145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065803|NCT05202145|Antifungal Agents|antifungal agents|mesh-ancestor
24828305|NCT02144792|Verapamil|verapamil|mesh-list
25065967|NCT04628429|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25065968|NCT04628429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065969|NCT04628429|Analgesics|analgesics|mesh-ancestor
25065970|NCT04628429|Sensory System Agents|sensory system agents|mesh-ancestor
25065971|NCT04628429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25066006|NCT04546178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25066011|NCT04477486|Venetoclax|venetoclax|mesh-list
25066012|NCT04477486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885143|NCT02346630|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24885144|NCT02346630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25066389|NCT03406247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25066390|NCT03406247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066391|NCT03406247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25066426|NCT03245918|Autonomic Agents|autonomic agents|mesh-ancestor
25066427|NCT03245918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25066428|NCT03245918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066429|NCT03245918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25405694|NCT03598595|Mitosis Modulators|mitosis modulators|mesh-ancestor
25066430|NCT03245918|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25066431|NCT03245918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25066432|NCT03245918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066433|NCT03205605|Mandelic Acids|mandelic acids|mesh-list
25066572|NCT02700451|Acetaminophen|acetaminophen|mesh-list
25066574|NCT02700451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25066575|NCT02700451|Analgesics|analgesics|mesh-ancestor
25066576|NCT02700451|Sensory System Agents|sensory system agents|mesh-ancestor
25066577|NCT02700451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25066578|NCT02700451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066579|NCT02700451|Antipyretics|antipyretics|mesh-ancestor
25066700|NCT02099188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25066702|NCT02099175|Leucovorin|leucovorin|mesh-list
25066703|NCT02099175|Docetaxel|docetaxel|mesh-list
25066704|NCT02099175|Fluorouracil|fluorouracil|mesh-list
25066705|NCT02099175|Etoposide|etoposide|mesh-list
25066706|NCT02099175|Doxorubicin|doxorubicin|mesh-list
24951597|NCT03902912|Hormones|hormones|mesh-ancestor
24772705|NCT01835184|Vemurafenib|vemurafenib|mesh-list
24885145|NCT02067975|Tryptophan|tryptophan|mesh-list
24885146|NCT02067975|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24885147|NCT02067975|Antidepressive Agents|antidepressive agents|mesh-ancestor
24885148|NCT02067975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24885149|NCT01964807|Nicotine|nicotine|mesh-list
24885151|NCT01964807|Autonomic Agents|autonomic agents|mesh-ancestor
24514139|NCT00588133|Tranexamic Acid|tranexamic acid|mesh-list
24509911|NCT00562640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509912|NCT00562640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24509913|NCT00562640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24509914|NCT00562640|Alkylating Agents|alkylating agents|mesh-ancestor
24509915|NCT00562640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509929|NCT00562809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24509930|NCT00562809|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24509931|NCT00562809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24509932|NCT00562809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509934|NCT00562835|Methylprednisolone|methylprednisolone|mesh-list
25066707|NCT02099175|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24951693|NCT03901716|Analgesics|analgesics|mesh-ancestor
24951694|NCT03901716|Sensory System Agents|sensory system agents|mesh-ancestor
24951695|NCT03901716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24951696|NCT03901716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24951697|NCT03901716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24951698|NCT03901716|Anesthetics, General|anesthetics, general|mesh-ancestor
24951699|NCT03901716|Anesthetics|anesthetics|mesh-ancestor
24951700|NCT03901716|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24951701|NCT03901716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24951702|NCT03901716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24951703|NCT03901716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25067256|NCT03445078|Selenium|selenium|mesh-list
25067257|NCT03445078|Antioxidants|antioxidants|mesh-ancestor
25067258|NCT03445078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067259|NCT03445078|Protective Agents|protective agents|mesh-ancestor
25067260|NCT03445078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067261|NCT03445078|Trace Elements|trace elements|mesh-ancestor
25067262|NCT03445078|Micronutrients|micronutrients|mesh-ancestor
25067263|NCT03444831|Buspirone|buspirone|mesh-list
25067264|NCT03444831|Omeprazole|omeprazole|mesh-list
25067265|NCT03444831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25067266|NCT03444831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25067267|NCT03444831|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25067268|NCT03444831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25067269|NCT03444831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067270|NCT03444831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25067271|NCT03444831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25067272|NCT03444831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25067273|NCT03444831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067274|NCT03444831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25067275|NCT03444831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25067276|NCT03444831|Serotonin Agents|serotonin agents|mesh-ancestor
25067385|NCT03443960|Antidepressive Agents|antidepressive agents|mesh-ancestor
25068824|NCT03431675|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25405695|NCT03598595|Antimalarials|antimalarials|mesh-ancestor
25068825|NCT03431675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25068828|NCT03431649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068829|NCT03431649|Vasodilator Agents|vasodilator agents|mesh-ancestor
25068830|NCT03431649|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25068831|NCT03431649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25068832|NCT03431649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24953604|NCT03883269|Erythromycin Estolate|erythromycin estolate|mesh-list
24953605|NCT03883269|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25068833|NCT03431649|Urological Agents|urological agents|mesh-ancestor
25068834|NCT03431649|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25068835|NCT03431623|Darbepoetin alfa|darbepoetin alfa|mesh-list
25068836|NCT03431623|Hematinics|hematinics|mesh-ancestor
25068837|NCT03431597|Micronutrients|micronutrients|mesh-list
25068838|NCT03431597|Trace Elements|trace elements|mesh-list
25068839|NCT03431597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068840|NCT03431558|Lactoferrin|lactoferrin|mesh-list
25068841|NCT03431558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25068842|NCT03431285|Ketamine|ketamine|mesh-list
25068843|NCT03431285|Morphine|morphine|mesh-list
25068844|NCT03431285|Analgesics|analgesics|mesh-ancestor
25068845|NCT03431285|Sensory System Agents|sensory system agents|mesh-ancestor
25069001|NCT03430024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25069002|NCT03430024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069003|NCT03429998|Evolocumab|evolocumab|mesh-list
25069004|NCT03429998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25069005|NCT03429998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25069006|NCT03429998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25069007|NCT03429998|Antimetabolites|antimetabolites|mesh-ancestor
25069008|NCT03429998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069009|NCT03429998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25069010|NCT03429998|Immunologic Factors|immunologic factors|mesh-ancestor
24953607|NCT03883269|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24953608|NCT03883269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24953609|NCT03883269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24953610|NCT03883269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953611|NCT03883269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24832064|NCT02170597|Anticoagulants|anticoagulants|mesh-ancestor
25069505|NCT03425994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25069506|NCT03425994|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24832129|NCT02170740|Antithrombins|antithrombins|mesh-ancestor
25069578|NCT03425617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24779460|NCT01876290|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25069579|NCT03425617|Cholinergic Agents|cholinergic agents|mesh-ancestor
25069580|NCT03425617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25069581|NCT03425617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069582|NCT03425552|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25069583|NCT03425552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25069584|NCT03425552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25069585|NCT03425552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25069586|NCT03425552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069587|NCT03425552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24772793|NCT01835938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24509935|NCT00562835|Vitamins|vitamins|mesh-ancestor
24509936|NCT00562835|Micronutrients|micronutrients|mesh-ancestor
24509937|NCT00562835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509938|NCT00562835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24509939|NCT00562835|Antiemetics|antiemetics|mesh-ancestor
24509940|NCT00562835|Autonomic Agents|autonomic agents|mesh-ancestor
24509944|NCT00562835|Hormones|hormones|mesh-ancestor
24509945|NCT00562835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24509946|NCT00562835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24509947|NCT00562835|Protective Agents|protective agents|mesh-ancestor
25069588|NCT03425552|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25069589|NCT03425552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25069591|NCT03425552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25069592|NCT03425552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069593|NCT03425552|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25069594|NCT03425552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25069595|NCT03425552|Dopamine Agents|dopamine agents|mesh-ancestor
25070819|NCT03415802|Tubulin Modulators|tubulin modulators|mesh-ancestor
25070820|NCT03415802|Antimitotic Agents|antimitotic agents|mesh-ancestor
25070848|NCT03415750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25070849|NCT03415750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25070850|NCT03415750|Antitubercular Agents|antitubercular agents|mesh-ancestor
25405696|NCT03598595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25121441|NCT03101995|Immunologic Factors|immunologic factors|mesh-ancestor
25121442|NCT03101995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121444|NCT03102242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121445|NCT03102450|Benzalkonium Compounds|benzalkonium compounds|mesh-list
25121446|NCT03102450|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25121447|NCT03102450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25121448|NCT03102021|Epoetin Alfa|epoetin alfa|mesh-list
25121449|NCT03102021|Hematinics|hematinics|mesh-ancestor
25121461|NCT03101800|Azathioprine|azathioprine|mesh-list
24715515|NCT01536717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715518|NCT01536743|Palbociclib|palbociclib|mesh-list
25070851|NCT03415750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25070852|NCT03415750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25070854|NCT03415711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25070855|NCT03415711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25070856|NCT03415711|Analgesics|analgesics|mesh-ancestor
25070857|NCT03415711|Sensory System Agents|sensory system agents|mesh-ancestor
25070858|NCT03415711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25070859|NCT03415711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070860|NCT03415711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25070861|NCT03415711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25070862|NCT03415646|Morphine|morphine|mesh-list
25070863|NCT03415646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25070864|NCT03415646|Narcotics|narcotics|mesh-ancestor
25070865|NCT03415646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25070866|NCT03415646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070867|NCT03415646|Analgesics|analgesics|mesh-ancestor
25070868|NCT03415646|Sensory System Agents|sensory system agents|mesh-ancestor
24833445|NCT02173951|Deferiprone|deferiprone|mesh-list
25070903|NCT03415191|Anesthetics, General|anesthetics, general|mesh-ancestor
25070904|NCT03415191|Anesthetics|anesthetics|mesh-ancestor
25071046|NCT03413371|Ropivacaine|ropivacaine|mesh-list
25071047|NCT03413371|Anesthetics, Local|anesthetics, local|mesh-ancestor
25071048|NCT03413371|Anesthetics|anesthetics|mesh-ancestor
25071704|NCT03406689|Nepafenac|nepafenac|mesh-list
25071050|NCT03413371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071051|NCT03413371|Sensory System Agents|sensory system agents|mesh-ancestor
25071096|NCT03413059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25071097|NCT03413059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071099|NCT03413020|Metronidazole|metronidazole|mesh-list
25071100|NCT03413020|Clarithromycin|clarithromycin|mesh-list
25071101|NCT03413020|Levofloxacin|levofloxacin|mesh-list
25071102|NCT03413020|Ofloxacin|ofloxacin|mesh-list
25071103|NCT03413020|Potassium Citrate|potassium citrate|mesh-list
25071104|NCT03413020|Esomeprazole|esomeprazole|mesh-list
25071105|NCT03413020|Bismuth|bismuth|mesh-list
25071106|NCT03413020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071107|NCT03413020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25071108|NCT03413020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25071109|NCT03413020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25071110|NCT03413020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25071111|NCT03413020|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25071112|NCT03413020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25071113|NCT03413020|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25071114|NCT03413020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25071115|NCT03413020|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25071116|NCT03413020|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25071117|NCT03413020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25071194|NCT03412474|Dexmedetomidine|dexmedetomidine|mesh-list
25071210|NCT03412474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953831|NCT03881111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24953832|NCT03881449|Aripiprazole|aripiprazole|mesh-list
24953833|NCT03881449|Antidepressive Agents|antidepressive agents|mesh-ancestor
24953834|NCT03881449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25685312|NCT01903837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685313|NCT01903837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25685314|NCT01903837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25685315|NCT01903837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25685316|NCT01903837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25685317|NCT01903837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25685318|NCT01903837|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25685319|NCT01903837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25685320|NCT01903837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25685321|NCT01903837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953835|NCT03881449|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24953836|NCT03881449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24953837|NCT03881449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24953838|NCT03881449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953839|NCT03881449|Dopamine Agonists|dopamine agonists|mesh-ancestor
24953840|NCT03881449|Dopamine Agents|dopamine agents|mesh-ancestor
25071303|NCT03411798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25071304|NCT03411798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25071305|NCT03411798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24834009|NCT02176499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25071341|NCT03411252|Adrenergic Agents|adrenergic agents|mesh-ancestor
24834048|NCT02176733|Immunologic Factors|immunologic factors|mesh-ancestor
25071411|NCT03410212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25071412|NCT03410212|Analgesics|analgesics|mesh-ancestor
25071413|NCT03410212|Sensory System Agents|sensory system agents|mesh-ancestor
25071414|NCT03410212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834123|NCT02177318|Bromides|bromides|mesh-list
25071449|NCT03409679|Murepavadin|murepavadin|mesh-list
25071450|NCT03409679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24953875|NCT03880903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24953876|NCT03880903|Respiratory System Agents|respiratory system agents|mesh-ancestor
24953877|NCT03880903|Tocolytic Agents|tocolytic agents|mesh-ancestor
24953878|NCT03880903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24953879|NCT03880903|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24953880|NCT03880903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25071512|NCT03408587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24834234|NCT02177461|Clonidine|clonidine|mesh-list
25071550|NCT03407976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24834265|NCT02177487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25071581|NCT03407521|Vasodilator Agents|vasodilator agents|mesh-ancestor
25071582|NCT03407521|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25071583|NCT03407521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071585|NCT03407404|Ketamine|ketamine|mesh-list
25071586|NCT03407404|Morphine|morphine|mesh-list
25071587|NCT03407404|Analgesics|analgesics|mesh-ancestor
25071588|NCT03407404|Sensory System Agents|sensory system agents|mesh-ancestor
25071589|NCT03407404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25071590|NCT03407404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071591|NCT03407404|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25071592|NCT03407404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25071593|NCT03407404|Anesthetics, General|anesthetics, general|mesh-ancestor
25071594|NCT03407404|Anesthetics|anesthetics|mesh-ancestor
25071595|NCT03407404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25071631|NCT03407027|Triamcinolone|triamcinolone|mesh-list
25071632|NCT03407027|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25071705|NCT03406689|Lubricant Eye Drops|lubricant eye drops|mesh-list
24834421|NCT02178449|Antiemetics|antiemetics|mesh-ancestor
25071740|NCT03406533|Midazolam|midazolam|mesh-list
25071741|NCT03406533|Dexmedetomidine|dexmedetomidine|mesh-list
25071742|NCT03406533|Remifentanil|remifentanil|mesh-list
25071743|NCT03406533|Propofol|propofol|mesh-list
25071744|NCT03406533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25071745|NCT03406533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24834501|NCT02179255|Hormones|hormones|mesh-list
24834656|NCT02180334|Analgesics|analgesics|mesh-ancestor
25071990|NCT03404635|Anticoagulants|anticoagulants|mesh-ancestor
25071991|NCT03404544|Carbetocin|carbetocin|mesh-list
25071992|NCT03404544|Oxytocin|oxytocin|mesh-list
25072030|NCT03404011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072063|NCT03403829|Antimetabolites|antimetabolites|mesh-ancestor
25072064|NCT03403829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072065|NCT03403829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25072066|NCT03403829|Antiviral Agents|antiviral agents|mesh-ancestor
25072067|NCT03403829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25072068|NCT03403829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25072069|NCT03403829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25072070|NCT03403829|Immunologic Factors|immunologic factors|mesh-ancestor
25072071|NCT03403829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072073|NCT03403790|Antidepressive Agents|antidepressive agents|mesh-ancestor
25072074|NCT03403790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25072448|NCT03401541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25072449|NCT03401541|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25072450|NCT03401515|Propranolol|propranolol|mesh-list
25072451|NCT03401515|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25072452|NCT03401515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25072453|NCT03401515|Adrenergic Agents|adrenergic agents|mesh-ancestor
25072454|NCT03401515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24759359|NCT01750801|Chlorhexidine|chlorhexidine|mesh-list
25072455|NCT03401515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072456|NCT03401515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072671|NCT03399955|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25072672|NCT03399955|Miltefosine|miltefosine|mesh-list
25072673|NCT03399955|Amebicides|amebicides|mesh-ancestor
25072674|NCT03399955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25072719|NCT03399708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072720|NCT03399708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25072775|NCT03399474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25072810|NCT03399435|Adrenergic Agents|adrenergic agents|mesh-ancestor
25072811|NCT03399435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25072812|NCT03399435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072813|NCT03399435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25072814|NCT03399435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25072815|NCT03399435|Autonomic Agents|autonomic agents|mesh-ancestor
25072846|NCT03399019|Anesthetics|anesthetics|mesh-ancestor
25072847|NCT03399019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25072848|NCT03399019|Analgesics|analgesics|mesh-ancestor
25072849|NCT03399019|Sensory System Agents|sensory system agents|mesh-ancestor
25072850|NCT03399019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24772901|NCT01836536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24509948|NCT00562835|Vitamin B Complex|vitamin b complex|mesh-ancestor
24509949|NCT00562913|Sorafenib|sorafenib|mesh-list
24509964|NCT00562952|Sympatholytics|sympatholytics|mesh-ancestor
24509965|NCT00562952|Autonomic Agents|autonomic agents|mesh-ancestor
24509966|NCT00562952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24509967|NCT00562952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509968|NCT00562952|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24509969|NCT00562952|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24509970|NCT00562952|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24509971|NCT00562952|Adrenergic Agents|adrenergic agents|mesh-ancestor
24443938|NCT00296257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072851|NCT03399019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25072852|NCT03399019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25072853|NCT03399019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25072854|NCT03399019|Adrenergic Agents|adrenergic agents|mesh-ancestor
25072855|NCT03399019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25072856|NCT03399019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072857|NCT03399019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25072858|NCT03399019|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25072859|NCT03399019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24759582|NCT01752790|Azathioprine|azathioprine|mesh-list
25073056|NCT03397797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073058|NCT03397706|Antiviral Agents|antiviral agents|mesh-ancestor
25073059|NCT03397706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25073060|NCT03397654|Pembrolizumab|pembrolizumab|mesh-list
25073061|NCT03397654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25073062|NCT03397654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073063|NCT03397615|Povidone-Iodine|povidone-iodine|mesh-list
25073381|NCT03395262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25073383|NCT03395223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836228|NCT02184559|Ropivacaine|ropivacaine|mesh-list
25073652|NCT03393949|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25073653|NCT03393949|Prednisolone|prednisolone|mesh-list
25073654|NCT03393949|Prednisolone acetate|prednisolone acetate|mesh-list
25073655|NCT03393949|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25073656|NCT03393949|Prednisolone phosphate|prednisolone phosphate|mesh-list
25073657|NCT03393949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25073658|NCT03393949|Antiemetics|antiemetics|mesh-ancestor
25073659|NCT03393949|Autonomic Agents|autonomic agents|mesh-ancestor
25073660|NCT03393949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25073661|NCT03393949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073662|NCT03393949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25073663|NCT03393949|Glucocorticoids|glucocorticoids|mesh-ancestor
25073665|NCT03393949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25073666|NCT03393949|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25073667|NCT03393949|Protective Agents|protective agents|mesh-ancestor
25073668|NCT03393949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25073669|NCT03393949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121593|NCT03101124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25121594|NCT03101124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25121595|NCT03101124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121596|NCT03101124|Hemostatics|hemostatics|mesh-ancestor
25121597|NCT03101124|Coagulants|coagulants|mesh-ancestor
25073670|NCT03393858|Antibodies|antibodies|mesh-list
25074251|NCT03389607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25074252|NCT03389607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074254|NCT03389490|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25074255|NCT03389490|Insulin Glargine|insulin glargine|mesh-list
25074256|NCT03389490|Insulin, Isophane|insulin, isophane|mesh-list
25074257|NCT03389490|Isophane Insulin, Human|isophane insulin, human|mesh-list
25074258|NCT03389490|Isophane insulin, beef|isophane insulin, beef|mesh-list
25074259|NCT03389490|Protamines|protamines|mesh-list
25074260|NCT03389490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25074261|NCT03389490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074262|NCT03389490|Heparin Antagonists|heparin antagonists|mesh-ancestor
25074263|NCT03389490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074317|NCT03389087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25074318|NCT03389087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25074319|NCT03389087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25074320|NCT03389087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25074321|NCT03389087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074322|NCT03389087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25074323|NCT03389061|Sofosbuvir|sofosbuvir|mesh-list
25074324|NCT03389061|Velpatasvir|velpatasvir|mesh-list
24954203|NCT03878667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954204|NCT03878667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24954206|NCT03878667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954207|NCT03878667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24954208|NCT03878264|Cortisone|cortisone|mesh-list
25074481|NCT03387956|Hormones|hormones|mesh-ancestor
25074482|NCT03387956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25074483|NCT03387956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25074484|NCT03387956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25074485|NCT03387956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25074486|NCT03387956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25074487|NCT03387956|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25074488|NCT03387956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25074489|NCT03387956|Respiratory System Agents|respiratory system agents|mesh-ancestor
25074591|NCT03387163|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25074592|NCT03387163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25074593|NCT03387163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25074594|NCT03387163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25074595|NCT03387163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074597|NCT03387111|Paclitaxel|paclitaxel|mesh-list
25074601|NCT03387111|Capecitabine|capecitabine|mesh-list
25074602|NCT03387111|Cetuximab|cetuximab|mesh-list
25074603|NCT03387111|Avelumab|avelumab|mesh-list
25074604|NCT03387111|Necitumumab|necitumumab|mesh-list
25074635|NCT03387098|Capecitabine|capecitabine|mesh-list
25074636|NCT03387098|Oxaliplatin|oxaliplatin|mesh-list
25074637|NCT03387098|Avelumab|avelumab|mesh-list
25074638|NCT03387098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24954243|NCT03877718|Dermatologic Agents|dermatologic agents|mesh-ancestor
24954244|NCT03877718|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24837738|NCT02192944|Chloroquine|chloroquine|mesh-list
25074776|NCT03386201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074777|NCT03386149|Loxoprofen|loxoprofen|mesh-list
25074778|NCT03386149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25074779|NCT03386149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25074780|NCT03386149|Analgesics|analgesics|mesh-ancestor
25074781|NCT03386149|Sensory System Agents|sensory system agents|mesh-ancestor
25074782|NCT03386149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25074783|NCT03386149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074784|NCT03386149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25074785|NCT03386149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25074786|NCT03386071|Trametinib|trametinib|mesh-list
25074854|NCT03385382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25074855|NCT03385382|Antiemetics|antiemetics|mesh-ancestor
25685322|NCT01903837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25685323|NCT01903837|Serotonin Agents|serotonin agents|mesh-ancestor
25685324|NCT01903837|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25685325|NCT01903837|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25685326|NCT01903837|Sensory System Agents|sensory system agents|mesh-ancestor
25685327|NCT01903993|Docetaxel|docetaxel|mesh-list
24614998|NCT01027429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24614999|NCT01027429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24615000|NCT01027429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615001|NCT01027429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615002|NCT01027429|Anesthetics, Local|anesthetics, local|mesh-ancestor
24615003|NCT01027429|Anesthetics|anesthetics|mesh-ancestor
24615004|NCT01027429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24615005|NCT01027429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615006|NCT01027429|Sensory System Agents|sensory system agents|mesh-ancestor
25074856|NCT03385382|Autonomic Agents|autonomic agents|mesh-ancestor
25074857|NCT03385382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25074957|NCT03384862|Micronutrients|micronutrients|mesh-ancestor
25074958|NCT03384862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074959|NCT03384862|Hematinics|hematinics|mesh-ancestor
25074960|NCT03384862|Vitamin B Complex|vitamin b complex|mesh-ancestor
24510000|NCT00563056|Dermatologic Agents|dermatologic agents|mesh-ancestor
24510051|NCT00563225|Insulin Glargine|insulin glargine|mesh-list
24510052|NCT00563225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24510053|NCT00563225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510055|NCT00563238|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24510056|NCT00563238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24510057|NCT00563238|Sympatholytics|sympatholytics|mesh-ancestor
24510070|NCT00563303|Hydrocortisone|hydrocortisone|mesh-list
24510203|NCT00563875|Aspirin|aspirin|mesh-list
24510204|NCT00563875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24510205|NCT00563875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24510206|NCT00563875|Analgesics|analgesics|mesh-ancestor
24510211|NCT00563875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24510227|NCT00563927|Antimetabolites|antimetabolites|mesh-ancestor
24510228|NCT00563927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510229|NCT00563927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24510230|NCT00563927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24510231|NCT00563927|Immunologic Factors|immunologic factors|mesh-ancestor
24510232|NCT00563927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510267|NCT00564057|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25074966|NCT03384524|Metoprolol|metoprolol|mesh-list
25074967|NCT03384524|Bromocriptine|bromocriptine|mesh-list
25074968|NCT03384524|Tamsulosin|tamsulosin|mesh-list
25074969|NCT03384524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25074970|NCT03384524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25075068|NCT03383406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25075069|NCT03383406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24954271|NCT03877549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24954273|NCT03877549|Autonomic Agents|autonomic agents|mesh-ancestor
24954274|NCT03877549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24954306|NCT03877692|Sympathomimetics|sympathomimetics|mesh-ancestor
24954307|NCT03877692|Autonomic Agents|autonomic agents|mesh-ancestor
25075082|NCT03383393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25075084|NCT03383393|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25075085|NCT03383393|Purinergic Agonists|purinergic agonists|mesh-ancestor
25075086|NCT03383393|Purinergic Agents|purinergic agents|mesh-ancestor
25075091|NCT03383367|Antioxidants|antioxidants|mesh-ancestor
25075130|NCT03383315|Autonomic Agents|autonomic agents|mesh-ancestor
25075131|NCT03383315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25075132|NCT03383315|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25075133|NCT03383315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25075134|NCT03383315|Dopamine Agents|dopamine agents|mesh-ancestor
25075135|NCT03383315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25075170|NCT03383094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25075171|NCT03383068|Metformin|metformin|mesh-list
25075172|NCT03383068|Exenatide|exenatide|mesh-list
25075300|NCT03381859|Grazoprevir|grazoprevir|mesh-list
25685328|NCT01903993|Atezolizumab|atezolizumab|mesh-list
25685329|NCT01903993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25685330|NCT01903993|Tubulin Modulators|tubulin modulators|mesh-ancestor
25685331|NCT01903993|Antimitotic Agents|antimitotic agents|mesh-ancestor
25685332|NCT01903993|Mitosis Modulators|mitosis modulators|mesh-ancestor
25685333|NCT01903993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685334|NCT01904058|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25685335|NCT01904058|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25685336|NCT01904058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25685337|NCT01904071|Morphine|morphine|mesh-list
25685338|NCT01904071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25685339|NCT01904071|Narcotics|narcotics|mesh-ancestor
25075301|NCT03381859|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25075302|NCT03381859|Antiviral Agents|antiviral agents|mesh-ancestor
25075303|NCT03381859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25075304|NCT03381833|Hepcidins|hepcidins|mesh-list
25075305|NCT03381833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24954341|NCT03877562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24954342|NCT03877562|Serotonin Agents|serotonin agents|mesh-ancestor
24954343|NCT03877601|Bevacizumab|bevacizumab|mesh-list
25075306|NCT03381781|Cytarabine|cytarabine|mesh-list
25075307|NCT03381781|Decitabine|decitabine|mesh-list
25075308|NCT03381781|Arsenic Trioxide|arsenic trioxide|mesh-list
25075309|NCT03381781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25075310|NCT03381781|Antimetabolites|antimetabolites|mesh-ancestor
25075311|NCT03381781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075312|NCT03381781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075313|NCT03381781|Antiviral Agents|antiviral agents|mesh-ancestor
25075314|NCT03381781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25075360|NCT03381664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25075392|NCT03381352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075393|NCT03381352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075394|NCT03381352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25075395|NCT03381352|Alkylating Agents|alkylating agents|mesh-ancestor
25075396|NCT03381352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25075397|NCT03381352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075398|NCT03381261|Botulinum Toxins|botulinum toxins|mesh-list
25075399|NCT03381261|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25075400|NCT03381261|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25075401|NCT03381261|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25075402|NCT03381261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25075403|NCT03381261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075404|NCT03381261|Cholinergic Agents|cholinergic agents|mesh-ancestor
25075405|NCT03381261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24954358|NCT03877315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954360|NCT03877315|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24954361|NCT03877315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24954362|NCT03877315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075536|NCT03380442|Ketamine|ketamine|mesh-list
25075537|NCT03380442|Psilocybin|psilocybin|mesh-list
25075539|NCT03380442|Sensory System Agents|sensory system agents|mesh-ancestor
24838730|NCT02199951|Piperaquine|piperaquine|mesh-list
25075570|NCT03380130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075572|NCT03380039|Fludarabine|fludarabine|mesh-list
25075573|NCT03380039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25075574|NCT03380039|Immunologic Factors|immunologic factors|mesh-ancestor
25075575|NCT03380039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075578|NCT03380039|Alkylating Agents|alkylating agents|mesh-ancestor
25075579|NCT03380039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075613|NCT03379181|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25075614|NCT03379181|Adrenergic Agents|adrenergic agents|mesh-ancestor
25075615|NCT03379181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25075616|NCT03379181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075617|NCT03379181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075618|NCT03379181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25075619|NCT03379181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25075620|NCT03379181|Vasodilator Agents|vasodilator agents|mesh-ancestor
25075621|NCT03379103|Propofol|propofol|mesh-list
25075622|NCT03379103|Sevoflurane|sevoflurane|mesh-list
24838815|NCT02200406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25075635|NCT03379012|Testosterone enanthate|testosterone enanthate|mesh-list
25075636|NCT03379012|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25075637|NCT03379012|Androgens|androgens|mesh-ancestor
25075638|NCT03379012|Hormones|hormones|mesh-ancestor
25075639|NCT03379012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25405697|NCT03598595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25685340|NCT01904071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25685341|NCT01904071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685342|NCT01904071|Analgesics|analgesics|mesh-ancestor
25685343|NCT01904071|Sensory System Agents|sensory system agents|mesh-ancestor
25075640|NCT03379012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460617|NCT00349076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24810859|NCT02043002|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24810860|NCT02043002|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24810861|NCT02043002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810862|NCT02043054|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25075641|NCT03379012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25075642|NCT03379012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075643|NCT03379012|Anabolic Agents|anabolic agents|mesh-ancestor
25075644|NCT03379012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25075645|NCT03379012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25075646|NCT03379012|Growth Substances|growth substances|mesh-ancestor
25075647|NCT03379012|Growth Inhibitors|growth inhibitors|mesh-ancestor
25075648|NCT03379012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25075649|NCT03379012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075650|NCT03379012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075651|NCT03378960|Omeprazole|omeprazole|mesh-list
25075685|NCT03378726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075687|NCT03378713|Testosterone|testosterone|mesh-list
25075688|NCT03378713|Testosterone undecanoate|testosterone undecanoate|mesh-list
25075755|NCT03378427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25075790|NCT03378297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25022420|NCT03662724|Venetoclax|venetoclax|mesh-list
25075791|NCT03378297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25075792|NCT03378297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25075793|NCT03378297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25075794|NCT03378297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24839002|NCT02201459|Interferons|interferons|mesh-list
24998467|NCT02691793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998468|NCT02691793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998469|NCT02688881|Sirolimus|sirolimus|mesh-list
24998470|NCT02688881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24998471|NCT02688881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24998472|NCT02688881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24998473|NCT02688881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998474|NCT02688881|Antifungal Agents|antifungal agents|mesh-ancestor
24998475|NCT02688881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24998476|NCT02688881|Immunologic Factors|immunologic factors|mesh-ancestor
24998477|NCT02688881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998478|NCT02630199|Paclitaxel|paclitaxel|mesh-list
24998479|NCT02630199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24998480|NCT02630199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998518|NCT02574455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24936449|NCT04040309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24998576|NCT02518594|Hormones|hormones|mesh-ancestor
24839315|NCT02203422|Cyclosporine|cyclosporine|mesh-list
24998605|NCT02448329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24998607|NCT02448329|Tubulin Modulators|tubulin modulators|mesh-ancestor
24998608|NCT02448329|Antimitotic Agents|antimitotic agents|mesh-ancestor
24998611|NCT02448329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998612|NCT02447419|Gefitinib|gefitinib|mesh-list
24998613|NCT02447419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998655|NCT02232087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24998656|NCT02232087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24998657|NCT02232087|Autonomic Agents|autonomic agents|mesh-ancestor
24998658|NCT02232087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24998659|NCT02232087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998660|NCT02232087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24998661|NCT02232087|Respiratory System Agents|respiratory system agents|mesh-ancestor
24998662|NCT02232087|Dermatologic Agents|dermatologic agents|mesh-ancestor
24936658|NCT04038073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936659|NCT04037774|Dexmedetomidine|dexmedetomidine|mesh-list
24936660|NCT04037774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24936661|NCT04037774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24936662|NCT04037774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936663|NCT04037774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24936665|NCT04037774|Sensory System Agents|sensory system agents|mesh-ancestor
24936666|NCT04037774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24936667|NCT04037774|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24936668|NCT04037774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24936669|NCT04037774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24936670|NCT04037774|Adrenergic Agents|adrenergic agents|mesh-ancestor
24936671|NCT04037774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25048619|NCT00680472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25048620|NCT00680472|Analgesics|analgesics|mesh-ancestor
25048621|NCT00680472|Sensory System Agents|sensory system agents|mesh-ancestor
25048622|NCT00680472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25048623|NCT00680472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048624|NCT00680472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24839441|NCT02204397|Ustekinumab|ustekinumab|mesh-list
24998721|NCT01376427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24998722|NCT01376427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998723|NCT01376427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24998724|NCT01376427|Glucocorticoids|glucocorticoids|mesh-ancestor
24998725|NCT01376427|Hormones|hormones|mesh-ancestor
24998765|NCT00777491|Fluorouracil|fluorouracil|mesh-list
24998766|NCT00777491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998767|NCT00777491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24998768|NCT00777491|Antimetabolites|antimetabolites|mesh-ancestor
24839701|NCT02205931|Clonazepam|clonazepam|mesh-list
24936788|NCT04036201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936790|NCT04036201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24936791|NCT04036201|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24936793|NCT04036201|Viscosupplements|viscosupplements|mesh-ancestor
24936794|NCT04036201|Protective Agents|protective agents|mesh-ancestor
24936795|NCT04036253|Epoetin Alfa|epoetin alfa|mesh-list
24936796|NCT04036253|Hematinics|hematinics|mesh-ancestor
24998912|NCT05422001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24998913|NCT05422001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24998914|NCT05422001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24998915|NCT05422001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998980|NCT05421416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999012|NCT05388006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999014|NCT05345249|Anesthetics, Local|anesthetics, local|mesh-ancestor
24999015|NCT05345249|Anesthetics|anesthetics|mesh-ancestor
24999016|NCT05345249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24999017|NCT05345249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999018|NCT05345249|Sensory System Agents|sensory system agents|mesh-ancestor
24999019|NCT05345249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24999020|NCT05326373|Fluorides|fluorides|mesh-list
24999021|NCT05326373|Tin Fluorides|tin fluorides|mesh-list
24999022|NCT05326373|Cariostatic Agents|cariostatic agents|mesh-ancestor
24999023|NCT05326373|Protective Agents|protective agents|mesh-ancestor
24999024|NCT05326373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048718|NCT00673478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25048719|NCT00673478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999169|NCT05083312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999267|NCT04795869|Immunoconjugates|immunoconjugates|mesh-list
24999268|NCT04795869|Immunologic Factors|immunologic factors|mesh-ancestor
24937092|NCT04033276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24937242|NCT04031703|Fluorouracil|fluorouracil|mesh-list
24937243|NCT04031703|Epirubicin|epirubicin|mesh-list
25048752|NCT00672997|Adrenergic Agents|adrenergic agents|mesh-ancestor
25048753|NCT00672997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25048754|NCT00672997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048755|NCT00672997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048756|NCT00672997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25048757|NCT00672997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25048758|NCT00672412|Lamivudine|lamivudine|mesh-list
25048759|NCT00672412|Zidovudine|zidovudine|mesh-list
25048760|NCT00672412|Nevirapine|nevirapine|mesh-list
25048761|NCT00672412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25048762|NCT00672412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24999394|NCT04469868|Analgesics, Opioid|analgesics, opioid|mesh-list
24999395|NCT04469868|Narcotics|narcotics|mesh-ancestor
24461551|NCT00352651|Pregabalin|pregabalin|mesh-list
24999396|NCT04469868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24999399|NCT04469868|Sensory System Agents|sensory system agents|mesh-ancestor
24999400|NCT04469868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937384|NCT04029428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937385|NCT04029428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24937386|NCT04029428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24937387|NCT04029428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24937388|NCT04029350|Osimertinib|osimertinib|mesh-list
24937389|NCT04029350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510268|NCT00564057|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24510269|NCT00564057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510270|NCT00564057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24510271|NCT00564057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24510272|NCT00564057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25405698|NCT03598595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24937390|NCT04029350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25048791|NCT00668772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048792|NCT00668772|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25048793|NCT00668772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25048795|NCT00668772|Adrenergic Agents|adrenergic agents|mesh-ancestor
25048796|NCT00667953|Temozolomide|temozolomide|mesh-list
25048797|NCT00667953|Imatinib Mesylate|imatinib mesylate|mesh-list
25048798|NCT00667953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25048799|NCT00667953|Alkylating Agents|alkylating agents|mesh-ancestor
25048800|NCT00667953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048801|NCT00667953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24840485|NCT02210702|Estradiol|estradiol|mesh-list
24798431|NCT01963559|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24999455|NCT04332341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999456|NCT04332341|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24999457|NCT04332341|Vasodilator Agents|vasodilator agents|mesh-ancestor
25075919|NCT03377283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24999568|NCT03981614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24999569|NCT03981614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24999570|NCT03981614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999594|NCT03912220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24999595|NCT03912220|Vasodilator Agents|vasodilator agents|mesh-ancestor
24999597|NCT03831295|Immunologic Factors|immunologic factors|mesh-ancestor
24999598|NCT03831295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999599|NCT03815643|Avelumab|avelumab|mesh-list
24999600|NCT03815643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24999601|NCT03815643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999602|NCT03810976|Gemcitabine|gemcitabine|mesh-list
24999603|NCT03810976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24999604|NCT03810976|Antimetabolites|antimetabolites|mesh-ancestor
24999605|NCT03810976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999606|NCT03810976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999607|NCT03810976|Antiviral Agents|antiviral agents|mesh-ancestor
24999608|NCT03810976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24999609|NCT03810976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24999610|NCT03810976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24999611|NCT03810976|Immunologic Factors|immunologic factors|mesh-ancestor
24999612|NCT03810976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999613|NCT03802084|Imatinib Mesylate|imatinib mesylate|mesh-list
24999614|NCT03802084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999615|NCT03802084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24999616|NCT03802084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24999617|NCT03802084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999618|NCT03781960|Nivolumab|nivolumab|mesh-list
24999619|NCT03781960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24999620|NCT03781960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999621|NCT03781960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25075920|NCT03377257|Oxazolidinones|oxazolidinones|mesh-list
25048822|NCT00663767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25048823|NCT00663767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24798448|NCT01963702|Antimitotic Agents|antimitotic agents|mesh-ancestor
24798453|NCT01963741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24798454|NCT01963741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798455|NCT01963741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798456|NCT01963754|Epinephrine|epinephrine|mesh-list
24798457|NCT01963754|Racepinephrine|racepinephrine|mesh-list
24798458|NCT01963754|Anesthetics|anesthetics|mesh-list
24798460|NCT01963754|Epinephryl borate|epinephryl borate|mesh-list
24798464|NCT01963754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24798465|NCT01963754|Adrenergic Agents|adrenergic agents|mesh-ancestor
24798466|NCT01963754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24656562|NCT01262612|Cediranib|cediranib|mesh-list
24798467|NCT01963754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798468|NCT01963754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24798469|NCT01963754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24798470|NCT01963754|Autonomic Agents|autonomic agents|mesh-ancestor
24798471|NCT01963754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24798472|NCT01963754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24798473|NCT01963754|Respiratory System Agents|respiratory system agents|mesh-ancestor
24798474|NCT01963754|Mydriatics|mydriatics|mesh-ancestor
25048827|NCT00662740|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24798475|NCT01963754|Sympathomimetics|sympathomimetics|mesh-ancestor
24798476|NCT01963754|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24798477|NCT01963754|Anesthetics, Local|anesthetics, local|mesh-ancestor
24798479|NCT01963832|Fluoxetine|fluoxetine|mesh-list
24798480|NCT01963832|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24798481|NCT01963832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24798482|NCT01963832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24798483|NCT01963832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999817|NCT03121014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24999818|NCT03121014|Immunologic Factors|immunologic factors|mesh-ancestor
24999819|NCT03121014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24999821|NCT03121014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24999822|NCT03121014|Alkylating Agents|alkylating agents|mesh-ancestor
24920948|NCT04195828|Antimitotic Agents|antimitotic agents|mesh-ancestor
24920949|NCT04195828|Mitosis Modulators|mitosis modulators|mesh-ancestor
24496227|NCT00503828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24920973|NCT04195373|Antifungal Agents|antifungal agents|mesh-ancestor
24920974|NCT04195373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24920975|NCT04195373|Antimetabolites|antimetabolites|mesh-ancestor
24920976|NCT04195373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920985|NCT04195243|Dapagliflozin|dapagliflozin|mesh-list
24999823|NCT03121014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24999824|NCT03121014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24999825|NCT03119363|Methamphetamine|methamphetamine|mesh-list
24999826|NCT03119363|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24999827|NCT03119363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999828|NCT03119363|Sympathomimetics|sympathomimetics|mesh-ancestor
24999829|NCT03119363|Autonomic Agents|autonomic agents|mesh-ancestor
24999830|NCT03119363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24999831|NCT03119363|Dopamine Agents|dopamine agents|mesh-ancestor
24999832|NCT03119363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24999833|NCT03119363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999834|NCT03119363|Adrenergic Agents|adrenergic agents|mesh-ancestor
24999835|NCT03119363|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24999836|NCT03119363|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24999837|NCT03119363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24461726|NCT00353340|Expectorants|expectorants|mesh-ancestor
24999838|NCT03119363|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24999839|NCT03113617|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
24999840|NCT03113617|Bombesin|bombesin|mesh-list
24999841|NCT03113617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999842|NCT03113617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24999843|NCT03113617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999844|NCT03113617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24999850|NCT03080259|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
24999851|NCT03080259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937844|NCT04025177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24937845|NCT04025177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24937847|NCT04025177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048861|NCT00662506|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24999903|NCT02884219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841068|NCT02213913|Prednisone|prednisone|mesh-list
25000097|NCT01700673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25000098|NCT01700673|Antimetabolites|antimetabolites|mesh-ancestor
25000099|NCT01700673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000100|NCT01700673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25000101|NCT01700673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25000102|NCT01700673|Immunologic Factors|immunologic factors|mesh-ancestor
25000103|NCT01700673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000104|NCT01371240|Secretin|secretin|mesh-list
25000105|NCT01371240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25000106|NCT01371240|Hormones|hormones|mesh-ancestor
25000107|NCT01371240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25000108|NCT01371240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000109|NCT00979693|Psilocybin|psilocybin|mesh-list
25000110|NCT00979693|Hallucinogens|hallucinogens|mesh-ancestor
25000111|NCT00979693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937959|NCT04023630|Rivaroxaban|rivaroxaban|mesh-list
24938026|NCT04023305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938028|NCT04022837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24938029|NCT04022837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24938030|NCT04022837|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24938031|NCT04022837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121896|NCT03098407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24938032|NCT04022837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938036|NCT04022811|Tobramycin|tobramycin|mesh-list
24938037|NCT04022811|Dexamethasone|dexamethasone|mesh-list
24798492|NCT01963832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24798493|NCT01963910|Mannitol|mannitol|mesh-list
24798494|NCT01963910|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24798496|NCT01963910|Natriuretic Agents|natriuretic agents|mesh-ancestor
25000113|NCT00799058|Dapivirine|dapivirine|mesh-list
25000127|NCT00775476|Protective Agents|protective agents|mesh-ancestor
25000128|NCT00775476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000129|NCT00775476|Antidotes|antidotes|mesh-ancestor
24841329|NCT02215395|Estradiol|estradiol|mesh-list
25048847|NCT00662597|Tubulin Modulators|tubulin modulators|mesh-ancestor
25048848|NCT00662597|Antimitotic Agents|antimitotic agents|mesh-ancestor
25048849|NCT00662597|Mitosis Modulators|mitosis modulators|mesh-ancestor
25048850|NCT00662597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048851|NCT00662506|Deoxyglucose|deoxyglucose|mesh-list
25048852|NCT00662506|Temozolomide|temozolomide|mesh-list
25048853|NCT00662506|Cediranib|cediranib|mesh-list
25048854|NCT00662506|Maleic acid|maleic acid|mesh-list
25048855|NCT00662506|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25048856|NCT00662506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25048857|NCT00662506|Alkylating Agents|alkylating agents|mesh-ancestor
25048858|NCT00662506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048859|NCT00662506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048860|NCT00662506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841896|NCT02218762|Glucocorticoids|glucocorticoids|mesh-ancestor
25000599|NCT04148105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25000600|NCT04148105|Protective Agents|protective agents|mesh-ancestor
25000601|NCT04148105|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25000602|NCT04148105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25000603|NCT04148105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25000605|NCT04147351|Atezolizumab|atezolizumab|mesh-list
25000606|NCT04147351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25000607|NCT04147351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25000608|NCT04147351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25000609|NCT04147351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25000610|NCT04147351|Growth Substances|growth substances|mesh-ancestor
24938657|NCT04017377|Tubulin Modulators|tubulin modulators|mesh-ancestor
24938658|NCT04017377|Antimitotic Agents|antimitotic agents|mesh-ancestor
24938659|NCT04017377|Mitosis Modulators|mitosis modulators|mesh-ancestor
25000785|NCT03342027|Bupropion|bupropion|mesh-list
25000786|NCT03342027|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25000787|NCT03342027|Antidepressive Agents|antidepressive agents|mesh-ancestor
25000788|NCT03342027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25000789|NCT03342027|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25048937|NCT00658008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25000820|NCT03053362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25000821|NCT03053362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25000822|NCT03053362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25000823|NCT03053362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000824|NCT03053362|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25000825|NCT03053362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25000826|NCT03053362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25000928|NCT05462613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25000929|NCT05462613|Growth Substances|growth substances|mesh-ancestor
25000930|NCT05462613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000931|NCT05462613|Growth Inhibitors|growth inhibitors|mesh-ancestor
24510301|NCT00564174|Antipyretics|antipyretics|mesh-ancestor
25000932|NCT05462613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25000933|NCT05462613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25000934|NCT05462613|Analgesics|analgesics|mesh-ancestor
25000935|NCT05462613|Sensory System Agents|sensory system agents|mesh-ancestor
25001003|NCT05461833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25001004|NCT05461833|Parasympatholytics|parasympatholytics|mesh-ancestor
25001005|NCT05461833|Autonomic Agents|autonomic agents|mesh-ancestor
25001006|NCT05461833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25001007|NCT05461833|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25001089|NCT05461261|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25001091|NCT05461261|Docetaxel|docetaxel|mesh-list
25001092|NCT05461261|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25001093|NCT05461261|Prednisolone phosphate|prednisolone phosphate|mesh-list
25001094|NCT05461261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25685344|NCT01904071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25001095|NCT05461261|Tubulin Modulators|tubulin modulators|mesh-ancestor
25001110|NCT05461261|Protective Agents|protective agents|mesh-ancestor
25049005|NCT00647231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25049006|NCT00647231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049008|NCT00647231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25049009|NCT00647231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25049010|NCT00647231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049011|NCT00647231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049013|NCT00646542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25049014|NCT00646542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049015|NCT00646542|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24461854|NCT00354146|Tipifarnib|tipifarnib|mesh-list
25049016|NCT00646542|Protease Inhibitors|protease inhibitors|mesh-ancestor
25049017|NCT00646542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049018|NCT00646542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049019|NCT00645177|Paclitaxel|paclitaxel|mesh-list
25049020|NCT00645177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25049021|NCT00645177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25049022|NCT00645177|Tubulin Modulators|tubulin modulators|mesh-ancestor
25049023|NCT00645177|Antimitotic Agents|antimitotic agents|mesh-ancestor
25049024|NCT00645177|Mitosis Modulators|mitosis modulators|mesh-ancestor
25049041|NCT00642148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049042|NCT00642148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25049043|NCT00642148|Respiratory System Agents|respiratory system agents|mesh-ancestor
25049044|NCT00642148|Glucocorticoids|glucocorticoids|mesh-ancestor
25049045|NCT00642148|Hormones|hormones|mesh-ancestor
25049046|NCT00642148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25049047|NCT00642148|Sympathomimetics|sympathomimetics|mesh-ancestor
25049048|NCT00641732|Enoxaparin|enoxaparin|mesh-list
25001290|NCT05388773|Carboplatin|carboplatin|mesh-list
25001291|NCT05388773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25001292|NCT05383482|Paclitaxel|paclitaxel|mesh-list
25001293|NCT05383482|Docetaxel|docetaxel|mesh-list
25001294|NCT05383482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25001295|NCT05383482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25001296|NCT05383482|Tubulin Modulators|tubulin modulators|mesh-ancestor
24922249|NCT04182191|Tenoxicam|tenoxicam|mesh-list
25001423|NCT05320120|Esketamine|esketamine|mesh-list
25001424|NCT05320120|Antidepressive Agents|antidepressive agents|mesh-ancestor
25001425|NCT05320120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24798543|NCT01964040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798545|NCT01964079|Amlodipine|amlodipine|mesh-list
24798546|NCT01964079|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24798547|NCT01964079|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24798548|NCT01964079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24798549|NCT01964079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049049|NCT00641732|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1h)-one|mesh-list
25049050|NCT00641732|Anticoagulants|anticoagulants|mesh-ancestor
25049051|NCT00641732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25049052|NCT00641732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25049053|NCT00641732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049054|NCT00641732|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25049055|NCT00641732|Antithrombins|antithrombins|mesh-ancestor
25049107|NCT00635193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25049108|NCT00635193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25049109|NCT00635193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25049110|NCT00635193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049111|NCT00635193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049112|NCT00635193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24510302|NCT00564174|Anticoagulants|anticoagulants|mesh-ancestor
25049113|NCT00635193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25049114|NCT00635193|Growth Substances|growth substances|mesh-ancestor
25049115|NCT00635193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049116|NCT00635193|Growth Inhibitors|growth inhibitors|mesh-ancestor
25001828|NCT05021315|Povidone-Iodine|povidone-iodine|mesh-list
25001830|NCT05021315|Plasma Substitutes|plasma substitutes|mesh-ancestor
25001831|NCT05021315|Blood Substitutes|blood substitutes|mesh-ancestor
25001832|NCT05021315|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25001833|NCT05021315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24843229|NCT02226341|Mycophenolic Acid|mycophenolic acid|mesh-list
25002238|NCT04796922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25002239|NCT04796922|Immunologic Factors|immunologic factors|mesh-ancestor
25002242|NCT04792502|Lenalidomide|lenalidomide|mesh-list
25049237|NCT00626106|Hormone Antagonists|hormone antagonists|mesh-ancestor
25049238|NCT00626106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25049239|NCT00626106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049240|NCT00626106|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25049241|NCT00626106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25049242|NCT00626106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25002535|NCT04539366|Cyclophosphamide|cyclophosphamide|mesh-list
25002536|NCT04539366|Fludarabine|fludarabine|mesh-list
25002537|NCT04539366|Fludarabine phosphate|fludarabine phosphate|mesh-list
25002538|NCT04539366|Immunologic Factors|immunologic factors|mesh-ancestor
25002539|NCT04539366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25002540|NCT04539366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25002541|NCT04539366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25002542|NCT04539366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25002544|NCT04539366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25002545|NCT04539366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25002546|NCT04539366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25002547|NCT04539366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25002548|NCT04539366|Antimetabolites|antimetabolites|mesh-ancestor
25002618|NCT04471233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25002619|NCT04471233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25002620|NCT04471233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25049288|NCT00624858|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25049290|NCT00624858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844152|NCT02231385|Acetic Acid|acetic acid|mesh-list
25049306|NCT00620256|Timolol|timolol|mesh-list
25049307|NCT00620256|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25049308|NCT00620256|Latanoprost|latanoprost|mesh-list
25049309|NCT00620256|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25049310|NCT00620256|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25049311|NCT00620256|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25049312|NCT00620256|Adrenergic Agents|adrenergic agents|mesh-ancestor
25049313|NCT00620256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25049314|NCT00620256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049315|NCT00620256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049316|NCT00620256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25049317|NCT00620256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25049318|NCT00618098|Thrombin|thrombin|mesh-list
25003126|NCT03959592|Carotenoids|carotenoids|mesh-list
25003127|NCT03959592|Antioxidants|antioxidants|mesh-ancestor
25003128|NCT03959592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25003129|NCT03959592|Protective Agents|protective agents|mesh-ancestor
25003130|NCT03959592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25003131|NCT03959085|Leucovorin|leucovorin|mesh-list
25003132|NCT03959085|Cytarabine|cytarabine|mesh-list
25003133|NCT03959085|Dexamethasone|dexamethasone|mesh-list
25003134|NCT03959085|Prednisolone|prednisolone|mesh-list
25003135|NCT03959085|Cyclophosphamide|cyclophosphamide|mesh-list
25003136|NCT03959085|Doxorubicin|doxorubicin|mesh-list
25003137|NCT03959085|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25003138|NCT03959085|Methotrexate|methotrexate|mesh-list
25003139|NCT03959085|Vincristine|vincristine|mesh-list
25003140|NCT03959085|Daunorubicin|daunorubicin|mesh-list
25003141|NCT03959085|Mercaptopurine|mercaptopurine|mesh-list
25003142|NCT03959085|Pegaspargase|pegaspargase|mesh-list
25003143|NCT03959085|Thioguanine|thioguanine|mesh-list
25003158|NCT03959085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25003159|NCT03959085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25003160|NCT03959085|Glucocorticoids|glucocorticoids|mesh-ancestor
25003161|NCT03959085|Hormones|hormones|mesh-ancestor
25003162|NCT03959085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25003163|NCT03959085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25003202|NCT03925532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25003203|NCT03925532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25003204|NCT03924986|Gemcitabine|gemcitabine|mesh-list
25003206|NCT03924986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25003207|NCT03924986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25003208|NCT03924986|Antimetabolites|antimetabolites|mesh-ancestor
25003209|NCT03924986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25003210|NCT03924986|Antiviral Agents|antiviral agents|mesh-ancestor
25003211|NCT03924986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25003212|NCT03924986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25003213|NCT03924986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25003214|NCT03924986|Immunologic Factors|immunologic factors|mesh-ancestor
25003215|NCT03924986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844588|NCT02233322|Ferrous gluconate|ferrous gluconate|mesh-list
24940799|NCT03997500|Norepinephrine|norepinephrine|mesh-list
24940800|NCT03997500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24940801|NCT03997500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24798625|NCT01964365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798626|NCT01964365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24798640|NCT01964391|Immunologic Factors|immunologic factors|mesh-ancestor
24798641|NCT01964391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798642|NCT01964391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24798643|NCT01964391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24798644|NCT01964391|Alkylating Agents|alkylating agents|mesh-ancestor
24798645|NCT01964391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24798646|NCT01964391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24798647|NCT01964391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24798648|NCT01964391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24798649|NCT01964391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998328|NCT03110510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24998329|NCT03110510|Immunologic Factors|immunologic factors|mesh-ancestor
24462191|NCT00355459|Tetracycline|tetracycline|mesh-list
24998330|NCT03110510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24998331|NCT03110510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24998332|NCT03110510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998333|NCT03110510|Antidotes|antidotes|mesh-ancestor
24998334|NCT03110510|Protective Agents|protective agents|mesh-ancestor
24998335|NCT03110510|Vitamin B Complex|vitamin b complex|mesh-ancestor
24998336|NCT03110510|Vitamins|vitamins|mesh-ancestor
24998337|NCT03110510|Micronutrients|micronutrients|mesh-ancestor
24998338|NCT03110484|Pemetrexed|pemetrexed|mesh-list
25049346|NCT00616330|Antifungal Agents|antifungal agents|mesh-ancestor
25049348|NCT00616148|Anticonvulsants|anticonvulsants|mesh-ancestor
25003399|NCT03721341|Hormones|hormones|mesh-list
25003400|NCT03721341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25003401|NCT03721341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25003409|NCT03703375|Gemcitabine|gemcitabine|mesh-list
25003410|NCT03703375|Azacitidine|azacitidine|mesh-list
24510273|NCT00564057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510274|NCT00564148|Bevacizumab|bevacizumab|mesh-list
24510275|NCT00564148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24510276|NCT00564148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510277|NCT00564148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24510278|NCT00564148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24510279|NCT00564148|Growth Substances|growth substances|mesh-ancestor
24510280|NCT00564148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510281|NCT00564148|Growth Inhibitors|growth inhibitors|mesh-ancestor
24510296|NCT00564174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25003411|NCT03703375|Romidepsin|romidepsin|mesh-list
25003412|NCT03703375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25003413|NCT03703375|Antimetabolites|antimetabolites|mesh-ancestor
25003414|NCT03703375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25003415|NCT03703375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25003416|NCT03703375|Antiviral Agents|antiviral agents|mesh-ancestor
24844783|NCT02234466|Hormones|hormones|mesh-ancestor
25049370|NCT00612820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25049371|NCT00612820|Respiratory System Agents|respiratory system agents|mesh-ancestor
25049372|NCT00612820|Dermatologic Agents|dermatologic agents|mesh-ancestor
25049373|NCT00612820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25049374|NCT00612820|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25003701|NCT03120624|Interferons|interferons|mesh-list
25003702|NCT03120624|Interferon-beta|interferon-beta|mesh-list
24510297|NCT00564174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510298|NCT00564174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24510299|NCT00564174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24510300|NCT00564174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25003704|NCT03120624|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
25003705|NCT03120624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25003706|NCT03120624|Antiviral Agents|antiviral agents|mesh-ancestor
25003707|NCT03120624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25003708|NCT03120624|Immunologic Factors|immunologic factors|mesh-ancestor
25003709|NCT03120624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25003710|NCT03120624|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25003711|NCT03120624|Trace Elements|trace elements|mesh-ancestor
25003712|NCT03120624|Micronutrients|micronutrients|mesh-ancestor
25049414|NCT00609323|Anesthetics, Local|anesthetics, local|mesh-ancestor
25003713|NCT03120624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25003714|NCT03120624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25003715|NCT03120624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122033|NCT03097068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122034|NCT03097068|Growth Inhibitors|growth inhibitors|mesh-ancestor
25003716|NCT03120624|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25003718|NCT03113422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25003919|NCT02923128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25003943|NCT02921022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25003947|NCT02921022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25003948|NCT02921022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25003949|NCT02921022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25003950|NCT02921022|Immunologic Factors|immunologic factors|mesh-ancestor
25003951|NCT02921022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25003989|NCT02865850|Darbepoetin alfa|darbepoetin alfa|mesh-list
25003990|NCT02865850|Hematinics|hematinics|mesh-ancestor
25004108|NCT02706873|Methotrexate|methotrexate|mesh-list
25004109|NCT02706873|Upadacitinib|upadacitinib|mesh-list
25004110|NCT02706873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24510303|NCT00564187|Irbesartan|irbesartan|mesh-list
25004111|NCT02706873|Abortifacient Agents|abortifacient agents|mesh-ancestor
25004112|NCT02706873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25004113|NCT02706873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004114|NCT02706873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25004115|NCT02706873|Antimetabolites|antimetabolites|mesh-ancestor
25004116|NCT02706873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004117|NCT02706873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25004118|NCT02706873|Dermatologic Agents|dermatologic agents|mesh-ancestor
25004119|NCT02706873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004120|NCT02706873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25004121|NCT02706873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25004122|NCT02706873|Immunologic Factors|immunologic factors|mesh-ancestor
25004123|NCT02706873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25004124|NCT02706873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25004125|NCT02706873|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25004126|NCT02706873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24941615|NCT03989557|Ticagrelor|ticagrelor|mesh-list
24941616|NCT03989557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24941620|NCT03989557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845797|NCT02239107|Antidotes|antidotes|mesh-ancestor
24798778|NCT01965080|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25004243|NCT02201381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25004244|NCT02201381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25004245|NCT02201381|Antinematodal Agents|antinematodal agents|mesh-ancestor
25004246|NCT02201381|Anthelmintics|anthelmintics|mesh-ancestor
25004247|NCT02201381|Tubulin Modulators|tubulin modulators|mesh-ancestor
25004248|NCT02201381|Antimitotic Agents|antimitotic agents|mesh-ancestor
25004249|NCT02201381|Mitosis Modulators|mitosis modulators|mesh-ancestor
25004250|NCT02201381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885262|NCT01164995|Adavosertib|adavosertib|mesh-list
25004316|NCT02151981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004317|NCT02151981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004318|NCT02087423|Durvalumab|durvalumab|mesh-list
25004319|NCT02087423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25004321|NCT02059499|Fluorouracil|fluorouracil|mesh-list
25004323|NCT02059499|Antimetabolites|antimetabolites|mesh-ancestor
25004324|NCT02059499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004325|NCT02059499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25004326|NCT02059499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25004327|NCT02059499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25004328|NCT02059499|Immunologic Factors|immunologic factors|mesh-ancestor
25004329|NCT02059499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941868|NCT03986905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24941869|NCT03986905|Cholinergic Agents|cholinergic agents|mesh-ancestor
24941870|NCT03986905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24622168|NCT01065870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25004499|NCT01074151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25004500|NCT01074151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004501|NCT01074151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24846092|NCT02241148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25049549|NCT00589823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25049550|NCT00589823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25049551|NCT00589823|Anesthetics, General|anesthetics, general|mesh-ancestor
25049552|NCT00589823|Anesthetics|anesthetics|mesh-ancestor
25685345|NCT01904149|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
25685346|NCT01904149|Tramadol|tramadol|mesh-list
25685347|NCT01904149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25049553|NCT00584974|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25049554|NCT00584974|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25049555|NCT00584974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25049556|NCT00584974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25049557|NCT00584974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049589|NCT00583609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25049591|NCT00581477|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25049592|NCT00581477|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25049594|NCT00580216|Warfarin|warfarin|mesh-list
25049595|NCT00580216|Idraparinux|idraparinux|mesh-list
25049596|NCT00580216|Idrabiotaparinux|idrabiotaparinux|mesh-list
25049597|NCT00580216|Anticoagulants|anticoagulants|mesh-ancestor
25049598|NCT00580216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24510405|NCT00564538|Thymoglobulin|thymoglobulin|mesh-list
24510406|NCT00564538|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24885253|NCT01300143|Estrogens|estrogens|mesh-ancestor
24885254|NCT01300143|Hormones|hormones|mesh-ancestor
25049600|NCT00580216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25049601|NCT00580216|Protease Inhibitors|protease inhibitors|mesh-ancestor
25049602|NCT00580216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24942286|NCT03982784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942288|NCT03982784|Sensory System Agents|sensory system agents|mesh-ancestor
24942289|NCT03982784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24767376|NCT01800422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767377|NCT01800435|Tranexamic Acid|tranexamic acid|mesh-list
24767378|NCT01800435|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
24767379|NCT01800435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24767380|NCT01800435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24767381|NCT01800435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767382|NCT01800435|Hemostatics|hemostatics|mesh-ancestor
24767383|NCT01800435|Coagulants|coagulants|mesh-ancestor
24767384|NCT01800487|Silymarin|silymarin|mesh-list
24767385|NCT01800487|Antioxidants|antioxidants|mesh-ancestor
24767386|NCT01800487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767387|NCT01800487|Protective Agents|protective agents|mesh-ancestor
24767388|NCT01800487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767389|NCT01800526|Acetylcysteine|acetylcysteine|mesh-list
24767390|NCT01800526|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24942439|NCT03980951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24942440|NCT03980951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942441|NCT03980951|Analgesics|analgesics|mesh-ancestor
24885255|NCT01300143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24885256|NCT01300143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885257|NCT01300143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24885258|NCT01300143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885259|NCT01199302|Brodalumab|brodalumab|mesh-list
24885260|NCT01199302|Dermatologic Agents|dermatologic agents|mesh-ancestor
24885261|NCT01164995|Carboplatin|carboplatin|mesh-list
24510414|NCT00564551|Calcium|calcium|mesh-list
24510430|NCT00564564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510431|NCT00564564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24510432|NCT00564564|Serotonin Agents|serotonin agents|mesh-ancestor
24510544|NCT00564824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510545|NCT00564824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24510546|NCT00564824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510547|NCT00564824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510548|NCT00564824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24885296|NCT00999401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885298|NCT00885963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942442|NCT03980951|Sensory System Agents|sensory system agents|mesh-ancestor
24942443|NCT03980951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24942446|NCT03980990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942447|NCT03980756|Esomeprazole|esomeprazole|mesh-list
25049754|NCT00570752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049756|NCT00570752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25049757|NCT00570752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049758|NCT00569387|Vaccines|vaccines|mesh-list
24950680|NCT03912974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25049798|NCT00563563|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24935239|NCT04053400|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24935240|NCT04053400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25405699|NCT03598309|Curcumin|curcumin|mesh-list
24935241|NCT04053400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935251|NCT04052711|Minocycline|minocycline|mesh-list
24935252|NCT04052711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24935253|NCT04052711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24935254|NCT04052854|Zanubrutinib|zanubrutinib|mesh-list
24935255|NCT04052854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935256|NCT04052854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24935257|NCT04052854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935258|NCT04052854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935259|NCT04052867|Lidocaine|lidocaine|mesh-list
24935467|NCT04050176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24935468|NCT04050176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935469|NCT04050059|Lidocaine|lidocaine|mesh-list
24885299|NCT00725127|Aspirin|aspirin|mesh-list
24885300|NCT00725127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24885301|NCT00725127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24885302|NCT00725127|Analgesics|analgesics|mesh-ancestor
24510614|NCT00565175|Histamine Agents|histamine agents|mesh-ancestor
24510615|NCT00565175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24510673|NCT00565253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510674|NCT00565253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24510675|NCT00565253|Respiratory System Agents|respiratory system agents|mesh-ancestor
24510676|NCT00565253|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24510678|NCT00565253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510679|NCT00565253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24885321|NCT00462943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885323|NCT00372073|Roscovitine|roscovitine|mesh-list
24510700|NCT00565331|Immunologic Factors|immunologic factors|mesh-ancestor
24510701|NCT00565331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510702|NCT00565331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24510703|NCT00565383|Fentanyl|fentanyl|mesh-list
24850265|NCT02252497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24510704|NCT00565383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24510705|NCT00565383|Narcotics|narcotics|mesh-ancestor
24510706|NCT00565383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24850401|NCT02252926|Bupivacaine|bupivacaine|mesh-list
24850403|NCT02252926|Anesthetics|anesthetics|mesh-ancestor
24812146|NCT02049970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812147|NCT02049970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24812148|NCT02049970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24812150|NCT02049970|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24850495|NCT02253264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850496|NCT02253264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24850497|NCT02253121|Insulin|insulin|mesh-list
24850498|NCT02253121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24850499|NCT02253121|Dapagliflozin|dapagliflozin|mesh-list
24850500|NCT02253121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24850501|NCT02253121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850502|NCT02253121|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24850512|NCT02253420|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24850513|NCT02253420|Hormone Antagonists|hormone antagonists|mesh-ancestor
24850532|NCT02253446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24850533|NCT02253446|Analgesics|analgesics|mesh-ancestor
24885342|NCT00225095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885343|NCT00225095|Viscosupplements|viscosupplements|mesh-ancestor
24885347|NCT00038727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885348|NCT05174312|Diuretics|diuretics|mesh-list
24885349|NCT05174312|Natriuretic Agents|natriuretic agents|mesh-ancestor
24885350|NCT05174312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885351|NCT05174195|Desogestrel|desogestrel|mesh-list
24885352|NCT05174195|Etonogestrel|etonogestrel|mesh-list
24885353|NCT05174195|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24885362|NCT05174195|Hormones|hormones|mesh-ancestor
24850535|NCT02253446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25405854|NCT03591510|Daunorubicin|daunorubicin|mesh-list
24850536|NCT02253446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850537|NCT02253446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24850538|NCT02253446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24850539|NCT02253446|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24850540|NCT02253446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850541|NCT02253446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850542|NCT02253459|Capecitabine|capecitabine|mesh-list
24850543|NCT02253459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24850544|NCT02253459|Antimetabolites|antimetabolites|mesh-ancestor
24850545|NCT02253459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850546|NCT02253459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850547|NCT02253485|Telbivudine|telbivudine|mesh-list
24850564|NCT02253524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850565|NCT02253524|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24850566|NCT02253524|Histamine Antagonists|histamine antagonists|mesh-ancestor
24850567|NCT02253524|Histamine Agents|histamine agents|mesh-ancestor
24850569|NCT02253550|Simeprevir|simeprevir|mesh-list
24850570|NCT02253550|Antiviral Agents|antiviral agents|mesh-ancestor
24850571|NCT02253550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24850572|NCT02253550|Protease Inhibitors|protease inhibitors|mesh-ancestor
24850573|NCT02253550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850574|NCT02253550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850575|NCT02253602|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24850576|NCT02253602|Hematinics|hematinics|mesh-ancestor
24850577|NCT02253602|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24647146|NCT01206530|Vitamins|vitamins|mesh-ancestor
24885372|NCT05173584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24885373|NCT05173584|Autonomic Agents|autonomic agents|mesh-ancestor
24885375|NCT05173584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885376|NCT05173584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24885377|NCT05173584|Respiratory System Agents|respiratory system agents|mesh-ancestor
24885378|NCT05173584|Tocolytic Agents|tocolytic agents|mesh-ancestor
24885379|NCT05173584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24850588|NCT02253784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24416351|NCT00202852|Infliximab|infliximab|mesh-list
24850589|NCT02253784|Antiemetics|antiemetics|mesh-ancestor
24850590|NCT02253784|Autonomic Agents|autonomic agents|mesh-ancestor
24850591|NCT02253784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24850592|NCT02253784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850593|NCT02253784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24850594|NCT02253784|Glucocorticoids|glucocorticoids|mesh-ancestor
24850595|NCT02253784|Hormones|hormones|mesh-ancestor
24850596|NCT02253784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24647191|NCT01206881|Antimitotic Agents|antimitotic agents|mesh-ancestor
24937061|NCT04033029|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24850738|NCT02253927|Ritonavir|ritonavir|mesh-list
24850739|NCT02253927|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24850740|NCT02253927|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24850741|NCT02253927|Protease Inhibitors|protease inhibitors|mesh-ancestor
24850742|NCT02253927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850743|NCT02253927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850744|NCT02253927|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24850745|NCT02253927|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24850746|NCT02253927|Antiviral Agents|antiviral agents|mesh-ancestor
24850747|NCT02253927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24672325|NCT01331590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24850748|NCT02253927|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24850764|NCT02253953|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24850765|NCT02253953|Protease Inhibitors|protease inhibitors|mesh-ancestor
24885380|NCT05173584|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24885381|NCT05173584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24885382|NCT05173584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24510797|NCT00565656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24510798|NCT00565656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850796|NCT02253966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24812174|NCT02050074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122201|NCT03095703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25122202|NCT03095703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25122203|NCT03095703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25122204|NCT03095703|Antifungal Agents|antifungal agents|mesh-ancestor
25122205|NCT03095703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25122206|NCT03095703|Immunologic Factors|immunologic factors|mesh-ancestor
24850869|NCT02254148|Purinergic Agents|purinergic agents|mesh-ancestor
24850870|NCT02254148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24850871|NCT02254148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24850872|NCT02254148|Sympatholytics|sympatholytics|mesh-ancestor
24850873|NCT02254148|Autonomic Agents|autonomic agents|mesh-ancestor
24850874|NCT02254148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24850875|NCT02254148|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24850876|NCT02254148|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24850877|NCT02254148|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24850878|NCT02254148|Adrenergic Agents|adrenergic agents|mesh-ancestor
24850879|NCT02254148|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24850880|NCT02254148|Protective Agents|protective agents|mesh-ancestor
24850881|NCT02254174|Tiotropium Bromide|tiotropium bromide|mesh-list
24761910|NCT01765296|Celecoxib|celecoxib|mesh-list
24761911|NCT01765296|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24850888|NCT02254174|Respiratory System Agents|respiratory system agents|mesh-ancestor
24850889|NCT02254174|Parasympatholytics|parasympatholytics|mesh-ancestor
24850890|NCT02254174|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24850891|NCT02254174|Cholinergic Agents|cholinergic agents|mesh-ancestor
24851019|NCT02254967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24851020|NCT02254980|Vitamin E|vitamin e|mesh-list
24444831|NCT00299247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24851121|NCT02255578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851122|NCT02255578|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24851124|NCT02255578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24851125|NCT02255578|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24851126|NCT02255578|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24851127|NCT02255591|Lidocaine|lidocaine|mesh-list
24937781|NCT04025593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24937782|NCT04025593|Immunologic Factors|immunologic factors|mesh-ancestor
24937783|NCT04025593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937784|NCT04025593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25023027|NCT03658109|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24937785|NCT04025593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24938066|NCT04022785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24938068|NCT04022785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938069|NCT04022785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812249|NCT02050893|Midazolam|midazolam|mesh-list
24445160|NCT00300586|Immunologic Factors|immunologic factors|mesh-ancestor
24445161|NCT00300586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445162|NCT00300586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24795369|NCT02953509|Antimetabolites|antimetabolites|mesh-ancestor
24795370|NCT02953509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795371|NCT02953509|Antiviral Agents|antiviral agents|mesh-ancestor
24783696|NCT01903278|Antiviral Agents|antiviral agents|mesh-ancestor
24783697|NCT01903278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783698|NCT01903291|Dimethyl Fumarate|dimethyl fumarate|mesh-list
24783699|NCT01903291|Dermatologic Agents|dermatologic agents|mesh-ancestor
24783700|NCT01903291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24783701|NCT01903291|Immunologic Factors|immunologic factors|mesh-ancestor
24783702|NCT01903291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685348|NCT01904149|Narcotics|narcotics|mesh-ancestor
25685349|NCT01904149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25685350|NCT01904149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685351|NCT01904149|Analgesics|analgesics|mesh-ancestor
25685352|NCT01904149|Sensory System Agents|sensory system agents|mesh-ancestor
25685353|NCT01904149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24783703|NCT01903421|Fentanyl|fentanyl|mesh-list
24783704|NCT01903421|Bupivacaine|bupivacaine|mesh-list
24783705|NCT01903421|Anesthetics|anesthetics|mesh-list
25685354|NCT01904149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25685355|NCT01904149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25685356|NCT01904149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24783706|NCT01903421|Propofol|propofol|mesh-list
24783707|NCT01903421|Sevoflurane|sevoflurane|mesh-list
24783708|NCT01903421|Isoflurane|isoflurane|mesh-list
24783709|NCT01903421|Anesthetics, Local|anesthetics, local|mesh-ancestor
24783710|NCT01903421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24783711|NCT01903421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795372|NCT02953509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24795373|NCT02953509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795374|NCT02953509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24795375|NCT02900560|Pembrolizumab|pembrolizumab|mesh-list
24978343|NCT04674826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24978344|NCT04674826|Immunologic Factors|immunologic factors|mesh-ancestor
24978345|NCT04674826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978499|NCT04183101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24916471|NCT04240496|Clozapine|clozapine|mesh-list
24978500|NCT04084626|Lenalidomide|lenalidomide|mesh-list
24978501|NCT04084626|Antibodies|antibodies|mesh-list
24978502|NCT04084626|Immunologic Factors|immunologic factors|mesh-ancestor
24978503|NCT04084626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978504|NCT04084626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24978505|NCT04084626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24978506|NCT04084626|Growth Substances|growth substances|mesh-ancestor
24978507|NCT04084626|Growth Inhibitors|growth inhibitors|mesh-ancestor
24978508|NCT04084626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978511|NCT04078568|Aspirin|aspirin|mesh-list
24978512|NCT04078568|Prednisolone|prednisolone|mesh-list
24978513|NCT04078568|Immunoglobulins|immunoglobulins|mesh-list
24978514|NCT04078568|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24978515|NCT04078568|gamma-Globulins|gamma-globulins|mesh-list
24978516|NCT04078568|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24978517|NCT04078568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25105837|NCT04850495|Immunoglobulins|immunoglobulins|mesh-list
25105838|NCT04850495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25105839|NCT04850495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25105840|NCT04850495|Immunologic Factors|immunologic factors|mesh-ancestor
24774487|NCT01845701|Antiviral Agents|antiviral agents|mesh-ancestor
24981643|NCT02220985|Mycophenolic Acid|mycophenolic acid|mesh-list
24981644|NCT02220985|Cyclophosphamide|cyclophosphamide|mesh-list
24981646|NCT02220985|Methotrexate|methotrexate|mesh-list
24981647|NCT02220985|Fludarabine|fludarabine|mesh-list
24981648|NCT02220985|Fludarabine phosphate|fludarabine phosphate|mesh-list
24981649|NCT02220985|Tacrolimus|tacrolimus|mesh-list
24981650|NCT02220985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24981651|NCT02220985|Immunologic Factors|immunologic factors|mesh-ancestor
24981652|NCT02220985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981653|NCT02220985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24981654|NCT02220985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24981655|NCT02220985|Alkylating Agents|alkylating agents|mesh-ancestor
24565789|NCT00782548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24468232|NCT00380614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24982375|NCT02913664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24982376|NCT02913664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24982377|NCT02913664|Protease Inhibitors|protease inhibitors|mesh-ancestor
24982378|NCT02913664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24982381|NCT02889133|Iron-Dextran Complex|iron-dextran complex|mesh-list
24982382|NCT02889133|Trace Elements|trace elements|mesh-ancestor
24982383|NCT02889133|Micronutrients|micronutrients|mesh-ancestor
24982384|NCT02889133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936290|NCT04042558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24982385|NCT02889133|Anticoagulants|anticoagulants|mesh-ancestor
24982386|NCT02889133|Plasma Substitutes|plasma substitutes|mesh-ancestor
24982387|NCT02889133|Blood Substitutes|blood substitutes|mesh-ancestor
24982388|NCT02889133|Hematinics|hematinics|mesh-ancestor
24982389|NCT02818582|Remdesivir|remdesivir|mesh-list
24982453|NCT02650648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24982454|NCT02650648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24982455|NCT02650648|Alkylating Agents|alkylating agents|mesh-ancestor
24982456|NCT02650648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982457|NCT02650648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24982458|NCT02650648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24982467|NCT02596503|Cefixime|cefixime|mesh-list
24920443|NCT04202484|Oxaliplatin|oxaliplatin|mesh-list
24982510|NCT02441686|Dexamethasone|dexamethasone|mesh-list
24982511|NCT02441686|Lenalidomide|lenalidomide|mesh-list
24982512|NCT02441686|Bortezomib|bortezomib|mesh-list
24982513|NCT02441686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24982514|NCT02441686|Antiemetics|antiemetics|mesh-ancestor
24982515|NCT02441686|Autonomic Agents|autonomic agents|mesh-ancestor
24982516|NCT02441686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24795966|NCT01947062|Immunologic Factors|immunologic factors|mesh-ancestor
24795768|NCT01945957|Oxytocics|oxytocics|mesh-ancestor
24629785|NCT01107938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24795769|NCT01945957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24795770|NCT01945957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795771|NCT01945983|Norepinephrine|norepinephrine|mesh-list
24795772|NCT01945983|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24795773|NCT01945983|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24795774|NCT01945983|Adrenergic Agents|adrenergic agents|mesh-ancestor
24982784|NCT00400218|Natriuretic Agents|natriuretic agents|mesh-ancestor
24982785|NCT00400218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982786|NCT00400218|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24982787|NCT00400218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24982789|NCT00398541|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24982790|NCT00398541|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24982791|NCT00398541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24982792|NCT00398541|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24982793|NCT00398541|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24982794|NCT00398541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982795|NCT00398541|Diuretics|diuretics|mesh-ancestor
24982796|NCT00398541|Natriuretic Agents|natriuretic agents|mesh-ancestor
24982797|NCT00398541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982798|NCT00398541|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24982799|NCT00398541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24982800|NCT00383721|Mometasone Furoate|mometasone furoate|mesh-list
24982801|NCT00383721|Formoterol Fumarate|formoterol fumarate|mesh-list
24982802|NCT00383721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24982803|NCT00383721|Autonomic Agents|autonomic agents|mesh-ancestor
24982804|NCT00383721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24982805|NCT00383721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784386|NCT01907685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784387|NCT01907724|Simeprevir|simeprevir|mesh-list
24784388|NCT01907724|Antiviral Agents|antiviral agents|mesh-ancestor
24784389|NCT01907724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24784390|NCT01907724|Protease Inhibitors|protease inhibitors|mesh-ancestor
24784391|NCT01907724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24784392|NCT01907724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784393|NCT01907776|Arbekacin|arbekacin|mesh-list
24774586|NCT01846559|Ticagrelor|ticagrelor|mesh-list
24784394|NCT01907776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24784396|NCT01907802|Dabrafenib|dabrafenib|mesh-list
24982849|NCT00383435|Dermatologic Agents|dermatologic agents|mesh-ancestor
24982850|NCT00383435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24982851|NCT00381485|Mometasone Furoate|mometasone furoate|mesh-list
24982852|NCT00381485|Formoterol Fumarate|formoterol fumarate|mesh-list
24982853|NCT00381485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24982854|NCT00381485|Autonomic Agents|autonomic agents|mesh-ancestor
24982855|NCT00381485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24982856|NCT00381485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982857|NCT00381485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24982858|NCT00381485|Respiratory System Agents|respiratory system agents|mesh-ancestor
24982859|NCT00381485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24982860|NCT00381485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24982861|NCT00381485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24982862|NCT00381485|Adrenergic Agents|adrenergic agents|mesh-ancestor
24982863|NCT00381485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24982864|NCT00381485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982957|NCT00092690|Simvastatin|simvastatin|mesh-list
24982958|NCT00092690|Ezetimibe|ezetimibe|mesh-list
24982968|NCT00092664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24982969|NCT00092664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24982970|NCT00092664|Antimetabolites|antimetabolites|mesh-ancestor
24982971|NCT00092664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982972|NCT00092664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24982973|NCT00092664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24982974|NCT00092664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24982975|NCT00092651|Simvastatin|simvastatin|mesh-list
24982976|NCT00092651|Ezetimibe|ezetimibe|mesh-list
24982977|NCT00092651|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
24982978|NCT00092651|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24982979|NCT00092651|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24982980|NCT00092651|Antimetabolites|antimetabolites|mesh-ancestor
24982981|NCT00092651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982982|NCT00092651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24982983|NCT00092651|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24983007|NCT00092599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983010|NCT00092586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24983011|NCT00092586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24983012|NCT00092586|Antimetabolites|antimetabolites|mesh-ancestor
24983013|NCT00092586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983014|NCT00092586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24983015|NCT00092573|Ezetimibe|ezetimibe|mesh-list
24983016|NCT00092573|Fenofibrate|fenofibrate|mesh-list
24983017|NCT00092573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24983018|NCT00092573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24983019|NCT00092573|Antimetabolites|antimetabolites|mesh-ancestor
24784405|NCT01907867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24784417|NCT01907984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24983033|NCT00092209|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24983034|NCT00092209|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24983035|NCT00092209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983036|NCT00092209|Diuretics|diuretics|mesh-ancestor
24983037|NCT00092209|Natriuretic Agents|natriuretic agents|mesh-ancestor
24983038|NCT00092209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983039|NCT00092209|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24983040|NCT00092209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24983041|NCT00092157|Simvastatin|simvastatin|mesh-list
24983042|NCT00092157|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24983043|NCT00092157|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24983044|NCT00092157|Antimetabolites|antimetabolites|mesh-ancestor
24983045|NCT00092157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983046|NCT00092157|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24983047|NCT00092157|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24983048|NCT00092157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24983049|NCT00090298|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24983050|NCT00090298|Simvastatin|simvastatin|mesh-list
24983051|NCT00090298|Ezetimibe|ezetimibe|mesh-list
24983052|NCT00090298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24983053|NCT00090298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24983054|NCT00090298|Antimetabolites|antimetabolites|mesh-ancestor
24450533|NCT00319488|Tocolytic Agents|tocolytic agents|mesh-ancestor
24983088|NCT02765854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24983090|NCT02765854|Autonomic Agents|autonomic agents|mesh-ancestor
24983091|NCT02765854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24983092|NCT02765854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983093|NCT02765854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24983094|NCT02765854|Glucocorticoids|glucocorticoids|mesh-ancestor
24983095|NCT02765854|Hormones|hormones|mesh-ancestor
24795877|NCT01946555|Sensory System Agents|sensory system agents|mesh-ancestor
24795878|NCT01946555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24795879|NCT01946555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24795880|NCT01946555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24983146|NCT02118610|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24983147|NCT02118610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24983148|NCT02118610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24983149|NCT02118610|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24983150|NCT02118610|Dopamine Agents|dopamine agents|mesh-ancestor
24983151|NCT02118610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24983152|NCT02118610|Adrenergic Agents|adrenergic agents|mesh-ancestor
24983153|NCT02118610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24983155|NCT02118610|Sensory System Agents|sensory system agents|mesh-ancestor
24983156|NCT02118610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24983157|NCT02083250|Fludarabine|fludarabine|mesh-list
24983158|NCT02083250|Fludarabine phosphate|fludarabine phosphate|mesh-list
24983159|NCT02083250|Busulfan|busulfan|mesh-list
24983160|NCT02083250|Vorinostat|vorinostat|mesh-list
24983161|NCT02083250|Clofarabine|clofarabine|mesh-list
24983162|NCT02083250|Thymoglobulin|thymoglobulin|mesh-list
24983163|NCT02083250|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24983197|NCT01857934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24983198|NCT01857934|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24983199|NCT01857934|Alkylating Agents|alkylating agents|mesh-ancestor
24983200|NCT01857934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983201|NCT01857934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24983202|NCT01857934|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24983203|NCT01857934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24983204|NCT01857934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24983205|NCT01857934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24983206|NCT01857934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24983207|NCT01857934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24983208|NCT01857934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24983209|NCT01857934|Tubulin Modulators|tubulin modulators|mesh-ancestor
24983210|NCT01857934|Antimitotic Agents|antimitotic agents|mesh-ancestor
24983314|NCT00719966|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24983315|NCT00719966|Hormone Antagonists|hormone antagonists|mesh-ancestor
24983316|NCT00719966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24983317|NCT00719966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983318|NCT00719966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24983320|NCT00637832|Cyclophosphamide|cyclophosphamide|mesh-list
24983321|NCT00637832|Rituximab|rituximab|mesh-list
24983322|NCT00637832|Doxorubicin|doxorubicin|mesh-list
24983323|NCT00637832|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24983324|NCT00637832|Vincristine|vincristine|mesh-list
24983325|NCT00637832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24983326|NCT00637832|Immunologic Factors|immunologic factors|mesh-ancestor
24983327|NCT00637832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983328|NCT00637832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24983329|NCT00637832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24983330|NCT00637832|Alkylating Agents|alkylating agents|mesh-ancestor
24983331|NCT00637832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983332|NCT00637832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24983333|NCT00637832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24983334|NCT00637832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24983335|NCT00637832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24983336|NCT00637832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24983337|NCT00637832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24983338|NCT00637832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24983339|NCT00637832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24984167|NCT04750395|Haloperidol decanoate|haloperidol decanoate|mesh-list
24984168|NCT04750395|Antiemetics|antiemetics|mesh-ancestor
24984169|NCT04750395|Autonomic Agents|autonomic agents|mesh-ancestor
24984170|NCT04750395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24984171|NCT04750395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984173|NCT04750395|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24984221|NCT04731272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24984222|NCT04731272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984223|NCT04714190|Paclitaxel|paclitaxel|mesh-list
24984224|NCT04714190|Irinotecan|irinotecan|mesh-list
24984225|NCT04714190|Apatinib|apatinib|mesh-list
24984226|NCT04714190|Trastuzumab|trastuzumab|mesh-list
24984227|NCT04714190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24984228|NCT04714190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24984229|NCT04714190|Tubulin Modulators|tubulin modulators|mesh-ancestor
24984230|NCT04714190|Antimitotic Agents|antimitotic agents|mesh-ancestor
24795961|NCT01947062|Cyclophosphamide|cyclophosphamide|mesh-list
24795962|NCT01947062|Cisplatin|cisplatin|mesh-list
24795963|NCT01947062|Etoposide|etoposide|mesh-list
24795964|NCT01947062|Etoposide phosphate|etoposide phosphate|mesh-list
24795965|NCT01947062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24795974|NCT01947062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24984260|NCT04702789|Adrenergic Agents|adrenergic agents|mesh-ancestor
24984261|NCT04702789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24984262|NCT04702789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984263|NCT04702789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984264|NCT04702789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24984265|NCT04702789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25106780|NCT03145012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106781|NCT03145012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106782|NCT03144778|Durvalumab|durvalumab|mesh-list
25106783|NCT03144778|Ipilimumab|ipilimumab|mesh-list
25106784|NCT03144778|Tremelimumab|tremelimumab|mesh-list
25106785|NCT03144778|Immunoglobulins|immunoglobulins|mesh-list
25106786|NCT03144778|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25106787|NCT03144778|Immunoglobulin G|immunoglobulin g|mesh-list
24539797|NCT00665678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24984441|NCT04508790|Dexamethasone|dexamethasone|mesh-list
24984442|NCT04508790|Dexamethasone acetate|dexamethasone acetate|mesh-list
24984443|NCT04508790|Pomalidomide|pomalidomide|mesh-list
24984444|NCT04508790|Ichthammol|ichthammol|mesh-list
24984445|NCT04508790|BB 1101|bb 1101|mesh-list
24984446|NCT04508790|Leflunomide|leflunomide|mesh-list
24984447|NCT04508790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24984448|NCT04508790|Antiemetics|antiemetics|mesh-ancestor
24984449|NCT04508790|Autonomic Agents|autonomic agents|mesh-ancestor
24984450|NCT04508790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25405855|NCT03591510|Mitoxantrone|mitoxantrone|mesh-list
24720311|NCT01567657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24984451|NCT04508790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984452|NCT04508790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24984453|NCT04508790|Glucocorticoids|glucocorticoids|mesh-ancestor
24984454|NCT04508790|Hormones|hormones|mesh-ancestor
24630432|NCT01111656|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24984455|NCT04508790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24984456|NCT04508790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24984457|NCT04508790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796106|NCT01947985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859653|NCT02304887|Denosumab|denosumab|mesh-list
24984543|NCT04418427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984544|NCT04418427|Growth Inhibitors|growth inhibitors|mesh-ancestor
24984545|NCT04418427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24984546|NCT04412863|Interferons|interferons|mesh-list
24984547|NCT04412863|Interferon-alpha|interferon-alpha|mesh-list
24984548|NCT04412863|Interferon alpha-2|interferon alpha-2|mesh-list
24984549|NCT04412863|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24984550|NCT04412863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24984551|NCT04412863|Antiviral Agents|antiviral agents|mesh-ancestor
24984552|NCT04412863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24984553|NCT04412863|Immunologic Factors|immunologic factors|mesh-ancestor
24984554|NCT04412863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984556|NCT04412785|Cyclosporins|cyclosporins|mesh-list
24984557|NCT04412785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984558|NCT04412785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984559|NCT04412785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24984560|NCT04412785|Immunologic Factors|immunologic factors|mesh-ancestor
24984561|NCT04412785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984562|NCT04412785|Antifungal Agents|antifungal agents|mesh-ancestor
24984563|NCT04412785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24984564|NCT04412785|Dermatologic Agents|dermatologic agents|mesh-ancestor
24984565|NCT04412785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24984566|NCT04412785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24984567|NCT04386616|Astegolimab|astegolimab|mesh-list
25106941|NCT03143465|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
24510799|NCT00565656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24510800|NCT00565656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24510801|NCT00565656|Growth Substances|growth substances|mesh-ancestor
24510802|NCT00565656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510803|NCT00565656|Growth Inhibitors|growth inhibitors|mesh-ancestor
24510804|NCT00565682|Etoricoxib|etoricoxib|mesh-list
25106942|NCT03143465|Katacalcin|katacalcin|mesh-list
25106943|NCT03143465|Vasodilator Agents|vasodilator agents|mesh-ancestor
25106944|NCT03143465|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25106945|NCT03143465|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24861012|NCT02314312|Hormones|hormones|mesh-ancestor
25106946|NCT03143465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25106947|NCT03143465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106948|NCT03143465|Urological Agents|urological agents|mesh-ancestor
25106949|NCT03143465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25106950|NCT03143465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985175|NCT03592693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985464|NCT03319316|Tremelimumab|tremelimumab|mesh-list
24985465|NCT03319316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24985466|NCT03319316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985507|NCT03268005|Metformin|metformin|mesh-list
24985508|NCT03268005|Insulin Aspart|insulin aspart|mesh-list
24985509|NCT03268005|Insulin, Long-Acting|insulin, long-acting|mesh-list
24985510|NCT03268005|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24985511|NCT03268005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24985512|NCT03268005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985513|NCT03257618|Temozolomide|temozolomide|mesh-list
24985514|NCT03257618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24510805|NCT00565682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24510806|NCT00565682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24464413|NCT00364754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24464415|NCT00364806|Prochlorperazine|prochlorperazine|mesh-list
24510810|NCT00565682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510811|NCT00565682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24510812|NCT00565682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24510840|NCT00565955|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25685358|NCT01904526|Guanfacine|guanfacine|mesh-list
24510841|NCT00565955|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24985515|NCT03257618|Alkylating Agents|alkylating agents|mesh-ancestor
24985516|NCT03257618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985517|NCT03257618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985519|NCT03228186|Pevonedistat|pevonedistat|mesh-list
24985520|NCT03228186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985632|NCT03009487|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24923355|NCT04170855|Furosemide|furosemide|mesh-list
24985633|NCT03009487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24985681|NCT02924272|Protease Inhibitors|protease inhibitors|mesh-ancestor
24985682|NCT02924272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24985683|NCT02924272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860969|NCT02314208|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
24986148|NCT02287311|Cyclophosphamide|cyclophosphamide|mesh-list
24986149|NCT02287311|Fludarabine|fludarabine|mesh-list
24986150|NCT02287311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24986151|NCT02287311|Immunologic Factors|immunologic factors|mesh-ancestor
24986152|NCT02287311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986153|NCT02287311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24986154|NCT02287311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24986155|NCT02287311|Alkylating Agents|alkylating agents|mesh-ancestor
24541348|NCT00672360|Folic Acid|folic acid|mesh-list
24986194|NCT02223520|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24986195|NCT02223520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510917|NCT00566592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24510918|NCT00566592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24510919|NCT00566592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510920|NCT00566644|Levonorgestrel|levonorgestrel|mesh-list
24796333|NCT01949363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24796334|NCT01949454|Fluorometholone|fluorometholone|mesh-list
24796335|NCT01949454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24796336|NCT01949454|Lubricant Eye Drops|lubricant eye drops|mesh-list
24796337|NCT01949454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24796338|NCT01949454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24796339|NCT01949454|Glucocorticoids|glucocorticoids|mesh-ancestor
24861137|NCT02315196|Epirubicin|epirubicin|mesh-list
24986475|NCT01442649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24986476|NCT01442649|Growth Substances|growth substances|mesh-ancestor
24986477|NCT01442649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986478|NCT01442649|Growth Inhibitors|growth inhibitors|mesh-ancestor
24986479|NCT01442649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24986480|NCT01442649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24986481|NCT01442649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24986482|NCT01442649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986484|NCT01442649|Protective Agents|protective agents|mesh-ancestor
24986485|NCT01442649|Vitamin B Complex|vitamin b complex|mesh-ancestor
24986486|NCT01442649|Vitamins|vitamins|mesh-ancestor
24986487|NCT01442649|Micronutrients|micronutrients|mesh-ancestor
24986488|NCT01442649|Hematinics|hematinics|mesh-ancestor
24986489|NCT01442649|Antimetabolites|antimetabolites|mesh-ancestor
24986490|NCT01442649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24986491|NCT01442649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24861216|NCT02316028|Decitabine|decitabine|mesh-list
25107022|NCT03142789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107023|NCT03142789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25107024|NCT03143010|Dexmedetomidine|dexmedetomidine|mesh-list
25107025|NCT03143010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25107026|NCT03143010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25107027|NCT03143010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107028|NCT03143010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25107029|NCT03143010|Analgesics|analgesics|mesh-ancestor
25107030|NCT03143010|Sensory System Agents|sensory system agents|mesh-ancestor
24796429|NCT01949909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796431|NCT01949935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24796432|NCT01949935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24796433|NCT01949935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24796434|NCT01949935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405856|NCT03591510|Idarubicin|idarubicin|mesh-list
24796435|NCT01949935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796436|NCT01949948|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24796437|NCT01949948|Tenecteplase|tenecteplase|mesh-list
24796438|NCT01949948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24796439|NCT01949948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24796440|NCT01949948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796446|NCT01950000|Analgesics|analgesics|mesh-ancestor
24861330|NCT02317146|Anesthetics|anesthetics|mesh-ancestor
24986729|NCT05188131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24986730|NCT05188131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24986731|NCT05188131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24986732|NCT05188131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986734|NCT05188118|Ipilimumab|ipilimumab|mesh-list
24986735|NCT05188118|Everolimus|everolimus|mesh-list
24986736|NCT05188118|Lenvatinib|lenvatinib|mesh-list
24986737|NCT05188118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24986738|NCT05188118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986739|NCT05188118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24986740|NCT05188118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986741|NCT05188118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24986742|NCT05188118|Immunologic Factors|immunologic factors|mesh-ancestor
24986743|NCT05188118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986762|NCT05169424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24986763|NCT05169424|Parasympatholytics|parasympatholytics|mesh-ancestor
24986764|NCT05169424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24986765|NCT05169424|Cholinergic Agents|cholinergic agents|mesh-ancestor
24986766|NCT05169424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24986767|NCT05169424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986768|NCT05165225|Cyclophosphamide|cyclophosphamide|mesh-list
24986769|NCT05165225|Docetaxel|docetaxel|mesh-list
24986770|NCT05165225|Epirubicin|epirubicin|mesh-list
24986771|NCT05165225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24986772|NCT05165225|Immunologic Factors|immunologic factors|mesh-ancestor
24986773|NCT05165225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986774|NCT05165225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24986775|NCT05165225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24986776|NCT05165225|Alkylating Agents|alkylating agents|mesh-ancestor
24986777|NCT05165225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986778|NCT05165225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986779|NCT05165225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24986780|NCT05165225|Tubulin Modulators|tubulin modulators|mesh-ancestor
24986781|NCT05165225|Antimitotic Agents|antimitotic agents|mesh-ancestor
24986782|NCT05165225|Mitosis Modulators|mitosis modulators|mesh-ancestor
24986783|NCT05165225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24986784|NCT05165225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24986785|NCT05165225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24986786|NCT05165225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541662|NCT00674557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24986815|NCT05160896|Growth Inhibitors|growth inhibitors|mesh-ancestor
24986817|NCT05160896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24986818|NCT05160896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24986819|NCT05160896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986820|NCT05160896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24986821|NCT05160896|Antimetabolites|antimetabolites|mesh-ancestor
24986822|NCT05160896|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24986848|NCT05076409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811152|NCT02045056|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24986849|NCT05076409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986850|NCT05076409|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24986851|NCT05076409|Hormone Antagonists|hormone antagonists|mesh-ancestor
24986852|NCT05076409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24986853|NCT05076409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986854|NCT05076409|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24986880|NCT05017545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986881|NCT05017545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986882|NCT05017545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24986884|NCT05017545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986885|NCT05017545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24986886|NCT05008575|Fludarabine|fludarabine|mesh-list
24986887|NCT05008575|Cyclophosphamide|cyclophosphamide|mesh-list
24986888|NCT05008575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25405857|NCT03591510|Midostaurin|midostaurin|mesh-list
25122518|NCT03093090|Furosemide|furosemide|mesh-list
24986889|NCT05008575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986890|NCT05008575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24986891|NCT05008575|Immunologic Factors|immunologic factors|mesh-ancestor
24986892|NCT05008575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986893|NCT05008575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24986894|NCT05008575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24986895|NCT05008575|Alkylating Agents|alkylating agents|mesh-ancestor
24986896|NCT05008575|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24986926|NCT04925193|Growth Substances|growth substances|mesh-ancestor
24986927|NCT04925193|Growth Inhibitors|growth inhibitors|mesh-ancestor
24986928|NCT04925180|Cyproterone Acetate|cyproterone acetate|mesh-list
24986929|NCT04925180|Cyproterone|cyproterone|mesh-list
24986930|NCT04925180|Androgen Antagonists|androgen antagonists|mesh-ancestor
24924607|NCT04158830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24986931|NCT04925180|Hormone Antagonists|hormone antagonists|mesh-ancestor
24986932|NCT04925180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24986933|NCT04925180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986934|NCT04925180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986935|NCT04925180|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24986936|NCT04925180|Contraceptive Agents|contraceptive agents|mesh-ancestor
24986937|NCT04925180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25107058|NCT03142646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24796459|NCT01950182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24796460|NCT01950182|Antimetabolites|antimetabolites|mesh-ancestor
24796461|NCT01950182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796462|NCT01950182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796463|NCT01950182|Antiviral Agents|antiviral agents|mesh-ancestor
24796464|NCT01950182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24541721|NCT00674752|Gabapentin|gabapentin|mesh-list
24986979|NCT04681417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24986980|NCT04681417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24986981|NCT04681417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24986983|NCT04681417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986984|NCT04681417|Tubulin Modulators|tubulin modulators|mesh-ancestor
24861566|NCT02318758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24987014|NCT04589832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987015|NCT04575181|Insulin|insulin|mesh-list
24987016|NCT04575181|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24987017|NCT04575181|Insulin Glargine|insulin glargine|mesh-list
24987018|NCT04575181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24987019|NCT04575181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987020|NCT04560881|Vaccines|vaccines|mesh-list
24987023|NCT04501120|Azacitidine|azacitidine|mesh-list
24987024|NCT04501120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24987026|NCT04501120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987027|NCT04501120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987028|NCT04501120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24987029|NCT04498715|Zoledronic Acid|zoledronic acid|mesh-list
24987048|NCT04447287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987050|NCT04447287|Sensory System Agents|sensory system agents|mesh-ancestor
24987051|NCT04447287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24987052|NCT04447287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24796526|NCT01950507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24796527|NCT01950507|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24796528|NCT01950507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24796529|NCT01950507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796530|NCT01950507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796531|NCT01950507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24796532|NCT01950507|Hormone Antagonists|hormone antagonists|mesh-ancestor
24796533|NCT01950507|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24796534|NCT01950507|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24508563|NCT00556127|Antiemetics|antiemetics|mesh-ancestor
24796535|NCT01950507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24796536|NCT01950546|Fluorides|fluorides|mesh-list
24796537|NCT01950546|Cariostatic Agents|cariostatic agents|mesh-ancestor
24796538|NCT01950546|Protective Agents|protective agents|mesh-ancestor
24796539|NCT01950546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796540|NCT01950585|Hydroxyurea|hydroxyurea|mesh-list
24796541|NCT01950585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796542|NCT01950585|Antisickling Agents|antisickling agents|mesh-ancestor
24987146|NCT03554044|Gemcitabine|gemcitabine|mesh-list
24987147|NCT03554044|Paclitaxel|paclitaxel|mesh-list
25685359|NCT01904526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24721533|NCT01575418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24721534|NCT01575418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24721535|NCT01575418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24721536|NCT01575418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721537|NCT01575418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24721538|NCT01575418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24721539|NCT01575418|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24987148|NCT03554044|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24987149|NCT03554044|Carboplatin|carboplatin|mesh-list
24987151|NCT03554044|Fulvestrant|fulvestrant|mesh-list
24931707|NCT04085913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24931708|NCT04085913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24931709|NCT04085913|Adrenergic Agents|adrenergic agents|mesh-ancestor
24508004|NCT00553748|Alovudine|alovudine|mesh-list
24931801|NCT04085094|Autonomic Agents|autonomic agents|mesh-ancestor
24931802|NCT04085094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24931803|NCT04085094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931804|NCT04085094|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24987152|NCT03554044|Anastrozole|anastrozole|mesh-list
24987153|NCT03554044|Exemestane|exemestane|mesh-list
24987154|NCT03554044|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
24987155|NCT03554044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24987156|NCT03554044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987157|NCT03554044|Tubulin Modulators|tubulin modulators|mesh-ancestor
24987158|NCT03554044|Antimitotic Agents|antimitotic agents|mesh-ancestor
25107060|NCT03142646|Alkylating Agents|alkylating agents|mesh-ancestor
24784976|NCT01911377|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24784977|NCT01911377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24784978|NCT01911377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24784979|NCT01911377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24784980|NCT01911377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784981|NCT01911377|Cholinergic Agents|cholinergic agents|mesh-ancestor
24784982|NCT01911377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24631444|NCT01118065|Everolimus|everolimus|mesh-list
24784983|NCT01911377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784984|NCT01911377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24784985|NCT01911377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24784986|NCT01911455|Acamprosate|acamprosate|mesh-list
24784987|NCT01911455|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24784988|NCT01911468|Metformin|metformin|mesh-list
24784989|NCT01911468|Liraglutide|liraglutide|mesh-list
24784990|NCT01911468|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24784991|NCT01911468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24784992|NCT01911468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784993|NCT01911468|Incretins|incretins|mesh-ancestor
24784994|NCT01911468|Hormones|hormones|mesh-ancestor
25107090|NCT03142620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25107091|NCT03142620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25107092|NCT03142620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25107093|NCT03142620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107094|NCT03142620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107095|NCT03142620|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25107096|NCT03142620|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25107097|NCT03142620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24587440|NCT00894985|Anticoagulants|anticoagulants|mesh-ancestor
25107098|NCT03142620|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24987175|NCT03554044|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24987177|NCT03554044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24987178|NCT03554044|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24987179|NCT03554044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24987180|NCT03552380|Nivolumab|nivolumab|mesh-list
24987181|NCT03552380|Ipilimumab|ipilimumab|mesh-list
24987182|NCT03552380|Entinostat|entinostat|mesh-list
24987183|NCT03552380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24987184|NCT03552380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987185|NCT03552380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24987186|NCT03552380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685360|NCT01904526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25685361|NCT01904526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25685362|NCT01904526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25685363|NCT01904526|Adrenergic Agents|adrenergic agents|mesh-ancestor
25685364|NCT01904526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25685365|NCT01904526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685366|NCT01904526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122585|NCT03092193|Gout Suppressants|gout suppressants|mesh-ancestor
25122586|NCT03092193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24987187|NCT03552380|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24987188|NCT03552380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24987189|NCT03470675|Ketamine|ketamine|mesh-list
24987190|NCT03470675|Morphine|morphine|mesh-list
24987191|NCT03470675|Analgesics|analgesics|mesh-ancestor
24987192|NCT03470675|Sensory System Agents|sensory system agents|mesh-ancestor
24987193|NCT03470675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24932292|NCT04081012|Antiviral Agents|antiviral agents|mesh-ancestor
24987219|NCT03452072|Timolol|timolol|mesh-list
24987220|NCT03452072|Petrolatum|petrolatum|mesh-list
24987221|NCT03452072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24987222|NCT03452072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24987223|NCT03452072|Adrenergic Agents|adrenergic agents|mesh-ancestor
24987224|NCT03452072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24987225|NCT03452072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987226|NCT03452072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987227|NCT03452072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24987228|NCT03452072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24987229|NCT03452072|Emollients|emollients|mesh-ancestor
24987230|NCT03452072|Dermatologic Agents|dermatologic agents|mesh-ancestor
24987231|NCT03433040|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
24987232|NCT03433040|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
24987233|NCT03433040|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24987234|NCT03433040|Hormone Antagonists|hormone antagonists|mesh-ancestor
24987235|NCT03433040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24987236|NCT03433040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987237|NCT03433040|Progestins|progestins|mesh-ancestor
24987238|NCT03433040|Hormones|hormones|mesh-ancestor
24987239|NCT03432065|Buspirone|buspirone|mesh-list
24987240|NCT03432065|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24987241|NCT03432065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24987242|NCT03432065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24987243|NCT03432065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987244|NCT03432065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24987245|NCT03432065|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24987246|NCT03432065|Serotonin Agents|serotonin agents|mesh-ancestor
24987247|NCT03432065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24987248|NCT03432065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987249|NCT03412799|Gemcitabine|gemcitabine|mesh-list
24987250|NCT03412799|Paclitaxel|paclitaxel|mesh-list
24987251|NCT03412799|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24987275|NCT03391882|Autonomic Agents|autonomic agents|mesh-ancestor
24987280|NCT03391882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24987281|NCT03391882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987282|NCT03357952|Daratumumab|daratumumab|mesh-list
24987283|NCT03357952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987297|NCT03066622|Olanzapine|olanzapine|mesh-list
24987298|NCT03066622|Antiemetics|antiemetics|mesh-ancestor
24987329|NCT02482753|Exemestane|exemestane|mesh-list
24987330|NCT02482753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987331|NCT02482753|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24987332|NCT02482753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24987333|NCT02482753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24987334|NCT02482753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987335|NCT02482753|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24987336|NCT02482753|Hormone Antagonists|hormone antagonists|mesh-ancestor
24987337|NCT02482753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24987338|NCT02482753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987339|NCT02420574|Albendazole|albendazole|mesh-list
24987340|NCT02420574|Anthelmintics|anthelmintics|mesh-ancestor
24590136|NCT00910780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24590137|NCT00910780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24590138|NCT00910780|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24590139|NCT00910780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24590140|NCT00910780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24796602|NCT01951053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24796603|NCT01951079|Digoxin|digoxin|mesh-list
24796604|NCT01951079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25685367|NCT01904721|Bimatoprost|bimatoprost|mesh-list
25685368|NCT01904721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24796605|NCT01951079|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24796606|NCT01951079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796607|NCT01951079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796608|NCT01951079|Protective Agents|protective agents|mesh-ancestor
24987389|NCT02101788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987390|NCT02101788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24987391|NCT02101788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24987392|NCT02101788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24987393|NCT02101788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24987394|NCT02101788|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24785018|NCT01911494|Adrenergic Agents|adrenergic agents|mesh-ancestor
24987395|NCT02101788|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24987396|NCT02101788|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24987397|NCT02101788|Hormone Antagonists|hormone antagonists|mesh-ancestor
24987398|NCT02101788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24987399|NCT02101788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987400|NCT02101788|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24987401|NCT02101788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24987402|NCT02101788|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24541885|NCT00675714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24987426|NCT01970410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24987427|NCT01970410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987428|NCT01970410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24987429|NCT01970410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24987441|NCT01936480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24987442|NCT01936480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24987457|NCT01842282|Amlexanox|amlexanox|mesh-list
24987458|NCT01842282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24987459|NCT01622335|Nitrous Oxide|nitrous oxide|mesh-list
24987460|NCT01622335|Anesthetics|anesthetics|mesh-ancestor
24987461|NCT01622335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24987462|NCT01622335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987463|NCT01622335|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24987464|NCT01622335|Anesthetics, General|anesthetics, general|mesh-ancestor
24987465|NCT01622335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24987466|NCT01622335|Analgesics|analgesics|mesh-ancestor
24796643|NCT01951430|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24796645|NCT01951430|Fluconazole|fluconazole|mesh-list
24796646|NCT01951430|Posaconazole|posaconazole|mesh-list
24796647|NCT01951430|Antifungal Agents|antifungal agents|mesh-list
24796648|NCT01951430|Clotrimazole|clotrimazole|mesh-list
24796650|NCT01951430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24796651|NCT01951430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24796661|NCT01951430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24796663|NCT01951430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24796664|NCT01951430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24796665|NCT01951430|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24627546|NCT01093300|Everolimus|everolimus|mesh-list
24796666|NCT01951430|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24796667|NCT01951430|Renal Agents|renal agents|mesh-ancestor
24796668|NCT01951430|Antimalarials|antimalarials|mesh-ancestor
24796669|NCT01951482|Bevacizumab|bevacizumab|mesh-list
24796670|NCT01951482|Cisplatin|cisplatin|mesh-list
24796671|NCT01951482|Pemetrexed|pemetrexed|mesh-list
24796672|NCT01951482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24796673|NCT01951482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796675|NCT01951482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24987473|NCT01362374|Paclitaxel|paclitaxel|mesh-list
24987474|NCT01362374|Docetaxel|docetaxel|mesh-list
24987475|NCT01362374|Oxaliplatin|oxaliplatin|mesh-list
24987476|NCT01362374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24987487|NCT01362374|Micronutrients|micronutrients|mesh-ancestor
24987488|NCT01248247|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24987489|NCT01248247|Sorafenib|sorafenib|mesh-list
24987490|NCT01248247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987491|NCT01248247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24987492|NCT01248247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24987493|NCT01248247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987494|NCT01164228|Gemcitabine|gemcitabine|mesh-list
25107105|NCT03142607|Dermatologic Agents|dermatologic agents|mesh-ancestor
24987495|NCT01164228|Sunitinib|sunitinib|mesh-list
24987496|NCT01164228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24987497|NCT01164228|Antimetabolites|antimetabolites|mesh-ancestor
24987498|NCT01164228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987499|NCT01164228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632387|NCT01123538|Progesterone|progesterone|mesh-list
24862645|NCT04850222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988368|NCT02935595|Analgesics|analgesics|mesh-ancestor
24625274|NCT01081535|Ketorolac|ketorolac|mesh-list
24988369|NCT02935595|Sensory System Agents|sensory system agents|mesh-ancestor
24988370|NCT02935595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24988371|NCT02935595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988372|NCT02935595|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24988459|NCT02780401|Vaccines|vaccines|mesh-list
24988460|NCT02780401|Sargramostim|sargramostim|mesh-list
24988461|NCT02780401|Immunologic Factors|immunologic factors|mesh-ancestor
24988462|NCT02780401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988463|NCT02760498|Cemiplimab|cemiplimab|mesh-list
24988464|NCT02760498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24988465|NCT02760498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988466|NCT02673151|Edetic Acid|edetic acid|mesh-list
24988511|NCT02567578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24988512|NCT02567578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577262|NCT00842660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24577263|NCT00842660|Immunologic Factors|immunologic factors|mesh-ancestor
24577264|NCT00842660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577265|NCT00842686|Bevacizumab|bevacizumab|mesh-list
24988518|NCT02523274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988519|NCT02523274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988520|NCT02523274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24988521|NCT02467270|Ponatinib|ponatinib|mesh-list
24988522|NCT02467270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988523|NCT02467270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24988524|NCT02467270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988525|NCT02467270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988526|NCT02452554|Maytansine|maytansine|mesh-list
24988527|NCT02452554|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
24988528|NCT02452554|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24988529|NCT02452554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24988530|NCT02452554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988573|NCT02323659|Interferons|interferons|mesh-list
24988574|NCT02323659|Interferon-alpha|interferon-alpha|mesh-list
24988575|NCT02323659|Interferon alpha-2|interferon alpha-2|mesh-list
24988576|NCT02323659|Methotrexate|methotrexate|mesh-list
24988577|NCT02323659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24988578|NCT02323659|Abortifacient Agents|abortifacient agents|mesh-ancestor
24988579|NCT02323659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24988580|NCT02323659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988581|NCT02323659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24988582|NCT02323659|Antimetabolites|antimetabolites|mesh-ancestor
24988583|NCT02323659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988628|NCT02143063|Anesthetics, Local|anesthetics, local|mesh-ancestor
24988640|NCT02143063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24988642|NCT02073097|Prednisone|prednisone|mesh-list
24632416|NCT01123811|Cetuximab|cetuximab|mesh-list
24988643|NCT02073097|Cyclophosphamide|cyclophosphamide|mesh-list
24988644|NCT02073097|Rituximab|rituximab|mesh-list
24988645|NCT02073097|Doxorubicin|doxorubicin|mesh-list
24988646|NCT02073097|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24988647|NCT02073097|Vincristine|vincristine|mesh-list
24988648|NCT02073097|Lenograstim|lenograstim|mesh-list
24988649|NCT02073097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24988728|NCT00882895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988729|NCT00882895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24988928|NCT05191888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24988929|NCT05191888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24864105|NCT00960297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864117|NCT00910650|Interleukin-2|interleukin-2|mesh-list
24813878|NCT02060734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813879|NCT02060734|Sensory System Agents|sensory system agents|mesh-ancestor
24813880|NCT02060734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24813881|NCT02060734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24813882|NCT02060734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24813883|NCT02060734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24990312|NCT03256045|Ichthammol|ichthammol|mesh-list
24990313|NCT03256045|BB 1101|bb 1101|mesh-list
24990314|NCT03256045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24990315|NCT03256045|Antiemetics|antiemetics|mesh-ancestor
24990316|NCT03256045|Autonomic Agents|autonomic agents|mesh-ancestor
24990317|NCT03256045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24990318|NCT03256045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990319|NCT03256045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24990320|NCT03256045|Glucocorticoids|glucocorticoids|mesh-ancestor
24990321|NCT03256045|Hormones|hormones|mesh-ancestor
24990322|NCT03256045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24544181|NCT00687648|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24990463|NCT02966301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990465|NCT02966119|Clopidogrel|clopidogrel|mesh-list
24990466|NCT02966119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24990467|NCT02966119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24990468|NCT02966119|Analgesics|analgesics|mesh-ancestor
24990469|NCT02966119|Sensory System Agents|sensory system agents|mesh-ancestor
24990470|NCT02966119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24990471|NCT02966119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990472|NCT02966119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24990474|NCT02966119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24990475|NCT02966119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24990476|NCT02966119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990477|NCT02966119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24990478|NCT02966119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24990479|NCT02966119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24797243|NCT01954784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24797244|NCT01954784|Antimetabolites|antimetabolites|mesh-ancestor
24990530|NCT02821026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24990531|NCT02821026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24990532|NCT02821026|Antifungal Agents|antifungal agents|mesh-ancestor
24990533|NCT02821026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24990534|NCT02821026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24990535|NCT02821026|Analgesics|analgesics|mesh-ancestor
24990536|NCT02821026|Sensory System Agents|sensory system agents|mesh-ancestor
24990537|NCT02821026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24990541|NCT02787239|Rituximab|rituximab|mesh-list
24990557|NCT02754154|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24990558|NCT02754154|Protease Inhibitors|protease inhibitors|mesh-ancestor
24990559|NCT02754154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24990560|NCT02754154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107414|NCT03140397|Estrogens|estrogens|mesh-ancestor
25107415|NCT03140397|Hormones|hormones|mesh-ancestor
24990653|NCT02373241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24990654|NCT02373241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24990655|NCT02373241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990657|NCT01941589|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24990658|NCT01941589|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24990659|NCT01941589|Prednisolone|prednisolone|mesh-list
24990660|NCT01941589|Prednisolone acetate|prednisolone acetate|mesh-list
24990661|NCT01941589|Hydrocortisone|hydrocortisone|mesh-list
24990662|NCT01941589|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24990663|NCT01941589|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24587585|NCT00895739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24990664|NCT01941589|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24990665|NCT01941589|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24990666|NCT01941589|Prednisolone phosphate|prednisolone phosphate|mesh-list
24990667|NCT01941589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24990668|NCT01941589|Antiemetics|antiemetics|mesh-ancestor
24990669|NCT01941589|Autonomic Agents|autonomic agents|mesh-ancestor
24990670|NCT01941589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24990671|NCT01941589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990672|NCT01941589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24990673|NCT01941589|Glucocorticoids|glucocorticoids|mesh-ancestor
24990674|NCT01941589|Hormones|hormones|mesh-ancestor
24990675|NCT01941589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24794378|NCT05251493|Iron|iron|mesh-list
24473575|NCT00403325|Growth Inhibitors|growth inhibitors|mesh-ancestor
24990676|NCT01941589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24990677|NCT01941589|Protective Agents|protective agents|mesh-ancestor
24990678|NCT01941589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24990679|NCT01941589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990680|NCT01845649|Estradiol|estradiol|mesh-list
24990681|NCT01845649|Estrogens|estrogens|mesh-ancestor
24990682|NCT01845649|Hormones|hormones|mesh-ancestor
24990683|NCT01845649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24990684|NCT01845649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990690|NCT01816139|Estradiol|estradiol|mesh-list
24990691|NCT01816139|Estrogens|estrogens|mesh-ancestor
24990742|NCT00936936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990743|NCT00936936|Antiviral Agents|antiviral agents|mesh-ancestor
24990744|NCT00936936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24990745|NCT00936936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24990746|NCT00936936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24722810|NCT01582672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24990747|NCT00936936|Immunologic Factors|immunologic factors|mesh-ancestor
24990748|NCT00936936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990749|NCT00936936|Tubulin Modulators|tubulin modulators|mesh-ancestor
24990750|NCT00936936|Antimitotic Agents|antimitotic agents|mesh-ancestor
24797251|NCT01954784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24797252|NCT01954784|Dermatologic Agents|dermatologic agents|mesh-ancestor
24797253|NCT01954784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24992062|NCT04500509|Analgesics|analgesics|mesh-ancestor
24992063|NCT04500509|Sensory System Agents|sensory system agents|mesh-ancestor
24865894|NCT04558866|Androgens|androgens|mesh-ancestor
24992375|NCT03854903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24992376|NCT03854903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632787|NCT01125696|Protease Inhibitors|protease inhibitors|mesh-ancestor
24992377|NCT03854903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24992378|NCT03854903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24992573|NCT03388190|Leucovorin|leucovorin|mesh-list
24992574|NCT03388190|Fluorouracil|fluorouracil|mesh-list
24992575|NCT03388190|Oxaliplatin|oxaliplatin|mesh-list
24992576|NCT03388190|Nivolumab|nivolumab|mesh-list
24785678|NCT01916005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785679|NCT01916057|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24785680|NCT01916057|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24866415|NCT05152667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992597|NCT03382834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24992599|NCT03382834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24992600|NCT03382834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992601|NCT03382834|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24992602|NCT03382834|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24992603|NCT03382834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24992647|NCT03255083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992648|NCT03255083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24992649|NCT03255083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24992650|NCT03255083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992651|NCT03253172|Potassium Citrate|potassium citrate|mesh-list
24992652|NCT03253172|Diuretics|diuretics|mesh-ancestor
24992653|NCT03253172|Natriuretic Agents|natriuretic agents|mesh-ancestor
24992702|NCT03085095|Hormone Antagonists|hormone antagonists|mesh-ancestor
24866512|NCT04702256|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24992777|NCT02891811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24866587|NCT05258955|Disinfectants|disinfectants|mesh-ancestor
24992835|NCT02802228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24992836|NCT02801448|Sulforaphane|sulforaphane|mesh-list
24992837|NCT02801448|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24992838|NCT02801448|Protective Agents|protective agents|mesh-ancestor
24934428|NCT04061265|Carticaine|carticaine|mesh-list
24992839|NCT02801448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992840|NCT02801448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992841|NCT02675790|Hydroxyurea|hydroxyurea|mesh-list
24992842|NCT02675790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992843|NCT02675790|Antisickling Agents|antisickling agents|mesh-ancestor
24992844|NCT02675790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24992845|NCT02675790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785695|NCT01916187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107736|NCT03137368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25107737|NCT03137368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107738|NCT03137368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25107740|NCT03137368|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25107741|NCT03137368|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24992876|NCT02650271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992877|NCT02650271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24992878|NCT02650271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24992879|NCT02649855|Docetaxel|docetaxel|mesh-list
24992880|NCT02649855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992881|NCT02649855|Tubulin Modulators|tubulin modulators|mesh-ancestor
24992882|NCT02649855|Antimitotic Agents|antimitotic agents|mesh-ancestor
24992883|NCT02649855|Mitosis Modulators|mitosis modulators|mesh-ancestor
24992884|NCT02649855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992885|NCT02570984|Omalizumab|omalizumab|mesh-list
24992886|NCT02570984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24866761|NCT04906278|Oxytocin|oxytocin|mesh-list
24992922|NCT02505204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25685369|NCT01904721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24723020|NCT01584271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24992925|NCT02505204|Adrenergic Agents|adrenergic agents|mesh-ancestor
24992926|NCT02505204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24866840|NCT04472299|Anesthetics, Local|anesthetics, local|mesh-ancestor
24992979|NCT01898312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24992980|NCT01898312|Luteolytic Agents|luteolytic agents|mesh-ancestor
24992981|NCT01898312|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24992982|NCT01898312|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24992984|NCT01883804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24992992|NCT01883804|Adrenergic Agents|adrenergic agents|mesh-ancestor
24992993|NCT01883804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24992994|NCT01883804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992996|NCT01881048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24993031|NCT01491763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993033|NCT01366898|Idarubicin|idarubicin|mesh-list
24993034|NCT01366898|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24993063|NCT01358201|Hormones|hormones|mesh-ancestor
24993064|NCT01358201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24993065|NCT01358201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24993066|NCT01358201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993112|NCT00925652|Alkylating Agents|alkylating agents|mesh-ancestor
24993113|NCT00925652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993114|NCT00925652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993115|NCT00925652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25107748|NCT03137290|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25107749|NCT03137290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107750|NCT03137290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107751|NCT03137290|Cholinergic Agents|cholinergic agents|mesh-ancestor
25107752|NCT03137290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24993161|NCT00186888|Immunologic Factors|immunologic factors|mesh-ancestor
24993162|NCT00186888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993163|NCT00186888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24993355|NCT05110781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993357|NCT05099276|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24993358|NCT05099276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24993359|NCT05099276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993360|NCT05099276|Hemostatics|hemostatics|mesh-ancestor
24993361|NCT05099276|Coagulants|coagulants|mesh-ancestor
24775751|NCT01854515|Protease Inhibitors|protease inhibitors|mesh-ancestor
24775752|NCT01854515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775753|NCT01854515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993379|NCT05077449|Hormone Antagonists|hormone antagonists|mesh-ancestor
24993380|NCT05077449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24993381|NCT05077449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107787|NCT03137082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24867418|NCT04527003|Anticonvulsants|anticonvulsants|mesh-ancestor
24867419|NCT04527003|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24867427|NCT04457323|Metoprolol|metoprolol|mesh-list
24993565|NCT05416762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24993566|NCT05416762|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24993567|NCT05416762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24993568|NCT05416580|Metformin|metformin|mesh-list
24993726|NCT05410223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24993727|NCT05410223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993728|NCT05410223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24993729|NCT05410223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24993730|NCT05410223|Antimalarials|antimalarials|mesh-ancestor
24993731|NCT05410223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24993732|NCT05410223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24993733|NCT05410223|Antacids|antacids|mesh-ancestor
24993734|NCT05410223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24993735|NCT05410223|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24993736|NCT05410223|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24993923|NCT05199311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994031|NCT05037487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24994698|NCT03347617|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24785888|NCT01917045|Dsuvia|dsuvia|mesh-list
24785889|NCT01917045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24785890|NCT01917045|Narcotics|narcotics|mesh-ancestor
25685370|NCT01904760|Dexmedetomidine|dexmedetomidine|mesh-list
24785891|NCT01917045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24785892|NCT01917045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785894|NCT01917045|Sensory System Agents|sensory system agents|mesh-ancestor
24548093|NCT00707551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25107910|NCT03135977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25107911|NCT03135977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107912|NCT03135977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107914|NCT03135912|Terbinafine|terbinafine|mesh-list
24797955|NCT01959191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24797956|NCT01959191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24797958|NCT01959191|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24797959|NCT01959191|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24548472|NCT00709644|Vitamin B Complex|vitamin b complex|mesh-ancestor
24994566|NCT03836014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994568|NCT03836014|Glucocorticoids|glucocorticoids|mesh-ancestor
24994570|NCT03836014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24994571|NCT03836014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24994572|NCT03836014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994573|NCT03836014|Protease Inhibitors|protease inhibitors|mesh-ancestor
24994574|NCT03836014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24994575|NCT03836014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994576|NCT03836014|Immunologic Factors|immunologic factors|mesh-ancestor
24994577|NCT03836014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24994578|NCT03836014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24994579|NCT03836014|Growth Substances|growth substances|mesh-ancestor
25107946|NCT03135795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24785963|NCT01917331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785964|NCT01917331|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24785965|NCT01917331|Respiratory System Agents|respiratory system agents|mesh-ancestor
24785966|NCT01917331|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24668958|NCT04406857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24668959|NCT04406857|Antimetabolites|antimetabolites|mesh-ancestor
24512171|NCT00573417|Modafinil|modafinil|mesh-list
24994605|NCT03792867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994606|NCT03792867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24994607|NCT03792867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24994608|NCT03792867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24868561|NCT04321174|Ritonavir|ritonavir|mesh-list
24510974|NCT00566800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510976|NCT00566865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24510977|NCT00566865|Antimetabolites|antimetabolites|mesh-ancestor
24511001|NCT00566904|Sensory System Agents|sensory system agents|mesh-ancestor
24994690|NCT03413995|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24994692|NCT03413995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994693|NCT03413995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994694|NCT03392428|177Lu-PSMA-617|177lu-psma-617|mesh-list
24994695|NCT03392428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24994696|NCT03392428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994697|NCT03347617|Pembrolizumab|pembrolizumab|mesh-list
24994708|NCT03315741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994709|NCT03315741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24994711|NCT03315741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24994745|NCT03175978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24994746|NCT03175978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24994747|NCT03175978|Antimetabolites|antimetabolites|mesh-ancestor
24994748|NCT03175978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994749|NCT03175978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994750|NCT03175978|Dermatologic Agents|dermatologic agents|mesh-ancestor
24994859|NCT02142738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994860|NCT02142738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24994861|NCT02142738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24994862|NCT02142738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24994863|NCT02072148|Cisplatin|cisplatin|mesh-list
24994864|NCT02072148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511002|NCT00566904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24994904|NCT00913705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994905|NCT00883480|Gemcitabine|gemcitabine|mesh-list
24868821|NCT02209545|Micronutrients|micronutrients|mesh-ancestor
24994965|NCT05418946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723799|NCT01589146|Tinzaparin|tinzaparin|mesh-list
24723800|NCT01589146|Dalteparin|dalteparin|mesh-list
24723801|NCT01589146|Anticoagulants|anticoagulants|mesh-ancestor
24723802|NCT01589146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24723803|NCT01589146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24723805|NCT01589159|Capecitabine|capecitabine|mesh-list
24723890|NCT01589562|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24723891|NCT01589562|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24723910|NCT01589744|Coagulants|coagulants|mesh-ancestor
24723911|NCT01589809|Niacinamide|niacinamide|mesh-list
24723913|NCT01589809|Nicotinic Acids|nicotinic acids|mesh-list
24723914|NCT01589809|Vitamins|vitamins|mesh-ancestor
24723915|NCT01589809|Micronutrients|micronutrients|mesh-ancestor
24723916|NCT01589809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723917|NCT01589809|Vitamin B Complex|vitamin b complex|mesh-ancestor
24723918|NCT01589809|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24994966|NCT05418946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24994967|NCT05418946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994968|NCT05418907|Exenatide|exenatide|mesh-list
24994969|NCT05418907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24994970|NCT05418907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994971|NCT05418907|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24994972|NCT05418907|Incretins|incretins|mesh-ancestor
24994973|NCT05418907|Hormones|hormones|mesh-ancestor
24994974|NCT05418907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24869220|NCT04278404|Guanfacine|guanfacine|mesh-list
24869312|NCT04278404|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24995348|NCT05270057|Immunologic Factors|immunologic factors|mesh-ancestor
24995349|NCT05270057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995350|NCT05270057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24995351|NCT05270057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24995352|NCT05270057|Alkylating Agents|alkylating agents|mesh-ancestor
24995353|NCT05270057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995354|NCT05270057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24995355|NCT05270057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24995356|NCT05270057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24511003|NCT00566904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24511004|NCT00566904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24511005|NCT00566904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24511006|NCT00566904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24869411|NCT03916185|Vaccines|vaccines|mesh-list
24995657|NCT04961580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24995877|NCT04555837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24995878|NCT04544995|Niraparib|niraparib|mesh-list
24995879|NCT04544995|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24995880|NCT04544995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24869906|NCT05116930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24472029|NCT00397787|Sunitinib|sunitinib|mesh-list
24996013|NCT04421248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996096|NCT04303403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996097|NCT04303403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996098|NCT04249310|Tiotropium Bromide|tiotropium bromide|mesh-list
24996100|NCT04249310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24996101|NCT04249310|Autonomic Agents|autonomic agents|mesh-ancestor
24996103|NCT04249310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996104|NCT04249310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24996151|NCT04173338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24996152|NCT04173325|Nivolumab|nivolumab|mesh-list
24996508|NCT03387852|Respiratory System Agents|respiratory system agents|mesh-ancestor
24996509|NCT03387852|Dermatologic Agents|dermatologic agents|mesh-ancestor
25685371|NCT01904760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25685372|NCT01904760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25685373|NCT01904760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685374|NCT01904760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25685375|NCT01904760|Analgesics|analgesics|mesh-ancestor
25685376|NCT01904760|Sensory System Agents|sensory system agents|mesh-ancestor
25685377|NCT01904760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25685378|NCT01904760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25685379|NCT01904760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25685380|NCT01904760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25685381|NCT01904760|Adrenergic Agents|adrenergic agents|mesh-ancestor
25685382|NCT01904760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25685383|NCT01904760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996510|NCT03387852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24996511|NCT03387852|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24996512|NCT03387852|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24996513|NCT03387852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24870554|NCT04998786|Hormones|hormones|mesh-ancestor
25108198|NCT03133845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25108199|NCT03133845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108200|NCT03133897|Dexamethasone|dexamethasone|mesh-list
25108201|NCT03133897|Prednisone|prednisone|mesh-list
24996663|NCT02921789|Tacrolimus|tacrolimus|mesh-list
24996664|NCT02921789|Basiliximab|basiliximab|mesh-list
24996665|NCT02921789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24996666|NCT02921789|Glucocorticoids|glucocorticoids|mesh-ancestor
24996667|NCT02921789|Hormones|hormones|mesh-ancestor
24996668|NCT02921789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24395464|NCT00136045|Rotigotine|rotigotine|mesh-list
24870673|NCT04577690|Autonomic Agents|autonomic agents|mesh-ancestor
24996755|NCT02133404|ASP7991|asp7991|mesh-list
24511007|NCT00566904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816411|NCT02076893|Ibuprofen|ibuprofen|mesh-list
24816412|NCT02076893|Gabapentin|gabapentin|mesh-list
24816413|NCT02076893|Tramadol|tramadol|mesh-list
24816414|NCT02076893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24464475|NCT00365001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24464476|NCT00365001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24464477|NCT00365001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24464478|NCT00365001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24464479|NCT00365040|Mitomycins|mitomycins|mesh-list
24464480|NCT00365040|Mitomycin|mitomycin|mesh-list
24464481|NCT00365040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24464482|NCT00365040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996756|NCT02133404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24996757|NCT02133404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996758|NCT02133404|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24996759|NCT02133404|Hormone Antagonists|hormone antagonists|mesh-ancestor
24996760|NCT02133404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24996761|NCT02038868|Tamsulosin|tamsulosin|mesh-list
24996762|NCT02038868|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24996763|NCT02038868|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24996764|NCT02038868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24996765|NCT02038868|Adrenergic Agents|adrenergic agents|mesh-ancestor
24996768|NCT02038868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996769|NCT02038868|Urological Agents|urological agents|mesh-ancestor
24996770|NCT01966471|Maytansine|maytansine|mesh-list
24996771|NCT01966471|Docetaxel|docetaxel|mesh-list
24996772|NCT01966471|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24996773|NCT01966471|Cyclophosphamide|cyclophosphamide|mesh-list
24996774|NCT01966471|Doxorubicin|doxorubicin|mesh-list
24996775|NCT01966471|Fluorouracil|fluorouracil|mesh-list
24996776|NCT01966471|Trastuzumab|trastuzumab|mesh-list
24996777|NCT01966471|Epirubicin|epirubicin|mesh-list
24996778|NCT01966471|Pertuzumab|pertuzumab|mesh-list
24996779|NCT01966471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24996780|NCT01966471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996781|NCT01966471|Tubulin Modulators|tubulin modulators|mesh-ancestor
24996782|NCT01966471|Antimitotic Agents|antimitotic agents|mesh-ancestor
24996783|NCT01966471|Mitosis Modulators|mitosis modulators|mesh-ancestor
24870777|NCT03942224|Autonomic Agents|autonomic agents|mesh-ancestor
24996862|NCT01307423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996863|NCT01307423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24996864|NCT01307423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24996865|NCT01307423|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24996866|NCT01307423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25108202|NCT03133897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24996874|NCT01307423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24578401|NCT00848939|Treprostinil|treprostinil|mesh-list
24996875|NCT01307423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24996876|NCT01307423|Growth Substances|growth substances|mesh-ancestor
24996877|NCT01307423|Growth Inhibitors|growth inhibitors|mesh-ancestor
24996878|NCT01307423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996879|NCT01030575|Inositol|inositol|mesh-list
24996880|NCT01030575|Vitamin B Complex|vitamin b complex|mesh-ancestor
24996881|NCT01030575|Vitamins|vitamins|mesh-ancestor
24996882|NCT01030575|Micronutrients|micronutrients|mesh-ancestor
24996883|NCT01030575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996884|NCT00911183|Prednisone|prednisone|mesh-list
24996885|NCT00911183|Cyclophosphamide|cyclophosphamide|mesh-list
24996886|NCT00911183|Rituximab|rituximab|mesh-list
24996887|NCT00911183|Doxorubicin|doxorubicin|mesh-list
24996888|NCT00911183|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24670263|NCT03117049|Antimitotic Agents|antimitotic agents|mesh-ancestor
24670264|NCT03117049|Mitosis Modulators|mitosis modulators|mesh-ancestor
25122811|NCT03090269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25122813|NCT03090269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122814|NCT03090269|Dopamine Agents|dopamine agents|mesh-ancestor
25122816|NCT03090087|Regadenoson|regadenoson|mesh-list
24670265|NCT03117049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24670266|NCT03117049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24670267|NCT03117049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24996889|NCT00911183|Vincristine|vincristine|mesh-list
24798183|NCT01961414|Aflibercept|aflibercept|mesh-list
24798184|NCT01961414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24798185|NCT01961414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24798186|NCT01961414|Growth Substances|growth substances|mesh-ancestor
24798187|NCT01961414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996958|NCT05420922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996959|NCT05420922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996999|NCT05420168|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24997000|NCT05420168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24997001|NCT05419921|Lidocaine|lidocaine|mesh-list
24997002|NCT05419921|Anesthetics, Local|anesthetics, local|mesh-ancestor
24997003|NCT05419921|Anesthetics|anesthetics|mesh-ancestor
24776053|NCT01856348|Vitamin D|vitamin d|mesh-list
24464483|NCT00365040|Alkylating Agents|alkylating agents|mesh-ancestor
24997004|NCT05419921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24997005|NCT05419921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997006|NCT05419921|Sensory System Agents|sensory system agents|mesh-ancestor
24997089|NCT05416840|Analgesics|analgesics|mesh-ancestor
24997090|NCT05416840|Sensory System Agents|sensory system agents|mesh-ancestor
24997091|NCT05416840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24997092|NCT05416840|Sympatholytics|sympatholytics|mesh-ancestor
24997093|NCT05416840|Autonomic Agents|autonomic agents|mesh-ancestor
24997094|NCT05416840|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24997095|NCT05416840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24997096|NCT05416840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24871126|NCT04809051|Metronidazole|metronidazole|mesh-list
24997170|NCT05344495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24997171|NCT05344495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24997172|NCT05344495|Anesthetics, General|anesthetics, general|mesh-ancestor
24997175|NCT05344495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24997176|NCT05344495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997247|NCT05279898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997248|NCT05279898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24997249|NCT05279898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24997250|NCT05279898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24997251|NCT05279898|Anesthetics, Local|anesthetics, local|mesh-ancestor
24997252|NCT05279898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24511025|NCT00567047|Vildagliptin|vildagliptin|mesh-list
24816428|NCT02076893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24816429|NCT02076893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24816430|NCT02076893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24816431|NCT02076893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24816432|NCT02076893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24856150|NCT02282956|Autonomic Agents|autonomic agents|mesh-ancestor
24856151|NCT02282956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24858180|NCT02295722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24858181|NCT02295722|Immunologic Factors|immunologic factors|mesh-ancestor
24858182|NCT02295722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858183|NCT02295722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24858184|NCT02295722|Alkylating Agents|alkylating agents|mesh-ancestor
24858185|NCT02295722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24858186|NCT02295748|Deflazacort|deflazacort|mesh-list
24858187|NCT02295748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25685384|NCT01904864|Iron|iron|mesh-list
25685385|NCT01904864|Micronutrients|micronutrients|mesh-ancestor
25685386|NCT01904864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685387|NCT01904864|Trace Elements|trace elements|mesh-ancestor
25685388|NCT01905423|Albendazole|albendazole|mesh-list
25685389|NCT01905423|Diethylcarbamazine|diethylcarbamazine|mesh-list
25685390|NCT01905423|Piperazine|piperazine|mesh-list
25685391|NCT01905423|Mebendazole|mebendazole|mesh-list
25685392|NCT01905423|Piperazine citrate|piperazine citrate|mesh-list
25685393|NCT01905423|Citric Acid|citric acid|mesh-list
25685394|NCT01905423|Sodium Citrate|sodium citrate|mesh-list
24858188|NCT02295748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24858189|NCT02295748|Immunologic Factors|immunologic factors|mesh-ancestor
24786190|NCT01918488|Diuretics|diuretics|mesh-ancestor
24858190|NCT02295748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858191|NCT02295787|Ketamine|ketamine|mesh-list
24858192|NCT02295787|Analgesics|analgesics|mesh-ancestor
24858193|NCT02295787|Sensory System Agents|sensory system agents|mesh-ancestor
24858194|NCT02295787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858195|NCT02295787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871439|NCT02618980|Hemostatics|hemostatics|mesh-list
24858886|NCT02300350|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
24858888|NCT02300350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24858889|NCT02300350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24858890|NCT02300350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24858891|NCT02300350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816433|NCT02076893|Antimanic Agents|antimanic agents|mesh-ancestor
24816434|NCT02076893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24885546|NCT05151588|Tubulin Modulators|tubulin modulators|mesh-ancestor
24464526|NCT00365287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24511038|NCT00567099|Antidepressive Agents|antidepressive agents|mesh-ancestor
24511039|NCT00567099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24511040|NCT00567099|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24511041|NCT00567099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24511042|NCT00567099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24464559|NCT00365339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464560|NCT00365339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24464561|NCT00365339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24885547|NCT05151588|Antimitotic Agents|antimitotic agents|mesh-ancestor
24885548|NCT05151588|Mitosis Modulators|mitosis modulators|mesh-ancestor
24885549|NCT05151588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885550|NCT05151588|Antimetabolites|antimetabolites|mesh-ancestor
24885551|NCT05151588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24885552|NCT05151588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24885553|NCT05151588|Immunologic Factors|immunologic factors|mesh-ancestor
24594673|NCT00935116|Etoricoxib|etoricoxib|mesh-list
24594674|NCT00935116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24594675|NCT00935116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24594676|NCT00935116|Analgesics|analgesics|mesh-ancestor
24594677|NCT00935116|Sensory System Agents|sensory system agents|mesh-ancestor
24594678|NCT00935116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24594679|NCT00935116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594680|NCT00935116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24594681|NCT00935116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24800672|NCT01977339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800673|NCT01977339|Sensory System Agents|sensory system agents|mesh-ancestor
24800707|NCT01977859|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24800708|NCT01977859|Natriuretic Agents|natriuretic agents|mesh-ancestor
24800709|NCT01977859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800711|NCT01977989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24800712|NCT01977989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24871686|NCT05110209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24802956|NCT01993472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24803008|NCT01993810|Immunoglobulin G|immunoglobulin g|mesh-list
24803009|NCT01993810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24597388|NCT00949065|Immunoglobulins|immunoglobulins|mesh-list
24803010|NCT01993810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24803011|NCT01993810|Tubulin Modulators|tubulin modulators|mesh-ancestor
24803012|NCT01993810|Antimitotic Agents|antimitotic agents|mesh-ancestor
24803013|NCT01993810|Mitosis Modulators|mitosis modulators|mesh-ancestor
24803014|NCT01993810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803015|NCT01993810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24803016|NCT01993810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24803192|NCT01995019|Prednisolone phosphate|prednisolone phosphate|mesh-list
24803193|NCT01995019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24803194|NCT01995019|Antiemetics|antiemetics|mesh-ancestor
24803195|NCT01995019|Autonomic Agents|autonomic agents|mesh-ancestor
24803196|NCT01995019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803334|NCT01995890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803335|NCT01995890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24803336|NCT01995890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24803338|NCT01996085|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24803439|NCT01996462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24803440|NCT01996462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24803441|NCT01996462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803442|NCT01996462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24803443|NCT01996462|Serotonin Agents|serotonin agents|mesh-ancestor
24803475|NCT01996475|Cholinergic Agents|cholinergic agents|mesh-ancestor
24803477|NCT01996488|Antiemetics|antiemetics|mesh-ancestor
24803478|NCT01996488|Autonomic Agents|autonomic agents|mesh-ancestor
24661924|NCT01291524|Anticonvulsants|anticonvulsants|mesh-ancestor
24803479|NCT01996488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803480|NCT01996488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803481|NCT01996488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24803482|NCT01996488|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24803483|NCT01996488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24803484|NCT01996488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24598169|NCT00954265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598171|NCT00954278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598172|NCT00954278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24598173|NCT00954278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598174|NCT00954278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622623|NCT01067677|Histamine Antagonists|histamine antagonists|mesh-ancestor
24622624|NCT01067677|Histamine Agents|histamine agents|mesh-ancestor
24622625|NCT01067677|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24622626|NCT01067677|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24622627|NCT01067677|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24598400|NCT00956059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598401|NCT00956059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24786194|NCT01918488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24803868|NCT01999153|Anesthetics, Local|anesthetics, local|mesh-ancestor
24803869|NCT01999153|Anesthetics|anesthetics|mesh-ancestor
24803870|NCT01999153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24803871|NCT01999153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803872|NCT01999153|Sensory System Agents|sensory system agents|mesh-ancestor
24803873|NCT01999153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24598731|NCT00957554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24598732|NCT00957554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598733|NCT00957554|Vasodilator Agents|vasodilator agents|mesh-ancestor
24598734|NCT00957554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24598735|NCT00957554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24804328|NCT02002078|Methylprednisolone|methylprednisolone|mesh-list
24804329|NCT02002078|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24804330|NCT02002078|Prednisolone|prednisolone|mesh-list
24804331|NCT02002078|Prednisolone acetate|prednisolone acetate|mesh-list
24804332|NCT02002078|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24804420|NCT02002377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24840411|NCT02210104|Immunologic Factors|immunologic factors|mesh-ancestor
24599312|NCT04770493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804798|NCT02005315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24804799|NCT02005315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804800|NCT02005315|Tubulin Modulators|tubulin modulators|mesh-ancestor
24804801|NCT02005315|Antimitotic Agents|antimitotic agents|mesh-ancestor
24804802|NCT02005315|Mitosis Modulators|mitosis modulators|mesh-ancestor
24776167|NCT01856985|Oxytocics|oxytocics|mesh-ancestor
24885554|NCT05151588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885555|NCT05142969|Chlorhexidine|chlorhexidine|mesh-list
24885556|NCT05142969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24804803|NCT02005315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804804|NCT02005315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24804806|NCT02005315|Antiviral Agents|antiviral agents|mesh-ancestor
24804807|NCT02005315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24663394|NCT01300962|Lapatinib|lapatinib|mesh-list
24804809|NCT02005315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24804810|NCT02005315|Immunologic Factors|immunologic factors|mesh-ancestor
24804811|NCT02005315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804812|NCT02005419|Metformin|metformin|mesh-list
24804813|NCT02005419|Gemcitabine|gemcitabine|mesh-list
24804814|NCT02005419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24804815|NCT02005419|Antimetabolites|antimetabolites|mesh-ancestor
24804816|NCT02005419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804817|NCT02005419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045684|NCT00927914|Ranirestat|ranirestat|mesh-list
24804818|NCT02005419|Antiviral Agents|antiviral agents|mesh-ancestor
24804819|NCT02005419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24396298|NCT00138541|Vildagliptin|vildagliptin|mesh-list
24804820|NCT02005419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24804821|NCT02005419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24804822|NCT02005419|Immunologic Factors|immunologic factors|mesh-ancestor
24804823|NCT02005419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804956|NCT02006173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804957|NCT02006173|Sensory System Agents|sensory system agents|mesh-ancestor
24804958|NCT02006173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24806697|NCT02017613|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
24806699|NCT02017613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872140|NCT05398679|Ofloxacin|ofloxacin|mesh-list
24807609|NCT02022722|Anesthetics, Local|anesthetics, local|mesh-ancestor
24807610|NCT02022722|Anesthetics|anesthetics|mesh-ancestor
24807611|NCT02022722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24807612|NCT02022722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807618|NCT02022722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24807620|NCT02022722|Immunologic Factors|immunologic factors|mesh-ancestor
24807621|NCT02022722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25108237|NCT03133780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24846736|NCT02243618|Rebamipide|rebamipide|mesh-list
24824584|NCT02124174|Anticonvulsants|anticonvulsants|mesh-ancestor
24824585|NCT02124174|GABA Agents|gaba agents|mesh-ancestor
24828409|NCT02145546|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24828410|NCT02145546|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24721675|NCT01576315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24831392|NCT02165046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24831393|NCT02165046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831394|NCT02165046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24831395|NCT02165046|Respiratory System Agents|respiratory system agents|mesh-ancestor
24831396|NCT02165046|Glucocorticoids|glucocorticoids|mesh-ancestor
24831397|NCT02165046|Hormones|hormones|mesh-ancestor
24831398|NCT02165046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24831567|NCT02166853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831568|NCT02166853|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24831569|NCT02166853|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24831570|NCT02166905|Poly I-C|poly i-c|mesh-list
24831571|NCT02166905|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24833470|NCT02174068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24833471|NCT02174068|Analgesics|analgesics|mesh-ancestor
24833475|NCT02174068|Antipyretics|antipyretics|mesh-ancestor
24815052|NCT02068170|Sunitinib|sunitinib|mesh-list
24835713|NCT02183298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24835714|NCT02183298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835715|NCT02183298|Incretins|incretins|mesh-ancestor
24835716|NCT02183298|Hormones|hormones|mesh-ancestor
24840412|NCT02210104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835717|NCT02183298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24396398|NCT00138970|Prednisolone phosphate|prednisolone phosphate|mesh-list
24835905|NCT02183532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835907|NCT02183571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24835908|NCT02183571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835909|NCT02183584|Linagliptin|linagliptin|mesh-list
24835910|NCT02183584|Rifampin|rifampin|mesh-list
24835911|NCT02183584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24835912|NCT02183584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108291|NCT03133195|Micronutrients|micronutrients|mesh-ancestor
25108292|NCT03133195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108293|NCT03133195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24838062|NCT02195115|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24787741|NCT01926899|Bortezomib|bortezomib|mesh-list
24787742|NCT01926899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787743|NCT01927029|Progesterone|progesterone|mesh-list
24787744|NCT01927029|Progestins|progestins|mesh-ancestor
24787745|NCT01927029|Hormones|hormones|mesh-ancestor
24787746|NCT01927029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25004730|NCT01945775|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25004734|NCT01858922|Cytarabine|cytarabine|mesh-list
24838063|NCT02195115|Antidepressive Agents|antidepressive agents|mesh-ancestor
24838064|NCT02195115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24838065|NCT02195115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24838066|NCT02195115|Analgesics|analgesics|mesh-ancestor
25685395|NCT01905423|DMP 777|dmp 777|mesh-list
24838067|NCT02195115|Sensory System Agents|sensory system agents|mesh-ancestor
24838167|NCT02195661|Chloral Hydrate|chloral hydrate|mesh-list
24885573|NCT05117307|Bupivacaine|bupivacaine|mesh-list
24885574|NCT05117307|Anesthetics, Local|anesthetics, local|mesh-ancestor
24885575|NCT05117307|Anesthetics|anesthetics|mesh-ancestor
24885576|NCT05117307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24885577|NCT05117307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885578|NCT05117307|Sensory System Agents|sensory system agents|mesh-ancestor
24885579|NCT05117307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838171|NCT02195661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838203|NCT02195973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838206|NCT02196142|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24838207|NCT02196142|Diuretics|diuretics|mesh-ancestor
24815119|NCT02068209|Tramadol|tramadol|mesh-list
24838408|NCT02197702|Cholecalciferol|cholecalciferol|mesh-list
24838410|NCT02197702|Micronutrients|micronutrients|mesh-ancestor
24838535|NCT02198417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838920|NCT02201121|Sympathomimetics|sympathomimetics|mesh-ancestor
24838921|NCT02201121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24838922|NCT02201121|Nasal Decongestants|nasal decongestants|mesh-ancestor
24839224|NCT02202967|Misoprostol|misoprostol|mesh-list
24839225|NCT02202967|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24839226|NCT02202967|Abortifacient Agents|abortifacient agents|mesh-ancestor
24839227|NCT02202967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24839228|NCT02202967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839229|NCT02202967|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24839230|NCT02202967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24839231|NCT02202967|Oxytocics|oxytocics|mesh-ancestor
24839232|NCT02202993|Mibefradil|mibefradil|mesh-list
24839233|NCT02202993|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24839234|NCT02202993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24839235|NCT02202993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24873065|NCT05426174|Vaccines|vaccines|mesh-list
24839467|NCT02204527|Cholecalciferol|cholecalciferol|mesh-list
24839468|NCT02204527|Vitamins|vitamins|mesh-list
24840307|NCT02209155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24840308|NCT02209155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840309|NCT02209155|Vasodilator Agents|vasodilator agents|mesh-ancestor
24840310|NCT02209350|Aspirin|aspirin|mesh-list
24840311|NCT02209350|Clopidogrel|clopidogrel|mesh-list
24840312|NCT02209350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24885631|NCT04995003|Cyclophosphamide|cyclophosphamide|mesh-list
24885632|NCT04995003|Pembrolizumab|pembrolizumab|mesh-list
24840313|NCT02209350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24840314|NCT02209350|Analgesics|analgesics|mesh-ancestor
24840315|NCT02209350|Sensory System Agents|sensory system agents|mesh-ancestor
24840316|NCT02209350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24840407|NCT02209987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840408|NCT02210104|Cyclophosphamide|cyclophosphamide|mesh-list
24840410|NCT02210104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24599791|NCT03908437|Naloxone|naloxone|mesh-list
24786315|NCT01919008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24786316|NCT01919008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108325|NCT03132623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25108326|NCT03132623|Antiviral Agents|antiviral agents|mesh-ancestor
25108327|NCT03132623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24670918|NCT01116648|Olaparib|olaparib|mesh-list
24670919|NCT01116648|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
24670920|NCT01116648|Cediranib|cediranib|mesh-list
24670921|NCT01116648|Maleic acid|maleic acid|mesh-list
24670922|NCT01116648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24670923|NCT01116648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24670925|NCT01116648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24670926|NCT01078662|Olaparib|olaparib|mesh-list
24670927|NCT01078662|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24670928|NCT01078662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24670932|NCT00680901|Oxaliplatin|oxaliplatin|mesh-list
25108328|NCT03132714|Amoxicillin|amoxicillin|mesh-list
25108329|NCT03132714|Metronidazole|metronidazole|mesh-list
24885633|NCT04995003|Nivolumab|nivolumab|mesh-list
24885634|NCT04995003|Fludarabine|fludarabine|mesh-list
24885635|NCT04995003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24885636|NCT04995003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24885637|NCT04995003|Immunologic Factors|immunologic factors|mesh-ancestor
24885638|NCT04995003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885639|NCT04995003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24885640|NCT04995003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25122987|NCT03088371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616191|NCT01034917|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24616193|NCT01034917|Antiviral Agents|antiviral agents|mesh-ancestor
24616194|NCT01034917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24726187|NCT01602185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24648446|NCT01214486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726188|NCT01602185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726189|NCT01602185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726190|NCT01602185|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24726191|NCT01602185|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24726192|NCT01602185|Respiratory System Agents|respiratory system agents|mesh-ancestor
24885641|NCT04995003|Alkylating Agents|alkylating agents|mesh-ancestor
24885642|NCT04995003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885643|NCT04995003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885644|NCT04995003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24885645|NCT04995003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24885646|NCT04991662|Phenylephrine|phenylephrine|mesh-list
24885647|NCT04991662|Oxymetazoline|oxymetazoline|mesh-list
25108331|NCT03132714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25108332|NCT03132714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25108333|NCT03132714|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24396545|NCT00139243|Docetaxel|docetaxel|mesh-list
24396642|NCT00139581|Tacrolimus|tacrolimus|mesh-list
24396643|NCT00139581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25108334|NCT03132714|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25108335|NCT03132714|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25108336|NCT03132714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25108337|NCT03132714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108338|NCT03132714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25108339|NCT03132714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25108340|NCT03132610|Andrographolide|andrographolide|mesh-list
25108341|NCT03132610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25108342|NCT03132610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25108343|NCT03132610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24840420|NCT02210104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24840421|NCT02210117|Bevacizumab|bevacizumab|mesh-list
24840422|NCT02210117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24840424|NCT02210117|Ipilimumab|ipilimumab|mesh-list
24840425|NCT02210117|Endothelial Growth Factors|endothelial growth factors|mesh-list
24840426|NCT02210117|Antibodies|antibodies|mesh-list
24840427|NCT02210117|Immunoglobulins|immunoglobulins|mesh-list
24840428|NCT02210117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24840518|NCT02210728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24840519|NCT02210728|Sympathomimetics|sympathomimetics|mesh-ancestor
24840520|NCT02210728|Autonomic Agents|autonomic agents|mesh-ancestor
25685396|NCT01905423|Anticoagulants|anticoagulants|mesh-ancestor
25685397|NCT01905423|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25685398|NCT01905423|Chelating Agents|chelating agents|mesh-ancestor
25685399|NCT01905423|Sequestering Agents|sequestering agents|mesh-ancestor
25685400|NCT01905423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685401|NCT01905423|Anthelmintics|anthelmintics|mesh-ancestor
25685402|NCT01905423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25685403|NCT01905423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25685404|NCT01905423|Anticestodal Agents|anticestodal agents|mesh-ancestor
25685405|NCT01905423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25685406|NCT01905423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25685407|NCT01905423|Tubulin Modulators|tubulin modulators|mesh-ancestor
25685408|NCT01905423|Antimitotic Agents|antimitotic agents|mesh-ancestor
25685409|NCT01905423|Mitosis Modulators|mitosis modulators|mesh-ancestor
25685410|NCT01905423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25685411|NCT01905423|Filaricides|filaricides|mesh-ancestor
25685412|NCT01905423|Antinematodal Agents|antinematodal agents|mesh-ancestor
25685413|NCT01905423|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25685414|NCT01905423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25685415|NCT01905592|Niraparib|niraparib|mesh-list
24464650|NCT00365755|Etoposide|etoposide|mesh-list
24464651|NCT00365755|Vincristine|vincristine|mesh-list
24464652|NCT00365755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24511048|NCT00567099|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24511049|NCT00567099|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24511051|NCT00567099|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24511052|NCT00567099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24511053|NCT00567099|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24511054|NCT00567099|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24511055|NCT00567177|Cyclosporine|cyclosporine|mesh-list
24511056|NCT00567177|Cyclosporins|cyclosporins|mesh-list
24511057|NCT00567177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885690|NCT04827836|Povidone-Iodine|povidone-iodine|mesh-list
24885691|NCT04827836|Povidone|povidone|mesh-list
24840521|NCT02210728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24840522|NCT02210728|Adrenergic Agents|adrenergic agents|mesh-ancestor
24840523|NCT02210728|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24840524|NCT02210754|Menthol|menthol|mesh-list
24840525|NCT02210754|Nicotine|nicotine|mesh-list
24840526|NCT02210754|Glycerol|glycerol|mesh-list
24840527|NCT02210754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24840528|NCT02210754|Autonomic Agents|autonomic agents|mesh-ancestor
24840529|NCT02210754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24396841|NCT00140114|Misoprostol|misoprostol|mesh-list
24840562|NCT02211066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24840563|NCT02211066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24840564|NCT02211066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24840565|NCT02211066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24840567|NCT02211066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24841101|NCT02213913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24841102|NCT02213913|Growth Substances|growth substances|mesh-ancestor
24841103|NCT02213913|Growth Inhibitors|growth inhibitors|mesh-ancestor
24841104|NCT02214004|Trastuzumab|trastuzumab|mesh-list
24841105|NCT02214004|Letrozole|letrozole|mesh-list
24841106|NCT02214004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24841107|NCT02214004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841229|NCT02214979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841230|NCT02214992|Telmisartan|telmisartan|mesh-list
24841231|NCT02214992|Ramipril|ramipril|mesh-list
24841232|NCT02214992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24776410|NCT01858025|Fluorouracil|fluorouracil|mesh-list
24885692|NCT04827836|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24885693|NCT04827836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24885694|NCT04827836|Plasma Substitutes|plasma substitutes|mesh-ancestor
24841233|NCT02214992|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24841264|NCT02215057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841968|NCT02219191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24841969|NCT02219191|Antimetabolites|antimetabolites|mesh-ancestor
25108410|NCT03132142|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25108411|NCT03132142|Protective Agents|protective agents|mesh-ancestor
25108413|NCT03132194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25108414|NCT03132194|Antimalarials|antimalarials|mesh-ancestor
25108415|NCT03132194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25108416|NCT03132194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25108417|NCT03132194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25108418|NCT03132194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25108419|NCT03132194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108420|NCT03132194|Leprostatic Agents|leprostatic agents|mesh-ancestor
25108421|NCT03132194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25108422|NCT03132376|Caseins|caseins|mesh-list
24848216|NCT04876066|Ketamine|ketamine|mesh-list
24842296|NCT02220530|Fentanyl|fentanyl|mesh-list
24842297|NCT02220530|Midazolam|midazolam|mesh-list
24842298|NCT02220530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24842299|NCT02220530|Narcotics|narcotics|mesh-ancestor
24842300|NCT02220530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24842301|NCT02220530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885695|NCT04827836|Blood Substitutes|blood substitutes|mesh-ancestor
24885696|NCT04827836|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24885697|NCT04827836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24885698|NCT04810208|Docetaxel|docetaxel|mesh-list
24885699|NCT04810208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885700|NCT04810208|Tubulin Modulators|tubulin modulators|mesh-ancestor
24885701|NCT04810208|Antimitotic Agents|antimitotic agents|mesh-ancestor
24885702|NCT04810208|Mitosis Modulators|mitosis modulators|mesh-ancestor
24885724|NCT04660890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24885725|NCT04660890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24885726|NCT04660890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885727|NCT04660890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464679|NCT00365898|Analgesics|analgesics|mesh-ancestor
24843131|NCT02225756|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24843132|NCT02225782|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24843133|NCT02225782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24843134|NCT02225782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24843135|NCT02225782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756379|NCT01732861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843945|NCT02230163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843947|NCT02230176|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
24843948|NCT02230176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843949|NCT02230176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24843950|NCT02230176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24843989|NCT02230553|Trametinib|trametinib|mesh-list
24815200|NCT02068625|Rasagiline|rasagiline|mesh-list
24815201|NCT02068625|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24815202|NCT02068625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815203|NCT02068625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815204|NCT02068625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24815205|NCT02068625|Protective Agents|protective agents|mesh-ancestor
24815206|NCT02068625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623359|NCT01071057|Sensory System Agents|sensory system agents|mesh-ancestor
24623360|NCT01071057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24623361|NCT01071057|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24623362|NCT01071122|Valsartan|valsartan|mesh-list
24623363|NCT01071122|Nifedipine|nifedipine|mesh-list
24623364|NCT01071122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24623365|NCT01071122|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24623366|NCT01071122|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24623367|NCT01071122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623368|NCT01071122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24696652|NCT01430650|Urological Agents|urological agents|mesh-ancestor
24845210|NCT02237027|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24845438|NCT02237937|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24845513|NCT02238171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24845514|NCT02238171|Respiratory System Agents|respiratory system agents|mesh-ancestor
24845515|NCT02238171|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24845517|NCT02238171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845518|NCT02238171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845519|NCT02238184|Ipratropium|ipratropium|mesh-list
24845520|NCT02238184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24845521|NCT02238184|Autonomic Agents|autonomic agents|mesh-ancestor
24845522|NCT02238184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845523|NCT02238184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845524|NCT02238184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24845525|NCT02238184|Respiratory System Agents|respiratory system agents|mesh-ancestor
24845526|NCT02238184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24727092|NCT01607983|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24727139|NCT01608217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727140|NCT01608217|Hormones|hormones|mesh-ancestor
24511104|NCT00567450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24511106|NCT00567463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24511107|NCT00567463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24511108|NCT00567463|Autonomic Agents|autonomic agents|mesh-ancestor
24816443|NCT02076945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816445|NCT02076945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24816446|NCT02076945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24816447|NCT02076945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24816448|NCT02076945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511203|NCT00567788|Bimatoprost|bimatoprost|mesh-list
24885940|NCT04122755|Sensory System Agents|sensory system agents|mesh-ancestor
24885941|NCT04122755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24464849|NCT00367094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24464850|NCT00367094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464851|NCT00367094|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24511232|NCT00567918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511233|NCT00567918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24511234|NCT00567918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396963|NCT00140478|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24511235|NCT00567918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464866|NCT00367172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24464907|NCT00367276|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24464908|NCT00367276|Hormone Antagonists|hormone antagonists|mesh-ancestor
24511236|NCT00567931|Tryptophan|tryptophan|mesh-list
24511237|NCT00567931|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24511238|NCT00567931|Antidepressive Agents|antidepressive agents|mesh-ancestor
24511239|NCT00567931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24464916|NCT00367302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24464917|NCT00367302|Narcotics|narcotics|mesh-ancestor
24511248|NCT00567983|Cyclosporine|cyclosporine|mesh-list
24511249|NCT00567983|Cyclosporins|cyclosporins|mesh-list
24886030|NCT03691051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886031|NCT03691051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886033|NCT03688802|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24886034|NCT03688802|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24845527|NCT02238184|Cholinergic Agents|cholinergic agents|mesh-ancestor
24845528|NCT02238184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845529|NCT02238184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845530|NCT02238197|Ipratropium|ipratropium|mesh-list
24845531|NCT02238197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24845532|NCT02238197|Autonomic Agents|autonomic agents|mesh-ancestor
24845533|NCT02238197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845534|NCT02238197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845535|NCT02238197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24845536|NCT02238197|Respiratory System Agents|respiratory system agents|mesh-ancestor
24874269|NCT04857307|GABA Agents|gaba agents|mesh-ancestor
24626558|NCT01087840|Antiviral Agents|antiviral agents|mesh-ancestor
24787808|NCT01927588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787809|NCT01927640|Cocaine|cocaine|mesh-list
24787810|NCT01927640|Dexmedetomidine|dexmedetomidine|mesh-list
24787811|NCT01927640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24787812|NCT01927640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24787813|NCT01927640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787814|NCT01927640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24787815|NCT01927640|Analgesics|analgesics|mesh-ancestor
24787816|NCT01927640|Sensory System Agents|sensory system agents|mesh-ancestor
24787817|NCT01927640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24787818|NCT01927640|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24787819|NCT01927640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24787820|NCT01927640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25685416|NCT01905592|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25685417|NCT01905592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25685418|NCT01905592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685419|NCT01905592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25685420|NCT01905657|Docetaxel|docetaxel|mesh-list
25685421|NCT01905657|Pembrolizumab|pembrolizumab|mesh-list
24727900|NCT01613209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24727901|NCT01613209|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24727902|NCT01613209|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24787821|NCT01927640|Adrenergic Agents|adrenergic agents|mesh-ancestor
24787822|NCT01927640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24787831|NCT01927679|Vitamin E|vitamin e|mesh-list
25004819|NCT01416935|Amiodarone|amiodarone|mesh-list
24886035|NCT03688802|Cholinergic Agents|cholinergic agents|mesh-ancestor
24886036|NCT03688802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24886037|NCT03688802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886038|NCT03688802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886039|NCT03630666|Hormones|hormones|mesh-list
24886040|NCT03630666|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24886041|NCT03630666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24886042|NCT03630666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886043|NCT03616418|Antihypertensive Agents|antihypertensive agents|mesh-list
24886044|NCT03616418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
24886045|NCT03595917|Prednisone|prednisone|mesh-list
24464935|NCT00367315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24464936|NCT00367315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397288|NCT00141258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845872|NCT02239835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24846163|NCT02241499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846165|NCT02241564|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
24846166|NCT02241564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24846167|NCT02241564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846168|NCT02241564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24874403|NCT04767984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24874404|NCT04767984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24874405|NCT04767984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24533627|NCT00644670|Antimetabolites|antimetabolites|mesh-ancestor
24394239|NCT00132639|Mitosis Modulators|mitosis modulators|mesh-ancestor
24886052|NCT03595917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24886053|NCT03595917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886054|NCT03595917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24886055|NCT03595917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886056|NCT03595917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886057|NCT03541083|Blinatumomab|blinatumomab|mesh-list
24886058|NCT03541083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886059|NCT03510598|Deoxycholic Acid|deoxycholic acid|mesh-list
24886060|NCT03510598|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24886061|NCT03510598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24886062|NCT03446612|Nitroprusside|nitroprusside|mesh-list
24886063|NCT03446612|Acetylcholine|acetylcholine|mesh-list
24886064|NCT03446612|Darbepoetin alfa|darbepoetin alfa|mesh-list
24511275|NCT00568074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24511276|NCT00568074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511277|NCT00568074|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24511278|NCT00568074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458332|NCT00337493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24404125|NCT00162604|Cefuroxime|cefuroxime|mesh-list
24533651|NCT00644722|Pyrithione zinc|pyrithione zinc|mesh-list
24533652|NCT00644722|Keratolytic Agents|keratolytic agents|mesh-ancestor
24533653|NCT00644722|Dermatologic Agents|dermatologic agents|mesh-ancestor
24533654|NCT00644735|Esomeprazole|esomeprazole|mesh-list
24533655|NCT00644735|Lansoprazole|lansoprazole|mesh-list
24533656|NCT00644735|Dexlansoprazole|dexlansoprazole|mesh-list
24533657|NCT00644735|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24533658|NCT00644735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24533684|NCT00644761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685422|NCT01905657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25685423|NCT01905657|Tubulin Modulators|tubulin modulators|mesh-ancestor
25685424|NCT01905657|Antimitotic Agents|antimitotic agents|mesh-ancestor
24728607|NCT01617213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24728608|NCT01617213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24728609|NCT01617213|Alkylating Agents|alkylating agents|mesh-ancestor
24728693|NCT01617707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533685|NCT00644774|Azithromycin|azithromycin|mesh-list
24533686|NCT00644774|Cefdinir|cefdinir|mesh-list
24533687|NCT00644774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24533688|NCT00644774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24533689|NCT00644800|Ziprasidone|ziprasidone|mesh-list
24533690|NCT00644800|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24444321|NCT00297466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24459011|NCT00343369|Hormones|hormones|mesh-ancestor
25108498|NCT03131791|Botulinum Toxins|botulinum toxins|mesh-list
25108499|NCT03131791|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25108500|NCT03131791|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25108501|NCT03131791|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25108502|NCT03131791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25108504|NCT03131791|Cholinergic Agents|cholinergic agents|mesh-ancestor
24541055|NCT00670670|Serotonin Agents|serotonin agents|mesh-ancestor
24541056|NCT00670670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25108558|NCT03131973|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24861388|NCT02317419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24861464|NCT02318017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861465|NCT02318017|Dopamine Agents|dopamine agents|mesh-ancestor
24861466|NCT02318017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24861467|NCT02318043|Fluticasone|fluticasone|mesh-list
24861468|NCT02318043|Budesonide|budesonide|mesh-list
24875172|NCT04346654|Dexamethasone|dexamethasone|mesh-list
24455450|NCT00945724|Tubulin Modulators|tubulin modulators|mesh-ancestor
24875173|NCT04346654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24875174|NCT04346654|Antiemetics|antiemetics|mesh-ancestor
24875175|NCT04346654|Autonomic Agents|autonomic agents|mesh-ancestor
24875176|NCT04346654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24861822|NCT02320357|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24861824|NCT02320357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24620817|NCT01059136|Natriuretic Agents|natriuretic agents|mesh-ancestor
24861825|NCT02320357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875203|NCT04329325|Dexamethasone|dexamethasone|mesh-list
24861946|NCT02321384|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24875240|NCT04316702|Sensory System Agents|sensory system agents|mesh-ancestor
25685425|NCT01905657|Mitosis Modulators|mitosis modulators|mesh-ancestor
25685426|NCT01905657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685427|NCT01905657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25685428|NCT01905683|Botulinum Toxins|botulinum toxins|mesh-list
25685429|NCT01905683|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25685430|NCT01905683|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25685431|NCT01905683|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24875241|NCT04316702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24875242|NCT04316702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24875243|NCT04316702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24875244|NCT04316702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875247|NCT04316702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24862031|NCT02322346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24862032|NCT02322372|Bupivacaine|bupivacaine|mesh-list
24862033|NCT02322372|Anesthetics|anesthetics|mesh-ancestor
24862071|NCT02322645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24862072|NCT02322645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24875431|NCT04176848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864571|NCT03344341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24864572|NCT03344341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815352|NCT02069808|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24815353|NCT02069808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866506|NCT04760717|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24886172|NCT02903160|Glucocorticoids|glucocorticoids|mesh-ancestor
24886173|NCT02903160|Hormones|hormones|mesh-ancestor
24886174|NCT02903160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24866507|NCT04760717|Diuretics|diuretics|mesh-ancestor
24814369|NCT02064348|Moxifloxacin|moxifloxacin|mesh-list
24814397|NCT02064465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24867348|NCT01064245|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24875644|NCT03982030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24875645|NCT03977194|Paclitaxel|paclitaxel|mesh-list
24875646|NCT03977194|Carboplatin|carboplatin|mesh-list
24875647|NCT03977194|Atezolizumab|atezolizumab|mesh-list
24875648|NCT03977194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24868078|NCT03831711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868080|NCT03831711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868081|NCT03831711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24868132|NCT03516292|Mitogens|mitogens|mesh-list
24868133|NCT03516292|Mitosis Modulators|mitosis modulators|mesh-ancestor
24868134|NCT03516292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868135|NCT03336541|Ketamine|ketamine|mesh-list
24868136|NCT03336541|Analgesics|analgesics|mesh-ancestor
24868137|NCT03336541|Sensory System Agents|sensory system agents|mesh-ancestor
24868138|NCT03336541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24868448|NCT04768569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24868450|NCT04645602|Pembrolizumab|pembrolizumab|mesh-list
24868451|NCT04645602|Lenvatinib|lenvatinib|mesh-list
24868452|NCT04645602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24548400|NCT00709332|Hematinics|hematinics|mesh-ancestor
24868545|NCT04351061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868547|NCT04334174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24868548|NCT04334174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24868549|NCT04325659|Lofexidine|lofexidine|mesh-list
24868550|NCT04325659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24868579|NCT04206761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24868580|NCT04206761|Dermatologic Agents|dermatologic agents|mesh-ancestor
24868581|NCT04206761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24868637|NCT03925246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24548603|NCT00710437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24868649|NCT03668639|Antiemetics|antiemetics|mesh-ancestor
24868650|NCT03668639|Autonomic Agents|autonomic agents|mesh-ancestor
24868651|NCT03668639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24868652|NCT03668639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868653|NCT03668639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24868654|NCT03668639|Glucocorticoids|glucocorticoids|mesh-ancestor
24868655|NCT03668639|Hormones|hormones|mesh-ancestor
24868656|NCT03668639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24868657|NCT03668639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24868658|NCT03668639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24868659|NCT03618693|Anesthetics|anesthetics|mesh-list
24868660|NCT03618693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24868661|NCT03618693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868662|NCT03600714|Interferons|interferons|mesh-list
24868663|NCT03600714|Ritonavir|ritonavir|mesh-list
24868664|NCT03600714|Lonafarnib|lonafarnib|mesh-list
24868665|NCT03600714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24868666|NCT03600714|Antiviral Agents|antiviral agents|mesh-ancestor
24875840|NCT03819465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24875841|NCT03819465|Antimetabolites|antimetabolites|mesh-ancestor
24875842|NCT03819465|Antiviral Agents|antiviral agents|mesh-ancestor
24870804|NCT03691584|Sequestering Agents|sequestering agents|mesh-ancestor
24870909|NCT02966873|Respiratory System Agents|respiratory system agents|mesh-ancestor
24870910|NCT02966873|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24870912|NCT02966873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870913|NCT02966873|Protective Agents|protective agents|mesh-ancestor
24870914|NCT02966873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870915|NCT02966873|Antidotes|antidotes|mesh-ancestor
24870916|NCT02631070|Luspatercept|luspatercept|mesh-list
24870917|NCT02631070|Hematinics|hematinics|mesh-ancestor
24870918|NCT02630641|Hormones|hormones|mesh-list
24870919|NCT02630641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24870920|NCT02630641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870921|NCT02616185|Tremelimumab|tremelimumab|mesh-list
24870922|NCT02616185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870923|NCT02513329|Bupivacaine|bupivacaine|mesh-list
24870924|NCT02513329|Anesthetics, Local|anesthetics, local|mesh-ancestor
24871466|NCT02458313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871468|NCT02426892|Nivolumab|nivolumab|mesh-list
24871469|NCT02426892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24871470|NCT02426892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108666|NCT03131037|Valacyclovir|valacyclovir|mesh-list
24871794|NCT04525898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24814972|NCT02067767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24814973|NCT02067767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24814974|NCT02067767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24814976|NCT02067780|Levofloxacin|levofloxacin|mesh-list
24814977|NCT02067780|Ofloxacin|ofloxacin|mesh-list
24814978|NCT02067780|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24872217|NCT05398393|Antiviral Agents|antiviral agents|mesh-ancestor
24872218|NCT05398393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24872743|NCT05232461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24872744|NCT05232461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24872745|NCT05232461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872746|NCT05232461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24873135|NCT05391971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24874760|NCT04576104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24876110|NCT03724084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24876111|NCT03724084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24876112|NCT03724084|Immunologic Factors|immunologic factors|mesh-ancestor
24876113|NCT03724084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24876114|NCT03724084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24876115|NCT03724084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24876116|NCT03724084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24876117|NCT03724084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24876153|NCT03719001|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24876154|NCT03719001|Protective Agents|protective agents|mesh-ancestor
24876469|NCT03512756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24876470|NCT03512756|Immunologic Factors|immunologic factors|mesh-ancestor
24815426|NCT02070198|Contraceptive Agents|contraceptive agents|mesh-ancestor
24876587|NCT03366103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24876588|NCT03355118|Anesthetics|anesthetics|mesh-list
24876589|NCT03355118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24876713|NCT03300544|Protective Agents|protective agents|mesh-ancestor
24876714|NCT03300544|Vitamin B Complex|vitamin b complex|mesh-ancestor
24876716|NCT03300544|Micronutrients|micronutrients|mesh-ancestor
24786635|NCT01921010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578918|NCT00852423|Amodiaquine|amodiaquine|mesh-list
24578920|NCT00852423|Mefloquine|mefloquine|mesh-list
24578921|NCT00852423|Antimalarials|antimalarials|mesh-ancestor
24578922|NCT00852423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24578923|NCT00852423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24578924|NCT00852423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24578925|NCT00852423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578926|NCT00852423|Antiviral Agents|antiviral agents|mesh-ancestor
24578927|NCT00852423|Schistosomicides|schistosomicides|mesh-ancestor
24578928|NCT00852423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24578929|NCT00852423|Anthelmintics|anthelmintics|mesh-ancestor
24578930|NCT00852436|Pregabalin|pregabalin|mesh-list
24578931|NCT00852436|Analgesics|analgesics|mesh-ancestor
24578932|NCT00852436|Sensory System Agents|sensory system agents|mesh-ancestor
24578933|NCT00852436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24578934|NCT00852436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108688|NCT03130842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25108689|NCT03130842|Anesthetics, General|anesthetics, general|mesh-ancestor
25108691|NCT03130842|GABA Modulators|gaba modulators|mesh-ancestor
25108692|NCT03130842|GABA Agents|gaba agents|mesh-ancestor
25108693|NCT03130842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25108694|NCT03130842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108695|NCT03130829|Fucoidan|fucoidan|mesh-list
24877044|NCT02974621|Endothelial Growth Factors|endothelial growth factors|mesh-list
24877046|NCT02974621|Immunoglobulins|immunoglobulins|mesh-list
24877047|NCT02974621|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24877048|NCT02974621|Immunoglobulin G|immunoglobulin g|mesh-list
24877049|NCT02974621|Maleic acid|maleic acid|mesh-list
24877050|NCT02974621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24877051|NCT02974621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24877052|NCT02974621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24877053|NCT02974621|Growth Substances|growth substances|mesh-ancestor
24877054|NCT02974621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24877055|NCT02974621|Growth Inhibitors|growth inhibitors|mesh-ancestor
24877056|NCT02974621|Immunologic Factors|immunologic factors|mesh-ancestor
24877057|NCT02974621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699557|NCT01447589|Nelfinavir|nelfinavir|mesh-list
24877388|NCT02756013|Carboplatin|carboplatin|mesh-list
24877389|NCT02756013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24815527|NCT02070718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24815528|NCT02070718|Analgesics|analgesics|mesh-ancestor
24815537|NCT02071004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24815538|NCT02071004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24815539|NCT02071004|Analgesics|analgesics|mesh-ancestor
24815540|NCT02071004|Sensory System Agents|sensory system agents|mesh-ancestor
24815541|NCT02071004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24479142|NCT00425724|Cyclosporins|cyclosporins|mesh-list
24479143|NCT00425724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24479144|NCT00425724|Glucocorticoids|glucocorticoids|mesh-ancestor
24479145|NCT00425724|Hormones|hormones|mesh-ancestor
24479146|NCT00425724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24479147|NCT00425724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880029|NCT04178460|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24880139|NCT04048343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398525|NCT00144807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24815497|NCT02070510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24880772|NCT03344419|Ketamine|ketamine|mesh-list
24880773|NCT03344419|Analgesics|analgesics|mesh-ancestor
24880774|NCT03344419|Sensory System Agents|sensory system agents|mesh-ancestor
24880775|NCT03344419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24880776|NCT03344419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880777|NCT03344419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24881082|NCT03083405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881083|NCT03083405|Adrenergic Agents|adrenergic agents|mesh-ancestor
24578940|NCT00852436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24578941|NCT00852436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24578942|NCT00852436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24578943|NCT00852436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24578944|NCT00852566|Imatinib Mesylate|imatinib mesylate|mesh-list
24578945|NCT00852566|Dasatinib|dasatinib|mesh-list
24578946|NCT00852566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578947|NCT00852566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24578948|NCT00852566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24578949|NCT00852566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578950|NCT00852579|Azithromycin|azithromycin|mesh-list
24786636|NCT01921192|Folic Acid|folic acid|mesh-list
24578951|NCT00852579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24578952|NCT00852579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24786637|NCT01921192|Hematinics|hematinics|mesh-ancestor
24786638|NCT01921192|Vitamin B Complex|vitamin b complex|mesh-ancestor
24786639|NCT01921192|Vitamins|vitamins|mesh-ancestor
24786640|NCT01921192|Micronutrients|micronutrients|mesh-ancestor
24786641|NCT01921192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786642|NCT01921218|Cyclosporine|cyclosporine|mesh-list
24786643|NCT01921218|Mycophenolic Acid|mycophenolic acid|mesh-list
24786644|NCT01921218|Prednisone|prednisone|mesh-list
24786645|NCT01921218|Abatacept|abatacept|mesh-list
24786646|NCT01921218|Tacrolimus|tacrolimus|mesh-list
24786647|NCT01921218|Cyclosporins|cyclosporins|mesh-list
24786648|NCT01921218|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
24786649|NCT01921218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24786650|NCT01921218|Glucocorticoids|glucocorticoids|mesh-ancestor
24786652|NCT01921218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24786653|NCT01921218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786654|NCT01921218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24786655|NCT01921218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673340|NCT01337323|Xhance|xhance|mesh-list
24881084|NCT03083405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24881085|NCT03083405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108738|NCT03130452|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24887370|NCT04517188|Povidone|povidone|mesh-list
24885414|NCT05173090|Anesthetics|anesthetics|mesh-ancestor
24885415|NCT05173090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24885416|NCT05173090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885806|NCT04537026|Dexamethasone acetate|dexamethasone acetate|mesh-list
24885807|NCT04537026|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24885839|NCT04409041|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24886471|NCT04525664|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24886472|NCT04525664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24886473|NCT04525664|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24886474|NCT04525664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886475|NCT04525664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886476|NCT04525664|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24886477|NCT04525664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24886478|NCT04525664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24886479|NCT04525729|Rituximab|rituximab|mesh-list
24886480|NCT04525729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24886481|NCT04525729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886482|NCT04525729|Immunologic Factors|immunologic factors|mesh-ancestor
24886483|NCT04525729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886484|NCT04525729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24886485|NCT04525521|Hand Sanitizers|hand sanitizers|mesh-list
24886486|NCT04525521|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24886487|NCT04525521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24886488|NCT04525521|Disinfectants|disinfectants|mesh-ancestor
24886489|NCT04525495|Dopamine|dopamine|mesh-list
24886490|NCT04525495|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24886704|NCT04523662|Apatinib|apatinib|mesh-list
24877390|NCT02756013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24699818|NCT01449188|Antipruritics|antipruritics|mesh-ancestor
24877391|NCT02756013|Tubulin Modulators|tubulin modulators|mesh-ancestor
24877392|NCT02756013|Antimitotic Agents|antimitotic agents|mesh-ancestor
24877429|NCT02692339|Glucocorticoids|glucocorticoids|mesh-ancestor
24877431|NCT02692339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24877433|NCT02692339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886175|NCT02903160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398909|NCT00146146|Letrozole|letrozole|mesh-list
24887369|NCT04517188|Povidone-Iodine|povidone-iodine|mesh-list
24887558|NCT04515238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887559|NCT04515238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24877565|NCT02535078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24877566|NCT02535078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24877567|NCT02529852|Prednisone|prednisone|mesh-list
24877568|NCT02529852|Cyclophosphamide|cyclophosphamide|mesh-list
24877569|NCT02529852|Doxorubicin|doxorubicin|mesh-list
24887637|NCT04514029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24887638|NCT04514029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24887639|NCT04514029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887640|NCT04514289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24887641|NCT04514081|Decitabine|decitabine|mesh-list
24887642|NCT04514081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24887643|NCT04514081|Antimetabolites|antimetabolites|mesh-ancestor
24465772|NCT00370669|Hormones|hormones|mesh-ancestor
24887708|NCT04513509|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24887710|NCT04513509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24887711|NCT04513509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24887712|NCT04513509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24887713|NCT04513509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24887714|NCT04513626|Raltegravir Potassium|raltegravir potassium|mesh-list
24887715|NCT04513626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24887716|NCT04513626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24877643|NCT02503709|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
24877644|NCT02503709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24877645|NCT02503709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24877646|NCT02503709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888033|NCT04509440|Immunologic Factors|immunologic factors|mesh-ancestor
24877720|NCT02473042|Promethazine|promethazine|mesh-list
24863261|NCT02136069|Infliximab|infliximab|mesh-list
24482431|NCT00438984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24877721|NCT02473042|Dexamethasone|dexamethasone|mesh-list
24877722|NCT02473042|Ondansetron|ondansetron|mesh-list
24877723|NCT02473042|Famotidine|famotidine|mesh-list
24877724|NCT02473042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24877725|NCT02473042|Antiemetics|antiemetics|mesh-ancestor
24877726|NCT02473042|Autonomic Agents|autonomic agents|mesh-ancestor
24877727|NCT02473042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24877728|NCT02473042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24877730|NCT02473042|Glucocorticoids|glucocorticoids|mesh-ancestor
24877739|NCT02473042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24877740|NCT02473042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24877741|NCT02473042|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24815585|NCT02071212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815586|NCT02071212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815589|NCT02071303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24815590|NCT02071303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24815591|NCT02071303|Analgesics|analgesics|mesh-ancestor
24815592|NCT02071303|Sensory System Agents|sensory system agents|mesh-ancestor
24815593|NCT02071303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24815594|NCT02071303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815595|NCT02071303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24815596|NCT02071303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24815597|NCT02071303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24815598|NCT02071303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24888447|NCT04505228|Parasympatholytics|parasympatholytics|mesh-ancestor
24888448|NCT04505228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25108744|NCT03130426|Insulin Glargine|insulin glargine|mesh-list
24511341|NCT00568347|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24511343|NCT00568347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24511344|NCT00568347|Autonomic Agents|autonomic agents|mesh-ancestor
24511345|NCT00568347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24511346|NCT00568347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108746|NCT03130426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25108747|NCT03130426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108749|NCT03130582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25108750|NCT03130582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108751|NCT03130582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25108752|NCT03130582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25108753|NCT03130582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25108754|NCT03130582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108755|NCT03130517|Immunoglobulins|immunoglobulins|mesh-list
25108756|NCT03130517|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25108757|NCT03130517|Antibodies|antibodies|mesh-list
25108758|NCT03130517|gamma-Globulins|gamma-globulins|mesh-list
25108759|NCT03130517|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24399039|NCT00146549|Paclitaxel|paclitaxel|mesh-list
25108760|NCT03130517|Immunologic Factors|immunologic factors|mesh-ancestor
25108761|NCT03130517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108762|NCT03130348|Dexamethasone|dexamethasone|mesh-list
24888449|NCT04505228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24816748|NCT02078596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816750|NCT02078596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24816751|NCT02078596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816752|NCT02078596|Antimanic Agents|antimanic agents|mesh-ancestor
24816753|NCT02078596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24816754|NCT02078596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24816755|NCT02078596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24816756|NCT02078609|Midostaurin|midostaurin|mesh-list
24816757|NCT02078609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816758|NCT02078609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24816759|NCT02078609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816760|NCT02078609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816761|NCT02078648|Poly I-C|poly i-c|mesh-list
24816762|NCT02078648|Bevacizumab|bevacizumab|mesh-list
24888837|NCT04500678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24888838|NCT04500678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863337|NCT05146245|Risperidone|risperidone|mesh-list
24466670|NCT00374478|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24888872|NCT04499898|Vasodilator Agents|vasodilator agents|mesh-ancestor
24877913|NCT02227199|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24877914|NCT02227199|Podophyllotoxin|podophyllotoxin|mesh-list
24877915|NCT02227199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24877917|NCT02227199|Immunoglobulins|immunoglobulins|mesh-list
24877918|NCT02227199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24877919|NCT02227199|Immunoconjugates|immunoconjugates|mesh-list
24877920|NCT02227199|Immunologic Factors|immunologic factors|mesh-ancestor
24889272|NCT04494763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24889273|NCT04494763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24889274|NCT04494763|Adrenergic Agents|adrenergic agents|mesh-ancestor
24889276|NCT04494763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889277|NCT04494763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889278|NCT04494763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24889279|NCT04494763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24889280|NCT04494763|Vasodilator Agents|vasodilator agents|mesh-ancestor
24889281|NCT04494828|Dexmedetomidine|dexmedetomidine|mesh-list
24889282|NCT04494828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24889283|NCT04494828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24889284|NCT04494828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889285|NCT04494828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24889286|NCT04494828|Analgesics|analgesics|mesh-ancestor
24889287|NCT04494828|Sensory System Agents|sensory system agents|mesh-ancestor
24890584|NCT04481815|Antimetabolites|antimetabolites|mesh-ancestor
24890585|NCT04481815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890586|NCT04481815|Dermatologic Agents|dermatologic agents|mesh-ancestor
24890587|NCT04481815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24890698|NCT04481256|Mitosis Modulators|mitosis modulators|mesh-ancestor
24890699|NCT04481256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890701|NCT04481100|Antifungal Agents|antifungal agents|mesh-ancestor
24890702|NCT04481100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24890703|NCT04481100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24890764|NCT04480268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890765|NCT04480268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24890766|NCT04480268|Antimetabolites|antimetabolites|mesh-ancestor
24890767|NCT04480268|Antiviral Agents|antiviral agents|mesh-ancestor
24890768|NCT04480268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24890769|NCT04480268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24890770|NCT04480268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24890771|NCT04480268|Immunologic Factors|immunologic factors|mesh-ancestor
25108764|NCT03130348|Bortezomib|bortezomib|mesh-list
25108765|NCT03130348|Ichthammol|ichthammol|mesh-list
25108766|NCT03130348|BB 1101|bb 1101|mesh-list
25108767|NCT03130348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24890772|NCT04480268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890773|NCT04480333|Antiviral Agents|antiviral agents|mesh-list
24890775|NCT04480333|Neuroprotective Agents|neuroprotective agents|mesh-list
24890776|NCT04480333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24890777|NCT04480333|Antimetabolites|antimetabolites|mesh-ancestor
24890964|NCT04477629|Abatacept|abatacept|mesh-list
24890965|NCT04477629|Tacrolimus|tacrolimus|mesh-list
24878258|NCT01998529|Cisplatin|cisplatin|mesh-list
24399276|NCT00147355|Metoclopramide|metoclopramide|mesh-list
24891356|NCT04472585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24891357|NCT04472585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24891358|NCT04472806|Endostar protein|endostar protein|mesh-list
24891359|NCT04472806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24891360|NCT04472806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24815662|NCT02071537|Gemcitabine|gemcitabine|mesh-list
24815663|NCT02071537|Chloroquine|chloroquine|mesh-list
24815664|NCT02071537|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24815665|NCT02071537|Carboplatin|carboplatin|mesh-list
24891719|NCT04467892|Protective Agents|protective agents|mesh-ancestor
24891720|NCT04467892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24891721|NCT04467892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24891722|NCT04467931|Losartan|losartan|mesh-list
24891723|NCT04467931|Timolol|timolol|mesh-list
24891724|NCT04467931|Propranolol|propranolol|mesh-list
24891725|NCT04467931|Metoprolol|metoprolol|mesh-list
24891801|NCT04467931|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24891961|NCT04466046|GABA Modulators|gaba modulators|mesh-ancestor
24878472|NCT01709123|Trace Elements|trace elements|mesh-ancestor
24878473|NCT01709123|Micronutrients|micronutrients|mesh-ancestor
24878512|NCT01585805|Gemcitabine|gemcitabine|mesh-list
24878513|NCT01585805|Cisplatin|cisplatin|mesh-list
24878514|NCT01585805|Veliparib|veliparib|mesh-list
25123409|NCT03085225|Durvalumab|durvalumab|mesh-list
24878515|NCT01585805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24878517|NCT01585805|Antimetabolites|antimetabolites|mesh-ancestor
24878518|NCT01585805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878519|NCT01585805|Antiviral Agents|antiviral agents|mesh-ancestor
24878520|NCT01585805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24878521|NCT01585805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24878522|NCT01585805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24878523|NCT01585805|Immunologic Factors|immunologic factors|mesh-ancestor
24878524|NCT01585805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24878525|NCT01585805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24878527|NCT01582191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24878528|NCT01582191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24878529|NCT01582191|Immunologic Factors|immunologic factors|mesh-ancestor
24878539|NCT01479842|Rituximab|rituximab|mesh-list
24878540|NCT01479842|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24878541|NCT01479842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24878542|NCT01479842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24878543|NCT01479842|Immunologic Factors|immunologic factors|mesh-ancestor
24878572|NCT01410942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878573|NCT01410942|Dopamine Agents|dopamine agents|mesh-ancestor
24816959|NCT02080078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24816960|NCT02080078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816961|NCT02080078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816962|NCT02080078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24892568|NCT04461925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892569|NCT04461925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24892570|NCT04461925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24892571|NCT04461925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24892573|NCT04461665|Ergocalciferols|ergocalciferols|mesh-list
24892574|NCT04461665|Cholecalciferol|cholecalciferol|mesh-list
24892575|NCT04461665|Vitamins|vitamins|mesh-list
24892576|NCT04461665|Micronutrients|micronutrients|mesh-ancestor
24892577|NCT04461665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892578|NCT04461665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24892650|NCT04460820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24892652|NCT04460820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892653|NCT04460807|Exemestane|exemestane|mesh-list
24892654|NCT04460807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24892715|NCT04460001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892716|NCT04460001|Growth Inhibitors|growth inhibitors|mesh-ancestor
24892717|NCT04460001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24892718|NCT04460001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24892719|NCT04460001|Glucocorticoids|glucocorticoids|mesh-ancestor
24892720|NCT04460001|Hormones|hormones|mesh-ancestor
24892721|NCT04460001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24892722|NCT04460092|Insulin|insulin|mesh-list
24892723|NCT04460092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24892724|NCT04460092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24892725|NCT04460092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879111|NCT05039177|Palbociclib|palbociclib|mesh-list
24879112|NCT05039177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24879113|NCT05039177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24879114|NCT05039177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24879115|NCT05039177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24879116|NCT05039177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879117|NCT05033054|Dapagliflozin|dapagliflozin|mesh-list
24879118|NCT05033054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24879119|NCT05033054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879120|NCT05033054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24879121|NCT05033054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879145|NCT05006599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879146|NCT04985500|Bupivacaine|bupivacaine|mesh-list
24879147|NCT04985500|Anesthetics, Local|anesthetics, local|mesh-ancestor
24879148|NCT04985500|Anesthetics|anesthetics|mesh-ancestor
24879292|NCT04910061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685432|NCT01905683|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25685433|NCT01905683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25692556|NCT02001987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731149|NCT01632722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24879293|NCT04910061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24879294|NCT04910061|Vasodilator Agents|vasodilator agents|mesh-ancestor
24879295|NCT04901208|Nicotine|nicotine|mesh-list
24879296|NCT04901208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24879297|NCT04901208|Autonomic Agents|autonomic agents|mesh-ancestor
24879305|NCT04892017|Trametinib|trametinib|mesh-list
24879307|NCT04892017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24879309|NCT04892017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879310|NCT04889079|Contraceptive Agents|contraceptive agents|mesh-list
24879311|NCT04889079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24879312|NCT04889079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879313|NCT04884412|Anesthetics|anesthetics|mesh-list
24879314|NCT04884412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24879315|NCT04884412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879316|NCT04862338|Niacinamide|niacinamide|mesh-list
24879318|NCT04862338|Nicotinic Acids|nicotinic acids|mesh-list
24879319|NCT04862338|Vitamin B Complex|vitamin b complex|mesh-ancestor
24879350|NCT04807673|Mitosis Modulators|mitosis modulators|mesh-ancestor
24879351|NCT04807673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879352|NCT04807673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24815759|NCT02071888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815760|NCT02071888|Protease Inhibitors|protease inhibitors|mesh-ancestor
24815761|NCT02071888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815763|NCT02071888|Immunologic Factors|immunologic factors|mesh-ancestor
24815764|NCT02071888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24815777|NCT02071966|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24815796|NCT02072083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24815797|NCT02072083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24815798|NCT02072083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815799|NCT02072083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24815800|NCT02072083|Analgesics|analgesics|mesh-ancestor
24475212|NCT00409461|Sirolimus|sirolimus|mesh-list
24475213|NCT00409461|Tacrolimus|tacrolimus|mesh-list
24475214|NCT00409461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24475215|NCT00409461|Immunologic Factors|immunologic factors|mesh-ancestor
24475216|NCT00409461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475217|NCT00409461|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24475218|NCT00409461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815811|NCT02072083|Anesthetics, General|anesthetics, general|mesh-ancestor
24898826|NCT04410081|Lazertinib|lazertinib|mesh-list
24879466|NCT04745559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879468|NCT04741997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24879469|NCT04741997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24879470|NCT04741997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24399802|NCT00148681|Mitosis Modulators|mitosis modulators|mesh-ancestor
24879471|NCT04741997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879472|NCT04740580|Acetylcysteine|acetylcysteine|mesh-list
24879473|NCT04740580|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24879474|NCT04740580|Glycine|glycine|mesh-list
24879475|NCT04740580|Antiviral Agents|antiviral agents|mesh-ancestor
24879527|NCT04701424|Insulin|insulin|mesh-list
24879528|NCT04701424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24879529|NCT04701424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476480|NCT00415116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476481|NCT00415116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24815832|NCT02072278|Citalopram|citalopram|mesh-list
24815833|NCT02072278|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24815834|NCT02072278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24815835|NCT02072278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24815836|NCT02072278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815837|NCT02072278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24815838|NCT02072278|Serotonin Agents|serotonin agents|mesh-ancestor
24815839|NCT02072278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815840|NCT02072278|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24815841|NCT02072278|Antidepressive Agents|antidepressive agents|mesh-ancestor
24815842|NCT02072278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25692557|NCT02001987|Dermatologic Agents|dermatologic agents|mesh-ancestor
25692558|NCT02001987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692559|NCT02001987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25123492|NCT03084250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25123493|NCT03084250|Entecavir|entecavir|mesh-list
24815843|NCT02072278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24815844|NCT02072278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24815845|NCT02072278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24879771|NCT04439799|Hormones|hormones|mesh-ancestor
24900138|NCT04397289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24900139|NCT04397289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900140|NCT04397289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24900141|NCT04397289|Antithrombins|antithrombins|mesh-ancestor
24900142|NCT04397289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24900143|NCT04397289|Protease Inhibitors|protease inhibitors|mesh-ancestor
24900144|NCT04397289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900146|NCT04397549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24900148|NCT04397549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24900149|NCT04397549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511347|NCT00568347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24900151|NCT04397549|Sensory System Agents|sensory system agents|mesh-ancestor
24900152|NCT04397549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24879807|NCT04402138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24879834|NCT04380311|Tacrolimus|tacrolimus|mesh-list
24879835|NCT04380311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24879836|NCT04380311|Immunologic Factors|immunologic factors|mesh-ancestor
24879837|NCT04380311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879838|NCT04380311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24879839|NCT04380311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24879840|NCT04380311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879841|NCT04369014|Anesthetics|anesthetics|mesh-list
24879842|NCT04369014|Propofol|propofol|mesh-list
24879843|NCT04369014|Etomidate|etomidate|mesh-list
24900321|NCT04395365|Antimalarials|antimalarials|mesh-ancestor
24900322|NCT04395365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24900323|NCT04395365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24900324|NCT04395183|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
24900325|NCT04395183|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24900326|NCT04395183|Antidepressive Agents|antidepressive agents|mesh-ancestor
24900327|NCT04395183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24900328|NCT04395105|Dexamethasone|dexamethasone|mesh-list
24900518|NCT04393246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900622|NCT04392557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900659|NCT04392128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24900660|NCT04392297|Antibodies|antibodies|mesh-list
24900661|NCT04392297|Immunoglobulin G|immunoglobulin g|mesh-list
24900825|NCT04391127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880045|NCT04155632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24880054|NCT04145518|Naproxen|naproxen|mesh-list
24901230|NCT04387201|Vitamin B 12|vitamin b 12|mesh-list
24815906|NCT02072512|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24815907|NCT02072512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24815908|NCT02072512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815909|NCT02072512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815910|NCT02072525|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24815911|NCT02072525|Immunologic Factors|immunologic factors|mesh-ancestor
24815912|NCT02072525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702335|NCT01465113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24880058|NCT04145518|Sensory System Agents|sensory system agents|mesh-ancestor
24880062|NCT04145518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24880080|NCT04131829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25108984|NCT03128346|Analgesics|analgesics|mesh-ancestor
25108985|NCT03128346|Sensory System Agents|sensory system agents|mesh-ancestor
25108986|NCT03128346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108987|NCT03128346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108988|NCT03128346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25108989|NCT03128346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25108990|NCT03128346|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25108991|NCT03128346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25108994|NCT03128346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24880316|NCT03872180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880317|NCT03872180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24880318|NCT03861611|Ibuprofen|ibuprofen|mesh-list
24880319|NCT03861611|Diclofenac|diclofenac|mesh-list
24880320|NCT03861611|Ketorolac|ketorolac|mesh-list
24880321|NCT03861611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25685434|NCT01905683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880322|NCT03861611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24880324|NCT03861611|Sensory System Agents|sensory system agents|mesh-ancestor
24880325|NCT03861611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24880326|NCT03861611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880327|NCT03861611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24880328|NCT03861611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24880329|NCT03861611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24880330|NCT03861611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24880331|NCT03861611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880341|NCT03829371|Dexamethasone|dexamethasone|mesh-list
24880344|NCT03829371|Melphalan|melphalan|mesh-list
24880345|NCT03829371|Bortezomib|bortezomib|mesh-list
24880346|NCT03829371|Daratumumab|daratumumab|mesh-list
24880347|NCT03829371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24880348|NCT03829371|Antiemetics|antiemetics|mesh-ancestor
24880349|NCT03829371|Autonomic Agents|autonomic agents|mesh-ancestor
24880350|NCT03829371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24880351|NCT03829371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880352|NCT03829371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24902492|NCT04372836|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24902604|NCT04372082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902606|NCT04372082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24902785|NCT04370587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24902786|NCT04370587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880651|NCT03526354|Serotonin Agents|serotonin agents|mesh-ancestor
24880728|NCT03418038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24880729|NCT03418038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24880730|NCT03418038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24880731|NCT03418038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24880732|NCT03418038|Antioxidants|antioxidants|mesh-ancestor
24880733|NCT03418038|Protective Agents|protective agents|mesh-ancestor
24880734|NCT03418038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24880735|NCT03418038|Alkylating Agents|alkylating agents|mesh-ancestor
24880736|NCT03418038|Dermatologic Agents|dermatologic agents|mesh-ancestor
24880737|NCT03418038|Keratolytic Agents|keratolytic agents|mesh-ancestor
24902957|NCT04368520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24902959|NCT04368507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24902960|NCT04368377|Aspirin|aspirin|mesh-list
24902961|NCT04368377|PENTA|penta|mesh-list
24818291|NCT02087683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818292|NCT02087683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24818293|NCT02087722|Melatonin|melatonin|mesh-list
24818294|NCT02087722|Antioxidants|antioxidants|mesh-ancestor
24880785|NCT03344419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880787|NCT03336398|Analgesics|analgesics|mesh-ancestor
24880788|NCT03336398|Sensory System Agents|sensory system agents|mesh-ancestor
24880789|NCT03336398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24880790|NCT03336398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880791|NCT03336398|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24880792|NCT03336398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24880793|NCT03336398|Anesthetics, General|anesthetics, general|mesh-ancestor
24880794|NCT03336398|Anesthetics|anesthetics|mesh-ancestor
24400116|NCT00149877|Tegaserod|tegaserod|mesh-list
24880795|NCT03336398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24880797|NCT03336398|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24880812|NCT03274752|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24880813|NCT03274752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24880814|NCT03274752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880815|NCT03274752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24880816|NCT03274752|Serotonin Agents|serotonin agents|mesh-ancestor
24880817|NCT03274752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880818|NCT03274752|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24880819|NCT03274752|Antidepressive Agents|antidepressive agents|mesh-ancestor
24880820|NCT03274752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24880821|NCT03274752|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24880822|NCT03274752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24880823|NCT03274752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24880873|NCT03238196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880874|NCT03224104|Temozolomide|temozolomide|mesh-list
24880875|NCT03224104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24815959|NCT02072811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24815960|NCT02072811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24815961|NCT02072967|Rituximab|rituximab|mesh-list
24815962|NCT02072967|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24815963|NCT02072967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24904077|NCT04359316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904078|NCT04359316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24904080|NCT04358965|Tranexamic Acid|tranexamic acid|mesh-list
24904081|NCT04358965|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24904082|NCT04358965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24904083|NCT04358965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904084|NCT04358965|Hemostatics|hemostatics|mesh-ancestor
24904085|NCT04358965|Coagulants|coagulants|mesh-ancestor
25075986|NCT03376841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25075988|NCT03376841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25075989|NCT03376789|MYL-1501D|myl-1501d|mesh-list
25075990|NCT03376789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25075991|NCT03376789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075992|NCT03376737|Pemetrexed|pemetrexed|mesh-list
25075993|NCT03376737|Apatinib|apatinib|mesh-list
25075994|NCT03376737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075995|NCT03376737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075996|NCT03376737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400203|NCT00150059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25075997|NCT03376737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25075998|NCT03376737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25075999|NCT03376737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25076000|NCT03376594|Loratadine|loratadine|mesh-list
25076001|NCT03376594|Antipruritics|antipruritics|mesh-ancestor
25076002|NCT03376594|Dermatologic Agents|dermatologic agents|mesh-ancestor
25076003|NCT03376594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25076004|NCT03376594|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25076005|NCT03376594|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25076006|NCT03376594|Histamine Antagonists|histamine antagonists|mesh-ancestor
25076007|NCT03376594|Histamine Agents|histamine agents|mesh-ancestor
25076008|NCT03376594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25076009|NCT03376594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076010|NCT03376594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076011|NCT03376555|Nitroglycerin|nitroglycerin|mesh-list
25076012|NCT03376555|Acetylcholine|acetylcholine|mesh-list
25076013|NCT03376555|Vasodilator Agents|vasodilator agents|mesh-ancestor
25076014|NCT03376555|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25076017|NCT03376555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076018|NCT03376555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076019|NCT03376529|Tazobactam|tazobactam|mesh-list
25076020|NCT03376529|Piperacillin|piperacillin|mesh-list
25076021|NCT03376529|Ceftazidime|ceftazidime|mesh-list
25076022|NCT03376529|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25076023|NCT03376529|Aztreonam|aztreonam|mesh-list
25076024|NCT03376529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25076025|NCT03376529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24626489|NCT01087580|Mitosis Modulators|mitosis modulators|mesh-ancestor
25076200|NCT03375112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962135|NCT03802162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25076202|NCT03375034|Anticonvulsants|anticonvulsants|mesh-ancestor
25076203|NCT03375034|GABA Modulators|gaba modulators|mesh-ancestor
25076204|NCT03375034|GABA Agents|gaba agents|mesh-ancestor
25076205|NCT03375034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25076206|NCT03375034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076207|NCT03375034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076208|NCT03374878|Contraceptive Agents|contraceptive agents|mesh-list
25076209|NCT03374878|Contraceptives, Oral|contraceptives, oral|mesh-list
25076210|NCT03374878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25076211|NCT03374878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882297|NCT01850108|Antifungal Agents|antifungal agents|mesh-ancestor
25685435|NCT01905683|Cholinergic Agents|cholinergic agents|mesh-ancestor
25685436|NCT01905683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25685437|NCT01905683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685438|NCT01905683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25685439|NCT01905683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24732549|NCT01640210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24732628|NCT01640587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24732629|NCT01640587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24732630|NCT01640587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24732631|NCT01640587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732632|NCT01640587|Antiviral Agents|antiviral agents|mesh-ancestor
24732633|NCT01640587|Schistosomicides|schistosomicides|mesh-ancestor
24732634|NCT01640587|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24732635|NCT01640587|Anthelmintics|anthelmintics|mesh-ancestor
24732636|NCT01640639|Thalidomide|thalidomide|mesh-list
25123572|NCT03083691|Nivolumab|nivolumab|mesh-list
25076398|NCT03373409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076399|NCT03373409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076479|NCT03372785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076480|NCT03372785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24957167|NCT03846765|Oxymetazoline|oxymetazoline|mesh-list
25076611|NCT03371849|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25076612|NCT03371849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24956064|NCT03857672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24956065|NCT03857672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956067|NCT03857399|Antifungal Agents|antifungal agents|mesh-ancestor
24956068|NCT03857399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24956069|NCT03857399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24956070|NCT03857399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956071|NCT03857711|Amiodarone|amiodarone|mesh-list
24956072|NCT03857711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24956073|NCT03857711|Vasodilator Agents|vasodilator agents|mesh-ancestor
24956074|NCT03857711|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24464414|NCT00364806|Metoclopramide|metoclopramide|mesh-list
24956182|NCT03856697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24956183|NCT03856502|Dexamethasone|dexamethasone|mesh-list
24956184|NCT03856502|Dexamethasone acetate|dexamethasone acetate|mesh-list
24956185|NCT03856502|Levobupivacaine|levobupivacaine|mesh-list
24956186|NCT03856502|BB 1101|bb 1101|mesh-list
24956187|NCT03856502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24956188|NCT03856502|Antiemetics|antiemetics|mesh-ancestor
24956189|NCT03856502|Autonomic Agents|autonomic agents|mesh-ancestor
24956190|NCT03856502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24885477|NCT05172310|FAPI-46|fapi-46|mesh-list
24956248|NCT03855865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956250|NCT03855865|Serotonin Agents|serotonin agents|mesh-ancestor
24956251|NCT03855865|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24956252|NCT03855865|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24956253|NCT03855865|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24956254|NCT03855865|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24956461|NCT03854344|Anesthetics, Local|anesthetics, local|mesh-ancestor
24956462|NCT03854344|Anesthetics|anesthetics|mesh-ancestor
24956463|NCT03854344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24956727|NCT03851835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956728|NCT03851835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24956729|NCT03851835|Antipruritics|antipruritics|mesh-ancestor
24464867|NCT00367185|Thalidomide|thalidomide|mesh-list
24956848|NCT03850587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24956849|NCT03850587|Narcotics|narcotics|mesh-ancestor
24956850|NCT03850587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24956851|NCT03850314|Glycine|glycine|mesh-list
24956852|NCT03850314|Glycine Agents|glycine agents|mesh-ancestor
24956853|NCT03850314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24956854|NCT03850314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956855|NCT03850314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956856|NCT03849885|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24956857|NCT03849885|Dermatologic Agents|dermatologic agents|mesh-ancestor
24886046|NCT03595917|Dasatinib|dasatinib|mesh-list
24956924|NCT03849209|Pancreatin|pancreatin|mesh-list
24956925|NCT03849209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24956926|NCT03849183|Nitroglycerin|nitroglycerin|mesh-list
25685440|NCT01905943|Cyclophosphamide|cyclophosphamide|mesh-list
25685441|NCT01905943|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25685442|NCT01905943|Chlorambucil|chlorambucil|mesh-list
25685443|NCT01905943|Fludarabine|fludarabine|mesh-list
25685444|NCT01905943|Obinutuzumab|obinutuzumab|mesh-list
25685445|NCT01905943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25685446|NCT01905943|Immunologic Factors|immunologic factors|mesh-ancestor
25685447|NCT01905943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685448|NCT01905943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25685449|NCT01905943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24956928|NCT03849235|Glucagon|glucagon|mesh-list
24956929|NCT03849235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24956930|NCT03849235|Hormones|hormones|mesh-ancestor
24956931|NCT03849235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24956932|NCT03849235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956933|NCT03849196|Bisacodyl|bisacodyl|mesh-list
24956934|NCT03849196|Cathartics|cathartics|mesh-ancestor
24956997|NCT03848065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956998|NCT03848091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24956999|NCT03848091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24957000|NCT03848039|Vaccines|vaccines|mesh-list
24957001|NCT03848039|Immunologic Factors|immunologic factors|mesh-ancestor
24957002|NCT03848039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957003|NCT03847818|Carboplatin|carboplatin|mesh-list
24957004|NCT03847818|Docetaxel|docetaxel|mesh-list
24957005|NCT03847818|Trastuzumab|trastuzumab|mesh-list
24957006|NCT03847818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24957012|NCT03847792|Dexamethasone|dexamethasone|mesh-list
24957013|NCT03847792|Fentanyl|fentanyl|mesh-list
24957014|NCT03847792|Bupivacaine|bupivacaine|mesh-list
24957162|NCT03846843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24957163|NCT03846960|Pulmonary Surfactants|pulmonary surfactants|mesh-list
24957164|NCT03846960|Respiratory System Agents|respiratory system agents|mesh-ancestor
24957165|NCT03846765|Phenylephrine|phenylephrine|mesh-list
24957166|NCT03846765|Dobutamine|dobutamine|mesh-list
24957174|NCT03846765|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24957321|NCT03845179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24957322|NCT03845179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957323|NCT03845153|Metformin|metformin|mesh-list
24957324|NCT03845153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24400641|NCT00151047|Mitosis Modulators|mitosis modulators|mesh-ancestor
24957325|NCT03845153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957327|NCT03845049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24957328|NCT03845049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24957329|NCT03845049|Growth Substances|growth substances|mesh-ancestor
24957330|NCT03845049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957331|NCT03845049|Growth Inhibitors|growth inhibitors|mesh-ancestor
24957332|NCT03845049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24957333|NCT03844841|Dexmedetomidine|dexmedetomidine|mesh-list
24957334|NCT03844841|Propofol|propofol|mesh-list
24957335|NCT03844841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24957336|NCT03844841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24476443|NCT00415064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24957337|NCT03844841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957338|NCT03844841|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24511348|NCT00568347|Respiratory System Agents|respiratory system agents|mesh-ancestor
24511349|NCT00568347|Dermatologic Agents|dermatologic agents|mesh-ancestor
24511350|NCT00568347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24511351|NCT00568347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24511352|NCT00568347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24511353|NCT00568347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24511354|NCT00568347|Adrenergic Agents|adrenergic agents|mesh-ancestor
24511384|NCT00568503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24957339|NCT03844841|Anesthetics, General|anesthetics, general|mesh-ancestor
24957340|NCT03844841|Anesthetics|anesthetics|mesh-ancestor
24957341|NCT03844841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24957342|NCT03844841|Analgesics|analgesics|mesh-ancestor
24957343|NCT03844841|Sensory System Agents|sensory system agents|mesh-ancestor
24957344|NCT03844841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24957345|NCT03844841|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24957346|NCT03844841|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24957347|NCT03844841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24957348|NCT03844841|Adrenergic Agents|adrenergic agents|mesh-ancestor
24957382|NCT03844932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957383|NCT03844932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24626681|NCT01088282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24626682|NCT01088282|Adrenergic Agents|adrenergic agents|mesh-ancestor
24626683|NCT01088282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24626684|NCT01088282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626685|NCT01088282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626686|NCT01088347|Mapatumumab|mapatumumab|mesh-list
24626687|NCT01088347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626688|NCT01088373|Lenalidomide|lenalidomide|mesh-list
24626689|NCT01088373|Azacitidine|azacitidine|mesh-list
24626690|NCT01088373|Immunologic Factors|immunologic factors|mesh-ancestor
24957527|NCT03844360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957589|NCT03843541|Expectorants|expectorants|mesh-ancestor
24732897|NCT01642108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732898|NCT01642108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732899|NCT01642134|Aspirin|aspirin|mesh-list
24732900|NCT01642134|Clopidogrel|clopidogrel|mesh-list
24732901|NCT01642134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24957590|NCT03843541|Respiratory System Agents|respiratory system agents|mesh-ancestor
24957591|NCT03843541|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24957592|NCT03843541|Antioxidants|antioxidants|mesh-ancestor
24957626|NCT03843515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24957627|NCT03843515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24957628|NCT03843515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24957629|NCT03843515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957630|NCT03843307|Immunologic Factors|immunologic factors|mesh-list
24957631|NCT03843307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957632|NCT03843060|Itraconazole|itraconazole|mesh-list
24957633|NCT03843060|Antifungal Agents|antifungal agents|mesh-ancestor
24957634|NCT03843060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24957636|NCT03843060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24957637|NCT03843060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24957638|NCT03843060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957639|NCT03843060|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24957640|NCT03843060|Hormone Antagonists|hormone antagonists|mesh-ancestor
24957641|NCT03843060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24957642|NCT03843060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957643|NCT03843060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24957648|NCT03843047|Nicotine|nicotine|mesh-list
24957797|NCT03841383|Dipyridamole|dipyridamole|mesh-list
24957802|NCT03841383|Vasodilator Agents|vasodilator agents|mesh-ancestor
24957804|NCT03841305|Hematinics|hematinics|mesh-ancestor
24886924|NCT04521556|Morphine|morphine|mesh-list
25078427|NCT03356730|Vitamins|vitamins|mesh-ancestor
25078428|NCT03356730|Micronutrients|micronutrients|mesh-ancestor
24957938|NCT03839251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887004|NCT04521140|Protective Agents|protective agents|mesh-ancestor
24626707|NCT01088477|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24626708|NCT01088477|Estrogens|estrogens|mesh-ancestor
24626709|NCT01088477|Hormones|hormones|mesh-ancestor
24626710|NCT01088477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24626711|NCT01088477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626712|NCT01088477|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24626713|NCT01088477|Contraceptive Agents|contraceptive agents|mesh-ancestor
24626714|NCT01088477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24626715|NCT01088477|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24626716|NCT01088516|Ritonavir|ritonavir|mesh-list
24626717|NCT01088516|Lopinavir|lopinavir|mesh-list
24957951|NCT03839160|Narcotics|narcotics|mesh-ancestor
24957952|NCT03839160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24957953|NCT03839160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957954|NCT03839160|Analgesics|analgesics|mesh-ancestor
24957955|NCT03839160|Sensory System Agents|sensory system agents|mesh-ancestor
24957956|NCT03839160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24957957|NCT03839134|Lidocaine|lidocaine|mesh-list
24957958|NCT03839134|Epinephrine|epinephrine|mesh-list
24957959|NCT03839134|Racepinephrine|racepinephrine|mesh-list
24957960|NCT03839134|Epinephryl borate|epinephryl borate|mesh-list
24957961|NCT03839134|Anesthetics, Local|anesthetics, local|mesh-ancestor
24957962|NCT03839134|Anesthetics|anesthetics|mesh-ancestor
24957963|NCT03839134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24957964|NCT03839134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957965|NCT03839134|Sensory System Agents|sensory system agents|mesh-ancestor
24778165|NCT01869569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24511386|NCT00568503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24511409|NCT00568672|Autonomic Agents|autonomic agents|mesh-ancestor
24511410|NCT00568672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24511411|NCT00568672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511412|NCT00568672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24511413|NCT00568672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24957966|NCT03839134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25685450|NCT01905943|Alkylating Agents|alkylating agents|mesh-ancestor
25685451|NCT01905943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685452|NCT01905943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25685453|NCT01905943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24958021|NCT03838575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24958022|NCT03838575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958024|NCT03838068|Procaine|procaine|mesh-list
24958025|NCT03838068|Anesthetics, Local|anesthetics, local|mesh-list
24958026|NCT03838068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958027|NCT03838068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24958028|NCT03838068|Sensory System Agents|sensory system agents|mesh-ancestor
24400682|NCT00151086|Alkylating Agents|alkylating agents|mesh-ancestor
24958029|NCT03838068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24887118|NCT04520139|Expectorants|expectorants|mesh-ancestor
24958094|NCT03836807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958096|NCT03836703|Trace Elements|trace elements|mesh-ancestor
24958097|NCT03836703|Micronutrients|micronutrients|mesh-ancestor
24958098|NCT03836703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958099|NCT03836885|Apremilast|apremilast|mesh-list
24958100|NCT03836885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24958101|NCT03836885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24958102|NCT03836885|Analgesics|analgesics|mesh-ancestor
24958103|NCT03836885|Sensory System Agents|sensory system agents|mesh-ancestor
24958104|NCT03836885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24958105|NCT03836885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958107|NCT03836885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24958164|NCT03836560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958166|NCT03836222|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24958167|NCT03836222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24958168|NCT03836222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958169|NCT03836222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24958170|NCT03836222|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24958171|NCT03836222|Protective Agents|protective agents|mesh-ancestor
24958172|NCT03836222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958198|NCT03835715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501488|NCT00528827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24778203|NCT01869907|Analgesics|analgesics|mesh-ancestor
24958200|NCT03835715|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24958201|NCT03835715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24958202|NCT03835715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958203|NCT03835715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24958205|NCT03835715|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24400790|NCT00151294|Parasympatholytics|parasympatholytics|mesh-ancestor
24400791|NCT00151294|Autonomic Agents|autonomic agents|mesh-ancestor
24400792|NCT00151294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24400793|NCT00151294|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24958206|NCT03835715|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24958207|NCT03835715|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24958208|NCT03835715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24958209|NCT03835442|Baclofen|baclofen|mesh-list
24958210|NCT03835442|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24784059|NCT01905631|Autonomic Agents|autonomic agents|mesh-ancestor
24784060|NCT01905631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24784061|NCT01905631|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24784062|NCT01905631|Histamine Antagonists|histamine antagonists|mesh-ancestor
24784063|NCT01905631|Histamine Agents|histamine agents|mesh-ancestor
24784064|NCT01905631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24784065|NCT01905631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784066|NCT01905631|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24784067|NCT01905631|Antipruritics|antipruritics|mesh-ancestor
24784068|NCT01905631|Dermatologic Agents|dermatologic agents|mesh-ancestor
24958320|NCT03834233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24958321|NCT03834233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24958322|NCT03834233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24958323|NCT03834233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958324|NCT03833999|Ondansetron|ondansetron|mesh-list
24958325|NCT03833999|Lactulose|lactulose|mesh-list
24958326|NCT03833999|Antiemetics|antiemetics|mesh-ancestor
24958327|NCT03833999|Autonomic Agents|autonomic agents|mesh-ancestor
24958328|NCT03833999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24958329|NCT03833999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958330|NCT03833999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24958331|NCT03833999|Antipruritics|antipruritics|mesh-ancestor
24958332|NCT03833999|Dermatologic Agents|dermatologic agents|mesh-ancestor
24784330|NCT01907529|Docetaxel|docetaxel|mesh-list
24784331|NCT01907529|Epirubicin|epirubicin|mesh-list
24784332|NCT01907529|Endostar protein|endostar protein|mesh-list
24784333|NCT01907529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24784334|NCT01907529|Immunologic Factors|immunologic factors|mesh-ancestor
24784335|NCT01907529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784336|NCT01907529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24626758|NCT01088620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24626759|NCT01088659|Tenofovir|tenofovir|mesh-list
24626760|NCT01088659|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25078430|NCT03356730|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25078431|NCT03356444|Docetaxel|docetaxel|mesh-list
25078432|NCT03356444|Abiraterone Acetate|abiraterone acetate|mesh-list
25078433|NCT03356444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25078434|NCT03356444|Tubulin Modulators|tubulin modulators|mesh-ancestor
25078435|NCT03356444|Antimitotic Agents|antimitotic agents|mesh-ancestor
25078436|NCT03356444|Mitosis Modulators|mitosis modulators|mesh-ancestor
25078437|NCT03356444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400914|NCT00151619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25078438|NCT03356444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25078467|NCT03356080|Keratolytic Agents|keratolytic agents|mesh-ancestor
25078468|NCT03356080|Dermatologic Agents|dermatologic agents|mesh-ancestor
25078469|NCT03356054|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24958334|NCT03833999|Serotonin Agents|serotonin agents|mesh-ancestor
24958335|NCT03833999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24958336|NCT03833999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958337|NCT03833999|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24958338|NCT03833999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24958339|NCT03833999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24958340|NCT03833999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24958341|NCT03833999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24958383|NCT03833947|Dexamethasone|dexamethasone|mesh-list
24958384|NCT03833947|Lidocaine|lidocaine|mesh-list
24958385|NCT03833947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24958386|NCT03833947|Antiemetics|antiemetics|mesh-ancestor
24958387|NCT03833947|Autonomic Agents|autonomic agents|mesh-ancestor
24958388|NCT03833947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24958389|NCT03833947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958390|NCT03833947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24958422|NCT03833362|Interferons|interferons|mesh-list
24958423|NCT03833362|Ritonavir|ritonavir|mesh-list
24958424|NCT03833362|Ribavirin|ribavirin|mesh-list
24958425|NCT03833362|Interferon-alpha|interferon-alpha|mesh-list
24958426|NCT03833362|Interferon alpha-2|interferon alpha-2|mesh-list
24958427|NCT03833362|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24958428|NCT03833362|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24958429|NCT03833362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24958430|NCT03833362|Antiviral Agents|antiviral agents|mesh-ancestor
24958431|NCT03833362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24958432|NCT03833362|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24958480|NCT03832660|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24958481|NCT03832660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24958482|NCT03832660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24958483|NCT03832660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24958484|NCT03832660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958485|NCT03832816|Dronabinol|dronabinol|mesh-list
24958486|NCT03832816|Hallucinogens|hallucinogens|mesh-ancestor
24958487|NCT03832816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958488|NCT03832816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24958489|NCT03832816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24958490|NCT03832816|Analgesics|analgesics|mesh-ancestor
24958491|NCT03832816|Sensory System Agents|sensory system agents|mesh-ancestor
24784607|NCT01909089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24784609|NCT01909115|Ergocalciferols|ergocalciferols|mesh-list
24784610|NCT01909115|Cholecalciferol|cholecalciferol|mesh-list
24784611|NCT01909115|Vitamins|vitamins|mesh-list
24784612|NCT01909115|Micronutrients|micronutrients|mesh-ancestor
24784613|NCT01909115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784614|NCT01909115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24784615|NCT01909115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24784616|NCT01909219|Picosulfate sodium|picosulfate sodium|mesh-list
24784617|NCT01909219|Magnesium citrate|magnesium citrate|mesh-list
24784618|NCT01909219|Cathartics|cathartics|mesh-ancestor
24784619|NCT01909219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24626791|NCT01088737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626792|NCT01088737|Interferon Inducers|interferon inducers|mesh-ancestor
24626793|NCT01088750|Prednisolone|prednisolone|mesh-list
24647426|NCT01208818|Dexamethasone|dexamethasone|mesh-list
24626796|NCT01088750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24626797|NCT01088750|Immunologic Factors|immunologic factors|mesh-ancestor
24626798|NCT01088750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626799|NCT01088750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24626800|NCT01088750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24626801|NCT01088750|Alkylating Agents|alkylating agents|mesh-ancestor
24626802|NCT01088750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626803|NCT01088750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626804|NCT01088750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24958599|NCT03831126|Betamethasone|betamethasone|mesh-list
24958628|NCT03830827|Serotonin Agents|serotonin agents|mesh-ancestor
24958629|NCT03830827|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24958630|NCT03830827|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24958644|NCT03830957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24958645|NCT03830957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958646|NCT03830489|Ascorbic Acid|ascorbic acid|mesh-list
24958647|NCT03830489|Antioxidants|antioxidants|mesh-ancestor
24958648|NCT03830489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958649|NCT03830489|Protective Agents|protective agents|mesh-ancestor
24958650|NCT03830489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958652|NCT03830489|Micronutrients|micronutrients|mesh-ancestor
24958653|NCT03830684|Baicalein|baicalein|mesh-list
24958654|NCT03830684|Antioxidants|antioxidants|mesh-ancestor
24958655|NCT03830684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958656|NCT03830684|Protective Agents|protective agents|mesh-ancestor
24958657|NCT03830684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958658|NCT03830684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078496|NCT03355716|Anesthetics|anesthetics|mesh-ancestor
25078497|NCT03355716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24958695|NCT03830164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24958780|NCT03829839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24958781|NCT03829839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24958782|NCT03829839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24958783|NCT03829839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24958784|NCT03829839|GABA Modulators|gaba modulators|mesh-ancestor
24958785|NCT03829839|GABA Agents|gaba agents|mesh-ancestor
24958786|NCT03829839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24958787|NCT03829839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958788|NCT03829943|Vitamin D|vitamin d|mesh-list
24958789|NCT03829943|Vitamins|vitamins|mesh-ancestor
24958790|NCT03829943|Micronutrients|micronutrients|mesh-ancestor
24958791|NCT03829943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958944|NCT03828682|Mycophenolic Acid|mycophenolic acid|mesh-list
24958945|NCT03828682|Prednisone|prednisone|mesh-list
24958946|NCT03828682|Methylprednisolone|methylprednisolone|mesh-list
24958947|NCT03828682|Tacrolimus|tacrolimus|mesh-list
24958948|NCT03828682|Thymoglobulin|thymoglobulin|mesh-list
24958949|NCT03828682|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24958950|NCT03828682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24958951|NCT03828682|Glucocorticoids|glucocorticoids|mesh-ancestor
24958952|NCT03828682|Hormones|hormones|mesh-ancestor
24958953|NCT03828682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24958954|NCT03828682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958955|NCT03828682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24958956|NCT03828682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24958957|NCT03828682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25078502|NCT03355716|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25078503|NCT03355716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24958958|NCT03828682|Immunologic Factors|immunologic factors|mesh-ancestor
25078504|NCT03355716|Anesthetics, General|anesthetics, general|mesh-ancestor
25078505|NCT03355716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24958959|NCT03828682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24958960|NCT03828682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24958961|NCT03828682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958962|NCT03828682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24958963|NCT03828682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24958964|NCT03828682|Antitubercular Agents|antitubercular agents|mesh-ancestor
24959100|NCT03827200|Ambrisentan|ambrisentan|mesh-list
24626807|NCT01088750|Hormones|hormones|mesh-ancestor
24626808|NCT01088750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24626809|NCT01088750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24626810|NCT01088750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24626811|NCT01088750|Tubulin Modulators|tubulin modulators|mesh-ancestor
24626812|NCT01088750|Antimitotic Agents|antimitotic agents|mesh-ancestor
24626813|NCT01088750|Mitosis Modulators|mitosis modulators|mesh-ancestor
24626814|NCT01088763|Dexamethasone|dexamethasone|mesh-list
24626815|NCT01088763|R04929097|r04929097|mesh-list
24734372|NCT01651988|Anesthetics|anesthetics|mesh-ancestor
24626816|NCT01088763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24626817|NCT01088763|Antiemetics|antiemetics|mesh-ancestor
24626818|NCT01088763|Autonomic Agents|autonomic agents|mesh-ancestor
24626819|NCT01088763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24626820|NCT01088763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959130|NCT03826875|Fluoxetine|fluoxetine|mesh-list
24959131|NCT03826875|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24959132|NCT03826875|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24959133|NCT03826875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24959134|NCT03826875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959135|NCT03826875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24959136|NCT03826875|Serotonin Agents|serotonin agents|mesh-ancestor
24959137|NCT03826875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959138|NCT03826875|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24959278|NCT03825809|Autonomic Agents|autonomic agents|mesh-ancestor
24959279|NCT03825809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24959280|NCT03825809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24959281|NCT03825809|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24959282|NCT03825809|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24959283|NCT03825809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24959284|NCT03825809|Anesthetics, General|anesthetics, general|mesh-ancestor
24959285|NCT03825809|Anesthetics|anesthetics|mesh-ancestor
24959286|NCT03825809|GABA Modulators|gaba modulators|mesh-ancestor
24959287|NCT03825809|GABA Agents|gaba agents|mesh-ancestor
24959288|NCT03825601|Flumazenil|flumazenil|mesh-list
24959289|NCT03825601|Antidotes|antidotes|mesh-ancestor
24959290|NCT03825601|Protective Agents|protective agents|mesh-ancestor
24959291|NCT03825601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959292|NCT03825601|GABA Modulators|gaba modulators|mesh-ancestor
24959293|NCT03825601|GABA Agents|gaba agents|mesh-ancestor
24959294|NCT03825601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24959295|NCT03825601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959296|NCT03825471|Analgesics, Opioid|analgesics, opioid|mesh-list
24959297|NCT03825471|Anesthetics|anesthetics|mesh-list
24959298|NCT03825471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24959299|NCT03825471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959300|NCT03825471|Narcotics|narcotics|mesh-ancestor
24959301|NCT03825471|Analgesics|analgesics|mesh-ancestor
24959302|NCT03825471|Sensory System Agents|sensory system agents|mesh-ancestor
24888363|NCT04505943|Antimetabolites|antimetabolites|mesh-ancestor
24960076|NCT03819348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078543|NCT03355560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078544|NCT03355482|Methylprednisolone|methylprednisolone|mesh-list
24959333|NCT03825250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24959334|NCT03825250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888531|NCT04503460|Hormones|hormones|mesh-ancestor
24959458|NCT03824665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24959527|NCT03824314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24959528|NCT03824314|Narcotics|narcotics|mesh-ancestor
24959529|NCT03824314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24959530|NCT03824314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959532|NCT03824314|Sensory System Agents|sensory system agents|mesh-ancestor
24959533|NCT03824314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24959534|NCT03824314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24959535|NCT03824314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24959611|NCT03823612|Calcium|calcium|mesh-list
24959612|NCT03823612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25078559|NCT03355482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25078560|NCT03355482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25078561|NCT03355482|Protective Agents|protective agents|mesh-ancestor
25078562|NCT03355482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25078563|NCT03355482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25078564|NCT03355469|Metformin|metformin|mesh-list
25078565|NCT03355469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25078566|NCT03355469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078567|NCT03355352|Sufentanil|sufentanil|mesh-list
24959613|NCT03823612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959614|NCT03823638|Mannitol|mannitol|mesh-list
24959615|NCT03823638|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24959616|NCT03823638|Diuretics|diuretics|mesh-ancestor
24959617|NCT03823638|Natriuretic Agents|natriuretic agents|mesh-ancestor
24959618|NCT03823638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959655|NCT03823079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24959656|NCT03823079|Antimetabolites|antimetabolites|mesh-ancestor
24959691|NCT03823482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959692|NCT03823040|Oxiconazole|oxiconazole|mesh-list
24959693|NCT03823040|Antifungal Agents|antifungal agents|mesh-ancestor
24959694|NCT03823040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24959720|NCT03822962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24959721|NCT03822962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959722|NCT03822962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24959723|NCT03822962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24959741|NCT03822663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401184|NCT00152360|Orlistat|orlistat|mesh-list
24401232|NCT00152542|Antioxidants|antioxidants|mesh-ancestor
24959742|NCT03822663|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24959743|NCT03822663|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24959744|NCT03822663|Purinergic Agents|purinergic agents|mesh-ancestor
24959745|NCT03822663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24959782|NCT03822520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959783|NCT03822520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24959784|NCT03822520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959855|NCT03821701|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24959924|NCT03821168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888982|NCT04499209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24888983|NCT04499209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24888984|NCT04499209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24888985|NCT04499209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24888986|NCT04499209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24888987|NCT04499209|Gout Suppressants|gout suppressants|mesh-ancestor
24888989|NCT04499209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24959975|NCT03820193|Analgesics|analgesics|mesh-ancestor
24959976|NCT03820193|Sensory System Agents|sensory system agents|mesh-ancestor
24959977|NCT03820193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24959978|NCT03820193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959979|NCT03820193|Antipyretics|antipyretics|mesh-ancestor
24959985|NCT03820193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24960069|NCT03819348|Antifungal Agents|antifungal agents|mesh-list
24960070|NCT03819348|Clotrimazole|clotrimazole|mesh-list
24960071|NCT03819348|Miconazole|miconazole|mesh-list
25112606|NCT03989609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24960072|NCT03819348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25078602|NCT03355170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24960073|NCT03819348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24960074|NCT03819348|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24960075|NCT03819348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24960077|NCT03819348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960078|NCT03819348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24960079|NCT03819348|Hormone Antagonists|hormone antagonists|mesh-ancestor
24960189|NCT03818932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24960191|NCT03818932|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24960192|NCT03818932|Narcotics|narcotics|mesh-ancestor
24960193|NCT03818932|Antitussive Agents|antitussive agents|mesh-ancestor
24960194|NCT03818932|Respiratory System Agents|respiratory system agents|mesh-ancestor
24960195|NCT03818932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24960200|NCT03818932|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24960201|NCT03818932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24960202|NCT03818932|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24960203|NCT03818932|Anesthetics, General|anesthetics, general|mesh-ancestor
24960204|NCT03818932|Anesthetics|anesthetics|mesh-ancestor
24960205|NCT03818932|GABA Modulators|gaba modulators|mesh-ancestor
24960206|NCT03818932|GABA Agents|gaba agents|mesh-ancestor
24960207|NCT03818919|Acetaminophen|acetaminophen|mesh-list
24960208|NCT03818919|Celecoxib|celecoxib|mesh-list
24960209|NCT03818919|Ketorolac|ketorolac|mesh-list
24960210|NCT03818919|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
24960211|NCT03818919|Diazepam|diazepam|mesh-list
24960212|NCT03818919|Gabapentin|gabapentin|mesh-list
24960277|NCT03818282|Antimitotic Agents|antimitotic agents|mesh-ancestor
24778561|NCT01871662|Silybin|silybin|mesh-list
24960279|NCT03818282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960282|NCT03818308|Sofosbuvir|sofosbuvir|mesh-list
24960283|NCT03818308|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
24960284|NCT03818308|Velpatasvir|velpatasvir|mesh-list
24960285|NCT03818308|Antiviral Agents|antiviral agents|mesh-ancestor
24960286|NCT03818308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24960287|NCT03817970|Ondansetron|ondansetron|mesh-list
24960288|NCT03817970|Palonosetron|palonosetron|mesh-list
24960289|NCT03817970|Granisetron|granisetron|mesh-list
24960290|NCT03817970|Antiemetics|antiemetics|mesh-ancestor
24960291|NCT03817970|Autonomic Agents|autonomic agents|mesh-ancestor
24960292|NCT03817970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24960293|NCT03817970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960294|NCT03817970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24960295|NCT03817970|Antipruritics|antipruritics|mesh-ancestor
24786337|NCT01919255|Sodium Citrate|sodium citrate|mesh-list
24786338|NCT01919255|Citric Acid|citric acid|mesh-list
24786339|NCT01919255|Anticoagulants|anticoagulants|mesh-ancestor
24786340|NCT01919255|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24786341|NCT01919255|Chelating Agents|chelating agents|mesh-ancestor
24960325|NCT03817931|Urological Agents|urological agents|mesh-ancestor
24960419|NCT03817268|Capecitabine|capecitabine|mesh-list
24960420|NCT03817268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24960421|NCT03817268|Antimetabolites|antimetabolites|mesh-ancestor
24960422|NCT03817268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960423|NCT03817268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24960424|NCT03817112|Dexmedetomidine|dexmedetomidine|mesh-list
24960425|NCT03817112|Propofol|propofol|mesh-list
24960426|NCT03817112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24960431|NCT03817112|Anesthetics|anesthetics|mesh-ancestor
24960438|NCT03817112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24889451|NCT04493463|Antiemetics|antiemetics|mesh-ancestor
24960475|NCT03816618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24960476|NCT03816618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960478|NCT03816267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24889500|NCT04492813|Remifentanil|remifentanil|mesh-list
24960509|NCT03816072|Propofol|propofol|mesh-list
24960510|NCT03816072|Sevoflurane|sevoflurane|mesh-list
24960511|NCT03816072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24960512|NCT03816072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24960513|NCT03816072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960514|NCT03816072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24960515|NCT03816072|Anesthetics, General|anesthetics, general|mesh-ancestor
24960516|NCT03816072|Anesthetics|anesthetics|mesh-ancestor
24960517|NCT03816072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24960518|NCT03816072|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24960519|NCT03816072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24960520|NCT03816072|Mydriatics|mydriatics|mesh-ancestor
24960521|NCT03816072|Autonomic Agents|autonomic agents|mesh-ancestor
24889537|NCT04492319|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24960544|NCT03816046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24960546|NCT03815864|Immunoglobulins|immunoglobulins|mesh-list
24960547|NCT03815864|Immunologic Factors|immunologic factors|mesh-ancestor
24401297|NCT00152633|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24401326|NCT00152724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960548|NCT03815864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960549|NCT03815942|Nivolumab|nivolumab|mesh-list
24960550|NCT03815942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24786681|NCT01921361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960781|NCT03813784|Capecitabine|capecitabine|mesh-list
24960782|NCT03813784|Oxaliplatin|oxaliplatin|mesh-list
24960783|NCT03813784|Apatinib|apatinib|mesh-list
24960784|NCT03813784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24960785|NCT03813784|Antimetabolites|antimetabolites|mesh-ancestor
24960786|NCT03813784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960787|NCT03813784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24960788|NCT03813784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24960789|NCT03813784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24960790|NCT03813979|Dolutegravir|dolutegravir|mesh-list
25078641|NCT03354962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25078642|NCT03354962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25078643|NCT03354962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25078644|NCT03354962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078645|NCT03354897|Torsemide|torsemide|mesh-list
25078646|NCT03354897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25078647|NCT03354897|Diuretics|diuretics|mesh-ancestor
25078648|NCT03354897|Natriuretic Agents|natriuretic agents|mesh-ancestor
25078649|NCT03354897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078650|NCT03354897|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25078651|NCT03354897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25078652|NCT03354897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960836|NCT03813771|Abortifacient Agents|abortifacient agents|mesh-ancestor
24960837|NCT03813771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24960838|NCT03813771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960839|NCT03813771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24960840|NCT03813771|Antimetabolites|antimetabolites|mesh-ancestor
25405858|NCT03591510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24960841|NCT03813771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960842|NCT03813771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24960843|NCT03813771|Dermatologic Agents|dermatologic agents|mesh-ancestor
24960877|NCT03813394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24960878|NCT03813394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24960879|NCT03813394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24960880|NCT03813394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24960881|NCT03813394|Growth Substances|growth substances|mesh-ancestor
24960882|NCT03813394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960883|NCT03813394|Growth Inhibitors|growth inhibitors|mesh-ancestor
24961228|NCT03809702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961229|NCT03809702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24961230|NCT03810261|Vitamin D|vitamin d|mesh-list
24961231|NCT03810261|Ergocalciferols|ergocalciferols|mesh-list
24961232|NCT03810261|Cholecalciferol|cholecalciferol|mesh-list
24961234|NCT03810261|Micronutrients|micronutrients|mesh-ancestor
24961235|NCT03810261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961236|NCT03810261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24961237|NCT03810261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24961238|NCT03809897|Nicotine|nicotine|mesh-list
24961239|NCT03809897|Varenicline|varenicline|mesh-list
24961459|NCT03808259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24961460|NCT03808259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24961461|NCT03808259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961486|NCT03807999|Gemcitabine|gemcitabine|mesh-list
24961487|NCT03807999|Paclitaxel|paclitaxel|mesh-list
24961488|NCT03807999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24961489|NCT03807999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24961490|NCT03807999|Tubulin Modulators|tubulin modulators|mesh-ancestor
24961491|NCT03807999|Antimitotic Agents|antimitotic agents|mesh-ancestor
24961492|NCT03807999|Mitosis Modulators|mitosis modulators|mesh-ancestor
24961493|NCT03807999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961494|NCT03807999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24961495|NCT03807999|Antimetabolites|antimetabolites|mesh-ancestor
24961496|NCT03807999|Antiviral Agents|antiviral agents|mesh-ancestor
24961497|NCT03807999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24961498|NCT03807999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24961559|NCT03806816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961560|NCT03806816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961562|NCT03807011|Remifentanil|remifentanil|mesh-list
24961563|NCT03807011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24961564|NCT03807011|Narcotics|narcotics|mesh-ancestor
24961565|NCT03807011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961566|NCT03807011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961567|NCT03807011|Analgesics|analgesics|mesh-ancestor
24961568|NCT03807011|Sensory System Agents|sensory system agents|mesh-ancestor
24961569|NCT03807011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961570|NCT03807011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24961571|NCT03807011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24961573|NCT03807011|Anesthetics|anesthetics|mesh-ancestor
24961577|NCT03806673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961578|NCT03806673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961579|NCT03806673|Sensory System Agents|sensory system agents|mesh-ancestor
24961580|NCT03806673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961581|NCT03806595|Lidocaine|lidocaine|mesh-list
24961582|NCT03806595|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24961583|NCT03806595|Anesthetics, Local|anesthetics, local|mesh-ancestor
24961584|NCT03806595|Anesthetics|anesthetics|mesh-ancestor
24864523|NCT03589976|Sirolimus|sirolimus|mesh-list
24510492|NCT00564655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24961585|NCT03806595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961586|NCT03806595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961587|NCT03806595|Sensory System Agents|sensory system agents|mesh-ancestor
24961588|NCT03806595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961589|NCT03806595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24961590|NCT03806595|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24961591|NCT03806595|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24890493|NCT04482985|Meclizine|meclizine|mesh-list
25078695|NCT03354312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078696|NCT03354312|Sensory System Agents|sensory system agents|mesh-ancestor
25078697|NCT03354312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078698|NCT03354312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25078699|NCT03354312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25078700|NCT03354312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24736337|NCT01661335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24736338|NCT01661335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25078701|NCT03354312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25078702|NCT03354312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078703|NCT03354312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25078704|NCT03354312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25078705|NCT03354312|Adrenergic Agents|adrenergic agents|mesh-ancestor
25078706|NCT03354312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25078707|NCT03354312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25078712|NCT03354312|Mydriatics|mydriatics|mesh-ancestor
24961601|NCT03806777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961602|NCT03806777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24961603|NCT03806777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24961604|NCT03806777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24961605|NCT03806777|Adrenergic Agents|adrenergic agents|mesh-ancestor
24961606|NCT03806777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24961607|NCT03806777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078717|NCT03354117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24961719|NCT03806374|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24961720|NCT03806374|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24961721|NCT03806101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24961722|NCT03806101|Abrocitinib|abrocitinib|mesh-list
24961723|NCT03806101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24890692|NCT04481256|Paclitaxel|paclitaxel|mesh-list
24961785|NCT03805282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787863|NCT01928043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961945|NCT03803553|Nivolumab|nivolumab|mesh-list
24961946|NCT03803553|Irinotecan|irinotecan|mesh-list
24961947|NCT03803553|Cetuximab|cetuximab|mesh-list
24961948|NCT03803553|Antimetabolites|antimetabolites|mesh-ancestor
24961949|NCT03803553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961950|NCT03803553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24961951|NCT03803553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24961952|NCT03803553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24961953|NCT03803553|Immunologic Factors|immunologic factors|mesh-ancestor
24961954|NCT03803553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961955|NCT03803553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24961956|NCT03803553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24961957|NCT03803553|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24961958|NCT03803553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24961959|NCT03803553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24961960|NCT03803787|Budesonide|budesonide|mesh-list
24961961|NCT03803787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24961962|NCT03803787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24961963|NCT03803787|Autonomic Agents|autonomic agents|mesh-ancestor
24961964|NCT03803787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961965|NCT03803787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961966|NCT03803787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24961967|NCT03803787|Respiratory System Agents|respiratory system agents|mesh-ancestor
24961968|NCT03803787|Glucocorticoids|glucocorticoids|mesh-ancestor
24961969|NCT03803787|Hormones|hormones|mesh-ancestor
24961970|NCT03803787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24961971|NCT03803449|Fentanyl|fentanyl|mesh-list
24961972|NCT03803449|Midazolam|midazolam|mesh-list
24961973|NCT03803449|Propofol|propofol|mesh-list
24713461|NCT01526161|Xhance|xhance|mesh-list
24962000|NCT03803371|Sensory System Agents|sensory system agents|mesh-ancestor
24962012|NCT03803254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24962013|NCT03803254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24962014|NCT03803254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962015|NCT03803124|Tolvaptan|tolvaptan|mesh-list
24962016|NCT03803124|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24962017|NCT03803124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078720|NCT03354117|Sensory System Agents|sensory system agents|mesh-ancestor
25078721|NCT03354117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078722|NCT03354117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078723|NCT03354117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25078724|NCT03354117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25078747|NCT03353883|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25078748|NCT03353883|Contraceptive Agents|contraceptive agents|mesh-ancestor
25078749|NCT03353883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24512921|NCT00577668|Autonomic Agents|autonomic agents|mesh-ancestor
25685454|NCT01905943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25685455|NCT01906008|Minocycline|minocycline|mesh-list
24617845|NCT01045902|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24617847|NCT01045902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24617848|NCT01045902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24617849|NCT01045902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24617850|NCT01045902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617851|NCT01045902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123813|NCT03081676|Glimepiride|glimepiride|mesh-list
25123814|NCT03081676|Glucagon|glucagon|mesh-list
24512924|NCT00577668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25078750|NCT03353883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962018|NCT03803124|Natriuretic Agents|natriuretic agents|mesh-ancestor
24962019|NCT03803124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962021|NCT03803267|Propofol|propofol|mesh-list
24962022|NCT03803267|Atracurium|atracurium|mesh-list
24962023|NCT03803267|Anesthetics|anesthetics|mesh-ancestor
24962024|NCT03803267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24962025|NCT03803267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962026|NCT03803267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24962027|NCT03803267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24962028|NCT03803267|Anesthetics, General|anesthetics, general|mesh-ancestor
24962029|NCT03803267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24962030|NCT03803267|Narcotics|narcotics|mesh-ancestor
24962031|NCT03803267|Analgesics|analgesics|mesh-ancestor
24962032|NCT03803267|Sensory System Agents|sensory system agents|mesh-ancestor
24962033|NCT03803267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962034|NCT03803267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24962041|NCT03803267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24962042|NCT03803267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962129|NCT03802214|Vedolizumab|vedolizumab|mesh-list
24962130|NCT03802214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24962131|NCT03802162|Memantine|memantine|mesh-list
24962132|NCT03802162|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24962133|NCT03802162|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24962134|NCT03802162|Dopamine Agents|dopamine agents|mesh-ancestor
24962136|NCT03802162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962168|NCT03801733|Sulfasalazine|sulfasalazine|mesh-list
24962169|NCT03801733|Atorvastatin|atorvastatin|mesh-list
24962170|NCT03801733|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24962171|NCT03801733|Simvastatin|simvastatin|mesh-list
24962172|NCT03801733|Pravastatin|pravastatin|mesh-list
24962173|NCT03801733|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24962174|NCT03801733|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24962175|NCT03801733|Antimetabolites|antimetabolites|mesh-ancestor
24962176|NCT03801733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962177|NCT03801733|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24962178|NCT03801733|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24962215|NCT03801564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962216|NCT03801564|Viscosupplements|viscosupplements|mesh-ancestor
24962217|NCT03801564|Protective Agents|protective agents|mesh-ancestor
24962219|NCT03801590|Vitamin B Complex|vitamin b complex|mesh-ancestor
24962220|NCT03801590|Vitamins|vitamins|mesh-ancestor
24962221|NCT03801590|Micronutrients|micronutrients|mesh-ancestor
24962352|NCT03800433|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24962353|NCT03800433|Antioxidants|antioxidants|mesh-ancestor
24401658|NCT00153634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24401659|NCT00153634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539447|NCT00663897|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24962377|NCT03799536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962378|NCT03799406|Vitamin D|vitamin d|mesh-list
24962379|NCT03799406|Cholecalciferol|cholecalciferol|mesh-list
24962380|NCT03799406|Vitamins|vitamins|mesh-ancestor
24962381|NCT03799406|Micronutrients|micronutrients|mesh-ancestor
25685456|NCT01906008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25685457|NCT01906008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25685458|NCT01906346|Cocaine|cocaine|mesh-list
25685459|NCT01906346|Anesthetics, Local|anesthetics, local|mesh-ancestor
25685460|NCT01906346|Anesthetics|anesthetics|mesh-ancestor
25685461|NCT01906346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25685462|NCT01906346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685463|NCT01906346|Sensory System Agents|sensory system agents|mesh-ancestor
25685464|NCT01906346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962382|NCT03799406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962383|NCT03799406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25123840|NCT03081416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25123841|NCT03081416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123843|NCT03081416|Sensory System Agents|sensory system agents|mesh-ancestor
25123844|NCT03081416|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24653048|NCT01241682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123845|NCT03081416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25123846|NCT03081416|Anesthetics, General|anesthetics, general|mesh-ancestor
25123847|NCT03081416|Anesthetics|anesthetics|mesh-ancestor
25123848|NCT03081416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24962384|NCT03799406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24962385|NCT03799224|Decitabine|decitabine|mesh-list
24962386|NCT03799224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24962388|NCT03799224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962389|NCT03799224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962390|NCT03799224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24962391|NCT03799315|Nicotine|nicotine|mesh-list
25078753|NCT03353883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962392|NCT03799315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24962393|NCT03799315|Autonomic Agents|autonomic agents|mesh-ancestor
24962394|NCT03799315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962395|NCT03799315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962397|NCT03799315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24962398|NCT03799315|Cholinergic Agents|cholinergic agents|mesh-ancestor
24962399|NCT03799315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24962400|NCT03799315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962402|NCT03799172|Antifungal Agents|antifungal agents|mesh-ancestor
24891327|NCT04473053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24962421|NCT03798912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24962422|NCT03798912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24962423|NCT03798912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962424|NCT03798899|Methoxyflurane|methoxyflurane|mesh-list
24962425|NCT03798899|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24962426|NCT03798899|Anesthetics, General|anesthetics, general|mesh-ancestor
24962427|NCT03798899|Anesthetics|anesthetics|mesh-ancestor
24962428|NCT03798899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24962429|NCT03798899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962430|NCT03798834|Anesthetics|anesthetics|mesh-list
24962431|NCT03798834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24962432|NCT03798834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962433|NCT03798821|Sulfalene|sulfalene|mesh-list
24962434|NCT03798821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24962435|NCT03798821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24962436|NCT03798821|Renal Agents|renal agents|mesh-ancestor
24962437|NCT03798821|Antimalarials|antimalarials|mesh-ancestor
25078765|NCT03353857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25078766|NCT03353857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078767|NCT03353857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25078768|NCT03353857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25078769|NCT03353857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25078770|NCT03353857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25078771|NCT03353857|Anesthetics, General|anesthetics, general|mesh-ancestor
25078772|NCT03353857|Anesthetics|anesthetics|mesh-ancestor
25078773|NCT03353857|GABA Modulators|gaba modulators|mesh-ancestor
25078774|NCT03353857|GABA Agents|gaba agents|mesh-ancestor
25078775|NCT03353857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25078776|NCT03353857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446801|NCT00306020|Analgesics|analgesics|mesh-ancestor
24788478|NCT01931592|Fosfomycin|fosfomycin|mesh-list
24788479|NCT01931592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24788480|NCT01931592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24788481|NCT01931592|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24788482|NCT01931592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24962611|NCT03797443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25685465|NCT01906346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25685466|NCT01906346|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25685467|NCT01906346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25685468|NCT01906346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25685469|NCT01906346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685470|NCT01906346|Dopamine Agents|dopamine agents|mesh-ancestor
25685471|NCT01906346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25685472|NCT01906372|Hormones|hormones|mesh-list
25685473|NCT01906372|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24962612|NCT03797443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24962613|NCT03797443|Immunologic Factors|immunologic factors|mesh-ancestor
24962642|NCT03796572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962643|NCT03796533|Posaconazole|posaconazole|mesh-list
24962644|NCT03796533|Antifungal Agents|antifungal agents|mesh-ancestor
24962645|NCT03796533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24962646|NCT03796533|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24962647|NCT03796533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24962648|NCT03796533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24962649|NCT03796533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24962650|NCT03796533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24962651|NCT03796533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24963082|NCT03792971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24962652|NCT03796533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962653|NCT03796533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24962654|NCT03796533|Hormone Antagonists|hormone antagonists|mesh-ancestor
24788523|NCT01932151|Terlipressin|terlipressin|mesh-list
24962655|NCT03796533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24627628|NCT01094210|Fluorides|fluorides|mesh-list
24962656|NCT03796533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962657|NCT03796403|Diclofenac|diclofenac|mesh-list
24962658|NCT03796403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24962682|NCT03796364|Endostar protein|endostar protein|mesh-list
24962683|NCT03796364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24962684|NCT03796364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24962685|NCT03796364|Growth Substances|growth substances|mesh-ancestor
24962686|NCT03796364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962687|NCT03796364|Growth Inhibitors|growth inhibitors|mesh-ancestor
24962688|NCT03796364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962690|NCT03795909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24962691|NCT03795909|Antiemetics|antiemetics|mesh-ancestor
24962692|NCT03795909|Autonomic Agents|autonomic agents|mesh-ancestor
24962693|NCT03795909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962694|NCT03795909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962695|NCT03795909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24962696|NCT03795909|Glucocorticoids|glucocorticoids|mesh-ancestor
24962698|NCT03795909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24962699|NCT03795909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24962700|NCT03795909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962701|NCT03795844|Liver Extracts|liver extracts|mesh-list
24962702|NCT03795844|Hematinics|hematinics|mesh-ancestor
24962703|NCT03795792|Curcumin|curcumin|mesh-list
24962704|NCT03795792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24962753|NCT03795597|Melphalan|melphalan|mesh-list
24626888|NCT01089088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626889|NCT01089088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24626890|NCT01089088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24626891|NCT01089088|Growth Substances|growth substances|mesh-ancestor
24626892|NCT01089088|Growth Inhibitors|growth inhibitors|mesh-ancestor
24626893|NCT01089088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24626894|NCT01089140|Tranexamic Acid|tranexamic acid|mesh-list
24626895|NCT01089140|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24626896|NCT01089140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24626897|NCT01089140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962884|NCT03794492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24962886|NCT03794492|Autonomic Agents|autonomic agents|mesh-ancestor
24962887|NCT03794492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962888|NCT03794492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24962889|NCT03794492|Glucocorticoids|glucocorticoids|mesh-ancestor
24962890|NCT03794492|Hormones|hormones|mesh-ancestor
24962891|NCT03794492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24962892|NCT03794492|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24962893|NCT03794492|Protective Agents|protective agents|mesh-ancestor
24962894|NCT03794492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24962895|NCT03794596|Aspirin|aspirin|mesh-list
24962896|NCT03794596|Avelumab|avelumab|mesh-list
24962897|NCT03794596|Lansoprazole|lansoprazole|mesh-list
24962898|NCT03794596|Dexlansoprazole|dexlansoprazole|mesh-list
24962899|NCT03794596|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24962900|NCT03794596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24962901|NCT03794596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24963065|NCT03792828|Analgesics|analgesics|mesh-ancestor
24963066|NCT03792828|Sensory System Agents|sensory system agents|mesh-ancestor
24963067|NCT03792828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24963068|NCT03792828|Antidepressive Agents|antidepressive agents|mesh-ancestor
24963069|NCT03792828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24963070|NCT03792828|Dopamine Agents|dopamine agents|mesh-ancestor
24963072|NCT03792724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24963073|NCT03792724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24963074|NCT03792724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24963075|NCT03792724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963076|NCT03792971|Dextromethorphan|dextromethorphan|mesh-list
24963077|NCT03792971|Avasopasem manganese|avasopasem manganese|mesh-list
24963078|NCT03792971|Antitussive Agents|antitussive agents|mesh-ancestor
24963079|NCT03792971|Respiratory System Agents|respiratory system agents|mesh-ancestor
24963080|NCT03792971|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24963081|NCT03792971|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24963085|NCT03792971|Antioxidants|antioxidants|mesh-ancestor
24963200|NCT03792347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24963201|NCT03792347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24963202|NCT03792321|Methyltestosterone|methyltestosterone|mesh-list
24963203|NCT03792321|Testosterone|testosterone|mesh-list
24963204|NCT03792321|Testosterone undecanoate|testosterone undecanoate|mesh-list
24963205|NCT03792321|Testosterone enanthate|testosterone enanthate|mesh-list
24963206|NCT03792321|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24963207|NCT03792321|Androgens|androgens|mesh-ancestor
24401778|NCT00153998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24963209|NCT03792321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24963210|NCT03792321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963211|NCT03792321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24963212|NCT03792321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24963213|NCT03792321|Anabolic Agents|anabolic agents|mesh-ancestor
24963214|NCT03792009|Bupivacaine|bupivacaine|mesh-list
24963215|NCT03792009|Anesthetics, Local|anesthetics, local|mesh-ancestor
24963279|NCT03791918|Estrogens|estrogens|mesh-ancestor
24963281|NCT03791918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24963282|NCT03791918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24963283|NCT03791814|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
24963284|NCT03791814|Antiviral Agents|antiviral agents|mesh-ancestor
24963285|NCT03791814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24963286|NCT03791801|Glycopyrrolate|glycopyrrolate|mesh-list
24963287|NCT03791801|Rocuronium|rocuronium|mesh-list
24963288|NCT03791801|Neostigmine|neostigmine|mesh-list
24963289|NCT03791801|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24963290|NCT03791801|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24963291|NCT03791801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24963292|NCT03791801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24963293|NCT03791801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963316|NCT03791827|Cyclosporins|cyclosporins|mesh-list
24963325|NCT03791827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24963326|NCT03791827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24963327|NCT03791827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24963328|NCT03791827|Glucocorticoids|glucocorticoids|mesh-ancestor
24963329|NCT03791827|Hormones|hormones|mesh-ancestor
24963330|NCT03791827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24963331|NCT03791827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24963332|NCT03791827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24963390|NCT03791294|Hyaluronic Acid|hyaluronic acid|mesh-list
24963391|NCT03791294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24963392|NCT03791294|Immunologic Factors|immunologic factors|mesh-ancestor
24963393|NCT03791294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963394|NCT03791294|Viscosupplements|viscosupplements|mesh-ancestor
24963395|NCT03791294|Protective Agents|protective agents|mesh-ancestor
24963396|NCT03791294|Sunscreening Agents|sunscreening agents|mesh-ancestor
24963397|NCT03791294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24963437|NCT03790787|Empagliflozin|empagliflozin|mesh-list
24963438|NCT03790787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24963439|NCT03790787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963440|NCT03790787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24963458|NCT03790605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24963459|NCT03790605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963460|NCT03790605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24963462|NCT03790605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24963463|NCT03790605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24963464|NCT03790605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963466|NCT03790345|Vitamin B 12|vitamin b 12|mesh-list
24963467|NCT03790345|Pyridoxine|pyridoxine|mesh-list
24963468|NCT03790345|Vitamin B 6|vitamin b 6|mesh-list
24963469|NCT03790345|Vitamin B Complex|vitamin b complex|mesh-list
24963470|NCT03790345|Micronutrients|micronutrients|mesh-ancestor
24963471|NCT03790345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963472|NCT03790618|Methamphetamine|methamphetamine|mesh-list
24963473|NCT03790618|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
24963474|NCT03790618|Hallucinogens|hallucinogens|mesh-ancestor
24963475|NCT03790618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963476|NCT03790618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24963477|NCT03790618|Serotonin Agents|serotonin agents|mesh-ancestor
24963478|NCT03790618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24963479|NCT03790618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963480|NCT03790618|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24511601|NCT00569790|Growth Inhibitors|growth inhibitors|mesh-ancestor
24963484|NCT03790618|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24963485|NCT03790618|Sympathomimetics|sympathomimetics|mesh-ancestor
24963486|NCT03790618|Autonomic Agents|autonomic agents|mesh-ancestor
24963487|NCT03790618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24963488|NCT03790618|Dopamine Agents|dopamine agents|mesh-ancestor
24963489|NCT03790618|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24963490|NCT03790566|Bupivacaine|bupivacaine|mesh-list
24715197|NCT01535079|Ibuprofen|ibuprofen|mesh-list
24963551|NCT03790293|Immunologic Factors|immunologic factors|mesh-ancestor
24963552|NCT03790293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963553|NCT03790293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24963554|NCT03790020|Bupivacaine|bupivacaine|mesh-list
24963555|NCT03790020|Anesthetics, Local|anesthetics, local|mesh-ancestor
24963556|NCT03790020|Anesthetics|anesthetics|mesh-ancestor
24963655|NCT03789799|Titanium dioxide|titanium dioxide|mesh-list
24963656|NCT03789799|Sunscreening Agents|sunscreening agents|mesh-ancestor
24963657|NCT03789799|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24963658|NCT03789799|Protective Agents|protective agents|mesh-ancestor
24963659|NCT03789799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963660|NCT03789799|Dermatologic Agents|dermatologic agents|mesh-ancestor
24963661|NCT03789799|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24963663|NCT03789370|Sevoflurane|sevoflurane|mesh-list
24963685|NCT03789422|Histamine Antagonists|histamine antagonists|mesh-ancestor
24963686|NCT03789422|Histamine Agents|histamine agents|mesh-ancestor
24963687|NCT03789422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24963688|NCT03789422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963689|NCT03789422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24464994|NCT00367497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886208|NCT02766335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886215|NCT02675439|Ipilimumab|ipilimumab|mesh-list
24886216|NCT02675439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24963691|NCT03789123|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24963692|NCT03789123|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24963693|NCT03789123|Estradiol|estradiol|mesh-list
24963694|NCT03789123|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24963695|NCT03789123|Nandrolone|nandrolone|mesh-list
24963696|NCT03789123|Estrogens|estrogens|mesh-ancestor
24963697|NCT03789123|Hormones|hormones|mesh-ancestor
24963698|NCT03789123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24963699|NCT03789123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963700|NCT03789123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24963701|NCT03789123|Contraceptive Agents|contraceptive agents|mesh-ancestor
24963702|NCT03789123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24963703|NCT03789123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24865064|NCT04682288|Ofloxacin|ofloxacin|mesh-list
24963704|NCT03789123|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24963705|NCT03789123|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24963706|NCT03789123|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24963707|NCT03789123|Hormone Antagonists|hormone antagonists|mesh-ancestor
24963708|NCT03789123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24963709|NCT03789123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24963710|NCT03789123|Androgens|androgens|mesh-ancestor
24963711|NCT03789123|Anabolic Agents|anabolic agents|mesh-ancestor
24571002|NCT00807755|Etoposide|etoposide|mesh-list
24886234|NCT02432378|Cisplatin|cisplatin|mesh-list
24886235|NCT02432378|Vaccines|vaccines|mesh-list
24886236|NCT02432378|Immunologic Factors|immunologic factors|mesh-ancestor
24886237|NCT02432378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465007|NCT00367497|Hormones|hormones|mesh-ancestor
24511600|NCT00569790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886257|NCT02090998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24886258|NCT02090998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886259|NCT02090998|Sensory System Agents|sensory system agents|mesh-ancestor
24886261|NCT02090998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24963778|NCT03789032|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24963779|NCT03789032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24963780|NCT03789032|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24963781|NCT03789032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24963782|NCT03789032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963784|NCT03788733|Antioxidants|antioxidants|mesh-ancestor
24963785|NCT03788733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963786|NCT03788733|Protective Agents|protective agents|mesh-ancestor
24963787|NCT03788733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963788|NCT03788733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24963789|NCT03788694|Ketamine|ketamine|mesh-list
24963790|NCT03788694|Analgesics|analgesics|mesh-ancestor
24892804|NCT04458454|Methocarbamol|methocarbamol|mesh-list
24963827|NCT03788681|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25078877|NCT03353012|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24892843|NCT04458285|Valsartan|valsartan|mesh-list
24963900|NCT03788018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24963902|NCT03788018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24963903|NCT03788018|Adrenergic Agents|adrenergic agents|mesh-ancestor
24963904|NCT03788018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24963905|NCT03788174|Apatinib|apatinib|mesh-list
24963906|NCT03788174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24963907|NCT03788174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24963908|NCT03788174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24963909|NCT03788174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963910|NCT03787927|Aspirin|aspirin|mesh-list
24963911|NCT03787927|Clopidogrel|clopidogrel|mesh-list
24963912|NCT03787927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24963913|NCT03787927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24963914|NCT03787927|Analgesics|analgesics|mesh-ancestor
24963915|NCT03787927|Sensory System Agents|sensory system agents|mesh-ancestor
24963916|NCT03787927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24892972|NCT04455802|Analgesics|analgesics|mesh-ancestor
24963984|NCT03786757|Protease Inhibitors|protease inhibitors|mesh-ancestor
24963985|NCT03786757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24963986|NCT03786757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963989|NCT03787030|Tocopherols|tocopherols|mesh-list
24963990|NCT03787030|alpha-Tocopherol|alpha-tocopherol|mesh-list
24963991|NCT03787030|Nitroglycerin|nitroglycerin|mesh-list
24963992|NCT03787030|Vitamins|vitamins|mesh-ancestor
24963993|NCT03787030|Micronutrients|micronutrients|mesh-ancestor
24963994|NCT03787030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963995|NCT03787030|Antioxidants|antioxidants|mesh-ancestor
24963996|NCT03787030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963997|NCT03787030|Protective Agents|protective agents|mesh-ancestor
24964033|NCT03786120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964034|NCT03785873|Leucovorin|leucovorin|mesh-list
24964035|NCT03785873|Fluorouracil|fluorouracil|mesh-list
24964036|NCT03785873|Nivolumab|nivolumab|mesh-list
24964110|NCT03785223|Methylphenidate|methylphenidate|mesh-list
24964111|NCT03785223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24964112|NCT03785223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964113|NCT03785223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24964114|NCT03785223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24964115|NCT03785223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24964116|NCT03785223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964117|NCT03785223|Dopamine Agents|dopamine agents|mesh-ancestor
24964118|NCT03785223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24964120|NCT03785015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24964121|NCT03785015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24964122|NCT03785015|Analgesics|analgesics|mesh-ancestor
24964123|NCT03785015|Sensory System Agents|sensory system agents|mesh-ancestor
24964124|NCT03785015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25123973|NCT03080545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25123974|NCT03080545|Glucocorticoids|glucocorticoids|mesh-ancestor
25123975|NCT03080545|Hormones|hormones|mesh-ancestor
24964125|NCT03785015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964126|NCT03785015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24964127|NCT03785015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24964128|NCT03785015|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24964129|NCT03785015|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24964225|NCT03784443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24964228|NCT03784443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964230|NCT03784443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24964231|NCT03784443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24964234|NCT03784443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24964235|NCT03784378|Agerafenib|agerafenib|mesh-list
24964264|NCT03784014|Futibatinib|futibatinib|mesh-list
24964265|NCT03784014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24964266|NCT03784014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24964267|NCT03784014|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24964268|NCT03784014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24964269|NCT03784014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964270|NCT03784014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24964272|NCT03784261|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24964273|NCT03784261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964274|NCT03784261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24964275|NCT03784261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24964276|NCT03784261|Immunologic Factors|immunologic factors|mesh-ancestor
25078909|NCT03352700|Anesthetics, Local|anesthetics, local|mesh-ancestor
24964277|NCT03784261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964278|NCT03784261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24964279|NCT03783897|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24964280|NCT03783897|Norgestimate|norgestimate|mesh-list
24964281|NCT03783897|Contraceptive Agents|contraceptive agents|mesh-list
24964282|NCT03783897|Contraceptives, Oral|contraceptives, oral|mesh-list
24964283|NCT03783897|Estradiol|estradiol|mesh-list
24964284|NCT03783897|Estrogens|estrogens|mesh-ancestor
24964285|NCT03783897|Hormones|hormones|mesh-ancestor
24964315|NCT03783936|Trastuzumab|trastuzumab|mesh-list
24964316|NCT03783936|Avelumab|avelumab|mesh-list
24964317|NCT03783936|Antimetabolites|antimetabolites|mesh-ancestor
24964318|NCT03783936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964319|NCT03783936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24964320|NCT03783936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24964321|NCT03783936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24964322|NCT03783936|Immunologic Factors|immunologic factors|mesh-ancestor
24964323|NCT03783936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964324|NCT03783936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24964325|NCT03783936|Antidotes|antidotes|mesh-ancestor
24964326|NCT03783936|Protective Agents|protective agents|mesh-ancestor
24964327|NCT03783936|Vitamin B Complex|vitamin b complex|mesh-ancestor
24964328|NCT03783936|Vitamins|vitamins|mesh-ancestor
24964329|NCT03783936|Micronutrients|micronutrients|mesh-ancestor
24964330|NCT03784040|Nivolumab|nivolumab|mesh-list
25078918|NCT03352674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25078919|NCT03352674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078920|NCT03352479|Analgesics, Opioid|analgesics, opioid|mesh-list
25078943|NCT03352349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25078944|NCT03352349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25078945|NCT03352128|Calcium|calcium|mesh-list
25078946|NCT03352128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24964407|NCT03783455|Protective Agents|protective agents|mesh-ancestor
24964408|NCT03783520|Sodium Hypochlorite|sodium hypochlorite|mesh-list
24964410|NCT03783520|Disinfectants|disinfectants|mesh-ancestor
24964411|NCT03783520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24964412|NCT03783338|Vitamin D|vitamin d|mesh-list
24964413|NCT03783338|Vitamins|vitamins|mesh-ancestor
24964414|NCT03783338|Micronutrients|micronutrients|mesh-ancestor
24964415|NCT03783338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865151|NCT04308837|Hormones|hormones|mesh-ancestor
24521329|NCT04876937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24521411|NCT04791059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24521412|NCT04791059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521573|NCT04647435|Analgesics|analgesics|mesh-ancestor
24521677|NCT04605861|Hormones|hormones|mesh-ancestor
25685474|NCT01906372|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
25685475|NCT01906372|beta-Endorphin|beta-endorphin|mesh-list
25685476|NCT01906372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24521678|NCT04605861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24457790|NCT00335231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24457791|NCT00335231|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24964416|NCT03783338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24964417|NCT03783312|Acetaminophen|acetaminophen|mesh-list
24886264|NCT02090998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24964419|NCT03783312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24964420|NCT03783312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24964421|NCT03783312|Analgesics|analgesics|mesh-ancestor
24964422|NCT03783312|Sensory System Agents|sensory system agents|mesh-ancestor
24964423|NCT03783312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24964424|NCT03783312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964425|NCT03783312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24964426|NCT03783312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24964427|NCT03783312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24964428|NCT03783312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24964429|NCT03783312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964430|NCT03783312|Antipyretics|antipyretics|mesh-ancestor
24964432|NCT03783429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24964433|NCT03783429|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24964434|NCT03783429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893481|NCT04449185|Amoxicillin|amoxicillin|mesh-list
24790346|NCT01942174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790347|NCT01942174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24790348|NCT01942174|Dermatologic Agents|dermatologic agents|mesh-ancestor
24790349|NCT01942174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24964457|NCT03783299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24964458|NCT03783273|Vitamin D|vitamin d|mesh-list
24964489|NCT03782935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24964490|NCT03782935|Antimetabolites|antimetabolites|mesh-ancestor
24964491|NCT03782935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964492|NCT03782935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24964493|NCT03782935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24886265|NCT02090998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886266|NCT02090998|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24886267|NCT02090998|Antidepressive Agents|antidepressive agents|mesh-ancestor
24886268|NCT02090998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24886269|NCT02090998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24886270|NCT02090998|Analgesics|analgesics|mesh-ancestor
24886303|NCT01595061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511854|NCT00571285|Ergocalciferols|ergocalciferols|mesh-list
24511855|NCT00571285|Cholecalciferol|cholecalciferol|mesh-list
24511856|NCT00571285|Vitamins|vitamins|mesh-list
24511857|NCT00571285|Micronutrients|micronutrients|mesh-ancestor
24511858|NCT00571285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511859|NCT00571285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24511860|NCT00571285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24511861|NCT00571298|Gemcitabine|gemcitabine|mesh-list
24964494|NCT03782935|Nootropic Agents|nootropic agents|mesh-ancestor
24964495|NCT03782831|Antibodies|antibodies|mesh-list
24964561|NCT03782025|Micronutrients|micronutrients|mesh-ancestor
24762539|NCT01768663|Ciprofloxacin|ciprofloxacin|mesh-list
24964617|NCT03781596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964618|NCT03781596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24790471|NCT01943019|Linagliptin|linagliptin|mesh-list
24964619|NCT03781596|Respiratory System Agents|respiratory system agents|mesh-ancestor
24964621|NCT03781596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24964622|NCT03781596|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24964623|NCT03781596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24964624|NCT03781596|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24964625|NCT03781596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24964626|NCT03781596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964627|NCT03781674|Progesterone|progesterone|mesh-list
24964628|NCT03781674|Progestins|progestins|mesh-ancestor
24964629|NCT03781674|Hormones|hormones|mesh-ancestor
24964630|NCT03781674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24763006|NCT01770769|Tinzaparin|tinzaparin|mesh-list
24964631|NCT03781674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964632|NCT03781635|Ketamine|ketamine|mesh-list
24964633|NCT03781635|Analgesics|analgesics|mesh-ancestor
24964634|NCT03781635|Sensory System Agents|sensory system agents|mesh-ancestor
24964635|NCT03781635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24936291|NCT04042558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24964636|NCT03781635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964637|NCT03781635|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24964638|NCT03781635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24964639|NCT03781635|Anesthetics, General|anesthetics, general|mesh-ancestor
24964640|NCT03781635|Anesthetics|anesthetics|mesh-ancestor
24964641|NCT03781635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24511862|NCT00571298|Sodium thiosulfate|sodium thiosulfate|mesh-list
24511863|NCT00571298|Amifostine|amifostine|mesh-list
24511864|NCT00571298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511867|NCT00571298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511868|NCT00571298|Antiviral Agents|antiviral agents|mesh-ancestor
24511873|NCT00571298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511874|NCT00571298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24511875|NCT00571298|Protective Agents|protective agents|mesh-ancestor
24511877|NCT00571298|Antioxidants|antioxidants|mesh-ancestor
24511878|NCT00571298|Antitubercular Agents|antitubercular agents|mesh-ancestor
24511879|NCT00571298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24893699|NCT04447105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24964679|NCT03781700|Glucocorticoids|glucocorticoids|mesh-ancestor
24964680|NCT03781700|Hormones|hormones|mesh-ancestor
24626965|NCT01089621|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24626966|NCT01089621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24626967|NCT01089621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24763629|NCT01775540|Dexamethasone|dexamethasone|mesh-list
24763695|NCT01775839|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24763865|NCT01777867|Autonomic Agents|autonomic agents|mesh-ancestor
24626968|NCT01089621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24626969|NCT01089621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626970|NCT01089621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24626971|NCT01089621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626972|NCT01089621|Analgesics|analgesics|mesh-ancestor
24764215|NCT01780181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626973|NCT01089621|Sensory System Agents|sensory system agents|mesh-ancestor
24626974|NCT01089621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24627001|NCT01089933|Sensory System Agents|sensory system agents|mesh-ancestor
24627002|NCT01089933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24627003|NCT01089959|Esomeprazole|esomeprazole|mesh-list
24627004|NCT01089959|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24627005|NCT01089959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25078949|NCT03352115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25078950|NCT03352115|Glucocorticoids|glucocorticoids|mesh-ancestor
24627006|NCT01089959|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24627007|NCT01089959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627008|NCT01089959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627009|NCT01089985|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24627010|NCT01089985|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24627011|NCT01089998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24627012|NCT01089998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24627013|NCT01089998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627014|NCT01090037|Epoprostenol|epoprostenol|mesh-list
24627015|NCT01090037|Beraprost|beraprost|mesh-list
24964707|NCT03781115|Olanzapine|olanzapine|mesh-list
24964708|NCT03781115|Ziprasidone|ziprasidone|mesh-list
24964741|NCT03781011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24964742|NCT03781011|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24964743|NCT03781011|Nootropic Agents|nootropic agents|mesh-ancestor
24964744|NCT03780933|Ascorbic Acid|ascorbic acid|mesh-list
24964746|NCT03780933|Micronutrients|micronutrients|mesh-ancestor
24964747|NCT03780933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964748|NCT03780933|Antioxidants|antioxidants|mesh-ancestor
24964749|NCT03780933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964750|NCT03780933|Protective Agents|protective agents|mesh-ancestor
24964751|NCT03780673|Rifaximin|rifaximin|mesh-list
24964783|NCT03780556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24964784|NCT03780556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964785|NCT03780556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24964786|NCT03780556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24964787|NCT03780621|Andrographolide|andrographolide|mesh-list
24964788|NCT03780621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24470968|NCT00392691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25078966|NCT03351842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078968|NCT03351842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25078969|NCT03351751|PF-06372865|pf-06372865|mesh-list
25078970|NCT03351751|GABA Modulators|gaba modulators|mesh-ancestor
25078971|NCT03351751|GABA Agents|gaba agents|mesh-ancestor
24511925|NCT00571714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24511926|NCT00571714|Immunologic Factors|immunologic factors|mesh-ancestor
24511927|NCT00571714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511928|NCT00571714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24511975|NCT00571805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886381|NCT04526470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24886382|NCT04526470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886383|NCT04526470|Tubulin Modulators|tubulin modulators|mesh-ancestor
24886384|NCT04526470|Antimitotic Agents|antimitotic agents|mesh-ancestor
24886385|NCT04526470|Mitosis Modulators|mitosis modulators|mesh-ancestor
24886386|NCT04526470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512094|NCT00572689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886419|NCT04526210|Nootropic Agents|nootropic agents|mesh-ancestor
24886420|NCT04526210|Chelating Agents|chelating agents|mesh-ancestor
24886421|NCT04526210|Sequestering Agents|sequestering agents|mesh-ancestor
24886422|NCT04526210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24886423|NCT04526210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24816531|NCT02077556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24816532|NCT02077556|Glucocorticoids|glucocorticoids|mesh-ancestor
24816533|NCT02077556|Hormones|hormones|mesh-ancestor
24816534|NCT02077556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24816535|NCT02077556|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24816536|NCT02077556|Protective Agents|protective agents|mesh-ancestor
24816537|NCT02077556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24816538|NCT02077634|Prednisone|prednisone|mesh-list
25078972|NCT03351751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25078973|NCT03351751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078974|NCT03351751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078975|NCT03351686|Tranexamic Acid|tranexamic acid|mesh-list
24964822|NCT03780569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964824|NCT03780205|Methamphetamine|methamphetamine|mesh-list
24964825|NCT03780205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24964826|NCT03780205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964827|NCT03780205|Sympathomimetics|sympathomimetics|mesh-ancestor
24964828|NCT03780205|Autonomic Agents|autonomic agents|mesh-ancestor
24964829|NCT03780205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24964830|NCT03780205|Dopamine Agents|dopamine agents|mesh-ancestor
24964831|NCT03780205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24964832|NCT03780205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964833|NCT03780205|Adrenergic Agents|adrenergic agents|mesh-ancestor
24964834|NCT03780205|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24964835|NCT03780205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24964836|NCT03780205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24964868|NCT03780049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24964869|NCT03780049|Immunologic Factors|immunologic factors|mesh-ancestor
24964870|NCT03780049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964871|NCT03780049|Antidotes|antidotes|mesh-ancestor
24964872|NCT03780049|Protective Agents|protective agents|mesh-ancestor
24964873|NCT03780049|Vitamin B Complex|vitamin b complex|mesh-ancestor
24964874|NCT03780049|Vitamins|vitamins|mesh-ancestor
24964875|NCT03780049|Micronutrients|micronutrients|mesh-ancestor
24964903|NCT03779789|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24964904|NCT03779685|Anesthetics|anesthetics|mesh-list
24964905|NCT03779685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24964906|NCT03779685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627062|NCT01090466|Immunologic Factors|immunologic factors|mesh-ancestor
24964938|NCT03779464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24964939|NCT03779464|Antimetabolites|antimetabolites|mesh-ancestor
24964940|NCT03779464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964941|NCT03779464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24964942|NCT03779464|Antiviral Agents|antiviral agents|mesh-ancestor
24964943|NCT03779464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24964944|NCT03779464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24964945|NCT03779464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25078993|NCT03351517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24964946|NCT03779464|Immunologic Factors|immunologic factors|mesh-ancestor
24964947|NCT03779464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964949|NCT03779568|Anesthetics, Local|anesthetics, local|mesh-ancestor
24964950|NCT03779568|Anesthetics|anesthetics|mesh-ancestor
24964951|NCT03779568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24964952|NCT03779568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964953|NCT03779568|Sensory System Agents|sensory system agents|mesh-ancestor
24964954|NCT03779568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24964956|NCT03779659|Benzocaine|benzocaine|mesh-list
24964957|NCT03779659|Anesthetics, Local|anesthetics, local|mesh-list
24964958|NCT03779659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24964959|NCT03779659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964960|NCT03779659|Sensory System Agents|sensory system agents|mesh-ancestor
24964992|NCT03779282|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24964993|NCT03779282|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24964995|NCT03779282|Adrenergic Agents|adrenergic agents|mesh-ancestor
24964996|NCT03779282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24817124|NCT02081287|Inositol|inositol|mesh-list
24402256|NCT00156299|Dexamethasone|dexamethasone|mesh-list
24627072|NCT01090596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24627085|NCT01090648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24627086|NCT01090648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24627087|NCT01090648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24769427|NCT01814189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24769467|NCT01814423|Chloroquine|chloroquine|mesh-list
24769544|NCT01814618|Budesonide|budesonide|mesh-list
24769617|NCT01814865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24769770|NCT01816035|Trastuzumab|trastuzumab|mesh-list
24769865|NCT01816620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627088|NCT01090648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627090|NCT01090648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24627106|NCT01090661|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24627107|NCT01090661|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24627108|NCT01090661|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24627109|NCT01090661|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24627110|NCT01090661|Antimetabolites|antimetabolites|mesh-ancestor
24627111|NCT01090661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24627112|NCT01090700|Simeprevir|simeprevir|mesh-list
24627113|NCT01090700|Dexetimide|dexetimide|mesh-list
24627114|NCT01090700|Citalopram|citalopram|mesh-list
24627115|NCT01090700|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24627116|NCT01090700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24627117|NCT01090700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24627118|NCT01090700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627119|NCT01090700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24627120|NCT01090700|Serotonin Agents|serotonin agents|mesh-ancestor
24627121|NCT01090700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627122|NCT01090700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24627123|NCT01090700|Antidepressive Agents|antidepressive agents|mesh-ancestor
24627124|NCT01090700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24627125|NCT01090700|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24627126|NCT01090700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24627127|NCT01090700|Parasympatholytics|parasympatholytics|mesh-ancestor
24816539|NCT02077634|Abiraterone Acetate|abiraterone acetate|mesh-list
24816540|NCT02077634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24816541|NCT02077634|Glucocorticoids|glucocorticoids|mesh-ancestor
24816542|NCT02077634|Hormones|hormones|mesh-ancestor
24816543|NCT02077634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24816544|NCT02077634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816545|NCT02077634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24620570|NCT01057628|Ipragliflozin|ipragliflozin|mesh-list
24627128|NCT01090700|Autonomic Agents|autonomic agents|mesh-ancestor
24965038|NCT03779035|Gemcitabine|gemcitabine|mesh-list
24965039|NCT03779035|Capecitabine|capecitabine|mesh-list
24965040|NCT03779035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24965041|NCT03779035|Antimetabolites|antimetabolites|mesh-ancestor
24965042|NCT03779035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965043|NCT03779035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965044|NCT03779035|Antiviral Agents|antiviral agents|mesh-ancestor
24965045|NCT03779035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24965046|NCT03779035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24965047|NCT03779035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24965048|NCT03779035|Immunologic Factors|immunologic factors|mesh-ancestor
24965049|NCT03779035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965050|NCT03779191|Bevacizumab|bevacizumab|mesh-list
24965051|NCT03779191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24965052|NCT03779191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965076|NCT03779087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24965077|NCT03779087|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25124110|NCT03079427|Gemcitabine|gemcitabine|mesh-list
24965078|NCT03779100|Lenvatinib|lenvatinib|mesh-list
24965079|NCT03779100|Antibodies|antibodies|mesh-list
24816546|NCT02077634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816547|NCT02077634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24816548|NCT02077634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816549|NCT02077634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816560|NCT02077712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24816561|NCT02077712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24816562|NCT02077712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24816563|NCT02077712|Adrenergic Agents|adrenergic agents|mesh-ancestor
24816568|NCT02077751|Vitamins|vitamins|mesh-ancestor
24512282|NCT00573950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512283|NCT00573950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24512284|NCT00573950|Vasodilator Agents|vasodilator agents|mesh-ancestor
24512285|NCT00573950|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24512286|NCT00573950|Protective Agents|protective agents|mesh-ancestor
24512300|NCT00574015|Bupivacaine|bupivacaine|mesh-list
24512301|NCT00574015|Anesthetics, Local|anesthetics, local|mesh-ancestor
24886733|NCT04523467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24886763|NCT04522882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24886764|NCT04522882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886765|NCT04523064|Empagliflozin|empagliflozin|mesh-list
24886766|NCT04523064|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24886767|NCT04523064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886768|NCT04523064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24886769|NCT04523064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886793|NCT04522336|Antimetabolites|antimetabolites|mesh-ancestor
24965119|NCT03778619|Fludarabine|fludarabine|mesh-list
24965120|NCT03778619|Interleukin-2|interleukin-2|mesh-list
24965121|NCT03778619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24965122|NCT03778619|Immunologic Factors|immunologic factors|mesh-ancestor
24965123|NCT03778619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965124|NCT03778619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24965125|NCT03778619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24965126|NCT03778619|Alkylating Agents|alkylating agents|mesh-ancestor
24965127|NCT03778619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965128|NCT03778619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965129|NCT03778619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24481994|NCT00437476|Antiviral Agents|antiviral agents|mesh-ancestor
24965130|NCT03778619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24965131|NCT03778619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24965132|NCT03778619|Analgesics|analgesics|mesh-ancestor
24965133|NCT03778619|Sensory System Agents|sensory system agents|mesh-ancestor
24965134|NCT03778619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24965135|NCT03778645|Epinephrine|epinephrine|mesh-list
24965136|NCT03778645|Racepinephrine|racepinephrine|mesh-list
24965165|NCT03778359|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24965166|NCT03778359|Contraceptive Agents|contraceptive agents|mesh-ancestor
24965167|NCT03778359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24965168|NCT03778359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965169|NCT03778359|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24965170|NCT03778359|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24965171|NCT03778359|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24771044|NCT01824420|Mandelic Acids|mandelic acids|mesh-list
24965177|NCT03778359|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24965179|NCT03778359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24965180|NCT03778359|Hormones|hormones|mesh-ancestor
24965181|NCT03778502|Rivaroxaban|rivaroxaban|mesh-list
24965182|NCT03778502|Apixaban|apixaban|mesh-list
24965183|NCT03778502|Edoxaban|edoxaban|mesh-list
24965184|NCT03778502|Dabigatran|dabigatran|mesh-list
24965185|NCT03778502|Anticoagulants|anticoagulants|mesh-list
24965186|NCT03778502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24965187|NCT03778502|Antithrombins|antithrombins|mesh-ancestor
24965188|NCT03778502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24886794|NCT04522336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24886795|NCT04522336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24965189|NCT03778502|Protease Inhibitors|protease inhibitors|mesh-ancestor
24739759|NCT01683955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965190|NCT03778502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24965074|NCT03779087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079009|NCT03351361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079010|NCT03351322|Minoxidil|minoxidil|mesh-list
24965595|NCT03775655|Dexmedetomidine|dexmedetomidine|mesh-list
24965596|NCT03775655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24965597|NCT03775655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24965598|NCT03775655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791464|NCT04411940|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24791465|NCT04411940|Dopamine Agents|dopamine agents|mesh-ancestor
24791466|NCT04411940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24791467|NCT04411940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791468|NCT04411940|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24791469|NCT04411940|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24791470|NCT04411940|Parasympatholytics|parasympatholytics|mesh-ancestor
24791471|NCT04411940|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24791472|NCT04411940|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24791473|NCT04411940|Cholinergic Agents|cholinergic agents|mesh-ancestor
24791474|NCT04411940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24791475|NCT04411940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24965772|NCT03774693|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24965773|NCT03774693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24965774|NCT03774693|Anesthetics, General|anesthetics, general|mesh-ancestor
24965775|NCT03774836|Morphine|morphine|mesh-list
24965776|NCT03774836|Tramadol|tramadol|mesh-list
24894733|NCT05388188|Analgesics|analgesics|mesh-ancestor
24965844|NCT03773744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791695|NCT03559660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24791696|NCT03559660|Immunologic Factors|immunologic factors|mesh-ancestor
24779713|NCT01878357|Artenimol|artenimol|mesh-list
24886796|NCT04522336|Immunologic Factors|immunologic factors|mesh-ancestor
24886797|NCT04522336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886798|NCT04522466|Hydroxychloroquine|hydroxychloroquine|mesh-list
24791697|NCT03559660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791698|NCT03559660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24791699|NCT03532516|Brivaracetam|brivaracetam|mesh-list
24791700|NCT03532516|Anticonvulsants|anticonvulsants|mesh-ancestor
24791701|NCT03496662|Gemcitabine|gemcitabine|mesh-list
24791702|NCT03496662|Paclitaxel|paclitaxel|mesh-list
24791703|NCT03496662|Nivolumab|nivolumab|mesh-list
24791704|NCT03496662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24791705|NCT03496662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791706|NCT03496662|Tubulin Modulators|tubulin modulators|mesh-ancestor
24791707|NCT03496662|Antimitotic Agents|antimitotic agents|mesh-ancestor
24791708|NCT03496662|Mitosis Modulators|mitosis modulators|mesh-ancestor
24791709|NCT03496662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791710|NCT03496662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24791711|NCT03496662|Antimetabolites|antimetabolites|mesh-ancestor
24791712|NCT03496662|Antiviral Agents|antiviral agents|mesh-ancestor
24791713|NCT03496662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24965851|NCT03773744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24936292|NCT04042558|Immunologic Factors|immunologic factors|mesh-ancestor
24965971|NCT03772262|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24965972|NCT03772262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24965973|NCT03772262|Antimetabolites|antimetabolites|mesh-ancestor
24965974|NCT03772262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24965975|NCT03772262|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24965976|NCT03772262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24965977|NCT03772262|Diuretics|diuretics|mesh-ancestor
24965978|NCT03772262|Natriuretic Agents|natriuretic agents|mesh-ancestor
24965979|NCT03772262|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24965980|NCT03772262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24965981|NCT03772223|Budesonide|budesonide|mesh-list
24965982|NCT03772223|Albuterol|albuterol|mesh-list
24965983|NCT03772223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24965984|NCT03772223|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24886799|NCT04522466|Antimalarials|antimalarials|mesh-ancestor
24965986|NCT03772223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24965987|NCT03772223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965988|NCT03772223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24965989|NCT03772223|Respiratory System Agents|respiratory system agents|mesh-ancestor
24965990|NCT03772223|Glucocorticoids|glucocorticoids|mesh-ancestor
24965994|NCT03772223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25685477|NCT01906372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685478|NCT01906372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24739854|NCT01684774|Anesthetics|anesthetics|mesh-ancestor
24965995|NCT03772223|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24965996|NCT03772223|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24966000|NCT03772223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966002|NCT03772106|Sevoflurane|sevoflurane|mesh-list
24966003|NCT03772106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24966004|NCT03772106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24894816|NCT05387187|Pentoxifylline|pentoxifylline|mesh-list
24966033|NCT03771846|Antiviral Agents|antiviral agents|mesh-ancestor
24966034|NCT03771846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24966035|NCT03771846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966036|NCT03771846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24966037|NCT03771846|Immunologic Factors|immunologic factors|mesh-ancestor
24966038|NCT03771846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966039|NCT03771846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24966040|NCT03771846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24966041|NCT03771846|Antidotes|antidotes|mesh-ancestor
24966042|NCT03771846|Protective Agents|protective agents|mesh-ancestor
24966043|NCT03771846|Vitamin B Complex|vitamin b complex|mesh-ancestor
24966044|NCT03771846|Vitamins|vitamins|mesh-ancestor
24966045|NCT03771846|Micronutrients|micronutrients|mesh-ancestor
24966046|NCT03771755|Acetaminophen|acetaminophen|mesh-list
24966047|NCT03771755|Ibuprofen|ibuprofen|mesh-list
24770970|NCT01823770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886800|NCT04522466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24886801|NCT04522466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24512351|NCT00574470|Daclizumab|daclizumab|mesh-list
24886831|NCT04521868|Protective Agents|protective agents|mesh-ancestor
24886832|NCT04521868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886833|NCT04521868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886834|NCT04522050|Gemcitabine|gemcitabine|mesh-list
24886835|NCT04522050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886836|NCT04522050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24966048|NCT03771755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24966049|NCT03771755|Analgesics|analgesics|mesh-ancestor
24966050|NCT03771755|Sensory System Agents|sensory system agents|mesh-ancestor
24966051|NCT03771755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24966052|NCT03771755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079119|NCT03350334|Sensory System Agents|sensory system agents|mesh-ancestor
25079120|NCT03350334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25079121|NCT03350334|Antidepressive Agents|antidepressive agents|mesh-ancestor
24771060|NCT01824433|Fluoxetine|fluoxetine|mesh-list
24966215|NCT03770208|Sensory System Agents|sensory system agents|mesh-ancestor
24966216|NCT03770208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24483045|NCT00441532|Lidocaine|lidocaine|mesh-list
24966217|NCT03770208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24966218|NCT03770208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24966219|NCT03770208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24966220|NCT03770208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24966221|NCT03770208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966222|NCT03770000|Romidepsin|romidepsin|mesh-list
24966263|NCT03770013|Analgesics|analgesics|mesh-ancestor
24966264|NCT03770013|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24966265|NCT03770013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24966266|NCT03770013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24966267|NCT03770013|Adrenergic Agents|adrenergic agents|mesh-ancestor
24966268|NCT03770013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24966269|NCT03770013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966270|NCT03770013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24402495|NCT00157547|Paroxetine|paroxetine|mesh-list
24402496|NCT00157547|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24402497|NCT00157547|Sertraline|sertraline|mesh-list
24402498|NCT00157547|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25079214|NCT03349359|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25079215|NCT03349359|Antiviral Agents|antiviral agents|mesh-ancestor
25079216|NCT03349359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25079217|NCT03349346|Rituximab|rituximab|mesh-list
25079218|NCT03349346|Carboplatin|carboplatin|mesh-list
25079219|NCT03349346|Etoposide|etoposide|mesh-list
25079220|NCT03349346|Ifosfamide|ifosfamide|mesh-list
25079221|NCT03349346|Idelalisib|idelalisib|mesh-list
24886837|NCT04522050|Antimetabolites|antimetabolites|mesh-ancestor
24465335|NCT00369031|Antiviral Agents|antiviral agents|mesh-ancestor
25079222|NCT03349346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25079230|NCT03349346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25079231|NCT03349346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685479|NCT01906372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618090|NCT01046786|Antiemetics|antiemetics|mesh-ancestor
25079232|NCT03349346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25079233|NCT03349346|Alkylating Agents|alkylating agents|mesh-ancestor
25079234|NCT03349216|Anesthetics|anesthetics|mesh-list
25079235|NCT03349216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25079236|NCT03349216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079237|NCT03349190|Ulipristal acetate|ulipristal acetate|mesh-list
24895536|NCT03900949|Gemtuzumab|gemtuzumab|mesh-list
24896203|NCT01169259|Vitamin D|vitamin d|mesh-list
24965323|NCT03777930|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24965324|NCT03777930|Contraceptive Agents|contraceptive agents|mesh-ancestor
24965325|NCT03777930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24965326|NCT03777930|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24965327|NCT03777930|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24965328|NCT03777930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24965329|NCT03777930|Appetite Stimulants|appetite stimulants|mesh-ancestor
24760885|NCT01760226|Mitosis Modulators|mitosis modulators|mesh-ancestor
24965330|NCT03777930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24965331|NCT03777579|Paclitaxel|paclitaxel|mesh-list
24965332|NCT03777579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24965333|NCT03777579|Antibodies|antibodies|mesh-list
24628553|NCT01099722|Respiratory System Agents|respiratory system agents|mesh-ancestor
24628554|NCT01099748|Methadone|methadone|mesh-list
24817560|NCT02084563|Cytarabine|cytarabine|mesh-list
24550625|NCT00721487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24550626|NCT00721487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550655|NCT00721552|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24760066|NCT01756170|Mitosis Modulators|mitosis modulators|mesh-ancestor
24760067|NCT01756170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760069|NCT01756183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24760070|NCT01756183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760071|NCT01756183|Tubulin Modulators|tubulin modulators|mesh-ancestor
24760072|NCT01756183|Antimitotic Agents|antimitotic agents|mesh-ancestor
24760073|NCT01756183|Mitosis Modulators|mitosis modulators|mesh-ancestor
24760074|NCT01756183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760075|NCT01756248|Aflibercept|aflibercept|mesh-list
24402499|NCT00157547|Serotonin|serotonin|mesh-list
24402768|NCT00158457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24402769|NCT00158457|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24402770|NCT00158457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24760076|NCT01756248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25028316|NCT03611985|Taxane|taxane|mesh-list
24760077|NCT01756248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24760078|NCT01756248|Growth Substances|growth substances|mesh-ancestor
24760139|NCT01756443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24760140|NCT01756443|Respiratory System Agents|respiratory system agents|mesh-ancestor
24760142|NCT01756443|Sympathomimetics|sympathomimetics|mesh-ancestor
24760143|NCT01756443|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24760144|NCT01756495|Moxifloxacin|moxifloxacin|mesh-list
24936294|NCT04042714|Antimetabolites|antimetabolites|mesh-ancestor
24936295|NCT04042714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936296|NCT04042714|Antiviral Agents|antiviral agents|mesh-ancestor
24998360|NCT03069378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998364|NCT03018834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24760186|NCT01756638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760187|NCT01756638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24897935|NCT04420247|Chloroquine|chloroquine|mesh-list
24760221|NCT01756781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24760222|NCT01756781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24760223|NCT01756781|Anesthetics, General|anesthetics, general|mesh-ancestor
24760224|NCT01756781|Anesthetics|anesthetics|mesh-ancestor
24760225|NCT01756781|GABA Modulators|gaba modulators|mesh-ancestor
24760226|NCT01756781|GABA Agents|gaba agents|mesh-ancestor
24550997|NCT00723515|Fluorides|fluorides|mesh-list
24550998|NCT00723515|Sodium Fluoride|sodium fluoride|mesh-list
24760227|NCT01756781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24760228|NCT01756781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760229|NCT01756781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760298|NCT01757236|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24760299|NCT01757236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24760329|NCT01757262|Purinergic Agents|purinergic agents|mesh-ancestor
24760330|NCT01757262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25685480|NCT01906515|Chrysarobin|chrysarobin|mesh-list
24740104|NCT01686386|Hormones|hormones|mesh-ancestor
24760331|NCT01757262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760332|NCT01757262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551208|NCT00724542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551210|NCT00724581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24551211|NCT00724581|Vasodilator Agents|vasodilator agents|mesh-ancestor
24551212|NCT00724581|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24551213|NCT00724581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24898013|NCT04419038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24760365|NCT01757756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24760367|NCT01757756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24760414|NCT01757899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24760415|NCT01757899|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24760563|NCT01758666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24760564|NCT01758666|Abortifacient Agents|abortifacient agents|mesh-ancestor
24898194|NCT04417348|Tretinoin|tretinoin|mesh-list
24760884|NCT01760226|Antimitotic Agents|antimitotic agents|mesh-ancestor
24760886|NCT01760252|Capecitabine|capecitabine|mesh-list
24760887|NCT01760252|Oxaliplatin|oxaliplatin|mesh-list
24760888|NCT01760252|Irinotecan|irinotecan|mesh-list
24760889|NCT01760252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24760890|NCT01760252|Antimetabolites|antimetabolites|mesh-ancestor
24760891|NCT01760252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760918|NCT01760421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24760919|NCT01760421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760920|NCT01760421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760921|NCT01760421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24760922|NCT01760460|Oxazolidinones|oxazolidinones|mesh-list
24760923|NCT01760460|Anacetrapib|anacetrapib|mesh-list
24760924|NCT01760460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24760925|NCT01760460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24760926|NCT01760460|Antimetabolites|antimetabolites|mesh-ancestor
24760927|NCT01760460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898561|NCT04412538|Vaccines|vaccines|mesh-list
24760985|NCT01760642|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24760986|NCT01760642|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24761073|NCT01760863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24761074|NCT01760967|Dexmedetomidine|dexmedetomidine|mesh-list
24761075|NCT01760967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24761172|NCT01761487|Gentamicins|gentamicins|mesh-list
24761173|NCT01761487|Polymyxins|polymyxins|mesh-list
24761174|NCT01761487|Colistin|colistin|mesh-list
24761175|NCT01761487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24761176|NCT01761487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24761177|NCT01761487|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24761178|NCT01761487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761180|NCT01761513|Esomeprazole|esomeprazole|mesh-list
24761182|NCT01761513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24761236|NCT01761877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761237|NCT01761877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761238|NCT01761916|Clonidine|clonidine|mesh-list
24761239|NCT01761916|Captopril|captopril|mesh-list
24761240|NCT01761916|Analgesics|analgesics|mesh-ancestor
24761241|NCT01761916|Sensory System Agents|sensory system agents|mesh-ancestor
24761242|NCT01761916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24620140|NCT01055535|Plasminogen|plasminogen|mesh-list
24620141|NCT01055535|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24620142|NCT01055535|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24620143|NCT01055535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620144|NCT01055652|Dapagliflozin|dapagliflozin|mesh-list
24620145|NCT01055652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24620146|NCT01055652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620147|NCT01055652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24620148|NCT01055652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620149|NCT01055691|Metformin|metformin|mesh-list
24620150|NCT01055691|Dapagliflozin|dapagliflozin|mesh-list
24620151|NCT01055691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25685481|NCT01906515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24761356|NCT01762332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24761357|NCT01762332|Narcotics|narcotics|mesh-ancestor
24761360|NCT01762332|Analgesics|analgesics|mesh-ancestor
24761369|NCT01762436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24761370|NCT01762436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24761371|NCT01762436|Sympatholytics|sympatholytics|mesh-ancestor
24761372|NCT01762436|Autonomic Agents|autonomic agents|mesh-ancestor
24761373|NCT01762436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24761374|NCT01762436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761507|NCT01762891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24761508|NCT01762891|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24761509|NCT01762891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24761510|NCT01762891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761511|NCT01762891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761512|NCT01762995|Ferrous fumarate|ferrous fumarate|mesh-list
24761513|NCT01762995|Dolutegravir|dolutegravir|mesh-list
24761514|NCT01762995|Calcium Carbonate|calcium carbonate|mesh-list
24761515|NCT01762995|Calcium|calcium|mesh-list
24761516|NCT01762995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24761517|NCT01762995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761518|NCT01762995|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24761519|NCT01762995|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24761520|NCT01762995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761521|NCT01762995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761522|NCT01762995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24761523|NCT01762995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24761525|NCT01762995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24761526|NCT01762995|Antacids|antacids|mesh-ancestor
24761554|NCT01763424|Calcitriol|calcitriol|mesh-list
24761555|NCT01763424|Niacinamide|niacinamide|mesh-list
24761556|NCT01763424|Niacin|niacin|mesh-list
24761557|NCT01763424|Nicotinic Acids|nicotinic acids|mesh-list
24761558|NCT01763424|Calcipotriene|calcipotriene|mesh-list
24761559|NCT01763424|Vitamin B Complex|vitamin b complex|mesh-ancestor
24761560|NCT01763424|Vitamins|vitamins|mesh-ancestor
24761561|NCT01763424|Micronutrients|micronutrients|mesh-ancestor
24761562|NCT01763424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761570|NCT01763424|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24761628|NCT01763541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24761629|NCT01763541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761630|NCT01763541|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24761631|NCT01763541|Fertility Agents|fertility agents|mesh-ancestor
24761632|NCT01763541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24776049|NCT01856205|gamma-Globulins|gamma-globulins|mesh-list
24476176|NCT00413387|Autonomic Agents|autonomic agents|mesh-ancestor
24761700|NCT01763749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761742|NCT01764178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761743|NCT01764178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24761744|NCT01764230|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24761745|NCT01764230|Luteolytic Agents|luteolytic agents|mesh-ancestor
24761746|NCT01764230|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24761747|NCT01764230|Contraceptive Agents|contraceptive agents|mesh-ancestor
24761748|NCT01764230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24761749|NCT01764230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899317|NCT04404881|Growth Substances|growth substances|mesh-ancestor
24761858|NCT01764867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24761859|NCT01764867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24552778|NCT00727753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762091|NCT01766089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24762092|NCT01766089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762093|NCT01766089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24762095|NCT01766089|Sensory System Agents|sensory system agents|mesh-ancestor
24762096|NCT01766089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24762097|NCT01766089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24762098|NCT01766089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25685482|NCT01906515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24762102|NCT01766089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762105|NCT01766154|Tirofiban|tirofiban|mesh-list
24762106|NCT01766154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24762107|NCT01766154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24762108|NCT01766154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762145|NCT01766375|Dermatologic Agents|dermatologic agents|mesh-ancestor
24762205|NCT01766843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762206|NCT01766843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24762207|NCT01766843|Respiratory System Agents|respiratory system agents|mesh-ancestor
24762208|NCT01766843|Glucocorticoids|glucocorticoids|mesh-ancestor
24762209|NCT01766843|Hormones|hormones|mesh-ancestor
24762210|NCT01766843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24762211|NCT01766843|Sympathomimetics|sympathomimetics|mesh-ancestor
24762212|NCT01766843|Antidotes|antidotes|mesh-ancestor
24762213|NCT01766843|Protective Agents|protective agents|mesh-ancestor
24762214|NCT01766960|Morphine|morphine|mesh-list
24762215|NCT01766960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24762216|NCT01766960|Narcotics|narcotics|mesh-ancestor
24762266|NCT01767363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24762267|NCT01767363|Adrenergic Agents|adrenergic agents|mesh-ancestor
24762268|NCT01767363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24762269|NCT01767363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762270|NCT01767363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762271|NCT01767363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24762272|NCT01767363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899583|NCT04402320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762306|NCT01767545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24762307|NCT01767545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24762308|NCT01767545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24762309|NCT01767545|Growth Substances|growth substances|mesh-ancestor
24762310|NCT01767545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762311|NCT01767545|Growth Inhibitors|growth inhibitors|mesh-ancestor
24965934|NCT03772613|Calcium heparin|calcium heparin|mesh-list
24965935|NCT03772613|Anticoagulants|anticoagulants|mesh-ancestor
24965936|NCT03772613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24965937|NCT03772613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24965938|NCT03772613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965939|NCT03772990|Calcium|calcium|mesh-list
24965940|NCT03772990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24965941|NCT03772990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965942|NCT03772483|Anesthetics|anesthetics|mesh-list
24776746|NCT01859728|Gemcitabine|gemcitabine|mesh-list
24762406|NCT01768260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899662|NCT04401839|Oxytocin|oxytocin|mesh-list
25079890|NCT03344393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079891|NCT03344328|Bortezomib|bortezomib|mesh-list
25079892|NCT03344328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079893|NCT03344302|Oxytocin|oxytocin|mesh-list
25079894|NCT03344302|Oxytocics|oxytocics|mesh-ancestor
25079895|NCT03344302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25079896|NCT03344302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079899|NCT03344094|Interferons|interferons|mesh-list
25079900|NCT03344094|Interferon-beta|interferon-beta|mesh-list
25079901|NCT03344094|Ocrelizumab|ocrelizumab|mesh-list
25079902|NCT03344094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079903|NCT03344094|Antiviral Agents|antiviral agents|mesh-ancestor
25079904|NCT03344094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25079905|NCT03344094|Immunologic Factors|immunologic factors|mesh-ancestor
25079906|NCT03344094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776794|NCT01860014|Poractant alfa|poractant alfa|mesh-list
24762427|NCT01768273|GABA Modulators|gaba modulators|mesh-ancestor
24762428|NCT01768273|GABA Agents|gaba agents|mesh-ancestor
24762429|NCT01768273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24762430|NCT01768273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762467|NCT01768338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24762468|NCT01768351|Calcitriol|calcitriol|mesh-list
24762469|NCT01768351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24762470|NCT01768351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762496|NCT01768377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24762497|NCT01768377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24762498|NCT01768377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24762499|NCT01768377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079907|NCT03344042|Fentanyl|fentanyl|mesh-list
25685483|NCT01906515|Analgesics|analgesics|mesh-ancestor
24762500|NCT01768377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24762502|NCT01768377|Analgesics|analgesics|mesh-ancestor
24762503|NCT01768377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24762504|NCT01768377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24762505|NCT01768377|Anesthetics, General|anesthetics, general|mesh-ancestor
24762506|NCT01768377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24762507|NCT01768377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24762508|NCT01768377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24762509|NCT01768377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24762510|NCT01768377|GABA Modulators|gaba modulators|mesh-ancestor
24762511|NCT01768377|GABA Agents|gaba agents|mesh-ancestor
24762512|NCT01768377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24762513|NCT01768390|Fluorides|fluorides|mesh-list
24762514|NCT01768390|Cariostatic Agents|cariostatic agents|mesh-ancestor
24762515|NCT01768390|Protective Agents|protective agents|mesh-ancestor
24762516|NCT01768390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762517|NCT01768455|Glimepiride|glimepiride|mesh-list
24762518|NCT01768455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24762519|NCT01768455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24762520|NCT01768455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899746|NCT04400890|Antioxidants|antioxidants|mesh-ancestor
24762550|NCT01768663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24762551|NCT01768663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762552|NCT01768663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24762553|NCT01768663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24403165|NCT00159484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24403166|NCT00159484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403167|NCT00159484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24762554|NCT01768663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24607407|NCT04665037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24762557|NCT01768663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24762558|NCT01768663|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24762559|NCT01768663|Antitubercular Agents|antitubercular agents|mesh-ancestor
24762560|NCT01768663|Leprostatic Agents|leprostatic agents|mesh-ancestor
24762561|NCT01768663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24762562|NCT01768663|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24762563|NCT01768663|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24762591|NCT01768780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24762592|NCT01768780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762594|NCT01768780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24762595|NCT01768780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24762596|NCT01768780|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24762597|NCT01768780|Cholinergic Agents|cholinergic agents|mesh-ancestor
24762598|NCT01768780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24762600|NCT01768884|Nitric Oxide|nitric oxide|mesh-list
24762601|NCT01768884|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24762602|NCT01768884|Autonomic Agents|autonomic agents|mesh-ancestor
24762603|NCT01768884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24762604|NCT01768884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762605|NCT01768884|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24762606|NCT01768884|Respiratory System Agents|respiratory system agents|mesh-ancestor
24762648|NCT01768988|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24762649|NCT01768988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24762650|NCT01768988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24762651|NCT01768988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24762652|NCT01769027|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24762653|NCT01769027|Azithromycin|azithromycin|mesh-list
24762654|NCT01769027|Penicillins|penicillins|mesh-list
24762655|NCT01769027|Penicillin G Benzathine|penicillin g benzathine|mesh-list
24762656|NCT01769027|Sertraline|sertraline|mesh-list
24899912|NCT04398927|Folfirinox|folfirinox|mesh-list
24762691|NCT01769118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762757|NCT01769664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24762758|NCT01769664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24762759|NCT01769664|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24762760|NCT01769664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762761|NCT01769664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762762|NCT01769664|Dermatologic Agents|dermatologic agents|mesh-ancestor
24762763|NCT01769677|Hydrocodone|hydrocodone|mesh-list
24762764|NCT01769677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24762765|NCT01769677|Narcotics|narcotics|mesh-ancestor
24740907|NCT01690598|Topotecan|topotecan|mesh-list
24762766|NCT01769677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24762767|NCT01769677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762768|NCT01769677|Analgesics|analgesics|mesh-ancestor
24762769|NCT01769677|Sensory System Agents|sensory system agents|mesh-ancestor
24620851|NCT01059396|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24899988|NCT04398316|Hydromorphone|hydromorphone|mesh-list
24762796|NCT01769781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24762797|NCT01769781|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24762798|NCT01769781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24553583|NCT00732121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762799|NCT01769781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762800|NCT01769781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762801|NCT01769781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24762802|NCT01769781|Hormone Antagonists|hormone antagonists|mesh-ancestor
24762803|NCT01769781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24762804|NCT01769781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762806|NCT01769820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24762807|NCT01769820|Antiemetics|antiemetics|mesh-ancestor
24762808|NCT01769820|Autonomic Agents|autonomic agents|mesh-ancestor
24886838|NCT04522050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886839|NCT04522050|Antiviral Agents|antiviral agents|mesh-ancestor
24886989|NCT04521140|Prednisolone acetate|prednisolone acetate|mesh-list
24886990|NCT04521140|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24886991|NCT04521140|Prednisolone phosphate|prednisolone phosphate|mesh-list
24886992|NCT04521140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24886993|NCT04521140|Antiemetics|antiemetics|mesh-ancestor
24886994|NCT04521140|Autonomic Agents|autonomic agents|mesh-ancestor
24886995|NCT04521140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24887039|NCT04520919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24887040|NCT04520919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887041|NCT04520503|Propofol|propofol|mesh-list
24887042|NCT04520503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24887043|NCT04520503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24816589|NCT02077803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816590|NCT02077920|Chlorhexidine|chlorhexidine|mesh-list
24762809|NCT01769820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24762810|NCT01769820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762811|NCT01769820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24762812|NCT01769820|Glucocorticoids|glucocorticoids|mesh-ancestor
24762813|NCT01769820|Hormones|hormones|mesh-ancestor
24762814|NCT01769820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24762815|NCT01769820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24965953|NCT03772262|Furosemide|furosemide|mesh-list
24965954|NCT03772262|Midazolam|midazolam|mesh-list
24965970|NCT03772262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079929|NCT03343977|Mitosis Modulators|mitosis modulators|mesh-ancestor
25079930|NCT03343977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079932|NCT03343873|Dexmedetomidine|dexmedetomidine|mesh-list
25079933|NCT03343873|Propofol|propofol|mesh-list
25079934|NCT03343873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25079935|NCT03343873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25079948|NCT03343873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25079949|NCT03343873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079950|NCT03343873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25079951|NCT03343873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25079952|NCT03343873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25079953|NCT03343873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25079954|NCT03343873|GABA Modulators|gaba modulators|mesh-ancestor
25079955|NCT03343873|GABA Agents|gaba agents|mesh-ancestor
25079956|NCT03343795|Progesterone|progesterone|mesh-list
25079957|NCT03343795|Progestins|progestins|mesh-ancestor
24777239|NCT01863173|Metoprolol|metoprolol|mesh-list
24762843|NCT01769898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24762844|NCT01769898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762845|NCT01769898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24762846|NCT01769898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762847|NCT01769898|Vasodilator Agents|vasodilator agents|mesh-ancestor
24762848|NCT01769898|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24762849|NCT01769898|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24762851|NCT01769911|Cytarabine|cytarabine|mesh-list
24762854|NCT01769911|Melphalan|melphalan|mesh-list
24762855|NCT01769911|Carmustine|carmustine|mesh-list
24762856|NCT01769911|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
25685484|NCT01906515|Sensory System Agents|sensory system agents|mesh-ancestor
24741001|NCT01691001|Dexmedetomidine|dexmedetomidine|mesh-list
24741002|NCT01691001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24741003|NCT01691001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24741004|NCT01691001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741005|NCT01691001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24741006|NCT01691001|Analgesics|analgesics|mesh-ancestor
24762857|NCT01769911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24762858|NCT01769911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24762859|NCT01769911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24762860|NCT01769911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24762861|NCT01769911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553646|NCT00732446|Protease Inhibitors|protease inhibitors|mesh-ancestor
24762862|NCT01769911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762863|NCT01769911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24762864|NCT01769911|Antimetabolites|antimetabolites|mesh-ancestor
24762865|NCT01769911|Antiviral Agents|antiviral agents|mesh-ancestor
24762866|NCT01769911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24762867|NCT01769911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24762868|NCT01769911|Immunologic Factors|immunologic factors|mesh-ancestor
24762869|NCT01769911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762870|NCT01769911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24762871|NCT01769911|Alkylating Agents|alkylating agents|mesh-ancestor
24762872|NCT01769911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24762873|NCT01769950|Choline|choline|mesh-list
24762874|NCT01769950|Lipotropic Agents|lipotropic agents|mesh-ancestor
24762875|NCT01769950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24762876|NCT01769950|Antimetabolites|antimetabolites|mesh-ancestor
24762877|NCT01769950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762878|NCT01769950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24762879|NCT01769950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24762880|NCT01769950|Nootropic Agents|nootropic agents|mesh-ancestor
24762881|NCT01770041|Acetaminophen|acetaminophen|mesh-list
24556101|NCT00745004|Antipruritics|antipruritics|mesh-ancestor
24762919|NCT01770171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24762920|NCT01770171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24762921|NCT01770171|Tubulin Modulators|tubulin modulators|mesh-ancestor
24762922|NCT01770171|Antimitotic Agents|antimitotic agents|mesh-ancestor
24762923|NCT01770171|Mitosis Modulators|mitosis modulators|mesh-ancestor
24762924|NCT01770171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762925|NCT01770171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24762926|NCT01770171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24762927|NCT01770171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24762928|NCT01770171|Growth Substances|growth substances|mesh-ancestor
24762929|NCT01770171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762930|NCT01770171|Growth Inhibitors|growth inhibitors|mesh-ancestor
24762931|NCT01770197|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24762932|NCT01770197|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24762933|NCT01770197|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24762934|NCT01770197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762980|NCT01770444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762982|NCT01770470|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24762983|NCT01770470|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24762984|NCT01770470|Antimetabolites|antimetabolites|mesh-ancestor
24762985|NCT01770470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900179|NCT04396938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24763025|NCT01770899|Montelukast|montelukast|mesh-list
24763026|NCT01770899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24763063|NCT01771146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763064|NCT01771185|Metformin|metformin|mesh-list
24763090|NCT01771406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24763091|NCT01771406|Vasodilator Agents|vasodilator agents|mesh-ancestor
24763092|NCT01771406|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24763093|NCT01771406|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24763094|NCT01771406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24763095|NCT01771406|Adrenergic Agents|adrenergic agents|mesh-ancestor
24763096|NCT01771406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24763097|NCT01771406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685485|NCT01906515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25685486|NCT01906515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685487|NCT01906515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25685488|NCT01906515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25685489|NCT01906658|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25685490|NCT01906658|Hormones|hormones|mesh-ancestor
24816591|NCT02077920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24816592|NCT02077920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24763106|NCT01771458|Sorafenib|sorafenib|mesh-list
24763107|NCT01771458|Letrozole|letrozole|mesh-list
24763108|NCT01771458|Dasatinib|dasatinib|mesh-list
24763109|NCT01771458|Lapatinib|lapatinib|mesh-list
24763110|NCT01771458|Vemurafenib|vemurafenib|mesh-list
24763111|NCT01771458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24763112|NCT01771458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24763113|NCT01771458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24763114|NCT01771458|Immunologic Factors|immunologic factors|mesh-ancestor
24763115|NCT01771458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763116|NCT01771458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24763117|NCT01771458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900282|NCT04395989|Paclitaxel|paclitaxel|mesh-list
24763151|NCT01771783|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24763152|NCT01771783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763153|NCT01771783|Protease Inhibitors|protease inhibitors|mesh-ancestor
24763154|NCT01771822|Ibuprofen|ibuprofen|mesh-list
24763155|NCT01771822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24763156|NCT01771822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24763206|NCT01772212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763207|NCT01772212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553934|NCT00733473|Budesonide|budesonide|mesh-list
24572178|NCT00813527|Fenofibrate|fenofibrate|mesh-list
24816593|NCT02077920|Disinfectants|disinfectants|mesh-ancestor
24816594|NCT02077933|Everolimus|everolimus|mesh-list
24816595|NCT02077933|Exemestane|exemestane|mesh-list
24887096|NCT04520178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24620191|NCT01055795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24620192|NCT01055795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24620193|NCT01055795|Growth Substances|growth substances|mesh-ancestor
24620194|NCT01055795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620195|NCT01055795|Growth Inhibitors|growth inhibitors|mesh-ancestor
24620196|NCT01055795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24620197|NCT01055795|Immunologic Factors|immunologic factors|mesh-ancestor
24620198|NCT01055795|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24620199|NCT01055795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25079965|NCT03343665|Nivolumab|nivolumab|mesh-list
25079966|NCT03343665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25079967|NCT03343665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079968|NCT03343665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25079969|NCT03343665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079971|NCT03343652|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25079972|NCT03343652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25079973|NCT03343652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079974|NCT03343652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25080009|NCT03343418|Coagulants|coagulants|mesh-ancestor
25080010|NCT03343418|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25080011|NCT03343418|Natriuretic Agents|natriuretic agents|mesh-ancestor
25080012|NCT03343418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080013|NCT03343366|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25080014|NCT03343366|Metronidazole|metronidazole|mesh-list
24620259|NCT01056172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620261|NCT01056172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24620262|NCT01056172|Immunologic Factors|immunologic factors|mesh-ancestor
24403497|NCT00160550|Nootropic Agents|nootropic agents|mesh-ancestor
24763208|NCT01772238|Amoxicillin|amoxicillin|mesh-list
24620263|NCT01056172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039922|NCT03594058|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24887214|NCT04518618|Anesthetics, General|anesthetics, general|mesh-ancestor
24887215|NCT04518618|Anesthetics|anesthetics|mesh-ancestor
24887216|NCT04518618|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24887217|NCT04518982|Lenalidomide|lenalidomide|mesh-list
24887218|NCT04518982|Immunologic Factors|immunologic factors|mesh-ancestor
24887219|NCT04518982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887262|NCT04518202|Sensory System Agents|sensory system agents|mesh-ancestor
24887263|NCT04518202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24887264|NCT04518202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24887266|NCT04518202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24709650|NCT01506557|Vitamins|vitamins|mesh-ancestor
24763209|NCT01772238|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24763210|NCT01772238|Clavulanic Acids|clavulanic acids|mesh-list
24763211|NCT01772238|Clavulanic Acid|clavulanic acid|mesh-list
24763212|NCT01772238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24763213|NCT01772238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24763214|NCT01772238|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24741454|NCT05288738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741456|NCT05288738|Analgesics|analgesics|mesh-ancestor
24741457|NCT05288738|Sensory System Agents|sensory system agents|mesh-ancestor
24741458|NCT05288738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24741459|NCT05288738|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24741460|NCT05288738|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24741461|NCT05288738|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24763215|NCT01772238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900435|NCT04394143|Diuretics|diuretics|mesh-ancestor
24763244|NCT01772381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763245|NCT01772381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24763246|NCT01772381|Glucocorticoids|glucocorticoids|mesh-ancestor
24763247|NCT01772381|Hormones|hormones|mesh-ancestor
24763248|NCT01772381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24763249|NCT01772381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24763250|NCT01772381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24763251|NCT01772420|Lenalidomide|lenalidomide|mesh-list
24763252|NCT01772420|Immunologic Factors|immunologic factors|mesh-ancestor
24763253|NCT01772420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763254|NCT01772420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24763255|NCT01772420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24763256|NCT01772420|Growth Substances|growth substances|mesh-ancestor
24763257|NCT01772420|Growth Inhibitors|growth inhibitors|mesh-ancestor
24763258|NCT01772420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24763333|NCT01772979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763334|NCT01772979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24763335|NCT01773005|Acetaminophen|acetaminophen|mesh-list
24763336|NCT01773005|Ibuprofen|ibuprofen|mesh-list
24763337|NCT01773005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24763338|NCT01773005|Analgesics|analgesics|mesh-ancestor
24763339|NCT01773005|Sensory System Agents|sensory system agents|mesh-ancestor
24763340|NCT01773005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24763341|NCT01773005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763342|NCT01773005|Antipyretics|antipyretics|mesh-ancestor
24763344|NCT01773005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25028684|NCT03608761|Rebamipide|rebamipide|mesh-list
24763350|NCT01773044|Anesthetics, Local|anesthetics, local|mesh-ancestor
24763352|NCT01773044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24763353|NCT01773044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763354|NCT01773044|Sensory System Agents|sensory system agents|mesh-ancestor
24620228|NCT01055964|Tacrolimus|tacrolimus|mesh-list
24763355|NCT01773044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24763356|NCT01773044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24763357|NCT01773044|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24763358|NCT01773044|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24763389|NCT01773408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24763390|NCT01773408|Antiviral Agents|antiviral agents|mesh-ancestor
24763392|NCT01773408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24763393|NCT01773408|Immunologic Factors|immunologic factors|mesh-ancestor
24763394|NCT01773408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763395|NCT01773408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24763396|NCT01773408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24763397|NCT01773408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24763398|NCT01773408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763399|NCT01773460|Everolimus|everolimus|mesh-list
24763400|NCT01773460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24763401|NCT01773460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24763402|NCT01773460|Immunologic Factors|immunologic factors|mesh-ancestor
24763403|NCT01773460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763404|NCT01773512|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24763436|NCT01773616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763437|NCT01773616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887268|NCT04518202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887269|NCT04518189|Lidocaine|lidocaine|mesh-list
24887270|NCT04518189|Anesthetics, Local|anesthetics, local|mesh-ancestor
24887271|NCT04518189|Anesthetics|anesthetics|mesh-ancestor
25685491|NCT01906658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25685492|NCT01906658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685493|NCT01906866|Melatonin|melatonin|mesh-list
25685494|NCT01906866|Antioxidants|antioxidants|mesh-ancestor
25685495|NCT01906866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685496|NCT01906866|Protective Agents|protective agents|mesh-ancestor
25685497|NCT01906866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685498|NCT01906866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24741604|NCT05291104|Folic Acid|folic acid|mesh-list
24741606|NCT05291104|Hematinics|hematinics|mesh-ancestor
24741607|NCT05291104|Vitamin B Complex|vitamin b complex|mesh-ancestor
24741608|NCT05291104|Vitamins|vitamins|mesh-ancestor
24741609|NCT05291104|Micronutrients|micronutrients|mesh-ancestor
24741610|NCT05291104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741611|NCT05291104|Lipotropic Agents|lipotropic agents|mesh-ancestor
24741612|NCT05291104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24741613|NCT05291104|Antimetabolites|antimetabolites|mesh-ancestor
24741650|NCT05290935|Antibodies|antibodies|mesh-list
24887272|NCT04518189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24966098|NCT03771768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966099|NCT03771768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966100|NCT03771638|Tenofovir|tenofovir|mesh-list
24966101|NCT03771638|Emtricitabine|emtricitabine|mesh-list
24966102|NCT03771638|Antiviral Agents|antiviral agents|mesh-ancestor
24966103|NCT03771638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24966104|NCT03771638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24966105|NCT03771638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24966106|NCT03771638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966108|NCT03771638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24900729|NCT04391621|Immunologic Factors|immunologic factors|mesh-ancestor
25080069|NCT03342443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080070|NCT03342443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25080071|NCT03342443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25080072|NCT03342352|Carboplatin|carboplatin|mesh-list
25080073|NCT03342352|Fluorouracil|fluorouracil|mesh-list
25080074|NCT03342352|Nivolumab|nivolumab|mesh-list
25080075|NCT03342352|Cetuximab|cetuximab|mesh-list
25080076|NCT03342352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25080077|NCT03342352|Antimetabolites|antimetabolites|mesh-ancestor
24777960|NCT01868126|Latanoprost|latanoprost|mesh-list
24818058|NCT02086903|Clopidogrel|clopidogrel|mesh-list
24763549|NCT01774565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24763550|NCT01774565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763551|NCT01774812|Ergocalciferols|ergocalciferols|mesh-list
24763552|NCT01774812|Vitamin D|vitamin d|mesh-list
24763553|NCT01774812|Alfacalcidol|alfacalcidol|mesh-list
24554262|NCT00735228|Pancreatin|pancreatin|mesh-list
24554264|NCT00735241|Leucovorin|leucovorin|mesh-list
24554333|NCT00735761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24620289|NCT01056237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24620290|NCT01056419|Propylthiouracil|propylthiouracil|mesh-list
24620291|NCT01056419|Antimetabolites|antimetabolites|mesh-ancestor
24620292|NCT01056419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620293|NCT01056419|Antithyroid Agents|antithyroid agents|mesh-ancestor
24900836|NCT04390854|Clotrimazole|clotrimazole|mesh-list
24763569|NCT01774838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763570|NCT01774864|Udenafil|udenafil|mesh-list
24763571|NCT01774864|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24763572|NCT01774864|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24763573|NCT01774864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763574|NCT01774864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763575|NCT01774877|Leflunomide|leflunomide|mesh-list
24763576|NCT01774877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900881|NCT04391439|Hormones|hormones|mesh-ancestor
24627214|NCT01091324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24627215|NCT01091324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24627216|NCT01091324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24966116|NCT03771066|Bisphenol A|bisphenol a|mesh-list
24966117|NCT03771066|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24966118|NCT03771066|Estrogens|estrogens|mesh-ancestor
24966119|NCT03771066|Hormones|hormones|mesh-ancestor
24966120|NCT03771066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24966121|NCT03771066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966122|NCT03771066|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25685499|NCT01907100|Cisplatin|cisplatin|mesh-list
25685500|NCT01907100|Pemetrexed|pemetrexed|mesh-list
25685501|NCT01907100|Nintedanib|nintedanib|mesh-list
25685502|NCT01907100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25685503|NCT01907100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25685504|NCT01907100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685505|NCT01907100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25685506|NCT01907100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25685507|NCT01907100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25685508|NCT01907113|Empagliflozin|empagliflozin|mesh-list
24966123|NCT03771066|Antioxidants|antioxidants|mesh-ancestor
25124508|NCT03075579|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25124509|NCT03075579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25124510|NCT03075579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24618241|NCT01047423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966124|NCT03771066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627217|NCT01091324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627218|NCT01091324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627219|NCT01091324|Antioxidants|antioxidants|mesh-ancestor
24627220|NCT01091324|Protective Agents|protective agents|mesh-ancestor
24627221|NCT01091337|Albuterol|albuterol|mesh-list
24627222|NCT01091337|Procaterol|procaterol|mesh-list
24627223|NCT01091337|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24966125|NCT03771066|Protective Agents|protective agents|mesh-ancestor
24966126|NCT03771092|Ferric gluconate|ferric gluconate|mesh-list
24966127|NCT03771092|Hematinics|hematinics|mesh-ancestor
24966128|NCT03770923|Montelukast|montelukast|mesh-list
24966129|NCT03770923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24451626|NCT00324467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24403789|NCT00161564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403790|NCT00161564|Immunologic Factors|immunologic factors|mesh-ancestor
24403793|NCT00161577|Ketorolac|ketorolac|mesh-list
24403795|NCT00161577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24403796|NCT00161577|Analgesics|analgesics|mesh-ancestor
24403797|NCT00161577|Sensory System Agents|sensory system agents|mesh-ancestor
24403798|NCT00161577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24403799|NCT00161577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403800|NCT00161577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24403801|NCT00161577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24966130|NCT03770923|Respiratory System Agents|respiratory system agents|mesh-ancestor
24966131|NCT03770923|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24966132|NCT03770923|Hormone Antagonists|hormone antagonists|mesh-ancestor
24764323|NCT01780610|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24764404|NCT01781377|Anesthetics|anesthetics|mesh-ancestor
24764405|NCT01781377|Antiemetics|antiemetics|mesh-ancestor
24764406|NCT01781377|Autonomic Agents|autonomic agents|mesh-ancestor
24764407|NCT01781377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24764408|NCT01781377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25028810|NCT03607851|Lacosamide|lacosamide|mesh-list
24764409|NCT01781377|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24901569|NCT04383548|Antibodies|antibodies|mesh-list
24764430|NCT01781507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764431|NCT01781507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764433|NCT01781663|Emollients|emollients|mesh-ancestor
24764434|NCT01781663|Dermatologic Agents|dermatologic agents|mesh-ancestor
24764435|NCT01781702|Celecoxib|celecoxib|mesh-list
24764436|NCT01781702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24764437|NCT01781702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24764438|NCT01781702|Analgesics|analgesics|mesh-ancestor
24764439|NCT01781702|Sensory System Agents|sensory system agents|mesh-ancestor
24764440|NCT01781702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24764445|NCT01781702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24764446|NCT01781702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24778911|NCT01872897|Antacids|antacids|mesh-ancestor
24764447|NCT01781702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764448|NCT01781871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24764449|NCT01781871|Immunologic Factors|immunologic factors|mesh-ancestor
24764450|NCT01781871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764451|NCT01781884|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
24764452|NCT01781884|GABA Agents|gaba agents|mesh-ancestor
24764453|NCT01781884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24764454|NCT01781884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685509|NCT01907113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25685510|NCT01907113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685511|NCT01907113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25685512|NCT01907113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685513|NCT01907217|Methohexital|methohexital|mesh-list
25685514|NCT01907217|Succinylcholine|succinylcholine|mesh-list
25685515|NCT01907217|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
25685516|NCT01907217|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25685517|NCT01907217|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24741945|NCT05294666|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24764455|NCT01781884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764456|NCT01781897|Mosapride|mosapride|mesh-list
24764457|NCT01781897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24764458|NCT01781897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24764459|NCT01781897|Serotonin Agents|serotonin agents|mesh-ancestor
24764460|NCT01781897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24764461|NCT01781897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764463|NCT01781936|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
24901611|NCT04383067|Aldesleukin|aldesleukin|mesh-list
24764499|NCT01782261|Protease Inhibitors|protease inhibitors|mesh-ancestor
24764500|NCT01782261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764501|NCT01782261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764519|NCT01782404|Chlorhexidine|chlorhexidine|mesh-list
24764520|NCT01782404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24404275|NCT00162968|Citalopram|citalopram|mesh-list
24764521|NCT01782404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24764522|NCT01782404|Disinfectants|disinfectants|mesh-ancestor
24764523|NCT01782443|Aflibercept|aflibercept|mesh-list
24764524|NCT01782443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24556102|NCT00745004|Dermatologic Agents|dermatologic agents|mesh-ancestor
24764525|NCT01782443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24764526|NCT01782443|Growth Substances|growth substances|mesh-ancestor
24764527|NCT01782443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764528|NCT01782443|Growth Inhibitors|growth inhibitors|mesh-ancestor
24764529|NCT01782443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24764530|NCT01782508|Interferons|interferons|mesh-list
24764531|NCT01782508|Imatinib Mesylate|imatinib mesylate|mesh-list
24764532|NCT01782508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24764533|NCT01782508|Antiviral Agents|antiviral agents|mesh-ancestor
24764534|NCT01782508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24764535|NCT01782508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24764536|NCT01782508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764537|NCT01782508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555268|NCT00740571|Adrenergic Agents|adrenergic agents|mesh-ancestor
24764539|NCT01782560|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24764540|NCT01782560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24764541|NCT01782560|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24764542|NCT01782560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764543|NCT01782560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764544|NCT01782573|Chlorhexidine|chlorhexidine|mesh-list
24486769|NCT00460057|Alendronate|alendronate|mesh-list
24764545|NCT01782573|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24764546|NCT01782573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24764556|NCT01782599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24764557|NCT01782599|Cholinergic Agents|cholinergic agents|mesh-ancestor
24764558|NCT01782599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24764559|NCT01782599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764561|NCT01782612|Sensory System Agents|sensory system agents|mesh-ancestor
24620358|NCT01056679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620359|NCT01056679|Immunologic Factors|immunologic factors|mesh-ancestor
24620360|NCT01056679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620361|NCT01056679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24620362|NCT01056679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24620363|NCT01056679|Growth Substances|growth substances|mesh-ancestor
24620364|NCT01056679|Growth Inhibitors|growth inhibitors|mesh-ancestor
24620365|NCT01056679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24620366|NCT01056679|Tubulin Modulators|tubulin modulators|mesh-ancestor
24620367|NCT01056679|Antimitotic Agents|antimitotic agents|mesh-ancestor
24764625|NCT01782950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764748|NCT01783964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24764749|NCT01783964|Antimetabolites|antimetabolites|mesh-ancestor
24403868|NCT00161811|Vaccines|vaccines|mesh-list
24764750|NCT01783964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764751|NCT01783964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24764752|NCT01783964|Antiviral Agents|antiviral agents|mesh-ancestor
24764753|NCT01783964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24901972|NCT04379219|Antimetabolites|antimetabolites|mesh-ancestor
24764781|NCT01784250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24764782|NCT01784250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764783|NCT01784250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764787|NCT01784250|Analgesics|analgesics|mesh-ancestor
24764796|NCT01784302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24764797|NCT01784302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25685518|NCT01907217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24742204|NCT05296317|Immunologic Factors|immunologic factors|mesh-ancestor
24742205|NCT05296317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742258|NCT05295173|Plasminogen|plasminogen|mesh-list
24764798|NCT01784302|Antiviral Agents|antiviral agents|mesh-ancestor
24764799|NCT01784302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24764800|NCT01784302|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24764801|NCT01784302|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24764802|NCT01784302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764803|NCT01784302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764804|NCT01784315|Chloroquine|chloroquine|mesh-list
24764805|NCT01784315|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24764806|NCT01784315|Primaquine|primaquine|mesh-list
24764860|NCT01784549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24764861|NCT01784549|Immunologic Factors|immunologic factors|mesh-ancestor
24764862|NCT01784549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764863|NCT01784549|Tubulin Modulators|tubulin modulators|mesh-ancestor
24764864|NCT01784549|Antimitotic Agents|antimitotic agents|mesh-ancestor
24966171|NCT03771053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966172|NCT03771053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24966173|NCT03771053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24966174|NCT03771053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966177|NCT03770416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24966178|NCT03770416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24966179|NCT03770416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966180|NCT03770702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24966181|NCT03770702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966182|NCT03770663|Cyclophosphamide|cyclophosphamide|mesh-list
24966183|NCT03770663|Azathioprine|azathioprine|mesh-list
24966184|NCT03770663|Tacrolimus|tacrolimus|mesh-list
24764873|NCT01784640|Pemetrexed|pemetrexed|mesh-list
24764889|NCT01784978|Everolimus|everolimus|mesh-list
24764890|NCT01784978|Sunitinib|sunitinib|mesh-list
24764891|NCT01784978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24902156|NCT04376970|Glucocorticoids|glucocorticoids|mesh-ancestor
24764955|NCT01785290|Autonomic Agents|autonomic agents|mesh-ancestor
24764956|NCT01785290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24764957|NCT01785290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764958|NCT01785290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24764959|NCT01785290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24764960|NCT01785290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24764961|NCT01785290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24764962|NCT01785290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24764963|NCT01785290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24764964|NCT01785290|Dopamine Agents|dopamine agents|mesh-ancestor
24403907|NCT00162149|Nevirapine|nevirapine|mesh-list
24764966|NCT01785290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764967|NCT01785290|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24764968|NCT01785446|Sufentanil|sufentanil|mesh-list
24764969|NCT01785446|Dexmedetomidine|dexmedetomidine|mesh-list
24764971|NCT01785446|Atracurium|atracurium|mesh-list
24764972|NCT01785446|Cisatracurium|cisatracurium|mesh-list
24764973|NCT01785446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24764974|NCT01785446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24764975|NCT01785446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764976|NCT01785446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24764977|NCT01785446|Analgesics|analgesics|mesh-ancestor
24764978|NCT01785446|Sensory System Agents|sensory system agents|mesh-ancestor
24902239|NCT04376073|Niraparib|niraparib|mesh-list
24765073|NCT01785979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24765075|NCT01785979|Hormones|hormones|mesh-ancestor
24765076|NCT01785979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24765077|NCT01785979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765078|NCT01785979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24765079|NCT01785979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24765080|NCT01785979|Amebicides|amebicides|mesh-ancestor
24765081|NCT01785979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24765082|NCT01785979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24765083|NCT01785979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24887527|NCT04515732|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24887528|NCT04515732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24765085|NCT01785979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24621937|NCT01064973|GABA Agonists|gaba agonists|mesh-ancestor
24765086|NCT01785979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25685519|NCT01907217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685520|NCT01907217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25685521|NCT01907217|Anesthetics, General|anesthetics, general|mesh-ancestor
24742347|NCT05273996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24742348|NCT05273996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24742349|NCT05273996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742350|NCT05273996|Dopamine Agents|dopamine agents|mesh-ancestor
24742351|NCT05273996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24742352|NCT05273996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742536|NCT05238506|Lidocaine|lidocaine|mesh-list
24765089|NCT01785979|Sensory System Agents|sensory system agents|mesh-ancestor
24765090|NCT01785979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24765091|NCT01785979|Filaricides|filaricides|mesh-ancestor
24765092|NCT01785979|Antinematodal Agents|antinematodal agents|mesh-ancestor
24765093|NCT01785979|Anthelmintics|anthelmintics|mesh-ancestor
24765094|NCT01786018|Cyclosporine|cyclosporine|mesh-list
24765095|NCT01786018|Methotrexate|methotrexate|mesh-list
24765096|NCT01786018|Busulfan|busulfan|mesh-list
24765097|NCT01786018|Thiotepa|thiotepa|mesh-list
24765098|NCT01786018|Cyclosporins|cyclosporins|mesh-list
24765112|NCT01786018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24765113|NCT01786018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24765114|NCT01786018|Antifungal Agents|antifungal agents|mesh-ancestor
24765115|NCT01786018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24765116|NCT01786018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24765117|NCT01786018|Alkylating Agents|alkylating agents|mesh-ancestor
24765118|NCT01786018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24765119|NCT01786018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24765121|NCT01786070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24765122|NCT01786070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24765124|NCT01786070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24765125|NCT01786070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765126|NCT01786070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24765133|NCT01786200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24765139|NCT01786200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24765140|NCT01786200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24765141|NCT01786200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24765142|NCT01786200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24765506|NCT01789086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24765143|NCT01786200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765144|NCT01786200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24765145|NCT01786200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24765147|NCT01786200|Antipyretics|antipyretics|mesh-ancestor
24765148|NCT01786226|Mifepristone|mifepristone|mesh-list
24765149|NCT01786226|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24765150|NCT01786226|Abortifacient Agents|abortifacient agents|mesh-ancestor
24765151|NCT01786226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24765152|NCT01786226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765153|NCT01786226|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24818207|NCT02087475|Irinotecan|irinotecan|mesh-list
24966230|NCT03770312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24966231|NCT03770312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24966232|NCT03770312|Antimetabolites|antimetabolites|mesh-ancestor
24966233|NCT03770312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966234|NCT03770312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966235|NCT03770312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24966236|NCT03770039|PF-06700841|pf-06700841|mesh-list
24966237|NCT03770039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24966238|NCT03770039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966239|NCT03770039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966240|NCT03770026|Clomiphene|clomiphene|mesh-list
24966241|NCT03770026|Enclomiphene|enclomiphene|mesh-list
24966242|NCT03770026|Zuclomiphene|zuclomiphene|mesh-list
24966243|NCT03770026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24966244|NCT03770026|Hormone Antagonists|hormone antagonists|mesh-ancestor
24966245|NCT03770026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25081973|NCT03325803|Lidocaine|lidocaine|mesh-list
24887529|NCT04515732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887530|NCT04515732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887532|NCT04515420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25685522|NCT01907217|Anesthetics|anesthetics|mesh-ancestor
25685523|NCT01907217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25685524|NCT01907321|Capsaicin|capsaicin|mesh-list
25685525|NCT01907321|Antipruritics|antipruritics|mesh-ancestor
25685526|NCT01907321|Dermatologic Agents|dermatologic agents|mesh-ancestor
25685527|NCT01907321|Sensory System Agents|sensory system agents|mesh-ancestor
25685528|NCT01907321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25685529|NCT01907321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124573|NCT03074773|Hormones|hormones|mesh-ancestor
25124574|NCT03074773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25124575|NCT03074773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24887609|NCT04514588|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24887610|NCT04514588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24887611|NCT04514588|Purinergic Agents|purinergic agents|mesh-ancestor
24887612|NCT04514588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24966246|NCT03770026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966247|NCT03770026|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24966248|NCT03770026|Fertility Agents|fertility agents|mesh-ancestor
24779677|NCT01878136|Plasminogen|plasminogen|mesh-list
25080219|NCT03341104|Anesthetics, Local|anesthetics, local|mesh-ancestor
25080220|NCT03341104|Anesthetics|anesthetics|mesh-ancestor
25080221|NCT03341104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25080222|NCT03341104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080223|NCT03341104|Sensory System Agents|sensory system agents|mesh-ancestor
25080224|NCT03341104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25080225|NCT03340922|Long-Acting Thyroid Stimulator|long-acting thyroid stimulator|mesh-list
25080226|NCT03340922|Immunologic Factors|immunologic factors|mesh-ancestor
25080227|NCT03340922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080236|NCT03340779|Dobutamine|dobutamine|mesh-list
25080237|NCT03340779|Norepinephrine|norepinephrine|mesh-list
24765245|NCT01787123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765246|NCT01787123|Nootropic Agents|nootropic agents|mesh-ancestor
24765247|NCT01787136|Dextromethorphan|dextromethorphan|mesh-list
24765248|NCT01787136|Antitussive Agents|antitussive agents|mesh-ancestor
24765249|NCT01787136|Respiratory System Agents|respiratory system agents|mesh-ancestor
24765250|NCT01787136|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24765251|NCT01787136|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24765252|NCT01787136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24765253|NCT01787136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765254|NCT01787136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765255|NCT01787344|Botulinum Toxins|botulinum toxins|mesh-list
24765256|NCT01787344|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24765257|NCT01787344|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24765258|NCT01787344|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24765259|NCT01787344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24765260|NCT01787344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765261|NCT01787344|Cholinergic Agents|cholinergic agents|mesh-ancestor
24765262|NCT01787344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24765263|NCT01787344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765264|NCT01787344|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24556103|NCT00745004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24556104|NCT00745004|Serotonin Agents|serotonin agents|mesh-ancestor
24556105|NCT00745004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24556106|NCT00745004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556107|NCT00745004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24556108|NCT00745004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24556109|NCT00745004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24556110|NCT00745004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24556111|NCT00745004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24556112|NCT00745017|Antidepressive Agents|antidepressive agents|mesh-list
24556113|NCT00745017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24556114|NCT00745043|Bronchodilator Agents|bronchodilator agents|mesh-list
24765284|NCT01787474|Lenograstim|lenograstim|mesh-list
24765285|NCT01787474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24765301|NCT01787630|Hyaluronic Acid|hyaluronic acid|mesh-list
24765302|NCT01787630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24765303|NCT01787630|Immunologic Factors|immunologic factors|mesh-ancestor
24765304|NCT01787630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765336|NCT01788176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24765337|NCT01788176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765338|NCT01788189|Lenalidomide|lenalidomide|mesh-list
24765339|NCT01788189|Immunologic Factors|immunologic factors|mesh-ancestor
24765340|NCT01788189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765341|NCT01788189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25685530|NCT01907334|Fluticasone|fluticasone|mesh-list
25685531|NCT01907334|Xhance|xhance|mesh-list
25685532|NCT01907334|Albuterol|albuterol|mesh-list
25685533|NCT01907334|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25685534|NCT01907334|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24742929|NCT05103696|Anesthetics, General|anesthetics, general|mesh-ancestor
24742930|NCT05103696|Anesthetics|anesthetics|mesh-ancestor
24742931|NCT05098041|Rifampin|rifampin|mesh-list
24742932|NCT05098041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24742933|NCT05098041|Antitubercular Agents|antitubercular agents|mesh-ancestor
24742934|NCT05098041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24742935|NCT05098041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24742936|NCT05098041|Leprostatic Agents|leprostatic agents|mesh-ancestor
24742937|NCT05098041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24742938|NCT05098041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24765342|NCT01788189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24765343|NCT01788189|Growth Substances|growth substances|mesh-ancestor
24765344|NCT01788189|Growth Inhibitors|growth inhibitors|mesh-ancestor
24765345|NCT01788189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24765346|NCT01788254|Talinolol|talinolol|mesh-list
24765347|NCT01788254|Torsemide|torsemide|mesh-list
24765348|NCT01788254|Midazolam|midazolam|mesh-list
24765349|NCT01788254|Codeine|codeine|mesh-list
24765350|NCT01788254|Pravastatin|pravastatin|mesh-list
24765351|NCT01788254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24765352|NCT01788254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24765371|NCT01788254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24765372|NCT01788254|Narcotics|narcotics|mesh-ancestor
24765373|NCT01788254|Analgesics|analgesics|mesh-ancestor
24765374|NCT01788254|Sensory System Agents|sensory system agents|mesh-ancestor
24765375|NCT01788254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24765376|NCT01788254|Antitussive Agents|antitussive agents|mesh-ancestor
24765377|NCT01788254|Respiratory System Agents|respiratory system agents|mesh-ancestor
24765378|NCT01788254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24765388|NCT01788280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24765389|NCT01788280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24765390|NCT01788280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24765391|NCT01788280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24765392|NCT01788280|Growth Substances|growth substances|mesh-ancestor
24765393|NCT01788280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765394|NCT01788280|Growth Inhibitors|growth inhibitors|mesh-ancestor
24765396|NCT01788332|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24765397|NCT01788332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24765398|NCT01788332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765399|NCT01788332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24765400|NCT01788371|Lamivudine|lamivudine|mesh-list
24765401|NCT01788371|Telbivudine|telbivudine|mesh-list
24765402|NCT01788371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24765403|NCT01788371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24765404|NCT01788371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24765405|NCT01788371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765406|NCT01788371|Antiviral Agents|antiviral agents|mesh-ancestor
24765407|NCT01788371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902665|NCT04371224|Leucovorin|leucovorin|mesh-list
24621024|NCT01060423|Cetuximab|cetuximab|mesh-list
24765430|NCT01788501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765431|NCT01788501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24765432|NCT01788501|Antimetabolites|antimetabolites|mesh-ancestor
24765469|NCT01788722|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24765470|NCT01788722|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24765471|NCT01788722|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24765472|NCT01788722|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24765473|NCT01788722|Hormone Antagonists|hormone antagonists|mesh-ancestor
24818248|NCT02087566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24765503|NCT01788982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24765504|NCT01788982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765505|NCT01789086|Liraglutide|liraglutide|mesh-list
24765507|NCT01789086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765508|NCT01789086|Incretins|incretins|mesh-ancestor
24765509|NCT01789086|Hormones|hormones|mesh-ancestor
25685535|NCT01907334|Methacholine Chloride|methacholine chloride|mesh-list
25685536|NCT01907334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25685537|NCT01907334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25685538|NCT01907334|Autonomic Agents|autonomic agents|mesh-ancestor
25685539|NCT01907334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25685540|NCT01907334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685541|NCT01907334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25685542|NCT01907334|Respiratory System Agents|respiratory system agents|mesh-ancestor
25685543|NCT01907334|Dermatologic Agents|dermatologic agents|mesh-ancestor
25685544|NCT01907334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24765510|NCT01789086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24743184|NCT04972552|Coenzyme Q10|coenzyme q10|mesh-list
24743185|NCT04972552|Micronutrients|micronutrients|mesh-ancestor
24743186|NCT04972552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743187|NCT04972552|Vitamins|vitamins|mesh-ancestor
24532751|NCT00640991|Insulin Glargine|insulin glargine|mesh-list
24651895|NCT01234454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24743233|NCT04936854|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24743234|NCT04936854|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24743236|NCT04936854|Prednisolone acetate|prednisolone acetate|mesh-list
24743237|NCT04936854|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24743238|NCT04936854|Prednisolone phosphate|prednisolone phosphate|mesh-list
24743239|NCT04936854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24743240|NCT04936854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24743241|NCT04936854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24765511|NCT01789099|Sargramostim|sargramostim|mesh-list
24765512|NCT01789099|Immunologic Factors|immunologic factors|mesh-ancestor
24765513|NCT01789099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765515|NCT01789125|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24765516|NCT01789125|Autonomic Agents|autonomic agents|mesh-ancestor
24765517|NCT01789125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24887617|NCT04514094|Cariostatic Agents|cariostatic agents|mesh-ancestor
24887618|NCT04514094|Protective Agents|protective agents|mesh-ancestor
24887619|NCT04514094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887620|NCT04514029|Dexamethasone|dexamethasone|mesh-list
24887621|NCT04514029|Simvastatin|simvastatin|mesh-list
24887622|NCT04514029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24887623|NCT04514029|Antiemetics|antiemetics|mesh-ancestor
24887624|NCT04514029|Autonomic Agents|autonomic agents|mesh-ancestor
24887625|NCT04514029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24710027|NCT01508104|Everolimus|everolimus|mesh-list
24887627|NCT04514029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24465802|NCT00370747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887690|NCT04513509|Diltiazem|diltiazem|mesh-list
24887691|NCT04513509|Bisoprolol|bisoprolol|mesh-list
24887692|NCT04513509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24887730|NCT04513340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24887731|NCT04513340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887732|NCT04513340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887733|NCT04513340|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24887734|NCT04513340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24465856|NCT00370825|Miltefosine|miltefosine|mesh-list
24887735|NCT04513379|Efavirenz|efavirenz|mesh-list
24887736|NCT04513379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24887737|NCT04513379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24887738|NCT04513379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887740|NCT04513379|Antiviral Agents|antiviral agents|mesh-ancestor
24887741|NCT04513379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24887742|NCT04513379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24887743|NCT04513379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24887744|NCT04513379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24887745|NCT04513379|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24512553|NCT00575614|Serotonin Agents|serotonin agents|mesh-ancestor
24765518|NCT01789125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765539|NCT01789216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24765540|NCT01789216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24765541|NCT01789216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24765542|NCT01789216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24765543|NCT01789216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24765544|NCT01789216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24765545|NCT01789216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25685545|NCT01907334|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25685546|NCT01907334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25685547|NCT01907334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25685548|NCT01907334|Adrenergic Agents|adrenergic agents|mesh-ancestor
25685549|NCT01907334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25685550|NCT01907334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685551|NCT01907334|Tocolytic Agents|tocolytic agents|mesh-ancestor
25685552|NCT01907334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25685553|NCT01907334|Glucocorticoids|glucocorticoids|mesh-ancestor
25685554|NCT01907334|Hormones|hormones|mesh-ancestor
25685555|NCT01907334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25685556|NCT01907334|Sympathomimetics|sympathomimetics|mesh-ancestor
25685557|NCT01907334|Miotics|miotics|mesh-ancestor
25685558|NCT01907334|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24743670|NCT04671082|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24743671|NCT04671082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743672|NCT04671082|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24743700|NCT04658823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743702|NCT04657094|Acalabrutinib|acalabrutinib|mesh-list
24743703|NCT04657094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24743704|NCT04657016|Tirzepatide|tirzepatide|mesh-list
24743705|NCT04657016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24743706|NCT04657016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743707|NCT04657016|Incretins|incretins|mesh-ancestor
24743708|NCT04657016|Hormones|hormones|mesh-ancestor
24743711|NCT04655144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24765546|NCT01789216|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24765548|NCT01789242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24765549|NCT01789242|Antiemetics|antiemetics|mesh-ancestor
24765550|NCT01789242|Autonomic Agents|autonomic agents|mesh-ancestor
24765551|NCT01789242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24765552|NCT01789242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765553|NCT01789242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24765554|NCT01789242|Glucocorticoids|glucocorticoids|mesh-ancestor
24404245|NCT00162864|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24765555|NCT01789242|Hormones|hormones|mesh-ancestor
24765557|NCT01789242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24765558|NCT01789242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24765559|NCT01789294|Mesalamine|mesalamine|mesh-list
24765560|NCT01789294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24765561|NCT01789294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24765562|NCT01789294|Analgesics|analgesics|mesh-ancestor
24765563|NCT01789294|Sensory System Agents|sensory system agents|mesh-ancestor
24765564|NCT01789294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24765565|NCT01789294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765566|NCT01789294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24765567|NCT01789294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24765568|NCT01789333|Riboflavin|riboflavin|mesh-list
24765569|NCT01789333|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24780920|NCT01887249|Metronidazole|metronidazole|mesh-list
24512554|NCT00575614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24512555|NCT00575614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512556|NCT00575614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512559|NCT00575627|Interferon-alpha|interferon-alpha|mesh-list
24512560|NCT00575627|Interferon alpha-2|interferon alpha-2|mesh-list
24512561|NCT00575627|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24512562|NCT00575627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512563|NCT00575627|Antiviral Agents|antiviral agents|mesh-ancestor
24512564|NCT00575627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24512570|NCT00575640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24512571|NCT00575640|Vasodilator Agents|vasodilator agents|mesh-ancestor
24765570|NCT01789333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24765571|NCT01789333|Vitamin B Complex|vitamin b complex|mesh-ancestor
24765572|NCT01789333|Vitamins|vitamins|mesh-ancestor
24765573|NCT01789333|Micronutrients|micronutrients|mesh-ancestor
24765574|NCT01789333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765595|NCT01789437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24765596|NCT01789437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765597|NCT01789437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24765598|NCT01789437|Glucocorticoids|glucocorticoids|mesh-ancestor
24765599|NCT01789437|Hormones|hormones|mesh-ancestor
24765600|NCT01789437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24765601|NCT01789437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24765602|NCT01789437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24765603|NCT01789619|Tacrolimus|tacrolimus|mesh-list
24765604|NCT01789619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24765605|NCT01789619|Immunologic Factors|immunologic factors|mesh-ancestor
24765606|NCT01789619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685559|NCT01907334|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
25685560|NCT01907334|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25685561|NCT01907334|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25685562|NCT01907334|Cholinergic Agents|cholinergic agents|mesh-ancestor
25685563|NCT01907490|Benzyl Alcohol|benzyl alcohol|mesh-list
25685564|NCT01907490|Anesthetics, Local|anesthetics, local|mesh-ancestor
25685565|NCT01907490|Anesthetics|anesthetics|mesh-ancestor
25685566|NCT01907490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25685567|NCT01907490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685568|NCT01907490|Sensory System Agents|sensory system agents|mesh-ancestor
25685569|NCT01907490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25685570|NCT01907607|Palbociclib|palbociclib|mesh-list
25124657|NCT03073850|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25124658|NCT03073850|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25124659|NCT03073850|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25124660|NCT03073850|Purinergic Agents|purinergic agents|mesh-ancestor
25124661|NCT03073850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24743936|NCT04564885|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24743937|NCT04564885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24765607|NCT01789619|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24765608|NCT01789619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24765609|NCT01789619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765610|NCT01789710|Bupropion|bupropion|mesh-list
24765611|NCT01789710|Nicotine|nicotine|mesh-list
24765612|NCT01789710|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24765613|NCT01789710|Autonomic Agents|autonomic agents|mesh-ancestor
24765614|NCT01789710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24765615|NCT01789710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765616|NCT01789710|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24765617|NCT01789710|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24765618|NCT01789710|Cholinergic Agents|cholinergic agents|mesh-ancestor
24765619|NCT01789710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24765620|NCT01789710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765621|NCT01789710|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24765622|NCT01789710|Antidepressive Agents|antidepressive agents|mesh-ancestor
24765623|NCT01789710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24765624|NCT01789710|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24902818|NCT04370288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24765656|NCT01789879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24765657|NCT01789879|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24765658|NCT01789879|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24765659|NCT01789879|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24765660|NCT01789879|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24765661|NCT01789879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24765662|NCT01789879|Contraceptive Agents|contraceptive agents|mesh-ancestor
24765663|NCT01789879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25080242|NCT03340779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966249|NCT03770026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24986217|NCT02122198|Leuprolide|leuprolide|mesh-list
24966250|NCT03770026|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24966251|NCT03770026|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24966253|NCT03770013|Dexmedetomidine|dexmedetomidine|mesh-list
25080264|NCT03340740|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24887890|NCT04510935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24887891|NCT04510935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887893|NCT04511195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24887894|NCT04511195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24887895|NCT04511195|Analgesics|analgesics|mesh-ancestor
24887896|NCT04511195|Sensory System Agents|sensory system agents|mesh-ancestor
24887897|NCT04511195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24512612|NCT00575861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512613|NCT00575861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512614|NCT00575861|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24512615|NCT00575861|Hormone Antagonists|hormone antagonists|mesh-ancestor
24512619|NCT00575874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512621|NCT00575913|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24512622|NCT00575913|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24512623|NCT00575913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24512624|NCT00575913|Adrenergic Agents|adrenergic agents|mesh-ancestor
24512625|NCT00575913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24512626|NCT00575913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816684|NCT02078336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816685|NCT02078336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25685571|NCT01907607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25685572|NCT01907607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25685573|NCT01907607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25685574|NCT01907607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685575|NCT01907815|Trametinib|trametinib|mesh-list
25685576|NCT01907815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25685577|NCT01907815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25685578|NCT01907815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512726|NCT00576329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24512727|NCT00576329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24512728|NCT00576329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24765680|NCT01789892|Autonomic Agents|autonomic agents|mesh-ancestor
24888002|NCT04509466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888003|NCT04509583|Vitamin E|vitamin e|mesh-list
24888004|NCT04509583|Vitamins|vitamins|mesh-ancestor
24888005|NCT04509583|Micronutrients|micronutrients|mesh-ancestor
24888006|NCT04509583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080265|NCT03340740|Histamine Antagonists|histamine antagonists|mesh-ancestor
25080266|NCT03340740|Histamine Agents|histamine agents|mesh-ancestor
25080267|NCT03340740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25080268|NCT03340740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080269|NCT03340740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080270|NCT03340701|Progesterone|progesterone|mesh-list
25080271|NCT03340701|Progestins|progestins|mesh-ancestor
25080272|NCT03340701|Hormones|hormones|mesh-ancestor
24404320|NCT00163111|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25080273|NCT03340701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25080274|NCT03340701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080275|NCT03340662|Itraconazole|itraconazole|mesh-list
25080276|NCT03340662|Rifampin|rifampin|mesh-list
25080277|NCT03340662|Fluvoxamine|fluvoxamine|mesh-list
24765664|NCT01789879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765665|NCT01789879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24765666|NCT01789879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24765667|NCT01789879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24765669|NCT01789879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24404343|NCT00163202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24404344|NCT00163202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24404345|NCT00163202|Antimetabolites|antimetabolites|mesh-ancestor
24404346|NCT00163202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404347|NCT00163202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24533371|NCT00643409|Renal Agents|renal agents|mesh-ancestor
24765670|NCT01789892|Methylprednisolone|methylprednisolone|mesh-list
24765671|NCT01789892|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24765672|NCT01789892|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24765673|NCT01789892|Prednisolone|prednisolone|mesh-list
24765674|NCT01789892|Prednisolone acetate|prednisolone acetate|mesh-list
24765675|NCT01789892|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24765676|NCT01789892|Prednisolone phosphate|prednisolone phosphate|mesh-list
24765677|NCT01789892|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24765678|NCT01789892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24888007|NCT04509583|Antioxidants|antioxidants|mesh-ancestor
24512730|NCT00576368|Insulin Glargine|insulin glargine|mesh-list
24512731|NCT00576368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24512732|NCT00576368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512733|NCT00576394|Insulin|insulin|mesh-list
24512734|NCT00576394|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24512735|NCT00576394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24512736|NCT00576394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512738|NCT00576433|Methotrexate|methotrexate|mesh-list
24512740|NCT00576433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24888323|NCT04506034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888326|NCT04506034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24888327|NCT04506034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24888328|NCT04506034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24744336|NCT04353284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744337|NCT04353284|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24744338|NCT04353284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24744339|NCT04353284|Anticoagulants|anticoagulants|mesh-ancestor
24744385|NCT04298983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24744386|NCT04298983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653097|NCT01242046|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24744395|NCT04294914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
24744396|NCT04294147|Erenumab|erenumab|mesh-list
24744399|NCT04294147|Analgesics|analgesics|mesh-ancestor
24744534|NCT04233801|Empagliflozin|empagliflozin|mesh-list
24744535|NCT04233801|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24744536|NCT04233801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888329|NCT04506034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24888330|NCT04506034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888331|NCT04506125|Chrysarobin|chrysarobin|mesh-list
24765682|NCT01789892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765689|NCT01789892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24404348|NCT00163202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24765690|NCT01789892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24765691|NCT01789892|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24765692|NCT01789892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765718|NCT01790022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765720|NCT01790022|Glucocorticoids|glucocorticoids|mesh-ancestor
24765721|NCT01790022|Hormones|hormones|mesh-ancestor
24765722|NCT01790022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24765723|NCT01790022|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24765724|NCT01790022|Protective Agents|protective agents|mesh-ancestor
24765725|NCT01790022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24765726|NCT01790022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24765727|NCT01790087|Moxifloxacin|moxifloxacin|mesh-list
24765728|NCT01790087|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24765729|NCT01790087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24765730|NCT01790087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24765731|NCT01790087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24765732|NCT01790087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24765733|NCT01790087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404366|NCT00163267|Clopidogrel|clopidogrel|mesh-list
24404367|NCT00163267|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24404368|NCT00163267|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24404369|NCT00163267|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24404370|NCT00163267|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24404371|NCT00163267|Purinergic Agents|purinergic agents|mesh-ancestor
24404372|NCT00163267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24404373|NCT00163267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404374|NCT00163267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404375|NCT00163306|Pantoprazole|pantoprazole|mesh-list
24404376|NCT00163306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24765734|NCT01790087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25685579|NCT01907815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685580|NCT01907854|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25685581|NCT01907854|Liraglutide|liraglutide|mesh-list
25685582|NCT01907854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25685583|NCT01907854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685584|NCT01907854|Incretins|incretins|mesh-ancestor
25685585|NCT01907854|Hormones|hormones|mesh-ancestor
25685586|NCT01907854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25685587|NCT01907854|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25685588|NCT01907854|Protease Inhibitors|protease inhibitors|mesh-ancestor
25685589|NCT01907854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25685590|NCT01907854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685591|NCT01908062|Naltrexone|naltrexone|mesh-list
25685592|NCT01908062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24744798|NCT04136262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744799|NCT04136262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24744800|NCT04136262|Dermatologic Agents|dermatologic agents|mesh-ancestor
24745043|NCT04012177|Lipotropic Agents|lipotropic agents|mesh-ancestor
24745044|NCT04012177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24745045|NCT04012177|Antimetabolites|antimetabolites|mesh-ancestor
24745046|NCT04012177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745049|NCT04012177|Nootropic Agents|nootropic agents|mesh-ancestor
24765735|NCT01790139|Simethicone|simethicone|mesh-list
24765736|NCT01790139|Antifoaming Agents|antifoaming agents|mesh-ancestor
24765737|NCT01790139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765738|NCT01790139|Emollients|emollients|mesh-ancestor
24765739|NCT01790139|Dermatologic Agents|dermatologic agents|mesh-ancestor
24765740|NCT01790165|Terbinafine|terbinafine|mesh-list
24765741|NCT01790165|Antifungal Agents|antifungal agents|mesh-ancestor
24765742|NCT01790165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24765743|NCT01790165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24888332|NCT04506125|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24888333|NCT04506125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24888337|NCT04506125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765841|NCT01790997|Clopidogrel|clopidogrel|mesh-list
24765842|NCT01790997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24765843|NCT01790997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24765844|NCT01790997|Analgesics|analgesics|mesh-ancestor
24765845|NCT01790997|Sensory System Agents|sensory system agents|mesh-ancestor
24404377|NCT00163306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24404378|NCT00163306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24765846|NCT01790997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24404380|NCT00163306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765847|NCT01790997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765848|NCT01790997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24765849|NCT01790997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24765850|NCT01790997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24765851|NCT01790997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24903067|NCT04367051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765878|NCT01791114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24765879|NCT01791114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24765880|NCT01791114|Vasodilator Agents|vasodilator agents|mesh-ancestor
24765881|NCT01791166|Antibodies|antibodies|mesh-list
24765882|NCT01791166|Immunologic Factors|immunologic factors|mesh-ancestor
24765883|NCT01791166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765884|NCT01791192|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24765885|NCT01791192|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24765886|NCT01791192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765887|NCT01791192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24765888|NCT01791192|Immunologic Factors|immunologic factors|mesh-ancestor
25080302|NCT03340662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24627224|NCT01091337|Autonomic Agents|autonomic agents|mesh-ancestor
24627225|NCT01091337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24765899|NCT01791296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24765901|NCT01791296|Sensory System Agents|sensory system agents|mesh-ancestor
24765902|NCT01791296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24765903|NCT01791296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24765904|NCT01791296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24765905|NCT01791296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24765906|NCT01791296|Adrenergic Agents|adrenergic agents|mesh-ancestor
24765907|NCT01791296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25685593|NCT01908062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25685594|NCT01908062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685595|NCT01908062|Sensory System Agents|sensory system agents|mesh-ancestor
25685596|NCT01908062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25685597|NCT01908101|Halichondrin B|halichondrin b|mesh-list
25685598|NCT01908101|Tubulin Modulators|tubulin modulators|mesh-ancestor
25685599|NCT01908101|Antimitotic Agents|antimitotic agents|mesh-ancestor
25685600|NCT01908101|Mitosis Modulators|mitosis modulators|mesh-ancestor
25685601|NCT01908101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745678|NCT03651102|Antisickling Agents|antisickling agents|mesh-ancestor
24745679|NCT03651102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24745680|NCT03651102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745681|NCT03651102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24745768|NCT03596385|Antioxidants|antioxidants|mesh-ancestor
24745769|NCT03596385|Protective Agents|protective agents|mesh-ancestor
24745770|NCT03596385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25124778|NCT03072849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24765908|NCT01791296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765909|NCT01791309|Panitumumab|panitumumab|mesh-list
24765910|NCT01791309|Vemurafenib|vemurafenib|mesh-list
24765911|NCT01791309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24765912|NCT01791309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24903160|NCT04365686|Anesthetics, General|anesthetics, general|mesh-ancestor
24765937|NCT01791400|Serotonin Agents|serotonin agents|mesh-ancestor
24765939|NCT01791439|Anesthetics, Local|anesthetics, local|mesh-ancestor
24765940|NCT01791439|Anesthetics|anesthetics|mesh-ancestor
24765941|NCT01791439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24765942|NCT01791439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530704|NCT00631943|Pregabalin|pregabalin|mesh-list
24765943|NCT01791439|Sensory System Agents|sensory system agents|mesh-ancestor
24765944|NCT01791439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24765945|NCT01791439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24765951|NCT01791608|Zinc Sulfate|zinc sulfate|mesh-list
24766035|NCT01792037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25080323|NCT03340376|Atezolizumab|atezolizumab|mesh-list
24966364|NCT03768882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24766037|NCT01792037|Autonomic Agents|autonomic agents|mesh-ancestor
24766038|NCT01792037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24766039|NCT01792037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24766040|NCT01792037|Glucocorticoids|glucocorticoids|mesh-ancestor
24766041|NCT01792037|Hormones|hormones|mesh-ancestor
24766066|NCT01792323|Insulin Lispro|insulin lispro|mesh-list
24766067|NCT01792323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24766068|NCT01792323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766069|NCT01792375|Dinoprostone|dinoprostone|mesh-list
24766102|NCT01792570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24766103|NCT01792700|Amoxicillin|amoxicillin|mesh-list
24766105|NCT01792700|Metronidazole|metronidazole|mesh-list
24766106|NCT01792700|Tetracycline|tetracycline|mesh-list
24766107|NCT01792700|Esomeprazole|esomeprazole|mesh-list
24766108|NCT01792700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24766109|NCT01792700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24766110|NCT01792700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24766111|NCT01792700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24766112|NCT01792700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24766113|NCT01792700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766114|NCT01792700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24766115|NCT01792700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24766116|NCT01792700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24766117|NCT01792700|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24766176|NCT01793038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811565|NCT02047175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811566|NCT02047175|Vasodilator Agents|vasodilator agents|mesh-ancestor
24811567|NCT02047175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24811568|NCT02047175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24811569|NCT02047175|Antimetabolites|antimetabolites|mesh-ancestor
24676990|NCT01353729|Zanamivir|zanamivir|mesh-list
24766178|NCT01793077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24766179|NCT01793077|Fertility Agents|fertility agents|mesh-ancestor
24766180|NCT01793077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25685602|NCT01908101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25685603|NCT01908127|Salicylic Acid|salicylic acid|mesh-list
25685604|NCT01908127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25685605|NCT01908127|Antifungal Agents|antifungal agents|mesh-ancestor
25685606|NCT01908127|Keratolytic Agents|keratolytic agents|mesh-ancestor
25685607|NCT01908127|Dermatologic Agents|dermatologic agents|mesh-ancestor
25685608|NCT01908140|Fluticasone|fluticasone|mesh-list
25685609|NCT01908140|Bromides|bromides|mesh-list
24766181|NCT01793077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766182|NCT01793077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24766183|NCT01793077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24766184|NCT01793259|Methotrexate|methotrexate|mesh-list
25685610|NCT01908140|Formoterol Fumarate|formoterol fumarate|mesh-list
24745867|NCT03546556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24745868|NCT03546556|Antimetabolites|antimetabolites|mesh-ancestor
24745869|NCT03546556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745870|NCT03546556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24745871|NCT03546556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24745884|NCT03529396|Chloroquine|chloroquine|mesh-list
24745885|NCT03529396|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24745886|NCT03529396|Primaquine|primaquine|mesh-list
24745887|NCT03529396|Amebicides|amebicides|mesh-ancestor
24745888|NCT03529396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24745889|NCT03529396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24766185|NCT01793259|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24766187|NCT01793259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24766188|NCT01793259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766189|NCT01793259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24766190|NCT01793259|Antimetabolites|antimetabolites|mesh-ancestor
24766191|NCT01793259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766192|NCT01793259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24766193|NCT01793259|Dermatologic Agents|dermatologic agents|mesh-ancestor
24766194|NCT01793259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24766195|NCT01793259|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24766251|NCT01793753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766253|NCT01793753|Anesthetics, General|anesthetics, general|mesh-ancestor
24766254|NCT01793753|Anesthetics|anesthetics|mesh-ancestor
24557114|NCT00751374|Mupirocin|mupirocin|mesh-list
24766255|NCT01793870|Carvedilol|carvedilol|mesh-list
24766256|NCT01793870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24766257|NCT01793870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24766258|NCT01793870|Adrenergic Agents|adrenergic agents|mesh-ancestor
24766259|NCT01793870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24766260|NCT01793870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766261|NCT01793870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766262|NCT01793870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24766263|NCT01793870|Antioxidants|antioxidants|mesh-ancestor
24766264|NCT01793870|Protective Agents|protective agents|mesh-ancestor
24766265|NCT01793870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24766266|NCT01793870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24766267|NCT01793870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24766268|NCT01793870|Vasodilator Agents|vasodilator agents|mesh-ancestor
24766269|NCT01793870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24766270|NCT01793870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24766271|NCT01793948|Metformin|metformin|mesh-list
24766272|NCT01793948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24766273|NCT01793948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766274|NCT01794078|Ambrisentan|ambrisentan|mesh-list
24766275|NCT01794078|Aminophylline|aminophylline|mesh-list
24766276|NCT01794078|Theophylline|theophylline|mesh-list
24888463|NCT04504851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888464|NCT04504851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24888465|NCT04504851|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24766277|NCT01794078|Ethylene|ethylene|mesh-list
24766278|NCT01794078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24766279|NCT01794078|Autonomic Agents|autonomic agents|mesh-ancestor
24766304|NCT01794091|Natriuretic Agents|natriuretic agents|mesh-ancestor
24766305|NCT01794091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24766306|NCT01794169|Cytarabine|cytarabine|mesh-list
24766307|NCT01794169|Azacitidine|azacitidine|mesh-list
24766308|NCT01794169|Daunorubicin|daunorubicin|mesh-list
24766309|NCT01794169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24766310|NCT01794169|Antimetabolites|antimetabolites|mesh-ancestor
25685611|NCT01908140|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25685612|NCT01908140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25685613|NCT01908140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25685614|NCT01908140|Autonomic Agents|autonomic agents|mesh-ancestor
25685615|NCT01908140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25685616|NCT01908140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685617|NCT01908140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25685618|NCT01908140|Respiratory System Agents|respiratory system agents|mesh-ancestor
25685619|NCT01908140|Dermatologic Agents|dermatologic agents|mesh-ancestor
25685620|NCT01908140|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25685621|NCT01908140|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24746362|NCT05437471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746363|NCT05437471|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24746454|NCT05432518|Afatinib|afatinib|mesh-list
24661663|NCT01290276|Antiemetics|antiemetics|mesh-ancestor
24746455|NCT05432518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746456|NCT05432518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24746457|NCT05432518|Immunologic Factors|immunologic factors|mesh-ancestor
24746458|NCT05432518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766311|NCT01794169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766312|NCT01794169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25080325|NCT03340376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24766313|NCT01794169|Antiviral Agents|antiviral agents|mesh-ancestor
24766314|NCT01794169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24766315|NCT01794169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24766316|NCT01794169|Immunologic Factors|immunologic factors|mesh-ancestor
24766317|NCT01794169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766318|NCT01794169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24766319|NCT01794169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24766320|NCT01794169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24766321|NCT01794169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24766322|NCT01794182|Glyburide|glyburide|mesh-list
24766323|NCT01794182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24766324|NCT01794182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766325|NCT01794208|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24766326|NCT01794208|Hormones|hormones|mesh-ancestor
24766327|NCT01794208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24903477|NCT04363866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24766356|NCT01794273|Ephedrine|ephedrine|mesh-list
24766358|NCT01794273|Mydriatics|mydriatics|mesh-ancestor
24766359|NCT01794273|Autonomic Agents|autonomic agents|mesh-ancestor
24404456|NCT00163488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24766360|NCT01794273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24766362|NCT01794273|Sympathomimetics|sympathomimetics|mesh-ancestor
24766370|NCT01794273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24766371|NCT01794273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766372|NCT01794273|Protective Agents|protective agents|mesh-ancestor
24766373|NCT01794273|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24766374|NCT01794351|Resveratrol|resveratrol|mesh-list
24766375|NCT01794351|Antioxidants|antioxidants|mesh-ancestor
24766406|NCT01794533|Epinephryl borate|epinephryl borate|mesh-list
24766407|NCT01794533|Anesthetics, Local|anesthetics, local|mesh-ancestor
24788509|NCT01931787|Thioctic Acid|thioctic acid|mesh-list
24766408|NCT01794533|Anesthetics|anesthetics|mesh-ancestor
24766409|NCT01794533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24766410|NCT01794533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766411|NCT01794533|Sensory System Agents|sensory system agents|mesh-ancestor
24766412|NCT01794533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24766413|NCT01794533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24766414|NCT01794533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24766415|NCT01794533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24766416|NCT01794533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24766417|NCT01794533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766418|NCT01794533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24766419|NCT01794533|Narcotics|narcotics|mesh-ancestor
24766453|NCT01794897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24766454|NCT01794975|Ketamine|ketamine|mesh-list
24766455|NCT01794975|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24766456|NCT01794975|Analgesics|analgesics|mesh-ancestor
24766457|NCT01794975|Sensory System Agents|sensory system agents|mesh-ancestor
24766458|NCT01794975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24766459|NCT01794975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766460|NCT01794975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24766461|NCT01794975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24766462|NCT01794975|Anesthetics, General|anesthetics, general|mesh-ancestor
25685622|NCT01908140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25685623|NCT01908140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25685624|NCT01908140|Adrenergic Agents|adrenergic agents|mesh-ancestor
25685625|NCT01908140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25685626|NCT01908140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685627|NCT01908140|Anticonvulsants|anticonvulsants|mesh-ancestor
25685628|NCT01908205|Oxytocin|oxytocin|mesh-list
25685629|NCT01908205|Oxytocics|oxytocics|mesh-ancestor
24766463|NCT01794975|Anesthetics|anesthetics|mesh-ancestor
25080326|NCT03340376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25685630|NCT01908205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25124842|NCT03072394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25124843|NCT03072394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124844|NCT03072394|Sensory System Agents|sensory system agents|mesh-ancestor
25124845|NCT03072394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24746944|NCT02535338|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24746945|NCT02535338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746946|NCT02535338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24747032|NCT02203773|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24747033|NCT02203773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24747034|NCT02203773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24747136|NCT01746173|Gemcitabine|gemcitabine|mesh-list
24618647|NCT01049425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24903616|NCT04362332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24766494|NCT01795183|Amisulpride|amisulpride|mesh-list
24766495|NCT01795183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24766496|NCT01795183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24766497|NCT01795183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24766498|NCT01795183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766499|NCT01795183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24766500|NCT01795183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24766501|NCT01795183|Dopamine Agents|dopamine agents|mesh-ancestor
24766502|NCT01795183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25685631|NCT01908205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685632|NCT01908582|Rifampin|rifampin|mesh-list
25685633|NCT01908582|Evacetrapib|evacetrapib|mesh-list
25685634|NCT01908582|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24766503|NCT01795183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766504|NCT01795183|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24766505|NCT01795183|Antidepressive Agents|antidepressive agents|mesh-ancestor
24766506|NCT01795209|Ranibizumab|ranibizumab|mesh-list
24766507|NCT01795209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24766508|NCT01795209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24766509|NCT01795209|Growth Substances|growth substances|mesh-ancestor
24766510|NCT01795209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766511|NCT01795209|Growth Inhibitors|growth inhibitors|mesh-ancestor
24766539|NCT01795235|Autonomic Agents|autonomic agents|mesh-ancestor
24766540|NCT01795235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24966367|NCT03768882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24966368|NCT03768882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24966369|NCT03768882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24966370|NCT03768869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24966371|NCT03768869|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24966372|NCT03768869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24966373|NCT03768869|Antitubercular Agents|antitubercular agents|mesh-ancestor
24966375|NCT03768713|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24966376|NCT03768713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24966377|NCT03768713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24966379|NCT03768713|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
24532575|NCT00640549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24532576|NCT00640549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24532577|NCT00640549|Antimetabolites|antimetabolites|mesh-ancestor
25080356|NCT03339804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25080357|NCT03339804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25080358|NCT03339804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25080359|NCT03339804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25080360|NCT03339804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25080361|NCT03339804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25080362|NCT03339752|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25080363|NCT03339752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25685635|NCT01908582|Antitubercular Agents|antitubercular agents|mesh-ancestor
25685636|NCT01908582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25685637|NCT01908582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25685638|NCT01908582|Leprostatic Agents|leprostatic agents|mesh-ancestor
25685639|NCT01908582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25685640|NCT01908582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25685641|NCT01908582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685642|NCT01908582|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25685643|NCT01908582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25685644|NCT01908582|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25685645|NCT01908582|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25685646|NCT01908582|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25124851|NCT03072329|Bupivacaine|bupivacaine|mesh-list
25124852|NCT03072329|Anesthetics, Local|anesthetics, local|mesh-ancestor
25124853|NCT03072329|Anesthetics|anesthetics|mesh-ancestor
25685647|NCT01908582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25124854|NCT03072329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25124855|NCT03072329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124856|NCT03072329|Sensory System Agents|sensory system agents|mesh-ancestor
25124857|NCT03072329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124859|NCT03072082|Metoprolol|metoprolol|mesh-list
25124860|NCT03072082|Isosorbide|isosorbide|mesh-list
25124861|NCT03072082|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25124862|NCT03072082|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25124863|NCT03072082|Trimetazidine|trimetazidine|mesh-list
25124864|NCT03072082|Clopidogrel|clopidogrel|mesh-list
25124865|NCT03072082|Atorvastatin|atorvastatin|mesh-list
25124866|NCT03072082|Calcium|calcium|mesh-list
24747503|NCT00700882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24747504|NCT00700882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24747570|NCT00496795|Docetaxel|docetaxel|mesh-list
24747571|NCT00496795|Epirubicin|epirubicin|mesh-list
25080364|NCT03339752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25080365|NCT03339752|Antimetabolites|antimetabolites|mesh-ancestor
25080366|NCT03339752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903754|NCT04361370|Olaparib|olaparib|mesh-list
24766547|NCT01795248|Liraglutide|liraglutide|mesh-list
24766548|NCT01795248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24766549|NCT01795248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766550|NCT01795248|Incretins|incretins|mesh-ancestor
24766551|NCT01795248|Hormones|hormones|mesh-ancestor
24766552|NCT01795248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24766553|NCT01795287|Anesthetics|anesthetics|mesh-list
24766554|NCT01795287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24766555|NCT01795287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766564|NCT01795430|Melphalan|melphalan|mesh-list
24766565|NCT01795430|Busulfan|busulfan|mesh-list
24766566|NCT01795430|Topotecan|topotecan|mesh-list
24766567|NCT01795430|Ifosfamide|ifosfamide|mesh-list
24766568|NCT01795430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24766569|NCT01795430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24766570|NCT01795430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24766571|NCT01795430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24766572|NCT01795430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24766573|NCT01795430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766574|NCT01795430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24766580|NCT01795430|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24766581|NCT01795599|Mifepristone|mifepristone|mesh-list
24766582|NCT01795599|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24404530|NCT00163761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24404531|NCT00163761|Tubulin Modulators|tubulin modulators|mesh-ancestor
24766583|NCT01795599|Abortifacient Agents|abortifacient agents|mesh-ancestor
24766584|NCT01795599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24766585|NCT01795599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766586|NCT01795599|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24766587|NCT01795599|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24766588|NCT01795599|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24766591|NCT01795599|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24766593|NCT01795599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24766594|NCT01795599|Luteolytic Agents|luteolytic agents|mesh-ancestor
24766595|NCT01795599|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25685648|NCT01908582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25685649|NCT01908582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25685650|NCT01908582|Antimetabolites|antimetabolites|mesh-ancestor
25685651|NCT01908582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25685652|NCT01908699|Beraprost|beraprost|mesh-list
25685653|NCT01908699|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25685654|NCT01908699|Vasodilator Agents|vasodilator agents|mesh-ancestor
25685655|NCT01908751|Vitamin D|vitamin d|mesh-list
25685656|NCT01908751|Ergocalciferols|ergocalciferols|mesh-list
25685657|NCT01908751|Cholecalciferol|cholecalciferol|mesh-list
25685658|NCT01908751|Vitamins|vitamins|mesh-list
25685659|NCT01908751|Micronutrients|micronutrients|mesh-ancestor
25685660|NCT01908751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685661|NCT01908751|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25685662|NCT01908751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25685663|NCT01908803|Ciprofloxacin|ciprofloxacin|mesh-list
25685664|NCT01908803|Dexamethasone|dexamethasone|mesh-list
25685665|NCT01908803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24618694|NCT01049464|Analgesics|analgesics|mesh-ancestor
24618695|NCT01049464|Sensory System Agents|sensory system agents|mesh-ancestor
24618696|NCT01049464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24618697|NCT01049464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618698|NCT01049464|Anesthetics|anesthetics|mesh-ancestor
24766596|NCT01795599|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24766597|NCT01795664|Fluticasone|fluticasone|mesh-list
24766624|NCT01795703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24766626|NCT01795703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24766627|NCT01795703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24766629|NCT01795794|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24766630|NCT01795794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24766631|NCT01795794|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24766632|NCT01795794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24766633|NCT01795794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766634|NCT01795820|Ticagrelor|ticagrelor|mesh-list
24766635|NCT01795820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24766636|NCT01795820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24766637|NCT01795820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24766638|NCT01795820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24788532|NCT01932177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24788533|NCT01932177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788534|NCT01932177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788535|NCT01932203|Aspirin|aspirin|mesh-list
24788536|NCT01932203|Cilostazol|cilostazol|mesh-list
24781265|NCT01888757|Lamotrigine|lamotrigine|mesh-list
24404532|NCT00163761|Antimitotic Agents|antimitotic agents|mesh-ancestor
24404533|NCT00163761|Mitosis Modulators|mitosis modulators|mesh-ancestor
24404534|NCT00163761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24404535|NCT00163761|Alkylating Agents|alkylating agents|mesh-ancestor
24404536|NCT00163969|Ketamine|ketamine|mesh-list
24888466|NCT04504851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788537|NCT01932203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24788538|NCT01932203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24788539|NCT01932203|Analgesics|analgesics|mesh-ancestor
24788540|NCT01932203|Sensory System Agents|sensory system agents|mesh-ancestor
24788541|NCT01932203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24788542|NCT01932203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766639|NCT01795820|Purinergic Agents|purinergic agents|mesh-ancestor
24766640|NCT01795820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24766641|NCT01795820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766642|NCT01795820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766643|NCT01795976|Cyclophosphamide|cyclophosphamide|mesh-list
24766670|NCT01796028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766672|NCT01796093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24766673|NCT01796093|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24766674|NCT01796093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24766675|NCT01796093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766676|NCT01796093|Protective Agents|protective agents|mesh-ancestor
24766677|NCT01796093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766678|NCT01796106|Fluorides|fluorides|mesh-list
24766679|NCT01796106|Fluorides, Topical|fluorides, topical|mesh-list
24766680|NCT01796106|Cariostatic Agents|cariostatic agents|mesh-ancestor
24766681|NCT01796106|Protective Agents|protective agents|mesh-ancestor
24766682|NCT01796106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766683|NCT01796132|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24766684|NCT01796132|Fluvoxamine|fluvoxamine|mesh-list
24766685|NCT01796132|Citalopram|citalopram|mesh-list
24766686|NCT01796132|Fluoxetine|fluoxetine|mesh-list
24766687|NCT01796132|Paroxetine|paroxetine|mesh-list
24766688|NCT01796132|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25685666|NCT01908803|Antiemetics|antiemetics|mesh-ancestor
25685667|NCT01908803|Autonomic Agents|autonomic agents|mesh-ancestor
25685668|NCT01908803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25685669|NCT01908803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685670|NCT01908803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25685671|NCT01908803|Glucocorticoids|glucocorticoids|mesh-ancestor
25685672|NCT01908803|Hormones|hormones|mesh-ancestor
25685673|NCT01908803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24748277|NCT02750319|Antioxidants|antioxidants|mesh-ancestor
24748278|NCT02750319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748279|NCT02750319|Protective Agents|protective agents|mesh-ancestor
24655054|NCT01254006|Vitamins|vitamins|mesh-ancestor
24437230|NCT00273026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25124895|NCT03072082|Sympatholytics|sympatholytics|mesh-ancestor
25124896|NCT03072082|Autonomic Agents|autonomic agents|mesh-ancestor
24766689|NCT01796132|Sertraline|sertraline|mesh-list
24766690|NCT01796132|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24766691|NCT01796132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24766692|NCT01796132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24766694|NCT01796132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24766697|NCT01796132|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24766699|NCT01796132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24766730|NCT01796418|Vasodilator Agents|vasodilator agents|mesh-ancestor
24766732|NCT01796444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24766733|NCT01796444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766734|NCT01796483|Clonidine|clonidine|mesh-list
24766735|NCT01796483|Analgesics|analgesics|mesh-ancestor
24766736|NCT01796483|Sensory System Agents|sensory system agents|mesh-ancestor
24766737|NCT01796483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24766738|NCT01796483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766739|NCT01796483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24766740|NCT01796483|Sympatholytics|sympatholytics|mesh-ancestor
24766741|NCT01796483|Autonomic Agents|autonomic agents|mesh-ancestor
24766742|NCT01796483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24766768|NCT01796613|Contraceptive Agents|contraceptive agents|mesh-ancestor
24766769|NCT01796613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24766770|NCT01796613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457959|NCT00335920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24457961|NCT00335920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24457963|NCT00335933|Analgesics|analgesics|mesh-ancestor
24457964|NCT00335933|Sensory System Agents|sensory system agents|mesh-ancestor
24457967|NCT00335933|Anticonvulsants|anticonvulsants|mesh-ancestor
24766771|NCT01796613|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24766773|NCT01796613|Hormones|hormones|mesh-ancestor
25080377|NCT03339700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24766774|NCT01796613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24766775|NCT01796613|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24766776|NCT01796613|Progestins|progestins|mesh-ancestor
24766797|NCT01796808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24903999|NCT04359485|Glycolic acid|glycolic acid|mesh-list
24766821|NCT01796938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766823|NCT01796951|Celecoxib|celecoxib|mesh-list
24766824|NCT01796951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24766825|NCT01796951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24766826|NCT01796951|Analgesics|analgesics|mesh-ancestor
24766827|NCT01796951|Sensory System Agents|sensory system agents|mesh-ancestor
24766828|NCT01796951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24766829|NCT01796951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623567|NCT01072318|Letrozole|letrozole|mesh-list
24766830|NCT01796951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24766831|NCT01796951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24766832|NCT01796951|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24766833|NCT01796951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24766834|NCT01796951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766835|NCT01796951|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24766836|NCT01796951|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24766837|NCT01796951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25685674|NCT01908803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25685675|NCT01908803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25685676|NCT01908803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25685677|NCT01908803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25685678|NCT01908803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25685679|NCT01908803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24766839|NCT01796951|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24766840|NCT01797107|Azithromycin|azithromycin|mesh-list
24766841|NCT01797107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24766842|NCT01797107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24766843|NCT01797133|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24766844|NCT01797133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24766845|NCT01797133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24766846|NCT01797133|Antitubercular Agents|antitubercular agents|mesh-ancestor
24557748|NCT00753779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24766847|NCT01797198|Repaglinide|repaglinide|mesh-list
24766877|NCT01797341|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24766878|NCT01797341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24766879|NCT01797341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766880|NCT01797601|Insulin|insulin|mesh-list
24766881|NCT01797601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24766882|NCT01797601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24766883|NCT01797601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766885|NCT01797666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24766886|NCT01797666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766887|NCT01797718|Letrozole|letrozole|mesh-list
24766888|NCT01797718|Testosterone|testosterone|mesh-list
24766889|NCT01797718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24766890|NCT01797718|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24766920|NCT01797900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24766921|NCT01797900|Tubulin Modulators|tubulin modulators|mesh-ancestor
24766922|NCT01797900|Antimitotic Agents|antimitotic agents|mesh-ancestor
24766923|NCT01797900|Mitosis Modulators|mitosis modulators|mesh-ancestor
24766924|NCT01797900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766925|NCT01797913|Gemcitabine|gemcitabine|mesh-list
25080378|NCT03339700|Alkylating Agents|alkylating agents|mesh-ancestor
25080379|NCT03339700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966420|NCT03768258|Testosterone undecanoate|testosterone undecanoate|mesh-list
24966422|NCT03768258|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24966423|NCT03768258|Androgens|androgens|mesh-ancestor
24966425|NCT03768258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24966426|NCT03768258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818396|NCT02088502|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24766950|NCT01797978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766951|NCT01797991|Dexamethasone|dexamethasone|mesh-list
24766952|NCT01797991|Dexamethasone acetate|dexamethasone acetate|mesh-list
24766953|NCT01797991|BB 1101|bb 1101|mesh-list
24766954|NCT01797991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24766955|NCT01797991|Antiemetics|antiemetics|mesh-ancestor
24766956|NCT01797991|Autonomic Agents|autonomic agents|mesh-ancestor
24766957|NCT01797991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24766958|NCT01797991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766959|NCT01797991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24766960|NCT01797991|Glucocorticoids|glucocorticoids|mesh-ancestor
24766961|NCT01797991|Hormones|hormones|mesh-ancestor
24888467|NCT04504851|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24766963|NCT01797991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24766975|NCT01798017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24766976|NCT01798017|Oxytocics|oxytocics|mesh-ancestor
24766977|NCT01798017|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24766979|NCT01798017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24766980|NCT01798017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24766981|NCT01798017|Contraceptive Agents|contraceptive agents|mesh-ancestor
24766982|NCT01798017|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24766983|NCT01798017|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24766984|NCT01798017|Hormone Antagonists|hormone antagonists|mesh-ancestor
24766985|NCT01798017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24766986|NCT01798017|Luteolytic Agents|luteolytic agents|mesh-ancestor
24766987|NCT01798017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24766988|NCT01798017|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24766989|NCT01798030|Vitamin D|vitamin d|mesh-list
24766990|NCT01798030|Vitamins|vitamins|mesh-ancestor
24766991|NCT01798030|Micronutrients|micronutrients|mesh-ancestor
24766992|NCT01798030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766993|NCT01798030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24766994|NCT01798108|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
24557967|NCT00755014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557968|NCT00755027|Rasagiline|rasagiline|mesh-list
24413885|NCT00195559|Estrogens|estrogens|mesh-ancestor
24404597|NCT00164125|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24557969|NCT00755027|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24557970|NCT00755027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557971|NCT00755027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557972|NCT00755027|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24767039|NCT01798472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24767040|NCT01798472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24767041|NCT01798472|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24767042|NCT01798472|Histamine Antagonists|histamine antagonists|mesh-ancestor
24767043|NCT01798472|Histamine Agents|histamine agents|mesh-ancestor
24767063|NCT01798537|Ionophores|ionophores|mesh-ancestor
24767064|NCT01798537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24767065|NCT01798537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767066|NCT01798537|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24767067|NCT01798537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767068|NCT01798576|Interferons|interferons|mesh-list
24767069|NCT01798576|Ribavirin|ribavirin|mesh-list
24767070|NCT01798576|Interferon-alpha|interferon-alpha|mesh-list
24767071|NCT01798576|Interferon alpha-2|interferon alpha-2|mesh-list
24767072|NCT01798576|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24767073|NCT01798576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767074|NCT01798576|Antiviral Agents|antiviral agents|mesh-ancestor
24767075|NCT01798576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24767076|NCT01798576|Antimetabolites|antimetabolites|mesh-ancestor
24767077|NCT01798576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767078|NCT01798576|Immunologic Factors|immunologic factors|mesh-ancestor
24767079|NCT01798576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767080|NCT01798602|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24767081|NCT01798602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24767082|NCT01798602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24767083|NCT01798602|Antimetabolites|antimetabolites|mesh-ancestor
25080393|NCT03339544|Sensory System Agents|sensory system agents|mesh-ancestor
24781587|NCT01890863|Autonomic Agents|autonomic agents|mesh-ancestor
24767084|NCT01798602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767085|NCT01798602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24767086|NCT01798602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24767088|NCT01798628|Abiraterone Acetate|abiraterone acetate|mesh-list
24767142|NCT01798979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24767143|NCT01798979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24767144|NCT01798979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24767145|NCT01798979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767146|NCT01798979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24767147|NCT01798979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24767148|NCT01798979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24767149|NCT01798979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24767150|NCT01798979|Anesthetics, General|anesthetics, general|mesh-ancestor
24767152|NCT01798979|GABA Modulators|gaba modulators|mesh-ancestor
24767153|NCT01798979|GABA Agents|gaba agents|mesh-ancestor
24767154|NCT01798979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24767155|NCT01798979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767156|NCT01799005|Micronutrients|micronutrients|mesh-list
24767157|NCT01799005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767158|NCT01799057|Metformin|metformin|mesh-list
24767159|NCT01799057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24767160|NCT01799057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767161|NCT01799083|Decitabine|decitabine|mesh-list
24767162|NCT01799083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24767163|NCT01799083|Antimetabolites|antimetabolites|mesh-ancestor
24767164|NCT01799083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767165|NCT01799083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767166|NCT01799083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767169|NCT01799109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24767170|NCT01799109|Autonomic Agents|autonomic agents|mesh-ancestor
24767171|NCT01799109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24767172|NCT01799109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904363|NCT04356144|Thrombin|thrombin|mesh-list
25080398|NCT03339544|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25080399|NCT03339544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25080400|NCT03339544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25685680|NCT01908803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124956|NCT03072121|Antimetabolites|antimetabolites|mesh-ancestor
25124957|NCT03072121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25124958|NCT03072121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25124959|NCT03072121|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25124961|NCT03072121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25080402|NCT03339427|Vitamin D|vitamin d|mesh-list
25080411|NCT03339362|Anesthetics|anesthetics|mesh-ancestor
25080412|NCT03339362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25080413|NCT03339362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080414|NCT03339362|Sensory System Agents|sensory system agents|mesh-ancestor
25080415|NCT03339362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25080416|NCT03339362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25080417|NCT03339362|Antiemetics|antiemetics|mesh-ancestor
25080418|NCT03339362|Autonomic Agents|autonomic agents|mesh-ancestor
25080419|NCT03339362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25080420|NCT03339362|Glucocorticoids|glucocorticoids|mesh-ancestor
25080421|NCT03339362|Hormones|hormones|mesh-ancestor
25080422|NCT03339362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25080423|NCT03339362|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25080424|NCT03339362|Protective Agents|protective agents|mesh-ancestor
25080425|NCT03339349|Enoxaparin|enoxaparin|mesh-list
25080426|NCT03339349|Anticoagulants|anticoagulants|mesh-ancestor
25080427|NCT03339349|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25080428|NCT03339349|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25080429|NCT03339349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080430|NCT03339258|Doxazosin|doxazosin|mesh-list
25080431|NCT03339258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25080432|NCT03339258|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24767201|NCT01799161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24767202|NCT01799161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767203|NCT01799161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767204|NCT01799161|Vasodilator Agents|vasodilator agents|mesh-ancestor
24767205|NCT01799161|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24767206|NCT01799161|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24767207|NCT01799161|Purinergic Agents|purinergic agents|mesh-ancestor
24767208|NCT01799161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24767210|NCT01799317|Ergocalciferols|ergocalciferols|mesh-list
24767211|NCT01799317|Vitamins|vitamins|mesh-ancestor
24767212|NCT01799317|Micronutrients|micronutrients|mesh-ancestor
24767213|NCT01799317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767247|NCT01799460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24888468|NCT04504851|Antitubercular Agents|antitubercular agents|mesh-ancestor
24404709|NCT00164710|Dapsone|dapsone|mesh-list
24767251|NCT01799460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24767252|NCT01799460|Dermatologic Agents|dermatologic agents|mesh-ancestor
24767254|NCT01799460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24767257|NCT01799486|Antiviral Agents|antiviral agents|mesh-ancestor
24767258|NCT01799486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24767259|NCT01799486|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24767260|NCT01799486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24767262|NCT01799486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767264|NCT01799603|Antiviral Agents|antiviral agents|mesh-ancestor
24767265|NCT01799603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24767266|NCT01799603|Protease Inhibitors|protease inhibitors|mesh-ancestor
24904490|NCT04355494|Eculizumab|eculizumab|mesh-list
24767299|NCT01799902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24558225|NCT00755859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24767300|NCT01799902|Cholinergic Agents|cholinergic agents|mesh-ancestor
24767301|NCT01799902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24767302|NCT01799902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767303|NCT01799902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767304|NCT01799902|Urological Agents|urological agents|mesh-ancestor
24767305|NCT01799954|Vaccines|vaccines|mesh-list
24767306|NCT01799954|Immunologic Factors|immunologic factors|mesh-ancestor
24767307|NCT01799954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767308|NCT01800006|Rivaroxaban|rivaroxaban|mesh-list
25685681|NCT01908803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685682|NCT01908803|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25685683|NCT01908803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25685684|NCT01908816|Ranibizumab|ranibizumab|mesh-list
25685685|NCT01908816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25685686|NCT01908816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24767336|NCT01800227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24767337|NCT01800227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767351|NCT01800357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24767414|NCT01800643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767415|NCT01800643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24767416|NCT01800643|Immunologic Factors|immunologic factors|mesh-ancestor
24767417|NCT01800643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818468|NCT02088970|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24767446|NCT01800799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25030120|NCT03598374|Folic Acid|folic acid|mesh-list
24767447|NCT01800799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24767448|NCT01800799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24767449|NCT01800799|Analgesics|analgesics|mesh-ancestor
24767450|NCT01800799|Sensory System Agents|sensory system agents|mesh-ancestor
24767451|NCT01800799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24767452|NCT01800799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767454|NCT01800799|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24767455|NCT01800799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24767456|NCT01800799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767457|NCT01800799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767458|NCT01800825|Clindamycin|clindamycin|mesh-list
24767459|NCT01800825|Clindamycin palmitate|clindamycin palmitate|mesh-list
24767460|NCT01800825|Clindamycin phosphate|clindamycin phosphate|mesh-list
24767461|NCT01800825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24767462|NCT01800825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24767463|NCT01800825|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24767464|NCT01800825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24888470|NCT04504851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24888471|NCT04504851|Leprostatic Agents|leprostatic agents|mesh-ancestor
24888472|NCT04504851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24888473|NCT04504851|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24888474|NCT04504851|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25080458|NCT03338348|Antimetabolites|antimetabolites|mesh-ancestor
25080459|NCT03338348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080460|NCT03338348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25080461|NCT03338348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404778|NCT00164801|Baclofen|baclofen|mesh-list
24404841|NCT00165035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404842|NCT00165048|Rofecoxib|rofecoxib|mesh-list
24811603|NCT02047422|Spironolactone|spironolactone|mesh-list
24811604|NCT02047422|Diuretics|diuretics|mesh-ancestor
24811605|NCT02047422|Natriuretic Agents|natriuretic agents|mesh-ancestor
24811606|NCT02047422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080465|NCT03338205|Ketamine|ketamine|mesh-list
25080466|NCT03338205|Analgesics|analgesics|mesh-ancestor
25080467|NCT03338205|Sensory System Agents|sensory system agents|mesh-ancestor
25080468|NCT03338205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25080469|NCT03338205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080470|NCT03338205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25080471|NCT03338205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25080472|NCT03338205|Anesthetics, General|anesthetics, general|mesh-ancestor
25080473|NCT03338205|Anesthetics|anesthetics|mesh-ancestor
25080474|NCT03338205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25080475|NCT03338205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24781656|NCT01891175|Anesthetics|anesthetics|mesh-list
24888549|NCT04502771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24888550|NCT04502771|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24888551|NCT04502771|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24888552|NCT04502771|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24888553|NCT04502771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24888554|NCT04502771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888555|NCT04502771|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24888556|NCT04502771|Hormone Antagonists|hormone antagonists|mesh-ancestor
24888557|NCT04502771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24888558|NCT04502771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888559|NCT04502771|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24888560|NCT04502771|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24888561|NCT04502849|Vitamin E|vitamin e|mesh-list
24888562|NCT04502849|Tocopherols|tocopherols|mesh-list
24752354|NCT01709994|Antipyretics|antipyretics|mesh-ancestor
24888563|NCT04502849|alpha-Tocopherol|alpha-tocopherol|mesh-list
24888564|NCT04502849|Vitamins|vitamins|mesh-ancestor
24888565|NCT04502849|Micronutrients|micronutrients|mesh-ancestor
24888566|NCT04502849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888567|NCT04502849|Antioxidants|antioxidants|mesh-ancestor
24888576|NCT04502641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888577|NCT04502641|Antimetabolites|antimetabolites|mesh-ancestor
24888578|NCT04502641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24888579|NCT04502641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24888580|NCT04502641|Immunologic Factors|immunologic factors|mesh-ancestor
24888581|NCT04502641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888582|NCT04502537|Epoetin Alfa|epoetin alfa|mesh-list
24888583|NCT04502537|Hematinics|hematinics|mesh-ancestor
24888584|NCT04502368|Dimercaprol|dimercaprol|mesh-list
24610881|NCT01005641|Exemestane|exemestane|mesh-list
24888585|NCT04502368|Chelating Agents|chelating agents|mesh-ancestor
24888632|NCT04501965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24888633|NCT04501965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24888634|NCT04501965|Antimalarials|antimalarials|mesh-ancestor
24888635|NCT04501965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24888636|NCT04501965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24888637|NCT04501965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24888638|NCT04501965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080476|NCT03338205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25080477|NCT03338205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25080478|NCT03338205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080480|NCT03337932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25080481|NCT03337932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25080482|NCT03337932|Antimalarials|antimalarials|mesh-ancestor
25080483|NCT03337932|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25080484|NCT03337932|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25080485|NCT03337841|Pembrolizumab|pembrolizumab|mesh-list
25080486|NCT03337841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25080487|NCT03337841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25080488|NCT03337828|Ethanol|ethanol|mesh-list
25080489|NCT03337828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25080490|NCT03337828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25080491|NCT03337828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25080492|NCT03337828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767471|NCT01801046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24767472|NCT01801046|Antimetabolites|antimetabolites|mesh-ancestor
24767473|NCT01801046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767474|NCT01801046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767475|NCT01801046|Antiviral Agents|antiviral agents|mesh-ancestor
24767476|NCT01801046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24767477|NCT01801046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24767478|NCT01801046|Immunologic Factors|immunologic factors|mesh-ancestor
24767577|NCT01802268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24767578|NCT01802268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24767579|NCT01802268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767580|NCT01802268|Antifungal Agents|antifungal agents|mesh-ancestor
24767581|NCT01802450|Dasatinib|dasatinib|mesh-list
24767582|NCT01802450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767583|NCT01802450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24767584|NCT01802450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620435|NCT01057069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24620436|NCT01057069|Alkylating Agents|alkylating agents|mesh-ancestor
24767656|NCT01802645|Levoleucovorin|levoleucovorin|mesh-list
24404934|NCT00165178|Immunologic Factors|immunologic factors|mesh-ancestor
24767657|NCT01802645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24767658|NCT01802645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767659|NCT01802645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24767660|NCT01802645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24767661|NCT01802645|Growth Substances|growth substances|mesh-ancestor
24767662|NCT01802645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767663|NCT01802645|Growth Inhibitors|growth inhibitors|mesh-ancestor
24767664|NCT01802645|Antimetabolites|antimetabolites|mesh-ancestor
24767665|NCT01802645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767666|NCT01802645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24767687|NCT01802684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767688|NCT01802749|Gemcitabine|gemcitabine|mesh-list
24767689|NCT01802749|Paclitaxel|paclitaxel|mesh-list
24619208|NCT01051388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24619209|NCT01051388|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24619210|NCT01051388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767690|NCT01802749|Bevacizumab|bevacizumab|mesh-list
24767691|NCT01802749|Carboplatin|carboplatin|mesh-list
24767692|NCT01802749|Doxorubicin|doxorubicin|mesh-list
24767693|NCT01802749|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24767694|NCT01802749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24767695|NCT01802749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767696|NCT01802749|Tubulin Modulators|tubulin modulators|mesh-ancestor
24767697|NCT01802749|Antimitotic Agents|antimitotic agents|mesh-ancestor
24767698|NCT01802749|Mitosis Modulators|mitosis modulators|mesh-ancestor
24767699|NCT01802749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767700|NCT01802749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24767701|NCT01802749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24767702|NCT01802749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24491010|NCT00480844|Risperidone|risperidone|mesh-list
24767703|NCT01802749|Growth Substances|growth substances|mesh-ancestor
24767704|NCT01802749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767705|NCT01802749|Growth Inhibitors|growth inhibitors|mesh-ancestor
24767706|NCT01802749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24767707|NCT01802749|Antimetabolites|antimetabolites|mesh-ancestor
24767708|NCT01802749|Antiviral Agents|antiviral agents|mesh-ancestor
24767709|NCT01802749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24767711|NCT01802749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24767712|NCT01802749|Immunologic Factors|immunologic factors|mesh-ancestor
24405008|NCT00165295|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24767713|NCT01802749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24767714|NCT01802749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24767715|NCT01802749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24767720|NCT01802892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24767721|NCT01802892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24767722|NCT01802892|Antiviral Agents|antiviral agents|mesh-ancestor
24904949|NCT04352062|Melatonin|melatonin|mesh-list
24767744|NCT01802931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24767745|NCT01802931|Hormone Antagonists|hormone antagonists|mesh-ancestor
25080495|NCT03337672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24767754|NCT01802970|Capecitabine|capecitabine|mesh-list
24767755|NCT01802970|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24767756|NCT01802970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24767757|NCT01802970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767758|NCT01802970|Tubulin Modulators|tubulin modulators|mesh-ancestor
24767759|NCT01802970|Antimitotic Agents|antimitotic agents|mesh-ancestor
24767760|NCT01802970|Mitosis Modulators|mitosis modulators|mesh-ancestor
24767761|NCT01802970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767762|NCT01802970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24405009|NCT00165295|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24811609|NCT02047422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811610|NCT02047422|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24811611|NCT02047422|Hormone Antagonists|hormone antagonists|mesh-ancestor
24405010|NCT00165295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24558774|NCT05434884|Salicylic Acid|salicylic acid|mesh-list
24558775|NCT05434884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24558776|NCT05434884|Antifungal Agents|antifungal agents|mesh-ancestor
24558777|NCT05434884|Keratolytic Agents|keratolytic agents|mesh-ancestor
24558778|NCT05434884|Dermatologic Agents|dermatologic agents|mesh-ancestor
24558779|NCT05434689|Dexamethasone|dexamethasone|mesh-list
24558780|NCT05434689|Daratumumab|daratumumab|mesh-list
24558782|NCT05434689|Antiemetics|antiemetics|mesh-ancestor
24558784|NCT05434689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24558785|NCT05434689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558786|NCT05434689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24558787|NCT05434689|Glucocorticoids|glucocorticoids|mesh-ancestor
25685687|NCT01908816|Growth Substances|growth substances|mesh-ancestor
25685688|NCT01908816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685689|NCT01908816|Growth Inhibitors|growth inhibitors|mesh-ancestor
25685690|NCT01908816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25685691|NCT01908829|Solifenacin Succinate|solifenacin succinate|mesh-list
25685692|NCT01908829|Mirabegron|mirabegron|mesh-list
24767873|NCT01804205|Analgesics|analgesics|mesh-ancestor
24767874|NCT01804205|Sensory System Agents|sensory system agents|mesh-ancestor
24767875|NCT01804205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24767876|NCT01804205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767877|NCT01804205|Anesthetics|anesthetics|mesh-ancestor
24767878|NCT01804205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24767879|NCT01804205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24767880|NCT01804205|Anticonvulsants|anticonvulsants|mesh-ancestor
24767881|NCT01804205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24767882|NCT01804205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24767883|NCT01804205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767884|NCT01804205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24767885|NCT01804205|Tocolytic Agents|tocolytic agents|mesh-ancestor
24767886|NCT01804205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24781746|NCT01891643|Elotuzumab|elotuzumab|mesh-list
24888639|NCT04501965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24888710|NCT04501367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888712|NCT04501107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24888713|NCT04501107|Insulin Lispro|insulin lispro|mesh-list
24405057|NCT00165399|Androgen Antagonists|androgen antagonists|mesh-ancestor
24888714|NCT04501107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24888715|NCT04501107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888716|NCT04501250|Insulin|insulin|mesh-list
24888717|NCT04501250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24888864|NCT04499898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888867|NCT04499898|Antioxidants|antioxidants|mesh-ancestor
24888868|NCT04499898|Protective Agents|protective agents|mesh-ancestor
24888869|NCT04499898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24888870|NCT04499898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24888871|NCT04499898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24888875|NCT04499885|Mineral Oil|mineral oil|mesh-list
24888877|NCT04499885|Dermatologic Agents|dermatologic agents|mesh-ancestor
24767888|NCT01804218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24767890|NCT01804218|Adrenergic Agents|adrenergic agents|mesh-ancestor
24767891|NCT01804218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24767919|NCT01804361|Dermatologic Agents|dermatologic agents|mesh-ancestor
24767920|NCT01804361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24767921|NCT01804361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24767922|NCT01804374|Everolimus|everolimus|mesh-list
24767923|NCT01804374|Sorafenib|sorafenib|mesh-list
24767924|NCT01804374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767925|NCT01804374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24767926|NCT01804374|Immunologic Factors|immunologic factors|mesh-ancestor
24767927|NCT01804374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767928|NCT01804374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24767929|NCT01804374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767930|NCT01804374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767931|NCT01804387|Lamivudine|lamivudine|mesh-list
24767933|NCT01804387|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
24767934|NCT01804387|Telbivudine|telbivudine|mesh-list
24405058|NCT00165399|Hormone Antagonists|hormone antagonists|mesh-ancestor
24405060|NCT00165399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445717|NCT00302354|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24540515|NCT00668239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540517|NCT00668304|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24767935|NCT01804387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24767936|NCT01804387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24767937|NCT01804387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767938|NCT01804387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767962|NCT01804595|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24767963|NCT01804595|Protective Agents|protective agents|mesh-ancestor
24767964|NCT01804595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767965|NCT01804595|Dermatologic Agents|dermatologic agents|mesh-ancestor
24767966|NCT01804712|Rituximab|rituximab|mesh-list
24767967|NCT01804712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24767968|NCT01804712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767969|NCT01804712|Immunologic Factors|immunologic factors|mesh-ancestor
24767970|NCT01804712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754007|NCT01718652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24754009|NCT01718678|Antioxidants|antioxidants|mesh-ancestor
24754010|NCT01718678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754011|NCT01718678|Protective Agents|protective agents|mesh-ancestor
24767971|NCT01804712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24767972|NCT01804777|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24767973|NCT01804777|Amiloride|amiloride|mesh-list
24767974|NCT01804777|Diuretics|diuretics|mesh-ancestor
24767975|NCT01804777|Natriuretic Agents|natriuretic agents|mesh-ancestor
24767977|NCT01804777|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24767978|NCT01804777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24767979|NCT01804777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24767980|NCT01804777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767981|NCT01804777|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24767982|NCT01804777|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24767983|NCT01804777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24767984|NCT01804777|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24768015|NCT01805232|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24768016|NCT01805232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768017|NCT01805232|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24966503|NCT03767335|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24966504|NCT03767335|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24966505|NCT03767335|Hormone Antagonists|hormone antagonists|mesh-ancestor
24405098|NCT00165464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24405099|NCT00165464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24405105|NCT00165477|Lenalidomide|lenalidomide|mesh-list
24966506|NCT03767335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24966507|NCT03767335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080496|NCT03337672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25080497|NCT03337672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080498|NCT03337672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25080499|NCT03337672|Analgesics|analgesics|mesh-ancestor
25080500|NCT03337672|Sensory System Agents|sensory system agents|mesh-ancestor
25080501|NCT03337672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25080502|NCT03337672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24512775|NCT00576550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24512776|NCT00576550|Glucocorticoids|glucocorticoids|mesh-ancestor
24512778|NCT00576550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24512779|NCT00576550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888908|NCT04499573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24888909|NCT04499573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24888911|NCT04499573|Antiemetics|antiemetics|mesh-ancestor
24512781|NCT00576550|Respiratory System Agents|respiratory system agents|mesh-ancestor
25080503|NCT03337672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25080504|NCT03337672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25080505|NCT03337672|Adrenergic Agents|adrenergic agents|mesh-ancestor
24405140|NCT00165555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24405141|NCT00165555|Chelating Agents|chelating agents|mesh-ancestor
24405142|NCT00165555|Sequestering Agents|sequestering agents|mesh-ancestor
25080506|NCT03337672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25080507|NCT03337672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768042|NCT01805388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24768044|NCT01805453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24768045|NCT01805453|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24768046|NCT01805453|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24768047|NCT01805453|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24768048|NCT01805453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768049|NCT01805531|Rivaroxaban|rivaroxaban|mesh-list
24768050|NCT01805531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24768051|NCT01805531|Antithrombins|antithrombins|mesh-ancestor
24768052|NCT01805531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24768053|NCT01805531|Protease Inhibitors|protease inhibitors|mesh-ancestor
24768054|NCT01805531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24768055|NCT01805531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685693|NCT01908829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25685694|NCT01908829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25685695|NCT01908829|Cholinergic Agents|cholinergic agents|mesh-ancestor
25685696|NCT01908829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24768056|NCT01805531|Anticoagulants|anticoagulants|mesh-ancestor
24768057|NCT01805544|Rivaroxaban|rivaroxaban|mesh-list
24768058|NCT01805544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24768059|NCT01805544|Antithrombins|antithrombins|mesh-ancestor
24768060|NCT01805544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24768061|NCT01805544|Protease Inhibitors|protease inhibitors|mesh-ancestor
24768062|NCT01805544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24768063|NCT01805544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768064|NCT01805544|Anticoagulants|anticoagulants|mesh-ancestor
24768067|NCT01805570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24768068|NCT01805570|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24768069|NCT01805570|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24512838|NCT00577057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512840|NCT00577109|Bevacizumab|bevacizumab|mesh-list
24512841|NCT00577109|Cetuximab|cetuximab|mesh-list
24512842|NCT00577109|Irinotecan|irinotecan|mesh-list
24889040|NCT04498793|Mitosis Modulators|mitosis modulators|mesh-ancestor
24466809|NCT00375076|Enoxaparin|enoxaparin|mesh-list
24512849|NCT00577109|Growth Inhibitors|growth inhibitors|mesh-ancestor
24512850|NCT00577109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24768073|NCT01805570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768074|NCT01805570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768075|NCT01805596|Clopidogrel|clopidogrel|mesh-list
24768076|NCT01805596|Ticagrelor|ticagrelor|mesh-list
24768077|NCT01805596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24768078|NCT01805596|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24768079|NCT01805596|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24768080|NCT01805596|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24768081|NCT01805596|Purinergic Agents|purinergic agents|mesh-ancestor
24624905|NCT01079312|Analgesics|analgesics|mesh-ancestor
24768082|NCT01805596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24768083|NCT01805596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768120|NCT01805817|Copper|copper|mesh-list
24768121|NCT01805817|Drospirenone|drospirenone|mesh-list
24768122|NCT01805817|Levonorgestrel|levonorgestrel|mesh-list
24768123|NCT01805817|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24768124|NCT01805817|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
24768125|NCT01805817|Estradiol|estradiol|mesh-list
24768126|NCT01805817|Estrogens|estrogens|mesh-ancestor
24768143|NCT01805817|Natriuretic Agents|natriuretic agents|mesh-ancestor
24768146|NCT01805856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24768147|NCT01805856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24768148|NCT01805908|Pertuzumab|pertuzumab|mesh-list
24768149|NCT01805908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24768150|NCT01805908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768151|NCT01805999|Psyllium|psyllium|mesh-list
24768152|NCT01805999|Calcium polycarbophil|calcium polycarbophil|mesh-list
24768153|NCT01805999|Cathartics|cathartics|mesh-ancestor
24768154|NCT01805999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24768155|NCT01805999|Antidiarrheals|antidiarrheals|mesh-ancestor
24512851|NCT00577109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24512852|NCT00577109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512853|NCT00577109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512854|NCT00577109|Antidotes|antidotes|mesh-ancestor
24512855|NCT00577109|Protective Agents|protective agents|mesh-ancestor
24512856|NCT00577109|Vitamin B Complex|vitamin b complex|mesh-ancestor
24512857|NCT00577109|Vitamins|vitamins|mesh-ancestor
24512909|NCT00577421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24512910|NCT00577421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24512911|NCT00577421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768156|NCT01806090|Clopidogrel|clopidogrel|mesh-list
24768187|NCT01806311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768188|NCT01806311|Vasodilator Agents|vasodilator agents|mesh-ancestor
24768189|NCT01806311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24405307|NCT00166465|Antimetabolites|antimetabolites|mesh-ancestor
24768190|NCT01806311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24768192|NCT01806324|Atorvastatin|atorvastatin|mesh-list
24768193|NCT01806324|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24768194|NCT01806324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24768195|NCT01806324|Antimetabolites|antimetabolites|mesh-ancestor
24768197|NCT01806324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24768198|NCT01806324|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24768199|NCT01806324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24768222|NCT01806415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24768223|NCT01806415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768225|NCT01806454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24768226|NCT01806454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768230|NCT01806753|Midazolam|midazolam|mesh-list
24768231|NCT01806753|Propofol|propofol|mesh-list
24768232|NCT01806753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24768233|NCT01806753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24768234|NCT01806753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768235|NCT01806753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24768236|NCT01806753|Anesthetics, General|anesthetics, general|mesh-ancestor
24768237|NCT01806753|Anesthetics|anesthetics|mesh-ancestor
24768238|NCT01806753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24768239|NCT01806753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24768240|NCT01806753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24768241|NCT01806753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24768242|NCT01806753|GABA Modulators|gaba modulators|mesh-ancestor
24512913|NCT00577421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512914|NCT00577421|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24512916|NCT00577668|Dexamethasone|dexamethasone|mesh-list
24768245|NCT01806753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768246|NCT01806792|Cholecalciferol|cholecalciferol|mesh-list
24768247|NCT01806792|Risedronic Acid|risedronic acid|mesh-list
24768248|NCT01806792|Etidronic Acid|etidronic acid|mesh-list
24768249|NCT01806792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24768250|NCT01806792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080576|NCT03337373|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25080578|NCT03337373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25080579|NCT03337373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080580|NCT03337282|Anesthetics|anesthetics|mesh-list
25080581|NCT03337282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25080582|NCT03337282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080583|NCT03337191|Morphine|morphine|mesh-list
25080584|NCT03337191|Levobupivacaine|levobupivacaine|mesh-list
25080585|NCT03337191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25080586|NCT03337191|Narcotics|narcotics|mesh-ancestor
25080587|NCT03337191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25080588|NCT03337191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080589|NCT03337191|Analgesics|analgesics|mesh-ancestor
25080590|NCT03337191|Sensory System Agents|sensory system agents|mesh-ancestor
25080623|NCT03336840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25080624|NCT03336840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080626|NCT03336840|Dermatologic Agents|dermatologic agents|mesh-ancestor
25080627|NCT03336840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25080628|NCT03336840|Histamine Antagonists|histamine antagonists|mesh-ancestor
24966582|NCT03766984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25080629|NCT03336840|Histamine Agents|histamine agents|mesh-ancestor
25080630|NCT03336840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25080631|NCT03336840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080632|NCT03336840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25080633|NCT03336840|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24405336|NCT00166491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405345|NCT00166556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24405346|NCT00166556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405359|NCT00166621|Buspirone|buspirone|mesh-list
24405360|NCT00166621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24405361|NCT00166621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24405362|NCT00166621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24405363|NCT00166621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405364|NCT00166621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24405365|NCT00166621|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24405369|NCT00166686|Clonidine|clonidine|mesh-list
24405383|NCT00166725|Octreotide|octreotide|mesh-list
24405384|NCT00166725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24405385|NCT00166725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24405386|NCT00166725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768323|NCT01807377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24768324|NCT01807377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768325|NCT01807429|Midazolam|midazolam|mesh-list
24768326|NCT01807429|Ketamine|ketamine|mesh-list
24768327|NCT01807429|Morphine|morphine|mesh-list
24768328|NCT01807429|Analgesics|analgesics|mesh-ancestor
24768329|NCT01807429|Sensory System Agents|sensory system agents|mesh-ancestor
24619534|NCT01052896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24619535|NCT01052896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24619536|NCT01052896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24768330|NCT01807429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24768331|NCT01807429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768332|NCT01807429|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24768333|NCT01807429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24768334|NCT01807429|Anesthetics, General|anesthetics, general|mesh-ancestor
24559411|NCT04908579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24768383|NCT01807611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24768386|NCT01807741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24768387|NCT01807741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24768388|NCT01807741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24768389|NCT01807741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768451|NCT01808300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24768452|NCT01808300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671016|NCT01323257|Ritonavir|ritonavir|mesh-list
24768453|NCT01808300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24768455|NCT01808300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24768458|NCT01808300|Antioxidants|antioxidants|mesh-ancestor
24768459|NCT01808300|Protective Agents|protective agents|mesh-ancestor
24768460|NCT01808300|Vitamin B Complex|vitamin b complex|mesh-ancestor
24768461|NCT01808300|Vitamins|vitamins|mesh-ancestor
24768462|NCT01808300|Micronutrients|micronutrients|mesh-ancestor
24768535|NCT01808898|Mepivacaine|mepivacaine|mesh-list
24768536|NCT01808898|Anesthetics|anesthetics|mesh-list
25080642|NCT03336840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25080644|NCT03336814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25080645|NCT03336814|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25080646|NCT03336801|Propofol|propofol|mesh-list
25080647|NCT03336801|Sevoflurane|sevoflurane|mesh-list
25080648|NCT03336801|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25080649|NCT03336801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25080650|NCT03336801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080651|NCT03336801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25080652|NCT03336801|Anesthetics, General|anesthetics, general|mesh-ancestor
25080653|NCT03336801|Anesthetics|anesthetics|mesh-ancestor
25080654|NCT03336801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25080655|NCT03336801|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24966650|NCT03766607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24768596|NCT01809340|Ketamine|ketamine|mesh-list
24768597|NCT01809340|Analgesics|analgesics|mesh-ancestor
24768598|NCT01809340|Sensory System Agents|sensory system agents|mesh-ancestor
24768599|NCT01809340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24559705|NCT04507906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24559706|NCT04507906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24559709|NCT04459598|Efavirenz|efavirenz|mesh-list
24559710|NCT04459598|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24559711|NCT04459598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24559712|NCT04459598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24559713|NCT04459598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24559714|NCT04459598|Antiviral Agents|antiviral agents|mesh-ancestor
24559715|NCT04459598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24559716|NCT04459598|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24559717|NCT04459598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24559718|NCT04459598|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24559722|NCT04448886|Pembrolizumab|pembrolizumab|mesh-list
24559723|NCT04448886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24768648|NCT01809743|Adenosine|adenosine|mesh-list
24768649|NCT01809743|Regadenoson|regadenoson|mesh-list
24768650|NCT01809743|Analgesics|analgesics|mesh-ancestor
24768651|NCT01809743|Sensory System Agents|sensory system agents|mesh-ancestor
24768652|NCT01809743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24768653|NCT01809743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768654|NCT01809743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24768655|NCT01809743|Vasodilator Agents|vasodilator agents|mesh-ancestor
24768656|NCT01809743|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24768691|NCT01809925|Antidiarrheals|antidiarrheals|mesh-ancestor
24768692|NCT01810185|Naltrexone|naltrexone|mesh-list
24768693|NCT01810185|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24768694|NCT01810185|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25685697|NCT01908829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685698|NCT01908829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755571|NCT01727427|Dabigatran|dabigatran|mesh-list
24755572|NCT01727427|Apixaban|apixaban|mesh-list
24755573|NCT01727427|Fondaparinux|fondaparinux|mesh-list
24768695|NCT01810185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768696|NCT01810185|Sensory System Agents|sensory system agents|mesh-ancestor
24768698|NCT01810237|Dabigatran|dabigatran|mesh-list
24768721|NCT01810367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24768722|NCT01810367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24768723|NCT01810367|Immunologic Factors|immunologic factors|mesh-ancestor
24768724|NCT01810367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889299|NCT04494529|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24768733|NCT01810458|Oxycodone|oxycodone|mesh-list
24768734|NCT01810458|Lorazepam|lorazepam|mesh-list
24768735|NCT01810458|Ondansetron|ondansetron|mesh-list
24768736|NCT01810458|Liver Extracts|liver extracts|mesh-list
24768737|NCT01810458|Anesthetics, Local|anesthetics, local|mesh-ancestor
24768738|NCT01810458|Anesthetics|anesthetics|mesh-ancestor
24768739|NCT01810458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24768740|NCT01810458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768741|NCT01810458|Sensory System Agents|sensory system agents|mesh-ancestor
24768742|NCT01810458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24768743|NCT01810458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24768744|NCT01810458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24768745|NCT01810458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24768746|NCT01810458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24768747|NCT01810458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768748|NCT01810458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24768749|NCT01810458|Narcotics|narcotics|mesh-ancestor
24768750|NCT01810458|Analgesics|analgesics|mesh-ancestor
24768751|NCT01810458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24768752|NCT01810458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24768775|NCT01810458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24768776|NCT01810549|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24768777|NCT01810549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24621127|NCT01060735|Vitamin D|vitamin d|mesh-list
24889300|NCT04494529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24889302|NCT04494529|Hormones|hormones|mesh-ancestor
24889303|NCT04494529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24889304|NCT04494529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889305|NCT04494529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24889306|NCT04494529|Respiratory System Agents|respiratory system agents|mesh-ancestor
24889307|NCT04494789|Fludrocortisone|fludrocortisone|mesh-list
25080656|NCT03336632|Cyclosporine|cyclosporine|mesh-list
24783328|NCT01901172|Posaconazole|posaconazole|mesh-list
24966745|NCT03765697|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24966746|NCT03765697|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24966747|NCT03765697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25080672|NCT03336632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25080674|NCT03336593|Immunologic Factors|immunologic factors|mesh-ancestor
25080675|NCT03336593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080676|NCT03336437|Estradiol|estradiol|mesh-list
25080679|NCT03336437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25080680|NCT03336437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080681|NCT03336346|Efavirenz|efavirenz|mesh-list
25080682|NCT03336346|Dolutegravir|dolutegravir|mesh-list
25080683|NCT03336346|Etonogestrel|etonogestrel|mesh-list
25080684|NCT03336346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25080685|NCT03336346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25080686|NCT03336346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25080687|NCT03336346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080688|NCT03336346|Antiviral Agents|antiviral agents|mesh-ancestor
25080689|NCT03336346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25080690|NCT03336346|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25080691|NCT03336346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25080692|NCT03336346|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25080693|NCT03336346|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25080694|NCT03336346|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25080695|NCT03336346|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24768888|NCT01811056|Contraceptive Agents|contraceptive agents|mesh-ancestor
24768889|NCT01811056|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25685699|NCT01908829|Urological Agents|urological agents|mesh-ancestor
25685700|NCT01908829|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25685701|NCT01908829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24768890|NCT01811056|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24768891|NCT01811056|Hormone Antagonists|hormone antagonists|mesh-ancestor
24768892|NCT01811056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24768893|NCT01811056|Luteolytic Agents|luteolytic agents|mesh-ancestor
24768894|NCT01811056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24768895|NCT01811056|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24768897|NCT01811160|Antioxidants|antioxidants|mesh-ancestor
24768898|NCT01811160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889308|NCT04494789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24889388|NCT04494126|Coagulants|coagulants|mesh-ancestor
24889408|NCT04493489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24889409|NCT04493489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24889410|NCT04493489|Vasodilator Agents|vasodilator agents|mesh-ancestor
24889448|NCT04493463|Sensory System Agents|sensory system agents|mesh-ancestor
24889449|NCT04493463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24889450|NCT04493463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24889452|NCT04493463|Autonomic Agents|autonomic agents|mesh-ancestor
24889453|NCT04493463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24889454|NCT04493463|Glucocorticoids|glucocorticoids|mesh-ancestor
24889456|NCT04493463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24624148|NCT01074905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24768900|NCT01811160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768901|NCT01811160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24559891|NCT04128748|Cytarabine|cytarabine|mesh-list
24768902|NCT01811251|Dexamethasone|dexamethasone|mesh-list
24768904|NCT01811251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24768953|NCT01811459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24768954|NCT01811459|Dopamine Agents|dopamine agents|mesh-ancestor
24768955|NCT01811459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24769078|NCT01812369|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24768956|NCT01811459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768957|NCT01811459|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24768961|NCT01811615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24768962|NCT01811615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768963|NCT01811667|Sirolimus|sirolimus|mesh-list
24560025|NCT03739710|Docetaxel|docetaxel|mesh-list
24560026|NCT03739710|Ipilimumab|ipilimumab|mesh-list
24560027|NCT03739710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24560028|NCT03739710|Tubulin Modulators|tubulin modulators|mesh-ancestor
24560029|NCT03739710|Antimitotic Agents|antimitotic agents|mesh-ancestor
24560030|NCT03739710|Mitosis Modulators|mitosis modulators|mesh-ancestor
24560031|NCT03739710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560032|NCT03739710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24906279|NCT04341493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24768978|NCT01811836|Micronutrients|micronutrients|mesh-ancestor
24560915|NCT01177540|Decitabine|decitabine|mesh-list
24768983|NCT01811849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24768984|NCT01811849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889544|NCT04492566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24889545|NCT04492358|Prednisone|prednisone|mesh-list
24889546|NCT04492358|Colchicine|colchicine|mesh-list
24889547|NCT04492358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24889548|NCT04492358|Glucocorticoids|glucocorticoids|mesh-ancestor
24889549|NCT04492358|Hormones|hormones|mesh-ancestor
24889550|NCT04492358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24889551|NCT04492358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889552|NCT04492358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24889553|NCT04492358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24889554|NCT04492358|Gout Suppressants|gout suppressants|mesh-ancestor
24889671|NCT04490967|Antifungal Agents|antifungal agents|mesh-ancestor
24889672|NCT04490967|Keratolytic Agents|keratolytic agents|mesh-ancestor
24889673|NCT04490967|Dermatologic Agents|dermatologic agents|mesh-ancestor
24513157|NCT00579475|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24513158|NCT00579475|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24768986|NCT01812018|Docetaxel|docetaxel|mesh-list
24768987|NCT01812018|Endostar protein|endostar protein|mesh-list
24768988|NCT01812018|Endostatins|endostatins|mesh-list
24768989|NCT01812018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24768990|NCT01812018|Antimetabolites|antimetabolites|mesh-ancestor
24768991|NCT01812018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768992|NCT01812018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768993|NCT01812018|Antiviral Agents|antiviral agents|mesh-ancestor
24768994|NCT01812018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24768995|NCT01812018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756489|NCT01733706|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24768996|NCT01812018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24768997|NCT01812018|Immunologic Factors|immunologic factors|mesh-ancestor
24768998|NCT01812018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768999|NCT01812018|Tubulin Modulators|tubulin modulators|mesh-ancestor
24769000|NCT01812018|Antimitotic Agents|antimitotic agents|mesh-ancestor
24769001|NCT01812018|Mitosis Modulators|mitosis modulators|mesh-ancestor
24769002|NCT01812018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24769003|NCT01812018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24769004|NCT01812018|Growth Substances|growth substances|mesh-ancestor
24769005|NCT01812018|Growth Inhibitors|growth inhibitors|mesh-ancestor
24769006|NCT01812096|Bortezomib|bortezomib|mesh-list
24769007|NCT01812096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24769008|NCT01812122|Glimepiride|glimepiride|mesh-list
24769009|NCT01812122|Vildagliptin|vildagliptin|mesh-list
24769010|NCT01812122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24769011|NCT01812122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24769012|NCT01812122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769013|NCT01812122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24769014|NCT01812122|Immunologic Factors|immunologic factors|mesh-ancestor
24769015|NCT01812122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24769051|NCT01812330|Purinergic Agents|purinergic agents|mesh-ancestor
24769066|NCT01812369|Doxorubicin|doxorubicin|mesh-list
24769067|NCT01812369|Vinblastine|vinblastine|mesh-list
24769068|NCT01812369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24769069|NCT01812369|Antimetabolites|antimetabolites|mesh-ancestor
24769070|NCT01812369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769071|NCT01812369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24782119|NCT01894295|Vitamin D|vitamin d|mesh-list
24769073|NCT01812369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24769074|NCT01812369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24769075|NCT01812369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24769076|NCT01812369|Immunologic Factors|immunologic factors|mesh-ancestor
24769077|NCT01812369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769084|NCT01812369|Mitosis Modulators|mitosis modulators|mesh-ancestor
24769085|NCT01812382|Retapamulin|retapamulin|mesh-list
24769086|NCT01812382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24769087|NCT01812382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24769088|NCT01812434|Sildenafil Citrate|sildenafil citrate|mesh-list
24769089|NCT01812434|Vasodilator Agents|vasodilator agents|mesh-ancestor
24769090|NCT01812434|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24769091|NCT01812434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24769092|NCT01812434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25080702|NCT03336346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24792663|NCT04854512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792664|NCT04848519|Pembrolizumab|pembrolizumab|mesh-list
24792665|NCT04848519|Propranolol|propranolol|mesh-list
24792666|NCT04848519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24792667|NCT04848519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24792668|NCT04848519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24792669|NCT04848519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24792670|NCT04848519|Adrenergic Agents|adrenergic agents|mesh-ancestor
24792671|NCT04848519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24792672|NCT04848519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792673|NCT04848519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792674|NCT04848519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24513159|NCT00579475|Hormone Antagonists|hormone antagonists|mesh-ancestor
24513160|NCT00579475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24513161|NCT00579475|Luteolytic Agents|luteolytic agents|mesh-ancestor
24513162|NCT00579475|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24623520|NCT01072045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623521|NCT01072045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24792675|NCT04848519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24792676|NCT04848519|Vasodilator Agents|vasodilator agents|mesh-ancestor
24792678|NCT04843046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24792679|NCT04843046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769093|NCT01812434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769117|NCT01812616|Sensory System Agents|sensory system agents|mesh-ancestor
24769118|NCT01812616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24769119|NCT01812616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769120|NCT01812642|N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|n-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|mesh-list
24769121|NCT01812642|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25685702|NCT01908829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25125178|NCT03070704|Incretins|incretins|mesh-ancestor
24769122|NCT01812642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24769123|NCT01812642|Dopamine Agents|dopamine agents|mesh-ancestor
24769124|NCT01812642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24769125|NCT01812642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769126|NCT01812642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769127|NCT01812720|Dexamethasone|dexamethasone|mesh-list
25080703|NCT03336346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080704|NCT03336346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25080705|NCT03336281|Ustekinumab|ustekinumab|mesh-list
25080706|NCT03336281|Dermatologic Agents|dermatologic agents|mesh-ancestor
25080707|NCT03336242|Cannabidiol|cannabidiol|mesh-list
25080708|NCT03336242|Anticonvulsants|anticonvulsants|mesh-ancestor
25080709|NCT03336125|Vitamin D|vitamin d|mesh-list
25080710|NCT03336125|Vitamins|vitamins|mesh-ancestor
25080711|NCT03336125|Micronutrients|micronutrients|mesh-ancestor
25080712|NCT03336125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080713|NCT03336125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24782185|NCT01894711|Trastuzumab|trastuzumab|mesh-list
24623522|NCT01072045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24906478|NCT04340388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588091|NCT00900874|Tocolytic Agents|tocolytic agents|mesh-ancestor
24769173|NCT01812954|Immunologic Factors|immunologic factors|mesh-ancestor
24769174|NCT01812954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24769175|NCT01812954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24769179|NCT01812954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24769180|NCT01812954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24769181|NCT01812954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24769182|NCT01812954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24769183|NCT01812954|Analgesics|analgesics|mesh-ancestor
24769184|NCT01812954|Sensory System Agents|sensory system agents|mesh-ancestor
24769206|NCT01813162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24769207|NCT01813162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769208|NCT01813162|Antifungal Agents|antifungal agents|mesh-ancestor
24769209|NCT01813201|Methyltestosterone|methyltestosterone|mesh-list
24769210|NCT01813201|Testosterone|testosterone|mesh-list
24769211|NCT01813201|Testosterone undecanoate|testosterone undecanoate|mesh-list
24769212|NCT01813201|Testosterone enanthate|testosterone enanthate|mesh-list
24769213|NCT01813201|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24769214|NCT01813201|Androgens|androgens|mesh-ancestor
24769216|NCT01813201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24769217|NCT01813201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769218|NCT01813201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24623523|NCT01072045|Vasodilator Agents|vasodilator agents|mesh-ancestor
24623557|NCT01072175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623558|NCT01072175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24623559|NCT01072175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623560|NCT01072175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623561|NCT01072240|Rituximab|rituximab|mesh-list
24623562|NCT01072240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24889968|NCT04487834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889970|NCT04487834|Dermatologic Agents|dermatologic agents|mesh-ancestor
24513226|NCT00580060|Molgramostim|molgramostim|mesh-list
24513261|NCT00580242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513262|NCT00580242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24513263|NCT00580242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24513264|NCT00580242|Growth Substances|growth substances|mesh-ancestor
24513265|NCT00580242|Growth Inhibitors|growth inhibitors|mesh-ancestor
24513266|NCT00580242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24769219|NCT01813201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24769220|NCT01813201|Anabolic Agents|anabolic agents|mesh-ancestor
24769221|NCT01813240|Minocycline|minocycline|mesh-list
24769222|NCT01813240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24769223|NCT01813240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24769224|NCT01813253|Irinotecan|irinotecan|mesh-list
24769225|NCT01813253|Nimotuzumab|nimotuzumab|mesh-list
24769226|NCT01813253|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24769227|NCT01813253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24769228|NCT01813253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24769229|NCT01813253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769230|NCT01813253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24769231|NCT01813253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24769232|NCT01813318|Acamprosate|acamprosate|mesh-list
24769233|NCT01813318|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24769234|NCT01813448|Fidaxomicin|fidaxomicin|mesh-list
25685703|NCT01908829|Adrenergic Agents|adrenergic agents|mesh-ancestor
25685704|NCT01908842|Buprenorphine|buprenorphine|mesh-list
24769235|NCT01813448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24906575|NCT04339348|Abortifacient Agents|abortifacient agents|mesh-ancestor
24769272|NCT01813591|Hormones|hormones|mesh-ancestor
24769273|NCT01813591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24906605|NCT04338906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24769288|NCT01813617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24769289|NCT01813617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24769290|NCT01813617|Abortifacient Agents|abortifacient agents|mesh-ancestor
24769293|NCT01813617|Antimetabolites|antimetabolites|mesh-ancestor
24621236|NCT01061112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24769294|NCT01813617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769295|NCT01813617|Dermatologic Agents|dermatologic agents|mesh-ancestor
24769296|NCT01813617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24769297|NCT01813617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24513269|NCT00580320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24620501|NCT01057329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24513270|NCT00580320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24513271|NCT00580320|Alkylating Agents|alkylating agents|mesh-ancestor
24513272|NCT00580320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816797|NCT02078895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24816798|NCT02078895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816799|NCT02078895|Cholinergic Agents|cholinergic agents|mesh-ancestor
24816800|NCT02078895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24769299|NCT01813617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24769300|NCT01813617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24769302|NCT01813643|Aripiprazole|aripiprazole|mesh-list
24769303|NCT01813643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24769304|NCT01813643|Serotonin Agents|serotonin agents|mesh-ancestor
24769305|NCT01813643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24769306|NCT01813643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769307|NCT01813643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769308|NCT01813643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24769309|NCT01813643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24769310|NCT01813643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24769311|NCT01813643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24769312|NCT01813643|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24769313|NCT01813643|Dopamine Agents|dopamine agents|mesh-ancestor
24769314|NCT01813643|Antidepressive Agents|antidepressive agents|mesh-ancestor
24890045|NCT04486781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24890046|NCT04486781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24890047|NCT04486612|Anesthetics|anesthetics|mesh-list
24890048|NCT04486612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24890049|NCT04486612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890050|NCT04486430|Salicylates|salicylates|mesh-list
24513297|NCT00580437|Adrenergic Agents|adrenergic agents|mesh-ancestor
24513298|NCT00580437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24890118|NCT04485702|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24890119|NCT04485702|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24890120|NCT04485702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24890121|NCT04485702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24890122|NCT04485702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24890123|NCT04485702|GABA Modulators|gaba modulators|mesh-ancestor
24467638|NCT00378313|Immunologic Factors|immunologic factors|mesh-ancestor
24467639|NCT00378313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467641|NCT00378313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24890134|NCT04485585|Urological Agents|urological agents|mesh-ancestor
24890135|NCT04485585|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24890136|NCT04485585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24890137|NCT04485585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24890138|NCT04485689|Capsaicin|capsaicin|mesh-list
24890139|NCT04485689|Antipruritics|antipruritics|mesh-ancestor
24890140|NCT04485689|Dermatologic Agents|dermatologic agents|mesh-ancestor
24890141|NCT04485689|Sensory System Agents|sensory system agents|mesh-ancestor
24890142|NCT04485689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24890143|NCT04485689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890144|NCT04485520|Chlorhexidine|chlorhexidine|mesh-list
24890234|NCT04485065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24890236|NCT04485052|Azacitidine|azacitidine|mesh-list
24890237|NCT04485052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24890238|NCT04485052|Antimetabolites|antimetabolites|mesh-ancestor
24890239|NCT04485052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890240|NCT04485052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24890241|NCT04485052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24769315|NCT01813643|Dopamine Agonists|dopamine agonists|mesh-ancestor
24769316|NCT01813643|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24769317|NCT01813643|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24769318|NCT01813643|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24769319|NCT01813643|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24769320|NCT01813656|Aripiprazole|aripiprazole|mesh-list
24769321|NCT01813656|Antidepressive Agents|antidepressive agents|mesh-ancestor
24769322|NCT01813656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24769323|NCT01813656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24769324|NCT01813656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24769325|NCT01813656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24769654|NCT01815125|Antipruritics|antipruritics|mesh-ancestor
24769327|NCT01813656|Dopamine Agonists|dopamine agonists|mesh-ancestor
24769328|NCT01813656|Dopamine Agents|dopamine agents|mesh-ancestor
24769329|NCT01813656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25030659|NCT03593954|Ritonavir|ritonavir|mesh-list
24769330|NCT01813656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769331|NCT01813656|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24769356|NCT01813955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769358|NCT01813955|Urological Agents|urological agents|mesh-ancestor
24769359|NCT01813981|Caffeine|caffeine|mesh-list
24769360|NCT01813981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24769361|NCT01813981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769362|NCT01813981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24769363|NCT01813981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24769364|NCT01813981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769365|NCT01813981|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24769366|NCT01813981|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24769367|NCT01813981|Purinergic Agents|purinergic agents|mesh-ancestor
24769368|NCT01813981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25039923|NCT03594058|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24405767|NCT00168363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24890242|NCT04484688|Bisoprolol|bisoprolol|mesh-list
24890243|NCT04484688|Perindopril|perindopril|mesh-list
24890244|NCT04484688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24890245|NCT04484688|Sympatholytics|sympatholytics|mesh-ancestor
24890258|NCT04484779|Insulin|insulin|mesh-list
24890261|NCT04484779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24890262|NCT04484779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769369|NCT01813994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
24769370|NCT01813994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24769371|NCT01813994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24769372|NCT01813994|Antimetabolites|antimetabolites|mesh-ancestor
24769373|NCT01813994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769374|NCT01813994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24769375|NCT01813994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24769376|NCT01814059|Sirolimus|sirolimus|mesh-list
24769377|NCT01814059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24769378|NCT01814059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24769379|NCT01814059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24769380|NCT01814059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24620462|NCT01057212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24620463|NCT01057212|Growth Substances|growth substances|mesh-ancestor
24620464|NCT01057212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620465|NCT01057212|Growth Inhibitors|growth inhibitors|mesh-ancestor
24620468|NCT01057264|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24620469|NCT01057264|Bevacizumab|bevacizumab|mesh-list
24620470|NCT01057264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24620471|NCT01057264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24620472|NCT01057264|Tubulin Modulators|tubulin modulators|mesh-ancestor
24620473|NCT01057264|Antimitotic Agents|antimitotic agents|mesh-ancestor
24620474|NCT01057264|Mitosis Modulators|mitosis modulators|mesh-ancestor
24620475|NCT01057264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620476|NCT01057264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24620477|NCT01057264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24906801|NCT04336891|Estradiol|estradiol|mesh-list
25080743|NCT03335956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25080744|NCT03335956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25080745|NCT03335904|Losartan|losartan|mesh-list
25080746|NCT03335904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25080747|NCT03335904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24620485|NCT01057264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24620486|NCT01057264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125279|NCT03070054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25125280|NCT03070054|Respiratory System Agents|respiratory system agents|mesh-ancestor
25125281|NCT03070054|Mydriatics|mydriatics|mesh-ancestor
25125282|NCT03070054|Sympathomimetics|sympathomimetics|mesh-ancestor
25125283|NCT03070054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24620487|NCT01057264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24620490|NCT01057329|Olanzapine|olanzapine|mesh-list
24620491|NCT01057329|Aripiprazole|aripiprazole|mesh-list
24620492|NCT01057329|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24620493|NCT01057329|Antiemetics|antiemetics|mesh-ancestor
24620494|NCT01057329|Autonomic Agents|autonomic agents|mesh-ancestor
24620495|NCT01057329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24620496|NCT01057329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620497|NCT01057329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24620498|NCT01057329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24620499|NCT01057329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24620500|NCT01057329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24769413|NCT01814163|Antimitotic Agents|antimitotic agents|mesh-ancestor
24769414|NCT01814163|Mitosis Modulators|mitosis modulators|mesh-ancestor
24906815|NCT04336891|Androgens|androgens|mesh-ancestor
24769449|NCT01814319|Uricosuric Agents|uricosuric agents|mesh-ancestor
24769450|NCT01814319|Gout Suppressants|gout suppressants|mesh-ancestor
24769451|NCT01814319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24769452|NCT01814319|Renal Agents|renal agents|mesh-ancestor
24769453|NCT01814410|Ethanol|ethanol|mesh-list
24769454|NCT01814410|Nicotine|nicotine|mesh-list
24769455|NCT01814410|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24769456|NCT01814410|Autonomic Agents|autonomic agents|mesh-ancestor
24769457|NCT01814410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24769458|NCT01814410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769459|NCT01814410|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24769489|NCT01814449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24712898|NCT01523093|Antipruritics|antipruritics|mesh-ancestor
24890314|NCT04484467|Dermatologic Agents|dermatologic agents|mesh-ancestor
24890346|NCT04483830|Anticoagulants|anticoagulants|mesh-ancestor
24890347|NCT04483830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24890348|NCT04483830|Antimetabolites|antimetabolites|mesh-ancestor
24890349|NCT04483830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890350|NCT04483830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24890351|NCT04483830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24890453|NCT04483258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890454|NCT04483284|Chlorotrianisene|chlorotrianisene|mesh-list
24890455|NCT04483284|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24890458|NCT04483284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24890459|NCT04483284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890461|NCT04483284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24890496|NCT04482985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24890532|NCT04482543|Abortifacient Agents|abortifacient agents|mesh-ancestor
24890588|NCT04481815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24769490|NCT01814449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769492|NCT01814449|Hormone Antagonists|hormone antagonists|mesh-ancestor
24560499|NCT02471833|Telmisartan|telmisartan|mesh-list
24769493|NCT01814449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24769494|NCT01814449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769495|NCT01814475|Vidarabine|vidarabine|mesh-list
24769496|NCT01814475|Fludarabine|fludarabine|mesh-list
24769497|NCT01814475|Fludarabine phosphate|fludarabine phosphate|mesh-list
24769498|NCT01814475|Busulfan|busulfan|mesh-list
24769499|NCT01814475|Thiotepa|thiotepa|mesh-list
24769500|NCT01814475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24769501|NCT01814475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24769502|NCT01814475|Antimetabolites|antimetabolites|mesh-ancestor
24769503|NCT01814475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769504|NCT01814475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24769573|NCT01814709|Rifampin|rifampin|mesh-list
24769601|NCT01814826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24769602|NCT01814826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24769603|NCT01814865|Prednisone|prednisone|mesh-list
24769604|NCT01814865|Anastrozole|anastrozole|mesh-list
24769605|NCT01814865|Abiraterone Acetate|abiraterone acetate|mesh-list
24769606|NCT01814865|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25685705|NCT01908842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25685706|NCT01908842|Narcotics|narcotics|mesh-ancestor
25685707|NCT01908842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25685708|NCT01908842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685709|NCT01908842|Analgesics|analgesics|mesh-ancestor
24769607|NCT01814865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24769608|NCT01814865|Glucocorticoids|glucocorticoids|mesh-ancestor
24769609|NCT01814865|Hormones|hormones|mesh-ancestor
24769610|NCT01814865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24769611|NCT01814865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769612|NCT01814865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24769613|NCT01814865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24769614|NCT01814865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24769615|NCT01814865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906979|NCT04334928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24769644|NCT01815047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24769646|NCT01815073|Immunologic Factors|immunologic factors|mesh-ancestor
24769648|NCT01815125|Ondansetron|ondansetron|mesh-list
24769649|NCT01815125|Antiemetics|antiemetics|mesh-ancestor
24769650|NCT01815125|Autonomic Agents|autonomic agents|mesh-ancestor
24769651|NCT01815125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24769652|NCT01815125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784221|NCT01906944|Glucocorticoids|glucocorticoids|mesh-ancestor
24769653|NCT01815125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24769655|NCT01815125|Dermatologic Agents|dermatologic agents|mesh-ancestor
24769656|NCT01815125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24769657|NCT01815125|Serotonin Agents|serotonin agents|mesh-ancestor
24769658|NCT01815125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24769659|NCT01815125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769660|NCT01815125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24769661|NCT01815125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24769662|NCT01815125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24769663|NCT01815125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24907033|NCT04334005|Vitamin D|vitamin d|mesh-list
24769686|NCT01815242|Antiviral Agents|antiviral agents|mesh-ancestor
24769687|NCT01815242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24769688|NCT01815242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24769689|NCT01815242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24769690|NCT01815242|Immunologic Factors|immunologic factors|mesh-ancestor
24769691|NCT01815242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769693|NCT01815255|Antiviral Agents|antiviral agents|mesh-ancestor
24513354|NCT00580905|Analgesics|analgesics|mesh-ancestor
24890623|NCT04481971|Hormones|hormones|mesh-ancestor
24517302|NCT00607178|Vaccines|vaccines|mesh-list
24890654|NCT04481789|Natriuretic Agents|natriuretic agents|mesh-ancestor
24890655|NCT04481789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890656|NCT04481789|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24890657|NCT04481789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24890658|NCT04481789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24890659|NCT04481789|Antioxidants|antioxidants|mesh-ancestor
24890660|NCT04481789|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24890661|NCT04481789|Protective Agents|protective agents|mesh-ancestor
24890662|NCT04481932|Trastuzumab|trastuzumab|mesh-list
24890663|NCT04481932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24890664|NCT04481932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24890665|NCT04481282|Terbutaline|terbutaline|mesh-list
24890667|NCT04481282|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24468007|NCT00379457|Topotecan|topotecan|mesh-list
24769694|NCT01815255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24769695|NCT01815255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24769707|NCT01815294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24769708|NCT01815294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24769709|NCT01815294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24769710|NCT01815294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24769711|NCT01815294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769712|NCT01815307|Gemcitabine|gemcitabine|mesh-list
24769713|NCT01815307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24769714|NCT01815307|Antimetabolites|antimetabolites|mesh-ancestor
24405854|NCT00168584|Micronutrients|micronutrients|mesh-ancestor
24769746|NCT01815658|Carbon Fiber|carbon fiber|mesh-list
24769747|NCT01815658|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24769757|NCT01815892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769758|NCT01815892|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24769759|NCT01815892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24769760|NCT01815892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769821|NCT01816334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24769822|NCT01816334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25080749|NCT03335904|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25080756|NCT03335826|Anesthetics|anesthetics|mesh-list
25080757|NCT03335826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25080758|NCT03335826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890693|NCT04481256|Carboplatin|carboplatin|mesh-list
24405855|NCT00168584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890694|NCT04481256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24890695|NCT04481256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24890696|NCT04481256|Tubulin Modulators|tubulin modulators|mesh-ancestor
24890697|NCT04481256|Antimitotic Agents|antimitotic agents|mesh-ancestor
24890700|NCT04481100|Itraconazole|itraconazole|mesh-list
24890704|NCT04481100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24890705|NCT04481100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24890706|NCT04481100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890707|NCT04481100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25080764|NCT03335579|Sufentanil|sufentanil|mesh-list
25080765|NCT03335579|Remifentanil|remifentanil|mesh-list
25080766|NCT03335579|Propofol|propofol|mesh-list
25080767|NCT03335579|Anesthetics|anesthetics|mesh-ancestor
25080768|NCT03335579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25080769|NCT03335579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080770|NCT03335579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25080771|NCT03335579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25080772|NCT03335579|Anesthetics, General|anesthetics, general|mesh-ancestor
24907162|NCT04332042|Tofacitinib|tofacitinib|mesh-list
24769827|NCT01816412|Tubulin Modulators|tubulin modulators|mesh-ancestor
24769828|NCT01816412|Antimitotic Agents|antimitotic agents|mesh-ancestor
24769829|NCT01816412|Mitosis Modulators|mitosis modulators|mesh-ancestor
24769830|NCT01816412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769831|NCT01816490|Silybin|silybin|mesh-list
24769832|NCT01816490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24769833|NCT01816490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24769834|NCT01816490|Protective Agents|protective agents|mesh-ancestor
24769835|NCT01816490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769836|NCT01816529|Diltiazem|diltiazem|mesh-list
24769837|NCT01816529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24769838|NCT01816529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24907200|NCT04331730|Aflibercept|aflibercept|mesh-list
24769862|NCT01816620|Antiemetics|antiemetics|mesh-ancestor
24769863|NCT01816620|Autonomic Agents|autonomic agents|mesh-ancestor
24769864|NCT01816620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24769866|NCT01816620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24769867|NCT01816620|Glucocorticoids|glucocorticoids|mesh-ancestor
24769868|NCT01816620|Hormones|hormones|mesh-ancestor
24769869|NCT01816620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24769870|NCT01816620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24769883|NCT01816646|Antiviral Agents|antiviral agents|mesh-ancestor
24769884|NCT01816646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24769885|NCT01816646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24769886|NCT01816646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769887|NCT01816659|Metformin|metformin|mesh-list
24769888|NCT01816659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24769889|NCT01816659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769890|NCT01816789|Buserelin|buserelin|mesh-list
24769891|NCT01816789|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24769892|NCT01816789|Fertility Agents|fertility agents|mesh-ancestor
24907245|NCT04331600|Analgesics|analgesics|mesh-ancestor
24769966|NCT01817283|Immunologic Factors|immunologic factors|mesh-ancestor
24769967|NCT01817283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24769968|NCT01817283|Alkylating Agents|alkylating agents|mesh-ancestor
24769969|NCT01817283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769982|NCT01817322|Glucocorticoids|glucocorticoids|mesh-ancestor
24769983|NCT01817322|Hormones|hormones|mesh-ancestor
24769984|NCT01817322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24704973|NCT01481519|Povidone|povidone|mesh-list
24769985|NCT01817322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24769986|NCT01817322|Protective Agents|protective agents|mesh-ancestor
24769987|NCT01817322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24769988|NCT01817322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24769989|NCT01817322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24769990|NCT01817322|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24769991|NCT01817322|Antitubercular Agents|antitubercular agents|mesh-ancestor
24769992|NCT01817322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24769993|NCT01817322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24769997|NCT01817322|Immunologic Factors|immunologic factors|mesh-ancestor
24769998|NCT01817348|Lidocaine|lidocaine|mesh-list
24769999|NCT01817348|Anesthetics, Local|anesthetics, local|mesh-ancestor
24770000|NCT01817348|Anesthetics|anesthetics|mesh-ancestor
24770001|NCT01817348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25080812|NCT03335436|Antimanic Agents|antimanic agents|mesh-ancestor
24890708|NCT04481100|Hormone Antagonists|hormone antagonists|mesh-ancestor
24890709|NCT04481100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24890710|NCT04481100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890711|NCT04481100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24890712|NCT04480827|Cholic Acids|cholic acids|mesh-list
25080813|NCT03335423|Metformin|metformin|mesh-list
25080814|NCT03335423|Codeine|codeine|mesh-list
25080815|NCT03335423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25080816|NCT03335423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080817|NCT03335423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24770023|NCT01817400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770024|NCT01817400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24770025|NCT01817400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24770026|NCT01817400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770027|NCT01817400|Antipyretics|antipyretics|mesh-ancestor
24770028|NCT01817400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24620520|NCT01057329|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24620521|NCT01057329|Adrenergic Agents|adrenergic agents|mesh-ancestor
24620523|NCT01057342|Carboplatin|carboplatin|mesh-list
24620524|NCT01057342|Vadimezan|vadimezan|mesh-list
24620525|NCT01057342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24620526|NCT01057342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24620527|NCT01057342|Tubulin Modulators|tubulin modulators|mesh-ancestor
24620528|NCT01057342|Antimitotic Agents|antimitotic agents|mesh-ancestor
24620529|NCT01057342|Mitosis Modulators|mitosis modulators|mesh-ancestor
24620530|NCT01057342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620531|NCT01057355|Ethanol|ethanol|mesh-list
24620532|NCT01057355|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24620533|NCT01057355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24620558|NCT01057563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24620559|NCT01057563|Tubulin Modulators|tubulin modulators|mesh-ancestor
24620560|NCT01057563|Antimitotic Agents|antimitotic agents|mesh-ancestor
24620561|NCT01057563|Mitosis Modulators|mitosis modulators|mesh-ancestor
24620562|NCT01057563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620563|NCT01057615|Ascorbic Acid|ascorbic acid|mesh-list
24890713|NCT04480827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24890714|NCT04480775|Methylprednisolone|methylprednisolone|mesh-list
24890715|NCT04480775|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24890716|NCT04480775|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24890717|NCT04480775|Prednisolone|prednisolone|mesh-list
24890718|NCT04480775|Prednisolone acetate|prednisolone acetate|mesh-list
24890808|NCT04479748|Glucocorticoids|glucocorticoids|mesh-ancestor
24890809|NCT04479748|Hormones|hormones|mesh-ancestor
24890810|NCT04479748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24890811|NCT04479748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24890812|NCT04479748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24890813|NCT04479748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24890814|NCT04479748|Protective Agents|protective agents|mesh-ancestor
24713389|NCT01525966|Paclitaxel|paclitaxel|mesh-list
24890815|NCT04479657|Cefuroxime|cefuroxime|mesh-list
24890816|NCT04479657|Cefuroxime axetil|cefuroxime axetil|mesh-list
24620565|NCT01057615|Micronutrients|micronutrients|mesh-ancestor
24620566|NCT01057615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620567|NCT01057615|Antioxidants|antioxidants|mesh-ancestor
24620568|NCT01057615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770114|NCT01817985|Antiviral Agents|antiviral agents|mesh-ancestor
24770115|NCT01817985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24770116|NCT01818024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24770117|NCT01818024|Immunologic Factors|immunologic factors|mesh-ancestor
24770118|NCT01818024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770119|NCT01818232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
24770120|NCT01818232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24770147|NCT01818856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24770148|NCT01818856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24770149|NCT01818856|Protease Inhibitors|protease inhibitors|mesh-ancestor
24770150|NCT01818856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770151|NCT01818856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890824|NCT04479865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24890829|NCT04479891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24890830|NCT04479891|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24890831|NCT04479891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24890832|NCT04479891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24890833|NCT04479891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890834|NCT04479891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24890835|NCT04479891|Hormone Antagonists|hormone antagonists|mesh-ancestor
24890836|NCT04479891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24890837|NCT04479891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890850|NCT04479371|Bupivacaine|bupivacaine|mesh-list
24890851|NCT04479371|Anesthetics, Local|anesthetics, local|mesh-ancestor
24890852|NCT04479371|Anesthetics|anesthetics|mesh-ancestor
24890853|NCT04479371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24890854|NCT04479371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890855|NCT04479371|Sensory System Agents|sensory system agents|mesh-ancestor
24890856|NCT04479371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24890857|NCT04479449|Otaplimastat|otaplimastat|mesh-list
24890858|NCT04479449|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24890859|NCT04479449|Protective Agents|protective agents|mesh-ancestor
24890860|NCT04479449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890861|NCT04478617|Metronidazole|metronidazole|mesh-list
24890862|NCT04478617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24890863|NCT04478617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24890864|NCT04478617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24890865|NCT04478617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24890866|NCT04478448|Favipiravir|favipiravir|mesh-list
24890867|NCT04478448|Antiviral Agents|antiviral agents|mesh-ancestor
24890868|NCT04478448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24890869|NCT04478461|Antibodies|antibodies|mesh-list
24890870|NCT04478461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24890871|NCT04478461|Immunologic Factors|immunologic factors|mesh-ancestor
24890872|NCT04478461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890873|NCT04478526|Norepinephrine|norepinephrine|mesh-list
24890874|NCT04478526|Serotonin|serotonin|mesh-list
24890875|NCT04478526|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
24770152|NCT01818856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24770153|NCT01818856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24770154|NCT01818856|Antiviral Agents|antiviral agents|mesh-ancestor
24770155|NCT01818856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24770156|NCT01818856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24770157|NCT01818856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24770159|NCT01818869|Analgesics|analgesics|mesh-ancestor
24770160|NCT01818869|Sensory System Agents|sensory system agents|mesh-ancestor
24770161|NCT01818869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24770162|NCT01818869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770163|NCT01818869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24770164|NCT01818869|Vasodilator Agents|vasodilator agents|mesh-ancestor
24770165|NCT01818869|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24770197|NCT01818973|Bevacizumab|bevacizumab|mesh-list
24770198|NCT01818973|Capecitabine|capecitabine|mesh-list
24770200|NCT01818973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24770201|NCT01818973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24770202|NCT01818973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24770203|NCT01818973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25045735|NCT00920985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24770204|NCT01818973|Growth Substances|growth substances|mesh-ancestor
24770205|NCT01818973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770206|NCT01818973|Growth Inhibitors|growth inhibitors|mesh-ancestor
24770207|NCT01818973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24770208|NCT01818973|Antimetabolites|antimetabolites|mesh-ancestor
24770209|NCT01818973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770210|NCT01819012|Isoflurane|isoflurane|mesh-list
24770211|NCT01819012|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24770212|NCT01819012|Anesthetics, General|anesthetics, general|mesh-ancestor
24770213|NCT01819012|Anesthetics|anesthetics|mesh-ancestor
24770214|NCT01819012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24770215|NCT01819012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770216|NCT01819051|Anti-Infective Agents|anti-infective agents|mesh-list
24770217|NCT01819051|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24890876|NCT04478526|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
24890877|NCT04478526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24890878|NCT04478526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24890879|NCT04478526|Adrenergic Agents|adrenergic agents|mesh-ancestor
24890880|NCT04478526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24890881|NCT04478526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770219|NCT01819064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24770220|NCT01819064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24501307|NCT00528008|Disinfectants|disinfectants|mesh-ancestor
24770221|NCT01819064|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24770222|NCT01819064|Autonomic Agents|autonomic agents|mesh-ancestor
24770223|NCT01819064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24770224|NCT01819064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770225|NCT01819064|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24907580|NCT04329585|Flumazenil|flumazenil|mesh-list
24770257|NCT01819259|Autonomic Agents|autonomic agents|mesh-ancestor
24770258|NCT01819259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24770259|NCT01819259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770260|NCT01819259|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24770261|NCT01819259|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24770262|NCT01819259|Cholinergic Agents|cholinergic agents|mesh-ancestor
24770263|NCT01819259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24770264|NCT01819259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770265|NCT01819285|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24770267|NCT01819285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24966858|NCT03764540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966859|NCT03764540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24966862|NCT03764527|Artemether|artemether|mesh-list
24966863|NCT03764527|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24966864|NCT03764527|Amodiaquine|amodiaquine|mesh-list
24966865|NCT03764527|Antimalarials|antimalarials|mesh-ancestor
24966866|NCT03764527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24966867|NCT03764527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24966868|NCT03764527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24890895|NCT04478357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24890896|NCT04478357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890897|NCT04478357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890898|NCT04478357|Urological Agents|urological agents|mesh-ancestor
24890902|NCT04478474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24890903|NCT04478474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24890938|NCT04478513|Fluvoxamine|fluvoxamine|mesh-list
24890939|NCT04478513|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24890940|NCT04478513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24890941|NCT04478513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24517419|NCT00607763|Micafungin|micafungin|mesh-list
24966871|NCT03764527|Schistosomicides|schistosomicides|mesh-ancestor
24770290|NCT01819441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24770291|NCT01819441|Protease Inhibitors|protease inhibitors|mesh-ancestor
24770292|NCT01819441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770293|NCT01819610|Ketorolac|ketorolac|mesh-list
24770294|NCT01819610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24770295|NCT01819610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24770296|NCT01819610|Analgesics|analgesics|mesh-ancestor
24770297|NCT01819610|Sensory System Agents|sensory system agents|mesh-ancestor
24770298|NCT01819610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24770299|NCT01819610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685710|NCT01908842|Sensory System Agents|sensory system agents|mesh-ancestor
24770300|NCT01819610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24770301|NCT01819610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24770302|NCT01819610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24770303|NCT01819610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770304|NCT01819610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770330|NCT01819857|Antiemetics|antiemetics|mesh-ancestor
24770331|NCT01819857|Autonomic Agents|autonomic agents|mesh-ancestor
24770332|NCT01819857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24770333|NCT01819857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770334|NCT01819857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24770335|NCT01819857|Antipruritics|antipruritics|mesh-ancestor
24517442|NCT00607958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24890942|NCT04478513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890943|NCT04478513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24890944|NCT04478513|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24890945|NCT04478513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24890946|NCT04478513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24890999|NCT04477590|Metformin|metformin|mesh-list
24891001|NCT04477590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891002|NCT04477525|Bupivacaine|bupivacaine|mesh-list
24891003|NCT04477525|Anesthetics, Local|anesthetics, local|mesh-ancestor
24770336|NCT01819857|Dermatologic Agents|dermatologic agents|mesh-ancestor
24770337|NCT01819857|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24770338|NCT01819857|Serotonin Agents|serotonin agents|mesh-ancestor
25080819|NCT03335423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25080820|NCT03335423|Analgesics|analgesics|mesh-ancestor
25080821|NCT03335423|Sensory System Agents|sensory system agents|mesh-ancestor
25080822|NCT03335423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25080823|NCT03335423|Antitussive Agents|antitussive agents|mesh-ancestor
25080824|NCT03335423|Respiratory System Agents|respiratory system agents|mesh-ancestor
25080825|NCT03335293|Epinephrine|epinephrine|mesh-list
25080826|NCT03335293|Racepinephrine|racepinephrine|mesh-list
25080827|NCT03335293|Epinephryl borate|epinephryl borate|mesh-list
25080828|NCT03335293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25080829|NCT03335293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25080830|NCT03335293|Adrenergic Agents|adrenergic agents|mesh-ancestor
25080831|NCT03335293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24770339|NCT01819857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24770340|NCT01819857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770341|NCT01819857|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24770342|NCT01819857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24891004|NCT04477525|Anesthetics|anesthetics|mesh-ancestor
24891005|NCT04477525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24891006|NCT04477525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891037|NCT04477304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891039|NCT04477304|Sensory System Agents|sensory system agents|mesh-ancestor
24891040|NCT04477304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891041|NCT04477096|Emtricitabine|emtricitabine|mesh-list
24891042|NCT04477096|Antiviral Agents|antiviral agents|mesh-ancestor
24891043|NCT04477096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24891044|NCT04477096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24891045|NCT04477096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24891046|NCT04477096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24891073|NCT04477018|Trace Elements|trace elements|mesh-ancestor
24891074|NCT04477018|Antioxidants|antioxidants|mesh-ancestor
24891075|NCT04477018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891076|NCT04477018|Protective Agents|protective agents|mesh-ancestor
24891077|NCT04477018|Sequestering Agents|sequestering agents|mesh-ancestor
24891078|NCT04476680|Vitamin D|vitamin d|mesh-list
24891079|NCT04476680|Vitamins|vitamins|mesh-ancestor
24891080|NCT04476680|Micronutrients|micronutrients|mesh-ancestor
24891081|NCT04476680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891082|NCT04476680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24891083|NCT04476459|Apatinib|apatinib|mesh-list
24401669|NCT00153660|Analgesics|analgesics|mesh-ancestor
24891084|NCT04476459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24891085|NCT04476459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24891086|NCT04476459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770391|NCT01820143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24770392|NCT01820143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24770393|NCT01820143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770394|NCT01820143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770395|NCT01820299|Vitamin D|vitamin d|mesh-list
24770396|NCT01820299|Grape Seed Extract|grape seed extract|mesh-list
24770397|NCT01820299|Vitamins|vitamins|mesh-ancestor
24770398|NCT01820299|Micronutrients|micronutrients|mesh-ancestor
24770399|NCT01820299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770400|NCT01820299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24770401|NCT01820299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24770402|NCT01820299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24770403|NCT01820299|Antioxidants|antioxidants|mesh-ancestor
24770404|NCT01820299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770405|NCT01820299|Protective Agents|protective agents|mesh-ancestor
24770406|NCT01820312|Paclitaxel|paclitaxel|mesh-list
24770407|NCT01820312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24770408|NCT01820312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24770409|NCT01820312|Tubulin Modulators|tubulin modulators|mesh-ancestor
24770410|NCT01820312|Antimitotic Agents|antimitotic agents|mesh-ancestor
24770411|NCT01820312|Mitosis Modulators|mitosis modulators|mesh-ancestor
24770412|NCT01820312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770414|NCT01820325|Carboplatin|carboplatin|mesh-list
24770415|NCT01820325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24907745|NCT04328194|Thrombin|thrombin|mesh-list
24770444|NCT01820455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24770445|NCT01820455|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24770446|NCT01820455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770447|NCT01820455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770448|NCT01820624|Tretinoin|tretinoin|mesh-list
24770449|NCT01820624|Lithium Carbonate|lithium carbonate|mesh-list
24770450|NCT01820624|Antidepressive Agents|antidepressive agents|mesh-ancestor
24770451|NCT01820624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24891089|NCT04476121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24891091|NCT04476121|Analgesics|analgesics|mesh-ancestor
24891092|NCT04476121|Sensory System Agents|sensory system agents|mesh-ancestor
24891093|NCT04476121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891094|NCT04476121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891095|NCT04476121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24891096|NCT04476121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24891097|NCT04476121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24770452|NCT01820624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770453|NCT01820624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770454|NCT01820624|Antimanic Agents|antimanic agents|mesh-ancestor
24770455|NCT01820624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24770456|NCT01820624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24770457|NCT01820624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770458|NCT01820624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24770459|NCT01820624|Keratolytic Agents|keratolytic agents|mesh-ancestor
24770460|NCT01820624|Dermatologic Agents|dermatologic agents|mesh-ancestor
24770461|NCT01820767|Ergocalciferols|ergocalciferols|mesh-list
24770462|NCT01820767|Atorvastatin|atorvastatin|mesh-list
24770463|NCT01820767|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24770464|NCT01820767|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24770465|NCT01820767|Antimetabolites|antimetabolites|mesh-ancestor
24770466|NCT01820767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770467|NCT01820767|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24770499|NCT01820897|Sulfamethoxazole|sulfamethoxazole|mesh-list
24770501|NCT01820897|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24707047|NCT01493843|Paclitaxel|paclitaxel|mesh-list
24770502|NCT01820897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24770503|NCT01820897|Renal Agents|renal agents|mesh-ancestor
24770504|NCT01820897|Antimalarials|antimalarials|mesh-ancestor
24770505|NCT01820897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24770506|NCT01820897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24770507|NCT01820897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24553586|NCT00732147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24553587|NCT00732147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553756|NCT00732784|Calcium|calcium|mesh-list
24770508|NCT01820897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770509|NCT01820897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770510|NCT01820897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24770534|NCT01821027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782665|NCT01897337|Aprepitant|aprepitant|mesh-list
24891108|NCT04476173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24891109|NCT04476173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891110|NCT04476173|Analgesics|analgesics|mesh-ancestor
24891111|NCT04476173|Sensory System Agents|sensory system agents|mesh-ancestor
24891112|NCT04476173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891113|NCT04476173|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24891114|NCT04476173|Anesthetics, General|anesthetics, general|mesh-ancestor
24891115|NCT04476173|Anesthetics|anesthetics|mesh-ancestor
24891116|NCT04476186|Acyclovir|acyclovir|mesh-list
24891117|NCT04476186|Antiviral Agents|antiviral agents|mesh-ancestor
24891118|NCT04476186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24891119|NCT04476069|Ibuprofen|ibuprofen|mesh-list
24891120|NCT04476069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24891128|NCT04476069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24816889|NCT02079506|Antimetabolites|antimetabolites|mesh-ancestor
24770536|NCT01821027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24770537|NCT01821027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770538|NCT01821027|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24770539|NCT01821027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24770540|NCT01821027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770542|NCT01821040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24770543|NCT01821040|Glucocorticoids|glucocorticoids|mesh-ancestor
24770544|NCT01821040|Hormones|hormones|mesh-ancestor
24770545|NCT01821040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24770546|NCT01821040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770547|NCT01821040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24770548|NCT01821040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24553823|NCT00732953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553824|NCT00732966|Losartan|losartan|mesh-list
24770549|NCT01821066|Tamoxifen|tamoxifen|mesh-list
24770550|NCT01821066|Palbociclib|palbociclib|mesh-list
24770551|NCT01821066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24770552|NCT01821066|Hormone Antagonists|hormone antagonists|mesh-ancestor
24770553|NCT01821066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24770554|NCT01821066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770555|NCT01821066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24770556|NCT01821066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24770557|NCT01821066|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24770558|NCT01821066|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24907846|NCT04326959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24770576|NCT01821235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816890|NCT02079506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816896|NCT02079506|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24816897|NCT02079545|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24816898|NCT02079545|Immunologic Factors|immunologic factors|mesh-ancestor
24816899|NCT02079545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891139|NCT04475887|Trace Elements|trace elements|mesh-ancestor
24891140|NCT04475887|Micronutrients|micronutrients|mesh-ancestor
24891141|NCT04475887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770577|NCT01821235|Anticonvulsants|anticonvulsants|mesh-ancestor
24770578|NCT01821235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24770579|NCT01821235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24770580|NCT01821235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24770581|NCT01821235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24770582|NCT01821235|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24770583|NCT01821235|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24770584|NCT01821235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24770585|NCT01821235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770608|NCT01821274|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24770609|NCT01821274|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24770610|NCT01821274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24770611|NCT01821274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770612|NCT01821274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24770613|NCT01821274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770614|NCT01821274|Vasodilator Agents|vasodilator agents|mesh-ancestor
24770615|NCT01821404|Atorvastatin|atorvastatin|mesh-list
24770616|NCT01821404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24770617|NCT01821404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24770618|NCT01821404|Antimetabolites|antimetabolites|mesh-ancestor
24770619|NCT01821404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770620|NCT01821404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24770621|NCT01821404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24770622|NCT01821404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770623|NCT01821430|Pregabalin|pregabalin|mesh-list
24770624|NCT01821430|Analgesics|analgesics|mesh-ancestor
24770625|NCT01821430|Sensory System Agents|sensory system agents|mesh-ancestor
24770626|NCT01821430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24770627|NCT01821430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770628|NCT01821430|Anticonvulsants|anticonvulsants|mesh-ancestor
25080846|NCT03335241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25080847|NCT03335241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25080848|NCT03335241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25080849|NCT03335241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25080850|NCT03335241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25080851|NCT03335241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080853|NCT03335124|Ascorbic Acid|ascorbic acid|mesh-list
25080855|NCT03335124|Hydrocortisone|hydrocortisone|mesh-list
25080856|NCT03335124|Micronutrients|micronutrients|mesh-ancestor
25080857|NCT03335124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080858|NCT03335124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25080859|NCT03335124|Antioxidants|antioxidants|mesh-ancestor
25080860|NCT03335124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080861|NCT03335124|Protective Agents|protective agents|mesh-ancestor
25080862|NCT03335124|Vitamin B Complex|vitamin b complex|mesh-ancestor
25080863|NCT03335098|Thalidomide|thalidomide|mesh-list
25080864|NCT03335098|Dexamethasone|dexamethasone|mesh-list
25080865|NCT03335098|Bortezomib|bortezomib|mesh-list
25080866|NCT03335098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25080867|NCT03335098|Antiemetics|antiemetics|mesh-ancestor
25080868|NCT03335098|Autonomic Agents|autonomic agents|mesh-ancestor
25080894|NCT03335059|Mitomycin|mitomycin|mesh-list
25080895|NCT03335059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25080896|NCT03335059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25080897|NCT03335059|Alkylating Agents|alkylating agents|mesh-ancestor
25080898|NCT03335059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080900|NCT03335059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25080901|NCT03335007|Aceclofenac|aceclofenac|mesh-list
24785295|NCT01913119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24770685|NCT01821703|Hormone Antagonists|hormone antagonists|mesh-ancestor
24770686|NCT01821703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24770687|NCT01821703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770688|NCT01821703|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24770689|NCT01821703|Diuretics|diuretics|mesh-ancestor
24770695|NCT01821846|Hormones|hormones|mesh-ancestor
24770696|NCT01821846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24770697|NCT01821872|Acetaminophen|acetaminophen|mesh-list
24770698|NCT01821872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24770699|NCT01821872|Analgesics|analgesics|mesh-ancestor
24406246|NCT00169533|Lapatinib|lapatinib|mesh-list
24908039|NCT04325061|Glucocorticoids|glucocorticoids|mesh-ancestor
24620572|NCT01057628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620573|NCT01057628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24620574|NCT01057628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620575|NCT01057654|Pravastatin|pravastatin|mesh-list
24620576|NCT01057654|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24620577|NCT01057654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24620578|NCT01057654|Antimetabolites|antimetabolites|mesh-ancestor
24620579|NCT01057654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770742|NCT01822080|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24770743|NCT01822080|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24770744|NCT01822080|Hormone Antagonists|hormone antagonists|mesh-ancestor
24770745|NCT01822080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24770746|NCT01822080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24770747|NCT01822080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24770749|NCT01822210|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24770750|NCT01822210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24770751|NCT01822210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770752|NCT01822210|Cholinergic Agents|cholinergic agents|mesh-ancestor
24770753|NCT01822210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24770754|NCT01822210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770755|NCT01822275|Temozolomide|temozolomide|mesh-list
24770756|NCT01822275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25031217|NCT03589222|Glucocorticoids|glucocorticoids|mesh-ancestor
24770757|NCT01822275|Alkylating Agents|alkylating agents|mesh-ancestor
24770770|NCT01822405|Tocotrienols|tocotrienols|mesh-list
24770771|NCT01822405|alpha-Tocopherol|alpha-tocopherol|mesh-list
24770772|NCT01822405|Pentoxifylline|pentoxifylline|mesh-list
24770773|NCT01822405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24770774|NCT01822405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908160|NCT04323527|Filaricides|filaricides|mesh-ancestor
24770802|NCT01822483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770803|NCT01822509|Nivolumab|nivolumab|mesh-list
24770804|NCT01822509|Ipilimumab|ipilimumab|mesh-list
24770805|NCT01822509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24561893|NCT00763633|Vitamins|vitamins|mesh-list
24770807|NCT01822509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24770808|NCT01822509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770809|NCT01822600|Omeprazole|omeprazole|mesh-list
24770810|NCT01822600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24770811|NCT01822600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24770812|NCT01822600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24770813|NCT01822600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770814|NCT01822600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770815|NCT01822613|Paclitaxel|paclitaxel|mesh-list
24770816|NCT01822613|Docetaxel|docetaxel|mesh-list
24770817|NCT01822613|Irinotecan|irinotecan|mesh-list
24770818|NCT01822613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24770819|NCT01822613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24770839|NCT01822639|Protease Inhibitors|protease inhibitors|mesh-ancestor
24770840|NCT01822730|Risperidone|risperidone|mesh-list
24770841|NCT01822730|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24770842|NCT01822730|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24770843|NCT01822730|Serotonin Agents|serotonin agents|mesh-ancestor
24770844|NCT01822730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24770845|NCT01822730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770846|NCT01822730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770847|NCT01822730|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24770849|NCT01822730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24770850|NCT01822730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24966941|NCT03764202|Sensory System Agents|sensory system agents|mesh-ancestor
24966944|NCT03764202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24966946|NCT03764202|Anesthetics|anesthetics|mesh-ancestor
24770851|NCT01822730|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24770852|NCT01822730|Dopamine Agents|dopamine agents|mesh-ancestor
24891233|NCT04474288|Immunologic Factors|immunologic factors|mesh-ancestor
24770858|NCT01822808|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
24770859|NCT01822808|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24770860|NCT01822808|Diuretics|diuretics|mesh-ancestor
24770861|NCT01822808|Natriuretic Agents|natriuretic agents|mesh-ancestor
24770862|NCT01822808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770863|NCT01822808|Vasodilator Agents|vasodilator agents|mesh-ancestor
24770864|NCT01822808|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24770865|NCT01822808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770866|NCT01822808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24770867|NCT01822860|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24770909|NCT01823081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24770910|NCT01823081|Growth Substances|growth substances|mesh-ancestor
24770911|NCT01823081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770912|NCT01823081|Growth Inhibitors|growth inhibitors|mesh-ancestor
24770913|NCT01823081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24770914|NCT01823081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24770915|NCT01823081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891142|NCT04475276|Thioctic Acid|thioctic acid|mesh-list
24891143|NCT04475276|Antioxidants|antioxidants|mesh-ancestor
24891184|NCT04475029|Morphine|morphine|mesh-list
24891185|NCT04475029|Methadone|methadone|mesh-list
24468453|NCT00381589|Autonomic Agents|autonomic agents|mesh-ancestor
24513449|NCT00581685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24513450|NCT00581685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513451|NCT00581685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24513452|NCT00581685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24513453|NCT00581685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24502872|NCT04137770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24406410|NCT00170196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24513454|NCT00581685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24513455|NCT00581685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24513456|NCT00581685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24513457|NCT00581685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24770916|NCT01823081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24770918|NCT01823081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24770919|NCT01823081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770983|NCT01823848|Mineral Oil|mineral oil|mesh-list
24770984|NCT01823848|Emollients|emollients|mesh-ancestor
24770985|NCT01823848|Dermatologic Agents|dermatologic agents|mesh-ancestor
24770986|NCT01823965|Ranibizumab|ranibizumab|mesh-list
24770987|NCT01823965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24770988|NCT01823965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24770989|NCT01823965|Growth Substances|growth substances|mesh-ancestor
24770990|NCT01823965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770991|NCT01823965|Growth Inhibitors|growth inhibitors|mesh-ancestor
24770992|NCT01823965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24770993|NCT01824043|Ranibizumab|ranibizumab|mesh-list
24770994|NCT01824043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24623683|NCT01073189|Fenoldopam|fenoldopam|mesh-list
24771030|NCT01824251|Immunologic Factors|immunologic factors|mesh-ancestor
24771031|NCT01824251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771032|NCT01824264|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24771033|NCT01824264|Licogliflozin|licogliflozin|mesh-list
24771034|NCT01824264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24771035|NCT01824264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771036|NCT01824264|Incretins|incretins|mesh-ancestor
24771137|NCT01825031|Azithromycin|azithromycin|mesh-list
24771073|NCT01824433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24771074|NCT01824433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24785746|NCT01916252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771075|NCT01824433|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24771076|NCT01824459|Oxaliplatin|oxaliplatin|mesh-list
24771105|NCT01824758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24771110|NCT01824758|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24967008|NCT03763396|Posaconazole|posaconazole|mesh-list
24771111|NCT01824758|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24771113|NCT01824758|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24558553|NCT00757835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562241|NCT00765154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24562242|NCT00765154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24562243|NCT00765154|Antiviral Agents|antiviral agents|mesh-ancestor
24562244|NCT00765154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24562245|NCT00765154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24562246|NCT00765154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24562247|NCT00765167|Chlorhexidine|chlorhexidine|mesh-list
24908488|NCT04319926|Lidocaine|lidocaine|mesh-list
24771117|NCT01824758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25080910|NCT03334981|Buprenorphine|buprenorphine|mesh-list
24562269|NCT00765271|Protease Inhibitors|protease inhibitors|mesh-ancestor
25080911|NCT03334981|Methadone|methadone|mesh-list
24966949|NCT03764163|Anesthetics, General|anesthetics, general|mesh-ancestor
24966950|NCT03764163|Anesthetics|anesthetics|mesh-ancestor
24966951|NCT03764163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24966952|NCT03764163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966953|NCT03764059|Chlorhexidine|chlorhexidine|mesh-list
24966954|NCT03764059|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24966955|NCT03764059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24966956|NCT03764059|Disinfectants|disinfectants|mesh-ancestor
24966957|NCT03764020|Melatonin|melatonin|mesh-list
24966958|NCT03764020|Antioxidants|antioxidants|mesh-ancestor
24966959|NCT03764020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966960|NCT03764020|Protective Agents|protective agents|mesh-ancestor
24966961|NCT03764020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966962|NCT03764020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24966963|NCT03763786|Cetrorelix|cetrorelix|mesh-list
24966964|NCT03763786|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24513458|NCT00581685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25685711|NCT01908842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25685712|NCT01908842|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25685713|NCT01908972|Prednisolone|prednisolone|mesh-list
25685714|NCT01908972|Propranolol|propranolol|mesh-list
25685715|NCT01908972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24513459|NCT00581685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24513460|NCT00581685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24891186|NCT04475029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24891188|NCT04475029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24891189|NCT04475029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891190|NCT04475029|Analgesics|analgesics|mesh-ancestor
24891191|NCT04475029|Sensory System Agents|sensory system agents|mesh-ancestor
24966965|NCT03763786|Fertility Agents|fertility agents|mesh-ancestor
24966966|NCT03763786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24966967|NCT03763786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966968|NCT03763786|Hormone Antagonists|hormone antagonists|mesh-ancestor
24966969|NCT03763786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24966970|NCT03763760|Dexamethasone|dexamethasone|mesh-list
24966971|NCT03763760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24966972|NCT03763760|Antiemetics|antiemetics|mesh-ancestor
25080912|NCT03334981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24771129|NCT01824888|Anti-Infective Agents|anti-infective agents|mesh-list
24771130|NCT01824888|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24771131|NCT01824927|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24771132|NCT01824927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24771133|NCT01824992|Interferons|interferons|mesh-list
24771134|NCT01824992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771135|NCT01824992|Antiviral Agents|antiviral agents|mesh-ancestor
24771136|NCT01824992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24891192|NCT04475029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891193|NCT04475029|Antitussive Agents|antitussive agents|mesh-ancestor
24891194|NCT04475029|Respiratory System Agents|respiratory system agents|mesh-ancestor
24891220|NCT04474262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891221|NCT04474262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891222|NCT04474262|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24891223|NCT04474262|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24891224|NCT04474262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24891225|NCT04474262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24891226|NCT04474262|Adrenergic Agents|adrenergic agents|mesh-ancestor
24891227|NCT04474262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24891228|NCT04474262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891230|NCT04474210|Antiviral Agents|antiviral agents|mesh-ancestor
24891231|NCT04474210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24891232|NCT04474288|Antibodies|antibodies|mesh-list
24541224|NCT00671593|Phenol|phenol|mesh-list
24891234|NCT04474288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891236|NCT04474093|Methamphetamine|methamphetamine|mesh-list
24771156|NCT01825031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24771158|NCT01825031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24771159|NCT01825031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24771160|NCT01825031|Antitubercular Agents|antitubercular agents|mesh-ancestor
24771161|NCT01825031|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24771162|NCT01825031|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24771163|NCT01825031|Antimetabolites|antimetabolites|mesh-ancestor
24771164|NCT01825031|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24771165|NCT01825031|Anthelmintics|anthelmintics|mesh-ancestor
24771166|NCT01825031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24771167|NCT01825031|Anticestodal Agents|anticestodal agents|mesh-ancestor
24771168|NCT01825031|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24771169|NCT01825031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24771195|NCT01825083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24771196|NCT01825083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24771197|NCT01825083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24771198|NCT01825083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24771199|NCT01825083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771201|NCT01825109|Immunologic Factors|immunologic factors|mesh-ancestor
24771202|NCT01825109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771204|NCT01825395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24771205|NCT01825395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24966996|NCT03763669|Inositol|inositol|mesh-list
24771206|NCT01825395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771207|NCT01825395|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24771208|NCT01825395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24771209|NCT01825395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782965|NCT01899326|Desipramine|desipramine|mesh-list
24891237|NCT04474093|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25685716|NCT01908972|Glucocorticoids|glucocorticoids|mesh-ancestor
25125563|NCT03067883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25125564|NCT03067883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25125565|NCT03067883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24517595|NCT00608790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24517596|NCT00608790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891287|NCT04473820|Prilocaine|prilocaine|mesh-list
24771211|NCT01825421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24771212|NCT01825447|Naltrexone|naltrexone|mesh-list
24771213|NCT01825447|Oxycodone|oxycodone|mesh-list
24771214|NCT01825447|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24771215|NCT01825447|Narcotics|narcotics|mesh-ancestor
24771216|NCT01825447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24771217|NCT01825447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771218|NCT01825447|Analgesics|analgesics|mesh-ancestor
24771219|NCT01825447|Sensory System Agents|sensory system agents|mesh-ancestor
24771220|NCT01825447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24771221|NCT01825447|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24771222|NCT01825447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24771295|NCT01825863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771296|NCT01825863|Sensory System Agents|sensory system agents|mesh-ancestor
24771297|NCT01825863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24406518|NCT00170729|Prednisolone|prednisolone|mesh-list
24406519|NCT00170729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24406520|NCT00170729|Methylprednisolone|methylprednisolone|mesh-list
24406522|NCT00170729|Prednisolone acetate|prednisolone acetate|mesh-list
24406528|NCT00170729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24908715|NCT04316936|Dexamethasone|dexamethasone|mesh-list
24771332|NCT01826149|Anesthetics|anesthetics|mesh-ancestor
24771333|NCT01826175|Clopidogrel|clopidogrel|mesh-list
24771334|NCT01826175|Ticagrelor|ticagrelor|mesh-list
24771335|NCT01826175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24771336|NCT01826175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24624390|NCT01075945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24771337|NCT01826175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24771338|NCT01826175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24771389|NCT01827020|Lidocaine|lidocaine|mesh-list
24771390|NCT01827020|Ketamine|ketamine|mesh-list
24771391|NCT01827020|Anesthetics, Local|anesthetics, local|mesh-ancestor
24771392|NCT01827020|Anesthetics|anesthetics|mesh-ancestor
24771393|NCT01827020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24771394|NCT01827020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782998|NCT01899755|Adalimumab|adalimumab|mesh-list
24891288|NCT04473820|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24446802|NCT00306020|Sensory System Agents|sensory system agents|mesh-ancestor
24446803|NCT00306020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24446804|NCT00306033|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24891475|NCT04470791|Immunologic Factors|immunologic factors|mesh-ancestor
24891476|NCT04470791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891477|NCT04470804|Cyclosporine|cyclosporine|mesh-list
24891479|NCT04470804|Cyclosporins|cyclosporins|mesh-list
24891480|NCT04470804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771395|NCT01827020|Sensory System Agents|sensory system agents|mesh-ancestor
24771396|NCT01827020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24771397|NCT01827020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24771398|NCT01827020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24771399|NCT01827020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24771401|NCT01827020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771403|NCT01827020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24771404|NCT01827020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24771405|NCT01827020|Anesthetics, General|anesthetics, general|mesh-ancestor
24771406|NCT01827020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25685717|NCT01908972|Hormones|hormones|mesh-ancestor
25685718|NCT01908972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25685719|NCT01908972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685720|NCT01908972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25685721|NCT01908972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25685722|NCT01908972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25685723|NCT01908972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25685724|NCT01908972|Adrenergic Agents|adrenergic agents|mesh-ancestor
25685725|NCT01908972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25692560|NCT02001987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24771407|NCT01827020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24771408|NCT01827020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24771410|NCT01827059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24771411|NCT01827059|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24771412|NCT01827059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771413|NCT01827072|Immunoglobulins|immunoglobulins|mesh-list
24771414|NCT01827072|Immunologic Factors|immunologic factors|mesh-ancestor
24771415|NCT01827072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771416|NCT01827124|Oxytocin|oxytocin|mesh-list
24771417|NCT01827124|Carbetocin|carbetocin|mesh-list
24562564|NCT00766909|Dermatologic Agents|dermatologic agents|mesh-ancestor
24562565|NCT00766909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24771430|NCT01827137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771431|NCT01827202|Candesartan|candesartan|mesh-list
24771432|NCT01827202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24771433|NCT01827202|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24771434|NCT01827202|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24771435|NCT01827202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771436|NCT01827228|HIV Antibodies|hiv antibodies|mesh-list
24771437|NCT01827228|Immunologic Factors|immunologic factors|mesh-ancestor
24771438|NCT01827228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771439|NCT01827280|Vildagliptin|vildagliptin|mesh-list
24771440|NCT01827280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24771443|NCT01827280|Protease Inhibitors|protease inhibitors|mesh-ancestor
24771444|NCT01827280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771445|NCT01827280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771448|NCT01827293|Lorazepam|lorazepam|mesh-list
24771449|NCT01827293|Anticonvulsants|anticonvulsants|mesh-ancestor
24771450|NCT01827293|Antiemetics|antiemetics|mesh-ancestor
24771451|NCT01827293|Autonomic Agents|autonomic agents|mesh-ancestor
24771452|NCT01827293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24771453|NCT01827293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771454|NCT01827293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24771455|NCT01827293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24771456|NCT01827293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24771457|NCT01827293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24771458|NCT01827293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24771459|NCT01827293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24771460|NCT01827293|GABA Modulators|gaba modulators|mesh-ancestor
24771461|NCT01827293|GABA Agents|gaba agents|mesh-ancestor
24967000|NCT03763669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967002|NCT03763409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24967003|NCT03763409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24967004|NCT03763409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24967005|NCT03763409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24967006|NCT03763409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967007|NCT03763396|Ketoconazole|ketoconazole|mesh-list
24967009|NCT03763396|Antifungal Agents|antifungal agents|mesh-ancestor
24967010|NCT03763396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24967011|NCT03763396|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24783059|NCT01900028|Olaparib|olaparib|mesh-list
24891481|NCT04470804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891482|NCT04470804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24891483|NCT04470804|Immunologic Factors|immunologic factors|mesh-ancestor
24891484|NCT04470804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891485|NCT04470804|Antifungal Agents|antifungal agents|mesh-ancestor
24891486|NCT04470804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24891487|NCT04470804|Dermatologic Agents|dermatologic agents|mesh-ancestor
24891488|NCT04470804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24891489|NCT04470804|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24891490|NCT04470804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24891491|NCT04470804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24891492|NCT04470804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967013|NCT03763396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24967023|NCT03763279|Triclosan|triclosan|mesh-list
25080944|NCT03334591|Apatinib|apatinib|mesh-list
25080945|NCT03334591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25080946|NCT03334591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25080947|NCT03334591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25080948|NCT03334591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080949|NCT03334513|Bevacizumab|bevacizumab|mesh-list
25080950|NCT03334513|Ranibizumab|ranibizumab|mesh-list
25080951|NCT03334513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25080952|NCT03334513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25080953|NCT03334513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25080954|NCT03334513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25080955|NCT03334513|Growth Substances|growth substances|mesh-ancestor
25080956|NCT03334513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080957|NCT03334513|Growth Inhibitors|growth inhibitors|mesh-ancestor
25080958|NCT03334487|Dexamethasone|dexamethasone|mesh-list
25080959|NCT03334487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25080960|NCT03334487|Antiemetics|antiemetics|mesh-ancestor
24771539|NCT01827735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24625969|NCT01084837|Bortezomib|bortezomib|mesh-list
24891493|NCT04470609|Vaccines|vaccines|mesh-list
24891494|NCT04470609|Immunologic Factors|immunologic factors|mesh-ancestor
24891495|NCT04470609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891496|NCT04470401|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24891497|NCT04470401|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24891559|NCT04469829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891560|NCT04469829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24891561|NCT04469829|Antimetabolites|antimetabolites|mesh-ancestor
24891588|NCT04469283|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24891589|NCT04469283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24891592|NCT04469283|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24891594|NCT04469283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24891595|NCT04469010|Ascorbic Acid|ascorbic acid|mesh-list
24891597|NCT04469010|Chelating Agents|chelating agents|mesh-list
24891598|NCT04469010|Vitamins|vitamins|mesh-ancestor
24891599|NCT04469010|Micronutrients|micronutrients|mesh-ancestor
24891600|NCT04469010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891601|NCT04469010|Trace Elements|trace elements|mesh-ancestor
24891602|NCT04469010|Antioxidants|antioxidants|mesh-ancestor
24891603|NCT04469010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891604|NCT04469010|Protective Agents|protective agents|mesh-ancestor
24891605|NCT04469010|Sequestering Agents|sequestering agents|mesh-ancestor
24891606|NCT04469114|Tofacitinib|tofacitinib|mesh-list
24771540|NCT01827735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24771541|NCT01827735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24771542|NCT01827735|Antiviral Agents|antiviral agents|mesh-ancestor
24771543|NCT01827735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24771544|NCT01827865|Etodolac|etodolac|mesh-list
24771545|NCT01827865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24771546|NCT01827865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24771547|NCT01827865|Analgesics|analgesics|mesh-ancestor
24771548|NCT01827865|Sensory System Agents|sensory system agents|mesh-ancestor
24771549|NCT01827865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24771550|NCT01827865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771551|NCT01827865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24771552|NCT01827865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24771553|NCT01827865|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24771554|NCT01827865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24771555|NCT01827865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771556|NCT01827865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771557|NCT01827878|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24771558|NCT01827878|Lisinopril|lisinopril|mesh-list
24771559|NCT01827878|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
24771560|NCT01827878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24771561|NCT01827878|Diuretics|diuretics|mesh-ancestor
24771562|NCT01827878|Natriuretic Agents|natriuretic agents|mesh-ancestor
24771588|NCT01828346|Antimetabolites|antimetabolites|mesh-ancestor
24771589|NCT01828346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771590|NCT01828346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771591|NCT01828346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771593|NCT01828359|Amlodipine|amlodipine|mesh-list
24771594|NCT01828359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24771595|NCT01828359|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24771596|NCT01828359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24771597|NCT01828359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771598|NCT01828359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24771606|NCT01828385|Sensory System Agents|sensory system agents|mesh-ancestor
24771607|NCT01828385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24771608|NCT01828385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771609|NCT01828385|Anesthetics|anesthetics|mesh-ancestor
24909056|NCT04313374|Analgesics|analgesics|mesh-ancestor
24771638|NCT01828437|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24771640|NCT01828437|Vitamin B Complex|vitamin b complex|mesh-ancestor
24771641|NCT01828437|Vitamins|vitamins|mesh-ancestor
24771642|NCT01828437|Micronutrients|micronutrients|mesh-ancestor
24771644|NCT01828463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771645|NCT01828463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771646|NCT01828489|Mitoxantrone|mitoxantrone|mesh-list
24771647|NCT01828489|Analgesics|analgesics|mesh-ancestor
24771648|NCT01828489|Sensory System Agents|sensory system agents|mesh-ancestor
24771649|NCT01828489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24771650|NCT01828489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771651|NCT01828489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771652|NCT01828489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24771653|NCT01828489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24771654|NCT01828489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771707|NCT01828892|Meropenem|meropenem|mesh-list
24771708|NCT01828892|Ceftazidime|ceftazidime|mesh-list
24771709|NCT01828892|Cefotaxime|cefotaxime|mesh-list
24771710|NCT01828892|Cefoxitin|cefoxitin|mesh-list
24771711|NCT01828892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24771712|NCT01828970|Insulin Aspart|insulin aspart|mesh-list
24771713|NCT01828970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24771714|NCT01828970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771717|NCT01829178|Fluorouracil|fluorouracil|mesh-list
24771718|NCT01829178|Silymarin|silymarin|mesh-list
24771719|NCT01829178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771720|NCT01829178|Tubulin Modulators|tubulin modulators|mesh-ancestor
24771721|NCT01829178|Antimitotic Agents|antimitotic agents|mesh-ancestor
24771722|NCT01829178|Mitosis Modulators|mitosis modulators|mesh-ancestor
24771723|NCT01829178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771729|NCT01829178|Antioxidants|antioxidants|mesh-ancestor
24771767|NCT01829698|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24562967|NCT00769171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24562968|NCT00769171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24562969|NCT00769171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24771812|NCT01829893|Hormone Antagonists|hormone antagonists|mesh-ancestor
24586108|NCT00889161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771819|NCT01830153|Everolimus|everolimus|mesh-list
24771820|NCT01830153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771821|NCT01830153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24771822|NCT01830153|Immunologic Factors|immunologic factors|mesh-ancestor
24771823|NCT01830153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771824|NCT01830218|Anesthetics|anesthetics|mesh-list
24771825|NCT01830218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24771826|NCT01830218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771827|NCT01830244|Paclitaxel|paclitaxel|mesh-list
24771828|NCT01830244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24771829|NCT01830244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771830|NCT01830244|Tubulin Modulators|tubulin modulators|mesh-ancestor
24771831|NCT01830244|Antimitotic Agents|antimitotic agents|mesh-ancestor
24771832|NCT01830244|Mitosis Modulators|mitosis modulators|mesh-ancestor
24771833|NCT01830244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771834|NCT01830270|Paclitaxel|paclitaxel|mesh-list
24771835|NCT01830270|Epirubicin|epirubicin|mesh-list
24771836|NCT01830270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24406672|NCT00170989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406673|NCT00170989|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24406674|NCT00170989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24406676|NCT00171002|Valsartan|valsartan|mesh-list
24406677|NCT00171002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24406678|NCT00171002|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24406679|NCT00171002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24406680|NCT00171002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406684|NCT00171002|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24406686|NCT00171015|Valsartan|valsartan|mesh-list
24771837|NCT01830270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771838|NCT01830270|Tubulin Modulators|tubulin modulators|mesh-ancestor
24771841|NCT01830270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771866|NCT01830335|Indomethacin|indomethacin|mesh-list
24771867|NCT01830335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24771868|NCT01830335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24771869|NCT01830335|Analgesics|analgesics|mesh-ancestor
24771870|NCT01830335|Sensory System Agents|sensory system agents|mesh-ancestor
24771871|NCT01830335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24771872|NCT01830335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771874|NCT01830335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24771875|NCT01830335|Gout Suppressants|gout suppressants|mesh-ancestor
24771876|NCT01830335|Tocolytic Agents|tocolytic agents|mesh-ancestor
24771877|NCT01830335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24771878|NCT01830335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24771879|NCT01830335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771880|NCT01830335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771882|NCT01830361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771883|NCT01830361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24771884|NCT01830361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771885|NCT01830361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771894|NCT01830465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24771895|NCT01830465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771896|NCT01830465|Immunologic Factors|immunologic factors|mesh-ancestor
24771897|NCT01830465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771935|NCT01830517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24891609|NCT04469114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891610|NCT04469062|Mirikizumab|mirikizumab|mesh-list
24891631|NCT04468685|Autonomic Agents|autonomic agents|mesh-ancestor
24891632|NCT04468685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891633|NCT04468685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891634|NCT04468685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24891635|NCT04468685|Antipruritics|antipruritics|mesh-ancestor
24891636|NCT04468685|Dermatologic Agents|dermatologic agents|mesh-ancestor
24891637|NCT04468685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24891638|NCT04468685|Serotonin Agents|serotonin agents|mesh-ancestor
24891639|NCT04468685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24891640|NCT04468685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891693|NCT04468282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891700|NCT04467918|Cannabidiol|cannabidiol|mesh-list
24891701|NCT04467918|Anticonvulsants|anticonvulsants|mesh-ancestor
24891702|NCT04467892|Methylprednisolone|methylprednisolone|mesh-list
24891703|NCT04467892|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24891704|NCT04467892|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24891705|NCT04467892|Prednisolone|prednisolone|mesh-list
24891706|NCT04467892|Prednisolone acetate|prednisolone acetate|mesh-list
24891707|NCT04467892|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24891708|NCT04467892|Prednisolone phosphate|prednisolone phosphate|mesh-list
24771939|NCT01830517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771940|NCT01830517|Vasodilator Agents|vasodilator agents|mesh-ancestor
24771941|NCT01830517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24771942|NCT01830517|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24771943|NCT01830517|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24771944|NCT01830530|Telmisartan|telmisartan|mesh-list
24771945|NCT01830530|Nifedipine|nifedipine|mesh-list
24771978|NCT01830777|Sensory System Agents|sensory system agents|mesh-ancestor
24771979|NCT01830777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24771980|NCT01830777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24771981|NCT01830829|Tamsulosin|tamsulosin|mesh-list
24771982|NCT01830829|Dutasteride|dutasteride|mesh-list
24771983|NCT01830829|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24771984|NCT01830829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24771985|NCT01830829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24771986|NCT01830829|Adrenergic Agents|adrenergic agents|mesh-ancestor
24772008|NCT01830946|Sequestering Agents|sequestering agents|mesh-ancestor
24772009|NCT01830946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772010|NCT01831011|Aspirin|aspirin|mesh-list
24772011|NCT01831011|Cinepazide|cinepazide|mesh-list
24772012|NCT01831011|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
24772013|NCT01831011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24772014|NCT01831011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24772015|NCT01831011|Analgesics|analgesics|mesh-ancestor
24772016|NCT01831011|Sensory System Agents|sensory system agents|mesh-ancestor
24772017|NCT01831011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24772018|NCT01831011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772019|NCT01831011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24772020|NCT01831011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24772021|NCT01831011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24772033|NCT01831050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772035|NCT01831193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24772036|NCT01831193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24772037|NCT01831193|Analgesics|analgesics|mesh-ancestor
24772038|NCT01831193|Sensory System Agents|sensory system agents|mesh-ancestor
24909507|NCT04308161|Vitamin D|vitamin d|mesh-list
25081062|NCT03333369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620623|NCT01057875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620624|NCT01057875|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24620625|NCT01057875|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24620626|NCT01057875|Purinergic Agents|purinergic agents|mesh-ancestor
24620627|NCT01057875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24620629|NCT01057966|Micronutrients|micronutrients|mesh-ancestor
24620630|NCT01057966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620631|NCT01058057|Atorvastatin|atorvastatin|mesh-list
24620632|NCT01058057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24620633|NCT01058057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24772156|NCT01832129|Hydroxocobalamin|hydroxocobalamin|mesh-list
24772224|NCT01832415|Bevacizumab|bevacizumab|mesh-list
24909742|NCT04305457|Nitric Oxide|nitric oxide|mesh-list
24772294|NCT01832922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772295|NCT01832922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24772331|NCT01832987|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24772332|NCT01832987|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24772333|NCT01832987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24772334|NCT01832987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772335|NCT01832987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772336|NCT01832987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24772370|NCT01833312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24772371|NCT01833312|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24772372|NCT01833312|Serotonin Agents|serotonin agents|mesh-ancestor
24772373|NCT01833312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24772374|NCT01833312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772375|NCT01833312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24772378|NCT01833312|Sensory System Agents|sensory system agents|mesh-ancestor
24772379|NCT01833312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24772380|NCT01833312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24772381|NCT01833351|Vitamins|vitamins|mesh-list
24772382|NCT01833351|Ascorbic Acid|ascorbic acid|mesh-list
24772383|NCT01833351|Micronutrients|micronutrients|mesh-ancestor
24772384|NCT01833351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772385|NCT01833351|Antioxidants|antioxidants|mesh-ancestor
24909912|NCT04304040|Immunologic Factors|immunologic factors|mesh-ancestor
24772553|NCT01834235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772589|NCT01834547|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24772590|NCT01834547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772662|NCT01834898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24772663|NCT01834898|Narcotics|narcotics|mesh-ancestor
24772664|NCT01834898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24772665|NCT01834898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772724|NCT01835236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772725|NCT01835236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24772726|NCT01835288|Arsenic Trioxide|arsenic trioxide|mesh-list
24772727|NCT01835288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772728|NCT01835314|Stiripentol|stiripentol|mesh-list
24772729|NCT01835314|Anticonvulsants|anticonvulsants|mesh-ancestor
24772741|NCT01835418|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24772742|NCT01835418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24772743|NCT01835418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772770|NCT01835665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24772771|NCT01835665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772772|NCT01835665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24772773|NCT01835665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772774|NCT01835665|Vasodilator Agents|vasodilator agents|mesh-ancestor
24772775|NCT01835678|Linagliptin|linagliptin|mesh-list
24783315|NCT01901003|GABA Modulators|gaba modulators|mesh-ancestor
24891709|NCT04467892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24891710|NCT04467892|Antiemetics|antiemetics|mesh-ancestor
24891711|NCT04467892|Autonomic Agents|autonomic agents|mesh-ancestor
24891734|NCT04467931|Telmisartan|telmisartan|mesh-list
24891735|NCT04467931|Clonidine|clonidine|mesh-list
24891736|NCT04467931|Carvedilol|carvedilol|mesh-list
24772776|NCT01835678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24772777|NCT01835678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772778|NCT01835678|Incretins|incretins|mesh-ancestor
24772779|NCT01835678|Hormones|hormones|mesh-ancestor
24772780|NCT01835678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24772781|NCT01835678|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24772782|NCT01835678|Protease Inhibitors|protease inhibitors|mesh-ancestor
24772783|NCT01835678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772784|NCT01835678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772785|NCT01835691|Vitamin D|vitamin d|mesh-list
24772786|NCT01835691|Ergocalciferols|ergocalciferols|mesh-list
24772787|NCT01835691|Cholecalciferol|cholecalciferol|mesh-list
24891740|NCT04467931|Olmesartan|olmesartan|mesh-list
24891741|NCT04467931|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24698665|NCT01442532|Midazolam|midazolam|mesh-list
24891742|NCT04467931|Enalapril|enalapril|mesh-list
24891743|NCT04467931|Enalaprilat|enalaprilat|mesh-list
24891744|NCT04467931|Lisinopril|lisinopril|mesh-list
24891745|NCT04467931|Irbesartan|irbesartan|mesh-list
24891828|NCT04467931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24891829|NCT04467931|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24891830|NCT04467931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24891831|NCT04467931|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24891953|NCT04466046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24891954|NCT04466046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891956|NCT04466046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24891957|NCT04466046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24891958|NCT04466046|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24891959|NCT04466046|Anesthetics, General|anesthetics, general|mesh-ancestor
24891960|NCT04466046|Anesthetics|anesthetics|mesh-ancestor
24891993|NCT04466176|Respiratory System Agents|respiratory system agents|mesh-ancestor
24891994|NCT04466176|Dermatologic Agents|dermatologic agents|mesh-ancestor
24891995|NCT04466176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24891996|NCT04466176|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24816919|NCT02079727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816920|NCT02079727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816921|NCT02079961|Micronutrients|micronutrients|mesh-list
24816922|NCT02079961|Trace Elements|trace elements|mesh-list
24816923|NCT02079961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816924|NCT02079974|Pravastatin|pravastatin|mesh-list
24816925|NCT02079974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24816926|NCT02079974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24772791|NCT01835691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24772792|NCT01835691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24910294|NCT04300686|Adalimumab|adalimumab|mesh-list
24772859|NCT01836289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772861|NCT01836289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24772862|NCT01836328|Methadone|methadone|mesh-list
24772863|NCT01836328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24772864|NCT01836328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24772865|NCT01836328|Narcotics|narcotics|mesh-ancestor
24772866|NCT01836328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24910352|NCT04299971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24620673|NCT01058252|Hormone Antagonists|hormone antagonists|mesh-ancestor
24620674|NCT01058252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24406910|NCT00171561|Valsartan|valsartan|mesh-list
24620675|NCT01058252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620676|NCT01058252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24620677|NCT01058252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24620678|NCT01058252|Analgesics|analgesics|mesh-ancestor
24620679|NCT01058252|Sensory System Agents|sensory system agents|mesh-ancestor
24620680|NCT01058252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24620681|NCT01058252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24620682|NCT01058252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24620683|NCT01058252|Gout Suppressants|gout suppressants|mesh-ancestor
24620684|NCT01058252|Tocolytic Agents|tocolytic agents|mesh-ancestor
24620685|NCT01058252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24620686|NCT01058252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24620687|NCT01058291|Apomorphine|apomorphine|mesh-list
24620689|NCT01058291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816928|NCT02079974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816930|NCT02079974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24816931|NCT02079974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816932|NCT02080026|Chloroquine|chloroquine|mesh-list
24892053|NCT04465942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24892054|NCT04465942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25692561|NCT02001987|Immunologic Factors|immunologic factors|mesh-ancestor
25692562|NCT02001987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25692563|NCT02001987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25692564|NCT02002221|Metformin|metformin|mesh-list
25692565|NCT02002221|Vildagliptin|vildagliptin|mesh-list
25692566|NCT02002221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25692567|NCT02002221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692568|NCT02002221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25692569|NCT02002221|Protease Inhibitors|protease inhibitors|mesh-ancestor
25692570|NCT02002221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692571|NCT02002221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692572|NCT02002650|Indomethacin|indomethacin|mesh-list
24892109|NCT04465851|Analgesics|analgesics|mesh-ancestor
24892110|NCT04465851|Sensory System Agents|sensory system agents|mesh-ancestor
24910382|NCT04298528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24772997|NCT01837290|Midazolam|midazolam|mesh-list
24772998|NCT01837290|Dexmedetomidine|dexmedetomidine|mesh-list
24772999|NCT01837290|Bupivacaine|bupivacaine|mesh-list
24773000|NCT01837290|Anesthetics, Local|anesthetics, local|mesh-ancestor
24773001|NCT01837290|Anesthetics|anesthetics|mesh-ancestor
24773002|NCT01837290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24773003|NCT01837290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773004|NCT01837290|Sensory System Agents|sensory system agents|mesh-ancestor
24624696|NCT01077726|Antimetabolites|antimetabolites|mesh-ancestor
24773005|NCT01837290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773006|NCT01837290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24773007|NCT01837290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24773008|NCT01837290|Analgesics|analgesics|mesh-ancestor
24773009|NCT01837290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24773010|NCT01837290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24773011|NCT01837290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24773012|NCT01837290|Adrenergic Agents|adrenergic agents|mesh-ancestor
24773013|NCT01837290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24773014|NCT01837290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081118|NCT03332888|Immunologic Factors|immunologic factors|mesh-ancestor
24773015|NCT01837290|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24773016|NCT01837290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24773017|NCT01837290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24773018|NCT01837290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24773019|NCT01837290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24773020|NCT01837290|Anesthetics, General|anesthetics, general|mesh-ancestor
24773021|NCT01837290|GABA Modulators|gaba modulators|mesh-ancestor
24773061|NCT01837394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25081148|NCT03332719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25081149|NCT03332719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25081151|NCT03332602|Folic Acid|folic acid|mesh-list
25081152|NCT03332602|Vitamin A|vitamin a|mesh-list
25081184|NCT03332524|Ibuprofen|ibuprofen|mesh-list
24773101|NCT01837446|Antipruritics|antipruritics|mesh-ancestor
24773102|NCT01837446|Dermatologic Agents|dermatologic agents|mesh-ancestor
24773103|NCT01837446|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24773104|NCT01837446|Immunologic Factors|immunologic factors|mesh-ancestor
24564307|NCT00775827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24773106|NCT01837498|Neostigmine|neostigmine|mesh-list
24773107|NCT01837498|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24773108|NCT01837498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773109|NCT01837498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773111|NCT01837498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24773149|NCT01837810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24773150|NCT01837810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24773186|NCT01838395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24773187|NCT01838395|Antimetabolites|antimetabolites|mesh-ancestor
24773188|NCT01838395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773189|NCT01838395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24773190|NCT01838395|Antiviral Agents|antiviral agents|mesh-ancestor
24773228|NCT01838473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783508|NCT01902342|Oseltamivir|oseltamivir|mesh-list
24892111|NCT04465851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24892140|NCT04465357|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
24892141|NCT04465357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773233|NCT01838538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24773234|NCT01838538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24773235|NCT01838538|Tubulin Modulators|tubulin modulators|mesh-ancestor
24773267|NCT01838772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24773268|NCT01838772|Antiviral Agents|antiviral agents|mesh-ancestor
24773269|NCT01838772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24773270|NCT01838772|Antimetabolites|antimetabolites|mesh-ancestor
24773271|NCT01838772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773272|NCT01838850|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24773306|NCT01839032|Mitosis Modulators|mitosis modulators|mesh-ancestor
24773307|NCT01839032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773309|NCT01839084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24773310|NCT01839084|Anesthetics, General|anesthetics, general|mesh-ancestor
24773311|NCT01839084|Anesthetics|anesthetics|mesh-ancestor
24773312|NCT01839084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24773313|NCT01839084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910787|NCT04294537|Anesthetics|anesthetics|mesh-list
24773392|NCT01839344|Protective Agents|protective agents|mesh-ancestor
24773393|NCT01839357|Rivaroxaban|rivaroxaban|mesh-list
24773394|NCT01839357|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24773395|NCT01839357|Antithrombins|antithrombins|mesh-ancestor
24773396|NCT01839357|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24773433|NCT01839630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773434|NCT01839630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819115|NCT02093403|Decitabine|decitabine|mesh-list
24819151|NCT02093728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24773490|NCT01839929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24773491|NCT01839929|Immunologic Factors|immunologic factors|mesh-ancestor
24773492|NCT01839929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773493|NCT01839929|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24892266|NCT04464629|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24892267|NCT04464629|Protective Agents|protective agents|mesh-ancestor
24892268|NCT04464512|Sufentanil|sufentanil|mesh-list
24892269|NCT04464512|Buprenorphine|buprenorphine|mesh-list
24892270|NCT04464512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24892271|NCT04464512|Narcotics|narcotics|mesh-ancestor
24892272|NCT04464512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24773494|NCT01839929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773524|NCT01840007|Metformin|metformin|mesh-list
24773525|NCT01840007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24773526|NCT01840007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773534|NCT01840189|Hydrocortisone|hydrocortisone|mesh-list
24773535|NCT01840189|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24773536|NCT01840189|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24773537|NCT01840189|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24773616|NCT01841008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24773617|NCT01841008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565190|NCT00779194|Antifungal Agents|antifungal agents|mesh-ancestor
24773618|NCT01841008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773619|NCT01841099|Mesalamine|mesalamine|mesh-list
24910967|NCT04292119|Crizotinib|crizotinib|mesh-list
24773652|NCT01841164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773654|NCT01841242|Povidone-Iodine|povidone-iodine|mesh-list
24773655|NCT01841242|Povidone|povidone|mesh-list
24773656|NCT01841242|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24773657|NCT01841242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24773658|NCT01841242|Disinfectants|disinfectants|mesh-ancestor
24773659|NCT01841242|Plasma Substitutes|plasma substitutes|mesh-ancestor
24773695|NCT01841411|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24773696|NCT01841411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24773697|NCT01841411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24783670|NCT01903109|Autonomic Agents|autonomic agents|mesh-ancestor
24892273|NCT04464512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892274|NCT04464512|Analgesics|analgesics|mesh-ancestor
24892275|NCT04464512|Sensory System Agents|sensory system agents|mesh-ancestor
24892276|NCT04464512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24892277|NCT04464512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24892278|NCT04464512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24892279|NCT04464512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24892280|NCT04464512|Anesthetics, General|anesthetics, general|mesh-ancestor
24892281|NCT04464512|Anesthetics|anesthetics|mesh-ancestor
24892282|NCT04464642|Methotrexate|methotrexate|mesh-list
24892283|NCT04464642|Tofacitinib|tofacitinib|mesh-list
24892284|NCT04464642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24892285|NCT04464642|Abortifacient Agents|abortifacient agents|mesh-ancestor
24892286|NCT04464642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24773699|NCT01841411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24773745|NCT01841658|Micronutrients|micronutrients|mesh-ancestor
24773746|NCT01841658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773747|NCT01841684|Anacetrapib|anacetrapib|mesh-list
24773748|NCT01841684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24773749|NCT01841684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24773750|NCT01841684|Antimetabolites|antimetabolites|mesh-ancestor
24773751|NCT01841684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773752|NCT01841684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24773754|NCT01841775|Ribavirin|ribavirin|mesh-list
24773802|NCT01842139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24773803|NCT01842165|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
24773804|NCT01842165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24773805|NCT01842165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773806|NCT01842230|Niacin|niacin|mesh-list
24773807|NCT01842230|Amlodipine|amlodipine|mesh-list
24773808|NCT01842230|Telmisartan|telmisartan|mesh-list
24773809|NCT01842230|Atorvastatin|atorvastatin|mesh-list
24773810|NCT01842230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24773811|NCT01842230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24773812|NCT01842230|Antimetabolites|antimetabolites|mesh-ancestor
24620739|NCT01058824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407197|NCT00172419|Antimetabolites|antimetabolites|mesh-ancestor
24407198|NCT00172419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407199|NCT00172419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24620740|NCT01058824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620741|NCT01058850|Rindopepimut|rindopepimut|mesh-list
24620742|NCT01058850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24620743|NCT01058850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24620745|NCT01058876|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24773825|NCT01842230|Vitamin B Complex|vitamin b complex|mesh-ancestor
24773826|NCT01842230|Vitamins|vitamins|mesh-ancestor
24773827|NCT01842230|Micronutrients|micronutrients|mesh-ancestor
24773828|NCT01842256|Amlodipine|amlodipine|mesh-list
24773924|NCT01842932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773925|NCT01842932|Parasympatholytics|parasympatholytics|mesh-ancestor
24773926|NCT01842932|Autonomic Agents|autonomic agents|mesh-ancestor
24911327|NCT04289792|Antimetabolites|antimetabolites|mesh-ancestor
24773955|NCT01843127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773956|NCT01843127|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24773957|NCT01843127|Incretins|incretins|mesh-ancestor
24565184|NCT00779129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565185|NCT00779194|Sirolimus|sirolimus|mesh-list
24773958|NCT01843127|Hormones|hormones|mesh-ancestor
24565186|NCT00779194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24565187|NCT00779194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24565188|NCT00779194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24773959|NCT01843127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24565189|NCT00779194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24773960|NCT01843127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24773961|NCT01843127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24773962|NCT01843127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773965|NCT01843153|Anesthetics|anesthetics|mesh-ancestor
24773966|NCT01843153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24774048|NCT01843452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24774049|NCT01843530|Cortisone|cortisone|mesh-list
24774050|NCT01843530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24774051|NCT01843556|Donepezil|donepezil|mesh-list
24774052|NCT01843556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24774053|NCT01843556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774054|NCT01843556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774128|NCT01843868|Antimitotic Agents|antimitotic agents|mesh-ancestor
24774252|NCT01844674|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24774253|NCT01844674|Parasympatholytics|parasympatholytics|mesh-ancestor
24774254|NCT01844674|Autonomic Agents|autonomic agents|mesh-ancestor
24774255|NCT01844674|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24774256|NCT01844674|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24774424|NCT01845428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24774426|NCT01845428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774427|NCT01845428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24774428|NCT01845428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24774429|NCT01845428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25081276|NCT03331562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25081277|NCT03331562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081279|NCT03331562|Micronutrients|micronutrients|mesh-ancestor
24911852|NCT04283331|Anesthetics|anesthetics|mesh-ancestor
25081314|NCT03331432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25081315|NCT03331302|Xenon|xenon|mesh-list
25081316|NCT03331302|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25081317|NCT03331302|Anesthetics, General|anesthetics, general|mesh-ancestor
25081318|NCT03331302|Anesthetics|anesthetics|mesh-ancestor
25081319|NCT03331302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24774460|NCT01845675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24774462|NCT01845675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774463|NCT01845675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774464|NCT01845675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24774465|NCT01845675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24774466|NCT01845675|Growth Substances|growth substances|mesh-ancestor
24774467|NCT01845675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774468|NCT01845675|Growth Inhibitors|growth inhibitors|mesh-ancestor
24774470|NCT01845688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24774471|NCT01845688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24774472|NCT01845688|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24774473|NCT01845688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24774474|NCT01845688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774475|NCT01845701|Artesunate|artesunate|mesh-list
24892287|NCT04464642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892288|NCT04464642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24892289|NCT04464642|Antimetabolites|antimetabolites|mesh-ancestor
24892290|NCT04464642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892291|NCT04464642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24892292|NCT04464642|Dermatologic Agents|dermatologic agents|mesh-ancestor
24892293|NCT04464642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24892294|NCT04464642|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24469415|NCT00385658|Simvastatin|simvastatin|mesh-list
24774477|NCT01845701|Artemether|artemether|mesh-list
24774478|NCT01845701|Piperaquine|piperaquine|mesh-list
24911942|NCT04282941|Ibuprofen|ibuprofen|mesh-list
24565781|NCT00782405|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24565783|NCT00782405|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24565785|NCT00782470|Coagulants|coagulants|mesh-ancestor
24565786|NCT00782548|Morphine|morphine|mesh-list
24565787|NCT00782548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24565788|NCT00782548|Narcotics|narcotics|mesh-ancestor
24774523|NCT01846026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24774524|NCT01846026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24774525|NCT01846117|Vitamin D|vitamin d|mesh-list
24774526|NCT01846117|Secoisolariciresinol|secoisolariciresinol|mesh-list
24774527|NCT01846117|Vitamins|vitamins|mesh-ancestor
24774528|NCT01846117|Micronutrients|micronutrients|mesh-ancestor
24774529|NCT01846117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776439|NCT01858090|Atropine|atropine|mesh-list
24774530|NCT01846117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24774531|NCT01846117|Phytoestrogens|phytoestrogens|mesh-ancestor
24774532|NCT01846117|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24774569|NCT01846390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24774570|NCT01846390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774572|NCT01846390|Glucocorticoids|glucocorticoids|mesh-ancestor
24774573|NCT01846390|Hormones|hormones|mesh-ancestor
24774574|NCT01846390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24912056|NCT04281706|Anesthetics|anesthetics|mesh-ancestor
24565813|NCT00782847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24565814|NCT00782847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565815|NCT00782847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774607|NCT01846832|Interferon alpha-2|interferon alpha-2|mesh-list
24774639|NCT01846975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774640|NCT01846975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24774682|NCT01847326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24774684|NCT01847339|Anesthetics, Local|anesthetics, local|mesh-ancestor
24774686|NCT01847339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24774687|NCT01847339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774688|NCT01847339|Sensory System Agents|sensory system agents|mesh-ancestor
24774689|NCT01847339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24774690|NCT01847404|Aspirin|aspirin|mesh-list
24774691|NCT01847404|Pantoprazole|pantoprazole|mesh-list
24774692|NCT01847404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24774693|NCT01847404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24774694|NCT01847404|Analgesics|analgesics|mesh-ancestor
24774695|NCT01847404|Sensory System Agents|sensory system agents|mesh-ancestor
24774696|NCT01847404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24774697|NCT01847404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774723|NCT01847495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774724|NCT01847495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774794|NCT01848106|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24774795|NCT01848106|Protease Inhibitors|protease inhibitors|mesh-ancestor
24774796|NCT01848106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774797|NCT01848106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774798|NCT01848106|Anticoagulants|anticoagulants|mesh-ancestor
24774799|NCT01848119|Gabapentin|gabapentin|mesh-list
24774800|NCT01848119|Analgesics|analgesics|mesh-ancestor
24774877|NCT01848379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774879|NCT01848613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24774880|NCT01848613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774881|NCT01848613|Tubulin Modulators|tubulin modulators|mesh-ancestor
24774914|NCT01848665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700459|NCT01452607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24700500|NCT01452711|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24700501|NCT01452711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774915|NCT01848691|Carbon Monoxide|carbon monoxide|mesh-list
24774916|NCT01848691|Antimetabolites|antimetabolites|mesh-ancestor
24774917|NCT01848691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774918|NCT01848691|Gasotransmitters|gasotransmitters|mesh-ancestor
24774919|NCT01848691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24774920|NCT01848691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775034|NCT01849861|Antithyroid Agents|antithyroid agents|mesh-ancestor
24775035|NCT01849861|Hormone Antagonists|hormone antagonists|mesh-ancestor
24775036|NCT01849861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24775037|NCT01849861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775138|NCT01850303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24775140|NCT01850511|Oxymetazoline|oxymetazoline|mesh-list
24775141|NCT01850511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24775142|NCT01850511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24775143|NCT01850511|Adrenergic Agents|adrenergic agents|mesh-ancestor
24775144|NCT01850511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24912579|NCT04273997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24566524|NCT00786279|Ethanol|ethanol|mesh-list
24566525|NCT00786279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24566526|NCT00786279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24620778|NCT01059058|Fluorides|fluorides|mesh-list
24620779|NCT01059058|Fluorides, Topical|fluorides, topical|mesh-list
24620780|NCT01059058|Cariostatic Agents|cariostatic agents|mesh-ancestor
24892295|NCT04464642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24892296|NCT04464642|Immunologic Factors|immunologic factors|mesh-ancestor
24892297|NCT04464642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24892298|NCT04464642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24892300|NCT04464616|Anesthetics|anesthetics|mesh-list
24892301|NCT04464616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24892302|NCT04464616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892303|NCT04464135|Acetic Acid|acetic acid|mesh-list
24620782|NCT01059058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620783|NCT01059084|Valacyclovir|valacyclovir|mesh-list
24620784|NCT01059084|Antiviral Agents|antiviral agents|mesh-ancestor
24775179|NCT01850680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24620785|NCT01059084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24775180|NCT01850680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24775181|NCT01850680|Immunologic Factors|immunologic factors|mesh-ancestor
24775182|NCT01850680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24775183|NCT01850680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24775184|NCT01850680|Hematinics|hematinics|mesh-ancestor
24775185|NCT01850680|Vitamin B Complex|vitamin b complex|mesh-ancestor
24775187|NCT01850680|Micronutrients|micronutrients|mesh-ancestor
24775189|NCT01850940|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24775267|NCT01851408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775269|NCT01851408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24775270|NCT01851408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24775271|NCT01851408|Antifungal Agents|antifungal agents|mesh-ancestor
24775278|NCT01851473|Anticonvulsants|anticonvulsants|mesh-ancestor
24775279|NCT01851473|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24775280|NCT01851473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775281|NCT01851473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775282|NCT01851473|Diuretics|diuretics|mesh-ancestor
24407472|NCT00174590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24407473|NCT00174590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407474|NCT00174590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775463|NCT01852461|Poractant alfa|poractant alfa|mesh-list
24775464|NCT01852461|Beractant|beractant|mesh-list
24775465|NCT01852461|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
24775466|NCT01852461|Respiratory System Agents|respiratory system agents|mesh-ancestor
25685726|NCT01908972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685727|NCT01908972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25685728|NCT01908972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25685729|NCT01908972|Vasodilator Agents|vasodilator agents|mesh-ancestor
24775467|NCT01852539|Dexmedetomidine|dexmedetomidine|mesh-list
25685730|NCT01909141|Metformin|metformin|mesh-list
25685731|NCT01909141|Pioglitazone|pioglitazone|mesh-list
25685732|NCT01909141|Carbamide Peroxide|carbamide peroxide|mesh-list
25010874|NCT02820857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24775468|NCT01852539|Propofol|propofol|mesh-list
24775469|NCT01852539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24775470|NCT01852539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24775471|NCT01852539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775472|NCT01852539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24775474|NCT01852539|Anesthetics|anesthetics|mesh-ancestor
24566845|NCT00788099|Immunologic Factors|immunologic factors|mesh-ancestor
24566846|NCT00788099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566847|NCT00788099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24566848|NCT00788112|Vorinostat|vorinostat|mesh-list
24566849|NCT00788112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566881|NCT00788333|Trastuzumab|trastuzumab|mesh-list
24775477|NCT01852539|Sensory System Agents|sensory system agents|mesh-ancestor
24775478|NCT01852539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24504722|NCT00537901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775479|NCT01852539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24775480|NCT01852539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24775481|NCT01852539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24892319|NCT04464005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24892320|NCT04464005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24892321|NCT04464005|Anticonvulsants|anticonvulsants|mesh-ancestor
24892322|NCT04464005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24714944|NCT01533545|Epinephrine|epinephrine|mesh-list
24892340|NCT04463875|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24892341|NCT04463875|Dermatologic Agents|dermatologic agents|mesh-ancestor
24892342|NCT04463875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24892343|NCT04463875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24892344|NCT04463875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24892345|NCT04463875|Analgesics|analgesics|mesh-ancestor
24892346|NCT04463875|Sensory System Agents|sensory system agents|mesh-ancestor
24892347|NCT04463875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24892348|NCT04463875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24892445|NCT04462796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24892446|NCT04462588|Metronidazole|metronidazole|mesh-list
24892447|NCT04462588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24892451|NCT04462614|Heparin|heparin|mesh-list
24892461|NCT04462822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24892516|NCT04462276|Atezolizumab|atezolizumab|mesh-list
24892518|NCT04462523|Prednisolone|prednisolone|mesh-list
24892519|NCT04462523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24892520|NCT04462523|Glucocorticoids|glucocorticoids|mesh-ancestor
24892521|NCT04462523|Hormones|hormones|mesh-ancestor
24892522|NCT04462523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24775482|NCT01852539|Adrenergic Agents|adrenergic agents|mesh-ancestor
24775483|NCT01852539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24775484|NCT01852539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775485|NCT01852565|Diltiazem|diltiazem|mesh-list
24775486|NCT01852565|Darapladib|darapladib|mesh-list
24775522|NCT01852786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24775523|NCT01852903|Vitamins|vitamins|mesh-list
24775524|NCT01852903|Ascorbic Acid|ascorbic acid|mesh-list
24775525|NCT01852903|Calcium ascorbate|calcium ascorbate|mesh-list
24775526|NCT01852903|Calcium|calcium|mesh-list
24775527|NCT01852903|Micronutrients|micronutrients|mesh-ancestor
24775528|NCT01852903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775529|NCT01852903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24775530|NCT01852903|Antioxidants|antioxidants|mesh-ancestor
24775967|NCT01855763|Metformin|metformin|mesh-list
24775531|NCT01852903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912926|NCT04269954|Heparin|heparin|mesh-list
24775561|NCT01853306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24775563|NCT01853423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24775564|NCT01853423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24775565|NCT01853423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24775566|NCT01853423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24775567|NCT01853423|Antifungal Agents|antifungal agents|mesh-ancestor
24775568|NCT01853423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24775569|NCT01853423|Immunologic Factors|immunologic factors|mesh-ancestor
24775570|NCT01853423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775571|NCT01853449|Fentanyl|fentanyl|mesh-list
24775572|NCT01853449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24775573|NCT01853449|Narcotics|narcotics|mesh-ancestor
24775574|NCT01853449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25081386|NCT03330613|Anesthetics|anesthetics|mesh-list
25685733|NCT01909141|Letrozole|letrozole|mesh-list
25685734|NCT01909141|Clomiphene|clomiphene|mesh-list
25685735|NCT01909141|Enclomiphene|enclomiphene|mesh-list
24613135|NCT01017354|Micronutrients|micronutrients|mesh-ancestor
24613136|NCT01017354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613137|NCT01017354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24775575|NCT01853449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775576|NCT01853449|Analgesics|analgesics|mesh-ancestor
25081420|NCT03329898|Estradiol|estradiol|mesh-list
25081421|NCT03329898|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25081422|NCT03329898|Dydrogesterone|dydrogesterone|mesh-list
25081423|NCT03329898|Estrogens|estrogens|mesh-ancestor
24775579|NCT01853449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24775580|NCT01853449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24775581|NCT01853449|Anesthetics, General|anesthetics, general|mesh-ancestor
24775582|NCT01853449|Anesthetics|anesthetics|mesh-ancestor
24566884|NCT00788398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24775583|NCT01853540|Sildenafil Citrate|sildenafil citrate|mesh-list
24775584|NCT01853540|Vasodilator Agents|vasodilator agents|mesh-ancestor
24775615|NCT01853800|Protease Inhibitors|protease inhibitors|mesh-ancestor
24775616|NCT01853800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775617|NCT01853800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775618|NCT01853800|Anticoagulants|anticoagulants|mesh-ancestor
24775619|NCT01853813|Bevacizumab|bevacizumab|mesh-list
24775620|NCT01853813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24775621|NCT01853813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24775622|NCT01853813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24775623|NCT01853813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24775624|NCT01853813|Growth Substances|growth substances|mesh-ancestor
24775625|NCT01853813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775627|NCT01853852|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
24913096|NCT04268563|Metformin|metformin|mesh-list
24775665|NCT01854086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775667|NCT01854203|Cisplatin|cisplatin|mesh-list
24775668|NCT01854203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24775706|NCT01854489|Buprenorphine|buprenorphine|mesh-list
24775707|NCT01854489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24775708|NCT01854489|Narcotics|narcotics|mesh-ancestor
24775741|NCT01854515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775742|NCT01854515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24775743|NCT01854515|Glucocorticoids|glucocorticoids|mesh-ancestor
24775744|NCT01854515|Hormones|hormones|mesh-ancestor
24775745|NCT01854515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24775746|NCT01854515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24775747|NCT01854515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24775748|NCT01854515|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24775788|NCT01854762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24775789|NCT01854762|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24775790|NCT01854762|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24775791|NCT01854970|Esomeprazole|esomeprazole|mesh-list
24775792|NCT01854970|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24775793|NCT01854970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24775794|NCT01854970|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24775795|NCT01854970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775796|NCT01854970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775838|NCT01855139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775839|NCT01855139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775840|NCT01855139|Anticoagulants|anticoagulants|mesh-ancestor
24775842|NCT01855256|Parasympatholytics|parasympatholytics|mesh-ancestor
24775843|NCT01855256|Autonomic Agents|autonomic agents|mesh-ancestor
24407581|NCT00174733|Hormones|hormones|mesh-ancestor
24775844|NCT01855256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24775845|NCT01855256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775846|NCT01855256|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24775963|NCT01855737|Warfarin|warfarin|mesh-list
24775964|NCT01855737|Anticoagulants|anticoagulants|mesh-ancestor
24775965|NCT01855763|Insulin|insulin|mesh-list
24775966|NCT01855763|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24775968|NCT01855763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24775969|NCT01855763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775970|NCT01855971|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24775971|NCT01855971|Antioxidants|antioxidants|mesh-ancestor
24775972|NCT01855971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775973|NCT01855971|Protective Agents|protective agents|mesh-ancestor
24784319|NCT01907373|Olmesartan|olmesartan|mesh-list
24892523|NCT04462523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685736|NCT01909141|Zuclomiphene|zuclomiphene|mesh-list
25685737|NCT01909141|Hormones|hormones|mesh-list
25685738|NCT01909141|Estradiol|estradiol|mesh-list
24892524|NCT04462523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25685739|NCT01909141|Testosterone|testosterone|mesh-list
24701014|NCT01456351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701015|NCT01456351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24701016|NCT01456351|Alkylating Agents|alkylating agents|mesh-ancestor
24701017|NCT01456364|Ticagrelor|ticagrelor|mesh-list
24701018|NCT01456364|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24701019|NCT01456364|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24701022|NCT01456364|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24892525|NCT04462523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24892526|NCT04462094|Ketamine|ketamine|mesh-list
24892527|NCT04462094|Anesthetics|anesthetics|mesh-ancestor
24892528|NCT04462094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24892529|NCT04462094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892530|NCT04462094|Analgesics|analgesics|mesh-ancestor
24892531|NCT04462094|Sensory System Agents|sensory system agents|mesh-ancestor
24892532|NCT04462094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24892533|NCT04462094|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24892534|NCT04462094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24892535|NCT04462094|Anesthetics, General|anesthetics, general|mesh-ancestor
24892536|NCT04462094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24892537|NCT04462094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24892561|NCT04461925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24892562|NCT04461925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776042|NCT01856166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24776043|NCT01856166|Anesthetics, General|anesthetics, general|mesh-ancestor
24776045|NCT01856166|Anesthetics, Local|anesthetics, local|mesh-ancestor
24776046|NCT01856205|Immunoglobulins|immunoglobulins|mesh-list
24776047|NCT01856205|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24776048|NCT01856205|Antibodies|antibodies|mesh-list
24776123|NCT01856803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24776124|NCT01856803|Immunologic Factors|immunologic factors|mesh-ancestor
24776125|NCT01856803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776126|NCT01856803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24776249|NCT01857349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24776285|NCT01857544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24776286|NCT01857544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24776287|NCT01857544|Growth Substances|growth substances|mesh-ancestor
24776288|NCT01857544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776289|NCT01857544|Growth Inhibitors|growth inhibitors|mesh-ancestor
24776290|NCT01857544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776430|NCT01858051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24776431|NCT01858077|Everolimus|everolimus|mesh-list
24407674|NCT00175032|Celecoxib|celecoxib|mesh-list
24776432|NCT01858077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776433|NCT01858077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24776434|NCT01858077|Immunologic Factors|immunologic factors|mesh-ancestor
24776435|NCT01858077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776436|NCT01858090|Diphenhydramine|diphenhydramine|mesh-list
24776437|NCT01858090|Promethazine|promethazine|mesh-list
24776438|NCT01858090|Diclofenac|diclofenac|mesh-list
24776440|NCT01858090|Ephedrine|ephedrine|mesh-list
24776441|NCT01858090|Fentanyl|fentanyl|mesh-list
24892634|NCT04460963|Adrenomedullin|adrenomedullin|mesh-list
24892635|NCT04460963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24892636|NCT04460963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24892637|NCT04460963|Autonomic Agents|autonomic agents|mesh-ancestor
24776442|NCT01858090|Sufentanil|sufentanil|mesh-list
24776443|NCT01858090|Meperidine|meperidine|mesh-list
24776444|NCT01858090|Metoclopramide|metoclopramide|mesh-list
24776445|NCT01858090|Propofol|propofol|mesh-list
24776480|NCT01858090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24776481|NCT01858090|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24776482|NCT01858090|Histamine Antagonists|histamine antagonists|mesh-ancestor
24776483|NCT01858090|Histamine Agents|histamine agents|mesh-ancestor
24776484|NCT01858090|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24776485|NCT01858090|Antipruritics|antipruritics|mesh-ancestor
25685740|NCT01909141|Progesterone|progesterone|mesh-list
25685741|NCT01909141|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25685742|NCT01909141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25685743|NCT01909141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685744|NCT01909141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685745|NCT01909141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24776582|NCT01858610|Diuretics|diuretics|mesh-ancestor
25685746|NCT01909141|Estrogens|estrogens|mesh-ancestor
25685747|NCT01909141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24701223|NCT01457716|Hormones|hormones|mesh-ancestor
24643990|NCT01188265|Anticonvulsants|anticonvulsants|mesh-ancestor
24701224|NCT01457716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24701225|NCT01457716|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24776583|NCT01858610|Natriuretic Agents|natriuretic agents|mesh-ancestor
24776584|NCT01858610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776585|NCT01858610|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24776586|NCT01858610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24776587|NCT01858610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776588|NCT01858610|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24776589|NCT01858610|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24776590|NCT01858623|Losartan|losartan|mesh-list
24776591|NCT01858623|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24776592|NCT01858623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24776593|NCT01858623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24776594|NCT01858623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24776652|NCT01858909|Melatonin|melatonin|mesh-list
24776653|NCT01858909|Antioxidants|antioxidants|mesh-ancestor
24776654|NCT01858909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776655|NCT01858909|Protective Agents|protective agents|mesh-ancestor
24776656|NCT01858909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776657|NCT01858909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24776658|NCT01858948|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24776659|NCT01858948|Antidepressive Agents|antidepressive agents|mesh-ancestor
24776660|NCT01858948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24776661|NCT01858948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24776662|NCT01858948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24776663|NCT01858948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24776664|NCT01858948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776665|NCT01858961|Interferons|interferons|mesh-list
24776666|NCT01858961|Ribavirin|ribavirin|mesh-list
24776667|NCT01858961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914048|NCT04258163|Antimetabolites|antimetabolites|mesh-ancestor
24914051|NCT04258163|Antiviral Agents|antiviral agents|mesh-ancestor
24620795|NCT01059110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620796|NCT01059110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24620797|NCT01059110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24620798|NCT01059110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24620799|NCT01059110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24620800|NCT01059110|Analgesics|analgesics|mesh-ancestor
24620801|NCT01059110|Sensory System Agents|sensory system agents|mesh-ancestor
24620802|NCT01059110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24620805|NCT01059110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24620806|NCT01059110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620807|NCT01059123|Amoxicillin|amoxicillin|mesh-list
24620808|NCT01059123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24620809|NCT01059123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24784548|NCT01908556|Letrozole|letrozole|mesh-list
24892638|NCT04460963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24892639|NCT04460963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892640|NCT04460963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24892641|NCT04460963|Respiratory System Agents|respiratory system agents|mesh-ancestor
24892642|NCT04460963|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24892643|NCT04460963|Vasodilator Agents|vasodilator agents|mesh-ancestor
24892644|NCT04460963|Protective Agents|protective agents|mesh-ancestor
24892645|NCT04460820|Doxorubicin|doxorubicin|mesh-list
24446823|NCT00306137|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24892867|NCT04457609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24892868|NCT04457609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24620811|NCT01059136|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24620812|NCT01059136|Hormone Antagonists|hormone antagonists|mesh-ancestor
24620813|NCT01059136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24620814|NCT01059136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620815|NCT01059136|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24620816|NCT01059136|Diuretics|diuretics|mesh-ancestor
24795852|NCT01946386|Respiratory System Agents|respiratory system agents|mesh-ancestor
24627439|NCT01092806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627440|NCT01092858|Methyltestosterone|methyltestosterone|mesh-list
25685748|NCT01909141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25685749|NCT01909141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25685750|NCT01909141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25685751|NCT01909141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25685752|NCT01909141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24613234|NCT01017796|Vitamins|vitamins|mesh-ancestor
24701349|NCT01458600|Metoprolol|metoprolol|mesh-list
24627441|NCT01092858|Testosterone|testosterone|mesh-list
24653785|NCT01245816|Eflornithine|eflornithine|mesh-list
24776753|NCT01859728|Antiviral Agents|antiviral agents|mesh-ancestor
24776754|NCT01859728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24776755|NCT01859728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776756|NCT01859728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24776757|NCT01859728|Immunologic Factors|immunologic factors|mesh-ancestor
24776787|NCT01859858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24776789|NCT01859858|Sensory System Agents|sensory system agents|mesh-ancestor
24776790|NCT01859858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24776791|NCT01859858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776792|NCT01859858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24776793|NCT01859858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24776795|NCT01860014|Beractant|beractant|mesh-list
24776796|NCT01860014|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
24776797|NCT01860014|Respiratory System Agents|respiratory system agents|mesh-ancestor
24776798|NCT01860066|Fluticasone|fluticasone|mesh-list
24776799|NCT01860066|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24776800|NCT01860066|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24776801|NCT01860066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24819450|NCT02095665|Tamsulosin|tamsulosin|mesh-list
24776836|NCT01860144|Growth Inhibitors|growth inhibitors|mesh-ancestor
24776862|NCT01860300|Amoxicillin|amoxicillin|mesh-list
24776863|NCT01860300|Clavulanic Acid|clavulanic acid|mesh-list
24776864|NCT01860300|Clavulanic Acids|clavulanic acids|mesh-list
24776870|NCT01860300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776871|NCT01860391|Fluorides|fluorides|mesh-list
24776872|NCT01860391|Cariostatic Agents|cariostatic agents|mesh-ancestor
24776873|NCT01860391|Protective Agents|protective agents|mesh-ancestor
24776874|NCT01860391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776875|NCT01860417|Mepivacaine|mepivacaine|mesh-list
24776876|NCT01860417|Anesthetics, Local|anesthetics, local|mesh-ancestor
24776877|NCT01860417|Anesthetics|anesthetics|mesh-ancestor
24776878|NCT01860417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24776879|NCT01860417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776880|NCT01860417|Sensory System Agents|sensory system agents|mesh-ancestor
24776882|NCT01860469|Vancomycin|vancomycin|mesh-list
24776883|NCT01860469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24776902|NCT01860625|Cholinergic Agents|cholinergic agents|mesh-ancestor
24776903|NCT01860625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24776904|NCT01860625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776905|NCT01860625|Nootropic Agents|nootropic agents|mesh-ancestor
24776906|NCT01860638|Bevacizumab|bevacizumab|mesh-list
24776907|NCT01860638|Temozolomide|temozolomide|mesh-list
24776908|NCT01860638|Lomustine|lomustine|mesh-list
24776909|NCT01860638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24776910|NCT01860638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776911|NCT01860638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24776912|NCT01860638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24776913|NCT01860638|Growth Substances|growth substances|mesh-ancestor
24776914|NCT01860638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776915|NCT01860638|Growth Inhibitors|growth inhibitors|mesh-ancestor
24776916|NCT01860638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24776917|NCT01860638|Alkylating Agents|alkylating agents|mesh-ancestor
24776918|NCT01860638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776919|NCT01860664|Hydrocortisone|hydrocortisone|mesh-list
24776920|NCT01860664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24776921|NCT01860690|Methotrexate|methotrexate|mesh-list
24776922|NCT01860690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24776923|NCT01860690|Abortifacient Agents|abortifacient agents|mesh-ancestor
24776924|NCT01860690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24576941|NCT00841113|Goserelin|goserelin|mesh-list
24776925|NCT01860690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776926|NCT01860690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24776927|NCT01860690|Antimetabolites|antimetabolites|mesh-ancestor
24777420|NCT01863888|Analgesics|analgesics|mesh-ancestor
24776928|NCT01860690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776929|NCT01860690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776930|NCT01860690|Dermatologic Agents|dermatologic agents|mesh-ancestor
24776931|NCT01860690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776932|NCT01860690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24776933|NCT01860690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25685753|NCT01909141|Hormone Antagonists|hormone antagonists|mesh-ancestor
24776934|NCT01860690|Immunologic Factors|immunologic factors|mesh-ancestor
24776935|NCT01860690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25685754|NCT01909141|Androgens|androgens|mesh-ancestor
24701475|NCT01459211|Hormones|hormones|mesh-ancestor
24701476|NCT01459211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24701477|NCT01459211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24701478|NCT01459211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701479|NCT01459211|Immunologic Factors|immunologic factors|mesh-ancestor
24701480|NCT01459211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24701481|NCT01459211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24701482|NCT01459211|Growth Substances|growth substances|mesh-ancestor
24701483|NCT01459211|Growth Inhibitors|growth inhibitors|mesh-ancestor
24701484|NCT01459250|S 20098|s 20098|mesh-list
24776970|NCT01860781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081545|NCT03329118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25081546|NCT03329118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24776971|NCT01860781|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24776972|NCT01860781|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24776973|NCT01860781|Dopamine Agents|dopamine agents|mesh-ancestor
24776974|NCT01860833|Ibuprofen|ibuprofen|mesh-list
24776975|NCT01860833|Celecoxib|celecoxib|mesh-list
24776976|NCT01860833|Diclofenac|diclofenac|mesh-list
24568305|NCT00795613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24777027|NCT01861223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24777028|NCT01861223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24777029|NCT01861223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407972|NCT00176020|Vitamin B Complex|vitamin b complex|mesh-ancestor
24408086|NCT00176527|Estramustine|estramustine|mesh-list
24777030|NCT01861223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627495|NCT01093092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24627496|NCT01093092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24914468|NCT04255056|Epirubicin|epirubicin|mesh-list
24777905|NCT01867775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25081550|NCT03329118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25081551|NCT03329118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24777086|NCT01861990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24777087|NCT01861990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24777088|NCT01861990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24777090|NCT01862003|Folic Acid|folic acid|mesh-list
24777128|NCT01862263|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24777129|NCT01862263|Protease Inhibitors|protease inhibitors|mesh-ancestor
24777130|NCT01862263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24914585|NCT04254081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620841|NCT01059396|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24819498|NCT02095782|Paclitaxel|paclitaxel|mesh-list
24620868|NCT01059422|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24620869|NCT01059461|Cerebrolysin|cerebrolysin|mesh-list
24620870|NCT01059461|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24620871|NCT01059461|Protective Agents|protective agents|mesh-ancestor
24620872|NCT01059461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777145|NCT01862302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24777146|NCT01862302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777147|NCT01862302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24777148|NCT01862354|Anesthetics|anesthetics|mesh-list
24777149|NCT01862354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24777150|NCT01862354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777151|NCT01862497|Carvedilol|carvedilol|mesh-list
24777152|NCT01862497|Prazosin|prazosin|mesh-list
24777153|NCT01862497|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24777154|NCT01862497|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24777155|NCT01862497|Adrenergic Agents|adrenergic agents|mesh-ancestor
24777156|NCT01862497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24777157|NCT01862497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777158|NCT01862497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777159|NCT01862497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24777160|NCT01862497|Antioxidants|antioxidants|mesh-ancestor
24777161|NCT01862497|Protective Agents|protective agents|mesh-ancestor
24777240|NCT01863173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25685755|NCT01909141|Progestins|progestins|mesh-ancestor
25685756|NCT01909141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25685757|NCT01909141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25685758|NCT01909141|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25685759|NCT01909141|Fertility Agents|fertility agents|mesh-ancestor
25685760|NCT01909141|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25685761|NCT01909141|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25685762|NCT01909336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25685763|NCT01909466|Aripiprazole|aripiprazole|mesh-list
25685764|NCT01909466|Antidepressive Agents|antidepressive agents|mesh-ancestor
25685765|NCT01909466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24785090|NCT01911949|Mydriatics|mydriatics|mesh-ancestor
24892870|NCT04457609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24777243|NCT01863173|Autonomic Agents|autonomic agents|mesh-ancestor
24777244|NCT01863173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24777245|NCT01863173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777246|NCT01863173|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24777247|NCT01863173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24777248|NCT01863173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24777249|NCT01863173|Adrenergic Agents|adrenergic agents|mesh-ancestor
24777250|NCT01863173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24777251|NCT01863173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777279|NCT01863251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777281|NCT01863277|Antioxidants|antioxidants|mesh-ancestor
24777282|NCT01863277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777283|NCT01863277|Protective Agents|protective agents|mesh-ancestor
25113671|NCT02392429|Cytarabine|cytarabine|mesh-list
24777284|NCT01863277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777285|NCT01863277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24777286|NCT01863355|Fentanyl|fentanyl|mesh-list
24777287|NCT01863355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24777288|NCT01863355|Narcotics|narcotics|mesh-ancestor
24777289|NCT01863355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24777290|NCT01863355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777291|NCT01863355|Analgesics|analgesics|mesh-ancestor
24777292|NCT01863355|Sensory System Agents|sensory system agents|mesh-ancestor
24777293|NCT01863355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24777295|NCT01863355|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24799182|NCT01967758|Amoxicillin|amoxicillin|mesh-list
24513643|NCT00584298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24513660|NCT00584389|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24513661|NCT00584389|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24893207|NCT04453189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893208|NCT04453189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893209|NCT04453189|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24893210|NCT04453189|Histamine Antagonists|histamine antagonists|mesh-ancestor
24893211|NCT04453189|Histamine Agents|histamine agents|mesh-ancestor
24893212|NCT04453189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24408240|NCT00177008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24541685|NCT00674674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893213|NCT04453189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893214|NCT04453124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
24777332|NCT01863511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
25081609|NCT03328481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25081610|NCT03328481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081612|NCT03328364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081613|NCT03328364|Tubulin Modulators|tubulin modulators|mesh-ancestor
25081614|NCT03328364|Antimitotic Agents|antimitotic agents|mesh-ancestor
24777334|NCT01863511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777335|NCT01863511|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24777336|NCT01863511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777337|NCT01863511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24777338|NCT01863589|Adefovir|adefovir|mesh-list
24777339|NCT01863589|Antiviral Agents|antiviral agents|mesh-ancestor
24777340|NCT01863589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24777341|NCT01863589|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24914822|NCT04251871|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
24777367|NCT01863641|Micronutrients|micronutrients|mesh-ancestor
24777368|NCT01863641|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24777369|NCT01863654|Montelukast|montelukast|mesh-list
24777370|NCT01863654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24777371|NCT01863654|Respiratory System Agents|respiratory system agents|mesh-ancestor
24777372|NCT01863654|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24777373|NCT01863654|Hormone Antagonists|hormone antagonists|mesh-ancestor
24777374|NCT01863654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24777375|NCT01863654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777376|NCT01863654|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25685766|NCT01909466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25685767|NCT01909466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25685768|NCT01909466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25685769|NCT01909466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586055|NCT00889018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24634192|NCT01132352|Nootropic Agents|nootropic agents|mesh-ancestor
24634194|NCT01132391|Vasodilator Agents|vasodilator agents|mesh-ancestor
24634237|NCT01132586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634238|NCT01132586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24634239|NCT01132586|Antiviral Agents|antiviral agents|mesh-ancestor
24634315|NCT01132781|Theophylline|theophylline|mesh-list
24777377|NCT01863654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24777378|NCT01863654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777379|NCT01863706|Misoprostol|misoprostol|mesh-list
24777380|NCT01863706|Oxytocin|oxytocin|mesh-list
24777381|NCT01863706|Oxytocics|oxytocics|mesh-ancestor
24777382|NCT01863706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24777417|NCT01863888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777418|NCT01863888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24777419|NCT01863888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24777534|NCT01864798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777535|NCT01864824|Vitamins|vitamins|mesh-list
24777536|NCT01864824|Folic Acid|folic acid|mesh-list
24785407|NCT01914133|Acarbose|acarbose|mesh-list
24893215|NCT04453124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24893216|NCT04453111|Hyaluronic Acid|hyaluronic acid|mesh-list
24893217|NCT04453111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24893246|NCT04452929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24893247|NCT04452929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893248|NCT04452929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24893249|NCT04452929|Vasodilator Agents|vasodilator agents|mesh-ancestor
24893250|NCT04452929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24893251|NCT04452929|Protective Agents|protective agents|mesh-ancestor
24893252|NCT04452929|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24893253|NCT04452929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24893254|NCT04452929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25081615|NCT03328364|Mitosis Modulators|mitosis modulators|mesh-ancestor
24627534|NCT01093235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24777611|NCT01865201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777612|NCT01865201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24777613|NCT01865201|Protective Agents|protective agents|mesh-ancestor
24777615|NCT01865279|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24893255|NCT04452929|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
24408427|NCT00177619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893483|NCT04449185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24893484|NCT04449185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24893485|NCT04449185|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24893562|NCT04448015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893563|NCT04448015|Analgesics|analgesics|mesh-ancestor
24893564|NCT04448015|Sensory System Agents|sensory system agents|mesh-ancestor
24893574|NCT04448028|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24893575|NCT04448028|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24893576|NCT04448028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24893770|NCT04446637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24893771|NCT04446637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24893772|NCT04446637|Adrenergic Agents|adrenergic agents|mesh-ancestor
24893852|NCT04445948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24777616|NCT01865279|Insulin, Long-Acting|insulin, long-acting|mesh-list
24777617|NCT01865279|Isophane Insulin, Human|isophane insulin, human|mesh-list
24777618|NCT01865279|Insulin, Isophane|insulin, isophane|mesh-list
24777619|NCT01865279|Isophane insulin, beef|isophane insulin, beef|mesh-list
24777620|NCT01865279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24777621|NCT01865279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777623|NCT01865292|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24777624|NCT01865292|Insulin Glargine|insulin glargine|mesh-list
24777625|NCT01865292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24777626|NCT01865292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625302|NCT01081561|Riboflavin|riboflavin|mesh-list
24777628|NCT01865305|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25685770|NCT01909466|Dopamine Agonists|dopamine agonists|mesh-ancestor
25685771|NCT01909466|Dopamine Agents|dopamine agents|mesh-ancestor
25685772|NCT01909466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25685773|NCT01909466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685774|NCT01909466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25685775|NCT01909466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25685776|NCT01909466|Serotonin Agents|serotonin agents|mesh-ancestor
24777631|NCT01865305|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25081625|NCT03328312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25081626|NCT03328312|Respiratory System Agents|respiratory system agents|mesh-ancestor
25081661|NCT03328234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081663|NCT03328117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081664|NCT03328117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25081665|NCT03328117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24777720|NCT01866059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24777722|NCT01866241|Misoprostol|misoprostol|mesh-list
24915168|NCT04173312|Anesthetics|anesthetics|mesh-ancestor
24569273|NCT00799838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24569274|NCT00799838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24569275|NCT00799838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569276|NCT00799890|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24569277|NCT00799890|Antioxidants|antioxidants|mesh-ancestor
24569278|NCT00799890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777741|NCT01866267|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24777742|NCT01866267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777743|NCT01866267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24777744|NCT01866267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24777781|NCT01866553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777783|NCT01866605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24777784|NCT01866605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24777785|NCT01866605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24777786|NCT01866605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777787|NCT01866605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24777788|NCT01866605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24777789|NCT01866605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24777790|NCT01866605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24777791|NCT01866605|Anesthetics, General|anesthetics, general|mesh-ancestor
24777793|NCT01866605|GABA Modulators|gaba modulators|mesh-ancestor
24777794|NCT01866605|GABA Agents|gaba agents|mesh-ancestor
24777795|NCT01866605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24777828|NCT01867268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777829|NCT01867268|Diuretics|diuretics|mesh-ancestor
24777830|NCT01867268|Natriuretic Agents|natriuretic agents|mesh-ancestor
24777831|NCT01867268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569317|NCT00800267|Timolol|timolol|mesh-list
24777833|NCT01867281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24777834|NCT01867281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24777868|NCT01867645|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24777869|NCT01867645|Antibodies|antibodies|mesh-list
24777870|NCT01867645|gamma-Globulins|gamma-globulins|mesh-list
24777871|NCT01867645|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24777872|NCT01867645|Immunologic Factors|immunologic factors|mesh-ancestor
24777873|NCT01867645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777874|NCT01867697|Leucovorin|leucovorin|mesh-list
24777875|NCT01867697|Folic Acid|folic acid|mesh-list
25081684|NCT03328052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24915310|NCT03432897|Olaparib|olaparib|mesh-list
24777903|NCT01867775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777906|NCT01867775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24777907|NCT01867775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25039926|NCT03594058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24893936|NCT04445935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893937|NCT04445935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893938|NCT04445935|Anticoagulants|anticoagulants|mesh-ancestor
24777908|NCT01867775|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24777909|NCT01867775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24777916|NCT01867866|Trifluridine|trifluridine|mesh-list
24777917|NCT01867866|Antimetabolites|antimetabolites|mesh-ancestor
24777918|NCT01867866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777919|NCT01867866|Antiviral Agents|antiviral agents|mesh-ancestor
24777920|NCT01867866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24777921|NCT01867892|Leucovorin|leucovorin|mesh-list
24777922|NCT01867892|Gemcitabine|gemcitabine|mesh-list
24777923|NCT01867892|Fluorouracil|fluorouracil|mesh-list
24777924|NCT01867892|Irinotecan|irinotecan|mesh-list
24777925|NCT01867892|Levoleucovorin|levoleucovorin|mesh-list
24777926|NCT01867892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24777961|NCT01868126|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24777962|NCT01868191|Thiamine|thiamine|mesh-list
24777963|NCT01868191|Benphothiamine|benphothiamine|mesh-list
24446927|NCT00306683|Diazoxide|diazoxide|mesh-list
24819602|NCT02096133|Micronutrients|micronutrients|mesh-ancestor
24819603|NCT02096133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24819604|NCT02096224|Sevoflurane|sevoflurane|mesh-list
24819605|NCT02096224|Desflurane|desflurane|mesh-list
24777999|NCT01868529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778000|NCT01868555|Insulin|insulin|mesh-list
24778001|NCT01868555|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24778002|NCT01868555|Insulin Aspart|insulin aspart|mesh-list
24778003|NCT01868555|Insulin, Long-Acting|insulin, long-acting|mesh-list
24778004|NCT01868555|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24778005|NCT01868555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24778006|NCT01868555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778007|NCT01868568|Insulin|insulin|mesh-list
24778037|NCT01868802|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24778038|NCT01868802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24778039|NCT01868802|Anesthetics, General|anesthetics, general|mesh-ancestor
24778040|NCT01868802|Anesthetics|anesthetics|mesh-ancestor
24778041|NCT01868802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24778042|NCT01868802|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24778088|NCT01869010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778089|NCT01869010|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24620875|NCT01059552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24620876|NCT01059552|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24620877|NCT01059552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620878|NCT01059552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620879|NCT01059604|Naproxen|naproxen|mesh-list
24620880|NCT01059604|Sumatriptan|sumatriptan|mesh-list
24620881|NCT01059604|Naratriptan|naratriptan|mesh-list
24620882|NCT01059604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24620883|NCT01059604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24620884|NCT01059604|Analgesics|analgesics|mesh-ancestor
24620885|NCT01059604|Sensory System Agents|sensory system agents|mesh-ancestor
24620886|NCT01059604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24620887|NCT01059604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620888|NCT01059604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24620889|NCT01059604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24620890|NCT01059604|Gout Suppressants|gout suppressants|mesh-ancestor
24620891|NCT01059604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24620892|NCT01059604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620893|NCT01059604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620894|NCT01059604|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24620895|NCT01059604|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24620896|NCT01059604|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24620897|NCT01059604|Serotonin Agents|serotonin agents|mesh-ancestor
24620898|NCT01059604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24620899|NCT01059890|Metronidazole|metronidazole|mesh-list
24620900|NCT01059890|Ciprofloxacin|ciprofloxacin|mesh-list
24778154|NCT01869569|Sensory System Agents|sensory system agents|mesh-ancestor
24780083|NCT01881100|Sodium Fluoride|sodium fluoride|mesh-list
24778155|NCT01869569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24778156|NCT01869569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778157|NCT01869569|Anticonvulsants|anticonvulsants|mesh-ancestor
24778158|NCT01869569|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24778159|NCT01869569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24778161|NCT01869569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24778162|NCT01869569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24778163|NCT01869569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24778164|NCT01869569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24778270|NCT01870115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24778271|NCT01870128|Hydroxychloroquine|hydroxychloroquine|mesh-list
24778272|NCT01870128|Sulfasalazine|sulfasalazine|mesh-list
24778273|NCT01870128|Methylprednisolone|methylprednisolone|mesh-list
25685777|NCT01909466|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25685778|NCT01909466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25685779|NCT01909466|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25685780|NCT01909466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24778274|NCT01870128|Methotrexate|methotrexate|mesh-list
24778275|NCT01870128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25685781|NCT01909791|Aflibercept|aflibercept|mesh-list
24915077|NCT04911517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915078|NCT04865978|Warfarin|warfarin|mesh-list
24778276|NCT01870128|Abortifacient Agents|abortifacient agents|mesh-ancestor
25081700|NCT03327727|VL-2397|vl-2397|mesh-list
25081701|NCT03327727|Antifungal Agents|antifungal agents|mesh-ancestor
25081702|NCT03327727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25081703|NCT03327727|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25081704|NCT03327727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25081705|NCT03327727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25081706|NCT03327727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081707|NCT03327727|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25081708|NCT03327727|Hormone Antagonists|hormone antagonists|mesh-ancestor
24915745|NCT04248621|Goserelin|goserelin|mesh-list
25081739|NCT03327506|GABA Agents|gaba agents|mesh-ancestor
25081740|NCT03327506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25081741|NCT03327506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778278|NCT01870128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778279|NCT01870128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24778280|NCT01870128|Antimetabolites|antimetabolites|mesh-ancestor
24778281|NCT01870128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778282|NCT01870128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24778283|NCT01870128|Dermatologic Agents|dermatologic agents|mesh-ancestor
24778284|NCT01870128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24915794|NCT04248205|Anesthetics|anesthetics|mesh-ancestor
24778316|NCT01870219|Sevoflurane|sevoflurane|mesh-list
24778318|NCT01870219|Analgesics|analgesics|mesh-ancestor
24778319|NCT01870219|Sensory System Agents|sensory system agents|mesh-ancestor
24893940|NCT04446130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24893941|NCT04446130|Antimetabolites|antimetabolites|mesh-ancestor
24894429|NCT04440488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24778320|NCT01870219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24778321|NCT01870219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778322|NCT01870219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24778323|NCT01870219|Anesthetics, General|anesthetics, general|mesh-ancestor
24778324|NCT01870219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24778325|NCT01870219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24778326|NCT01870219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24778327|NCT01870219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24778328|NCT01870219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915822|NCT04248179|Sufentanil|sufentanil|mesh-list
24778359|NCT01870440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778361|NCT01870466|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24778362|NCT01870466|Simvastatin|simvastatin|mesh-list
24778363|NCT01870466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24778364|NCT01870466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24778365|NCT01870466|Antimetabolites|antimetabolites|mesh-ancestor
24778366|NCT01870466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778367|NCT01870466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24778368|NCT01870466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24778369|NCT01870466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24778370|NCT01870466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24778371|NCT01870466|Autonomic Agents|autonomic agents|mesh-ancestor
24778372|NCT01870466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24778373|NCT01870466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778400|NCT01870635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24778401|NCT01870635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24778402|NCT01870635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24778406|NCT01870648|Antiemetics|antiemetics|mesh-ancestor
25081901|NCT03326180|Anesthetics, Local|anesthetics, local|mesh-ancestor
25081758|NCT03327389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25081759|NCT03327389|Analgesics|analgesics|mesh-ancestor
25081760|NCT03327389|Sensory System Agents|sensory system agents|mesh-ancestor
25081761|NCT03327389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24916026|NCT04245371|Anesthetics, Local|anesthetics, local|mesh-ancestor
24570216|NCT00803842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24570217|NCT00803842|Antimalarials|antimalarials|mesh-ancestor
24570218|NCT00803842|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25685782|NCT01909791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25685783|NCT01909791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25685784|NCT01909791|Growth Substances|growth substances|mesh-ancestor
25685785|NCT01909791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685786|NCT01909791|Growth Inhibitors|growth inhibitors|mesh-ancestor
24915138|NCT04648319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24915139|NCT04648319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738402|NCT01675206|Hemostatics|hemostatics|mesh-ancestor
24915149|NCT04539873|Gout Suppressants|gout suppressants|mesh-ancestor
24915150|NCT04539873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24915151|NCT04539873|Tubulin Modulators|tubulin modulators|mesh-ancestor
24915152|NCT04539873|Antimitotic Agents|antimitotic agents|mesh-ancestor
24915153|NCT04539873|Mitosis Modulators|mitosis modulators|mesh-ancestor
24915154|NCT04539873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915155|NCT04539873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915156|NCT04538092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25065417|NCT03450798|Anesthetics|anesthetics|mesh-list
24570219|NCT00803842|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24570221|NCT00803868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24570222|NCT00803868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24620947|NCT01060163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24620948|NCT01060163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24620949|NCT01060163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620950|NCT01060163|Hemostatics|hemostatics|mesh-ancestor
24620951|NCT01060163|Coagulants|coagulants|mesh-ancestor
24620952|NCT01060176|Tranexamic Acid|tranexamic acid|mesh-list
24620953|NCT01060176|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24620954|NCT01060176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24620955|NCT01060176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620956|NCT01060176|Hemostatics|hemostatics|mesh-ancestor
24620957|NCT01060176|Coagulants|coagulants|mesh-ancestor
24620958|NCT01060189|Tranexamic Acid|tranexamic acid|mesh-list
24620959|NCT01060189|Urinastatin|urinastatin|mesh-list
24797885|NCT01958944|Vasodilator Agents|vasodilator agents|mesh-ancestor
24778552|NCT01871649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24778553|NCT01871649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24778554|NCT01871649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24778555|NCT01871649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24778556|NCT01871662|Interferons|interferons|mesh-list
24778557|NCT01871662|Ribavirin|ribavirin|mesh-list
24778558|NCT01871662|Interferon-alpha|interferon-alpha|mesh-list
24778559|NCT01871662|Interferon alpha-2|interferon alpha-2|mesh-list
24778560|NCT01871662|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24778597|NCT01871701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24778630|NCT01871740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24778631|NCT01871740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778632|NCT01871740|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24778633|NCT01871740|Protease Inhibitors|protease inhibitors|mesh-ancestor
24778634|NCT01871740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24778635|NCT01871753|Anti-Infective Agents|anti-infective agents|mesh-list
24778636|NCT01871792|Pitavastatin|pitavastatin|mesh-list
24778637|NCT01871792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24778638|NCT01871792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24778639|NCT01871792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24778640|NCT01871792|Antimetabolites|antimetabolites|mesh-ancestor
24894430|NCT04440488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894431|NCT04440488|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24894432|NCT04440488|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24778669|NCT01871857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25685787|NCT01909791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25685788|NCT01909804|Ribavirin|ribavirin|mesh-list
25685789|NCT01909804|Antiviral Agents|antiviral agents|mesh-ancestor
25685790|NCT01909804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25685791|NCT01909804|Antimetabolites|antimetabolites|mesh-ancestor
25685792|NCT01909804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685793|NCT01910064|Adapalene|adapalene|mesh-list
25685794|NCT01910064|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25685795|NCT01910064|Dermatologic Agents|dermatologic agents|mesh-ancestor
25685796|NCT01910064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25685797|NCT01910064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25685798|NCT01910064|Analgesics|analgesics|mesh-ancestor
25685799|NCT01910064|Sensory System Agents|sensory system agents|mesh-ancestor
25685800|NCT01910064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25685801|NCT01910064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685802|NCT01910064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25685803|NCT01910064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24778671|NCT01871922|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24778672|NCT01871922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24778673|NCT01871922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24778674|NCT01871922|Autonomic Agents|autonomic agents|mesh-ancestor
24778675|NCT01871922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24778676|NCT01871922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778677|NCT01871922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24778678|NCT01871922|Respiratory System Agents|respiratory system agents|mesh-ancestor
24408708|NCT00179114|GABA Agents|gaba agents|mesh-ancestor
24408709|NCT00179231|Olanzapine|olanzapine|mesh-list
24820345|NCT02099240|Leprostatic Agents|leprostatic agents|mesh-ancestor
24681405|NCT01380314|Antifungal Agents|antifungal agents|mesh-ancestor
24778679|NCT01871922|Mydriatics|mydriatics|mesh-ancestor
24778680|NCT01871922|Parasympatholytics|parasympatholytics|mesh-ancestor
24778681|NCT01871922|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24778682|NCT01871922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24778683|NCT01871922|Cholinergic Agents|cholinergic agents|mesh-ancestor
24778684|NCT01871922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24778685|NCT01871922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778686|NCT01871935|Sufentanil|sufentanil|mesh-list
24778687|NCT01871935|Remifentanil|remifentanil|mesh-list
24778718|NCT01871974|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24778719|NCT01871974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24778720|NCT01871974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24778721|NCT01871974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778722|NCT01871987|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24778723|NCT01871987|Antidepressive Agents|antidepressive agents|mesh-ancestor
24778724|NCT01871987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24778725|NCT01871987|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24778726|NCT01871987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24778727|NCT01871987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24778728|NCT01871987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778729|NCT01872013|ASP7991|asp7991|mesh-list
24778730|NCT01872013|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24630136|NCT01109693|Sertraline|sertraline|mesh-list
24778731|NCT01872013|Hormone Antagonists|hormone antagonists|mesh-ancestor
24778758|NCT01872403|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24778759|NCT01872403|Carboplatin|carboplatin|mesh-list
24778760|NCT01872403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24786024|NCT01917617|Cisplatin|cisplatin|mesh-list
24894433|NCT04440696|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
24894434|NCT04440696|Chelating Agents|chelating agents|mesh-ancestor
24894435|NCT04440696|Sequestering Agents|sequestering agents|mesh-ancestor
24778762|NCT01872403|Tubulin Modulators|tubulin modulators|mesh-ancestor
24778763|NCT01872403|Antimitotic Agents|antimitotic agents|mesh-ancestor
24778764|NCT01872403|Mitosis Modulators|mitosis modulators|mesh-ancestor
24778765|NCT01872403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778766|NCT01872416|Doxorubicin|doxorubicin|mesh-list
24778767|NCT01872416|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24778768|NCT01872416|Ifosfamide|ifosfamide|mesh-list
24778769|NCT01872416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24778770|NCT01872416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24778771|NCT01872416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24778772|NCT01872416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24778773|NCT01872416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25081770|NCT03327272|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24627617|NCT01094015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24627618|NCT01094015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24627619|NCT01094015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24778806|NCT01872494|Serotonin Agents|serotonin agents|mesh-ancestor
24778807|NCT01872494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24778808|NCT01872494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778837|NCT01872754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778838|NCT01872754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24778839|NCT01872754|Anesthetics, General|anesthetics, general|mesh-ancestor
24778841|NCT01872754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24778842|NCT01872754|Narcotics|narcotics|mesh-ancestor
24778843|NCT01872754|Analgesics|analgesics|mesh-ancestor
24778844|NCT01872754|Sensory System Agents|sensory system agents|mesh-ancestor
24778867|NCT01872858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24778868|NCT01872858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778869|NCT01872858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25685804|NCT01910181|Vemurafenib|vemurafenib|mesh-list
25065449|NCT05322265|Adrenergic Agents|adrenergic agents|mesh-ancestor
25065450|NCT05322265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24778901|NCT01872884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24778902|NCT01872884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778903|NCT01872884|Analgesics|analgesics|mesh-ancestor
24778904|NCT01872884|Sensory System Agents|sensory system agents|mesh-ancestor
24778907|NCT01872884|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24550675|NCT00721552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778910|NCT01872897|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
24778912|NCT01872897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778913|NCT01872897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24778914|NCT01872923|Bleomycin|bleomycin|mesh-list
24778915|NCT01872923|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24778916|NCT01872923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24778917|NCT01872936|Ribavirin|ribavirin|mesh-list
24778918|NCT01872936|Antimetabolites|antimetabolites|mesh-ancestor
24778919|NCT01872936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778920|NCT01872936|Antiviral Agents|antiviral agents|mesh-ancestor
24571272|NCT00808977|Mesalamine|mesalamine|mesh-list
24778921|NCT01872936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24778922|NCT01872962|Gemcitabine|gemcitabine|mesh-list
24778923|NCT01872962|Cisplatin|cisplatin|mesh-list
24778924|NCT01872962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24778956|NCT01873027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24778957|NCT01873027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24778958|NCT01873027|Immunologic Factors|immunologic factors|mesh-ancestor
24778959|NCT01873027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778960|NCT01873027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25081825|NCT03327116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25081826|NCT03327116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24681465|NCT01380522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24408769|NCT00179465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24779040|NCT01873378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779041|NCT01873378|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24779042|NCT01873378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24779043|NCT01873378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779044|NCT01873430|Melatonin|melatonin|mesh-list
24779045|NCT01873430|Antioxidants|antioxidants|mesh-ancestor
24779046|NCT01873430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779047|NCT01873430|Protective Agents|protective agents|mesh-ancestor
24779048|NCT01873430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625427|NCT01082198|Vaccines|vaccines|mesh-list
24779049|NCT01873430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24779051|NCT01873443|Rituximab|rituximab|mesh-list
24779052|NCT01873443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24916542|NCT04239625|Vitamin A|vitamin a|mesh-list
24779090|NCT01873807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24779091|NCT01873807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24779117|NCT01873833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779118|NCT01873833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24779119|NCT01873833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24779120|NCT01873833|Alkylating Agents|alkylating agents|mesh-ancestor
24779121|NCT01873833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779131|NCT01874002|Sirolimus|sirolimus|mesh-list
24779216|NCT01874717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24779217|NCT01874717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24779218|NCT01874717|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24916669|NCT04238208|Antipruritics|antipruritics|mesh-ancestor
24779238|NCT01874847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779299|NCT01875172|Dopamine Agents|dopamine agents|mesh-ancestor
24779335|NCT01875263|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24779336|NCT01875263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24779337|NCT01875263|Renal Agents|renal agents|mesh-ancestor
24779338|NCT01875263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25081853|NCT03326752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081854|NCT03326752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779561|NCT01876849|Hormones|hormones|mesh-ancestor
24779562|NCT01876849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25685805|NCT01910181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25685806|NCT01910181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25685807|NCT01910181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616075|NCT01033903|Misoprostol|misoprostol|mesh-list
24779563|NCT01876862|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24779564|NCT01876862|Antiviral Agents|antiviral agents|mesh-ancestor
24779565|NCT01876862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24779566|NCT01876966|Ritonavir|ritonavir|mesh-list
24779567|NCT01876966|Darunavir|darunavir|mesh-list
24779568|NCT01876966|Lumefantrine|lumefantrine|mesh-list
24779569|NCT01876966|Artemether|artemether|mesh-list
24779570|NCT01876966|Etravirine|etravirine|mesh-list
24779571|NCT01876966|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24779572|NCT01876966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24917073|NCT04233996|Meropenem|meropenem|mesh-list
24779603|NCT01877226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24779604|NCT01877226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779606|NCT01877226|Sensory System Agents|sensory system agents|mesh-ancestor
24779607|NCT01877226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24779608|NCT01877226|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24779609|NCT01877226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24779610|NCT01877226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24779611|NCT01877226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779612|NCT01877226|Adrenergic Agents|adrenergic agents|mesh-ancestor
24779613|NCT01877226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24894436|NCT04440696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894437|NCT04440280|Acetylcysteine|acetylcysteine|mesh-list
24471498|NCT00395655|Hydralazine|hydralazine|mesh-list
24779843|NCT01879202|Dopamine Agents|dopamine agents|mesh-ancestor
24779844|NCT01879202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24779846|NCT01879241|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24779847|NCT01879241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24779848|NCT01879241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779849|NCT01879241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24779850|NCT01879241|Protective Agents|protective agents|mesh-ancestor
24779851|NCT01879241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779852|NCT01879293|Metformin|metformin|mesh-list
24779853|NCT01879293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24779854|NCT01879293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779855|NCT01879358|Sirolimus|sirolimus|mesh-list
24779856|NCT01879358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24779888|NCT01879514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24779889|NCT01879514|Glucocorticoids|glucocorticoids|mesh-ancestor
24779890|NCT01879514|Hormones|hormones|mesh-ancestor
24779891|NCT01879514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24779892|NCT01879514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779893|NCT01879514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24779894|NCT01879514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779895|NCT01879527|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24779896|NCT01879527|Amiloride|amiloride|mesh-list
24779897|NCT01879527|Amiloride, hydrochlorothiazide drug combination|amiloride, hydrochlorothiazide drug combination|mesh-list
24779898|NCT01879527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24779899|NCT01879527|Diuretics|diuretics|mesh-ancestor
24779900|NCT01879527|Natriuretic Agents|natriuretic agents|mesh-ancestor
24779901|NCT01879527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779902|NCT01879527|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24621019|NCT01060410|Alkylating Agents|alkylating agents|mesh-ancestor
24917405|NCT04230083|Dienogest|dienogest|mesh-list
24779947|NCT01880138|Anesthetics|anesthetics|mesh-list
24779948|NCT01880138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24779949|NCT01880138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779950|NCT01880216|Enoxaparin|enoxaparin|mesh-list
24779951|NCT01880216|Enoxaparin sodium|enoxaparin sodium|mesh-list
24611221|NCT01007851|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24408771|NCT00179465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24408772|NCT00179465|Anticonvulsants|anticonvulsants|mesh-ancestor
24408773|NCT00179465|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
24408774|NCT00179465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24779952|NCT01880216|Bemiparin|bemiparin|mesh-list
24779953|NCT01880216|Anticoagulants|anticoagulants|mesh-ancestor
24513779|NCT00585091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24779955|NCT01880216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24779956|NCT01880216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779957|NCT01880307|Prednisolone|prednisolone|mesh-list
24779958|NCT01880307|Azathioprine|azathioprine|mesh-list
24779959|NCT01880307|Infliximab|infliximab|mesh-list
24779960|NCT01880307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24779961|NCT01880307|Glucocorticoids|glucocorticoids|mesh-ancestor
24779962|NCT01880307|Hormones|hormones|mesh-ancestor
25685808|NCT01910181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950332|NCT00999804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950333|NCT00999804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24915542|NCT01341600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779963|NCT01880307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24780000|NCT01880385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24780001|NCT01880385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24780002|NCT01880385|Alkylating Agents|alkylating agents|mesh-ancestor
24780003|NCT01880385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780004|NCT01880385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24780005|NCT01880385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24917499|NCT04229355|Sorafenib|sorafenib|mesh-list
24780041|NCT01880658|Capecitabine|capecitabine|mesh-list
24917523|NCT04229498|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24780079|NCT01881074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24780080|NCT01881100|Listerine|listerine|mesh-list
24780081|NCT01881100|Fluorides|fluorides|mesh-list
24780082|NCT01881100|Fluorides, Topical|fluorides, topical|mesh-list
24798710|NCT01964586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25081935|NCT03326050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25081936|NCT03326050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24780128|NCT01881919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780129|NCT01881919|Protective Agents|protective agents|mesh-ancestor
24780130|NCT01881919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917670|NCT04227483|Hormones|hormones|mesh-ancestor
24780198|NCT01882374|Vasodilator Agents|vasodilator agents|mesh-ancestor
24780199|NCT01882387|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
24780229|NCT01882530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780230|NCT01882556|Botulinum Toxins|botulinum toxins|mesh-list
24780235|NCT01882556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780236|NCT01882556|Cholinergic Agents|cholinergic agents|mesh-ancestor
24780237|NCT01882556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24780238|NCT01882556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780239|NCT01882556|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24780240|NCT01882556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25081937|NCT03326050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24780242|NCT01882660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24780243|NCT01882660|Antimetabolites|antimetabolites|mesh-ancestor
25081942|NCT03326050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25081944|NCT03326050|Antitubercular Agents|antitubercular agents|mesh-ancestor
25081945|NCT03326050|Leprostatic Agents|leprostatic agents|mesh-ancestor
25081946|NCT03326050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25081947|NCT03326050|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25081948|NCT03326050|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24780403|NCT01884298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780405|NCT01884298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24780406|NCT01884298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24780407|NCT01884298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24780408|NCT01884298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24780431|NCT01884428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24780432|NCT01884428|Antiviral Agents|antiviral agents|mesh-ancestor
24780433|NCT01884428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24780434|NCT01884428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780435|NCT01884428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24780436|NCT01884428|Immunologic Factors|immunologic factors|mesh-ancestor
24780437|NCT01884428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780438|NCT01884428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24780439|NCT01884428|Glucocorticoids|glucocorticoids|mesh-ancestor
24780450|NCT01884441|Gemcitabine|gemcitabine|mesh-list
24780452|NCT01884441|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24780453|NCT01884441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24780454|NCT01884441|Antimetabolites|antimetabolites|mesh-ancestor
24780455|NCT01884441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780456|NCT01884441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25685809|NCT01910311|Rifampin|rifampin|mesh-list
25685810|NCT01910311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25685811|NCT01910311|Antitubercular Agents|antitubercular agents|mesh-ancestor
25685812|NCT01910311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25685813|NCT01910311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25685814|NCT01910311|Leprostatic Agents|leprostatic agents|mesh-ancestor
24953443|NCT03885141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24953444|NCT03885141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953445|NCT03885141|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24953447|NCT03885141|GABA Agents|gaba agents|mesh-ancestor
24953448|NCT03885141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24953449|NCT03885141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953450|NCT03884972|Venetoclax|venetoclax|mesh-list
24953451|NCT03884972|Trabectedin|trabectedin|mesh-list
24780487|NCT01884558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24780488|NCT01884558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780489|NCT01884558|Antifungal Agents|antifungal agents|mesh-ancestor
24780490|NCT01884558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25081952|NCT03326050|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24780491|NCT01884623|Methotrexate|methotrexate|mesh-list
24780493|NCT01884623|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24780494|NCT01884623|Abortifacient Agents|abortifacient agents|mesh-ancestor
24780495|NCT01884623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24780496|NCT01884623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780497|NCT01884623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24780499|NCT01884623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780500|NCT01884623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24780501|NCT01884623|Dermatologic Agents|dermatologic agents|mesh-ancestor
24780502|NCT01884623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780503|NCT01884623|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24918049|NCT04224350|Tacrolimus|tacrolimus|mesh-list
24780543|NCT01884857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918097|NCT04223739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780575|NCT01884909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780576|NCT01884935|Natalizumab|natalizumab|mesh-list
24780577|NCT01884935|Immunologic Factors|immunologic factors|mesh-ancestor
24780578|NCT01884935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780579|NCT01885013|Metformin|metformin|mesh-list
24780581|NCT01885013|Doxorubicin|doxorubicin|mesh-list
24780619|NCT01885338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780621|NCT01885338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780622|NCT01885338|Antidotes|antidotes|mesh-ancestor
24780623|NCT01885364|Remifentanil|remifentanil|mesh-list
24780624|NCT01885364|Propofol|propofol|mesh-list
24780625|NCT01885364|Esmolol|esmolol|mesh-list
24918173|NCT04222062|Carmustine|carmustine|mesh-list
24780657|NCT01885481|Glucocorticoids|glucocorticoids|mesh-ancestor
24780658|NCT01885481|Hormones|hormones|mesh-ancestor
24780659|NCT01885481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24780660|NCT01885481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24780661|NCT01885481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24780662|NCT01885481|Protease Inhibitors|protease inhibitors|mesh-ancestor
24572541|NCT00815373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24572542|NCT00815373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572544|NCT00815373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24572545|NCT00815373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24616549|NCT01037998|Gefitinib|gefitinib|mesh-list
24627774|NCT01094925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627775|NCT01094925|Antimanic Agents|antimanic agents|mesh-ancestor
24780760|NCT01886209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24780761|NCT01886209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24780762|NCT01886209|Antiemetics|antiemetics|mesh-ancestor
24513792|NCT00585143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24513793|NCT00585156|Celecoxib|celecoxib|mesh-list
24513794|NCT00585156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24471559|NCT00395915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24471560|NCT00395915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24513815|NCT00585442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513827|NCT00585455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24513828|NCT00585455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513829|NCT00585455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24513830|NCT00585455|Serotonin Agents|serotonin agents|mesh-ancestor
25685815|NCT01910311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25685816|NCT01910311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25685817|NCT01910311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685818|NCT01910311|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25685819|NCT01910311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25685820|NCT01910311|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25685821|NCT01910311|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24915722|NCT04249063|Lidocaine|lidocaine|mesh-list
24915723|NCT04249063|Anesthetics|anesthetics|mesh-list
24915724|NCT04249063|Anesthetics, Local|anesthetics, local|mesh-list
24915725|NCT04249063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24915726|NCT04249063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915757|NCT04248621|Hormones|hormones|mesh-ancestor
24915797|NCT04248205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24915798|NCT04248205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24915799|NCT04248205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915800|NCT04247984|Bevacizumab|bevacizumab|mesh-list
24915801|NCT04247984|Fluorouracil|fluorouracil|mesh-list
24915802|NCT04247984|Capecitabine|capecitabine|mesh-list
24915803|NCT04247984|Irinotecan|irinotecan|mesh-list
24450429|NCT00319033|Bosentan|bosentan|mesh-list
24819672|NCT02096601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819674|NCT02096601|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25065505|NCT05321524|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
25065506|NCT05321524|Cathartics|cathartics|mesh-ancestor
24513831|NCT00585455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513833|NCT00585520|Progestins|progestins|mesh-ancestor
24894495|NCT04440436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24894496|NCT04440436|Immunologic Factors|immunologic factors|mesh-ancestor
24894497|NCT04440436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894498|NCT04440436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24894548|NCT04439773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24780764|NCT01886209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24780766|NCT01886209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24780767|NCT01886209|Protective Agents|protective agents|mesh-ancestor
24780768|NCT01886248|Antithrombins|antithrombins|mesh-list
24780769|NCT01886248|Antithrombin III|antithrombin iii|mesh-list
24780770|NCT01886248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24780804|NCT01886443|Melatonin|melatonin|mesh-list
24780805|NCT01886443|Antithrombins|antithrombins|mesh-list
24780806|NCT01886443|Antithrombin III|antithrombin iii|mesh-list
24780807|NCT01886443|Epoetin Alfa|epoetin alfa|mesh-list
24780808|NCT01886443|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
24780809|NCT01886443|Antioxidants|antioxidants|mesh-ancestor
24780810|NCT01886443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780811|NCT01886443|Protective Agents|protective agents|mesh-ancestor
24780812|NCT01886443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780873|NCT01886794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24780875|NCT01887119|Eplerenone|eplerenone|mesh-list
24780876|NCT01887119|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24780877|NCT01887119|Hormone Antagonists|hormone antagonists|mesh-ancestor
24780878|NCT01887119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24780879|NCT01887119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780880|NCT01887119|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24780881|NCT01887119|Diuretics|diuretics|mesh-ancestor
24780882|NCT01887119|Natriuretic Agents|natriuretic agents|mesh-ancestor
24780883|NCT01887119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24780884|NCT01887158|Bisacodyl|bisacodyl|mesh-list
24894549|NCT04439773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894551|NCT04439773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24894552|NCT04439773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25405859|NCT03591510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25685822|NCT01910311|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25685823|NCT01910311|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25685824|NCT01910519|Vaccines|vaccines|mesh-list
25685825|NCT01910519|Immunologic Factors|immunologic factors|mesh-ancestor
25685826|NCT01910519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685827|NCT01910636|Sofosbuvir|sofosbuvir|mesh-list
25685828|NCT01910636|Antiviral Agents|antiviral agents|mesh-ancestor
25685829|NCT01910636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25685830|NCT01911065|Vaccines|vaccines|mesh-list
25685831|NCT01911065|Immunologic Factors|immunologic factors|mesh-ancestor
25685832|NCT01911065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685833|NCT01911169|Vitamin D|vitamin d|mesh-list
25685834|NCT01911169|Cholecalciferol|cholecalciferol|mesh-list
25685835|NCT01911169|Vitamins|vitamins|mesh-list
25685836|NCT01911169|Micronutrients|micronutrients|mesh-ancestor
25685837|NCT01911169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685838|NCT01911169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25685839|NCT01911169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25685840|NCT01911260|Chelating Agents|chelating agents|mesh-list
25065532|NCT05321329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25065533|NCT05321329|Antimetabolites|antimetabolites|mesh-ancestor
25065534|NCT05321329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065535|NCT05321329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065539|NCT05321121|Dexmedetomidine|dexmedetomidine|mesh-list
25065540|NCT05321121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25065553|NCT05320926|Aspirin|aspirin|mesh-list
24894553|NCT04439773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24894554|NCT04439773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24894555|NCT04439773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24894556|NCT04439773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894558|NCT04439474|Cholecalciferol|cholecalciferol|mesh-list
24894559|NCT04439474|Vitamins|vitamins|mesh-ancestor
24894560|NCT04439474|Micronutrients|micronutrients|mesh-ancestor
24894561|NCT04439474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894562|NCT04439474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24895049|NCT05191875|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24895051|NCT05191875|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
24895084|NCT05069298|Protective Agents|protective agents|mesh-ancestor
24472073|NCT00398008|Buprenorphine|buprenorphine|mesh-list
24780885|NCT01887158|Cathartics|cathartics|mesh-ancestor
24780886|NCT01887158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24780887|NCT01887158|Laxatives|laxatives|mesh-ancestor
24780888|NCT01887184|Dexmedetomidine|dexmedetomidine|mesh-list
24409040|NCT00180791|Etoposide|etoposide|mesh-list
24780889|NCT01887184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25081999|NCT03325790|Antioxidants|antioxidants|mesh-ancestor
24780890|NCT01887184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24780891|NCT01887184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780892|NCT01887184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24572963|NCT00817375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572964|NCT00817375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24572965|NCT00817375|Serotonin Agents|serotonin agents|mesh-ancestor
24572966|NCT00817375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572967|NCT00817375|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24572968|NCT00817375|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24572969|NCT00817375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24572970|NCT00817375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24572971|NCT00817375|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24572972|NCT00817375|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24572973|NCT00817375|Histamine Antagonists|histamine antagonists|mesh-ancestor
24572974|NCT00817375|Histamine Agents|histamine agents|mesh-ancestor
24781044|NCT01887704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24781045|NCT01887704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781046|NCT01887704|Antipyretics|antipyretics|mesh-ancestor
24781047|NCT01887704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24781048|NCT01887704|Immunologic Factors|immunologic factors|mesh-ancestor
24781199|NCT01888536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24781200|NCT01888536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24781201|NCT01888536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781202|NCT01888536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24781203|NCT01888536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24781204|NCT01888536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24781205|NCT01888536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24799674|NCT01970072|GABA Agents|gaba agents|mesh-ancestor
24799675|NCT01970072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24799676|NCT01970072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799677|NCT01970202|Enoxaparin|enoxaparin|mesh-list
24799678|NCT01970202|Enoxaparin sodium|enoxaparin sodium|mesh-list
24799679|NCT01970202|Anticoagulants|anticoagulants|mesh-ancestor
24799680|NCT01970202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24799681|NCT01970202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24796219|NCT01948765|Propofol|propofol|mesh-list
24781248|NCT01888731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24781249|NCT01888731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25685841|NCT01911260|Sequestering Agents|sequestering agents|mesh-ancestor
25685842|NCT01911260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685843|NCT01911351|Nitrous Oxide|nitrous oxide|mesh-list
25685844|NCT01911351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25685845|NCT01911351|Anesthetics, General|anesthetics, general|mesh-ancestor
25685846|NCT01911351|Anesthetics|anesthetics|mesh-ancestor
25685847|NCT01911351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24915993|NCT04246502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781250|NCT01888731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24781251|NCT01888731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24781252|NCT01888744|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24781254|NCT01888744|Progesterone|progesterone|mesh-list
25082035|NCT03325348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25082036|NCT03325348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25082037|NCT03325348|Adrenergic Agents|adrenergic agents|mesh-ancestor
25082038|NCT03325348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25082039|NCT03325348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24781337|NCT01888978|Antimetabolites|antimetabolites|mesh-ancestor
24781338|NCT01888978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786602|NCT01920919|Glucocorticoids|glucocorticoids|mesh-ancestor
24409096|NCT00180908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24514445|NCT00590629|Antimetabolites|antimetabolites|mesh-ancestor
24521784|NCT04519476|Immunologic Factors|immunologic factors|mesh-ancestor
24895109|NCT05014919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24895117|NCT05014919|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24514554|NCT00591526|Antiviral Agents|antiviral agents|mesh-ancestor
24514555|NCT00591526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24514556|NCT00591526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24514557|NCT00591526|Immunologic Factors|immunologic factors|mesh-ancestor
24514558|NCT00591526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514716|NCT00592566|Dexamethasone|dexamethasone|mesh-list
24781339|NCT01888978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24781371|NCT01889004|Adrenergic Agents|adrenergic agents|mesh-ancestor
24781372|NCT01889004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24781373|NCT01889004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781375|NCT01889056|Hematinics|hematinics|mesh-ancestor
24781376|NCT01889095|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24781377|NCT01889095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24781378|NCT01889095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781379|NCT01889134|Alendronate|alendronate|mesh-list
24781380|NCT01889134|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24781381|NCT01889134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781382|NCT01889173|Cyclobenzaprine|cyclobenzaprine|mesh-list
24781383|NCT01889173|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24621064|NCT01060514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781419|NCT01889446|Calcium|calcium|mesh-list
24781449|NCT01889680|Vitamins|vitamins|mesh-ancestor
24781450|NCT01889680|Micronutrients|micronutrients|mesh-ancestor
24781451|NCT01889680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24799682|NCT01970202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799683|NCT01970215|Atorvastatin|atorvastatin|mesh-list
24799684|NCT01970215|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24799685|NCT01970215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24799686|NCT01970215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24799687|NCT01970215|Antimetabolites|antimetabolites|mesh-ancestor
24799688|NCT01970215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799689|NCT01970215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24799690|NCT01970215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24799691|NCT01970215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24799692|NCT01970280|Enoxaparin|enoxaparin|mesh-list
24799693|NCT01970280|Anticoagulants|anticoagulants|mesh-ancestor
24799694|NCT01970280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24799695|NCT01970280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24786711|NCT01921374|Complement System Proteins|complement system proteins|mesh-list
24514717|NCT00592566|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24514738|NCT00592579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514739|NCT00592618|Acetylcysteine|acetylcysteine|mesh-list
24514740|NCT00592618|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24799696|NCT01970280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781452|NCT01889680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24781486|NCT01889914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781487|NCT01889966|Sildenafil Citrate|sildenafil citrate|mesh-list
24781488|NCT01889966|Vasodilator Agents|vasodilator agents|mesh-ancestor
24781489|NCT01889966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24781490|NCT01889966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25685848|NCT01911351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685849|NCT01911351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25685850|NCT01911351|Analgesics|analgesics|mesh-ancestor
25685851|NCT01911351|Sensory System Agents|sensory system agents|mesh-ancestor
25065617|NCT05320094|Protective Agents|protective agents|mesh-ancestor
25065618|NCT05320094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065619|NCT05320094|Cathartics|cathartics|mesh-ancestor
25065620|NCT05320094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24950415|NCT03916432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25065624|NCT05311813|Hydroxychloroquine|hydroxychloroquine|mesh-list
24916006|NCT04246255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24781491|NCT01889966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781492|NCT01889966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781493|NCT01889966|Urological Agents|urological agents|mesh-ancestor
24781494|NCT01889979|Tramadol|tramadol|mesh-list
25082041|NCT03325348|Autonomic Agents|autonomic agents|mesh-ancestor
24781542|NCT01890538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24781543|NCT01890538|Protective Agents|protective agents|mesh-ancestor
24781544|NCT01890538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781545|NCT01890538|Nootropic Agents|nootropic agents|mesh-ancestor
24633028|NCT01127009|Bortezomib|bortezomib|mesh-list
24633029|NCT01127009|Etoposide phosphate|etoposide phosphate|mesh-list
25033268|NCT03574857|Metolazone|metolazone|mesh-list
24781547|NCT01890538|Autonomic Agents|autonomic agents|mesh-ancestor
24781548|NCT01890538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24781549|NCT01890538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24781550|NCT01890538|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24781616|NCT01890902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781617|NCT01890902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24781618|NCT01890902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24781619|NCT01890902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24781620|NCT01890902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781621|NCT01890902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781622|NCT01890941|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24781623|NCT01890941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24781624|NCT01890993|Liraglutide|liraglutide|mesh-list
24781625|NCT01890993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24781626|NCT01890993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621097|NCT01060683|Analgesics|analgesics|mesh-ancestor
24621098|NCT01060683|Sensory System Agents|sensory system agents|mesh-ancestor
24621099|NCT01060683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24621103|NCT01060696|Mefenamic Acid|mefenamic acid|mesh-list
24781701|NCT01891435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781739|NCT01891526|Isotretinoin|isotretinoin|mesh-list
24781740|NCT01891526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24781812|NCT01892150|Dermatologic Agents|dermatologic agents|mesh-ancestor
24781952|NCT01893229|Oxcarbazepine|oxcarbazepine|mesh-list
24781953|NCT01893229|Valproic Acid|valproic acid|mesh-list
24782059|NCT01893658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24919608|NCT04209803|Vasodilator Agents|vasodilator agents|mesh-ancestor
24782148|NCT01894412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24919899|NCT04207450|Glutaral|glutaral|mesh-list
24782477|NCT01896349|Bupropion|bupropion|mesh-list
24782478|NCT01896349|Sertraline|sertraline|mesh-list
24782479|NCT01896349|Fluoxetine|fluoxetine|mesh-list
24782480|NCT01896349|Paroxetine|paroxetine|mesh-list
24782481|NCT01896349|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24782482|NCT01896349|Nortriptyline|nortriptyline|mesh-list
24782483|NCT01896349|Imipramine|imipramine|mesh-list
24782484|NCT01896349|Clomipramine|clomipramine|mesh-list
24782485|NCT01896349|Antidepressive Agents|antidepressive agents|mesh-list
24782486|NCT01896349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24782487|NCT01896349|Serotonin Agents|serotonin agents|mesh-ancestor
24782488|NCT01896349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24919992|NCT04205916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24782751|NCT01897740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782752|NCT01897740|Urological Agents|urological agents|mesh-ancestor
25685852|NCT01911351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25685853|NCT01911429|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25685854|NCT01911429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25685855|NCT01911429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25685856|NCT01911429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25685857|NCT01911429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685858|NCT01911429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25685859|NCT01911429|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25685860|NCT01911429|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25685861|NCT01911429|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25685862|NCT01911429|Adrenergic Agents|adrenergic agents|mesh-ancestor
24782753|NCT01897753|Hormones|hormones|mesh-list
25065685|NCT05303311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25065686|NCT05303311|Antiemetics|antiemetics|mesh-ancestor
25065687|NCT05303311|Autonomic Agents|autonomic agents|mesh-ancestor
25065688|NCT05303311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25065689|NCT05303311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916080|NCT04245046|Vasodilator Agents|vasodilator agents|mesh-ancestor
24916081|NCT04245046|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24916082|NCT04245046|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24916083|NCT04245319|Acitretin|acitretin|mesh-list
24916084|NCT04245319|Keratolytic Agents|keratolytic agents|mesh-ancestor
24916085|NCT04245319|Dermatologic Agents|dermatologic agents|mesh-ancestor
24782754|NCT01897753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24782755|NCT01897753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782756|NCT01897779|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
24782757|NCT01897779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920160|NCT04204837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800201|NCT01973933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24800203|NCT01973933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920198|NCT04204798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24782818|NCT01898182|Plant Growth Regulators|plant growth regulators|mesh-ancestor
24782819|NCT01898182|Growth Substances|growth substances|mesh-ancestor
24782820|NCT01898182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782821|NCT01898221|Ethanol|ethanol|mesh-list
24782822|NCT01898221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24782823|NCT01898221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24782824|NCT01898221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24782825|NCT01898221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782826|NCT01898338|Daptomycin|daptomycin|mesh-list
24782827|NCT01898338|Fosfomycin|fosfomycin|mesh-list
24782828|NCT01898338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24782849|NCT01898507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24782850|NCT01898507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24920258|NCT04204044|Hematinics|hematinics|mesh-ancestor
24782904|NCT01898819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24782905|NCT01898819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24782906|NCT01898819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24782908|NCT01898819|Adrenergic Agents|adrenergic agents|mesh-ancestor
24782909|NCT01898819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24920318|NCT04203368|Adenosine|adenosine|mesh-list
24783123|NCT01900301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24783125|NCT01900301|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24783126|NCT01900301|Cholinergic Agents|cholinergic agents|mesh-ancestor
24783127|NCT01900301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24783132|NCT01900327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24783133|NCT01900327|Antimetabolites|antimetabolites|mesh-ancestor
25082177|NCT03324425|Antimetabolites|antimetabolites|mesh-ancestor
25082178|NCT03324425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082179|NCT03324425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25082180|NCT03324425|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24783248|NCT01900795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24783249|NCT01900795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783250|NCT01900795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783252|NCT01900847|Morphine|morphine|mesh-list
24783253|NCT01900847|Analgesics|analgesics|mesh-ancestor
24783487|NCT01902186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24783488|NCT01902186|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24998368|NCT03009201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783489|NCT01902186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24783490|NCT01902186|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24783491|NCT01902186|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24783493|NCT01902225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24820675|NCT02100852|Obinutuzumab|obinutuzumab|mesh-list
24820676|NCT02100852|Chlorambucil|chlorambucil|mesh-list
25685863|NCT01911429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25685864|NCT01911429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685865|NCT01911429|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25685866|NCT01911429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25685867|NCT01911429|Serotonin Agents|serotonin agents|mesh-ancestor
25685868|NCT01911429|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25685869|NCT01911429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25685870|NCT01911429|Dopamine Agents|dopamine agents|mesh-ancestor
25685871|NCT01911442|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25685872|NCT01911442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25065774|NCT05260528|Antimetabolites|antimetabolites|mesh-ancestor
24436224|NCT00269555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950643|NCT03913806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950644|NCT03913806|Growth Inhibitors|growth inhibitors|mesh-ancestor
24950645|NCT03913455|Carboplatin|carboplatin|mesh-list
24950646|NCT03913455|Guadecitabine|guadecitabine|mesh-list
24950647|NCT03913455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950648|NCT03913468|Ascorbic Acid|ascorbic acid|mesh-list
24950684|NCT03912857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950685|NCT03912857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24950686|NCT03912857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950687|NCT03912857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783494|NCT01902225|Romidepsin|romidepsin|mesh-list
24783495|NCT01902225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24783496|NCT01902225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783497|NCT01902225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24783498|NCT01902225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24783499|NCT01902225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24784310|NCT01907308|Antimitotic Agents|antimitotic agents|mesh-ancestor
24633260|NCT01127841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783500|NCT01902225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783502|NCT01902238|Ethiodized Oil|ethiodized oil|mesh-list
24783503|NCT01902238|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24620552|NCT01057511|Hormones|hormones|mesh-ancestor
24783760|NCT01903785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24783761|NCT01903785|Adrenergic Agents|adrenergic agents|mesh-ancestor
24783762|NCT01903785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24783763|NCT01903785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783765|NCT01903824|Donepezil|donepezil|mesh-list
24783766|NCT01903824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24783767|NCT01903824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783768|NCT01903824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783769|NCT01903824|Cholinergic Agents|cholinergic agents|mesh-ancestor
24783770|NCT01903824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24783771|NCT01903824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783772|NCT01903824|Nootropic Agents|nootropic agents|mesh-ancestor
24783780|NCT01904045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784012|NCT01905371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24826543|NCT02135055|Midazolam|midazolam|mesh-list
24784032|NCT01905566|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24784033|NCT01905566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24784034|NCT01905566|Purinergic Agents|purinergic agents|mesh-ancestor
24784035|NCT01905566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24784036|NCT01905566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576150|NCT00837174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576151|NCT00837187|Dexmedetomidine|dexmedetomidine|mesh-list
24826869|NCT02136641|Anesthetics|anesthetics|mesh-ancestor
24784071|NCT01905696|Antiviral Agents|antiviral agents|mesh-ancestor
24784072|NCT01905696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24784073|NCT01905696|Expectorants|expectorants|mesh-ancestor
24784074|NCT01905696|Respiratory System Agents|respiratory system agents|mesh-ancestor
24784075|NCT01905696|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24784076|NCT01905696|Antioxidants|antioxidants|mesh-ancestor
24784077|NCT01905696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784078|NCT01905696|Protective Agents|protective agents|mesh-ancestor
24409270|NCT00181662|Analgesics|analgesics|mesh-ancestor
24784079|NCT01905696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784080|NCT01905696|Antidotes|antidotes|mesh-ancestor
24784081|NCT01905774|Deferasirox|deferasirox|mesh-list
24784082|NCT01905774|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24784083|NCT01905774|Chelating Agents|chelating agents|mesh-ancestor
24784084|NCT01905774|Sequestering Agents|sequestering agents|mesh-ancestor
25405860|NCT03591510|Antimetabolites|antimetabolites|mesh-ancestor
25685873|NCT01911442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25685874|NCT01911442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25685875|NCT01911442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685876|NCT01911442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25685877|NCT01911442|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25685878|NCT01911442|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25685879|NCT01911442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25685880|NCT01911442|Adrenergic Agents|adrenergic agents|mesh-ancestor
25685881|NCT01911442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25685882|NCT01911442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685883|NCT01911442|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24784085|NCT01905774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784086|NCT01905904|Sevoflurane|sevoflurane|mesh-list
24784087|NCT01905904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24785401|NCT01914081|Antioxidants|antioxidants|mesh-ancestor
24784131|NCT01906411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24784180|NCT01906788|Artemether|artemether|mesh-list
24784181|NCT01906788|Primaquine|primaquine|mesh-list
24714874|NCT01533220|Nasal Decongestants|nasal decongestants|mesh-ancestor
24784187|NCT01906801|Diacetylrhein|diacetylrhein|mesh-list
24784188|NCT01906801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24784189|NCT01906814|Carboplatin|carboplatin|mesh-list
24784190|NCT01906814|Etoposide|etoposide|mesh-list
24784191|NCT01906814|Etoposide phosphate|etoposide phosphate|mesh-list
24784192|NCT01906814|Vincristine|vincristine|mesh-list
24784193|NCT01906814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784196|NCT01906814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24784197|NCT01906814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24784198|NCT01906814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784199|NCT01906814|Tubulin Modulators|tubulin modulators|mesh-ancestor
24784200|NCT01906814|Antimitotic Agents|antimitotic agents|mesh-ancestor
24784201|NCT01906814|Mitosis Modulators|mitosis modulators|mesh-ancestor
24784207|NCT01906879|Bismuth|bismuth|mesh-list
24784208|NCT01906879|Antacids|antacids|mesh-ancestor
24921028|NCT04195074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24784256|NCT01907061|Antidotes|antidotes|mesh-ancestor
24784257|NCT01907074|Cholic Acids|cholic acids|mesh-list
24784258|NCT01907074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24784260|NCT01907165|Temozolomide|temozolomide|mesh-list
24784261|NCT01907165|Disulfiram|disulfiram|mesh-list
24784262|NCT01907165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24682363|NCT01386151|Mitogens|mitogens|mesh-list
24921100|NCT04194294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24784515|NCT01908348|Erythritol|erythritol|mesh-list
24784522|NCT01908387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24784523|NCT01908452|Pyridoxine|pyridoxine|mesh-list
24784524|NCT01908452|Vitamin B Complex|vitamin b complex|mesh-ancestor
24784525|NCT01908452|Vitamins|vitamins|mesh-ancestor
24784526|NCT01908452|Micronutrients|micronutrients|mesh-ancestor
24784527|NCT01908452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784528|NCT01908465|Ebastine|ebastine|mesh-list
24576579|NCT00839358|Midodrine|midodrine|mesh-list
24784529|NCT01908465|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24784530|NCT01908465|Histamine Antagonists|histamine antagonists|mesh-ancestor
24784532|NCT01908465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24784533|NCT01908465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784534|NCT01908465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784535|NCT01908478|Gemcitabine|gemcitabine|mesh-list
24784536|NCT01908478|Veliparib|veliparib|mesh-list
24784537|NCT01908478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24784538|NCT01908478|Antimetabolites|antimetabolites|mesh-ancestor
24784539|NCT01908478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784540|NCT01908478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784541|NCT01908478|Antiviral Agents|antiviral agents|mesh-ancestor
24784760|NCT01910259|Serotonin Agents|serotonin agents|mesh-ancestor
24784761|NCT01910259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784762|NCT01910259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24784763|NCT01910259|Antidepressive Agents|antidepressive agents|mesh-ancestor
24784764|NCT01910259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24785073|NCT01911949|Bupivacaine|bupivacaine|mesh-list
24785074|NCT01911949|Anesthetics, Local|anesthetics, local|mesh-ancestor
24785075|NCT01911949|Anesthetics|anesthetics|mesh-ancestor
24785076|NCT01911949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24785077|NCT01911949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785078|NCT01911949|Sensory System Agents|sensory system agents|mesh-ancestor
24785079|NCT01911949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24785080|NCT01911949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24785081|NCT01911949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24785082|NCT01911949|Adrenergic Agents|adrenergic agents|mesh-ancestor
24785394|NCT01914042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24785396|NCT01914042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24785573|NCT01915134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24785574|NCT01915134|Immunologic Factors|immunologic factors|mesh-ancestor
24785575|NCT01915134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785576|NCT01915134|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24409487|NCT00182169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409488|NCT00182221|Fibrin fragment D|fibrin fragment d|mesh-list
25065921|NCT04768166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065922|NCT04768166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24534429|NCT00646984|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25065937|NCT04760041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25065938|NCT04760041|Anesthetics, General|anesthetics, general|mesh-ancestor
25065939|NCT04760041|Anesthetics|anesthetics|mesh-ancestor
25065940|NCT04760041|GABA Modulators|gaba modulators|mesh-ancestor
24409489|NCT00182221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24785649|NCT01915758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24785650|NCT01915758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785651|NCT01915758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24785652|NCT01915758|Keratolytic Agents|keratolytic agents|mesh-ancestor
24785653|NCT01915758|Dermatologic Agents|dermatologic agents|mesh-ancestor
24785654|NCT01915901|Dimethyl Fumarate|dimethyl fumarate|mesh-list
24785655|NCT01915901|Bismuth|bismuth|mesh-list
24785656|NCT01915901|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
24785657|NCT01915901|Antacids|antacids|mesh-ancestor
24785658|NCT01915901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785659|NCT01915901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24785660|NCT01915901|Dermatologic Agents|dermatologic agents|mesh-ancestor
24785661|NCT01915901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24785750|NCT01916265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24785751|NCT01916265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785867|NCT01916954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24785868|NCT01916954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24785869|NCT01916954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24785870|NCT01917019|4-Aminopyridine|4-aminopyridine|mesh-list
24785871|NCT01917019|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24621312|NCT01061450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621313|NCT01061450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24621327|NCT01061697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621328|NCT01061697|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24621329|NCT01061697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24621330|NCT01061697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24621331|NCT01061697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24621332|NCT01061697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24621333|NCT01061749|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24621334|NCT01061749|Immunologic Factors|immunologic factors|mesh-ancestor
24621335|NCT01061749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786099|NCT01918098|Oxycodone|oxycodone|mesh-list
24870458|NCT05161221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24786100|NCT01918098|Naloxone|naloxone|mesh-list
24786101|NCT01918098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24786102|NCT01918098|Narcotics|narcotics|mesh-ancestor
24786103|NCT01918098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24786104|NCT01918098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786105|NCT01918098|Analgesics|analgesics|mesh-ancestor
24786106|NCT01918098|Sensory System Agents|sensory system agents|mesh-ancestor
24786107|NCT01918098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24786108|NCT01918098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24786109|NCT01918111|Adenosine|adenosine|mesh-list
24786110|NCT01918111|Analgesics|analgesics|mesh-ancestor
24786111|NCT01918111|Sensory System Agents|sensory system agents|mesh-ancestor
24786112|NCT01918111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24800704|NCT01977430|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24800705|NCT01977443|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24800706|NCT01977443|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24627925|NCT01095679|GABA Agents|gaba agents|mesh-ancestor
24787614|NCT01925937|Vitamins|vitamins|mesh-ancestor
24786256|NCT01918852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786257|NCT01918852|Growth Inhibitors|growth inhibitors|mesh-ancestor
24786258|NCT01918852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24786259|NCT01918852|Antimetabolites|antimetabolites|mesh-ancestor
24786260|NCT01918852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786261|NCT01918865|Metformin|metformin|mesh-list
24786262|NCT01918865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24786263|NCT01918865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786264|NCT01918878|Aflibercept|aflibercept|mesh-list
25685884|NCT01911442|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25685885|NCT01911442|Serotonin Agents|serotonin agents|mesh-ancestor
25685886|NCT01911442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25685887|NCT01911442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25685888|NCT01911442|Dopamine Agents|dopamine agents|mesh-ancestor
25685889|NCT01911546|Everolimus|everolimus|mesh-list
25685890|NCT01911546|Tacrolimus|tacrolimus|mesh-list
25685891|NCT01911546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24786265|NCT01918878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24786266|NCT01918878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24786267|NCT01918878|Growth Substances|growth substances|mesh-ancestor
24786268|NCT01918878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786269|NCT01918878|Growth Inhibitors|growth inhibitors|mesh-ancestor
24786478|NCT01920191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801108|NCT01980849|Nadroparin|nadroparin|mesh-list
24801109|NCT01980849|Anticoagulants|anticoagulants|mesh-ancestor
24801110|NCT01980849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24801112|NCT01980849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786595|NCT01920919|Dexamethasone|dexamethasone|mesh-list
24786596|NCT01920919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24786597|NCT01920919|Antiemetics|antiemetics|mesh-ancestor
24786598|NCT01920919|Autonomic Agents|autonomic agents|mesh-ancestor
24786599|NCT01920919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24786600|NCT01920919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786601|NCT01920919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24786808|NCT01921868|Nootropic Agents|nootropic agents|mesh-ancestor
24786809|NCT01921920|Omeprazole|omeprazole|mesh-list
24786810|NCT01921920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24786866|NCT01922154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787050|NCT01923376|Laxatives|laxatives|mesh-ancestor
24787051|NCT01923454|Acetazolamide|acetazolamide|mesh-list
24787052|NCT01923454|Anticonvulsants|anticonvulsants|mesh-ancestor
24787089|NCT01923623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24409647|NCT00182663|Dexamethasone|dexamethasone|mesh-list
24787248|NCT01924104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24787249|NCT01924104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24787250|NCT01924104|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24787251|NCT01924104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24787287|NCT01924286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787364|NCT01924624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24787366|NCT01924624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787367|NCT01924624|Leprostatic Agents|leprostatic agents|mesh-ancestor
24787435|NCT01925287|Sensory System Agents|sensory system agents|mesh-ancestor
24787436|NCT01925287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24787437|NCT01925287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787438|NCT01925287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24787439|NCT01925287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24787440|NCT01925287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787441|NCT01925287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787442|NCT01925287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787443|NCT01925300|Bisoprolol|bisoprolol|mesh-list
24787444|NCT01925300|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24787445|NCT01925300|Calcium|calcium|mesh-list
24787446|NCT01925300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24787447|NCT01925300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787449|NCT01925300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24787450|NCT01925300|Antimetabolites|antimetabolites|mesh-ancestor
24922293|NCT04181567|S 20098|s 20098|mesh-list
25082271|NCT03323684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25082272|NCT03323684|Antipyretics|antipyretics|mesh-ancestor
25082273|NCT03323684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25082274|NCT03323684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25082275|NCT03323684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25082276|NCT03323684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25082277|NCT03323684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25082278|NCT03323684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082279|NCT03323671|Mefenamic Acid|mefenamic acid|mesh-list
25082280|NCT03323671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25082281|NCT03323671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25082282|NCT03323671|Analgesics|analgesics|mesh-ancestor
25082283|NCT03323671|Sensory System Agents|sensory system agents|mesh-ancestor
25082286|NCT03323671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25082288|NCT03323671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25082289|NCT03323671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787620|NCT01926041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787621|NCT01926041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787622|NCT01926132|Ascorbic Acid|ascorbic acid|mesh-list
24787623|NCT01926132|Antioxidants|antioxidants|mesh-ancestor
24787624|NCT01926132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787625|NCT01926132|Protective Agents|protective agents|mesh-ancestor
24787626|NCT01926132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787644|NCT01926236|Fluorouracil|fluorouracil|mesh-list
24787645|NCT01926236|Oxaliplatin|oxaliplatin|mesh-list
25066056|NCT04368429|Immunologic Factors|immunologic factors|mesh-ancestor
25066057|NCT04368429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066058|NCT04366908|Calcifediol|calcifediol|mesh-list
25066059|NCT04366908|Vitamins|vitamins|mesh-ancestor
25066060|NCT04366908|Micronutrients|micronutrients|mesh-ancestor
25066061|NCT04366908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787685|NCT01926548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24787749|NCT01927224|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24787750|NCT01927224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24787751|NCT01927224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24787752|NCT01927224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24787754|NCT01927263|Dermatologic Agents|dermatologic agents|mesh-ancestor
24397176|NCT00140998|Estrogens|estrogens|mesh-ancestor
24787755|NCT01927263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24787756|NCT01927263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24787757|NCT01927315|Fenofibrate|fenofibrate|mesh-list
24787758|NCT01927315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24787795|NCT01927588|Everolimus|everolimus|mesh-list
24787796|NCT01927588|Tacrolimus|tacrolimus|mesh-list
24787797|NCT01927588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24621454|NCT01062490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24621455|NCT01062503|Zoledronic Acid|zoledronic acid|mesh-list
24621456|NCT01062503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24627961|NCT01095809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082292|NCT03323619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25082293|NCT03323619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082295|NCT03323593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24787877|NCT01928056|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24787952|NCT01928511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787953|NCT01928537|ON 01910|on 01910|mesh-list
24787954|NCT01928537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787955|NCT01928537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24787956|NCT01928537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787990|NCT01928888|Histamine Antagonists|histamine antagonists|mesh-ancestor
24788037|NCT01929213|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24788038|NCT01929213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788072|NCT01929278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788111|NCT01929512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24788114|NCT01929577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621524|NCT01062932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24621525|NCT01062932|Antimetabolites|antimetabolites|mesh-ancestor
24621526|NCT01062932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621527|NCT01062945|Doxazosin|doxazosin|mesh-list
24621528|NCT01062945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24621529|NCT01062945|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24621530|NCT01062945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24621531|NCT01062945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24788261|NCT01930552|Vitamin B Complex|vitamin b complex|mesh-ancestor
24788262|NCT01930552|Vitamins|vitamins|mesh-ancestor
24788268|NCT01930591|Clopidogrel|clopidogrel|mesh-list
24788270|NCT01930591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24788310|NCT01930734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788311|NCT01930734|Protective Agents|protective agents|mesh-ancestor
24788312|NCT01930773|Clopidogrel|clopidogrel|mesh-list
24788313|NCT01930773|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24514741|NCT00592618|Antiviral Agents|antiviral agents|mesh-ancestor
24788358|NCT01930877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24788366|NCT01930916|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
24788367|NCT01930916|Lupus Coagulation Inhibitor|lupus coagulation inhibitor|mesh-list
24788449|NCT01931410|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24788451|NCT01931410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24788452|NCT01931410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788453|NCT01931410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24788454|NCT01931410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24788455|NCT01931410|Oxytocics|oxytocics|mesh-ancestor
24788612|NCT01932385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788613|NCT01932385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788695|NCT01932918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788696|NCT01932918|Analgesics|analgesics|mesh-ancestor
25685892|NCT01911546|Immunologic Factors|immunologic factors|mesh-ancestor
25685893|NCT01911546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685894|NCT01911546|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25685895|NCT01911546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25685896|NCT01911546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438311|NCT00275457|Dopamine Agents|dopamine agents|mesh-ancestor
24438324|NCT00275535|Prednisone|prednisone|mesh-list
24916329|NCT04242017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24916330|NCT04241705|Lumefantrine|lumefantrine|mesh-list
24916331|NCT04241705|Artemether|artemether|mesh-list
24916332|NCT04241705|Primaquine|primaquine|mesh-list
24916333|NCT04241705|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24916334|NCT04241705|Antimalarials|antimalarials|mesh-ancestor
24788697|NCT01932918|Sensory System Agents|sensory system agents|mesh-ancestor
24788698|NCT01932918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24788699|NCT01932918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25033556|NCT03572647|Epoetin Alfa|epoetin alfa|mesh-list
24788700|NCT01932918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24788701|NCT01932918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24922934|NCT04174872|Anesthetics|anesthetics|mesh-ancestor
24788740|NCT01933360|Misoprostol|misoprostol|mesh-list
24788741|NCT01933360|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24788742|NCT01933360|Abortifacient Agents|abortifacient agents|mesh-ancestor
24788743|NCT01933360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24788744|NCT01933360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789056|NCT01935492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24789057|NCT01935492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24789058|NCT01935492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24789059|NCT01935492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24789063|NCT01935505|Varenicline|varenicline|mesh-list
24789064|NCT01935505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24789065|NCT01935505|Autonomic Agents|autonomic agents|mesh-ancestor
25082349|NCT03323385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24789273|NCT01936090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789274|NCT01936090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24789307|NCT01936233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24789308|NCT01936233|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24789309|NCT01936233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24789310|NCT01936233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789311|NCT01936233|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24789312|NCT01936233|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24789313|NCT01936233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24789314|NCT01936233|Antipyretics|antipyretics|mesh-ancestor
24789315|NCT01936233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24923138|NCT04172363|Octenidine|octenidine|mesh-list
24789422|NCT01937156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24789423|NCT01937156|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24789424|NCT01937156|Serotonin Agents|serotonin agents|mesh-ancestor
24789425|NCT01937156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24789426|NCT01937156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789427|NCT01937169|Levodopa|levodopa|mesh-list
24789428|NCT01937169|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24789429|NCT01937169|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24789430|NCT01937169|Dopamine Agents|dopamine agents|mesh-ancestor
24923172|NCT04172259|Cyclophosphamide|cyclophosphamide|mesh-list
24789524|NCT01937728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542203|NCT00677521|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24542204|NCT00677521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542208|NCT00677664|Glatiramer Acetate|glatiramer acetate|mesh-list
24789525|NCT01937728|Antiviral Agents|antiviral agents|mesh-ancestor
24789530|NCT01937728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789531|NCT01937754|Nitric Oxide|nitric oxide|mesh-list
24789532|NCT01937754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24789533|NCT01937754|Autonomic Agents|autonomic agents|mesh-ancestor
24923215|NCT04171817|Disinfectants|disinfectants|mesh-ancestor
24621629|NCT01063205|Respiratory System Agents|respiratory system agents|mesh-ancestor
24628041|NCT01096277|Protease Inhibitors|protease inhibitors|mesh-ancestor
24628043|NCT01096277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628044|NCT01096329|Methyltestosterone|methyltestosterone|mesh-list
24628045|NCT01096329|Testosterone|testosterone|mesh-list
25082411|NCT03322878|Magnesium Sulfate|magnesium sulfate|mesh-list
25082412|NCT03322878|Analgesics|analgesics|mesh-ancestor
25082413|NCT03322878|Sensory System Agents|sensory system agents|mesh-ancestor
25082414|NCT03322878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082415|NCT03322878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685897|NCT01911546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25685898|NCT01911780|Amlodipine|amlodipine|mesh-list
25685899|NCT01911780|Telmisartan|telmisartan|mesh-list
25685900|NCT01911780|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25685901|NCT01911780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25685902|NCT01911780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25685903|NCT01911780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25082416|NCT03322878|Anesthetics|anesthetics|mesh-ancestor
25066136|NCT04221087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25066137|NCT04221087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25066138|NCT04221087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066139|NCT04205786|Vitamin B 12|vitamin b 12|mesh-list
25066140|NCT04205786|Hydroxocobalamin|hydroxocobalamin|mesh-list
25066141|NCT04205786|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25066142|NCT04205786|Vitamins|vitamins|mesh-ancestor
25066143|NCT04205786|Micronutrients|micronutrients|mesh-ancestor
25066144|NCT04205786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066145|NCT04205786|Vitamin B Complex|vitamin b complex|mesh-ancestor
25066146|NCT04205786|Hematinics|hematinics|mesh-ancestor
25082417|NCT03322878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25082418|NCT03322878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25082419|NCT03322878|Anticonvulsants|anticonvulsants|mesh-ancestor
24628046|NCT01096329|Testosterone undecanoate|testosterone undecanoate|mesh-list
25082420|NCT03322878|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24621632|NCT01063205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621633|NCT01063205|Protective Agents|protective agents|mesh-ancestor
24621634|NCT01063205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621637|NCT01063218|Dermatologic Agents|dermatologic agents|mesh-ancestor
24621638|NCT01063257|Clofarabine|clofarabine|mesh-list
24621639|NCT01063257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24621640|NCT01063257|Antimetabolites|antimetabolites|mesh-ancestor
24621641|NCT01063257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621642|NCT01063257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24621663|NCT01063426|Enoxaparin sodium|enoxaparin sodium|mesh-list
24621664|NCT01063426|Atorvastatin|atorvastatin|mesh-list
24621665|NCT01063426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24621666|NCT01063426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24621667|NCT01063426|Antimetabolites|antimetabolites|mesh-ancestor
24621668|NCT01063426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621669|NCT01063426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24621670|NCT01063426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24621671|NCT01063426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621672|NCT01063426|Anticoagulants|anticoagulants|mesh-ancestor
24789653|NCT01938300|Magnesium Sulfate|magnesium sulfate|mesh-list
24789654|NCT01938300|Analgesics|analgesics|mesh-ancestor
24789655|NCT01938300|Sensory System Agents|sensory system agents|mesh-ancestor
24789656|NCT01938300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24789657|NCT01938300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789658|NCT01938300|Anesthetics|anesthetics|mesh-ancestor
24789659|NCT01938300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24789660|NCT01938300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24789661|NCT01938300|Anticonvulsants|anticonvulsants|mesh-ancestor
24789662|NCT01938300|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24875283|NCT04253964|Pembrolizumab|pembrolizumab|mesh-list
24789730|NCT01938820|Entecavir|entecavir|mesh-list
24789731|NCT01938820|Antiviral Agents|antiviral agents|mesh-ancestor
24789732|NCT01938820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24789733|NCT01938859|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24789772|NCT01939093|Autonomic Agents|autonomic agents|mesh-ancestor
24789773|NCT01939093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24789774|NCT01939093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24789775|NCT01939093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24923401|NCT04170790|Hormones|hormones|mesh-ancestor
24789831|NCT01939418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789832|NCT01939418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24789833|NCT01939418|Antimetabolites|antimetabolites|mesh-ancestor
24923428|NCT04170439|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24789915|NCT01939691|Difluprednate|difluprednate|mesh-list
24789916|NCT01939691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24789917|NCT01939691|Glucocorticoids|glucocorticoids|mesh-ancestor
24789919|NCT01939691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24789920|NCT01939691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685904|NCT01911780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685905|NCT01911780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25685906|NCT01911780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685907|NCT01911780|Vasodilator Agents|vasodilator agents|mesh-ancestor
25685908|NCT01911780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25685909|NCT01911780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25685910|NCT01911780|Diuretics|diuretics|mesh-ancestor
25685911|NCT01911780|Natriuretic Agents|natriuretic agents|mesh-ancestor
25685912|NCT01911780|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25685913|NCT01911845|Ribavirin|ribavirin|mesh-list
24819778|NCT02097173|Antimetabolites|antimetabolites|mesh-ancestor
24819779|NCT02097173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819780|NCT02097173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24819782|NCT02097173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819783|NCT02097173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24819784|NCT02097173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24789921|NCT01939691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24789922|NCT01939691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789923|NCT01939691|Antiemetics|antiemetics|mesh-ancestor
24628058|NCT01096355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628060|NCT01096420|Anticonvulsants|anticonvulsants|mesh-ancestor
24621683|NCT01063439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621684|NCT01063439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621685|NCT01063439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24923529|NCT04169763|Nelfinavir|nelfinavir|mesh-list
25082480|NCT03322358|Antipruritics|antipruritics|mesh-ancestor
25082481|NCT03322358|Dermatologic Agents|dermatologic agents|mesh-ancestor
25082482|NCT03322150|Atropine|atropine|mesh-list
25082483|NCT03322150|Glycopyrrolate|glycopyrrolate|mesh-list
25082484|NCT03322150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25082485|NCT03322150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24621687|NCT01063439|Antiviral Agents|antiviral agents|mesh-ancestor
24621688|NCT01063439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24621689|NCT01063439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24621690|NCT01063439|Immunologic Factors|immunologic factors|mesh-ancestor
24621691|NCT01063439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621692|NCT01063439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24621693|NCT01063439|Alkylating Agents|alkylating agents|mesh-ancestor
24621694|NCT01063439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24621695|NCT01063478|Everolimus|everolimus|mesh-list
24621696|NCT01063478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24621697|NCT01063478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24621698|NCT01063478|Immunologic Factors|immunologic factors|mesh-ancestor
24621699|NCT01063478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621700|NCT01063504|Teriparatide|teriparatide|mesh-list
24790021|NCT01940224|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24790022|NCT01940224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24790023|NCT01940224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24790024|NCT01940250|Magnesium Sulfate|magnesium sulfate|mesh-list
24790026|NCT01940250|Sensory System Agents|sensory system agents|mesh-ancestor
24790027|NCT01940250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24790028|NCT01940250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790029|NCT01940250|Anesthetics|anesthetics|mesh-ancestor
24790030|NCT01940250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24790035|NCT01940250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790036|NCT01940250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24790038|NCT01940250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24790039|NCT01940393|Cetirizine|cetirizine|mesh-list
24790040|NCT01940393|Fexofenadine|fexofenadine|mesh-list
24790041|NCT01940393|Desloratadine|desloratadine|mesh-list
24790042|NCT01940393|Ebastine|ebastine|mesh-list
24790043|NCT01940393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24790044|NCT01940393|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24790045|NCT01940393|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24790046|NCT01940393|Histamine Antagonists|histamine antagonists|mesh-ancestor
24790047|NCT01940393|Histamine Agents|histamine agents|mesh-ancestor
24582468|NCT00869908|Insulin|insulin|mesh-list
24790048|NCT01940393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24790165|NCT01941173|Calcium|calcium|mesh-list
24790166|NCT01941173|Levoleucovorin|levoleucovorin|mesh-list
24790167|NCT01941173|Endothelial Growth Factors|endothelial growth factors|mesh-list
24790168|NCT01941173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24923635|NCT04168619|Immunologic Factors|immunologic factors|mesh-ancestor
24790208|NCT01941329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24790209|NCT01941329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24790210|NCT01941329|Growth Substances|growth substances|mesh-ancestor
25405936|NCT03587584|Anesthetics|anesthetics|mesh-ancestor
25685914|NCT01911845|Antimetabolites|antimetabolites|mesh-ancestor
25685915|NCT01911845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685916|NCT01911845|Antiviral Agents|antiviral agents|mesh-ancestor
25685917|NCT01911845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25685918|NCT01912222|Ixazomib|ixazomib|mesh-list
25685919|NCT01912222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24916529|NCT04239859|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24916530|NCT04239859|Keratolytic Agents|keratolytic agents|mesh-ancestor
24916532|NCT04239560|Trace Elements|trace elements|mesh-ancestor
25066209|NCT04092673|Trastuzumab|trastuzumab|mesh-list
24916533|NCT04239560|Micronutrients|micronutrients|mesh-ancestor
24916534|NCT04239560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790211|NCT01941329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790212|NCT01941329|Growth Inhibitors|growth inhibitors|mesh-ancestor
24790213|NCT01941329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990351|NCT03186456|Antipyretics|antipyretics|mesh-ancestor
24790215|NCT01941407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24923674|NCT04167774|Paclitaxel|paclitaxel|mesh-list
24582792|NCT00871598|Immunologic Factors|immunologic factors|mesh-ancestor
24582793|NCT00871598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790410|NCT01942343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790411|NCT01942369|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24790412|NCT01942369|Luteolytic Agents|luteolytic agents|mesh-ancestor
24790510|NCT01943188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24790511|NCT01943188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24790513|NCT01943240|Anesthetics, Local|anesthetics, local|mesh-ancestor
24790514|NCT01943240|Anesthetics|anesthetics|mesh-ancestor
24790515|NCT01943240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24790516|NCT01943240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790517|NCT01943240|Sensory System Agents|sensory system agents|mesh-ancestor
24790520|NCT01943305|Immunologic Factors|immunologic factors|mesh-ancestor
24790521|NCT01943305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884883|NCT03316586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24790534|NCT01943422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790535|NCT01943422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24790536|NCT01943422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25082487|NCT03322150|Autonomic Agents|autonomic agents|mesh-ancestor
24790537|NCT01943422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790538|NCT01943487|Verapamil|verapamil|mesh-list
24790539|NCT01943487|Tamsulosin|tamsulosin|mesh-list
24583019|NCT00873210|Growth Substances|growth substances|mesh-ancestor
24790540|NCT01943487|Solifenacin Succinate|solifenacin succinate|mesh-list
24790541|NCT01943487|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24621779|NCT01063920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24621796|NCT01064102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621797|NCT01064102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621798|NCT01064115|Cetirizine|cetirizine|mesh-list
24885951|NCT04054999|Hydroxocobalamin|hydroxocobalamin|mesh-list
24790661|NCT01944085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24790662|NCT01944085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790663|NCT01944085|Antioxidants|antioxidants|mesh-ancestor
24790664|NCT01944085|Protective Agents|protective agents|mesh-ancestor
24628091|NCT01096511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24802233|NCT01988961|Immunologic Factors|immunologic factors|mesh-ancestor
24802676|NCT01991561|Antacids|antacids|mesh-ancestor
24802677|NCT01991561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802678|NCT01991561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25082488|NCT03322150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082489|NCT03322150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082490|NCT03322150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25082491|NCT03322150|Respiratory System Agents|respiratory system agents|mesh-ancestor
25082492|NCT03322150|Mydriatics|mydriatics|mesh-ancestor
25082493|NCT03322150|Parasympatholytics|parasympatholytics|mesh-ancestor
25082504|NCT03322098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24790678|NCT01944215|Caffeine|caffeine|mesh-list
24790679|NCT01944215|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24790680|NCT01944215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790681|NCT01944215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24790683|NCT01944215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790684|NCT01944215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24790685|NCT01944215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24790686|NCT01944215|Purinergic Agents|purinergic agents|mesh-ancestor
24790687|NCT01944215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24790688|NCT01944384|Spironolactone|spironolactone|mesh-list
24790689|NCT01944384|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25685920|NCT01912222|Protease Inhibitors|protease inhibitors|mesh-ancestor
25685921|NCT01912222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25685922|NCT01912222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685923|NCT01912274|Azacitidine|azacitidine|mesh-list
25685924|NCT01912274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24916637|NCT04238884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24916639|NCT04238884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24790690|NCT01944384|Hormone Antagonists|hormone antagonists|mesh-ancestor
24790711|NCT01944436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24790712|NCT01944436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24790720|NCT01944657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24790722|NCT01944683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25033769|NCT03571308|Hormones|hormones|mesh-ancestor
24790723|NCT01944683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24790724|NCT01944683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24790725|NCT01944683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790726|NCT01944683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24790727|NCT01944683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24790728|NCT01944683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24790729|NCT01944683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24790730|NCT01944683|Anesthetics, General|anesthetics, general|mesh-ancestor
24790731|NCT01944683|Anesthetics|anesthetics|mesh-ancestor
24790732|NCT01944683|GABA Modulators|gaba modulators|mesh-ancestor
24790733|NCT01944683|GABA Agents|gaba agents|mesh-ancestor
24790734|NCT01944683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24790735|NCT01944683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790736|NCT01944735|Mannitol|mannitol|mesh-list
24790737|NCT01944735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24790738|NCT01944735|Diuretics|diuretics|mesh-ancestor
24790739|NCT01944735|Natriuretic Agents|natriuretic agents|mesh-ancestor
24790740|NCT01944735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790741|NCT01944800|Ticagrelor|ticagrelor|mesh-list
24790742|NCT01944800|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24790743|NCT01944800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24790744|NCT01944800|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24790745|NCT01944800|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24790746|NCT01944800|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24790747|NCT01944800|Purinergic Agents|purinergic agents|mesh-ancestor
24790748|NCT01944800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24790749|NCT01944800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790750|NCT01944800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790751|NCT01944852|Icodextrin|icodextrin|mesh-list
24790752|NCT01944852|Dialysis Solutions|dialysis solutions|mesh-ancestor
24790753|NCT01944852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24790754|NCT01945021|Crizotinib|crizotinib|mesh-list
24790755|NCT01945021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24790756|NCT01945021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24790757|NCT01945021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24790758|NCT01945021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802055|NCT01986998|Glucocorticoids|glucocorticoids|mesh-ancestor
24790759|NCT01945047|Midazolam|midazolam|mesh-list
24790760|NCT01945047|Ketamine|ketamine|mesh-list
24790761|NCT01945047|Analgesics|analgesics|mesh-ancestor
24790762|NCT01945047|Sensory System Agents|sensory system agents|mesh-ancestor
24790763|NCT01945047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24790764|NCT01945047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790765|NCT01945047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24790766|NCT01945047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24790767|NCT01945047|Anesthetics, General|anesthetics, general|mesh-ancestor
24790768|NCT01945047|Anesthetics|anesthetics|mesh-ancestor
24790769|NCT01945047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24790770|NCT01945047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24790771|NCT01945047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24790779|NCT01945047|GABA Modulators|gaba modulators|mesh-ancestor
24790831|NCT01945528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790832|NCT01945528|Sensory System Agents|sensory system agents|mesh-ancestor
24583558|NCT00875173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583559|NCT00875173|Protective Agents|protective agents|mesh-ancestor
24583560|NCT00875173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583569|NCT00875238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24583570|NCT00875238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24583571|NCT00875238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583572|NCT00875238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24621801|NCT01064115|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25685925|NCT01912274|Antimetabolites|antimetabolites|mesh-ancestor
25685926|NCT01912274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621802|NCT01064115|Histamine Antagonists|histamine antagonists|mesh-ancestor
24621803|NCT01064115|Histamine Agents|histamine agents|mesh-ancestor
25066247|NCT04033237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25066248|NCT04033237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066250|NCT04019873|Rilpivirine|rilpivirine|mesh-list
24621804|NCT01064115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24621805|NCT01064115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621806|NCT01064115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621807|NCT01064141|Vaccines|vaccines|mesh-list
24621808|NCT01064141|Immunologic Factors|immunologic factors|mesh-ancestor
24621809|NCT01064141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621810|NCT01064154|Carvedilol|carvedilol|mesh-list
24621811|NCT01064154|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24621812|NCT01064154|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24790950|NCT05410093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790951|NCT05410093|Protective Agents|protective agents|mesh-ancestor
24790952|NCT05410093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24791002|NCT05408247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791013|NCT05406895|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24628111|NCT01096654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24924140|NCT04162535|Lidocaine|lidocaine|mesh-list
24791053|NCT05375747|Anesthetics, General|anesthetics, general|mesh-ancestor
24791054|NCT05375747|Anesthetics|anesthetics|mesh-ancestor
24791120|NCT05273567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791157|NCT05155527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24791158|NCT05151146|Metformin|metformin|mesh-list
24791159|NCT05151146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24791160|NCT05151146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621849|NCT01064232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621850|NCT01064232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621851|NCT01064232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24621852|NCT01064232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24791299|NCT04773392|Mycophenolic Acid|mycophenolic acid|mesh-list
24628124|NCT01096706|Neurokinin A|neurokinin a|mesh-list
24628125|NCT01096706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24628126|NCT01096706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24628127|NCT01096706|Analgesics|analgesics|mesh-ancestor
24892517|NCT04462276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791954|NCT02138617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24791956|NCT02138617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791957|NCT02138617|Growth Inhibitors|growth inhibitors|mesh-ancestor
24791958|NCT02138617|Antimetabolites|antimetabolites|mesh-ancestor
24791959|NCT02138617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791960|NCT02138617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24613337|NCT01018381|Ethanol|ethanol|mesh-list
24791984|NCT02035137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550682|NCT00721747|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24791985|NCT02035137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791986|NCT02035137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24792118|NCT05412147|Micronutrients|micronutrients|mesh-ancestor
24792119|NCT05412147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792142|NCT05411900|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24792342|NCT05312892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24792605|NCT04917055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24792606|NCT04917055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924864|NCT04156152|Listerine|listerine|mesh-list
24792775|NCT04721353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24792776|NCT04721353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792777|NCT04721353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792779|NCT04714619|Anastrozole|anastrozole|mesh-list
24792780|NCT04714619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24792788|NCT04714619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792789|NCT04714619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24803819|NCT01998685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803821|NCT01998685|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24803822|NCT01998698|Lidocaine|lidocaine|mesh-list
24803823|NCT01998698|Dipivefrin|dipivefrin|mesh-list
24803824|NCT01998698|Hyaluronic Acid|hyaluronic acid|mesh-list
24803825|NCT01998698|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25685927|NCT01912274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25033875|NCT03570541|Anesthetics|anesthetics|mesh-ancestor
25685928|NCT01912274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25685929|NCT01912352|Methylphenidate|methylphenidate|mesh-list
25685930|NCT01912352|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24916836|NCT04236453|Tenofovir|tenofovir|mesh-list
24803826|NCT01998698|Adrenergic Agents|adrenergic agents|mesh-ancestor
24803827|NCT01998698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24585952|NCT00888342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24793167|NCT03977233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793168|NCT03977233|Antidotes|antidotes|mesh-ancestor
24793169|NCT03977233|Protective Agents|protective agents|mesh-ancestor
24793170|NCT03977233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793171|NCT03977233|Vitamin B Complex|vitamin b complex|mesh-ancestor
24793172|NCT03977233|Vitamins|vitamins|mesh-ancestor
24793173|NCT03977233|Micronutrients|micronutrients|mesh-ancestor
24793174|NCT03873389|Ocrelizumab|ocrelizumab|mesh-list
24793175|NCT03873389|Immunologic Factors|immunologic factors|mesh-ancestor
24793176|NCT03873389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793499|NCT03395704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24793501|NCT03328884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24793502|NCT03328884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24793509|NCT03299309|Immunologic Factors|immunologic factors|mesh-ancestor
25082675|NCT03321110|Coenzyme Q10|coenzyme q10|mesh-list
25082676|NCT03321110|Micronutrients|micronutrients|mesh-ancestor
24967528|NCT03759067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24967529|NCT03759067|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24967530|NCT03759067|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24967531|NCT03759067|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24967532|NCT03759067|Purinergic Agents|purinergic agents|mesh-ancestor
24967533|NCT03759067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24967534|NCT03759067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967535|NCT03759067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967536|NCT03758950|Mometasone Furoate|mometasone furoate|mesh-list
24967537|NCT03758950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24967538|NCT03758950|Dermatologic Agents|dermatologic agents|mesh-ancestor
24967539|NCT03758950|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24967540|NCT03758859|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24967541|NCT03758859|Hyaluronic Acid|hyaluronic acid|mesh-list
24967582|NCT03758469|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24967583|NCT03758469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24967584|NCT03758469|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24967586|NCT03758469|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24967587|NCT03758469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24967589|NCT03758339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967590|NCT03758339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24967591|NCT03758339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24967592|NCT03758339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967593|NCT03758235|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24967594|NCT03758235|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24967595|NCT03758235|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24967596|NCT03758235|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24967597|NCT03758235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24967598|NCT03758235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967599|NCT03758235|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24967600|NCT03758235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24967601|NCT03758235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967602|NCT03758235|Cholinergic Agents|cholinergic agents|mesh-ancestor
24967603|NCT03758235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24967604|NCT03758144|Rifaximin|rifaximin|mesh-list
24967605|NCT03758144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24967606|NCT03758144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24967644|NCT03757858|Immunologic Factors|immunologic factors|mesh-ancestor
24967681|NCT03757403|Mitosis Modulators|mitosis modulators|mesh-ancestor
24967682|NCT03757403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967683|NCT03757403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967684|NCT03757403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24967685|NCT03757390|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
24967686|NCT03757390|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24967687|NCT03757390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24967702|NCT03757364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967703|NCT03757364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967704|NCT03757364|Dermatologic Agents|dermatologic agents|mesh-ancestor
24967705|NCT03757364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24967706|NCT03757364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24967707|NCT03757364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24967708|NCT03757364|Immunologic Factors|immunologic factors|mesh-ancestor
25685931|NCT01912352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916922|NCT04235478|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24916923|NCT04235478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24916927|NCT04235478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916928|NCT04235478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24916929|NCT04235478|Immunologic Factors|immunologic factors|mesh-ancestor
24916930|NCT04235426|Vitamin B 12|vitamin b 12|mesh-list
25066298|NCT03756311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066299|NCT03740126|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25066300|NCT03740126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25066301|NCT03740126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441110|NCT00286130|Oxaliplatin|oxaliplatin|mesh-list
24441111|NCT00286130|Irinotecan|irinotecan|mesh-list
24441112|NCT00286130|Cetuximab|cetuximab|mesh-list
24967709|NCT03757364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24967710|NCT03757364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24967711|NCT03757338|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24967712|NCT03757338|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24967713|NCT03757338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967714|NCT03757338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24967715|NCT03757338|Immunologic Factors|immunologic factors|mesh-ancestor
24967716|NCT03757338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793724|NCT02625610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967724|NCT03757221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967725|NCT03757156|Aspirin|aspirin|mesh-list
24967726|NCT03757156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24967727|NCT03757156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24967728|NCT03757156|Analgesics|analgesics|mesh-ancestor
24967729|NCT03757156|Sensory System Agents|sensory system agents|mesh-ancestor
24967730|NCT03757156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24967731|NCT03757156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967732|NCT03757156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24967733|NCT03757156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24967734|NCT03757156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24967735|NCT03757156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24967736|NCT03757156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967737|NCT03757156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24967738|NCT03757156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24804629|NCT02004067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24925855|NCT04147390|Mycophenolic Acid|mycophenolic acid|mesh-list
25082754|NCT03320447|Anesthetics, Local|anesthetics, local|mesh-ancestor
25082755|NCT03320447|Anesthetics|anesthetics|mesh-ancestor
25082756|NCT03320447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24967885|NCT03756064|Mitosis Modulators|mitosis modulators|mesh-ancestor
24967886|NCT03756064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793751|NCT02542696|Apomorphine|apomorphine|mesh-list
24793753|NCT02542696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967989|NCT03755466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24967990|NCT03755466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967997|NCT03755427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967998|NCT03755427|Antacids|antacids|mesh-ancestor
24967999|NCT03755427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926189|NCT04143906|Antimetabolites|antimetabolites|mesh-ancestor
24968166|NCT03753581|Antimetabolites|antimetabolites|mesh-ancestor
24542625|NCT00679614|Analgesics|analgesics|mesh-ancestor
24968167|NCT03753581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968168|NCT03753581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24968169|NCT03753581|Antiviral Agents|antiviral agents|mesh-ancestor
24968170|NCT03753581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24968171|NCT03753581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25685932|NCT01912352|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25685933|NCT01912352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25685934|NCT01912352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25685935|NCT01912352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685936|NCT01912352|Dopamine Agents|dopamine agents|mesh-ancestor
25685937|NCT01912352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25685938|NCT01912456|Complement C1s|complement c1s|mesh-list
25685939|NCT01912456|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25685940|NCT01912456|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
25685941|NCT01912456|Immunologic Factors|immunologic factors|mesh-ancestor
25685942|NCT01912456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685943|NCT01912456|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24441694|NCT00288041|Tubulin Modulators|tubulin modulators|mesh-ancestor
24441695|NCT00288041|Antimitotic Agents|antimitotic agents|mesh-ancestor
24441696|NCT00288041|Mitosis Modulators|mitosis modulators|mesh-ancestor
24441698|NCT00288158|Allopurinol|allopurinol|mesh-list
24968172|NCT03753581|Immunologic Factors|immunologic factors|mesh-ancestor
24968173|NCT03753581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968174|NCT03753581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24968175|NCT03753581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24968176|NCT03753581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24968177|NCT03753581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24968178|NCT03753581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24968179|NCT03753581|Abortifacient Agents|abortifacient agents|mesh-ancestor
24968180|NCT03753581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24968181|NCT03753581|Dermatologic Agents|dermatologic agents|mesh-ancestor
24968182|NCT03753581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24968183|NCT03753581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24968184|NCT03753581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24968295|NCT03752229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25082785|NCT03320109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25082786|NCT03320109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25082788|NCT03320031|Linagliptin|linagliptin|mesh-list
25082789|NCT03320031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25082790|NCT03320031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082791|NCT03320031|Incretins|incretins|mesh-ancestor
25082792|NCT03320031|Hormones|hormones|mesh-ancestor
24926499|NCT04141319|Analgesics|analgesics|mesh-ancestor
25082825|NCT03319784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25082826|NCT03319784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25082827|NCT03319706|Olmesartan|olmesartan|mesh-list
24926657|NCT04139772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24926658|NCT04139772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926659|NCT04139772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24793831|NCT01530373|Solifenacin Succinate|solifenacin succinate|mesh-list
24793832|NCT01530373|Analgesics|analgesics|mesh-ancestor
24793833|NCT01530373|Sensory System Agents|sensory system agents|mesh-ancestor
24793834|NCT01530373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24968596|NCT03750071|Avelumab|avelumab|mesh-list
24968597|NCT03750071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24968598|NCT03750071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24968599|NCT03749915|Tetracaine|tetracaine|mesh-list
24968600|NCT03749915|Anesthetics, Local|anesthetics, local|mesh-ancestor
24968601|NCT03749915|Anesthetics|anesthetics|mesh-ancestor
24968602|NCT03749915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24968603|NCT03749915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968654|NCT03749642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968655|NCT03749642|Antimanic Agents|antimanic agents|mesh-ancestor
24968656|NCT03749642|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24804975|NCT02006355|Ropivacaine|ropivacaine|mesh-list
24968657|NCT03749642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24968658|NCT03749642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24968659|NCT03749642|Serotonin Agents|serotonin agents|mesh-ancestor
24968660|NCT03749642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24968661|NCT03749642|Antidepressive Agents|antidepressive agents|mesh-ancestor
24968662|NCT03749590|Magnesium Sulfate|magnesium sulfate|mesh-list
24968663|NCT03749590|Analgesics|analgesics|mesh-ancestor
24968664|NCT03749590|Sensory System Agents|sensory system agents|mesh-ancestor
24968665|NCT03749590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24968666|NCT03749590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968667|NCT03749590|Anesthetics|anesthetics|mesh-ancestor
24968668|NCT03749590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24968669|NCT03749590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24968670|NCT03749590|Anticonvulsants|anticonvulsants|mesh-ancestor
24968676|NCT03749590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24968677|NCT03749408|Mannitol|mannitol|mesh-list
24968678|NCT03749408|Bupivacaine|bupivacaine|mesh-list
24968679|NCT03749408|Anesthetics, Local|anesthetics, local|mesh-ancestor
24968680|NCT03749408|Anesthetics|anesthetics|mesh-ancestor
24968681|NCT03749408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24968682|NCT03749408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968683|NCT03749408|Sensory System Agents|sensory system agents|mesh-ancestor
24968709|NCT03748940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25685944|NCT01912456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25685945|NCT01912612|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25685946|NCT01912612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25066437|NCT03205605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24968710|NCT03748940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24968711|NCT03748940|Analgesics|analgesics|mesh-ancestor
24968712|NCT03748940|Sensory System Agents|sensory system agents|mesh-ancestor
24793897|NCT00572169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24793898|NCT00572169|Glucocorticoids|glucocorticoids|mesh-ancestor
24793899|NCT00572169|Hormones|hormones|mesh-ancestor
24793900|NCT00572169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24927016|NCT04136535|Carboplatin|carboplatin|mesh-list
24968736|NCT03748290|Anticonvulsants|anticonvulsants|mesh-ancestor
24968737|NCT03748290|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24968738|NCT03748290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24968739|NCT03748290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927070|NCT04135898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24968857|NCT03747536|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24968858|NCT03747536|Autonomic Agents|autonomic agents|mesh-ancestor
24968859|NCT03747536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24968980|NCT03746340|Anesthetics, General|anesthetics, general|mesh-ancestor
24968981|NCT03746340|Anesthetics|anesthetics|mesh-ancestor
24968982|NCT03746340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24968983|NCT03746340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24968984|NCT03746327|Tedizolid phosphate|tedizolid phosphate|mesh-list
25082897|NCT03319121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082898|NCT03319121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581642|NCT00865644|Imiquimod|imiquimod|mesh-list
25082903|NCT03319121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082904|NCT03319121|Vasodilator Agents|vasodilator agents|mesh-ancestor
24927339|NCT04134026|Epoetin Alfa|epoetin alfa|mesh-list
24927597|NCT04131582|Empagliflozin|empagliflozin|mesh-list
24969290|NCT03744091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24969291|NCT03744091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24969292|NCT03744091|Analgesics|analgesics|mesh-ancestor
24969293|NCT03744091|Sensory System Agents|sensory system agents|mesh-ancestor
24969294|NCT03744091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969295|NCT03744091|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24969296|NCT03744091|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24969297|NCT03744091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24628300|NCT01097980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24628301|NCT01097980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24628302|NCT01097980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806272|NCT02014714|Analgesics|analgesics|mesh-ancestor
24806273|NCT02014714|Sensory System Agents|sensory system agents|mesh-ancestor
24806274|NCT02014714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24806275|NCT02014714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24806276|NCT02014714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24806277|NCT02014714|Anesthetics, General|anesthetics, general|mesh-ancestor
24806278|NCT02014714|Anesthetics|anesthetics|mesh-ancestor
24806279|NCT02014727|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24806280|NCT02014727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24806281|NCT02014727|Immunologic Factors|immunologic factors|mesh-ancestor
24806282|NCT02014727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806283|NCT02014727|Antacids|antacids|mesh-ancestor
24927633|NCT04131309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24628329|NCT01098201|Certolizumab Pegol|certolizumab pegol|mesh-list
24628330|NCT01098201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24628331|NCT01098201|Immunologic Factors|immunologic factors|mesh-ancestor
24806372|NCT02015494|Hemagglutinins|hemagglutinins|mesh-list
24806500|NCT02016274|Paclitaxel|paclitaxel|mesh-list
25082980|NCT03318757|Anesthetics|anesthetics|mesh-ancestor
24969614|NCT03741933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969615|NCT03741933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969616|NCT03741933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24969617|NCT03741933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24969618|NCT03741933|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24969619|NCT03741933|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24794027|NCT05414292|Antifungal Agents|antifungal agents|mesh-ancestor
24970835|NCT03730714|Autonomic Agents|autonomic agents|mesh-ancestor
24794028|NCT05414292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24794029|NCT05414292|Immunologic Factors|immunologic factors|mesh-ancestor
24794030|NCT05414292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970009|NCT03737721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970010|NCT03737708|Adalimumab|adalimumab|mesh-list
25685947|NCT01912612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24970011|NCT03737708|Methotrexate|methotrexate|mesh-list
24970012|NCT03737708|Abatacept|abatacept|mesh-list
24970013|NCT03737708|Tacrolimus|tacrolimus|mesh-list
24928448|NCT04121767|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24917034|NCT04234932|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24917035|NCT04234321|Mitogens|mitogens|mesh-list
24917036|NCT04234321|Mitosis Modulators|mitosis modulators|mesh-ancestor
24951381|NCT03905564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24951383|NCT03904849|Anticonvulsants|anticonvulsants|mesh-ancestor
24951384|NCT03905018|Tadalafil|tadalafil|mesh-list
24951385|NCT03905018|Vasodilator Agents|vasodilator agents|mesh-ancestor
24951386|NCT03905018|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24951387|NCT03905018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24951388|NCT03905018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951391|NCT03904836|Tobramycin|tobramycin|mesh-list
24970363|NCT03733691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24970364|NCT03733691|Growth Substances|growth substances|mesh-ancestor
24970365|NCT03733691|Growth Inhibitors|growth inhibitors|mesh-ancestor
24970366|NCT03733691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970367|NCT03733691|Protease Inhibitors|protease inhibitors|mesh-ancestor
24970368|NCT03733691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24970445|NCT03733275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24970446|NCT03733275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970447|NCT03733171|Epinephrine|epinephrine|mesh-list
24970448|NCT03733171|Hemostatics|hemostatics|mesh-list
24970449|NCT03733171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24970450|NCT03733171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24928939|NCT04117243|Misoprostol|misoprostol|mesh-list
24970730|NCT03731169|Hormone Antagonists|hormone antagonists|mesh-ancestor
24970731|NCT03731169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24970732|NCT03731169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083191|NCT03317574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25083192|NCT03317574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970757|NCT03731091|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24970758|NCT03731091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24970759|NCT03731091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970760|NCT03731091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24970762|NCT03731091|Micronutrients|micronutrients|mesh-ancestor
24970763|NCT03731091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24970764|NCT03730857|Olanzapine|olanzapine|mesh-list
24970765|NCT03730857|Risperidone|risperidone|mesh-list
24970766|NCT03730857|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24970767|NCT03730857|Antipsychotic Agents|antipsychotic agents|mesh-list
24970768|NCT03730857|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24970769|NCT03730857|Serotonin Agents|serotonin agents|mesh-ancestor
24970770|NCT03730857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24970771|NCT03730857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970772|NCT03730857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970773|NCT03730857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24970774|NCT03730857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24970775|NCT03730857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24970776|NCT03730857|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24970777|NCT03730857|Dopamine Agents|dopamine agents|mesh-ancestor
24970778|NCT03730857|Antiemetics|antiemetics|mesh-ancestor
24970779|NCT03730857|Autonomic Agents|autonomic agents|mesh-ancestor
24970780|NCT03730857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970781|NCT03730857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24970782|NCT03730857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24970783|NCT03730857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24970784|NCT03730857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24970785|NCT03730857|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24970813|NCT03730740|Growth Inhibitors|growth inhibitors|mesh-ancestor
24970814|NCT03730740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970815|NCT03730714|Epinephrine|epinephrine|mesh-list
24970816|NCT03730714|Racepinephrine|racepinephrine|mesh-list
24970818|NCT03730714|Anesthetics|anesthetics|mesh-list
24970819|NCT03730714|Anesthetics, Local|anesthetics, local|mesh-list
24970820|NCT03730714|Epinephryl borate|epinephryl borate|mesh-list
24970821|NCT03730714|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24970822|NCT03730714|Narcotics|narcotics|mesh-ancestor
25685948|NCT01912612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25685949|NCT01912612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685950|NCT01912612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25685951|NCT01912612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685952|NCT01912612|Analgesics|analgesics|mesh-ancestor
25685953|NCT01912612|Sensory System Agents|sensory system agents|mesh-ancestor
25685954|NCT01912612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25685955|NCT01912612|Antidepressive Agents|antidepressive agents|mesh-ancestor
25685956|NCT01912612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24819855|NCT02097407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444304|NCT00297375|Narcotics|narcotics|mesh-ancestor
24970823|NCT03730714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24970824|NCT03730714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970825|NCT03730714|Analgesics|analgesics|mesh-ancestor
24970826|NCT03730714|Sensory System Agents|sensory system agents|mesh-ancestor
24970827|NCT03730714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970828|NCT03730714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24970829|NCT03730714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24970830|NCT03730714|Adrenergic Agents|adrenergic agents|mesh-ancestor
24970831|NCT03730714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24970832|NCT03730714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970833|NCT03730714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24970834|NCT03730714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24970836|NCT03730714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24970837|NCT03730714|Respiratory System Agents|respiratory system agents|mesh-ancestor
24970838|NCT03730714|Mydriatics|mydriatics|mesh-ancestor
24970839|NCT03730714|Sympathomimetics|sympathomimetics|mesh-ancestor
24970840|NCT03730714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24970841|NCT03730675|Sorafenib|sorafenib|mesh-list
24970842|NCT03730675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970843|NCT03730675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24970844|NCT03730675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24970845|NCT03730675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970846|NCT03730584|Ropivacaine|ropivacaine|mesh-list
24970847|NCT03730584|Anesthetics, Local|anesthetics, local|mesh-ancestor
24970848|NCT03730584|Anesthetics|anesthetics|mesh-ancestor
24929406|NCT04113226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24970866|NCT03730402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970870|NCT03730363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24970871|NCT03730363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24970872|NCT03730363|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24970873|NCT03730311|Elsulfavirine|elsulfavirine|mesh-list
24970874|NCT03730311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24970875|NCT03730311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24970876|NCT03730311|Antiviral Agents|antiviral agents|mesh-ancestor
24412666|NCT00191750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412686|NCT00191828|Antiemetics|antiemetics|mesh-ancestor
24970877|NCT03730311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24970879|NCT03730272|Sensory System Agents|sensory system agents|mesh-ancestor
24970880|NCT03730272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970881|NCT03730272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908736|NCT04317157|Caffeine|caffeine|mesh-list
24970882|NCT03730181|Isoniazid|isoniazid|mesh-list
24970883|NCT03730181|Rifapentine|rifapentine|mesh-list
24970884|NCT03730181|Antitubercular Agents|antitubercular agents|mesh-ancestor
24970885|NCT03730181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24970886|NCT03730181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24970887|NCT03730181|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24970895|NCT03730064|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24970896|NCT03730064|Antiviral Agents|antiviral agents|mesh-ancestor
24970897|NCT03730064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24970898|NCT03730064|Expectorants|expectorants|mesh-ancestor
24970899|NCT03730064|Respiratory System Agents|respiratory system agents|mesh-ancestor
24970900|NCT03730064|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24970901|NCT03730064|Antioxidants|antioxidants|mesh-ancestor
24970902|NCT03730064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970903|NCT03730064|Protective Agents|protective agents|mesh-ancestor
24970904|NCT03730064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929527|NCT04111159|Propofol|propofol|mesh-list
25685957|NCT01912612|Dopamine Agents|dopamine agents|mesh-ancestor
25685958|NCT01912716|Indomethacin|indomethacin|mesh-list
25685959|NCT01912716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25685960|NCT01912716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25685961|NCT01912716|Analgesics|analgesics|mesh-ancestor
25685962|NCT01912716|Sensory System Agents|sensory system agents|mesh-ancestor
25685963|NCT01912716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24819878|NCT02097459|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24819891|NCT02097511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24819892|NCT02097511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819893|NCT02097511|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24819894|NCT02097511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24819895|NCT02097511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24819896|NCT02097511|Adrenergic Agents|adrenergic agents|mesh-ancestor
24819897|NCT02097511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24819898|NCT02097511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819899|NCT02097511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24819904|NCT02097589|Atorvastatin|atorvastatin|mesh-list
24587486|NCT00895115|Vitamin E|vitamin e|mesh-list
24587552|NCT00895609|Cholinergic Agents|cholinergic agents|mesh-ancestor
24587553|NCT00895609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24587554|NCT00895609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587555|NCT00895609|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24587557|NCT00895609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24587558|NCT00895648|Pemetrexed|pemetrexed|mesh-list
24587559|NCT00895648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587560|NCT00895648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587561|NCT00895648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587562|NCT00895648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24412687|NCT00191828|Autonomic Agents|autonomic agents|mesh-ancestor
24587563|NCT00895648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24587564|NCT00895674|Sorafenib|sorafenib|mesh-list
24587565|NCT00895674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587566|NCT00895674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24587567|NCT00895674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587568|NCT00895674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971966|NCT03721432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24971167|NCT03727763|Cetuximab|cetuximab|mesh-list
24971168|NCT03727763|Vemurafenib|vemurafenib|mesh-list
25083242|NCT03317197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971169|NCT03727763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24971170|NCT03727763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929995|NCT04106557|Anticonvulsants|anticonvulsants|mesh-ancestor
24971378|NCT03726242|Cromakalim|cromakalim|mesh-list
24971379|NCT03726242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24971380|NCT03726242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24971381|NCT03726242|Autonomic Agents|autonomic agents|mesh-ancestor
24971382|NCT03726242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24971383|NCT03726242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971384|NCT03726242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24971385|NCT03726242|Respiratory System Agents|respiratory system agents|mesh-ancestor
24971386|NCT03726242|Parasympatholytics|parasympatholytics|mesh-ancestor
24971387|NCT03726242|Vasodilator Agents|vasodilator agents|mesh-ancestor
24971388|NCT03726216|Dalbavancin|dalbavancin|mesh-list
24971389|NCT03726216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24971390|NCT03726216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24971391|NCT03726177|Aspirin|aspirin|mesh-list
25685964|NCT01912716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685965|NCT01912716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25685966|NCT01912716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25685967|NCT01912716|Gout Suppressants|gout suppressants|mesh-ancestor
25685968|NCT01912716|Tocolytic Agents|tocolytic agents|mesh-ancestor
25685969|NCT01912716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25685970|NCT01912716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25685971|NCT01912716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25685972|NCT01912716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685973|NCT01912768|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25685974|NCT01912781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25685975|NCT01912807|Ondansetron|ondansetron|mesh-list
25685976|NCT01912807|Antiemetics|antiemetics|mesh-ancestor
25685977|NCT01912807|Autonomic Agents|autonomic agents|mesh-ancestor
25685978|NCT01912807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25685979|NCT01912807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447904|NCT00309855|Hormone Antagonists|hormone antagonists|mesh-ancestor
24917138|NCT04233502|Melatonin|melatonin|mesh-list
24917139|NCT04233502|Antioxidants|antioxidants|mesh-ancestor
24917140|NCT04233502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917141|NCT04233502|Protective Agents|protective agents|mesh-ancestor
24917142|NCT04233502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971392|NCT03726177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24971393|NCT03726177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24971394|NCT03726177|Analgesics|analgesics|mesh-ancestor
24971395|NCT03726177|Sensory System Agents|sensory system agents|mesh-ancestor
24971396|NCT03726177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24971397|NCT03726177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971398|NCT03726177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24971399|NCT03726177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24971400|NCT03726177|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24971401|NCT03726177|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24930055|NCT04106050|Lidocaine|lidocaine|mesh-list
24971486|NCT03725891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971487|NCT03725891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24971488|NCT03725891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24971489|NCT03725891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24971490|NCT03725891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24971491|NCT03725891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971492|NCT03725891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24971493|NCT03725891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24971494|NCT03725891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24971495|NCT03725891|Antipyretics|antipyretics|mesh-ancestor
24971497|NCT03725878|Hematinics|hematinics|mesh-ancestor
24971498|NCT03725878|Vitamin B Complex|vitamin b complex|mesh-ancestor
24971499|NCT03725878|Vitamins|vitamins|mesh-ancestor
24971500|NCT03725878|Micronutrients|micronutrients|mesh-ancestor
24971501|NCT03725878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971502|NCT03725709|Anesthetics|anesthetics|mesh-list
24971967|NCT03721380|Methadone|methadone|mesh-list
24971504|NCT03725709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971505|NCT03725553|Vasopressins|vasopressins|mesh-list
24971506|NCT03725553|Arginine Vasopressin|arginine vasopressin|mesh-list
24971507|NCT03725553|Hemostatics|hemostatics|mesh-ancestor
24971508|NCT03725553|Coagulants|coagulants|mesh-ancestor
24971509|NCT03725553|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24971510|NCT03725553|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24971511|NCT03725553|Natriuretic Agents|natriuretic agents|mesh-ancestor
24971512|NCT03725553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971548|NCT03725228|Tocolytic Agents|tocolytic agents|mesh-ancestor
24971583|NCT03724578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971584|NCT03724578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24971585|NCT03724578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24971586|NCT03724578|Antioxidants|antioxidants|mesh-ancestor
25083276|NCT03317067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24808391|NCT02026921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808392|NCT02026921|Tubulin Modulators|tubulin modulators|mesh-ancestor
24808393|NCT02026921|Antimitotic Agents|antimitotic agents|mesh-ancestor
24971649|NCT03723395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971650|NCT03723395|Antifungal Agents|antifungal agents|mesh-ancestor
24971651|NCT03723395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24971652|NCT03723395|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24971653|NCT03723395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24971654|NCT03723395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24971655|NCT03723395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24971656|NCT03723395|Hormone Antagonists|hormone antagonists|mesh-ancestor
25685980|NCT01912807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25685981|NCT01912807|Antipruritics|antipruritics|mesh-ancestor
25685982|NCT01912807|Dermatologic Agents|dermatologic agents|mesh-ancestor
25685983|NCT01912807|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25685984|NCT01912807|Serotonin Agents|serotonin agents|mesh-ancestor
25685985|NCT01912807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25685986|NCT01912807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25685987|NCT01912807|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25685988|NCT01912807|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25685989|NCT01912807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25685990|NCT01912807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24971657|NCT03723395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24971658|NCT03723395|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24971659|NCT03723395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24971660|NCT03723395|Antitubercular Agents|antitubercular agents|mesh-ancestor
24971661|NCT03723395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24971662|NCT03723395|Leprostatic Agents|leprostatic agents|mesh-ancestor
24971663|NCT03723395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25034329|NCT03565458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24971698|NCT03723252|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24971699|NCT03723252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971700|NCT03723252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24971701|NCT03723252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971703|NCT03723187|Anticoagulants|anticoagulants|mesh-ancestor
24971735|NCT03723083|Growth Inhibitors|growth inhibitors|mesh-ancestor
24971736|NCT03723083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24971738|NCT03723031|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24971739|NCT03723031|Abortifacient Agents|abortifacient agents|mesh-ancestor
24971740|NCT03723031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24971741|NCT03723031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971742|NCT03723031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24971743|NCT03723031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24971823|NCT03722329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971825|NCT03722303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24971826|NCT03722290|Metformin|metformin|mesh-list
24930534|NCT04100772|Vaccines|vaccines|mesh-list
24971877|NCT03721744|Mitosis Modulators|mitosis modulators|mesh-ancestor
24971878|NCT03721744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971879|NCT03721744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24971880|NCT03721744|Antimetabolites|antimetabolites|mesh-ancestor
24971881|NCT03721744|Antiviral Agents|antiviral agents|mesh-ancestor
24971882|NCT03721744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24971883|NCT03721744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24971884|NCT03721744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24971885|NCT03721744|Immunologic Factors|immunologic factors|mesh-ancestor
24971886|NCT03721744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971888|NCT03721679|Nivolumab|nivolumab|mesh-list
24971889|NCT03721679|Durvalumab|durvalumab|mesh-list
24971957|NCT03721432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971958|NCT03721432|Anticonvulsants|anticonvulsants|mesh-ancestor
24971959|NCT03721432|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24971960|NCT03721432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24971961|NCT03721432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971962|NCT03721432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24971963|NCT03721432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24971964|NCT03721432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24971965|NCT03721432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24972008|NCT03720873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972010|NCT03720756|Trace Elements|trace elements|mesh-ancestor
24972011|NCT03720756|Micronutrients|micronutrients|mesh-ancestor
24972012|NCT03720756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972023|NCT03720665|Caffeine|caffeine|mesh-list
24972024|NCT03720665|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24972025|NCT03720665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972026|NCT03720665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24972027|NCT03720665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972028|NCT03720665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972029|NCT03720665|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24972066|NCT03720288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972067|NCT03720288|Diuretics|diuretics|mesh-ancestor
24972102|NCT03720067|Adrenergic Agents|adrenergic agents|mesh-ancestor
24972321|NCT03719053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24972322|NCT03719053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972323|NCT03719053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972376|NCT03718507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24972377|NCT03718507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24972378|NCT03718507|Cholinergic Agents|cholinergic agents|mesh-ancestor
24972379|NCT03718507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24972380|NCT03718507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794420|NCT05233709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25685991|NCT01912807|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25685992|NCT01912872|Omalizumab|omalizumab|mesh-list
25066530|NCT02951377|Hormones|hormones|mesh-ancestor
25066531|NCT02951377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25066532|NCT02951377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25066533|NCT02951377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066534|NCT02951377|Anesthetics, Local|anesthetics, local|mesh-ancestor
24972438|NCT03717909|Antimanic Agents|antimanic agents|mesh-ancestor
24972439|NCT03717909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24972440|NCT03717909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24972441|NCT03717909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24972443|NCT03717740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24972444|NCT03717740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24972445|NCT03717740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24972446|NCT03717740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972447|NCT03717740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972449|NCT03717701|Esomeprazole|esomeprazole|mesh-list
24972450|NCT03717701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24972451|NCT03717701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972452|NCT03717701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24972453|NCT03717701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24972454|NCT03717701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24972455|NCT03717701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972456|NCT03717701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972457|NCT03717688|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24972458|NCT03717688|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24972459|NCT03717688|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24972460|NCT03717688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24972461|NCT03717688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972541|NCT03716804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24972542|NCT03716804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972543|NCT03716804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972783|NCT03715322|Tobramycin|tobramycin|mesh-list
24972784|NCT03715322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24910803|NCT04294056|Anesthetics|anesthetics|mesh-ancestor
24972818|NCT03715023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24972819|NCT03715023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972820|NCT03715023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973044|NCT03712735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24973045|NCT03712735|Narcotics|narcotics|mesh-ancestor
24973079|NCT03712540|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24973080|NCT03712540|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24973108|NCT03712397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973109|NCT03712397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973110|NCT03712397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973111|NCT03712241|Indomethacin|indomethacin|mesh-list
24973112|NCT03712241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24973113|NCT03712241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24973206|NCT03711240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24973207|NCT03711240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973208|NCT03711240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083325|NCT03316599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973210|NCT03711240|Protective Agents|protective agents|mesh-ancestor
24973211|NCT03711240|Vitamin B Complex|vitamin b complex|mesh-ancestor
24973213|NCT03711240|Micronutrients|micronutrients|mesh-ancestor
24973215|NCT03710863|Vorolanib|vorolanib|mesh-list
24973219|NCT03710811|Insulin|insulin|mesh-list
24973220|NCT03710811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24973221|NCT03710811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973222|NCT03710655|Histamine|histamine|mesh-list
24973223|NCT03710655|Histamine Agonists|histamine agonists|mesh-ancestor
24973224|NCT03710655|Histamine Agents|histamine agents|mesh-ancestor
24973225|NCT03710655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24973226|NCT03710655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973227|NCT03710655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973262|NCT03710395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24931855|NCT04085250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24973376|NCT03709940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24973377|NCT03709940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25685993|NCT01912872|Budesonide|budesonide|mesh-list
25685994|NCT01912872|Formoterol Fumarate|formoterol fumarate|mesh-list
25685995|NCT01912872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25685996|NCT01912872|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25685997|NCT01912872|Autonomic Agents|autonomic agents|mesh-ancestor
25685998|NCT01912872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24917271|NCT04231617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24973378|NCT03709940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973379|NCT03709940|Dopamine Agents|dopamine agents|mesh-ancestor
24973380|NCT03709940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24973381|NCT03709927|Moxifloxacin|moxifloxacin|mesh-list
24973382|NCT03709927|Fosfomycin|fosfomycin|mesh-list
24413743|NCT00195078|Gefitinib|gefitinib|mesh-list
24794583|NCT04910386|Gemcitabine|gemcitabine|mesh-list
24794584|NCT04910386|Cisplatin|cisplatin|mesh-list
24794585|NCT04910386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24794586|NCT04910386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24794587|NCT04910386|Antimetabolites|antimetabolites|mesh-ancestor
24973611|NCT03708458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973612|NCT03708341|Melatonin|melatonin|mesh-list
24973613|NCT03708341|Antioxidants|antioxidants|mesh-ancestor
24973624|NCT03708133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24973625|NCT03708133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24973626|NCT03708120|Insect Repellents|insect repellents|mesh-list
24973627|NCT03708120|Protective Agents|protective agents|mesh-ancestor
24973628|NCT03708120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973641|NCT03707899|Amlodipine|amlodipine|mesh-list
24973642|NCT03707899|Telmisartan|telmisartan|mesh-list
24973643|NCT03707899|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
24973644|NCT03707899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24973645|NCT03707899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24973648|NCT03707899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973649|NCT03707899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24973650|NCT03707899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973651|NCT03707899|Vasodilator Agents|vasodilator agents|mesh-ancestor
24973652|NCT03707899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24973737|NCT03707509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24973738|NCT03707509|Immunologic Factors|immunologic factors|mesh-ancestor
24973739|NCT03707509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973740|NCT03707483|Ascorbic Acid|ascorbic acid|mesh-list
24973741|NCT03707483|Vitamins|vitamins|mesh-ancestor
24973742|NCT03707483|Micronutrients|micronutrients|mesh-ancestor
24973743|NCT03707483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973810|NCT03706703|Endostar protein|endostar protein|mesh-list
24973811|NCT03706703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973812|NCT03706703|Tubulin Modulators|tubulin modulators|mesh-ancestor
24973813|NCT03706703|Antimitotic Agents|antimitotic agents|mesh-ancestor
24973814|NCT03706703|Mitosis Modulators|mitosis modulators|mesh-ancestor
24973815|NCT03706703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973851|NCT03706300|Respiratory System Agents|respiratory system agents|mesh-ancestor
24973852|NCT03706300|Nasal Decongestants|nasal decongestants|mesh-ancestor
24973853|NCT03706300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24973854|NCT03706300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24973855|NCT03706300|Sympathomimetics|sympathomimetics|mesh-ancestor
24973856|NCT03706300|Adrenergic Agents|adrenergic agents|mesh-ancestor
24973857|NCT03706300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24973858|NCT03706300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973860|NCT03706300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24973861|NCT03706300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24973862|NCT03706300|Appetite Depressants|appetite depressants|mesh-ancestor
24973863|NCT03706300|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24973864|NCT03706287|Cisplatin|cisplatin|mesh-list
24973865|NCT03706287|Carboplatin|carboplatin|mesh-list
24973866|NCT03706287|Pemetrexed|pemetrexed|mesh-list
24587921|NCT00898794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24587922|NCT00898794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24587923|NCT00898794|Growth Substances|growth substances|mesh-ancestor
24587924|NCT00898794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587925|NCT00898794|Growth Inhibitors|growth inhibitors|mesh-ancestor
24587926|NCT00898846|Tegafur|tegafur|mesh-list
24587927|NCT00898846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24973902|NCT03705858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24973933|NCT03705559|Narcotics|narcotics|mesh-ancestor
24973934|NCT03705559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24973935|NCT03705559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973936|NCT03705559|Analgesics|analgesics|mesh-ancestor
24973937|NCT03705559|Sensory System Agents|sensory system agents|mesh-ancestor
24973938|NCT03705559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24973939|NCT03705533|Telmisartan|telmisartan|mesh-list
24822295|NCT02110810|Analgesics|analgesics|mesh-ancestor
24822296|NCT02110810|Sensory System Agents|sensory system agents|mesh-ancestor
25685999|NCT01912872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973940|NCT03705533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24917328|NCT04231123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917329|NCT04231123|Sensory System Agents|sensory system agents|mesh-ancestor
24917330|NCT04231123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24917332|NCT04231279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24917333|NCT04231279|Hormones|hormones|mesh-ancestor
24917334|NCT04231279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24917375|NCT04230460|Ethanol|ethanol|mesh-list
25066660|NCT02194595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25066661|NCT02168140|Thioctic Acid|thioctic acid|mesh-list
25066662|NCT02168140|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25066663|NCT02168140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24973941|NCT03705533|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24973942|NCT03705533|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24790413|NCT01942369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24973943|NCT03705533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973945|NCT05177666|Pertuzumab|pertuzumab|mesh-list
24973946|NCT05177666|Vemurafenib|vemurafenib|mesh-list
24973947|NCT05177666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24974036|NCT05176119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24974037|NCT05176119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974038|NCT05176119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24974039|NCT05176119|Narcotics|narcotics|mesh-ancestor
24974040|NCT05175703|Paclitaxel|paclitaxel|mesh-list
24974041|NCT05175703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24974042|NCT05175703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24974043|NCT05175703|Tubulin Modulators|tubulin modulators|mesh-ancestor
24974044|NCT05175703|Antimitotic Agents|antimitotic agents|mesh-ancestor
24974045|NCT05175703|Mitosis Modulators|mitosis modulators|mesh-ancestor
25084752|NCT03303573|Hematinics|hematinics|mesh-ancestor
24974046|NCT05175703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974047|NCT05175625|Myeloma Proteins|myeloma proteins|mesh-list
24974048|NCT05175625|Paraproteins|paraproteins|mesh-list
24974049|NCT05175625|Immunologic Factors|immunologic factors|mesh-ancestor
24974220|NCT05095831|Pancrelipase|pancrelipase|mesh-list
24974222|NCT05095831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24974223|NCT05065801|Folfirinox|folfirinox|mesh-list
24974224|NCT05065801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24974225|NCT05052307|Vaccines|vaccines|mesh-list
24974226|NCT05052307|Immunologic Factors|immunologic factors|mesh-ancestor
24974227|NCT05052307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974228|NCT05051436|Tadalafil|tadalafil|mesh-list
24974229|NCT05051436|Mirabegron|mirabegron|mesh-list
24974230|NCT05051436|Vasodilator Agents|vasodilator agents|mesh-ancestor
24974231|NCT05051436|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24974232|NCT05051436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24974233|NCT05051436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24822297|NCT02110810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24414416|NCT00197548|Vitamin B Complex|vitamin b complex|mesh-list
24974572|NCT04394481|Autonomic Agents|autonomic agents|mesh-ancestor
24974573|NCT04394481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24974575|NCT04394481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24974810|NCT05249725|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24974811|NCT05249725|Protective Agents|protective agents|mesh-ancestor
24794871|NCT04233866|Fluorouracil|fluorouracil|mesh-list
24794872|NCT04233866|Irinotecan|irinotecan|mesh-list
24794873|NCT04233866|Calcium|calcium|mesh-list
24794874|NCT04233866|Levoleucovorin|levoleucovorin|mesh-list
24974965|NCT04892173|Cetuximab|cetuximab|mesh-list
24974966|NCT04892173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24974967|NCT04892173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25686000|NCT01912872|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25686001|NCT01912872|Respiratory System Agents|respiratory system agents|mesh-ancestor
25686002|NCT01912872|Glucocorticoids|glucocorticoids|mesh-ancestor
25686003|NCT01912872|Hormones|hormones|mesh-ancestor
25034470|NCT03564509|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25686004|NCT01912872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25686005|NCT01912872|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25686006|NCT01912872|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25686007|NCT01912872|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25686008|NCT01912872|Adrenergic Agents|adrenergic agents|mesh-ancestor
25686009|NCT01912872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25686010|NCT01912872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974968|NCT04862585|Diphenhydramine|diphenhydramine|mesh-list
24974969|NCT04862585|Promethazine|promethazine|mesh-list
24974970|NCT04862585|Dexamethasone|dexamethasone|mesh-list
25066692|NCT02099188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25066693|NCT02099188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25066695|NCT02099188|Protective Agents|protective agents|mesh-ancestor
24974971|NCT04862585|Dexamethasone acetate|dexamethasone acetate|mesh-list
24974973|NCT04862585|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24974974|NCT04862585|Famotidine|famotidine|mesh-list
24974975|NCT04862585|Ranitidine|ranitidine|mesh-list
24974976|NCT04862585|Cimetidine|cimetidine|mesh-list
24974977|NCT04862585|BB 1101|bb 1101|mesh-list
24974978|NCT04862585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24975012|NCT04862585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24975013|NCT04847596|Ofatumumab|ofatumumab|mesh-list
24975014|NCT04847596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24975015|NCT04844268|Vaccines|vaccines|mesh-list
24975018|NCT04818216|Niacinamide|niacinamide|mesh-list
25083409|NCT03316326|Antimetabolites|antimetabolites|mesh-ancestor
25083410|NCT03316313|Antibodies|antibodies|mesh-list
25083411|NCT03316313|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
25083438|NCT03315845|Anesthetics|anesthetics|mesh-list
25083439|NCT03315845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25083440|NCT03315845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083441|NCT03315676|Esomeprazole|esomeprazole|mesh-list
25083442|NCT03315676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25083829|NCT03312257|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25083830|NCT03312257|Cholinergic Agents|cholinergic agents|mesh-ancestor
25083831|NCT03312257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25083832|NCT03312257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083834|NCT03312244|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
25083835|NCT03312244|Anticonvulsants|anticonvulsants|mesh-ancestor
25083836|NCT03312244|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25083837|NCT03312244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813699|NCT02059967|Paclitaxel|paclitaxel|mesh-list
25083838|NCT03312244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934094|NCT04063904|Contraceptive Agents|contraceptive agents|mesh-ancestor
25083872|NCT03311971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083873|NCT03311971|Adrenergic Agents|adrenergic agents|mesh-ancestor
25083874|NCT03311971|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25083875|NCT03311971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25083876|NCT03311971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25083877|NCT03311971|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25083981|NCT03311321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083982|NCT03311321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25084277|NCT03308201|Fulvestrant|fulvestrant|mesh-list
25084278|NCT03308201|Exemestane|exemestane|mesh-list
25084279|NCT03308201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25084280|NCT03308201|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25084281|NCT03308201|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25084282|NCT03308201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25084283|NCT03308201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084284|NCT03308201|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25084285|NCT03308201|Hormone Antagonists|hormone antagonists|mesh-ancestor
25084286|NCT03308201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25084287|NCT03308201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084288|NCT03308201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25084289|NCT03308201|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25084290|NCT03308149|Triamcinolone|triamcinolone|mesh-list
25084291|NCT03308149|Bupivacaine|bupivacaine|mesh-list
25084292|NCT03308149|Anesthetics, Local|anesthetics, local|mesh-ancestor
25084293|NCT03308149|Anesthetics|anesthetics|mesh-ancestor
25084416|NCT03307213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25084417|NCT03307213|Immunologic Factors|immunologic factors|mesh-ancestor
25084418|NCT03307213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084419|NCT03307213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25084444|NCT03306940|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25084445|NCT03306940|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25084446|NCT03306940|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25084447|NCT03306940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25084448|NCT03306940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084449|NCT03306940|Cholinergic Agents|cholinergic agents|mesh-ancestor
25084450|NCT03306940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25084451|NCT03306940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084452|NCT03306940|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25686011|NCT01912872|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25686012|NCT01912963|Trastuzumab|trastuzumab|mesh-list
25686013|NCT01912963|Pertuzumab|pertuzumab|mesh-list
25084453|NCT03306940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084454|NCT03306914|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
25084455|NCT03306914|Plasma Substitutes|plasma substitutes|mesh-ancestor
25084456|NCT03306914|Blood Substitutes|blood substitutes|mesh-ancestor
25084458|NCT03306836|Calcium heparin|calcium heparin|mesh-list
25084459|NCT03306836|Anticoagulants|anticoagulants|mesh-ancestor
25084460|NCT03306836|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25084461|NCT03306836|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25084462|NCT03306836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084464|NCT03306745|Hematinics|hematinics|mesh-ancestor
25084465|NCT03306745|Vitamin B Complex|vitamin b complex|mesh-ancestor
25084466|NCT03306745|Vitamins|vitamins|mesh-ancestor
25084467|NCT03306745|Micronutrients|micronutrients|mesh-ancestor
25084468|NCT03306745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084469|NCT03306732|Thiamine|thiamine|mesh-list
25084506|NCT03306472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25084595|NCT03305068|Celecoxib|celecoxib|mesh-list
24543539|NCT00684190|Esomeprazole|esomeprazole|mesh-list
24934814|NCT04057755|Cholinergic Agents|cholinergic agents|mesh-ancestor
25084621|NCT03304457|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25084622|NCT03304457|Antiemetics|antiemetics|mesh-ancestor
25084623|NCT03304457|Autonomic Agents|autonomic agents|mesh-ancestor
25084624|NCT03304457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084625|NCT03304457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084626|NCT03304457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25084627|NCT03304457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25084628|NCT03304457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24759706|NCT01754116|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25084629|NCT03304457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24759780|NCT01754805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24759781|NCT01754805|Immunologic Factors|immunologic factors|mesh-ancestor
25084630|NCT03304457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25084631|NCT03304457|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25084632|NCT03304457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25084633|NCT03304457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25084634|NCT03304457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084706|NCT03303924|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25084707|NCT03303924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25084708|NCT03303924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084710|NCT03303677|Ciprofloxacin|ciprofloxacin|mesh-list
25084711|NCT03303677|Gentamicins|gentamicins|mesh-list
25084712|NCT03303677|Mupirocin|mupirocin|mesh-list
25084713|NCT03303677|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25084714|NCT03303677|Trimethoprim|trimethoprim|mesh-list
25084715|NCT03303677|Sulfamethoxazole|sulfamethoxazole|mesh-list
25084716|NCT03303677|Budesonide|budesonide|mesh-list
24934935|NCT04056845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25084751|NCT03303573|Epoetin Alfa|epoetin alfa|mesh-list
25084753|NCT03303495|Leucovorin|leucovorin|mesh-list
25084754|NCT03303495|Bevacizumab|bevacizumab|mesh-list
25084755|NCT03303495|Fluorouracil|fluorouracil|mesh-list
25084842|NCT03302689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25084843|NCT03302689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084844|NCT03302689|Sensory System Agents|sensory system agents|mesh-ancestor
25084845|NCT03302689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084846|NCT03302650|Norepinephrine|norepinephrine|mesh-list
25084847|NCT03302650|Angiotensin II|angiotensin ii|mesh-list
25084849|NCT03302650|Angiotensinogen|angiotensinogen|mesh-list
25084850|NCT03302650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25084851|NCT03302650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25084852|NCT03302650|Adrenergic Agents|adrenergic agents|mesh-ancestor
25084853|NCT03302650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25084854|NCT03302650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625436|NCT01082237|Citalopram|citalopram|mesh-list
24822496|NCT02112214|Bismuth|bismuth|mesh-list
25084913|NCT03302364|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25084914|NCT03302364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25084915|NCT03302364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25084916|NCT03302364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25084917|NCT03302364|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25084919|NCT03302351|Dexmedetomidine|dexmedetomidine|mesh-list
25084920|NCT03302351|Ketamine|ketamine|mesh-list
25084921|NCT03302351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25084961|NCT03302221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24917715|NCT04226885|Fentanyl|fentanyl|mesh-list
25084996|NCT03302065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084997|NCT03302065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084999|NCT03302065|Respiratory System Agents|respiratory system agents|mesh-ancestor
25085124|NCT03301207|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25085286|NCT03299517|Sensory System Agents|sensory system agents|mesh-ancestor
25085287|NCT03299517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25085288|NCT03299517|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25085289|NCT03299517|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25085290|NCT03299517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25085291|NCT03299517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085292|NCT03299517|Vasodilator Agents|vasodilator agents|mesh-ancestor
25085293|NCT03299517|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25085294|NCT03299517|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25085295|NCT03299517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25085296|NCT03299517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085297|NCT03299517|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25085298|NCT03299517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25085299|NCT03299517|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25085300|NCT03299426|Vaccines|vaccines|mesh-list
25085301|NCT03299426|Immunologic Factors|immunologic factors|mesh-ancestor
25085302|NCT03299426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085303|NCT03299387|Gentamicins|gentamicins|mesh-list
25085304|NCT03299387|Nitrofurantoin|nitrofurantoin|mesh-list
25085305|NCT03299387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25085306|NCT03299387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24760545|NCT01758471|Glipizide|glipizide|mesh-list
25085307|NCT03299387|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25085308|NCT03299387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085309|NCT03299387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085310|NCT03299387|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25085311|NCT03299387|Renal Agents|renal agents|mesh-ancestor
25085312|NCT03299296|Enoxaparin|enoxaparin|mesh-list
25085313|NCT03299296|Rivaroxaban|rivaroxaban|mesh-list
25085314|NCT03299296|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24822568|NCT02112578|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24822569|NCT02112578|Histamine Antagonists|histamine antagonists|mesh-ancestor
25085319|NCT03299296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085320|NCT03299296|Anticoagulants|anticoagulants|mesh-ancestor
25085321|NCT03299296|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25085322|NCT03299296|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25085323|NCT03299257|Donepezil|donepezil|mesh-list
25085324|NCT03299257|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25085325|NCT03299257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085326|NCT03299257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085327|NCT03299257|Cholinergic Agents|cholinergic agents|mesh-ancestor
25085328|NCT03299257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25085329|NCT03299257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085330|NCT03299257|Nootropic Agents|nootropic agents|mesh-ancestor
25085332|NCT03299036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25085333|NCT03299036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25085334|NCT03299036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25085335|NCT03299036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25085336|NCT03299036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085337|NCT03299036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085338|NCT03298958|Sirolimus|sirolimus|mesh-list
25085339|NCT03298958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25085340|NCT03298958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25085341|NCT03298958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25085342|NCT03298958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25085343|NCT03298958|Antifungal Agents|antifungal agents|mesh-ancestor
25085344|NCT03298958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25085345|NCT03298958|Immunologic Factors|immunologic factors|mesh-ancestor
25085346|NCT03298958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085347|NCT03298906|Ticlopidine|ticlopidine|mesh-list
25085348|NCT03298906|Esketamine|esketamine|mesh-list
25085349|NCT03298906|Antidepressive Agents|antidepressive agents|mesh-ancestor
25085350|NCT03298906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25085351|NCT03298906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25085352|NCT03298906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25085458|NCT03298191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085460|NCT03298191|Sensory System Agents|sensory system agents|mesh-ancestor
25066772|NCT00493896|PENTA|penta|mesh-list
25085461|NCT03298191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25085462|NCT03298191|Anesthetics|anesthetics|mesh-ancestor
25085463|NCT03298191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25085464|NCT03298191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25085465|NCT03298191|Anticonvulsants|anticonvulsants|mesh-ancestor
25085500|NCT03297879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25085502|NCT03297502|Tacrolimus|tacrolimus|mesh-list
25085503|NCT03297502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25085504|NCT03297502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25085505|NCT03297502|Analgesics|analgesics|mesh-ancestor
25085588|NCT03296579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25085589|NCT03296579|Anticonvulsants|anticonvulsants|mesh-ancestor
25085590|NCT03296579|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25085591|NCT03296579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25085592|NCT03296579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085593|NCT03296579|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25085594|NCT03296579|Tocolytic Agents|tocolytic agents|mesh-ancestor
25085595|NCT03296579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25085596|NCT03296579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25085597|NCT03296579|Autonomic Agents|autonomic agents|mesh-ancestor
25085598|NCT03296579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25085599|NCT03296579|Respiratory System Agents|respiratory system agents|mesh-ancestor
25085728|NCT03295825|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25085729|NCT03295825|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25085730|NCT03295825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085732|NCT03295786|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25085733|NCT03295786|Sympathomimetics|sympathomimetics|mesh-ancestor
25085734|NCT03295786|Autonomic Agents|autonomic agents|mesh-ancestor
25085735|NCT03295786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25085736|NCT03295786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085737|NCT03295786|Dopamine Agents|dopamine agents|mesh-ancestor
25085738|NCT03295786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25085740|NCT03295786|Protective Agents|protective agents|mesh-ancestor
25085741|NCT03295760|Ubiquinone|ubiquinone|mesh-list
25085742|NCT03295760|Coenzyme Q10|coenzyme q10|mesh-list
25085743|NCT03295760|Micronutrients|micronutrients|mesh-ancestor
25085819|NCT03294772|Hand Sanitizers|hand sanitizers|mesh-list
25085820|NCT03294772|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25085821|NCT03294772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25085822|NCT03294772|Disinfectants|disinfectants|mesh-ancestor
25085823|NCT03294707|Coal Tar|coal tar|mesh-list
25085824|NCT03294707|Keratolytic Agents|keratolytic agents|mesh-ancestor
25085825|NCT03294707|Dermatologic Agents|dermatologic agents|mesh-ancestor
25085826|NCT03294577|Cyclophosphamide|cyclophosphamide|mesh-list
25085827|NCT03294577|Docetaxel|docetaxel|mesh-list
25085828|NCT03294577|Doxorubicin|doxorubicin|mesh-list
25085829|NCT03294577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25085830|NCT03294577|Immunologic Factors|immunologic factors|mesh-ancestor
25085831|NCT03294577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085832|NCT03294577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25085833|NCT03294577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25085834|NCT03294577|Alkylating Agents|alkylating agents|mesh-ancestor
25085835|NCT03294577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085836|NCT03294577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25085837|NCT03294577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25085838|NCT03294577|Tubulin Modulators|tubulin modulators|mesh-ancestor
25085839|NCT03294577|Antimitotic Agents|antimitotic agents|mesh-ancestor
25085840|NCT03294577|Mitosis Modulators|mitosis modulators|mesh-ancestor
25085841|NCT03294577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25085842|NCT03294577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25085843|NCT03294577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25085844|NCT03294577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085845|NCT03294551|Vaccines|vaccines|mesh-list
25085846|NCT03294551|Immunologic Factors|immunologic factors|mesh-ancestor
25085847|NCT03294551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085848|NCT03294525|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24761128|NCT01761201|Levofloxacin|levofloxacin|mesh-list
24761129|NCT01761201|Ofloxacin|ofloxacin|mesh-list
25085849|NCT03294525|Mirtazapine|mirtazapine|mesh-list
25085850|NCT03294525|Citalopram|citalopram|mesh-list
25085855|NCT03294525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686014|NCT01912963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25686015|NCT01912963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25686016|NCT01913340|Epoetin Alfa|epoetin alfa|mesh-list
25085867|NCT03294525|Histamine Antagonists|histamine antagonists|mesh-ancestor
25085868|NCT03294525|Histamine Agents|histamine agents|mesh-ancestor
25085869|NCT03294525|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25085870|NCT03294525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24415428|NCT00199433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415597|NCT00200226|Abortifacient Agents|abortifacient agents|mesh-ancestor
25085871|NCT03294525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25085872|NCT03294525|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25085873|NCT03294525|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25085874|NCT03294525|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25085875|NCT03294525|Adrenergic Agents|adrenergic agents|mesh-ancestor
25085876|NCT03294525|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25085877|NCT03294525|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25085878|NCT03294525|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25085879|NCT03294486|Flucytosine|flucytosine|mesh-list
25085880|NCT03294486|Antifungal Agents|antifungal agents|mesh-ancestor
25085881|NCT03294486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25085882|NCT03294486|Antimetabolites|antimetabolites|mesh-ancestor
25085883|NCT03294486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085884|NCT03294395|Gentamicins|gentamicins|mesh-list
25085885|NCT03294395|Ceftriaxone|ceftriaxone|mesh-list
25085886|NCT03294395|Fosfomycin|fosfomycin|mesh-list
25085887|NCT03294395|Ertapenem|ertapenem|mesh-list
25085888|NCT03294395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25085889|NCT03294395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25085890|NCT03294395|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25085891|NCT03294395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085892|NCT03294395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085893|NCT03294382|Botulinum Toxins|botulinum toxins|mesh-list
25085894|NCT03294382|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25085895|NCT03294382|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25085932|NCT03294161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25085936|NCT03294070|Amlodipine|amlodipine|mesh-list
25086003|NCT03293472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25086036|NCT03293108|Calcium|calcium|mesh-list
25086037|NCT03293108|Vitamins|vitamins|mesh-ancestor
25086038|NCT03293108|Micronutrients|micronutrients|mesh-ancestor
25086039|NCT03293108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086040|NCT03293108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25086041|NCT03293108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25086042|NCT03293069|Deferiprone|deferiprone|mesh-list
25086043|NCT03293069|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25086044|NCT03293069|Chelating Agents|chelating agents|mesh-ancestor
25086045|NCT03293069|Sequestering Agents|sequestering agents|mesh-ancestor
25086071|NCT03292822|Paclitaxel|paclitaxel|mesh-list
25086072|NCT03292822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25086073|NCT03292822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25086074|NCT03292822|Tubulin Modulators|tubulin modulators|mesh-ancestor
25086075|NCT03292822|Antimitotic Agents|antimitotic agents|mesh-ancestor
25086076|NCT03292822|Mitosis Modulators|mitosis modulators|mesh-ancestor
25086077|NCT03292822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086078|NCT03292796|Bimatoprost|bimatoprost|mesh-list
25086079|NCT03292796|Latanoprost|latanoprost|mesh-list
25086080|NCT03292796|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25086081|NCT03292796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25086082|NCT03292796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25086083|NCT03292744|Cholecalciferol|cholecalciferol|mesh-list
25086212|NCT03290963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25086213|NCT03290963|Anesthetics, General|anesthetics, general|mesh-ancestor
25686017|NCT01913340|Hematinics|hematinics|mesh-ancestor
25686018|NCT01913405|Factor VIII|factor viii|mesh-list
25686019|NCT01913405|BAX 855|bax 855|mesh-list
25686020|NCT01913405|Coagulants|coagulants|mesh-ancestor
25686021|NCT01913470|Losartan|losartan|mesh-list
25686022|NCT01913470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25686023|NCT01913470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25686024|NCT01913470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25086314|NCT03290417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686025|NCT01913470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24415632|NCT00200434|Nebivolol|nebivolol|mesh-list
25086315|NCT03290417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25086316|NCT03290417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25086317|NCT03290417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25086318|NCT03290417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25086319|NCT03290417|Analgesics|analgesics|mesh-ancestor
25086320|NCT03290417|Sensory System Agents|sensory system agents|mesh-ancestor
25086321|NCT03290417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25086322|NCT03290417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25086354|NCT03289871|Antifungal Agents|antifungal agents|mesh-ancestor
25086355|NCT03289871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25086356|NCT03289819|Paclitaxel|paclitaxel|mesh-list
25086357|NCT03289819|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25086358|NCT03289819|Cyclophosphamide|cyclophosphamide|mesh-list
25086359|NCT03289819|Pembrolizumab|pembrolizumab|mesh-list
25086360|NCT03289819|Epirubicin|epirubicin|mesh-list
25086361|NCT03289819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25086362|NCT03289819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25086363|NCT03289819|Tubulin Modulators|tubulin modulators|mesh-ancestor
25086364|NCT03289819|Antimitotic Agents|antimitotic agents|mesh-ancestor
25086365|NCT03289819|Mitosis Modulators|mitosis modulators|mesh-ancestor
25086366|NCT03289819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086367|NCT03289819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25086368|NCT03289819|Immunologic Factors|immunologic factors|mesh-ancestor
25086401|NCT03289559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25086403|NCT03289559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25086404|NCT03289559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25086405|NCT03289559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086406|NCT03289559|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25086407|NCT03289559|Hormone Antagonists|hormone antagonists|mesh-ancestor
25086408|NCT03289520|Clopidogrel|clopidogrel|mesh-list
25086409|NCT03289520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25086442|NCT03289390|Sensory System Agents|sensory system agents|mesh-ancestor
25086561|NCT03288428|Narcotics|narcotics|mesh-ancestor
25086562|NCT03288428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25086563|NCT03288428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086565|NCT03288428|Sensory System Agents|sensory system agents|mesh-ancestor
25086566|NCT03288428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24669778|NCT03613181|Paclitaxel|paclitaxel|mesh-list
25086620|NCT03288038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25086621|NCT03287921|Bronchodilator Agents|bronchodilator agents|mesh-list
25086622|NCT03287921|Autonomic Agents|autonomic agents|mesh-ancestor
25086623|NCT03287921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25086624|NCT03287921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086625|NCT03287921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25086626|NCT03287921|Respiratory System Agents|respiratory system agents|mesh-ancestor
25086627|NCT03287882|Micronutrients|micronutrients|mesh-list
25086628|NCT03287882|Trace Elements|trace elements|mesh-list
25086629|NCT03287882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086630|NCT03287609|Evolocumab|evolocumab|mesh-list
25086631|NCT03287609|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25086632|NCT03287609|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25086834|NCT03285607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25086836|NCT03285568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24456519|NCT00331513|Vorinostat|vorinostat|mesh-list
25086850|NCT03285503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086852|NCT03285503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25086853|NCT03285503|Serotonin Agents|serotonin agents|mesh-ancestor
25086854|NCT03285503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25086855|NCT03285503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25086856|NCT03285503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25086857|NCT03285503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25086858|NCT03285360|Fluorides|fluorides|mesh-list
25086859|NCT03285360|Fluorides, Topical|fluorides, topical|mesh-list
25086860|NCT03285360|Cariostatic Agents|cariostatic agents|mesh-ancestor
25086861|NCT03285360|Protective Agents|protective agents|mesh-ancestor
25086862|NCT03285360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086863|NCT03285165|Propofol|propofol|mesh-list
25082587|NCT03321825|Hyaluronic Acid|hyaluronic acid|mesh-list
25082588|NCT03321825|Anesthetics, Local|anesthetics, local|mesh-ancestor
25086866|NCT03285165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086867|NCT03285165|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25086868|NCT03285165|Anesthetics, General|anesthetics, general|mesh-ancestor
25086870|NCT03285087|Dexmedetomidine|dexmedetomidine|mesh-list
25086871|NCT03285087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25086872|NCT03285087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24917925|NCT04225065|Disinfectants|disinfectants|mesh-ancestor
24917926|NCT04224831|Mitogens|mitogens|mesh-list
24917927|NCT04224831|Mitosis Modulators|mitosis modulators|mesh-ancestor
24917928|NCT04224831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917929|NCT04224818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24917930|NCT04224818|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24917931|NCT04224818|Luteolytic Agents|luteolytic agents|mesh-ancestor
25086873|NCT03285087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086874|NCT03285087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25086875|NCT03285087|Analgesics|analgesics|mesh-ancestor
25086876|NCT03285087|Sensory System Agents|sensory system agents|mesh-ancestor
25086877|NCT03285087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25086878|NCT03285087|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25086879|NCT03285087|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25086880|NCT03285087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25086881|NCT03285087|Adrenergic Agents|adrenergic agents|mesh-ancestor
25086882|NCT03285087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25086883|NCT03285087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086884|NCT03284762|Rivaroxaban|rivaroxaban|mesh-list
25087016|NCT03283202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25087017|NCT03283202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25087018|NCT03283202|Alkylating Agents|alkylating agents|mesh-ancestor
25087019|NCT03283202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087020|NCT03283202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25087021|NCT03283202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25087022|NCT03283202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25087023|NCT03283202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25087024|NCT03283202|Glucocorticoids|glucocorticoids|mesh-ancestor
25087025|NCT03283202|Hormones|hormones|mesh-ancestor
25087026|NCT03283202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25087034|NCT03283176|Hydroxocobalamin|hydroxocobalamin|mesh-list
25087035|NCT03283176|Vitamins|vitamins|mesh-ancestor
25087036|NCT03283176|Micronutrients|micronutrients|mesh-ancestor
25087037|NCT03283176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087038|NCT03283176|Hematinics|hematinics|mesh-ancestor
25087039|NCT03283176|Vitamin B Complex|vitamin b complex|mesh-ancestor
25087040|NCT03283059|Donepezil|donepezil|mesh-list
24453041|NCT05354258|Antimitotic Agents|antimitotic agents|mesh-ancestor
25087092|NCT03282838|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25087093|NCT03282838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25087094|NCT03282838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25087334|NCT03280004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25087335|NCT03279978|Midazolam|midazolam|mesh-list
25087336|NCT03279978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25087337|NCT03279978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25087338|NCT03279978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25087405|NCT03279757|Autonomic Agents|autonomic agents|mesh-ancestor
25087406|NCT03279757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25087407|NCT03279757|Respiratory System Agents|respiratory system agents|mesh-ancestor
25087409|NCT03279757|Sympathomimetics|sympathomimetics|mesh-ancestor
25087410|NCT03279757|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25087411|NCT03279692|Pembrolizumab|pembrolizumab|mesh-list
25087412|NCT03279692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25087413|NCT03279692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25087426|NCT03279601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087427|NCT03279601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25087428|NCT03279601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25087429|NCT03279601|Alkylating Agents|alkylating agents|mesh-ancestor
25087430|NCT03279562|Nalmefene|nalmefene|mesh-list
25087431|NCT03279562|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25087432|NCT03279562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087433|NCT03279562|Sensory System Agents|sensory system agents|mesh-ancestor
25087434|NCT03279562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25087435|NCT03279549|Mitogens|mitogens|mesh-list
25087436|NCT03279549|Mitosis Modulators|mitosis modulators|mesh-ancestor
25686026|NCT01913470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686027|NCT01913483|Heparin|heparin|mesh-list
25686028|NCT01913483|Calcium heparin|calcium heparin|mesh-list
25686029|NCT01913483|Bivalirudin|bivalirudin|mesh-list
25686030|NCT01913483|Anticoagulants|anticoagulants|mesh-ancestor
25686031|NCT01913483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25686032|NCT01913483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25686033|NCT01913483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918015|NCT04224441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24918016|NCT04224441|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25087437|NCT03279549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087438|NCT03279536|Lactoferrin|lactoferrin|mesh-list
25087439|NCT03279536|Dextrans|dextrans|mesh-list
25087440|NCT03279536|Iron-Dextran Complex|iron-dextran complex|mesh-list
25087441|NCT03279536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25087442|NCT03279536|Anticoagulants|anticoagulants|mesh-ancestor
25087443|NCT03279536|Plasma Substitutes|plasma substitutes|mesh-ancestor
25087444|NCT03279536|Blood Substitutes|blood substitutes|mesh-ancestor
25087445|NCT03279536|Hematinics|hematinics|mesh-ancestor
25087449|NCT03279341|Prucalopride|prucalopride|mesh-list
25087450|NCT03279341|Bisacodyl|bisacodyl|mesh-list
25087451|NCT03279341|Laxatives|laxatives|mesh-ancestor
25087452|NCT03279341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25087453|NCT03279341|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
25087454|NCT03279341|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25087458|NCT03279341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087460|NCT03279328|Petrolatum|petrolatum|mesh-list
25087461|NCT03279328|Emollients|emollients|mesh-ancestor
25087462|NCT03279328|Dermatologic Agents|dermatologic agents|mesh-ancestor
24895649|NCT03675893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895651|NCT03643367|Sevoflurane|sevoflurane|mesh-list
24895652|NCT03643367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24895653|NCT03643367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24895654|NCT03643367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515090|NCT00594373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24515091|NCT00594373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24515092|NCT00594542|Lidocaine|lidocaine|mesh-list
24515093|NCT00594542|Anesthetics, Local|anesthetics, local|mesh-ancestor
24515094|NCT00594542|Anesthetics|anesthetics|mesh-ancestor
24515095|NCT00594542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24515096|NCT00594542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515097|NCT00594542|Sensory System Agents|sensory system agents|mesh-ancestor
24515098|NCT00594542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24515099|NCT00594542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24476512|NCT00415311|Coagulants|coagulants|mesh-ancestor
24895746|NCT03233243|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25087493|NCT03279120|Antiviral Agents|antiviral agents|mesh-ancestor
25087494|NCT03279120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25087495|NCT03279120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25087496|NCT03279120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25087497|NCT03279120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25087498|NCT03279120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087499|NCT03279120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25087500|NCT03279120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25087501|NCT03279120|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25087502|NCT03279120|Contraceptive Agents|contraceptive agents|mesh-ancestor
25087503|NCT03279120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25087504|NCT03279120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087505|NCT03279120|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25087506|NCT03279120|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25087507|NCT03279120|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24763056|NCT01771146|Oxaliplatin|oxaliplatin|mesh-list
25087509|NCT03278938|Citalopram|citalopram|mesh-list
25087510|NCT03278938|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25087511|NCT03278938|Antidepressive Agents|antidepressive agents|mesh-ancestor
25087512|NCT03278938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25686034|NCT01913483|Antithrombins|antithrombins|mesh-ancestor
25686035|NCT01913483|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25686036|NCT01913483|Protease Inhibitors|protease inhibitors|mesh-ancestor
25686037|NCT01913483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25686038|NCT01913535|Aticaprant|aticaprant|mesh-list
25686039|NCT01913535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25087513|NCT03278938|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25087514|NCT03278938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25686040|NCT01913535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918160|NCT04222920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24918161|NCT04222517|Hemostatics|hemostatics|mesh-list
24918162|NCT04222517|Coagulants|coagulants|mesh-ancestor
24918163|NCT04222686|Losartan|losartan|mesh-list
24918164|NCT04222686|Perindopril|perindopril|mesh-list
24918165|NCT04222686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24918172|NCT04222686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918174|NCT04222062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24918175|NCT04222062|Alkylating Agents|alkylating agents|mesh-ancestor
24918176|NCT04222062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087515|NCT03278938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25087516|NCT03278938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087517|NCT03278938|Dopamine Agents|dopamine agents|mesh-ancestor
25087518|NCT03278938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25087519|NCT03278938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087520|NCT03278938|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25087536|NCT03278808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25087538|NCT03278808|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25087539|NCT03278808|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25087540|NCT03278808|Antimalarials|antimalarials|mesh-ancestor
25087568|NCT03278522|Autonomic Agents|autonomic agents|mesh-ancestor
25087569|NCT03278522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25087570|NCT03278522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087571|NCT03278522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25087572|NCT03278522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25087573|NCT03278522|Serotonin Agents|serotonin agents|mesh-ancestor
25087574|NCT03278522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25087575|NCT03278522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087576|NCT03278483|Rifampin|rifampin|mesh-list
25087577|NCT03278483|Isoniazid|isoniazid|mesh-list
24763057|NCT01771146|Irinotecan|irinotecan|mesh-list
25087582|NCT03278483|Leprostatic Agents|leprostatic agents|mesh-ancestor
24763132|NCT05318443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25087583|NCT03278483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25087584|NCT03278483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25087585|NCT03278483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087586|NCT03278483|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25087605|NCT03278431|Oxantel pamoate|oxantel pamoate|mesh-list
25087606|NCT03278431|DMP 777|dmp 777|mesh-list
25087624|NCT03278431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087625|NCT03278405|Avelumab|avelumab|mesh-list
25087626|NCT03278405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25087627|NCT03278405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25087628|NCT03278379|Avelumab|avelumab|mesh-list
25087629|NCT03278379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25087630|NCT03278379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25087631|NCT03278314|Ivacaftor|ivacaftor|mesh-list
25087632|NCT03278314|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25087633|NCT03278314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25087634|NCT03278314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087635|NCT03278262|Aflibercept|aflibercept|mesh-list
25087636|NCT03278262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25087637|NCT03278262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25087638|NCT03278262|Growth Substances|growth substances|mesh-ancestor
25087639|NCT03278262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087640|NCT03278262|Growth Inhibitors|growth inhibitors|mesh-ancestor
25087641|NCT03278262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25087642|NCT03278015|Gemcitabine|gemcitabine|mesh-list
25087643|NCT03278015|Paclitaxel|paclitaxel|mesh-list
25087644|NCT03278015|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25087645|NCT03278015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25087678|NCT03277573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25087679|NCT03277573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087680|NCT03277573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25087681|NCT03277573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25686041|NCT01913535|Sensory System Agents|sensory system agents|mesh-ancestor
25686042|NCT01913535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686043|NCT01913639|Leucovorin|leucovorin|mesh-list
25686044|NCT01913639|Fluorouracil|fluorouracil|mesh-list
25686045|NCT01913639|Oxaliplatin|oxaliplatin|mesh-list
25686046|NCT01913639|Antimetabolites|antimetabolites|mesh-ancestor
25686047|NCT01913639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686048|NCT01913639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25686049|NCT01913639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25686050|NCT01913639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24918306|NCT04220931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918307|NCT04220996|Vortioxetine|vortioxetine|mesh-list
24918308|NCT04220996|Antidepressive Agents|antidepressive agents|mesh-ancestor
24918309|NCT04220996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24918310|NCT04220996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24918311|NCT04220996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24918312|NCT04220996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24493207|NCT00489983|Gemcitabine|gemcitabine|mesh-list
25087683|NCT03277482|Tremelimumab|tremelimumab|mesh-list
25087684|NCT03277482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25087685|NCT03277482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25087686|NCT03277430|Tacrolimus|tacrolimus|mesh-list
25087687|NCT03277430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25087727|NCT03277339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25087731|NCT03277222|Insulin|insulin|mesh-list
25087732|NCT03277222|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25087733|NCT03277222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25087734|NCT03277222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087735|NCT03277209|Plerixafor|plerixafor|mesh-list
24670714|NCT01998971|Acetaminophen|acetaminophen|mesh-list
25087752|NCT03277001|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25087753|NCT03277001|Protease Inhibitors|protease inhibitors|mesh-ancestor
25087754|NCT03277001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25087755|NCT03277001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087756|NCT03277001|Anticoagulants|anticoagulants|mesh-ancestor
25087757|NCT03277001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25087758|NCT03277001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25087759|NCT03276858|Midazolam|midazolam|mesh-list
25087760|NCT03276858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25087761|NCT03276858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24417016|NCT00204737|Prednisone|prednisone|mesh-list
24417017|NCT00204737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25087762|NCT03276858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25087763|NCT03276858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25087764|NCT03276858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087768|NCT03276858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25087769|NCT03276858|Anesthetics, General|anesthetics, general|mesh-ancestor
25087770|NCT03276858|Anesthetics|anesthetics|mesh-ancestor
25087771|NCT03276858|GABA Modulators|gaba modulators|mesh-ancestor
25087777|NCT03276832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25087778|NCT03276832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25087779|NCT03276832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24895748|NCT03215706|Paclitaxel|paclitaxel|mesh-list
25087780|NCT03276832|Immunologic Factors|immunologic factors|mesh-ancestor
25087781|NCT03276832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087782|NCT03276832|Interferon Inducers|interferon inducers|mesh-ancestor
25087783|NCT03276689|Pregabalin|pregabalin|mesh-list
25087784|NCT03276689|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25087785|NCT03276689|Analgesics|analgesics|mesh-ancestor
25087786|NCT03276689|Sensory System Agents|sensory system agents|mesh-ancestor
25087787|NCT03276689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25087788|NCT03276689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087789|NCT03276689|Anticonvulsants|anticonvulsants|mesh-ancestor
25087790|NCT03276689|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25087791|NCT03276689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25087792|NCT03276689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087793|NCT03276689|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25087794|NCT03276689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25087795|NCT03276689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25087830|NCT03276572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087832|NCT03276520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25087858|NCT03276156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087859|NCT03276143|Enoxaparin|enoxaparin|mesh-list
25087860|NCT03276143|Apixaban|apixaban|mesh-list
25087861|NCT03276143|Anticoagulants|anticoagulants|mesh-ancestor
25087862|NCT03276143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24895749|NCT03215706|Carboplatin|carboplatin|mesh-list
25686051|NCT01913639|Immunologic Factors|immunologic factors|mesh-ancestor
25686052|NCT01913639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686053|NCT01913639|Antidotes|antidotes|mesh-ancestor
25686054|NCT01913639|Protective Agents|protective agents|mesh-ancestor
25686055|NCT01913639|Vitamin B Complex|vitamin b complex|mesh-ancestor
25686056|NCT01913639|Vitamins|vitamins|mesh-ancestor
25686057|NCT01913639|Micronutrients|micronutrients|mesh-ancestor
25686058|NCT01914159|Ranibizumab|ranibizumab|mesh-list
25686059|NCT01914159|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24895757|NCT03215706|Mitosis Modulators|mitosis modulators|mesh-ancestor
24895758|NCT03215706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895759|NCT03215706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24895760|NCT03215706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24895761|NCT03215706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24895762|NCT03215706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24895764|NCT03151057|Idelalisib|idelalisib|mesh-list
25087864|NCT03276143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087865|NCT03276143|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25087866|NCT03276143|Antithrombins|antithrombins|mesh-ancestor
25087867|NCT03276143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25087868|NCT03276143|Protease Inhibitors|protease inhibitors|mesh-ancestor
25087869|NCT03276143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25087870|NCT03276013|Pembrolizumab|pembrolizumab|mesh-list
25087871|NCT03276013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25087872|NCT03276013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25087873|NCT03275701|Triumeq|triumeq|mesh-list
25087874|NCT03275701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25087875|NCT03275701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25087876|NCT03275701|Antiviral Agents|antiviral agents|mesh-ancestor
25087877|NCT03275701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25087878|NCT03275558|Sunitinib|sunitinib|mesh-list
25087879|NCT03275558|Axitinib|axitinib|mesh-list
25087880|NCT03275558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25087881|NCT03275558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25087882|NCT03275558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25087883|NCT03275558|Growth Substances|growth substances|mesh-ancestor
25087884|NCT03275558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087885|NCT03275558|Growth Inhibitors|growth inhibitors|mesh-ancestor
25087886|NCT03275558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25087887|NCT03275558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25087920|NCT03275376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25087921|NCT03275207|Dexmedetomidine|dexmedetomidine|mesh-list
25087922|NCT03275207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25087923|NCT03275207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25087924|NCT03275207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087925|NCT03275207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25087926|NCT03275207|Analgesics|analgesics|mesh-ancestor
25087927|NCT03275207|Sensory System Agents|sensory system agents|mesh-ancestor
25087928|NCT03275207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25087929|NCT03275207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25087930|NCT03275207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25087931|NCT03275207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25087932|NCT03275207|Adrenergic Agents|adrenergic agents|mesh-ancestor
25087933|NCT03275207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25087934|NCT03275207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087935|NCT03275116|Bromides|bromides|mesh-list
25087936|NCT03275116|Formoterol Fumarate|formoterol fumarate|mesh-list
25087937|NCT03275116|Tiotropium Bromide|tiotropium bromide|mesh-list
25087938|NCT03275116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25087939|NCT03275116|Autonomic Agents|autonomic agents|mesh-ancestor
25087940|NCT03275116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25087941|NCT03275116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087942|NCT03275116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25087943|NCT03275116|Respiratory System Agents|respiratory system agents|mesh-ancestor
25087944|NCT03275116|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25087945|NCT03275116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25087946|NCT03275116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25087947|NCT03275116|Adrenergic Agents|adrenergic agents|mesh-ancestor
25686060|NCT01914159|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25686061|NCT01914159|Growth Substances|growth substances|mesh-ancestor
25686062|NCT01914159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686063|NCT01914159|Growth Inhibitors|growth inhibitors|mesh-ancestor
25686064|NCT01914159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25686065|NCT01914393|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25686066|NCT01914393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25686067|NCT01914393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25686068|NCT01914393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24822931|NCT02114346|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24895773|NCT03060434|Acetaminophen|acetaminophen|mesh-list
24895775|NCT03060434|Pregabalin|pregabalin|mesh-list
24895776|NCT03060434|Pentoxifylline|pentoxifylline|mesh-list
24895777|NCT03060434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24895778|NCT03060434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24895779|NCT03060434|Analgesics|analgesics|mesh-ancestor
24895780|NCT03060434|Sensory System Agents|sensory system agents|mesh-ancestor
25087948|NCT03275116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25087949|NCT03275116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087950|NCT03275116|Parasympatholytics|parasympatholytics|mesh-ancestor
25087951|NCT03275116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25087952|NCT03275116|Cholinergic Agents|cholinergic agents|mesh-ancestor
25087954|NCT03275090|SMOFlipid|smoflipid|mesh-list
25087955|NCT03275090|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25087956|NCT03275090|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25088047|NCT03274167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25088048|NCT03274167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872796|NCT05440487|Chelating Agents|chelating agents|mesh-list
25088049|NCT03274167|Antimanic Agents|antimanic agents|mesh-ancestor
25088052|NCT03274102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088054|NCT03274024|Mitomycin|mitomycin|mesh-list
25088055|NCT03274024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25088056|NCT03274024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25088057|NCT03274024|Alkylating Agents|alkylating agents|mesh-ancestor
25088058|NCT03274024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088246|NCT05074628|Nitrofurantoin|nitrofurantoin|mesh-list
25088247|NCT05074628|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25088249|NCT05074628|Renal Agents|renal agents|mesh-ancestor
25088250|NCT05074628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24523547|NCT05341999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895790|NCT03060434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24895791|NCT03060434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24895792|NCT03060434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24895793|NCT03060434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24895794|NCT03060434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24895795|NCT03060434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24895796|NCT03060434|Antipyretics|antipyretics|mesh-ancestor
24895797|NCT03060434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24895798|NCT03060434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24895799|NCT03060434|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24895800|NCT03060434|Protective Agents|protective agents|mesh-ancestor
24895801|NCT03060434|Vasodilator Agents|vasodilator agents|mesh-ancestor
24895802|NCT03060434|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24895803|NCT03060434|Antioxidants|antioxidants|mesh-ancestor
24895804|NCT03022097|Bromides|bromides|mesh-list
24895805|NCT03022097|Formoterol Fumarate|formoterol fumarate|mesh-list
25088253|NCT05074602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25088254|NCT05074602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25088255|NCT05074602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25088256|NCT05074602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25088257|NCT05074602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088258|NCT05074602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25088259|NCT05074602|Hormone Antagonists|hormone antagonists|mesh-ancestor
25088260|NCT05074602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25088261|NCT05074602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088262|NCT05074602|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25088263|NCT05074602|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25088264|NCT05074589|Leucovorin|leucovorin|mesh-list
25686069|NCT01914393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686070|NCT01914393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25686071|NCT01914393|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25686072|NCT01914393|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25686073|NCT01914393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25686074|NCT01914393|Adrenergic Agents|adrenergic agents|mesh-ancestor
25686075|NCT01914393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25686076|NCT01914393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520945|NCT05225610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24520947|NCT05225610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25088265|NCT05074589|Fluorouracil|fluorouracil|mesh-list
25088266|NCT05074589|Irinotecan|irinotecan|mesh-list
25088267|NCT05074589|Levoleucovorin|levoleucovorin|mesh-list
25088268|NCT05074589|Antimetabolites|antimetabolites|mesh-ancestor
25088331|NCT04933669|Imatinib Mesylate|imatinib mesylate|mesh-list
25088332|NCT04933669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25088333|NCT04933669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25088334|NCT04933669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25088335|NCT04933669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088361|NCT04877821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25088362|NCT04877821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25088363|NCT04877821|Tubulin Modulators|tubulin modulators|mesh-ancestor
25088364|NCT04877821|Antimitotic Agents|antimitotic agents|mesh-ancestor
25088365|NCT04877821|Mitosis Modulators|mitosis modulators|mesh-ancestor
25088366|NCT04877821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417618|NCT00206960|Risperidone|risperidone|mesh-list
25088367|NCT04877821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25088368|NCT04877821|Immunologic Factors|immunologic factors|mesh-ancestor
24792202|NCT05411718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24515474|NCT00597597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24621871|NCT01064349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25088369|NCT04877821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088370|NCT04877821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25088374|NCT04877821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25088375|NCT04877821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25088376|NCT04877821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25088377|NCT04877821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25088399|NCT04647383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25088400|NCT04647383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25088401|NCT04647383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088403|NCT04630002|Darunavir|darunavir|mesh-list
25088404|NCT04630002|Etravirine|etravirine|mesh-list
25088405|NCT04630002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25088406|NCT04630002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25088407|NCT04630002|Protease Inhibitors|protease inhibitors|mesh-ancestor
25088408|NCT04630002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764774|NCT01784120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25088409|NCT04630002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088433|NCT04427904|Lidocaine|lidocaine|mesh-list
25088434|NCT04427904|Epinephrine|epinephrine|mesh-list
25088435|NCT04427904|Racepinephrine|racepinephrine|mesh-list
25088436|NCT04427904|Bupivacaine|bupivacaine|mesh-list
25088437|NCT04427904|Epinephryl borate|epinephryl borate|mesh-list
25088487|NCT04149899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25088490|NCT03920527|Itraconazole|itraconazole|mesh-list
25088491|NCT03920527|Antifungal Agents|antifungal agents|mesh-ancestor
25088492|NCT03920527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25088493|NCT03920527|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25088494|NCT03920527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25088495|NCT03920527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25088496|NCT03920527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088497|NCT03920527|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25088498|NCT03920527|Hormone Antagonists|hormone antagonists|mesh-ancestor
25088499|NCT03920527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25088500|NCT03920527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088532|NCT03849651|Melphalan|melphalan|mesh-list
25088533|NCT03849651|Thiotepa|thiotepa|mesh-list
25088534|NCT03849651|Fludarabine|fludarabine|mesh-list
25088535|NCT03849651|Blinatumomab|blinatumomab|mesh-list
25088536|NCT03849651|Thymoglobulin|thymoglobulin|mesh-list
25088537|NCT03849651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25088538|NCT03849651|Immunologic Factors|immunologic factors|mesh-ancestor
24764265|NCT01780311|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24417776|NCT00207753|Ivermectin|ivermectin|mesh-list
25088539|NCT03849651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088540|NCT03849651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25088541|NCT03849651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25088542|NCT03849651|Alkylating Agents|alkylating agents|mesh-ancestor
25088543|NCT03849651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686077|NCT01914393|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25088544|NCT03849651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25686078|NCT01914393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25686079|NCT01914393|Serotonin Agents|serotonin agents|mesh-ancestor
25088700|NCT03272425|Antioxidants|antioxidants|mesh-ancestor
25088701|NCT03272425|Protective Agents|protective agents|mesh-ancestor
25088731|NCT03272477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25088732|NCT03272477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25088733|NCT03272477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25088734|NCT03272477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25088735|NCT03272477|Hormone Antagonists|hormone antagonists|mesh-ancestor
25088736|NCT03272477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25088737|NCT03272477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25088738|NCT03272477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25088739|NCT03272477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25088740|NCT03272477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25088741|NCT03272477|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25088742|NCT03272477|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25088743|NCT03272477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25088744|NCT03272477|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25088745|NCT03272477|Fertility Agents|fertility agents|mesh-ancestor
25088746|NCT03272477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25088747|NCT03272503|Pimozide|pimozide|mesh-list
25088748|NCT03272503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25088749|NCT03272503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25088780|NCT03272295|Cathartics|cathartics|mesh-ancestor
25088781|NCT03272295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25088782|NCT03272334|Pembrolizumab|pembrolizumab|mesh-list
25088783|NCT03272334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25088784|NCT03272334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25088785|NCT03271866|Metformin|metformin|mesh-list
25088786|NCT03271866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25088787|NCT03271866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088788|NCT03271918|Cabergoline|cabergoline|mesh-list
25088789|NCT03271918|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25088790|NCT03271918|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24822989|NCT02114502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25088791|NCT03271918|Dopamine Agonists|dopamine agonists|mesh-ancestor
25088792|NCT03271918|Dopamine Agents|dopamine agents|mesh-ancestor
25088794|NCT03271918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088795|NCT03271918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088954|NCT03269760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25089124|NCT03269162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25089125|NCT03269162|Tubulin Modulators|tubulin modulators|mesh-ancestor
25089126|NCT03269162|Antimitotic Agents|antimitotic agents|mesh-ancestor
25089127|NCT03269162|Mitosis Modulators|mitosis modulators|mesh-ancestor
24764934|NCT01785108|Ibuprofen|ibuprofen|mesh-list
24765010|NCT01785641|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25090070|NCT03260972|Chloroprocaine|chloroprocaine|mesh-list
25090071|NCT03260972|Anesthetics, Local|anesthetics, local|mesh-ancestor
25090072|NCT03260972|Anesthetics|anesthetics|mesh-ancestor
25090073|NCT03260972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25090074|NCT03260972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090075|NCT03260972|Sensory System Agents|sensory system agents|mesh-ancestor
25090076|NCT03260972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25090077|NCT03260920|Oxytocin|oxytocin|mesh-list
25686080|NCT01914393|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25686081|NCT01914393|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25686082|NCT01914393|Dopamine Agents|dopamine agents|mesh-ancestor
25686083|NCT01914666|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25686084|NCT01914666|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25686085|NCT01914666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25686086|NCT01914666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25090354|NCT03258372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25090355|NCT03258372|Antitubercular Agents|antitubercular agents|mesh-ancestor
25090356|NCT03258372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24520995|NCT05210725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918488|NCT04218890|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
25090667|NCT03255473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090981|NCT03251690|Emtricitabine|emtricitabine|mesh-list
25090982|NCT03251690|Efavirenz|efavirenz|mesh-list
25090983|NCT03251690|Rilpivirine|rilpivirine|mesh-list
25090984|NCT03251690|Antiviral Agents|antiviral agents|mesh-ancestor
25090985|NCT03251690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25090986|NCT03251690|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25090987|NCT03251690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25090988|NCT03251690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090989|NCT03251690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896008|NCT02677181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24896009|NCT02677181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24896010|NCT02677181|Antitubercular Agents|antitubercular agents|mesh-ancestor
24896011|NCT02677181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25090990|NCT03251690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25090991|NCT03251690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25090992|NCT03251690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25090993|NCT03251690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25090994|NCT03251690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25090995|NCT03251690|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24822990|NCT02114502|Antimetabolites|antimetabolites|mesh-ancestor
25090996|NCT03251690|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25090997|NCT03251690|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25090998|NCT03251859|Ticagrelor|ticagrelor|mesh-list
25090999|NCT03251859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25091000|NCT03251859|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25091085|NCT03251170|Anesthetics|anesthetics|mesh-ancestor
25091086|NCT03251170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24789445|NCT01937182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25091087|NCT03251170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25091088|NCT03251170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25091089|NCT03251170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25091093|NCT03251170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25091094|NCT03251170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25091095|NCT03251170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25091096|NCT03251170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25091097|NCT03251170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25091098|NCT03251170|GABA Modulators|gaba modulators|mesh-ancestor
25091099|NCT03251170|GABA Agents|gaba agents|mesh-ancestor
25091100|NCT03251222|Dexmedetomidine|dexmedetomidine|mesh-list
25091101|NCT03251222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25091102|NCT03251222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25091103|NCT03251222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896012|NCT02677181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24896014|NCT02640664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24896015|NCT02640664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24817355|NCT02083055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24817356|NCT02083055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24817358|NCT02083055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25091104|NCT03251222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25091106|NCT03251222|Sensory System Agents|sensory system agents|mesh-ancestor
25091107|NCT03251222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25091197|NCT03250338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091200|NCT03250104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25091202|NCT03250143|Azathioprine|azathioprine|mesh-list
25091203|NCT03250143|Cyclosporins|cyclosporins|mesh-list
25091204|NCT03250143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091205|NCT03250143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091206|NCT03250143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25091207|NCT03250143|Immunologic Factors|immunologic factors|mesh-ancestor
25091208|NCT03250143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091209|NCT03250143|Antifungal Agents|antifungal agents|mesh-ancestor
25091210|NCT03250143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25091211|NCT03250143|Dermatologic Agents|dermatologic agents|mesh-ancestor
25091212|NCT03250143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25091213|NCT03250143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25686087|NCT01914666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686088|NCT01914666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25686089|NCT01914666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686091|NCT01914666|Sensory System Agents|sensory system agents|mesh-ancestor
25686092|NCT01914666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686093|NCT01914666|Antidepressive Agents|antidepressive agents|mesh-ancestor
25066897|NCT03449693|Magnesium Oxide|magnesium oxide|mesh-list
25066898|NCT03449693|Antacids|antacids|mesh-ancestor
25686094|NCT01914666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25686095|NCT01914666|Dopamine Agents|dopamine agents|mesh-ancestor
25686096|NCT01914757|Benralizumab|benralizumab|mesh-list
25686097|NCT01914757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25686098|NCT01914757|Respiratory System Agents|respiratory system agents|mesh-ancestor
25066899|NCT03449693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857662|NCT02293356|Nimotuzumab|nimotuzumab|mesh-list
24777477|NCT01864213|Anesthetics|anesthetics|mesh-ancestor
25091214|NCT03250143|Antimetabolites|antimetabolites|mesh-ancestor
25091215|NCT03250143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25091216|NCT03250143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25091217|NCT03250039|Abrocitinib|abrocitinib|mesh-list
24418452|NCT00209638|Irinotecan|irinotecan|mesh-list
25091218|NCT03250039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25091219|NCT03250039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091344|NCT03249337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25091384|NCT03249168|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25091385|NCT03249168|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25091386|NCT03249168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25091387|NCT03249168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25091452|NCT03248765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25091453|NCT03248765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091458|NCT03248817|Oxymetazoline|oxymetazoline|mesh-list
25091459|NCT03248817|Bupivacaine|bupivacaine|mesh-list
25091460|NCT03248817|Anesthetics, Local|anesthetics, local|mesh-ancestor
25091461|NCT03248817|Anesthetics|anesthetics|mesh-ancestor
25091462|NCT03248817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25091688|NCT03247283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456864|NCT00332436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25091730|NCT03247400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25091731|NCT03247400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25091732|NCT03247400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091733|NCT03247296|Ribavirin|ribavirin|mesh-list
25091734|NCT03247296|Sofosbuvir|sofosbuvir|mesh-list
25091735|NCT03247296|Antimetabolites|antimetabolites|mesh-ancestor
25091736|NCT03247296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091737|NCT03247296|Antiviral Agents|antiviral agents|mesh-ancestor
25092112|NCT03244319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092907|NCT03238131|Anticestodal Agents|anticestodal agents|mesh-ancestor
25092113|NCT03244319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092115|NCT03244553|Laxatives|laxatives|mesh-ancestor
25092116|NCT03244553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25092117|NCT03244553|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
25092118|NCT03244553|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25092119|NCT03244553|Serotonin Agents|serotonin agents|mesh-ancestor
25092120|NCT03244553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25092121|NCT03244553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092122|NCT03244553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092225|NCT03243500|Anesthetics, Local|anesthetics, local|mesh-ancestor
25092226|NCT03243500|Anesthetics|anesthetics|mesh-ancestor
25092227|NCT03243500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25092228|NCT03243500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817359|NCT02083055|Adrenergic Agents|adrenergic agents|mesh-ancestor
24817360|NCT02083055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24817361|NCT02083055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686099|NCT01914926|Metoprolol|metoprolol|mesh-list
25686100|NCT01914926|Diltiazem|diltiazem|mesh-list
25686101|NCT01914926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25686102|NCT01914926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25686103|NCT01914926|Sympatholytics|sympatholytics|mesh-ancestor
25686104|NCT01914926|Autonomic Agents|autonomic agents|mesh-ancestor
25686105|NCT01914926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686106|NCT01914926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092229|NCT03243500|Sensory System Agents|sensory system agents|mesh-ancestor
25092385|NCT03242278|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25092386|NCT03242278|Protease Inhibitors|protease inhibitors|mesh-ancestor
25092387|NCT03242278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092388|NCT03242278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092389|NCT03242278|Anticoagulants|anticoagulants|mesh-ancestor
25092390|NCT03242304|Hydrocortisone|hydrocortisone|mesh-list
25092391|NCT03242304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25092392|NCT03242239|Trastuzumab|trastuzumab|mesh-list
25092393|NCT03242239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25092394|NCT03242239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25092395|NCT03241875|Pregabalin|pregabalin|mesh-list
25092396|NCT03241875|Gabapentin|gabapentin|mesh-list
25092397|NCT03241875|Analgesics|analgesics|mesh-ancestor
25092398|NCT03241875|Sensory System Agents|sensory system agents|mesh-ancestor
25092399|NCT03241875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25092400|NCT03241875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092401|NCT03241875|Anticonvulsants|anticonvulsants|mesh-ancestor
25092402|NCT03241875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25092439|NCT03241784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25092501|NCT03241745|Nivolumab|nivolumab|mesh-list
25092502|NCT03241745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25092503|NCT03241745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25092504|NCT03241745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25092505|NCT03241745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092506|NCT03241602|Lidocaine|lidocaine|mesh-list
25092507|NCT03241602|Anesthetics, Local|anesthetics, local|mesh-ancestor
25092508|NCT03241602|Anesthetics|anesthetics|mesh-ancestor
25092509|NCT03241602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25092510|NCT03241602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092511|NCT03241602|Sensory System Agents|sensory system agents|mesh-ancestor
25092512|NCT03241602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25092513|NCT03241602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25092908|NCT03238131|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25092551|NCT03241381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092552|NCT03241381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25092553|NCT03241303|Acarbose|acarbose|mesh-list
25092618|NCT03240783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092619|NCT03240783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25092620|NCT03240783|Respiratory System Agents|respiratory system agents|mesh-ancestor
24468111|NCT00379886|Anesthetics|anesthetics|mesh-ancestor
25092660|NCT03239691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25092661|NCT03239691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25092698|NCT03239964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25092699|NCT03239964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823074|NCT02114736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24823075|NCT02114736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25092700|NCT03239964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25092732|NCT03239327|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25092734|NCT03239327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25092735|NCT03239327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092849|NCT03238430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25092850|NCT03238430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092851|NCT03238430|Analgesics|analgesics|mesh-ancestor
25092852|NCT03238430|Sensory System Agents|sensory system agents|mesh-ancestor
25092853|NCT03238430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25092854|NCT03238430|Anesthetics, Local|anesthetics, local|mesh-ancestor
25092855|NCT03238430|Anesthetics|anesthetics|mesh-ancestor
25092856|NCT03238482|Fluticasone|fluticasone|mesh-list
25092857|NCT03238482|Xhance|xhance|mesh-list
25092858|NCT03238482|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25092859|NCT03238482|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25092864|NCT03238482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092890|NCT03238612|Oseltamivir|oseltamivir|mesh-list
25092891|NCT03238612|Antiviral Agents|antiviral agents|mesh-list
25092892|NCT03238612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25092893|NCT03238612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25092894|NCT03238612|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25092895|NCT03238612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092896|NCT03238612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092897|NCT03238612|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24515589|NCT00598247|Mitosis Modulators|mitosis modulators|mesh-ancestor
24515590|NCT00598247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515591|NCT00598338|Prucalopride|prucalopride|mesh-list
24515592|NCT00598338|Laxatives|laxatives|mesh-ancestor
24515593|NCT00598338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24515594|NCT00598338|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24896138|NCT01668719|Dexamethasone|dexamethasone|mesh-list
25092898|NCT03238612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25092899|NCT03238638|Pembrolizumab|pembrolizumab|mesh-list
25092900|NCT03238638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25092901|NCT03238638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25092903|NCT03238131|Albendazole|albendazole|mesh-list
25092904|NCT03238131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25092905|NCT03238131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25092906|NCT03238131|Anthelmintics|anthelmintics|mesh-ancestor
25092909|NCT03238131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25092910|NCT03238131|Tubulin Modulators|tubulin modulators|mesh-ancestor
25092911|NCT03238131|Antimitotic Agents|antimitotic agents|mesh-ancestor
25092938|NCT03238157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092939|NCT03237936|Cyclosporine|cyclosporine|mesh-list
25092940|NCT03237936|Cyclosporins|cyclosporins|mesh-list
25092941|NCT03237936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092942|NCT03237936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092943|NCT03237936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25092944|NCT03237936|Immunologic Factors|immunologic factors|mesh-ancestor
25092945|NCT03237936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092946|NCT03237936|Antifungal Agents|antifungal agents|mesh-ancestor
25092947|NCT03237936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25092948|NCT03237936|Dermatologic Agents|dermatologic agents|mesh-ancestor
25092949|NCT03237936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25092950|NCT03237936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25092951|NCT03238183|Hyaluronic Acid|hyaluronic acid|mesh-list
25092952|NCT03238183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25092953|NCT03238183|Immunologic Factors|immunologic factors|mesh-ancestor
25092954|NCT03238183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092955|NCT03238183|Viscosupplements|viscosupplements|mesh-ancestor
25092956|NCT03238183|Protective Agents|protective agents|mesh-ancestor
25092957|NCT03237637|Propranolol|propranolol|mesh-list
24469473|NCT00385970|Protective Agents|protective agents|mesh-ancestor
25092995|NCT03237533|Hormones|hormones|mesh-ancestor
25092996|NCT03237533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25092997|NCT03237533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25092998|NCT03237533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25092999|NCT03237533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093000|NCT03237533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25093001|NCT03237533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25093037|NCT03237416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25093038|NCT03237416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25093039|NCT03237416|Anesthetics, General|anesthetics, general|mesh-ancestor
25093041|NCT03237416|GABA Modulators|gaba modulators|mesh-ancestor
25093042|NCT03237416|GABA Agents|gaba agents|mesh-ancestor
24469691|NCT00386802|Miconazole|miconazole|mesh-list
25093067|NCT03237260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25093095|NCT03236805|Analgesics|analgesics|mesh-ancestor
25093096|NCT03236805|Sensory System Agents|sensory system agents|mesh-ancestor
25093097|NCT03236805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25093098|NCT03236805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093099|NCT03236805|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25093100|NCT03236805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25093101|NCT03236805|Anesthetics, General|anesthetics, general|mesh-ancestor
25093102|NCT03236805|Anesthetics|anesthetics|mesh-ancestor
25082639|NCT03321318|Vitamins|vitamins|mesh-ancestor
24918730|NCT04216758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24918731|NCT04216758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617160|NCT01041378|Dexamethasone|dexamethasone|mesh-list
24617161|NCT01041378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24617162|NCT01041378|Antiemetics|antiemetics|mesh-ancestor
24617163|NCT01041378|Autonomic Agents|autonomic agents|mesh-ancestor
24617428|NCT01043211|Anesthetics|anesthetics|mesh-ancestor
24617429|NCT01043211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24918735|NCT04216784|Furosemide|furosemide|mesh-list
24896154|NCT01668719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24896155|NCT01668719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419513|NCT00212290|Nateglinide|nateglinide|mesh-list
24420063|NCT00215046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896177|NCT01515748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24896178|NCT01515748|Tubulin Modulators|tubulin modulators|mesh-ancestor
24896179|NCT01515748|Antimitotic Agents|antimitotic agents|mesh-ancestor
24896180|NCT01515748|Mitosis Modulators|mitosis modulators|mesh-ancestor
24896181|NCT01515748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896182|NCT01515748|Antimetabolites|antimetabolites|mesh-ancestor
24896183|NCT01515748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24896206|NCT01169259|Vitamins|vitamins|mesh-list
24896234|NCT01117441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896235|NCT01117441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24896236|NCT01117441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24896237|NCT01117441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24896238|NCT01117441|Antiemetics|antiemetics|mesh-ancestor
24896239|NCT01117441|Autonomic Agents|autonomic agents|mesh-ancestor
24896240|NCT01117441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24896241|NCT01117441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24896242|NCT01117441|Glucocorticoids|glucocorticoids|mesh-ancestor
24896243|NCT01117441|Hormones|hormones|mesh-ancestor
24896274|NCT00127673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896276|NCT00127673|Serotonin Agents|serotonin agents|mesh-ancestor
24896277|NCT00127673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896278|NCT04438421|Chlorhexidine|chlorhexidine|mesh-list
25093103|NCT03236805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25093104|NCT03236805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25093105|NCT03236805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25093106|NCT03236805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25093107|NCT03236805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093108|NCT03236805|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25093109|NCT03236805|Narcotics|narcotics|mesh-ancestor
25093110|NCT03236974|Fulvestrant|fulvestrant|mesh-list
25093111|NCT03236974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25093112|NCT03236974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25093113|NCT03236974|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25093114|NCT03236974|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25093147|NCT03236883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25093148|NCT03236883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25093149|NCT03236883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25093150|NCT03236883|Immunologic Factors|immunologic factors|mesh-ancestor
25093151|NCT03236883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093152|NCT03236961|Moxifloxacin|moxifloxacin|mesh-list
25093153|NCT03236961|Metronidazole|metronidazole|mesh-list
25093187|NCT03236740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25093188|NCT03236740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093191|NCT03236740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25093192|NCT03236740|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25093193|NCT03236740|Contraceptive Agents|contraceptive agents|mesh-ancestor
25093194|NCT03236740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25093226|NCT03236987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25093227|NCT03236987|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25093228|NCT03236987|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25093229|NCT03236987|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25093230|NCT03236987|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25686107|NCT01914926|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25686108|NCT01914926|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25686109|NCT01914926|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25686110|NCT01914926|Adrenergic Agents|adrenergic agents|mesh-ancestor
25686111|NCT01914926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25686112|NCT01914926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686113|NCT01914926|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25093231|NCT03236987|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25093266|NCT03236324|Autonomic Agents|autonomic agents|mesh-ancestor
25093273|NCT03236233|Antiviral Agents|antiviral agents|mesh-ancestor
25093274|NCT03236233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25093275|NCT03236233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25093276|NCT03236233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093277|NCT03236220|Acetylcysteine|acetylcysteine|mesh-list
25093278|NCT03236220|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25093279|NCT03236220|Antiviral Agents|antiviral agents|mesh-ancestor
25093280|NCT03236220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25093281|NCT03236220|Expectorants|expectorants|mesh-ancestor
25093282|NCT03236220|Respiratory System Agents|respiratory system agents|mesh-ancestor
25093311|NCT03236155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25093312|NCT03235921|Nitroglycerin|nitroglycerin|mesh-list
25093313|NCT03235921|Vasodilator Agents|vasodilator agents|mesh-ancestor
25093314|NCT03235973|Fludarabine|fludarabine|mesh-list
25093315|NCT03235973|Busulfan|busulfan|mesh-list
25093316|NCT03235973|Cladribine|cladribine|mesh-list
25093317|NCT03235973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25093318|NCT03235973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093319|NCT03235973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25093320|NCT03235973|Immunologic Factors|immunologic factors|mesh-ancestor
25093321|NCT03235973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093322|NCT03235973|Alkylating Agents|alkylating agents|mesh-ancestor
25093323|NCT03235973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24896280|NCT04438421|Hydrogen Peroxide|hydrogen peroxide|mesh-list
24896281|NCT04438421|Hyaluronic Acid|hyaluronic acid|mesh-list
24896282|NCT04438421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24896283|NCT04438421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24473301|NCT00402506|Pyridoxal|pyridoxal|mesh-list
25093324|NCT03235973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24769928|NCT01816997|Pravastatin|pravastatin|mesh-list
24470959|NCT00392691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25093361|NCT03235531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093363|NCT03235531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24769996|NCT01817322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25093433|NCT03234816|Bupivacaine|bupivacaine|mesh-list
25093434|NCT03234816|Anesthetics, Local|anesthetics, local|mesh-ancestor
25093435|NCT03234816|Anesthetics|anesthetics|mesh-ancestor
25093436|NCT03234816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25093465|NCT03234673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25093466|NCT03234673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093467|NCT03234673|Dermatologic Agents|dermatologic agents|mesh-ancestor
25093469|NCT03234517|Clindamycin palmitate|clindamycin palmitate|mesh-list
25093470|NCT03234517|Clindamycin phosphate|clindamycin phosphate|mesh-list
25093471|NCT03234517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25093472|NCT03234517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25093473|NCT03234517|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25093474|NCT03234517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25093475|NCT03234517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093476|NCT03234244|Cholecalciferol|cholecalciferol|mesh-list
25093477|NCT03234244|Vitamin D|vitamin d|mesh-list
25093478|NCT03234244|Bazedoxifene|bazedoxifene|mesh-list
25093479|NCT03234244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25093480|NCT03234244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093481|NCT03234244|Vitamins|vitamins|mesh-ancestor
25093509|NCT03234699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25093510|NCT03234699|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25093511|NCT03234699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24792898|NCT04408118|Paclitaxel|paclitaxel|mesh-list
24896327|NCT04437836|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24896328|NCT04437836|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25093512|NCT03234699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25093513|NCT03234699|Antidepressive Agents|antidepressive agents|mesh-ancestor
25093514|NCT03234699|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25093515|NCT03234699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25093517|NCT03234699|Dopamine Agents|dopamine agents|mesh-ancestor
25093518|NCT03234699|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25093519|NCT03234699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25093520|NCT03234699|Anticonvulsants|anticonvulsants|mesh-ancestor
25093521|NCT03234400|Dapivirine|dapivirine|mesh-list
25093522|NCT03234400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25093523|NCT03234400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25093524|NCT03234400|Antiviral Agents|antiviral agents|mesh-ancestor
25093525|NCT03234400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25093526|NCT03234413|Botulinum Toxins|botulinum toxins|mesh-list
25093559|NCT03234296|Renal Agents|renal agents|mesh-ancestor
25093560|NCT03234296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25093561|NCT03234296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25093562|NCT03234296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25093563|NCT03234296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093564|NCT03234296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25093565|NCT03234296|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25093593|NCT03233932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25093594|NCT03233932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24896331|NCT04437836|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24896344|NCT04437693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24896345|NCT04437693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896347|NCT04437693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24420588|NCT00216385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25093599|NCT03233815|Sevoflurane|sevoflurane|mesh-list
25093600|NCT03233815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25093601|NCT03233815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25093602|NCT03233815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770104|NCT01817972|Certolizumab Pegol|certolizumab pegol|mesh-list
25093603|NCT03233815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25093604|NCT03233815|Anesthetics, General|anesthetics, general|mesh-ancestor
25093605|NCT03233815|Anesthetics|anesthetics|mesh-ancestor
24770176|NCT01818908|Immunologic Factors|immunologic factors|mesh-ancestor
24770177|NCT01818908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770178|NCT01818908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24770179|NCT01818908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24770180|NCT01818908|Alkylating Agents|alkylating agents|mesh-ancestor
24770181|NCT01818908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473438|NCT00402792|Acetaminophen|acetaminophen|mesh-list
24896589|NCT04434404|Silymarin|silymarin|mesh-list
25093670|NCT03232957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25093671|NCT03232957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25093672|NCT03232957|Narcotics|narcotics|mesh-ancestor
25093673|NCT03232957|Analgesics|analgesics|mesh-ancestor
25093674|NCT03232632|Flutemetamol|flutemetamol|mesh-list
25093675|NCT03232632|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24420839|NCT00216879|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24421019|NCT00217503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24421077|NCT00217555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24793023|NCT04270175|Dexamethasone|dexamethasone|mesh-list
24896409|NCT04436601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24896436|NCT04436328|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24719122|NCT01559298|Aspirin|aspirin|mesh-list
25093676|NCT03232632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093678|NCT03232710|Antidepressive Agents|antidepressive agents|mesh-ancestor
25093679|NCT03232710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25093706|NCT03232450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25093707|NCT03232450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25093708|NCT03232450|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25093709|NCT03232450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25093710|NCT03232450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093711|NCT03232450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25093712|NCT03232450|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25093740|NCT03232307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25093741|NCT03232307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25093742|NCT03232307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25093743|NCT03232307|Antiemetics|antiemetics|mesh-ancestor
25093744|NCT03232307|Autonomic Agents|autonomic agents|mesh-ancestor
25093745|NCT03232307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25093746|NCT03232307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25093747|NCT03232307|Glucocorticoids|glucocorticoids|mesh-ancestor
24421118|NCT00217698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25686114|NCT01914926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24437347|NCT00273442|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24437349|NCT00273455|Bimatoprost|bimatoprost|mesh-list
24437385|NCT00273481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24437386|NCT00273481|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24437387|NCT00273507|Paclitaxel|paclitaxel|mesh-list
24918972|NCT04214938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24918973|NCT04214938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24918974|NCT04214938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918975|NCT04214938|Nasal Decongestants|nasal decongestants|mesh-ancestor
24437488|NCT00273871|Tacrolimus|tacrolimus|mesh-list
24477976|NCT00421096|Gemcitabine|gemcitabine|mesh-list
24515838|NCT00599573|Dermatologic Agents|dermatologic agents|mesh-ancestor
24515839|NCT00599573|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25093749|NCT03232307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25093783|NCT03232034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25093785|NCT03232125|Ramosetron|ramosetron|mesh-list
25093786|NCT03232125|Antiemetics|antiemetics|mesh-ancestor
24823235|NCT02115763|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24823236|NCT02115763|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24823237|NCT02115763|Purinergic Agents|purinergic agents|mesh-ancestor
24579440|NCT00855101|Voriconazole|voriconazole|mesh-list
24823238|NCT02115763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24823239|NCT02115776|Amoxicillin|amoxicillin|mesh-list
24823240|NCT02115776|Clavulanic Acid|clavulanic acid|mesh-list
24421157|NCT00217932|Anticonvulsants|anticonvulsants|mesh-ancestor
24421164|NCT00217932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24422186|NCT00221520|Anesthetics|anesthetics|mesh-ancestor
24421165|NCT00217932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24421166|NCT00217932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24421167|NCT00218049|Vanoxerine|vanoxerine|mesh-list
24421168|NCT00218049|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24421169|NCT00218049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25093815|NCT03232112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25093817|NCT03231813|Dermatologic Agents|dermatologic agents|mesh-ancestor
25093818|NCT03231683|Ketamine|ketamine|mesh-list
25093819|NCT03231683|Remifentanil|remifentanil|mesh-list
25093820|NCT03231683|Propofol|propofol|mesh-list
25093821|NCT03231683|Esketamine|esketamine|mesh-list
25093822|NCT03231683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25093823|NCT03231683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25093824|NCT03231683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686115|NCT01914926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25686116|NCT01914926|Vasodilator Agents|vasodilator agents|mesh-ancestor
25686117|NCT01915108|Remifentanil|remifentanil|mesh-list
25686118|NCT01915108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25686119|NCT01915108|Narcotics|narcotics|mesh-ancestor
25686120|NCT01915108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25686121|NCT01915108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686122|NCT01915108|Analgesics|analgesics|mesh-ancestor
25686123|NCT01915108|Sensory System Agents|sensory system agents|mesh-ancestor
25686124|NCT01915108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686125|NCT01915303|Cabergoline|cabergoline|mesh-list
25093825|NCT03231683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24919017|NCT04214821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24919018|NCT04214821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919019|NCT04214821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919020|NCT04214821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24919021|NCT04214821|Renal Agents|renal agents|mesh-ancestor
24535953|NCT00650052|Zonisamide|zonisamide|mesh-list
24437567|NCT00274001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25093826|NCT03231683|Anesthetics, General|anesthetics, general|mesh-ancestor
25093827|NCT03231683|Anesthetics|anesthetics|mesh-ancestor
25093828|NCT03231683|Analgesics|analgesics|mesh-ancestor
25093829|NCT03231683|Sensory System Agents|sensory system agents|mesh-ancestor
25093852|NCT03231215|Dexamethasone|dexamethasone|mesh-list
25093853|NCT03231215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25093854|NCT03231215|Antiemetics|antiemetics|mesh-ancestor
25093855|NCT03231215|Autonomic Agents|autonomic agents|mesh-ancestor
25093856|NCT03231215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25093857|NCT03231215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093858|NCT03231215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25093859|NCT03231215|Glucocorticoids|glucocorticoids|mesh-ancestor
25093861|NCT03231215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25093862|NCT03231215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25093863|NCT03231215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25093864|NCT03231033|Pioglitazone|pioglitazone|mesh-list
25093865|NCT03231033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25093866|NCT03231033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093903|NCT03230734|Antimitotic Agents|antimitotic agents|mesh-ancestor
25093904|NCT03230734|Mitosis Modulators|mitosis modulators|mesh-ancestor
25093905|NCT03230734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093906|NCT03230539|Ulipristal acetate|ulipristal acetate|mesh-list
25093907|NCT03230539|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25093908|NCT03230539|Contraceptive Agents|contraceptive agents|mesh-ancestor
25093909|NCT03230539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25093910|NCT03230539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093911|NCT03230539|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25093912|NCT03230474|Morphine|morphine|mesh-list
25093913|NCT03230474|Naloxone|naloxone|mesh-list
25093914|NCT03230474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24421170|NCT00218049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24421344|NCT00218348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421345|NCT00218348|Adrenergic Agents|adrenergic agents|mesh-ancestor
24421346|NCT00218348|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24421347|NCT00218348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24421350|NCT00218361|Hydromorphone|hydromorphone|mesh-list
25093915|NCT03230474|Narcotics|narcotics|mesh-ancestor
25093916|NCT03230474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25093917|NCT03230474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093948|NCT03229746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25093950|NCT03229746|Tubulin Modulators|tubulin modulators|mesh-ancestor
25093951|NCT03229746|Antimitotic Agents|antimitotic agents|mesh-ancestor
25093952|NCT03229746|Mitosis Modulators|mitosis modulators|mesh-ancestor
25093953|NCT03229746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093954|NCT03229746|Antimalarials|antimalarials|mesh-ancestor
25093986|NCT03230058|Antifungal Agents|antifungal agents|mesh-ancestor
25093987|NCT03230058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25093988|NCT03230058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25093989|NCT03230058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25093990|NCT03230058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25093991|NCT03230058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093992|NCT03230058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25093993|NCT03230058|Hormone Antagonists|hormone antagonists|mesh-ancestor
25094137|NCT03228667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24477322|NCT00418249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25686126|NCT01915303|Pasireotide|pasireotide|mesh-list
25686127|NCT01915303|Hormones|hormones|mesh-ancestor
25686128|NCT01915303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25686129|NCT01915303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686130|NCT01915303|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25686131|NCT01915303|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25686132|NCT01915303|Dopamine Agonists|dopamine agonists|mesh-ancestor
24919104|NCT04214145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25094016|NCT03229889|Tadalafil|tadalafil|mesh-list
25094017|NCT03229889|Tamsulosin|tamsulosin|mesh-list
25094018|NCT03229889|Vasodilator Agents|vasodilator agents|mesh-ancestor
25094019|NCT03229889|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25094020|NCT03229889|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25094021|NCT03229889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094022|NCT03229889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094023|NCT03229889|Urological Agents|urological agents|mesh-ancestor
25094024|NCT03229889|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25094025|NCT03229889|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25094026|NCT03229889|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25094027|NCT03229889|Adrenergic Agents|adrenergic agents|mesh-ancestor
24477410|NCT00418509|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25094062|NCT03228992|Analgesics|analgesics|mesh-ancestor
25094063|NCT03228992|Sensory System Agents|sensory system agents|mesh-ancestor
24896604|NCT04434430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24896605|NCT04434430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24896606|NCT04434430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24515859|NCT00599716|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24515860|NCT00599716|Immunologic Factors|immunologic factors|mesh-ancestor
24515861|NCT00599716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515870|NCT00599807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24515872|NCT00599820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24515873|NCT00599820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793290|NCT03581370|Penicillanic Acid|penicillanic acid|mesh-list
25094064|NCT03228992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25094097|NCT03228628|Sensory System Agents|sensory system agents|mesh-ancestor
25094098|NCT03228628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25094100|NCT03228823|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
25094101|NCT03228823|Vasodilator Agents|vasodilator agents|mesh-ancestor
25094102|NCT03228823|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25094103|NCT03228823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25094104|NCT03228823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094105|NCT03228823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25094134|NCT03228667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25094135|NCT03228667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25094136|NCT03228667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25094174|NCT03228862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25094175|NCT03228303|Imatinib Mesylate|imatinib mesylate|mesh-list
25094176|NCT03228303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25094177|NCT03228303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24456992|NCT00332891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25094213|NCT03228108|Clavulanic Acid|clavulanic acid|mesh-list
25094214|NCT03228108|Fosfomycin|fosfomycin|mesh-list
24515878|NCT00599820|Growth Inhibitors|growth inhibitors|mesh-ancestor
25686133|NCT01915303|Dopamine Agents|dopamine agents|mesh-ancestor
25686134|NCT01915303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25686135|NCT01915303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686136|NCT01915732|Clindamycin|clindamycin|mesh-list
25686137|NCT01915732|Clindamycin palmitate|clindamycin palmitate|mesh-list
25686138|NCT01915732|Clindamycin phosphate|clindamycin phosphate|mesh-list
25686139|NCT01915732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25686140|NCT01915732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24494233|NCT00494468|GABA Agonists|gaba agonists|mesh-ancestor
24952014|NCT03898752|Micronutrients|micronutrients|mesh-ancestor
24657192|NCT01266174|Serotonin Agents|serotonin agents|mesh-ancestor
24952015|NCT03898752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952017|NCT03899285|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24952018|NCT03899285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24952019|NCT03899285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24952020|NCT03899285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952021|NCT03899285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24521097|NCT05112081|Botulinum Toxins|botulinum toxins|mesh-list
24521100|NCT05112081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24521101|NCT05112081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24515880|NCT00599833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24896618|NCT04434365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896619|NCT04434365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24896621|NCT04434365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24896622|NCT04434365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24473712|NCT00403910|Hormone Antagonists|hormone antagonists|mesh-ancestor
24515881|NCT00599833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25094215|NCT03228108|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25094216|NCT03228108|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
25094217|NCT03228108|Trimethoprim|trimethoprim|mesh-list
25094248|NCT03227731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25094250|NCT03227731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094251|NCT03227731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25094252|NCT03227731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25094253|NCT03227900|Lidocaine|lidocaine|mesh-list
25094254|NCT03227900|Anesthetics, Local|anesthetics, local|mesh-ancestor
25094255|NCT03227900|Anesthetics|anesthetics|mesh-ancestor
24478453|NCT00422864|Vitamins|vitamins|mesh-ancestor
25094278|NCT03227679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25094279|NCT03227679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094280|NCT03227679|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25094281|NCT03227679|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25094282|NCT03227679|Cholinergic Agents|cholinergic agents|mesh-ancestor
25094283|NCT03227679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25094284|NCT03227679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094318|NCT03227653|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25094319|NCT03227653|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25094320|NCT03227653|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25094321|NCT03227653|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25094354|NCT03227432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24873404|NCT05253131|Durvalumab|durvalumab|mesh-list
25094355|NCT03227432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094356|NCT03227432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25094357|NCT03227432|Glucocorticoids|glucocorticoids|mesh-ancestor
25094359|NCT03227432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25094360|NCT03227432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25094380|NCT03226821|Tesamorelin|tesamorelin|mesh-list
25094381|NCT03226821|Growth Substances|growth substances|mesh-ancestor
25094385|NCT03226431|Ascorbic Acid|ascorbic acid|mesh-list
25094386|NCT03226431|Antioxidants|antioxidants|mesh-ancestor
25094387|NCT03226431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094388|NCT03226431|Protective Agents|protective agents|mesh-ancestor
25094389|NCT03226431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094390|NCT03226431|Vitamins|vitamins|mesh-ancestor
25094391|NCT03226431|Micronutrients|micronutrients|mesh-ancestor
25094434|NCT03226340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094435|NCT03226340|Vasodilator Agents|vasodilator agents|mesh-ancestor
25686141|NCT01915732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25686142|NCT01915732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25686143|NCT01915732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686144|NCT01915823|Fluticasone|fluticasone|mesh-list
25686145|NCT01915823|Xhance|xhance|mesh-list
25686146|NCT01915823|Azelastine|azelastine|mesh-list
25686147|NCT01915823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25686148|NCT01915823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25686149|NCT01915823|Autonomic Agents|autonomic agents|mesh-ancestor
25686150|NCT01915823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686151|NCT01915823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686152|NCT01915823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25686153|NCT01915823|Respiratory System Agents|respiratory system agents|mesh-ancestor
25094436|NCT03226340|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25094437|NCT03226340|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24421921|NCT00220584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421924|NCT00220584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24421925|NCT00220584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421928|NCT00220623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25094469|NCT03226080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25094470|NCT03226080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094471|NCT03225963|Temozolomide|temozolomide|mesh-list
24804053|NCT02000726|Citalopram|citalopram|mesh-list
24515883|NCT00599885|Telmisartan|telmisartan|mesh-list
24515884|NCT00599885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24896623|NCT04434365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896624|NCT04434365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24896625|NCT04434365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24896626|NCT04434365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896637|NCT04434365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24896638|NCT04434248|Ritonavir|ritonavir|mesh-list
24896639|NCT04434248|Lopinavir|lopinavir|mesh-list
25094472|NCT03225963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25094473|NCT03225963|Alkylating Agents|alkylating agents|mesh-ancestor
25094474|NCT03225963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094475|NCT03225963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771097|NCT01824758|Rocuronium|rocuronium|mesh-list
25094476|NCT03225924|Prednisone|prednisone|mesh-list
25094477|NCT03225924|Cyclophosphamide|cyclophosphamide|mesh-list
25094478|NCT03225924|Rituximab|rituximab|mesh-list
24479027|NCT00425243|GABA Agonists|gaba agonists|mesh-ancestor
25094493|NCT03225924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25094494|NCT03225924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094495|NCT03225924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25094496|NCT03225924|Glucocorticoids|glucocorticoids|mesh-ancestor
25094497|NCT03225924|Hormones|hormones|mesh-ancestor
25094498|NCT03225924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25094499|NCT03225924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25094500|NCT03225924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25094501|NCT03225924|Tubulin Modulators|tubulin modulators|mesh-ancestor
25094502|NCT03225924|Antimitotic Agents|antimitotic agents|mesh-ancestor
25094503|NCT03225924|Mitosis Modulators|mitosis modulators|mesh-ancestor
25094504|NCT03226145|Scopolamine|scopolamine|mesh-list
24708693|NCT01502046|Analgesics|analgesics|mesh-ancestor
24421964|NCT00220766|Immunologic Factors|immunologic factors|mesh-ancestor
24421965|NCT00220766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421966|NCT00220818|Lansoprazole|lansoprazole|mesh-list
24421967|NCT00220818|Dexlansoprazole|dexlansoprazole|mesh-list
25094505|NCT03226145|Bisacodyl|bisacodyl|mesh-list
25094506|NCT03226145|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25094507|NCT03226145|Cathartics|cathartics|mesh-ancestor
25094508|NCT03226145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25094509|NCT03226145|Laxatives|laxatives|mesh-ancestor
25094510|NCT03226145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25094511|NCT03226145|Antiemetics|antiemetics|mesh-ancestor
25094512|NCT03226145|Autonomic Agents|autonomic agents|mesh-ancestor
25094513|NCT03226145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25094514|NCT03226145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094515|NCT03226145|Mydriatics|mydriatics|mesh-ancestor
25094560|NCT03225326|Carticaine|carticaine|mesh-list
25094561|NCT03225326|Anesthetics, Local|anesthetics, local|mesh-ancestor
25094562|NCT03225326|Anesthetics|anesthetics|mesh-ancestor
24479112|NCT00425568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094582|NCT03224923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25094583|NCT03224923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094585|NCT03224923|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25094586|NCT03224923|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25094587|NCT03224923|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25094588|NCT03224923|Purinergic Agents|purinergic agents|mesh-ancestor
25094589|NCT03224923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25094590|NCT03224637|Acetaminophen|acetaminophen|mesh-list
25094591|NCT03224637|Ketorolac|ketorolac|mesh-list
25094592|NCT03224637|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25686154|NCT01915823|Dermatologic Agents|dermatologic agents|mesh-ancestor
25686155|NCT01915823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25686156|NCT01915823|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25686157|NCT01915823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25686158|NCT01915823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437871|NCT00274599|Telmisartan|telmisartan|mesh-list
24919332|NCT04212429|Ofloxacin|ofloxacin|mesh-list
25094594|NCT03224637|Analgesics|analgesics|mesh-ancestor
25094595|NCT03224637|Sensory System Agents|sensory system agents|mesh-ancestor
25094596|NCT03224637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25094597|NCT03224637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094598|NCT03224637|Antipyretics|antipyretics|mesh-ancestor
25094599|NCT03224637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25094600|NCT03224637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25094601|NCT03224637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25094602|NCT03224637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25094603|NCT03224637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094632|NCT03224338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094633|NCT03224338|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25094634|NCT03224338|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24422029|NCT00221000|Dermatologic Agents|dermatologic agents|mesh-ancestor
25094635|NCT03224338|Antiviral Agents|antiviral agents|mesh-ancestor
25094636|NCT03224338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25094637|NCT03224377|Antibodies|antibodies|mesh-list
25094638|NCT03224377|Immunoglobulins|immunoglobulins|mesh-list
24896640|NCT04434248|Hydroxychloroquine|hydroxychloroquine|mesh-list
24896641|NCT04434248|Chloroquine|chloroquine|mesh-list
24896642|NCT04434248|Favipiravir|favipiravir|mesh-list
24515983|NCT00600158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24896652|NCT04434248|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24896653|NCT04434248|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24896654|NCT04434248|Antimalarials|antimalarials|mesh-ancestor
24896655|NCT04434248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24896656|NCT04434248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24896657|NCT04434248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24896659|NCT04434105|Triamcinolone|triamcinolone|mesh-list
25094639|NCT03224377|Immunologic Factors|immunologic factors|mesh-ancestor
25094640|NCT03224377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094641|NCT03224221|Fluorouracil|fluorouracil|mesh-list
25094642|NCT03224221|Apatinib|apatinib|mesh-list
25094643|NCT03224221|Antimetabolites|antimetabolites|mesh-ancestor
25094644|NCT03224221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094645|NCT03224221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25094646|NCT03224221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25094683|NCT03223844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25094717|NCT03223402|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25094718|NCT03223402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25094720|NCT03223402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094721|NCT03223402|Antiviral Agents|antiviral agents|mesh-ancestor
25094722|NCT03223402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25094723|NCT03223402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25094757|NCT03223064|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25094758|NCT03223064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25094759|NCT03223064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094797|NCT03222687|Immunologic Factors|immunologic factors|mesh-ancestor
25094798|NCT03222687|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24793585|NCT03091881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422030|NCT00221026|Methoxsalen|methoxsalen|mesh-list
24422156|NCT00221481|GABA Agents|gaba agents|mesh-ancestor
24422157|NCT00221481|Antimanic Agents|antimanic agents|mesh-ancestor
24422158|NCT00221494|Pindolol|pindolol|mesh-list
24422159|NCT00221494|Citalopram|citalopram|mesh-list
24422160|NCT00221494|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24422164|NCT00221494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24422233|NCT00221650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422234|NCT00221650|Antiviral Agents|antiviral agents|mesh-ancestor
24422235|NCT00221650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24422236|NCT00221689|Baclofen|baclofen|mesh-list
24793586|NCT03032406|Hydroxychloroquine|hydroxychloroquine|mesh-list
25686159|NCT01915823|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25686160|NCT01915823|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24494360|NCT00494897|Dermatologic Agents|dermatologic agents|mesh-ancestor
24494361|NCT00494897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24494362|NCT00494897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24494363|NCT00494897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24953476|NCT03884348|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24953477|NCT03884348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24953478|NCT03884348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24896675|NCT04434144|Hydroxychloroquine|hydroxychloroquine|mesh-list
25095961|NCT03215056|Anesthetics|anesthetics|mesh-ancestor
24896677|NCT04434144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24896678|NCT04434144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24896679|NCT04434144|Antimalarials|antimalarials|mesh-ancestor
24896680|NCT04434144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24896681|NCT04434144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24896682|NCT04434144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896683|NCT04434144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896684|NCT04434144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24896687|NCT04434170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24817525|NCT02084446|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24817526|NCT02084446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24817527|NCT02084446|Glucocorticoids|glucocorticoids|mesh-ancestor
24817529|NCT02084446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24817530|NCT02084446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817531|NCT02084446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24817532|NCT02084446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24817533|NCT02084446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25094799|NCT03222687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094800|NCT03222687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094802|NCT03222518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25094803|NCT03222518|Piroxicam|piroxicam|mesh-list
25094835|NCT03222323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25094836|NCT03222323|Adrenergic Agents|adrenergic agents|mesh-ancestor
25094837|NCT03222323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25094838|NCT03222323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094839|NCT03222323|Anesthetics, Local|anesthetics, local|mesh-ancestor
25094840|NCT03222323|Anesthetics|anesthetics|mesh-ancestor
25094841|NCT03222089|Leucovorin|leucovorin|mesh-list
25094842|NCT03222089|Fluorouracil|fluorouracil|mesh-list
25094843|NCT03222089|Oxaliplatin|oxaliplatin|mesh-list
25094844|NCT03222089|Irinotecan|irinotecan|mesh-list
25094845|NCT03222089|Interleukin-2|interleukin-2|mesh-list
25094846|NCT03222089|Molgramostim|molgramostim|mesh-list
25094877|NCT03222310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25094878|NCT03222310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094879|NCT03222310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24422298|NCT00221975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422299|NCT00221975|Antimanic Agents|antimanic agents|mesh-ancestor
24422300|NCT00221975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24422326|NCT00222079|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24422327|NCT00222079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422330|NCT00222144|Imatinib Mesylate|imatinib mesylate|mesh-list
25094881|NCT03222167|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25094882|NCT03222167|Antiviral Agents|antiviral agents|mesh-ancestor
25094883|NCT03222167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25094884|NCT03221816|Folic Acid|folic acid|mesh-list
25094885|NCT03221816|Pyridoxine|pyridoxine|mesh-list
25094886|NCT03221816|Vitamin B 12|vitamin b 12|mesh-list
25094887|NCT03221816|Hematinics|hematinics|mesh-ancestor
25094888|NCT03221816|Vitamin B Complex|vitamin b complex|mesh-ancestor
25094889|NCT03221816|Vitamins|vitamins|mesh-ancestor
25686161|NCT01915823|Histamine Antagonists|histamine antagonists|mesh-ancestor
25686162|NCT01915823|Histamine Agents|histamine agents|mesh-ancestor
25686163|NCT01915823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25686164|NCT01915849|Licogliflozin|licogliflozin|mesh-list
25686165|NCT01915849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25686166|NCT01915849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686167|NCT01915849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25094914|NCT03221907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25094915|NCT03221907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25094917|NCT03221881|Doxorubicin|doxorubicin|mesh-list
25094918|NCT03221881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25686168|NCT01915849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686169|NCT01915914|Fluticasone|fluticasone|mesh-list
25686170|NCT01915914|Xhance|xhance|mesh-list
24521218|NCT04958538|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24521220|NCT04958538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24521221|NCT04958538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094919|NCT03221881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967313|NCT03760770|Riboflavin|riboflavin|mesh-list
25094921|NCT03221881|Antimitotic Agents|antimitotic agents|mesh-ancestor
25094922|NCT03221881|Mitosis Modulators|mitosis modulators|mesh-ancestor
25094923|NCT03221881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094924|NCT03221881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25094925|NCT03221881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25094926|NCT03221881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25094927|NCT03221881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094928|NCT03221946|Diclofenac|diclofenac|mesh-list
25094929|NCT03221946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25094930|NCT03221946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25094931|NCT03221946|Analgesics|analgesics|mesh-ancestor
25094932|NCT03221946|Sensory System Agents|sensory system agents|mesh-ancestor
25094934|NCT03221946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094935|NCT03221946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25094936|NCT03221946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25094937|NCT03221946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24479825|NCT00428519|Aprepitant|aprepitant|mesh-list
25094970|NCT03221504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25094971|NCT03221504|Adrenergic Agents|adrenergic agents|mesh-ancestor
25094972|NCT03221504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25094973|NCT03221504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094974|NCT03221504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094975|NCT03221504|Sympathomimetics|sympathomimetics|mesh-ancestor
25094976|NCT03221504|Autonomic Agents|autonomic agents|mesh-ancestor
25094977|NCT03221504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24823481|NCT02117583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24823482|NCT02117583|Narcotics|narcotics|mesh-ancestor
24823483|NCT02117583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24422462|NCT00222547|Vitamin A|vitamin a|mesh-list
25095012|NCT03221166|Thalidomide|thalidomide|mesh-list
25095013|NCT03221166|Infliximab|infliximab|mesh-list
25095014|NCT03221166|Dermatologic Agents|dermatologic agents|mesh-ancestor
25095015|NCT03221166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25095016|NCT03221166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25095017|NCT03221166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25095018|NCT03221166|Immunologic Factors|immunologic factors|mesh-ancestor
24967344|NCT03760445|Daunorubicin|daunorubicin|mesh-list
25095019|NCT03221166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095021|NCT03221166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25095022|NCT03221166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25095023|NCT03221166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24457122|NCT00333151|Metformin|metformin|mesh-list
25095060|NCT03220815|Dopamine Agents|dopamine agents|mesh-ancestor
25095061|NCT03220815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25095062|NCT03220815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095093|NCT03220867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25095094|NCT03220867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25095095|NCT03220867|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25095096|NCT03220867|Dopamine Agents|dopamine agents|mesh-ancestor
25095097|NCT03220789|Methamphetamine|methamphetamine|mesh-list
25095098|NCT03220789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25095099|NCT03220789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095100|NCT03220789|Sympathomimetics|sympathomimetics|mesh-ancestor
25095156|NCT03220542|Esomeprazole|esomeprazole|mesh-list
24771919|NCT01830491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24771920|NCT01830491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24771921|NCT01830491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24771922|NCT01830491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095157|NCT03220542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25095158|NCT03220542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25686171|NCT01915914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25686172|NCT01915914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25686173|NCT01915914|Autonomic Agents|autonomic agents|mesh-ancestor
25686174|NCT01915914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686175|NCT01915914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686176|NCT01915914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25686177|NCT01915914|Respiratory System Agents|respiratory system agents|mesh-ancestor
25686178|NCT01915914|Dermatologic Agents|dermatologic agents|mesh-ancestor
25686179|NCT01915914|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24521259|NCT04919096|Aflibercept|aflibercept|mesh-list
24617725|NCT01045278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24521266|NCT04909697|Sivelestat|sivelestat|mesh-list
25095159|NCT03220542|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25095160|NCT03220542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25095161|NCT03220542|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25095162|NCT03220542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25095163|NCT03220542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896753|NCT04433156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24896754|NCT04433156|Alkylating Agents|alkylating agents|mesh-ancestor
24896755|NCT04433156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422463|NCT00222547|Albendazole|albendazole|mesh-list
24422464|NCT00222547|Vitamins|vitamins|mesh-ancestor
24478350|NCT00422526|Progesterone|progesterone|mesh-list
25095164|NCT03220542|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25095165|NCT03220542|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25095166|NCT03220542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25095167|NCT03220542|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25095168|NCT03220542|Protective Agents|protective agents|mesh-ancestor
25095169|NCT03220542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095170|NCT03220542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095172|NCT03220490|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25095173|NCT03220490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25095174|NCT03220490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25095175|NCT03220490|Adrenergic Agents|adrenergic agents|mesh-ancestor
25095176|NCT03220490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25095177|NCT03220490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095178|NCT03220490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095179|NCT03220490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25095208|NCT03220126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25095209|NCT03220126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24823549|NCT02117752|Antimalarials|antimalarials|mesh-ancestor
24823550|NCT02117752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24823559|NCT02117830|Moxifloxacin|moxifloxacin|mesh-list
25095210|NCT03220191|Palbociclib|palbociclib|mesh-list
25095211|NCT03220191|Rabeprazole|rabeprazole|mesh-list
25095212|NCT03220191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095213|NCT03220191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25095214|NCT03220191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25095215|NCT03220191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095216|NCT03220191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25095217|NCT03220191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25095218|NCT03220191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24771923|NCT01830491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25095220|NCT03220113|Dexamethasone|dexamethasone|mesh-list
25095221|NCT03220113|Lidocaine|lidocaine|mesh-list
25095222|NCT03220113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25095223|NCT03220113|Antiemetics|antiemetics|mesh-ancestor
25095224|NCT03220113|Autonomic Agents|autonomic agents|mesh-ancestor
24967410|NCT03760276|Antifungal Agents|antifungal agents|mesh-ancestor
25095225|NCT03220113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25095261|NCT03219762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095263|NCT03219970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095298|NCT03219710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25095299|NCT03219710|Serotonin Agents|serotonin agents|mesh-ancestor
25095300|NCT03219710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25686180|NCT01915940|Timolol|timolol|mesh-list
25686181|NCT01915940|Bimatoprost|bimatoprost|mesh-list
25095301|NCT03219710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095302|NCT03219710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25686182|NCT01915940|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25686183|NCT01915940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25686184|NCT01915940|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25686185|NCT01915940|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25686186|NCT01915940|Adrenergic Agents|adrenergic agents|mesh-ancestor
25686187|NCT01915940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25686188|NCT01915940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919468|NCT04211805|Vaccines|vaccines|mesh-list
24823574|NCT02117830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24823576|NCT02117830|Fertility Agents|fertility agents|mesh-ancestor
25095479|NCT03218657|Levamisole|levamisole|mesh-list
25095480|NCT03218657|Cyclosporins|cyclosporins|mesh-list
25095481|NCT03218657|Androgens|androgens|mesh-list
24897042|NCT04430361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24897044|NCT04430361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095482|NCT03218657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25095483|NCT03218657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095484|NCT03218657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24480961|NCT00432978|Bosentan|bosentan|mesh-list
25095517|NCT03218852|Alkylating Agents|alkylating agents|mesh-ancestor
25095518|NCT03218852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095519|NCT03218852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095520|NCT03218852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25095521|NCT03218852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25095522|NCT03218852|Glucocorticoids|glucocorticoids|mesh-ancestor
25095523|NCT03218852|Hormones|hormones|mesh-ancestor
25095524|NCT03218852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25095525|NCT03218852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25095558|NCT03218059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25095559|NCT03218059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095560|NCT03218059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25095562|NCT03218059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095563|NCT03218059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095564|NCT03218059|Dermatologic Agents|dermatologic agents|mesh-ancestor
25095565|NCT03218059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25095566|NCT03218059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25095567|NCT03218059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24897045|NCT04430361|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24516464|NCT00602082|Capecitabine|capecitabine|mesh-list
24516465|NCT00602082|Streptozocin|streptozocin|mesh-list
24516466|NCT00602082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24897075|NCT04429633|Candesartan|candesartan|mesh-list
24897076|NCT04429633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24897077|NCT04429633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24897078|NCT04429633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25095568|NCT03218059|Immunologic Factors|immunologic factors|mesh-ancestor
25095605|NCT03217942|Mitosis Modulators|mitosis modulators|mesh-ancestor
25095606|NCT03217942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095637|NCT03217474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25095638|NCT03217474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25095639|NCT03217474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25095640|NCT03217474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095642|NCT03217734|Methotrexate|methotrexate|mesh-list
25095643|NCT03217734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25095644|NCT03217734|Abortifacient Agents|abortifacient agents|mesh-ancestor
25095645|NCT03217734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25095646|NCT03217734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095647|NCT03217734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25095648|NCT03217734|Antimetabolites|antimetabolites|mesh-ancestor
25095673|NCT03216759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686189|NCT01915940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686190|NCT01915940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25686191|NCT01915940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25686192|NCT01916109|Gemcitabine|gemcitabine|mesh-list
25686193|NCT01916109|Carboplatin|carboplatin|mesh-list
25686194|NCT01916109|Panitumumab|panitumumab|mesh-list
25686195|NCT01916109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25686196|NCT01916109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24919536|NCT04210713|Minocycline|minocycline|mesh-list
25095674|NCT03216759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25095675|NCT03216759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25095676|NCT03216759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25095677|NCT03216759|Adrenergic Agents|adrenergic agents|mesh-ancestor
25095678|NCT03216759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25095679|NCT03216759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095680|NCT03216733|Sirolimus|sirolimus|mesh-list
25095681|NCT03216733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25095682|NCT03216733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25095683|NCT03216733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25095684|NCT03216733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095685|NCT03216733|Antifungal Agents|antifungal agents|mesh-ancestor
25095686|NCT03216733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25095687|NCT03216733|Immunologic Factors|immunologic factors|mesh-ancestor
25095688|NCT03216733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095689|NCT03216915|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25095690|NCT03216915|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24804066|NCT02000804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25095691|NCT03216915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095692|NCT03216915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25095726|NCT03216941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25095728|NCT03216941|Anesthetics|anesthetics|mesh-ancestor
25095729|NCT03216941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25095730|NCT03216941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25095731|NCT03216941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25095732|NCT03216941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25095767|NCT03216356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25095770|NCT03216356|Antitubercular Agents|antitubercular agents|mesh-ancestor
25095771|NCT03216356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25095772|NCT03216356|Antimetabolites|antimetabolites|mesh-ancestor
25095805|NCT03216564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772529|NCT01834183|Immunologic Factors|immunologic factors|mesh-ancestor
25095806|NCT03216564|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25095807|NCT03216304|Calcium, Dietary|calcium, dietary|mesh-list
25095836|NCT03216447|Tacrolimus|tacrolimus|mesh-list
25095837|NCT03216447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25095838|NCT03216447|Immunologic Factors|immunologic factors|mesh-ancestor
25095839|NCT03216447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095840|NCT03216447|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24897079|NCT04429633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897080|NCT04429282|Ibuprofen|ibuprofen|mesh-list
24897081|NCT04429282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24897082|NCT04429282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24897083|NCT04429282|Analgesics|analgesics|mesh-ancestor
24897084|NCT04429282|Sensory System Agents|sensory system agents|mesh-ancestor
24897085|NCT04429282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24897086|NCT04429282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897087|NCT04429282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24897088|NCT04429282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24516475|NCT00602095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24516476|NCT00602095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516477|NCT00602095|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24516478|NCT00602095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24516479|NCT00602095|Oxytocics|oxytocics|mesh-ancestor
24516480|NCT00602134|Mercaptopurine|mercaptopurine|mesh-list
25095841|NCT03216447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25095842|NCT03216447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095843|NCT03216538|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
24423056|NCT00224510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24423057|NCT00224523|Mometasone Furoate|mometasone furoate|mesh-list
24423058|NCT00224523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24423059|NCT00224523|Dermatologic Agents|dermatologic agents|mesh-ancestor
24423060|NCT00224523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24423061|NCT00224549|Amlodipine|amlodipine|mesh-list
25686197|NCT01916109|Antimetabolites|antimetabolites|mesh-ancestor
25686198|NCT01916109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686199|NCT01916109|Antiviral Agents|antiviral agents|mesh-ancestor
25686200|NCT01916109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24919600|NCT04209699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24423062|NCT00224549|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24423064|NCT00224549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24423065|NCT00224549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25095844|NCT03216538|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25095845|NCT03216538|Immunologic Factors|immunologic factors|mesh-ancestor
25095846|NCT03216538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095847|NCT03216538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095848|NCT03216538|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25095849|NCT03216538|Protective Agents|protective agents|mesh-ancestor
25095850|NCT03216538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25095877|NCT03215797|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24772601|NCT01834547|Purinergic Agents|purinergic agents|mesh-ancestor
25095878|NCT03215797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25095879|NCT03215797|Adrenergic Agents|adrenergic agents|mesh-ancestor
25095880|NCT03215797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25095881|NCT03215797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095882|NCT03215797|Protective Agents|protective agents|mesh-ancestor
25095884|NCT03215693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095885|NCT03215693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25095886|NCT03215693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25095887|NCT03215693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095957|NCT03215069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095958|NCT03215056|Methoxyflurane|methoxyflurane|mesh-list
25095959|NCT03215056|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25095960|NCT03215056|Anesthetics, General|anesthetics, general|mesh-ancestor
25095999|NCT03214770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25096000|NCT03214770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096001|NCT03214770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24423178|NCT00224978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24423180|NCT00224978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24423181|NCT00225030|Antihypertensive Agents|antihypertensive agents|mesh-list
24614082|NCT01022463|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24423219|NCT00225108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423220|NCT00225160|Acetylcarnitine|acetylcarnitine|mesh-list
24423246|NCT00225173|Antimetabolites|antimetabolites|mesh-ancestor
25096124|NCT03213977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25096125|NCT03213977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25096126|NCT03213977|Alkylating Agents|alkylating agents|mesh-ancestor
25096156|NCT03213769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096157|NCT03213769|Vitamins|vitamins|mesh-ancestor
25096192|NCT03213587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25096193|NCT03213587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25096194|NCT03213587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25096195|NCT03213587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096197|NCT03213392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25096198|NCT03213392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096199|NCT03213353|Acetaminophen|acetaminophen|mesh-list
25096200|NCT03213353|Phenylpropanolamine|phenylpropanolamine|mesh-list
25096201|NCT03213353|Phenylephrine|phenylephrine|mesh-list
25096202|NCT03213353|Oxymetazoline|oxymetazoline|mesh-list
25096238|NCT03213145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25096239|NCT03213145|Antitubercular Agents|antitubercular agents|mesh-ancestor
25096240|NCT03213145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25096241|NCT03213145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25096275|NCT03212807|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25096276|NCT03212807|Growth Substances|growth substances|mesh-ancestor
25096277|NCT03212807|Growth Inhibitors|growth inhibitors|mesh-ancestor
25096278|NCT03212807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25096279|NCT03212807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25096280|NCT03213002|Capecitabine|capecitabine|mesh-list
24423247|NCT00225173|Antiviral Agents|antiviral agents|mesh-ancestor
25096307|NCT03212820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096309|NCT03212820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25096310|NCT03212820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25096311|NCT03212820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25096312|NCT03212820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25096313|NCT03212833|Insulin|insulin|mesh-list
25686201|NCT01916109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25686202|NCT01916109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25686203|NCT01916109|Immunologic Factors|immunologic factors|mesh-ancestor
24623801|NCT01073670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24919605|NCT04209959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24919606|NCT04209803|Minoxidil|minoxidil|mesh-list
24919607|NCT04209803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25067030|NCT03447925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25067031|NCT03447925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067032|NCT03447925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25067033|NCT03447925|Antifungal Agents|antifungal agents|mesh-ancestor
25067034|NCT03447925|Keratolytic Agents|keratolytic agents|mesh-ancestor
25067036|NCT03447873|Cobicistat|cobicistat|mesh-list
25096314|NCT03212833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25096315|NCT03212833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096317|NCT03212677|Trace Elements|trace elements|mesh-ancestor
25096318|NCT03212677|Micronutrients|micronutrients|mesh-ancestor
24773216|NCT01838460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773217|NCT01838460|Respiratory System Agents|respiratory system agents|mesh-ancestor
25096414|NCT03211871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25096415|NCT03211871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25096416|NCT03211871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096417|NCT03211871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25096418|NCT03211871|Analgesics|analgesics|mesh-ancestor
25096419|NCT03211871|Sensory System Agents|sensory system agents|mesh-ancestor
25096420|NCT03211871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25096421|NCT03211871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25096422|NCT03211871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25096423|NCT03211871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25096424|NCT03211871|Adrenergic Agents|adrenergic agents|mesh-ancestor
25096425|NCT03211871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25096426|NCT03211871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096427|NCT03211897|Midazolam|midazolam|mesh-list
25096428|NCT03211897|Haloperidol|haloperidol|mesh-list
25096458|NCT03211897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25096459|NCT03211988|Entinostat|entinostat|mesh-list
25096460|NCT03211988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25096506|NCT03211650|Protective Agents|protective agents|mesh-ancestor
25096507|NCT03211455|Lidocaine|lidocaine|mesh-list
25096508|NCT03211455|Anesthetics, Local|anesthetics, local|mesh-ancestor
25096509|NCT03211455|Anesthetics|anesthetics|mesh-ancestor
25096510|NCT03211455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25096572|NCT03210610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25096573|NCT03210766|Nabilone|nabilone|mesh-list
25096574|NCT03210766|Antiemetics|antiemetics|mesh-ancestor
25096575|NCT03210766|Autonomic Agents|autonomic agents|mesh-ancestor
25096576|NCT03210766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25096577|NCT03210766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096580|NCT03210766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25096581|NCT03210766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25096582|NCT03210766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25096583|NCT03210545|Betamethasone|betamethasone|mesh-list
25096584|NCT03210545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25096585|NCT03210545|Glucocorticoids|glucocorticoids|mesh-ancestor
25096586|NCT03210545|Hormones|hormones|mesh-ancestor
25096587|NCT03210545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25096588|NCT03210545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096617|NCT03210532|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25096618|NCT03210246|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25096761|NCT03209648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25096762|NCT03209648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096763|NCT03209648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24483531|NCT00443950|Etanercept|etanercept|mesh-list
25686204|NCT01916109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686205|NCT01916109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25686206|NCT01916226|Cetirizine|cetirizine|mesh-list
25686207|NCT01916226|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25686208|NCT01916226|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25686209|NCT01916226|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25686210|NCT01916226|Histamine Antagonists|histamine antagonists|mesh-ancestor
25686211|NCT01916226|Histamine Agents|histamine agents|mesh-ancestor
25686212|NCT01916226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24494713|NCT00496561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494714|NCT00496600|Everolimus|everolimus|mesh-list
24494715|NCT00496600|Epothilone B|epothilone b|mesh-list
24494724|NCT00496652|Zalutumumab|zalutumumab|mesh-list
24773647|NCT01841164|Hormone Antagonists|hormone antagonists|mesh-ancestor
25096797|NCT03209115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25096798|NCT03209115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096799|NCT03209115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25096800|NCT03209115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25096801|NCT03209115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25096802|NCT03209115|Disinfectants|disinfectants|mesh-ancestor
25096804|NCT03209193|Desflurane|desflurane|mesh-list
25096805|NCT03209193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25096806|NCT03209193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25096843|NCT03208972|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25096844|NCT03208972|Menotropins|menotropins|mesh-list
25096845|NCT03208972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25096846|NCT03208972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096847|NCT03208972|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25096848|NCT03208972|Fertility Agents|fertility agents|mesh-ancestor
25096916|NCT03208465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25096917|NCT03208465|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25096918|NCT03208465|Protease Inhibitors|protease inhibitors|mesh-ancestor
25096919|NCT03208465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25096920|NCT03208465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096921|NCT03208465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25096958|NCT03208309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25096959|NCT03208426|Amoxicillin|amoxicillin|mesh-list
25096988|NCT03208335|Growth Substances|growth substances|mesh-ancestor
25096989|NCT03208335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096990|NCT03208335|Growth Inhibitors|growth inhibitors|mesh-ancestor
25096992|NCT03207698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24773800|NCT01842139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25096994|NCT03207308|Vitamin A|vitamin a|mesh-list
25096995|NCT03207308|Vitamins|vitamins|mesh-ancestor
25096996|NCT03207308|Micronutrients|micronutrients|mesh-ancestor
25096997|NCT03207308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096998|NCT03207529|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
25096999|NCT03207529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25097000|NCT03207529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097001|NCT03207295|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25097002|NCT03207295|Natriuretic Agents|natriuretic agents|mesh-ancestor
25097003|NCT03207295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483983|NCT00446043|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25097057|NCT03207165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25097058|NCT03207165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25097059|NCT03207542|Daratumumab|daratumumab|mesh-list
25097060|NCT03207542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097061|NCT03207204|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25097062|NCT03207204|Carbamide Peroxide|carbamide peroxide|mesh-list
25097063|NCT03207204|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25097064|NCT03207204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25097065|NCT03207477|Mydriatics|mydriatics|mesh-list
25097066|NCT03207477|Autonomic Agents|autonomic agents|mesh-ancestor
25097067|NCT03207477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25097072|NCT03207100|Antihypertensive Agents|antihypertensive agents|mesh-list
25097073|NCT03206957|Endostatins|endostatins|mesh-list
25097074|NCT03206957|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
25097075|NCT03206957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097076|NCT03206957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25097086|NCT03206944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25097087|NCT03206944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097088|NCT03206944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25097089|NCT03206944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25097162|NCT03206658|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25097195|NCT03206177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097196|NCT03206255|Vaccines|vaccines|mesh-list
25097197|NCT03206255|Immunologic Factors|immunologic factors|mesh-ancestor
25686213|NCT01916226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686214|NCT01916226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686215|NCT01916629|Sunscreening Agents|sunscreening agents|mesh-list
25686216|NCT01916629|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25686217|NCT01916629|Protective Agents|protective agents|mesh-ancestor
25067043|NCT03447873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25097198|NCT03206255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097199|NCT03206411|Hormones|hormones|mesh-list
25097200|NCT03206411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25097201|NCT03206411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097434|NCT03204032|Antimetabolites|antimetabolites|mesh-ancestor
25097436|NCT03204045|Oxycodone|oxycodone|mesh-list
25097437|NCT03204045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25097438|NCT03204045|Narcotics|narcotics|mesh-ancestor
25097439|NCT03204045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25097440|NCT03204045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097441|NCT03204045|Analgesics|analgesics|mesh-ancestor
25097442|NCT03204045|Sensory System Agents|sensory system agents|mesh-ancestor
24486759|NCT00459940|Pioglitazone|pioglitazone|mesh-list
25097510|NCT03203590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097511|NCT03203590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24823974|NCT02120599|Vitamins|vitamins|mesh-ancestor
24823975|NCT02120599|Micronutrients|micronutrients|mesh-ancestor
24823976|NCT02120599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097513|NCT03203590|Antimitotic Agents|antimitotic agents|mesh-ancestor
25097514|NCT03203590|Mitosis Modulators|mitosis modulators|mesh-ancestor
25097515|NCT03203590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097516|NCT03203590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25097517|NCT03203590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25097518|NCT03203616|Trastuzumab|trastuzumab|mesh-list
25097519|NCT03203616|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24487340|NCT00462787|Dexamethasone|dexamethasone|mesh-list
25097582|NCT03203031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097584|NCT03203070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25097585|NCT03203070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25097586|NCT03203070|Analgesics|analgesics|mesh-ancestor
25097587|NCT03203070|Sensory System Agents|sensory system agents|mesh-ancestor
25097588|NCT03203070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25097589|NCT03203070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097590|NCT03203070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24897122|NCT04429191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24897123|NCT04429191|Immunologic Factors|immunologic factors|mesh-ancestor
24897124|NCT04429191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897125|NCT04429035|Vitamin K|vitamin k|mesh-list
24897126|NCT04429035|Vitamin K 2|vitamin k 2|mesh-list
24897127|NCT04429035|Vitamins|vitamins|mesh-ancestor
24897128|NCT04429035|Micronutrients|micronutrients|mesh-ancestor
24478835|NCT00424801|Moxonidine|moxonidine|mesh-list
24817636|NCT02084654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24817637|NCT02084719|Antibodies|antibodies|mesh-list
24817638|NCT02084719|Immunologic Factors|immunologic factors|mesh-ancestor
24817639|NCT02084719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097591|NCT03203070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25097592|NCT03203070|Antipyretics|antipyretics|mesh-ancestor
25097594|NCT03202875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25097597|NCT03202875|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25097598|NCT03202875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25097599|NCT03202875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487786|NCT00465075|Hormones|hormones|mesh-ancestor
25097629|NCT03202563|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24423696|NCT00226564|Alfentanil|alfentanil|mesh-list
25097630|NCT03202563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097631|NCT03202615|Lactoferrin|lactoferrin|mesh-list
25097632|NCT03202615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25097633|NCT03202459|Pregabalin|pregabalin|mesh-list
25097634|NCT03202459|Gabapentin|gabapentin|mesh-list
25097635|NCT03202459|Analgesics|analgesics|mesh-ancestor
25097636|NCT03202459|Sensory System Agents|sensory system agents|mesh-ancestor
25097637|NCT03202459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25097638|NCT03202459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097639|NCT03202459|Anticonvulsants|anticonvulsants|mesh-ancestor
25097640|NCT03202459|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25097641|NCT03202459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25097642|NCT03202459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067066|NCT03447470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25067067|NCT03447470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25067068|NCT03447470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24952124|NCT03897452|Analgesics|analgesics|mesh-ancestor
25097751|NCT03201952|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25097827|NCT03200938|Dermatologic Agents|dermatologic agents|mesh-ancestor
25097828|NCT03200938|Sunscreening Agents|sunscreening agents|mesh-ancestor
25097913|NCT03200613|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25097915|NCT03200613|Dalteparin|dalteparin|mesh-list
25097916|NCT03200613|Apixaban|apixaban|mesh-list
25097917|NCT03200613|Anticoagulants|anticoagulants|mesh-ancestor
25097918|NCT03200613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25097919|NCT03200613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25097920|NCT03200613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097921|NCT03200613|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25097926|NCT03200392|Chromium|chromium|mesh-list
25097927|NCT03200392|Trace Elements|trace elements|mesh-ancestor
25097928|NCT03200392|Micronutrients|micronutrients|mesh-ancestor
25097929|NCT03200392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097930|NCT03200093|Vancomycin|vancomycin|mesh-list
25097931|NCT03200093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25097932|NCT03200093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25097933|NCT03200197|Menthol|menthol|mesh-list
25097934|NCT03200197|Antipruritics|antipruritics|mesh-ancestor
25097935|NCT03200197|Dermatologic Agents|dermatologic agents|mesh-ancestor
25097936|NCT03200210|Febuxostat|febuxostat|mesh-list
25097937|NCT03200210|Gout Suppressants|gout suppressants|mesh-ancestor
25097971|NCT03199989|Oxaliplatin|oxaliplatin|mesh-list
25097972|NCT03199989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25097973|NCT03199989|Antimetabolites|antimetabolites|mesh-ancestor
25097974|NCT03199989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097975|NCT03199989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097976|NCT03200002|Mycophenolic Acid|mycophenolic acid|mesh-list
25097977|NCT03200002|Cyclophosphamide|cyclophosphamide|mesh-list
25097978|NCT03200002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25098012|NCT03199976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25098013|NCT03199976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098014|NCT03199976|Anticonvulsants|anticonvulsants|mesh-ancestor
25098015|NCT03199976|Tocolytic Agents|tocolytic agents|mesh-ancestor
25098016|NCT03199976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25098017|NCT03199976|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25098018|NCT03199976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25098019|NCT03199976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25098081|NCT03199820|Dinoprostone|dinoprostone|mesh-list
25098082|NCT03199820|Oxytocics|oxytocics|mesh-ancestor
24967759|NCT03756987|Ropivacaine|ropivacaine|mesh-list
24516656|NCT00602693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24516657|NCT00602693|Antimetabolites|antimetabolites|mesh-ancestor
24897263|NCT04426721|Viscosupplements|viscosupplements|mesh-ancestor
24897264|NCT04426721|Protective Agents|protective agents|mesh-ancestor
25098086|NCT03199339|Bupropion|bupropion|mesh-list
25098087|NCT03199339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25098088|NCT03199339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25098089|NCT03199339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25098090|NCT03199339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098091|NCT03199339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25098092|NCT03199339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25098093|NCT03199339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25098094|NCT03199339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25098095|NCT03199339|Anesthetics, General|anesthetics, general|mesh-ancestor
25098125|NCT03199482|Autonomic Agents|autonomic agents|mesh-ancestor
25098126|NCT03199482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25098127|NCT03199482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686218|NCT01916629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686219|NCT01916629|Dermatologic Agents|dermatologic agents|mesh-ancestor
25686220|NCT01916681|Misoprostol|misoprostol|mesh-list
25098128|NCT03199482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25098129|NCT03199482|Glucocorticoids|glucocorticoids|mesh-ancestor
25098130|NCT03199482|Hormones|hormones|mesh-ancestor
25405937|NCT03587584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25686221|NCT01916681|Oxytocin|oxytocin|mesh-list
25686222|NCT01916681|Oxytocics|oxytocics|mesh-ancestor
25686223|NCT01916681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25067094|NCT03447093|Propylthiouracil|propylthiouracil|mesh-list
24587022|NCT00893100|Diltiazem|diltiazem|mesh-list
24919788|NCT04208581|Cholinergic Agents|cholinergic agents|mesh-ancestor
24919789|NCT04208581|Anticonvulsants|anticonvulsants|mesh-ancestor
24494828|NCT00497224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676849|NCT01352572|Analgesics|analgesics|mesh-ancestor
25098131|NCT03199482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25098132|NCT03199482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25098133|NCT03199482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25098134|NCT03199430|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
25098135|NCT03199430|Antioxidants|antioxidants|mesh-ancestor
25098136|NCT03199430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098137|NCT03199430|Protective Agents|protective agents|mesh-ancestor
25098138|NCT03199430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098139|NCT03199430|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24490620|NCT00479206|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24967784|NCT03756818|Paclitaxel|paclitaxel|mesh-list
24516664|NCT00602693|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25098161|NCT03199170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098163|NCT03199170|Sensory System Agents|sensory system agents|mesh-ancestor
25098164|NCT03199170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25098165|NCT03199157|Fentanyl|fentanyl|mesh-list
25098166|NCT03199157|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25098167|NCT03199157|Narcotics|narcotics|mesh-ancestor
25098168|NCT03199157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25098169|NCT03199157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098170|NCT03199157|Analgesics|analgesics|mesh-ancestor
25098171|NCT03199157|Sensory System Agents|sensory system agents|mesh-ancestor
25098172|NCT03199157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25098173|NCT03199157|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25098174|NCT03199157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25098175|NCT03199157|Anesthetics, General|anesthetics, general|mesh-ancestor
25098176|NCT03199157|Anesthetics|anesthetics|mesh-ancestor
25098177|NCT03199105|Tetracaine|tetracaine|mesh-list
25098178|NCT03199105|Anesthetics, Local|anesthetics, local|mesh-ancestor
25098179|NCT03199105|Anesthetics|anesthetics|mesh-ancestor
25098180|NCT03199105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25098181|NCT03199105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098182|NCT03199105|Sensory System Agents|sensory system agents|mesh-ancestor
25098183|NCT03199105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25098184|NCT03198637|Cisatracurium|cisatracurium|mesh-list
25098185|NCT03198637|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25098186|NCT03198637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25098187|NCT03198637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25098188|NCT03198637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098189|NCT03198819|Cefotaxime|cefotaxime|mesh-list
25098190|NCT03198819|Cefoxitin|cefoxitin|mesh-list
25098191|NCT03198819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25098212|NCT03198585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098213|NCT03198585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25098214|NCT03198585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098216|NCT03198403|Bupivacaine|bupivacaine|mesh-list
25098217|NCT03198403|Anesthetics, Local|anesthetics, local|mesh-ancestor
25098218|NCT03198403|Anesthetics|anesthetics|mesh-ancestor
24897284|NCT04426578|Perhexiline|perhexiline|mesh-list
25098220|NCT03198403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098221|NCT03198403|Sensory System Agents|sensory system agents|mesh-ancestor
25098222|NCT03198403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686224|NCT01916681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686225|NCT01916681|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25686226|NCT01916681|Abortifacient Agents|abortifacient agents|mesh-ancestor
25686227|NCT01916681|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25686228|NCT01916681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25686229|NCT01916824|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25686230|NCT01916824|Mirtazapine|mirtazapine|mesh-list
25686231|NCT01916824|Citalopram|citalopram|mesh-list
25686232|NCT01916824|Bupropion|bupropion|mesh-list
25098223|NCT03198403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25098224|NCT03198403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24521437|NCT04763135|Citalopram|citalopram|mesh-list
24521438|NCT04763135|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24521439|NCT04763135|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25098225|NCT03198403|Adrenergic Agents|adrenergic agents|mesh-ancestor
25098226|NCT03198403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25098227|NCT03198403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098228|NCT03198403|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25098229|NCT03198403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24775257|NCT01851278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098230|NCT03198403|Autonomic Agents|autonomic agents|mesh-ancestor
25098231|NCT03198403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25098232|NCT03198403|Respiratory System Agents|respiratory system agents|mesh-ancestor
25098233|NCT03198403|Mydriatics|mydriatics|mesh-ancestor
25098234|NCT03198403|Sympathomimetics|sympathomimetics|mesh-ancestor
25098235|NCT03198403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24824089|NCT02121444|Antiviral Agents|antiviral agents|mesh-ancestor
25098236|NCT03198442|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25098237|NCT03198442|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25098238|NCT03198442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098240|NCT03198949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25098241|NCT03198949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25098242|NCT03198949|Immunologic Factors|immunologic factors|mesh-ancestor
25098243|NCT03198949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098271|NCT03198195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25098272|NCT03198195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25098273|NCT03198130|Cemiplimab|cemiplimab|mesh-list
25098274|NCT03198130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25098275|NCT03198130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25098276|NCT03198169|Anti-Infective Agents|anti-infective agents|mesh-list
25098277|NCT03198169|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25098278|NCT03197961|Tenofovir|tenofovir|mesh-list
25098279|NCT03197961|Emtricitabine|emtricitabine|mesh-list
25098280|NCT03197961|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25098281|NCT03197961|Medroxyprogesterone|medroxyprogesterone|mesh-list
25098282|NCT03197961|Antiviral Agents|antiviral agents|mesh-ancestor
25098285|NCT03197961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25098286|NCT03197961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25098287|NCT03197961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098288|NCT03197961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25098289|NCT03197961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24789600|NCT01938092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25098290|NCT03197961|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25098322|NCT03197818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25098323|NCT03197818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098324|NCT03197818|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25098325|NCT03197818|Respiratory System Agents|respiratory system agents|mesh-ancestor
25098326|NCT03197818|Glucocorticoids|glucocorticoids|mesh-ancestor
25098327|NCT03197818|Hormones|hormones|mesh-ancestor
25098328|NCT03197818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25098329|NCT03197818|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25098366|NCT03197571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25098367|NCT03197571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25098368|NCT03197571|Growth Substances|growth substances|mesh-ancestor
25098396|NCT03197584|Fulvestrant|fulvestrant|mesh-list
25098397|NCT03197584|Avelumab|avelumab|mesh-list
25098398|NCT03197584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25098399|NCT03197584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098400|NCT03197584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25098401|NCT03197584|Immunologic Factors|immunologic factors|mesh-ancestor
25098402|NCT03197584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098403|NCT03197584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25098404|NCT03197584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25098405|NCT03197584|Alkylating Agents|alkylating agents|mesh-ancestor
25098623|NCT03196466|Analgesics|analgesics|mesh-ancestor
25098406|NCT03197584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25098407|NCT03197584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25098408|NCT03197584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25098409|NCT03197584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25098410|NCT03197584|Growth Substances|growth substances|mesh-ancestor
25098483|NCT03197207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25098484|NCT03197207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686233|NCT01916824|Fluoxetine|fluoxetine|mesh-list
25686234|NCT01916824|Paroxetine|paroxetine|mesh-list
25686235|NCT01916824|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25686236|NCT01916824|Sertraline|sertraline|mesh-list
24492691|NCT00487422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25098515|NCT03197077|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25098516|NCT03197077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25098517|NCT03197077|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25098519|NCT03196869|Cisplatin|cisplatin|mesh-list
25098520|NCT03196869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25098521|NCT03196921|Amphotericin B|amphotericin b|mesh-list
25098522|NCT03196921|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25098523|NCT03196921|Amebicides|amebicides|mesh-ancestor
25098524|NCT03196921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25098525|NCT03196921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25098526|NCT03196921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25098527|NCT03196921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25098528|NCT03196921|Antifungal Agents|antifungal agents|mesh-ancestor
25098529|NCT03196986|Bevacizumab|bevacizumab|mesh-list
24492931|NCT00488670|Citalopram|citalopram|mesh-list
25098555|NCT03197103|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25098556|NCT03197103|Antioxidants|antioxidants|mesh-ancestor
25098557|NCT03197103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098558|NCT03197103|Protective Agents|protective agents|mesh-ancestor
25098559|NCT03197103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098560|NCT03197103|Antidotes|antidotes|mesh-ancestor
25098561|NCT03196817|Betamethasone|betamethasone|mesh-list
25098562|NCT03196817|Betamethasone Valerate|betamethasone valerate|mesh-list
25098563|NCT03196817|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25098564|NCT03196817|Betamethasone benzoate|betamethasone benzoate|mesh-list
25098565|NCT03196817|Lidocaine|lidocaine|mesh-list
25098566|NCT03196817|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25098567|NCT03196817|Anesthetics, Local|anesthetics, local|mesh-ancestor
25098568|NCT03196817|Anesthetics|anesthetics|mesh-ancestor
25098569|NCT03196817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24793761|NCT02515591|Dimercaprol|dimercaprol|mesh-list
24897285|NCT04426578|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24897286|NCT04426578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24474390|NCT00405860|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24474391|NCT00405860|Antitubercular Agents|antitubercular agents|mesh-ancestor
24474392|NCT00405860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24474393|NCT00405860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24474394|NCT00405860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25098570|NCT03196817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098571|NCT03196817|Sensory System Agents|sensory system agents|mesh-ancestor
25098572|NCT03196817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25098573|NCT03196817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25098574|NCT03196817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24775640|NCT01853956|GABA Agents|gaba agents|mesh-ancestor
25098575|NCT03196817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25098597|NCT03196648|Fluorides|fluorides|mesh-list
25098598|NCT03196648|Antioxidants|antioxidants|mesh-list
25098599|NCT03196648|Cariostatic Agents|cariostatic agents|mesh-ancestor
25098600|NCT03196648|Protective Agents|protective agents|mesh-ancestor
25098601|NCT03196648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098602|NCT03196648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098603|NCT03196466|Topiramate|topiramate|mesh-list
25098604|NCT03196466|Pregabalin|pregabalin|mesh-list
25098605|NCT03196466|Lamotrigine|lamotrigine|mesh-list
25098606|NCT03196466|Zonisamide|zonisamide|mesh-list
25098607|NCT03196466|Lacosamide|lacosamide|mesh-list
25098608|NCT03196466|Carbamazepine|carbamazepine|mesh-list
25098609|NCT03196466|Phenytoin|phenytoin|mesh-list
25098610|NCT03196466|Oxcarbazepine|oxcarbazepine|mesh-list
25098611|NCT03196466|Rufinamide|rufinamide|mesh-list
25098612|NCT03196466|Cannabidiol|cannabidiol|mesh-list
25098613|NCT03196466|Levetiracetam|levetiracetam|mesh-list
25098614|NCT03196466|Valproic Acid|valproic acid|mesh-list
25098615|NCT03196466|Brivaracetam|brivaracetam|mesh-list
25098616|NCT03196466|Phenobarbital|phenobarbital|mesh-list
25098617|NCT03196466|Clobazam|clobazam|mesh-list
25098618|NCT03196466|Ethosuximide|ethosuximide|mesh-list
25098619|NCT03196466|Stiripentol|stiripentol|mesh-list
25098620|NCT03196466|Tiagabine|tiagabine|mesh-list
25098621|NCT03196466|Primidone|primidone|mesh-list
25098622|NCT03196466|Felbamate|felbamate|mesh-list
25098624|NCT03196466|Sensory System Agents|sensory system agents|mesh-ancestor
25098625|NCT03196466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25098626|NCT03196466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098627|NCT03196466|Anticonvulsants|anticonvulsants|mesh-ancestor
24474395|NCT00405860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474396|NCT00405925|Lamivudine|lamivudine|mesh-list
24474397|NCT00405925|Zidovudine|zidovudine|mesh-list
24474398|NCT00405925|Abacavir|abacavir|mesh-list
25098628|NCT03196466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25098629|NCT03196466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25098630|NCT03196466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098631|NCT03196466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25098633|NCT03196466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25098659|NCT03196401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25098660|NCT03196401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24775711|NCT01854489|Analgesics|analgesics|mesh-ancestor
25098661|NCT03196479|Ketamine|ketamine|mesh-list
25098662|NCT03196479|Propofol|propofol|mesh-list
25098663|NCT03196479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25098664|NCT03196479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25275736|NCT02369549|Curcumin|curcumin|mesh-list
25098665|NCT03196479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098666|NCT03196479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25098667|NCT03196479|Anesthetics, General|anesthetics, general|mesh-ancestor
25098669|NCT03196479|Analgesics|analgesics|mesh-ancestor
25098670|NCT03196479|Sensory System Agents|sensory system agents|mesh-ancestor
25098671|NCT03196479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25098672|NCT03196479|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25098673|NCT03196479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25098674|NCT03196479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25098675|NCT03196479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25098676|NCT03196479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098677|NCT03196531|Loratadine|loratadine|mesh-list
25098678|NCT03196531|Antipruritics|antipruritics|mesh-ancestor
25098679|NCT03196531|Dermatologic Agents|dermatologic agents|mesh-ancestor
25098680|NCT03196531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25098681|NCT03196531|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24493605|NCT00491712|Hormones|hormones|mesh-ancestor
25098715|NCT03195582|Disinfectants|disinfectants|mesh-ancestor
25098716|NCT03195582|Dermatologic Agents|dermatologic agents|mesh-ancestor
25098717|NCT03195569|Paclitaxel|paclitaxel|mesh-list
25098718|NCT03195569|Bevacizumab|bevacizumab|mesh-list
25098720|NCT03195569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25098721|NCT03195569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25098722|NCT03195569|Tubulin Modulators|tubulin modulators|mesh-ancestor
25098757|NCT03195933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25098758|NCT03195543|Thrombin|thrombin|mesh-list
25098759|NCT03195543|Hemostatics|hemostatics|mesh-ancestor
25098760|NCT03195543|Coagulants|coagulants|mesh-ancestor
25098761|NCT03195530|Propofol|propofol|mesh-list
24494154|NCT00494078|Insulin Aspart|insulin aspart|mesh-list
25098783|NCT03195491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098785|NCT03195413|Epinephrine|epinephrine|mesh-list
25098786|NCT03195413|Racepinephrine|racepinephrine|mesh-list
25098787|NCT03195413|Bupivacaine|bupivacaine|mesh-list
25098788|NCT03195413|Epinephryl borate|epinephryl borate|mesh-list
25098789|NCT03195413|Anesthetics, Local|anesthetics, local|mesh-ancestor
25098790|NCT03195413|Anesthetics|anesthetics|mesh-ancestor
25098791|NCT03195413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25098792|NCT03195413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098793|NCT03195413|Sensory System Agents|sensory system agents|mesh-ancestor
25098794|NCT03195413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25098795|NCT03195413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25098796|NCT03195413|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25098797|NCT03195413|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25098798|NCT03195413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25098799|NCT03195413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098800|NCT03195413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25098801|NCT03195413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25098802|NCT03195413|Adrenergic Agents|adrenergic agents|mesh-ancestor
24424213|NCT00228319|Antioxidants|antioxidants|mesh-ancestor
25098845|NCT03195270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098846|NCT03194984|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25098847|NCT03194984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25098848|NCT03194984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25098850|NCT03195309|Ropivacaine|ropivacaine|mesh-list
24919849|NCT04208061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24919851|NCT04208061|Antithrombins|antithrombins|mesh-ancestor
25098851|NCT03195309|Anesthetics, Local|anesthetics, local|mesh-ancestor
25098852|NCT03195309|Anesthetics|anesthetics|mesh-ancestor
25098853|NCT03195309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25098854|NCT03195309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098855|NCT03195309|Sensory System Agents|sensory system agents|mesh-ancestor
25098856|NCT03195309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25098857|NCT03195309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25098858|NCT03195309|Narcotics|narcotics|mesh-ancestor
25098859|NCT03195309|Analgesics|analgesics|mesh-ancestor
25098860|NCT03195309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25098893|NCT03194620|Proanthocyanidin|proanthocyanidin|mesh-list
25098894|NCT03194620|Epicatechin gallate|epicatechin gallate|mesh-list
25098895|NCT03194620|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
25098896|NCT03194620|Procyanidin|procyanidin|mesh-list
25098897|NCT03194620|Theaflavin|theaflavin|mesh-list
25098898|NCT03194620|Antioxidants|antioxidants|mesh-ancestor
25098899|NCT03194620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098900|NCT03194620|Protective Agents|protective agents|mesh-ancestor
25098901|NCT03194620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098902|NCT03194620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25098903|NCT03194620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25098904|NCT03194620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25098905|NCT03194620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25098932|NCT03194659|Lipotropic Agents|lipotropic agents|mesh-ancestor
25098933|NCT03194659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25098934|NCT03194659|Antimetabolites|antimetabolites|mesh-ancestor
24776021|NCT01856127|Antidepressive Agents|antidepressive agents|mesh-ancestor
25098935|NCT03194659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098936|NCT03194659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24776093|NCT01856517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098937|NCT03194659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25098938|NCT03194659|Nootropic Agents|nootropic agents|mesh-ancestor
25098939|NCT03194594|Dexamethasone|dexamethasone|mesh-list
25098940|NCT03194594|Ketamine|ketamine|mesh-list
25098941|NCT03194594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25098942|NCT03194594|Antiemetics|antiemetics|mesh-ancestor
25098943|NCT03194594|Autonomic Agents|autonomic agents|mesh-ancestor
25098944|NCT03194594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25098945|NCT03194594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098946|NCT03194594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25098947|NCT03194594|Glucocorticoids|glucocorticoids|mesh-ancestor
25098948|NCT03194594|Hormones|hormones|mesh-ancestor
25098949|NCT03194594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25098950|NCT03194594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25098951|NCT03194594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25098952|NCT03194594|Analgesics|analgesics|mesh-ancestor
25098969|NCT03194555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098971|NCT03194555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25098972|NCT03194555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25098973|NCT03194139|Avasopasem manganese|avasopasem manganese|mesh-list
25098974|NCT03194139|Antioxidants|antioxidants|mesh-ancestor
25098975|NCT03194139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098976|NCT03194139|Protective Agents|protective agents|mesh-ancestor
25098977|NCT03194139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098978|NCT03194204|Doxycycline|doxycycline|mesh-list
25098979|NCT03194204|Uric Acid|uric acid|mesh-list
25098980|NCT03194204|Rheumatoid Factor|rheumatoid factor|mesh-list
25098981|NCT03194204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25098982|NCT03194204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24516683|NCT00602719|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24897302|NCT04426669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24897303|NCT04426669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24897304|NCT04426669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24897305|NCT04426669|Analgesics|analgesics|mesh-ancestor
24968110|NCT03754543|Iron|iron|mesh-list
25686237|NCT01916824|Antidepressive Agents|antidepressive agents|mesh-list
24824279|NCT02122627|Ergocalciferols|ergocalciferols|mesh-list
24824280|NCT02122627|Cholecalciferol|cholecalciferol|mesh-list
24824281|NCT02122627|Vitamins|vitamins|mesh-list
25686238|NCT01916824|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25686239|NCT01916824|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24919933|NCT04207112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24824282|NCT02122627|Micronutrients|micronutrients|mesh-ancestor
24824283|NCT02122627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424505|NCT00229567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24516722|NCT00602901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24516723|NCT00602901|Gout Suppressants|gout suppressants|mesh-ancestor
24516724|NCT00602901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24516725|NCT00602901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25099025|NCT03193749|Vasodilator Agents|vasodilator agents|mesh-ancestor
25099026|NCT03193749|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25099027|NCT03193749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25099028|NCT03193749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099029|NCT03193749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25099030|NCT03193749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25099031|NCT03193749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25099032|NCT03193749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25099033|NCT03193749|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25099034|NCT03193749|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25099035|NCT03193749|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25099037|NCT03193944|Ergocalciferols|ergocalciferols|mesh-list
25099038|NCT03193944|Cholecalciferol|cholecalciferol|mesh-list
25099039|NCT03193944|Vitamins|vitamins|mesh-list
25099040|NCT03193944|Micronutrients|micronutrients|mesh-ancestor
25099041|NCT03193944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099042|NCT03193944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25099043|NCT03193944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25099044|NCT03193957|Etanercept|etanercept|mesh-list
25099045|NCT03193957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25099046|NCT03193957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25099047|NCT03193957|Analgesics|analgesics|mesh-ancestor
25099048|NCT03193957|Sensory System Agents|sensory system agents|mesh-ancestor
25099049|NCT03193957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25099050|NCT03193957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516726|NCT00602901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516727|NCT00603031|Glucagon|glucagon|mesh-list
24516728|NCT00603031|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
24516729|NCT00603031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24516730|NCT00603031|Hormones|hormones|mesh-ancestor
24516733|NCT00603031|Incretins|incretins|mesh-ancestor
24897327|NCT04426487|Progesterone|progesterone|mesh-list
24897328|NCT04426487|Progestins|progestins|mesh-ancestor
24897329|NCT04426487|Hormones|hormones|mesh-ancestor
24897330|NCT04426487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24897331|NCT04426487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897332|NCT04426097|Iodine|iodine|mesh-list
24897333|NCT04426097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24897334|NCT04426097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24897335|NCT04426097|Trace Elements|trace elements|mesh-ancestor
24897336|NCT04426097|Micronutrients|micronutrients|mesh-ancestor
25099051|NCT03193957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25099052|NCT03193957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25099053|NCT03193957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25099054|NCT03193957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25099055|NCT03193957|Immunologic Factors|immunologic factors|mesh-ancestor
25099056|NCT03193814|Apatinib|apatinib|mesh-list
25099057|NCT03193814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099058|NCT03193814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25099059|NCT03193814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25099060|NCT03193814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099061|NCT03193788|Folic Acid|folic acid|mesh-list
25099062|NCT03193788|Vitamin B 12|vitamin b 12|mesh-list
25099063|NCT03193788|Dexamethasone|dexamethasone|mesh-list
25099064|NCT03193788|Pemetrexed|pemetrexed|mesh-list
25099065|NCT03193788|Vitamins|vitamins|mesh-ancestor
25099066|NCT03193788|Micronutrients|micronutrients|mesh-ancestor
24521657|NCT04622904|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24919994|NCT04205916|Hormones|hormones|mesh-ancestor
24919995|NCT04205916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24919996|NCT04205916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25099067|NCT03193788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099068|NCT03193788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25099103|NCT03193918|Paclitaxel|paclitaxel|mesh-list
25099104|NCT03193918|Ramucirumab|ramucirumab|mesh-list
25099105|NCT03193918|Crenolanib|crenolanib|mesh-list
25099106|NCT03193918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25099107|NCT03193918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099108|NCT03193918|Tubulin Modulators|tubulin modulators|mesh-ancestor
25099109|NCT03193918|Antimitotic Agents|antimitotic agents|mesh-ancestor
24497498|NCT00510263|Hormones|hormones|mesh-ancestor
25099138|NCT03193359|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25099139|NCT03193359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25099141|NCT03193359|Cholinergic Agents|cholinergic agents|mesh-ancestor
25099183|NCT03193281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099184|NCT03193281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25099185|NCT03193281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25099186|NCT03193281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099187|NCT03193606|Fluorides|fluorides|mesh-list
25099188|NCT03193606|Cariostatic Agents|cariostatic agents|mesh-ancestor
25099189|NCT03193606|Protective Agents|protective agents|mesh-ancestor
25099190|NCT03193606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776329|NCT01857752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25099191|NCT03193203|Etanercept|etanercept|mesh-list
25099192|NCT03193203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25099193|NCT03193203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25099194|NCT03193203|Analgesics|analgesics|mesh-ancestor
25099195|NCT03193203|Sensory System Agents|sensory system agents|mesh-ancestor
25099196|NCT03193203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25099197|NCT03193203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099198|NCT03193203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25099199|NCT03193203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25099232|NCT03192969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25099234|NCT03192969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25099235|NCT03192566|Acetaminophen|acetaminophen|mesh-list
25099236|NCT03192566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25099237|NCT03192566|Analgesics|analgesics|mesh-ancestor
24424591|NCT00229996|Norethindrone Acetate|norethindrone acetate|mesh-list
25099238|NCT03192566|Sensory System Agents|sensory system agents|mesh-ancestor
25099239|NCT03192566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25099240|NCT03192566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394168|NCT00132444|UC-781|uc-781|mesh-list
25099268|NCT03192657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099270|NCT03192644|Oxaliplatin|oxaliplatin|mesh-list
25099271|NCT03192644|Ethiodized Oil|ethiodized oil|mesh-list
25099272|NCT03192644|Epirubicin|epirubicin|mesh-list
25099273|NCT03192644|Calcium|calcium|mesh-list
25099274|NCT03192644|Levoleucovorin|levoleucovorin|mesh-list
25099275|NCT03192644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099276|NCT03192644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25099277|NCT03192644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099279|NCT03192644|Protective Agents|protective agents|mesh-ancestor
25099280|NCT03192644|Vitamin B Complex|vitamin b complex|mesh-ancestor
25099281|NCT03192644|Vitamins|vitamins|mesh-ancestor
25099282|NCT03192644|Micronutrients|micronutrients|mesh-ancestor
25099283|NCT03192644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25099284|NCT03192644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25099285|NCT03192644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25099286|NCT03192644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25099287|NCT03192644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099288|NCT03192527|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25099289|NCT03192527|Luteolytic Agents|luteolytic agents|mesh-ancestor
25099290|NCT03192527|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25099314|NCT03192449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099315|NCT03192449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099316|NCT03192735|Oxaliplatin|oxaliplatin|mesh-list
25099317|NCT03192735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099318|NCT03192371|Vaccines|vaccines|mesh-list
25686240|NCT01916824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25686241|NCT01916824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25686242|NCT01916824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686243|NCT01916824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24439104|NCT00277550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623860|NCT01073826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25099319|NCT03192371|Immunologic Factors|immunologic factors|mesh-ancestor
25099320|NCT03192371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099321|NCT03192111|Entinostat|entinostat|mesh-list
25099322|NCT03192111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099323|NCT03192111|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25099324|NCT03192111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25099325|NCT03192111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099326|NCT03192293|Metformin|metformin|mesh-list
25099327|NCT03192293|Fulvestrant|fulvestrant|mesh-list
25099328|NCT03192293|Simvastatin|simvastatin|mesh-list
25099329|NCT03192293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25099330|NCT03192293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099331|NCT03192293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25099332|NCT03192293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25099333|NCT03192293|Antimetabolites|antimetabolites|mesh-ancestor
25099334|NCT03192293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099335|NCT03192293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25099336|NCT03192293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25099337|NCT03192293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25099338|NCT03192293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24424596|NCT00229996|Fertility Agents|fertility agents|mesh-ancestor
24424692|NCT00230451|Mitosis Modulators|mitosis modulators|mesh-ancestor
24424693|NCT00230451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424751|NCT00230542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24424752|NCT00230568|Donepezil|donepezil|mesh-list
25099339|NCT03192293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099340|NCT03192293|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25099399|NCT03191981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25099400|NCT03191981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25099401|NCT03191981|Growth Substances|growth substances|mesh-ancestor
25099402|NCT03191981|Growth Inhibitors|growth inhibitors|mesh-ancestor
25099404|NCT03191903|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25099405|NCT03191903|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25099406|NCT03191903|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25099407|NCT03191903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25099408|NCT03191903|Glucocorticoids|glucocorticoids|mesh-ancestor
25099410|NCT03191903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25099411|NCT03191903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099412|NCT03191903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25099413|NCT03191903|Immunologic Factors|immunologic factors|mesh-ancestor
25099414|NCT03191903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25099415|NCT03191903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099416|NCT03191721|Triclosan|triclosan|mesh-list
25099417|NCT03191721|Anti-Infective Agents|anti-infective agents|mesh-list
25099418|NCT03191721|Fluorides|fluorides|mesh-list
25099419|NCT03191721|Cariostatic Agents|cariostatic agents|mesh-ancestor
25099420|NCT03191721|Protective Agents|protective agents|mesh-ancestor
25099421|NCT03191721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099422|NCT03191721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25099423|NCT03191721|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25099424|NCT03191721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25099425|NCT03191721|Antimetabolites|antimetabolites|mesh-ancestor
25099426|NCT03191721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099452|NCT03191162|Immunologic Factors|immunologic factors|mesh-ancestor
25099453|NCT03191162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099454|NCT03191162|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25099455|NCT03191162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25099456|NCT03191162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25099460|NCT03191097|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
25099461|NCT03191097|Antiviral Agents|antiviral agents|mesh-ancestor
25099462|NCT03191097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25099463|NCT03190798|Canagliflozin|canagliflozin|mesh-list
25099464|NCT03190798|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25099465|NCT03190798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099466|NCT03190798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25099467|NCT03190798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686244|NCT01916824|Serotonin Agents|serotonin agents|mesh-ancestor
25686245|NCT01916824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521736|NCT04553536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24521737|NCT04553536|Anticonvulsants|anticonvulsants|mesh-ancestor
24521738|NCT04553536|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24521739|NCT04553536|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24521743|NCT04553536|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24521744|NCT04553536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24521745|NCT04553536|Cholinergic Agents|cholinergic agents|mesh-ancestor
24521746|NCT04553536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24521747|NCT04553536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521748|NCT04553536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25099468|NCT03190681|Methylphenidate|methylphenidate|mesh-list
25099469|NCT03190681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25099470|NCT03190681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099471|NCT03190681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25099472|NCT03190681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24499641|NCT00520338|Analgesics|analgesics|mesh-ancestor
25099505|NCT03190642|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25099506|NCT03190642|Prednisolone phosphate|prednisolone phosphate|mesh-list
25099507|NCT03190642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25099509|NCT03190642|Autonomic Agents|autonomic agents|mesh-ancestor
25099510|NCT03190642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25099511|NCT03190642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099512|NCT03190642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25099532|NCT03190304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099534|NCT03189953|Exenatide|exenatide|mesh-list
25099535|NCT03189953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25099536|NCT03189953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099537|NCT03189953|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25099538|NCT03189953|Incretins|incretins|mesh-ancestor
25099539|NCT03189953|Hormones|hormones|mesh-ancestor
25275917|NCT02368561|Hylan|hylan|mesh-list
25099540|NCT03189953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25099541|NCT03190239|Pemetrexed|pemetrexed|mesh-list
25099542|NCT03190239|Apatinib|apatinib|mesh-list
25099543|NCT03190239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099550|NCT03189914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099551|NCT03189836|Rituximab|rituximab|mesh-list
25099552|NCT03189836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25099553|NCT03189836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099554|NCT03189836|Immunologic Factors|immunologic factors|mesh-ancestor
25099555|NCT03189836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099556|NCT03189836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25099557|NCT03189771|Salicylic Acid|salicylic acid|mesh-list
25099558|NCT03189771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25099559|NCT03189771|Antifungal Agents|antifungal agents|mesh-ancestor
25099560|NCT03189771|Keratolytic Agents|keratolytic agents|mesh-ancestor
25099561|NCT03189771|Dermatologic Agents|dermatologic agents|mesh-ancestor
25099562|NCT03189901|Simendan|simendan|mesh-list
25099563|NCT03189901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25099564|NCT03189901|Vasodilator Agents|vasodilator agents|mesh-ancestor
24499742|NCT00520897|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25099587|NCT03189069|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25099588|NCT03189069|Antithrombins|antithrombins|mesh-ancestor
25099589|NCT03189069|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25099591|NCT03189069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25099592|NCT03189069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099593|NCT03189329|Lidocaine|lidocaine|mesh-list
25099594|NCT03189329|Levobupivacaine|levobupivacaine|mesh-list
25099595|NCT03189329|Anesthetics, Local|anesthetics, local|mesh-ancestor
25099596|NCT03189329|Anesthetics|anesthetics|mesh-ancestor
25099597|NCT03189329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25099598|NCT03189329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099599|NCT03189329|Sensory System Agents|sensory system agents|mesh-ancestor
25099600|NCT03189329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25099601|NCT03189329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25686246|NCT01916824|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25686247|NCT01916824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25686248|NCT01916824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686249|NCT01916824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25686250|NCT01916824|Dopamine Agents|dopamine agents|mesh-ancestor
25686251|NCT01916824|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25686252|NCT01916824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25686253|NCT01916824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25686254|NCT01916824|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25686255|NCT01916824|Analgesics|analgesics|mesh-ancestor
24439109|NCT00277589|Trace Elements|trace elements|mesh-ancestor
25099602|NCT03189329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25099603|NCT03189329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25099604|NCT03189329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25099605|NCT03189329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099606|NCT03188978|Atorvastatin|atorvastatin|mesh-list
25099610|NCT03188978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099611|NCT03188978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25099612|NCT03188978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25099613|NCT03188978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25099614|NCT03188835|Glycerol|glycerol|mesh-list
25099615|NCT03188835|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25099616|NCT03188835|Protective Agents|protective agents|mesh-ancestor
25099639|NCT03188471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25099640|NCT03188471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099641|NCT03188471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25099642|NCT03188471|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25099643|NCT03188471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25099644|NCT03188471|Antipyretics|antipyretics|mesh-ancestor
25099645|NCT03188510|Mirikizumab|mirikizumab|mesh-list
25099646|NCT03188510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24776881|NCT01860417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25099647|NCT03188510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25099648|NCT03188510|Analgesics|analgesics|mesh-ancestor
25099649|NCT03188510|Sensory System Agents|sensory system agents|mesh-ancestor
25099650|NCT03188510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25099651|NCT03188510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099652|NCT03188510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25099653|NCT03188510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25099654|NCT03188510|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25099655|NCT03188510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25099656|NCT03188198|Prednisone|prednisone|mesh-list
25099657|NCT03188198|Cyclophosphamide|cyclophosphamide|mesh-list
25099658|NCT03188198|Rituximab|rituximab|mesh-list
25099659|NCT03188198|Doxorubicin|doxorubicin|mesh-list
24516745|NCT00603083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24516747|NCT00603083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24516748|NCT00603083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516749|NCT00603083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425702|NCT00234091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25099663|NCT03188198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25099664|NCT03188198|Immunologic Factors|immunologic factors|mesh-ancestor
25099665|NCT03188198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099666|NCT03188198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25099667|NCT03188198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25099668|NCT03188198|Alkylating Agents|alkylating agents|mesh-ancestor
25099680|NCT03188198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25099681|NCT03188198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25099682|NCT03188198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25099684|NCT03188198|Antimitotic Agents|antimitotic agents|mesh-ancestor
25099685|NCT03188198|Mitosis Modulators|mitosis modulators|mesh-ancestor
25099687|NCT03188289|Hyaluronic Acid|hyaluronic acid|mesh-list
25099688|NCT03188289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25099689|NCT03188289|Immunologic Factors|immunologic factors|mesh-ancestor
25099690|NCT03188289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099691|NCT03188289|Viscosupplements|viscosupplements|mesh-ancestor
25099692|NCT03188289|Protective Agents|protective agents|mesh-ancestor
25099693|NCT03188289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25099694|NCT03188289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25099695|NCT03188289|Antimetabolites|antimetabolites|mesh-ancestor
25099696|NCT03188289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897389|NCT04425590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24897391|NCT04425590|Sensory System Agents|sensory system agents|mesh-ancestor
24897392|NCT04425590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24897393|NCT04425590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897394|NCT04425590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25686256|NCT01916824|Sensory System Agents|sensory system agents|mesh-ancestor
25686257|NCT01916824|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25686258|NCT01916824|Histamine Antagonists|histamine antagonists|mesh-ancestor
25686259|NCT01916824|Histamine Agents|histamine agents|mesh-ancestor
25686260|NCT01916824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25686261|NCT01916824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24897395|NCT04425590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24474488|NCT00406172|Growth Inhibitors|growth inhibitors|mesh-ancestor
24897401|NCT04425590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24897402|NCT04425590|Antipyretics|antipyretics|mesh-ancestor
24897403|NCT04425590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24897404|NCT04425590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25099697|NCT03188289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25099698|NCT03188289|Chelating Agents|chelating agents|mesh-ancestor
25099699|NCT03188289|Sequestering Agents|sequestering agents|mesh-ancestor
25099700|NCT03188289|Hemostatics|hemostatics|mesh-ancestor
25099701|NCT03188289|Coagulants|coagulants|mesh-ancestor
25099702|NCT03188276|Sofosbuvir|sofosbuvir|mesh-list
25099703|NCT03188276|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25099705|NCT03188276|Antiviral Agents|antiviral agents|mesh-ancestor
25099706|NCT03188276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25099707|NCT03188159|Vinorelbine|vinorelbine|mesh-list
25099708|NCT03188159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25099709|NCT03188159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099710|NCT03188159|Tubulin Modulators|tubulin modulators|mesh-ancestor
25099711|NCT03188159|Antimitotic Agents|antimitotic agents|mesh-ancestor
25099712|NCT03188159|Mitosis Modulators|mitosis modulators|mesh-ancestor
25099713|NCT03188159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099714|NCT03187912|Riboflavin|riboflavin|mesh-list
25099715|NCT03187912|Vitamin B Complex|vitamin b complex|mesh-ancestor
25099716|NCT03187912|Vitamins|vitamins|mesh-ancestor
24425695|NCT00234091|Lopinavir|lopinavir|mesh-list
24425696|NCT00234091|Nelfinavir|nelfinavir|mesh-list
24425697|NCT00234091|Lamivudine|lamivudine|mesh-list
24425698|NCT00234091|Zidovudine|zidovudine|mesh-list
24425699|NCT00234091|Nevirapine|nevirapine|mesh-list
24425700|NCT00234091|Abacavir|abacavir|mesh-list
24425701|NCT00234091|Efavirenz|efavirenz|mesh-list
24425704|NCT00234091|Protease Inhibitors|protease inhibitors|mesh-ancestor
24425735|NCT00234182|Immunologic Factors|immunologic factors|mesh-ancestor
25099717|NCT03187912|Micronutrients|micronutrients|mesh-ancestor
25099718|NCT03187912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099719|NCT03187912|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25099720|NCT03187912|Dermatologic Agents|dermatologic agents|mesh-ancestor
25099721|NCT03188146|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25099722|NCT03188146|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24776954|NCT01860742|Antiviral Agents|antiviral agents|mesh-ancestor
24776955|NCT01860742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24776956|NCT01860742|Immunologic Factors|immunologic factors|mesh-ancestor
25099723|NCT03188146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25099724|NCT03187899|Ropivacaine|ropivacaine|mesh-list
25099725|NCT03187899|Anesthetics, Local|anesthetics, local|mesh-ancestor
25099726|NCT03187899|Anesthetics|anesthetics|mesh-ancestor
25099727|NCT03187899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25099728|NCT03187899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099786|NCT03187093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25099787|NCT03187093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099788|NCT03187093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25099789|NCT03187093|Serotonin Agents|serotonin agents|mesh-ancestor
25099790|NCT03187093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099791|NCT03187093|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25099792|NCT03187093|Antidepressive Agents|antidepressive agents|mesh-ancestor
25099793|NCT03187093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25099794|NCT03187093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25099795|NCT03187093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25099796|NCT03187093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24777041|NCT01861340|Hormones|hormones|mesh-ancestor
25099797|NCT03187093|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25099798|NCT03187093|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25099799|NCT03187093|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25099800|NCT03187093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25099801|NCT03187223|Melphalan|melphalan|mesh-list
24546498|NCT00698763|Vasodilator Agents|vasodilator agents|mesh-ancestor
25099802|NCT03187223|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24516757|NCT00603109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24516758|NCT00603109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516760|NCT00603135|Anticonvulsants|anticonvulsants|mesh-ancestor
24516761|NCT00603135|Nootropic Agents|nootropic agents|mesh-ancestor
24516762|NCT00603317|Amoxicillin|amoxicillin|mesh-list
24439678|NCT00279760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24897415|NCT04425642|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24897416|NCT04425642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897418|NCT04425642|Autonomic Agents|autonomic agents|mesh-ancestor
24897419|NCT04425642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24897420|NCT04425642|Dopamine Agents|dopamine agents|mesh-ancestor
24897421|NCT04425642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24897422|NCT04425642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099803|NCT03187223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25099804|NCT03187223|Alkylating Agents|alkylating agents|mesh-ancestor
25099805|NCT03187223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099806|NCT03187223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099807|NCT03187223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25099808|NCT03187223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25099809|NCT03187223|Immunologic Factors|immunologic factors|mesh-ancestor
25099810|NCT03187223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099811|NCT03187392|Lidocaine|lidocaine|mesh-list
24502755|NCT04447716|Venetoclax|venetoclax|mesh-list
25099874|NCT03187015|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25099875|NCT03187015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25099876|NCT03187080|Bupivacaine|bupivacaine|mesh-list
25099877|NCT03187080|Anesthetics, Local|anesthetics, local|mesh-list
25099878|NCT03187080|Anesthetics|anesthetics|mesh-list
25099879|NCT03187080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25099880|NCT03187080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099881|NCT03187080|Sensory System Agents|sensory system agents|mesh-ancestor
24474489|NCT00406237|Tigecycline|tigecycline|mesh-list
25099993|NCT03186443|Anticonvulsants|anticonvulsants|mesh-ancestor
25099994|NCT03186443|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25099995|NCT03186443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25099996|NCT03186443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099997|NCT03186443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25099998|NCT03186443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25099999|NCT03186443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25100016|NCT03186131|Ibandronic Acid|ibandronic acid|mesh-list
25100017|NCT03186131|Vitamins|vitamins|mesh-ancestor
25100018|NCT03186131|Micronutrients|micronutrients|mesh-ancestor
25100019|NCT03186131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100020|NCT03186131|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25100021|NCT03186040|Lacosamide|lacosamide|mesh-list
25100022|NCT03186040|Anticonvulsants|anticonvulsants|mesh-ancestor
25100023|NCT03186040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25100024|NCT03186040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25100025|NCT03186040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25100026|NCT03186040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100027|NCT03186001|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25100028|NCT03186001|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25100029|NCT03186001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25100030|NCT03186001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25100031|NCT03186001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100032|NCT03186001|Cholinergic Agents|cholinergic agents|mesh-ancestor
24777294|NCT01863355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25100033|NCT03186001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25100034|NCT03186001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100041|NCT03185871|Sensory System Agents|sensory system agents|mesh-ancestor
25100042|NCT03185871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100043|NCT03185871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100044|NCT03185871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25100045|NCT03185871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25100046|NCT03185871|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25100047|NCT03185871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24426147|NCT00235157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25100048|NCT03185871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100049|NCT03185871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100051|NCT03185988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25100052|NCT03185988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25100053|NCT03185845|Warfarin|warfarin|mesh-list
25100054|NCT03185845|Anticoagulants|anticoagulants|mesh-ancestor
25100055|NCT03185611|Rifaximin|rifaximin|mesh-list
25100056|NCT03185611|Azathioprine|azathioprine|mesh-list
24920151|NCT04205097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920152|NCT04205097|Cholinergic Agents|cholinergic agents|mesh-ancestor
24920153|NCT04205097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24920154|NCT04205097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920155|NCT04205097|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24920156|NCT04205097|Autonomic Agents|autonomic agents|mesh-ancestor
24920157|NCT04205097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24920158|NCT04204837|Nivolumab|nivolumab|mesh-list
24495333|NCT00499642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920166|NCT04204980|Immunologic Factors|immunologic factors|mesh-ancestor
24777365|NCT01863641|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25100057|NCT03185611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25100058|NCT03185611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25100059|NCT03185611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25100061|NCT03185611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100085|NCT03185364|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25100086|NCT03185364|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25100087|NCT03185364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100088|NCT03185364|Urological Agents|urological agents|mesh-ancestor
25100090|NCT03185403|Ropivacaine|ropivacaine|mesh-list
25100091|NCT03185403|Anesthetics, Local|anesthetics, local|mesh-ancestor
25100092|NCT03185403|Anesthetics|anesthetics|mesh-ancestor
25100093|NCT03185403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25100094|NCT03185403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100095|NCT03185403|Sensory System Agents|sensory system agents|mesh-ancestor
24968484|NCT03750773|Analgesics|analgesics|mesh-ancestor
24516765|NCT00603317|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24897423|NCT04425642|Adrenergic Agents|adrenergic agents|mesh-ancestor
24897424|NCT04425642|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25100096|NCT03185403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100097|NCT03185403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25100098|NCT03185403|Narcotics|narcotics|mesh-ancestor
25100099|NCT03185403|Analgesics|analgesics|mesh-ancestor
25100100|NCT03185403|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25100101|NCT03185403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25100102|NCT03185403|Anesthetics, General|anesthetics, general|mesh-ancestor
25100103|NCT03185793|Benzbromarone|benzbromarone|mesh-list
25100104|NCT03185793|Uricosuric Agents|uricosuric agents|mesh-ancestor
25100105|NCT03185793|Gout Suppressants|gout suppressants|mesh-ancestor
25100106|NCT03185793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25100107|NCT03185793|Renal Agents|renal agents|mesh-ancestor
25100108|NCT03185351|Midazolam|midazolam|mesh-list
25100109|NCT03185351|Bupivacaine|bupivacaine|mesh-list
25100110|NCT03185351|Anesthetics, Local|anesthetics, local|mesh-ancestor
25100111|NCT03185351|Anesthetics|anesthetics|mesh-ancestor
24426249|NCT00235287|Candesartan cilexetil|candesartan cilexetil|mesh-list
25100112|NCT03185351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25100138|NCT03184844|Thalidomide|thalidomide|mesh-list
25100139|NCT03184844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25100140|NCT03184844|Immunologic Factors|immunologic factors|mesh-ancestor
25100141|NCT03184844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100142|NCT03184844|Leprostatic Agents|leprostatic agents|mesh-ancestor
25100143|NCT03184844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25100144|NCT03184844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25100145|NCT03184844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25100146|NCT03184844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25100147|NCT03184844|Growth Substances|growth substances|mesh-ancestor
25100148|NCT03184844|Growth Inhibitors|growth inhibitors|mesh-ancestor
25686262|NCT01916824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25686263|NCT01916824|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25686264|NCT01916824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25686265|NCT01916824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25686266|NCT01916824|Adrenergic Agents|adrenergic agents|mesh-ancestor
25686267|NCT01916824|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25686268|NCT01916824|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25686269|NCT01916824|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25686270|NCT01916941|Prazosin|prazosin|mesh-list
25686271|NCT01916941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25100149|NCT03184844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25100150|NCT03185143|Acetaminophen|acetaminophen|mesh-list
25100151|NCT03185143|Sumatriptan|sumatriptan|mesh-list
25100152|NCT03185143|Naltrexone|naltrexone|mesh-list
25100153|NCT03185143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25100154|NCT03185143|Analgesics|analgesics|mesh-ancestor
25100155|NCT03185143|Sensory System Agents|sensory system agents|mesh-ancestor
25100156|NCT03185143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100157|NCT03185143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100158|NCT03185143|Antipyretics|antipyretics|mesh-ancestor
25100162|NCT03185143|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25100196|NCT03184870|Micronutrients|micronutrients|mesh-ancestor
25100197|NCT03185130|Diphenhydramine|diphenhydramine|mesh-list
25100198|NCT03185130|Promethazine|promethazine|mesh-list
25100199|NCT03185130|Prochlorperazine|prochlorperazine|mesh-list
25100200|NCT03185130|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25100201|NCT03185130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25100202|NCT03185130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25100203|NCT03185130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100204|NCT03185130|Anesthetics, Local|anesthetics, local|mesh-ancestor
25100205|NCT03185130|Anesthetics|anesthetics|mesh-ancestor
24506067|NCT00544011|Irinotecan|irinotecan|mesh-list
25100235|NCT03184805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100236|NCT03184805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25100237|NCT03184805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25100238|NCT03184805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100239|NCT03184805|Antipyretics|antipyretics|mesh-ancestor
25100240|NCT03184649|Acetaminophen|acetaminophen|mesh-list
25100241|NCT03184649|Ibuprofen|ibuprofen|mesh-list
25100242|NCT03184649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25100243|NCT03184649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25100245|NCT03184649|Sensory System Agents|sensory system agents|mesh-ancestor
25100829|NCT03179839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100246|NCT03184649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100247|NCT03184649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100248|NCT03184649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25100249|NCT03184649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25100250|NCT03184649|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25100251|NCT03184649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100252|NCT03184649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100287|NCT03184363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100288|NCT03184363|Cholinergic Agents|cholinergic agents|mesh-ancestor
25100289|NCT03184363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25100290|NCT03184766|Ibuprofen|ibuprofen|mesh-list
25100291|NCT03184766|Pseudoephedrine|pseudoephedrine|mesh-list
25100292|NCT03184766|Ephedrine|ephedrine|mesh-list
24506347|NCT00544791|Melatonin|melatonin|mesh-list
24897425|NCT04425642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24897442|NCT04425681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100327|NCT03184194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25100328|NCT03184194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25100329|NCT03184194|Immunologic Factors|immunologic factors|mesh-ancestor
25100330|NCT03184194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100331|NCT03184194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24506589|NCT00546130|polysaccharide-K|polysaccharide-k|mesh-list
25100368|NCT03183596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100369|NCT03183596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100397|NCT03183297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25100398|NCT03183297|Analgesics|analgesics|mesh-ancestor
25100399|NCT03183297|Sensory System Agents|sensory system agents|mesh-ancestor
25100400|NCT03183297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100401|NCT03183297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100402|NCT03183297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25100403|NCT03183297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25100404|NCT03183297|Gout Suppressants|gout suppressants|mesh-ancestor
25100405|NCT03183297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25100406|NCT03183297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100407|NCT03183297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100408|NCT03183297|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25100409|NCT03183297|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25100410|NCT03183297|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25100411|NCT03183297|Histamine Antagonists|histamine antagonists|mesh-ancestor
25100412|NCT03183297|Histamine Agents|histamine agents|mesh-ancestor
25100413|NCT03183297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25100414|NCT03183544|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25100415|NCT03183544|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24521974|NCT04388683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521975|NCT04388683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25067182|NCT03446495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067183|NCT03446495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24920326|NCT04203368|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24920327|NCT04203368|Purinergic Agonists|purinergic agonists|mesh-ancestor
24920328|NCT04203368|Purinergic Agents|purinergic agents|mesh-ancestor
24920329|NCT04203368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24920330|NCT04203368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920331|NCT04203368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24506912|NCT00547508|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25100473|NCT03182634|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25100474|NCT03182634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25100475|NCT03182634|Hormone Antagonists|hormone antagonists|mesh-ancestor
25100476|NCT03182634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25100514|NCT03182257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24426543|NCT00236288|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24426544|NCT00236288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24426565|NCT00236327|Fentanyl|fentanyl|mesh-list
24426590|NCT00236366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24426591|NCT00236366|Narcotics|narcotics|mesh-ancestor
24426629|NCT00236418|Topiramate|topiramate|mesh-list
25100515|NCT03182257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100516|NCT03182257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100518|NCT03182374|Viscosupplements|viscosupplements|mesh-ancestor
25100519|NCT03182374|Protective Agents|protective agents|mesh-ancestor
25100520|NCT03182374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100521|NCT03182322|Insulin|insulin|mesh-list
25100522|NCT03182322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24777832|NCT01867281|Aspirin|aspirin|mesh-list
25100523|NCT03182322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100524|NCT03181919|Letrozole|letrozole|mesh-list
25100525|NCT03181919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25100560|NCT03181880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25100561|NCT03181880|Autonomic Agents|autonomic agents|mesh-ancestor
25100562|NCT03181880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100563|NCT03181880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100597|NCT03181685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25100598|NCT03181685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100599|NCT03181685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25100600|NCT03181685|Fertility Agents|fertility agents|mesh-ancestor
25100601|NCT03181685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25100602|NCT03181685|Hormone Antagonists|hormone antagonists|mesh-ancestor
25100603|NCT03181464|Lidocaine|lidocaine|mesh-list
25100620|NCT03181360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25100621|NCT03181360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100622|NCT03181815|Cytarabine|cytarabine|mesh-list
25100623|NCT03181815|Cladribine|cladribine|mesh-list
25100624|NCT03181815|Aclarubicin|aclarubicin|mesh-list
25100625|NCT03181815|Aclacinomycins|aclacinomycins|mesh-list
25100626|NCT03181815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25100627|NCT03181815|Antimetabolites|antimetabolites|mesh-ancestor
24968604|NCT03749915|Sensory System Agents|sensory system agents|mesh-ancestor
24897444|NCT04425707|Ivermectin|ivermectin|mesh-list
24897445|NCT04425707|Antimalarials|antimalarials|mesh-ancestor
24897446|NCT04425707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24897447|NCT04425707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24897448|NCT04425707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24897449|NCT04425707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24897450|NCT04425707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897451|NCT04425707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25686272|NCT01916941|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25686273|NCT01916941|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25686274|NCT01916941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25686275|NCT01916941|Adrenergic Agents|adrenergic agents|mesh-ancestor
25686276|NCT01916941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25686277|NCT01916941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686278|NCT01916941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686279|NCT01917006|Botulinum Toxins|botulinum toxins|mesh-list
25686280|NCT01917006|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25686281|NCT01917006|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25686282|NCT01917006|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24920392|NCT04202952|Antiviral Agents|antiviral agents|mesh-ancestor
24920393|NCT04202952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24920394|NCT04202835|Cyclophosphamide|cyclophosphamide|mesh-list
24920395|NCT04202835|Thymoglobulin|thymoglobulin|mesh-list
24920396|NCT04202835|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24920397|NCT04202835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24920398|NCT04202835|Immunologic Factors|immunologic factors|mesh-ancestor
24897452|NCT04425824|Rituximab|rituximab|mesh-list
24474515|NCT00406341|Difluprednate|difluprednate|mesh-list
24474516|NCT00406341|Glucocorticoids|glucocorticoids|mesh-ancestor
25100628|NCT03181815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100629|NCT03181815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25100630|NCT03181815|Antiviral Agents|antiviral agents|mesh-ancestor
25100631|NCT03181815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25100632|NCT03181815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25100633|NCT03181815|Immunologic Factors|immunologic factors|mesh-ancestor
25100634|NCT03181815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100635|NCT03181815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25100636|NCT03181815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25100637|NCT03181815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25100638|NCT03181815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100639|NCT03181815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25100640|NCT03181178|Micronutrients|micronutrients|mesh-list
25100641|NCT03181178|Trace Elements|trace elements|mesh-list
25100642|NCT03181178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100643|NCT03181113|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25100644|NCT03181113|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25100645|NCT03181113|Antiviral Agents|antiviral agents|mesh-ancestor
25100646|NCT03181113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25100710|NCT03180632|GABA Modulators|gaba modulators|mesh-ancestor
24824411|NCT02123355|Analgesics|analgesics|mesh-ancestor
24824412|NCT02123355|Sensory System Agents|sensory system agents|mesh-ancestor
24824413|NCT02123355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24426732|NCT00236548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25100722|NCT03180593|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25100723|NCT03180593|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25100724|NCT03180593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100725|NCT03180593|Vasodilator Agents|vasodilator agents|mesh-ancestor
25100726|NCT03180593|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25100727|NCT03180593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25100728|NCT03180593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25100729|NCT03180593|Adrenergic Agents|adrenergic agents|mesh-ancestor
25100730|NCT03180593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25100731|NCT03180593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100733|NCT03180229|Antiemetics|antiemetics|mesh-ancestor
25100734|NCT03180229|Autonomic Agents|autonomic agents|mesh-ancestor
25100735|NCT03180229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100736|NCT03180229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100737|NCT03180229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25100738|NCT03180229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25100739|NCT03180229|Serotonin Agents|serotonin agents|mesh-ancestor
25100740|NCT03180229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25100741|NCT03180229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100742|NCT03180346|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25100743|NCT03180346|Laxatives|laxatives|mesh-ancestor
24474517|NCT00406341|Hormones|hormones|mesh-ancestor
24474518|NCT00406341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24516784|NCT00603356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24426733|NCT00236548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25100744|NCT03180346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25686283|NCT01917006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25686284|NCT01917006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686285|NCT01917006|Cholinergic Agents|cholinergic agents|mesh-ancestor
25686286|NCT01917006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25686287|NCT01917006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686288|NCT01917006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25100745|NCT03180359|Vaccines|vaccines|mesh-list
25100746|NCT03180359|Immunologic Factors|immunologic factors|mesh-ancestor
25100753|NCT03180125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100754|NCT03180125|Sensory System Agents|sensory system agents|mesh-ancestor
25100755|NCT03180125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100756|NCT03180125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25100757|NCT03180125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25100758|NCT03180125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25100759|NCT03180125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25100760|NCT03180125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100761|NCT03180125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25100762|NCT03180125|Immunologic Factors|immunologic factors|mesh-ancestor
25100763|NCT03180125|Viscosupplements|viscosupplements|mesh-ancestor
25100764|NCT03180125|Protective Agents|protective agents|mesh-ancestor
25100765|NCT03180242|Trastuzumab|trastuzumab|mesh-list
25100766|NCT03180242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25100767|NCT03180242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25100768|NCT03180281|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25100769|NCT03180281|Glimepiride|glimepiride|mesh-list
25100770|NCT03180281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25100771|NCT03180281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526074|NCT01845441|Midazolam|midazolam|mesh-list
24474592|NCT00406861|Respiratory System Agents|respiratory system agents|mesh-ancestor
24474593|NCT00406861|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24474594|NCT00406861|Hormone Antagonists|hormone antagonists|mesh-ancestor
24474595|NCT00406861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24897530|NCT04424875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897531|NCT04424875|Protective Agents|protective agents|mesh-ancestor
24897532|NCT04424875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897635|NCT04423627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24897636|NCT04423627|Adrenergic Agents|adrenergic agents|mesh-ancestor
24897637|NCT04423627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24897638|NCT04423861|Nitazoxanide|nitazoxanide|mesh-list
24897639|NCT04423861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24897640|NCT04423861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25100803|NCT03180190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100804|NCT03180190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25100806|NCT03180099|Anesthetics, Local|anesthetics, local|mesh-ancestor
25100807|NCT03180099|Anesthetics|anesthetics|mesh-ancestor
25100808|NCT03180099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25100809|NCT03180099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100810|NCT03180099|Sensory System Agents|sensory system agents|mesh-ancestor
25100811|NCT03180099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100812|NCT03179839|Fluvoxamine|fluvoxamine|mesh-list
25100813|NCT03179839|Sertraline|sertraline|mesh-list
25100814|NCT03179839|Antidepressive Agents|antidepressive agents|mesh-ancestor
25100827|NCT03179839|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25100828|NCT03179839|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24474738|NCT00407212|Maleic acid|maleic acid|mesh-list
24474739|NCT00407212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474740|NCT00407212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474741|NCT00407225|Difluprednate|difluprednate|mesh-list
24897665|NCT04423510|Phenol|phenol|mesh-list
24897666|NCT04423510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24897667|NCT04423510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24897668|NCT04423510|Disinfectants|disinfectants|mesh-ancestor
24897669|NCT04423510|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
24897670|NCT04423510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24897671|NCT04423107|Acetaminophen|acetaminophen|mesh-list
24897672|NCT04423107|Ibuprofen|ibuprofen|mesh-list
24897673|NCT04423107|Oxycodone|oxycodone|mesh-list
24897674|NCT04423107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24897675|NCT04423107|Analgesics|analgesics|mesh-ancestor
24897676|NCT04423107|Sensory System Agents|sensory system agents|mesh-ancestor
24897677|NCT04423107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24897678|NCT04423107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897679|NCT04423107|Antipyretics|antipyretics|mesh-ancestor
24897680|NCT04423107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24897681|NCT04423107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24897682|NCT04423107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24897683|NCT04423107|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24897684|NCT04423107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100834|NCT03179735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25100835|NCT03179735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25100836|NCT03179618|Vasodilator Agents|vasodilator agents|mesh-list
24623968|NCT01074073|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24623969|NCT01074073|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24623970|NCT01074073|Dopamine Agents|dopamine agents|mesh-ancestor
24623972|NCT01074086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623973|NCT01074086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24623974|NCT01074086|Immunologic Factors|immunologic factors|mesh-ancestor
24623976|NCT01074138|Tirbanibulin|tirbanibulin|mesh-list
25100837|NCT03179618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25100838|NCT03179618|Lipid Regulating Agents|lipid regulating agents|mesh-list
25100839|NCT03179332|Insulin Lispro|insulin lispro|mesh-list
24426923|NCT00236834|Ofloxacin|ofloxacin|mesh-list
24426944|NCT00236873|Topiramate|topiramate|mesh-list
24426963|NCT00236912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24426964|NCT00236912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427009|NCT00237172|Imatinib Mesylate|imatinib mesylate|mesh-list
24824434|NCT02123368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100840|NCT03179332|Insulin Aspart|insulin aspart|mesh-list
25100841|NCT03179332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25100842|NCT03179332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100843|NCT03179527|Vasodilator Agents|vasodilator agents|mesh-list
25100844|NCT03179527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25100845|NCT03179527|Lipid Regulating Agents|lipid regulating agents|mesh-list
25100846|NCT03179514|Vasodilator Agents|vasodilator agents|mesh-list
25100847|NCT03179514|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25100848|NCT03179514|Lipid Regulating Agents|lipid regulating agents|mesh-list
25100849|NCT03179384|Ceftriaxone|ceftriaxone|mesh-list
25100850|NCT03179384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25100851|NCT03179384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25100852|NCT03179293|Propofol|propofol|mesh-list
25100853|NCT03179293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25100854|NCT03179293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25100855|NCT03179293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100856|NCT03179293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25100857|NCT03179293|Anesthetics, General|anesthetics, general|mesh-ancestor
25100858|NCT03179293|Anesthetics|anesthetics|mesh-ancestor
25100859|NCT03179280|Insulin|insulin|mesh-list
25100860|NCT03179280|Insulin Aspart|insulin aspart|mesh-list
25100862|NCT03179280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100864|NCT03178994|Antifungal Agents|antifungal agents|mesh-ancestor
25100865|NCT03178994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24897685|NCT04423107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897686|NCT04423107|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24897687|NCT04423107|Narcotics|narcotics|mesh-ancestor
24897688|NCT04423107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24897689|NCT04423276|Donepezil|donepezil|mesh-list
24474745|NCT00407225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474746|NCT00407251|Epothilone B|epothilone b|mesh-list
24474747|NCT00407251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474748|NCT00407251|Tubulin Modulators|tubulin modulators|mesh-ancestor
24474912|NCT00408148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25100866|NCT03178994|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24824435|NCT02123368|Viscosupplements|viscosupplements|mesh-ancestor
25100867|NCT03178994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25100868|NCT03178994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100869|NCT03178994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100870|NCT03178994|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25100871|NCT03178994|Hormone Antagonists|hormone antagonists|mesh-ancestor
25100872|NCT03178994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25100899|NCT03178955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25100900|NCT03178955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25100901|NCT03178955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25100902|NCT03178955|Immunologic Factors|immunologic factors|mesh-ancestor
25100904|NCT03178864|Rivaroxaban|rivaroxaban|mesh-list
25100905|NCT03178864|Anticoagulants|anticoagulants|mesh-ancestor
25100906|NCT03178864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25686289|NCT01917006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686290|NCT01917136|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25686291|NCT01917136|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25686292|NCT01917136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686293|NCT01917214|Sunitinib|sunitinib|mesh-list
25686294|NCT01917214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25686295|NCT01917214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25100908|NCT03178864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100909|NCT03178864|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25100910|NCT03178864|Antithrombins|antithrombins|mesh-ancestor
25100911|NCT03178864|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25100912|NCT03178864|Protease Inhibitors|protease inhibitors|mesh-ancestor
25100913|NCT03178864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100914|NCT03178656|Sorafenib|sorafenib|mesh-list
25100915|NCT03178656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25100916|NCT03178656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25100917|NCT03178656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100918|NCT03178656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100919|NCT03178721|Calcium|calcium|mesh-list
25100920|NCT03178721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25100952|NCT03178292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25100953|NCT03178292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25100954|NCT03178292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25100955|NCT03178292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100961|NCT03178422|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25100962|NCT03178422|Autonomic Agents|autonomic agents|mesh-ancestor
25100980|NCT03178539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25100981|NCT03178539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25100982|NCT03178539|Analgesics|analgesics|mesh-ancestor
25100983|NCT03178539|Sensory System Agents|sensory system agents|mesh-ancestor
25100984|NCT03178539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100985|NCT03178539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100986|NCT03178539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25100987|NCT03178539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25100988|NCT03178539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25100989|NCT03178539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100990|NCT03178539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100991|NCT03178500|Clomiphene|clomiphene|mesh-list
25100992|NCT03178500|Enclomiphene|enclomiphene|mesh-list
25100993|NCT03178500|Zuclomiphene|zuclomiphene|mesh-list
25100994|NCT03178500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25100995|NCT03178500|Hormone Antagonists|hormone antagonists|mesh-ancestor
24427051|NCT00237250|Vildagliptin|vildagliptin|mesh-list
24427191|NCT00237614|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24427192|NCT00237614|Antioxidants|antioxidants|mesh-ancestor
24427193|NCT00237614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427194|NCT00237614|Protective Agents|protective agents|mesh-ancestor
24427195|NCT00237614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100996|NCT03178500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25100997|NCT03178500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100998|NCT03178500|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25100999|NCT03178500|Fertility Agents|fertility agents|mesh-ancestor
25101000|NCT03178500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25101001|NCT03178500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25101002|NCT03178500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25101004|NCT03178526|L 647318|l 647318|mesh-list
25101005|NCT03178526|Dihydromevinolin|dihydromevinolin|mesh-list
25101006|NCT03178526|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25101007|NCT03178526|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25101008|NCT03178526|Antimetabolites|antimetabolites|mesh-ancestor
25101009|NCT03178526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101010|NCT03178526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25101014|NCT03178123|Antibodies|antibodies|mesh-list
25101017|NCT03178123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101018|NCT03178123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25101114|NCT03177538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101115|NCT03177538|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25101116|NCT03177538|Fertility Agents|fertility agents|mesh-ancestor
25101117|NCT03177538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25101118|NCT03177434|Lactulose|lactulose|mesh-list
25101119|NCT03177434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25101120|NCT03177174|Docetaxel|docetaxel|mesh-list
25101121|NCT03177174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25101122|NCT03177174|Tubulin Modulators|tubulin modulators|mesh-ancestor
25101138|NCT03177252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101140|NCT03177317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25101141|NCT03177317|Antiemetics|antiemetics|mesh-ancestor
25101142|NCT03177317|Autonomic Agents|autonomic agents|mesh-ancestor
25101143|NCT03177317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101144|NCT03177317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101145|NCT03177317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25101146|NCT03177317|Glucocorticoids|glucocorticoids|mesh-ancestor
25101147|NCT03177317|Hormones|hormones|mesh-ancestor
25101148|NCT03177317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25101149|NCT03177317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24427196|NCT00237614|Antidotes|antidotes|mesh-ancestor
25101150|NCT03177317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516861|NCT00604344|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24516862|NCT00604344|Insulin Detemir|insulin detemir|mesh-list
24516863|NCT00604344|Isophane Insulin, Human|isophane insulin, human|mesh-list
24516864|NCT00604344|Insulin, Isophane|insulin, isophane|mesh-list
24516865|NCT00604344|Isophane insulin, beef|isophane insulin, beef|mesh-list
24516866|NCT00604344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24516867|NCT00604344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516868|NCT00604357|Sirolimus|sirolimus|mesh-list
25101151|NCT03177239|Nivolumab|nivolumab|mesh-list
25101152|NCT03177239|Ipilimumab|ipilimumab|mesh-list
25101153|NCT03177239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25101154|NCT03177239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25101155|NCT03177239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25101156|NCT03177239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101157|NCT03176849|Vitamin D|vitamin d|mesh-list
25101158|NCT03176849|Ergocalciferols|ergocalciferols|mesh-list
25101159|NCT03176849|Cholecalciferol|cholecalciferol|mesh-list
25101160|NCT03176849|Vitamins|vitamins|mesh-list
25101161|NCT03176849|Micronutrients|micronutrients|mesh-ancestor
25101162|NCT03176849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101163|NCT03176849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25101164|NCT03176849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25101165|NCT03177109|Fluorides|fluorides|mesh-list
25101166|NCT03177109|Fluorides, Topical|fluorides, topical|mesh-list
25101167|NCT03177109|Cariostatic Agents|cariostatic agents|mesh-ancestor
25101168|NCT03177109|Protective Agents|protective agents|mesh-ancestor
25101169|NCT03177109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101170|NCT03176966|Vitamin E|vitamin e|mesh-list
25101171|NCT03176966|Ropinirole|ropinirole|mesh-list
25101172|NCT03176966|Vitamins|vitamins|mesh-ancestor
25101173|NCT03176966|Micronutrients|micronutrients|mesh-ancestor
25101174|NCT03176966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101175|NCT03176966|Antioxidants|antioxidants|mesh-ancestor
25101176|NCT03176966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427334|NCT00237939|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24427335|NCT00237939|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25101177|NCT03176966|Protective Agents|protective agents|mesh-ancestor
25101178|NCT03176966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24968768|NCT03748082|Nitric Oxide|nitric oxide|mesh-list
24516882|NCT00604396|Isophane insulin, beef|isophane insulin, beef|mesh-list
24897852|NCT04421209|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24897853|NCT04421209|Adrenergic Agents|adrenergic agents|mesh-ancestor
24897854|NCT04421209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24897855|NCT04421209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897856|NCT04421209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101179|NCT03176966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25101195|NCT03176758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25101196|NCT03176758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101198|NCT03176693|Phenoxybenzamine|phenoxybenzamine|mesh-list
25101199|NCT03176693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25101200|NCT03176693|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25101201|NCT03176693|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25101202|NCT03176693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25101203|NCT03176693|Adrenergic Agents|adrenergic agents|mesh-ancestor
25101204|NCT03176693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25101205|NCT03176693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101206|NCT03176693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101207|NCT03176693|Vasodilator Agents|vasodilator agents|mesh-ancestor
25101208|NCT03177070|Methylene Blue|methylene blue|mesh-list
25101209|NCT03177070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25101210|NCT03177070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101211|NCT03176628|Niacinamide|niacinamide|mesh-list
25101212|NCT03176628|Vitamin B Complex|vitamin b complex|mesh-ancestor
25101213|NCT03176628|Vitamins|vitamins|mesh-ancestor
25101214|NCT03176628|Micronutrients|micronutrients|mesh-ancestor
25101215|NCT03176628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101216|NCT03176524|Glucagon|glucagon|mesh-list
25101217|NCT03176524|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25101218|NCT03176524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25101219|NCT03176524|Hormones|hormones|mesh-ancestor
25101220|NCT03176524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25101221|NCT03176524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101222|NCT03176524|Incretins|incretins|mesh-ancestor
25101223|NCT03176264|Bevacizumab|bevacizumab|mesh-list
25101224|NCT03176264|Spartalizumab|spartalizumab|mesh-list
24897857|NCT04421209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24897858|NCT04421209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24897859|NCT04421209|Vasodilator Agents|vasodilator agents|mesh-ancestor
24897861|NCT04421079|Antioxidants|antioxidants|mesh-ancestor
25101662|NCT03173508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24897877|NCT04420936|Anesthetics, Local|anesthetics, local|mesh-ancestor
25101225|NCT03176264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25101226|NCT03176264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25101227|NCT03176264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25101228|NCT03176264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25101229|NCT03176264|Growth Substances|growth substances|mesh-ancestor
25101230|NCT03176264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101231|NCT03176264|Growth Inhibitors|growth inhibitors|mesh-ancestor
25101232|NCT03176264|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25101233|NCT03176264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101234|NCT03176563|Fosfomycin|fosfomycin|mesh-list
25101235|NCT03176563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25101236|NCT03176563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25101237|NCT03176316|Naloxone|naloxone|mesh-list
25101238|NCT03176316|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25101239|NCT03176316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101240|NCT03176316|Sensory System Agents|sensory system agents|mesh-ancestor
25101241|NCT03176316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101273|NCT03176186|Anesthetics, General|anesthetics, general|mesh-ancestor
25101274|NCT03176186|Anesthetics|anesthetics|mesh-ancestor
25101275|NCT03176186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24778670|NCT01871922|Atropine|atropine|mesh-list
25101276|NCT03176186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101277|NCT03175939|Fluorouracil|fluorouracil|mesh-list
25101278|NCT03175939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25101279|NCT03175939|Antimetabolites|antimetabolites|mesh-ancestor
25101280|NCT03175939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101281|NCT03175939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24427469|NCT00238225|Hormones|hormones|mesh-ancestor
24427523|NCT00238316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427524|NCT00238329|Interferons|interferons|mesh-list
24427525|NCT00238329|Interferon-alpha|interferon-alpha|mesh-list
24427526|NCT00238329|Interferon alpha-2|interferon alpha-2|mesh-list
24427527|NCT00238329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24920672|NCT04200040|Alkylating Agents|alkylating agents|mesh-ancestor
24920674|NCT04200040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427528|NCT00238329|Thalidomide|thalidomide|mesh-list
25101282|NCT03175939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25101283|NCT03175939|Immunologic Factors|immunologic factors|mesh-ancestor
25101300|NCT03175679|Analgesics|analgesics|mesh-ancestor
25101301|NCT03175679|Sensory System Agents|sensory system agents|mesh-ancestor
25101302|NCT03175679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101313|NCT03175666|Avelumab|avelumab|mesh-list
25101314|NCT03175666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25101315|NCT03175666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25101316|NCT03175666|Tubulin Modulators|tubulin modulators|mesh-ancestor
25101317|NCT03175666|Antimitotic Agents|antimitotic agents|mesh-ancestor
25101318|NCT03175666|Mitosis Modulators|mitosis modulators|mesh-ancestor
25101319|NCT03175666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101320|NCT03175666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25101321|NCT03175666|Immunologic Factors|immunologic factors|mesh-ancestor
25101322|NCT03175666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101323|NCT03175666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25101324|NCT03175666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25101325|NCT03175666|Alkylating Agents|alkylating agents|mesh-ancestor
25101326|NCT03175666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25101330|NCT03175666|Growth Substances|growth substances|mesh-ancestor
25101331|NCT03175666|Growth Inhibitors|growth inhibitors|mesh-ancestor
25101332|NCT03175666|Antimetabolites|antimetabolites|mesh-ancestor
25101333|NCT03175666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25101334|NCT03175666|Antidotes|antidotes|mesh-ancestor
25101335|NCT03175666|Protective Agents|protective agents|mesh-ancestor
25101336|NCT03175666|Vitamin B Complex|vitamin b complex|mesh-ancestor
25101337|NCT03175666|Vitamins|vitamins|mesh-ancestor
25101338|NCT03175666|Micronutrients|micronutrients|mesh-ancestor
25101339|NCT03175705|Interleukin-2|interleukin-2|mesh-list
25101340|NCT03175705|Tegafur|tegafur|mesh-list
25101341|NCT03175705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24897878|NCT04420936|Anesthetics|anesthetics|mesh-ancestor
24897879|NCT04420936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24897880|NCT04420936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897881|NCT04420936|Sensory System Agents|sensory system agents|mesh-ancestor
24897882|NCT04420936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24897893|NCT04420533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24897894|NCT04420533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24897895|NCT04420533|Adrenergic Agents|adrenergic agents|mesh-ancestor
24897896|NCT04420533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24897897|NCT04420533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513478|NCT00582582|Docetaxel|docetaxel|mesh-list
25101409|NCT03174977|Antiviral Agents|antiviral agents|mesh-ancestor
25101410|NCT03174977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25101411|NCT03174977|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25101412|NCT03174977|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25101413|NCT03174977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25101414|NCT03174977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101415|NCT03175016|Irinotecan|irinotecan|mesh-list
25101416|NCT03175016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25101417|NCT03175016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25101418|NCT03175016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25101419|NCT03175016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968903|NCT03747341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24897898|NCT04420533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897900|NCT04419948|Ibuprofen|ibuprofen|mesh-list
24897901|NCT04419948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24475009|NCT00408525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24475010|NCT00408525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475011|NCT00408525|Cholinergic Agents|cholinergic agents|mesh-ancestor
24475012|NCT00408525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24475033|NCT00408551|Immunologic Factors|immunologic factors|mesh-ancestor
24475034|NCT00408551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24475035|NCT00408551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25686296|NCT01917214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25686297|NCT01917214|Growth Substances|growth substances|mesh-ancestor
25040033|NCT03494504|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25040034|NCT03494504|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25040041|NCT03475706|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25040042|NCT03475706|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25040043|NCT03475706|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25040044|NCT03475706|Adrenergic Agents|adrenergic agents|mesh-ancestor
25040045|NCT03475706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25040046|NCT03475706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608594|NCT00992693|Ribavirin|ribavirin|mesh-list
25040056|NCT03471767|Antidepressive Agents|antidepressive agents|mesh-ancestor
25040057|NCT03471767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24897953|NCT04419662|Nasal Decongestants|nasal decongestants|mesh-ancestor
24897954|NCT04419662|Respiratory System Agents|respiratory system agents|mesh-ancestor
24897955|NCT04419662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24897956|NCT04419662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24427564|NCT00238368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24427565|NCT00238368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427566|NCT00238368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24897957|NCT04419662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24897958|NCT04419662|Adrenergic Agents|adrenergic agents|mesh-ancestor
24897959|NCT04419662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24475062|NCT00408772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24475063|NCT00408772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24475064|NCT00408772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24475065|NCT00408772|Growth Substances|growth substances|mesh-ancestor
24475066|NCT00408772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475067|NCT00408772|Growth Inhibitors|growth inhibitors|mesh-ancestor
24475068|NCT00408772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24897962|NCT04419493|Heparin|heparin|mesh-list
24475116|NCT00408941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24475118|NCT00409019|Adefovir|adefovir|mesh-list
24475119|NCT00409019|Telbivudine|telbivudine|mesh-list
24475120|NCT00409019|Antiviral Agents|antiviral agents|mesh-ancestor
24475121|NCT00409019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24475122|NCT00409019|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24475123|NCT00409019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24475124|NCT00409019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24475125|NCT00409019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475126|NCT00409019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25101455|NCT03174561|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25101457|NCT03174561|Antioxidants|antioxidants|mesh-ancestor
25101458|NCT03174561|Protective Agents|protective agents|mesh-ancestor
25101459|NCT03174561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101460|NCT03174782|Bupivacaine|bupivacaine|mesh-list
25101461|NCT03174782|Anesthetics, Local|anesthetics, local|mesh-ancestor
25101462|NCT03174782|Anesthetics|anesthetics|mesh-ancestor
24480623|NCT00431392|Vasodilator Agents|vasodilator agents|mesh-ancestor
24898034|NCT04419025|Respiratory System Agents|respiratory system agents|mesh-ancestor
24898035|NCT04419025|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24898036|NCT04419025|Antioxidants|antioxidants|mesh-ancestor
24898037|NCT04419025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898038|NCT04419025|Protective Agents|protective agents|mesh-ancestor
24898039|NCT04419025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898040|NCT04419025|Antidotes|antidotes|mesh-ancestor
24898041|NCT04418908|Cetrorelix|cetrorelix|mesh-list
24898042|NCT04418908|Estradiol|estradiol|mesh-list
24898043|NCT04418908|Estrogens|estrogens|mesh-ancestor
24898044|NCT04418908|Hormones|hormones|mesh-ancestor
24516993|NCT00605137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24516994|NCT00605137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516995|NCT00605371|Lamotrigine|lamotrigine|mesh-list
24898077|NCT04418154|Paclitaxel|paclitaxel|mesh-list
25686298|NCT01917214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686299|NCT01917214|Growth Inhibitors|growth inhibitors|mesh-ancestor
25686300|NCT01917214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25686301|NCT01917214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25686302|NCT01917214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686303|NCT01917656|Metformin|metformin|mesh-list
25686304|NCT01917656|Liraglutide|liraglutide|mesh-list
25686305|NCT01917656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25686306|NCT01917656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686307|NCT01917656|Incretins|incretins|mesh-ancestor
25686308|NCT01917656|Hormones|hormones|mesh-ancestor
24898133|NCT04418128|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24898139|NCT04417920|Mitomycin|mitomycin|mesh-list
25040098|NCT03427125|Sevelamer|sevelamer|mesh-list
25040099|NCT03427125|Chelating Agents|chelating agents|mesh-ancestor
25040119|NCT03412890|Contraceptive Agents|contraceptive agents|mesh-ancestor
25040120|NCT03412890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25040121|NCT03412890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25040122|NCT03412890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25040123|NCT03412890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25040124|NCT03412890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25040125|NCT03412890|Androgen Antagonists|androgen antagonists|mesh-ancestor
25040126|NCT03412890|Hormone Antagonists|hormone antagonists|mesh-ancestor
25040127|NCT03404115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25276413|NCT02365181|Ropivacaine|ropivacaine|mesh-list
24898140|NCT04417920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24898141|NCT04417920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898142|NCT04417920|Alkylating Agents|alkylating agents|mesh-ancestor
24898143|NCT04417920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898144|NCT04417920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24898145|NCT04417920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24898146|NCT04418102|Palmitic Acid|palmitic acid|mesh-list
24898147|NCT04418102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24898148|NCT04418102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898149|NCT04417985|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24898150|NCT04417985|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24475248|NCT00409630|Fluticasone|fluticasone|mesh-list
24475249|NCT00409630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25101463|NCT03174782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25101464|NCT03174782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101465|NCT03174782|Sensory System Agents|sensory system agents|mesh-ancestor
25101466|NCT03174782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101467|NCT03174756|Chlorhexidine|chlorhexidine|mesh-list
25101468|NCT03174756|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25101469|NCT03174756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25101497|NCT03174678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101499|NCT03174171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25101500|NCT03174171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25101501|NCT03174171|Immunologic Factors|immunologic factors|mesh-ancestor
25101502|NCT03174171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101503|NCT03174080|Fluorides|fluorides|mesh-list
25101504|NCT03174080|Cariostatic Agents|cariostatic agents|mesh-ancestor
25101505|NCT03174080|Protective Agents|protective agents|mesh-ancestor
25101506|NCT03174080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101507|NCT03174236|Metronidazole|metronidazole|mesh-list
25101508|NCT03174236|Gentamicins|gentamicins|mesh-list
25101509|NCT03174236|Ceftriaxone|ceftriaxone|mesh-list
25101510|NCT03174236|Penicillins|penicillins|mesh-list
25101511|NCT03174236|Penicillin G|penicillin g|mesh-list
25101582|NCT03173898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25101583|NCT03173898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101585|NCT03173781|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25101586|NCT03173781|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25101587|NCT03173963|Empagliflozin|empagliflozin|mesh-list
25101588|NCT03173963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25101589|NCT03173963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101590|NCT03173963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25101591|NCT03173963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101631|NCT03173235|Micronutrients|micronutrients|mesh-ancestor
25101632|NCT03173235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101633|NCT03173235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25101638|NCT03173365|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25101639|NCT03173365|Adrenergic Agents|adrenergic agents|mesh-ancestor
25101640|NCT03173365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25101641|NCT03173365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101642|NCT03173365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101643|NCT03173339|Remifentanil|remifentanil|mesh-list
25686309|NCT01917656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25686310|NCT01917773|Octreotide|octreotide|mesh-list
25686311|NCT01917773|Bisacodyl|bisacodyl|mesh-list
25686312|NCT01917773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25686313|NCT01917773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25686314|NCT01917773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25686315|NCT01917773|Cathartics|cathartics|mesh-ancestor
25686316|NCT01917773|Laxatives|laxatives|mesh-ancestor
25686317|NCT01918306|Cisplatin|cisplatin|mesh-list
25686318|NCT01918306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25686319|NCT01918332|Valsartan|valsartan|mesh-list
25686320|NCT01918332|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25040283|NCT03208985|Ulipristal acetate|ulipristal acetate|mesh-list
25040284|NCT03208985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25040285|NCT03208985|Contraceptive Agents|contraceptive agents|mesh-ancestor
25040286|NCT03208985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25040301|NCT03191864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25040302|NCT03191864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040304|NCT03191864|Respiratory System Agents|respiratory system agents|mesh-ancestor
25040305|NCT03191864|Dermatologic Agents|dermatologic agents|mesh-ancestor
25101644|NCT03173339|Sevoflurane|sevoflurane|mesh-list
25101645|NCT03173339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25101646|NCT03173339|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25101647|NCT03173339|Anesthetics, General|anesthetics, general|mesh-ancestor
25101648|NCT03173339|Anesthetics|anesthetics|mesh-ancestor
25101649|NCT03173339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25101650|NCT03173339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101651|NCT03173339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25101652|NCT03173339|Narcotics|narcotics|mesh-ancestor
25101653|NCT03173339|Analgesics|analgesics|mesh-ancestor
25101654|NCT03173339|Sensory System Agents|sensory system agents|mesh-ancestor
25101655|NCT03173339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101656|NCT03173326|Anesthetics|anesthetics|mesh-list
25101657|NCT03173326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24824533|NCT02123628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25101658|NCT03173326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101659|NCT03173508|Acetazolamide|acetazolamide|mesh-list
25101660|NCT03173508|Anticonvulsants|anticonvulsants|mesh-ancestor
25101661|NCT03173508|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25101665|NCT03173508|Natriuretic Agents|natriuretic agents|mesh-ancestor
25101666|NCT03173508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101688|NCT03172871|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25101689|NCT03172871|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25101690|NCT03172871|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25101691|NCT03172988|Dexamethasone|dexamethasone|mesh-list
25101692|NCT03172988|Dexamethasone acetate|dexamethasone acetate|mesh-list
25101693|NCT03172988|Flurbiprofen|flurbiprofen|mesh-list
25101694|NCT03172988|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
25101695|NCT03172988|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25101703|NCT03172988|Glucocorticoids|glucocorticoids|mesh-ancestor
25101704|NCT03172988|Hormones|hormones|mesh-ancestor
25101705|NCT03172988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25101706|NCT03172988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25101707|NCT03172988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25101708|NCT03172988|Protease Inhibitors|protease inhibitors|mesh-ancestor
25101709|NCT03172988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25101710|NCT03172988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101711|NCT03172988|Analgesics|analgesics|mesh-ancestor
25101712|NCT03172988|Sensory System Agents|sensory system agents|mesh-ancestor
25101713|NCT03172988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25101714|NCT03172988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25101715|NCT03172988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25101753|NCT03172676|Amoxicillin|amoxicillin|mesh-list
25101754|NCT03172676|Clarithromycin|clarithromycin|mesh-list
25101755|NCT03172676|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25101756|NCT03172676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24898276|NCT04415983|Nitazoxanide|nitazoxanide|mesh-list
24898277|NCT04415983|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24898278|NCT04415983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24898279|NCT04415983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24517123|NCT00606125|Sorafenib|sorafenib|mesh-list
24517124|NCT00606125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517125|NCT00606125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24517126|NCT00606125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517127|NCT00606125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517128|NCT00606164|Bryostatin 1|bryostatin 1|mesh-list
24517129|NCT00606164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24517130|NCT00606164|Immunologic Factors|immunologic factors|mesh-ancestor
25686321|NCT01918332|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25686322|NCT01918332|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25686323|NCT01918332|Antimetabolites|antimetabolites|mesh-ancestor
25686324|NCT01918332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686325|NCT01918332|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25686326|NCT01918332|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25686327|NCT01918332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25686328|NCT01918332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24589194|NCT00906061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589195|NCT00906061|Tubulin Modulators|tubulin modulators|mesh-ancestor
24589196|NCT00906061|Antimitotic Agents|antimitotic agents|mesh-ancestor
24589197|NCT00906061|Mitosis Modulators|mitosis modulators|mesh-ancestor
24589198|NCT00906113|Melphalan|melphalan|mesh-list
24589199|NCT00906113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24589200|NCT00906113|Alkylating Agents|alkylating agents|mesh-ancestor
25040363|NCT03148860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040364|NCT03148860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25040365|NCT03148860|Antimetabolites|antimetabolites|mesh-ancestor
25040366|NCT03148860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040367|NCT03148860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25040368|NCT03148860|Dermatologic Agents|dermatologic agents|mesh-ancestor
25040369|NCT03148860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25040370|NCT03148860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25040371|NCT03148860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25040372|NCT03148860|Immunologic Factors|immunologic factors|mesh-ancestor
25040373|NCT03148860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25040411|NCT03094416|Esomeprazole|esomeprazole|mesh-list
24517131|NCT00606164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898391|NCT04414800|Sensory System Agents|sensory system agents|mesh-ancestor
24824709|NCT02124954|Anesthetics|anesthetics|mesh-ancestor
25101757|NCT03172676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25101758|NCT03172676|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25101759|NCT03172676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25101760|NCT03172676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101761|NCT03172676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24526936|NCT00613769|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25101794|NCT03172299|Growth Substances|growth substances|mesh-ancestor
25101795|NCT03172299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101796|NCT03172299|Growth Inhibitors|growth inhibitors|mesh-ancestor
25101797|NCT03172299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25101798|NCT03172533|Dienogest|dienogest|mesh-list
25101799|NCT03172533|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25101800|NCT03172533|Estradiol|estradiol|mesh-list
25101801|NCT03172533|Estrogens|estrogens|mesh-ancestor
25101802|NCT03172533|Hormones|hormones|mesh-ancestor
25101829|NCT03172234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101830|NCT03172234|Antimanic Agents|antimanic agents|mesh-ancestor
25101831|NCT03172234|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25101832|NCT03172234|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24730103|NCT01625871|Lumefantrine|lumefantrine|mesh-list
25101833|NCT03172234|Antiviral Agents|antiviral agents|mesh-ancestor
25101834|NCT03172234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25101835|NCT03172234|Dopamine Agents|dopamine agents|mesh-ancestor
25101836|NCT03172234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25101837|NCT03171974|Dexamethasone|dexamethasone|mesh-list
25101838|NCT03171974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25101839|NCT03171974|Antiemetics|antiemetics|mesh-ancestor
25101840|NCT03171974|Autonomic Agents|autonomic agents|mesh-ancestor
25101841|NCT03171974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101842|NCT03171974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101843|NCT03171974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25101844|NCT03171974|Glucocorticoids|glucocorticoids|mesh-ancestor
25101872|NCT03172052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101874|NCT03172052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25101875|NCT03172052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686329|NCT01918332|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25686330|NCT01918332|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25686331|NCT01918371|Ranibizumab|ranibizumab|mesh-list
25686332|NCT01918371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25686333|NCT01918371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25686334|NCT01918371|Growth Substances|growth substances|mesh-ancestor
25686335|NCT01918371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686336|NCT01918371|Growth Inhibitors|growth inhibitors|mesh-ancestor
25686337|NCT01918371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25692573|NCT02002650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25692574|NCT02002650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25692575|NCT02002650|Analgesics|analgesics|mesh-ancestor
25692576|NCT02002650|Sensory System Agents|sensory system agents|mesh-ancestor
25692577|NCT02002650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25692578|NCT02002650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692579|NCT02002650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25692580|NCT02002650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25692581|NCT02002650|Gout Suppressants|gout suppressants|mesh-ancestor
24607099|NCT05213481|Carbamazepine|carbamazepine|mesh-list
24607100|NCT05213481|Anticonvulsants|anticonvulsants|mesh-ancestor
24607101|NCT05213481|Antimanic Agents|antimanic agents|mesh-ancestor
24607102|NCT05213481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24607103|NCT05213481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24853498|NCT02268565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24853499|NCT02268565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24607211|NCT04994561|Niacinamide|niacinamide|mesh-list
24607212|NCT04994561|Metformin|metformin|mesh-list
25101876|NCT03172065|Dexmedetomidine|dexmedetomidine|mesh-list
25101877|NCT03172065|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25101878|NCT03172065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25101879|NCT03172065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101880|NCT03172065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25101881|NCT03172065|Analgesics|analgesics|mesh-ancestor
25101882|NCT03172065|Sensory System Agents|sensory system agents|mesh-ancestor
25101883|NCT03172065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101884|NCT03172065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25101885|NCT03172065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25101886|NCT03172065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25101887|NCT03172065|Adrenergic Agents|adrenergic agents|mesh-ancestor
25101888|NCT03172065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25101889|NCT03172065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101890|NCT03171818|Darbepoetin alfa|darbepoetin alfa|mesh-list
25101891|NCT03171818|Hematinics|hematinics|mesh-ancestor
24427839|NCT00239083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101892|NCT03171831|Mycophenolic Acid|mycophenolic acid|mesh-list
25101893|NCT03171831|Cyclophosphamide|cyclophosphamide|mesh-list
25101894|NCT03171831|Busulfan|busulfan|mesh-list
25101895|NCT03171831|Methotrexate|methotrexate|mesh-list
25101896|NCT03171831|Fludarabine|fludarabine|mesh-list
25101898|NCT03171831|Thymoglobulin|thymoglobulin|mesh-list
25101899|NCT03171831|Basiliximab|basiliximab|mesh-list
25101918|NCT03171831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25101919|NCT03171831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25101920|NCT03171831|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25082912|NCT03319043|Budesonide|budesonide|mesh-list
24898392|NCT04414800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24898393|NCT04414800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898394|NCT04414800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24898395|NCT04414800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24898396|NCT04414800|Anesthetics, General|anesthetics, general|mesh-ancestor
24898398|NCT04414800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24898399|NCT04414800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24817756|NCT02085577|Analgesics|analgesics|mesh-ancestor
24817757|NCT02085577|Sensory System Agents|sensory system agents|mesh-ancestor
24817758|NCT02085577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101921|NCT03171831|Antitubercular Agents|antitubercular agents|mesh-ancestor
25101922|NCT03171831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25101923|NCT03171831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25101925|NCT03171727|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25101926|NCT03171727|Tinzaparin|tinzaparin|mesh-list
25101927|NCT03171727|Dalteparin|dalteparin|mesh-list
25101928|NCT03171727|Anticoagulants|anticoagulants|mesh-ancestor
25101929|NCT03171727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25101930|NCT03171727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25101931|NCT03171727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101932|NCT03171623|Globalagliatin|globalagliatin|mesh-list
25101933|NCT03171623|Enzyme Activators|enzyme activators|mesh-ancestor
25101934|NCT03171623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101935|NCT03171740|Midazolam|midazolam|mesh-list
25101936|NCT03171740|Dexmedetomidine|dexmedetomidine|mesh-list
25101937|NCT03171740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25101938|NCT03171740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25101939|NCT03171740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25101940|NCT03171740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686338|NCT01918761|Pemetrexed|pemetrexed|mesh-list
25686339|NCT01918761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25686340|NCT01918761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25686341|NCT01918761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686342|NCT01918761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25686343|NCT01918761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25686344|NCT01919164|Mitogens|mitogens|mesh-list
25686345|NCT01919164|Mitosis Modulators|mitosis modulators|mesh-ancestor
25692582|NCT02002650|Tocolytic Agents|tocolytic agents|mesh-ancestor
25686346|NCT01919164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686348|NCT01919190|Anesthetics, Local|anesthetics, local|mesh-ancestor
24440034|NCT00281489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24853500|NCT02268565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24853501|NCT02268565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853502|NCT02268565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25101941|NCT03171740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25101943|NCT03171740|Sensory System Agents|sensory system agents|mesh-ancestor
25101944|NCT03171740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101945|NCT03171740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25101946|NCT03171740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25101947|NCT03171740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25101948|NCT03171740|Adrenergic Agents|adrenergic agents|mesh-ancestor
25101949|NCT03171740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24817759|NCT02085577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898560|NCT04412850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24898562|NCT04412538|Immunologic Factors|immunologic factors|mesh-ancestor
24898563|NCT04412538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898564|NCT04412642|Methoxyflurane|methoxyflurane|mesh-list
24898565|NCT04412642|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24898566|NCT04412642|Anesthetics, General|anesthetics, general|mesh-ancestor
24898567|NCT04412642|Anesthetics|anesthetics|mesh-ancestor
24898568|NCT04412642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24898569|NCT04412642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898570|NCT04412421|Vitamins|vitamins|mesh-list
24898571|NCT04412421|Micronutrients|micronutrients|mesh-ancestor
25101950|NCT03171740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101951|NCT03171740|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25101953|NCT03171740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25101988|NCT03171610|Anesthetics|anesthetics|mesh-ancestor
25101989|NCT03171597|Vasodilator Agents|vasodilator agents|mesh-list
25101990|NCT03171597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25101991|NCT03171597|Lipid Regulating Agents|lipid regulating agents|mesh-list
25101993|NCT03171389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102018|NCT03171220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25102020|NCT03171220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102021|NCT03171220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102026|NCT03171220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25102027|NCT03170713|Ibuprofen|ibuprofen|mesh-list
25102028|NCT03170713|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
25102029|NCT03170713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25102030|NCT03170713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25102031|NCT03170713|Analgesics|analgesics|mesh-ancestor
25102032|NCT03170713|Sensory System Agents|sensory system agents|mesh-ancestor
25102033|NCT03170713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25102034|NCT03170713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102035|NCT03170713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25102036|NCT03170713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25102037|NCT03170713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24518238|NCT05329857|Metformin|metformin|mesh-list
25102068|NCT03170739|Sensory System Agents|sensory system agents|mesh-ancestor
25102069|NCT03170739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25102070|NCT03170739|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25102071|NCT03170739|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25102072|NCT03170739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24898572|NCT04412421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898573|NCT04412304|Dalteparin|dalteparin|mesh-list
25686349|NCT01919190|Anesthetics|anesthetics|mesh-ancestor
25686350|NCT01919190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25686351|NCT01919190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686352|NCT01919190|Sensory System Agents|sensory system agents|mesh-ancestor
25686353|NCT01919190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686354|NCT01919216|Citalopram|citalopram|mesh-list
25686355|NCT01919216|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24607488|NCT04477512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24607491|NCT04469842|Azathioprine|azathioprine|mesh-list
24607514|NCT04442581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24607515|NCT04442581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607516|NCT04433780|Tenofovir|tenofovir|mesh-list
24607517|NCT04433780|Lamivudine|lamivudine|mesh-list
24607518|NCT04433780|Antiviral Agents|antiviral agents|mesh-ancestor
24607519|NCT04433780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24898574|NCT04412304|Tinzaparin|tinzaparin|mesh-list
25039192|NCT04029610|Sensory System Agents|sensory system agents|mesh-ancestor
24898575|NCT04412304|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25102073|NCT03170739|Adrenergic Agents|adrenergic agents|mesh-ancestor
25102074|NCT03170739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25102075|NCT03170739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102076|NCT03170739|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25102077|NCT03170739|Sympathomimetics|sympathomimetics|mesh-ancestor
25102078|NCT03170739|Autonomic Agents|autonomic agents|mesh-ancestor
25102079|NCT03170739|Dopamine Agents|dopamine agents|mesh-ancestor
25102080|NCT03170739|Protective Agents|protective agents|mesh-ancestor
25102097|NCT03170323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25102098|NCT03170323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25102099|NCT03170323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25102100|NCT03170323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779707|NCT01878318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25102101|NCT03170323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25102102|NCT03170323|Antitubercular Agents|antitubercular agents|mesh-ancestor
24898576|NCT04412304|Anticoagulants|anticoagulants|mesh-ancestor
24898577|NCT04412304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24898578|NCT04412304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24898579|NCT04412304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898580|NCT04412291|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24898581|NCT04412291|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24475661|NCT00411034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24475662|NCT00411034|Narcotics|narcotics|mesh-ancestor
24475722|NCT00411203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24898678|NCT04411433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24898679|NCT04411433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24898680|NCT04411433|Antimalarials|antimalarials|mesh-ancestor
24898681|NCT04411433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24898682|NCT04411433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24898683|NCT04411433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24898684|NCT04411433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898685|NCT04411433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24898686|NCT04411433|Antiviral Agents|antiviral agents|mesh-ancestor
24898687|NCT04411446|Vitamin D|vitamin d|mesh-list
24898688|NCT04411446|Cholecalciferol|cholecalciferol|mesh-list
24898689|NCT04411446|Vitamins|vitamins|mesh-ancestor
24898690|NCT04411446|Micronutrients|micronutrients|mesh-ancestor
24898691|NCT04411446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898704|NCT04411329|Hormones|hormones|mesh-ancestor
24898732|NCT04411160|Autonomic Agents|autonomic agents|mesh-ancestor
24898733|NCT04411160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24898734|NCT04411160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24898735|NCT04411160|Respiratory System Agents|respiratory system agents|mesh-ancestor
24898736|NCT04411160|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24898737|NCT04411160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24475757|NCT00411320|Antiemetics|antiemetics|mesh-ancestor
24898766|NCT04410887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24898769|NCT04411030|Itraconazole|itraconazole|mesh-list
24898790|NCT04411030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24898791|NCT04411030|Hormone Antagonists|hormone antagonists|mesh-ancestor
24898792|NCT04411030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24898793|NCT04411030|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24898795|NCT04410588|Levobupivacaine|levobupivacaine|mesh-list
24898796|NCT04410588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25686356|NCT01919216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25686357|NCT01919216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25686358|NCT01919216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686359|NCT01919216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25686360|NCT01919216|Serotonin Agents|serotonin agents|mesh-ancestor
25686361|NCT01919216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686362|NCT01919216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24898905|NCT04409691|Immunologic Factors|immunologic factors|mesh-ancestor
24898906|NCT04409691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853527|NCT02268773|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
24853528|NCT02268773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24853529|NCT02268773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24607631|NCT04192266|Hormones|hormones|mesh-ancestor
24607639|NCT04191135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24607640|NCT04191135|Antimetabolites|antimetabolites|mesh-ancestor
24607641|NCT04191135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898907|NCT04409769|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
24898909|NCT04409769|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
25102103|NCT03170323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25102104|NCT03170336|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25102105|NCT03170336|Amiloride|amiloride|mesh-list
25102106|NCT03170336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25102107|NCT03170336|Diuretics|diuretics|mesh-ancestor
25102108|NCT03170336|Natriuretic Agents|natriuretic agents|mesh-ancestor
24428119|NCT00239538|Telmisartan|telmisartan|mesh-list
25102109|NCT03170336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102110|NCT03170336|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25102111|NCT03170336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25102112|NCT03170336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102113|NCT03170336|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
25102114|NCT03170336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25102115|NCT03170336|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
25102116|NCT03170336|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25102117|NCT03170284|Bevacizumab|bevacizumab|mesh-list
25102118|NCT03170284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24616818|NCT01039363|Cytarabine|cytarabine|mesh-list
25102119|NCT03170284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102120|NCT03170284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24969120|NCT03745404|Anesthetics|anesthetics|mesh-ancestor
24898910|NCT04409769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24898911|NCT04409769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24898912|NCT04409223|Sunitinib|sunitinib|mesh-list
24898913|NCT04409223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898914|NCT04409223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24898915|NCT04409223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24898916|NCT04409223|Growth Substances|growth substances|mesh-ancestor
24898935|NCT04409327|Dactolisib|dactolisib|mesh-list
24475958|NCT00412126|Insulin|insulin|mesh-list
24475959|NCT00412126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24475960|NCT00412126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475961|NCT00412152|Oxycodone|oxycodone|mesh-list
24898959|NCT04408911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24898960|NCT04408911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898961|NCT04408313|Naltrexone|naltrexone|mesh-list
24898962|NCT04408313|Buprenorphine|buprenorphine|mesh-list
24898963|NCT04408313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24898964|NCT04408313|Narcotics|narcotics|mesh-ancestor
24898965|NCT04408313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24898966|NCT04408313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898967|NCT04408313|Analgesics|analgesics|mesh-ancestor
24517254|NCT00606957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24517255|NCT00606983|Tamsulosin|tamsulosin|mesh-list
24517256|NCT00606983|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24517257|NCT00606983|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24517258|NCT00606983|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24517259|NCT00606983|Adrenergic Agents|adrenergic agents|mesh-ancestor
24517260|NCT00606983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24517274|NCT00607035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24517286|NCT00607074|Antimitotic Agents|antimitotic agents|mesh-ancestor
24517287|NCT00607074|Mitosis Modulators|mitosis modulators|mesh-ancestor
24517288|NCT00607074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517645|NCT00609011|Temozolomide|temozolomide|mesh-list
25686363|NCT01919216|Antidepressive Agents|antidepressive agents|mesh-ancestor
25686364|NCT01919216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25686365|NCT01919229|Letrozole|letrozole|mesh-list
25686366|NCT01919229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25686367|NCT01919229|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25686368|NCT01919229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25686369|NCT01919229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25686370|NCT01919229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686371|NCT01919229|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24607842|NCT03331484|Rivaroxaban|rivaroxaban|mesh-list
24853560|NCT02268968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24853561|NCT02268968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853562|NCT02268968|Sensory System Agents|sensory system agents|mesh-ancestor
24853563|NCT02268968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24853564|NCT02268968|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24853565|NCT02268968|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24853566|NCT02268968|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24853567|NCT02268968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24853568|NCT02268968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853570|NCT02269046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24853571|NCT02269046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24607844|NCT03331484|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24607867|NCT03275818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24607873|NCT03274804|Maraviroc|maraviroc|mesh-list
24607874|NCT03274804|Pembrolizumab|pembrolizumab|mesh-list
24607875|NCT03274804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24607876|NCT03274804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607877|NCT03274804|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24607878|NCT03274804|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24428147|NCT00239707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428149|NCT00239746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25102121|NCT03170284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25102122|NCT03170284|Growth Substances|growth substances|mesh-ancestor
25102123|NCT03170284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102124|NCT03170284|Growth Inhibitors|growth inhibitors|mesh-ancestor
25102125|NCT03170050|Lidocaine|lidocaine|mesh-list
25102126|NCT03170050|Anesthetics, Local|anesthetics, local|mesh-ancestor
25102127|NCT03170050|Anesthetics|anesthetics|mesh-ancestor
25102128|NCT03170050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25102129|NCT03170050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102130|NCT03170050|Sensory System Agents|sensory system agents|mesh-ancestor
25102131|NCT03170050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25102132|NCT03170050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25102133|NCT03170050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25102134|NCT03170050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24518591|NCT04786275|Analgesics|analgesics|mesh-ancestor
25102160|NCT03169959|Incretins|incretins|mesh-ancestor
25102161|NCT03169959|Hormones|hormones|mesh-ancestor
25102162|NCT03169959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25102163|NCT03169959|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25102164|NCT03169959|Protease Inhibitors|protease inhibitors|mesh-ancestor
25102165|NCT03169959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102166|NCT03169751|Caffeine|caffeine|mesh-list
25102167|NCT03169751|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25102168|NCT03169751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686372|NCT01919229|Hormone Antagonists|hormone antagonists|mesh-ancestor
25686373|NCT01919229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25686374|NCT01919229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686375|NCT01919411|Amoxicillin|amoxicillin|mesh-list
25686376|NCT01919411|Clavulanic Acid|clavulanic acid|mesh-list
25686377|NCT01919411|Clavulanic Acids|clavulanic acids|mesh-list
25686378|NCT01919411|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25686379|NCT01919411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25686380|NCT01919411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25686381|NCT01919411|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25686382|NCT01919411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25686383|NCT01919411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686384|NCT01919450|Regadenoson|regadenoson|mesh-list
25686385|NCT01919450|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25686386|NCT01919450|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25686387|NCT01919450|Purinergic Agonists|purinergic agonists|mesh-ancestor
25686388|NCT01919450|Purinergic Agents|purinergic agents|mesh-ancestor
25686389|NCT01919450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25686390|NCT01919450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686391|NCT01919450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686392|NCT01919489|Insulin Glargine|insulin glargine|mesh-list
24607952|NCT03084237|Docetaxel|docetaxel|mesh-list
24607953|NCT03084237|Trastuzumab|trastuzumab|mesh-list
24607954|NCT03084237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607955|NCT03084237|Tubulin Modulators|tubulin modulators|mesh-ancestor
24607965|NCT03077698|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25102169|NCT03169751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25102170|NCT03169751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102171|NCT03169751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102172|NCT03169751|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24969139|NCT03745261|Fluticasone|fluticasone|mesh-list
24517647|NCT00609011|Alkylating Agents|alkylating agents|mesh-ancestor
24517648|NCT00609011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517649|NCT00609011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517650|NCT00609063|Atorvastatin|atorvastatin|mesh-list
25102180|NCT03169764|Capecitabine|capecitabine|mesh-list
25102210|NCT03169764|Hormone Antagonists|hormone antagonists|mesh-ancestor
25102211|NCT03169764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25102212|NCT03169738|Leucovorin|leucovorin|mesh-list
25102213|NCT03169738|Cyclophosphamide|cyclophosphamide|mesh-list
25102214|NCT03169738|Bevacizumab|bevacizumab|mesh-list
25102215|NCT03169738|Fluorouracil|fluorouracil|mesh-list
25102216|NCT03169738|Capecitabine|capecitabine|mesh-list
24899140|NCT04406376|Prednisone|prednisone|mesh-list
24899141|NCT04406376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24899142|NCT04406376|Glucocorticoids|glucocorticoids|mesh-ancestor
24899143|NCT04406376|Hormones|hormones|mesh-ancestor
24899144|NCT04406376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24899145|NCT04406376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899146|NCT04406376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24899147|NCT04406376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24899148|NCT04406246|Nitazoxanide|nitazoxanide|mesh-list
24899161|NCT04406259|Verapamil|verapamil|mesh-list
24899229|NCT04405375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24481505|NCT00435279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24899304|NCT04404946|Respiratory System Agents|respiratory system agents|mesh-ancestor
24899305|NCT04404946|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24899306|NCT04404946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24899307|NCT04404946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24899308|NCT04404946|Adrenergic Agents|adrenergic agents|mesh-ancestor
24899309|NCT04404946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24476216|NCT00413504|Antithrombins|antithrombins|mesh-ancestor
24476217|NCT00413504|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24517836|NCT00610142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24899314|NCT04404881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24899315|NCT04404881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24899316|NCT04404881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24476218|NCT00413504|Protease Inhibitors|protease inhibitors|mesh-ancestor
24476219|NCT00413504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476220|NCT00413504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476221|NCT00413504|Anticoagulants|anticoagulants|mesh-ancestor
24476222|NCT00413504|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24476223|NCT00413504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24476224|NCT00413608|Clopidogrel|clopidogrel|mesh-list
24476340|NCT00414245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25102218|NCT03169738|Nivolumab|nivolumab|mesh-list
25686393|NCT01919489|Liraglutide|liraglutide|mesh-list
25686394|NCT01919489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25686395|NCT01919489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686396|NCT01919489|Incretins|incretins|mesh-ancestor
25686397|NCT01919489|Hormones|hormones|mesh-ancestor
24428243|NCT00240019|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24428246|NCT00240032|Cetirizine|cetirizine|mesh-list
25102219|NCT03169738|Fulvestrant|fulvestrant|mesh-list
25686398|NCT01919489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25686399|NCT01919606|Bupivacaine|bupivacaine|mesh-list
25686400|NCT01919606|Anesthetics, Local|anesthetics, local|mesh-ancestor
25686401|NCT01919606|Anesthetics|anesthetics|mesh-ancestor
25686402|NCT01919606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24853600|NCT02269176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24853601|NCT02269176|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24853602|NCT02269176|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25102221|NCT03169738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102222|NCT03169738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102223|NCT03169738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25102224|NCT03169738|Immunologic Factors|immunologic factors|mesh-ancestor
25102225|NCT03169738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102226|NCT03169738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25102227|NCT03169738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25102228|NCT03169738|Alkylating Agents|alkylating agents|mesh-ancestor
25102229|NCT03169738|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25102259|NCT03169933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102261|NCT03169790|Paclitaxel|paclitaxel|mesh-list
25102262|NCT03169790|Cyclophosphamide|cyclophosphamide|mesh-list
25102263|NCT03169790|Bevacizumab|bevacizumab|mesh-list
25102264|NCT03169790|Rituximab|rituximab|mesh-list
25102265|NCT03169790|Fluorouracil|fluorouracil|mesh-list
25102266|NCT03169790|Capecitabine|capecitabine|mesh-list
25102267|NCT03169790|Oxaliplatin|oxaliplatin|mesh-list
25102268|NCT03169790|Avelumab|avelumab|mesh-list
25102269|NCT03169790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25102272|NCT03169790|Antimitotic Agents|antimitotic agents|mesh-ancestor
25102273|NCT03169790|Mitosis Modulators|mitosis modulators|mesh-ancestor
25102274|NCT03169790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102275|NCT03169790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24518328|NCT05291403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24476352|NCT00414323|Antidepressive Agents|antidepressive agents|mesh-ancestor
24476392|NCT00414648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24476393|NCT00414648|Immunologic Factors|immunologic factors|mesh-ancestor
24476394|NCT00414648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476395|NCT00414687|Iloprost|iloprost|mesh-list
24476396|NCT00414687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24476397|NCT00414687|Vasodilator Agents|vasodilator agents|mesh-ancestor
24476398|NCT00414739|Benzalkonium Compounds|benzalkonium compounds|mesh-list
24899521|NCT04403321|Cyclosporins|cyclosporins|mesh-list
24899522|NCT04403321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24899523|NCT04403321|Immunologic Factors|immunologic factors|mesh-ancestor
24899524|NCT04403321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899525|NCT04403321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24899526|NCT04403321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899707|NCT04401007|Anesthetics, Local|anesthetics, local|mesh-ancestor
24899708|NCT04401007|Anesthetics|anesthetics|mesh-ancestor
25102308|NCT03169777|Fluorouracil|fluorouracil|mesh-list
25102309|NCT03169777|Capecitabine|capecitabine|mesh-list
25102310|NCT03169777|Oxaliplatin|oxaliplatin|mesh-list
25102311|NCT03169777|Nivolumab|nivolumab|mesh-list
25102312|NCT03169777|Cetuximab|cetuximab|mesh-list
25102313|NCT03169777|Fulvestrant|fulvestrant|mesh-list
25102314|NCT03169777|Avelumab|avelumab|mesh-list
25102315|NCT03169777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102316|NCT03169777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102317|NCT03169777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25102318|NCT03169777|Immunologic Factors|immunologic factors|mesh-ancestor
25102319|NCT03169777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779864|NCT01879423|Lamotrigine|lamotrigine|mesh-list
25102320|NCT03169777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25102321|NCT03169777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25102322|NCT03169777|Alkylating Agents|alkylating agents|mesh-ancestor
25102323|NCT03169777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25102345|NCT03169582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25102346|NCT03169582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102347|NCT03169582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102348|NCT03169582|Urological Agents|urological agents|mesh-ancestor
25102349|NCT03169348|Sofosbuvir|sofosbuvir|mesh-list
25102350|NCT03169348|Ledipasvir|ledipasvir|mesh-list
25102351|NCT03169348|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25102352|NCT03169348|Antiviral Agents|antiviral agents|mesh-ancestor
25102353|NCT03169348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25686403|NCT01919606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686404|NCT01919606|Sensory System Agents|sensory system agents|mesh-ancestor
25686405|NCT01919606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686406|NCT01919697|Plecanatide|plecanatide|mesh-list
24899709|NCT04401007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25686407|NCT01919697|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
24899763|NCT04400188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24900080|NCT04397913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24900081|NCT04397913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900082|NCT04397913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900083|NCT04397497|Mavrilimumab|mavrilimumab|mesh-list
25102354|NCT03169504|Fluticasone|fluticasone|mesh-list
25102356|NCT03169504|Bromides|bromides|mesh-list
25102357|NCT03169504|Tiotropium Bromide|tiotropium bromide|mesh-list
25102358|NCT03169504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25102359|NCT03169504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25102360|NCT03169504|Autonomic Agents|autonomic agents|mesh-ancestor
25102361|NCT03169504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25102362|NCT03169504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102363|NCT03169504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25102364|NCT03169504|Respiratory System Agents|respiratory system agents|mesh-ancestor
25102365|NCT03169504|Dermatologic Agents|dermatologic agents|mesh-ancestor
25102366|NCT03169504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25102367|NCT03169504|Parasympatholytics|parasympatholytics|mesh-ancestor
25102390|NCT03169569|Coagulants|coagulants|mesh-ancestor
25102391|NCT03169413|Adenosine|adenosine|mesh-list
25102392|NCT03169413|Analgesics|analgesics|mesh-ancestor
25102393|NCT03169413|Sensory System Agents|sensory system agents|mesh-ancestor
25102394|NCT03169413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25102395|NCT03169413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779974|NCT01880307|Immunologic Factors|immunologic factors|mesh-ancestor
24824835|NCT02125578|Interferons|interferons|mesh-list
24428450|NCT00240474|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24428451|NCT00240513|Minocycline|minocycline|mesh-list
24428452|NCT00240513|Tretinoin|tretinoin|mesh-list
24428453|NCT00240513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25102396|NCT03169413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25102397|NCT03169413|Vasodilator Agents|vasodilator agents|mesh-ancestor
25102398|NCT03169413|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25102399|NCT03169413|Purinergic Agonists|purinergic agonists|mesh-ancestor
25102400|NCT03169413|Purinergic Agents|purinergic agents|mesh-ancestor
25102401|NCT03169413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24969188|NCT03745105|Antiemetics|antiemetics|mesh-ancestor
24900084|NCT04397497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24900085|NCT04397341|Docetaxel|docetaxel|mesh-list
24900086|NCT04397341|Fluorouracil|fluorouracil|mesh-list
24900087|NCT04397341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24900088|NCT04397341|Tubulin Modulators|tubulin modulators|mesh-ancestor
24900089|NCT04397341|Antimitotic Agents|antimitotic agents|mesh-ancestor
24900090|NCT04397341|Mitosis Modulators|mitosis modulators|mesh-ancestor
24900091|NCT04397341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817948|NCT02086032|Progestins|progestins|mesh-ancestor
24817949|NCT02086097|Ibuprofen|ibuprofen|mesh-list
24900180|NCT04396938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24900244|NCT04396223|Dermatologic Agents|dermatologic agents|mesh-ancestor
24900245|NCT04396223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900246|NCT04396223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24900247|NCT04396223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24900248|NCT04396223|Immunologic Factors|immunologic factors|mesh-ancestor
24900249|NCT04396223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24900250|NCT04396223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24900251|NCT04396223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24900253|NCT04396067|Isotretinoin|isotretinoin|mesh-list
24900254|NCT04396067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24900255|NCT04396067|Keratolytic Agents|keratolytic agents|mesh-ancestor
25102402|NCT03169413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102404|NCT03169335|Bevacizumab|bevacizumab|mesh-list
25102405|NCT03169335|Carboplatin|carboplatin|mesh-list
24428454|NCT00240513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25102495|NCT03168191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428502|NCT00240630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428503|NCT00240630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608537|NCT00992472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853656|NCT02269358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24853657|NCT02269358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24853658|NCT02269449|Hemostatics|hemostatics|mesh-list
24853659|NCT02269449|Coagulants|coagulants|mesh-ancestor
25102406|NCT03169335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25102407|NCT03169335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102408|NCT03169335|Tubulin Modulators|tubulin modulators|mesh-ancestor
25102409|NCT03169335|Antimitotic Agents|antimitotic agents|mesh-ancestor
25102410|NCT03169335|Mitosis Modulators|mitosis modulators|mesh-ancestor
25102411|NCT03169335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102412|NCT03169335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25102413|NCT03169335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25102414|NCT03169335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25102415|NCT03169335|Growth Substances|growth substances|mesh-ancestor
25102416|NCT03169335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102449|NCT03168958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102451|NCT03168958|Sensory System Agents|sensory system agents|mesh-ancestor
24969212|NCT03745040|Anesthetics|anesthetics|mesh-ancestor
24969217|NCT03744988|Androgens|androgens|mesh-list
24900256|NCT04396067|Dermatologic Agents|dermatologic agents|mesh-ancestor
24900257|NCT04396184|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24900258|NCT04396184|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24900259|NCT04396184|Dermatologic Agents|dermatologic agents|mesh-ancestor
24900260|NCT04395768|Vitamin D|vitamin d|mesh-list
24900261|NCT04395768|Cholecalciferol|cholecalciferol|mesh-list
24900293|NCT04395989|Antimetabolites|antimetabolites|mesh-ancestor
24900294|NCT04395989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24900295|NCT04395989|Immunologic Factors|immunologic factors|mesh-ancestor
24900296|NCT04395989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900299|NCT04395612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900300|NCT04395612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818009|NCT02086474|Hyaluronic Acid|hyaluronic acid|mesh-list
24818010|NCT02086474|Anesthetics, Local|anesthetics, local|mesh-ancestor
24428504|NCT00240630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24428505|NCT00240630|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24428506|NCT00240630|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24428507|NCT00240630|Serotonin Agents|serotonin agents|mesh-ancestor
24428508|NCT00240630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24428509|NCT00240656|Carvedilol|carvedilol|mesh-list
24428510|NCT00240656|Captopril|captopril|mesh-list
24818012|NCT02086474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24818013|NCT02086474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818014|NCT02086474|Sensory System Agents|sensory system agents|mesh-ancestor
24818015|NCT02086474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24900355|NCT04395170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900356|NCT04394897|Remifentanil|remifentanil|mesh-list
24900357|NCT04394897|Propofol|propofol|mesh-list
24900358|NCT04394897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24900359|NCT04394897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24900431|NCT04394377|Protease Inhibitors|protease inhibitors|mesh-ancestor
24900432|NCT04394377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900433|NCT04394143|Mannitol|mannitol|mesh-list
24477223|NCT00417898|Aspirin|aspirin|mesh-list
24900436|NCT04394143|Natriuretic Agents|natriuretic agents|mesh-ancestor
24900437|NCT04394143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900438|NCT04393883|Pembrolizumab|pembrolizumab|mesh-list
24900439|NCT04393883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24900440|NCT04393883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24900441|NCT04393805|Heparin|heparin|mesh-list
24900442|NCT04393805|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24789679|NCT01938456|Tubulin Modulators|tubulin modulators|mesh-ancestor
25102452|NCT03168958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25102453|NCT03168958|Antitussive Agents|antitussive agents|mesh-ancestor
25102454|NCT03168958|Respiratory System Agents|respiratory system agents|mesh-ancestor
24520381|NCT02419287|Crizotinib|crizotinib|mesh-list
25102488|NCT03168568|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25102489|NCT03168568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102490|NCT03168191|Menthol|menthol|mesh-list
25102491|NCT03168191|Nicotine|nicotine|mesh-list
25102492|NCT03168191|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25686408|NCT01919697|Enzyme Activators|enzyme activators|mesh-ancestor
25686409|NCT01919697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686410|NCT01919697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25686411|NCT01919723|Ticagrelor|ticagrelor|mesh-list
25686412|NCT01919723|Eptifibatide|eptifibatide|mesh-list
25102493|NCT03168191|Autonomic Agents|autonomic agents|mesh-ancestor
25102494|NCT03168191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25102600|NCT03167372|Cholinergic Agents|cholinergic agents|mesh-ancestor
25102601|NCT03167372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25102602|NCT03167372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102603|NCT03167372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102604|NCT03167385|Apatinib|apatinib|mesh-list
25102605|NCT03167385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102606|NCT03167385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25102607|NCT03167385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102608|NCT03167385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102609|NCT03167268|Lycopene|lycopene|mesh-list
25102610|NCT03167268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25102611|NCT03167268|Antioxidants|antioxidants|mesh-ancestor
25102613|NCT03167268|Protective Agents|protective agents|mesh-ancestor
25102614|NCT03167268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102615|NCT03167268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25102616|NCT03167268|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25102617|NCT03167268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102621|NCT03167216|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24428629|NCT00240812|Respiratory System Agents|respiratory system agents|mesh-ancestor
24428630|NCT00240812|Nasal Decongestants|nasal decongestants|mesh-ancestor
24428631|NCT00240812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25274039|NCT02381158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25274040|NCT02381158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274041|NCT02381158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25274042|NCT02381158|Respiratory System Agents|respiratory system agents|mesh-ancestor
25274043|NCT02381028|Emollients|emollients|mesh-list
25274044|NCT02381028|Dermatologic Agents|dermatologic agents|mesh-ancestor
25274045|NCT02381379|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25274046|NCT02381379|Antiviral Agents|antiviral agents|mesh-ancestor
25274047|NCT02381379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25274048|NCT02381145|Resveratrol|resveratrol|mesh-list
25274049|NCT02381145|Antioxidants|antioxidants|mesh-ancestor
24851404|NCT02256748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851406|NCT02256774|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
24851407|NCT02256774|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24851408|NCT02256774|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24651016|NCT01228682|Tolvaptan|tolvaptan|mesh-list
24428634|NCT00240812|Adrenergic Agents|adrenergic agents|mesh-ancestor
24428635|NCT00240812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24428636|NCT00240825|Acetaminophen|acetaminophen|mesh-list
24428637|NCT00240825|Ibuprofen|ibuprofen|mesh-list
24428638|NCT00240825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24428639|NCT00240825|Analgesics|analgesics|mesh-ancestor
24428640|NCT00240825|Sensory System Agents|sensory system agents|mesh-ancestor
24428682|NCT00240942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24455342|NCT01691833|Vitamins|vitamins|mesh-ancestor
24395237|NCT00135499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24459795|NCT00346489|Antimetabolites|antimetabolites|mesh-ancestor
24411526|NCT00189358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25241765|NCT05299593|Timolol|timolol|mesh-list
25241766|NCT05299593|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25241767|NCT05299593|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25241779|NCT05299580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241780|NCT05299567|Azithromycin|azithromycin|mesh-list
25241781|NCT05299567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25241782|NCT05299567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25241783|NCT05299554|Hydrocortisone|hydrocortisone|mesh-list
25241784|NCT05299554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24395238|NCT00135499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24395239|NCT00135499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24395240|NCT00135499|Tubulin Modulators|tubulin modulators|mesh-ancestor
24395241|NCT00135499|Antimitotic Agents|antimitotic agents|mesh-ancestor
24395242|NCT00135499|Mitosis Modulators|mitosis modulators|mesh-ancestor
24395244|NCT00135525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24395245|NCT00135525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24395246|NCT00135525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24395247|NCT00135525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395321|NCT00135746|Autonomic Agents|autonomic agents|mesh-ancestor
24395411|NCT00135941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24395412|NCT00135941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424814|NCT00230958|Ribavirin|ribavirin|mesh-list
24395600|NCT00136461|Bryostatin 1|bryostatin 1|mesh-list
24395601|NCT00136461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24395602|NCT00136461|Keratolytic Agents|keratolytic agents|mesh-ancestor
24395603|NCT00136461|Dermatologic Agents|dermatologic agents|mesh-ancestor
24395604|NCT00136461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24395605|NCT00136461|Immunologic Factors|immunologic factors|mesh-ancestor
24395606|NCT00136461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395607|NCT00136474|Amifostine|amifostine|mesh-list
24395608|NCT00136474|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24395609|NCT00136474|Protective Agents|protective agents|mesh-ancestor
24459803|NCT00346489|Alkylating Agents|alkylating agents|mesh-ancestor
24459804|NCT00346489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25241804|NCT05277285|Antidotes|antidotes|mesh-ancestor
25241805|NCT05277285|Protective Agents|protective agents|mesh-ancestor
25241806|NCT05277285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241807|NCT05277285|Antioxidants|antioxidants|mesh-ancestor
25241808|NCT05277285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241809|NCT05277285|Antitubercular Agents|antitubercular agents|mesh-ancestor
25241810|NCT05277285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25241811|NCT05277285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25241812|NCT05277285|Chelating Agents|chelating agents|mesh-ancestor
25241813|NCT05277285|Sequestering Agents|sequestering agents|mesh-ancestor
25241815|NCT05259943|Hallucinogens|hallucinogens|mesh-ancestor
25241816|NCT05259943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241817|NCT05259943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25241818|NCT05253287|Hormones|hormones|mesh-list
24851426|NCT02256813|Warfarin|warfarin|mesh-list
24851427|NCT02256813|Vitamins|vitamins|mesh-ancestor
24851428|NCT02256813|Micronutrients|micronutrients|mesh-ancestor
24851429|NCT02256813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851430|NCT02256813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24428894|NCT00241449|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24428895|NCT00241449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24428896|NCT00241449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24428897|NCT00241475|Gefitinib|gefitinib|mesh-list
24428898|NCT00241475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24428899|NCT00241475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24428900|NCT00241475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428902|NCT00241488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24953694|NCT03882489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395613|NCT00136487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25241819|NCT05253287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24395614|NCT00136487|Analgesics|analgesics|mesh-ancestor
24395615|NCT00136487|Sensory System Agents|sensory system agents|mesh-ancestor
24395616|NCT00136487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25241820|NCT05253287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241821|NCT05238649|Vaccines|vaccines|mesh-list
25241822|NCT05238649|Immunologic Factors|immunologic factors|mesh-ancestor
25241823|NCT05238649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241839|NCT05227300|Lidocaine|lidocaine|mesh-list
25241840|NCT05227300|Epinephrine|epinephrine|mesh-list
25241841|NCT05227300|Anesthetics, Local|anesthetics, local|mesh-ancestor
25241842|NCT05227300|Anesthetics|anesthetics|mesh-ancestor
25241843|NCT05227300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25241844|NCT05227300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241845|NCT05227300|Sensory System Agents|sensory system agents|mesh-ancestor
25241846|NCT05227300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25241847|NCT05227300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25241848|NCT05227300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25241849|NCT05227300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25241850|NCT05227300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25241851|NCT05227300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455371|NCT01600079|Immunologic Factors|immunologic factors|mesh-ancestor
24455372|NCT01600079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455373|NCT01539447|Naproxen|naproxen|mesh-list
24455374|NCT01539447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24455375|NCT01539447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24455376|NCT01539447|Analgesics|analgesics|mesh-ancestor
24455377|NCT01539447|Sensory System Agents|sensory system agents|mesh-ancestor
24455378|NCT01539447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24455379|NCT01539447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455380|NCT01539447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24455381|NCT01539447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24455382|NCT01539447|Gout Suppressants|gout suppressants|mesh-ancestor
24455383|NCT01539447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24395890|NCT00137085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395921|NCT00137202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24395924|NCT00137202|Sensory System Agents|sensory system agents|mesh-ancestor
24395925|NCT00137202|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24395926|NCT00137202|Histamine Antagonists|histamine antagonists|mesh-ancestor
25241852|NCT05227300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25241853|NCT05227300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25241854|NCT05227300|Adrenergic Agents|adrenergic agents|mesh-ancestor
25241855|NCT05227300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25241856|NCT05227300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25241857|NCT05227300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25241858|NCT05227300|Autonomic Agents|autonomic agents|mesh-ancestor
25241859|NCT05227300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25241860|NCT05227300|Respiratory System Agents|respiratory system agents|mesh-ancestor
25241861|NCT05227300|Mydriatics|mydriatics|mesh-ancestor
25241862|NCT05227300|Sympathomimetics|sympathomimetics|mesh-ancestor
25241863|NCT05227300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25241864|NCT05208190|Clozapine|clozapine|mesh-list
25241865|NCT05208190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25241866|NCT05208190|Serotonin Agents|serotonin agents|mesh-ancestor
25241867|NCT05208190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25241868|NCT05208190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241869|NCT05208190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851434|NCT02256813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24851435|NCT02256813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24851436|NCT02256813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24851437|NCT02256813|Anesthetics, General|anesthetics, general|mesh-ancestor
25069240|NCT03428139|Vitamins|vitamins|mesh-ancestor
24396578|NCT00139269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24396579|NCT00139269|Immunologic Factors|immunologic factors|mesh-ancestor
24396580|NCT00139269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396586|NCT00139282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396587|NCT00139282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396588|NCT00139282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24396612|NCT00139386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396614|NCT00139516|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24396615|NCT00139516|Autonomic Agents|autonomic agents|mesh-ancestor
24396616|NCT00139516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24396617|NCT00139516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396618|NCT00139516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24396619|NCT00139516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24396620|NCT00139516|Cholinergic Agents|cholinergic agents|mesh-ancestor
24396621|NCT00139516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24774885|NCT01848639|Spironolactone|spironolactone|mesh-list
24396622|NCT00139516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396623|NCT00139555|Amlodipine|amlodipine|mesh-list
24396624|NCT00139555|Benazepril|benazepril|mesh-list
24396625|NCT00139555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24396678|NCT00139685|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24396679|NCT00139685|Contraceptive Agents|contraceptive agents|mesh-list
24396708|NCT00139711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396710|NCT00139711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24396711|NCT00139711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25241870|NCT05208190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25241871|NCT05208190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25241872|NCT05208190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25241873|NCT05208190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25241874|NCT05208190|GABA Antagonists|gaba antagonists|mesh-ancestor
25241875|NCT05208190|GABA Agents|gaba agents|mesh-ancestor
25241876|NCT05196308|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25241877|NCT05196308|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25241878|NCT05196308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25241879|NCT05196308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241880|NCT05196308|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25241881|NCT05196308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25241882|NCT05196308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241884|NCT05196308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25241885|NCT05179239|Paclitaxel|paclitaxel|mesh-list
25241886|NCT05179239|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25241887|NCT05179239|Cisplatin|cisplatin|mesh-list
25241888|NCT05179239|Carboplatin|carboplatin|mesh-list
24396715|NCT00139724|Cholinergic Agents|cholinergic agents|mesh-ancestor
24396716|NCT00139724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24396717|NCT00139724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396718|NCT00139724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396719|NCT00139724|Urological Agents|urological agents|mesh-ancestor
24396757|NCT00139867|Immunologic Factors|immunologic factors|mesh-ancestor
24396758|NCT00139867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396759|NCT00139867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24396760|NCT00139867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24396817|NCT00140062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24396838|NCT00140101|Antimitotic Agents|antimitotic agents|mesh-ancestor
24396839|NCT00140101|Mitosis Modulators|mitosis modulators|mesh-ancestor
24396840|NCT00140101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241889|NCT05179239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25241890|NCT05179239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25241891|NCT05179239|Tubulin Modulators|tubulin modulators|mesh-ancestor
25241892|NCT05179239|Antimitotic Agents|antimitotic agents|mesh-ancestor
25241893|NCT05179239|Mitosis Modulators|mitosis modulators|mesh-ancestor
25241894|NCT05179239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241895|NCT05178628|Gemcitabine|gemcitabine|mesh-list
25241896|NCT05178628|Paclitaxel|paclitaxel|mesh-list
25241897|NCT05178628|Tinzaparin|tinzaparin|mesh-list
25241898|NCT05178628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25241907|NCT05178628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25241908|NCT05178628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25241909|NCT05178628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25241910|NCT05178628|Immunologic Factors|immunologic factors|mesh-ancestor
25241911|NCT05178628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241912|NCT05178628|Anticoagulants|anticoagulants|mesh-ancestor
25241913|NCT05178628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25241914|NCT05178628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24851439|NCT02256813|GABA Modulators|gaba modulators|mesh-ancestor
24851440|NCT02256813|GABA Agents|gaba agents|mesh-ancestor
24851441|NCT02256813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24851442|NCT02256813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851443|NCT02256813|Anticoagulants|anticoagulants|mesh-ancestor
24851444|NCT02256813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24690081|NCT01399151|Vitamin D|vitamin d|mesh-list
24396842|NCT00140114|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24396926|NCT00140361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396928|NCT00140361|Schistosomicides|schistosomicides|mesh-ancestor
24396929|NCT00140361|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24396930|NCT00140361|Anthelmintics|anthelmintics|mesh-ancestor
24396931|NCT00140361|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24396932|NCT00140361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396933|NCT00140361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459823|NCT00346502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24459824|NCT00346502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24396934|NCT00140361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24396936|NCT00140452|Thalidomide|thalidomide|mesh-list
24439818|NCT00280462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24439819|NCT00280462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24460389|NCT00348335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24460390|NCT00348335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24460391|NCT00348361|Fluticasone|fluticasone|mesh-list
24460392|NCT00348361|Xhance|xhance|mesh-list
24460393|NCT00348361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24397198|NCT00141063|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
24397199|NCT00141063|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24397200|NCT00141063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397232|NCT00141154|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24397233|NCT00141154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24397234|NCT00141154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24397235|NCT00141154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397237|NCT00141167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24397265|NCT00141232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24851454|NCT02256813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24851456|NCT02256813|Coagulants|coagulants|mesh-ancestor
24851457|NCT02256813|Antitussive Agents|antitussive agents|mesh-ancestor
24851458|NCT02256813|Respiratory System Agents|respiratory system agents|mesh-ancestor
24851459|NCT02256813|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24397266|NCT00141232|Antimetabolites|antimetabolites|mesh-ancestor
24397267|NCT00141232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397268|NCT00141232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24397276|NCT00141245|Anticonvulsants|anticonvulsants|mesh-ancestor
24397277|NCT00141245|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24397278|NCT00141245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24397303|NCT00141310|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24397304|NCT00141310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24397305|NCT00141310|Urological Agents|urological agents|mesh-ancestor
24397357|NCT00141388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24397358|NCT00141388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24397359|NCT00141388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24397360|NCT00141388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24397361|NCT00141388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24397363|NCT00141401|Analgesics|analgesics|mesh-ancestor
25241933|NCT05147493|Dexamethasone|dexamethasone|mesh-list
25241934|NCT05147493|Cyclophosphamide|cyclophosphamide|mesh-list
25241935|NCT05147493|Lenalidomide|lenalidomide|mesh-list
25241936|NCT05147493|Bortezomib|bortezomib|mesh-list
25241937|NCT05147493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25241938|NCT05147493|Immunologic Factors|immunologic factors|mesh-ancestor
25241939|NCT05147493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241940|NCT05147493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25241941|NCT05147493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25241942|NCT05147493|Alkylating Agents|alkylating agents|mesh-ancestor
25241943|NCT05147493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241944|NCT05147493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25241945|NCT05147493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25241946|NCT05147493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25241947|NCT05147493|Antiemetics|antiemetics|mesh-ancestor
25241948|NCT05147493|Autonomic Agents|autonomic agents|mesh-ancestor
25241949|NCT05147493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25241950|NCT05147493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25241951|NCT05147493|Glucocorticoids|glucocorticoids|mesh-ancestor
25241952|NCT05147493|Hormones|hormones|mesh-ancestor
24851479|NCT02256878|Sensory System Agents|sensory system agents|mesh-ancestor
24851480|NCT02256878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851481|NCT02256878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851482|NCT02256878|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24444850|NCT00299364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24495203|NCT00498979|Immunologic Factors|immunologic factors|mesh-ancestor
25069331|NCT03427216|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24397396|NCT00141427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24397397|NCT00141427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24397438|NCT00141557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24397440|NCT00141557|Androgens|androgens|mesh-ancestor
24397441|NCT00141570|Methyltestosterone|methyltestosterone|mesh-list
24397442|NCT00141570|Estrogens|estrogens|mesh-list
24397484|NCT00141648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24397485|NCT00141648|Alkylating Agents|alkylating agents|mesh-ancestor
25241959|NCT05122182|Proxigermanium|proxigermanium|mesh-list
25241960|NCT05122182|Candesartan|candesartan|mesh-list
25241961|NCT05122182|Candesartan cilexetil|candesartan cilexetil|mesh-list
25241962|NCT05122182|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25241963|NCT05122182|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25241964|NCT05122182|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25241965|NCT05122182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25241966|NCT05122182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25241967|NCT05122182|Interferon Inducers|interferon inducers|mesh-ancestor
25241968|NCT05122182|Immunologic Factors|immunologic factors|mesh-ancestor
25241969|NCT05122182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241970|NCT05072262|Dexamethasone|dexamethasone|mesh-list
25241971|NCT05072262|Nepafenac|nepafenac|mesh-list
25241972|NCT05072262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25241973|NCT05072262|Antiemetics|antiemetics|mesh-ancestor
25241974|NCT05072262|Autonomic Agents|autonomic agents|mesh-ancestor
25241975|NCT05072262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25241976|NCT05072262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241977|NCT05072262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25241978|NCT05072262|Glucocorticoids|glucocorticoids|mesh-ancestor
25241979|NCT05072262|Hormones|hormones|mesh-ancestor
25241980|NCT05072262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25241981|NCT05072262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24851486|NCT02256878|Adrenergic Agents|adrenergic agents|mesh-ancestor
24851487|NCT02256878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24851488|NCT02256943|Amitriptyline|amitriptyline|mesh-list
25155269|NCT05431595|Antiemetics|antiemetics|mesh-ancestor
24444851|NCT00299364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25069363|NCT03426982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24397486|NCT00141648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397487|NCT00141648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24397488|NCT00141648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24397489|NCT00141648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24397707|NCT00142402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397708|NCT00142402|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24397738|NCT00142480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24397739|NCT00142480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24397740|NCT00142480|Growth Substances|growth substances|mesh-ancestor
24397741|NCT00142480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397742|NCT00142480|Growth Inhibitors|growth inhibitors|mesh-ancestor
24397743|NCT00142480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24397744|NCT00142480|Antimetabolites|antimetabolites|mesh-ancestor
24397745|NCT00142480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397746|NCT00142493|Midazolam|midazolam|mesh-list
24397747|NCT00142493|Dexmedetomidine|dexmedetomidine|mesh-list
24397749|NCT00142493|Propofol|propofol|mesh-list
24397750|NCT00142493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24397751|NCT00142493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25241992|NCT05061017|Nivolumab|nivolumab|mesh-list
25241993|NCT05061017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25241994|NCT05061017|Immunologic Factors|immunologic factors|mesh-ancestor
25241995|NCT05061017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25241996|NCT05061017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25241997|NCT05061017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25241998|NCT05061017|Alkylating Agents|alkylating agents|mesh-ancestor
25241999|NCT05061017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242000|NCT05061017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242001|NCT05061017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25242002|NCT05061017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25242003|NCT05061017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25242004|NCT05056155|Lubricant Eye Drops|lubricant eye drops|mesh-list
25242005|NCT05056155|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25242006|NCT05056155|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25242007|NCT05054348|Pembrolizumab|pembrolizumab|mesh-list
25242008|NCT05054348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25242009|NCT05054348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24397792|NCT00142571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24397793|NCT00142571|Immunologic Factors|immunologic factors|mesh-ancestor
24397794|NCT00142571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397795|NCT00142571|Tubulin Modulators|tubulin modulators|mesh-ancestor
24397866|NCT00142883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24397867|NCT00142883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24455491|NCT00107198|Mitosis Modulators|mitosis modulators|mesh-ancestor
24398007|NCT00143221|Sildenafil Citrate|sildenafil citrate|mesh-list
24398008|NCT00143221|Vasodilator Agents|vasodilator agents|mesh-ancestor
24398040|NCT00143286|Cholinergic Agents|cholinergic agents|mesh-ancestor
24398041|NCT00143286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24398042|NCT00143286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398043|NCT00143286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398044|NCT00143299|Varenicline|varenicline|mesh-list
24398045|NCT00143299|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24398126|NCT00143546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24398127|NCT00143559|Antibodies|antibodies|mesh-list
24398134|NCT00143572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398135|NCT00143572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24398167|NCT00143689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24398168|NCT00143702|Riboflavin|riboflavin|mesh-list
24398169|NCT00143702|Thiamine|thiamine|mesh-list
24398170|NCT00143702|Abacavir|abacavir|mesh-list
24398171|NCT00143702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24398172|NCT00143702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24398173|NCT00143702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398174|NCT00143702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398175|NCT00143702|Antiviral Agents|antiviral agents|mesh-ancestor
24398176|NCT00143702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25242017|NCT05037812|Ketorolac|ketorolac|mesh-list
25242018|NCT05037812|Clonidine|clonidine|mesh-list
25242019|NCT05037812|Epinephrine|epinephrine|mesh-list
25242020|NCT05037812|Morphine|morphine|mesh-list
25242021|NCT05037812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25242022|NCT05037812|Narcotics|narcotics|mesh-ancestor
25242023|NCT05037812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25242024|NCT05037812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242025|NCT05037812|Analgesics|analgesics|mesh-ancestor
25242026|NCT05037812|Sensory System Agents|sensory system agents|mesh-ancestor
25242027|NCT05037812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25242028|NCT05037812|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25242029|NCT05037812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25242030|NCT05037812|Adrenergic Agents|adrenergic agents|mesh-ancestor
25242031|NCT05037812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25242032|NCT05037812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242034|NCT05037812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25242044|NCT05037812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25242045|NCT05037812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25242046|NCT05037812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25242047|NCT05037812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25242048|NCT05037812|Sympatholytics|sympatholytics|mesh-ancestor
25242049|NCT05037812|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25242051|NCT05022654|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25242052|NCT05022654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25242053|NCT05022654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25242054|NCT05022654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242055|NCT05022654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242056|NCT05020457|Paclitaxel|paclitaxel|mesh-list
25242057|NCT05020457|Docetaxel|docetaxel|mesh-list
25242058|NCT05020457|Cisplatin|cisplatin|mesh-list
25242059|NCT05020457|Pemetrexed|pemetrexed|mesh-list
25242060|NCT05020457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25242061|NCT05020457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242062|NCT05020457|Tubulin Modulators|tubulin modulators|mesh-ancestor
25242063|NCT05020457|Antimitotic Agents|antimitotic agents|mesh-ancestor
25242064|NCT05020457|Mitosis Modulators|mitosis modulators|mesh-ancestor
25242065|NCT05020457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242066|NCT05020457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25242067|NCT05020457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25242068|NCT05020457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25242069|NCT05012943|Vaccines|vaccines|mesh-list
25242070|NCT05012943|Immunologic Factors|immunologic factors|mesh-ancestor
25242071|NCT05012943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651402|NCT01231490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24398177|NCT00143702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24398363|NCT00144222|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24398364|NCT00144222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398365|NCT00144248|Nevirapine|nevirapine|mesh-list
24398366|NCT00144248|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24398367|NCT00144248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24398368|NCT00144248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398369|NCT00144248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398431|NCT00144365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24398432|NCT00144378|Irinotecan|irinotecan|mesh-list
24398433|NCT00144378|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24398436|NCT00144378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398471|NCT00144456|Eldecalcitol|eldecalcitol|mesh-list
24398472|NCT00144456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24425681|NCT00234000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24671488|NCT01326221|Emtricitabine|emtricitabine|mesh-list
24398679|NCT00145301|Analgesics|analgesics|mesh-ancestor
24398680|NCT00145301|Sensory System Agents|sensory system agents|mesh-ancestor
24398735|NCT00145444|Serotonin Agents|serotonin agents|mesh-ancestor
24398736|NCT00145444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24398739|NCT00145483|Sildenafil Citrate|sildenafil citrate|mesh-list
24398740|NCT00145483|Vasodilator Agents|vasodilator agents|mesh-ancestor
24398741|NCT00145483|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24398780|NCT00145639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24398814|NCT00145730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398815|NCT00145730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398850|NCT00145990|Methacholine Chloride|methacholine chloride|mesh-list
24398852|NCT00145990|Autonomic Agents|autonomic agents|mesh-ancestor
24398853|NCT00145990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24398854|NCT00145990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398855|NCT00145990|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24398856|NCT00145990|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
24398857|NCT00145990|Respiratory System Agents|respiratory system agents|mesh-ancestor
24398889|NCT00146042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24398890|NCT00146042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24398976|NCT00146289|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24399015|NCT00146497|Autonomic Agents|autonomic agents|mesh-ancestor
25242072|NCT05008354|Pyridoxine|pyridoxine|mesh-list
25242073|NCT05008354|Vitamin B Complex|vitamin b complex|mesh-ancestor
25242074|NCT05008354|Vitamins|vitamins|mesh-ancestor
25242075|NCT05008354|Micronutrients|micronutrients|mesh-ancestor
24775380|NCT01851941|Antimetabolites|antimetabolites|mesh-ancestor
25242076|NCT05008354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242077|NCT04988841|Nivolumab|nivolumab|mesh-list
25242078|NCT04988841|Ipilimumab|ipilimumab|mesh-list
25242079|NCT04988841|Laxatives|laxatives|mesh-list
25242080|NCT04988841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25242081|NCT04988841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25242082|NCT04988841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242083|NCT04988841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25242084|NCT04988841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242085|NCT04988841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25242086|NCT04979377|Insulin|insulin|mesh-list
25242087|NCT04979377|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25242088|NCT04979377|Hormones|hormones|mesh-list
25242089|NCT04979377|Testosterone|testosterone|mesh-list
24399448|NCT00147836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24399450|NCT00147836|Gliclazide|gliclazide|mesh-list
24399451|NCT00147836|Isophane Insulin, Human|isophane insulin, human|mesh-list
24399452|NCT00147836|Insulin, Isophane|insulin, isophane|mesh-list
24399453|NCT00147836|Isophane insulin, beef|isophane insulin, beef|mesh-list
24399454|NCT00147836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24399455|NCT00147836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399488|NCT00147875|Mitosis Modulators|mitosis modulators|mesh-ancestor
24399489|NCT00147901|Cyclophosphamide|cyclophosphamide|mesh-list
24399490|NCT00147901|Fludarabine|fludarabine|mesh-list
24399491|NCT00147901|Alemtuzumab|alemtuzumab|mesh-list
24399492|NCT00147901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24399493|NCT00147901|Immunologic Factors|immunologic factors|mesh-ancestor
24399698|NCT00148421|Hematinics|hematinics|mesh-ancestor
24399700|NCT00148447|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24399725|NCT00148499|Anesthetics|anesthetics|mesh-ancestor
24399726|NCT00148499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24399727|NCT00148499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399728|NCT00148499|Sensory System Agents|sensory system agents|mesh-ancestor
24399729|NCT00148499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24399730|NCT00148499|Expectorants|expectorants|mesh-ancestor
24399731|NCT00148499|Respiratory System Agents|respiratory system agents|mesh-ancestor
24399732|NCT00148551|Triamcinolone|triamcinolone|mesh-list
24399733|NCT00148551|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24425972|NCT00234897|Adalimumab|adalimumab|mesh-list
24399824|NCT00148720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399825|NCT00148746|Cyclosporine|cyclosporine|mesh-list
24399826|NCT00148746|Prednisolone|prednisolone|mesh-list
24399856|NCT00148772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399857|NCT00148785|Ritonavir|ritonavir|mesh-list
24399858|NCT00148785|Indinavir|indinavir|mesh-list
24399859|NCT00148785|Fosamprenavir|fosamprenavir|mesh-list
24399860|NCT00148785|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24440489|NCT00283335|Gemfibrozil|gemfibrozil|mesh-list
24399861|NCT00148785|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24400455|NCT00150579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25686413|NCT01919723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24400456|NCT00150579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24459874|NCT00346749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24459875|NCT00346749|Autonomic Agents|autonomic agents|mesh-ancestor
24400457|NCT00150579|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24400458|NCT00150605|Carbamazepine|carbamazepine|mesh-list
24400459|NCT00150605|Anticonvulsants|anticonvulsants|mesh-ancestor
24400460|NCT00150605|Antimanic Agents|antimanic agents|mesh-ancestor
24400461|NCT00150605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24400462|NCT00150605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25242105|NCT04974996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242106|NCT04974996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25242107|NCT04974996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25242108|NCT04974996|Alkylating Agents|alkylating agents|mesh-ancestor
25242109|NCT04974996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242110|NCT04974996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242111|NCT04974996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25242112|NCT04974996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25242113|NCT04974996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25242114|NCT04974996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25242115|NCT04974996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25242116|NCT04974996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25242117|NCT04974996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25242118|NCT04974996|Glucocorticoids|glucocorticoids|mesh-ancestor
25242119|NCT04974996|Hormones|hormones|mesh-ancestor
25242120|NCT04974996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25242121|NCT04974996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25242122|NCT04974996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25242123|NCT04974996|Tubulin Modulators|tubulin modulators|mesh-ancestor
25242124|NCT04974996|Antimitotic Agents|antimitotic agents|mesh-ancestor
25242125|NCT04974996|Mitosis Modulators|mitosis modulators|mesh-ancestor
25242128|NCT04955158|Dexmedetomidine|dexmedetomidine|mesh-list
25242129|NCT04955158|Ketamine|ketamine|mesh-list
25242130|NCT04955158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25242131|NCT04955158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25242132|NCT04955158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775557|NCT01853306|Veliparib|veliparib|mesh-list
25242133|NCT04955158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25242134|NCT04955158|Analgesics|analgesics|mesh-ancestor
24812225|NCT02050594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25069509|NCT03425929|Oxytocin|oxytocin|mesh-list
24400497|NCT00150670|Cisplatin|cisplatin|mesh-list
24400498|NCT00150670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24400499|NCT00150696|Risedronic Acid|risedronic acid|mesh-list
24400626|NCT00151034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400627|NCT00151034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24400629|NCT00151034|Antiviral Agents|antiviral agents|mesh-ancestor
24426228|NCT00235261|Hormones|hormones|mesh-ancestor
24400749|NCT00151242|Immunologic Factors|immunologic factors|mesh-ancestor
24400750|NCT00151242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400751|NCT00151242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25242142|NCT04955158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242143|NCT04955158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25242144|NCT04955158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25242145|NCT04955158|Anesthetics, General|anesthetics, general|mesh-ancestor
25242146|NCT04955158|Anesthetics|anesthetics|mesh-ancestor
25242147|NCT04955158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25242148|NCT04955158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25242149|NCT04928391|Dexmedetomidine|dexmedetomidine|mesh-list
25242150|NCT04928391|Nalbuphine|nalbuphine|mesh-list
25242151|NCT04928391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25242152|NCT04928391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25242153|NCT04928391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242154|NCT04928391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25242155|NCT04928391|Analgesics|analgesics|mesh-ancestor
25242156|NCT04928391|Sensory System Agents|sensory system agents|mesh-ancestor
25242157|NCT04928391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25242158|NCT04928391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25242159|NCT04928391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25242160|NCT04928391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25242161|NCT04928391|Adrenergic Agents|adrenergic agents|mesh-ancestor
25242162|NCT04928391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25242163|NCT04928391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242164|NCT04928391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25242165|NCT04928391|Narcotics|narcotics|mesh-ancestor
25242166|NCT04928352|Bupivacaine|bupivacaine|mesh-list
25242167|NCT04928352|Anesthetics, Local|anesthetics, local|mesh-ancestor
25242168|NCT04928352|Anesthetics|anesthetics|mesh-ancestor
25242169|NCT04928352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25242170|NCT04928352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812226|NCT02050594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812227|NCT02050594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24812228|NCT02050594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812230|NCT02050672|Vitamin B Complex|vitamin b complex|mesh-ancestor
24790142|NCT01941056|Vaccines|vaccines|mesh-list
24790149|NCT01941134|Contraceptives, Oral|contraceptives, oral|mesh-list
24790151|NCT01941134|Estrogens|estrogens|mesh-ancestor
24790152|NCT01941134|Hormones|hormones|mesh-ancestor
24790153|NCT01941134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24790154|NCT01941134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790155|NCT01941134|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24790156|NCT01941134|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24790157|NCT01941134|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24790158|NCT01941134|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24790159|NCT01941134|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25007190|NCT04069585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25007191|NCT04069585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007198|NCT04055753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007200|NCT04029012|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25007201|NCT04029012|Anesthetics, General|anesthetics, general|mesh-ancestor
25007203|NCT04029012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25242171|NCT04928352|Sensory System Agents|sensory system agents|mesh-ancestor
25242172|NCT04928352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25242173|NCT04928300|Dexmedetomidine|dexmedetomidine|mesh-list
25242174|NCT04928300|Ketamine|ketamine|mesh-list
25242175|NCT04928300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25242176|NCT04928300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25242177|NCT04928300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242178|NCT04928300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25242179|NCT04928300|Analgesics|analgesics|mesh-ancestor
25242180|NCT04928300|Sensory System Agents|sensory system agents|mesh-ancestor
25242181|NCT04928300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25242182|NCT04928300|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25242183|NCT04928300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25242184|NCT04928300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25242185|NCT04928300|Adrenergic Agents|adrenergic agents|mesh-ancestor
25242186|NCT04928300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25242187|NCT04928300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242188|NCT04928300|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25242189|NCT04928300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25242190|NCT04928300|Anesthetics, General|anesthetics, general|mesh-ancestor
25242191|NCT04928300|Anesthetics|anesthetics|mesh-ancestor
25242192|NCT04928300|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25242193|NCT04928300|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25242194|NCT04913870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
25242195|NCT04913870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242196|NCT04910464|Tranexamic Acid|tranexamic acid|mesh-list
25242197|NCT04910464|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25242198|NCT04910464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25242199|NCT04910464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242200|NCT04910464|Hemostatics|hemostatics|mesh-ancestor
25242201|NCT04910464|Coagulants|coagulants|mesh-ancestor
25242202|NCT04910269|Immunoglobulins|immunoglobulins|mesh-list
25242203|NCT04910269|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25242204|NCT04910269|Antibodies|antibodies|mesh-list
25242205|NCT04910269|Immunologic Factors|immunologic factors|mesh-ancestor
25242206|NCT04910269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242207|NCT04905901|Tranexamic Acid|tranexamic acid|mesh-list
25242208|NCT04905901|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25242209|NCT04905901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25242210|NCT04905901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242211|NCT04905901|Hemostatics|hemostatics|mesh-ancestor
25242212|NCT04905901|Coagulants|coagulants|mesh-ancestor
25242213|NCT04895735|Pembrolizumab|pembrolizumab|mesh-list
24853917|NCT02270918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853918|NCT02270918|Anticoagulants|anticoagulants|mesh-ancestor
24456663|NCT00331955|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24456664|NCT00331955|Vorinostat|vorinostat|mesh-list
24456665|NCT00331955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25242214|NCT04895735|Pemetrexed|pemetrexed|mesh-list
25242215|NCT04895735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25242216|NCT04895735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242217|NCT04895735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25242218|NCT04895735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242219|NCT04895735|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25242220|NCT04895735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25242221|NCT04868708|Paclitaxel|paclitaxel|mesh-list
25242222|NCT04868708|Bevacizumab|bevacizumab|mesh-list
25242223|NCT04868708|Carboplatin|carboplatin|mesh-list
25242224|NCT04868708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25242225|NCT04868708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242226|NCT04868708|Tubulin Modulators|tubulin modulators|mesh-ancestor
25242227|NCT04868708|Antimitotic Agents|antimitotic agents|mesh-ancestor
25242228|NCT04868708|Mitosis Modulators|mitosis modulators|mesh-ancestor
25242229|NCT04868708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242230|NCT04868708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25045177|NCT00990327|Purinergic Agonists|purinergic agonists|mesh-ancestor
25045178|NCT00990327|Purinergic Agents|purinergic agents|mesh-ancestor
25155270|NCT05431595|Autonomic Agents|autonomic agents|mesh-ancestor
25155271|NCT05431595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25155272|NCT05431595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155273|NCT05431595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25007204|NCT04029012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109786|NCT03122314|Sensory System Agents|sensory system agents|mesh-ancestor
25109787|NCT03122314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25109788|NCT03122314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109789|NCT03122314|Antipyretics|antipyretics|mesh-ancestor
25109790|NCT03122314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25109791|NCT03122314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24790576|NCT01943760|Tramadol|tramadol|mesh-list
25109792|NCT03122314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25109793|NCT03122067|Oxytocin|oxytocin|mesh-list
25109794|NCT03122067|Oxytocics|oxytocics|mesh-ancestor
25109795|NCT03122067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25109796|NCT03122067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109797|NCT03121833|Endostar protein|endostar protein|mesh-list
25109798|NCT03121833|Endostatins|endostatins|mesh-list
25109799|NCT03121833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25109800|NCT03121833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25109801|NCT03121833|Growth Substances|growth substances|mesh-ancestor
25109802|NCT03121833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109803|NCT03121833|Growth Inhibitors|growth inhibitors|mesh-ancestor
25109804|NCT03121833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109805|NCT03121807|Leucovorin|leucovorin|mesh-list
25109806|NCT03121807|Fluorouracil|fluorouracil|mesh-list
24400942|NCT00151710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400943|NCT00151736|Etodolac|etodolac|mesh-list
24400944|NCT00151736|Chlorambucil|chlorambucil|mesh-list
24400945|NCT00151736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24400946|NCT00151736|Alkylating Agents|alkylating agents|mesh-ancestor
24400951|NCT00151736|Analgesics|analgesics|mesh-ancestor
24400954|NCT00151736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400955|NCT00151736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24400956|NCT00151736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24400957|NCT00151736|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24400958|NCT00151736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24400959|NCT00151736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400987|NCT00151827|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24459877|NCT00346749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277099|NCT02360423|Sirolimus|sirolimus|mesh-list
24459878|NCT00346749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24400988|NCT00151827|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24400989|NCT00151827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401124|NCT00152191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686414|NCT01919723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25686415|NCT01919723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25686416|NCT01919723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25686417|NCT01919723|Purinergic Agents|purinergic agents|mesh-ancestor
24401713|NCT00153764|Vitamins|vitamins|mesh-list
24401714|NCT00153764|Micronutrients|micronutrients|mesh-ancestor
24401748|NCT00153946|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24401749|NCT00153946|Antioxidants|antioxidants|mesh-ancestor
24401750|NCT00153946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401751|NCT00153946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24402047|NCT00154700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25242231|NCT04868708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25242232|NCT04868708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25242233|NCT04868708|Growth Substances|growth substances|mesh-ancestor
25242234|NCT04868708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242235|NCT04868708|Growth Inhibitors|growth inhibitors|mesh-ancestor
24775907|NCT01855568|Antimetabolites|antimetabolites|mesh-ancestor
25155275|NCT05431595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25155276|NCT05431595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25155277|NCT05431595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25155278|NCT05431595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25155279|NCT05431595|Dopamine Agents|dopamine agents|mesh-ancestor
25155280|NCT05431595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25155281|NCT05431595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25155282|NCT05431595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25155283|NCT05431595|Anticonvulsants|anticonvulsants|mesh-ancestor
25155284|NCT05431595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25155285|NCT05431595|GABA Agents|gaba agents|mesh-ancestor
25155286|NCT05431595|Antimanic Agents|antimanic agents|mesh-ancestor
25155287|NCT05426681|Glyburide|glyburide|mesh-list
25155288|NCT05426681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25155289|NCT05426681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155290|NCT05426395|Vitamins|vitamins|mesh-list
25155291|NCT05426395|Hydroxocobalamin|hydroxocobalamin|mesh-list
24402048|NCT00154700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402049|NCT00154700|Tubulin Modulators|tubulin modulators|mesh-ancestor
24402084|NCT00154778|Vitamin B Complex|vitamin b complex|mesh-ancestor
24402123|NCT00154882|Cisplatin|cisplatin|mesh-list
24402309|NCT00156403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24402310|NCT00156403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24402311|NCT00156403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426533|NCT00236275|Telbivudine|telbivudine|mesh-list
24402862|NCT00158574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24402863|NCT00158574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402864|NCT00158574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403616|NCT00161070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24403872|NCT00161837|Immunologic Factors|immunologic factors|mesh-ancestor
24403997|NCT00162383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24404751|NCT00164749|Analgesics|analgesics|mesh-ancestor
24404760|NCT00164775|Imipramine|imipramine|mesh-list
25242245|NCT04855513|Metformin|metformin|mesh-list
25242246|NCT04855513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25242247|NCT04855513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242248|NCT04840459|Bamlanivimab|bamlanivimab|mesh-list
25242249|NCT04840459|Antiviral Agents|antiviral agents|mesh-ancestor
25242250|NCT04840459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25242251|NCT04778787|Dapagliflozin|dapagliflozin|mesh-list
25242252|NCT04778787|Digoxin|digoxin|mesh-list
25242253|NCT04778787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25242254|NCT04778787|Vasodilator Agents|vasodilator agents|mesh-list
25242255|NCT04778787|Diuretics|diuretics|mesh-list
25242256|NCT04778787|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
25242257|NCT04778787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25242258|NCT04778787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405750|NCT00168181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24405751|NCT00168181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405753|NCT00168350|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24405754|NCT00168350|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24405755|NCT00168350|Dopamine Agents|dopamine agents|mesh-ancestor
24405756|NCT00168350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24406009|NCT00169013|Sensory System Agents|sensory system agents|mesh-ancestor
24406010|NCT00169013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24406011|NCT00169013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406013|NCT00169013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24406014|NCT00169013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24406015|NCT00169013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24406016|NCT00169013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24406017|NCT00169013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24441159|NCT00286260|Anticonvulsants|anticonvulsants|mesh-ancestor
24406018|NCT00169013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24406019|NCT00169013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24406020|NCT00169013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406021|NCT00169013|Antimanic Agents|antimanic agents|mesh-ancestor
24406022|NCT00169026|Antipsychotic Agents|antipsychotic agents|mesh-list
25242259|NCT04778787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25242260|NCT04778787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242261|NCT04778787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25242262|NCT04778787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25242263|NCT04778787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25242264|NCT04778787|Protective Agents|protective agents|mesh-ancestor
25242265|NCT04778787|Natriuretic Agents|natriuretic agents|mesh-ancestor
25242266|NCT04778787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25242267|NCT04772222|Dexmedetomidine|dexmedetomidine|mesh-list
25242268|NCT04772222|Morphine|morphine|mesh-list
25242269|NCT04772222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25242270|NCT04772222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25242271|NCT04772222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045180|NCT00990327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045181|NCT00987272|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25045182|NCT00987272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25045183|NCT00987272|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25045184|NCT00987272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25045185|NCT00987272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25045186|NCT00987272|Analgesics|analgesics|mesh-ancestor
25045187|NCT00987272|Sensory System Agents|sensory system agents|mesh-ancestor
25155305|NCT05426161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406028|NCT00169026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24406029|NCT00169026|Serotonin Agents|serotonin agents|mesh-ancestor
24406030|NCT00169026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24406031|NCT00169026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406373|NCT00169988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24406375|NCT00169988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24884400|NCT00664937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24406380|NCT00169988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24406443|NCT00170378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24406444|NCT00170378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406447|NCT00170404|Vitamin A|vitamin a|mesh-list
24406448|NCT00170404|Thiamine|thiamine|mesh-list
24406449|NCT00170404|Selenium|selenium|mesh-list
24406450|NCT00170404|Micronutrients|micronutrients|mesh-list
24406451|NCT00170404|Trace Elements|trace elements|mesh-list
24406452|NCT00170404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406453|NCT00170404|Hematinics|hematinics|mesh-ancestor
24406454|NCT00170404|Vitamin B Complex|vitamin b complex|mesh-ancestor
24406455|NCT00170404|Antioxidants|antioxidants|mesh-ancestor
24406521|NCT00170729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24406523|NCT00170729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24406524|NCT00170729|Prednisolone phosphate|prednisolone phosphate|mesh-list
24406525|NCT00170729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24406526|NCT00170729|Glucocorticoids|glucocorticoids|mesh-ancestor
24406527|NCT00170729|Hormones|hormones|mesh-ancestor
24406681|NCT00171002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24406709|NCT00171067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24406710|NCT00171067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24406711|NCT00171067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25242272|NCT04772222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25242273|NCT04772222|Analgesics|analgesics|mesh-ancestor
25242274|NCT04772222|Sensory System Agents|sensory system agents|mesh-ancestor
25242275|NCT04772222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25242276|NCT04772222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25242277|NCT04772222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25242278|NCT04772222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25242279|NCT04772222|Adrenergic Agents|adrenergic agents|mesh-ancestor
25242280|NCT04772222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25277163|NCT02359643|Aspirin|aspirin|mesh-list
25242281|NCT04772222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242282|NCT04772222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25242283|NCT04772222|Narcotics|narcotics|mesh-ancestor
25242284|NCT04767256|Dexamethasone|dexamethasone|mesh-list
25242285|NCT04767256|Dexmedetomidine|dexmedetomidine|mesh-list
25242286|NCT04767256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25242287|NCT04767256|Antiemetics|antiemetics|mesh-ancestor
25242288|NCT04767256|Autonomic Agents|autonomic agents|mesh-ancestor
25242289|NCT04767256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25242290|NCT04767256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155309|NCT05421065|Hallucinogens|hallucinogens|mesh-ancestor
25155310|NCT05421065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155311|NCT05421065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25155315|NCT05419180|Stiripentol|stiripentol|mesh-list
25155316|NCT05419180|Anticonvulsants|anticonvulsants|mesh-ancestor
25155317|NCT05419089|Cisplatin|cisplatin|mesh-list
25155318|NCT05419089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069648|NCT03424928|Leprostatic Agents|leprostatic agents|mesh-ancestor
24406794|NCT00171288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24406795|NCT00171327|Valsartan|valsartan|mesh-list
24406931|NCT00171574|Protective Agents|protective agents|mesh-ancestor
24406932|NCT00171574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406933|NCT00171587|Vatalanib|vatalanib|mesh-list
24427199|NCT00237627|Bortezomib|bortezomib|mesh-list
24427222|NCT00237731|Narcotics|narcotics|mesh-ancestor
24407341|NCT00174317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24407342|NCT00174317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24407343|NCT00174317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25242291|NCT04767256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25242292|NCT04767256|Glucocorticoids|glucocorticoids|mesh-ancestor
25242293|NCT04767256|Hormones|hormones|mesh-ancestor
25242294|NCT04767256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25242295|NCT04767256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25242296|NCT04767256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242297|NCT04767256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25242298|NCT04767256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25242299|NCT04767256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25242300|NCT04767256|Analgesics|analgesics|mesh-ancestor
25242301|NCT04767256|Sensory System Agents|sensory system agents|mesh-ancestor
25242302|NCT04767256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25242303|NCT04767256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25242304|NCT04767256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25242305|NCT04767256|Adrenergic Agents|adrenergic agents|mesh-ancestor
25242306|NCT04767256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25242307|NCT04767256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242308|NCT04766983|Dimercaprol|dimercaprol|mesh-list
25242309|NCT04766983|Chelating Agents|chelating agents|mesh-ancestor
25242310|NCT04766983|Sequestering Agents|sequestering agents|mesh-ancestor
25242311|NCT04766983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274054|NCT02381145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25274055|NCT02381080|Voriconazole|voriconazole|mesh-list
25274056|NCT02381080|Erythromycin|erythromycin|mesh-list
25274057|NCT02381080|Erythromycin Estolate|erythromycin estolate|mesh-list
25274058|NCT02381080|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25274059|NCT02381080|Erythromycin stearate|erythromycin stearate|mesh-list
24407500|NCT00174629|Antiviral Agents|antiviral agents|mesh-ancestor
24407346|NCT00174330|Atorvastatin|atorvastatin|mesh-list
24407370|NCT00174356|Paclitaxel|paclitaxel|mesh-list
24407371|NCT00174356|Carboplatin|carboplatin|mesh-list
24407372|NCT00174356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25007234|NCT03824808|Anesthetics|anesthetics|mesh-ancestor
25007235|NCT03824808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25007236|NCT03824808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007237|NCT03824808|Sensory System Agents|sensory system agents|mesh-ancestor
25007238|NCT03824808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25007239|NCT03824808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25242312|NCT04754815|Paclitaxel|paclitaxel|mesh-list
25242313|NCT04754815|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25242314|NCT04754815|Pembrolizumab|pembrolizumab|mesh-list
25242315|NCT04754815|Pemetrexed|pemetrexed|mesh-list
25242316|NCT04754815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25242317|NCT04754815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242318|NCT04754815|Tubulin Modulators|tubulin modulators|mesh-ancestor
25242319|NCT04754815|Antimitotic Agents|antimitotic agents|mesh-ancestor
25242320|NCT04754815|Mitosis Modulators|mitosis modulators|mesh-ancestor
25242321|NCT04754815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242402|NCT04573673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25242324|NCT04754815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25242325|NCT04754815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25007240|NCT03824808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25007241|NCT03824808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25007242|NCT03824808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25007243|NCT03824808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407501|NCT00174629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24407502|NCT00174629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407503|NCT00174629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24407504|NCT00174629|Immunologic Factors|immunologic factors|mesh-ancestor
24407505|NCT00174629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407506|NCT00174629|Tubulin Modulators|tubulin modulators|mesh-ancestor
24407507|NCT00174629|Antimitotic Agents|antimitotic agents|mesh-ancestor
24407508|NCT00174629|Mitosis Modulators|mitosis modulators|mesh-ancestor
24407631|NCT00174876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407632|NCT00174876|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24776178|NCT01856985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24776179|NCT01856985|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24407633|NCT00174876|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24407634|NCT00174876|Serotonin Agents|serotonin agents|mesh-ancestor
24407667|NCT00174928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24407668|NCT00174928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407692|NCT00175032|Antipyretics|antipyretics|mesh-ancestor
24408513|NCT00178100|Paroxetine|paroxetine|mesh-list
24408675|NCT00179062|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24408677|NCT00179062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24408843|NCT00179738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408844|NCT00179751|Gemcitabine|gemcitabine|mesh-list
24408845|NCT00179751|Lenalidomide|lenalidomide|mesh-list
24409060|NCT00180843|Bromides|bromides|mesh-list
24409061|NCT00180843|Albuterol|albuterol|mesh-list
24409062|NCT00180843|Ipratropium|ipratropium|mesh-list
24790233|NCT01941602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790234|NCT01941732|Sildenafil Citrate|sildenafil citrate|mesh-list
24790235|NCT01941732|Vasodilator Agents|vasodilator agents|mesh-ancestor
24790236|NCT01941732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24790237|NCT01941732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24790238|NCT01941732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24790239|NCT01941732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790240|NCT01941732|Urological Agents|urological agents|mesh-ancestor
24790241|NCT01941758|Vaccines|vaccines|mesh-list
24790242|NCT01941758|Immunologic Factors|immunologic factors|mesh-ancestor
24790243|NCT01941758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790244|NCT01941771|Capecitabine|capecitabine|mesh-list
24790245|NCT01941771|Vinorelbine|vinorelbine|mesh-list
24790246|NCT01941771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24790247|NCT01941771|Antimetabolites|antimetabolites|mesh-ancestor
24790248|NCT01941771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242336|NCT04696731|Cyclophosphamide|cyclophosphamide|mesh-list
25242337|NCT04696731|Fludarabine|fludarabine|mesh-list
24409233|NCT00181558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409235|NCT00181571|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24409236|NCT00181571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409237|NCT00181571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24776180|NCT01856998|Propofol|propofol|mesh-list
24421179|NCT00218075|Dopamine Agents|dopamine agents|mesh-ancestor
25007296|NCT03797560|Pregabalin|pregabalin|mesh-list
25007297|NCT03797560|Analgesics|analgesics|mesh-ancestor
24409308|NCT00181727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24409309|NCT00181727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409310|NCT00181727|Antimanic Agents|antimanic agents|mesh-ancestor
24409311|NCT00181727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24409312|NCT00181727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24409337|NCT00181779|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24409989|NCT00183989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409990|NCT00183989|Analgesics|analgesics|mesh-ancestor
24427958|NCT00239382|Analgesics|analgesics|mesh-ancestor
24410116|NCT00184587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24410117|NCT00184587|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24410422|NCT00185224|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24410423|NCT00185224|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24410424|NCT00185224|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24410425|NCT00185224|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
24410427|NCT00185224|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24410428|NCT00185237|Estradiol|estradiol|mesh-list
24410429|NCT00185237|Estrogens|estrogens|mesh-ancestor
24410430|NCT00185237|Hormones|hormones|mesh-ancestor
24459939|NCT00346879|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24411913|NCT00190411|Vasodilator Agents|vasodilator agents|mesh-ancestor
25242340|NCT04696731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242341|NCT04696731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25242342|NCT04696731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25242343|NCT04696731|Alkylating Agents|alkylating agents|mesh-ancestor
25242344|NCT04696731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242345|NCT04696731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242346|NCT04696731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25242347|NCT04674358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24411914|NCT00190411|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24412484|NCT00191503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24412486|NCT00191503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412488|NCT00191503|Antiviral Agents|antiviral agents|mesh-ancestor
24412489|NCT00191503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24412490|NCT00191503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412607|NCT00191672|Gemcitabine|gemcitabine|mesh-list
24412608|NCT00191672|Paclitaxel|paclitaxel|mesh-list
24412719|NCT00191880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412720|NCT00191880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412721|NCT00191880|Adrenergic Agents|adrenergic agents|mesh-ancestor
24413171|NCT00193245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007305|NCT03797560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24790263|NCT01941888|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24413173|NCT00193245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24416107|NCT00202007|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24416539|NCT00203372|Doxorubicin|doxorubicin|mesh-list
24416540|NCT00203372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24416541|NCT00203372|Immunologic Factors|immunologic factors|mesh-ancestor
24416542|NCT00203372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416543|NCT00203372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24416544|NCT00203372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24416545|NCT00203372|Alkylating Agents|alkylating agents|mesh-ancestor
24416546|NCT00203372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416547|NCT00203372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24416761|NCT00203905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416873|NCT00204321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416874|NCT00204347|Risperidone|risperidone|mesh-list
24416911|NCT00204451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416912|NCT00204451|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24416913|NCT00204451|Contraceptive Agents|contraceptive agents|mesh-ancestor
24416914|NCT00204451|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24416976|NCT00204581|Sensory System Agents|sensory system agents|mesh-ancestor
24416977|NCT00204581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24417086|NCT00205283|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24417091|NCT00205283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25242348|NCT04674358|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25242349|NCT04654351|Icatibant|icatibant|mesh-list
25242350|NCT04654351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25242351|NCT04654351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25242352|NCT04654351|Analgesics|analgesics|mesh-ancestor
25242353|NCT04654351|Sensory System Agents|sensory system agents|mesh-ancestor
25242354|NCT04654351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25242355|NCT04654351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242356|NCT04654351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25242357|NCT04654351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25242358|NCT04654351|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
25242359|NCT04654351|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
25242360|NCT04654351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812255|NCT02050893|Anesthetics, General|anesthetics, general|mesh-ancestor
24812256|NCT02050893|Anesthetics|anesthetics|mesh-ancestor
24812257|NCT02050893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24812258|NCT02050893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24851499|NCT02256943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24851500|NCT02256943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24851501|NCT02256943|Analgesics|analgesics|mesh-ancestor
25277247|NCT02359331|Antacids|antacids|mesh-ancestor
24851502|NCT02256943|Sensory System Agents|sensory system agents|mesh-ancestor
24851503|NCT02256943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851504|NCT02256943|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24851505|NCT02256943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24851506|NCT02256943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25069716|NCT03424629|Methotrexate|methotrexate|mesh-list
24417936|NCT00208195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24417937|NCT00208195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417938|NCT00208195|Antimanic Agents|antimanic agents|mesh-ancestor
24417939|NCT00208195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24417940|NCT00208195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25007306|NCT03797560|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24417943|NCT00208208|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24417945|NCT00208208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24417946|NCT00208208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460010|NCT00347100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24460011|NCT00347100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417947|NCT00208208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418682|NCT00209885|Esketamine|esketamine|mesh-list
24418683|NCT00209885|Anesthetics, Local|anesthetics, local|mesh-ancestor
24418684|NCT00209885|Anesthetics|anesthetics|mesh-ancestor
24418685|NCT00209885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24674170|NCT01342237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24674217|NCT01342328|Adrenergic Agents|adrenergic agents|mesh-ancestor
24674218|NCT01342328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24674219|NCT01342328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674220|NCT01342562|Anesthetics|anesthetics|mesh-list
24674240|NCT01342679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24674241|NCT01342679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24674242|NCT01342679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674244|NCT01342692|Lenalidomide|lenalidomide|mesh-list
24674285|NCT01342874|Inositol|inositol|mesh-list
24674286|NCT01342874|Vitamin B Complex|vitamin b complex|mesh-ancestor
24674287|NCT01342874|Vitamins|vitamins|mesh-ancestor
24674288|NCT01342874|Micronutrients|micronutrients|mesh-ancestor
24674289|NCT01342874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674290|NCT01342939|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24674291|NCT01342939|Incretins|incretins|mesh-list
24674292|NCT01342939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24674293|NCT01342939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674294|NCT01342939|Hormones|hormones|mesh-ancestor
24674296|NCT01342939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24418721|NCT00209924|GABA Agonists|gaba agonists|mesh-ancestor
24418722|NCT00209924|GABA Agents|gaba agents|mesh-ancestor
24418723|NCT00209924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24418724|NCT00209924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242361|NCT04654351|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25242362|NCT04654351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25242363|NCT04654351|Immunologic Factors|immunologic factors|mesh-ancestor
25242364|NCT04642352|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25242365|NCT04642352|Bupivacaine|bupivacaine|mesh-list
25242366|NCT04642352|Anesthetics, Local|anesthetics, local|mesh-ancestor
25242367|NCT04642352|Anesthetics|anesthetics|mesh-ancestor
25242368|NCT04642352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25242369|NCT04642352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242370|NCT04642352|Sensory System Agents|sensory system agents|mesh-ancestor
25242371|NCT04642352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25242372|NCT04642352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25242373|NCT04642352|Glucocorticoids|glucocorticoids|mesh-ancestor
25242374|NCT04642352|Hormones|hormones|mesh-ancestor
25242375|NCT04642352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25242376|NCT04642352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25242377|NCT04642352|Immunologic Factors|immunologic factors|mesh-ancestor
25242378|NCT04614493|Temozolomide|temozolomide|mesh-list
25242379|NCT04614493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25242380|NCT04614493|Alkylating Agents|alkylating agents|mesh-ancestor
25242381|NCT04614493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242382|NCT04614493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25274060|NCT02381080|Antifungal Agents|antifungal agents|mesh-ancestor
24851508|NCT02256956|Amitriptyline|amitriptyline|mesh-list
24851509|NCT02256956|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24851510|NCT02256956|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24851511|NCT02256956|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25069737|NCT03424408|Aspirin|aspirin|mesh-list
24418763|NCT00210028|Hormone Antagonists|hormone antagonists|mesh-ancestor
24419099|NCT00211250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419327|NCT00211718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24419328|NCT00211744|Topiramate|topiramate|mesh-list
25686418|NCT01919723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25686419|NCT01919723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686420|NCT01919723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686421|NCT01919801|Icatibant|icatibant|mesh-list
25686422|NCT01919801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25686423|NCT01919801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25686424|NCT01919801|Analgesics|analgesics|mesh-ancestor
25686425|NCT01919801|Sensory System Agents|sensory system agents|mesh-ancestor
25686426|NCT01919801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686427|NCT01919801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686428|NCT01919801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25686429|NCT01919801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25686430|NCT01919801|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
25686431|NCT01919801|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
25686432|NCT01919801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686433|NCT01919801|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25686434|NCT01919801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24419662|NCT00213252|Prednisolone phosphate|prednisolone phosphate|mesh-list
24419663|NCT00213252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24419664|NCT00213252|Glucocorticoids|glucocorticoids|mesh-ancestor
24419665|NCT00213252|Hormones|hormones|mesh-ancestor
24442010|NCT00289419|Sympathomimetics|sympathomimetics|mesh-ancestor
24442011|NCT00289419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24419742|NCT00213564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24419743|NCT00213564|Immunologic Factors|immunologic factors|mesh-ancestor
24419744|NCT00213564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24419745|NCT00213564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24419746|NCT00213564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24419747|NCT00213577|Botulinum Toxins|botulinum toxins|mesh-list
24419748|NCT00213577|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24419749|NCT00213577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24419750|NCT00213577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419751|NCT00213577|Cholinergic Agents|cholinergic agents|mesh-ancestor
24419752|NCT00213577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24419753|NCT00213577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419992|NCT00214864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460023|NCT00347113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460024|NCT00347113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460025|NCT00347139|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24460026|NCT00347139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24460027|NCT00347139|Autonomic Agents|autonomic agents|mesh-ancestor
24790276|NCT01941888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790277|NCT01941901|Calcium, Dietary|calcium, dietary|mesh-list
24429612|NCT00244517|Narcotics|narcotics|mesh-ancestor
24421176|NCT00218075|Carbidopa|carbidopa|mesh-list
24421177|NCT00218075|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24421178|NCT00218075|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25007317|NCT03737565|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25007318|NCT03737565|Antidepressive Agents|antidepressive agents|mesh-ancestor
25007319|NCT03737565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24429694|NCT00244907|Estrogens|estrogens|mesh-ancestor
24421407|NCT00218530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24851512|NCT02256956|Cholinergic Agents|cholinergic agents|mesh-ancestor
24851516|NCT02256956|Urological Agents|urological agents|mesh-ancestor
24421408|NCT00218530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24421409|NCT00218530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24421474|NCT00219245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421475|NCT00219245|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24421476|NCT00219245|Protective Agents|protective agents|mesh-ancestor
24421477|NCT00219258|Zoledronic Acid|zoledronic acid|mesh-list
24421478|NCT00219258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24421531|NCT00219466|Dermatologic Agents|dermatologic agents|mesh-ancestor
24421532|NCT00219466|Sunscreening Agents|sunscreening agents|mesh-ancestor
24507005|NCT00548067|Amlodipine|amlodipine|mesh-list
24421731|NCT00220064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421732|NCT00220064|Antidotes|antidotes|mesh-ancestor
24421733|NCT00220064|Protective Agents|protective agents|mesh-ancestor
24421734|NCT00220064|Vitamin B Complex|vitamin b complex|mesh-ancestor
24421735|NCT00220064|Vitamins|vitamins|mesh-ancestor
24421736|NCT00220064|Micronutrients|micronutrients|mesh-ancestor
24421737|NCT00220103|Capecitabine|capecitabine|mesh-list
24421738|NCT00220103|Epirubicin|epirubicin|mesh-list
24421739|NCT00220103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421740|NCT00220103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24421741|NCT00220103|Antimetabolites|antimetabolites|mesh-ancestor
24421835|NCT00220298|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24421837|NCT00220298|Hormones|hormones|mesh-ancestor
24421838|NCT00220298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24460041|NCT00347152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460042|NCT00347152|GABA Agents|gaba agents|mesh-ancestor
24460043|NCT00347152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24460044|NCT00347152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422163|NCT00221494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422166|NCT00221494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422167|NCT00221494|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24422168|NCT00221494|Antidepressive Agents|antidepressive agents|mesh-ancestor
24422169|NCT00221494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24422170|NCT00221494|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24422171|NCT00221494|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24422172|NCT00221494|Adrenergic Agents|adrenergic agents|mesh-ancestor
24610582|NCT01003561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24610583|NCT01003561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610584|NCT01003613|Tranilast|tranilast|mesh-list
24610585|NCT01003613|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24610586|NCT01003613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24610587|NCT01003613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24422648|NCT00223301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24422649|NCT00223301|Antitubercular Agents|antitubercular agents|mesh-ancestor
24422650|NCT00223301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24422668|NCT00223418|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24422669|NCT00223418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24460068|NCT00347204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460069|NCT00347204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460071|NCT00347256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460073|NCT00347295|Brotizolam|brotizolam|mesh-list
24460074|NCT00347295|Anticonvulsants|anticonvulsants|mesh-ancestor
24460075|NCT00347295|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24460076|NCT00347295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24460077|NCT00347295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24460079|NCT00347295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24460080|NCT00347295|GABA Modulators|gaba modulators|mesh-ancestor
24460081|NCT00347295|GABA Agents|gaba agents|mesh-ancestor
24424150|NCT00228033|Calcium Carbonate|calcium carbonate|mesh-list
24424152|NCT00228033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24424263|NCT00228475|Respiratory System Agents|respiratory system agents|mesh-ancestor
24424265|NCT00228475|Hormones|hormones|mesh-ancestor
24424266|NCT00228475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24424267|NCT00228488|Gefitinib|gefitinib|mesh-list
24424268|NCT00228488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424269|NCT00228488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24424270|NCT00228488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851517|NCT02256956|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24651838|NCT01234142|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25081494|NCT03329339|Vitamins|vitamins|mesh-ancestor
25069752|NCT03424408|Antipyretics|antipyretics|mesh-ancestor
24424271|NCT00228488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424272|NCT00228514|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24424273|NCT00228514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24424274|NCT00228514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24424275|NCT00228514|Antimetabolites|antimetabolites|mesh-ancestor
24424276|NCT00228514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424310|NCT00228605|Anesthetics, General|anesthetics, general|mesh-ancestor
24424311|NCT00228605|Anesthetics|anesthetics|mesh-ancestor
24424312|NCT00228839|Infliximab|infliximab|mesh-list
24424313|NCT00228839|Dermatologic Agents|dermatologic agents|mesh-ancestor
24424806|NCT00230815|Hormones|hormones|mesh-ancestor
25007334|NCT03700970|Bupivacaine|bupivacaine|mesh-list
25007335|NCT03700970|Anesthetics, Local|anesthetics, local|mesh-ancestor
24790292|NCT01941953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24790293|NCT01941953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790294|NCT01941953|Antimetabolites|antimetabolites|mesh-ancestor
24790295|NCT01941953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790296|NCT01941953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24790297|NCT01941953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24790298|NCT01941953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24790299|NCT01941953|Immunologic Factors|immunologic factors|mesh-ancestor
24790301|NCT01941966|Mitomycins|mitomycins|mesh-list
24790302|NCT01941966|Mitomycin|mitomycin|mesh-list
24790303|NCT01941966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24790304|NCT01941966|Antimetabolites|antimetabolites|mesh-ancestor
25686435|NCT01919801|Immunologic Factors|immunologic factors|mesh-ancestor
25686436|NCT01919996|Azithromycin|azithromycin|mesh-list
25686437|NCT01919996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25686438|NCT01919996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25686439|NCT01920152|Hyaluronic Acid|hyaluronic acid|mesh-list
25686440|NCT01920152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25686441|NCT01920152|Immunologic Factors|immunologic factors|mesh-ancestor
25686442|NCT01920152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686443|NCT01920152|Viscosupplements|viscosupplements|mesh-ancestor
25686444|NCT01920152|Protective Agents|protective agents|mesh-ancestor
25686445|NCT01920282|Nebivolol|nebivolol|mesh-list
25686446|NCT01920282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24674863|NCT04216134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674864|NCT04216134|Anticoagulants|anticoagulants|mesh-ancestor
24674865|NCT04216134|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24674866|NCT04216134|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24674867|NCT04213677|Dapagliflozin|dapagliflozin|mesh-list
24674868|NCT04213677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24674869|NCT04213677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424809|NCT00230815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24424831|NCT00230984|Androgens|androgens|mesh-ancestor
24424832|NCT00230984|Hormones|hormones|mesh-ancestor
24424833|NCT00230984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24424839|NCT00230997|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24424840|NCT00230997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24424843|NCT00230997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24424844|NCT00230997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424845|NCT00230997|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24424917|NCT00231335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24425008|NCT00231582|Alkylating Agents|alkylating agents|mesh-ancestor
24425009|NCT00231595|Topiramate|topiramate|mesh-list
24425010|NCT00231595|Anticonvulsants|anticonvulsants|mesh-ancestor
25007336|NCT03700970|Anesthetics|anesthetics|mesh-ancestor
25007337|NCT03700970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25007338|NCT03700970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007339|NCT03700970|Sensory System Agents|sensory system agents|mesh-ancestor
25007340|NCT03700970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25007341|NCT03686345|Midostaurin|midostaurin|mesh-list
25007342|NCT03686345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242398|NCT04573673|Emodin|emodin|mesh-list
25242399|NCT04573673|Cathartics|cathartics|mesh-ancestor
25242400|NCT04573673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25242401|NCT04573673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25242403|NCT04573673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242404|NCT04538066|Bryostatin 1|bryostatin 1|mesh-list
25242405|NCT04538066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25242406|NCT04538066|Immunologic Factors|immunologic factors|mesh-ancestor
24486955|NCT00460733|Vitamin D|vitamin d|mesh-list
24486956|NCT00460733|Cholecalciferol|cholecalciferol|mesh-list
24486957|NCT00460733|Risedronic Acid|risedronic acid|mesh-list
24486958|NCT00460733|Calcium|calcium|mesh-list
25242407|NCT04538066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242408|NCT04538066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069756|NCT03424356|Bromides|bromides|mesh-list
25007343|NCT03686345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25007344|NCT03686345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25007345|NCT03686345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425021|NCT00231634|Topiramate|topiramate|mesh-list
24425022|NCT00231634|Anticonvulsants|anticonvulsants|mesh-ancestor
24425023|NCT00231634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24425024|NCT00231634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425026|NCT00231647|Anticonvulsants|anticonvulsants|mesh-ancestor
24425027|NCT00231647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24425028|NCT00231647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425029|NCT00231660|Topiramate|topiramate|mesh-list
24425127|NCT00232063|Cyclosporins|cyclosporins|mesh-list
24425128|NCT00232063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24425161|NCT00232102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425162|NCT00232115|Pimecrolimus|pimecrolimus|mesh-list
24425163|NCT00232115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24425164|NCT00232115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24425186|NCT00232167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24425489|NCT00233532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425491|NCT00233532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425493|NCT00233532|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24425494|NCT00233532|Protease Inhibitors|protease inhibitors|mesh-ancestor
25686447|NCT01920282|Vasodilator Agents|vasodilator agents|mesh-ancestor
25686448|NCT01920282|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25686449|NCT01920282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25686450|NCT01920282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25686451|NCT01920282|Adrenergic Agents|adrenergic agents|mesh-ancestor
25686452|NCT01920282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25686453|NCT01920282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686454|NCT01920282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675089|NCT03160521|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24425495|NCT00233532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24425534|NCT00233584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24425536|NCT00233610|Bicalutamide|bicalutamide|mesh-list
24425537|NCT00233610|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24790318|NCT01941979|Antidotes|antidotes|mesh-ancestor
24790335|NCT01942109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24790336|NCT01942109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790350|NCT01942174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24790351|NCT01942174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24790352|NCT01942174|Immunologic Factors|immunologic factors|mesh-ancestor
24790353|NCT01942174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24790354|NCT01942174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24790356|NCT01942187|Bupropion|bupropion|mesh-list
24790357|NCT01942187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24790363|NCT01942187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790364|NCT01942187|Dopamine Agents|dopamine agents|mesh-ancestor
24427106|NCT00237419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24790365|NCT01942187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24426031|NCT00234949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24426033|NCT00234962|Lopinavir|lopinavir|mesh-list
24426034|NCT00234962|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25007360|NCT03647488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007361|NCT03647488|Tubulin Modulators|tubulin modulators|mesh-ancestor
25007362|NCT03647488|Antimitotic Agents|antimitotic agents|mesh-ancestor
25007363|NCT03647488|Mitosis Modulators|mitosis modulators|mesh-ancestor
25007364|NCT03647488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007365|NCT03647488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25007366|NCT03632759|Liraglutide|liraglutide|mesh-list
25007367|NCT03632759|Golimumab|golimumab|mesh-list
24486959|NCT00460733|Vitamins|vitamins|mesh-ancestor
25007368|NCT03632759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25007369|NCT03632759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007370|NCT03632759|Incretins|incretins|mesh-ancestor
25007371|NCT03632759|Hormones|hormones|mesh-ancestor
25007372|NCT03632759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25007373|NCT03632759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25007374|NCT03632759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25007375|NCT03632759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25007376|NCT03632759|Immunologic Factors|immunologic factors|mesh-ancestor
25007377|NCT03618537|Dexamethasone|dexamethasone|mesh-list
25007378|NCT03618537|Ixazomib|ixazomib|mesh-list
25007379|NCT03618537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25007382|NCT03618537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25007383|NCT03618537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007384|NCT03618537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25007385|NCT03618537|Glucocorticoids|glucocorticoids|mesh-ancestor
25007386|NCT03618537|Hormones|hormones|mesh-ancestor
25007389|NCT03618537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242409|NCT04503252|Cefazolin|cefazolin|mesh-list
24426303|NCT00235729|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24426304|NCT00235729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426305|NCT00235729|Sensory System Agents|sensory system agents|mesh-ancestor
24426306|NCT00235729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24426310|NCT00235729|Adrenergic Agents|adrenergic agents|mesh-ancestor
24426319|NCT00235794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24426320|NCT00235794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24426321|NCT00235794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24426322|NCT00235794|Antifungal Agents|antifungal agents|mesh-ancestor
24426323|NCT00235794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24426324|NCT00235794|Immunologic Factors|immunologic factors|mesh-ancestor
24426325|NCT00235794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426326|NCT00235820|Adalimumab|adalimumab|mesh-list
24427023|NCT00237198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427071|NCT00237302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427072|NCT00237328|Heparin|heparin|mesh-list
24427073|NCT00237328|Anticoagulants|anticoagulants|mesh-ancestor
24427074|NCT00237328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24427075|NCT00237328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24427076|NCT00237328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427077|NCT00237341|Fentanyl|fentanyl|mesh-list
24427078|NCT00237341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24427079|NCT00237341|Narcotics|narcotics|mesh-ancestor
24427080|NCT00237341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24427081|NCT00237341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686455|NCT01920477|Ofatumumab|ofatumumab|mesh-list
24427083|NCT00237341|Sensory System Agents|sensory system agents|mesh-ancestor
24427084|NCT00237341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24427085|NCT00237341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24427086|NCT00237341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24427087|NCT00237341|Anesthetics, General|anesthetics, general|mesh-ancestor
24427088|NCT00237341|Anesthetics|anesthetics|mesh-ancestor
24427089|NCT00237367|Rabeprazole|rabeprazole|mesh-list
24427090|NCT00237367|Pantoprazole|pantoprazole|mesh-list
24427091|NCT00237367|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24460181|NCT00347581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24460183|NCT00347646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24460184|NCT00347646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24460185|NCT00347646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460186|NCT00347685|Tramadol|tramadol|mesh-list
24418509|NCT00209703|Micronutrients|micronutrients|mesh-ancestor
24427119|NCT00237484|Infliximab|infliximab|mesh-list
24427120|NCT00237484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427121|NCT00237484|Antiviral Agents|antiviral agents|mesh-ancestor
24427122|NCT00237484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24428309|NCT00240123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24428727|NCT00241059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24428728|NCT00241059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24428759|NCT00241124|Protease Inhibitors|protease inhibitors|mesh-ancestor
24428760|NCT00241124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428761|NCT00241124|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24428762|NCT00241124|Protective Agents|protective agents|mesh-ancestor
24428763|NCT00241124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442980|NCT00293371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24442981|NCT00293371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25242410|NCT04503252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25242411|NCT04503252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25242412|NCT04500418|Cenicriviroc|cenicriviroc|mesh-list
25242413|NCT04500418|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25242414|NCT04500418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429777|NCT00245089|Cyclophosphamide|cyclophosphamide|mesh-list
24429778|NCT00245089|Vincristine|vincristine|mesh-list
24429779|NCT00245089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24429906|NCT00245414|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24429907|NCT00245414|Interferon-alpha|interferon-alpha|mesh-list
24429908|NCT00245414|Antiviral Agents|antiviral agents|mesh-ancestor
24429909|NCT00245414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24429937|NCT00245505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24429938|NCT00245505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429940|NCT00245505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24429941|NCT00245596|Sildenafil Citrate|sildenafil citrate|mesh-list
24431675|NCT00252668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24430111|NCT00246194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24430393|NCT00247559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24430478|NCT00247988|Docetaxel|docetaxel|mesh-list
24430479|NCT00247988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24430485|NCT00248053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24430486|NCT00248053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24430487|NCT00248053|Analgesics|analgesics|mesh-ancestor
24430488|NCT00248053|Sensory System Agents|sensory system agents|mesh-ancestor
24430489|NCT00248053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24430490|NCT00248053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430491|NCT00248053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24430492|NCT00248053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24430493|NCT00248053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24430494|NCT00248053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430495|NCT00248053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430558|NCT00248248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25242415|NCT04500418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25242416|NCT04500418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25242417|NCT04500418|Antiviral Agents|antiviral agents|mesh-ancestor
25242418|NCT04500418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25242419|NCT04488159|Leucovorin|leucovorin|mesh-list
25242420|NCT04488159|Fluorouracil|fluorouracil|mesh-list
25242421|NCT04488159|Capecitabine|capecitabine|mesh-list
25242422|NCT04488159|Oxaliplatin|oxaliplatin|mesh-list
25242423|NCT04488159|Antimetabolites|antimetabolites|mesh-ancestor
25242424|NCT04488159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675579|NCT01344174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675580|NCT01344174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24675581|NCT01344174|Glucocorticoids|glucocorticoids|mesh-ancestor
24675582|NCT01344174|Hormones|hormones|mesh-ancestor
24675583|NCT01344174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24812598|NCT02053766|Propofol|propofol|mesh-list
25242425|NCT04488159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25242426|NCT04488159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242427|NCT04488159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25069772|NCT03424356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24430559|NCT00248248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24430560|NCT00248248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430561|NCT00248248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430563|NCT00248261|Sertraline|sertraline|mesh-list
24430564|NCT00248261|Antidepressive Agents|antidepressive agents|mesh-ancestor
24430565|NCT00248261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24430566|NCT00248261|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24430579|NCT00248300|Chlorhexidine|chlorhexidine|mesh-list
24430584|NCT00248313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24430608|NCT00248430|Immunologic Factors|immunologic factors|mesh-ancestor
24430609|NCT00248430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430610|NCT00248430|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24430611|NCT00248430|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24430612|NCT00248430|Antiviral Agents|antiviral agents|mesh-ancestor
24430613|NCT00248430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24430615|NCT00248443|Chelating Agents|chelating agents|mesh-ancestor
24430616|NCT00248443|Sequestering Agents|sequestering agents|mesh-ancestor
24430617|NCT00248443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430618|NCT00248456|Betamethasone|betamethasone|mesh-list
24430619|NCT00248456|Betamethasone Valerate|betamethasone valerate|mesh-list
24430707|NCT00249132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24430708|NCT00249132|Serotonin Agents|serotonin agents|mesh-ancestor
24430709|NCT00249132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430710|NCT00249132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430765|NCT00249197|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24430766|NCT00249197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24430767|NCT00249210|Levofloxacin|levofloxacin|mesh-list
24430768|NCT00249210|Ofloxacin|ofloxacin|mesh-list
24430769|NCT00249210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24430770|NCT00249210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24430815|NCT00249366|Antiemetics|antiemetics|mesh-ancestor
24430816|NCT00249366|Autonomic Agents|autonomic agents|mesh-ancestor
24430817|NCT00249366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24430818|NCT00249366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430825|NCT00249366|GABA Modulators|gaba modulators|mesh-ancestor
24430932|NCT00249847|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24430934|NCT00249847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24430982|NCT00249912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24430983|NCT00249912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24430984|NCT00249912|Antimetabolites|antimetabolites|mesh-ancestor
24430985|NCT00249912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430986|NCT00249912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24430987|NCT00249912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24431017|NCT00250029|Oxaliplatin|oxaliplatin|mesh-list
24431018|NCT00250029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24431019|NCT00250029|Antimetabolites|antimetabolites|mesh-ancestor
25686456|NCT01920477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25686457|NCT01920555|Midazolam|midazolam|mesh-list
25686458|NCT01920555|Ketamine|ketamine|mesh-list
25686459|NCT01920555|Analgesics|analgesics|mesh-ancestor
25686460|NCT01920555|Sensory System Agents|sensory system agents|mesh-ancestor
25686461|NCT01920555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24507723|NCT00551590|Hormones|hormones|mesh-ancestor
25242428|NCT04488159|Immunologic Factors|immunologic factors|mesh-ancestor
25686462|NCT01920555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686463|NCT01920555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25686464|NCT01920555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25242429|NCT04488159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242430|NCT04488159|Antidotes|antidotes|mesh-ancestor
25242431|NCT04488159|Protective Agents|protective agents|mesh-ancestor
25242432|NCT04488159|Vitamin B Complex|vitamin b complex|mesh-ancestor
25242433|NCT04488159|Vitamins|vitamins|mesh-ancestor
25242434|NCT04488159|Micronutrients|micronutrients|mesh-ancestor
25242435|NCT04445246|Iloprost|iloprost|mesh-list
25242436|NCT04445246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25242437|NCT04445246|Vasodilator Agents|vasodilator agents|mesh-ancestor
25242438|NCT04414761|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25242439|NCT04414761|Medroxyprogesterone|medroxyprogesterone|mesh-list
24692597|NCT01415505|Nebivolol|nebivolol|mesh-list
24431209|NCT00250796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24431210|NCT00250796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24431211|NCT00250796|Growth Substances|growth substances|mesh-ancestor
24431212|NCT00250796|Growth Inhibitors|growth inhibitors|mesh-ancestor
24431544|NCT00252200|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24431545|NCT00252200|Natriuretic Agents|natriuretic agents|mesh-ancestor
24431546|NCT00252200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431547|NCT00252226|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24431568|NCT00252291|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
24431569|NCT00252291|Respiratory System Agents|respiratory system agents|mesh-ancestor
24431570|NCT00252291|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24431571|NCT00252291|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24431572|NCT00252291|Cholinergic Agents|cholinergic agents|mesh-ancestor
24431573|NCT00252291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431574|NCT00252291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431575|NCT00252304|Zinc Sulfate|zinc sulfate|mesh-list
24431576|NCT00252304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431577|NCT00252304|Astringents|astringents|mesh-ancestor
24431578|NCT00252304|Dermatologic Agents|dermatologic agents|mesh-ancestor
24431844|NCT00253123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431845|NCT00253123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24431846|NCT00253123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24431847|NCT00253123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24431848|NCT00253123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24790372|NCT01942187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24790373|NCT01942187|Dopamine Agonists|dopamine agonists|mesh-ancestor
24790374|NCT01942187|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24790375|NCT01942187|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24790376|NCT01942187|Serotonin Agents|serotonin agents|mesh-ancestor
24790377|NCT01942187|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24790378|NCT01942187|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24790380|NCT01942187|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24790382|NCT01942291|Nicotinic Acids|nicotinic acids|mesh-list
24790383|NCT01942291|Vitamins|vitamins|mesh-ancestor
24790384|NCT01942291|Micronutrients|micronutrients|mesh-ancestor
24790385|NCT01942291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790386|NCT01942291|Vitamin B Complex|vitamin b complex|mesh-ancestor
25007426|NCT03579160|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25007427|NCT03579160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25007428|NCT03579160|Emollients|emollients|mesh-ancestor
25007429|NCT03579160|Dermatologic Agents|dermatologic agents|mesh-ancestor
25007430|NCT03556696|Remifentanil|remifentanil|mesh-list
25007431|NCT03556696|Propofol|propofol|mesh-list
25007432|NCT03556696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25007433|NCT03556696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25007434|NCT03556696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007435|NCT03556696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25007436|NCT03556696|Anesthetics, General|anesthetics, general|mesh-ancestor
25007437|NCT03556696|Anesthetics|anesthetics|mesh-ancestor
25007438|NCT03556696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25007439|NCT03556696|Narcotics|narcotics|mesh-ancestor
25007440|NCT03556696|Analgesics|analgesics|mesh-ancestor
25007441|NCT03556696|Sensory System Agents|sensory system agents|mesh-ancestor
25007442|NCT03556696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25007443|NCT03531736|Cyclophosphamide|cyclophosphamide|mesh-list
25007444|NCT03531736|Fludarabine|fludarabine|mesh-list
24790387|NCT01942291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24790388|NCT01942291|Antimetabolites|antimetabolites|mesh-ancestor
25007445|NCT03531736|Rituximab|rituximab|mesh-list
25242443|NCT04414761|Ganirelix|ganirelix|mesh-list
25242444|NCT04414761|Progestins|progestins|mesh-ancestor
25242445|NCT04414761|Hormones|hormones|mesh-ancestor
25405938|NCT03587584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242446|NCT04414761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25242447|NCT04414761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642427|NCT01179412|Iodine|iodine|mesh-list
25007446|NCT03531736|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25007447|NCT03531736|Thymoglobulin|thymoglobulin|mesh-list
25007448|NCT03531736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25007449|NCT03531736|Immunologic Factors|immunologic factors|mesh-ancestor
25007450|NCT03531736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007451|NCT03531736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25007452|NCT03531736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25007453|NCT03531736|Alkylating Agents|alkylating agents|mesh-ancestor
24431853|NCT00253136|Serotonin Agents|serotonin agents|mesh-ancestor
24431903|NCT00253201|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24431904|NCT00253201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431927|NCT00253227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431929|NCT00253227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431930|NCT00253227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431931|NCT00253227|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24431932|NCT00253227|Autonomic Agents|autonomic agents|mesh-ancestor
24431933|NCT00253227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24431934|NCT00253227|Nootropic Agents|nootropic agents|mesh-ancestor
24431935|NCT00253266|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24431936|NCT00253266|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24431937|NCT00253266|Antidepressive Agents|antidepressive agents|mesh-ancestor
24431938|NCT00253266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24431939|NCT00253266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24431940|NCT00253266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24431941|NCT00253266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24431942|NCT00253266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507834|NCT00552656|Antifungal Agents|antifungal agents|mesh-ancestor
24432023|NCT00253474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432087|NCT00253552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432089|NCT00253552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24432090|NCT00253552|Alkylating Agents|alkylating agents|mesh-ancestor
24432091|NCT00253552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432092|NCT00253552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432354|NCT00254553|Androgens|androgens|mesh-ancestor
24432198|NCT00253955|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24432200|NCT00253955|Renal Agents|renal agents|mesh-ancestor
24432201|NCT00253955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24432202|NCT00253955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24432203|NCT00253955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24432258|NCT00254137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432259|NCT00254137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432292|NCT00254241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432293|NCT00254241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432295|NCT00254241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24432296|NCT00254241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24776817|NCT01860066|Hormones|hormones|mesh-ancestor
24432297|NCT00254241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24432298|NCT00254241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24432299|NCT00254241|Dopamine Agents|dopamine agents|mesh-ancestor
24432300|NCT00254241|Antidepressive Agents|antidepressive agents|mesh-ancestor
24432301|NCT00254254|Exenatide|exenatide|mesh-list
24432325|NCT00254371|Androgens|androgens|mesh-list
24790429|NCT01942382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24790430|NCT01942382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790431|NCT01942382|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24790432|NCT01942382|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24790433|NCT01942382|Dopamine Agents|dopamine agents|mesh-ancestor
24432332|NCT00254449|Antipruritics|antipruritics|mesh-ancestor
24432333|NCT00254449|Dermatologic Agents|dermatologic agents|mesh-ancestor
24432334|NCT00254449|Sensory System Agents|sensory system agents|mesh-ancestor
24460269|NCT00347867|Urological Agents|urological agents|mesh-ancestor
25242448|NCT04414761|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25242449|NCT04414761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25242450|NCT04414761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25242451|NCT04414761|Contraceptive Agents|contraceptive agents|mesh-ancestor
24432390|NCT00254709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24432391|NCT00254709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432393|NCT00254709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24432394|NCT00254709|Immunologic Factors|immunologic factors|mesh-ancestor
24432395|NCT00254709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432396|NCT00254735|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24432397|NCT00254735|Clomipramine|clomipramine|mesh-list
24432687|NCT00255710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24432688|NCT00255710|Immunologic Factors|immunologic factors|mesh-ancestor
24432689|NCT00255710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432690|NCT00255710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24432691|NCT00255710|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24432692|NCT00255710|Alkylating Agents|alkylating agents|mesh-ancestor
24460278|NCT00347984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24433298|NCT00258089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24433299|NCT00258102|Levofloxacin|levofloxacin|mesh-list
24433300|NCT00258102|Ofloxacin|ofloxacin|mesh-list
24433301|NCT00258102|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24433302|NCT00258102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24433303|NCT00258102|Renal Agents|renal agents|mesh-ancestor
24433304|NCT00258102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24433305|NCT00258102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24433306|NCT00258102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24433617|NCT00259220|Erythromycin stearate|erythromycin stearate|mesh-list
24433618|NCT00259220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24433619|NCT00259220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24433620|NCT00259220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24433621|NCT00259220|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24433622|NCT00259220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433779|NCT00259883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24433780|NCT00259883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433782|NCT00259896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24433783|NCT00259896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433784|NCT00259896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24433785|NCT00259896|Incretins|incretins|mesh-ancestor
24433818|NCT00260143|Methyltestosterone|methyltestosterone|mesh-list
24433819|NCT00260143|Testosterone|testosterone|mesh-list
24433820|NCT00260143|Testosterone undecanoate|testosterone undecanoate|mesh-list
24433821|NCT00260143|Testosterone enanthate|testosterone enanthate|mesh-list
24435101|NCT00265031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435103|NCT00265031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24435104|NCT00265031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24435105|NCT00265031|Glucocorticoids|glucocorticoids|mesh-ancestor
24435125|NCT00265252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25242452|NCT04414761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25242453|NCT04414761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25242454|NCT04414761|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25242455|NCT04414761|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25242456|NCT04414761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24435164|NCT00265304|Sensory System Agents|sensory system agents|mesh-ancestor
24435165|NCT00265304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24435166|NCT00265304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435201|NCT00265486|Epoetin Alfa|epoetin alfa|mesh-list
24435202|NCT00265486|Hematinics|hematinics|mesh-ancestor
24435203|NCT00265551|Olanzapine|olanzapine|mesh-list
24435204|NCT00265551|Antiemetics|antiemetics|mesh-ancestor
24435205|NCT00265551|Autonomic Agents|autonomic agents|mesh-ancestor
24435206|NCT00265551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24435243|NCT00265733|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
24425060|NCT00231855|Docetaxel|docetaxel|mesh-list
24508060|NCT00554125|Antifungal Agents|antifungal agents|mesh-ancestor
24435740|NCT00267917|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24435741|NCT00267917|Cholinergic Agents|cholinergic agents|mesh-ancestor
24435742|NCT00267943|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24435743|NCT00267943|Telmisartan|telmisartan|mesh-list
24435744|NCT00267943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24435745|NCT00267943|Diuretics|diuretics|mesh-ancestor
24435746|NCT00267943|Natriuretic Agents|natriuretic agents|mesh-ancestor
24435747|NCT00267943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776994|NCT01861015|Epinephrine|epinephrine|mesh-list
24435748|NCT00267943|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24435749|NCT00267943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24435750|NCT00267943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435751|NCT00267943|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24435752|NCT00267943|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24435753|NCT00268138|Fluorides|fluorides|mesh-list
24435754|NCT00268138|Cariostatic Agents|cariostatic agents|mesh-ancestor
24435755|NCT00268138|Protective Agents|protective agents|mesh-ancestor
24435756|NCT00268138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435995|NCT00268619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24435996|NCT00268632|Risedronic Acid|risedronic acid|mesh-list
24435997|NCT00268632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24435998|NCT00268632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24436024|NCT00268697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436027|NCT00268710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24436028|NCT00268710|Tubulin Modulators|tubulin modulators|mesh-ancestor
24436282|NCT00269620|Estrogens|estrogens|mesh-ancestor
24460472|NCT00348452|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24508131|NCT00554242|Vitamins|vitamins|mesh-ancestor
24436783|NCT00271349|Respiratory System Agents|respiratory system agents|mesh-ancestor
25242457|NCT04414761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242458|NCT04414761|Hormone Antagonists|hormone antagonists|mesh-ancestor
25242459|NCT04414761|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25242460|NCT04414761|Fertility Agents|fertility agents|mesh-ancestor
25242461|NCT04414748|Cetrorelix|cetrorelix|mesh-list
25242462|NCT04414748|Dydrogesterone|dydrogesterone|mesh-list
25242463|NCT04414748|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25242464|NCT04414748|Fertility Agents|fertility agents|mesh-ancestor
24851526|NCT02256956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24851529|NCT02257008|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24436784|NCT00271349|Glucocorticoids|glucocorticoids|mesh-ancestor
24436786|NCT00271349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24436788|NCT00271401|Anticoagulants|anticoagulants|mesh-ancestor
24436789|NCT00271401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24436790|NCT00271401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24436791|NCT00271401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436792|NCT00271414|Fentanyl|fentanyl|mesh-list
24436793|NCT00271414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24436794|NCT00271414|Narcotics|narcotics|mesh-ancestor
24436795|NCT00271414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24436796|NCT00271414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436797|NCT00271414|Analgesics|analgesics|mesh-ancestor
24436798|NCT00271414|Sensory System Agents|sensory system agents|mesh-ancestor
24436799|NCT00271414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24436800|NCT00271414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24436801|NCT00271414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24436802|NCT00271414|Anesthetics, General|anesthetics, general|mesh-ancestor
24436803|NCT00271414|Anesthetics|anesthetics|mesh-ancestor
24436804|NCT00271427|Selenium|selenium|mesh-list
24436805|NCT00271427|Antioxidants|antioxidants|mesh-ancestor
24436889|NCT00271973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24436890|NCT00271973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436892|NCT00271973|Sensory System Agents|sensory system agents|mesh-ancestor
24436893|NCT00271973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24436894|NCT00272012|Insulin glulisine|insulin glulisine|mesh-list
24436895|NCT00272012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24436896|NCT00272012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436897|NCT00272025|Citalopram|citalopram|mesh-list
24436898|NCT00272025|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24436899|NCT00272025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24437005|NCT00272454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437006|NCT00272454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24437007|NCT00272454|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24437008|NCT00272454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24437009|NCT00272454|Antipyretics|antipyretics|mesh-ancestor
24437010|NCT00272454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24437011|NCT00272454|Autonomic Agents|autonomic agents|mesh-ancestor
24437012|NCT00272454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24437013|NCT00272454|Respiratory System Agents|respiratory system agents|mesh-ancestor
24437014|NCT00272454|Vasodilator Agents|vasodilator agents|mesh-ancestor
24437015|NCT00272454|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24437054|NCT00272584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24437055|NCT00272584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437083|NCT00272636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24437084|NCT00272636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242468|NCT04414748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25242469|NCT04414748|Progestins|progestins|mesh-ancestor
25242470|NCT04414748|Hormones|hormones|mesh-ancestor
25242471|NCT04394182|Ritonavir|ritonavir|mesh-list
25242472|NCT04394182|Lopinavir|lopinavir|mesh-list
25242473|NCT04394182|Azithromycin|azithromycin|mesh-list
25242474|NCT04394182|Hydroxychloroquine|hydroxychloroquine|mesh-list
25242475|NCT04394182|Tazobactam|tazobactam|mesh-list
25242476|NCT04394182|Piperacillin|piperacillin|mesh-list
25242477|NCT04394182|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25242478|NCT04394182|Heparin|heparin|mesh-list
25242479|NCT04394182|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25242480|NCT04394182|Tinzaparin|tinzaparin|mesh-list
25242481|NCT04394182|Dalteparin|dalteparin|mesh-list
25242482|NCT04394182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24437087|NCT00272636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24437088|NCT00272636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24437113|NCT00272714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24437114|NCT00272714|Hormone Antagonists|hormone antagonists|mesh-ancestor
24437115|NCT00272714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25081568|NCT03328936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24437116|NCT00272714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437117|NCT00272714|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24437118|NCT00272714|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24437119|NCT00272740|Fulvestrant|fulvestrant|mesh-list
24437120|NCT00272740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24437121|NCT00272740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24437122|NCT00272740|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24437124|NCT00272740|Hormone Antagonists|hormone antagonists|mesh-ancestor
24437125|NCT00272740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24437126|NCT00272740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437127|NCT00272753|Budesonide|budesonide|mesh-list
24437128|NCT00272753|Albuterol|albuterol|mesh-list
24437129|NCT00272753|Formoterol Fumarate|formoterol fumarate|mesh-list
24437215|NCT00273013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437216|NCT00273013|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24460345|NCT00348244|Ketorolac|ketorolac|mesh-list
24460346|NCT00348244|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24460347|NCT00348244|Prednisolone phosphate|prednisolone phosphate|mesh-list
24421413|NCT00218569|Naltrexone|naltrexone|mesh-list
24437217|NCT00273013|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24437218|NCT00273013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437219|NCT00273026|Fluticasone|fluticasone|mesh-list
24437250|NCT00273039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24437621|NCT00274066|Ipratropium|ipratropium|mesh-list
24437622|NCT00274066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24437623|NCT00274066|Autonomic Agents|autonomic agents|mesh-ancestor
24437624|NCT00274066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24437625|NCT00274066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437626|NCT00274066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24437690|NCT00274144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24460348|NCT00348244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24460349|NCT00348244|Glucocorticoids|glucocorticoids|mesh-ancestor
24460350|NCT00348244|Hormones|hormones|mesh-ancestor
24460351|NCT00348244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24460352|NCT00348244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421483|NCT00219310|Famciclovir|famciclovir|mesh-list
24437691|NCT00274144|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24437692|NCT00274144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24437693|NCT00274144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437694|NCT00274170|Octreotide|octreotide|mesh-list
24437695|NCT00274170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24437696|NCT00274170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25242483|NCT04394182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25242484|NCT04394182|Protease Inhibitors|protease inhibitors|mesh-ancestor
25242485|NCT04394182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25242486|NCT04394182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242487|NCT04394182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25242488|NCT04394182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25242489|NCT04394182|Antiviral Agents|antiviral agents|mesh-ancestor
24437701|NCT00274235|Mefloquine|mefloquine|mesh-list
24437702|NCT00274235|Antimalarials|antimalarials|mesh-ancestor
24437703|NCT00274235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24437801|NCT00274521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437802|NCT00274521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24437803|NCT00274521|Respiratory System Agents|respiratory system agents|mesh-ancestor
24437804|NCT00274521|Parasympatholytics|parasympatholytics|mesh-ancestor
24437805|NCT00274521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24437806|NCT00274521|Cholinergic Agents|cholinergic agents|mesh-ancestor
24437807|NCT00274521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24437808|NCT00274521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437810|NCT00274534|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24437811|NCT00274534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24437812|NCT00274534|Autonomic Agents|autonomic agents|mesh-ancestor
24437813|NCT00274534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24438549|NCT00276133|Antioxidants|antioxidants|mesh-ancestor
24437888|NCT00274612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24437889|NCT00274638|Losartan|losartan|mesh-list
24437890|NCT00274638|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24437891|NCT00274638|Telmisartan|telmisartan|mesh-list
24437892|NCT00274638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24437893|NCT00274638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24437894|NCT00274638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24437895|NCT00274638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24437896|NCT00274638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242490|NCT04394182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25242491|NCT04394182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25242492|NCT04394182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25242493|NCT04394182|Anticoagulants|anticoagulants|mesh-ancestor
25242494|NCT04394182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25242495|NCT04394182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25242496|NCT04394182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25242497|NCT04394182|Antimalarials|antimalarials|mesh-ancestor
25242498|NCT04394182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24460353|NCT00348244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24437898|NCT00274638|Natriuretic Agents|natriuretic agents|mesh-ancestor
24437899|NCT00274638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437900|NCT00274638|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24438417|NCT00275912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24438418|NCT00275912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24438419|NCT00275912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24438420|NCT00275912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438421|NCT00275912|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24438425|NCT00275925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24438427|NCT00275925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24438428|NCT00275925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438429|NCT00275925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24438430|NCT00275925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24438448|NCT00276003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24438449|NCT00276003|Antimetabolites|antimetabolites|mesh-ancestor
24438450|NCT00276003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438451|NCT00276003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438453|NCT00276003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24438454|NCT00276003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438455|NCT00276003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24438456|NCT00276003|Immunologic Factors|immunologic factors|mesh-ancestor
24438457|NCT00276003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438458|NCT00276003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24438483|NCT00276055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24438542|NCT00276133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24438543|NCT00276133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24438544|NCT00276133|Antimetabolites|antimetabolites|mesh-ancestor
24438545|NCT00276133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438546|NCT00276133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24438547|NCT00276133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24438548|NCT00276133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438551|NCT00276133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438552|NCT00276146|Dipyridamole|dipyridamole|mesh-list
24438553|NCT00276146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24438554|NCT00276146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438555|NCT00276146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438708|NCT00276679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24438709|NCT00276679|Alkylating Agents|alkylating agents|mesh-ancestor
24790439|NCT01942460|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24790440|NCT01942460|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24790442|NCT01942551|Dutasteride|dutasteride|mesh-list
24790443|NCT01942551|Vasodilator Agents|vasodilator agents|mesh-ancestor
24790444|NCT01942551|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25242499|NCT04394182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25242500|NCT04394182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25242501|NCT04394182|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25242502|NCT04388319|Zonisamide|zonisamide|mesh-list
25242503|NCT04388319|Bupropion|bupropion|mesh-list
25242504|NCT04388319|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25242505|NCT04388319|Antidepressive Agents|antidepressive agents|mesh-ancestor
25242506|NCT04388319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24790445|NCT01942551|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24790446|NCT01942551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24790447|NCT01942551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790448|NCT01942551|Urological Agents|urological agents|mesh-ancestor
24790449|NCT01942551|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24790450|NCT01942551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24790454|NCT01942577|Protective Agents|protective agents|mesh-list
24438739|NCT00276705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24438740|NCT00276705|Growth Substances|growth substances|mesh-ancestor
24438741|NCT00276705|Growth Inhibitors|growth inhibitors|mesh-ancestor
24438742|NCT00276718|Carboplatin|carboplatin|mesh-list
24438743|NCT00276718|Etoposide|etoposide|mesh-list
24438744|NCT00276718|Bleomycin|bleomycin|mesh-list
24438745|NCT00276718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438746|NCT00276718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24438747|NCT00276718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24438748|NCT00276718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24438749|NCT00276718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438750|NCT00276718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438751|NCT00276718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24438752|NCT00276731|Cyclophosphamide|cyclophosphamide|mesh-list
24438753|NCT00276731|Carboplatin|carboplatin|mesh-list
24438754|NCT00276731|Etoposide|etoposide|mesh-list
24438755|NCT00276731|Vincristine|vincristine|mesh-list
24438756|NCT00276731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24438757|NCT00276731|Immunologic Factors|immunologic factors|mesh-ancestor
24438758|NCT00276731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438759|NCT00276731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24438760|NCT00276731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24438761|NCT00276731|Alkylating Agents|alkylating agents|mesh-ancestor
24438794|NCT00276757|Antidotes|antidotes|mesh-ancestor
25007492|NCT03498014|Analgesics|analgesics|mesh-ancestor
24884419|NCT00586391|Ipilimumab|ipilimumab|mesh-list
24438795|NCT00276757|Protective Agents|protective agents|mesh-ancestor
24438796|NCT00276757|Vitamin B Complex|vitamin b complex|mesh-ancestor
24438797|NCT00276757|Vitamins|vitamins|mesh-ancestor
24438798|NCT00276757|Micronutrients|micronutrients|mesh-ancestor
24434381|NCT00262379|Epoetin Alfa|epoetin alfa|mesh-list
24438844|NCT00276809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438846|NCT00276809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24438847|NCT00276809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24438849|NCT00276809|Autonomic Agents|autonomic agents|mesh-ancestor
24438850|NCT00276809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24438851|NCT00276809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24438852|NCT00276809|Glucocorticoids|glucocorticoids|mesh-ancestor
24438853|NCT00276809|Hormones|hormones|mesh-ancestor
24438854|NCT00276809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24438861|NCT00276809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438862|NCT00276809|Antiviral Agents|antiviral agents|mesh-ancestor
24438863|NCT00276809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24438864|NCT00276809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24438866|NCT00276835|Interleukin-2|interleukin-2|mesh-list
24438867|NCT00276835|Genistein|genistein|mesh-list
24438868|NCT00276835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438869|NCT00276835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24438870|NCT00276835|Analgesics|analgesics|mesh-ancestor
24438880|NCT00276835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25242507|NCT04388319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25242508|NCT04388319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25242509|NCT04388319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25242510|NCT04388319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242511|NCT04388319|Dopamine Agents|dopamine agents|mesh-ancestor
25242512|NCT04388319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24438882|NCT00276835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438883|NCT00276835|Phytoestrogens|phytoestrogens|mesh-ancestor
24438916|NCT00276874|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24438917|NCT00276874|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24438919|NCT00276874|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24438920|NCT00276874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24438921|NCT00276874|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24438922|NCT00276874|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24438924|NCT00276900|Antidepressive Agents|antidepressive agents|mesh-ancestor
24438925|NCT00276900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24438926|NCT00276900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24438991|NCT00277043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438992|NCT00277043|Tubulin Modulators|tubulin modulators|mesh-ancestor
24438993|NCT00277043|Antimitotic Agents|antimitotic agents|mesh-ancestor
24438994|NCT00277043|Mitosis Modulators|mitosis modulators|mesh-ancestor
24438995|NCT00277043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438996|NCT00277069|Carboplatin|carboplatin|mesh-list
24438997|NCT00277069|Capecitabine|capecitabine|mesh-list
24438998|NCT00277069|Vinorelbine|vinorelbine|mesh-list
24438999|NCT00277069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439000|NCT00277069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24439001|NCT00277069|Antimetabolites|antimetabolites|mesh-ancestor
24439002|NCT00277069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439003|NCT00277069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24439004|NCT00277069|Tubulin Modulators|tubulin modulators|mesh-ancestor
24439012|NCT00277082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24439014|NCT00277108|Citalopram|citalopram|mesh-list
24439027|NCT00277199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439092|NCT00277511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439093|NCT00277511|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24439094|NCT00277511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24439096|NCT00277537|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24439097|NCT00277537|Diuretics|diuretics|mesh-ancestor
24439098|NCT00277537|Natriuretic Agents|natriuretic agents|mesh-ancestor
24439099|NCT00277537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439100|NCT00277550|Tegaserod|tegaserod|mesh-list
24439126|NCT00277641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24460378|NCT00348322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24460379|NCT00348335|Cyclosporine|cyclosporine|mesh-list
24460380|NCT00348335|Cyclosporins|cyclosporins|mesh-list
24439127|NCT00277641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439238|NCT00278187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24439239|NCT00278187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24439240|NCT00278187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439241|NCT00278187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24460381|NCT00348335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462853|NCT00357682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24439242|NCT00278187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24439243|NCT00278187|Growth Substances|growth substances|mesh-ancestor
24439362|NCT00278382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25007500|NCT03458247|Hormone Antagonists|hormone antagonists|mesh-ancestor
24439396|NCT00278421|Doxorubicin|doxorubicin|mesh-list
24439637|NCT00279578|Tranexamic Acid|tranexamic acid|mesh-list
24439638|NCT00279578|Factor VIII|factor viii|mesh-list
24439673|NCT00279760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439706|NCT00280007|Bevacizumab|bevacizumab|mesh-list
24434912|NCT00264251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439807|NCT00280423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439809|NCT00280436|Antiemetics|antiemetics|mesh-ancestor
24439810|NCT00280436|Autonomic Agents|autonomic agents|mesh-ancestor
24439811|NCT00280436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24439812|NCT00280436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439813|NCT00280436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24439814|NCT00280436|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24439815|NCT00280436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24439816|NCT00280436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439838|NCT00280501|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24439839|NCT00280514|Moxifloxacin|moxifloxacin|mesh-list
24439840|NCT00280514|Cefpirome|cefpirome|mesh-list
24439898|NCT00280787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24439899|NCT00280787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460394|NCT00348361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24460395|NCT00348361|Autonomic Agents|autonomic agents|mesh-ancestor
24460396|NCT00348361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24777410|NCT01863823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460397|NCT00348361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439900|NCT00280787|Tubulin Modulators|tubulin modulators|mesh-ancestor
24439901|NCT00280787|Antimitotic Agents|antimitotic agents|mesh-ancestor
25242520|NCT04377503|Methylprednisolone|methylprednisolone|mesh-list
25242521|NCT04377503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25242522|NCT04377503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25242524|NCT04377503|Prednisolone acetate|prednisolone acetate|mesh-list
25242525|NCT04377503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25242526|NCT04377503|Prednisolone phosphate|prednisolone phosphate|mesh-list
25242527|NCT04377503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25242528|NCT04377503|Antiemetics|antiemetics|mesh-ancestor
25242529|NCT04377503|Autonomic Agents|autonomic agents|mesh-ancestor
25242595|NCT04256018|Mogamulizumab|mogamulizumab|mesh-list
24439996|NCT00281255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24439997|NCT00281255|Gout Suppressants|gout suppressants|mesh-ancestor
24439998|NCT00281255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24439999|NCT00281255|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24440000|NCT00281255|Antioxidants|antioxidants|mesh-ancestor
24440001|NCT00281255|Protective Agents|protective agents|mesh-ancestor
24440002|NCT00281255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440003|NCT00281255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24440004|NCT00281255|Sympathomimetics|sympathomimetics|mesh-ancestor
24440005|NCT00281255|Autonomic Agents|autonomic agents|mesh-ancestor
24440006|NCT00281255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24440007|NCT00281255|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24440008|NCT00281255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24440009|NCT00281255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24440010|NCT00281255|Adrenergic Agents|adrenergic agents|mesh-ancestor
24440047|NCT00281567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440048|NCT00281567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24440173|NCT00281931|Alkylating Agents|alkylating agents|mesh-ancestor
24440440|NCT00283114|Lintuzumab|lintuzumab|mesh-list
24440441|NCT00283114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24440442|NCT00283114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440443|NCT00283179|Risperidone|risperidone|mesh-list
24440444|NCT00283179|Aripiprazole|aripiprazole|mesh-list
24460402|NCT00348387|Vaccines|vaccines|mesh-list
24460403|NCT00348387|Immunologic Factors|immunologic factors|mesh-ancestor
24440445|NCT00283179|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24440621|NCT00283985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440622|NCT00283985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24440623|NCT00283985|Abortifacient Agents|abortifacient agents|mesh-ancestor
24440624|NCT00283985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24440625|NCT00283985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24440626|NCT00283985|Antimetabolites|antimetabolites|mesh-ancestor
24440627|NCT00283985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440628|NCT00283985|Dermatologic Agents|dermatologic agents|mesh-ancestor
24440629|NCT00283985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24440630|NCT00283985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24440631|NCT00283985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24440632|NCT00283985|Immunologic Factors|immunologic factors|mesh-ancestor
24440840|NCT00284973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440841|NCT00285051|Ondansetron|ondansetron|mesh-list
24440842|NCT00285051|Antiemetics|antiemetics|mesh-ancestor
24440843|NCT00285051|Autonomic Agents|autonomic agents|mesh-ancestor
24440844|NCT00285051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24440845|NCT00285051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460410|NCT00348400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24460411|NCT00348400|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24460412|NCT00348400|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24460413|NCT00348400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25242530|NCT04377503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25242531|NCT04377503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242532|NCT04377503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25242533|NCT04377503|Glucocorticoids|glucocorticoids|mesh-ancestor
25242534|NCT04377503|Hormones|hormones|mesh-ancestor
25242535|NCT04377503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25242536|NCT04377503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25242537|NCT04377503|Protective Agents|protective agents|mesh-ancestor
25242538|NCT04377503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24956860|NCT03849833|Vitamin D|vitamin d|mesh-list
24460414|NCT00348400|Adrenergic Agents|adrenergic agents|mesh-ancestor
24460415|NCT00348400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24440920|NCT00285376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24441058|NCT00285883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441059|NCT00285883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24441129|NCT00286143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441130|NCT00286143|Analgesics|analgesics|mesh-ancestor
24441131|NCT00286143|Sensory System Agents|sensory system agents|mesh-ancestor
24441132|NCT00286143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24441133|NCT00286143|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24441134|NCT00286143|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24441135|NCT00286143|Anesthetics, General|anesthetics, general|mesh-ancestor
24441286|NCT00286962|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24441287|NCT00286962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24441288|NCT00286962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441290|NCT00286988|Anticonvulsants|anticonvulsants|mesh-ancestor
24441291|NCT00286988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24441292|NCT00286988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441293|NCT00287027|Antipsychotic Agents|antipsychotic agents|mesh-list
24441294|NCT00287027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441295|NCT00287027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24441296|NCT00287027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24441297|NCT00287027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24441298|NCT00287066|Insulin|insulin|mesh-list
24441299|NCT00287066|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24441300|NCT00287066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24441301|NCT00287066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441302|NCT00287105|Imatinib Mesylate|imatinib mesylate|mesh-list
24441303|NCT00287105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441316|NCT00287157|Autonomic Agents|autonomic agents|mesh-ancestor
24441415|NCT00287352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24441423|NCT00287352|Serotonin Agents|serotonin agents|mesh-ancestor
24441722|NCT00288184|Antimetabolites|antimetabolites|mesh-ancestor
24441723|NCT00288184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441724|NCT00288184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441725|NCT00288184|Gout Suppressants|gout suppressants|mesh-ancestor
24441726|NCT00288184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24441727|NCT00288184|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24441728|NCT00288184|Antioxidants|antioxidants|mesh-ancestor
24441729|NCT00288184|Protective Agents|protective agents|mesh-ancestor
24441834|NCT00288483|Antimetabolites|antimetabolites|mesh-ancestor
24441835|NCT00288483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423457|NCT00226096|Metoprolol|metoprolol|mesh-list
24441836|NCT00288483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24441837|NCT00288483|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24441838|NCT00288522|Lanreotide|lanreotide|mesh-list
24441839|NCT00288522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441840|NCT00288535|Sirolimus|sirolimus|mesh-list
24441841|NCT00288535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24441842|NCT00288535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24441843|NCT00288535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24441844|NCT00288535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441845|NCT00288535|Antifungal Agents|antifungal agents|mesh-ancestor
24441846|NCT00288535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24441847|NCT00288535|Immunologic Factors|immunologic factors|mesh-ancestor
24441848|NCT00288535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441849|NCT00288548|Metoprolol|metoprolol|mesh-list
24441850|NCT00288548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25242539|NCT04377503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242540|NCT04360473|Magnesium Sulfate|magnesium sulfate|mesh-list
25242541|NCT04360473|Ketamine|ketamine|mesh-list
25242542|NCT04360473|Anesthetics|anesthetics|mesh-list
25242543|NCT04360473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25242544|NCT04360473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081636|NCT03328312|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24444857|NCT00299377|Anticoagulants|anticoagulants|mesh-ancestor
24495675|NCT00501579|Prednisolone|prednisolone|mesh-list
24441851|NCT00288548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24441884|NCT00288717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441886|NCT00288730|Natriuretic Agents|natriuretic agents|mesh-ancestor
24441887|NCT00288730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441888|NCT00288743|Insulin|insulin|mesh-list
24441889|NCT00288743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24441920|NCT00288873|Ergocalciferols|ergocalciferols|mesh-list
24703125|NCT01469884|Cyclosporins|cyclosporins|mesh-list
24441932|NCT00289042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441934|NCT00289250|Pyrimethamine|pyrimethamine|mesh-list
24441935|NCT00289250|Sulfadoxine|sulfadoxine|mesh-list
24441936|NCT00289250|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24441937|NCT00289250|Antimalarials|antimalarials|mesh-ancestor
24441938|NCT00289250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24441939|NCT00289250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24441940|NCT00289250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24441941|NCT00289250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441994|NCT00289419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25242545|NCT04360473|Analgesics|analgesics|mesh-ancestor
25242546|NCT04360473|Sensory System Agents|sensory system agents|mesh-ancestor
25686465|NCT01920555|Anesthetics, General|anesthetics, general|mesh-ancestor
25686466|NCT01920555|Anesthetics|anesthetics|mesh-ancestor
25686467|NCT01920555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25686468|NCT01920555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25686469|NCT01920555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25686470|NCT01920555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25242547|NCT04360473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25242548|NCT04360473|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25242550|NCT04360473|Anesthetics, General|anesthetics, general|mesh-ancestor
25242551|NCT04360473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25242552|NCT04360473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25242553|NCT04360473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25242554|NCT04360473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242555|NCT04360473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25242556|NCT04360473|Anticonvulsants|anticonvulsants|mesh-ancestor
25242557|NCT04360473|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25242558|NCT04360473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25242559|NCT04360473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25242560|NCT04360473|Tocolytic Agents|tocolytic agents|mesh-ancestor
25242561|NCT04360473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25242562|NCT04360070|Ketamine|ketamine|mesh-list
25242563|NCT04360070|Analgesics|analgesics|mesh-ancestor
25242564|NCT04360070|Sensory System Agents|sensory system agents|mesh-ancestor
25242565|NCT04360070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25242566|NCT04360070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242567|NCT04360070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25242568|NCT04360070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25242569|NCT04360070|Anesthetics, General|anesthetics, general|mesh-ancestor
24441997|NCT00289419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24441998|NCT00289419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441999|NCT00289419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442000|NCT00289419|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24442001|NCT00289419|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25242571|NCT04360070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25242572|NCT04360070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25242573|NCT04360070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25242574|NCT04360070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25242575|NCT04360070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242577|NCT04358549|Antiviral Agents|antiviral agents|mesh-ancestor
25242578|NCT04358549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25274061|NCT02381080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25274062|NCT02381080|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25274063|NCT02381080|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25274064|NCT02381080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274065|NCT02381080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274066|NCT02381080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25274067|NCT02381080|Hormone Antagonists|hormone antagonists|mesh-ancestor
25274068|NCT02381080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25274069|NCT02381080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274070|NCT02381080|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25274071|NCT02381080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25274072|NCT02381080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24777761|NCT01866514|Lidocaine|lidocaine|mesh-list
25274073|NCT02381080|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25274074|NCT02380898|Ketorolac|ketorolac|mesh-list
25274075|NCT02380898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25274076|NCT02380898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25274077|NCT02380898|Analgesics|analgesics|mesh-ancestor
25274078|NCT02380898|Sensory System Agents|sensory system agents|mesh-ancestor
25274079|NCT02380898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25274080|NCT02380898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274081|NCT02380898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25274082|NCT02380898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25007496|NCT03458247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24790459|NCT01942681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24460493|NCT00348504|Dobutamine|dobutamine|mesh-list
24790460|NCT01942681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790461|NCT01942681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24790462|NCT01942681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24790463|NCT01942681|Cholinergic Agents|cholinergic agents|mesh-ancestor
24790464|NCT01942681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24790465|NCT01942681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790466|NCT01942681|Urological Agents|urological agents|mesh-ancestor
25007497|NCT03458247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25007498|NCT03458247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25007499|NCT03458247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007501|NCT03458247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25007502|NCT03458247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007519|NCT03417180|Sensory System Agents|sensory system agents|mesh-ancestor
25007520|NCT03417180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25007523|NCT03342196|Thiotepa|thiotepa|mesh-list
25007524|NCT03342196|Mitogens|mitogens|mesh-list
25007525|NCT03342196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007526|NCT03342196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007527|NCT03342196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25007528|NCT03342196|Immunologic Factors|immunologic factors|mesh-ancestor
25007529|NCT03342196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007530|NCT03342196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25007531|NCT03342196|Alkylating Agents|alkylating agents|mesh-ancestor
25007532|NCT03342196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25242579|NCT04295486|Aspirin|aspirin|mesh-list
25242580|NCT04295486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25242581|NCT04295486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25242582|NCT04295486|Analgesics|analgesics|mesh-ancestor
25242583|NCT04295486|Sensory System Agents|sensory system agents|mesh-ancestor
25242584|NCT04295486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25242585|NCT04295486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242586|NCT04295486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25242587|NCT04295486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25242588|NCT04295486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25242589|NCT04295486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25007533|NCT03342196|Mitosis Modulators|mitosis modulators|mesh-ancestor
25007534|NCT03322566|Pembrolizumab|pembrolizumab|mesh-list
25007535|NCT03322566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25007536|NCT03322566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007537|NCT03322540|Pembrolizumab|pembrolizumab|mesh-list
25007538|NCT03322540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25007539|NCT03322540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007540|NCT03321188|Paclitaxel|paclitaxel|mesh-list
25007541|NCT03321188|Carboplatin|carboplatin|mesh-list
25007542|NCT03321188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25007543|NCT03321188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007544|NCT03321188|Tubulin Modulators|tubulin modulators|mesh-ancestor
25007545|NCT03321188|Antimitotic Agents|antimitotic agents|mesh-ancestor
25007546|NCT03321188|Mitosis Modulators|mitosis modulators|mesh-ancestor
25007547|NCT03321188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007548|NCT03315026|Siltuximab|siltuximab|mesh-list
25007549|NCT03315026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109808|NCT03121807|Antimetabolites|antimetabolites|mesh-ancestor
25109809|NCT03121807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109810|NCT03121807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24442136|NCT00290082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460436|NCT00348413|Dermatologic Agents|dermatologic agents|mesh-ancestor
24460437|NCT00348413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460438|NCT00348413|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24460439|NCT00348413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24460440|NCT00348413|Immunologic Factors|immunologic factors|mesh-ancestor
24442203|NCT00290420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24442208|NCT00290485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442209|NCT00290602|Methylprednisolone|methylprednisolone|mesh-list
25277978|NCT02354547|Topotecan|topotecan|mesh-list
24442210|NCT00290602|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24442211|NCT00290602|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24442213|NCT00290602|Prednisolone acetate|prednisolone acetate|mesh-list
24436196|NCT00269334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24442243|NCT00290628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442244|NCT00290628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442245|NCT00290628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24442246|NCT00290628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442247|NCT00290628|Antifungal Agents|antifungal agents|mesh-ancestor
24442279|NCT00290641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24442280|NCT00290641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24442281|NCT00290641|Antimetabolites|antimetabolites|mesh-ancestor
24442282|NCT00290641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442283|NCT00290641|Antifungal Agents|antifungal agents|mesh-ancestor
24442558|NCT00291616|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24442560|NCT00291616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442561|NCT00291616|Antiviral Agents|antiviral agents|mesh-ancestor
24442562|NCT00291616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24442563|NCT00291616|Immunologic Factors|immunologic factors|mesh-ancestor
24442564|NCT00291616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442588|NCT00291746|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24442589|NCT00291746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25242590|NCT04295486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242591|NCT04295486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25155326|NCT05417113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956972|NCT03848182|Antimetabolites|antimetabolites|mesh-ancestor
24460448|NCT00348413|Glucocorticoids|glucocorticoids|mesh-ancestor
24460449|NCT00348413|Hormones|hormones|mesh-ancestor
24442599|NCT00291759|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24442600|NCT00291759|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24442659|NCT00291915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24442660|NCT00291915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24442661|NCT00291915|Immunologic Factors|immunologic factors|mesh-ancestor
24442662|NCT00291915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24442663|NCT00291915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24442664|NCT00291915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24442665|NCT00291980|Vaccines|vaccines|mesh-list
24442666|NCT00291980|Immunologic Factors|immunologic factors|mesh-ancestor
24442670|NCT00292071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24442671|NCT00292071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442672|NCT00292071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442674|NCT00292110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24442675|NCT00292110|Narcotics|narcotics|mesh-ancestor
24442676|NCT00292110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24436390|NCT00269828|Antimitotic Agents|antimitotic agents|mesh-ancestor
24442763|NCT00292526|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24442765|NCT00292526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442766|NCT00292526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436433|NCT00269893|Abciximab|abciximab|mesh-list
24442901|NCT00293163|Protective Agents|protective agents|mesh-ancestor
24442912|NCT00293228|Antitubercular Agents|antitubercular agents|mesh-ancestor
24442913|NCT00293228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24442914|NCT00293228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25242592|NCT04295486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25242593|NCT04295486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25242594|NCT04295486|Antipyretics|antipyretics|mesh-ancestor
25242603|NCT04248335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25242604|NCT04248335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25242605|NCT04248335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25242606|NCT04248335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25242607|NCT04248335|Anesthetics, General|anesthetics, general|mesh-ancestor
25242608|NCT04248335|Anesthetics|anesthetics|mesh-ancestor
24436472|NCT00270075|Epoetin Alfa|epoetin alfa|mesh-list
24442939|NCT00293332|Growth Inhibitors|growth inhibitors|mesh-ancestor
24436613|NCT00270556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24442940|NCT00293332|Tubulin Modulators|tubulin modulators|mesh-ancestor
24460450|NCT00348413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24460451|NCT00348413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24460452|NCT00348413|Protective Agents|protective agents|mesh-ancestor
24424326|NCT00228865|Insulin|insulin|mesh-list
25242609|NCT04248335|GABA Modulators|gaba modulators|mesh-ancestor
25242610|NCT04248335|GABA Agents|gaba agents|mesh-ancestor
25242611|NCT04248335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25242612|NCT04248335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242613|NCT04248335|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25242614|NCT04248335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25242615|NCT04248335|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25242616|NCT04248335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25242617|NCT04232358|Anesthetics|anesthetics|mesh-list
25242618|NCT04232358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25242619|NCT04232358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851564|NCT02257242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24851565|NCT02257242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24851566|NCT02257242|Immunologic Factors|immunologic factors|mesh-ancestor
24851567|NCT02257242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851568|NCT02257242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24851569|NCT02257242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24851570|NCT02257242|Tubulin Modulators|tubulin modulators|mesh-ancestor
24851571|NCT02257242|Antimitotic Agents|antimitotic agents|mesh-ancestor
24812287|NCT02051153|Modafinil|modafinil|mesh-list
24851572|NCT02257242|Mitosis Modulators|mitosis modulators|mesh-ancestor
24859054|NCT02301494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694104|NCT01423864|Prednisolone|prednisolone|mesh-list
24442978|NCT00293371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24442979|NCT00293371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790526|NCT01943422|Interferons|interferons|mesh-list
24790527|NCT01943422|Interferon-alpha|interferon-alpha|mesh-list
24678145|NCT01360034|Indomethacin|indomethacin|mesh-list
24790528|NCT01943422|Interferon alpha-2|interferon alpha-2|mesh-list
24790529|NCT01943422|Vemurafenib|vemurafenib|mesh-list
24790530|NCT01943422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24790531|NCT01943422|Antiviral Agents|antiviral agents|mesh-ancestor
24790532|NCT01943422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25007551|NCT03311308|Pembrolizumab|pembrolizumab|mesh-list
25007552|NCT03311308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25007553|NCT03311308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007554|NCT03311308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25242622|NCT04221828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25242623|NCT04221828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242624|NCT04221828|Tubulin Modulators|tubulin modulators|mesh-ancestor
25242625|NCT04221828|Antimitotic Agents|antimitotic agents|mesh-ancestor
25242626|NCT04221828|Mitosis Modulators|mitosis modulators|mesh-ancestor
25242627|NCT04221828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242628|NCT04221191|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25242629|NCT04221191|Dermatologic Agents|dermatologic agents|mesh-ancestor
25242630|NCT04221191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25242631|NCT04221191|Immunologic Factors|immunologic factors|mesh-ancestor
25242632|NCT04221191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242633|NCT04216953|Atezolizumab|atezolizumab|mesh-list
25242634|NCT04216953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242635|NCT04204343|Bupivacaine|bupivacaine|mesh-list
25242636|NCT04204343|Anesthetics, Local|anesthetics, local|mesh-ancestor
25242637|NCT04204343|Anesthetics|anesthetics|mesh-ancestor
25242638|NCT04204343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25242639|NCT04204343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242640|NCT04204343|Sensory System Agents|sensory system agents|mesh-ancestor
25242641|NCT04204343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25242642|NCT04146922|Anti-Infective Agents|anti-infective agents|mesh-list
25242643|NCT04146922|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25242644|NCT04126538|Pirfenidone|pirfenidone|mesh-list
25007601|NCT03189719|Pembrolizumab|pembrolizumab|mesh-list
24778221|NCT01870011|Propofol|propofol|mesh-list
25007602|NCT03189719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007603|NCT03189719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25007604|NCT03184155|Nicardipine|nicardipine|mesh-list
25007605|NCT03184155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25007606|NCT03184155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25007607|NCT03184155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25007608|NCT03184155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007609|NCT03184155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25278037|NCT02353949|Flutemetamol|flutemetamol|mesh-list
25007610|NCT03184155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007611|NCT03184155|Vasodilator Agents|vasodilator agents|mesh-ancestor
25007612|NCT03161912|Aflibercept|aflibercept|mesh-list
24678338|NCT01361373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460460|NCT00348439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24438635|NCT00276575|Growth Inhibitors|growth inhibitors|mesh-ancestor
25007613|NCT03161912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25242645|NCT04126538|Analgesics|analgesics|mesh-ancestor
25242646|NCT04126538|Sensory System Agents|sensory system agents|mesh-ancestor
25242647|NCT04126538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25242648|NCT04126538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242649|NCT04126538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25242650|NCT04126538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25242651|NCT04126538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25242652|NCT04126538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25242653|NCT04126538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24443037|NCT00293475|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24443039|NCT00293475|Natriuretic Agents|natriuretic agents|mesh-ancestor
24443040|NCT00293475|Protective Agents|protective agents|mesh-ancestor
24443041|NCT00293475|Antioxidants|antioxidants|mesh-ancestor
24443042|NCT00293475|Antitubercular Agents|antitubercular agents|mesh-ancestor
24443043|NCT00293475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24443044|NCT00293475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24443045|NCT00293475|Chelating Agents|chelating agents|mesh-ancestor
24443046|NCT00293475|Sequestering Agents|sequestering agents|mesh-ancestor
24790612|NCT01943942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583170|NCT00873509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24443362|NCT00294606|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25686471|NCT01920555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686472|NCT01920555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25686473|NCT01920555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25686474|NCT01920555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25686475|NCT01920555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25686476|NCT01920555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25686477|NCT01920555|GABA Modulators|gaba modulators|mesh-ancestor
25686478|NCT01920555|GABA Agents|gaba agents|mesh-ancestor
25686479|NCT01920568|Vitamin D|vitamin d|mesh-list
24443363|NCT00294606|Mydriatics|mydriatics|mesh-ancestor
24443364|NCT00294606|Autonomic Agents|autonomic agents|mesh-ancestor
24443365|NCT00294606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24443366|NCT00294606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443367|NCT00294606|Sympathomimetics|sympathomimetics|mesh-ancestor
24443368|NCT00294606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24443369|NCT00294606|Nasal Decongestants|nasal decongestants|mesh-ancestor
25242654|NCT04124601|Nivolumab|nivolumab|mesh-list
25242655|NCT04124601|Ipilimumab|ipilimumab|mesh-list
25242656|NCT04124601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25155327|NCT05417113|Sensory System Agents|sensory system agents|mesh-ancestor
25007648|NCT03072043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460514|NCT00348517|Laxatives|laxatives|mesh-ancestor
24426712|NCT00236535|Acetaminophen|acetaminophen|mesh-list
24460555|NCT00348725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460556|NCT00348725|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24460557|NCT00348738|Epoetin Alfa|epoetin alfa|mesh-list
24460558|NCT00348738|Hematinics|hematinics|mesh-ancestor
25007649|NCT03072043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25007650|NCT03016013|Methotrexate|methotrexate|mesh-list
25007651|NCT03016013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25007652|NCT03016013|Abortifacient Agents|abortifacient agents|mesh-ancestor
25007653|NCT03016013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25007654|NCT03016013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007655|NCT03016013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25007656|NCT03016013|Antimetabolites|antimetabolites|mesh-ancestor
25007658|NCT03016013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007673|NCT03015324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24460570|NCT00348894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24460571|NCT00348894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460572|NCT00348920|Bupivacaine|bupivacaine|mesh-list
24460573|NCT00348920|Anesthetics, Local|anesthetics, local|mesh-ancestor
24460574|NCT00348920|Anesthetics|anesthetics|mesh-ancestor
25242657|NCT04124601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242658|NCT04124601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25242659|NCT04124601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242660|NCT04118010|Vitamin D|vitamin d|mesh-list
25242661|NCT04118010|Ergocalciferols|ergocalciferols|mesh-list
25242662|NCT04118010|Cholecalciferol|cholecalciferol|mesh-list
25242663|NCT04118010|Vitamins|vitamins|mesh-list
25242664|NCT04118010|Micronutrients|micronutrients|mesh-ancestor
25242665|NCT04118010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242666|NCT04118010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24778314|NCT01870219|Ketamine|ketamine|mesh-list
25242667|NCT04118010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25242668|NCT04086212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25242669|NCT04086212|Icodextrin|icodextrin|mesh-list
25242670|NCT04086212|Dialysis Solutions|dialysis solutions|mesh-list
25242671|NCT05361408|Zoledronic Acid|zoledronic acid|mesh-list
25242672|NCT05361408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24851574|NCT02257242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24851575|NCT02257242|Alkylating Agents|alkylating agents|mesh-ancestor
24460575|NCT00348920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24427058|NCT00237263|Entacapone|entacapone|mesh-list
24443477|NCT00295100|Hormone Antagonists|hormone antagonists|mesh-ancestor
24443484|NCT00295100|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24460633|NCT00349115|Immunologic Factors|immunologic factors|mesh-ancestor
24443499|NCT00295243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24621765|NCT01063842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24621766|NCT01063842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621767|NCT01063842|Antipyretics|antipyretics|mesh-ancestor
24621768|NCT01063842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24621769|NCT01063842|Narcotics|narcotics|mesh-ancestor
24621770|NCT01063842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24621772|NCT01063920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24621773|NCT01063920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24621774|NCT01063920|Analgesics|analgesics|mesh-ancestor
24621775|NCT01063920|Sensory System Agents|sensory system agents|mesh-ancestor
24621776|NCT01063920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24621777|NCT01063920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007660|NCT03016013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25007670|NCT03015324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25007671|NCT03015324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25007672|NCT03015324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007686|NCT02909452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25007687|NCT02909452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242673|NCT05361408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778441|NCT01870895|Ramosetron|ramosetron|mesh-list
25242674|NCT05361278|Chlorhexidine|chlorhexidine|mesh-list
25242675|NCT05361278|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25242676|NCT05361278|Sodium Hypochlorite|sodium hypochlorite|mesh-list
25242677|NCT05361278|Eusol|eusol|mesh-list
25242678|NCT05361278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25242679|NCT05361278|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25242680|NCT05361278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25242681|NCT05361278|Disinfectants|disinfectants|mesh-ancestor
25007693|NCT02909036|Alkylating Agents|alkylating agents|mesh-ancestor
25007694|NCT02909036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007695|NCT02909036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007696|NCT02909036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25007705|NCT02898506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24460749|NCT00349401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24439386|NCT00278408|Hormones|hormones|mesh-ancestor
25007709|NCT02880293|Thiotepa|thiotepa|mesh-list
25007710|NCT02880293|Fludarabine|fludarabine|mesh-list
24678929|NCT01365117|Insulin|insulin|mesh-list
24443509|NCT00295308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24443511|NCT00295308|Autonomic Agents|autonomic agents|mesh-ancestor
24443512|NCT00295308|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24443513|NCT00295308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24443514|NCT00295308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24443515|NCT00295308|Adrenergic Agents|adrenergic agents|mesh-ancestor
24443516|NCT00295308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24443517|NCT00295308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443518|NCT00295347|Fludrocortisone|fludrocortisone|mesh-list
24443520|NCT00295347|Citalopram|citalopram|mesh-list
25242682|NCT05361278|Dermatologic Agents|dermatologic agents|mesh-ancestor
25242683|NCT05361057|Cytarabine|cytarabine|mesh-list
25242684|NCT05361057|Azacitidine|azacitidine|mesh-list
25242685|NCT05361057|Daunorubicin|daunorubicin|mesh-list
25242686|NCT05361057|Venetoclax|venetoclax|mesh-list
25242687|NCT05361057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25242688|NCT05361057|Antimetabolites|antimetabolites|mesh-ancestor
25242689|NCT05361057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242690|NCT05361057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242691|NCT05361057|Antiviral Agents|antiviral agents|mesh-ancestor
25242693|NCT05361057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25242694|NCT05361057|Immunologic Factors|immunologic factors|mesh-ancestor
25242695|NCT05361057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242696|NCT05361057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24797610|NCT01956864|Micronutrients|micronutrients|mesh-ancestor
24443521|NCT00295347|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24443522|NCT00295347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24443526|NCT00295347|Serotonin Agents|serotonin agents|mesh-ancestor
25109819|NCT03121807|Micronutrients|micronutrients|mesh-ancestor
25109820|NCT03121521|Melatonin|melatonin|mesh-list
25109821|NCT03121521|Antioxidants|antioxidants|mesh-ancestor
24621799|NCT01064115|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24621800|NCT01064115|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24790630|NCT01944033|Terbutaline|terbutaline|mesh-list
24790631|NCT01944033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24460809|NCT00349557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24460811|NCT00349557|Hormone Antagonists|hormone antagonists|mesh-ancestor
24460812|NCT00349557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24460813|NCT00349583|Cyclosporine|cyclosporine|mesh-list
24460814|NCT00349583|Cyclosporins|cyclosporins|mesh-list
24460815|NCT00349583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460829|NCT00349596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460830|NCT00349596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460873|NCT00349986|Insulin Glargine|insulin glargine|mesh-list
24443559|NCT00295425|Cyclosporins|cyclosporins|mesh-list
24443560|NCT00295425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443561|NCT00295425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443562|NCT00295425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24443563|NCT00295425|Immunologic Factors|immunologic factors|mesh-ancestor
24443564|NCT00295425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443565|NCT00295425|Antifungal Agents|antifungal agents|mesh-ancestor
24886322|NCT00165724|Nootropic Agents|nootropic agents|mesh-ancestor
25686480|NCT01920568|Zoledronic Acid|zoledronic acid|mesh-list
25686481|NCT01920568|Denosumab|denosumab|mesh-list
25686482|NCT01920568|Calcium|calcium|mesh-list
25686483|NCT01920568|Vitamins|vitamins|mesh-ancestor
25686484|NCT01920568|Micronutrients|micronutrients|mesh-ancestor
25686485|NCT01920568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686486|NCT01920568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25686487|NCT01920568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25686488|NCT01920711|Valsartan|valsartan|mesh-list
25242697|NCT05361057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25242698|NCT05361057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25242699|NCT05361057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24439528|NCT00279240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24513575|NCT00583518|Parathyroid Hormone|parathyroid hormone|mesh-list
24460889|NCT00350051|Hormones|hormones|mesh-ancestor
24460890|NCT00350051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24460891|NCT00350051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460892|NCT00350051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24460893|NCT00350051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460894|NCT00350077|Vitamins|vitamins|mesh-list
24460895|NCT00350077|Ascorbic Acid|ascorbic acid|mesh-list
24460896|NCT00350077|Micronutrients|micronutrients|mesh-ancestor
24460897|NCT00350077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460898|NCT00350077|Antioxidants|antioxidants|mesh-ancestor
24460899|NCT00350077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460900|NCT00350077|Protective Agents|protective agents|mesh-ancestor
24460901|NCT00350090|Epoetin Alfa|epoetin alfa|mesh-list
24460943|NCT00350181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24460944|NCT00350181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24460945|NCT00350181|Alkylating Agents|alkylating agents|mesh-ancestor
24460946|NCT00350181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460947|NCT00350181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460948|NCT00350181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24460949|NCT00350181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24460950|NCT00350181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24460951|NCT00350181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24460952|NCT00350181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460980|NCT00350441|Vasodilator Agents|vasodilator agents|mesh-ancestor
24460981|NCT00350441|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24460982|NCT00350441|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24460983|NCT00350441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24778622|NCT01871740|Enalapril|enalapril|mesh-list
24460984|NCT00350441|Urological Agents|urological agents|mesh-ancestor
25242700|NCT05360979|Endostatins|endostatins|mesh-list
25242701|NCT05360979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242702|NCT05360979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25242703|NCT05360979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25242704|NCT05360979|Growth Substances|growth substances|mesh-ancestor
25242705|NCT05360979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242706|NCT05360979|Growth Inhibitors|growth inhibitors|mesh-ancestor
25242707|NCT05360953|Clonidine|clonidine|mesh-list
25242708|NCT05360953|Doxazosin|doxazosin|mesh-list
25007796|NCT02737475|Immunologic Factors|immunologic factors|mesh-ancestor
24790651|NCT01944085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790652|NCT01944085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24790653|NCT01944085|Analgesics|analgesics|mesh-ancestor
24790654|NCT01944085|Sensory System Agents|sensory system agents|mesh-ancestor
24790655|NCT01944085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25007757|NCT02740127|Ropivacaine|ropivacaine|mesh-list
25007758|NCT02740127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25007759|NCT02740127|Antiemetics|antiemetics|mesh-ancestor
25007760|NCT02740127|Autonomic Agents|autonomic agents|mesh-ancestor
25007761|NCT02740127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25007762|NCT02740127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007763|NCT02740127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24790659|NCT01944085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24790660|NCT01944085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25007764|NCT02740127|Glucocorticoids|glucocorticoids|mesh-ancestor
25007765|NCT02740127|Hormones|hormones|mesh-ancestor
25007766|NCT02740127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25007767|NCT02740127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25007768|NCT02740127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007769|NCT02740127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007770|NCT02740127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25007771|NCT02740127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25007772|NCT02740127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25007773|NCT02740127|Anesthetics, General|anesthetics, general|mesh-ancestor
25007774|NCT02740127|Anesthetics|anesthetics|mesh-ancestor
25007775|NCT02740127|Anesthetics, Local|anesthetics, local|mesh-ancestor
25007776|NCT02740127|Sensory System Agents|sensory system agents|mesh-ancestor
25007777|NCT02740127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25007778|NCT02740127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24509493|NCT00560547|Epoetin Alfa|epoetin alfa|mesh-list
25242709|NCT05360953|Analgesics|analgesics|mesh-ancestor
25242710|NCT05360953|Sensory System Agents|sensory system agents|mesh-ancestor
25242711|NCT05360953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25242712|NCT05360953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854339|NCT02273271|Alovudine|alovudine|mesh-list
24461158|NCT00351143|Respiratory System Agents|respiratory system agents|mesh-ancestor
24509531|NCT00560820|Chelating Agents|chelating agents|mesh-ancestor
24440766|NCT00284687|Schistosomicides|schistosomicides|mesh-ancestor
24790694|NCT01944384|Diuretics|diuretics|mesh-ancestor
24790702|NCT01944436|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
24790703|NCT01944436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24790704|NCT01944436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790705|NCT01944436|Cholinergic Agents|cholinergic agents|mesh-ancestor
24790706|NCT01944436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24790707|NCT01944436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790708|NCT01944436|Nootropic Agents|nootropic agents|mesh-ancestor
24886720|NCT04523675|Antidotes|antidotes|mesh-ancestor
25242713|NCT05360953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25242714|NCT05360953|Sympatholytics|sympatholytics|mesh-ancestor
25242715|NCT05360953|Autonomic Agents|autonomic agents|mesh-ancestor
25242716|NCT05360953|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25242717|NCT05360953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25242718|NCT05360953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25242719|NCT05360953|Adrenergic Agents|adrenergic agents|mesh-ancestor
25242720|NCT05360953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25242721|NCT05360953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242722|NCT05360953|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25242723|NCT05360953|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25242724|NCT05360953|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25242725|NCT05360784|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25242726|NCT05360784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25007795|NCT02737475|Vaccines|vaccines|mesh-list
25007798|NCT02737475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25007799|NCT02737475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25007800|NCT02737475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25007801|NCT02737475|Alkylating Agents|alkylating agents|mesh-ancestor
25007802|NCT02737475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007803|NCT02737475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007804|NCT02737475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25007805|NCT02737475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25007806|NCT02737475|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24679702|NCT01370135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25007807|NCT02709512|Cisplatin|cisplatin|mesh-list
25007808|NCT02709512|Pemetrexed|pemetrexed|mesh-list
24461216|NCT00351364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24461217|NCT00351364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461218|NCT00351403|Ribavirin|ribavirin|mesh-list
24461219|NCT00351403|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24461220|NCT00351403|Antimetabolites|antimetabolites|mesh-ancestor
24440819|NCT00284947|Prednisolone|prednisolone|mesh-list
24461236|NCT00351546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461241|NCT00351585|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24461242|NCT00351585|Protease Inhibitors|protease inhibitors|mesh-ancestor
24461244|NCT00351585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461246|NCT00351637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24461247|NCT00351637|Narcotics|narcotics|mesh-ancestor
25242727|NCT05360784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25242728|NCT05360784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25242729|NCT05360784|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25242730|NCT05360784|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25242731|NCT05360784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25242732|NCT05360784|Adrenergic Agents|adrenergic agents|mesh-ancestor
25242733|NCT05360784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25242734|NCT05360784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851583|NCT02257398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24851584|NCT02257398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24495876|NCT00502385|Cediranib|cediranib|mesh-list
24461248|NCT00351637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24461249|NCT00351637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461250|NCT00351637|Analgesics|analgesics|mesh-ancestor
24440966|NCT00285428|Veltuzumab|veltuzumab|mesh-list
25692583|NCT02002650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25692584|NCT02002650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25692585|NCT02002650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692586|NCT02002650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692587|NCT02002767|Velpatasvir|velpatasvir|mesh-list
25692588|NCT02002767|Antiviral Agents|antiviral agents|mesh-ancestor
25692589|NCT02002767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25692590|NCT02002832|Risperidone|risperidone|mesh-list
25692591|NCT02002832|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25692592|NCT02002832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25692593|NCT02002832|Serotonin Agents|serotonin agents|mesh-ancestor
24461294|NCT00351884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24461295|NCT00351884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461296|NCT00351884|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24461297|NCT00351884|Protease Inhibitors|protease inhibitors|mesh-ancestor
24461298|NCT00351884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461299|NCT00351884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461300|NCT00351910|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24461301|NCT00351910|Amitriptyline|amitriptyline|mesh-list
24461302|NCT00351910|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24461304|NCT00351910|Bupropion|bupropion|mesh-list
24461305|NCT00351910|Fluoxetine|fluoxetine|mesh-list
24461306|NCT00351910|Paroxetine|paroxetine|mesh-list
24461307|NCT00351910|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24461308|NCT00351910|Sertraline|sertraline|mesh-list
24461309|NCT00351910|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24461310|NCT00351910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24461311|NCT00351910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24779018|NCT01873339|Darapladib|darapladib|mesh-list
24461312|NCT00351910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461313|NCT00351910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24461314|NCT00351910|Serotonin Agents|serotonin agents|mesh-ancestor
24461315|NCT00351910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242735|NCT05360784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242736|NCT05360602|Thioctic Acid|thioctic acid|mesh-list
25242737|NCT05360602|Antioxidants|antioxidants|mesh-ancestor
25242738|NCT05360602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242739|NCT05360602|Protective Agents|protective agents|mesh-ancestor
25242740|NCT05360602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242741|NCT05360602|Vitamin B Complex|vitamin b complex|mesh-ancestor
25242742|NCT05360602|Vitamins|vitamins|mesh-ancestor
25242743|NCT05360602|Micronutrients|micronutrients|mesh-ancestor
24461316|NCT00351910|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24461317|NCT00351910|Antidepressive Agents|antidepressive agents|mesh-ancestor
24461321|NCT00351910|Dopamine Agents|dopamine agents|mesh-ancestor
24461322|NCT00351910|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24461323|NCT00351910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24461324|NCT00351910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461325|NCT00351910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24461326|NCT00351910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25242744|NCT05360537|Insulin Glargine|insulin glargine|mesh-list
25242745|NCT05360537|Liraglutide|liraglutide|mesh-list
25242746|NCT05360537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25242747|NCT05360537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242748|NCT05360537|Incretins|incretins|mesh-ancestor
25242749|NCT05360537|Hormones|hormones|mesh-ancestor
25242750|NCT05360537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25274083|NCT02380898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25274084|NCT02380898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274085|NCT02380898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275641|NCT02370758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275642|NCT02370849|Nimotuzumab|nimotuzumab|mesh-list
25275643|NCT02370849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25275644|NCT02370849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25275645|NCT02370550|Cyclosporine|cyclosporine|mesh-list
25275646|NCT02370550|Prednisone|prednisone|mesh-list
25275647|NCT02370550|Calcium Carbonate|calcium carbonate|mesh-list
24612424|NCT01013909|Bifonazole|bifonazole|mesh-list
24461327|NCT00351910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24461384|NCT00352183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24461385|NCT00352183|Antimetabolites|antimetabolites|mesh-ancestor
24461386|NCT00352183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461387|NCT00352183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24461388|NCT00352183|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24461389|NCT00352183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461390|NCT00352196|Risperidone|risperidone|mesh-list
24461391|NCT00352196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24461392|NCT00352196|Serotonin Agents|serotonin agents|mesh-ancestor
24461401|NCT00352196|Dopamine Agents|dopamine agents|mesh-ancestor
24461403|NCT00352235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24461404|NCT00352235|Immunologic Factors|immunologic factors|mesh-ancestor
24461405|NCT00352235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461419|NCT00352287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24461420|NCT00352300|Paclitaxel|paclitaxel|mesh-list
24461421|NCT00352300|Carboplatin|carboplatin|mesh-list
24461422|NCT00352300|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24461423|NCT00352300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461435|NCT00352339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24461436|NCT00352339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461437|NCT00352339|Dopamine Agonists|dopamine agonists|mesh-ancestor
24779103|NCT01873820|Calcium|calcium|mesh-list
24790709|NCT01944436|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24790710|NCT01944436|Autonomic Agents|autonomic agents|mesh-ancestor
24790713|NCT01944436|Protective Agents|protective agents|mesh-ancestor
25007809|NCT02709512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007810|NCT02709512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25007811|NCT02709512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007812|NCT02709512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25007813|NCT02709512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25007859|NCT02611232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25007860|NCT02611232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007861|NCT02611232|Incretins|incretins|mesh-ancestor
25007862|NCT02611232|Hormones|hormones|mesh-ancestor
25007863|NCT02611232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25007864|NCT02604433|Luspatercept|luspatercept|mesh-list
25007865|NCT02604433|Hematinics|hematinics|mesh-ancestor
25007866|NCT02582775|Vidarabine|vidarabine|mesh-list
25007867|NCT02582775|Mycophenolic Acid|mycophenolic acid|mesh-list
25007868|NCT02582775|Cyclophosphamide|cyclophosphamide|mesh-list
25007869|NCT02582775|Busulfan|busulfan|mesh-list
25007870|NCT02582775|Fludarabine|fludarabine|mesh-list
25242751|NCT05360511|Epoetin Alfa|epoetin alfa|mesh-list
25242752|NCT05360511|Hematinics|hematinics|mesh-ancestor
25242753|NCT05360433|Oxycodone|oxycodone|mesh-list
25242754|NCT05360433|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25242755|NCT05360433|Narcotics|narcotics|mesh-ancestor
25242756|NCT05360433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24851585|NCT02257398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24851587|NCT02257398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007871|NCT02582775|Fludarabine phosphate|fludarabine phosphate|mesh-list
25007873|NCT02582775|Thymoglobulin|thymoglobulin|mesh-list
25007874|NCT02582775|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25007875|NCT02582775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25007876|NCT02582775|Immunologic Factors|immunologic factors|mesh-ancestor
25007877|NCT02582775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007878|NCT02582775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25007879|NCT02582775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25007880|NCT02582775|Alkylating Agents|alkylating agents|mesh-ancestor
25007881|NCT02582775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007882|NCT02582775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461498|NCT00352469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24462863|NCT00357708|Antimetabolites|antimetabolites|mesh-ancestor
24550706|NCT00721773|Protease Inhibitors|protease inhibitors|mesh-ancestor
24550707|NCT00721773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550708|NCT00721877|Resveratrol|resveratrol|mesh-list
24550709|NCT00721877|Antioxidants|antioxidants|mesh-ancestor
24550710|NCT00721877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550711|NCT00721877|Protective Agents|protective agents|mesh-ancestor
24550712|NCT00721877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550713|NCT00721877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550714|NCT00721877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24550715|NCT00721916|Leucovorin|leucovorin|mesh-list
24550716|NCT00721916|Oxaliplatin|oxaliplatin|mesh-list
24550717|NCT00721916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550718|NCT00721916|Antidotes|antidotes|mesh-ancestor
24550719|NCT00721916|Protective Agents|protective agents|mesh-ancestor
24550720|NCT00721916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242757|NCT05360433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242758|NCT05360433|Analgesics|analgesics|mesh-ancestor
25242759|NCT05360433|Sensory System Agents|sensory system agents|mesh-ancestor
25242760|NCT05360433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25242761|NCT05360394|Paclitaxel|paclitaxel|mesh-list
25242762|NCT05360394|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25242763|NCT05360394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25242764|NCT05360394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242765|NCT05360394|Tubulin Modulators|tubulin modulators|mesh-ancestor
25242766|NCT05360394|Antimitotic Agents|antimitotic agents|mesh-ancestor
25242767|NCT05360394|Mitosis Modulators|mitosis modulators|mesh-ancestor
25242768|NCT05360394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242769|NCT05360342|Vitamins|vitamins|mesh-list
25242770|NCT05360342|Vitamin K|vitamin k|mesh-list
25242771|NCT05360342|Vitamin K 1|vitamin k 1|mesh-list
25242772|NCT05360342|Micronutrients|micronutrients|mesh-ancestor
25242773|NCT05360342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242774|NCT05360342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25242775|NCT05360342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24851588|NCT02257398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652442|NCT01238224|Urological Agents|urological agents|mesh-ancestor
24550721|NCT00721916|Vitamin B Complex|vitamin b complex|mesh-ancestor
24550723|NCT00721916|Micronutrients|micronutrients|mesh-ancestor
24550743|NCT00722098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24550744|NCT00722098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25007940|NCT02420821|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24550848|NCT00722852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550849|NCT00722930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24550850|NCT00722930|Immunologic Factors|immunologic factors|mesh-ancestor
24550878|NCT00723060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24550912|NCT00723164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550913|NCT00723216|Enoxaparin|enoxaparin|mesh-list
24550914|NCT00723216|Anticoagulants|anticoagulants|mesh-ancestor
24550915|NCT00723216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24550916|NCT00723216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24550917|NCT00723216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550918|NCT00723242|Ribavirin|ribavirin|mesh-list
24550919|NCT00723242|Antimetabolites|antimetabolites|mesh-ancestor
24550920|NCT00723242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550921|NCT00723242|Antiviral Agents|antiviral agents|mesh-ancestor
24551001|NCT00723515|Cariostatic Agents|cariostatic agents|mesh-ancestor
24551002|NCT00723515|Protective Agents|protective agents|mesh-ancestor
24551003|NCT00723515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24551004|NCT00723515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24551005|NCT00723658|Cytarabine|cytarabine|mesh-list
24551006|NCT00723658|Thalidomide|thalidomide|mesh-list
24551007|NCT00723658|Dexamethasone|dexamethasone|mesh-list
24551008|NCT00723658|Cyclophosphamide|cyclophosphamide|mesh-list
24551046|NCT00723658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24552615|NCT02060487|Vasodilator Agents|vasodilator agents|mesh-ancestor
24551047|NCT00723658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24551048|NCT00723658|Growth Substances|growth substances|mesh-ancestor
24551049|NCT00723658|Growth Inhibitors|growth inhibitors|mesh-ancestor
24551071|NCT00723918|Analgesics|analgesics|mesh-ancestor
24551072|NCT00723918|Sensory System Agents|sensory system agents|mesh-ancestor
24551073|NCT00723918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24551074|NCT00723918|Antitussive Agents|antitussive agents|mesh-ancestor
24551075|NCT00723918|Respiratory System Agents|respiratory system agents|mesh-ancestor
24551076|NCT00723970|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24551077|NCT00723970|Antidepressive Agents|antidepressive agents|mesh-ancestor
24551078|NCT00723970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24551079|NCT00723970|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24551080|NCT00723970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24551081|NCT00723970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25242776|NCT05360342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242777|NCT05360342|Hemostatics|hemostatics|mesh-ancestor
25242778|NCT05360342|Coagulants|coagulants|mesh-ancestor
25242788|NCT05360160|Venetoclax|venetoclax|mesh-list
24551082|NCT00723970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551083|NCT00723983|Sumatriptan|sumatriptan|mesh-list
24551087|NCT00723983|Serotonin Agents|serotonin agents|mesh-ancestor
24551088|NCT00723983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24551089|NCT00723983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551090|NCT00723983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551091|NCT00724022|Mycophenolic Acid|mycophenolic acid|mesh-list
24551092|NCT00724022|Prednisolone|prednisolone|mesh-list
24551122|NCT00724035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24551190|NCT00724360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24551191|NCT00724386|Paclitaxel|paclitaxel|mesh-list
24551192|NCT00724386|Vinorelbine|vinorelbine|mesh-list
24551193|NCT00724386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24790783|NCT01945099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790785|NCT01945268|Immunologic Factors|immunologic factors|mesh-ancestor
24790804|NCT01945450|Clindamycin palmitate|clindamycin palmitate|mesh-list
24790805|NCT01945450|Clindamycin phosphate|clindamycin phosphate|mesh-list
24790806|NCT01945450|Gentamicins|gentamicins|mesh-list
25007883|NCT02582775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25007884|NCT02582775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25007885|NCT02582775|Antimetabolites|antimetabolites|mesh-ancestor
24790809|NCT01945450|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25007921|NCT02519738|Silver Nitrate|silver nitrate|mesh-list
25007922|NCT02519738|Triamcinolone|triamcinolone|mesh-list
25007923|NCT02519738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25007924|NCT02519738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25007925|NCT02519738|Glucocorticoids|glucocorticoids|mesh-ancestor
25007926|NCT02519738|Hormones|hormones|mesh-ancestor
25242789|NCT05360160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242790|NCT05360147|Metformin|metformin|mesh-list
25242791|NCT05360147|Liraglutide|liraglutide|mesh-list
25242792|NCT05360147|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24704830|NCT01480752|Lornoxicam|lornoxicam|mesh-list
25242793|NCT05360147|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
25242794|NCT05360147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242795|NCT05360147|Incretins|incretins|mesh-ancestor
25242796|NCT05360147|Hormones|hormones|mesh-ancestor
25274089|NCT02380755|Clomiphene|clomiphene|mesh-list
25274090|NCT02380755|Enclomiphene|enclomiphene|mesh-list
25007927|NCT02519738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25007928|NCT02519738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007929|NCT02519738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25007930|NCT02519738|Immunologic Factors|immunologic factors|mesh-ancestor
24551243|NCT00724672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24551244|NCT00724672|Immunologic Factors|immunologic factors|mesh-ancestor
24551245|NCT00724685|Ropivacaine|ropivacaine|mesh-list
24551247|NCT00724685|Anesthetics|anesthetics|mesh-ancestor
24551248|NCT00724685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24551249|NCT00724685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551250|NCT00724685|Sensory System Agents|sensory system agents|mesh-ancestor
24551398|NCT00726011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551400|NCT00726258|Analgesics|analgesics|mesh-ancestor
24551401|NCT00726258|Sensory System Agents|sensory system agents|mesh-ancestor
24551402|NCT00726258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24551403|NCT00726258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551404|NCT00726258|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24551405|NCT00726258|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24551406|NCT00726258|Anesthetics, General|anesthetics, general|mesh-ancestor
24551407|NCT00726258|Anesthetics|anesthetics|mesh-ancestor
24510025|NCT00563147|Sirolimus|sirolimus|mesh-list
24551418|NCT00726466|Growth Inhibitors|growth inhibitors|mesh-ancestor
24551419|NCT00726466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24551420|NCT00726505|Dapagliflozin|dapagliflozin|mesh-list
24551421|NCT00726505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24551422|NCT00726505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551438|NCT00726687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442090|NCT00290017|Pemetrexed|pemetrexed|mesh-list
24551484|NCT00726726|Anesthetics, General|anesthetics, general|mesh-ancestor
24551485|NCT00726726|Anesthetics|anesthetics|mesh-ancestor
24551487|NCT00726726|GABA Agents|gaba agents|mesh-ancestor
24551488|NCT00726726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24551489|NCT00726726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551490|NCT00726726|Anticoagulants|anticoagulants|mesh-ancestor
24551491|NCT00726726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24551492|NCT00726726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24551493|NCT00726726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24551494|NCT00726726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24551495|NCT00726726|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24551496|NCT00726726|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24551497|NCT00726726|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24551498|NCT00726726|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24551499|NCT00726726|Purinergic Agents|purinergic agents|mesh-ancestor
24551500|NCT00726726|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24551501|NCT00726726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24551502|NCT00726726|Hemostatics|hemostatics|mesh-ancestor
24551503|NCT00726726|Coagulants|coagulants|mesh-ancestor
24551504|NCT00726726|Antitussive Agents|antitussive agents|mesh-ancestor
24551505|NCT00726726|Respiratory System Agents|respiratory system agents|mesh-ancestor
24551506|NCT00726726|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24551507|NCT00726726|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24551521|NCT05373277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24790833|NCT01945528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24790834|NCT01945528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25102624|NCT03167216|Histamine Agents|histamine agents|mesh-ancestor
24790835|NCT01945528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24790836|NCT01945528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24790837|NCT01945528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25242797|NCT05360147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25242798|NCT05360030|Ketamine|ketamine|mesh-list
25242799|NCT05360030|Naloxone|naloxone|mesh-list
25242800|NCT05360030|Analgesics|analgesics|mesh-ancestor
25242801|NCT05360030|Sensory System Agents|sensory system agents|mesh-ancestor
25242802|NCT05360030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25274091|NCT02380755|Zuclomiphene|zuclomiphene|mesh-list
25070101|NCT03421860|Antiemetics|antiemetics|mesh-ancestor
24790838|NCT01945528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790839|NCT01945554|Bupivacaine|bupivacaine|mesh-list
24790840|NCT01945554|Anesthetics, Local|anesthetics, local|mesh-ancestor
24790841|NCT01945554|Anesthetics|anesthetics|mesh-ancestor
24790842|NCT01945554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24790843|NCT01945554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790844|NCT01945554|Sensory System Agents|sensory system agents|mesh-ancestor
24790845|NCT01945554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24790846|NCT01945684|Botulinum Toxins|botulinum toxins|mesh-list
24790847|NCT01945684|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24790848|NCT01945684|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25007939|NCT02420821|Antibodies|antibodies|mesh-list
25007948|NCT02420821|Immunologic Factors|immunologic factors|mesh-ancestor
25007949|NCT02420821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25007950|NCT02420821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25007951|NCT02420821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551606|NCT05366062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24551607|NCT05366062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24551608|NCT05366062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24551610|NCT05358587|Anesthetics, Local|anesthetics, local|mesh-list
24551611|NCT05358587|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24551612|NCT05358587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24551613|NCT05358587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551614|NCT05358587|Sensory System Agents|sensory system agents|mesh-ancestor
24779479|NCT01876355|Sensory System Agents|sensory system agents|mesh-ancestor
24551615|NCT05358587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24779480|NCT01876355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24779481|NCT01876355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779482|NCT01876355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24551702|NCT05124275|Autonomic Agents|autonomic agents|mesh-ancestor
24551703|NCT05124275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24551704|NCT05124275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551706|NCT05124275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25242803|NCT05360030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242805|NCT05360030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25242806|NCT05360030|Anesthetics, General|anesthetics, general|mesh-ancestor
25242807|NCT05360030|Anesthetics|anesthetics|mesh-ancestor
25242808|NCT05360030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24551774|NCT05065567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24551775|NCT05065567|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24551780|NCT05036408|Coal Tar|coal tar|mesh-list
24551781|NCT05036408|Keratolytic Agents|keratolytic agents|mesh-ancestor
24551782|NCT05036408|Dermatologic Agents|dermatologic agents|mesh-ancestor
24552157|NCT04130204|Gout Suppressants|gout suppressants|mesh-ancestor
24487698|NCT00464503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24552046|NCT04237103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24552047|NCT04237103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25242809|NCT05360030|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25242810|NCT05360030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25242811|NCT05360030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25242812|NCT05360030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242814|NCT05359939|Choline|choline|mesh-list
25242815|NCT05359939|Lipotropic Agents|lipotropic agents|mesh-ancestor
25242816|NCT05359939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25242817|NCT05359939|Antimetabolites|antimetabolites|mesh-ancestor
25242818|NCT05359939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242819|NCT05359939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25242820|NCT05359939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25242821|NCT05359939|Nootropic Agents|nootropic agents|mesh-ancestor
25242822|NCT05359874|Bevacizumab|bevacizumab|mesh-list
24851589|NCT02257398|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24851591|NCT02257398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24851592|NCT02257398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851593|NCT02257398|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25070119|NCT03421821|Anesthetics|anesthetics|mesh-ancestor
24552048|NCT04237103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24552049|NCT04237103|Immunologic Factors|immunologic factors|mesh-ancestor
24552050|NCT04237103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24552051|NCT04237103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24552052|NCT04213794|Sodium thiosulfate|sodium thiosulfate|mesh-list
24552053|NCT04213794|Cisplatin|cisplatin|mesh-list
24552054|NCT04213794|Doxorubicin|doxorubicin|mesh-list
24552055|NCT04213794|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24552056|NCT04213794|Daunorubicin|daunorubicin|mesh-list
24552057|NCT04213794|Antidotes|antidotes|mesh-list
24552153|NCT04144465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24552154|NCT04144465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552155|NCT04144465|Protective Agents|protective agents|mesh-ancestor
24552156|NCT04130204|Colchicine|colchicine|mesh-list
25109828|NCT03121664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25109829|NCT03121664|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25109830|NCT03121664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25109831|NCT03121664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25109832|NCT03121664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109833|NCT03121664|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24552162|NCT04130204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552164|NCT04126317|Aflibercept|aflibercept|mesh-list
24552168|NCT04126317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552169|NCT04126317|Growth Inhibitors|growth inhibitors|mesh-ancestor
24552170|NCT04126317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552172|NCT04120636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24552173|NCT04120636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24552174|NCT04120636|Analgesics|analgesics|mesh-ancestor
24552175|NCT04120636|Sensory System Agents|sensory system agents|mesh-ancestor
24552176|NCT04120636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24552177|NCT04120636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552178|NCT04120636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24552179|NCT04120636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24442726|NCT00292344|Rifaximin|rifaximin|mesh-list
25242823|NCT05359874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25242824|NCT05359874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242825|NCT05359874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25242826|NCT05359874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25242827|NCT05359874|Growth Substances|growth substances|mesh-ancestor
25242828|NCT05359874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242829|NCT05359874|Growth Inhibitors|growth inhibitors|mesh-ancestor
24461279|NCT00351715|Respiratory System Agents|respiratory system agents|mesh-ancestor
24552611|NCT02060487|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24552612|NCT02060487|Chelating Agents|chelating agents|mesh-ancestor
24552613|NCT02060487|Sequestering Agents|sequestering agents|mesh-ancestor
24552614|NCT02060487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552616|NCT02060487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24552617|NCT02060487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24552618|NCT02060487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24552619|NCT02060487|Urological Agents|urological agents|mesh-ancestor
24779649|NCT01877746|Immunologic Factors|immunologic factors|mesh-ancestor
25008044|NCT02339740|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25008045|NCT02339740|Keratolytic Agents|keratolytic agents|mesh-ancestor
25008046|NCT02339740|Dermatologic Agents|dermatologic agents|mesh-ancestor
25008047|NCT02291445|Peppermint oil|peppermint oil|mesh-list
25008048|NCT02291445|Antiemetics|antiemetics|mesh-ancestor
25008049|NCT02291445|Autonomic Agents|autonomic agents|mesh-ancestor
25008050|NCT02291445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25008051|NCT02291445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008052|NCT02291445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25274092|NCT02380755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24851601|NCT02257463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24851602|NCT02257463|Respiratory System Agents|respiratory system agents|mesh-ancestor
25008053|NCT02291445|Parasympatholytics|parasympatholytics|mesh-ancestor
25008054|NCT02262026|Saracatinib|saracatinib|mesh-list
24779662|NCT01877954|Xhance|xhance|mesh-list
25008055|NCT02262026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008056|NCT02262026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25008057|NCT02262026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552806|NCT00727831|Protective Agents|protective agents|mesh-ancestor
24552807|NCT00727831|Vitamin B Complex|vitamin b complex|mesh-ancestor
24552808|NCT00727831|Vitamins|vitamins|mesh-ancestor
24552809|NCT00727831|Micronutrients|micronutrients|mesh-ancestor
24552810|NCT00727870|Glycerol|glycerol|mesh-list
24552811|NCT00727870|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24552812|NCT00727870|Protective Agents|protective agents|mesh-ancestor
24552813|NCT00727870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552814|NCT00727935|Lidocaine|lidocaine|mesh-list
24552815|NCT00727935|Ropivacaine|ropivacaine|mesh-list
24552816|NCT00727935|Anesthetics, Local|anesthetics, local|mesh-ancestor
24552817|NCT00727935|Anesthetics|anesthetics|mesh-ancestor
24552818|NCT00727935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24552819|NCT00727935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552834|NCT00727948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24552836|NCT00727948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24552842|NCT00727948|Antipyretics|antipyretics|mesh-ancestor
24552870|NCT00728000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24552871|NCT00728000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24790955|NCT05409820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24790956|NCT05409820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790957|NCT05409391|Insulin|insulin|mesh-list
24790958|NCT05409391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24888108|NCT04509258|Expectorants|expectorants|mesh-ancestor
24854628|NCT02274181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24854629|NCT02274181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854630|NCT02274181|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24553008|NCT00728780|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24553009|NCT00728780|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24553010|NCT00728780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553011|NCT00728832|Morphine|morphine|mesh-list
24553012|NCT00728832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24553013|NCT00728832|Narcotics|narcotics|mesh-ancestor
24553014|NCT00728832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24553035|NCT00729131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24487934|NCT00465673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24487935|NCT00465673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553036|NCT00729131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24553037|NCT00729131|Analgesics|analgesics|mesh-ancestor
24510404|NCT00564538|Tacrolimus|tacrolimus|mesh-list
24553153|NCT00729768|Dermatologic Agents|dermatologic agents|mesh-ancestor
24553157|NCT00729768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24553158|NCT00729768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24553159|NCT00729768|Antitubercular Agents|antitubercular agents|mesh-ancestor
24553160|NCT00729768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24553161|NCT00729794|Methylprednisolone|methylprednisolone|mesh-list
24553162|NCT00729794|Hydrocortisone|hydrocortisone|mesh-list
24553163|NCT00729794|Vasopressins|vasopressins|mesh-list
24553164|NCT00729794|Arginine Vasopressin|arginine vasopressin|mesh-list
24553165|NCT00729794|Epinephrine|epinephrine|mesh-list
24553166|NCT00729794|Racepinephrine|racepinephrine|mesh-list
24553167|NCT00729794|Epinephryl borate|epinephryl borate|mesh-list
24553168|NCT00729794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24553169|NCT00729794|Antiemetics|antiemetics|mesh-ancestor
24553170|NCT00729794|Autonomic Agents|autonomic agents|mesh-ancestor
25070140|NCT03421496|Vigabatrin|vigabatrin|mesh-list
25070141|NCT03421496|Anticonvulsants|anticonvulsants|mesh-ancestor
25070144|NCT03421496|GABA Agents|gaba agents|mesh-ancestor
24553171|NCT00729794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24553207|NCT00729911|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24553234|NCT00729976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553237|NCT00730054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24553238|NCT00730054|Narcotics|narcotics|mesh-ancestor
25242849|NCT05359627|Polymyxins|polymyxins|mesh-list
25242850|NCT05359627|Polymyxin B|polymyxin b|mesh-list
25242851|NCT05359627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25242852|NCT05359627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25242853|NCT05359497|Liver Extracts|liver extracts|mesh-list
25242854|NCT05359497|Hematinics|hematinics|mesh-ancestor
25242855|NCT05359432|Empagliflozin|empagliflozin|mesh-list
25242856|NCT05359432|Vildagliptin|vildagliptin|mesh-list
25242857|NCT05359432|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25242858|NCT05359432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242859|NCT05359432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25242860|NCT05359432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242861|NCT05359432|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25242862|NCT05359432|Protease Inhibitors|protease inhibitors|mesh-ancestor
24553295|NCT00730223|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24553296|NCT00730223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24553297|NCT00730223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24553298|NCT00730223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24553311|NCT00730288|Immunologic Factors|immunologic factors|mesh-ancestor
24553323|NCT00730366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24553324|NCT00730366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553325|NCT00730366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553326|NCT00730366|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24553327|NCT00730366|Renal Agents|renal agents|mesh-ancestor
24553328|NCT00730392|Etanercept|etanercept|mesh-list
24553329|NCT00730392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25686489|NCT01920711|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25686490|NCT01920711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25686491|NCT01920711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24510473|NCT00564642|Antidotes|antidotes|mesh-ancestor
25686492|NCT01920711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24790967|NCT05409339|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24790975|NCT05409157|Cathartics|cathartics|mesh-ancestor
24790976|NCT05409157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24790977|NCT05409157|Laxatives|laxatives|mesh-ancestor
24790992|NCT05408247|Acetylcysteine|acetylcysteine|mesh-list
24790993|NCT05408247|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24790994|NCT05408247|Antiviral Agents|antiviral agents|mesh-ancestor
24790996|NCT05408247|Expectorants|expectorants|mesh-ancestor
25008075|NCT02097680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25008076|NCT02097680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008077|NCT02025556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25008078|NCT02025556|Immunologic Factors|immunologic factors|mesh-ancestor
25008079|NCT02025556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008080|NCT01995578|Azacitidine|azacitidine|mesh-list
24779741|NCT01878513|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25008081|NCT01995578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25008082|NCT01995578|Antimetabolites|antimetabolites|mesh-ancestor
25008083|NCT01995578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008084|NCT01995578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008085|NCT01995578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25008086|NCT01986075|Amphetamine|amphetamine|mesh-list
25008087|NCT01986075|Adderall|adderall|mesh-list
25008088|NCT01986075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25008089|NCT01986075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008090|NCT01986075|Sympathomimetics|sympathomimetics|mesh-ancestor
25242863|NCT05359432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25242864|NCT05359419|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25242865|NCT05359419|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25242866|NCT05359419|Dermatologic Agents|dermatologic agents|mesh-ancestor
24851622|NCT02257476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24851626|NCT02257502|Growth Substances|growth substances|mesh-ancestor
25008091|NCT01986075|Autonomic Agents|autonomic agents|mesh-ancestor
25008092|NCT01986075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25008105|NCT01850888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25008106|NCT01850888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446877|NCT00306410|Vitamin D|vitamin d|mesh-list
24446878|NCT00306410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24446879|NCT00306410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553368|NCT00730535|Urological Agents|urological agents|mesh-ancestor
24553369|NCT00730574|Vitamins|vitamins|mesh-list
24553370|NCT00730574|Folic Acid|folic acid|mesh-list
24553371|NCT00730574|Vitamin B 12|vitamin b 12|mesh-list
24553372|NCT00730574|Hydroxocobalamin|hydroxocobalamin|mesh-list
24553373|NCT00730574|Vitamin B Complex|vitamin b complex|mesh-list
24553374|NCT00730574|Micronutrients|micronutrients|mesh-ancestor
24553375|NCT00730574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553376|NCT00730574|Hematinics|hematinics|mesh-ancestor
24553403|NCT00731003|Antidepressive Agents|antidepressive agents|mesh-ancestor
24553404|NCT00731003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24553405|NCT00731016|Zoledronic Acid|zoledronic acid|mesh-list
24553407|NCT00731016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24553408|NCT00731016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553409|NCT00731016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24553416|NCT00731068|Mitogens|mitogens|mesh-list
24553418|NCT00731068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553419|NCT00731146|Anesthetics|anesthetics|mesh-list
24553420|NCT00731146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24553421|NCT00731146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553456|NCT00731289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24779806|NCT01878864|Anesthetics|anesthetics|mesh-ancestor
24553457|NCT00731289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553458|NCT00731289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24553459|NCT00731289|Viscosupplements|viscosupplements|mesh-ancestor
24553492|NCT00731523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242867|NCT05359354|Vaccines|vaccines|mesh-list
25242868|NCT05359354|Immunologic Factors|immunologic factors|mesh-ancestor
25242869|NCT05359354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242870|NCT05359341|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25242871|NCT05359341|Empagliflozin|empagliflozin|mesh-list
25242872|NCT05359341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25242873|NCT05359341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25242874|NCT05359341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25278471|NCT02351804|Anesthetics|anesthetics|mesh-ancestor
25242875|NCT05359341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242876|NCT05359341|Incretins|incretins|mesh-ancestor
25242877|NCT05359341|Hormones|hormones|mesh-ancestor
25242878|NCT05359341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25242879|NCT05359341|Protease Inhibitors|protease inhibitors|mesh-ancestor
25242880|NCT05359341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25242881|NCT05359341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851629|NCT02257502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24553494|NCT00731562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24553495|NCT00731562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24553496|NCT00731562|Cholinergic Agents|cholinergic agents|mesh-ancestor
24553497|NCT00731562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24553498|NCT00731562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510613|NCT00565175|Histamine Antagonists|histamine antagonists|mesh-ancestor
24553615|NCT00732290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24553616|NCT00732290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24553617|NCT00732290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553619|NCT00732407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24553625|NCT00732420|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24553626|NCT00732420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24553627|NCT00732420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553652|NCT00732446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24553660|NCT00732485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24553662|NCT00732485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553663|NCT00732485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24553664|NCT00732511|Metoprolol|metoprolol|mesh-list
24553665|NCT00732511|Carvedilol|carvedilol|mesh-list
24553666|NCT00732511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24553667|NCT00732511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24553668|NCT00732511|Sympatholytics|sympatholytics|mesh-ancestor
24553669|NCT00732511|Autonomic Agents|autonomic agents|mesh-ancestor
24553670|NCT00732511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24553671|NCT00732511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553672|NCT00732511|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24553673|NCT00732511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24553674|NCT00732511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24553856|NCT00733083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24553857|NCT00733083|Glucocorticoids|glucocorticoids|mesh-ancestor
24553858|NCT00733083|Hormones|hormones|mesh-ancestor
24553859|NCT00733083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24553860|NCT00733083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24553861|NCT00733083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24553862|NCT00733083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24553863|NCT00733083|Narcotics|narcotics|mesh-ancestor
24553864|NCT00733083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25008107|NCT01850888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24888480|NCT04504552|Avelumab|avelumab|mesh-list
24553998|NCT00733720|Naltrexone|naltrexone|mesh-list
24553999|NCT00733720|Buprenorphine|buprenorphine|mesh-list
24554000|NCT00733720|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
24554001|NCT00733720|Naloxone|naloxone|mesh-list
24554002|NCT00733720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24554003|NCT00733720|Narcotics|narcotics|mesh-ancestor
24554004|NCT00733720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24554005|NCT00733720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554011|NCT00733785|Rosiglitazone|rosiglitazone|mesh-list
24554012|NCT00733785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24554013|NCT00733785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554014|NCT00733811|Deferiprone|deferiprone|mesh-list
24554015|NCT00733811|Deferoxamine|deferoxamine|mesh-list
24554016|NCT00733811|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25242882|NCT05359237|Vincristine|vincristine|mesh-list
25242883|NCT05359237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25242884|NCT05359237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242885|NCT05359237|Tubulin Modulators|tubulin modulators|mesh-ancestor
25242886|NCT05359237|Antimitotic Agents|antimitotic agents|mesh-ancestor
25242887|NCT05359237|Mitosis Modulators|mitosis modulators|mesh-ancestor
25274093|NCT02380755|Hormone Antagonists|hormone antagonists|mesh-ancestor
24495994|NCT00502892|Carboplatin|carboplatin|mesh-list
24554018|NCT00733811|Sequestering Agents|sequestering agents|mesh-ancestor
24759007|NCT01748929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24554047|NCT00733967|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24554048|NCT00733967|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24554049|NCT00733967|Cholinergic Agents|cholinergic agents|mesh-ancestor
24554050|NCT00733967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24554051|NCT00733967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554052|NCT00733967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554054|NCT00734123|Rimonabant|rimonabant|mesh-list
24554055|NCT00734123|Enalapril|enalapril|mesh-list
24554056|NCT00734123|Clopidogrel|clopidogrel|mesh-list
24554277|NCT00735241|Antimetabolites|antimetabolites|mesh-ancestor
24554278|NCT00735241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555273|NCT00740922|Anticoagulants|anticoagulants|mesh-ancestor
24554279|NCT00735241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24554280|NCT00735241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24554472|NCT00736801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24554474|NCT00736801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24554475|NCT00736801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554478|NCT00736801|Dermatologic Agents|dermatologic agents|mesh-ancestor
25008130|NCT01746849|Cyclophosphamide|cyclophosphamide|mesh-list
25008131|NCT01746849|Thiotepa|thiotepa|mesh-list
25008132|NCT01746849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25008133|NCT01746849|Immunologic Factors|immunologic factors|mesh-ancestor
24885371|NCT05173584|Albuterol|albuterol|mesh-list
25008149|NCT01745588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25008150|NCT01745588|Glucocorticoids|glucocorticoids|mesh-ancestor
25008151|NCT01745588|Hormones|hormones|mesh-ancestor
25008152|NCT01745588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25242888|NCT05359237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242889|NCT05359172|Tranexamic Acid|tranexamic acid|mesh-list
25242890|NCT05359172|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25242891|NCT05359172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25242892|NCT05359172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242893|NCT05359172|Hemostatics|hemostatics|mesh-ancestor
25242894|NCT05359172|Coagulants|coagulants|mesh-ancestor
25242895|NCT05359146|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
25242896|NCT05359146|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25242897|NCT05359146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242898|NCT05359133|Tetrodotoxin|tetrodotoxin|mesh-list
25242899|NCT05359133|Anesthetics, Local|anesthetics, local|mesh-ancestor
25242900|NCT05359133|Anesthetics|anesthetics|mesh-ancestor
25242901|NCT05359133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25242902|NCT05359133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242903|NCT05359133|Sensory System Agents|sensory system agents|mesh-ancestor
25008153|NCT01745588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25008154|NCT01745588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008155|NCT01745588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25008156|NCT01745588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25008157|NCT01745588|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25008158|NCT01745588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25008159|NCT01745588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008160|NCT01745588|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25008161|NCT01745588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25008162|NCT01745588|Immunologic Factors|immunologic factors|mesh-ancestor
25008163|NCT01745588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25008164|NCT01745588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25008167|NCT01318486|Heparin|heparin|mesh-list
25008168|NCT01318486|Anticoagulants|anticoagulants|mesh-ancestor
24554656|NCT00737542|Anesthetics, Local|anesthetics, local|mesh-ancestor
24554657|NCT00737542|Anesthetics|anesthetics|mesh-ancestor
24554658|NCT00737542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24554659|NCT00737542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554660|NCT00737542|Sensory System Agents|sensory system agents|mesh-ancestor
24554661|NCT00737542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24554662|NCT00737542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24554663|NCT00737542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24554664|NCT00737542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25109849|NCT03121573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24571777|NCT00811785|Trace Elements|trace elements|mesh-ancestor
24554665|NCT00737542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24554666|NCT00737542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554667|NCT00737555|Tosedostat|tosedostat|mesh-list
24554668|NCT00737555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24554669|NCT00737555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554670|NCT00737659|Mycophenolic Acid|mycophenolic acid|mesh-list
24554671|NCT00737659|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24554672|NCT00737659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24554720|NCT00737789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24510796|NCT00565656|Bevacizumab|bevacizumab|mesh-list
24554733|NCT00737867|Vinorelbine|vinorelbine|mesh-list
24554759|NCT00737971|Growth Substances|growth substances|mesh-ancestor
24554760|NCT00737971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554761|NCT00737971|Growth Inhibitors|growth inhibitors|mesh-ancestor
25242904|NCT05359133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25242905|NCT05359133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25242906|NCT05359133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25242907|NCT05359133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554765|NCT00737971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24554766|NCT00737971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24554767|NCT00737971|Immunologic Factors|immunologic factors|mesh-ancestor
24554768|NCT00737971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24554769|NCT00737971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554770|NCT00737997|Morphine|morphine|mesh-list
24554771|NCT00737997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24554772|NCT00737997|Narcotics|narcotics|mesh-ancestor
24554773|NCT00737997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24554774|NCT00737997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554775|NCT00737997|Analgesics|analgesics|mesh-ancestor
24551666|NCT05206877|Insulin|insulin|mesh-list
24551667|NCT05206877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24551668|NCT05206877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24551669|NCT05206877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551670|NCT05204290|Pembrolizumab|pembrolizumab|mesh-list
24551671|NCT05204290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24551672|NCT05204290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24551673|NCT05203445|Pembrolizumab|pembrolizumab|mesh-list
24554777|NCT00737997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24554778|NCT00738088|Gliclazide|gliclazide|mesh-list
24554779|NCT00738088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24554780|NCT00738088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554781|NCT00738153|Insulin Detemir|insulin detemir|mesh-list
24554904|NCT00738621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24779986|NCT01880372|Protective Agents|protective agents|mesh-ancestor
24555039|NCT00739531|Respiratory System Agents|respiratory system agents|mesh-ancestor
24555100|NCT00740064|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24555102|NCT00740064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555103|NCT00740064|Antiviral Agents|antiviral agents|mesh-ancestor
24555221|NCT00740467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24555222|NCT00740467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24555223|NCT00740467|Alkylating Agents|alkylating agents|mesh-ancestor
24628831|NCT01101620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24555224|NCT00740467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555249|NCT00740571|Amitriptyline|amitriptyline|mesh-list
24555250|NCT00740571|Analgesics|analgesics|mesh-ancestor
24555259|NCT00740571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24555260|NCT00740571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24555261|NCT00740571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24555262|NCT00740571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24555263|NCT00740571|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24555264|NCT00740571|Antidepressive Agents|antidepressive agents|mesh-ancestor
24555265|NCT00740571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24555266|NCT00740571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24555267|NCT00740571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24555269|NCT00740571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24555270|NCT00740883|Warfarin|warfarin|mesh-list
24555271|NCT00740883|Anticoagulants|anticoagulants|mesh-ancestor
24555272|NCT00740922|Becaplermin|becaplermin|mesh-list
24555305|NCT00741117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555306|NCT00741117|Protective Agents|protective agents|mesh-ancestor
24555307|NCT00741117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555311|NCT00741143|Sequestering Agents|sequestering agents|mesh-ancestor
24555312|NCT00741143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555314|NCT00741169|Simeprevir|simeprevir|mesh-list
24555315|NCT00741169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24555316|NCT00741169|Antitubercular Agents|antitubercular agents|mesh-ancestor
24555317|NCT00741169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24555318|NCT00741169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24555319|NCT00741169|Leprostatic Agents|leprostatic agents|mesh-ancestor
24555320|NCT00741169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24555321|NCT00741169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24555322|NCT00741169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462428|NCT00356083|Respiratory System Agents|respiratory system agents|mesh-ancestor
24555323|NCT00741169|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24555324|NCT00741169|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24555325|NCT00741169|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24555368|NCT00741325|Lenograstim|lenograstim|mesh-list
24555369|NCT00741325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24555370|NCT00741325|Immunologic Factors|immunologic factors|mesh-ancestor
24555371|NCT00741325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555372|NCT00741325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24555373|NCT00741325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24555415|NCT00741585|Telmisartan|telmisartan|mesh-list
24555417|NCT00741585|Candesartan|candesartan|mesh-list
24555418|NCT00741585|Candesartan cilexetil|candesartan cilexetil|mesh-list
24555419|NCT00741585|Ramipril|ramipril|mesh-list
24555420|NCT00741585|Olmesartan|olmesartan|mesh-list
24555421|NCT00741585|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24555422|NCT00741585|Enalapril|enalapril|mesh-list
24555423|NCT00741585|Enalaprilat|enalaprilat|mesh-list
24555424|NCT00741585|Lisinopril|lisinopril|mesh-list
24555425|NCT00741585|Irbesartan|irbesartan|mesh-list
24555426|NCT00741585|Antihypertensive Agents|antihypertensive agents|mesh-list
24555427|NCT00741585|Quinapril|quinapril|mesh-list
24555441|NCT00741585|Adrenergic Agents|adrenergic agents|mesh-ancestor
24555442|NCT00741585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24555443|NCT00741585|Antioxidants|antioxidants|mesh-ancestor
24555482|NCT00741767|Autonomic Agents|autonomic agents|mesh-ancestor
24555483|NCT00741767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24555518|NCT00741884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555520|NCT00741897|Fexofenadine|fexofenadine|mesh-list
24555521|NCT00741897|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24555522|NCT00741897|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24555523|NCT00741897|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24555524|NCT00741897|Histamine Antagonists|histamine antagonists|mesh-ancestor
24555525|NCT00741897|Histamine Agents|histamine agents|mesh-ancestor
24555578|NCT00742092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24555612|NCT00742300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555614|NCT00742300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24555615|NCT00742300|Alkylating Agents|alkylating agents|mesh-ancestor
24555616|NCT00742300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555681|NCT00742768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555683|NCT00742768|Coagulants|coagulants|mesh-ancestor
24555684|NCT00742807|Alfentanil|alfentanil|mesh-list
24555685|NCT00742807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24555686|NCT00742807|Narcotics|narcotics|mesh-ancestor
24555687|NCT00742807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24555688|NCT00742807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555689|NCT00742807|Analgesics|analgesics|mesh-ancestor
24555690|NCT00742807|Sensory System Agents|sensory system agents|mesh-ancestor
24555691|NCT00742807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24555692|NCT00742807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24555693|NCT00742807|Anesthetics, General|anesthetics, general|mesh-ancestor
25008199|NCT01042522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25008200|NCT00958737|Leucovorin|leucovorin|mesh-list
25008201|NCT00958737|Fluorouracil|fluorouracil|mesh-list
25008202|NCT00958737|Capecitabine|capecitabine|mesh-list
25008203|NCT00958737|Oxaliplatin|oxaliplatin|mesh-list
25008204|NCT00958737|Calcium|calcium|mesh-list
25008205|NCT00958737|Levoleucovorin|levoleucovorin|mesh-list
25008206|NCT00958737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25008216|NCT00958737|Vitamin B Complex|vitamin b complex|mesh-ancestor
25008217|NCT00958737|Vitamins|vitamins|mesh-ancestor
25008218|NCT00958737|Micronutrients|micronutrients|mesh-ancestor
25008219|NCT00826462|Triamcinolone|triamcinolone|mesh-list
25008220|NCT00826462|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25008221|NCT00826462|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25008222|NCT00826462|Naproxen|naproxen|mesh-list
25008223|NCT00826462|Lidocaine|lidocaine|mesh-list
25008224|NCT00826462|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25008225|NCT00826462|Anesthetics, Local|anesthetics, local|mesh-ancestor
25008226|NCT00826462|Anesthetics|anesthetics|mesh-ancestor
25008227|NCT00826462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25008228|NCT00826462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008229|NCT00826462|Sensory System Agents|sensory system agents|mesh-ancestor
25008230|NCT00826462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25008231|NCT00826462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24510983|NCT00566891|Tirofiban|tirofiban|mesh-list
24555793|NCT00743587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555794|NCT00743678|Cetuximab|cetuximab|mesh-list
24555795|NCT00743678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24555796|NCT00743678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24555797|NCT00743743|Resveratrol|resveratrol|mesh-list
24555798|NCT00743743|Antioxidants|antioxidants|mesh-ancestor
24555799|NCT00743743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555800|NCT00743743|Protective Agents|protective agents|mesh-ancestor
24555801|NCT00743743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555802|NCT00743743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24555803|NCT00743743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24555804|NCT00743782|Hormones|hormones|mesh-list
24555805|NCT00743782|Parathyroid Hormone|parathyroid hormone|mesh-list
24555807|NCT00743782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555812|NCT00743834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24780103|NCT01881503|HBOC 201|hboc 201|mesh-list
24555813|NCT00743834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555816|NCT00743834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24555831|NCT00743847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24555832|NCT00743847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555833|NCT00743847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555834|NCT00743860|Darapladib|darapladib|mesh-list
24555835|NCT00743860|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
24555836|NCT00743860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462477|NCT00356395|Protease Inhibitors|protease inhibitors|mesh-ancestor
24555837|NCT00743860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555838|NCT00743873|Mitogens|mitogens|mesh-list
24555839|NCT00743873|Mitosis Modulators|mitosis modulators|mesh-ancestor
24555840|NCT00743873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555841|NCT00743886|Mitogens|mitogens|mesh-list
24555842|NCT00743886|Mitosis Modulators|mitosis modulators|mesh-ancestor
24555843|NCT00743886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555899|NCT00744185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24555900|NCT00744185|Vasodilator Agents|vasodilator agents|mesh-ancestor
24555901|NCT00744224|Exenatide|exenatide|mesh-list
24555902|NCT00744224|Prednisolone|prednisolone|mesh-list
24555903|NCT00744224|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24555904|NCT00744224|Methylprednisolone|methylprednisolone|mesh-list
24555905|NCT00744224|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24555906|NCT00744224|Prednisolone acetate|prednisolone acetate|mesh-list
24555907|NCT00744224|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24555908|NCT00744224|Prednisolone phosphate|prednisolone phosphate|mesh-list
24555909|NCT00744224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24555910|NCT00744224|Glucocorticoids|glucocorticoids|mesh-ancestor
24555911|NCT00744224|Hormones|hormones|mesh-ancestor
24488305|NCT00467636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24555912|NCT00744224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25242932|NCT05358977|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25242935|NCT05358912|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25109850|NCT03121573|Dopamine Agents|dopamine agents|mesh-ancestor
24555913|NCT00744224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555914|NCT00744224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24555915|NCT00744224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24555916|NCT00744224|Antiemetics|antiemetics|mesh-ancestor
24555917|NCT00744224|Autonomic Agents|autonomic agents|mesh-ancestor
24555922|NCT00744224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24555923|NCT00744224|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24555924|NCT00744224|Incretins|incretins|mesh-ancestor
24556124|NCT00745069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556126|NCT00745069|Sensory System Agents|sensory system agents|mesh-ancestor
24556127|NCT00745069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24556128|NCT00745069|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24556129|NCT00745069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24556130|NCT00745069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24556131|NCT00745069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556133|NCT00745069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24556134|NCT00745147|Laxatives|laxatives|mesh-list
24556204|NCT00746031|Goserelin|goserelin|mesh-list
24556205|NCT00746031|Cetrorelix|cetrorelix|mesh-list
24556206|NCT00746031|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24556207|NCT00746031|Hormones|hormones|mesh-ancestor
24556208|NCT00746031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24556209|NCT00746031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556210|NCT00746031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24556211|NCT00746031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556212|NCT00746031|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24556213|NCT00746031|Fertility Agents|fertility agents|mesh-ancestor
24556214|NCT00746031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24556442|NCT00747721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24556443|NCT00747721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556444|NCT00747721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24556445|NCT00747721|Analgesics|analgesics|mesh-ancestor
24556446|NCT00747721|Sensory System Agents|sensory system agents|mesh-ancestor
24556447|NCT00747721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24780248|NCT01883011|Piracetam|piracetam|mesh-list
24556448|NCT00747721|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24556449|NCT00747721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24556450|NCT00747721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24556451|NCT00747721|Adrenergic Agents|adrenergic agents|mesh-ancestor
24556452|NCT00747721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24556453|NCT00747721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556455|NCT00747799|Sorafenib|sorafenib|mesh-list
24556456|NCT00747799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556457|NCT00747799|Antimetabolites|antimetabolites|mesh-ancestor
24556458|NCT00747799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556459|NCT00747799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24885624|NCT05024513|Antimetabolites|antimetabolites|mesh-ancestor
24556576|NCT00748176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24556577|NCT00748176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556578|NCT00748202|Complement C1s|complement c1s|mesh-list
24556579|NCT00748202|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
24556580|NCT00748202|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
24556581|NCT00748202|Immunologic Factors|immunologic factors|mesh-ancestor
24556582|NCT00748202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556662|NCT00748644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24556663|NCT00748644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24556664|NCT00748787|Psyllium|psyllium|mesh-list
24556665|NCT00748787|Calcium polycarbophil|calcium polycarbophil|mesh-list
24556666|NCT00748787|Cathartics|cathartics|mesh-ancestor
25008322|NCT00344487|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25008339|NCT00281658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008340|NCT00281658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25008341|NCT00281658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25008342|NCT05209529|Durvalumab|durvalumab|mesh-list
25008343|NCT05209529|Olaparib|olaparib|mesh-list
25008344|NCT05209529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25008345|NCT05209529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008346|NCT05209529|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25008347|NCT05209529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25008348|NCT05209529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556727|NCT00749359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556801|NCT00749723|Thiotepa|thiotepa|mesh-list
24556802|NCT00749723|Trofosfamide|trofosfamide|mesh-list
24556803|NCT00749723|Cyclophosphamide|cyclophosphamide|mesh-list
25242942|NCT05358639|Olaparib|olaparib|mesh-list
25242943|NCT05358639|Navitoclax|navitoclax|mesh-list
25242944|NCT05358639|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25242945|NCT05358639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25242946|NCT05358639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242947|NCT05358639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242948|NCT05358548|Paclitaxel|paclitaxel|mesh-list
25242949|NCT05358548|Carboplatin|carboplatin|mesh-list
25242950|NCT05358548|Pembrolizumab|pembrolizumab|mesh-list
25242951|NCT05358548|Fluorouracil|fluorouracil|mesh-list
25242952|NCT05358548|Pemetrexed|pemetrexed|mesh-list
25242953|NCT05358548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25242954|NCT05358548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242955|NCT05358548|Tubulin Modulators|tubulin modulators|mesh-ancestor
25242956|NCT05358548|Antimitotic Agents|antimitotic agents|mesh-ancestor
25242957|NCT05358548|Mitosis Modulators|mitosis modulators|mesh-ancestor
25242958|NCT05358548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851652|NCT02257697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24851653|NCT02257697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24851654|NCT02257697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24556846|NCT00749918|Cholecalciferol|cholecalciferol|mesh-list
24556848|NCT00749918|Micronutrients|micronutrients|mesh-ancestor
24556849|NCT00749918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556850|NCT00749918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24556851|NCT00749918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24556852|NCT00750048|Acetaminophen|acetaminophen|mesh-list
24556853|NCT00750048|Naloxone|naloxone|mesh-list
24556854|NCT00750048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24556856|NCT00750048|Sensory System Agents|sensory system agents|mesh-ancestor
24556857|NCT00750048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24556858|NCT00750048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556859|NCT00750048|Antipyretics|antipyretics|mesh-ancestor
24556917|NCT00750347|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24556918|NCT00750347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24556919|NCT00750347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556920|NCT00750347|Hormones|hormones|mesh-ancestor
24556921|NCT00750347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24556922|NCT00750386|Paclitaxel|paclitaxel|mesh-list
24556923|NCT00750386|Carboplatin|carboplatin|mesh-list
24556924|NCT00750386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24557066|NCT00751205|Acetylcarnitine|acetylcarnitine|mesh-list
24557068|NCT00751205|Prednisolone|prednisolone|mesh-list
24557069|NCT00751205|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24557070|NCT00751205|Methylprednisolone|methylprednisolone|mesh-list
24557071|NCT00751205|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24557072|NCT00751205|Prednisolone acetate|prednisolone acetate|mesh-list
24557073|NCT00751205|Sagopilone|sagopilone|mesh-list
24557074|NCT00751205|Epothilones|epothilones|mesh-list
24557075|NCT00751205|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24557076|NCT00751205|Prednisolone phosphate|prednisolone phosphate|mesh-list
24557397|NCT00752479|Methylprednisolone|methylprednisolone|mesh-list
24557398|NCT00752479|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24557399|NCT00752479|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24557400|NCT00752479|Prednisolone|prednisolone|mesh-list
24557401|NCT00752479|Prednisolone acetate|prednisolone acetate|mesh-list
24557402|NCT00752479|Cyclosporins|cyclosporins|mesh-list
24557449|NCT00752635|Cyproterone Acetate|cyproterone acetate|mesh-list
24557450|NCT00752635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24557451|NCT00752635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24557452|NCT00752635|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24557453|NCT00752635|Norgestimate|norgestimate|mesh-list
24557900|NCT00754780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24557901|NCT00754780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24557925|NCT00754871|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24557926|NCT00754871|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24557927|NCT00754871|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24462639|NCT00357149|Cisplatin|cisplatin|mesh-list
24557928|NCT00754871|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24557929|NCT00754871|Hormone Antagonists|hormone antagonists|mesh-ancestor
24557930|NCT00754871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24557932|NCT00754871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24558031|NCT00755157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24558032|NCT00755157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24558033|NCT00755157|Growth Substances|growth substances|mesh-ancestor
24558034|NCT00755157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558035|NCT00755157|Growth Inhibitors|growth inhibitors|mesh-ancestor
24558036|NCT00755157|Tubulin Modulators|tubulin modulators|mesh-ancestor
24558037|NCT00755157|Antimitotic Agents|antimitotic agents|mesh-ancestor
24558038|NCT00755157|Mitosis Modulators|mitosis modulators|mesh-ancestor
25242959|NCT05358548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25242960|NCT05358548|Antimetabolites|antimetabolites|mesh-ancestor
25242961|NCT05358548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25242962|NCT05358548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25242963|NCT05358548|Immunologic Factors|immunologic factors|mesh-ancestor
25686493|NCT01920711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25242964|NCT05358548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242965|NCT05358548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25242966|NCT05358548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24558039|NCT00755157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558041|NCT00755170|Vinorelbine|vinorelbine|mesh-list
24558042|NCT00755170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24558043|NCT00755170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24558044|NCT00755170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24558045|NCT00755170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24558047|NCT00755170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558081|NCT00755313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24558082|NCT00755313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24558083|NCT00755313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24511105|NCT00567463|Fluticasone|fluticasone|mesh-list
24558095|NCT00755352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558096|NCT00755352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24558097|NCT00755352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24558098|NCT00755352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24558099|NCT00755404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24558429|NCT00757185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24558430|NCT00757185|Anabolic Agents|anabolic agents|mesh-ancestor
24558431|NCT00757185|Hormone Antagonists|hormone antagonists|mesh-ancestor
24558432|NCT00757198|Remifentanil|remifentanil|mesh-list
24558433|NCT00757198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24558434|NCT00757198|Narcotics|narcotics|mesh-ancestor
24558435|NCT00757198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24558436|NCT00757198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558437|NCT00757198|Analgesics|analgesics|mesh-ancestor
24558438|NCT00757198|Sensory System Agents|sensory system agents|mesh-ancestor
24558439|NCT00757198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24558445|NCT00757315|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24558446|NCT00757315|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24558447|NCT00757315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24558448|NCT00757315|Glucocorticoids|glucocorticoids|mesh-ancestor
24558449|NCT00757315|Hormones|hormones|mesh-ancestor
24558450|NCT00757315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24558451|NCT00757315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558452|NCT00757315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24558453|NCT00757315|Immunologic Factors|immunologic factors|mesh-ancestor
24558506|NCT00757549|Cetuximab|cetuximab|mesh-list
24558507|NCT00757549|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24558535|NCT00757731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24558536|NCT00757731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24558537|NCT00757731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558538|NCT00757731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24558539|NCT00757731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558540|NCT00757731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24558541|NCT00757731|Analgesics|analgesics|mesh-ancestor
24558542|NCT00757731|Sensory System Agents|sensory system agents|mesh-ancestor
24558543|NCT00757731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24558544|NCT00757731|Antidepressive Agents|antidepressive agents|mesh-ancestor
24558545|NCT00757731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24558546|NCT00757835|Timolol|timolol|mesh-list
24558547|NCT00757835|Latanoprost|latanoprost|mesh-list
24558548|NCT00757835|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24558549|NCT00757835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24558609|NCT00758199|Prednisolone acetate|prednisolone acetate|mesh-list
24584142|NCT00878670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584143|NCT00878670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25242967|NCT05358548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25274094|NCT02380755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24851685|NCT02258009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24851687|NCT02258204|Analgesics|analgesics|mesh-ancestor
24851688|NCT02258204|Sensory System Agents|sensory system agents|mesh-ancestor
25405939|NCT03587584|Sensory System Agents|sensory system agents|mesh-ancestor
24584149|NCT00878748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584150|NCT00878748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24584151|NCT00878748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008380|NCT05209295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25008381|NCT05209295|Antimetabolites|antimetabolites|mesh-ancestor
25008415|NCT05208801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008416|NCT05208801|Sensory System Agents|sensory system agents|mesh-ancestor
25008417|NCT05208801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25008418|NCT05208801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25008419|NCT05208801|Narcotics|narcotics|mesh-ancestor
25008420|NCT05208801|Analgesics|analgesics|mesh-ancestor
24558723|NCT05435560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24558725|NCT05435560|Sensory System Agents|sensory system agents|mesh-ancestor
24558726|NCT05435560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24558727|NCT05435560|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24558728|NCT05435560|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24558729|NCT05435560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24558730|NCT05435560|Adrenergic Agents|adrenergic agents|mesh-ancestor
24558731|NCT05435560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24558732|NCT05435560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671004|NCT01323101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24558802|NCT05434559|Insulin|insulin|mesh-list
24558803|NCT05434559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24558812|NCT05434377|Micronutrients|micronutrients|mesh-ancestor
24558914|NCT05414305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24558915|NCT05414305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558916|NCT05414305|Sensory System Agents|sensory system agents|mesh-ancestor
25242975|NCT05358509|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25242976|NCT05358509|Ferric Compounds|ferric compounds|mesh-list
25242977|NCT05358509|Hematinics|hematinics|mesh-ancestor
25242978|NCT05357885|Antibodies|antibodies|mesh-list
25242979|NCT05357885|Immunologic Factors|immunologic factors|mesh-ancestor
25242980|NCT05357885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242981|NCT05357872|Anesthetics|anesthetics|mesh-list
24496197|NCT00503659|Miotics|miotics|mesh-ancestor
24558917|NCT05414305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24558918|NCT05414305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24558919|NCT05414305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24559291|NCT05117554|Anesthetics|anesthetics|mesh-ancestor
24559292|NCT05117554|GABA Modulators|gaba modulators|mesh-ancestor
24559293|NCT05117554|GABA Agents|gaba agents|mesh-ancestor
24559294|NCT05117554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24559295|NCT05117554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621826|NCT01064180|Carvedilol|carvedilol|mesh-list
24621827|NCT01064180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24621828|NCT01064180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24621829|NCT01064180|Adrenergic Agents|adrenergic agents|mesh-ancestor
24621830|NCT01064180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24621831|NCT01064180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621832|NCT01064180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621833|NCT01064180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24621834|NCT01064180|Antioxidants|antioxidants|mesh-ancestor
24621835|NCT01064180|Protective Agents|protective agents|mesh-ancestor
24621836|NCT01064180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24621837|NCT01064180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25008422|NCT05208398|Apixaban|apixaban|mesh-list
25008439|NCT05208294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008440|NCT05208294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25008441|NCT05208294|Antidepressive Agents|antidepressive agents|mesh-ancestor
25008443|NCT05208268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25008444|NCT05208268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25008445|NCT05208268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25008446|NCT05208268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25008447|NCT05208268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008448|NCT05207904|Paclitaxel|paclitaxel|mesh-list
25008449|NCT05207904|Carboplatin|carboplatin|mesh-list
25242982|NCT05357872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25242983|NCT05357872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25242984|NCT05357846|Paclitaxel|paclitaxel|mesh-list
25242985|NCT05357846|Cisplatin|cisplatin|mesh-list
25242986|NCT05357846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25242987|NCT05357846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25242988|NCT05357846|Tubulin Modulators|tubulin modulators|mesh-ancestor
25242989|NCT05357846|Antimitotic Agents|antimitotic agents|mesh-ancestor
25242990|NCT05357846|Mitosis Modulators|mitosis modulators|mesh-ancestor
24683246|NCT01390896|Anticoagulants|anticoagulants|mesh-ancestor
25008450|NCT05207904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25008451|NCT05207904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008452|NCT05207904|Tubulin Modulators|tubulin modulators|mesh-ancestor
25008453|NCT05207904|Antimitotic Agents|antimitotic agents|mesh-ancestor
25008454|NCT05207904|Mitosis Modulators|mitosis modulators|mesh-ancestor
25008455|NCT05207904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008456|NCT05207774|Oxytocin|oxytocin|mesh-list
25008457|NCT05207774|Oxytocics|oxytocics|mesh-ancestor
25008458|NCT05207774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24559703|NCT04507906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25242991|NCT05357846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627766|NCT01094925|Anticonvulsants|anticonvulsants|mesh-ancestor
24890331|NCT04484259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24559839|NCT04285229|Ixekizumab|ixekizumab|mesh-list
25242992|NCT05357820|Itraconazole|itraconazole|mesh-list
25242993|NCT05357820|Rifampin|rifampin|mesh-list
25242994|NCT05357820|Antifungal Agents|antifungal agents|mesh-ancestor
25242995|NCT05357820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25242996|NCT05357820|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25242997|NCT05357820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25242998|NCT05357820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444866|NCT00299455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24560057|NCT03680352|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24560058|NCT03680352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25008491|NCT05207514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25008493|NCT05207436|Oxytocics|oxytocics|mesh-ancestor
25008494|NCT05207436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25008495|NCT05207436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008496|NCT05187338|Pembrolizumab|pembrolizumab|mesh-list
25008497|NCT05187338|Ipilimumab|ipilimumab|mesh-list
25008498|NCT05187338|Durvalumab|durvalumab|mesh-list
25008499|NCT05187338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25008500|NCT05187338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008501|NCT05187338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25008502|NCT05187338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008510|NCT05186467|Sensory System Agents|sensory system agents|mesh-ancestor
25008511|NCT05186467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25008512|NCT05186467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008514|NCT05186467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25008515|NCT05186467|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25008516|NCT05186467|Anticonvulsants|anticonvulsants|mesh-ancestor
25008517|NCT05186467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25008518|NCT05186467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25008519|NCT05186467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008520|NCT05186467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25008521|NCT05186467|Tocolytic Agents|tocolytic agents|mesh-ancestor
25008522|NCT05186467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25008523|NCT05182892|Dopamine|dopamine|mesh-list
25008524|NCT05182892|Dopamine Agonists|dopamine agonists|mesh-list
25008530|NCT05182892|Dopamine Agents|dopamine agents|mesh-ancestor
25008531|NCT05182892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25008532|NCT05182892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008533|NCT05182892|Protective Agents|protective agents|mesh-ancestor
25008534|NCT05171673|Diclofenac|diclofenac|mesh-list
25242999|NCT05357820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243000|NCT05357820|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25243001|NCT05357820|Hormone Antagonists|hormone antagonists|mesh-ancestor
25243002|NCT05357820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25243003|NCT05357820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24560367|NCT02870920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24560369|NCT02813824|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
24560370|NCT02813824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25686494|NCT01920802|Olanzapine|olanzapine|mesh-list
25686495|NCT01920802|Iloperidone|iloperidone|mesh-list
24560371|NCT02813824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24560372|NCT02813824|Analgesics|analgesics|mesh-ancestor
24560373|NCT02813824|Sensory System Agents|sensory system agents|mesh-ancestor
24560374|NCT02813824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24560375|NCT02813824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464915|NCT00367302|Methadone|methadone|mesh-list
24560389|NCT02783300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24560390|NCT02783300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560392|NCT02726997|Carboplatin|carboplatin|mesh-list
24560393|NCT02726997|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24560394|NCT02726997|Durvalumab|durvalumab|mesh-list
24560395|NCT02726997|Immunoglobulins|immunoglobulins|mesh-list
24560485|NCT02476279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24560486|NCT02476279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24560503|NCT02471833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780871|NCT01886794|Estrogens|estrogens|mesh-list
24560638|NCT02106988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24560639|NCT02106988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24560640|NCT02106988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24560641|NCT02106988|Glucocorticoids|glucocorticoids|mesh-ancestor
25243004|NCT05357820|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25243005|NCT05357820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25243006|NCT05357820|Antitubercular Agents|antitubercular agents|mesh-ancestor
25243007|NCT05357820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25243008|NCT05357820|Leprostatic Agents|leprostatic agents|mesh-ancestor
24560643|NCT02106988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24560644|NCT02106988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24560645|NCT02106988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24560646|NCT02106988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24560647|NCT02106988|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24560648|NCT02106988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24560649|NCT02106988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24560650|NCT02106988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560651|NCT02106988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24560652|NCT02106988|Alkylating Agents|alkylating agents|mesh-ancestor
24560657|NCT02018861|Rituximab|rituximab|mesh-list
24560696|NCT01721759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24560786|NCT01451515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561062|NCT00567580|Contraceptive Agents|contraceptive agents|mesh-ancestor
24561063|NCT00567580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24561064|NCT00485693|Epinephrine|epinephrine|mesh-list
24561065|NCT00485693|Bupivacaine|bupivacaine|mesh-list
24561066|NCT00485693|Anesthetics, Local|anesthetics, local|mesh-ancestor
24561067|NCT00485693|Anesthetics|anesthetics|mesh-ancestor
25008558|NCT05149287|Sensory System Agents|sensory system agents|mesh-ancestor
25008559|NCT05149287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25008560|NCT05149287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25008561|NCT05149287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25008562|NCT05149287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25008563|NCT05149287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25243009|NCT05357820|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25243010|NCT05357820|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25243011|NCT05357820|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25243012|NCT05357820|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25243013|NCT05357820|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25275649|NCT02370550|Cyclosporins|cyclosporins|mesh-list
25275650|NCT02370550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25275651|NCT02370550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275652|NCT02370550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24444871|NCT00299520|Iclaprim|iclaprim|mesh-list
25070282|NCT03420742|Anesthetics|anesthetics|mesh-ancestor
24561070|NCT00485693|Sensory System Agents|sensory system agents|mesh-ancestor
24561071|NCT00485693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24561072|NCT00485693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24561074|NCT00485693|Adrenergic Agents|adrenergic agents|mesh-ancestor
24561075|NCT00485693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24561076|NCT00485693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243016|NCT05357794|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24488014|NCT00466180|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24488169|NCT00466895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24488170|NCT00466895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24488171|NCT00466895|Growth Substances|growth substances|mesh-ancestor
25243017|NCT05357794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25243018|NCT05357794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25243019|NCT05357768|Formaldehyde|formaldehyde|mesh-list
25243020|NCT05357768|Disinfectants|disinfectants|mesh-ancestor
25243021|NCT05357768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24444872|NCT00299520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24444873|NCT00299520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24444874|NCT00299520|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24444875|NCT00299520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444876|NCT00299520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561312|NCT00759317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24561314|NCT00759421|Sertindole|sertindole|mesh-list
24561315|NCT00759421|Antiemetics|antiemetics|mesh-ancestor
24561316|NCT00759421|Autonomic Agents|autonomic agents|mesh-ancestor
24561317|NCT00759421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24561318|NCT00759421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561319|NCT00759421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24561320|NCT00759421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24561321|NCT00759421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24561349|NCT00759551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24561350|NCT00759551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24561351|NCT00759551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24561352|NCT00759551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561353|NCT00759720|Glyburide|glyburide|mesh-list
24561354|NCT00759720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24561413|NCT00760045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561414|NCT00760045|Viscosupplements|viscosupplements|mesh-ancestor
24561415|NCT00760045|Protective Agents|protective agents|mesh-ancestor
24561416|NCT00760149|Rifampin|rifampin|mesh-list
24561417|NCT00760149|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24561418|NCT00760149|Antitubercular Agents|antitubercular agents|mesh-ancestor
24561419|NCT00760149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24561420|NCT00760149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24561421|NCT00760149|Leprostatic Agents|leprostatic agents|mesh-ancestor
24561422|NCT00760149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24561423|NCT00760149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24561424|NCT00760149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561425|NCT00760149|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24561426|NCT00760149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24561427|NCT00760149|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24561428|NCT00760149|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24561429|NCT00760149|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25243042|NCT05357547|Buspirone|buspirone|mesh-list
25243043|NCT05357547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25243044|NCT05357547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25243045|NCT05357547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25243046|NCT05357547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243047|NCT05357547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25243048|NCT05357547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25243049|NCT05357547|Serotonin Agents|serotonin agents|mesh-ancestor
24791407|NCT04487990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24791408|NCT04487990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791409|NCT04476979|Dexamethasone|dexamethasone|mesh-list
25686496|NCT01920802|Antiemetics|antiemetics|mesh-ancestor
25686497|NCT01920802|Autonomic Agents|autonomic agents|mesh-ancestor
25686498|NCT01920802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686499|NCT01920802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686500|NCT01920802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24791410|NCT04476979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24791411|NCT04476979|Antiemetics|antiemetics|mesh-ancestor
25686501|NCT01920802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25686502|NCT01920802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24561430|NCT00760149|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24561431|NCT00760175|Vaccines|vaccines|mesh-list
24561432|NCT00760175|Immunologic Factors|immunologic factors|mesh-ancestor
24561518|NCT00761228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561519|NCT00761241|Gemcitabine|gemcitabine|mesh-list
24561520|NCT00761241|Interferons|interferons|mesh-list
24561521|NCT00761241|Interferon-alpha|interferon-alpha|mesh-list
24561523|NCT00761241|Docetaxel|docetaxel|mesh-list
24561631|NCT00761722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24561632|NCT00761722|Antimetabolites|antimetabolites|mesh-ancestor
24561633|NCT00761722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008564|NCT05149287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008565|NCT05149287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25008566|NCT05149287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25008567|NCT05122130|Melatonin|melatonin|mesh-list
25008568|NCT05122130|Antioxidants|antioxidants|mesh-ancestor
25109852|NCT03121417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24561637|NCT00761852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24561638|NCT00761852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561639|NCT00761904|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24561640|NCT00761904|Simvastatin|simvastatin|mesh-list
24561641|NCT00761904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24561642|NCT00761904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24561643|NCT00761904|Antimetabolites|antimetabolites|mesh-ancestor
24561644|NCT00761904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561645|NCT00761904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24561699|NCT00762398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24561700|NCT00762398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24561702|NCT00762398|Sensory System Agents|sensory system agents|mesh-ancestor
24561743|NCT00762658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24561744|NCT00762658|Respiratory System Agents|respiratory system agents|mesh-ancestor
24561745|NCT00762671|Ebselen|ebselen|mesh-list
24561746|NCT00762671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24561747|NCT00762671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24561748|NCT00762671|Analgesics|analgesics|mesh-ancestor
25243050|NCT05357547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25243051|NCT05357547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243052|NCT05357456|Epinephrine|epinephrine|mesh-list
25243053|NCT05357456|Racepinephrine|racepinephrine|mesh-list
25243054|NCT05357456|Epinephryl borate|epinephryl borate|mesh-list
25243055|NCT05357456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24444932|NCT00299754|Oxytocics|oxytocics|mesh-ancestor
24561749|NCT00762671|Sensory System Agents|sensory system agents|mesh-ancestor
24561750|NCT00762671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24561751|NCT00762671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561752|NCT00762671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24561753|NCT00762671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24561754|NCT00762671|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24561755|NCT00762671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24561756|NCT00762671|Antioxidants|antioxidants|mesh-ancestor
24561757|NCT00762671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561758|NCT00762671|Protective Agents|protective agents|mesh-ancestor
24562011|NCT00764036|Anthelmintics|anthelmintics|mesh-ancestor
24562012|NCT00764062|Amoxicillin|amoxicillin|mesh-list
24562013|NCT00764062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24562029|NCT00764166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562030|NCT00764244|Triamcinolone|triamcinolone|mesh-list
24562031|NCT00764244|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24562032|NCT00764244|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24562033|NCT00764244|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24562034|NCT00764244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24562039|NCT00764244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24562040|NCT00764244|Immunologic Factors|immunologic factors|mesh-ancestor
24562041|NCT00764244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562049|NCT00764374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562050|NCT00764374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24562051|NCT00764413|Methylprednisolone|methylprednisolone|mesh-list
24562052|NCT00764413|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24562053|NCT00764413|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24562055|NCT00764413|Prednisolone acetate|prednisolone acetate|mesh-list
24562056|NCT00764413|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24562057|NCT00764413|Prednisolone phosphate|prednisolone phosphate|mesh-list
24562058|NCT00764413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24562059|NCT00764413|Antiemetics|antiemetics|mesh-ancestor
24562060|NCT00764413|Autonomic Agents|autonomic agents|mesh-ancestor
24562061|NCT00764413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24562062|NCT00764413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562362|NCT00766181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24562363|NCT00766181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24562364|NCT00766181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562366|NCT00766220|Cetuximab|cetuximab|mesh-list
24562367|NCT00766220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24562368|NCT00766220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24562369|NCT00766220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562370|NCT00766220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562371|NCT00766220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562372|NCT00766220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24562373|NCT00766246|Bevacizumab|bevacizumab|mesh-list
24562374|NCT00766246|Carboplatin|carboplatin|mesh-list
24562375|NCT00766246|Docetaxel|docetaxel|mesh-list
24562376|NCT00766246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24562377|NCT00766246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562378|NCT00766246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24562379|NCT00766246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25243056|NCT05357456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25243057|NCT05357456|Adrenergic Agents|adrenergic agents|mesh-ancestor
25243058|NCT05357456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25243059|NCT05357456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243060|NCT05357456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243061|NCT05357456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24781119|NCT01888120|Ziconotide|ziconotide|mesh-list
25243062|NCT05357456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24444934|NCT00299819|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24444935|NCT00299819|Immunologic Factors|immunologic factors|mesh-ancestor
24444936|NCT00299819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444937|NCT00299845|Lansoprazole|lansoprazole|mesh-list
24444938|NCT00299845|Dexlansoprazole|dexlansoprazole|mesh-list
24444939|NCT00299845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24444940|NCT00299845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24444941|NCT00299845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24444942|NCT00299845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25070313|NCT03420638|Mydriatics|mydriatics|mesh-ancestor
24562380|NCT00766246|Growth Substances|growth substances|mesh-ancestor
24562381|NCT00766246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562382|NCT00766246|Growth Inhibitors|growth inhibitors|mesh-ancestor
24562383|NCT00766246|Tubulin Modulators|tubulin modulators|mesh-ancestor
24562384|NCT00766246|Antimitotic Agents|antimitotic agents|mesh-ancestor
24562418|NCT00766350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24562419|NCT00766350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24671026|NCT01323257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279102|NCT02346539|Nicotine|nicotine|mesh-list
24562420|NCT00766350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562422|NCT00766350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24562463|NCT00766545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562485|NCT00766662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562486|NCT00766662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24562487|NCT00766662|Renal Agents|renal agents|mesh-ancestor
24562488|NCT00766805|Propranolol|propranolol|mesh-list
24562489|NCT00766805|Isosorbide|isosorbide|mesh-list
24562493|NCT00766805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24562494|NCT00766805|Adrenergic Agents|adrenergic agents|mesh-ancestor
24562495|NCT00766805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24562496|NCT00766805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109879|NCT03121690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109880|NCT03121690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25109881|NCT03121690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109882|NCT03121547|Tramadol|tramadol|mesh-list
25109883|NCT03121547|Tapentadol|tapentadol|mesh-list
25109884|NCT03121547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109885|NCT03121547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25109886|NCT03121547|Narcotics|narcotics|mesh-ancestor
25109887|NCT03121547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25109888|NCT03121547|Analgesics|analgesics|mesh-ancestor
25109889|NCT03121547|Sensory System Agents|sensory system agents|mesh-ancestor
25109890|NCT03121547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25109891|NCT03121547|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25109892|NCT03121547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25109893|NCT03121547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25109894|NCT03121547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109895|NCT03121547|Adrenergic Agents|adrenergic agents|mesh-ancestor
25109896|NCT03121547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25109897|NCT03121339|Vaccines|vaccines|mesh-list
25109898|NCT03121339|Immunologic Factors|immunologic factors|mesh-ancestor
25109899|NCT03121339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109900|NCT03121261|Clonidine|clonidine|mesh-list
24781210|NCT01888562|Ponatinib|ponatinib|mesh-list
25109901|NCT03121261|Levobupivacaine|levobupivacaine|mesh-list
25243063|NCT05357456|Autonomic Agents|autonomic agents|mesh-ancestor
25243064|NCT05357456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25243065|NCT05357456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25243066|NCT05357456|Respiratory System Agents|respiratory system agents|mesh-ancestor
25243067|NCT05357456|Mydriatics|mydriatics|mesh-ancestor
25243068|NCT05357456|Sympathomimetics|sympathomimetics|mesh-ancestor
25243069|NCT05357456|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25243070|NCT05357430|Propofol|propofol|mesh-list
25243071|NCT05357430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25243072|NCT05357430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24444943|NCT00299845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444945|NCT00299858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24444946|NCT00299858|Autonomic Agents|autonomic agents|mesh-ancestor
24444947|NCT00299858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24444948|NCT00299858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109903|NCT03121261|Sensory System Agents|sensory system agents|mesh-ancestor
25109904|NCT03121261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25109905|NCT03121261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109906|NCT03121261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25109907|NCT03121261|Sympatholytics|sympatholytics|mesh-ancestor
25109908|NCT03121261|Autonomic Agents|autonomic agents|mesh-ancestor
24562499|NCT00766805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24562500|NCT00766805|Vasodilator Agents|vasodilator agents|mesh-ancestor
24562501|NCT00766805|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24562510|NCT00766818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562512|NCT00766818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24562513|NCT00766818|Antiviral Agents|antiviral agents|mesh-ancestor
24562514|NCT00766818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24562515|NCT00766818|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24562568|NCT00767091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562569|NCT00767091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562570|NCT00767091|Cholinergic Agents|cholinergic agents|mesh-ancestor
24562571|NCT00767091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24562695|NCT00767715|Serotonin Agents|serotonin agents|mesh-ancestor
24562696|NCT00767715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24562697|NCT00767715|Dopamine Agents|dopamine agents|mesh-ancestor
24562698|NCT00767715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25008601|NCT04947059|Antimetabolites|antimetabolites|mesh-ancestor
25243073|NCT05357430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243074|NCT05357430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25243075|NCT05357430|Anesthetics, General|anesthetics, general|mesh-ancestor
25243076|NCT05357430|Anesthetics|anesthetics|mesh-ancestor
24444968|NCT00299884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444969|NCT00299884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24444970|NCT00299884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24444971|NCT00299884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444972|NCT00299910|Montelukast|montelukast|mesh-list
24444973|NCT00299910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25008602|NCT04947059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008603|NCT04947059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008604|NCT04947059|Antiviral Agents|antiviral agents|mesh-ancestor
25008605|NCT04947059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24684507|NCT05244252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24684508|NCT05244252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684509|NCT05244252|Sensory System Agents|sensory system agents|mesh-ancestor
24684510|NCT05244252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24684512|NCT05243251|Antiemetics|antiemetics|mesh-ancestor
24684513|NCT05243251|Autonomic Agents|autonomic agents|mesh-ancestor
24684514|NCT05243251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24684515|NCT05243251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008606|NCT04947059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25008607|NCT04947059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25008608|NCT04947059|Immunologic Factors|immunologic factors|mesh-ancestor
25008609|NCT04947059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008610|NCT04947059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25008611|NCT04947059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25008614|NCT04938609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25008615|NCT04938609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008616|NCT04921735|Cisatracurium|cisatracurium|mesh-list
25008617|NCT04921735|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25008618|NCT04921735|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25008619|NCT04921735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25008620|NCT04921735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791520|NCT04127851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24791521|NCT04127851|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25008621|NCT04908475|Apremilast|apremilast|mesh-list
25008622|NCT04908475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25008623|NCT04908475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25008624|NCT04908475|Analgesics|analgesics|mesh-ancestor
25008625|NCT04908475|Sensory System Agents|sensory system agents|mesh-ancestor
25008626|NCT04908475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25008627|NCT04908475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008633|NCT04908475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008634|NCT04879368|Trifluridine|trifluridine|mesh-list
24563299|NCT00770900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563300|NCT00770952|Pioglitazone|pioglitazone|mesh-list
24563301|NCT00770952|Glimepiride|glimepiride|mesh-list
24563302|NCT00770952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24563303|NCT00770952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563304|NCT00770952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24563305|NCT00770952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24563306|NCT00770952|Immunologic Factors|immunologic factors|mesh-ancestor
24563307|NCT00770978|Ceftobiprole|ceftobiprole|mesh-list
24563308|NCT00770978|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
24462768|NCT00357604|Ritonavir|ritonavir|mesh-list
24563309|NCT00770978|Cephalosporins|cephalosporins|mesh-list
24563310|NCT00770978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24563311|NCT00770978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24563312|NCT00771004|Pioglitazone|pioglitazone|mesh-list
24563313|NCT00771004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24563314|NCT00771004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243085|NCT05357326|Atropine|atropine|mesh-list
25243086|NCT05357326|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25243087|NCT05357326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24563368|NCT00771342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563369|NCT00771342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24563370|NCT00771342|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24563371|NCT00771342|Vasodilator Agents|vasodilator agents|mesh-ancestor
24781351|NCT01888978|Antidotes|antidotes|mesh-ancestor
24563372|NCT00771342|Gasotransmitters|gasotransmitters|mesh-ancestor
24563373|NCT00771342|Protective Agents|protective agents|mesh-ancestor
24563375|NCT00771368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25686503|NCT01920802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25686504|NCT01920802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25686505|NCT01920802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25686506|NCT01920802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25686507|NCT01920802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25686508|NCT01920802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686509|NCT01920802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24684633|NCT04941937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24684634|NCT04941937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684635|NCT04941937|Immunologic Factors|immunologic factors|mesh-ancestor
24684636|NCT04941937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24684637|NCT04941937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24684638|NCT04941937|Growth Substances|growth substances|mesh-ancestor
24684639|NCT04941937|Growth Inhibitors|growth inhibitors|mesh-ancestor
24684640|NCT04941937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24563376|NCT00771368|Autonomic Agents|autonomic agents|mesh-ancestor
24563377|NCT00771368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24563381|NCT00771368|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24563382|NCT00771368|Antioxidants|antioxidants|mesh-ancestor
24563383|NCT00771368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563384|NCT00771368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24563385|NCT00771368|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24563386|NCT00771368|Vasodilator Agents|vasodilator agents|mesh-ancestor
24563387|NCT00771368|Gasotransmitters|gasotransmitters|mesh-ancestor
24563388|NCT00771368|Protective Agents|protective agents|mesh-ancestor
24563389|NCT00771381|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
24563390|NCT00771381|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24563452|NCT00771563|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24563453|NCT00771563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24563455|NCT00771641|Trace Elements|trace elements|mesh-ancestor
24563456|NCT00771641|Micronutrients|micronutrients|mesh-ancestor
24563457|NCT00771641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563458|NCT00771680|Insulin|insulin|mesh-list
24563459|NCT00771680|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24563460|NCT00771680|Insulin Aspart|insulin aspart|mesh-list
24563466|NCT00771680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24563470|NCT00771706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563472|NCT00771719|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
24563473|NCT00771719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24563474|NCT00771719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24563476|NCT00771823|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24563477|NCT00771823|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24563478|NCT00771823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563540|NCT00772265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563541|NCT00772291|Pregabalin|pregabalin|mesh-list
24563542|NCT00772291|Analgesics|analgesics|mesh-ancestor
24563543|NCT00772291|Sensory System Agents|sensory system agents|mesh-ancestor
24563544|NCT00772291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24563545|NCT00772291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243089|NCT05357326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25243090|NCT05357326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25243091|NCT05357326|Autonomic Agents|autonomic agents|mesh-ancestor
25243092|NCT05357326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25243093|NCT05357326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243094|NCT05357326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25243095|NCT05357326|Respiratory System Agents|respiratory system agents|mesh-ancestor
25243096|NCT05357326|Mydriatics|mydriatics|mesh-ancestor
25243097|NCT05357326|Parasympatholytics|parasympatholytics|mesh-ancestor
25243098|NCT05357326|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25243099|NCT05357326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25243100|NCT05357326|Cholinergic Agents|cholinergic agents|mesh-ancestor
25070346|NCT03420378|Vitamin D|vitamin d|mesh-list
24563546|NCT00772291|Anticonvulsants|anticonvulsants|mesh-ancestor
24563547|NCT00772291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25686510|NCT01920802|Serotonin Agents|serotonin agents|mesh-ancestor
25686511|NCT01920893|Mometasone Furoate|mometasone furoate|mesh-list
25686512|NCT01920893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25686513|NCT01920893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25686514|NCT01920893|Dermatologic Agents|dermatologic agents|mesh-ancestor
25686515|NCT01920893|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25686516|NCT01920893|Immunologic Factors|immunologic factors|mesh-ancestor
25686517|NCT01920893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686518|NCT01921205|Lacosamide|lacosamide|mesh-list
25686519|NCT01921205|Anticonvulsants|anticonvulsants|mesh-ancestor
24684909|NCT03308578|Antimetabolites|antimetabolites|mesh-ancestor
24684910|NCT03308578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855071|NCT02277132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24563548|NCT00772291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24563549|NCT00772291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563550|NCT00772291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24563551|NCT00772291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24563561|NCT00772395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24563562|NCT00772395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563563|NCT00772395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24563605|NCT00772551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24563606|NCT00772551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24563607|NCT00772551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24563608|NCT00772551|Antiviral Agents|antiviral agents|mesh-ancestor
24563609|NCT00772551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24891508|NCT04470076|Pemetrexed|pemetrexed|mesh-list
24563610|NCT00772551|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24563611|NCT00772551|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24563612|NCT00772551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563613|NCT00772564|Atorvastatin|atorvastatin|mesh-list
24563614|NCT00772564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24563615|NCT00772564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24563616|NCT00772564|Antimetabolites|antimetabolites|mesh-ancestor
24563617|NCT00772564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563618|NCT00772564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24563619|NCT00772564|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24563620|NCT00772564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563621|NCT00772616|Sufentanil|sufentanil|mesh-list
24563622|NCT00772616|Remifentanil|remifentanil|mesh-list
24563703|NCT00772902|Antiviral Agents|antiviral agents|mesh-ancestor
24563704|NCT00772902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24563705|NCT00772902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24563706|NCT00772902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24563715|NCT00773084|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24563717|NCT00773084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24563718|NCT00773084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563719|NCT00773084|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24563720|NCT00773084|Diuretics|diuretics|mesh-ancestor
24563721|NCT00773084|Natriuretic Agents|natriuretic agents|mesh-ancestor
24563722|NCT00773084|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24563723|NCT00773084|Protease Inhibitors|protease inhibitors|mesh-ancestor
24563724|NCT00773084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563725|NCT00773084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563726|NCT00773084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24563727|NCT00773084|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24563728|NCT00773084|Protective Agents|protective agents|mesh-ancestor
24563746|NCT00773188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563747|NCT00773188|Growth Inhibitors|growth inhibitors|mesh-ancestor
24563748|NCT00773188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24563749|NCT00773188|Tubulin Modulators|tubulin modulators|mesh-ancestor
24563750|NCT00773188|Antimitotic Agents|antimitotic agents|mesh-ancestor
24563751|NCT00773188|Mitosis Modulators|mitosis modulators|mesh-ancestor
24563752|NCT00773188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563753|NCT00773201|Sotalol|sotalol|mesh-list
24563754|NCT00773201|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24563755|NCT00773201|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24563756|NCT00773201|Adrenergic Agents|adrenergic agents|mesh-ancestor
25243101|NCT05357326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25243102|NCT05357326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243103|NCT05357196|Gemcitabine|gemcitabine|mesh-list
25243104|NCT05357196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25243105|NCT05357196|Antimetabolites|antimetabolites|mesh-ancestor
25243106|NCT05357196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243107|NCT05357196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24563769|NCT00773552|Cholinergic Agents|cholinergic agents|mesh-ancestor
24563770|NCT00773552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24563771|NCT00773552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686520|NCT01921205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25686521|NCT01921205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25686522|NCT01921205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24855086|NCT02277171|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24855087|NCT02277171|Vasodilator Agents|vasodilator agents|mesh-ancestor
24855088|NCT02277171|Gasotransmitters|gasotransmitters|mesh-ancestor
24855089|NCT02277171|Protective Agents|protective agents|mesh-ancestor
24685038|NCT02871219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24685039|NCT02607956|Dolutegravir|dolutegravir|mesh-list
24682630|NCT01387243|Orlistat|orlistat|mesh-list
24685108|NCT02215122|Respiratory System Agents|respiratory system agents|mesh-ancestor
24685109|NCT02215122|Glucocorticoids|glucocorticoids|mesh-ancestor
24685110|NCT02215122|Hormones|hormones|mesh-ancestor
24685111|NCT02215122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24563772|NCT00773552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563773|NCT00773552|Urological Agents|urological agents|mesh-ancestor
24563775|NCT00773578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24563776|NCT00773578|Autonomic Agents|autonomic agents|mesh-ancestor
24563777|NCT00773578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24563778|NCT00773578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563779|NCT00773578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24563780|NCT00773578|Respiratory System Agents|respiratory system agents|mesh-ancestor
24563781|NCT00773578|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24563782|NCT00773578|Antioxidants|antioxidants|mesh-ancestor
24791612|NCT03785691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24563818|NCT00773708|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24563819|NCT00773708|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24563820|NCT00773708|Antiviral Agents|antiviral agents|mesh-ancestor
24563821|NCT00773708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24563822|NCT00773708|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24563823|NCT00773708|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25243108|NCT05357196|Antiviral Agents|antiviral agents|mesh-ancestor
24781479|NCT01889849|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25243109|NCT05357196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25243110|NCT05357196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25243111|NCT05357196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25243112|NCT05357196|Immunologic Factors|immunologic factors|mesh-ancestor
25243113|NCT05357196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243115|NCT05357066|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25243116|NCT05357066|Anesthetics, General|anesthetics, general|mesh-ancestor
25243117|NCT05357066|Anesthetics|anesthetics|mesh-ancestor
24445119|NCT00300404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24445120|NCT00300404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24445121|NCT00300404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24563824|NCT00773708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563825|NCT00773708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563826|NCT00773812|Mecamylamine|mecamylamine|mesh-list
24563845|NCT00773916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24563847|NCT00774007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24563848|NCT00774007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24563849|NCT00774007|Analgesics|analgesics|mesh-ancestor
24563850|NCT00774007|Sensory System Agents|sensory system agents|mesh-ancestor
24563851|NCT00774007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24563872|NCT00774189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24563873|NCT00774189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24563874|NCT00774189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563875|NCT00774189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563876|NCT00774189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24563877|NCT00774189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24563878|NCT00774241|Bevacizumab|bevacizumab|mesh-list
24791590|NCT03873246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791591|NCT03873246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791592|NCT03866577|Immunoglobulins|immunoglobulins|mesh-list
24791593|NCT03866577|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24791594|NCT03866577|Antibodies|antibodies|mesh-list
24791595|NCT03866577|gamma-Globulins|gamma-globulins|mesh-list
24791596|NCT03866577|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25686523|NCT01921205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686524|NCT01921270|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25686525|NCT01921270|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25686526|NCT01921270|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25686527|NCT01921270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25686528|NCT01921270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686529|NCT01921270|Cholinergic Agents|cholinergic agents|mesh-ancestor
25686530|NCT01921270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25686531|NCT01921270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686532|NCT01921270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24685251|NCT00492167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24685252|NCT00492167|Immunologic Factors|immunologic factors|mesh-ancestor
24791597|NCT03866577|Immunologic Factors|immunologic factors|mesh-ancestor
24791598|NCT03866577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791600|NCT03785691|Mirtazapine|mirtazapine|mesh-list
24791601|NCT03785691|Antiemetics|antiemetics|mesh-ancestor
24791602|NCT03785691|Autonomic Agents|autonomic agents|mesh-ancestor
24791603|NCT03785691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24791604|NCT03785691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791605|NCT03785691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24791606|NCT03785691|Antipruritics|antipruritics|mesh-ancestor
24791607|NCT03785691|Dermatologic Agents|dermatologic agents|mesh-ancestor
24781582|NCT01890863|Xhance|xhance|mesh-list
24791608|NCT03785691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24791609|NCT03785691|Serotonin Agents|serotonin agents|mesh-ancestor
24791610|NCT03785691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24791611|NCT03785691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791614|NCT03785691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24791615|NCT03785691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25008673|NCT04720963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25008674|NCT04720963|Adrenergic Agents|adrenergic agents|mesh-ancestor
25008675|NCT04720963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25008676|NCT04720963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008677|NCT04699357|Atropine|atropine|mesh-list
25008678|NCT04699357|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25008679|NCT04699357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25008680|NCT04699357|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25008681|NCT04699357|Autonomic Agents|autonomic agents|mesh-ancestor
25008682|NCT04699357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25008683|NCT04699357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008684|NCT04699357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25008685|NCT04699357|Respiratory System Agents|respiratory system agents|mesh-ancestor
25008686|NCT04699357|Mydriatics|mydriatics|mesh-ancestor
25008687|NCT04699357|Parasympatholytics|parasympatholytics|mesh-ancestor
24563902|NCT00774280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25243118|NCT05357066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25243119|NCT05357066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243120|NCT05357066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24445122|NCT00300404|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24445123|NCT00300404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812295|NCT02051231|Oxytocics|oxytocics|mesh-ancestor
24812296|NCT02051231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24812297|NCT02051231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812298|NCT02051387|Cannabidiol|cannabidiol|mesh-list
24812299|NCT02051387|Olanzapine|olanzapine|mesh-list
24812300|NCT02051387|Risperidone|risperidone|mesh-list
24812301|NCT02051387|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24812302|NCT02051387|Amisulpride|amisulpride|mesh-list
24812303|NCT02051387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24812304|NCT02051387|Serotonin Agents|serotonin agents|mesh-ancestor
24653169|NCT01242267|Bortezomib|bortezomib|mesh-list
24445124|NCT00300404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445125|NCT00300443|Bimatoprost|bimatoprost|mesh-list
24445126|NCT00300443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24445127|NCT00300508|Anastrozole|anastrozole|mesh-list
24445128|NCT00300508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24445129|NCT00300508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445130|NCT00300508|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24445131|NCT00300508|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24626423|NCT01087398|Cyclosporine|cyclosporine|mesh-list
24563904|NCT00774319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24563905|NCT00774358|Aldesleukin|aldesleukin|mesh-list
24563906|NCT00774358|Interleukin-2|interleukin-2|mesh-list
24563907|NCT00774358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24563908|NCT00774358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24563909|NCT00774358|Analgesics|analgesics|mesh-ancestor
24563910|NCT00774358|Sensory System Agents|sensory system agents|mesh-ancestor
24563911|NCT00774358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24563912|NCT00774358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563913|NCT00774358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25686533|NCT01921270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686534|NCT01921296|Cyclobenzaprine|cyclobenzaprine|mesh-list
24563914|NCT00774358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24563915|NCT00774358|Antiviral Agents|antiviral agents|mesh-ancestor
24563916|NCT00774358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24563917|NCT00774423|Riluzole|riluzole|mesh-list
24685485|NCT05271539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24685486|NCT05271539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24685487|NCT05271539|Growth Substances|growth substances|mesh-ancestor
24812693|NCT02054143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24812694|NCT02054143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24812695|NCT02054143|Anesthetics, General|anesthetics, general|mesh-ancestor
24563918|NCT00774423|Anticonvulsants|anticonvulsants|mesh-ancestor
24563919|NCT00774423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24563924|NCT00774423|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24563925|NCT00774423|Protective Agents|protective agents|mesh-ancestor
24563927|NCT00774462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24563928|NCT00774462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24563929|NCT00774462|Immunologic Factors|immunologic factors|mesh-ancestor
24563930|NCT00774462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563931|NCT00774462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24563932|NCT00774475|Clopidogrel|clopidogrel|mesh-list
24563933|NCT00774475|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24563934|NCT00774475|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24563935|NCT00774475|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24563936|NCT00774475|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24563937|NCT00774475|Purinergic Agents|purinergic agents|mesh-ancestor
24563938|NCT00774475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25243128|NCT05357040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25243129|NCT05357040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243130|NCT05357040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25243131|NCT05357040|Analgesics|analgesics|mesh-ancestor
25243132|NCT05357040|Sensory System Agents|sensory system agents|mesh-ancestor
25243133|NCT05357040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25243134|NCT05357027|Cyclophosphamide|cyclophosphamide|mesh-list
25243135|NCT05357027|Fludarabine|fludarabine|mesh-list
25243136|NCT05357027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25243137|NCT05357027|Immunologic Factors|immunologic factors|mesh-ancestor
25243138|NCT05357027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243139|NCT05357027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25243140|NCT05357027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25243141|NCT05357027|Alkylating Agents|alkylating agents|mesh-ancestor
25274095|NCT02380755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957420|NCT03844451|Epinephrine|epinephrine|mesh-list
24489603|NCT00474279|Hormones|hormones|mesh-list
24563940|NCT00774475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563941|NCT00774488|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
24563942|NCT00774488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24563943|NCT00774488|Incretins|incretins|mesh-ancestor
24563944|NCT00774488|Hormones|hormones|mesh-ancestor
24563945|NCT00774488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24563946|NCT00774488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563986|NCT00774644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563987|NCT00774644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563988|NCT00774644|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24563989|NCT00774644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24563990|NCT00774683|Raltegravir Potassium|raltegravir potassium|mesh-list
24563992|NCT00774683|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24563993|NCT00774683|Antiviral Agents|antiviral agents|mesh-ancestor
24563994|NCT00774683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24563995|NCT00774683|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24563996|NCT00774683|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24564010|NCT00774722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24564011|NCT00774722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24564012|NCT00774735|Dolutegravir|dolutegravir|mesh-list
24564013|NCT00774735|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24564016|NCT00774735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564018|NCT00774735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25686535|NCT01921296|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25686536|NCT01921296|Antidepressive Agents|antidepressive agents|mesh-ancestor
25686537|NCT01921296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25686538|NCT01921296|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25686539|NCT01921296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686540|NCT01921296|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24685705|NCT05245760|Mitosis Modulators|mitosis modulators|mesh-ancestor
24685706|NCT05245760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685707|NCT05243199|Valsartan|valsartan|mesh-list
24685708|NCT05243199|Irbesartan|irbesartan|mesh-list
24683066|NCT01389713|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24685724|NCT05235737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24685725|NCT05235737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24685726|NCT05233982|Olaparib|olaparib|mesh-list
24564019|NCT00774735|Antiviral Agents|antiviral agents|mesh-ancestor
24564020|NCT00774735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24564025|NCT00774813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564026|NCT00774813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24564027|NCT00774813|Serotonin Agents|serotonin agents|mesh-ancestor
24564028|NCT00774813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564029|NCT00774813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24555041|NCT00739531|Antioxidants|antioxidants|mesh-ancestor
24573622|NCT00821158|Antioxidants|antioxidants|mesh-list
25274102|NCT02380768|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25274103|NCT02380768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25274104|NCT02380768|Disinfectants|disinfectants|mesh-ancestor
25274105|NCT02380625|Azithromycin|azithromycin|mesh-list
24445165|NCT00300664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851745|NCT02258763|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24851746|NCT02258763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24851747|NCT02258763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24851748|NCT02258763|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24851749|NCT02258763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851750|NCT02258763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851751|NCT02258815|Dinutuximab|dinutuximab|mesh-list
24851752|NCT02258815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653300|NCT01243203|Varenicline|varenicline|mesh-list
25070375|NCT03419949|Lamotrigine|lamotrigine|mesh-list
24564030|NCT00774813|Antidepressive Agents|antidepressive agents|mesh-ancestor
24564031|NCT00774813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24564032|NCT00774878|Fulvestrant|fulvestrant|mesh-list
24564033|NCT00774878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24781766|NCT01891643|Growth Inhibitors|growth inhibitors|mesh-ancestor
24564034|NCT00774878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24564035|NCT00774878|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24564036|NCT00774878|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24564037|NCT00774878|Hormone Antagonists|hormone antagonists|mesh-ancestor
24564038|NCT00774878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24564039|NCT00774878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564041|NCT00774904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25243146|NCT05356169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25243147|NCT05356091|Sevoflurane|sevoflurane|mesh-list
25243148|NCT05356091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25243149|NCT05356091|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25243150|NCT05356091|Anesthetics, General|anesthetics, general|mesh-ancestor
25243151|NCT05356091|Anesthetics|anesthetics|mesh-ancestor
25243152|NCT05356091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25243153|NCT05356091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243154|NCT05356078|Antidepressive Agents|antidepressive agents|mesh-list
25243155|NCT05356078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24564050|NCT00774969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24564051|NCT00774982|Mercaptopurine|mercaptopurine|mesh-list
24564052|NCT00774982|Antimetabolites|antimetabolites|mesh-ancestor
25102625|NCT03167216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24564104|NCT00775125|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24564105|NCT00775125|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24564106|NCT00775125|Protease Inhibitors|protease inhibitors|mesh-ancestor
24564107|NCT00775125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405940|NCT03587584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686541|NCT01921296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686542|NCT01921296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25686543|NCT01921296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25686544|NCT01921387|Cytarabine|cytarabine|mesh-list
25686545|NCT01921387|Etoposide|etoposide|mesh-list
25686546|NCT01921387|Podophyllotoxin|podophyllotoxin|mesh-list
25686547|NCT01921387|Etoposide phosphate|etoposide phosphate|mesh-list
25686548|NCT01921387|Melphalan|melphalan|mesh-list
25686549|NCT01921387|Mechlorethamine|mechlorethamine|mesh-list
24685962|NCT05135039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685963|NCT05129332|Vitamin E|vitamin e|mesh-list
24685964|NCT05129332|Vitamins|vitamins|mesh-ancestor
24685965|NCT05129332|Micronutrients|micronutrients|mesh-ancestor
24685966|NCT05129332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685967|NCT05129332|Antioxidants|antioxidants|mesh-ancestor
24685968|NCT05129332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686003|NCT05088928|Rivaroxaban|rivaroxaban|mesh-list
24564108|NCT00775125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564109|NCT00775125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24564110|NCT00775125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24564111|NCT00775125|Antiviral Agents|antiviral agents|mesh-ancestor
24564112|NCT00775125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24564113|NCT00775125|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24564114|NCT00775125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24564115|NCT00775151|Amlodipine|amlodipine|mesh-list
24445187|NCT00300729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496452|NCT00504946|Vitamin D|vitamin d|mesh-list
24564116|NCT00775151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24564117|NCT00775151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24564118|NCT00775151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24564119|NCT00775151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564132|NCT00775177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24564133|NCT00775242|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24564134|NCT00775242|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24564136|NCT00775242|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24564137|NCT00775242|Estrogens|estrogens|mesh-list
24564138|NCT00775242|Progesterone|progesterone|mesh-list
24564139|NCT00775242|Progestins|progestins|mesh-list
24564140|NCT00775242|Hormones|hormones|mesh-ancestor
24564141|NCT00775242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24564142|NCT00775242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564143|NCT00775242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24564144|NCT00775242|Contraceptive Agents|contraceptive agents|mesh-ancestor
24564145|NCT00775242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24564146|NCT00775242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24564147|NCT00775255|Clarithromycin|clarithromycin|mesh-list
24564148|NCT00775255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24564149|NCT00775255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24564150|NCT00775255|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24564151|NCT00775255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564152|NCT00775255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781813|NCT01892176|Ubiquinone|ubiquinone|mesh-list
24564153|NCT00775255|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24564154|NCT00775255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24564155|NCT00775294|Maraviroc|maraviroc|mesh-list
24564156|NCT00775294|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24564157|NCT00775294|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24512093|NCT00572689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25243174|NCT05355844|Dermatologic Agents|dermatologic agents|mesh-ancestor
25243176|NCT05355610|Dexamethasone|dexamethasone|mesh-list
25243177|NCT05355610|Dexamethasone acetate|dexamethasone acetate|mesh-list
25243178|NCT05355610|BB 1101|bb 1101|mesh-list
24564187|NCT00775541|Micronutrients|micronutrients|mesh-ancestor
24564188|NCT00775541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564189|NCT00775541|Antioxidants|antioxidants|mesh-ancestor
24564190|NCT00775541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564191|NCT00775541|Protective Agents|protective agents|mesh-ancestor
24564193|NCT00775580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24564194|NCT00775580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24564201|NCT00775580|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24564202|NCT00775580|Adrenergic Agents|adrenergic agents|mesh-ancestor
25686550|NCT01921387|Carmustine|carmustine|mesh-list
25686551|NCT01921387|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25686552|NCT01921387|Antibodies|antibodies|mesh-list
25686553|NCT01921387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25686554|NCT01921387|Immunologic Factors|immunologic factors|mesh-ancestor
25686555|NCT01921387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686556|NCT01921387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25686557|NCT01921387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440367|NCT00282503|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24440368|NCT00282503|Dermatologic Agents|dermatologic agents|mesh-ancestor
24564203|NCT00775580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24564204|NCT00775580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564205|NCT00775619|Carvedilol|carvedilol|mesh-list
24555143|NCT00740194|Estradiol|estradiol|mesh-list
24564206|NCT00775619|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24564207|NCT00775619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24564208|NCT00775619|Adrenergic Agents|adrenergic agents|mesh-ancestor
24564209|NCT00775619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24564210|NCT00775619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564211|NCT00775619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564212|NCT00775619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24564213|NCT00775619|Antioxidants|antioxidants|mesh-ancestor
24564214|NCT00775619|Protective Agents|protective agents|mesh-ancestor
24564215|NCT00775619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24564225|NCT00775632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24564234|NCT00775632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564235|NCT00775632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24564236|NCT00775632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24564237|NCT00775632|Immunologic Factors|immunologic factors|mesh-ancestor
24564238|NCT00775632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24564239|NCT00775632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24564240|NCT00775632|Antifungal Agents|antifungal agents|mesh-ancestor
24564241|NCT00775632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24564242|NCT00775632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24564243|NCT00775632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24564244|NCT00775697|Montelukast|montelukast|mesh-list
24564245|NCT00775697|Leukotriene Antagonists|leukotriene antagonists|mesh-list
24564246|NCT00775697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24555160|NCT00740285|Lidocaine|lidocaine|mesh-list
25243181|NCT05355610|Autonomic Agents|autonomic agents|mesh-ancestor
25243182|NCT05355610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25243183|NCT05355610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243184|NCT05355610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25243185|NCT05355610|Glucocorticoids|glucocorticoids|mesh-ancestor
25243186|NCT05355610|Hormones|hormones|mesh-ancestor
25274109|NCT02380625|Atorvastatin|atorvastatin|mesh-list
25274110|NCT02380625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25274111|NCT02380625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24564249|NCT00775697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24564251|NCT00775697|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24564252|NCT00775697|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24564253|NCT00775697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564255|NCT00775736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24564257|NCT00775736|Insulin, Long-Acting|insulin, long-acting|mesh-list
24564258|NCT00775736|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24564259|NCT00775736|Biphasic Insulins|biphasic insulins|mesh-list
24564260|NCT00775736|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24564261|NCT00775736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24564262|NCT00775736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564263|NCT00775749|Nicotine|nicotine|mesh-list
24564264|NCT00775749|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24564265|NCT00775749|Autonomic Agents|autonomic agents|mesh-ancestor
24564266|NCT00775749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24564267|NCT00775749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564268|NCT00775749|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24564269|NCT00775749|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24564270|NCT00775749|Cholinergic Agents|cholinergic agents|mesh-ancestor
24564271|NCT00775749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24564272|NCT00775749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564273|NCT00775762|Aspirin|aspirin|mesh-list
24564274|NCT00775762|Clopidogrel|clopidogrel|mesh-list
24564286|NCT00775762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24564288|NCT00775762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564289|NCT00775762|Antipyretics|antipyretics|mesh-ancestor
24564290|NCT00775762|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25686558|NCT01921387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25686559|NCT01921387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25686560|NCT01921387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24686562|NCT04706767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24686563|NCT04706767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24686564|NCT04706767|Adrenergic Agents|adrenergic agents|mesh-ancestor
24686565|NCT04706767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24686567|NCT04699383|Allopurinol|allopurinol|mesh-list
24686568|NCT04699383|Antimetabolites|antimetabolites|mesh-ancestor
24686569|NCT04699383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686570|NCT04699383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564292|NCT00775762|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24564299|NCT00775814|Natriuretic Agents|natriuretic agents|mesh-ancestor
24564300|NCT00775814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564301|NCT00775814|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24564302|NCT00775814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25109909|NCT03121261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24564310|NCT00775827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24564311|NCT00775840|Candesartan|candesartan|mesh-list
24564312|NCT00775840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24564313|NCT00775840|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24564314|NCT00775840|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24564315|NCT00775840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564316|NCT00775879|Sevoflurane|sevoflurane|mesh-list
24564317|NCT00775879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24564318|NCT00775879|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24564354|NCT00776022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24564355|NCT00776022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564356|NCT00776022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564357|NCT00776074|Leuprolide|leuprolide|mesh-list
24564358|NCT00776074|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24564359|NCT00776074|Fertility Agents|fertility agents|mesh-ancestor
24564360|NCT00776074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24564361|NCT00776074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243187|NCT05355610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25243188|NCT05355610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25243189|NCT05355610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25243190|NCT05355610|Protease Inhibitors|protease inhibitors|mesh-ancestor
25243191|NCT05355610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25243192|NCT05355610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243193|NCT05355610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25243194|NCT05355610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24445206|NCT00300794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24445207|NCT00300794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445208|NCT00300833|Tirofiban|tirofiban|mesh-list
24445209|NCT00300833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24445210|NCT00300833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24445211|NCT00300833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445212|NCT00300833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24445213|NCT00300846|Aripiprazole|aripiprazole|mesh-list
24445214|NCT00300846|Antidepressive Agents|antidepressive agents|mesh-ancestor
24564367|NCT00776113|Adrenergic Agents|adrenergic agents|mesh-ancestor
24564368|NCT00776113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24564369|NCT00776113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658549|NCT01272531|Valproic Acid|valproic acid|mesh-list
25243195|NCT05355610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25243196|NCT05355597|Clonidine|clonidine|mesh-list
25243197|NCT05355597|Epinephrine|epinephrine|mesh-list
25243198|NCT05355597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25243199|NCT05355597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25243200|NCT05355597|Adrenergic Agents|adrenergic agents|mesh-ancestor
25243201|NCT05355597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25243202|NCT05355597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243203|NCT05355597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243204|NCT05355597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25243205|NCT05355597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25243206|NCT05355597|Autonomic Agents|autonomic agents|mesh-ancestor
25686561|NCT01921387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686562|NCT01921387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25686563|NCT01921387|Antimetabolites|antimetabolites|mesh-ancestor
25686564|NCT01921387|Antiviral Agents|antiviral agents|mesh-ancestor
25686565|NCT01921387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25686566|NCT01921387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25686567|NCT01921387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24686992|NCT04454203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686993|NCT04454203|Sensory System Agents|sensory system agents|mesh-ancestor
24683853|NCT01394419|Antidotes|antidotes|mesh-ancestor
24687041|NCT04399746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687043|NCT04399746|Micronutrients|micronutrients|mesh-ancestor
24687044|NCT04399746|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24687045|NCT04399746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24687046|NCT04399746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24687047|NCT04399746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24687076|NCT04394130|Ropivacaine|ropivacaine|mesh-list
24687077|NCT04394130|Anesthetics, Local|anesthetics, local|mesh-ancestor
25243207|NCT05355597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25243208|NCT05355597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25243209|NCT05355597|Respiratory System Agents|respiratory system agents|mesh-ancestor
25243210|NCT05355597|Mydriatics|mydriatics|mesh-ancestor
25243211|NCT05355597|Sympathomimetics|sympathomimetics|mesh-ancestor
25243212|NCT05355597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25243213|NCT05355597|Analgesics|analgesics|mesh-ancestor
25243214|NCT05355597|Sensory System Agents|sensory system agents|mesh-ancestor
25243215|NCT05355597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25243216|NCT05355597|Sympatholytics|sympatholytics|mesh-ancestor
25243217|NCT05355597|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25243218|NCT05355467|Tenofovir|tenofovir|mesh-list
25243219|NCT05355467|Antiviral Agents|antiviral agents|mesh-ancestor
25243220|NCT05355467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25274112|NCT02380625|Antimetabolites|antimetabolites|mesh-ancestor
24445224|NCT00300846|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24445225|NCT00300846|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24564374|NCT00776113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24564375|NCT00776113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24564376|NCT00776113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24564377|NCT00776113|Vasodilator Agents|vasodilator agents|mesh-ancestor
24564388|NCT00776139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564389|NCT00776217|Loratadine|loratadine|mesh-list
24564390|NCT00776217|Antipruritics|antipruritics|mesh-ancestor
24564392|NCT00776217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24564393|NCT00776217|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25243221|NCT05355467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25243222|NCT05355467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25243223|NCT05355467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25243224|NCT05355467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243225|NCT05355467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25243226|NCT05355467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25243228|NCT05355441|Sensory System Agents|sensory system agents|mesh-ancestor
25243229|NCT05355441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25243230|NCT05355441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243240|NCT05355337|Pramipexole|pramipexole|mesh-list
24445245|NCT00300924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445246|NCT00300937|Ubiquinone|ubiquinone|mesh-list
24445247|NCT00300937|Coenzyme Q10|coenzyme q10|mesh-list
24445248|NCT00300937|Micronutrients|micronutrients|mesh-ancestor
24445249|NCT00300937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445250|NCT00300937|Vitamins|vitamins|mesh-ancestor
24445251|NCT00300950|Gemcitabine|gemcitabine|mesh-list
25070450|NCT03419559|Durvalumab|durvalumab|mesh-list
24564469|NCT00776516|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24564470|NCT00776516|Antitubercular Agents|antitubercular agents|mesh-ancestor
25686568|NCT01921387|Alkylating Agents|alkylating agents|mesh-ancestor
25686569|NCT01921387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25686570|NCT01921387|Keratolytic Agents|keratolytic agents|mesh-ancestor
25686571|NCT01921387|Dermatologic Agents|dermatologic agents|mesh-ancestor
25686572|NCT01921387|Tubulin Modulators|tubulin modulators|mesh-ancestor
25686573|NCT01921387|Antimitotic Agents|antimitotic agents|mesh-ancestor
25686574|NCT01921387|Mitosis Modulators|mitosis modulators|mesh-ancestor
25686575|NCT01921751|Gemcitabine|gemcitabine|mesh-list
25686576|NCT01921751|Paclitaxel|paclitaxel|mesh-list
25686577|NCT01921751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25686578|NCT01921751|Capecitabine|capecitabine|mesh-list
24564471|NCT00776516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24564472|NCT00776516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24611740|NCT01010516|Micronutrients|micronutrients|mesh-ancestor
24684029|NCT01395199|Amlodipine|amlodipine|mesh-list
24684067|NCT01395420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24855155|NCT02277730|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24855156|NCT02277730|Mydriatics|mydriatics|mesh-ancestor
24855157|NCT02277730|Autonomic Agents|autonomic agents|mesh-ancestor
24855158|NCT02277730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24855159|NCT02277730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855160|NCT02277730|Sympathomimetics|sympathomimetics|mesh-ancestor
24564474|NCT00776516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24564475|NCT00776516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564476|NCT00776516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564477|NCT00776516|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24564478|NCT00776516|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24564479|NCT00776516|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24564480|NCT00776516|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24564481|NCT00776516|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24564482|NCT00776516|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24564483|NCT00776516|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24919604|NCT04209959|Nifekalant|nifekalant|mesh-list
24564484|NCT00776516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24564485|NCT00776516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24564486|NCT00776516|Adrenergic Agents|adrenergic agents|mesh-ancestor
24564511|NCT00776633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24564512|NCT00776633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24564513|NCT00776633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24564514|NCT00776633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24564515|NCT00776633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564516|NCT00776633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24564517|NCT00776633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24564518|NCT00776633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564519|NCT00776633|Antipyretics|antipyretics|mesh-ancestor
24564520|NCT00776633|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24564521|NCT00776633|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24564522|NCT00776633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24564523|NCT00776633|Purinergic Agents|purinergic agents|mesh-ancestor
24555335|NCT00741195|Bevacizumab|bevacizumab|mesh-list
24564531|NCT00776646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24564532|NCT00776646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564542|NCT00776698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24564543|NCT00776698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24564544|NCT00776698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24564545|NCT00776698|Growth Substances|growth substances|mesh-ancestor
24564546|NCT00776698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564547|NCT00776698|Growth Inhibitors|growth inhibitors|mesh-ancestor
24564548|NCT00776698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24564549|NCT00776698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24564550|NCT00776698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24564551|NCT00776698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564552|NCT00776698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564554|NCT00776724|Epirubicin|epirubicin|mesh-list
24564706|NCT00777543|Protective Agents|protective agents|mesh-ancestor
24564708|NCT00777569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24564709|NCT00777569|Autonomic Agents|autonomic agents|mesh-ancestor
24564710|NCT00777569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24564711|NCT00777569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564712|NCT00777569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24564714|NCT00777569|Cholinergic Agents|cholinergic agents|mesh-ancestor
24564715|NCT00777569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25243241|NCT05355337|Antioxidants|antioxidants|mesh-ancestor
25686579|NCT01921751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25686580|NCT01921751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25686581|NCT01921751|Tubulin Modulators|tubulin modulators|mesh-ancestor
25686582|NCT01921751|Antimitotic Agents|antimitotic agents|mesh-ancestor
25686583|NCT01921751|Mitosis Modulators|mitosis modulators|mesh-ancestor
25686584|NCT01921751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686585|NCT01921751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25686586|NCT01921751|Antimetabolites|antimetabolites|mesh-ancestor
25686587|NCT01921751|Antiviral Agents|antiviral agents|mesh-ancestor
25686588|NCT01921751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25243242|NCT05355337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687850|NCT03635021|Panitumumab|panitumumab|mesh-list
25243243|NCT05355337|Protective Agents|protective agents|mesh-ancestor
25243244|NCT05355337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243245|NCT05355337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25243246|NCT05355337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25243247|NCT05355337|Dopamine Agonists|dopamine agonists|mesh-ancestor
25243249|NCT05355337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25243250|NCT05355272|Hormones|hormones|mesh-list
24851758|NCT02258828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851759|NCT02258828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564716|NCT00777569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564717|NCT00777595|Moxifloxacin|moxifloxacin|mesh-list
24564718|NCT00777595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24564719|NCT00777595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24564720|NCT00777595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24564721|NCT00777595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24564722|NCT00777595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564723|NCT00777595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564724|NCT00777595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24564725|NCT00777673|Paclitaxel|paclitaxel|mesh-list
24564726|NCT00777673|Cyclophosphamide|cyclophosphamide|mesh-list
24564727|NCT00777673|Bevacizumab|bevacizumab|mesh-list
24564728|NCT00777673|Carboplatin|carboplatin|mesh-list
24564729|NCT00777673|Doxorubicin|doxorubicin|mesh-list
24564739|NCT00777673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564741|NCT00777673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24564743|NCT00777673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24564744|NCT00777673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24564745|NCT00777673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24564759|NCT00777738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24564761|NCT00777933|Tacrolimus|tacrolimus|mesh-list
24564762|NCT00777933|Cyclosporins|cyclosporins|mesh-list
24564763|NCT00777933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24564764|NCT00777933|Immunologic Factors|immunologic factors|mesh-ancestor
24564765|NCT00777933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564766|NCT00777933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24564767|NCT00777933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564768|NCT00777933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564769|NCT00777933|Antifungal Agents|antifungal agents|mesh-ancestor
24564770|NCT00777933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24564771|NCT00777933|Dermatologic Agents|dermatologic agents|mesh-ancestor
24564772|NCT00777933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24564773|NCT00777959|Sirolimus|sirolimus|mesh-list
24564818|NCT00778011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564819|NCT00778011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24564830|NCT00778011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24791639|NCT03714880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24791640|NCT03714880|Luteolytic Agents|luteolytic agents|mesh-ancestor
24791641|NCT03714880|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24791642|NCT03714880|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24791643|NCT03659734|Analgesics, Opioid|analgesics, opioid|mesh-list
24791644|NCT03659734|Narcotics|narcotics|mesh-ancestor
24791645|NCT03659734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24564839|NCT00778024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24564841|NCT00778024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564842|NCT00778024|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24564843|NCT00778024|Antidepressive Agents|antidepressive agents|mesh-ancestor
25243251|NCT05355272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25243252|NCT05355272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243253|NCT05355051|Pembrolizumab|pembrolizumab|mesh-list
25243254|NCT05355051|Azacitidine|azacitidine|mesh-list
25243255|NCT05355051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25243256|NCT05355051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25243257|NCT05355051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25243258|NCT05355051|Antimetabolites|antimetabolites|mesh-ancestor
24564847|NCT00778024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564848|NCT00778037|Cyclobenzaprine|cyclobenzaprine|mesh-list
24564849|NCT00778037|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24564850|NCT00778037|Antidepressive Agents|antidepressive agents|mesh-ancestor
24564851|NCT00778037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24564852|NCT00778037|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24564853|NCT00778037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564855|NCT00778037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686589|NCT01921751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24688348|NCT03092011|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24688349|NCT03092011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24688350|NCT03092011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24688351|NCT03092011|Adrenergic Agents|adrenergic agents|mesh-ancestor
24688404|NCT03071601|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24688405|NCT03071601|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24688406|NCT03071601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24688448|NCT03061903|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24564856|NCT00778037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24564857|NCT00778037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24564859|NCT00778050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24564860|NCT00778050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24564861|NCT00778063|Dexmedetomidine|dexmedetomidine|mesh-list
24564862|NCT00778063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24564863|NCT00778063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25243259|NCT05355051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243260|NCT05355051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25243272|NCT05354986|Plasma Substitutes|plasma substitutes|mesh-ancestor
25243273|NCT05354986|Blood Substitutes|blood substitutes|mesh-ancestor
25243274|NCT05354700|Carboplatin|carboplatin|mesh-list
25243275|NCT05354700|Etoposide|etoposide|mesh-list
25243276|NCT05354700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25243277|NCT05354700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25243278|NCT05354700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24445259|NCT00300950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24445260|NCT00300950|Immunologic Factors|immunologic factors|mesh-ancestor
24445261|NCT00300950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445263|NCT00301002|Dermatologic Agents|dermatologic agents|mesh-ancestor
24445264|NCT00301002|Immunologic Factors|immunologic factors|mesh-ancestor
25274114|NCT02380625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25274115|NCT02380625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24445278|NCT00301093|Imatinib Mesylate|imatinib mesylate|mesh-list
24445279|NCT00301093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445280|NCT00301093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24445281|NCT00301093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445282|NCT00301093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445283|NCT00301106|Interleukin-12|interleukin-12|mesh-list
24445284|NCT00301106|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24445285|NCT00301106|Immunologic Factors|immunologic factors|mesh-ancestor
24445286|NCT00301106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445287|NCT00301106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24564864|NCT00778063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243279|NCT05354700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25243280|NCT05354700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25243281|NCT05354700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243282|NCT05351541|Zolpidem|zolpidem|mesh-list
25243283|NCT05351541|Modafinil|modafinil|mesh-list
25243284|NCT05351541|Psilocybin|psilocybin|mesh-list
25243285|NCT05351541|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
25243286|NCT05351541|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25243287|NCT05351541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243288|NCT05351541|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25243289|NCT05351541|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25243290|NCT05351541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25243291|NCT05351541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243292|NCT05351541|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25243293|NCT05351541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25243294|NCT05351541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25243295|NCT05351541|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25243296|NCT05351541|GABA Agonists|gaba agonists|mesh-ancestor
25243297|NCT05351541|GABA Agents|gaba agents|mesh-ancestor
25243298|NCT05351541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25686590|NCT01921751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25686591|NCT01921751|Immunologic Factors|immunologic factors|mesh-ancestor
25686592|NCT01921751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686593|NCT01921829|Diuretics|diuretics|mesh-list
25686594|NCT01921829|Natriuretic Agents|natriuretic agents|mesh-ancestor
25686595|NCT01921829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686596|NCT01921894|Vitamin D|vitamin d|mesh-list
25686597|NCT01921894|Cholecalciferol|cholecalciferol|mesh-list
25686598|NCT01921894|Vitamins|vitamins|mesh-ancestor
25686599|NCT01921894|Micronutrients|micronutrients|mesh-ancestor
24688754|NCT02711826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24688755|NCT02711826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24688756|NCT02711826|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24688757|NCT02711826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24688758|NCT02711826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24688759|NCT02711826|Anesthetics, Local|anesthetics, local|mesh-ancestor
24688761|NCT02711826|Antiemetics|antiemetics|mesh-ancestor
24688808|NCT02636569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24855189|NCT02277886|Esomeprazole|esomeprazole|mesh-list
24855190|NCT02277886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25243299|NCT05351541|Hallucinogens|hallucinogens|mesh-ancestor
25243300|NCT05351541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25243301|NCT05351541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25243302|NCT05351541|Serotonin Agents|serotonin agents|mesh-ancestor
25243303|NCT05351541|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25274116|NCT02380625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274117|NCT02380625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25274118|NCT02380625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25274119|NCT02380625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25274120|NCT02380625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25274121|NCT02380625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25274122|NCT02380625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25274123|NCT02380625|Growth Substances|growth substances|mesh-ancestor
25274124|NCT02380625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274125|NCT02380625|Growth Inhibitors|growth inhibitors|mesh-ancestor
25274126|NCT02380625|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25008718|NCT04626024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25008719|NCT04626024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25008720|NCT04626024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564894|NCT00778128|Gemcitabine|gemcitabine|mesh-list
24564895|NCT00778128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24564896|NCT00778128|Antimetabolites|antimetabolites|mesh-ancestor
24564897|NCT00778128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564898|NCT00778128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24564899|NCT00778128|Antiviral Agents|antiviral agents|mesh-ancestor
24564900|NCT00778128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24564901|NCT00778128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564902|NCT00778128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24564903|NCT00778128|Immunologic Factors|immunologic factors|mesh-ancestor
25243304|NCT05348200|Clobetasol|clobetasol|mesh-list
25243305|NCT05348200|Lidocaine|lidocaine|mesh-list
25243306|NCT05348200|Halobetasol|halobetasol|mesh-list
25243307|NCT05348200|Anesthetics, Local|anesthetics, local|mesh-ancestor
25243308|NCT05348200|Anesthetics|anesthetics|mesh-ancestor
25243309|NCT05348200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25243310|NCT05348200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243311|NCT05348200|Sensory System Agents|sensory system agents|mesh-ancestor
25243312|NCT05348200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25243313|NCT05348200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25275653|NCT02370550|Glucocorticoids|glucocorticoids|mesh-ancestor
24564908|NCT00778180|Furosemide|furosemide|mesh-list
24564961|NCT00778271|Sensory System Agents|sensory system agents|mesh-ancestor
24564962|NCT00778271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24564963|NCT00778271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564964|NCT00778271|Anticonvulsants|anticonvulsants|mesh-ancestor
24564965|NCT00778271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24564966|NCT00778271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24564967|NCT00778271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24564968|NCT00778271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24564978|NCT00778297|Immunologic Factors|immunologic factors|mesh-ancestor
24564979|NCT00778297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564980|NCT00778349|Metformin|metformin|mesh-list
25686600|NCT01921894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686601|NCT01921894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25686602|NCT01921894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25686603|NCT01922011|Vancomycin|vancomycin|mesh-list
25686604|NCT01922011|Daptomycin|daptomycin|mesh-list
25686605|NCT01922011|Nafcillin|nafcillin|mesh-list
25686606|NCT01922011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25686607|NCT01922011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25686608|NCT01922037|Omalizumab|omalizumab|mesh-list
25686609|NCT01922037|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25686610|NCT01922037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24689151|NCT02293109|Prednisolone|prednisolone|mesh-list
24689176|NCT02293109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24689177|NCT02293109|Glucocorticoids|glucocorticoids|mesh-ancestor
24689178|NCT02293109|Hormones|hormones|mesh-ancestor
24689179|NCT02293109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24689180|NCT02293109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24689401|NCT01564537|Antiemetics|antiemetics|mesh-ancestor
24565035|NCT00778557|Cefprozil|cefprozil|mesh-list
24565039|NCT00778583|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24565040|NCT00778583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24565042|NCT00778583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24565043|NCT00778596|Prednisolone|prednisolone|mesh-list
24565044|NCT00778596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24565045|NCT00778596|Glucocorticoids|glucocorticoids|mesh-ancestor
24565047|NCT00778596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24565048|NCT00778596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565049|NCT00778596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24565050|NCT00778596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24565051|NCT00778609|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
24584531|NCT00880815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24584532|NCT00880815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24584533|NCT00880815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24584534|NCT00880815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24584535|NCT00880815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24584536|NCT00880815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24584537|NCT00880815|Alkylating Agents|alkylating agents|mesh-ancestor
24584538|NCT00880828|Acetaminophen|acetaminophen|mesh-list
24584543|NCT00880828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584544|NCT00880828|Antipyretics|antipyretics|mesh-ancestor
24584545|NCT00880841|Buprenorphine|buprenorphine|mesh-list
24584546|NCT00880841|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
24565082|NCT00778713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24565083|NCT00778713|Diuretics|diuretics|mesh-ancestor
24565084|NCT00778713|Natriuretic Agents|natriuretic agents|mesh-ancestor
24565085|NCT00778713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565086|NCT00778713|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24565087|NCT00778713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24565088|NCT00778713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565091|NCT00778713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565092|NCT00778726|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24565094|NCT00778726|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24565095|NCT00778726|Diuretics|diuretics|mesh-ancestor
24565096|NCT00778726|Natriuretic Agents|natriuretic agents|mesh-ancestor
24565097|NCT00778726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565098|NCT00778726|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24565099|NCT00778726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24565102|NCT00778726|Protease Inhibitors|protease inhibitors|mesh-ancestor
24565176|NCT00779129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24565177|NCT00779129|Alkylating Agents|alkylating agents|mesh-ancestor
24565178|NCT00779129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243314|NCT05348200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25243315|NCT05348200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25243316|NCT05348200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24445293|NCT00301145|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24445294|NCT00301145|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24445295|NCT00301145|Cholinergic Agents|cholinergic agents|mesh-ancestor
24445296|NCT00301145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24445297|NCT00301145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565179|NCT00779129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24565220|NCT00779233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24565222|NCT00779350|Antidepressive Agents|antidepressive agents|mesh-ancestor
25686611|NCT01922037|Respiratory System Agents|respiratory system agents|mesh-ancestor
25686612|NCT01922089|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25686613|NCT01922089|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25686614|NCT01922089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686615|NCT01922102|Ranibizumab|ranibizumab|mesh-list
25686616|NCT01922102|Verteporfin|verteporfin|mesh-list
25686617|NCT01922102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25686618|NCT01922102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24565225|NCT00779350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24565226|NCT00779350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24565227|NCT00779350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565228|NCT00779350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24565230|NCT00779350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565231|NCT00779376|Zidovudine|zidovudine|mesh-list
24565232|NCT00779376|Antimetabolites|antimetabolites|mesh-ancestor
24565233|NCT00779376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565234|NCT00779376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24565235|NCT00779376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24565236|NCT00779376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565237|NCT00779376|Antiviral Agents|antiviral agents|mesh-ancestor
24565242|NCT00779389|Dasatinib|dasatinib|mesh-list
24565263|NCT00779454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565264|NCT00779454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24565265|NCT00779454|Antiviral Agents|antiviral agents|mesh-ancestor
24565266|NCT00779454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24565267|NCT00779454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565268|NCT00779454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24565269|NCT00779454|Immunologic Factors|immunologic factors|mesh-ancestor
24565270|NCT00779454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243317|NCT05348200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243318|NCT05348200|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25243319|NCT05348200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25243320|NCT05348200|Glucocorticoids|glucocorticoids|mesh-ancestor
25243321|NCT05348200|Hormones|hormones|mesh-ancestor
25243322|NCT05348200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25243323|NCT05347199|Amisulpride|amisulpride|mesh-list
25243324|NCT05347199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25243325|NCT05347199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25280027|NCT02341365|Vitamin D|vitamin d|mesh-list
25243332|NCT05347199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243333|NCT05347199|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25243334|NCT05347199|Antidepressive Agents|antidepressive agents|mesh-ancestor
24565279|NCT00779493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24565280|NCT00779493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24565281|NCT00779493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24565282|NCT00779493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565283|NCT00779493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565285|NCT00779649|Cathartics|cathartics|mesh-ancestor
24565286|NCT00779649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24565287|NCT00779649|Laxatives|laxatives|mesh-ancestor
24565288|NCT00779714|Cytarabine|cytarabine|mesh-list
24565289|NCT00779714|Paclitaxel|paclitaxel|mesh-list
24565290|NCT00779714|Cisplatin|cisplatin|mesh-list
24565291|NCT00779714|Dacarbazine|dacarbazine|mesh-list
24565292|NCT00779714|Treosulfan|treosulfan|mesh-list
24565293|NCT00779714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24565294|NCT00779714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24565295|NCT00779714|Tubulin Modulators|tubulin modulators|mesh-ancestor
24565299|NCT00779714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24565300|NCT00779714|Antimetabolites|antimetabolites|mesh-ancestor
24565301|NCT00779714|Antiviral Agents|antiviral agents|mesh-ancestor
24565302|NCT00779714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24565333|NCT00779805|Pseudoephedrine|pseudoephedrine|mesh-list
25243341|NCT05345522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25243342|NCT05345522|Antibodies|antibodies|mesh-list
25243343|NCT05345522|Immunoglobulins|immunoglobulins|mesh-list
25243344|NCT05345522|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25243345|NCT05345522|Immunologic Factors|immunologic factors|mesh-ancestor
25243346|NCT05345522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243347|NCT05345522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25243360|NCT05343767|Metformin|metformin|mesh-list
25243361|NCT05343767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25243362|NCT05343767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243363|NCT05343260|Propofol|propofol|mesh-list
25243364|NCT05343260|Sevoflurane|sevoflurane|mesh-list
25243365|NCT05343260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24445343|NCT00301301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24445344|NCT00301301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24851793|NCT02259179|Dopamine Agents|dopamine agents|mesh-ancestor
24851794|NCT02259179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24851795|NCT02259179|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24851796|NCT02259179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24584554|NCT00880841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24584555|NCT00880841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24584556|NCT00880854|Tremelimumab|tremelimumab|mesh-list
24584557|NCT00880854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584559|NCT00880867|Interferon Inducers|interferon inducers|mesh-ancestor
24621152|NCT01060826|Hormones|hormones|mesh-ancestor
24584560|NCT00880867|Immunologic Factors|immunologic factors|mesh-ancestor
24584561|NCT00880867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565334|NCT00779805|Ephedrine|ephedrine|mesh-list
24565335|NCT00779805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24565336|NCT00779805|Autonomic Agents|autonomic agents|mesh-ancestor
24565337|NCT00779805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25243366|NCT05343260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25243367|NCT05343260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243368|NCT05343260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25243369|NCT05343260|Anesthetics, General|anesthetics, general|mesh-ancestor
25243370|NCT05343260|Anesthetics|anesthetics|mesh-ancestor
25243371|NCT05343260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25243372|NCT05343260|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25243373|NCT05342974|Misoprostol|misoprostol|mesh-list
25243374|NCT05342974|Atorvastatin|atorvastatin|mesh-list
25243375|NCT05342974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25243377|NCT05342974|Antimetabolites|antimetabolites|mesh-ancestor
25243378|NCT05342974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243379|NCT05342974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25243380|NCT05342974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25243381|NCT05342974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25243382|NCT05342974|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25243383|NCT05342974|Abortifacient Agents|abortifacient agents|mesh-ancestor
25243384|NCT05342974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25243385|NCT05342974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243386|NCT05342974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25243387|NCT05342974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25243388|NCT05342974|Oxytocics|oxytocics|mesh-ancestor
25243389|NCT05342467|Dinoprostone|dinoprostone|mesh-list
25243390|NCT05342467|Gemeprost|gemeprost|mesh-list
25243391|NCT05342467|Oxytocics|oxytocics|mesh-ancestor
25243392|NCT05342467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25243393|NCT05342467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243394|NCT05342467|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25243395|NCT05342467|Abortifacient Agents|abortifacient agents|mesh-ancestor
25243396|NCT05340205|Misoprostol|misoprostol|mesh-list
25243397|NCT05340205|Tranexamic Acid|tranexamic acid|mesh-list
24851798|NCT02259309|Misoprostol|misoprostol|mesh-list
24851799|NCT02259309|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24851800|NCT02259309|Abortifacient Agents|abortifacient agents|mesh-ancestor
24851801|NCT02259309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24851802|NCT02259309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851803|NCT02259309|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24851804|NCT02259309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24851805|NCT02259309|Oxytocics|oxytocics|mesh-ancestor
24851806|NCT02259361|4-Aminopyridine|4-aminopyridine|mesh-list
24851807|NCT02259361|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24851808|NCT02259361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24565338|NCT00779805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565358|NCT00779831|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24565359|NCT00779831|Sympathomimetics|sympathomimetics|mesh-ancestor
24565360|NCT00779831|Adrenergic Agents|adrenergic agents|mesh-ancestor
24565361|NCT00779831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24565362|NCT00779831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565363|NCT00779896|Tazarotene|tazarotene|mesh-list
24565364|NCT00779896|Dermatologic Agents|dermatologic agents|mesh-ancestor
24565365|NCT00779896|Keratolytic Agents|keratolytic agents|mesh-ancestor
24565366|NCT00779922|Lenalidomide|lenalidomide|mesh-list
24565367|NCT00779922|Immunologic Factors|immunologic factors|mesh-ancestor
24565368|NCT00779922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565397|NCT00780104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24565398|NCT00780104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565399|NCT00780104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565400|NCT00780104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24565401|NCT00780104|Antimetabolites|antimetabolites|mesh-ancestor
24565402|NCT00780104|Antiviral Agents|antiviral agents|mesh-ancestor
24565403|NCT00780104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24565404|NCT00780104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24565405|NCT00780104|Immunologic Factors|immunologic factors|mesh-ancestor
24565406|NCT00780104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565407|NCT00780104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24565408|NCT00780104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24690327|NCT01400828|Histamine Agents|histamine agents|mesh-ancestor
24565409|NCT00780104|Antifungal Agents|antifungal agents|mesh-ancestor
24565410|NCT00780104|Analgesics|analgesics|mesh-ancestor
24565411|NCT00780104|Sensory System Agents|sensory system agents|mesh-ancestor
24565412|NCT00780104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24565413|NCT00780169|Sorafenib|sorafenib|mesh-list
24565414|NCT00780169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24565415|NCT00780169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24565416|NCT00780169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565417|NCT00780169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008768|NCT04474223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24565437|NCT00780325|Anticonvulsants|anticonvulsants|mesh-ancestor
24565438|NCT00780325|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24565439|NCT00780325|Diuretics|diuretics|mesh-ancestor
24565440|NCT00780325|Natriuretic Agents|natriuretic agents|mesh-ancestor
24565441|NCT00780377|Bradykinin|bradykinin|mesh-list
24565442|NCT00780377|Kininogens|kininogens|mesh-list
24565443|NCT00780377|Vasodilator Agents|vasodilator agents|mesh-ancestor
24565444|NCT00780377|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
24565445|NCT00780377|Protease Inhibitors|protease inhibitors|mesh-ancestor
24565446|NCT00780377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565447|NCT00780377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565449|NCT00780598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25243398|NCT05340205|Oxytocin|oxytocin|mesh-list
25243399|NCT05340205|Oxytocics|oxytocics|mesh-ancestor
25243400|NCT05340205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25243401|NCT05340205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243402|NCT05340205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25243403|NCT05340205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25243404|NCT05340205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243405|NCT05340205|Hemostatics|hemostatics|mesh-ancestor
25243406|NCT05340205|Coagulants|coagulants|mesh-ancestor
25243407|NCT05340205|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25243408|NCT05340205|Abortifacient Agents|abortifacient agents|mesh-ancestor
25243409|NCT05340205|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25243410|NCT05340205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25243411|NCT05335317|Hormones|hormones|mesh-list
25274128|NCT02380625|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24565452|NCT00780637|Kininogens|kininogens|mesh-list
24565453|NCT00780637|Vasodilator Agents|vasodilator agents|mesh-ancestor
24565507|NCT00780832|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24782354|NCT01895569|Metformin|metformin|mesh-list
24565508|NCT00780832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565509|NCT00780832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565510|NCT00780832|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24565511|NCT00780832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24565512|NCT00780832|Purinergic Agents|purinergic agents|mesh-ancestor
24565513|NCT00780832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24565514|NCT00780832|Cholinergic Agents|cholinergic agents|mesh-ancestor
24565515|NCT00780858|Ganirelix|ganirelix|mesh-list
24565516|NCT00780858|Hormone Antagonists|hormone antagonists|mesh-ancestor
24565517|NCT00780858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24565518|NCT00780858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565519|NCT00781105|Telbivudine|telbivudine|mesh-list
24565520|NCT00781105|Antiviral Agents|antiviral agents|mesh-ancestor
24565521|NCT00781105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24565537|NCT00781131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24565538|NCT00781131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24565539|NCT00781157|Phenylephrine|phenylephrine|mesh-list
24565540|NCT00781157|Oxymetazoline|oxymetazoline|mesh-list
24565541|NCT00781157|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24565542|NCT00781157|Mydriatics|mydriatics|mesh-ancestor
24565543|NCT00781157|Autonomic Agents|autonomic agents|mesh-ancestor
24565544|NCT00781157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24565545|NCT00781157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565546|NCT00781157|Sympathomimetics|sympathomimetics|mesh-ancestor
24565547|NCT00781157|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24565548|NCT00781157|Nasal Decongestants|nasal decongestants|mesh-ancestor
24621853|NCT01064232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24621854|NCT01064232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24621855|NCT01064232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24791659|NCT03623633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24791660|NCT03623633|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24791661|NCT03623633|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24791662|NCT03619850|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25686619|NCT01922102|Growth Substances|growth substances|mesh-ancestor
24791663|NCT03619850|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24791665|NCT03619850|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24791666|NCT03619850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24565549|NCT00781157|Respiratory System Agents|respiratory system agents|mesh-ancestor
24886958|NCT04521491|Leucovorin|leucovorin|mesh-list
24565563|NCT00781261|Zoledronic Acid|zoledronic acid|mesh-list
24565568|NCT00781287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24565569|NCT00781287|Antiviral Agents|antiviral agents|mesh-ancestor
24565578|NCT00781300|Antiemetics|antiemetics|mesh-ancestor
24565597|NCT00781352|Sensory System Agents|sensory system agents|mesh-ancestor
24565598|NCT00781352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24565599|NCT00781378|Plasminogen|plasminogen|mesh-list
24565600|NCT00781378|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24565601|NCT00781378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25243413|NCT05335317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445352|NCT00301301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24445353|NCT00301301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565602|NCT00781378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24782426|NCT01896011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24782427|NCT01896011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008770|NCT04474223|Autonomic Agents|autonomic agents|mesh-ancestor
25008771|NCT04474223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25008772|NCT04474223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008773|NCT04474223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25008774|NCT04474223|Glucocorticoids|glucocorticoids|mesh-ancestor
25008775|NCT04474223|Hormones|hormones|mesh-ancestor
25008776|NCT04474223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25008777|NCT04474223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25008778|NCT04474223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008779|NCT04400799|Enoxaparin|enoxaparin|mesh-list
25008780|NCT04400799|Anticoagulants|anticoagulants|mesh-ancestor
25008781|NCT04400799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24565603|NCT00781378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565604|NCT00781404|Adenosine|adenosine|mesh-list
24565605|NCT00781404|Analgesics|analgesics|mesh-ancestor
24565606|NCT00781404|Sensory System Agents|sensory system agents|mesh-ancestor
24565607|NCT00781404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24565608|NCT00781404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565609|NCT00781404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24565610|NCT00781404|Vasodilator Agents|vasodilator agents|mesh-ancestor
24565611|NCT00781404|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24565612|NCT00781404|Purinergic Agonists|purinergic agonists|mesh-ancestor
24565613|NCT00781404|Purinergic Agents|purinergic agents|mesh-ancestor
24565614|NCT00781404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24565615|NCT00781404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565616|NCT00781417|Vitamin D|vitamin d|mesh-list
24565617|NCT00781417|Ergocalciferols|ergocalciferols|mesh-list
24565618|NCT00781417|Cholecalciferol|cholecalciferol|mesh-list
24565619|NCT00781417|Vitamins|vitamins|mesh-list
24565620|NCT00781417|Micronutrients|micronutrients|mesh-ancestor
24565623|NCT00781417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24565624|NCT00781482|Zolpidem|zolpidem|mesh-list
24565625|NCT00781482|Eszopiclone|eszopiclone|mesh-list
24565651|NCT00781573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24565652|NCT00781573|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24565653|NCT00781573|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24565654|NCT00781573|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24565655|NCT00781573|Purinergic Agents|purinergic agents|mesh-ancestor
24565656|NCT00781573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24565657|NCT00781573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565658|NCT00781573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782428|NCT01896011|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24565659|NCT00781586|Caffeine|caffeine|mesh-list
24565660|NCT00781586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565661|NCT00781586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24565662|NCT00781586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24565663|NCT00781586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565664|NCT00781586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565665|NCT00781586|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24565678|NCT00781755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24565692|NCT00781846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24565693|NCT00781846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24565694|NCT00781846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24691052|NCT01404806|Antiviral Agents|antiviral agents|mesh-ancestor
24565695|NCT00781846|Growth Substances|growth substances|mesh-ancestor
24565696|NCT00781846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565697|NCT00781846|Growth Inhibitors|growth inhibitors|mesh-ancestor
24565698|NCT00781846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24671030|NCT01323257|Antiviral Agents|antiviral agents|mesh-ancestor
24565714|NCT00782041|Immunologic Factors|immunologic factors|mesh-ancestor
24565715|NCT00782041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445361|NCT00301392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445362|NCT00301392|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24445364|NCT00301405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24953718|NCT03882164|Tacrolimus|tacrolimus|mesh-list
24565717|NCT00782041|Protective Agents|protective agents|mesh-ancestor
24565718|NCT00782041|Vitamin B Complex|vitamin b complex|mesh-ancestor
24565719|NCT00782041|Vitamins|vitamins|mesh-ancestor
24565720|NCT00782041|Micronutrients|micronutrients|mesh-ancestor
24565721|NCT00782041|Hematinics|hematinics|mesh-ancestor
24565722|NCT00782093|Volociximab|volociximab|mesh-list
24565723|NCT00782093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24565724|NCT00782093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24565725|NCT00782093|Growth Substances|growth substances|mesh-ancestor
24565728|NCT00782093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24565729|NCT00782106|Immunoglobulins|immunoglobulins|mesh-list
24565730|NCT00782106|Antibodies|antibodies|mesh-list
24670999|NCT01323101|Doxycycline|doxycycline|mesh-list
24565743|NCT00782301|Maraviroc|maraviroc|mesh-list
24565744|NCT00782301|Etravirine|etravirine|mesh-list
24565745|NCT00782301|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24565746|NCT00782301|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24565747|NCT00782301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565748|NCT00782301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24565749|NCT00782301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24565750|NCT00782301|Antiviral Agents|antiviral agents|mesh-ancestor
24565751|NCT00782301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24565752|NCT00782301|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24565753|NCT00782301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24565754|NCT00782301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24565755|NCT00782301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565756|NCT00782327|Losartan|losartan|mesh-list
24565757|NCT00782327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25243433|NCT05332587|Rituximab|rituximab|mesh-list
25243434|NCT05332587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25243435|NCT05332587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25243436|NCT05332587|Immunologic Factors|immunologic factors|mesh-ancestor
25243437|NCT05332587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243438|NCT05332587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24565759|NCT00782327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24565771|NCT00782405|Histamine Antagonists|histamine antagonists|mesh-ancestor
24565773|NCT00782405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24565819|NCT00782951|Morphine|morphine|mesh-list
24565822|NCT00782951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24565823|NCT00782951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565824|NCT00782951|Analgesics|analgesics|mesh-ancestor
24565825|NCT00782951|Sensory System Agents|sensory system agents|mesh-ancestor
25243454|NCT05326308|Zanubrutinib|zanubrutinib|mesh-list
25243455|NCT05326308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25243456|NCT05326308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25243457|NCT05326308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25243458|NCT05326308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565831|NCT00783016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565832|NCT00783016|Analgesics|analgesics|mesh-ancestor
24565833|NCT00783016|Sensory System Agents|sensory system agents|mesh-ancestor
24565834|NCT00783016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24565835|NCT00783042|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24565836|NCT00783042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24565837|NCT00783042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24791672|NCT03583710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791673|NCT03583710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24791674|NCT03583710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24791675|NCT03583710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24791676|NCT03583710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24791677|NCT03583710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791678|NCT03583710|Keratolytic Agents|keratolytic agents|mesh-ancestor
25686620|NCT01922102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686621|NCT01922102|Growth Inhibitors|growth inhibitors|mesh-ancestor
24691520|NCT01407471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24691521|NCT01407471|Glucocorticoids|glucocorticoids|mesh-ancestor
24791679|NCT03583710|Dermatologic Agents|dermatologic agents|mesh-ancestor
24791680|NCT03583710|Tubulin Modulators|tubulin modulators|mesh-ancestor
24791681|NCT03583710|Antimitotic Agents|antimitotic agents|mesh-ancestor
24791682|NCT03583710|Mitosis Modulators|mitosis modulators|mesh-ancestor
24791683|NCT03583710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24791686|NCT03580928|Acalabrutinib|acalabrutinib|mesh-list
24791687|NCT03580928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556388|NCT00747409|Insulin, Isophane|insulin, isophane|mesh-list
24565839|NCT00783042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565840|NCT00783042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24565841|NCT00783042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24565842|NCT00783042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565843|NCT00783068|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
24565844|NCT00783068|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24565845|NCT00783068|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24565846|NCT00783068|Cholinergic Agents|cholinergic agents|mesh-ancestor
24565847|NCT00783068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24565848|NCT00783068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565849|NCT00783068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565851|NCT00783081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24565852|NCT00783081|Autonomic Agents|autonomic agents|mesh-ancestor
24628992|NCT01102465|Diuretics|diuretics|mesh-ancestor
24565853|NCT00783081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24565854|NCT00783081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565855|NCT00783081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24565856|NCT00783081|Respiratory System Agents|respiratory system agents|mesh-ancestor
24565857|NCT00783081|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24565869|NCT00783107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556467|NCT00747877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24556468|NCT00747877|Immunologic Factors|immunologic factors|mesh-ancestor
24556469|NCT00747877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556470|NCT00747877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25008798|NCT04365985|Naltrexone|naltrexone|mesh-list
25008799|NCT04365985|Ketamine|ketamine|mesh-list
25008800|NCT04365985|Analgesics|analgesics|mesh-ancestor
25008801|NCT04365985|Sensory System Agents|sensory system agents|mesh-ancestor
25008802|NCT04365985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24565884|NCT00783172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565885|NCT00783172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24565886|NCT00783172|Antiviral Agents|antiviral agents|mesh-ancestor
24565887|NCT00783172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24565888|NCT00783172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25243476|NCT05325177|Ibuprofen|ibuprofen|mesh-list
25243477|NCT05325177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25243478|NCT05325177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25243479|NCT05325177|Analgesics|analgesics|mesh-ancestor
25243480|NCT05325177|Sensory System Agents|sensory system agents|mesh-ancestor
24565889|NCT00783172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24565890|NCT00783172|Immunologic Factors|immunologic factors|mesh-ancestor
24565891|NCT00783172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565941|NCT00783484|Anesthetics, General|anesthetics, general|mesh-ancestor
24565942|NCT00783484|Anesthetics|anesthetics|mesh-ancestor
24565943|NCT00783484|GABA Modulators|gaba modulators|mesh-ancestor
24565944|NCT00783484|GABA Agents|gaba agents|mesh-ancestor
24565945|NCT00783484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24565946|NCT00783484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565947|NCT00783484|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24565948|NCT00783484|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24565949|NCT00783484|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24565950|NCT00783484|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24565961|NCT00783523|Antimalarials|antimalarials|mesh-ancestor
24565962|NCT00783523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24565963|NCT00783523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24565964|NCT00783601|Montelukast|montelukast|mesh-list
24565965|NCT00783601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24565966|NCT00783601|Respiratory System Agents|respiratory system agents|mesh-ancestor
24565967|NCT00783601|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24565968|NCT00783601|Hormone Antagonists|hormone antagonists|mesh-ancestor
24565969|NCT00783601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25686622|NCT01922102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25686623|NCT01922102|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25686624|NCT01922102|Dermatologic Agents|dermatologic agents|mesh-ancestor
24692292|NCT01412632|Anesthetics, Local|anesthetics, local|mesh-ancestor
24565970|NCT00783601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565971|NCT00783601|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24565972|NCT00783601|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24565973|NCT00783601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565975|NCT00783653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566000|NCT00783744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24566001|NCT00783744|Metformin|metformin|mesh-list
24566002|NCT00783744|Insulin Glargine|insulin glargine|mesh-list
24566003|NCT00783744|Glimepiride|glimepiride|mesh-list
24566004|NCT00783744|Isophane Insulin, Human|isophane insulin, human|mesh-list
24566005|NCT00783744|Insulin, Isophane|insulin, isophane|mesh-list
24566006|NCT00783744|Isophane insulin, beef|isophane insulin, beef|mesh-list
24566007|NCT00783744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24566008|NCT00783744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566009|NCT00783744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24566010|NCT00783744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24566011|NCT00783744|Immunologic Factors|immunologic factors|mesh-ancestor
24566012|NCT00783900|Metoprolol|metoprolol|mesh-list
25243481|NCT05325177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25243482|NCT05325177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243483|NCT05325177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25243484|NCT05325177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25243485|NCT05325177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25243486|NCT05325177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25243487|NCT05325177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851841|NCT02259595|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24851842|NCT02259595|Disufenton sodium|disufenton sodium|mesh-list
24851843|NCT02259595|Antiviral Agents|antiviral agents|mesh-ancestor
24851844|NCT02259595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24851845|NCT02259595|Expectorants|expectorants|mesh-ancestor
24851846|NCT02259595|Respiratory System Agents|respiratory system agents|mesh-ancestor
24851847|NCT02259595|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24496838|NCT00507052|Antiviral Agents|antiviral agents|mesh-ancestor
24782559|NCT01896518|Cholinergic Agents|cholinergic agents|mesh-ancestor
25243498|NCT05312385|Propofol|propofol|mesh-list
25243499|NCT05312385|Isoflurane|isoflurane|mesh-list
25243500|NCT05312385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25243501|NCT05312385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25243502|NCT05312385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243503|NCT05312385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25243504|NCT05312385|Anesthetics, General|anesthetics, general|mesh-ancestor
25243505|NCT05312385|Anesthetics|anesthetics|mesh-ancestor
25243506|NCT05312385|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25243507|NCT05310968|Aspirin|aspirin|mesh-list
25243508|NCT05310968|Tirofiban|tirofiban|mesh-list
25243509|NCT05310968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25243510|NCT05310968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25243511|NCT05310968|Analgesics|analgesics|mesh-ancestor
25243512|NCT05310968|Sensory System Agents|sensory system agents|mesh-ancestor
25243513|NCT05310968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25243514|NCT05310968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243515|NCT05310968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25243516|NCT05310968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25243517|NCT05310968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25243518|NCT05310968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25243519|NCT05310968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243520|NCT05310968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25243521|NCT05310968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25243522|NCT05310968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25243523|NCT05310968|Antipyretics|antipyretics|mesh-ancestor
25243524|NCT05307198|Capecitabine|capecitabine|mesh-list
25243525|NCT05307198|Oxaliplatin|oxaliplatin|mesh-list
25243526|NCT05307198|Antibodies|antibodies|mesh-list
24791689|NCT03559686|Certolizumab Pegol|certolizumab pegol|mesh-list
24791690|NCT03559686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24791691|NCT03559686|Immunologic Factors|immunologic factors|mesh-ancestor
24791692|NCT03559686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791693|NCT03559686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24791734|NCT03333005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24791736|NCT03333005|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24791737|NCT03333005|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24791738|NCT03148366|Levofloxacin|levofloxacin|mesh-list
25686625|NCT01922115|Trospium chloride|trospium chloride|mesh-list
24791739|NCT03148366|Ofloxacin|ofloxacin|mesh-list
24791740|NCT03148366|Bismuth|bismuth|mesh-list
24477841|NCT00420537|Everolimus|everolimus|mesh-list
24791741|NCT03148366|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24791742|NCT03148366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24791743|NCT03148366|Renal Agents|renal agents|mesh-ancestor
24791744|NCT03148366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24791745|NCT03148366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24791746|NCT03148366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24791747|NCT03148366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24791748|NCT03148366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791749|NCT03148366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25243530|NCT05307198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25243531|NCT05307198|Antimetabolites|antimetabolites|mesh-ancestor
25243532|NCT05307198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243533|NCT05307198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25243534|NCT05303220|Branebrutinib|branebrutinib|mesh-list
25243535|NCT05303220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25243536|NCT05303220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25243537|NCT05303220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243538|NCT05294965|Fenoterol|fenoterol|mesh-list
25243541|NCT05294965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25243542|NCT05294965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243544|NCT05294965|Respiratory System Agents|respiratory system agents|mesh-ancestor
25243545|NCT05294965|Sympathomimetics|sympathomimetics|mesh-ancestor
25243546|NCT05294965|Tocolytic Agents|tocolytic agents|mesh-ancestor
24445382|NCT00301457|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24445383|NCT00301457|Hormone Antagonists|hormone antagonists|mesh-ancestor
24445384|NCT00301457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24445406|NCT00301522|Antimitotic Agents|antimitotic agents|mesh-ancestor
24445407|NCT00301522|Mitosis Modulators|mitosis modulators|mesh-ancestor
24791750|NCT03148366|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24566114|NCT00784446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566115|NCT00784446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25280484|NCT02338011|Gefitinib|gefitinib|mesh-list
24566116|NCT00784446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566117|NCT00784472|Morphine|morphine|mesh-list
24566118|NCT00784472|Oxycodone|oxycodone|mesh-list
24566119|NCT00784472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24566120|NCT00784472|Narcotics|narcotics|mesh-ancestor
25008805|NCT04365985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25008806|NCT04365985|Anesthetics, General|anesthetics, general|mesh-ancestor
25008807|NCT04365985|Anesthetics|anesthetics|mesh-ancestor
25243547|NCT05294965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25243548|NCT05294965|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25243549|NCT05294965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25243550|NCT05294965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25243551|NCT05294965|Adrenergic Agents|adrenergic agents|mesh-ancestor
25243552|NCT05294965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25243553|NCT05294965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274129|NCT02380521|Exenatide|exenatide|mesh-list
25274130|NCT02380521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25274131|NCT02380521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274132|NCT02380521|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25274133|NCT02380521|Incretins|incretins|mesh-ancestor
25274134|NCT02380521|Hormones|hormones|mesh-ancestor
25274135|NCT02380521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25274136|NCT02380586|Anesthetics|anesthetics|mesh-list
25274137|NCT02380586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25274138|NCT02380586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274139|NCT02380417|Ropivacaine|ropivacaine|mesh-list
25274140|NCT02380417|Anesthetics, Local|anesthetics, local|mesh-ancestor
25274141|NCT02380417|Anesthetics|anesthetics|mesh-ancestor
25274142|NCT02380417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25274143|NCT02380417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274144|NCT02380417|Sensory System Agents|sensory system agents|mesh-ancestor
25274145|NCT02380417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686626|NCT01922115|Parasympatholytics|parasympatholytics|mesh-ancestor
25686627|NCT01922115|Autonomic Agents|autonomic agents|mesh-ancestor
25686628|NCT01922115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686629|NCT01922115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693321|NCT01419548|Paclitaxel|paclitaxel|mesh-list
24566123|NCT00784472|Analgesics|analgesics|mesh-ancestor
24566124|NCT00784472|Sensory System Agents|sensory system agents|mesh-ancestor
24566135|NCT00784498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566136|NCT00784498|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24566138|NCT00784498|Anesthetics|anesthetics|mesh-ancestor
24566139|NCT00784498|Analgesics|analgesics|mesh-ancestor
24566154|NCT00784511|Ergocalciferols|ergocalciferols|mesh-list
24566155|NCT00784511|Cholecalciferol|cholecalciferol|mesh-list
24566156|NCT00784511|Vitamins|vitamins|mesh-list
24556670|NCT00748891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566158|NCT00784511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566159|NCT00784511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24566160|NCT00784511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24566162|NCT00784589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25243565|NCT05290753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25243566|NCT05290753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243568|NCT05290220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25243569|NCT05290220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25243570|NCT05290220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274148|NCT02380313|Glucocorticoids|glucocorticoids|mesh-ancestor
25274152|NCT02380313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25274153|NCT02380313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25274154|NCT02380352|Amoxicillin|amoxicillin|mesh-list
25274155|NCT02380352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24445411|NCT00301535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24445412|NCT00301535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24566168|NCT00784667|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24920129|NCT04205305|Vasodilator Agents|vasodilator agents|mesh-ancestor
24566169|NCT00784667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24566170|NCT00784667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566171|NCT00784667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24566172|NCT00784667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566173|NCT00784667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566174|NCT00784680|Tamoxifen|tamoxifen|mesh-list
24566175|NCT00784680|Anastrozole|anastrozole|mesh-list
24566176|NCT00784680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24566177|NCT00784680|Hormone Antagonists|hormone antagonists|mesh-ancestor
24566178|NCT00784680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24566179|NCT00784680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566180|NCT00784680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24566181|NCT00784680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566182|NCT00784680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24566183|NCT00784680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24566195|NCT00784745|Antiemetics|antiemetics|mesh-ancestor
24566210|NCT00784797|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24512524|NCT00575523|Cholinergic Agents|cholinergic agents|mesh-ancestor
25243571|NCT05290220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243572|NCT05289440|Esketamine|esketamine|mesh-list
25243573|NCT05289440|Antidepressive Agents|antidepressive agents|mesh-ancestor
25243574|NCT05289440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25243575|NCT05283408|Dexmedetomidine|dexmedetomidine|mesh-list
25243576|NCT05283408|Esketamine|esketamine|mesh-list
25243577|NCT05283408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25243578|NCT05283408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25243579|NCT05283408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243580|NCT05283408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25243581|NCT05283408|Analgesics|analgesics|mesh-ancestor
25243582|NCT05283408|Sensory System Agents|sensory system agents|mesh-ancestor
25243583|NCT05283408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25243584|NCT05283408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25274156|NCT02380352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25274157|NCT02380131|Capecitabine|capecitabine|mesh-list
25274158|NCT02380131|Oxaliplatin|oxaliplatin|mesh-list
25686630|NCT01922115|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25686631|NCT01922115|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24693641|NCT01421693|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24566242|NCT00784862|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24566243|NCT00784862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24566267|NCT00784940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24566268|NCT00784940|Hormone Antagonists|hormone antagonists|mesh-ancestor
24566269|NCT00784940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24566296|NCT00785018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566297|NCT00785018|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24566298|NCT00785018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24566317|NCT00785122|Sargramostim|sargramostim|mesh-list
24566318|NCT00785122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24566319|NCT00785122|Immunologic Factors|immunologic factors|mesh-ancestor
24566320|NCT00785122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566321|NCT00785122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24566322|NCT00785122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24566323|NCT00785122|Alkylating Agents|alkylating agents|mesh-ancestor
24566324|NCT00785122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566325|NCT00785122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008816|NCT04249258|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25008817|NCT04249258|Sympathomimetics|sympathomimetics|mesh-ancestor
25008818|NCT04249258|Autonomic Agents|autonomic agents|mesh-ancestor
24566326|NCT00785122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24566327|NCT00785122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24566328|NCT00785122|Interferon Inducers|interferon inducers|mesh-ancestor
24566330|NCT00785200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24566331|NCT00785200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24566332|NCT00785200|Disinfectants|disinfectants|mesh-ancestor
24887531|NCT04515420|Norepinephrine|norepinephrine|mesh-list
24566345|NCT00785382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24566346|NCT00785382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24566347|NCT00785382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566348|NCT00785382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24566349|NCT00785382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24566350|NCT00785382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24566351|NCT00785382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24566352|NCT00785382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24566353|NCT00785395|Oxytocin|oxytocin|mesh-list
25243585|NCT05283408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25243586|NCT05283408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25243587|NCT05283408|Adrenergic Agents|adrenergic agents|mesh-ancestor
25275654|NCT02370550|Hormones|hormones|mesh-ancestor
24653834|NCT01245946|Doxycycline|doxycycline|mesh-list
24566354|NCT00785395|Oxytocics|oxytocics|mesh-ancestor
24566355|NCT00785395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24566356|NCT00785395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566357|NCT00785421|Leucovorin|leucovorin|mesh-list
24566358|NCT00785421|Folic Acid|folic acid|mesh-list
24566377|NCT00785421|Vitamins|vitamins|mesh-ancestor
24566379|NCT00785421|Hematinics|hematinics|mesh-ancestor
24566380|NCT00785421|Anticoagulants|anticoagulants|mesh-ancestor
24566381|NCT00785421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24566382|NCT00785421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24566383|NCT00785434|Citalopram|citalopram|mesh-list
24566399|NCT00785460|Sequestering Agents|sequestering agents|mesh-ancestor
24566400|NCT00785460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566401|NCT00785473|Cholecalciferol|cholecalciferol|mesh-list
24566402|NCT00785473|Vitamin D|vitamin d|mesh-list
24566403|NCT00785473|Calcium Carbonate|calcium carbonate|mesh-list
24566404|NCT00785473|Calcium|calcium|mesh-list
24566405|NCT00785473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24566406|NCT00785473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566408|NCT00785473|Micronutrients|micronutrients|mesh-ancestor
24566409|NCT00785473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24566410|NCT00785473|Antacids|antacids|mesh-ancestor
24566411|NCT00785473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566412|NCT00785473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24566413|NCT00785551|Quinine|quinine|mesh-list
24566414|NCT00785551|Antimalarials|antimalarials|mesh-ancestor
25686632|NCT01922115|Cholinergic Agents|cholinergic agents|mesh-ancestor
24566415|NCT00785551|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24566448|NCT00785811|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24782806|NCT01898104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25405941|NCT03586999|Nivolumab|nivolumab|mesh-list
24566449|NCT00785811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24566450|NCT00785811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566451|NCT00785811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566454|NCT00785863|Remifentanil|remifentanil|mesh-list
24566455|NCT00785863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24566456|NCT00785863|Narcotics|narcotics|mesh-ancestor
24566457|NCT00785863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24566458|NCT00785863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566459|NCT00785863|Analgesics|analgesics|mesh-ancestor
24566460|NCT00785863|Sensory System Agents|sensory system agents|mesh-ancestor
24566461|NCT00785863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24566462|NCT00785863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24566463|NCT00785863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24566464|NCT00785863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24566465|NCT00785863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24566466|NCT00785863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24566467|NCT00785863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566468|NCT00785863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566487|NCT00786110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566488|NCT00786110|Tubulin Modulators|tubulin modulators|mesh-ancestor
24566489|NCT00786110|Antimitotic Agents|antimitotic agents|mesh-ancestor
25243588|NCT05283408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25243589|NCT05283408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243590|NCT05283408|Antidepressive Agents|antidepressive agents|mesh-ancestor
25243591|NCT05283408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25243592|NCT05281068|Danazol|danazol|mesh-list
25243593|NCT05281068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25243594|NCT05281068|Hormone Antagonists|hormone antagonists|mesh-ancestor
25243595|NCT05281068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25243596|NCT05281068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243597|NCT05276284|Atezolizumab|atezolizumab|mesh-list
25243598|NCT05276284|Mercaptopurine|mercaptopurine|mesh-list
24445428|NCT00301574|Autonomic Agents|autonomic agents|mesh-ancestor
24445429|NCT00301574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24445430|NCT00301574|Nootropic Agents|nootropic agents|mesh-ancestor
24445431|NCT00301587|Folic Acid|folic acid|mesh-list
24445432|NCT00301587|Moxifloxacin|moxifloxacin|mesh-list
24445433|NCT00301587|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24566520|NCT00786253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24566521|NCT00786253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566583|NCT00786461|Silver Nitrate|silver nitrate|mesh-list
24566584|NCT00786461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24566585|NCT00786461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24566586|NCT00786513|Anti-Infective Agents|anti-infective agents|mesh-list
24566587|NCT00786513|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24566588|NCT00786552|Paclitaxel|paclitaxel|mesh-list
24566589|NCT00786552|Pemetrexed|pemetrexed|mesh-list
24629027|NCT01102673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566590|NCT00786552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24566591|NCT00786552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791767|NCT03118232|Blood Substitutes|blood substitutes|mesh-ancestor
25008821|NCT04249258|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25008822|NCT04249258|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25008828|NCT04235608|Propofol|propofol|mesh-list
25008829|NCT04235608|Sevoflurane|sevoflurane|mesh-list
25008830|NCT04235608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25008831|NCT04235608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25008832|NCT04235608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008833|NCT04235608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25008834|NCT04235608|Anesthetics, General|anesthetics, general|mesh-ancestor
25008835|NCT04235608|Anesthetics|anesthetics|mesh-ancestor
25008836|NCT04235608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25008837|NCT04235608|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25008838|NCT04231838|Nicotine|nicotine|mesh-list
25008851|NCT04146324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25008853|NCT04141579|Evolocumab|evolocumab|mesh-list
24566631|NCT00786734|Pitavastatin|pitavastatin|mesh-list
24566632|NCT00786734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24566633|NCT00786734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24566634|NCT00786734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25243599|NCT05276284|Thioguanine|thioguanine|mesh-list
25243600|NCT05276284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25243601|NCT05276284|Antimetabolites|antimetabolites|mesh-ancestor
25243602|NCT05276284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243603|NCT05276284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25243604|NCT05276284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25243606|NCT05276284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243607|NCT05276284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25243608|NCT05276284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25243609|NCT05276219|Furosemide|furosemide|mesh-list
25243610|NCT05276219|Isosorbide|isosorbide|mesh-list
25243611|NCT05276219|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25243612|NCT05276219|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25243613|NCT05276219|Diuretics|diuretics|mesh-ancestor
24445459|NCT00301587|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24445460|NCT00301600|Mycophenolic Acid|mycophenolic acid|mesh-list
24445461|NCT00301600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24445462|NCT00301600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445463|NCT00301600|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24445464|NCT00301600|Antitubercular Agents|antitubercular agents|mesh-ancestor
24445465|NCT00301600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24445466|NCT00301600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24445467|NCT00301600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445468|NCT00301600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445469|NCT00301613|Mycophenolic Acid|mycophenolic acid|mesh-list
24445470|NCT00301613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24445471|NCT00301613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445472|NCT00301613|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24445473|NCT00301613|Antitubercular Agents|antitubercular agents|mesh-ancestor
24445474|NCT00301613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24445475|NCT00301613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24445476|NCT00301613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445477|NCT00301613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566641|NCT00786851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566642|NCT00786851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24566643|NCT00786851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24566644|NCT00786851|Growth Substances|growth substances|mesh-ancestor
25243616|NCT05276219|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25243617|NCT05276219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25243618|NCT05276219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243620|NCT05276219|Vasodilator Agents|vasodilator agents|mesh-ancestor
25243621|NCT05276219|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25243625|NCT05270863|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25243626|NCT05270863|Carbachol|carbachol|mesh-list
25243627|NCT05270863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25243633|NCT05270863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243634|NCT05270863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243635|NCT05270863|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25243636|NCT05270863|Miotics|miotics|mesh-ancestor
25243637|NCT05270863|Autonomic Agents|autonomic agents|mesh-ancestor
25243638|NCT05270863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25243639|NCT05270863|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25243640|NCT05270863|Cholinergic Agents|cholinergic agents|mesh-ancestor
25243641|NCT05270863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25243642|NCT05270863|Analgesics|analgesics|mesh-ancestor
25243643|NCT05270863|Sensory System Agents|sensory system agents|mesh-ancestor
25243644|NCT05270863|Protective Agents|protective agents|mesh-ancestor
25243645|NCT05265910|Loratadine|loratadine|mesh-list
25243646|NCT05265910|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
24445526|NCT00301782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445527|NCT00301782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24445528|NCT00301782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24445529|NCT00301782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24445530|NCT00301782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445550|NCT00301860|Fludarabine phosphate|fludarabine phosphate|mesh-list
24445551|NCT00301860|Fludarabine|fludarabine|mesh-list
24445553|NCT00301860|Cyclosporins|cyclosporins|mesh-list
24445554|NCT00301860|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24445555|NCT00301860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24445556|NCT00301860|Abortifacient Agents|abortifacient agents|mesh-ancestor
24445557|NCT00301860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24445558|NCT00301860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445559|NCT00301860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24445560|NCT00301860|Antimetabolites|antimetabolites|mesh-ancestor
24445561|NCT00301860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445584|NCT00301912|Methotrexate|methotrexate|mesh-list
24445585|NCT00301912|Fludarabine phosphate|fludarabine phosphate|mesh-list
25243647|NCT05265910|Dextrans|dextrans|mesh-list
25243648|NCT05265910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25243649|NCT05265910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25243650|NCT05265910|Antipruritics|antipruritics|mesh-ancestor
25243657|NCT05265910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25243658|NCT05265910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243659|NCT05265910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243660|NCT05265910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25243661|NCT05265910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25243662|NCT05265910|Analgesics|analgesics|mesh-ancestor
25243663|NCT05265910|Sensory System Agents|sensory system agents|mesh-ancestor
25243664|NCT05265910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25243665|NCT05265910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25243666|NCT05265910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25243667|NCT05265910|Anticoagulants|anticoagulants|mesh-ancestor
25243668|NCT05265910|Plasma Substitutes|plasma substitutes|mesh-ancestor
25243669|NCT05265910|Blood Substitutes|blood substitutes|mesh-ancestor
25243675|NCT05254548|Flurbiprofen|flurbiprofen|mesh-list
25243676|NCT05254548|Midazolam|midazolam|mesh-list
25243677|NCT05254548|Omeprazole|omeprazole|mesh-list
25243678|NCT05254548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25243679|NCT05254548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25243680|NCT05254548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25243681|NCT05254548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243682|NCT05254548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25243683|NCT05254548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25243684|NCT05254548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24445589|NCT00301912|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24445590|NCT00301912|Abortifacient Agents|abortifacient agents|mesh-ancestor
24445600|NCT00301912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24445601|NCT00301912|Immunologic Factors|immunologic factors|mesh-ancestor
24445602|NCT00301912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24445603|NCT00301912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24445635|NCT00301938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445636|NCT00301938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24445637|NCT00301938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445638|NCT00301938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445639|NCT00301951|Mycophenolic Acid|mycophenolic acid|mesh-list
24445640|NCT00301951|Fludarabine|fludarabine|mesh-list
24445641|NCT00301951|Fludarabine phosphate|fludarabine phosphate|mesh-list
24445642|NCT00301951|Busulfan|busulfan|mesh-list
24445643|NCT00301951|Tacrolimus|tacrolimus|mesh-list
24445644|NCT00301951|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24445645|NCT00301951|Sargramostim|sargramostim|mesh-list
24445646|NCT00301951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25243685|NCT05254548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25243686|NCT05254548|Anesthetics, General|anesthetics, general|mesh-ancestor
25243687|NCT05254548|Anesthetics|anesthetics|mesh-ancestor
25243688|NCT05254548|GABA Modulators|gaba modulators|mesh-ancestor
25243689|NCT05254548|GABA Agents|gaba agents|mesh-ancestor
25243690|NCT05254548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25243691|NCT05254548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243692|NCT05254548|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25243693|NCT05254548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25243694|NCT05254548|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25243695|NCT05254548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25243696|NCT05254548|Analgesics|analgesics|mesh-ancestor
25243697|NCT05254548|Sensory System Agents|sensory system agents|mesh-ancestor
25243698|NCT05254548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25243713|NCT05246943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243714|NCT05246943|Hemostatics|hemostatics|mesh-ancestor
25243715|NCT05246943|Coagulants|coagulants|mesh-ancestor
25243716|NCT05245591|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
25243717|NCT05245591|Anticoagulants|anticoagulants|mesh-ancestor
24699896|NCT01449448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24851877|NCT02259777|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
24445650|NCT00301951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24445651|NCT00301951|Immunologic Factors|immunologic factors|mesh-ancestor
24445652|NCT00301951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445653|NCT00301951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24445654|NCT00301951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445656|NCT00301951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24445657|NCT00301951|Antitubercular Agents|antitubercular agents|mesh-ancestor
24445658|NCT00301951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24445659|NCT00301951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24445660|NCT00301951|Alkylating Agents|alkylating agents|mesh-ancestor
24445661|NCT00301951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24445662|NCT00301951|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25243775|NCT05226351|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25243776|NCT05226351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25243777|NCT05226351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243778|NCT05226351|Hormones|hormones|mesh-ancestor
25243779|NCT05226351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25243788|NCT05220280|Imatinib Mesylate|imatinib mesylate|mesh-list
25243789|NCT05220280|Infliximab|infliximab|mesh-list
25243790|NCT05220280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25243791|NCT05220280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25243792|NCT05220280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25243793|NCT05220280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243794|NCT05220280|Dermatologic Agents|dermatologic agents|mesh-ancestor
25243795|NCT05220280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25243796|NCT05220280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25243797|NCT05219435|Nivolumab|nivolumab|mesh-list
24445705|NCT00302341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24445707|NCT00302341|Antimalarials|antimalarials|mesh-ancestor
24445708|NCT00302341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24851878|NCT02259777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24497200|NCT00508885|Niacinamide|niacinamide|mesh-list
24445737|NCT00302393|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24445738|NCT00302393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24445739|NCT00302393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24445740|NCT00302393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445741|NCT00302393|Dopamine Agents|dopamine agents|mesh-ancestor
25070949|NCT03414879|Anesthetics|anesthetics|mesh-ancestor
24566652|NCT00787007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24566653|NCT00787007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566654|NCT00787111|Fluoxetine|fluoxetine|mesh-list
24566655|NCT00787111|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25243813|NCT05200845|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24566656|NCT00787111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25243827|NCT05189002|Dalteparin|dalteparin|mesh-list
25243828|NCT05189002|Anticoagulants|anticoagulants|mesh-ancestor
25243829|NCT05189002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25243830|NCT05189002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25243831|NCT05189002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274164|NCT02380131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25274165|NCT02380118|Midazolam|midazolam|mesh-list
25274166|NCT02380118|Haloperidol|haloperidol|mesh-list
25274167|NCT02380118|Olanzapine|olanzapine|mesh-list
25274168|NCT02380118|Haloperidol decanoate|haloperidol decanoate|mesh-list
25274169|NCT02380118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25274170|NCT02380118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25686633|NCT01922115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25686634|NCT01922115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783146|NCT01900405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25274171|NCT02380118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25274172|NCT02380118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274173|NCT02380118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25274174|NCT02380118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25274175|NCT02380118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25274176|NCT02380118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25274177|NCT02380118|Anesthetics, General|anesthetics, general|mesh-ancestor
25274179|NCT02380118|GABA Modulators|gaba modulators|mesh-ancestor
25070983|NCT03414450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243840|NCT05183139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25243841|NCT05183139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243842|NCT05183139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25243843|NCT05183139|Glucocorticoids|glucocorticoids|mesh-ancestor
24445755|NCT00302419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445756|NCT00302432|Menthol|menthol|mesh-list
24445757|NCT00302432|Antipruritics|antipruritics|mesh-ancestor
24445758|NCT00302432|Dermatologic Agents|dermatologic agents|mesh-ancestor
24445759|NCT00302484|Zoledronic Acid|zoledronic acid|mesh-list
24445760|NCT00302484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24445761|NCT00302484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445762|NCT00302497|Basiliximab|basiliximab|mesh-list
24445763|NCT00302497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25243844|NCT05183139|Hormones|hormones|mesh-ancestor
25243845|NCT05183139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25243846|NCT05183139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25243847|NCT05183139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25243848|NCT05183139|Immunologic Factors|immunologic factors|mesh-ancestor
25243849|NCT05183139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25243850|NCT05183139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25243851|NCT05183139|Growth Substances|growth substances|mesh-ancestor
25243852|NCT05183139|Growth Inhibitors|growth inhibitors|mesh-ancestor
25243853|NCT05183139|Protease Inhibitors|protease inhibitors|mesh-ancestor
25243854|NCT05183139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25243855|NCT05183139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243856|NCT05176964|Capecitabine|capecitabine|mesh-list
25243857|NCT05176964|Oxaliplatin|oxaliplatin|mesh-list
25243858|NCT05176964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25243859|NCT05176964|Antimetabolites|antimetabolites|mesh-ancestor
25243860|NCT05176964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243861|NCT05176964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783188|NCT01900587|Tapentadol|tapentadol|mesh-list
25243874|NCT05170789|Dexamethasone|dexamethasone|mesh-list
25243875|NCT05170789|Elotuzumab|elotuzumab|mesh-list
25243876|NCT05170789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25243877|NCT05170789|Antiemetics|antiemetics|mesh-ancestor
25071016|NCT03413722|Everolimus|everolimus|mesh-list
25243878|NCT05170789|Autonomic Agents|autonomic agents|mesh-ancestor
25243879|NCT05170789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25243880|NCT05170789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243881|NCT05170789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25243882|NCT05170789|Glucocorticoids|glucocorticoids|mesh-ancestor
25071017|NCT03413722|Tacrolimus|tacrolimus|mesh-list
25071018|NCT03413722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25071019|NCT03413722|Immunologic Factors|immunologic factors|mesh-ancestor
25071020|NCT03413722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445791|NCT00302627|Pamidronate|pamidronate|mesh-list
24445792|NCT00302627|Vitamins|vitamins|mesh-list
24445810|NCT00302666|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24445811|NCT00302666|Contraceptive Agents|contraceptive agents|mesh-ancestor
24445812|NCT00302666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25243883|NCT05170789|Hormones|hormones|mesh-ancestor
25243884|NCT05170789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25243885|NCT05170789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25243886|NCT05170789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25243887|NCT05170230|Terlipressin|terlipressin|mesh-list
25243888|NCT05170230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25243889|NCT05170230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25243890|NCT05167513|Metformin|metformin|mesh-list
25243891|NCT05167513|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25243892|NCT05167513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25243893|NCT05167513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243894|NCT05167513|Incretins|incretins|mesh-ancestor
25243895|NCT05167513|Hormones|hormones|mesh-ancestor
25243896|NCT05167513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25243897|NCT05167513|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25243898|NCT05167513|Protease Inhibitors|protease inhibitors|mesh-ancestor
25243899|NCT05167513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851889|NCT02259790|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
24851890|NCT02259790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24851891|NCT02259790|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24851892|NCT02259790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24566657|NCT00787111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24566658|NCT00787111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243939|NCT05154279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25243940|NCT05154279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25243941|NCT05154136|Itraconazole|itraconazole|mesh-list
25243942|NCT05154136|Antifungal Agents|antifungal agents|mesh-ancestor
25243943|NCT05154136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25243944|NCT05154136|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25243945|NCT05154136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25243946|NCT05154136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25243947|NCT05154136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243948|NCT05154136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25243949|NCT05154136|Hormone Antagonists|hormone antagonists|mesh-ancestor
25243950|NCT05154136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25243951|NCT05154136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243952|NCT05154136|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25243953|NCT05152472|Atezolizumab|atezolizumab|mesh-list
25243954|NCT05152472|Imatinib Mesylate|imatinib mesylate|mesh-list
25243955|NCT05152472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25243956|NCT05152472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25243957|NCT05152472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25243958|NCT05152472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851894|NCT02259790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24851897|NCT02259790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24851898|NCT02259790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24851899|NCT02259803|Amlodipine|amlodipine|mesh-list
24851900|NCT02259803|Telmisartan|telmisartan|mesh-list
24851901|NCT02259803|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
24851902|NCT02259803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24851903|NCT02259803|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24851904|NCT02259803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24851905|NCT02259803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566659|NCT00787111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25243959|NCT05147558|Pembrolizumab|pembrolizumab|mesh-list
25243960|NCT05147558|Lenvatinib|lenvatinib|mesh-list
25243961|NCT05147558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25243962|NCT05147558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25243963|NCT05147558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25243964|NCT05147558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25243965|NCT05147558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243966|NCT05130814|Hyaluronic Acid|hyaluronic acid|mesh-list
25243975|NCT05129722|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25243976|NCT05129722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25243977|NCT05129722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25243978|NCT05129722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25243979|NCT05129722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25243980|NCT05129722|Hormone Antagonists|hormone antagonists|mesh-ancestor
25243981|NCT05129722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25243982|NCT05129722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25243983|NCT05129722|Diuretics|diuretics|mesh-ancestor
24851909|NCT02259803|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24566668|NCT00787371|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24566669|NCT00787371|Interferon-alpha|interferon-alpha|mesh-list
24566670|NCT00787371|Antiviral Agents|antiviral agents|mesh-ancestor
24512557|NCT00575627|Interferons|interferons|mesh-list
24566738|NCT00787501|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24566739|NCT00787501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566740|NCT00787553|Cefazolin|cefazolin|mesh-list
24566741|NCT00787553|Tinidazole|tinidazole|mesh-list
24566742|NCT00787553|Imidazole|imidazole|mesh-list
24566743|NCT00787553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24566744|NCT00787553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24566746|NCT00787553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566747|NCT00787553|Alkylating Agents|alkylating agents|mesh-ancestor
24566748|NCT00787553|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
24566749|NCT00787553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25243984|NCT05129722|Natriuretic Agents|natriuretic agents|mesh-ancestor
25243985|NCT05129722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25243986|NCT05129722|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25243987|NCT05129722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25243988|NCT05111002|Doxycycline|doxycycline|mesh-list
25243989|NCT05111002|Lefamulin|lefamulin|mesh-list
25243990|NCT05111002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25243991|NCT05111002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25243992|NCT05111002|Antimalarials|antimalarials|mesh-ancestor
25243993|NCT05111002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25243994|NCT05111002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25244042|NCT05076110|Analgesics|analgesics|mesh-ancestor
25244043|NCT05076110|Sensory System Agents|sensory system agents|mesh-ancestor
25244044|NCT05076110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25244045|NCT05076110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244046|NCT05076110|Antipyretics|antipyretics|mesh-ancestor
25244047|NCT05076110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25244048|NCT05076110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25244049|NCT05076110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25244050|NCT05076110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25244051|NCT05076110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25244052|NCT05076110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244053|NCT05076110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25244054|NCT05076110|Narcotics|narcotics|mesh-ancestor
25244055|NCT05076110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25244056|NCT05076110|Anticonvulsants|anticonvulsants|mesh-ancestor
25244057|NCT05076110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25244058|NCT05076110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25244059|NCT05076110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25244060|NCT05076110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25244061|NCT05076110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24851914|NCT02259816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24654449|NCT01249638|Growth Substances|growth substances|mesh-ancestor
24445833|NCT00302692|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25244062|NCT05076110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25244063|NCT05076110|Antimanic Agents|antimanic agents|mesh-ancestor
25244064|NCT05076110|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25244065|NCT05076110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25244066|NCT05074706|Antibodies|antibodies|mesh-list
25244067|NCT05074706|Immunoglobulin G|immunoglobulin g|mesh-list
25244068|NCT05074706|Immunologic Factors|immunologic factors|mesh-ancestor
25244069|NCT05074706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274180|NCT02380118|GABA Agents|gaba agents|mesh-ancestor
25274181|NCT02380118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25274182|NCT02380118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274183|NCT02380118|Antiemetics|antiemetics|mesh-ancestor
25274184|NCT02380118|Autonomic Agents|autonomic agents|mesh-ancestor
25274185|NCT02380118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25274186|NCT02380118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25274187|NCT02380118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25274188|NCT02380118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25274189|NCT02380118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25274190|NCT02380118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25274191|NCT02380118|Serotonin Agents|serotonin agents|mesh-ancestor
25274192|NCT02380118|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25274193|NCT02380118|Dopamine Agents|dopamine agents|mesh-ancestor
25274194|NCT02380118|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25274195|NCT02380001|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
25274196|NCT02380001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25274197|NCT02380001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25274198|NCT02380001|Analgesics|analgesics|mesh-ancestor
25274199|NCT02380001|Sensory System Agents|sensory system agents|mesh-ancestor
25274200|NCT02380001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24566901|NCT00788463|Hormones|hormones|mesh-ancestor
24566902|NCT00788463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24566903|NCT00788463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566904|NCT00788463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24893706|NCT04446923|Adrenergic Agents|adrenergic agents|mesh-ancestor
25686635|NCT01922115|Urological Agents|urological agents|mesh-ancestor
24566956|NCT00788749|Glucocorticoids|glucocorticoids|mesh-ancestor
24566984|NCT00788931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566985|NCT00789061|Lansoprazole|lansoprazole|mesh-list
24566986|NCT00789061|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24566987|NCT00789061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24566988|NCT00789061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24566989|NCT00789061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567006|NCT00789165|Cholinergic Agents|cholinergic agents|mesh-ancestor
24567028|NCT00789308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567048|NCT00789308|Plasma Substitutes|plasma substitutes|mesh-ancestor
24567049|NCT00789308|Blood Substitutes|blood substitutes|mesh-ancestor
24567050|NCT00789386|Midazolam|midazolam|mesh-list
24567051|NCT00789386|Remifentanil|remifentanil|mesh-list
24567052|NCT00789386|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24567053|NCT00789386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24783732|NCT01903681|Melatonin|melatonin|mesh-list
24567054|NCT00789386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24567055|NCT00789386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567056|NCT00789386|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24567057|NCT00789386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25244070|NCT05071937|Talazoparib|talazoparib|mesh-list
25244071|NCT05071937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25244072|NCT05071937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25244073|NCT05071937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244074|NCT05071937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244075|NCT05065021|Paclitaxel|paclitaxel|mesh-list
25244076|NCT05065021|Bevacizumab|bevacizumab|mesh-list
25244077|NCT05065021|Niraparib|niraparib|mesh-list
25244078|NCT05065021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25244079|NCT05065021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244080|NCT05065021|Tubulin Modulators|tubulin modulators|mesh-ancestor
25244081|NCT05065021|Antimitotic Agents|antimitotic agents|mesh-ancestor
25244082|NCT05065021|Mitosis Modulators|mitosis modulators|mesh-ancestor
25244083|NCT05065021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244084|NCT05065021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25244085|NCT05065021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25244086|NCT05065021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25244087|NCT05065021|Growth Substances|growth substances|mesh-ancestor
25244088|NCT05065021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045229|NCT00982696|Sensory System Agents|sensory system agents|mesh-ancestor
25045230|NCT00982696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045231|NCT00982696|Mitosis Modulators|mitosis modulators|mesh-ancestor
25045232|NCT00982696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045233|NCT00982696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25045234|NCT00981617|ALKS-33|alks-33|mesh-list
25045235|NCT00981617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25045236|NCT00981617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045237|NCT00981617|Sensory System Agents|sensory system agents|mesh-ancestor
25045238|NCT00981617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045239|NCT00981357|Naproxen|naproxen|mesh-list
24851915|NCT02259816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24851916|NCT02259816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244095|NCT05059535|Sensory System Agents|sensory system agents|mesh-ancestor
25244096|NCT05059535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25244097|NCT05059535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244107|NCT05038410|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25244108|NCT05038410|Immunologic Factors|immunologic factors|mesh-ancestor
25244109|NCT05038410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244110|NCT05035927|Psilocybin|psilocybin|mesh-list
25244111|NCT05035927|Hallucinogens|hallucinogens|mesh-ancestor
25244112|NCT05035927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244113|NCT05035927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25244116|NCT05021900|Tenalisib|tenalisib|mesh-list
25244117|NCT05021900|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
25244118|NCT05021900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25244119|NCT05021900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244120|NCT05014542|Analgesics|analgesics|mesh-list
25244121|NCT05014542|Sensory System Agents|sensory system agents|mesh-ancestor
25244122|NCT05014542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25244123|NCT05014542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244124|NCT05003713|Prednisone|prednisone|mesh-list
25244125|NCT05003713|Cortisone|cortisone|mesh-list
25244126|NCT05003713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25244127|NCT05003713|Glucocorticoids|glucocorticoids|mesh-ancestor
25244128|NCT05003713|Hormones|hormones|mesh-ancestor
25686636|NCT01922258|Brexpiprazole|brexpiprazole|mesh-list
25244129|NCT05003713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25244130|NCT05003713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244131|NCT05003713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25244132|NCT05003713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244133|NCT05002946|Naltrexone|naltrexone|mesh-list
25244134|NCT05002946|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25244135|NCT05002946|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25244136|NCT05002946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155337|NCT05411861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
25155338|NCT05411861|Sensory System Agents|sensory system agents|mesh-ancestor
25155339|NCT05411861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25155340|NCT05411861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155341|NCT05411237|Paclitaxel|paclitaxel|mesh-list
25155342|NCT05411237|Doxorubicin|doxorubicin|mesh-list
25155343|NCT05411237|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25155344|NCT05411237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25155345|NCT05411237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25155346|NCT05411237|Tubulin Modulators|tubulin modulators|mesh-ancestor
25155347|NCT05411237|Antimitotic Agents|antimitotic agents|mesh-ancestor
24851927|NCT02259829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25244137|NCT05002946|Sensory System Agents|sensory system agents|mesh-ancestor
25244138|NCT05002946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25244139|NCT04996017|Atezolizumab|atezolizumab|mesh-list
25244140|NCT04996017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244141|NCT04994223|Rivaroxaban|rivaroxaban|mesh-list
25244142|NCT04994223|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25244143|NCT04994223|Antithrombins|antithrombins|mesh-ancestor
25244144|NCT04994223|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25244145|NCT04994223|Protease Inhibitors|protease inhibitors|mesh-ancestor
25244146|NCT04994223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25244147|NCT04994223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244148|NCT04994223|Anticoagulants|anticoagulants|mesh-ancestor
24445838|NCT00302692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445840|NCT00302705|Enalapril|enalapril|mesh-list
24445841|NCT00302705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25244196|NCT04930237|Magnesium Hydroxide|magnesium hydroxide|mesh-list
25244197|NCT04930237|Calcium|calcium|mesh-list
25244198|NCT04930237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25244199|NCT04930237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244200|NCT04930237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244201|NCT04930237|Cathartics|cathartics|mesh-ancestor
25244202|NCT04930237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25244203|NCT04930237|Laxatives|laxatives|mesh-ancestor
25244204|NCT04930237|Antacids|antacids|mesh-ancestor
25244205|NCT04930237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25244206|NCT04930237|Sensory System Agents|sensory system agents|mesh-ancestor
25244207|NCT04930237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25244208|NCT04930237|Antidiarrheals|antidiarrheals|mesh-ancestor
25244209|NCT04928261|Trastuzumab|trastuzumab|mesh-list
25244210|NCT04928261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25244211|NCT04928261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244212|NCT04922944|Vaccines|vaccines|mesh-list
24851938|NCT02259855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24851940|NCT02259855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24851941|NCT02259855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24851942|NCT02259855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24851943|NCT02259855|Protease Inhibitors|protease inhibitors|mesh-ancestor
24851944|NCT02259855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851945|NCT02259855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654657|NCT01250808|Bortezomib|bortezomib|mesh-list
24567085|NCT00789464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24567086|NCT00789464|Renal Agents|renal agents|mesh-ancestor
24567087|NCT00789464|Antimalarials|antimalarials|mesh-ancestor
24567088|NCT00789464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24567089|NCT00789464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24567090|NCT00789464|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24567091|NCT00789464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25244218|NCT04907851|Denosumab|denosumab|mesh-list
25244219|NCT04907851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25244220|NCT04907851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274201|NCT02380001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274202|NCT02380001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25274203|NCT02380001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25274204|NCT02379754|Gentamicins|gentamicins|mesh-list
25274205|NCT02379754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24636130|NCT01143025|Anesthetics|anesthetics|mesh-ancestor
25274206|NCT02379754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25274207|NCT02379754|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25274208|NCT02379754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274209|NCT02379754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274210|NCT02380053|Celiprolol|celiprolol|mesh-list
25274211|NCT02380053|Bisoprolol|bisoprolol|mesh-list
25274212|NCT02380053|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25274213|NCT02380053|Sympatholytics|sympatholytics|mesh-ancestor
25274214|NCT02380053|Autonomic Agents|autonomic agents|mesh-ancestor
25274215|NCT02380053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25274216|NCT02380053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274217|NCT02380053|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25274218|NCT02380053|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25274219|NCT02380053|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25274220|NCT02380053|Adrenergic Agents|adrenergic agents|mesh-ancestor
25274221|NCT02380053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25244223|NCT04904536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25244224|NCT04904536|Antimetabolites|antimetabolites|mesh-ancestor
25244225|NCT04904536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244226|NCT04904536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25244227|NCT04904536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25244228|NCT04904536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25244229|NCT04902859|Clonidine|clonidine|mesh-list
25244230|NCT04902859|Analgesics|analgesics|mesh-ancestor
25244231|NCT04902859|Sensory System Agents|sensory system agents|mesh-ancestor
25244232|NCT04902859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25244233|NCT04902859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244234|NCT04902859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25244235|NCT04902859|Sympatholytics|sympatholytics|mesh-ancestor
25244236|NCT04902859|Autonomic Agents|autonomic agents|mesh-ancestor
25244237|NCT04902859|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25244238|NCT04902859|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25244239|NCT04902859|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25244240|NCT04902859|Adrenergic Agents|adrenergic agents|mesh-ancestor
25244241|NCT04902859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24784238|NCT01907048|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25244242|NCT04902859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244243|NCT04895306|Methyltestosterone|methyltestosterone|mesh-list
25244244|NCT04895306|Testosterone|testosterone|mesh-list
25244245|NCT04895306|Testosterone undecanoate|testosterone undecanoate|mesh-list
25244246|NCT04895306|Testosterone enanthate|testosterone enanthate|mesh-list
25244247|NCT04895306|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25244248|NCT04895306|Androgens|androgens|mesh-ancestor
25244249|NCT04895306|Hormones|hormones|mesh-ancestor
25244250|NCT04895306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25244251|NCT04895306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244252|NCT04895306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25244253|NCT04895306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244254|NCT04895306|Anabolic Agents|anabolic agents|mesh-ancestor
25244255|NCT04878107|Docetaxel|docetaxel|mesh-list
25244256|NCT04878107|Apatinib|apatinib|mesh-list
25244257|NCT04878107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244258|NCT04878107|Tubulin Modulators|tubulin modulators|mesh-ancestor
25244259|NCT04878107|Antimitotic Agents|antimitotic agents|mesh-ancestor
24851957|NCT02259868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24851961|NCT02259868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24851962|NCT02259868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24851963|NCT02259920|p-Hydroxyamphetamine|p-hydroxyamphetamine|mesh-list
24851965|NCT02259920|Autonomic Agents|autonomic agents|mesh-ancestor
24851966|NCT02259920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851967|NCT02259920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851968|NCT02259920|Sympathomimetics|sympathomimetics|mesh-ancestor
24851969|NCT02259946|Bromides|bromides|mesh-list
25244260|NCT04878107|Mitosis Modulators|mitosis modulators|mesh-ancestor
25686637|NCT01922258|Serotonin Agents|serotonin agents|mesh-ancestor
25686638|NCT01922258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25686639|NCT01922258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686640|NCT01922258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686641|NCT01922258|Dopamine Agonists|dopamine agonists|mesh-ancestor
25686642|NCT01922258|Dopamine Agents|dopamine agents|mesh-ancestor
25686643|NCT01922271|Glycopyrrolate|glycopyrrolate|mesh-list
25244261|NCT04878107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244262|NCT04878107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25244263|NCT04878107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25244264|NCT04873063|Beclomethasone|beclomethasone|mesh-list
25244265|NCT04873063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25244271|NCT04873063|Respiratory System Agents|respiratory system agents|mesh-ancestor
25244277|NCT04854395|Bupivacaine|bupivacaine|mesh-list
25244278|NCT04854395|Anesthetics, Local|anesthetics, local|mesh-ancestor
25244279|NCT04854395|Anesthetics|anesthetics|mesh-ancestor
25244280|NCT04854395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25244281|NCT04854395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244282|NCT04854395|Sensory System Agents|sensory system agents|mesh-ancestor
25244283|NCT04854395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25244284|NCT04853043|Cetuximab|cetuximab|mesh-list
25244285|NCT04853043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25244286|NCT04853043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244287|NCT04851301|Naloxone|naloxone|mesh-list
25244288|NCT04851301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25244289|NCT04851301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244290|NCT04851301|Sensory System Agents|sensory system agents|mesh-ancestor
25244291|NCT04851301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25244292|NCT04840888|Itraconazole|itraconazole|mesh-list
25244293|NCT04840888|Carbamazepine|carbamazepine|mesh-list
25244294|NCT04840888|Omeprazole|omeprazole|mesh-list
25244295|NCT04840888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25244296|NCT04840888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25244297|NCT04840888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24851970|NCT02259946|Tiotropium Bromide|tiotropium bromide|mesh-list
24851972|NCT02259946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24851973|NCT02259946|Autonomic Agents|autonomic agents|mesh-ancestor
24851974|NCT02259946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851975|NCT02259946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244298|NCT04840888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25244299|NCT04840888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244300|NCT04840888|Antifungal Agents|antifungal agents|mesh-ancestor
25244301|NCT04840888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25244302|NCT04840888|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25244303|NCT04840888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25244304|NCT04840888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25244305|NCT04840888|Hormone Antagonists|hormone antagonists|mesh-ancestor
25244306|NCT04840888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25244307|NCT04840888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244308|NCT04840888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25244309|NCT04840888|Anticonvulsants|anticonvulsants|mesh-ancestor
25244310|NCT04840888|Antimanic Agents|antimanic agents|mesh-ancestor
25244311|NCT04840888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25244334|NCT04828083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25244335|NCT04828083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25244336|NCT04828083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25244337|NCT04828083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25244338|NCT04828083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244339|NCT04796194|Pembrolizumab|pembrolizumab|mesh-list
25244340|NCT04796194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25244341|NCT04796194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244359|NCT04789148|Oxytocin|oxytocin|mesh-list
25244360|NCT04789148|Oxytocics|oxytocics|mesh-ancestor
25244361|NCT04789148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25244362|NCT04789148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244363|NCT04787835|Anesthetics|anesthetics|mesh-list
25244364|NCT04787835|Anesthetics, Local|anesthetics, local|mesh-list
25244365|NCT04787835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25244366|NCT04787835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244367|NCT04787835|Sensory System Agents|sensory system agents|mesh-ancestor
25686644|NCT01922271|Albuterol|albuterol|mesh-list
25686645|NCT01922271|Tiotropium Bromide|tiotropium bromide|mesh-list
25686646|NCT01922271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25686647|NCT01922271|Autonomic Agents|autonomic agents|mesh-ancestor
25686648|NCT01922271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686649|NCT01922271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036690|NCT03544671|Vitamin D|vitamin d|mesh-list
25244368|NCT04787835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25244369|NCT04767841|Metformin|metformin|mesh-list
25244370|NCT04767841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24851976|NCT02259946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24851977|NCT02259946|Respiratory System Agents|respiratory system agents|mesh-ancestor
24851978|NCT02259946|Parasympatholytics|parasympatholytics|mesh-ancestor
25244409|NCT04754945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24445857|NCT00302822|Efavirenz|efavirenz|mesh-list
24445858|NCT00302822|Lopinavir|lopinavir|mesh-list
24445859|NCT00302822|Enfuvirtide|enfuvirtide|mesh-list
24445860|NCT00302822|Antiviral Agents|antiviral agents|mesh-ancestor
24445861|NCT00302822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24445862|NCT00302822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24445863|NCT00302822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24445864|NCT00302822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812314|NCT02051387|Antiemetics|antiemetics|mesh-ancestor
25244410|NCT04754945|Alkylating Agents|alkylating agents|mesh-ancestor
25244411|NCT04754945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244432|NCT04748848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244433|NCT04748848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25244434|NCT04732182|Donepezil|donepezil|mesh-list
25244435|NCT04732182|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25244436|NCT04732182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25244437|NCT04732182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244438|NCT04732182|Cholinergic Agents|cholinergic agents|mesh-ancestor
25244439|NCT04732182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25244440|NCT04732182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244441|NCT04732182|Nootropic Agents|nootropic agents|mesh-ancestor
24785127|NCT01912118|Propofol|propofol|mesh-list
24812324|NCT02051413|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24812325|NCT02051413|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24812337|NCT02051530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24812339|NCT02051569|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24812340|NCT02051569|Antidepressive Agents|antidepressive agents|mesh-ancestor
24812341|NCT02051569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24812342|NCT02051621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
24812343|NCT02051738|Mebendazole|mebendazole|mesh-list
24812344|NCT02051738|Piperazine|piperazine|mesh-list
24812345|NCT02051738|Piperazine citrate|piperazine citrate|mesh-list
24812346|NCT02051738|DMP 777|dmp 777|mesh-list
24812347|NCT02051738|Antinematodal Agents|antinematodal agents|mesh-ancestor
24812348|NCT02051738|Anthelmintics|anthelmintics|mesh-ancestor
25274231|NCT02379767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274232|NCT02379767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25274233|NCT02379767|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25274234|NCT02379767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274235|NCT02379767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274236|NCT02379715|Remifentanil|remifentanil|mesh-list
25274237|NCT02379715|Desflurane|desflurane|mesh-list
25274238|NCT02379715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25274239|NCT02379715|Narcotics|narcotics|mesh-ancestor
25274240|NCT02379715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25274241|NCT02379715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274242|NCT02379715|Analgesics|analgesics|mesh-ancestor
25274243|NCT02379715|Sensory System Agents|sensory system agents|mesh-ancestor
25274244|NCT02379715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25274245|NCT02379715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25274246|NCT02379715|Anesthetics, General|anesthetics, general|mesh-ancestor
25274247|NCT02379715|Anesthetics|anesthetics|mesh-ancestor
25274248|NCT02379663|Enoxaparin|enoxaparin|mesh-list
25274249|NCT02379663|Rivaroxaban|rivaroxaban|mesh-list
25274250|NCT02379663|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25274251|NCT02379663|Antithrombins|antithrombins|mesh-ancestor
25274252|NCT02379663|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25274253|NCT02379663|Protease Inhibitors|protease inhibitors|mesh-ancestor
25274254|NCT02379663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274255|NCT02379663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274256|NCT02379663|Anticoagulants|anticoagulants|mesh-ancestor
25274257|NCT02379663|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25274258|NCT02379663|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25274259|NCT02379546|Desflurane|desflurane|mesh-list
25274260|NCT02379546|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25244462|NCT04731467|Tubulin Modulators|tubulin modulators|mesh-ancestor
25244463|NCT04731467|Antimitotic Agents|antimitotic agents|mesh-ancestor
25244464|NCT04731467|Mitosis Modulators|mitosis modulators|mesh-ancestor
25244465|NCT04731467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244466|NCT04731467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25244467|NCT04731467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25244469|NCT04730362|Sevoflurane|sevoflurane|mesh-list
25244470|NCT04730362|Anesthetics|anesthetics|mesh-ancestor
25244471|NCT04730362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25244472|NCT04730362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244473|NCT04730362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25244474|NCT04730362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25244475|NCT04730362|Anesthetics, General|anesthetics, general|mesh-ancestor
25244476|NCT04730362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25244477|NCT04730362|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25244478|NCT04726085|Ibuprofen|ibuprofen|mesh-list
25244479|NCT04726085|Indomethacin|indomethacin|mesh-list
25244480|NCT04726085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25244481|NCT04726085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25244482|NCT04726085|Analgesics|analgesics|mesh-ancestor
25244483|NCT04726085|Sensory System Agents|sensory system agents|mesh-ancestor
25244484|NCT04726085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24972448|NCT03717701|Metformin|metformin|mesh-list
25244485|NCT04726085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244486|NCT04726085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25244487|NCT04726085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25244488|NCT04726085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25244489|NCT04726085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25244490|NCT04726085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244491|NCT04726085|Gout Suppressants|gout suppressants|mesh-ancestor
25244492|NCT04726085|Tocolytic Agents|tocolytic agents|mesh-ancestor
25244493|NCT04726085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25244494|NCT04718220|Antibodies|antibodies|mesh-list
25244495|NCT04718220|Immunologic Factors|immunologic factors|mesh-ancestor
25244496|NCT04718220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851981|NCT02259946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24851982|NCT02259946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851984|NCT02259959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24851985|NCT02259959|Tiotropium Bromide|tiotropium bromide|mesh-list
24851986|NCT02259959|Olodaterol|olodaterol|mesh-list
24851987|NCT02259959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24851988|NCT02259959|Autonomic Agents|autonomic agents|mesh-ancestor
24851989|NCT02259959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851990|NCT02259959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851991|NCT02259959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24851992|NCT02259959|Respiratory System Agents|respiratory system agents|mesh-ancestor
24851993|NCT02259959|Parasympatholytics|parasympatholytics|mesh-ancestor
24851994|NCT02259959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24851995|NCT02259959|Cholinergic Agents|cholinergic agents|mesh-ancestor
24851996|NCT02259959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24851997|NCT02259959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851998|NCT02259985|Itasetron|itasetron|mesh-list
24851999|NCT02259985|Antiemetics|antiemetics|mesh-ancestor
24852009|NCT02259998|Dipyridamole|dipyridamole|mesh-list
25244497|NCT04713709|Naloxone|naloxone|mesh-list
25244498|NCT04713709|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25244499|NCT04713709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244500|NCT04713709|Sensory System Agents|sensory system agents|mesh-ancestor
25244501|NCT04713709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25244502|NCT04711837|Propofol|propofol|mesh-list
25244503|NCT04711837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25244504|NCT04711837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25244526|NCT04688788|Immunologic Factors|immunologic factors|mesh-ancestor
25244527|NCT04688788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244528|NCT04688788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25244529|NCT04688788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25244530|NCT04688788|Antiemetics|antiemetics|mesh-ancestor
25244531|NCT04688788|Autonomic Agents|autonomic agents|mesh-ancestor
25244532|NCT04688788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25244533|NCT04688788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25244534|NCT04688788|Glucocorticoids|glucocorticoids|mesh-ancestor
25244535|NCT04688788|Hormones|hormones|mesh-ancestor
25244536|NCT04688788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25244537|NCT04688788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25244538|NCT04688788|Protective Agents|protective agents|mesh-ancestor
25244539|NCT04688788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25244540|NCT04688788|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25244541|NCT04688788|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25244542|NCT04688788|Histamine Antagonists|histamine antagonists|mesh-ancestor
25244543|NCT04688788|Histamine Agents|histamine agents|mesh-ancestor
25244544|NCT04688788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25244545|NCT04688788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244546|NCT04685694|Misoprostol|misoprostol|mesh-list
25244547|NCT04685694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25244548|NCT04685694|Abortifacient Agents|abortifacient agents|mesh-ancestor
25244549|NCT04685694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25244550|NCT04685694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244551|NCT04685694|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25244552|NCT04685694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25244553|NCT04685694|Oxytocics|oxytocics|mesh-ancestor
24852032|NCT02260024|Antioxidants|antioxidants|mesh-ancestor
24852033|NCT02260024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567092|NCT00789464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244582|NCT04669288|Azithromycin|azithromycin|mesh-list
25244583|NCT04669288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25244584|NCT04669288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25244585|NCT04650243|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25244586|NCT04650243|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25244590|NCT04644627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25244591|NCT04644627|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25244592|NCT04644627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25244593|NCT04644627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244594|NCT04639037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25244595|NCT04635774|Insulin|insulin|mesh-list
25244596|NCT04635774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25244597|NCT04635774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244598|NCT04624828|Androgens|androgens|mesh-list
25244599|NCT04624828|Hormones|hormones|mesh-ancestor
25244600|NCT04624828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25244601|NCT04624828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244605|NCT04615624|Furosemide|furosemide|mesh-list
25244606|NCT04615624|Diuretics|diuretics|mesh-ancestor
25244607|NCT04615624|Natriuretic Agents|natriuretic agents|mesh-ancestor
25244608|NCT04615624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244609|NCT04615624|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25244610|NCT04615624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25244611|NCT04615624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244612|NCT04614909|Temozolomide|temozolomide|mesh-list
25244613|NCT04614909|Olaparib|olaparib|mesh-list
25244614|NCT04614909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25244615|NCT04614909|Alkylating Agents|alkylating agents|mesh-ancestor
25244616|NCT04614909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852034|NCT02260024|Protective Agents|protective agents|mesh-ancestor
24852042|NCT02260037|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24852043|NCT02260037|Histamine Antagonists|histamine antagonists|mesh-ancestor
24852045|NCT02260037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24852046|NCT02260037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852047|NCT02260037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852049|NCT02260050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24852050|NCT02260050|Histamine Antagonists|histamine antagonists|mesh-ancestor
24852052|NCT02260050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24852053|NCT02260050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852054|NCT02260050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852055|NCT02260063|Epinastine|epinastine|mesh-list
24852056|NCT02260063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24852057|NCT02260063|Histamine Antagonists|histamine antagonists|mesh-ancestor
24852058|NCT02260063|Histamine Agents|histamine agents|mesh-ancestor
24852059|NCT02260063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24852060|NCT02260063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852061|NCT02260063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852062|NCT02260089|Telmisartan|telmisartan|mesh-list
24852063|NCT02260089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25244617|NCT04614909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638071|NCT01154790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24638072|NCT01154790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25244618|NCT04614909|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25244619|NCT04614909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25244620|NCT04580147|Aflibercept|aflibercept|mesh-list
25244621|NCT04580147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25244622|NCT04580147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25244623|NCT04580147|Growth Substances|growth substances|mesh-ancestor
25244624|NCT04580147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244625|NCT04580147|Growth Inhibitors|growth inhibitors|mesh-ancestor
25244626|NCT04580147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244627|NCT04553133|Letrozole|letrozole|mesh-list
25244628|NCT04553133|Fulvestrant|fulvestrant|mesh-list
25244629|NCT04553133|Palbociclib|palbociclib|mesh-list
25244630|NCT04553133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244631|NCT04553133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25244632|NCT04553133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25244633|NCT04553133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25244634|NCT04553133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244635|NCT04553133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25244636|NCT04553133|Hormone Antagonists|hormone antagonists|mesh-ancestor
25244637|NCT04553133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25244638|NCT04553133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244639|NCT04553133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25244642|NCT04547166|Bevacizumab|bevacizumab|mesh-list
25244643|NCT04547166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25244644|NCT04547166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244645|NCT04547166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25244646|NCT04547166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25244647|NCT04547166|Growth Substances|growth substances|mesh-ancestor
25244648|NCT04547166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244649|NCT04547166|Growth Inhibitors|growth inhibitors|mesh-ancestor
25244650|NCT04545762|Vidarabine|vidarabine|mesh-list
25244651|NCT04545762|Cyclophosphamide|cyclophosphamide|mesh-list
25244652|NCT04545762|Fludarabine|fludarabine|mesh-list
25244653|NCT04545762|Fludarabine phosphate|fludarabine phosphate|mesh-list
25244654|NCT04545762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24852073|NCT02260206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852075|NCT02260323|Antirheumatic Agents|antirheumatic agents|mesh-list
24852076|NCT02260336|Celecoxib|celecoxib|mesh-list
24852077|NCT02260336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24852078|NCT02260336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24852079|NCT02260336|Analgesics|analgesics|mesh-ancestor
24852080|NCT02260336|Sensory System Agents|sensory system agents|mesh-ancestor
24852081|NCT02260336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24852082|NCT02260336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852083|NCT02260336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24852084|NCT02260336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24852085|NCT02260336|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24852086|NCT02260336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24852087|NCT02260336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24655274|NCT01255475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244655|NCT04545762|Immunologic Factors|immunologic factors|mesh-ancestor
25244665|NCT04545762|Antiviral Agents|antiviral agents|mesh-ancestor
25244666|NCT04545762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25274261|NCT02379546|Anesthetics, General|anesthetics, general|mesh-ancestor
25274262|NCT02379546|Anesthetics|anesthetics|mesh-ancestor
25274263|NCT02379546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25274264|NCT02379546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274265|NCT02379650|Hydroxychloroquine|hydroxychloroquine|mesh-list
25274266|NCT02379650|Antimalarials|antimalarials|mesh-ancestor
25274267|NCT02379650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25274268|NCT02379650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25274269|NCT02379650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25274270|NCT02379650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274271|NCT02379650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274272|NCT02379650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25274273|NCT02379676|Clopidogrel|clopidogrel|mesh-list
25274274|NCT02379676|Ticagrelor|ticagrelor|mesh-list
25274275|NCT02379676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25274276|NCT02379676|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25274277|NCT02379676|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25686650|NCT01922271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25686651|NCT01922271|Respiratory System Agents|respiratory system agents|mesh-ancestor
25274278|NCT02379676|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25274279|NCT02379676|Purinergic Agents|purinergic agents|mesh-ancestor
25274280|NCT02379676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25274281|NCT02379676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274282|NCT02379676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275655|NCT02370550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25275656|NCT02370550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25275657|NCT02370550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25275658|NCT02370550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852088|NCT02260336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852090|NCT02260414|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24852091|NCT02260414|Dalteparin|dalteparin|mesh-list
24852092|NCT02260414|Anticoagulants|anticoagulants|mesh-ancestor
24852093|NCT02260414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24852094|NCT02260414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24852095|NCT02260414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852096|NCT02260505|Imatinib Mesylate|imatinib mesylate|mesh-list
24852097|NCT02260505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24852098|NCT02260505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24852099|NCT02260505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852100|NCT02260505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852108|NCT02260544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655323|NCT01255878|Gabapentin|gabapentin|mesh-list
24786030|NCT01917617|Antiviral Agents|antiviral agents|mesh-ancestor
24791798|NCT03073694|Melphalan|melphalan|mesh-list
25244673|NCT04539223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25244674|NCT04539223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25244675|NCT04539223|Antimetabolites|antimetabolites|mesh-ancestor
25244676|NCT04539223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244677|NCT04539223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25244678|NCT04535882|polysaccharide-K|polysaccharide-k|mesh-list
25244679|NCT04535882|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25244680|NCT04535882|Immunologic Factors|immunologic factors|mesh-ancestor
25244681|NCT04535882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244682|NCT04535882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25244683|NCT04535882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244684|NCT04535882|Antiviral Agents|antiviral agents|mesh-ancestor
25244685|NCT04535882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25244686|NCT04535882|Interferon Inducers|interferon inducers|mesh-ancestor
25244687|NCT04535882|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25244688|NCT04535882|Protective Agents|protective agents|mesh-ancestor
25244689|NCT04532099|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25244690|NCT04532099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25244691|NCT04532099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25244692|NCT04505410|Infliximab|infliximab|mesh-list
25244693|NCT04505410|Ustekinumab|ustekinumab|mesh-list
25244694|NCT04505410|Tofacitinib|tofacitinib|mesh-list
25244695|NCT04505410|Dermatologic Agents|dermatologic agents|mesh-ancestor
25244696|NCT04505410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25244697|NCT04505410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25244698|NCT04505410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25244699|NCT04505410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25244700|NCT04505410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621315|NCT01061450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445869|NCT00302822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25071792|NCT03406299|Vitamins|vitamins|mesh-ancestor
24567093|NCT00789464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24567094|NCT00789464|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24567095|NCT00789464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24567096|NCT00789503|Vitamin D|vitamin d|mesh-list
24567097|NCT00789503|Cholecalciferol|cholecalciferol|mesh-list
24567098|NCT00789503|Calcium|calcium|mesh-list
24567099|NCT00789503|Vitamins|vitamins|mesh-ancestor
25008857|NCT04141579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567100|NCT00789503|Micronutrients|micronutrients|mesh-ancestor
24852130|NCT02260687|Growth Inhibitors|growth inhibitors|mesh-ancestor
24498634|NCT00515736|Trace Elements|trace elements|mesh-ancestor
24852140|NCT02260947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24852141|NCT02260947|Analgesics|analgesics|mesh-ancestor
24791799|NCT03073694|Mitomycins|mitomycins|mesh-list
25244736|NCT04502095|Antimalarials|antimalarials|mesh-ancestor
25244737|NCT04502095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25244738|NCT04502095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25244739|NCT04502095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25244740|NCT04502095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25244741|NCT04502095|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25244742|NCT04492254|Enoxaparin|enoxaparin|mesh-list
25244743|NCT04492254|Anticoagulants|anticoagulants|mesh-ancestor
25244744|NCT04492254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25244747|NCT04485130|Disulfiram|disulfiram|mesh-list
25244748|NCT04485130|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25244749|NCT04485130|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25244750|NCT04485130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25244751|NCT04485130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244752|NCT04475835|Heparin|heparin|mesh-list
25244753|NCT04475835|Bivalirudin|bivalirudin|mesh-list
25244754|NCT04475835|Anticoagulants|anticoagulants|mesh-ancestor
25244755|NCT04475835|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25244756|NCT04475835|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25244757|NCT04475835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244758|NCT04475835|Antithrombins|antithrombins|mesh-ancestor
25244759|NCT04475835|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25244760|NCT04475835|Protease Inhibitors|protease inhibitors|mesh-ancestor
25244761|NCT04475835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25244762|NCT04474470|Cetuximab|cetuximab|mesh-list
25244763|NCT04474470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25244764|NCT04474470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244765|NCT04471246|Cephalexin|cephalexin|mesh-list
25244766|NCT04471246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25244767|NCT04471246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25244768|NCT04466150|Ocrelizumab|ocrelizumab|mesh-list
24852142|NCT02260947|Sensory System Agents|sensory system agents|mesh-ancestor
24852143|NCT02260947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24852144|NCT02260947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852145|NCT02260947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24852146|NCT02260947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24852147|NCT02260947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24852148|NCT02260947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621361|NCT01061853|Hormones|hormones|mesh-ancestor
24852149|NCT02260947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852150|NCT02260947|Anticonvulsants|anticonvulsants|mesh-ancestor
24852151|NCT02260947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24655486|NCT01256866|Anesthetics|anesthetics|mesh-ancestor
24791801|NCT03073694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24567116|NCT00789568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567141|NCT00789646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24567142|NCT00789646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25244773|NCT04463368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25244774|NCT04463368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244775|NCT04463368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25244776|NCT04463368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244777|NCT04460326|Insulin|insulin|mesh-list
25244778|NCT04460326|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25244779|NCT04460326|Insulin Glargine|insulin glargine|mesh-list
25244780|NCT04460326|Insulin Aspart|insulin aspart|mesh-list
25244781|NCT04460326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25244782|NCT04460326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244783|NCT04460066|Paclitaxel|paclitaxel|mesh-list
25244784|NCT04460066|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25244785|NCT04460066|Antibodies|antibodies|mesh-list
25244786|NCT04460066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25244787|NCT04460066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244788|NCT04460066|Tubulin Modulators|tubulin modulators|mesh-ancestor
25244789|NCT04460066|Antimitotic Agents|antimitotic agents|mesh-ancestor
25244790|NCT04460066|Mitosis Modulators|mitosis modulators|mesh-ancestor
25244791|NCT04460066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244792|NCT04460066|Immunologic Factors|immunologic factors|mesh-ancestor
25244793|NCT04460066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852153|NCT02260947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24852154|NCT02260947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24852155|NCT02260947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24567143|NCT00789646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567145|NCT00789711|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24567146|NCT00789711|Insulin Aspart|insulin aspart|mesh-list
24567147|NCT00789711|Insulin Detemir|insulin detemir|mesh-list
24567148|NCT00789711|Biphasic Insulins|biphasic insulins|mesh-list
24567149|NCT00789711|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24567150|NCT00789711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25008864|NCT04094519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244807|NCT04436926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244808|NCT04436926|Analgesics|analgesics|mesh-ancestor
25244809|NCT04436926|Sensory System Agents|sensory system agents|mesh-ancestor
25244810|NCT04436926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25244811|NCT04428372|Mannitol|mannitol|mesh-list
25244812|NCT04428372|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25244813|NCT04428372|Diuretics|diuretics|mesh-ancestor
25244814|NCT04428372|Natriuretic Agents|natriuretic agents|mesh-ancestor
24852163|NCT02261025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25244835|NCT04387240|Artesunate|artesunate|mesh-list
24852164|NCT02261025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244836|NCT04387240|Artemisinins|artemisinins|mesh-list
25244837|NCT04387240|Artemisinin|artemisinin|mesh-list
25244838|NCT04387240|Antimalarials|antimalarials|mesh-ancestor
25244839|NCT04387240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25244840|NCT04387240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25244841|NCT04387240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25244842|NCT04387240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244843|NCT04387240|Antiviral Agents|antiviral agents|mesh-ancestor
25244844|NCT04387240|Schistosomicides|schistosomicides|mesh-ancestor
25244845|NCT04387240|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25244846|NCT04387240|Anthelmintics|anthelmintics|mesh-ancestor
25244853|NCT04378621|Adalimumab|adalimumab|mesh-list
25244854|NCT04378621|Etanercept|etanercept|mesh-list
25244855|NCT04378621|Golimumab|golimumab|mesh-list
25244856|NCT04378621|Infliximab|infliximab|mesh-list
25244857|NCT04378621|Certolizumab Pegol|certolizumab pegol|mesh-list
25244858|NCT04378621|Tofacitinib|tofacitinib|mesh-list
25244859|NCT04378621|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
25244860|NCT04378621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25244861|NCT04378621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24706596|NCT01490905|Analgesics|analgesics|mesh-ancestor
25244862|NCT04378621|Dermatologic Agents|dermatologic agents|mesh-ancestor
25244863|NCT04378621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25244864|NCT04378621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25244865|NCT04378621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25244866|NCT04378621|Analgesics|analgesics|mesh-ancestor
25244867|NCT04378621|Sensory System Agents|sensory system agents|mesh-ancestor
25244868|NCT04378621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25244869|NCT04378621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244870|NCT04378621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25244871|NCT04378621|Immunologic Factors|immunologic factors|mesh-ancestor
25244872|NCT04378621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25244873|NCT04378621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25244874|NCT04378621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852166|NCT02261025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24852167|NCT02261025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24852168|NCT02261025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24852169|NCT02261025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852170|NCT02261025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24852171|NCT02261025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25244875|NCT04378621|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25244885|NCT04373317|Pimavanserin|pimavanserin|mesh-list
25244886|NCT04373317|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25244887|NCT04373317|Antidepressive Agents|antidepressive agents|mesh-ancestor
25244888|NCT04373317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25244889|NCT04373317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25244890|NCT04373317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25244891|NCT04373317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25244892|NCT04373317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244893|NCT04373317|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25244894|NCT04373317|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25244895|NCT04373317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25244896|NCT04373317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25244897|NCT04373317|Serotonin Agents|serotonin agents|mesh-ancestor
25244898|NCT04373317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24786723|NCT01921374|Estrogens|estrogens|mesh-ancestor
25244899|NCT04373317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244904|NCT04357457|Almitrine|almitrine|mesh-list
25244905|NCT04357457|Respiratory System Agents|respiratory system agents|mesh-ancestor
24852185|NCT02261064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24852186|NCT02261077|Scopolamine|scopolamine|mesh-list
24852187|NCT02261077|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24852188|NCT02261077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24852189|NCT02261077|Antiemetics|antiemetics|mesh-ancestor
24852190|NCT02261077|Autonomic Agents|autonomic agents|mesh-ancestor
24852191|NCT02261077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24852192|NCT02261077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852193|NCT02261077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24852199|NCT02261077|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25274290|NCT02379299|Hormones|hormones|mesh-list
25274291|NCT02379299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25274292|NCT02379299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274293|NCT02379000|Triamcinolone|triamcinolone|mesh-list
25274300|NCT02379000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25274302|NCT02379000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25274303|NCT02379000|Immunologic Factors|immunologic factors|mesh-ancestor
25274304|NCT02379000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274305|NCT02379000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274306|NCT02379026|Vitamin D|vitamin d|mesh-list
25274307|NCT02379026|Cholecalciferol|cholecalciferol|mesh-list
25274308|NCT02379026|Vitamins|vitamins|mesh-ancestor
25274309|NCT02379026|Micronutrients|micronutrients|mesh-ancestor
25274310|NCT02379026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274311|NCT02379026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25274312|NCT02379026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25274313|NCT02379156|Midodrine|midodrine|mesh-list
25274314|NCT02379156|Sympathomimetics|sympathomimetics|mesh-ancestor
25274315|NCT02379156|Autonomic Agents|autonomic agents|mesh-ancestor
25274316|NCT02379156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25274317|NCT02379156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852204|NCT02261090|Protective Agents|protective agents|mesh-ancestor
24852205|NCT02261090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852206|NCT02261090|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24852207|NCT02261090|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24959154|NCT03826615|Gabapentin|gabapentin|mesh-list
24852208|NCT02261090|Dopamine Agonists|dopamine agonists|mesh-ancestor
24852209|NCT02261090|Dopamine Agents|dopamine agents|mesh-ancestor
24852219|NCT02261103|Dopamine Agents|dopamine agents|mesh-ancestor
24852220|NCT02261103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24852221|NCT02261116|Telmisartan|telmisartan|mesh-list
24852222|NCT02261116|Candesartan|candesartan|mesh-list
24852223|NCT02261116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24852224|NCT02261116|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24852225|NCT02261116|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25244910|NCT04334330|Trastuzumab|trastuzumab|mesh-list
25244911|NCT04334330|Fulvestrant|fulvestrant|mesh-list
25244912|NCT04334330|Palbociclib|palbociclib|mesh-list
25244913|NCT04334330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25244914|NCT04334330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25244915|NCT04334330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25244916|NCT04334330|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25244917|NCT04334330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25244918|NCT04334330|Hormone Antagonists|hormone antagonists|mesh-ancestor
25244919|NCT04334330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25244920|NCT04334330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244921|NCT04334330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25244922|NCT04334330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25244923|NCT04334330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25244929|NCT04331717|Leuprolide|leuprolide|mesh-list
25244930|NCT04331717|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25244931|NCT04331717|Fertility Agents|fertility agents|mesh-ancestor
25244932|NCT04331717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25244933|NCT04331717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244934|NCT04331717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25244935|NCT04331717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24567183|NCT00790075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24567184|NCT00790075|Serotonin Agents|serotonin agents|mesh-ancestor
24567185|NCT00790075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24567186|NCT00790075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567187|NCT00790075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567188|NCT00790075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24567189|NCT00790075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24567190|NCT00790075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24567191|NCT00790075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24567192|NCT00790075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24567193|NCT00790075|Dopamine Agents|dopamine agents|mesh-ancestor
24567194|NCT00790101|Risedronic Acid|risedronic acid|mesh-list
24567216|NCT00790114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24567217|NCT00790114|Anesthetics, General|anesthetics, general|mesh-ancestor
24567218|NCT00790114|Anesthetics|anesthetics|mesh-ancestor
24567219|NCT00790114|GABA Modulators|gaba modulators|mesh-ancestor
24567220|NCT00790114|GABA Agents|gaba agents|mesh-ancestor
24567221|NCT00790114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25244991|NCT04313985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25244998|NCT04311177|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25244999|NCT04311177|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25245000|NCT04311177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245002|NCT04303507|Chloroquine|chloroquine|mesh-list
25245003|NCT04303507|Antimalarials|antimalarials|mesh-ancestor
25245004|NCT04303507|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25245005|NCT04303507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25245006|NCT04303507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25245007|NCT04303507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25245008|NCT04303507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245009|NCT04303507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25245010|NCT04303507|Amebicides|amebicides|mesh-ancestor
24852251|NCT02261376|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24852252|NCT02261376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24852253|NCT02261376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812361|NCT02051751|Antimitotic Agents|antimitotic agents|mesh-ancestor
24812362|NCT02051751|Mitosis Modulators|mitosis modulators|mesh-ancestor
24852254|NCT02261506|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24852255|NCT02261506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24852256|NCT02261506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24852257|NCT02261506|Antitubercular Agents|antitubercular agents|mesh-ancestor
24852258|NCT02261662|Ribavirin|ribavirin|mesh-list
24852259|NCT02261662|Betamethasone|betamethasone|mesh-list
24852260|NCT02261662|Antimetabolites|antimetabolites|mesh-ancestor
25281395|NCT02331927|Growth Substances|growth substances|mesh-ancestor
24852261|NCT02261662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852262|NCT02261662|Antiviral Agents|antiviral agents|mesh-ancestor
24852263|NCT02261662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24852264|NCT02261662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24852265|NCT02261662|Glucocorticoids|glucocorticoids|mesh-ancestor
24852266|NCT02261662|Hormones|hormones|mesh-ancestor
24852267|NCT02261662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24852268|NCT02261662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852269|NCT02261662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24852270|NCT02261662|Respiratory System Agents|respiratory system agents|mesh-ancestor
24655898|NCT01258634|Vitamins|vitamins|mesh-ancestor
25072107|NCT03403140|Etanercept|etanercept|mesh-list
24567254|NCT00790387|Tirofiban|tirofiban|mesh-list
24567255|NCT00790387|Anticoagulants|anticoagulants|mesh-ancestor
25245013|NCT04297332|Nicotine|nicotine|mesh-list
25245014|NCT04297332|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25245015|NCT04297332|Autonomic Agents|autonomic agents|mesh-ancestor
25245016|NCT04297332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25245027|NCT04293562|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25245028|NCT04293562|Methotrexate|methotrexate|mesh-list
25245029|NCT04293562|Etoposide|etoposide|mesh-list
25245030|NCT04293562|Etoposide phosphate|etoposide phosphate|mesh-list
25245031|NCT04293562|Daunorubicin|daunorubicin|mesh-list
25245032|NCT04293562|Asparaginase|asparaginase|mesh-list
25245033|NCT04293562|Mitoxantrone|mitoxantrone|mesh-list
25245034|NCT04293562|Podophyllotoxin|podophyllotoxin|mesh-list
25245035|NCT04293562|Gemtuzumab|gemtuzumab|mesh-list
24855669|NCT02280525|Antimetabolites|antimetabolites|mesh-ancestor
25245036|NCT04293562|Dexrazoxane|dexrazoxane|mesh-list
25245037|NCT04293562|Razoxane|razoxane|mesh-list
25245038|NCT04293562|Calicheamicins|calicheamicins|mesh-list
25245039|NCT04293562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25245041|NCT04293562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25245042|NCT04293562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245043|NCT04293562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25245044|NCT04293562|Antimetabolites|antimetabolites|mesh-ancestor
25245045|NCT04293562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245046|NCT04293562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25245047|NCT04293562|Dermatologic Agents|dermatologic agents|mesh-ancestor
25245048|NCT04293562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078507|NCT03355716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24567256|NCT00790387|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24567257|NCT00790387|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24567258|NCT00790387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245049|NCT04293562|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25245050|NCT04293562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25245051|NCT04293562|Immunologic Factors|immunologic factors|mesh-ancestor
25245052|NCT04293562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25245053|NCT04293562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25245054|NCT04293562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25245055|NCT04293562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25245056|NCT04293562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25245057|NCT04293562|Antiviral Agents|antiviral agents|mesh-ancestor
25245058|NCT04293562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25245059|NCT04293562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25245060|NCT04293562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25245061|NCT04293562|Analgesics|analgesics|mesh-ancestor
25245062|NCT04293562|Sensory System Agents|sensory system agents|mesh-ancestor
25245063|NCT04293562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25245072|NCT04286295|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25245073|NCT04286295|Autonomic Agents|autonomic agents|mesh-ancestor
25245074|NCT04286295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25245075|NCT04286295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245076|NCT04286295|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25245077|NCT04286295|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25245078|NCT04286295|Cholinergic Agents|cholinergic agents|mesh-ancestor
25245079|NCT04286295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25245080|NCT04286295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245081|NCT04275713|Metformin|metformin|mesh-list
25245082|NCT04275713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25245083|NCT04275713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852279|NCT02261675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24852280|NCT02261675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24852281|NCT02261675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24852282|NCT02261675|Adrenergic Agents|adrenergic agents|mesh-ancestor
24852283|NCT02261675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24567259|NCT00790387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24567260|NCT00790413|Rituximab|rituximab|mesh-list
24567261|NCT00790413|Fludarabine|fludarabine|mesh-list
24567262|NCT00790413|Thiotepa|thiotepa|mesh-list
24567263|NCT00790413|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24567264|NCT00790413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24567265|NCT00790413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24567266|NCT00790413|Immunologic Factors|immunologic factors|mesh-ancestor
24567267|NCT00790413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567268|NCT00790413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24567269|NCT00790413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245084|NCT04271917|Acetaminophen|acetaminophen|mesh-list
25245085|NCT04271917|Ibuprofen|ibuprofen|mesh-list
25245086|NCT04271917|Cannabidiol|cannabidiol|mesh-list
25245087|NCT04271917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25245088|NCT04271917|Analgesics|analgesics|mesh-ancestor
25245089|NCT04271917|Sensory System Agents|sensory system agents|mesh-ancestor
25245090|NCT04271917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686652|NCT01922271|Parasympatholytics|parasympatholytics|mesh-ancestor
25686653|NCT01922271|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25686654|NCT01922271|Cholinergic Agents|cholinergic agents|mesh-ancestor
25686655|NCT01922271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25686656|NCT01922271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686657|NCT01922271|Tocolytic Agents|tocolytic agents|mesh-ancestor
25245091|NCT04271917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245093|NCT04271917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25245094|NCT04271917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25245095|NCT04271917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25245096|NCT04271917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25245097|NCT04271917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25245098|NCT04271917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245099|NCT04271917|Anticonvulsants|anticonvulsants|mesh-ancestor
25245100|NCT04266353|Resveratrol|resveratrol|mesh-list
25245101|NCT04266353|Antioxidants|antioxidants|mesh-ancestor
25245102|NCT04266353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245103|NCT04266353|Protective Agents|protective agents|mesh-ancestor
25245104|NCT04266353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245105|NCT04266353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25245106|NCT04266353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25245107|NCT04266275|Curcumin|curcumin|mesh-list
25245113|NCT04266275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245114|NCT04266275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25245115|NCT04266275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25245116|NCT04266275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25245117|NCT04266275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25245118|NCT04266275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245119|NCT04265911|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25245120|NCT04265911|Immunologic Factors|immunologic factors|mesh-ancestor
25245121|NCT04265911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245122|NCT04265105|Fluticasone|fluticasone|mesh-list
25245123|NCT04265105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25245124|NCT04265105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25245125|NCT04265105|Autonomic Agents|autonomic agents|mesh-ancestor
25245126|NCT04265105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25245127|NCT04265105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245128|NCT04265105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25245129|NCT04265105|Respiratory System Agents|respiratory system agents|mesh-ancestor
25245130|NCT04265105|Dermatologic Agents|dermatologic agents|mesh-ancestor
25245131|NCT04265105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25245135|NCT04250064|Bevacizumab|bevacizumab|mesh-list
25245136|NCT04250064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25245137|NCT04250064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25245138|NCT04250064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25245139|NCT04250064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25245140|NCT04250064|Growth Substances|growth substances|mesh-ancestor
24852286|NCT02261779|Tranylcypromine|tranylcypromine|mesh-list
24852287|NCT02261779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24852288|NCT02261779|Keratolytic Agents|keratolytic agents|mesh-ancestor
24852289|NCT02261779|Dermatologic Agents|dermatologic agents|mesh-ancestor
24852290|NCT02261779|Antidepressive Agents|antidepressive agents|mesh-ancestor
24852291|NCT02261779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24852292|NCT02261779|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24567284|NCT00790439|Basiliximab|basiliximab|mesh-list
24567315|NCT00790595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567317|NCT00790608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24567318|NCT00790608|Autonomic Agents|autonomic agents|mesh-ancestor
24567319|NCT00790608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24567320|NCT00790608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567321|NCT00790608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24567322|NCT00790608|Respiratory System Agents|respiratory system agents|mesh-ancestor
24567323|NCT00790608|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24567324|NCT00790608|Antioxidants|antioxidants|mesh-ancestor
24567325|NCT00790608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567326|NCT00790608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24567327|NCT00790608|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24567328|NCT00790608|Vasodilator Agents|vasodilator agents|mesh-ancestor
24567329|NCT00790608|Gasotransmitters|gasotransmitters|mesh-ancestor
25245148|NCT04249544|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25245149|NCT04249544|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25245150|NCT04249544|Dopamine Agonists|dopamine agonists|mesh-ancestor
25245151|NCT04249544|Dopamine Agents|dopamine agents|mesh-ancestor
25245152|NCT04249544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24567330|NCT00790608|Protective Agents|protective agents|mesh-ancestor
24567331|NCT00790777|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24567332|NCT00790777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24567345|NCT00790816|Lapatinib|lapatinib|mesh-list
24567346|NCT00790816|Antineoplastic Agents|antineoplastic agents|mesh-list
24641373|NCT01173068|Ertapenem|ertapenem|mesh-list
24567347|NCT00790816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24567348|NCT00790816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567349|NCT00790816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567350|NCT00790881|Lumefantrine|lumefantrine|mesh-list
24567351|NCT00790881|Artemether|artemether|mesh-list
24567352|NCT00790881|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24567353|NCT00790881|Antimalarials|antimalarials|mesh-ancestor
24567354|NCT00790881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24567355|NCT00790881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24567356|NCT00790881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24567357|NCT00790894|Epothilones|epothilones|mesh-list
24567358|NCT00790894|Tubulin Modulators|tubulin modulators|mesh-ancestor
24567359|NCT00790894|Antimitotic Agents|antimitotic agents|mesh-ancestor
24567360|NCT00790894|Mitosis Modulators|mitosis modulators|mesh-ancestor
24567361|NCT00790894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567362|NCT00790894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24567363|NCT00790920|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
24567364|NCT00790920|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24567365|NCT00790920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24567409|NCT00791024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24567410|NCT00791024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245165|NCT04239092|Topotecan|topotecan|mesh-list
25245166|NCT04239092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25245167|NCT04239092|Immunologic Factors|immunologic factors|mesh-ancestor
25245168|NCT04239092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245169|NCT04239092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25245170|NCT04239092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25245171|NCT04239092|Alkylating Agents|alkylating agents|mesh-ancestor
25245172|NCT04239092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245173|NCT04239092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25245174|NCT04239092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25245175|NCT04239092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24567416|NCT00791167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24567417|NCT00791167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24567418|NCT00791167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567419|NCT00791167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24557403|NCT00752479|Basiliximab|basiliximab|mesh-list
24852314|NCT02261896|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24567420|NCT00791167|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24567421|NCT00791167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24567423|NCT00791167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24567424|NCT00791167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567425|NCT00791167|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24567426|NCT00791167|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24567427|NCT00791167|Dopamine Agents|dopamine agents|mesh-ancestor
24567428|NCT00791193|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24567429|NCT00791193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24567434|NCT00791193|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24567435|NCT00791193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24567436|NCT00791193|Serotonin Agents|serotonin agents|mesh-ancestor
24567437|NCT00791193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24567438|NCT00791193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557465|NCT00752635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24567478|NCT00791284|Serotonin Agents|serotonin agents|mesh-ancestor
24567479|NCT00791284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24788234|NCT01930396|Heparin|heparin|mesh-list
25245218|NCT04207060|Indomethacin|indomethacin|mesh-list
25245219|NCT04207060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25245220|NCT04207060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25245221|NCT04207060|Analgesics|analgesics|mesh-ancestor
25245222|NCT04207060|Sensory System Agents|sensory system agents|mesh-ancestor
25245223|NCT04207060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25245224|NCT04207060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245225|NCT04207060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25245226|NCT04207060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25245227|NCT04207060|Gout Suppressants|gout suppressants|mesh-ancestor
25245228|NCT04207060|Tocolytic Agents|tocolytic agents|mesh-ancestor
25245229|NCT04207060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25245230|NCT04207060|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25245231|NCT04207060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25245232|NCT04207060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245233|NCT04202692|Magnesium trisilicate|magnesium trisilicate|mesh-list
25245234|NCT04202692|Hyaluronic Acid|hyaluronic acid|mesh-list
25245235|NCT04202692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25245236|NCT04202692|Immunologic Factors|immunologic factors|mesh-ancestor
25245248|NCT04179864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245249|NCT04179864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24835067|NCT02182206|Nintedanib|nintedanib|mesh-list
24700785|NCT01455129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24700786|NCT01455129|Cholinergic Agents|cholinergic agents|mesh-ancestor
24700787|NCT01455129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24700788|NCT01455129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700789|NCT01455142|Insulin|insulin|mesh-list
24700790|NCT01455142|Insulin Aspart|insulin aspart|mesh-list
24700791|NCT01455142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24700792|NCT01455142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700793|NCT01455233|Moxifloxacin|moxifloxacin|mesh-list
24700794|NCT01455233|Besifloxacin|besifloxacin|mesh-list
24700795|NCT01455233|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24700796|NCT01455233|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24700797|NCT01455233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24700798|NCT01455233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24700799|NCT01455233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24700800|NCT01455233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24499608|NCT00520247|Folic Acid|folic acid|mesh-list
24852320|NCT02261922|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24852321|NCT02261922|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24852322|NCT02261922|Purinergic Agents|purinergic agents|mesh-ancestor
24852323|NCT02261922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24700827|NCT01455337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24627985|NCT01095939|Benazepril|benazepril|mesh-list
25245250|NCT04179864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24567480|NCT00791284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245251|NCT04168710|Bupivacaine|bupivacaine|mesh-list
25245252|NCT04168710|Anesthetics, Local|anesthetics, local|mesh-ancestor
25245253|NCT04168710|Anesthetics|anesthetics|mesh-ancestor
25245254|NCT04168710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25245255|NCT04168710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245256|NCT04168710|Sensory System Agents|sensory system agents|mesh-ancestor
25245257|NCT04168710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25245258|NCT04166110|Oxymetazoline|oxymetazoline|mesh-list
25245259|NCT04166110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25245260|NCT04166110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25245261|NCT04166110|Adrenergic Agents|adrenergic agents|mesh-ancestor
25245262|NCT04166110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25245263|NCT04166110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245264|NCT04166110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245265|NCT04166110|Sympathomimetics|sympathomimetics|mesh-ancestor
25245266|NCT04166110|Autonomic Agents|autonomic agents|mesh-ancestor
25245267|NCT04166110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25245268|NCT04166110|Nasal Decongestants|nasal decongestants|mesh-ancestor
25072278|NCT03402113|Midazolam|midazolam|mesh-list
24852324|NCT02261922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852325|NCT02261922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567491|NCT00791349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24567492|NCT00791349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24567493|NCT00791349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24567494|NCT00791349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567529|NCT00791505|Sulfamethoxazole|sulfamethoxazole|mesh-list
24567530|NCT00791505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24567531|NCT00791505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24567532|NCT00791505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24567533|NCT00791505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24567534|NCT00791505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567535|NCT00791505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567536|NCT00791505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24567537|NCT00791505|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24567538|NCT00791505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24567552|NCT00791531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567553|NCT00791531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24567555|NCT00791531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567556|NCT00791531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24567558|NCT00791531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567559|NCT00791531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24567560|NCT00791531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24567562|NCT00791531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24567563|NCT00791531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24567564|NCT00791544|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24567566|NCT00791544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25245270|NCT04166110|Respiratory System Agents|respiratory system agents|mesh-ancestor
25274318|NCT02379156|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25274319|NCT02379156|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25274320|NCT02379156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25274321|NCT02379156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25274322|NCT02379156|Adrenergic Agents|adrenergic agents|mesh-ancestor
25274323|NCT02379156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25274324|NCT02379156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274325|NCT02378623|Apixaban|apixaban|mesh-list
25274326|NCT02378623|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25274327|NCT02378623|Antithrombins|antithrombins|mesh-ancestor
25274328|NCT02378623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25274329|NCT02378623|Protease Inhibitors|protease inhibitors|mesh-ancestor
25274330|NCT02378623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274331|NCT02378623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274332|NCT02378623|Anticoagulants|anticoagulants|mesh-ancestor
25274333|NCT02378740|Ketamine|ketamine|mesh-list
25274334|NCT02378740|Analgesics|analgesics|mesh-ancestor
24567567|NCT00791544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24567568|NCT00791544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567569|NCT00791544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567570|NCT00791622|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24567571|NCT00791622|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24567572|NCT00791622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24567586|NCT00791713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24567587|NCT00791713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24567588|NCT00791713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567589|NCT00791713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24567590|NCT00791713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24567591|NCT00791713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24567592|NCT00791713|Serotonin Agents|serotonin agents|mesh-ancestor
24567593|NCT00791713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24567620|NCT00791804|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24567621|NCT00791804|Narcotics|narcotics|mesh-ancestor
24567622|NCT00791804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24567623|NCT00791804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567624|NCT00791804|Analgesics|analgesics|mesh-ancestor
24567625|NCT00791804|Sensory System Agents|sensory system agents|mesh-ancestor
25245271|NCT04150458|Choline|choline|mesh-list
25245272|NCT04150458|Lipotropic Agents|lipotropic agents|mesh-ancestor
25245273|NCT04150458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25245274|NCT04150458|Antimetabolites|antimetabolites|mesh-ancestor
25245275|NCT04150458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245276|NCT04150458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24788450|NCT01931410|Abortifacient Agents|abortifacient agents|mesh-ancestor
25245277|NCT04150458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25245278|NCT04150458|Nootropic Agents|nootropic agents|mesh-ancestor
24852331|NCT02262143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852332|NCT02262143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24852333|NCT02262143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24852334|NCT02262143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852335|NCT02262156|Antidepressive Agents|antidepressive agents|mesh-list
24852336|NCT02262156|Serotonin|serotonin|mesh-list
24852337|NCT02262156|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
24852339|NCT02262156|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25072312|NCT03402087|Antimetabolites|antimetabolites|mesh-ancestor
25008877|NCT04064359|Immunologic Factors|immunologic factors|mesh-ancestor
24791812|NCT03069703|Rituximab|rituximab|mesh-list
24791813|NCT03069703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24791814|NCT03069703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791815|NCT03069703|Immunologic Factors|immunologic factors|mesh-ancestor
24791816|NCT03069703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791817|NCT03069703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24791821|NCT03049189|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
24791822|NCT03049189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791823|NCT03049189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24567626|NCT00791804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24567627|NCT00791804|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24567628|NCT00791804|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24567629|NCT00791804|Anesthetics, General|anesthetics, general|mesh-ancestor
24567631|NCT00791830|Irbesartan|irbesartan|mesh-list
24567632|NCT00791830|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24567633|NCT00791830|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24567634|NCT00791830|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24567635|NCT00791830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567636|NCT00791856|Methyltestosterone|methyltestosterone|mesh-list
24567637|NCT00791856|Testosterone|testosterone|mesh-list
24567638|NCT00791856|Testosterone undecanoate|testosterone undecanoate|mesh-list
24567639|NCT00791856|Testosterone enanthate|testosterone enanthate|mesh-list
24567640|NCT00791856|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24567655|NCT00791960|Autonomic Agents|autonomic agents|mesh-ancestor
24567656|NCT00791960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24567657|NCT00791960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567658|NCT00791960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24567659|NCT00791960|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24567664|NCT00792012|Temozolomide|temozolomide|mesh-list
24567665|NCT00792012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25072330|NCT03402048|Docetaxel|docetaxel|mesh-list
24567667|NCT00792012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567668|NCT00792012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24567669|NCT00792025|Sunitinib|sunitinib|mesh-list
24567670|NCT00792025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24567671|NCT00792025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24567672|NCT00792025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24567673|NCT00792025|Growth Substances|growth substances|mesh-ancestor
24567674|NCT00792025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567675|NCT00792025|Growth Inhibitors|growth inhibitors|mesh-ancestor
24567676|NCT00792025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24567677|NCT00792025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567678|NCT00792025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567679|NCT00792168|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24567680|NCT00792168|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24567681|NCT00792168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24567683|NCT00792168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567684|NCT00792168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24567685|NCT00792168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567686|NCT00792168|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24567687|NCT00792168|Antidepressive Agents|antidepressive agents|mesh-ancestor
24567688|NCT00792168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24567690|NCT00792181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25008878|NCT04064359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008879|NCT03938584|Ascorbic Acid|ascorbic acid|mesh-list
25008880|NCT03938584|Vitamins|vitamins|mesh-ancestor
25008881|NCT03938584|Micronutrients|micronutrients|mesh-ancestor
25008882|NCT03938584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008883|NCT03938584|Antioxidants|antioxidants|mesh-ancestor
25008884|NCT03938584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008885|NCT03938584|Protective Agents|protective agents|mesh-ancestor
25008886|NCT03917381|Docetaxel|docetaxel|mesh-list
25008887|NCT03917381|Pembrolizumab|pembrolizumab|mesh-list
25008889|NCT03917381|Tubulin Modulators|tubulin modulators|mesh-ancestor
24567693|NCT00792181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567694|NCT00792181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25245310|NCT04102800|Benralizumab|benralizumab|mesh-list
25245311|NCT04102800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25245312|NCT04102800|Respiratory System Agents|respiratory system agents|mesh-ancestor
25245313|NCT04101461|Iron|iron|mesh-list
25245315|NCT04101461|Trace Elements|trace elements|mesh-ancestor
25245316|NCT04101461|Micronutrients|micronutrients|mesh-ancestor
25245317|NCT04101461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245318|NCT04101461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24852351|NCT02262169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852353|NCT02262299|Analgesics|analgesics|mesh-ancestor
24852354|NCT02262299|Sensory System Agents|sensory system agents|mesh-ancestor
24852355|NCT02262299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24852356|NCT02262299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859059|NCT02301494|Hormones|hormones|mesh-ancestor
24445905|NCT00303017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24445906|NCT00303017|Analgesics|analgesics|mesh-ancestor
24567695|NCT00792181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24567696|NCT00792181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24567713|NCT00792246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24567714|NCT00792246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567715|NCT00792246|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24567717|NCT00792324|Etravirine|etravirine|mesh-list
24567718|NCT00792324|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24567719|NCT00792324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24567720|NCT00792324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567721|NCT00792324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567722|NCT00792324|Antiviral Agents|antiviral agents|mesh-ancestor
24567723|NCT00792324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24567724|NCT00792324|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24567725|NCT00792324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25245320|NCT04094207|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25245321|NCT04094207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25245322|NCT04094207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245323|NCT04094207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25245324|NCT04094207|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25245325|NCT04094207|Protective Agents|protective agents|mesh-ancestor
25245326|NCT04094207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245327|NCT04094207|Vasodilator Agents|vasodilator agents|mesh-ancestor
25245328|NCT04094207|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25245329|NCT04094207|Antioxidants|antioxidants|mesh-ancestor
25245330|NCT04083560|Hydroxocobalamin|hydroxocobalamin|mesh-list
25245331|NCT04083560|Vitamin B 12|vitamin b 12|mesh-list
25245332|NCT04083560|Hematinics|hematinics|mesh-ancestor
25245333|NCT04083560|Vitamin B Complex|vitamin b complex|mesh-ancestor
25245334|NCT04083560|Vitamins|vitamins|mesh-ancestor
25245335|NCT04083560|Micronutrients|micronutrients|mesh-ancestor
25245336|NCT04083560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245344|NCT04081545|Analgesics, Opioid|analgesics, opioid|mesh-list
25245345|NCT04081545|Analgesics|analgesics|mesh-list
25245346|NCT04081545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
25245347|NCT04081545|Anesthetics|anesthetics|mesh-list
24567742|NCT00792350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567743|NCT00792363|Irinotecan|irinotecan|mesh-list
24567744|NCT00792363|Panitumumab|panitumumab|mesh-list
24567745|NCT00792363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24567746|NCT00792363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24567747|NCT00792363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567748|NCT00792363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567749|NCT00792363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24567750|NCT00792363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24567751|NCT00792376|Diclofenac|diclofenac|mesh-list
24567752|NCT00792376|Etoricoxib|etoricoxib|mesh-list
24557641|NCT00753168|Timolol|timolol|mesh-list
25245348|NCT04081545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25245349|NCT04081545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245350|NCT04081545|Narcotics|narcotics|mesh-ancestor
25245351|NCT04081545|Sensory System Agents|sensory system agents|mesh-ancestor
25245352|NCT04081545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25245353|NCT04071769|Xenon|xenon|mesh-list
24643266|NCT01184833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24643272|NCT01184911|Pyrimethamine|pyrimethamine|mesh-list
25245354|NCT04071769|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25082404|NCT03322969|Paclitaxel|paclitaxel|mesh-list
25245355|NCT04071769|Anesthetics, General|anesthetics, general|mesh-ancestor
25245356|NCT04071769|Anesthetics|anesthetics|mesh-ancestor
25245357|NCT04071769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25245358|NCT04071769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245359|NCT04069819|Cilostazol|cilostazol|mesh-list
25245360|NCT04069819|Citalopram|citalopram|mesh-list
25245361|NCT04069819|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25245362|NCT04069819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25245363|NCT04069819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25245364|NCT04069819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245365|NCT04069819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25245366|NCT04069819|Serotonin Agents|serotonin agents|mesh-ancestor
24499881|NCT00521430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24589418|NCT00907400|Sensory System Agents|sensory system agents|mesh-ancestor
24589419|NCT00907400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24589420|NCT00907400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589421|NCT00907400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24589422|NCT00907400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24589423|NCT00907400|Gout Suppressants|gout suppressants|mesh-ancestor
24589424|NCT00907400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24589425|NCT00907400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589426|NCT00907400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589431|NCT00907452|Melphalan|melphalan|mesh-list
24589432|NCT00907452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24589433|NCT00907452|Antiemetics|antiemetics|mesh-ancestor
24589434|NCT00907452|Autonomic Agents|autonomic agents|mesh-ancestor
24589435|NCT00907452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24589444|NCT00907452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24589445|NCT00907452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24589446|NCT00907452|Growth Substances|growth substances|mesh-ancestor
24589447|NCT00907452|Growth Inhibitors|growth inhibitors|mesh-ancestor
24589448|NCT00907452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24589449|NCT00907452|Alkylating Agents|alkylating agents|mesh-ancestor
24589450|NCT00907452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499946|NCT00521781|Leuprolide|leuprolide|mesh-list
24567760|NCT00792376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24567761|NCT00792376|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24567762|NCT00792376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567763|NCT00792376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567764|NCT00792376|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24567767|NCT00792584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24567768|NCT00792584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24567769|NCT00792584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567770|NCT00792584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567771|NCT00792584|Antiviral Agents|antiviral agents|mesh-ancestor
24567772|NCT00792584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25245367|NCT04069819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245368|NCT04069819|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25245369|NCT04069819|Antidepressive Agents|antidepressive agents|mesh-ancestor
25245370|NCT04069819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25245371|NCT04069819|Autonomic Agents|autonomic agents|mesh-ancestor
25245372|NCT04069819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25245373|NCT04069819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25245374|NCT04069819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25245375|NCT04069819|Respiratory System Agents|respiratory system agents|mesh-ancestor
25245376|NCT04069819|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25245377|NCT04069819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25245378|NCT04069819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25245379|NCT04069819|Vasodilator Agents|vasodilator agents|mesh-ancestor
25245380|NCT04069819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25245381|NCT04069819|Protective Agents|protective agents|mesh-ancestor
25245382|NCT04069819|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25245383|NCT04069819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25245384|NCT04069819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25686658|NCT01922271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25686659|NCT01922271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25245385|NCT04068246|Metformin|metformin|mesh-list
25245386|NCT04068246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25245387|NCT04068246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245388|NCT04059484|Tamoxifen|tamoxifen|mesh-list
25245389|NCT04059484|Letrozole|letrozole|mesh-list
25245390|NCT04059484|Fulvestrant|fulvestrant|mesh-list
25245391|NCT04059484|Anastrozole|anastrozole|mesh-list
25245392|NCT04059484|Exemestane|exemestane|mesh-list
25245393|NCT04059484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25245394|NCT04059484|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25245395|NCT04059484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25245396|NCT04059484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589464|NCT00907504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589465|NCT00907504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24589466|NCT00907504|Immunologic Factors|immunologic factors|mesh-ancestor
24589467|NCT00907504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589468|NCT00907608|Darbepoetin alfa|darbepoetin alfa|mesh-list
24589469|NCT00907608|Hematinics|hematinics|mesh-ancestor
24589470|NCT00907751|Rituximab|rituximab|mesh-list
24589471|NCT00907751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24589472|NCT00907751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589474|NCT00907751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589475|NCT00907751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24589476|NCT00907764|Regadenoson|regadenoson|mesh-list
24589477|NCT00907764|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
24634508|NCT01133743|Growth Substances|growth substances|mesh-ancestor
24634509|NCT01133743|Growth Inhibitors|growth inhibitors|mesh-ancestor
24634510|NCT01133743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24634511|NCT01133743|Leprostatic Agents|leprostatic agents|mesh-ancestor
24852365|NCT02262325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24852366|NCT02262325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24852367|NCT02262325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24852368|NCT02262325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567773|NCT00792584|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24567774|NCT00792584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24567775|NCT00792584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24567776|NCT00792584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24567777|NCT00792584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24567778|NCT00792584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24567779|NCT00792662|Methylphenidate|methylphenidate|mesh-list
24567780|NCT00792662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24567781|NCT00792662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567782|NCT00792662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24567783|NCT00792662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25008890|NCT03917381|Antimitotic Agents|antimitotic agents|mesh-ancestor
24567784|NCT00792662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24567785|NCT00792662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567786|NCT00792662|Dopamine Agents|dopamine agents|mesh-ancestor
24567813|NCT00792818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24567814|NCT00792818|Analgesics|analgesics|mesh-ancestor
24567815|NCT00792818|Sensory System Agents|sensory system agents|mesh-ancestor
24567840|NCT00793052|Hormones|hormones|mesh-ancestor
24567841|NCT00793052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24567842|NCT00793052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24567843|NCT00793052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24567890|NCT00793377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24567891|NCT00793377|Immunologic Factors|immunologic factors|mesh-ancestor
24567892|NCT00793377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567893|NCT00793377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24567894|NCT00793377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25245397|NCT04059484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245398|NCT04059484|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25245399|NCT04059484|Hormone Antagonists|hormone antagonists|mesh-ancestor
25245400|NCT04059484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25245401|NCT04059484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245402|NCT04059484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25245403|NCT04059484|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25245404|NCT04059484|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25245405|NCT04059484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25245406|NCT04059484|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25245407|NCT04056624|Carotenoids|carotenoids|mesh-list
25245408|NCT04056624|Antioxidants|antioxidants|mesh-ancestor
25245409|NCT04056624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440973|NCT00285519|Doxazosin|doxazosin|mesh-list
25245410|NCT04056624|Protective Agents|protective agents|mesh-ancestor
25245411|NCT04056624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245412|NCT04034862|Lamivudine|lamivudine|mesh-list
25245413|NCT04034862|Dolutegravir|dolutegravir|mesh-list
25245414|NCT04034862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25245415|NCT04034862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25245416|NCT04034862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852369|NCT02262325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852371|NCT02262416|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24852372|NCT02262416|Fertility Agents|fertility agents|mesh-ancestor
24852373|NCT02262416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24852374|NCT02262416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852375|NCT02262416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24852376|NCT02262416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24634512|NCT01133743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24634513|NCT01133743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24589481|NCT00907764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24589482|NCT00907764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589483|NCT00907764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589514|NCT00907985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24589515|NCT00907985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25155352|NCT05411237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25245417|NCT04034862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245418|NCT04034862|Antiviral Agents|antiviral agents|mesh-ancestor
25245419|NCT04034862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25245420|NCT04034862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25245421|NCT04034862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25245422|NCT04034862|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25245423|NCT04034862|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25245424|NCT03999515|Abiraterone Acetate|abiraterone acetate|mesh-list
25245425|NCT03999515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25245426|NCT03999515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25245427|NCT03999515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25245428|NCT03999515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245429|NCT03999515|Hormone Antagonists|hormone antagonists|mesh-ancestor
25245430|NCT03999515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25245431|NCT03999515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245432|NCT03999515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25245448|NCT03987022|Acetaminophen|acetaminophen|mesh-list
25245449|NCT03987022|Ketorolac|ketorolac|mesh-list
25245450|NCT03987022|Oxycodone|oxycodone|mesh-list
25245451|NCT03987022|Hydromorphone|hydromorphone|mesh-list
25245452|NCT03987022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25245453|NCT03987022|Narcotics|narcotics|mesh-ancestor
25245454|NCT03987022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25245455|NCT03987022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245456|NCT03987022|Analgesics|analgesics|mesh-ancestor
25245457|NCT03987022|Sensory System Agents|sensory system agents|mesh-ancestor
25245458|NCT03987022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24589526|NCT00907985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24589527|NCT00907985|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24589528|NCT00907985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24589529|NCT00908024|Cetuximab|cetuximab|mesh-list
24852378|NCT02262455|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24852379|NCT02262455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24852380|NCT02262455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24852381|NCT02262455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24852382|NCT02262455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24852383|NCT02262455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589530|NCT00908024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24589531|NCT00908024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589533|NCT00908050|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24589534|NCT00908050|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24589535|NCT00908050|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24589536|NCT00908050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24589537|NCT00908050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589553|NCT00908089|Prednisolone phosphate|prednisolone phosphate|mesh-list
24589554|NCT00908089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24589555|NCT00908089|Glucocorticoids|glucocorticoids|mesh-ancestor
24589557|NCT00908089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24589558|NCT00908089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589559|NCT00908089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24589560|NCT00908089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589561|NCT00908089|Antiemetics|antiemetics|mesh-ancestor
24589562|NCT00908089|Autonomic Agents|autonomic agents|mesh-ancestor
24589563|NCT00908089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24589564|NCT00908089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24589565|NCT00908089|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24589566|NCT00908089|Protective Agents|protective agents|mesh-ancestor
24589567|NCT00908089|Dermatologic Agents|dermatologic agents|mesh-ancestor
24589568|NCT00908089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24634618|NCT01134406|Hylan|hylan|mesh-list
24567895|NCT00793377|Alkylating Agents|alkylating agents|mesh-ancestor
25245459|NCT03987022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25245460|NCT03987022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25245461|NCT03987022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25245462|NCT03987022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25245463|NCT03987022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25245464|NCT03987022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25245465|NCT03987022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245466|NCT03987022|Antipyretics|antipyretics|mesh-ancestor
25245467|NCT03984188|Theophylline|theophylline|mesh-list
25245468|NCT03984188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25245469|NCT03984188|Autonomic Agents|autonomic agents|mesh-ancestor
25245470|NCT03984188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25245471|NCT03984188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245472|NCT03984188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25245473|NCT03984188|Respiratory System Agents|respiratory system agents|mesh-ancestor
25245474|NCT03984188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25245475|NCT03984188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25245476|NCT03984188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245477|NCT03984188|Vasodilator Agents|vasodilator agents|mesh-ancestor
25245478|NCT03984188|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25245479|NCT03984188|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25245480|NCT03984188|Purinergic Agents|purinergic agents|mesh-ancestor
25245481|NCT03984188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25245482|NCT03983876|Adalimumab|adalimumab|mesh-list
25245483|NCT03983876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25245484|NCT03983876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25245485|NCT03982082|Coal Tar|coal tar|mesh-list
25245486|NCT03982082|Keratolytic Agents|keratolytic agents|mesh-ancestor
25245487|NCT03982082|Dermatologic Agents|dermatologic agents|mesh-ancestor
25245488|NCT03949153|Nivolumab|nivolumab|mesh-list
25245489|NCT03949153|Ipilimumab|ipilimumab|mesh-list
25245490|NCT03949153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25245491|NCT03949153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25245492|NCT03949153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25245493|NCT03949153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245494|NCT03944044|Acetaminophen|acetaminophen|mesh-list
25245495|NCT03944044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24589569|NCT00908089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24589591|NCT00908167|Immunologic Factors|immunologic factors|mesh-ancestor
24589592|NCT00908167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589593|NCT00908167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24589594|NCT00908167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589596|NCT00908180|Cyclosporine|cyclosporine|mesh-list
24589597|NCT00908180|Etoposide|etoposide|mesh-list
24589598|NCT00908180|Melphalan|melphalan|mesh-list
24589599|NCT00908180|Alemtuzumab|alemtuzumab|mesh-list
24589600|NCT00908180|Carmustine|carmustine|mesh-list
24589617|NCT00908180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24589618|NCT00908180|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24589619|NCT00908180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24589621|NCT00908180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24852386|NCT02262481|Progestins|progestins|mesh-ancestor
24852387|NCT02262481|Hormones|hormones|mesh-ancestor
24852388|NCT02262481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24852389|NCT02262481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852390|NCT02262520|Digoxin|digoxin|mesh-list
24852391|NCT02262520|Apixaban|apixaban|mesh-list
24852392|NCT02262520|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24852393|NCT02262520|Antithrombins|antithrombins|mesh-ancestor
24852394|NCT02262520|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24852395|NCT02262520|Protease Inhibitors|protease inhibitors|mesh-ancestor
24852396|NCT02262520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852397|NCT02262520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856031|NCT02282280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852398|NCT02262520|Anticoagulants|anticoagulants|mesh-ancestor
24567896|NCT00793377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567897|NCT00793377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24567898|NCT00793377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24671033|NCT01323257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24671034|NCT01323257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24671035|NCT01323257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24671036|NCT01323257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24671037|NCT01323296|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25245496|NCT03944044|Analgesics|analgesics|mesh-ancestor
25245497|NCT03944044|Sensory System Agents|sensory system agents|mesh-ancestor
25245498|NCT03944044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25245499|NCT03944044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245500|NCT03944044|Antipyretics|antipyretics|mesh-ancestor
25245506|NCT03926754|Mirabegron|mirabegron|mesh-list
25245507|NCT03926754|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25245508|NCT03926754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25245509|NCT03926754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25245510|NCT03926754|Adrenergic Agents|adrenergic agents|mesh-ancestor
25245511|NCT03926754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25245512|NCT03926754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628074|NCT01096498|Levonorgestrel|levonorgestrel|mesh-list
25245522|NCT03905928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245523|NCT03905928|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25245524|NCT03905928|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25245525|NCT03905928|Cholinergic Agents|cholinergic agents|mesh-ancestor
24589638|NCT00908297|Micronutrients|micronutrients|mesh-ancestor
24589639|NCT00908297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589640|NCT00908297|Vitamins|vitamins|mesh-ancestor
24589641|NCT00908323|Vaccines|vaccines|mesh-list
24852413|NCT02262533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24852414|NCT02262533|Sympatholytics|sympatholytics|mesh-ancestor
24852415|NCT02262533|Autonomic Agents|autonomic agents|mesh-ancestor
24852416|NCT02262533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24589642|NCT00908323|Immunologic Factors|immunologic factors|mesh-ancestor
24589643|NCT00908323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589644|NCT00908336|Docetaxel|docetaxel|mesh-list
24589645|NCT00908336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24589646|NCT00908336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589647|NCT00908336|Tubulin Modulators|tubulin modulators|mesh-ancestor
24589648|NCT00908336|Antimitotic Agents|antimitotic agents|mesh-ancestor
24589649|NCT00908336|Mitosis Modulators|mitosis modulators|mesh-ancestor
24589650|NCT00908336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671039|NCT01323296|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24671040|NCT01323296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25245526|NCT03905928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25245527|NCT03905928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274335|NCT02378740|Sensory System Agents|sensory system agents|mesh-ancestor
25274336|NCT02378740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25274337|NCT02378740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274338|NCT02378740|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25274339|NCT02378740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25274340|NCT02378740|Anesthetics, General|anesthetics, general|mesh-ancestor
25274341|NCT02378740|Anesthetics|anesthetics|mesh-ancestor
25274342|NCT02378740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25274343|NCT02378740|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25274344|NCT02378740|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25274345|NCT02378740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25274346|NCT02378740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274347|NCT02378649|Sildenafil Citrate|sildenafil citrate|mesh-list
25274348|NCT02378649|Vasodilator Agents|vasodilator agents|mesh-ancestor
25274349|NCT02378649|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25274350|NCT02378649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25274351|NCT02378649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274352|NCT02378649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274353|NCT02378649|Urological Agents|urological agents|mesh-ancestor
25686660|NCT01922271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25274354|NCT02378428|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
25274355|NCT02378428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25274356|NCT02378428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589651|NCT00908336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24589652|NCT00908336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589653|NCT00908362|Fluticasone|fluticasone|mesh-list
24589655|NCT00908362|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24589656|NCT00908362|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24589657|NCT00908362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24589658|NCT00908362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24621704|NCT01063530|Fluorides|fluorides|mesh-list
24589681|NCT00908453|Anticonvulsants|anticonvulsants|mesh-ancestor
24589682|NCT00908453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24589683|NCT00908453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24589684|NCT00908453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589685|NCT00908531|Letrozole|letrozole|mesh-list
24589686|NCT00908531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589687|NCT00908531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24589688|NCT00908531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24589689|NCT00908531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589697|NCT00908661|Coagulants|coagulants|mesh-ancestor
24589698|NCT00908674|Cyproterone Acetate|cyproterone acetate|mesh-list
24589699|NCT00908674|Cyproterone|cyproterone|mesh-list
24589700|NCT00908674|Androgen Antagonists|androgen antagonists|mesh-ancestor
24589701|NCT00908674|Hormone Antagonists|hormone antagonists|mesh-ancestor
24589702|NCT00908674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24589703|NCT00908674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589704|NCT00908674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589705|NCT00908674|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24589706|NCT00908674|Contraceptive Agents|contraceptive agents|mesh-ancestor
24589707|NCT00908674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24589708|NCT00908713|Methylprednisolone|methylprednisolone|mesh-list
24671041|NCT01323335|Rasburicase|rasburicase|mesh-list
24567899|NCT00793377|Tubulin Modulators|tubulin modulators|mesh-ancestor
24567900|NCT00793377|Antimitotic Agents|antimitotic agents|mesh-ancestor
24567901|NCT00793377|Mitosis Modulators|mitosis modulators|mesh-ancestor
24567902|NCT00793377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24589760|NCT00908869|Immunologic Factors|immunologic factors|mesh-ancestor
24589761|NCT00908869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589762|NCT00908869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24589763|NCT00908869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24589764|NCT00908869|Alkylating Agents|alkylating agents|mesh-ancestor
24589765|NCT00908869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589766|NCT00908869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589767|NCT00908869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24589768|NCT00908869|Antiviral Agents|antiviral agents|mesh-ancestor
24589769|NCT00908869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24589770|NCT00908869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24589771|NCT00908869|Tubulin Modulators|tubulin modulators|mesh-ancestor
24589772|NCT00908869|Antimitotic Agents|antimitotic agents|mesh-ancestor
24852417|NCT02262533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852418|NCT02262533|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24852419|NCT02262533|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24852420|NCT02262533|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24852422|NCT02262533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24852423|NCT02262546|Moxifloxacin|moxifloxacin|mesh-list
24852424|NCT02262546|Pramipexole|pramipexole|mesh-list
24852425|NCT02262546|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24589773|NCT00908869|Mitosis Modulators|mitosis modulators|mesh-ancestor
24589774|NCT00908921|Glimepiride|glimepiride|mesh-list
24567974|NCT00793754|Sensory System Agents|sensory system agents|mesh-ancestor
24567975|NCT00793754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24567976|NCT00793754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245576|NCT03877809|Antifungal Agents|antifungal agents|mesh-ancestor
25245577|NCT03877809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25245578|NCT03877809|Immunologic Factors|immunologic factors|mesh-ancestor
25245579|NCT03877809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245580|NCT03875391|Oxytocin|oxytocin|mesh-list
25245581|NCT03875391|Oxytocics|oxytocics|mesh-ancestor
25245582|NCT03875391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25245583|NCT03875391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245584|NCT03866421|Liver Extracts|liver extracts|mesh-list
25686661|NCT01922271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25245585|NCT03866421|Hematinics|hematinics|mesh-ancestor
24589775|NCT00908921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24589776|NCT00908921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24634712|NCT01134692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24634713|NCT01134692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24634714|NCT01134692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634715|NCT01134692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24634716|NCT01134692|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24634717|NCT01134692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24634719|NCT01134718|Antiviral Agents|antiviral agents|mesh-ancestor
24634720|NCT01134718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24634721|NCT01134718|Protease Inhibitors|protease inhibitors|mesh-ancestor
24589797|NCT00909077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589798|NCT00909077|Immunologic Factors|immunologic factors|mesh-ancestor
24589799|NCT00909077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589800|NCT00909077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24589812|NCT00909077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589813|NCT00909129|Interferons|interferons|mesh-list
24589814|NCT00909129|Ribavirin|ribavirin|mesh-list
24589816|NCT00909129|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24589817|NCT00909129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589818|NCT00909129|Antiviral Agents|antiviral agents|mesh-ancestor
24589819|NCT00909129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24589828|NCT00909168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24567986|NCT00793754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24567987|NCT00793754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24567988|NCT00793754|Antimetabolites|antimetabolites|mesh-ancestor
24567989|NCT00793754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24567990|NCT00793754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24567992|NCT00793767|Hematinics|hematinics|mesh-ancestor
24567993|NCT00793845|Cyclophosphamide|cyclophosphamide|mesh-list
24567994|NCT00793845|Melphalan|melphalan|mesh-list
24567995|NCT00793845|Thiotepa|thiotepa|mesh-list
24567996|NCT00793845|Carboplatin|carboplatin|mesh-list
24567997|NCT00793845|Etoposide|etoposide|mesh-list
24567998|NCT00793845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24567999|NCT00793845|Immunologic Factors|immunologic factors|mesh-ancestor
24568006|NCT00793845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24568016|NCT00793858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24568018|NCT00793897|Carboplatin|carboplatin|mesh-list
25245593|NCT03849313|Adalimumab|adalimumab|mesh-list
25245594|NCT03849313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25245595|NCT03849313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25245605|NCT03840226|Magnesium Oxide|magnesium oxide|mesh-list
25245606|NCT03840226|Antacids|antacids|mesh-ancestor
25245607|NCT03840226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245608|NCT03840226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25245609|NCT03836001|Serlopitant|serlopitant|mesh-list
25245610|NCT03836001|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25245611|NCT03836001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25245612|NCT03836001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245613|NCT03836001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589829|NCT00909168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589830|NCT00909233|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24589831|NCT00909233|Vasodilator Agents|vasodilator agents|mesh-ancestor
24589832|NCT00909233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24589833|NCT00909233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24589834|NCT00909233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589835|NCT00909233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589836|NCT00909233|Urological Agents|urological agents|mesh-ancestor
24589838|NCT00909311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24589839|NCT00909311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24589840|NCT00909311|Protease Inhibitors|protease inhibitors|mesh-ancestor
24589841|NCT00909311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589842|NCT00909311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589843|NCT00909311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24589844|NCT00909311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24589845|NCT00909311|Antiviral Agents|antiviral agents|mesh-ancestor
24852427|NCT02262546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24852428|NCT02262546|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24852429|NCT02262546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24852430|NCT02262546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852431|NCT02262546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589846|NCT00909311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25686662|NCT01922271|Adrenergic Agents|adrenergic agents|mesh-ancestor
24652067|NCT01235637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24589847|NCT00909311|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24589848|NCT00909311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24589849|NCT00909337|Bosentan|bosentan|mesh-list
24589850|NCT00909337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24589851|NCT00909337|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24589852|NCT00909337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589853|NCT00909402|Capecitabine|capecitabine|mesh-list
24589854|NCT00909402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589855|NCT00909402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24589856|NCT00909402|Antimetabolites|antimetabolites|mesh-ancestor
24589857|NCT00909402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589957|NCT00909987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25245639|NCT03815175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25245640|NCT03815175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25245642|NCT03815175|Sensory System Agents|sensory system agents|mesh-ancestor
25245643|NCT03815175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25245644|NCT03815175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245645|NCT03815175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25245646|NCT03815175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25245647|NCT03815175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25245648|NCT03815175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25245649|NCT03815175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245650|NCT03815175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25245651|NCT03815175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24589900|NCT00909688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24589901|NCT00909688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24589902|NCT00909831|Hydroxychloroquine|hydroxychloroquine|mesh-list
24589904|NCT00909831|Antimalarials|antimalarials|mesh-ancestor
24589905|NCT00909831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24589906|NCT00909831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24589907|NCT00909831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24589908|NCT00909831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589909|NCT00909831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589910|NCT00909831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24589911|NCT00909831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24589912|NCT00909831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24589913|NCT00909831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589914|NCT00909831|Antifungal Agents|antifungal agents|mesh-ancestor
24589915|NCT00909831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24589916|NCT00909831|Immunologic Factors|immunologic factors|mesh-ancestor
25072675|NCT03399955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24568019|NCT00793897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24568020|NCT00793897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24568021|NCT00793897|Tubulin Modulators|tubulin modulators|mesh-ancestor
24568022|NCT00793897|Antimitotic Agents|antimitotic agents|mesh-ancestor
24557798|NCT00754039|Fenofibrate|fenofibrate|mesh-list
24557821|NCT00754351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568023|NCT00793897|Mitosis Modulators|mitosis modulators|mesh-ancestor
24568024|NCT00793897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568025|NCT00793923|Dexamethasone|dexamethasone|mesh-list
24568026|NCT00793923|Ranibizumab|ranibizumab|mesh-list
24568027|NCT00793923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24568028|NCT00793923|Antiemetics|antiemetics|mesh-ancestor
24568029|NCT00793923|Autonomic Agents|autonomic agents|mesh-ancestor
24568030|NCT00793923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24671043|NCT01323335|Gout Suppressants|gout suppressants|mesh-ancestor
24568037|NCT00793923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24568038|NCT00793923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24568039|NCT00793923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24568040|NCT00793923|Growth Substances|growth substances|mesh-ancestor
24568041|NCT00793923|Growth Inhibitors|growth inhibitors|mesh-ancestor
25245652|NCT03815175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25245653|NCT03815175|Antipyretics|antipyretics|mesh-ancestor
25245669|NCT03802058|Antimitotic Agents|antimitotic agents|mesh-ancestor
25245670|NCT03802058|Mitosis Modulators|mitosis modulators|mesh-ancestor
25245671|NCT03802058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245672|NCT03795194|Clavulanic Acid|clavulanic acid|mesh-list
25245673|NCT03795194|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25245674|NCT03795194|Clavulanic Acids|clavulanic acids|mesh-list
24589917|NCT00909831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686663|NCT01922271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24589919|NCT00909883|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24589920|NCT00909883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24589921|NCT00909883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589922|NCT00909883|Cholinergic Agents|cholinergic agents|mesh-ancestor
24589948|NCT00909987|Capecitabine|capecitabine|mesh-list
24589949|NCT00909987|Oxaliplatin|oxaliplatin|mesh-list
24589950|NCT00909987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24589951|NCT00909987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589952|NCT00909987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24589953|NCT00909987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24656803|NCT01264289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24589954|NCT00909987|Growth Substances|growth substances|mesh-ancestor
24589955|NCT00909987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589956|NCT00909987|Growth Inhibitors|growth inhibitors|mesh-ancestor
24589958|NCT00909987|Antimetabolites|antimetabolites|mesh-ancestor
24589959|NCT00909987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589960|NCT00910013|Ropivacaine|ropivacaine|mesh-list
24589961|NCT00910013|Anesthetics, Local|anesthetics, local|mesh-ancestor
24589963|NCT00910013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24589964|NCT00910013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589965|NCT00910013|Sensory System Agents|sensory system agents|mesh-ancestor
24568043|NCT00793975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24568044|NCT00793988|Anesthetics|anesthetics|mesh-list
24568045|NCT00793988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24568046|NCT00793988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568047|NCT00794209|Fentanyl|fentanyl|mesh-list
24568048|NCT00794209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24568049|NCT00794209|Narcotics|narcotics|mesh-ancestor
24568050|NCT00794209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24568054|NCT00794209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24568055|NCT00794209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24568056|NCT00794209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24568057|NCT00794209|Anesthetics, General|anesthetics, general|mesh-ancestor
24568058|NCT00794209|Anesthetics|anesthetics|mesh-ancestor
24568059|NCT00794235|Sorafenib|sorafenib|mesh-list
24568060|NCT00794235|Dacarbazine|dacarbazine|mesh-list
24568061|NCT00794235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24568076|NCT00794625|Valproic Acid|valproic acid|mesh-list
24568077|NCT00794625|Risperidone|risperidone|mesh-list
24568078|NCT00794625|Dextroamphetamine|dextroamphetamine|mesh-list
24568084|NCT00794625|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24568085|NCT00794625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24568086|NCT00794625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24568087|NCT00794625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24568088|NCT00794625|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24568089|NCT00794625|Dopamine Agents|dopamine agents|mesh-ancestor
24568090|NCT00794625|Anticonvulsants|anticonvulsants|mesh-ancestor
25245675|NCT03795194|Ampicillin|ampicillin|mesh-list
25245676|NCT03795194|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25245677|NCT03795194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25245678|NCT03795194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245679|NCT03795194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25245685|NCT03783442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25245687|NCT03783442|Tubulin Modulators|tubulin modulators|mesh-ancestor
25245688|NCT03783442|Antimitotic Agents|antimitotic agents|mesh-ancestor
25245689|NCT03783442|Mitosis Modulators|mitosis modulators|mesh-ancestor
25245690|NCT03783442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245691|NCT03783442|Antimetabolites|antimetabolites|mesh-ancestor
25245692|NCT03783442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25245693|NCT03783442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25245694|NCT03783442|Immunologic Factors|immunologic factors|mesh-ancestor
25245695|NCT03783442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245696|NCT03781817|Ketamine|ketamine|mesh-list
25245697|NCT03781817|Analgesics|analgesics|mesh-ancestor
25245698|NCT03781817|Sensory System Agents|sensory system agents|mesh-ancestor
25245699|NCT03781817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24589966|NCT00910013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24589967|NCT00910052|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24589968|NCT00910052|Hemostatics|hemostatics|mesh-ancestor
24589969|NCT00910052|Coagulants|coagulants|mesh-ancestor
24589970|NCT00910065|Aspirin|aspirin|mesh-list
24590000|NCT00910221|Antimetabolites|antimetabolites|mesh-ancestor
24590001|NCT00910221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590002|NCT00910221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24590003|NCT00910221|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24590004|NCT00910221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590005|NCT00910234|Epoetin Alfa|epoetin alfa|mesh-list
24590006|NCT00910234|Hematinics|hematinics|mesh-ancestor
24590007|NCT00910351|Ciprofloxacin|ciprofloxacin|mesh-list
24590008|NCT00910351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25102626|NCT03167216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590103|NCT00910754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24590104|NCT00910754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590105|NCT00910754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24590106|NCT00910754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24590142|NCT00910806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24590143|NCT00910806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24590144|NCT00910806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24568177|NCT00795015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24590145|NCT00910806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590147|NCT00910806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24590148|NCT00910806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24959901|NCT03821454|Antimetabolites|antimetabolites|mesh-ancestor
24590149|NCT00910806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24590150|NCT00910806|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24590151|NCT00910806|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24590152|NCT00910897|Thalidomide|thalidomide|mesh-list
24590162|NCT00910897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24590163|NCT00910897|Glucocorticoids|glucocorticoids|mesh-ancestor
24590165|NCT00910897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24590166|NCT00910897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24590167|NCT00910897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25245700|NCT03781817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245701|NCT03781817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25245702|NCT03781817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25245703|NCT03781817|Anesthetics, General|anesthetics, general|mesh-ancestor
25245704|NCT03781817|Anesthetics|anesthetics|mesh-ancestor
25245705|NCT03781817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25245706|NCT03781817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25245707|NCT03781817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25245708|NCT03781817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25245709|NCT03781817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245716|NCT03770455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24568189|NCT00795171|Antimitotic Agents|antimitotic agents|mesh-ancestor
25245734|NCT03746275|Sensory System Agents|sensory system agents|mesh-ancestor
25245735|NCT03746275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25245736|NCT03746275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634805|NCT01135446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24634806|NCT01135446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590170|NCT00910897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590171|NCT00910897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24852432|NCT02262546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24852433|NCT02262546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24852434|NCT02262546|Contraceptive Agents|contraceptive agents|mesh-ancestor
24852435|NCT02262546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24852436|NCT02262546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852437|NCT02262546|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24852438|NCT02262546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24590177|NCT00910897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24590178|NCT00910897|Growth Substances|growth substances|mesh-ancestor
24590179|NCT00910897|Growth Inhibitors|growth inhibitors|mesh-ancestor
24590180|NCT00910975|Interferons|interferons|mesh-list
24590181|NCT00910975|Ribavirin|ribavirin|mesh-list
24590182|NCT00910975|Interferon-alpha|interferon-alpha|mesh-list
24590183|NCT00910975|Interferon alpha-2|interferon alpha-2|mesh-list
24568091|NCT00794625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24568092|NCT00794625|GABA Agents|gaba agents|mesh-ancestor
24568093|NCT00794625|Antimanic Agents|antimanic agents|mesh-ancestor
24568094|NCT00794625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24568095|NCT00794625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24568096|NCT00794625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24568097|NCT00794625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24568099|NCT00794638|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24568104|NCT00794638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24568118|NCT00794703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24568119|NCT00794703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568120|NCT00794703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24568122|NCT00794755|Vitamin K 1|vitamin k 1|mesh-list
24568123|NCT00794755|Vitamins|vitamins|mesh-ancestor
24671044|NCT01323335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24568124|NCT00794755|Micronutrients|micronutrients|mesh-ancestor
24568125|NCT00794755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568126|NCT00794755|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24568127|NCT00794755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24888711|NCT04501107|Insulin|insulin|mesh-list
24568137|NCT00794859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24568138|NCT00794859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24568140|NCT00794885|Folic Acid|folic acid|mesh-list
24568174|NCT00794976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568175|NCT00795015|Insulin|insulin|mesh-list
24568176|NCT00795015|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24568178|NCT00795015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568180|NCT00795106|Antipruritics|antipruritics|mesh-ancestor
24568181|NCT00795106|Dermatologic Agents|dermatologic agents|mesh-ancestor
24568182|NCT00795106|Sensory System Agents|sensory system agents|mesh-ancestor
24568183|NCT00795106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24568184|NCT00795106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568185|NCT00795171|Docetaxel|docetaxel|mesh-list
24568186|NCT00795171|Sunitinib|sunitinib|mesh-list
24568187|NCT00795171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24568188|NCT00795171|Tubulin Modulators|tubulin modulators|mesh-ancestor
25245747|NCT03746275|Antithrombins|antithrombins|mesh-ancestor
25245748|NCT03746275|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25245749|NCT03746275|Protease Inhibitors|protease inhibitors|mesh-ancestor
25245750|NCT03746275|Anticoagulants|anticoagulants|mesh-ancestor
24590184|NCT00910975|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24590185|NCT00910975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24590186|NCT00910975|Antiviral Agents|antiviral agents|mesh-ancestor
24590187|NCT00910975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24590188|NCT00910975|Antimetabolites|antimetabolites|mesh-ancestor
24590189|NCT00910975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590190|NCT00910975|Immunologic Factors|immunologic factors|mesh-ancestor
24590191|NCT00910975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590192|NCT00911066|Azacitidine|azacitidine|mesh-list
24590193|NCT00911066|Pevonedistat|pevonedistat|mesh-list
24590194|NCT00911066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24590195|NCT00911066|Antimetabolites|antimetabolites|mesh-ancestor
24590196|NCT00911066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590197|NCT00911066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24590198|NCT00911066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590199|NCT00911092|Fluorouracil|fluorouracil|mesh-list
24590200|NCT00911092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24590201|NCT00911092|Antimetabolites|antimetabolites|mesh-ancestor
24590202|NCT00911092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590203|NCT00911092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24634819|NCT01135550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24634820|NCT01135550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634821|NCT01135550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24590224|NCT00911235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24590225|NCT00911235|Urological Agents|urological agents|mesh-ancestor
24590226|NCT00911261|Oxymorphone|oxymorphone|mesh-list
24590227|NCT00911261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24590228|NCT00911261|Narcotics|narcotics|mesh-ancestor
24590229|NCT00911261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24590230|NCT00911261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590231|NCT00911261|Analgesics|analgesics|mesh-ancestor
24590232|NCT00911261|Sensory System Agents|sensory system agents|mesh-ancestor
24590233|NCT00911261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24590234|NCT00911261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24590235|NCT00911287|Oxymorphone|oxymorphone|mesh-list
24590236|NCT00911287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24493319|NCT00490399|Antiviral Agents|antiviral agents|mesh-ancestor
25245784|NCT03720990|Cholic Acids|cholic acids|mesh-list
25245785|NCT03720990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25245786|NCT03719326|Paclitaxel|paclitaxel|mesh-list
25245787|NCT03719326|Doxorubicin|doxorubicin|mesh-list
25245788|NCT03719326|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25245813|NCT03685890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245814|NCT03674424|Avelumab|avelumab|mesh-list
25245815|NCT03674424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25245816|NCT03674424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25245817|NCT03671330|Letrozole|letrozole|mesh-list
25245818|NCT03671330|Goserelin|goserelin|mesh-list
25245819|NCT03671330|Anastrozole|anastrozole|mesh-list
25245820|NCT03671330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25245821|NCT03671330|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25245822|NCT03671330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25245823|NCT03671330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25245824|NCT03671330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245825|NCT03671330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25245826|NCT03671330|Hormone Antagonists|hormone antagonists|mesh-ancestor
25245827|NCT03671330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25245828|NCT03671330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245829|NCT03671330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25274357|NCT02378428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274358|NCT02378428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25274359|NCT02378415|Ketamine|ketamine|mesh-list
25274360|NCT02378415|Analgesics|analgesics|mesh-ancestor
25274361|NCT02378415|Sensory System Agents|sensory system agents|mesh-ancestor
24590369|NCT00912275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686664|NCT01922271|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24590370|NCT00912275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24590371|NCT00912275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590372|NCT00912327|Cetuximab|cetuximab|mesh-list
24590381|NCT00912379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590382|NCT00912379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24590383|NCT00912379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24590385|NCT00912392|Etoposide|etoposide|mesh-list
24590386|NCT00912392|Endostar protein|endostar protein|mesh-list
24590387|NCT00912392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24590388|NCT00912392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24590389|NCT00912392|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24590390|NCT00912392|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24590391|NCT00912392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590392|NCT00912392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590393|NCT00912392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24590394|NCT00912392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24590395|NCT00912392|Growth Substances|growth substances|mesh-ancestor
24590396|NCT00912392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590397|NCT00912392|Growth Inhibitors|growth inhibitors|mesh-ancestor
24590398|NCT00912444|Cyclophosphamide|cyclophosphamide|mesh-list
24590399|NCT00912444|Docetaxel|docetaxel|mesh-list
24590400|NCT00912444|Doxorubicin|doxorubicin|mesh-list
24852446|NCT02262546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24590406|NCT00912444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24590407|NCT00912444|Alkylating Agents|alkylating agents|mesh-ancestor
24590408|NCT00912444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590409|NCT00912444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24590410|NCT00912444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25245830|NCT03670355|Tenofovir|tenofovir|mesh-list
25245831|NCT03670355|Antiviral Agents|antiviral agents|mesh-ancestor
25245832|NCT03670355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25245833|NCT03670355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25245834|NCT03670355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25245835|NCT03670355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25245836|NCT03670355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245837|NCT03670355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25245838|NCT03670355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25245839|NCT03654066|Botulinum Toxins|botulinum toxins|mesh-list
25245840|NCT03654066|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25245841|NCT03654066|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25245842|NCT03654066|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25245843|NCT03654066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25245844|NCT03654066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245845|NCT03654066|Cholinergic Agents|cholinergic agents|mesh-ancestor
25245846|NCT03654066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25245847|NCT03654066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245848|NCT03654066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25245849|NCT03654066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25245850|NCT03641755|Olaparib|olaparib|mesh-list
25245851|NCT03641755|Sapacitabine|sapacitabine|mesh-list
25245852|NCT03641755|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25245853|NCT03641755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25245854|NCT03641755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245855|NCT03641755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25245856|NCT03604549|Ethiodized Oil|ethiodized oil|mesh-list
25245857|NCT03604549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25245858|NCT03587636|Bupivacaine|bupivacaine|mesh-list
25245859|NCT03587636|Anesthetics, Local|anesthetics, local|mesh-ancestor
25245860|NCT03587636|Anesthetics|anesthetics|mesh-ancestor
25245861|NCT03587636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25245862|NCT03587636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245863|NCT03587636|Sensory System Agents|sensory system agents|mesh-ancestor
25245864|NCT03587636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25245865|NCT03576690|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
25245866|NCT03576690|Atoltivimab|atoltivimab|mesh-list
25245867|NCT03576690|Odesivimab|odesivimab|mesh-list
25245868|NCT03576690|Maftivimab|maftivimab|mesh-list
25245869|NCT03576690|Antiviral Agents|antiviral agents|mesh-ancestor
25245870|NCT03576690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25245871|NCT03570697|Evolocumab|evolocumab|mesh-list
25245872|NCT03570697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25245873|NCT03570697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24791392|NCT04538053|Cefazolin|cefazolin|mesh-list
24590464|NCT00912639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590465|NCT00912678|Mycophenolic Acid|mycophenolic acid|mesh-list
24590467|NCT00912678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24590471|NCT00912678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590472|NCT00912678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590473|NCT00912678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24590474|NCT00912678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24590475|NCT00912678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24590485|NCT00912756|Respiratory System Agents|respiratory system agents|mesh-ancestor
24590486|NCT00912756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24590487|NCT00912756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24590488|NCT00912756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590489|NCT00912756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24590490|NCT00912756|Vasodilator Agents|vasodilator agents|mesh-ancestor
24590491|NCT00912756|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24590492|NCT00912756|Protective Agents|protective agents|mesh-ancestor
24568365|NCT00795808|Enclomiphene|enclomiphene|mesh-list
24568192|NCT00795171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24568193|NCT00795171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24568194|NCT00795171|Growth Substances|growth substances|mesh-ancestor
24568195|NCT00795171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568196|NCT00795171|Growth Inhibitors|growth inhibitors|mesh-ancestor
24568197|NCT00795171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24568198|NCT00795171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24568200|NCT00795223|Bupivacaine|bupivacaine|mesh-list
24568201|NCT00795223|Anesthetics, Local|anesthetics, local|mesh-ancestor
24568202|NCT00795223|Anesthetics|anesthetics|mesh-ancestor
24557954|NCT00754962|Antidepressive Agents|antidepressive agents|mesh-ancestor
24557955|NCT00754962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24557956|NCT00754962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24557957|NCT00754962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24557960|NCT00754962|Adrenergic Agents|adrenergic agents|mesh-ancestor
24568218|NCT00795262|Micronutrients|micronutrients|mesh-ancestor
24568219|NCT00795262|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25245874|NCT03570697|Antimetabolites|antimetabolites|mesh-ancestor
25245875|NCT03570697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245876|NCT03570697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25245877|NCT03567473|Dexamethasone|dexamethasone|mesh-list
25245878|NCT03567473|Dexamethasone acetate|dexamethasone acetate|mesh-list
25245879|NCT03567473|Epinephrine|epinephrine|mesh-list
25245880|NCT03567473|Racepinephrine|racepinephrine|mesh-list
25245881|NCT03567473|Epinephryl borate|epinephryl borate|mesh-list
25245882|NCT03567473|BB 1101|bb 1101|mesh-list
25245883|NCT03567473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25245884|NCT03567473|Antiemetics|antiemetics|mesh-ancestor
25245885|NCT03567473|Autonomic Agents|autonomic agents|mesh-ancestor
25245886|NCT03567473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25245887|NCT03567473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245888|NCT03567473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25245889|NCT03567473|Glucocorticoids|glucocorticoids|mesh-ancestor
25245890|NCT03567473|Hormones|hormones|mesh-ancestor
25245891|NCT03567473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25705137|NCT02194088|Autonomic Agents|autonomic agents|mesh-ancestor
25245892|NCT03567473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25245893|NCT03567473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25245894|NCT03567473|Protease Inhibitors|protease inhibitors|mesh-ancestor
25245895|NCT03567473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25245896|NCT03567473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590495|NCT00912756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590496|NCT00912821|Dialysis Solutions|dialysis solutions|mesh-list
24590497|NCT00912821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24634906|NCT01135758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24634907|NCT01135758|Anesthetics, General|anesthetics, general|mesh-ancestor
24634908|NCT01135758|Anesthetics|anesthetics|mesh-ancestor
24634909|NCT01135758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24590498|NCT00912860|Interferons|interferons|mesh-list
24590499|NCT00912860|Interferon-beta|interferon-beta|mesh-list
24590500|NCT00912860|Interferon beta-1a|interferon beta-1a|mesh-list
24590501|NCT00912860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24590502|NCT00912860|Antiviral Agents|antiviral agents|mesh-ancestor
24590503|NCT00912860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24590504|NCT00912860|Immunologic Factors|immunologic factors|mesh-ancestor
24590505|NCT00912860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590506|NCT00912860|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24590507|NCT00912899|Noscapine|noscapine|mesh-list
24590508|NCT00912899|Antitussive Agents|antitussive agents|mesh-ancestor
24590509|NCT00912899|Respiratory System Agents|respiratory system agents|mesh-ancestor
24590511|NCT00912938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24590519|NCT00913029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590520|NCT00913029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590530|NCT00913107|Carbamazepine|carbamazepine|mesh-list
24590531|NCT00913107|Anticonvulsants|anticonvulsants|mesh-list
24590532|NCT00913107|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24590533|NCT00913107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24590534|NCT00913107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590535|NCT00913107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24590536|NCT00913107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590537|NCT00913107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24590538|NCT00913107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24590539|NCT00913107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24568220|NCT00795262|Protease Inhibitors|protease inhibitors|mesh-ancestor
24568221|NCT00795262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24568222|NCT00795262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24568223|NCT00795301|Capecitabine|capecitabine|mesh-list
24568224|NCT00795301|Oxaliplatin|oxaliplatin|mesh-list
25245897|NCT03567473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25245898|NCT03567473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25245899|NCT03567473|Adrenergic Agents|adrenergic agents|mesh-ancestor
25245900|NCT03567473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25245901|NCT03567473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25245902|NCT03567473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25245903|NCT03567473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25245904|NCT03567473|Respiratory System Agents|respiratory system agents|mesh-ancestor
25245905|NCT03567473|Mydriatics|mydriatics|mesh-ancestor
25245906|NCT03567473|Sympathomimetics|sympathomimetics|mesh-ancestor
25245907|NCT03567473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25245908|NCT03557294|Varenicline|varenicline|mesh-list
25245909|NCT03557294|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25245910|NCT03557294|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25245911|NCT03557294|Cholinergic Agents|cholinergic agents|mesh-ancestor
25245912|NCT03557294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25245913|NCT03557294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245914|NCT03557294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245915|NCT03540420|Atezolizumab|atezolizumab|mesh-list
25245916|NCT03540420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25245917|NCT03537391|Fluorides|fluorides|mesh-list
25245918|NCT03537391|Cariostatic Agents|cariostatic agents|mesh-ancestor
25245919|NCT03537391|Protective Agents|protective agents|mesh-ancestor
25245920|NCT03537391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245921|NCT03527043|Citalopram|citalopram|mesh-list
25245922|NCT03527043|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25245923|NCT03527043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25245924|NCT03527043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25245925|NCT03527043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245926|NCT03527043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25245927|NCT03527043|Serotonin Agents|serotonin agents|mesh-ancestor
25245928|NCT03527043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245929|NCT03527043|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24590546|NCT00913107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24590547|NCT00913107|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24590548|NCT00913107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24590550|NCT00913120|Anticoagulants|anticoagulants|mesh-ancestor
24590551|NCT00913120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24590552|NCT00913120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25155354|NCT05409885|Anesthetics|anesthetics|mesh-list
24590553|NCT00913120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568226|NCT00795301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24568227|NCT00795301|Antimetabolites|antimetabolites|mesh-ancestor
24888773|NCT04500743|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24568350|NCT00795756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24568351|NCT00795756|Antimetabolites|antimetabolites|mesh-ancestor
24568353|NCT00795756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24568354|NCT00795756|Dermatologic Agents|dermatologic agents|mesh-ancestor
24568355|NCT00795756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24568356|NCT00795756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24568357|NCT00795756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24568358|NCT00795756|Immunologic Factors|immunologic factors|mesh-ancestor
24568359|NCT00795756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24568360|NCT00795756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24568361|NCT00795756|Antiviral Agents|antiviral agents|mesh-ancestor
24568362|NCT00795756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24568363|NCT00795808|Metformin|metformin|mesh-list
24568364|NCT00795808|Clomiphene|clomiphene|mesh-list
25245930|NCT03527043|Antidepressive Agents|antidepressive agents|mesh-ancestor
25245931|NCT03527043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25245932|NCT03519997|Pembrolizumab|pembrolizumab|mesh-list
25245933|NCT03519997|Bavituximab|bavituximab|mesh-list
25245934|NCT03519997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25245935|NCT03519997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25245936|NCT03513406|Glycopyrrolate|glycopyrrolate|mesh-list
25245937|NCT03513406|Neostigmine|neostigmine|mesh-list
25245938|NCT03513406|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25245939|NCT03513406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25245940|NCT03513406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245941|NCT03513406|Cholinergic Agents|cholinergic agents|mesh-ancestor
25245942|NCT03513406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25245943|NCT03513406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245944|NCT03513406|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25245945|NCT03513406|Autonomic Agents|autonomic agents|mesh-ancestor
24590556|NCT00913224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24590557|NCT00913224|Analgesics|analgesics|mesh-ancestor
24590558|NCT00913224|Sensory System Agents|sensory system agents|mesh-ancestor
24590559|NCT00913224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24590560|NCT00913224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590578|NCT00913250|Interferon beta-1a|interferon beta-1a|mesh-list
24590579|NCT00913250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24590580|NCT00913250|Immunologic Factors|immunologic factors|mesh-ancestor
24590581|NCT00913250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590583|NCT00913250|Antiviral Agents|antiviral agents|mesh-ancestor
24590584|NCT00913250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24590586|NCT00913276|Sevoflurane|sevoflurane|mesh-list
24590587|NCT00913276|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24590588|NCT00913276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24590589|NCT00913276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590590|NCT00913276|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24590591|NCT00913276|Anesthetics, General|anesthetics, general|mesh-ancestor
24590597|NCT00913315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24590599|NCT00913315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24590600|NCT00913315|Adrenergic Agents|adrenergic agents|mesh-ancestor
24590601|NCT00913315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24568371|NCT00795808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24568372|NCT00795808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24568385|NCT00795847|Natriuretic Agents|natriuretic agents|mesh-ancestor
24568386|NCT00795847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568387|NCT00795847|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24568388|NCT00795847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24568389|NCT00795899|Paclitaxel|paclitaxel|mesh-list
25008896|NCT03837873|Cyclophosphamide|cyclophosphamide|mesh-list
24791829|NCT03043313|Tucatinib|tucatinib|mesh-list
24791830|NCT03043313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24791831|NCT03043313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791832|NCT03043313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24791833|NCT03043313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24791834|NCT03043313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791835|NCT02998268|Paclitaxel|paclitaxel|mesh-list
24791836|NCT02998268|Carboplatin|carboplatin|mesh-list
24791837|NCT02998268|Pembrolizumab|pembrolizumab|mesh-list
25245946|NCT03513406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25245947|NCT03513406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25245948|NCT03513406|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25245949|NCT03513406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25245950|NCT03503318|Risperidone|risperidone|mesh-list
25245951|NCT03503318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25245952|NCT03503318|Serotonin Agents|serotonin agents|mesh-ancestor
25245953|NCT03503318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25245954|NCT03503318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245955|NCT03503318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245956|NCT03503318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25686665|NCT01922336|Infliximab|infliximab|mesh-list
24665720|NCT01314300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24665721|NCT01314300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665723|NCT01314339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24665724|NCT01314339|Cholinergic Agents|cholinergic agents|mesh-ancestor
24665725|NCT01314339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25245957|NCT03503318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25245958|NCT03503318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25245959|NCT03503318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25245960|NCT03503318|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25245961|NCT03503318|Dopamine Agents|dopamine agents|mesh-ancestor
25245962|NCT03495960|Rituximab|rituximab|mesh-list
25245963|NCT03495960|Methotrexate|methotrexate|mesh-list
25245964|NCT03495960|Lenalidomide|lenalidomide|mesh-list
25245965|NCT03495960|Temozolomide|temozolomide|mesh-list
25245966|NCT03495960|Procarbazine|procarbazine|mesh-list
25245967|NCT03495960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25245968|NCT03495960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25245969|NCT03495960|Immunologic Factors|immunologic factors|mesh-ancestor
25245970|NCT03495960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25245971|NCT03495960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24590602|NCT00913315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590603|NCT00913315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590604|NCT00913315|Urological Agents|urological agents|mesh-ancestor
24590613|NCT00913328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24590614|NCT00913328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852480|NCT02262611|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
24852482|NCT02262611|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24590615|NCT00913328|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24590616|NCT00913328|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24590617|NCT00913328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590619|NCT00913341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24590620|NCT00913341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24590621|NCT00913341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590622|NCT00913341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24590623|NCT00913341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24493794|NCT00492466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24590624|NCT00913341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24590625|NCT00913341|GABA Modulators|gaba modulators|mesh-ancestor
24791838|NCT02998268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24791839|NCT02998268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791840|NCT02998268|Tubulin Modulators|tubulin modulators|mesh-ancestor
24791841|NCT02998268|Antimitotic Agents|antimitotic agents|mesh-ancestor
24791842|NCT02998268|Mitosis Modulators|mitosis modulators|mesh-ancestor
24791843|NCT02998268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791844|NCT02998268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24791845|NCT02955082|Carboplatin|carboplatin|mesh-list
24791846|NCT02955082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791847|NCT02944617|Micronutrients|micronutrients|mesh-list
24791848|NCT02944617|Trace Elements|trace elements|mesh-list
24568390|NCT00795899|Cyclophosphamide|cyclophosphamide|mesh-list
24568391|NCT00795899|Trastuzumab|trastuzumab|mesh-list
24568392|NCT00795899|Epirubicin|epirubicin|mesh-list
24568393|NCT00795899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24568394|NCT00795899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24568401|NCT00795899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568402|NCT00795899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24568403|NCT00795899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24568404|NCT00795899|Alkylating Agents|alkylating agents|mesh-ancestor
24568405|NCT00795899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24568406|NCT00795899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24568407|NCT00795899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24568408|NCT00795899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24568409|NCT00795899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25686666|NCT01922336|Dermatologic Agents|dermatologic agents|mesh-ancestor
25686667|NCT01922336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25686668|NCT01922336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25686669|NCT01922739|Hydrocodone|hydrocodone|mesh-list
25686670|NCT01922739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25686671|NCT01922739|Narcotics|narcotics|mesh-ancestor
25686672|NCT01922739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25686673|NCT01922739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667866|NCT05261516|Sensory System Agents|sensory system agents|mesh-ancestor
24668298|NCT04978259|Remdesivir|remdesivir|mesh-list
24668299|NCT04978259|Antimetabolites|antimetabolites|mesh-ancestor
24668300|NCT04978259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24668301|NCT04978259|Antiviral Agents|antiviral agents|mesh-ancestor
24668302|NCT04978259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24568410|NCT00795899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24568411|NCT00795912|Atorvastatin|atorvastatin|mesh-list
24568412|NCT00795912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24568413|NCT00795912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25245974|NCT03495960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25245975|NCT03495960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25245976|NCT03495960|Antimetabolites|antimetabolites|mesh-ancestor
25245977|NCT03495960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25245978|NCT03495960|Dermatologic Agents|dermatologic agents|mesh-ancestor
25245979|NCT03495960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25245980|NCT03495960|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25245981|NCT03495960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25245982|NCT03495960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25245983|NCT03495960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25245984|NCT03495960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25245985|NCT03495960|Growth Substances|growth substances|mesh-ancestor
25245986|NCT03495960|Growth Inhibitors|growth inhibitors|mesh-ancestor
25245987|NCT03495960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25245988|NCT03495960|Alkylating Agents|alkylating agents|mesh-ancestor
25245989|NCT03493854|Paclitaxel|paclitaxel|mesh-list
25245990|NCT03493854|Docetaxel|docetaxel|mesh-list
25245991|NCT03493854|Cyclophosphamide|cyclophosphamide|mesh-list
25245992|NCT03493854|Doxorubicin|doxorubicin|mesh-list
24590627|NCT00913341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24590628|NCT00913341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590629|NCT00913367|Insulin|insulin|mesh-list
24590630|NCT00913367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24590631|NCT00913367|Metformin|metformin|mesh-list
24590632|NCT00913367|Insulin Glargine|insulin glargine|mesh-list
24590633|NCT00913367|Glimepiride|glimepiride|mesh-list
24590634|NCT00913367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24590635|NCT00913367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590639|NCT00913419|Amitriptyline|amitriptyline|mesh-list
24590640|NCT00913419|Cyclobenzaprine|cyclobenzaprine|mesh-list
24590641|NCT00913419|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24590642|NCT00913419|Antidepressive Agents|antidepressive agents|mesh-ancestor
24590643|NCT00913419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24590644|NCT00913419|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24590645|NCT00913419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590647|NCT00913419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25008907|NCT03837873|Alkylating Agents|alkylating agents|mesh-ancestor
25008908|NCT03837873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008909|NCT03837873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008910|NCT03837873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25008911|NCT03837873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25008912|NCT03837873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25008913|NCT03837873|Antiemetics|antiemetics|mesh-ancestor
25008914|NCT03837873|Autonomic Agents|autonomic agents|mesh-ancestor
25008915|NCT03837873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25008916|NCT03837873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24894588|NCT04438980|Prednisolone|prednisolone|mesh-list
24568453|NCT00796081|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25686674|NCT01922739|Analgesics|analgesics|mesh-ancestor
25686675|NCT01922739|Sensory System Agents|sensory system agents|mesh-ancestor
25686676|NCT01922739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686677|NCT01922739|Antitussive Agents|antitussive agents|mesh-ancestor
25686678|NCT01922739|Respiratory System Agents|respiratory system agents|mesh-ancestor
25686679|NCT01922934|Topiramate|topiramate|mesh-list
25686680|NCT01922934|Phentermine|phentermine|mesh-list
25686681|NCT01922934|Anticonvulsants|anticonvulsants|mesh-ancestor
25686682|NCT01922934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25686683|NCT01922934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686684|NCT01922934|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24568454|NCT00796081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25686685|NCT01922934|Appetite Depressants|appetite depressants|mesh-ancestor
24568455|NCT00796081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24568456|NCT00796081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24568457|NCT00796081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568458|NCT00796081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24568459|NCT00796081|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24568486|NCT00796185|Dopamine Agents|dopamine agents|mesh-ancestor
24568488|NCT00796198|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24568489|NCT00796198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24568491|NCT00796211|Calcipotriene|calcipotriene|mesh-list
24568492|NCT00796211|Dermatologic Agents|dermatologic agents|mesh-ancestor
24568493|NCT00796211|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24568494|NCT00796211|Antidepressive Agents|antidepressive agents|mesh-ancestor
24568495|NCT00796211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24568496|NCT00796211|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24568564|NCT00796432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24568565|NCT00796432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568566|NCT00796432|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24568567|NCT00796432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25245993|NCT03493854|Trastuzumab|trastuzumab|mesh-list
25245994|NCT03493854|Pertuzumab|pertuzumab|mesh-list
25245995|NCT03493854|Hormones|hormones|mesh-list
25245996|NCT03493854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25245997|NCT03493854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25245998|NCT03493854|Tubulin Modulators|tubulin modulators|mesh-ancestor
25245999|NCT03493854|Antimitotic Agents|antimitotic agents|mesh-ancestor
25246000|NCT03493854|Mitosis Modulators|mitosis modulators|mesh-ancestor
25246001|NCT03493854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246002|NCT03493854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25246003|NCT03493854|Immunologic Factors|immunologic factors|mesh-ancestor
25246004|NCT03493854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246005|NCT03493854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25246006|NCT03493854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25246007|NCT03493854|Alkylating Agents|alkylating agents|mesh-ancestor
25246008|NCT03493854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25246009|NCT03493854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25246010|NCT03493854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24590648|NCT00913419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24590649|NCT00913419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24590650|NCT00913419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24590651|NCT00913419|Analgesics|analgesics|mesh-ancestor
24590652|NCT00913419|Sensory System Agents|sensory system agents|mesh-ancestor
24590653|NCT00913419|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24590654|NCT00913419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24590655|NCT00913419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24590656|NCT00913419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590657|NCT00913419|Adrenergic Agents|adrenergic agents|mesh-ancestor
24960146|NCT03818997|Atezolizumab|atezolizumab|mesh-list
24590658|NCT00913419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24590659|NCT00913484|Disulfiram|disulfiram|mesh-list
24590660|NCT00913484|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24590715|NCT00913666|Interferon-beta|interferon-beta|mesh-list
24590667|NCT00913497|Insulin glulisine|insulin glulisine|mesh-list
24590668|NCT00913497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24852489|NCT02262611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852490|NCT02262624|Telmisartan|telmisartan|mesh-list
24852491|NCT02262624|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24852492|NCT02262624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24852493|NCT02262624|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24590695|NCT00913588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590696|NCT00913588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24590697|NCT00913588|Antidepressive Agents|antidepressive agents|mesh-ancestor
24590699|NCT00913588|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24590700|NCT00913588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24568568|NCT00796432|Dopamine Agents|dopamine agents|mesh-ancestor
24568570|NCT00796458|Hormones|hormones|mesh-list
24568571|NCT00796458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25686686|NCT01922934|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25686687|NCT01922934|Sympathomimetics|sympathomimetics|mesh-ancestor
25686688|NCT01922934|Autonomic Agents|autonomic agents|mesh-ancestor
24568572|NCT00796458|Tubulin Modulators|tubulin modulators|mesh-ancestor
24568573|NCT00796458|Antimitotic Agents|antimitotic agents|mesh-ancestor
24568574|NCT00796458|Mitosis Modulators|mitosis modulators|mesh-ancestor
25246011|NCT03493854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25246012|NCT03493854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25246013|NCT03493854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25246014|NCT03493854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25246015|NCT03479554|Antihypertensive Agents|antihypertensive agents|mesh-list
25246016|NCT03476239|Blinatumomab|blinatumomab|mesh-list
25246017|NCT03476239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246018|NCT03469713|Nivolumab|nivolumab|mesh-list
25246019|NCT03469713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25246020|NCT03469713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246021|NCT03469713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25246022|NCT03469713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246029|NCT03440892|Sulfasalazine|sulfasalazine|mesh-list
25246030|NCT03440892|Methotrexate|methotrexate|mesh-list
25246031|NCT03440892|Abatacept|abatacept|mesh-list
25246032|NCT03440892|Tofacitinib|tofacitinib|mesh-list
25246033|NCT03440892|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25246034|NCT03440892|Abortifacient Agents|abortifacient agents|mesh-ancestor
25246035|NCT03440892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24568591|NCT00796471|Dopamine Agents|dopamine agents|mesh-ancestor
25246036|NCT03440892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246037|NCT03440892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25246038|NCT03440892|Antimetabolites|antimetabolites|mesh-ancestor
25246039|NCT03440892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246040|NCT03440892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246041|NCT03440892|Dermatologic Agents|dermatologic agents|mesh-ancestor
25246042|NCT03440892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25246043|NCT03440892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25246044|NCT03440892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24590701|NCT00913588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590702|NCT00913614|SR 46349B|sr 46349b|mesh-list
24590703|NCT00913614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24590704|NCT00913614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24590705|NCT00913614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590706|NCT00913614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24590707|NCT00913614|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24590708|NCT00913614|Serotonin Agents|serotonin agents|mesh-ancestor
24590709|NCT00913614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24590710|NCT00913614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590711|NCT00913653|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24590712|NCT00913653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24590713|NCT00913653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590714|NCT00913666|Interferons|interferons|mesh-list
24852496|NCT02262624|Diuretics|diuretics|mesh-ancestor
24852497|NCT02262624|Natriuretic Agents|natriuretic agents|mesh-ancestor
24852498|NCT02262624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852499|NCT02262624|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24852500|NCT02262624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24852501|NCT02262637|Telmisartan|telmisartan|mesh-list
24852502|NCT02262637|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
24657332|NCT01266772|Autonomic Agents|autonomic agents|mesh-ancestor
25246045|NCT03440892|Immunologic Factors|immunologic factors|mesh-ancestor
25246046|NCT03440892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25246047|NCT03440892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25246048|NCT03440892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25246049|NCT03440892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25246050|NCT03440892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25246051|NCT03440892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25246052|NCT03440892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25246053|NCT03440892|Analgesics|analgesics|mesh-ancestor
25246054|NCT03440892|Sensory System Agents|sensory system agents|mesh-ancestor
25246055|NCT03440892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25246056|NCT03440892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25246057|NCT03440892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25246067|NCT03401749|Chlorhexidine|chlorhexidine|mesh-list
25246068|NCT03401749|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25246069|NCT03401749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25246070|NCT03401749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25246071|NCT03401749|Disinfectants|disinfectants|mesh-ancestor
25246072|NCT03401749|Dermatologic Agents|dermatologic agents|mesh-ancestor
25274362|NCT02378415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24590755|NCT00913809|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24590756|NCT00913809|Antidepressive Agents|antidepressive agents|mesh-ancestor
24590757|NCT00913809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24590758|NCT00913809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590792|NCT00913861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24590793|NCT00913861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590794|NCT00913861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24590795|NCT00913861|Anesthetics, General|anesthetics, general|mesh-ancestor
24590797|NCT00913861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24590798|NCT00913861|Narcotics|narcotics|mesh-ancestor
25155355|NCT05409885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24590840|NCT00913965|Sympatholytics|sympatholytics|mesh-ancestor
24590841|NCT00913965|Autonomic Agents|autonomic agents|mesh-ancestor
24590842|NCT00913965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24590843|NCT00913965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590844|NCT00913965|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24590845|NCT00913965|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24590855|NCT00914004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590856|NCT00914004|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24590857|NCT00914004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24590858|NCT00914004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24590859|NCT00914004|Adrenergic Agents|adrenergic agents|mesh-ancestor
24590860|NCT00914004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24590861|NCT00914004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590862|NCT00914017|Atorvastatin|atorvastatin|mesh-list
25073066|NCT03397537|Letrozole|letrozole|mesh-list
24568575|NCT00796458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568576|NCT00796458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24568577|NCT00796458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568578|NCT00796471|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24568579|NCT00796471|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24568580|NCT00796471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24568581|NCT00796471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24568582|NCT00796471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568583|NCT00796471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24568584|NCT00796471|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24568585|NCT00796471|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24568586|NCT00796471|Serotonin Agents|serotonin agents|mesh-ancestor
24568587|NCT00796471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24568588|NCT00796471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568590|NCT00796471|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25246085|NCT03391284|Acetaminophen|acetaminophen|mesh-list
25246086|NCT03391284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25246087|NCT03391284|Analgesics|analgesics|mesh-ancestor
25246088|NCT03391284|Sensory System Agents|sensory system agents|mesh-ancestor
25246089|NCT03391284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25246090|NCT03391284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246091|NCT03391284|Antipyretics|antipyretics|mesh-ancestor
25246092|NCT03369223|Nivolumab|nivolumab|mesh-list
25246093|NCT03369223|Ipilimumab|ipilimumab|mesh-list
25246094|NCT03369223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25246095|NCT03369223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246096|NCT03369223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25246097|NCT03369223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246098|NCT03361345|Tranexamic Acid|tranexamic acid|mesh-list
25246099|NCT03361345|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25246100|NCT03361345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25246101|NCT03361345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246102|NCT03361345|Hemostatics|hemostatics|mesh-ancestor
25246103|NCT03361345|Coagulants|coagulants|mesh-ancestor
25246104|NCT03360916|Atorvastatin|atorvastatin|mesh-list
25246105|NCT03360916|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25246106|NCT03360916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25246107|NCT03360916|Antimetabolites|antimetabolites|mesh-ancestor
25246108|NCT03360916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246109|NCT03360916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25246110|NCT03360916|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25246111|NCT03360916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25246112|NCT03359863|Pirfenidone|pirfenidone|mesh-list
25246113|NCT03359863|Analgesics|analgesics|mesh-ancestor
24852504|NCT02262637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24852505|NCT02262637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24852506|NCT02262637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852507|NCT02262637|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24852508|NCT02262637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24657393|NCT01267084|Hormones|hormones|mesh-ancestor
24590863|NCT00914017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24590864|NCT00914017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24590865|NCT00914017|Antimetabolites|antimetabolites|mesh-ancestor
24590866|NCT00914017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590867|NCT00914017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24590868|NCT00914017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24590869|NCT00914017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590870|NCT00914056|Lactulose|lactulose|mesh-list
24590871|NCT00914056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24590872|NCT00914095|Methylphenidate|methylphenidate|mesh-list
24590873|NCT00914095|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24590882|NCT00914121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24590926|NCT00914368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24590927|NCT00914368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590928|NCT00914368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590929|NCT00914394|Phenylephrine|phenylephrine|mesh-list
24590930|NCT00914394|Oxymetazoline|oxymetazoline|mesh-list
24568609|NCT00796640|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24568610|NCT00796640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25008917|NCT03837873|Glucocorticoids|glucocorticoids|mesh-ancestor
24792652|NCT04887831|Antimetabolites|antimetabolites|mesh-ancestor
24568611|NCT00796640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24568612|NCT00796640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24568613|NCT00796640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568614|NCT00796640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24568615|NCT00796640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24568616|NCT00796640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24568617|NCT00796640|Serotonin Agents|serotonin agents|mesh-ancestor
24568618|NCT00796640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24568619|NCT00796640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246114|NCT03359863|Sensory System Agents|sensory system agents|mesh-ancestor
25246115|NCT03359863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25246116|NCT03359863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246117|NCT03359863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25246118|NCT03359863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25246119|NCT03359863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25246120|NCT03359863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25246121|NCT03359863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246122|NCT03357419|Clindamycin|clindamycin|mesh-list
25246123|NCT03357419|Clindamycin palmitate|clindamycin palmitate|mesh-list
25246124|NCT03357419|Clindamycin phosphate|clindamycin phosphate|mesh-list
25246125|NCT03357419|Cephalexin|cephalexin|mesh-list
25246126|NCT03357419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25246127|NCT03357419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25246128|NCT03357419|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25246129|NCT03357419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25246130|NCT03357419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246131|NCT03351998|Atorvastatin|atorvastatin|mesh-list
25246132|NCT03351998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25246133|NCT03351998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25246134|NCT03351998|Antimetabolites|antimetabolites|mesh-ancestor
25246135|NCT03351998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246136|NCT03351998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25246137|NCT03351998|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25246138|NCT03351998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590931|NCT00914394|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
24590932|NCT00914394|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24590933|NCT00914394|Mydriatics|mydriatics|mesh-ancestor
24590934|NCT00914394|Autonomic Agents|autonomic agents|mesh-ancestor
24590935|NCT00914394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24590936|NCT00914394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590937|NCT00914394|Sympathomimetics|sympathomimetics|mesh-ancestor
24590938|NCT00914394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25129484|NCT03040817|Serotonin Agents|serotonin agents|mesh-ancestor
24590972|NCT00914498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590974|NCT00914524|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24590975|NCT00914524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24590976|NCT00914524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24590992|NCT00914641|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24590993|NCT00914641|Antithrombins|antithrombins|mesh-ancestor
24590994|NCT00914641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24590995|NCT00914641|Protease Inhibitors|protease inhibitors|mesh-ancestor
24590996|NCT00914641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590997|NCT00914641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590998|NCT00914641|Anticoagulants|anticoagulants|mesh-ancestor
24590999|NCT00914654|Formoterol Fumarate|formoterol fumarate|mesh-list
24852512|NCT02262650|Telmisartan|telmisartan|mesh-list
24852513|NCT02262650|Clopidogrel|clopidogrel|mesh-list
24852514|NCT02262650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24591005|NCT00914654|Respiratory System Agents|respiratory system agents|mesh-ancestor
24591006|NCT00914654|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24591007|NCT00914654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24591008|NCT00914654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24591009|NCT00914654|Adrenergic Agents|adrenergic agents|mesh-ancestor
24568620|NCT00796640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24568621|NCT00796640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25246154|NCT03331289|Dapagliflozin|dapagliflozin|mesh-list
25246155|NCT03331289|Exenatide|exenatide|mesh-list
25246156|NCT03331289|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25246157|NCT03331289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246158|NCT03331289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25246159|NCT03331289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246160|NCT03331289|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25246161|NCT03331289|Incretins|incretins|mesh-ancestor
25246162|NCT03331289|Hormones|hormones|mesh-ancestor
25246163|NCT03331289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25246164|NCT03324282|Avelumab|avelumab|mesh-list
25246165|NCT03324282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25246166|NCT03324282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246176|NCT03320642|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
25246177|NCT03320642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274363|NCT02378415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591010|NCT00914654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24591011|NCT00914654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591013|NCT00914667|Fesoterodine|fesoterodine|mesh-list
24591014|NCT00914667|Anticoagulants|anticoagulants|mesh-ancestor
24591015|NCT00914667|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24591016|NCT00914667|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24591017|NCT00914667|Cholinergic Agents|cholinergic agents|mesh-ancestor
24591034|NCT00914693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24591049|NCT00914797|Tocolytic Agents|tocolytic agents|mesh-ancestor
24591050|NCT00914797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24591051|NCT00914797|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24591052|NCT00914797|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24591053|NCT00914797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24591054|NCT00914797|Adrenergic Agents|adrenergic agents|mesh-ancestor
24591055|NCT00914797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24591056|NCT00914797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591057|NCT00914836|Betamethasone|betamethasone|mesh-list
24591058|NCT00914836|Betamethasone Valerate|betamethasone valerate|mesh-list
24591081|NCT00914888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24591082|NCT00914888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24568668|NCT00796900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24568669|NCT00796900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24568670|NCT00797017|Fentanyl|fentanyl|mesh-list
24568671|NCT00797017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24568672|NCT00797017|Narcotics|narcotics|mesh-ancestor
24568673|NCT00797017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24629154|NCT01103401|Hormones|hormones|mesh-ancestor
24568674|NCT00797017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568675|NCT00797017|Analgesics|analgesics|mesh-ancestor
24568676|NCT00797017|Sensory System Agents|sensory system agents|mesh-ancestor
24568677|NCT00797017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24568678|NCT00797017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24568679|NCT00797017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24568701|NCT00797056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568702|NCT00797056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25246178|NCT03320642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246179|NCT03283007|Nintedanib|nintedanib|mesh-list
25246180|NCT03283007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25686689|NCT01922934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686690|NCT01922934|Adrenergic Agents|adrenergic agents|mesh-ancestor
25246181|NCT03283007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25246182|NCT03283007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25246183|NCT03283007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246184|NCT03268057|Avelumab|avelumab|mesh-list
25246185|NCT03268057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25246186|NCT03268057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246193|NCT03230565|Ropivacaine|ropivacaine|mesh-list
25246194|NCT03230565|Anesthetics, Local|anesthetics, local|mesh-ancestor
25246195|NCT03230565|Anesthetics|anesthetics|mesh-ancestor
25246196|NCT03230565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25246197|NCT03230565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246198|NCT03230565|Sensory System Agents|sensory system agents|mesh-ancestor
25246199|NCT03230565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082666|NCT03321136|Hallucinogens|hallucinogens|mesh-ancestor
24591087|NCT00914901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591088|NCT00914901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24591089|NCT00914901|Respiratory System Agents|respiratory system agents|mesh-ancestor
24591090|NCT00914901|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24591091|NCT00914901|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24591092|NCT00914901|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24591093|NCT00914901|Adrenergic Agents|adrenergic agents|mesh-ancestor
24591094|NCT00914901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24591095|NCT00914901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591097|NCT00914953|Oxytocics|oxytocics|mesh-ancestor
24591098|NCT00914953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24569311|NCT00800215|Lacosamide|lacosamide|mesh-list
24591099|NCT00914953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591100|NCT00915070|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
24591101|NCT00915070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24591102|NCT00915070|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24591103|NCT00915070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591104|NCT00915083|Amrubicin|amrubicin|mesh-list
24591105|NCT00915083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24852515|NCT02262650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24852516|NCT02262650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24852517|NCT02262650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24568703|NCT00797056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24568704|NCT00797056|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24568705|NCT00797056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24568706|NCT00797056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568707|NCT00797056|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24568708|NCT00797056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24568709|NCT00797056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24568711|NCT00797056|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24568712|NCT00797056|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24568713|NCT00797056|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24568714|NCT00797056|Purinergic Agents|purinergic agents|mesh-ancestor
24568715|NCT00797056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24568717|NCT00797160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24568718|NCT00797160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24568719|NCT00797160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568720|NCT00797160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24568721|NCT00797160|Anesthetics, General|anesthetics, general|mesh-ancestor
24568722|NCT00797160|Anesthetics|anesthetics|mesh-ancestor
24568723|NCT00797264|Ketamine|ketamine|mesh-list
24568724|NCT00797264|Morphine|morphine|mesh-list
24568725|NCT00797264|Analgesics|analgesics|mesh-ancestor
24791849|NCT02944617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791850|NCT02862548|Antiviral Agents|antiviral agents|mesh-list
24791851|NCT02862548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24791852|NCT02818738|Levamisole|levamisole|mesh-list
25246206|NCT03194906|Memantine|memantine|mesh-list
25246207|NCT03194906|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25246208|NCT03194906|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25246209|NCT03194906|Dopamine Agents|dopamine agents|mesh-ancestor
25246210|NCT03194906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25246211|NCT03194906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246212|NCT03194906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246213|NCT03194906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25246214|NCT03194906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25246215|NCT03192397|Mycophenolic Acid|mycophenolic acid|mesh-list
25246216|NCT03192397|Sirolimus|sirolimus|mesh-list
25246217|NCT03192397|Cyclophosphamide|cyclophosphamide|mesh-list
25246218|NCT03192397|Melphalan|melphalan|mesh-list
25246219|NCT03192397|Fludarabine|fludarabine|mesh-list
25246220|NCT03192397|Fludarabine phosphate|fludarabine phosphate|mesh-list
25246221|NCT03192397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25246222|NCT03192397|Immunologic Factors|immunologic factors|mesh-ancestor
25246223|NCT03192397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246224|NCT03192397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25246225|NCT03192397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25246226|NCT03192397|Alkylating Agents|alkylating agents|mesh-ancestor
25246227|NCT03192397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852520|NCT02262650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852521|NCT02262650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852522|NCT02262650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24852523|NCT02262650|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24852524|NCT02262650|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24852525|NCT02262676|Rivaroxaban|rivaroxaban|mesh-list
24852526|NCT02262676|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24852527|NCT02262676|Antithrombins|antithrombins|mesh-ancestor
24500879|NCT00526175|Methotrexate|methotrexate|mesh-list
24591130|NCT00915252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24591131|NCT00915252|Antimetabolites|antimetabolites|mesh-ancestor
24591132|NCT00915252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591133|NCT00915252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25155356|NCT05409885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591134|NCT00915252|Antiviral Agents|antiviral agents|mesh-ancestor
24591135|NCT00915252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24591138|NCT00915252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591140|NCT00915252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24591141|NCT00915252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24591142|NCT00915252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24591144|NCT00915369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24635062|NCT01136759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591145|NCT00915369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24852533|NCT02262702|Acetaminophen|acetaminophen|mesh-list
24852534|NCT02262702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24791853|NCT02818738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24791854|NCT02818738|Immunologic Factors|immunologic factors|mesh-ancestor
24791855|NCT02818738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791856|NCT02818738|Antinematodal Agents|antinematodal agents|mesh-ancestor
24791857|NCT02818738|Anthelmintics|anthelmintics|mesh-ancestor
24791858|NCT02818738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24791859|NCT02818738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24791860|NCT02818738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24791861|NCT02704208|Nicotine|nicotine|mesh-list
24791862|NCT02704208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24568727|NCT00797264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24568728|NCT00797264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568729|NCT00797264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25246228|NCT03192397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246229|NCT03192397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25246230|NCT03192397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25246231|NCT03192397|Antimetabolites|antimetabolites|mesh-ancestor
25246232|NCT03192397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25246233|NCT03192397|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25246234|NCT03192397|Antitubercular Agents|antitubercular agents|mesh-ancestor
25246235|NCT03192397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25246236|NCT03192397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25246237|NCT03192397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25246238|NCT03192397|Antifungal Agents|antifungal agents|mesh-ancestor
25246239|NCT03172936|Spartalizumab|spartalizumab|mesh-list
25246240|NCT03172936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25246241|NCT03172936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246242|NCT03172936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246243|NCT03168464|Nivolumab|nivolumab|mesh-list
25246244|NCT03168464|Ipilimumab|ipilimumab|mesh-list
25246245|NCT03168464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25246246|NCT03168464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246247|NCT03168464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25246248|NCT03168464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246249|NCT03160079|Pembrolizumab|pembrolizumab|mesh-list
25246250|NCT03160079|Blinatumomab|blinatumomab|mesh-list
25246251|NCT03160079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25246252|NCT03160079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246253|NCT03158064|Durvalumab|durvalumab|mesh-list
25246254|NCT03158064|Tremelimumab|tremelimumab|mesh-list
25246255|NCT03158064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24591146|NCT00915369|Tubulin Modulators|tubulin modulators|mesh-ancestor
24591147|NCT00915369|Antimitotic Agents|antimitotic agents|mesh-ancestor
24591148|NCT00915369|Mitosis Modulators|mitosis modulators|mesh-ancestor
24591149|NCT00915369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591150|NCT00915382|Cisplatin|cisplatin|mesh-list
24591159|NCT00915408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24591161|NCT00915408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591162|NCT00915408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591163|NCT00915408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24591164|NCT00915408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24591165|NCT00915408|Antiemetics|antiemetics|mesh-ancestor
24591166|NCT00915408|Autonomic Agents|autonomic agents|mesh-ancestor
24591167|NCT00915408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24591168|NCT00915408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24591169|NCT00915408|Glucocorticoids|glucocorticoids|mesh-ancestor
24591197|NCT00915512|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24591198|NCT00915512|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24591199|NCT00915512|Dopamine Agents|dopamine agents|mesh-ancestor
24591201|NCT00915564|Methadone|methadone|mesh-list
24568791|NCT00797485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246257|NCT03152058|Certolizumab Pegol|certolizumab pegol|mesh-list
25246258|NCT03152058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25246259|NCT03152058|Immunologic Factors|immunologic factors|mesh-ancestor
25246260|NCT03152058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246261|NCT03152058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25246262|NCT03138252|Oxytocin|oxytocin|mesh-list
25246263|NCT03138252|Oxytocics|oxytocics|mesh-ancestor
25246264|NCT03138252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25246265|NCT03138252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246266|NCT03122717|Gefitinib|gefitinib|mesh-list
25246267|NCT03122717|Osimertinib|osimertinib|mesh-list
25246268|NCT03122717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246269|NCT03122717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25246270|NCT03122717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25246271|NCT03122717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591202|NCT00915564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24591203|NCT00915564|Narcotics|narcotics|mesh-ancestor
24591204|NCT00915564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24591205|NCT00915564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591206|NCT00915564|Analgesics|analgesics|mesh-ancestor
24591207|NCT00915564|Sensory System Agents|sensory system agents|mesh-ancestor
24591208|NCT00915564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24591209|NCT00915564|Antitussive Agents|antitussive agents|mesh-ancestor
24591210|NCT00915564|Respiratory System Agents|respiratory system agents|mesh-ancestor
24591211|NCT00915564|Antiviral Agents|antiviral agents|mesh-ancestor
24591212|NCT00915564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24591213|NCT00915564|Protease Inhibitors|protease inhibitors|mesh-ancestor
24591214|NCT00915564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591215|NCT00915564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591216|NCT00915577|Interferons|interferons|mesh-list
24591217|NCT00915577|Interferon-beta|interferon-beta|mesh-list
24591229|NCT00915616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073238|NCT03396250|Naproxen|naproxen|mesh-list
24568792|NCT00797485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24568793|NCT00797485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24568794|NCT00797485|Immunologic Factors|immunologic factors|mesh-ancestor
24568795|NCT00797485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24568796|NCT00797485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24568797|NCT00797485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24568798|NCT00797485|Antidotes|antidotes|mesh-ancestor
24568799|NCT00797485|Protective Agents|protective agents|mesh-ancestor
24568800|NCT00797485|Vitamin B Complex|vitamin b complex|mesh-ancestor
24568801|NCT00797485|Vitamins|vitamins|mesh-ancestor
25686691|NCT01922934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25686692|NCT01922934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686693|NCT01923129|Prazosin|prazosin|mesh-list
25686694|NCT01923129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24568802|NCT00797485|Micronutrients|micronutrients|mesh-ancestor
25008930|NCT03837873|Tubulin Modulators|tubulin modulators|mesh-ancestor
24494437|NCT00495287|Cytarabine|cytarabine|mesh-list
24568823|NCT00797745|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24568946|NCT00798148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24568947|NCT00798148|Alkylating Agents|alkylating agents|mesh-ancestor
24568948|NCT00798148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24591233|NCT00915694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24591234|NCT00915694|Alkylating Agents|alkylating agents|mesh-ancestor
24591235|NCT00915694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591236|NCT00915694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591237|NCT00915694|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24591238|NCT00915694|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24591239|NCT00915694|Protease Inhibitors|protease inhibitors|mesh-ancestor
24591240|NCT00915694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24568954|NCT00798213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24568955|NCT00798252|Paclitaxel|paclitaxel|mesh-list
24568956|NCT00798252|Docetaxel|docetaxel|mesh-list
24568957|NCT00798252|Doxorubicin|doxorubicin|mesh-list
24568958|NCT00798252|Capecitabine|capecitabine|mesh-list
24568959|NCT00798252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24568960|NCT00798252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24568961|NCT00798252|Tubulin Modulators|tubulin modulators|mesh-ancestor
24568962|NCT00798252|Antimitotic Agents|antimitotic agents|mesh-ancestor
24568963|NCT00798252|Mitosis Modulators|mitosis modulators|mesh-ancestor
24671048|NCT01323335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568964|NCT00798252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568965|NCT00798252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24568966|NCT00798252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24568967|NCT00798252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24568968|NCT00798252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24568987|NCT00798395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24568988|NCT00798395|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24568989|NCT00798395|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24568990|NCT00798395|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24568991|NCT00798395|Adrenergic Agents|adrenergic agents|mesh-ancestor
24568992|NCT00798395|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24568993|NCT00798395|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24569022|NCT00798616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24569023|NCT00798616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24569025|NCT00798616|Prednisolone acetate|prednisolone acetate|mesh-list
24569026|NCT00798616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24569027|NCT00798616|Prednisolone phosphate|prednisolone phosphate|mesh-list
24569028|NCT00798616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24569030|NCT00798616|Autonomic Agents|autonomic agents|mesh-ancestor
24591242|NCT00915694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24591243|NCT00915694|Antiviral Agents|antiviral agents|mesh-ancestor
24591244|NCT00915694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24591245|NCT00915733|Aspirin|aspirin|mesh-list
24591246|NCT00915733|Cilostazol|cilostazol|mesh-list
24591247|NCT00915733|Clopidogrel|clopidogrel|mesh-list
24591248|NCT00915733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24591249|NCT00915733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24591250|NCT00915733|Analgesics|analgesics|mesh-ancestor
24591251|NCT00915733|Sensory System Agents|sensory system agents|mesh-ancestor
24591252|NCT00915733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25155357|NCT05408312|Vaccines|vaccines|mesh-list
24591253|NCT00915733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852536|NCT02262702|Sensory System Agents|sensory system agents|mesh-ancestor
24852537|NCT02262702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24852538|NCT02262702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852539|NCT02262702|Antipyretics|antipyretics|mesh-ancestor
24591262|NCT00915733|Antipyretics|antipyretics|mesh-ancestor
24793293|NCT03581370|Renal Agents|renal agents|mesh-ancestor
24569031|NCT00798616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24569032|NCT00798616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569033|NCT00798616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24569035|NCT00798616|Hormones|hormones|mesh-ancestor
24569036|NCT00798616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24569037|NCT00798616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24569038|NCT00798616|Protective Agents|protective agents|mesh-ancestor
25686695|NCT01923129|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25686696|NCT01923129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24569039|NCT00798616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24569040|NCT00798616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24569041|NCT00798772|Micronutrients|micronutrients|mesh-list
24569042|NCT00798772|Trace Elements|trace elements|mesh-list
24569043|NCT00798772|Antioxidants|antioxidants|mesh-list
24569044|NCT00798772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569045|NCT00798772|Protective Agents|protective agents|mesh-ancestor
24569046|NCT00798772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569047|NCT00798785|Rituximab|rituximab|mesh-list
24569048|NCT00798785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24591278|NCT00915746|Antifungal Agents|antifungal agents|mesh-ancestor
24591279|NCT00915746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24591280|NCT00915746|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24591281|NCT00915746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24591282|NCT00915746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591283|NCT00915746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591284|NCT00915746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24591285|NCT00915746|Hormone Antagonists|hormone antagonists|mesh-ancestor
24591286|NCT00915746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24591287|NCT00915746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591288|NCT00915746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24591289|NCT00915785|Azacitidine|azacitidine|mesh-list
24591290|NCT00915785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24591291|NCT00915785|Antimetabolites|antimetabolites|mesh-ancestor
24591292|NCT00915785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591293|NCT00915785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591294|NCT00915785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073274|NCT03396107|Hormones|hormones|mesh-ancestor
24569105|NCT00799045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569106|NCT00799045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569107|NCT00799071|Posaconazole|posaconazole|mesh-list
24569108|NCT00799071|Antifungal Agents|antifungal agents|mesh-ancestor
24569109|NCT00799071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24569110|NCT00799071|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24569111|NCT00799071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24569148|NCT00799149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24569149|NCT00799149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569150|NCT00799149|Antimanic Agents|antimanic agents|mesh-ancestor
24629266|NCT01103830|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24569151|NCT00799149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24569152|NCT00799149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24569153|NCT00799149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24569154|NCT00799149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24569155|NCT00799149|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24569176|NCT00799175|Respiratory System Agents|respiratory system agents|mesh-ancestor
24569177|NCT00799175|Mydriatics|mydriatics|mesh-ancestor
24569178|NCT00799175|Sympathomimetics|sympathomimetics|mesh-ancestor
24569179|NCT00799175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25246352|NCT03034642|Dimercaprol|dimercaprol|mesh-list
25246353|NCT03034642|Chelating Agents|chelating agents|mesh-ancestor
24591295|NCT00915811|Fludarabine|fludarabine|mesh-list
24591297|NCT00915811|Thymoglobulin|thymoglobulin|mesh-list
24591298|NCT00915811|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24591300|NCT00915811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591301|NCT00915811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24591302|NCT00915811|Immunologic Factors|immunologic factors|mesh-ancestor
24591303|NCT00915811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591304|NCT00915811|Alkylating Agents|alkylating agents|mesh-ancestor
24591305|NCT00915811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24591306|NCT00915811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24591307|NCT00915837|Triamcinolone|triamcinolone|mesh-list
24591308|NCT00915837|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24591309|NCT00915837|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24591310|NCT00915837|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24591311|NCT00915837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24591312|NCT00915837|Glucocorticoids|glucocorticoids|mesh-ancestor
24591314|NCT00915837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24591346|NCT00916045|Cyclophosphamide|cyclophosphamide|mesh-list
24591348|NCT00916045|Busulfan|busulfan|mesh-list
24591349|NCT00916045|Thiotepa|thiotepa|mesh-list
24591350|NCT00916045|Fludarabine|fludarabine|mesh-list
24591351|NCT00916045|Fludarabine phosphate|fludarabine phosphate|mesh-list
24591352|NCT00916045|Cyclosporins|cyclosporins|mesh-list
24591353|NCT00916045|Thymoglobulin|thymoglobulin|mesh-list
24591354|NCT00916045|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24591356|NCT00916045|Immunologic Factors|immunologic factors|mesh-ancestor
24591357|NCT00916045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852544|NCT02262715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852546|NCT02262741|Tremelimumab|tremelimumab|mesh-list
24569180|NCT00799175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24569181|NCT00799175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24569182|NCT00799175|Analgesics|analgesics|mesh-ancestor
24569184|NCT00799175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24569185|NCT00799175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24569186|NCT00799175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24569187|NCT00799188|Everolimus|everolimus|mesh-list
24569188|NCT00799188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24569189|NCT00799188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24569190|NCT00799188|Immunologic Factors|immunologic factors|mesh-ancestor
25274370|NCT02378415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25274371|NCT02378415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25274372|NCT02378415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274373|NCT02378441|Metformin|metformin|mesh-list
25274374|NCT02378441|Atorvastatin|atorvastatin|mesh-list
25274375|NCT02378441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25274376|NCT02378441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274377|NCT02378441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25274378|NCT02378441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25274379|NCT02378441|Antimetabolites|antimetabolites|mesh-ancestor
24852561|NCT02262793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24591358|NCT00916045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24591359|NCT00916045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24591360|NCT00916045|Alkylating Agents|alkylating agents|mesh-ancestor
24591386|NCT00916123|Antimitotic Agents|antimitotic agents|mesh-ancestor
24591387|NCT00916123|Mitosis Modulators|mitosis modulators|mesh-ancestor
24591388|NCT00916123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591389|NCT00916123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24591392|NCT00916123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24591393|NCT00916123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591394|NCT00916123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24591395|NCT00916201|Cannabidiol|cannabidiol|mesh-list
24591396|NCT00916201|Anticonvulsants|anticonvulsants|mesh-ancestor
24591397|NCT00916253|Modafinil|modafinil|mesh-list
25155358|NCT05408312|Immunologic Factors|immunologic factors|mesh-ancestor
24591398|NCT00916253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24591399|NCT00916253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591400|NCT00916253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24591401|NCT00916253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24591402|NCT00916253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25073318|NCT03395873|Decitabine|decitabine|mesh-list
24791863|NCT02704208|Autonomic Agents|autonomic agents|mesh-ancestor
24791864|NCT02704208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24791865|NCT02704208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791866|NCT02704208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24791867|NCT02704208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24791868|NCT02704208|Cholinergic Agents|cholinergic agents|mesh-ancestor
24791869|NCT02704208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24791870|NCT02704208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791871|NCT02553460|Leucovorin|leucovorin|mesh-list
24791872|NCT02553460|Cytarabine|cytarabine|mesh-list
24889205|NCT04495933|Vaccines|vaccines|mesh-list
25008932|NCT03837873|Mitosis Modulators|mitosis modulators|mesh-ancestor
25008933|NCT03837873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25008934|NCT03837873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25008935|NCT03837873|Growth Substances|growth substances|mesh-ancestor
25008936|NCT03837873|Growth Inhibitors|growth inhibitors|mesh-ancestor
24791895|NCT02553460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25008964|NCT03753555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008965|NCT03753555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25008966|NCT03753555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25246368|NCT03011684|Tamoxifen|tamoxifen|mesh-list
25246369|NCT03011684|Letrozole|letrozole|mesh-list
25246370|NCT03011684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246371|NCT03011684|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25246372|NCT03011684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25246373|NCT03011684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25246374|NCT03011684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686697|NCT01923129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25246375|NCT03011684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25246376|NCT03011684|Hormone Antagonists|hormone antagonists|mesh-ancestor
25246377|NCT03011684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25246378|NCT03011684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246379|NCT03011684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25246380|NCT03011684|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25246382|NCT03011684|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25246384|NCT03002389|Xhance|xhance|mesh-list
25246385|NCT03002389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25246386|NCT03002389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25246387|NCT03002389|Autonomic Agents|autonomic agents|mesh-ancestor
25246388|NCT03002389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25246389|NCT03002389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591412|NCT00916409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591413|NCT00916448|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24591414|NCT00916448|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24591415|NCT00916448|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24591416|NCT00916448|Protease Inhibitors|protease inhibitors|mesh-ancestor
24591417|NCT00916448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591418|NCT00916448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591419|NCT00916448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24591420|NCT00916448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24591421|NCT00916448|Antiviral Agents|antiviral agents|mesh-ancestor
25008967|NCT03753555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25008968|NCT03753555|Antimetabolites|antimetabolites|mesh-ancestor
25008969|NCT03753555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008970|NCT03753555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25008971|NCT03753555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25008972|NCT03753555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24569195|NCT00799201|Sensory System Agents|sensory system agents|mesh-ancestor
24569196|NCT00799201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24569197|NCT00799214|Metronidazole|metronidazole|mesh-list
24569198|NCT00799214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24569199|NCT00799214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24569200|NCT00799214|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24569201|NCT00799214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24569202|NCT00799240|Cisplatin|cisplatin|mesh-list
24569203|NCT00799240|Pemetrexed|pemetrexed|mesh-list
24569204|NCT00799240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24569205|NCT00799240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24569206|NCT00799240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24569207|NCT00799240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569208|NCT00799240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24569209|NCT00799240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24569210|NCT00799240|Immunologic Factors|immunologic factors|mesh-ancestor
24569211|NCT00799240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569212|NCT00799266|Zoledronic Acid|zoledronic acid|mesh-list
24569213|NCT00799266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24569215|NCT00799448|Insulin|insulin|mesh-list
24512998|NCT00578097|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24569256|NCT00799760|Zanamivir|zanamivir|mesh-list
24569260|NCT00799760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569279|NCT00799890|Protective Agents|protective agents|mesh-ancestor
24569280|NCT00799890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569281|NCT00799890|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24569282|NCT00799890|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24569283|NCT00799890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24569284|NCT00799890|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24569285|NCT00799968|Fibrinolytic Agents|fibrinolytic agents|mesh-list
24569286|NCT00799968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24569300|NCT00800150|Melphalan|melphalan|mesh-list
24569301|NCT00800150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24569302|NCT00800150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24569303|NCT00800150|Antimetabolites|antimetabolites|mesh-ancestor
24569304|NCT00800150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569305|NCT00800150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24569306|NCT00800150|Immunologic Factors|immunologic factors|mesh-ancestor
24569307|NCT00800150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569308|NCT00800150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24569312|NCT00800215|Anticonvulsants|anticonvulsants|mesh-ancestor
25246390|NCT03002389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25246391|NCT03002389|Respiratory System Agents|respiratory system agents|mesh-ancestor
25246392|NCT03002389|Dermatologic Agents|dermatologic agents|mesh-ancestor
25246393|NCT03002389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25246394|NCT02983045|Paclitaxel|paclitaxel|mesh-list
25246395|NCT02983045|Cisplatin|cisplatin|mesh-list
25246396|NCT02983045|Carboplatin|carboplatin|mesh-list
25246397|NCT02983045|Nivolumab|nivolumab|mesh-list
25246398|NCT02983045|Pemetrexed|pemetrexed|mesh-list
25246399|NCT02983045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25246400|NCT02983045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246401|NCT02983045|Tubulin Modulators|tubulin modulators|mesh-ancestor
24591422|NCT00916448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24591423|NCT00916461|Minocycline|minocycline|mesh-list
24591424|NCT00916461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24591425|NCT00916461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24591427|NCT00916500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591428|NCT00916526|Mannitol|mannitol|mesh-list
24591429|NCT00916526|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24591430|NCT00916526|Diuretics|diuretics|mesh-ancestor
24852562|NCT02262793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24852563|NCT02262793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24852564|NCT02262793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852565|NCT02262858|Telmisartan|telmisartan|mesh-list
24852566|NCT02262858|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24852567|NCT02262858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24501018|NCT00526409|Cytarabine|cytarabine|mesh-list
24591437|NCT00916630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591438|NCT00916630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591439|NCT00916630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24591440|NCT00916630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24591442|NCT00916669|Enoxaparin|enoxaparin|mesh-list
24591443|NCT00916669|Enoxaparin sodium|enoxaparin sodium|mesh-list
24591444|NCT00916669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591445|NCT00916669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24591446|NCT00916669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24591447|NCT00916669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24591448|NCT00916669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591449|NCT00916669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591450|NCT00916669|Anticoagulants|anticoagulants|mesh-ancestor
24591451|NCT00916669|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24591452|NCT00916669|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24591453|NCT00916695|Everolimus|everolimus|mesh-list
24591454|NCT00916695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591455|NCT00916695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24591456|NCT00916695|Immunologic Factors|immunologic factors|mesh-ancestor
24591457|NCT00916695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246402|NCT02983045|Antimitotic Agents|antimitotic agents|mesh-ancestor
25246403|NCT02983045|Mitosis Modulators|mitosis modulators|mesh-ancestor
25246404|NCT02983045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246405|NCT02983045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24591458|NCT00916760|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25246406|NCT02983045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25246407|NCT02983045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25246408|NCT02983045|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24569364|NCT00800306|Autonomic Agents|autonomic agents|mesh-ancestor
25246429|NCT02939989|Sofosbuvir|sofosbuvir|mesh-list
25246430|NCT02939989|Antimetabolites|antimetabolites|mesh-ancestor
25246431|NCT02939989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246432|NCT02939989|Antiviral Agents|antiviral agents|mesh-ancestor
25246433|NCT02939989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25246434|NCT02919969|Pembrolizumab|pembrolizumab|mesh-list
25246435|NCT02919969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25246436|NCT02919969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246437|NCT02917564|Triamcinolone|triamcinolone|mesh-list
25246438|NCT02917564|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25246439|NCT02917564|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24591488|NCT00916942|Sensory System Agents|sensory system agents|mesh-ancestor
24591489|NCT00916942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24591490|NCT00916942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24591491|NCT00916942|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24591492|NCT00916942|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24591494|NCT00916942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591495|NCT00916942|Antipruritics|antipruritics|mesh-ancestor
24591496|NCT00916942|Dermatologic Agents|dermatologic agents|mesh-ancestor
24591497|NCT00917059|Citalopram|citalopram|mesh-list
24591498|NCT00917059|Bupropion|bupropion|mesh-list
24591499|NCT00917059|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24591500|NCT00917059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24591501|NCT00917059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25131005|NCT03029455|VX-659|vx-659|mesh-list
24591502|NCT00917059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591521|NCT00917163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25073385|NCT03395171|Vitamin D|vitamin d|mesh-list
24569313|NCT00800215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24569314|NCT00800215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24569315|NCT00800215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24569316|NCT00800215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569318|NCT00800267|Latanoprost|latanoprost|mesh-list
24569319|NCT00800267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24569320|NCT00800267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24569321|NCT00800267|Adrenergic Agents|adrenergic agents|mesh-ancestor
24569322|NCT00800267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24569323|NCT00800267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569324|NCT00800267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569325|NCT00800267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24569326|NCT00800267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24569327|NCT00800267|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24569328|NCT00800267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24569329|NCT00800280|Cimetidine|cimetidine|mesh-list
24569330|NCT00800280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24569331|NCT00800280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24569332|NCT00800280|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24569333|NCT00800280|Histamine Antagonists|histamine antagonists|mesh-ancestor
24569334|NCT00800280|Histamine Agents|histamine agents|mesh-ancestor
24569335|NCT00800280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24569336|NCT00800280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569337|NCT00800280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569338|NCT00800280|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24889301|NCT04494529|Glucocorticoids|glucocorticoids|mesh-ancestor
24569363|NCT00800306|Sympathomimetics|sympathomimetics|mesh-ancestor
24569365|NCT00800306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24569366|NCT00800306|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24569367|NCT00800306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24569368|NCT00800306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24569369|NCT00800306|Adrenergic Agents|adrenergic agents|mesh-ancestor
24569370|NCT00800306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24569371|NCT00800319|ALKS-33|alks-33|mesh-list
24569372|NCT00800319|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24569373|NCT00800319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569374|NCT00800319|Sensory System Agents|sensory system agents|mesh-ancestor
24569375|NCT00800319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24569376|NCT00800358|Calcitriol|calcitriol|mesh-list
25246440|NCT02917564|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25246441|NCT02917564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25246442|NCT02917564|Glucocorticoids|glucocorticoids|mesh-ancestor
25246443|NCT02917564|Hormones|hormones|mesh-ancestor
25246444|NCT02917564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25246445|NCT02917564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246446|NCT02917564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25246447|NCT02917564|Immunologic Factors|immunologic factors|mesh-ancestor
25246448|NCT02917564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25246449|NCT02917564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246450|NCT02903680|Dexamethasone|dexamethasone|mesh-list
25246451|NCT02903680|Dexamethasone acetate|dexamethasone acetate|mesh-list
25246452|NCT02903680|BB 1101|bb 1101|mesh-list
25246453|NCT02903680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25246454|NCT02903680|Antiemetics|antiemetics|mesh-ancestor
25246455|NCT02903680|Autonomic Agents|autonomic agents|mesh-ancestor
25246456|NCT02903680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24591522|NCT00917163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24591523|NCT00917163|Antifungal Agents|antifungal agents|mesh-ancestor
24591526|NCT00917241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24591527|NCT00917241|Antiemetics|antiemetics|mesh-ancestor
24591528|NCT00917241|Autonomic Agents|autonomic agents|mesh-ancestor
24591529|NCT00917241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24591530|NCT00917241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591531|NCT00917241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24569377|NCT00800358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24569378|NCT00800358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569379|NCT00800358|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24569380|NCT00800358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24569381|NCT00800358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569382|NCT00800358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24569395|NCT00800423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24569396|NCT00800423|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24569397|NCT00800423|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24791907|NCT02553460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24791909|NCT02553460|Dermatologic Agents|dermatologic agents|mesh-ancestor
24791910|NCT02553460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24791911|NCT02553460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24791912|NCT02553460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25008983|NCT03734029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008984|NCT03734029|Tubulin Modulators|tubulin modulators|mesh-ancestor
25008985|NCT03734029|Antimitotic Agents|antimitotic agents|mesh-ancestor
25008986|NCT03734029|Mitosis Modulators|mitosis modulators|mesh-ancestor
24791923|NCT02553460|Tubulin Modulators|tubulin modulators|mesh-ancestor
24791924|NCT02553460|Antimitotic Agents|antimitotic agents|mesh-ancestor
24791925|NCT02553460|Mitosis Modulators|mitosis modulators|mesh-ancestor
24791926|NCT02553460|Analgesics|analgesics|mesh-ancestor
24791927|NCT02553460|Sensory System Agents|sensory system agents|mesh-ancestor
25009007|NCT03716609|Cathartics|cathartics|mesh-ancestor
25009008|NCT03716609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25009009|NCT03709355|Clarithromycin|clarithromycin|mesh-list
25009010|NCT03709355|Rifampin|rifampin|mesh-list
25009011|NCT03709355|Rifabutin|rifabutin|mesh-list
25009012|NCT03709355|Elsulfavirine|elsulfavirine|mesh-list
25009013|NCT03709355|Omeprazole|omeprazole|mesh-list
25009014|NCT03709355|Atorvastatin|atorvastatin|mesh-list
25009015|NCT03709355|Levonorgestrel|levonorgestrel|mesh-list
25009016|NCT03709355|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25009017|NCT03709355|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25009018|NCT03709355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25009019|NCT03709355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25009020|NCT03709355|Antimetabolites|antimetabolites|mesh-ancestor
25009021|NCT03709355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009022|NCT03709355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25009023|NCT03709355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25009024|NCT03709355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25009025|NCT03709355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24569399|NCT00800462|Bromides|bromides|mesh-list
24569430|NCT00800527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24569431|NCT00800527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24569432|NCT00800527|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24569433|NCT00800527|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24569434|NCT00800527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24569435|NCT00800527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569436|NCT00800527|Antimanic Agents|antimanic agents|mesh-ancestor
24569437|NCT00800527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24569438|NCT00800527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25246457|NCT02903680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246458|NCT02903680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25246459|NCT02903680|Glucocorticoids|glucocorticoids|mesh-ancestor
25246460|NCT02903680|Hormones|hormones|mesh-ancestor
25246461|NCT02903680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25246462|NCT02903680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25246463|NCT02903680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246464|NCT02903680|Protease Inhibitors|protease inhibitors|mesh-ancestor
24591532|NCT00917241|Glucocorticoids|glucocorticoids|mesh-ancestor
24591533|NCT00917241|Hormones|hormones|mesh-ancestor
24852570|NCT02262858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852571|NCT02262858|Diuretics|diuretics|mesh-ancestor
24852572|NCT02262858|Natriuretic Agents|natriuretic agents|mesh-ancestor
24852573|NCT02262858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852574|NCT02262858|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24852575|NCT02262858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24569439|NCT00800527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24569440|NCT00800527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24569441|NCT00800527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24569442|NCT00800527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24569443|NCT00800553|Donepezil|donepezil|mesh-list
24569444|NCT00800553|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24569446|NCT00800553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569447|NCT00800553|Cholinergic Agents|cholinergic agents|mesh-ancestor
24569448|NCT00800553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24569449|NCT00800553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569450|NCT00800553|Nootropic Agents|nootropic agents|mesh-ancestor
24569451|NCT00800566|Clofarabine|clofarabine|mesh-list
24569452|NCT00800566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24569453|NCT00800566|Antimetabolites|antimetabolites|mesh-ancestor
24569454|NCT00800566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569455|NCT00800566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24569483|NCT00800748|Antimetabolites|antimetabolites|mesh-ancestor
24569488|NCT00800761|Deferoxamine|deferoxamine|mesh-list
24569489|NCT00800761|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24671051|NCT01323374|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24569490|NCT00800761|Chelating Agents|chelating agents|mesh-ancestor
24569491|NCT00800761|Sequestering Agents|sequestering agents|mesh-ancestor
24569492|NCT00800761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569493|NCT00800761|Siderophores|siderophores|mesh-ancestor
24569494|NCT00800787|Immunoglobulins|immunoglobulins|mesh-list
24569495|NCT00800787|Immunologic Factors|immunologic factors|mesh-ancestor
24569496|NCT00800787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569497|NCT00800800|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24569498|NCT00800800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24569499|NCT00800800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24569500|NCT00800800|Antimetabolites|antimetabolites|mesh-ancestor
24569501|NCT00800800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569502|NCT00800800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24569503|NCT00800800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24569504|NCT00800800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24569505|NCT00800826|Dexmedetomidine|dexmedetomidine|mesh-list
24569506|NCT00800826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24569507|NCT00800826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24569508|NCT00800826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569549|NCT00801047|Anesthetics|anesthetics|mesh-ancestor
24569550|NCT00801047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24569551|NCT00801047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569552|NCT00801047|Sensory System Agents|sensory system agents|mesh-ancestor
24569553|NCT00801047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24569554|NCT00801047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24569555|NCT00801047|Narcotics|narcotics|mesh-ancestor
24569556|NCT00801047|Analgesics|analgesics|mesh-ancestor
24569558|NCT00801086|Tempol|tempol|mesh-list
24569559|NCT00801086|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24569560|NCT00801086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24569561|NCT00801086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24569562|NCT00801086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569563|NCT00801086|Antioxidants|antioxidants|mesh-ancestor
24569564|NCT00801086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246465|NCT02903680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25246466|NCT02903680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246467|NCT02877134|Ustekinumab|ustekinumab|mesh-list
25246468|NCT02877134|Dermatologic Agents|dermatologic agents|mesh-ancestor
25246469|NCT02811263|Epoetin Alfa|epoetin alfa|mesh-list
25246470|NCT02811263|Hematinics|hematinics|mesh-ancestor
24852576|NCT02262897|Paclitaxel|paclitaxel|mesh-list
24591534|NCT00917241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24591543|NCT00917254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591544|NCT00917345|Captopril|captopril|mesh-list
24591545|NCT00917345|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24591546|NCT00917345|Protease Inhibitors|protease inhibitors|mesh-ancestor
24591547|NCT00917345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591563|NCT00917397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24591565|NCT00917397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591566|NCT00917397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24591567|NCT00917397|Serotonin Agents|serotonin agents|mesh-ancestor
24591568|NCT00917397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591569|NCT00917527|Atorvastatin|atorvastatin|mesh-list
24591570|NCT00917527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24591571|NCT00917527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24591572|NCT00917527|Antimetabolites|antimetabolites|mesh-ancestor
24569565|NCT00801086|Protective Agents|protective agents|mesh-ancestor
25686698|NCT01923129|Adrenergic Agents|adrenergic agents|mesh-ancestor
24569583|NCT00801177|Necitumumab|necitumumab|mesh-list
24569584|NCT00801177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24569585|NCT00801177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24569586|NCT00801177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24569587|NCT00801177|Immunologic Factors|immunologic factors|mesh-ancestor
24569588|NCT00801177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967510|NCT03759093|Antiemetics|antiemetics|mesh-ancestor
24569590|NCT00801255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24569591|NCT00801255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24569592|NCT00801268|Emodin|emodin|mesh-list
24791964|NCT02138617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24791965|NCT02138617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24791966|NCT02138617|Antidotes|antidotes|mesh-ancestor
24791967|NCT02138617|Protective Agents|protective agents|mesh-ancestor
24791968|NCT02138617|Vitamin B Complex|vitamin b complex|mesh-ancestor
24791970|NCT02138617|Micronutrients|micronutrients|mesh-ancestor
24791971|NCT02053363|Tranexamic Acid|tranexamic acid|mesh-list
24889455|NCT04493463|Hormones|hormones|mesh-ancestor
25009034|NCT03709355|Contraceptive Agents|contraceptive agents|mesh-ancestor
25009035|NCT03709355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25009036|NCT03709355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009037|NCT03709355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25009038|NCT03709355|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25009051|NCT03709355|Estrogens|estrogens|mesh-ancestor
25009058|NCT03700658|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25009059|NCT03700658|Medroxyprogesterone|medroxyprogesterone|mesh-list
25246488|NCT02732288|Protective Agents|protective agents|mesh-ancestor
25246489|NCT02732288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246490|NCT02732288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24591573|NCT00917527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591574|NCT00917527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24591575|NCT00917527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24591576|NCT00917527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591577|NCT00917592|Amoxicillin|amoxicillin|mesh-list
24591578|NCT00917592|Clavulanic Acids|clavulanic acids|mesh-list
24591579|NCT00917592|Clavulanic Acid|clavulanic acid|mesh-list
24591580|NCT00917592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24591581|NCT00917592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24591582|NCT00917592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591583|NCT00917592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591584|NCT00917592|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24591585|NCT00917748|Docetaxel|docetaxel|mesh-list
24591586|NCT00917748|Modafinil|modafinil|mesh-list
24569637|NCT00801385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24569638|NCT00801385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569640|NCT00801411|Docetaxel|docetaxel|mesh-list
24569641|NCT00801411|Doxorubicin|doxorubicin|mesh-list
24569642|NCT00801411|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24569643|NCT00801411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24569644|NCT00801411|Immunologic Factors|immunologic factors|mesh-ancestor
24569645|NCT00801411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569646|NCT00801411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24569647|NCT00801411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24569648|NCT00801411|Alkylating Agents|alkylating agents|mesh-ancestor
24569649|NCT00801411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569650|NCT00801411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24569651|NCT00801411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24569652|NCT00801411|Tubulin Modulators|tubulin modulators|mesh-ancestor
24569653|NCT00801411|Antimitotic Agents|antimitotic agents|mesh-ancestor
24569654|NCT00801411|Mitosis Modulators|mitosis modulators|mesh-ancestor
24569655|NCT00801411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24569656|NCT00801411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24569657|NCT00801411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24569658|NCT00801411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24569659|NCT00801450|Triamcinolone|triamcinolone|mesh-list
24569660|NCT00801450|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24569661|NCT00801450|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25009080|NCT03669133|Protective Agents|protective agents|mesh-ancestor
24569705|NCT00801528|Ropivacaine|ropivacaine|mesh-list
24569706|NCT00801528|Anesthetics, Local|anesthetics, local|mesh-ancestor
24569708|NCT00801528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24569709|NCT00801528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246491|NCT02726581|Dexamethasone|dexamethasone|mesh-list
25246492|NCT02726581|Nivolumab|nivolumab|mesh-list
25246493|NCT02726581|Pomalidomide|pomalidomide|mesh-list
25246494|NCT02726581|Elotuzumab|elotuzumab|mesh-list
25246495|NCT02726581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25246496|NCT02726581|Antiemetics|antiemetics|mesh-ancestor
25246497|NCT02726581|Autonomic Agents|autonomic agents|mesh-ancestor
25246498|NCT02726581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25246499|NCT02726581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246500|NCT02726581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25246501|NCT02726581|Glucocorticoids|glucocorticoids|mesh-ancestor
25246502|NCT02726581|Hormones|hormones|mesh-ancestor
25246503|NCT02726581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25246504|NCT02726581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25246505|NCT02726581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591587|NCT00917748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591588|NCT00917748|Tubulin Modulators|tubulin modulators|mesh-ancestor
24591589|NCT00917748|Antimitotic Agents|antimitotic agents|mesh-ancestor
24591590|NCT00917748|Mitosis Modulators|mitosis modulators|mesh-ancestor
24591591|NCT00917748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591592|NCT00917748|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24591593|NCT00917748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591594|NCT00917748|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24591595|NCT00917748|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24591596|NCT00917748|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24591597|NCT00917761|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24591598|NCT00917761|Interferon-alpha|interferon-alpha|mesh-list
24591622|NCT00917891|Antiviral Agents|antiviral agents|mesh-ancestor
24591623|NCT00917891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24591624|NCT00917904|Dapivirine|dapivirine|mesh-list
24591625|NCT00917904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24591626|NCT00917904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24591627|NCT00917904|Antiviral Agents|antiviral agents|mesh-ancestor
24591628|NCT00917904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24569710|NCT00801528|Sensory System Agents|sensory system agents|mesh-ancestor
24569711|NCT00801528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24569712|NCT00801528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24569714|NCT00801528|Analgesics|analgesics|mesh-ancestor
24569715|NCT00801528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24569716|NCT00801528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24569717|NCT00801528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24569718|NCT00801528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24569719|NCT00801528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569720|NCT00801580|Doxorubicin|doxorubicin|mesh-list
24569721|NCT00801580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24569722|NCT00801580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24569723|NCT00801580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24569724|NCT00801580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24569725|NCT00801580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24569730|NCT00801606|Micronutrients|micronutrients|mesh-list
24569731|NCT00801606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569732|NCT00801697|Vaccines|vaccines|mesh-list
24569733|NCT00801697|Immunologic Factors|immunologic factors|mesh-ancestor
24569734|NCT00801697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569735|NCT00801736|Paclitaxel|paclitaxel|mesh-list
24569736|NCT00801736|Cisplatin|cisplatin|mesh-list
24495603|NCT00501254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24569737|NCT00801736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24569738|NCT00801736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24569739|NCT00801736|Tubulin Modulators|tubulin modulators|mesh-ancestor
24569740|NCT00801736|Antimitotic Agents|antimitotic agents|mesh-ancestor
24569741|NCT00801736|Mitosis Modulators|mitosis modulators|mesh-ancestor
24569742|NCT00801736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569743|NCT00801788|Oxycodone|oxycodone|mesh-list
24569744|NCT00801788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24569745|NCT00801788|Narcotics|narcotics|mesh-ancestor
24569746|NCT00801788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24569747|NCT00801788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246512|NCT02726581|Growth Substances|growth substances|mesh-ancestor
25246513|NCT02726581|Growth Inhibitors|growth inhibitors|mesh-ancestor
25246518|NCT02672098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24852577|NCT02262897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24852578|NCT02262897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24852579|NCT02262897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591638|NCT00918021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24591657|NCT00918086|Vitamin D|vitamin d|mesh-list
24591658|NCT00918086|Vitamins|vitamins|mesh-ancestor
24569750|NCT00801788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24569751|NCT00801853|Interleukin-4|interleukin-4|mesh-list
24569757|NCT00801866|Bevacizumab|bevacizumab|mesh-list
24569832|NCT00802009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24569833|NCT00802009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569834|NCT00802009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24569835|NCT00802009|Glucocorticoids|glucocorticoids|mesh-ancestor
24569836|NCT00802009|Hormones|hormones|mesh-ancestor
24569837|NCT00802009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24569838|NCT00802009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24569839|NCT00802009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24569840|NCT00802009|Anesthetics, Local|anesthetics, local|mesh-ancestor
24569841|NCT00802009|Anesthetics|anesthetics|mesh-ancestor
24569842|NCT00802009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24569843|NCT00802009|Sensory System Agents|sensory system agents|mesh-ancestor
24569844|NCT00802035|Baclofen|baclofen|mesh-list
24569845|NCT00802035|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24569846|NCT00802035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569847|NCT00802035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24569848|NCT00802035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24569849|NCT00802035|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24569850|NCT00802035|GABA Agonists|gaba agonists|mesh-ancestor
24569851|NCT00802035|GABA Agents|gaba agents|mesh-ancestor
24569852|NCT00802035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24559328|NCT05022927|Bevacizumab|bevacizumab|mesh-list
24569853|NCT00802035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569854|NCT00802048|Ropivacaine|ropivacaine|mesh-list
24569855|NCT00802048|Anesthetics, Local|anesthetics, local|mesh-list
24569856|NCT00802048|Anesthetics|anesthetics|mesh-list
24569857|NCT00802048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24569858|NCT00802048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591659|NCT00918086|Micronutrients|micronutrients|mesh-ancestor
24591660|NCT00918086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591661|NCT00918086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24591662|NCT00918177|Levodopa|levodopa|mesh-list
24591663|NCT00918177|Carbidopa|carbidopa|mesh-list
24591682|NCT00918190|Antiemetics|antiemetics|mesh-ancestor
24591683|NCT00918190|Autonomic Agents|autonomic agents|mesh-ancestor
24591684|NCT00918190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24591685|NCT00918190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591686|NCT00918190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24591687|NCT00918190|Glucocorticoids|glucocorticoids|mesh-ancestor
24591688|NCT00918190|Hormones|hormones|mesh-ancestor
24591689|NCT00918190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24967810|NCT03756298|Antimetabolites|antimetabolites|mesh-ancestor
24591690|NCT00918190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24591691|NCT00918190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591692|NCT00918190|Protease Inhibitors|protease inhibitors|mesh-ancestor
24591693|NCT00918190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591694|NCT00918190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591695|NCT00918190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24591696|NCT00918190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24591697|NCT00918190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24591698|NCT00918190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24591699|NCT00918190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24569886|NCT00802230|Terbutaline|terbutaline|mesh-list
24569887|NCT00802230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24569888|NCT00802230|Autonomic Agents|autonomic agents|mesh-ancestor
24569889|NCT00802230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24569890|NCT00802230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569891|NCT00802230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24569892|NCT00802230|Respiratory System Agents|respiratory system agents|mesh-ancestor
24569893|NCT00802230|Sympathomimetics|sympathomimetics|mesh-ancestor
24569894|NCT00802230|Tocolytic Agents|tocolytic agents|mesh-ancestor
24569895|NCT00802230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24569896|NCT00802230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24569897|NCT00802230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24569898|NCT00802230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24548790|NCT00712062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24548791|NCT00712062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24569899|NCT00802230|Adrenergic Agents|adrenergic agents|mesh-ancestor
24569900|NCT00802230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25246541|NCT02594384|Rituximab|rituximab|mesh-list
25246542|NCT02594384|Atezolizumab|atezolizumab|mesh-list
25246543|NCT02594384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25246544|NCT02594384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246545|NCT02594384|Immunologic Factors|immunologic factors|mesh-ancestor
25246546|NCT02594384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246550|NCT02557945|Sensory System Agents|sensory system agents|mesh-ancestor
25246551|NCT02557945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25246552|NCT02557945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246553|NCT02557945|Anticonvulsants|anticonvulsants|mesh-ancestor
25246554|NCT02557945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25246555|NCT02557945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25246556|NCT02557945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25246557|NCT02557945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25246558|NCT02557945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25246559|NCT02557945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25246560|NCT02557945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25246561|NCT02557945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246562|NCT02557945|Antimanic Agents|antimanic agents|mesh-ancestor
25246563|NCT02525757|Paclitaxel|paclitaxel|mesh-list
24591700|NCT00918190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24591701|NCT00918190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24591702|NCT00918190|Anesthetics, General|anesthetics, general|mesh-ancestor
24591703|NCT00918190|Anesthetics|anesthetics|mesh-ancestor
24591704|NCT00918190|GABA Modulators|gaba modulators|mesh-ancestor
24591705|NCT00918190|GABA Agents|gaba agents|mesh-ancestor
24591706|NCT00918190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24591707|NCT00918190|Antipruritics|antipruritics|mesh-ancestor
24591708|NCT00918190|Dermatologic Agents|dermatologic agents|mesh-ancestor
24591709|NCT00918190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24591710|NCT00918190|Serotonin Agents|serotonin agents|mesh-ancestor
24591711|NCT00918190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24591712|NCT00918307|Varenicline|varenicline|mesh-list
24852586|NCT02262936|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24852587|NCT02262936|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24852588|NCT02262936|Cholinergic Agents|cholinergic agents|mesh-ancestor
24852589|NCT02262936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24852590|NCT02262936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852591|NCT02262936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852592|NCT02262936|Urological Agents|urological agents|mesh-ancestor
24852593|NCT02262936|Hemostatics|hemostatics|mesh-ancestor
24852594|NCT02262936|Coagulants|coagulants|mesh-ancestor
24852595|NCT02262936|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24852596|NCT02262936|Natriuretic Agents|natriuretic agents|mesh-ancestor
24852597|NCT02263027|Vaccines|vaccines|mesh-list
24852598|NCT02263027|Immunologic Factors|immunologic factors|mesh-ancestor
24792037|NCT05413096|Propolis|propolis|mesh-list
24792038|NCT05413096|Diclofenac|diclofenac|mesh-list
24792039|NCT05413096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24792040|NCT05413096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24792041|NCT05413096|Analgesics|analgesics|mesh-ancestor
25009082|NCT03637491|Talazoparib|talazoparib|mesh-list
25009083|NCT03637491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25009084|NCT03637491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009085|NCT03637491|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25009086|NCT03637491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25009108|NCT03498391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009109|NCT03477162|Metformin|metformin|mesh-list
25009110|NCT03477162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25009111|NCT03477162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009112|NCT03461952|Nivolumab|nivolumab|mesh-list
25009113|NCT03461952|Ipilimumab|ipilimumab|mesh-list
24570423|NCT00804856|Immunologic Factors|immunologic factors|mesh-ancestor
25686699|NCT01923129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25686700|NCT01923129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686701|NCT01923129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686702|NCT01923311|Elvitegravir|elvitegravir|mesh-list
25246568|NCT02525757|Tubulin Modulators|tubulin modulators|mesh-ancestor
25246569|NCT02525757|Antimitotic Agents|antimitotic agents|mesh-ancestor
25246570|NCT02525757|Mitosis Modulators|mitosis modulators|mesh-ancestor
25246571|NCT02525757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246574|NCT02524249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246575|NCT02524249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25246576|NCT02524249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25246577|NCT02524249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246578|NCT02524249|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25246579|NCT02524249|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25246580|NCT02524249|Purinergic Agents|purinergic agents|mesh-ancestor
25246581|NCT02524249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25246583|NCT02501954|Carboplatin|carboplatin|mesh-list
25246584|NCT02501954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25246585|NCT02501954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246586|NCT02501954|Tubulin Modulators|tubulin modulators|mesh-ancestor
25246587|NCT02501954|Antimitotic Agents|antimitotic agents|mesh-ancestor
24591806|NCT00919178|Immunologic Factors|immunologic factors|mesh-ancestor
24591807|NCT00919178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591809|NCT00919204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591810|NCT00919204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25009122|NCT03420508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24559471|NCT04767061|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24559472|NCT04767061|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24559473|NCT04767061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24559474|NCT04767061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24559475|NCT04767061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24559476|NCT04767061|Sympathomimetics|sympathomimetics|mesh-ancestor
24569924|NCT00802321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569925|NCT00802321|Hormone Antagonists|hormone antagonists|mesh-ancestor
24569926|NCT00802321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24569927|NCT00802321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569928|NCT00802334|Ritonavir|ritonavir|mesh-list
24569929|NCT00802334|Lopinavir|lopinavir|mesh-list
24569930|NCT00802334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24569931|NCT00802334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24569932|NCT00802334|Protease Inhibitors|protease inhibitors|mesh-ancestor
24569933|NCT00802334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24569934|NCT00802334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569935|NCT00802334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24569936|NCT00802334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24569937|NCT00802334|Antiviral Agents|antiviral agents|mesh-ancestor
24569938|NCT00802334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24569939|NCT00802334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24569940|NCT00802334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24569941|NCT00802373|Solifenacin Succinate|solifenacin succinate|mesh-list
24569942|NCT00802373|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24569943|NCT00802373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24569944|NCT00802373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24671053|NCT01323374|Dopamine Agents|dopamine agents|mesh-ancestor
24569945|NCT00802373|Cholinergic Agents|cholinergic agents|mesh-ancestor
24569946|NCT00802373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24569947|NCT00802373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569948|NCT00802373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569953|NCT00802451|Analgesics|analgesics|mesh-ancestor
24569998|NCT00802646|Anesthetics, General|anesthetics, general|mesh-ancestor
24569999|NCT00802646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24570015|NCT00802802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24570017|NCT00802802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967940|NCT03755700|Vitamin E|vitamin e|mesh-list
24570018|NCT00802802|Antiviral Agents|antiviral agents|mesh-ancestor
24671054|NCT01323374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25246588|NCT02501954|Mitosis Modulators|mitosis modulators|mesh-ancestor
25246589|NCT02501954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246590|NCT02488967|Paclitaxel|paclitaxel|mesh-list
25246591|NCT02488967|Cyclophosphamide|cyclophosphamide|mesh-list
25246592|NCT02488967|Carboplatin|carboplatin|mesh-list
25246593|NCT02488967|Doxorubicin|doxorubicin|mesh-list
25686703|NCT01923311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25686704|NCT01923311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25686705|NCT01923311|Antiviral Agents|antiviral agents|mesh-ancestor
25686706|NCT01923311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24548987|NCT00712764|Purinergic Agonists|purinergic agonists|mesh-ancestor
24548988|NCT00712764|Purinergic Agents|purinergic agents|mesh-ancestor
25246594|NCT02488967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24591812|NCT00919204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591814|NCT00919243|Allopurinol|allopurinol|mesh-list
24591815|NCT00919243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24591826|NCT00919243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24591827|NCT00919243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24591828|NCT00919243|Antioxidants|antioxidants|mesh-ancestor
24591829|NCT00919243|Protective Agents|protective agents|mesh-ancestor
24591832|NCT00919282|Gemcitabine|gemcitabine|mesh-list
24591833|NCT00919282|Levoleucovorin|levoleucovorin|mesh-list
24591834|NCT00919282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24591835|NCT00919282|Antimetabolites|antimetabolites|mesh-ancestor
24591836|NCT00919282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25155359|NCT05408312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591837|NCT00919282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591838|NCT00919282|Antiviral Agents|antiviral agents|mesh-ancestor
24591839|NCT00919282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24591840|NCT00919282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591841|NCT00919282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24852599|NCT02263027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852600|NCT02263066|Factor VIII|factor viii|mesh-list
24852601|NCT02263066|Coagulants|coagulants|mesh-ancestor
24852602|NCT02263105|Temozolomide|temozolomide|mesh-list
24852603|NCT02263105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24852604|NCT02263105|Alkylating Agents|alkylating agents|mesh-ancestor
24852605|NCT02263105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852606|NCT02263105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24852607|NCT02263170|Phenobarbital|phenobarbital|mesh-list
24852608|NCT02263170|Anticonvulsants|anticonvulsants|mesh-ancestor
24852609|NCT02263170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24852610|NCT02263170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24591842|NCT00919282|Immunologic Factors|immunologic factors|mesh-ancestor
25073511|NCT03394573|Aflibercept|aflibercept|mesh-list
24570019|NCT00802802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24570020|NCT00802802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24570021|NCT00802802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24570022|NCT00802802|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24570023|NCT00802802|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24570024|NCT00802802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24570025|NCT00802802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25246595|NCT02488967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25246596|NCT02488967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25246597|NCT02488967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246598|NCT02488967|Tubulin Modulators|tubulin modulators|mesh-ancestor
25246599|NCT02488967|Antimitotic Agents|antimitotic agents|mesh-ancestor
25246600|NCT02488967|Mitosis Modulators|mitosis modulators|mesh-ancestor
25246601|NCT02488967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246602|NCT02488967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25246603|NCT02488967|Immunologic Factors|immunologic factors|mesh-ancestor
25246604|NCT02488967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246605|NCT02488967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25246606|NCT02488967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25246607|NCT02488967|Alkylating Agents|alkylating agents|mesh-ancestor
25246608|NCT02488967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25246610|NCT02488967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25246611|NCT02488967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25246612|NCT02488967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25246613|NCT02451982|Cyclophosphamide|cyclophosphamide|mesh-list
25246614|NCT02451982|Nivolumab|nivolumab|mesh-list
25246615|NCT02451982|Immunologic Factors|immunologic factors|mesh-ancestor
25246616|NCT02451982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246617|NCT02451982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25246618|NCT02451982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25246619|NCT02451982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25246620|NCT02451982|Alkylating Agents|alkylating agents|mesh-ancestor
25246621|NCT02451982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246622|NCT02451982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246623|NCT02451982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25246624|NCT02451982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25686707|NCT01923311|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25686708|NCT01923311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25246625|NCT02451982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24591843|NCT00919282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591844|NCT00919282|Antidotes|antidotes|mesh-ancestor
24591911|NCT00919542|Antifungal Agents|antifungal agents|mesh-ancestor
24591912|NCT00919542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24591913|NCT00919542|Dermatologic Agents|dermatologic agents|mesh-ancestor
24591914|NCT00919542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24591915|NCT00919542|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24591944|NCT00919776|Antifungal Agents|antifungal agents|mesh-ancestor
24591945|NCT00919776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24591946|NCT00919776|Dermatologic Agents|dermatologic agents|mesh-ancestor
24592029|NCT00920088|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24592032|NCT00920088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24592033|NCT00920088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24592034|NCT00920088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24592035|NCT00920088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24592036|NCT00920088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25073539|NCT03394430|Anesthetics|anesthetics|mesh-ancestor
24570026|NCT00802802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24570027|NCT00802802|Antitubercular Agents|antitubercular agents|mesh-ancestor
24570028|NCT00802802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24570029|NCT00802802|Leprostatic Agents|leprostatic agents|mesh-ancestor
24570030|NCT00802802|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24570031|NCT00802802|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24570032|NCT00802802|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24570033|NCT00802815|Etanercept|etanercept|mesh-list
24570035|NCT00802815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24570036|NCT00802815|Analgesics|analgesics|mesh-ancestor
24570088|NCT00803218|Xhance|xhance|mesh-list
24570089|NCT00803218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24570090|NCT00803218|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24570091|NCT00803218|Autonomic Agents|autonomic agents|mesh-ancestor
24570092|NCT00803218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24570093|NCT00803218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570094|NCT00803218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24570095|NCT00803218|Respiratory System Agents|respiratory system agents|mesh-ancestor
24570096|NCT00803218|Dermatologic Agents|dermatologic agents|mesh-ancestor
24570097|NCT00803218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24570098|NCT00803309|Interferons|interferons|mesh-list
24570099|NCT00803309|Ribavirin|ribavirin|mesh-list
24570100|NCT00803309|Interferon-alpha|interferon-alpha|mesh-list
25082768|NCT03320187|Nitroglycerin|nitroglycerin|mesh-list
24570122|NCT00803374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570123|NCT00803387|Travoprost|travoprost|mesh-list
24570124|NCT00803387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24570142|NCT00803530|Ascorbic Acid|ascorbic acid|mesh-list
24570143|NCT00803530|Antioxidants|antioxidants|mesh-ancestor
24570144|NCT00803530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570145|NCT00803530|Protective Agents|protective agents|mesh-ancestor
24570146|NCT00803530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570147|NCT00803530|Vitamins|vitamins|mesh-ancestor
24570148|NCT00803530|Micronutrients|micronutrients|mesh-ancestor
24570149|NCT00803556|Paclitaxel|paclitaxel|mesh-list
24570150|NCT00803556|Trastuzumab|trastuzumab|mesh-list
24570151|NCT00803556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24570152|NCT00803556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570177|NCT00803725|Anesthetics|anesthetics|mesh-ancestor
24570178|NCT00803725|Anesthetics, Local|anesthetics, local|mesh-ancestor
24570179|NCT00803764|Naproxen|naproxen|mesh-list
24570180|NCT00803764|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24570181|NCT00803764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25246626|NCT02445131|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25246627|NCT02445131|Obinutuzumab|obinutuzumab|mesh-list
25246628|NCT02445131|Idelalisib|idelalisib|mesh-list
25246629|NCT02445131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25246630|NCT02445131|Alkylating Agents|alkylating agents|mesh-ancestor
25246631|NCT02445131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246632|NCT02445131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246633|NCT02445131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25246634|NCT02445131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25246635|NCT02420717|Leucovorin|leucovorin|mesh-list
25246636|NCT02420717|Cytarabine|cytarabine|mesh-list
25246637|NCT02420717|Dexamethasone|dexamethasone|mesh-list
25246643|NCT02420717|Doxorubicin|doxorubicin|mesh-list
25246644|NCT02420717|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24592037|NCT00920088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24592038|NCT00920101|Atorvastatin|atorvastatin|mesh-list
24592039|NCT00920101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24592057|NCT00920153|Dacarbazine|dacarbazine|mesh-list
24940113|NCT04003688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592060|NCT00920153|Vindesine|vindesine|mesh-list
24592061|NCT00920153|Mitoguazone|mitoguazone|mesh-list
24592062|NCT00920153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24592063|NCT00920153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24570182|NCT00803764|Analgesics|analgesics|mesh-ancestor
24570183|NCT00803764|Sensory System Agents|sensory system agents|mesh-ancestor
24570184|NCT00803764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24570185|NCT00803764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570186|NCT00803764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24623524|NCT01072058|Adalimumab|adalimumab|mesh-list
24570271|NCT00804115|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24570272|NCT00804115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24570273|NCT00804115|Miotics|miotics|mesh-ancestor
24570274|NCT00804115|Autonomic Agents|autonomic agents|mesh-ancestor
24570275|NCT00804115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24570295|NCT00804271|Memantine|memantine|mesh-list
24570296|NCT00804271|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24570297|NCT00804271|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24570298|NCT00804271|Dopamine Agents|dopamine agents|mesh-ancestor
24570299|NCT00804271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24570300|NCT00804271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570301|NCT00804271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570315|NCT00804336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570316|NCT00804336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24570317|NCT00804336|Immunologic Factors|immunologic factors|mesh-ancestor
24570318|NCT00804336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570319|NCT00804336|Hormones|hormones|mesh-ancestor
24570320|NCT00804336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24570321|NCT00804388|Vitamin E|vitamin e|mesh-list
24570322|NCT00804388|Vitamins|vitamins|mesh-ancestor
24570323|NCT00804388|Micronutrients|micronutrients|mesh-ancestor
24570324|NCT00804388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570325|NCT00804388|Antioxidants|antioxidants|mesh-ancestor
24570341|NCT00804440|Ibuprofen|ibuprofen|mesh-list
24570359|NCT00804531|Prednisolone phosphate|prednisolone phosphate|mesh-list
24570360|NCT00804531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24570361|NCT00804531|Antiemetics|antiemetics|mesh-ancestor
24570362|NCT00804531|Autonomic Agents|autonomic agents|mesh-ancestor
24570363|NCT00804531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24570364|NCT00804531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570365|NCT00804531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24570366|NCT00804531|Glucocorticoids|glucocorticoids|mesh-ancestor
24570367|NCT00804531|Hormones|hormones|mesh-ancestor
24570368|NCT00804531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24570369|NCT00804531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24570370|NCT00804531|Protective Agents|protective agents|mesh-ancestor
24570371|NCT00804531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24570372|NCT00804531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570373|NCT00804622|Tenofovir|tenofovir|mesh-list
24570407|NCT00804830|Growth Substances|growth substances|mesh-ancestor
24570408|NCT00804830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570409|NCT00804830|Growth Inhibitors|growth inhibitors|mesh-ancestor
24570410|NCT00804830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24629370|NCT01104883|Iodine|iodine|mesh-list
24570418|NCT00804856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570419|NCT00804856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570421|NCT00804856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24570422|NCT00804856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25246645|NCT02420717|Methotrexate|methotrexate|mesh-list
25246646|NCT02420717|Vincristine|vincristine|mesh-list
25246647|NCT02420717|Daunorubicin|daunorubicin|mesh-list
25246648|NCT02420717|Dasatinib|dasatinib|mesh-list
25246649|NCT02420717|Mercaptopurine|mercaptopurine|mesh-list
25246650|NCT02420717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25246651|NCT02420717|Antibodies|antibodies|mesh-list
25246652|NCT02420717|Immunoglobulins|immunoglobulins|mesh-list
25246653|NCT02420717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25246654|NCT02420717|BB 1101|bb 1101|mesh-list
24592064|NCT00920153|Antiemetics|antiemetics|mesh-ancestor
24592065|NCT00920153|Autonomic Agents|autonomic agents|mesh-ancestor
25686709|NCT01923311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592066|NCT00920153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24592067|NCT00920153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592068|NCT00920153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24592069|NCT00920153|Glucocorticoids|glucocorticoids|mesh-ancestor
24592070|NCT00920153|Hormones|hormones|mesh-ancestor
25686710|NCT01923363|Tazobactam|tazobactam|mesh-list
24592071|NCT00920153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24852615|NCT02263170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852617|NCT02263170|GABA Agents|gaba agents|mesh-ancestor
24852618|NCT02263170|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24852619|NCT02263170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24852620|NCT02263170|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24570445|NCT00804921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24570446|NCT00804921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24570447|NCT00804921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24570448|NCT00804921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24570449|NCT00804921|Adrenergic Agents|adrenergic agents|mesh-ancestor
24570450|NCT00804921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24570451|NCT00804921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570466|NCT00804947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24570467|NCT00804947|Alkylating Agents|alkylating agents|mesh-ancestor
24570468|NCT00804947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570469|NCT00804947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570470|NCT00804947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24570471|NCT00804947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24570472|NCT00804947|Immunologic Factors|immunologic factors|mesh-ancestor
24570474|NCT00804960|Letrozole|letrozole|mesh-list
24570516|NCT00805090|Antifungal Agents|antifungal agents|mesh-ancestor
24570517|NCT00805090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24570518|NCT00805090|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24570519|NCT00805090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24570520|NCT00805090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24570521|NCT00805090|Hormone Antagonists|hormone antagonists|mesh-ancestor
24570522|NCT00805090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24570546|NCT00805233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24570547|NCT00805298|Methylprednisolone|methylprednisolone|mesh-list
24570548|NCT00805298|Epinephrine|epinephrine|mesh-list
24570549|NCT00805298|Racepinephrine|racepinephrine|mesh-list
24570550|NCT00805298|Epinephryl borate|epinephryl borate|mesh-list
24570551|NCT00805298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24570552|NCT00805298|Antiemetics|antiemetics|mesh-ancestor
24570553|NCT00805298|Autonomic Agents|autonomic agents|mesh-ancestor
24570555|NCT00805298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570556|NCT00805298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24570605|NCT00805311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24570606|NCT00805519|Chloroquine|chloroquine|mesh-list
24570607|NCT00805519|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24570608|NCT00805519|Prednisolone|prednisolone|mesh-list
24570609|NCT00805519|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24570610|NCT00805519|Methylprednisolone|methylprednisolone|mesh-list
24570611|NCT00805519|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24570612|NCT00805519|Prednisolone acetate|prednisolone acetate|mesh-list
24570613|NCT00805519|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24570614|NCT00805519|Prednisolone phosphate|prednisolone phosphate|mesh-list
24570615|NCT00805519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24570616|NCT00805519|Glucocorticoids|glucocorticoids|mesh-ancestor
24570617|NCT00805519|Hormones|hormones|mesh-ancestor
25102627|NCT03167216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570618|NCT00805519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25246655|NCT02420717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25246656|NCT02420717|Immunologic Factors|immunologic factors|mesh-ancestor
25246657|NCT02420717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246658|NCT02420717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25246659|NCT02420717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25246660|NCT02420717|Alkylating Agents|alkylating agents|mesh-ancestor
25246661|NCT02420717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246662|NCT02420717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246663|NCT02420717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25246665|NCT02420717|Antiemetics|antiemetics|mesh-ancestor
25246666|NCT02420717|Autonomic Agents|autonomic agents|mesh-ancestor
25246667|NCT02420717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25246668|NCT02420717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24812363|NCT02051751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812365|NCT02051842|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24592072|NCT00920153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24592073|NCT00920153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24592074|NCT00920153|Antimetabolites|antimetabolites|mesh-ancestor
25686711|NCT01923363|Piperacillin|piperacillin|mesh-list
24447750|NCT00309543|Antimetabolites|antimetabolites|mesh-ancestor
24592075|NCT00920153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592076|NCT00920153|Antiviral Agents|antiviral agents|mesh-ancestor
24592114|NCT00920244|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24592115|NCT00920244|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24592116|NCT00920244|Cholinergic Agents|cholinergic agents|mesh-ancestor
24592117|NCT00920244|Vasodilator Agents|vasodilator agents|mesh-ancestor
24592118|NCT00920244|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24592119|NCT00920244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24592120|NCT00920244|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24592121|NCT00920244|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24592122|NCT00920244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24592123|NCT00920244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592124|NCT00920244|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24592125|NCT00920244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24592126|NCT00920244|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24592127|NCT00920270|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24592140|NCT00920296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24592141|NCT00920296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24570619|NCT00805519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570620|NCT00805519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24570621|NCT00805519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570622|NCT00805519|Antiemetics|antiemetics|mesh-ancestor
24570623|NCT00805519|Autonomic Agents|autonomic agents|mesh-ancestor
24570624|NCT00805519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24570625|NCT00805519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24570626|NCT00805519|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24570628|NCT00805519|Amebicides|amebicides|mesh-ancestor
24570629|NCT00805519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24570630|NCT00805519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24570631|NCT00805519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24570632|NCT00805519|Antimalarials|antimalarials|mesh-ancestor
24570633|NCT00805519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24570736|NCT00806299|Antidiarrheals|antidiarrheals|mesh-list
24570737|NCT00806299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24570738|NCT00806468|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24570739|NCT00806468|Hemostatics|hemostatics|mesh-ancestor
24570740|NCT00806468|Coagulants|coagulants|mesh-ancestor
24570741|NCT00806468|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24570742|NCT00806468|Natriuretic Agents|natriuretic agents|mesh-ancestor
25246669|NCT02420717|Glucocorticoids|glucocorticoids|mesh-ancestor
25246670|NCT02420717|Hormones|hormones|mesh-ancestor
25246671|NCT02420717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25246672|NCT02420717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25246673|NCT02420717|Protease Inhibitors|protease inhibitors|mesh-ancestor
25246674|NCT02420717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25246675|NCT02420717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25246676|NCT02420717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25246677|NCT02420717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25246678|NCT02420717|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25246679|NCT02420717|Abortifacient Agents|abortifacient agents|mesh-ancestor
25246680|NCT02420717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25246681|NCT02420717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25686712|NCT01923363|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25686713|NCT01923363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25686714|NCT01923363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25686715|NCT01923363|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25686716|NCT01923363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25686717|NCT01923363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686718|NCT01923467|Nicotine|nicotine|mesh-list
25686719|NCT01923467|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25686720|NCT01923467|Autonomic Agents|autonomic agents|mesh-ancestor
25246682|NCT02420717|Antimetabolites|antimetabolites|mesh-ancestor
25246683|NCT02420717|Dermatologic Agents|dermatologic agents|mesh-ancestor
24940196|NCT04003181|Bile Acids and Salts|bile acids and salts|mesh-list
25246684|NCT02420717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25246685|NCT02420717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25246686|NCT02420717|Antiviral Agents|antiviral agents|mesh-ancestor
25246687|NCT02420717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25246688|NCT02420717|Antidotes|antidotes|mesh-ancestor
25246689|NCT02420717|Protective Agents|protective agents|mesh-ancestor
25246690|NCT02420717|Vitamin B Complex|vitamin b complex|mesh-ancestor
25246692|NCT02420717|Micronutrients|micronutrients|mesh-ancestor
24592485|NCT00922129|Tacrolimus|tacrolimus|mesh-list
24592143|NCT00920296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24592144|NCT00920296|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24592145|NCT00920296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24592149|NCT00920413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592151|NCT00920413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592152|NCT00920413|Protective Agents|protective agents|mesh-ancestor
24570743|NCT00806468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570745|NCT00806481|Chelating Agents|chelating agents|mesh-ancestor
25102658|NCT03167164|Alkylating Agents|alkylating agents|mesh-ancestor
24570749|NCT00806611|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24570751|NCT00806611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24570752|NCT00806611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570753|NCT00806663|Sunitinib|sunitinib|mesh-list
24570754|NCT00806663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570755|NCT00806663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24570756|NCT00806663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24560004|NCT03802305|Anesthetics|anesthetics|mesh-list
24560005|NCT03802305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24560006|NCT03802305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570767|NCT00806741|Mydriatics|mydriatics|mesh-ancestor
24570861|NCT00806923|Antiviral Agents|antiviral agents|mesh-ancestor
24570862|NCT00806923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24570863|NCT00806923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24570864|NCT00806923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24570865|NCT00806923|Immunologic Factors|immunologic factors|mesh-ancestor
24570866|NCT00806936|Insulin|insulin|mesh-list
24570867|NCT00806936|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24570868|NCT00806936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24570869|NCT00806936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570871|NCT00806962|Immunologic Factors|immunologic factors|mesh-ancestor
24570872|NCT00806962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570873|NCT00807053|Ciclesonide|ciclesonide|mesh-list
24570874|NCT00807053|Glucocorticoids|glucocorticoids|mesh-ancestor
24570875|NCT00807053|Hormones|hormones|mesh-ancestor
24570876|NCT00807053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24570906|NCT00807196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24570907|NCT00807196|Alkylating Agents|alkylating agents|mesh-ancestor
24570908|NCT00807196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570909|NCT00807196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570910|NCT00807196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24570945|NCT00807443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24570954|NCT00807521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24570955|NCT00807521|Antiemetics|antiemetics|mesh-ancestor
24570956|NCT00807521|Autonomic Agents|autonomic agents|mesh-ancestor
24570957|NCT00807521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24570958|NCT00807521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570959|NCT00807521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24570960|NCT00807521|Glucocorticoids|glucocorticoids|mesh-ancestor
24570961|NCT00807521|Hormones|hormones|mesh-ancestor
24570962|NCT00807521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24570963|NCT00807521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24570964|NCT00807521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570965|NCT00807534|Bromides|bromides|mesh-list
24570966|NCT00807534|Ipratropium|ipratropium|mesh-list
24570967|NCT00807534|Anticonvulsants|anticonvulsants|mesh-ancestor
24570968|NCT00807534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24571013|NCT00807807|Folic Acid|folic acid|mesh-list
24571014|NCT00807807|Vitamin B Complex|vitamin b complex|mesh-list
25246696|NCT02420717|Mitosis Modulators|mitosis modulators|mesh-ancestor
25246697|NCT02420717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25246698|NCT02408068|Dexamethasone|dexamethasone|mesh-list
25246699|NCT02408068|Hydrocortisone|hydrocortisone|mesh-list
25246700|NCT02408068|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25246701|NCT02408068|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24940211|NCT04003090|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
25246702|NCT02408068|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25246703|NCT02408068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25246705|NCT02408068|Autonomic Agents|autonomic agents|mesh-ancestor
24592154|NCT00920465|Mifepristone|mifepristone|mesh-list
24592155|NCT00920465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24592156|NCT00920465|Abortifacient Agents|abortifacient agents|mesh-ancestor
24592157|NCT00920465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24592158|NCT00920465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592159|NCT00920465|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24592160|NCT00920465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24592161|NCT00920465|Oxytocics|oxytocics|mesh-ancestor
24592162|NCT00920465|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24571015|NCT00807807|Hematinics|hematinics|mesh-ancestor
24571016|NCT00807807|Vitamins|vitamins|mesh-ancestor
24571017|NCT00807807|Micronutrients|micronutrients|mesh-ancestor
24571018|NCT00807807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571019|NCT00807859|Paclitaxel|paclitaxel|mesh-list
24571020|NCT00807859|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24571021|NCT00807859|Capecitabine|capecitabine|mesh-list
24571022|NCT00807859|Trastuzumab|trastuzumab|mesh-list
24571023|NCT00807859|Lapatinib|lapatinib|mesh-list
24571024|NCT00807859|Trebananib|trebananib|mesh-list
24571025|NCT00807859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24571026|NCT00807859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24571027|NCT00807859|Tubulin Modulators|tubulin modulators|mesh-ancestor
24571028|NCT00807859|Antimitotic Agents|antimitotic agents|mesh-ancestor
24571057|NCT00808002|Emtricitabine|emtricitabine|mesh-list
24571058|NCT00808002|Raltegravir Potassium|raltegravir potassium|mesh-list
24571059|NCT00808002|Maraviroc|maraviroc|mesh-list
24571060|NCT00808002|Antiviral Agents|antiviral agents|mesh-ancestor
24571061|NCT00808002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571062|NCT00808002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24571063|NCT00808002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24571064|NCT00808002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571065|NCT00808002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571066|NCT00808002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24571067|NCT00808002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24571068|NCT00808002|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24571069|NCT00808002|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24571070|NCT00808002|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24571071|NCT00808002|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24571072|NCT00808002|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24571073|NCT00808054|Lidocaine|lidocaine|mesh-list
24571074|NCT00808054|Prilocaine|prilocaine|mesh-list
24571075|NCT00808054|Anesthetics, Local|anesthetics, local|mesh-ancestor
24571076|NCT00808054|Anesthetics|anesthetics|mesh-ancestor
24571077|NCT00808054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24571078|NCT00808054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571089|NCT00808145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24571090|NCT00808145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24571091|NCT00808145|Antimetabolites|antimetabolites|mesh-ancestor
24571092|NCT00808145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571093|NCT00808145|Antiviral Agents|antiviral agents|mesh-ancestor
24571094|NCT00808145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571095|NCT00808145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571096|NCT00808145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24571097|NCT00808145|Immunologic Factors|immunologic factors|mesh-ancestor
24571098|NCT00808145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571099|NCT00808145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24571100|NCT00808171|Lidocaine|lidocaine|mesh-list
24571101|NCT00808171|Nitrous Oxide|nitrous oxide|mesh-list
24571132|NCT00808184|GABA Modulators|gaba modulators|mesh-ancestor
24571133|NCT00808184|GABA Agents|gaba agents|mesh-ancestor
24571134|NCT00808184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24571135|NCT00808184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571136|NCT00808184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24571137|NCT00808184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24571189|NCT00808366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24571191|NCT00808366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24571192|NCT00808366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246706|NCT02408068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686721|NCT01923467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686722|NCT01923467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246707|NCT02408068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246708|NCT02408068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25246709|NCT02408068|Glucocorticoids|glucocorticoids|mesh-ancestor
25246710|NCT02408068|Hormones|hormones|mesh-ancestor
25246711|NCT02408068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25246712|NCT02408068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25246713|NCT02408068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812369|NCT02051868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24812370|NCT02051868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812371|NCT02051868|Tubulin Modulators|tubulin modulators|mesh-ancestor
24812372|NCT02051868|Antimitotic Agents|antimitotic agents|mesh-ancestor
24812373|NCT02051868|Mitosis Modulators|mitosis modulators|mesh-ancestor
24812374|NCT02051868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571194|NCT00808366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24571195|NCT00808366|Dermatologic Agents|dermatologic agents|mesh-ancestor
24571196|NCT00808392|Vaccines|vaccines|mesh-list
24571197|NCT00808392|Immunologic Factors|immunologic factors|mesh-ancestor
24571198|NCT00808392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571199|NCT00808418|Docetaxel|docetaxel|mesh-list
24571200|NCT00808418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24571225|NCT00808743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24571226|NCT00808743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24571228|NCT00808743|Sensory System Agents|sensory system agents|mesh-ancestor
24571229|NCT00808743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24571230|NCT00808743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571231|NCT00808743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24571232|NCT00808743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24571233|NCT00808743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24571234|NCT00808743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24571235|NCT00808743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24560218|NCT03205137|Vasodilator Agents|vasodilator agents|mesh-ancestor
24890044|NCT04486781|Pembrolizumab|pembrolizumab|mesh-list
24571245|NCT00808795|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24571246|NCT00808795|Antioxidants|antioxidants|mesh-ancestor
24571247|NCT00808795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571248|NCT00808795|Protective Agents|protective agents|mesh-ancestor
24571271|NCT00808951|Anthelmintics|anthelmintics|mesh-ancestor
24571273|NCT00808977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24571274|NCT00808977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24571275|NCT00808977|Analgesics|analgesics|mesh-ancestor
24571276|NCT00808977|Sensory System Agents|sensory system agents|mesh-ancestor
24571277|NCT00808977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25246715|NCT02407509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246716|NCT02407509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25246717|NCT02407509|Immunologic Factors|immunologic factors|mesh-ancestor
25246718|NCT02407509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246719|NCT02386826|Bevacizumab|bevacizumab|mesh-list
25246720|NCT02386826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25246721|NCT02386826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246722|NCT02386826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25246723|NCT02386826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25246724|NCT02386826|Growth Substances|growth substances|mesh-ancestor
25246725|NCT02386826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246726|NCT02386826|Growth Inhibitors|growth inhibitors|mesh-ancestor
25274380|NCT02378441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274381|NCT02378441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24592321|NCT00921284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24592322|NCT00921284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592323|NCT00921284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24592324|NCT00921284|Analgesics|analgesics|mesh-ancestor
24592325|NCT00921284|Sensory System Agents|sensory system agents|mesh-ancestor
24592486|NCT00922129|Cyclosporins|cyclosporins|mesh-list
24592439|NCT00921726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592465|NCT00921804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24812403|NCT02052024|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24812406|NCT02052024|Cholinergic Agents|cholinergic agents|mesh-ancestor
25246745|NCT02324608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25246746|NCT02324608|Cetuximab|cetuximab|mesh-list
25246747|NCT02324608|Antibodies|antibodies|mesh-list
25246748|NCT02324608|Immunoglobulins|immunoglobulins|mesh-list
25246749|NCT02324608|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25246750|NCT02324608|Immunologic Factors|immunologic factors|mesh-ancestor
25246751|NCT02324608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246752|NCT02324608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246754|NCT02294032|Immunologic Factors|immunologic factors|mesh-ancestor
25246755|NCT02294032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246756|NCT02210559|Gemcitabine|gemcitabine|mesh-list
25246757|NCT02210559|Paclitaxel|paclitaxel|mesh-list
25246758|NCT02210559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25246759|NCT02210559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246760|NCT02210559|Tubulin Modulators|tubulin modulators|mesh-ancestor
25246761|NCT02210559|Antimitotic Agents|antimitotic agents|mesh-ancestor
25246762|NCT02210559|Mitosis Modulators|mitosis modulators|mesh-ancestor
25246763|NCT02210559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246764|NCT02210559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25246765|NCT02210559|Antimetabolites|antimetabolites|mesh-ancestor
25246766|NCT02210559|Antiviral Agents|antiviral agents|mesh-ancestor
25246767|NCT02210559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25246768|NCT02210559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25246769|NCT02210559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25246770|NCT02210559|Immunologic Factors|immunologic factors|mesh-ancestor
25246771|NCT02210559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246772|NCT02208544|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24592477|NCT00921830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24592478|NCT00921830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592479|NCT00921830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592481|NCT00921973|Immunologic Factors|immunologic factors|mesh-ancestor
24592482|NCT00921973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592483|NCT00922129|Cyclosporine|cyclosporine|mesh-list
24592484|NCT00922129|Sirolimus|sirolimus|mesh-list
24592487|NCT00922129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24592488|NCT00922129|Immunologic Factors|immunologic factors|mesh-ancestor
24592513|NCT00922467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592514|NCT00922467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592516|NCT00922506|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24592517|NCT00922506|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24592518|NCT00922506|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24592519|NCT00922506|Cholinergic Agents|cholinergic agents|mesh-ancestor
24571278|NCT00808977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571279|NCT00808977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24571280|NCT00808977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24571281|NCT00809016|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24571282|NCT00809016|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24571325|NCT00809172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24571326|NCT00809172|Dermatologic Agents|dermatologic agents|mesh-ancestor
24571327|NCT00809172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571328|NCT00809172|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24571329|NCT00809172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24571330|NCT00809172|Immunologic Factors|immunologic factors|mesh-ancestor
24571331|NCT00809172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24571332|NCT00809172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24571333|NCT00809172|Antifungal Agents|antifungal agents|mesh-ancestor
24571334|NCT00809172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571335|NCT00809172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24571336|NCT00809198|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24571337|NCT00809198|Hyaluronic Acid|hyaluronic acid|mesh-list
24571338|NCT00809198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24571339|NCT00809198|Immunologic Factors|immunologic factors|mesh-ancestor
24571340|NCT00809198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571341|NCT00809198|Viscosupplements|viscosupplements|mesh-ancestor
24571342|NCT00809198|Protective Agents|protective agents|mesh-ancestor
24571343|NCT00809198|Laxatives|laxatives|mesh-ancestor
24571344|NCT00809198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24571345|NCT00809237|Hydroxychloroquine|hydroxychloroquine|mesh-list
24571346|NCT00809237|Gefitinib|gefitinib|mesh-list
24571347|NCT00809237|Antimalarials|antimalarials|mesh-ancestor
24571348|NCT00809237|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24571349|NCT00809237|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24571350|NCT00809237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571351|NCT00809237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24968481|NCT03750916|Mitosis Modulators|mitosis modulators|mesh-ancestor
24571352|NCT00809237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571382|NCT00809627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009152|NCT03334539|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24792096|NCT05412576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593253|NCT00927602|Anticoagulants|anticoagulants|mesh-ancestor
24792097|NCT05412576|Sensory System Agents|sensory system agents|mesh-ancestor
25686723|NCT01923467|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24550123|NCT00719173|Aprepitant|aprepitant|mesh-list
24792098|NCT05412576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25009153|NCT03334539|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25009154|NCT03269344|Gabapentin|gabapentin|mesh-list
25009155|NCT03269344|Analgesics|analgesics|mesh-ancestor
25009156|NCT03269344|Sensory System Agents|sensory system agents|mesh-ancestor
25246773|NCT02208544|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25246774|NCT02208544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246775|NCT02193841|Calcium|calcium|mesh-list
25246776|NCT02193841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25246777|NCT02193841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246778|NCT02174861|Erenumab|erenumab|mesh-list
25246779|NCT02174861|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25246780|NCT02174861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246781|NCT02174861|Analgesics|analgesics|mesh-ancestor
25246782|NCT02174861|Sensory System Agents|sensory system agents|mesh-ancestor
25246783|NCT02174861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25246784|NCT02174861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246785|NCT02174549|Tirapazamine|tirapazamine|mesh-list
25246786|NCT02174549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246787|NCT02164955|Pomalidomide|pomalidomide|mesh-list
25246788|NCT02164955|Immunologic Factors|immunologic factors|mesh-ancestor
24592521|NCT00922506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592523|NCT00922506|Urological Agents|urological agents|mesh-ancestor
24592524|NCT00922506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25009157|NCT03269344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25009158|NCT03269344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009159|NCT03269344|Anticonvulsants|anticonvulsants|mesh-ancestor
25009160|NCT03269344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25109933|NCT03120962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25109934|NCT03120962|Narcotics|narcotics|mesh-ancestor
25109935|NCT03120962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25109936|NCT03120962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109937|NCT03120962|Analgesics|analgesics|mesh-ancestor
25109938|NCT03120962|Sensory System Agents|sensory system agents|mesh-ancestor
25109939|NCT03120962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25109940|NCT03120962|Anticonvulsants|anticonvulsants|mesh-ancestor
25109941|NCT03120962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25109942|NCT03120962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25109943|NCT03120962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25283307|NCT04807920|Cholinergic Agents|cholinergic agents|mesh-ancestor
25109944|NCT03120962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24571383|NCT00809627|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24571384|NCT00809627|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24571385|NCT00809627|Purinergic Agents|purinergic agents|mesh-ancestor
24571386|NCT00809627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24571388|NCT00809692|Histamine phosphate|histamine phosphate|mesh-list
24571389|NCT00809692|Histamine Agonists|histamine agonists|mesh-ancestor
24571390|NCT00809692|Histamine Agents|histamine agents|mesh-ancestor
24571391|NCT00809692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24571392|NCT00809692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560427|NCT02677545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24560428|NCT02677545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24671017|NCT01323257|Darunavir|darunavir|mesh-list
24571393|NCT00809692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571394|NCT00809705|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24571395|NCT00809705|Incretins|incretins|mesh-ancestor
24571396|NCT00809705|Hormones|hormones|mesh-ancestor
24571397|NCT00809705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24571398|NCT00809705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571399|NCT00809718|Raltegravir Potassium|raltegravir potassium|mesh-list
24571400|NCT00809718|Rifapentine|rifapentine|mesh-list
24571401|NCT00809718|Rifampin|rifampin|mesh-list
24571402|NCT00809718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24571403|NCT00809718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24571404|NCT00809718|Antiviral Agents|antiviral agents|mesh-ancestor
24571405|NCT00809718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571406|NCT00809718|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24571407|NCT00809718|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24571442|NCT00809913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25686724|NCT01923467|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25686725|NCT01923467|Cholinergic Agents|cholinergic agents|mesh-ancestor
25686726|NCT01923467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24940277|NCT04002440|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24571443|NCT00809913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571444|NCT00809913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25246789|NCT02164955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246790|NCT02164955|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25246791|NCT02164955|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25246792|NCT02164955|Growth Substances|growth substances|mesh-ancestor
25246793|NCT02164955|Growth Inhibitors|growth inhibitors|mesh-ancestor
25246794|NCT02164955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246795|NCT02148796|Broncho-Vaxom|broncho-vaxom|mesh-list
25246796|NCT02148796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24592542|NCT00922532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24592543|NCT00922532|Respiratory System Agents|respiratory system agents|mesh-ancestor
24592544|NCT00922532|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24592545|NCT00922532|Antioxidants|antioxidants|mesh-ancestor
24592546|NCT00922532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592547|NCT00922532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24592548|NCT00922532|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24592549|NCT00922532|Vasodilator Agents|vasodilator agents|mesh-ancestor
24592550|NCT00922532|Gasotransmitters|gasotransmitters|mesh-ancestor
24592551|NCT00922532|Protective Agents|protective agents|mesh-ancestor
24592552|NCT00922584|Sorafenib|sorafenib|mesh-list
24592605|NCT00923234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24592607|NCT00923234|Growth Inhibitors|growth inhibitors|mesh-ancestor
24592653|NCT00923637|Oxaliplatin|oxaliplatin|mesh-list
24592654|NCT00923637|Pemetrexed|pemetrexed|mesh-list
24592655|NCT00923637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24592656|NCT00923637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592668|NCT00923676|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24592669|NCT00923676|Fenofibrate|fenofibrate|mesh-list
24592670|NCT00923676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24592671|NCT00923676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24592672|NCT00923676|Antimetabolites|antimetabolites|mesh-ancestor
24592673|NCT00923676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592674|NCT00923676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24592675|NCT00923676|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24592676|NCT00923676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073707|NCT03393702|Gabapentin|gabapentin|mesh-list
24571445|NCT00809913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24571446|NCT00809913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571447|NCT00809913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571448|NCT00809913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283364|NCT04662723|Prednisolone|prednisolone|mesh-list
24571449|NCT00809913|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24571450|NCT00809913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24571451|NCT00809939|Progesterone|progesterone|mesh-list
24571452|NCT00809939|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
24571453|NCT00809939|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
24571454|NCT00809939|Progestins|progestins|mesh-ancestor
24571455|NCT00809939|Hormones|hormones|mesh-ancestor
24571456|NCT00809939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24571457|NCT00809939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571458|NCT00809939|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24571459|NCT00809939|Hormone Antagonists|hormone antagonists|mesh-ancestor
24571460|NCT00810030|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24571461|NCT00810030|Hematinics|hematinics|mesh-ancestor
25246797|NCT02148796|Immunologic Factors|immunologic factors|mesh-ancestor
25246798|NCT02148796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246799|NCT02113163|Metformin|metformin|mesh-list
25246800|NCT02113163|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
25246801|NCT02113163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25246802|NCT02113163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246803|NCT02113163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25246804|NCT02113163|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25246805|NCT02107937|Paclitaxel|paclitaxel|mesh-list
25246806|NCT02107937|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25246807|NCT02107937|Carboplatin|carboplatin|mesh-list
25246808|NCT02107937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25246809|NCT02107937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246810|NCT02107937|Tubulin Modulators|tubulin modulators|mesh-ancestor
25246811|NCT02107937|Antimitotic Agents|antimitotic agents|mesh-ancestor
25686727|NCT01923467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686728|NCT01923896|Cycloserine|cycloserine|mesh-list
25246813|NCT02107937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246815|NCT02095184|Anastrozole|anastrozole|mesh-list
25246816|NCT02095184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246817|NCT02095184|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25246818|NCT02095184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25246819|NCT02095184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25246820|NCT02095184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246822|NCT02095184|Hormone Antagonists|hormone antagonists|mesh-ancestor
25246823|NCT02095184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24592677|NCT00923741|Talactoferrin alfa|talactoferrin alfa|mesh-list
24592868|NCT00925912|Sensory System Agents|sensory system agents|mesh-ancestor
24592869|NCT00925912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24592870|NCT00925951|Acetaminophen|acetaminophen|mesh-list
24592871|NCT00925951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24592872|NCT00925951|Analgesics|analgesics|mesh-ancestor
24592873|NCT00925951|Sensory System Agents|sensory system agents|mesh-ancestor
24592874|NCT00925951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24592875|NCT00925951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592876|NCT00925951|Antipyretics|antipyretics|mesh-ancestor
24592877|NCT00925977|Insulin|insulin|mesh-list
24592878|NCT00925977|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24592879|NCT00925977|Insulin Glargine|insulin glargine|mesh-list
24592880|NCT00925977|Insulin glulisine|insulin glulisine|mesh-list
24592881|NCT00925977|Isophane Insulin, Human|isophane insulin, human|mesh-list
24592882|NCT00925977|Insulin, Isophane|insulin, isophane|mesh-list
24560493|NCT02476279|Gout Suppressants|gout suppressants|mesh-ancestor
24571507|NCT00810524|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
24571508|NCT00810524|Telbivudine|telbivudine|mesh-list
24571509|NCT00810524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24968643|NCT03749642|Sensory System Agents|sensory system agents|mesh-ancestor
24571510|NCT00810524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24571511|NCT00810524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571615|NCT00811031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24571616|NCT00811031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571617|NCT00811031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24571619|NCT00811083|Antidotes|antidotes|mesh-ancestor
24571620|NCT00811083|Protective Agents|protective agents|mesh-ancestor
24571621|NCT00811083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283417|NCT04593563|Psilocybin|psilocybin|mesh-list
24571622|NCT00811083|Chelating Agents|chelating agents|mesh-ancestor
24571623|NCT00811083|Sequestering Agents|sequestering agents|mesh-ancestor
24571624|NCT00811083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571625|NCT00811096|Chloroquine|chloroquine|mesh-list
24571627|NCT00811096|Amebicides|amebicides|mesh-ancestor
24571628|NCT00811096|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24571629|NCT00811096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24571630|NCT00811096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571631|NCT00811096|Antimalarials|antimalarials|mesh-ancestor
24571632|NCT00811096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24571639|NCT00811200|Triamcinolone|triamcinolone|mesh-list
24571640|NCT00811200|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24571641|NCT00811200|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24571642|NCT00811200|Ranibizumab|ranibizumab|mesh-list
24571643|NCT00811200|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24571644|NCT00811200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24571645|NCT00811200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24571646|NCT00811200|Growth Substances|growth substances|mesh-ancestor
24571647|NCT00811200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571648|NCT00811200|Growth Inhibitors|growth inhibitors|mesh-ancestor
24571649|NCT00811200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24571650|NCT00811200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24571651|NCT00811200|Glucocorticoids|glucocorticoids|mesh-ancestor
24571652|NCT00811200|Hormones|hormones|mesh-ancestor
24571653|NCT00811200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24571654|NCT00811200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24571655|NCT00811200|Immunologic Factors|immunologic factors|mesh-ancestor
24571656|NCT00811200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571657|NCT00811200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686730|NCT01923896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25686731|NCT01923896|Renal Agents|renal agents|mesh-ancestor
24571658|NCT00811226|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25246824|NCT02095184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246825|NCT02095184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25246826|NCT02094625|Acetylcysteine|acetylcysteine|mesh-list
25246827|NCT02094625|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25246828|NCT02094625|Antiviral Agents|antiviral agents|mesh-ancestor
25246829|NCT02094625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25246830|NCT02094625|Expectorants|expectorants|mesh-ancestor
25246831|NCT02094625|Respiratory System Agents|respiratory system agents|mesh-ancestor
25246832|NCT02094625|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25246833|NCT02094625|Antioxidants|antioxidants|mesh-ancestor
25246834|NCT02094625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246835|NCT02094625|Protective Agents|protective agents|mesh-ancestor
25246837|NCT02094625|Antidotes|antidotes|mesh-ancestor
25246838|NCT02085265|Telmisartan|telmisartan|mesh-list
25246839|NCT02085265|Perindopril|perindopril|mesh-list
25246840|NCT02085265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24592885|NCT00925977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592887|NCT00926016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24592888|NCT00926016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592889|NCT00926055|Simvastatin|simvastatin|mesh-list
24592890|NCT00926055|Ezetimibe|ezetimibe|mesh-list
24852626|NCT02263196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24496740|NCT00506506|Expectorants|expectorants|mesh-ancestor
24852627|NCT02263196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852628|NCT02263196|Plasma Substitutes|plasma substitutes|mesh-ancestor
24852629|NCT02263196|Blood Substitutes|blood substitutes|mesh-ancestor
24852630|NCT02263248|Buprenorphine|buprenorphine|mesh-list
24852631|NCT02263248|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24593048|NCT00926835|Dexetimide|dexetimide|mesh-list
24852654|NCT02263495|Paclitaxel|paclitaxel|mesh-list
24852655|NCT02263495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24593101|NCT00926835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24593103|NCT00926900|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24593104|NCT00926900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24593105|NCT00926900|Renal Agents|renal agents|mesh-ancestor
24593106|NCT00926900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24593107|NCT00926900|Antitubercular Agents|antitubercular agents|mesh-ancestor
24593108|NCT00926900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24593109|NCT00926900|Antimetabolites|antimetabolites|mesh-ancestor
24571659|NCT00811226|Olmesartan|olmesartan|mesh-list
24571660|NCT00811226|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24571661|NCT00811226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24571662|NCT00811226|Diuretics|diuretics|mesh-ancestor
24571663|NCT00811226|Natriuretic Agents|natriuretic agents|mesh-ancestor
24571664|NCT00811226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571665|NCT00811226|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24571666|NCT00811226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24571667|NCT00811226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890180|NCT04485299|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24571684|NCT00811330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24571685|NCT00811330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24571686|NCT00811330|Antimetabolites|antimetabolites|mesh-ancestor
24571687|NCT00811330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571688|NCT00811330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24571689|NCT00811330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24571690|NCT00811330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25246841|NCT02085265|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25246842|NCT02085265|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25246843|NCT02085265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246844|NCT02085265|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25246845|NCT02085265|Protease Inhibitors|protease inhibitors|mesh-ancestor
25246846|NCT02085265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25246847|NCT02052739|Brexanolone|brexanolone|mesh-list
25246848|NCT02052739|Neurosteroids|neurosteroids|mesh-ancestor
25246849|NCT02052739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25686732|NCT01923896|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25686733|NCT01923896|Antitubercular Agents|antitubercular agents|mesh-ancestor
25686734|NCT01923896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25686735|NCT01923896|Antimetabolites|antimetabolites|mesh-ancestor
25686736|NCT01923896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246850|NCT02052739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246851|NCT02052739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246852|NCT02052739|GABA Modulators|gaba modulators|mesh-ancestor
25246853|NCT02052739|GABA Agents|gaba agents|mesh-ancestor
25246854|NCT02043587|Leucovorin|leucovorin|mesh-list
25246855|NCT02043587|Cytarabine|cytarabine|mesh-list
25246856|NCT02043587|Prednisone|prednisone|mesh-list
25246857|NCT02043587|Hydrocortisone|hydrocortisone|mesh-list
25246858|NCT02043587|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25246859|NCT02043587|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25246860|NCT02043587|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25246861|NCT02043587|Cyclophosphamide|cyclophosphamide|mesh-list
25246862|NCT02043587|Rituximab|rituximab|mesh-list
25246863|NCT02043587|Methotrexate|methotrexate|mesh-list
25246864|NCT02043587|Etoposide|etoposide|mesh-list
25246865|NCT02043587|Vincristine|vincristine|mesh-list
25246866|NCT02043587|Daunorubicin|daunorubicin|mesh-list
25246867|NCT02043587|Dasatinib|dasatinib|mesh-list
24593127|NCT00926965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24593128|NCT00926965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593130|NCT00926965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24593131|NCT00926965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24593248|NCT00927602|Antithrombins|antithrombins|mesh-ancestor
24852656|NCT02263495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24852657|NCT02263495|Tubulin Modulators|tubulin modulators|mesh-ancestor
24852658|NCT02263495|Antimitotic Agents|antimitotic agents|mesh-ancestor
24852659|NCT02263495|Mitosis Modulators|mitosis modulators|mesh-ancestor
24954112|NCT03879356|Antidotes|antidotes|mesh-ancestor
24571691|NCT00811356|Rosiglitazone|rosiglitazone|mesh-list
24571692|NCT00811356|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24571701|NCT00811356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571702|NCT00811369|Fulvestrant|fulvestrant|mesh-list
24571703|NCT00811369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24792166|NCT05411757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24792167|NCT05411757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24792168|NCT05411757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24792169|NCT05411757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24792170|NCT05411757|Growth Substances|growth substances|mesh-ancestor
24792171|NCT05411757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792172|NCT05411757|Growth Inhibitors|growth inhibitors|mesh-ancestor
24792173|NCT05411757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24792174|NCT05411757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24792175|NCT05411757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009252|NCT02627963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25009254|NCT02627963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009255|NCT02520063|Everolimus|everolimus|mesh-list
25009256|NCT02520063|Letrozole|letrozole|mesh-list
24571713|NCT00811408|Antiviral Agents|antiviral agents|mesh-ancestor
24571714|NCT00811408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571715|NCT00811408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571716|NCT00811408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571718|NCT00811421|Sulfadoxine|sulfadoxine|mesh-list
24571719|NCT00811421|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24571720|NCT00811421|Mefloquine|mefloquine|mesh-list
24571721|NCT00811421|Antimalarials|antimalarials|mesh-ancestor
24571722|NCT00811421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25686737|NCT01924169|Lenalidomide|lenalidomide|mesh-list
25686738|NCT01924169|Vaccines|vaccines|mesh-list
25686739|NCT01924169|Immunologic Factors|immunologic factors|mesh-ancestor
25686740|NCT01924169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686741|NCT01924169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25686742|NCT01924169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25686743|NCT01924169|Growth Substances|growth substances|mesh-ancestor
25686744|NCT01924169|Growth Inhibitors|growth inhibitors|mesh-ancestor
25686745|NCT01924169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25686746|NCT01924182|Morphine|morphine|mesh-list
24571723|NCT00811421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24571724|NCT00811421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571725|NCT00811421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24571726|NCT00811421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571727|NCT00811421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571728|NCT00811421|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24571729|NCT00811421|Renal Agents|renal agents|mesh-ancestor
24571730|NCT00811447|Docetaxel|docetaxel|mesh-list
24571731|NCT00811447|Fluorouracil|fluorouracil|mesh-list
24571732|NCT00811447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24571733|NCT00811447|Tubulin Modulators|tubulin modulators|mesh-ancestor
24571734|NCT00811447|Antimitotic Agents|antimitotic agents|mesh-ancestor
24571735|NCT00811447|Mitosis Modulators|mitosis modulators|mesh-ancestor
24571736|NCT00811447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571737|NCT00811447|Antimetabolites|antimetabolites|mesh-ancestor
24890264|NCT04484844|Fluorides|fluorides|mesh-list
24571804|NCT00811876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24571805|NCT00811876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571806|NCT00811876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24571807|NCT00811876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24571808|NCT00811915|Sirolimus|sirolimus|mesh-list
24571809|NCT00811915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24571810|NCT00811915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571811|NCT00811915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25246868|NCT02043587|Asparaginase|asparaginase|mesh-list
25246869|NCT02043587|Pegaspargase|pegaspargase|mesh-list
25246870|NCT02043587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25246871|NCT02043587|Immunologic Factors|immunologic factors|mesh-ancestor
25246872|NCT02043587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246873|NCT02043587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25246874|NCT02043587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25246875|NCT02043587|Alkylating Agents|alkylating agents|mesh-ancestor
25246876|NCT02043587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246877|NCT02043587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24852660|NCT02263495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658824|NCT01274221|Dopamine Agents|dopamine agents|mesh-ancestor
24593249|NCT00927602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24593250|NCT00927602|Protease Inhibitors|protease inhibitors|mesh-ancestor
24593251|NCT00927602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593252|NCT00927602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593254|NCT00927602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24593255|NCT00927602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24593257|NCT00927615|Anticoagulants|anticoagulants|mesh-ancestor
24593258|NCT00927615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24593259|NCT00927654|Iloprost|iloprost|mesh-list
24593260|NCT00927654|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24593261|NCT00927654|Vasodilator Agents|vasodilator agents|mesh-ancestor
24593262|NCT00927693|Calcium|calcium|mesh-list
24593263|NCT00927693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24593283|NCT00927732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24593284|NCT00927732|Cholinergic Agents|cholinergic agents|mesh-ancestor
24593285|NCT00927732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24593286|NCT00927732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24571812|NCT00811915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24571813|NCT00811915|Antifungal Agents|antifungal agents|mesh-ancestor
24571814|NCT00811915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24571815|NCT00811915|Immunologic Factors|immunologic factors|mesh-ancestor
25009266|NCT02520063|Hormone Antagonists|hormone antagonists|mesh-ancestor
24571816|NCT00811915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571817|NCT00811967|Ribavirin|ribavirin|mesh-list
24571818|NCT00811967|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24571819|NCT00811967|Interferon-alpha|interferon-alpha|mesh-list
24571851|NCT00811993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24560793|NCT01451515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24560794|NCT01451515|Glucocorticoids|glucocorticoids|mesh-ancestor
24560795|NCT01451515|Hormones|hormones|mesh-ancestor
24560796|NCT01451515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24560797|NCT01451515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24560798|NCT01451515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24560801|NCT01451515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571874|NCT00812019|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24571875|NCT00812123|Cyclosporine|cyclosporine|mesh-list
24571876|NCT00812123|Sirolimus|sirolimus|mesh-list
24571877|NCT00812123|Mycophenolic Acid|mycophenolic acid|mesh-list
24571878|NCT00812123|Prednisone|prednisone|mesh-list
24571879|NCT00812123|Cyclosporins|cyclosporins|mesh-list
24571880|NCT00812123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24571883|NCT00812123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24571884|NCT00812123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571885|NCT00812123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24571886|NCT00812123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24571887|NCT00812123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571888|NCT00812123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571889|NCT00812123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24571890|NCT00812123|Immunologic Factors|immunologic factors|mesh-ancestor
24571891|NCT00812123|Antifungal Agents|antifungal agents|mesh-ancestor
25246878|NCT02043587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25246879|NCT02043587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25246880|NCT02043587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25246881|NCT02043587|Glucocorticoids|glucocorticoids|mesh-ancestor
25246882|NCT02043587|Hormones|hormones|mesh-ancestor
24906592|NCT04338763|Antimetabolites|antimetabolites|mesh-ancestor
25246883|NCT02043587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25246884|NCT02043587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25246885|NCT02043587|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25246886|NCT02043587|Abortifacient Agents|abortifacient agents|mesh-ancestor
25246887|NCT02043587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25246888|NCT02043587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25246889|NCT02043587|Antimetabolites|antimetabolites|mesh-ancestor
25246890|NCT02043587|Dermatologic Agents|dermatologic agents|mesh-ancestor
25246891|NCT02043587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25246892|NCT02043587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25246893|NCT02043587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25246894|NCT02043587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25246895|NCT02043587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25246896|NCT02043587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24593287|NCT00927732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24593288|NCT00927732|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24593289|NCT00927732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24593291|NCT00927771|Hydroquinone|hydroquinone|mesh-list
24593292|NCT00927771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24593293|NCT00927771|Dermatologic Agents|dermatologic agents|mesh-ancestor
24593294|NCT00927771|Antioxidants|antioxidants|mesh-ancestor
24572454|NCT00814944|Immunologic Factors|immunologic factors|mesh-ancestor
24593295|NCT00927771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571892|NCT00812123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571893|NCT00812123|Dermatologic Agents|dermatologic agents|mesh-ancestor
24571894|NCT00812123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24571895|NCT00812123|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24571927|NCT00812292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24571928|NCT00812318|Cabotegravir|cabotegravir|mesh-list
24571942|NCT00812344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571943|NCT00812344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571944|NCT00812344|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24571946|NCT00812344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24571947|NCT00812344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571948|NCT00812344|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24571949|NCT00812370|Bivalirudin|bivalirudin|mesh-list
24571950|NCT00812370|Antithrombins|antithrombins|mesh-ancestor
24571952|NCT00812370|Protease Inhibitors|protease inhibitors|mesh-ancestor
25705138|NCT02194088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24571963|NCT00812396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24571970|NCT00812422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24571971|NCT00812422|Analgesics|analgesics|mesh-ancestor
24571972|NCT00812422|Sensory System Agents|sensory system agents|mesh-ancestor
24571973|NCT00812422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24571974|NCT00812422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571975|NCT00812422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24571976|NCT00812422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24571977|NCT00812422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24571978|NCT00812422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571992|NCT00812513|Anticoagulants|anticoagulants|mesh-ancestor
24571993|NCT00812513|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
24571994|NCT00812513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24571995|NCT00812513|Growth Substances|growth substances|mesh-ancestor
24571996|NCT00812513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571997|NCT00812578|Cholecalciferol|cholecalciferol|mesh-list
25405942|NCT03586999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24450054|NCT00317733|Sensory System Agents|sensory system agents|mesh-ancestor
24450055|NCT00317733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24450056|NCT00317733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450057|NCT00317733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24450058|NCT00317733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24450059|NCT00317733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24450063|NCT00317746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24571999|NCT00812578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24572000|NCT00812578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572001|NCT00812578|Vitamins|vitamins|mesh-ancestor
24497431|NCT00510016|Sensory System Agents|sensory system agents|mesh-ancestor
24560917|NCT01177540|Antimetabolites|antimetabolites|mesh-ancestor
24572013|NCT00812669|Alkylating Agents|alkylating agents|mesh-ancestor
24572014|NCT00812669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572015|NCT00812669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246897|NCT02043587|Antiviral Agents|antiviral agents|mesh-ancestor
25246898|NCT02043587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25246899|NCT02043587|Antidotes|antidotes|mesh-ancestor
25246900|NCT02043587|Protective Agents|protective agents|mesh-ancestor
25246901|NCT02043587|Vitamin B Complex|vitamin b complex|mesh-ancestor
25246902|NCT02043587|Vitamins|vitamins|mesh-ancestor
25246903|NCT02043587|Micronutrients|micronutrients|mesh-ancestor
25246904|NCT02043587|Tubulin Modulators|tubulin modulators|mesh-ancestor
25246905|NCT02043587|Antimitotic Agents|antimitotic agents|mesh-ancestor
25246906|NCT02043587|Mitosis Modulators|mitosis modulators|mesh-ancestor
25246907|NCT02043587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24593296|NCT00927771|Protective Agents|protective agents|mesh-ancestor
24593376|NCT00928330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24852661|NCT02263495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24852663|NCT02263495|Antiviral Agents|antiviral agents|mesh-ancestor
24852664|NCT02263495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24852665|NCT02263495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852666|NCT02263495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24852667|NCT02263495|Immunologic Factors|immunologic factors|mesh-ancestor
24852668|NCT02263495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852669|NCT02263638|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24593377|NCT00928330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24593378|NCT00928330|Tubulin Modulators|tubulin modulators|mesh-ancestor
24852686|NCT02263690|Sensory System Agents|sensory system agents|mesh-ancestor
24572018|NCT00812669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25009287|NCT02425644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25009288|NCT02425644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25009289|NCT02425644|Analgesics|analgesics|mesh-ancestor
25009290|NCT02425644|Sensory System Agents|sensory system agents|mesh-ancestor
25009291|NCT02425644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25009292|NCT02425644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009294|NCT02425644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25009295|NCT02425644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25009296|NCT02425644|Immunologic Factors|immunologic factors|mesh-ancestor
25009297|NCT02425644|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25009298|NCT02425644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009299|NCT02395614|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25009300|NCT02395614|Gentamicins|gentamicins|mesh-list
25009301|NCT02395614|Cefazolin|cefazolin|mesh-list
25009302|NCT02395614|Bacitracin|bacitracin|mesh-list
25009303|NCT02395614|Chlorhexidine|chlorhexidine|mesh-list
25009304|NCT02395614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25009305|NCT02395614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25009306|NCT02395614|Disinfectants|disinfectants|mesh-ancestor
25009307|NCT02395614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25009308|NCT02395614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25009309|NCT02395614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009310|NCT02270957|Abatacept|abatacept|mesh-list
25009311|NCT02270957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25686747|NCT01924182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25686748|NCT01924182|Narcotics|narcotics|mesh-ancestor
25686749|NCT01924182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25686750|NCT01924182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686751|NCT01924182|Analgesics|analgesics|mesh-ancestor
25686752|NCT01924182|Sensory System Agents|sensory system agents|mesh-ancestor
25686753|NCT01924182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686754|NCT01924299|Fluconazole|fluconazole|mesh-list
25009312|NCT02270957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009313|NCT02270957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585254|NCT00884546|Growth Substances|growth substances|mesh-ancestor
25009314|NCT02270957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24572029|NCT00812760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572030|NCT00812786|Cyclosporine|cyclosporine|mesh-list
24572031|NCT00812786|Mycophenolic Acid|mycophenolic acid|mesh-list
24572032|NCT00812786|Everolimus|everolimus|mesh-list
24572033|NCT00812786|Tacrolimus|tacrolimus|mesh-list
24572034|NCT00812786|Cyclosporins|cyclosporins|mesh-list
24572035|NCT00812786|Immunosuppressive Agents|immunosuppressive agents|mesh-list
24572036|NCT00812786|Immunologic Factors|immunologic factors|mesh-ancestor
24572037|NCT00812786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572038|NCT00812786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24572039|NCT00812786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24561054|NCT00567580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561055|NCT00567580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25246908|NCT02043587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25246909|NCT01933724|Prednisone|prednisone|mesh-list
25246910|NCT01933724|Glucocorticoids|glucocorticoids|mesh-list
25246911|NCT01933724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25246912|NCT01933724|Hormones|hormones|mesh-ancestor
25246913|NCT01933724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25246914|NCT01933724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246915|NCT01933724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25246916|NCT01933724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246917|NCT01840592|Doxorubicin|doxorubicin|mesh-list
25246918|NCT01840592|Sorafenib|sorafenib|mesh-list
25246919|NCT01840592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25246920|NCT01840592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246921|NCT01840592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25246922|NCT01840592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24852687|NCT02263690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24852688|NCT02263690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24658954|NCT01274793|Mosapride|mosapride|mesh-list
24593548|NCT00930033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24593549|NCT00930033|Growth Substances|growth substances|mesh-ancestor
24593550|NCT00930033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593551|NCT00930033|Growth Inhibitors|growth inhibitors|mesh-ancestor
24593552|NCT00930033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24593553|NCT00930033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593554|NCT00930033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852689|NCT02263690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24852690|NCT02263690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24852691|NCT02263690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24852692|NCT02263690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852693|NCT02263872|Minocycline|minocycline|mesh-list
24852694|NCT02263872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24561056|NCT00567580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24561057|NCT00567580|Androgen Antagonists|androgen antagonists|mesh-ancestor
24561058|NCT00567580|Hormone Antagonists|hormone antagonists|mesh-ancestor
24572078|NCT00812994|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24572079|NCT00812994|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24561077|NCT00485693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24561078|NCT00485693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24561080|NCT00485693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24561081|NCT00485693|Respiratory System Agents|respiratory system agents|mesh-ancestor
24561083|NCT00485693|Sympathomimetics|sympathomimetics|mesh-ancestor
25283727|NCT03868150|Vasodilator Agents|vasodilator agents|mesh-ancestor
24572194|NCT00813696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24572195|NCT00813696|Immunologic Factors|immunologic factors|mesh-ancestor
24572196|NCT00813696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572197|NCT00813722|Losartan|losartan|mesh-list
24572198|NCT00813722|Atenolol|atenolol|mesh-list
24572199|NCT00813722|Amlodipine|amlodipine|mesh-list
24572200|NCT00813722|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24572201|NCT00813722|Calcium|calcium|mesh-list
24572202|NCT00813722|Diuretics|diuretics|mesh-list
24572203|NCT00813722|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24572204|NCT00813722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24572293|NCT00814125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24572294|NCT00814125|Hormone Antagonists|hormone antagonists|mesh-ancestor
24572295|NCT00814125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24572296|NCT00814125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246923|NCT01840592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050680|NCT00478595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24487528|NCT00463723|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24701927|NCT01462968|Anticoagulants|anticoagulants|mesh-ancestor
24701928|NCT01462968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25246924|NCT01840592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246925|NCT01840592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25246926|NCT01757626|Molgramostim|molgramostim|mesh-list
25246927|NCT01757626|Sargramostim|sargramostim|mesh-list
25246928|NCT01757626|Immunologic Factors|immunologic factors|mesh-ancestor
25246929|NCT01757626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246930|NCT01757626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246931|NCT01722812|Cromolyn Sodium|cromolyn sodium|mesh-list
25246932|NCT01722812|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
25246933|NCT01722812|Immunologic Factors|immunologic factors|mesh-ancestor
25246934|NCT01722812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246935|NCT01722812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25246936|NCT01722812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25246937|NCT01722812|Respiratory System Agents|respiratory system agents|mesh-ancestor
24852696|NCT02263924|Tocotrienols|tocotrienols|mesh-list
24852698|NCT02263924|Tocopherols|tocopherols|mesh-list
24852699|NCT02263924|Antioxidants|antioxidants|mesh-ancestor
24593556|NCT00930072|Bupivacaine|bupivacaine|mesh-list
24593557|NCT00930072|Anesthetics, Local|anesthetics, local|mesh-ancestor
24593558|NCT00930072|Anesthetics|anesthetics|mesh-ancestor
24593614|NCT00930306|Anesthetics, General|anesthetics, general|mesh-ancestor
24593641|NCT00930345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24593642|NCT00930345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24593643|NCT00930345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24593644|NCT00930345|Growth Substances|growth substances|mesh-ancestor
24593645|NCT00930345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593646|NCT00930345|Growth Inhibitors|growth inhibitors|mesh-ancestor
25073786|NCT03393364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24572311|NCT00814216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24572312|NCT00814216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572314|NCT00814216|Respiratory System Agents|respiratory system agents|mesh-ancestor
24572315|NCT00814216|Dermatologic Agents|dermatologic agents|mesh-ancestor
24572316|NCT00814216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24572317|NCT00814229|Vaccines|vaccines|mesh-list
24572318|NCT00814229|Aluminum sulfate|aluminum sulfate|mesh-list
24572319|NCT00814229|Immunologic Factors|immunologic factors|mesh-ancestor
24572320|NCT00814229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572321|NCT00814229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24572322|NCT00814268|Aspirin|aspirin|mesh-list
24572323|NCT00814268|Clopidogrel|clopidogrel|mesh-list
24572324|NCT00814268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24572325|NCT00814268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24572326|NCT00814268|Analgesics|analgesics|mesh-ancestor
24572327|NCT00814268|Sensory System Agents|sensory system agents|mesh-ancestor
24572328|NCT00814268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24572329|NCT00814268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498355|NCT00514111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498356|NCT00514111|Antiviral Agents|antiviral agents|mesh-ancestor
24572330|NCT00814268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24572331|NCT00814268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24572332|NCT00814268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24572333|NCT00814268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24572334|NCT00814268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572337|NCT00814268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24572343|NCT00814268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24572345|NCT00814281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24572346|NCT00814281|Respiratory System Agents|respiratory system agents|mesh-ancestor
24572347|NCT00814281|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24572378|NCT00814541|Doxorubicin|doxorubicin|mesh-list
24572380|NCT00814541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24572381|NCT00814541|Antiemetics|antiemetics|mesh-ancestor
24572382|NCT00814541|Autonomic Agents|autonomic agents|mesh-ancestor
24572383|NCT00814541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24572384|NCT00814541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572385|NCT00814541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25686755|NCT01924299|Ketoconazole|ketoconazole|mesh-list
25686756|NCT01924299|Antifungal Agents|antifungal agents|mesh-ancestor
25686757|NCT01924299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25686758|NCT01924299|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24572386|NCT00814541|Glucocorticoids|glucocorticoids|mesh-ancestor
24572387|NCT00814541|Hormones|hormones|mesh-ancestor
25686759|NCT01924299|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24702054|NCT01463852|Vincristine|vincristine|mesh-list
24572388|NCT00814541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24572389|NCT00814541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24572390|NCT00814541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572391|NCT00814541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24572392|NCT00814541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24572393|NCT00814541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24572394|NCT00814541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24572396|NCT00814593|Carmustine|carmustine|mesh-list
25246940|NCT01689519|Vemurafenib|vemurafenib|mesh-list
25246941|NCT01689519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246942|NCT01689519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25246943|NCT01689519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25246944|NCT01689519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246945|NCT01682941|Phytoestrogens|phytoestrogens|mesh-list
25246946|NCT01682941|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25246947|NCT01682941|Estrogens|estrogens|mesh-ancestor
25246948|NCT01682941|Hormones|hormones|mesh-ancestor
25246949|NCT01682941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25246950|NCT01682941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246951|NCT01628029|Melatonin|melatonin|mesh-list
25246952|NCT01628029|Methylphenidate|methylphenidate|mesh-list
25246953|NCT01628029|Antioxidants|antioxidants|mesh-ancestor
24593647|NCT00930345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24593648|NCT00930345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593649|NCT00930345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593650|NCT00930358|Anesthetics|anesthetics|mesh-list
24593651|NCT00930358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24593652|NCT00930358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593653|NCT00930475|Carboplatin|carboplatin|mesh-list
24593655|NCT00930475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24593701|NCT00930670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24593702|NCT00930670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24852729|NCT02263976|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24852730|NCT02263989|Telmisartan|telmisartan|mesh-list
24852731|NCT02263989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24852732|NCT02263989|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24852733|NCT02263989|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24852734|NCT02263989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572429|NCT00814762|Immunologic Factors|immunologic factors|mesh-ancestor
24572430|NCT00814762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572431|NCT00814866|Adalimumab|adalimumab|mesh-list
24572432|NCT00814866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24498357|NCT00514111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24572433|NCT00814866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24572434|NCT00814905|Clindamycin|clindamycin|mesh-list
24572435|NCT00814905|Clindamycin palmitate|clindamycin palmitate|mesh-list
24572436|NCT00814905|Clindamycin phosphate|clindamycin phosphate|mesh-list
24572437|NCT00814905|Gentamicins|gentamicins|mesh-list
24572438|NCT00814905|Ampicillin|ampicillin|mesh-list
24572439|NCT00814905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24572440|NCT00814905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24572442|NCT00814905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24572443|NCT00814905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572444|NCT00814918|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24572445|NCT00814918|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24572446|NCT00814918|Dermatologic Agents|dermatologic agents|mesh-ancestor
24572447|NCT00814944|Sirolimus|sirolimus|mesh-list
24572448|NCT00814944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24572449|NCT00814944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24572450|NCT00814944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24572451|NCT00814944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572452|NCT00814944|Antifungal Agents|antifungal agents|mesh-ancestor
24572453|NCT00814944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24572455|NCT00814944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572456|NCT00815022|Fentanyl|fentanyl|mesh-list
24792263|NCT05392972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24792264|NCT05392972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792265|NCT05387525|Diclofenac|diclofenac|mesh-list
24792266|NCT05387525|Tirbanibulin|tirbanibulin|mesh-list
24792267|NCT05387525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24792278|NCT05384951|Vitamin D|vitamin d|mesh-list
24572480|NCT00815048|Sensory System Agents|sensory system agents|mesh-ancestor
24572481|NCT00815048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686760|NCT01924299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24572482|NCT00815048|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24572483|NCT00815048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24572484|NCT00815048|Anesthetics, General|anesthetics, general|mesh-ancestor
24572573|NCT00815568|Antimetabolites|antimetabolites|mesh-ancestor
25246954|NCT01628029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246955|NCT01628029|Protective Agents|protective agents|mesh-ancestor
25246956|NCT01628029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246957|NCT01628029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25246958|NCT01628029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25246959|NCT01628029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25246960|NCT01628029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25246961|NCT01628029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25246962|NCT01628029|Dopamine Agents|dopamine agents|mesh-ancestor
25246963|NCT01628029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25246964|NCT01622088|Pramipexole|pramipexole|mesh-list
25246965|NCT01622088|Antioxidants|antioxidants|mesh-ancestor
25246966|NCT01622088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25246967|NCT01622088|Protective Agents|protective agents|mesh-ancestor
25246968|NCT01622088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246969|NCT01622088|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25246970|NCT01622088|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24852735|NCT02264002|Metoprolol|metoprolol|mesh-list
24852736|NCT02264002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24593840|NCT00931138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593888|NCT00931437|Vitamin K|vitamin k|mesh-list
24593924|NCT00931645|Fludarabine|fludarabine|mesh-list
24593925|NCT00931645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24593926|NCT00931645|Immunologic Factors|immunologic factors|mesh-ancestor
24593938|NCT00931645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24635714|NCT01140932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24593941|NCT00931645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24593942|NCT00931645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24593943|NCT00931645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24593944|NCT00931645|Antimetabolites|antimetabolites|mesh-ancestor
24593945|NCT00931645|Antiviral Agents|antiviral agents|mesh-ancestor
24593946|NCT00931645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24593947|NCT00931697|Mefloquine|mefloquine|mesh-list
24593948|NCT00931697|Antimalarials|antimalarials|mesh-ancestor
24572596|NCT00815646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572597|NCT00815646|Urological Agents|urological agents|mesh-ancestor
24572599|NCT00815841|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24572600|NCT00815841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572601|NCT00815841|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24572602|NCT00815841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24572603|NCT00815841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24572604|NCT00815841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572605|NCT00815841|Dopamine Agents|dopamine agents|mesh-ancestor
24572606|NCT00815841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24572708|NCT00816413|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24572709|NCT00816413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24572710|NCT00816413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572711|NCT00816413|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24572712|NCT00816413|Antitubercular Agents|antitubercular agents|mesh-ancestor
24572713|NCT00816413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24443812|NCT00295997|Abortifacient Agents|abortifacient agents|mesh-ancestor
24443826|NCT00296010|Cyclophosphamide|cyclophosphamide|mesh-list
24572791|NCT00816712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572792|NCT00816712|Anabolic Agents|anabolic agents|mesh-ancestor
24572795|NCT00816790|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24443860|NCT00296023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443861|NCT00296023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24443862|NCT00296023|Antimetabolites|antimetabolites|mesh-ancestor
24792281|NCT05384951|Micronutrients|micronutrients|mesh-ancestor
24792282|NCT05384951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792283|NCT05384951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24792284|NCT05384951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25009344|NCT02054104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25009345|NCT02054104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25246971|NCT01622088|Dopamine Agonists|dopamine agonists|mesh-ancestor
25246972|NCT01622088|Dopamine Agents|dopamine agents|mesh-ancestor
25246973|NCT01622088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25246974|NCT01608451|Cholecalciferol|cholecalciferol|mesh-list
25246975|NCT01608451|Vitamin D|vitamin d|mesh-list
25246976|NCT01608451|Progesterone|progesterone|mesh-list
25246977|NCT01608451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25246978|NCT01608451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25246979|NCT01608451|Vitamins|vitamins|mesh-ancestor
25246980|NCT01608451|Micronutrients|micronutrients|mesh-ancestor
25246981|NCT01608451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25246982|NCT01608451|Progestins|progestins|mesh-ancestor
25246983|NCT01608451|Hormones|hormones|mesh-ancestor
25246984|NCT01608451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25246985|NCT01486264|Botulinum Toxins|botulinum toxins|mesh-list
25246986|NCT01486264|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25246987|NCT01486264|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25246988|NCT01486264|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24593949|NCT00931697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24593950|NCT00931697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24593951|NCT00931697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24593952|NCT00931736|Rifampin|rifampin|mesh-list
24593953|NCT00931736|Isoniazid|isoniazid|mesh-list
24593954|NCT00931736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24593955|NCT00931736|Antitubercular Agents|antitubercular agents|mesh-ancestor
24593956|NCT00931736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24593957|NCT00931736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24593958|NCT00931736|Leprostatic Agents|leprostatic agents|mesh-ancestor
24593959|NCT00931736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24593960|NCT00931736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593972|NCT00931775|Pindolol|pindolol|mesh-list
24593973|NCT00931775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24593974|NCT00931775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24593975|NCT00931775|Adrenergic Agents|adrenergic agents|mesh-ancestor
24593976|NCT00931775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24593977|NCT00931775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593978|NCT00931775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593979|NCT00931775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24593980|NCT00931775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25009346|NCT02054104|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25009347|NCT02054104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25009348|NCT02054104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25009349|NCT01954979|Abatacept|abatacept|mesh-list
25009350|NCT01954979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25009351|NCT01954979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009352|NCT01954979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009353|NCT01954979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25009354|NCT01954979|Immunologic Factors|immunologic factors|mesh-ancestor
25009355|NCT01954979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009356|NCT01954979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25009357|NCT01899144|Albuterol|albuterol|mesh-list
25009358|NCT01899144|Procaterol|procaterol|mesh-list
25009359|NCT01899144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25009360|NCT01899144|Autonomic Agents|autonomic agents|mesh-ancestor
25009361|NCT01899144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25009362|NCT01899144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009363|NCT01899144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25009365|NCT01899144|Tocolytic Agents|tocolytic agents|mesh-ancestor
25009366|NCT01899144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24572845|NCT00816894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24572846|NCT00816894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572847|NCT00816894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24572882|NCT00817011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24572883|NCT00817011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24572914|NCT00817037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24572915|NCT00817037|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24572916|NCT00817245|Amoxicillin|amoxicillin|mesh-list
24572917|NCT00817245|Metronidazole|metronidazole|mesh-list
24572919|NCT00817245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24443313|NCT00294463|Contraceptive Agents|contraceptive agents|mesh-ancestor
25246995|NCT01486264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25246996|NCT01370330|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
25246997|NCT01370330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25246998|NCT01370330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25246999|NCT01370330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247000|NCT01370330|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25247001|NCT01345175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25247002|NCT01345175|Metronidazole|metronidazole|mesh-list
25247004|NCT01345175|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25247005|NCT01345175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25247006|NCT01345175|Antitubercular Agents|antitubercular agents|mesh-ancestor
25247007|NCT01345175|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25247008|NCT01345175|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25247009|NCT01345175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25247010|NCT01285479|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24593981|NCT00931775|Serotonin Agents|serotonin agents|mesh-ancestor
24593982|NCT00931775|Vasodilator Agents|vasodilator agents|mesh-ancestor
24593983|NCT00931788|Antihypertensive Agents|antihypertensive agents|mesh-list
24593984|NCT00931827|Levonorgestrel|levonorgestrel|mesh-list
24593985|NCT00931827|Etonogestrel|etonogestrel|mesh-list
24593986|NCT00931827|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24593987|NCT00931827|Contraceptive Agents|contraceptive agents|mesh-ancestor
24593988|NCT00931827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24593989|NCT00931827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594156|NCT00932867|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24594157|NCT00932867|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24594158|NCT00932867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594159|NCT00932880|Amlodipine|amlodipine|mesh-list
24594160|NCT00932880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24594161|NCT00932880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24594169|NCT00932971|Interferon-alpha|interferon-alpha|mesh-list
24594170|NCT00932971|Interferon alpha-2|interferon alpha-2|mesh-list
24594171|NCT00932971|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
24594172|NCT00932971|Antiviral Agents|antiviral agents|mesh-ancestor
25073852|NCT03392740|Lisinopril|lisinopril|mesh-list
24572939|NCT00817284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572940|NCT00817284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24572941|NCT00817284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24572942|NCT00817284|Growth Substances|growth substances|mesh-ancestor
24572943|NCT00817284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572944|NCT00817284|Growth Inhibitors|growth inhibitors|mesh-ancestor
24573090|NCT00817765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24573218|NCT00818610|Cefuroxime|cefuroxime|mesh-list
24573219|NCT00818610|Cefuroxime axetil|cefuroxime axetil|mesh-list
24573220|NCT00818610|Lactams|lactams|mesh-list
24573221|NCT00818610|beta-Lactams|beta-lactams|mesh-list
24573222|NCT00818610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24573223|NCT00818610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24573224|NCT00818610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24573225|NCT00818610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573226|NCT00818610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671069|NCT01323465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24891069|NCT04477018|Chelating Agents|chelating agents|mesh-list
24561814|NCT00762944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24561815|NCT00762944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24561816|NCT00762957|Metformin|metformin|mesh-list
25247011|NCT01285479|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25247012|NCT01285479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247014|NCT01285479|Immunologic Factors|immunologic factors|mesh-ancestor
25247015|NCT01285479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247016|NCT01234532|Anastrozole|anastrozole|mesh-list
25247017|NCT01234532|Entinostat|entinostat|mesh-list
25247018|NCT01234532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25247019|NCT01234532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247020|NCT01234532|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25247021|NCT01234532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25247022|NCT01234532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25247023|NCT01234532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247024|NCT01234532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25247025|NCT01234532|Hormone Antagonists|hormone antagonists|mesh-ancestor
25247026|NCT01234532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25247027|NCT01234532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247028|NCT01234532|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25247029|NCT01217931|Bevacizumab|bevacizumab|mesh-list
25247030|NCT01217931|Everolimus|everolimus|mesh-list
24594173|NCT00932971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24594174|NCT00932971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24594202|NCT00933179|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
24594203|NCT00933179|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
24594205|NCT00933179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24594206|NCT00933179|Contraceptive Agents|contraceptive agents|mesh-ancestor
24594211|NCT00933179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24594212|NCT00933179|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24852772|NCT02264093|Adrenergic Agents|adrenergic agents|mesh-ancestor
24852773|NCT02264093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24594213|NCT00933179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24594214|NCT00933179|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
24594215|NCT00933179|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24594216|NCT00933179|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24594218|NCT00933179|Hormones|hormones|mesh-ancestor
24594219|NCT00933179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24594220|NCT00933205|Tipranavir|tipranavir|mesh-list
24561817|NCT00762957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24573327|NCT00819377|Milrinone|milrinone|mesh-list
24573328|NCT00819377|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24573329|NCT00819377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24573330|NCT00819377|Vasodilator Agents|vasodilator agents|mesh-ancestor
24573416|NCT00819845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573417|NCT00819845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573432|NCT00819962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24573433|NCT00819962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573434|NCT00819962|Sensory System Agents|sensory system agents|mesh-ancestor
24573435|NCT00819962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24573437|NCT00819975|Chelating Agents|chelating agents|mesh-ancestor
24573438|NCT00819975|Sequestering Agents|sequestering agents|mesh-ancestor
24573439|NCT00819975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573464|NCT00820092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24573465|NCT00820092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573466|NCT00820118|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24573467|NCT00820118|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24573511|NCT00820469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24573512|NCT00820482|Menotropins|menotropins|mesh-list
24573513|NCT00820482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24573515|NCT00820482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24573516|NCT00820482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573517|NCT00820547|Cyclophosphamide|cyclophosphamide|mesh-list
24573518|NCT00820547|Bevacizumab|bevacizumab|mesh-list
24573519|NCT00820547|Docetaxel|docetaxel|mesh-list
24573593|NCT00820911|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24573594|NCT00820911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24573644|NCT00821301|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24671078|NCT01323465|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25247031|NCT01217931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25247032|NCT01217931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247035|NCT01217931|Growth Substances|growth substances|mesh-ancestor
25247036|NCT01217931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247037|NCT01217931|Growth Inhibitors|growth inhibitors|mesh-ancestor
25247038|NCT01217931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25247039|NCT01217931|Immunologic Factors|immunologic factors|mesh-ancestor
25247040|NCT01154335|Everolimus|everolimus|mesh-list
25247041|NCT01154335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247042|NCT01154335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25247043|NCT01154335|Immunologic Factors|immunologic factors|mesh-ancestor
25247044|NCT01154335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247045|NCT01143116|Silver Nitrate|silver nitrate|mesh-list
25247046|NCT01143116|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25247047|NCT01143116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25247048|NCT01033032|Amrubicin|amrubicin|mesh-list
25247049|NCT01033032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247050|NCT00750698|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25247051|NCT00750698|Entinostat|entinostat|mesh-list
24594223|NCT00933205|Antiviral Agents|antiviral agents|mesh-ancestor
24594244|NCT00933231|Antiemetics|antiemetics|mesh-ancestor
24594245|NCT00933231|Autonomic Agents|autonomic agents|mesh-ancestor
24594246|NCT00933231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24594247|NCT00933231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24594248|NCT00933231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24594249|NCT00933231|Protective Agents|protective agents|mesh-ancestor
24594250|NCT00933231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24940449|NCT04001400|Rabeprazole|rabeprazole|mesh-list
24940450|NCT04001400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24940451|NCT04001400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24594251|NCT00933231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24594252|NCT00933231|Antitubercular Agents|antitubercular agents|mesh-ancestor
25045240|NCT00981357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24671079|NCT01323465|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24671080|NCT01323465|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24671081|NCT01323465|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24562135|NCT00764725|Analgesics|analgesics|mesh-ancestor
24562136|NCT00764725|Sensory System Agents|sensory system agents|mesh-ancestor
24562137|NCT00764725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24562147|NCT00764855|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24562148|NCT00764855|Anesthetics, General|anesthetics, general|mesh-ancestor
24562149|NCT00764855|Anesthetics|anesthetics|mesh-ancestor
24562150|NCT00764907|Leucovorin|leucovorin|mesh-list
24562151|NCT00764907|Cytarabine|cytarabine|mesh-list
24562165|NCT00764907|Vindesine|vindesine|mesh-list
24573772|NCT00822055|Maleic acid|maleic acid|mesh-list
24562166|NCT00764907|Levoleucovorin|levoleucovorin|mesh-list
24562167|NCT00764907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24573827|NCT00822211|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24573828|NCT00822211|Protease Inhibitors|protease inhibitors|mesh-ancestor
24573829|NCT00822211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573830|NCT00822211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573864|NCT00822380|Ascorbic Acid|ascorbic acid|mesh-list
24573865|NCT00822380|Micronutrients|micronutrients|mesh-list
24573866|NCT00822380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573867|NCT00822380|Hematinics|hematinics|mesh-ancestor
24573868|NCT00822380|Vitamin B Complex|vitamin b complex|mesh-ancestor
24573869|NCT00822380|Vitamins|vitamins|mesh-ancestor
24573870|NCT00822380|Antioxidants|antioxidants|mesh-ancestor
25247052|NCT00750698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247053|NCT00750698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25247054|NCT00750698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25247055|NCT00750698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247056|NCT00750698|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25247057|NCT00655993|Simvastatin|simvastatin|mesh-list
25247058|NCT00655993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25247059|NCT00655993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25247060|NCT00655993|Antimetabolites|antimetabolites|mesh-ancestor
25247061|NCT00655993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247062|NCT00655993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25247063|NCT00655993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25045241|NCT00981357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25045243|NCT00981357|Sensory System Agents|sensory system agents|mesh-ancestor
25045244|NCT00981357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045245|NCT00981357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045246|NCT00981357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25045247|NCT00981357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24969140|NCT03745261|Xhance|xhance|mesh-list
25045248|NCT00981357|Gout Suppressants|gout suppressants|mesh-ancestor
25045249|NCT00981357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25045250|NCT00981357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045251|NCT00981357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045252|NCT00979251|Oseltamivir|oseltamivir|mesh-list
25045253|NCT00979251|Amantadine|amantadine|mesh-list
25045254|NCT00979251|Antiviral Agents|antiviral agents|mesh-ancestor
25045255|NCT00979251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25045256|NCT00979251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045257|NCT00979251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045258|NCT00979251|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24594253|NCT00933231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24594254|NCT00933231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24594255|NCT00933231|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24594256|NCT00933231|Protease Inhibitors|protease inhibitors|mesh-ancestor
25686761|NCT01924299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686762|NCT01924299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25686763|NCT01924299|Hormone Antagonists|hormone antagonists|mesh-ancestor
24635793|NCT01141153|Anticoagulants|anticoagulants|mesh-ancestor
25686764|NCT01924299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25686765|NCT01924299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594257|NCT00933231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24594258|NCT00933231|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24594259|NCT00933231|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24594261|NCT00933283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24594262|NCT00933283|Narcotics|narcotics|mesh-ancestor
24573871|NCT00822380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573872|NCT00822380|Protective Agents|protective agents|mesh-ancestor
24573873|NCT00822393|Busulfan|busulfan|mesh-list
24573874|NCT00822393|Treosulfan|treosulfan|mesh-list
24573875|NCT00822393|Alkylating Agents|alkylating agents|mesh-ancestor
24573876|NCT00822393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573877|NCT00822393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24573878|NCT00822393|Immunologic Factors|immunologic factors|mesh-ancestor
25247071|NCT00551616|Levonorgestrel|levonorgestrel|mesh-list
25247072|NCT00551616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25247073|NCT00551616|Contraceptive Agents|contraceptive agents|mesh-ancestor
25247074|NCT00551616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25247075|NCT00551616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247076|NCT00551616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25247077|NCT00551616|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25247078|NCT00551616|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24594263|NCT00933283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24594264|NCT00933283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594265|NCT00933283|Analgesics|analgesics|mesh-ancestor
24594266|NCT00933283|Sensory System Agents|sensory system agents|mesh-ancestor
24594267|NCT00933283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24594268|NCT00933283|Antitussive Agents|antitussive agents|mesh-ancestor
24594269|NCT00933283|Respiratory System Agents|respiratory system agents|mesh-ancestor
24594271|NCT00933309|Rosiglitazone|rosiglitazone|mesh-list
24594272|NCT00933309|Exemestane|exemestane|mesh-list
24594273|NCT00933309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24594274|NCT00933309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594304|NCT00933426|Lenalidomide|lenalidomide|mesh-list
24594305|NCT00933426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24573929|NCT00822549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574071|NCT00823381|Protective Agents|protective agents|mesh-ancestor
24574104|NCT00823641|Infliximab|infliximab|mesh-list
24574105|NCT00823641|Dermatologic Agents|dermatologic agents|mesh-ancestor
24574106|NCT00823641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24574107|NCT00823641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24574108|NCT00823849|Cilostazol|cilostazol|mesh-list
24574109|NCT00823849|Probucol|probucol|mesh-list
24574110|NCT00823849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24574111|NCT00823849|Autonomic Agents|autonomic agents|mesh-ancestor
24574112|NCT00823849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24574113|NCT00823849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574114|NCT00823849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24574140|NCT00823875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24574141|NCT00823875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574142|NCT00823875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24574143|NCT00823875|Respiratory System Agents|respiratory system agents|mesh-ancestor
24574144|NCT00823875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24574145|NCT00823875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24574146|NCT00823875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574147|NCT00823875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24574148|NCT00823875|Vasodilator Agents|vasodilator agents|mesh-ancestor
24574149|NCT00823875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24574351|NCT00825058|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24574359|NCT00825058|Adrenergic Agents|adrenergic agents|mesh-ancestor
24574361|NCT00825071|Ondansetron|ondansetron|mesh-list
24574362|NCT00825071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25247104|NCT00492050|Valacyclovir|valacyclovir|mesh-list
24594410|NCT00933790|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24594411|NCT00933790|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24594414|NCT00933816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24594415|NCT00933816|Antimetabolites|antimetabolites|mesh-ancestor
24594416|NCT00933816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574363|NCT00825071|Antiemetics|antiemetics|mesh-ancestor
24574364|NCT00825071|Autonomic Agents|autonomic agents|mesh-ancestor
24574365|NCT00825071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24671097|NCT01323491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24671098|NCT01323491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671100|NCT01323491|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24574389|NCT00825097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24574390|NCT00825097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574392|NCT00825123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24574393|NCT00825123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24574394|NCT00825123|Sympatholytics|sympatholytics|mesh-ancestor
24574395|NCT00825123|Autonomic Agents|autonomic agents|mesh-ancestor
24574396|NCT00825123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24574397|NCT00825123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574398|NCT00825123|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24562516|NCT00766818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24792514|NCT05085002|Letrozole|letrozole|mesh-list
24513545|NCT00583271|Ethanol|ethanol|mesh-list
25109957|NCT03120936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25109958|NCT03120936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25109959|NCT03120936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24891552|NCT04470050|Adrenergic Agents|adrenergic agents|mesh-ancestor
24574460|NCT00825253|Biphasic Insulins|biphasic insulins|mesh-list
24891593|NCT04469283|Purinergic Agents|purinergic agents|mesh-ancestor
24891652|NCT04468139|Quercetin|quercetin|mesh-list
24574505|NCT00825851|Nicotine|nicotine|mesh-list
24574506|NCT00825851|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24574507|NCT00825851|Autonomic Agents|autonomic agents|mesh-ancestor
25247144|NCT00456261|Growth Inhibitors|growth inhibitors|mesh-ancestor
25247111|NCT00492050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25247112|NCT00492050|Antiviral Agents|antiviral agents|mesh-ancestor
25247113|NCT00492050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25247115|NCT00488072|Antidepressive Agents|antidepressive agents|mesh-ancestor
25247116|NCT00488072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25247117|NCT00488072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25247118|NCT00488072|Histamine Antagonists|histamine antagonists|mesh-ancestor
24574516|NCT00825864|Diclofenac|diclofenac|mesh-list
24574517|NCT00825864|Dexamethasone acetate|dexamethasone acetate|mesh-list
24574518|NCT00825864|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24891820|NCT04467931|Antioxidants|antioxidants|mesh-ancestor
24574623|NCT00826553|Anticonvulsants|anticonvulsants|mesh-ancestor
24574624|NCT00826553|Antiemetics|antiemetics|mesh-ancestor
24574625|NCT00826553|Autonomic Agents|autonomic agents|mesh-ancestor
24574626|NCT00826553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24574628|NCT00826566|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24574629|NCT00826566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574630|NCT00826566|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24574631|NCT00826566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574671|NCT00826826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24574672|NCT00826839|Leuprolide|leuprolide|mesh-list
24574673|NCT00826839|Contraceptive Agents|contraceptive agents|mesh-list
24574674|NCT00826839|Contraceptives, Oral|contraceptives, oral|mesh-list
24500147|NCT00523055|Lidocaine|lidocaine|mesh-list
24574675|NCT00826839|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
24574676|NCT00826839|Ganirelix|ganirelix|mesh-list
24574677|NCT00826839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24574678|NCT00826839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574699|NCT00826891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24574700|NCT00826891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25247223|NCT00075387|Antioxidants|antioxidants|mesh-ancestor
24574701|NCT00826891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247119|NCT00488072|Histamine Agents|histamine agents|mesh-ancestor
25247120|NCT00488072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25247121|NCT00488072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247122|NCT00488072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247123|NCT00488072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25247124|NCT00488072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25247125|NCT00488072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25247126|NCT00488072|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25247127|NCT00488072|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25247128|NCT00488072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25247129|NCT00488072|Adrenergic Agents|adrenergic agents|mesh-ancestor
25247130|NCT00488072|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25247131|NCT00488072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25247132|NCT00488072|Serotonin Agents|serotonin agents|mesh-ancestor
25247133|NCT00488072|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24852776|NCT02264093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24852777|NCT02264093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24594417|NCT00933816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24594418|NCT00933816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24594419|NCT00933816|Immunologic Factors|immunologic factors|mesh-ancestor
24594420|NCT00933816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594421|NCT00933816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24594511|NCT00934193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594514|NCT00934232|Alkylating Agents|alkylating agents|mesh-ancestor
24594515|NCT00934232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594516|NCT00934232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24594517|NCT00934232|Immunologic Factors|immunologic factors|mesh-ancestor
24594518|NCT00934232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852778|NCT02264093|Vasodilator Agents|vasodilator agents|mesh-ancestor
24852779|NCT02264106|Pantoprazole|pantoprazole|mesh-list
24852780|NCT02264106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24852781|NCT02264106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24852782|NCT02264106|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24852783|NCT02264106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24659728|NCT01279499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24594519|NCT00934232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24594520|NCT00934232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24574703|NCT00826930|Antioxidants|antioxidants|mesh-ancestor
24574704|NCT00826930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574705|NCT00826930|Protective Agents|protective agents|mesh-ancestor
24574706|NCT00826930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574707|NCT00826930|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24574708|NCT00826930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24574709|NCT00826969|Ciclesonide|ciclesonide|mesh-list
24574710|NCT00826969|Glucocorticoids|glucocorticoids|mesh-ancestor
24574711|NCT00826969|Hormones|hormones|mesh-ancestor
25009549|NCT05213143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25009550|NCT05213143|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24898152|NCT04418089|Simvastatin|simvastatin|mesh-list
24574762|NCT00827307|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24574763|NCT00827320|Levetiracetam|levetiracetam|mesh-list
24574764|NCT00827320|Anticonvulsants|anticonvulsants|mesh-ancestor
24574765|NCT00827320|Nootropic Agents|nootropic agents|mesh-ancestor
24574766|NCT00827346|Clopidogrel|clopidogrel|mesh-list
24574767|NCT00827346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24574768|NCT00827346|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24574769|NCT00827346|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24574770|NCT00827346|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24574811|NCT00827554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25247134|NCT00456261|Gemcitabine|gemcitabine|mesh-list
25247135|NCT00456261|Bevacizumab|bevacizumab|mesh-list
25247136|NCT00456261|Carboplatin|carboplatin|mesh-list
25247137|NCT00456261|Pemetrexed|pemetrexed|mesh-list
25247138|NCT00456261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25247139|NCT00456261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247140|NCT00456261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25247141|NCT00456261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25247142|NCT00456261|Growth Substances|growth substances|mesh-ancestor
25247143|NCT00456261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247145|NCT00456261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25247146|NCT00456261|Antimetabolites|antimetabolites|mesh-ancestor
25247147|NCT00456261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247148|NCT00456261|Antiviral Agents|antiviral agents|mesh-ancestor
25247149|NCT00456261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25247150|NCT00456261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25247151|NCT00456261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25247152|NCT00456261|Immunologic Factors|immunologic factors|mesh-ancestor
25247153|NCT00456261|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25247154|NCT00456261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24940554|NCT04000386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274382|NCT02378441|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25274383|NCT02378441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274384|NCT02378532|Chloroquine|chloroquine|mesh-list
25274385|NCT02378532|Temozolomide|temozolomide|mesh-list
25274386|NCT02378532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24594521|NCT00934232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24594522|NCT00934245|Vaccines|vaccines|mesh-list
24594523|NCT00934245|Immunologic Factors|immunologic factors|mesh-ancestor
24594524|NCT00934245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594525|NCT00934258|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24594526|NCT00934258|Fenofibrate|fenofibrate|mesh-list
24594527|NCT00934258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24594528|NCT00934258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24594529|NCT00934258|Antimetabolites|antimetabolites|mesh-ancestor
24594530|NCT00934258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594531|NCT00934258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24594564|NCT00934492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24594565|NCT00934492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24594566|NCT00934518|Cetuximab|cetuximab|mesh-list
24594567|NCT00934518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24594568|NCT00934518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24594569|NCT00934531|Donepezil|donepezil|mesh-list
24594570|NCT00934531|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24594571|NCT00934531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594572|NCT00934531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594573|NCT00934531|Cholinergic Agents|cholinergic agents|mesh-ancestor
24594574|NCT00934531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24594575|NCT00934531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594576|NCT00934531|Nootropic Agents|nootropic agents|mesh-ancestor
24574813|NCT00827580|Eniluracil|eniluracil|mesh-list
24574829|NCT00827684|Antifungal Agents|antifungal agents|mesh-ancestor
24574830|NCT00827684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24574831|NCT00827684|Immunologic Factors|immunologic factors|mesh-ancestor
24574832|NCT00827684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574833|NCT00827814|Dutasteride|dutasteride|mesh-list
24574834|NCT00827814|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24969287|NCT03744091|Dronabinol|dronabinol|mesh-list
24574835|NCT00827814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24574836|NCT00827814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759022|NCT01749085|Antifungal Agents|antifungal agents|mesh-ancestor
24574888|NCT00828282|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24574889|NCT00828282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574890|NCT00828373|Lidocaine|lidocaine|mesh-list
24574891|NCT00828373|Anesthetics, Local|anesthetics, local|mesh-ancestor
24574892|NCT00828373|Anesthetics|anesthetics|mesh-ancestor
25009551|NCT05213143|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24891992|NCT04466176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24574981|NCT00828815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574983|NCT00828815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24574985|NCT00828919|Crizotinib|crizotinib|mesh-list
25247195|NCT00110110|Antimitotic Agents|antimitotic agents|mesh-ancestor
24575004|NCT00828971|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24575005|NCT00828971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24575006|NCT00828971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24575007|NCT00828971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24575008|NCT00828971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24575009|NCT00828971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575010|NCT00828971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247155|NCT00362219|Morphine|morphine|mesh-list
25247156|NCT00362219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25247157|NCT00362219|Narcotics|narcotics|mesh-ancestor
25247158|NCT00362219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25247159|NCT00362219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247160|NCT00362219|Analgesics|analgesics|mesh-ancestor
25247161|NCT00362219|Sensory System Agents|sensory system agents|mesh-ancestor
25247162|NCT00362219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25247163|NCT00345345|Alemtuzumab|alemtuzumab|mesh-list
25247171|NCT00215813|Immunologic Factors|immunologic factors|mesh-ancestor
25247172|NCT00215813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247178|NCT00124891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
24594580|NCT00934687|Botulinum Toxins|botulinum toxins|mesh-list
24594581|NCT00934687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25686766|NCT01924299|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24594589|NCT00934687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24594590|NCT00934687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24594592|NCT00934713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24594593|NCT00934713|Respiratory System Agents|respiratory system agents|mesh-ancestor
24594594|NCT00934713|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24594595|NCT00934713|Hormone Antagonists|hormone antagonists|mesh-ancestor
24852784|NCT02264106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594596|NCT00934713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24594597|NCT00934713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594598|NCT00934713|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24594599|NCT00934713|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24502728|NCT04549168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594625|NCT00934739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24594626|NCT00934739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25074004|NCT03391427|Ketamine|ketamine|mesh-list
24575011|NCT00828971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24575012|NCT00828971|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24575013|NCT00828971|Contraceptive Agents|contraceptive agents|mesh-ancestor
24575014|NCT00828971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24575015|NCT00828971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575016|NCT00828971|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24575017|NCT00828971|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24575018|NCT00828971|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24575019|NCT00828997|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24575020|NCT00828997|Immunologic Factors|immunologic factors|mesh-ancestor
24575021|NCT00828997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575022|NCT00829023|Ethanol|ethanol|mesh-list
25009595|NCT05212246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009596|NCT05212246|Interferon Inducers|interferon inducers|mesh-ancestor
25009600|NCT05211622|Thioctic Acid|thioctic acid|mesh-list
25009601|NCT05211622|Chlorhexidine|chlorhexidine|mesh-list
25009602|NCT05211622|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25009603|NCT05211622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25247179|NCT00110110|Cyclosporine|cyclosporine|mesh-list
25247180|NCT00110110|Carboplatin|carboplatin|mesh-list
25247181|NCT00110110|Etoposide|etoposide|mesh-list
25247182|NCT00110110|Vincristine|vincristine|mesh-list
25247183|NCT00110110|Cyclosporins|cyclosporins|mesh-list
25247184|NCT00110110|Lenograstim|lenograstim|mesh-list
25247185|NCT00110110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247186|NCT00110110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25247187|NCT00110110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25247188|NCT00110110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25247189|NCT00110110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25247190|NCT00110110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247191|NCT00110110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25247192|NCT00110110|Immunologic Factors|immunologic factors|mesh-ancestor
25247193|NCT00110110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247194|NCT00110110|Tubulin Modulators|tubulin modulators|mesh-ancestor
25247196|NCT00110110|Mitosis Modulators|mitosis modulators|mesh-ancestor
25247197|NCT00110110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25247198|NCT00110110|Antifungal Agents|antifungal agents|mesh-ancestor
25247199|NCT00110110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25247200|NCT00110110|Dermatologic Agents|dermatologic agents|mesh-ancestor
25247201|NCT00110110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25247202|NCT00110110|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24594627|NCT00934739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24594628|NCT00934739|Growth Substances|growth substances|mesh-ancestor
24594629|NCT00934739|Growth Inhibitors|growth inhibitors|mesh-ancestor
24594630|NCT00934739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24594631|NCT00934739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24594633|NCT00934739|Sensory System Agents|sensory system agents|mesh-ancestor
24594634|NCT00934739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24594635|NCT00934739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24594636|NCT00934739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594637|NCT00934752|Paclitaxel|paclitaxel|mesh-list
24594656|NCT00934895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24594657|NCT00934895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24594658|NCT00934895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24594659|NCT00934895|Tubulin Modulators|tubulin modulators|mesh-ancestor
24594660|NCT00934895|Antimitotic Agents|antimitotic agents|mesh-ancestor
24594685|NCT00935116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594687|NCT00935194|Antiviral Agents|antiviral agents|mesh-ancestor
24594688|NCT00935194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24594689|NCT00935194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25284213|NCT05080803|Ranibizumab|ranibizumab|mesh-list
24594690|NCT00935194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594691|NCT00935246|Dexetimide|dexetimide|mesh-list
24594727|NCT00935363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594728|NCT00935363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594729|NCT00935363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24500626|NCT00525239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25009604|NCT05211622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25009605|NCT05211622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25009606|NCT05211622|Disinfectants|disinfectants|mesh-ancestor
25009607|NCT05211622|Dermatologic Agents|dermatologic agents|mesh-ancestor
25009608|NCT05211622|Antioxidants|antioxidants|mesh-ancestor
25009609|NCT05211622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009610|NCT05211622|Protective Agents|protective agents|mesh-ancestor
25009611|NCT05211622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009612|NCT05211622|Vitamin B Complex|vitamin b complex|mesh-ancestor
25009613|NCT05211622|Vitamins|vitamins|mesh-ancestor
25009614|NCT05211622|Micronutrients|micronutrients|mesh-ancestor
25009615|NCT05211583|Progesterone|progesterone|mesh-list
25009616|NCT05211583|Progestins|progestins|mesh-ancestor
25009617|NCT05211583|Hormones|hormones|mesh-ancestor
24575091|NCT00829322|Modafinil|modafinil|mesh-list
24575092|NCT00829322|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24575171|NCT00829894|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24575295|NCT00830505|Respiratory System Agents|respiratory system agents|mesh-ancestor
24575296|NCT00830505|Dermatologic Agents|dermatologic agents|mesh-ancestor
24575297|NCT00830505|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24575298|NCT00830505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24575299|NCT00830505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24575300|NCT00830505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24575318|NCT00830609|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25247203|NCT00075387|Sodium thiosulfate|sodium thiosulfate|mesh-list
25247204|NCT00075387|Cyclophosphamide|cyclophosphamide|mesh-list
25247205|NCT00075387|Carboplatin|carboplatin|mesh-list
25247206|NCT00075387|Etoposide|etoposide|mesh-list
25247207|NCT00075387|Etoposide phosphate|etoposide phosphate|mesh-list
25247208|NCT00075387|Antidotes|antidotes|mesh-list
25247209|NCT00075387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25247210|NCT00075387|Immunologic Factors|immunologic factors|mesh-ancestor
25247211|NCT00075387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247212|NCT00075387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25247213|NCT00075387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25247214|NCT00075387|Alkylating Agents|alkylating agents|mesh-ancestor
25247215|NCT00075387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247216|NCT00075387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247217|NCT00075387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25247218|NCT00075387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25247219|NCT00075387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25247220|NCT00075387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25247221|NCT00075387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25247225|NCT00075387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25247226|NCT00075387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25247227|NCT00075387|Chelating Agents|chelating agents|mesh-ancestor
25247228|NCT00075387|Sequestering Agents|sequestering agents|mesh-ancestor
25247229|NCT00061945|Leucovorin|leucovorin|mesh-list
24594730|NCT00935363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24594731|NCT00935363|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24594732|NCT00935363|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24594733|NCT00935363|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24594734|NCT00935363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24594735|NCT00935363|Antifungal Agents|antifungal agents|mesh-ancestor
24594736|NCT00935363|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24594737|NCT00935363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24594738|NCT00935363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24594739|NCT00935363|Hormone Antagonists|hormone antagonists|mesh-ancestor
24594740|NCT00935363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24594762|NCT00935467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25074051|NCT03390972|Dexmedetomidine|dexmedetomidine|mesh-list
24575319|NCT00830609|Interferon-alpha|interferon-alpha|mesh-list
24575320|NCT00830609|Antimetabolites|antimetabolites|mesh-ancestor
24575321|NCT00830609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575322|NCT00830609|Antiviral Agents|antiviral agents|mesh-ancestor
24575323|NCT00830609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24575324|NCT00830609|Immunologic Factors|immunologic factors|mesh-ancestor
24575325|NCT00830609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575326|NCT00830830|Hyaluronic Acid|hyaluronic acid|mesh-list
24575327|NCT00830830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24575328|NCT00830830|Immunologic Factors|immunologic factors|mesh-ancestor
24575329|NCT00830830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575349|NCT00830856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575351|NCT00830856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24575352|NCT00830856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24575357|NCT00830856|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24575359|NCT00830856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24575360|NCT00830856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575361|NCT00830856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24575362|NCT00830856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24575363|NCT00830856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24575364|NCT00830856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24575365|NCT00830856|Antimetabolites|antimetabolites|mesh-ancestor
25009643|NCT05210595|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25009644|NCT05210595|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25009645|NCT05210595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25009646|NCT05210595|Purinergic Agents|purinergic agents|mesh-ancestor
25009647|NCT05210595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25009648|NCT05210595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009649|NCT05210595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009655|NCT05210517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009656|NCT05210517|Uricosuric Agents|uricosuric agents|mesh-ancestor
25009657|NCT05210517|Gout Suppressants|gout suppressants|mesh-ancestor
25009658|NCT05210517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25009659|NCT05210517|Renal Agents|renal agents|mesh-ancestor
25109979|NCT03120923|Sensory System Agents|sensory system agents|mesh-ancestor
24575414|NCT00831376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24575415|NCT00831376|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24575416|NCT00831376|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24575417|NCT00831376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24575418|NCT00831376|Adrenergic Agents|adrenergic agents|mesh-ancestor
24575419|NCT00831376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25247230|NCT00061945|Cytarabine|cytarabine|mesh-list
25247231|NCT00061945|Acyclovir|acyclovir|mesh-list
25247232|NCT00061945|Trimethoprim|trimethoprim|mesh-list
25247233|NCT00061945|Sulfamethoxazole|sulfamethoxazole|mesh-list
25247234|NCT00061945|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25247235|NCT00061945|Dexamethasone|dexamethasone|mesh-list
25247236|NCT00061945|Cyclophosphamide|cyclophosphamide|mesh-list
25247237|NCT00061945|Methotrexate|methotrexate|mesh-list
25247238|NCT00061945|Vincristine|vincristine|mesh-list
25247239|NCT00061945|Imatinib Mesylate|imatinib mesylate|mesh-list
25247240|NCT00061945|Daunorubicin|daunorubicin|mesh-list
25247242|NCT00061945|Mercaptopurine|mercaptopurine|mesh-list
25247243|NCT00061945|Alemtuzumab|alemtuzumab|mesh-list
25247244|NCT00061945|Allopurinol|allopurinol|mesh-list
25247245|NCT00061945|Levoleucovorin|levoleucovorin|mesh-list
25247246|NCT00061945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24594764|NCT00935467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24594765|NCT00935480|Raltegravir Potassium|raltegravir potassium|mesh-list
24594766|NCT00935480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24594767|NCT00935480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24594768|NCT00935480|Antiviral Agents|antiviral agents|mesh-ancestor
24594769|NCT00935480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24594770|NCT00935480|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24594771|NCT00935480|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24594772|NCT00935480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594773|NCT00935480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594789|NCT00935506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594790|NCT00935506|Antipyretics|antipyretics|mesh-ancestor
24594791|NCT00935506|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24575420|NCT00831376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575422|NCT00831506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24575423|NCT00831506|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24575424|NCT00831506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575425|NCT00831506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575426|NCT00831506|Protective Agents|protective agents|mesh-ancestor
24575481|NCT00832013|Anesthetics|anesthetics|mesh-ancestor
24575482|NCT00832039|Selenious Acid|selenious acid|mesh-list
24575494|NCT00832182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575495|NCT00832208|Amphotericin B|amphotericin b|mesh-list
24575496|NCT00832208|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24575497|NCT00832208|Amebicides|amebicides|mesh-ancestor
24575498|NCT00832208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24575499|NCT00832208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24575500|NCT00832208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24575501|NCT00832208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24575502|NCT00832208|Antifungal Agents|antifungal agents|mesh-ancestor
24575503|NCT00832221|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24575504|NCT00832221|Raclopride|raclopride|mesh-list
24575567|NCT00832442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24575568|NCT00832442|Sympatholytics|sympatholytics|mesh-ancestor
24575569|NCT00832442|Autonomic Agents|autonomic agents|mesh-ancestor
24575570|NCT00832442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24575571|NCT00832442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575572|NCT00832442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24575573|NCT00832442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24575574|NCT00832442|Adrenergic Agents|adrenergic agents|mesh-ancestor
24575575|NCT00832442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24575576|NCT00832442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575577|NCT00832442|Antioxidants|antioxidants|mesh-ancestor
24575578|NCT00832442|Protective Agents|protective agents|mesh-ancestor
24563315|NCT00771017|Leuprolide|leuprolide|mesh-list
24575579|NCT00832442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24575580|NCT00832442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24575581|NCT00832442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24575582|NCT00832442|Vasodilator Agents|vasodilator agents|mesh-ancestor
25247247|NCT00061945|Immunologic Factors|immunologic factors|mesh-ancestor
25247248|NCT00061945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247249|NCT00061945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25247250|NCT00061945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25247251|NCT00061945|Alkylating Agents|alkylating agents|mesh-ancestor
25247252|NCT00061945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247253|NCT00061945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247254|NCT00061945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25247255|NCT00061945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25247256|NCT00061945|Antiemetics|antiemetics|mesh-ancestor
25247257|NCT00061945|Autonomic Agents|autonomic agents|mesh-ancestor
25247258|NCT00061945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25247259|NCT00061945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25247260|NCT00061945|Glucocorticoids|glucocorticoids|mesh-ancestor
24594792|NCT00935506|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24594793|NCT00935506|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24594794|NCT00935506|Purinergic Agents|purinergic agents|mesh-ancestor
24594795|NCT00935506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24594796|NCT00935545|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
24594797|NCT00935545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24852786|NCT02264119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24852787|NCT02264119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24852788|NCT02264119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24852789|NCT02264119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594798|NCT00935545|Immunologic Factors|immunologic factors|mesh-ancestor
24594799|NCT00935545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594800|NCT00935558|Interleukin-2|interleukin-2|mesh-list
24594825|NCT00935571|Sevoflurane|sevoflurane|mesh-list
24594826|NCT00935571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24594827|NCT00935571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24792701|NCT04777006|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24575676|NCT00833326|Tubulin Modulators|tubulin modulators|mesh-ancestor
24575677|NCT00833326|Mitosis Modulators|mitosis modulators|mesh-ancestor
24575678|NCT00833326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575679|NCT00833339|Mifepristone|mifepristone|mesh-list
24575680|NCT00833339|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24575681|NCT00833339|Abortifacient Agents|abortifacient agents|mesh-ancestor
24575682|NCT00833339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24575723|NCT00833534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704902|NCT01480986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575724|NCT00833534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24575725|NCT00833534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24575726|NCT00833534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24575727|NCT00833534|Growth Substances|growth substances|mesh-ancestor
24575728|NCT00833534|Growth Inhibitors|growth inhibitors|mesh-ancestor
24575730|NCT00833729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24575731|NCT00833729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24575733|NCT00833729|Sensory System Agents|sensory system agents|mesh-ancestor
24575734|NCT00833729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24575735|NCT00833729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575737|NCT00833729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24575738|NCT00833729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24575739|NCT00833729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24575740|NCT00833729|Immunologic Factors|immunologic factors|mesh-ancestor
24575742|NCT00833768|Chelating Agents|chelating agents|mesh-ancestor
24575751|NCT00833807|Mitosis Modulators|mitosis modulators|mesh-ancestor
24575752|NCT00833807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575753|NCT00833963|Trastuzumab|trastuzumab|mesh-list
24969452|NCT03742531|Oxytocin|oxytocin|mesh-list
24575755|NCT00833963|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24575756|NCT00833963|Maytansine|maytansine|mesh-list
24575757|NCT00833963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24575758|NCT00833963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24575759|NCT00833963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24575760|NCT00833963|Tubulin Modulators|tubulin modulators|mesh-ancestor
24575761|NCT00833963|Antimitotic Agents|antimitotic agents|mesh-ancestor
24575762|NCT00833963|Mitosis Modulators|mitosis modulators|mesh-ancestor
25247261|NCT00061945|Hormones|hormones|mesh-ancestor
25247262|NCT00061945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25247263|NCT00061945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25247264|NCT00061945|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25247265|NCT00061945|Abortifacient Agents|abortifacient agents|mesh-ancestor
25247266|NCT00061945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25247267|NCT00061945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25247268|NCT00061945|Antimetabolites|antimetabolites|mesh-ancestor
25247269|NCT00061945|Dermatologic Agents|dermatologic agents|mesh-ancestor
25247270|NCT00061945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25247271|NCT00061945|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25247272|NCT00061945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25247273|NCT00061945|Antiviral Agents|antiviral agents|mesh-ancestor
25247274|NCT00061945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25247275|NCT00061945|Antidotes|antidotes|mesh-ancestor
25247276|NCT00061945|Protective Agents|protective agents|mesh-ancestor
24594828|NCT00935571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594829|NCT00935571|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24594830|NCT00935571|Anesthetics, General|anesthetics, general|mesh-ancestor
24594868|NCT00935805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24594869|NCT00935805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24595225|NCT00937300|Antiviral Agents|antiviral agents|mesh-ancestor
24594870|NCT00935805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24594871|NCT00935805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961359|NCT03809065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24594872|NCT00935805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24594873|NCT00935805|Vasodilator Agents|vasodilator agents|mesh-ancestor
24594887|NCT00935961|Tubulin Modulators|tubulin modulators|mesh-ancestor
24594888|NCT00935961|Antimitotic Agents|antimitotic agents|mesh-ancestor
24594889|NCT00935961|Mitosis Modulators|mitosis modulators|mesh-ancestor
25074091|NCT03390738|Nivolumab|nivolumab|mesh-list
24575763|NCT00833963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575764|NCT00834184|Nikkomycin|nikkomycin|mesh-list
24575765|NCT00834184|Antifungal Agents|antifungal agents|mesh-ancestor
24575790|NCT00834457|Abacavir|abacavir|mesh-list
24575791|NCT00834457|Dideoxynucleosides|dideoxynucleosides|mesh-list
24575792|NCT00834457|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24575793|NCT00834457|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24575794|NCT00834457|Protease Inhibitors|protease inhibitors|mesh-ancestor
24575795|NCT00834457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575796|NCT00834457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575797|NCT00834457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24575798|NCT00834457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25686767|NCT01924299|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24705032|NCT01481831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24705034|NCT01481831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24575818|NCT00834470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24575819|NCT00834470|Cholinergic Agents|cholinergic agents|mesh-ancestor
24575820|NCT00834470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24575821|NCT00834470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575833|NCT00834600|Diuretics|diuretics|mesh-ancestor
24575834|NCT00834600|Natriuretic Agents|natriuretic agents|mesh-ancestor
24575835|NCT00834600|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24575836|NCT00834600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24575882|NCT00835029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24575883|NCT00835029|Antifungal Agents|antifungal agents|mesh-ancestor
25284391|NCT04423601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575884|NCT00835029|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24575885|NCT00835029|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24575886|NCT00835029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575887|NCT00835029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575888|NCT00835029|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24575889|NCT00835029|Hormone Antagonists|hormone antagonists|mesh-ancestor
24575890|NCT00835029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24969485|NCT03742323|Idelalisib|idelalisib|mesh-list
25109980|NCT03120923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25109981|NCT03120923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25109982|NCT03120923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25109983|NCT03120923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24575919|NCT00835471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009684|NCT05210192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009685|NCT05210166|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
25009686|NCT05210166|Antioxidants|antioxidants|mesh-ancestor
25009687|NCT05210166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009688|NCT05210166|Protective Agents|protective agents|mesh-ancestor
25009689|NCT05210166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247277|NCT00061945|Vitamin B Complex|vitamin b complex|mesh-ancestor
25247278|NCT00061945|Vitamins|vitamins|mesh-ancestor
25247279|NCT00061945|Micronutrients|micronutrients|mesh-ancestor
25247280|NCT00061945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25247281|NCT00061945|Tubulin Modulators|tubulin modulators|mesh-ancestor
25247282|NCT00061945|Antimitotic Agents|antimitotic agents|mesh-ancestor
25247283|NCT00061945|Mitosis Modulators|mitosis modulators|mesh-ancestor
25247284|NCT00061945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25247285|NCT00061945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25247286|NCT00061945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25247287|NCT00061945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25247288|NCT00061945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25247289|NCT00061945|Gout Suppressants|gout suppressants|mesh-ancestor
25247290|NCT00061945|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25247291|NCT00061945|Antioxidants|antioxidants|mesh-ancestor
24594890|NCT00935961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594891|NCT00935961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24594892|NCT00935961|Immunologic Factors|immunologic factors|mesh-ancestor
24594893|NCT00935961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594894|NCT00936013|Oseltamivir|oseltamivir|mesh-list
24594895|NCT00936013|Antiviral Agents|antiviral agents|mesh-ancestor
24594896|NCT00936013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24594897|NCT00936013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594957|NCT00936195|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24594901|NCT00936091|Micronutrients|micronutrients|mesh-ancestor
24594920|NCT00936156|Immunologic Factors|immunologic factors|mesh-ancestor
24594921|NCT00936156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594922|NCT00936182|Fluconazole|fluconazole|mesh-list
25009690|NCT05210166|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25009691|NCT05210166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009693|NCT05210153|Antidepressive Agents|antidepressive agents|mesh-ancestor
25009694|NCT05210153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25009695|NCT05210153|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25009696|NCT05210153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25009697|NCT05210153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25686768|NCT01924299|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25686769|NCT01924429|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25686770|NCT01924429|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25009698|NCT05210153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009699|NCT05210153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25009700|NCT05210153|Serotonin Agents|serotonin agents|mesh-ancestor
25009701|NCT05210153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575961|NCT00835939|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24575963|NCT00835939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24575964|NCT00835939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575965|NCT00835965|Dexamethasone|dexamethasone|mesh-list
24575966|NCT00835965|Dexamethasone acetate|dexamethasone acetate|mesh-list
24575967|NCT00835965|Aprepitant|aprepitant|mesh-list
24575968|NCT00835965|Fosaprepitant|fosaprepitant|mesh-list
24575969|NCT00835965|BB 1101|bb 1101|mesh-list
24575970|NCT00835965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24575971|NCT00835965|Antiemetics|antiemetics|mesh-ancestor
24575972|NCT00835965|Autonomic Agents|autonomic agents|mesh-ancestor
24892695|NCT04460443|Sofosbuvir|sofosbuvir|mesh-list
24575983|NCT00835965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575984|NCT00835965|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24575986|NCT00836043|Alemtuzumab|alemtuzumab|mesh-list
24576000|NCT00836212|Lopinavir|lopinavir|mesh-list
24576020|NCT00836316|Anesthetics, Local|anesthetics, local|mesh-ancestor
24576022|NCT00836316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24576023|NCT00836316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576024|NCT00836316|Sensory System Agents|sensory system agents|mesh-ancestor
24576025|NCT00836316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24576026|NCT00836368|Vitamin E|vitamin e|mesh-list
24576027|NCT00836368|Tocopherols|tocopherols|mesh-list
24576028|NCT00836368|Tocotrienols|tocotrienols|mesh-list
24576029|NCT00836368|alpha-Tocopherol|alpha-tocopherol|mesh-list
24576030|NCT00836368|gamma-Tocopherol|gamma-tocopherol|mesh-list
24576031|NCT00836368|Vitamins|vitamins|mesh-ancestor
24576032|NCT00836368|Micronutrients|micronutrients|mesh-ancestor
24576033|NCT00836368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576034|NCT00836368|Antioxidants|antioxidants|mesh-ancestor
24576035|NCT00836368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576046|NCT00836485|Ketotifen|ketotifen|mesh-list
25247292|NCT00061945|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25247293|NCT00061945|Renal Agents|renal agents|mesh-ancestor
25247294|NCT00061945|Antimalarials|antimalarials|mesh-ancestor
25247295|NCT00061945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25247296|NCT00061945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25247297|NCT00061945|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25247298|NCT00061945|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25247299|NCT00061945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25247300|NCT00061945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25247301|NCT00004494|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
25247302|NCT00004494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25247303|NCT00004494|Vasodilator Agents|vasodilator agents|mesh-ancestor
25247304|NCT00004494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25247305|NCT00004494|Protective Agents|protective agents|mesh-ancestor
24594947|NCT00936195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594949|NCT00936195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24594950|NCT00936195|Antiviral Agents|antiviral agents|mesh-ancestor
24594951|NCT00936195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24594952|NCT00936195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24594953|NCT00936195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24594954|NCT00936195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24594955|NCT00936195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24564226|NCT00775632|Abortifacient Agents|abortifacient agents|mesh-ancestor
24594959|NCT00936195|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24594960|NCT00936195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24594961|NCT00936195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24594963|NCT00936234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24594964|NCT00936234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594965|NCT00936234|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24576119|NCT00836914|Idelalisib|idelalisib|mesh-list
24576120|NCT00836914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24576121|NCT00836914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24576122|NCT00836914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576123|NCT00837044|Naproxen|naproxen|mesh-list
24576124|NCT00837044|Sumatriptan|sumatriptan|mesh-list
24576125|NCT00837044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24576126|NCT00837044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24576127|NCT00837044|Analgesics|analgesics|mesh-ancestor
24576128|NCT00837044|Sensory System Agents|sensory system agents|mesh-ancestor
24576129|NCT00837044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24576130|NCT00837044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576131|NCT00837044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24576132|NCT00837044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24576133|NCT00837044|Gout Suppressants|gout suppressants|mesh-ancestor
24576134|NCT00837044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24576135|NCT00837044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24576197|NCT00837564|Citalopram|citalopram|mesh-list
24576240|NCT00837746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24576241|NCT00837746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576242|NCT00837746|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24576243|NCT00837785|Dimethyl Fumarate|dimethyl fumarate|mesh-list
24631941|NCT01121055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24631942|NCT01121055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24576244|NCT00837785|Dermatologic Agents|dermatologic agents|mesh-ancestor
24576245|NCT00837785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24576246|NCT00837785|Immunologic Factors|immunologic factors|mesh-ancestor
24576247|NCT00837785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576248|NCT00837837|Chlorpheniramine|chlorpheniramine|mesh-list
24576249|NCT00837837|Antipruritics|antipruritics|mesh-ancestor
25009709|NCT05210140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009710|NCT05210140|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25009711|NCT05210140|Antidepressive Agents|antidepressive agents|mesh-ancestor
25009712|NCT05210140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24576299|NCT00837941|Sensory System Agents|sensory system agents|mesh-ancestor
25247306|NCT00004494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247307|NCT04073433|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25247308|NCT04073433|Hallucinogens|hallucinogens|mesh-ancestor
25247309|NCT04073433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247310|NCT04073433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25247311|NCT04073433|Serotonin Agents|serotonin agents|mesh-ancestor
25247312|NCT04073433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25247313|NCT04073433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247314|NCT04073433|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25247315|NCT04073433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25247316|NCT04073433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25247317|NCT04073433|Adrenergic Agents|adrenergic agents|mesh-ancestor
25247319|NCT04018612|Acetaminophen|acetaminophen|mesh-list
25247320|NCT04018612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25247321|NCT04018612|Analgesics|analgesics|mesh-ancestor
25247322|NCT04018612|Sensory System Agents|sensory system agents|mesh-ancestor
25247323|NCT04018612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25247324|NCT04018612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594986|NCT00936390|Hormone Antagonists|hormone antagonists|mesh-ancestor
24594987|NCT00936390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24635926|NCT01141894|Respiratory System Agents|respiratory system agents|mesh-ancestor
24635927|NCT01141894|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24635928|NCT01141894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24595222|NCT00937300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24595223|NCT00937300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24595224|NCT00937300|Antimetabolites|antimetabolites|mesh-ancestor
24576308|NCT00837941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24576309|NCT00837941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24576379|NCT00838240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24576381|NCT00838240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576382|NCT00838240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24576383|NCT00838240|Antiviral Agents|antiviral agents|mesh-ancestor
24576384|NCT00838240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24576385|NCT00838240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24576386|NCT00838240|Immunologic Factors|immunologic factors|mesh-ancestor
24576387|NCT00838240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576388|NCT00838240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24576467|NCT00838760|TMC-310911|tmc-310911|mesh-list
24576468|NCT00838760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24576469|NCT00838760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24576470|NCT00838760|Protease Inhibitors|protease inhibitors|mesh-ancestor
24576471|NCT00838760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24576472|NCT00838760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576473|NCT00838760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24576500|NCT00838955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576503|NCT00838968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24576504|NCT00838968|Antiviral Agents|antiviral agents|mesh-ancestor
24576505|NCT00838968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24576521|NCT00839085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576522|NCT00839085|Vitamins|vitamins|mesh-ancestor
24576523|NCT00839085|Micronutrients|micronutrients|mesh-ancestor
24576524|NCT00839085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24576525|NCT00839085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24576526|NCT00839111|Irinotecan|irinotecan|mesh-list
24576527|NCT00839111|Sorafenib|sorafenib|mesh-list
24576528|NCT00839111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25247325|NCT04018612|Antipyretics|antipyretics|mesh-ancestor
25247337|NCT03937895|Pembrolizumab|pembrolizumab|mesh-list
25274387|NCT02378532|Alkylating Agents|alkylating agents|mesh-ancestor
24595227|NCT00937300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24595251|NCT00937625|Fludarabine|fludarabine|mesh-list
25146450|NCT02921269|Antibodies|antibodies|mesh-list
24595252|NCT00937625|Fludarabine phosphate|fludarabine phosphate|mesh-list
24595253|NCT00937625|Interleukin-2|interleukin-2|mesh-list
24595254|NCT00937625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24595255|NCT00937625|Immunologic Factors|immunologic factors|mesh-ancestor
24595256|NCT00937625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595257|NCT00937625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24595267|NCT00937625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24595268|NCT00937625|Analgesics|analgesics|mesh-ancestor
24595269|NCT00937625|Sensory System Agents|sensory system agents|mesh-ancestor
24595270|NCT00937625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24595271|NCT00937664|Gemcitabine|gemcitabine|mesh-list
24595272|NCT00937664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24595273|NCT00937664|Antimetabolites|antimetabolites|mesh-ancestor
24595274|NCT00937664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595275|NCT00937664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24595276|NCT00937664|Antiviral Agents|antiviral agents|mesh-ancestor
24576529|NCT00839111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24576530|NCT00839111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444022|NCT00296530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576626|NCT00839462|Vitamins|vitamins|mesh-ancestor
25009735|NCT05209217|Analgesics|analgesics|mesh-ancestor
25009736|NCT05209217|Sensory System Agents|sensory system agents|mesh-ancestor
25009737|NCT05209217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25009738|NCT05209217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009739|NCT05209217|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25009740|NCT05209217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25009741|NCT05209217|Anesthetics, General|anesthetics, general|mesh-ancestor
25009742|NCT05209217|Anesthetics|anesthetics|mesh-ancestor
25009743|NCT05209217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25009744|NCT05209217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25009745|NCT05209217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25009746|NCT05209217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25009747|NCT05209217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009749|NCT05191264|Sensory System Agents|sensory system agents|mesh-ancestor
25009750|NCT05191264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25009751|NCT05191264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009752|NCT05190627|Loratadine|loratadine|mesh-list
25009753|NCT05190627|Sirolimus|sirolimus|mesh-list
25009754|NCT05190627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25009755|NCT05190627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25009756|NCT05190627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25009757|NCT05190627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009758|NCT05190627|Antifungal Agents|antifungal agents|mesh-ancestor
25009759|NCT05190627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25009782|NCT05188326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009783|NCT05188326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009784|NCT05188326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25009785|NCT05187039|Anesthetics|anesthetics|mesh-list
25009786|NCT05187039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25247338|NCT03937895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25247339|NCT03937895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247340|NCT03904381|Fluorouracil|fluorouracil|mesh-list
25247341|NCT03904381|Antimetabolites|antimetabolites|mesh-ancestor
25247342|NCT03904381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247343|NCT03904381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25247344|NCT03904381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247345|NCT03904381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25247346|NCT03904381|Immunologic Factors|immunologic factors|mesh-ancestor
25686771|NCT01924429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686772|NCT01924429|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24705797|NCT01486888|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24705806|NCT01486901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247347|NCT03904381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247348|NCT03876873|Anesthetics|anesthetics|mesh-list
25247349|NCT03876873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25247350|NCT03876873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247351|NCT03819660|Amifampridine|amifampridine|mesh-list
25247352|NCT03819660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25247353|NCT03819660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25247354|NCT03819660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247355|NCT03819660|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24595277|NCT00937664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24595278|NCT00937664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595279|NCT00937664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24961429|NCT03808805|Dermatologic Agents|dermatologic agents|mesh-ancestor
24595280|NCT00937664|Immunologic Factors|immunologic factors|mesh-ancestor
24595281|NCT00937664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595311|NCT00937924|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24595316|NCT00937924|Sensory System Agents|sensory system agents|mesh-ancestor
24595317|NCT00937924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24595318|NCT00937924|Antiemetics|antiemetics|mesh-ancestor
24595319|NCT00937924|Autonomic Agents|autonomic agents|mesh-ancestor
24595320|NCT00937924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24595321|NCT00937924|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24595322|NCT00937924|Histamine Antagonists|histamine antagonists|mesh-ancestor
24576671|NCT00839683|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24576672|NCT00839683|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24576673|NCT00839683|Antimetabolites|antimetabolites|mesh-ancestor
24576738|NCT00840242|Nicotine|nicotine|mesh-list
24576739|NCT00840242|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24576740|NCT00840242|Autonomic Agents|autonomic agents|mesh-ancestor
24576741|NCT00840242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24576742|NCT00840242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576743|NCT00840242|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24576744|NCT00840242|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24576745|NCT00840242|Cholinergic Agents|cholinergic agents|mesh-ancestor
24576746|NCT00840242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576747|NCT00840242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576748|NCT00840333|Levofloxacin|levofloxacin|mesh-list
24576749|NCT00840333|Ofloxacin|ofloxacin|mesh-list
24576750|NCT00840333|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25009791|NCT05186454|Bupivacaine|bupivacaine|mesh-list
24576752|NCT00840333|Renal Agents|renal agents|mesh-ancestor
24576756|NCT00840333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24576801|NCT00840580|Levofloxacin|levofloxacin|mesh-list
24576803|NCT00840580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24576804|NCT00840580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24576805|NCT00840580|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24576806|NCT00840580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25247356|NCT03819660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25247357|NCT03819660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247366|NCT03800381|Rifampin|rifampin|mesh-list
25247367|NCT03800381|Isoniazid|isoniazid|mesh-list
25247368|NCT03800381|Pyrazinamide|pyrazinamide|mesh-list
25247369|NCT03800381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25247370|NCT03800381|Antitubercular Agents|antitubercular agents|mesh-ancestor
25247371|NCT03800381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25247372|NCT03800381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24595325|NCT00937924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595327|NCT00937924|Antipruritics|antipruritics|mesh-ancestor
24595337|NCT00938171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24595338|NCT00938171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595340|NCT00938184|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24595341|NCT00938184|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24595342|NCT00938184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24595343|NCT00938184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577124|NCT00842114|Vincristine|vincristine|mesh-list
25686773|NCT01924429|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25686774|NCT01924429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24577199|NCT00842491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940735|NCT03998670|Methamphetamine|methamphetamine|mesh-list
24940736|NCT03998670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24940737|NCT03998670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705960|NCT01487993|Metformin|metformin|mesh-list
24577225|NCT00842582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577227|NCT00842595|Rituximab|rituximab|mesh-list
24577228|NCT00842595|Vinorelbine|vinorelbine|mesh-list
24577229|NCT00842595|Ifosfamide|ifosfamide|mesh-list
24577230|NCT00842595|Mitoxantrone|mitoxantrone|mesh-list
24577231|NCT00842595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24577232|NCT00842595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577233|NCT00842595|Immunologic Factors|immunologic factors|mesh-ancestor
24577234|NCT00842595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577235|NCT00842595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24792821|NCT04609098|Antimalarials|antimalarials|mesh-ancestor
24792822|NCT04609098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24792823|NCT04609098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24792824|NCT04609098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24792826|NCT04605614|Pembrolizumab|pembrolizumab|mesh-list
24577430|NCT00844142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577431|NCT00844142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24577448|NCT00844207|Chloroquine|chloroquine|mesh-list
24577449|NCT00844207|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24577450|NCT00844207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24577451|NCT00844207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24577452|NCT00844207|Amebicides|amebicides|mesh-ancestor
24577453|NCT00844207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24577454|NCT00844207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24577455|NCT00844207|Antimalarials|antimalarials|mesh-ancestor
24577456|NCT00844207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24577478|NCT00844311|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24577479|NCT00844311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24577480|NCT00844311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577481|NCT00844324|Candesartan|candesartan|mesh-list
24577482|NCT00844324|Candesartan cilexetil|candesartan cilexetil|mesh-list
24577484|NCT00844324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24577485|NCT00844324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24577486|NCT00844324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577488|NCT00844337|Gentamicins|gentamicins|mesh-list
24577489|NCT00844337|Penicillins|penicillins|mesh-list
24577514|NCT00844350|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24577515|NCT00844402|Atorvastatin|atorvastatin|mesh-list
25247373|NCT03800381|Leprostatic Agents|leprostatic agents|mesh-ancestor
25247374|NCT03800381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25247375|NCT03800381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25247376|NCT03800381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247377|NCT03800381|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25247378|NCT03800381|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25247379|NCT03800381|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25247380|NCT03800381|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25247381|NCT03800381|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24595346|NCT00938184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595347|NCT00938184|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24595348|NCT00938184|Antidepressive Agents|antidepressive agents|mesh-ancestor
24595349|NCT00938184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24577516|NCT00844402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24577517|NCT00844402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24577519|NCT00844402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577520|NCT00844402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24577521|NCT00844402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24577522|NCT00844402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577525|NCT00844454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24577609|NCT00845104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577610|NCT00845104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25009815|NCT05186454|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25009816|NCT05186454|Anesthetics, General|anesthetics, general|mesh-ancestor
25009817|NCT05186454|GABA Modulators|gaba modulators|mesh-ancestor
25009818|NCT05186454|GABA Agents|gaba agents|mesh-ancestor
25009819|NCT05186454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25686775|NCT01924429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686776|NCT01924429|Dopamine Agents|dopamine agents|mesh-ancestor
25686777|NCT01924429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25686778|NCT01924767|Empagliflozin|empagliflozin|mesh-list
25009820|NCT05186454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009821|NCT05176080|Fulvestrant|fulvestrant|mesh-list
25009822|NCT05176080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25009823|NCT05176080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009824|NCT05176080|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25009825|NCT05176080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25009826|NCT05176080|Hormone Antagonists|hormone antagonists|mesh-ancestor
25009828|NCT05176080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577660|NCT00845546|Antipruritics|antipruritics|mesh-ancestor
24577661|NCT00845546|Dermatologic Agents|dermatologic agents|mesh-ancestor
24577662|NCT00845546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24577663|NCT00845546|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24577664|NCT00845546|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24577665|NCT00845546|Histamine Antagonists|histamine antagonists|mesh-ancestor
24577666|NCT00845546|Histamine Agents|histamine agents|mesh-ancestor
24577776|NCT00845819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24577777|NCT00845819|Antifungal Agents|antifungal agents|mesh-ancestor
24577778|NCT00845819|Ionophores|ionophores|mesh-ancestor
24577779|NCT00845819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24577780|NCT00845819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577781|NCT00845884|Bevacizumab|bevacizumab|mesh-list
24577783|NCT00845884|Docetaxel|docetaxel|mesh-list
24577784|NCT00845884|Capecitabine|capecitabine|mesh-list
24577785|NCT00845884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24577786|NCT00845884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577787|NCT00845884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24577788|NCT00845884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24577789|NCT00845884|Growth Substances|growth substances|mesh-ancestor
24577879|NCT00846196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577880|NCT00846196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24577881|NCT00846196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577882|NCT00846196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24577883|NCT00846235|Glycerol|glycerol|mesh-list
24577884|NCT00846235|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24577972|NCT00846443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24577973|NCT00846508|Cisplatin|cisplatin|mesh-list
24577974|NCT00846508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577975|NCT00846612|Bevacizumab|bevacizumab|mesh-list
24577976|NCT00846612|Doxorubicin|doxorubicin|mesh-list
24577977|NCT00846612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24444046|NCT00296608|Vitamins|vitamins|mesh-ancestor
24577999|NCT00846625|Hormones|hormones|mesh-ancestor
24578088|NCT00846872|Hormones|hormones|mesh-list
25247382|NCT03800381|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25247383|NCT03800381|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25247384|NCT03800381|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25247385|NCT03800381|Antimetabolites|antimetabolites|mesh-ancestor
25247386|NCT03800381|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25247387|NCT03755973|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24595350|NCT00938184|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24595351|NCT00938184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24595352|NCT00938184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595353|NCT00938197|Amlodipine|amlodipine|mesh-list
24595354|NCT00938197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24595355|NCT00938197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24595356|NCT00938197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25074195|NCT03390036|Triamcinolone|triamcinolone|mesh-list
24578251|NCT00847834|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24578252|NCT00847834|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24578253|NCT00847860|Aspirin|aspirin|mesh-list
24578254|NCT00847860|Cilostazol|cilostazol|mesh-list
24578255|NCT00847860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24578256|NCT00847860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24578257|NCT00847860|Analgesics|analgesics|mesh-ancestor
24578258|NCT00847860|Sensory System Agents|sensory system agents|mesh-ancestor
24578259|NCT00847860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24578260|NCT00847860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109998|NCT03120728|Contraceptive Agents|contraceptive agents|mesh-list
25109999|NCT03120728|Estradiol|estradiol|mesh-list
25110000|NCT03120728|Estrogens|estrogens|mesh-ancestor
25110001|NCT03120728|Hormones|hormones|mesh-ancestor
25110002|NCT03120728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25110003|NCT03120728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110004|NCT03120728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24578351|NCT00848692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24578353|NCT00848770|Esmolol|esmolol|mesh-list
24578354|NCT00848770|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24578355|NCT00848770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24578356|NCT00848770|Adrenergic Agents|adrenergic agents|mesh-ancestor
24578357|NCT00848770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24578358|NCT00848770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578359|NCT00848770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578371|NCT00848796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24578372|NCT00848796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578373|NCT00848809|Vancomycin|vancomycin|mesh-list
24578374|NCT00848809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24578375|NCT00848809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24578376|NCT00848848|Vaccines|vaccines|mesh-list
24578377|NCT00848848|Immunologic Factors|immunologic factors|mesh-ancestor
24578378|NCT00848848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578379|NCT00848861|Midazolam|midazolam|mesh-list
24578380|NCT00848861|Meperidine|meperidine|mesh-list
24578381|NCT00848861|Propofol|propofol|mesh-list
24578382|NCT00848861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24578383|NCT00848861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24578384|NCT00848861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578385|NCT00848861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24578386|NCT00848861|Anesthetics, General|anesthetics, general|mesh-ancestor
24578423|NCT00849030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24578424|NCT00849030|Hormone Antagonists|hormone antagonists|mesh-ancestor
24893087|NCT04454307|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24578427|NCT00849030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24578428|NCT00849030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578429|NCT00849030|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24578430|NCT00849030|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24578431|NCT00849030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24578432|NCT00849030|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24578433|NCT00849030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24578434|NCT00849030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24578447|NCT00849082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24578450|NCT00849095|Formoterol Fumarate|formoterol fumarate|mesh-list
24578451|NCT00849095|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24578452|NCT00849095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24578453|NCT00849095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25247388|NCT03755973|Hormones|hormones|mesh-ancestor
25247389|NCT03755973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25247390|NCT03755973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247391|NCT03747159|Belimumab|belimumab|mesh-list
25247392|NCT03747159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25247393|NCT03747159|Immunologic Factors|immunologic factors|mesh-ancestor
25247394|NCT03747159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247395|NCT03732495|Denosumab|denosumab|mesh-list
24595358|NCT00938197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24595359|NCT00938197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595360|NCT00938197|Vasodilator Agents|vasodilator agents|mesh-ancestor
24595361|NCT00938236|Cyclosporine|cyclosporine|mesh-list
24595362|NCT00938236|Cyclosporins|cyclosporins|mesh-list
24595363|NCT00938236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595364|NCT00938236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595365|NCT00938236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24595366|NCT00938236|Immunologic Factors|immunologic factors|mesh-ancestor
24595367|NCT00938236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501747|NCT00530907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24595368|NCT00938236|Antifungal Agents|antifungal agents|mesh-ancestor
24595369|NCT00938236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24595370|NCT00938236|Dermatologic Agents|dermatologic agents|mesh-ancestor
24595371|NCT00938236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24595372|NCT00938236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24595373|NCT00938262|Rifampin|rifampin|mesh-list
24595406|NCT00938379|Protective Agents|protective agents|mesh-ancestor
24595407|NCT00938379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595408|NCT00938405|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
24595409|NCT00938405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24595410|NCT00938405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24595412|NCT00938405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595414|NCT00938509|Ibuprofen|ibuprofen|mesh-list
24595415|NCT00938509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24578454|NCT00849095|Autonomic Agents|autonomic agents|mesh-ancestor
24578455|NCT00849095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24578456|NCT00849095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578457|NCT00849095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24578458|NCT00849095|Respiratory System Agents|respiratory system agents|mesh-ancestor
24578499|NCT00849264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24578500|NCT00849264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24578501|NCT00849264|Growth Substances|growth substances|mesh-ancestor
24578502|NCT00849264|Growth Inhibitors|growth inhibitors|mesh-ancestor
24578504|NCT00849316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24578505|NCT00849316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578506|NCT00849329|Lapatinib|lapatinib|mesh-list
24578507|NCT00849329|Esomeprazole|esomeprazole|mesh-list
24578508|NCT00849329|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25247396|NCT03732495|Lenvatinib|lenvatinib|mesh-list
25247397|NCT03732495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247398|NCT03732495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25247399|NCT03732495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25247400|NCT03732495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247401|NCT03732495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25247402|NCT03732495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247403|NCT03728426|Letermovir|letermovir|mesh-list
25247404|NCT03728426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25247405|NCT03728426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25247406|NCT03728426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247407|NCT03728426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247408|NCT03728426|Antiviral Agents|antiviral agents|mesh-ancestor
25247409|NCT03728426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25247410|NCT03715166|Bumetanide|bumetanide|mesh-list
25247411|NCT03715166|Diuretics|diuretics|mesh-ancestor
25247412|NCT03715166|Natriuretic Agents|natriuretic agents|mesh-ancestor
25247413|NCT03715166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247414|NCT03715166|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25247415|NCT03715166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25247417|NCT03680053|Cetrorelix|cetrorelix|mesh-list
25247418|NCT03680053|Dydrogesterone|dydrogesterone|mesh-list
25247419|NCT03680053|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25247420|NCT03680053|Fertility Agents|fertility agents|mesh-ancestor
25247421|NCT03680053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24595416|NCT00938509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24595417|NCT00938509|Analgesics|analgesics|mesh-ancestor
24595418|NCT00938509|Sensory System Agents|sensory system agents|mesh-ancestor
24595419|NCT00938509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24595420|NCT00938509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595421|NCT00938509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24595422|NCT00938509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24595423|NCT00938509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24595424|NCT00938509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595425|NCT00938509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595434|NCT00938522|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24595435|NCT00938522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595436|NCT00938522|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24595437|NCT00938522|Vasodilator Agents|vasodilator agents|mesh-ancestor
24578509|NCT00849329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24578510|NCT00849329|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24565306|NCT00779714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24578565|NCT00849550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578566|NCT00849550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24578567|NCT00849550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24578569|NCT00849550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578570|NCT00849550|Growth Inhibitors|growth inhibitors|mesh-ancestor
24578571|NCT00849550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24578572|NCT00849550|Antimetabolites|antimetabolites|mesh-ancestor
24578573|NCT00849550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578574|NCT00849550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24792937|NCT04339101|Mechlorethamine|mechlorethamine|mesh-list
24792938|NCT04339101|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
24792939|NCT04339101|Tacrolimus|tacrolimus|mesh-list
24792940|NCT04339101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24792941|NCT04339101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792942|NCT04339101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24792943|NCT04339101|Immunologic Factors|immunologic factors|mesh-ancestor
24792944|NCT04339101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792945|NCT04339101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25686779|NCT01924767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25686780|NCT01924767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686781|NCT01924767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24792946|NCT04339101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24792947|NCT04339101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24792948|NCT04339101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24792949|NCT04339101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24792950|NCT04339101|Antifungal Agents|antifungal agents|mesh-ancestor
24565522|NCT00781105|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24578763|NCT00851565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578764|NCT00851565|Dermatologic Agents|dermatologic agents|mesh-ancestor
24578765|NCT00851565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25247422|NCT03680053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247423|NCT03680053|Hormone Antagonists|hormone antagonists|mesh-ancestor
25247424|NCT03680053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25247425|NCT03680053|Progestins|progestins|mesh-ancestor
25247426|NCT03680053|Hormones|hormones|mesh-ancestor
25247427|NCT03648385|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25247428|NCT03648385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25247429|NCT03648385|Immunologic Factors|immunologic factors|mesh-ancestor
25247430|NCT03648385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247431|NCT03636152|Hydroxychloroquine|hydroxychloroquine|mesh-list
25247432|NCT03636152|Chloroquine|chloroquine|mesh-list
25247433|NCT03636152|Antimalarials|antimalarials|mesh-ancestor
25247434|NCT03636152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25247435|NCT03636152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25247436|NCT03636152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25247437|NCT03636152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25247438|NCT03636152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595438|NCT00938522|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24595439|NCT00938522|Protective Agents|protective agents|mesh-ancestor
24595440|NCT00938522|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24595441|NCT00938522|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24595442|NCT00938522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595445|NCT00938600|Cholecalciferol|cholecalciferol|mesh-list
24595446|NCT00938600|Vitamins|vitamins|mesh-list
24595447|NCT00938600|Micronutrients|micronutrients|mesh-ancestor
24595468|NCT00938743|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24595469|NCT00938743|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24595470|NCT00938743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24595471|NCT00938743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24595472|NCT00938743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595473|NCT00938743|Adrenergic Agents|adrenergic agents|mesh-ancestor
24852805|NCT02264145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852806|NCT02264158|Telmisartan|telmisartan|mesh-list
24852807|NCT02264158|Lacidipine|lacidipine|mesh-list
24954141|NCT03879122|Tubulin Modulators|tubulin modulators|mesh-ancestor
24578766|NCT00851565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24578768|NCT00851708|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24578769|NCT00851708|Antiviral Agents|antiviral agents|mesh-ancestor
24578770|NCT00851708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24578772|NCT00851708|Respiratory System Agents|respiratory system agents|mesh-ancestor
24578773|NCT00851708|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24578774|NCT00851708|Antioxidants|antioxidants|mesh-ancestor
24578775|NCT00851708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578840|NCT00852189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578841|NCT00852228|Cetuximab|cetuximab|mesh-list
24578842|NCT00852228|Oxaliplatin|oxaliplatin|mesh-list
24578843|NCT00852228|Irinotecan|irinotecan|mesh-list
24578844|NCT00852228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24578845|NCT00852228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578846|NCT00852228|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24578847|NCT00852228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24578848|NCT00852228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24578849|NCT00852228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578851|NCT00852332|Docetaxel|docetaxel|mesh-list
24578886|NCT00852410|Lidocaine|lidocaine|mesh-list
24578970|NCT00852683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25686782|NCT01924767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686783|NCT01924871|Remifentanil|remifentanil|mesh-list
25686784|NCT01924871|Desflurane|desflurane|mesh-list
25686785|NCT01924871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24578971|NCT00852683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24578972|NCT00852683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24578973|NCT00852709|Cyclophosphamide|cyclophosphamide|mesh-list
24578974|NCT00852709|Clofarabine|clofarabine|mesh-list
24578975|NCT00852709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24578976|NCT00852709|Immunologic Factors|immunologic factors|mesh-ancestor
24578977|NCT00852709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578978|NCT00852709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24578979|NCT00852709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24578980|NCT00852709|Alkylating Agents|alkylating agents|mesh-ancestor
24578981|NCT00852709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578982|NCT00852709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578994|NCT00852956|Betahistine|betahistine|mesh-list
25247439|NCT03636152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25247440|NCT03636152|Amebicides|amebicides|mesh-ancestor
25247441|NCT03617523|Vaccines|vaccines|mesh-list
25247442|NCT03617523|Immunologic Factors|immunologic factors|mesh-ancestor
25247443|NCT03617523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274388|NCT02378532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274389|NCT02378532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25274390|NCT02378532|Amebicides|amebicides|mesh-ancestor
25274391|NCT02378532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25274392|NCT02378532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25274393|NCT02378532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25274394|NCT02378532|Antimalarials|antimalarials|mesh-ancestor
25274395|NCT02378532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25274396|NCT02378298|Methylprednisolone|methylprednisolone|mesh-list
25274397|NCT02378298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25274398|NCT02378298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25274399|NCT02378298|Prednisolone|prednisolone|mesh-list
25274400|NCT02378298|Prednisolone acetate|prednisolone acetate|mesh-list
25274401|NCT02378298|Rituximab|rituximab|mesh-list
25274402|NCT02378298|Methotrexate|methotrexate|mesh-list
25274403|NCT02378298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24852808|NCT02264158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24852809|NCT02264158|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24852810|NCT02264158|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24852811|NCT02264158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852812|NCT02264158|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24852813|NCT02264158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25074264|NCT03389490|Coagulants|coagulants|mesh-ancestor
24852814|NCT02264158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24852815|NCT02264158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852816|NCT02264171|Ketoconazole|ketoconazole|mesh-list
24852817|NCT02264171|Tamsulosin|tamsulosin|mesh-list
24852818|NCT02264171|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24852819|NCT02264171|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24595474|NCT00938743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24595475|NCT00938743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595476|NCT00938821|Morphine|morphine|mesh-list
24595477|NCT00938821|Bupivacaine|bupivacaine|mesh-list
24595478|NCT00938821|Anesthetics, Local|anesthetics, local|mesh-ancestor
24595493|NCT00938990|Midazolam|midazolam|mesh-list
24595494|NCT00938990|Etomidate|etomidate|mesh-list
24595495|NCT00938990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24595496|NCT00938990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24595497|NCT00938990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24595498|NCT00938990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595526|NCT00939328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24595527|NCT00939328|Alkylating Agents|alkylating agents|mesh-ancestor
24595528|NCT00939328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792980|NCT04321551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24792981|NCT04321551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792982|NCT04321551|Androgens|androgens|mesh-ancestor
24792983|NCT04321551|Hormones|hormones|mesh-ancestor
24792985|NCT04321551|Anabolic Agents|anabolic agents|mesh-ancestor
24792986|NCT04305158|Nitrous Oxide|nitrous oxide|mesh-list
24792987|NCT04305158|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24792988|NCT04305158|Anesthetics, General|anesthetics, general|mesh-ancestor
24579079|NCT00853216|Narcotics|narcotics|mesh-ancestor
24579080|NCT00853216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24579085|NCT00853268|Oxycodone|oxycodone|mesh-list
24579150|NCT00853554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24579151|NCT00853554|Narcotics|narcotics|mesh-ancestor
24579152|NCT00853554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24579153|NCT00853554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579154|NCT00853554|Analgesics|analgesics|mesh-ancestor
24579155|NCT00853554|Sensory System Agents|sensory system agents|mesh-ancestor
25247444|NCT03563157|Leucovorin|leucovorin|mesh-list
25247445|NCT03563157|Paclitaxel|paclitaxel|mesh-list
25247446|NCT03563157|Cyclophosphamide|cyclophosphamide|mesh-list
25247447|NCT03563157|Fluorouracil|fluorouracil|mesh-list
25247448|NCT03563157|Capecitabine|capecitabine|mesh-list
25247449|NCT03563157|Oxaliplatin|oxaliplatin|mesh-list
25247450|NCT03563157|Cetuximab|cetuximab|mesh-list
25247451|NCT03563157|Avelumab|avelumab|mesh-list
25247452|NCT03563157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25247453|NCT03563157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247454|NCT03563157|Tubulin Modulators|tubulin modulators|mesh-ancestor
25247455|NCT03563157|Antimitotic Agents|antimitotic agents|mesh-ancestor
25247456|NCT03563157|Mitosis Modulators|mitosis modulators|mesh-ancestor
25247457|NCT03563157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247458|NCT03563157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25247459|NCT03563157|Immunologic Factors|immunologic factors|mesh-ancestor
25247460|NCT03563157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247461|NCT03563157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25247462|NCT03563157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25247463|NCT03563157|Alkylating Agents|alkylating agents|mesh-ancestor
25247464|NCT03563157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25247465|NCT03563157|Antimetabolites|antimetabolites|mesh-ancestor
25247466|NCT03563157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25247467|NCT03563157|Antidotes|antidotes|mesh-ancestor
25247468|NCT03563157|Protective Agents|protective agents|mesh-ancestor
25247469|NCT03563157|Vitamin B Complex|vitamin b complex|mesh-ancestor
25247470|NCT03563157|Vitamins|vitamins|mesh-ancestor
25247471|NCT03563157|Micronutrients|micronutrients|mesh-ancestor
25247472|NCT03563157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25247473|NCT03546192|Vaccines|vaccines|mesh-list
25247474|NCT03546192|Immunologic Factors|immunologic factors|mesh-ancestor
24595529|NCT00939458|Lamotrigine|lamotrigine|mesh-list
24595530|NCT00939458|Anticonvulsants|anticonvulsants|mesh-ancestor
24595531|NCT00939458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24852820|NCT02264171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24852821|NCT02264171|Adrenergic Agents|adrenergic agents|mesh-ancestor
24852822|NCT02264171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24595532|NCT00939458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24595533|NCT00939458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595534|NCT00939458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24595535|NCT00939458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595536|NCT00939458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24595537|NCT00939458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24595538|NCT00939458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24595539|NCT00939458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24595540|NCT00939458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24595541|NCT00939497|Risperidone|risperidone|mesh-list
24595542|NCT00939497|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24595543|NCT00939497|Serotonin Agents|serotonin agents|mesh-ancestor
24595544|NCT00939497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24503209|NCT02670252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24595574|NCT00939588|Protease Inhibitors|protease inhibitors|mesh-ancestor
24595575|NCT00939588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595576|NCT00939614|Lamotrigine|lamotrigine|mesh-list
24595577|NCT00939614|Anticonvulsants|anticonvulsants|mesh-ancestor
24595578|NCT00939614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24595579|NCT00939614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24595580|NCT00939614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595581|NCT00939614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24595582|NCT00939614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595583|NCT00939614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24595588|NCT00939718|Vitamin B 12|vitamin b 12|mesh-list
25247475|NCT03546192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247495|NCT03517449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247497|NCT03517449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25247498|NCT03517449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25247499|NCT03517449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25247500|NCT03517449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25247501|NCT03517449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25247502|NCT03514368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25247503|NCT03514368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686786|NCT01924871|Narcotics|narcotics|mesh-ancestor
25247504|NCT03514368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247505|NCT03490292|Paclitaxel|paclitaxel|mesh-list
25247506|NCT03490292|Carboplatin|carboplatin|mesh-list
25247507|NCT03490292|Avelumab|avelumab|mesh-list
25247508|NCT03490292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25247509|NCT03490292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247510|NCT03490292|Tubulin Modulators|tubulin modulators|mesh-ancestor
25247511|NCT03490292|Antimitotic Agents|antimitotic agents|mesh-ancestor
25247512|NCT03490292|Mitosis Modulators|mitosis modulators|mesh-ancestor
25247513|NCT03490292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247514|NCT03490292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25247515|NCT03480698|Cerebrolysin|cerebrolysin|mesh-list
24595597|NCT00939757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24595638|NCT00939926|Risperidone|risperidone|mesh-list
24595639|NCT00939926|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24595640|NCT00939926|Serotonin Agents|serotonin agents|mesh-ancestor
24595641|NCT00939926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24595642|NCT00939926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595665|NCT00939965|Dermatologic Agents|dermatologic agents|mesh-ancestor
24595666|NCT00940069|Pemetrexed|pemetrexed|mesh-list
24595667|NCT00940069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24595668|NCT00940069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595669|NCT00940069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595670|NCT00940069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24595671|NCT00940069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24595672|NCT00940121|Mirabegron|mirabegron|mesh-list
24595673|NCT00940121|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24595674|NCT00940121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24595675|NCT00940121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24595676|NCT00940121|Adrenergic Agents|adrenergic agents|mesh-ancestor
24595677|NCT00940121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24595678|NCT00940121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595679|NCT00940121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595680|NCT00940121|Urological Agents|urological agents|mesh-ancestor
24595681|NCT00940238|Dexetimide|dexetimide|mesh-list
24595682|NCT00940238|Citalopram|citalopram|mesh-list
24501887|NCT00531440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24852824|NCT02264171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595683|NCT00940238|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24595684|NCT00940238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24595685|NCT00940238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24595686|NCT00940238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579156|NCT00853554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24579157|NCT00853684|Capecitabine|capecitabine|mesh-list
24579158|NCT00853684|Endostar protein|endostar protein|mesh-list
24579159|NCT00853684|Endostatins|endostatins|mesh-list
25247552|NCT03387085|Immunologic Factors|immunologic factors|mesh-ancestor
24579161|NCT00853684|Antimetabolites|antimetabolites|mesh-ancestor
24579162|NCT00853684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579245|NCT00854009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24579246|NCT00854009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24579247|NCT00854035|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24579248|NCT00854035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24579249|NCT00854035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247516|NCT03480698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25247517|NCT03480698|Protective Agents|protective agents|mesh-ancestor
25247518|NCT03480698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247519|NCT03480698|Nootropic Agents|nootropic agents|mesh-ancestor
25247520|NCT03474744|Rituximab|rituximab|mesh-list
25247521|NCT03474744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25247522|NCT03474744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247523|NCT03474744|Immunologic Factors|immunologic factors|mesh-ancestor
25247524|NCT03474744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247525|NCT03474744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25247526|NCT03474094|Atezolizumab|atezolizumab|mesh-list
25247527|NCT03474094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25247528|NCT03474094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247529|NCT03474094|Immunologic Factors|immunologic factors|mesh-ancestor
25247530|NCT03474094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247531|NCT03470922|Nivolumab|nivolumab|mesh-list
25247532|NCT03470922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25247533|NCT03470922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247534|NCT03470922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25247535|NCT03470922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247538|NCT03387085|Leucovorin|leucovorin|mesh-list
25247540|NCT03387085|Cyclophosphamide|cyclophosphamide|mesh-list
25247541|NCT03387085|Bevacizumab|bevacizumab|mesh-list
25247542|NCT03387085|Fluorouracil|fluorouracil|mesh-list
25247543|NCT03387085|Capecitabine|capecitabine|mesh-list
25247544|NCT03387085|Avelumab|avelumab|mesh-list
25247545|NCT03387085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25247546|NCT03387085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247547|NCT03387085|Tubulin Modulators|tubulin modulators|mesh-ancestor
24595723|NCT00940381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24595724|NCT00940381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24595725|NCT00940381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24595726|NCT00940381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24595727|NCT00940381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24595729|NCT00940381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24595730|NCT00940381|Immunologic Factors|immunologic factors|mesh-ancestor
24595731|NCT00940381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595732|NCT00940420|Ribavirin|ribavirin|mesh-list
24595733|NCT00940420|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24595734|NCT00940420|Interferon-alpha|interferon-alpha|mesh-list
24595735|NCT00940420|Antimetabolites|antimetabolites|mesh-ancestor
24595736|NCT00940420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595737|NCT00940420|Antiviral Agents|antiviral agents|mesh-ancestor
24595738|NCT00940420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24595739|NCT00940420|Immunologic Factors|immunologic factors|mesh-ancestor
24595740|NCT00940420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595741|NCT00940472|Metformin|metformin|mesh-list
24595742|NCT00940472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24595743|NCT00940472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595744|NCT00940498|Gedatolisib|gedatolisib|mesh-list
24595745|NCT00940498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24595746|NCT00940498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595764|NCT00940524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24595765|NCT00940524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24595766|NCT00940524|Abortifacient Agents|abortifacient agents|mesh-ancestor
24595767|NCT00940524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24595768|NCT00940524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24595769|NCT00940524|Antimetabolites|antimetabolites|mesh-ancestor
24595770|NCT00940524|Dermatologic Agents|dermatologic agents|mesh-ancestor
24595771|NCT00940524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595772|NCT00940524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25247548|NCT03387085|Antimitotic Agents|antimitotic agents|mesh-ancestor
25247549|NCT03387085|Mitosis Modulators|mitosis modulators|mesh-ancestor
25247550|NCT03387085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247551|NCT03387085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25247563|NCT03387085|Antimetabolites|antimetabolites|mesh-ancestor
25247564|NCT03387085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25247565|NCT03387085|Antidotes|antidotes|mesh-ancestor
25247566|NCT03387085|Protective Agents|protective agents|mesh-ancestor
25247567|NCT03387085|Vitamin B Complex|vitamin b complex|mesh-ancestor
25247568|NCT03387085|Vitamins|vitamins|mesh-ancestor
25247569|NCT03387085|Micronutrients|micronutrients|mesh-ancestor
25247581|NCT03337646|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25247582|NCT03337646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25247583|NCT03337646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247584|NCT03337646|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25247585|NCT03337646|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25247586|NCT03337646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25247587|NCT03337646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247588|NCT03337646|Dopamine Agents|dopamine agents|mesh-ancestor
24595784|NCT00940550|Zolpidem|zolpidem|mesh-list
24595785|NCT00940550|Temazepam|temazepam|mesh-list
24595786|NCT00940550|Antioxidants|antioxidants|mesh-ancestor
24595787|NCT00940550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595788|NCT00940550|Protective Agents|protective agents|mesh-ancestor
24595789|NCT00940550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595790|NCT00940550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24595791|NCT00940550|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24595793|NCT00940550|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24595794|NCT00940550|GABA Agonists|gaba agonists|mesh-ancestor
24595823|NCT00940667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24595824|NCT00940667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595825|NCT00940667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24595826|NCT00940667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595827|NCT00940667|Vasodilator Agents|vasodilator agents|mesh-ancestor
24707499|NCT01496261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24595828|NCT00940667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24595829|NCT00940667|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24595830|NCT00940667|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24595831|NCT00940680|Losartan|losartan|mesh-list
24595832|NCT00940680|Amlodipine|amlodipine|mesh-list
24595833|NCT00940680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24595834|NCT00940680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24595835|NCT00940680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24595836|NCT00940680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595837|NCT00940680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24595838|NCT00940680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595839|NCT00940680|Vasodilator Agents|vasodilator agents|mesh-ancestor
24595840|NCT00940680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24595841|NCT00940680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24595842|NCT00940680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24595843|NCT00940693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24595846|NCT00940693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25247589|NCT03337646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25247590|NCT03334318|Allopurinol|allopurinol|mesh-list
25247591|NCT03334318|Antimetabolites|antimetabolites|mesh-ancestor
24708776|NCT01502904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25247592|NCT03334318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595850|NCT00940693|Analgesics|analgesics|mesh-ancestor
24595851|NCT00940693|Sensory System Agents|sensory system agents|mesh-ancestor
24595852|NCT00940693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24595882|NCT00940784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24595883|NCT00940784|Purinergic Agents|purinergic agents|mesh-ancestor
24595884|NCT00940784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24595885|NCT00940836|Acetaminophen|acetaminophen|mesh-list
24595886|NCT00940836|Chlorpheniramine|chlorpheniramine|mesh-list
24595887|NCT00940836|Phenylephrine|phenylephrine|mesh-list
24852829|NCT02264171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24852830|NCT02264171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852831|NCT02264171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24852832|NCT02264171|Hormone Antagonists|hormone antagonists|mesh-ancestor
24595888|NCT00940836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24961711|NCT03806374|Analgesics|analgesics|mesh-ancestor
24595889|NCT00940836|Analgesics|analgesics|mesh-ancestor
24595890|NCT00940836|Sensory System Agents|sensory system agents|mesh-ancestor
24595891|NCT00940836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24595892|NCT00940836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595893|NCT00940836|Antipyretics|antipyretics|mesh-ancestor
24595894|NCT00940836|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24595895|NCT00940836|Mydriatics|mydriatics|mesh-ancestor
24595896|NCT00940836|Autonomic Agents|autonomic agents|mesh-ancestor
24595897|NCT00940836|Sympathomimetics|sympathomimetics|mesh-ancestor
24595898|NCT00940836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24595899|NCT00940836|Nasal Decongestants|nasal decongestants|mesh-ancestor
24595900|NCT00940836|Respiratory System Agents|respiratory system agents|mesh-ancestor
24595901|NCT00940836|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24595902|NCT00940836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24595903|NCT00940836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24595904|NCT00940836|Adrenergic Agents|adrenergic agents|mesh-ancestor
24595905|NCT00940836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24595906|NCT00940836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595907|NCT00940836|Protective Agents|protective agents|mesh-ancestor
24595908|NCT00940836|Antipruritics|antipruritics|mesh-ancestor
25247645|NCT03218085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25247647|NCT03123029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247657|NCT03012581|Nivolumab|nivolumab|mesh-list
25247658|NCT03012581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25247659|NCT03012581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247660|NCT03012581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25247661|NCT03012581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247662|NCT02915302|Vaccines|vaccines|mesh-list
25247663|NCT02915302|Immunologic Factors|immunologic factors|mesh-ancestor
25247664|NCT02915302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247665|NCT02914405|Nivolumab|nivolumab|mesh-list
24595909|NCT00940836|Dermatologic Agents|dermatologic agents|mesh-ancestor
24595910|NCT00940836|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24595911|NCT00940836|Histamine Antagonists|histamine antagonists|mesh-ancestor
24595916|NCT00940862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24595917|NCT00940914|2beta-carbomethoxy-3beta-(4-iodophenyl)tropane|2beta-carbomethoxy-3beta-(4-iodophenyl)tropane|mesh-list
24595918|NCT00940914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24595919|NCT00940914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595921|NCT00940953|Budesonide|budesonide|mesh-list
24595922|NCT00940953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24595923|NCT00940953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24595924|NCT00940953|Autonomic Agents|autonomic agents|mesh-ancestor
24595925|NCT00940953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24595926|NCT00940953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595927|NCT00940953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24595928|NCT00940953|Respiratory System Agents|respiratory system agents|mesh-ancestor
24595929|NCT00940953|Glucocorticoids|glucocorticoids|mesh-ancestor
24595930|NCT00940953|Hormones|hormones|mesh-ancestor
24595931|NCT00940953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24502078|NCT05319834|Aspirin|aspirin|mesh-list
24595932|NCT00940953|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24595942|NCT00941057|Tetrahydrofolates|tetrahydrofolates|mesh-list
24595944|NCT00941057|Calcium|calcium|mesh-list
24595945|NCT00941057|Nandrolone|nandrolone|mesh-list
24595946|NCT00941057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24595947|NCT00941057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595948|NCT00941057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24595949|NCT00941057|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24595950|NCT00941057|Contraceptive Agents|contraceptive agents|mesh-ancestor
24595951|NCT00941057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24595952|NCT00941057|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24595953|NCT00941057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24595954|NCT00941057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25247666|NCT02914405|Dinutuximab|dinutuximab|mesh-list
25247667|NCT02914405|Immunoglobulins|immunoglobulins|mesh-list
25247668|NCT02914405|Immunoglobulin G|immunoglobulin g|mesh-list
25247669|NCT02914405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25247670|NCT02914405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247671|NCT02914405|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25247672|NCT02914405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247673|NCT02914405|Immunologic Factors|immunologic factors|mesh-ancestor
25247803|NCT02258659|Hydroxyurea|hydroxyurea|mesh-list
25247675|NCT02908269|Vaccines|vaccines|mesh-list
25247676|NCT02908269|Immunologic Factors|immunologic factors|mesh-ancestor
25247677|NCT02908269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247678|NCT02900664|Trametinib|trametinib|mesh-list
25247679|NCT02900664|Spartalizumab|spartalizumab|mesh-list
25247680|NCT02900664|Nazartinib|nazartinib|mesh-list
25247681|NCT02900664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247682|NCT02900664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25247683|NCT02900664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25247684|NCT02900664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247685|NCT02900664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25247686|NCT02859012|Axitinib|axitinib|mesh-list
25247687|NCT02859012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247688|NCT02859012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25247689|NCT02859012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25247690|NCT02859012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247691|NCT02807467|Dexmedetomidine|dexmedetomidine|mesh-list
25247692|NCT02807467|Propofol|propofol|mesh-list
25247693|NCT02807467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25247694|NCT02807467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25247695|NCT02807467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247696|NCT02807467|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25247697|NCT02807467|Anesthetics, General|anesthetics, general|mesh-ancestor
25247698|NCT02807467|Anesthetics|anesthetics|mesh-ancestor
25247699|NCT02807467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25247700|NCT02807467|Analgesics|analgesics|mesh-ancestor
25247701|NCT02807467|Sensory System Agents|sensory system agents|mesh-ancestor
25247702|NCT02807467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25247703|NCT02807467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25247704|NCT02807467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25247705|NCT02807467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25247706|NCT02807467|Adrenergic Agents|adrenergic agents|mesh-ancestor
25247707|NCT02807467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24595960|NCT00941057|Androgens|androgens|mesh-ancestor
24595961|NCT00941057|Hormones|hormones|mesh-ancestor
24595962|NCT00941057|Anabolic Agents|anabolic agents|mesh-ancestor
24595963|NCT00941057|Vitamin B Complex|vitamin b complex|mesh-ancestor
24595964|NCT00941057|Vitamins|vitamins|mesh-ancestor
24595965|NCT00941057|Micronutrients|micronutrients|mesh-ancestor
24595966|NCT00941083|Raltegravir Potassium|raltegravir potassium|mesh-list
24595967|NCT00941083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24595968|NCT00941083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24595969|NCT00941083|Antiviral Agents|antiviral agents|mesh-ancestor
24595970|NCT00941083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24595971|NCT00941083|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24595972|NCT00941083|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24595973|NCT00941083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595990|NCT00941109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595992|NCT00941135|Cetuximab|cetuximab|mesh-list
24595993|NCT00941135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24595994|NCT00941135|Tubulin Modulators|tubulin modulators|mesh-ancestor
24595995|NCT00941135|Antimitotic Agents|antimitotic agents|mesh-ancestor
24595996|NCT00941135|Mitosis Modulators|mitosis modulators|mesh-ancestor
24595997|NCT00941135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595998|NCT00941135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24595999|NCT00941148|Insulin|insulin|mesh-list
24596000|NCT00941148|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24596001|NCT00941148|Metformin|metformin|mesh-list
24596002|NCT00941148|Insulin Detemir|insulin detemir|mesh-list
24596003|NCT00941148|Insulin, Isophane|insulin, isophane|mesh-list
24596004|NCT00941148|Isophane Insulin, Human|isophane insulin, human|mesh-list
24671132|NCT01323712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24671133|NCT01323751|Ricolinostat|ricolinostat|mesh-list
24671134|NCT01323751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24671135|NCT01323751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24579252|NCT00854035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24579384|NCT00854776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579385|NCT00854776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24579386|NCT00854776|Immunologic Factors|immunologic factors|mesh-ancestor
24579387|NCT00854776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579388|NCT00854776|Antacids|antacids|mesh-ancestor
24579389|NCT00854802|Ribavirin|ribavirin|mesh-list
24579390|NCT00854802|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24579391|NCT00854802|Cyclosporine|cyclosporine|mesh-list
24579392|NCT00854802|Antimetabolites|antimetabolites|mesh-ancestor
25274405|NCT02378298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25247719|NCT02617589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247721|NCT02617589|Alkylating Agents|alkylating agents|mesh-ancestor
25247722|NCT02614859|Metformin|metformin|mesh-list
25247723|NCT02614859|Bicalutamide|bicalutamide|mesh-list
25247724|NCT02614859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25247725|NCT02614859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247726|NCT02614859|Androgen Antagonists|androgen antagonists|mesh-ancestor
25247727|NCT02614859|Hormone Antagonists|hormone antagonists|mesh-ancestor
25247728|NCT02614859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24596134|NCT00941967|Antimetabolites|antimetabolites|mesh-ancestor
25247729|NCT02614859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25274404|NCT02378298|Prednisolone phosphate|prednisolone phosphate|mesh-list
24671136|NCT01323751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671137|NCT01323751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671138|NCT01324063|Cytarabine|cytarabine|mesh-list
24671139|NCT01324063|Daunorubicin|daunorubicin|mesh-list
24596005|NCT00941148|Isophane insulin, beef|isophane insulin, beef|mesh-list
24596006|NCT00941148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24596007|NCT00941148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596008|NCT00941161|Metformin|metformin|mesh-list
24596009|NCT00941161|Glimepiride|glimepiride|mesh-list
24596010|NCT00941161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24596011|NCT00941161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596068|NCT00941460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24596069|NCT00941460|Alkylating Agents|alkylating agents|mesh-ancestor
24596070|NCT00941460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596071|NCT00941460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596072|NCT00941473|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24596073|NCT00941473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24596074|NCT00941473|Glucocorticoids|glucocorticoids|mesh-ancestor
24596075|NCT00941473|Hormones|hormones|mesh-ancestor
24596076|NCT00941473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24596077|NCT00941473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596078|NCT00941473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24596079|NCT00941473|Immunologic Factors|immunologic factors|mesh-ancestor
24596080|NCT00941499|Leucovorin|leucovorin|mesh-list
24596081|NCT00941499|Bevacizumab|bevacizumab|mesh-list
24596082|NCT00941499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24596083|NCT00941499|Cetuximab|cetuximab|mesh-list
24596084|NCT00941499|Fluorouracil|fluorouracil|mesh-list
24596085|NCT00941499|Oxaliplatin|oxaliplatin|mesh-list
24940849|NCT03997006|Mydriatics|mydriatics|mesh-ancestor
24596114|NCT00941785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25247741|NCT02519348|Bevacizumab|bevacizumab|mesh-list
25247742|NCT02519348|Durvalumab|durvalumab|mesh-list
25247743|NCT02519348|Tremelimumab|tremelimumab|mesh-list
25247744|NCT02519348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25247745|NCT02519348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247746|NCT02519348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25247747|NCT02519348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25247748|NCT02519348|Growth Substances|growth substances|mesh-ancestor
25247749|NCT02519348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247750|NCT02519348|Growth Inhibitors|growth inhibitors|mesh-ancestor
25274406|NCT02378298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25274407|NCT02378298|Immunologic Factors|immunologic factors|mesh-ancestor
25274408|NCT02378298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274409|NCT02378298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25274410|NCT02378298|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24502259|NCT05317572|Morphine|morphine|mesh-list
25274411|NCT02378298|Abortifacient Agents|abortifacient agents|mesh-ancestor
25274412|NCT02378298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25285220|NCT05391451|Anesthetics|anesthetics|mesh-list
25274413|NCT02378298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25274414|NCT02378298|Antimetabolites|antimetabolites|mesh-ancestor
25274415|NCT02378298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274416|NCT02378298|Dermatologic Agents|dermatologic agents|mesh-ancestor
25274417|NCT02378298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274418|NCT02378298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25274419|NCT02378298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25274420|NCT02378298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25274421|NCT02378298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25274422|NCT02378298|Antiemetics|antiemetics|mesh-ancestor
25274423|NCT02378298|Autonomic Agents|autonomic agents|mesh-ancestor
25274424|NCT02378298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25274425|NCT02378298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25274426|NCT02378298|Glucocorticoids|glucocorticoids|mesh-ancestor
25274427|NCT02378298|Hormones|hormones|mesh-ancestor
25274428|NCT02378298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25274429|NCT02378298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25274430|NCT02378298|Protective Agents|protective agents|mesh-ancestor
25274431|NCT02378298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25274432|NCT02378389|Docetaxel|docetaxel|mesh-list
25274433|NCT02378389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25274434|NCT02378389|Tubulin Modulators|tubulin modulators|mesh-ancestor
25274435|NCT02378389|Antimitotic Agents|antimitotic agents|mesh-ancestor
24596130|NCT00941967|Gemcitabine|gemcitabine|mesh-list
24596131|NCT00941967|Oxaliplatin|oxaliplatin|mesh-list
24596132|NCT00941967|Sorafenib|sorafenib|mesh-list
24596133|NCT00941967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24596142|NCT00941967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596143|NCT00941967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24596144|NCT00942006|Doxycycline|doxycycline|mesh-list
24596171|NCT00942201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596172|NCT00942201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24596173|NCT00942201|Glucocorticoids|glucocorticoids|mesh-ancestor
24596174|NCT00942201|Hormones|hormones|mesh-ancestor
24596175|NCT00942201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24596176|NCT00942201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24596177|NCT00942201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596215|NCT00942435|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24596216|NCT00942435|Protease Inhibitors|protease inhibitors|mesh-ancestor
24596217|NCT00942435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596218|NCT00942435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596238|NCT00942539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24596239|NCT00942539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24596240|NCT00942539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24596241|NCT00942539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596242|NCT00942539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24596243|NCT00942539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24596244|NCT00942539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24596245|NCT00942539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24596246|NCT00942539|Anesthetics, General|anesthetics, general|mesh-ancestor
24596248|NCT00942539|GABA Modulators|gaba modulators|mesh-ancestor
24596249|NCT00942539|GABA Agents|gaba agents|mesh-ancestor
24596250|NCT00942539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24812436|NCT02052167|Immunologic Factors|immunologic factors|mesh-ancestor
25247751|NCT02473276|Morphine|morphine|mesh-list
25686787|NCT01924871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25247752|NCT02473276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25247753|NCT02473276|Narcotics|narcotics|mesh-ancestor
25247754|NCT02473276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25247755|NCT02473276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247756|NCT02473276|Analgesics|analgesics|mesh-ancestor
25247757|NCT02473276|Sensory System Agents|sensory system agents|mesh-ancestor
25247758|NCT02473276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25247759|NCT02457702|Glycerol|glycerol|mesh-list
25247760|NCT02457702|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25247761|NCT02457702|Protective Agents|protective agents|mesh-ancestor
25247762|NCT02457702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247763|NCT02403505|BCG Vaccine|bcg vaccine|mesh-list
25247764|NCT02403505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25247765|NCT02403505|Immunologic Factors|immunologic factors|mesh-ancestor
25247766|NCT02403505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247767|NCT02346747|Immunologic Factors|immunologic factors|mesh-list
25247768|NCT02346747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247769|NCT02309645|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25247770|NCT02309645|Hemostatics|hemostatics|mesh-ancestor
25247771|NCT02309645|Coagulants|coagulants|mesh-ancestor
25247772|NCT02292706|Sofosbuvir|sofosbuvir|mesh-list
25247773|NCT02292706|Antiviral Agents|antiviral agents|mesh-ancestor
25247774|NCT02292706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25247775|NCT02286414|Vitamins|vitamins|mesh-list
25247776|NCT02286414|Vitamin K|vitamin k|mesh-list
25247777|NCT02286414|Warfarin|warfarin|mesh-list
25247778|NCT02286414|Rivaroxaban|rivaroxaban|mesh-list
25247779|NCT02286414|Dabigatran|dabigatran|mesh-list
25247780|NCT02286414|Apixaban|apixaban|mesh-list
25247781|NCT02286414|Acenocoumarol|acenocoumarol|mesh-list
25247782|NCT02286414|Fluindione|fluindione|mesh-list
25247783|NCT02286414|Micronutrients|micronutrients|mesh-ancestor
25247784|NCT02286414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247785|NCT02286414|Anticoagulants|anticoagulants|mesh-ancestor
25247786|NCT02286414|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25247787|NCT02286414|Antithrombins|antithrombins|mesh-ancestor
25247788|NCT02286414|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25247789|NCT02286414|Protease Inhibitors|protease inhibitors|mesh-ancestor
25247790|NCT02286414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25247791|NCT02286414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247792|NCT02286414|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25247793|NCT02286414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25247794|NCT02286414|Hemostatics|hemostatics|mesh-ancestor
25247795|NCT02286414|Coagulants|coagulants|mesh-ancestor
25247796|NCT02267603|Pembrolizumab|pembrolizumab|mesh-list
25274436|NCT02378389|Mitosis Modulators|mitosis modulators|mesh-ancestor
24596254|NCT00942565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24596256|NCT00942565|Sensory System Agents|sensory system agents|mesh-ancestor
24596257|NCT00942565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24596258|NCT00942565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596259|NCT00942565|Antipyretics|antipyretics|mesh-ancestor
24596260|NCT00942565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24596261|NCT00942565|Narcotics|narcotics|mesh-ancestor
24596262|NCT00942565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24596263|NCT00942591|Interferons|interferons|mesh-list
24596264|NCT00942591|Interferon-beta|interferon-beta|mesh-list
24636035|NCT01142492|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24596265|NCT00942591|Atorvastatin|atorvastatin|mesh-list
24596266|NCT00942591|Interferon beta-1b|interferon beta-1b|mesh-list
24596267|NCT00942591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596268|NCT00942591|Antiviral Agents|antiviral agents|mesh-ancestor
24596269|NCT00942591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24596270|NCT00942591|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24596271|NCT00942591|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24596272|NCT00942591|Antimetabolites|antimetabolites|mesh-ancestor
24596273|NCT00942591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596284|NCT00942617|Sensory System Agents|sensory system agents|mesh-ancestor
24596285|NCT00942617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24596286|NCT00942617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596287|NCT00942617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24596288|NCT00942617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24596289|NCT00942617|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24596290|NCT00942617|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24970200|NCT03735368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24596291|NCT00942617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596292|NCT00942617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24596293|NCT00942617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24812464|NCT02052323|Schistosomicides|schistosomicides|mesh-ancestor
24812465|NCT02052323|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24812466|NCT02052323|Anthelmintics|anthelmintics|mesh-ancestor
24579424|NCT00855088|Ritonavir|ritonavir|mesh-list
24579459|NCT00855153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24579460|NCT00855153|Renal Agents|renal agents|mesh-ancestor
24579461|NCT00855153|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24579462|NCT00855153|Antitubercular Agents|antitubercular agents|mesh-ancestor
25247797|NCT02267603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25247798|NCT02267603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247799|NCT02258659|Paclitaxel|paclitaxel|mesh-list
25247800|NCT02258659|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25247801|NCT02258659|Carboplatin|carboplatin|mesh-list
25247802|NCT02258659|Fluorouracil|fluorouracil|mesh-list
25247809|NCT02258659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247811|NCT02258659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25247812|NCT02258659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25247813|NCT02258659|Immunologic Factors|immunologic factors|mesh-ancestor
25247814|NCT02258659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247815|NCT02258659|Antisickling Agents|antisickling agents|mesh-ancestor
25247816|NCT02258659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25247817|NCT02258659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25247824|NCT02111850|Aldesleukin|aldesleukin|mesh-list
25247825|NCT02111850|Cyclophosphamide|cyclophosphamide|mesh-list
25247826|NCT02111850|Fludarabine|fludarabine|mesh-list
25247827|NCT02111850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25247828|NCT02111850|Immunologic Factors|immunologic factors|mesh-ancestor
25247829|NCT02111850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247830|NCT02111850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25247831|NCT02111850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24812468|NCT02052336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24812469|NCT02052336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24812470|NCT02052336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24596318|NCT00942773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24596319|NCT00942773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596320|NCT00942773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596321|NCT00942773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24596326|NCT00942838|Cisplatin|cisplatin|mesh-list
24596327|NCT00942838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596328|NCT00942864|Ranibizumab|ranibizumab|mesh-list
24596329|NCT00942864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24596330|NCT00942864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24596331|NCT00942864|Growth Substances|growth substances|mesh-ancestor
24596332|NCT00942864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596333|NCT00942864|Growth Inhibitors|growth inhibitors|mesh-ancestor
24596334|NCT00942864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596335|NCT00943059|Acipimox|acipimox|mesh-list
24596336|NCT00943059|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24596337|NCT00943059|Antimetabolites|antimetabolites|mesh-ancestor
24596338|NCT00943059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596339|NCT00943059|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24596340|NCT00943137|Fluorouracil|fluorouracil|mesh-list
24596359|NCT00943228|Antitubercular Agents|antitubercular agents|mesh-ancestor
24596360|NCT00943228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24596361|NCT00943228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24596362|NCT00943228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661164|NCT01288326|Liraglutide|liraglutide|mesh-list
24596363|NCT00943228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596364|NCT00943267|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
24596365|NCT00943267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24596366|NCT00943293|Fludarabine|fludarabine|mesh-list
24596367|NCT00943293|Melphalan|melphalan|mesh-list
24596368|NCT00943293|Alemtuzumab|alemtuzumab|mesh-list
24596369|NCT00943293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596370|NCT00943293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579463|NCT00855153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24579464|NCT00855153|Antimetabolites|antimetabolites|mesh-ancestor
25247832|NCT02111850|Alkylating Agents|alkylating agents|mesh-ancestor
25247833|NCT02111850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247834|NCT02111850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247835|NCT02111850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25247836|NCT02111850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25247837|NCT02111850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25247838|NCT02111850|Antiviral Agents|antiviral agents|mesh-ancestor
25247839|NCT02111850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25247840|NCT02049905|Gemcitabine|gemcitabine|mesh-list
25247841|NCT02049905|Docetaxel|docetaxel|mesh-list
24708662|NCT01501916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708663|NCT01501916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25247842|NCT02049905|Doxorubicin|doxorubicin|mesh-list
25686788|NCT01924871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247843|NCT02049905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25247844|NCT02049905|Ifosfamide|ifosfamide|mesh-list
25247845|NCT02049905|Isophosphamide mustard|isophosphamide mustard|mesh-list
25247846|NCT02049905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25247847|NCT02049905|Antimetabolites|antimetabolites|mesh-ancestor
25247848|NCT02049905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247849|NCT02049905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247850|NCT02049905|Antiviral Agents|antiviral agents|mesh-ancestor
25247851|NCT02049905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25247852|NCT02049905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25247853|NCT02049905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25247854|NCT02049905|Immunologic Factors|immunologic factors|mesh-ancestor
25247855|NCT02049905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247856|NCT02049905|Tubulin Modulators|tubulin modulators|mesh-ancestor
25247857|NCT02049905|Antimitotic Agents|antimitotic agents|mesh-ancestor
25247858|NCT02049905|Mitosis Modulators|mitosis modulators|mesh-ancestor
25041893|NCT01565655|Peficitinib|peficitinib|mesh-list
25247859|NCT02049905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25247860|NCT02049905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25247861|NCT02049905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25247862|NCT02049905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25247863|NCT02049905|Alkylating Agents|alkylating agents|mesh-ancestor
25247864|NCT01472562|Rituximab|rituximab|mesh-list
25247865|NCT01472562|Lenalidomide|lenalidomide|mesh-list
25247866|NCT01472562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25247867|NCT01472562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247868|NCT01472562|Immunologic Factors|immunologic factors|mesh-ancestor
24596371|NCT00943293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24596372|NCT00943293|Immunologic Factors|immunologic factors|mesh-ancestor
24596373|NCT00943293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596374|NCT00943293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24596375|NCT00943293|Alkylating Agents|alkylating agents|mesh-ancestor
24596376|NCT00943293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24596377|NCT00943293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24596378|NCT00943345|Indomethacin|indomethacin|mesh-list
24596379|NCT00943345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24596380|NCT00943345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24596381|NCT00943345|Analgesics|analgesics|mesh-ancestor
24596382|NCT00943345|Sensory System Agents|sensory system agents|mesh-ancestor
24596383|NCT00943345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24596384|NCT00943345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596385|NCT00943345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24596386|NCT00943345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24596387|NCT00943345|Gout Suppressants|gout suppressants|mesh-ancestor
24596388|NCT00943345|Tocolytic Agents|tocolytic agents|mesh-ancestor
24596461|NCT00943839|Sunitinib|sunitinib|mesh-list
24596462|NCT00943839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596463|NCT00943839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24596476|NCT00943930|Sympathomimetics|sympathomimetics|mesh-ancestor
24596477|NCT00943930|Autonomic Agents|autonomic agents|mesh-ancestor
24596478|NCT00943930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24596479|NCT00943930|Dopamine Agents|dopamine agents|mesh-ancestor
24596480|NCT00943930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24596481|NCT00943930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596482|NCT00943930|Adrenergic Agents|adrenergic agents|mesh-ancestor
24596483|NCT00943930|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25247869|NCT01472562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247870|NCT01472562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25247871|NCT01472562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25247872|NCT01472562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25247873|NCT01472562|Growth Substances|growth substances|mesh-ancestor
25247874|NCT01472562|Growth Inhibitors|growth inhibitors|mesh-ancestor
25247875|NCT01362998|Fentanyl|fentanyl|mesh-list
25247876|NCT01362998|Morphine|morphine|mesh-list
25247877|NCT01362998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25247878|NCT01362998|Narcotics|narcotics|mesh-ancestor
25247879|NCT01362998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25247880|NCT01362998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247881|NCT01362998|Analgesics|analgesics|mesh-ancestor
25686789|NCT01924871|Analgesics|analgesics|mesh-ancestor
25686790|NCT01924871|Sensory System Agents|sensory system agents|mesh-ancestor
25247882|NCT01362998|Sensory System Agents|sensory system agents|mesh-ancestor
24709045|NCT01503905|Trastuzumab|trastuzumab|mesh-list
25247883|NCT01362998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25247884|NCT01362998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25247885|NCT01362998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25247886|NCT01362998|Anesthetics, General|anesthetics, general|mesh-ancestor
25247887|NCT01362998|Anesthetics|anesthetics|mesh-ancestor
25247888|NCT01302327|Exenatide|exenatide|mesh-list
25247889|NCT01302327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25247890|NCT01302327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247891|NCT01302327|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25247892|NCT01302327|Incretins|incretins|mesh-ancestor
25247893|NCT01302327|Hormones|hormones|mesh-ancestor
25247894|NCT01302327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25247895|NCT01259648|Remifentanil|remifentanil|mesh-list
25247896|NCT01259648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25247897|NCT01259648|Narcotics|narcotics|mesh-ancestor
25247898|NCT01259648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25247899|NCT01259648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247900|NCT01259648|Analgesics|analgesics|mesh-ancestor
25247901|NCT01259648|Sensory System Agents|sensory system agents|mesh-ancestor
25247902|NCT01259648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25247903|NCT01192555|Cyclophosphamide|cyclophosphamide|mesh-list
25247904|NCT01192555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25247905|NCT01192555|Immunologic Factors|immunologic factors|mesh-ancestor
25247906|NCT01192555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247907|NCT01192555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25247908|NCT01192555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25247909|NCT01192555|Alkylating Agents|alkylating agents|mesh-ancestor
25247910|NCT01192555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247911|NCT01192555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247912|NCT01192555|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24596521|NCT00943956|Androgen Antagonists|androgen antagonists|mesh-ancestor
24596522|NCT00943956|Hormone Antagonists|hormone antagonists|mesh-ancestor
24596523|NCT00943956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24596524|NCT00943982|Interferons|interferons|mesh-list
24596525|NCT00943982|Interferon-gamma|interferon-gamma|mesh-list
24596526|NCT00943982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596528|NCT00943982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24596529|NCT00944177|Metformin|metformin|mesh-list
24596530|NCT00944177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24596531|NCT00944177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596532|NCT00944242|Sertraline|sertraline|mesh-list
24596533|NCT00944242|Antidepressive Agents|antidepressive agents|mesh-ancestor
24596534|NCT00944242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24596535|NCT00944242|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24596536|NCT00944242|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24596537|NCT00944242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24596538|NCT00944242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812485|NCT02052687|Imiquimod|imiquimod|mesh-list
24812486|NCT02052687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24812487|NCT02052687|Immunologic Factors|immunologic factors|mesh-ancestor
24812488|NCT02052687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812489|NCT02052687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812490|NCT02052687|Interferon Inducers|interferon inducers|mesh-ancestor
24596566|NCT00944333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596567|NCT00944346|Metformin|metformin|mesh-list
24596568|NCT00944346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24596569|NCT00944346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596570|NCT00944359|Zinc|zinc|mesh-list
24596571|NCT00944359|Trace Elements|trace elements|mesh-ancestor
24596572|NCT00944359|Micronutrients|micronutrients|mesh-ancestor
24596573|NCT00944359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596574|NCT00944385|Urinastatin|urinastatin|mesh-list
24596575|NCT00944385|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25247913|NCT00819546|Everolimus|everolimus|mesh-list
25247914|NCT00819546|Midostaurin|midostaurin|mesh-list
25247915|NCT00819546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247916|NCT00819546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25247917|NCT00819546|Immunologic Factors|immunologic factors|mesh-ancestor
25247918|NCT00819546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247919|NCT00819546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25247920|NCT00819546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25247921|NCT00819546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247922|NCT00762554|Fentanyl|fentanyl|mesh-list
25686791|NCT01924871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25247923|NCT00762554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25247924|NCT00762554|Narcotics|narcotics|mesh-ancestor
25247925|NCT00762554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25247926|NCT00762554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247927|NCT00762554|Analgesics|analgesics|mesh-ancestor
25247928|NCT00762554|Sensory System Agents|sensory system agents|mesh-ancestor
25247929|NCT00762554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25247930|NCT00762554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25247931|NCT00762554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25247932|NCT00762554|Anesthetics, General|anesthetics, general|mesh-ancestor
25247933|NCT00762554|Anesthetics|anesthetics|mesh-ancestor
25247934|NCT00590187|Sapacitabine|sapacitabine|mesh-list
25247935|NCT00590187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247936|NCT00135200|Tositumomab I-131|tositumomab i-131|mesh-list
25247937|NCT00135200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247938|NCT02535052|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25247939|NCT02535052|Immunologic Factors|immunologic factors|mesh-ancestor
25247940|NCT02535052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247942|NCT02535104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247943|NCT02535104|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25247944|NCT02535104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25247945|NCT02535104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247946|NCT02535130|Amikacin|amikacin|mesh-list
25247947|NCT02535130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25247948|NCT02535130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25247949|NCT02534961|Cefazolin|cefazolin|mesh-list
25247950|NCT02534961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25247951|NCT02534961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25247952|NCT02535039|Methylprednisolone|methylprednisolone|mesh-list
25247953|NCT02535039|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25247954|NCT02535039|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25247955|NCT02535039|Prednisolone|prednisolone|mesh-list
24596586|NCT00944398|Trace Elements|trace elements|mesh-ancestor
24596587|NCT00944398|Astringents|astringents|mesh-ancestor
24596588|NCT00944398|Dermatologic Agents|dermatologic agents|mesh-ancestor
24596589|NCT00944424|Vitamin D|vitamin d|mesh-list
24596590|NCT00944424|Ergocalciferols|ergocalciferols|mesh-list
24596591|NCT00944424|Cholecalciferol|cholecalciferol|mesh-list
24596592|NCT00944424|Vitamins|vitamins|mesh-list
24596593|NCT00944424|Docetaxel|docetaxel|mesh-list
24596594|NCT00944424|Micronutrients|micronutrients|mesh-ancestor
24596595|NCT00944424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596596|NCT00944424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596597|NCT00944424|Tubulin Modulators|tubulin modulators|mesh-ancestor
24596598|NCT00944424|Antimitotic Agents|antimitotic agents|mesh-ancestor
24596599|NCT00944424|Mitosis Modulators|mitosis modulators|mesh-ancestor
24596653|NCT00944684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596655|NCT00944684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24596656|NCT00944723|Vitamins|vitamins|mesh-list
24596657|NCT00944723|Zinc|zinc|mesh-list
24596658|NCT00944723|Vitamin B Complex|vitamin b complex|mesh-list
24596659|NCT00944723|Zinc Sulfate|zinc sulfate|mesh-list
24596660|NCT00944723|Micronutrients|micronutrients|mesh-ancestor
24596661|NCT00944723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970354|NCT03733860|Alprostadil|alprostadil|mesh-list
24596662|NCT00944723|Trace Elements|trace elements|mesh-ancestor
24596663|NCT00944723|Astringents|astringents|mesh-ancestor
24596664|NCT00944723|Dermatologic Agents|dermatologic agents|mesh-ancestor
24596665|NCT00944801|Doxorubicin|doxorubicin|mesh-list
24596666|NCT00944801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24596667|NCT00944801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24596841|NCT00945997|Abortifacient Agents|abortifacient agents|mesh-ancestor
24596668|NCT00944801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596669|NCT00944801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24579465|NCT00855153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579466|NCT00855205|Rituximab|rituximab|mesh-list
24579467|NCT00855205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24579468|NCT00855205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632485|NCT01124318|Lactulose|lactulose|mesh-list
24579469|NCT00855205|Immunologic Factors|immunologic factors|mesh-ancestor
24579470|NCT00855205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579471|NCT00855205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24579472|NCT00855270|Hydrocortisone|hydrocortisone|mesh-list
24579506|NCT00855686|Memantine|memantine|mesh-list
24579507|NCT00855686|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24579508|NCT00855686|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24579509|NCT00855686|Dopamine Agents|dopamine agents|mesh-ancestor
24579510|NCT00855686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24579511|NCT00855686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579512|NCT00855686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579513|NCT00855686|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24579514|NCT00855686|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24579519|NCT00855777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25247956|NCT02535039|Prednisolone acetate|prednisolone acetate|mesh-list
25247957|NCT02535039|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25247958|NCT02535039|Prednisolone phosphate|prednisolone phosphate|mesh-list
25247959|NCT02535039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25247960|NCT02535039|Antiemetics|antiemetics|mesh-ancestor
25247961|NCT02535039|Autonomic Agents|autonomic agents|mesh-ancestor
25247962|NCT02535039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25247963|NCT02535039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247964|NCT02535039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25247965|NCT02535039|Glucocorticoids|glucocorticoids|mesh-ancestor
25247966|NCT02535039|Hormones|hormones|mesh-ancestor
25247967|NCT02535039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25247968|NCT02535039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25247969|NCT02535039|Protective Agents|protective agents|mesh-ancestor
25247970|NCT02535039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25247971|NCT02535039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25247972|NCT02534870|Ritonavir|ritonavir|mesh-list
25247973|NCT02534870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25247974|NCT02534870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25247975|NCT02534870|Protease Inhibitors|protease inhibitors|mesh-ancestor
25247976|NCT02534870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25247977|NCT02534870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247978|NCT02534870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25247979|NCT02534870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25247980|NCT02534870|Antiviral Agents|antiviral agents|mesh-ancestor
25247981|NCT02534870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25247982|NCT02534870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24596670|NCT00944801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24596671|NCT00944801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596672|NCT00944801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596674|NCT00944814|Trace Elements|trace elements|mesh-ancestor
24596675|NCT00944814|Micronutrients|micronutrients|mesh-ancestor
24596676|NCT00944814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596677|NCT00944840|Amodiaquine|amodiaquine|mesh-list
24596678|NCT00944840|Antimalarials|antimalarials|mesh-ancestor
24596679|NCT00944840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24596711|NCT00944957|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24962059|NCT03803215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24596712|NCT00944957|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24596713|NCT00944957|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24596714|NCT00944957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24596715|NCT00944957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24596716|NCT00944957|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24596717|NCT00944957|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24596719|NCT00944996|Fluoxetine|fluoxetine|mesh-list
24596720|NCT00944996|Paroxetine|paroxetine|mesh-list
24596721|NCT00944996|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24596722|NCT00944996|Sertraline|sertraline|mesh-list
24596723|NCT00944996|Clomipramine|clomipramine|mesh-list
24596724|NCT00944996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24596725|NCT00944996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24596726|NCT00944996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24812497|NCT02052713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25248183|NCT02533765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812498|NCT02052713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812499|NCT02052713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812500|NCT02052713|Urological Agents|urological agents|mesh-ancestor
24812501|NCT02052713|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24852840|NCT02264184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852841|NCT02264184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25247983|NCT02534870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25247984|NCT02534753|Ascorbic Acid|ascorbic acid|mesh-list
25247985|NCT02534753|Antioxidants|antioxidants|mesh-ancestor
25247986|NCT02534753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247987|NCT02534753|Protective Agents|protective agents|mesh-ancestor
25247988|NCT02534753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247989|NCT02534753|Vitamins|vitamins|mesh-ancestor
25247990|NCT02534753|Micronutrients|micronutrients|mesh-ancestor
25247991|NCT02534571|Epinephrine|epinephrine|mesh-list
25247992|NCT02534571|Hemostatics|hemostatics|mesh-list
25247993|NCT02534571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25247994|NCT02534571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24709627|NCT01506505|Sensory System Agents|sensory system agents|mesh-ancestor
24709628|NCT01506505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24709629|NCT01506505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25247995|NCT02534571|Adrenergic Agents|adrenergic agents|mesh-ancestor
25247996|NCT02534571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25247997|NCT02534571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25247998|NCT02534571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25247999|NCT02534571|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25248000|NCT02534571|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25248001|NCT02534571|Autonomic Agents|autonomic agents|mesh-ancestor
25248002|NCT02534571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25248003|NCT02534571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25248004|NCT02534571|Respiratory System Agents|respiratory system agents|mesh-ancestor
25248005|NCT02534571|Mydriatics|mydriatics|mesh-ancestor
25248006|NCT02534571|Sympathomimetics|sympathomimetics|mesh-ancestor
25248007|NCT02534571|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25248008|NCT02534571|Coagulants|coagulants|mesh-ancestor
25248009|NCT02534506|Nivolumab|nivolumab|mesh-list
25248010|NCT02534506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25248011|NCT02534506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248012|NCT02534506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25248013|NCT02534506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248014|NCT02534415|Hyaluronic Acid|hyaluronic acid|mesh-list
25248015|NCT02534415|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25248016|NCT02534415|Immunologic Factors|immunologic factors|mesh-ancestor
25248017|NCT02534415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248018|NCT02534415|Viscosupplements|viscosupplements|mesh-ancestor
25248019|NCT02534415|Protective Agents|protective agents|mesh-ancestor
25248020|NCT02534610|Etoricoxib|etoricoxib|mesh-list
25248021|NCT02534610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25248022|NCT02534610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25248023|NCT02534610|Analgesics|analgesics|mesh-ancestor
24852857|NCT02264236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852858|NCT02264301|Puerarin|puerarin|mesh-list
24852859|NCT02264301|Vasodilator Agents|vasodilator agents|mesh-ancestor
24852860|NCT02264522|Dialysis Solutions|dialysis solutions|mesh-list
24852861|NCT02264522|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24852862|NCT02264561|Caffeine|caffeine|mesh-list
24852863|NCT02264561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24852864|NCT02264561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852865|NCT02264561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24852866|NCT02264561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852867|NCT02264561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852868|NCT02264561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24852869|NCT02264561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24852870|NCT02264561|Purinergic Agents|purinergic agents|mesh-ancestor
24661509|NCT01289756|Serotonin Agents|serotonin agents|mesh-ancestor
24596796|NCT00945529|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24596797|NCT00945529|Antioxidants|antioxidants|mesh-ancestor
24596831|NCT00945919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24596832|NCT00945919|Narcotics|narcotics|mesh-ancestor
24596833|NCT00945919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24596834|NCT00945919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596835|NCT00945919|Analgesics|analgesics|mesh-ancestor
24596836|NCT00945919|Sensory System Agents|sensory system agents|mesh-ancestor
24596837|NCT00945919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24596838|NCT00945919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24596839|NCT00945997|Misoprostol|misoprostol|mesh-list
24596840|NCT00945997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24596842|NCT00945997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24579520|NCT00855777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24579522|NCT00855777|Sensory System Agents|sensory system agents|mesh-ancestor
24579548|NCT00856037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24579549|NCT00856037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579550|NCT00856037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579551|NCT00856037|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24579552|NCT00856063|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24579553|NCT00856063|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24579554|NCT00856063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24793000|NCT04302324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25686792|NCT01924871|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25686793|NCT01924871|Anesthetics, General|anesthetics, general|mesh-ancestor
25686794|NCT01924871|Anesthetics|anesthetics|mesh-ancestor
25686795|NCT01924949|Sofosbuvir|sofosbuvir|mesh-list
25248024|NCT02534610|Sensory System Agents|sensory system agents|mesh-ancestor
25248025|NCT02534610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25248026|NCT02534610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248027|NCT02534610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25248028|NCT02534610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25248029|NCT02534610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25248030|NCT02534610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25248031|NCT02534610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248032|NCT02534610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248033|NCT02534363|Aripiprazole|aripiprazole|mesh-list
25248034|NCT02534363|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25248035|NCT02534363|Ziprasidone|ziprasidone|mesh-list
25248036|NCT02534363|Antidepressive Agents|antidepressive agents|mesh-ancestor
25248037|NCT02534363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25248040|NCT02534363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25248041|NCT02534363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248042|NCT02534363|Dopamine Agonists|dopamine agonists|mesh-ancestor
25248043|NCT02534363|Dopamine Agents|dopamine agents|mesh-ancestor
25248044|NCT02534363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25248045|NCT02534363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248046|NCT02534363|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25248047|NCT02534363|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25248048|NCT02534363|Serotonin Agents|serotonin agents|mesh-ancestor
25248049|NCT02534363|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25248050|NCT02534363|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25248051|NCT02534363|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25248052|NCT02534363|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25274437|NCT02378389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596843|NCT00945997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596845|NCT00945997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24596846|NCT00945997|Oxytocics|oxytocics|mesh-ancestor
24596847|NCT00946036|Sertraline|sertraline|mesh-list
24596848|NCT00946036|Antidepressive Agents|antidepressive agents|mesh-ancestor
24596849|NCT00946036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24596850|NCT00946036|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24596851|NCT00946036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24596852|NCT00946036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24962140|NCT03801746|Cyclosporine|cyclosporine|mesh-list
24596853|NCT00946036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596854|NCT00946036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24596855|NCT00946036|Serotonin Agents|serotonin agents|mesh-ancestor
24503797|NCT00532909|Growth Substances|growth substances|mesh-ancestor
24596888|NCT00946374|Antifungal Agents|antifungal agents|mesh-ancestor
24596889|NCT00946374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24596890|NCT00946374|Dermatologic Agents|dermatologic agents|mesh-ancestor
24596891|NCT00946374|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24596892|NCT00946387|Ondansetron|ondansetron|mesh-list
24596893|NCT00946387|Antiemetics|antiemetics|mesh-ancestor
24596894|NCT00946387|Autonomic Agents|autonomic agents|mesh-ancestor
24596895|NCT00946387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24596896|NCT00946387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596897|NCT00946387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24596898|NCT00946387|Antipruritics|antipruritics|mesh-ancestor
24596899|NCT00946387|Dermatologic Agents|dermatologic agents|mesh-ancestor
24596900|NCT00946387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24596901|NCT00946387|Serotonin Agents|serotonin agents|mesh-ancestor
24596902|NCT00946387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24852876|NCT02264587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24852877|NCT02264587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248053|NCT02534376|Simvastatin|simvastatin|mesh-list
24852878|NCT02264587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25248054|NCT02534376|Ezetimibe|ezetimibe|mesh-list
25248055|NCT02534376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25248056|NCT02534376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25248057|NCT02534376|Antimetabolites|antimetabolites|mesh-ancestor
25248058|NCT02534376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248059|NCT02534376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25248060|NCT02534376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25248061|NCT02534376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248062|NCT02534636|Interferons|interferons|mesh-list
25248063|NCT02534636|Interferon-alpha|interferon-alpha|mesh-list
25248064|NCT02534636|Interferon alpha-2|interferon alpha-2|mesh-list
25248065|NCT02534636|BMS-986165|bms-986165|mesh-list
25248066|NCT02534636|Famotidine|famotidine|mesh-list
25248067|NCT02534636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248068|NCT02534636|Antiviral Agents|antiviral agents|mesh-ancestor
25248069|NCT02534636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25248070|NCT02534636|Immunologic Factors|immunologic factors|mesh-ancestor
25248071|NCT02534636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248072|NCT02534636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25248073|NCT02534636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25248074|NCT02534636|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25248075|NCT02534636|Histamine Antagonists|histamine antagonists|mesh-ancestor
25248076|NCT02534636|Histamine Agents|histamine agents|mesh-ancestor
25248077|NCT02534636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25248078|NCT02534636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248079|NCT02534636|Dermatologic Agents|dermatologic agents|mesh-ancestor
25248080|NCT02534636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25248081|NCT02534636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248083|NCT02534467|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25248084|NCT02534467|Respiratory System Agents|respiratory system agents|mesh-ancestor
25248085|NCT02534467|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25248086|NCT02534467|Hormone Antagonists|hormone antagonists|mesh-ancestor
25248087|NCT02534467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25248088|NCT02534467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248089|NCT02534467|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25248090|NCT02534467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24596905|NCT00946387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24596906|NCT00946387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24596907|NCT00946387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24596908|NCT00946387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24596910|NCT00946465|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24596911|NCT00946465|Protease Inhibitors|protease inhibitors|mesh-ancestor
24596912|NCT00946465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596913|NCT00946465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596914|NCT00946465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24596915|NCT00946491|Haloperidol|haloperidol|mesh-list
24596916|NCT00946491|Haloperidol decanoate|haloperidol decanoate|mesh-list
24596917|NCT00946491|Antiemetics|antiemetics|mesh-ancestor
24671142|NCT01324063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24596918|NCT00946491|Autonomic Agents|autonomic agents|mesh-ancestor
24596919|NCT00946491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24636075|NCT01142635|Bromides|bromides|mesh-list
24596920|NCT00946491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596921|NCT00946491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24597033|NCT00946907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597034|NCT00946907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24597035|NCT00946907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24597036|NCT00946907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24597037|NCT00946907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24597038|NCT00946907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597039|NCT00946907|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24597040|NCT00946907|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24597041|NCT00946907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597071|NCT00947063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597072|NCT00947063|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25248091|NCT02534467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248092|NCT02534337|Leucovorin|leucovorin|mesh-list
25248093|NCT02534337|Gemcitabine|gemcitabine|mesh-list
25248094|NCT02534337|Fluorouracil|fluorouracil|mesh-list
25248095|NCT02534337|Oxaliplatin|oxaliplatin|mesh-list
25248096|NCT02534337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25248097|NCT02534337|Antimetabolites|antimetabolites|mesh-ancestor
25248098|NCT02534337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248099|NCT02534337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248100|NCT02534337|Antiviral Agents|antiviral agents|mesh-ancestor
25248101|NCT02534337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25248102|NCT02534337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248103|NCT02534337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25248104|NCT02534337|Immunologic Factors|immunologic factors|mesh-ancestor
25248105|NCT02534337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248106|NCT02534337|Antidotes|antidotes|mesh-ancestor
25248107|NCT02534337|Protective Agents|protective agents|mesh-ancestor
25248108|NCT02534337|Vitamin B Complex|vitamin b complex|mesh-ancestor
25248109|NCT02534337|Vitamins|vitamins|mesh-ancestor
25248110|NCT02534337|Micronutrients|micronutrients|mesh-ancestor
25248111|NCT02534623|Fentanyl|fentanyl|mesh-list
24710347|NCT01509755|Hormones|hormones|mesh-ancestor
25248112|NCT02534623|Bupivacaine|bupivacaine|mesh-list
25248113|NCT02534623|Anesthetics|anesthetics|mesh-list
25248114|NCT02534623|Propofol|propofol|mesh-list
25248115|NCT02534623|Sevoflurane|sevoflurane|mesh-list
25248116|NCT02534623|Anesthetics, Local|anesthetics, local|mesh-ancestor
25248117|NCT02534623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25248118|NCT02534623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248119|NCT02534623|Sensory System Agents|sensory system agents|mesh-ancestor
25248120|NCT02534623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25248121|NCT02534623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25248124|NCT02534623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25248125|NCT02534623|Narcotics|narcotics|mesh-ancestor
25248126|NCT02534623|Analgesics|analgesics|mesh-ancestor
25248127|NCT02534623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25248128|NCT02534623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25248129|NCT02534623|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25248130|NCT02534454|Nicotine|nicotine|mesh-list
25248131|NCT02534454|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25248132|NCT02534454|Autonomic Agents|autonomic agents|mesh-ancestor
25248133|NCT02534454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25248134|NCT02534454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248135|NCT02534454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24597106|NCT00947128|Serotonin Agents|serotonin agents|mesh-ancestor
24597153|NCT00947375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24597154|NCT00947375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24597155|NCT00947375|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24962212|NCT03801564|Hyaluronic Acid|hyaluronic acid|mesh-list
24597156|NCT00947375|Dopamine Agents|dopamine agents|mesh-ancestor
24597157|NCT00947375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24597158|NCT00947375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597159|NCT00947375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24597160|NCT00947375|Anticonvulsants|anticonvulsants|mesh-ancestor
24597161|NCT00947375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24597162|NCT00947375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24597163|NCT00947375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24597164|NCT00947375|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24597165|NCT00947388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24597189|NCT00947466|Narcotics|narcotics|mesh-ancestor
24597190|NCT00947466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24597191|NCT00947466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597192|NCT00947466|Analgesics|analgesics|mesh-ancestor
24597193|NCT00947466|Sensory System Agents|sensory system agents|mesh-ancestor
24597194|NCT00947466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24597195|NCT00947466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24597197|NCT00947596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24597198|NCT00947596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24597199|NCT00947596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24597200|NCT00947596|Autonomic Agents|autonomic agents|mesh-ancestor
24852884|NCT02264587|Serotonin Agents|serotonin agents|mesh-ancestor
24852885|NCT02264626|Remifentanil|remifentanil|mesh-list
24852886|NCT02264626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24852887|NCT02264626|Narcotics|narcotics|mesh-ancestor
24793001|NCT04302324|Antiemetics|antiemetics|mesh-ancestor
24793002|NCT04302324|Autonomic Agents|autonomic agents|mesh-ancestor
24793003|NCT04302324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24793004|NCT04302324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793005|NCT04302324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25009950|NCT04827979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009951|NCT04827979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25248136|NCT02534454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25248137|NCT02534454|Cholinergic Agents|cholinergic agents|mesh-ancestor
25248138|NCT02534454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25248139|NCT02534454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248140|NCT02534402|Prednisone|prednisone|mesh-list
25248141|NCT02534402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25248142|NCT02534402|Glucocorticoids|glucocorticoids|mesh-ancestor
25248143|NCT02534402|Hormones|hormones|mesh-ancestor
25248144|NCT02534402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25248145|NCT02534402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248146|NCT02534402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25248147|NCT02534402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248148|NCT02533908|Fentanyl|fentanyl|mesh-list
25248149|NCT02533908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25248150|NCT02533908|Narcotics|narcotics|mesh-ancestor
25692594|NCT02002832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24710445|NCT01510574|Misoprostol|misoprostol|mesh-list
25248151|NCT02533908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25248152|NCT02533908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248153|NCT02533908|Analgesics|analgesics|mesh-ancestor
25248154|NCT02533908|Sensory System Agents|sensory system agents|mesh-ancestor
25248155|NCT02533908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25248156|NCT02533908|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25248157|NCT02533908|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25248158|NCT02533908|Anesthetics, General|anesthetics, general|mesh-ancestor
25248160|NCT02533973|Calcipotriene|calcipotriene|mesh-list
25248161|NCT02533973|Dermatologic Agents|dermatologic agents|mesh-ancestor
25248162|NCT02533791|Vaccines|vaccines|mesh-list
24794107|NCT05413902|Hormones|hormones|mesh-ancestor
25248163|NCT02533791|Immunologic Factors|immunologic factors|mesh-ancestor
25248164|NCT02533791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248165|NCT02533648|Allopurinol|allopurinol|mesh-list
25248166|NCT02533648|Antimetabolites|antimetabolites|mesh-ancestor
25248167|NCT02533648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248168|NCT02533648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248169|NCT02533648|Gout Suppressants|gout suppressants|mesh-ancestor
24852888|NCT02264626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24852889|NCT02264626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852891|NCT02264626|Sensory System Agents|sensory system agents|mesh-ancestor
24852892|NCT02264626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24852893|NCT02264665|Everolimus|everolimus|mesh-list
24852894|NCT02264665|Sunitinib|sunitinib|mesh-list
24661839|NCT01291212|Hormones|hormones|mesh-ancestor
24597201|NCT00947596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24597202|NCT00947596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597203|NCT00947596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24597204|NCT00947596|Respiratory System Agents|respiratory system agents|mesh-ancestor
24597205|NCT00947596|Mydriatics|mydriatics|mesh-ancestor
24597206|NCT00947596|Parasympatholytics|parasympatholytics|mesh-ancestor
24597207|NCT00947596|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24597208|NCT00947596|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24597209|NCT00947596|Cholinergic Agents|cholinergic agents|mesh-ancestor
24597210|NCT00947596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24597211|NCT00947596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597212|NCT00947713|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24597213|NCT00947713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24597214|NCT00947713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597215|NCT00947739|Camptothecin|camptothecin|mesh-list
24597216|NCT00947739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24597217|NCT00947739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597218|NCT00947739|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24597259|NCT00947895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24597260|NCT00947895|Glucocorticoids|glucocorticoids|mesh-ancestor
24597261|NCT00947895|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24597262|NCT00947895|Protective Agents|protective agents|mesh-ancestor
24852895|NCT02264665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24852896|NCT02264665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24852897|NCT02264665|Immunologic Factors|immunologic factors|mesh-ancestor
24661896|NCT01291459|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24597263|NCT00947895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25248170|NCT02533648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25248171|NCT02533648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25248172|NCT02533648|Antioxidants|antioxidants|mesh-ancestor
25248173|NCT02533648|Protective Agents|protective agents|mesh-ancestor
25248174|NCT02533648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248175|NCT02533440|Anesthetics|anesthetics|mesh-list
25248176|NCT02533440|Anesthetics, Local|anesthetics, local|mesh-list
25248177|NCT02533440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25248178|NCT02533440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248179|NCT02533440|Sensory System Agents|sensory system agents|mesh-ancestor
25248180|NCT02533440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25248181|NCT02533765|Olaparib|olaparib|mesh-list
25248182|NCT02533765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25248184|NCT02533765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248185|NCT02533765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248187|NCT02533557|Epinephrine|epinephrine|mesh-list
25248188|NCT02533557|Racepinephrine|racepinephrine|mesh-list
25248189|NCT02533557|Epinephryl borate|epinephryl borate|mesh-list
25248190|NCT02533557|Anesthetics, Local|anesthetics, local|mesh-ancestor
25248191|NCT02533557|Anesthetics|anesthetics|mesh-ancestor
25248192|NCT02533557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25686796|NCT01924949|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
24710845|NCT01511887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248193|NCT02533557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248194|NCT02533557|Sensory System Agents|sensory system agents|mesh-ancestor
25248195|NCT02533557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25248196|NCT02533557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25248197|NCT02533557|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25248198|NCT02533557|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25248200|NCT02533557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248201|NCT02533557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25248202|NCT02533557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25248203|NCT02533557|Adrenergic Agents|adrenergic agents|mesh-ancestor
25248204|NCT02533557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25248205|NCT02533557|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25248206|NCT02533557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25248207|NCT02533557|Autonomic Agents|autonomic agents|mesh-ancestor
24597324|NCT00948662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24597325|NCT00948662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24597326|NCT00948662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24597327|NCT00948662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597328|NCT00948662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597329|NCT00948662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24597330|NCT00948662|Hormone Antagonists|hormone antagonists|mesh-ancestor
24597331|NCT00948662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24597332|NCT00948662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597333|NCT00948662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24597336|NCT00948727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597337|NCT00948727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597338|NCT00948727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24597339|NCT00948727|Immunologic Factors|immunologic factors|mesh-ancestor
24597340|NCT00948727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597341|NCT00948727|Antifungal Agents|antifungal agents|mesh-ancestor
24597342|NCT00948727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24597343|NCT00948727|Dermatologic Agents|dermatologic agents|mesh-ancestor
24597344|NCT00948727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24597345|NCT00948727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24597346|NCT00948740|Vitamin D|vitamin d|mesh-list
24597347|NCT00948740|Ergocalciferols|ergocalciferols|mesh-list
24597348|NCT00948740|Vitamins|vitamins|mesh-ancestor
24597349|NCT00948740|Micronutrients|micronutrients|mesh-ancestor
24597350|NCT00948740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597351|NCT00948740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24597352|NCT00948740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24597353|NCT00948779|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24597354|NCT00948779|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24504023|NCT00533741|Antacids|antacids|mesh-ancestor
24597377|NCT00948987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636103|NCT01142778|Bevacizumab|bevacizumab|mesh-list
24597380|NCT00949026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24597381|NCT00949026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25248208|NCT02533557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25248209|NCT02533557|Respiratory System Agents|respiratory system agents|mesh-ancestor
25248210|NCT02533557|Mydriatics|mydriatics|mesh-ancestor
25248211|NCT02533557|Sympathomimetics|sympathomimetics|mesh-ancestor
25248212|NCT02533557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25248213|NCT02533544|Tenofovir|tenofovir|mesh-list
25248214|NCT02533544|Antiviral Agents|antiviral agents|mesh-ancestor
25248215|NCT02533544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25248216|NCT02533544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25248217|NCT02533544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25248218|NCT02533544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248219|NCT02533544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248220|NCT02533544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25248221|NCT02533544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25248222|NCT02533492|Triclosan|triclosan|mesh-list
25248223|NCT02533492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25248225|NCT02533492|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25248226|NCT02533492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25248227|NCT02533492|Antimetabolites|antimetabolites|mesh-ancestor
25248228|NCT02533492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248229|NCT02533492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25248230|NCT02533323|Gemcitabine|gemcitabine|mesh-list
25686797|NCT01924949|Ledipasvir|ledipasvir|mesh-list
25248231|NCT02533323|Oxaliplatin|oxaliplatin|mesh-list
24956946|NCT03848611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956947|NCT03848767|Insulin Lispro|insulin lispro|mesh-list
24854281|NCT02272868|Rifaximin|rifaximin|mesh-list
24711083|NCT01513200|Heparin|heparin|mesh-list
24711084|NCT01513200|Calcium heparin|calcium heparin|mesh-list
24711085|NCT01513200|Anticoagulants|anticoagulants|mesh-ancestor
25248232|NCT02533323|Pegaspargase|pegaspargase|mesh-list
25248233|NCT02533323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25248234|NCT02533323|Antimetabolites|antimetabolites|mesh-ancestor
25248235|NCT02533323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248236|NCT02533323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248244|NCT02533336|Anthelmintics|anthelmintics|mesh-ancestor
25248245|NCT02533336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24597382|NCT00949026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24597383|NCT00949026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597384|NCT00949026|Antifungal Agents|antifungal agents|mesh-ancestor
24597385|NCT00949026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24597386|NCT00949026|Immunologic Factors|immunologic factors|mesh-ancestor
24597387|NCT00949026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597389|NCT00949065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24597391|NCT00949065|gamma-Globulins|gamma-globulins|mesh-list
24597392|NCT00949065|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24597393|NCT00949065|Immunologic Factors|immunologic factors|mesh-ancestor
24597394|NCT00949065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597395|NCT00949130|Linezolid|linezolid|mesh-list
24597396|NCT00949130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24597397|NCT00949130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24597398|NCT00949130|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24597399|NCT00949130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597400|NCT00949130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597401|NCT00949182|Doxorubicin|doxorubicin|mesh-list
24597402|NCT00949182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24597403|NCT00949182|Mitomycins|mitomycins|mesh-list
24597404|NCT00949182|Mitomycin|mitomycin|mesh-list
24597405|NCT00949182|Sorafenib|sorafenib|mesh-list
24597406|NCT00949182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24597407|NCT00949182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597408|NCT00949182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24597409|NCT00949182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24597410|NCT00949182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597411|NCT00949182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597412|NCT00949182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24597413|NCT00949182|Alkylating Agents|alkylating agents|mesh-ancestor
25074897|NCT03385161|Ethanol|ethanol|mesh-list
25009952|NCT04827979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009953|NCT04827979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25009988|NCT04814355|Celecoxib|celecoxib|mesh-list
25009989|NCT04814355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25009990|NCT04814355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25248246|NCT02533336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25248247|NCT02533349|Pantoprazole|pantoprazole|mesh-list
25248248|NCT02533349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25248249|NCT02533349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25248250|NCT02533349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25248251|NCT02533349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248252|NCT02533349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248253|NCT02533284|Magnesium Sulfate|magnesium sulfate|mesh-list
25248254|NCT02533284|Analgesics|analgesics|mesh-ancestor
25248255|NCT02533284|Sensory System Agents|sensory system agents|mesh-ancestor
25248256|NCT02533284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25248257|NCT02533284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248258|NCT02533284|Anesthetics|anesthetics|mesh-ancestor
25248259|NCT02533284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25248260|NCT02533284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25248261|NCT02533284|Anticonvulsants|anticonvulsants|mesh-ancestor
25248262|NCT02533284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25248263|NCT02533284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25248264|NCT02533284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248265|NCT02533284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25248266|NCT02533284|Tocolytic Agents|tocolytic agents|mesh-ancestor
25686798|NCT01924949|Antiviral Agents|antiviral agents|mesh-ancestor
25686799|NCT01924949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25686800|NCT01925144|Omeprazole|omeprazole|mesh-list
25686801|NCT01925144|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25686802|NCT01925144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25686803|NCT01925144|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24711292|NCT01514487|Hormones|hormones|mesh-ancestor
25248267|NCT02533284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25248268|NCT02533141|Simvastatin|simvastatin|mesh-list
25248269|NCT02533141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25248270|NCT02533141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25248271|NCT02533141|Antimetabolites|antimetabolites|mesh-ancestor
25248272|NCT02533141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248273|NCT02533141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25248274|NCT02533141|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25248275|NCT02533141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597414|NCT00949182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24597415|NCT00949247|Bevacizumab|bevacizumab|mesh-list
24597416|NCT00949247|Trastuzumab|trastuzumab|mesh-list
24597417|NCT00949247|Carboplatin|carboplatin|mesh-list
24597418|NCT00949247|Docetaxel|docetaxel|mesh-list
24597419|NCT00949247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24597452|NCT00949377|Sensory System Agents|sensory system agents|mesh-ancestor
24597453|NCT00949377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24597454|NCT00949442|Insulin|insulin|mesh-list
24597455|NCT00949442|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24597456|NCT00949442|Insulin Glargine|insulin glargine|mesh-list
24852902|NCT02264665|Growth Inhibitors|growth inhibitors|mesh-ancestor
24852903|NCT02264665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24852904|NCT02264665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597457|NCT00949442|Glimepiride|glimepiride|mesh-list
24597458|NCT00949442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24597459|NCT00949442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043219|NCT01302249|Timolol|timolol|mesh-list
24597460|NCT00949442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24597461|NCT00949442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24597462|NCT00949442|Immunologic Factors|immunologic factors|mesh-ancestor
24597464|NCT00949455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597465|NCT00949455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24597466|NCT00949455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597467|NCT00949455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597469|NCT00949494|Hyaluronic Acid|hyaluronic acid|mesh-list
24597470|NCT00949494|Viscosupplements|viscosupplements|mesh-ancestor
24597471|NCT00949494|Protective Agents|protective agents|mesh-ancestor
24597472|NCT00949494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597473|NCT00949494|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24597486|NCT00949546|Immunologic Factors|immunologic factors|mesh-ancestor
24597488|NCT00949572|Aluminum sulfate|aluminum sulfate|mesh-list
24597489|NCT00949572|Immunologic Factors|immunologic factors|mesh-ancestor
25248276|NCT02533011|Heparin|heparin|mesh-list
25248277|NCT02533011|Anticoagulants|anticoagulants|mesh-ancestor
25248278|NCT02533011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25248279|NCT02533011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25248280|NCT02533011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248281|NCT02533076|Capsaicin|capsaicin|mesh-list
25248282|NCT02533076|Antipruritics|antipruritics|mesh-ancestor
25248283|NCT02533076|Dermatologic Agents|dermatologic agents|mesh-ancestor
25248284|NCT02533076|Sensory System Agents|sensory system agents|mesh-ancestor
25248285|NCT02533076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25248286|NCT02533076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248287|NCT02533219|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
25248288|NCT02533219|Dopamine Agents|dopamine agents|mesh-ancestor
25248289|NCT02533219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25248290|NCT02533219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248291|NCT02533219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248292|NCT02532790|Prednisone|prednisone|mesh-list
25248293|NCT02532790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25248294|NCT02532790|Glucocorticoids|glucocorticoids|mesh-ancestor
25248295|NCT02532790|Hormones|hormones|mesh-ancestor
25248296|NCT02532790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25248297|NCT02532790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248298|NCT02532790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25248299|NCT02532790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25274438|NCT02377960|Antihypertensive Agents|antihypertensive agents|mesh-list
25274439|NCT02378129|Methamphetamine|methamphetamine|mesh-list
25274440|NCT02378129|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25274441|NCT02378129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274442|NCT02378129|Sympathomimetics|sympathomimetics|mesh-ancestor
25274443|NCT02378129|Autonomic Agents|autonomic agents|mesh-ancestor
25274444|NCT02378129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25274445|NCT02378129|Dopamine Agents|dopamine agents|mesh-ancestor
25274446|NCT02378129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25686804|NCT01925144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24956965|NCT03848533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956966|NCT03848533|Antioxidants|antioxidants|mesh-ancestor
25274447|NCT02378129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274448|NCT02378129|Adrenergic Agents|adrenergic agents|mesh-ancestor
25248402|NCT02532114|Niclosamide|niclosamide|mesh-list
25248406|NCT02532114|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25274449|NCT02378129|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25274450|NCT02378129|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25274451|NCT02378129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25274452|NCT02378129|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25274453|NCT02377856|Interferons|interferons|mesh-list
25274454|NCT02377856|Ribavirin|ribavirin|mesh-list
25274455|NCT02377856|Interferon-alpha|interferon-alpha|mesh-list
25274456|NCT02377856|Interferon alpha-2|interferon alpha-2|mesh-list
24597502|NCT00949598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597503|NCT00949598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24597504|NCT00949598|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24597505|NCT00949598|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24597506|NCT00949598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24597507|NCT00949624|Docetaxel|docetaxel|mesh-list
24597508|NCT00949624|Axitinib|axitinib|mesh-list
24597509|NCT00949624|Crenolanib|crenolanib|mesh-list
24597517|NCT00949663|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
24597518|NCT00949663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24597519|NCT00949663|Incretins|incretins|mesh-ancestor
24597520|NCT00949663|Hormones|hormones|mesh-ancestor
25705139|NCT02194088|Respiratory System Agents|respiratory system agents|mesh-ancestor
24597521|NCT00949663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24636117|NCT01142843|Propolis|propolis|mesh-list
24597522|NCT00949663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597523|NCT00949728|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24597524|NCT00949728|Hemostatics|hemostatics|mesh-ancestor
24597529|NCT00949780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597531|NCT00949832|Vitamin D|vitamin d|mesh-list
24597532|NCT00949832|Ergocalciferols|ergocalciferols|mesh-list
24597533|NCT00949832|Cholecalciferol|cholecalciferol|mesh-list
24597534|NCT00949832|Vitamins|vitamins|mesh-list
24597535|NCT00949832|Calcium|calcium|mesh-list
24597536|NCT00949832|Micronutrients|micronutrients|mesh-ancestor
24597537|NCT00949832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597538|NCT00949832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24597539|NCT00949832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24597540|NCT00949949|Gemcitabine|gemcitabine|mesh-list
24597541|NCT00949949|Everolimus|everolimus|mesh-list
24597542|NCT00949949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597543|NCT00949949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25074971|NCT03384524|Sympatholytics|sympatholytics|mesh-ancestor
25009991|NCT04814355|Analgesics|analgesics|mesh-ancestor
25009992|NCT04814355|Sensory System Agents|sensory system agents|mesh-ancestor
25009993|NCT04814355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25009994|NCT04814355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110058|NCT03120715|Hormones|hormones|mesh-ancestor
24579620|NCT00856570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24579621|NCT00856570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579622|NCT00856570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579623|NCT00856570|Urological Agents|urological agents|mesh-ancestor
24579624|NCT00856596|Sertaconazole|sertaconazole|mesh-list
24579625|NCT00856596|Antifungal Agents|antifungal agents|mesh-ancestor
25248300|NCT02532777|Mycophenolic Acid|mycophenolic acid|mesh-list
24579691|NCT00857077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24579692|NCT00857077|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25248301|NCT02532777|Prednisone|prednisone|mesh-list
25248302|NCT02532777|Methylprednisolone|methylprednisolone|mesh-list
25248303|NCT02532777|Cyclophosphamide|cyclophosphamide|mesh-list
25248304|NCT02532777|Leflunomide|leflunomide|mesh-list
25248305|NCT02532777|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25248306|NCT02532777|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25248307|NCT02532777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25248308|NCT02532777|Immunologic Factors|immunologic factors|mesh-ancestor
25248309|NCT02532777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248310|NCT02532777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25248311|NCT02532777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25248312|NCT02532777|Alkylating Agents|alkylating agents|mesh-ancestor
25248313|NCT02532777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248314|NCT02532777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248315|NCT02532777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25686805|NCT01925144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711812|NCT01517022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24711813|NCT01517022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711814|NCT01517165|Pioglitazone|pioglitazone|mesh-list
24711815|NCT01517165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24711816|NCT01517165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711817|NCT01517308|Interferons|interferons|mesh-list
24711818|NCT01517308|Ribavirin|ribavirin|mesh-list
24711819|NCT01517308|Interferon-alpha|interferon-alpha|mesh-list
24711820|NCT01517308|Interferon alpha-2|interferon alpha-2|mesh-list
24711821|NCT01517308|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24711822|NCT01517308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24711823|NCT01517308|Antiviral Agents|antiviral agents|mesh-ancestor
24711824|NCT01517308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24711855|NCT01517399|Midazolam|midazolam|mesh-list
25248316|NCT02532777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25248317|NCT02532777|Glucocorticoids|glucocorticoids|mesh-ancestor
25248318|NCT02532777|Hormones|hormones|mesh-ancestor
25248319|NCT02532777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25248320|NCT02532777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25248321|NCT02532777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25248322|NCT02532777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25248323|NCT02532777|Antitubercular Agents|antitubercular agents|mesh-ancestor
25248324|NCT02532777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25248325|NCT02532777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25248326|NCT02532777|Antiemetics|antiemetics|mesh-ancestor
25248327|NCT02532777|Autonomic Agents|autonomic agents|mesh-ancestor
25248328|NCT02532777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25248329|NCT02532777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25274457|NCT02377856|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24852905|NCT02264665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674478|NCT05164549|Methadone|methadone|mesh-list
24852906|NCT02264743|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24597544|NCT00949949|Antimetabolites|antimetabolites|mesh-ancestor
24597545|NCT00949949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597546|NCT00949949|Antiviral Agents|antiviral agents|mesh-ancestor
24597547|NCT00949949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24597548|NCT00949949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597549|NCT00949949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24597550|NCT00949949|Immunologic Factors|immunologic factors|mesh-ancestor
24597551|NCT00949949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597552|NCT00949962|Leuprolide|leuprolide|mesh-list
25083204|NCT03317457|Durvalumab|durvalumab|mesh-list
24597553|NCT00949962|Androgen Antagonists|androgen antagonists|mesh-list
24597554|NCT00949962|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24597555|NCT00949962|Fertility Agents|fertility agents|mesh-ancestor
24597556|NCT00949962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24597557|NCT00949962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597558|NCT00949962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24597559|NCT00949962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597560|NCT00949962|Hormone Antagonists|hormone antagonists|mesh-ancestor
24597561|NCT00949962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24597562|NCT00950027|Povidone-Iodine|povidone-iodine|mesh-list
24597563|NCT00950027|Povidone|povidone|mesh-list
24597564|NCT00950027|Plasma Substitutes|plasma substitutes|mesh-ancestor
24597565|NCT00950027|Blood Substitutes|blood substitutes|mesh-ancestor
24597566|NCT00950027|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24597567|NCT00950027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24597568|NCT00950066|Amlodipine|amlodipine|mesh-list
24597569|NCT00950066|Irbesartan|irbesartan|mesh-list
24597570|NCT00950066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24597571|NCT00950066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25686806|NCT01925170|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
25686807|NCT01925170|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25686808|NCT01925170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686809|NCT01925183|Interferons|interferons|mesh-list
25686810|NCT01925183|Ribavirin|ribavirin|mesh-list
25686811|NCT01925183|Interferon-alpha|interferon-alpha|mesh-list
25686812|NCT01925183|Interferon alpha-2|interferon alpha-2|mesh-list
25686813|NCT01925183|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25686814|NCT01925183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25686815|NCT01925183|Antiviral Agents|antiviral agents|mesh-ancestor
25686816|NCT01925183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25686817|NCT01925183|Antimetabolites|antimetabolites|mesh-ancestor
25686818|NCT01925183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686819|NCT01925183|Immunologic Factors|immunologic factors|mesh-ancestor
24597572|NCT00950066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24597588|NCT00950105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24597589|NCT00950105|Immunologic Factors|immunologic factors|mesh-ancestor
24597590|NCT00950196|Amantadine|amantadine|mesh-list
24597591|NCT00950196|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25075000|NCT03384277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25248330|NCT02532777|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25248331|NCT02532777|Protective Agents|protective agents|mesh-ancestor
25248332|NCT02532777|Protease Inhibitors|protease inhibitors|mesh-ancestor
25248333|NCT02532413|Entecavir|entecavir|mesh-list
25248334|NCT02532413|Poly I-C|poly i-c|mesh-list
25248335|NCT02532413|Antiviral Agents|antiviral agents|mesh-ancestor
25248336|NCT02532413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25248337|NCT02532413|Interferon Inducers|interferon inducers|mesh-ancestor
25248338|NCT02532413|Immunologic Factors|immunologic factors|mesh-ancestor
25248339|NCT02532413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248340|NCT02532634|Dexamethasone|dexamethasone|mesh-list
25248341|NCT02532634|Dexamethasone acetate|dexamethasone acetate|mesh-list
25248342|NCT02532634|Aprepitant|aprepitant|mesh-list
25248343|NCT02532634|Fosaprepitant|fosaprepitant|mesh-list
25248344|NCT02532634|Palonosetron|palonosetron|mesh-list
25248345|NCT02532634|Ramosetron|ramosetron|mesh-list
25248346|NCT02532634|BB 1101|bb 1101|mesh-list
25248347|NCT02532634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25248348|NCT02532634|Antiemetics|antiemetics|mesh-ancestor
25248349|NCT02532634|Autonomic Agents|autonomic agents|mesh-ancestor
25248350|NCT02532634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25248351|NCT02532634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248352|NCT02532634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25248353|NCT02532634|Glucocorticoids|glucocorticoids|mesh-ancestor
25248354|NCT02532634|Hormones|hormones|mesh-ancestor
25705140|NCT02194088|Mydriatics|mydriatics|mesh-ancestor
25248355|NCT02532634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25248356|NCT02532634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25248357|NCT02532634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248358|NCT02532634|Protease Inhibitors|protease inhibitors|mesh-ancestor
25248359|NCT02532634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248360|NCT02532634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248361|NCT02532634|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25248403|NCT02532114|Anticestodal Agents|anticestodal agents|mesh-ancestor
25248363|NCT02532634|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25248364|NCT02532634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25248365|NCT02532634|Serotonin Agents|serotonin agents|mesh-ancestor
25248366|NCT02532400|Goserelin|goserelin|mesh-list
25248367|NCT02532400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25248368|NCT02532400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597592|NCT00950196|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24597593|NCT00950196|Antiviral Agents|antiviral agents|mesh-ancestor
24636119|NCT01142869|Cetuximab|cetuximab|mesh-list
24597619|NCT00950339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24597620|NCT00950339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597621|NCT00950339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597622|NCT00950339|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24597623|NCT00950339|Histamine Antagonists|histamine antagonists|mesh-ancestor
24597624|NCT00950339|Histamine Agents|histamine agents|mesh-ancestor
24597625|NCT00950339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24597626|NCT00950339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597627|NCT00950391|Tacrolimus|tacrolimus|mesh-list
24597628|NCT00950391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24852907|NCT02264743|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24597629|NCT00950391|Immunologic Factors|immunologic factors|mesh-ancestor
24597638|NCT00950404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597639|NCT00950404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597640|NCT00950404|Urological Agents|urological agents|mesh-ancestor
24597642|NCT00950417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24597643|NCT00950417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597644|NCT00950430|Corticosterone|corticosterone|mesh-list
24597645|NCT00950430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24597646|NCT00950534|Insulin Glargine|insulin glargine|mesh-list
24597647|NCT00950534|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24597648|NCT00950534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597649|NCT00950586|Dextromethorphan|dextromethorphan|mesh-list
24597650|NCT00950586|Antitussive Agents|antitussive agents|mesh-ancestor
24597651|NCT00950586|Respiratory System Agents|respiratory system agents|mesh-ancestor
24597652|NCT00950586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24597653|NCT00950586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25686820|NCT01925183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712196|NCT01519076|Dermatologic Agents|dermatologic agents|mesh-ancestor
24712197|NCT01519102|Hormones|hormones|mesh-list
24712200|NCT01519128|Rilpivirine|rilpivirine|mesh-list
24597654|NCT00950586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24597655|NCT00950586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597679|NCT00950794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25248369|NCT02532491|Risperidone|risperidone|mesh-list
25248370|NCT02532491|Aripiprazole|aripiprazole|mesh-list
25248371|NCT02532491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25248372|NCT02532491|Serotonin Agents|serotonin agents|mesh-ancestor
25248373|NCT02532491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25248374|NCT02532491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248375|NCT02532491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248376|NCT02532491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25248377|NCT02532491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25248378|NCT02532491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25248379|NCT02532491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25248380|NCT02532491|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25248381|NCT02532491|Dopamine Agents|dopamine agents|mesh-ancestor
25248382|NCT02532491|Antidepressive Agents|antidepressive agents|mesh-ancestor
25248383|NCT02532491|Dopamine Agonists|dopamine agonists|mesh-ancestor
25248384|NCT02532491|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25248385|NCT02532491|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25248386|NCT02532491|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25248387|NCT02532491|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25248388|NCT02532569|Vaccines|vaccines|mesh-list
25248389|NCT02532569|Immunologic Factors|immunologic factors|mesh-ancestor
25248390|NCT02532569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248391|NCT02532309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25248392|NCT02532309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25248393|NCT02532309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25248394|NCT02532309|Antimetabolites|antimetabolites|mesh-ancestor
25248395|NCT02532309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248396|NCT02532309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25248397|NCT02532309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25248398|NCT02532309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248399|NCT02532335|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
25248400|NCT02532335|Cathartics|cathartics|mesh-ancestor
25248401|NCT02532335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25248404|NCT02532114|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25248405|NCT02532114|Anthelmintics|anthelmintics|mesh-ancestor
25248407|NCT02532114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25248408|NCT02532114|Antinematodal Agents|antinematodal agents|mesh-ancestor
24597688|NCT00950794|Adrenergic Agents|adrenergic agents|mesh-ancestor
24597689|NCT00950794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24597690|NCT00950794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597691|NCT00950820|Capecitabine|capecitabine|mesh-list
24597692|NCT00950820|Oxaliplatin|oxaliplatin|mesh-list
24597693|NCT00950820|Panitumumab|panitumumab|mesh-list
24597694|NCT00950820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24597695|NCT00950820|Antimetabolites|antimetabolites|mesh-ancestor
24597696|NCT00950820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597697|NCT00950820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597698|NCT00950820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24597699|NCT00950898|Caffeine|caffeine|mesh-list
24597700|NCT00950898|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24597701|NCT00950898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597703|NCT00950898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597704|NCT00950898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597705|NCT00950898|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24597706|NCT00950898|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24597707|NCT00950898|Purinergic Agents|purinergic agents|mesh-ancestor
24852909|NCT02264743|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24852910|NCT02264743|Estrogens|estrogens|mesh-ancestor
24597727|NCT00951223|Interferon alfacon-1|interferon alfacon-1|mesh-list
24597728|NCT00951223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597729|NCT00951223|Antiviral Agents|antiviral agents|mesh-ancestor
24597730|NCT00951223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24597731|NCT00951236|Cortisone|cortisone|mesh-list
25686821|NCT01925274|Irinotecan|irinotecan|mesh-list
25686822|NCT01925274|Cetuximab|cetuximab|mesh-list
25686823|NCT01925274|Gedatolisib|gedatolisib|mesh-list
24597732|NCT00951236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25686824|NCT01925274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24940956|NCT03996564|Antitussive Agents|antitussive agents|mesh-ancestor
24597733|NCT00951431|Esomeprazole|esomeprazole|mesh-list
24597734|NCT00951431|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24597735|NCT00951431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24597736|NCT00951431|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24597737|NCT00951431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248409|NCT02532270|Phenylephrine|phenylephrine|mesh-list
25248410|NCT02532270|Oxymetazoline|oxymetazoline|mesh-list
25248411|NCT02532270|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25248412|NCT02532270|Mydriatics|mydriatics|mesh-ancestor
25248413|NCT02532270|Autonomic Agents|autonomic agents|mesh-ancestor
25248414|NCT02532270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25248415|NCT02532270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248416|NCT02532270|Sympathomimetics|sympathomimetics|mesh-ancestor
25248417|NCT02532270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25248418|NCT02532270|Nasal Decongestants|nasal decongestants|mesh-ancestor
25248419|NCT02532270|Respiratory System Agents|respiratory system agents|mesh-ancestor
25248420|NCT02532270|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25248421|NCT02532270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25248422|NCT02532270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25248423|NCT02532270|Adrenergic Agents|adrenergic agents|mesh-ancestor
25248424|NCT02532270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25102659|NCT03167164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24808105|NCT02025166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24808106|NCT02025166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25248425|NCT02532270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248426|NCT02532270|Protective Agents|protective agents|mesh-ancestor
25248427|NCT02532062|Vitamin D|vitamin d|mesh-list
25248428|NCT02532062|Cholecalciferol|cholecalciferol|mesh-list
25248429|NCT02532062|Vitamins|vitamins|mesh-ancestor
25248430|NCT02532062|Micronutrients|micronutrients|mesh-ancestor
25248431|NCT02532062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248432|NCT02532062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25248433|NCT02532062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25248434|NCT02531984|Azithromycin|azithromycin|mesh-list
25248435|NCT02531984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25248436|NCT02531984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25248437|NCT02532140|Cefepime|cefepime|mesh-list
25248438|NCT02532140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25248439|NCT02532140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25248440|NCT02532192|Cytarabine|cytarabine|mesh-list
25248441|NCT02532192|Ciprofloxacin|ciprofloxacin|mesh-list
25248442|NCT02532192|Fluconazole|fluconazole|mesh-list
25248443|NCT02532192|Dexamethasone|dexamethasone|mesh-list
25248444|NCT02532192|Rituximab|rituximab|mesh-list
25248445|NCT02532192|Cisplatin|cisplatin|mesh-list
25248446|NCT02532192|Belinostat|belinostat|mesh-list
25248447|NCT02532192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25248448|NCT02532192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248449|NCT02532192|Immunologic Factors|immunologic factors|mesh-ancestor
25248450|NCT02532192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248451|NCT02532192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25248452|NCT02532192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25248453|NCT02532192|Antiemetics|antiemetics|mesh-ancestor
24597760|NCT00951600|Anticonvulsants|anticonvulsants|mesh-ancestor
24597761|NCT00951600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24597762|NCT00951600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24597763|NCT00951600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24597764|NCT00951600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597780|NCT00951847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24597781|NCT00951847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597782|NCT00951847|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24597783|NCT00951847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24597784|NCT00952003|Bevacizumab|bevacizumab|mesh-list
24597785|NCT00952003|Docetaxel|docetaxel|mesh-list
24597786|NCT00952003|Oxaliplatin|oxaliplatin|mesh-list
24597787|NCT00952003|Irinotecan|irinotecan|mesh-list
24597788|NCT00952003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24597789|NCT00952003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597790|NCT00952003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24597791|NCT00952003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24597792|NCT00952003|Growth Substances|growth substances|mesh-ancestor
24597793|NCT00952003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597794|NCT00952003|Growth Inhibitors|growth inhibitors|mesh-ancestor
25686825|NCT01925274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25686826|NCT01925274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24614630|NCT01025505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24614631|NCT01025505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24614632|NCT01025505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712915|NCT01523119|Antipruritics|antipruritics|mesh-ancestor
25248454|NCT02532192|Autonomic Agents|autonomic agents|mesh-ancestor
25248455|NCT02532192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25248456|NCT02532192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25248457|NCT02532192|Glucocorticoids|glucocorticoids|mesh-ancestor
25248458|NCT02532192|Hormones|hormones|mesh-ancestor
25248459|NCT02532192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25248460|NCT02532192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25248461|NCT02532192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25248462|NCT02532192|Antimetabolites|antimetabolites|mesh-ancestor
25248463|NCT02532192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248464|NCT02532192|Antiviral Agents|antiviral agents|mesh-ancestor
25248465|NCT02532192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25248466|NCT02532192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25248467|NCT02532192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25248468|NCT02532192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25248469|NCT02532192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25248470|NCT02532192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248471|NCT02532192|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25248472|NCT02532192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25248473|NCT02532192|Antifungal Agents|antifungal agents|mesh-ancestor
25248474|NCT02532192|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25248475|NCT02532192|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25248476|NCT02532192|Hormone Antagonists|hormone antagonists|mesh-ancestor
25248477|NCT02532192|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25248478|NCT02532192|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25248479|NCT02532192|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25248480|NCT02532153|Ketamine|ketamine|mesh-list
25248481|NCT02532153|Analgesics|analgesics|mesh-ancestor
25248482|NCT02532153|Sensory System Agents|sensory system agents|mesh-ancestor
25248483|NCT02532153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25248484|NCT02532153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248485|NCT02532153|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25248486|NCT02532153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25248487|NCT02532153|Anesthetics, General|anesthetics, general|mesh-ancestor
25248488|NCT02532153|Anesthetics|anesthetics|mesh-ancestor
25248489|NCT02532153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25248490|NCT02532153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25248491|NCT02532153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25248492|NCT02532153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25248493|NCT02532153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248494|NCT02532322|Acetaminophen|acetaminophen|mesh-list
24597843|NCT00952029|Vitamins|vitamins|mesh-ancestor
24597844|NCT00952029|Micronutrients|micronutrients|mesh-ancestor
24597845|NCT00952094|Cinacalcet|cinacalcet|mesh-list
24962516|NCT03799757|Bupivacaine|bupivacaine|mesh-list
24597933|NCT00952861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25248551|NCT02531490|Vasodilator Agents|vasodilator agents|mesh-ancestor
24597909|NCT00952627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597910|NCT00952627|Protective Agents|protective agents|mesh-ancestor
24597911|NCT00952627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24597913|NCT00952640|Vitamins|vitamins|mesh-ancestor
24597914|NCT00952640|Micronutrients|micronutrients|mesh-ancestor
24597916|NCT00952796|Moxifloxacin|moxifloxacin|mesh-list
25248495|NCT02532322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25248496|NCT02532322|Analgesics|analgesics|mesh-ancestor
25248497|NCT02532322|Sensory System Agents|sensory system agents|mesh-ancestor
25248498|NCT02532322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25248499|NCT02532322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248500|NCT02532322|Antipyretics|antipyretics|mesh-ancestor
25248501|NCT02531997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25248502|NCT02531997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25248503|NCT02531997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248504|NCT02532023|Curcumin|curcumin|mesh-list
25248505|NCT02532023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25686827|NCT01925274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686828|NCT01925274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25686829|NCT01925274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24713117|NCT01524237|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24713118|NCT01524237|Anesthetics, General|anesthetics, general|mesh-ancestor
24713120|NCT01524237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24713121|NCT01524237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24713122|NCT01524237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24713123|NCT01524237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24713124|NCT01524237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248506|NCT02532023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25248507|NCT02532023|Analgesics|analgesics|mesh-ancestor
25248508|NCT02532023|Sensory System Agents|sensory system agents|mesh-ancestor
25248509|NCT02532023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25248510|NCT02532023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248511|NCT02532023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25248512|NCT02532023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25248513|NCT02532023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248514|NCT02532023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248515|NCT02532023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597928|NCT00952861|Doxycycline|doxycycline|mesh-list
24597929|NCT00952861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24597930|NCT00952861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24597931|NCT00952861|Antimalarials|antimalarials|mesh-ancestor
24597932|NCT00952861|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24597935|NCT00952913|Dexlansoprazole|dexlansoprazole|mesh-list
24597936|NCT00952913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24597937|NCT00952913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24597938|NCT00952913|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24852919|NCT02264769|Oxytocics|oxytocics|mesh-ancestor
24852920|NCT02264769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24852921|NCT02264769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852922|NCT02264795|Lidocaine|lidocaine|mesh-list
24597945|NCT00952952|Sensory System Agents|sensory system agents|mesh-ancestor
24597946|NCT00952952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24597947|NCT00952952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597948|NCT00952952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24597949|NCT00952952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24597950|NCT00952978|Omeprazole|omeprazole|mesh-list
24597951|NCT00952978|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24597952|NCT00952978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24597953|NCT00952978|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24597954|NCT00952978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597955|NCT00952978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597956|NCT00952991|Vildagliptin|vildagliptin|mesh-list
24597957|NCT00952991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24597958|NCT00952991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597959|NCT00952991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24597960|NCT00952991|Protease Inhibitors|protease inhibitors|mesh-ancestor
24597961|NCT00952991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597962|NCT00952991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248538|NCT02531854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248539|NCT02531854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597963|NCT00953108|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24597964|NCT00953108|Citalopram|citalopram|mesh-list
25248540|NCT02531854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248541|NCT02531854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25248542|NCT02531854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25248543|NCT02531490|Labetalol|labetalol|mesh-list
25248544|NCT02531490|Methyldopa|methyldopa|mesh-list
25248545|NCT02531490|Nifedipine|nifedipine|mesh-list
25248546|NCT02531490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25248547|NCT02531490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25248548|NCT02531490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248549|NCT02531490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25248550|NCT02531490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248552|NCT02531490|Tocolytic Agents|tocolytic agents|mesh-ancestor
25248553|NCT02531490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25686830|NCT01925274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25692595|NCT02002832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692596|NCT02002832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692597|NCT02002832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25692598|NCT02002832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25692599|NCT02002832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25692600|NCT02002832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24713261|NCT01524809|Biphasic Insulins|biphasic insulins|mesh-list
25248554|NCT02531490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25248555|NCT02531490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25248556|NCT02531490|Adrenergic Agents|adrenergic agents|mesh-ancestor
25248557|NCT02531490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25248558|NCT02531490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25248559|NCT02531490|Sympathomimetics|sympathomimetics|mesh-ancestor
25248560|NCT02531490|Autonomic Agents|autonomic agents|mesh-ancestor
25248561|NCT02531490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25248562|NCT02531490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25248563|NCT02531490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25248564|NCT02531490|Sympatholytics|sympatholytics|mesh-ancestor
25248565|NCT02531490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25248566|NCT02531490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25248567|NCT02531490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24971179|NCT03727646|Micronutrients|micronutrients|mesh-ancestor
24971180|NCT03727646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248568|NCT02531581|Furosemide|furosemide|mesh-list
25248569|NCT02531581|Diuretics|diuretics|mesh-list
25248570|NCT02531581|Natriuretic Agents|natriuretic agents|mesh-ancestor
25248571|NCT02531581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248572|NCT02531581|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25248573|NCT02531581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25274458|NCT02377856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597999|NCT00953303|Autonomic Agents|autonomic agents|mesh-ancestor
24598000|NCT00953303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24598001|NCT00953303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598002|NCT00953303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24598003|NCT00953303|Hormones|hormones|mesh-ancestor
24598004|NCT00953303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24598005|NCT00953303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24598006|NCT00953303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598007|NCT00953303|Protease Inhibitors|protease inhibitors|mesh-ancestor
24598008|NCT00953303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598009|NCT00953303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598010|NCT00953303|Diuretics|diuretics|mesh-ancestor
24598011|NCT00953303|Natriuretic Agents|natriuretic agents|mesh-ancestor
24598012|NCT00953303|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24598013|NCT00953303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24598018|NCT00953303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24598020|NCT00953303|Adrenergic Agents|adrenergic agents|mesh-ancestor
24598021|NCT00953303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24598022|NCT00953303|Protective Agents|protective agents|mesh-ancestor
24598023|NCT00953303|Dopamine Agents|dopamine agents|mesh-ancestor
24598024|NCT00953303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24598025|NCT00953355|Metformin|metformin|mesh-list
24598026|NCT00953355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24598027|NCT00953355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598028|NCT00953381|Omeprazole|omeprazole|mesh-list
24598029|NCT00953381|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24598030|NCT00953381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24598031|NCT00953381|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24579693|NCT00857077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579694|NCT00857077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579695|NCT00857077|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24579717|NCT00857142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24971181|NCT03727646|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24579718|NCT00857155|Clopidogrel|clopidogrel|mesh-list
24579719|NCT00857155|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24579720|NCT00857155|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24579721|NCT00857155|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24579722|NCT00857155|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24579723|NCT00857155|Purinergic Agents|purinergic agents|mesh-ancestor
24579724|NCT00857155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25248574|NCT02531581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248575|NCT02531672|Choline|choline|mesh-list
25248576|NCT02531672|Lipotropic Agents|lipotropic agents|mesh-ancestor
25248577|NCT02531672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25248578|NCT02531672|Antimetabolites|antimetabolites|mesh-ancestor
25248579|NCT02531672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248580|NCT02531672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25248581|NCT02531672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25248582|NCT02531672|Nootropic Agents|nootropic agents|mesh-ancestor
25686831|NCT01925469|Benzocaine|benzocaine|mesh-list
25248583|NCT02531568|Warfarin|warfarin|mesh-list
25248584|NCT02531568|Anticoagulants|anticoagulants|mesh-ancestor
25248585|NCT02531451|Aspirin|aspirin|mesh-list
25248586|NCT02531451|Ibuprofen|ibuprofen|mesh-list
25248587|NCT02531451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25248588|NCT02531451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25248589|NCT02531451|Analgesics|analgesics|mesh-ancestor
25248590|NCT02531451|Sensory System Agents|sensory system agents|mesh-ancestor
25248591|NCT02531451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25248592|NCT02531451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248593|NCT02531451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25248594|NCT02531451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25248595|NCT02531451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25248596|NCT02531451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248597|NCT02531451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248598|NCT02531451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25248599|NCT02531451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25248600|NCT02531451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25248601|NCT02531451|Antipyretics|antipyretics|mesh-ancestor
25248602|NCT02531529|Fentanyl|fentanyl|mesh-list
25248603|NCT02531529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25248604|NCT02531529|Narcotics|narcotics|mesh-ancestor
24598032|NCT00953381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598033|NCT00953381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598034|NCT00953394|Octreotide|octreotide|mesh-list
24598049|NCT00953459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24598050|NCT00953459|Growth Substances|growth substances|mesh-ancestor
24598051|NCT00953459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598052|NCT00953459|Growth Inhibitors|growth inhibitors|mesh-ancestor
24598053|NCT00953459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24598054|NCT00953459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598055|NCT00953459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598056|NCT00953459|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24598057|NCT00953472|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25286644|NCT03890744|Docetaxel|docetaxel|mesh-list
24598058|NCT00953472|Natriuretic Agents|natriuretic agents|mesh-ancestor
24598059|NCT00953472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598060|NCT00953498|Pioglitazone|pioglitazone|mesh-list
24598061|NCT00953498|Rosiglitazone|rosiglitazone|mesh-list
24598062|NCT00953498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24598063|NCT00953498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598064|NCT00953537|Capecitabine|capecitabine|mesh-list
24598065|NCT00953537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24598066|NCT00953537|Antimetabolites|antimetabolites|mesh-ancestor
24598067|NCT00953537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598068|NCT00953537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598069|NCT00953550|Rocuronium|rocuronium|mesh-list
24598070|NCT00953550|Succinylcholine|succinylcholine|mesh-list
24598071|NCT00953550|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24598072|NCT00953550|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24598073|NCT00953550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24598074|NCT00953550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24598075|NCT00953550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598076|NCT00953550|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
24598077|NCT00953589|Ribavirin|ribavirin|mesh-list
24598078|NCT00953589|Antimetabolites|antimetabolites|mesh-ancestor
25248605|NCT02531529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25248606|NCT02531529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248607|NCT02531529|Analgesics|analgesics|mesh-ancestor
25248608|NCT02531529|Sensory System Agents|sensory system agents|mesh-ancestor
25248609|NCT02531529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25248610|NCT02531529|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25248611|NCT02531529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25248612|NCT02531529|Anesthetics, General|anesthetics, general|mesh-ancestor
25248613|NCT02531529|Anesthetics|anesthetics|mesh-ancestor
25248614|NCT02531841|Dexamethasone acetate|dexamethasone acetate|mesh-list
25248615|NCT02531841|Dexamethasone|dexamethasone|mesh-list
25248616|NCT02531841|Etoposide phosphate|etoposide phosphate|mesh-list
25248617|NCT02531841|Etoposide|etoposide|mesh-list
25248618|NCT02531841|Ifosfamide|ifosfamide|mesh-list
25248619|NCT02531841|Isophosphamide mustard|isophosphamide mustard|mesh-list
25248620|NCT02531841|Thiotepa|thiotepa|mesh-list
25248621|NCT02531841|Carmustine|carmustine|mesh-list
25248622|NCT02531841|Busulfan|busulfan|mesh-list
25248623|NCT02531841|BB 1101|bb 1101|mesh-list
25248624|NCT02531841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25248625|NCT02531841|Antiemetics|antiemetics|mesh-ancestor
25248626|NCT02531841|Autonomic Agents|autonomic agents|mesh-ancestor
25248627|NCT02531841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25248628|NCT02531841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248629|NCT02531841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25248630|NCT02531841|Glucocorticoids|glucocorticoids|mesh-ancestor
25248631|NCT02531841|Hormones|hormones|mesh-ancestor
25248632|NCT02531841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25248633|NCT02531841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25248634|NCT02531841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248635|NCT02531841|Protease Inhibitors|protease inhibitors|mesh-ancestor
25248636|NCT02531841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248637|NCT02531841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248638|NCT02531841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25248639|NCT02531841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25248640|NCT02531841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25248641|NCT02531841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25248642|NCT02531841|Alkylating Agents|alkylating agents|mesh-ancestor
25248643|NCT02531841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25248644|NCT02531841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25248645|NCT02531841|Immunologic Factors|immunologic factors|mesh-ancestor
25248646|NCT02531737|Docetaxel|docetaxel|mesh-list
24598097|NCT00953771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598098|NCT00953914|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
24598099|NCT00953914|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24598100|NCT00953914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598111|NCT00954005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598112|NCT00954005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24598113|NCT00954005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24598115|NCT00954005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598116|NCT00954005|Antiviral Agents|antiviral agents|mesh-ancestor
24598117|NCT00954005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24598118|NCT00954005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598119|NCT00954005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24598120|NCT00954096|Nicotine|nicotine|mesh-list
24598121|NCT00954096|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24598122|NCT00954096|Autonomic Agents|autonomic agents|mesh-ancestor
24852925|NCT02264795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24852926|NCT02264795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852927|NCT02264795|Sensory System Agents|sensory system agents|mesh-ancestor
24852928|NCT02264795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24852929|NCT02264795|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24852930|NCT02264795|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24852931|NCT02264795|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24852932|NCT02264795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24852933|NCT02264795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852934|NCT02264834|Sufentanil|sufentanil|mesh-list
24852936|NCT02264834|Levobupivacaine|levobupivacaine|mesh-list
24598123|NCT00954096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24598124|NCT00954096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598125|NCT00954096|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24598126|NCT00954096|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24598127|NCT00954096|Cholinergic Agents|cholinergic agents|mesh-ancestor
24598128|NCT00954096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24598129|NCT00954096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598131|NCT00954135|Sorafenib|sorafenib|mesh-list
25075270|NCT03382431|PC-786|pc-786|mesh-list
24579729|NCT00857168|Hormones|hormones|mesh-ancestor
25248647|NCT02531737|Nintedanib|nintedanib|mesh-list
25248648|NCT02531737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248649|NCT02531737|Tubulin Modulators|tubulin modulators|mesh-ancestor
25248650|NCT02531737|Antimitotic Agents|antimitotic agents|mesh-ancestor
25248651|NCT02531737|Mitosis Modulators|mitosis modulators|mesh-ancestor
25248652|NCT02531737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248653|NCT02531737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25248654|NCT02531737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248655|NCT02531412|Spironolactone|spironolactone|mesh-list
25248656|NCT02531412|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25248657|NCT02531412|Hormone Antagonists|hormone antagonists|mesh-ancestor
25248658|NCT02531412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25248659|NCT02531412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248660|NCT02531412|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25248661|NCT02531412|Diuretics|diuretics|mesh-ancestor
25248662|NCT02531412|Natriuretic Agents|natriuretic agents|mesh-ancestor
25248663|NCT02531477|Propofol|propofol|mesh-list
25248664|NCT02531477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25686832|NCT01925469|Anesthetics, Local|anesthetics, local|mesh-ancestor
24614717|NCT01026116|Epirubicin|epirubicin|mesh-list
24503642|NCT00532454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248665|NCT02531477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25248666|NCT02531477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248667|NCT02531477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25248668|NCT02531477|Anesthetics, General|anesthetics, general|mesh-ancestor
25248669|NCT02531477|Anesthetics|anesthetics|mesh-ancestor
25248670|NCT02531724|Simendan|simendan|mesh-list
25248671|NCT02531724|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25248672|NCT02531724|Vasodilator Agents|vasodilator agents|mesh-ancestor
25248673|NCT02531724|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25248674|NCT02531724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25248675|NCT02531724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248676|NCT02531724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248677|NCT02531724|Protective Agents|protective agents|mesh-ancestor
25248678|NCT02531724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248679|NCT02531165|Aspirin|aspirin|mesh-list
25248680|NCT02531165|Heparin|heparin|mesh-list
25248681|NCT02531165|Fentanyl|fentanyl|mesh-list
25248682|NCT02531165|Morphine|morphine|mesh-list
25248683|NCT02531165|Ticagrelor|ticagrelor|mesh-list
24598132|NCT00954135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24598133|NCT00954135|Immunologic Factors|immunologic factors|mesh-ancestor
24598134|NCT00954135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598135|NCT00954135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24598136|NCT00954135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24598137|NCT00954135|Alkylating Agents|alkylating agents|mesh-ancestor
24598138|NCT00954135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598139|NCT00954135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598140|NCT00954135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24598141|NCT00954135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24598142|NCT00954135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598143|NCT00954200|Ibuprofen|ibuprofen|mesh-list
24598144|NCT00954200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24598156|NCT00954252|Analgesics|analgesics|mesh-ancestor
24598157|NCT00954252|Sensory System Agents|sensory system agents|mesh-ancestor
24598158|NCT00954252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24598159|NCT00954252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598160|NCT00954252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24598161|NCT00954252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25248684|NCT02531165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25248685|NCT02531165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25248686|NCT02531165|Analgesics|analgesics|mesh-ancestor
25248687|NCT02531165|Sensory System Agents|sensory system agents|mesh-ancestor
25248688|NCT02531165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25248689|NCT02531165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248690|NCT02531165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25248691|NCT02531165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25248692|NCT02531165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25248693|NCT02531165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25248694|NCT02531165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248695|NCT02531165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25248696|NCT02531165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25248697|NCT02531165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248698|NCT02531165|Antipyretics|antipyretics|mesh-ancestor
25248699|NCT02531165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25248700|NCT02531165|Narcotics|narcotics|mesh-ancestor
25248701|NCT02531165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25248702|NCT02531165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25248703|NCT02531165|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25248704|NCT02531165|Anesthetics, General|anesthetics, general|mesh-ancestor
25248705|NCT02531165|Anesthetics|anesthetics|mesh-ancestor
25248706|NCT02531165|Anticoagulants|anticoagulants|mesh-ancestor
25248707|NCT02531165|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25248708|NCT02531165|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25248709|NCT02531165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25248710|NCT02531165|Purinergic Agents|purinergic agents|mesh-ancestor
25248711|NCT02531165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25248712|NCT02531191|Peficitinib|peficitinib|mesh-list
25248713|NCT02531191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248714|NCT02531191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686833|NCT01925469|Anesthetics|anesthetics|mesh-ancestor
25248715|NCT02531191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25248716|NCT02531191|Immunologic Factors|immunologic factors|mesh-ancestor
25248717|NCT02531191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248718|NCT02531152|Latanoprost|latanoprost|mesh-list
25248719|NCT02531152|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25248720|NCT02531152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25248721|NCT02530918|Ranibizumab|ranibizumab|mesh-list
25248722|NCT02530918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25248723|NCT02530918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25248724|NCT02530918|Growth Substances|growth substances|mesh-ancestor
25248725|NCT02530918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248726|NCT02530918|Growth Inhibitors|growth inhibitors|mesh-ancestor
25248727|NCT02530918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25274459|NCT02377856|Antiviral Agents|antiviral agents|mesh-ancestor
25274460|NCT02377856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25274461|NCT02377856|Antimetabolites|antimetabolites|mesh-ancestor
25274462|NCT02377856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274463|NCT02377856|Immunologic Factors|immunologic factors|mesh-ancestor
25274464|NCT02377856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274466|NCT02377778|Propofol|propofol|mesh-list
25274467|NCT02377778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24598223|NCT00954603|Antiemetics|antiemetics|mesh-ancestor
24598224|NCT00954603|Autonomic Agents|autonomic agents|mesh-ancestor
24598225|NCT00954603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24598226|NCT00954603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24598227|NCT00954603|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24598228|NCT00954603|Dopamine Agents|dopamine agents|mesh-ancestor
24598229|NCT00954603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24598230|NCT00954603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598231|NCT00954603|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24598232|NCT00954642|Paclitaxel|paclitaxel|mesh-list
24598233|NCT00954642|Bevacizumab|bevacizumab|mesh-list
24598234|NCT00954642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24598235|NCT00954642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598236|NCT00954642|Tubulin Modulators|tubulin modulators|mesh-ancestor
24598237|NCT00954642|Antimitotic Agents|antimitotic agents|mesh-ancestor
24598238|NCT00954642|Mitosis Modulators|mitosis modulators|mesh-ancestor
24598239|NCT00954642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598240|NCT00954642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24598266|NCT00954811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24598267|NCT00954811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598268|NCT00954889|Tamsulosin|tamsulosin|mesh-list
24598269|NCT00954889|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24598270|NCT00954889|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24598271|NCT00954889|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24598311|NCT00955214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598313|NCT00955227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24598314|NCT00955227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24598315|NCT00955227|Antimetabolites|antimetabolites|mesh-ancestor
24598316|NCT00955227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598317|NCT00955227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24598318|NCT00955240|Fluorouracil|fluorouracil|mesh-list
24598319|NCT00955240|Cetuximab|cetuximab|mesh-list
24598320|NCT00955240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598321|NCT00955240|Antimetabolites|antimetabolites|mesh-ancestor
25248728|NCT02530788|Selenium|selenium|mesh-list
25248729|NCT02530788|Selenious Acid|selenious acid|mesh-list
25248730|NCT02530788|Sodium Selenite|sodium selenite|mesh-list
25248731|NCT02530788|Antioxidants|antioxidants|mesh-ancestor
25248732|NCT02530788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248733|NCT02530788|Protective Agents|protective agents|mesh-ancestor
25248734|NCT02530788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248735|NCT02530788|Trace Elements|trace elements|mesh-ancestor
25248736|NCT02530788|Micronutrients|micronutrients|mesh-ancestor
25248737|NCT02530801|Bevacizumab|bevacizumab|mesh-list
25248738|NCT02530801|Fluorouracil|fluorouracil|mesh-list
25248739|NCT02530801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25248740|NCT02530801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248741|NCT02530801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25248742|NCT02530801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25248743|NCT02530801|Growth Substances|growth substances|mesh-ancestor
25248744|NCT02530801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248745|NCT02530801|Growth Inhibitors|growth inhibitors|mesh-ancestor
25248746|NCT02530801|Antimetabolites|antimetabolites|mesh-ancestor
25248747|NCT02530801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248748|NCT02530801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25248749|NCT02530801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25248750|NCT02530801|Immunologic Factors|immunologic factors|mesh-ancestor
25248751|NCT02530827|Hypolipidemic Agents|hypolipidemic agents|mesh-list
25248752|NCT02530827|Antimetabolites|antimetabolites|mesh-ancestor
25248753|NCT02530827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248754|NCT02530827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25248755|NCT02530879|Esomeprazole|esomeprazole|mesh-list
25248756|NCT02530879|Omeprazole|omeprazole|mesh-list
25248757|NCT02530879|Lansoprazole|lansoprazole|mesh-list
25248758|NCT02530879|Dexlansoprazole|dexlansoprazole|mesh-list
25248759|NCT02530879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25248760|NCT02530879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25248761|NCT02530879|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25248762|NCT02530879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248763|NCT02530879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248764|NCT02530632|Propofol|propofol|mesh-list
25248765|NCT02530632|Sevoflurane|sevoflurane|mesh-list
25248766|NCT02530632|Anesthetics|anesthetics|mesh-ancestor
25248767|NCT02530632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24598332|NCT00955318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24598333|NCT00955318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24598335|NCT00955318|Dopamine Agents|dopamine agents|mesh-ancestor
24598336|NCT00955318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24598337|NCT00955318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598338|NCT00955526|Istradefylline|istradefylline|mesh-list
24598339|NCT00955526|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
24598340|NCT00955526|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24598341|NCT00955526|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24598342|NCT00955526|Purinergic Agents|purinergic agents|mesh-ancestor
24598343|NCT00955526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24598344|NCT00955526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598345|NCT00955526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598346|NCT00955604|Rasagiline|rasagiline|mesh-list
24598358|NCT00955630|Growth Substances|growth substances|mesh-ancestor
24598359|NCT00955630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598360|NCT00955630|Growth Inhibitors|growth inhibitors|mesh-ancestor
24598361|NCT00955630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598363|NCT00955695|Gefitinib|gefitinib|mesh-list
25248768|NCT02530632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248769|NCT02530632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25248770|NCT02530632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25248771|NCT02530632|Anesthetics, General|anesthetics, general|mesh-ancestor
25248772|NCT02530632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25248773|NCT02530632|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25248774|NCT02530411|Fulvestrant|fulvestrant|mesh-list
25248775|NCT02530411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25248776|NCT02530411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248777|NCT02530411|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25248778|NCT02530411|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25248779|NCT02530411|Hormone Antagonists|hormone antagonists|mesh-ancestor
25248780|NCT02530411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25248781|NCT02530411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248782|NCT02530424|Trastuzumab|trastuzumab|mesh-list
25248783|NCT02530424|Pertuzumab|pertuzumab|mesh-list
25248784|NCT02530424|Fulvestrant|fulvestrant|mesh-list
25248785|NCT02530424|Palbociclib|palbociclib|mesh-list
25248786|NCT02530424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25248787|NCT02530424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248788|NCT02530424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25248789|NCT02530424|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25248790|NCT02530424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25248791|NCT02530424|Hormone Antagonists|hormone antagonists|mesh-ancestor
25248792|NCT02530424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25248793|NCT02530424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248794|NCT02530424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25248795|NCT02530424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248796|NCT02530424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248807|NCT02530502|Pembrolizumab|pembrolizumab|mesh-list
25248808|NCT02530502|Temozolomide|temozolomide|mesh-list
25248809|NCT02530502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24598437|NCT00956163|Cariostatic Agents|cariostatic agents|mesh-ancestor
24598438|NCT00956163|Protective Agents|protective agents|mesh-ancestor
24598439|NCT00956163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598440|NCT00956163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24598441|NCT00956163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714249|NCT01529541|Incretins|incretins|mesh-ancestor
24714251|NCT01529541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24598442|NCT00956163|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24598471|NCT00956202|Immunologic Factors|immunologic factors|mesh-ancestor
24598472|NCT00956202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598474|NCT00956215|Fosaprepitant|fosaprepitant|mesh-list
24598475|NCT00956215|Antiemetics|antiemetics|mesh-ancestor
24598476|NCT00956215|Autonomic Agents|autonomic agents|mesh-ancestor
24598477|NCT00956215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24598478|NCT00956215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598479|NCT00956215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24598480|NCT00956215|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24598481|NCT00956215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24598482|NCT00956215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598483|NCT00956267|Letrozole|letrozole|mesh-list
24598484|NCT00956267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598485|NCT00956267|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24598486|NCT00956267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24852958|NCT02264847|Fertility Agents|fertility agents|mesh-ancestor
24852959|NCT02264847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24852960|NCT02264847|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24852961|NCT02264847|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24852962|NCT02264873|Decitabine|decitabine|mesh-list
24662877|NCT01297192|Mirabegron|mirabegron|mesh-list
24598517|NCT00956397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24598518|NCT00956397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24598519|NCT00956436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24598520|NCT00956436|Sorafenib|sorafenib|mesh-list
24598521|NCT00956436|Liver Extracts|liver extracts|mesh-list
24598522|NCT00956436|Antibodies|antibodies|mesh-list
24598523|NCT00956436|Immunoglobulins|immunoglobulins|mesh-list
24598524|NCT00956436|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24598525|NCT00956436|Immunologic Factors|immunologic factors|mesh-ancestor
24598526|NCT00956436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598527|NCT00956436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248810|NCT02530502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248811|NCT02530502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25248812|NCT02530502|Alkylating Agents|alkylating agents|mesh-ancestor
25248813|NCT02530502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248814|NCT02530489|Paclitaxel|paclitaxel|mesh-list
25248815|NCT02530489|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25248816|NCT02530489|Atezolizumab|atezolizumab|mesh-list
25248817|NCT02530489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24808344|NCT02026765|Heparin|heparin|mesh-list
25248818|NCT02530489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25248819|NCT02530489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248820|NCT02530489|Tubulin Modulators|tubulin modulators|mesh-ancestor
25248821|NCT02530489|Antimitotic Agents|antimitotic agents|mesh-ancestor
25248822|NCT02530489|Mitosis Modulators|mitosis modulators|mesh-ancestor
25248823|NCT02530489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248824|NCT02530489|Immunologic Factors|immunologic factors|mesh-ancestor
25248825|NCT02530489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248826|NCT02530359|Pirfenidone|pirfenidone|mesh-list
25248827|NCT02530359|Analgesics|analgesics|mesh-ancestor
25248828|NCT02530359|Sensory System Agents|sensory system agents|mesh-ancestor
25248829|NCT02530359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25248830|NCT02530359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248831|NCT02530359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25248832|NCT02530359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25248833|NCT02530359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25248834|NCT02530359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25248835|NCT02530359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248836|NCT02530320|Palbociclib|palbociclib|mesh-list
25248837|NCT02530320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248838|NCT02530320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25248839|NCT02530320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248840|NCT02530320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248841|NCT02529982|Curcumin|curcumin|mesh-list
25248842|NCT02529982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25686834|NCT01925469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25686835|NCT01925469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248843|NCT02529982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25248844|NCT02529982|Analgesics|analgesics|mesh-ancestor
25248845|NCT02529982|Sensory System Agents|sensory system agents|mesh-ancestor
24614770|NCT01026311|Vitamins|vitamins|mesh-ancestor
24598528|NCT00956436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24598529|NCT00956436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598530|NCT00956436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598531|NCT00956436|Hematinics|hematinics|mesh-ancestor
24598532|NCT00956462|Dexamethasone|dexamethasone|mesh-list
24598533|NCT00956462|Ketorolac|ketorolac|mesh-list
24598534|NCT00956462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
24598535|NCT00956462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24598536|NCT00956462|Antiemetics|antiemetics|mesh-ancestor
24598538|NCT00956462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24598539|NCT00956462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598541|NCT00956462|Glucocorticoids|glucocorticoids|mesh-ancestor
24598542|NCT00956462|Hormones|hormones|mesh-ancestor
24598543|NCT00956462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24598550|NCT00956462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24598551|NCT00956462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852978|NCT02264912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598552|NCT00956462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598553|NCT00956644|Amlodipine|amlodipine|mesh-list
24598554|NCT00956644|Irbesartan|irbesartan|mesh-list
24598555|NCT00956644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24598556|NCT00956644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24598576|NCT00956748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24598577|NCT00956748|Glucocorticoids|glucocorticoids|mesh-ancestor
24598578|NCT00956748|Hormones|hormones|mesh-ancestor
24598579|NCT00956748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24598580|NCT00956748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24971564|NCT03724838|Anticoagulants|anticoagulants|mesh-ancestor
24598581|NCT00956748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598592|NCT00956748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24598593|NCT00956748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24598594|NCT00956748|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24579785|NCT00857753|Narcotics|narcotics|mesh-ancestor
24579786|NCT00857753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24579787|NCT00857753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579788|NCT00857753|Analgesics|analgesics|mesh-ancestor
24579789|NCT00857753|Sensory System Agents|sensory system agents|mesh-ancestor
24579790|NCT00857753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24579791|NCT00857753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25248846|NCT02529982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25248847|NCT02529982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248848|NCT02529982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25248849|NCT02529982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25248850|NCT02529982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248851|NCT02529982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248852|NCT02529982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248853|NCT02530060|Tenofovir|tenofovir|mesh-list
25248854|NCT02530060|Emtricitabine|emtricitabine|mesh-list
25248855|NCT02530060|Rilpivirine|rilpivirine|mesh-list
25248856|NCT02530060|Antiviral Agents|antiviral agents|mesh-ancestor
25248857|NCT02530060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25248858|NCT02530060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25248859|NCT02530060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25248860|NCT02530060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248861|NCT02530060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248862|NCT02530060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25248863|NCT02530060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25248864|NCT02530047|Interferons|interferons|mesh-list
25248865|NCT02530047|Interferon-beta|interferon-beta|mesh-list
25248866|NCT02530047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248867|NCT02530047|Antiviral Agents|antiviral agents|mesh-ancestor
25248868|NCT02530047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25248869|NCT02530047|Immunologic Factors|immunologic factors|mesh-ancestor
25248870|NCT02530047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248871|NCT02529969|Curcumin|curcumin|mesh-list
25248872|NCT02529969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25248873|NCT02529969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25248874|NCT02529969|Analgesics|analgesics|mesh-ancestor
25248875|NCT02529969|Sensory System Agents|sensory system agents|mesh-ancestor
25248876|NCT02529969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25248877|NCT02529969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248878|NCT02529969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25686836|NCT01925469|Sensory System Agents|sensory system agents|mesh-ancestor
25248879|NCT02529969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24598595|NCT00956748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24598596|NCT00956787|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
24598597|NCT00956787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24598598|NCT00956787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598620|NCT00957060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598621|NCT00957060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598622|NCT00957060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24598623|NCT00957060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24598624|NCT00957060|Immunologic Factors|immunologic factors|mesh-ancestor
24598625|NCT00957125|Bevacizumab|bevacizumab|mesh-list
24598626|NCT00957125|Docetaxel|docetaxel|mesh-list
24598627|NCT00957125|Epirubicin|epirubicin|mesh-list
24636206|NCT01143948|Insulin|insulin|mesh-list
24598628|NCT00957125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24852977|NCT02264912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852979|NCT02264938|Antioxidants|antioxidants|mesh-list
24852980|NCT02264938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663002|NCT01297894|Colistin|colistin|mesh-list
24598629|NCT00957125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598630|NCT00957125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24598631|NCT00957125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24598632|NCT00957125|Growth Substances|growth substances|mesh-ancestor
24598633|NCT00957125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598634|NCT00957125|Growth Inhibitors|growth inhibitors|mesh-ancestor
24598635|NCT00957125|Tubulin Modulators|tubulin modulators|mesh-ancestor
24598636|NCT00957125|Antimitotic Agents|antimitotic agents|mesh-ancestor
24598637|NCT00957125|Mitosis Modulators|mitosis modulators|mesh-ancestor
24598638|NCT00957125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598644|NCT00957177|Analgesics|analgesics|mesh-ancestor
25248880|NCT02529969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248881|NCT02529969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248882|NCT02529969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248883|NCT02529878|Paclitaxel|paclitaxel|mesh-list
25248884|NCT02529878|Apatinib|apatinib|mesh-list
25248885|NCT02529878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25248886|NCT02529878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248887|NCT02529878|Tubulin Modulators|tubulin modulators|mesh-ancestor
25248888|NCT02529878|Antimitotic Agents|antimitotic agents|mesh-ancestor
25248889|NCT02529878|Mitosis Modulators|mitosis modulators|mesh-ancestor
25248890|NCT02529878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248891|NCT02529878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25248892|NCT02529878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248893|NCT02529839|Cyclophosphamide|cyclophosphamide|mesh-list
25248894|NCT02529839|Fludarabine|fludarabine|mesh-list
25248895|NCT02529839|Alemtuzumab|alemtuzumab|mesh-list
25248896|NCT02529839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25248897|NCT02529839|Immunologic Factors|immunologic factors|mesh-ancestor
25248898|NCT02529839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248899|NCT02529839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25248900|NCT02529839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25248901|NCT02529839|Alkylating Agents|alkylating agents|mesh-ancestor
25248902|NCT02529839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248903|NCT02529839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248904|NCT02529839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25248905|NCT02529839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25248906|NCT02529787|Dexlansoprazole|dexlansoprazole|mesh-list
25248907|NCT02529787|Lansoprazole|lansoprazole|mesh-list
25248908|NCT02529787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25248909|NCT02529787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25248910|NCT02529787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25248911|NCT02529787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248912|NCT02529787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248913|NCT02529774|Leucovorin|leucovorin|mesh-list
25248914|NCT02529774|Dexamethasone|dexamethasone|mesh-list
25248915|NCT02529774|Capecitabine|capecitabine|mesh-list
25248916|NCT02529774|Oxaliplatin|oxaliplatin|mesh-list
25248917|NCT02529774|Fluorouracil|fluorouracil|mesh-list
25248918|NCT02529774|Floxuridine|floxuridine|mesh-list
25248919|NCT02529774|Heparin|heparin|mesh-list
25248920|NCT02529774|Levoleucovorin|levoleucovorin|mesh-list
25248921|NCT02529774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25248922|NCT02529774|Antiemetics|antiemetics|mesh-ancestor
24598650|NCT00957177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25692601|NCT02002832|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24714834|NCT01533129|Hormones|hormones|mesh-ancestor
24598651|NCT00957177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598652|NCT00957177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24598654|NCT00957177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24598668|NCT00957190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598670|NCT00957203|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
24598671|NCT00957203|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24598672|NCT00957203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24598673|NCT00957203|Purinergic Agents|purinergic agents|mesh-ancestor
24598688|NCT00957320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598689|NCT00957320|Antifungal Agents|antifungal agents|mesh-ancestor
24598690|NCT00957320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24598691|NCT00957320|Immunologic Factors|immunologic factors|mesh-ancestor
24598692|NCT00957320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598694|NCT00957346|Mifepristone|mifepristone|mesh-list
24598695|NCT00957346|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24598696|NCT00957346|Abortifacient Agents|abortifacient agents|mesh-ancestor
24598697|NCT00957346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24598698|NCT00957346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598700|NCT00957346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24598701|NCT00957346|Oxytocics|oxytocics|mesh-ancestor
24598702|NCT00957346|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24598703|NCT00957346|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24598710|NCT00957346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24598711|NCT00957346|Luteolytic Agents|luteolytic agents|mesh-ancestor
24598712|NCT00957346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24598713|NCT00957346|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24598714|NCT00957385|Lenalidomide|lenalidomide|mesh-list
24852981|NCT02264938|Protective Agents|protective agents|mesh-ancestor
24852982|NCT02264938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852984|NCT02265068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24598715|NCT00957385|Immunologic Factors|immunologic factors|mesh-ancestor
24598716|NCT00957385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579792|NCT00857753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24579793|NCT00857753|Anesthetics, General|anesthetics, general|mesh-ancestor
25248923|NCT02529774|Autonomic Agents|autonomic agents|mesh-ancestor
25248924|NCT02529774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25248925|NCT02529774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248926|NCT02529774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25248927|NCT02529774|Glucocorticoids|glucocorticoids|mesh-ancestor
25248928|NCT02529774|Hormones|hormones|mesh-ancestor
25248929|NCT02529774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25248930|NCT02529774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25248931|NCT02529774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248932|NCT02529774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25248933|NCT02529774|Antimetabolites|antimetabolites|mesh-ancestor
25248934|NCT02529774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248935|NCT02529774|Antidotes|antidotes|mesh-ancestor
25248936|NCT02529774|Protective Agents|protective agents|mesh-ancestor
25248937|NCT02529774|Vitamin B Complex|vitamin b complex|mesh-ancestor
25248938|NCT02529774|Vitamins|vitamins|mesh-ancestor
25248939|NCT02529774|Micronutrients|micronutrients|mesh-ancestor
25248940|NCT02529774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25248941|NCT02529774|Immunologic Factors|immunologic factors|mesh-ancestor
25248942|NCT02529774|Anticoagulants|anticoagulants|mesh-ancestor
25248943|NCT02529774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25248944|NCT02529774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25248945|NCT02529514|Baclofen|baclofen|mesh-list
25248946|NCT02529514|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25248947|NCT02529514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248948|NCT02529514|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25248949|NCT02529514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25248950|NCT02529514|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25248951|NCT02529514|GABA Agonists|gaba agonists|mesh-ancestor
25248952|NCT02529514|GABA Agents|gaba agents|mesh-ancestor
25248953|NCT02529514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25248954|NCT02529514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248955|NCT02529579|Gemcitabine|gemcitabine|mesh-list
25248956|NCT02529579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25248957|NCT02529579|Antimetabolites|antimetabolites|mesh-ancestor
25248958|NCT02529579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598717|NCT00957385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25686837|NCT01925469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24598718|NCT00957385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24598720|NCT00957385|Growth Inhibitors|growth inhibitors|mesh-ancestor
24598721|NCT00957385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598723|NCT00957411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598750|NCT00957879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598751|NCT00957879|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24598753|NCT00957879|Micronutrients|micronutrients|mesh-ancestor
24598754|NCT00957879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24598755|NCT00958022|Carboplatin|carboplatin|mesh-list
24598757|NCT00958022|Etoposide phosphate|etoposide phosphate|mesh-list
24598758|NCT00958022|Panobinostat|panobinostat|mesh-list
24598759|NCT00958022|Podophyllotoxin|podophyllotoxin|mesh-list
24598760|NCT00958022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598761|NCT00958022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24598762|NCT00958022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24598763|NCT00958022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24598764|NCT00958022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598854|NCT05352282|Anesthetics|anesthetics|mesh-ancestor
24598765|NCT00958022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598766|NCT00958022|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24598800|NCT00958204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24598801|NCT00958204|Antidepressive Agents|antidepressive agents|mesh-ancestor
24598803|NCT00958204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24598804|NCT00958204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24598805|NCT00958204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598806|NCT00958269|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24598807|NCT00958269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24598808|NCT00958269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598809|NCT00958269|Incretins|incretins|mesh-ancestor
24598810|NCT00958269|Hormones|hormones|mesh-ancestor
24598811|NCT00958269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25248959|NCT02529579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25248960|NCT02529579|Antiviral Agents|antiviral agents|mesh-ancestor
25248961|NCT02529579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25248962|NCT02529579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248963|NCT02529579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25248964|NCT02529579|Immunologic Factors|immunologic factors|mesh-ancestor
25248965|NCT02529579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248966|NCT02529540|Methamphetamine|methamphetamine|mesh-list
25248967|NCT02529540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25248968|NCT02529540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248969|NCT02529540|Sympathomimetics|sympathomimetics|mesh-ancestor
25248970|NCT02529540|Autonomic Agents|autonomic agents|mesh-ancestor
25248971|NCT02529540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25248972|NCT02529540|Dopamine Agents|dopamine agents|mesh-ancestor
25248973|NCT02529540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25248974|NCT02529540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248975|NCT02529540|Adrenergic Agents|adrenergic agents|mesh-ancestor
25248976|NCT02529540|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25248977|NCT02529540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25248978|NCT02529540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25248979|NCT02529540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25248980|NCT02529631|Orlistat|orlistat|mesh-list
25248981|NCT02529631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25248982|NCT02529631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248983|NCT02529631|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25248984|NCT02529631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25248985|NCT02529670|Lidocaine|lidocaine|mesh-list
25248986|NCT02529670|Anesthetics, Local|anesthetics, local|mesh-ancestor
25248987|NCT02529670|Anesthetics|anesthetics|mesh-ancestor
25248988|NCT02529670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25248989|NCT02529670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25248990|NCT02529670|Sensory System Agents|sensory system agents|mesh-ancestor
25248991|NCT02529670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25248992|NCT02529670|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25248993|NCT02529670|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25248994|NCT02529670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25248995|NCT02529670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25274468|NCT02377778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24663126|NCT01298401|Gemcitabine|gemcitabine|mesh-list
24598815|NCT00958269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941197|NCT03994055|Antioxidants|antioxidants|mesh-list
24598816|NCT00958321|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24598817|NCT00958321|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24504669|NCT00537563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24598830|NCT00958425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598831|NCT00958425|Viscosupplements|viscosupplements|mesh-ancestor
24598832|NCT00958425|Protective Agents|protective agents|mesh-ancestor
24598833|NCT00958451|Ergocalciferols|ergocalciferols|mesh-list
24598835|NCT00958451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24598836|NCT00958451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598843|NCT05352282|Fentanyl|fentanyl|mesh-list
24598844|NCT05352282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24598845|NCT05352282|Narcotics|narcotics|mesh-ancestor
24598846|NCT05352282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24598847|NCT05352282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598848|NCT05352282|Analgesics|analgesics|mesh-ancestor
24598849|NCT05352282|Sensory System Agents|sensory system agents|mesh-ancestor
24598850|NCT05352282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24598851|NCT05352282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24598852|NCT05352282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24598853|NCT05352282|Anesthetics, General|anesthetics, general|mesh-ancestor
24598863|NCT05352165|Pembrolizumab|pembrolizumab|mesh-list
25248996|NCT02529670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25248997|NCT02529683|NuvaRing|nuvaring|mesh-list
25248998|NCT02529683|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25248999|NCT02529683|Contraceptive Agents|contraceptive agents|mesh-ancestor
25249000|NCT02529683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25249001|NCT02529683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249002|NCT02529761|Sorafenib|sorafenib|mesh-list
25249003|NCT02529761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25249004|NCT02529761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25249005|NCT02529761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25249006|NCT02529761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249007|NCT02529449|Ipragliflozin|ipragliflozin|mesh-list
25249008|NCT02529449|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25249009|NCT02529449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249010|NCT02529449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25249011|NCT02529449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249012|NCT02529124|Caseins|caseins|mesh-list
25249013|NCT02529124|Chelating Agents|chelating agents|mesh-ancestor
25249014|NCT02529124|Sequestering Agents|sequestering agents|mesh-ancestor
25249015|NCT02529124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249016|NCT02529059|Tenofovir|tenofovir|mesh-list
25249017|NCT02529059|Emtricitabine|emtricitabine|mesh-list
25249018|NCT02529059|Rilpivirine|rilpivirine|mesh-list
25249019|NCT02529059|Antiviral Agents|antiviral agents|mesh-ancestor
25249020|NCT02529059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25249021|NCT02529059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25249022|NCT02529059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25249023|NCT02529059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25249024|NCT02529059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249025|NCT02529059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25249026|NCT02529059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25249027|NCT02529241|Delpazolid|delpazolid|mesh-list
25249028|NCT02529241|Oxazolidinones|oxazolidinones|mesh-list
25249029|NCT02529241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25249030|NCT02529241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25249031|NCT02529241|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25249032|NCT02529241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25249033|NCT02529241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274469|NCT02377778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274470|NCT02377778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25274471|NCT02377778|Anesthetics, General|anesthetics, general|mesh-ancestor
24598874|NCT05352126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24598875|NCT05352113|Antidepressive Agents|antidepressive agents|mesh-list
24598876|NCT05352113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24504689|NCT00537836|Estradiol|estradiol|mesh-list
24598909|NCT05351736|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24598910|NCT05351736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24598911|NCT05351736|Adrenergic Agents|adrenergic agents|mesh-ancestor
24598912|NCT05351736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24598913|NCT05351736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598914|NCT05351736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24598915|NCT05351736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25686838|NCT01925612|Prednisone|prednisone|mesh-list
24598920|NCT05351684|Dolutegravir|dolutegravir|mesh-list
24598921|NCT05351684|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24598922|NCT05351684|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25249034|NCT02529202|Dexmedetomidine|dexmedetomidine|mesh-list
25249035|NCT02529202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25249036|NCT02529202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25249037|NCT02529202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249038|NCT02529202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25249039|NCT02529202|Analgesics|analgesics|mesh-ancestor
25249040|NCT02529202|Sensory System Agents|sensory system agents|mesh-ancestor
25249041|NCT02529202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25249042|NCT02529202|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25249043|NCT02529202|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25249044|NCT02529202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25249045|NCT02529202|Adrenergic Agents|adrenergic agents|mesh-ancestor
25249046|NCT02529202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25249047|NCT02529202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249048|NCT02529293|Insulin Lispro|insulin lispro|mesh-list
25249049|NCT02529293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25249050|NCT02529293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249051|NCT02528695|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25249052|NCT02528695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249054|NCT02528877|Fludarabine|fludarabine|mesh-list
25249055|NCT02528877|Fludarabine phosphate|fludarabine phosphate|mesh-list
25249056|NCT02528877|Melphalan|melphalan|mesh-list
24971932|NCT03721614|Everolimus|everolimus|mesh-list
25249057|NCT02528877|Mechlorethamine|mechlorethamine|mesh-list
25249058|NCT02528877|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25249059|NCT02528877|Tacrolimus|tacrolimus|mesh-list
25249060|NCT02528877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25249061|NCT02528877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25249062|NCT02528877|Antimetabolites|antimetabolites|mesh-ancestor
25249063|NCT02528877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249064|NCT02528877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25249065|NCT02528877|Immunologic Factors|immunologic factors|mesh-ancestor
25249066|NCT02528877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287223|NCT04837235|Hemay005|hemay005|mesh-list
25249067|NCT02528877|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25249068|NCT02528877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25249069|NCT02528877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25249070|NCT02528877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25249071|NCT02528877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25249072|NCT02528877|Antifungal Agents|antifungal agents|mesh-ancestor
25249073|NCT02528877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25249074|NCT02528877|Alkylating Agents|alkylating agents|mesh-ancestor
25249075|NCT02528877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25249076|NCT02528825|Remifentanil|remifentanil|mesh-list
24598937|NCT05351606|Cholinergic Agents|cholinergic agents|mesh-ancestor
24598938|NCT05351606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24598939|NCT05351606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963071|NCT03792724|Nivolumab|nivolumab|mesh-list
24598940|NCT05351606|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24598941|NCT05351606|Antidepressive Agents|antidepressive agents|mesh-ancestor
24598942|NCT05351606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24598943|NCT05351606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24598944|NCT05351606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24598945|NCT05351606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24598946|NCT05351606|Dopamine Agents|dopamine agents|mesh-ancestor
24598959|NCT05351502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598960|NCT05351502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24598961|NCT05351502|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24598962|NCT05351502|Vasodilator Agents|vasodilator agents|mesh-ancestor
24598963|NCT05351502|Gasotransmitters|gasotransmitters|mesh-ancestor
24598964|NCT05351502|Protective Agents|protective agents|mesh-ancestor
24598965|NCT05351385|Dimercaprol|dimercaprol|mesh-list
24598966|NCT05351385|Chelating Agents|chelating agents|mesh-ancestor
24598967|NCT05351385|Sequestering Agents|sequestering agents|mesh-ancestor
25249081|NCT02528825|Analgesics|analgesics|mesh-ancestor
25249082|NCT02528825|Sensory System Agents|sensory system agents|mesh-ancestor
25249083|NCT02528825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25249084|NCT02528760|Erythromycin|erythromycin|mesh-list
25249085|NCT02528760|Erythromycin Estolate|erythromycin estolate|mesh-list
25249086|NCT02528760|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25249087|NCT02528760|Erythromycin stearate|erythromycin stearate|mesh-list
25249088|NCT02528760|Metoclopramide|metoclopramide|mesh-list
25249089|NCT02528760|Antiemetics|antiemetics|mesh-ancestor
25249090|NCT02528760|Autonomic Agents|autonomic agents|mesh-ancestor
25249091|NCT02528760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25249092|NCT02528760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249093|NCT02528760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25249094|NCT02528760|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25249095|NCT02528760|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25249096|NCT02528760|Dopamine Agents|dopamine agents|mesh-ancestor
25249097|NCT02528760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25249098|NCT02528760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249099|NCT02528760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25249100|NCT02528760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25249101|NCT02528760|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25249102|NCT02528760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25249103|NCT02528526|Inositol|inositol|mesh-list
25249104|NCT02528526|Vitamin B Complex|vitamin b complex|mesh-ancestor
25249105|NCT02528526|Vitamins|vitamins|mesh-ancestor
25249106|NCT02528526|Micronutrients|micronutrients|mesh-ancestor
25249107|NCT02528526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249108|NCT02528461|Sofosbuvir|sofosbuvir|mesh-list
25249109|NCT02528461|Liver Extracts|liver extracts|mesh-list
25249110|NCT02528461|Hematinics|hematinics|mesh-ancestor
25249111|NCT02528461|Antiviral Agents|antiviral agents|mesh-ancestor
25249112|NCT02528461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25249113|NCT02528513|Fentanyl|fentanyl|mesh-list
25249114|NCT02528513|Midazolam|midazolam|mesh-list
25249115|NCT02528513|Dexmedetomidine|dexmedetomidine|mesh-list
25249116|NCT02528513|Propofol|propofol|mesh-list
25249117|NCT02528513|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25249118|NCT02528513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25249119|NCT02528513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249120|NCT02528513|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25249121|NCT02528513|Anesthetics, General|anesthetics, general|mesh-ancestor
25249122|NCT02528513|Anesthetics|anesthetics|mesh-ancestor
25249123|NCT02528513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25249124|NCT02528513|Analgesics|analgesics|mesh-ancestor
24599031|NCT05350501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599032|NCT05350501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24599033|NCT05350501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599043|NCT05350384|Autonomic Agents|autonomic agents|mesh-ancestor
24599044|NCT05350384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24599045|NCT05350384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599046|NCT05350384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24599047|NCT05350384|Glucocorticoids|glucocorticoids|mesh-ancestor
24599048|NCT05350384|Hormones|hormones|mesh-ancestor
24599049|NCT05350384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24599050|NCT05350384|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24599051|NCT05350384|Protective Agents|protective agents|mesh-ancestor
24599052|NCT05350384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24599063|NCT05350371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599064|NCT05348668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24599065|NCT05348668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599066|NCT05348668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599067|NCT05296161|Ocrelizumab|ocrelizumab|mesh-list
24599068|NCT05296161|Immunologic Factors|immunologic factors|mesh-ancestor
24599069|NCT05296161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599070|NCT05280457|Nivolumab|nivolumab|mesh-list
24599071|NCT05280457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24853000|NCT02265289|Purinergic Agents|purinergic agents|mesh-ancestor
24853001|NCT02265289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25249130|NCT02528513|Adrenergic Agents|adrenergic agents|mesh-ancestor
25249131|NCT02528513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25249132|NCT02528513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249133|NCT02528513|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25249134|NCT02528513|Narcotics|narcotics|mesh-ancestor
25249135|NCT02528513|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25249136|NCT02528513|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25249137|NCT02528513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25249138|NCT02528513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25249139|NCT02528513|GABA Modulators|gaba modulators|mesh-ancestor
25249140|NCT02528513|GABA Agents|gaba agents|mesh-ancestor
25249141|NCT02528175|Capecitabine|capecitabine|mesh-list
25249142|NCT02528175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25686839|NCT01925612|Cyclophosphamide|cyclophosphamide|mesh-list
25249143|NCT02528175|Antimetabolites|antimetabolites|mesh-ancestor
25249144|NCT02528175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249145|NCT02528175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25249146|NCT02528396|Insulin Lispro|insulin lispro|mesh-list
25249147|NCT02528396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25249148|NCT02528396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249149|NCT02528201|Celecoxib|celecoxib|mesh-list
25249150|NCT02528201|Diclofenac|diclofenac|mesh-list
25249151|NCT02528201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25249152|NCT02528201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25249153|NCT02528201|Analgesics|analgesics|mesh-ancestor
25249154|NCT02528201|Sensory System Agents|sensory system agents|mesh-ancestor
25249155|NCT02528201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25249156|NCT02528201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249157|NCT02528201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25249158|NCT02528201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25249159|NCT02528201|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25249160|NCT02528201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25249161|NCT02528201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25249162|NCT02528201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274472|NCT02377778|Anesthetics|anesthetics|mesh-ancestor
24599126|NCT05178550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24599127|NCT05178550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24599147|NCT05100654|Doxycycline|doxycycline|mesh-list
24599148|NCT05100654|Ciprofloxacin|ciprofloxacin|mesh-list
24599149|NCT05100654|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24599150|NCT05100654|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24599151|NCT05100654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24599152|NCT05100654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24599153|NCT05100654|Antimalarials|antimalarials|mesh-ancestor
24599154|NCT05100654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24599155|NCT05100654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24599156|NCT05100654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24599157|NCT05100654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24599158|NCT05100654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24599159|NCT05100654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599160|NCT05100654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599161|NCT05100654|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24599162|NCT05100654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24599163|NCT05100654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24599164|NCT05100654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24579859|NCT00858338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579860|NCT00858338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579861|NCT00858377|Complement Factor H|complement factor h|mesh-list
24579883|NCT00858455|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24579884|NCT00858455|Antiviral Agents|antiviral agents|mesh-ancestor
24579885|NCT00858455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24579886|NCT00858624|Ketamine|ketamine|mesh-list
25249163|NCT02528383|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25249164|NCT02528383|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25249165|NCT02528383|Estradiol|estradiol|mesh-list
25249166|NCT02528383|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25249167|NCT02528383|Estrogens|estrogens|mesh-ancestor
25249168|NCT02528383|Hormones|hormones|mesh-ancestor
25249169|NCT02528383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25249170|NCT02528383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249171|NCT02528383|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25249172|NCT02528383|Contraceptive Agents|contraceptive agents|mesh-ancestor
25249173|NCT02528383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25249174|NCT02528383|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25249175|NCT02528279|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25249176|NCT02528279|Antimalarials|antimalarials|mesh-ancestor
25249177|NCT02528279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25249178|NCT02528279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25249179|NCT02528279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25249180|NCT02528448|Plasma-lyte 148|plasma-lyte 148|mesh-list
25249181|NCT02528448|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25249182|NCT02528448|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25249183|NCT02528136|Oxytocin|oxytocin|mesh-list
25249184|NCT02528136|Carbetocin|carbetocin|mesh-list
25249185|NCT02528136|Oxytocics|oxytocics|mesh-ancestor
25249186|NCT02528136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25249187|NCT02528136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249188|NCT02528123|Tobramycin|tobramycin|mesh-list
24715751|NCT01538446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24715752|NCT01538446|Purinergic Agents|purinergic agents|mesh-ancestor
24766239|NCT01793519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24766240|NCT01793519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766241|NCT01793519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24766242|NCT01793519|Immunologic Factors|immunologic factors|mesh-ancestor
24766243|NCT01793636|Everolimus|everolimus|mesh-list
24834373|NCT02178124|Donepezil|donepezil|mesh-list
25249189|NCT02528123|Ofloxacin|ofloxacin|mesh-list
25249190|NCT02528123|Dexamethasone|dexamethasone|mesh-list
25249191|NCT02528123|Benoxinate|benoxinate|mesh-list
25249192|NCT02528123|Proxymetacaine|proxymetacaine|mesh-list
24599205|NCT05003245|Growth Inhibitors|growth inhibitors|mesh-ancestor
24636268|NCT01144312|Analgesics|analgesics|mesh-ancestor
24599206|NCT05003245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599221|NCT04966663|Gemcitabine|gemcitabine|mesh-list
24599222|NCT04966663|Carboplatin|carboplatin|mesh-list
24599223|NCT04966663|Nivolumab|nivolumab|mesh-list
24599238|NCT04966663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24599243|NCT04919369|Vitamins|vitamins|mesh-list
24599244|NCT04919369|Vitamin A|vitamin a|mesh-list
24599245|NCT04919369|Atezolizumab|atezolizumab|mesh-list
24853009|NCT02265328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853010|NCT02265328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24853011|NCT02265328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25249193|NCT02528123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25249194|NCT02528123|Antiemetics|antiemetics|mesh-ancestor
25249195|NCT02528123|Autonomic Agents|autonomic agents|mesh-ancestor
25249196|NCT02528123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25249197|NCT02528123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249198|NCT02528123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25249199|NCT02528123|Glucocorticoids|glucocorticoids|mesh-ancestor
25249200|NCT02528123|Hormones|hormones|mesh-ancestor
25249201|NCT02528123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25249202|NCT02528123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25249203|NCT02528123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25249204|NCT02528123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25249205|NCT02528123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25249206|NCT02528123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25249207|NCT02528123|Renal Agents|renal agents|mesh-ancestor
25249208|NCT02528123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25249209|NCT02528123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25249210|NCT02528123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25705141|NCT02194088|Parasympatholytics|parasympatholytics|mesh-ancestor
25249211|NCT02528123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249212|NCT02528123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25249213|NCT02528123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25249214|NCT02528123|Anesthetics, Local|anesthetics, local|mesh-ancestor
25249215|NCT02528123|Anesthetics|anesthetics|mesh-ancestor
25249216|NCT02528123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25249217|NCT02528123|Sensory System Agents|sensory system agents|mesh-ancestor
25249218|NCT02528019|Glimepiride|glimepiride|mesh-list
25249219|NCT02528019|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25249220|NCT02528019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25249221|NCT02528019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25249222|NCT02528019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249223|NCT02528019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25249224|NCT02528019|Immunologic Factors|immunologic factors|mesh-ancestor
25249225|NCT02528019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249226|NCT02527941|Metronidazole|metronidazole|mesh-list
25249227|NCT02527941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25249228|NCT02527941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25249229|NCT02527941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25249230|NCT02527941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24599325|NCT04722718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24599326|NCT04722718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599327|NCT04722718|Tubulin Modulators|tubulin modulators|mesh-ancestor
24963172|NCT03792295|Acetaminophen|acetaminophen|mesh-list
24599328|NCT04722718|Antimitotic Agents|antimitotic agents|mesh-ancestor
24599329|NCT04722718|Mitosis Modulators|mitosis modulators|mesh-ancestor
25686840|NCT01925612|Rituximab|rituximab|mesh-list
25686841|NCT01925612|Doxorubicin|doxorubicin|mesh-list
25686842|NCT01925612|Vincristine|vincristine|mesh-list
25686843|NCT01925612|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25686844|NCT01925612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25686845|NCT01925612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25686846|NCT01925612|Immunologic Factors|immunologic factors|mesh-ancestor
25686847|NCT01925612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686848|NCT01925612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24599330|NCT04722718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599331|NCT04722718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24599332|NCT04722718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24599333|NCT04720547|Zolpidem|zolpidem|mesh-list
24599334|NCT04720547|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24599335|NCT04720547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24599336|NCT04720547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24599337|NCT04720547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504815|NCT00538265|Mycophenolic Acid|mycophenolic acid|mesh-list
24599350|NCT04718285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599351|NCT04718285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24599352|NCT04718285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24599353|NCT04718285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599354|NCT04718285|Antiviral Agents|antiviral agents|mesh-ancestor
24599355|NCT04718285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24599357|NCT04699604|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24599358|NCT04699604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24599359|NCT04699604|Histamine Antagonists|histamine antagonists|mesh-ancestor
24599360|NCT04699604|Histamine Agents|histamine agents|mesh-ancestor
24599361|NCT04699604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24599362|NCT04699604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599364|NCT04687800|Dexamethasone|dexamethasone|mesh-list
24599365|NCT04687800|Difluprednate|difluprednate|mesh-list
24599366|NCT04687800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24599367|NCT04687800|Antiemetics|antiemetics|mesh-ancestor
24599373|NCT04687800|Hormones|hormones|mesh-ancestor
25249231|NCT02527993|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25249232|NCT02527993|Liraglutide|liraglutide|mesh-list
25249233|NCT02527993|Acarbose|acarbose|mesh-list
25249234|NCT02527993|Verapamil|verapamil|mesh-list
25249235|NCT02527993|Pasireotide|pasireotide|mesh-list
25249236|NCT02527993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25249237|NCT02527993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249238|NCT02527993|Incretins|incretins|mesh-ancestor
25249239|NCT02527993|Hormones|hormones|mesh-ancestor
25249240|NCT02527993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25249241|NCT02527993|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25249242|NCT02527993|Protease Inhibitors|protease inhibitors|mesh-ancestor
25249243|NCT02527993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25249244|NCT02527993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249245|NCT02527993|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25249246|NCT02527993|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25249247|NCT02527993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25249248|NCT02527993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25249249|NCT02527993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25249250|NCT02527993|Vasodilator Agents|vasodilator agents|mesh-ancestor
25249251|NCT02527733|Ranibizumab|ranibizumab|mesh-list
25249252|NCT02527733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25249253|NCT02527733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25249254|NCT02527733|Growth Substances|growth substances|mesh-ancestor
25249255|NCT02527733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249256|NCT02527733|Growth Inhibitors|growth inhibitors|mesh-ancestor
25249257|NCT02527733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25249258|NCT02527746|Cyclophosphamide|cyclophosphamide|mesh-list
25249259|NCT02527746|Epirubicin|epirubicin|mesh-list
25249260|NCT02527746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25249261|NCT02527746|Immunologic Factors|immunologic factors|mesh-ancestor
25249262|NCT02527746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249263|NCT02527746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25249264|NCT02527746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25249265|NCT02527746|Alkylating Agents|alkylating agents|mesh-ancestor
25249266|NCT02527746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249267|NCT02527746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25249268|NCT02527746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25249269|NCT02527746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25274473|NCT02377778|Anticonvulsants|anticonvulsants|mesh-ancestor
24853018|NCT02265562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24853019|NCT02265562|Abortifacient Agents|abortifacient agents|mesh-ancestor
24853020|NCT02265562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24853021|NCT02265562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663541|NCT01302145|Metformin|metformin|mesh-list
24599394|NCT04619082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24599395|NCT04619082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716084|NCT01539720|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24716085|NCT01539720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24716088|NCT01539733|Haloperidol decanoate|haloperidol decanoate|mesh-list
24716089|NCT01539733|Antiemetics|antiemetics|mesh-ancestor
24716090|NCT01539733|Autonomic Agents|autonomic agents|mesh-ancestor
24716091|NCT01539733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24716092|NCT01539733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599396|NCT04619082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24599397|NCT04619082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24599399|NCT04591431|Trastuzumab|trastuzumab|mesh-list
24599400|NCT04591431|Ipilimumab|ipilimumab|mesh-list
24599401|NCT04591431|Pertuzumab|pertuzumab|mesh-list
24599402|NCT04591431|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24599403|NCT04591431|Everolimus|everolimus|mesh-list
24599404|NCT04591431|Atezolizumab|atezolizumab|mesh-list
24599405|NCT04591431|Lapatinib|lapatinib|mesh-list
24599406|NCT04591431|Palbociclib|palbociclib|mesh-list
24599407|NCT04591431|Vemurafenib|vemurafenib|mesh-list
24599408|NCT04591431|Maytansine|maytansine|mesh-list
24599409|NCT04591431|Ponatinib|ponatinib|mesh-list
24599410|NCT04591431|Entrectinib|entrectinib|mesh-list
24599411|NCT04591431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24599412|NCT04591431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599413|NCT04591431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24599414|NCT04591431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636294|NCT01144650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24636295|NCT01144650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24599444|NCT04577014|Antimitotic Agents|antimitotic agents|mesh-ancestor
24579948|NCT00858767|Coagulants|coagulants|mesh-ancestor
24579949|NCT00858767|Vitamins|vitamins|mesh-ancestor
24579950|NCT00858767|Micronutrients|micronutrients|mesh-ancestor
24579951|NCT00858767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579952|NCT00858806|Imatinib Mesylate|imatinib mesylate|mesh-list
24579953|NCT00858806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25249270|NCT02527746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25249271|NCT02527746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25249272|NCT02527746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25249273|NCT02527785|Oxaliplatin|oxaliplatin|mesh-list
25249275|NCT02527785|Tegafur|tegafur|mesh-list
25249276|NCT02527785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25249277|NCT02527785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25249278|NCT02527785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25249279|NCT02527785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25249280|NCT02527785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249281|NCT02527785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25249282|NCT02527785|Antimetabolites|antimetabolites|mesh-ancestor
25249283|NCT02527824|Oxaliplatin|oxaliplatin|mesh-list
25249284|NCT02527824|Irinotecan|irinotecan|mesh-list
25249285|NCT02527824|Tegafur|tegafur|mesh-list
25249286|NCT02527824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25249287|NCT02527824|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25249288|NCT02527824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25249289|NCT02527824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25249290|NCT02527824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249291|NCT02527824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25249292|NCT02527824|Antimetabolites|antimetabolites|mesh-ancestor
25249293|NCT02527811|Urinastatin|urinastatin|mesh-list
25249294|NCT02527811|Trypsin Inhibitors|trypsin inhibitors|mesh-list
25249295|NCT02527811|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25249296|NCT02527811|Protease Inhibitors|protease inhibitors|mesh-ancestor
25249297|NCT02527811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25249298|NCT02527811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249299|NCT02527863|Tolvaptan|tolvaptan|mesh-list
25249300|NCT02527863|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25249301|NCT02527863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249302|NCT02527863|Natriuretic Agents|natriuretic agents|mesh-ancestor
25274474|NCT02377778|GABA Modulators|gaba modulators|mesh-ancestor
25686849|NCT01925612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25686850|NCT01925612|Alkylating Agents|alkylating agents|mesh-ancestor
25686851|NCT01925612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686852|NCT01925612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25686853|NCT01925612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25686854|NCT01925612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24599452|NCT04562129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24599453|NCT04562129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599454|NCT04562129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24716179|NCT01540500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24716180|NCT01540500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24599457|NCT04562129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24599475|NCT04492956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24599476|NCT04492956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24853022|NCT02265562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24853023|NCT02265562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24853024|NCT02265562|Oxytocics|oxytocics|mesh-ancestor
24853025|NCT02265562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24599477|NCT04492956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24599478|NCT04492956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599479|NCT04492956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24599480|NCT04492956|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24599482|NCT04492956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24599483|NCT04492956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599484|NCT04488952|Anesthetics|anesthetics|mesh-list
24599485|NCT04488952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24599486|NCT04488952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599520|NCT04444804|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24599522|NCT04444804|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24599537|NCT04413799|Ketamine|ketamine|mesh-list
24599538|NCT04413799|Anesthetics, Local|anesthetics, local|mesh-ancestor
24579954|NCT00858806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24579955|NCT00858806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579956|NCT00858806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579957|NCT00858897|Insulin|insulin|mesh-list
24579958|NCT00858897|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24579959|NCT00858897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24579961|NCT00859079|Insulin|insulin|mesh-list
24579985|NCT00859183|Antifungal Agents|antifungal agents|mesh-ancestor
24579986|NCT00859183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24579987|NCT00859183|Immunologic Factors|immunologic factors|mesh-ancestor
25249303|NCT02527863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249304|NCT02527772|Leucovorin|leucovorin|mesh-list
25249305|NCT02527772|Gemcitabine|gemcitabine|mesh-list
25249306|NCT02527772|Fluorouracil|fluorouracil|mesh-list
25249307|NCT02527772|Doxorubicin|doxorubicin|mesh-list
25249308|NCT02527772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25249309|NCT02527772|Oxaliplatin|oxaliplatin|mesh-list
25249310|NCT02527772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25249311|NCT02527772|Antimetabolites|antimetabolites|mesh-ancestor
25249312|NCT02527772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249313|NCT02527772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25249314|NCT02527772|Antiviral Agents|antiviral agents|mesh-ancestor
25249315|NCT02527772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25249316|NCT02527772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25249317|NCT02527772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25249318|NCT02527772|Immunologic Factors|immunologic factors|mesh-ancestor
25249319|NCT02527772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249320|NCT02527772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25249321|NCT02527772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25249322|NCT02527772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25249323|NCT02527772|Antidotes|antidotes|mesh-ancestor
25249324|NCT02527772|Protective Agents|protective agents|mesh-ancestor
25249325|NCT02527772|Vitamin B Complex|vitamin b complex|mesh-ancestor
25249326|NCT02527772|Vitamins|vitamins|mesh-ancestor
25249327|NCT02527772|Micronutrients|micronutrients|mesh-ancestor
25249328|NCT02527668|Vitamin D|vitamin d|mesh-list
25249329|NCT02527668|Cholecalciferol|cholecalciferol|mesh-list
25249330|NCT02527668|Calcifediol|calcifediol|mesh-list
25249331|NCT02527668|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
25249332|NCT02527668|Vitamins|vitamins|mesh-ancestor
25249333|NCT02527668|Micronutrients|micronutrients|mesh-ancestor
25249334|NCT02527668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249335|NCT02527668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25249336|NCT02527668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24599539|NCT04413799|Anesthetics|anesthetics|mesh-ancestor
24504914|NCT00538525|Antimitotic Agents|antimitotic agents|mesh-ancestor
24599561|NCT04370509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394075|NCT00132054|Irinotecan|irinotecan|mesh-list
24599562|NCT04370509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599563|NCT04355130|Vitamin B 12|vitamin b 12|mesh-list
25686855|NCT01925612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25686856|NCT01925612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24599564|NCT04355130|Hydroxocobalamin|hydroxocobalamin|mesh-list
24599565|NCT04355130|Vitamins|vitamins|mesh-ancestor
24599566|NCT04355130|Micronutrients|micronutrients|mesh-ancestor
24599567|NCT04355130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599568|NCT04355130|Vitamin B Complex|vitamin b complex|mesh-ancestor
24853026|NCT02265562|Vasodilator Agents|vasodilator agents|mesh-ancestor
24853027|NCT02265562|Urological Agents|urological agents|mesh-ancestor
24853028|NCT02265575|Hyaluronic Acid|hyaluronic acid|mesh-list
24853029|NCT02265575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24599569|NCT04355130|Hematinics|hematinics|mesh-ancestor
24599570|NCT04340505|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
24599571|NCT04340505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24599572|NCT04340505|Glucocorticoids|glucocorticoids|mesh-ancestor
24599573|NCT04340505|Hormones|hormones|mesh-ancestor
24599574|NCT04340505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24599575|NCT04340505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599576|NCT04293744|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24599577|NCT04291105|Cemiplimab|cemiplimab|mesh-list
24599578|NCT04291105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24599579|NCT04291105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599580|NCT04237012|Dexamethasone|dexamethasone|mesh-list
24579988|NCT00859183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580001|NCT00859274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24580010|NCT00859352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580011|NCT00859352|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24580012|NCT00859352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24580013|NCT00859352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24580014|NCT00859352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24580069|NCT00859885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580070|NCT00859885|Antipyretics|antipyretics|mesh-ancestor
24580071|NCT00859885|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24580072|NCT00859885|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24580073|NCT00859885|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24580075|NCT00859885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24580076|NCT00859911|Micronutrients|micronutrients|mesh-list
25249337|NCT02527603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25249338|NCT02527603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25249339|NCT02527603|Analgesics|analgesics|mesh-ancestor
25249340|NCT02527603|Sensory System Agents|sensory system agents|mesh-ancestor
25249341|NCT02527603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25249342|NCT02527603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249343|NCT02527603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25249344|NCT02527603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25249345|NCT02527564|Suvorexant|suvorexant|mesh-list
25249346|NCT02527564|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25249347|NCT02527564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25249348|NCT02527564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25249349|NCT02527564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249350|NCT02527564|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25249351|NCT02527564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25249352|NCT02527564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274475|NCT02377778|GABA Agents|gaba agents|mesh-ancestor
25274476|NCT02377778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25274477|NCT02377778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274479|NCT02377609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25274480|NCT02377609|Immunologic Factors|immunologic factors|mesh-ancestor
25274481|NCT02377609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274482|NCT02377609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25274483|NCT02377609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24599581|NCT04237012|Lubricant Eye Drops|lubricant eye drops|mesh-list
24599582|NCT04237012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24599583|NCT04237012|Antiemetics|antiemetics|mesh-ancestor
24599584|NCT04237012|Autonomic Agents|autonomic agents|mesh-ancestor
24599585|NCT04237012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24599586|NCT04237012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599587|NCT04237012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24599588|NCT04237012|Glucocorticoids|glucocorticoids|mesh-ancestor
24599590|NCT04237012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24599591|NCT04237012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24599592|NCT04237012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599594|NCT04237012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24599611|NCT04206163|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24599612|NCT04206163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599613|NCT04170153|Niraparib|niraparib|mesh-list
24599614|NCT04170153|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24599615|NCT04170153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405943|NCT03586999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24615066|NCT01027611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24716426|NCT01541475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24599616|NCT04170153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599617|NCT04170153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25249362|NCT02527213|Sodium thiosulfate|sodium thiosulfate|mesh-list
25249363|NCT02527213|Antidotes|antidotes|mesh-ancestor
25249364|NCT02527213|Protective Agents|protective agents|mesh-ancestor
25249365|NCT02527213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249366|NCT02527213|Antioxidants|antioxidants|mesh-ancestor
25249367|NCT02527213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249368|NCT02527213|Antitubercular Agents|antitubercular agents|mesh-ancestor
25249369|NCT02527213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25249370|NCT02527213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25249371|NCT02527213|Chelating Agents|chelating agents|mesh-ancestor
25249372|NCT02527213|Sequestering Agents|sequestering agents|mesh-ancestor
25249373|NCT02527174|Cytarabine|cytarabine|mesh-list
25249374|NCT02527174|Idarubicin|idarubicin|mesh-list
25249375|NCT02527174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25249376|NCT02527174|Antimetabolites|antimetabolites|mesh-ancestor
25249377|NCT02527174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249378|NCT02527174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25249379|NCT02527174|Antiviral Agents|antiviral agents|mesh-ancestor
25249380|NCT02527174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25249381|NCT02527174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25249382|NCT02527174|Immunologic Factors|immunologic factors|mesh-ancestor
25249383|NCT02527174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249384|NCT02527174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25249385|NCT02527174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25249386|NCT02527174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25249387|NCT02527174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25249388|NCT02527109|Nifedipine|nifedipine|mesh-list
25249389|NCT02527109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24599639|NCT04119024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599640|NCT04119024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599641|NCT04119024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24599642|NCT04119024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24853030|NCT02265575|Immunologic Factors|immunologic factors|mesh-ancestor
24853031|NCT02265575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599644|NCT04119024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24599645|NCT04119024|Analgesics|analgesics|mesh-ancestor
24599646|NCT04119024|Sensory System Agents|sensory system agents|mesh-ancestor
24599647|NCT04119024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24599677|NCT04079452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24599678|NCT04079452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24599679|NCT04079452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25249390|NCT02527109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25249391|NCT02527109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249392|NCT02527109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25249393|NCT02527109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249394|NCT02527109|Vasodilator Agents|vasodilator agents|mesh-ancestor
25249396|NCT02527109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25249397|NCT02527096|Lamivudine|lamivudine|mesh-list
25249398|NCT02527096|Dolutegravir|dolutegravir|mesh-list
25249399|NCT02527096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24972520|NCT03717038|Antiviral Agents|antiviral agents|mesh-ancestor
25249400|NCT02527096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25249401|NCT02527096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25249402|NCT02527096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249403|NCT02527096|Antiviral Agents|antiviral agents|mesh-ancestor
25249404|NCT02527096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25249405|NCT02527096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25249406|NCT02527096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25249407|NCT02527096|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25249408|NCT02527096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25249409|NCT02527083|Ketamine|ketamine|mesh-list
25249410|NCT02527083|Remifentanil|remifentanil|mesh-list
25249411|NCT02527083|Propofol|propofol|mesh-list
25249412|NCT02527083|Sevoflurane|sevoflurane|mesh-list
25249413|NCT02527083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25249414|NCT02527083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25249415|NCT02527083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249416|NCT02527083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25686857|NCT01925612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25686858|NCT01925612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716512|NCT01542138|Niacin|niacin|mesh-list
25249417|NCT02527083|Anesthetics, General|anesthetics, general|mesh-ancestor
25249418|NCT02527083|Anesthetics|anesthetics|mesh-ancestor
25249419|NCT02527083|Analgesics|analgesics|mesh-ancestor
25249420|NCT02527083|Sensory System Agents|sensory system agents|mesh-ancestor
25249421|NCT02527083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25249422|NCT02527083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25249423|NCT02527083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25249424|NCT02527083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25249425|NCT02527083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25249426|NCT02527083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599685|NCT04009824|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24599686|NCT04009824|Immunologic Factors|immunologic factors|mesh-ancestor
24599687|NCT04009824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599688|NCT04009824|Antacids|antacids|mesh-ancestor
24599689|NCT04009824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599690|NCT04009824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24599697|NCT03973177|Phenol|phenol|mesh-list
24599698|NCT03973177|Methylprednisolone|methylprednisolone|mesh-list
24599699|NCT03973177|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24505014|NCT00539071|Risperidone|risperidone|mesh-list
24599713|NCT03973177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24599714|NCT03973177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24599715|NCT03973177|Protective Agents|protective agents|mesh-ancestor
24599716|NCT03973177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24599717|NCT03973177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599718|NCT03973177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24599719|NCT03973177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24599720|NCT03973177|Disinfectants|disinfectants|mesh-ancestor
24599721|NCT03973177|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
24599722|NCT03973177|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24599723|NCT03951493|Zoledronic Acid|zoledronic acid|mesh-list
24853033|NCT02265575|Protective Agents|protective agents|mesh-ancestor
24853034|NCT02265718|Methylphenidate|methylphenidate|mesh-list
24853035|NCT02265718|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25249427|NCT02527083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25249428|NCT02527083|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25249429|NCT02527083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25249430|NCT02527083|Narcotics|narcotics|mesh-ancestor
25249431|NCT02526888|Diltiazem|diltiazem|mesh-list
25249432|NCT02526888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25249433|NCT02526888|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25249434|NCT02526888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25249435|NCT02526888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249436|NCT02526888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25249437|NCT02526888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249438|NCT02526888|Vasodilator Agents|vasodilator agents|mesh-ancestor
25249439|NCT02526914|Vasopressins|vasopressins|mesh-list
25249440|NCT02526914|Arginine Vasopressin|arginine vasopressin|mesh-list
25249441|NCT02526914|Oxytocin|oxytocin|mesh-list
25249442|NCT02526914|Oxytocics|oxytocics|mesh-ancestor
25249443|NCT02526914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25249444|NCT02526914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249445|NCT02526914|Hemostatics|hemostatics|mesh-ancestor
25249446|NCT02526914|Coagulants|coagulants|mesh-ancestor
25249447|NCT02526914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25249448|NCT02526914|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25249449|NCT02526914|Natriuretic Agents|natriuretic agents|mesh-ancestor
25249450|NCT02527005|Azithromycin|azithromycin|mesh-list
25249451|NCT02527005|Pyrimethamine|pyrimethamine|mesh-list
25249452|NCT02527005|Sulfadoxine|sulfadoxine|mesh-list
25249453|NCT02527005|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25249454|NCT02527005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25249455|NCT02527005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25249456|NCT02527005|Antimalarials|antimalarials|mesh-ancestor
25249457|NCT02527005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25249458|NCT02527005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25249459|NCT02527005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25249460|NCT02527005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25249461|NCT02527005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249462|NCT02527005|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25249463|NCT02527005|Renal Agents|renal agents|mesh-ancestor
25249464|NCT02526953|Paclitaxel|paclitaxel|mesh-list
25249465|NCT02526953|Capecitabine|capecitabine|mesh-list
25249466|NCT02526953|Mitomycins|mitomycins|mesh-list
25249467|NCT02526953|Mitomycin|mitomycin|mesh-list
25249468|NCT02526953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24812647|NCT02053922|Abortifacient Agents|abortifacient agents|mesh-ancestor
24716604|NCT01542697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24716606|NCT01542710|Bimatoprost|bimatoprost|mesh-list
24716607|NCT01542710|Travoprost|travoprost|mesh-list
24716608|NCT01542710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24716609|NCT01542710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24716610|NCT01542710|Adrenergic Agents|adrenergic agents|mesh-ancestor
25249469|NCT02526953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25249470|NCT02526953|Tubulin Modulators|tubulin modulators|mesh-ancestor
25249471|NCT02526953|Antimitotic Agents|antimitotic agents|mesh-ancestor
25249472|NCT02526953|Mitosis Modulators|mitosis modulators|mesh-ancestor
24599753|NCT03913559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24599754|NCT03913559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24599755|NCT03913559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24599756|NCT03913559|Immunologic Factors|immunologic factors|mesh-ancestor
24599757|NCT03913559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24599758|NCT03913559|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24599760|NCT03913559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24599761|NCT03913559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24599762|NCT03913559|Analgesics|analgesics|mesh-ancestor
24599763|NCT03913559|Sensory System Agents|sensory system agents|mesh-ancestor
24599764|NCT03913559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24599765|NCT03913559|Antipyretics|antipyretics|mesh-ancestor
24599766|NCT03913559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24599767|NCT03913559|Antiemetics|antiemetics|mesh-ancestor
24599772|NCT03913559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24599773|NCT03913559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24599774|NCT03913559|Protective Agents|protective agents|mesh-ancestor
24599775|NCT03913559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24599776|NCT03913559|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24599777|NCT03913559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24599778|NCT03913559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24599779|NCT03913559|Anesthetics, Local|anesthetics, local|mesh-ancestor
24599780|NCT03913559|Anesthetics|anesthetics|mesh-ancestor
24599862|NCT03449758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24599864|NCT03449758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599865|NCT03449758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599866|NCT03449758|Dermatologic Agents|dermatologic agents|mesh-ancestor
24599867|NCT03449758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24599868|NCT03449758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24599869|NCT03449758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24599870|NCT03449758|Immunologic Factors|immunologic factors|mesh-ancestor
24599871|NCT03449758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24599872|NCT03449758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24599873|NCT03449758|Antimalarials|antimalarials|mesh-ancestor
24599874|NCT03449758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24599875|NCT03449758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25249473|NCT02526953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249474|NCT02526953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25249475|NCT02526953|Antimetabolites|antimetabolites|mesh-ancestor
25249476|NCT02526953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25249477|NCT02526953|Alkylating Agents|alkylating agents|mesh-ancestor
25249478|NCT02526953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25249479|NCT02526953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25249481|NCT02526979|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25249482|NCT02526979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25249483|NCT02526979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25249484|NCT02526979|Adrenergic Agents|adrenergic agents|mesh-ancestor
25249485|NCT02526979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25249486|NCT02526979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249487|NCT02526979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249488|NCT02526979|Urological Agents|urological agents|mesh-ancestor
25249489|NCT02526875|Amlodipine|amlodipine|mesh-list
25249490|NCT02526875|Telmisartan|telmisartan|mesh-list
25249491|NCT02526875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25249492|NCT02526875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25686859|NCT01925612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25686860|NCT01925612|Glucocorticoids|glucocorticoids|mesh-ancestor
25686861|NCT01925612|Hormones|hormones|mesh-ancestor
25686862|NCT01925612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25686863|NCT01925612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25686864|NCT01925612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25686865|NCT01925612|Tubulin Modulators|tubulin modulators|mesh-ancestor
25249493|NCT02526875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24972674|NCT03715777|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25249494|NCT02526875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249495|NCT02526875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25249496|NCT02526875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249497|NCT02526875|Vasodilator Agents|vasodilator agents|mesh-ancestor
25249498|NCT02526875|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25249499|NCT02526875|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25249500|NCT02526810|Insulin|insulin|mesh-list
25249501|NCT02526810|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25249502|NCT02526810|Insulin Glargine|insulin glargine|mesh-list
25249503|NCT02526810|Insulin Lispro|insulin lispro|mesh-list
25249504|NCT02526810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25249505|NCT02526810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249506|NCT02526758|Budesonide|budesonide|mesh-list
25249507|NCT02526758|Beclomethasone|beclomethasone|mesh-list
25249508|NCT02526758|Formoterol Fumarate|formoterol fumarate|mesh-list
25249509|NCT02526758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24599877|NCT03449758|Amebicides|amebicides|mesh-ancestor
24599878|NCT03449758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24599879|NCT03449758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24599880|NCT03449758|Analgesics|analgesics|mesh-ancestor
24599881|NCT03449758|Sensory System Agents|sensory system agents|mesh-ancestor
24599882|NCT03449758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24599883|NCT03449758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24599884|NCT03449758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24599886|NCT03387761|Ipilimumab|ipilimumab|mesh-list
24599887|NCT03387761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24963422|NCT03791125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24599888|NCT03387761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599889|NCT03387761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24599890|NCT03387761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599895|NCT03282799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24599896|NCT03282799|Contraceptive Agents|contraceptive agents|mesh-ancestor
24599897|NCT03282799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24599898|NCT03282799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599899|NCT03282799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24599900|NCT03280030|Midostaurin|midostaurin|mesh-list
24599901|NCT03280030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599902|NCT03280030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24599903|NCT03280030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24599904|NCT03280030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599905|NCT03187262|Daratumumab|daratumumab|mesh-list
24599906|NCT03187262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24853048|NCT02265731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853049|NCT02265731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24599937|NCT03032328|Vitamins|vitamins|mesh-ancestor
24599938|NCT03032328|Micronutrients|micronutrients|mesh-ancestor
24599939|NCT03032328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599940|NCT03032328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24599941|NCT03024684|Atorvastatin|atorvastatin|mesh-list
24599942|NCT03024684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25249510|NCT02526758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25249511|NCT02526758|Autonomic Agents|autonomic agents|mesh-ancestor
25249512|NCT02526758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25249513|NCT02526758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249514|NCT02526758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25249515|NCT02526758|Respiratory System Agents|respiratory system agents|mesh-ancestor
25249516|NCT02526758|Glucocorticoids|glucocorticoids|mesh-ancestor
25249517|NCT02526758|Hormones|hormones|mesh-ancestor
25249518|NCT02526758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25249519|NCT02526758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25249520|NCT02526758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25249521|NCT02526758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25249522|NCT02526758|Adrenergic Agents|adrenergic agents|mesh-ancestor
25249523|NCT02526758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25249524|NCT02526758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249526|NCT02526615|Rosiglitazone|rosiglitazone|mesh-list
25249527|NCT02526615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25249528|NCT02526615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249529|NCT02526745|Vaccines|vaccines|mesh-list
25249530|NCT02526745|Immunologic Factors|immunologic factors|mesh-ancestor
25249531|NCT02526745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249532|NCT02526316|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25249533|NCT02526316|Freund's Adjuvant|freund's adjuvant|mesh-list
25249534|NCT02526316|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25249535|NCT02526316|Immunologic Factors|immunologic factors|mesh-ancestor
25249536|NCT02526316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249538|NCT02526303|Warfarin|warfarin|mesh-list
25249539|NCT02526303|Calcium|calcium|mesh-list
25249540|NCT02526303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25249541|NCT02526303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249542|NCT02526303|Anticoagulants|anticoagulants|mesh-ancestor
25249543|NCT02526303|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25249544|NCT02526303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25249545|NCT02526303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249546|NCT02526394|Vaccines|vaccines|mesh-list
25249547|NCT02526394|Immunologic Factors|immunologic factors|mesh-ancestor
24853065|NCT02265770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24853066|NCT02265770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24599984|NCT02923739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599985|NCT02923739|Tubulin Modulators|tubulin modulators|mesh-ancestor
24599986|NCT02923739|Antimitotic Agents|antimitotic agents|mesh-ancestor
24599987|NCT02923739|Mitosis Modulators|mitosis modulators|mesh-ancestor
24599988|NCT02923739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599989|NCT02923739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24599990|NCT02923739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24599991|NCT02923739|Growth Substances|growth substances|mesh-ancestor
24599992|NCT02923739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600033|NCT02826486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600034|NCT02826486|Vitamin B Complex|vitamin b complex|mesh-ancestor
24600035|NCT02826486|Vitamins|vitamins|mesh-ancestor
24600036|NCT02826486|Micronutrients|micronutrients|mesh-ancestor
24600037|NCT02815592|Carboplatin|carboplatin|mesh-list
24600040|NCT02815592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24600041|NCT02815592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24600042|NCT02815592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24600043|NCT02815592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600044|NCT02815592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600046|NCT02748707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24600047|NCT02748707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600048|NCT02748707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24600049|NCT02748707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600050|NCT02748707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600051|NCT02748707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25115454|NCT03116087|Testosterone|testosterone|mesh-list
24600052|NCT02748707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24600053|NCT02748707|Analgesics|analgesics|mesh-ancestor
24600054|NCT02748707|Sensory System Agents|sensory system agents|mesh-ancestor
24600055|NCT02748707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24600056|NCT02748707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600057|NCT02748707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24580077|NCT00859911|Trace Elements|trace elements|mesh-list
25249548|NCT02526394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249562|NCT02526199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25249563|NCT02526199|Antiemetics|antiemetics|mesh-ancestor
25249564|NCT02526199|Autonomic Agents|autonomic agents|mesh-ancestor
25249565|NCT02526199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25249566|NCT02526199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249567|NCT02526199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25249568|NCT02526199|Glucocorticoids|glucocorticoids|mesh-ancestor
25249569|NCT02526199|Hormones|hormones|mesh-ancestor
25249570|NCT02526199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25249571|NCT02526199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25249572|NCT02526199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25249573|NCT02526199|Anesthetics, Local|anesthetics, local|mesh-ancestor
25249574|NCT02526199|Anesthetics|anesthetics|mesh-ancestor
25249575|NCT02526199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25249576|NCT02526199|Sensory System Agents|sensory system agents|mesh-ancestor
25249577|NCT02526199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25249578|NCT02526199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25249579|NCT02526199|Adrenergic Agents|adrenergic agents|mesh-ancestor
25249580|NCT02526199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25249581|NCT02526199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249582|NCT02526199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25249583|NCT02526199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25249584|NCT02526199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25249585|NCT02526199|Respiratory System Agents|respiratory system agents|mesh-ancestor
24600062|NCT02711137|Paclitaxel|paclitaxel|mesh-list
24600063|NCT02711137|Azacitidine|azacitidine|mesh-list
24600064|NCT02711137|Rucaparib|rucaparib|mesh-list
24600065|NCT02711137|INCB057643|incb057643|mesh-list
24600066|NCT02711137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24600067|NCT02711137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600068|NCT02711137|Tubulin Modulators|tubulin modulators|mesh-ancestor
24600069|NCT02711137|Antimitotic Agents|antimitotic agents|mesh-ancestor
24600070|NCT02711137|Mitosis Modulators|mitosis modulators|mesh-ancestor
24600071|NCT02711137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600072|NCT02711137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24600083|NCT02703584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853081|NCT02265770|Mitosis Modulators|mitosis modulators|mesh-ancestor
24600103|NCT02573324|Temozolomide|temozolomide|mesh-list
24600104|NCT02573324|Immunoconjugates|immunoconjugates|mesh-list
25249586|NCT02526199|Mydriatics|mydriatics|mesh-ancestor
25249587|NCT02526199|Sympathomimetics|sympathomimetics|mesh-ancestor
25249588|NCT02526199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25249589|NCT02526030|Aripiprazole|aripiprazole|mesh-list
25249590|NCT02526030|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25249591|NCT02526030|Ziprasidone|ziprasidone|mesh-list
25249592|NCT02526030|Antidepressive Agents|antidepressive agents|mesh-ancestor
25249593|NCT02526030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25249594|NCT02526030|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25249595|NCT02526030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25249608|NCT02526030|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25249615|NCT02525848|Dexamethasone|dexamethasone|mesh-list
25249616|NCT02525848|Gabapentin|gabapentin|mesh-list
25249617|NCT02525848|Aprepitant|aprepitant|mesh-list
25249618|NCT02525848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25249619|NCT02525848|Antiemetics|antiemetics|mesh-ancestor
25249620|NCT02525848|Autonomic Agents|autonomic agents|mesh-ancestor
25249621|NCT02525848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25249622|NCT02525848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249623|NCT02525848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25249624|NCT02525848|Glucocorticoids|glucocorticoids|mesh-ancestor
25249625|NCT02525848|Hormones|hormones|mesh-ancestor
25249626|NCT02525848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25249627|NCT02525848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25249628|NCT02525848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25249629|NCT02525848|Analgesics|analgesics|mesh-ancestor
24600131|NCT02470091|Denosumab|denosumab|mesh-list
24600132|NCT02470091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24600133|NCT02470091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600134|NCT02465138|Ketorolac|ketorolac|mesh-list
24600135|NCT02465138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24600147|NCT02440425|Pembrolizumab|pembrolizumab|mesh-list
24600148|NCT02440425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24600149|NCT02440425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600150|NCT02440425|Tubulin Modulators|tubulin modulators|mesh-ancestor
24600151|NCT02440425|Antimitotic Agents|antimitotic agents|mesh-ancestor
24600152|NCT02440425|Mitosis Modulators|mitosis modulators|mesh-ancestor
24600153|NCT02440425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600154|NCT02440425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24600162|NCT02296684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600163|NCT02296684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24600164|NCT02286830|Zoledronic Acid|zoledronic acid|mesh-list
24600165|NCT02286830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24600166|NCT02286830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249630|NCT02525848|Sensory System Agents|sensory system agents|mesh-ancestor
25249631|NCT02525848|Anticonvulsants|anticonvulsants|mesh-ancestor
25249632|NCT02525848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25249633|NCT02525848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25249634|NCT02525848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25249635|NCT02525848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25249672|NCT02525172|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25275664|NCT02370550|Dermatologic Agents|dermatologic agents|mesh-ancestor
25275665|NCT02370550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25275666|NCT02370550|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25275667|NCT02370550|Antacids|antacids|mesh-ancestor
25275668|NCT02370550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25275669|NCT02370433|Glycopyrrolate|glycopyrrolate|mesh-list
25275670|NCT02370433|Neostigmine|neostigmine|mesh-list
25275671|NCT02370433|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25275672|NCT02370433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25405944|NCT03586999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24557471|NCT00752635|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24455089|NCT02876107|Antibodies|antibodies|mesh-list
24717142|NCT01545856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24717143|NCT01545856|Dopamine Agents|dopamine agents|mesh-ancestor
24717151|NCT01545947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717152|NCT01545947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717153|NCT01545947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24717154|NCT01545947|Antimetabolites|antimetabolites|mesh-ancestor
24717155|NCT01546051|BCI-838|bci-838|mesh-list
24717161|NCT01546090|Alprazolam|alprazolam|mesh-list
24717180|NCT01546116|Lamivudine|lamivudine|mesh-list
24717181|NCT01546116|Adefovir|adefovir|mesh-list
24717212|NCT01546701|Morphine|morphine|mesh-list
25275673|NCT02370433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275674|NCT02370433|Cholinergic Agents|cholinergic agents|mesh-ancestor
25275675|NCT02370433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25275676|NCT02370433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600331|NCT01026220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25249642|NCT02525822|Tazarotene|tazarotene|mesh-list
25249643|NCT02525822|Dermatologic Agents|dermatologic agents|mesh-ancestor
25249644|NCT02525822|Keratolytic Agents|keratolytic agents|mesh-ancestor
25249645|NCT02525484|Pirfenidone|pirfenidone|mesh-list
25249646|NCT02525484|Analgesics|analgesics|mesh-ancestor
25249647|NCT02525484|Sensory System Agents|sensory system agents|mesh-ancestor
25249648|NCT02525484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25249649|NCT02525484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794551|NCT05005455|Growth Inhibitors|growth inhibitors|mesh-ancestor
25249650|NCT02525484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25249651|NCT02525484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25249652|NCT02525484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25249653|NCT02525484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25249654|NCT02525484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25249655|NCT02525146|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25249656|NCT02525146|Antiviral Agents|antiviral agents|mesh-ancestor
25249657|NCT02525146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25249658|NCT02525211|Ropivacaine|ropivacaine|mesh-list
25249660|NCT02525211|Anesthetics|anesthetics|mesh-ancestor
25249661|NCT02525211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25249662|NCT02525211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249663|NCT02525211|Sensory System Agents|sensory system agents|mesh-ancestor
25249664|NCT02525211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25249665|NCT02525172|Rituximab|rituximab|mesh-list
25249666|NCT02525172|Methotrexate|methotrexate|mesh-list
25249667|NCT02525172|Bortezomib|bortezomib|mesh-list
25249668|NCT02525172|Immunoglobulins|immunoglobulins|mesh-list
25249669|NCT02525172|Antibodies|antibodies|mesh-list
25249670|NCT02525172|gamma-Globulins|gamma-globulins|mesh-list
25249671|NCT02525172|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25249673|NCT02525172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25249674|NCT02525172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25249675|NCT02525172|Immunologic Factors|immunologic factors|mesh-ancestor
25249676|NCT02525172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249677|NCT02525172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25249678|NCT02525172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25249679|NCT02525172|Abortifacient Agents|abortifacient agents|mesh-ancestor
25249680|NCT02525172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25249681|NCT02525172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25249682|NCT02525172|Antimetabolites|antimetabolites|mesh-ancestor
25249683|NCT02525172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249684|NCT02525172|Dermatologic Agents|dermatologic agents|mesh-ancestor
25249685|NCT02525172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25249686|NCT02525172|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25249687|NCT02525172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25686866|NCT01925612|Antimitotic Agents|antimitotic agents|mesh-ancestor
25686867|NCT01925612|Mitosis Modulators|mitosis modulators|mesh-ancestor
25686868|NCT01925703|Ferric gluconate|ferric gluconate|mesh-list
25686869|NCT01925703|Hematinics|hematinics|mesh-ancestor
25686870|NCT01925768|Apremilast|apremilast|mesh-list
25686871|NCT01925768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25686872|NCT01925768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25686873|NCT01925768|Analgesics|analgesics|mesh-ancestor
25686874|NCT01925768|Sensory System Agents|sensory system agents|mesh-ancestor
25686875|NCT01925768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686876|NCT01925768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686877|NCT01925768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25249688|NCT02525172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24717276|NCT01547104|Hormones|hormones|mesh-ancestor
25249689|NCT02525250|Lenalidomide|lenalidomide|mesh-list
24600374|NCT00567567|Tretinoin|tretinoin|mesh-list
24600375|NCT00567567|Podophyllotoxin|podophyllotoxin|mesh-list
24600376|NCT00567567|Isotretinoin|isotretinoin|mesh-list
24600377|NCT00567567|Lenograstim|lenograstim|mesh-list
24600378|NCT00567567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24600379|NCT00567567|Immunologic Factors|immunologic factors|mesh-ancestor
24600380|NCT00567567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600381|NCT00567567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24600382|NCT00567567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24600383|NCT00567567|Alkylating Agents|alkylating agents|mesh-ancestor
24600384|NCT00567567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600385|NCT00567567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600386|NCT00567567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24600388|NCT00567567|Micronutrients|micronutrients|mesh-ancestor
24600389|NCT00567567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24600390|NCT00567567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24600391|NCT00567567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24600392|NCT00567567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24853107|NCT02265822|GABA Modulators|gaba modulators|mesh-ancestor
24853108|NCT02265822|GABA Agents|gaba agents|mesh-ancestor
24853109|NCT02265822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24853110|NCT02265822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853111|NCT02265822|Antioxidants|antioxidants|mesh-ancestor
24853112|NCT02265822|Protective Agents|protective agents|mesh-ancestor
24853114|NCT02265874|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24853115|NCT02265874|Autonomic Agents|autonomic agents|mesh-ancestor
24853116|NCT02265874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24853117|NCT02265874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853118|NCT02265874|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24853119|NCT02265874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24853120|NCT02265874|Cholinergic Agents|cholinergic agents|mesh-ancestor
24600393|NCT00567567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24600394|NCT00567567|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24600395|NCT00567567|Tubulin Modulators|tubulin modulators|mesh-ancestor
24600396|NCT00567567|Antimitotic Agents|antimitotic agents|mesh-ancestor
24580078|NCT00859911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580079|NCT00860119|Alprazolam|alprazolam|mesh-list
24580080|NCT00860119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24580081|NCT00860119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24580082|NCT00860119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249690|NCT02525250|Immunologic Factors|immunologic factors|mesh-ancestor
25249691|NCT02525250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249692|NCT02525250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25249693|NCT02525250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25249694|NCT02525250|Growth Substances|growth substances|mesh-ancestor
25249695|NCT02525250|Growth Inhibitors|growth inhibitors|mesh-ancestor
25249696|NCT02525250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25249697|NCT02525237|Apatinib|apatinib|mesh-list
25249698|NCT02525237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25249699|NCT02525237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25249700|NCT02525237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102660|NCT03167164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25249701|NCT02525237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249702|NCT02525276|Hormones|hormones|mesh-list
25249703|NCT02525276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25249704|NCT02525276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249705|NCT02525302|Halofuginone|halofuginone|mesh-list
25249706|NCT02525302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25249708|NCT02525302|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25249709|NCT02525302|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25249710|NCT02525302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25249711|NCT02525302|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25249712|NCT02525302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25249713|NCT02525302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249714|NCT02525302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25249715|NCT02525302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25249716|NCT02525302|Growth Substances|growth substances|mesh-ancestor
25249717|NCT02525302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249718|NCT02525302|Growth Inhibitors|growth inhibitors|mesh-ancestor
25249719|NCT02525081|Ramipril|ramipril|mesh-list
25249720|NCT02525081|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25249721|NCT02525081|Protease Inhibitors|protease inhibitors|mesh-ancestor
25686878|NCT01925768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25249722|NCT02525081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274495|NCT02377661|Amlodipine|amlodipine|mesh-list
24600397|NCT00567567|Mitosis Modulators|mitosis modulators|mesh-ancestor
24600398|NCT00567567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24600399|NCT00567567|Keratolytic Agents|keratolytic agents|mesh-ancestor
24600400|NCT00567567|Dermatologic Agents|dermatologic agents|mesh-ancestor
24600401|NCT00450450|Lenograstim|lenograstim|mesh-list
24600402|NCT00450450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24600403|NCT00450450|Immunologic Factors|immunologic factors|mesh-ancestor
24600404|NCT00450450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600405|NCT00346164|Doxorubicin|doxorubicin|mesh-list
24600406|NCT00346164|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24600408|NCT00346164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24600409|NCT00346164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600410|NCT00346164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24636359|NCT01144923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24636360|NCT01144923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24636361|NCT01144923|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24636362|NCT01144923|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24600411|NCT00346164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24600429|NCT00082706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600430|NCT00082706|Antidotes|antidotes|mesh-ancestor
24600431|NCT00082706|Protective Agents|protective agents|mesh-ancestor
24600432|NCT00082706|Vitamin B Complex|vitamin b complex|mesh-ancestor
24600434|NCT00082706|Micronutrients|micronutrients|mesh-ancestor
24600435|NCT00958503|Thiamphenicol|thiamphenicol|mesh-list
24600436|NCT00958503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24600437|NCT00958503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24600438|NCT00958633|Citalopram|citalopram|mesh-list
24600439|NCT00958633|Bupropion|bupropion|mesh-list
24600440|NCT00958633|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24600441|NCT00958633|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24600442|NCT00958633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24853121|NCT02265874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24973167|NCT03711474|Antiemetics|antiemetics|mesh-ancestor
24853122|NCT02265874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249723|NCT02525081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249724|NCT02525081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25249725|NCT02525016|Lidocaine|lidocaine|mesh-list
25249726|NCT02525016|Anesthetics, Local|anesthetics, local|mesh-ancestor
25249727|NCT02525016|Anesthetics|anesthetics|mesh-ancestor
25249728|NCT02525016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25249729|NCT02525016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249730|NCT02525016|Sensory System Agents|sensory system agents|mesh-ancestor
25249731|NCT02525016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25249732|NCT02525016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25249733|NCT02525016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25249734|NCT02525016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25249740|NCT02525003|Vitamins|vitamins|mesh-list
25249741|NCT02525003|Micronutrients|micronutrients|mesh-ancestor
25249742|NCT02525003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249743|NCT02525003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25249744|NCT02525003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25249745|NCT02525458|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
25249746|NCT02525458|Vasodilator Agents|vasodilator agents|mesh-ancestor
25249747|NCT02525458|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25249748|NCT02525458|Protective Agents|protective agents|mesh-ancestor
25249749|NCT02525458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249750|NCT02524899|Guanfacine|guanfacine|mesh-list
25249751|NCT02524899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25249752|NCT02524899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25249753|NCT02524899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25249754|NCT02524899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25249755|NCT02524899|Adrenergic Agents|adrenergic agents|mesh-ancestor
25249756|NCT02524899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25249757|NCT02524899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249758|NCT02524899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249760|NCT02524964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25249761|NCT02524964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25249762|NCT02524964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24600449|NCT00958633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24600450|NCT00958633|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24600451|NCT00958633|Dopamine Agents|dopamine agents|mesh-ancestor
24600452|NCT00958633|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25406021|NCT03582033|Hormones|hormones|mesh-ancestor
24600453|NCT00958633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24600454|NCT00958633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600455|NCT00958750|Minoxidil|minoxidil|mesh-list
24600456|NCT00958750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24600457|NCT00958750|Vasodilator Agents|vasodilator agents|mesh-ancestor
24600458|NCT00958854|Thalidomide|thalidomide|mesh-list
24600459|NCT00958854|Cyclophosphamide|cyclophosphamide|mesh-list
24600460|NCT00958854|Fludarabine|fludarabine|mesh-list
24600461|NCT00958854|Fludarabine phosphate|fludarabine phosphate|mesh-list
24600462|NCT00958854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24600463|NCT00958854|Immunologic Factors|immunologic factors|mesh-ancestor
24600464|NCT00958854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600465|NCT00958854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24600488|NCT00959062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600489|NCT00959062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24600490|NCT00959062|Sympatholytics|sympatholytics|mesh-ancestor
24600491|NCT00959062|Autonomic Agents|autonomic agents|mesh-ancestor
24600492|NCT00959062|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24600493|NCT00959062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24600494|NCT00959062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24600495|NCT00959062|Adrenergic Agents|adrenergic agents|mesh-ancestor
24600496|NCT00959062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24600497|NCT00959062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600499|NCT00959075|Vitamins|vitamins|mesh-ancestor
24600532|NCT00959231|Alkylating Agents|alkylating agents|mesh-ancestor
24600533|NCT00959231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600534|NCT00959231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600535|NCT00959231|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25249763|NCT02524964|Analgesics|analgesics|mesh-ancestor
25249764|NCT02524964|Sensory System Agents|sensory system agents|mesh-ancestor
25249765|NCT02524964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25249766|NCT02524964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249767|NCT02524964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25249768|NCT02524964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25249769|NCT02524964|Anticoagulants|anticoagulants|mesh-ancestor
25249770|NCT02524964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25249771|NCT02524964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25249772|NCT02524964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25249773|NCT02524964|Immunologic Factors|immunologic factors|mesh-ancestor
25249775|NCT02524821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25249776|NCT02524821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249777|NCT02524743|Acetaminophen|acetaminophen|mesh-list
25249778|NCT02524743|Lidocaine|lidocaine|mesh-list
25249779|NCT02524743|Anesthetics, Local|anesthetics, local|mesh-ancestor
25249780|NCT02524743|Anesthetics|anesthetics|mesh-ancestor
25249781|NCT02524743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25249782|NCT02524743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249783|NCT02524743|Sensory System Agents|sensory system agents|mesh-ancestor
25249784|NCT02524743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25249785|NCT02524743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25249786|NCT02524743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25249787|NCT02524743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25249788|NCT02524743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25249789|NCT02524743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249790|NCT02524743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25249791|NCT02524743|Analgesics|analgesics|mesh-ancestor
25249792|NCT02524743|Antipyretics|antipyretics|mesh-ancestor
25249793|NCT02524652|Ropivacaine|ropivacaine|mesh-list
25249794|NCT02524652|Anesthetics, Local|anesthetics, local|mesh-ancestor
25249795|NCT02524652|Anesthetics|anesthetics|mesh-ancestor
25249796|NCT02524652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25249797|NCT02524652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249798|NCT02524652|Sensory System Agents|sensory system agents|mesh-ancestor
25249799|NCT02524652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25249800|NCT02524639|Sirolimus|sirolimus|mesh-list
25249801|NCT02524639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25249802|NCT02524639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25249803|NCT02524639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24600543|NCT00959231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24853125|NCT02266030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24853126|NCT02266030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24853127|NCT02266030|Analgesics|analgesics|mesh-ancestor
24853128|NCT02266030|Sensory System Agents|sensory system agents|mesh-ancestor
24717692|NCT01549431|Autonomic Agents|autonomic agents|mesh-ancestor
24853129|NCT02266030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24853130|NCT02266030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853131|NCT02266030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24853132|NCT02266030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24600544|NCT00959231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24600545|NCT00959231|Antitubercular Agents|antitubercular agents|mesh-ancestor
24600546|NCT00959231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24600547|NCT00959335|Bicalutamide|bicalutamide|mesh-list
24600548|NCT00959335|Androgen Antagonists|androgen antagonists|mesh-ancestor
24600549|NCT00959335|Hormone Antagonists|hormone antagonists|mesh-ancestor
24600550|NCT00959335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24600551|NCT00959335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600552|NCT00959335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600554|NCT00959387|Cisplatin|cisplatin|mesh-list
24600555|NCT00959387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24600563|NCT00959400|Narcotics|narcotics|mesh-ancestor
24600564|NCT00959400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24600565|NCT00959400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600574|NCT00959439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24600576|NCT00959439|Analgesics|analgesics|mesh-ancestor
24600577|NCT00959439|Sensory System Agents|sensory system agents|mesh-ancestor
24600578|NCT00959439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24600579|NCT00959439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600580|NCT00959439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24600581|NCT00959439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24600582|NCT00959439|Gout Suppressants|gout suppressants|mesh-ancestor
24600583|NCT00959439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24998776|NCT00759655|Factor VIII|factor viii|mesh-list
24580083|NCT00860119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24580084|NCT00860119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24580085|NCT00860119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24580086|NCT00860119|GABA Modulators|gaba modulators|mesh-ancestor
24580087|NCT00860119|GABA Agents|gaba agents|mesh-ancestor
24580088|NCT00860119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25249804|NCT02524639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25249805|NCT02524639|Antifungal Agents|antifungal agents|mesh-ancestor
25249806|NCT02524639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25249807|NCT02524639|Immunologic Factors|immunologic factors|mesh-ancestor
25249808|NCT02524639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249809|NCT02524444|Pyrimethamine|pyrimethamine|mesh-list
25249810|NCT02524444|Sulfadoxine|sulfadoxine|mesh-list
25249811|NCT02524444|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25249812|NCT02524444|Mefloquine|mefloquine|mesh-list
25249813|NCT02524444|Antimalarials|antimalarials|mesh-ancestor
25249814|NCT02524444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25249815|NCT02524444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25249816|NCT02524444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25249817|NCT02524444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25249818|NCT02524444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25249819|NCT02524444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249820|NCT02524444|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25249821|NCT02524444|Renal Agents|renal agents|mesh-ancestor
25249822|NCT02524405|Corticosterone|corticosterone|mesh-list
25249823|NCT02524405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25249824|NCT02524301|Diprenorphine|diprenorphine|mesh-list
25249825|NCT02524301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25249826|NCT02524301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249827|NCT02524301|Sensory System Agents|sensory system agents|mesh-ancestor
25249828|NCT02524301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25249829|NCT02524210|Omeprazole|omeprazole|mesh-list
24973331|NCT03710252|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24973332|NCT03710252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24973334|NCT03710174|Salicylic Acid|salicylic acid|mesh-list
25249830|NCT02524210|Rabeprazole|rabeprazole|mesh-list
25249831|NCT02524210|Dabigatran|dabigatran|mesh-list
25249832|NCT02524210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25249833|NCT02524210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25249834|NCT02524210|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25249835|NCT02524210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25249836|NCT02524210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249837|NCT02524210|Antithrombins|antithrombins|mesh-ancestor
25249838|NCT02524210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25686879|NCT01925768|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25249839|NCT02524210|Protease Inhibitors|protease inhibitors|mesh-ancestor
24600584|NCT00959439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600585|NCT00959439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600586|NCT00959478|Carbon Monoxide|carbon monoxide|mesh-list
24600587|NCT00959478|Antimetabolites|antimetabolites|mesh-ancestor
24600588|NCT00959478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600589|NCT00959478|Gasotransmitters|gasotransmitters|mesh-ancestor
24600590|NCT00959478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24600591|NCT00959478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600592|NCT00959517|Artesunate|artesunate|mesh-list
24600593|NCT00959517|Chloroquine|chloroquine|mesh-list
24600594|NCT00959517|Pyrimethamine|pyrimethamine|mesh-list
24600595|NCT00959517|Primaquine|primaquine|mesh-list
24600596|NCT00959517|Sulfadoxine|sulfadoxine|mesh-list
24600597|NCT00959517|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24600598|NCT00959517|Antimalarials|antimalarials|mesh-ancestor
24600599|NCT00959517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24600600|NCT00959517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24600601|NCT00959517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24600602|NCT00959517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600603|NCT00959517|Antiviral Agents|antiviral agents|mesh-ancestor
24600604|NCT00959517|Schistosomicides|schistosomicides|mesh-ancestor
24600605|NCT00959517|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24600606|NCT00959517|Anthelmintics|anthelmintics|mesh-ancestor
24600607|NCT00959517|Amebicides|amebicides|mesh-ancestor
24600608|NCT00959517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24600609|NCT00959517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24853133|NCT02266030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24853134|NCT02266030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24664532|NCT01307488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24600610|NCT00959517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600611|NCT00959517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600612|NCT00959517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24600613|NCT00959517|Renal Agents|renal agents|mesh-ancestor
24600614|NCT00959569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24600615|NCT00959569|Esmolol|esmolol|mesh-list
24600616|NCT00959569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24600617|NCT00959569|Adrenergic Agents|adrenergic agents|mesh-ancestor
24580089|NCT00860119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580090|NCT00860223|Digoxin|digoxin|mesh-list
25249840|NCT02524210|Anticoagulants|anticoagulants|mesh-ancestor
25249841|NCT02523820|Fluticasone|fluticasone|mesh-list
25249843|NCT02523820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25249844|NCT02523820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25249845|NCT02523820|Autonomic Agents|autonomic agents|mesh-ancestor
25249846|NCT02523820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25249847|NCT02523820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249848|NCT02523820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25249849|NCT02523820|Respiratory System Agents|respiratory system agents|mesh-ancestor
25249850|NCT02523820|Dermatologic Agents|dermatologic agents|mesh-ancestor
25249851|NCT02523820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25274496|NCT02377661|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25274497|NCT02377661|Olmesartan|olmesartan|mesh-list
25274498|NCT02377661|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25274499|NCT02377661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25274500|NCT02377661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25274501|NCT02377661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25274502|NCT02377661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274503|NCT02377661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25274504|NCT02377661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274505|NCT02377661|Vasodilator Agents|vasodilator agents|mesh-ancestor
25274506|NCT02377661|Diuretics|diuretics|mesh-ancestor
25274507|NCT02377661|Natriuretic Agents|natriuretic agents|mesh-ancestor
25274508|NCT02377661|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25274509|NCT02377661|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25274510|NCT02377661|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25274511|NCT02377401|Zanamivir|zanamivir|mesh-list
25274512|NCT02377401|Antiviral Agents|antiviral agents|mesh-ancestor
25274513|NCT02377401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25274514|NCT02377401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274515|NCT02377401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274516|NCT02377388|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25274517|NCT02377388|Saxagliptin|saxagliptin|mesh-list
25274518|NCT02377388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25274519|NCT02377388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600618|NCT00959569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24600619|NCT00959569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600620|NCT00959569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600621|NCT00959569|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24600652|NCT00959686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600687|NCT00959972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24600688|NCT00959972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600689|NCT00960037|Vitamin D|vitamin d|mesh-list
24504801|NCT00538187|Bortezomib|bortezomib|mesh-list
24600690|NCT00960037|Cholecalciferol|cholecalciferol|mesh-list
24600691|NCT00960037|Vitamins|vitamins|mesh-ancestor
24600692|NCT00960037|Micronutrients|micronutrients|mesh-ancestor
24600716|NCT00960284|Fluorouracil|fluorouracil|mesh-list
24600743|NCT00960336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24600744|NCT00960336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600745|NCT00960336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600748|NCT00960349|Cediranib|cediranib|mesh-list
24600749|NCT00960349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600750|NCT00960349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24600751|NCT00960349|Antimetabolites|antimetabolites|mesh-ancestor
24600752|NCT00960349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600753|NCT00960349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24600754|NCT00960349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600755|NCT00960453|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24600756|NCT00960453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24600757|NCT00960453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600758|NCT00960453|Incretins|incretins|mesh-ancestor
24600759|NCT00960453|Hormones|hormones|mesh-ancestor
24600760|NCT00960453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24600761|NCT00960453|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24600762|NCT00960453|Protease Inhibitors|protease inhibitors|mesh-ancestor
24600763|NCT00960453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600764|NCT00960453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580151|NCT00860899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24580152|NCT00860899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580153|NCT00860899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24580154|NCT00860899|Sympatholytics|sympatholytics|mesh-ancestor
25249852|NCT02523911|Magnesium Sulfate|magnesium sulfate|mesh-list
25249853|NCT02523911|Simethicone|simethicone|mesh-list
25249854|NCT02523911|Sodium sulfate|sodium sulfate|mesh-list
25249855|NCT02523911|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25249856|NCT02523911|Analgesics|analgesics|mesh-ancestor
25249857|NCT02523911|Sensory System Agents|sensory system agents|mesh-ancestor
25249858|NCT02523911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25249859|NCT02523911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249860|NCT02523911|Anesthetics|anesthetics|mesh-ancestor
25249861|NCT02523911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25249862|NCT02523911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25249863|NCT02523911|Anticonvulsants|anticonvulsants|mesh-ancestor
25249864|NCT02523911|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25249865|NCT02523911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25249866|NCT02523911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249867|NCT02523911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25249868|NCT02523911|Tocolytic Agents|tocolytic agents|mesh-ancestor
25249869|NCT02523911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25249870|NCT02523911|Antifoaming Agents|antifoaming agents|mesh-ancestor
25249871|NCT02523911|Emollients|emollients|mesh-ancestor
25249872|NCT02523911|Dermatologic Agents|dermatologic agents|mesh-ancestor
25249873|NCT02523911|Cathartics|cathartics|mesh-ancestor
25249874|NCT02523911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25249876|NCT02523898|Clomiphene|clomiphene|mesh-list
25249878|NCT02523898|Zuclomiphene|zuclomiphene|mesh-list
25249879|NCT02523898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25249880|NCT02523898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249881|NCT02523898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25249882|NCT02523898|Hormone Antagonists|hormone antagonists|mesh-ancestor
25249883|NCT02523898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25249884|NCT02523898|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25249885|NCT02523898|Fertility Agents|fertility agents|mesh-ancestor
25249886|NCT02523898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25249887|NCT02523898|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24600765|NCT00960479|Ribavirin|ribavirin|mesh-list
24636412|NCT01145326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24853135|NCT02266030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853136|NCT02266030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24853138|NCT02266030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457501|NCT00334594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636421|NCT01145404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636423|NCT01145404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24600785|NCT00960544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600787|NCT00960557|Combretastatin|combretastatin|mesh-list
24600788|NCT00960557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24600789|NCT00960557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600790|NCT00960557|Tubulin Modulators|tubulin modulators|mesh-ancestor
24600791|NCT00960557|Antimitotic Agents|antimitotic agents|mesh-ancestor
24600808|NCT00960713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24600809|NCT00960713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600810|NCT00960713|Immunologic Factors|immunologic factors|mesh-ancestor
24600811|NCT00960713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600812|NCT00960713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24600813|NCT00960739|Topotecan|topotecan|mesh-list
24600814|NCT00960739|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24600815|NCT00960739|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24600816|NCT00960739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24600817|NCT00960739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600818|NCT00960739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600819|NCT00960739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600820|NCT00960739|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24600821|NCT00960817|Aspirin|aspirin|mesh-list
24600822|NCT00960817|Dipyridamole|dipyridamole|mesh-list
24636424|NCT01145404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636425|NCT01145430|Doxorubicin|doxorubicin|mesh-list
25249888|NCT02523898|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25249889|NCT02523768|Basiliximab|basiliximab|mesh-list
25249890|NCT02523768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24636426|NCT01145430|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24636427|NCT01145430|Veliparib|veliparib|mesh-list
25249891|NCT02523768|Immunologic Factors|immunologic factors|mesh-ancestor
25249892|NCT02523768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249893|NCT02524184|Sildenafil Citrate|sildenafil citrate|mesh-list
25249901|NCT02523833|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25249902|NCT02523833|Autonomic Agents|autonomic agents|mesh-ancestor
25249903|NCT02523833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25249904|NCT02523833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249905|NCT02523833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25249906|NCT02523833|Respiratory System Agents|respiratory system agents|mesh-ancestor
24973483|NCT03708926|Abaloparatide|abaloparatide|mesh-list
25249907|NCT02523833|Tocolytic Agents|tocolytic agents|mesh-ancestor
25249908|NCT02523833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25249909|NCT02523833|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25249910|NCT02523833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25249911|NCT02523833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25249912|NCT02523833|Adrenergic Agents|adrenergic agents|mesh-ancestor
25249913|NCT02523833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25249914|NCT02523833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249916|NCT02523859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25249917|NCT02523859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25249918|NCT02523859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249919|NCT02523859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25249920|NCT02523859|Anesthetics, General|anesthetics, general|mesh-ancestor
25249921|NCT02523859|Anesthetics|anesthetics|mesh-ancestor
25249922|NCT02523846|Morphine|morphine|mesh-list
25249923|NCT02523846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25249924|NCT02523846|Narcotics|narcotics|mesh-ancestor
25249925|NCT02523846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25249926|NCT02523846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636432|NCT01145430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636433|NCT01145430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636434|NCT01145430|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24636435|NCT01145456|Gemcitabine|gemcitabine|mesh-list
24636436|NCT01145456|R04929097|r04929097|mesh-list
24636437|NCT01145456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24636438|NCT01145456|Antimetabolites|antimetabolites|mesh-ancestor
24600823|NCT00960817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24600825|NCT00960817|Analgesics|analgesics|mesh-ancestor
24600826|NCT00960817|Sensory System Agents|sensory system agents|mesh-ancestor
24600827|NCT00960817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24600828|NCT00960817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600829|NCT00960817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24600830|NCT00960817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24600831|NCT00960817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24600832|NCT00960817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24600833|NCT00960817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600834|NCT00960817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24600850|NCT00960830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24600851|NCT00960830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24600852|NCT00960830|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24853140|NCT02266030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24853141|NCT02266030|Autonomic Agents|autonomic agents|mesh-ancestor
24853142|NCT02266030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24459332|NCT00344409|Darbepoetin alfa|darbepoetin alfa|mesh-list
24600863|NCT00960921|Micronutrients|micronutrients|mesh-ancestor
24600864|NCT00960921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600865|NCT00960921|Hematinics|hematinics|mesh-ancestor
24600866|NCT00960960|Paclitaxel|paclitaxel|mesh-list
24600867|NCT00960960|Bevacizumab|bevacizumab|mesh-list
25249927|NCT02523846|Analgesics|analgesics|mesh-ancestor
25249928|NCT02523846|Sensory System Agents|sensory system agents|mesh-ancestor
25249929|NCT02523846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25249986|NCT02523755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25249987|NCT02523547|Entecavir|entecavir|mesh-list
25249988|NCT02523547|Antiviral Agents|antiviral agents|mesh-ancestor
25249989|NCT02523547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25249990|NCT02523703|N-Methylaspartate|n-methylaspartate|mesh-list
25249991|NCT02523703|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
25249992|NCT02523703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25249993|NCT02523703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25249994|NCT02523703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25249995|NCT02523703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25249996|NCT02523638|Interferons|interferons|mesh-list
25249997|NCT02523638|Interferon-alpha|interferon-alpha|mesh-list
25249998|NCT02523638|Interferon alpha-2|interferon alpha-2|mesh-list
25249999|NCT02523638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25250000|NCT02523638|Antiviral Agents|antiviral agents|mesh-ancestor
25250001|NCT02523638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25250002|NCT02523638|Immunologic Factors|immunologic factors|mesh-ancestor
25250003|NCT02523638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250004|NCT02523664|Hydrocortisone|hydrocortisone|mesh-list
25250005|NCT02523664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25250006|NCT02523300|Methylprednisolone|methylprednisolone|mesh-list
25250007|NCT02523300|Glucocorticoids|glucocorticoids|mesh-list
25250008|NCT02523300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25250009|NCT02523300|Antiemetics|antiemetics|mesh-ancestor
25250010|NCT02523300|Autonomic Agents|autonomic agents|mesh-ancestor
24998982|NCT05421000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24998983|NCT05421000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998984|NCT05419362|Avelumab|avelumab|mesh-list
24998985|NCT05419362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24998986|NCT05419362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998987|NCT05418504|Anesthetics|anesthetics|mesh-list
24600944|NCT00961363|Incretins|incretins|mesh-ancestor
24600945|NCT00961363|Hormones|hormones|mesh-ancestor
25250011|NCT02523300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25250012|NCT02523300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250013|NCT02523300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25250014|NCT02523300|Hormones|hormones|mesh-ancestor
25250015|NCT02523300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25250016|NCT02523300|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25250017|NCT02523300|Protective Agents|protective agents|mesh-ancestor
24863055|NCT03635788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600969|NCT00961467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24600970|NCT00961467|Growth Substances|growth substances|mesh-ancestor
24600971|NCT00961467|Growth Inhibitors|growth inhibitors|mesh-ancestor
24600972|NCT00961467|Leprostatic Agents|leprostatic agents|mesh-ancestor
24600973|NCT00961467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24600974|NCT00961467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24600992|NCT00961753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600993|NCT00961753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24600994|NCT00961753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24600995|NCT00961753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24600996|NCT00961753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600997|NCT00961753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600999|NCT00961844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24601008|NCT00961857|Hormones|hormones|mesh-ancestor
24718445|NCT01554930|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24718446|NCT01554930|Protective Agents|protective agents|mesh-ancestor
24718448|NCT01554930|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24718450|NCT01554930|Natriuretic Agents|natriuretic agents|mesh-ancestor
24718451|NCT01554956|Plasminogen|plasminogen|mesh-list
24718452|NCT01554956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24718453|NCT01554956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24718454|NCT01554956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718455|NCT01554969|Capecitabine|capecitabine|mesh-list
24718456|NCT01554969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24718457|NCT01554969|Antimetabolites|antimetabolites|mesh-ancestor
24718458|NCT01554969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718459|NCT01554969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718460|NCT01554995|Linezolid|linezolid|mesh-list
24718461|NCT01554995|Delpazolid|delpazolid|mesh-list
25250018|NCT02523131|Insulin|insulin|mesh-list
25250019|NCT02523131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25250020|NCT02523131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250021|NCT02523144|Dexmedetomidine|dexmedetomidine|mesh-list
25250022|NCT02523144|Chloral Hydrate|chloral hydrate|mesh-list
25250023|NCT02523144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25250024|NCT02523144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25250025|NCT02523144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250026|NCT02523144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25250028|NCT02523144|Sensory System Agents|sensory system agents|mesh-ancestor
25250029|NCT02523144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25250030|NCT02523144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25250031|NCT02523144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25250032|NCT02523144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25250033|NCT02523144|Adrenergic Agents|adrenergic agents|mesh-ancestor
25250034|NCT02523144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25250035|NCT02523144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250036|NCT02523092|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25250037|NCT02523092|Hormones|hormones|mesh-ancestor
25250038|NCT02523092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25250039|NCT02523092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250040|NCT02523053|Fluorouracil|fluorouracil|mesh-list
25250041|NCT02523053|Antimetabolites|antimetabolites|mesh-ancestor
25250042|NCT02523053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250043|NCT02523053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25250044|NCT02523053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25250045|NCT02523053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25250046|NCT02523053|Immunologic Factors|immunologic factors|mesh-ancestor
25250047|NCT02523053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250048|NCT02522897|Ranibizumab|ranibizumab|mesh-list
25250049|NCT02522897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25250050|NCT02522897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25250051|NCT02522897|Growth Substances|growth substances|mesh-ancestor
25250052|NCT02522897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250053|NCT02522897|Growth Inhibitors|growth inhibitors|mesh-ancestor
25250054|NCT02522897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25250055|NCT02522975|Epoetin Alfa|epoetin alfa|mesh-list
25250056|NCT02522975|Hematinics|hematinics|mesh-ancestor
25250057|NCT02522910|Docetaxel|docetaxel|mesh-list
25250058|NCT02522910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24636479|NCT01145703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24636480|NCT01145703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24636481|NCT01145807|Terbinafine|terbinafine|mesh-list
24636482|NCT01145807|Antifungal Agents|antifungal agents|mesh-ancestor
24636483|NCT01145807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25686880|NCT01925768|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25686881|NCT01925768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25686882|NCT01925768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686883|NCT01925781|Nicotine|nicotine|mesh-list
25686884|NCT01925781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25686885|NCT01925781|Autonomic Agents|autonomic agents|mesh-ancestor
25686886|NCT01925781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686887|NCT01925781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686888|NCT01925781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25686889|NCT01925781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25686890|NCT01925781|Cholinergic Agents|cholinergic agents|mesh-ancestor
25686891|NCT01925781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25686892|NCT01925781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686893|NCT01925950|Beclomethasone|beclomethasone|mesh-list
24636484|NCT01145807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636485|NCT01145807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395387|NCT00135876|Dalteparin|dalteparin|mesh-list
24601073|NCT00962533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24601074|NCT00962533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24601075|NCT00962533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601076|NCT00962533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601077|NCT00962624|Vaccines|vaccines|mesh-list
24601078|NCT00962624|Immunologic Factors|immunologic factors|mesh-ancestor
24601079|NCT00962624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601080|NCT00962637|Citric Acid|citric acid|mesh-list
24601081|NCT00962637|Sodium Citrate|sodium citrate|mesh-list
24601096|NCT00962637|Hormone Antagonists|hormone antagonists|mesh-ancestor
24601097|NCT00962637|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24601098|NCT00962637|Fertility Agents|fertility agents|mesh-ancestor
24601099|NCT00962637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24601100|NCT00962637|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24853157|NCT02266160|Anesthetics|anesthetics|mesh-ancestor
24853158|NCT02266160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24853159|NCT02266160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853160|NCT02266160|Sensory System Agents|sensory system agents|mesh-ancestor
24999026|NCT05322902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24580155|NCT00860899|Autonomic Agents|autonomic agents|mesh-ancestor
24580156|NCT00860899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24580157|NCT00860899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24580158|NCT00860899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24580159|NCT00860899|Adrenergic Agents|adrenergic agents|mesh-ancestor
24580160|NCT00860899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24580161|NCT00860899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580162|NCT00860899|Anesthetics, Local|anesthetics, local|mesh-ancestor
24580163|NCT00860899|Anesthetics|anesthetics|mesh-ancestor
24580164|NCT00860899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24580186|NCT00860964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580187|NCT00860964|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24580189|NCT00860964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24580190|NCT00860964|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25250064|NCT02522858|Ephedrine|ephedrine|mesh-list
25250065|NCT02522858|Dexmedetomidine|dexmedetomidine|mesh-list
25250066|NCT02522858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25250067|NCT02522858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25250068|NCT02522858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250069|NCT02522858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25250070|NCT02522858|Analgesics|analgesics|mesh-ancestor
25250071|NCT02522858|Sensory System Agents|sensory system agents|mesh-ancestor
25250072|NCT02522858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25250073|NCT02522858|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25250074|NCT02522858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25250075|NCT02522858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25250076|NCT02522858|Adrenergic Agents|adrenergic agents|mesh-ancestor
25250077|NCT02522858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25250078|NCT02522858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250079|NCT02522858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25250080|NCT02522858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25250081|NCT02522858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25250082|NCT02522858|Autonomic Agents|autonomic agents|mesh-ancestor
25250083|NCT02522858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25250084|NCT02522858|Respiratory System Agents|respiratory system agents|mesh-ancestor
25250085|NCT02522858|Mydriatics|mydriatics|mesh-ancestor
25250086|NCT02522858|Parasympatholytics|parasympatholytics|mesh-ancestor
24853161|NCT02266160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24853162|NCT02266160|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24664878|NCT01309074|Serotonin Agents|serotonin agents|mesh-ancestor
24601101|NCT00962637|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24601102|NCT00962663|Ibuprofen|ibuprofen|mesh-list
24601112|NCT00962663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601113|NCT00962663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601114|NCT00962715|Interferons|interferons|mesh-list
24601115|NCT00962715|Interferon-alpha|interferon-alpha|mesh-list
24601116|NCT00962715|Interferon alpha-2|interferon alpha-2|mesh-list
24601117|NCT00962715|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24601118|NCT00962715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24601119|NCT00962715|Antiviral Agents|antiviral agents|mesh-ancestor
24601120|NCT00962715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24601121|NCT00962715|Immunologic Factors|immunologic factors|mesh-ancestor
25692602|NCT02002832|Dopamine Agents|dopamine agents|mesh-ancestor
24718724|NCT01556737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24636499|NCT01145846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24636500|NCT01145846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24636501|NCT01145846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636502|NCT01145859|Rivaroxaban|rivaroxaban|mesh-list
24636503|NCT01145859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24601200|NCT00963443|Respiratory System Agents|respiratory system agents|mesh-ancestor
24601201|NCT00963443|Nasal Decongestants|nasal decongestants|mesh-ancestor
24601202|NCT00963443|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24601203|NCT00963443|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24601204|NCT00963443|Sympathomimetics|sympathomimetics|mesh-ancestor
24601205|NCT00963443|Adrenergic Agents|adrenergic agents|mesh-ancestor
24601206|NCT00963443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24601207|NCT00963534|Rituximab|rituximab|mesh-list
24601208|NCT00963534|Lenalidomide|lenalidomide|mesh-list
24601209|NCT00963534|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24601210|NCT00963534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24601211|NCT00963534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24601212|NCT00963534|Immunologic Factors|immunologic factors|mesh-ancestor
24580213|NCT00861029|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24580231|NCT00861042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24580232|NCT00861042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24580233|NCT00861042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580235|NCT00861068|Anticonvulsants|anticonvulsants|mesh-ancestor
25250087|NCT02522858|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25250088|NCT02522858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25250089|NCT02522858|Cholinergic Agents|cholinergic agents|mesh-ancestor
25250090|NCT02522858|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25250091|NCT02522858|Sympathomimetics|sympathomimetics|mesh-ancestor
25250092|NCT02522858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25250093|NCT02522754|Vaccines|vaccines|mesh-list
25250094|NCT02522754|Immunologic Factors|immunologic factors|mesh-ancestor
25250095|NCT02522754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250096|NCT02522936|Muramidase|muramidase|mesh-list
25250097|NCT02522936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25250098|NCT02522650|Amiloride|amiloride|mesh-list
25250099|NCT02522650|Triamterene|triamterene|mesh-list
25250100|NCT02522650|Diuretics|diuretics|mesh-ancestor
25250101|NCT02522650|Natriuretic Agents|natriuretic agents|mesh-ancestor
25250102|NCT02522650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250103|NCT02522650|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
25250104|NCT02522650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25250105|NCT02522650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25250106|NCT02522650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250107|NCT02522650|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
25250108|NCT02522650|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25250109|NCT02522572|Plerixafor|plerixafor|mesh-list
25250110|NCT02522572|Bortezomib|bortezomib|mesh-list
25250111|NCT02522572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25250112|NCT02522572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25250113|NCT02522572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25250114|NCT02522572|Antiviral Agents|antiviral agents|mesh-ancestor
25250115|NCT02522572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25274520|NCT02377388|Incretins|incretins|mesh-ancestor
25274521|NCT02377388|Hormones|hormones|mesh-ancestor
25274522|NCT02377388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25274523|NCT02377388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24601213|NCT00963534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601214|NCT00963534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24601215|NCT00963534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24601216|NCT00963534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24636516|NCT01145950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636517|NCT01145950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24636518|NCT01145950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24636519|NCT01145950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24636520|NCT01145950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24601217|NCT00963534|Growth Substances|growth substances|mesh-ancestor
24601218|NCT00963534|Growth Inhibitors|growth inhibitors|mesh-ancestor
24601219|NCT00963534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24601220|NCT00963534|Alkylating Agents|alkylating agents|mesh-ancestor
24601221|NCT00963534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601222|NCT00963573|Loratadine|loratadine|mesh-list
24601223|NCT00963573|Betamethasone|betamethasone|mesh-list
24601224|NCT00963573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24601225|NCT00963573|Glucocorticoids|glucocorticoids|mesh-ancestor
24601226|NCT00963573|Hormones|hormones|mesh-ancestor
24812503|NCT02052713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812504|NCT02052713|Hormone Antagonists|hormone antagonists|mesh-ancestor
24812505|NCT02052713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24812506|NCT02052726|Vaccines|vaccines|mesh-list
24812507|NCT02052726|Immunologic Factors|immunologic factors|mesh-ancestor
24812508|NCT02052726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812509|NCT02052908|Naproxen|naproxen|mesh-list
24812510|NCT02052908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24812511|NCT02052908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24812512|NCT02052908|Analgesics|analgesics|mesh-ancestor
24601228|NCT00963573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601229|NCT00963573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25250116|NCT02522234|Lenograstim|lenograstim|mesh-list
25250117|NCT02522234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25250118|NCT02522234|Immunologic Factors|immunologic factors|mesh-ancestor
25250119|NCT02522234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250120|NCT02522221|Warfarin|warfarin|mesh-list
25250121|NCT02522221|Anticoagulants|anticoagulants|mesh-ancestor
25250122|NCT02522169|Infliximab|infliximab|mesh-list
25250123|NCT02522169|Dermatologic Agents|dermatologic agents|mesh-ancestor
25250124|NCT02522169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25250125|NCT02522169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25250126|NCT02522208|Hydralazine|hydralazine|mesh-list
25250127|NCT02522208|Isosorbide|isosorbide|mesh-list
25250128|NCT02522208|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25250129|NCT02522208|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25250130|NCT02522208|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25250131|NCT02522208|Diuretics|diuretics|mesh-ancestor
25250132|NCT02522208|Natriuretic Agents|natriuretic agents|mesh-ancestor
25250133|NCT02522208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250134|NCT02522208|Vasodilator Agents|vasodilator agents|mesh-ancestor
25250135|NCT02522208|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25250136|NCT02522208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250137|NCT02522208|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25250138|NCT02522078|Misoprostol|misoprostol|mesh-list
25250139|NCT02522078|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25250140|NCT02522078|Abortifacient Agents|abortifacient agents|mesh-ancestor
25250141|NCT02522078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25250142|NCT02522078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250143|NCT02522078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25250144|NCT02522078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25250145|NCT02522078|Oxytocics|oxytocics|mesh-ancestor
25250146|NCT02522117|Atorvastatin|atorvastatin|mesh-list
25250147|NCT02522117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25250148|NCT02522117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25250149|NCT02522117|Antimetabolites|antimetabolites|mesh-ancestor
25250150|NCT02522117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250151|NCT02522117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25250152|NCT02522117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25250153|NCT02522117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25250154|NCT02522130|Naproxen|naproxen|mesh-list
25250155|NCT02522130|Lidocaine|lidocaine|mesh-list
25250156|NCT02522130|Misoprostol|misoprostol|mesh-list
25250157|NCT02522130|Anesthetics, Local|anesthetics, local|mesh-ancestor
25250158|NCT02522130|Anesthetics|anesthetics|mesh-ancestor
25250159|NCT02522130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25250160|NCT02522130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601235|NCT00963573|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24601236|NCT00963573|Histamine Antagonists|histamine antagonists|mesh-ancestor
24601237|NCT00963573|Histamine Agents|histamine agents|mesh-ancestor
24601238|NCT00963573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24601278|NCT00963729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24601279|NCT00963729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24601280|NCT00963729|Tubulin Modulators|tubulin modulators|mesh-ancestor
24601281|NCT00963729|Antimitotic Agents|antimitotic agents|mesh-ancestor
24601282|NCT00963729|Mitosis Modulators|mitosis modulators|mesh-ancestor
24601283|NCT00963729|Antimetabolites|antimetabolites|mesh-ancestor
24601284|NCT00963729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24601285|NCT00963729|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24601286|NCT00963729|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24601287|NCT00963729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601288|NCT00963729|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24601289|NCT00963729|Hormone Antagonists|hormone antagonists|mesh-ancestor
25686894|NCT01925950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25686895|NCT01925950|Glucocorticoids|glucocorticoids|mesh-ancestor
24601290|NCT00963729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24601292|NCT00963729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24601293|NCT00963729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24601294|NCT00963768|Canagliflozin|canagliflozin|mesh-list
24601295|NCT00963768|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24636525|NCT01145976|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24636526|NCT01145976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25048732|NCT00673062|Ephedrine|ephedrine|mesh-list
24580236|NCT00861068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24580237|NCT00861068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24580238|NCT00861068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24580239|NCT00861068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580277|NCT00861250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250238|NCT02521662|Cholinergic Agents|cholinergic agents|mesh-ancestor
24580303|NCT00861328|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24580304|NCT00861328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24580305|NCT00861328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580306|NCT00861328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580307|NCT00861328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24580308|NCT00861328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24580309|NCT00861328|Glycine Agents|glycine agents|mesh-ancestor
24580310|NCT00861328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24580311|NCT00861328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580312|NCT00861367|Aspirin|aspirin|mesh-list
24580313|NCT00861367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24580314|NCT00861367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24580315|NCT00861367|Analgesics|analgesics|mesh-ancestor
24580316|NCT00861367|Sensory System Agents|sensory system agents|mesh-ancestor
25250164|NCT02522130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25250165|NCT02522130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25250166|NCT02522130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25250167|NCT02522130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250168|NCT02522130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25250169|NCT02522130|Abortifacient Agents|abortifacient agents|mesh-ancestor
25250170|NCT02522130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25250171|NCT02522130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25250172|NCT02522130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25250174|NCT02522130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25250175|NCT02522130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25250176|NCT02522130|Analgesics|analgesics|mesh-ancestor
25250177|NCT02522130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25250178|NCT02522130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25250179|NCT02522130|Gout Suppressants|gout suppressants|mesh-ancestor
25250180|NCT02522130|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25250181|NCT02522130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25250182|NCT02522039|Timolol|timolol|mesh-list
25250183|NCT02522039|Dorzolamide|dorzolamide|mesh-list
25250184|NCT02522039|Latanoprost|latanoprost|mesh-list
25250185|NCT02522039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25250186|NCT02522039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25250187|NCT02522039|Adrenergic Agents|adrenergic agents|mesh-ancestor
24636527|NCT01145976|Immunologic Factors|immunologic factors|mesh-ancestor
24636528|NCT01145976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636529|NCT01145976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24812519|NCT02052908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24853164|NCT02266173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24853165|NCT02266173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24853166|NCT02266264|Hydrocortisone|hydrocortisone|mesh-list
24853167|NCT02266264|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24853168|NCT02266264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24853169|NCT02266303|Insulin|insulin|mesh-list
24853170|NCT02266303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24853171|NCT02266303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636530|NCT01145976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24636531|NCT01145976|Alkylating Agents|alkylating agents|mesh-ancestor
24601296|NCT00963768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601297|NCT00963768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24601330|NCT00963976|Sympathomimetics|sympathomimetics|mesh-ancestor
24601331|NCT00963976|Autonomic Agents|autonomic agents|mesh-ancestor
24973932|NCT03705559|Analgesics, Opioid|analgesics, opioid|mesh-list
24601332|NCT00963976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24601334|NCT00963976|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24601335|NCT00963976|Vasodilator Agents|vasodilator agents|mesh-ancestor
24601358|NCT00964080|Antidotes|antidotes|mesh-ancestor
24601359|NCT00964080|Protective Agents|protective agents|mesh-ancestor
24461624|NCT00352950|Panitumumab|panitumumab|mesh-list
24601385|NCT00964106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24601386|NCT00964106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601387|NCT00964106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25250188|NCT02522039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25250189|NCT02522039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250190|NCT02522039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250191|NCT02522039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25250192|NCT02522039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25250193|NCT02522039|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25250194|NCT02522039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24665465|NCT01312376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25250195|NCT02522039|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25250196|NCT02522039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25250197|NCT02522013|Aminophylline|aminophylline|mesh-list
25250198|NCT02522013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25250199|NCT02522013|Autonomic Agents|autonomic agents|mesh-ancestor
25250200|NCT02522013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25250201|NCT02522013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250203|NCT02522013|Respiratory System Agents|respiratory system agents|mesh-ancestor
25250204|NCT02522013|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25250205|NCT02522013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25250206|NCT02522013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25250207|NCT02522013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250208|NCT02522013|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25250209|NCT02522013|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25250210|NCT02522013|Purinergic Agents|purinergic agents|mesh-ancestor
25250211|NCT02522013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25250212|NCT02522013|Protective Agents|protective agents|mesh-ancestor
25250213|NCT02521831|Bupivacaine|bupivacaine|mesh-list
25250214|NCT02521831|Anesthetics|anesthetics|mesh-list
25250215|NCT02521831|Isoflurane|isoflurane|mesh-list
25250216|NCT02521831|Anesthetics, Local|anesthetics, local|mesh-ancestor
25250217|NCT02521831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25250218|NCT02521831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250219|NCT02521831|Sensory System Agents|sensory system agents|mesh-ancestor
25250220|NCT02521831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25250221|NCT02521831|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25250222|NCT02521831|Anesthetics, General|anesthetics, general|mesh-ancestor
25250223|NCT02521714|Lenalidomide|lenalidomide|mesh-list
25250224|NCT02521714|Immunologic Factors|immunologic factors|mesh-ancestor
25250225|NCT02521714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250226|NCT02521714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25250227|NCT02521714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24601392|NCT00964106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601393|NCT00964106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24601394|NCT00964106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24601395|NCT00964106|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24601396|NCT00964106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24601397|NCT00964106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24601398|NCT00964106|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24601399|NCT00964106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24601400|NCT00964106|Purinergic Agents|purinergic agents|mesh-ancestor
24601401|NCT00964106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24601402|NCT00964106|Antitubercular Agents|antitubercular agents|mesh-ancestor
24601403|NCT00964106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24601404|NCT00964106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24601405|NCT00964106|Leprostatic Agents|leprostatic agents|mesh-ancestor
24601406|NCT00964106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24601407|NCT00964106|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24601408|NCT00964106|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24601409|NCT00964106|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24601410|NCT00964106|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24601411|NCT00964106|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24853173|NCT02266329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24601412|NCT00964106|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24601414|NCT00964106|Antifungal Agents|antifungal agents|mesh-ancestor
24601415|NCT00964106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24601416|NCT00964106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24601417|NCT00964106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24601418|NCT00964106|Hormone Antagonists|hormone antagonists|mesh-ancestor
24601419|NCT00964106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24601420|NCT00964106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24601421|NCT00964106|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25250228|NCT02521714|Growth Substances|growth substances|mesh-ancestor
25250229|NCT02521714|Growth Inhibitors|growth inhibitors|mesh-ancestor
25250230|NCT02521714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25250231|NCT02521662|Nicotine|nicotine|mesh-list
25250232|NCT02521662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25250233|NCT02521662|Autonomic Agents|autonomic agents|mesh-ancestor
25250234|NCT02521662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25250235|NCT02521662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250236|NCT02521662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25250237|NCT02521662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25250239|NCT02521662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25250240|NCT02521662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601556|NCT00964691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24601558|NCT00964691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24461743|NCT00353561|Fluconazole|fluconazole|mesh-list
24853175|NCT02266329|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24853176|NCT02266329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24853177|NCT02266329|Adrenergic Agents|adrenergic agents|mesh-ancestor
24601565|NCT00964704|Trastuzumab|trastuzumab|mesh-list
24601566|NCT00964704|Docetaxel|docetaxel|mesh-list
24601567|NCT00964704|Capecitabine|capecitabine|mesh-list
24601568|NCT00964704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24601569|NCT00964704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759600|NCT01752959|Analgesics|analgesics|mesh-ancestor
24601570|NCT00964704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24601571|NCT00964704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25250272|NCT02521636|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25250273|NCT02521636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25250274|NCT02521298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25250275|NCT02521298|Methylprednisolone|methylprednisolone|mesh-list
25250276|NCT02521298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25250277|NCT02521298|Prednisolone|prednisolone|mesh-list
25250278|NCT02521298|Prednisolone acetate|prednisolone acetate|mesh-list
25250279|NCT02521298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25250280|NCT02521298|Prednisolone phosphate|prednisolone phosphate|mesh-list
25250281|NCT02521298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25250282|NCT02521298|Antiemetics|antiemetics|mesh-ancestor
25250283|NCT02521298|Autonomic Agents|autonomic agents|mesh-ancestor
25250284|NCT02521298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25250285|NCT02521298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250286|NCT02521298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25250287|NCT02521298|Glucocorticoids|glucocorticoids|mesh-ancestor
25250288|NCT02521298|Hormones|hormones|mesh-ancestor
25250289|NCT02521298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25250290|NCT02521298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25250291|NCT02521298|Protective Agents|protective agents|mesh-ancestor
25250292|NCT02521298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25250293|NCT02521298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25250294|NCT02521246|Losartan|losartan|mesh-list
25250295|NCT02521246|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25250296|NCT02521246|Candesartan|candesartan|mesh-list
25250297|NCT02521246|Candesartan cilexetil|candesartan cilexetil|mesh-list
25250298|NCT02521246|Chlorthalidone|chlorthalidone|mesh-list
25250299|NCT02521246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25250300|NCT02521246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25250301|NCT02521246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25250302|NCT02521246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25250303|NCT02521246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250304|NCT02521246|Diuretics|diuretics|mesh-ancestor
25250305|NCT02521246|Natriuretic Agents|natriuretic agents|mesh-ancestor
25250306|NCT02521246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601575|NCT00964704|Tubulin Modulators|tubulin modulators|mesh-ancestor
24601576|NCT00964704|Antimitotic Agents|antimitotic agents|mesh-ancestor
24601577|NCT00964704|Mitosis Modulators|mitosis modulators|mesh-ancestor
24601578|NCT00964704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601579|NCT00964704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24601580|NCT00964704|Antimetabolites|antimetabolites|mesh-ancestor
24601581|NCT00964730|Moxifloxacin|moxifloxacin|mesh-list
24601582|NCT00964730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24601583|NCT00964730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24601584|NCT00964730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24601585|NCT00964730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24601586|NCT00964730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601587|NCT00964730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601588|NCT00964730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24601589|NCT00964756|Ganciclovir|ganciclovir|mesh-list
24601590|NCT00964756|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
24601591|NCT00964756|Antiviral Agents|antiviral agents|mesh-ancestor
24601592|NCT00964756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24601593|NCT00964756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24601594|NCT00964756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601595|NCT00964756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601596|NCT00964769|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24601597|NCT00964769|Immunologic Factors|immunologic factors|mesh-ancestor
24636575|NCT01146067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636576|NCT01146067|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24636577|NCT01146067|Protective Agents|protective agents|mesh-ancestor
24636578|NCT01146093|Pravastatin|pravastatin|mesh-list
24636579|NCT01146093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24601598|NCT00964769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636581|NCT01146093|Antimetabolites|antimetabolites|mesh-ancestor
24601599|NCT00964808|Oxycodone|oxycodone|mesh-list
24580317|NCT00861367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24580318|NCT00861367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580319|NCT00861367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24580323|NCT00861367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580324|NCT00861367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24580325|NCT00861367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24580327|NCT00861367|Antipyretics|antipyretics|mesh-ancestor
24580328|NCT00861406|Interferons|interferons|mesh-list
24580329|NCT00861406|Interferon-alpha|interferon-alpha|mesh-list
24580330|NCT00861406|Interferon alpha-2|interferon alpha-2|mesh-list
24580331|NCT00861406|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25250307|NCT02521246|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25250308|NCT02521246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25250309|NCT02521233|Losartan|losartan|mesh-list
25250310|NCT02521233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25250311|NCT02521233|Candesartan|candesartan|mesh-list
25250312|NCT02521233|Candesartan cilexetil|candesartan cilexetil|mesh-list
25250313|NCT02521233|Chlorthalidone|chlorthalidone|mesh-list
25250314|NCT02521233|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25250315|NCT02521233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25250316|NCT02521233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25250317|NCT02521233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25250318|NCT02521233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250319|NCT02521233|Diuretics|diuretics|mesh-ancestor
25250320|NCT02521233|Natriuretic Agents|natriuretic agents|mesh-ancestor
25250321|NCT02521233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250322|NCT02521233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25250323|NCT02521233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25250324|NCT02521207|Ibuprofen|ibuprofen|mesh-list
25250325|NCT02521207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25250326|NCT02521207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25250327|NCT02521207|Analgesics|analgesics|mesh-ancestor
25250328|NCT02521207|Sensory System Agents|sensory system agents|mesh-ancestor
25250329|NCT02521207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25250330|NCT02521207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250331|NCT02521207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25250332|NCT02521207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25250333|NCT02521207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25250334|NCT02521207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25250335|NCT02521207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250336|NCT02521051|Bevacizumab|bevacizumab|mesh-list
25274524|NCT02377388|Protease Inhibitors|protease inhibitors|mesh-ancestor
24601600|NCT00964808|Buprenorphine|buprenorphine|mesh-list
24601632|NCT00965107|Anesthetics, General|anesthetics, general|mesh-ancestor
24601633|NCT00965107|Anesthetics|anesthetics|mesh-ancestor
24601634|NCT00965107|Anticonvulsants|anticonvulsants|mesh-ancestor
24601635|NCT00965107|GABA Modulators|gaba modulators|mesh-ancestor
24601636|NCT00965107|GABA Agents|gaba agents|mesh-ancestor
24601637|NCT00965107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24601638|NCT00965107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601639|NCT00965120|Bradykinin|bradykinin|mesh-list
24601640|NCT00965120|Kininogens|kininogens|mesh-list
24601641|NCT00965120|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-list
24601642|NCT00965120|Vasodilator Agents|vasodilator agents|mesh-ancestor
24601643|NCT00965120|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
24601644|NCT00965120|Protease Inhibitors|protease inhibitors|mesh-ancestor
24601645|NCT00965120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601646|NCT00965120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601681|NCT00965549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24853185|NCT02266485|Pravastatin|pravastatin|mesh-list
24853186|NCT02266485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24853187|NCT02266485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24601688|NCT00965640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24601689|NCT00965640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601690|NCT00965653|Folic Acid|folic acid|mesh-list
24601691|NCT00965653|Methotrexate|methotrexate|mesh-list
24601692|NCT00965653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24601693|NCT00965653|Abortifacient Agents|abortifacient agents|mesh-ancestor
24601694|NCT00965653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24601695|NCT00965653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601696|NCT00965653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24601697|NCT00965653|Antimetabolites|antimetabolites|mesh-ancestor
24601698|NCT00965653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580332|NCT00861406|Vaccines|vaccines|mesh-list
24580345|NCT00861419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24580347|NCT00861419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24580348|NCT00861419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24580350|NCT00861419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580351|NCT00861419|Growth Inhibitors|growth inhibitors|mesh-ancestor
24580356|NCT00861419|Vitamins|vitamins|mesh-ancestor
24580357|NCT00861419|Micronutrients|micronutrients|mesh-ancestor
24580358|NCT00861445|Lacosamide|lacosamide|mesh-list
24580359|NCT00861445|Anticonvulsants|anticonvulsants|mesh-ancestor
24580360|NCT00861445|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24580361|NCT00861445|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24580362|NCT00861445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25250337|NCT02521051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25250338|NCT02521051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25250339|NCT02521051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25250340|NCT02521051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25250341|NCT02521051|Growth Substances|growth substances|mesh-ancestor
25250342|NCT02521051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250343|NCT02521051|Growth Inhibitors|growth inhibitors|mesh-ancestor
25250344|NCT02521155|Fenbendazole|fenbendazole|mesh-list
25250345|NCT02521155|Antinematodal Agents|antinematodal agents|mesh-ancestor
25250346|NCT02521155|Anthelmintics|anthelmintics|mesh-ancestor
25250347|NCT02521155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25250348|NCT02521155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25250349|NCT02521064|Prednisone|prednisone|mesh-list
25250350|NCT02521064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25250351|NCT02521064|Glucocorticoids|glucocorticoids|mesh-ancestor
25250352|NCT02521064|Hormones|hormones|mesh-ancestor
25250353|NCT02521064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25250354|NCT02521064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250355|NCT02521064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25250356|NCT02521064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25250357|NCT02521077|Ascorbic Acid|ascorbic acid|mesh-list
25250358|NCT02521077|Vitamins|vitamins|mesh-ancestor
25250359|NCT02521077|Micronutrients|micronutrients|mesh-ancestor
25250360|NCT02521077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250361|NCT02521077|Antioxidants|antioxidants|mesh-ancestor
25250362|NCT02521077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250363|NCT02521077|Protective Agents|protective agents|mesh-ancestor
25250364|NCT02521038|Ticagrelor|ticagrelor|mesh-list
25250365|NCT02521038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25250366|NCT02521038|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25250367|NCT02521038|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24601699|NCT00965653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24601700|NCT00965653|Dermatologic Agents|dermatologic agents|mesh-ancestor
24601701|NCT00965653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601702|NCT00965653|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24601703|NCT00965653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24601704|NCT00965653|Immunologic Factors|immunologic factors|mesh-ancestor
24601705|NCT00965653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24601706|NCT00965653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24601707|NCT00965653|Hematinics|hematinics|mesh-ancestor
24601708|NCT00965653|Vitamin B Complex|vitamin b complex|mesh-ancestor
24601710|NCT00965653|Micronutrients|micronutrients|mesh-ancestor
24601711|NCT00965666|Etanercept|etanercept|mesh-list
24601712|NCT00965666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24601713|NCT00965666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24601714|NCT00965666|Analgesics|analgesics|mesh-ancestor
24601715|NCT00965666|Sensory System Agents|sensory system agents|mesh-ancestor
24601716|NCT00965666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24601717|NCT00965666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601718|NCT00965666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24601719|NCT00965666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24601752|NCT00965874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24601753|NCT00965874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601754|NCT00965874|Anesthetics|anesthetics|mesh-ancestor
24601755|NCT00965874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24601756|NCT00965874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24601757|NCT00965874|Anticonvulsants|anticonvulsants|mesh-ancestor
24601790|NCT00965926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601791|NCT00965926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601792|NCT00965926|Urological Agents|urological agents|mesh-ancestor
24601793|NCT00965991|Metformin|metformin|mesh-list
24853196|NCT02266511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24853197|NCT02266511|Adrenergic Agents|adrenergic agents|mesh-ancestor
24853198|NCT02266511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24853199|NCT02266511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250368|NCT02521038|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25250369|NCT02521038|Purinergic Agents|purinergic agents|mesh-ancestor
25250370|NCT02521038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25250371|NCT02521038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250372|NCT02521038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250373|NCT02520934|Miglustat|miglustat|mesh-list
25250374|NCT02520934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25250375|NCT02520934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250376|NCT02520934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25250377|NCT02520934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25250378|NCT02520934|Antiviral Agents|antiviral agents|mesh-ancestor
25250379|NCT02520934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25250380|NCT02520934|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25250381|NCT02520934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25250382|NCT02520934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250383|NCT02520921|Aspirin|aspirin|mesh-list
25250384|NCT02520921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25250385|NCT02520921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25250386|NCT02520921|Analgesics|analgesics|mesh-ancestor
25250387|NCT02520921|Sensory System Agents|sensory system agents|mesh-ancestor
24461361|NCT00352092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25250388|NCT02520921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25250389|NCT02520921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250390|NCT02520921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25250391|NCT02520921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25250392|NCT02520921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25250393|NCT02520921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25250394|NCT02520921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250395|NCT02520921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25250396|NCT02520921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25250397|NCT02520921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25250398|NCT02520921|Antipyretics|antipyretics|mesh-ancestor
25250399|NCT02521012|Vitamin D|vitamin d|mesh-list
25250400|NCT02521012|Ergocalciferols|ergocalciferols|mesh-list
25250401|NCT02521012|Cholecalciferol|cholecalciferol|mesh-list
25250402|NCT02521012|Vitamins|vitamins|mesh-list
25250403|NCT02521012|Micronutrients|micronutrients|mesh-ancestor
25250404|NCT02521012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250405|NCT02521012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25274525|NCT02377388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601869|NCT00966290|Acenocoumarol|acenocoumarol|mesh-list
24601870|NCT00966290|Fluindione|fluindione|mesh-list
24601871|NCT00966290|Phenindione|phenindione|mesh-list
24601872|NCT00966316|Aspirin|aspirin|mesh-list
24601873|NCT00966316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24601902|NCT00966472|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24601903|NCT00966472|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24601904|NCT00966472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24601905|NCT00966472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24601906|NCT00966472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601907|NCT00966472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601908|NCT00966472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24601909|NCT00966472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24601911|NCT00966472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24601912|NCT00966472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24601913|NCT00966576|Timolol|timolol|mesh-list
24601914|NCT00966576|Brinzolamide|brinzolamide|mesh-list
24601915|NCT00966576|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24601916|NCT00966576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24601917|NCT00966576|Adrenergic Agents|adrenergic agents|mesh-ancestor
24601985|NCT00966836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24601986|NCT00966836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24601987|NCT00966836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601988|NCT00966836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601989|NCT00966836|Antiviral Agents|antiviral agents|mesh-ancestor
24601990|NCT00966901|Nicotine|nicotine|mesh-list
24601991|NCT00966901|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24601992|NCT00966901|Autonomic Agents|autonomic agents|mesh-ancestor
24853200|NCT02266511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853201|NCT02266511|Urological Agents|urological agents|mesh-ancestor
24853202|NCT02266524|Tamsulosin|tamsulosin|mesh-list
24665327|NCT01311739|Hematinics|hematinics|mesh-ancestor
24974430|NCT04682860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24602027|NCT00967057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580363|NCT00861445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580364|NCT00861510|ON 01910|on 01910|mesh-list
24580365|NCT00861510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24580366|NCT00861510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24580367|NCT00861510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580368|NCT00861510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580369|NCT00861523|Thiamine|thiamine|mesh-list
24580370|NCT00861523|Promethazine|promethazine|mesh-list
25250406|NCT02521012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25250407|NCT02520635|Temozolomide|temozolomide|mesh-list
25250408|NCT02520635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25250409|NCT02520635|Alkylating Agents|alkylating agents|mesh-ancestor
25250410|NCT02520635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250411|NCT02520635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25250412|NCT02520752|Midazolam|midazolam|mesh-list
25250413|NCT02520752|Caffeine|caffeine|mesh-list
25250414|NCT02520752|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25250415|NCT02520752|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25250492|NCT02520180|Everolimus|everolimus|mesh-list
25250416|NCT02520752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25250417|NCT02520752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250418|NCT02520752|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25250419|NCT02520752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25250420|NCT02520752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25250421|NCT02520752|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25250422|NCT02520752|Anesthetics, General|anesthetics, general|mesh-ancestor
25250424|NCT02520752|GABA Modulators|gaba modulators|mesh-ancestor
25250425|NCT02520752|GABA Agents|gaba agents|mesh-ancestor
25250426|NCT02520752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25250427|NCT02520752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250428|NCT02520752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25250429|NCT02520752|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25250430|NCT02520752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25250431|NCT02520752|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25250432|NCT02520752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25250433|NCT02520752|Purinergic Agents|purinergic agents|mesh-ancestor
25274526|NCT02377388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274527|NCT02377193|Mycophenolic Acid|mycophenolic acid|mesh-list
25274528|NCT02377193|Tacrolimus|tacrolimus|mesh-list
25274529|NCT02377193|Basiliximab|basiliximab|mesh-list
25275677|NCT02370433|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24602028|NCT00967057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24602029|NCT00967057|Glucocorticoids|glucocorticoids|mesh-ancestor
24602030|NCT00967057|Hormones|hormones|mesh-ancestor
24602031|NCT00967057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24602032|NCT00967057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24602033|NCT00967057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602034|NCT00967057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24602035|NCT00967057|Abortifacient Agents|abortifacient agents|mesh-ancestor
25686896|NCT01925950|Hormones|hormones|mesh-ancestor
24602036|NCT00967057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24602039|NCT00967057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602040|NCT00967057|Dermatologic Agents|dermatologic agents|mesh-ancestor
24602041|NCT00967057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24602042|NCT00967057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24602043|NCT00967057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24602044|NCT00967057|Immunologic Factors|immunologic factors|mesh-ancestor
24602045|NCT00967057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24602046|NCT00967057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24602047|NCT00967057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24602048|NCT00967057|Tubulin Modulators|tubulin modulators|mesh-ancestor
24636620|NCT01146431|Anesthetics|anesthetics|mesh-list
24602049|NCT00967057|Antimitotic Agents|antimitotic agents|mesh-ancestor
24602071|NCT00967109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24602072|NCT00967109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24602073|NCT00967109|Analgesics|analgesics|mesh-ancestor
24602074|NCT00967109|Sensory System Agents|sensory system agents|mesh-ancestor
24602075|NCT00967109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24602076|NCT00967109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602077|NCT00967109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24602078|NCT00967109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24602079|NCT00967135|Pregabalin|pregabalin|mesh-list
24602080|NCT00967135|Analgesics|analgesics|mesh-ancestor
24602081|NCT00967135|Sensory System Agents|sensory system agents|mesh-ancestor
24580371|NCT00861523|Diphenhydramine|diphenhydramine|mesh-list
24580372|NCT00861523|Vitamin B Complex|vitamin b complex|mesh-ancestor
24580381|NCT00861523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24580382|NCT00861523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580383|NCT00861523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24580384|NCT00861523|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24580385|NCT00861523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25250434|NCT02520570|Urinastatin|urinastatin|mesh-list
25250435|NCT02520570|Trypsin Inhibitors|trypsin inhibitors|mesh-list
25250436|NCT02520570|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25250437|NCT02520570|Protease Inhibitors|protease inhibitors|mesh-ancestor
25250438|NCT02520570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25250439|NCT02520570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250440|NCT02520479|Pegaspargase|pegaspargase|mesh-list
25250441|NCT02520479|Asparaginase|asparaginase|mesh-list
25250442|NCT02520479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25250443|NCT02520947|Desflurane|desflurane|mesh-list
25250444|NCT02520947|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25250445|NCT02520947|Anesthetics, General|anesthetics, general|mesh-ancestor
25250446|NCT02520947|Anesthetics|anesthetics|mesh-ancestor
25250447|NCT02520947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25250448|NCT02520947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250449|NCT02520505|Citric Acid|citric acid|mesh-list
25250450|NCT02520505|Sodium Citrate|sodium citrate|mesh-list
25250451|NCT02520505|Clomiphene|clomiphene|mesh-list
25250452|NCT02520505|Enclomiphene|enclomiphene|mesh-list
25250453|NCT02520505|Zuclomiphene|zuclomiphene|mesh-list
25250454|NCT02520505|Anticoagulants|anticoagulants|mesh-ancestor
25250455|NCT02520505|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25250456|NCT02520505|Chelating Agents|chelating agents|mesh-ancestor
25250457|NCT02520505|Sequestering Agents|sequestering agents|mesh-ancestor
25250458|NCT02520505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250459|NCT02520505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25250460|NCT02520505|Hormone Antagonists|hormone antagonists|mesh-ancestor
25250461|NCT02520505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25250462|NCT02520505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250463|NCT02520505|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25250464|NCT02520505|Fertility Agents|fertility agents|mesh-ancestor
25250465|NCT02520505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25250466|NCT02520505|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25250467|NCT02520505|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25250468|NCT02520453|Durvalumab|durvalumab|mesh-list
24602082|NCT00967135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24602083|NCT00967135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602084|NCT00967135|Anticonvulsants|anticonvulsants|mesh-ancestor
24602094|NCT00967148|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24602096|NCT00967148|Anticoagulants|anticoagulants|mesh-ancestor
24602097|NCT00967148|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24602098|NCT00967148|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24602099|NCT00967148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602100|NCT00967174|Nicotine|nicotine|mesh-list
24602101|NCT00967174|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24602102|NCT00967174|Autonomic Agents|autonomic agents|mesh-ancestor
24602110|NCT00967213|Ranibizumab|ranibizumab|mesh-list
24602111|NCT00967213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24602112|NCT00967213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24602113|NCT00967213|Growth Substances|growth substances|mesh-ancestor
24602114|NCT00967213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602115|NCT00967213|Growth Inhibitors|growth inhibitors|mesh-ancestor
24602116|NCT00967213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602117|NCT00967252|Atorvastatin|atorvastatin|mesh-list
24602118|NCT00967252|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24602119|NCT00967252|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24743138|NCT04981912|Rituximab|rituximab|mesh-list
24853203|NCT02266524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24853204|NCT02266524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24853205|NCT02266524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24853206|NCT02266524|Adrenergic Agents|adrenergic agents|mesh-ancestor
24853207|NCT02266524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24853208|NCT02266524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602192|NCT00967538|Immunologic Factors|immunologic factors|mesh-ancestor
24853209|NCT02266524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853210|NCT02266524|Urological Agents|urological agents|mesh-ancestor
24853211|NCT02266537|Doxazosin|doxazosin|mesh-list
24853212|NCT02266537|Tamsulosin|tamsulosin|mesh-list
25250469|NCT02520453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25250470|NCT02520453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25250471|NCT02520817|Vitamins|vitamins|mesh-list
25250472|NCT02520817|Ascorbic Acid|ascorbic acid|mesh-list
25250473|NCT02520817|Vitamin E|vitamin e|mesh-list
25250474|NCT02520817|Vitamin A|vitamin a|mesh-list
25250475|NCT02520817|Lactulose|lactulose|mesh-list
25250476|NCT02520817|Micronutrients|micronutrients|mesh-ancestor
25250477|NCT02520817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250478|NCT02520817|Antioxidants|antioxidants|mesh-ancestor
25250479|NCT02520817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250480|NCT02520817|Protective Agents|protective agents|mesh-ancestor
25250481|NCT02520817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25250482|NCT02520219|Endostar protein|endostar protein|mesh-list
25250483|NCT02520219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25250484|NCT02520219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25250485|NCT02520219|Growth Substances|growth substances|mesh-ancestor
25250486|NCT02520219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250487|NCT02520219|Growth Inhibitors|growth inhibitors|mesh-ancestor
25250488|NCT02520219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25250489|NCT02520245|Cemiplimab|cemiplimab|mesh-list
25250490|NCT02520245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25250491|NCT02520245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25250493|NCT02520180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25250494|NCT02520180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25250495|NCT02520180|Immunologic Factors|immunologic factors|mesh-ancestor
25250496|NCT02520180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250497|NCT02520115|Dexamethasone|dexamethasone|mesh-list
25250498|NCT02520115|Dexamethasone acetate|dexamethasone acetate|mesh-list
25250499|NCT02520115|Valproic Acid|valproic acid|mesh-list
25250500|NCT02520115|Ichthammol|ichthammol|mesh-list
25250501|NCT02520115|BB 1101|bb 1101|mesh-list
25250502|NCT02520115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25250503|NCT02520115|Antiemetics|antiemetics|mesh-ancestor
25250504|NCT02520115|Autonomic Agents|autonomic agents|mesh-ancestor
25250505|NCT02520115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25250506|NCT02520115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250507|NCT02520115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25250508|NCT02520115|Glucocorticoids|glucocorticoids|mesh-ancestor
25250509|NCT02520115|Hormones|hormones|mesh-ancestor
25250510|NCT02520115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25250511|NCT02520115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25250512|NCT02520115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602156|NCT00967421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24743287|NCT04899843|Zinc Sulfate|zinc sulfate|mesh-list
24743288|NCT04899843|Astringents|astringents|mesh-ancestor
24743289|NCT04899843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461935|NCT00354380|Anthelmintics|anthelmintics|mesh-ancestor
24602157|NCT00967421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602158|NCT00967434|Atorvastatin|atorvastatin|mesh-list
24602159|NCT00967434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24602160|NCT00967434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24602161|NCT00967434|Antimetabolites|antimetabolites|mesh-ancestor
24760503|NCT01758263|Metoprolol|metoprolol|mesh-list
24615417|NCT01029678|Mitosis Modulators|mitosis modulators|mesh-ancestor
24602162|NCT00967434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602163|NCT00967434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24602164|NCT00967434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24602165|NCT00967434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24602166|NCT00967512|Cytarabine|cytarabine|mesh-list
24602167|NCT00967512|Idarubicin|idarubicin|mesh-list
24602168|NCT00967512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24602169|NCT00967512|Antimetabolites|antimetabolites|mesh-ancestor
24602170|NCT00967512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602171|NCT00967512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602190|NCT00967538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24602191|NCT00967538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24853219|NCT02266537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853220|NCT02266537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853221|NCT02266537|Urological Agents|urological agents|mesh-ancestor
24853222|NCT02266537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24853224|NCT02266589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24853225|NCT02266784|Nicotine|nicotine|mesh-list
24853226|NCT02266784|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24853227|NCT02266784|Autonomic Agents|autonomic agents|mesh-ancestor
24602194|NCT00967603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602195|NCT00967603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24602196|NCT00967603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24602197|NCT00967603|Growth Substances|growth substances|mesh-ancestor
24602198|NCT00967603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602199|NCT00967603|Growth Inhibitors|growth inhibitors|mesh-ancestor
25250513|NCT02520115|Protease Inhibitors|protease inhibitors|mesh-ancestor
25250514|NCT02520115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25250515|NCT02520115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250516|NCT02520115|Anticonvulsants|anticonvulsants|mesh-ancestor
25250517|NCT02520115|GABA Agents|gaba agents|mesh-ancestor
25250518|NCT02520115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25250519|NCT02520115|Antimanic Agents|antimanic agents|mesh-ancestor
25250520|NCT02520115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25250521|NCT02520115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25250522|NCT02520115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25250523|NCT02520115|Dermatologic Agents|dermatologic agents|mesh-ancestor
25250524|NCT02519816|Plasma-lyte 148|plasma-lyte 148|mesh-list
25250525|NCT02519816|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25250526|NCT02519816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25250527|NCT02520102|Sargramostim|sargramostim|mesh-list
25250528|NCT02520102|Immunologic Factors|immunologic factors|mesh-ancestor
25250529|NCT02520102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250530|NCT02519543|Metformin|metformin|mesh-list
25250531|NCT02519543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25250532|NCT02519543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250533|NCT02519582|Niclosamide|niclosamide|mesh-list
25250534|NCT02519582|Anticestodal Agents|anticestodal agents|mesh-ancestor
25250535|NCT02519582|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25250536|NCT02519582|Anthelmintics|anthelmintics|mesh-ancestor
25250537|NCT02519582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25250538|NCT02519582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25250539|NCT02519582|Antinematodal Agents|antinematodal agents|mesh-ancestor
25250540|NCT02519699|Norepinephrine|norepinephrine|mesh-list
25250541|NCT02519699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25250542|NCT02519699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25250543|NCT02519699|Adrenergic Agents|adrenergic agents|mesh-ancestor
25250544|NCT02519699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25250545|NCT02519699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250546|NCT02519699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250547|NCT02519699|Sympathomimetics|sympathomimetics|mesh-ancestor
25250548|NCT02519699|Autonomic Agents|autonomic agents|mesh-ancestor
25250549|NCT02519699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25250550|NCT02519699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25250551|NCT02519608|Aspirin|aspirin|mesh-list
24602200|NCT00967603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24602201|NCT00967603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24602217|NCT00967655|Irinotecan|irinotecan|mesh-list
24602219|NCT00967655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24602220|NCT00967655|Antimetabolites|antimetabolites|mesh-ancestor
24602221|NCT00967655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602222|NCT00967655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602223|NCT00967655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25686897|NCT01925950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24602224|NCT00967655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24602225|NCT00967655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24602226|NCT00967655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24602227|NCT00967707|Gabapentin|gabapentin|mesh-list
24602228|NCT00967707|Donepezil|donepezil|mesh-list
24602229|NCT00967707|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24602230|NCT00967707|Analgesics|analgesics|mesh-ancestor
24602231|NCT00967707|Sensory System Agents|sensory system agents|mesh-ancestor
24602232|NCT00967707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24602233|NCT00967707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602234|NCT00967707|Anticonvulsants|anticonvulsants|mesh-ancestor
24602235|NCT00967707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24602258|NCT00967772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602259|NCT00967772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602260|NCT00967772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24602261|NCT00967772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24853228|NCT02266784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24853229|NCT02266784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602280|NCT00967954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602284|NCT00967967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24602285|NCT00967967|Dermatologic Agents|dermatologic agents|mesh-ancestor
24602286|NCT00967967|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24602287|NCT00967967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24602288|NCT00967967|Cholinergic Agents|cholinergic agents|mesh-ancestor
24602289|NCT00967967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24602290|NCT00967967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602292|NCT00967967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24580386|NCT00861523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25250552|NCT02519608|Clopidogrel|clopidogrel|mesh-list
25250553|NCT02519608|Ticagrelor|ticagrelor|mesh-list
25250554|NCT02519608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25250555|NCT02519608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25250556|NCT02519608|Analgesics|analgesics|mesh-ancestor
25250557|NCT02519608|Sensory System Agents|sensory system agents|mesh-ancestor
25250558|NCT02519608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25250559|NCT02519608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250560|NCT02519608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25250561|NCT02519608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25250562|NCT02519608|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25250563|NCT02519608|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25250564|NCT02519608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250565|NCT02519608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25250566|NCT02519608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25250567|NCT02519608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25250568|NCT02519608|Antipyretics|antipyretics|mesh-ancestor
25250570|NCT02519608|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25250571|NCT02519608|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25250572|NCT02519608|Purinergic Agents|purinergic agents|mesh-ancestor
25250573|NCT02519608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25250574|NCT02519660|Lidocaine|lidocaine|mesh-list
25250575|NCT02519660|Tetracaine|tetracaine|mesh-list
25250576|NCT02519660|Prilocaine|prilocaine|mesh-list
25250577|NCT02519660|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25250578|NCT02519660|Anesthetics, Local|anesthetics, local|mesh-ancestor
25250579|NCT02519660|Anesthetics|anesthetics|mesh-ancestor
25250580|NCT02519660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25250581|NCT02519660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250582|NCT02519660|Sensory System Agents|sensory system agents|mesh-ancestor
25250583|NCT02519660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25250584|NCT02519660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25250585|NCT02519660|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25250586|NCT02519660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25250587|NCT02519660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24602293|NCT00967967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24602294|NCT00967967|Histamine Antagonists|histamine antagonists|mesh-ancestor
24602295|NCT00967967|Histamine Agents|histamine agents|mesh-ancestor
24602296|NCT00968006|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24602297|NCT00968006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24602298|NCT00968006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602299|NCT00968006|Incretins|incretins|mesh-ancestor
24602300|NCT00968006|Hormones|hormones|mesh-ancestor
25045267|NCT00978497|Ribavirin|ribavirin|mesh-list
24602301|NCT00968006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24602428|NCT00968760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24602460|NCT00968929|Streptokinase|streptokinase|mesh-list
24602461|NCT00968929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24602462|NCT00968929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24602463|NCT00968929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602464|NCT00968955|Ropivacaine|ropivacaine|mesh-list
24602465|NCT00968955|Anesthetics, Local|anesthetics, local|mesh-ancestor
24602466|NCT00968955|Anesthetics|anesthetics|mesh-ancestor
24602467|NCT00968955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25250588|NCT02519660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250589|NCT02519660|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25250590|NCT02519413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25250591|NCT02519413|Dermatologic Agents|dermatologic agents|mesh-ancestor
25250592|NCT02519413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25250593|NCT02519413|Immunologic Factors|immunologic factors|mesh-ancestor
25250594|NCT02519413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250595|NCT02519335|Dexrazoxane|dexrazoxane|mesh-list
25250596|NCT02519335|Razoxane|razoxane|mesh-list
25250597|NCT02519335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25250598|NCT02519335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25250599|NCT02519335|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25250600|NCT02519335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25250601|NCT02519335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25250602|NCT02519335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250603|NCT02519335|Protective Agents|protective agents|mesh-ancestor
25250604|NCT02519335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250605|NCT02519335|Antimitotic Agents|antimitotic agents|mesh-ancestor
25250606|NCT02519335|Mitosis Modulators|mitosis modulators|mesh-ancestor
25250608|NCT02519322|Ipilimumab|ipilimumab|mesh-list
25250609|NCT02519322|Immunoglobulins|immunoglobulins|mesh-list
25250610|NCT02519322|Immunoglobulin G|immunoglobulin g|mesh-list
25250611|NCT02519322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25250612|NCT02519322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25250613|NCT02519322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25250614|NCT02519322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250615|NCT02519322|Immunologic Factors|immunologic factors|mesh-ancestor
25250616|NCT02519322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250617|NCT02519400|Amitriptyline|amitriptyline|mesh-list
25250618|NCT02519400|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25250619|NCT02519400|Antidepressive Agents|antidepressive agents|mesh-ancestor
25250620|NCT02519400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25250621|NCT02519400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25250622|NCT02519400|Analgesics|analgesics|mesh-ancestor
25250623|NCT02519400|Sensory System Agents|sensory system agents|mesh-ancestor
25250629|NCT02519400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250630|NCT02519400|Adrenergic Agents|adrenergic agents|mesh-ancestor
25250631|NCT02519400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25250632|NCT02519153|Sildenafil Citrate|sildenafil citrate|mesh-list
25250633|NCT02519153|Vasodilator Agents|vasodilator agents|mesh-ancestor
25250634|NCT02519153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25250635|NCT02519153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25250636|NCT02519153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25250637|NCT02519153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250638|NCT02519153|Urological Agents|urological agents|mesh-ancestor
25250639|NCT02519010|Amlodipine|amlodipine|mesh-list
25250640|NCT02519010|Valsartan|valsartan|mesh-list
24602532|NCT00969293|Analgesics|analgesics|mesh-ancestor
24602533|NCT00969293|Sensory System Agents|sensory system agents|mesh-ancestor
24462246|NCT00355602|Metronidazole|metronidazole|mesh-list
24853243|NCT02265484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24853244|NCT02265484|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24853245|NCT02265484|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24853246|NCT02265484|Hormone Antagonists|hormone antagonists|mesh-ancestor
24602711|NCT00970580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602712|NCT00970697|Becaplermin|becaplermin|mesh-list
24602713|NCT00970697|Anticoagulants|anticoagulants|mesh-ancestor
24602714|NCT00970697|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
24602715|NCT00970697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24602716|NCT00970697|Growth Substances|growth substances|mesh-ancestor
24602717|NCT00970697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602718|NCT00970762|Rocuronium|rocuronium|mesh-list
24602719|NCT00970762|Vecuronium Bromide|vecuronium bromide|mesh-list
24602720|NCT00970762|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24602721|NCT00970762|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24602722|NCT00970762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24602723|NCT00970762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24720970|NCT01571791|Ketorolac|ketorolac|mesh-list
24602774|NCT00970957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24602775|NCT00970957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602776|NCT00970957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24602790|NCT00970970|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24863056|NCT03635788|Antiviral Agents|antiviral agents|mesh-ancestor
24602823|NCT00971126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24602824|NCT00971126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24602825|NCT00971126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602826|NCT00971126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24853255|NCT02266927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24999447|NCT04332341|Niacin|niacin|mesh-list
25250641|NCT02519010|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
25250642|NCT02519010|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25250643|NCT02519010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24588138|NCT00901147|Panobinostat|panobinostat|mesh-list
25250644|NCT02519010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25250645|NCT02519010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250646|NCT02519010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25250647|NCT02519010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250648|NCT02519010|Vasodilator Agents|vasodilator agents|mesh-ancestor
25250649|NCT02519010|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25250650|NCT02519010|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25250651|NCT02518802|Pemetrexed|pemetrexed|mesh-list
25250652|NCT02518802|Gefitinib|gefitinib|mesh-list
25250653|NCT02518802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25250654|NCT02518802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25250655|NCT02518802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250656|NCT02518802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25250657|NCT02518802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25250658|NCT02518802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25250674|NCT02518763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25250675|NCT02518763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25250676|NCT02518789|Fentanyl|fentanyl|mesh-list
25250677|NCT02518789|Midazolam|midazolam|mesh-list
25250678|NCT02518789|Dexmedetomidine|dexmedetomidine|mesh-list
25250679|NCT02518789|Remifentanil|remifentanil|mesh-list
25250680|NCT02518789|Propofol|propofol|mesh-list
25250681|NCT02518789|Etomidate|etomidate|mesh-list
25250682|NCT02518789|Atracurium|atracurium|mesh-list
24602906|NCT00971659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602909|NCT00971659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24602910|NCT00971659|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24602911|NCT00971659|Protease Inhibitors|protease inhibitors|mesh-ancestor
24602912|NCT00971659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24602913|NCT00971659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602914|NCT00971659|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24602915|NCT00971685|Dexamethasone|dexamethasone|mesh-list
24853262|NCT02266927|Dermatologic Agents|dermatologic agents|mesh-ancestor
24602935|NCT00971724|Glucocorticoids|glucocorticoids|mesh-ancestor
24602937|NCT00971724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24602938|NCT00971724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602939|NCT00971724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24602940|NCT00971724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602941|NCT00971763|Gemcitabine|gemcitabine|mesh-list
24602942|NCT00971763|Prednisolone|prednisolone|mesh-list
24602943|NCT00971763|Cyclophosphamide|cyclophosphamide|mesh-list
24602944|NCT00971763|Rituximab|rituximab|mesh-list
24602945|NCT00971763|Vincristine|vincristine|mesh-list
24602980|NCT00971815|Antidepressive Agents|antidepressive agents|mesh-ancestor
24603005|NCT00971893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24603006|NCT00971893|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24603007|NCT00971893|Protective Agents|protective agents|mesh-ancestor
24603008|NCT00971893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24603009|NCT00971893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603010|NCT00972075|Melatonin|melatonin|mesh-list
24603017|NCT00972101|Rituximab|rituximab|mesh-list
25250683|NCT02518789|Rocuronium|rocuronium|mesh-list
25250684|NCT02518789|Cisatracurium|cisatracurium|mesh-list
25250685|NCT02518789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25250686|NCT02518789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25250687|NCT02518789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250688|NCT02518789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25250689|NCT02518789|Anesthetics, General|anesthetics, general|mesh-ancestor
25686898|NCT01925950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250691|NCT02518789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25250692|NCT02518789|Analgesics|analgesics|mesh-ancestor
25250693|NCT02518789|Sensory System Agents|sensory system agents|mesh-ancestor
25250694|NCT02518789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25250695|NCT02518789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25250696|NCT02518789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25250697|NCT02518789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25250698|NCT02518789|Adrenergic Agents|adrenergic agents|mesh-ancestor
25250699|NCT02518789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25250700|NCT02518789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250701|NCT02518789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25250702|NCT02518789|Narcotics|narcotics|mesh-ancestor
25250703|NCT02518789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25250704|NCT02518789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25250705|NCT02518789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25250706|NCT02518789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25250707|NCT02518789|GABA Modulators|gaba modulators|mesh-ancestor
25250708|NCT02518789|GABA Agents|gaba agents|mesh-ancestor
25250709|NCT02518789|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25250710|NCT02518789|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25250711|NCT02518789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25250712|NCT02518789|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25250713|NCT02518789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25250714|NCT02518789|Cholinergic Agents|cholinergic agents|mesh-ancestor
25274530|NCT02377193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25274531|NCT02377193|Immunologic Factors|immunologic factors|mesh-ancestor
25274532|NCT02377193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274533|NCT02377193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25274534|NCT02377193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274535|NCT02377193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274536|NCT02377193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25274537|NCT02377193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25274538|NCT02377193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25274539|NCT02377193|Antitubercular Agents|antitubercular agents|mesh-ancestor
25274540|NCT02377193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25274541|NCT02377193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25274542|NCT02377180|Anesthetics|anesthetics|mesh-list
24853265|NCT02266940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24853266|NCT02266940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24853267|NCT02266940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24603117|NCT00972426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603118|NCT00972426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24603119|NCT00972426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24462565|NCT00356954|Vitamins|vitamins|mesh-ancestor
24603212|NCT00972907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24603213|NCT00972907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603214|NCT00972907|Vasodilator Agents|vasodilator agents|mesh-ancestor
24603215|NCT00972907|Tocolytic Agents|tocolytic agents|mesh-ancestor
24603216|NCT00972907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24603217|NCT00972933|Ipilimumab|ipilimumab|mesh-list
24603218|NCT00972933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24603219|NCT00972933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24853269|NCT02267044|Ropivacaine|ropivacaine|mesh-list
24853270|NCT02267044|Anesthetics, Local|anesthetics, local|mesh-ancestor
24853271|NCT02267044|Anesthetics|anesthetics|mesh-ancestor
24853272|NCT02267044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24853273|NCT02267044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853274|NCT02267044|Sensory System Agents|sensory system agents|mesh-ancestor
24853275|NCT02267044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24853276|NCT02267057|Acetaminophen|acetaminophen|mesh-list
24853277|NCT02267057|Buprenorphine|buprenorphine|mesh-list
24853278|NCT02267057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24853279|NCT02267057|Analgesics|analgesics|mesh-ancestor
24853280|NCT02267057|Sensory System Agents|sensory system agents|mesh-ancestor
24853281|NCT02267057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24853282|NCT02267057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853283|NCT02267057|Antipyretics|antipyretics|mesh-ancestor
24853284|NCT02267057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24853285|NCT02267057|Narcotics|narcotics|mesh-ancestor
24853287|NCT02267057|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25250715|NCT02518958|Nivolumab|nivolumab|mesh-list
25250716|NCT02518958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25250717|NCT02518958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25250718|NCT02518958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24957874|NCT03839771|Ivosidenib|ivosidenib|mesh-list
24941839|NCT03987152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24941840|NCT03987152|Immunologic Factors|immunologic factors|mesh-ancestor
24941841|NCT03987152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721263|NCT01572805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24721264|NCT01572831|Tin Fluorides|tin fluorides|mesh-list
24721265|NCT01572831|Cariostatic Agents|cariostatic agents|mesh-ancestor
24721266|NCT01572831|Protective Agents|protective agents|mesh-ancestor
24721267|NCT01572831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721304|NCT01573286|Hormones|hormones|mesh-ancestor
25250719|NCT02518958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250720|NCT02518698|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25250721|NCT02518698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25250722|NCT02518503|Atorvastatin|atorvastatin|mesh-list
25250723|NCT02518503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25250724|NCT02518503|Simvastatin|simvastatin|mesh-list
25250725|NCT02518503|Pravastatin|pravastatin|mesh-list
25250726|NCT02518503|Lovastatin|lovastatin|mesh-list
25250727|NCT02518503|L 647318|l 647318|mesh-list
25250728|NCT02518503|Dihydromevinolin|dihydromevinolin|mesh-list
25250729|NCT02518503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25250730|NCT02518503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25250731|NCT02518503|Antimetabolites|antimetabolites|mesh-ancestor
25250732|NCT02518503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250733|NCT02518503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25250734|NCT02518503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25250735|NCT02518503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25250736|NCT02518451|Valsartan|valsartan|mesh-list
25250737|NCT02518451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25250738|NCT02518451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25250739|NCT02518451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25250740|NCT02518451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250741|NCT02518373|Omeprazole|omeprazole|mesh-list
25250742|NCT02518373|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25250744|NCT02518373|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25250745|NCT02518373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25250746|NCT02518373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250747|NCT02518516|Atorvastatin|atorvastatin|mesh-list
25250748|NCT02518516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25250749|NCT02518516|Simvastatin|simvastatin|mesh-list
25250750|NCT02518516|Pravastatin|pravastatin|mesh-list
25250751|NCT02518516|Lovastatin|lovastatin|mesh-list
25250752|NCT02518516|L 647318|l 647318|mesh-list
25250753|NCT02518516|Dihydromevinolin|dihydromevinolin|mesh-list
25250754|NCT02518516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25250755|NCT02518516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25250756|NCT02518516|Antimetabolites|antimetabolites|mesh-ancestor
25274543|NCT02377180|Anesthetics, Local|anesthetics, local|mesh-list
24603245|NCT00972985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24759029|NCT01749085|Hormone Antagonists|hormone antagonists|mesh-ancestor
24603260|NCT00973037|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24603261|NCT00973037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24603262|NCT00973050|Bicalutamide|bicalutamide|mesh-list
24603263|NCT00973050|Androgen Antagonists|androgen antagonists|mesh-ancestor
24603264|NCT00973050|Hormone Antagonists|hormone antagonists|mesh-ancestor
24603265|NCT00973050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24603321|NCT00973232|Narcotics|narcotics|mesh-ancestor
24603322|NCT00973232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24603324|NCT00973245|Rivaroxaban|rivaroxaban|mesh-list
24603325|NCT00973245|Anticoagulants|anticoagulants|mesh-ancestor
24603326|NCT00973245|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24603327|NCT00973245|Antithrombins|antithrombins|mesh-ancestor
24603328|NCT00973245|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24603418|NCT00973687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24603419|NCT00973687|Glucocorticoids|glucocorticoids|mesh-ancestor
25686899|NCT01925950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25686900|NCT01925950|Respiratory System Agents|respiratory system agents|mesh-ancestor
25686901|NCT01925989|Insulin Glargine|insulin glargine|mesh-list
25686902|NCT01925989|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25686903|NCT01925989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686904|NCT01926444|Trimebutine|trimebutine|mesh-list
25686905|NCT01926444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25686906|NCT01926444|Parasympatholytics|parasympatholytics|mesh-ancestor
25686907|NCT01926444|Autonomic Agents|autonomic agents|mesh-ancestor
24603421|NCT00973687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24603422|NCT00973687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25686908|NCT01926444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24603423|NCT00973687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603424|NCT00973713|Everolimus|everolimus|mesh-list
24603441|NCT00973804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603442|NCT00973804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24603443|NCT00973804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24603444|NCT00973804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24603445|NCT00973804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603446|NCT00973804|Antifungal Agents|antifungal agents|mesh-ancestor
24603448|NCT00973869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24603449|NCT00973869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24603450|NCT00973869|Analgesics|analgesics|mesh-ancestor
24603451|NCT00973869|Sensory System Agents|sensory system agents|mesh-ancestor
25250757|NCT02518516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250758|NCT02518516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25250759|NCT02518516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25250760|NCT02518516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25250761|NCT02518438|Tramadol|tramadol|mesh-list
25250762|NCT02518438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25250763|NCT02518438|Narcotics|narcotics|mesh-ancestor
25250764|NCT02518438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25250765|NCT02518438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250766|NCT02518438|Analgesics|analgesics|mesh-ancestor
25250767|NCT02518438|Sensory System Agents|sensory system agents|mesh-ancestor
25250768|NCT02518438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25250769|NCT02518295|Sulfalene|sulfalene|mesh-list
25250770|NCT02518295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25250771|NCT02518295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25250772|NCT02518295|Renal Agents|renal agents|mesh-ancestor
25250773|NCT02518295|Antimalarials|antimalarials|mesh-ancestor
25250774|NCT02518295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25250775|NCT02518295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25250776|NCT02518152|Alendronate|alendronate|mesh-list
25250777|NCT02518152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25250778|NCT02518152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250779|NCT02518022|Insulin|insulin|mesh-list
25250780|NCT02518022|Insulin Lispro|insulin lispro|mesh-list
25250781|NCT02518022|Insulin Aspart|insulin aspart|mesh-list
25250782|NCT02518022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25250783|NCT02518022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250784|NCT02517814|Vitamin D|vitamin d|mesh-list
25250785|NCT02517814|Vitamins|vitamins|mesh-ancestor
25250786|NCT02517814|Micronutrients|micronutrients|mesh-ancestor
25250966|NCT02516631|Oxytocics|oxytocics|mesh-ancestor
25250787|NCT02517814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250829|NCT02517918|Antifungal Agents|antifungal agents|mesh-ancestor
25250788|NCT02517814|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25250789|NCT02517827|Paclitaxel|paclitaxel|mesh-list
25250790|NCT02517827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25250791|NCT02517827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25250792|NCT02517827|Tubulin Modulators|tubulin modulators|mesh-ancestor
25250793|NCT02517827|Antimitotic Agents|antimitotic agents|mesh-ancestor
25250794|NCT02517827|Mitosis Modulators|mitosis modulators|mesh-ancestor
25250795|NCT02517827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250796|NCT02517788|Interferons|interferons|mesh-list
25250797|NCT02517788|Interferon-beta|interferon-beta|mesh-list
25250798|NCT02517788|Interferon beta-1a|interferon beta-1a|mesh-list
25274544|NCT02377180|Capsaicin|capsaicin|mesh-list
24603460|NCT00973882|Etoposide|etoposide|mesh-list
24853291|NCT02267122|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24853292|NCT02267122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24853293|NCT02267122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603509|NCT00974155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603510|NCT00974155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24603512|NCT00974155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24603513|NCT00974155|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24603514|NCT00974155|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24603515|NCT00974155|Parasympatholytics|parasympatholytics|mesh-ancestor
24603516|NCT00974155|Autonomic Agents|autonomic agents|mesh-ancestor
24603517|NCT00974155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24603518|NCT00974155|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24603519|NCT00974155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24603520|NCT00974155|Cholinergic Agents|cholinergic agents|mesh-ancestor
24603522|NCT00974181|Paclitaxel|paclitaxel|mesh-list
24603523|NCT00974181|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24462742|NCT00357448|Immunotoxins|immunotoxins|mesh-list
24853306|NCT02267239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853308|NCT02267239|Antifungal Agents|antifungal agents|mesh-ancestor
24721589|NCT01575678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721590|NCT01575678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24721592|NCT01575717|Ergocalciferols|ergocalciferols|mesh-list
24721593|NCT01575717|Cholecalciferol|cholecalciferol|mesh-list
24721610|NCT01575795|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24941854|NCT03986762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24941855|NCT03986762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24941856|NCT03986762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24941857|NCT03986762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941858|NCT03986762|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24941859|NCT03986905|Scopolamine|scopolamine|mesh-list
24941860|NCT03986905|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24853309|NCT02267304|Morphine|morphine|mesh-list
24853310|NCT02267304|Naloxone|naloxone|mesh-list
24853311|NCT02267304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24853312|NCT02267304|Narcotics|narcotics|mesh-ancestor
24853313|NCT02267304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24853314|NCT02267304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853315|NCT02267304|Analgesics|analgesics|mesh-ancestor
24853316|NCT02267304|Sensory System Agents|sensory system agents|mesh-ancestor
24853317|NCT02267304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24853318|NCT02267304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24853319|NCT02267408|Warfarin|warfarin|mesh-list
24666206|NCT01318044|Thiopental|thiopental|mesh-list
24603611|NCT00974753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24603612|NCT00974753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24603613|NCT00974753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25250799|NCT02517788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25250800|NCT02517788|Antiviral Agents|antiviral agents|mesh-ancestor
25250801|NCT02517788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25250802|NCT02517788|Immunologic Factors|immunologic factors|mesh-ancestor
25250803|NCT02517788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250804|NCT02517788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25250805|NCT02517957|Loperamide|loperamide|mesh-list
25250806|NCT02517957|Antidiarrheals|antidiarrheals|mesh-list
25250807|NCT02517957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25250808|NCT02517918|Zoledronic Acid|zoledronic acid|mesh-list
25250809|NCT02517918|Sirolimus|sirolimus|mesh-list
25250810|NCT02517918|Methotrexate|methotrexate|mesh-list
25250811|NCT02517918|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25250812|NCT02517918|Abortifacient Agents|abortifacient agents|mesh-ancestor
25250813|NCT02517918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25250814|NCT02517918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250815|NCT02517918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25250816|NCT02517918|Antimetabolites|antimetabolites|mesh-ancestor
25250817|NCT02517918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250818|NCT02517918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25250819|NCT02517918|Dermatologic Agents|dermatologic agents|mesh-ancestor
25250820|NCT02517918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25250821|NCT02517918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25250822|NCT02517918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25250823|NCT02517918|Immunologic Factors|immunologic factors|mesh-ancestor
25250824|NCT02517918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25250825|NCT02517918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25250826|NCT02517918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25250827|NCT02517918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25250967|NCT02516527|Ipilimumab|ipilimumab|mesh-list
25250828|NCT02517918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25250830|NCT02517918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25250831|NCT02517736|Sorafenib|sorafenib|mesh-list
25250832|NCT02517736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24974907|NCT05023369|Dexamethasone|dexamethasone|mesh-list
25686909|NCT01926444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686910|NCT01926496|Imiquimod|imiquimod|mesh-list
25686911|NCT01926496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25686912|NCT01926496|Immunologic Factors|immunologic factors|mesh-ancestor
25686913|NCT01926496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686914|NCT01926496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25686915|NCT01926496|Interferon Inducers|interferon inducers|mesh-ancestor
25686916|NCT01926626|Moclobemide|moclobemide|mesh-list
25686917|NCT01926626|Nicotine|nicotine|mesh-list
25686918|NCT01926626|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25686919|NCT01926626|Autonomic Agents|autonomic agents|mesh-ancestor
25686920|NCT01926626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686921|NCT01926626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250833|NCT02517736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25250834|NCT02517736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25250835|NCT02517736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250836|NCT02517684|Prednisolone|prednisolone|mesh-list
25250837|NCT02517684|Azathioprine|azathioprine|mesh-list
25250838|NCT02517684|Infliximab|infliximab|mesh-list
25250839|NCT02517684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24853331|NCT02267655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603666|NCT00974805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24603667|NCT00974805|Autonomic Agents|autonomic agents|mesh-ancestor
24603710|NCT00975065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603711|NCT00975065|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24603712|NCT00975065|Protease Inhibitors|protease inhibitors|mesh-ancestor
24603713|NCT00975065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603714|NCT00975065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603715|NCT00975078|Prednisone|prednisone|mesh-list
24603716|NCT00975078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24603717|NCT00975078|Glucocorticoids|glucocorticoids|mesh-ancestor
24603718|NCT00975078|Hormones|hormones|mesh-ancestor
24603719|NCT00975078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24603720|NCT00975078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603721|NCT00975078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24603722|NCT00975078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603723|NCT00975104|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
24603724|NCT00975104|Immunologic Factors|immunologic factors|mesh-ancestor
24603725|NCT00975104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628878|NCT01101698|Hemostatics|hemostatics|mesh-ancestor
24603771|NCT00975494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250840|NCT02517684|Glucocorticoids|glucocorticoids|mesh-ancestor
25250841|NCT02517684|Hormones|hormones|mesh-ancestor
25250842|NCT02517684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25250843|NCT02517684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250844|NCT02517684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25250845|NCT02517684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25250846|NCT02517684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25250847|NCT02517684|Dermatologic Agents|dermatologic agents|mesh-ancestor
25250848|NCT02517684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25250849|NCT02517684|Antimetabolites|antimetabolites|mesh-ancestor
25250850|NCT02517684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250851|NCT02517684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25250852|NCT02517684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25250853|NCT02517684|Immunologic Factors|immunologic factors|mesh-ancestor
25250854|NCT02517619|Dexamethasone|dexamethasone|mesh-list
25250855|NCT02517619|Prednisolone|prednisolone|mesh-list
25250856|NCT02517619|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25250857|NCT02517619|Methylprednisolone|methylprednisolone|mesh-list
25250858|NCT02517619|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25250859|NCT02517619|Prednisolone acetate|prednisolone acetate|mesh-list
25250860|NCT02517619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25250861|NCT02517619|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25250862|NCT02517619|Prednisolone phosphate|prednisolone phosphate|mesh-list
25250863|NCT02517619|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25250864|NCT02517619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25250865|NCT02517619|Antiemetics|antiemetics|mesh-ancestor
25250866|NCT02517619|Autonomic Agents|autonomic agents|mesh-ancestor
25250867|NCT02517619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25250868|NCT02517619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250869|NCT02517619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25250870|NCT02517619|Glucocorticoids|glucocorticoids|mesh-ancestor
25250871|NCT02517619|Hormones|hormones|mesh-ancestor
25250872|NCT02517619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25250873|NCT02517619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25250874|NCT02517619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25250875|NCT02517619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25250876|NCT02517619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25250877|NCT02517619|Protective Agents|protective agents|mesh-ancestor
25250878|NCT02517372|Pemirolast|pemirolast|mesh-list
25250879|NCT02517372|Histamine Antagonists|histamine antagonists|mesh-ancestor
25250880|NCT02517372|Histamine Agents|histamine agents|mesh-ancestor
25250881|NCT02517372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25274546|NCT02377180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250882|NCT02517372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250883|NCT02517372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250884|NCT02517489|Hydrocortisone|hydrocortisone|mesh-list
25250885|NCT02517489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25250886|NCT02517424|Dronabinol|dronabinol|mesh-list
25250887|NCT02517424|Hallucinogens|hallucinogens|mesh-ancestor
25250888|NCT02517424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250889|NCT02517424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25250890|NCT02517424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25250891|NCT02517424|Analgesics|analgesics|mesh-ancestor
24603897|NCT00976092|Clopidogrel|clopidogrel|mesh-list
24603930|NCT00976170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603931|NCT00976170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24603932|NCT00976170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603933|NCT00976170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603934|NCT00976222|Ranibizumab|ranibizumab|mesh-list
24603935|NCT00976222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24603936|NCT00976222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24603937|NCT00976222|Growth Substances|growth substances|mesh-ancestor
24603963|NCT00976300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603964|NCT00976300|Antifungal Agents|antifungal agents|mesh-ancestor
24603975|NCT00976651|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24603976|NCT00976651|Fertility Agents|fertility agents|mesh-ancestor
24603977|NCT00976651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24603978|NCT00976651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603981|NCT00976690|Antimetabolites|antimetabolites|mesh-ancestor
24603982|NCT00976690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603983|NCT00976690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24603984|NCT00976690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24974985|NCT04862585|Antiemetics|antiemetics|mesh-ancestor
24603985|NCT00976690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24604030|NCT00976794|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24604032|NCT00976963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24604033|NCT00976963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24604034|NCT00976976|Cisplatin|cisplatin|mesh-list
24604044|NCT00977028|Lidocaine|lidocaine|mesh-list
24604045|NCT00977028|Epinephrine|epinephrine|mesh-list
24604046|NCT00977028|Racepinephrine|racepinephrine|mesh-list
24604047|NCT00977028|Anesthetics|anesthetics|mesh-list
24604048|NCT00977028|Epinephryl borate|epinephryl borate|mesh-list
24604049|NCT00977028|Anesthetics, Local|anesthetics, local|mesh-ancestor
24604050|NCT00977028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24604051|NCT00977028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604052|NCT00977028|Sensory System Agents|sensory system agents|mesh-ancestor
24604053|NCT00977028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24604054|NCT00977028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24604055|NCT00977028|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25250892|NCT02517424|Sensory System Agents|sensory system agents|mesh-ancestor
25250893|NCT02517424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25250894|NCT02517424|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25250895|NCT02517424|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25250896|NCT02517424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25250897|NCT02517424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250898|NCT02517424|Hormones|hormones|mesh-ancestor
25250899|NCT02517424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25250900|NCT02517307|Heparin|heparin|mesh-list
25250901|NCT02517307|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25250902|NCT02517307|Glycerol|glycerol|mesh-list
25250903|NCT02517307|Anticoagulants|anticoagulants|mesh-ancestor
25250904|NCT02517307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25250905|NCT02517307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25250906|NCT02517307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250907|NCT02517307|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25250908|NCT02517307|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25250909|NCT02517307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25250910|NCT02517307|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25250911|NCT02517307|Protective Agents|protective agents|mesh-ancestor
25250912|NCT02517307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250913|NCT02517164|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
25250914|NCT02517164|Calcifediol|calcifediol|mesh-list
25250915|NCT02517164|Vitamins|vitamins|mesh-ancestor
25250916|NCT02517164|Micronutrients|micronutrients|mesh-ancestor
25250917|NCT02517164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250918|NCT02517164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25274545|NCT02377180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25274547|NCT02377180|Sensory System Agents|sensory system agents|mesh-ancestor
25274548|NCT02377180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25274550|NCT02377180|Dermatologic Agents|dermatologic agents|mesh-ancestor
25274552|NCT02377076|Calcium|calcium|mesh-list
25274553|NCT02377076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25274554|NCT02377076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604058|NCT00977028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629044|NCT01102699|Lenograstim|lenograstim|mesh-list
24604107|NCT00977223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604108|NCT00977223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24604109|NCT00977223|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24604110|NCT00977223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24604111|NCT00977223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604113|NCT00977249|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24604114|NCT00977249|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24604115|NCT00977249|Cholinergic Agents|cholinergic agents|mesh-ancestor
24604116|NCT00977249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24604117|NCT00977249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604118|NCT00977249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604119|NCT00977288|Atorvastatin|atorvastatin|mesh-list
24604120|NCT00977288|Anacetrapib|anacetrapib|mesh-list
24604121|NCT00977288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25250919|NCT02516826|Olmesartan|olmesartan|mesh-list
25250920|NCT02516826|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25250921|NCT02516826|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25250922|NCT02516826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25250923|NCT02516826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25250924|NCT02516826|Antimetabolites|antimetabolites|mesh-ancestor
25250925|NCT02516826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250926|NCT02516826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25250927|NCT02516826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25250928|NCT02516826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25250929|NCT02516826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25250930|NCT02516826|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25250931|NCT02516826|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25250932|NCT02517099|Azithromycin|azithromycin|mesh-list
25250933|NCT02517099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25250934|NCT02517099|Beclomethasone|beclomethasone|mesh-list
25250935|NCT02517099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25250936|NCT02517099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25250937|NCT02517099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25250938|NCT02517099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25250939|NCT02517099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250940|NCT02517099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25250941|NCT02517099|Glucocorticoids|glucocorticoids|mesh-ancestor
25250942|NCT02517099|Hormones|hormones|mesh-ancestor
25250943|NCT02517099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25250944|NCT02517099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250945|NCT02517099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25250946|NCT02517099|Respiratory System Agents|respiratory system agents|mesh-ancestor
25250947|NCT02516774|Adalimumab|adalimumab|mesh-list
25250948|NCT02516774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25250949|NCT02516774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25250950|NCT02516618|Fasinumab|fasinumab|mesh-list
25250951|NCT02516618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25250952|NCT02516618|Analgesics|analgesics|mesh-ancestor
25250953|NCT02516618|Sensory System Agents|sensory system agents|mesh-ancestor
25250954|NCT02516618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25250955|NCT02516618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250956|NCT02516904|Rezafungin|rezafungin|mesh-list
25250957|NCT02516904|Antifungal Agents|antifungal agents|mesh-ancestor
25250958|NCT02516904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25250959|NCT02516631|Misoprostol|misoprostol|mesh-list
25250960|NCT02516631|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25250961|NCT02516631|Abortifacient Agents|abortifacient agents|mesh-ancestor
25250962|NCT02516631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25250963|NCT02516631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250964|NCT02516631|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25250965|NCT02516631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25250968|NCT02516527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25250969|NCT02516527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25250970|NCT02516527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25250971|NCT02516527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250973|NCT02516475|Astringents|astringents|mesh-ancestor
25275678|NCT02370433|Autonomic Agents|autonomic agents|mesh-ancestor
24798484|NCT01963832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24798485|NCT01963832|Serotonin Agents|serotonin agents|mesh-ancestor
24722065|NCT01578434|Calcium|calcium|mesh-list
24798486|NCT01963832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250974|NCT02516475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250975|NCT02516475|Dermatologic Agents|dermatologic agents|mesh-ancestor
25250976|NCT02516423|Zoledronic Acid|zoledronic acid|mesh-list
24604254|NCT00978159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604255|NCT00978159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604256|NCT00978159|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24604257|NCT00978159|Histamine Antagonists|histamine antagonists|mesh-ancestor
24604258|NCT00978159|Histamine Agents|histamine agents|mesh-ancestor
24604259|NCT00978159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24604260|NCT00978159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604262|NCT00978172|Mefloquine|mefloquine|mesh-list
24604263|NCT00978172|Antimalarials|antimalarials|mesh-ancestor
24604264|NCT00978172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24604265|NCT00978172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24604266|NCT00978172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24604267|NCT00978172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604268|NCT00978172|Antiviral Agents|antiviral agents|mesh-ancestor
24604269|NCT00978172|Schistosomicides|schistosomicides|mesh-ancestor
24604270|NCT00978172|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24629174|NCT01103518|Cyproterone|cyproterone|mesh-list
24853363|NCT02267707|Mitosis Modulators|mitosis modulators|mesh-ancestor
24853364|NCT02267707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853365|NCT02267707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24853366|NCT02267707|Antimetabolites|antimetabolites|mesh-ancestor
24853367|NCT02267707|Antiviral Agents|antiviral agents|mesh-ancestor
24853368|NCT02267707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24853369|NCT02267707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24853370|NCT02267707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24853371|NCT02267707|Immunologic Factors|immunologic factors|mesh-ancestor
24853372|NCT02267707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853373|NCT02267720|Salicylic Acid|salicylic acid|mesh-list
24604348|NCT00978718|Trace Elements|trace elements|mesh-ancestor
24604425|NCT00979472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25250977|NCT02516423|Dexamethasone|dexamethasone|mesh-list
25250978|NCT02516423|Lenalidomide|lenalidomide|mesh-list
25250979|NCT02516423|Ixazomib|ixazomib|mesh-list
25250980|NCT02516423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25102661|NCT03167164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24604426|NCT00979472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25250981|NCT02516423|Antiemetics|antiemetics|mesh-ancestor
25250982|NCT02516423|Autonomic Agents|autonomic agents|mesh-ancestor
25250983|NCT02516423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25250984|NCT02516423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25250985|NCT02516423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25250986|NCT02516423|Glucocorticoids|glucocorticoids|mesh-ancestor
25250987|NCT02516423|Hormones|hormones|mesh-ancestor
25250988|NCT02516423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25250989|NCT02516423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25250990|NCT02516423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25250991|NCT02516423|Immunologic Factors|immunologic factors|mesh-ancestor
25250992|NCT02516423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25250993|NCT02516423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25250994|NCT02516423|Growth Substances|growth substances|mesh-ancestor
25250995|NCT02516423|Growth Inhibitors|growth inhibitors|mesh-ancestor
25250996|NCT02516423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25250997|NCT02516423|Protease Inhibitors|protease inhibitors|mesh-ancestor
25250998|NCT02516423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25250999|NCT02516423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251000|NCT02516436|Buprenorphine|buprenorphine|mesh-list
25251001|NCT02516436|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25251002|NCT02516436|Narcotics|narcotics|mesh-ancestor
25251003|NCT02516436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25251004|NCT02516436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251005|NCT02516436|Analgesics|analgesics|mesh-ancestor
25251006|NCT02516436|Sensory System Agents|sensory system agents|mesh-ancestor
25251007|NCT02516436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25251008|NCT02516436|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25251009|NCT02516462|Hormones|hormones|mesh-list
25251010|NCT02516462|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25251011|NCT02516462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25251012|NCT02516462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251013|NCT02516085|Metformin|metformin|mesh-list
24671163|NCT01324076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25686922|NCT01926626|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24615594|NCT01030614|Hormones|hormones|mesh-ancestor
24671167|NCT01324089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671168|NCT01324089|Protective Agents|protective agents|mesh-ancestor
24671169|NCT01324089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604441|NCT00979563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604443|NCT00979589|Aspirin|aspirin|mesh-list
24604444|NCT00979589|Clopidogrel|clopidogrel|mesh-list
24604445|NCT00979589|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24604446|NCT00979589|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24604447|NCT00979589|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24604482|NCT00979706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24604483|NCT00979706|Immunologic Factors|immunologic factors|mesh-ancestor
24604484|NCT00979706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604485|NCT00979706|Antifungal Agents|antifungal agents|mesh-ancestor
24604486|NCT00979706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24604487|NCT00979706|Dermatologic Agents|dermatologic agents|mesh-ancestor
24604518|NCT00979966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24604519|NCT00979966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24604520|NCT00979966|Growth Substances|growth substances|mesh-ancestor
24604521|NCT00979966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604522|NCT00979966|Growth Inhibitors|growth inhibitors|mesh-ancestor
24604523|NCT00979966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24604524|NCT00979966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24853388|NCT02267980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24853389|NCT02267980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853390|NCT02267980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24853391|NCT02267980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24853392|NCT02267980|Anesthetics, General|anesthetics, general|mesh-ancestor
24604607|NCT00980408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24580387|NCT00861523|Anesthetics, Local|anesthetics, local|mesh-ancestor
24632620|NCT01124799|Ciprofloxacin|ciprofloxacin|mesh-list
24580389|NCT00861523|Sensory System Agents|sensory system agents|mesh-ancestor
24580390|NCT00861523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24580392|NCT00861523|Autonomic Agents|autonomic agents|mesh-ancestor
24580410|NCT00861640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24580411|NCT00861640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580412|NCT00861640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580413|NCT00861731|Simvastatin|simvastatin|mesh-list
25251014|NCT02516085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25251015|NCT02516085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251016|NCT02516059|Oxycodone|oxycodone|mesh-list
25251017|NCT02516059|Naloxone|naloxone|mesh-list
25251018|NCT02516059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25251019|NCT02516059|Narcotics|narcotics|mesh-ancestor
25251020|NCT02516059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25251021|NCT02516059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251022|NCT02516059|Analgesics|analgesics|mesh-ancestor
25251023|NCT02516059|Sensory System Agents|sensory system agents|mesh-ancestor
25251024|NCT02516059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25251025|NCT02516059|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25251026|NCT02515968|Propofol|propofol|mesh-list
25251027|NCT02515968|Desflurane|desflurane|mesh-list
25251028|NCT02515968|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25117537|NCT05027516|Azithromycin|azithromycin|mesh-list
25251029|NCT02515968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25251030|NCT02515968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251031|NCT02515968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25251032|NCT02515968|Anesthetics, General|anesthetics, general|mesh-ancestor
25251033|NCT02515968|Anesthetics|anesthetics|mesh-ancestor
25251034|NCT02515968|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25251035|NCT02515955|Minocycline|minocycline|mesh-list
25251036|NCT02515955|Amphetamine|amphetamine|mesh-list
25251037|NCT02515955|Dextroamphetamine|dextroamphetamine|mesh-list
25251038|NCT02515955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25251039|NCT02515955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25251040|NCT02515955|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25251041|NCT02515955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251042|NCT02515955|Sympathomimetics|sympathomimetics|mesh-ancestor
25251043|NCT02515955|Autonomic Agents|autonomic agents|mesh-ancestor
25251044|NCT02515955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25251045|NCT02515955|Dopamine Agents|dopamine agents|mesh-ancestor
25251046|NCT02515955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24604608|NCT00980408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604615|NCT00980408|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25686923|NCT01926626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24604616|NCT00980408|Antitubercular Agents|antitubercular agents|mesh-ancestor
24604617|NCT00980408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24604618|NCT00980408|Antimetabolites|antimetabolites|mesh-ancestor
24604621|NCT00980473|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24604622|NCT00980473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24604641|NCT00980603|Docetaxel|docetaxel|mesh-list
24604642|NCT00980603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604643|NCT00980603|Tubulin Modulators|tubulin modulators|mesh-ancestor
24604644|NCT00980603|Antimitotic Agents|antimitotic agents|mesh-ancestor
24604645|NCT00980603|Mitosis Modulators|mitosis modulators|mesh-ancestor
24604646|NCT00980603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604681|NCT00981006|Mitosis Modulators|mitosis modulators|mesh-ancestor
24604682|NCT00981006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604773|NCT00981708|Growth Inhibitors|growth inhibitors|mesh-ancestor
24604775|NCT00981721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604776|NCT00981721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24604891|NCT00982046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24604893|NCT00982124|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24604895|NCT00982202|Pioglitazone|pioglitazone|mesh-list
24604896|NCT00982202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24604897|NCT00982202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580414|NCT00861731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24580415|NCT00861731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24580416|NCT00861731|Antimetabolites|antimetabolites|mesh-ancestor
24580417|NCT00861731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580419|NCT00861731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24580420|NCT00861731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580421|NCT00861783|Oxaliplatin|oxaliplatin|mesh-list
24580423|NCT00861783|Camptothecin|camptothecin|mesh-list
24580424|NCT00861783|ON 01910|on 01910|mesh-list
24580425|NCT00861783|Glycine|glycine|mesh-list
24580426|NCT00861783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24580427|NCT00861783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24580428|NCT00861783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24580429|NCT00861783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580430|NCT00861783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580431|NCT00861783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24580432|NCT00861783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25251047|NCT02515955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251048|NCT02515955|Adrenergic Agents|adrenergic agents|mesh-ancestor
25251049|NCT02515955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25251050|NCT02515955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25251051|NCT02515955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25251052|NCT02515955|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25251053|NCT02515929|Proanthocyanidin|proanthocyanidin|mesh-list
25251054|NCT02515929|Procyanidin|procyanidin|mesh-list
25251055|NCT02515929|Antioxidants|antioxidants|mesh-ancestor
25251056|NCT02515929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251057|NCT02515929|Protective Agents|protective agents|mesh-ancestor
25251058|NCT02515929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251059|NCT02515929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25251060|NCT02515929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25251061|NCT02515929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25251062|NCT02515877|Carboplatin|carboplatin|mesh-list
25251063|NCT02515877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25251064|NCT02515864|Moxifloxacin|moxifloxacin|mesh-list
25251065|NCT02515864|Dotinurad|dotinurad|mesh-list
25251066|NCT02515864|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25251067|NCT02515864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25251068|NCT02515864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25251069|NCT02515864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25251070|NCT02515864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25251071|NCT02515864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251072|NCT02515864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251073|NCT02515864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604927|NCT00982436|Antimitotic Agents|antimitotic agents|mesh-ancestor
24604928|NCT00982436|Mitosis Modulators|mitosis modulators|mesh-ancestor
24604929|NCT00982436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604931|NCT00982449|Antiviral Agents|antiviral agents|mesh-ancestor
24604932|NCT00982449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24604933|NCT00982449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24604934|NCT00982449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604935|NCT00982449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671180|NCT01324180|Asparaginase|asparaginase|mesh-list
24671181|NCT01324180|Pegaspargase|pegaspargase|mesh-list
24671182|NCT01324180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24671183|NCT01324180|Antiemetics|antiemetics|mesh-ancestor
24671184|NCT01324180|Autonomic Agents|autonomic agents|mesh-ancestor
24671185|NCT01324180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24671186|NCT01324180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671187|NCT01324180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24671188|NCT01324180|Glucocorticoids|glucocorticoids|mesh-ancestor
24671190|NCT01324180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24671191|NCT01324180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24671192|NCT01324180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24671193|NCT01324180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24671194|NCT01324180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24580433|NCT00861783|Glycine Agents|glycine agents|mesh-ancestor
24580434|NCT00861783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24580435|NCT00861783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580436|NCT00861861|Atorvastatin|atorvastatin|mesh-list
24580437|NCT00861861|Pitavastatin|pitavastatin|mesh-list
24580438|NCT00861861|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24580439|NCT00861861|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24580440|NCT00861861|Antimetabolites|antimetabolites|mesh-ancestor
24580441|NCT00861861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580443|NCT00861861|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24580453|NCT00861874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24580471|NCT00861926|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25251074|NCT02515864|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25251075|NCT02515864|Contraceptive Agents|contraceptive agents|mesh-ancestor
25251076|NCT02515864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25251077|NCT02515864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251078|NCT02515864|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25251079|NCT02515864|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25251080|NCT02515864|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25251081|NCT02515864|Uricosuric Agents|uricosuric agents|mesh-ancestor
25251082|NCT02515864|Gout Suppressants|gout suppressants|mesh-ancestor
25251083|NCT02515864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25251084|NCT02515864|Renal Agents|renal agents|mesh-ancestor
25251085|NCT02515682|Equol|equol|mesh-list
25251086|NCT02515682|Phytoestrogens|phytoestrogens|mesh-ancestor
25251087|NCT02515682|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25251088|NCT02515682|Estrogens|estrogens|mesh-ancestor
25251089|NCT02515682|Hormones|hormones|mesh-ancestor
25251090|NCT02515682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25251091|NCT02515682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251092|NCT02515695|Interferons|interferons|mesh-list
25251093|NCT02515695|Interferon-beta|interferon-beta|mesh-list
25251094|NCT02515695|Interferon beta-1a|interferon beta-1a|mesh-list
25251095|NCT02515695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25251096|NCT02515695|Antiviral Agents|antiviral agents|mesh-ancestor
25251097|NCT02515695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25251098|NCT02515695|Immunologic Factors|immunologic factors|mesh-ancestor
25251099|NCT02515695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251100|NCT02515695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25251101|NCT02515734|Leucovorin|leucovorin|mesh-list
25251102|NCT02515734|Bevacizumab|bevacizumab|mesh-list
25251103|NCT02515734|Cetuximab|cetuximab|mesh-list
25251104|NCT02515734|Fluorouracil|fluorouracil|mesh-list
25251105|NCT02515734|Oxaliplatin|oxaliplatin|mesh-list
25251106|NCT02515734|Irinotecan|irinotecan|mesh-list
24853407|NCT02268019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24853408|NCT02268019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24853409|NCT02268019|Adrenergic Agents|adrenergic agents|mesh-ancestor
24604982|NCT00982631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604983|NCT00982631|Antifungal Agents|antifungal agents|mesh-ancestor
24604984|NCT00982631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24604985|NCT00982631|Immunologic Factors|immunologic factors|mesh-ancestor
24629558|NCT01106118|Urological Agents|urological agents|mesh-ancestor
24605070|NCT00983125|Adrenergic Agents|adrenergic agents|mesh-ancestor
24605096|NCT00983203|Lubricant Eye Drops|lubricant eye drops|mesh-list
24605097|NCT00983203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24853410|NCT02268019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24853411|NCT02268019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674978|NCT03685188|Oxycodone|oxycodone|mesh-list
24605098|NCT00983255|Tedizolid phosphate|tedizolid phosphate|mesh-list
24605099|NCT00983255|Tedizolid|tedizolid|mesh-list
24605100|NCT00983255|Oxazolidinones|oxazolidinones|mesh-list
24605101|NCT00983255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24605102|NCT00983255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24605103|NCT00983255|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24605104|NCT00983255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605105|NCT00983255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605106|NCT00983268|Capecitabine|capecitabine|mesh-list
24605107|NCT00983268|Vorinostat|vorinostat|mesh-list
24605108|NCT00983268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24605109|NCT00983268|Antimetabolites|antimetabolites|mesh-ancestor
24605110|NCT00983268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605111|NCT00983268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605112|NCT00983268|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24605113|NCT00983268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605114|NCT00983320|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24605115|NCT00983320|Antidepressive Agents|antidepressive agents|mesh-ancestor
24605182|NCT00983554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24605184|NCT00983554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251107|NCT02515734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25251108|NCT02515734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24462625|NCT00357084|Antiemetics|antiemetics|mesh-ancestor
25251109|NCT02515734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25251110|NCT02515734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25251111|NCT02515734|Growth Substances|growth substances|mesh-ancestor
25251112|NCT02515734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251113|NCT02515734|Growth Inhibitors|growth inhibitors|mesh-ancestor
25251114|NCT02515734|Antimetabolites|antimetabolites|mesh-ancestor
25251115|NCT02515734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251116|NCT02515734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25251117|NCT02515734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25251118|NCT02515734|Immunologic Factors|immunologic factors|mesh-ancestor
25251119|NCT02515734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25251120|NCT02515734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25251121|NCT02515734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251122|NCT02515734|Antidotes|antidotes|mesh-ancestor
25251123|NCT02515734|Protective Agents|protective agents|mesh-ancestor
25251124|NCT02515734|Vitamin B Complex|vitamin b complex|mesh-ancestor
25251125|NCT02515734|Vitamins|vitamins|mesh-ancestor
25251126|NCT02515734|Micronutrients|micronutrients|mesh-ancestor
25251127|NCT02515604|Misoprostol|misoprostol|mesh-list
25251128|NCT02515604|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25251129|NCT02515604|Abortifacient Agents|abortifacient agents|mesh-ancestor
25251130|NCT02515604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25251131|NCT02515604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251132|NCT02515604|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25251133|NCT02515604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25251134|NCT02515604|Oxytocics|oxytocics|mesh-ancestor
25251135|NCT02515617|Silver Sulfadiazine|silver sulfadiazine|mesh-list
25251136|NCT02515617|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25251137|NCT02515617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25251138|NCT02515526|Tolbutamide|tolbutamide|mesh-list
25251139|NCT02515526|Ethanol|ethanol|mesh-list
25251140|NCT02515526|Digoxin|digoxin|mesh-list
25251141|NCT02515526|Midazolam|midazolam|mesh-list
25251142|NCT02515526|Dextromethorphan|dextromethorphan|mesh-list
25251143|NCT02515526|Caffeine|caffeine|mesh-list
25251144|NCT02515526|Omeprazole|omeprazole|mesh-list
25251145|NCT02515526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25251146|NCT02515526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25251147|NCT02515526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25251148|NCT02515526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605191|NCT00983736|Tramadol|tramadol|mesh-list
24605320|NCT00984464|Antimitotic Agents|antimitotic agents|mesh-ancestor
24605229|NCT00983944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24605231|NCT00983944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24605232|NCT00983944|Tubulin Modulators|tubulin modulators|mesh-ancestor
24605233|NCT00983944|Antimitotic Agents|antimitotic agents|mesh-ancestor
24605234|NCT00983944|Mitosis Modulators|mitosis modulators|mesh-ancestor
24605236|NCT00983996|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24605237|NCT00983996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404145|NCT03682068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605239|NCT00984152|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24605240|NCT00984152|Raltegravir Potassium|raltegravir potassium|mesh-list
24605241|NCT00984152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24605242|NCT00984152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24605243|NCT00984152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605244|NCT00984152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605245|NCT00984152|Antiviral Agents|antiviral agents|mesh-ancestor
24812525|NCT02052973|Propolis|propolis|mesh-list
25251149|NCT02515526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25251150|NCT02515526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25251151|NCT02515526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25251152|NCT02515526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25251153|NCT02515526|Anesthetics, General|anesthetics, general|mesh-ancestor
25251154|NCT02515526|Anesthetics|anesthetics|mesh-ancestor
25251155|NCT02515526|GABA Modulators|gaba modulators|mesh-ancestor
25251156|NCT02515526|GABA Agents|gaba agents|mesh-ancestor
25251157|NCT02515526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25251158|NCT02515526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251159|NCT02515526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25251160|NCT02515526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25251161|NCT02515526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25251162|NCT02515526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251163|NCT02515526|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25251164|NCT02515526|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25251165|NCT02515526|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25251166|NCT02515526|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25251167|NCT02515526|Purinergic Agents|purinergic agents|mesh-ancestor
25251168|NCT02515526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25251169|NCT02515526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25251170|NCT02515526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25251171|NCT02515526|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25251172|NCT02515526|Protective Agents|protective agents|mesh-ancestor
25251173|NCT02515526|Antitussive Agents|antitussive agents|mesh-ancestor
25251174|NCT02515526|Respiratory System Agents|respiratory system agents|mesh-ancestor
25251175|NCT02515526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25251176|NCT02515526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25251177|NCT02515526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25251178|NCT02515448|Gentamicins|gentamicins|mesh-list
25251179|NCT02515448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25251180|NCT02515448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25251181|NCT02515448|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25251182|NCT02515448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251183|NCT02515448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251184|NCT02515435|Apatinib|apatinib|mesh-list
25251185|NCT02515435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25251186|NCT02515435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25251187|NCT02515435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251188|NCT02515435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251189|NCT02515565|Erythromycin|erythromycin|mesh-list
25251190|NCT02515565|Erythromycin Estolate|erythromycin estolate|mesh-list
25251191|NCT02515565|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25251192|NCT02515565|Erythromycin stearate|erythromycin stearate|mesh-list
25251193|NCT02515565|Cephalosporins|cephalosporins|mesh-list
25251194|NCT02515565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25251195|NCT02515565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25251196|NCT02515565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25251197|NCT02515565|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25251198|NCT02515565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251199|NCT02515565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251200|NCT02515201|Taurolidine|taurolidine|mesh-list
25251201|NCT02515201|Heparin|heparin|mesh-list
25251202|NCT02515201|Calcium heparin|calcium heparin|mesh-list
25251203|NCT02515201|Anticoagulants|anticoagulants|mesh-ancestor
25251204|NCT02515201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24605318|NCT00984464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605319|NCT00984464|Tubulin Modulators|tubulin modulators|mesh-ancestor
24605325|NCT00984633|Sevoflurane|sevoflurane|mesh-list
24605326|NCT00984633|Rocuronium|rocuronium|mesh-list
24605327|NCT00984633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25083870|NCT03311971|Dopamine Agents|dopamine agents|mesh-ancestor
24605328|NCT00984633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24605329|NCT00984633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605330|NCT00984633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24605331|NCT00984633|Anesthetics, General|anesthetics, general|mesh-ancestor
24605333|NCT00984633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24605334|NCT00984633|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24605335|NCT00984633|Anticonvulsants|anticonvulsants|mesh-ancestor
24605336|NCT00984633|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24605337|NCT00984633|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24605338|NCT00984633|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24605339|NCT00984633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24605340|NCT00984724|Nicotine|nicotine|mesh-list
24605341|NCT00984724|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24605342|NCT00984724|Autonomic Agents|autonomic agents|mesh-ancestor
24605442|NCT00984997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24629931|NCT01108744|Mannitol|mannitol|mesh-list
25251205|NCT02515201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25251206|NCT02515201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251207|NCT02515201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25251208|NCT02515201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25251209|NCT02515201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25251210|NCT02515240|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25251211|NCT02515240|Immunologic Factors|immunologic factors|mesh-ancestor
25251212|NCT02515240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251213|NCT02515227|Pembrolizumab|pembrolizumab|mesh-list
25251214|NCT02515227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25251215|NCT02515227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25251216|NCT02515422|Ketamine|ketamine|mesh-list
25251217|NCT02515422|Bupivacaine|bupivacaine|mesh-list
25251218|NCT02515422|Anesthetics, Local|anesthetics, local|mesh-ancestor
25251219|NCT02515422|Anesthetics|anesthetics|mesh-ancestor
25251220|NCT02515422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25251221|NCT02515422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251222|NCT02515422|Sensory System Agents|sensory system agents|mesh-ancestor
25251223|NCT02515422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25251224|NCT02515422|Analgesics|analgesics|mesh-ancestor
25251225|NCT02515422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25251226|NCT02515422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25251227|NCT02515422|Anesthetics, General|anesthetics, general|mesh-ancestor
25251228|NCT02515422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25251229|NCT02515422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25251230|NCT02515422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25251231|NCT02515422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274555|NCT02377076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25274556|NCT02376972|Rifaximin|rifaximin|mesh-list
25274557|NCT02376972|Metronidazole|metronidazole|mesh-list
25274558|NCT02376972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25274559|NCT02376972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25274560|NCT02376972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25274561|NCT02376972|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25274562|NCT02376972|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25274563|NCT02376881|Epoetin Alfa|epoetin alfa|mesh-list
25274564|NCT02376881|Hematinics|hematinics|mesh-ancestor
25274565|NCT02376985|Everolimus|everolimus|mesh-list
25274566|NCT02376985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25274567|NCT02376985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25274568|NCT02376985|Immunologic Factors|immunologic factors|mesh-ancestor
25274569|NCT02376985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274570|NCT02376803|Warfarin|warfarin|mesh-list
25274571|NCT02376803|Anticoagulants|anticoagulants|mesh-ancestor
25274572|NCT02376478|Folic Acid|folic acid|mesh-list
25274573|NCT02376478|Sulfasalazine|sulfasalazine|mesh-list
25274574|NCT02376478|Adalimumab|adalimumab|mesh-list
24671222|NCT01324258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24671223|NCT01324258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671224|NCT01324258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24671225|NCT01324258|Immunologic Factors|immunologic factors|mesh-ancestor
24671226|NCT01324258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671227|NCT01324258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24671228|NCT01324284|Lubiprostone|lubiprostone|mesh-list
24671229|NCT01324284|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24671230|NCT01324284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24446789|NCT00305903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24812543|NCT02053402|Cholecalciferol|cholecalciferol|mesh-list
24812544|NCT02053402|Vitamins|vitamins|mesh-ancestor
24812545|NCT02053402|Micronutrients|micronutrients|mesh-ancestor
24812546|NCT02053402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605552|NCT00986037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24605553|NCT00986037|Immunologic Factors|immunologic factors|mesh-ancestor
24605554|NCT00986037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605555|NCT00986050|Sirolimus|sirolimus|mesh-list
24605556|NCT00986050|Abciximab|abciximab|mesh-list
24605557|NCT00986050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24605558|NCT00986050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24812552|NCT02053519|Micronutrients|micronutrients|mesh-ancestor
24812553|NCT02053519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605679|NCT00986765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24605680|NCT00986765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24605681|NCT00986765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24605682|NCT00986765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24605683|NCT00986765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605684|NCT00986765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24605685|NCT00986765|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24605686|NCT00986765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605688|NCT00986765|Anticoagulants|anticoagulants|mesh-ancestor
25251232|NCT02515188|Acetaminophen|acetaminophen|mesh-list
25251233|NCT02515188|Propacetamol|propacetamol|mesh-list
25251234|NCT02515188|Analgesics|analgesics|mesh-ancestor
25251235|NCT02515188|Sensory System Agents|sensory system agents|mesh-ancestor
25251236|NCT02515188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25251237|NCT02515188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251238|NCT02515188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25251239|NCT02515188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25251240|NCT02515188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25251241|NCT02515188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25251242|NCT02515188|Antipyretics|antipyretics|mesh-ancestor
25251243|NCT02514941|Acetaminophen|acetaminophen|mesh-list
25251244|NCT02514941|Amoxicillin|amoxicillin|mesh-list
25251245|NCT02514941|Talinolol|talinolol|mesh-list
25251246|NCT02514941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25251247|NCT02514941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25251248|NCT02514941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25251249|NCT02514941|Analgesics|analgesics|mesh-ancestor
25251250|NCT02514941|Sensory System Agents|sensory system agents|mesh-ancestor
25251251|NCT02514941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25251252|NCT02514941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251253|NCT02514941|Antipyretics|antipyretics|mesh-ancestor
25251254|NCT02514941|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25251255|NCT02514941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25251256|NCT02514941|Adrenergic Agents|adrenergic agents|mesh-ancestor
25251257|NCT02514941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25251258|NCT02514941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251259|NCT02514941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25251260|NCT02514941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25251261|NCT02514980|Ketamine|ketamine|mesh-list
25251262|NCT02514980|Bupivacaine|bupivacaine|mesh-list
25251263|NCT02514980|Anesthetics, Local|anesthetics, local|mesh-ancestor
25251264|NCT02514980|Anesthetics|anesthetics|mesh-ancestor
25251265|NCT02514980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25251266|NCT02514980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251267|NCT02514980|Sensory System Agents|sensory system agents|mesh-ancestor
25251268|NCT02514980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25251269|NCT02514980|Analgesics|analgesics|mesh-ancestor
25251270|NCT02514980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25251271|NCT02514980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25251272|NCT02514980|Anesthetics, General|anesthetics, general|mesh-ancestor
25251273|NCT02514980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25251274|NCT02514980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24605721|NCT00987038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24605722|NCT00987038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24605978|NCT00988481|Anticonvulsants|anticonvulsants|mesh-ancestor
24606061|NCT00988780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24630242|NCT01110486|Mitosis Modulators|mitosis modulators|mesh-ancestor
24606099|NCT00988897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24606100|NCT00988897|Growth Substances|growth substances|mesh-ancestor
24606101|NCT00988897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606102|NCT00988897|Growth Inhibitors|growth inhibitors|mesh-ancestor
24606115|NCT00988910|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
24606116|NCT00988910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24606117|NCT00988910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606172|NCT00989300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606174|NCT00989352|Methotrexate|methotrexate|mesh-list
24606175|NCT00989352|Lomustine|lomustine|mesh-list
24606177|NCT00989352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24606178|NCT00989352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24606179|NCT00989352|Immunologic Factors|immunologic factors|mesh-ancestor
24606180|NCT00989352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606181|NCT00989352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24606182|NCT00989352|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24606183|NCT00989352|Abortifacient Agents|abortifacient agents|mesh-ancestor
24606184|NCT00989352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24606185|NCT00989352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24606186|NCT00989352|Antimetabolites|antimetabolites|mesh-ancestor
24606187|NCT00989352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630351|NCT01111227|Propofol|propofol|mesh-list
24606216|NCT00989508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606217|NCT00989508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24606237|NCT00989625|Serotonin Agents|serotonin agents|mesh-ancestor
25251275|NCT02514980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25251276|NCT02514980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251277|NCT02514954|Insulin Lispro|insulin lispro|mesh-list
25251278|NCT02514954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25251279|NCT02514954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251280|NCT02514850|Insulin Lispro|insulin lispro|mesh-list
25251281|NCT02514850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25251282|NCT02514850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251283|NCT02514681|Gemcitabine|gemcitabine|mesh-list
25251284|NCT02514681|Paclitaxel|paclitaxel|mesh-list
25251285|NCT02514681|Vinorelbine|vinorelbine|mesh-list
25251286|NCT02514681|Docetaxel|docetaxel|mesh-list
25251287|NCT02514681|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25251288|NCT02514681|Capecitabine|capecitabine|mesh-list
25251289|NCT02514681|Trastuzumab|trastuzumab|mesh-list
25251290|NCT02514681|Pertuzumab|pertuzumab|mesh-list
25251291|NCT02514681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25251292|NCT02514681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25251293|NCT02514681|Tubulin Modulators|tubulin modulators|mesh-ancestor
25251294|NCT02514681|Antimitotic Agents|antimitotic agents|mesh-ancestor
25251295|NCT02514681|Mitosis Modulators|mitosis modulators|mesh-ancestor
25251296|NCT02514681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251297|NCT02514681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24462718|NCT00357318|Sunitinib|sunitinib|mesh-list
25251298|NCT02514681|Antimetabolites|antimetabolites|mesh-ancestor
25251299|NCT02514681|Antiviral Agents|antiviral agents|mesh-ancestor
25251300|NCT02514681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25251301|NCT02514681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251302|NCT02514681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25251303|NCT02514681|Immunologic Factors|immunologic factors|mesh-ancestor
25251304|NCT02514681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251305|NCT02514681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25251306|NCT02514642|Clopidogrel|clopidogrel|mesh-list
25251307|NCT02514642|Ticagrelor|ticagrelor|mesh-list
25251308|NCT02514642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25251309|NCT02514642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25251310|NCT02514642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25251311|NCT02514642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25251312|NCT02514642|Purinergic Agents|purinergic agents|mesh-ancestor
24606238|NCT00989625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24606239|NCT00989651|Paclitaxel|paclitaxel|mesh-list
24606240|NCT00989651|Bevacizumab|bevacizumab|mesh-list
24606241|NCT00989651|Cisplatin|cisplatin|mesh-list
24606242|NCT00989651|Carboplatin|carboplatin|mesh-list
24853432|NCT02268149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853436|NCT02268201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24853438|NCT02268201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853439|NCT02268201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24853440|NCT02268201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24853441|NCT02268201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606287|NCT00989703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606288|NCT00989703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24606289|NCT00989703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24606290|NCT00989703|Immunologic Factors|immunologic factors|mesh-ancestor
24606291|NCT00989703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24606292|NCT00989703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24606293|NCT00989716|Antihypertensive Agents|antihypertensive agents|mesh-list
24606294|NCT00989716|Nitroglycerin|nitroglycerin|mesh-list
24606295|NCT00989716|Vasodilator Agents|vasodilator agents|mesh-ancestor
24606296|NCT00989729|Methylprednisolone|methylprednisolone|mesh-list
24606324|NCT00989807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24606326|NCT00989820|Keratolytic Agents|keratolytic agents|mesh-ancestor
24606327|NCT00989820|Dermatologic Agents|dermatologic agents|mesh-ancestor
24580472|NCT00861926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24580473|NCT00861926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24580474|NCT00861926|Adrenergic Agents|adrenergic agents|mesh-ancestor
24723273|NCT01586299|Ibuprofen|ibuprofen|mesh-list
24580475|NCT00861926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24580476|NCT00861926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580477|NCT00861926|Tocolytic Agents|tocolytic agents|mesh-ancestor
24580478|NCT00861926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24580479|NCT00861926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24580480|NCT00861926|Glucocorticoids|glucocorticoids|mesh-ancestor
24580481|NCT00861926|Hormones|hormones|mesh-ancestor
24580482|NCT00861926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24580483|NCT00861939|Bupropion|bupropion|mesh-list
25010056|NCT04700007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25010057|NCT04700007|Histamine Agonists|histamine agonists|mesh-ancestor
25010058|NCT04681079|Albuterol|albuterol|mesh-list
25010059|NCT04681079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25010060|NCT04681079|Autonomic Agents|autonomic agents|mesh-ancestor
25010061|NCT04681079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25251313|NCT02514642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25251314|NCT02514642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251315|NCT02514642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251316|NCT02514629|Metformin|metformin|mesh-list
25251317|NCT02514629|Methyltestosterone|methyltestosterone|mesh-list
25251318|NCT02514629|Testosterone|testosterone|mesh-list
25251319|NCT02514629|Testosterone undecanoate|testosterone undecanoate|mesh-list
25251320|NCT02514629|Testosterone enanthate|testosterone enanthate|mesh-list
25251321|NCT02514629|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25251322|NCT02514629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25251323|NCT02514629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251324|NCT02514629|Androgens|androgens|mesh-ancestor
25251325|NCT02514629|Hormones|hormones|mesh-ancestor
25251326|NCT02514629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25251327|NCT02514629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25251328|NCT02514629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25251329|NCT02514629|Anabolic Agents|anabolic agents|mesh-ancestor
25251330|NCT02514538|Acetaminophen|acetaminophen|mesh-list
25251331|NCT02514538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25251332|NCT02514538|Analgesics|analgesics|mesh-ancestor
25251333|NCT02514538|Sensory System Agents|sensory system agents|mesh-ancestor
25251334|NCT02514538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25251335|NCT02514538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251336|NCT02514538|Antipyretics|antipyretics|mesh-ancestor
25251337|NCT02514343|Magnesium Sulfate|magnesium sulfate|mesh-list
25251338|NCT02514343|Bupivacaine|bupivacaine|mesh-list
25251339|NCT02514343|Anesthetics, Local|anesthetics, local|mesh-ancestor
25251340|NCT02514343|Anesthetics|anesthetics|mesh-ancestor
24606328|NCT00989898|Insulin|insulin|mesh-list
24606329|NCT00989898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24606330|NCT00989898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606331|NCT00990028|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24630497|NCT01111968|Vaccines|vaccines|mesh-list
24606416|NCT00990392|Dermatologic Agents|dermatologic agents|mesh-ancestor
24606496|NCT00990678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24606511|NCT00990691|Adrenergic Agents|adrenergic agents|mesh-ancestor
24606512|NCT00990691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24606513|NCT00990691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606515|NCT00990795|Cyclosporins|cyclosporins|mesh-list
24606516|NCT00990795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606517|NCT00990795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606518|NCT00990795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24606541|NCT00990834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24606542|NCT00990834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606544|NCT00990847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24606545|NCT00990847|Autonomic Agents|autonomic agents|mesh-ancestor
24606546|NCT00990847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24606547|NCT00990847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606548|NCT00990847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24606549|NCT00990847|Respiratory System Agents|respiratory system agents|mesh-ancestor
24606550|NCT00990847|Sympathomimetics|sympathomimetics|mesh-ancestor
24606551|NCT00990847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24606552|NCT00990847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24606553|NCT00990847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24853478|NCT02268435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24853479|NCT02268435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251341|NCT02514343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25251342|NCT02514343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686924|NCT01926626|Cholinergic Agents|cholinergic agents|mesh-ancestor
25251343|NCT02514343|Sensory System Agents|sensory system agents|mesh-ancestor
25251344|NCT02514343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25251345|NCT02514343|Analgesics|analgesics|mesh-ancestor
25251346|NCT02514343|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25251347|NCT02514343|Anticonvulsants|anticonvulsants|mesh-ancestor
25251348|NCT02514343|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25251349|NCT02514343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25251350|NCT02514343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251351|NCT02514343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25251352|NCT02514343|Tocolytic Agents|tocolytic agents|mesh-ancestor
25251353|NCT02514343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25251354|NCT02514330|Dihydrotachysterol|dihydrotachysterol|mesh-list
25251355|NCT02514330|Vitamins|vitamins|mesh-ancestor
25251356|NCT02514330|Micronutrients|micronutrients|mesh-ancestor
25251357|NCT02514330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251358|NCT02514330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25251359|NCT02514421|Gemcitabine|gemcitabine|mesh-list
25251360|NCT02514421|Paclitaxel|paclitaxel|mesh-list
25251361|NCT02514421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25251362|NCT02514421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25251363|NCT02514421|Tubulin Modulators|tubulin modulators|mesh-ancestor
25251364|NCT02514421|Antimitotic Agents|antimitotic agents|mesh-ancestor
25251365|NCT02514421|Mitosis Modulators|mitosis modulators|mesh-ancestor
25251366|NCT02514421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251367|NCT02514421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25251368|NCT02514421|Antimetabolites|antimetabolites|mesh-ancestor
25251369|NCT02514421|Antiviral Agents|antiviral agents|mesh-ancestor
25251370|NCT02514421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25251371|NCT02514421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251372|NCT02514421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25251373|NCT02514421|Immunologic Factors|immunologic factors|mesh-ancestor
25251374|NCT02514421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251375|NCT02514200|Riboflavin|riboflavin|mesh-list
24853480|NCT02268487|Sertraline|sertraline|mesh-list
24853481|NCT02268487|Antidepressive Agents|antidepressive agents|mesh-ancestor
24606589|NCT00991133|Antimetabolites|antimetabolites|mesh-ancestor
24606590|NCT00991159|Bococizumab|bococizumab|mesh-list
24606591|NCT00991159|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24606592|NCT00991159|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24606594|NCT00991159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606595|NCT00991159|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24606596|NCT00991211|Cyclophosphamide|cyclophosphamide|mesh-list
24606597|NCT00991211|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24606598|NCT00991211|Doxorubicin|doxorubicin|mesh-list
24606599|NCT00991211|Vincristine|vincristine|mesh-list
24606600|NCT00991211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24606601|NCT00991211|Immunologic Factors|immunologic factors|mesh-ancestor
24606602|NCT00991211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606664|NCT00991705|Atorvastatin|atorvastatin|mesh-list
24606665|NCT00991705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24606666|NCT00991705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24606667|NCT00991705|Antimetabolites|antimetabolites|mesh-ancestor
24606695|NCT00991744|Antiemetics|antiemetics|mesh-ancestor
24606696|NCT00991744|Autonomic Agents|autonomic agents|mesh-ancestor
24853482|NCT02268487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24853483|NCT02268487|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24853484|NCT02268487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24853485|NCT02268487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24853486|NCT02268487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853487|NCT02268487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24853488|NCT02268487|Serotonin Agents|serotonin agents|mesh-ancestor
24606697|NCT00991744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24606698|NCT00991744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24606699|NCT00991744|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24606700|NCT00991744|Protective Agents|protective agents|mesh-ancestor
25251376|NCT02514200|Vitamin B Complex|vitamin b complex|mesh-ancestor
25251378|NCT02514200|Micronutrients|micronutrients|mesh-ancestor
25251379|NCT02514200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251380|NCT02514200|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25251381|NCT02514200|Dermatologic Agents|dermatologic agents|mesh-ancestor
25251382|NCT02514018|Vaccines|vaccines|mesh-list
25251383|NCT02514018|Immunologic Factors|immunologic factors|mesh-ancestor
25251384|NCT02514018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251385|NCT02513875|Vitamin D|vitamin d|mesh-list
25251386|NCT02513875|Vitamins|vitamins|mesh-ancestor
25251387|NCT02513875|Micronutrients|micronutrients|mesh-ancestor
25251388|NCT02513875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723561|NCT01588002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25251389|NCT02513875|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25251390|NCT02513849|Tamoxifen|tamoxifen|mesh-list
25251391|NCT02513849|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25251392|NCT02513849|Hormone Antagonists|hormone antagonists|mesh-ancestor
25251393|NCT02513849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25251394|NCT02513849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251395|NCT02513849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25251396|NCT02513849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25251397|NCT02513849|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25251398|NCT02513849|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25251399|NCT02513849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25251400|NCT02513862|Heparin|heparin|mesh-list
25251401|NCT02513862|Protamines|protamines|mesh-list
25251402|NCT02513862|Anticoagulants|anticoagulants|mesh-ancestor
25251403|NCT02513862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25251404|NCT02513862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25251405|NCT02513862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251406|NCT02513862|Heparin Antagonists|heparin antagonists|mesh-ancestor
25251407|NCT02513862|Coagulants|coagulants|mesh-ancestor
25251408|NCT02513927|Metoprolol|metoprolol|mesh-list
25251409|NCT02513927|Nifedipine|nifedipine|mesh-list
25251410|NCT02513927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25251411|NCT02513927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25251412|NCT02513927|Sympatholytics|sympatholytics|mesh-ancestor
25251413|NCT02513927|Autonomic Agents|autonomic agents|mesh-ancestor
25251414|NCT02513927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25251415|NCT02513927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251416|NCT02513927|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24606798|NCT05408208|Hormones|hormones|mesh-ancestor
24606799|NCT05408208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24606800|NCT05408104|Tolvaptan|tolvaptan|mesh-list
24606801|NCT05408104|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24606802|NCT05408104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606803|NCT05408104|Natriuretic Agents|natriuretic agents|mesh-ancestor
24606817|NCT05408065|Hormones|hormones|mesh-ancestor
24606821|NCT05408065|Immunologic Factors|immunologic factors|mesh-ancestor
24606822|NCT05408065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606823|NCT05408065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606824|NCT05408065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24606825|NCT05408065|Viscosupplements|viscosupplements|mesh-ancestor
24606826|NCT05408065|Protective Agents|protective agents|mesh-ancestor
24606827|NCT05408000|Propofol|propofol|mesh-list
24606828|NCT05408000|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24606829|NCT05408000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24606857|NCT05407636|Aflibercept|aflibercept|mesh-list
24606858|NCT05407636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24606859|NCT05407636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24606860|NCT05407636|Growth Substances|growth substances|mesh-ancestor
24606861|NCT05407636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606862|NCT05407636|Growth Inhibitors|growth inhibitors|mesh-ancestor
24606863|NCT05407636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24606864|NCT05407597|Icatibant|icatibant|mesh-list
24606867|NCT05407597|Analgesics|analgesics|mesh-ancestor
25251417|NCT02513927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25251418|NCT02513927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25251419|NCT02513927|Adrenergic Agents|adrenergic agents|mesh-ancestor
25251420|NCT02513927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25251421|NCT02513927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251422|NCT02513927|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25251423|NCT02513927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25251424|NCT02513927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25251425|NCT02513927|Vasodilator Agents|vasodilator agents|mesh-ancestor
25251426|NCT02513927|Tocolytic Agents|tocolytic agents|mesh-ancestor
25251427|NCT02513927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25251428|NCT02513654|Lamotrigine|lamotrigine|mesh-list
25251429|NCT02513654|Anticonvulsants|anticonvulsants|mesh-ancestor
25251430|NCT02513654|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25251431|NCT02513654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25251432|NCT02513654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686925|NCT01926626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25251433|NCT02513654|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24533528|NCT00644306|Immunologic Factors|immunologic factors|mesh-ancestor
25251434|NCT02513654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615800|NCT01031966|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24615801|NCT01031966|Immunologic Factors|immunologic factors|mesh-ancestor
24615802|NCT01031966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615803|NCT01031992|Tranexamic Acid|tranexamic acid|mesh-list
24615804|NCT01031992|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24615805|NCT01031992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25251435|NCT02513654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25251436|NCT02513654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25251437|NCT02513654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25251438|NCT02513654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25251439|NCT02513654|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25251440|NCT02513888|Vitamin D|vitamin d|mesh-list
25251441|NCT02513888|Vitamins|vitamins|mesh-ancestor
25251442|NCT02513888|Micronutrients|micronutrients|mesh-ancestor
25251443|NCT02513888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251444|NCT02513888|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25251445|NCT02513693|Rocuronium|rocuronium|mesh-list
25251446|NCT02513693|Neostigmine|neostigmine|mesh-list
25251447|NCT02513693|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25251448|NCT02513693|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25251449|NCT02513693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25251450|NCT02513693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25251451|NCT02513693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251452|NCT02513693|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25251453|NCT02513693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251454|NCT02513693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251455|NCT02513693|Cholinergic Agents|cholinergic agents|mesh-ancestor
25251456|NCT02513693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25251457|NCT02513693|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24606876|NCT05407597|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24606902|NCT05407246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606904|NCT05407233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24606905|NCT05407233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24606906|NCT05407233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606907|NCT05407207|Immunologic Factors|immunologic factors|mesh-list
24606908|NCT05407207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251466|NCT02513433|Sensory System Agents|sensory system agents|mesh-ancestor
25251467|NCT02513433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25251468|NCT02513381|Vitamin D|vitamin d|mesh-list
25251469|NCT02513381|Cholecalciferol|cholecalciferol|mesh-list
25251470|NCT02513381|Vitamins|vitamins|mesh-ancestor
25251471|NCT02513381|Micronutrients|micronutrients|mesh-ancestor
25251472|NCT02513381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251473|NCT02513381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25251474|NCT02513381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25251475|NCT02513394|Palbociclib|palbociclib|mesh-list
25251476|NCT02513394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25251477|NCT02513394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25251478|NCT02513394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251479|NCT02513394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251480|NCT02513355|Cisplatin|cisplatin|mesh-list
25251481|NCT02513355|Endostar protein|endostar protein|mesh-list
25251482|NCT02513355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25251483|NCT02513355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25251484|NCT02513355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25251485|NCT02513355|Growth Substances|growth substances|mesh-ancestor
25251486|NCT02513355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251487|NCT02513355|Growth Inhibitors|growth inhibitors|mesh-ancestor
25274575|NCT02376478|Etanercept|etanercept|mesh-list
25274576|NCT02376478|Methotrexate|methotrexate|mesh-list
25274577|NCT02376478|Mercaptopurine|mercaptopurine|mesh-list
25274578|NCT02376478|Infliximab|infliximab|mesh-list
25686926|NCT01926626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686927|NCT01926626|Antidepressive Agents|antidepressive agents|mesh-ancestor
25686928|NCT01926626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25686929|NCT01926626|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25686930|NCT01926626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25686931|NCT01926782|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25686932|NCT01926782|Immunologic Factors|immunologic factors|mesh-ancestor
25686933|NCT01926782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686934|NCT01926886|Trastuzumab|trastuzumab|mesh-list
25274579|NCT02376478|Folic Acid Antagonists|folic acid antagonists|mesh-list
24723928|NCT01589952|Interferons|interferons|mesh-list
25274580|NCT02376478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25274581|NCT02376478|Abortifacient Agents|abortifacient agents|mesh-ancestor
25274582|NCT02376478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25274583|NCT02376478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274584|NCT02376478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25274585|NCT02376478|Antimetabolites|antimetabolites|mesh-ancestor
25274586|NCT02376478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274587|NCT02376478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25274588|NCT02376478|Dermatologic Agents|dermatologic agents|mesh-ancestor
25274589|NCT02376478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274590|NCT02376478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25274591|NCT02376478|Immunologic Factors|immunologic factors|mesh-ancestor
25274592|NCT02376478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25274593|NCT02376478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25274594|NCT02376478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25274595|NCT02376478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25274596|NCT02376478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24631046|NCT01115959|Valproic Acid|valproic acid|mesh-list
24631088|NCT01116128|Glucocorticoids|glucocorticoids|mesh-ancestor
25251488|NCT02513290|Loratadine|loratadine|mesh-list
25251489|NCT02513290|Antipruritics|antipruritics|mesh-ancestor
25251490|NCT02513290|Dermatologic Agents|dermatologic agents|mesh-ancestor
25251491|NCT02513290|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25251492|NCT02513290|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25251493|NCT02513290|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25251494|NCT02513290|Histamine Antagonists|histamine antagonists|mesh-ancestor
25251495|NCT02513290|Histamine Agents|histamine agents|mesh-ancestor
25251496|NCT02513290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25251497|NCT02513290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251498|NCT02513290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251499|NCT02513342|Docetaxel|docetaxel|mesh-list
25251500|NCT02513342|Endostar protein|endostar protein|mesh-list
25251501|NCT02513342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25251502|NCT02513342|Tubulin Modulators|tubulin modulators|mesh-ancestor
25251503|NCT02513342|Antimitotic Agents|antimitotic agents|mesh-ancestor
25251504|NCT02513342|Mitosis Modulators|mitosis modulators|mesh-ancestor
25251505|NCT02513342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251506|NCT02513342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25251507|NCT02513342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25251508|NCT02513342|Growth Substances|growth substances|mesh-ancestor
25251509|NCT02513342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251510|NCT02513342|Growth Inhibitors|growth inhibitors|mesh-ancestor
25251511|NCT02513004|Clopidogrel|clopidogrel|mesh-list
25251512|NCT02513004|Ticagrelor|ticagrelor|mesh-list
25251513|NCT02513004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25251514|NCT02513004|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25251515|NCT02513004|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25251516|NCT02513004|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25251517|NCT02513004|Purinergic Agents|purinergic agents|mesh-ancestor
25251518|NCT02513004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25251520|NCT02513004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251522|NCT02513147|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25251523|NCT02513147|Darunavir|darunavir|mesh-list
25251524|NCT02513147|Fosamprenavir|fosamprenavir|mesh-list
25251525|NCT02513147|Dolutegravir|dolutegravir|mesh-list
25251526|NCT02513147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25251527|NCT02513147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25251528|NCT02513147|Protease Inhibitors|protease inhibitors|mesh-ancestor
25251529|NCT02513147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251530|NCT02513147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251531|NCT02513147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25251532|NCT02513147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25251533|NCT02513147|Antiviral Agents|antiviral agents|mesh-ancestor
25251534|NCT02513147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25251535|NCT02513147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24631136|NCT01116193|Dexamethasone|dexamethasone|mesh-list
25251536|NCT02513147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25251537|NCT02513147|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25251538|NCT02513147|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25251539|NCT02513069|Nicotine|nicotine|mesh-list
25251540|NCT02513069|Carbon Monoxide|carbon monoxide|mesh-list
25251541|NCT02513069|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25251542|NCT02513069|Autonomic Agents|autonomic agents|mesh-ancestor
25251543|NCT02513069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25251544|NCT02513069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251545|NCT02513069|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25251546|NCT02513069|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25251547|NCT02513069|Cholinergic Agents|cholinergic agents|mesh-ancestor
25251548|NCT02513069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25251549|NCT02513069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251550|NCT02513069|Antimetabolites|antimetabolites|mesh-ancestor
25251551|NCT02513069|Gasotransmitters|gasotransmitters|mesh-ancestor
25251552|NCT02512887|Anesthetics|anesthetics|mesh-list
24628967|NCT01102439|Analgesics|analgesics|mesh-ancestor
25251553|NCT02512887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25251554|NCT02512887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251555|NCT02512562|Simeprevir|simeprevir|mesh-list
25251556|NCT02512562|Odalasvir|odalasvir|mesh-list
25251557|NCT02512562|Antiviral Agents|antiviral agents|mesh-ancestor
25251558|NCT02512562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25251559|NCT02512562|Protease Inhibitors|protease inhibitors|mesh-ancestor
25251560|NCT02512562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251561|NCT02512562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251562|NCT02512536|Botulinum Toxins|botulinum toxins|mesh-list
25251563|NCT02512536|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25251564|NCT02512536|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25251565|NCT02512536|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25251566|NCT02512536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25251567|NCT02512536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251568|NCT02512536|Cholinergic Agents|cholinergic agents|mesh-ancestor
25251569|NCT02512536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25251570|NCT02512536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251571|NCT02512536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25251572|NCT02512536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25251573|NCT02512601|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
25251574|NCT02512601|Anticoagulants|anticoagulants|mesh-ancestor
25251575|NCT02512601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25251576|NCT02512601|Antimetabolites|antimetabolites|mesh-ancestor
25251577|NCT02512601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251578|NCT02512601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25251579|NCT02512601|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25251580|NCT02512601|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25251581|NCT02512601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25045269|NCT00978497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045270|NCT00978497|Antiviral Agents|antiviral agents|mesh-ancestor
25045271|NCT00978497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25045272|NCT00978016|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
24965058|NCT03779087|Amoxicillin|amoxicillin|mesh-list
25251582|NCT02512601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251583|NCT02512614|Anti-Infective Agents|anti-infective agents|mesh-list
25251584|NCT02512614|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25251585|NCT02512471|Ropivacaine|ropivacaine|mesh-list
25251586|NCT02512471|Anesthetics, Local|anesthetics, local|mesh-ancestor
25251587|NCT02512471|Anesthetics|anesthetics|mesh-ancestor
25251588|NCT02512471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25251589|NCT02512471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251590|NCT02512471|Sensory System Agents|sensory system agents|mesh-ancestor
25251591|NCT02512471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25251592|NCT02512523|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25251593|NCT02512523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25251594|NCT02512523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251595|NCT02512523|Incretins|incretins|mesh-ancestor
25251596|NCT02512523|Hormones|hormones|mesh-ancestor
25251597|NCT02512523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25118318|NCT04245865|Vitamins|vitamins|mesh-ancestor
25251598|NCT02512523|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25251599|NCT02512523|Protease Inhibitors|protease inhibitors|mesh-ancestor
25251600|NCT02512523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251601|NCT02512523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251602|NCT02512380|Docetaxel|docetaxel|mesh-list
25251603|NCT02512380|Oxaliplatin|oxaliplatin|mesh-list
25251604|NCT02512380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25251605|NCT02512380|Tubulin Modulators|tubulin modulators|mesh-ancestor
25251606|NCT02512380|Antimitotic Agents|antimitotic agents|mesh-ancestor
25251607|NCT02512380|Mitosis Modulators|mitosis modulators|mesh-ancestor
25251608|NCT02512380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251609|NCT02512315|Cisplatin|cisplatin|mesh-list
25251610|NCT02512315|Docetaxel|docetaxel|mesh-list
24724277|NCT01592110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251611|NCT02512315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25251612|NCT02512315|Tubulin Modulators|tubulin modulators|mesh-ancestor
25251613|NCT02512315|Antimitotic Agents|antimitotic agents|mesh-ancestor
25251614|NCT02512315|Mitosis Modulators|mitosis modulators|mesh-ancestor
25251615|NCT02512315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251617|NCT02512055|Ketamine|ketamine|mesh-list
25251618|NCT02512055|Analgesics|analgesics|mesh-ancestor
25251619|NCT02512055|Sensory System Agents|sensory system agents|mesh-ancestor
25251620|NCT02512055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25251621|NCT02512055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251622|NCT02512055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25251623|NCT02512055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25251624|NCT02512055|Anesthetics, General|anesthetics, general|mesh-ancestor
25251625|NCT02512055|Anesthetics|anesthetics|mesh-ancestor
25251626|NCT02512055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25251627|NCT02512055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25251628|NCT02512055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25251629|NCT02512055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25251630|NCT02512055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251631|NCT02512055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25251632|NCT02512055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25251633|NCT02512055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25251634|NCT02512055|Autonomic Agents|autonomic agents|mesh-ancestor
25251635|NCT02512055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25251636|NCT02512055|Respiratory System Agents|respiratory system agents|mesh-ancestor
25251637|NCT02512055|Mydriatics|mydriatics|mesh-ancestor
25251638|NCT02512055|Parasympatholytics|parasympatholytics|mesh-ancestor
25251639|NCT02512055|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25251640|NCT02512055|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25251641|NCT02512055|Cholinergic Agents|cholinergic agents|mesh-ancestor
25251642|NCT02511873|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-list
25251643|NCT02511873|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25251644|NCT02511873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25251645|NCT02511873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251646|NCT02511873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251647|NCT02511795|Olaparib|olaparib|mesh-list
25251648|NCT02511795|Adavosertib|adavosertib|mesh-list
25251649|NCT02511795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25251650|NCT02511795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251651|NCT02511795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251652|NCT02511795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25251653|NCT02511613|Squalamine|squalamine|mesh-list
25251654|NCT02511613|Ranibizumab|ranibizumab|mesh-list
25251655|NCT02511613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25251656|NCT02511613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25251657|NCT02511613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25686935|NCT01926886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25251658|NCT02511613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25251659|NCT02511613|Growth Substances|growth substances|mesh-ancestor
25251660|NCT02511613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084678|NCT03304093|Nivolumab|nivolumab|mesh-list
25251661|NCT02511613|Growth Inhibitors|growth inhibitors|mesh-ancestor
25251662|NCT02511613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25251663|NCT02511613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25251664|NCT02511613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25251665|NCT02511613|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25251666|NCT02511613|Protective Agents|protective agents|mesh-ancestor
25251667|NCT02511665|Metformin|metformin|mesh-list
25251668|NCT02511665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25251669|NCT02511665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251670|NCT02511847|Afatinib|afatinib|mesh-list
25251671|NCT02511847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25251672|NCT02511847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25251673|NCT02511847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251674|NCT02511847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251675|NCT02511639|Everolimus|everolimus|mesh-list
25251676|NCT02511639|Letrozole|letrozole|mesh-list
25251677|NCT02511639|Anastrozole|anastrozole|mesh-list
25251678|NCT02511639|Exemestane|exemestane|mesh-list
25251679|NCT02511639|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25251680|NCT02511639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25251681|NCT02511639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25251682|NCT02511639|Immunologic Factors|immunologic factors|mesh-ancestor
25251683|NCT02511639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084745|NCT03303651|Narcotics|narcotics|mesh-ancestor
25251684|NCT02511639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25251685|NCT02511639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251686|NCT02511639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251687|NCT02511639|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25251688|NCT02511639|Hormone Antagonists|hormone antagonists|mesh-ancestor
25251689|NCT02511639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25251690|NCT02511639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25251691|NCT02511483|Propranolol|propranolol|mesh-list
25251692|NCT02511483|Morphine|morphine|mesh-list
25251693|NCT02511483|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25251694|NCT02511483|Narcotics|narcotics|mesh-ancestor
25251695|NCT02511483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25251696|NCT02511483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251697|NCT02511483|Analgesics|analgesics|mesh-ancestor
25251698|NCT02511483|Sensory System Agents|sensory system agents|mesh-ancestor
24724571|NCT01593566|Bupivacaine|bupivacaine|mesh-list
24724572|NCT01593566|Anesthetics, Local|anesthetics, local|mesh-ancestor
24724592|NCT01593644|Vasodilator Agents|vasodilator agents|mesh-ancestor
25251699|NCT02511483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25251700|NCT02511483|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25084803|NCT03303053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793134|NCT04074460|Anesthetics|anesthetics|mesh-ancestor
24793137|NCT04073303|Botulinum Toxins|botulinum toxins|mesh-list
25010101|NCT04643405|Paclitaxel|paclitaxel|mesh-list
25010102|NCT04643405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25010103|NCT04643405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24580585|NCT00862394|Adrenergic Agents|adrenergic agents|mesh-ancestor
25251701|NCT02511483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25251702|NCT02511483|Adrenergic Agents|adrenergic agents|mesh-ancestor
25251703|NCT02511483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25251704|NCT02511483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251705|NCT02511483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25251706|NCT02511483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25251707|NCT02511483|Vasodilator Agents|vasodilator agents|mesh-ancestor
25251708|NCT02511704|Nicotine|nicotine|mesh-list
25251709|NCT02511704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25251710|NCT02511704|Autonomic Agents|autonomic agents|mesh-ancestor
25251711|NCT02511704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25251712|NCT02511704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251713|NCT02511704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25251714|NCT02511704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25251715|NCT02511704|Cholinergic Agents|cholinergic agents|mesh-ancestor
25251716|NCT02511704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25251717|NCT02511704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251718|NCT02511574|Progesterone|progesterone|mesh-list
25251719|NCT02511574|Progestins|progestins|mesh-ancestor
25251720|NCT02511574|Hormones|hormones|mesh-ancestor
25251721|NCT02511574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25251722|NCT02511574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251723|NCT02511405|Bevacizumab|bevacizumab|mesh-list
25251724|NCT02511405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25251725|NCT02511405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25251726|NCT02511405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25251727|NCT02511405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25251728|NCT02511405|Growth Substances|growth substances|mesh-ancestor
25251729|NCT02511405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251730|NCT02511405|Growth Inhibitors|growth inhibitors|mesh-ancestor
25251731|NCT02511353|Ivermectin|ivermectin|mesh-list
25251732|NCT02511353|Piperaquine|piperaquine|mesh-list
25686936|NCT01926886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25686937|NCT01926977|Ranibizumab|ranibizumab|mesh-list
25251733|NCT02511353|Artenimol|artenimol|mesh-list
25251734|NCT02511353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25686938|NCT01926977|Aflibercept|aflibercept|mesh-list
25251735|NCT02511353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25155417|NCT05374564|Flutemetamol|flutemetamol|mesh-list
25084817|NCT03302871|Cholinergic Agents|cholinergic agents|mesh-ancestor
25251736|NCT02511353|Antimalarials|antimalarials|mesh-ancestor
25251737|NCT02511353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25274597|NCT02376478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25274598|NCT02376478|Analgesics|analgesics|mesh-ancestor
25274599|NCT02376478|Sensory System Agents|sensory system agents|mesh-ancestor
25274600|NCT02376478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25274601|NCT02376478|Hematinics|hematinics|mesh-ancestor
25274602|NCT02376478|Vitamin B Complex|vitamin b complex|mesh-ancestor
25274603|NCT02376478|Vitamins|vitamins|mesh-ancestor
25274604|NCT02376478|Micronutrients|micronutrients|mesh-ancestor
25274605|NCT02376478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25274606|NCT02376595|Bromides|bromides|mesh-list
25274607|NCT02376595|Rocuronium|rocuronium|mesh-list
25274608|NCT02376595|Anticonvulsants|anticonvulsants|mesh-ancestor
25274609|NCT02376595|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25274610|NCT02376595|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25274611|NCT02376595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25274612|NCT02376595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25274613|NCT02376595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274614|NCT02376452|Leucovorin|leucovorin|mesh-list
25274615|NCT02376452|Fluorouracil|fluorouracil|mesh-list
25274616|NCT02376452|Raltitrexed|raltitrexed|mesh-list
25274617|NCT02376452|Irinotecan|irinotecan|mesh-list
25274618|NCT02376452|Antimetabolites|antimetabolites|mesh-ancestor
25274619|NCT02376452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274620|NCT02376452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25274621|NCT02376452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25274622|NCT02376452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25274623|NCT02376452|Immunologic Factors|immunologic factors|mesh-ancestor
25274624|NCT02376452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274625|NCT02376452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25274626|NCT02376452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25274627|NCT02376452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274628|NCT02376452|Antidotes|antidotes|mesh-ancestor
25274629|NCT02376452|Protective Agents|protective agents|mesh-ancestor
25274630|NCT02376452|Vitamin B Complex|vitamin b complex|mesh-ancestor
25274631|NCT02376452|Vitamins|vitamins|mesh-ancestor
25274632|NCT02376452|Micronutrients|micronutrients|mesh-ancestor
25274633|NCT02376452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25274634|NCT02376413|Trastuzumab|trastuzumab|mesh-list
25274635|NCT02376413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25274636|NCT02376413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24533591|NCT00644553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24533592|NCT00644553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24631665|NCT01119482|Vaccines|vaccines|mesh-list
24632428|NCT01123876|Veliparib|veliparib|mesh-list
24580586|NCT00862394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24580604|NCT00862472|Cloprostenol|cloprostenol|mesh-list
24580605|NCT00862472|Luteolytic Agents|luteolytic agents|mesh-ancestor
24580606|NCT00862472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24580607|NCT00862472|Contraceptive Agents|contraceptive agents|mesh-ancestor
24580608|NCT00862472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24580609|NCT00862472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580610|NCT00862472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24580611|NCT00862472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24580612|NCT00862472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24580613|NCT00862472|Adrenergic Agents|adrenergic agents|mesh-ancestor
24580614|NCT00862472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24580615|NCT00862472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580616|NCT00862472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24580630|NCT00862693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24580631|NCT00862693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580636|NCT00862706|Telbivudine|telbivudine|mesh-list
24580669|NCT00863148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580670|NCT00863148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24580671|NCT00863148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24580672|NCT00863148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24580673|NCT00863148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24580674|NCT00863148|Antimetabolites|antimetabolites|mesh-ancestor
24580694|NCT00863239|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24580695|NCT00863239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24580696|NCT00863239|Antiviral Agents|antiviral agents|mesh-ancestor
24580697|NCT00863239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24580698|NCT00863239|Antimetabolites|antimetabolites|mesh-ancestor
24580699|NCT00863239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580700|NCT00863239|Immunologic Factors|immunologic factors|mesh-ancestor
24580701|NCT00863239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580702|NCT00863252|Mycophenolic Acid|mycophenolic acid|mesh-list
24580703|NCT00863252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24580704|NCT00863252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24580705|NCT00863252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24580706|NCT00863252|Antitubercular Agents|antitubercular agents|mesh-ancestor
25251738|NCT02511418|Simvastatin|simvastatin|mesh-list
25251739|NCT02511418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25251740|NCT02511418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25251741|NCT02511418|Antimetabolites|antimetabolites|mesh-ancestor
25251742|NCT02511418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251743|NCT02511418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25251744|NCT02511418|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25251745|NCT02511418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251746|NCT02511366|Caseins|caseins|mesh-list
25251747|NCT02511366|Chelating Agents|chelating agents|mesh-ancestor
25251748|NCT02511366|Sequestering Agents|sequestering agents|mesh-ancestor
25251749|NCT02511366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251750|NCT02511340|HH-GV-678|hh-gv-678|mesh-list
25251751|NCT02511340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25251752|NCT02511340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251753|NCT02511340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251754|NCT02511223|Olaparib|olaparib|mesh-list
25274637|NCT02376309|Nandrolone|nandrolone|mesh-list
24631740|NCT01119742|Butenafine|butenafine|mesh-list
25251755|NCT02511223|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25251756|NCT02511223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251757|NCT02511223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251758|NCT02511223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25251759|NCT02511145|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
25251760|NCT02511145|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25251761|NCT02511145|Dermatologic Agents|dermatologic agents|mesh-ancestor
25251763|NCT02511210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25251764|NCT02511210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251765|NCT02511054|Chloroquine|chloroquine|mesh-list
25251766|NCT02511054|Pyrimethamine|pyrimethamine|mesh-list
25251767|NCT02511054|Amebicides|amebicides|mesh-ancestor
25251768|NCT02511054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25251769|NCT02511054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25251770|NCT02511054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25251771|NCT02511054|Antimalarials|antimalarials|mesh-ancestor
25251772|NCT02511054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25251773|NCT02511054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25251774|NCT02511054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251775|NCT02511054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251776|NCT02511067|Ranibizumab|ranibizumab|mesh-list
25251777|NCT02511067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25251778|NCT02511067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25251779|NCT02511067|Growth Substances|growth substances|mesh-ancestor
25251780|NCT02511067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251781|NCT02511067|Growth Inhibitors|growth inhibitors|mesh-ancestor
25251782|NCT02511067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25251783|NCT02510976|Prucalopride|prucalopride|mesh-list
25251784|NCT02510976|Laxatives|laxatives|mesh-ancestor
25251785|NCT02510976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25251786|NCT02510976|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
25251787|NCT02510976|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25251788|NCT02510976|Serotonin Agents|serotonin agents|mesh-ancestor
25251789|NCT02510976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25251790|NCT02510976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251791|NCT02510976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251792|NCT02510781|Carboplatin|carboplatin|mesh-list
25251793|NCT02510781|Docetaxel|docetaxel|mesh-list
25251794|NCT02510781|Trastuzumab|trastuzumab|mesh-list
25251795|NCT02510781|Epirubicin|epirubicin|mesh-list
25251796|NCT02510781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25404146|NCT03682068|Antiviral Agents|antiviral agents|mesh-ancestor
24837890|NCT02194179|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25251797|NCT02510781|Tubulin Modulators|tubulin modulators|mesh-ancestor
25251798|NCT02510781|Antimitotic Agents|antimitotic agents|mesh-ancestor
25251800|NCT02510781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251801|NCT02510781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25251802|NCT02510781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25251803|NCT02510781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25251804|NCT02510781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25251805|NCT02510781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251807|NCT02510911|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25251808|NCT02510911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251809|NCT02510911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25251810|NCT02510911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251811|NCT02510911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251812|NCT02510911|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25251813|NCT02510911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25251814|NCT02510911|Purinergic Agents|purinergic agents|mesh-ancestor
25251815|NCT02510911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25251816|NCT02510872|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25251817|NCT02510872|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25251818|NCT02510872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251819|NCT02510950|Temozolomide|temozolomide|mesh-list
25251820|NCT02510950|Poly ICLC|poly iclc|mesh-list
25251821|NCT02510950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25251822|NCT02510950|Alkylating Agents|alkylating agents|mesh-ancestor
25251823|NCT02510950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251824|NCT02510950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25251825|NCT02510950|Interferon Inducers|interferon inducers|mesh-ancestor
25251826|NCT02510950|Immunologic Factors|immunologic factors|mesh-ancestor
25251827|NCT02510950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251828|NCT02510586|Sevoflurane|sevoflurane|mesh-list
25251829|NCT02510586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25251830|NCT02510586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25251831|NCT02510586|Anesthetics, General|anesthetics, general|mesh-ancestor
25251832|NCT02510586|Anesthetics|anesthetics|mesh-ancestor
24533691|NCT00644800|Serotonin Agents|serotonin agents|mesh-ancestor
24533692|NCT00644800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24533693|NCT00644800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686939|NCT01926977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24958037|NCT03838094|Calcium|calcium|mesh-list
24533694|NCT00644800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533695|NCT00644800|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24533696|NCT00644800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24533697|NCT00644800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24580707|NCT00863252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24580708|NCT00863252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24580709|NCT00863252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580710|NCT00863252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580711|NCT00863291|Buprenorphine|buprenorphine|mesh-list
24580753|NCT00863460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24580754|NCT00863460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24580755|NCT00863460|Abortifacient Agents|abortifacient agents|mesh-ancestor
24580756|NCT00863460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24580757|NCT00863460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24580758|NCT00863460|Antimetabolites|antimetabolites|mesh-ancestor
24580759|NCT00863460|Dermatologic Agents|dermatologic agents|mesh-ancestor
24580760|NCT00863460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251833|NCT02510586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25251834|NCT02510586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251835|NCT02510534|Menotropins|menotropins|mesh-list
25251836|NCT02510534|Progesterone|progesterone|mesh-list
25251837|NCT02510534|Progestins|progestins|mesh-ancestor
25251838|NCT02510534|Hormones|hormones|mesh-ancestor
25251839|NCT02510534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25251840|NCT02510534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251841|NCT02510534|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25251842|NCT02510534|Fertility Agents|fertility agents|mesh-ancestor
25251843|NCT02510534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25251844|NCT02510612|Dexmedetomidine|dexmedetomidine|mesh-list
25251845|NCT02510612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25251846|NCT02510612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25251847|NCT02510612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251848|NCT02510612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25251849|NCT02510612|Analgesics|analgesics|mesh-ancestor
25251850|NCT02510612|Sensory System Agents|sensory system agents|mesh-ancestor
25251851|NCT02510612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25251852|NCT02510612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25251853|NCT02510612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25251854|NCT02510612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25251855|NCT02510612|Adrenergic Agents|adrenergic agents|mesh-ancestor
25251856|NCT02510612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25251857|NCT02510612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251858|NCT02510963|Tenofovir|tenofovir|mesh-list
25251859|NCT02510963|Antiviral Agents|antiviral agents|mesh-ancestor
25251860|NCT02510963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25251861|NCT02510963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25251862|NCT02510963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24580761|NCT00863460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24760254|NCT01756989|Leprostatic Agents|leprostatic agents|mesh-ancestor
24580762|NCT00863460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24580763|NCT00863460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24893814|NCT04446234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24580819|NCT00863785|Antidotes|antidotes|mesh-ancestor
24580820|NCT00863837|Terlipressin|terlipressin|mesh-list
24580821|NCT00863837|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25251863|NCT02510963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251864|NCT02510963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251865|NCT02510963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25251866|NCT02510963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25251867|NCT02510287|Lidocaine|lidocaine|mesh-list
25251868|NCT02510287|Fentanyl|fentanyl|mesh-list
25251869|NCT02510287|Bupivacaine|bupivacaine|mesh-list
25251870|NCT02510287|Anesthetics, Local|anesthetics, local|mesh-ancestor
25251871|NCT02510287|Anesthetics|anesthetics|mesh-ancestor
25251872|NCT02510287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25251873|NCT02510287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251874|NCT02510287|Sensory System Agents|sensory system agents|mesh-ancestor
25251875|NCT02510287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25251876|NCT02510287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25251877|NCT02510287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25251878|NCT02510287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25251879|NCT02510287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25251880|NCT02510287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251881|NCT02510287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25251882|NCT02510287|Narcotics|narcotics|mesh-ancestor
25251883|NCT02510287|Analgesics|analgesics|mesh-ancestor
25251884|NCT02510287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25251885|NCT02510287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25251886|NCT02510287|Anesthetics, General|anesthetics, general|mesh-ancestor
25251887|NCT02510248|1-2-isopropoxy-2-oxidodihydro-4H,6H-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1H,3H)-dione|1-2-isopropoxy-2-oxidodihydro-4h,6h-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1h,3h)-dione|mesh-list
25251888|NCT02510248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251889|NCT02510248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251890|NCT02510469|Apatinib|apatinib|mesh-list
25251891|NCT02510469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25251892|NCT02510469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25251893|NCT02510469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274638|NCT02376309|Androgens|androgens|mesh-ancestor
25050901|NCT00463242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24450112|NCT00317785|Antitubercular Agents|antitubercular agents|mesh-ancestor
24450113|NCT00317785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24450115|NCT00317798|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24450116|NCT00317798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24450128|NCT00317811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24580822|NCT00863837|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24580823|NCT00863837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24580824|NCT00863837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580825|NCT00863837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580826|NCT00863850|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24580827|NCT00863850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24580828|NCT00863850|Alkylating Agents|alkylating agents|mesh-ancestor
24580829|NCT00863850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580830|NCT00863850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24580831|NCT00863863|Griseofulvin|griseofulvin|mesh-list
24580832|NCT00863863|Antifungal Agents|antifungal agents|mesh-ancestor
24580833|NCT00863863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24580834|NCT00863889|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24580835|NCT00863889|Methylprednisolone|methylprednisolone|mesh-list
24580836|NCT00863889|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25251894|NCT02510469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251895|NCT02510222|Magnesium Sulfate|magnesium sulfate|mesh-list
25251896|NCT02510222|Analgesics|analgesics|mesh-ancestor
25251897|NCT02510222|Sensory System Agents|sensory system agents|mesh-ancestor
25251898|NCT02510222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25251899|NCT02510222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251900|NCT02510222|Anesthetics|anesthetics|mesh-ancestor
25251901|NCT02510222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25251902|NCT02510222|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25251903|NCT02510222|Anticonvulsants|anticonvulsants|mesh-ancestor
25251904|NCT02510222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25251905|NCT02510222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25251906|NCT02510222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251907|NCT02510222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25251908|NCT02510222|Tocolytic Agents|tocolytic agents|mesh-ancestor
25251909|NCT02510222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25251910|NCT02510235|Hyaluronic Acid|hyaluronic acid|mesh-list
25251911|NCT02510235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25251912|NCT02510235|Immunologic Factors|immunologic factors|mesh-ancestor
25251913|NCT02510235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251914|NCT02510235|Viscosupplements|viscosupplements|mesh-ancestor
25251915|NCT02510235|Protective Agents|protective agents|mesh-ancestor
25251916|NCT02510157|Dexamethasone|dexamethasone|mesh-list
25251917|NCT02510157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25251918|NCT02510157|Antiemetics|antiemetics|mesh-ancestor
25251919|NCT02510157|Autonomic Agents|autonomic agents|mesh-ancestor
25251920|NCT02510157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25251921|NCT02510157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686940|NCT01926977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24629397|NCT01105013|Antifungal Agents|antifungal agents|mesh-ancestor
25000451|NCT04437485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24580837|NCT00863889|Prednisolone|prednisolone|mesh-list
24586334|NCT00890253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24586335|NCT00890253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586336|NCT00890253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24586338|NCT00890253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24586339|NCT00890253|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24586340|NCT00890253|Antitubercular Agents|antitubercular agents|mesh-ancestor
24586341|NCT00890253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24586342|NCT00890253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24586343|NCT00890253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251922|NCT02510157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25251923|NCT02510157|Glucocorticoids|glucocorticoids|mesh-ancestor
25251924|NCT02510157|Hormones|hormones|mesh-ancestor
25251925|NCT02510157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25251926|NCT02510157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25251927|NCT02510157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25251928|NCT02510053|Caspofungin|caspofungin|mesh-list
25251929|NCT02510053|Antifungal Agents|antifungal agents|mesh-ancestor
25251930|NCT02510053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25251931|NCT02510053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251932|NCT02510053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251933|NCT02509949|Dexmedetomidine|dexmedetomidine|mesh-list
25251934|NCT02509949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25251935|NCT02509949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25251936|NCT02509949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251937|NCT02509949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25251938|NCT02509949|Analgesics|analgesics|mesh-ancestor
25251939|NCT02509949|Sensory System Agents|sensory system agents|mesh-ancestor
25251940|NCT02509949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25251941|NCT02509949|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25251942|NCT02509949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25251943|NCT02509949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25251944|NCT02509949|Adrenergic Agents|adrenergic agents|mesh-ancestor
25251945|NCT02509949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25251946|NCT02509949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251947|NCT02509923|Rabeprazole|rabeprazole|mesh-list
25251948|NCT02509923|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25251949|NCT02509923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25251950|NCT02509923|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25251951|NCT02509923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251952|NCT02509923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010106|NCT04643405|Mitosis Modulators|mitosis modulators|mesh-ancestor
25251961|NCT02509806|Apatinib|apatinib|mesh-list
25251962|NCT02509806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25251963|NCT02509806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25251964|NCT02509806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25251965|NCT02509806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251966|NCT02509728|Choline|choline|mesh-list
25251967|NCT02509728|Lipotropic Agents|lipotropic agents|mesh-ancestor
25251968|NCT02509728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25251969|NCT02509728|Antimetabolites|antimetabolites|mesh-ancestor
25251970|NCT02509728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251971|NCT02509728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25251972|NCT02509728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25251973|NCT02509728|Nootropic Agents|nootropic agents|mesh-ancestor
25274639|NCT02376309|Hormones|hormones|mesh-ancestor
25274640|NCT02376309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25274641|NCT02376309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274642|NCT02376309|Anabolic Agents|anabolic agents|mesh-ancestor
25274643|NCT02376088|Methimazole|methimazole|mesh-list
25274644|NCT02376088|Antithyroid Agents|antithyroid agents|mesh-ancestor
25274645|NCT02376088|Hormone Antagonists|hormone antagonists|mesh-ancestor
25274646|NCT02376088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25274647|NCT02376088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274648|NCT02376296|Docetaxel|docetaxel|mesh-list
25274649|NCT02376296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25274650|NCT02376296|Tubulin Modulators|tubulin modulators|mesh-ancestor
25274651|NCT02376296|Antimitotic Agents|antimitotic agents|mesh-ancestor
25274652|NCT02376296|Mitosis Modulators|mitosis modulators|mesh-ancestor
25275679|NCT02370433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24462840|NCT00357682|Esomeprazole|esomeprazole|mesh-list
24533720|NCT00644956|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24533721|NCT00644956|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24533722|NCT00644956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533723|NCT00644956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533724|NCT00644956|Urological Agents|urological agents|mesh-ancestor
24533725|NCT00644982|Sertraline|sertraline|mesh-list
25251975|NCT02509429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25251977|NCT02509429|Insulin, Long-Acting|insulin, long-acting|mesh-list
25251978|NCT02509429|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25251979|NCT02509429|Insulin Lispro|insulin lispro|mesh-list
25251980|NCT02509429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25251981|NCT02509429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251982|NCT02509273|Clonidine|clonidine|mesh-list
25251983|NCT02509273|Midazolam|midazolam|mesh-list
25251984|NCT02509273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25251985|NCT02509273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25251986|NCT02509273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25251987|NCT02509273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25251988|NCT02509273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25251989|NCT02509273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25251990|NCT02509273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25251991|NCT02509273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25251992|NCT02509273|Anesthetics, General|anesthetics, general|mesh-ancestor
25251993|NCT02509273|Anesthetics|anesthetics|mesh-ancestor
25251994|NCT02509273|GABA Modulators|gaba modulators|mesh-ancestor
25251995|NCT02509273|GABA Agents|gaba agents|mesh-ancestor
25251996|NCT02509273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25251997|NCT02509273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25251998|NCT02509273|Analgesics|analgesics|mesh-ancestor
25251999|NCT02509273|Sensory System Agents|sensory system agents|mesh-ancestor
25252000|NCT02509273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25252001|NCT02509273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25252002|NCT02509273|Sympatholytics|sympatholytics|mesh-ancestor
25252003|NCT02509273|Autonomic Agents|autonomic agents|mesh-ancestor
25252004|NCT02509273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25252005|NCT02509273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25252006|NCT02509273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25252007|NCT02509273|Adrenergic Agents|adrenergic agents|mesh-ancestor
25252011|NCT02509468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25252012|NCT02509468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24533743|NCT00645034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533744|NCT00645034|Urological Agents|urological agents|mesh-ancestor
25252013|NCT02509468|Antifungal Agents|antifungal agents|mesh-ancestor
25252014|NCT02509468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25252015|NCT02509468|Immunologic Factors|immunologic factors|mesh-ancestor
25252016|NCT02509468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252017|NCT02509559|Propranolol|propranolol|mesh-list
25252018|NCT02509559|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25252019|NCT02509559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25252020|NCT02509559|Adrenergic Agents|adrenergic agents|mesh-ancestor
25252021|NCT02509559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25252022|NCT02509559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252023|NCT02509559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252024|NCT02509559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25252025|NCT02509559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25252026|NCT02509559|Vasodilator Agents|vasodilator agents|mesh-ancestor
25252027|NCT02509351|Misoprostol|misoprostol|mesh-list
25252028|NCT02509351|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25252029|NCT02509351|Abortifacient Agents|abortifacient agents|mesh-ancestor
25252030|NCT02509351|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25252031|NCT02509351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252032|NCT02509351|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25252033|NCT02509351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25252034|NCT02509351|Oxytocics|oxytocics|mesh-ancestor
25252035|NCT02509286|Leucovorin|leucovorin|mesh-list
25252036|NCT02509286|Paclitaxel|paclitaxel|mesh-list
25252037|NCT02509286|Docetaxel|docetaxel|mesh-list
25252038|NCT02509286|Carboplatin|carboplatin|mesh-list
25252039|NCT02509286|Fluorouracil|fluorouracil|mesh-list
25252040|NCT02509286|Oxaliplatin|oxaliplatin|mesh-list
25252041|NCT02509286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25252042|NCT02509286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25252043|NCT02509286|Tubulin Modulators|tubulin modulators|mesh-ancestor
25252044|NCT02509286|Antimitotic Agents|antimitotic agents|mesh-ancestor
25252045|NCT02509286|Mitosis Modulators|mitosis modulators|mesh-ancestor
25252046|NCT02509286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252047|NCT02509286|Antimetabolites|antimetabolites|mesh-ancestor
25252048|NCT02509286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25252049|NCT02509286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25252050|NCT02509286|Immunologic Factors|immunologic factors|mesh-ancestor
25252051|NCT02509286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252052|NCT02509286|Antidotes|antidotes|mesh-ancestor
25252053|NCT02509286|Protective Agents|protective agents|mesh-ancestor
25252054|NCT02509286|Vitamin B Complex|vitamin b complex|mesh-ancestor
25252055|NCT02509286|Vitamins|vitamins|mesh-ancestor
25252056|NCT02509286|Micronutrients|micronutrients|mesh-ancestor
25252057|NCT02509234|Irinotecan|irinotecan|mesh-list
25000573|NCT04179890|Afatinib|afatinib|mesh-list
25000574|NCT04179890|Mitogens|mitogens|mesh-list
25000575|NCT04179890|Mitosis Modulators|mitosis modulators|mesh-ancestor
25000576|NCT04179890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000577|NCT04179890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25252058|NCT02509234|Trabectedin|trabectedin|mesh-list
25252059|NCT02509234|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25252060|NCT02509234|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25252061|NCT02509234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25252062|NCT02509234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252063|NCT02509234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25252064|NCT02509234|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25252065|NCT02509234|Alkylating Agents|alkylating agents|mesh-ancestor
25252066|NCT02509208|Hemostatics|hemostatics|mesh-list
25252067|NCT02509208|Coagulants|coagulants|mesh-ancestor
25252068|NCT02509195|Lamivudine|lamivudine|mesh-list
25252069|NCT02509195|Abacavir|abacavir|mesh-list
25252070|NCT02509195|Dolutegravir|dolutegravir|mesh-list
25252071|NCT02509195|Triumeq|triumeq|mesh-list
25252072|NCT02509195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25252073|NCT02509195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25252074|NCT02509195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085553|NCT03296930|Ritonavir|ritonavir|mesh-list
25252075|NCT02509195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252077|NCT02509195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25252078|NCT02509195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25252079|NCT02509195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25252080|NCT02509195|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25252081|NCT02509195|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25252082|NCT02509143|Ramosetron|ramosetron|mesh-list
25252083|NCT02509143|Antiemetics|antiemetics|mesh-list
25252084|NCT02509143|Autonomic Agents|autonomic agents|mesh-ancestor
25252085|NCT02509143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25252086|NCT02509143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252087|NCT02509143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25252088|NCT02509143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25252089|NCT02509143|Serotonin Agents|serotonin agents|mesh-ancestor
25252090|NCT02509143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25252091|NCT02509143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252092|NCT02508870|Azacitidine|azacitidine|mesh-list
25252093|NCT02508870|Atezolizumab|atezolizumab|mesh-list
25252094|NCT02508870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25252095|NCT02508870|Antimetabolites|antimetabolites|mesh-ancestor
25252096|NCT02508870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252097|NCT02508870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25252098|NCT02508870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25252099|NCT02509091|Amikacin|amikacin|mesh-list
25252100|NCT02509091|Dimercaprol|dimercaprol|mesh-list
25252101|NCT02509091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25252102|NCT02509091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25252103|NCT02509091|Chelating Agents|chelating agents|mesh-ancestor
24633396|NCT01129310|Irinotecan|irinotecan|mesh-list
25252105|NCT02509091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252107|NCT02509052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25252108|NCT02509052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252109|NCT02509052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25252110|NCT02509052|Immunologic Factors|immunologic factors|mesh-ancestor
25252111|NCT02509052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252112|NCT02508857|Ketorolac|ketorolac|mesh-list
25252113|NCT02508857|Magnesium Sulfate|magnesium sulfate|mesh-list
25252114|NCT02508857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25252115|NCT02508857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25252116|NCT02508857|Analgesics|analgesics|mesh-ancestor
25252117|NCT02508857|Sensory System Agents|sensory system agents|mesh-ancestor
25252118|NCT02508857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25252119|NCT02508857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252120|NCT02508857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25252121|NCT02508857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25252122|NCT02508857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25252123|NCT02508857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25252124|NCT02508857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252125|NCT02508857|Anesthetics|anesthetics|mesh-ancestor
25252126|NCT02508857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25252127|NCT02508857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25252128|NCT02508857|Anticonvulsants|anticonvulsants|mesh-ancestor
25252129|NCT02508857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25252130|NCT02508857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25252131|NCT02508857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25252132|NCT02508857|Tocolytic Agents|tocolytic agents|mesh-ancestor
25252133|NCT02508857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25252134|NCT02508922|Vitamin D|vitamin d|mesh-list
25252135|NCT02508922|Cholecalciferol|cholecalciferol|mesh-list
25252136|NCT02508922|Vitamins|vitamins|mesh-ancestor
25252137|NCT02508922|Micronutrients|micronutrients|mesh-ancestor
25252138|NCT02508922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252139|NCT02508922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24922970|NCT04174261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24922971|NCT04174261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24922972|NCT04174261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24922973|NCT04174261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24922974|NCT04174261|Purinergic Agents|purinergic agents|mesh-ancestor
24922975|NCT04174261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24922976|NCT04174261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922977|NCT04174261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922978|NCT04173871|Snake venom protein C activator|snake venom protein c activator|mesh-list
24922979|NCT04173871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24394747|NCT00134095|Irinotecan|irinotecan|mesh-list
25010107|NCT04643405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010108|NCT04643405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25010109|NCT04643405|Antimetabolites|antimetabolites|mesh-ancestor
25010110|NCT04643405|Antiviral Agents|antiviral agents|mesh-ancestor
24586344|NCT00890253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010111|NCT04643405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25010112|NCT04643405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24586345|NCT00890279|Imidapril|imidapril|mesh-list
25010113|NCT04643405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25010114|NCT04643405|Immunologic Factors|immunologic factors|mesh-ancestor
25010115|NCT04643405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010116|NCT04625803|Apatinib|apatinib|mesh-list
24580867|NCT00863902|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24580868|NCT00863902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24580869|NCT00863902|Histamine Antagonists|histamine antagonists|mesh-ancestor
24580871|NCT00863902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24580872|NCT00863902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580873|NCT00863902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580875|NCT00863915|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24580964|NCT00864136|Levonorgestrel|levonorgestrel|mesh-list
25252140|NCT02508922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25252141|NCT02508805|Diclofenac|diclofenac|mesh-list
25252142|NCT02508805|Tizanidine|tizanidine|mesh-list
25252143|NCT02508805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25252144|NCT02508805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25252145|NCT02508805|Analgesics|analgesics|mesh-ancestor
25252146|NCT02508805|Sensory System Agents|sensory system agents|mesh-ancestor
25252147|NCT02508805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25252148|NCT02508805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252149|NCT02508805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25252150|NCT02508805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25252151|NCT02508805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25252152|NCT02508805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25252153|NCT02508805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252154|NCT02508805|Anticonvulsants|anticonvulsants|mesh-ancestor
25252155|NCT02508805|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25252156|NCT02508805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25252157|NCT02508805|Parasympatholytics|parasympatholytics|mesh-ancestor
25252158|NCT02508805|Autonomic Agents|autonomic agents|mesh-ancestor
25252159|NCT02508805|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25252160|NCT02508805|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25252161|NCT02508805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25252162|NCT02508805|Adrenergic Agents|adrenergic agents|mesh-ancestor
24498609|NCT00515554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24498610|NCT00515554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498611|NCT00515554|Immunologic Factors|immunologic factors|mesh-ancestor
24498612|NCT00515554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498613|NCT00515554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24923003|NCT04174131|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24923004|NCT04174131|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24923024|NCT04173988|Alkylating Agents|alkylating agents|mesh-ancestor
25102663|NCT03167164|Growth Substances|growth substances|mesh-ancestor
24923025|NCT04173988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923026|NCT04173988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923027|NCT04173988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24923028|NCT04173793|Ezetimibe|ezetimibe|mesh-list
24923029|NCT04173793|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24923030|NCT04173793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24923031|NCT04173793|Antimetabolites|antimetabolites|mesh-ancestor
24923032|NCT04173793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923033|NCT04173793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24923045|NCT04173403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923046|NCT04173403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24923047|NCT04173585|Bortezomib|bortezomib|mesh-list
24923048|NCT04173585|Gemtuzumab|gemtuzumab|mesh-list
24923049|NCT04173585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923050|NCT04173585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24923051|NCT04173390|Pregabalin|pregabalin|mesh-list
24923052|NCT04173390|Analgesics|analgesics|mesh-ancestor
24923053|NCT04173390|Sensory System Agents|sensory system agents|mesh-ancestor
24923054|NCT04173390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24923055|NCT04173390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923056|NCT04173390|Anticonvulsants|anticonvulsants|mesh-ancestor
24923057|NCT04173390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24923058|NCT04173390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24580965|NCT00864136|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24580966|NCT00864136|Contraceptive Agents|contraceptive agents|mesh-ancestor
24580967|NCT00864136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24580968|NCT00864136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581083|NCT00864396|Lansoprazole|lansoprazole|mesh-list
24581084|NCT00864396|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24581085|NCT00864396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25252163|NCT02508805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25252164|NCT02509104|Tamsulosin|tamsulosin|mesh-list
25252165|NCT02509104|Dutasteride|dutasteride|mesh-list
25252166|NCT02509104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25252167|NCT02509104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25252168|NCT02509104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25252169|NCT02509104|Adrenergic Agents|adrenergic agents|mesh-ancestor
25252170|NCT02509104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25252171|NCT02509104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252172|NCT02509104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252173|NCT02509104|Urological Agents|urological agents|mesh-ancestor
25252174|NCT02509104|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25252175|NCT02509104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25252176|NCT02509104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25252177|NCT02509104|Hormone Antagonists|hormone antagonists|mesh-ancestor
25252178|NCT02509104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25252179|NCT02508753|Moxifloxacin|moxifloxacin|mesh-list
25252180|NCT02508753|Tazobactam|tazobactam|mesh-list
25252181|NCT02508753|Ceftolozane|ceftolozane|mesh-list
25252182|NCT02508753|Cephalosporins|cephalosporins|mesh-list
25252183|NCT02508753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25252184|NCT02508753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25252185|NCT02508753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25252186|NCT02508753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25252187|NCT02508753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25252188|NCT02508753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252189|NCT02508753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25252190|NCT02508753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25252191|NCT02508623|Rifaximin|rifaximin|mesh-list
25252192|NCT02508623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25252193|NCT02508623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25252194|NCT02508623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25252195|NCT02508584|Antibodies|antibodies|mesh-list
25252196|NCT02508584|Immunologic Factors|immunologic factors|mesh-ancestor
24923059|NCT04173390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923060|NCT04173390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24923061|NCT04173390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24923062|NCT04173390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24923063|NCT04173390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24923064|NCT04173390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24923066|NCT04173611|Anesthetics, Local|anesthetics, local|mesh-ancestor
24923067|NCT04173611|Anesthetics|anesthetics|mesh-ancestor
24923068|NCT04173611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24923089|NCT04172961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24923090|NCT04172987|Tirzepatide|tirzepatide|mesh-list
24923091|NCT04172987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24923092|NCT04172987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923093|NCT04172987|Incretins|incretins|mesh-ancestor
24923094|NCT04172987|Hormones|hormones|mesh-ancestor
24923095|NCT04172987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24923096|NCT04172922|Sirolimus|sirolimus|mesh-list
24923097|NCT04172922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24923098|NCT04172922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24923099|NCT04172922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24923100|NCT04172922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923101|NCT04172922|Antifungal Agents|antifungal agents|mesh-ancestor
24923102|NCT04172922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24923103|NCT04172922|Immunologic Factors|immunologic factors|mesh-ancestor
24923104|NCT04172922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923105|NCT04172727|Bupivacaine|bupivacaine|mesh-list
24923106|NCT04172727|Anesthetics, Local|anesthetics, local|mesh-ancestor
24923107|NCT04172727|Anesthetics|anesthetics|mesh-ancestor
24923108|NCT04172727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24498701|NCT00516009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24498702|NCT00516009|Antiemetics|antiemetics|mesh-ancestor
24498703|NCT00516009|Autonomic Agents|autonomic agents|mesh-ancestor
24498704|NCT00516009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24498705|NCT00516009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498707|NCT00516009|Glucocorticoids|glucocorticoids|mesh-ancestor
25252197|NCT02508584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252211|NCT02508311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25252213|NCT02508311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25252214|NCT02508311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252215|NCT02508311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25252216|NCT02508311|Respiratory System Agents|respiratory system agents|mesh-ancestor
25252217|NCT02508311|Tocolytic Agents|tocolytic agents|mesh-ancestor
25252218|NCT02508311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25252219|NCT02508311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25252220|NCT02508311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25252221|NCT02508311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25252222|NCT02508311|Adrenergic Agents|adrenergic agents|mesh-ancestor
25252223|NCT02508311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25252224|NCT02508311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252225|NCT02508350|Daptomycin|daptomycin|mesh-list
25252226|NCT02508350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25252227|NCT02508350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25252228|NCT02508168|Metformin|metformin|mesh-list
25252229|NCT02508168|Alogliptin|alogliptin|mesh-list
25252230|NCT02508168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25252231|NCT02508168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252232|NCT02508168|Incretins|incretins|mesh-ancestor
25252233|NCT02508168|Hormones|hormones|mesh-ancestor
25252234|NCT02508168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24923111|NCT04172727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24624153|NCT01074905|Schistosomicides|schistosomicides|mesh-ancestor
24624154|NCT01074905|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24624155|NCT01074905|Anthelmintics|anthelmintics|mesh-ancestor
24624156|NCT01074905|Amebicides|amebicides|mesh-ancestor
24624157|NCT01074905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24624158|NCT01074905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24624159|NCT01074905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24624160|NCT01074905|Analgesics|analgesics|mesh-ancestor
25252235|NCT02508168|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24624161|NCT01074905|Sensory System Agents|sensory system agents|mesh-ancestor
24624162|NCT01074905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25252236|NCT02508168|Protease Inhibitors|protease inhibitors|mesh-ancestor
25252237|NCT02508168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085710|NCT03295955|Amoxicillin|amoxicillin|mesh-list
25252238|NCT02508168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252239|NCT02508246|Cisplatin|cisplatin|mesh-list
25252240|NCT02508246|Docetaxel|docetaxel|mesh-list
25252241|NCT02508246|Adavosertib|adavosertib|mesh-list
25252242|NCT02508246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25252243|NCT02508246|Tubulin Modulators|tubulin modulators|mesh-ancestor
25252244|NCT02508246|Antimitotic Agents|antimitotic agents|mesh-ancestor
25252245|NCT02508246|Mitosis Modulators|mitosis modulators|mesh-ancestor
25252246|NCT02508246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252247|NCT02508246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25252248|NCT02508142|Scopolamine|scopolamine|mesh-list
25252249|NCT02508142|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25252250|NCT02508142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25252251|NCT02508142|Antiemetics|antiemetics|mesh-ancestor
25252252|NCT02508142|Autonomic Agents|autonomic agents|mesh-ancestor
25252253|NCT02508142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25252254|NCT02508142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252255|NCT02508142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25252256|NCT02508142|Mydriatics|mydriatics|mesh-ancestor
25252257|NCT02508142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25252258|NCT02508142|Cholinergic Agents|cholinergic agents|mesh-ancestor
25252259|NCT02508142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25252260|NCT02508142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252261|NCT02508142|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25252262|NCT02508142|Parasympatholytics|parasympatholytics|mesh-ancestor
25252263|NCT02508220|Oxytocin|oxytocin|mesh-list
25252264|NCT02508220|Oxytocics|oxytocics|mesh-ancestor
25252265|NCT02508220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25252266|NCT02508220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252267|NCT02508064|Fostemsavir|fostemsavir|mesh-list
25252268|NCT02508064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25252269|NCT02508064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25252270|NCT02508064|Antiviral Agents|antiviral agents|mesh-ancestor
25252271|NCT02508064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25252272|NCT02508064|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25252273|NCT02508064|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24624166|NCT01074905|Antinematodal Agents|antinematodal agents|mesh-ancestor
24624168|NCT01074970|Rucaparib|rucaparib|mesh-list
24498740|NCT00516152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24498741|NCT00516152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498742|NCT00516152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24498743|NCT00516152|Antimetabolites|antimetabolites|mesh-ancestor
24498744|NCT00516152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923153|NCT04172220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24923154|NCT04172220|Anesthetics, General|anesthetics, general|mesh-ancestor
24923155|NCT04172220|GABA Modulators|gaba modulators|mesh-ancestor
24923156|NCT04172220|GABA Agents|gaba agents|mesh-ancestor
24923157|NCT04172220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24923158|NCT04172220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923159|NCT04172064|Dobutamine|dobutamine|mesh-list
24923160|NCT04172064|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24923161|NCT04172064|Sympathomimetics|sympathomimetics|mesh-ancestor
24923162|NCT04172064|Autonomic Agents|autonomic agents|mesh-ancestor
24923173|NCT04172259|Docetaxel|docetaxel|mesh-list
24923174|NCT04172259|Doxorubicin|doxorubicin|mesh-list
24923175|NCT04172259|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24923176|NCT04172259|Trastuzumab|trastuzumab|mesh-list
24923177|NCT04172259|Epirubicin|epirubicin|mesh-list
24923178|NCT04172259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24923179|NCT04172259|Immunologic Factors|immunologic factors|mesh-ancestor
24923180|NCT04172259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923181|NCT04172259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24923182|NCT04172259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24923183|NCT04172259|Alkylating Agents|alkylating agents|mesh-ancestor
24726672|NCT01605240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24726674|NCT01605240|Antipyretics|antipyretics|mesh-ancestor
24395108|NCT00135122|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24923225|NCT04171843|Cyclophosphamide|cyclophosphamide|mesh-list
24923226|NCT04171843|Fludarabine|fludarabine|mesh-list
24923227|NCT04171843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24923228|NCT04171843|Immunologic Factors|immunologic factors|mesh-ancestor
25252274|NCT02508064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252275|NCT02507934|Hyaluronic Acid|hyaluronic acid|mesh-list
25252276|NCT02507934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25252277|NCT02507934|Immunologic Factors|immunologic factors|mesh-ancestor
25252278|NCT02507934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252279|NCT02507934|Viscosupplements|viscosupplements|mesh-ancestor
25252280|NCT02507934|Protective Agents|protective agents|mesh-ancestor
25252281|NCT02507843|Vitamin D|vitamin d|mesh-list
25252282|NCT02507843|Cholecalciferol|cholecalciferol|mesh-list
25252283|NCT02507843|Vitamins|vitamins|mesh-ancestor
25252284|NCT02507843|Micronutrients|micronutrients|mesh-ancestor
25252285|NCT02507843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252286|NCT02507843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25252287|NCT02507843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25274653|NCT02376296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274654|NCT02376192|Phenylephrine|phenylephrine|mesh-list
25274655|NCT02376192|Oxymetazoline|oxymetazoline|mesh-list
25274656|NCT02376192|Ephedrine|ephedrine|mesh-list
25274657|NCT02376192|Bupivacaine|bupivacaine|mesh-list
25274658|NCT02376192|Anesthetics, Local|anesthetics, local|mesh-ancestor
25274659|NCT02376192|Anesthetics|anesthetics|mesh-ancestor
25252686|NCT02505893|Sirolimus|sirolimus|mesh-list
25274661|NCT02376192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274662|NCT02376192|Sensory System Agents|sensory system agents|mesh-ancestor
25274663|NCT02376192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25274664|NCT02376192|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25274665|NCT02376192|Mydriatics|mydriatics|mesh-ancestor
25274666|NCT02376192|Autonomic Agents|autonomic agents|mesh-ancestor
25274667|NCT02376192|Sympathomimetics|sympathomimetics|mesh-ancestor
25274668|NCT02376192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25274669|NCT02376192|Nasal Decongestants|nasal decongestants|mesh-ancestor
25274670|NCT02376192|Respiratory System Agents|respiratory system agents|mesh-ancestor
25274671|NCT02376192|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25274672|NCT02376192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25274673|NCT02376192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25274674|NCT02376192|Adrenergic Agents|adrenergic agents|mesh-ancestor
25274675|NCT02376192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25274676|NCT02376192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274677|NCT02376192|Protective Agents|protective agents|mesh-ancestor
25274678|NCT02376192|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25274679|NCT02376049|Betamethasone|betamethasone|mesh-list
25274680|NCT02376049|Betamethasone Valerate|betamethasone valerate|mesh-list
25274681|NCT02376049|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24923257|NCT04171739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24923258|NCT04171739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24923259|NCT04171739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923260|NCT04171739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24923261|NCT04171739|Hormone Antagonists|hormone antagonists|mesh-ancestor
24923262|NCT04171739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24923263|NCT04171739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923264|NCT04171739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24923265|NCT04171739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24923266|NCT04171739|Antitubercular Agents|antitubercular agents|mesh-ancestor
24923267|NCT04171739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24923268|NCT04171739|Leprostatic Agents|leprostatic agents|mesh-ancestor
24923269|NCT04171739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25048950|NCT00656357|Cocaine|cocaine|mesh-list
24581086|NCT00864396|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24581114|NCT00864448|Protease Inhibitors|protease inhibitors|mesh-ancestor
24581115|NCT00864448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581116|NCT00864448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581117|NCT00864448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24581118|NCT00864474|Maraviroc|maraviroc|mesh-list
24581119|NCT00864474|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24581120|NCT00864474|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24581121|NCT00864474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686941|NCT01926977|Growth Substances|growth substances|mesh-ancestor
24942102|NCT03984357|Gemcitabine|gemcitabine|mesh-list
24942103|NCT03984357|Antibodies|antibodies|mesh-list
24726735|NCT01605344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24726737|NCT01605357|Mannitol|mannitol|mesh-list
24581122|NCT00864474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24581123|NCT00864474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24581124|NCT00864474|Antiviral Agents|antiviral agents|mesh-ancestor
24581125|NCT00864474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24581126|NCT00864474|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24581142|NCT00864526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24581176|NCT00864604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24581177|NCT00864604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24581179|NCT00864604|Sensory System Agents|sensory system agents|mesh-ancestor
24581180|NCT00864604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24581181|NCT00864604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581182|NCT00864604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24581183|NCT00864604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24581184|NCT00864604|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24581185|NCT00864604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24581186|NCT00864604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581205|NCT00864669|Metformin|metformin|mesh-list
24581206|NCT00864669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24632718|NCT01125423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581207|NCT00864669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581209|NCT00864734|Glyburide|glyburide|mesh-list
24581210|NCT00864734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24581211|NCT00864734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581212|NCT00864747|Propranolol|propranolol|mesh-list
24581213|NCT00864747|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24581214|NCT00864747|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24581215|NCT00864747|Adrenergic Agents|adrenergic agents|mesh-ancestor
24581216|NCT00864747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581217|NCT00864747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581218|NCT00864747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581219|NCT00864747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24581220|NCT00864747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24581221|NCT00864747|Vasodilator Agents|vasodilator agents|mesh-ancestor
25252289|NCT02507583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25252290|NCT02507583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252291|NCT02507648|Oseltamivir|oseltamivir|mesh-list
25252292|NCT02507648|Antiviral Agents|antiviral agents|mesh-ancestor
25252293|NCT02507648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25252294|NCT02507648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25252295|NCT02507648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252296|NCT02507635|Levocetirizine|levocetirizine|mesh-list
25252297|NCT02507635|Desloratadine|desloratadine|mesh-list
25252298|NCT02507635|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25252299|NCT02507635|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25252300|NCT02507635|Histamine Antagonists|histamine antagonists|mesh-ancestor
25252301|NCT02507635|Histamine Agents|histamine agents|mesh-ancestor
25252302|NCT02507635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25252303|NCT02507635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923270|NCT04171739|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24923291|NCT04171466|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24923292|NCT04171466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24923294|NCT04171180|Formoterol Fumarate|formoterol fumarate|mesh-list
24923295|NCT04171180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24923297|NCT04171180|Autonomic Agents|autonomic agents|mesh-ancestor
24923314|NCT04171193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24923315|NCT04171193|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24923316|NCT04171193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24923317|NCT04171193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24923318|NCT04171193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923319|NCT04171193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24923320|NCT04171193|Serotonin Agents|serotonin agents|mesh-ancestor
24923321|NCT04171193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923322|NCT04171193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24923323|NCT04171193|Anesthetics, General|anesthetics, general|mesh-ancestor
24923324|NCT04171193|Anesthetics|anesthetics|mesh-ancestor
24923325|NCT04171193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24923326|NCT04171349|Dexmedetomidine|dexmedetomidine|mesh-list
25686942|NCT01926977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686943|NCT01926977|Growth Inhibitors|growth inhibitors|mesh-ancestor
25686944|NCT01926977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25686945|NCT01927055|Mannitol|mannitol|mesh-list
24726899|NCT01606722|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24726900|NCT01606722|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24726901|NCT01606722|Protease Inhibitors|protease inhibitors|mesh-ancestor
24726902|NCT01606722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616326|NCT01036035|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24616327|NCT01036035|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24616328|NCT01036035|Cholinergic Agents|cholinergic agents|mesh-ancestor
24923327|NCT04171349|Carticaine|carticaine|mesh-list
24923328|NCT04171349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24923329|NCT04171349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24923330|NCT04171349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923331|NCT04171349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24498943|NCT00516854|Parasympatholytics|parasympatholytics|mesh-ancestor
24498944|NCT00516854|Autonomic Agents|autonomic agents|mesh-ancestor
24498945|NCT00516854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24498946|NCT00516880|Rosiglitazone|rosiglitazone|mesh-list
24498947|NCT00516880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24498948|NCT00516880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498949|NCT00516945|Lamivudine|lamivudine|mesh-list
25252304|NCT02507635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252305|NCT02507635|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25252306|NCT02507635|Cholinergic Agents|cholinergic agents|mesh-ancestor
24923393|NCT04170790|Sildenafil Citrate|sildenafil citrate|mesh-list
25252307|NCT02507570|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25252308|NCT02507570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25252309|NCT02507479|Thiotepa|thiotepa|mesh-list
25252310|NCT02507479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25252311|NCT02507479|Alkylating Agents|alkylating agents|mesh-ancestor
25252312|NCT02507479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252313|NCT02507479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25252314|NCT02507479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25252315|NCT02507479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25252316|NCT02507479|Immunologic Factors|immunologic factors|mesh-ancestor
25252317|NCT02507479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252318|NCT02507700|Bupivacaine|bupivacaine|mesh-list
25252319|NCT02507700|Sevoflurane|sevoflurane|mesh-list
25252320|NCT02507700|Anesthetics, Local|anesthetics, local|mesh-ancestor
25252321|NCT02507700|Anesthetics|anesthetics|mesh-ancestor
25252322|NCT02507700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25252323|NCT02507700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252324|NCT02507700|Sensory System Agents|sensory system agents|mesh-ancestor
25252325|NCT02507700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25252326|NCT02507700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25252327|NCT02507700|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25252328|NCT02507700|Anesthetics, General|anesthetics, general|mesh-ancestor
25252330|NCT02507609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102665|NCT03167164|Antimetabolites|antimetabolites|mesh-ancestor
25252331|NCT02507609|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25252332|NCT02507609|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25252333|NCT02507609|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25252334|NCT02507609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25252335|NCT02507440|Lidocaine|lidocaine|mesh-list
25252336|NCT02507440|Propofol|propofol|mesh-list
25252337|NCT02507440|Anesthetics, Local|anesthetics, local|mesh-ancestor
25252338|NCT02507440|Anesthetics|anesthetics|mesh-ancestor
25252339|NCT02507440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25252340|NCT02507440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252341|NCT02507440|Sensory System Agents|sensory system agents|mesh-ancestor
25252342|NCT02507440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25252343|NCT02507440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25252344|NCT02507440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24923403|NCT04170790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923404|NCT04170790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24923405|NCT04170790|Protease Inhibitors|protease inhibitors|mesh-ancestor
24923430|NCT04170439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24923431|NCT04170439|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24923432|NCT04170439|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25686946|NCT01927055|Droxidopa|droxidopa|mesh-list
25686947|NCT01927055|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25686948|NCT01927055|Diuretics|diuretics|mesh-ancestor
25686949|NCT01927055|Natriuretic Agents|natriuretic agents|mesh-ancestor
25686950|NCT01927055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686951|NCT01927055|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25686952|NCT01927055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25686953|NCT01927120|Sirolimus|sirolimus|mesh-list
24727034|NCT01607762|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24727035|NCT01607762|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24727036|NCT01607762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24727037|NCT01607762|Serotonin Agents|serotonin agents|mesh-ancestor
24727038|NCT01607762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24727039|NCT01607762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923433|NCT04170439|Trace Elements|trace elements|mesh-ancestor
24923434|NCT04170439|Micronutrients|micronutrients|mesh-ancestor
24923436|NCT04170504|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24923437|NCT04170504|Abortifacient Agents|abortifacient agents|mesh-ancestor
24923438|NCT04170504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24923439|NCT04170504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923440|NCT04170504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24923441|NCT04170504|Antimetabolites|antimetabolites|mesh-ancestor
24923442|NCT04170504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923443|NCT04170504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923444|NCT04170504|Dermatologic Agents|dermatologic agents|mesh-ancestor
24923445|NCT04170504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24923446|NCT04170504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24923447|NCT04170504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24923448|NCT04170504|Immunologic Factors|immunologic factors|mesh-ancestor
24923449|NCT04170504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24923450|NCT04170504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24923452|NCT04170270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24923453|NCT04170270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24923454|NCT04170270|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24923455|NCT04170270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24923456|NCT04170270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923457|NCT04170179|Lenvatinib|lenvatinib|mesh-list
24923458|NCT04170179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24581222|NCT00864760|Gabapentin|gabapentin|mesh-list
24581223|NCT00864760|Analgesics|analgesics|mesh-ancestor
24581224|NCT00864760|Sensory System Agents|sensory system agents|mesh-ancestor
24581225|NCT00864760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25010149|NCT04581148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581235|NCT00864760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581236|NCT00864760|Antimanic Agents|antimanic agents|mesh-ancestor
24581237|NCT00864773|Endothelial Growth Factors|endothelial growth factors|mesh-list
24581238|NCT00864773|Growth Substances|growth substances|mesh-ancestor
24581239|NCT00864773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252345|NCT02507440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25252361|NCT02507362|Blood Substitutes|blood substitutes|mesh-ancestor
25252375|NCT02507323|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25252376|NCT02507323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25252377|NCT02507323|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24923459|NCT04170179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24923460|NCT04170179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24923461|NCT04170179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923488|NCT04170088|Tranexamic Acid|tranexamic acid|mesh-list
24923489|NCT04170088|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24923490|NCT04170088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24923491|NCT04170088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499094|NCT00517725|Antioxidants|antioxidants|mesh-ancestor
24923492|NCT04170088|Hemostatics|hemostatics|mesh-ancestor
24923493|NCT04170088|Coagulants|coagulants|mesh-ancestor
24923494|NCT04169945|Erythritol|erythritol|mesh-list
24923495|NCT04169945|Vasodilator Agents|vasodilator agents|mesh-ancestor
24923496|NCT04169867|Nivolumab|nivolumab|mesh-list
24923497|NCT04169867|Ipilimumab|ipilimumab|mesh-list
24923498|NCT04169867|Atezolizumab|atezolizumab|mesh-list
24923499|NCT04169867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24923500|NCT04169867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923501|NCT04169867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24923502|NCT04169867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923503|NCT04169854|Lidocaine|lidocaine|mesh-list
24923504|NCT04169854|Anesthetics, Local|anesthetics, local|mesh-ancestor
24923505|NCT04169854|Anesthetics|anesthetics|mesh-ancestor
24923506|NCT04169854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25686954|NCT01927120|Aldesleukin|aldesleukin|mesh-list
25686955|NCT01927120|Tacrolimus|tacrolimus|mesh-list
25686956|NCT01927120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25686957|NCT01927120|Immunologic Factors|immunologic factors|mesh-ancestor
25686958|NCT01927120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686959|NCT01927120|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24727184|NCT01608373|Anesthetics, Local|anesthetics, local|mesh-ancestor
24727185|NCT01608373|Anesthetics|anesthetics|mesh-ancestor
24727186|NCT01608373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24727187|NCT01608373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727195|NCT01608412|Everolimus|everolimus|mesh-list
24727207|NCT01608464|Irinotecan|irinotecan|mesh-list
24727208|NCT01608464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727209|NCT01608464|Tubulin Modulators|tubulin modulators|mesh-ancestor
24727210|NCT01608464|Antimitotic Agents|antimitotic agents|mesh-ancestor
24727219|NCT01608464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24923507|NCT04169854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923508|NCT04169854|Sensory System Agents|sensory system agents|mesh-ancestor
24923509|NCT04169854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24923510|NCT04169854|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24923511|NCT04169854|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24923512|NCT04169854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25252378|NCT02507323|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25252379|NCT02507323|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25252380|NCT02507323|Purinergic Agents|purinergic agents|mesh-ancestor
25252381|NCT02507323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25252382|NCT02507323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252383|NCT02507323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252384|NCT02507245|Hormones|hormones|mesh-list
25252385|NCT02507245|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
25252386|NCT02507245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25252400|NCT02506998|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25252401|NCT02506998|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
25252402|NCT02506998|Histamine Agonists|histamine agonists|mesh-ancestor
25252403|NCT02506998|Histamine Agents|histamine agents|mesh-ancestor
25252404|NCT02506998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25252405|NCT02506998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252406|NCT02506998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252408|NCT02507167|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25252409|NCT02507167|Antitubercular Agents|antitubercular agents|mesh-ancestor
25252410|NCT02507167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25252411|NCT02507167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25252412|NCT02507167|Leprostatic Agents|leprostatic agents|mesh-ancestor
25252413|NCT02507167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25252414|NCT02507167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25252415|NCT02507167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923538|NCT04169763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24923539|NCT04169763|Antiviral Agents|antiviral agents|mesh-ancestor
24923540|NCT04169763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24923541|NCT04169256|Bupivacaine|bupivacaine|mesh-list
24923542|NCT04169256|Anesthetics, Local|anesthetics, local|mesh-ancestor
24923543|NCT04169256|Anesthetics|anesthetics|mesh-ancestor
24923544|NCT04169256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24923545|NCT04169256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923546|NCT04169256|Sensory System Agents|sensory system agents|mesh-ancestor
24923547|NCT04169256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24923564|NCT04169464|Sofosbuvir|sofosbuvir|mesh-list
24923565|NCT04169464|Antiviral Agents|antiviral agents|mesh-ancestor
24923566|NCT04169464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24923567|NCT04169230|Citalopram|citalopram|mesh-list
24923568|NCT04169230|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24923569|NCT04169230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24923570|NCT04169230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24923571|NCT04169230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923572|NCT04169230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24923573|NCT04169230|Serotonin Agents|serotonin agents|mesh-ancestor
24893935|NCT04445935|Protease Inhibitors|protease inhibitors|mesh-ancestor
24581357|NCT00864968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581358|NCT00864981|Bupropion|bupropion|mesh-list
25686960|NCT01927120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25686961|NCT01927120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686962|NCT01927120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25686963|NCT01927120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25686964|NCT01927120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25686965|NCT01927120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25686966|NCT01927120|Antifungal Agents|antifungal agents|mesh-ancestor
25686967|NCT01927120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25686968|NCT01927120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24727242|NCT01608698|Hormones|hormones|mesh-ancestor
24581359|NCT00864981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25252416|NCT02507167|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25252417|NCT02507167|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25252418|NCT02507167|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25252419|NCT02507167|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25252420|NCT02507167|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25252421|NCT02507167|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25252423|NCT02507076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25252424|NCT02507076|Alkylating Agents|alkylating agents|mesh-ancestor
25252425|NCT02507076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252426|NCT02507076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25252427|NCT02507076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25252428|NCT02507076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25252429|NCT02507076|Immunologic Factors|immunologic factors|mesh-ancestor
25252430|NCT02507076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252431|NCT02507206|Dihydrexidine|dihydrexidine|mesh-list
25252432|NCT02507206|Dopamine Agonists|dopamine agonists|mesh-ancestor
25252433|NCT02507206|Dopamine Agents|dopamine agents|mesh-ancestor
25252434|NCT02507206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25252435|NCT02507206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252436|NCT02507206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252437|NCT02507128|Liraglutide|liraglutide|mesh-list
25252438|NCT02507128|Glucagon|glucagon|mesh-list
25252439|NCT02507128|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25252440|NCT02507128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25252441|NCT02507128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252442|NCT02507128|Incretins|incretins|mesh-ancestor
25252443|NCT02507128|Hormones|hormones|mesh-ancestor
25252444|NCT02507128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25252445|NCT02507128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25252446|NCT02506803|Gemcitabine|gemcitabine|mesh-list
25252447|NCT02506803|Paclitaxel|paclitaxel|mesh-list
25252448|NCT02506803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25252449|NCT02506803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923574|NCT04169230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923575|NCT04169230|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24923576|NCT04169230|Antidepressive Agents|antidepressive agents|mesh-ancestor
24923577|NCT04169230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24923578|NCT04169269|Enoxaparin|enoxaparin|mesh-list
24923579|NCT04169269|Rivaroxaban|rivaroxaban|mesh-list
24923590|NCT04168879|Anesthetics, Local|anesthetics, local|mesh-ancestor
24923592|NCT04168879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24923593|NCT04168879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923594|NCT04168879|Sensory System Agents|sensory system agents|mesh-ancestor
24923595|NCT04168879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24923596|NCT04168944|Lenvatinib|lenvatinib|mesh-list
24923597|NCT04168944|Immunosuppressive Agents|immunosuppressive agents|mesh-list
24923598|NCT04168944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923599|NCT04168944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24923600|NCT04168944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24923601|NCT04168944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923602|NCT04168944|Immunologic Factors|immunologic factors|mesh-ancestor
24923603|NCT04168944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923604|NCT04168723|Moxifloxacin|moxifloxacin|mesh-list
24923605|NCT04168723|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24923606|NCT04168723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24923607|NCT04168723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24923634|NCT04168619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24923636|NCT04168619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24923637|NCT04168619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24923638|NCT04168294|Propofol|propofol|mesh-list
24923639|NCT04168294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24923640|NCT04168294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24923641|NCT04168294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923642|NCT04168294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24923643|NCT04168294|Anesthetics, General|anesthetics, general|mesh-ancestor
25252450|NCT02506803|Tubulin Modulators|tubulin modulators|mesh-ancestor
25252451|NCT02506803|Antimitotic Agents|antimitotic agents|mesh-ancestor
24923648|NCT04168138|Cytarabine|cytarabine|mesh-list
25252452|NCT02506803|Mitosis Modulators|mitosis modulators|mesh-ancestor
25252453|NCT02506803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686969|NCT01927120|Antiviral Agents|antiviral agents|mesh-ancestor
25252454|NCT02506803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25252455|NCT02506803|Antimetabolites|antimetabolites|mesh-ancestor
25252456|NCT02506803|Antiviral Agents|antiviral agents|mesh-ancestor
25252457|NCT02506803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25252458|NCT02506803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25252459|NCT02506803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25252460|NCT02506803|Immunologic Factors|immunologic factors|mesh-ancestor
25252461|NCT02506803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252462|NCT02507154|Cetuximab|cetuximab|mesh-list
25252463|NCT02507154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25252464|NCT02507154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25252465|NCT02506842|Leucovorin|leucovorin|mesh-list
25252466|NCT02506842|Folic Acid|folic acid|mesh-list
25252467|NCT02506842|Gemcitabine|gemcitabine|mesh-list
25252468|NCT02506842|Fluorouracil|fluorouracil|mesh-list
25252469|NCT02506842|Oxaliplatin|oxaliplatin|mesh-list
25252470|NCT02506842|Levoleucovorin|levoleucovorin|mesh-list
25252471|NCT02506842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25252472|NCT02506842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252473|NCT02506842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25252474|NCT02506842|Antimetabolites|antimetabolites|mesh-ancestor
25252475|NCT02506842|Antiviral Agents|antiviral agents|mesh-ancestor
25252476|NCT02506842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25252477|NCT02506842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25252478|NCT02506842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25086207|NCT03290963|Analgesics|analgesics|mesh-ancestor
25252479|NCT02506842|Immunologic Factors|immunologic factors|mesh-ancestor
25252480|NCT02506842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252481|NCT02506842|Antidotes|antidotes|mesh-ancestor
25252482|NCT02506842|Protective Agents|protective agents|mesh-ancestor
25252483|NCT02506842|Vitamin B Complex|vitamin b complex|mesh-ancestor
25252484|NCT02506842|Vitamins|vitamins|mesh-ancestor
25252485|NCT02506842|Micronutrients|micronutrients|mesh-ancestor
25252486|NCT02506842|Hematinics|hematinics|mesh-ancestor
25252487|NCT02506699|Analgesics|analgesics|mesh-list
25252488|NCT02506699|Sensory System Agents|sensory system agents|mesh-ancestor
25252489|NCT02506699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25252490|NCT02506699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252491|NCT02506777|Metformin|metformin|mesh-list
24923650|NCT04168138|Aclarubicin|aclarubicin|mesh-list
24923651|NCT04168138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24923652|NCT04168138|Antimetabolites|antimetabolites|mesh-ancestor
24923653|NCT04168138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923654|NCT04168138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923655|NCT04168138|Antiviral Agents|antiviral agents|mesh-ancestor
24923656|NCT04168138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24923657|NCT04168138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24923676|NCT04167774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24923677|NCT04167774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923678|NCT04167774|Tubulin Modulators|tubulin modulators|mesh-ancestor
24923679|NCT04167774|Antimitotic Agents|antimitotic agents|mesh-ancestor
24923680|NCT04167774|Mitosis Modulators|mitosis modulators|mesh-ancestor
24923681|NCT04167774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923682|NCT04167982|Isotretinoin|isotretinoin|mesh-list
24923683|NCT04167982|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24923684|NCT04167982|Dermatologic Agents|dermatologic agents|mesh-ancestor
24923685|NCT04167982|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24923686|NCT04167566|Artemisinins|artemisinins|mesh-list
24923687|NCT04167566|Artemisinin|artemisinin|mesh-list
24923688|NCT04167566|Antimalarials|antimalarials|mesh-ancestor
24923689|NCT04167566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24923690|NCT04167566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24923691|NCT04167566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24923692|NCT04167306|Bupropion|bupropion|mesh-list
24923693|NCT04167306|Varenicline|varenicline|mesh-list
24923694|NCT04167306|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24923695|NCT04167306|Antidepressive Agents|antidepressive agents|mesh-ancestor
24923696|NCT04167306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24923697|NCT04167306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24581360|NCT00864981|Antidepressive Agents|antidepressive agents|mesh-ancestor
24581361|NCT00864981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24581362|NCT00864981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24581363|NCT00864981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24581364|NCT00864981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24581365|NCT00864981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581366|NCT00864981|Dopamine Agents|dopamine agents|mesh-ancestor
24581367|NCT00864981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581368|NCT00864981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581369|NCT00864981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25010150|NCT04574232|Triamcinolone|triamcinolone|mesh-list
24581370|NCT00864981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24581371|NCT00864981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581373|NCT00865007|Lopinavir|lopinavir|mesh-list
24581374|NCT00865007|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25252492|NCT02506777|Cyclophosphamide|cyclophosphamide|mesh-list
25252493|NCT02506777|Doxorubicin|doxorubicin|mesh-list
25252494|NCT02506777|Fluorouracil|fluorouracil|mesh-list
25252496|NCT02506777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25252497|NCT02506777|Immunologic Factors|immunologic factors|mesh-ancestor
25252498|NCT02506777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252499|NCT02506777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25252500|NCT02506777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25252501|NCT02506777|Alkylating Agents|alkylating agents|mesh-ancestor
25086248|NCT03290703|Rabeprazole|rabeprazole|mesh-list
25252502|NCT02506777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252503|NCT02506777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25252504|NCT02506777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25252505|NCT02506777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25252506|NCT02506777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25252507|NCT02506777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25252508|NCT02506777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25252509|NCT02506777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25252510|NCT02506777|Antioxidants|antioxidants|mesh-ancestor
25252511|NCT02506777|Protective Agents|protective agents|mesh-ancestor
25252512|NCT02506777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25252513|NCT02506777|Antimetabolites|antimetabolites|mesh-ancestor
25252514|NCT02506777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25252515|NCT02506647|Insulin|insulin|mesh-list
25252516|NCT02506647|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25252517|NCT02506647|Insulin Glargine|insulin glargine|mesh-list
25252518|NCT02506647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25252519|NCT02506647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252520|NCT02506790|Toremifene|toremifene|mesh-list
25252521|NCT02506790|Metformin|metformin|mesh-list
25252522|NCT02506790|Melatonin|melatonin|mesh-list
24923698|NCT04167306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24923699|NCT04167306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24923700|NCT04167306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923701|NCT04167306|Dopamine Agents|dopamine agents|mesh-ancestor
24923702|NCT04167306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24923711|NCT04167696|Fludarabine|fludarabine|mesh-list
24923712|NCT04167696|Fludarabine phosphate|fludarabine phosphate|mesh-list
24923713|NCT04167696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24923714|NCT04167696|Immunologic Factors|immunologic factors|mesh-ancestor
24923715|NCT04167696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923716|NCT04167696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24923717|NCT04167696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24923718|NCT04167696|Alkylating Agents|alkylating agents|mesh-ancestor
24923719|NCT04167696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923720|NCT04167696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923721|NCT04167696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24923722|NCT04167696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24923723|NCT04167696|Antimetabolites|antimetabolites|mesh-ancestor
24923753|NCT04166721|Atezolizumab|atezolizumab|mesh-list
24923754|NCT04166721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923755|NCT04166734|Pembrolizumab|pembrolizumab|mesh-list
24923756|NCT04166734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24923757|NCT04166734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923758|NCT04166890|Epinephrine|epinephrine|mesh-list
24923759|NCT04166890|Carticaine|carticaine|mesh-list
24923760|NCT04166890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24923761|NCT04166890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24923762|NCT04166890|Adrenergic Agents|adrenergic agents|mesh-ancestor
24923763|NCT04166890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24923764|NCT04166890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923765|NCT04166890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581375|NCT00865007|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24581376|NCT00865007|Protease Inhibitors|protease inhibitors|mesh-ancestor
24581377|NCT00865007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581378|NCT00865007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581395|NCT00865059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24581396|NCT00865059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24581418|NCT00865085|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24581419|NCT00865085|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24727648|NCT01611896|Selenium|selenium|mesh-list
24581420|NCT00865085|Parasympatholytics|parasympatholytics|mesh-ancestor
24581421|NCT00865085|Autonomic Agents|autonomic agents|mesh-ancestor
25252523|NCT02506790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25252524|NCT02506790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252525|NCT02506790|Antioxidants|antioxidants|mesh-ancestor
25252526|NCT02506790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252527|NCT02506790|Protective Agents|protective agents|mesh-ancestor
25252528|NCT02506790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25252529|NCT02506790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25252530|NCT02506790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25252531|NCT02506790|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25252532|NCT02506790|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25252533|NCT02506790|Hormone Antagonists|hormone antagonists|mesh-ancestor
25252534|NCT02506790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25252535|NCT02506790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25252536|NCT02506894|Magnesium Sulfate|magnesium sulfate|mesh-list
25252537|NCT02506894|Analgesics|analgesics|mesh-ancestor
25252538|NCT02506894|Sensory System Agents|sensory system agents|mesh-ancestor
25252539|NCT02506894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25252540|NCT02506894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252541|NCT02506894|Anesthetics|anesthetics|mesh-ancestor
25252542|NCT02506894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25252543|NCT02506894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25252544|NCT02506894|Anticonvulsants|anticonvulsants|mesh-ancestor
25252545|NCT02506894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25252546|NCT02506894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25252547|NCT02506894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252548|NCT02506894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25252549|NCT02506894|Tocolytic Agents|tocolytic agents|mesh-ancestor
25252550|NCT02506894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25252551|NCT02506829|Nicotine|nicotine|mesh-list
25252552|NCT02506829|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24923766|NCT04166890|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24923767|NCT04166890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24923768|NCT04166890|Autonomic Agents|autonomic agents|mesh-ancestor
24923769|NCT04166890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24923770|NCT04166890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24923771|NCT04166890|Respiratory System Agents|respiratory system agents|mesh-ancestor
24923772|NCT04166890|Mydriatics|mydriatics|mesh-ancestor
24923773|NCT04166890|Sympathomimetics|sympathomimetics|mesh-ancestor
24923774|NCT04166890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24923775|NCT04166890|Anesthetics, Local|anesthetics, local|mesh-ancestor
24923776|NCT04166890|Anesthetics|anesthetics|mesh-ancestor
24923777|NCT04166890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24923778|NCT04166890|Sensory System Agents|sensory system agents|mesh-ancestor
24923779|NCT04166604|Trifluridine|trifluridine|mesh-list
24923804|NCT04166786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24923806|NCT04166786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24923807|NCT04166786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923808|NCT04166786|Anabolic Agents|anabolic agents|mesh-ancestor
24923809|NCT04166786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24923810|NCT04166786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24923811|NCT04166786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24923812|NCT04166786|Emollients|emollients|mesh-ancestor
24923813|NCT04166786|Dermatologic Agents|dermatologic agents|mesh-ancestor
24923814|NCT04166812|Nitric Oxide|nitric oxide|mesh-list
24923815|NCT04166812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24923816|NCT04166812|Autonomic Agents|autonomic agents|mesh-ancestor
24923822|NCT04166812|Antioxidants|antioxidants|mesh-ancestor
25252553|NCT02506829|Autonomic Agents|autonomic agents|mesh-ancestor
25252554|NCT02506829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25252555|NCT02506829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252556|NCT02506829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25252557|NCT02506829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25252558|NCT02506829|Cholinergic Agents|cholinergic agents|mesh-ancestor
25252559|NCT02506829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24630095|NCT01109498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25252560|NCT02506829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252562|NCT02506686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25252563|NCT02506686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25252564|NCT02506855|Ropivacaine|ropivacaine|mesh-list
25252565|NCT02506855|Anesthetics, Local|anesthetics, local|mesh-ancestor
25252566|NCT02506855|Anesthetics|anesthetics|mesh-ancestor
25686970|NCT01927341|Panitumumab|panitumumab|mesh-list
24727726|NCT01612286|Endostatins|endostatins|mesh-list
25252567|NCT02506855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25252568|NCT02506855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252569|NCT02506855|Sensory System Agents|sensory system agents|mesh-ancestor
25252570|NCT02506855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25252571|NCT02506348|Diclofenac|diclofenac|mesh-list
25252572|NCT02506348|Nepafenac|nepafenac|mesh-list
25252573|NCT02506348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25252574|NCT02506348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25252575|NCT02506348|Analgesics|analgesics|mesh-ancestor
25252576|NCT02506348|Sensory System Agents|sensory system agents|mesh-ancestor
25252577|NCT02506348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25252578|NCT02506348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252579|NCT02506348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25252580|NCT02506348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25252581|NCT02506348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25252582|NCT02506348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25252583|NCT02506348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252584|NCT02506439|Vitamin D|vitamin d|mesh-list
25252585|NCT02506439|Ergocalciferols|ergocalciferols|mesh-list
25252586|NCT02506439|Cholecalciferol|cholecalciferol|mesh-list
25252587|NCT02506439|Vitamins|vitamins|mesh-list
25252588|NCT02506439|Micronutrients|micronutrients|mesh-ancestor
25252589|NCT02506439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252590|NCT02506439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25252591|NCT02506439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25252592|NCT02506231|Leucovorin|leucovorin|mesh-list
25252593|NCT02506231|Folic Acid|folic acid|mesh-list
25252594|NCT02506231|Levoleucovorin|levoleucovorin|mesh-list
25252595|NCT02506231|Antidotes|antidotes|mesh-ancestor
25252596|NCT02506231|Protective Agents|protective agents|mesh-ancestor
25252597|NCT02506231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252598|NCT02506231|Vitamin B Complex|vitamin b complex|mesh-ancestor
25252599|NCT02506231|Vitamins|vitamins|mesh-ancestor
25252600|NCT02506231|Micronutrients|micronutrients|mesh-ancestor
25252601|NCT02506231|Hematinics|hematinics|mesh-ancestor
24624172|NCT01074970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252602|NCT02506335|Cholic Acids|cholic acids|mesh-list
24624173|NCT01074996|Leucovorin|leucovorin|mesh-list
24624174|NCT01074996|Antidotes|antidotes|mesh-ancestor
24624175|NCT01074996|Protective Agents|protective agents|mesh-ancestor
24625867|NCT01084031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24624176|NCT01074996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624177|NCT01074996|Vitamin B Complex|vitamin b complex|mesh-ancestor
24624179|NCT01074996|Micronutrients|micronutrients|mesh-ancestor
24624198|NCT01075126|Antimanic Agents|antimanic agents|mesh-ancestor
24624199|NCT01075126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24624200|NCT01075126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24624201|NCT01075126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624202|NCT01075126|Anticonvulsants|anticonvulsants|mesh-ancestor
24923925|NCT04165850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24923926|NCT04165850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24923927|NCT04165850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923928|NCT04165850|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24923929|NCT04165850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24923930|NCT04165512|Triamcinolone|triamcinolone|mesh-list
24923931|NCT04165512|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24923932|NCT04165512|Bupivacaine|bupivacaine|mesh-list
24923933|NCT04165512|Anesthetics, Local|anesthetics, local|mesh-ancestor
24923934|NCT04165512|Anesthetics|anesthetics|mesh-ancestor
24630096|NCT01109498|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24923935|NCT04165512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24923936|NCT04165512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923937|NCT04165512|Sensory System Agents|sensory system agents|mesh-ancestor
24923938|NCT04165512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25252603|NCT02506335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25252604|NCT02506296|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25252605|NCT02506296|Protease Inhibitors|protease inhibitors|mesh-ancestor
25252606|NCT02506296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25252607|NCT02506296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252608|NCT02506296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25252609|NCT02506296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252610|NCT02506140|Aspirin|aspirin|mesh-list
25252611|NCT02506140|Clopidogrel|clopidogrel|mesh-list
25252612|NCT02506140|Ticagrelor|ticagrelor|mesh-list
25252613|NCT02506140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25686971|NCT01927341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25252614|NCT02506140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25252616|NCT02506140|Sensory System Agents|sensory system agents|mesh-ancestor
25252617|NCT02506140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25252618|NCT02506140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252619|NCT02506140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25252620|NCT02506140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25252621|NCT02506140|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25252622|NCT02506140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25252623|NCT02506140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252624|NCT02506140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25252625|NCT02506140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25252626|NCT02506140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25252628|NCT02506140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25252629|NCT02506140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25252630|NCT02506140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25252631|NCT02506140|Purinergic Agents|purinergic agents|mesh-ancestor
25252632|NCT02506140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25252633|NCT02506023|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25252634|NCT02506023|Hemostatics|hemostatics|mesh-ancestor
25252635|NCT02506023|Coagulants|coagulants|mesh-ancestor
25252636|NCT02506023|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25252637|NCT02506023|Natriuretic Agents|natriuretic agents|mesh-ancestor
25252638|NCT02506023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274682|NCT02376049|Betamethasone benzoate|betamethasone benzoate|mesh-list
25274683|NCT02376049|Clobetasol|clobetasol|mesh-list
25274684|NCT02376049|Pimecrolimus|pimecrolimus|mesh-list
25274685|NCT02376049|Emollients|emollients|mesh-list
25274686|NCT02376049|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25274687|NCT02376049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25274688|NCT02376049|Glucocorticoids|glucocorticoids|mesh-ancestor
25274689|NCT02376049|Hormones|hormones|mesh-ancestor
25274690|NCT02376049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25274691|NCT02376049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923975|NCT04165174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924037|NCT04164355|Urological Agents|urological agents|mesh-ancestor
24924038|NCT04164368|Lenalidomide|lenalidomide|mesh-list
24924039|NCT04164368|Immunologic Factors|immunologic factors|mesh-ancestor
24924040|NCT04164368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924041|NCT04164368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24924042|NCT04164368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24924097|NCT04163354|Fluorides, Topical|fluorides, topical|mesh-list
24924098|NCT04163354|Cariostatic Agents|cariostatic agents|mesh-ancestor
24924099|NCT04163354|Protective Agents|protective agents|mesh-ancestor
24924100|NCT04163354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924101|NCT04163354|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24924102|NCT04163354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24924103|NCT04163276|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24924104|NCT04163276|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24924105|NCT04163276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924106|NCT04163588|Metolazone|metolazone|mesh-list
24924107|NCT04163588|Diuretics|diuretics|mesh-list
24924108|NCT04163588|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
24924109|NCT04163588|Natriuretic Agents|natriuretic agents|mesh-ancestor
24924110|NCT04163588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924111|NCT04163588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24924112|NCT04163588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924113|NCT04163588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24924114|NCT04163588|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24924115|NCT04163237|Sorafenib|sorafenib|mesh-list
24924116|NCT04163237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924117|NCT04163237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24924118|NCT04163237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924119|NCT04163237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924120|NCT04162743|Trazodone|trazodone|mesh-list
24581422|NCT00865085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24581423|NCT00865085|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24581424|NCT00865085|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24581425|NCT00865085|Cholinergic Agents|cholinergic agents|mesh-ancestor
24581426|NCT00865111|Bupropion|bupropion|mesh-list
24581427|NCT00865111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24581428|NCT00865111|Antidepressive Agents|antidepressive agents|mesh-ancestor
24581429|NCT00865111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25252639|NCT02505997|Midazolam|midazolam|mesh-list
24727846|NCT01613040|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25252640|NCT02505997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25252641|NCT02505997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25252642|NCT02505997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25252643|NCT02505997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252644|NCT02505997|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25252645|NCT02505997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25252646|NCT02505997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25252647|NCT02505997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25252648|NCT02505997|Anesthetics, General|anesthetics, general|mesh-ancestor
25252649|NCT02505997|Anesthetics|anesthetics|mesh-ancestor
25252650|NCT02505997|GABA Modulators|gaba modulators|mesh-ancestor
25252651|NCT02505997|GABA Agents|gaba agents|mesh-ancestor
25252652|NCT02505997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25252653|NCT02505997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252654|NCT02505815|Hydrocortisone|hydrocortisone|mesh-list
25252655|NCT02505815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25252656|NCT02505802|Botulinum Toxins|botulinum toxins|mesh-list
25252657|NCT02505802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25252658|NCT02505802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25252659|NCT02505802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25252660|NCT02505802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252661|NCT02505802|Cholinergic Agents|cholinergic agents|mesh-ancestor
25252662|NCT02505802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25252663|NCT02505802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252664|NCT02505802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25252665|NCT02505802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25252666|NCT02505841|Ropivacaine|ropivacaine|mesh-list
25252667|NCT02505841|Succinylcholine|succinylcholine|mesh-list
25252668|NCT02505841|Curare|curare|mesh-list
25252669|NCT02505841|Anesthetics, Local|anesthetics, local|mesh-ancestor
25252670|NCT02505841|Anesthetics|anesthetics|mesh-ancestor
25252671|NCT02505841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24924122|NCT04162743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24924123|NCT04162743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24924124|NCT04162743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522951|NCT03012971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24924139|NCT04162834|Urological Agents|urological agents|mesh-ancestor
24924141|NCT04162535|Propofol|propofol|mesh-list
24924142|NCT04162535|Anesthetics|anesthetics|mesh-list
24924143|NCT04162535|Sevoflurane|sevoflurane|mesh-list
24924144|NCT04162535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
24924145|NCT04162535|Anesthetics, Local|anesthetics, local|mesh-ancestor
24924146|NCT04162535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24924147|NCT04162535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924148|NCT04162535|Sensory System Agents|sensory system agents|mesh-ancestor
24924161|NCT04162522|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24924162|NCT04162522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24924163|NCT04162522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24924164|NCT04162522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924166|NCT04162522|Serotonin Agents|serotonin agents|mesh-ancestor
24924167|NCT04162522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924168|NCT04162522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24924169|NCT04162522|Antidepressive Agents|antidepressive agents|mesh-ancestor
24924170|NCT04162522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24924171|NCT04162522|Dopamine Agonists|dopamine agonists|mesh-ancestor
24924172|NCT04162522|Dopamine Agents|dopamine agents|mesh-ancestor
24924173|NCT04162028|Ketamine|ketamine|mesh-list
24924177|NCT04162028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924178|NCT04162028|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24924179|NCT04162028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24924181|NCT04162028|Anesthetics|anesthetics|mesh-ancestor
24924182|NCT04162028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24924183|NCT04162028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24924184|NCT04162028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24924185|NCT04162028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25252672|NCT02505841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252673|NCT02505841|Sensory System Agents|sensory system agents|mesh-ancestor
25252674|NCT02505841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686972|NCT01927341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25686973|NCT01927718|Thalidomide|thalidomide|mesh-list
25686974|NCT01927718|Lenalidomide|lenalidomide|mesh-list
25686975|NCT01927718|Immunologic Factors|immunologic factors|mesh-ancestor
24727918|NCT01613469|Micronutrients|micronutrients|mesh-ancestor
24727919|NCT01613482|Trastuzumab|trastuzumab|mesh-list
24727931|NCT01613547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25252675|NCT02505841|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
25252676|NCT02505841|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25252677|NCT02505841|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25252678|NCT02505841|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25252679|NCT02505841|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25252680|NCT02505841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25252681|NCT02505841|Cholinergic Agents|cholinergic agents|mesh-ancestor
25252682|NCT02505841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25252683|NCT02505841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252684|NCT02505776|Bimatoprost|bimatoprost|mesh-list
25252685|NCT02505776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25252687|NCT02505893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25252688|NCT02505893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25252689|NCT02505893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25252690|NCT02505893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25252691|NCT02505893|Antifungal Agents|antifungal agents|mesh-ancestor
25252692|NCT02505893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25252693|NCT02505893|Immunologic Factors|immunologic factors|mesh-ancestor
25252694|NCT02505893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252695|NCT02505971|Propranolol|propranolol|mesh-list
25252696|NCT02505971|Nadolol|nadolol|mesh-list
25252697|NCT02505971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25252698|NCT02505971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25252699|NCT02505971|Adrenergic Agents|adrenergic agents|mesh-ancestor
25252700|NCT02505971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25252701|NCT02505971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252702|NCT02505971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252703|NCT02505971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25252704|NCT02505971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25252705|NCT02505971|Vasodilator Agents|vasodilator agents|mesh-ancestor
25252706|NCT02505971|Sympatholytics|sympatholytics|mesh-ancestor
25252707|NCT02505971|Autonomic Agents|autonomic agents|mesh-ancestor
24924186|NCT04162028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924187|NCT04161976|Insulin Lispro|insulin lispro|mesh-list
24924188|NCT04161976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24924189|NCT04161976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924190|NCT04161768|Norfloxacin|norfloxacin|mesh-list
24924191|NCT04161768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24924192|NCT04161768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24924193|NCT04161768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24924194|NCT04161768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24924195|NCT04161768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924196|NCT04161768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924197|NCT04161768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924198|NCT04161768|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24924199|NCT04161768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24624220|NCT01075464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24624221|NCT01075464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624222|NCT01075464|Tubulin Modulators|tubulin modulators|mesh-ancestor
24626568|NCT01087866|Metformin|metformin|mesh-list
24499834|NCT00521248|Buprenorphine|buprenorphine|mesh-list
24499835|NCT00521248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24499836|NCT00521248|Narcotics|narcotics|mesh-ancestor
24499837|NCT00521248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24499838|NCT00521248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499839|NCT00521248|Analgesics|analgesics|mesh-ancestor
24624239|NCT01075490|Analgesics|analgesics|mesh-ancestor
24624240|NCT01075490|Sensory System Agents|sensory system agents|mesh-ancestor
24624241|NCT01075490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24924200|NCT04161690|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
24924201|NCT04161690|Ropivacaine|ropivacaine|mesh-list
24924203|NCT04161690|Anesthetics|anesthetics|mesh-ancestor
25252708|NCT02505971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25252709|NCT02505880|Anesthetics|anesthetics|mesh-list
25252710|NCT02505880|Anesthetics, Local|anesthetics, local|mesh-list
25252711|NCT02505880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25252712|NCT02505880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252713|NCT02505880|Sensory System Agents|sensory system agents|mesh-ancestor
25252714|NCT02505880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25686976|NCT01927718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686977|NCT01927718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25252716|NCT02505633|Epinephrine|epinephrine|mesh-list
25252717|NCT02505633|Racepinephrine|racepinephrine|mesh-list
25252718|NCT02505633|Epinephryl borate|epinephryl borate|mesh-list
25252719|NCT02505633|Anesthetics, Local|anesthetics, local|mesh-ancestor
25252720|NCT02505633|Anesthetics|anesthetics|mesh-ancestor
25252721|NCT02505633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25252722|NCT02505633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252723|NCT02505633|Sensory System Agents|sensory system agents|mesh-ancestor
25252724|NCT02505633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25252725|NCT02505633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25252726|NCT02505633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25252727|NCT02505633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25252728|NCT02505633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25252729|NCT02505633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252730|NCT02505633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25252731|NCT02505633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25252732|NCT02505633|Adrenergic Agents|adrenergic agents|mesh-ancestor
25252733|NCT02505633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25252734|NCT02505633|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25252735|NCT02505633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25252737|NCT02505633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25252738|NCT02505633|Respiratory System Agents|respiratory system agents|mesh-ancestor
25252740|NCT02505633|Sympathomimetics|sympathomimetics|mesh-ancestor
25252741|NCT02505633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25252742|NCT02505451|Dobutamine|dobutamine|mesh-list
25252743|NCT02505451|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25252744|NCT02505451|Sympathomimetics|sympathomimetics|mesh-ancestor
25252745|NCT02505451|Autonomic Agents|autonomic agents|mesh-ancestor
25252746|NCT02505451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25252747|NCT02505451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252748|NCT02505451|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25252749|NCT02505451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25252750|NCT02505451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25252751|NCT02505451|Adrenergic Agents|adrenergic agents|mesh-ancestor
24924219|NCT04161664|Mitosis Modulators|mitosis modulators|mesh-ancestor
24924220|NCT04161664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924222|NCT04161729|Analgesics|analgesics|mesh-ancestor
24924223|NCT04161729|Sensory System Agents|sensory system agents|mesh-ancestor
24924224|NCT04161729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24924225|NCT04161729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924226|NCT04161729|Anesthetics|anesthetics|mesh-ancestor
24924227|NCT04161729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24924228|NCT04161729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24924229|NCT04161729|Anticonvulsants|anticonvulsants|mesh-ancestor
24924230|NCT04161729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24924231|NCT04161729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24499913|NCT00521521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924242|NCT04161586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24924243|NCT04161508|Glycopyrrolate|glycopyrrolate|mesh-list
24924244|NCT04161508|Neostigmine|neostigmine|mesh-list
24924245|NCT04161508|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24924246|NCT04161508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924247|NCT04161508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924248|NCT04161508|Cholinergic Agents|cholinergic agents|mesh-ancestor
24924250|NCT04161508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924251|NCT04161508|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24924252|NCT04161508|Autonomic Agents|autonomic agents|mesh-ancestor
24924253|NCT04161508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24924254|NCT04161508|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24924255|NCT04161508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24924256|NCT04161508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24924257|NCT04161560|Cetuximab|cetuximab|mesh-list
24924258|NCT04161560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24924259|NCT04161560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924260|NCT04161482|Furosemide|furosemide|mesh-list
25252752|NCT02505451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25252753|NCT02505451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252754|NCT02505451|Protective Agents|protective agents|mesh-ancestor
25252755|NCT02505477|Acetylcysteine|acetylcysteine|mesh-list
25252756|NCT02505477|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25252757|NCT02505477|Antiviral Agents|antiviral agents|mesh-ancestor
25252758|NCT02505477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25252759|NCT02505477|Expectorants|expectorants|mesh-ancestor
25252760|NCT02505477|Respiratory System Agents|respiratory system agents|mesh-ancestor
25252761|NCT02505477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25252762|NCT02505477|Antioxidants|antioxidants|mesh-ancestor
25252763|NCT02505477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252764|NCT02505477|Protective Agents|protective agents|mesh-ancestor
25252765|NCT02505477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252766|NCT02505477|Antidotes|antidotes|mesh-ancestor
25252768|NCT02505516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25252769|NCT02505516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252770|NCT02505568|Infliximab|infliximab|mesh-list
25252771|NCT02505568|Dermatologic Agents|dermatologic agents|mesh-ancestor
25252772|NCT02505568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25252773|NCT02505568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25252774|NCT02505581|Metronidazole|metronidazole|mesh-list
25252775|NCT02505581|Ciprofloxacin|ciprofloxacin|mesh-list
25252776|NCT02505581|Cefuroxime|cefuroxime|mesh-list
25252777|NCT02505581|Cefuroxime axetil|cefuroxime axetil|mesh-list
25252778|NCT02505581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25252779|NCT02505581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25252780|NCT02505581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25252781|NCT02505581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25252782|NCT02505581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25252783|NCT02505581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25252784|NCT02505581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25252785|NCT02505581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252786|NCT02505581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25252787|NCT02505581|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25252788|NCT02505581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25252789|NCT02505360|Hyaluronic Acid|hyaluronic acid|mesh-list
25252790|NCT02505360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25252791|NCT02505360|Immunologic Factors|immunologic factors|mesh-ancestor
25252792|NCT02505360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252793|NCT02505360|Viscosupplements|viscosupplements|mesh-ancestor
25252794|NCT02505360|Protective Agents|protective agents|mesh-ancestor
25252795|NCT02505295|Selenium|selenium|mesh-list
24924272|NCT04161339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924311|NCT04161209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499963|NCT00521859|Vidarabine|vidarabine|mesh-list
24522959|NCT02992522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522960|NCT02992522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24499993|NCT00522015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499994|NCT00522015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499995|NCT00522015|Cholinergic Agents|cholinergic agents|mesh-ancestor
24499996|NCT00522015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24499997|NCT00522015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499998|NCT00522015|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24499999|NCT00522015|Protective Agents|protective agents|mesh-ancestor
24500000|NCT00522132|Artesunate|artesunate|mesh-list
24500001|NCT00522132|Antimalarials|antimalarials|mesh-ancestor
24500002|NCT00522132|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24500003|NCT00522132|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24500004|NCT00522132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24924332|NCT04161001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24924333|NCT04161001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24924334|NCT04161001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24924335|NCT04161001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924336|NCT04161001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24924337|NCT04161001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924338|NCT04161001|Vasodilator Agents|vasodilator agents|mesh-ancestor
24924339|NCT04161001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24924340|NCT04161001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24924341|NCT04161001|Antimetabolites|antimetabolites|mesh-ancestor
24924342|NCT04161001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24924343|NCT04161001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24924344|NCT04161001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25252796|NCT02505295|Antioxidants|antioxidants|mesh-ancestor
25252797|NCT02505295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252798|NCT02505295|Protective Agents|protective agents|mesh-ancestor
25252799|NCT02505295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252800|NCT02505295|Trace Elements|trace elements|mesh-ancestor
25252801|NCT02505295|Micronutrients|micronutrients|mesh-ancestor
25252802|NCT02505282|Vitamin K|vitamin k|mesh-list
25252803|NCT02505282|Vitamins|vitamins|mesh-ancestor
25252804|NCT02505282|Micronutrients|micronutrients|mesh-ancestor
25252805|NCT02505282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252806|NCT02505282|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25252807|NCT02505282|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25252808|NCT02505282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252809|NCT02505282|Hemostatics|hemostatics|mesh-ancestor
25252810|NCT02505282|Coagulants|coagulants|mesh-ancestor
25252811|NCT02505399|Clopidogrel|clopidogrel|mesh-list
25252812|NCT02505399|Ticagrelor|ticagrelor|mesh-list
25252813|NCT02505399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25252814|NCT02505399|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25252815|NCT02505399|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25252816|NCT02505399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25252817|NCT02505399|Purinergic Agents|purinergic agents|mesh-ancestor
25252818|NCT02505399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25252819|NCT02505399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252820|NCT02505399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252821|NCT02505386|Ertapenem|ertapenem|mesh-list
25252822|NCT02505386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25252912|NCT02504450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25252823|NCT02505386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25252824|NCT02505009|Tenofovir|tenofovir|mesh-list
25252825|NCT02505009|Entecavir|entecavir|mesh-list
25252826|NCT02505009|Antiviral Agents|antiviral agents|mesh-ancestor
25252827|NCT02505009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25252828|NCT02505009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25252829|NCT02505009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25252830|NCT02505009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25252831|NCT02505009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252832|NCT02505009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25252833|NCT02505009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25252834|NCT02505048|Rucaparib|rucaparib|mesh-list
25252835|NCT02505048|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25252836|NCT02505048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25252837|NCT02505048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252838|NCT02505048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924375|NCT04160897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924376|NCT04160897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24924377|NCT04160897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24924378|NCT04160598|Fentanyl|fentanyl|mesh-list
24924410|NCT04160416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924411|NCT04160520|Morphine|morphine|mesh-list
24924412|NCT04160520|Pramipexole|pramipexole|mesh-list
24924413|NCT04160520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24924414|NCT04160520|Narcotics|narcotics|mesh-ancestor
24924415|NCT04160520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24924416|NCT04160520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924417|NCT04160520|Analgesics|analgesics|mesh-ancestor
24924418|NCT04160520|Sensory System Agents|sensory system agents|mesh-ancestor
24924419|NCT04160520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24924420|NCT04160520|Antioxidants|antioxidants|mesh-ancestor
24924421|NCT04160520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924422|NCT04160520|Protective Agents|protective agents|mesh-ancestor
24924423|NCT04160520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24924424|NCT04160520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24924425|NCT04160520|Dopamine Agonists|dopamine agonists|mesh-ancestor
24924426|NCT04160520|Dopamine Agents|dopamine agents|mesh-ancestor
24924427|NCT04160520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24924428|NCT04160611|Midazolam|midazolam|mesh-list
24924447|NCT04160195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924448|NCT04160195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24924449|NCT04160195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24924450|NCT04160195|Alkylating Agents|alkylating agents|mesh-ancestor
24924451|NCT04160195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924452|NCT04160195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924453|NCT04160195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24924455|NCT04160026|Piperaquine|piperaquine|mesh-list
24924456|NCT04160026|Sulfadoxine|sulfadoxine|mesh-list
24924457|NCT04160026|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24924458|NCT04160026|Antimalarials|antimalarials|mesh-ancestor
24924459|NCT04160026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24924460|NCT04160026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24581430|NCT00865111|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24581442|NCT00865137|Immunologic Factors|immunologic factors|mesh-ancestor
24581443|NCT00865137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252839|NCT02505113|Montelukast|montelukast|mesh-list
25252840|NCT02505113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25686978|NCT01927718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24728269|NCT01615211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24728270|NCT01615211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728271|NCT01615211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842626|NCT02222428|Autonomic Agents|autonomic agents|mesh-ancestor
24474385|NCT00405847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24728272|NCT01615211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24728285|NCT01615224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24728286|NCT01615224|Oxytocics|oxytocics|mesh-ancestor
24728287|NCT01615289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25252841|NCT02505113|Respiratory System Agents|respiratory system agents|mesh-ancestor
25252842|NCT02505113|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25252843|NCT02505113|Hormone Antagonists|hormone antagonists|mesh-ancestor
25252844|NCT02505113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25252845|NCT02505113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252846|NCT02505113|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25252847|NCT02505113|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25252848|NCT02505113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252849|NCT02504944|Propranolol|propranolol|mesh-list
25252850|NCT02504944|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25252851|NCT02504944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25252852|NCT02504944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25252853|NCT02504944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25252854|NCT02504944|Adrenergic Agents|adrenergic agents|mesh-ancestor
25252855|NCT02504944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25252856|NCT02504944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252857|NCT02504944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252858|NCT02504944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25252859|NCT02504944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25252860|NCT02504944|Vasodilator Agents|vasodilator agents|mesh-ancestor
25252861|NCT02504996|Acetaminophen|acetaminophen|mesh-list
25252862|NCT02504996|Morphine|morphine|mesh-list
25252863|NCT02504996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25252864|NCT02504996|Narcotics|narcotics|mesh-ancestor
25252865|NCT02504996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25252866|NCT02504996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252867|NCT02504996|Analgesics|analgesics|mesh-ancestor
25252868|NCT02504996|Sensory System Agents|sensory system agents|mesh-ancestor
25252869|NCT02504996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25252870|NCT02504996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25252871|NCT02504996|Antipyretics|antipyretics|mesh-ancestor
25252872|NCT02504983|Sorafenib|sorafenib|mesh-list
25252873|NCT02504983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25001464|NCT05296603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25001465|NCT05296278|Lenvatinib|lenvatinib|mesh-list
25001466|NCT05296278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25001467|NCT05296278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25001468|NCT05296278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25001469|NCT05296278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252874|NCT02504983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25252875|NCT02504983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25252876|NCT02504983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252877|NCT02505087|Acetylcysteine|acetylcysteine|mesh-list
25252878|NCT02505087|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25252879|NCT02505087|Antiviral Agents|antiviral agents|mesh-ancestor
25252880|NCT02505087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25252881|NCT02505087|Expectorants|expectorants|mesh-ancestor
25252882|NCT02505087|Respiratory System Agents|respiratory system agents|mesh-ancestor
25252883|NCT02505087|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25252884|NCT02505087|Antioxidants|antioxidants|mesh-ancestor
25252885|NCT02505087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252886|NCT02505087|Protective Agents|protective agents|mesh-ancestor
25686979|NCT01927718|Growth Substances|growth substances|mesh-ancestor
25686980|NCT01927718|Growth Inhibitors|growth inhibitors|mesh-ancestor
25686981|NCT01927718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25686982|NCT01927718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25686983|NCT01927718|Leprostatic Agents|leprostatic agents|mesh-ancestor
25686984|NCT01927718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25686985|NCT01927718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25686986|NCT01927757|Etanercept|etanercept|mesh-list
25686987|NCT01927757|Methotrexate|methotrexate|mesh-list
25686988|NCT01927757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25686989|NCT01927757|Abortifacient Agents|abortifacient agents|mesh-ancestor
25686990|NCT01927757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25686991|NCT01927757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25686992|NCT01927757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25686993|NCT01927757|Antimetabolites|antimetabolites|mesh-ancestor
24728364|NCT01615757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24728365|NCT01615757|Antiviral Agents|antiviral agents|mesh-ancestor
24728366|NCT01615757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24728367|NCT01615757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25252887|NCT02505087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252888|NCT02505087|Antidotes|antidotes|mesh-ancestor
25252889|NCT02504801|Budesonide|budesonide|mesh-list
25252890|NCT02504801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25001488|NCT05294263|Varenicline|varenicline|mesh-list
25001489|NCT05294263|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25001490|NCT05294263|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25001491|NCT05294263|Cholinergic Agents|cholinergic agents|mesh-ancestor
25001492|NCT05294263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25075922|NCT03377257|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24644642|NCT01192230|Tubulin Modulators|tubulin modulators|mesh-ancestor
24644643|NCT01192230|Antimitotic Agents|antimitotic agents|mesh-ancestor
24644644|NCT01192230|Mitosis Modulators|mitosis modulators|mesh-ancestor
24644645|NCT01192230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644646|NCT01192230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24924473|NCT04159870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24924474|NCT04159870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924475|NCT04159870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924476|NCT04159870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924477|NCT04159870|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25252891|NCT02504801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25252892|NCT02504801|Autonomic Agents|autonomic agents|mesh-ancestor
25252893|NCT02504801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25252894|NCT02504801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252895|NCT02504801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25252896|NCT02504801|Respiratory System Agents|respiratory system agents|mesh-ancestor
25252897|NCT02504801|Glucocorticoids|glucocorticoids|mesh-ancestor
25252898|NCT02504801|Hormones|hormones|mesh-ancestor
25252899|NCT02504801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25252900|NCT02504450|Haloperidol|haloperidol|mesh-list
25252901|NCT02504450|Ziprasidone|ziprasidone|mesh-list
25252902|NCT02504450|Loxapine|loxapine|mesh-list
25252903|NCT02504450|Antiemetics|antiemetics|mesh-ancestor
25252904|NCT02504450|Autonomic Agents|autonomic agents|mesh-ancestor
25252905|NCT02504450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25252906|NCT02504450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252907|NCT02504450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25252908|NCT02504450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25252909|NCT02504450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25252910|NCT02504450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25252911|NCT02504450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24924478|NCT04159870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24924527|NCT04159155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24924528|NCT04159155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924529|NCT04159155|Tubulin Modulators|tubulin modulators|mesh-ancestor
24624242|NCT01075490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624243|NCT01075490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24624244|NCT01075490|Sympatholytics|sympatholytics|mesh-ancestor
24624245|NCT01075490|Autonomic Agents|autonomic agents|mesh-ancestor
24624246|NCT01075490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24624247|NCT01075490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24624248|NCT01075490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24624249|NCT01075490|Adrenergic Agents|adrenergic agents|mesh-ancestor
24624250|NCT01075490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24624251|NCT01075490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624263|NCT01075529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624265|NCT01075529|Serotonin Agents|serotonin agents|mesh-ancestor
25686994|NCT01927757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25686995|NCT01927757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25686996|NCT01927757|Dermatologic Agents|dermatologic agents|mesh-ancestor
25686997|NCT01927757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25686998|NCT01927757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25686999|NCT01927757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24728448|NCT01616186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24624266|NCT01075529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624267|NCT01075529|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24624268|NCT01075529|Antidepressive Agents|antidepressive agents|mesh-ancestor
24624269|NCT01075529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24624270|NCT01075529|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24624271|NCT01075529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24748435|NCT02595892|Gemcitabine|gemcitabine|mesh-list
24924531|NCT04159155|Mitosis Modulators|mitosis modulators|mesh-ancestor
24924532|NCT04159155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924533|NCT04159155|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24924534|NCT04159155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924535|NCT04159142|Paclitaxel|paclitaxel|mesh-list
24924536|NCT04159142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24924537|NCT04159142|Carboplatin|carboplatin|mesh-list
24924538|NCT04159142|Capecitabine|capecitabine|mesh-list
24924539|NCT04159142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24924540|NCT04159142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24581453|NCT00865176|Diuretics|diuretics|mesh-ancestor
25252925|NCT02504476|Midazolam|midazolam|mesh-list
25252926|NCT02504476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25252927|NCT02504476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25252928|NCT02504476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25252929|NCT02504476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252930|NCT02504476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25252931|NCT02504476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25252932|NCT02504476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25252933|NCT02504476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25252934|NCT02504476|Anesthetics, General|anesthetics, general|mesh-ancestor
25252935|NCT02504476|Anesthetics|anesthetics|mesh-ancestor
25252936|NCT02504476|GABA Modulators|gaba modulators|mesh-ancestor
25252937|NCT02504476|GABA Agents|gaba agents|mesh-ancestor
25252938|NCT02504476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25252939|NCT02504476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252940|NCT02504463|Naltrexone|naltrexone|mesh-list
25252941|NCT02504463|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25252942|NCT02504463|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25252943|NCT02504463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252944|NCT02504463|Sensory System Agents|sensory system agents|mesh-ancestor
25252945|NCT02504463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25252946|NCT02504398|Methamphetamine|methamphetamine|mesh-list
25252947|NCT02504398|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25252971|NCT02504359|Podophyllotoxin|podophyllotoxin|mesh-list
25252950|NCT02504398|Autonomic Agents|autonomic agents|mesh-ancestor
25252951|NCT02504398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25252952|NCT02504398|Dopamine Agents|dopamine agents|mesh-ancestor
25252953|NCT02504398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25252954|NCT02504398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252955|NCT02504398|Adrenergic Agents|adrenergic agents|mesh-ancestor
25252956|NCT02504398|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25252957|NCT02504398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25252958|NCT02504398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24924542|NCT04159142|Antimitotic Agents|antimitotic agents|mesh-ancestor
24924543|NCT04159142|Mitosis Modulators|mitosis modulators|mesh-ancestor
24924544|NCT04159142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924545|NCT04159142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24924546|NCT04159142|Antimetabolites|antimetabolites|mesh-ancestor
24924548|NCT04159077|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24924549|NCT04159077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24924550|NCT04159077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24924551|NCT04159077|Adrenergic Agents|adrenergic agents|mesh-ancestor
24924552|NCT04159077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24924553|NCT04159077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924554|NCT04159077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924555|NCT04159077|Urological Agents|urological agents|mesh-ancestor
24924557|NCT04158934|BAX 855|bax 855|mesh-list
24924558|NCT04158934|Coagulants|coagulants|mesh-ancestor
24924559|NCT04158947|Trastuzumab|trastuzumab|mesh-list
24924560|NCT04158947|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24939298|NCT04011410|Hydroxychloroquine|hydroxychloroquine|mesh-list
24793214|NCT03747042|Letrozole|letrozole|mesh-list
24793215|NCT03747042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793216|NCT03747042|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24793217|NCT03747042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25687000|NCT01927757|Immunologic Factors|immunologic factors|mesh-ancestor
24793219|NCT03747042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793220|NCT03747042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24793221|NCT03747042|Hormone Antagonists|hormone antagonists|mesh-ancestor
24800381|NCT01975324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581471|NCT00865267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24581472|NCT00865319|Deoxyglucose|deoxyglucose|mesh-list
24581473|NCT00865319|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24581474|NCT00865319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24581476|NCT00865319|Antimetabolites|antimetabolites|mesh-ancestor
24581495|NCT00865384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24581496|NCT00865384|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24581497|NCT00865384|Histamine Antagonists|histamine antagonists|mesh-ancestor
24581498|NCT00865384|Histamine Agents|histamine agents|mesh-ancestor
24581499|NCT00865384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581615|NCT00865605|Hormones|hormones|mesh-ancestor
25010179|NCT04548973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24902160|NCT04377048|Gemcitabine|gemcitabine|mesh-list
24581616|NCT00865605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24581617|NCT00865605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581618|NCT00865618|Eplerenone|eplerenone|mesh-list
24581619|NCT00865618|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24581620|NCT00865618|Hormone Antagonists|hormone antagonists|mesh-ancestor
24581621|NCT00865618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24581622|NCT00865618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581623|NCT00865618|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24581624|NCT00865618|Diuretics|diuretics|mesh-ancestor
25252959|NCT02504398|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25252960|NCT02504372|Pembrolizumab|pembrolizumab|mesh-list
25252961|NCT02504372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25252962|NCT02504372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25252963|NCT02504359|Cytarabine|cytarabine|mesh-list
25252964|NCT02504359|Methotrexate|methotrexate|mesh-list
25252965|NCT02504359|Etoposide|etoposide|mesh-list
25252966|NCT02504359|Etoposide phosphate|etoposide phosphate|mesh-list
25252967|NCT02504359|Melphalan|melphalan|mesh-list
25252968|NCT02504359|Mechlorethamine|mechlorethamine|mesh-list
25252969|NCT02504359|Carmustine|carmustine|mesh-list
25252970|NCT02504359|Ixazomib|ixazomib|mesh-list
25252972|NCT02504359|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25252973|NCT02504359|Tacrolimus|tacrolimus|mesh-list
25252974|NCT02504359|Glycine|glycine|mesh-list
25252975|NCT02504359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25252976|NCT02504359|Abortifacient Agents|abortifacient agents|mesh-ancestor
25252977|NCT02504359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25252978|NCT02504359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25252979|NCT02504359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25252980|NCT02504359|Antimetabolites|antimetabolites|mesh-ancestor
24500245|NCT00523406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924571|NCT04158674|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24924572|NCT04158674|Vasodilator Agents|vasodilator agents|mesh-ancestor
24924573|NCT04158674|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24924574|NCT04158674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24924575|NCT04158674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924576|NCT04158674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924577|NCT04158674|Protective Agents|protective agents|mesh-ancestor
24924578|NCT04158674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924579|NCT04158778|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
24924580|NCT04158778|Hallucinogens|hallucinogens|mesh-ancestor
24924581|NCT04158778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924582|NCT04158778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24924583|NCT04158778|Serotonin Agents|serotonin agents|mesh-ancestor
24924584|NCT04158778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24924585|NCT04158778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924586|NCT04158778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24924587|NCT04158778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24924588|NCT04158778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24924589|NCT04158778|Adrenergic Agents|adrenergic agents|mesh-ancestor
24924590|NCT04158700|Pembrolizumab|pembrolizumab|mesh-list
24924591|NCT04158700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24798509|NCT01964001|Vitamins|vitamins|mesh-list
24581625|NCT00865618|Natriuretic Agents|natriuretic agents|mesh-ancestor
24581643|NCT00865644|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24581644|NCT00865644|Immunologic Factors|immunologic factors|mesh-ancestor
25687001|NCT01927757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24581645|NCT00865644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581647|NCT00865644|Interferon Inducers|interferon inducers|mesh-ancestor
24581672|NCT00865696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24581673|NCT00865696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24581674|NCT00865696|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24581675|NCT00865696|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24581676|NCT00865696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24581677|NCT00865696|Adrenergic Agents|adrenergic agents|mesh-ancestor
24581678|NCT00865696|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24581679|NCT00865696|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24581680|NCT00865696|Serotonin Agents|serotonin agents|mesh-ancestor
24581681|NCT00865696|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24581682|NCT00865748|Metformin|metformin|mesh-list
24581702|NCT00865878|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24581703|NCT00865878|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24581728|NCT00865943|Citalopram|citalopram|mesh-list
24581729|NCT00865943|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24581730|NCT00865943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24581731|NCT00865943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24581732|NCT00865943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581733|NCT00865943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25252981|NCT02504359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25252982|NCT02504359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25252983|NCT02504359|Dermatologic Agents|dermatologic agents|mesh-ancestor
25252984|NCT02504359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25252985|NCT02504359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25252986|NCT02504359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25252987|NCT02504359|Immunologic Factors|immunologic factors|mesh-ancestor
25252988|NCT02504359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25252989|NCT02504359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25252990|NCT02504359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25252991|NCT02504359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25252992|NCT02504359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25252993|NCT02504359|Antiviral Agents|antiviral agents|mesh-ancestor
25252994|NCT02504359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25252995|NCT02504359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25252996|NCT02504359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25252997|NCT02504359|Alkylating Agents|alkylating agents|mesh-ancestor
25252998|NCT02504359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24630727|NCT01113229|Misoprostol|misoprostol|mesh-list
25252999|NCT02504359|Protease Inhibitors|protease inhibitors|mesh-ancestor
25253000|NCT02504359|Keratolytic Agents|keratolytic agents|mesh-ancestor
25253001|NCT02504359|Tubulin Modulators|tubulin modulators|mesh-ancestor
25253002|NCT02504359|Antimitotic Agents|antimitotic agents|mesh-ancestor
25253003|NCT02504359|Mitosis Modulators|mitosis modulators|mesh-ancestor
25253004|NCT02504359|Glycine Agents|glycine agents|mesh-ancestor
24924592|NCT04158700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924593|NCT04158713|Piperaquine|piperaquine|mesh-list
24924594|NCT04158713|Artenimol|artenimol|mesh-list
24924595|NCT04158713|Antimalarials|antimalarials|mesh-ancestor
24924596|NCT04158713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24924597|NCT04158713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24500267|NCT00523458|Efavirenz|efavirenz|mesh-list
24500268|NCT00523458|Nevirapine|nevirapine|mesh-list
24500269|NCT00523458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24500270|NCT00523458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24500271|NCT00523458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24500272|NCT00523458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500273|NCT00523458|Antiviral Agents|antiviral agents|mesh-ancestor
24500274|NCT00523458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24924600|NCT04158830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25120593|NCT03290079|Pembrolizumab|pembrolizumab|mesh-list
24924601|NCT04158830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24924602|NCT04158830|Analgesics|analgesics|mesh-ancestor
24748473|NCT02512172|Pembrolizumab|pembrolizumab|mesh-list
24924603|NCT04158830|Sensory System Agents|sensory system agents|mesh-ancestor
24924604|NCT04158830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24924605|NCT04158830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253005|NCT02504359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25253006|NCT02504307|Sirolimus|sirolimus|mesh-list
25253007|NCT02504307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25253008|NCT02504307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25253009|NCT02504307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25253010|NCT02504307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25253011|NCT02504307|Antifungal Agents|antifungal agents|mesh-ancestor
25253012|NCT02504307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24728597|NCT01617200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24728598|NCT01617200|Serotonin Agents|serotonin agents|mesh-ancestor
24728599|NCT01617213|Lenalidomide|lenalidomide|mesh-list
24728600|NCT01617213|Melphalan|melphalan|mesh-list
24728613|NCT01617226|Azacitidine|azacitidine|mesh-list
25253013|NCT02504307|Immunologic Factors|immunologic factors|mesh-ancestor
25253014|NCT02504307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274692|NCT02376049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25274693|NCT02376049|Respiratory System Agents|respiratory system agents|mesh-ancestor
25274694|NCT02376049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25274695|NCT02376049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25274696|NCT02376049|Analgesics|analgesics|mesh-ancestor
25274697|NCT02376049|Sensory System Agents|sensory system agents|mesh-ancestor
25274698|NCT02376049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25274699|NCT02376049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25274700|NCT02376049|Dermatologic Agents|dermatologic agents|mesh-ancestor
25274701|NCT02376049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25274702|NCT02376049|Immunologic Factors|immunologic factors|mesh-ancestor
25274703|NCT02376049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25274704|NCT02376049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274705|NCT02376049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274706|NCT02376205|Bupivacaine|bupivacaine|mesh-list
25274707|NCT02376205|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25274708|NCT02376205|Anesthetics, Local|anesthetics, local|mesh-ancestor
25274709|NCT02376205|Anesthetics|anesthetics|mesh-ancestor
25274710|NCT02376205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25274711|NCT02376205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274712|NCT02376205|Sensory System Agents|sensory system agents|mesh-ancestor
25274713|NCT02376205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25274714|NCT02376075|Linagliptin|linagliptin|mesh-list
25274715|NCT02376075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25274716|NCT02376075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274717|NCT02376075|Incretins|incretins|mesh-ancestor
25274718|NCT02376075|Hormones|hormones|mesh-ancestor
25274719|NCT02376075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25274720|NCT02376075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25274721|NCT02376075|Protease Inhibitors|protease inhibitors|mesh-ancestor
25274722|NCT02376075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274723|NCT02376075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274724|NCT02375828|Glyburide|glyburide|mesh-list
25274725|NCT02375828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25274726|NCT02375828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274727|NCT02376335|Rituximab|rituximab|mesh-list
25253052|NCT02504164|GABA Agents|gaba agents|mesh-ancestor
24924721|NCT04157010|Abortifacient Agents|abortifacient agents|mesh-ancestor
24924722|NCT04157010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24924723|NCT04157010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924724|NCT04157010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24924725|NCT04157010|Antimetabolites|antimetabolites|mesh-ancestor
24924726|NCT04157010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924727|NCT04157010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924728|NCT04157010|Dermatologic Agents|dermatologic agents|mesh-ancestor
24924729|NCT04157010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924730|NCT04157010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24924731|NCT04157010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24924732|NCT04157010|Immunologic Factors|immunologic factors|mesh-ancestor
24748653|NCT02283281|Dronabinol|dronabinol|mesh-list
25253015|NCT02504346|Osimertinib|osimertinib|mesh-list
25253016|NCT02504346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25253017|NCT02504346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25253018|NCT02504346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25253019|NCT02504346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253020|NCT02504229|Oxaliplatin|oxaliplatin|mesh-list
25253022|NCT02504333|Gemcitabine|gemcitabine|mesh-list
25253023|NCT02504333|Paclitaxel|paclitaxel|mesh-list
25253024|NCT02504333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25253025|NCT02504333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25253026|NCT02504333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25253027|NCT02504333|Tubulin Modulators|tubulin modulators|mesh-ancestor
25253028|NCT02504333|Antimitotic Agents|antimitotic agents|mesh-ancestor
25253029|NCT02504333|Mitosis Modulators|mitosis modulators|mesh-ancestor
25687002|NCT01927757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25687003|NCT01927757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25687004|NCT01927757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25253030|NCT02504333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728665|NCT01617590|Antimetabolites|antimetabolites|mesh-ancestor
24728666|NCT01617590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728667|NCT01617590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24728668|NCT01617590|Dermatologic Agents|dermatologic agents|mesh-ancestor
24728669|NCT01617590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728670|NCT01617590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24728671|NCT01617590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24728672|NCT01617590|Immunologic Factors|immunologic factors|mesh-ancestor
25253031|NCT02504333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25253032|NCT02504333|Antimetabolites|antimetabolites|mesh-ancestor
25253033|NCT02504333|Antiviral Agents|antiviral agents|mesh-ancestor
25253034|NCT02504333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25253035|NCT02504333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25253036|NCT02504333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25253037|NCT02504333|Immunologic Factors|immunologic factors|mesh-ancestor
25253038|NCT02504333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253040|NCT02504164|Midazolam|midazolam|mesh-list
25253041|NCT02504164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25253042|NCT02504164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25253043|NCT02504164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25253044|NCT02504164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253045|NCT02504164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25253046|NCT02504164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25253047|NCT02504164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25253048|NCT02504164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25253049|NCT02504164|Anesthetics, General|anesthetics, general|mesh-ancestor
25253050|NCT02504164|Anesthetics|anesthetics|mesh-ancestor
25253051|NCT02504164|GABA Modulators|gaba modulators|mesh-ancestor
25253056|NCT02504138|Propofol|propofol|mesh-list
25253057|NCT02504138|Desflurane|desflurane|mesh-list
24924769|NCT04156555|Clavulanic Acids|clavulanic acids|mesh-list
24924770|NCT04156555|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24924778|NCT04156425|Golimumab|golimumab|mesh-list
24924782|NCT04156425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24924783|NCT04156425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924784|NCT04156425|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24924785|NCT04156425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24924786|NCT04156425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24924787|NCT04156425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924810|NCT04156451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24924811|NCT04156451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924813|NCT04156464|Phenobarbital|phenobarbital|mesh-list
24924814|NCT04156464|Anticonvulsants|anticonvulsants|mesh-ancestor
24924815|NCT04156464|Antiemetics|antiemetics|mesh-ancestor
24500465|NCT00524433|Tezosentan|tezosentan|mesh-list
24924817|NCT04156464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24924818|NCT04156464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924819|NCT04156464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24924820|NCT04156464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24924821|NCT04156464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24924822|NCT04156464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24924823|NCT04156464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24924824|NCT04156464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24924825|NCT04156464|GABA Modulators|gaba modulators|mesh-ancestor
24924826|NCT04156464|GABA Agents|gaba agents|mesh-ancestor
24924827|NCT04156464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24924828|NCT04156464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924829|NCT04156464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24924830|NCT04156464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24924831|NCT04156464|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24924832|NCT04156464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24581734|NCT00865943|Serotonin Agents|serotonin agents|mesh-ancestor
24581735|NCT00865943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581736|NCT00865943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25687005|NCT01927757|Analgesics|analgesics|mesh-ancestor
25687006|NCT01927757|Sensory System Agents|sensory system agents|mesh-ancestor
25687007|NCT01927757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25687008|NCT01927757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25687009|NCT01927757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25687010|NCT01927887|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25687011|NCT01927887|Hematinics|hematinics|mesh-ancestor
25687012|NCT01927887|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24581737|NCT00865943|Antidepressive Agents|antidepressive agents|mesh-ancestor
25253058|NCT02504138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25253059|NCT02504138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253060|NCT02504138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25253061|NCT02504138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25253062|NCT02504138|Anesthetics, General|anesthetics, general|mesh-ancestor
25253063|NCT02504138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25253064|NCT02504125|Tranexamic Acid|tranexamic acid|mesh-list
25253065|NCT02504125|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25253066|NCT02504125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25253067|NCT02504125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253069|NCT02504125|Coagulants|coagulants|mesh-ancestor
25253070|NCT02503826|Midazolam|midazolam|mesh-list
25253071|NCT02503826|Sufentanil|sufentanil|mesh-list
25253072|NCT02503826|Dsuvia|dsuvia|mesh-list
25253073|NCT02503826|Propofol|propofol|mesh-list
25253074|NCT02503826|Cisatracurium|cisatracurium|mesh-list
25253075|NCT02503826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25253076|NCT02503826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25253077|NCT02503826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253078|NCT02503826|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25253079|NCT02503826|Anesthetics, General|anesthetics, general|mesh-ancestor
25253080|NCT02503826|Anesthetics|anesthetics|mesh-ancestor
25253081|NCT02503826|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25253082|NCT02503826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25253083|NCT02503826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25253084|NCT02503826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25253085|NCT02503826|GABA Modulators|gaba modulators|mesh-ancestor
25253086|NCT02503826|GABA Agents|gaba agents|mesh-ancestor
25253090|NCT02503826|Narcotics|narcotics|mesh-ancestor
25253091|NCT02503826|Analgesics|analgesics|mesh-ancestor
25253092|NCT02503826|Sensory System Agents|sensory system agents|mesh-ancestor
25274733|NCT02375880|Gemcitabine|gemcitabine|mesh-list
24924833|NCT04156464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24924834|NCT04156204|Tacrolimus|tacrolimus|mesh-list
24924835|NCT04156204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24924836|NCT04156204|Immunologic Factors|immunologic factors|mesh-ancestor
24924837|NCT04156204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523089|NCT02607215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24523090|NCT02607215|Tubulin Modulators|tubulin modulators|mesh-ancestor
24523091|NCT02607215|Antimitotic Agents|antimitotic agents|mesh-ancestor
24523092|NCT02607215|Mitosis Modulators|mitosis modulators|mesh-ancestor
24523093|NCT02607215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523094|NCT02589353|Acarbose|acarbose|mesh-list
24523095|NCT02589353|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24924845|NCT04156035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24924846|NCT04156035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924847|NCT04156035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24924848|NCT04156035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24924849|NCT04156035|Anesthetics, General|anesthetics, general|mesh-ancestor
24924850|NCT04156035|Anesthetics|anesthetics|mesh-ancestor
24924851|NCT04156035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24924852|NCT04156035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24924853|NCT04156035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24924854|NCT04156035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24924855|NCT04156035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924856|NCT04156035|Anticonvulsants|anticonvulsants|mesh-ancestor
24924857|NCT04156035|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24924858|NCT04156035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24500530|NCT00524836|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24500531|NCT00524836|Histamine Antagonists|histamine antagonists|mesh-ancestor
24500532|NCT00524836|Histamine Agents|histamine agents|mesh-ancestor
24500533|NCT00524836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24793243|NCT03703102|KHK4083|khk4083|mesh-list
24793244|NCT03703102|Dermatologic Agents|dermatologic agents|mesh-ancestor
24793245|NCT03690011|Cyclophosphamide|cyclophosphamide|mesh-list
24793246|NCT03690011|Fludarabine|fludarabine|mesh-list
24793247|NCT03690011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24793248|NCT03690011|Immunologic Factors|immunologic factors|mesh-ancestor
24793249|NCT03690011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581746|NCT00865943|Cholinergic Agents|cholinergic agents|mesh-ancestor
24581763|NCT00866008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24581764|NCT00866008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25253093|NCT02503826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25253094|NCT02503826|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24728934|NCT01618929|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24728935|NCT01618929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728936|NCT01619007|Rivaroxaban|rivaroxaban|mesh-list
24728937|NCT01619007|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24728938|NCT01619007|Antithrombins|antithrombins|mesh-ancestor
24728939|NCT01619007|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25253095|NCT02503826|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25253096|NCT02504008|Zoledronic Acid|zoledronic acid|mesh-list
25253097|NCT02504008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25253098|NCT02504008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253099|NCT02503904|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25253100|NCT02503904|Metronidazole|metronidazole|mesh-list
25253101|NCT02503904|Lidocaine|lidocaine|mesh-list
25253102|NCT02503904|Epinephrine|epinephrine|mesh-list
25253103|NCT02503904|Anesthetics, Local|anesthetics, local|mesh-ancestor
25253104|NCT02503904|Anesthetics|anesthetics|mesh-ancestor
25253105|NCT02503904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25253106|NCT02503904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253107|NCT02503904|Sensory System Agents|sensory system agents|mesh-ancestor
25253108|NCT02503904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25253109|NCT02503904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25253110|NCT02503904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25253111|NCT02503904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25253112|NCT02503904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25253113|NCT02503904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253114|NCT02503904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25253115|NCT02503904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25253116|NCT02503904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25253117|NCT02503904|Adrenergic Agents|adrenergic agents|mesh-ancestor
25253118|NCT02503904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25253119|NCT02503904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25253120|NCT02503904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25253121|NCT02503904|Autonomic Agents|autonomic agents|mesh-ancestor
25253122|NCT02503904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24500534|NCT00524836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500535|NCT00524836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500536|NCT00524849|Zoledronic Acid|zoledronic acid|mesh-list
24500537|NCT00524849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24500538|NCT00524849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500540|NCT00524875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24500541|NCT00524875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24500542|NCT00524875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24500543|NCT00524875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24500544|NCT00524875|Growth Substances|growth substances|mesh-ancestor
24523096|NCT02589353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24523097|NCT02589353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523098|NCT02589353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24523099|NCT02589353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523100|NCT02588248|Peppermint oil|peppermint oil|mesh-list
24523101|NCT02588248|Menthol|menthol|mesh-list
24523137|NCT02512926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24523138|NCT02512926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24523139|NCT02512926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24523140|NCT02512497|Vidarabine|vidarabine|mesh-list
24924859|NCT04156035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24500548|NCT00524901|Hematinics|hematinics|mesh-ancestor
24500549|NCT00524914|Apomorphine|apomorphine|mesh-list
24500550|NCT00524914|Emetics|emetics|mesh-ancestor
24500551|NCT00524914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500552|NCT00524914|Autonomic Agents|autonomic agents|mesh-ancestor
24500553|NCT00524914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24500554|NCT00524914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24500555|NCT00524914|Dopamine Agonists|dopamine agonists|mesh-ancestor
24500556|NCT00524914|Dopamine Agents|dopamine agents|mesh-ancestor
24500557|NCT00524914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24500559|NCT00524927|Methoxyflurane|methoxyflurane|mesh-list
25253123|NCT02503904|Respiratory System Agents|respiratory system agents|mesh-ancestor
25687013|NCT01927887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25687014|NCT01928186|Alovudine|alovudine|mesh-list
25687015|NCT01928186|Antiviral Agents|antiviral agents|mesh-ancestor
25687016|NCT01928186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25687017|NCT01928199|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25687018|NCT01928199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25687019|NCT01928199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253125|NCT02503904|Sympathomimetics|sympathomimetics|mesh-ancestor
25253126|NCT02503904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25253127|NCT02503904|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25253128|NCT02503904|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25253129|NCT02503943|Metformin|metformin|mesh-list
25253130|NCT02503943|Liraglutide|liraglutide|mesh-list
25253131|NCT02503943|Mitiglinide|mitiglinide|mesh-list
25253132|NCT02503943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25253133|NCT02503943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253134|NCT02503943|Incretins|incretins|mesh-ancestor
25253135|NCT02503943|Hormones|hormones|mesh-ancestor
25253136|NCT02503943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25253137|NCT02503761|Meropenem|meropenem|mesh-list
25253138|NCT02503761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25253139|NCT02503761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25253140|NCT02503462|Ritonavir|ritonavir|mesh-list
25253141|NCT02503462|Darunavir|darunavir|mesh-list
25253142|NCT02503462|Cobicistat|cobicistat|mesh-list
25253143|NCT02503462|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25253144|NCT02503462|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25253145|NCT02503462|Protease Inhibitors|protease inhibitors|mesh-ancestor
25253146|NCT02503462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25253147|NCT02503462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253148|NCT02503462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25253149|NCT02503462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25253150|NCT02503462|Antiviral Agents|antiviral agents|mesh-ancestor
25253151|NCT02503462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25253152|NCT02503462|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25253153|NCT02503462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25253154|NCT02503319|Tranexamic Acid|tranexamic acid|mesh-list
25253156|NCT02503319|Oxytocics|oxytocics|mesh-ancestor
25253157|NCT02503319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25253158|NCT02503319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253159|NCT02503319|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25253160|NCT02503319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24924884|NCT04155983|Anesthetics|anesthetics|mesh-ancestor
24924885|NCT04155983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24924886|NCT04155983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924887|NCT04155983|Sensory System Agents|sensory system agents|mesh-ancestor
24924888|NCT04155983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24924889|NCT04155658|Fluorides|fluorides|mesh-list
24924890|NCT04155658|Cariostatic Agents|cariostatic agents|mesh-ancestor
24924891|NCT04155658|Protective Agents|protective agents|mesh-ancestor
24924892|NCT04155658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924893|NCT04155918|Allopurinol|allopurinol|mesh-list
24924894|NCT04155918|Febuxostat|febuxostat|mesh-list
24924895|NCT04155918|Antimetabolites|antimetabolites|mesh-ancestor
24924896|NCT04155918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924897|NCT04155918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924898|NCT04155918|Gout Suppressants|gout suppressants|mesh-ancestor
24924899|NCT04155918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24924900|NCT04155918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24924916|NCT04155554|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
24924917|NCT04155554|Triumeq|triumeq|mesh-list
24924918|NCT04155554|Antiviral Agents|antiviral agents|mesh-ancestor
24924919|NCT04155554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24924920|NCT04155554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24924921|NCT04155554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24924922|NCT04155554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924923|NCT04155554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924924|NCT04155554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24924925|NCT04155554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24397465|NCT00141596|Furosemide|furosemide|mesh-list
24581768|NCT00866021|Ritonavir|ritonavir|mesh-list
25010196|NCT04538040|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25010197|NCT04538040|Antiviral Agents|antiviral agents|mesh-ancestor
25010198|NCT04538040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25010199|NCT04538040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25010200|NCT04538040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25010201|NCT04538040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25253172|NCT02503189|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25253173|NCT02503189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25253174|NCT02503176|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25253175|NCT02503176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25253176|NCT02503163|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25253177|NCT02503163|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24616620|NCT01038388|Lenalidomide|lenalidomide|mesh-list
24616621|NCT01038388|Bortezomib|bortezomib|mesh-list
24942232|NCT03982862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616622|NCT01038388|Vorinostat|vorinostat|mesh-list
24616623|NCT01038388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24616624|NCT01038388|Antiemetics|antiemetics|mesh-ancestor
24616625|NCT01038388|Autonomic Agents|autonomic agents|mesh-ancestor
24729151|NCT01620112|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24729152|NCT01620112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24729153|NCT01620112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24729154|NCT01620112|Adrenergic Agents|adrenergic agents|mesh-ancestor
24729155|NCT01620112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25253178|NCT02502968|Cytarabine|cytarabine|mesh-list
25253179|NCT02502968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25253180|NCT02502968|Antimetabolites|antimetabolites|mesh-ancestor
25253181|NCT02502968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253182|NCT02502968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25253183|NCT02502968|Antiviral Agents|antiviral agents|mesh-ancestor
25253184|NCT02502968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25253185|NCT02502968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25253186|NCT02502968|Immunologic Factors|immunologic factors|mesh-ancestor
25253187|NCT02502968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253188|NCT02502981|Chlorthalidone|chlorthalidone|mesh-list
25253189|NCT02502981|Spironolactone|spironolactone|mesh-list
25253190|NCT02502981|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
25253191|NCT02502981|Diuretics|diuretics|mesh-list
25253192|NCT02502981|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
25253193|NCT02502981|Mineralocorticoids|mineralocorticoids|mesh-list
25253194|NCT02502981|Hormone Antagonists|hormone antagonists|mesh-ancestor
25253240|NCT02502877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25253195|NCT02502981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25253196|NCT02502981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253197|NCT02502981|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25253198|NCT02502981|Natriuretic Agents|natriuretic agents|mesh-ancestor
25045274|NCT00978016|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25045275|NCT00978016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045276|NCT00978016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045277|NCT00978016|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25045278|NCT00978016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045279|NCT00978016|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25045280|NCT00978016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045281|NCT00978016|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25045282|NCT00978016|GABA Agonists|gaba agonists|mesh-ancestor
25045283|NCT00978016|GABA Agents|gaba agents|mesh-ancestor
25045284|NCT00978016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25045285|NCT00975091|Entecavir|entecavir|mesh-list
24924927|NCT04155554|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24624272|NCT01075529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24624274|NCT01075555|Pravastatin|pravastatin|mesh-list
24624275|NCT01075555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624276|NCT01075555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24624277|NCT01075555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404147|NCT03682068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25687020|NCT01928199|Incretins|incretins|mesh-ancestor
25687021|NCT01928199|Hormones|hormones|mesh-ancestor
25687022|NCT01928199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25687023|NCT01928199|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25687024|NCT01928199|Protease Inhibitors|protease inhibitors|mesh-ancestor
25687025|NCT01928199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687026|NCT01928199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687027|NCT01928225|Vaccines|vaccines|mesh-list
25687028|NCT01928225|Immunologic Factors|immunologic factors|mesh-ancestor
25687029|NCT01928225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687030|NCT01928290|Leucovorin|leucovorin|mesh-list
25687031|NCT01928290|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
25687032|NCT01928290|Tetrahydrofolates|tetrahydrofolates|mesh-list
25687033|NCT01928290|Fluorouracil|fluorouracil|mesh-list
25687034|NCT01928290|Oxaliplatin|oxaliplatin|mesh-list
25687035|NCT01928290|Trastuzumab|trastuzumab|mesh-list
25687036|NCT01928290|Irinotecan|irinotecan|mesh-list
25687037|NCT01928290|Levoleucovorin|levoleucovorin|mesh-list
24729256|NCT01620814|Misoprostol|misoprostol|mesh-list
24729257|NCT01620814|Dinoprostone|dinoprostone|mesh-list
24729258|NCT01620814|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24729259|NCT01620814|Abortifacient Agents|abortifacient agents|mesh-ancestor
24729260|NCT01620814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24729262|NCT01620814|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24729276|NCT01620944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24729277|NCT01620944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24624278|NCT01075555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624279|NCT01075555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24500608|NCT00525239|Lopinavir|lopinavir|mesh-list
24500609|NCT00525239|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24624280|NCT01075555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24624281|NCT01075555|Antimetabolites|antimetabolites|mesh-ancestor
24624282|NCT01075555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24624283|NCT01075555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24624284|NCT01075581|Epinephrine|epinephrine|mesh-list
24624285|NCT01075581|Racepinephrine|racepinephrine|mesh-list
24624286|NCT01075581|Epinephryl borate|epinephryl borate|mesh-list
24624287|NCT01075581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25253199|NCT02502981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25253200|NCT02502981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25253201|NCT02502981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253202|NCT02502981|Hormones|hormones|mesh-ancestor
25253203|NCT02502682|Chlorhexidine|chlorhexidine|mesh-list
25253204|NCT02502682|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25253205|NCT02502682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25253206|NCT02502682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25253207|NCT02502682|Disinfectants|disinfectants|mesh-ancestor
25253208|NCT02502682|Dermatologic Agents|dermatologic agents|mesh-ancestor
25253209|NCT02502643|Picibanil|picibanil|mesh-list
25253210|NCT02502643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25253211|NCT02502565|Uric Acid|uric acid|mesh-list
25253212|NCT02502565|Antioxidants|antioxidants|mesh-ancestor
25253213|NCT02502565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253214|NCT02502565|Protective Agents|protective agents|mesh-ancestor
25253215|NCT02502565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253216|NCT02502825|Methacholine Chloride|methacholine chloride|mesh-list
25253217|NCT02502825|Miotics|miotics|mesh-ancestor
25253218|NCT02502825|Autonomic Agents|autonomic agents|mesh-ancestor
25253219|NCT02502825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25253220|NCT02502825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253221|NCT02502825|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25253222|NCT02502825|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
25253223|NCT02502825|Respiratory System Agents|respiratory system agents|mesh-ancestor
25253224|NCT02502825|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25253225|NCT02502825|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25253226|NCT02502825|Cholinergic Agents|cholinergic agents|mesh-ancestor
25253227|NCT02502825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25253228|NCT02502825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253229|NCT02502799|Methylphenidate|methylphenidate|mesh-list
25253230|NCT02502799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25253231|NCT02502799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253232|NCT02502799|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25253233|NCT02502799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25253234|NCT02502799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25253235|NCT02502799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253236|NCT02502799|Dopamine Agents|dopamine agents|mesh-ancestor
25253237|NCT02502799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25253238|NCT02502877|Midazolam|midazolam|mesh-list
25253239|NCT02502877|Propofol|propofol|mesh-list
25253241|NCT02502877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24624312|NCT01075698|Telmisartan|telmisartan|mesh-list
24624313|NCT01075698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25687038|NCT01928290|Antimetabolites|antimetabolites|mesh-ancestor
25687039|NCT01928290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687040|NCT01928290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25687041|NCT01928290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25687042|NCT01928290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25687043|NCT01928290|Immunologic Factors|immunologic factors|mesh-ancestor
25687044|NCT01928290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624314|NCT01075698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24924941|NCT04155229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24924942|NCT04155229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729417|NCT01621451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24729418|NCT01621451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24729419|NCT01621451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24924943|NCT04155229|Antipyretics|antipyretics|mesh-ancestor
24924944|NCT04155229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24924945|NCT04155229|Narcotics|narcotics|mesh-ancestor
24924946|NCT04155229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24924947|NCT04155229|Antitussive Agents|antitussive agents|mesh-ancestor
24924948|NCT04155229|Respiratory System Agents|respiratory system agents|mesh-ancestor
24924949|NCT04155229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24924950|NCT04155229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24924951|NCT04155229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24924952|NCT04155190|Veratrum Alkaloids|veratrum alkaloids|mesh-list
24924953|NCT04155190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24924954|NCT04155476|Nitroglycerin|nitroglycerin|mesh-list
24924955|NCT04155476|Vasodilator Agents|vasodilator agents|mesh-ancestor
24924956|NCT04154852|Folic Acid|folic acid|mesh-list
24924957|NCT04154852|Adalimumab|adalimumab|mesh-list
25049117|NCT00635193|Immunologic Factors|immunologic factors|mesh-ancestor
25010202|NCT04538040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010203|NCT04538040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25010204|NCT04538040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25010205|NCT04530305|Upadacitinib|upadacitinib|mesh-list
25010206|NCT04530305|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25010207|NCT04530305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24902278|NCT04374981|Celecoxib|celecoxib|mesh-list
24581771|NCT00866021|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24581772|NCT00866021|Protease Inhibitors|protease inhibitors|mesh-ancestor
24581773|NCT00866021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581774|NCT00866021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581775|NCT00866021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24581776|NCT00866021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24581777|NCT00866021|Antiviral Agents|antiviral agents|mesh-ancestor
24581778|NCT00866021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24581779|NCT00866021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24581781|NCT00866060|Memantine|memantine|mesh-list
24581811|NCT00866229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24581812|NCT00866229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581813|NCT00866437|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24581814|NCT00866437|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24581815|NCT00866437|Estropipate|estropipate|mesh-list
24581816|NCT00866437|Estradiol|estradiol|mesh-list
24581817|NCT00866437|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24581883|NCT00866593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581884|NCT00866593|Serotonin Agents|serotonin agents|mesh-ancestor
24581885|NCT00866593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581886|NCT00866593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24581887|NCT00866593|Antidepressive Agents|antidepressive agents|mesh-ancestor
24581892|NCT00866593|Autonomic Agents|autonomic agents|mesh-ancestor
24581998|NCT00866996|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24581999|NCT00866996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25253242|NCT02502877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253243|NCT02502877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25253244|NCT02502877|Anesthetics, General|anesthetics, general|mesh-ancestor
25253245|NCT02502877|Anesthetics|anesthetics|mesh-ancestor
25253246|NCT02502877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25253247|NCT02502877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25253248|NCT02502877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25253249|NCT02502877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25253250|NCT02502877|GABA Modulators|gaba modulators|mesh-ancestor
25253251|NCT02502877|GABA Agents|gaba agents|mesh-ancestor
25087205|NCT03280927|Efinaconazole|efinaconazole|mesh-list
24631345|NCT01117116|Hormones|hormones|mesh-ancestor
24631346|NCT01117116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24631347|NCT01117116|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24631354|NCT01117129|Methotrexate|methotrexate|mesh-list
25253252|NCT02502877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25253253|NCT02502877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253254|NCT02502500|Celecoxib|celecoxib|mesh-list
25253255|NCT02502500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25253256|NCT02502500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25687045|NCT01928290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25687046|NCT01928290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24712591|NCT01521624|Metformin|metformin|mesh-list
25253257|NCT02502500|Analgesics|analgesics|mesh-ancestor
25253258|NCT02502500|Sensory System Agents|sensory system agents|mesh-ancestor
24924959|NCT04154852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24729459|NCT01621698|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24729460|NCT01621698|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24924960|NCT04154852|Abortifacient Agents|abortifacient agents|mesh-ancestor
24924961|NCT04154852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24924962|NCT04154852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924964|NCT04154852|Antimetabolites|antimetabolites|mesh-ancestor
24924971|NCT04154852|Immunologic Factors|immunologic factors|mesh-ancestor
24924972|NCT04154852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24924973|NCT04154852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24924974|NCT04154852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24924975|NCT04154852|Hematinics|hematinics|mesh-ancestor
24924976|NCT04154852|Vitamin B Complex|vitamin b complex|mesh-ancestor
24582000|NCT00866996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582001|NCT00866996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24759026|NCT01749085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24582028|NCT00867152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24582029|NCT00867152|Antiviral Agents|antiviral agents|mesh-ancestor
24582030|NCT00867152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24582031|NCT00867152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24582037|NCT00867295|Cefazolin|cefazolin|mesh-list
25110076|NCT03120494|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25110077|NCT03120494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25110078|NCT03120494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25110080|NCT03120494|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24582089|NCT00868010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24582090|NCT00868010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582091|NCT00868010|Cholinergic Agents|cholinergic agents|mesh-ancestor
24582092|NCT00868010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24582093|NCT00868010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582094|NCT00868010|Nootropic Agents|nootropic agents|mesh-ancestor
24582095|NCT00868023|Formoterol Fumarate|formoterol fumarate|mesh-list
24582096|NCT00868023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24582097|NCT00868023|Autonomic Agents|autonomic agents|mesh-ancestor
24582098|NCT00868023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24582099|NCT00868023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253263|NCT02502500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25253264|NCT02502500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25253265|NCT02502500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25253266|NCT02502500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274734|NCT02375880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25274735|NCT02375880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25274736|NCT02375880|Antimetabolites|antimetabolites|mesh-ancestor
25274737|NCT02375880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274738|NCT02375880|Antiviral Agents|antiviral agents|mesh-ancestor
25274739|NCT02375880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25274740|NCT02375880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274741|NCT02375880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25274742|NCT02375880|Immunologic Factors|immunologic factors|mesh-ancestor
25274743|NCT02375880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274744|NCT02375867|Methylprednisolone|methylprednisolone|mesh-list
25274745|NCT02375867|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25274746|NCT02375867|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25274747|NCT02375867|Prednisolone|prednisolone|mesh-list
25274748|NCT02375867|Prednisolone acetate|prednisolone acetate|mesh-list
25274749|NCT02375867|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25274750|NCT02375867|Prednisolone phosphate|prednisolone phosphate|mesh-list
25274751|NCT02375867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25274752|NCT02375867|Antiemetics|antiemetics|mesh-ancestor
25274753|NCT02375867|Autonomic Agents|autonomic agents|mesh-ancestor
24924977|NCT04154852|Vitamins|vitamins|mesh-ancestor
24523243|NCT02341911|Immunologic Factors|immunologic factors|mesh-ancestor
24523244|NCT02341911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523246|NCT02336750|Fosaprepitant|fosaprepitant|mesh-list
24523247|NCT02336750|Mirtazapine|mirtazapine|mesh-list
24523248|NCT02336750|Antiemetics|antiemetics|mesh-ancestor
24523249|NCT02336750|Autonomic Agents|autonomic agents|mesh-ancestor
24523250|NCT02336750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24523251|NCT02336750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523252|NCT02336750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24523253|NCT02336750|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25687047|NCT01928290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25687048|NCT01928290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24523254|NCT02336750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24523255|NCT02336750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687049|NCT01928290|Antidotes|antidotes|mesh-ancestor
25687050|NCT01928290|Protective Agents|protective agents|mesh-ancestor
24523256|NCT02336750|Antidepressive Agents|antidepressive agents|mesh-ancestor
24523257|NCT02336750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24523258|NCT02336750|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24523259|NCT02336750|Histamine Antagonists|histamine antagonists|mesh-ancestor
24523261|NCT02336750|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24523262|NCT02336750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24924989|NCT04154813|Serotonin Agents|serotonin agents|mesh-ancestor
24924990|NCT04154813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24924991|NCT04154813|Antidepressive Agents|antidepressive agents|mesh-ancestor
24924992|NCT04154813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24924993|NCT04154813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24924994|NCT04154813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24925016|NCT04155008|Mirtazapine|mirtazapine|mesh-list
24925017|NCT04155008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24925018|NCT04155008|Antiemetics|antiemetics|mesh-ancestor
24925019|NCT04155008|Autonomic Agents|autonomic agents|mesh-ancestor
25253267|NCT02502110|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25253268|NCT02502110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25253269|NCT02502110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25253270|NCT02502110|Antimetabolites|antimetabolites|mesh-ancestor
25253271|NCT02502110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253272|NCT02502110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25253273|NCT02502110|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25253274|NCT02502110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25253275|NCT02502344|Metformin|metformin|mesh-list
25253276|NCT02502344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25253277|NCT02502344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253278|NCT02502175|Methadone|methadone|mesh-list
25253279|NCT02502175|Opium|opium|mesh-list
25253280|NCT02502175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25253281|NCT02502175|Narcotics|narcotics|mesh-ancestor
25253282|NCT02502175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25253283|NCT02502175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253284|NCT02502175|Analgesics|analgesics|mesh-ancestor
25253285|NCT02502175|Sensory System Agents|sensory system agents|mesh-ancestor
25253286|NCT02502175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25253287|NCT02502175|Antitussive Agents|antitussive agents|mesh-ancestor
25253288|NCT02502175|Respiratory System Agents|respiratory system agents|mesh-ancestor
25253289|NCT02502175|Antidiarrheals|antidiarrheals|mesh-ancestor
25253290|NCT02502175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25253291|NCT02502032|Cisatracurium|cisatracurium|mesh-list
25253292|NCT02502032|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25253293|NCT02502032|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25253294|NCT02502032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25253295|NCT02502032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253296|NCT02502708|Cyclophosphamide|cyclophosphamide|mesh-list
25253297|NCT02502708|Temozolomide|temozolomide|mesh-list
25253298|NCT02502708|Etoposide|etoposide|mesh-list
25253299|NCT02502708|Tryptophan|tryptophan|mesh-list
25253300|NCT02502708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25253301|NCT02502708|Immunologic Factors|immunologic factors|mesh-ancestor
25253302|NCT02502708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253303|NCT02502708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25253304|NCT02502708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25253305|NCT02502708|Alkylating Agents|alkylating agents|mesh-ancestor
25253306|NCT02502708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253307|NCT02502708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25253308|NCT02502708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25253309|NCT02502708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25253310|NCT02502708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25253318|NCT02501941|Sensory System Agents|sensory system agents|mesh-ancestor
24925040|NCT04155008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24925041|NCT04155008|Adrenergic Agents|adrenergic agents|mesh-ancestor
24631489|NCT01118559|Darexaban|darexaban|mesh-list
24925042|NCT04155008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24925043|NCT04155008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24925044|NCT04155008|Serotonin Agents|serotonin agents|mesh-ancestor
24925045|NCT04155008|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24925046|NCT04155008|Hallucinogens|hallucinogens|mesh-ancestor
24925047|NCT04155008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24925048|NCT04155008|Analgesics|analgesics|mesh-ancestor
24925049|NCT04155008|Sensory System Agents|sensory system agents|mesh-ancestor
24925050|NCT04155008|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25404148|NCT03682068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925051|NCT04155008|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24925052|NCT04154735|Rifaximin|rifaximin|mesh-list
24925053|NCT04154735|Cyclophosphamide|cyclophosphamide|mesh-list
24925054|NCT04154735|Fludarabine|fludarabine|mesh-list
24397774|NCT00142545|Emetics|emetics|mesh-ancestor
24925059|NCT04154735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925072|NCT04154722|Azithromycin|azithromycin|mesh-list
25253319|NCT02501941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25253320|NCT02501941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253321|NCT02501941|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25253322|NCT02501941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25253323|NCT02501941|Anesthetics, General|anesthetics, general|mesh-ancestor
25253324|NCT02501941|Anesthetics|anesthetics|mesh-ancestor
25253325|NCT02501941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25253326|NCT02501941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25253327|NCT02501941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25253328|NCT02501941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25253329|NCT02501941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253330|NCT02501837|Oxytocin|oxytocin|mesh-list
25253331|NCT02501837|Oxytocics|oxytocics|mesh-ancestor
25253332|NCT02501837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25253333|NCT02501837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253334|NCT02501863|Fentanyl|fentanyl|mesh-list
25253335|NCT02501863|Ropivacaine|ropivacaine|mesh-list
25253336|NCT02501863|Anesthetics, Local|anesthetics, local|mesh-ancestor
25253337|NCT02501863|Anesthetics|anesthetics|mesh-ancestor
25253338|NCT02501863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25253339|NCT02501863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253340|NCT02501863|Sensory System Agents|sensory system agents|mesh-ancestor
25253341|NCT02501863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25253342|NCT02501863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25253343|NCT02501863|Narcotics|narcotics|mesh-ancestor
25253344|NCT02501863|Analgesics|analgesics|mesh-ancestor
25253345|NCT02501863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25253346|NCT02501863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25253347|NCT02501863|Anesthetics, General|anesthetics, general|mesh-ancestor
25253348|NCT02501798|Methylphenidate|methylphenidate|mesh-list
25253349|NCT02501798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25253350|NCT02501798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253351|NCT02501798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25253352|NCT02501798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25253353|NCT02501798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25253354|NCT02501798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253355|NCT02501798|Dopamine Agents|dopamine agents|mesh-ancestor
24500772|NCT00525681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24500773|NCT00525681|Immunologic Factors|immunologic factors|mesh-ancestor
24500774|NCT00525681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500775|NCT00525681|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24500776|NCT00525681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24500777|NCT00525681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500778|NCT00525681|Antifungal Agents|antifungal agents|mesh-ancestor
24500779|NCT00525681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24500780|NCT00525681|Dermatologic Agents|dermatologic agents|mesh-ancestor
24500793|NCT00525694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500794|NCT00525694|Dopamine Agents|dopamine agents|mesh-ancestor
24500800|NCT00525759|Docetaxel|docetaxel|mesh-list
24523344|NCT01754857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24523345|NCT01754857|Growth Substances|growth substances|mesh-ancestor
24523346|NCT01754857|Growth Inhibitors|growth inhibitors|mesh-ancestor
24925111|NCT04153734|Paclitaxel|paclitaxel|mesh-list
24925112|NCT04153734|Carboplatin|carboplatin|mesh-list
24925113|NCT04153734|Pembrolizumab|pembrolizumab|mesh-list
24925114|NCT04153734|Pemetrexed|pemetrexed|mesh-list
24925115|NCT04153734|Cisplatin|cisplatin|mesh-list
24925116|NCT04153734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24925117|NCT04153734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24925118|NCT04153734|Tubulin Modulators|tubulin modulators|mesh-ancestor
24925119|NCT04153734|Antimitotic Agents|antimitotic agents|mesh-ancestor
24925120|NCT04153734|Mitosis Modulators|mitosis modulators|mesh-ancestor
24397946|NCT00143130|Sensory System Agents|sensory system agents|mesh-ancestor
24925123|NCT04153734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925124|NCT04153734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24925125|NCT04153734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24925126|NCT04153201|Hydroxychloroquine|hydroxychloroquine|mesh-list
24925127|NCT04153201|Antimalarials|antimalarials|mesh-list
25253356|NCT02501798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25253357|NCT02501850|Metformin|metformin|mesh-list
25253358|NCT02501850|Liraglutide|liraglutide|mesh-list
25253359|NCT02501850|Exenatide|exenatide|mesh-list
25253360|NCT02501850|Lixisenatide|lixisenatide|mesh-list
25253361|NCT02501850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25253362|NCT02501850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253363|NCT02501850|Incretins|incretins|mesh-ancestor
25253365|NCT02501850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25253366|NCT02501850|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25253368|NCT02501564|Codeine|codeine|mesh-list
25253369|NCT02501564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25253370|NCT02501564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25253371|NCT02501564|Analgesics|analgesics|mesh-ancestor
25253372|NCT02501564|Sensory System Agents|sensory system agents|mesh-ancestor
25253373|NCT02501564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25253374|NCT02501564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253375|NCT02501564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25253376|NCT02501564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25253377|NCT02501564|Gout Suppressants|gout suppressants|mesh-ancestor
25253378|NCT02501564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25253379|NCT02501564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25253380|NCT02501564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253381|NCT02501564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25253382|NCT02501564|Narcotics|narcotics|mesh-ancestor
25253383|NCT02501564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25253384|NCT02501564|Antitussive Agents|antitussive agents|mesh-ancestor
25253385|NCT02501564|Respiratory System Agents|respiratory system agents|mesh-ancestor
25253386|NCT02501616|Metformin|metformin|mesh-list
25253387|NCT02501616|Dapagliflozin|dapagliflozin|mesh-list
25253388|NCT02501616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25253389|NCT02501616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253390|NCT02501616|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25253391|NCT02501616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253392|NCT02501603|Paclitaxel|paclitaxel|mesh-list
25253393|NCT02501603|Afatinib|afatinib|mesh-list
25253394|NCT02501603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25253395|NCT02501603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25253396|NCT02501603|Tubulin Modulators|tubulin modulators|mesh-ancestor
25253397|NCT02501603|Antimitotic Agents|antimitotic agents|mesh-ancestor
25253398|NCT02501603|Mitosis Modulators|mitosis modulators|mesh-ancestor
25253399|NCT02501603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253400|NCT02501603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24523404|NCT01293682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24523406|NCT01253161|Hormones|hormones|mesh-ancestor
24523407|NCT01253161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24523408|NCT01253161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523409|NCT00887536|Cyclophosphamide|cyclophosphamide|mesh-list
24523444|NCT00867321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24523445|NCT00867321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523447|NCT00467142|Bevacizumab|bevacizumab|mesh-list
24523448|NCT00467142|Fluorouracil|fluorouracil|mesh-list
24523449|NCT00467142|Irinotecan|irinotecan|mesh-list
24925142|NCT04153383|Protective Agents|protective agents|mesh-ancestor
24925143|NCT04153383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925144|NCT04153253|Aflibercept|aflibercept|mesh-list
24925145|NCT04153253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24925146|NCT04153253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24925147|NCT04153253|Growth Substances|growth substances|mesh-ancestor
24925148|NCT04153253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925149|NCT04153253|Growth Inhibitors|growth inhibitors|mesh-ancestor
24925150|NCT04153253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24925151|NCT04153123|Epinephrine|epinephrine|mesh-list
24925152|NCT04153123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24925153|NCT04153123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24925154|NCT04153123|Adrenergic Agents|adrenergic agents|mesh-ancestor
24925155|NCT04153123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24925156|NCT04153123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925157|NCT04153123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925158|NCT04153123|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24925159|NCT04153123|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24925160|NCT04153123|Autonomic Agents|autonomic agents|mesh-ancestor
24925203|NCT04152889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24925204|NCT04152889|Tubulin Modulators|tubulin modulators|mesh-ancestor
24925205|NCT04152889|Antimitotic Agents|antimitotic agents|mesh-ancestor
24925206|NCT04152889|Mitosis Modulators|mitosis modulators|mesh-ancestor
24582100|NCT00868023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24729831|NCT01624103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582101|NCT00868023|Respiratory System Agents|respiratory system agents|mesh-ancestor
25253401|NCT02501603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25253402|NCT02501213|Furosemide|furosemide|mesh-list
25253403|NCT02501213|Spironolactone|spironolactone|mesh-list
25253404|NCT02501213|Diuretics|diuretics|mesh-ancestor
25253405|NCT02501213|Natriuretic Agents|natriuretic agents|mesh-ancestor
25253406|NCT02501213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253407|NCT02501213|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25253408|NCT02501213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25253409|NCT02501213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253410|NCT02501213|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25253411|NCT02501213|Hormone Antagonists|hormone antagonists|mesh-ancestor
25253412|NCT02501213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25253413|NCT02501213|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25253414|NCT02501200|Ezetimibe|ezetimibe|mesh-list
25253415|NCT02501200|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25253416|NCT02501200|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25253417|NCT02501200|Antimetabolites|antimetabolites|mesh-ancestor
25253418|NCT02501200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253419|NCT02501200|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25253420|NCT02501291|Thalidomide|thalidomide|mesh-list
25253421|NCT02501291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25253422|NCT02501291|Immunologic Factors|immunologic factors|mesh-ancestor
25253423|NCT02501291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253424|NCT02501291|Leprostatic Agents|leprostatic agents|mesh-ancestor
25253425|NCT02501291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25253426|NCT02501291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25253427|NCT02501291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25087557|NCT03278782|Romidepsin|romidepsin|mesh-list
25253428|NCT02501291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25253429|NCT02501291|Growth Substances|growth substances|mesh-ancestor
25253430|NCT02501291|Growth Inhibitors|growth inhibitors|mesh-ancestor
25253431|NCT02501291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25253432|NCT02501278|Cisplatin|cisplatin|mesh-list
25253433|NCT02501278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25253434|NCT02501109|Aripiprazole|aripiprazole|mesh-list
25253435|NCT02501109|Antidepressive Agents|antidepressive agents|mesh-ancestor
25253436|NCT02501109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24925207|NCT04152889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925266|NCT04151849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523564|NCT05341843|Antidepressive Agents|antidepressive agents|mesh-ancestor
24523565|NCT05341843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24523566|NCT05341843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24523567|NCT05341843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24523568|NCT05341843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24398264|NCT00144040|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24925292|NCT04151472|Idebenone|idebenone|mesh-list
24925293|NCT04151472|Antioxidants|antioxidants|mesh-ancestor
24925294|NCT04151472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925295|NCT04151472|Protective Agents|protective agents|mesh-ancestor
24925297|NCT04151472|Micronutrients|micronutrients|mesh-ancestor
25253437|NCT02501109|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25253438|NCT02501109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25253439|NCT02501109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25253440|NCT02501109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253441|NCT02501109|Dopamine Agonists|dopamine agonists|mesh-ancestor
25253442|NCT02501109|Dopamine Agents|dopamine agents|mesh-ancestor
25253443|NCT02501109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25253444|NCT02501109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253445|NCT02501109|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25253446|NCT02501109|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25253447|NCT02501109|Serotonin Agents|serotonin agents|mesh-ancestor
25253448|NCT02501109|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25253449|NCT02501109|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25253450|NCT02501109|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25253451|NCT02501109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25253452|NCT02500927|Naquotinib|naquotinib|mesh-list
25253453|NCT02500927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25253454|NCT02500927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25253455|NCT02500927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25253456|NCT02500927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687051|NCT01928290|Vitamin B Complex|vitamin b complex|mesh-ancestor
25253458|NCT02500784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25253459|NCT02500784|Autonomic Agents|autonomic agents|mesh-ancestor
25253460|NCT02500784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25253461|NCT02500784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253462|NCT02500784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25253463|NCT02500784|Respiratory System Agents|respiratory system agents|mesh-ancestor
25253464|NCT02500784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25253465|NCT02500784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25253466|NCT02500784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25253467|NCT02500784|Adrenergic Agents|adrenergic agents|mesh-ancestor
25253468|NCT02500784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25253469|NCT02500784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253470|NCT02500940|Leucovorin|leucovorin|mesh-list
25253471|NCT02500940|Fluorouracil|fluorouracil|mesh-list
25253472|NCT02500940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25253473|NCT02500940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925300|NCT04151719|Anticonvulsants|anticonvulsants|mesh-ancestor
24925345|NCT04150965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925346|NCT04150965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24925347|NCT04150965|Glucocorticoids|glucocorticoids|mesh-ancestor
25253474|NCT02500940|Antimetabolites|antimetabolites|mesh-ancestor
25253475|NCT02500940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925360|NCT04150965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24925361|NCT04150965|Leprostatic Agents|leprostatic agents|mesh-ancestor
24925362|NCT04150965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24925363|NCT04150965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24582103|NCT00868023|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24582202|NCT00868569|Antidotes|antidotes|mesh-ancestor
24582203|NCT00868569|Protective Agents|protective agents|mesh-ancestor
24582204|NCT00868569|Vitamin B Complex|vitamin b complex|mesh-ancestor
24582205|NCT00868569|Vitamins|vitamins|mesh-ancestor
24582206|NCT00868569|Micronutrients|micronutrients|mesh-ancestor
24582207|NCT00868634|Bevacizumab|bevacizumab|mesh-list
24582208|NCT00868634|Capecitabine|capecitabine|mesh-list
24582210|NCT00868634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24582234|NCT00868764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24582235|NCT00868764|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24582237|NCT00868764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24582238|NCT00868764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582239|NCT00868816|Oxaliplatin|oxaliplatin|mesh-list
24582240|NCT00868816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010221|NCT04477265|Solifenacin Succinate|solifenacin succinate|mesh-list
24582282|NCT00869063|Analgesics|analgesics|mesh-ancestor
24582283|NCT00869063|Sensory System Agents|sensory system agents|mesh-ancestor
24582284|NCT00869063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24582285|NCT00869063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582286|NCT00869063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24582287|NCT00869063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24582288|NCT00869063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24582289|NCT00869063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24582290|NCT00869063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582291|NCT00869180|Diclofenac|diclofenac|mesh-list
24582292|NCT00869180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24582293|NCT00869180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24582294|NCT00869180|Analgesics|analgesics|mesh-ancestor
24582295|NCT00869180|Sensory System Agents|sensory system agents|mesh-ancestor
24582296|NCT00869180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24582298|NCT00869180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24894188|NCT04443387|Vitamin D|vitamin d|mesh-list
24582359|NCT00869271|Oxaliplatin|oxaliplatin|mesh-list
25253476|NCT02500940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25253477|NCT02500940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25253478|NCT02500940|Immunologic Factors|immunologic factors|mesh-ancestor
25253479|NCT02500940|Antidotes|antidotes|mesh-ancestor
25253480|NCT02500940|Protective Agents|protective agents|mesh-ancestor
25253481|NCT02500940|Vitamin B Complex|vitamin b complex|mesh-ancestor
25253482|NCT02500940|Vitamins|vitamins|mesh-ancestor
25253483|NCT02500940|Micronutrients|micronutrients|mesh-ancestor
25253484|NCT02500667|Rifampin|rifampin|mesh-list
25253485|NCT02500667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25253486|NCT02500667|Antitubercular Agents|antitubercular agents|mesh-ancestor
25253487|NCT02500667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25253488|NCT02500667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25253489|NCT02500667|Leprostatic Agents|leprostatic agents|mesh-ancestor
25253490|NCT02500667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25253491|NCT02500667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939650|NCT04008186|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25253492|NCT02500667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253493|NCT02500667|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25274757|NCT02375867|Glucocorticoids|glucocorticoids|mesh-ancestor
25274758|NCT02375867|Hormones|hormones|mesh-ancestor
25274759|NCT02375867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25274760|NCT02375867|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24925367|NCT04150575|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24925368|NCT04150575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24925369|NCT04150575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24925370|NCT04150575|Tubulin Modulators|tubulin modulators|mesh-ancestor
24925371|NCT04150575|Antimitotic Agents|antimitotic agents|mesh-ancestor
24925372|NCT04150575|Mitosis Modulators|mitosis modulators|mesh-ancestor
24925373|NCT04150575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523691|NCT05341076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274761|NCT02375867|Protective Agents|protective agents|mesh-ancestor
25274762|NCT02375867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25274763|NCT02375867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25274764|NCT02375646|Heparin|heparin|mesh-list
25274765|NCT02375646|Enoxaparin|enoxaparin|mesh-list
25274766|NCT02375646|Warfarin|warfarin|mesh-list
25274767|NCT02375646|Anticoagulants|anticoagulants|mesh-ancestor
25274768|NCT02375646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25274769|NCT02375646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25274770|NCT02375646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274771|NCT02375464|Octreotide|octreotide|mesh-list
25274772|NCT02375464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25274773|NCT02375464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25274774|NCT02375464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25274775|NCT02375503|Vitamin D|vitamin d|mesh-list
25274776|NCT02375503|Calcium|calcium|mesh-list
25274777|NCT02375503|Vitamins|vitamins|mesh-ancestor
24523693|NCT05340985|Ergocalciferols|ergocalciferols|mesh-list
24523695|NCT05340985|Calcifediol|calcifediol|mesh-list
25274778|NCT02375503|Micronutrients|micronutrients|mesh-ancestor
25274779|NCT02375503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274780|NCT02375503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25274781|NCT02375503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25274782|NCT02375243|Dexmedetomidine|dexmedetomidine|mesh-list
25274783|NCT02375243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25274784|NCT02375243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25274785|NCT02375243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274786|NCT02375243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25274787|NCT02375243|Analgesics|analgesics|mesh-ancestor
25274788|NCT02375243|Sensory System Agents|sensory system agents|mesh-ancestor
24925385|NCT04150536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925386|NCT04150731|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24925387|NCT04150731|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24925388|NCT04150731|Estradiol|estradiol|mesh-list
24925389|NCT04150731|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24925390|NCT04150731|Estrogens|estrogens|mesh-ancestor
24925391|NCT04150731|Hormones|hormones|mesh-ancestor
24925392|NCT04150731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24523715|NCT05340803|Sensory System Agents|sensory system agents|mesh-ancestor
24523716|NCT05340803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24925394|NCT04150731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24925395|NCT04150731|Contraceptive Agents|contraceptive agents|mesh-ancestor
24925396|NCT04150731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24925397|NCT04150731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24925398|NCT04150757|Ketamine|ketamine|mesh-list
24925399|NCT04150757|Analgesics|analgesics|mesh-ancestor
25087982|NCT03274895|Disinfectants|disinfectants|mesh-ancestor
24925400|NCT04150757|Sensory System Agents|sensory system agents|mesh-ancestor
24925401|NCT04150757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24925402|NCT04150757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687052|NCT01928290|Vitamins|vitamins|mesh-ancestor
25687053|NCT01928290|Micronutrients|micronutrients|mesh-ancestor
25687054|NCT01928329|Exenatide|exenatide|mesh-list
25687055|NCT01928329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25687056|NCT01928329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687057|NCT01928329|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25687058|NCT01928329|Incretins|incretins|mesh-ancestor
25687059|NCT01928329|Hormones|hormones|mesh-ancestor
24855490|NCT02279875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24925403|NCT04150757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24925404|NCT04150757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24925406|NCT04150757|Anesthetics|anesthetics|mesh-ancestor
25253502|NCT02500446|Dolutegravir|dolutegravir|mesh-list
25253503|NCT02500446|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25253504|NCT02500446|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25253505|NCT02500446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25253506|NCT02500446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253507|NCT02500446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25253508|NCT02500446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25253509|NCT02500446|Antiviral Agents|antiviral agents|mesh-ancestor
25253510|NCT02500446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25253512|NCT02500524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25253513|NCT02500524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253514|NCT02500563|Caseins|caseins|mesh-list
25253515|NCT02500563|Chelating Agents|chelating agents|mesh-ancestor
25253516|NCT02500563|Sequestering Agents|sequestering agents|mesh-ancestor
25253517|NCT02500563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253518|NCT02500511|Vaccines|vaccines|mesh-list
25253519|NCT02500511|Immunologic Factors|immunologic factors|mesh-ancestor
25253520|NCT02500511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253521|NCT02500498|Abatacept|abatacept|mesh-list
25253522|NCT02500498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25253523|NCT02500498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253524|NCT02500498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25253525|NCT02500498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25253526|NCT02500498|Immunologic Factors|immunologic factors|mesh-ancestor
25253527|NCT02500498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253528|NCT02500498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25253529|NCT02500459|Topotecan|topotecan|mesh-list
25253530|NCT02500459|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25253531|NCT02500459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25253532|NCT02500459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25253533|NCT02500459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253534|NCT02500459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25253535|NCT02500329|Acarbose|acarbose|mesh-list
25253536|NCT02500329|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25253537|NCT02500329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25253538|NCT02500329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253539|NCT02500329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25253540|NCT02500329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253541|NCT02500225|Sevoflurane|sevoflurane|mesh-list
24925411|NCT04150757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925413|NCT04150289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24925414|NCT04150289|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24925434|NCT04150367|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24925435|NCT04150367|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24925436|NCT04150367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24925437|NCT04150367|Antimetabolites|antimetabolites|mesh-ancestor
24925438|NCT04150367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24925440|NCT04150172|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24925441|NCT04150172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24925442|NCT04150172|Antioxidants|antioxidants|mesh-ancestor
24925443|NCT04150172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925444|NCT04150172|Protective Agents|protective agents|mesh-ancestor
24925445|NCT04150172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925446|NCT04150172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925447|NCT04149938|Lidocaine|lidocaine|mesh-list
24925448|NCT04149938|Anesthetics, Local|anesthetics, local|mesh-ancestor
24925449|NCT04149938|Anesthetics|anesthetics|mesh-ancestor
24925450|NCT04149938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24925451|NCT04149938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925452|NCT04149938|Sensory System Agents|sensory system agents|mesh-ancestor
24925453|NCT04149938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24925454|NCT04149938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24523724|NCT05340803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24523725|NCT05340803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24925460|NCT04150146|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24925461|NCT04150146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24925462|NCT04150146|Antioxidants|antioxidants|mesh-ancestor
24925463|NCT04150146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624329|NCT01075776|Cholinergic Agents|cholinergic agents|mesh-ancestor
25692603|NCT02002832|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24624330|NCT01075776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24624331|NCT01075776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582360|NCT00869271|Antimetabolites|antimetabolites|mesh-ancestor
24582361|NCT00869271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582362|NCT00869271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24582363|NCT00869271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582364|NCT00869271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25253542|NCT02500225|Etomidate|etomidate|mesh-list
25253543|NCT02500225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25253544|NCT02500225|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25253545|NCT02500225|Anesthetics, General|anesthetics, general|mesh-ancestor
25253546|NCT02500225|Anesthetics|anesthetics|mesh-ancestor
25253547|NCT02500225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25253548|NCT02500225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253549|NCT02500225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25253550|NCT02500225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25253551|NCT02500212|Tacrolimus|tacrolimus|mesh-list
25253552|NCT02500212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25253553|NCT02500212|Immunologic Factors|immunologic factors|mesh-ancestor
25253554|NCT02500212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253555|NCT02500212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25253556|NCT02500212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25253557|NCT02500212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253558|NCT02500017|Melatonin|melatonin|mesh-list
25253559|NCT02500017|Antioxidants|antioxidants|mesh-ancestor
25253560|NCT02500017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253561|NCT02500017|Protective Agents|protective agents|mesh-ancestor
25253562|NCT02500017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253563|NCT02500017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25253564|NCT02500108|Domperidone|domperidone|mesh-list
25253565|NCT02500108|Antiemetics|antiemetics|mesh-ancestor
25253566|NCT02500108|Autonomic Agents|autonomic agents|mesh-ancestor
25253567|NCT02500108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25253568|NCT02500108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253569|NCT02500108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25253570|NCT02500108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25253571|NCT02500108|Dopamine Agents|dopamine agents|mesh-ancestor
25253572|NCT02500108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25253573|NCT02500108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253574|NCT02500238|Carbon Monoxide|carbon monoxide|mesh-list
25253575|NCT02500238|Antimetabolites|antimetabolites|mesh-ancestor
24624332|NCT01075776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624333|NCT01075776|Natriuretic Agents|natriuretic agents|mesh-ancestor
24624334|NCT01075789|Lidocaine|lidocaine|mesh-list
24624335|NCT01075789|Anesthetics, Local|anesthetics, local|mesh-ancestor
24624336|NCT01075789|Anesthetics|anesthetics|mesh-ancestor
24624337|NCT01075789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24624338|NCT01075789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624339|NCT01075789|Sensory System Agents|sensory system agents|mesh-ancestor
24624340|NCT01075789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24624341|NCT01075789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24624342|NCT01075789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24624343|NCT01075789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24925464|NCT04150146|Protective Agents|protective agents|mesh-ancestor
24925465|NCT04150146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925466|NCT04150146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925467|NCT04150107|Insulin|insulin|mesh-list
24925468|NCT04150107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24925469|NCT04150107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24925470|NCT04150107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582365|NCT00869271|Immunologic Factors|immunologic factors|mesh-ancestor
24582372|NCT00869310|Dexamethasone|dexamethasone|mesh-list
24632874|NCT01125982|Anesthetics, General|anesthetics, general|mesh-ancestor
24582373|NCT00869310|Dexamethasone acetate|dexamethasone acetate|mesh-list
24582375|NCT00869310|Metoclopramide|metoclopramide|mesh-list
24582377|NCT00869310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24582378|NCT00869310|Antiemetics|antiemetics|mesh-ancestor
24582379|NCT00869310|Autonomic Agents|autonomic agents|mesh-ancestor
24582383|NCT00869310|Glucocorticoids|glucocorticoids|mesh-ancestor
25010227|NCT04477265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010228|NCT04477265|Urological Agents|urological agents|mesh-ancestor
25010229|NCT04464070|Aspirin|aspirin|mesh-list
25010230|NCT04464070|Niacin|niacin|mesh-list
25010231|NCT04464070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25010232|NCT04464070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25010233|NCT04464070|Analgesics|analgesics|mesh-ancestor
24616827|NCT01039363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24582385|NCT00869310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24582386|NCT00869310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24582387|NCT00869310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582388|NCT00869310|Protease Inhibitors|protease inhibitors|mesh-ancestor
24582389|NCT00869310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24582390|NCT00869310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582391|NCT00869310|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24582392|NCT00869310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24582393|NCT00869310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24582394|NCT00869310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24582395|NCT00869310|Dopamine Agents|dopamine agents|mesh-ancestor
24582396|NCT00869427|Ascorbic Acid|ascorbic acid|mesh-list
24582398|NCT00869427|Micronutrients|micronutrients|mesh-ancestor
24582399|NCT00869427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582400|NCT00869427|Antioxidants|antioxidants|mesh-ancestor
24582401|NCT00869427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582402|NCT00869427|Protective Agents|protective agents|mesh-ancestor
24582403|NCT00869492|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24582404|NCT00869492|Dermatologic Agents|dermatologic agents|mesh-ancestor
24582405|NCT00869570|Capecitabine|capecitabine|mesh-list
25253576|NCT02500238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253577|NCT02500238|Gasotransmitters|gasotransmitters|mesh-ancestor
25253578|NCT02500238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25253579|NCT02500238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253583|NCT02500251|Rituximab|rituximab|mesh-list
25253584|NCT02500251|Bortezomib|bortezomib|mesh-list
25253585|NCT02500251|Belimumab|belimumab|mesh-list
25253586|NCT02500251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25253587|NCT02500251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25253588|NCT02500251|Immunologic Factors|immunologic factors|mesh-ancestor
25253589|NCT02500251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253590|NCT02500251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25253591|NCT02500251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25253592|NCT02500069|Caseins|caseins|mesh-list
25253593|NCT02500069|Chelating Agents|chelating agents|mesh-ancestor
25253594|NCT02500069|Sequestering Agents|sequestering agents|mesh-ancestor
25274789|NCT02375243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24925471|NCT04149483|Atorvastatin|atorvastatin|mesh-list
24925472|NCT04149483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24501174|NCT00527137|Darbepoetin alfa|darbepoetin alfa|mesh-list
24523726|NCT05340803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24523727|NCT05340803|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24523728|NCT05340803|Anesthetics, General|anesthetics, general|mesh-ancestor
24523751|NCT05340725|Sensory System Agents|sensory system agents|mesh-ancestor
24523752|NCT05340725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24523753|NCT05340725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24523754|NCT05340725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24523755|NCT05340725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24523756|NCT05340725|Adrenergic Agents|adrenergic agents|mesh-ancestor
24523757|NCT05340725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24523758|NCT05340725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523759|NCT05340634|Contraceptive Agents|contraceptive agents|mesh-list
24523760|NCT05340634|Contraceptives, Oral|contraceptives, oral|mesh-list
24925473|NCT04149483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24925474|NCT04149483|Antimetabolites|antimetabolites|mesh-ancestor
24925475|NCT04149483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925476|NCT04149483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24925477|NCT04149483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24925478|NCT04149483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925479|NCT04149678|Cyclosporine|cyclosporine|mesh-list
24925480|NCT04149678|Cyclosporins|cyclosporins|mesh-list
24925482|NCT04149678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925483|NCT04149678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582406|NCT00869570|Sorafenib|sorafenib|mesh-list
24582408|NCT00869570|Antimetabolites|antimetabolites|mesh-ancestor
24582425|NCT00869596|Tocolytic Agents|tocolytic agents|mesh-ancestor
24582426|NCT00869596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25687060|NCT01928329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25687061|NCT01928381|Pregabalin|pregabalin|mesh-list
25687062|NCT01928381|Analgesics|analgesics|mesh-ancestor
24582427|NCT00869596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24582428|NCT00869596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24582429|NCT00869596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24582430|NCT00869596|Adrenergic Agents|adrenergic agents|mesh-ancestor
24582507|NCT00870142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582508|NCT00870142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24582509|NCT00870142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582510|NCT00870142|Vasodilator Agents|vasodilator agents|mesh-ancestor
24582511|NCT00870220|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24582512|NCT00870220|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25253595|NCT02500069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253596|NCT02500004|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25253597|NCT02500004|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25253598|NCT02500004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253599|NCT02499874|Tenofovir|tenofovir|mesh-list
25253600|NCT02499874|Lamivudine|lamivudine|mesh-list
25253601|NCT02499874|Zidovudine|zidovudine|mesh-list
25253602|NCT02499874|Emtricitabine|emtricitabine|mesh-list
25253603|NCT02499874|Efavirenz|efavirenz|mesh-list
25253604|NCT02499874|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25253605|NCT02499874|Antiviral Agents|antiviral agents|mesh-ancestor
25253606|NCT02499874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25253607|NCT02499874|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25253608|NCT02499874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25253609|NCT02499874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25253610|NCT02499874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253611|NCT02499874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25253612|NCT02499874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25253613|NCT02499874|Antimetabolites|antimetabolites|mesh-ancestor
25253614|NCT02499874|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25253615|NCT02499874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25253616|NCT02499874|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25253617|NCT02499874|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25253618|NCT02499874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25253619|NCT02499874|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25253620|NCT02499835|Pembrolizumab|pembrolizumab|mesh-list
25253621|NCT02499835|Immunoglobulins|immunoglobulins|mesh-list
25253622|NCT02499835|Immunoglobulin G|immunoglobulin g|mesh-list
25253623|NCT02499835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24925484|NCT04149678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24925485|NCT04149678|Immunologic Factors|immunologic factors|mesh-ancestor
24501204|NCT00527267|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24523761|NCT05340634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24523762|NCT05340634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523763|NCT05340634|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24523765|NCT05340530|Avibactam|avibactam|mesh-list
24523766|NCT05340530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24523767|NCT05340530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24523768|NCT05340530|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24925503|NCT04149626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24925504|NCT04149626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24925505|NCT04149626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24925506|NCT04149626|Adrenergic Agents|adrenergic agents|mesh-ancestor
24925507|NCT04149626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24925515|NCT04149626|Anesthetics|anesthetics|mesh-ancestor
24925516|NCT04149626|GABA Modulators|gaba modulators|mesh-ancestor
24925517|NCT04149626|GABA Agents|gaba agents|mesh-ancestor
24925518|NCT04149626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24925519|NCT04149626|Narcotics|narcotics|mesh-ancestor
24582514|NCT00870220|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24582515|NCT00870220|Estrogens|estrogens|mesh-ancestor
24582516|NCT00870220|Hormones|hormones|mesh-ancestor
24582517|NCT00870220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24582533|NCT00870298|Warfarin|warfarin|mesh-list
24582598|NCT00870571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24582599|NCT00870571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582600|NCT00870571|Vasodilator Agents|vasodilator agents|mesh-ancestor
24582602|NCT00870636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25253624|NCT02499835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25253625|NCT02499835|Immunologic Factors|immunologic factors|mesh-ancestor
25253626|NCT02499835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253627|NCT02499978|Darunavir|darunavir|mesh-list
25253628|NCT02499978|Dolutegravir|dolutegravir|mesh-list
25253629|NCT02499978|Cobicistat|cobicistat|mesh-list
24730871|NCT01631058|Glucocorticoids|glucocorticoids|mesh-ancestor
24730872|NCT01631058|Hormones|hormones|mesh-ancestor
24730912|NCT01631357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730913|NCT01631357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25253630|NCT02499978|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
25253631|NCT02499978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25253632|NCT02499978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25253633|NCT02499978|Protease Inhibitors|protease inhibitors|mesh-ancestor
25253634|NCT02499978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25253635|NCT02499978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253636|NCT02499978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25253637|NCT02499978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25253638|NCT02499978|Antiviral Agents|antiviral agents|mesh-ancestor
25253639|NCT02499978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25253723|NCT02499237|Zoledronic Acid|zoledronic acid|mesh-list
25253640|NCT02499978|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25253641|NCT02499978|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25253642|NCT02499978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25253643|NCT02499978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25253644|NCT02499965|Anesthetics|anesthetics|mesh-list
25253645|NCT02499965|Ethyl Chloride|ethyl chloride|mesh-list
25088208|NCT05075460|Azacitidine|azacitidine|mesh-list
25088209|NCT05075460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25253646|NCT02499965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25253647|NCT02499965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253648|NCT02499965|Anesthetics, Local|anesthetics, local|mesh-ancestor
25253649|NCT02499965|Sensory System Agents|sensory system agents|mesh-ancestor
25253650|NCT02499965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25253651|NCT02499861|Decitabine|decitabine|mesh-list
25253652|NCT02499861|Genistein|genistein|mesh-list
25253653|NCT02499861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25253654|NCT02499861|Antimetabolites|antimetabolites|mesh-ancestor
25253655|NCT02499861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253656|NCT02499861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24925526|NCT04149444|Trifluridine|trifluridine|mesh-list
24925527|NCT04149444|Antimetabolites|antimetabolites|mesh-ancestor
24925528|NCT04149444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925529|NCT04149444|Antiviral Agents|antiviral agents|mesh-ancestor
24398789|NCT00145652|Hematinics|hematinics|mesh-ancestor
24925534|NCT04149275|Nivolumab|nivolumab|mesh-list
24925535|NCT04149275|Ipilimumab|ipilimumab|mesh-list
24925536|NCT04149275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24925537|NCT04149275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24925538|NCT04149275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24749573|NCT00579527|Cyclosporine|cyclosporine|mesh-list
24925539|NCT04149275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582603|NCT00870636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582605|NCT00870636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24582606|NCT00870636|Growth Substances|growth substances|mesh-ancestor
24582607|NCT00870636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582608|NCT00870636|Growth Inhibitors|growth inhibitors|mesh-ancestor
24582682|NCT00871065|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24582683|NCT00871065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24582684|NCT00871065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24582685|NCT00871065|Urological Agents|urological agents|mesh-ancestor
24582686|NCT00871104|Vancomycin|vancomycin|mesh-list
24582687|NCT00871104|Imipenem|imipenem|mesh-list
24582688|NCT00871104|Fosfomycin|fosfomycin|mesh-list
24582689|NCT00871104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24582690|NCT00871104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24582691|NCT00871156|Chloroquine|chloroquine|mesh-list
24582704|NCT00871156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24582705|NCT00871156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582706|NCT00871156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24582708|NCT00871156|Antinematodal Agents|antinematodal agents|mesh-ancestor
24582709|NCT00871156|Anthelmintics|anthelmintics|mesh-ancestor
24582710|NCT00871208|Retapamulin|retapamulin|mesh-list
24582711|NCT00871208|Hydrocortisone|hydrocortisone|mesh-list
24582712|NCT00871208|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24582713|NCT00871208|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25110121|NCT05465330|Propofol|propofol|mesh-list
25010243|NCT04464070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25010244|NCT04464070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687063|NCT01928381|Sensory System Agents|sensory system agents|mesh-ancestor
25687064|NCT01928381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25687065|NCT01928381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687066|NCT01928381|Anticonvulsants|anticonvulsants|mesh-ancestor
25010245|NCT04464070|Antipyretics|antipyretics|mesh-ancestor
25010246|NCT04464070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25010247|NCT04464070|Antimetabolites|antimetabolites|mesh-ancestor
25010248|NCT04464070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25010249|NCT04464070|Vasodilator Agents|vasodilator agents|mesh-ancestor
25010250|NCT04464070|Vitamin B Complex|vitamin b complex|mesh-ancestor
25010251|NCT04464070|Vitamins|vitamins|mesh-ancestor
25010252|NCT04464070|Micronutrients|micronutrients|mesh-ancestor
25010255|NCT04360980|Colchicine|colchicine|mesh-list
25010256|NCT04360980|Gout Suppressants|gout suppressants|mesh-ancestor
25010257|NCT04360980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25010258|NCT04360980|Tubulin Modulators|tubulin modulators|mesh-ancestor
25010259|NCT04360980|Antimitotic Agents|antimitotic agents|mesh-ancestor
25010260|NCT04360980|Mitosis Modulators|mitosis modulators|mesh-ancestor
25010261|NCT04360980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010262|NCT04360980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010263|NCT04331704|Tenofovir|tenofovir|mesh-list
25010264|NCT04331704|Emtricitabine|emtricitabine|mesh-list
25010265|NCT04331704|Antiviral Agents|antiviral agents|mesh-ancestor
25010266|NCT04331704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25253657|NCT02499861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25253658|NCT02499861|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25253659|NCT02499861|Protective Agents|protective agents|mesh-ancestor
25253660|NCT02499861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253661|NCT02499861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25253663|NCT02499861|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25253664|NCT02499861|Estrogens|estrogens|mesh-ancestor
25253665|NCT02499861|Hormones|hormones|mesh-ancestor
25253666|NCT02499861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25253667|NCT02499822|Ramipril|ramipril|mesh-list
25253668|NCT02499822|Nifedipine|nifedipine|mesh-list
25253669|NCT02499822|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25253670|NCT02499822|Protease Inhibitors|protease inhibitors|mesh-ancestor
24925541|NCT04148963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24925542|NCT04148963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24925543|NCT04148963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24925544|NCT04148963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925545|NCT04148963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24925546|NCT04148963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24925547|NCT04148963|Dopamine Agents|dopamine agents|mesh-ancestor
24925548|NCT04148963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24925549|NCT04148963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925550|NCT04149327|Amoxicillin|amoxicillin|mesh-list
24925551|NCT04149327|Metronidazole|metronidazole|mesh-list
24925552|NCT04149327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24925553|NCT04149327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24925554|NCT04149327|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24523793|NCT05340439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24523794|NCT05340413|Olaparib|olaparib|mesh-list
24523797|NCT05340413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523798|NCT05340413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24523891|NCT05338723|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24523892|NCT05338723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24523893|NCT05338723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24523894|NCT05338723|Antimetabolites|antimetabolites|mesh-ancestor
25155432|NCT05371899|Chiauranib|chiauranib|mesh-list
24523895|NCT05338723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523903|NCT05338671|Sensory System Agents|sensory system agents|mesh-ancestor
25010267|NCT04331704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25010268|NCT04331704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25010269|NCT04331704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25010270|NCT04331704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010271|NCT04331704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25010272|NCT04331704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25010273|NCT04313075|Leronlimab|leronlimab|mesh-list
25010285|NCT04305756|Enoxaparin|enoxaparin|mesh-list
25010286|NCT04305756|Anticoagulants|anticoagulants|mesh-ancestor
25010287|NCT04305756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25253671|NCT02499822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25253672|NCT02499822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253673|NCT02499822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25253674|NCT02499822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25253675|NCT02499822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25253676|NCT02499822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25253677|NCT02499822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253678|NCT02499822|Vasodilator Agents|vasodilator agents|mesh-ancestor
25253679|NCT02499822|Tocolytic Agents|tocolytic agents|mesh-ancestor
25253680|NCT02499822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25253681|NCT02499757|Nicotine|nicotine|mesh-list
25253682|NCT02499757|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25253683|NCT02499757|Autonomic Agents|autonomic agents|mesh-ancestor
25253684|NCT02499757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25253685|NCT02499757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253686|NCT02499757|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25253687|NCT02499757|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25253688|NCT02499757|Cholinergic Agents|cholinergic agents|mesh-ancestor
25253689|NCT02499757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25253690|NCT02499757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253691|NCT02499627|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25253692|NCT02499627|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25253693|NCT02499627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25253694|NCT02499627|Alkylating Agents|alkylating agents|mesh-ancestor
25253695|NCT02499627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253696|NCT02499627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25253697|NCT02499627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25253698|NCT02499614|Crizotinib|crizotinib|mesh-list
25253699|NCT02499614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24523926|NCT05338502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24523927|NCT05338502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925561|NCT04149067|Hormones|hormones|mesh-ancestor
24925562|NCT04149067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24925563|NCT04149067|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24925564|NCT04149067|Protease Inhibitors|protease inhibitors|mesh-ancestor
24925565|NCT04149067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925566|NCT04149067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925567|NCT04149067|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24925568|NCT04149106|Pyrimethamine|pyrimethamine|mesh-list
24925569|NCT04149106|Sulfadoxine|sulfadoxine|mesh-list
24925570|NCT04149106|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24925571|NCT04149106|Amodiaquine|amodiaquine|mesh-list
24925572|NCT04149106|Artenimol|artenimol|mesh-list
24925573|NCT04149106|Antimalarials|antimalarials|mesh-ancestor
24925574|NCT04149106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24925575|NCT04149106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24925576|NCT04149106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24925577|NCT04149106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24925578|NCT04149106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925604|NCT04149132|Autonomic Agents|autonomic agents|mesh-ancestor
24925579|NCT04149106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925580|NCT04149106|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24925581|NCT04149106|Renal Agents|renal agents|mesh-ancestor
24925582|NCT04149015|Paclitaxel|paclitaxel|mesh-list
25010288|NCT04305756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25010289|NCT04305756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582718|NCT00871208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24582719|NCT00871208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24582720|NCT00871247|Finasteride|finasteride|mesh-list
24582721|NCT00871247|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24582848|NCT00872209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24582849|NCT00872209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24582850|NCT00872209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24582851|NCT00872209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24582852|NCT00872209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102666|NCT03167164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24582853|NCT00872209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582854|NCT00872209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582855|NCT00872209|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24582856|NCT00872209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24582857|NCT00872235|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24582858|NCT00872235|Quinapril|quinapril|mesh-list
24582859|NCT00872235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24582860|NCT00872235|Diuretics|diuretics|mesh-ancestor
24582902|NCT00872469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582904|NCT00872469|Coagulants|coagulants|mesh-ancestor
24582905|NCT00872482|Nimotuzumab|nimotuzumab|mesh-list
24582906|NCT00872482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25253700|NCT02499614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25253701|NCT02499614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25253702|NCT02499614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253703|NCT02499484|Nitroglycerin|nitroglycerin|mesh-list
24731373|NCT01634399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24731374|NCT01634399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731376|NCT01634412|Cyclobenzaprine|cyclobenzaprine|mesh-list
24731378|NCT01634412|Antidepressive Agents|antidepressive agents|mesh-ancestor
25253704|NCT02499484|Vasodilator Agents|vasodilator agents|mesh-ancestor
25253706|NCT02499445|Remifentanil|remifentanil|mesh-list
25253707|NCT02499445|Propofol|propofol|mesh-list
25253708|NCT02499445|Sevoflurane|sevoflurane|mesh-list
25253709|NCT02499445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25253710|NCT02499445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25253711|NCT02499445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253712|NCT02499445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25253713|NCT02499445|Anesthetics, General|anesthetics, general|mesh-ancestor
25253714|NCT02499445|Anesthetics|anesthetics|mesh-ancestor
25253715|NCT02499445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25253716|NCT02499445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25253717|NCT02499445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25253718|NCT02499445|Narcotics|narcotics|mesh-ancestor
25253719|NCT02499445|Analgesics|analgesics|mesh-ancestor
25253720|NCT02499445|Sensory System Agents|sensory system agents|mesh-ancestor
25253721|NCT02499445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25253722|NCT02499445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25253724|NCT02499237|Denosumab|denosumab|mesh-list
25253725|NCT02499237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24925583|NCT04149015|Fluorouracil|fluorouracil|mesh-list
24925584|NCT04149015|Oxaliplatin|oxaliplatin|mesh-list
24925585|NCT04149015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24925586|NCT04149015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24925587|NCT04149015|Tubulin Modulators|tubulin modulators|mesh-ancestor
24925588|NCT04149015|Antimitotic Agents|antimitotic agents|mesh-ancestor
24925589|NCT04149015|Mitosis Modulators|mitosis modulators|mesh-ancestor
24925590|NCT04149015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925591|NCT04149015|Antimetabolites|antimetabolites|mesh-ancestor
24523936|NCT05338489|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24925592|NCT04149015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24925593|NCT04149015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24925594|NCT04149015|Immunologic Factors|immunologic factors|mesh-ancestor
24925595|NCT04149015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925596|NCT04149171|Tranexamic Acid|tranexamic acid|mesh-list
24925597|NCT04149171|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24925598|NCT04149171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24925599|NCT04149171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925600|NCT04149171|Hemostatics|hemostatics|mesh-ancestor
24925601|NCT04149171|Coagulants|coagulants|mesh-ancestor
24925602|NCT04149132|Nitric Oxide|nitric oxide|mesh-list
24925603|NCT04149132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24925606|NCT04149132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925607|NCT04149132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24925608|NCT04149132|Respiratory System Agents|respiratory system agents|mesh-ancestor
24523950|NCT05338489|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24523951|NCT05338489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24523959|NCT05338476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24523960|NCT05338476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24523961|NCT05338476|Anesthetics, General|anesthetics, general|mesh-ancestor
24523962|NCT05338476|Anesthetics|anesthetics|mesh-ancestor
24523964|NCT05338476|GABA Agents|gaba agents|mesh-ancestor
25253726|NCT02499237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253727|NCT02499393|Magnesium Sulfate|magnesium sulfate|mesh-list
25253728|NCT02499393|Analgesics|analgesics|mesh-ancestor
25253729|NCT02499393|Sensory System Agents|sensory system agents|mesh-ancestor
25253730|NCT02499393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25253731|NCT02499393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253732|NCT02499393|Anesthetics|anesthetics|mesh-ancestor
25253733|NCT02499393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25253734|NCT02499393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25253735|NCT02499393|Anticonvulsants|anticonvulsants|mesh-ancestor
25253736|NCT02499393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25253737|NCT02499393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25253738|NCT02499393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253739|NCT02499393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25687067|NCT01928381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25687068|NCT01928381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25687069|NCT01928381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253740|NCT02499393|Tocolytic Agents|tocolytic agents|mesh-ancestor
25253741|NCT02499393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25253742|NCT02499224|Monoclonal antibody YYB-101|monoclonal antibody yyb-101|mesh-list
25253743|NCT02499224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25253745|NCT02499341|Tramadol|tramadol|mesh-list
25253746|NCT02499341|Analgesics|analgesics|mesh-ancestor
25253747|NCT02499341|Sensory System Agents|sensory system agents|mesh-ancestor
25253748|NCT02499341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25253749|NCT02499341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253750|NCT02499341|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25253751|NCT02499341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25253752|NCT02499341|Anesthetics, General|anesthetics, general|mesh-ancestor
25253753|NCT02499341|Anesthetics|anesthetics|mesh-ancestor
25253754|NCT02499341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25253755|NCT02499341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25253756|NCT02499341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25253757|NCT02499341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25253758|NCT02499341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253759|NCT02499341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25253760|NCT02499341|Narcotics|narcotics|mesh-ancestor
25253761|NCT02498938|Protease Inhibitors|protease inhibitors|mesh-list
25253762|NCT02498938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25253763|NCT02498938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253764|NCT02498977|Cyclosporine|cyclosporine|mesh-list
25002245|NCT04792502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25002246|NCT04792502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25002249|NCT04792502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25002252|NCT04780321|Antibodies|antibodies|mesh-list
24925617|NCT04148898|Bevacizumab|bevacizumab|mesh-list
24925618|NCT04148898|Osimertinib|osimertinib|mesh-list
24925619|NCT04148898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25253765|NCT02498977|Mycophenolic Acid|mycophenolic acid|mesh-list
25253766|NCT02498977|Azathioprine|azathioprine|mesh-list
25253767|NCT02498977|Tacrolimus|tacrolimus|mesh-list
25253768|NCT02498977|Cyclosporins|cyclosporins|mesh-list
25253769|NCT02498977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25253770|NCT02498977|Immunologic Factors|immunologic factors|mesh-ancestor
25088642|NCT03461120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25088643|NCT03384212|Cytarabine|cytarabine|mesh-list
25253771|NCT02498977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253772|NCT02498977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24925620|NCT04148898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24925621|NCT04148898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24925622|NCT04148898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24925623|NCT04148898|Growth Substances|growth substances|mesh-ancestor
25254122|NCT02496715|Xhance|xhance|mesh-list
24925627|NCT04148898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925628|NCT04148898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925630|NCT04148885|Carboplatin|carboplatin|mesh-list
24925631|NCT04148885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24925632|NCT04148885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399008|NCT00146484|Insulin|insulin|mesh-list
24925659|NCT04148820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24925660|NCT04148820|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24925662|NCT04148820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24925663|NCT04148833|Paclitaxel|paclitaxel|mesh-list
24925664|NCT04148833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24925665|NCT04148833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24925666|NCT04148833|Tubulin Modulators|tubulin modulators|mesh-ancestor
24925667|NCT04148833|Antimitotic Agents|antimitotic agents|mesh-ancestor
24925668|NCT04148833|Mitosis Modulators|mitosis modulators|mesh-ancestor
25002253|NCT04780321|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25002254|NCT04780321|Immunologic Factors|immunologic factors|mesh-ancestor
24582907|NCT00872482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582908|NCT00872586|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24582909|NCT00872586|Olmesartan|olmesartan|mesh-list
24582910|NCT00872586|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24582911|NCT00872586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25253773|NCT02498977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25253774|NCT02498977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253775|NCT02498977|Antifungal Agents|antifungal agents|mesh-ancestor
25253776|NCT02498977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25253777|NCT02498977|Dermatologic Agents|dermatologic agents|mesh-ancestor
25253778|NCT02498977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25253779|NCT02498977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25253780|NCT02498977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731709|NCT01636128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24731711|NCT01636141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24731712|NCT01636180|Clopidogrel|clopidogrel|mesh-list
24731713|NCT01636180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24731714|NCT01636180|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24731728|NCT01636310|Nicotine|nicotine|mesh-list
25253781|NCT02498977|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25253782|NCT02498977|Antitubercular Agents|antitubercular agents|mesh-ancestor
25253783|NCT02498977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25253784|NCT02498977|Antimetabolites|antimetabolites|mesh-ancestor
25253785|NCT02498977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25253786|NCT02498756|Ipilimumab|ipilimumab|mesh-list
25253787|NCT02498756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25253788|NCT02498756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25253789|NCT02498756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25253790|NCT02498756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253791|NCT02498860|Pemetrexed|pemetrexed|mesh-list
25253792|NCT02498860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25253793|NCT02498860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25253794|NCT02498860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253795|NCT02498860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25253796|NCT02498860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25274790|NCT02375243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25274791|NCT02375243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24925669|NCT04148833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925692|NCT04148599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24925693|NCT04148599|Adrenergic Agents|adrenergic agents|mesh-ancestor
24925694|NCT04148599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24582913|NCT00872586|Natriuretic Agents|natriuretic agents|mesh-ancestor
24582914|NCT00872586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582915|NCT00872586|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24582916|NCT00872586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24582917|NCT00872586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582918|NCT00872586|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24582919|NCT00872586|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24582921|NCT00872625|Docetaxel|docetaxel|mesh-list
24582923|NCT00872625|Epirubicin|epirubicin|mesh-list
24582924|NCT00872625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24582939|NCT00872625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24582940|NCT00872625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24582941|NCT00872625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24582942|NCT00872651|Timolol|timolol|mesh-list
24582943|NCT00872651|Travoprost|travoprost|mesh-list
24582944|NCT00872651|Latanoprost|latanoprost|mesh-list
24582945|NCT00872651|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25253797|NCT02498496|Magnesium Sulfate|magnesium sulfate|mesh-list
25253798|NCT02498496|Analgesics|analgesics|mesh-ancestor
25253799|NCT02498496|Sensory System Agents|sensory system agents|mesh-ancestor
25253800|NCT02498496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25253801|NCT02498496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253802|NCT02498496|Anesthetics|anesthetics|mesh-ancestor
25253803|NCT02498496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25253804|NCT02498496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25253805|NCT02498496|Anticonvulsants|anticonvulsants|mesh-ancestor
25253806|NCT02498496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25253807|NCT02498496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25253808|NCT02498496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253809|NCT02498496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25253810|NCT02498496|Tocolytic Agents|tocolytic agents|mesh-ancestor
25253811|NCT02498496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25253812|NCT02498535|Nitric Oxide|nitric oxide|mesh-list
25253813|NCT02498535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25253814|NCT02498535|Autonomic Agents|autonomic agents|mesh-ancestor
25253815|NCT02498535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25253816|NCT02498535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687070|NCT01928381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25687071|NCT01928381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25687072|NCT01928381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25687073|NCT01928381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25687074|NCT01928381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25687075|NCT01928433|Ciprofloxacin|ciprofloxacin|mesh-list
25687076|NCT01928433|Finafloxacin|finafloxacin|mesh-list
24731785|NCT01636557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25253817|NCT02498535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25253818|NCT02498535|Respiratory System Agents|respiratory system agents|mesh-ancestor
25253819|NCT02498535|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25253821|NCT02498535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253822|NCT02498535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25274792|NCT02375243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24925842|NCT04147208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925844|NCT04147208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24925845|NCT04147208|Antiviral Agents|antiviral agents|mesh-ancestor
24925852|NCT04147481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925853|NCT04147481|Sensory System Agents|sensory system agents|mesh-ancestor
24925854|NCT04147481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24925856|NCT04147390|Tacrolimus|tacrolimus|mesh-list
24925857|NCT04147390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24925858|NCT04147390|Immunologic Factors|immunologic factors|mesh-ancestor
24925859|NCT04147390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925860|NCT04147390|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24925861|NCT04147390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925862|NCT04147390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925863|NCT04147390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24925864|NCT04147390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24925865|NCT04147390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24925866|NCT04147390|Antitubercular Agents|antitubercular agents|mesh-ancestor
25002299|NCT04747314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24582946|NCT00872651|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24583054|NCT00873262|Hormones|hormones|mesh-ancestor
24583055|NCT00873262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24583056|NCT00873262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583057|NCT00873262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24583058|NCT00873262|Contraceptive Agents|contraceptive agents|mesh-ancestor
24583059|NCT00873262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25010313|NCT04223661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25010314|NCT04223661|Antiemetics|antiemetics|mesh-ancestor
25010315|NCT04223661|Autonomic Agents|autonomic agents|mesh-ancestor
25010316|NCT04223661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25010317|NCT04223661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010318|NCT04223661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25010319|NCT04223661|Glucocorticoids|glucocorticoids|mesh-ancestor
25010320|NCT04223661|Hormones|hormones|mesh-ancestor
25010321|NCT04223661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25010322|NCT04223661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25010323|NCT04223661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010324|NCT04223661|Immunologic Factors|immunologic factors|mesh-ancestor
25010325|NCT04223661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25010326|NCT04223661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25010327|NCT04223661|Growth Substances|growth substances|mesh-ancestor
25010328|NCT04223661|Growth Inhibitors|growth inhibitors|mesh-ancestor
25010329|NCT04218240|Lofexidine|lofexidine|mesh-list
25010330|NCT04218240|Pregabalin|pregabalin|mesh-list
25010331|NCT04218240|Analgesics|analgesics|mesh-ancestor
25010332|NCT04218240|Sensory System Agents|sensory system agents|mesh-ancestor
25010333|NCT04218240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25253823|NCT02498535|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25253824|NCT02498535|Vasodilator Agents|vasodilator agents|mesh-ancestor
25253825|NCT02498535|Gasotransmitters|gasotransmitters|mesh-ancestor
25253826|NCT02498535|Protective Agents|protective agents|mesh-ancestor
25253827|NCT02498457|Calcium|calcium|mesh-list
25253828|NCT02498457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25253829|NCT02498457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253830|NCT02498509|Mometasone Furoate|mometasone furoate|mesh-list
25253831|NCT02498509|Levocabastine|levocabastine|mesh-list
25253832|NCT02498509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25253833|NCT02498509|Dermatologic Agents|dermatologic agents|mesh-ancestor
25253834|NCT02498509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25253835|NCT02498509|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25253836|NCT02498509|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25253837|NCT02498509|Histamine Antagonists|histamine antagonists|mesh-ancestor
25253838|NCT02498509|Histamine Agents|histamine agents|mesh-ancestor
25253839|NCT02498509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25253840|NCT02498509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687077|NCT01928433|Fluoroquinolones|fluoroquinolones|mesh-list
25253841|NCT02498509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253843|NCT02498301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25253844|NCT02498301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24925875|NCT04147260|Ciprofloxacin|ciprofloxacin|mesh-list
24925876|NCT04147260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24925877|NCT04147260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24925878|NCT04147260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24925879|NCT04147260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24925880|NCT04147260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24524009|NCT05326490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24524010|NCT05326490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524011|NCT05325489|Budesonide|budesonide|mesh-list
24524012|NCT05325489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24524013|NCT05325489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24524014|NCT05325489|Autonomic Agents|autonomic agents|mesh-ancestor
24524015|NCT05325489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24524016|NCT05325489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925896|NCT04146220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24925897|NCT04146220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925898|NCT04146220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24925899|NCT04146220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24925900|NCT04146376|Tranexamic Acid|tranexamic acid|mesh-list
24925901|NCT04146376|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24925937|NCT04146259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24925938|NCT04146259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925940|NCT04146259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925941|NCT04146259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24925942|NCT04146259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25253845|NCT02498301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25253846|NCT02498288|Isotretinoin|isotretinoin|mesh-list
25253847|NCT02498288|Dermatologic Agents|dermatologic agents|mesh-ancestor
25253848|NCT02498171|Fentanyl|fentanyl|mesh-list
25253849|NCT02498171|Morphine|morphine|mesh-list
25253850|NCT02498171|Bupivacaine|bupivacaine|mesh-list
25253851|NCT02498171|Anesthetics, Local|anesthetics, local|mesh-ancestor
25253852|NCT02498171|Anesthetics|anesthetics|mesh-ancestor
25253853|NCT02498171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25253854|NCT02498171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253855|NCT02498171|Sensory System Agents|sensory system agents|mesh-ancestor
25253856|NCT02498171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25253857|NCT02498171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25253858|NCT02498171|Narcotics|narcotics|mesh-ancestor
25253859|NCT02498171|Analgesics|analgesics|mesh-ancestor
25253860|NCT02498171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25253861|NCT02498171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25253862|NCT02498171|Anesthetics, General|anesthetics, general|mesh-ancestor
25253863|NCT02498145|Nicotine|nicotine|mesh-list
25253864|NCT02498145|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25253865|NCT02498145|Autonomic Agents|autonomic agents|mesh-ancestor
25253866|NCT02498145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25253867|NCT02498145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253868|NCT02498145|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25253869|NCT02498145|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25253870|NCT02498145|Cholinergic Agents|cholinergic agents|mesh-ancestor
25253871|NCT02498145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25253872|NCT02498145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253873|NCT02497911|Bupivacaine|bupivacaine|mesh-list
25253874|NCT02497911|Anesthetics, Local|anesthetics, local|mesh-ancestor
25253875|NCT02497911|Anesthetics|anesthetics|mesh-ancestor
25253876|NCT02497911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25253877|NCT02497911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253878|NCT02497911|Sensory System Agents|sensory system agents|mesh-ancestor
25253879|NCT02497911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25253880|NCT02498015|Ribavirin|ribavirin|mesh-list
25253881|NCT02498015|Antimetabolites|antimetabolites|mesh-ancestor
25253882|NCT02498015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253883|NCT02498015|Antiviral Agents|antiviral agents|mesh-ancestor
25253884|NCT02498015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25253885|NCT02498002|Lidocaine|lidocaine|mesh-list
25253886|NCT02498002|Anesthetics, Local|anesthetics, local|mesh-ancestor
25253887|NCT02498002|Anesthetics|anesthetics|mesh-ancestor
25253888|NCT02498002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25253889|NCT02498002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253890|NCT02498002|Sensory System Agents|sensory system agents|mesh-ancestor
24732150|NCT01638078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24732151|NCT01638078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25253891|NCT02498002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24925996|NCT04145921|Tacrine|tacrine|mesh-list
24399468|NCT00147875|Antimetabolites|antimetabolites|mesh-ancestor
24624397|NCT01076062|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24624398|NCT01076062|Abortifacient Agents|abortifacient agents|mesh-ancestor
24926027|NCT04145193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24926028|NCT04145102|Propolis|propolis|mesh-list
24926029|NCT04145102|Fluorides|fluorides|mesh-list
24926030|NCT04145102|Cariostatic Agents|cariostatic agents|mesh-ancestor
24926031|NCT04145102|Protective Agents|protective agents|mesh-ancestor
24926032|NCT04145102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926033|NCT04145102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24926034|NCT04145336|Indomethacin|indomethacin|mesh-list
24926035|NCT04145336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24926036|NCT04145336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24926037|NCT04145336|Analgesics|analgesics|mesh-ancestor
24926038|NCT04145336|Sensory System Agents|sensory system agents|mesh-ancestor
24926039|NCT04145336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24926040|NCT04145336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926041|NCT04145336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24926042|NCT04145336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24926043|NCT04145336|Gout Suppressants|gout suppressants|mesh-ancestor
24926044|NCT04145336|Tocolytic Agents|tocolytic agents|mesh-ancestor
24926045|NCT04145336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24926046|NCT04145336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24926047|NCT04145336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24926049|NCT04145232|Nivolumab|nivolumab|mesh-list
24926050|NCT04145232|Ipilimumab|ipilimumab|mesh-list
24926051|NCT04145232|Atezolizumab|atezolizumab|mesh-list
24926052|NCT04145232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25010334|NCT04218240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010335|NCT04218240|Anticonvulsants|anticonvulsants|mesh-ancestor
25010336|NCT04218240|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25010337|NCT04218240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24583063|NCT00873275|Bevacizumab|bevacizumab|mesh-list
24583064|NCT00873275|Fluorouracil|fluorouracil|mesh-list
24583065|NCT00873275|Oxaliplatin|oxaliplatin|mesh-list
24583066|NCT00873275|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24583102|NCT00873353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583103|NCT00873353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24583104|NCT00873353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24583105|NCT00873366|Tamoxifen|tamoxifen|mesh-list
24583106|NCT00873366|Dextromethorphan|dextromethorphan|mesh-list
24583107|NCT00873366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583108|NCT00873366|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24583109|NCT00873366|Hormone Antagonists|hormone antagonists|mesh-ancestor
24632963|NCT01126450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24583110|NCT00873366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25253892|NCT02498002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25253893|NCT02498002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25253894|NCT02498002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25253895|NCT02498002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25253896|NCT02498002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253897|NCT02497833|Tretinoin|tretinoin|mesh-list
25253898|NCT02497833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25253899|NCT02497833|Keratolytic Agents|keratolytic agents|mesh-ancestor
25253900|NCT02497833|Dermatologic Agents|dermatologic agents|mesh-ancestor
25253901|NCT02497820|Aspirin|aspirin|mesh-list
25253902|NCT02497820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25253903|NCT02497820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25253904|NCT02497820|Analgesics|analgesics|mesh-ancestor
25253905|NCT02497820|Sensory System Agents|sensory system agents|mesh-ancestor
25253906|NCT02497820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25253907|NCT02497820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253908|NCT02497820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25253909|NCT02497820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25253910|NCT02497820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25253911|NCT02497820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25253912|NCT02497820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253913|NCT02497820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25687078|NCT01928433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25687079|NCT01928433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25253914|NCT02497820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24617073|NCT01040702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24617081|NCT01040936|Atorvastatin|atorvastatin|mesh-list
24617082|NCT01040936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24617083|NCT01040936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25253915|NCT02497820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25253916|NCT02497820|Antipyretics|antipyretics|mesh-ancestor
25253917|NCT02497638|Metformin|metformin|mesh-list
25253918|NCT02497638|Biguanides|biguanides|mesh-list
25253919|NCT02497638|Atorvastatin|atorvastatin|mesh-list
24926053|NCT04145232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926054|NCT04145232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25155433|NCT05371899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926055|NCT04145232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926057|NCT04144920|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24926058|NCT04144920|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24926059|NCT04144920|Adrenergic Agents|adrenergic agents|mesh-ancestor
24926060|NCT04144920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24926061|NCT04144920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926062|NCT04144920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926063|NCT04144920|Sympathomimetics|sympathomimetics|mesh-ancestor
24926064|NCT04144920|Autonomic Agents|autonomic agents|mesh-ancestor
24926065|NCT04144920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24926066|NCT04144920|Nasal Decongestants|nasal decongestants|mesh-ancestor
24926067|NCT04144920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24926068|NCT04144920|Respiratory System Agents|respiratory system agents|mesh-ancestor
24618930|NCT01050322|Lapatinib|lapatinib|mesh-list
24926069|NCT04144712|Caffeine|caffeine|mesh-list
24583111|NCT00873366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583112|NCT00873366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24583113|NCT00873366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583120|NCT00873366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24583152|NCT00873483|Progestins|progestins|mesh-ancestor
24583154|NCT00873496|Hydroxychloroquine|hydroxychloroquine|mesh-list
25088888|NCT03270839|Meclizine|meclizine|mesh-list
24583216|NCT00873769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583217|NCT00873769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24583218|NCT00873769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24583219|NCT00873769|Dopamine Agents|dopamine agents|mesh-ancestor
24583220|NCT00873769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24903155|NCT04365686|Propofol|propofol|mesh-list
24583240|NCT00873795|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24583241|NCT00873795|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24583242|NCT00873795|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24583243|NCT00873795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24583244|NCT00873808|Zoledronic Acid|zoledronic acid|mesh-list
24583245|NCT00873808|Ibandronic Acid|ibandronic acid|mesh-list
24583246|NCT00873808|Clodronic Acid|clodronic acid|mesh-list
24583247|NCT00873808|Tetracycline|tetracycline|mesh-list
24583248|NCT00873808|Demeclocycline|demeclocycline|mesh-list
24583249|NCT00873808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24583299|NCT00874003|Adrenergic Agents|adrenergic agents|mesh-ancestor
24583300|NCT00874003|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24583301|NCT00874003|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24583302|NCT00874003|Serotonin Agents|serotonin agents|mesh-ancestor
24583303|NCT00874003|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24583304|NCT00874042|Gemcitabine|gemcitabine|mesh-list
24583305|NCT00874042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24583306|NCT00874042|Antimetabolites|antimetabolites|mesh-ancestor
24583307|NCT00874042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583308|NCT00874042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583309|NCT00874042|Antiviral Agents|antiviral agents|mesh-ancestor
24583310|NCT00874042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24583311|NCT00874042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24583312|NCT00874042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24583313|NCT00874042|Immunologic Factors|immunologic factors|mesh-ancestor
25253920|NCT02497638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25253921|NCT02497638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253922|NCT02497638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25687080|NCT01928433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25687081|NCT01928433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25687082|NCT01928433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687083|NCT01928433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687084|NCT01928433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25253923|NCT02497638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25253924|NCT02497638|Antimetabolites|antimetabolites|mesh-ancestor
25687085|NCT01928433|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25687086|NCT01928433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25687087|NCT01928433|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25687088|NCT01928433|Renal Agents|renal agents|mesh-ancestor
25687089|NCT01928433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25687090|NCT01928446|Lithium Carbonate|lithium carbonate|mesh-list
25687091|NCT01928446|Antidepressive Agents|antidepressive agents|mesh-ancestor
25687092|NCT01928446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24732359|NCT01638962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24732360|NCT01638962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24732361|NCT01638962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24732362|NCT01638962|Tocolytic Agents|tocolytic agents|mesh-ancestor
24732363|NCT01638962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24732364|NCT01638988|Metformin|metformin|mesh-list
24732365|NCT01638988|Clomiphene|clomiphene|mesh-list
24732366|NCT01638988|Enclomiphene|enclomiphene|mesh-list
24732367|NCT01638988|Zuclomiphene|zuclomiphene|mesh-list
24732368|NCT01638988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24732369|NCT01638988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732371|NCT01638988|Hormone Antagonists|hormone antagonists|mesh-ancestor
24732372|NCT01638988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24732373|NCT01638988|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25253925|NCT02497638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253926|NCT02497638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25253927|NCT02497638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25253928|NCT02497638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25253929|NCT02497716|Rivaroxaban|rivaroxaban|mesh-list
25253930|NCT02497716|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25253931|NCT02497716|Antithrombins|antithrombins|mesh-ancestor
25253932|NCT02497716|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25253933|NCT02497716|Protease Inhibitors|protease inhibitors|mesh-ancestor
25253934|NCT02497716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25253935|NCT02497716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253936|NCT02497716|Anticoagulants|anticoagulants|mesh-ancestor
25253937|NCT02497547|Oxytocin|oxytocin|mesh-list
25253938|NCT02497547|Oxytocics|oxytocics|mesh-ancestor
24926071|NCT04144712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926072|NCT04144712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24926073|NCT04144712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926074|NCT04144712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24926075|NCT04144712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24926076|NCT04144712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24926077|NCT04144712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24926078|NCT04144712|Purinergic Agents|purinergic agents|mesh-ancestor
24926079|NCT04144712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24926080|NCT04144933|Acetaminophen|acetaminophen|mesh-list
24926081|NCT04144933|Dexamethasone|dexamethasone|mesh-list
24926082|NCT04144933|Lidocaine|lidocaine|mesh-list
24926083|NCT04144933|Magnesium Sulfate|magnesium sulfate|mesh-list
24926084|NCT04144933|Sufentanil|sufentanil|mesh-list
24583314|NCT00874042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088946|NCT03269760|Zolpidem|zolpidem|mesh-list
24583315|NCT00874068|Palmitic Acid|palmitic acid|mesh-list
24583358|NCT00874315|Antimetabolites|antimetabolites|mesh-ancestor
24583359|NCT00874315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583360|NCT00874315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24583361|NCT00874315|Immunologic Factors|immunologic factors|mesh-ancestor
24583362|NCT00874315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583363|NCT00874315|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24583364|NCT00874315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24583365|NCT00874315|Antifungal Agents|antifungal agents|mesh-ancestor
24583366|NCT00874315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25687093|NCT01928446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687094|NCT01928446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687095|NCT01928446|Antimanic Agents|antimanic agents|mesh-ancestor
25687096|NCT01928446|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25687097|NCT01928446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25687098|NCT01928446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687099|NCT01928680|Cisplatin|cisplatin|mesh-list
25687100|NCT01928680|Capecitabine|capecitabine|mesh-list
25687101|NCT01928680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25687102|NCT01928680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25687103|NCT01928680|Antimetabolites|antimetabolites|mesh-ancestor
25687104|NCT01928680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617134|NCT01041170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617136|NCT01041183|Antiemetics|antiemetics|mesh-ancestor
24617137|NCT01041183|Autonomic Agents|autonomic agents|mesh-ancestor
24617138|NCT01041183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24617140|NCT01041183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24583367|NCT00874315|Dermatologic Agents|dermatologic agents|mesh-ancestor
24583380|NCT00874328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24583497|NCT00874744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583499|NCT00874809|Insulin, Short-Acting|insulin, short-acting|mesh-list
24583500|NCT00874809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24583501|NCT00874809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583503|NCT00874861|Interferon Inducers|interferon inducers|mesh-ancestor
24583504|NCT00874861|Immunologic Factors|immunologic factors|mesh-ancestor
25010399|NCT04181476|Sunscreening Agents|sunscreening agents|mesh-list
24583505|NCT00874861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583506|NCT00874874|Sorafenib|sorafenib|mesh-list
24583507|NCT00874874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583508|NCT00874874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24583509|NCT00874874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24583510|NCT00874874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583511|NCT00874926|Factor VIII|factor viii|mesh-list
24583512|NCT00874926|Coagulants|coagulants|mesh-ancestor
24583513|NCT00874978|Lenalidomide|lenalidomide|mesh-list
24583514|NCT00874978|Immunologic Factors|immunologic factors|mesh-ancestor
24583515|NCT00874978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253939|NCT02497547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25253940|NCT02497547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253941|NCT02497508|Nivolumab|nivolumab|mesh-list
25253942|NCT02497508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25253943|NCT02497508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25253944|NCT02497508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25253945|NCT02497508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253946|NCT02497313|Metformin|metformin|mesh-list
25253947|NCT02497313|Cholecystokinin|cholecystokinin|mesh-list
25253948|NCT02497313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25253949|NCT02497313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253950|NCT02497313|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25253951|NCT02497313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25253952|NCT02497378|Dexamethasone|dexamethasone|mesh-list
25253953|NCT02497378|Bortezomib|bortezomib|mesh-list
24926089|NCT04144933|Analgesics, Opioid|analgesics, opioid|mesh-list
24926090|NCT04144933|Ondansetron|ondansetron|mesh-list
24926112|NCT04144933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926113|NCT04144933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24632075|NCT01121848|Leucovorin|leucovorin|mesh-list
24926114|NCT04144933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24926115|NCT04144933|Analgesics|analgesics|mesh-ancestor
24926116|NCT04144933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24926117|NCT04144933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24926118|NCT04144933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24926119|NCT04144933|Adrenergic Agents|adrenergic agents|mesh-ancestor
24926120|NCT04144933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24524066|NCT05305014|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24524067|NCT05305014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24524068|NCT05293041|Arginine Vasopressin|arginine vasopressin|mesh-list
24524072|NCT05293041|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24524073|NCT05293041|Natriuretic Agents|natriuretic agents|mesh-ancestor
24524074|NCT05293041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524075|NCT05282277|Raclopride|raclopride|mesh-list
24524076|NCT05282277|Estradiol|estradiol|mesh-list
24926121|NCT04144933|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24926122|NCT04144933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24926123|NCT04144933|Anesthetics, General|anesthetics, general|mesh-ancestor
24926124|NCT04144933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24926125|NCT04144933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24926126|NCT04144933|Antipyretics|antipyretics|mesh-ancestor
24926127|NCT04144933|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24926128|NCT04144933|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24926130|NCT04144933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25687105|NCT01928693|Moxifloxacin|moxifloxacin|mesh-list
25687106|NCT01928693|Gatifloxacin|gatifloxacin|mesh-list
25687107|NCT01928693|Besifloxacin|besifloxacin|mesh-list
25687108|NCT01928693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25687109|NCT01928693|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25687110|NCT01928693|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24926131|NCT04144933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24926132|NCT04144933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24926133|NCT04144933|Antimanic Agents|antimanic agents|mesh-ancestor
25253954|NCT02497378|Daratumumab|daratumumab|mesh-list
24926159|NCT04144153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24926160|NCT04144153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926161|NCT04144153|Narcotics|narcotics|mesh-ancestor
25253955|NCT02497378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25253956|NCT02497378|Antiemetics|antiemetics|mesh-ancestor
25253957|NCT02497378|Autonomic Agents|autonomic agents|mesh-ancestor
25253958|NCT02497378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25253959|NCT02497378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253960|NCT02497378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25253961|NCT02497378|Glucocorticoids|glucocorticoids|mesh-ancestor
25253962|NCT02497378|Hormones|hormones|mesh-ancestor
25253963|NCT02497378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25253964|NCT02497378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25253965|NCT02497378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25253966|NCT02497326|Heparin|heparin|mesh-list
25253967|NCT02497326|Tramadol|tramadol|mesh-list
25253968|NCT02497326|Anticoagulants|anticoagulants|mesh-ancestor
25253969|NCT02497326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25253970|NCT02497326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25253971|NCT02497326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253972|NCT02497326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25253973|NCT02497326|Narcotics|narcotics|mesh-ancestor
25253974|NCT02497326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25253975|NCT02497326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25253976|NCT02497326|Analgesics|analgesics|mesh-ancestor
25253977|NCT02497326|Sensory System Agents|sensory system agents|mesh-ancestor
25253978|NCT02497326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25253979|NCT02497300|Amiloride|amiloride|mesh-list
25253980|NCT02497300|Spironolactone|spironolactone|mesh-list
25253981|NCT02497300|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25253982|NCT02497300|Hormone Antagonists|hormone antagonists|mesh-ancestor
25253983|NCT02497300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25253984|NCT02497300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102755|NCT03166865|Protective Agents|protective agents|mesh-ancestor
25253985|NCT02497300|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25253986|NCT02497300|Diuretics|diuretics|mesh-ancestor
25253987|NCT02497300|Natriuretic Agents|natriuretic agents|mesh-ancestor
25253988|NCT02497300|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
25253989|NCT02497300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25253990|NCT02497300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24940057|NCT04004117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24940058|NCT04004117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24926162|NCT04144153|Analgesics|analgesics|mesh-ancestor
24926163|NCT04144153|Sensory System Agents|sensory system agents|mesh-ancestor
24926164|NCT04144153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24926166|NCT04144101|Aceclofenac|aceclofenac|mesh-list
24926167|NCT04144101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24926168|NCT04144101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24399722|NCT00148499|Benzocaine|benzocaine|mesh-list
24926180|NCT04143880|Progestins|progestins|mesh-ancestor
24926182|NCT04143880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24926183|NCT04143880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926184|NCT04143906|Gemcitabine|gemcitabine|mesh-list
24926185|NCT04143906|Carboplatin|carboplatin|mesh-list
24926186|NCT04143906|Vinorelbine|vinorelbine|mesh-list
24926187|NCT04143906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926188|NCT04143906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24524086|NCT05282277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24524087|NCT05282277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24524088|NCT05282277|Dopamine Agents|dopamine agents|mesh-ancestor
24524089|NCT05282277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24524090|NCT05282277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524091|NCT05279833|Sotalol|sotalol|mesh-list
24926190|NCT04143906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926191|NCT04143906|Antiviral Agents|antiviral agents|mesh-ancestor
25253991|NCT02497300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25253992|NCT02497300|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24926192|NCT04143906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24583595|NCT00875537|Dermatologic Agents|dermatologic agents|mesh-ancestor
24583596|NCT00875537|Sensory System Agents|sensory system agents|mesh-ancestor
24583597|NCT00875537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24583598|NCT00875537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583599|NCT00875745|Sorafenib|sorafenib|mesh-list
24583600|NCT00875745|Vorinostat|vorinostat|mesh-list
24583601|NCT00875745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583602|NCT00875745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24583603|NCT00875745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24583621|NCT00875771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24583623|NCT00875784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25253993|NCT02497118|Vinorelbine|vinorelbine|mesh-list
25253994|NCT02497118|Endostatins|endostatins|mesh-list
25253995|NCT02497118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25253996|NCT02497118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25253997|NCT02497118|Tubulin Modulators|tubulin modulators|mesh-ancestor
25253998|NCT02497118|Antimitotic Agents|antimitotic agents|mesh-ancestor
25253999|NCT02497118|Mitosis Modulators|mitosis modulators|mesh-ancestor
25254000|NCT02497118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254001|NCT02497118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25254002|NCT02497118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25254003|NCT02497118|Growth Substances|growth substances|mesh-ancestor
25254004|NCT02497118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254005|NCT02497118|Growth Inhibitors|growth inhibitors|mesh-ancestor
25254006|NCT02497222|RNS60|rns60|mesh-list
25254007|NCT02497222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25254008|NCT02497222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25254009|NCT02497222|Analgesics|analgesics|mesh-ancestor
25254010|NCT02497222|Sensory System Agents|sensory system agents|mesh-ancestor
25254011|NCT02497222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254012|NCT02497222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254013|NCT02497222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25254014|NCT02497222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25254015|NCT02497222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25254016|NCT02497157|Leucovorin|leucovorin|mesh-list
25254017|NCT02497157|Bevacizumab|bevacizumab|mesh-list
25254018|NCT02497157|Fluorouracil|fluorouracil|mesh-list
25254019|NCT02497157|Oxaliplatin|oxaliplatin|mesh-list
25254020|NCT02497157|Irinotecan|irinotecan|mesh-list
25254021|NCT02497157|Calcium|calcium|mesh-list
25254022|NCT02497157|Levoleucovorin|levoleucovorin|mesh-list
25254023|NCT02497157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25254024|NCT02497157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25254025|NCT02497157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25254026|NCT02497157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25254027|NCT02497157|Growth Substances|growth substances|mesh-ancestor
25254028|NCT02497157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254029|NCT02497157|Growth Inhibitors|growth inhibitors|mesh-ancestor
25254030|NCT02497157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25254031|NCT02497157|Antimetabolites|antimetabolites|mesh-ancestor
25254032|NCT02497157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254033|NCT02497157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25254034|NCT02497157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25254035|NCT02497157|Immunologic Factors|immunologic factors|mesh-ancestor
25002456|NCT04637386|Anesthetics|anesthetics|mesh-list
25002457|NCT04637386|Anesthetics, Local|anesthetics, local|mesh-list
25002458|NCT04637386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25002459|NCT04637386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25002460|NCT04637386|Sensory System Agents|sensory system agents|mesh-ancestor
25002461|NCT04637386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254037|NCT02497157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25254038|NCT02497157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25254040|NCT02497157|Protective Agents|protective agents|mesh-ancestor
25254041|NCT02497157|Vitamin B Complex|vitamin b complex|mesh-ancestor
25254042|NCT02497157|Vitamins|vitamins|mesh-ancestor
25254043|NCT02497157|Micronutrients|micronutrients|mesh-ancestor
25254044|NCT02497365|Cefazolin|cefazolin|mesh-list
25254045|NCT02497365|Tobramycin|tobramycin|mesh-list
24632193|NCT01122602|Aspirin|aspirin|mesh-list
25254046|NCT02497365|Besifloxacin|besifloxacin|mesh-list
25254047|NCT02497365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25254048|NCT02497365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25254049|NCT02497365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25254050|NCT02497365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25254051|NCT02497365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25254052|NCT02497365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254053|NCT02497365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25254054|NCT02497079|Formaldehyde|formaldehyde|mesh-list
25254055|NCT02497079|Disinfectants|disinfectants|mesh-ancestor
25254056|NCT02497079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25254057|NCT02497053|Pemetrexed|pemetrexed|mesh-list
25254058|NCT02497053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25254059|NCT02497053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25254060|NCT02497053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254061|NCT02497053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25254062|NCT02497053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25274793|NCT02375243|Adrenergic Agents|adrenergic agents|mesh-ancestor
25274794|NCT02375243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25274795|NCT02375243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274796|NCT02375217|Glycopyrrolate|glycopyrrolate|mesh-list
25274797|NCT02375217|Neostigmine|neostigmine|mesh-list
25274798|NCT02375217|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25274799|NCT02375217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274800|NCT02375217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274801|NCT02375217|Cholinergic Agents|cholinergic agents|mesh-ancestor
25274802|NCT02375217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25274803|NCT02375217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274804|NCT02375217|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25274805|NCT02375217|Autonomic Agents|autonomic agents|mesh-ancestor
25254063|NCT02496988|Temozolomide|temozolomide|mesh-list
25254064|NCT02496988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25254065|NCT02496988|Alkylating Agents|alkylating agents|mesh-ancestor
25254066|NCT02496988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254067|NCT02496988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25254068|NCT02496962|Atorvastatin|atorvastatin|mesh-list
25254069|NCT02496962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25254070|NCT02496962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25254071|NCT02496962|Antimetabolites|antimetabolites|mesh-ancestor
25254072|NCT02496962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254073|NCT02496962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25049268|NCT00625651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25049269|NCT00625651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25049270|NCT00625651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25049271|NCT00625651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25049272|NCT00625651|Growth Substances|growth substances|mesh-ancestor
24926264|NCT04143165|Anesthetics, Local|anesthetics, local|mesh-ancestor
24926265|NCT04143165|Anesthetics|anesthetics|mesh-ancestor
24926266|NCT04143165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24524092|NCT05279833|Dronedarone|dronedarone|mesh-list
24524093|NCT05279833|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24926270|NCT04143165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24926271|NCT04143165|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24926272|NCT04143165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24926273|NCT04143165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24926274|NCT04143165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926276|NCT04143256|Antipruritics|antipruritics|mesh-ancestor
25254074|NCT02496962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25254075|NCT02496962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25254076|NCT02496975|Cyclosporine|cyclosporine|mesh-list
25254077|NCT02496975|Cyclosporins|cyclosporins|mesh-list
25254078|NCT02496975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25254079|NCT02496975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254080|NCT02496975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25254081|NCT02496975|Immunologic Factors|immunologic factors|mesh-ancestor
25254082|NCT02496975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254083|NCT02496975|Antifungal Agents|antifungal agents|mesh-ancestor
25254084|NCT02496975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25254085|NCT02496975|Dermatologic Agents|dermatologic agents|mesh-ancestor
25254086|NCT02496975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25254087|NCT02496975|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25254088|NCT02496754|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25254089|NCT02496754|Hormones|hormones|mesh-ancestor
25254090|NCT02496754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25254091|NCT02496754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254092|NCT02496910|Amlodipine|amlodipine|mesh-list
25254093|NCT02496910|Telmisartan|telmisartan|mesh-list
25254094|NCT02496910|Chlorthalidone|chlorthalidone|mesh-list
25254095|NCT02496910|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
25254096|NCT02496910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25254097|NCT02496910|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25254098|NCT02496910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25404149|NCT03682068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24617228|NCT01041729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24617230|NCT01041755|N-Methylaspartate|n-methylaspartate|mesh-list
24617231|NCT01041755|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
24617232|NCT01041755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24617233|NCT01041755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24617234|NCT01041755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617235|NCT01041755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617236|NCT01041872|Lidocaine|lidocaine|mesh-list
24617237|NCT01041872|Propofol|propofol|mesh-list
25254099|NCT02496910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254100|NCT02496910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24926278|NCT04143412|Ramipril|ramipril|mesh-list
25254101|NCT02496910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254102|NCT02496910|Vasodilator Agents|vasodilator agents|mesh-ancestor
25254103|NCT02496910|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25254104|NCT02496910|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25254105|NCT02496910|Diuretics|diuretics|mesh-ancestor
25254106|NCT02496910|Natriuretic Agents|natriuretic agents|mesh-ancestor
25254107|NCT02496910|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25254108|NCT02496741|Metformin|metformin|mesh-list
25254109|NCT02496741|Chloroquine|chloroquine|mesh-list
25254110|NCT02496741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24926287|NCT04143412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24926288|NCT04143412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926289|NCT04143412|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24926291|NCT04143412|Natriuretic Agents|natriuretic agents|mesh-ancestor
24926292|NCT04143191|Sorafenib|sorafenib|mesh-list
24926293|NCT04143191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926294|NCT04143191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24926295|NCT04143191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24926296|NCT04143191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624401|NCT01076140|Lisinopril|lisinopril|mesh-list
24624402|NCT01076140|Nebivolol|nebivolol|mesh-list
24926297|NCT04142931|Nivolumab|nivolumab|mesh-list
24926298|NCT04142931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24926299|NCT04142931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926300|NCT04142931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24926301|NCT04142931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926302|NCT04142840|Dexmedetomidine|dexmedetomidine|mesh-list
24926303|NCT04142840|Propofol|propofol|mesh-list
24926304|NCT04142840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24926305|NCT04142840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24926306|NCT04142840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926307|NCT04142840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25254111|NCT02496741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254112|NCT02496741|Amebicides|amebicides|mesh-ancestor
25254113|NCT02496741|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25254114|NCT02496741|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25254115|NCT02496741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25254116|NCT02496741|Antimalarials|antimalarials|mesh-ancestor
25254117|NCT02496741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25254118|NCT02496832|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
25254119|NCT02496832|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25254120|NCT02496832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254121|NCT02496715|Fluticasone|fluticasone|mesh-list
25254127|NCT02496715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254128|NCT02496715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254130|NCT02496715|Respiratory System Agents|respiratory system agents|mesh-ancestor
25254131|NCT02496715|Dermatologic Agents|dermatologic agents|mesh-ancestor
25254132|NCT02496715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25687111|NCT01928693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25687112|NCT01928693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25687113|NCT01928693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25687114|NCT01928693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25687115|NCT01928693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687116|NCT01928693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687117|NCT01928693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25687118|NCT01928693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25687119|NCT01928693|Contraceptive Agents|contraceptive agents|mesh-ancestor
25687120|NCT01928693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25687121|NCT01928693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687122|NCT01928693|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25687123|NCT01928693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25687124|NCT01928693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25254133|NCT02496715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25254134|NCT02496715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25254135|NCT02496715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25254136|NCT02496715|Adrenergic Agents|adrenergic agents|mesh-ancestor
25254137|NCT02496715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25254138|NCT02496715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254139|NCT02496650|Dexmedetomidine|dexmedetomidine|mesh-list
25254140|NCT02496650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25254141|NCT02496650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25254142|NCT02496650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254143|NCT02496650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25254144|NCT02496650|Analgesics|analgesics|mesh-ancestor
25254145|NCT02496650|Sensory System Agents|sensory system agents|mesh-ancestor
25254146|NCT02496650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254147|NCT02496650|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25254148|NCT02496650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25254149|NCT02496650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25254150|NCT02496650|Adrenergic Agents|adrenergic agents|mesh-ancestor
25254151|NCT02496650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25254152|NCT02496650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254153|NCT02496494|Tacrolimus|tacrolimus|mesh-list
25254154|NCT02496494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25254155|NCT02496494|Immunologic Factors|immunologic factors|mesh-ancestor
25254156|NCT02496494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254157|NCT02496494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25254158|NCT02496494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25254159|NCT02496494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254160|NCT02496377|Epoetin Alfa|epoetin alfa|mesh-list
25254161|NCT02496377|Glycine|glycine|mesh-list
25254162|NCT02496377|Hematinics|hematinics|mesh-ancestor
25254163|NCT02496377|Glycine Agents|glycine agents|mesh-ancestor
25002563|NCT04518462|Bupivacaine|bupivacaine|mesh-list
25002564|NCT04518462|Anesthetics, Local|anesthetics, local|mesh-ancestor
25002565|NCT04518462|Anesthetics|anesthetics|mesh-ancestor
24926315|NCT04142840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24926317|NCT04142840|Adrenergic Agents|adrenergic agents|mesh-ancestor
24926338|NCT04142762|Anesthetics, General|anesthetics, general|mesh-ancestor
24524214|NCT05158686|Mitosis Modulators|mitosis modulators|mesh-ancestor
24524215|NCT05158686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524216|NCT05157997|Antibodies|antibodies|mesh-list
24524217|NCT05157997|Immunologic Factors|immunologic factors|mesh-ancestor
24524218|NCT05157997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926339|NCT04142762|Anesthetics|anesthetics|mesh-ancestor
24926340|NCT04142762|GABA Modulators|gaba modulators|mesh-ancestor
24583661|NCT00876135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24583662|NCT00876135|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24583675|NCT00876226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583747|NCT00876655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24583749|NCT00876772|Antiemetics|antiemetics|mesh-ancestor
24583773|NCT00876850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24583774|NCT00876850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25254164|NCT02496377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25254165|NCT02496377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254166|NCT02496377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254168|NCT02496455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25254169|NCT02496455|Narcotics|narcotics|mesh-ancestor
25254170|NCT02496455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25254171|NCT02496455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254172|NCT02496455|Analgesics|analgesics|mesh-ancestor
25254173|NCT02496455|Sensory System Agents|sensory system agents|mesh-ancestor
25687125|NCT01928719|Nicotine|nicotine|mesh-list
25687126|NCT01928719|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25687127|NCT01928719|Autonomic Agents|autonomic agents|mesh-ancestor
25687128|NCT01928719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25687129|NCT01928719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404150|NCT03682068|Immunologic Factors|immunologic factors|mesh-ancestor
24733061|NCT01643083|Rifaximin|rifaximin|mesh-list
24733062|NCT01643083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25254174|NCT02496455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254175|NCT02496299|Dexamethasone|dexamethasone|mesh-list
25254176|NCT02496299|Bupivacaine|bupivacaine|mesh-list
25254177|NCT02496299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25254178|NCT02496299|Antiemetics|antiemetics|mesh-ancestor
25254179|NCT02496299|Autonomic Agents|autonomic agents|mesh-ancestor
25254180|NCT02496299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254181|NCT02496299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254182|NCT02496299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25254183|NCT02496299|Glucocorticoids|glucocorticoids|mesh-ancestor
25254184|NCT02496299|Hormones|hormones|mesh-ancestor
25254185|NCT02496299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25254186|NCT02496299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25254187|NCT02496299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25254188|NCT02496299|Anesthetics, Local|anesthetics, local|mesh-ancestor
25254189|NCT02496299|Anesthetics|anesthetics|mesh-ancestor
24926341|NCT04142762|GABA Agents|gaba agents|mesh-ancestor
24926342|NCT04142762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24926343|NCT04142762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926344|NCT04142762|Estrogens|estrogens|mesh-ancestor
24926345|NCT04142762|Hormones|hormones|mesh-ancestor
24926346|NCT04142762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24926347|NCT04142762|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24926348|NCT04142762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24926349|NCT04142762|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24926350|NCT04142762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24926351|NCT04142762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24926352|NCT04142762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24926353|NCT04142762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24926354|NCT04142762|Antifungal Agents|antifungal agents|mesh-ancestor
24926355|NCT04142762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24926356|NCT04142762|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24926357|NCT04142762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24926358|NCT04142762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24400033|NCT00149292|Serotonin Agents|serotonin agents|mesh-ancestor
24926364|NCT04142762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24926385|NCT04142749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926386|NCT04142749|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24926387|NCT04142749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24926388|NCT04142749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24926389|NCT04142749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926390|NCT04142151|Aspirin|aspirin|mesh-list
24926391|NCT04142151|Clopidogrel|clopidogrel|mesh-list
24632512|NCT01124383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24926392|NCT04142151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24926393|NCT04142151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24926394|NCT04142151|Analgesics|analgesics|mesh-ancestor
24926395|NCT04142151|Sensory System Agents|sensory system agents|mesh-ancestor
24926396|NCT04142151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24926397|NCT04142151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926398|NCT04142151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25254190|NCT02496299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25254191|NCT02496299|Sensory System Agents|sensory system agents|mesh-ancestor
25254192|NCT02496286|Bevacizumab|bevacizumab|mesh-list
25254193|NCT02496286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25254194|NCT02496286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25254195|NCT02496286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25254196|NCT02496286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25254197|NCT02496286|Growth Substances|growth substances|mesh-ancestor
25254198|NCT02496286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254199|NCT02496286|Growth Inhibitors|growth inhibitors|mesh-ancestor
25254200|NCT02496182|Pirfenidone|pirfenidone|mesh-list
25254201|NCT02496182|Analgesics|analgesics|mesh-ancestor
25254202|NCT02496182|Sensory System Agents|sensory system agents|mesh-ancestor
25254203|NCT02496182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254204|NCT02496182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926407|NCT04142151|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24926408|NCT04142151|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24926409|NCT04142151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24926410|NCT04142151|Purinergic Agents|purinergic agents|mesh-ancestor
25687130|NCT01928719|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25687131|NCT01928719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24733206|NCT01644071|Dexetimide|dexetimide|mesh-list
24733207|NCT01644071|Citalopram|citalopram|mesh-list
24733208|NCT01644071|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24733211|NCT01644071|Autonomic Agents|autonomic agents|mesh-ancestor
24926411|NCT04142151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24926412|NCT04141995|Leucovorin|leucovorin|mesh-list
24926413|NCT04141995|Fluorouracil|fluorouracil|mesh-list
24926414|NCT04141995|Oxaliplatin|oxaliplatin|mesh-list
24583775|NCT00876850|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24583776|NCT00876850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24583777|NCT00876850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583778|NCT00876889|Riluzole|riluzole|mesh-list
24632514|NCT01124383|GABA Agents|gaba agents|mesh-ancestor
24583779|NCT00876889|Anticonvulsants|anticonvulsants|mesh-ancestor
24583864|NCT00877175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583865|NCT00877175|Protective Agents|protective agents|mesh-ancestor
24583866|NCT00877175|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24583867|NCT00877175|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24583868|NCT00877175|Cholinergic Agents|cholinergic agents|mesh-ancestor
24583869|NCT00877227|Leucovorin|leucovorin|mesh-list
25110123|NCT05465330|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24583870|NCT00877227|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
24583871|NCT00877227|Levoleucovorin|levoleucovorin|mesh-list
24583872|NCT00877227|Antidotes|antidotes|mesh-ancestor
24583873|NCT00877227|Protective Agents|protective agents|mesh-ancestor
24583874|NCT00877227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583875|NCT00877227|Vitamin B Complex|vitamin b complex|mesh-ancestor
24583876|NCT00877227|Vitamins|vitamins|mesh-ancestor
24583877|NCT00877227|Micronutrients|micronutrients|mesh-ancestor
24583878|NCT00877253|Carboplatin|carboplatin|mesh-list
24583879|NCT00877253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583880|NCT00877266|Mepivacaine|mepivacaine|mesh-list
24583881|NCT00877266|Anesthetics, Local|anesthetics, local|mesh-ancestor
24583882|NCT00877266|Anesthetics|anesthetics|mesh-ancestor
24583883|NCT00877266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24633081|NCT01127178|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2h)-one|mesh-list
24583893|NCT00877422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633083|NCT01127178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24583918|NCT00877591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24583919|NCT00877591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24583920|NCT00877591|Antiviral Agents|antiviral agents|mesh-ancestor
24583921|NCT00877591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24583922|NCT00877591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24583923|NCT00877591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24583924|NCT00877591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24583925|NCT00877591|Narcotics|narcotics|mesh-ancestor
24583926|NCT00877591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25110127|NCT05465330|Anesthetics, General|anesthetics, general|mesh-ancestor
24584065|NCT00878345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584067|NCT00878345|GABA Modulators|gaba modulators|mesh-ancestor
24584068|NCT00878345|GABA Agents|gaba agents|mesh-ancestor
24584069|NCT00878371|Morphine|morphine|mesh-list
24584070|NCT00878371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25254233|NCT02495922|Dexamethasone|dexamethasone|mesh-list
25254234|NCT02495922|Lenalidomide|lenalidomide|mesh-list
25254235|NCT02495922|Bortezomib|bortezomib|mesh-list
25254236|NCT02495922|Elotuzumab|elotuzumab|mesh-list
25254237|NCT02495922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25254238|NCT02495922|Antiemetics|antiemetics|mesh-ancestor
25254239|NCT02495922|Autonomic Agents|autonomic agents|mesh-ancestor
25254240|NCT02495922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254241|NCT02495922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254242|NCT02495922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24926416|NCT04141995|Camptothecin|camptothecin|mesh-list
24926417|NCT04141995|Digoxin|digoxin|mesh-list
24926418|NCT04141995|Calcium|calcium|mesh-list
24926419|NCT04141995|Levoleucovorin|levoleucovorin|mesh-list
24926420|NCT04141995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24926421|NCT04141995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926422|NCT04141995|Antimetabolites|antimetabolites|mesh-ancestor
24926423|NCT04141995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926424|NCT04141995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25687132|NCT01928719|Cholinergic Agents|cholinergic agents|mesh-ancestor
25687133|NCT01928719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25687134|NCT01928719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926425|NCT04141995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584071|NCT00878371|Narcotics|narcotics|mesh-ancestor
24584072|NCT00878371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25687135|NCT01928758|Nicotine|nicotine|mesh-list
24584073|NCT00878371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584077|NCT00878449|Etoposide|etoposide|mesh-list
24584097|NCT00878540|Antidepressive Agents|antidepressive agents|mesh-ancestor
24584098|NCT00878540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24584099|NCT00878540|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24584100|NCT00878540|Histamine Antagonists|histamine antagonists|mesh-ancestor
24584101|NCT00878540|Histamine Agents|histamine agents|mesh-ancestor
24584102|NCT00878540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24584103|NCT00878540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584104|NCT00878540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584105|NCT00878540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24584106|NCT00878540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24584107|NCT00878540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24584108|NCT00878540|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24584120|NCT00878657|Gemcitabine|gemcitabine|mesh-list
24671123|NCT01323608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671124|NCT01323608|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24584179|NCT00878917|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24584180|NCT00878917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584181|NCT00878917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584182|NCT00878943|Sildenafil Citrate|sildenafil citrate|mesh-list
24584183|NCT00878943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894557|NCT04439474|Vitamin D|vitamin d|mesh-list
24793563|NCT03123913|Androgens|androgens|mesh-ancestor
24793565|NCT03123913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24793566|NCT03123913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793567|NCT03123913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24793568|NCT03123913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793569|NCT03123913|Anabolic Agents|anabolic agents|mesh-ancestor
24793570|NCT03115567|Triamcinolone|triamcinolone|mesh-list
24793571|NCT03115567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24793572|NCT03115567|Glucocorticoids|glucocorticoids|mesh-ancestor
24793573|NCT03115567|Hormones|hormones|mesh-ancestor
24793574|NCT03115567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24793575|NCT03115567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793576|NCT03091881|Granisetron|granisetron|mesh-list
25110124|NCT05465330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25110125|NCT05465330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110126|NCT05465330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25254249|NCT02495922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25254250|NCT02495922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25254251|NCT02495922|Growth Substances|growth substances|mesh-ancestor
25254252|NCT02495922|Growth Inhibitors|growth inhibitors|mesh-ancestor
25254253|NCT02495688|Anesthetics|anesthetics|mesh-list
24926426|NCT04141995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24926427|NCT04141995|Immunologic Factors|immunologic factors|mesh-ancestor
24926428|NCT04141995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24926429|NCT04141995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24750582|NCT01699490|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24926430|NCT04141995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24926431|NCT04141995|Antidotes|antidotes|mesh-ancestor
24926432|NCT04141995|Protective Agents|protective agents|mesh-ancestor
24926433|NCT04141995|Vitamin B Complex|vitamin b complex|mesh-ancestor
24926434|NCT04141995|Vitamins|vitamins|mesh-ancestor
24926435|NCT04141995|Micronutrients|micronutrients|mesh-ancestor
24926436|NCT04141995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24926437|NCT04141995|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24926438|NCT04141995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24926439|NCT04142411|Insulin|insulin|mesh-list
24926440|NCT04142411|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24926441|NCT04142411|Hyaluronic Acid|hyaluronic acid|mesh-list
24926442|NCT04142411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24926443|NCT04142411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926444|NCT04142411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24926445|NCT04142411|Immunologic Factors|immunologic factors|mesh-ancestor
24926447|NCT04142411|Protective Agents|protective agents|mesh-ancestor
24926464|NCT04141410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926466|NCT04141410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570050|NCT00802828|Histamine Agents|histamine agents|mesh-ancestor
24584192|NCT00879008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24584193|NCT00879008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24584194|NCT00879008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24584195|NCT00879008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584196|NCT00879008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733430|NCT01646229|Polymyxin B|polymyxin b|mesh-list
24733431|NCT01646229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24733432|NCT01646229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24584197|NCT00879008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584198|NCT00879008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24584199|NCT00879008|Contraceptive Agents|contraceptive agents|mesh-ancestor
24584200|NCT00879008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24584201|NCT00879008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584202|NCT00879008|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24584203|NCT00879008|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24584204|NCT00879008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24584206|NCT00879021|Analgesics|analgesics|mesh-ancestor
24584207|NCT00879021|Sensory System Agents|sensory system agents|mesh-ancestor
24584208|NCT00879021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254254|NCT02495688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25254255|NCT02495688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254256|NCT02495584|Vitamin D|vitamin d|mesh-list
25254257|NCT02495584|Ergocalciferols|ergocalciferols|mesh-list
25254258|NCT02495584|Cholecalciferol|cholecalciferol|mesh-list
25254259|NCT02495584|Vitamins|vitamins|mesh-list
25254260|NCT02495584|Micronutrients|micronutrients|mesh-ancestor
25254261|NCT02495584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254262|NCT02495584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25254263|NCT02495584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25254264|NCT02495636|Atezolizumab|atezolizumab|mesh-list
25254265|NCT02495636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25254266|NCT02495818|Lidocaine|lidocaine|mesh-list
25254267|NCT02495818|Anesthetics, Local|anesthetics, local|mesh-ancestor
25254268|NCT02495818|Anesthetics|anesthetics|mesh-ancestor
25254269|NCT02495818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25254270|NCT02495818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254271|NCT02495818|Sensory System Agents|sensory system agents|mesh-ancestor
25254272|NCT02495818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254273|NCT02495818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25254274|NCT02495818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25254275|NCT02495818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25254276|NCT02495818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25254277|NCT02495818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254278|NCT02495662|Prednisolone|prednisolone|mesh-list
24926468|NCT04141553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24926469|NCT04141553|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24926470|NCT04141553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24926471|NCT04141553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926472|NCT04141553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24926473|NCT04141553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926474|NCT04141553|Vasodilator Agents|vasodilator agents|mesh-ancestor
24926475|NCT04141319|Ketorolac|ketorolac|mesh-list
24926476|NCT04141319|Epinephrine|epinephrine|mesh-list
24926477|NCT04141319|Ropivacaine|ropivacaine|mesh-list
24926478|NCT04141319|Anesthetics, Local|anesthetics, local|mesh-ancestor
24926479|NCT04141319|Anesthetics|anesthetics|mesh-ancestor
24926480|NCT04141319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24926481|NCT04141319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926482|NCT04141319|Sensory System Agents|sensory system agents|mesh-ancestor
24926483|NCT04141319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24926484|NCT04141319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24926485|NCT04141319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24926486|NCT04141319|Adrenergic Agents|adrenergic agents|mesh-ancestor
24926487|NCT04141319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24926488|NCT04141319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926489|NCT04141319|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24926490|NCT04141319|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24926491|NCT04141319|Autonomic Agents|autonomic agents|mesh-ancestor
24926492|NCT04141319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24926493|NCT04141319|Respiratory System Agents|respiratory system agents|mesh-ancestor
24926494|NCT04141319|Mydriatics|mydriatics|mesh-ancestor
24926495|NCT04141319|Sympathomimetics|sympathomimetics|mesh-ancestor
24926496|NCT04141319|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24926497|NCT04141319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24926498|NCT04141319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24926500|NCT04141319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25687136|NCT01928758|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25687137|NCT01928758|Autonomic Agents|autonomic agents|mesh-ancestor
25687138|NCT01928758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24926501|NCT04141319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24926502|NCT04141319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25254279|NCT02495662|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25254280|NCT02495662|Methylprednisolone|methylprednisolone|mesh-list
25254281|NCT02495662|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25254282|NCT02495662|Prednisolone acetate|prednisolone acetate|mesh-list
25254283|NCT02495662|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25254284|NCT02495662|Prednisolone phosphate|prednisolone phosphate|mesh-list
25254285|NCT02495662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25254286|NCT02495662|Glucocorticoids|glucocorticoids|mesh-ancestor
25254288|NCT02495662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25254289|NCT02495662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254290|NCT02495662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25254291|NCT02495662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25254292|NCT02495662|Antiemetics|antiemetics|mesh-ancestor
25254293|NCT02495662|Autonomic Agents|autonomic agents|mesh-ancestor
25254294|NCT02495662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254295|NCT02495662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25254296|NCT02495662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25254297|NCT02495662|Protective Agents|protective agents|mesh-ancestor
25254298|NCT02496052|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25254299|NCT02496052|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25254300|NCT02496052|Estradiol|estradiol|mesh-list
25254301|NCT02496052|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25254302|NCT02496052|Dydrogesterone|dydrogesterone|mesh-list
25254303|NCT02496052|Estrogens|estrogens|mesh-ancestor
25254304|NCT02496052|Hormones|hormones|mesh-ancestor
25254305|NCT02496052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25254306|NCT02496052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254307|NCT02496052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25254308|NCT02496052|Contraceptive Agents|contraceptive agents|mesh-ancestor
25254309|NCT02496052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25254310|NCT02496052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25254311|NCT02496052|Progestins|progestins|mesh-ancestor
25254312|NCT02495532|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25254313|NCT02495519|Imatinib Mesylate|imatinib mesylate|mesh-list
25254314|NCT02495519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25254315|NCT02495519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25254316|NCT02495519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25254317|NCT02495519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926517|NCT04140487|Venetoclax|venetoclax|mesh-list
24926518|NCT04140487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24926519|NCT04140487|Antimetabolites|antimetabolites|mesh-ancestor
24926520|NCT04140487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926521|NCT04140487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926522|NCT04140487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24926523|NCT04140448|Ranibizumab|ranibizumab|mesh-list
24926524|NCT04140448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24926525|NCT04140448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24926526|NCT04140448|Growth Substances|growth substances|mesh-ancestor
24926527|NCT04140448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926528|NCT04140448|Growth Inhibitors|growth inhibitors|mesh-ancestor
24926530|NCT04140513|Deoxyglucose|deoxyglucose|mesh-list
24926538|NCT04140461|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24926540|NCT04140461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24926541|NCT04140461|Amebicides|amebicides|mesh-ancestor
24926542|NCT04140461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24926543|NCT04140461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24926544|NCT04140461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24926545|NCT04140461|Antifungal Agents|antifungal agents|mesh-ancestor
24926546|NCT04140461|Antimetabolites|antimetabolites|mesh-ancestor
24926547|NCT04140461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926548|NCT04140591|Propranolol|propranolol|mesh-list
24926549|NCT04140591|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25049291|NCT00624858|Dopamine Agents|dopamine agents|mesh-ancestor
24584209|NCT00879021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584210|NCT00879021|Anticonvulsants|anticonvulsants|mesh-ancestor
24584255|NCT00879164|Sensory System Agents|sensory system agents|mesh-ancestor
24584256|NCT00879164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24584257|NCT00879177|Varenicline|varenicline|mesh-list
24584258|NCT00879177|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24584259|NCT00879177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24584336|NCT00879931|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24584337|NCT00879931|Prednisolone|prednisolone|mesh-list
24584338|NCT00879931|Prednisolone acetate|prednisolone acetate|mesh-list
24584339|NCT00879931|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24584340|NCT00879931|Prednisolone phosphate|prednisolone phosphate|mesh-list
24584341|NCT00879931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24584342|NCT00879931|Antiemetics|antiemetics|mesh-ancestor
24584343|NCT00879931|Autonomic Agents|autonomic agents|mesh-ancestor
24584344|NCT00879931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24584345|NCT00879931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584346|NCT00879931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24584347|NCT00879931|Glucocorticoids|glucocorticoids|mesh-ancestor
24584349|NCT00879931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24584350|NCT00879931|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24584395|NCT00880243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24584397|NCT00880243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584398|NCT00880243|Analgesics|analgesics|mesh-ancestor
24584399|NCT00880243|Sensory System Agents|sensory system agents|mesh-ancestor
24584400|NCT00880243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254318|NCT02495181|Aflibercept|aflibercept|mesh-list
25254319|NCT02495181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25102759|NCT03166787|Carbon Monoxide|carbon monoxide|mesh-list
25254320|NCT02495181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25254321|NCT02495181|Growth Substances|growth substances|mesh-ancestor
25254322|NCT02495181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254323|NCT02495181|Growth Inhibitors|growth inhibitors|mesh-ancestor
25254324|NCT02495181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25254325|NCT02495324|Valsartan|valsartan|mesh-list
25254326|NCT02495324|Olmesartan|olmesartan|mesh-list
25254327|NCT02495324|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25254328|NCT02495324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25254329|NCT02495324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25254330|NCT02495324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25254331|NCT02495324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274806|NCT02375217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25274807|NCT02375217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25274808|NCT02375217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25274809|NCT02375217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25274810|NCT02375139|Metformin|metformin|mesh-list
25274811|NCT02375139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25274812|NCT02375139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274813|NCT02375191|Fentanyl|fentanyl|mesh-list
25274814|NCT02375191|Dexmedetomidine|dexmedetomidine|mesh-list
25274815|NCT02375191|Ropivacaine|ropivacaine|mesh-list
25274816|NCT02375191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24926550|NCT04140591|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24926551|NCT04140591|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24926552|NCT04140591|Adrenergic Agents|adrenergic agents|mesh-ancestor
24926553|NCT04140591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24926554|NCT04140591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926555|NCT04140591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926556|NCT04140591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24926557|NCT04140591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24926558|NCT04140591|Vasodilator Agents|vasodilator agents|mesh-ancestor
24926559|NCT04140591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24926560|NCT04140422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24926561|NCT04140422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24926562|NCT04140409|Octreotide|octreotide|mesh-list
24926563|NCT04140409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24926564|NCT04140409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24926565|NCT04140409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926566|NCT04140318|Paclitaxel|paclitaxel|mesh-list
24926567|NCT04140318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24926568|NCT04140318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926570|NCT04140318|Antimitotic Agents|antimitotic agents|mesh-ancestor
24926571|NCT04140318|Mitosis Modulators|mitosis modulators|mesh-ancestor
24926572|NCT04140318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926573|NCT04140006|Alendronate|alendronate|mesh-list
24624404|NCT01076140|Protease Inhibitors|protease inhibitors|mesh-ancestor
24624405|NCT01076140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24624406|NCT01076140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25002753|NCT04369937|Pembrolizumab|pembrolizumab|mesh-list
24584401|NCT00880243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24584402|NCT00880282|Sirolimus|sirolimus|mesh-list
24584403|NCT00880282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24633189|NCT01127555|Antimetabolites|antimetabolites|mesh-ancestor
24584453|NCT00880386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733640|NCT01647685|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25051065|NCT00443287|Respiratory System Agents|respiratory system agents|mesh-ancestor
25051066|NCT00443287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25051067|NCT00443287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25051068|NCT00443287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051069|NCT00443287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25051070|NCT00443287|Vasodilator Agents|vasodilator agents|mesh-ancestor
24584455|NCT00880412|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24584456|NCT00880412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584457|NCT00880412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584458|NCT00880412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24584459|NCT00880412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24584460|NCT00880412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24584461|NCT00880412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584462|NCT00880412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24584464|NCT00880477|Vaccines|vaccines|mesh-list
24584465|NCT00880477|Pentetic Acid|pentetic acid|mesh-list
24584466|NCT00880477|Immunologic Factors|immunologic factors|mesh-ancestor
25254332|NCT02495220|Dexmedetomidine|dexmedetomidine|mesh-list
25254333|NCT02495220|Bupivacaine|bupivacaine|mesh-list
25254334|NCT02495220|Anesthetics, Local|anesthetics, local|mesh-ancestor
25254335|NCT02495220|Anesthetics|anesthetics|mesh-ancestor
25254336|NCT02495220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25254337|NCT02495220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254338|NCT02495220|Sensory System Agents|sensory system agents|mesh-ancestor
25254339|NCT02495220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254340|NCT02495220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25254341|NCT02495220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25254342|NCT02495220|Analgesics|analgesics|mesh-ancestor
25254343|NCT02495220|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25254345|NCT02495220|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25254346|NCT02495220|Adrenergic Agents|adrenergic agents|mesh-ancestor
25254347|NCT02495220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25254348|NCT02495220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254350|NCT02495285|Plasma Substitutes|plasma substitutes|mesh-ancestor
25254351|NCT02495285|Blood Substitutes|blood substitutes|mesh-ancestor
25254352|NCT02495272|Oxytocin|oxytocin|mesh-list
25254353|NCT02495272|Oxytocics|oxytocics|mesh-ancestor
25254354|NCT02495272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25254355|NCT02495272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254356|NCT02495415|Fenretinide|fenretinide|mesh-list
25254357|NCT02495415|Retinamide|retinamide|mesh-list
25254358|NCT02495415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25254359|NCT02495415|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25254360|NCT02495415|Protective Agents|protective agents|mesh-ancestor
25254361|NCT02495415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624407|NCT01076140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24624408|NCT01076140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24624409|NCT01076140|Protective Agents|protective agents|mesh-ancestor
24624410|NCT01076140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624411|NCT01076140|Vasodilator Agents|vasodilator agents|mesh-ancestor
24624427|NCT01076322|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24624428|NCT01076322|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24624429|NCT01076322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24624430|NCT01076322|Adrenergic Agents|adrenergic agents|mesh-ancestor
24624431|NCT01076322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24624432|NCT01076322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524227|NCT05149898|Anticonvulsants|anticonvulsants|mesh-ancestor
24524228|NCT05137730|Parathyroid Hormone|parathyroid hormone|mesh-list
24524229|NCT05137730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25001587|NCT05278338|Denosumab|denosumab|mesh-list
24524230|NCT05137730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24524231|NCT05128071|Progesterone|progesterone|mesh-list
24524232|NCT05128071|Progestins|progestins|mesh-ancestor
24524233|NCT05128071|Hormones|hormones|mesh-ancestor
24584467|NCT00880477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584468|NCT00880477|Antidotes|antidotes|mesh-ancestor
24584469|NCT00880477|Protective Agents|protective agents|mesh-ancestor
25687139|NCT01928758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687140|NCT01928758|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25687141|NCT01928758|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25687142|NCT01928758|Cholinergic Agents|cholinergic agents|mesh-ancestor
25687143|NCT01928758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25687144|NCT01928758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687145|NCT01928771|Benralizumab|benralizumab|mesh-list
24733724|NCT01648218|Insulin|insulin|mesh-list
24584470|NCT00880477|Chelating Agents|chelating agents|mesh-ancestor
24584471|NCT00880477|Sequestering Agents|sequestering agents|mesh-ancestor
24584472|NCT00880477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584474|NCT00880477|Anticoagulants|anticoagulants|mesh-ancestor
24584475|NCT00880477|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24584476|NCT00880529|Morphine|morphine|mesh-list
24584477|NCT00880529|Bupivacaine|bupivacaine|mesh-list
24584517|NCT00880815|Thymoglobulin|thymoglobulin|mesh-list
24584518|NCT00880815|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24584519|NCT00880815|Immunologic Factors|immunologic factors|mesh-ancestor
24584520|NCT00880815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584521|NCT00880815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584522|NCT00880815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24584523|NCT00880815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24584524|NCT00880815|Abortifacient Agents|abortifacient agents|mesh-ancestor
24584525|NCT00880815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24584562|NCT00881049|Imatinib Mesylate|imatinib mesylate|mesh-list
24584563|NCT00881049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584564|NCT00881049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24584565|NCT00881049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584566|NCT00881049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584568|NCT00881088|Nadroparin|nadroparin|mesh-list
24584569|NCT00881088|Fondaparinux|fondaparinux|mesh-list
24584570|NCT00881088|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24584571|NCT00881088|Antithrombins|antithrombins|mesh-ancestor
24584572|NCT00881088|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24584573|NCT00881088|Protease Inhibitors|protease inhibitors|mesh-ancestor
24584593|NCT00881127|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24584594|NCT00881127|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24513948|NCT00586443|Everolimus|everolimus|mesh-list
24584613|NCT00881140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25254362|NCT02495363|Bupivacaine|bupivacaine|mesh-list
25254363|NCT02495363|Anesthetics, Local|anesthetics, local|mesh-ancestor
25254364|NCT02495363|Anesthetics|anesthetics|mesh-ancestor
25254365|NCT02495363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25254366|NCT02495363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624436|NCT01076439|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
24624437|NCT01076439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24624438|NCT01076439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24624439|NCT01076439|Autonomic Agents|autonomic agents|mesh-ancestor
24624440|NCT01076439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24624441|NCT01076439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624442|NCT01076439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24624443|NCT01076439|Respiratory System Agents|respiratory system agents|mesh-ancestor
24624444|NCT01076439|Dermatologic Agents|dermatologic agents|mesh-ancestor
24624445|NCT01076439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24624446|NCT01076439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24624447|NCT01076439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24624448|NCT01076439|Analgesics|analgesics|mesh-ancestor
24584614|NCT00881140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584615|NCT00881140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24584616|NCT00881140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24584617|NCT00881140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25010429|NCT04066751|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25010430|NCT04066751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25010431|NCT04066751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010432|NCT04065789|Dexamethasone|dexamethasone|mesh-list
25010433|NCT04065789|Lenalidomide|lenalidomide|mesh-list
25010434|NCT04065789|Daratumumab|daratumumab|mesh-list
25010435|NCT04065789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25010436|NCT04065789|Antiemetics|antiemetics|mesh-ancestor
25010437|NCT04065789|Autonomic Agents|autonomic agents|mesh-ancestor
25010443|NCT04065789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25010444|NCT04065789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25010445|NCT04065789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010446|NCT04065789|Immunologic Factors|immunologic factors|mesh-ancestor
25010447|NCT04065789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25010448|NCT04065789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25010449|NCT04065789|Growth Substances|growth substances|mesh-ancestor
24584668|NCT00881231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24584669|NCT00881231|Respiratory System Agents|respiratory system agents|mesh-ancestor
24584670|NCT00881231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25687146|NCT01928771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24617446|NCT01043211|Respiratory System Agents|respiratory system agents|mesh-ancestor
24584671|NCT00881231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24584672|NCT00881231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584673|NCT00881231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25254388|NCT02494830|Ketamine|ketamine|mesh-list
25254389|NCT02494830|Analgesics|analgesics|mesh-ancestor
25254390|NCT02494830|Sensory System Agents|sensory system agents|mesh-ancestor
24633226|NCT01127672|Lidocaine|lidocaine|mesh-list
25254391|NCT02494830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254392|NCT02494830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254393|NCT02494830|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25254394|NCT02494830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25254395|NCT02494830|Anesthetics, General|anesthetics, general|mesh-ancestor
25254396|NCT02494830|Anesthetics|anesthetics|mesh-ancestor
25254397|NCT02494830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25254398|NCT02494830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25254399|NCT02494830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25254400|NCT02494830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25254401|NCT02494830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254402|NCT02494804|Temozolomide|temozolomide|mesh-list
25254403|NCT02494804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25254404|NCT02494804|Alkylating Agents|alkylating agents|mesh-ancestor
24624449|NCT01076439|Sensory System Agents|sensory system agents|mesh-ancestor
24624450|NCT01076439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24624451|NCT01076439|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24624452|NCT01076439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24624453|NCT01076439|Histamine Antagonists|histamine antagonists|mesh-ancestor
24624454|NCT01076439|Histamine Agents|histamine agents|mesh-ancestor
24624455|NCT01076439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24584674|NCT00881231|Vasodilator Agents|vasodilator agents|mesh-ancestor
24584675|NCT00881231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24584676|NCT00881231|Protective Agents|protective agents|mesh-ancestor
24584677|NCT00881231|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24584678|NCT00881231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24584679|NCT00881231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584680|NCT00881296|Gemcitabine|gemcitabine|mesh-list
24584681|NCT00881296|Carboplatin|carboplatin|mesh-list
24584682|NCT00881296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584683|NCT00881296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24584718|NCT00881413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24584719|NCT00881413|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24584720|NCT00881413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102760|NCT03166787|Vitamins|vitamins|mesh-ancestor
24584721|NCT00881413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584723|NCT00881426|Cephalosporins|cephalosporins|mesh-list
24584724|NCT00881426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24584725|NCT00881426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24584726|NCT00881491|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24584727|NCT00881491|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24584728|NCT00881491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24584729|NCT00881491|Antitubercular Agents|antitubercular agents|mesh-ancestor
24584730|NCT00881517|Immunoglobulins|immunoglobulins|mesh-list
24584731|NCT00881517|Immunologic Factors|immunologic factors|mesh-ancestor
24584732|NCT00881517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584733|NCT00881543|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24584734|NCT00881543|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24584735|NCT00881543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24584736|NCT00881543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584737|NCT00881543|Incretins|incretins|mesh-ancestor
24584738|NCT00881543|Hormones|hormones|mesh-ancestor
24584739|NCT00881543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24584740|NCT00881543|Protease Inhibitors|protease inhibitors|mesh-ancestor
24584773|NCT00881582|Interferon-alpha|interferon-alpha|mesh-list
24584774|NCT00881582|Interferon alpha-2|interferon alpha-2|mesh-list
24584775|NCT00881582|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24584776|NCT00881582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584777|NCT00881582|Antiviral Agents|antiviral agents|mesh-ancestor
24584778|NCT00881582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24584779|NCT00881582|Immunologic Factors|immunologic factors|mesh-ancestor
24584780|NCT00881582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584846|NCT00881764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010453|NCT04047953|Oxaliplatin|oxaliplatin|mesh-list
24904399|NCT04355845|Sumatriptan|sumatriptan|mesh-list
24584847|NCT00881790|Fluorides|fluorides|mesh-list
24584848|NCT00881790|Fluorides, Topical|fluorides, topical|mesh-list
25687147|NCT01928771|Respiratory System Agents|respiratory system agents|mesh-ancestor
24584849|NCT00881790|Cariostatic Agents|cariostatic agents|mesh-ancestor
24584850|NCT00881790|Protective Agents|protective agents|mesh-ancestor
24584851|NCT00881790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584853|NCT00881816|Capecitabine|capecitabine|mesh-list
24584854|NCT00881816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25254563|NCT02494284|Analgesics|analgesics|mesh-ancestor
24524437|NCT04922424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524438|NCT04922424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24524439|NCT04922424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24524440|NCT04922424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24524441|NCT04914741|Prednisolone|prednisolone|mesh-list
24524442|NCT04914741|Cyclophosphamide|cyclophosphamide|mesh-list
24524443|NCT04914741|Rituximab|rituximab|mesh-list
24926633|NCT04139824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584872|NCT00882024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24584873|NCT00882024|Analgesics|analgesics|mesh-ancestor
24584874|NCT00882024|Sensory System Agents|sensory system agents|mesh-ancestor
24584875|NCT00882024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24584955|NCT00882388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584956|NCT00882388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24584957|NCT00882388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24584958|NCT00882388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25254466|NCT02494895|Analgesics|analgesics|mesh-ancestor
25254467|NCT02494895|Sensory System Agents|sensory system agents|mesh-ancestor
25254468|NCT02494895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254469|NCT02494895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254470|NCT02494895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25254471|NCT02494895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25089505|NCT03265002|Cathartics|cathartics|mesh-ancestor
25254472|NCT02494895|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25254473|NCT02494895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25254480|NCT02494895|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25254481|NCT02494895|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25254482|NCT02494895|Purinergic Agents|purinergic agents|mesh-ancestor
25254483|NCT02494895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24524475|NCT04818229|Moxifloxacin|moxifloxacin|mesh-list
24524476|NCT04818229|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24524477|NCT04818229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24524478|NCT04818229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24524479|NCT04818229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24524480|NCT04818229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24926669|NCT04139629|Antibodies|antibodies|mesh-list
24926693|NCT04138979|Cyclophosphamide|cyclophosphamide|mesh-list
24926694|NCT04138979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24926695|NCT04138979|Immunologic Factors|immunologic factors|mesh-ancestor
24926696|NCT04138979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926697|NCT04138979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24926698|NCT04138979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24926699|NCT04138979|Alkylating Agents|alkylating agents|mesh-ancestor
24926700|NCT04138979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25002939|NCT04191616|Hormones|hormones|mesh-ancestor
24584960|NCT00882388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584961|NCT00882388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24570771|NCT00806741|Sympathomimetics|sympathomimetics|mesh-ancestor
24570772|NCT00806741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24585022|NCT00882765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585023|NCT00882765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585024|NCT00882765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24585025|NCT00882765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24585026|NCT00882765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585027|NCT00882765|Phytoestrogens|phytoestrogens|mesh-ancestor
24585028|NCT00882765|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24585029|NCT00882765|Estrogens|estrogens|mesh-ancestor
24585030|NCT00882765|Hormones|hormones|mesh-ancestor
24585031|NCT00882765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24585032|NCT00882856|Bisoprolol|bisoprolol|mesh-list
24585033|NCT00882856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24585034|NCT00882856|Sympatholytics|sympatholytics|mesh-ancestor
24585091|NCT00883194|Anesthetics, Local|anesthetics, local|mesh-ancestor
24585093|NCT00883194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24585094|NCT00883194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687148|NCT01928849|Valproic Acid|valproic acid|mesh-list
24585095|NCT00883194|Sensory System Agents|sensory system agents|mesh-ancestor
24585096|NCT00883194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24585116|NCT00883506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585119|NCT00883506|Protective Agents|protective agents|mesh-ancestor
25254485|NCT02494856|Esomeprazole|esomeprazole|mesh-list
25254486|NCT02494856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25254487|NCT02494856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25254488|NCT02494856|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25254489|NCT02494856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25254490|NCT02494856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254491|NCT02494856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25254492|NCT02494856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25254493|NCT02494856|Analgesics|analgesics|mesh-ancestor
25254494|NCT02494856|Sensory System Agents|sensory system agents|mesh-ancestor
25254495|NCT02494856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254496|NCT02494856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254497|NCT02494856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25254498|NCT02494856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25254499|NCT02494856|Gout Suppressants|gout suppressants|mesh-ancestor
25254500|NCT02494856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25254501|NCT02495064|Mometasone Furoate|mometasone furoate|mesh-list
25254502|NCT02495064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25254503|NCT02495064|Dermatologic Agents|dermatologic agents|mesh-ancestor
25254504|NCT02495064|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25254505|NCT02494687|Domperidone|domperidone|mesh-list
25254506|NCT02494687|Antiemetics|antiemetics|mesh-ancestor
25254507|NCT02494687|Autonomic Agents|autonomic agents|mesh-ancestor
25254508|NCT02494687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24926701|NCT04138979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926702|NCT04138979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24926705|NCT04138992|Docetaxel|docetaxel|mesh-list
24926706|NCT04138992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24926707|NCT04138992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926708|NCT04138992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24926709|NCT04138992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24926710|NCT04138992|Growth Substances|growth substances|mesh-ancestor
24926711|NCT04138992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926712|NCT04138992|Growth Inhibitors|growth inhibitors|mesh-ancestor
24926713|NCT04138992|Tubulin Modulators|tubulin modulators|mesh-ancestor
24926714|NCT04138992|Antimitotic Agents|antimitotic agents|mesh-ancestor
24926715|NCT04138992|Mitosis Modulators|mitosis modulators|mesh-ancestor
24926716|NCT04138992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926717|NCT04139070|Bleomycin|bleomycin|mesh-list
24524501|NCT04792190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24524502|NCT04792190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524503|NCT04772196|Vitamin D|vitamin d|mesh-list
24524504|NCT04772196|Cholecalciferol|cholecalciferol|mesh-list
24524505|NCT04772196|Vitamins|vitamins|mesh-ancestor
24524506|NCT04772196|Micronutrients|micronutrients|mesh-ancestor
24524548|NCT04739592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24444825|NCT00299234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926721|NCT04138901|Anesthetics, Local|anesthetics, local|mesh-ancestor
24926722|NCT04138901|Anesthetics|anesthetics|mesh-ancestor
25254509|NCT02494687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254510|NCT02494687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25254511|NCT02494687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25254512|NCT02494687|Dopamine Agents|dopamine agents|mesh-ancestor
25254513|NCT02494687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25254514|NCT02494687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254515|NCT02494609|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25254516|NCT02494609|Contraceptive Agents|contraceptive agents|mesh-list
25254517|NCT02494609|Contraceptives, Oral|contraceptives, oral|mesh-list
25254518|NCT02494609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25254519|NCT02494609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254520|NCT02494609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25254521|NCT02494609|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25254522|NCT02494609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254523|NCT02494609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25254524|NCT02494531|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25254525|NCT02494531|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25254672|NCT02493192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25254526|NCT02494531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254527|NCT02494505|Mycophenolic Acid|mycophenolic acid|mesh-list
25254528|NCT02494505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25254529|NCT02494505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25254530|NCT02494505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25254531|NCT02494505|Antitubercular Agents|antitubercular agents|mesh-ancestor
25254532|NCT02494505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25254533|NCT02494505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25254534|NCT02494505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25254535|NCT02494505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254536|NCT02494466|Montelukast|montelukast|mesh-list
25254537|NCT02494466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25254538|NCT02494466|Respiratory System Agents|respiratory system agents|mesh-ancestor
25254539|NCT02494466|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25254540|NCT02494466|Hormone Antagonists|hormone antagonists|mesh-ancestor
25254541|NCT02494466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25254542|NCT02494466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254579|NCT02494284|Purinergic Agents|purinergic agents|mesh-ancestor
25254544|NCT02494466|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25254545|NCT02494466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254546|NCT02494349|Tamsulosin|tamsulosin|mesh-list
25254547|NCT02494349|Solifenacin Succinate|solifenacin succinate|mesh-list
25254548|NCT02494349|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25254549|NCT02494349|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25254550|NCT02494349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25254551|NCT02494349|Adrenergic Agents|adrenergic agents|mesh-ancestor
24926744|NCT04138888|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24926745|NCT04138888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24926746|NCT04138888|Diuretics|diuretics|mesh-ancestor
24926747|NCT04138888|Natriuretic Agents|natriuretic agents|mesh-ancestor
24926748|NCT04138888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926749|NCT04138888|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24926750|NCT04138888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24926751|NCT04138888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926754|NCT04138836|Itraconazole|itraconazole|mesh-list
24926758|NCT04138836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24926759|NCT04138836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24926760|NCT04138836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926761|NCT04138836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24926762|NCT04138836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24926763|NCT04138836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24926764|NCT04138836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24926765|NCT04138836|Anesthetics, General|anesthetics, general|mesh-ancestor
24926766|NCT04138836|Anesthetics|anesthetics|mesh-ancestor
24926767|NCT04138836|GABA Modulators|gaba modulators|mesh-ancestor
24926768|NCT04138836|GABA Agents|gaba agents|mesh-ancestor
24926769|NCT04138836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24926770|NCT04138836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926771|NCT04138836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24926772|NCT04138836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24926773|NCT04138836|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24926774|NCT04138836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24926775|NCT04138836|Antifungal Agents|antifungal agents|mesh-ancestor
24926776|NCT04138836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24926777|NCT04138836|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24926778|NCT04138836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24926779|NCT04138836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24926780|NCT04138836|Hormone Antagonists|hormone antagonists|mesh-ancestor
24400774|NCT00151255|Keratolytic Agents|keratolytic agents|mesh-ancestor
24524558|NCT04703075|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24585120|NCT00883506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585121|NCT00883532|Budesonide|budesonide|mesh-list
25254552|NCT02494349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25254553|NCT02494349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254554|NCT02494349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254555|NCT02494349|Urological Agents|urological agents|mesh-ancestor
25254556|NCT02494349|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25254557|NCT02494349|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25254558|NCT02494349|Cholinergic Agents|cholinergic agents|mesh-ancestor
25254559|NCT02494284|Aspirin|aspirin|mesh-list
25254560|NCT02494284|Clopidogrel|clopidogrel|mesh-list
25254561|NCT02494284|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25254562|NCT02494284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25254564|NCT02494284|Sensory System Agents|sensory system agents|mesh-ancestor
25254565|NCT02494284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24734377|NCT01652014|Tacrolimus|tacrolimus|mesh-list
25254566|NCT02494284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254567|NCT02494284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25254568|NCT02494284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25254569|NCT02494284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25254570|NCT02494284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25254571|NCT02494284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721377|NCT01573741|Ketamine|ketamine|mesh-list
25254572|NCT02494284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25254573|NCT02494284|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25254574|NCT02494284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25254575|NCT02494284|Antipyretics|antipyretics|mesh-ancestor
25254576|NCT02494284|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25254577|NCT02494284|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25254578|NCT02494284|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25254580|NCT02494284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25254581|NCT02493933|Acetylcysteine|acetylcysteine|mesh-list
25254582|NCT02493933|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25254583|NCT02493933|Phytoestrogens|phytoestrogens|mesh-list
25254584|NCT02493933|Antiviral Agents|antiviral agents|mesh-ancestor
25254585|NCT02493933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25254586|NCT02493933|Expectorants|expectorants|mesh-ancestor
24524582|NCT04688658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24524584|NCT04666961|Tamoxifen|tamoxifen|mesh-list
24524585|NCT04666961|Anastrozole|anastrozole|mesh-list
24926792|NCT04138719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926793|NCT04138719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24926794|NCT04138719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24926795|NCT04138719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24926796|NCT04138719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24926797|NCT04138368|Psychotropic Drugs|psychotropic drugs|mesh-list
24926798|NCT04138290|Antidepressive Agents|antidepressive agents|mesh-list
24926799|NCT04138290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24926801|NCT04138472|Fentanyl|fentanyl|mesh-list
24926802|NCT04138472|Dexmedetomidine|dexmedetomidine|mesh-list
24926803|NCT04138472|Anesthetics, Local|anesthetics, local|mesh-ancestor
24633496|NCT01129596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24633497|NCT01129596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633498|NCT01129596|Nootropic Agents|nootropic agents|mesh-ancestor
24633499|NCT01129713|Esomeprazole|esomeprazole|mesh-list
24633500|NCT01129713|Omeprazole|omeprazole|mesh-list
24633501|NCT01129713|Lansoprazole|lansoprazole|mesh-list
24926804|NCT04138472|Anesthetics|anesthetics|mesh-ancestor
24926805|NCT04138472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24926806|NCT04138472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926807|NCT04138472|Sensory System Agents|sensory system agents|mesh-ancestor
24926808|NCT04138472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24926809|NCT04138472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24926810|NCT04138472|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24926811|NCT04138472|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24926812|NCT04138472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24926813|NCT04138472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926814|NCT04138472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24998416|NCT02881957|Cholecalciferol|cholecalciferol|mesh-list
24926815|NCT04138472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24926816|NCT04138472|Analgesics|analgesics|mesh-ancestor
24926817|NCT04138472|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24926818|NCT04138472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24926819|NCT04138472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24926820|NCT04138472|Adrenergic Agents|adrenergic agents|mesh-ancestor
24926821|NCT04138472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24585122|NCT00883532|Pulmonary Surfactants|pulmonary surfactants|mesh-list
24585123|NCT00883532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24585124|NCT00883532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24585126|NCT00883532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24585127|NCT00883532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585128|NCT00883532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24585129|NCT00883532|Respiratory System Agents|respiratory system agents|mesh-ancestor
25254587|NCT02493933|Respiratory System Agents|respiratory system agents|mesh-ancestor
25254588|NCT02493933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25254589|NCT02493933|Antioxidants|antioxidants|mesh-ancestor
25254590|NCT02493933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254591|NCT02493933|Protective Agents|protective agents|mesh-ancestor
25254592|NCT02493933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254593|NCT02493933|Antidotes|antidotes|mesh-ancestor
25254594|NCT02493933|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25687149|NCT01928849|Anticonvulsants|anticonvulsants|mesh-ancestor
25254595|NCT02493933|Estrogens|estrogens|mesh-ancestor
25254596|NCT02493933|Hormones|hormones|mesh-ancestor
25254597|NCT02493933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25254598|NCT02493959|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25254599|NCT02493959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25254600|NCT02493959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254601|NCT02493959|Incretins|incretins|mesh-ancestor
25254602|NCT02493959|Hormones|hormones|mesh-ancestor
25254603|NCT02493959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25254604|NCT02493959|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25254605|NCT02493959|Protease Inhibitors|protease inhibitors|mesh-ancestor
25254606|NCT02493959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25254607|NCT02493959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254608|NCT02493894|Cefazolin|cefazolin|mesh-list
25254609|NCT02493894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25254611|NCT02493725|Eculizumab|eculizumab|mesh-list
25254612|NCT02493725|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25254613|NCT02493725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25254614|NCT02493725|Immunologic Factors|immunologic factors|mesh-ancestor
25254615|NCT02493725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254616|NCT02493738|Itraconazole|itraconazole|mesh-list
25254617|NCT02493738|Antifungal Agents|antifungal agents|mesh-ancestor
25254618|NCT02493738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25254619|NCT02493738|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24926822|NCT04138472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24926823|NCT04138472|Narcotics|narcotics|mesh-ancestor
24926824|NCT04138472|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24926825|NCT04138472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24926832|NCT04138264|Sensory System Agents|sensory system agents|mesh-ancestor
24926833|NCT04138264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24926834|NCT04138485|Immunoglobulins|immunoglobulins|mesh-list
24926835|NCT04138485|Immunologic Factors|immunologic factors|mesh-ancestor
24926836|NCT04138485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926837|NCT04138251|Empagliflozin|empagliflozin|mesh-list
24926838|NCT04138251|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24926839|NCT04138251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926840|NCT04138251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24926841|NCT04138251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926842|NCT04137978|Potassium Citrate|potassium citrate|mesh-list
24926843|NCT04137978|Diuretics|diuretics|mesh-ancestor
24926844|NCT04137978|Natriuretic Agents|natriuretic agents|mesh-ancestor
24926845|NCT04137978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926855|NCT04138238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24926856|NCT04138238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926857|NCT04138238|Antifungal Agents|antifungal agents|mesh-ancestor
24926858|NCT04138238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24926859|NCT04138238|Immunologic Factors|immunologic factors|mesh-ancestor
24926860|NCT04138238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524586|NCT04666961|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24524587|NCT04666961|Hormone Antagonists|hormone antagonists|mesh-ancestor
24524588|NCT04666961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24524589|NCT04666961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524590|NCT04666961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24524591|NCT04666961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24524592|NCT04666961|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24524593|NCT04666961|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24524594|NCT04666961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24524595|NCT04666961|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24585130|NCT00883532|Glucocorticoids|glucocorticoids|mesh-ancestor
24585131|NCT00883532|Hormones|hormones|mesh-ancestor
25254620|NCT02493738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25254621|NCT02493738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25254622|NCT02493738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254623|NCT02493738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25254624|NCT02493738|Hormone Antagonists|hormone antagonists|mesh-ancestor
25254625|NCT02493738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25254626|NCT02493738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254627|NCT02493738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25254628|NCT02493582|Apatinib|apatinib|mesh-list
25254629|NCT02493582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25254630|NCT02493582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25254631|NCT02493582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404151|NCT03682068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254632|NCT02493582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254634|NCT02493504|Anticoagulants|anticoagulants|mesh-ancestor
25254635|NCT02493504|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25254636|NCT02493504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25254637|NCT02493504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254638|NCT02493465|Everolimus|everolimus|mesh-list
25254639|NCT02493465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25254640|NCT02493465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25254641|NCT02493465|Immunologic Factors|immunologic factors|mesh-ancestor
25254642|NCT02493465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274817|NCT02375191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25274818|NCT02375191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274819|NCT02375191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25274826|NCT02375191|Adrenergic Agents|adrenergic agents|mesh-ancestor
25274827|NCT02375191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24524596|NCT04666961|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24502719|NCT04630886|Hemostatics|hemostatics|mesh-ancestor
24926869|NCT04137640|Cyclophosphamide|cyclophosphamide|mesh-list
24926871|NCT04137640|Letrozole|letrozole|mesh-list
24926872|NCT04137640|Epirubicin|epirubicin|mesh-list
24926873|NCT04137640|Palbociclib|palbociclib|mesh-list
24926874|NCT04137640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24926875|NCT04137640|Immunologic Factors|immunologic factors|mesh-ancestor
24926876|NCT04137640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926877|NCT04137640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24585132|NCT00883532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24585133|NCT00883623|Lenalidomide|lenalidomide|mesh-list
24585134|NCT00883623|Immunologic Factors|immunologic factors|mesh-ancestor
24585175|NCT00883935|Dolutegravir|dolutegravir|mesh-list
24585176|NCT00883935|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24585177|NCT00883935|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24633274|NCT01127880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633275|NCT01127906|Oxycodone|oxycodone|mesh-list
24585178|NCT00883935|Protease Inhibitors|protease inhibitors|mesh-ancestor
24585201|NCT00884260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585202|NCT00884260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24585203|NCT00884260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24585204|NCT00884260|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24585205|NCT00884299|Antioxidants|antioxidants|mesh-list
24585206|NCT00884299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585207|NCT00884299|Protective Agents|protective agents|mesh-ancestor
24585208|NCT00884299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585209|NCT00884416|Sorafenib|sorafenib|mesh-list
24585210|NCT00884416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585211|NCT00884416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24585226|NCT00884494|Insulin|insulin|mesh-list
24585256|NCT00884663|Propranolol|propranolol|mesh-list
24585257|NCT00884663|Candesartan|candesartan|mesh-list
24585258|NCT00884663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24585259|NCT00884663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24585260|NCT00884663|Adrenergic Agents|adrenergic agents|mesh-ancestor
24585261|NCT00884663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24585262|NCT00884663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585263|NCT00884663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585264|NCT00884663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24585265|NCT00884663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24585266|NCT00884663|Vasodilator Agents|vasodilator agents|mesh-ancestor
24633290|NCT01128075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633291|NCT01128075|Antiviral Agents|antiviral agents|mesh-ancestor
24585267|NCT00884663|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24585268|NCT00884663|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24585270|NCT00884676|Epothilone B|epothilone b|mesh-list
24585271|NCT00884676|Epothilones|epothilones|mesh-list
24585272|NCT00884676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585273|NCT00884676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24585274|NCT00884676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24585275|NCT00884676|Growth Substances|growth substances|mesh-ancestor
25254643|NCT02493335|Budesonide|budesonide|mesh-list
25254644|NCT02493335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24633641|NCT01130506|Cytarabine|cytarabine|mesh-list
24633702|NCT01130805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24633703|NCT01130805|Antimetabolites|antimetabolites|mesh-ancestor
25687150|NCT01928849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25254645|NCT02493335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24734765|NCT01653665|Sargramostim|sargramostim|mesh-list
24734766|NCT01653665|Immunologic Factors|immunologic factors|mesh-ancestor
24734767|NCT01653665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734776|NCT01653717|Vidarabine|vidarabine|mesh-list
24734777|NCT01653717|Cyclophosphamide|cyclophosphamide|mesh-list
24734778|NCT01653717|Fludarabine|fludarabine|mesh-list
24734779|NCT01653717|Fludarabine phosphate|fludarabine phosphate|mesh-list
24734780|NCT01653717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24734800|NCT01653990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25254646|NCT02493335|Autonomic Agents|autonomic agents|mesh-ancestor
25254647|NCT02493335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254648|NCT02493335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254649|NCT02493335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25254650|NCT02493335|Respiratory System Agents|respiratory system agents|mesh-ancestor
25254651|NCT02493335|Glucocorticoids|glucocorticoids|mesh-ancestor
25254653|NCT02493335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25254654|NCT02493179|Serratiopeptidase|serratiopeptidase|mesh-list
25254655|NCT02493179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25254656|NCT02493179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25254657|NCT02493179|Analgesics|analgesics|mesh-ancestor
25254658|NCT02493179|Sensory System Agents|sensory system agents|mesh-ancestor
24926878|NCT04137640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24926879|NCT04137640|Alkylating Agents|alkylating agents|mesh-ancestor
24926880|NCT04137640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926920|NCT04137432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926921|NCT04137198|Sufentanil|sufentanil|mesh-list
24926922|NCT04137198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24926923|NCT04137198|Narcotics|narcotics|mesh-ancestor
24926924|NCT04137198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24926925|NCT04137198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926926|NCT04137198|Analgesics|analgesics|mesh-ancestor
24926927|NCT04137198|Sensory System Agents|sensory system agents|mesh-ancestor
24926928|NCT04137198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24926929|NCT04137198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24926930|NCT04137198|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24926931|NCT04137198|Anesthetics, General|anesthetics, general|mesh-ancestor
24926932|NCT04137198|Anesthetics|anesthetics|mesh-ancestor
24926934|NCT04137185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24926935|NCT04137185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926936|NCT04137328|Liraglutide|liraglutide|mesh-list
24926937|NCT04137328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24926938|NCT04137328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585276|NCT00884676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585277|NCT00884676|Growth Inhibitors|growth inhibitors|mesh-ancestor
24585288|NCT00884767|Levoleucovorin|levoleucovorin|mesh-list
24585290|NCT00884767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586744|NCT00892112|Plasma Substitutes|plasma substitutes|mesh-list
24586745|NCT00892112|Immunoglobulins|immunoglobulins|mesh-list
24586746|NCT00892112|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24586747|NCT00892112|Antibodies|antibodies|mesh-list
24586748|NCT00892112|gamma-Globulins|gamma-globulins|mesh-list
24586749|NCT00892112|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24586750|NCT00892112|Immunologic Factors|immunologic factors|mesh-ancestor
24586751|NCT00892112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586752|NCT00892112|Blood Substitutes|blood substitutes|mesh-ancestor
24586753|NCT00892125|Carbamazepine|carbamazepine|mesh-list
24586754|NCT00892125|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24586755|NCT00892125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24586756|NCT00892125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24793632|NCT02897063|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24585354|NCT00885066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585355|NCT00885066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24585356|NCT00885274|Magnesium Oxide|magnesium oxide|mesh-list
25010454|NCT04047953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25010455|NCT04047953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010456|NCT04047953|Tubulin Modulators|tubulin modulators|mesh-ancestor
25010457|NCT04047953|Antimitotic Agents|antimitotic agents|mesh-ancestor
25687151|NCT01928849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687152|NCT01928849|GABA Agents|gaba agents|mesh-ancestor
25687153|NCT01928849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25687154|NCT01928849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687155|NCT01928849|Antimanic Agents|antimanic agents|mesh-ancestor
25687156|NCT01928849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25687157|NCT01928849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25687158|NCT01928849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24942599|NCT03979469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24942600|NCT03979469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24942601|NCT03979469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24942602|NCT03979469|Adrenergic Agents|adrenergic agents|mesh-ancestor
24942603|NCT03979469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24942604|NCT03979469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942605|NCT03979469|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24942606|NCT03979469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24942607|NCT03979469|Anesthetics, General|anesthetics, general|mesh-ancestor
25010458|NCT04047953|Mitosis Modulators|mitosis modulators|mesh-ancestor
25010459|NCT04047953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010460|NCT04031599|Hormones|hormones|mesh-list
24585407|NCT00885443|Anesthetics, General|anesthetics, general|mesh-ancestor
24585409|NCT00885443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25254659|NCT02493179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254660|NCT02493179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254661|NCT02493179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25254662|NCT02493179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25254663|NCT02493192|Meperidine|meperidine|mesh-list
25254664|NCT02493192|Haloperidol|haloperidol|mesh-list
25254665|NCT02493192|Haloperidol decanoate|haloperidol decanoate|mesh-list
25254666|NCT02493192|Antiemetics|antiemetics|mesh-ancestor
25254667|NCT02493192|Autonomic Agents|autonomic agents|mesh-ancestor
25254668|NCT02493192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254669|NCT02493192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254670|NCT02493192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25254671|NCT02493192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25254683|NCT02493192|Sensory System Agents|sensory system agents|mesh-ancestor
25254684|NCT02493192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25254685|NCT02493283|Dapsone|dapsone|mesh-list
25254686|NCT02493283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25254687|NCT02493283|Antimalarials|antimalarials|mesh-ancestor
25254688|NCT02493283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24394722|NCT00134030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25089705|NCT03263299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25089706|NCT03263299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25089707|NCT03263299|Analgesics|analgesics|mesh-ancestor
25089708|NCT03263299|Sensory System Agents|sensory system agents|mesh-ancestor
25254689|NCT02493283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25254690|NCT02493283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25254691|NCT02493283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25254692|NCT02493283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254693|NCT02493283|Leprostatic Agents|leprostatic agents|mesh-ancestor
25254694|NCT02493283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25254695|NCT02493231|Ketamine|ketamine|mesh-list
25254696|NCT02493231|Nefopam|nefopam|mesh-list
25254697|NCT02493231|Analgesics|analgesics|mesh-ancestor
25254698|NCT02493231|Sensory System Agents|sensory system agents|mesh-ancestor
25254699|NCT02493231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254700|NCT02493231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254701|NCT02493231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25254702|NCT02493231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25254703|NCT02493231|Anesthetics, General|anesthetics, general|mesh-ancestor
25254704|NCT02493231|Anesthetics|anesthetics|mesh-ancestor
25254705|NCT02493231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25254706|NCT02493231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25254707|NCT02493231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25254708|NCT02493231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25254709|NCT02493231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254710|NCT02493231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25254711|NCT02493049|Domperidone|domperidone|mesh-list
25254712|NCT02493049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254713|NCT02493049|Antiemetics|antiemetics|mesh-ancestor
25254714|NCT02493049|Autonomic Agents|autonomic agents|mesh-ancestor
25254715|NCT02493049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25687159|NCT01928927|Telmisartan|telmisartan|mesh-list
25687160|NCT01928927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25687161|NCT01928927|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25687162|NCT01928927|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25687163|NCT01928927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687164|NCT01928940|Trametinib|trametinib|mesh-list
25687165|NCT01928940|Dabrafenib|dabrafenib|mesh-list
25687166|NCT01928940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25687167|NCT01928940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24734929|NCT01654731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25254716|NCT02493049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254717|NCT02493049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25254718|NCT02493049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25254719|NCT02493049|Dopamine Agents|dopamine agents|mesh-ancestor
25254720|NCT02493049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24926969|NCT04137029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24926970|NCT04137029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926971|NCT04137029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24926972|NCT04137029|Respiratory System Agents|respiratory system agents|mesh-ancestor
24926973|NCT04137029|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25254739|NCT02492945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254740|NCT02492945|Sensory System Agents|sensory system agents|mesh-ancestor
25254741|NCT02492945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254742|NCT02492945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25254743|NCT02492945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25254744|NCT02492945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25254745|NCT02492945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25254746|NCT02492945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254748|NCT02492503|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25254749|NCT02492503|Carboplatin|carboplatin|mesh-list
25254750|NCT02492503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25254751|NCT02492503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25254752|NCT02492503|Tubulin Modulators|tubulin modulators|mesh-ancestor
25254753|NCT02492503|Antimitotic Agents|antimitotic agents|mesh-ancestor
25254754|NCT02492503|Mitosis Modulators|mitosis modulators|mesh-ancestor
25254755|NCT02492503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254756|NCT02492477|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25254757|NCT02492477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25254758|NCT02492477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25254759|NCT02492477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254760|NCT02492464|Red yeast rice|red yeast rice|mesh-list
25254761|NCT02492464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25254762|NCT02492464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25254763|NCT02492464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25254764|NCT02492464|Antimetabolites|antimetabolites|mesh-ancestor
25254765|NCT02492464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254766|NCT02492464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25254767|NCT02492464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25254768|NCT02492412|Cyclosporine|cyclosporine|mesh-list
25254769|NCT02492412|Cyclosporins|cyclosporins|mesh-list
25254770|NCT02492412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25254771|NCT02492412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254772|NCT02492412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25254773|NCT02492412|Immunologic Factors|immunologic factors|mesh-ancestor
25254774|NCT02492412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254775|NCT02492412|Antifungal Agents|antifungal agents|mesh-ancestor
25254776|NCT02492412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25254777|NCT02492412|Dermatologic Agents|dermatologic agents|mesh-ancestor
25254778|NCT02492412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25254779|NCT02492412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25254780|NCT02492568|Pembrolizumab|pembrolizumab|mesh-list
25254781|NCT02492568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25254782|NCT02492568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25254783|NCT02492386|Everolimus|everolimus|mesh-list
25254784|NCT02492386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25254789|NCT02492438|Immunologic Factors|immunologic factors|mesh-ancestor
25254790|NCT02492438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254791|NCT02492581|Nalmefene|nalmefene|mesh-list
25254792|NCT02492581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25254793|NCT02492581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254794|NCT02492581|Sensory System Agents|sensory system agents|mesh-ancestor
24926982|NCT04137029|Anticonvulsants|anticonvulsants|mesh-ancestor
24926983|NCT04136886|Cisplatin|cisplatin|mesh-list
24926984|NCT04136886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926985|NCT04136613|Copper|copper|mesh-list
25102761|NCT03166787|Micronutrients|micronutrients|mesh-ancestor
24926999|NCT04136743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24927001|NCT04136782|Paclitaxel|paclitaxel|mesh-list
24927002|NCT04136782|Docetaxel|docetaxel|mesh-list
24927003|NCT04136782|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24927004|NCT04136782|Carboplatin|carboplatin|mesh-list
24927005|NCT04136782|Epirubicin|epirubicin|mesh-list
24927006|NCT04136782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25687168|NCT01928940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927007|NCT04136782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585410|NCT00885443|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24585411|NCT00885508|Lenalidomide|lenalidomide|mesh-list
24585412|NCT00885508|Immunologic Factors|immunologic factors|mesh-ancestor
24585413|NCT00885508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585414|NCT00885508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24585415|NCT00885508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24585416|NCT00885508|Growth Substances|growth substances|mesh-ancestor
24585417|NCT00885508|Growth Inhibitors|growth inhibitors|mesh-ancestor
24585418|NCT00885508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585420|NCT00885586|Analgesics|analgesics|mesh-ancestor
24585421|NCT00885586|Sensory System Agents|sensory system agents|mesh-ancestor
24585422|NCT00885586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24585423|NCT00885586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585424|NCT00885586|Anticonvulsants|anticonvulsants|mesh-ancestor
24585425|NCT00885586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24585426|NCT00885586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24585427|NCT00885586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24585428|NCT00885586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24585429|NCT00885586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24585430|NCT00885586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24585431|NCT00885586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24585432|NCT00885586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585433|NCT00885586|Antimanic Agents|antimanic agents|mesh-ancestor
24633383|NCT01129258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24585434|NCT00885599|Listerine|listerine|mesh-list
24585435|NCT00885599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
24585458|NCT00885690|Sertindole|sertindole|mesh-list
24585459|NCT00885690|Antiemetics|antiemetics|mesh-ancestor
24585460|NCT00885690|Autonomic Agents|autonomic agents|mesh-ancestor
24585461|NCT00885690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24585462|NCT00885690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585463|NCT00885690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24585464|NCT00885690|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24585465|NCT00885690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24585564|NCT00886106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24585565|NCT00886106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24585566|NCT00886106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24585567|NCT00886106|Anesthetics, General|anesthetics, general|mesh-ancestor
24585569|NCT00886106|GABA Modulators|gaba modulators|mesh-ancestor
24585608|NCT00886275|Anesthetics, General|anesthetics, general|mesh-ancestor
24585609|NCT00886275|Anesthetics|anesthetics|mesh-ancestor
24585610|NCT00886275|GABA Modulators|gaba modulators|mesh-ancestor
24585611|NCT00886275|GABA Agents|gaba agents|mesh-ancestor
24585613|NCT00886314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24585614|NCT00886314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24585615|NCT00886314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24585616|NCT00886314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585617|NCT00886314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25254795|NCT02492581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254796|NCT02492373|Clobetasol|clobetasol|mesh-list
25254797|NCT02492373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25254798|NCT02492373|Glucocorticoids|glucocorticoids|mesh-ancestor
25254799|NCT02492373|Hormones|hormones|mesh-ancestor
25254800|NCT02492373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25254801|NCT02492373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254802|NCT02492490|Basiliximab|basiliximab|mesh-list
25254803|NCT02492490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25254804|NCT02492490|Immunologic Factors|immunologic factors|mesh-ancestor
25254805|NCT02492490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254806|NCT02492308|Basiliximab|basiliximab|mesh-list
24927008|NCT04136782|Tubulin Modulators|tubulin modulators|mesh-ancestor
24927009|NCT04136782|Antimitotic Agents|antimitotic agents|mesh-ancestor
24927010|NCT04136782|Mitosis Modulators|mitosis modulators|mesh-ancestor
24927011|NCT04136782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927012|NCT04136782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24927013|NCT04136782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24524755|NCT04446962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524756|NCT04446962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24524757|NCT04446962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24524779|NCT04369742|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24524780|NCT04369742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524781|NCT04369742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524782|NCT04369742|Antimalarials|antimalarials|mesh-ancestor
24524784|NCT04369742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24524785|NCT04369742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24524786|NCT04369742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24524787|NCT04369742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24927014|NCT04136782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24927015|NCT04136782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927017|NCT04136535|Pemetrexed|pemetrexed|mesh-list
24965443|NCT03776851|Hematinics|hematinics|mesh-ancestor
24927018|NCT04136535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751154|NCT01702506|Antacids|antacids|mesh-list
24927019|NCT04136535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927020|NCT04136535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927022|NCT04136535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24927025|NCT04136639|Fluorides|fluorides|mesh-list
25254807|NCT02492308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25254808|NCT02492308|Immunologic Factors|immunologic factors|mesh-ancestor
25254809|NCT02492308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254810|NCT02492360|Cisplatin|cisplatin|mesh-list
25254811|NCT02492360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25254812|NCT02492282|Remifentanil|remifentanil|mesh-list
25254813|NCT02492282|Propofol|propofol|mesh-list
25254814|NCT02492282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25254815|NCT02492282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25254816|NCT02492282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254817|NCT02492282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25254818|NCT02492282|Anesthetics, General|anesthetics, general|mesh-ancestor
25254819|NCT02492282|Anesthetics|anesthetics|mesh-ancestor
25254820|NCT02492282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25254821|NCT02492282|Narcotics|narcotics|mesh-ancestor
25254822|NCT02492282|Analgesics|analgesics|mesh-ancestor
25254823|NCT02492282|Sensory System Agents|sensory system agents|mesh-ancestor
25254824|NCT02492282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254825|NCT02492126|Citric Acid|citric acid|mesh-list
25254826|NCT02492126|Sodium Citrate|sodium citrate|mesh-list
25254827|NCT02492126|Anticoagulants|anticoagulants|mesh-ancestor
25254828|NCT02492126|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25254829|NCT02492126|Chelating Agents|chelating agents|mesh-ancestor
25254830|NCT02492126|Sequestering Agents|sequestering agents|mesh-ancestor
25254831|NCT02492126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254832|NCT02492230|Warfarin|warfarin|mesh-list
25254833|NCT02492230|Anticoagulants|anticoagulants|mesh-ancestor
25254834|NCT02492178|Artesunate|artesunate|mesh-list
25254835|NCT02492178|Quinine|quinine|mesh-list
25254836|NCT02492178|Antimalarials|antimalarials|mesh-ancestor
25254837|NCT02492178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25254838|NCT02492178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25254839|NCT02492178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25254840|NCT02492178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25254841|NCT02492178|Antiviral Agents|antiviral agents|mesh-ancestor
25254842|NCT02492178|Schistosomicides|schistosomicides|mesh-ancestor
25254843|NCT02492178|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25254844|NCT02492178|Anthelmintics|anthelmintics|mesh-ancestor
25254845|NCT02492178|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25254846|NCT02492178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254849|NCT02492178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25254851|NCT02492178|Sensory System Agents|sensory system agents|mesh-ancestor
25254852|NCT02492217|Adalimumab|adalimumab|mesh-list
25254853|NCT02492217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25254854|NCT02492217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25254855|NCT02492087|Tranexamic Acid|tranexamic acid|mesh-list
24927046|NCT04136600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927047|NCT04136327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24927071|NCT04135898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24927072|NCT04135898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24927073|NCT04135898|Growth Substances|growth substances|mesh-ancestor
24927074|NCT04135898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927075|NCT04135898|Growth Inhibitors|growth inhibitors|mesh-ancestor
24927076|NCT04135885|Folic Acid|folic acid|mesh-list
24927077|NCT04135885|Hematinics|hematinics|mesh-ancestor
24927078|NCT04135885|Vitamin B Complex|vitamin b complex|mesh-ancestor
25254856|NCT02492087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25254857|NCT02492087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25254858|NCT02492087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254859|NCT02492087|Hemostatics|hemostatics|mesh-ancestor
25254860|NCT02492087|Coagulants|coagulants|mesh-ancestor
25254861|NCT02492074|Dronabinol|dronabinol|mesh-list
25254862|NCT02492074|Cannabidiol|cannabidiol|mesh-list
25254863|NCT02492074|Anticonvulsants|anticonvulsants|mesh-ancestor
25254864|NCT02492074|Hallucinogens|hallucinogens|mesh-ancestor
25254865|NCT02492074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254866|NCT02492074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25254867|NCT02492074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25254868|NCT02492074|Analgesics|analgesics|mesh-ancestor
25254869|NCT02492074|Sensory System Agents|sensory system agents|mesh-ancestor
25254870|NCT02492074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254871|NCT02492074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25254872|NCT02492074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25254873|NCT02492074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25254874|NCT02492074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254875|NCT02492074|Hormones|hormones|mesh-ancestor
25254876|NCT02492074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25254877|NCT02491697|Capecitabine|capecitabine|mesh-list
25254878|NCT02491697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25254879|NCT02491697|Antimetabolites|antimetabolites|mesh-ancestor
25254880|NCT02491697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254881|NCT02491697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25254882|NCT02491749|Anesthetics|anesthetics|mesh-list
25254883|NCT02491749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25254884|NCT02491749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254885|NCT02491736|Ketoprofen|ketoprofen|mesh-list
25254886|NCT02491736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25254887|NCT02491736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25254888|NCT02491736|Analgesics|analgesics|mesh-ancestor
25254889|NCT02491736|Sensory System Agents|sensory system agents|mesh-ancestor
25254890|NCT02491736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254891|NCT02491736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254892|NCT02491736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25254893|NCT02491736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25254894|NCT02491736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25254895|NCT02491736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25254896|NCT02491736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254897|NCT02491970|Fluticasone|fluticasone|mesh-list
25254898|NCT02491970|Xhance|xhance|mesh-list
25254899|NCT02491970|Formoterol Fumarate|formoterol fumarate|mesh-list
25254900|NCT02491970|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25254901|NCT02491970|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25254902|NCT02491970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25254903|NCT02491970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25254904|NCT02491970|Autonomic Agents|autonomic agents|mesh-ancestor
25254905|NCT02491970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254906|NCT02491970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254907|NCT02491970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25254908|NCT02491970|Respiratory System Agents|respiratory system agents|mesh-ancestor
25254909|NCT02491970|Dermatologic Agents|dermatologic agents|mesh-ancestor
25254910|NCT02491970|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25274844|NCT02375100|Acetaminophen|acetaminophen|mesh-list
25254911|NCT02491970|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25254912|NCT02491970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25254913|NCT02491970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25254914|NCT02491970|Adrenergic Agents|adrenergic agents|mesh-ancestor
25254915|NCT02491970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24927109|NCT04135677|Antithrombins|antithrombins|mesh-ancestor
24927110|NCT04135677|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24927111|NCT04135677|Protease Inhibitors|protease inhibitors|mesh-ancestor
24927112|NCT04135677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927113|NCT04135677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927114|NCT04135677|Anticoagulants|anticoagulants|mesh-ancestor
24927115|NCT04135781|Paclitaxel|paclitaxel|mesh-list
24927116|NCT04135781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24927117|NCT04135781|Capecitabine|capecitabine|mesh-list
24927118|NCT04135781|Oxaliplatin|oxaliplatin|mesh-list
24927119|NCT04135781|Tegafur|tegafur|mesh-list
24927120|NCT04135781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24927121|NCT04135781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927122|NCT04135781|Tubulin Modulators|tubulin modulators|mesh-ancestor
24927123|NCT04135781|Antimitotic Agents|antimitotic agents|mesh-ancestor
24927131|NCT04135313|Capecitabine|capecitabine|mesh-list
24927132|NCT04135313|Oxaliplatin|oxaliplatin|mesh-list
24927133|NCT04135313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24927134|NCT04135313|Antimetabolites|antimetabolites|mesh-ancestor
25122782|NCT03090503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24927135|NCT04135313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927136|NCT04135313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927137|NCT04135378|Ascorbic Acid|ascorbic acid|mesh-list
24927138|NCT04135378|Vitamins|vitamins|mesh-ancestor
24927139|NCT04135378|Micronutrients|micronutrients|mesh-ancestor
24927140|NCT04135378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927141|NCT04135378|Antioxidants|antioxidants|mesh-ancestor
25003337|NCT03794778|Paclitaxel|paclitaxel|mesh-list
24585618|NCT00886314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24585619|NCT00886314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24585620|NCT00886314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24585621|NCT00886314|Anesthetics, General|anesthetics, general|mesh-ancestor
24585622|NCT00886314|Anesthetics|anesthetics|mesh-ancestor
24585623|NCT00886314|GABA Modulators|gaba modulators|mesh-ancestor
24585681|NCT00886678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24585682|NCT00886678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585683|NCT00886678|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24585684|NCT00886678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24585685|NCT00886717|Paclitaxel|paclitaxel|mesh-list
24585686|NCT00886717|Carboplatin|carboplatin|mesh-list
24395656|NCT00136552|Rituximab|rituximab|mesh-list
24585687|NCT00886717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24585688|NCT00886717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585689|NCT00886717|Tubulin Modulators|tubulin modulators|mesh-ancestor
24585690|NCT00886717|Antimitotic Agents|antimitotic agents|mesh-ancestor
24585709|NCT00886873|Contraceptive Agents|contraceptive agents|mesh-ancestor
24585710|NCT00886873|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24585711|NCT00886873|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24585712|NCT00886873|Hormone Antagonists|hormone antagonists|mesh-ancestor
24585713|NCT00886873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24585714|NCT00886873|Luteolytic Agents|luteolytic agents|mesh-ancestor
24585715|NCT00886873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24585727|NCT00886990|Ritonavir|ritonavir|mesh-list
25254916|NCT02491970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254917|NCT02491970|Glucocorticoids|glucocorticoids|mesh-ancestor
25254918|NCT02491970|Hormones|hormones|mesh-ancestor
25254919|NCT02491970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25254920|NCT02491970|Sympathomimetics|sympathomimetics|mesh-ancestor
25274828|NCT02375191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274829|NCT02375191|Anesthetics, Local|anesthetics, local|mesh-ancestor
25274830|NCT02375191|Anesthetics|anesthetics|mesh-ancestor
25274831|NCT02375191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25274832|NCT02375191|Narcotics|narcotics|mesh-ancestor
25274833|NCT02375191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25274834|NCT02375191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25274835|NCT02375191|Anesthetics, General|anesthetics, general|mesh-ancestor
25274836|NCT02375178|Biguanides|biguanides|mesh-list
25274837|NCT02375178|Chlorhexidine|chlorhexidine|mesh-list
25274838|NCT02375178|Polihexanide|polihexanide|mesh-list
25274839|NCT02375178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25274840|NCT02375178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25274841|NCT02375178|Disinfectants|disinfectants|mesh-ancestor
25274842|NCT02375178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25274843|NCT02375178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524921|NCT04200417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24927148|NCT04135690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927150|NCT04135456|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24927151|NCT04135456|Diuretics|diuretics|mesh-ancestor
24927152|NCT04135456|Natriuretic Agents|natriuretic agents|mesh-ancestor
24927153|NCT04135456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089792|NCT03263065|Psyllium|psyllium|mesh-list
24927161|NCT04134897|Capecitabine|capecitabine|mesh-list
24927162|NCT04134897|Oxaliplatin|oxaliplatin|mesh-list
24927163|NCT04134897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24927164|NCT04134897|Antimetabolites|antimetabolites|mesh-ancestor
24927165|NCT04134897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927166|NCT04134897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927167|NCT04135014|Midazolam|midazolam|mesh-list
24927168|NCT04135014|Dexmedetomidine|dexmedetomidine|mesh-list
25254921|NCT02491879|Ketoprofen|ketoprofen|mesh-list
25254922|NCT02491879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24927169|NCT04135014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24927173|NCT04135014|Analgesics|analgesics|mesh-ancestor
25254923|NCT02491879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25254924|NCT02491879|Analgesics|analgesics|mesh-ancestor
25254925|NCT02491879|Sensory System Agents|sensory system agents|mesh-ancestor
25254926|NCT02491879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254927|NCT02491879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254928|NCT02491879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25254929|NCT02491879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25254930|NCT02491879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25254931|NCT02491879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25254932|NCT02491879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254933|NCT02491723|Azithromycin|azithromycin|mesh-list
25254934|NCT02491723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25254935|NCT02491723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25254936|NCT02491320|Letrozole|letrozole|mesh-list
25254937|NCT02491320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25254938|NCT02491320|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25254939|NCT02491320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25254940|NCT02491320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25254941|NCT02491320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254942|NCT02491320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25254943|NCT02491320|Hormone Antagonists|hormone antagonists|mesh-ancestor
25254944|NCT02491320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25254945|NCT02491320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254946|NCT02491242|Dolutegravir|dolutegravir|mesh-list
25254947|NCT02491242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25254948|NCT02491242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25254949|NCT02491242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25254950|NCT02491242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254951|NCT02491242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25254952|NCT02491242|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25254953|NCT02491242|Antiviral Agents|antiviral agents|mesh-ancestor
25254954|NCT02491242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25254955|NCT02491268|Cilostazol|cilostazol|mesh-list
25254956|NCT02491268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25254957|NCT02491268|Autonomic Agents|autonomic agents|mesh-ancestor
25254958|NCT02491268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25254959|NCT02491268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254960|NCT02491268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25254961|NCT02491268|Respiratory System Agents|respiratory system agents|mesh-ancestor
25254962|NCT02491268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25254963|NCT02491268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24624483|NCT01076530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503032|NCT03539614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24524922|NCT04200417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24524923|NCT04200417|Alkylating Agents|alkylating agents|mesh-ancestor
24524945|NCT04176783|Analgesics, Opioid|analgesics, opioid|mesh-list
24524947|NCT04176783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24524948|NCT04176783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524949|NCT04176783|Analgesics|analgesics|mesh-ancestor
24524950|NCT04176783|Sensory System Agents|sensory system agents|mesh-ancestor
24524951|NCT04176783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24624484|NCT01076530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624485|NCT01076530|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24624486|NCT01076530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24624487|NCT01076556|Cyclophosphamide|cyclophosphamide|mesh-list
24624488|NCT01076556|Rituximab|rituximab|mesh-list
24624489|NCT01076556|Alvocidib|alvocidib|mesh-list
25003423|NCT03703271|Methotrexate|methotrexate|mesh-list
24585771|NCT00887029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24585772|NCT00887029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793633|NCT02897063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24793634|NCT02897063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24793635|NCT02897063|Adrenergic Agents|adrenergic agents|mesh-ancestor
24793636|NCT02897063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24793637|NCT02897063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793638|NCT02897063|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24793639|NCT02897063|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25010491|NCT03911661|Warfarin|warfarin|mesh-list
25010492|NCT03911661|Anticoagulants|anticoagulants|mesh-ancestor
25010493|NCT03908255|Vitamins|vitamins|mesh-list
25010494|NCT03908255|Micronutrients|micronutrients|mesh-ancestor
25010495|NCT03908255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010496|NCT03900754|Oxytocin|oxytocin|mesh-list
25010497|NCT03900754|Oxytocics|oxytocics|mesh-ancestor
25010498|NCT03900754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25010499|NCT03900754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010500|NCT03897244|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25010501|NCT03897244|Amoxicillin|amoxicillin|mesh-list
25010502|NCT03897244|Metronidazole|metronidazole|mesh-list
25010503|NCT03897244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25010504|NCT03897244|Rabeprazole|rabeprazole|mesh-list
25010505|NCT03897244|Bismuth|bismuth|mesh-list
24585781|NCT00887042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585863|NCT00887380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24585864|NCT00887380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24585865|NCT00887380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585866|NCT00887380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24585867|NCT00887380|Hormone Antagonists|hormone antagonists|mesh-ancestor
25254967|NCT02491268|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25254968|NCT02491268|Protective Agents|protective agents|mesh-ancestor
25254969|NCT02491268|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25254970|NCT02491268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25254971|NCT02491268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25254972|NCT02491606|Tafenoquine|tafenoquine|mesh-list
25254973|NCT02491606|Antimalarials|antimalarials|mesh-ancestor
25254974|NCT02491606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25254975|NCT02491606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25254976|NCT02491606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25254977|NCT02491515|Denosumab|denosumab|mesh-list
25254978|NCT02491515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25254979|NCT02491515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254980|NCT02491398|Rituximab|rituximab|mesh-list
25254981|NCT02491398|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25254982|NCT02491398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25254983|NCT02491398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25254984|NCT02491398|Immunologic Factors|immunologic factors|mesh-ancestor
25254985|NCT02491398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25254986|NCT02491398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25254987|NCT02491398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25254988|NCT02491398|Alkylating Agents|alkylating agents|mesh-ancestor
24524971|NCT04171258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524973|NCT04171258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24524975|NCT04141644|Osimertinib|osimertinib|mesh-list
24524976|NCT04141644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24524984|NCT04140266|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24524986|NCT04140266|Antiviral Agents|antiviral agents|mesh-ancestor
24524987|NCT04140266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24524988|NCT04140266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24525049|NCT04032626|Lenalidomide|lenalidomide|mesh-list
24525050|NCT04032626|Immunologic Factors|immunologic factors|mesh-ancestor
24525051|NCT04032626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525073|NCT04001829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525074|NCT04001829|Tubulin Modulators|tubulin modulators|mesh-ancestor
24525075|NCT04001829|Antimitotic Agents|antimitotic agents|mesh-ancestor
24525076|NCT04001829|Mitosis Modulators|mitosis modulators|mesh-ancestor
24525077|NCT04001829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254989|NCT02491398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25254990|NCT02491450|Sofosbuvir|sofosbuvir|mesh-list
25254991|NCT02491450|Antiviral Agents|antiviral agents|mesh-ancestor
25254992|NCT02491450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25254993|NCT02491528|Insulin|insulin|mesh-list
25254994|NCT02491528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25254995|NCT02491528|Insulin Aspart|insulin aspart|mesh-list
25254996|NCT02491528|Insulin, Long-Acting|insulin, long-acting|mesh-list
25254997|NCT02491528|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25254998|NCT02491528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25254999|NCT02491528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255000|NCT02491086|Nicotine|nicotine|mesh-list
25255001|NCT02491086|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25255002|NCT02491086|Autonomic Agents|autonomic agents|mesh-ancestor
25255003|NCT02491086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25255004|NCT02491086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255005|NCT02491086|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25255006|NCT02491086|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25255007|NCT02491086|Cholinergic Agents|cholinergic agents|mesh-ancestor
25255008|NCT02491086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25255009|NCT02491086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255010|NCT02490982|Teriflunomide|teriflunomide|mesh-list
25255011|NCT02490982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25255012|NCT02490982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25255013|NCT02490982|Analgesics|analgesics|mesh-ancestor
25255014|NCT02490982|Sensory System Agents|sensory system agents|mesh-ancestor
25255015|NCT02490982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25255016|NCT02490982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255017|NCT02490982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25255018|NCT02490982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24735602|NCT01657838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24650556|NCT01226355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24735603|NCT01657838|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24735613|NCT01657851|Dutasteride|dutasteride|mesh-list
24735615|NCT01657851|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25255019|NCT02490982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25255020|NCT02490982|Immunologic Factors|immunologic factors|mesh-ancestor
25255021|NCT02490930|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25255022|NCT02490930|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25255023|NCT02490930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255024|NCT02490930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25255025|NCT02490930|Immunologic Factors|immunologic factors|mesh-ancestor
25255026|NCT02490930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255027|NCT02490904|Eplerenone|eplerenone|mesh-list
25255028|NCT02490904|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25255029|NCT02490904|Hormone Antagonists|hormone antagonists|mesh-ancestor
25255030|NCT02490904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25255031|NCT02490904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255032|NCT02490904|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25255033|NCT02490904|Diuretics|diuretics|mesh-ancestor
25255034|NCT02490904|Natriuretic Agents|natriuretic agents|mesh-ancestor
25255035|NCT02490904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25255036|NCT02490657|Iloprost|iloprost|mesh-list
24396473|NCT00139074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25255037|NCT02490657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25255038|NCT02490657|Vasodilator Agents|vasodilator agents|mesh-ancestor
25255039|NCT02490592|Fluorides|fluorides|mesh-list
25255040|NCT02490592|Cariostatic Agents|cariostatic agents|mesh-ancestor
25255041|NCT02490592|Protective Agents|protective agents|mesh-ancestor
24927202|NCT04134650|Hormones|hormones|mesh-ancestor
24927382|NCT04133155|Mitosis Modulators|mitosis modulators|mesh-ancestor
24927203|NCT04134650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24927204|NCT04134650|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24927205|NCT04134650|Protease Inhibitors|protease inhibitors|mesh-ancestor
24927206|NCT04134650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927207|NCT04134650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927208|NCT04134715|Contraceptive Agents|contraceptive agents|mesh-list
24927209|NCT04134715|Contraceptives, Oral|contraceptives, oral|mesh-list
24927210|NCT04134715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24927211|NCT04134715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927212|NCT04134715|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24927214|NCT04134468|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24927215|NCT04134468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24927216|NCT04134468|Antimetabolites|antimetabolites|mesh-ancestor
24927217|NCT04134468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927218|NCT04134468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927219|NCT04134468|Antiviral Agents|antiviral agents|mesh-ancestor
24927220|NCT04134468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24525235|NCT03809884|Potassium Citrate|potassium citrate|mesh-list
24525236|NCT03809884|Diuretics|diuretics|mesh-ancestor
24927221|NCT04134468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927222|NCT04134468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24927231|NCT04134416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927232|NCT04134416|Cholinergic Agents|cholinergic agents|mesh-ancestor
24927233|NCT04134416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24927234|NCT04134416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927236|NCT04134182|Nivolumab|nivolumab|mesh-list
24927237|NCT04134182|Ipilimumab|ipilimumab|mesh-list
24927238|NCT04134182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24927239|NCT04134182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927240|NCT04134182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24927241|NCT04134182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585868|NCT00887380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24585869|NCT00887380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585870|NCT00887601|Donepezil|donepezil|mesh-list
24585871|NCT00887601|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24585872|NCT00887601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687169|NCT01928940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687170|NCT01929031|Ibuprofen|ibuprofen|mesh-list
25687171|NCT01929031|Caffeine|caffeine|mesh-list
25687172|NCT01929031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25687173|NCT01929031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25687174|NCT01929031|Analgesics|analgesics|mesh-ancestor
25255042|NCT02490592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255043|NCT02490774|Levonorgestrel|levonorgestrel|mesh-list
25255044|NCT02490774|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25255045|NCT02490774|Contraceptive Agents|contraceptive agents|mesh-ancestor
25255046|NCT02490774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25255047|NCT02490774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255048|NCT02490774|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25255049|NCT02490774|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25255050|NCT02490774|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25255051|NCT02490865|RNS60|rns60|mesh-list
25255052|NCT02490865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25255053|NCT02490865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25255054|NCT02490865|Analgesics|analgesics|mesh-ancestor
25255055|NCT02490865|Sensory System Agents|sensory system agents|mesh-ancestor
25255056|NCT02490865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25255057|NCT02490865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255058|NCT02490865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25255059|NCT02490865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25255060|NCT02490865|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25255061|NCT02490839|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25255062|NCT02490839|Amoxicillin|amoxicillin|mesh-list
25255063|NCT02490839|Metronidazole|metronidazole|mesh-list
25255064|NCT02490839|Tetracycline|tetracycline|mesh-list
25255065|NCT02490839|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25255066|NCT02490839|Rabeprazole|rabeprazole|mesh-list
25255067|NCT02490839|Bismuth|bismuth|mesh-list
25255068|NCT02490839|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25255069|NCT02490839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25255070|NCT02490839|Antitubercular Agents|antitubercular agents|mesh-ancestor
25255071|NCT02490839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25255072|NCT02490839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25255073|NCT02490839|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25255074|NCT02490839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25255075|NCT02490839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255076|NCT02490839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927242|NCT04134130|Methyltestosterone|methyltestosterone|mesh-list
24927243|NCT04134130|Testosterone|testosterone|mesh-list
24927247|NCT04134130|Androgens|androgens|mesh-ancestor
24927248|NCT04134130|Hormones|hormones|mesh-ancestor
24927249|NCT04134130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24927250|NCT04134130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927251|NCT04134130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24927252|NCT04134130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927253|NCT04134130|Anabolic Agents|anabolic agents|mesh-ancestor
24927254|NCT04134273|Clindamycin|clindamycin|mesh-list
24927255|NCT04134273|Clindamycin palmitate|clindamycin palmitate|mesh-list
24927260|NCT04134273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927261|NCT04134273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927263|NCT04134598|Letrozole|letrozole|mesh-list
24927264|NCT04134598|Anastrozole|anastrozole|mesh-list
24927265|NCT04134598|Exemestane|exemestane|mesh-list
24927266|NCT04134598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927267|NCT04134598|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24927268|NCT04134598|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24927269|NCT04134598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927270|NCT04134598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927271|NCT04134598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24927272|NCT04134598|Hormone Antagonists|hormone antagonists|mesh-ancestor
24585873|NCT00887601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585874|NCT00887601|Cholinergic Agents|cholinergic agents|mesh-ancestor
24585875|NCT00887601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25010530|NCT03854110|Antiviral Agents|antiviral agents|mesh-ancestor
25010531|NCT03854110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25010532|NCT03854110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25010533|NCT03854110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25010534|NCT03854110|Immunologic Factors|immunologic factors|mesh-ancestor
25010535|NCT03854110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010536|NCT03851081|Vincristine|vincristine|mesh-list
25010537|NCT03851081|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25010538|NCT03851081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25010539|NCT03851081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010540|NCT03851081|Tubulin Modulators|tubulin modulators|mesh-ancestor
25010541|NCT03851081|Antimitotic Agents|antimitotic agents|mesh-ancestor
25010542|NCT03851081|Mitosis Modulators|mitosis modulators|mesh-ancestor
25010543|NCT03851081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010544|NCT03851081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24735842|NCT01659047|Idelalisib|idelalisib|mesh-list
24735843|NCT01659047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24735844|NCT01659047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735845|NCT01659047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735846|NCT01659086|Vaccines|vaccines|mesh-list
24735847|NCT01659086|Immunologic Factors|immunologic factors|mesh-ancestor
24735848|NCT01659086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735849|NCT01659099|Prednisone|prednisone|mesh-list
24735850|NCT01659099|Cyclophosphamide|cyclophosphamide|mesh-list
24735851|NCT01659099|Rituximab|rituximab|mesh-list
24735852|NCT01659099|Doxorubicin|doxorubicin|mesh-list
24735853|NCT01659099|Vincristine|vincristine|mesh-list
25010545|NCT03851081|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25255077|NCT02490839|Antacids|antacids|mesh-ancestor
24397051|NCT00140647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255078|NCT02490839|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25255079|NCT02490527|Simvastatin|simvastatin|mesh-list
25255080|NCT02490527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25255081|NCT02490527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25255082|NCT02490527|Antimetabolites|antimetabolites|mesh-ancestor
25255083|NCT02490527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255084|NCT02490527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25255085|NCT02490527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25255086|NCT02490527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255087|NCT02490540|Sufentanil|sufentanil|mesh-list
25255088|NCT02490540|Dsuvia|dsuvia|mesh-list
25255089|NCT02490540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25255090|NCT02490540|Narcotics|narcotics|mesh-ancestor
25255091|NCT02490540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25255092|NCT02490540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255093|NCT02490540|Analgesics|analgesics|mesh-ancestor
25255094|NCT02490540|Sensory System Agents|sensory system agents|mesh-ancestor
25255095|NCT02490540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25255096|NCT02490540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25255097|NCT02490540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25255098|NCT02490540|Anesthetics, General|anesthetics, general|mesh-ancestor
25255099|NCT02490540|Anesthetics|anesthetics|mesh-ancestor
25255100|NCT02490436|Cetuximab|cetuximab|mesh-list
25255101|NCT02490436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25255102|NCT02490436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25255103|NCT02490449|Dexlansoprazole|dexlansoprazole|mesh-list
25687175|NCT01929031|Sensory System Agents|sensory system agents|mesh-ancestor
25687176|NCT01929031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25687177|NCT01929031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687178|NCT01929031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25687179|NCT01929031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25687180|NCT01929031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25687181|NCT01929031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687182|NCT01929031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687183|NCT01929031|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25687184|NCT01929031|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25687185|NCT01929031|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25687186|NCT01929031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25687187|NCT01929031|Purinergic Agents|purinergic agents|mesh-ancestor
25687188|NCT01929031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25687189|NCT01929044|Anisodamine|anisodamine|mesh-list
25687190|NCT01929044|Scopolamine|scopolamine|mesh-list
25687191|NCT01929044|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25687192|NCT01929044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25687193|NCT01929044|Antiemetics|antiemetics|mesh-ancestor
25687194|NCT01929044|Autonomic Agents|autonomic agents|mesh-ancestor
25687195|NCT01929044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24927310|NCT04134052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24617670|NCT01044810|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24617671|NCT01044810|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24617672|NCT01044810|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24617673|NCT01044810|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24617676|NCT01044888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24617677|NCT01044888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24617678|NCT01044888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617680|NCT01044992|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24617681|NCT01044992|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24617682|NCT01044992|Dopamine Agents|dopamine agents|mesh-ancestor
24927276|NCT04134598|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24927277|NCT04134598|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24927278|NCT04134598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24927280|NCT04134078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24927281|NCT04134078|Autonomic Agents|autonomic agents|mesh-ancestor
24927282|NCT04134078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25255193|NCT02489760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24927283|NCT04134078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927284|NCT04134078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24927285|NCT04134078|Respiratory System Agents|respiratory system agents|mesh-ancestor
24927286|NCT04134078|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24927288|NCT04134078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927289|NCT04134078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24927290|NCT04134078|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24927291|NCT04134078|Vasodilator Agents|vasodilator agents|mesh-ancestor
24927292|NCT04134078|Gasotransmitters|gasotransmitters|mesh-ancestor
25010581|NCT03667716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25010582|NCT03667716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010583|NCT03667716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25010584|NCT03667716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010585|NCT03665129|Avdoralimab|avdoralimab|mesh-list
25010587|NCT03665129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25010588|NCT03665129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010589|NCT03665129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25010590|NCT03665129|Antiviral Agents|antiviral agents|mesh-ancestor
25010591|NCT03665129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25110182|NCT05464979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25110183|NCT05464979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110184|NCT05464979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25110186|NCT05464979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25110187|NCT05464979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25110188|NCT05464979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25110189|NCT05464979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25110190|NCT05464979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25110191|NCT05464979|GABA Modulators|gaba modulators|mesh-ancestor
25010666|NCT03428958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255104|NCT02490449|Lansoprazole|lansoprazole|mesh-list
25255105|NCT02490449|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25255106|NCT02490449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25255107|NCT02490449|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25687196|NCT01929044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687197|NCT01929044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25687198|NCT01929044|Mydriatics|mydriatics|mesh-ancestor
25687199|NCT01929044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25687200|NCT01929044|Cholinergic Agents|cholinergic agents|mesh-ancestor
25687201|NCT01929044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25687202|NCT01929044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687203|NCT01929044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25687204|NCT01929044|Parasympatholytics|parasympatholytics|mesh-ancestor
25687205|NCT01929044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25687206|NCT01929044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25687207|NCT01929044|Adrenergic Agents|adrenergic agents|mesh-ancestor
25687208|NCT01929044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25687209|NCT01929044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25255108|NCT02490449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255109|NCT02490449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255110|NCT02490605|Salicylic Acid|salicylic acid|mesh-list
25255111|NCT02490605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25255112|NCT02490605|Antifungal Agents|antifungal agents|mesh-ancestor
25255113|NCT02490605|Keratolytic Agents|keratolytic agents|mesh-ancestor
25255114|NCT02490605|Dermatologic Agents|dermatologic agents|mesh-ancestor
25255115|NCT02490345|Gabapentin|gabapentin|mesh-list
25255116|NCT02490345|Analgesics|analgesics|mesh-ancestor
25255117|NCT02490345|Sensory System Agents|sensory system agents|mesh-ancestor
25255118|NCT02490345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25255119|NCT02490345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255120|NCT02490345|Anticonvulsants|anticonvulsants|mesh-ancestor
25255121|NCT02490345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25255122|NCT02490345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25255123|NCT02490345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25255124|NCT02490345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25255125|NCT02490345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24927308|NCT04134052|Anesthetics|anesthetics|mesh-ancestor
24927309|NCT04134052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24927380|NCT04133155|Tubulin Modulators|tubulin modulators|mesh-ancestor
24927314|NCT04134052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24927315|NCT04134052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24927316|NCT04134052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24927317|NCT04134052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24927318|NCT04134052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24927319|NCT04134052|GABA Modulators|gaba modulators|mesh-ancestor
24927320|NCT04134052|GABA Agents|gaba agents|mesh-ancestor
24927321|NCT04133961|Phenylephrine|phenylephrine|mesh-list
24927322|NCT04133961|Oxymetazoline|oxymetazoline|mesh-list
24927323|NCT04133961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24927324|NCT04133961|Mydriatics|mydriatics|mesh-ancestor
24525238|NCT03809884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525239|NCT03809884|Expectorants|expectorants|mesh-ancestor
24525240|NCT03809884|Respiratory System Agents|respiratory system agents|mesh-ancestor
24525241|NCT03760718|Chloroprocaine|chloroprocaine|mesh-list
24525242|NCT03760718|Procaine|procaine|mesh-list
24525243|NCT03760718|Anesthetics, Local|anesthetics, local|mesh-ancestor
24525244|NCT03760718|Anesthetics|anesthetics|mesh-ancestor
24525245|NCT03760718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24525246|NCT03760718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525247|NCT03760718|Sensory System Agents|sensory system agents|mesh-ancestor
24525254|NCT03737253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24525255|NCT03737253|Fertility Agents|fertility agents|mesh-ancestor
25010668|NCT03393611|Fludarabine|fludarabine|mesh-list
25010669|NCT03393611|Melphalan|melphalan|mesh-list
25010670|NCT03393611|Daunorubicin|daunorubicin|mesh-list
25010671|NCT03393611|Thymoglobulin|thymoglobulin|mesh-list
25010725|NCT03150914|Sirolimus|sirolimus|mesh-list
25010726|NCT03150914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25010727|NCT03150914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25010728|NCT03150914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25010729|NCT03150914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010730|NCT03150914|Antifungal Agents|antifungal agents|mesh-ancestor
25010731|NCT03150914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25010732|NCT03150914|Immunologic Factors|immunologic factors|mesh-ancestor
25010733|NCT03150914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010734|NCT03098485|Azithromycin|azithromycin|mesh-list
25010735|NCT03098485|Levofloxacin|levofloxacin|mesh-list
25010736|NCT03098485|Ofloxacin|ofloxacin|mesh-list
25010737|NCT03098485|Cefpodoxime|cefpodoxime|mesh-list
25010738|NCT03098485|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
25255126|NCT02490345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25255127|NCT02490345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25255128|NCT02490345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255129|NCT02490345|Antimanic Agents|antimanic agents|mesh-ancestor
25255130|NCT02490072|Dexmedetomidine|dexmedetomidine|mesh-list
25255131|NCT02490072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25255132|NCT02490072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25255133|NCT02490072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255134|NCT02490072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25255135|NCT02490072|Analgesics|analgesics|mesh-ancestor
25255136|NCT02490072|Sensory System Agents|sensory system agents|mesh-ancestor
25255137|NCT02490072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25255138|NCT02490072|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25255139|NCT02490072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25255140|NCT02490072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25255141|NCT02490072|Adrenergic Agents|adrenergic agents|mesh-ancestor
25255142|NCT02490072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25255143|NCT02490072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255144|NCT02490241|Lithium Carbonate|lithium carbonate|mesh-list
25255145|NCT02490241|Antidepressive Agents|antidepressive agents|mesh-ancestor
25255146|NCT02490241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25255147|NCT02490241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255148|NCT02490241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255149|NCT02490241|Antimanic Agents|antimanic agents|mesh-ancestor
25255150|NCT02490241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25255151|NCT02490241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24525256|NCT03737253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24525257|NCT03724994|Gemcitabine|gemcitabine|mesh-list
24525259|NCT03724994|Fluorouracil|fluorouracil|mesh-list
24525260|NCT03724994|Folfirinox|folfirinox|mesh-list
24927381|NCT04133155|Antimitotic Agents|antimitotic agents|mesh-ancestor
24525261|NCT03724994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24525262|NCT03724994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525263|NCT03724994|Tubulin Modulators|tubulin modulators|mesh-ancestor
24525264|NCT03724994|Antimitotic Agents|antimitotic agents|mesh-ancestor
24927325|NCT04133961|Autonomic Agents|autonomic agents|mesh-ancestor
24927326|NCT04133961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24927327|NCT04133961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927328|NCT04133961|Sympathomimetics|sympathomimetics|mesh-ancestor
24927329|NCT04133961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24927330|NCT04133961|Nasal Decongestants|nasal decongestants|mesh-ancestor
24927331|NCT04133961|Respiratory System Agents|respiratory system agents|mesh-ancestor
24927332|NCT04133961|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24927333|NCT04133961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24927334|NCT04133961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24927335|NCT04133961|Adrenergic Agents|adrenergic agents|mesh-ancestor
24927345|NCT04133974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927347|NCT04133974|Sensory System Agents|sensory system agents|mesh-ancestor
24927348|NCT04133974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24927349|NCT04133974|Antitussive Agents|antitussive agents|mesh-ancestor
24927350|NCT04133974|Respiratory System Agents|respiratory system agents|mesh-ancestor
24927351|NCT04134637|Bupivacaine|bupivacaine|mesh-list
24927352|NCT04134637|Anesthetics, Local|anesthetics, local|mesh-ancestor
24927353|NCT04134637|Anesthetics|anesthetics|mesh-ancestor
25255152|NCT02490241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927354|NCT04134637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24927355|NCT04134637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274850|NCT02375100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25274851|NCT02375100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274852|NCT02375100|Sensory System Agents|sensory system agents|mesh-ancestor
25274853|NCT02375100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25274854|NCT02375100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25274856|NCT02375100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25274857|NCT02375100|Narcotics|narcotics|mesh-ancestor
25274858|NCT02375022|Endostar protein|endostar protein|mesh-list
25274859|NCT02375022|Endostatins|endostatins|mesh-list
25274860|NCT02375022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25274861|NCT02375022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25274862|NCT02375022|Growth Substances|growth substances|mesh-ancestor
25274863|NCT02375022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274864|NCT02375022|Growth Inhibitors|growth inhibitors|mesh-ancestor
25274865|NCT02375022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25274866|NCT02374853|Vancomycin|vancomycin|mesh-list
25274867|NCT02374853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25274868|NCT02374853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25274869|NCT02374736|Immunoglobulins|immunoglobulins|mesh-list
25274870|NCT02374736|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25274871|NCT02374736|Antibodies|antibodies|mesh-list
25274872|NCT02374736|Immunoglobulin G|immunoglobulin g|mesh-list
25274873|NCT02374736|Immunologic Factors|immunologic factors|mesh-ancestor
25274874|NCT02374736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274875|NCT02374931|Estradiol|estradiol|mesh-list
25274876|NCT02374931|Estrogens|estrogens|mesh-ancestor
25274877|NCT02374931|Hormones|hormones|mesh-ancestor
25274878|NCT02374931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25274879|NCT02374931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274880|NCT02374632|Octreotide|octreotide|mesh-list
25274881|NCT02374632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25274882|NCT02374632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25274883|NCT02374632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25274884|NCT02374645|Gefitinib|gefitinib|mesh-list
25274885|NCT02374645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25274886|NCT02374645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25051127|NCT00437112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25051128|NCT00437112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051130|NCT00436683|Chelating Agents|chelating agents|mesh-ancestor
25051131|NCT00436683|Sequestering Agents|sequestering agents|mesh-ancestor
25051132|NCT00436683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051133|NCT00436670|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25051134|NCT00436670|Immunologic Factors|immunologic factors|mesh-ancestor
25051135|NCT00436670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736165|NCT01660477|Antifungal Agents|antifungal agents|mesh-ancestor
24736166|NCT01660542|Docetaxel|docetaxel|mesh-list
24736167|NCT01660542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24736168|NCT01660542|Tubulin Modulators|tubulin modulators|mesh-ancestor
24736169|NCT01660542|Antimitotic Agents|antimitotic agents|mesh-ancestor
24736170|NCT01660542|Mitosis Modulators|mitosis modulators|mesh-ancestor
24736171|NCT01660542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736172|NCT01660594|Calcium|calcium|mesh-list
24736175|NCT01660620|Betaxolol|betaxolol|mesh-list
25274887|NCT02374645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274888|NCT02374645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25274889|NCT02374489|Ceritinib|ceritinib|mesh-list
25274890|NCT02374489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25274891|NCT02374489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25274892|NCT02374489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25274893|NCT02374489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927374|NCT04133428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24927375|NCT04133428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927377|NCT04133155|Paclitaxel|paclitaxel|mesh-list
24927378|NCT04133155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24927379|NCT04133155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927383|NCT04133155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927384|NCT04133155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24927385|NCT04133155|Antimetabolites|antimetabolites|mesh-ancestor
24927386|NCT04133155|Antiviral Agents|antiviral agents|mesh-ancestor
24927387|NCT04133155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24927388|NCT04133155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927389|NCT04133155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24525265|NCT03724994|Mitosis Modulators|mitosis modulators|mesh-ancestor
24525266|NCT03724994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525267|NCT03724994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25010739|NCT03098485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25010740|NCT03098485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25010741|NCT03098485|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25010742|NCT03098485|Renal Agents|renal agents|mesh-ancestor
24967565|NCT03758677|Immunologic Factors|immunologic factors|mesh-ancestor
24967566|NCT03758677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397367|NCT00141401|Anticonvulsants|anticonvulsants|mesh-ancestor
24967567|NCT03758677|Tubulin Modulators|tubulin modulators|mesh-ancestor
24967568|NCT03758677|Antimitotic Agents|antimitotic agents|mesh-ancestor
24967569|NCT03758677|Mitosis Modulators|mitosis modulators|mesh-ancestor
24967570|NCT03758677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24967571|NCT03758677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24967572|NCT03758677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24585883|NCT00887757|Gemcitabine|gemcitabine|mesh-list
24585884|NCT00887757|Navitoclax|navitoclax|mesh-list
24585885|NCT00887757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24585886|NCT00887757|Antimetabolites|antimetabolites|mesh-ancestor
25687210|NCT01929044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25687211|NCT01929044|Analgesics|analgesics|mesh-ancestor
25687212|NCT01929044|Sensory System Agents|sensory system agents|mesh-ancestor
25687213|NCT01929044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25687214|NCT01929044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25687215|NCT01929044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25687216|NCT01929044|Vasodilator Agents|vasodilator agents|mesh-ancestor
25687217|NCT01929044|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25687218|NCT01929044|Antioxidants|antioxidants|mesh-ancestor
25687219|NCT01929044|Protective Agents|protective agents|mesh-ancestor
25687220|NCT01929083|Ibutilide|ibutilide|mesh-list
25687221|NCT01929083|Progesterone|progesterone|mesh-list
25687222|NCT01929083|Progestins|progestins|mesh-ancestor
25687223|NCT01929083|Hormones|hormones|mesh-ancestor
25687224|NCT01929083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25687225|NCT01929083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687226|NCT01929083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25687227|NCT01929135|Atorvastatin|atorvastatin|mesh-list
24585887|NCT00887757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585888|NCT00887757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585889|NCT00887757|Antiviral Agents|antiviral agents|mesh-ancestor
24585890|NCT00887757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24585891|NCT00887757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24585892|NCT00887757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24585893|NCT00887757|Immunologic Factors|immunologic factors|mesh-ancestor
24585894|NCT00887757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585895|NCT00887770|Moxifloxacin|moxifloxacin|mesh-list
24978717|NCT03125642|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24585896|NCT00887770|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
24633796|NCT01131195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633799|NCT01131195|Alkylating Agents|alkylating agents|mesh-ancestor
24585918|NCT00888082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25255153|NCT02490085|Insulin|insulin|mesh-list
25255154|NCT02490085|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25255155|NCT02490085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25255156|NCT02490085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255157|NCT02489955|Tobramycin|tobramycin|mesh-list
25255158|NCT02489955|Amikacin|amikacin|mesh-list
25255159|NCT02489955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25255160|NCT02489955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25255161|NCT02490176|Liraglutide|liraglutide|mesh-list
25255162|NCT02490176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25255163|NCT02490176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255164|NCT02490176|Incretins|incretins|mesh-ancestor
25255165|NCT02490176|Hormones|hormones|mesh-ancestor
25255166|NCT02490176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25255167|NCT02490098|Insulin|insulin|mesh-list
25255168|NCT02490098|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25255169|NCT02490098|Glucagon|glucagon|mesh-list
25255170|NCT02490098|Hormones|hormones|mesh-list
25255171|NCT02490098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25255172|NCT02490098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255173|NCT02490098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25255174|NCT02490098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24525268|NCT03724994|Antimetabolites|antimetabolites|mesh-ancestor
24525269|NCT03724994|Antiviral Agents|antiviral agents|mesh-ancestor
24525270|NCT03724994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24525271|NCT03724994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525272|NCT03724994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24525294|NCT03695510|Pembrolizumab|pembrolizumab|mesh-list
24525296|NCT03695510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24525297|NCT03695510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525298|NCT03695510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24927391|NCT04133155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927392|NCT04133337|Apatinib|apatinib|mesh-list
24927393|NCT04133337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927402|NCT04133506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24927408|NCT04133506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927409|NCT04133506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24927410|NCT04133506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24927411|NCT04133506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927413|NCT04133194|Mesalamine|mesalamine|mesh-list
24927414|NCT04133194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24525299|NCT03695510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525300|NCT03695510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525301|NCT03673527|Tacrolimus|tacrolimus|mesh-list
25255175|NCT02489604|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25255176|NCT02489604|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25255177|NCT02489604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255183|NCT02489786|Digoxin|digoxin|mesh-list
25255184|NCT02489786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25255185|NCT02489786|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25255186|NCT02489786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255187|NCT02489786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255188|NCT02489786|Protective Agents|protective agents|mesh-ancestor
25255189|NCT02489786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255190|NCT02489760|Adalimumab|adalimumab|mesh-list
25255191|NCT02489760|Etanercept|etanercept|mesh-list
25255192|NCT02489760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25255194|NCT02489760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25255195|NCT02489760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25255196|NCT02489760|Analgesics|analgesics|mesh-ancestor
25255197|NCT02489760|Sensory System Agents|sensory system agents|mesh-ancestor
24625820|NCT01083797|Chloral Hydrate|chloral hydrate|mesh-list
24625821|NCT01083797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24625822|NCT01083797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24625823|NCT01083797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625824|NCT01083797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24625825|NCT01083797|Analgesics|analgesics|mesh-ancestor
24625826|NCT01083797|Sensory System Agents|sensory system agents|mesh-ancestor
25255198|NCT02489760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25255199|NCT02489760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255200|NCT02489760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25255201|NCT02489760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25255202|NCT02489760|Immunologic Factors|immunologic factors|mesh-ancestor
25255203|NCT02489929|Azacitidine|azacitidine|mesh-list
25255204|NCT02489929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25255205|NCT02489929|Antimetabolites|antimetabolites|mesh-ancestor
25255206|NCT02489929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255207|NCT02489929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25255208|NCT02489929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255209|NCT02489864|Terlipressin|terlipressin|mesh-list
25255210|NCT02489864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25255211|NCT02489864|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25255212|NCT02489240|Vitamin D|vitamin d|mesh-list
25255213|NCT02489240|Cholecalciferol|cholecalciferol|mesh-list
25255214|NCT02489240|Vitamins|vitamins|mesh-ancestor
25255215|NCT02489240|Micronutrients|micronutrients|mesh-ancestor
25255216|NCT02489240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255217|NCT02489240|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25255218|NCT02489240|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25255219|NCT02489461|Efavirenz|efavirenz|mesh-list
25255220|NCT02489461|Elsulfavirine|elsulfavirine|mesh-list
24525318|NCT03663504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927415|NCT04133194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24927416|NCT04133194|Analgesics|analgesics|mesh-ancestor
24927417|NCT04133194|Sensory System Agents|sensory system agents|mesh-ancestor
24927418|NCT04133194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24927419|NCT04133194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927420|NCT04133194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24927421|NCT04133194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24927422|NCT04133259|Tenofovir|tenofovir|mesh-list
24927423|NCT04133259|Entecavir|entecavir|mesh-list
24927424|NCT04133259|Antibodies|antibodies|mesh-list
24927425|NCT04133259|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24927426|NCT04133259|Immunologic Factors|immunologic factors|mesh-ancestor
24927427|NCT04133259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927428|NCT04133259|Antiviral Agents|antiviral agents|mesh-ancestor
24927429|NCT04133259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24927430|NCT04133259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24927431|NCT04133259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24927432|NCT04133259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927433|NCT04133259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927435|NCT04133259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24927438|NCT04133051|Bupivacaine|bupivacaine|mesh-list
24927439|NCT04133051|Anesthetics, Local|anesthetics, local|mesh-ancestor
24525319|NCT03663504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525320|NCT03658772|Pembrolizumab|pembrolizumab|mesh-list
24525321|NCT03658772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24525322|NCT03658772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927452|NCT04132583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24586008|NCT00888797|Sensory System Agents|sensory system agents|mesh-ancestor
25010768|NCT03049449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010769|NCT03049449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010770|NCT03049449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25010771|NCT03000569|Levodopa|levodopa|mesh-list
25010772|NCT03000569|Antiparkinson Agents|antiparkinson agents|mesh-list
25010773|NCT03000569|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25010831|NCT02939573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25010832|NCT02939573|Antimalarials|antimalarials|mesh-ancestor
24895050|NCT05191875|Renal Agents|renal agents|mesh-ancestor
25687228|NCT01929135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25687229|NCT01929135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25687230|NCT01929135|Antimetabolites|antimetabolites|mesh-ancestor
25687231|NCT01929135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687232|NCT01929135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25687233|NCT01929135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25010841|NCT02929589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25010842|NCT02929589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25010843|NCT02929589|Analgesics|analgesics|mesh-ancestor
25010844|NCT02929589|Sensory System Agents|sensory system agents|mesh-ancestor
25255221|NCT02489461|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25255222|NCT02489461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25255223|NCT02489461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25255224|NCT02489461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255225|NCT02489461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255226|NCT02489461|Antiviral Agents|antiviral agents|mesh-ancestor
25255227|NCT02489461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25255228|NCT02489461|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25255229|NCT02489461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25255230|NCT02489461|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25255231|NCT02489461|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25255232|NCT02489461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25255233|NCT02489461|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25255234|NCT02489461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25255236|NCT02489487|Darunavir|darunavir|mesh-list
25255237|NCT02489487|Raltegravir Potassium|raltegravir potassium|mesh-list
25255238|NCT02489487|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25255239|NCT02489487|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25255240|NCT02489487|Protease Inhibitors|protease inhibitors|mesh-ancestor
25255241|NCT02489487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255242|NCT02489487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255243|NCT02489487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25255244|NCT02489487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25255245|NCT02489487|Antiviral Agents|antiviral agents|mesh-ancestor
25255246|NCT02489487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25255247|NCT02489487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25255248|NCT02489487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25255249|NCT02489487|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25049402|NCT00612118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049403|NCT00612118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049404|NCT00612118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25049405|NCT00612118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25049406|NCT00612118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25049407|NCT00612118|Histamine Antagonists|histamine antagonists|mesh-ancestor
25049408|NCT00612118|Histamine Agents|histamine agents|mesh-ancestor
25049409|NCT00612118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25049412|NCT00609323|Lidocaine|lidocaine|mesh-list
24927453|NCT04132583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24927454|NCT04132583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24927455|NCT04132583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927456|NCT04132583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927457|NCT04132479|Amoxicillin|amoxicillin|mesh-list
24927458|NCT04132479|Clarithromycin|clarithromycin|mesh-list
24927459|NCT04132479|Tinidazole|tinidazole|mesh-list
24927460|NCT04132479|Rabeprazole|rabeprazole|mesh-list
24927461|NCT04132479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24927462|NCT04132479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24927463|NCT04132479|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24503344|NCT01840566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24525323|NCT03655691|Botulinum Toxins|botulinum toxins|mesh-list
25255250|NCT02489487|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25255251|NCT02489266|Aldesleukin|aldesleukin|mesh-list
25255252|NCT02489266|Cyclophosphamide|cyclophosphamide|mesh-list
25255253|NCT02489266|Fludarabine|fludarabine|mesh-list
25255254|NCT02489266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25255255|NCT02489266|Immunologic Factors|immunologic factors|mesh-ancestor
25255256|NCT02489266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255257|NCT02489266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24525324|NCT03655691|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25255258|NCT02489266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25255259|NCT02489266|Alkylating Agents|alkylating agents|mesh-ancestor
25255260|NCT02489266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255261|NCT02489266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25255262|NCT02489266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25255263|NCT02489266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25255264|NCT02489266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25255265|NCT02489266|Antiviral Agents|antiviral agents|mesh-ancestor
25255266|NCT02489266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25255267|NCT02489513|Ivosidenib|ivosidenib|mesh-list
25255268|NCT02489513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25255269|NCT02489513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255270|NCT02489513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255271|NCT02489409|Gemcitabine|gemcitabine|mesh-list
25255272|NCT02489409|Vinorelbine|vinorelbine|mesh-list
25255273|NCT02489409|Endostatins|endostatins|mesh-list
25255274|NCT02489409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25255275|NCT02489409|Antimetabolites|antimetabolites|mesh-ancestor
25255276|NCT02489409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255277|NCT02489409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25255278|NCT02489409|Antiviral Agents|antiviral agents|mesh-ancestor
25255279|NCT02489409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25255280|NCT02489409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255281|NCT02489409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25255282|NCT02489409|Immunologic Factors|immunologic factors|mesh-ancestor
25255283|NCT02489409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255284|NCT02489409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25255285|NCT02489409|Tubulin Modulators|tubulin modulators|mesh-ancestor
25255286|NCT02489409|Antimitotic Agents|antimitotic agents|mesh-ancestor
25255287|NCT02489409|Mitosis Modulators|mitosis modulators|mesh-ancestor
25255288|NCT02489409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25255289|NCT02489409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25255290|NCT02489409|Growth Substances|growth substances|mesh-ancestor
25255291|NCT02489409|Growth Inhibitors|growth inhibitors|mesh-ancestor
25255292|NCT02489019|Fentanyl|fentanyl|mesh-list
25255293|NCT02489019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25255294|NCT02489019|Narcotics|narcotics|mesh-ancestor
25255295|NCT02489019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25255296|NCT02489019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255297|NCT02489019|Analgesics|analgesics|mesh-ancestor
25255298|NCT02489019|Sensory System Agents|sensory system agents|mesh-ancestor
25255299|NCT02489019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25255300|NCT02489019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25255301|NCT02489019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25255302|NCT02489019|Anesthetics, General|anesthetics, general|mesh-ancestor
24927469|NCT04132479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24927470|NCT04132479|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24927471|NCT04132479|Alkylating Agents|alkylating agents|mesh-ancestor
24927472|NCT04132479|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
24927473|NCT04132479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24927474|NCT04132479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24927475|NCT04132674|Tenofovir|tenofovir|mesh-list
24927476|NCT04132674|Emtricitabine|emtricitabine|mesh-list
24927477|NCT04132674|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
24927478|NCT04132674|Antiviral Agents|antiviral agents|mesh-ancestor
24927479|NCT04132674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24927480|NCT04132674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24927481|NCT04132674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24503360|NCT01730937|Sorafenib|sorafenib|mesh-list
24525405|NCT03521102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25255303|NCT02489019|Anesthetics|anesthetics|mesh-ancestor
25255304|NCT02488889|Ethanol|ethanol|mesh-list
25255305|NCT02488889|Varenicline|varenicline|mesh-list
25255306|NCT02488889|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25255307|NCT02488889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25255308|NCT02488889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25255309|NCT02488889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255310|NCT02488889|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25255311|NCT02488889|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25255312|NCT02488889|Cholinergic Agents|cholinergic agents|mesh-ancestor
25255313|NCT02488889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25255314|NCT02488889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255315|NCT02488902|Mefloquine|mefloquine|mesh-list
25255316|NCT02488902|Tafenoquine|tafenoquine|mesh-list
25255317|NCT02488902|Antimalarials|antimalarials|mesh-ancestor
25255318|NCT02488902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25255319|NCT02488902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25255320|NCT02488902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25255321|NCT02488993|Rifaximin|rifaximin|mesh-list
25255322|NCT02488993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25255323|NCT02488993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25255324|NCT02488993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25255325|NCT02489097|Nitrous Oxide|nitrous oxide|mesh-list
25255326|NCT02489097|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25255327|NCT02489097|Anesthetics, General|anesthetics, general|mesh-ancestor
25255328|NCT02489097|Anesthetics|anesthetics|mesh-ancestor
25255329|NCT02489097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24736494|NCT01662518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25255330|NCT02489097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255331|NCT02489097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25255332|NCT02489097|Analgesics|analgesics|mesh-ancestor
25255333|NCT02489097|Sensory System Agents|sensory system agents|mesh-ancestor
25255334|NCT02489097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25255335|NCT02488694|Pemetrexed|pemetrexed|mesh-list
25255336|NCT02488694|Afatinib|afatinib|mesh-list
25255337|NCT02488694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25255338|NCT02488694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255339|NCT02488694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255340|NCT02488694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24525581|NCT03100786|Antiemetics|antiemetics|mesh-ancestor
25255341|NCT02488694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25255342|NCT02488694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25255343|NCT02488473|Dexmedetomidine|dexmedetomidine|mesh-list
25255344|NCT02488473|Ropivacaine|ropivacaine|mesh-list
25255345|NCT02488473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25255346|NCT02488473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25255347|NCT02488473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255348|NCT02488473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25255349|NCT02488473|Analgesics|analgesics|mesh-ancestor
25255350|NCT02488473|Sensory System Agents|sensory system agents|mesh-ancestor
25255351|NCT02488473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25255352|NCT02488473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24525496|NCT03259867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525497|NCT03259867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24402076|NCT00154739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927495|NCT04132648|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24927496|NCT04132648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24927497|NCT04132648|Analgesics|analgesics|mesh-ancestor
24927498|NCT04132648|Sensory System Agents|sensory system agents|mesh-ancestor
24927499|NCT04132648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24624528|NCT01076595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624529|NCT01076595|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24624530|NCT01076621|Norethindrone|norethindrone|mesh-list
24624531|NCT01076621|Norethindrone Acetate|norethindrone acetate|mesh-list
24624532|NCT01076621|Estradiol|estradiol|mesh-list
24624533|NCT01076621|Estrogens|estrogens|mesh-ancestor
24624534|NCT01076621|Hormones|hormones|mesh-ancestor
24624535|NCT01076621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24624536|NCT01076621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624537|NCT01076621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24503394|NCT01614171|Hormones|hormones|mesh-list
24525500|NCT03255915|Emtricitabine|emtricitabine|mesh-list
24525501|NCT03255915|Antiviral Agents|antiviral agents|mesh-ancestor
25010847|NCT02929589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25010892|NCT02767531|Orlistat|orlistat|mesh-list
25010893|NCT02767531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25010894|NCT02767531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010895|NCT02767531|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25010896|NCT02767531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25010897|NCT02757898|Biotin|biotin|mesh-list
25010898|NCT02757898|Vitamin B Complex|vitamin b complex|mesh-ancestor
25010899|NCT02757898|Vitamins|vitamins|mesh-ancestor
25010900|NCT02757898|Micronutrients|micronutrients|mesh-ancestor
25010901|NCT02757898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010902|NCT02737306|Leronlimab|leronlimab|mesh-list
25010933|NCT02589691|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25010934|NCT02589691|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25010935|NCT02589691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25010936|NCT02589691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010937|NCT02583048|Dolutegravir|dolutegravir|mesh-list
25010938|NCT02583048|Bedaquiline|bedaquiline|mesh-list
25010939|NCT02583048|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25010940|NCT02583048|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25010941|NCT02583048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25010942|NCT02583048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255353|NCT02488473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25255354|NCT02488473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25255355|NCT02488473|Adrenergic Agents|adrenergic agents|mesh-ancestor
25255356|NCT02488473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25255357|NCT02488473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687234|NCT01929135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687235|NCT01929291|Vaccines|vaccines|mesh-list
24958899|NCT03829150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24736543|NCT01662869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25255358|NCT02488473|Anesthetics, Local|anesthetics, local|mesh-ancestor
25255359|NCT02488473|Anesthetics|anesthetics|mesh-ancestor
25255360|NCT02488512|Edotreotide|edotreotide|mesh-list
25255361|NCT02488512|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25255362|NCT02488512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255363|NCT02488564|Metformin|metformin|mesh-list
25255364|NCT02488564|Docetaxel|docetaxel|mesh-list
25255365|NCT02488564|Doxorubicin|doxorubicin|mesh-list
25255366|NCT02488564|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25255367|NCT02488564|Trastuzumab|trastuzumab|mesh-list
25255368|NCT02488564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25255369|NCT02488564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255370|NCT02488564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25255371|NCT02488564|Tubulin Modulators|tubulin modulators|mesh-ancestor
25255372|NCT02488564|Antimitotic Agents|antimitotic agents|mesh-ancestor
25255373|NCT02488564|Mitosis Modulators|mitosis modulators|mesh-ancestor
24525582|NCT03100786|Autonomic Agents|autonomic agents|mesh-ancestor
25255374|NCT02488564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255376|NCT02488564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24525503|NCT03255915|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24525513|NCT03195374|Narcotics|narcotics|mesh-ancestor
24525519|NCT03193216|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
24525521|NCT03193216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525522|NCT03193216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24525523|NCT03188068|Sirolimus|sirolimus|mesh-list
24525524|NCT03188068|Prednisolone|prednisolone|mesh-list
24525525|NCT03188068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24525526|NCT03188068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24525527|NCT03188068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24525528|NCT03188068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525529|NCT03188068|Antifungal Agents|antifungal agents|mesh-ancestor
24624539|NCT01076621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24624540|NCT01076621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24624541|NCT01076621|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24624543|NCT01076621|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24624544|NCT01076634|Insulin|insulin|mesh-list
24624545|NCT01076634|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24624546|NCT01076634|Insulin, Long-Acting|insulin, long-acting|mesh-list
24624547|NCT01076634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24503403|NCT01582776|Growth Substances|growth substances|mesh-ancestor
24402130|NCT00154895|Minocycline|minocycline|mesh-list
24525568|NCT03112434|Botulinum Toxins|botulinum toxins|mesh-list
25010943|NCT02583048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25010944|NCT02583048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25010945|NCT02583048|Antiviral Agents|antiviral agents|mesh-ancestor
24967795|NCT03756727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967796|NCT03756727|Antioxidants|antioxidants|mesh-ancestor
24967797|NCT03756727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967798|NCT03756727|Protective Agents|protective agents|mesh-ancestor
24586009|NCT00888797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24586010|NCT00888797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24586011|NCT00888797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24586012|NCT00888797|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24586013|NCT00888797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24586014|NCT00888797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24586016|NCT00888810|Lapatinib|lapatinib|mesh-list
24586017|NCT00888810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24586018|NCT00888810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24586019|NCT00888810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255377|NCT02488564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25255378|NCT02488564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255379|NCT02488564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25255380|NCT02488590|Bronchodilator Agents|bronchodilator agents|mesh-list
25255381|NCT02488590|Autonomic Agents|autonomic agents|mesh-ancestor
25255382|NCT02488590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25255383|NCT02488590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255384|NCT02488590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25255385|NCT02488590|Respiratory System Agents|respiratory system agents|mesh-ancestor
25255386|NCT02488603|Tamoxifen|tamoxifen|mesh-list
25687236|NCT01929291|Immunologic Factors|immunologic factors|mesh-ancestor
25687237|NCT01929291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687238|NCT01929317|Ropinirole|ropinirole|mesh-list
25255387|NCT02488603|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25255388|NCT02488603|Hormone Antagonists|hormone antagonists|mesh-ancestor
25255389|NCT02488603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25255390|NCT02488603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255391|NCT02488603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25255392|NCT02488603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25255393|NCT02488603|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25255394|NCT02488603|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25255395|NCT02488603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25255396|NCT02488538|Fluoxetine|fluoxetine|mesh-list
25255397|NCT02488538|Contraceptive Agents|contraceptive agents|mesh-list
25255398|NCT02488538|Contraceptives, Oral|contraceptives, oral|mesh-list
25255399|NCT02488538|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25255400|NCT02488538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25255401|NCT02488538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255402|NCT02488538|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25255403|NCT02488538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24525578|NCT03112434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24525580|NCT03100786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24525583|NCT03100786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24525584|NCT03100786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525585|NCT03100786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24525586|NCT03100786|Glucocorticoids|glucocorticoids|mesh-ancestor
24525587|NCT03100786|Hormones|hormones|mesh-ancestor
24525588|NCT03100786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24525589|NCT03100786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24525590|NCT03100786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525591|NCT03051516|Vaccines|vaccines|mesh-list
24525592|NCT03051516|Immunologic Factors|immunologic factors|mesh-ancestor
24525593|NCT03051516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525594|NCT03034200|TIC10 compound|tic10 compound|mesh-list
24525595|NCT03034200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525596|NCT03015974|Mycophenolic Acid|mycophenolic acid|mesh-list
24525610|NCT03015974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525611|NCT03015974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525612|NCT03015974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24525613|NCT03015974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24525614|NCT03015974|Glucocorticoids|glucocorticoids|mesh-ancestor
24525615|NCT03015974|Hormones|hormones|mesh-ancestor
24525616|NCT03015974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24525617|NCT03015974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24525618|NCT03015974|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24525619|NCT03015974|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24525620|NCT03015974|Antitubercular Agents|antitubercular agents|mesh-ancestor
24525621|NCT03015974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24624550|NCT01076673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24927500|NCT04132648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927501|NCT04132648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24647791|NCT01210742|Hylan|hylan|mesh-list
24586020|NCT00888810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090200|NCT03259529|Alkylating Agents|alkylating agents|mesh-ancestor
24586021|NCT00888810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586022|NCT00888810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24586023|NCT00888836|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25255404|NCT02488538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25255405|NCT02488538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255406|NCT02488538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25255407|NCT02488538|Serotonin Agents|serotonin agents|mesh-ancestor
25255408|NCT02488538|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25255409|NCT02488538|Antidepressive Agents|antidepressive agents|mesh-ancestor
25255410|NCT02488538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25255411|NCT02488538|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25255412|NCT02488538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25255413|NCT02488538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255414|NCT02488538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25255415|NCT02488616|Insulin|insulin|mesh-list
25255416|NCT02488616|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25255417|NCT02488616|Hormones|hormones|mesh-list
25255418|NCT02488616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25255419|NCT02488616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255420|NCT02488616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25255421|NCT02488642|Isosorbide|isosorbide|mesh-list
25255422|NCT02488642|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25255423|NCT02488642|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25255424|NCT02488642|Misoprostol|misoprostol|mesh-list
25255425|NCT02488642|Oxytocin|oxytocin|mesh-list
25255426|NCT02488642|Oxytocics|oxytocics|mesh-ancestor
25255427|NCT02488642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25255428|NCT02488642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255429|NCT02488642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25255430|NCT02488642|Abortifacient Agents|abortifacient agents|mesh-ancestor
25255431|NCT02488642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25255432|NCT02488642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25255433|NCT02488642|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25255434|NCT02488642|Diuretics|diuretics|mesh-ancestor
25255435|NCT02488642|Natriuretic Agents|natriuretic agents|mesh-ancestor
25255436|NCT02488642|Vasodilator Agents|vasodilator agents|mesh-ancestor
25255437|NCT02488642|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25274894|NCT02374320|Bupivacaine|bupivacaine|mesh-list
24927502|NCT04132648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24927503|NCT04132648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927504|NCT04132648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927545|NCT04132115|Gentamicins|gentamicins|mesh-list
24927505|NCT04132648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927507|NCT04132570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24927508|NCT04132570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24927509|NCT04132570|Autonomic Agents|autonomic agents|mesh-ancestor
24927510|NCT04132570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24927511|NCT04132570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927512|NCT04132570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24927513|NCT04132570|Respiratory System Agents|respiratory system agents|mesh-ancestor
24525641|NCT03013504|Tubulin Modulators|tubulin modulators|mesh-ancestor
24525642|NCT03013504|Antimitotic Agents|antimitotic agents|mesh-ancestor
24525643|NCT03013504|Mitosis Modulators|mitosis modulators|mesh-ancestor
24525644|NCT03013504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24525645|NCT03013504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24525646|NCT03013504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24525647|NCT03013504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24525648|NCT03013504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525650|NCT02974049|Albendazole|albendazole|mesh-list
24927525|NCT04132557|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
24927526|NCT04132557|Dextroamphetamine|dextroamphetamine|mesh-list
24927528|NCT04132557|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24927529|NCT04132557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927530|NCT04132557|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24927531|NCT04132557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24927532|NCT04132557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24398655|NCT00145210|Vasodilator Agents|vasodilator agents|mesh-ancestor
24398657|NCT00145210|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24927533|NCT04132557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927535|NCT04132557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24927536|NCT04132557|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24927537|NCT04132557|Adrenergic Agents|adrenergic agents|mesh-ancestor
24927538|NCT04132557|Sympathomimetics|sympathomimetics|mesh-ancestor
24572149|NCT00813332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25011165|NCT01578954|Lenalidomide|lenalidomide|mesh-list
25255438|NCT02488642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255439|NCT02488486|Remifentanil|remifentanil|mesh-list
25255440|NCT02488486|Propofol|propofol|mesh-list
25255441|NCT02488486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25255442|NCT02488486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25255443|NCT02488486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255444|NCT02488486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25255445|NCT02488486|Anesthetics, General|anesthetics, general|mesh-ancestor
25255446|NCT02488486|Anesthetics|anesthetics|mesh-ancestor
25255447|NCT02488486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25255448|NCT02488486|Narcotics|narcotics|mesh-ancestor
25255449|NCT02488486|Analgesics|analgesics|mesh-ancestor
25255450|NCT02488486|Sensory System Agents|sensory system agents|mesh-ancestor
25255451|NCT02488486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25274895|NCT02374320|Anesthetics, Local|anesthetics, local|mesh-ancestor
25274896|NCT02374320|Anesthetics|anesthetics|mesh-ancestor
25274897|NCT02374320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25274898|NCT02374320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274899|NCT02374320|Sensory System Agents|sensory system agents|mesh-ancestor
25274900|NCT02374320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25687239|NCT01929317|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25274901|NCT02374567|Topiramate|topiramate|mesh-list
25274902|NCT02374567|Diphenhydramine|diphenhydramine|mesh-list
25274903|NCT02374567|Promethazine|promethazine|mesh-list
25274904|NCT02374567|Pregabalin|pregabalin|mesh-list
25274905|NCT02374567|Lamotrigine|lamotrigine|mesh-list
25274906|NCT02374567|Lacosamide|lacosamide|mesh-list
25274907|NCT02374567|Carbamazepine|carbamazepine|mesh-list
25274908|NCT02374567|Phenytoin|phenytoin|mesh-list
25274909|NCT02374567|Oxcarbazepine|oxcarbazepine|mesh-list
25274910|NCT02374567|Nicergoline|nicergoline|mesh-list
25274911|NCT02374567|Midazolam|midazolam|mesh-list
25274912|NCT02374567|Diazepam|diazepam|mesh-list
25274913|NCT02374567|Triazolam|triazolam|mesh-list
25274914|NCT02374567|Acamprosate|acamprosate|mesh-list
25274915|NCT02374567|Gabapentin|gabapentin|mesh-list
25274916|NCT02374567|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25274917|NCT02374567|Amitriptyline|amitriptyline|mesh-list
25274918|NCT02374567|Methotrimeprazine|methotrimeprazine|mesh-list
25274919|NCT02374567|Levetiracetam|levetiracetam|mesh-list
25274920|NCT02374567|Valproic Acid|valproic acid|mesh-list
24927539|NCT04132557|Autonomic Agents|autonomic agents|mesh-ancestor
24927540|NCT04132557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24927541|NCT04132063|Levetiracetam|levetiracetam|mesh-list
24927542|NCT04132063|Anticonvulsants|anticonvulsants|mesh-ancestor
24927543|NCT04132063|Nootropic Agents|nootropic agents|mesh-ancestor
24927557|NCT04132115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24927558|NCT04132115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24927559|NCT04132115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24927560|NCT04132115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927561|NCT04132115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927562|NCT04132115|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24927563|NCT04132115|Antiviral Agents|antiviral agents|mesh-ancestor
24399070|NCT00146562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24399071|NCT00146562|Hematinics|hematinics|mesh-ancestor
24399073|NCT00146575|Paclitaxel|paclitaxel|mesh-list
24399074|NCT00146575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24399075|NCT00146575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927564|NCT04132011|Morphine|morphine|mesh-list
24927565|NCT04132011|Oxycodone|oxycodone|mesh-list
24927566|NCT04132011|Analgesics, Opioid|analgesics, opioid|mesh-list
24927567|NCT04132011|Hydromorphone|hydromorphone|mesh-list
24927568|NCT04132011|Narcotics|narcotics|mesh-ancestor
25255452|NCT02488057|Liraglutide|liraglutide|mesh-list
25255453|NCT02488057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25255454|NCT02488057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255455|NCT02488057|Incretins|incretins|mesh-ancestor
25255456|NCT02488057|Hormones|hormones|mesh-ancestor
25255457|NCT02488057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25255458|NCT02488291|Sufentanil|sufentanil|mesh-list
25255459|NCT02488291|Dsuvia|dsuvia|mesh-list
25255460|NCT02488291|Ropivacaine|ropivacaine|mesh-list
25255461|NCT02488291|Anesthetics, Local|anesthetics, local|mesh-list
25255462|NCT02488291|Anesthetics|anesthetics|mesh-list
25255463|NCT02488291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25255464|NCT02488291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255465|NCT02488291|Sensory System Agents|sensory system agents|mesh-ancestor
25255466|NCT02488291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25255467|NCT02488291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25255468|NCT02488291|Narcotics|narcotics|mesh-ancestor
25255469|NCT02488291|Analgesics|analgesics|mesh-ancestor
25255470|NCT02488291|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25255471|NCT02488291|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25255472|NCT02488291|Anesthetics, General|anesthetics, general|mesh-ancestor
25255473|NCT02488135|Hemostatics|hemostatics|mesh-list
25255474|NCT02488135|Coagulants|coagulants|mesh-ancestor
25255475|NCT02487940|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25255476|NCT02487940|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25255477|NCT02487940|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25255478|NCT02487940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25255479|NCT02487953|Nicotine|nicotine|mesh-list
25687240|NCT01929317|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25687241|NCT01929317|Dopamine Agonists|dopamine agonists|mesh-ancestor
25687242|NCT01929317|Dopamine Agents|dopamine agents|mesh-ancestor
25255480|NCT02487953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25255481|NCT02487953|Autonomic Agents|autonomic agents|mesh-ancestor
25255482|NCT02487953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25255483|NCT02487953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255484|NCT02487953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25255485|NCT02487953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25255486|NCT02487953|Cholinergic Agents|cholinergic agents|mesh-ancestor
25255487|NCT02487953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25255488|NCT02487953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255489|NCT02487914|Lidocaine|lidocaine|mesh-list
25255490|NCT02487914|Anesthetics, Local|anesthetics, local|mesh-ancestor
25255491|NCT02487914|Anesthetics|anesthetics|mesh-ancestor
25255492|NCT02487914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25255493|NCT02487914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255494|NCT02487914|Sensory System Agents|sensory system agents|mesh-ancestor
25255495|NCT02487914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25255496|NCT02487914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25255497|NCT02487914|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25255498|NCT02487914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25255499|NCT02487914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25255500|NCT02487914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255501|NCT02487680|Chromium|chromium|mesh-list
25255502|NCT02487680|Picolinic acid|picolinic acid|mesh-list
25255503|NCT02487680|Trace Elements|trace elements|mesh-ancestor
25255504|NCT02487680|Micronutrients|micronutrients|mesh-ancestor
25255505|NCT02487680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255506|NCT02487680|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25255507|NCT02487680|Chelating Agents|chelating agents|mesh-ancestor
25255508|NCT02487680|Sequestering Agents|sequestering agents|mesh-ancestor
24525762|NCT02773212|Sympathomimetics|sympathomimetics|mesh-ancestor
24525763|NCT02773212|Autonomic Agents|autonomic agents|mesh-ancestor
24525764|NCT02773212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24525765|NCT02773212|Dopamine Agents|dopamine agents|mesh-ancestor
24525766|NCT02773212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24525767|NCT02773212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525768|NCT02773212|Adrenergic Agents|adrenergic agents|mesh-ancestor
24927598|NCT04131582|Linagliptin|linagliptin|mesh-list
24927599|NCT04131582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24927600|NCT04131582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927601|NCT04131582|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24927605|NCT04131582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24927606|NCT04131582|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24927607|NCT04131582|Protease Inhibitors|protease inhibitors|mesh-ancestor
24927608|NCT04131582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927609|NCT04131283|Epinephrine|epinephrine|mesh-list
24927610|NCT04131283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24927611|NCT04131283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24927612|NCT04131283|Adrenergic Agents|adrenergic agents|mesh-ancestor
24927613|NCT04131283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24927614|NCT04131283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927615|NCT04131283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927618|NCT04131283|Autonomic Agents|autonomic agents|mesh-ancestor
25255509|NCT02487680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255510|NCT02487706|Dolutegravir|dolutegravir|mesh-list
25255511|NCT02487706|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25255512|NCT02487706|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25255513|NCT02487706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255514|NCT02487706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255515|NCT02487706|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25255516|NCT02487706|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25255517|NCT02487706|Antiviral Agents|antiviral agents|mesh-ancestor
25255518|NCT02487706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25255519|NCT02487732|Ticagrelor|ticagrelor|mesh-list
25255520|NCT02487732|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25255521|NCT02487732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25255522|NCT02487732|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25255523|NCT02487732|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25255524|NCT02487732|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25255525|NCT02487732|Purinergic Agents|purinergic agents|mesh-ancestor
25255526|NCT02487732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25255527|NCT02487732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255528|NCT02487732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255529|NCT02487823|Bicalutamide|bicalutamide|mesh-list
25255530|NCT02487823|Buserelin|buserelin|mesh-list
25255531|NCT02487823|Androgen Antagonists|androgen antagonists|mesh-ancestor
25255532|NCT02487823|Hormone Antagonists|hormone antagonists|mesh-ancestor
25255533|NCT02487823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25255534|NCT02487823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255535|NCT02487823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25255536|NCT02487823|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25255537|NCT02487823|Fertility Agents|fertility agents|mesh-ancestor
25255538|NCT02487823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25255540|NCT02487719|Hematinics|hematinics|mesh-ancestor
25255541|NCT02487433|Tofacitinib|tofacitinib|mesh-list
25255542|NCT02487433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25255543|NCT02487433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255544|NCT02487433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255545|NCT02487407|Simendan|simendan|mesh-list
25255546|NCT02487407|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25255547|NCT02487407|Vasodilator Agents|vasodilator agents|mesh-ancestor
25255548|NCT02487407|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24927624|NCT04131283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24927625|NCT04131309|Dexamethasone|dexamethasone|mesh-list
24927652|NCT04131231|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24927653|NCT04131231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24927654|NCT04131231|Immunologic Factors|immunologic factors|mesh-ancestor
24927655|NCT04131231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25255602|NCT02487316|Crizotinib|crizotinib|mesh-list
24927656|NCT04131231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24927658|NCT04131231|Analgesics|analgesics|mesh-ancestor
24927682|NCT04130815|Diuretics|diuretics|mesh-ancestor
24927683|NCT04130815|Natriuretic Agents|natriuretic agents|mesh-ancestor
24927684|NCT04130815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927685|NCT04130815|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24927686|NCT04130815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24927687|NCT04130815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927688|NCT04130672|Hemostatics|hemostatics|mesh-list
24927689|NCT04130672|Coagulants|coagulants|mesh-ancestor
25011171|NCT01578954|Growth Inhibitors|growth inhibitors|mesh-ancestor
25011172|NCT01578954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011173|NCT01250912|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
25011174|NCT01250912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011175|NCT01250912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011176|NCT01250912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011177|NCT01250912|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25011212|NCT01111305|Reslizumab|reslizumab|mesh-list
25011213|NCT01111305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25011214|NCT01111305|Respiratory System Agents|respiratory system agents|mesh-ancestor
25011215|NCT01111305|Filaricides|filaricides|mesh-ancestor
25011216|NCT01111305|Antinematodal Agents|antinematodal agents|mesh-ancestor
25011217|NCT01111305|Anthelmintics|anthelmintics|mesh-ancestor
25011218|NCT01111305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25011219|NCT01111305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25011220|NCT01111305|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25011221|NCT01111305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011222|NCT01111305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011223|NCT00921856|Acetylcholine|acetylcholine|mesh-list
25011224|NCT00921856|Vasodilator Agents|vasodilator agents|mesh-ancestor
25011225|NCT00921856|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25011226|NCT00921856|Cholinergic Agents|cholinergic agents|mesh-ancestor
25011227|NCT00921856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25011228|NCT00921856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011229|NCT00921856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011230|NCT00792831|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
25011232|NCT00792831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011268|NCT00477412|BB 1101|bb 1101|mesh-list
25011269|NCT00477412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25011270|NCT00477412|Immunologic Factors|immunologic factors|mesh-ancestor
25255549|NCT02487407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25255550|NCT02487407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255551|NCT02487407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255552|NCT02487407|Protective Agents|protective agents|mesh-ancestor
25255553|NCT02487407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255554|NCT02487381|Dronabinol|dronabinol|mesh-list
25255555|NCT02487381|Cannabidiol|cannabidiol|mesh-list
25255556|NCT02487381|Anticonvulsants|anticonvulsants|mesh-ancestor
25255557|NCT02487381|Hallucinogens|hallucinogens|mesh-ancestor
25255558|NCT02487381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255559|NCT02487381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25255560|NCT02487381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25255561|NCT02487381|Analgesics|analgesics|mesh-ancestor
25255562|NCT02487381|Sensory System Agents|sensory system agents|mesh-ancestor
25255563|NCT02487381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25255564|NCT02487381|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25255565|NCT02487381|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25255566|NCT02487381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25051196|NCT00434226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25051197|NCT00434226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051198|NCT00434226|Tubulin Modulators|tubulin modulators|mesh-ancestor
25051199|NCT00434226|Antimitotic Agents|antimitotic agents|mesh-ancestor
24736884|NCT01664507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736885|NCT01664507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736886|NCT01664507|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24736887|NCT01664507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24736888|NCT01664507|Autonomic Agents|autonomic agents|mesh-ancestor
24736889|NCT01664507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25255567|NCT02487381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255568|NCT02487381|Hormones|hormones|mesh-ancestor
24525851|NCT02619253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927757|NCT04129697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24927758|NCT04129697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927759|NCT04129697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24927760|NCT04129697|Glucocorticoids|glucocorticoids|mesh-ancestor
24927761|NCT04129697|Hormones|hormones|mesh-ancestor
24927762|NCT04129697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24927763|NCT04129697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24402683|NCT00158171|Folic Acid|folic acid|mesh-list
24624554|NCT01076673|Protective Agents|protective agents|mesh-ancestor
24624556|NCT01076790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24624557|NCT01076790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24624558|NCT01076790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624559|NCT01076790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24586081|NCT00889135|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24624561|NCT01076790|Sensory System Agents|sensory system agents|mesh-ancestor
24624562|NCT01076790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24624563|NCT01076790|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24624564|NCT01076790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24624565|NCT01076790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24624566|NCT01076790|Adrenergic Agents|adrenergic agents|mesh-ancestor
24624567|NCT01076790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24624568|NCT01076790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624569|NCT01076803|Lanreotide|lanreotide|mesh-list
24624570|NCT01076803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011271|NCT00477412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011272|NCT00477412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25011273|NCT00477412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25011274|NCT00477412|Alkylating Agents|alkylating agents|mesh-ancestor
25011275|NCT00477412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011276|NCT00477412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011277|NCT00477412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25011278|NCT00477412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25255569|NCT02487381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25255570|NCT02487849|Carboplatin|carboplatin|mesh-list
25255571|NCT02487849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25255572|NCT02487329|Calcium, Dietary|calcium, dietary|mesh-list
25255573|NCT02487329|Calcium|calcium|mesh-list
25255574|NCT02487329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25255575|NCT02487329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255576|NCT02487329|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25255577|NCT02487355|Magnesium Sulfate|magnesium sulfate|mesh-list
25255578|NCT02487355|Dexmedetomidine|dexmedetomidine|mesh-list
25255579|NCT02487355|Bupivacaine|bupivacaine|mesh-list
25255580|NCT02487355|Anesthetics, Local|anesthetics, local|mesh-ancestor
25255581|NCT02487355|Anesthetics|anesthetics|mesh-ancestor
25687243|NCT01929317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25687244|NCT01929317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687245|NCT01929317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687246|NCT01929343|Lidocaine|lidocaine|mesh-list
25687247|NCT01929343|Anesthetics, Local|anesthetics, local|mesh-ancestor
25687248|NCT01929343|Anesthetics|anesthetics|mesh-ancestor
25687249|NCT01929343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25687250|NCT01929343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687251|NCT01929343|Sensory System Agents|sensory system agents|mesh-ancestor
25687252|NCT01929343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25687253|NCT01929343|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25687254|NCT01929343|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24399431|NCT00147758|Antimetabolites|antimetabolites|mesh-ancestor
25255582|NCT02487355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25255583|NCT02487355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255584|NCT02487355|Sensory System Agents|sensory system agents|mesh-ancestor
25255585|NCT02487355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25255586|NCT02487355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25255587|NCT02487355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25255588|NCT02487355|Analgesics|analgesics|mesh-ancestor
25255589|NCT02487355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25255590|NCT02487355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25255591|NCT02487355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25255592|NCT02487355|Adrenergic Agents|adrenergic agents|mesh-ancestor
25255593|NCT02487355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25255594|NCT02487355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255595|NCT02487355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25255596|NCT02487355|Anticonvulsants|anticonvulsants|mesh-ancestor
25255597|NCT02487355|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25255598|NCT02487355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25255599|NCT02487355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24624580|NCT01076816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24624581|NCT01076816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24624582|NCT01076816|Adrenergic Agents|adrenergic agents|mesh-ancestor
24624583|NCT01076816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24624584|NCT01076816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927779|NCT04129710|Methotrexate|methotrexate|mesh-list
24927780|NCT04129710|Etoposide|etoposide|mesh-list
24927781|NCT04129710|Lenalidomide|lenalidomide|mesh-list
24927782|NCT04129710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24927783|NCT04129710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927784|NCT04129710|Immunologic Factors|immunologic factors|mesh-ancestor
24927785|NCT04129710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927786|NCT04129710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24927787|NCT04129710|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24927788|NCT04129710|Abortifacient Agents|abortifacient agents|mesh-ancestor
24927789|NCT04129710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24927790|NCT04129710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24927791|NCT04129710|Antimetabolites|antimetabolites|mesh-ancestor
24927792|NCT04129710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402833|NCT00158548|Amebicides|amebicides|mesh-ancestor
24927832|NCT04128800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24927833|NCT04128800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255601|NCT02487355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25255603|NCT02487316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25255604|NCT02487316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25255605|NCT02487316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255606|NCT02487316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255607|NCT02487212|Clobetasol|clobetasol|mesh-list
25255608|NCT02487212|Petrolatum|petrolatum|mesh-list
25255609|NCT02487212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25255610|NCT02487212|Glucocorticoids|glucocorticoids|mesh-ancestor
25255611|NCT02487212|Hormones|hormones|mesh-ancestor
25255612|NCT02487212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25255613|NCT02487212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255614|NCT02487212|Emollients|emollients|mesh-ancestor
25255615|NCT02487212|Dermatologic Agents|dermatologic agents|mesh-ancestor
25255616|NCT02487069|Cyclosporine|cyclosporine|mesh-list
25255617|NCT02487069|Mycophenolic Acid|mycophenolic acid|mesh-list
25255618|NCT02487069|Methotrexate|methotrexate|mesh-list
25255619|NCT02487069|Cyclosporins|cyclosporins|mesh-list
25255620|NCT02487069|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25255621|NCT02487069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25255622|NCT02487069|Abortifacient Agents|abortifacient agents|mesh-ancestor
25255623|NCT02487069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25255624|NCT02487069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255625|NCT02487069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25255626|NCT02487069|Antimetabolites|antimetabolites|mesh-ancestor
25255627|NCT02487069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255628|NCT02487069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25255629|NCT02487069|Dermatologic Agents|dermatologic agents|mesh-ancestor
25255630|NCT02487069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255631|NCT02487069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25255632|NCT02487069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25255633|NCT02487069|Immunologic Factors|immunologic factors|mesh-ancestor
24943259|NCT03972748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24943260|NCT03972748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943261|NCT03972748|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25255634|NCT02487069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25255635|NCT02487069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25255636|NCT02487069|Antifungal Agents|antifungal agents|mesh-ancestor
25255637|NCT02487069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25255638|NCT02487069|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25255639|NCT02487069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25255640|NCT02487069|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25255641|NCT02487069|Antitubercular Agents|antitubercular agents|mesh-ancestor
25255642|NCT02487069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25255643|NCT02487082|Melatonin|melatonin|mesh-list
25255644|NCT02487082|Donepezil|donepezil|mesh-list
25255645|NCT02487082|Antioxidants|antioxidants|mesh-ancestor
25255646|NCT02487082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255647|NCT02487082|Protective Agents|protective agents|mesh-ancestor
25255648|NCT02487082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255649|NCT02487082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25255650|NCT02487082|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25255651|NCT02487082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24526081|NCT01845441|Sensory System Agents|sensory system agents|mesh-ancestor
24526082|NCT01845441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24526083|NCT01845441|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24526090|NCT01845441|Narcotics|narcotics|mesh-ancestor
24526131|NCT01114217|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24526132|NCT01114217|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24526133|NCT01114204|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24526134|NCT01114204|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24526135|NCT01114204|Hematinics|hematinics|mesh-ancestor
24526136|NCT01114204|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24526137|NCT01114204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24526138|NCT01114139|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24526139|NCT01114139|Hematinics|hematinics|mesh-ancestor
24526140|NCT01114139|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24526141|NCT01114139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24526142|NCT01059071|Eflornithine|eflornithine|mesh-list
24526144|NCT01059071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24526145|NCT01059071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526146|NCT01059071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24526147|NCT01059071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24526148|NCT01059071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24526149|NCT01059071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586078|NCT00889096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24586079|NCT00889096|Vasodilator Agents|vasodilator agents|mesh-ancestor
24586082|NCT00889135|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24586083|NCT00889148|Gabapentin|gabapentin|mesh-list
24586084|NCT00889148|Analgesics|analgesics|mesh-ancestor
24586085|NCT00889148|Sensory System Agents|sensory system agents|mesh-ancestor
24586086|NCT00889148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24586087|NCT00889148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586088|NCT00889148|Anticonvulsants|anticonvulsants|mesh-ancestor
24586089|NCT00889148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25011306|NCT00369317|Cytarabine|cytarabine|mesh-list
25011325|NCT00369317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25011326|NCT00261807|Daptomycin|daptomycin|mesh-list
25011327|NCT00261807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25011328|NCT00261807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25255652|NCT02487082|Cholinergic Agents|cholinergic agents|mesh-ancestor
25255653|NCT02487082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25255654|NCT02487082|Nootropic Agents|nootropic agents|mesh-ancestor
25255655|NCT02486822|Oxytocin|oxytocin|mesh-list
25255656|NCT02486822|Oxytocics|oxytocics|mesh-ancestor
25255657|NCT02486822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25255658|NCT02486822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255659|NCT02486848|Minoxidil|minoxidil|mesh-list
25255660|NCT02486848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25255661|NCT02486848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25255662|NCT02486848|Vasodilator Agents|vasodilator agents|mesh-ancestor
25255663|NCT02486926|Remifentanil|remifentanil|mesh-list
25255664|NCT02486926|Alfentanil|alfentanil|mesh-list
25687255|NCT01929343|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25687256|NCT01929343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25687257|NCT01929343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255666|NCT02486926|Sevoflurane|sevoflurane|mesh-list
25255667|NCT02486926|Rocuronium|rocuronium|mesh-list
25255668|NCT02486926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25255669|NCT02486926|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25255670|NCT02486926|Anesthetics, General|anesthetics, general|mesh-ancestor
25255671|NCT02486926|Anesthetics|anesthetics|mesh-ancestor
25255672|NCT02486926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25255673|NCT02486926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255674|NCT02486926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25255675|NCT02486926|Narcotics|narcotics|mesh-ancestor
25255676|NCT02486926|Analgesics|analgesics|mesh-ancestor
25255677|NCT02486926|Sensory System Agents|sensory system agents|mesh-ancestor
25123638|NCT03083080|Autonomic Agents|autonomic agents|mesh-ancestor
25255678|NCT02486926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25255679|NCT02486926|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25255680|NCT02486926|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25255681|NCT02486926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24927896|NCT04128254|Apixaban|apixaban|mesh-list
24927897|NCT04128254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24927898|NCT04128254|Antithrombins|antithrombins|mesh-ancestor
24927899|NCT04128254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24927900|NCT04128254|Protease Inhibitors|protease inhibitors|mesh-ancestor
24927901|NCT04128254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927902|NCT04128254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927903|NCT04128254|Anticoagulants|anticoagulants|mesh-ancestor
24526152|NCT01059071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24526153|NCT01059071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24526154|NCT01059071|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
24526156|NCT00934700|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24526157|NCT00934700|Anesthetics, General|anesthetics, general|mesh-ancestor
24526158|NCT00934700|Anesthetics|anesthetics|mesh-ancestor
24526159|NCT00934700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24526160|NCT00934700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754130|NCT01719185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25090411|NCT03257930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25110226|NCT05464862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25110227|NCT05464862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25110228|NCT05464862|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25110229|NCT05464862|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25110230|NCT05464862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25110231|NCT05464862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110260|NCT05464745|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25110261|NCT05464745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25255682|NCT02486926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25255683|NCT02486926|Anticonvulsants|anticonvulsants|mesh-ancestor
25255684|NCT02486926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25255685|NCT02486926|GABA Modulators|gaba modulators|mesh-ancestor
25255686|NCT02486926|GABA Agents|gaba agents|mesh-ancestor
25255687|NCT02486926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25255688|NCT02486926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255689|NCT02486744|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25255690|NCT02486744|Hormones|hormones|mesh-ancestor
25255691|NCT02486744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25255692|NCT02486744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255693|NCT02486432|Levodopa|levodopa|mesh-list
25255694|NCT02486432|Carbidopa|carbidopa|mesh-list
25255695|NCT02486432|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25255696|NCT02486432|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25255697|NCT02486432|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25255698|NCT02486432|Dopamine Agents|dopamine agents|mesh-ancestor
25255699|NCT02486432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25255700|NCT02486432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255701|NCT02486432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255702|NCT02486432|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25255703|NCT02486432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255704|NCT02486432|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25255705|NCT02486432|Immunologic Factors|immunologic factors|mesh-ancestor
25255706|NCT02486432|Dopamine Agonists|dopamine agonists|mesh-ancestor
24526236|NCT00605215|Interferon-beta|interferon-beta|mesh-list
24526237|NCT00605215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526238|NCT00605215|Antiviral Agents|antiviral agents|mesh-ancestor
25687258|NCT01929460|Ciprofloxacin|ciprofloxacin|mesh-list
24737070|NCT01666600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737071|NCT01666665|Metformin|metformin|mesh-list
24737072|NCT01666665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24526239|NCT00605215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24526286|NCT00290511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24526292|NCT00255216|Policosanol|policosanol|mesh-list
24526293|NCT00255216|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24526294|NCT00255216|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24526295|NCT00255216|Antimetabolites|antimetabolites|mesh-ancestor
24526296|NCT00255216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526297|NCT00255216|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24927921|NCT04128137|Fludrocortisone|fludrocortisone|mesh-list
24927922|NCT04128137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24927923|NCT04127747|Rituximab|rituximab|mesh-list
24927924|NCT04127747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25049497|NCT00602329|Antimetabolites|antimetabolites|mesh-ancestor
25110268|NCT05464680|Chelating Agents|chelating agents|mesh-ancestor
25110269|NCT05464680|Sequestering Agents|sequestering agents|mesh-ancestor
25110270|NCT05464680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011363|NCT05215743|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25011364|NCT05215743|Chelating Agents|chelating agents|mesh-ancestor
25011365|NCT05215743|Sequestering Agents|sequestering agents|mesh-ancestor
25011367|NCT05215730|Trace Elements|trace elements|mesh-ancestor
25011368|NCT05215730|Micronutrients|micronutrients|mesh-ancestor
25011369|NCT05215730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011370|NCT05215665|Lenvatinib|lenvatinib|mesh-list
25011371|NCT05215665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011372|NCT05215665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25011373|NCT05215665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011374|NCT05215665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011375|NCT05215366|Arginine Vasopressin|arginine vasopressin|mesh-list
25011376|NCT05215366|Hemostatics|hemostatics|mesh-ancestor
25011377|NCT05215366|Coagulants|coagulants|mesh-ancestor
25011378|NCT05215366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24572714|NCT00816413|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
24968201|NCT03753477|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24968202|NCT03753477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24968203|NCT03753477|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24968204|NCT03753477|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25255707|NCT02486445|Rivaroxaban|rivaroxaban|mesh-list
25255708|NCT02486445|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24401205|NCT00152412|Histamine Agents|histamine agents|mesh-ancestor
25255709|NCT02486445|Antithrombins|antithrombins|mesh-ancestor
25255710|NCT02486445|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25255711|NCT02486445|Protease Inhibitors|protease inhibitors|mesh-ancestor
25255712|NCT02486445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255713|NCT02486445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255714|NCT02486445|Anticoagulants|anticoagulants|mesh-ancestor
25255715|NCT02486510|Maraviroc|maraviroc|mesh-list
25255716|NCT02486510|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25255717|NCT02486510|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25255718|NCT02486510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255719|NCT02486510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25255720|NCT02486510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25255721|NCT02486510|Antiviral Agents|antiviral agents|mesh-ancestor
25255722|NCT02486510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25255723|NCT02486510|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25255724|NCT02486549|Bupivacaine|bupivacaine|mesh-list
24927925|NCT04127747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927926|NCT04127747|Immunologic Factors|immunologic factors|mesh-ancestor
24927927|NCT04127747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927928|NCT04127747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24927929|NCT04127916|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24526377|NCT00611416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24526378|NCT00611416|Purinergic Agents|purinergic agents|mesh-ancestor
24526379|NCT00611416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24526380|NCT00611416|Antioxidants|antioxidants|mesh-ancestor
24526381|NCT00611416|Protective Agents|protective agents|mesh-ancestor
24526382|NCT00611416|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24927940|NCT04128020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24927941|NCT04128020|Antimetabolites|antimetabolites|mesh-ancestor
24927942|NCT04128020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752180|NCT01708837|Anesthetics|anesthetics|mesh-ancestor
25687259|NCT01929460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25687260|NCT01929460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25687261|NCT01929460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24456562|NCT00331708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24737164|NCT01667263|Hormone Antagonists|hormone antagonists|mesh-ancestor
24737165|NCT01667263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24927944|NCT04127721|Fludarabine|fludarabine|mesh-list
24927946|NCT04127721|Tacrolimus|tacrolimus|mesh-list
24927947|NCT04127721|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24927948|NCT04127721|Abortifacient Agents|abortifacient agents|mesh-ancestor
24927949|NCT04127721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24927950|NCT04127721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927951|NCT04127721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24526403|NCT00611507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526412|NCT00611611|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25049516|NCT00595699|Citalopram|citalopram|mesh-list
24968206|NCT03753269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24968207|NCT03753269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24968208|NCT03753269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968209|NCT03753269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24968210|NCT03753269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968211|NCT03753269|Vasodilator Agents|vasodilator agents|mesh-ancestor
24968212|NCT03753269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24968213|NCT03753269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24968214|NCT03752931|Celiprolol|celiprolol|mesh-list
24968215|NCT03752931|Diltiazem|diltiazem|mesh-list
24968216|NCT03752931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24968217|NCT03752931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24968218|NCT03752931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24968219|NCT03752931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968220|NCT03752931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24968221|NCT03752931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968222|NCT03752931|Vasodilator Agents|vasodilator agents|mesh-ancestor
24968223|NCT03752931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24968224|NCT03752931|Sympathomimetics|sympathomimetics|mesh-ancestor
24968225|NCT03752931|Autonomic Agents|autonomic agents|mesh-ancestor
24968226|NCT03752931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24968227|NCT03752931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25255725|NCT02486549|Anesthetics, Local|anesthetics, local|mesh-ancestor
25255726|NCT02486549|Anesthetics|anesthetics|mesh-ancestor
25255727|NCT02486549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25255728|NCT02486549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255729|NCT02486549|Sensory System Agents|sensory system agents|mesh-ancestor
25255730|NCT02486549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25274921|NCT02374567|Lorazepam|lorazepam|mesh-list
25274922|NCT02374567|Clonazepam|clonazepam|mesh-list
25274923|NCT02374567|Phenobarbital|phenobarbital|mesh-list
25274924|NCT02374567|Clobazam|clobazam|mesh-list
25274925|NCT02374567|Zaleplon|zaleplon|mesh-list
25274926|NCT02374567|Nitrazepam|nitrazepam|mesh-list
25274927|NCT02374567|Chlormethiazole|chlormethiazole|mesh-list
25274928|NCT02374567|Memantine|memantine|mesh-list
25274929|NCT02374567|Biperiden|biperiden|mesh-list
25274930|NCT02374567|Haloperidol|haloperidol|mesh-list
25274931|NCT02374567|Pimozide|pimozide|mesh-list
25274932|NCT02374567|Olanzapine|olanzapine|mesh-list
25274933|NCT02374567|Zolpidem|zolpidem|mesh-list
25274934|NCT02374567|Alprazolam|alprazolam|mesh-list
25274935|NCT02374567|Zopiclone|zopiclone|mesh-list
25274936|NCT02374567|S 20098|s 20098|mesh-list
25274937|NCT02374567|Chloral Hydrate|chloral hydrate|mesh-list
25274938|NCT02374567|Doxepin|doxepin|mesh-list
25274939|NCT02374567|Oxazepam|oxazepam|mesh-list
25274940|NCT02374567|Temazepam|temazepam|mesh-list
25274941|NCT02374567|Brotizolam|brotizolam|mesh-list
25274942|NCT02374567|Lormetazepam|lormetazepam|mesh-list
25274943|NCT02374567|Flurazepam|flurazepam|mesh-list
25274944|NCT02374567|Mirtazapine|mirtazapine|mesh-list
25274945|NCT02374567|Buspirone|buspirone|mesh-list
25274946|NCT02374567|Trazodone|trazodone|mesh-list
25274947|NCT02374567|Fluvoxamine|fluvoxamine|mesh-list
24526413|NCT00611611|Immunologic Factors|immunologic factors|mesh-ancestor
24526414|NCT00611611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687262|NCT01929460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25687263|NCT01929460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687264|NCT01929460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687265|NCT01929460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25687266|NCT01929460|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24526419|NCT00611650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526421|NCT00611650|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24526422|NCT00611650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526423|NCT00611650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24526424|NCT00611663|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24624617|NCT01077427|Gemcitabine|gemcitabine|mesh-list
24624618|NCT01077427|Capecitabine|capecitabine|mesh-list
24624619|NCT01077427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624620|NCT01077427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24624621|NCT01077427|Antimetabolites|antimetabolites|mesh-ancestor
24624622|NCT01077427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624623|NCT01077427|Antiviral Agents|antiviral agents|mesh-ancestor
24624624|NCT01077427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24968228|NCT03752931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24968229|NCT03752931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24968230|NCT03752931|Adrenergic Agents|adrenergic agents|mesh-ancestor
24968231|NCT03752931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25011411|NCT05214872|Mitosis Modulators|mitosis modulators|mesh-ancestor
25011416|NCT05214820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011547|NCT04811118|Mitosis Modulators|mitosis modulators|mesh-ancestor
25011548|NCT04811118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011550|NCT04793685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25011551|NCT04793685|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25011552|NCT04793685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25011553|NCT04793685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25011554|NCT04793685|Adrenergic Agents|adrenergic agents|mesh-ancestor
25011555|NCT04793685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25011556|NCT04793685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011557|NCT04793685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255731|NCT02486601|Paclitaxel|paclitaxel|mesh-list
25255732|NCT02486601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25255733|NCT02486601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25255734|NCT02486601|Tubulin Modulators|tubulin modulators|mesh-ancestor
25255735|NCT02486601|Antimitotic Agents|antimitotic agents|mesh-ancestor
25255736|NCT02486601|Mitosis Modulators|mitosis modulators|mesh-ancestor
25255737|NCT02486601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255738|NCT02486640|Interferons|interferons|mesh-list
25255739|NCT02486640|Interferon-beta|interferon-beta|mesh-list
25255740|NCT02486640|Interferon beta-1b|interferon beta-1b|mesh-list
25255741|NCT02486640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25255742|NCT02486640|Antiviral Agents|antiviral agents|mesh-ancestor
25255743|NCT02486640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25255744|NCT02486640|Immunologic Factors|immunologic factors|mesh-ancestor
25255745|NCT02486640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255746|NCT02486640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25255747|NCT02486458|Listerine|listerine|mesh-list
25255748|NCT02486458|Fluorides|fluorides|mesh-list
25255749|NCT02486458|Sodium Fluoride|sodium fluoride|mesh-list
25255750|NCT02486458|Fluorides, Topical|fluorides, topical|mesh-list
25255751|NCT02486458|Cariostatic Agents|cariostatic agents|mesh-ancestor
24624625|NCT01077427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24624626|NCT01077427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24624627|NCT01077427|Immunologic Factors|immunologic factors|mesh-ancestor
24624628|NCT01077427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624629|NCT01077453|Letrozole|letrozole|mesh-list
24624630|NCT01077453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624631|NCT01077453|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24624632|NCT01077453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24624633|NCT01077453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24624634|NCT01077453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624635|NCT01077453|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24624636|NCT01077453|Hormone Antagonists|hormone antagonists|mesh-ancestor
25004049|NCT02764541|Palbociclib|palbociclib|mesh-list
24648247|NCT01213355|Scopolamine|scopolamine|mesh-list
25011568|NCT04703036|Acetylcysteine|acetylcysteine|mesh-list
25011569|NCT04703036|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25011571|NCT04703036|Antiviral Agents|antiviral agents|mesh-ancestor
25011572|NCT04703036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25011573|NCT04703036|Expectorants|expectorants|mesh-ancestor
25011574|NCT04703036|Respiratory System Agents|respiratory system agents|mesh-ancestor
25011575|NCT04703036|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25011576|NCT04703036|Antioxidants|antioxidants|mesh-ancestor
25011577|NCT04703036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011578|NCT04703036|Protective Agents|protective agents|mesh-ancestor
24401640|NCT00153556|Vaccines|vaccines|mesh-list
25011591|NCT04647084|Anesthetics|anesthetics|mesh-ancestor
25011592|NCT04647084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25011593|NCT04647084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011594|NCT04647084|Sensory System Agents|sensory system agents|mesh-ancestor
25011595|NCT04647084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25011596|NCT04647084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25011597|NCT04647084|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25011598|NCT04647084|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25011659|NCT04471675|Docetaxel|docetaxel|mesh-list
25011660|NCT04471675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011661|NCT04471675|Tubulin Modulators|tubulin modulators|mesh-ancestor
25011662|NCT04471675|Antimitotic Agents|antimitotic agents|mesh-ancestor
25011663|NCT04471675|Mitosis Modulators|mitosis modulators|mesh-ancestor
25011664|NCT04471675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011671|NCT04439513|Hemostatics|hemostatics|mesh-list
25011672|NCT04439513|Coagulants|coagulants|mesh-ancestor
25011707|NCT04304144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25011708|NCT04304144|Alkylating Agents|alkylating agents|mesh-ancestor
25011709|NCT04304144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011710|NCT04304144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011711|NCT04304144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25011712|NCT04304144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25011713|NCT04304144|Antiemetics|antiemetics|mesh-ancestor
25011714|NCT04304144|Autonomic Agents|autonomic agents|mesh-ancestor
25011715|NCT04304144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25011716|NCT04304144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25011717|NCT04304144|Glucocorticoids|glucocorticoids|mesh-ancestor
25011718|NCT04304144|Hormones|hormones|mesh-ancestor
25011719|NCT04304144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25011720|NCT04304144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25011721|NCT04256629|Allopurinol|allopurinol|mesh-list
25011722|NCT04256629|Verinurad|verinurad|mesh-list
25011723|NCT04256629|Antimetabolites|antimetabolites|mesh-ancestor
25255752|NCT02486458|Protective Agents|protective agents|mesh-ancestor
25255753|NCT02486458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255754|NCT02486458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25255755|NCT02486458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25255756|NCT02486484|Aflibercept|aflibercept|mesh-list
25255757|NCT02486484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25255758|NCT02486484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25255759|NCT02486484|Growth Substances|growth substances|mesh-ancestor
25255760|NCT02486484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255761|NCT02486484|Growth Inhibitors|growth inhibitors|mesh-ancestor
25255762|NCT02486484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25255763|NCT02486341|Insulin|insulin|mesh-list
25255764|NCT02486341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25255765|NCT02486341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255766|NCT02486198|Oxaliplatin|oxaliplatin|mesh-list
24927976|NCT04127396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24927977|NCT04127396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927978|NCT04127396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24927979|NCT04127500|Dexmedetomidine|dexmedetomidine|mesh-list
24927980|NCT04127500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24927981|NCT04127500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24927982|NCT04127500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927983|NCT04127500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24927985|NCT04127500|Sensory System Agents|sensory system agents|mesh-ancestor
24927986|NCT04127500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24927987|NCT04127500|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24927988|NCT04127500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24927989|NCT04127500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24927990|NCT04127500|Adrenergic Agents|adrenergic agents|mesh-ancestor
25004064|NCT02763579|Carboplatin|carboplatin|mesh-list
25011724|NCT04256629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011725|NCT04256629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011726|NCT04256629|Gout Suppressants|gout suppressants|mesh-ancestor
25011727|NCT04256629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25011728|NCT04256629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25011729|NCT04256629|Antioxidants|antioxidants|mesh-ancestor
25011735|NCT04231084|Tezosentan|tezosentan|mesh-list
25011736|NCT04231084|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25687267|NCT01929460|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24737470|NCT01669044|Adrenergic Agents|adrenergic agents|mesh-ancestor
24737471|NCT01669044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24847959|NCT05330364|Cladribine|cladribine|mesh-list
24737473|NCT01669083|Diketopiperazines|diketopiperazines|mesh-list
25011737|NCT04231084|Autonomic Agents|autonomic agents|mesh-ancestor
25011738|NCT04231084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25011749|NCT04231084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25110350|NCT05463861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110351|NCT05463861|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25110353|NCT05463861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25110354|NCT05463861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011762|NCT04083963|Paclitaxel|paclitaxel|mesh-list
25011763|NCT04083963|Cyclophosphamide|cyclophosphamide|mesh-list
25011764|NCT04083963|Carboplatin|carboplatin|mesh-list
25011765|NCT04083963|Doxorubicin|doxorubicin|mesh-list
24573233|NCT00818675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25011807|NCT03771586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25011808|NCT03771586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25011809|NCT03771586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25011810|NCT03771586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25011811|NCT03771586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011812|NCT03767582|Nivolumab|nivolumab|mesh-list
25011813|NCT03767582|Vaccines|vaccines|mesh-list
25011824|NCT03706885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011825|NCT03706885|Antiviral Agents|antiviral agents|mesh-ancestor
25011826|NCT03706885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25011827|NCT03706885|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25255767|NCT02486198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25255768|NCT02486133|Ritonavir|ritonavir|mesh-list
25255769|NCT02486133|Darunavir|darunavir|mesh-list
25255770|NCT02486133|Tenofovir|tenofovir|mesh-list
25255771|NCT02486133|Lamivudine|lamivudine|mesh-list
25255772|NCT02486133|Emtricitabine|emtricitabine|mesh-list
25255773|NCT02486133|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25255774|NCT02486133|Abacavir|abacavir|mesh-list
25255775|NCT02486133|Dolutegravir|dolutegravir|mesh-list
25255776|NCT02486133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25255777|NCT02486133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25255778|NCT02486133|Protease Inhibitors|protease inhibitors|mesh-ancestor
25255779|NCT02486133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255780|NCT02486133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255781|NCT02486133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25255782|NCT02486133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25255783|NCT02486133|Antiviral Agents|antiviral agents|mesh-ancestor
25255784|NCT02486133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25255785|NCT02486133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24927991|NCT04127500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24927992|NCT04127500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927993|NCT04127357|Fluorides|fluorides|mesh-list
24526447|NCT00611728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24928002|NCT04127084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928004|NCT04126941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24928005|NCT04126941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928006|NCT04127058|Iloperidone|iloperidone|mesh-list
24928007|NCT04127058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24928008|NCT04127058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25090504|NCT03257319|Analgesics|analgesics|mesh-ancestor
24928009|NCT04127058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24928010|NCT04127058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928011|NCT04127058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24928012|NCT04127019|Paclitaxel|paclitaxel|mesh-list
24928013|NCT04127019|Docetaxel|docetaxel|mesh-list
24928014|NCT04127019|Cyclophosphamide|cyclophosphamide|mesh-list
24928015|NCT04127019|Fluorouracil|fluorouracil|mesh-list
24928016|NCT04127019|Epirubicin|epirubicin|mesh-list
24928017|NCT04127019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24928018|NCT04127019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24928019|NCT04127019|Tubulin Modulators|tubulin modulators|mesh-ancestor
24928020|NCT04127019|Antimitotic Agents|antimitotic agents|mesh-ancestor
25255786|NCT02486133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25687268|NCT01929642|Sirolimus|sirolimus|mesh-list
25687269|NCT01929642|Everolimus|everolimus|mesh-list
25687270|NCT01929642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25687271|NCT01929642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25687272|NCT01929642|Immunologic Factors|immunologic factors|mesh-ancestor
24959415|NCT03825133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959416|NCT03825133|Viscosupplements|viscosupplements|mesh-ancestor
24959417|NCT03825133|Protective Agents|protective agents|mesh-ancestor
24959418|NCT03824847|Clarithromycin|clarithromycin|mesh-list
24959419|NCT03824847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24737524|NCT01669304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24737525|NCT01669304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24737527|NCT01669304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25255787|NCT02486133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25255788|NCT02486133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25255789|NCT02486133|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25255790|NCT02486133|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25255791|NCT02486055|Coenzyme Q10|coenzyme q10|mesh-list
25255792|NCT02486055|Micronutrients|micronutrients|mesh-ancestor
25255793|NCT02486055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255795|NCT02486289|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
25255796|NCT02486289|Chelating Agents|chelating agents|mesh-ancestor
25255797|NCT02486289|Sequestering Agents|sequestering agents|mesh-ancestor
25255798|NCT02486289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255799|NCT02486276|Cilostazol|cilostazol|mesh-list
25255800|NCT02486276|Sumatriptan|sumatriptan|mesh-list
25255801|NCT02486276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25255802|NCT02486276|Autonomic Agents|autonomic agents|mesh-ancestor
25255803|NCT02486276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25255804|NCT02486276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255805|NCT02486276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25255806|NCT02486276|Respiratory System Agents|respiratory system agents|mesh-ancestor
25255807|NCT02486276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25255808|NCT02486276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25255809|NCT02486276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255810|NCT02486276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25255811|NCT02486276|Vasodilator Agents|vasodilator agents|mesh-ancestor
25255812|NCT02486276|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25255813|NCT02486276|Protective Agents|protective agents|mesh-ancestor
25255814|NCT02486276|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25255815|NCT02486276|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25255816|NCT02486276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255817|NCT02486276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25255818|NCT02486276|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25255819|NCT02486276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25255820|NCT02486276|Serotonin Agents|serotonin agents|mesh-ancestor
25255821|NCT02486276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25255822|NCT02485990|Olaparib|olaparib|mesh-list
25255823|NCT02485990|Tremelimumab|tremelimumab|mesh-list
25255824|NCT02485990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25255825|NCT02485990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255826|NCT02485990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255827|NCT02485990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25255828|NCT02485821|Misoprostol|misoprostol|mesh-list
25255829|NCT02485821|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25255830|NCT02485821|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25255831|NCT02485821|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25255832|NCT02485821|Estradiol|estradiol|mesh-list
25255833|NCT02485821|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24928063|NCT04126811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24928064|NCT04126811|Alkylating Agents|alkylating agents|mesh-ancestor
24928065|NCT04126811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24928066|NCT04126811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24928067|NCT04126811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24928068|NCT04126668|Vorolanib|vorolanib|mesh-list
24928069|NCT04126668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24526448|NCT00611728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526480|NCT00611793|Growth Inhibitors|growth inhibitors|mesh-ancestor
24526481|NCT00611793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24526515|NCT00611910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25687273|NCT01929642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687274|NCT01929642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25687275|NCT01929642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25687276|NCT01929642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25687277|NCT01929642|Antifungal Agents|antifungal agents|mesh-ancestor
25687278|NCT01929759|Tenofovir|tenofovir|mesh-list
25687279|NCT01929759|Emtricitabine|emtricitabine|mesh-list
25687280|NCT01929759|Cobicistat|cobicistat|mesh-list
25692604|NCT02002832|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24959423|NCT03824847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959426|NCT03824743|Plasma-lyte 148|plasma-lyte 148|mesh-list
24526516|NCT00611910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526517|NCT00611910|Tubulin Modulators|tubulin modulators|mesh-ancestor
24526518|NCT00611910|Antimitotic Agents|antimitotic agents|mesh-ancestor
24526519|NCT00611910|Mitosis Modulators|mitosis modulators|mesh-ancestor
24526520|NCT00611910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526521|NCT00611910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24526522|NCT00611910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24526523|NCT00611910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24526524|NCT00611910|Antifungal Agents|antifungal agents|mesh-ancestor
24526525|NCT00611910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24526529|NCT00611936|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24526530|NCT00611936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24526531|NCT00611936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24526532|NCT00611936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526533|NCT00611936|Adrenergic Agents|adrenergic agents|mesh-ancestor
24526534|NCT00611936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24526535|NCT00611936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526536|NCT00611962|Paclitaxel|paclitaxel|mesh-list
24526537|NCT00611962|Oxaliplatin|oxaliplatin|mesh-list
24526538|NCT00611962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24526539|NCT00611962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011828|NCT03706885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25011829|NCT03706885|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25011830|NCT03706885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25011831|NCT03706885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25011832|NCT03706885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25011833|NCT03560960|Pramlintide|pramlintide|mesh-list
25255834|NCT02485821|Estrogens|estrogens|mesh-ancestor
25255835|NCT02485821|Hormones|hormones|mesh-ancestor
25255836|NCT02485821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25255837|NCT02485821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255838|NCT02485821|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25255839|NCT02485821|Contraceptive Agents|contraceptive agents|mesh-ancestor
25255840|NCT02485821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25255841|NCT02485821|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25255842|NCT02485821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25255843|NCT02485821|Abortifacient Agents|abortifacient agents|mesh-ancestor
25255844|NCT02485821|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25255845|NCT02485821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25255846|NCT02485821|Oxytocics|oxytocics|mesh-ancestor
25255847|NCT02485821|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25255848|NCT02485821|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25255849|NCT02485873|Vitamin K|vitamin k|mesh-list
25255850|NCT02485873|Rivaroxaban|rivaroxaban|mesh-list
25255851|NCT02485873|Vitamins|vitamins|mesh-ancestor
25255852|NCT02485873|Micronutrients|micronutrients|mesh-ancestor
25255853|NCT02485873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255854|NCT02485873|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25255855|NCT02485873|Antithrombins|antithrombins|mesh-ancestor
25255856|NCT02485873|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25255857|NCT02485873|Protease Inhibitors|protease inhibitors|mesh-ancestor
25255858|NCT02485873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255859|NCT02485873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255860|NCT02485873|Anticoagulants|anticoagulants|mesh-ancestor
25255861|NCT02485873|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25255862|NCT02485873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25255863|NCT02485873|Hemostatics|hemostatics|mesh-ancestor
25255864|NCT02485873|Coagulants|coagulants|mesh-ancestor
25255865|NCT02485548|Fluorouracil|fluorouracil|mesh-list
25255866|NCT02485548|Raltitrexed|raltitrexed|mesh-list
25255867|NCT02485548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25255868|NCT02485548|Antimetabolites|antimetabolites|mesh-ancestor
24526541|NCT00611962|Antimitotic Agents|antimitotic agents|mesh-ancestor
24526542|NCT00611962|Mitosis Modulators|mitosis modulators|mesh-ancestor
24526543|NCT00611962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526605|NCT00612287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24526606|NCT00612287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526608|NCT00612287|Sensory System Agents|sensory system agents|mesh-ancestor
24526609|NCT00612287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24526610|NCT00612287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25692605|NCT02002832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25692606|NCT02002832|Adrenergic Agents|adrenergic agents|mesh-ancestor
24526612|NCT00612469|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24526613|NCT00612469|Listerine|listerine|mesh-list
24526614|NCT00612469|Vancomycin|vancomycin|mesh-list
24526615|NCT00612469|Fluorides|fluorides|mesh-list
24526616|NCT00612469|Sodium Fluoride|sodium fluoride|mesh-list
24526617|NCT00612469|Cariostatic Agents|cariostatic agents|mesh-ancestor
24526618|NCT00612469|Protective Agents|protective agents|mesh-ancestor
24526619|NCT00612469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928133|NCT04125394|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24928134|NCT04125394|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24928135|NCT04125082|Insulin|insulin|mesh-list
24928136|NCT04125082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24928137|NCT04125082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24928138|NCT04125082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011834|NCT03560960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24968622|NCT03749733|Megestrol|megestrol|mesh-list
24968694|NCT03749356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968696|NCT03749226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24968697|NCT03749226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24968698|NCT03749174|Anesthetics|anesthetics|mesh-list
24968699|NCT03749174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24968700|NCT03749174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968702|NCT03749096|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24968703|NCT03749096|Antibodies|antibodies|mesh-list
24968704|NCT03749096|gamma-Globulins|gamma-globulins|mesh-list
24968705|NCT03749096|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24968706|NCT03749096|Immunologic Factors|immunologic factors|mesh-ancestor
24968707|NCT03749096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586178|NCT00889434|Micronutrients|micronutrients|mesh-ancestor
24586179|NCT00889499|Tropisetron|tropisetron|mesh-list
24586180|NCT00889499|Antiemetics|antiemetics|mesh-ancestor
24586181|NCT00889499|Autonomic Agents|autonomic agents|mesh-ancestor
24586182|NCT00889499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24586183|NCT00889499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586184|NCT00889499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24586185|NCT00889499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24586186|NCT00889499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24586187|NCT00889499|Serotonin Agents|serotonin agents|mesh-ancestor
24586188|NCT00889499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24586189|NCT00889499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255869|NCT02485548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255870|NCT02485548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25255871|NCT02485548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25255872|NCT02485548|Immunologic Factors|immunologic factors|mesh-ancestor
25255873|NCT02485548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255874|NCT02485548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25255875|NCT02485548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255876|NCT02485613|Dexamethasone|dexamethasone|mesh-list
25090582|NCT03256487|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25090583|NCT03256149|Dexamethasone|dexamethasone|mesh-list
25090584|NCT03256149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25090585|NCT03256149|Antiemetics|antiemetics|mesh-ancestor
25255877|NCT02485613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25255878|NCT02485613|Antiemetics|antiemetics|mesh-ancestor
25255879|NCT02485613|Autonomic Agents|autonomic agents|mesh-ancestor
25255880|NCT02485613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25255881|NCT02485613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255882|NCT02485613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25255883|NCT02485613|Glucocorticoids|glucocorticoids|mesh-ancestor
25255884|NCT02485613|Hormones|hormones|mesh-ancestor
25255885|NCT02485613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25255886|NCT02485613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25255887|NCT02485613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25255888|NCT02485431|Deflazacort|deflazacort|mesh-list
25255889|NCT02485431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25255890|NCT02485431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25255891|NCT02485431|Immunologic Factors|immunologic factors|mesh-ancestor
24403556|NCT00160888|Protease Inhibitors|protease inhibitors|mesh-ancestor
24928149|NCT04125121|Anesthetics|anesthetics|mesh-ancestor
24928150|NCT04125121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24928151|NCT04125121|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24928152|NCT04124822|Prednisolone|prednisolone|mesh-list
24928154|NCT04124822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24928155|NCT04124822|Glucocorticoids|glucocorticoids|mesh-ancestor
24928156|NCT04124822|Hormones|hormones|mesh-ancestor
24928157|NCT04124822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24928158|NCT04124822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928159|NCT04124822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24928161|NCT04124822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24928162|NCT04124822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24928163|NCT04124822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24928164|NCT04124822|Analgesics|analgesics|mesh-ancestor
24928165|NCT04124822|Sensory System Agents|sensory system agents|mesh-ancestor
24928166|NCT04124822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24928167|NCT04124822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24928168|NCT04124822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24928169|NCT04124822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928170|NCT04124887|Calcium, Dietary|calcium, dietary|mesh-list
24928171|NCT04124887|Listerine|listerine|mesh-list
24928172|NCT04124887|Calcium|calcium|mesh-list
24928173|NCT04124887|Fluorides|fluorides|mesh-list
24928174|NCT04124887|Sodium Fluoride|sodium fluoride|mesh-list
24928175|NCT04124887|Caseins|caseins|mesh-list
24928176|NCT04124887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24526733|NCT00612989|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
24928177|NCT04124887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928178|NCT04124887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24403589|NCT00161018|Serotonin Agents|serotonin agents|mesh-ancestor
25255892|NCT02485431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255894|NCT02485444|Oxytocics|oxytocics|mesh-ancestor
25255895|NCT02485444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25255896|NCT02485444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255897|NCT02485340|Isosorbide|isosorbide|mesh-list
25255898|NCT02485340|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25255899|NCT02485340|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25255900|NCT02485340|Sumatriptan|sumatriptan|mesh-list
25255901|NCT02485340|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25255902|NCT02485340|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25255903|NCT02485340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25255904|NCT02485340|Serotonin Agents|serotonin agents|mesh-ancestor
25255905|NCT02485340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25255906|NCT02485340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255907|NCT02485340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255908|NCT02485340|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25255909|NCT02485340|Diuretics|diuretics|mesh-ancestor
25255910|NCT02485340|Natriuretic Agents|natriuretic agents|mesh-ancestor
25255911|NCT02485340|Vasodilator Agents|vasodilator agents|mesh-ancestor
25255912|NCT02485340|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25255913|NCT02485327|Insulin|insulin|mesh-list
25255914|NCT02485327|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25255915|NCT02485327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25255916|NCT02485327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255917|NCT02485249|Dexamethasone|dexamethasone|mesh-list
25255918|NCT02485249|Dexamethasone acetate|dexamethasone acetate|mesh-list
25255919|NCT02485249|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25255920|NCT02485249|BB 1101|bb 1101|mesh-list
25255921|NCT02485249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25255922|NCT02485249|Antiemetics|antiemetics|mesh-ancestor
25255923|NCT02485249|Autonomic Agents|autonomic agents|mesh-ancestor
25255924|NCT02485249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25255925|NCT02485249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255926|NCT02485249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25255927|NCT02485249|Glucocorticoids|glucocorticoids|mesh-ancestor
25255928|NCT02485249|Hormones|hormones|mesh-ancestor
25255929|NCT02485249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25255930|NCT02485249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25255931|NCT02485249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526651|NCT00612547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24526652|NCT00612547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526653|NCT00612547|Antiviral Agents|antiviral agents|mesh-ancestor
24526654|NCT00612547|Schistosomicides|schistosomicides|mesh-ancestor
24526674|NCT00612612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24526675|NCT00612625|Glucagon|glucagon|mesh-list
24526676|NCT00612625|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24526677|NCT00612625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24526678|NCT00612625|Hormones|hormones|mesh-ancestor
24526679|NCT00612625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24526680|NCT00612625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526681|NCT00612625|Incretins|incretins|mesh-ancestor
24526682|NCT00612638|Irinotecan|irinotecan|mesh-list
24526683|NCT00612638|Temozolomide|temozolomide|mesh-list
24526684|NCT00612638|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
24526685|NCT00612638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24526688|NCT00612638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526690|NCT00612638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24526691|NCT00612638|Alkylating Agents|alkylating agents|mesh-ancestor
24526714|NCT00612859|Nootropic Agents|nootropic agents|mesh-ancestor
24526715|NCT00612898|Lamivudine|lamivudine|mesh-list
24526716|NCT00612898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24526717|NCT00612898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24526718|NCT00612898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24526719|NCT00612898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526720|NCT00612898|Antiviral Agents|antiviral agents|mesh-ancestor
25255932|NCT02485249|Protease Inhibitors|protease inhibitors|mesh-ancestor
25255933|NCT02485249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255934|NCT02485249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255935|NCT02485145|Diclofenac|diclofenac|mesh-list
25255936|NCT02485145|Orphenadrine|orphenadrine|mesh-list
25255937|NCT02485145|Bupivacaine|bupivacaine|mesh-list
25255938|NCT02485145|Baclofen|baclofen|mesh-list
25255939|NCT02485145|Anesthetics, Local|anesthetics, local|mesh-ancestor
25255940|NCT02485145|Anesthetics|anesthetics|mesh-ancestor
25255941|NCT02485145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25255942|NCT02485145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255943|NCT02485145|Sensory System Agents|sensory system agents|mesh-ancestor
25255944|NCT02485145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25255945|NCT02485145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25255946|NCT02485145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25255947|NCT02485145|Analgesics|analgesics|mesh-ancestor
25255948|NCT02485145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25255949|NCT02485145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25255950|NCT02485145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25255951|NCT02485145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255952|NCT02485145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255953|NCT02485145|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25255954|NCT02485145|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25255955|NCT02485145|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25255956|NCT02485145|GABA Agonists|gaba agonists|mesh-ancestor
25255957|NCT02485145|GABA Agents|gaba agents|mesh-ancestor
25255958|NCT02485145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25255959|NCT02485145|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25255960|NCT02485145|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25255961|NCT02485145|Parasympatholytics|parasympatholytics|mesh-ancestor
25255962|NCT02485145|Autonomic Agents|autonomic agents|mesh-ancestor
25255963|NCT02485145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25255964|NCT02485145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25255965|NCT02485145|Cholinergic Agents|cholinergic agents|mesh-ancestor
25255966|NCT02485145|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
25255967|NCT02485145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25255968|NCT02485041|Mirodenafil|mirodenafil|mesh-list
25255969|NCT02485041|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25255970|NCT02485041|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25255971|NCT02485041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255972|NCT02485041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255973|NCT02485262|Sofosbuvir|sofosbuvir|mesh-list
25255974|NCT02485262|Simeprevir|simeprevir|mesh-list
25255975|NCT02485262|Antiviral Agents|antiviral agents|mesh-ancestor
24928265|NCT04124094|Respiratory System Agents|respiratory system agents|mesh-ancestor
24928266|NCT04124094|Dermatologic Agents|dermatologic agents|mesh-ancestor
24928267|NCT04124094|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24928268|NCT04124094|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24928269|NCT04124094|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24928270|NCT04124094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24928271|NCT04124094|Adrenergic Agents|adrenergic agents|mesh-ancestor
24928272|NCT04124094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24928273|NCT04124094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928274|NCT04124094|Glucocorticoids|glucocorticoids|mesh-ancestor
24928275|NCT04124094|Hormones|hormones|mesh-ancestor
24928276|NCT04124094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24928277|NCT04124094|Sympathomimetics|sympathomimetics|mesh-ancestor
24928278|NCT04124094|Antidotes|antidotes|mesh-ancestor
24928279|NCT04124094|Protective Agents|protective agents|mesh-ancestor
24928280|NCT04124068|Hydrogen Peroxide|hydrogen peroxide|mesh-list
24928281|NCT04124068|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24928282|NCT04124068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24928283|NCT04124081|Entecavir|entecavir|mesh-list
24928284|NCT04124081|Antiviral Agents|antiviral agents|mesh-ancestor
24928285|NCT04124081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24928286|NCT04123925|Nivolumab|nivolumab|mesh-list
24943746|NCT03967496|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24943747|NCT03967496|Protease Inhibitors|protease inhibitors|mesh-ancestor
24943748|NCT03967496|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24928287|NCT04123925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24928288|NCT04123925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24928289|NCT04123925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24504249|NCT00534651|Analgesics|analgesics|mesh-ancestor
24526779|NCT00613145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24526780|NCT00613145|Antimetabolites|antimetabolites|mesh-ancestor
24526781|NCT00613145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928290|NCT04123925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928291|NCT04123587|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24624649|NCT01077505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25255976|NCT02485262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25255977|NCT02485262|Protease Inhibitors|protease inhibitors|mesh-ancestor
25255978|NCT02485262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25255984|NCT02484885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25255985|NCT02484885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255986|NCT02484963|Zolpidem|zolpidem|mesh-list
25255987|NCT02484963|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25255988|NCT02484963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25255989|NCT02484963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25255990|NCT02484963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25255991|NCT02484963|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25255992|NCT02484963|GABA Agonists|gaba agonists|mesh-ancestor
25255993|NCT02484963|GABA Agents|gaba agents|mesh-ancestor
25255994|NCT02484963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25255995|NCT02484963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25255996|NCT02485067|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25255997|NCT02485067|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25255998|NCT02485067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25255999|NCT02485067|Cholinergic Agents|cholinergic agents|mesh-ancestor
25256000|NCT02485067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25256001|NCT02485067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256002|NCT02485067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256003|NCT02485067|Urological Agents|urological agents|mesh-ancestor
25256004|NCT02485080|Sofosbuvir|sofosbuvir|mesh-list
25256005|NCT02485080|Simeprevir|simeprevir|mesh-list
25256006|NCT02485080|Antiviral Agents|antiviral agents|mesh-ancestor
25256007|NCT02485080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25256008|NCT02485080|Protease Inhibitors|protease inhibitors|mesh-ancestor
25256009|NCT02485080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256010|NCT02485080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256011|NCT02485184|Propranolol|propranolol|mesh-list
25256012|NCT02485184|Warfarin|warfarin|mesh-list
25256013|NCT02485184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25256014|NCT02485184|Anticoagulants|anticoagulants|mesh-ancestor
25256015|NCT02485184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25256016|NCT02485184|Adrenergic Agents|adrenergic agents|mesh-ancestor
24624657|NCT01077505|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24624658|NCT01077505|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
24624659|NCT01077505|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24624660|NCT01077557|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24624661|NCT01077557|Antiviral Agents|antiviral agents|mesh-ancestor
24624662|NCT01077557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24624663|NCT01077570|Repaglinide|repaglinide|mesh-list
24624664|NCT01077570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24624665|NCT01077570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624666|NCT01077609|Fluticasone|fluticasone|mesh-list
24624667|NCT01077609|Xhance|xhance|mesh-list
24624668|NCT01077609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24624669|NCT01077609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24504287|NCT00534898|Fenretinide|fenretinide|mesh-list
24526789|NCT00613223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24624670|NCT01077609|Autonomic Agents|autonomic agents|mesh-ancestor
24624671|NCT01077609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24624672|NCT01077609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624673|NCT01077609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24624674|NCT01077609|Respiratory System Agents|respiratory system agents|mesh-ancestor
24624675|NCT01077609|Dermatologic Agents|dermatologic agents|mesh-ancestor
24624676|NCT01077609|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24624677|NCT01077648|Trastuzumab|trastuzumab|mesh-list
25687281|NCT01929759|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25687282|NCT01929759|Elvitegravir|elvitegravir|mesh-list
24928293|NCT04123717|Acetaminophen|acetaminophen|mesh-list
24928294|NCT04123717|Ibuprofen|ibuprofen|mesh-list
25256017|NCT02485184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25256018|NCT02485184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256019|NCT02485184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256020|NCT02485184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25256021|NCT02485184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25256030|NCT02485106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256031|NCT02485106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25256035|NCT02485106|Vasodilator Agents|vasodilator agents|mesh-ancestor
25256036|NCT02485106|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25256037|NCT02485106|Antioxidants|antioxidants|mesh-ancestor
25256038|NCT02485028|Mirodenafil|mirodenafil|mesh-list
25256039|NCT02485028|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25256040|NCT02485028|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25256041|NCT02485028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256042|NCT02485028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256043|NCT02485015|Apatinib|apatinib|mesh-list
25256044|NCT02485015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256045|NCT02485015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25256046|NCT02485015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978718|NCT03125642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25256047|NCT02485015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256048|NCT02484768|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25256049|NCT02484768|Hematinics|hematinics|mesh-ancestor
25256050|NCT02484833|Cetuximab|cetuximab|mesh-list
25256051|NCT02484833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25256052|NCT02484833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25274948|NCT02374567|Tranylcypromine|tranylcypromine|mesh-list
25274949|NCT02374567|Bromazepam|bromazepam|mesh-list
25274950|NCT02374567|Risperidone|risperidone|mesh-list
25274951|NCT02374567|Melatonin|melatonin|mesh-list
25274952|NCT02374567|Aripiprazole|aripiprazole|mesh-list
25274953|NCT02374567|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25274954|NCT02374567|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25274955|NCT02374567|Ziprasidone|ziprasidone|mesh-list
25274956|NCT02374567|Clozapine|clozapine|mesh-list
25274957|NCT02374567|Amisulpride|amisulpride|mesh-list
24928310|NCT04123652|Anesthetics|anesthetics|mesh-ancestor
24928311|NCT04123652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24928312|NCT04123652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526798|NCT00613288|Testosterone|testosterone|mesh-list
24526799|NCT00613288|Androgens|androgens|mesh-ancestor
24526800|NCT00613288|Hormones|hormones|mesh-ancestor
24526801|NCT00613288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24526802|NCT00613288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928314|NCT04123652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24928315|NCT04123652|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24928316|NCT04123652|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24928317|NCT04123652|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24928318|NCT04123652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24928319|NCT04123652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928320|NCT04123652|Analgesics|analgesics|mesh-ancestor
24928321|NCT04123652|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24928322|NCT04123652|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24928323|NCT04123652|Anesthetics, General|anesthetics, general|mesh-ancestor
24928324|NCT04123652|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24928325|NCT04123652|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24928326|NCT04123652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24928327|NCT04123743|Sunscreening Agents|sunscreening agents|mesh-list
24928328|NCT04123743|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24928329|NCT04123743|Protective Agents|protective agents|mesh-ancestor
25004331|NCT02059499|Interferon Inducers|interferon inducers|mesh-ancestor
25011857|NCT03424525|Renal Agents|renal agents|mesh-ancestor
25011867|NCT03284853|Latanoprost|latanoprost|mesh-list
25011891|NCT03166761|Autonomic Agents|autonomic agents|mesh-ancestor
25011892|NCT03166761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25256054|NCT02484677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256055|NCT02484677|Tubulin Modulators|tubulin modulators|mesh-ancestor
25256056|NCT02484677|Antimitotic Agents|antimitotic agents|mesh-ancestor
25256057|NCT02484677|Mitosis Modulators|mitosis modulators|mesh-ancestor
25256058|NCT02484677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256059|NCT02484573|Propranolol|propranolol|mesh-list
25256060|NCT02484573|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25256061|NCT02484573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25256062|NCT02484573|Adrenergic Agents|adrenergic agents|mesh-ancestor
24943886|NCT03966079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24943887|NCT03966079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738035|NCT01672450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24738036|NCT01672450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738037|NCT01672450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25256063|NCT02484573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25256064|NCT02484573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256065|NCT02484573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256066|NCT02484573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25256073|NCT02484755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256076|NCT02484248|Dermatologic Agents|dermatologic agents|mesh-ancestor
25256077|NCT02484248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25256078|NCT02484248|Histamine Antagonists|histamine antagonists|mesh-ancestor
25256079|NCT02484248|Histamine Agents|histamine agents|mesh-ancestor
25256080|NCT02484248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25274958|NCT02374567|Flupenthixol|flupenthixol|mesh-list
24928330|NCT04123743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928331|NCT04123743|Dermatologic Agents|dermatologic agents|mesh-ancestor
24928333|NCT04123392|Busulfan|busulfan|mesh-list
24504334|NCT00535379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24504341|NCT00535418|Letrozole|letrozole|mesh-list
24526840|NCT00613457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24526841|NCT00613457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24526842|NCT00613457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24526843|NCT00613457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24526844|NCT00613457|Abortifacient Agents|abortifacient agents|mesh-ancestor
24526845|NCT00613457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24526846|NCT00613457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25011893|NCT03166761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011894|NCT03166761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25011895|NCT03166761|Glucocorticoids|glucocorticoids|mesh-ancestor
25011896|NCT03166761|Hormones|hormones|mesh-ancestor
25011897|NCT03166761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25011898|NCT03166761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25011899|NCT03166761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011900|NCT03166761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25011901|NCT03166761|Immunologic Factors|immunologic factors|mesh-ancestor
25011902|NCT03166761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011903|NCT03166761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011904|NCT03153410|Cyclophosphamide|cyclophosphamide|mesh-list
25011905|NCT03153410|Pembrolizumab|pembrolizumab|mesh-list
25011906|NCT03153410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25011907|NCT03153410|Immunologic Factors|immunologic factors|mesh-ancestor
25011908|NCT03153410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011909|NCT03153410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25011910|NCT03153410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25011911|NCT03153410|Alkylating Agents|alkylating agents|mesh-ancestor
25011957|NCT02767804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011958|NCT02767804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25256081|NCT02484248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256082|NCT02484248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256083|NCT02484248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25256084|NCT02484287|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25256085|NCT02484287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25256086|NCT02484300|Melatonin|melatonin|mesh-list
25256087|NCT02484300|Antioxidants|antioxidants|mesh-ancestor
25256088|NCT02484300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256089|NCT02484300|Protective Agents|protective agents|mesh-ancestor
25256090|NCT02484300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256091|NCT02484300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25256092|NCT02484352|Oxycodone|oxycodone|mesh-list
25256093|NCT02484352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25256094|NCT02484352|Narcotics|narcotics|mesh-ancestor
25256095|NCT02484352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25256096|NCT02484352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256097|NCT02484352|Analgesics|analgesics|mesh-ancestor
25687283|NCT01929759|Antiviral Agents|antiviral agents|mesh-ancestor
25687284|NCT01929759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25687285|NCT01929759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25687286|NCT01929759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25687287|NCT01929759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24738190|NCT01673997|Adrenergic Agents|adrenergic agents|mesh-ancestor
24738191|NCT01673997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24738192|NCT01673997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256098|NCT02484352|Sensory System Agents|sensory system agents|mesh-ancestor
24526848|NCT00613457|Dermatologic Agents|dermatologic agents|mesh-ancestor
24526849|NCT00613457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24526852|NCT00613457|Antiviral Agents|antiviral agents|mesh-ancestor
24526902|NCT00613717|Micronutrients|micronutrients|mesh-ancestor
24526940|NCT00613782|Testosterone|testosterone|mesh-list
24526941|NCT00613782|Testosterone undecanoate|testosterone undecanoate|mesh-list
24526942|NCT00613782|Testosterone enanthate|testosterone enanthate|mesh-list
24928344|NCT04123392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24928346|NCT04123392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24928347|NCT04123288|ACT-709478|act-709478|mesh-list
24928348|NCT04123288|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24928349|NCT04123288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24928350|NCT04123288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928351|NCT04123288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24928352|NCT04123288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928353|NCT04123210|Vitamin A|vitamin a|mesh-list
24928354|NCT04123210|Vitamins|vitamins|mesh-ancestor
24928355|NCT04123210|Micronutrients|micronutrients|mesh-ancestor
24928356|NCT04123210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928357|NCT04123041|Nicotine|nicotine|mesh-list
24928358|NCT04123041|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24928359|NCT04123041|Autonomic Agents|autonomic agents|mesh-ancestor
24526944|NCT00613782|Androgens|androgens|mesh-ancestor
24526945|NCT00613782|Hormones|hormones|mesh-ancestor
25004394|NCT01814657|Sensory System Agents|sensory system agents|mesh-ancestor
25011959|NCT02767804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011960|NCT02767804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011961|NCT02721069|Diazepam|diazepam|mesh-list
25011962|NCT02721069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25011963|NCT02721069|Anticonvulsants|anticonvulsants|mesh-ancestor
25011964|NCT02721069|Antiemetics|antiemetics|mesh-ancestor
25011965|NCT02721069|Autonomic Agents|autonomic agents|mesh-ancestor
25011966|NCT02721069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25011967|NCT02721069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011968|NCT02721069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25011969|NCT02721069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25256099|NCT02484352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25256101|NCT02484170|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25256102|NCT02484170|Diuretics|diuretics|mesh-ancestor
25256103|NCT02484170|Natriuretic Agents|natriuretic agents|mesh-ancestor
25256104|NCT02484170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256105|NCT02484209|Metformin|metformin|mesh-list
25256106|NCT02484209|Glimepiride|glimepiride|mesh-list
25256107|NCT02484209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25256108|NCT02484209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256109|NCT02484209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25256110|NCT02484209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25256111|NCT02484209|Immunologic Factors|immunologic factors|mesh-ancestor
25256112|NCT02484339|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25256113|NCT02484339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256114|NCT02484261|Bortezomib|bortezomib|mesh-list
25256115|NCT02484261|Pravastatin|pravastatin|mesh-list
25256116|NCT02484261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256117|NCT02484261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25256118|NCT02484261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25256119|NCT02484261|Antimetabolites|antimetabolites|mesh-ancestor
25256120|NCT02484261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256121|NCT02484261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25256122|NCT02484261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25256123|NCT02484261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256124|NCT02484053|Rituximab|rituximab|mesh-list
25256125|NCT02484053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25256126|NCT02484053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256127|NCT02484053|Immunologic Factors|immunologic factors|mesh-ancestor
25256128|NCT02484053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687288|NCT01929759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687289|NCT01929759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25687290|NCT01929759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25687291|NCT01929759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25256129|NCT02484053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25256130|NCT02483767|Goserelin|goserelin|mesh-list
24526946|NCT00613782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24526947|NCT00613782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526948|NCT00613782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24526949|NCT00613782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526950|NCT00613782|Anabolic Agents|anabolic agents|mesh-ancestor
24526951|NCT00613808|Nitric Oxide|nitric oxide|mesh-list
24526952|NCT00613808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24526953|NCT00613808|Autonomic Agents|autonomic agents|mesh-ancestor
24526954|NCT00613808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24526955|NCT00613808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526956|NCT00613808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24526957|NCT00613808|Respiratory System Agents|respiratory system agents|mesh-ancestor
24526958|NCT00613808|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24526960|NCT00613808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526961|NCT00613808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24526962|NCT00613808|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24526963|NCT00613808|Vasodilator Agents|vasodilator agents|mesh-ancestor
24526964|NCT00613808|Gasotransmitters|gasotransmitters|mesh-ancestor
24526965|NCT00613808|Protective Agents|protective agents|mesh-ancestor
24928360|NCT04123041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24928361|NCT04123041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928362|NCT04123041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24928363|NCT04123041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24928364|NCT04123041|Cholinergic Agents|cholinergic agents|mesh-ancestor
24928365|NCT04123041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24752673|NCT01711528|Dexamethasone|dexamethasone|mesh-list
24928366|NCT04123041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928368|NCT04123249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
24928369|NCT04123249|Anesthetics|anesthetics|mesh-list
24928370|NCT04123249|Sevoflurane|sevoflurane|mesh-list
24928371|NCT04123249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24928372|NCT04123249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24928381|NCT04122911|Alkylating Agents|alkylating agents|mesh-ancestor
24928383|NCT04122911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256131|NCT02483767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25256132|NCT02483767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256133|NCT02484027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25256134|NCT02484027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25256135|NCT02484027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25256136|NCT02484027|Antimetabolites|antimetabolites|mesh-ancestor
25256137|NCT02484027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256138|NCT02484027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25256139|NCT02484027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25256140|NCT02484027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256141|NCT02483715|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25256142|NCT02483715|Amoxicillin|amoxicillin|mesh-list
25256143|NCT02483715|Metronidazole|metronidazole|mesh-list
25256144|NCT02483715|Tetracycline|tetracycline|mesh-list
25256145|NCT02483715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25256146|NCT02483715|Rabeprazole|rabeprazole|mesh-list
25256148|NCT02483715|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25256149|NCT02483715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25256150|NCT02483715|Antitubercular Agents|antitubercular agents|mesh-ancestor
25256151|NCT02483715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25256152|NCT02483715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25256153|NCT02483715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25256154|NCT02483715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25256155|NCT02483715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256156|NCT02483715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256157|NCT02483715|Antacids|antacids|mesh-ancestor
25256158|NCT02483715|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25256159|NCT02483793|Tamsulosin|tamsulosin|mesh-list
25256160|NCT02483793|Oxybutynin|oxybutynin|mesh-list
25256161|NCT02483793|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25256162|NCT02483793|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25256163|NCT02483793|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25256164|NCT02483793|Adrenergic Agents|adrenergic agents|mesh-ancestor
25256165|NCT02483793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25256166|NCT02483793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256167|NCT02483793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256168|NCT02483793|Urological Agents|urological agents|mesh-ancestor
24526966|NCT00613847|Trastuzumab|trastuzumab|mesh-list
24526967|NCT00613847|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
24526968|NCT00613847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24526969|NCT00613847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526970|NCT00613847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526972|NCT00613964|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
24526973|NCT00613964|Natriuretic Agents|natriuretic agents|mesh-ancestor
24526974|NCT00613964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526975|NCT00613964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24526976|NCT00613964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526977|NCT00614029|Sumatriptan|sumatriptan|mesh-list
24526978|NCT00614029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24526979|NCT00614029|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24526980|NCT00614029|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24526981|NCT00614029|Serotonin Agents|serotonin agents|mesh-ancestor
24526982|NCT00614029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24527007|NCT00614328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24527008|NCT00614328|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24527010|NCT00614328|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24941872|NCT03986905|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25011970|NCT02721069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25011971|NCT02721069|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25011972|NCT02721069|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24895319|NCT04537715|Itraconazole|itraconazole|mesh-list
25012164|NCT01856270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25012165|NCT01856270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012166|NCT01856270|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25012167|NCT01856270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25012168|NCT01856270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25012169|NCT01856270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012171|NCT01856270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25012172|NCT01503515|Fluconazole|fluconazole|mesh-list
25012173|NCT01503515|Voriconazole|voriconazole|mesh-list
25012174|NCT01503515|Caspofungin|caspofungin|mesh-list
25012175|NCT01503515|Antifungal Agents|antifungal agents|mesh-ancestor
25012176|NCT01503515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25012177|NCT01503515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25012178|NCT01503515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25012179|NCT01503515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25012180|NCT01503515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256174|NCT02483793|Cholinergic Agents|cholinergic agents|mesh-ancestor
25256175|NCT02483897|Tetracaine|tetracaine|mesh-list
25256176|NCT02483897|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25256177|NCT02483897|Anesthetics, Local|anesthetics, local|mesh-ancestor
25256178|NCT02483897|Anesthetics|anesthetics|mesh-ancestor
25256179|NCT02483897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25256180|NCT02483897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256181|NCT02483897|Sensory System Agents|sensory system agents|mesh-ancestor
25256182|NCT02483897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25256183|NCT02483897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25256184|NCT02483845|Natalizumab|natalizumab|mesh-list
25256185|NCT02483845|Immunologic Factors|immunologic factors|mesh-ancestor
25256186|NCT02483845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928386|NCT04122599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928387|NCT04122599|Protective Agents|protective agents|mesh-ancestor
24928388|NCT04122599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928389|NCT04122599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24928391|NCT04122716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24928392|NCT04122716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928393|NCT04122716|Incretins|incretins|mesh-ancestor
24928395|NCT04122716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24928396|NCT04122560|Fluconazole|fluconazole|mesh-list
24928397|NCT04122560|Antifungal Agents|antifungal agents|mesh-ancestor
24928398|NCT04122560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24928399|NCT04122560|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24928400|NCT04122560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24928401|NCT04122560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24928402|NCT04122560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928403|NCT04122560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24928404|NCT04122560|Hormone Antagonists|hormone antagonists|mesh-ancestor
24928405|NCT04122560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24928406|NCT04122560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738685|NCT01676649|Mitosis Modulators|mitosis modulators|mesh-ancestor
24738701|NCT01676987|Formoterol Fumarate|formoterol fumarate|mesh-list
24738702|NCT01676987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24738703|NCT01676987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24738705|NCT01676987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24738706|NCT01676987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738707|NCT01676987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24738708|NCT01676987|Respiratory System Agents|respiratory system agents|mesh-ancestor
24738710|NCT01676987|Hormones|hormones|mesh-ancestor
24738711|NCT01676987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24738714|NCT01676987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24928407|NCT04122560|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24928408|NCT04122560|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24928409|NCT04122066|Sofosbuvir|sofosbuvir|mesh-list
24928410|NCT04122066|Antiviral Agents|antiviral agents|mesh-ancestor
24527011|NCT00614328|GABA Agonists|gaba agonists|mesh-ancestor
24527012|NCT00614328|GABA Agents|gaba agents|mesh-ancestor
24527013|NCT00614328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25256281|NCT02483143|Antiviral Agents|antiviral agents|mesh-ancestor
24527015|NCT00614471|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24527025|NCT00614536|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24527026|NCT00614536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527028|NCT00614588|Anesthetics|anesthetics|mesh-list
25256200|NCT02484001|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25256201|NCT02484001|Anticonvulsants|anticonvulsants|mesh-ancestor
25256202|NCT02484001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25256203|NCT02484001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25256204|NCT02484001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25256205|NCT02484001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256206|NCT02483923|Ropivacaine|ropivacaine|mesh-list
25256207|NCT02483923|Anesthetics, Local|anesthetics, local|mesh-ancestor
25256208|NCT02483923|Anesthetics|anesthetics|mesh-ancestor
25256209|NCT02483923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25256210|NCT02483923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256211|NCT02483923|Sensory System Agents|sensory system agents|mesh-ancestor
25256212|NCT02483923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25256213|NCT02483884|Bombesin|bombesin|mesh-list
25256214|NCT02483884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25256215|NCT02483884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256216|NCT02483884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256217|NCT02483689|Bupivacaine|bupivacaine|mesh-list
25256218|NCT02483689|Anesthetics, Local|anesthetics, local|mesh-list
25256219|NCT02483689|Anesthetics|anesthetics|mesh-list
25256220|NCT02483689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25256221|NCT02483689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256222|NCT02483689|Sensory System Agents|sensory system agents|mesh-ancestor
25256223|NCT02483689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25256224|NCT02483871|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25256225|NCT02483871|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25256226|NCT02483871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25256227|NCT02483871|Antimetabolites|antimetabolites|mesh-ancestor
25256228|NCT02483871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256229|NCT02483871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24928413|NCT04122105|Vasodilator Agents|vasodilator agents|mesh-ancestor
24928414|NCT04122105|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24928415|NCT04122105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24928416|NCT04122105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24928417|NCT04122105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928418|NCT04122105|Urological Agents|urological agents|mesh-ancestor
24928420|NCT04122222|Immunologic Factors|immunologic factors|mesh-ancestor
25687292|NCT01929759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25687293|NCT01929759|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25687294|NCT01929863|Metformin|metformin|mesh-list
25687295|NCT01929863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25687296|NCT01929863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687297|NCT01929876|Itraconazole|itraconazole|mesh-list
25687298|NCT01929876|Antifungal Agents|antifungal agents|mesh-ancestor
25687299|NCT01929876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25687300|NCT01929876|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25687301|NCT01929876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25687302|NCT01929876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687303|NCT01929876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738779|NCT01677364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738780|NCT01677390|Everolimus|everolimus|mesh-list
24738781|NCT01677390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24928421|NCT04122222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928422|NCT04121975|Endostar protein|endostar protein|mesh-list
24928423|NCT04121975|Endostatins|endostatins|mesh-list
24928424|NCT04121975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24928425|NCT04121975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24928426|NCT04121975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24928427|NCT04121975|Growth Substances|growth substances|mesh-ancestor
24527044|NCT00614653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24527045|NCT00614653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527046|NCT00614666|Nikkomycin|nikkomycin|mesh-list
24527047|NCT00614666|Antifungal Agents|antifungal agents|mesh-ancestor
24527048|NCT00614666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24527049|NCT00614666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527050|NCT00614666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527051|NCT00614679|Tigecycline|tigecycline|mesh-list
24527052|NCT00614679|Heparin|heparin|mesh-list
24527053|NCT00614679|Anticoagulants|anticoagulants|mesh-ancestor
24527054|NCT00614679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24527055|NCT00614679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24527056|NCT00614679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527057|NCT00614679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24527058|NCT00614679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24527059|NCT00614679|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24527060|NCT00614679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527061|NCT00614757|Acetylcysteine|acetylcysteine|mesh-list
25256230|NCT02483871|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25256231|NCT02483871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256232|NCT02483598|Buspirone|buspirone|mesh-list
25256233|NCT02483598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25256234|NCT02483598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25256235|NCT02483598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25256236|NCT02483598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256237|NCT02483598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25256238|NCT02483598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25256239|NCT02483598|Serotonin Agents|serotonin agents|mesh-ancestor
25256240|NCT02483598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25256241|NCT02483598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256242|NCT02483624|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
25256243|NCT02483624|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25256245|NCT02483624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256246|NCT02483624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256247|NCT02483325|Fludarabine|fludarabine|mesh-list
25256248|NCT02483325|Busulfan|busulfan|mesh-list
25256249|NCT02483325|Thymoglobulin|thymoglobulin|mesh-list
25256250|NCT02483325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256251|NCT02483325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256252|NCT02483325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25256253|NCT02483325|Immunologic Factors|immunologic factors|mesh-ancestor
25256254|NCT02483325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256255|NCT02483325|Alkylating Agents|alkylating agents|mesh-ancestor
25256256|NCT02483325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25256257|NCT02483325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25256258|NCT02483299|Metformin|metformin|mesh-list
25256259|NCT02483299|Liraglutide|liraglutide|mesh-list
25256260|NCT02483299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25256261|NCT02483299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256262|NCT02483299|Incretins|incretins|mesh-ancestor
25256263|NCT02483299|Hormones|hormones|mesh-ancestor
25256264|NCT02483299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25256265|NCT02483182|Acyclovir|acyclovir|mesh-list
25256266|NCT02483182|Antiviral Agents|antiviral agents|mesh-ancestor
25256267|NCT02483182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25256268|NCT02483130|Acetylcysteine|acetylcysteine|mesh-list
25256269|NCT02483130|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25256270|NCT02483130|Antiviral Agents|antiviral agents|mesh-ancestor
25256271|NCT02483130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24527099|NCT00614965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527100|NCT00614965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24527101|NCT00614965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25687304|NCT01929876|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25687305|NCT01929876|Hormone Antagonists|hormone antagonists|mesh-ancestor
25692607|NCT02002832|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24527140|NCT00615173|Alkylating Agents|alkylating agents|mesh-ancestor
24617971|NCT01046266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617972|NCT01046279|Bevacizumab|bevacizumab|mesh-list
24617973|NCT01046279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24617974|NCT01046279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617975|NCT01046279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24617976|NCT01046279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24617977|NCT01046279|Growth Substances|growth substances|mesh-ancestor
24617978|NCT01046279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617980|NCT01046383|Caseins|caseins|mesh-list
24527141|NCT00615173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527142|NCT00615173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24404253|NCT00162877|Rabeprazole|rabeprazole|mesh-list
24928440|NCT04121910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24928441|NCT04121910|Hormone Antagonists|hormone antagonists|mesh-ancestor
24928442|NCT04121910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24928443|NCT04121910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928444|NCT04121910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24928445|NCT04121767|Warfarin|warfarin|mesh-list
24928446|NCT04121767|Edoxaban|edoxaban|mesh-list
24928447|NCT04121767|Anticoagulants|anticoagulants|mesh-ancestor
24504449|NCT00536276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24527148|NCT00615186|Temozolomide|temozolomide|mesh-list
24527149|NCT00615186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24527150|NCT00615186|Alkylating Agents|alkylating agents|mesh-ancestor
24527151|NCT00615186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527152|NCT00615186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527153|NCT00615212|Rosiglitazone|rosiglitazone|mesh-list
24527154|NCT00615212|Flurbiprofen|flurbiprofen|mesh-list
24527156|NCT00615212|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24527157|NCT00615212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24527158|NCT00615212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24527159|NCT00615212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527160|NCT00615212|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24527161|NCT00615212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24527162|NCT00615212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24527165|NCT00615212|Anesthetics|anesthetics|mesh-ancestor
25256272|NCT02483130|Expectorants|expectorants|mesh-ancestor
25256273|NCT02483130|Respiratory System Agents|respiratory system agents|mesh-ancestor
25256274|NCT02483130|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25256275|NCT02483130|Antioxidants|antioxidants|mesh-ancestor
25256276|NCT02483130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256277|NCT02483130|Protective Agents|protective agents|mesh-ancestor
25256278|NCT02483130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256279|NCT02483130|Antidotes|antidotes|mesh-ancestor
25256280|NCT02483143|Acetylcysteine|acetylcysteine|mesh-list
25256282|NCT02483143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25256283|NCT02483143|Expectorants|expectorants|mesh-ancestor
25256284|NCT02483143|Respiratory System Agents|respiratory system agents|mesh-ancestor
25256285|NCT02483143|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25256286|NCT02483143|Antioxidants|antioxidants|mesh-ancestor
25256287|NCT02483143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256288|NCT02483143|Protective Agents|protective agents|mesh-ancestor
25256289|NCT02483143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256290|NCT02483169|Aspirin|aspirin|mesh-list
25256291|NCT02483169|Cilostazol|cilostazol|mesh-list
25256292|NCT02483169|Probucol|probucol|mesh-list
25256293|NCT02483169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25256294|NCT02483169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25256295|NCT02483169|Analgesics|analgesics|mesh-ancestor
25256296|NCT02483169|Sensory System Agents|sensory system agents|mesh-ancestor
25256297|NCT02483169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25256298|NCT02483169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256299|NCT02483169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25256300|NCT02483169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25256301|NCT02483169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25256302|NCT02483169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25687306|NCT01929876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25687307|NCT01929876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687308|NCT01929876|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25687309|NCT01929889|Iloperidone|iloperidone|mesh-list
25687310|NCT01929889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25687311|NCT01929889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25687312|NCT01929889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25687313|NCT01929889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256303|NCT02483169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256304|NCT02483169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25256305|NCT02483169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25256306|NCT02483169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256308|NCT02483169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25256309|NCT02483169|Autonomic Agents|autonomic agents|mesh-ancestor
25256310|NCT02483169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25256311|NCT02483169|Respiratory System Agents|respiratory system agents|mesh-ancestor
25256312|NCT02483169|Vasodilator Agents|vasodilator agents|mesh-ancestor
25256313|NCT02483169|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25256314|NCT02483169|Protective Agents|protective agents|mesh-ancestor
24405184|NCT00165737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24405185|NCT00165737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527175|NCT00615212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24527176|NCT00615212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24527177|NCT00615212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24527178|NCT00615212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24928457|NCT04121689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928459|NCT04121611|Heparin|heparin|mesh-list
24928460|NCT04121611|Calcium heparin|calcium heparin|mesh-list
24928461|NCT04121611|Anticoagulants|anticoagulants|mesh-ancestor
24928462|NCT04121611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24928463|NCT04121611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24928464|NCT04121611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928465|NCT04121611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24928466|NCT04121611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24928467|NCT04121611|Analgesics|analgesics|mesh-ancestor
24928468|NCT04121611|Sensory System Agents|sensory system agents|mesh-ancestor
24928469|NCT04121611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24928470|NCT04121611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012210|NCT00357565|Fludarabine phosphate|fludarabine phosphate|mesh-list
25012211|NCT00357565|Melphalan|melphalan|mesh-list
25012212|NCT00357565|Busulfan|busulfan|mesh-list
25012213|NCT00357565|Cyclosporins|cyclosporins|mesh-list
25012214|NCT00357565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25012215|NCT00357565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25012216|NCT00357565|Antimetabolites|antimetabolites|mesh-ancestor
25012217|NCT00357565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012218|NCT00357565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25012219|NCT00357565|Immunologic Factors|immunologic factors|mesh-ancestor
25012220|NCT00357565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012221|NCT00357565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25012222|NCT00357565|Antifungal Agents|antifungal agents|mesh-ancestor
24968933|NCT03746821|Biotin|biotin|mesh-list
25012224|NCT00357565|Dermatologic Agents|dermatologic agents|mesh-ancestor
25012225|NCT00357565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25012226|NCT00357565|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25012227|NCT00357565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25012228|NCT00357565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25012229|NCT00357565|Antitubercular Agents|antitubercular agents|mesh-ancestor
25012230|NCT00357565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25012253|NCT00136903|Prednisone|prednisone|mesh-list
25012254|NCT00136903|Methylprednisolone|methylprednisolone|mesh-list
25012255|NCT00136903|Tacrolimus|tacrolimus|mesh-list
25012256|NCT00136903|Cyclosporins|cyclosporins|mesh-list
25012257|NCT00136903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25012258|NCT00136903|Glucocorticoids|glucocorticoids|mesh-ancestor
25012259|NCT00136903|Hormones|hormones|mesh-ancestor
25012260|NCT00136903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25012273|NCT00136903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25274981|NCT02374567|Sertraline|sertraline|mesh-list
25256324|NCT02483156|Antimetabolites|antimetabolites|mesh-ancestor
25256325|NCT02483156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256326|NCT02483156|Antiviral Agents|antiviral agents|mesh-ancestor
25256327|NCT02483156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25256328|NCT02483221|Morphine|morphine|mesh-list
25256329|NCT02483221|Hydromorphone|hydromorphone|mesh-list
25256330|NCT02483221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25256331|NCT02483221|Narcotics|narcotics|mesh-ancestor
25256332|NCT02483221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25256333|NCT02483221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928471|NCT04121611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24928472|NCT04121611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24928473|NCT04121611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24928474|NCT04121611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24739024|NCT01678703|Oxytocics|oxytocics|mesh-ancestor
24739025|NCT01678716|Micronutrients|micronutrients|mesh-list
24739026|NCT01678716|Trace Elements|trace elements|mesh-list
24739037|NCT01678937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24739038|NCT01678937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739039|NCT01678937|Antifungal Agents|antifungal agents|mesh-ancestor
24739040|NCT01678937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24739041|NCT01678937|Dermatologic Agents|dermatologic agents|mesh-ancestor
24739042|NCT01678937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24739043|NCT01678937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24928475|NCT04121611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24928477|NCT04121819|Cytarabine|cytarabine|mesh-list
24928478|NCT04121819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24928479|NCT04121819|Antimetabolites|antimetabolites|mesh-ancestor
24928480|NCT04121819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928481|NCT04121819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24928482|NCT04121819|Antiviral Agents|antiviral agents|mesh-ancestor
24928488|NCT04121780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24928489|NCT04121780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012304|NCT05218616|Sunitinib|sunitinib|mesh-list
25012305|NCT05218616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25012306|NCT05218616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25012307|NCT05218616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25012308|NCT05218616|Growth Substances|growth substances|mesh-ancestor
25012336|NCT05218161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012337|NCT05217836|Hepcidins|hepcidins|mesh-list
25012338|NCT05217836|Chrysarobin|chrysarobin|mesh-list
25012339|NCT05217836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25012340|NCT05217836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25012341|NCT05217836|Analgesics|analgesics|mesh-ancestor
25012342|NCT05217836|Sensory System Agents|sensory system agents|mesh-ancestor
25012343|NCT05217836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25012344|NCT05217836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012345|NCT05217836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25012346|NCT05217836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25012347|NCT05217836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25012348|NCT05217355|Botulinum Toxins|botulinum toxins|mesh-list
24405830|NCT00168493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25012349|NCT05217355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25012350|NCT05217355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25012351|NCT05217355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25012352|NCT05217355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25012354|NCT05217355|Cholinergic Agents|cholinergic agents|mesh-ancestor
25012393|NCT05217069|Vitamin B Complex|vitamin b complex|mesh-ancestor
25012405|NCT05215470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25012406|NCT05215470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25012407|NCT05215470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25012408|NCT05215470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012409|NCT05193565|Mycophenolic Acid|mycophenolic acid|mesh-list
25012410|NCT05193565|Sirolimus|sirolimus|mesh-list
25256334|NCT02483221|Analgesics|analgesics|mesh-ancestor
25256335|NCT02483221|Sensory System Agents|sensory system agents|mesh-ancestor
25256336|NCT02483221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25256337|NCT02483195|Minoxidil|minoxidil|mesh-list
25256338|NCT02483195|Spironolactone|spironolactone|mesh-list
25256339|NCT02483195|Finasteride|finasteride|mesh-list
25256340|NCT02483195|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25256341|NCT02483195|Hormone Antagonists|hormone antagonists|mesh-ancestor
25256342|NCT02483195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25256343|NCT02483195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256344|NCT02483195|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25256345|NCT02483195|Diuretics|diuretics|mesh-ancestor
25256346|NCT02483195|Natriuretic Agents|natriuretic agents|mesh-ancestor
25256347|NCT02483195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24928491|NCT04121533|Cholecalciferol|cholecalciferol|mesh-list
25687314|NCT01929889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25687315|NCT01929980|Bortezomib|bortezomib|mesh-list
25687316|NCT01929980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25687317|NCT01930045|Raltegravir Potassium|raltegravir potassium|mesh-list
25687318|NCT01930045|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
25687319|NCT01930045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25687320|NCT01930045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25687321|NCT01930045|Antiviral Agents|antiviral agents|mesh-ancestor
25687322|NCT01930045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25687323|NCT01930045|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24928494|NCT04121533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928495|NCT04121533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24928496|NCT04121533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24928498|NCT04121416|Oxycodone|oxycodone|mesh-list
24928499|NCT04121416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24928500|NCT04121416|Narcotics|narcotics|mesh-ancestor
24928501|NCT04121416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24928502|NCT04121416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928503|NCT04121416|Analgesics|analgesics|mesh-ancestor
24928504|NCT04121416|Sensory System Agents|sensory system agents|mesh-ancestor
24928505|NCT04121416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24928506|NCT04121416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24928507|NCT04121416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24928508|NCT04121416|Anesthetics, General|anesthetics, general|mesh-ancestor
24928509|NCT04121416|Anesthetics|anesthetics|mesh-ancestor
24928510|NCT04121039|Apatinib|apatinib|mesh-list
24928511|NCT04121039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24928512|NCT04121039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24928513|NCT04121039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24928514|NCT04121039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256348|NCT02483195|Vasodilator Agents|vasodilator agents|mesh-ancestor
25256349|NCT02483195|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25256350|NCT02483195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25256351|NCT02483195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256352|NCT02483195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256353|NCT02483195|Urological Agents|urological agents|mesh-ancestor
25274959|NCT02374567|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
25274960|NCT02374567|Perphenazine|perphenazine|mesh-list
25274961|NCT02374567|Sertindole|sertindole|mesh-list
25274962|NCT02374567|Fluphenazine|fluphenazine|mesh-list
25274963|NCT02374567|Fluphenazine depot|fluphenazine depot|mesh-list
25274964|NCT02374567|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
25274965|NCT02374567|Sulpiride|sulpiride|mesh-list
25274966|NCT02374567|Thioridazine|thioridazine|mesh-list
25274967|NCT02374567|Clopenthixol|clopenthixol|mesh-list
25274968|NCT02374567|Pipamperone|pipamperone|mesh-list
25274969|NCT02374567|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
25274970|NCT02374567|Chlorprothixene|chlorprothixene|mesh-list
25274971|NCT02374567|Fluspirilene|fluspirilene|mesh-list
25274972|NCT02374567|Benperidol|benperidol|mesh-list
25274973|NCT02374567|Bromperidol|bromperidol|mesh-list
25274974|NCT02374567|Perazine|perazine|mesh-list
25274975|NCT02374567|Rivastigmine|rivastigmine|mesh-list
25274976|NCT02374567|Piracetam|piracetam|mesh-list
25274977|NCT02374567|Donepezil|donepezil|mesh-list
25274978|NCT02374567|Galantamine|galantamine|mesh-list
25274979|NCT02374567|Citalopram|citalopram|mesh-list
25274980|NCT02374567|Bupropion|bupropion|mesh-list
25274982|NCT02374567|Fluoxetine|fluoxetine|mesh-list
25274983|NCT02374567|Paroxetine|paroxetine|mesh-list
25274984|NCT02374567|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25274985|NCT02374567|Nortriptyline|nortriptyline|mesh-list
25274986|NCT02374567|Reboxetine|reboxetine|mesh-list
25274987|NCT02374567|Imipramine|imipramine|mesh-list
25274988|NCT02374567|Clomipramine|clomipramine|mesh-list
25274989|NCT02374567|Mianserin|mianserin|mesh-list
25274990|NCT02374567|Moclobemide|moclobemide|mesh-list
25274991|NCT02374567|Opipramol|opipramol|mesh-list
25274992|NCT02374567|Maprotiline|maprotiline|mesh-list
25274993|NCT02374567|Trimipramine|trimipramine|mesh-list
25274994|NCT02374567|Hydroxyzine|hydroxyzine|mesh-list
25274995|NCT02374567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25274996|NCT02374567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25274997|NCT02374567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25274998|NCT02374567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25274999|NCT02374567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25275000|NCT02374567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25275001|NCT02374567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25275002|NCT02374567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25275003|NCT02374567|Anesthetics, General|anesthetics, general|mesh-ancestor
25275004|NCT02374567|Anesthetics|anesthetics|mesh-ancestor
25275005|NCT02374567|GABA Modulators|gaba modulators|mesh-ancestor
25275006|NCT02374567|GABA Agents|gaba agents|mesh-ancestor
25275007|NCT02374567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25275008|NCT02374567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275009|NCT02374567|Analgesics|analgesics|mesh-ancestor
25275010|NCT02374567|Sensory System Agents|sensory system agents|mesh-ancestor
24928552|NCT04120753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504540|NCT00536770|Immunologic Factors|immunologic factors|mesh-ancestor
24504541|NCT00536770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504542|NCT00536770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24504547|NCT00536770|Vitamins|vitamins|mesh-ancestor
24527182|NCT00615303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527183|NCT00615303|Emollients|emollients|mesh-ancestor
24527192|NCT00615446|Sunitinib|sunitinib|mesh-list
24527193|NCT00615446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24527194|NCT00615446|Antimetabolites|antimetabolites|mesh-ancestor
24527195|NCT00615446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928553|NCT04120753|Vasodilator Agents|vasodilator agents|mesh-ancestor
24928554|NCT04120753|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24928555|NCT04120753|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24928556|NCT04120974|Insulin|insulin|mesh-list
24928557|NCT04120974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24928558|NCT04120974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928559|NCT04120922|Calcium Carbonate|calcium carbonate|mesh-list
24928560|NCT04120922|Calcium|calcium|mesh-list
24928561|NCT04120922|Sevelamer|sevelamer|mesh-list
24928562|NCT04120922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24928563|NCT04120922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928564|NCT04120922|Antacids|antacids|mesh-ancestor
24928565|NCT04120922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928566|NCT04120922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24928567|NCT04120922|Chelating Agents|chelating agents|mesh-ancestor
24928568|NCT04120922|Sequestering Agents|sequestering agents|mesh-ancestor
24928569|NCT04120831|Abatacept|abatacept|mesh-list
24928570|NCT04120831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24928571|NCT04120831|Immunologic Factors|immunologic factors|mesh-ancestor
24928572|NCT04120831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527220|NCT00615602|Trastuzumab|trastuzumab|mesh-list
25012411|NCT05193565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25012412|NCT05193565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25012413|NCT05193565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25012414|NCT05193565|Antitubercular Agents|antitubercular agents|mesh-ancestor
25012415|NCT05193565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25012416|NCT05193565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25012417|NCT05193565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25012418|NCT05193565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012419|NCT05193565|Antifungal Agents|antifungal agents|mesh-ancestor
25012420|NCT05193565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25256354|NCT02483026|Vitamin D|vitamin d|mesh-list
25256355|NCT02483026|Vitamins|vitamins|mesh-list
25256356|NCT02483026|Micronutrients|micronutrients|mesh-ancestor
25256357|NCT02483026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256358|NCT02483026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25256359|NCT02483078|Leronlimab|leronlimab|mesh-list
25256360|NCT02483078|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25256361|NCT02483078|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25256374|NCT02483104|Mitosis Modulators|mitosis modulators|mesh-ancestor
25256375|NCT02483104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256376|NCT02483104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25256377|NCT02483104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256378|NCT02482740|Tamoxifen|tamoxifen|mesh-list
25256379|NCT02482740|Letrozole|letrozole|mesh-list
25256380|NCT02482740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256381|NCT02482740|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25256382|NCT02482740|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25256383|NCT02482740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256384|NCT02482740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256385|NCT02482740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25256386|NCT02482740|Hormone Antagonists|hormone antagonists|mesh-ancestor
24527221|NCT00615602|Epirubicin|epirubicin|mesh-list
24527222|NCT00615602|Fluorouracil|fluorouracil|mesh-list
24527223|NCT00615602|Mitogens|mitogens|mesh-list
24527224|NCT00615602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24527225|NCT00615602|Immunologic Factors|immunologic factors|mesh-ancestor
24527226|NCT00615602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527227|NCT00615602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24527228|NCT00615602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24527229|NCT00615602|Alkylating Agents|alkylating agents|mesh-ancestor
24527230|NCT00615602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527231|NCT00615602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527232|NCT00615602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24527233|NCT00615602|Tubulin Modulators|tubulin modulators|mesh-ancestor
24527234|NCT00615602|Antimitotic Agents|antimitotic agents|mesh-ancestor
24527235|NCT00615602|Mitosis Modulators|mitosis modulators|mesh-ancestor
24527236|NCT00615602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24527237|NCT00615602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25687324|NCT01930045|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24739292|NCT01680250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739293|NCT01680250|Antifungal Agents|antifungal agents|mesh-ancestor
24527238|NCT00615602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24527239|NCT00615602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25012421|NCT05193565|Immunologic Factors|immunologic factors|mesh-ancestor
25012422|NCT05193565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573880|NCT00822393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25012486|NCT05141305|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25012487|NCT05141305|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25012488|NCT05141305|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25012489|NCT05141305|Purinergic Agents|purinergic agents|mesh-ancestor
25012490|NCT05141305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25012491|NCT05065294|Psilocybin|psilocybin|mesh-list
25012492|NCT05065294|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
25012493|NCT05065294|Hallucinogens|hallucinogens|mesh-ancestor
25012793|NCT04423588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25256391|NCT02482740|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25256392|NCT02482740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25256393|NCT02482766|Poractant alfa|poractant alfa|mesh-list
25256394|NCT02482766|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
25256395|NCT02482766|Respiratory System Agents|respiratory system agents|mesh-ancestor
25256396|NCT02482857|Aspirin|aspirin|mesh-list
25256397|NCT02482857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25256398|NCT02482857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25256399|NCT02482857|Analgesics|analgesics|mesh-ancestor
25256400|NCT02482857|Sensory System Agents|sensory system agents|mesh-ancestor
25256401|NCT02482857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25256402|NCT02482857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256403|NCT02482857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25256404|NCT02482857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25256405|NCT02482857|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25256406|NCT02482857|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25275011|NCT02374567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25012496|NCT05065294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25012497|NCT05065294|Serotonin Agents|serotonin agents|mesh-ancestor
24969150|NCT03745261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969151|NCT03745261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24969152|NCT03745261|Respiratory System Agents|respiratory system agents|mesh-ancestor
24969153|NCT03745261|Dermatologic Agents|dermatologic agents|mesh-ancestor
25012498|NCT05065294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25012499|NCT05065294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012500|NCT05065294|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25012501|NCT05052970|Dexamethasone|dexamethasone|mesh-list
25012522|NCT05052970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25012523|NCT05052970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25012524|NCT05029973|Bevacizumab|bevacizumab|mesh-list
25012525|NCT05029973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25012526|NCT05029973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25012527|NCT05029973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25012528|NCT05029973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25012529|NCT05029973|Growth Substances|growth substances|mesh-ancestor
25012530|NCT05029973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012531|NCT05029973|Growth Inhibitors|growth inhibitors|mesh-ancestor
25012532|NCT05008783|Capecitabine|capecitabine|mesh-list
25012533|NCT05008783|Oxaliplatin|oxaliplatin|mesh-list
25012534|NCT05008783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25012535|NCT05008783|Antimetabolites|antimetabolites|mesh-ancestor
25012536|NCT05008783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012537|NCT05008783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25012538|NCT04986579|Trastuzumab|trastuzumab|mesh-list
25012539|NCT04986579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25012540|NCT04986579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25012541|NCT04930315|Apatinib|apatinib|mesh-list
25012542|NCT04930315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25012543|NCT04930315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25012544|NCT04930315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25012545|NCT04930315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012548|NCT04903210|Niacinamide|niacinamide|mesh-list
25012549|NCT04903210|Niacin|niacin|mesh-list
25012550|NCT04903210|Nicotinic Acids|nicotinic acids|mesh-list
25012551|NCT04903210|Vitamin B Complex|vitamin b complex|mesh-ancestor
25012552|NCT04903210|Vitamins|vitamins|mesh-ancestor
25012553|NCT04903210|Micronutrients|micronutrients|mesh-ancestor
25687325|NCT01930045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687326|NCT01930045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012554|NCT04903210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012555|NCT04903210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25012556|NCT04903210|Antimetabolites|antimetabolites|mesh-ancestor
25012560|NCT04896658|Dexamethasone|dexamethasone|mesh-list
25012561|NCT04896658|Cyclophosphamide|cyclophosphamide|mesh-list
25012562|NCT04896658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25012563|NCT04896658|Immunologic Factors|immunologic factors|mesh-ancestor
25012564|NCT04896658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012565|NCT04896658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25012566|NCT04896658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25012567|NCT04896658|Alkylating Agents|alkylating agents|mesh-ancestor
25012568|NCT04896658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012569|NCT04896658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25012570|NCT04896658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25012571|NCT04896658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25012572|NCT04896658|Antiemetics|antiemetics|mesh-ancestor
25012573|NCT04896658|Autonomic Agents|autonomic agents|mesh-ancestor
25012574|NCT04896658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25256407|NCT02482857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256408|NCT02482857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25256409|NCT02482857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25256410|NCT02482857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256411|NCT02482857|Antipyretics|antipyretics|mesh-ancestor
25256412|NCT02482961|Colistin|colistin|mesh-list
25256413|NCT02482961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24928587|NCT04120623|Insulin Aspart|insulin aspart|mesh-list
24928588|NCT04120623|Dapagliflozin|dapagliflozin|mesh-list
24928589|NCT04120623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24928590|NCT04120623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928591|NCT04120623|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24928592|NCT04120623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928593|NCT04120363|Methyltestosterone|methyltestosterone|mesh-list
24928594|NCT04120363|Testosterone|testosterone|mesh-list
24928595|NCT04120363|Testosterone undecanoate|testosterone undecanoate|mesh-list
24928596|NCT04120363|Testosterone enanthate|testosterone enanthate|mesh-list
24928597|NCT04120363|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24928598|NCT04120363|Androgens|androgens|mesh-ancestor
24928599|NCT04120363|Hormones|hormones|mesh-ancestor
24942939|NCT03976544|Progestins|progestins|mesh-ancestor
25012588|NCT04769401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25012589|NCT04769401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012591|NCT04742023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25110390|NCT05463627|Metformin|metformin|mesh-list
25110391|NCT05463627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25110392|NCT05463627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110393|NCT05463614|Propranolol|propranolol|mesh-list
25110394|NCT05463614|Propafenone|propafenone|mesh-list
25110395|NCT05463614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25110396|NCT05463614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25110397|NCT05463614|Adrenergic Agents|adrenergic agents|mesh-ancestor
25110398|NCT05463614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25110399|NCT05463614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110400|NCT05463614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110401|NCT05463614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25110402|NCT05463614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25110403|NCT05463614|Vasodilator Agents|vasodilator agents|mesh-ancestor
25110404|NCT05463614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25110405|NCT05463614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25110406|NCT05463614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25110407|NCT05463601|Tamoxifen|tamoxifen|mesh-list
25110408|NCT05463601|Letrozole|letrozole|mesh-list
25110409|NCT05463601|Fulvestrant|fulvestrant|mesh-list
25110410|NCT05463601|Exemestane|exemestane|mesh-list
25110411|NCT05463601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25110412|NCT05463601|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25110413|NCT05463601|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25110414|NCT05463601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25110415|NCT05463601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110416|NCT05463601|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25110417|NCT05463601|Hormone Antagonists|hormone antagonists|mesh-ancestor
25110419|NCT05463601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574115|NCT00823849|Respiratory System Agents|respiratory system agents|mesh-ancestor
25110428|NCT05463588|Sympathomimetics|sympathomimetics|mesh-ancestor
25110429|NCT05463588|Autonomic Agents|autonomic agents|mesh-ancestor
25110430|NCT05463588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25110431|NCT05463588|Dopamine Agents|dopamine agents|mesh-ancestor
25012593|NCT04733157|Tranexamic Acid|tranexamic acid|mesh-list
25012594|NCT04733157|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25012595|NCT04733157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25012596|NCT04733157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256414|NCT02482961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25012598|NCT04733157|Coagulants|coagulants|mesh-ancestor
25012600|NCT04724252|Analgesics|analgesics|mesh-ancestor
25012601|NCT04724252|Sensory System Agents|sensory system agents|mesh-ancestor
25256415|NCT02482818|Pregabalin|pregabalin|mesh-list
25256416|NCT02482818|Analgesics|analgesics|mesh-ancestor
25256417|NCT02482818|Sensory System Agents|sensory system agents|mesh-ancestor
25256418|NCT02482818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25256419|NCT02482818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256420|NCT02482818|Anticonvulsants|anticonvulsants|mesh-ancestor
25256421|NCT02482818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25256422|NCT02482818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25256423|NCT02482818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256424|NCT02482818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25256425|NCT02482818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25256426|NCT02482818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24928600|NCT04120363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24928601|NCT04120363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928602|NCT04120363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24928603|NCT04120363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24928604|NCT04120363|Anabolic Agents|anabolic agents|mesh-ancestor
24928605|NCT04120311|Dexamethasone|dexamethasone|mesh-list
24928606|NCT04120311|Dexamethasone acetate|dexamethasone acetate|mesh-list
24928607|NCT04120311|BB 1101|bb 1101|mesh-list
24928608|NCT04120311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24928609|NCT04120311|Antiemetics|antiemetics|mesh-ancestor
24928610|NCT04120311|Autonomic Agents|autonomic agents|mesh-ancestor
24928611|NCT04120311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24404417|NCT00163397|Ciclesonide|ciclesonide|mesh-list
24527247|NCT00615667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24527248|NCT00615667|Immunologic Factors|immunologic factors|mesh-ancestor
24798798|NCT01965301|Anesthetics, Local|anesthetics, local|mesh-ancestor
25012602|NCT04724252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25012603|NCT04724252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012643|NCT04700423|Moxidectin|moxidectin|mesh-list
25012644|NCT04700423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25012645|NCT04700423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25012646|NCT04700423|Anthelmintics|anthelmintics|mesh-ancestor
25012647|NCT04700423|Anticestodal Agents|anticestodal agents|mesh-ancestor
25012648|NCT04700423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25012649|NCT04700423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25012650|NCT04700423|Tubulin Modulators|tubulin modulators|mesh-ancestor
25012651|NCT04700423|Antimitotic Agents|antimitotic agents|mesh-ancestor
25012652|NCT04700423|Mitosis Modulators|mitosis modulators|mesh-ancestor
25012653|NCT04700423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012654|NCT04700423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25012655|NCT04700423|Antinematodal Agents|antinematodal agents|mesh-ancestor
25012656|NCT04666454|Adenosine|adenosine|mesh-list
24969361|NCT03743727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24969362|NCT03743649|Lorazepam|lorazepam|mesh-list
24969363|NCT03743649|Haloperidol|haloperidol|mesh-list
24969364|NCT03743649|Haloperidol decanoate|haloperidol decanoate|mesh-list
24969365|NCT03743649|Antiemetics|antiemetics|mesh-ancestor
24969366|NCT03743649|Autonomic Agents|autonomic agents|mesh-ancestor
24969367|NCT03743649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25012657|NCT04666454|Dipyridamole|dipyridamole|mesh-list
25012658|NCT04666454|Apixaban|apixaban|mesh-list
25012659|NCT04666454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25012660|NCT04666454|Antithrombins|antithrombins|mesh-ancestor
25012661|NCT04666454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25012685|NCT04600921|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25012686|NCT04600921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012687|NCT04600921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25012688|NCT04600921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012689|NCT04573777|Evolocumab|evolocumab|mesh-list
25012690|NCT04573777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25012691|NCT04573777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25012692|NCT04573777|Antimetabolites|antimetabolites|mesh-ancestor
25012693|NCT04573777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256435|NCT02482649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25256436|NCT02482649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739641|NCT01683149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24739643|NCT01683149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25012711|NCT04546126|Autonomic Agents|autonomic agents|mesh-ancestor
25012712|NCT04546126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25012713|NCT04546126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012714|NCT04546126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25012732|NCT04531176|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25012733|NCT04531176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012734|NCT04531176|Sensory System Agents|sensory system agents|mesh-ancestor
25012735|NCT04531176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25012749|NCT04531176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25012750|NCT04531176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25012751|NCT04531176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25012752|NCT04531176|Anticonvulsants|anticonvulsants|mesh-ancestor
25012753|NCT04531176|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25012754|NCT04531176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25012755|NCT04531176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25012756|NCT04531176|Appetite Depressants|appetite depressants|mesh-ancestor
25012757|NCT04531176|Sympathomimetics|sympathomimetics|mesh-ancestor
24574298|NCT00824811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24574312|NCT00825019|Paroxetine|paroxetine|mesh-list
25012776|NCT04437108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012777|NCT04437108|Urological Agents|urological agents|mesh-ancestor
25012778|NCT04434300|Daptomycin|daptomycin|mesh-list
25012779|NCT04434300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25090980|NCT03251690|Tenofovir|tenofovir|mesh-list
25012780|NCT04434300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25012791|NCT04423588|Dexlansoprazole|dexlansoprazole|mesh-list
25012792|NCT04423588|Lansoprazole|lansoprazole|mesh-list
25012823|NCT04315896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012824|NCT04315896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25012825|NCT04307797|Exenatide|exenatide|mesh-list
25012826|NCT04307797|Glucagon|glucagon|mesh-list
25012827|NCT04307797|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25012828|NCT04307797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25012829|NCT04307797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012830|NCT04307797|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24969658|NCT03741426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24969659|NCT03741426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24969660|NCT03741426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25256442|NCT02482636|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25256443|NCT02482636|Immunologic Factors|immunologic factors|mesh-ancestor
25256444|NCT02482636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256445|NCT02482311|Adavosertib|adavosertib|mesh-list
25256446|NCT02482311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256447|NCT02482311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969661|NCT03741426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24522901|NCT03049735|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25012886|NCT04186988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25012887|NCT04143659|Levonorgestrel|levonorgestrel|mesh-list
25012888|NCT04143659|Levonorgestrel butanoate|levonorgestrel butanoate|mesh-list
25013090|NCT03740334|Glucocorticoids|glucocorticoids|mesh-ancestor
25012889|NCT04143659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25012891|NCT04143659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25012892|NCT04143659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012893|NCT04143659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25012894|NCT04143659|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25012895|NCT04143659|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25012896|NCT04143659|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25012898|NCT04136366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25012937|NCT04090684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25012938|NCT04090684|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25012939|NCT04090684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25012940|NCT04090684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25012941|NCT04090684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091051|NCT03251417|Irinotecan|irinotecan|mesh-list
25012942|NCT04090684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25012943|NCT04090684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25012944|NCT04090684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25012945|NCT04090684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25687327|NCT01930045|Antacids|antacids|mesh-ancestor
25687328|NCT01930045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25687329|NCT01930188|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25012946|NCT04090684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25012947|NCT04090684|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25012948|NCT04090684|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25012953|NCT04045301|Omalizumab|omalizumab|mesh-list
25012954|NCT04045301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25012955|NCT04045301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25012956|NCT04045301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25012957|NCT04045301|Respiratory System Agents|respiratory system agents|mesh-ancestor
24574575|NCT00826358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24574576|NCT00826358|Antimetabolites|antimetabolites|mesh-ancestor
24574577|NCT00826358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574578|NCT00826358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25012991|NCT03939104|Anthelmintics|anthelmintics|mesh-ancestor
25012993|NCT03913091|Anesthetics, Local|anesthetics, local|mesh-ancestor
25012994|NCT03913091|Anesthetics|anesthetics|mesh-ancestor
25012995|NCT03913091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25012996|NCT03913091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012997|NCT03913091|Sensory System Agents|sensory system agents|mesh-ancestor
24817322|NCT02082665|Dabrafenib|dabrafenib|mesh-list
25013040|NCT03822637|Antiviral Agents|antiviral agents|mesh-ancestor
25013041|NCT03822637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25013043|NCT03822637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25013044|NCT03822637|Antioxidants|antioxidants|mesh-ancestor
25013045|NCT03822637|Protective Agents|protective agents|mesh-ancestor
25013046|NCT03822637|Antidotes|antidotes|mesh-ancestor
25013047|NCT03802565|Tolperisone|tolperisone|mesh-list
25013048|NCT03802565|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25013049|NCT03802565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013050|NCT03802565|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25013051|NCT03802565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25013052|NCT03763422|Temozolomide|temozolomide|mesh-list
25013053|NCT03763422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25256448|NCT02482272|Lamivudine|lamivudine|mesh-list
25256449|NCT02482272|Adefovir|adefovir|mesh-list
25256450|NCT02482272|Entecavir|entecavir|mesh-list
25256451|NCT02482272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25256452|NCT02482272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25256453|NCT02482272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256454|NCT02482272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256455|NCT02482272|Antiviral Agents|antiviral agents|mesh-ancestor
24527263|NCT00615758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527301|NCT00615810|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25013054|NCT03763422|Alkylating Agents|alkylating agents|mesh-ancestor
25013055|NCT03763422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013056|NCT03763422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013058|NCT03752307|Methylprednisolone|methylprednisolone|mesh-list
25013059|NCT03752307|Isoxsuprine|isoxsuprine|mesh-list
25013060|NCT03752307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25013061|NCT03752307|Glucocorticoids|glucocorticoids|mesh-ancestor
25013062|NCT03752307|Hormones|hormones|mesh-ancestor
25013063|NCT03752307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25013064|NCT03752307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013067|NCT03752307|Antiemetics|antiemetics|mesh-ancestor
25013088|NCT03740334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013089|NCT03740334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25013096|NCT03740334|Immunologic Factors|immunologic factors|mesh-ancestor
25013097|NCT03637556|Deferasirox|deferasirox|mesh-list
25013098|NCT03637556|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25013099|NCT03637556|Chelating Agents|chelating agents|mesh-ancestor
25013100|NCT03637556|Sequestering Agents|sequestering agents|mesh-ancestor
25013101|NCT03637556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013102|NCT03627897|Bupivacaine|bupivacaine|mesh-list
25013103|NCT03627897|Anesthetics, Local|anesthetics, local|mesh-ancestor
25013104|NCT03627897|Anesthetics|anesthetics|mesh-ancestor
25013146|NCT03452111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25013147|NCT03452111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013148|NCT03452111|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25013149|NCT03452111|Contraceptive Agents|contraceptive agents|mesh-ancestor
25013150|NCT03452111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25013151|NCT03452111|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25013152|NCT03441555|Venetoclax|venetoclax|mesh-list
24586283|NCT00890110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586284|NCT00890110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24586285|NCT00890110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24586286|NCT00890110|Growth Substances|growth substances|mesh-ancestor
24586287|NCT00890110|Growth Inhibitors|growth inhibitors|mesh-ancestor
25013197|NCT03416179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25013198|NCT03416179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25013199|NCT03416179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25013200|NCT03353922|Cyclobenzaprine|cyclobenzaprine|mesh-list
25013202|NCT03353922|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25013203|NCT03353922|Antidepressive Agents|antidepressive agents|mesh-ancestor
25013204|NCT03353922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25013205|NCT03353922|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25013207|NCT03353922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25013208|NCT03353922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25013209|NCT03353922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25013210|NCT03353922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25013211|NCT03346239|Citalopram|citalopram|mesh-list
25013212|NCT03346239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25013213|NCT03346239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25013214|NCT03346239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25013215|NCT03346239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013216|NCT03346239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25013217|NCT03346239|Serotonin Agents|serotonin agents|mesh-ancestor
25110469|NCT05463367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25110470|NCT05463367|Gout Suppressants|gout suppressants|mesh-ancestor
25110471|NCT05463367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25110472|NCT05463367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256456|NCT02482272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25256457|NCT02482272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25256458|NCT02482272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25256459|NCT02482402|Iloprost|iloprost|mesh-list
24527302|NCT00615810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24527303|NCT00615810|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24527304|NCT00615810|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24527305|NCT00615810|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24527306|NCT00615810|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24527348|NCT00616031|Vasodilator Agents|vasodilator agents|mesh-ancestor
24527349|NCT00616044|Anesthetics|anesthetics|mesh-list
24527350|NCT00616044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24527351|NCT00616044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527352|NCT00616070|Difluprednate|difluprednate|mesh-list
24527353|NCT00616070|Glucocorticoids|glucocorticoids|mesh-ancestor
24798831|NCT01965353|Growth Substances|growth substances|mesh-ancestor
25013425|NCT02733042|Lenalidomide|lenalidomide|mesh-list
25110473|NCT05463367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110474|NCT05463367|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25110475|NCT05463367|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25110476|NCT05463367|Dopamine Agents|dopamine agents|mesh-ancestor
25110477|NCT05463367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25110478|NCT05463367|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25110479|NCT05463367|Antitussive Agents|antitussive agents|mesh-ancestor
25110480|NCT05463367|Respiratory System Agents|respiratory system agents|mesh-ancestor
25110481|NCT05463367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25110482|NCT05463367|Immunologic Factors|immunologic factors|mesh-ancestor
25110483|NCT05463367|Dopamine Agonists|dopamine agonists|mesh-ancestor
25110484|NCT05463367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25013225|NCT03188705|Clopidogrel|clopidogrel|mesh-list
25013226|NCT03188705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25013227|NCT03188705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25013228|NCT03188705|Analgesics|analgesics|mesh-ancestor
25013229|NCT03188705|Sensory System Agents|sensory system agents|mesh-ancestor
25013230|NCT03188705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25013231|NCT03188705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013232|NCT03188705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25013233|NCT03188705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25013234|NCT03188705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25013235|NCT03188705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25013236|NCT03188705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013237|NCT03188705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25013238|NCT03188705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25013239|NCT03188705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25013240|NCT03188705|Antipyretics|antipyretics|mesh-ancestor
25013241|NCT03188705|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25013242|NCT03188705|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25687330|NCT01930188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25687331|NCT01930188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013244|NCT03188705|Purinergic Agents|purinergic agents|mesh-ancestor
25013245|NCT03188705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25256477|NCT02482155|Sensory System Agents|sensory system agents|mesh-ancestor
24527355|NCT00616070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24527356|NCT00616070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527357|NCT00616187|Interferons|interferons|mesh-list
24527358|NCT00616187|Interferon-beta|interferon-beta|mesh-list
24527359|NCT00616187|Atorvastatin|atorvastatin|mesh-list
24527360|NCT00616187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527361|NCT00616187|Antiviral Agents|antiviral agents|mesh-ancestor
25013249|NCT03173456|Acetaminophen|acetaminophen|mesh-list
25013250|NCT03173456|Ibuprofen|ibuprofen|mesh-list
25013251|NCT03173456|Oxycodone|oxycodone|mesh-list
25013252|NCT03173456|Hydrocodone|hydrocodone|mesh-list
25013272|NCT03161678|Ticagrelor|ticagrelor|mesh-list
25013273|NCT03161678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25013274|NCT03161678|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25013275|NCT03161678|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25013276|NCT03161678|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24970054|NCT03736980|Psilocybin|psilocybin|mesh-list
25013369|NCT02992015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25013370|NCT02992015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25013371|NCT02992015|Immunologic Factors|immunologic factors|mesh-ancestor
25013372|NCT02992015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013373|NCT02991495|Vaccines|vaccines|mesh-list
25013374|NCT02991495|Immunologic Factors|immunologic factors|mesh-ancestor
25013375|NCT02991495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013376|NCT02918370|Aripiprazole|aripiprazole|mesh-list
25013377|NCT02918370|Antidepressive Agents|antidepressive agents|mesh-ancestor
25013378|NCT02918370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25013379|NCT02918370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25013380|NCT02918370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25013381|NCT02918370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25013382|NCT02918370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013383|NCT02918370|Dopamine Agonists|dopamine agonists|mesh-ancestor
25013384|NCT02918370|Dopamine Agents|dopamine agents|mesh-ancestor
25013385|NCT02918370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25013386|NCT02918370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013387|NCT02918370|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25013388|NCT02918370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25013422|NCT02845323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013423|NCT02733042|Rituximab|rituximab|mesh-list
25013424|NCT02733042|Durvalumab|durvalumab|mesh-list
25013473|NCT02575144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25013474|NCT02575144|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25013475|NCT02575144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25013476|NCT02575144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256478|NCT02482155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25256479|NCT02482155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256480|NCT02482155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25256481|NCT02482155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25256482|NCT02482155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25256483|NCT02482155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275012|NCT02374567|Anticonvulsants|anticonvulsants|mesh-ancestor
24527366|NCT00616187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527369|NCT00616187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24928621|NCT04120311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928622|NCT04120259|Metformin|metformin|mesh-list
24928623|NCT04120259|Acetic Acid|acetic acid|mesh-list
24928624|NCT04120259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24928625|NCT04120259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928626|NCT04120259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24928627|NCT04120259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24928628|NCT04120350|Rituximab|rituximab|mesh-list
24928629|NCT04120350|Methotrexate|methotrexate|mesh-list
24928630|NCT04120350|Lenalidomide|lenalidomide|mesh-list
24928631|NCT04120350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24928632|NCT04120350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24928633|NCT04120350|Immunologic Factors|immunologic factors|mesh-ancestor
24928634|NCT04120350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928635|NCT04120350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24943095|NCT03974685|Niacin|niacin|mesh-list
25013477|NCT02575144|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25013478|NCT02575144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25013480|NCT02574286|Vitamins|vitamins|mesh-ancestor
25013481|NCT02574286|Micronutrients|micronutrients|mesh-ancestor
25013482|NCT02574286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013533|NCT02313870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25013534|NCT02313870|Antimetabolites|antimetabolites|mesh-ancestor
25013535|NCT02313870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013536|NCT02313870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013537|NCT02313870|Dermatologic Agents|dermatologic agents|mesh-ancestor
25013538|NCT02313870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25013539|NCT02313870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25013540|NCT02313870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25013541|NCT02313870|Immunologic Factors|immunologic factors|mesh-ancestor
25013542|NCT02313870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25013543|NCT02313870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25013544|NCT02313870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25013545|NCT02313870|Glucocorticoids|glucocorticoids|mesh-ancestor
25013546|NCT02313870|Hormones|hormones|mesh-ancestor
25013547|NCT02313870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25013548|NCT02271932|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25013549|NCT02271932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24970336|NCT03734159|Anesthetics|anesthetics|mesh-ancestor
24970337|NCT03734159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24970338|NCT03734159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970339|NCT03734159|Sensory System Agents|sensory system agents|mesh-ancestor
24970340|NCT03734159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970341|NCT03734068|Doxorubicin|doxorubicin|mesh-list
24970342|NCT03734068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24970343|NCT03734068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970344|NCT03734068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24970345|NCT03734068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25256484|NCT02482155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256485|NCT02482090|Cyclophosphamide|cyclophosphamide|mesh-list
25256486|NCT02482090|Fludarabine|fludarabine|mesh-list
25256487|NCT02482090|Interleukin-2|interleukin-2|mesh-list
25013882|NCT05221411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256490|NCT02482090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256491|NCT02482090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25256492|NCT02482090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25256494|NCT02482090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256495|NCT02482090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256496|NCT02482090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25256497|NCT02482090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25256498|NCT02482090|Analgesics|analgesics|mesh-ancestor
25256499|NCT02482090|Sensory System Agents|sensory system agents|mesh-ancestor
25256500|NCT02482090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25256501|NCT02482324|Ibuprofen|ibuprofen|mesh-list
25256502|NCT02482324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25256503|NCT02482324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25256504|NCT02482324|Analgesics|analgesics|mesh-ancestor
24928636|NCT04120350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24928638|NCT04120350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24928639|NCT04120350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25013637|NCT01446016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013638|NCT01399918|Bevacizumab|bevacizumab|mesh-list
25013639|NCT01399918|Everolimus|everolimus|mesh-list
25013640|NCT01399918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25013641|NCT01399918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013642|NCT01399918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25013643|NCT01399918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25013660|NCT01078454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25013661|NCT01078454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25013725|NCT05223010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25013726|NCT05223010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013727|NCT05223010|Antioxidants|antioxidants|mesh-ancestor
25013728|NCT05223010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013729|NCT05223010|Protective Agents|protective agents|mesh-ancestor
25013730|NCT05222646|Metoclopramide|metoclopramide|mesh-list
25013731|NCT05222646|Antiemetics|antiemetics|mesh-ancestor
25013732|NCT05222646|Autonomic Agents|autonomic agents|mesh-ancestor
25013733|NCT05222646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25687332|NCT01930188|Incretins|incretins|mesh-ancestor
25687333|NCT01930188|Hormones|hormones|mesh-ancestor
25013734|NCT05222646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013735|NCT05222646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25013782|NCT05222204|Immunologic Factors|immunologic factors|mesh-ancestor
25013783|NCT05222204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013784|NCT05222191|Chlorthalidone|chlorthalidone|mesh-list
25013785|NCT05222191|Spironolactone|spironolactone|mesh-list
25013786|NCT05222191|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25013843|NCT05221645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013844|NCT05221645|Immunologic Factors|immunologic factors|mesh-ancestor
25013845|NCT05221645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013846|NCT05221645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25013847|NCT05221645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24586315|NCT00890214|Calcium heparin|calcium heparin|mesh-list
24586316|NCT00890214|Tezosentan|tezosentan|mesh-list
24586317|NCT00890214|Anticoagulants|anticoagulants|mesh-ancestor
24586318|NCT00890214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24586319|NCT00890214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24633998|NCT01131780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24410669|NCT00186862|Analgesics|analgesics|mesh-ancestor
24586320|NCT00890214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586321|NCT00890214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24586322|NCT00890214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24586323|NCT00890214|Vasodilator Agents|vasodilator agents|mesh-ancestor
24586371|NCT00890487|Hyaluronic Acid|hyaluronic acid|mesh-list
24586372|NCT00890487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24586373|NCT00890487|Immunologic Factors|immunologic factors|mesh-ancestor
24586374|NCT00890487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013874|NCT05221437|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25013875|NCT05221437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25013876|NCT05221411|Mycophenolic Acid|mycophenolic acid|mesh-list
25013878|NCT05221411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25013879|NCT05221411|Immunologic Factors|immunologic factors|mesh-ancestor
25013880|NCT05221411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013881|NCT05221411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24575799|NCT00834457|Antiviral Agents|antiviral agents|mesh-ancestor
24575800|NCT00834457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24575801|NCT00834457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24575802|NCT00834457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25110576|NCT05442580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25110577|NCT05442580|Immunologic Factors|immunologic factors|mesh-ancestor
25256506|NCT02482324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25256507|NCT02482324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256508|NCT02482324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25256509|NCT02482324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24928640|NCT04120350|Antimetabolites|antimetabolites|mesh-ancestor
24928641|NCT04120350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928642|NCT04120350|Dermatologic Agents|dermatologic agents|mesh-ancestor
24928643|NCT04120350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527382|NCT00616382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24527383|NCT00616382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527401|NCT00616408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24527402|NCT00616408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527403|NCT00616460|Bivalirudin|bivalirudin|mesh-list
25110580|NCT05442580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25110581|NCT05442580|Alkylating Agents|alkylating agents|mesh-ancestor
25110582|NCT05442580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110583|NCT05442580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25110584|NCT05442580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25013932|NCT05220228|Prucalopride|prucalopride|mesh-list
25013933|NCT05220228|Laxatives|laxatives|mesh-ancestor
25013934|NCT05220228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25013967|NCT05197374|Estrogens|estrogens|mesh-ancestor
25013968|NCT05197374|Hormones|hormones|mesh-ancestor
25013969|NCT05197374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25013970|NCT05197374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013971|NCT05197374|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25013972|NCT05197374|Contraceptive Agents|contraceptive agents|mesh-ancestor
25013973|NCT05197374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25013974|NCT05197374|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25013975|NCT05191290|Heparin|heparin|mesh-list
25013976|NCT05191290|Calcium heparin|calcium heparin|mesh-list
25013977|NCT05191290|Citric Acid|citric acid|mesh-list
25013978|NCT05191290|Sodium Citrate|sodium citrate|mesh-list
24410670|NCT00186862|Sensory System Agents|sensory system agents|mesh-ancestor
25013979|NCT05191290|Anticoagulants|anticoagulants|mesh-ancestor
24740766|NCT01690221|Diltiazem|diltiazem|mesh-list
24740767|NCT01690221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24740768|NCT01690221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24740769|NCT01690221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24740770|NCT01690221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740771|NCT01690221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24740786|NCT01690286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24740788|NCT01690286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24740789|NCT01690325|Cyclophosphamide|cyclophosphamide|mesh-list
25013980|NCT05191290|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25013981|NCT05191290|Chelating Agents|chelating agents|mesh-ancestor
25013982|NCT05191290|Sequestering Agents|sequestering agents|mesh-ancestor
25013983|NCT05191290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013984|NCT05191290|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25013985|NCT05191290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25110623|NCT05434663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25014047|NCT05095311|Cetirizine|cetirizine|mesh-list
25014048|NCT05095311|Nedocromil|nedocromil|mesh-list
25014049|NCT05095311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25014050|NCT05095311|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25014051|NCT05095311|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25014052|NCT05095311|Histamine Antagonists|histamine antagonists|mesh-ancestor
25014053|NCT05095311|Histamine Agents|histamine agents|mesh-ancestor
25014054|NCT05095311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25014055|NCT05095311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014093|NCT05049278|Oxymetazoline|oxymetazoline|mesh-list
25014094|NCT05049278|Norepinephrine|norepinephrine|mesh-list
25014095|NCT05049278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25014096|NCT05049278|Mydriatics|mydriatics|mesh-ancestor
25014097|NCT05049278|Autonomic Agents|autonomic agents|mesh-ancestor
25014098|NCT05049278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25014099|NCT05049278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014100|NCT05049278|Sympathomimetics|sympathomimetics|mesh-ancestor
25014101|NCT05049278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25014102|NCT05049278|Nasal Decongestants|nasal decongestants|mesh-ancestor
25014103|NCT05049278|Respiratory System Agents|respiratory system agents|mesh-ancestor
25256516|NCT02481960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256517|NCT02481960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256518|NCT02481960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256520|NCT02481791|Propofol|propofol|mesh-list
25256521|NCT02481791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25256522|NCT02481791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25014169|NCT04963816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25014170|NCT04963816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25014171|NCT04963816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25014172|NCT04963816|Protease Inhibitors|protease inhibitors|mesh-ancestor
25014173|NCT04963816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25014174|NCT04963816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014176|NCT04963816|Anesthetics|anesthetics|mesh-ancestor
24627300|NCT01091792|Growth Substances|growth substances|mesh-ancestor
24794229|NCT05356936|Cholecalciferol|cholecalciferol|mesh-list
24794231|NCT05356936|Vitamin K|vitamin k|mesh-list
24794232|NCT05356936|Vitamin K 2|vitamin k 2|mesh-list
24794233|NCT05356936|Micronutrients|micronutrients|mesh-ancestor
24794234|NCT05356936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794235|NCT05356936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24794236|NCT05356936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24794237|NCT05356936|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24794238|NCT05356936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24794239|NCT05356936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794240|NCT05356936|Hemostatics|hemostatics|mesh-ancestor
24794241|NCT05356936|Coagulants|coagulants|mesh-ancestor
24794242|NCT05352178|Ascorbic Acid|ascorbic acid|mesh-list
25687334|NCT01930188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25687335|NCT01930188|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25687336|NCT01930188|Protease Inhibitors|protease inhibitors|mesh-ancestor
25687337|NCT01930188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687338|NCT01930188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687339|NCT01930487|Antioxidants|antioxidants|mesh-list
25687340|NCT01930487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687341|NCT01930487|Protective Agents|protective agents|mesh-ancestor
25687342|NCT01930487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741017|NCT01691053|Hormone Antagonists|hormone antagonists|mesh-ancestor
24741018|NCT01691053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24741019|NCT01691053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741020|NCT01691053|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24741022|NCT01691053|Natriuretic Agents|natriuretic agents|mesh-ancestor
24741023|NCT01691118|Antihypertensive Agents|antihypertensive agents|mesh-list
24741024|NCT01691209|Hydrocortisone|hydrocortisone|mesh-list
24741026|NCT01691365|Vitamins|vitamins|mesh-list
24794243|NCT05352178|Methyltestosterone|methyltestosterone|mesh-list
24794244|NCT05352178|Androgens|androgens|mesh-list
24794245|NCT05352178|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24794246|NCT05352178|Hormones|hormones|mesh-ancestor
24794248|NCT05352178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576141|NCT00837044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25014222|NCT04891250|Ivermectin|ivermectin|mesh-list
25014223|NCT04891250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25014224|NCT04891250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25014225|NCT04889703|Salicylic Acid|salicylic acid|mesh-list
25014226|NCT04889703|Salicylates|salicylates|mesh-list
25014227|NCT04889703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25014228|NCT04889703|Antifungal Agents|antifungal agents|mesh-ancestor
25014229|NCT04889703|Keratolytic Agents|keratolytic agents|mesh-ancestor
25014230|NCT04889703|Dermatologic Agents|dermatologic agents|mesh-ancestor
25014231|NCT04889703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25014232|NCT04889703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25014233|NCT04889703|Analgesics|analgesics|mesh-ancestor
25014234|NCT04889703|Sensory System Agents|sensory system agents|mesh-ancestor
25014271|NCT04814433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014272|NCT04814433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25014273|NCT04814433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25014274|NCT04814433|Adrenergic Agents|adrenergic agents|mesh-ancestor
25014275|NCT04814433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25014276|NCT04814433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25014277|NCT04814433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25014278|NCT04814433|Autonomic Agents|autonomic agents|mesh-ancestor
25014287|NCT04814433|Coagulants|coagulants|mesh-ancestor
25256523|NCT02481791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256524|NCT02481791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25256525|NCT02481791|Anesthetics, General|anesthetics, general|mesh-ancestor
25256526|NCT02481791|Anesthetics|anesthetics|mesh-ancestor
24527420|NCT00616538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24527421|NCT00616538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527422|NCT00616538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24527423|NCT00616538|Respiratory System Agents|respiratory system agents|mesh-ancestor
24527424|NCT00616538|Dermatologic Agents|dermatologic agents|mesh-ancestor
24527425|NCT00616538|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24527426|NCT00616551|Octreotide|octreotide|mesh-list
24527427|NCT00616551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24527428|NCT00616551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25014300|NCT04789499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014301|NCT04789499|Vasodilator Agents|vasodilator agents|mesh-ancestor
25014302|NCT04789499|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25014303|NCT04789499|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25014304|NCT04789499|Purinergic Agents|purinergic agents|mesh-ancestor
25014305|NCT04789499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25014306|NCT04765644|Celecoxib|celecoxib|mesh-list
25014307|NCT04765644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25014308|NCT04765644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25014310|NCT04765644|Sensory System Agents|sensory system agents|mesh-ancestor
25014311|NCT04765644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25014312|NCT04765644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014313|NCT04765644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25014314|NCT04765644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25014315|NCT04765644|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25014316|NCT04765644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25014317|NCT04765644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687343|NCT01930747|Remifentanil|remifentanil|mesh-list
25687344|NCT01930747|Sevoflurane|sevoflurane|mesh-list
25687345|NCT01930747|Rocuronium|rocuronium|mesh-list
25687346|NCT01930747|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25687347|NCT01930747|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25687348|NCT01930747|Anesthetics, General|anesthetics, general|mesh-ancestor
25687349|NCT01930747|Anesthetics|anesthetics|mesh-ancestor
25687350|NCT01930747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25687351|NCT01930747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687352|NCT01930747|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25687353|NCT01930747|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25687354|NCT01930747|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25687355|NCT01930747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24741129|NCT01692158|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24741130|NCT01692158|Tinzaparin|tinzaparin|mesh-list
24741131|NCT01692158|Dalteparin|dalteparin|mesh-list
24741132|NCT01692158|Anticoagulants|anticoagulants|mesh-ancestor
24741133|NCT01692158|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24741134|NCT01692158|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24741135|NCT01692158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741136|NCT01692171|Heparin|heparin|mesh-list
24741137|NCT01692171|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24741138|NCT01692171|Tinzaparin|tinzaparin|mesh-list
24741139|NCT01692171|Dalteparin|dalteparin|mesh-list
24741140|NCT01692171|Anticoagulants|anticoagulants|mesh-ancestor
24741141|NCT01692171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25014318|NCT04765644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014348|NCT04671355|Fluticasone|fluticasone|mesh-list
25014349|NCT04671355|Xhance|xhance|mesh-list
25014350|NCT04671355|Beclomethasone|beclomethasone|mesh-list
25014351|NCT04671355|Glycopyrrolate|glycopyrrolate|mesh-list
25014352|NCT04671355|Formoterol Fumarate|formoterol fumarate|mesh-list
25014403|NCT04564898|Growth Inhibitors|growth inhibitors|mesh-ancestor
25014404|NCT04564898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25014405|NCT04564898|Antimetabolites|antimetabolites|mesh-ancestor
25014406|NCT04564898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014407|NCT04564898|Antiviral Agents|antiviral agents|mesh-ancestor
25014408|NCT04564898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25014409|NCT04562779|Naltrexone|naltrexone|mesh-list
25014410|NCT04562779|Ketamine|ketamine|mesh-list
25014411|NCT04562779|Analgesics|analgesics|mesh-ancestor
25014412|NCT04562779|Sensory System Agents|sensory system agents|mesh-ancestor
25014467|NCT04509050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014469|NCT04503993|Immunoglobulins|immunoglobulins|mesh-list
25014470|NCT04503993|Immunologic Factors|immunologic factors|mesh-ancestor
25014471|NCT04503993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014472|NCT04484922|Dexmedetomidine|dexmedetomidine|mesh-list
25014473|NCT04484922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25014474|NCT04484922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25014475|NCT04484922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014476|NCT04484922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25014477|NCT04484922|Analgesics|analgesics|mesh-ancestor
25014478|NCT04484922|Sensory System Agents|sensory system agents|mesh-ancestor
25256536|NCT02481635|Paclitaxel|paclitaxel|mesh-list
24527429|NCT00616551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527430|NCT00616681|Oxcarbazepine|oxcarbazepine|mesh-list
24527431|NCT00616681|Anticonvulsants|anticonvulsants|mesh-ancestor
24527432|NCT00616681|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24527433|NCT00616681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24527434|NCT00616681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24928644|NCT04120350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24928645|NCT04120350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24928646|NCT04120350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24971133|NCT03728192|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24971134|NCT03728192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24971136|NCT03728192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971137|NCT03728153|Fluoxetine|fluoxetine|mesh-list
24971138|NCT03728153|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24971139|NCT03728153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24971140|NCT03728153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24971141|NCT03728153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971142|NCT03728153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24971143|NCT03728153|Serotonin Agents|serotonin agents|mesh-ancestor
25687356|NCT01930747|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25687357|NCT01930747|Narcotics|narcotics|mesh-ancestor
25687358|NCT01930747|Analgesics|analgesics|mesh-ancestor
25687359|NCT01930747|Sensory System Agents|sensory system agents|mesh-ancestor
25687360|NCT01930890|Mycophenolic Acid|mycophenolic acid|mesh-list
25687361|NCT01930890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25687362|NCT01930890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25687363|NCT01930890|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25687364|NCT01930890|Antitubercular Agents|antitubercular agents|mesh-ancestor
25687365|NCT01930890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25687366|NCT01930890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25687367|NCT01930890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24971144|NCT03728153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971145|NCT03728153|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24971146|NCT03728153|Antidepressive Agents|antidepressive agents|mesh-ancestor
25014523|NCT04390945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25014525|NCT04390945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014526|NCT04390945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25014527|NCT04381364|Ciclesonide|ciclesonide|mesh-list
25014528|NCT04381364|Glucocorticoids|glucocorticoids|mesh-ancestor
25014529|NCT04381364|Hormones|hormones|mesh-ancestor
25014530|NCT04381364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25014531|NCT04381364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014532|NCT04381364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25014608|NCT04204941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25014609|NCT04204941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25014610|NCT04204941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25014611|NCT04204941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25014612|NCT04204941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25014613|NCT04204941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014614|NCT04198766|Pembrolizumab|pembrolizumab|mesh-list
25014616|NCT04198766|Immunologic Factors|immunologic factors|mesh-ancestor
25014617|NCT04198766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014618|NCT04198766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25014619|NCT04198766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25014620|NCT04198116|Guanfacine|guanfacine|mesh-list
25014621|NCT04198116|Varenicline|varenicline|mesh-list
25014622|NCT04198116|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25014623|NCT04198116|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25014624|NCT04198116|Cholinergic Agents|cholinergic agents|mesh-ancestor
25014625|NCT04198116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24928648|NCT04120350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24928649|NCT04120350|Growth Substances|growth substances|mesh-ancestor
24928650|NCT04120350|Growth Inhibitors|growth inhibitors|mesh-ancestor
24928652|NCT04120519|Dexamethasone|dexamethasone|mesh-list
24928653|NCT04120519|Cyclophosphamide|cyclophosphamide|mesh-list
24928654|NCT04120519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24928655|NCT04120519|Immunologic Factors|immunologic factors|mesh-ancestor
24650828|NCT01228214|Antipyretics|antipyretics|mesh-ancestor
25014662|NCT04067609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014663|NCT04067609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25014664|NCT04067609|Glucocorticoids|glucocorticoids|mesh-ancestor
25014665|NCT04067609|Hormones|hormones|mesh-ancestor
25014666|NCT04067609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25014667|NCT04067609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25014668|NCT04067609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24576674|NCT00839683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014674|NCT04042077|Vancomycin|vancomycin|mesh-list
25014675|NCT04042077|Tazobactam|tazobactam|mesh-list
25014676|NCT04042077|Linezolid|linezolid|mesh-list
25014677|NCT04042077|Piperacillin|piperacillin|mesh-list
25014678|NCT04042077|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25014679|NCT04042077|Tigecycline|tigecycline|mesh-list
25014680|NCT04042077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25014720|NCT04008238|Trabectedin|trabectedin|mesh-list
25014721|NCT04008238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25014722|NCT04008238|Alkylating Agents|alkylating agents|mesh-ancestor
25014723|NCT04008238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014724|NCT04008238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25014725|NCT03995017|Nivolumab|nivolumab|mesh-list
25014753|NCT03923374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687368|NCT01930890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687369|NCT01931059|Risperidone|risperidone|mesh-list
25687370|NCT01931059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25687371|NCT01931059|Serotonin Agents|serotonin agents|mesh-ancestor
25687372|NCT01931059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25687373|NCT01931059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576818|NCT00840580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25014813|NCT03814200|Antitubercular Agents|antitubercular agents|mesh-ancestor
25014814|NCT03814200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25014815|NCT03814200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25014816|NCT03814200|Leprostatic Agents|leprostatic agents|mesh-ancestor
25014817|NCT03814200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25014818|NCT03814200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25014819|NCT03814200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014820|NCT03814200|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25014821|NCT03814200|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25014822|NCT03814200|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25014823|NCT03814200|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25014824|NCT03814200|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25014825|NCT03814200|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25014826|NCT03811847|Methylphenidate|methylphenidate|mesh-list
25014827|NCT03811847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25014828|NCT03811847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256553|NCT02481609|Antiviral Agents|antiviral agents|mesh-ancestor
25256554|NCT02481609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24928662|NCT04120519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24928663|NCT04120519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24504659|NCT00537550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24504660|NCT00537550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24504661|NCT00537550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24504668|NCT00537563|Telithromycin|telithromycin|mesh-list
24527435|NCT00616681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527436|NCT00616681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24527437|NCT00616681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24527438|NCT00616694|Risedronic Acid|risedronic acid|mesh-list
24527439|NCT00616694|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25014830|NCT03811847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25014831|NCT03811847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25014832|NCT03811847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014833|NCT03811847|Dopamine Agents|dopamine agents|mesh-ancestor
25014834|NCT03811847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25014835|NCT03809624|Pembrolizumab|pembrolizumab|mesh-list
25014837|NCT03809624|Immunologic Factors|immunologic factors|mesh-ancestor
25014838|NCT03809624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014840|NCT03809624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25014859|NCT03740009|Bazedoxifene|bazedoxifene|mesh-list
25014860|NCT03740009|Estrogens|estrogens|mesh-list
25014861|NCT03740009|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25014862|NCT03740009|Hormones|hormones|mesh-ancestor
25014863|NCT03740009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25014864|NCT03740009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014865|NCT03740009|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25014866|NCT03740009|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25014867|NCT03740009|Hormone Antagonists|hormone antagonists|mesh-ancestor
25014868|NCT03740009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25014869|NCT03738852|Insulin|insulin|mesh-list
25014870|NCT03738852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25014897|NCT03674320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25014898|NCT03674320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014899|NCT03674320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25014900|NCT03674320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25014901|NCT03674320|Anabolic Agents|anabolic agents|mesh-ancestor
25014902|NCT03673007|Contraceptive Agents|contraceptive agents|mesh-list
25014903|NCT03673007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25014904|NCT03673007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014905|NCT03650894|Nivolumab|nivolumab|mesh-list
25014906|NCT03650894|Ipilimumab|ipilimumab|mesh-list
25014907|NCT03650894|Bicalutamide|bicalutamide|mesh-list
25014908|NCT03650894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25014909|NCT03650894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25014910|NCT03650894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25014911|NCT03650894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014912|NCT03650894|Androgen Antagonists|androgen antagonists|mesh-ancestor
25014913|NCT03650894|Hormone Antagonists|hormone antagonists|mesh-ancestor
25256555|NCT02481609|Expectorants|expectorants|mesh-ancestor
25256556|NCT02481609|Respiratory System Agents|respiratory system agents|mesh-ancestor
25256557|NCT02481609|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25256558|NCT02481609|Antioxidants|antioxidants|mesh-ancestor
25404152|NCT03682068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24741714|NCT05290090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741715|NCT05290090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24741716|NCT05290090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24741717|NCT05290090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24741718|NCT05290090|Growth Substances|growth substances|mesh-ancestor
24741719|NCT05290090|Growth Inhibitors|growth inhibitors|mesh-ancestor
24741720|NCT05290090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24741721|NCT05290090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24741733|NCT05292742|Capecitabine|capecitabine|mesh-list
24741734|NCT05292742|Trastuzumab|trastuzumab|mesh-list
24741735|NCT05292742|Pertuzumab|pertuzumab|mesh-list
24741736|NCT05292742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24741737|NCT05292742|Antimetabolites|antimetabolites|mesh-ancestor
24420365|NCT00215748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256559|NCT02481609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256560|NCT02481609|Protective Agents|protective agents|mesh-ancestor
25256561|NCT02481609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256562|NCT02481609|Antidotes|antidotes|mesh-ancestor
25256563|NCT02481453|Sirolimus|sirolimus|mesh-list
25256564|NCT02481453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25256565|NCT02481453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25256566|NCT02481453|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25256567|NCT02481453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256568|NCT02481453|Antifungal Agents|antifungal agents|mesh-ancestor
24527441|NCT00616694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527445|NCT00616720|Interferons|interferons|mesh-list
24527459|NCT00616746|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24527460|NCT00616746|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24527461|NCT00616746|Cholinergic Agents|cholinergic agents|mesh-ancestor
25014914|NCT03650894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25014915|NCT03650894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014916|NCT03639610|Dexamethasone|dexamethasone|mesh-list
25014917|NCT03639610|Melphalan|melphalan|mesh-list
25014918|NCT03639610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25014919|NCT03639610|Antiemetics|antiemetics|mesh-ancestor
25014920|NCT03639610|Autonomic Agents|autonomic agents|mesh-ancestor
25014921|NCT03639610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25014922|NCT03639610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014923|NCT03639610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25014925|NCT03639610|Hormones|hormones|mesh-ancestor
25014928|NCT03639610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25014929|NCT03639610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25014930|NCT03639610|Alkylating Agents|alkylating agents|mesh-ancestor
25014931|NCT03639610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014932|NCT03639610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25014933|NCT03639610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25014946|NCT03589729|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
25014948|NCT03589729|Cladribine|cladribine|mesh-list
25014949|NCT03589729|Gemtuzumab|gemtuzumab|mesh-list
25014950|NCT03589729|Dexrazoxane|dexrazoxane|mesh-list
25014951|NCT03589729|Razoxane|razoxane|mesh-list
25014952|NCT03589729|Calicheamicins|calicheamicins|mesh-list
25014953|NCT03589729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25014954|NCT03589729|Antimetabolites|antimetabolites|mesh-ancestor
25014955|NCT03589729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014956|NCT03589729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25014957|NCT03589729|Antiviral Agents|antiviral agents|mesh-ancestor
25687374|NCT01931059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687375|NCT01931059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25687376|NCT01931059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25687377|NCT01931059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25687378|NCT01931059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25687379|NCT01931059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25687380|NCT01931059|Dopamine Agents|dopamine agents|mesh-ancestor
25687381|NCT01931150|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25687382|NCT01931150|Dapsone|dapsone|mesh-list
25687383|NCT01931150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25687384|NCT01931150|Antimalarials|antimalarials|mesh-ancestor
25687385|NCT01931150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25687386|NCT01931150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25687387|NCT01931150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25687388|NCT01931150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687389|NCT01931150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618239|NCT01047423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24618240|NCT01047423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24618243|NCT01047488|Imipramine|imipramine|mesh-list
24618244|NCT01047488|Analgesics|analgesics|mesh-ancestor
24618245|NCT01047488|Sensory System Agents|sensory system agents|mesh-ancestor
24618246|NCT01047488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24618247|NCT01047488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618248|NCT01047488|Anticonvulsants|anticonvulsants|mesh-ancestor
24618249|NCT01047488|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24618250|NCT01047488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24618251|NCT01047488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618253|NCT01047488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25014958|NCT03589729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25014959|NCT03589729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25014960|NCT03589729|Immunologic Factors|immunologic factors|mesh-ancestor
25014961|NCT03589729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014962|NCT03589729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24632139|NCT01122251|Lercanidipine|lercanidipine|mesh-list
25014967|NCT03589729|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25014968|NCT03589729|Protective Agents|protective agents|mesh-ancestor
25014969|NCT03589729|Antimitotic Agents|antimitotic agents|mesh-ancestor
25014970|NCT03589729|Mitosis Modulators|mitosis modulators|mesh-ancestor
25014971|NCT03588754|Propranolol|propranolol|mesh-list
25014972|NCT03588754|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25014973|NCT03588754|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25014974|NCT03588754|Adrenergic Agents|adrenergic agents|mesh-ancestor
25014975|NCT03588754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25014976|NCT03588754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014977|NCT03588754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014978|NCT03588754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25014979|NCT03588754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25014980|NCT03588754|Vasodilator Agents|vasodilator agents|mesh-ancestor
25014981|NCT03569293|Upadacitinib|upadacitinib|mesh-list
25014982|NCT03569293|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25014983|NCT03569293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25014984|NCT03569293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25014985|NCT03569293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014986|NCT03569293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25014987|NCT03568630|Chrysarobin|chrysarobin|mesh-list
25014988|NCT03568630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25014989|NCT03568630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25014990|NCT03568630|Analgesics|analgesics|mesh-ancestor
25014991|NCT03568630|Sensory System Agents|sensory system agents|mesh-ancestor
25256594|NCT02481323|Natriuretic Agents|natriuretic agents|mesh-ancestor
24527463|NCT00616746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527464|NCT00616746|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24527465|NCT00616746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24527466|NCT00616746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24527504|NCT00616889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527505|NCT00616915|Bupropion|bupropion|mesh-list
24527506|NCT00616915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24527507|NCT00616915|Antidepressive Agents|antidepressive agents|mesh-ancestor
25014994|NCT03568630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25014995|NCT03568630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25015011|NCT03495388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25015012|NCT03495388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015014|NCT03495388|Sensory System Agents|sensory system agents|mesh-ancestor
25015015|NCT03495388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24586451|NCT00890708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24586452|NCT00890708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687390|NCT01931150|Leprostatic Agents|leprostatic agents|mesh-ancestor
25687391|NCT01931163|Everolimus|everolimus|mesh-list
25687392|NCT01931163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25687393|NCT01931163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25687394|NCT01931163|Immunologic Factors|immunologic factors|mesh-ancestor
25687395|NCT01931163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687396|NCT01931202|Citalopram|citalopram|mesh-list
25687397|NCT01931202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25687398|NCT01931202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25687399|NCT01931202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25687400|NCT01931202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687401|NCT01931202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24586453|NCT00890708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24634032|NCT01131806|Glucocorticoids|glucocorticoids|mesh-ancestor
24634033|NCT01131806|Hormones|hormones|mesh-ancestor
24634034|NCT01131806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24634035|NCT01131806|Sympathomimetics|sympathomimetics|mesh-ancestor
24634036|NCT01131845|Treprostinil|treprostinil|mesh-list
24634037|NCT01131845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24586455|NCT00890708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24586456|NCT00890708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586458|NCT00890747|Sunitinib|sunitinib|mesh-list
24586459|NCT00890747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586460|NCT00890747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24586461|NCT00890747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24586462|NCT00890747|Growth Substances|growth substances|mesh-ancestor
24586463|NCT00890747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586464|NCT00890747|Growth Inhibitors|growth inhibitors|mesh-ancestor
24586465|NCT00890747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24586466|NCT00890747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24586467|NCT00890747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586468|NCT00890786|Bevacizumab|bevacizumab|mesh-list
24586469|NCT00890786|Irinotecan|irinotecan|mesh-list
24586470|NCT00890786|Temozolomide|temozolomide|mesh-list
24586471|NCT00890786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24586472|NCT00890786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586517|NCT00891072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586518|NCT00891072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24586519|NCT00891072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24586520|NCT00891072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24586521|NCT00891072|Immunologic Factors|immunologic factors|mesh-ancestor
24586522|NCT00891072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586523|NCT00891072|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24586524|NCT00891072|Protective Agents|protective agents|mesh-ancestor
25256576|NCT02481323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25256577|NCT02481323|Autonomic Agents|autonomic agents|mesh-ancestor
25256578|NCT02481323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25256580|NCT02481323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25256581|NCT02481323|Respiratory System Agents|respiratory system agents|mesh-ancestor
25256582|NCT02481323|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25256583|NCT02481323|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25256584|NCT02481323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256585|NCT02481323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24527508|NCT00616915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24527509|NCT00616915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24527510|NCT00616915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24928664|NCT04120519|Antiemetics|antiemetics|mesh-ancestor
24928665|NCT04120519|Autonomic Agents|autonomic agents|mesh-ancestor
24928666|NCT04120519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24928667|NCT04120519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24928668|NCT04120519|Glucocorticoids|glucocorticoids|mesh-ancestor
24928669|NCT04120519|Hormones|hormones|mesh-ancestor
24928670|NCT04120519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24928671|NCT04120519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24928672|NCT04120519|Leprostatic Agents|leprostatic agents|mesh-ancestor
24928673|NCT04120519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24928674|NCT04120519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24928675|NCT04120519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24586525|NCT00891072|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24586526|NCT00891072|Contraceptive Agents|contraceptive agents|mesh-ancestor
25015085|NCT03221309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25015086|NCT03205761|Olaparib|olaparib|mesh-list
25015087|NCT03205761|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25015088|NCT03205761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25015089|NCT03205761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015153|NCT03059446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25015154|NCT03059446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25015155|NCT03059446|Antiviral Agents|antiviral agents|mesh-ancestor
25015156|NCT03059446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25015158|NCT03051282|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25015159|NCT03051282|Protease Inhibitors|protease inhibitors|mesh-ancestor
25015160|NCT03051282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404153|NCT03681691|Estradiol|estradiol|mesh-list
25687402|NCT01931202|Serotonin Agents|serotonin agents|mesh-ancestor
24742019|NCT05294393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24742027|NCT05294055|Cyclophosphamide|cyclophosphamide|mesh-list
24742028|NCT05294055|Etoposide|etoposide|mesh-list
24742029|NCT05294055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24742030|NCT05294055|Immunologic Factors|immunologic factors|mesh-ancestor
24742031|NCT05294055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742032|NCT05294055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24742034|NCT05294055|Alkylating Agents|alkylating agents|mesh-ancestor
25015161|NCT03051282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015162|NCT03051282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25015163|NCT03039673|Interleukin-2|interleukin-2|mesh-list
25015164|NCT03039673|Riluzole|riluzole|mesh-list
24895990|NCT02677181|Mycophenolic Acid|mycophenolic acid|mesh-list
25015203|NCT02962102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015204|NCT02962102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25015205|NCT02962102|Vitamins|vitamins|mesh-ancestor
25015206|NCT02962102|Micronutrients|micronutrients|mesh-ancestor
25015207|NCT02962102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25015208|NCT02950259|Indomethacin|indomethacin|mesh-list
25015211|NCT02950259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25015212|NCT02950259|Immunologic Factors|immunologic factors|mesh-ancestor
25015213|NCT02950259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015214|NCT02950259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25015215|NCT02950259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25015216|NCT02950259|Alkylating Agents|alkylating agents|mesh-ancestor
25015217|NCT02950259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015218|NCT02950259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015219|NCT02950259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25015220|NCT02950259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25015221|NCT02950259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25015222|NCT02950259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25015232|NCT02950259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25015233|NCT02950259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25015234|NCT02947750|Folic Acid|folic acid|mesh-list
25015235|NCT02947750|Hematinics|hematinics|mesh-ancestor
25256586|NCT02481323|Vasodilator Agents|vasodilator agents|mesh-ancestor
25256587|NCT02481323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25256588|NCT02481323|Protective Agents|protective agents|mesh-ancestor
25256589|NCT02481323|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25256590|NCT02481323|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25256591|NCT02481323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256592|NCT02481323|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25256593|NCT02481323|Diuretics|diuretics|mesh-ancestor
24928684|NCT04120337|Sensory System Agents|sensory system agents|mesh-ancestor
24928685|NCT04120337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24504678|NCT00537602|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25015236|NCT02947750|Vitamin B Complex|vitamin b complex|mesh-ancestor
25015238|NCT02947750|Micronutrients|micronutrients|mesh-ancestor
24971836|NCT03722173|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24971837|NCT03722173|Hormone Antagonists|hormone antagonists|mesh-ancestor
24971841|NCT03721991|Butyric Acid|butyric acid|mesh-list
25015259|NCT02818517|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25015260|NCT02818517|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25015261|NCT02818517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25015262|NCT02818517|Adrenergic Agents|adrenergic agents|mesh-ancestor
24411841|NCT00190229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411842|NCT00190229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25015263|NCT02818517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25015264|NCT02818517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015265|NCT02818517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015266|NCT02818517|Protease Inhibitors|protease inhibitors|mesh-ancestor
25015267|NCT02818517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25015268|NCT02812524|Ipilimumab|ipilimumab|mesh-list
25015269|NCT02812524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25015270|NCT02812524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015271|NCT02812524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25015272|NCT02812524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687403|NCT01931202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687404|NCT01931202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25687405|NCT01931202|Antidepressive Agents|antidepressive agents|mesh-ancestor
25687406|NCT01931202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25687407|NCT01931475|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25687408|NCT01931475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25687409|NCT01931475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24742284|NCT05288062|Pomalidomide|pomalidomide|mesh-list
24742285|NCT05288062|Ichthammol|ichthammol|mesh-list
24742286|NCT05288062|BB 1101|bb 1101|mesh-list
24742287|NCT05288062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24742288|NCT05288062|Antiemetics|antiemetics|mesh-ancestor
24742289|NCT05288062|Autonomic Agents|autonomic agents|mesh-ancestor
24742290|NCT05288062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24742291|NCT05288062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742365|NCT05273242|Antimalarials|antimalarials|mesh-ancestor
24742366|NCT05273242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25015273|NCT02777424|Thrombin|thrombin|mesh-list
25015274|NCT02777424|Hemostatics|hemostatics|mesh-ancestor
25015275|NCT02777424|Coagulants|coagulants|mesh-ancestor
25015287|NCT02734290|Tubulin Modulators|tubulin modulators|mesh-ancestor
25015288|NCT02734290|Antimitotic Agents|antimitotic agents|mesh-ancestor
25015289|NCT02734290|Mitosis Modulators|mitosis modulators|mesh-ancestor
25015290|NCT02734290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015291|NCT02734290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25015292|NCT02734290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25015293|NCT02734290|Antimetabolites|antimetabolites|mesh-ancestor
25110699|NCT05397600|Bimatoprost|bimatoprost|mesh-list
25110700|NCT05397600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25110701|NCT05395507|Interferons|interferons|mesh-list
25110702|NCT05395507|Interferon-alpha|interferon-alpha|mesh-list
25256596|NCT02481479|Saxagliptin|saxagliptin|mesh-list
25256597|NCT02481479|Incretins|incretins|mesh-ancestor
25256598|NCT02481479|Hormones|hormones|mesh-ancestor
25256637|NCT02481076|Coccidiostats|coccidiostats|mesh-ancestor
24527512|NCT00616915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527513|NCT00616915|Dopamine Agents|dopamine agents|mesh-ancestor
24896013|NCT02640664|Ranibizumab|ranibizumab|mesh-list
25015294|NCT02630368|Cyclophosphamide|cyclophosphamide|mesh-list
25015295|NCT02630368|Avelumab|avelumab|mesh-list
25015333|NCT02581085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015334|NCT02581085|Protective Agents|protective agents|mesh-ancestor
25015351|NCT02538666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25015353|NCT02538666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25015401|NCT02476058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25015402|NCT02476058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015403|NCT02476058|Anesthetics, Local|anesthetics, local|mesh-ancestor
25015404|NCT02476058|Anesthetics|anesthetics|mesh-ancestor
25015405|NCT02476058|Sensory System Agents|sensory system agents|mesh-ancestor
25015407|NCT02476058|Antiemetics|antiemetics|mesh-ancestor
25015436|NCT02392637|Gemcitabine|gemcitabine|mesh-list
25015437|NCT02392637|Paclitaxel|paclitaxel|mesh-list
25015438|NCT02392637|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25015439|NCT02392637|Cisplatin|cisplatin|mesh-list
25015440|NCT02392637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25015441|NCT02392637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015442|NCT02392637|Tubulin Modulators|tubulin modulators|mesh-ancestor
25015443|NCT02392637|Antimitotic Agents|antimitotic agents|mesh-ancestor
25015444|NCT02392637|Mitosis Modulators|mitosis modulators|mesh-ancestor
25110758|NCT05373225|Retinol acetate|retinol acetate|mesh-list
25015445|NCT02392637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015446|NCT02392637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25015448|NCT02392637|Antiviral Agents|antiviral agents|mesh-ancestor
25015449|NCT02392637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25015450|NCT02392637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25015454|NCT02372630|Linagliptin|linagliptin|mesh-list
25015489|NCT02245230|Oxymetazoline|oxymetazoline|mesh-list
25015490|NCT02245230|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
25015491|NCT02245230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25015492|NCT02245230|Mydriatics|mydriatics|mesh-ancestor
25015493|NCT02245230|Autonomic Agents|autonomic agents|mesh-ancestor
25015494|NCT02245230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25015495|NCT02245230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015496|NCT02245230|Sympathomimetics|sympathomimetics|mesh-ancestor
25687410|NCT01931475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25687411|NCT01931475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687412|NCT01931475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25687413|NCT01931475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687414|NCT01931475|Analgesics|analgesics|mesh-ancestor
25687415|NCT01931475|Sensory System Agents|sensory system agents|mesh-ancestor
25687416|NCT01931475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25687417|NCT01931475|Antidepressive Agents|antidepressive agents|mesh-ancestor
25015497|NCT02245230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25015498|NCT02245230|Nasal Decongestants|nasal decongestants|mesh-ancestor
24618367|NCT01048034|Antimetabolites|antimetabolites|mesh-ancestor
24618368|NCT01048034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618369|NCT01048034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618370|NCT01048034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618372|NCT01048047|Amlodipine|amlodipine|mesh-list
24618373|NCT01048047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24618374|NCT01048047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24618375|NCT01048047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24742707|NCT05192629|GABA Agents|gaba agents|mesh-ancestor
25015506|NCT02245230|Protective Agents|protective agents|mesh-ancestor
25015507|NCT02245230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25015508|NCT02245230|Vasodilator Agents|vasodilator agents|mesh-ancestor
25015509|NCT02245230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25015510|NCT02245230|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
25015511|NCT02245230|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25256607|NCT02481193|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25256608|NCT02481193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25256609|NCT02481193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25256610|NCT02481193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527557|NCT00617370|Immunologic Factors|immunologic factors|mesh-ancestor
24527558|NCT00617370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527559|NCT00617370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24411949|NCT00190502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527560|NCT00617370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24527561|NCT00617370|Alkylating Agents|alkylating agents|mesh-ancestor
24527574|NCT00617500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527575|NCT00617513|Prucalopride|prucalopride|mesh-list
24527576|NCT00617513|Laxatives|laxatives|mesh-ancestor
24527577|NCT00617513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24928686|NCT04120337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25049620|NCT00580125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25049621|NCT00580125|Serotonin Agents|serotonin agents|mesh-ancestor
25015517|NCT02164643|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24972131|NCT03720041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24972132|NCT03720041|Protease Inhibitors|protease inhibitors|mesh-ancestor
24972133|NCT03720041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972134|NCT03720041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972135|NCT03720041|Immunologic Factors|immunologic factors|mesh-ancestor
24972136|NCT03720041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24972137|NCT03720041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24972138|NCT03720041|Growth Substances|growth substances|mesh-ancestor
24972139|NCT03720041|Growth Inhibitors|growth inhibitors|mesh-ancestor
24972140|NCT03720041|Glycine Agents|glycine agents|mesh-ancestor
24972141|NCT03720041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24586563|NCT00891306|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24586564|NCT00891306|Cyclosporins|cyclosporins|mesh-list
24586565|NCT00891306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24586566|NCT00891306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586567|NCT00891306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24586568|NCT00891306|Immunologic Factors|immunologic factors|mesh-ancestor
24586569|NCT00891306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586570|NCT00891306|Antifungal Agents|antifungal agents|mesh-ancestor
24586571|NCT00891306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24586572|NCT00891306|Dermatologic Agents|dermatologic agents|mesh-ancestor
24586579|NCT00891306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24586580|NCT00891306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25015536|NCT02123823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015537|NCT02123823|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25015538|NCT02123823|Hormone Antagonists|hormone antagonists|mesh-ancestor
25015539|NCT02123823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25256611|NCT02481180|T0001|t0001|mesh-list
25404154|NCT03681691|Estrogens|estrogens|mesh-ancestor
25687418|NCT01931475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25687419|NCT01931475|Dopamine Agents|dopamine agents|mesh-ancestor
25687420|NCT01931527|Rasburicase|rasburicase|mesh-list
25687421|NCT01931527|Gout Suppressants|gout suppressants|mesh-ancestor
25687422|NCT01931527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25687423|NCT01931566|Pioglitazone|pioglitazone|mesh-list
25687424|NCT01931566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25687425|NCT01931566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687426|NCT01931839|Ivacaftor|ivacaftor|mesh-list
25687427|NCT01931839|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24522769|NCT03145766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522770|NCT03127592|Etodolac|etodolac|mesh-list
24522771|NCT03127592|Cyclobenzaprine|cyclobenzaprine|mesh-list
24618401|NCT01048177|Anesthetics|anesthetics|mesh-ancestor
24618402|NCT01048177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24407706|NCT00175123|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24407707|NCT00175123|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24407708|NCT00175123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25256612|NCT02481180|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
25256613|NCT02481180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256614|NCT02481180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25256615|NCT02481180|Immunologic Factors|immunologic factors|mesh-ancestor
25256616|NCT02480946|Methotrexate|methotrexate|mesh-list
25256617|NCT02480946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25256618|NCT02480946|Abortifacient Agents|abortifacient agents|mesh-ancestor
25256619|NCT02480946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25256620|NCT02480946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256621|NCT02480946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25256622|NCT02480946|Antimetabolites|antimetabolites|mesh-ancestor
25256638|NCT02481076|Proton Ionophores|proton ionophores|mesh-ancestor
24928689|NCT04120337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24928690|NCT04120337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928692|NCT04119921|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24624678|NCT01077648|Lapatinib|lapatinib|mesh-list
24624679|NCT01077648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24624680|NCT01077648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624681|NCT01077648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24624682|NCT01077648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24624683|NCT01077648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624684|NCT01077661|Nebivolol|nebivolol|mesh-list
25049635|NCT00579020|Moxifloxacin|moxifloxacin|mesh-list
25015549|NCT01774721|Gefitinib|gefitinib|mesh-list
25015550|NCT01774721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015551|NCT01774721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25015552|NCT01774721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25015553|NCT01774721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015554|NCT01747447|Vitamin D|vitamin d|mesh-list
25015555|NCT01747447|Ergocalciferols|ergocalciferols|mesh-list
25015556|NCT01747447|Cholecalciferol|cholecalciferol|mesh-list
25015557|NCT01747447|Vitamins|vitamins|mesh-list
25015558|NCT01747447|Micronutrients|micronutrients|mesh-ancestor
25015559|NCT01747447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015560|NCT01747447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25015592|NCT01599494|Ganirelix|ganirelix|mesh-list
25015593|NCT01599494|Progestins|progestins|mesh-ancestor
25015594|NCT01599494|Hormones|hormones|mesh-ancestor
25015595|NCT01599494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015596|NCT01599494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015597|NCT01599494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25015598|NCT01599494|Hormone Antagonists|hormone antagonists|mesh-ancestor
25015599|NCT01518517|Asparaginase|asparaginase|mesh-list
25015600|NCT01518517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412185|NCT00190918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25015601|NCT01496118|Panobinostat|panobinostat|mesh-list
25015602|NCT01496118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015603|NCT01496118|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25015604|NCT01496118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25015605|NCT01496118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015606|NCT01415674|Afatinib|afatinib|mesh-list
25015631|NCT01304511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015633|NCT01286207|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25015634|NCT01286207|Serotonin Agents|serotonin agents|mesh-ancestor
25015635|NCT01286207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25015636|NCT01286207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015637|NCT01286207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015643|NCT01227187|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
25687428|NCT01931839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25687429|NCT01931839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692608|NCT02002832|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25692609|NCT02002884|Botulinum Toxins|botulinum toxins|mesh-list
25692610|NCT02002884|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25692611|NCT02002884|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25692612|NCT02002884|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25015644|NCT01227187|Protein C|protein c|mesh-list
25015645|NCT01227187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24743341|NCT04871425|Sensory System Agents|sensory system agents|mesh-ancestor
24652056|NCT01235455|Interferon beta-1b|interferon beta-1b|mesh-list
25015646|NCT01227187|Anticoagulants|anticoagulants|mesh-ancestor
25256631|NCT02480946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25256632|NCT02481076|Monensin|monensin|mesh-list
25256633|NCT02481076|Antifungal Agents|antifungal agents|mesh-ancestor
25256634|NCT02481076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25256635|NCT02481076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25256636|NCT02481076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25256642|NCT02481076|Ionophores|ionophores|mesh-ancestor
25256643|NCT02481076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25256644|NCT02481076|Sodium Ionophores|sodium ionophores|mesh-ancestor
25256645|NCT02480894|Maraviroc|maraviroc|mesh-list
24624685|NCT01077661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24624686|NCT01077661|Vasodilator Agents|vasodilator agents|mesh-ancestor
24624687|NCT01077661|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24624688|NCT01077661|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24624689|NCT01077661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24624690|NCT01077661|Adrenergic Agents|adrenergic agents|mesh-ancestor
24624691|NCT01077661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24624692|NCT01077661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624693|NCT01077661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629797|NCT01107951|Antiemetics|antiemetics|mesh-ancestor
24504700|NCT00537862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24504701|NCT00537862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504702|NCT00537862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015647|NCT01227187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25015648|NCT01227187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25015649|NCT01227187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015682|NCT01056159|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25015683|NCT01056159|Respiratory System Agents|respiratory system agents|mesh-ancestor
25015684|NCT01056159|Tocolytic Agents|tocolytic agents|mesh-ancestor
25015685|NCT01056159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25015686|NCT01056159|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25015687|NCT01056159|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25015688|NCT01056159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25015689|NCT01056159|Adrenergic Agents|adrenergic agents|mesh-ancestor
25015690|NCT01056159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25110759|NCT05373225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24972258|NCT03719261|Eusol|eusol|mesh-list
25015691|NCT01056159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015692|NCT00988260|Ganirelix|ganirelix|mesh-list
25015693|NCT00988260|Hormone Antagonists|hormone antagonists|mesh-ancestor
25015694|NCT00988260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015695|NCT00988260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110791|NCT05360576|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25110792|NCT05360576|Contraceptive Agents|contraceptive agents|mesh-ancestor
25110793|NCT05360576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25110794|NCT05360576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25110795|NCT05360576|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25110796|NCT05360576|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25015717|NCT00972738|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25015718|NCT00972738|Hormone Antagonists|hormone antagonists|mesh-ancestor
25015719|NCT00972738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015720|NCT00972738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015721|NCT00972738|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25015722|NCT00972738|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25015723|NCT00972738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015724|NCT00972738|Antipruritics|antipruritics|mesh-ancestor
25015725|NCT00972738|Dermatologic Agents|dermatologic agents|mesh-ancestor
25015726|NCT00972738|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25015727|NCT00972738|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25015728|NCT00972738|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25015729|NCT00972738|Histamine Antagonists|histamine antagonists|mesh-ancestor
25015730|NCT00972738|Histamine Agents|histamine agents|mesh-ancestor
25256646|NCT02480894|Fostemsavir|fostemsavir|mesh-list
25256647|NCT02480894|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25256648|NCT02480894|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25256649|NCT02480894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256650|NCT02480894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25687430|NCT01931865|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25687431|NCT01931865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25687432|NCT01931865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25687433|NCT01931865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687434|NCT01931865|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25687435|NCT01931865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25687436|NCT01931865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618479|NCT01048515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25256651|NCT02480894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25256652|NCT02480894|Antiviral Agents|antiviral agents|mesh-ancestor
25256653|NCT02480894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25256654|NCT02480894|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25256655|NCT02480881|Fostemsavir|fostemsavir|mesh-list
25256656|NCT02480881|Contraceptive Agents|contraceptive agents|mesh-list
25256657|NCT02480881|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
25256658|NCT02480881|Contraceptives, Oral|contraceptives, oral|mesh-list
24504703|NCT00537888|Fluconazole|fluconazole|mesh-list
24504704|NCT00537888|Antifungal Agents|antifungal agents|mesh-ancestor
24504705|NCT00537888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24527578|NCT00617513|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24527579|NCT00617513|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24527580|NCT00617513|Serotonin Agents|serotonin agents|mesh-ancestor
24527581|NCT00617513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24527582|NCT00617513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527583|NCT00617513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527584|NCT00617565|Insulin|insulin|mesh-list
24527585|NCT00617565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24527586|NCT00617565|Insulin Aspart|insulin aspart|mesh-list
24527587|NCT00617565|Biphasic Insulins|biphasic insulins|mesh-list
24629871|NCT01108393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24928694|NCT04119921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24928695|NCT04119921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24928696|NCT04119921|Analgesics|analgesics|mesh-ancestor
24928697|NCT04119921|Sensory System Agents|sensory system agents|mesh-ancestor
24928698|NCT04119921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24928699|NCT04119921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928700|NCT04119921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24928701|NCT04119921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24928702|NCT04119921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24504731|NCT00537966|Ritonavir|ritonavir|mesh-list
24527588|NCT00617565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24527589|NCT00617565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015731|NCT00972738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25015732|NCT00968201|Montelukast|montelukast|mesh-list
25015733|NCT00968201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25015734|NCT00968201|Respiratory System Agents|respiratory system agents|mesh-ancestor
25015735|NCT00968201|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25015736|NCT00968201|Hormone Antagonists|hormone antagonists|mesh-ancestor
25015737|NCT00968201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015738|NCT00968201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015739|NCT00968201|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25015740|NCT00968201|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25015741|NCT00968201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015742|NCT00968149|Montelukast|montelukast|mesh-list
25015743|NCT00968149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25015761|NCT00963469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25015762|NCT00963469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015763|NCT00963469|Antipruritics|antipruritics|mesh-ancestor
25015764|NCT00963469|Dermatologic Agents|dermatologic agents|mesh-ancestor
25015765|NCT00963469|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25015766|NCT00963469|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25687437|NCT01931865|Cholinergic Agents|cholinergic agents|mesh-ancestor
25687438|NCT01931865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25687439|NCT01931878|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25687440|NCT01931878|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25687441|NCT01931878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25687442|NCT01931878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448721|NCT00312806|Pantoprazole|pantoprazole|mesh-list
25015767|NCT00963469|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25015768|NCT00963469|Histamine Antagonists|histamine antagonists|mesh-ancestor
25256659|NCT02480881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25256660|NCT02480881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256661|NCT02480881|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25256662|NCT02480881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25256663|NCT02480881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25256664|NCT02480881|Antiviral Agents|antiviral agents|mesh-ancestor
25256665|NCT02480881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25256666|NCT02480881|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25256667|NCT02480881|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25256668|NCT02480881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256669|NCT02480881|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25256670|NCT02480881|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25256671|NCT02480881|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25256672|NCT02480881|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
25256673|NCT02480881|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25256674|NCT02480647|Levonorgestrel|levonorgestrel|mesh-list
25256675|NCT02480647|Etonogestrel|etonogestrel|mesh-list
25256676|NCT02480647|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25256677|NCT02480647|Contraceptive Agents|contraceptive agents|mesh-ancestor
25256678|NCT02480647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25256679|NCT02480647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256680|NCT02480647|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25256681|NCT02480647|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25256682|NCT02480647|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24527590|NCT00617643|Nevirapine|nevirapine|mesh-list
24527591|NCT00617643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24527592|NCT00617643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24527593|NCT00617643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527594|NCT00617643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527595|NCT00617643|Antiviral Agents|antiviral agents|mesh-ancestor
24527596|NCT00617643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24527597|NCT00617643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24527598|NCT00617643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24527601|NCT00617656|Gemcitabine|gemcitabine|mesh-list
24527616|NCT00617656|Mitosis Modulators|mitosis modulators|mesh-ancestor
24527617|NCT00617695|Zolmitriptan|zolmitriptan|mesh-list
24527618|NCT00617695|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24527619|NCT00617695|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24527620|NCT00617695|Serotonin Agents|serotonin agents|mesh-ancestor
24527621|NCT00617695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24527622|NCT00617695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798908|NCT01966133|Ethiodized Oil|ethiodized oil|mesh-list
25015769|NCT00963469|Histamine Agents|histamine agents|mesh-ancestor
24972396|NCT03718377|Anesthetics|anesthetics|mesh-list
25015830|NCT00898677|Sumatriptan|sumatriptan|mesh-list
25015831|NCT00898677|Rizatriptan|rizatriptan|mesh-list
25015832|NCT00898677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25015833|NCT00898677|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25015834|NCT00898677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25015835|NCT00898677|Serotonin Agents|serotonin agents|mesh-ancestor
25015836|NCT00898677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25015837|NCT00898677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015838|NCT00898677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015839|NCT00897949|Rizatriptan|rizatriptan|mesh-list
25015840|NCT00897949|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25015841|NCT00897949|Serotonin Agents|serotonin agents|mesh-ancestor
25015842|NCT00897949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25015843|NCT00897949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015844|NCT00897949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015845|NCT00897104|Sumatriptan|sumatriptan|mesh-list
25015846|NCT00897104|Rizatriptan|rizatriptan|mesh-list
25015847|NCT00897104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25015848|NCT00897104|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25015901|NCT00725374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015902|NCT00725374|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25015913|NCT00711607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015915|NCT00703014|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25015916|NCT00703014|Ganirelix|ganirelix|mesh-list
25015917|NCT00703014|Progestins|progestins|mesh-ancestor
25015918|NCT00703014|Hormones|hormones|mesh-ancestor
25404155|NCT03681691|Hormones|hormones|mesh-ancestor
24744086|NCT04516317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24744087|NCT04516317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24744088|NCT04516317|Antiviral Agents|antiviral agents|mesh-ancestor
24744089|NCT04516317|Schistosomicides|schistosomicides|mesh-ancestor
24744090|NCT04516317|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24744091|NCT04516317|Anthelmintics|anthelmintics|mesh-ancestor
24744092|NCT04516317|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24444208|NCT00296959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24744093|NCT04516317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744094|NCT04516317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24744095|NCT04516317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24744096|NCT04516317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24744097|NCT04516317|Analgesics|analgesics|mesh-ancestor
24744098|NCT04516317|Sensory System Agents|sensory system agents|mesh-ancestor
25015919|NCT00703014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015920|NCT00703014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015921|NCT00703014|Hormone Antagonists|hormone antagonists|mesh-ancestor
25015922|NCT00702988|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25015923|NCT00702988|Hormones|hormones|mesh-ancestor
24515583|NCT00598247|Paclitaxel|paclitaxel|mesh-list
25015944|NCT00702624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25091892|NCT03246399|Lorecivivint|lorecivivint|mesh-list
25256683|NCT02480608|Imatinib Mesylate|imatinib mesylate|mesh-list
25256684|NCT02480608|Hydroxyurea|hydroxyurea|mesh-list
25256685|NCT02480608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256686|NCT02480608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25256687|NCT02480608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256688|NCT02480608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256689|NCT02480608|Antisickling Agents|antisickling agents|mesh-ancestor
25256690|NCT02480608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25256691|NCT02480543|Misoprostol|misoprostol|mesh-list
25256692|NCT02480543|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25256693|NCT02480543|Abortifacient Agents|abortifacient agents|mesh-ancestor
25256694|NCT02480543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25256695|NCT02480543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256696|NCT02480543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25256697|NCT02480543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25256698|NCT02480543|Oxytocics|oxytocics|mesh-ancestor
25256702|NCT02480634|Zoledronic Acid|zoledronic acid|mesh-list
24527623|NCT00617695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651710|NCT01233505|Capecitabine|capecitabine|mesh-list
25015945|NCT00702624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015946|NCT00702624|Progestins|progestins|mesh-ancestor
25015948|NCT00702546|Hormones|hormones|mesh-list
25015952|NCT00702546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015953|NCT00702546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015954|NCT00702546|Progestins|progestins|mesh-ancestor
25015955|NCT00702546|Hormone Antagonists|hormone antagonists|mesh-ancestor
25015956|NCT00702520|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25015958|NCT00702520|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25015959|NCT00702520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015960|NCT00702520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015961|NCT00702520|Luteolytic Agents|luteolytic agents|mesh-ancestor
25015962|NCT00702520|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25015963|NCT00702520|Contraceptive Agents|contraceptive agents|mesh-ancestor
25015964|NCT00702520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25015965|NCT00702520|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25015966|NCT00702520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25016008|NCT00647933|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25016009|NCT00647933|Lynestrenol|lynestrenol|mesh-list
25687443|NCT01931878|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25687444|NCT01931878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25687445|NCT01931878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687446|NCT01931878|Cholinergic Agents|cholinergic agents|mesh-ancestor
25687447|NCT01931878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25687448|NCT01932060|Oxytocin|oxytocin|mesh-list
25687449|NCT01932060|Oxytocics|oxytocics|mesh-ancestor
25687450|NCT01932060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25687451|NCT01932060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687452|NCT01932112|Adenosine|adenosine|mesh-list
25687453|NCT01932112|Analgesics|analgesics|mesh-ancestor
25687454|NCT01932112|Sensory System Agents|sensory system agents|mesh-ancestor
25687455|NCT01932112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25687456|NCT01932112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744191|NCT04464577|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24744192|NCT04464577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24744193|NCT04464577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24744194|NCT04464577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744195|NCT04464577|Dopamine Agents|dopamine agents|mesh-ancestor
24652930|NCT01240941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24744197|NCT04464577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744209|NCT04464577|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24744213|NCT04430855|Upadacitinib|upadacitinib|mesh-list
24744214|NCT04430855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
24744215|NCT04430855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24744216|NCT04430855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24744217|NCT04430855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744218|NCT04430855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24744219|NCT04430517|Niacinamide|niacinamide|mesh-list
24744220|NCT04430517|Niacin|niacin|mesh-list
24744221|NCT04430517|Nicotinic Acids|nicotinic acids|mesh-list
25016010|NCT00647933|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25016011|NCT00647933|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25016012|NCT00647933|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25016013|NCT00647933|Contraceptive Agents|contraceptive agents|mesh-ancestor
25016014|NCT00647933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25016015|NCT00647933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016016|NCT00647933|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25016017|NCT00647933|Estrogens|estrogens|mesh-ancestor
25016019|NCT00647933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25016020|NCT00647933|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25016031|NCT00616967|Carboplatin|carboplatin|mesh-list
25016032|NCT00616967|Vorinostat|vorinostat|mesh-list
25016033|NCT00616967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25016034|NCT00616967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25016035|NCT00616967|Tubulin Modulators|tubulin modulators|mesh-ancestor
25016036|NCT00616967|Antimitotic Agents|antimitotic agents|mesh-ancestor
25016049|NCT00519857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016050|NCT00519857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25016051|NCT00519857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25016052|NCT00519857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25016053|NCT00519857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25016055|NCT00519857|Hormones|hormones|mesh-ancestor
25016056|NCT00480662|Alendronate|alendronate|mesh-list
25016057|NCT00480662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24412393|NCT00191373|Gemcitabine|gemcitabine|mesh-list
25016058|NCT00480662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016059|NCT00461032|Montelukast|montelukast|mesh-list
25016060|NCT00461032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25016061|NCT00461032|Respiratory System Agents|respiratory system agents|mesh-ancestor
25016062|NCT00461032|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25016063|NCT00461032|Hormone Antagonists|hormone antagonists|mesh-ancestor
25016064|NCT00461032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25016065|NCT00461032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016066|NCT00461032|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25016067|NCT00461032|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25016068|NCT00461032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016069|NCT00446056|Ketotifen|ketotifen|mesh-list
25016070|NCT00446056|Montelukast|montelukast|mesh-list
25687457|NCT01932112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25687458|NCT01932112|Vasodilator Agents|vasodilator agents|mesh-ancestor
25687459|NCT01932112|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25687460|NCT01932112|Purinergic Agonists|purinergic agonists|mesh-ancestor
25687461|NCT01932112|Purinergic Agents|purinergic agents|mesh-ancestor
25687462|NCT01932112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25687463|NCT01932112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687464|NCT01932697|Docetaxel|docetaxel|mesh-list
25687465|NCT01932697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25687466|NCT01932697|Tubulin Modulators|tubulin modulators|mesh-ancestor
25687467|NCT01932697|Antimitotic Agents|antimitotic agents|mesh-ancestor
25687468|NCT01932697|Mitosis Modulators|mitosis modulators|mesh-ancestor
25687469|NCT01932697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687470|NCT01932762|Ribavirin|ribavirin|mesh-list
25687471|NCT01932762|Grazoprevir|grazoprevir|mesh-list
25687472|NCT01932762|Antimetabolites|antimetabolites|mesh-ancestor
25687473|NCT01932762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687474|NCT01932762|Antiviral Agents|antiviral agents|mesh-ancestor
24744341|NCT04348864|Immunologic Factors|immunologic factors|mesh-ancestor
24744342|NCT04348864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744343|NCT04344262|Atracurium|atracurium|mesh-list
24653064|NCT01241773|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24744344|NCT04344262|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24744362|NCT04321993|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
24744363|NCT04321993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24744364|NCT04321993|Antimetabolites|antimetabolites|mesh-ancestor
24744368|NCT04310150|Hemostatics|hemostatics|mesh-list
25016071|NCT00446056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25016072|NCT00446056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016073|NCT00446056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016074|NCT00446056|Respiratory System Agents|respiratory system agents|mesh-ancestor
25016075|NCT00446056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25016092|NCT00442338|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25016093|NCT00442338|Hormone Antagonists|hormone antagonists|mesh-ancestor
25256703|NCT02480634|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25256704|NCT02480634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256705|NCT02480751|Beraprost|beraprost|mesh-list
24527627|NCT00617747|Serotonin Agents|serotonin agents|mesh-ancestor
24527628|NCT00617747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24527629|NCT00617747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527630|NCT00617747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527632|NCT00617760|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24928703|NCT04119921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24928704|NCT04119921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928705|NCT04119921|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24928706|NCT04119921|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24928707|NCT04120064|Cholecalciferol|cholecalciferol|mesh-list
24928708|NCT04120064|Vitamin D|vitamin d|mesh-list
24928709|NCT04120064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24928710|NCT04120064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016094|NCT00442338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25016095|NCT00442338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016096|NCT00442338|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25016097|NCT00442338|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25016098|NCT00442338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016099|NCT00442338|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25016100|NCT00442338|Autonomic Agents|autonomic agents|mesh-ancestor
25016153|NCT00394069|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25016154|NCT00394069|Hormone Antagonists|hormone antagonists|mesh-ancestor
25016155|NCT00394069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25016156|NCT00394069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016157|NCT00394069|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25016158|NCT00394069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25016159|NCT00394069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016160|NCT00389740|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25016161|NCT00389740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016162|NCT00389740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24972714|NCT03715556|Amiodarone|amiodarone|mesh-list
24896175|NCT01515748|Oxaliplatin|oxaliplatin|mesh-list
25016216|NCT00140946|Respiratory System Agents|respiratory system agents|mesh-ancestor
25016217|NCT00140946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25016218|NCT00140946|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25016219|NCT00140946|Hormone Antagonists|hormone antagonists|mesh-ancestor
25016220|NCT00140946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25016221|NCT00140946|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25016223|NCT00140881|Montelukast|montelukast|mesh-list
25016259|NCT00092885|Respiratory System Agents|respiratory system agents|mesh-ancestor
25016261|NCT00092885|Hormone Antagonists|hormone antagonists|mesh-ancestor
25687475|NCT01932762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25687476|NCT01932788|Vitamin D|vitamin d|mesh-list
25687477|NCT01932788|Cholecalciferol|cholecalciferol|mesh-list
25687478|NCT01932788|Vitamins|vitamins|mesh-list
25687479|NCT01932788|Micronutrients|micronutrients|mesh-ancestor
25687480|NCT01932788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687481|NCT01932788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25687482|NCT01932788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25687483|NCT01932996|Nicotine|nicotine|mesh-list
25687484|NCT01932996|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24744485|NCT04264637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24744486|NCT04264637|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24744487|NCT04264637|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24744488|NCT04264637|Histamine Antagonists|histamine antagonists|mesh-ancestor
24744489|NCT04264637|Histamine Agents|histamine agents|mesh-ancestor
24744490|NCT04264637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24744491|NCT04262687|Bevacizumab|bevacizumab|mesh-list
24744492|NCT04262687|Pembrolizumab|pembrolizumab|mesh-list
24744493|NCT04262687|Capecitabine|capecitabine|mesh-list
24744494|NCT04262687|Oxaliplatin|oxaliplatin|mesh-list
24744496|NCT04262687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256706|NCT02480751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25256707|NCT02480751|Vasodilator Agents|vasodilator agents|mesh-ancestor
25256708|NCT02480465|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25256709|NCT02480465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25256710|NCT02480465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256711|NCT02480465|Incretins|incretins|mesh-ancestor
25256712|NCT02480465|Hormones|hormones|mesh-ancestor
25256713|NCT02480465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25256714|NCT02480465|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25256715|NCT02480465|Protease Inhibitors|protease inhibitors|mesh-ancestor
24754133|NCT01719185|Vitamins|vitamins|mesh-ancestor
25256716|NCT02480465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256717|NCT02480465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256718|NCT02480400|Dexetimide|dexetimide|mesh-list
25256719|NCT02480400|Citalopram|citalopram|mesh-list
25256720|NCT02480400|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25256721|NCT02480400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25256722|NCT02480400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25256723|NCT02480400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256724|NCT02480400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25256725|NCT02480400|Serotonin Agents|serotonin agents|mesh-ancestor
25256726|NCT02480400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527645|NCT00617877|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24527646|NCT00617877|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24527649|NCT00617877|Natriuretic Agents|natriuretic agents|mesh-ancestor
24527650|NCT00617877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527651|NCT00617877|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24527652|NCT00617877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25016262|NCT00092885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25016263|NCT00092885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016264|NCT00092885|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25016265|NCT00092885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25016266|NCT00092885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016267|NCT00092131|Montelukast|montelukast|mesh-list
25016268|NCT00092131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25016269|NCT00092131|Respiratory System Agents|respiratory system agents|mesh-ancestor
25016270|NCT00092131|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25016271|NCT00092131|Hormone Antagonists|hormone antagonists|mesh-ancestor
25016272|NCT00092131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25016273|NCT00092131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578600|NCT00849615|Protective Agents|protective agents|mesh-ancestor
24578601|NCT00849615|Vitamin B Complex|vitamin b complex|mesh-ancestor
24578602|NCT00849615|Vitamins|vitamins|mesh-ancestor
24578603|NCT00849615|Micronutrients|micronutrients|mesh-ancestor
24578604|NCT00849615|Hematinics|hematinics|mesh-ancestor
24578605|NCT00849745|Alemtuzumab|alemtuzumab|mesh-list
24578606|NCT00849745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24578607|NCT00849745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25092004|NCT03245229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24972905|NCT03714360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25687485|NCT01932996|Autonomic Agents|autonomic agents|mesh-ancestor
25687486|NCT01932996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25687487|NCT01932996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687488|NCT01932996|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25687489|NCT01932996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25687490|NCT01932996|Cholinergic Agents|cholinergic agents|mesh-ancestor
25687491|NCT01932996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25687492|NCT01932996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687493|NCT01933048|Vaccines|vaccines|mesh-list
25687494|NCT01933048|Immunologic Factors|immunologic factors|mesh-ancestor
25687495|NCT01933048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687496|NCT01933217|Methylphenidate|methylphenidate|mesh-list
24744619|NCT04224558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24744620|NCT04224558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24744621|NCT04224558|Antipruritics|antipruritics|mesh-ancestor
24744622|NCT04224558|Dermatologic Agents|dermatologic agents|mesh-ancestor
24744623|NCT04223570|Protoporphyrin IX|protoporphyrin ix|mesh-list
24972906|NCT03714360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972907|NCT03714360|Hemostatics|hemostatics|mesh-ancestor
24972908|NCT03714360|Coagulants|coagulants|mesh-ancestor
24586594|NCT00891332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586595|NCT00891332|Vitamin B Complex|vitamin b complex|mesh-ancestor
24586596|NCT00891332|Vitamins|vitamins|mesh-ancestor
24586597|NCT00891332|Micronutrients|micronutrients|mesh-ancestor
25016304|NCT00092092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25016305|NCT00092092|Respiratory System Agents|respiratory system agents|mesh-ancestor
25016306|NCT00092092|Glucocorticoids|glucocorticoids|mesh-ancestor
25016307|NCT00092092|Hormones|hormones|mesh-ancestor
25016308|NCT00092092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25016309|NCT00092092|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25016310|NCT00092092|Hormone Antagonists|hormone antagonists|mesh-ancestor
25016311|NCT00092092|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25016312|NCT00092092|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25016313|NCT00092092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016314|NCT00092066|Cholecalciferol|cholecalciferol|mesh-list
25016315|NCT00092066|Vitamin D|vitamin d|mesh-list
25016316|NCT00092066|Alendronate|alendronate|mesh-list
24896233|NCT01117441|Alkylating Agents|alkylating agents|mesh-ancestor
25016328|NCT00092040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016329|NCT00092040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25016330|NCT00092040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25016348|NCT00090142|Montelukast|montelukast|mesh-list
25016349|NCT00090142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25016350|NCT00090142|Respiratory System Agents|respiratory system agents|mesh-ancestor
25016351|NCT00090142|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25256727|NCT02480400|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25256728|NCT02480400|Antidepressive Agents|antidepressive agents|mesh-ancestor
25256729|NCT02480400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25256730|NCT02480400|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25256731|NCT02480400|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25256732|NCT02480400|Parasympatholytics|parasympatholytics|mesh-ancestor
25256733|NCT02480400|Autonomic Agents|autonomic agents|mesh-ancestor
25256734|NCT02480400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25256735|NCT02480400|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25256736|NCT02480400|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25256737|NCT02480400|Cholinergic Agents|cholinergic agents|mesh-ancestor
25256738|NCT02480387|Sofosbuvir|sofosbuvir|mesh-list
24527654|NCT00617955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527655|NCT00617955|Hemostatics|hemostatics|mesh-ancestor
24527656|NCT00617955|Coagulants|coagulants|mesh-ancestor
25016362|NCT00076973|Hormone Antagonists|hormone antagonists|mesh-ancestor
25016363|NCT00076973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25016364|NCT00076973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016365|NCT00076973|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25016366|NCT00076973|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25016367|NCT00076973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016369|NCT00043108|Carboplatin|carboplatin|mesh-list
25016371|NCT00043108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25016394|NCT05225597|Miotics|miotics|mesh-ancestor
24972984|NCT03713346|Sequestering Agents|sequestering agents|mesh-ancestor
25016395|NCT05225597|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25016396|NCT05225597|Cholinergic Agents|cholinergic agents|mesh-ancestor
25016397|NCT05225597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25016398|NCT05225597|Analgesics|analgesics|mesh-ancestor
25016399|NCT05225597|Sensory System Agents|sensory system agents|mesh-ancestor
25016400|NCT05225597|Protective Agents|protective agents|mesh-ancestor
25110835|NCT05341323|Ketamine|ketamine|mesh-list
25110836|NCT05341323|Bupivacaine|bupivacaine|mesh-list
24972993|NCT03713216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25016406|NCT05225077|Dapagliflozin|dapagliflozin|mesh-list
25016407|NCT05225077|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24896275|NCT00127673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25687497|NCT01933217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25687498|NCT01933217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687499|NCT01933217|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25016419|NCT05224388|Heparin|heparin|mesh-list
24744745|NCT04159818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744746|NCT04159818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24744747|NCT04159818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24744748|NCT04157881|Rabeprazole|rabeprazole|mesh-list
24744749|NCT04157881|Dabigatran|dabigatran|mesh-list
25016420|NCT05224388|Enoxaparin|enoxaparin|mesh-list
25016421|NCT05224388|Anticoagulants|anticoagulants|mesh-ancestor
25016422|NCT05224388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25016447|NCT05224167|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25016448|NCT05224167|Histamine Antagonists|histamine antagonists|mesh-ancestor
25016449|NCT05224167|Histamine Agents|histamine agents|mesh-ancestor
25016450|NCT05224167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25016451|NCT05224128|Imatinib Mesylate|imatinib mesylate|mesh-list
25256739|NCT02480387|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25256740|NCT02480387|Ledipasvir|ledipasvir|mesh-list
25256741|NCT02480387|Antiviral Agents|antiviral agents|mesh-ancestor
25256742|NCT02480387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25256743|NCT02480088|Palonosetron|palonosetron|mesh-list
25256744|NCT02480088|Ramosetron|ramosetron|mesh-list
25256745|NCT02480088|Antiemetics|antiemetics|mesh-ancestor
25256746|NCT02480088|Autonomic Agents|autonomic agents|mesh-ancestor
25256747|NCT02480088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25256748|NCT02480088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256749|NCT02480088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25256750|NCT02480088|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24527668|NCT00618046|Anticonvulsants|anticonvulsants|mesh-ancestor
24527675|NCT00618059|Pilocarpine|pilocarpine|mesh-list
24527705|NCT00618124|Growth Inhibitors|growth inhibitors|mesh-ancestor
24527706|NCT00618124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24527707|NCT00618124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092057|NCT03244956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25092058|NCT03244956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24928711|NCT04120064|Vitamins|vitamins|mesh-ancestor
24928712|NCT04120064|Micronutrients|micronutrients|mesh-ancestor
24928713|NCT04120064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25016452|NCT05224128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25016453|NCT05224128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25016454|NCT05224128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25016455|NCT05224128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016456|NCT05223907|Propofol|propofol|mesh-list
25016457|NCT05223907|Etomidate|etomidate|mesh-list
25016458|NCT05223907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25016459|NCT05223907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25016460|NCT05223907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016461|NCT05223907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25016462|NCT05223907|Anesthetics, General|anesthetics, general|mesh-ancestor
25016463|NCT05223907|Anesthetics|anesthetics|mesh-ancestor
25016464|NCT05223647|Carboplatin|carboplatin|mesh-list
25016465|NCT05223647|Etoposide|etoposide|mesh-list
25016466|NCT05223647|Durvalumab|durvalumab|mesh-list
25016474|NCT05223400|Clindamycin|clindamycin|mesh-list
24578914|NCT00852423|Lumefantrine|lumefantrine|mesh-list
24578915|NCT00852423|Artemether|artemether|mesh-list
24973085|NCT03712475|Pregabalin|pregabalin|mesh-list
24973086|NCT03712475|Analgesics|analgesics|mesh-ancestor
24973087|NCT03712475|Sensory System Agents|sensory system agents|mesh-ancestor
24973088|NCT03712475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24973089|NCT03712475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973090|NCT03712475|Anticonvulsants|anticonvulsants|mesh-ancestor
24973091|NCT03712475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24973092|NCT03712475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24973093|NCT03712475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256751|NCT02480088|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25256752|NCT02480088|Serotonin Agents|serotonin agents|mesh-ancestor
25256753|NCT02480088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25687500|NCT01933217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25687501|NCT01933217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25687502|NCT01933217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687503|NCT01933217|Dopamine Agents|dopamine agents|mesh-ancestor
25687504|NCT01933217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25687505|NCT01933334|Pirfenidone|pirfenidone|mesh-list
25256754|NCT02480088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256755|NCT02480335|Bosentan|bosentan|mesh-list
25256756|NCT02480335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25256757|NCT02480335|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24744891|NCT04096066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24744892|NCT04096066|Growth Substances|growth substances|mesh-ancestor
24744893|NCT04096066|Growth Inhibitors|growth inhibitors|mesh-ancestor
24744906|NCT04084548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744924|NCT04083495|Cyclophosphamide|cyclophosphamide|mesh-list
25687506|NCT01933334|Analgesics|analgesics|mesh-ancestor
24744925|NCT04083495|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24744926|NCT04083495|Fludarabine|fludarabine|mesh-list
24744927|NCT04083495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24744928|NCT04083495|Immunologic Factors|immunologic factors|mesh-ancestor
24744929|NCT04083495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744936|NCT04082676|Bupivacaine|bupivacaine|mesh-list
25256758|NCT02480335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256759|NCT02480049|Montelukast|montelukast|mesh-list
25256760|NCT02480049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25256761|NCT02480049|Respiratory System Agents|respiratory system agents|mesh-ancestor
25256762|NCT02480049|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25256763|NCT02480049|Hormone Antagonists|hormone antagonists|mesh-ancestor
24755264|NCT01725542|Protease Inhibitors|protease inhibitors|mesh-ancestor
25256764|NCT02480049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25256765|NCT02480049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256766|NCT02480049|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25256767|NCT02480049|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25256768|NCT02480049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256769|NCT02479971|Clindamycin|clindamycin|mesh-list
25256770|NCT02479971|Clindamycin palmitate|clindamycin palmitate|mesh-list
25256771|NCT02479971|Clindamycin phosphate|clindamycin phosphate|mesh-list
25256772|NCT02479971|Gentamicins|gentamicins|mesh-list
25256773|NCT02479971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24928715|NCT04119752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24928716|NCT04119752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24928717|NCT04119752|Analgesics|analgesics|mesh-ancestor
24928718|NCT04119752|Sensory System Agents|sensory system agents|mesh-ancestor
25079673|NCT03346226|Anesthetics|anesthetics|mesh-ancestor
24928719|NCT04119752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24928720|NCT04119752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928721|NCT04119752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24928731|NCT04119622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25092060|NCT03244774|Paclitaxel|paclitaxel|mesh-list
24928732|NCT04119674|Temozolomide|temozolomide|mesh-list
24928733|NCT04119674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24928734|NCT04119674|Alkylating Agents|alkylating agents|mesh-ancestor
24928735|NCT04119674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928736|NCT04119674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24928737|NCT04119297|Heparinoids|heparinoids|mesh-list
24928738|NCT04119297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24973094|NCT03712475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24973095|NCT03712475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24973096|NCT03712475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24973097|NCT03712475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24973098|NCT03712475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25016530|NCT05137600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016531|NCT05137600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25016532|NCT05137600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25016533|NCT05137600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25016534|NCT05137600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25016535|NCT05137600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25016536|NCT05137600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25016538|NCT05137548|Antiviral Agents|antiviral agents|mesh-ancestor
25016539|NCT05137548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25016540|NCT05137548|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25016541|NCT05137548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25016542|NCT05137548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687507|NCT01933334|Sensory System Agents|sensory system agents|mesh-ancestor
25687508|NCT01933334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25687509|NCT01933334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687510|NCT01933334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25687511|NCT01933334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25687512|NCT01933334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25687513|NCT01933334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25687514|NCT01933334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25687515|NCT01933425|Rocuronium|rocuronium|mesh-list
25687516|NCT01933425|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25016558|NCT05072704|Analgesics|analgesics|mesh-ancestor
25016559|NCT05072704|Sensory System Agents|sensory system agents|mesh-ancestor
25016560|NCT05072704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25016561|NCT05072704|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25016562|NCT05072704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25016599|NCT04987372|Analgesics|analgesics|mesh-ancestor
25016600|NCT04987372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25016601|NCT04987372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25016602|NCT04987372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25016603|NCT04987372|Adrenergic Agents|adrenergic agents|mesh-ancestor
25016604|NCT04987372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25016605|NCT04987372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25016606|NCT04987372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25016607|NCT04987372|Anesthetics, General|anesthetics, general|mesh-ancestor
25016608|NCT04987372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25016609|NCT04987372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25016610|NCT04987372|Anticonvulsants|anticonvulsants|mesh-ancestor
25016611|NCT04987372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25016612|NCT04987372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25016655|NCT04840264|Fluorouracil|fluorouracil|mesh-list
25016656|NCT04840264|Oxaliplatin|oxaliplatin|mesh-list
25016657|NCT04840264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256774|NCT02479971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25256775|NCT02479971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25256776|NCT02479971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256777|NCT02479971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256778|NCT02479854|Montelukast|montelukast|mesh-list
25256779|NCT02479854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25256780|NCT02479854|Respiratory System Agents|respiratory system agents|mesh-ancestor
25256781|NCT02479854|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25256782|NCT02479854|Hormone Antagonists|hormone antagonists|mesh-ancestor
25256783|NCT02479854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25256784|NCT02479854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256785|NCT02479854|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25256786|NCT02479854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25256787|NCT02479854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256788|NCT02479867|Cefadroxil|cefadroxil|mesh-list
24928739|NCT04119297|Anticoagulants|anticoagulants|mesh-ancestor
24504753|NCT00537966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24527709|NCT00618163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24527710|NCT00618163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24527711|NCT00618163|Analgesics|analgesics|mesh-ancestor
24527712|NCT00618163|Sensory System Agents|sensory system agents|mesh-ancestor
24527713|NCT00618163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24527714|NCT00618163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527715|NCT00618163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25016661|NCT04840264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016662|NCT04840264|Antimetabolites|antimetabolites|mesh-ancestor
25016663|NCT04840264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25016664|NCT04840264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25016665|NCT04840264|Immunologic Factors|immunologic factors|mesh-ancestor
25016666|NCT04840264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016668|NCT04822467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25016669|NCT04822467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25016670|NCT04822467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25016671|NCT04822467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016673|NCT04808973|Dolutegravir|dolutegravir|mesh-list
24586664|NCT00891670|Clopidogrel|clopidogrel|mesh-list
24586665|NCT00891670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24586666|NCT00891670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24586667|NCT00891670|Analgesics|analgesics|mesh-ancestor
24586668|NCT00891670|Sensory System Agents|sensory system agents|mesh-ancestor
24586669|NCT00891670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24586670|NCT00891670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586715|NCT00891761|Autonomic Agents|autonomic agents|mesh-ancestor
25016697|NCT04787692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25016699|NCT04741945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25016700|NCT04741945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016701|NCT04741074|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25016710|NCT04667949|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25687517|NCT01933425|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25687518|NCT01933425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25687519|NCT01933425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25016711|NCT04667949|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25016712|NCT04667949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016713|NCT04667949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25016714|NCT04667949|Immunologic Factors|immunologic factors|mesh-ancestor
25016715|NCT04667949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016716|NCT04661137|Dexamethasone|dexamethasone|mesh-list
25016717|NCT04661137|Daratumumab|daratumumab|mesh-list
25016718|NCT04661137|Pomalidomide|pomalidomide|mesh-list
25256789|NCT02479867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24756182|NCT01731561|Rituximab|rituximab|mesh-list
25256790|NCT02479867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25256791|NCT02479958|Chlorhexidine|chlorhexidine|mesh-list
25256792|NCT02479958|Anti-Infective Agents|anti-infective agents|mesh-list
25256793|NCT02479958|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25256794|NCT02479958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25256795|NCT02479958|Disinfectants|disinfectants|mesh-ancestor
25256796|NCT02479789|Lidocaine|lidocaine|mesh-list
25256797|NCT02479789|Anesthetics, Local|anesthetics, local|mesh-ancestor
25256798|NCT02479789|Anesthetics|anesthetics|mesh-ancestor
25256799|NCT02479789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25256800|NCT02479789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256801|NCT02479789|Sensory System Agents|sensory system agents|mesh-ancestor
25256802|NCT02479789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25256803|NCT02479789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24527721|NCT00618176|Lamivudine|lamivudine|mesh-list
24928740|NCT04119739|Ibuprofen|ibuprofen|mesh-list
24928741|NCT04119739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24928742|NCT04119739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24928743|NCT04119739|Analgesics|analgesics|mesh-ancestor
24928744|NCT04119739|Sensory System Agents|sensory system agents|mesh-ancestor
24928745|NCT04119739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25016719|NCT04661137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25016720|NCT04661137|Antiemetics|antiemetics|mesh-ancestor
25016721|NCT04661137|Autonomic Agents|autonomic agents|mesh-ancestor
25016722|NCT04661137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25016723|NCT04661137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016724|NCT04661137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25016725|NCT04661137|Glucocorticoids|glucocorticoids|mesh-ancestor
25016729|NCT04661137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25016742|NCT04544280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25016743|NCT04544280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25016744|NCT04544280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016745|NCT04544280|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25016746|NCT04544280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25016747|NCT04544280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016748|NCT04544280|Cholinergic Agents|cholinergic agents|mesh-ancestor
25016749|NCT04544280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25016750|NCT04544007|Poly ICLC|poly iclc|mesh-list
25016751|NCT04544007|Interferon Inducers|interferon inducers|mesh-ancestor
25016752|NCT04544007|Immunologic Factors|immunologic factors|mesh-ancestor
25016753|NCT04544007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016754|NCT04510207|Vaccines|vaccines|mesh-list
25016755|NCT04510207|Immunologic Factors|immunologic factors|mesh-ancestor
25016805|NCT04356495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25016806|NCT04356495|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25016807|NCT04356495|Immunologic Factors|immunologic factors|mesh-ancestor
25016808|NCT04356495|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25016822|NCT04200911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016823|NCT04140162|Dexamethasone|dexamethasone|mesh-list
25016824|NCT04140162|Lenalidomide|lenalidomide|mesh-list
25016825|NCT04140162|Bortezomib|bortezomib|mesh-list
25016826|NCT04140162|Daratumumab|daratumumab|mesh-list
25016827|NCT04140162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25016828|NCT04140162|Antiemetics|antiemetics|mesh-ancestor
25687520|NCT01933425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687521|NCT01933464|Cromolyn Sodium|cromolyn sodium|mesh-list
25687522|NCT01933464|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
25687523|NCT01933464|Immunologic Factors|immunologic factors|mesh-ancestor
25687524|NCT01933464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016829|NCT04140162|Autonomic Agents|autonomic agents|mesh-ancestor
25016847|NCT04104178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25016872|NCT03918915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25687525|NCT01933464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25016873|NCT03918915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016874|NCT03918915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25016875|NCT03918915|Respiratory System Agents|respiratory system agents|mesh-ancestor
25016876|NCT03918915|Mydriatics|mydriatics|mesh-ancestor
25016877|NCT03918915|Parasympatholytics|parasympatholytics|mesh-ancestor
25016878|NCT03918915|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25016879|NCT03918915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25016880|NCT03918915|Cholinergic Agents|cholinergic agents|mesh-ancestor
25016881|NCT03918915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25016882|NCT03918915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016884|NCT03882918|Analgesics|analgesics|mesh-ancestor
25016885|NCT03882918|Sensory System Agents|sensory system agents|mesh-ancestor
25016886|NCT03882918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25016887|NCT03882918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016888|NCT03882918|Anticonvulsants|anticonvulsants|mesh-ancestor
25016889|NCT03882918|GABA Agonists|gaba agonists|mesh-ancestor
25016890|NCT03882918|GABA Agents|gaba agents|mesh-ancestor
25016891|NCT03882918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25016892|NCT03882918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016893|NCT03878459|Pioglitazone|pioglitazone|mesh-list
25016894|NCT03878459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25016895|NCT03878459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973533|NCT03708848|Expectorants|expectorants|mesh-ancestor
24973534|NCT03708848|Respiratory System Agents|respiratory system agents|mesh-ancestor
24973536|NCT03708822|Nimotuzumab|nimotuzumab|mesh-list
25256804|NCT02479789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25256805|NCT02479789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25256806|NCT02479789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25256807|NCT02479789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256808|NCT02479815|Micronutrients|micronutrients|mesh-list
25256809|NCT02479815|Trace Elements|trace elements|mesh-list
24928746|NCT04119739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928747|NCT04119739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24928748|NCT04119739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24928749|NCT04119739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24928750|NCT04119739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24928751|NCT04119739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928752|NCT04118920|Insulin|insulin|mesh-list
24928753|NCT04118920|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24928754|NCT04118920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24973537|NCT03708822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973538|NCT03708822|Tubulin Modulators|tubulin modulators|mesh-ancestor
24973542|NCT03708822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24973543|NCT03708718|Prednisolone|prednisolone|mesh-list
24973544|NCT03708718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24973545|NCT03708718|Glucocorticoids|glucocorticoids|mesh-ancestor
24973546|NCT03708718|Hormones|hormones|mesh-ancestor
24973547|NCT03708718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24973548|NCT03708718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016954|NCT03772353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016955|NCT03772353|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25016956|NCT03772353|Hormone Antagonists|hormone antagonists|mesh-ancestor
25016957|NCT03772353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25016958|NCT03772353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017013|NCT03582774|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25017017|NCT03512210|Sofosbuvir|sofosbuvir|mesh-list
25017018|NCT03512210|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25017019|NCT03512210|Velpatasvir|velpatasvir|mesh-list
25017020|NCT03512210|Antiviral Agents|antiviral agents|mesh-ancestor
25017021|NCT03512210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25017022|NCT03506412|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25017023|NCT03506412|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25017024|NCT03506412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017025|NCT03383770|Anesthetics|anesthetics|mesh-list
25017026|NCT03383770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25017027|NCT03383770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017028|NCT03278665|Pembrolizumab|pembrolizumab|mesh-list
25017029|NCT03278665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25017030|NCT03278665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25017031|NCT03198689|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25017065|NCT02668783|Ibuprofen|ibuprofen|mesh-list
25017066|NCT02668783|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25687526|NCT01933464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25687527|NCT01933464|Respiratory System Agents|respiratory system agents|mesh-ancestor
24745264|NCT03846570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24745270|NCT03846570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24745276|NCT03846570|Hormones|hormones|mesh-ancestor
25017067|NCT02668783|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25017068|NCT02668783|Etonogestrel|etonogestrel|mesh-list
25017069|NCT02668783|Estradiol|estradiol|mesh-list
25017070|NCT02668783|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25017071|NCT02668783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25017072|NCT02668783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25017074|NCT02668783|Sensory System Agents|sensory system agents|mesh-ancestor
25017075|NCT02668783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25017076|NCT02668783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017077|NCT02668783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25017078|NCT02668783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25017079|NCT02668783|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25017080|NCT02668783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25017081|NCT02668783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017082|NCT02668783|Estrogens|estrogens|mesh-ancestor
25256810|NCT02479815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256811|NCT02479828|Ropivacaine|ropivacaine|mesh-list
25256812|NCT02479828|Anesthetics, Local|anesthetics, local|mesh-ancestor
25256813|NCT02479828|Anesthetics|anesthetics|mesh-ancestor
25256814|NCT02479828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25256815|NCT02479828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256816|NCT02479828|Sensory System Agents|sensory system agents|mesh-ancestor
25256817|NCT02479828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25256818|NCT02479711|Methamphetamine|methamphetamine|mesh-list
24928755|NCT04118920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928756|NCT04119336|Dexamethasone|dexamethasone|mesh-list
24928757|NCT04119336|Cyclophosphamide|cyclophosphamide|mesh-list
24928758|NCT04119336|Nivolumab|nivolumab|mesh-list
24928759|NCT04119336|Ixazomib|ixazomib|mesh-list
24928760|NCT04119336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24928761|NCT04119336|Immunologic Factors|immunologic factors|mesh-ancestor
24928762|NCT04119336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504781|NCT00538070|Glycine|glycine|mesh-list
24504782|NCT00538070|Glycine Agents|glycine agents|mesh-ancestor
24504783|NCT00538070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24504786|NCT00538096|Blinatumomab|blinatumomab|mesh-list
24527722|NCT00618176|Zidovudine|zidovudine|mesh-list
25017083|NCT02668783|Hormones|hormones|mesh-ancestor
25017147|NCT02409342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25017187|NCT02316834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25017188|NCT02293655|Methylphenidate|methylphenidate|mesh-list
25017189|NCT02293655|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25017190|NCT02293655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017191|NCT02293655|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25017192|NCT02293655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25017193|NCT02293655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25017254|NCT01965132|Etanercept|etanercept|mesh-list
25017255|NCT01965132|Golimumab|golimumab|mesh-list
25017256|NCT01965132|Abatacept|abatacept|mesh-list
25017257|NCT01965132|Infliximab|infliximab|mesh-list
25017258|NCT01965132|Upadacitinib|upadacitinib|mesh-list
25017259|NCT01965132|Ustekinumab|ustekinumab|mesh-list
25017260|NCT01965132|Ixekizumab|ixekizumab|mesh-list
25017261|NCT01965132|Tofacitinib|tofacitinib|mesh-list
25017262|NCT01965132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25017263|NCT01965132|Immunologic Factors|immunologic factors|mesh-ancestor
25017264|NCT01965132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017265|NCT01965132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25017266|NCT01965132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25017267|NCT01965132|Dermatologic Agents|dermatologic agents|mesh-ancestor
25017268|NCT01965132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25125248|NCT03070275|Coagulants|coagulants|mesh-ancestor
25017269|NCT01965132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25017281|NCT01891344|Rucaparib|rucaparib|mesh-list
25017314|NCT01648751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687528|NCT01933594|Romidepsin|romidepsin|mesh-list
25687529|NCT01933594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25687530|NCT01933594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25687531|NCT01933672|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25687532|NCT01933672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25687533|NCT01933672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017315|NCT01498770|Olanzapine|olanzapine|mesh-list
25687534|NCT01933672|Incretins|incretins|mesh-ancestor
25017316|NCT01498770|Risperidone|risperidone|mesh-list
25017317|NCT01498770|Aripiprazole|aripiprazole|mesh-list
25017318|NCT01498770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25017319|NCT01498770|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25017320|NCT01498770|Ziprasidone|ziprasidone|mesh-list
25017321|NCT01498770|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25017322|NCT01498770|Clozapine|clozapine|mesh-list
25017323|NCT01498770|Asenapine|asenapine|mesh-list
25017324|NCT01498770|Amisulpride|amisulpride|mesh-list
25017325|NCT01498770|Iloperidone|iloperidone|mesh-list
25017326|NCT01498770|Sertindole|sertindole|mesh-list
25017327|NCT01498770|Zotepine|zotepine|mesh-list
25256819|NCT02479711|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25256820|NCT02479711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256821|NCT02479711|Sympathomimetics|sympathomimetics|mesh-ancestor
25256822|NCT02479711|Autonomic Agents|autonomic agents|mesh-ancestor
25256823|NCT02479711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25256824|NCT02479711|Dopamine Agents|dopamine agents|mesh-ancestor
25256825|NCT02479711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25256826|NCT02479711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256827|NCT02479711|Adrenergic Agents|adrenergic agents|mesh-ancestor
25256828|NCT02479711|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25275018|NCT02374567|Antimanic Agents|antimanic agents|mesh-ancestor
24527725|NCT00618176|Didanosine|didanosine|mesh-list
24527726|NCT00618176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24527727|NCT00618176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24527728|NCT00618176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404889|NCT00165139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527751|NCT00618228|Sensory System Agents|sensory system agents|mesh-ancestor
24527752|NCT00618228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24527753|NCT00618228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092363|NCT03242616|Pemetrexed|pemetrexed|mesh-list
24527754|NCT00618228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24527755|NCT00618228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24527756|NCT00618228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24592827|NCT00925730|Pimecrolimus|pimecrolimus|mesh-list
25017328|NCT01498770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25017329|NCT01498770|Serotonin Agents|serotonin agents|mesh-ancestor
25017330|NCT01498770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25017331|NCT01498770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017333|NCT01498770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25017383|NCT01277211|NuvaRing|nuvaring|mesh-list
25017384|NCT01277211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25017385|NCT01277211|Contraceptive Agents|contraceptive agents|mesh-ancestor
25017386|NCT01277211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25017396|NCT01244828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25017397|NCT01244828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25017398|NCT01244828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25017399|NCT01244828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587939|NCT00898950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587940|NCT00898950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24587941|NCT00898950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24587942|NCT00898950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24587943|NCT00898950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24587944|NCT00898950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587945|NCT00898950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24587946|NCT00898950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24587947|NCT00898950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587949|NCT00898950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24587950|NCT00898950|Antifungal Agents|antifungal agents|mesh-ancestor
24587951|NCT00898950|Keratolytic Agents|keratolytic agents|mesh-ancestor
24586808|NCT00892307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586809|NCT00892320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24586810|NCT00892320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24586811|NCT00892320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24586812|NCT00892320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24586813|NCT00892320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586814|NCT00892320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24580218|NCT00861029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25017434|NCT01005056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25017436|NCT00967746|Etonogestrel|etonogestrel|mesh-list
25017437|NCT00967746|Desogestrel|desogestrel|mesh-list
25017438|NCT00967746|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25687535|NCT01933672|Hormones|hormones|mesh-ancestor
25017439|NCT00967746|Contraceptive Agents|contraceptive agents|mesh-ancestor
25692613|NCT02002884|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25017440|NCT00967746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25017441|NCT00967746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017442|NCT00967746|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25017496|NCT00725413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25017497|NCT00725413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256829|NCT02479711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25256830|NCT02479711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25256831|NCT02479711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25275019|NCT02374567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25275020|NCT02374567|Serotonin Agents|serotonin agents|mesh-ancestor
25275021|NCT02374567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25275022|NCT02374567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25275023|NCT02374567|Dopamine Agents|dopamine agents|mesh-ancestor
25275024|NCT02374567|Antioxidants|antioxidants|mesh-ancestor
25275025|NCT02374567|Protective Agents|protective agents|mesh-ancestor
25275026|NCT02374567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25275027|NCT02374567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25275028|NCT02374567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25092459|NCT03241888|Megestrol|megestrol|mesh-list
25275029|NCT02374567|Antidepressive Agents|antidepressive agents|mesh-ancestor
24928764|NCT04119336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24928765|NCT04119336|Alkylating Agents|alkylating agents|mesh-ancestor
24928766|NCT04119336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652724|NCT01239888|Tibolone|tibolone|mesh-list
25017498|NCT00725413|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25017499|NCT00651807|Etonogestrel|etonogestrel|mesh-list
25017500|NCT00651807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25017501|NCT00651807|Contraceptive Agents|contraceptive agents|mesh-ancestor
25017502|NCT00651807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25017503|NCT00651807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017504|NCT00651807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25017505|NCT00620464|Etonogestrel|etonogestrel|mesh-list
25017506|NCT00620464|Desogestrel|desogestrel|mesh-list
25017517|NCT00620464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25017548|NCT00413764|Tibolone|tibolone|mesh-list
25017610|NCT00159796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25017611|NCT00159796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25017612|NCT00159796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017613|NCT00159796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25017614|NCT00159796|Serotonin Agents|serotonin agents|mesh-ancestor
25017615|NCT00159744|Olanzapine|olanzapine|mesh-list
24974169|NCT05155540|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24974170|NCT05155540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24974171|NCT05155540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24974172|NCT05155540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974174|NCT05148637|Lidocaine|lidocaine|mesh-list
24974175|NCT05148637|Fentanyl|fentanyl|mesh-list
24974176|NCT05148637|Anesthetics|anesthetics|mesh-list
24974178|NCT05148637|Desflurane|desflurane|mesh-list
25017643|NCT00143182|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25017644|NCT00143182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25017645|NCT00143182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25017646|NCT00143182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017647|NCT00143182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25017648|NCT00143182|Serotonin Agents|serotonin agents|mesh-ancestor
25017649|NCT03705442|Loperamide|loperamide|mesh-list
25017650|NCT03705442|Antidiarrheals|antidiarrheals|mesh-list
25017651|NCT03705442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25111033|NCT05272826|Dexamethasone|dexamethasone|mesh-list
25111034|NCT05272826|Bortezomib|bortezomib|mesh-list
25111035|NCT05272826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25111036|NCT05272826|Antiemetics|antiemetics|mesh-ancestor
25111037|NCT05272826|Autonomic Agents|autonomic agents|mesh-ancestor
25111038|NCT05272826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25111039|NCT05272826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092518|NCT03241641|Tenofovir|tenofovir|mesh-list
25111040|NCT05272826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25111041|NCT05272826|Glucocorticoids|glucocorticoids|mesh-ancestor
25111042|NCT05272826|Hormones|hormones|mesh-ancestor
25111043|NCT05272826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25111044|NCT05272826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25017686|NCT03704909|Epinephrine|epinephrine|mesh-list
25256832|NCT02479620|Dexamethasone|dexamethasone|mesh-list
25692614|NCT02002884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24745403|NCT03785106|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24745404|NCT03785106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24745496|NCT03759184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24745497|NCT03759184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24944094|NCT03963466|Tranexamic Acid|tranexamic acid|mesh-list
24745508|NCT03748784|Aflibercept|aflibercept|mesh-list
24745509|NCT03748784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24745510|NCT03748784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25256833|NCT02479620|Dexamethasone acetate|dexamethasone acetate|mesh-list
25256834|NCT02479620|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25256835|NCT02479620|BB 1101|bb 1101|mesh-list
25256836|NCT02479620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24928767|NCT04119336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24928768|NCT04119336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24928769|NCT04119336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24928770|NCT04119336|Antiemetics|antiemetics|mesh-ancestor
24928771|NCT04119336|Autonomic Agents|autonomic agents|mesh-ancestor
24928772|NCT04119336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25017687|NCT03704909|Racepinephrine|racepinephrine|mesh-list
25017688|NCT03704909|Ephedrine|ephedrine|mesh-list
25017689|NCT03704909|Epinephryl borate|epinephryl borate|mesh-list
25017690|NCT03704909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25017691|NCT03704909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25017692|NCT03704909|Adrenergic Agents|adrenergic agents|mesh-ancestor
25017693|NCT03704909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25017778|NCT03704506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25017779|NCT03704506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25017780|NCT03704480|Durvalumab|durvalumab|mesh-list
25017781|NCT03704480|Tremelimumab|tremelimumab|mesh-list
25017782|NCT03704480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25017783|NCT03704480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25017788|NCT03704246|Antibodies|antibodies|mesh-list
25017832|NCT03703596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017834|NCT03703427|Vinorelbine|vinorelbine|mesh-list
25017835|NCT03703427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25017836|NCT03703427|Antimetabolites|antimetabolites|mesh-ancestor
25017837|NCT03703427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017838|NCT03703427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25017839|NCT03703427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25017840|NCT03703427|Tubulin Modulators|tubulin modulators|mesh-ancestor
25017841|NCT03703427|Antimitotic Agents|antimitotic agents|mesh-ancestor
25017842|NCT03703427|Mitosis Modulators|mitosis modulators|mesh-ancestor
25017856|NCT03703349|Tocolytic Agents|tocolytic agents|mesh-ancestor
25111052|NCT05262322|Apixaban|apixaban|mesh-list
25111053|NCT05262322|Edoxaban|edoxaban|mesh-list
25111054|NCT05262322|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25111055|NCT05262322|Antithrombins|antithrombins|mesh-ancestor
25111056|NCT05262322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25256837|NCT02479620|Antiemetics|antiemetics|mesh-ancestor
25256838|NCT02479620|Autonomic Agents|autonomic agents|mesh-ancestor
25256839|NCT02479620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25256840|NCT02479620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256841|NCT02479620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25256842|NCT02479620|Glucocorticoids|glucocorticoids|mesh-ancestor
25256843|NCT02479620|Hormones|hormones|mesh-ancestor
25275030|NCT02374567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24928777|NCT04119336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24928778|NCT04119336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25111057|NCT05262322|Protease Inhibitors|protease inhibitors|mesh-ancestor
25111058|NCT05262322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25111059|NCT05262322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25111060|NCT05262322|Anticoagulants|anticoagulants|mesh-ancestor
25111061|NCT05261386|Betadex|betadex|mesh-list
24758640|NCT01747083|Metformin|metformin|mesh-list
25017902|NCT03703063|Vitamin B Complex|vitamin b complex|mesh-ancestor
25017903|NCT03703063|Vitamins|vitamins|mesh-ancestor
25017904|NCT03703063|Micronutrients|micronutrients|mesh-ancestor
25017905|NCT03702985|Capecitabine|capecitabine|mesh-list
25017906|NCT03702985|Irinotecan|irinotecan|mesh-list
25687536|NCT01933672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25687537|NCT01933672|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25687538|NCT01933672|Protease Inhibitors|protease inhibitors|mesh-ancestor
25687539|NCT01933672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687540|NCT01933672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687541|NCT01933776|Vaccines|vaccines|mesh-list
25687542|NCT01933776|Immunologic Factors|immunologic factors|mesh-ancestor
25687543|NCT01933776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653808|NCT01245868|Lidocaine|lidocaine|mesh-list
25017907|NCT03702985|Amifostine|amifostine|mesh-list
25017908|NCT03702985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25017909|NCT03702985|Antimetabolites|antimetabolites|mesh-ancestor
25017910|NCT03702985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017911|NCT03702985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25017912|NCT03702985|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25017913|NCT03702985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25017914|NCT03702985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25017915|NCT03702985|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25017916|NCT03702985|Protective Agents|protective agents|mesh-ancestor
25017917|NCT03702985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017919|NCT03702959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25017920|NCT03702959|Glucocorticoids|glucocorticoids|mesh-ancestor
25017921|NCT03702959|Hormones|hormones|mesh-ancestor
25017922|NCT03702959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25017923|NCT03702959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580889|NCT00863941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24580890|NCT00863941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580894|NCT00863980|Telmisartan|telmisartan|mesh-list
25017954|NCT03702803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017955|NCT03702738|Acetylcysteine|acetylcysteine|mesh-list
25017956|NCT03702738|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25017957|NCT03702738|Antiviral Agents|antiviral agents|mesh-ancestor
25017958|NCT03702738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25017959|NCT03702738|Expectorants|expectorants|mesh-ancestor
25017960|NCT03702738|Respiratory System Agents|respiratory system agents|mesh-ancestor
25017961|NCT03702738|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25017962|NCT03702738|Antioxidants|antioxidants|mesh-ancestor
25018009|NCT03702491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25018011|NCT03702426|Norfloxacin|norfloxacin|mesh-list
25018012|NCT03702426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25018013|NCT03702426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25018014|NCT03702426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25018015|NCT03702426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25018016|NCT03702426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256859|NCT02479490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25018017|NCT03702426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018018|NCT03702426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018019|NCT03702426|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25018020|NCT03702426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25018021|NCT03702400|Phenylephrine|phenylephrine|mesh-list
25018022|NCT03702400|Oxymetazoline|oxymetazoline|mesh-list
25018023|NCT03702400|Norepinephrine|norepinephrine|mesh-list
25018024|NCT03702400|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25018025|NCT03702400|Mydriatics|mydriatics|mesh-ancestor
25018026|NCT03702400|Autonomic Agents|autonomic agents|mesh-ancestor
24580974|NCT00864149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25018052|NCT03702140|Teriparatide|teriparatide|mesh-list
25256844|NCT02479620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25256845|NCT02479620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25256846|NCT02479620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256847|NCT02479620|Protease Inhibitors|protease inhibitors|mesh-ancestor
25687544|NCT01933880|Methylphenidate|methylphenidate|mesh-list
25687545|NCT01933880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25687546|NCT01933880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687547|NCT01933880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25687548|NCT01933880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25687549|NCT01933880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25687550|NCT01933880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687551|NCT01933880|Dopamine Agents|dopamine agents|mesh-ancestor
25687552|NCT01933880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25687553|NCT01933919|Fluvoxamine|fluvoxamine|mesh-list
25256848|NCT02479620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24928779|NCT04119336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24928780|NCT04119336|Protease Inhibitors|protease inhibitors|mesh-ancestor
24928781|NCT04119336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24928783|NCT04119037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24928784|NCT04119037|Narcotics|narcotics|mesh-ancestor
24928785|NCT04119037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24928786|NCT04119037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928787|NCT04119037|Analgesics|analgesics|mesh-ancestor
24928788|NCT04119037|Sensory System Agents|sensory system agents|mesh-ancestor
24928789|NCT04119037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24928790|NCT04118855|Axitinib|axitinib|mesh-list
24928791|NCT04118855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504803|NCT00538187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527757|NCT00618241|Raltegravir Potassium|raltegravir potassium|mesh-list
24527758|NCT00618241|Lamotrigine|lamotrigine|mesh-list
25018053|NCT03702140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25018054|NCT03702140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018055|NCT03702140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25018056|NCT03702023|Acetaminophen|acetaminophen|mesh-list
25018057|NCT03702023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25018058|NCT03702023|Analgesics|analgesics|mesh-ancestor
25018059|NCT03702023|Sensory System Agents|sensory system agents|mesh-ancestor
25018060|NCT03702023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018068|NCT03701984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018069|NCT03701984|Sensory System Agents|sensory system agents|mesh-ancestor
25018070|NCT03701984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018071|NCT03701984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25018072|NCT03701984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25018073|NCT03701984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25018074|NCT03701984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25018076|NCT03701984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25018100|NCT03701880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018101|NCT03701750|Heparin|heparin|mesh-list
25018102|NCT03701750|Enoxaparin|enoxaparin|mesh-list
25018103|NCT03701750|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25018104|NCT03701750|Tinzaparin|tinzaparin|mesh-list
25018105|NCT03701750|Dalteparin|dalteparin|mesh-list
25018106|NCT03701750|Enoxaparin sodium|enoxaparin sodium|mesh-list
25018107|NCT03701750|Anticoagulants|anticoagulants|mesh-ancestor
25018108|NCT03701750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25018109|NCT03701750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25018110|NCT03701750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018111|NCT03701698|Methylprednisolone|methylprednisolone|mesh-list
25018151|NCT03701529|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25018153|NCT03701503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25018154|NCT03701503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018160|NCT03701451|Decitabine|decitabine|mesh-list
25256849|NCT02479620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256850|NCT02479503|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25256851|NCT02479503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25256852|NCT02479490|Prednisone|prednisone|mesh-list
25256853|NCT02479490|Everolimus|everolimus|mesh-list
25256854|NCT02479490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25256855|NCT02479490|Glucocorticoids|glucocorticoids|mesh-ancestor
25256856|NCT02479490|Hormones|hormones|mesh-ancestor
25256857|NCT02479490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25256858|NCT02479490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256860|NCT02479490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256861|NCT02479490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25256862|NCT02479490|Immunologic Factors|immunologic factors|mesh-ancestor
25256863|NCT02479204|Atenolol|atenolol|mesh-list
25256864|NCT02479204|Diltiazem|diltiazem|mesh-list
24527760|NCT00618241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24527761|NCT00618241|Antiviral Agents|antiviral agents|mesh-ancestor
24527762|NCT00618241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24527763|NCT00618241|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24527764|NCT00618241|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24527765|NCT00618241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527766|NCT00618241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527767|NCT00618241|Anticonvulsants|anticonvulsants|mesh-ancestor
24527768|NCT00618241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24527777|NCT00618254|Granisetron|granisetron|mesh-list
24928792|NCT04118855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24928793|NCT04118855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24928794|NCT04118855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745831|NCT03576417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745833|NCT03573115|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24745834|NCT03573115|Dermatologic Agents|dermatologic agents|mesh-ancestor
24529972|NCT00628576|Dalteparin|dalteparin|mesh-list
24745837|NCT03573115|Analgesics|analgesics|mesh-ancestor
24928795|NCT04118842|Rifampin|rifampin|mesh-list
25018161|NCT03701451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25018162|NCT03701451|Antimetabolites|antimetabolites|mesh-ancestor
25018163|NCT03701451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018164|NCT03701451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018165|NCT03701451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018166|NCT03701321|Dexamethasone|dexamethasone|mesh-list
25018167|NCT03701321|Dexamethasone acetate|dexamethasone acetate|mesh-list
25018168|NCT03701321|Bortezomib|bortezomib|mesh-list
25018169|NCT03701321|Venetoclax|venetoclax|mesh-list
25018170|NCT03701321|Daratumumab|daratumumab|mesh-list
25018171|NCT03701321|Ichthammol|ichthammol|mesh-list
24974747|NCT05294172|Gemcitabine|gemcitabine|mesh-list
24974749|NCT05294172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24974750|NCT05294172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24974751|NCT05294172|Antimetabolites|antimetabolites|mesh-ancestor
24974752|NCT05294172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256865|NCT02479204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25256866|NCT02479204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25256867|NCT02479204|Sympatholytics|sympatholytics|mesh-ancestor
25256868|NCT02479204|Autonomic Agents|autonomic agents|mesh-ancestor
25256869|NCT02479204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25256870|NCT02479204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256871|NCT02479204|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25256872|NCT02479204|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25256873|NCT02479204|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25256874|NCT02479204|Adrenergic Agents|adrenergic agents|mesh-ancestor
25256875|NCT02479204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25256876|NCT02479204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256877|NCT02479204|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25256878|NCT02479204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25256879|NCT02479204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24928803|NCT04118842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928804|NCT04118842|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24928805|NCT04118842|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24928806|NCT04118842|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24928807|NCT04118842|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24928808|NCT04118842|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24928809|NCT04118842|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24928813|NCT04118556|Infliximab|infliximab|mesh-list
24928814|NCT04118556|Vedolizumab|vedolizumab|mesh-list
24974753|NCT05294172|Antiviral Agents|antiviral agents|mesh-ancestor
24974754|NCT05294172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24974755|NCT05294172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24586942|NCT00892892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092870|NCT03238482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24586943|NCT00892892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24586944|NCT00892892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586946|NCT00892892|Sympatholytics|sympatholytics|mesh-ancestor
24586947|NCT00892892|Autonomic Agents|autonomic agents|mesh-ancestor
25018188|NCT03701256|Atracurium|atracurium|mesh-list
25018189|NCT03701256|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25018190|NCT03701256|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25018191|NCT03701256|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25018192|NCT03701256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018193|NCT03701256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018194|NCT03701256|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25018195|NCT03701256|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25018196|NCT03701256|Cholinergic Agents|cholinergic agents|mesh-ancestor
25018197|NCT03701256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25018198|NCT03701256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018199|NCT03701126|Bupivacaine|bupivacaine|mesh-list
25687554|NCT01933919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687555|NCT01933919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687556|NCT01933919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25687557|NCT01933919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25687558|NCT01933919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24745979|NCT03460379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745980|NCT03460379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24745981|NCT03460379|Serotonin Agents|serotonin agents|mesh-ancestor
24745982|NCT03460379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687559|NCT01933919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687560|NCT01933919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25018200|NCT03701126|Anesthetics, Local|anesthetics, local|mesh-ancestor
25018201|NCT03701126|Anesthetics|anesthetics|mesh-ancestor
25018202|NCT03701126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25018203|NCT03701126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018204|NCT03701126|Sensory System Agents|sensory system agents|mesh-ancestor
25018205|NCT03701126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018207|NCT03701087|Vitamins|vitamins|mesh-ancestor
25018222|NCT03700814|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25018223|NCT03700814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25018224|NCT03700814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25018225|NCT03700814|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25018226|NCT03700814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018227|NCT03700814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018228|NCT03700801|Insulin|insulin|mesh-list
25018229|NCT03700801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25018230|NCT03700801|Metformin|metformin|mesh-list
25018231|NCT03700801|Insulin Aspart|insulin aspart|mesh-list
25018232|NCT03700801|Dapagliflozin|dapagliflozin|mesh-list
25018233|NCT03700801|Saxagliptin|saxagliptin|mesh-list
25018234|NCT03700801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25018235|NCT03700801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018236|NCT03700801|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25018237|NCT03700801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018238|NCT03700801|Incretins|incretins|mesh-ancestor
25018239|NCT03700801|Hormones|hormones|mesh-ancestor
25018240|NCT03700801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25018241|NCT03700801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25018242|NCT03700801|Protease Inhibitors|protease inhibitors|mesh-ancestor
25018243|NCT03700801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256880|NCT02479204|Vasodilator Agents|vasodilator agents|mesh-ancestor
25256881|NCT02479581|Floxacillin|floxacillin|mesh-list
25256882|NCT02479581|Dexamethasone|dexamethasone|mesh-list
25256883|NCT02479581|Methylprednisolone|methylprednisolone|mesh-list
25256884|NCT02479581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25256885|NCT02479581|Scopolamine|scopolamine|mesh-list
25256886|NCT02479581|Morphine|morphine|mesh-list
25256887|NCT02479581|Anesthetics|anesthetics|mesh-list
25256888|NCT02479581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25256889|NCT02479581|Antiemetics|antiemetics|mesh-ancestor
25256890|NCT02479581|Autonomic Agents|autonomic agents|mesh-ancestor
25256891|NCT02479581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24928815|NCT04118556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24928816|NCT04118556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24928817|NCT04118556|Immunologic Factors|immunologic factors|mesh-ancestor
24928818|NCT04118556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527778|NCT00618254|Antiemetics|antiemetics|mesh-ancestor
24527779|NCT00618254|Autonomic Agents|autonomic agents|mesh-ancestor
24527780|NCT00618254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24527781|NCT00618254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527782|NCT00618254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24527783|NCT00618254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24527784|NCT00618254|Serotonin Agents|serotonin agents|mesh-ancestor
24527785|NCT00618254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24527786|NCT00618254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527787|NCT00618280|Nicotine|nicotine|mesh-list
24527788|NCT00618280|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25687561|NCT01933919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25687562|NCT01933919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25687563|NCT01933919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25687564|NCT01933919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25687565|NCT01933919|Serotonin Agents|serotonin agents|mesh-ancestor
25687566|NCT01933919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25687567|NCT01933919|Antidepressive Agents|antidepressive agents|mesh-ancestor
24527789|NCT00618280|Autonomic Agents|autonomic agents|mesh-ancestor
24527790|NCT00618280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24494245|NCT00494572|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24494246|NCT00494572|Hormone Antagonists|hormone antagonists|mesh-ancestor
24494247|NCT00494572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24494248|NCT00494572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494249|NCT00494572|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24527791|NCT00618280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527792|NCT00618280|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24527793|NCT00618280|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24527794|NCT00618280|Cholinergic Agents|cholinergic agents|mesh-ancestor
24527795|NCT00618280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24527796|NCT00618280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928819|NCT04118556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24928820|NCT04118556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24928821|NCT04118556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24928822|NCT04118556|Antifungal Agents|antifungal agents|mesh-ancestor
24581379|NCT00865007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24581380|NCT00865007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24581381|NCT00865007|Antiviral Agents|antiviral agents|mesh-ancestor
24581382|NCT00865007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25018330|NCT03700177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25018331|NCT03700177|Sensory System Agents|sensory system agents|mesh-ancestor
25256892|NCT02479581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256893|NCT02479581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25256894|NCT02479581|Glucocorticoids|glucocorticoids|mesh-ancestor
25256895|NCT02479581|Hormones|hormones|mesh-ancestor
25256896|NCT02479581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25256897|NCT02479581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25256898|NCT02479581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256899|NCT02479581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256900|NCT02479581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25256901|NCT02479581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25256902|NCT02479581|Narcotics|narcotics|mesh-ancestor
25256903|NCT02479581|Analgesics|analgesics|mesh-ancestor
25256904|NCT02479581|Sensory System Agents|sensory system agents|mesh-ancestor
25256905|NCT02479581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25256906|NCT02479581|Protective Agents|protective agents|mesh-ancestor
25256907|NCT02479581|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25256908|NCT02479581|Mydriatics|mydriatics|mesh-ancestor
25256909|NCT02479581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25256910|NCT02479581|Cholinergic Agents|cholinergic agents|mesh-ancestor
25256911|NCT02479581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25256912|NCT02479581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25256913|NCT02479581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25256914|NCT02479581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25256915|NCT02479256|Tamoxifen|tamoxifen|mesh-list
25256916|NCT02479256|Citric Acid|citric acid|mesh-list
25256917|NCT02479256|Sodium Citrate|sodium citrate|mesh-list
25256918|NCT02479256|Clomiphene|clomiphene|mesh-list
25256919|NCT02479256|Enclomiphene|enclomiphene|mesh-list
25256920|NCT02479256|Zuclomiphene|zuclomiphene|mesh-list
25256921|NCT02479256|Anticoagulants|anticoagulants|mesh-ancestor
25256922|NCT02479256|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24928824|NCT04118556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24928825|NCT04118556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24928826|NCT04118556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24928827|NCT04118556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24928828|NCT04118556|Analgesics|analgesics|mesh-ancestor
24928829|NCT04118556|Sensory System Agents|sensory system agents|mesh-ancestor
24945222|NCT03952832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018338|NCT03699956|Carboplatin|carboplatin|mesh-list
25018339|NCT03699956|Etoposide|etoposide|mesh-list
25018340|NCT03699956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24974862|NCT05207709|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24974863|NCT05207709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25018360|NCT03699774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018361|NCT03699774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25687568|NCT01933919|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25687569|NCT01933919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25687570|NCT01933919|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25687571|NCT01933984|Fluticasone|fluticasone|mesh-list
25687572|NCT01933984|Fenoterol|fenoterol|mesh-list
25018362|NCT03699774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018363|NCT03699696|Propofol|propofol|mesh-list
25687573|NCT01933984|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25687574|NCT01933984|Bronchodilator Agents|bronchodilator agents|mesh-list
25687575|NCT01933984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24618565|NCT01048983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24618566|NCT01048983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618567|NCT01048983|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24618568|NCT01048983|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25018364|NCT03699696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25018542|NCT03698630|Methylprednisolone|methylprednisolone|mesh-list
25018365|NCT03699696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25018366|NCT03699696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25111180|NCT05102721|Avelumab|avelumab|mesh-list
24446947|NCT00306722|Fospropofol|fospropofol|mesh-list
25018387|NCT03699449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25018388|NCT03699423|Atropine|atropine|mesh-list
25018389|NCT03699423|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25018390|NCT03699423|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25018391|NCT03699423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25018392|NCT03699423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25018393|NCT03699423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25018394|NCT03699423|Autonomic Agents|autonomic agents|mesh-ancestor
25018395|NCT03699423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018396|NCT03699423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018450|NCT03699215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018451|NCT03699215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018452|NCT03699215|Protective Agents|protective agents|mesh-ancestor
25018453|NCT03699215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018454|NCT03699202|Ziresovir|ziresovir|mesh-list
25018455|NCT03699202|Antiviral Agents|antiviral agents|mesh-ancestor
25018456|NCT03699202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25018457|NCT03699033|Paclitaxel|paclitaxel|mesh-list
25018458|NCT03699033|Carboplatin|carboplatin|mesh-list
25018459|NCT03699033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25018460|NCT03699033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018461|NCT03699033|Tubulin Modulators|tubulin modulators|mesh-ancestor
25018462|NCT03699033|Antimitotic Agents|antimitotic agents|mesh-ancestor
25018475|NCT03698916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25018476|NCT03698916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018477|NCT03698916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018478|NCT03698851|Methamphetamine|methamphetamine|mesh-list
25018479|NCT03698851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25018492|NCT03698734|Evening primrose oil|evening primrose oil|mesh-list
25018493|NCT03698734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25018494|NCT03698734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25018495|NCT03698734|Analgesics|analgesics|mesh-ancestor
25093141|NCT03236883|Gemcitabine|gemcitabine|mesh-list
25018496|NCT03698734|Sensory System Agents|sensory system agents|mesh-ancestor
25018497|NCT03698734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018498|NCT03698734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018499|NCT03698734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25256923|NCT02479256|Chelating Agents|chelating agents|mesh-ancestor
25256924|NCT02479256|Sequestering Agents|sequestering agents|mesh-ancestor
25256925|NCT02479256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256926|NCT02479256|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25256927|NCT02479256|Hormone Antagonists|hormone antagonists|mesh-ancestor
25256928|NCT02479256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24928830|NCT04118556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24928831|NCT04118556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24928833|NCT04118699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24928834|NCT04118699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24928835|NCT04118699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24928836|NCT04118777|Ropivacaine|ropivacaine|mesh-list
24928837|NCT04118777|Anesthetics, Local|anesthetics, local|mesh-ancestor
24928838|NCT04118777|Anesthetics|anesthetics|mesh-ancestor
24928839|NCT04118777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24928840|NCT04118777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945349|NCT03951402|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25018500|NCT03698734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25018501|NCT03698734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25018502|NCT03698734|Antimetabolites|antimetabolites|mesh-ancestor
25687577|NCT01933984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25687578|NCT01933984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687579|NCT01933984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25687580|NCT01933984|Respiratory System Agents|respiratory system agents|mesh-ancestor
25687581|NCT01933984|Dermatologic Agents|dermatologic agents|mesh-ancestor
24494414|NCT00495118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24494415|NCT00495118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24494416|NCT00495118|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24494417|NCT00495118|Dopamine Agents|dopamine agents|mesh-ancestor
24494418|NCT00495183|Biperiden|biperiden|mesh-list
24494419|NCT00495183|Caffeine|caffeine|mesh-list
24494421|NCT00495183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746155|NCT03260504|Pembrolizumab|pembrolizumab|mesh-list
24746156|NCT03260504|Interleukin-2|interleukin-2|mesh-list
25018503|NCT03698734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018504|NCT03698734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25018505|NCT03698734|Dermatologic Agents|dermatologic agents|mesh-ancestor
25018507|NCT03698695|Donepezil|donepezil|mesh-list
25018508|NCT03698695|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25018509|NCT03698695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018510|NCT03698695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018511|NCT03698695|Cholinergic Agents|cholinergic agents|mesh-ancestor
25018512|NCT03698695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25018513|NCT03698695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018514|NCT03698695|Nootropic Agents|nootropic agents|mesh-ancestor
25018515|NCT03698695|Antimalarials|antimalarials|mesh-ancestor
25018541|NCT03698630|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25018545|NCT03698630|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25018546|NCT03698630|Prednisolone phosphate|prednisolone phosphate|mesh-list
25018547|NCT03698630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25018548|NCT03698630|Antiemetics|antiemetics|mesh-ancestor
25018549|NCT03698630|Autonomic Agents|autonomic agents|mesh-ancestor
25018550|NCT03698630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018551|NCT03698630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018552|NCT03698630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25018553|NCT03698630|Glucocorticoids|glucocorticoids|mesh-ancestor
25018554|NCT03698630|Hormones|hormones|mesh-ancestor
25093237|NCT03236584|Tenofovir|tenofovir|mesh-list
25018555|NCT03698630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25018556|NCT03698630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25018557|NCT03698630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018598|NCT03698474|Anesthetics|anesthetics|mesh-ancestor
25018599|NCT03698474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25018600|NCT03698474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25018619|NCT03698435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018621|NCT03698383|Trastuzumab|trastuzumab|mesh-list
25018651|NCT03698227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018652|NCT03698227|Antimitotic Agents|antimitotic agents|mesh-ancestor
25018653|NCT03698227|Mitosis Modulators|mitosis modulators|mesh-ancestor
25018654|NCT03698045|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25018655|NCT03698045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25018656|NCT03697889|Naproxen|naproxen|mesh-list
25018657|NCT03697889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25018658|NCT03697889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25018659|NCT03697889|Analgesics|analgesics|mesh-ancestor
25018660|NCT03697889|Sensory System Agents|sensory system agents|mesh-ancestor
25018661|NCT03697889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018662|NCT03697889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256929|NCT02479256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018663|NCT03697889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25256930|NCT02479256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25256931|NCT02479256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256932|NCT02479256|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25256933|NCT02479256|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25256934|NCT02479256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25256935|NCT02479256|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25256936|NCT02479256|Fertility Agents|fertility agents|mesh-ancestor
25256937|NCT02479256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25687582|NCT01933984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25687583|NCT01933984|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25687584|NCT01933984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25687585|NCT01933984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25687586|NCT01933984|Adrenergic Agents|adrenergic agents|mesh-ancestor
25687587|NCT01933984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25687588|NCT01933984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687589|NCT01933984|Sympathomimetics|sympathomimetics|mesh-ancestor
24504860|NCT00538395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527797|NCT00618345|Everolimus|everolimus|mesh-list
24527798|NCT00618345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746202|NCT03237702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746203|NCT03237702|Protective Agents|protective agents|mesh-ancestor
24746204|NCT03237702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746205|NCT03236311|Adenosine|adenosine|mesh-list
24746206|NCT03236311|Regadenoson|regadenoson|mesh-list
24746207|NCT03236311|Analgesics|analgesics|mesh-ancestor
24527828|NCT00618423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24527829|NCT00618423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527830|NCT00618423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24527831|NCT00618423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24527832|NCT00618423|Anesthetics, General|anesthetics, general|mesh-ancestor
25018664|NCT03697889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25018665|NCT03697889|Gout Suppressants|gout suppressants|mesh-ancestor
24975132|NCT04698031|Clopidogrel|clopidogrel|mesh-list
24975133|NCT04698031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24975134|NCT04698031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24975135|NCT04698031|Analgesics|analgesics|mesh-ancestor
24975136|NCT04698031|Sensory System Agents|sensory system agents|mesh-ancestor
24975137|NCT04698031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24975138|NCT04698031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975139|NCT04698031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24975140|NCT04698031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24975141|NCT04698031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24975142|NCT04698031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25111219|NCT05031026|Dexmedetomidine|dexmedetomidine|mesh-list
25111220|NCT05031026|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25111221|NCT05031026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25111222|NCT05031026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25111223|NCT05031026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25018699|NCT03697681|Tranexamic Acid|tranexamic acid|mesh-list
25018700|NCT03697681|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25018701|NCT03697681|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25018795|NCT03696940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25018796|NCT03696940|Antimetabolites|antimetabolites|mesh-ancestor
25018797|NCT03696940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018798|NCT03696940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25018836|NCT03696329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018837|NCT03696290|Aztreonam|aztreonam|mesh-list
24975262|NCT04421378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24975263|NCT04421378|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24975264|NCT04421378|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24975265|NCT04421378|Growth Substances|growth substances|mesh-ancestor
24975266|NCT04421378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975267|NCT04421378|Growth Inhibitors|growth inhibitors|mesh-ancestor
24975268|NCT04421378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24975269|NCT04421378|Alkylating Agents|alkylating agents|mesh-ancestor
24975271|NCT04410445|Nivolumab|nivolumab|mesh-list
25018838|NCT03696290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25018839|NCT03696290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25018840|NCT03696212|Pembrolizumab|pembrolizumab|mesh-list
25018841|NCT03696212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25018842|NCT03696212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018843|NCT03696186|Phenobarbital|phenobarbital|mesh-list
25018844|NCT03696186|Anticonvulsants|anticonvulsants|mesh-ancestor
25018845|NCT03696186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25018846|NCT03696186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25018847|NCT03696186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018848|NCT03696186|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25018849|NCT03696186|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25018873|NCT03695952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25018874|NCT03695952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018875|NCT03695952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018877|NCT03695887|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25018878|NCT03695887|Anesthetics, General|anesthetics, general|mesh-ancestor
25687591|NCT01933984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25687592|NCT01934192|Metoclopramide|metoclopramide|mesh-list
25687593|NCT01934192|Antiemetics|antiemetics|mesh-ancestor
25687594|NCT01934192|Autonomic Agents|autonomic agents|mesh-ancestor
25687595|NCT01934192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25687596|NCT01934192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687597|NCT01934192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24746246|NCT03192046|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24746247|NCT03192046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24944171|NCT03962829|1-(3-chlorophenyl)piperazine|1-(3-chlorophenyl)piperazine|mesh-list
24944172|NCT03962829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24944173|NCT03962829|Serotonin Agents|serotonin agents|mesh-ancestor
24746249|NCT03190369|Viscosupplements|viscosupplements|mesh-ancestor
24746250|NCT03190369|Protective Agents|protective agents|mesh-ancestor
24746251|NCT03190369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746253|NCT05438316|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24746254|NCT05438316|Protease Inhibitors|protease inhibitors|mesh-ancestor
25687598|NCT01934192|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25687599|NCT01934192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25018879|NCT03695887|Anesthetics|anesthetics|mesh-ancestor
25018880|NCT03695887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25018881|NCT03695887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018882|NCT03695887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25018883|NCT03695887|Analgesics|analgesics|mesh-ancestor
25018884|NCT03695887|Sensory System Agents|sensory system agents|mesh-ancestor
25018885|NCT03695887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018886|NCT03695861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25018887|NCT03695861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25018888|NCT03695861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018889|NCT03695835|Sargramostim|sargramostim|mesh-list
25018890|NCT03695835|Immunologic Factors|immunologic factors|mesh-ancestor
25018891|NCT03695835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018892|NCT03695822|Mirabegron|mirabegron|mesh-list
25018893|NCT03695822|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25018894|NCT03695822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25018895|NCT03695822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25018896|NCT03695822|Adrenergic Agents|adrenergic agents|mesh-ancestor
25018897|NCT03695822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25018921|NCT03695705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25018922|NCT03695705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25019053|NCT03693885|Oxytocics|oxytocics|mesh-ancestor
25018930|NCT03695640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25687600|NCT01934192|Dopamine Agents|dopamine agents|mesh-ancestor
25687601|NCT01934192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25687602|NCT01934192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687603|NCT01934218|Hyaluronic Acid|hyaluronic acid|mesh-list
25687604|NCT01934218|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25687605|NCT01934218|Immunologic Factors|immunologic factors|mesh-ancestor
25687606|NCT01934218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687607|NCT01934218|Viscosupplements|viscosupplements|mesh-ancestor
25687608|NCT01934218|Protective Agents|protective agents|mesh-ancestor
25687609|NCT01934231|Amoxicillin|amoxicillin|mesh-list
25687610|NCT01934231|Clavulanic Acid|clavulanic acid|mesh-list
25687611|NCT01934231|Clavulanic Acids|clavulanic acids|mesh-list
25687612|NCT01934231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25687613|NCT01934231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25687614|NCT01934231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25687615|NCT01934231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25687616|NCT01934231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687617|NCT01934231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687618|NCT01934556|Ranibizumab|ranibizumab|mesh-list
25687619|NCT01934556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25687620|NCT01934556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25687621|NCT01934556|Growth Substances|growth substances|mesh-ancestor
25687622|NCT01934556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687623|NCT01934556|Growth Inhibitors|growth inhibitors|mesh-ancestor
25018931|NCT03695640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746304|NCT05438108|Growth Substances|growth substances|mesh-ancestor
24746305|NCT05438108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018932|NCT03695640|Anesthetics|anesthetics|mesh-ancestor
25018933|NCT03695640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25018934|NCT03695640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25018935|NCT03695640|Anticonvulsants|anticonvulsants|mesh-ancestor
25018936|NCT03695640|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25018937|NCT03695640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25018938|NCT03695640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018939|NCT03695640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25018940|NCT03695640|Tocolytic Agents|tocolytic agents|mesh-ancestor
25018941|NCT03695640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25018942|NCT03695445|Norepinephrine|norepinephrine|mesh-list
25018943|NCT03695445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25018944|NCT03695445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25018945|NCT03695445|Adrenergic Agents|adrenergic agents|mesh-ancestor
25018949|NCT03695445|Sympathomimetics|sympathomimetics|mesh-ancestor
25018964|NCT03695029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25018965|NCT03695029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25018966|NCT03695029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25018967|NCT03695029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018968|NCT03695029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018969|NCT03695029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25018970|NCT03695029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25018971|NCT03694977|Spartalizumab|spartalizumab|mesh-list
25018972|NCT03694977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25018973|NCT03694977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928841|NCT04118777|Sensory System Agents|sensory system agents|mesh-ancestor
24928842|NCT04118777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24928843|NCT04118153|Abatacept|abatacept|mesh-list
25018974|NCT03694977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018975|NCT03694886|Caffeine|caffeine|mesh-list
25018976|NCT03694886|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25018977|NCT03694886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018978|NCT03694886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25018979|NCT03694886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018980|NCT03694886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018981|NCT03694886|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25018982|NCT03694886|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25018983|NCT03694886|Purinergic Agents|purinergic agents|mesh-ancestor
25018984|NCT03694886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24975451|NCT03680274|Protective Agents|protective agents|mesh-ancestor
24975540|NCT03477539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24975542|NCT03476681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24975543|NCT03476681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586982|NCT00893009|Theophylline|theophylline|mesh-list
24586983|NCT00893009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24586984|NCT00893009|Autonomic Agents|autonomic agents|mesh-ancestor
25018987|NCT03694873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25018988|NCT03694873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25018989|NCT03694873|Analgesics|analgesics|mesh-ancestor
25018990|NCT03694873|Sensory System Agents|sensory system agents|mesh-ancestor
25018991|NCT03694873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018992|NCT03694873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018993|NCT03694873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25018994|NCT03694873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25019060|NCT03693872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019061|NCT03693872|Autonomic Agents|autonomic agents|mesh-ancestor
25019062|NCT03693872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25019063|NCT03693872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25019064|NCT03693872|Dopamine Agents|dopamine agents|mesh-ancestor
25019065|NCT03693872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25019066|NCT03693872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019067|NCT03693872|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25019068|NCT03693872|Sympathomimetics|sympathomimetics|mesh-ancestor
25019069|NCT03693872|Protective Agents|protective agents|mesh-ancestor
25111308|NCT04965506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25111309|NCT04965506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25111310|NCT04964024|Antibodies|antibodies|mesh-list
25111311|NCT04964024|Immunologic Factors|immunologic factors|mesh-ancestor
25687624|NCT01934556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25687625|NCT01934582|Treprostinil|treprostinil|mesh-list
25111312|NCT04964024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687626|NCT01934582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25687627|NCT01934790|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25687628|NCT01934790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25687630|NCT01934894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25687631|NCT01934894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25687632|NCT01934894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24746409|NCT05436678|Ciprofloxacin|ciprofloxacin|mesh-list
24746410|NCT05436678|Celecoxib|celecoxib|mesh-list
24746411|NCT05436678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24746412|NCT05436678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24746413|NCT05436678|Analgesics|analgesics|mesh-ancestor
24746414|NCT05436678|Sensory System Agents|sensory system agents|mesh-ancestor
24746446|NCT05436522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25111313|NCT04954313|Chlorhexidine|chlorhexidine|mesh-list
25111314|NCT04954313|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25019172|NCT03693222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25019174|NCT03693183|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25019175|NCT03693183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25019176|NCT03693183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25019177|NCT03693183|Analgesics|analgesics|mesh-ancestor
25019178|NCT03693183|Sensory System Agents|sensory system agents|mesh-ancestor
25019179|NCT03693183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25019180|NCT03693183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019181|NCT03693183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25019182|NCT03693183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25019183|NCT03693183|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25256953|NCT02479308|Moxifloxacin|moxifloxacin|mesh-list
25256954|NCT02479308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24928844|NCT04118153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24928845|NCT04118153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928846|NCT04118153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24928847|NCT04118153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24928848|NCT04118153|Immunologic Factors|immunologic factors|mesh-ancestor
24928849|NCT04118153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928850|NCT04118153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24928851|NCT04117919|Triamcinolone|triamcinolone|mesh-list
24928852|NCT04117919|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24945499|NCT03950271|Oxaliplatin|oxaliplatin|mesh-list
25019184|NCT03693183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25019224|NCT03692754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25019225|NCT03692754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25019226|NCT03692754|Antimetabolites|antimetabolites|mesh-ancestor
25019227|NCT03692754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019228|NCT03692754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25019229|NCT03692754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25019230|NCT03692754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25019231|NCT03692546|Bupivacaine|bupivacaine|mesh-list
25019232|NCT03692546|Anesthetics, Local|anesthetics, local|mesh-ancestor
25019233|NCT03692546|Anesthetics|anesthetics|mesh-ancestor
25019234|NCT03692546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24975690|NCT03239145|Pembrolizumab|pembrolizumab|mesh-list
25019235|NCT03692546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019236|NCT03692546|Sensory System Agents|sensory system agents|mesh-ancestor
25019237|NCT03692546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25019238|NCT03692481|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25019239|NCT03692481|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25019527|NCT03690739|Growth Inhibitors|growth inhibitors|mesh-ancestor
25019240|NCT03692481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019242|NCT03692416|Ibuprofen|ibuprofen|mesh-list
25019243|NCT03692416|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25019244|NCT03692416|Methotrexate|methotrexate|mesh-list
25019245|NCT03692416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25019246|NCT03692416|Glucocorticoids|glucocorticoids|mesh-ancestor
25019331|NCT03691922|Adrenergic Agents|adrenergic agents|mesh-ancestor
25019332|NCT03691922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25019333|NCT03691922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019334|NCT03691922|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25687633|NCT01934894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687634|NCT01934972|Cycloserine|cycloserine|mesh-list
25687635|NCT01934972|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25687636|NCT01934972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25687637|NCT01934972|Renal Agents|renal agents|mesh-ancestor
25687638|NCT01934972|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25687639|NCT01934972|Antitubercular Agents|antitubercular agents|mesh-ancestor
24746525|NCT05351086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24746526|NCT05351086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746527|NCT05351086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746528|NCT05351086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24746529|NCT05351086|Analgesics|analgesics|mesh-ancestor
24746530|NCT05351086|Sensory System Agents|sensory system agents|mesh-ancestor
24746531|NCT05351086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24746532|NCT05265286|Factor VIII|factor viii|mesh-list
24746533|NCT05265286|Coagulants|coagulants|mesh-ancestor
24409726|NCT00182806|Irinotecan|irinotecan|mesh-list
25019335|NCT03691922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25019336|NCT03691922|Autonomic Agents|autonomic agents|mesh-ancestor
25019337|NCT03691922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25019366|NCT03691688|Sensory System Agents|sensory system agents|mesh-ancestor
25019367|NCT03691688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25019368|NCT03691688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019369|NCT03691688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25019370|NCT03691688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25019371|NCT03691688|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25019372|NCT03691688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25256955|NCT02479308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25019373|NCT03691688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515858|NCT00599716|Hyaluronic Acid|hyaluronic acid|mesh-list
25256956|NCT02479308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25256957|NCT02479308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25256958|NCT02479308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256959|NCT02479308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256960|NCT02479308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256961|NCT02479347|Chlorhexidine|chlorhexidine|mesh-list
25256962|NCT02479347|Povidone-Iodine|povidone-iodine|mesh-list
25256963|NCT02479347|Povidone|povidone|mesh-list
25256964|NCT02479347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25256965|NCT02479347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24928853|NCT04117919|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24928854|NCT04117919|Hydrocortisone|hydrocortisone|mesh-list
24928855|NCT04117919|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24928856|NCT04117919|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24928857|NCT04117919|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24798959|NCT01966263|Autonomic Agents|autonomic agents|mesh-ancestor
25019434|NCT03691467|Protective Agents|protective agents|mesh-ancestor
25019435|NCT03691454|Docetaxel|docetaxel|mesh-list
25019436|NCT03691454|Oxaliplatin|oxaliplatin|mesh-list
25019437|NCT03691454|Trastuzumab|trastuzumab|mesh-list
25019438|NCT03691454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019439|NCT03691454|Tubulin Modulators|tubulin modulators|mesh-ancestor
25019440|NCT03691454|Antimitotic Agents|antimitotic agents|mesh-ancestor
25019441|NCT03691454|Mitosis Modulators|mitosis modulators|mesh-ancestor
25019442|NCT03691454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019443|NCT03691454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25019444|NCT03691415|Deoxycholic Acid|deoxycholic acid|mesh-list
25019445|NCT03691415|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25019446|NCT03691415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25093687|NCT03232710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093695|NCT03232554|Iron|iron|mesh-list
25019471|NCT03691090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019472|NCT03691090|Tubulin Modulators|tubulin modulators|mesh-ancestor
25019473|NCT03691090|Antimitotic Agents|antimitotic agents|mesh-ancestor
25019480|NCT03691038|Analgesics|analgesics|mesh-ancestor
25019481|NCT03691038|Sensory System Agents|sensory system agents|mesh-ancestor
25019482|NCT03691038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25019483|NCT03691038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019484|NCT03691038|Anticonvulsants|anticonvulsants|mesh-ancestor
25019516|NCT03690739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25019517|NCT03690739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019518|NCT03690739|Tubulin Modulators|tubulin modulators|mesh-ancestor
25019519|NCT03690739|Antimitotic Agents|antimitotic agents|mesh-ancestor
25019520|NCT03690739|Mitosis Modulators|mitosis modulators|mesh-ancestor
25687640|NCT01934972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25687641|NCT01934972|Antimetabolites|antimetabolites|mesh-ancestor
25687642|NCT01934972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687643|NCT01935622|Doxycycline|doxycycline|mesh-list
25687644|NCT01935622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25687645|NCT01935622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25687646|NCT01935622|Antimalarials|antimalarials|mesh-ancestor
25687647|NCT01935622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25687648|NCT01935622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25687649|NCT01935700|Colchicine|colchicine|mesh-list
25019521|NCT03690739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687651|NCT01935700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25687652|NCT01935700|Tubulin Modulators|tubulin modulators|mesh-ancestor
25687653|NCT01935700|Antimitotic Agents|antimitotic agents|mesh-ancestor
25019522|NCT03690739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25019523|NCT03690739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25019524|NCT03690739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25019525|NCT03690739|Growth Substances|growth substances|mesh-ancestor
25019526|NCT03690739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515879|NCT00599833|Cetuximab|cetuximab|mesh-list
25019577|NCT03690323|Paclitaxel|paclitaxel|mesh-list
25019578|NCT03690323|Folfirinox|folfirinox|mesh-list
25019579|NCT03690323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25019580|NCT03690323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019581|NCT03690323|Tubulin Modulators|tubulin modulators|mesh-ancestor
25019582|NCT03690323|Antimitotic Agents|antimitotic agents|mesh-ancestor
25019583|NCT03690323|Mitosis Modulators|mitosis modulators|mesh-ancestor
25019584|NCT03690323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019586|NCT03690323|Antimetabolites|antimetabolites|mesh-ancestor
25256966|NCT02479347|Disinfectants|disinfectants|mesh-ancestor
25256967|NCT02479347|Plasma Substitutes|plasma substitutes|mesh-ancestor
25256968|NCT02479347|Blood Substitutes|blood substitutes|mesh-ancestor
25256969|NCT02479555|Dexamethasone|dexamethasone|mesh-list
25256970|NCT02479555|Dexamethasone acetate|dexamethasone acetate|mesh-list
25256971|NCT02479555|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25256972|NCT02479555|BB 1101|bb 1101|mesh-list
24928858|NCT04117919|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24928859|NCT04117919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24928860|NCT04117919|Glucocorticoids|glucocorticoids|mesh-ancestor
24928861|NCT04117919|Hormones|hormones|mesh-ancestor
24928862|NCT04117919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24928863|NCT04117919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928864|NCT04117919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24928865|NCT04117919|Immunologic Factors|immunologic factors|mesh-ancestor
24928866|NCT04117919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24928867|NCT04117919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093758|NCT03232216|Vitamin D|vitamin d|mesh-list
25111409|NCT04846491|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25111410|NCT04846491|Interferon-alpha|interferon-alpha|mesh-list
25111411|NCT04846491|Antiviral Agents|antiviral agents|mesh-ancestor
25111412|NCT04846491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25111413|NCT04846491|Immunologic Factors|immunologic factors|mesh-ancestor
25111414|NCT04846491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25111417|NCT04841434|Methotrexate|methotrexate|mesh-list
25111418|NCT04841434|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25111419|NCT04841434|Abortifacient Agents|abortifacient agents|mesh-ancestor
24976105|NCT01411267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25019596|NCT03690115|Ponatinib|ponatinib|mesh-list
25019597|NCT03690115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019598|NCT03690115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25019599|NCT03690115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25019600|NCT03690115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019601|NCT03689998|Melatonin|melatonin|mesh-list
25019602|NCT03689998|Antioxidants|antioxidants|mesh-ancestor
25019603|NCT03689998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019604|NCT03689998|Protective Agents|protective agents|mesh-ancestor
25019617|NCT03689465|Mycophenolic Acid|mycophenolic acid|mesh-list
25019618|NCT03689465|Methotrexate|methotrexate|mesh-list
25019619|NCT03689465|Cyclosporins|cyclosporins|mesh-list
25019620|NCT03689465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25019621|NCT03689465|Abortifacient Agents|abortifacient agents|mesh-ancestor
25019622|NCT03689465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25019623|NCT03689465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019624|NCT03689465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25019625|NCT03689465|Antimetabolites|antimetabolites|mesh-ancestor
25019626|NCT03689465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687654|NCT01935700|Mitosis Modulators|mitosis modulators|mesh-ancestor
25687655|NCT01935700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687656|NCT01935700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25687657|NCT01935791|Glucagon|glucagon|mesh-list
25687658|NCT01935791|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24746722|NCT04100096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24746762|NCT03819296|Glucocorticoids|glucocorticoids|mesh-ancestor
25687659|NCT01935791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25687660|NCT01935791|Hormones|hormones|mesh-ancestor
25687661|NCT01935791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25687662|NCT01935791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687663|NCT01935791|Incretins|incretins|mesh-ancestor
24746763|NCT03819296|Hormones|hormones|mesh-ancestor
25019627|NCT03689465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019628|NCT03689465|Dermatologic Agents|dermatologic agents|mesh-ancestor
25019629|NCT03689465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25019630|NCT03689465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25019677|NCT03689075|Tacrolimus|tacrolimus|mesh-list
25019678|NCT03689075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25019679|NCT03689075|Immunologic Factors|immunologic factors|mesh-ancestor
25019680|NCT03689075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019691|NCT03688971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25019692|NCT03688971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25019693|NCT03688971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019694|NCT03688971|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25019695|NCT03688971|Hormone Antagonists|hormone antagonists|mesh-ancestor
25019696|NCT03688971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25019697|NCT03688971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019700|NCT03688958|Cadexomer iodine|cadexomer iodine|mesh-list
25019728|NCT03688464|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25019729|NCT03688464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25019730|NCT03688464|Anesthetics, Local|anesthetics, local|mesh-ancestor
25256973|NCT02479555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25256974|NCT02479555|Antiemetics|antiemetics|mesh-ancestor
25256975|NCT02479555|Autonomic Agents|autonomic agents|mesh-ancestor
25256976|NCT02479555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25256977|NCT02479555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256978|NCT02479555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25256979|NCT02479555|Glucocorticoids|glucocorticoids|mesh-ancestor
25256980|NCT02479555|Hormones|hormones|mesh-ancestor
25256981|NCT02479555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25256982|NCT02479555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24928868|NCT04117893|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24928869|NCT04117893|Hyaluronic Acid|hyaluronic acid|mesh-list
24928870|NCT04117893|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24928871|NCT04117893|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25019731|NCT03688464|Anesthetics|anesthetics|mesh-ancestor
25019732|NCT03688464|Sensory System Agents|sensory system agents|mesh-ancestor
25019733|NCT03688464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25019734|NCT03688464|Antiemetics|antiemetics|mesh-ancestor
25019735|NCT03688464|Autonomic Agents|autonomic agents|mesh-ancestor
25019736|NCT03688464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25019737|NCT03688464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25019738|NCT03688464|Histamine Antagonists|histamine antagonists|mesh-ancestor
25019739|NCT03688464|Histamine Agents|histamine agents|mesh-ancestor
25019740|NCT03688464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25019741|NCT03688464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25019742|NCT03688464|Antipruritics|antipruritics|mesh-ancestor
25019743|NCT03688464|Dermatologic Agents|dermatologic agents|mesh-ancestor
25019744|NCT03688451|Rituximab|rituximab|mesh-list
24976238|NCT04335669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25019745|NCT03688451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25019746|NCT03688451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019747|NCT03688451|Immunologic Factors|immunologic factors|mesh-ancestor
25019748|NCT03688451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019749|NCT03688451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25019750|NCT03688295|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25019751|NCT03688295|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25019752|NCT03688295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25019753|NCT03688295|Antitubercular Agents|antitubercular agents|mesh-ancestor
25019754|NCT03688269|Dexamethasone|dexamethasone|mesh-list
25019755|NCT03688269|Ropivacaine|ropivacaine|mesh-list
25019756|NCT03688269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25019757|NCT03688269|Antiemetics|antiemetics|mesh-ancestor
25687664|NCT01936181|Infliximab|infliximab|mesh-list
25687665|NCT01936181|Dermatologic Agents|dermatologic agents|mesh-ancestor
25687666|NCT01936181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25687667|NCT01936181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25687668|NCT01936363|Niacinamide|niacinamide|mesh-list
24746928|NCT02663908|Leuprolide|leuprolide|mesh-list
24746929|NCT02663908|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24746930|NCT02663908|Fertility Agents|fertility agents|mesh-ancestor
24746931|NCT02663908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24746932|NCT02663908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746933|NCT02663908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24746934|NCT02663908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746947|NCT02535338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24746948|NCT02535338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746950|NCT02500797|Ipilimumab|ipilimumab|mesh-list
24411406|NCT00188942|Serotonin Agents|serotonin agents|mesh-ancestor
24746952|NCT02500797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746953|NCT02500797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24746954|NCT02500797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944189|NCT03962725|Propofol|propofol|mesh-list
24944190|NCT03962725|Anesthetics|anesthetics|mesh-list
24413770|NCT00195195|Sirolimus|sirolimus|mesh-list
24746983|NCT02426658|Pemetrexed|pemetrexed|mesh-list
24746984|NCT02426658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746985|NCT02426658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24746986|NCT02426658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746987|NCT02426658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25687669|NCT01936363|Vitamin B Complex|vitamin b complex|mesh-ancestor
25687670|NCT01936363|Vitamins|vitamins|mesh-ancestor
25687671|NCT01936363|Micronutrients|micronutrients|mesh-ancestor
25687672|NCT01936363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687673|NCT01936519|Cyclosporine|cyclosporine|mesh-list
24747002|NCT02333292|Antiviral Agents|antiviral agents|mesh-ancestor
24747003|NCT02333292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25019758|NCT03688269|Autonomic Agents|autonomic agents|mesh-ancestor
25019759|NCT03688269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25019763|NCT03688269|Hormones|hormones|mesh-ancestor
25019770|NCT03688269|Sensory System Agents|sensory system agents|mesh-ancestor
25111427|NCT04841434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25111428|NCT04841434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24976320|NCT04154800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25111450|NCT04823065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019776|NCT03688191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25019777|NCT03688191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25019778|NCT03688191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019779|NCT03688191|Antifungal Agents|antifungal agents|mesh-ancestor
25019780|NCT03688191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25019781|NCT03688191|Immunologic Factors|immunologic factors|mesh-ancestor
25019782|NCT03688191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019784|NCT03687931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25019785|NCT03687931|Antiemetics|antiemetics|mesh-ancestor
25687674|NCT01936519|Mycophenolic Acid|mycophenolic acid|mesh-list
25687675|NCT01936519|Everolimus|everolimus|mesh-list
25687676|NCT01936519|Tacrolimus|tacrolimus|mesh-list
25687677|NCT01936519|Cyclosporins|cyclosporins|mesh-list
25687678|NCT01936519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
25687679|NCT01936519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25687680|NCT01936519|Immunologic Factors|immunologic factors|mesh-ancestor
25687681|NCT01936519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687682|NCT01936519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687683|NCT01936519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687684|NCT01936519|Antifungal Agents|antifungal agents|mesh-ancestor
25687685|NCT01936519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25687686|NCT01936519|Dermatologic Agents|dermatologic agents|mesh-ancestor
25687687|NCT01936519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25687688|NCT01936519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25687689|NCT01936519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25687690|NCT01936519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25687691|NCT01936519|Antitubercular Agents|antitubercular agents|mesh-ancestor
25687692|NCT01936519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25687693|NCT01936649|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
25687694|NCT01936649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25687695|NCT01936649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687696|NCT01936649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687697|NCT01936649|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25687698|NCT01936844|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25687699|NCT01936844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25687700|NCT01936870|Fesoterodine|fesoterodine|mesh-list
25687701|NCT01936870|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25687702|NCT01936870|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24747004|NCT02333292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24747005|NCT02333292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24747014|NCT02277106|Brexanolone|brexanolone|mesh-list
24747015|NCT02277106|Neurosteroids|neurosteroids|mesh-ancestor
24747016|NCT02277106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25005576|NCT03503370|Disinfectants|disinfectants|mesh-ancestor
24747025|NCT02203773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25019786|NCT03687931|Autonomic Agents|autonomic agents|mesh-ancestor
25019787|NCT03687931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25019788|NCT03687931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019789|NCT03687931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25019790|NCT03687931|Glucocorticoids|glucocorticoids|mesh-ancestor
25019791|NCT03687931|Hormones|hormones|mesh-ancestor
25019792|NCT03687931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25019793|NCT03687931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25019794|NCT03687931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019826|NCT03687463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25019827|NCT03687463|Antimetabolites|antimetabolites|mesh-ancestor
25256983|NCT02479555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256984|NCT02479555|Protease Inhibitors|protease inhibitors|mesh-ancestor
25256985|NCT02479555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25256986|NCT02479555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256987|NCT02479399|Ipragliflozin|ipragliflozin|mesh-list
24928931|NCT04117009|Remifentanil|remifentanil|mesh-list
24928872|NCT04117893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24928878|NCT04117893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24928880|NCT04117893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24928882|NCT04117893|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24928889|NCT04117776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24928890|NCT04117776|Disinfectants|disinfectants|mesh-ancestor
24928891|NCT04117776|Dermatologic Agents|dermatologic agents|mesh-ancestor
25019828|NCT03687463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019829|NCT03687463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019830|NCT03687463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25019832|NCT03687268|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25019833|NCT03687268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019834|NCT03687268|Sensory System Agents|sensory system agents|mesh-ancestor
25019835|NCT03687268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25019836|NCT03687255|Tazobactam|tazobactam|mesh-list
25019837|NCT03687255|Piperacillin|piperacillin|mesh-list
25019838|NCT03687255|Cefepime|cefepime|mesh-list
25019839|NCT03687255|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25019885|NCT03686722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25019886|NCT03686722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019897|NCT03686657|Metformin|metformin|mesh-list
25019898|NCT03686657|Celecoxib|celecoxib|mesh-list
25019940|NCT03686163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587036|NCT00893217|Immunologic Factors|immunologic factors|mesh-ancestor
24587037|NCT00893217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587038|NCT00893217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24587040|NCT00893256|Citalopram|citalopram|mesh-list
24587105|NCT00893490|Mitomycin|mitomycin|mesh-list
24587106|NCT00893490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24587107|NCT00893490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019996|NCT03685032|Dermatologic Agents|dermatologic agents|mesh-ancestor
25019997|NCT03685032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25019998|NCT03685032|Serotonin Agents|serotonin agents|mesh-ancestor
25019999|NCT03685032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25020000|NCT03685032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020001|NCT03685032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25020002|NCT03685032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25020003|NCT03685032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25256988|NCT02479399|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25687703|NCT01936870|Cholinergic Agents|cholinergic agents|mesh-ancestor
25687704|NCT01936870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25687705|NCT01936870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687706|NCT01936870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687707|NCT01936870|Urological Agents|urological agents|mesh-ancestor
25687708|NCT01936896|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25687709|NCT01936896|Protein C Inhibitor|protein c inhibitor|mesh-list
25687710|NCT01936896|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24618639|NCT01049425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24618640|NCT01049425|Alkylating Agents|alkylating agents|mesh-ancestor
24618641|NCT01049425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618642|NCT01049425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618643|NCT01049425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24618644|NCT01049425|Tubulin Modulators|tubulin modulators|mesh-ancestor
24618645|NCT01049425|Antimitotic Agents|antimitotic agents|mesh-ancestor
24618646|NCT01049425|Mitosis Modulators|mitosis modulators|mesh-ancestor
24747147|NCT01746173|Immunologic Factors|immunologic factors|mesh-ancestor
24537206|NCT00653952|Paclitaxel|paclitaxel|mesh-list
24747148|NCT01746173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944195|NCT03962725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944196|NCT03962725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24747155|NCT01746173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24747156|NCT01746173|Antimetabolites|antimetabolites|mesh-ancestor
24747157|NCT01746173|Antiviral Agents|antiviral agents|mesh-ancestor
24747165|NCT01746173|Hormones|hormones|mesh-ancestor
25256989|NCT02479399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256990|NCT02479399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25256991|NCT02479399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25256992|NCT02479178|Docetaxel|docetaxel|mesh-list
25256993|NCT02479178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25256994|NCT02479178|Tubulin Modulators|tubulin modulators|mesh-ancestor
25256995|NCT02479178|Antimitotic Agents|antimitotic agents|mesh-ancestor
24928894|NCT04117750|Calcium Carbonate|calcium carbonate|mesh-list
24928895|NCT04117750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24928896|NCT04117750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928898|NCT04117750|Micronutrients|micronutrients|mesh-ancestor
24928899|NCT04117750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24928900|NCT04117750|Antacids|antacids|mesh-ancestor
24928901|NCT04117750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928902|NCT04117750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24928903|NCT04117698|Ethambutol|ethambutol|mesh-list
24928904|NCT04117698|Antitubercular Agents|antitubercular agents|mesh-ancestor
24928905|NCT04117698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24928906|NCT04117698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24928907|NCT04118322|Peppermint oil|peppermint oil|mesh-list
24527856|NCT00618501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24527857|NCT00618501|Antimetabolites|antimetabolites|mesh-ancestor
24527871|NCT00618501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24527872|NCT00618501|Antidotes|antidotes|mesh-ancestor
24527873|NCT00618501|Protective Agents|protective agents|mesh-ancestor
24527874|NCT00618501|Vitamin B Complex|vitamin b complex|mesh-ancestor
24527875|NCT00618501|Vitamins|vitamins|mesh-ancestor
25020004|NCT03685032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25020055|NCT03684564|Protease Inhibitors|protease inhibitors|mesh-ancestor
25020056|NCT03684564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25020057|NCT03684564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020062|NCT03684447|Propofol|propofol|mesh-list
25020063|NCT03684447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25020064|NCT03684447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24928932|NCT04117009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25020065|NCT03684447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020066|NCT03684447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25020067|NCT03684447|Anesthetics, General|anesthetics, general|mesh-ancestor
25020068|NCT03684447|Anesthetics|anesthetics|mesh-ancestor
25020069|NCT03684395|Warfarin|warfarin|mesh-list
25020070|NCT03684395|Rivaroxaban|rivaroxaban|mesh-list
25020110|NCT03683329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25687711|NCT01936896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25687712|NCT01936896|Protease Inhibitors|protease inhibitors|mesh-ancestor
25687713|NCT01936896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687714|NCT01936896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687715|NCT01936909|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25687716|NCT01936909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25687717|NCT01937026|Probenecid|probenecid|mesh-list
25687718|NCT01937026|Uricosuric Agents|uricosuric agents|mesh-ancestor
25687719|NCT01937026|Gout Suppressants|gout suppressants|mesh-ancestor
25687720|NCT01937026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25687721|NCT01937026|Renal Agents|renal agents|mesh-ancestor
25687722|NCT01937117|Trastuzumab|trastuzumab|mesh-list
25687723|NCT01937117|Pertuzumab|pertuzumab|mesh-list
25687724|NCT01937117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25687725|NCT01937117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25687726|NCT01937260|Brodalumab|brodalumab|mesh-list
25687727|NCT01937260|Dermatologic Agents|dermatologic agents|mesh-ancestor
25687728|NCT01937299|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24411790|NCT00190008|Nootropic Agents|nootropic agents|mesh-ancestor
24411791|NCT00190021|Donepezil|donepezil|mesh-list
24411792|NCT00190021|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24411793|NCT00190021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411794|NCT00190021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411795|NCT00190021|Cholinergic Agents|cholinergic agents|mesh-ancestor
24411796|NCT00190021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25020111|NCT03683277|Dexamethasone|dexamethasone|mesh-list
25020127|NCT03683277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25020128|NCT03683277|Growth Substances|growth substances|mesh-ancestor
25020164|NCT03682939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020165|NCT03682718|Misoprostol|misoprostol|mesh-list
25020166|NCT03682718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25020167|NCT03682718|Abortifacient Agents|abortifacient agents|mesh-ancestor
25020168|NCT03682718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25256996|NCT02479178|Mitosis Modulators|mitosis modulators|mesh-ancestor
25256997|NCT02479178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25256998|NCT02479230|Gemcitabine|gemcitabine|mesh-list
25256999|NCT02479230|Vaccines|vaccines|mesh-list
25257000|NCT02479230|Immunologic Factors|immunologic factors|mesh-ancestor
25257001|NCT02479230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257002|NCT02479230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25257003|NCT02479230|Antimetabolites|antimetabolites|mesh-ancestor
25257004|NCT02479230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257005|NCT02479230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25257006|NCT02479230|Antiviral Agents|antiviral agents|mesh-ancestor
25257007|NCT02479230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25257008|NCT02479230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257009|NCT02479230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25257010|NCT02479217|Docetaxel|docetaxel|mesh-list
25257011|NCT02479217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25257012|NCT02479217|Tubulin Modulators|tubulin modulators|mesh-ancestor
25257013|NCT02479217|Antimitotic Agents|antimitotic agents|mesh-ancestor
25257014|NCT02479217|Mitosis Modulators|mitosis modulators|mesh-ancestor
25257015|NCT02479217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257016|NCT02479529|Norepinephrine|norepinephrine|mesh-list
24527877|NCT00618501|Tubulin Modulators|tubulin modulators|mesh-ancestor
24527900|NCT00618527|Immunologic Factors|immunologic factors|mesh-ancestor
24527901|NCT00618527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527902|NCT00618527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24527903|NCT00618579|Warfarin|warfarin|mesh-list
24527904|NCT00618579|Anticoagulants|anticoagulants|mesh-ancestor
24527905|NCT00618631|Carfentanil|carfentanil|mesh-list
24527906|NCT00618631|Nicotine|nicotine|mesh-list
24527907|NCT00618631|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24527908|NCT00618631|Autonomic Agents|autonomic agents|mesh-ancestor
24928908|NCT04118322|Antiemetics|antiemetics|mesh-ancestor
24928909|NCT04118322|Autonomic Agents|autonomic agents|mesh-ancestor
24928910|NCT04118322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24798975|NCT01966289|Guadecitabine|guadecitabine|mesh-list
25020169|NCT03682718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020170|NCT03682718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25020171|NCT03682718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25020172|NCT03682718|Oxytocics|oxytocics|mesh-ancestor
25020173|NCT03682692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25020174|NCT03682692|Protease Inhibitors|protease inhibitors|mesh-ancestor
25020175|NCT03682692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25020176|NCT03682692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020177|NCT03682653|Azithromycin|azithromycin|mesh-list
25020178|NCT03682653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25020188|NCT03682497|Spironolactone|spironolactone|mesh-list
25020189|NCT03682497|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25020190|NCT03682497|Hormone Antagonists|hormone antagonists|mesh-ancestor
25020191|NCT03682497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25687729|NCT01937299|Travoprost|travoprost|mesh-list
25687730|NCT01937299|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25687731|NCT01937299|Brinzolamide|brinzolamide|mesh-list
25687732|NCT01937299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25687733|NCT01937299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25687734|NCT01937299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25687735|NCT01937299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25687736|NCT01937299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25687737|NCT01937299|Adrenergic Agents|adrenergic agents|mesh-ancestor
25687738|NCT01937299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24944211|NCT03962725|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24444122|NCT00296751|Analgesics|analgesics|mesh-ancestor
25020194|NCT03682497|Diuretics|diuretics|mesh-ancestor
25020240|NCT03682172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25094149|NCT03228576|Everolimus|everolimus|mesh-list
25020241|NCT03682172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020242|NCT03682172|Incretins|incretins|mesh-ancestor
25020243|NCT03682029|Ascorbic Acid|ascorbic acid|mesh-list
25020257|NCT03681652|Antimetabolites|antimetabolites|mesh-ancestor
25020258|NCT03681652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020259|NCT03681652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25020260|NCT03681652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25687739|NCT01937299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020261|NCT03681652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25020262|NCT03681652|Immunologic Factors|immunologic factors|mesh-ancestor
24928933|NCT04117009|Narcotics|narcotics|mesh-ancestor
25020263|NCT03681652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257017|NCT02479529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25257018|NCT02479529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25257019|NCT02479529|Adrenergic Agents|adrenergic agents|mesh-ancestor
25257020|NCT02479529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25257021|NCT02479529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257022|NCT02479529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257023|NCT02479529|Sympathomimetics|sympathomimetics|mesh-ancestor
25257024|NCT02479529|Autonomic Agents|autonomic agents|mesh-ancestor
25257025|NCT02479529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25257026|NCT02479529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25257027|NCT02479165|Oxycodone|oxycodone|mesh-list
25257028|NCT02479165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25257029|NCT02479165|Narcotics|narcotics|mesh-ancestor
24928911|NCT04118322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928912|NCT04118322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24928913|NCT04118322|Parasympatholytics|parasympatholytics|mesh-ancestor
24928914|NCT04117139|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24928915|NCT04117139|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24928916|NCT04117139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928918|NCT04117178|Donepezil|donepezil|mesh-list
24928919|NCT04117178|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24928920|NCT04117178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24928921|NCT04117178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928922|NCT04117178|Cholinergic Agents|cholinergic agents|mesh-ancestor
24928923|NCT04117178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24799004|NCT01966575|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25020362|NCT03680638|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25020364|NCT03680638|Protective Agents|protective agents|mesh-ancestor
25020365|NCT03680638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020366|NCT03680638|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25020367|NCT03680638|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25020368|NCT03680638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25020399|NCT03680495|Methylprednisolone|methylprednisolone|mesh-list
25020400|NCT03680495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25020401|NCT03680495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25020402|NCT03680495|Prednisolone|prednisolone|mesh-list
25020403|NCT03680495|Prednisolone acetate|prednisolone acetate|mesh-list
25020404|NCT03680495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25020405|NCT03680495|Prednisolone phosphate|prednisolone phosphate|mesh-list
25020406|NCT03680495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25020407|NCT03680495|Antiemetics|antiemetics|mesh-ancestor
25020408|NCT03680495|Autonomic Agents|autonomic agents|mesh-ancestor
25020409|NCT03680495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25020410|NCT03680495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020411|NCT03680495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25020412|NCT03680495|Glucocorticoids|glucocorticoids|mesh-ancestor
25687740|NCT01937299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687741|NCT01937299|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25687742|NCT01937299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687743|NCT01937312|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25687744|NCT01937312|Travoprost|travoprost|mesh-list
25687745|NCT01937312|Brinzolamide|brinzolamide|mesh-list
25687746|NCT01937312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24618663|NCT01049438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24618664|NCT01049438|Renal Agents|renal agents|mesh-ancestor
24618665|NCT01049438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24618666|NCT01049438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618667|NCT01049438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618668|NCT01049438|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25020413|NCT03680495|Hormones|hormones|mesh-ancestor
25020414|NCT03680495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25020415|NCT03680495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25020422|NCT03680404|Tempol|tempol|mesh-list
25020452|NCT03680339|Oxytocin|oxytocin|mesh-list
25020453|NCT03680339|Oxytocics|oxytocics|mesh-ancestor
25020454|NCT03680339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25020462|NCT03680183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25257030|NCT02479165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25020472|NCT03679897|Levobupivacaine|levobupivacaine|mesh-list
25257031|NCT02479165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257032|NCT02479165|Analgesics|analgesics|mesh-ancestor
25257033|NCT02479165|Sensory System Agents|sensory system agents|mesh-ancestor
25257034|NCT02479165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25257035|NCT02479022|Insulin|insulin|mesh-list
25257036|NCT02479022|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25257037|NCT02479022|Insulin Glargine|insulin glargine|mesh-list
25257038|NCT02479022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25257039|NCT02479022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257040|NCT02479074|Prednisolone|prednisolone|mesh-list
25257041|NCT02479074|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25257042|NCT02479074|Methylprednisolone|methylprednisolone|mesh-list
25257043|NCT02479074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24928924|NCT04117178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928926|NCT04117178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24928927|NCT04117178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24928928|NCT04117178|Dopamine Agents|dopamine agents|mesh-ancestor
24928929|NCT04117178|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24928930|NCT04117178|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24928934|NCT04117009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24928935|NCT04117009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928936|NCT04117009|Analgesics|analgesics|mesh-ancestor
25094275|NCT03227679|Varenicline|varenicline|mesh-list
24527909|NCT00618631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25020473|NCT03679897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25020474|NCT03679897|Anesthetics, Local|anesthetics, local|mesh-ancestor
25020475|NCT03679897|Anesthetics|anesthetics|mesh-ancestor
25020476|NCT03679897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25020477|NCT03679897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020478|NCT03679897|Sensory System Agents|sensory system agents|mesh-ancestor
25020506|NCT03679442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25020507|NCT03679442|Antioxidants|antioxidants|mesh-ancestor
25020508|NCT03679442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020509|NCT03679442|Protective Agents|protective agents|mesh-ancestor
25020510|NCT03679390|Ketamine|ketamine|mesh-list
25020511|NCT03679390|Analgesics|analgesics|mesh-ancestor
25020512|NCT03679390|Sensory System Agents|sensory system agents|mesh-ancestor
25020513|NCT03679390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25020514|NCT03679390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020515|NCT03679390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25020516|NCT03679390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25020517|NCT03679390|Anesthetics, General|anesthetics, general|mesh-ancestor
25020518|NCT03679390|Anesthetics|anesthetics|mesh-ancestor
25020519|NCT03679390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25020520|NCT03679390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25020521|NCT03679390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25020522|NCT03679390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25020523|NCT03679390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020524|NCT03679325|Vitamin D|vitamin d|mesh-list
25020525|NCT03679325|Vitamins|vitamins|mesh-ancestor
25020526|NCT03679325|Micronutrients|micronutrients|mesh-ancestor
25020527|NCT03679325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020528|NCT03679325|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24699668|NCT01448330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687747|NCT01937312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25687748|NCT01937312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25687749|NCT01937312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25687750|NCT01937312|Adrenergic Agents|adrenergic agents|mesh-ancestor
25687751|NCT01937312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25687752|NCT01937312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687753|NCT01937312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687754|NCT01937312|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25687755|NCT01937312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687756|NCT01937364|Baclofen|baclofen|mesh-list
25020529|NCT03679182|Olanzapine|olanzapine|mesh-list
25020530|NCT03679182|Antiemetics|antiemetics|mesh-ancestor
25020541|NCT03679182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25020542|NCT03679182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020543|NCT03679182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25020544|NCT03679182|Serotonin Agents|serotonin agents|mesh-ancestor
25020545|NCT03679065|Acetaminophen|acetaminophen|mesh-list
25020546|NCT03679065|Dexamethasone|dexamethasone|mesh-list
25020547|NCT03679065|Dexamethasone acetate|dexamethasone acetate|mesh-list
25020548|NCT03679065|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25020550|NCT03679065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25020552|NCT03679065|Autonomic Agents|autonomic agents|mesh-ancestor
25020553|NCT03679065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25020554|NCT03679065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020603|NCT03679013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25257044|NCT02479074|Prednisolone acetate|prednisolone acetate|mesh-list
25257045|NCT02479074|Montelukast|montelukast|mesh-list
25257046|NCT02479074|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25257047|NCT02479074|Prednisolone phosphate|prednisolone phosphate|mesh-list
25257048|NCT02479074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25257049|NCT02479074|Glucocorticoids|glucocorticoids|mesh-ancestor
25257050|NCT02479074|Hormones|hormones|mesh-ancestor
25257051|NCT02479074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25257052|NCT02479074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257053|NCT02479074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25257054|NCT02479074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25257055|NCT02479074|Antiemetics|antiemetics|mesh-ancestor
25257056|NCT02479074|Autonomic Agents|autonomic agents|mesh-ancestor
25257057|NCT02479074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24527910|NCT00618631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527911|NCT00618631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25094347|NCT03227432|Dexamethasone|dexamethasone|mesh-list
24527912|NCT00618631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24527913|NCT00618631|Cholinergic Agents|cholinergic agents|mesh-ancestor
24527914|NCT00618631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24928938|NCT04117009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24928940|NCT04117243|Tranexamic Acid|tranexamic acid|mesh-list
25020604|NCT03679013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020606|NCT03679013|Anticonvulsants|anticonvulsants|mesh-ancestor
25020607|NCT03679013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25020608|NCT03679013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24527931|NCT00618657|Carboplatin|carboplatin|mesh-list
25020609|NCT03679013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25020610|NCT03679013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25020611|NCT03679013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25020626|NCT03678792|Buprenorphine|buprenorphine|mesh-list
25020628|NCT03678792|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25020629|NCT03678792|Naloxone|naloxone|mesh-list
25020630|NCT03678792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25020631|NCT03678792|Narcotics|narcotics|mesh-ancestor
25020632|NCT03678792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25020633|NCT03678792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020634|NCT03678792|Analgesics|analgesics|mesh-ancestor
24817528|NCT02084446|Hormones|hormones|mesh-ancestor
25020675|NCT03678480|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25020676|NCT03678480|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25020677|NCT03678480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25020678|NCT03678428|Leucovorin|leucovorin|mesh-list
25687757|NCT01937364|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25687758|NCT01937364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687759|NCT01937364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25687760|NCT01937364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25687761|NCT01937364|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25020679|NCT03678428|Oxaliplatin|oxaliplatin|mesh-list
24445448|NCT00301587|Micronutrients|micronutrients|mesh-ancestor
24445450|NCT00301587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25020680|NCT03678428|Irinotecan|irinotecan|mesh-list
25020681|NCT03678428|Floxuridine|floxuridine|mesh-list
25020682|NCT03678428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25020683|NCT03678428|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25020684|NCT03678428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25020685|NCT03678428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25020725|NCT03678038|Glucocorticoids|glucocorticoids|mesh-ancestor
25020726|NCT03678038|Hormones|hormones|mesh-ancestor
25020727|NCT03678038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24584277|NCT00879372|Tianeptine|tianeptine|mesh-list
25020728|NCT03678038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020729|NCT03678038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25020730|NCT03678038|Immunologic Factors|immunologic factors|mesh-ancestor
25020731|NCT03678038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25020732|NCT03678038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020733|NCT03678012|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25020734|NCT03678012|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25020735|NCT03678012|Hematinics|hematinics|mesh-ancestor
25020736|NCT03678012|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25020796|NCT03677258|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25020797|NCT03677258|Immunologic Factors|immunologic factors|mesh-ancestor
25020802|NCT03676985|Antibodies|antibodies|mesh-list
25257058|NCT02479074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25257059|NCT02479074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25257060|NCT02479074|Protective Agents|protective agents|mesh-ancestor
25257061|NCT02479074|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25257062|NCT02479074|Respiratory System Agents|respiratory system agents|mesh-ancestor
25257063|NCT02479074|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25257064|NCT02479074|Hormone Antagonists|hormone antagonists|mesh-ancestor
24928942|NCT04117243|Oxytocics|oxytocics|mesh-ancestor
24928943|NCT04117243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24928944|NCT04117243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928945|NCT04117243|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24928946|NCT04117243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25020863|NCT03676413|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25020864|NCT03676413|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25020865|NCT03676413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25020866|NCT03676413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25020867|NCT03676413|Autonomic Agents|autonomic agents|mesh-ancestor
25020878|NCT03676413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25020879|NCT03676413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020917|NCT03676140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25020918|NCT03676140|Anthelmintics|anthelmintics|mesh-ancestor
25020919|NCT03676140|Anticestodal Agents|anticestodal agents|mesh-ancestor
25020920|NCT03676140|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25020921|NCT03676140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25020922|NCT03676140|Tubulin Modulators|tubulin modulators|mesh-ancestor
25020923|NCT03676140|Antimitotic Agents|antimitotic agents|mesh-ancestor
25020924|NCT03676140|Mitosis Modulators|mitosis modulators|mesh-ancestor
25020925|NCT03676140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020982|NCT03675815|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25020983|NCT03675815|Protease Inhibitors|protease inhibitors|mesh-ancestor
25020984|NCT03675815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25020985|NCT03675815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020986|NCT03675815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25020987|NCT03675815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25020988|NCT03675815|Antiviral Agents|antiviral agents|mesh-ancestor
25687762|NCT01937364|GABA Agonists|gaba agonists|mesh-ancestor
25687763|NCT01937364|GABA Agents|gaba agents|mesh-ancestor
25687764|NCT01937364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25687765|NCT01937364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687766|NCT01937390|Bromides|bromides|mesh-list
25687767|NCT01937390|Tiotropium Bromide|tiotropium bromide|mesh-list
25687768|NCT01937390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25687769|NCT01937390|Autonomic Agents|autonomic agents|mesh-ancestor
25020989|NCT03675815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25687770|NCT01937390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24527932|NCT00618657|Trastuzumab|trastuzumab|mesh-list
25020990|NCT03675815|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25020994|NCT03675815|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25021032|NCT03675555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25021033|NCT03675555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24587155|NCT00893594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25021178|NCT03674294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021180|NCT03674294|Glucocorticoids|glucocorticoids|mesh-ancestor
25021181|NCT03674294|Hormones|hormones|mesh-ancestor
25021182|NCT03674294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25021183|NCT03674294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25021184|NCT03674294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25021185|NCT03674294|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25257065|NCT02479074|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25257066|NCT02479074|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25257067|NCT02479074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257068|NCT02478879|Teriparatide|teriparatide|mesh-list
25257069|NCT02478879|Parathyroid Hormone|parathyroid hormone|mesh-list
25257070|NCT02478879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928947|NCT04117243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928948|NCT04117243|Hemostatics|hemostatics|mesh-ancestor
24928949|NCT04117243|Coagulants|coagulants|mesh-ancestor
24928950|NCT04117243|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24928951|NCT04117243|Abortifacient Agents|abortifacient agents|mesh-ancestor
24928952|NCT04117243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24946274|NCT03941561|Tegafur|tegafur|mesh-list
25021186|NCT03674294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25021241|NCT03674008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25021242|NCT03674008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021243|NCT03674008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25021244|NCT03674008|Anesthetics, General|anesthetics, general|mesh-ancestor
25021245|NCT03674008|Anesthetics|anesthetics|mesh-ancestor
25021246|NCT03673995|Inositol|inositol|mesh-list
25021247|NCT03673995|Vitamin B Complex|vitamin b complex|mesh-ancestor
25021248|NCT03673995|Vitamins|vitamins|mesh-ancestor
25021249|NCT03673995|Micronutrients|micronutrients|mesh-ancestor
25021250|NCT03673995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021260|NCT03673605|Protease Inhibitors|protease inhibitors|mesh-ancestor
25021261|NCT03673605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25021262|NCT03673605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021263|NCT03673501|Sunitinib|sunitinib|mesh-list
25021267|NCT03673501|Growth Substances|growth substances|mesh-ancestor
25111669|NCT04727307|Atezolizumab|atezolizumab|mesh-list
25111670|NCT04727307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25111671|NCT04727307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25111672|NCT04727307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25111673|NCT04727307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25111674|NCT04727307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25111675|NCT04727307|Growth Substances|growth substances|mesh-ancestor
25111676|NCT04727307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977853|NCT01863550|Immunologic Factors|immunologic factors|mesh-ancestor
25111677|NCT04727307|Growth Inhibitors|growth inhibitors|mesh-ancestor
24584996|NCT00882609|Fluorides|fluorides|mesh-list
25021334|NCT03672812|Liraglutide|liraglutide|mesh-list
25021335|NCT03672812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25021336|NCT03672812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021337|NCT03672812|Incretins|incretins|mesh-ancestor
25021338|NCT03672812|Hormones|hormones|mesh-ancestor
24587154|NCT00893594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25021339|NCT03672812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25021340|NCT03672435|Proxymetacaine|proxymetacaine|mesh-list
25021341|NCT03672435|Anesthetics, Local|anesthetics, local|mesh-ancestor
25021342|NCT03672435|Anesthetics|anesthetics|mesh-ancestor
25021343|NCT03672435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25021344|NCT03672435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021377|NCT03671941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25021378|NCT03671941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25021379|NCT03671941|Purinergic Agents|purinergic agents|mesh-ancestor
25021380|NCT03671941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25021381|NCT03671941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021382|NCT03671941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021383|NCT03671915|Insulin|insulin|mesh-list
25021384|NCT03671915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25021385|NCT03671915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021386|NCT03671759|Caffeine|caffeine|mesh-list
24748000|NCT02999633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24748001|NCT02999633|Antiemetics|antiemetics|mesh-ancestor
25257071|NCT02478879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25257072|NCT02478879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25257073|NCT02478645|Ramosetron|ramosetron|mesh-list
25257074|NCT02478645|Antiemetics|antiemetics|mesh-ancestor
25257075|NCT02478645|Autonomic Agents|autonomic agents|mesh-ancestor
25257076|NCT02478645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25257077|NCT02478645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257078|NCT02478645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25257079|NCT02478645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25257080|NCT02478645|Serotonin Agents|serotonin agents|mesh-ancestor
24928953|NCT04117243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24928955|NCT04117191|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24928956|NCT04117191|Antidepressive Agents|antidepressive agents|mesh-ancestor
24928958|NCT04116931|Clopidogrel|clopidogrel|mesh-list
24928959|NCT04116931|Ticagrelor|ticagrelor|mesh-list
24928960|NCT04116931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24928961|NCT04116931|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24928962|NCT04116931|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24928963|NCT04116931|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24928964|NCT04116931|Purinergic Agents|purinergic agents|mesh-ancestor
24928965|NCT04116931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24928966|NCT04116931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928967|NCT04116931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928968|NCT04116554|Bupivacaine|bupivacaine|mesh-list
24928969|NCT04116554|Anesthetics, Local|anesthetics, local|mesh-ancestor
24928970|NCT04116554|Anesthetics|anesthetics|mesh-ancestor
24504979|NCT00538811|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24504980|NCT00538811|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25021387|NCT03671759|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25021388|NCT03671759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021389|NCT03671759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25021390|NCT03671759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25021391|NCT03671759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021392|NCT03671759|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25021394|NCT03671759|Purinergic Agents|purinergic agents|mesh-ancestor
25021434|NCT03671538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25021435|NCT03671538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25021436|NCT03671538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021437|NCT03671538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24978025|NCT00381381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978027|NCT00381381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24978028|NCT00381381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978029|NCT00381381|Nootropic Agents|nootropic agents|mesh-ancestor
24978030|NCT00102648|Temozolomide|temozolomide|mesh-list
24978031|NCT00102648|Lonafarnib|lonafarnib|mesh-list
24978032|NCT00102648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24978033|NCT00102648|Alkylating Agents|alkylating agents|mesh-ancestor
24978034|NCT00102648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587122|NCT00893555|Antifungal Agents|antifungal agents|mesh-ancestor
24587123|NCT00893555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24587124|NCT00893555|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24587125|NCT00893555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24587126|NCT00893555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587127|NCT00893555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587153|NCT00893594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24587156|NCT00893594|Gout Suppressants|gout suppressants|mesh-ancestor
24587157|NCT00893594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24587158|NCT00893594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257081|NCT02478645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25094734|NCT03223220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25257082|NCT02478645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257084|NCT02478515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25257085|NCT02478515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25257086|NCT02478515|Growth Substances|growth substances|mesh-ancestor
25257087|NCT02478515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257088|NCT02478515|Growth Inhibitors|growth inhibitors|mesh-ancestor
25257089|NCT02478515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25687771|NCT01937390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687772|NCT01937390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24748087|NCT02964585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748088|NCT02950766|Ipilimumab|ipilimumab|mesh-list
24812334|NCT02051530|Tryptophan|tryptophan|mesh-list
25257090|NCT02478424|Cyclosporine|cyclosporine|mesh-list
25257091|NCT02478424|Methotrexate|methotrexate|mesh-list
25257092|NCT02478424|Cannabidiol|cannabidiol|mesh-list
25257093|NCT02478424|Cyclosporins|cyclosporins|mesh-list
25257094|NCT02478424|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25257095|NCT02478424|Abortifacient Agents|abortifacient agents|mesh-ancestor
25257096|NCT02478424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25257097|NCT02478424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257098|NCT02478424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25257099|NCT02478424|Antimetabolites|antimetabolites|mesh-ancestor
24928971|NCT04116554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24928972|NCT04116554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928973|NCT04116554|Sensory System Agents|sensory system agents|mesh-ancestor
24928974|NCT04116554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24928975|NCT04116528|Ketamine|ketamine|mesh-list
24928976|NCT04116528|Buprenorphine|buprenorphine|mesh-list
24928977|NCT04116528|Analgesics|analgesics|mesh-ancestor
24928978|NCT04116528|Sensory System Agents|sensory system agents|mesh-ancestor
24928979|NCT04116528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24928980|NCT04116528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928981|NCT04116528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24928982|NCT04116528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24928983|NCT04116528|Anesthetics, General|anesthetics, general|mesh-ancestor
24928984|NCT04116528|Anesthetics|anesthetics|mesh-ancestor
24928985|NCT04116528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24799022|NCT01966653|Fosfomycin|fosfomycin|mesh-list
24587159|NCT00893607|Methoxamine|methoxamine|mesh-list
24587160|NCT00893607|Sympathomimetics|sympathomimetics|mesh-ancestor
24587161|NCT00893607|Autonomic Agents|autonomic agents|mesh-ancestor
25021474|NCT03671174|Antimalarials|antimalarials|mesh-ancestor
25021475|NCT03671174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25021476|NCT03671174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25021477|NCT03671174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25021478|NCT03671161|Insulin|insulin|mesh-list
25021479|NCT03671161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25021480|NCT03671161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021481|NCT03671109|Piperaquine|piperaquine|mesh-list
25021482|NCT03671109|Artenimol|artenimol|mesh-list
25021483|NCT03671109|Antimalarials|antimalarials|mesh-ancestor
25021484|NCT03671109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25021485|NCT03671109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25021486|NCT03671109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25021487|NCT03671070|Epinephrine|epinephrine|mesh-list
25021537|NCT03670901|Immunologic Factors|immunologic factors|mesh-ancestor
25021538|NCT03670901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021539|NCT03670901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25021540|NCT03670888|Rituximab|rituximab|mesh-list
25021541|NCT03670888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25094805|NCT03222518|Analgesics|analgesics|mesh-ancestor
25021542|NCT03670888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25021543|NCT03670888|Immunologic Factors|immunologic factors|mesh-ancestor
25021544|NCT03670888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021545|NCT03670888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25021546|NCT03670875|Curcumin|curcumin|mesh-list
25021547|NCT03670875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25021548|NCT03670875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25021549|NCT03670875|Analgesics|analgesics|mesh-ancestor
25021550|NCT03670875|Sensory System Agents|sensory system agents|mesh-ancestor
25021551|NCT03670875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25021558|NCT03670758|Protein S|protein s|mesh-list
25021597|NCT03669783|Vincristine|vincristine|mesh-list
25021598|NCT03669783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25021599|NCT03669783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25021600|NCT03669783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25021601|NCT03669783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25257106|NCT02478424|Immunologic Factors|immunologic factors|mesh-ancestor
25257107|NCT02478424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25257108|NCT02478424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25257109|NCT02478424|Antifungal Agents|antifungal agents|mesh-ancestor
25257110|NCT02478424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25257111|NCT02478424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25257112|NCT02478424|Anticonvulsants|anticonvulsants|mesh-ancestor
25257114|NCT02478710|Tobramycin|tobramycin|mesh-list
25687773|NCT01937390|Respiratory System Agents|respiratory system agents|mesh-ancestor
25687774|NCT01937390|Parasympatholytics|parasympatholytics|mesh-ancestor
25257115|NCT02478710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24654988|NCT01252758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24852022|NCT02260011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748204|NCT02787551|Insulin Glargine|insulin glargine|mesh-list
24748205|NCT02787551|Pioglitazone|pioglitazone|mesh-list
24748206|NCT02787551|Liraglutide|liraglutide|mesh-list
24505010|NCT00538967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25687775|NCT01937390|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25687776|NCT01937390|Cholinergic Agents|cholinergic agents|mesh-ancestor
25687777|NCT01937390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25687778|NCT01937390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505011|NCT00538967|Antimalarials|antimalarials|mesh-ancestor
24505012|NCT00538967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24505013|NCT00538967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24527915|NCT00618631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527916|NCT00618631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24527917|NCT00618631|Narcotics|narcotics|mesh-ancestor
24527918|NCT00618631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24527919|NCT00618631|Analgesics|analgesics|mesh-ancestor
24527929|NCT00618657|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24527930|NCT00618657|Bevacizumab|bevacizumab|mesh-list
24527933|NCT00618657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24527935|NCT00618657|Immunoglobulins|immunoglobulins|mesh-list
24527936|NCT00618657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24527941|NCT00618657|Mitosis Modulators|mitosis modulators|mesh-ancestor
24527942|NCT00618657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771769|NCT01829711|Immunotoxin HA22|immunotoxin ha22|mesh-list
25111712|NCT04677049|Niacin|niacin|mesh-list
25021670|NCT03669445|Hormones|hormones|mesh-ancestor
25021671|NCT03669445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25021672|NCT03669445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25021673|NCT03669445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25021674|NCT03669445|Immunologic Factors|immunologic factors|mesh-ancestor
25021675|NCT03669445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25021676|NCT03669445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25021677|NCT03669445|Growth Substances|growth substances|mesh-ancestor
25021678|NCT03669445|Growth Inhibitors|growth inhibitors|mesh-ancestor
25021679|NCT03669445|Protease Inhibitors|protease inhibitors|mesh-ancestor
25021680|NCT03669445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25021681|NCT03669445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021734|NCT03668860|Betamethasone Valerate|betamethasone valerate|mesh-list
25021735|NCT03668860|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25021736|NCT03668860|Betamethasone benzoate|betamethasone benzoate|mesh-list
25021737|NCT03668860|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
25021738|NCT03668860|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25021739|NCT03668860|BB 1101|bb 1101|mesh-list
25021740|NCT03668860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25021741|NCT03668860|Antiemetics|antiemetics|mesh-ancestor
25021742|NCT03668860|Autonomic Agents|autonomic agents|mesh-ancestor
25021743|NCT03668860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25021744|NCT03668860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021745|NCT03668860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25257116|NCT02478710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25257117|NCT02478294|Warfarin|warfarin|mesh-list
25257124|NCT02478268|Anesthetics, General|anesthetics, general|mesh-ancestor
25257125|NCT02478268|Anesthetics|anesthetics|mesh-ancestor
25257126|NCT02478268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25257127|NCT02478268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257129|NCT02478125|Lenograstim|lenograstim|mesh-list
25257130|NCT02478125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25257131|NCT02478125|Tubulin Modulators|tubulin modulators|mesh-ancestor
25257132|NCT02478125|Antimitotic Agents|antimitotic agents|mesh-ancestor
25257133|NCT02478125|Mitosis Modulators|mitosis modulators|mesh-ancestor
25257134|NCT02478125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257135|NCT02478125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25257136|NCT02478125|Immunologic Factors|immunologic factors|mesh-ancestor
25257137|NCT02478125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257138|NCT02478047|Dexamethasone|dexamethasone|mesh-list
25687779|NCT01937390|Anticonvulsants|anticonvulsants|mesh-ancestor
25687780|NCT01937559|Tranexamic Acid|tranexamic acid|mesh-list
25687781|NCT01937559|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25687782|NCT01937559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25687783|NCT01937559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687784|NCT01937559|Hemostatics|hemostatics|mesh-ancestor
24527944|NCT00618657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24748268|NCT02753998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748269|NCT02750319|Acetylcysteine|acetylcysteine|mesh-list
24748270|NCT02750319|Amiodarone|amiodarone|mesh-list
24748280|NCT02750319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748281|NCT02750319|Antidotes|antidotes|mesh-ancestor
24748282|NCT02750319|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24748283|NCT02750319|Vasodilator Agents|vasodilator agents|mesh-ancestor
24748284|NCT02750319|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24748285|NCT02750319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24748286|NCT02750319|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24527945|NCT00618657|Growth Substances|growth substances|mesh-ancestor
24527955|NCT00618696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527956|NCT00618852|Furosemide|furosemide|mesh-list
24527957|NCT00618852|Diuretics|diuretics|mesh-ancestor
24527958|NCT00618852|Natriuretic Agents|natriuretic agents|mesh-ancestor
25045289|NCT00973284|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25045290|NCT00973284|Diuretics|diuretics|mesh-ancestor
25045291|NCT00973284|Natriuretic Agents|natriuretic agents|mesh-ancestor
25045292|NCT00973284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045293|NCT00971035|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25045294|NCT00971035|Immunologic Factors|immunologic factors|mesh-ancestor
25045295|NCT00971035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045296|NCT00969722|Tretinoin|tretinoin|mesh-list
25045297|NCT00969722|Molgramostim|molgramostim|mesh-list
25045298|NCT00969722|Isotretinoin|isotretinoin|mesh-list
25045299|NCT00969722|Sargramostim|sargramostim|mesh-list
25045300|NCT00969722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045301|NCT00969722|Keratolytic Agents|keratolytic agents|mesh-ancestor
25045302|NCT00969722|Dermatologic Agents|dermatologic agents|mesh-ancestor
25045303|NCT00969722|Immunologic Factors|immunologic factors|mesh-ancestor
25045305|NCT00968942|Botulinum Toxins|botulinum toxins|mesh-list
24799053|NCT01966783|Analgesics|analgesics|mesh-ancestor
25021746|NCT03668860|Glucocorticoids|glucocorticoids|mesh-ancestor
25021747|NCT03668860|Hormones|hormones|mesh-ancestor
25021748|NCT03668860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25021749|NCT03668860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25021750|NCT03668860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25021751|NCT03668860|Protease Inhibitors|protease inhibitors|mesh-ancestor
25021752|NCT03668860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25021753|NCT03668860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021754|NCT03668860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25021755|NCT03668860|Respiratory System Agents|respiratory system agents|mesh-ancestor
25021787|NCT03668418|Antimetabolites|antimetabolites|mesh-list
25021788|NCT03668418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25021798|NCT03668418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25021799|NCT03668418|Immunologic Factors|immunologic factors|mesh-ancestor
25021800|NCT03668418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021801|NCT03668418|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25257140|NCT02478047|Antiemetics|antiemetics|mesh-list
25257141|NCT02478047|Tropisetron|tropisetron|mesh-list
25257142|NCT02478047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25257143|NCT02478047|Autonomic Agents|autonomic agents|mesh-ancestor
25257144|NCT02478047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25257145|NCT02478047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257146|NCT02478047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25257147|NCT02478047|Glucocorticoids|glucocorticoids|mesh-ancestor
25257148|NCT02478047|Hormones|hormones|mesh-ancestor
25257149|NCT02478047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25095124|NCT03220256|Lamotrigine|lamotrigine|mesh-list
25257160|NCT02478242|Analgesics|analgesics|mesh-ancestor
25257161|NCT02478242|Sensory System Agents|sensory system agents|mesh-ancestor
25257162|NCT02478242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25257163|NCT02478242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687785|NCT01937559|Coagulants|coagulants|mesh-ancestor
25687786|NCT01937598|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25687787|NCT01937598|Liraglutide|liraglutide|mesh-list
25687788|NCT01937598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25687789|NCT01937598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687790|NCT01937598|Incretins|incretins|mesh-ancestor
25687791|NCT01937598|Hormones|hormones|mesh-ancestor
25687792|NCT01937598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25687793|NCT01937598|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25687794|NCT01937598|Protease Inhibitors|protease inhibitors|mesh-ancestor
24701375|NCT01458626|Mirtazapine|mirtazapine|mesh-list
25257164|NCT02478242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25257165|NCT02478242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25257166|NCT02478242|Anticoagulants|anticoagulants|mesh-ancestor
25095119|NCT03220555|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24538386|NCT00659074|Serotonin Agents|serotonin agents|mesh-ancestor
24748364|NCT02678572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24748365|NCT02678572|Alkylating Agents|alkylating agents|mesh-ancestor
24748366|NCT02678572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412762|NCT00191971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24412763|NCT00191971|Immunologic Factors|immunologic factors|mesh-ancestor
24748372|NCT02674061|Pembrolizumab|pembrolizumab|mesh-list
25095120|NCT03220555|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24799078|NCT01966913|Growth Inhibitors|growth inhibitors|mesh-ancestor
25021802|NCT03668418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25021803|NCT03668418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25021804|NCT03668418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25021805|NCT03668262|Atracurium|atracurium|mesh-list
25021806|NCT03668262|Cisatracurium|cisatracurium|mesh-list
25021809|NCT03668262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25111743|NCT04665531|Anesthetics, Local|anesthetics, local|mesh-ancestor
25111744|NCT04665531|Anesthetics|anesthetics|mesh-ancestor
25111745|NCT04665531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25111746|NCT04665531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25111747|NCT04665531|Sensory System Agents|sensory system agents|mesh-ancestor
25111748|NCT04665531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25111765|NCT04631029|Carboplatin|carboplatin|mesh-list
25111766|NCT04631029|Etoposide|etoposide|mesh-list
25111767|NCT04631029|Etoposide phosphate|etoposide phosphate|mesh-list
25111768|NCT04631029|Atezolizumab|atezolizumab|mesh-list
25111769|NCT04631029|Podophyllotoxin|podophyllotoxin|mesh-list
24978346|NCT04594408|Epinephrine|epinephrine|mesh-list
24978445|NCT04409795|Metformin|metformin|mesh-list
24978446|NCT04409795|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24978447|NCT04409795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24978448|NCT04409795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978449|NCT04409795|Incretins|incretins|mesh-ancestor
24978450|NCT04409795|Hormones|hormones|mesh-ancestor
24978451|NCT04409795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24978452|NCT04409795|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25021876|NCT03667326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021877|NCT03667326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25021878|NCT03667326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25021879|NCT03667326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25021881|NCT03667326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021882|NCT03667326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25021883|NCT03667326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25021885|NCT03667326|Antipyretics|antipyretics|mesh-ancestor
25257167|NCT02478242|Protease Inhibitors|protease inhibitors|mesh-ancestor
25257168|NCT02478242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257169|NCT02478242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257170|NCT02478242|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25257171|NCT02478242|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25257172|NCT02478242|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25257173|NCT02478242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25257174|NCT02478242|Immunologic Factors|immunologic factors|mesh-ancestor
25257175|NCT02478229|Sofosbuvir|sofosbuvir|mesh-list
25257176|NCT02478229|Ledipasvir|ledipasvir|mesh-list
25257177|NCT02478229|Antiviral Agents|antiviral agents|mesh-ancestor
25257178|NCT02478229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25257179|NCT02478021|Hydrocortisone|hydrocortisone|mesh-list
25021886|NCT03667313|Sirolimus|sirolimus|mesh-list
25021887|NCT03667313|Paclitaxel|paclitaxel|mesh-list
25021936|NCT03667001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25021937|NCT03667001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021938|NCT03667001|Sensory System Agents|sensory system agents|mesh-ancestor
25021939|NCT03667001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25687795|NCT01937598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687796|NCT01937598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687797|NCT01937715|Bevacizumab|bevacizumab|mesh-list
25687798|NCT01937715|Gedatolisib|gedatolisib|mesh-list
25687799|NCT01937715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25687800|NCT01937715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25687801|NCT01937715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25687802|NCT01937715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25687803|NCT01937715|Growth Substances|growth substances|mesh-ancestor
25687804|NCT01937715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748474|NCT02512172|Azacitidine|azacitidine|mesh-list
24748475|NCT02512172|Romidepsin|romidepsin|mesh-list
24748476|NCT02512172|Cc-486|cc-486|mesh-list
25021940|NCT03667001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25021941|NCT03667001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25021942|NCT03667001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25021943|NCT03667001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25021944|NCT03667001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021945|NCT03666949|Anesthetics|anesthetics|mesh-list
25021980|NCT03666650|Protease Inhibitors|protease inhibitors|mesh-ancestor
25021981|NCT03666650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25021982|NCT03666650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021983|NCT03666650|Anticoagulants|anticoagulants|mesh-ancestor
25021984|NCT03666546|Methamphetamine|methamphetamine|mesh-list
25021985|NCT03666546|Lactulose|lactulose|mesh-list
25021986|NCT03666546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25021987|NCT03666546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25021988|NCT03666546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021989|NCT03666546|Sympathomimetics|sympathomimetics|mesh-ancestor
25021990|NCT03666546|Autonomic Agents|autonomic agents|mesh-ancestor
25021991|NCT03666546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25021992|NCT03666546|Dopamine Agents|dopamine agents|mesh-ancestor
25021993|NCT03666546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25021994|NCT03666546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021995|NCT03666546|Adrenergic Agents|adrenergic agents|mesh-ancestor
25021996|NCT03666546|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25021997|NCT03666546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25021998|NCT03666546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25021999|NCT03666546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25022000|NCT03666494|Fentanyl|fentanyl|mesh-list
25022001|NCT03666494|Ketamine|ketamine|mesh-list
25022002|NCT03666494|Propofol|propofol|mesh-list
25022003|NCT03666494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25022004|NCT03666494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25022030|NCT03666390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25022031|NCT03666390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24896780|NCT04432714|Doxorubicin|doxorubicin|mesh-list
25022092|NCT03666195|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24978637|NCT03441282|Narcotics|narcotics|mesh-ancestor
24978638|NCT03441282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24978639|NCT03441282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978640|NCT03441282|Analgesics|analgesics|mesh-ancestor
24978641|NCT03441282|Sensory System Agents|sensory system agents|mesh-ancestor
24978642|NCT03441282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24978643|NCT03441282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24978644|NCT03441282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24978645|NCT03441282|Anesthetics, General|anesthetics, general|mesh-ancestor
24978646|NCT03441282|Anesthetics|anesthetics|mesh-ancestor
24978647|NCT03432741|Gemcitabine|gemcitabine|mesh-list
24978648|NCT03432741|Deoxyglucose|deoxyglucose|mesh-list
24978649|NCT03432741|Rituximab|rituximab|mesh-list
24978666|NCT03432741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25257180|NCT02478021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25257181|NCT02478034|Fludrocortisone|fludrocortisone|mesh-list
24978667|NCT03432741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24978668|NCT03432741|Antimetabolites|antimetabolites|mesh-ancestor
24978669|NCT03432741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25111774|NCT04631029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25111775|NCT04631029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25111776|NCT04631029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25111777|NCT04631029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25111778|NCT04631029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25111779|NCT04631029|Immunologic Factors|immunologic factors|mesh-ancestor
25111780|NCT04631029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25111781|NCT04631029|Keratolytic Agents|keratolytic agents|mesh-ancestor
25111782|NCT04631029|Dermatologic Agents|dermatologic agents|mesh-ancestor
25111783|NCT04631029|Tubulin Modulators|tubulin modulators|mesh-ancestor
25111784|NCT04631029|Antimitotic Agents|antimitotic agents|mesh-ancestor
25111785|NCT04631029|Mitosis Modulators|mitosis modulators|mesh-ancestor
25022093|NCT03665779|Pyridoxine|pyridoxine|mesh-list
25022094|NCT03665779|Isosorbide|isosorbide|mesh-list
25022095|NCT03665779|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25687805|NCT01937715|Growth Inhibitors|growth inhibitors|mesh-ancestor
25687806|NCT01937715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25022096|NCT03665779|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25022097|NCT03665779|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25022098|NCT03665779|Diuretics|diuretics|mesh-ancestor
25022099|NCT03665779|Natriuretic Agents|natriuretic agents|mesh-ancestor
25022100|NCT03665779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022101|NCT03665779|Vasodilator Agents|vasodilator agents|mesh-ancestor
25022102|NCT03665779|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25022103|NCT03665779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022104|NCT03665779|Vitamin B Complex|vitamin b complex|mesh-ancestor
25022116|NCT03665766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25022117|NCT03665766|Renal Agents|renal agents|mesh-ancestor
25022118|NCT03665766|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25022119|NCT03665766|Antitubercular Agents|antitubercular agents|mesh-ancestor
25022120|NCT03665766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25022121|NCT03665766|Antimetabolites|antimetabolites|mesh-ancestor
25022123|NCT03665753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25022124|NCT03665753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25022125|NCT03665753|Analgesics|analgesics|mesh-ancestor
25022126|NCT03665753|Sensory System Agents|sensory system agents|mesh-ancestor
25022158|NCT03665545|Antiviral Agents|antiviral agents|mesh-ancestor
25022159|NCT03665545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25022160|NCT03665519|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25022161|NCT03665519|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25022162|NCT03665519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25022163|NCT03665454|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25275038|NCT02374567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25275039|NCT02374567|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25275040|NCT02374567|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25275041|NCT02374567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25275042|NCT02374567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275043|NCT02374567|Dopamine Agonists|dopamine agonists|mesh-ancestor
25275044|NCT02374567|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25022165|NCT03665454|Immunologic Factors|immunologic factors|mesh-ancestor
25022166|NCT03665454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022167|NCT03665454|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25022168|NCT03665454|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25022169|NCT03665454|Dopamine Agonists|dopamine agonists|mesh-ancestor
24586098|NCT00889161|Curcumin|curcumin|mesh-list
24586099|NCT00889161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25022223|NCT03664986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25022224|NCT03664986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022225|NCT03664986|Sensory System Agents|sensory system agents|mesh-ancestor
25022226|NCT03664986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25022227|NCT03664908|Antibodies|antibodies|mesh-list
25022228|NCT03664908|Immunologic Factors|immunologic factors|mesh-ancestor
25022229|NCT03664908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022230|NCT03664895|Goserelin|goserelin|mesh-list
25022231|NCT03664895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25022232|NCT03664895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25022233|NCT03664869|Mitomycins|mitomycins|mesh-list
25022234|NCT03664869|Mitomycin|mitomycin|mesh-list
25022235|NCT03664869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25022236|NCT03664869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25022237|NCT03664869|Alkylating Agents|alkylating agents|mesh-ancestor
25022238|NCT03664869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022240|NCT03664869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022288|NCT03664388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25022289|NCT03664388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25022290|NCT03664388|Purinergic Agents|purinergic agents|mesh-ancestor
25022291|NCT03664388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25022292|NCT03664388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022293|NCT03664388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022294|NCT03664375|Botulinum Toxins|botulinum toxins|mesh-list
25022295|NCT03664375|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25022296|NCT03664375|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25022309|NCT03664115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25022310|NCT03664115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819539|NCT02095899|Rufinamide|rufinamide|mesh-list
25022311|NCT03664115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022312|NCT03664115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25022313|NCT03664115|Hormone Antagonists|hormone antagonists|mesh-ancestor
25022314|NCT03664115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25022315|NCT03664115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022316|NCT03664115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25022317|NCT03664063|Azithromycin|azithromycin|mesh-list
24748729|NCT02204241|Hormones|hormones|mesh-ancestor
25022374|NCT03663478|Ropivacaine|ropivacaine|mesh-list
25022375|NCT03663478|Anesthetics, Local|anesthetics, local|mesh-ancestor
25022376|NCT03663478|Anesthetics|anesthetics|mesh-ancestor
25022377|NCT03663478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25257187|NCT02477956|Micronutrients|micronutrients|mesh-ancestor
25257188|NCT02477956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257189|NCT02477956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25257190|NCT02477956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25257191|NCT02477969|Metformin|metformin|mesh-list
25257192|NCT02477969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25049664|NCT00579020|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25022433|NCT03662620|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25022434|NCT03662620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25022435|NCT03662620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022436|NCT03662620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25022437|NCT03662620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022438|NCT03662620|Vasodilator Agents|vasodilator agents|mesh-ancestor
25022439|NCT03662620|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25022440|NCT03662620|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25022441|NCT03662620|Diuretics|diuretics|mesh-ancestor
25022442|NCT03662620|Natriuretic Agents|natriuretic agents|mesh-ancestor
25022443|NCT03662620|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25022444|NCT03662568|Ritonavir|ritonavir|mesh-list
25022445|NCT03662568|Tenofovir|tenofovir|mesh-list
25022446|NCT03662568|Entecavir|entecavir|mesh-list
25111858|NCT04569747|Anastrozole|anastrozole|mesh-list
25111859|NCT04569747|Leuprolide|leuprolide|mesh-list
25111860|NCT04569747|Exemestane|exemestane|mesh-list
25111861|NCT04569747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25111862|NCT04569747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25111863|NCT04569747|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25111864|NCT04569747|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25111865|NCT04569747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25111866|NCT04569747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25111867|NCT04569747|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25111868|NCT04569747|Hormone Antagonists|hormone antagonists|mesh-ancestor
25111869|NCT04569747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24979097|NCT00688376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587198|NCT00893724|Respiratory System Agents|respiratory system agents|mesh-ancestor
24587199|NCT00893724|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24587200|NCT00893724|Antidotes|antidotes|mesh-ancestor
24587201|NCT00893724|Vitamin B Complex|vitamin b complex|mesh-ancestor
24587202|NCT00893724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24587203|NCT00893724|Antimetabolites|antimetabolites|mesh-ancestor
24587204|NCT00893724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24587205|NCT00893724|Vasodilator Agents|vasodilator agents|mesh-ancestor
24587206|NCT00893841|Pramipexole|pramipexole|mesh-list
24587207|NCT00893841|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24587208|NCT00893841|Antidepressive Agents|antidepressive agents|mesh-ancestor
24587209|NCT00893841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24587210|NCT00893841|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24587211|NCT00893841|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24587212|NCT00893841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24587253|NCT00893906|Vaccines|vaccines|mesh-list
25022485|NCT03662412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25022486|NCT03662412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25022487|NCT03662412|Antifungal Agents|antifungal agents|mesh-ancestor
25022488|NCT03662412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25022489|NCT03662412|Immunologic Factors|immunologic factors|mesh-ancestor
25022490|NCT03662412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022493|NCT03662269|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25022494|NCT03662269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25257193|NCT02477969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257194|NCT02477995|Vaccines|vaccines|mesh-list
25257195|NCT02477995|Immunologic Factors|immunologic factors|mesh-ancestor
25257196|NCT02477995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257197|NCT02477891|Daratumumab|daratumumab|mesh-list
25257198|NCT02477891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25257199|NCT02477852|Rifampin|rifampin|mesh-list
25257200|NCT02477852|Isoniazid|isoniazid|mesh-list
25257201|NCT02477852|Pyrazinamide|pyrazinamide|mesh-list
25257202|NCT02477852|Ethambutol|ethambutol|mesh-list
25257203|NCT02477852|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25687807|NCT01937715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25155495|NCT05353140|Aspirin|aspirin|mesh-list
25155496|NCT05353140|Rivaroxaban|rivaroxaban|mesh-list
25155497|NCT05353140|Clopidogrel|clopidogrel|mesh-list
25155498|NCT05353140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24655059|NCT01254071|Dutasteride|dutasteride|mesh-list
25022495|NCT03662269|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25022496|NCT03662269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022497|NCT03662269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022498|NCT03662269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25022499|NCT03662269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25022500|NCT03662269|Analgesics|analgesics|mesh-ancestor
25022501|NCT03662269|Sensory System Agents|sensory system agents|mesh-ancestor
25022502|NCT03662269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25022503|NCT03662269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022504|NCT03662269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25022505|NCT03662269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25022506|NCT03662269|Gout Suppressants|gout suppressants|mesh-ancestor
25022507|NCT03662269|Tocolytic Agents|tocolytic agents|mesh-ancestor
25022508|NCT03662269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25022509|NCT03662269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25022510|NCT03662113|Domperidone|domperidone|mesh-list
25022511|NCT03662113|Simethicone|simethicone|mesh-list
25022512|NCT03662113|Antiemetics|antiemetics|mesh-ancestor
25022537|NCT03662035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25022538|NCT03662035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022539|NCT03662035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022540|NCT03661892|Dronabinol|dronabinol|mesh-list
25022541|NCT03661892|Hallucinogens|hallucinogens|mesh-ancestor
25022542|NCT03661892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022543|NCT03661892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25022544|NCT03661892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25022545|NCT03661892|Analgesics|analgesics|mesh-ancestor
25022546|NCT03661892|Sensory System Agents|sensory system agents|mesh-ancestor
25022547|NCT03661892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25022548|NCT03661892|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25022549|NCT03661892|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25022550|NCT03661892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25022551|NCT03661892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022552|NCT03661892|Hormones|hormones|mesh-ancestor
25022553|NCT03661892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25022554|NCT03661788|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25022555|NCT03661788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25022556|NCT03661788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25022557|NCT03661788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25022573|NCT03661775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022574|NCT03661775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25022575|NCT03661775|Tocolytic Agents|tocolytic agents|mesh-ancestor
25022576|NCT03661775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24979176|NCT05173298|Growth Inhibitors|growth inhibitors|mesh-ancestor
24979177|NCT05156814|Dydrogesterone|dydrogesterone|mesh-list
24979178|NCT05156814|Progestins|progestins|mesh-ancestor
24979179|NCT05156814|Hormones|hormones|mesh-ancestor
24979180|NCT05156814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24979182|NCT05152888|Evolocumab|evolocumab|mesh-list
25022609|NCT03661515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25022610|NCT03661515|Antimetabolites|antimetabolites|mesh-ancestor
25022611|NCT03661515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022612|NCT03661515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25022616|NCT03661515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25022617|NCT03661515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25022618|NCT03661515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25022619|NCT03661515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25257205|NCT02477852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25257206|NCT02477852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25257207|NCT02477852|Leprostatic Agents|leprostatic agents|mesh-ancestor
25257208|NCT02477852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25257209|NCT02477852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275045|NCT02374567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25155499|NCT05353140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25155500|NCT05353140|Analgesics|analgesics|mesh-ancestor
25155501|NCT05353140|Sensory System Agents|sensory system agents|mesh-ancestor
25155502|NCT05353140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24527959|NCT00618852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527960|NCT00618852|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25022620|NCT03661515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022621|NCT03661489|Propofol|propofol|mesh-list
25022622|NCT03661489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25022623|NCT03661489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25022624|NCT03661489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022625|NCT03661489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25022626|NCT03661489|Anesthetics, General|anesthetics, general|mesh-ancestor
25022627|NCT03661489|Anesthetics|anesthetics|mesh-ancestor
25022628|NCT03661463|Aspirin|aspirin|mesh-list
25022629|NCT03661463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25022630|NCT03661463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25022631|NCT03661463|Analgesics|analgesics|mesh-ancestor
25022632|NCT03661463|Sensory System Agents|sensory system agents|mesh-ancestor
25022633|NCT03661463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25022666|NCT03661125|Saracatinib|saracatinib|mesh-list
25022667|NCT03661125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25022668|NCT03661125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022669|NCT03661125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022670|NCT03660917|Riluzole|riluzole|mesh-list
25022671|NCT03660917|Anticonvulsants|anticonvulsants|mesh-ancestor
25022672|NCT03660917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25022673|NCT03660917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25022674|NCT03660917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25022675|NCT03660917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022676|NCT03660917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979223|NCT05116774|Eculizumab|eculizumab|mesh-list
25022677|NCT03660917|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25022678|NCT03660917|Protective Agents|protective agents|mesh-ancestor
25022679|NCT03660761|Apatinib|apatinib|mesh-list
25022680|NCT03660761|Temozolomide|temozolomide|mesh-list
25022681|NCT03660761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25022682|NCT03660761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25022683|NCT03660761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022684|NCT03660761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022685|NCT03660761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25022686|NCT03660761|Alkylating Agents|alkylating agents|mesh-ancestor
25111870|NCT04569747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25111874|NCT04569747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25111876|NCT04569747|Fertility Agents|fertility agents|mesh-ancestor
25111877|NCT04569747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25111878|NCT04553705|Quinine|quinine|mesh-list
25111879|NCT04553705|Antimalarials|antimalarials|mesh-ancestor
25111880|NCT04553705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25111881|NCT04553705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25111882|NCT04553705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25111883|NCT04553705|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25111884|NCT04553705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25111885|NCT04553705|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25111886|NCT04553705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25111887|NCT04553705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25111888|NCT04553705|Analgesics|analgesics|mesh-ancestor
25111889|NCT04553705|Sensory System Agents|sensory system agents|mesh-ancestor
24928989|NCT04116528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928990|NCT04116528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24928992|NCT04116528|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24928993|NCT04116827|Tamoxifen|tamoxifen|mesh-list
24928994|NCT04116827|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24928995|NCT04116827|Hormone Antagonists|hormone antagonists|mesh-ancestor
25095711|NCT03216876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928996|NCT04116827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24928997|NCT04116827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928998|NCT04116827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24928999|NCT04116827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929000|NCT04116827|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24929001|NCT04116827|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24505024|NCT00539071|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24505025|NCT00539071|Dopamine Agents|dopamine agents|mesh-ancestor
24505026|NCT00539123|Buprenorphine|buprenorphine|mesh-list
24527961|NCT00618852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24946549|NCT03937518|Strontium ranelate|strontium ranelate|mesh-list
24586772|NCT00892125|Sensory System Agents|sensory system agents|mesh-ancestor
25022699|NCT03660475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25687808|NCT01937715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022700|NCT03660436|Mycophenolic Acid|mycophenolic acid|mesh-list
25022726|NCT03660293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022727|NCT03660293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25022728|NCT03660293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25022729|NCT03660293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022730|NCT03660293|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25022731|NCT03660293|Protease Inhibitors|protease inhibitors|mesh-ancestor
25022732|NCT03660293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25022733|NCT03660267|Caffeine|caffeine|mesh-list
25022734|NCT03660267|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25022735|NCT03660267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022736|NCT03660267|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25022737|NCT03660267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022738|NCT03660267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257216|NCT02477852|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25257217|NCT02477852|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25257218|NCT02477852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25257219|NCT02477852|Antimetabolites|antimetabolites|mesh-ancestor
25257220|NCT02477852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25257221|NCT02477813|Temozolomide|temozolomide|mesh-list
25257222|NCT02477813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25257223|NCT02477813|Alkylating Agents|alkylating agents|mesh-ancestor
25257224|NCT02477813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257225|NCT02477813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25257226|NCT02477566|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25257227|NCT02477566|Luteolytic Agents|luteolytic agents|mesh-ancestor
25257228|NCT02477566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25257229|NCT02477566|Contraceptive Agents|contraceptive agents|mesh-ancestor
25257230|NCT02477566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25257231|NCT02477566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257232|NCT02477566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25257233|NCT02477566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25257234|NCT02477566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25257235|NCT02477631|Deferiprone|deferiprone|mesh-list
25257236|NCT02477631|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25257237|NCT02477631|Chelating Agents|chelating agents|mesh-ancestor
24527962|NCT00618852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527963|NCT00618969|Busulfan|busulfan|mesh-list
25095765|NCT03216356|Cycloserine|cycloserine|mesh-list
25095832|NCT03216395|Respiratory System Agents|respiratory system agents|mesh-ancestor
25095833|NCT03216395|Mydriatics|mydriatics|mesh-ancestor
25095834|NCT03216395|Sympathomimetics|sympathomimetics|mesh-ancestor
25095835|NCT03216395|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24587296|NCT00894062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587297|NCT00894062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24587298|NCT00894062|Immunologic Factors|immunologic factors|mesh-ancestor
24587299|NCT00894062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587300|NCT00894088|Mycophenolic Acid|mycophenolic acid|mesh-list
24587301|NCT00894088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24587302|NCT00894088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587303|NCT00894088|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24587304|NCT00894088|Antitubercular Agents|antitubercular agents|mesh-ancestor
24587305|NCT00894088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24587306|NCT00894088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24587307|NCT00894088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587333|NCT00894374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24587334|NCT00894374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587336|NCT00894374|Schistosomicides|schistosomicides|mesh-ancestor
24587337|NCT00894374|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24587338|NCT00894374|Anthelmintics|anthelmintics|mesh-ancestor
24587340|NCT00894439|BLI-489|bli-489|mesh-list
24587341|NCT00894439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24587342|NCT00894439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24587343|NCT00894439|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25687809|NCT01937871|Tadalafil|tadalafil|mesh-list
25687810|NCT01937871|Tamsulosin|tamsulosin|mesh-list
25687811|NCT01937871|Vasodilator Agents|vasodilator agents|mesh-ancestor
25687812|NCT01937871|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25687813|NCT01937871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24749152|NCT01619085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749153|NCT01606098|Bevacizumab|bevacizumab|mesh-list
24749154|NCT01606098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24749155|NCT01606098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749165|NCT01499095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749166|NCT01499082|Insulin|insulin|mesh-list
24625902|NCT01084200|Anesthetics|anesthetics|mesh-ancestor
24587344|NCT00894439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587346|NCT00894569|Paclitaxel|paclitaxel|mesh-list
25022769|NCT03659851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022770|NCT03659851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022771|NCT03659851|Protective Agents|protective agents|mesh-ancestor
25022772|NCT03659851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022780|NCT03659435|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25022781|NCT03659435|Protective Agents|protective agents|mesh-ancestor
25022782|NCT03659383|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25022783|NCT03659383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022784|NCT03659305|Bevacizumab|bevacizumab|mesh-list
25022785|NCT03659305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25022786|NCT03659305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25022787|NCT03659305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25022788|NCT03659305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25022789|NCT03659305|Growth Substances|growth substances|mesh-ancestor
25022790|NCT03659305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022791|NCT03659305|Growth Inhibitors|growth inhibitors|mesh-ancestor
25022792|NCT03659292|Anesthetics|anesthetics|mesh-list
25022793|NCT03659292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25022814|NCT03659084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022815|NCT03659058|Colchicine|colchicine|mesh-list
25022816|NCT03659058|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25022817|NCT03659058|Antioxidants|antioxidants|mesh-list
25022818|NCT03659058|Silymarin|silymarin|mesh-list
25022819|NCT03659058|Gout Suppressants|gout suppressants|mesh-ancestor
25022820|NCT03659058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25022821|NCT03659058|Tubulin Modulators|tubulin modulators|mesh-ancestor
25022822|NCT03659058|Antimitotic Agents|antimitotic agents|mesh-ancestor
25022823|NCT03659058|Mitosis Modulators|mitosis modulators|mesh-ancestor
25022824|NCT03659058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022825|NCT03659058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25022826|NCT03659058|Protective Agents|protective agents|mesh-ancestor
24527980|NCT00619021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527981|NCT00619021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24527982|NCT00619021|Immunologic Factors|immunologic factors|mesh-ancestor
24527983|NCT00619021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527984|NCT00619034|Diclofenac|diclofenac|mesh-list
24527985|NCT00619034|Dorzolamide|dorzolamide|mesh-list
24527986|NCT00619034|Latanoprost|latanoprost|mesh-list
24405276|NCT00166413|Thalidomide|thalidomide|mesh-list
24528021|NCT00619268|Interferons|interferons|mesh-list
24528022|NCT00619268|Interferon-alpha|interferon-alpha|mesh-list
24528023|NCT00619268|Interferon alpha-2|interferon alpha-2|mesh-list
24528024|NCT00619268|Sirolimus|sirolimus|mesh-list
24528025|NCT00619268|Bevacizumab|bevacizumab|mesh-list
24528026|NCT00619268|Sunitinib|sunitinib|mesh-list
24528027|NCT00619268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24528028|NCT00619268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528029|NCT00619268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24528030|NCT00619268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24929002|NCT04116827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24929004|NCT04116411|Temozolomide|temozolomide|mesh-list
24929005|NCT04116411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24929006|NCT04116411|Alkylating Agents|alkylating agents|mesh-ancestor
24929007|NCT04116411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929008|NCT04116411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929009|NCT04116411|Antiviral Agents|antiviral agents|mesh-ancestor
24929010|NCT04116411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24929011|NCT04116359|Cisplatin|cisplatin|mesh-list
24929012|NCT04116359|Etoposide|etoposide|mesh-list
24929013|NCT04116359|Etoposide phosphate|etoposide phosphate|mesh-list
24929014|NCT04116359|Podophyllotoxin|podophyllotoxin|mesh-list
25687814|NCT01937871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687815|NCT01937871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687816|NCT01937871|Urological Agents|urological agents|mesh-ancestor
25687817|NCT01937871|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25687818|NCT01937871|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25687819|NCT01937871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25687820|NCT01937871|Adrenergic Agents|adrenergic agents|mesh-ancestor
24749307|NCT01204242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749308|NCT01204242|Sensory System Agents|sensory system agents|mesh-ancestor
24749336|NCT01166113|Prednisone|prednisone|mesh-list
24749338|NCT01166113|Pomalidomide|pomalidomide|mesh-list
24749365|NCT01160107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749366|NCT01160107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24946737|NCT03935984|Vasodilator Agents|vasodilator agents|mesh-ancestor
25022835|NCT03658850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25257245|NCT02477514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25257246|NCT02477514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25257247|NCT02477514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257248|NCT02477514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25257249|NCT02477514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25257250|NCT02477514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25095917|NCT03215498|Insulin|insulin|mesh-list
25257251|NCT02477514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25257252|NCT02477514|Anesthetics, General|anesthetics, general|mesh-ancestor
25257253|NCT02477514|Anesthetics|anesthetics|mesh-ancestor
25257254|NCT02477514|GABA Modulators|gaba modulators|mesh-ancestor
25257255|NCT02477514|GABA Agents|gaba agents|mesh-ancestor
25257256|NCT02477514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25257257|NCT02477514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257258|NCT02477514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25257259|NCT02477514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25257270|NCT02477501|Adrenergic Agents|adrenergic agents|mesh-ancestor
25257271|NCT02477501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25257272|NCT02477501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257273|NCT02477501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929015|NCT04116359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929016|NCT04116359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24929017|NCT04116359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24929018|NCT04116359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24929019|NCT04116359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022869|NCT03658746|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25022870|NCT03658746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25022871|NCT03658746|Antitubercular Agents|antitubercular agents|mesh-ancestor
25022872|NCT03658746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25022873|NCT03658746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25022874|NCT03658746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25022875|NCT03658746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022876|NCT03658746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022877|NCT03658746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25022878|NCT03658746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25022879|NCT03658746|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25022905|NCT03658733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25022906|NCT03658733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25022907|NCT03658733|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25022908|NCT03658733|Renal Agents|renal agents|mesh-ancestor
25022909|NCT03658733|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25022910|NCT03658733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25022911|NCT03658733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25022912|NCT03658733|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25022913|NCT03658720|Ibuprofen|ibuprofen|mesh-list
25095981|NCT03214731|Antimalarials|antimalarials|mesh-ancestor
25022914|NCT03658720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25022915|NCT03658720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25022916|NCT03658720|Analgesics|analgesics|mesh-ancestor
25022917|NCT03658720|Sensory System Agents|sensory system agents|mesh-ancestor
25022918|NCT03658720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25022919|NCT03658720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022920|NCT03658720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25022921|NCT03658720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25022922|NCT03658720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25022923|NCT03658720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022924|NCT03658720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022925|NCT03658590|Dexamethasone|dexamethasone|mesh-list
25687821|NCT01937871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25687822|NCT01937871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687823|NCT01937975|Grazoprevir|grazoprevir|mesh-list
25687824|NCT01937975|Antiviral Agents|antiviral agents|mesh-ancestor
25687825|NCT01937975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25687826|NCT01938040|Ibuprofen|ibuprofen|mesh-list
25687827|NCT01938040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24749405|NCT01098032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749406|NCT01098032|Protective Agents|protective agents|mesh-ancestor
24749408|NCT01096368|Cyclophosphamide|cyclophosphamide|mesh-list
25022926|NCT03658590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25022927|NCT03658590|Antiemetics|antiemetics|mesh-ancestor
25022928|NCT03658590|Autonomic Agents|autonomic agents|mesh-ancestor
25022929|NCT03658590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25022955|NCT03658473|Antioxidants|antioxidants|mesh-ancestor
25022956|NCT03658473|Protective Agents|protective agents|mesh-ancestor
25022957|NCT03658447|Pembrolizumab|pembrolizumab|mesh-list
25022958|NCT03658447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25022959|NCT03658447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25022960|NCT03658421|Dexmedetomidine|dexmedetomidine|mesh-list
25022961|NCT03658421|Morphine|morphine|mesh-list
25022962|NCT03658421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25022966|NCT03658421|Analgesics|analgesics|mesh-ancestor
25022978|NCT03658408|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25022979|NCT03658408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25022980|NCT03658408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022982|NCT03658330|Ketamine|ketamine|mesh-list
25022983|NCT03658330|Analgesics|analgesics|mesh-ancestor
25022990|NCT03658330|Anesthetics|anesthetics|mesh-ancestor
25257274|NCT02477501|Sympathomimetics|sympathomimetics|mesh-ancestor
25257275|NCT02477501|Autonomic Agents|autonomic agents|mesh-ancestor
25257276|NCT02477501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25257277|NCT02477501|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25257278|NCT02477501|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24929020|NCT04116359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929021|NCT04116359|Keratolytic Agents|keratolytic agents|mesh-ancestor
24929022|NCT04116359|Dermatologic Agents|dermatologic agents|mesh-ancestor
24929023|NCT04116359|Tubulin Modulators|tubulin modulators|mesh-ancestor
24929024|NCT04116359|Antimitotic Agents|antimitotic agents|mesh-ancestor
24929025|NCT04116359|Mitosis Modulators|mitosis modulators|mesh-ancestor
24929026|NCT04115982|Cholecalciferol|cholecalciferol|mesh-list
24929028|NCT04115982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24929029|NCT04115982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155503|NCT05353140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505042|NCT00539331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505043|NCT00539331|Tubulin Modulators|tubulin modulators|mesh-ancestor
24505044|NCT00539331|Antimitotic Agents|antimitotic agents|mesh-ancestor
24528031|NCT00619268|Growth Substances|growth substances|mesh-ancestor
24528032|NCT00619268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023000|NCT03658317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023001|NCT03658317|Protective Agents|protective agents|mesh-ancestor
25023002|NCT03658317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023003|NCT03658291|Levofloxacin|levofloxacin|mesh-list
25023004|NCT03658291|Ofloxacin|ofloxacin|mesh-list
25023005|NCT03658291|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25023006|NCT03658291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25023007|NCT03658291|Renal Agents|renal agents|mesh-ancestor
24413785|NCT00195286|Tazobactam|tazobactam|mesh-list
25023008|NCT03658291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24979666|NCT03034356|Levetiracetam|levetiracetam|mesh-list
24979706|NCT02973997|Pembrolizumab|pembrolizumab|mesh-list
24979707|NCT02973997|Lenvatinib|lenvatinib|mesh-list
24979708|NCT02973997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24979709|NCT02973997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979710|NCT02973997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24979711|NCT02973997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24979712|NCT02973997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979713|NCT02968602|Minocycline|minocycline|mesh-list
24979714|NCT02968602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24587400|NCT00894712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587401|NCT00894751|Dexmedetomidine|dexmedetomidine|mesh-list
24587402|NCT00894751|Propofol|propofol|mesh-list
24587403|NCT00894751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24587404|NCT00894751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24587405|NCT00894751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587406|NCT00894751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24587407|NCT00894751|Anesthetics, General|anesthetics, general|mesh-ancestor
24587408|NCT00894751|Anesthetics|anesthetics|mesh-ancestor
24587409|NCT00894751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24587436|NCT00894959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25687828|NCT01938040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25687829|NCT01938040|Analgesics|analgesics|mesh-ancestor
25687830|NCT01938040|Sensory System Agents|sensory system agents|mesh-ancestor
25687831|NCT01938040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023009|NCT03658291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25023010|NCT03658291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25023011|NCT03658291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25023012|NCT03658291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023013|NCT03658291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023014|NCT03658291|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25023015|NCT03658291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25257279|NCT02477488|Allopurinol|allopurinol|mesh-list
25257280|NCT02477488|Antimetabolites|antimetabolites|mesh-ancestor
25023131|NCT03657420|Antiemetics|antiemetics|mesh-ancestor
25257283|NCT02477488|Gout Suppressants|gout suppressants|mesh-ancestor
25257284|NCT02477488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25257285|NCT02477488|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25257287|NCT02477488|Protective Agents|protective agents|mesh-ancestor
25257288|NCT02477488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257289|NCT02477436|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
25257290|NCT02477436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25257291|NCT02477436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257292|NCT02477436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257293|NCT02477397|Fluticasone|fluticasone|mesh-list
25257294|NCT02477397|Xhance|xhance|mesh-list
25257295|NCT02477397|Budesonide|budesonide|mesh-list
24528033|NCT00619268|Growth Inhibitors|growth inhibitors|mesh-ancestor
24528034|NCT00619268|Antiviral Agents|antiviral agents|mesh-ancestor
24528035|NCT00619268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24528036|NCT00619268|Immunologic Factors|immunologic factors|mesh-ancestor
24528037|NCT00619268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24528038|NCT00619268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25023016|NCT03658213|Goserelin|goserelin|mesh-list
25023017|NCT03658213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25023018|NCT03658213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023019|NCT03658109|Lidocaine|lidocaine|mesh-list
25023020|NCT03658109|Anesthetics, Local|anesthetics, local|mesh-ancestor
25023047|NCT03657979|Sensory System Agents|sensory system agents|mesh-ancestor
25023048|NCT03657979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023049|NCT03657966|Gemcitabine|gemcitabine|mesh-list
25023050|NCT03657966|Paclitaxel|paclitaxel|mesh-list
25023051|NCT03657966|Carboplatin|carboplatin|mesh-list
25023052|NCT03657966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25023053|NCT03657966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023054|NCT03657966|Tubulin Modulators|tubulin modulators|mesh-ancestor
25023055|NCT03657966|Antimitotic Agents|antimitotic agents|mesh-ancestor
25023056|NCT03657966|Mitosis Modulators|mitosis modulators|mesh-ancestor
25023057|NCT03657966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023058|NCT03657966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25023066|NCT03657862|Fluorides|fluorides|mesh-list
25023098|NCT03657550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023099|NCT03657550|Vasodilator Agents|vasodilator agents|mesh-ancestor
25023100|NCT03657550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25023101|NCT03657550|Antimetabolites|antimetabolites|mesh-ancestor
25023102|NCT03657550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25023103|NCT03657550|Vitamin B Complex|vitamin b complex|mesh-ancestor
25023104|NCT03657550|Vitamins|vitamins|mesh-ancestor
25023105|NCT03657550|Micronutrients|micronutrients|mesh-ancestor
25023106|NCT03657472|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
25023107|NCT03657472|Atorvastatin|atorvastatin|mesh-list
25023108|NCT03657472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25023109|NCT03657472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25023110|NCT03657472|Antimetabolites|antimetabolites|mesh-ancestor
25023111|NCT03657472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023112|NCT03657472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25023113|NCT03657472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25023114|NCT03657472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25023115|NCT03657472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25023116|NCT03657446|Moxifloxacin|moxifloxacin|mesh-list
25023117|NCT03657446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25023118|NCT03657446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25023119|NCT03657446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25023120|NCT03657446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25023121|NCT03657446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25023122|NCT03657446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023123|NCT03657446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979816|NCT05241054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979818|NCT05241028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979819|NCT05241028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24979820|NCT05241028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24749605|NCT00579527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24749606|NCT00579527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24749607|NCT00579527|Protective Agents|protective agents|mesh-ancestor
24749608|NCT00579527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24749609|NCT00579527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24749610|NCT00576836|Parathyroid Hormone|parathyroid hormone|mesh-list
24625934|NCT01084408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24625935|NCT01084408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24625936|NCT01084408|Tubulin Modulators|tubulin modulators|mesh-ancestor
24625937|NCT01084408|Antimitotic Agents|antimitotic agents|mesh-ancestor
24414033|NCT00195845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618850|NCT01049880|Ascorbic Acid|ascorbic acid|mesh-list
24618851|NCT01049880|Gemcitabine|gemcitabine|mesh-list
24618852|NCT01049880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24618864|NCT01049880|Vitamins|vitamins|mesh-ancestor
24618865|NCT01049880|Micronutrients|micronutrients|mesh-ancestor
24618866|NCT01049932|Rilpivirine|rilpivirine|mesh-list
24618867|NCT01049932|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24618868|NCT01049932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24618869|NCT01049932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24655496|NCT01257009|Atorvastatin|atorvastatin|mesh-list
24618870|NCT01049932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618871|NCT01049932|Antiviral Agents|antiviral agents|mesh-ancestor
24618872|NCT01049932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24618912|NCT01050270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24618913|NCT01050270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618915|NCT01050270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24618916|NCT01050270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24979821|NCT05241028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979824|NCT05240456|Solifenacin Succinate|solifenacin succinate|mesh-list
25023129|NCT03657420|Pomalidomide|pomalidomide|mesh-list
25023130|NCT03657420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25257300|NCT02477397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24528039|NCT00619268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528040|NCT00619268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24528041|NCT00619268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24929031|NCT04115982|Micronutrients|micronutrients|mesh-ancestor
24929032|NCT04115982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24929034|NCT04116255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24929035|NCT04116255|Antifungal Agents|antifungal agents|mesh-ancestor
24929036|NCT04116255|Keratolytic Agents|keratolytic agents|mesh-ancestor
24929037|NCT04116255|Dermatologic Agents|dermatologic agents|mesh-ancestor
24929047|NCT04115904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25687832|NCT01938040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687833|NCT01938040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25687834|NCT01938040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25687835|NCT01938040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25687836|NCT01938040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687837|NCT01938040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687838|NCT01938079|Ketamine|ketamine|mesh-list
25687839|NCT01938079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25687840|NCT01938079|Analgesics|analgesics|mesh-ancestor
25687841|NCT01938079|Sensory System Agents|sensory system agents|mesh-ancestor
25687842|NCT01938079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25687843|NCT01938079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687844|NCT01938079|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25687845|NCT01938079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25687846|NCT01938079|Anesthetics, General|anesthetics, general|mesh-ancestor
25687847|NCT01938079|Anesthetics|anesthetics|mesh-ancestor
25687848|NCT01938079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25687849|NCT01938079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25687850|NCT01938079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25687851|NCT01938079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25687852|NCT01938079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687853|NCT01938430|Sofosbuvir|sofosbuvir|mesh-list
25687854|NCT01938430|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25687855|NCT01938430|Ledipasvir|ledipasvir|mesh-list
25687856|NCT01938430|Antiviral Agents|antiviral agents|mesh-ancestor
25687857|NCT01938430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25687858|NCT01938573|Gemcitabine|gemcitabine|mesh-list
25687859|NCT01938573|Sirolimus|sirolimus|mesh-list
25687860|NCT01938573|Cisplatin|cisplatin|mesh-list
25687861|NCT01938573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24625938|NCT01084408|Mitosis Modulators|mitosis modulators|mesh-ancestor
24625939|NCT01084408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625940|NCT01084473|Dexmedetomidine|dexmedetomidine|mesh-list
24625941|NCT01084473|Morphine|morphine|mesh-list
24625942|NCT01084473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24625943|NCT01084473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25051246|NCT00429923|Difluprednate|difluprednate|mesh-list
24625944|NCT01084473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625945|NCT01084473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24749694|NCT00551928|Prednisone|prednisone|mesh-list
24929048|NCT04115904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24929049|NCT04115904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929050|NCT04116138|Antisecretory factor|antisecretory factor|mesh-list
24929051|NCT04116138|Antidiarrheals|antidiarrheals|mesh-ancestor
24929052|NCT04116138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25112048|NCT04527055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25112049|NCT04527055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25112050|NCT04527055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25112051|NCT04527055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25112052|NCT04527055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25112053|NCT04527055|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25112054|NCT04527055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25112055|NCT04527055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112056|NCT04527055|Antacids|antacids|mesh-ancestor
25112057|NCT04527055|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25257308|NCT02477397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25257309|NCT02477397|Glucocorticoids|glucocorticoids|mesh-ancestor
25257310|NCT02477397|Hormones|hormones|mesh-ancestor
25257311|NCT02477397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25257312|NCT02477397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25257313|NCT02477397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25257320|NCT02477267|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25257322|NCT02477267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25257323|NCT02477267|Narcotics|narcotics|mesh-ancestor
25257324|NCT02477267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24528042|NCT00619268|Antifungal Agents|antifungal agents|mesh-ancestor
24528043|NCT00619268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24528044|NCT00619333|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24528045|NCT00619333|Hormones|hormones|mesh-ancestor
24528046|NCT00619333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24528071|NCT00619424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24528072|NCT00619528|Alemtuzumab|alemtuzumab|mesh-list
24528073|NCT00619528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24528074|NCT00619528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023173|NCT03656965|Antiviral Agents|antiviral agents|mesh-ancestor
25023174|NCT03656965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25023175|NCT03656952|Moxifloxacin|moxifloxacin|mesh-list
25023176|NCT03656952|PF-06700841|pf-06700841|mesh-list
25023177|NCT03656952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25023178|NCT03656952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25023179|NCT03656952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25023180|NCT03656952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25023181|NCT03656952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25023182|NCT03656952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023183|NCT03656952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023184|NCT03656952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25023185|NCT03656783|Tenofovir|tenofovir|mesh-list
25023186|NCT03656783|Emtricitabine|emtricitabine|mesh-list
25023187|NCT03656783|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25023188|NCT03656783|Antiviral Agents|antiviral agents|mesh-ancestor
25023189|NCT03656783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25023190|NCT03656783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25023191|NCT03656783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25687862|NCT01938573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25687863|NCT01938573|Antimetabolites|antimetabolites|mesh-ancestor
25687864|NCT01938573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687865|NCT01938573|Antiviral Agents|antiviral agents|mesh-ancestor
25687866|NCT01938573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25687867|NCT01938573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687868|NCT01938573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25687869|NCT01938573|Immunologic Factors|immunologic factors|mesh-ancestor
25687870|NCT01938573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687871|NCT01938573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25687872|NCT01938573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25687873|NCT01938573|Antifungal Agents|antifungal agents|mesh-ancestor
25023192|NCT03656783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25023193|NCT03656783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023194|NCT03656783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25023195|NCT03656783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25023196|NCT03656679|Iodine|iodine|mesh-list
25023197|NCT03656679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25023198|NCT03656679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25023213|NCT03656666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25023214|NCT03656666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25023215|NCT03656666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023216|NCT03656666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25023217|NCT03656666|Immunologic Factors|immunologic factors|mesh-ancestor
25023218|NCT03656666|Leprostatic Agents|leprostatic agents|mesh-ancestor
25023219|NCT03656666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25023220|NCT03656666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25023221|NCT03656666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25023222|NCT03656666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25023223|NCT03656666|Growth Substances|growth substances|mesh-ancestor
25023224|NCT03656666|Growth Inhibitors|growth inhibitors|mesh-ancestor
25023225|NCT03656666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25257325|NCT02477267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257326|NCT02477267|Analgesics|analgesics|mesh-ancestor
25257327|NCT02477267|Sensory System Agents|sensory system agents|mesh-ancestor
25257328|NCT02477267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25257329|NCT02477267|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25257330|NCT02477280|Methylphenidate|methylphenidate|mesh-list
25257343|NCT02477306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257338|NCT02477280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25257339|NCT02477306|Rabeprazole|rabeprazole|mesh-list
25257340|NCT02477306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25257341|NCT02477306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24929070|NCT04115800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24929071|NCT04115800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24929072|NCT04115800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24929073|NCT04115800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929074|NCT04115800|Antifungal Agents|antifungal agents|mesh-ancestor
24929075|NCT04115800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24929076|NCT04115800|Immunologic Factors|immunologic factors|mesh-ancestor
24929077|NCT04115800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929078|NCT04115423|Adalimumab|adalimumab|mesh-list
24929079|NCT04115423|Etanercept|etanercept|mesh-list
24929080|NCT04115423|Golimumab|golimumab|mesh-list
24947373|NCT03929744|Anesthetics|anesthetics|mesh-ancestor
25023227|NCT03656627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24979893|NCT04984083|Hemostatics|hemostatics|mesh-ancestor
25023259|NCT03656484|Metronidazole|metronidazole|mesh-list
25023260|NCT03656484|Tetracycline|tetracycline|mesh-list
25023261|NCT03656484|Melatonin|melatonin|mesh-list
25023262|NCT03656484|Hyaluronic Acid|hyaluronic acid|mesh-list
25023263|NCT03656484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25023264|NCT03656484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25023265|NCT03656484|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25023266|NCT03656484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25023267|NCT03656484|Antioxidants|antioxidants|mesh-ancestor
25023268|NCT03656484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023269|NCT03656484|Protective Agents|protective agents|mesh-ancestor
25023270|NCT03656484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023317|NCT03656094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023318|NCT03656094|Tubulin Modulators|tubulin modulators|mesh-ancestor
25023319|NCT03656094|Antimitotic Agents|antimitotic agents|mesh-ancestor
25023320|NCT03656094|Mitosis Modulators|mitosis modulators|mesh-ancestor
24420367|NCT00215774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25023321|NCT03656094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023322|NCT03656094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25023323|NCT03656094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25023324|NCT03656094|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25023325|NCT03656094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25023331|NCT03655964|Olmesartan|olmesartan|mesh-list
25023383|NCT03655665|Ofloxacin|ofloxacin|mesh-list
25023384|NCT03655665|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25023385|NCT03655665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25023386|NCT03655665|Renal Agents|renal agents|mesh-ancestor
25023387|NCT03655665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25023388|NCT03655665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25687874|NCT01938625|Cyclosporine|cyclosporine|mesh-list
25687875|NCT01938625|Ribavirin|ribavirin|mesh-list
25687877|NCT01938625|Tacrolimus|tacrolimus|mesh-list
25687878|NCT01938625|Cyclosporins|cyclosporins|mesh-list
25023389|NCT03655665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25687879|NCT01938625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25023390|NCT03655665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25023391|NCT03655665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023392|NCT03655665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023393|NCT03655665|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25096354|NCT03212599|Disulfiram|disulfiram|mesh-list
25023394|NCT03655665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25023395|NCT03655535|PAZ320|paz320|mesh-list
25023396|NCT03655535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25023397|NCT03655535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023398|NCT03655457|Poractant alfa|poractant alfa|mesh-list
25023399|NCT03655457|Beractant|beractant|mesh-list
25112078|NCT04488367|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25112079|NCT04488367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25257342|NCT02477306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25257350|NCT02476955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25257351|NCT02476955|Tubulin Modulators|tubulin modulators|mesh-ancestor
25257352|NCT02476955|Antimitotic Agents|antimitotic agents|mesh-ancestor
25257353|NCT02476955|Mitosis Modulators|mitosis modulators|mesh-ancestor
24929081|NCT04115423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
24929083|NCT04115423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24929084|NCT04115423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24929085|NCT04115423|Dermatologic Agents|dermatologic agents|mesh-ancestor
24929086|NCT04115423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24624704|NCT01077752|Anesthetics|anesthetics|mesh-ancestor
24624705|NCT01077752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24624706|NCT01077752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505103|NCT00539799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24947377|NCT03929575|Calcium|calcium|mesh-list
25112080|NCT04488367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112081|NCT04488367|Hemostatics|hemostatics|mesh-ancestor
25112082|NCT04488367|Coagulants|coagulants|mesh-ancestor
24587447|NCT00894998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24587448|NCT00894998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24587449|NCT00894998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587450|NCT00895063|Botulinum Toxins|botulinum toxins|mesh-list
24587451|NCT00895063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24587452|NCT00895063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24587453|NCT00895063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587454|NCT00895063|Cholinergic Agents|cholinergic agents|mesh-ancestor
24587455|NCT00895063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24587483|NCT00895089|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24587484|NCT00895089|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24587485|NCT00895089|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24587487|NCT00895115|Vitamins|vitamins|mesh-ancestor
24587488|NCT00895115|Micronutrients|micronutrients|mesh-ancestor
24587489|NCT00895115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587490|NCT00895115|Antioxidants|antioxidants|mesh-ancestor
24587491|NCT00895115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587492|NCT00895115|Protective Agents|protective agents|mesh-ancestor
24587493|NCT00895128|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24587494|NCT00895128|Dasatinib|dasatinib|mesh-list
24587495|NCT00895128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587496|NCT00895128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24587497|NCT00895128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587519|NCT00895323|Immunologic Factors|immunologic factors|mesh-ancestor
24587520|NCT00895323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587522|NCT00895362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24587523|NCT00895362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24587524|NCT00895362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587525|NCT00895362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24587526|NCT00895362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587528|NCT00895505|Warfarin|warfarin|mesh-list
24587534|NCT00895557|Varenicline|varenicline|mesh-list
24587535|NCT00895557|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25687880|NCT01938625|Immunologic Factors|immunologic factors|mesh-ancestor
25687881|NCT01938625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687882|NCT01938625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25687883|NCT01938625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687884|NCT01938625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687885|NCT01938625|Antifungal Agents|antifungal agents|mesh-ancestor
24749983|NCT01695226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24749984|NCT01695226|Analgesics|analgesics|mesh-ancestor
24587536|NCT00895557|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24587537|NCT00895557|Cholinergic Agents|cholinergic agents|mesh-ancestor
24587538|NCT00895557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24587539|NCT00895557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587540|NCT00895557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587541|NCT00895570|Modafinil|modafinil|mesh-list
25023417|NCT03654820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25023418|NCT03654794|Tacrolimus|tacrolimus|mesh-list
25023419|NCT03654794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25257354|NCT02476955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023420|NCT03654794|Immunologic Factors|immunologic factors|mesh-ancestor
24528075|NCT00619541|Fluorouracil|fluorouracil|mesh-list
24528077|NCT00619541|Antimetabolites|antimetabolites|mesh-ancestor
24528097|NCT00619697|Glimepiride|glimepiride|mesh-list
24528098|NCT00619697|Biphasic Insulins|biphasic insulins|mesh-list
25023421|NCT03654794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023422|NCT03654794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25023463|NCT03654144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25023464|NCT03654144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25023465|NCT03654144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023518|NCT03653663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25023519|NCT03653663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25023520|NCT03653663|Antimetabolites|antimetabolites|mesh-ancestor
25023521|NCT03653663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023522|NCT03653663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25023523|NCT03653663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25023524|NCT03653663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25023526|NCT03653520|Tramadol|tramadol|mesh-list
25023527|NCT03653520|Ondansetron|ondansetron|mesh-list
25023528|NCT03653520|Antiemetics|antiemetics|mesh-ancestor
25023529|NCT03653520|Autonomic Agents|autonomic agents|mesh-ancestor
25023530|NCT03653520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023531|NCT03653520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023532|NCT03653520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25023533|NCT03653520|Antipruritics|antipruritics|mesh-ancestor
25023534|NCT03653520|Dermatologic Agents|dermatologic agents|mesh-ancestor
25023535|NCT03653520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25023536|NCT03653520|Serotonin Agents|serotonin agents|mesh-ancestor
25023537|NCT03653520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25023538|NCT03653520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023539|NCT03653520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25023540|NCT03653520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25023541|NCT03653520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25023568|NCT03653260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25023569|NCT03653260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023571|NCT03653052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25023572|NCT03653052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25112111|NCT04415840|Lugol's solution|lugol's solution|mesh-list
25112112|NCT04415840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24980285|NCT05420454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24980286|NCT05420454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24980287|NCT05420454|Alkylating Agents|alkylating agents|mesh-ancestor
24980288|NCT05420454|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24980289|NCT05420454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24980290|NCT05420454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24980291|NCT05420454|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24980292|NCT05420454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24634124|NCT01132170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24634125|NCT01132170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24634126|NCT01132170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24634127|NCT01132183|Valproic Acid|valproic acid|mesh-list
24634128|NCT01132183|Anticonvulsants|anticonvulsants|mesh-ancestor
24634129|NCT01132183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634130|NCT01132183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587588|NCT00895739|Immunologic Factors|immunologic factors|mesh-ancestor
24587589|NCT00895739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624710|NCT01077752|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24624711|NCT01077752|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24624712|NCT01077752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25687886|NCT01938625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25687887|NCT01938625|Dermatologic Agents|dermatologic agents|mesh-ancestor
24750053|NCT01696370|Trimetazidine|trimetazidine|mesh-list
24750054|NCT01696370|Vasodilator Agents|vasodilator agents|mesh-ancestor
24944369|NCT03961126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24944370|NCT03961126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944372|NCT03961048|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24944373|NCT03961048|Anesthetics, Local|anesthetics, local|mesh-ancestor
24944374|NCT03961048|Anesthetics|anesthetics|mesh-ancestor
24944375|NCT03961048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24944376|NCT03961048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624713|NCT01077752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624714|NCT01077752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24587590|NCT00895739|Antifungal Agents|antifungal agents|mesh-ancestor
24587591|NCT00895739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25023613|NCT03652870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023614|NCT03652870|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25023615|NCT03652870|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25023616|NCT03652870|Cholinergic Agents|cholinergic agents|mesh-ancestor
25023617|NCT03652870|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25023618|NCT03652870|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25023619|NCT03652870|Adrenergic Agents|adrenergic agents|mesh-ancestor
25023620|NCT03652857|Apatinib|apatinib|mesh-list
25023621|NCT03652857|Vinorelbine|vinorelbine|mesh-list
25023622|NCT03652857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023623|NCT03652857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25023624|NCT03652857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25023625|NCT03652857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023626|NCT03652857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25023627|NCT03652857|Tubulin Modulators|tubulin modulators|mesh-ancestor
25023628|NCT03652857|Antimitotic Agents|antimitotic agents|mesh-ancestor
25023629|NCT03652857|Mitosis Modulators|mitosis modulators|mesh-ancestor
25023630|NCT03652792|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25023631|NCT03652792|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25023632|NCT03652792|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25023633|NCT03652792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023634|NCT03652753|Acetylcysteine|acetylcysteine|mesh-list
25023635|NCT03652753|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25023636|NCT03652753|Antiviral Agents|antiviral agents|mesh-ancestor
25023637|NCT03652753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25023638|NCT03652753|Expectorants|expectorants|mesh-ancestor
25023659|NCT03652571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023673|NCT03652480|Antiemetics|antiemetics|mesh-ancestor
25023674|NCT03652480|Autonomic Agents|autonomic agents|mesh-ancestor
25023675|NCT03652480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024654|NCT03643666|Magnesium Sulfate|magnesium sulfate|mesh-list
25023676|NCT03652480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023677|NCT03652480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25257369|NCT02477007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25257370|NCT02477007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257371|NCT02477007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25257372|NCT02477007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25257373|NCT02477007|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25257374|NCT02477007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257375|NCT02477007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257376|NCT02477007|Antipyretics|antipyretics|mesh-ancestor
25257377|NCT02476799|Ketorolac|ketorolac|mesh-list
25257378|NCT02476799|Fentanyl|fentanyl|mesh-list
25257379|NCT02476799|Ropivacaine|ropivacaine|mesh-list
25257380|NCT02476799|Anesthetics, Local|anesthetics, local|mesh-ancestor
25257381|NCT02476799|Anesthetics|anesthetics|mesh-ancestor
25257382|NCT02476799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24624716|NCT01077752|Analgesics|analgesics|mesh-ancestor
24624717|NCT01077752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24624718|NCT01077752|Antipyretics|antipyretics|mesh-ancestor
24929087|NCT04115423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25687888|NCT01938625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25687889|NCT01938625|Antimetabolites|antimetabolites|mesh-ancestor
25687890|NCT01938625|Antiviral Agents|antiviral agents|mesh-ancestor
25687891|NCT01938625|Protease Inhibitors|protease inhibitors|mesh-ancestor
25687892|NCT01938664|Candesartan|candesartan|mesh-list
25687893|NCT01938664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25687894|NCT01938664|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25687895|NCT01938664|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25687896|NCT01938664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929088|NCT04115423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24929089|NCT04115423|Analgesics|analgesics|mesh-ancestor
24929090|NCT04115423|Sensory System Agents|sensory system agents|mesh-ancestor
24929091|NCT04115423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023678|NCT03652480|Glucocorticoids|glucocorticoids|mesh-ancestor
25023680|NCT03652480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25023681|NCT03652480|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25023682|NCT03652480|Protective Agents|protective agents|mesh-ancestor
25023683|NCT03652480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25023684|NCT03652480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023685|NCT03652467|Chlorotrianisene|chlorotrianisene|mesh-list
25023686|NCT03652467|Deferoxamine|deferoxamine|mesh-list
25023687|NCT03652467|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25023688|NCT03652467|Estrogens|estrogens|mesh-ancestor
25023690|NCT03652467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25023691|NCT03652467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023692|NCT03652467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25023693|NCT03652467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023694|NCT03652467|Siderophores|siderophores|mesh-ancestor
25023695|NCT03652467|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25023698|NCT03652467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023699|NCT03652441|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25023700|NCT03652441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25023701|NCT03652441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023702|NCT03652428|Gemcitabine|gemcitabine|mesh-list
25023704|NCT03652428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25023705|NCT03652428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023706|NCT03652428|Tubulin Modulators|tubulin modulators|mesh-ancestor
25023707|NCT03652428|Antimitotic Agents|antimitotic agents|mesh-ancestor
25023708|NCT03652428|Mitosis Modulators|mitosis modulators|mesh-ancestor
25023709|NCT03652428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023710|NCT03652428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25023711|NCT03652428|Antimetabolites|antimetabolites|mesh-ancestor
25023712|NCT03652428|Antiviral Agents|antiviral agents|mesh-ancestor
25023713|NCT03652428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25023738|NCT03652116|Bupivacaine|bupivacaine|mesh-list
25023739|NCT03652116|Anesthetics, Local|anesthetics, local|mesh-ancestor
25023740|NCT03652116|Anesthetics|anesthetics|mesh-ancestor
25023741|NCT03652116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25023742|NCT03652116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023743|NCT03652116|Sensory System Agents|sensory system agents|mesh-ancestor
25023744|NCT03652116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023745|NCT03652116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25023746|NCT03652116|Narcotics|narcotics|mesh-ancestor
25023747|NCT03652116|Analgesics|analgesics|mesh-ancestor
25023748|NCT03652116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25023749|NCT03652103|Bupivacaine|bupivacaine|mesh-list
25023750|NCT03652103|Anesthetics, Local|anesthetics, local|mesh-ancestor
25023769|NCT03651882|Oxytocics|oxytocics|mesh-ancestor
25023770|NCT03651882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25023771|NCT03651882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023772|NCT03651726|Palmidrol|palmidrol|mesh-list
25023773|NCT03651726|Dronabinol|dronabinol|mesh-list
25023774|NCT03651726|Hallucinogens|hallucinogens|mesh-ancestor
25023780|NCT03651726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023781|NCT03651726|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25023782|NCT03651726|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25023783|NCT03651726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25066068|NCT04331067|Nivolumab|nivolumab|mesh-list
25023784|NCT03651726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257383|NCT02476799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257384|NCT02476799|Sensory System Agents|sensory system agents|mesh-ancestor
25257385|NCT02476799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25257386|NCT02476799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25257388|NCT02476799|Analgesics|analgesics|mesh-ancestor
25023789|NCT03651726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25023790|NCT03651726|Antiviral Agents|antiviral agents|mesh-ancestor
25023791|NCT03651726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25023792|NCT03651674|Olanzapine|olanzapine|mesh-list
25023793|NCT03651674|Clozapine|clozapine|mesh-list
25023794|NCT03651674|Antiemetics|antiemetics|mesh-ancestor
25023795|NCT03651674|Autonomic Agents|autonomic agents|mesh-ancestor
25023796|NCT03651674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023797|NCT03651674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687897|NCT01938846|Paclitaxel|paclitaxel|mesh-list
25687898|NCT01938846|Exemestane|exemestane|mesh-list
25023835|NCT03651427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112113|NCT04415840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25112114|NCT04415840|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25112116|NCT04415840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112117|NCT04415840|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25112118|NCT04415840|Protective Agents|protective agents|mesh-ancestor
25112119|NCT04415840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25112120|NCT04415840|Hemostatics|hemostatics|mesh-ancestor
25112121|NCT04415840|Coagulants|coagulants|mesh-ancestor
25023841|NCT03651219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023842|NCT03651219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023843|NCT03651219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24980595|NCT05097326|Misoprostol|misoprostol|mesh-list
24980596|NCT05097326|Mifepristone|mifepristone|mesh-list
24980597|NCT05097326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24980598|NCT05097326|Abortifacient Agents|abortifacient agents|mesh-ancestor
24980599|NCT05097326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24980600|NCT05097326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980601|NCT05097326|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24980602|NCT05097326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24980603|NCT05097326|Oxytocics|oxytocics|mesh-ancestor
24980604|NCT05097326|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24980605|NCT05097326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24980606|NCT05097326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24980607|NCT05097326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25257392|NCT02476799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25257393|NCT02476799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25257394|NCT02476799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25257395|NCT02476799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25257396|NCT02476799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25257397|NCT02476799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257398|NCT02476799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257399|NCT02477098|Ropivacaine|ropivacaine|mesh-list
25257400|NCT02477098|Anesthetics, Local|anesthetics, local|mesh-ancestor
25257401|NCT02477098|Anesthetics|anesthetics|mesh-ancestor
24528123|NCT00619905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24980608|NCT05097326|Contraceptive Agents|contraceptive agents|mesh-ancestor
24980609|NCT05097326|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24980610|NCT05097326|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25023844|NCT03650998|Ropivacaine|ropivacaine|mesh-list
25023845|NCT03650998|Anesthetics, Local|anesthetics, local|mesh-ancestor
25023846|NCT03650998|Anesthetics|anesthetics|mesh-ancestor
25023847|NCT03650998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25023848|NCT03650998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023849|NCT03650998|Sensory System Agents|sensory system agents|mesh-ancestor
25023850|NCT03650998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023851|NCT03650881|Adapalene|adapalene|mesh-list
25023852|NCT03650881|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25023853|NCT03650881|Dermatologic Agents|dermatologic agents|mesh-ancestor
24516456|NCT00602017|Vasodilator Agents|vasodilator agents|mesh-ancestor
25023910|NCT03650270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25023911|NCT03650270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25023912|NCT03650270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25023913|NCT03650270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023914|NCT03650270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25023915|NCT03650270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25023916|NCT03650270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25023917|NCT03650270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25023918|NCT03650270|Anesthetics, General|anesthetics, general|mesh-ancestor
25023920|NCT03650270|GABA Modulators|gaba modulators|mesh-ancestor
25023921|NCT03650270|GABA Agents|gaba agents|mesh-ancestor
25023922|NCT03650270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25023923|NCT03650270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023924|NCT03650270|Anticonvulsants|anticonvulsants|mesh-ancestor
25023925|NCT03650270|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25023926|NCT03650270|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25023927|NCT03650270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25023928|NCT03650270|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25023952|NCT03649945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023953|NCT03649945|Tubulin Modulators|tubulin modulators|mesh-ancestor
25023954|NCT03649945|Antimitotic Agents|antimitotic agents|mesh-ancestor
25023955|NCT03649945|Mitosis Modulators|mitosis modulators|mesh-ancestor
25023956|NCT03649945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023957|NCT03649945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25023958|NCT03649945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25023959|NCT03649945|Growth Substances|growth substances|mesh-ancestor
25023960|NCT03649945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023961|NCT03649945|Growth Inhibitors|growth inhibitors|mesh-ancestor
25023962|NCT03649763|Lidocaine|lidocaine|mesh-list
25023963|NCT03649763|Bupivacaine|bupivacaine|mesh-list
25023964|NCT03649763|Anesthetics, Local|anesthetics, local|mesh-ancestor
25023965|NCT03649763|Anesthetics|anesthetics|mesh-ancestor
25023966|NCT03649763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25023967|NCT03649763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023968|NCT03649763|Sensory System Agents|sensory system agents|mesh-ancestor
25023969|NCT03649763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023982|NCT03649711|Aspirin|aspirin|mesh-list
25023983|NCT03649711|Clopidogrel|clopidogrel|mesh-list
25023984|NCT03649711|Ticagrelor|ticagrelor|mesh-list
25023985|NCT03649711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25023986|NCT03649711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25023987|NCT03649711|Analgesics|analgesics|mesh-ancestor
25023988|NCT03649711|Sensory System Agents|sensory system agents|mesh-ancestor
25023989|NCT03649711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023991|NCT03649711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25024025|NCT03649334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25257403|NCT02477098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257404|NCT02477098|Sensory System Agents|sensory system agents|mesh-ancestor
25257405|NCT02477098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25257406|NCT02477072|Heparin|heparin|mesh-list
25257407|NCT02477072|Calcium heparin|calcium heparin|mesh-list
25096911|NCT03208465|Empagliflozin|empagliflozin|mesh-list
25024032|NCT03649334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25024033|NCT03649334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25024034|NCT03649334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25024035|NCT03649334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024036|NCT03649269|Bezafibrate|bezafibrate|mesh-list
25024037|NCT03649269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25024038|NCT03649269|Antimetabolites|antimetabolites|mesh-ancestor
25024039|NCT03649269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024040|NCT03649269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25024041|NCT03649243|Propolis|propolis|mesh-list
25024094|NCT03648970|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25024095|NCT03648970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25024096|NCT03648970|Antimetabolites|antimetabolites|mesh-ancestor
25024097|NCT03648970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024098|NCT03648970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25024099|NCT03648970|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25024100|NCT03648970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024101|NCT03648697|Cyclophosphamide|cyclophosphamide|mesh-list
25024102|NCT03648697|Fludarabine|fludarabine|mesh-list
25024103|NCT03648697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25024104|NCT03648697|Immunologic Factors|immunologic factors|mesh-ancestor
25024105|NCT03648697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024106|NCT03648697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25024117|NCT03648684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024118|NCT03648684|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25024119|NCT03648684|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25024120|NCT03648684|Purinergic Agents|purinergic agents|mesh-ancestor
25024121|NCT03648684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25024122|NCT03648671|Rasagiline|rasagiline|mesh-list
25024123|NCT03648671|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25024124|NCT03648671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024135|NCT03648658|Antipyretics|antipyretics|mesh-ancestor
25024136|NCT03648554|Dulaglutide|dulaglutide|mesh-list
25024137|NCT03648554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25257408|NCT02477072|Anticoagulants|anticoagulants|mesh-ancestor
25257409|NCT02477072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25257410|NCT02477072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25257411|NCT02477072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257412|NCT02476929|Nitrous Oxide|nitrous oxide|mesh-list
25257413|NCT02476929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25257414|NCT02476929|Anesthetics, General|anesthetics, general|mesh-ancestor
25257415|NCT02476929|Anesthetics|anesthetics|mesh-ancestor
25257416|NCT02476929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25257417|NCT02476929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257418|NCT02476929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25687899|NCT01938846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25687900|NCT01938846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25257419|NCT02476929|Analgesics|analgesics|mesh-ancestor
25257420|NCT02476929|Sensory System Agents|sensory system agents|mesh-ancestor
25257421|NCT02476929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25257422|NCT02476903|Hyaluronic Acid|hyaluronic acid|mesh-list
25257423|NCT02476903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25257424|NCT02476903|Immunologic Factors|immunologic factors|mesh-ancestor
24929124|NCT04115449|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24929125|NCT04115449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24929126|NCT04115449|Adrenergic Agents|adrenergic agents|mesh-ancestor
24929127|NCT04115449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25096976|NCT03208101|Vaccines|vaccines|mesh-list
24929128|NCT04115449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528107|NCT00619710|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
24528108|NCT00619710|Cilastatin|cilastatin|mesh-list
24528109|NCT00619710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24528110|NCT00619710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24528111|NCT00619710|Protease Inhibitors|protease inhibitors|mesh-ancestor
24528112|NCT00619710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024138|NCT03648554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024170|NCT03648333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25024171|NCT03648333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25024172|NCT03648333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25024173|NCT03648333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024174|NCT03648333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25024175|NCT03648333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024176|NCT03648333|Vasodilator Agents|vasodilator agents|mesh-ancestor
25024177|NCT03648333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25024178|NCT03648333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25024179|NCT03648333|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25024180|NCT03648333|Antimetabolites|antimetabolites|mesh-ancestor
25024181|NCT03648333|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25024182|NCT03648333|Vitamin B Complex|vitamin b complex|mesh-ancestor
25024183|NCT03648333|Vitamins|vitamins|mesh-ancestor
25024184|NCT03648333|Micronutrients|micronutrients|mesh-ancestor
25024185|NCT03648229|Timolol|timolol|mesh-list
25024186|NCT03648229|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25024187|NCT03648229|Latanoprost|latanoprost|mesh-list
25024188|NCT03648229|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25024189|NCT03648229|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25024190|NCT03648229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25024191|NCT03648229|Adrenergic Agents|adrenergic agents|mesh-ancestor
25024192|NCT03648229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25024193|NCT03648229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024194|NCT03648229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024195|NCT03648229|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25024196|NCT03648229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25024197|NCT03648125|Salicylic Acid|salicylic acid|mesh-list
25024198|NCT03648125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25024199|NCT03648125|Antifungal Agents|antifungal agents|mesh-ancestor
25024200|NCT03648125|Keratolytic Agents|keratolytic agents|mesh-ancestor
25024201|NCT03648125|Dermatologic Agents|dermatologic agents|mesh-ancestor
25024212|NCT03648008|Narcotics|narcotics|mesh-ancestor
25024213|NCT03648008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25024214|NCT03648008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024215|NCT03648008|Analgesics|analgesics|mesh-ancestor
25024216|NCT03648008|Sensory System Agents|sensory system agents|mesh-ancestor
25024217|NCT03648008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024218|NCT03647982|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25024219|NCT03647982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25024220|NCT03647982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024221|NCT03647982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024222|NCT03647982|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25024223|NCT03647982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25024224|NCT03647982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024225|NCT03647982|Cholinergic Agents|cholinergic agents|mesh-ancestor
25687901|NCT01938846|Tubulin Modulators|tubulin modulators|mesh-ancestor
25687902|NCT01938846|Antimitotic Agents|antimitotic agents|mesh-ancestor
25687903|NCT01938846|Mitosis Modulators|mitosis modulators|mesh-ancestor
25687904|NCT01938846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587598|NCT00895778|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25024295|NCT03647579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25257425|NCT02476903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257426|NCT02476903|Viscosupplements|viscosupplements|mesh-ancestor
25257427|NCT02476903|Protective Agents|protective agents|mesh-ancestor
25257428|NCT02476864|Macitentan|macitentan|mesh-list
25257429|NCT02476864|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25257430|NCT02476864|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25257431|NCT02476864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257432|NCT02476864|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25257433|NCT02476981|Ephedrine|ephedrine|mesh-list
25257434|NCT02476981|Midazolam|midazolam|mesh-list
25257435|NCT02476981|Dexmedetomidine|dexmedetomidine|mesh-list
25112176|NCT04328714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25112182|NCT04318704|Ifenprodil|ifenprodil|mesh-list
25112183|NCT04318704|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25112184|NCT04318704|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25112185|NCT04318704|Adrenergic Agents|adrenergic agents|mesh-ancestor
25112186|NCT04318704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25112187|NCT04318704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112188|NCT04318704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112189|NCT04318704|Vasodilator Agents|vasodilator agents|mesh-ancestor
25112192|NCT04310540|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25112209|NCT04282018|Zanubrutinib|zanubrutinib|mesh-list
25112210|NCT04282018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25112211|NCT04282018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25024299|NCT03647514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25024300|NCT03647514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25024301|NCT03647423|Cyclophosphamide|cyclophosphamide|mesh-list
25024303|NCT03647423|Avelumab|avelumab|mesh-list
25024304|NCT03647423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25024305|NCT03647423|Immunologic Factors|immunologic factors|mesh-ancestor
25024306|NCT03647423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024307|NCT03647423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25024308|NCT03647423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25024309|NCT03647423|Alkylating Agents|alkylating agents|mesh-ancestor
25024355|NCT03646721|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25024356|NCT03646721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25024357|NCT03646721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024358|NCT03646721|Incretins|incretins|mesh-ancestor
25024359|NCT03646721|Hormones|hormones|mesh-ancestor
25024360|NCT03646721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25024361|NCT03646721|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25024362|NCT03646721|Protease Inhibitors|protease inhibitors|mesh-ancestor
25024363|NCT03646721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024364|NCT03646721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024365|NCT03646526|Amitriptyline|amitriptyline|mesh-list
25024366|NCT03646526|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25024415|NCT03646292|Empagliflozin|empagliflozin|mesh-list
24589066|NCT00905541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024416|NCT03646292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25112213|NCT04282018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112238|NCT04267120|Pembrolizumab|pembrolizumab|mesh-list
25112239|NCT04267120|Lenvatinib|lenvatinib|mesh-list
25024473|NCT03645304|Ropivacaine|ropivacaine|mesh-list
25024474|NCT03645304|Anesthetics, Local|anesthetics, local|mesh-ancestor
25024475|NCT03645304|Anesthetics|anesthetics|mesh-ancestor
25024486|NCT03645187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25024487|NCT03645187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25024488|NCT03645187|Analgesics|analgesics|mesh-ancestor
25257436|NCT02476981|Remifentanil|remifentanil|mesh-list
25257437|NCT02476981|Propofol|propofol|mesh-list
25257438|NCT02476981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24528115|NCT00619840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24528116|NCT00619840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024490|NCT03645187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024491|NCT03645187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024492|NCT03645187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25024493|NCT03645187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25024494|NCT03645187|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25024495|NCT03645187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25024496|NCT03645187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024497|NCT03645187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024500|NCT03645109|Vitamins|vitamins|mesh-ancestor
25024501|NCT03645109|Micronutrients|micronutrients|mesh-ancestor
25024505|NCT03645057|Tacrolimus|tacrolimus|mesh-list
24981275|NCT04022876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25024539|NCT03644667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25024540|NCT03644667|Antitubercular Agents|antitubercular agents|mesh-ancestor
25024541|NCT03644667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25024543|NCT03644667|Antiemetics|antiemetics|mesh-ancestor
25024544|NCT03644667|Autonomic Agents|autonomic agents|mesh-ancestor
25024545|NCT03644667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024546|NCT03644667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25024547|NCT03644667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25024548|NCT03644667|Protective Agents|protective agents|mesh-ancestor
25024549|NCT03644641|Propofol|propofol|mesh-list
25024550|NCT03644641|Desflurane|desflurane|mesh-list
25024551|NCT03644641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25024552|NCT03644641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25024553|NCT03644641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024554|NCT03644641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25024595|NCT03644446|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25024596|NCT03644446|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25024597|NCT03644446|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25024598|NCT03644446|Adrenergic Agents|adrenergic agents|mesh-ancestor
25024599|NCT03644446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25024600|NCT03644446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024611|NCT03644147|Antipyretics|antipyretics|mesh-ancestor
25024616|NCT03643900|Indomethacin|indomethacin|mesh-list
25024617|NCT03643900|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25024618|NCT03643900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25024619|NCT03643900|Analgesics|analgesics|mesh-ancestor
25024620|NCT03643900|Sensory System Agents|sensory system agents|mesh-ancestor
25024621|NCT03643900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024622|NCT03643900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024623|NCT03643900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25024639|NCT03643874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25024640|NCT03643874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25024641|NCT03643874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25024642|NCT03643874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25024643|NCT03643874|Adrenergic Agents|adrenergic agents|mesh-ancestor
25024644|NCT03643874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25024645|NCT03643874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112240|NCT04267120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25112241|NCT04267120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25112242|NCT04267120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25112243|NCT04267120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257439|NCT02476981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25257440|NCT02476981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257441|NCT02476981|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25257442|NCT02476981|Anesthetics, General|anesthetics, general|mesh-ancestor
25257443|NCT02476981|Anesthetics|anesthetics|mesh-ancestor
25257444|NCT02476981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25257445|NCT02476981|Analgesics|analgesics|mesh-ancestor
24528120|NCT00619840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528121|NCT00619840|Dopamine Agents|dopamine agents|mesh-ancestor
24528122|NCT00619840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25024647|NCT03643757|Anesthetics, Local|anesthetics, local|mesh-ancestor
25024648|NCT03643757|Anesthetics|anesthetics|mesh-ancestor
25024649|NCT03643757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25024650|NCT03643757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024651|NCT03643757|Sensory System Agents|sensory system agents|mesh-ancestor
25024652|NCT03643757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024653|NCT03643666|Dexamethasone|dexamethasone|mesh-list
25024655|NCT03643666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25024656|NCT03643666|Antiemetics|antiemetics|mesh-ancestor
25024657|NCT03643666|Autonomic Agents|autonomic agents|mesh-ancestor
25024658|NCT03643666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024659|NCT03643666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024660|NCT03643666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25024661|NCT03643666|Glucocorticoids|glucocorticoids|mesh-ancestor
25024663|NCT03643666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25024706|NCT03643276|Fludarabine phosphate|fludarabine phosphate|mesh-list
25024707|NCT03643276|Etoposide|etoposide|mesh-list
25687905|NCT01938846|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24750708|NCT01700322|Ticagrelor|ticagrelor|mesh-list
25024708|NCT03643276|Vincristine|vincristine|mesh-list
25024709|NCT03643276|Bortezomib|bortezomib|mesh-list
25024710|NCT03643276|Daunorubicin|daunorubicin|mesh-list
25024711|NCT03643276|Mercaptopurine|mercaptopurine|mesh-list
25024712|NCT03643276|Pegaspargase|pegaspargase|mesh-list
25024833|NCT03642509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024834|NCT03642509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024836|NCT03642353|Listerine|listerine|mesh-list
25024837|NCT03642353|Triclosan|triclosan|mesh-list
25024838|NCT03642353|Sodium Fluoride|sodium fluoride|mesh-list
25024839|NCT03642353|Cariostatic Agents|cariostatic agents|mesh-ancestor
25024840|NCT03642353|Protective Agents|protective agents|mesh-ancestor
25024841|NCT03642353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024842|NCT03642353|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25024843|NCT03642353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25024844|NCT03642353|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25024845|NCT03642353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25024846|NCT03642353|Antimetabolites|antimetabolites|mesh-ancestor
25024848|NCT03642353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24587601|NCT00895778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24587602|NCT00895778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587603|NCT00895791|Umirolimus|umirolimus|mesh-list
24587604|NCT00895791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24587605|NCT00895791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24587606|NCT00895791|Immunologic Factors|immunologic factors|mesh-ancestor
24587607|NCT00895791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587608|NCT00895804|Pindolol|pindolol|mesh-list
24587609|NCT00895804|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24587610|NCT00895804|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24587611|NCT00895804|Adrenergic Agents|adrenergic agents|mesh-ancestor
24587612|NCT00895804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25257446|NCT02476981|Sensory System Agents|sensory system agents|mesh-ancestor
25257447|NCT02476981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25257448|NCT02476981|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25257449|NCT02476981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25257450|NCT02476981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25257451|NCT02476981|Adrenergic Agents|adrenergic agents|mesh-ancestor
25257452|NCT02476981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25257453|NCT02476981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257454|NCT02476981|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24929138|NCT04115410|Vinblastine|vinblastine|mesh-list
24929139|NCT04115410|Osimertinib|osimertinib|mesh-list
24929140|NCT04115410|Afatinib|afatinib|mesh-list
24929141|NCT04115410|Crizotinib|crizotinib|mesh-list
24929142|NCT04115410|Ceritinib|ceritinib|mesh-list
24929143|NCT04115410|Antineoplastic Agents|antineoplastic agents|mesh-list
24929144|NCT04115410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24929145|NCT04115410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24929146|NCT04115410|Antimetabolites|antimetabolites|mesh-ancestor
25097340|NCT03204331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24929147|NCT04115410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929148|NCT04115410|Antiviral Agents|antiviral agents|mesh-ancestor
24929149|NCT04115410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24929150|NCT04115410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24929151|NCT04115410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24587613|NCT00895804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587614|NCT00895804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587625|NCT00895882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587627|NCT00895960|Dasatinib|dasatinib|mesh-list
25024877|NCT03641690|Anti-Infective Agents|anti-infective agents|mesh-list
25024878|NCT03641690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25024893|NCT03641456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024894|NCT03641456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024895|NCT03641456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25024896|NCT03641456|Glucocorticoids|glucocorticoids|mesh-ancestor
25024897|NCT03641456|Hormones|hormones|mesh-ancestor
25024898|NCT03641456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25024900|NCT03641456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25024932|NCT03640728|Tenofovir|tenofovir|mesh-list
25024933|NCT03640728|Entecavir|entecavir|mesh-list
25024934|NCT03640728|Antiviral Agents|antiviral agents|mesh-ancestor
25024935|NCT03640728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25024936|NCT03640728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25024937|NCT03640728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25024938|NCT03640728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687906|NCT01938846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25051258|NCT00427856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25051259|NCT00427856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051260|NCT00427856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051261|NCT00427440|Rilotumumab|rilotumumab|mesh-list
25051262|NCT00427440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25051263|NCT00427440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24750770|NCT01700491|Anesthetics|anesthetics|mesh-ancestor
24750787|NCT01700569|Alkylating Agents|alkylating agents|mesh-ancestor
24750805|NCT01700790|Lopinavir|lopinavir|mesh-list
24750806|NCT01700790|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24750807|NCT01700790|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24750808|NCT01700790|Protease Inhibitors|protease inhibitors|mesh-ancestor
24750809|NCT01700790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750811|NCT01700790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25024939|NCT03640728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024940|NCT03640728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25024941|NCT03640728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25024942|NCT03640650|Triamcinolone|triamcinolone|mesh-list
25024943|NCT03640650|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25024944|NCT03640650|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25024945|NCT03640650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25024946|NCT03640650|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25024947|NCT03640650|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25024948|NCT03640650|Glucocorticoids|glucocorticoids|mesh-ancestor
25024949|NCT03640650|Hormones|hormones|mesh-ancestor
25024950|NCT03640650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25024951|NCT03640650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024952|NCT03640650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25024953|NCT03640650|Immunologic Factors|immunologic factors|mesh-ancestor
25024954|NCT03640650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024955|NCT03640650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024956|NCT03640650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25024958|NCT03640468|Midazolam|midazolam|mesh-list
25024980|NCT03640468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25024981|NCT03640468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25024982|NCT03640468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25024983|NCT03640468|GABA Modulators|gaba modulators|mesh-ancestor
25024984|NCT03640468|GABA Agents|gaba agents|mesh-ancestor
25024985|NCT03640403|Artesunate|artesunate|mesh-list
25024986|NCT03640403|Piperaquine|piperaquine|mesh-list
25024987|NCT03640403|Amodiaquine|amodiaquine|mesh-list
25024988|NCT03640403|Artenimol|artenimol|mesh-list
25257455|NCT02476981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25257456|NCT02476981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25257457|NCT02476981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25257458|NCT02476981|GABA Modulators|gaba modulators|mesh-ancestor
25257459|NCT02476981|GABA Agents|gaba agents|mesh-ancestor
25257460|NCT02476981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25257461|NCT02476981|Narcotics|narcotics|mesh-ancestor
25257462|NCT02476981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25257463|NCT02476981|Sympathomimetics|sympathomimetics|mesh-ancestor
25257464|NCT02476981|Autonomic Agents|autonomic agents|mesh-ancestor
25257465|NCT02476981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25257466|NCT02476825|Fluticasone|fluticasone|mesh-list
25257467|NCT02476825|Xhance|xhance|mesh-list
25257468|NCT02476825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25257469|NCT02476825|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24505175|NCT00540202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24505176|NCT00540202|Analgesics|analgesics|mesh-ancestor
24505177|NCT00540202|Sensory System Agents|sensory system agents|mesh-ancestor
24505178|NCT00540241|Pemetrexed|pemetrexed|mesh-list
24505179|NCT00540241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799138|NCT01967459|Vitamins|vitamins|mesh-ancestor
25024989|NCT03640403|Antimalarials|antimalarials|mesh-ancestor
25687907|NCT01938846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687908|NCT01938846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25687909|NCT01938846|Hormone Antagonists|hormone antagonists|mesh-ancestor
25687910|NCT01938846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25687911|NCT01938846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687912|NCT01938989|Methamphetamine|methamphetamine|mesh-list
25687913|NCT01938989|beta-Endorphin|beta-endorphin|mesh-list
25687914|NCT01938989|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25687915|NCT01938989|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
25687916|NCT01938989|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25687917|NCT01938989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687918|NCT01938989|Sympathomimetics|sympathomimetics|mesh-ancestor
25687919|NCT01938989|Autonomic Agents|autonomic agents|mesh-ancestor
25024990|NCT03640403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25024991|NCT03640403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24750988|NCT01701466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25024992|NCT03640403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25024993|NCT03640403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25024994|NCT03640403|Antiviral Agents|antiviral agents|mesh-ancestor
25024995|NCT03640403|Schistosomicides|schistosomicides|mesh-ancestor
25024996|NCT03640403|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25024997|NCT03640403|Anthelmintics|anthelmintics|mesh-ancestor
25024998|NCT03640390|Magnesium Sulfate|magnesium sulfate|mesh-list
25024999|NCT03640390|Dexmedetomidine|dexmedetomidine|mesh-list
25025047|NCT03640247|Analgesics|analgesics|mesh-ancestor
25025048|NCT03640247|Sensory System Agents|sensory system agents|mesh-ancestor
25112317|NCT04186598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25112318|NCT04186598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25112319|NCT04186598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112320|NCT04186598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25112321|NCT04186598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112322|NCT04186598|Vasodilator Agents|vasodilator agents|mesh-ancestor
25112323|NCT04186598|Tocolytic Agents|tocolytic agents|mesh-ancestor
25112324|NCT04186598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25112325|NCT04174170|Sertraline|sertraline|mesh-list
25112326|NCT04174170|Brexpiprazole|brexpiprazole|mesh-list
25025074|NCT03640156|Oxytocics|oxytocics|mesh-ancestor
25025075|NCT03640156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25025076|NCT03640156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025077|NCT03640026|Tacrolimus|tacrolimus|mesh-list
25025078|NCT03640026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25025079|NCT03640026|Immunologic Factors|immunologic factors|mesh-ancestor
25025080|NCT03640026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025081|NCT03640026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25025082|NCT03640026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25025083|NCT03640026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025084|NCT03639922|Imatinib Mesylate|imatinib mesylate|mesh-list
25025085|NCT03639922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25025115|NCT03639727|Chelating Agents|chelating agents|mesh-ancestor
25025116|NCT03639727|Sequestering Agents|sequestering agents|mesh-ancestor
25025117|NCT03639727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025119|NCT03639714|Ipilimumab|ipilimumab|mesh-list
25025120|NCT03639714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25025121|NCT03639714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25025122|NCT03639714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25025123|NCT03639714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025124|NCT03639571|Ibuprofen|ibuprofen|mesh-list
25025125|NCT03639571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25025126|NCT03639571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25025127|NCT03639571|Analgesics|analgesics|mesh-ancestor
25097480|NCT03204019|Antimetabolites|antimetabolites|mesh-ancestor
25025128|NCT03639571|Sensory System Agents|sensory system agents|mesh-ancestor
25025129|NCT03639571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25025130|NCT03639571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025131|NCT03639571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25025132|NCT03639571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25025133|NCT03639571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25025134|NCT03639571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25025135|NCT03639571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025136|NCT03639545|Metformin|metformin|mesh-list
25025137|NCT03639545|Empagliflozin|empagliflozin|mesh-list
25025138|NCT03639545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25025139|NCT03639545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025142|NCT03639532|Tacrine|tacrine|mesh-list
25025181|NCT03639480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25025182|NCT03639480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25025183|NCT03639480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25025184|NCT03639480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257470|NCT02476825|Autonomic Agents|autonomic agents|mesh-ancestor
25257471|NCT02476825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25257472|NCT02476825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257473|NCT02476825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25257474|NCT02476825|Respiratory System Agents|respiratory system agents|mesh-ancestor
24505180|NCT00540241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505181|NCT00540241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799145|NCT01967472|Amodiaquine|amodiaquine|mesh-list
25025185|NCT03639480|Vasodilator Agents|vasodilator agents|mesh-ancestor
25025186|NCT03639480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25687920|NCT01938989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24447108|NCT00307502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25025187|NCT03639480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25025188|NCT03639467|Gemcitabine|gemcitabine|mesh-list
25025189|NCT03639467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25025190|NCT03639467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25025204|NCT03639428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25025205|NCT03639428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25025206|NCT03639428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25025207|NCT03639428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25025208|NCT03639428|Anesthetics, General|anesthetics, general|mesh-ancestor
25025209|NCT03639428|Anesthetics|anesthetics|mesh-ancestor
25025210|NCT03639428|GABA Modulators|gaba modulators|mesh-ancestor
25025211|NCT03639428|GABA Agents|gaba agents|mesh-ancestor
25025212|NCT03639428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25025213|NCT03639428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025214|NCT03639415|Oxycodone|oxycodone|mesh-list
25025215|NCT03639415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25025216|NCT03639415|Narcotics|narcotics|mesh-ancestor
25025217|NCT03639415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25025218|NCT03639415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743448|NCT04793867|Xenon|xenon|mesh-list
25025219|NCT03639415|Analgesics|analgesics|mesh-ancestor
25025363|NCT03638063|Vasodilator Agents|vasodilator agents|mesh-ancestor
25025220|NCT03639415|Sensory System Agents|sensory system agents|mesh-ancestor
25025221|NCT03639415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25025222|NCT03639363|Chlorhexidine|chlorhexidine|mesh-list
25025223|NCT03639363|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25025224|NCT03639363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25025225|NCT03639363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25025226|NCT03639363|Disinfectants|disinfectants|mesh-ancestor
25025227|NCT03639363|Dermatologic Agents|dermatologic agents|mesh-ancestor
25025228|NCT03639168|Cisplatin|cisplatin|mesh-list
25025229|NCT03639168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25025251|NCT03638869|Antitussive Agents|antitussive agents|mesh-ancestor
25025252|NCT03638869|Respiratory System Agents|respiratory system agents|mesh-ancestor
25025253|NCT03638869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25025254|NCT03638856|Misoprostol|misoprostol|mesh-list
25025255|NCT03638856|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25025256|NCT03638856|Abortifacient Agents|abortifacient agents|mesh-ancestor
25025257|NCT03638856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25025258|NCT03638856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025259|NCT03638856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25025260|NCT03638856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25025261|NCT03638856|Oxytocics|oxytocics|mesh-ancestor
25025262|NCT03638726|Atropine|atropine|mesh-list
25025263|NCT03638726|Phenylephrine|phenylephrine|mesh-list
25025264|NCT03638726|Epinephrine|epinephrine|mesh-list
25025265|NCT03638726|Racepinephrine|racepinephrine|mesh-list
25025266|NCT03638726|Oxymetazoline|oxymetazoline|mesh-list
25025267|NCT03638726|Cyclopentolate|cyclopentolate|mesh-list
25025268|NCT03638726|Epinephryl borate|epinephryl borate|mesh-list
25025269|NCT03638726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25025270|NCT03638726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25025271|NCT03638726|Adrenergic Agents|adrenergic agents|mesh-ancestor
25025272|NCT03638726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25025273|NCT03638726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917021|NCT04234776|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25025274|NCT03638726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025286|NCT03638726|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25025287|NCT03638726|Protective Agents|protective agents|mesh-ancestor
25025288|NCT03638726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25025289|NCT03638726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25025290|NCT03638726|Parasympatholytics|parasympatholytics|mesh-ancestor
25025291|NCT03638726|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25025292|NCT03638726|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25025293|NCT03638726|Cholinergic Agents|cholinergic agents|mesh-ancestor
24982019|NCT04454411|Narcotics|narcotics|mesh-ancestor
25025294|NCT03638648|Capecitabine|capecitabine|mesh-list
24982093|NCT04250636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982094|NCT04250636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24982095|NCT04246996|Gentamicins|gentamicins|mesh-list
24982096|NCT04246996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25257475|NCT02476825|Dermatologic Agents|dermatologic agents|mesh-ancestor
25257476|NCT02476825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25687921|NCT01938989|Dopamine Agents|dopamine agents|mesh-ancestor
25257477|NCT02476526|Acetylcysteine|acetylcysteine|mesh-list
25257478|NCT02476526|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24505182|NCT00540241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25687922|NCT01938989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24751243|NCT01702857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751244|NCT01702857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24751245|NCT01702857|Antacids|antacids|mesh-ancestor
24751246|NCT01702857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751247|NCT01702857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24751248|NCT01702974|Vitamin D|vitamin d|mesh-list
24751249|NCT01702974|Cholecalciferol|cholecalciferol|mesh-list
24505183|NCT00540241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24505185|NCT00540280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505186|NCT00540280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24929153|NCT04115410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929155|NCT04115410|Antimitotic Agents|antimitotic agents|mesh-ancestor
25025326|NCT03638310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25025327|NCT03638310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25025328|NCT03638310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025329|NCT03638297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
25025330|NCT03638297|Antibodies|antibodies|mesh-list
25025331|NCT03638297|Immunologic Factors|immunologic factors|mesh-ancestor
25025332|NCT03638297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025333|NCT03638297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25025351|NCT03638076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25025352|NCT03638076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25025353|NCT03638076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25025354|NCT03638063|Adenosine|adenosine|mesh-list
25025355|NCT03638063|Capsaicin|capsaicin|mesh-list
25025356|NCT03638063|Antipruritics|antipruritics|mesh-ancestor
25025357|NCT03638063|Dermatologic Agents|dermatologic agents|mesh-ancestor
25025358|NCT03638063|Sensory System Agents|sensory system agents|mesh-ancestor
25025359|NCT03638063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25025360|NCT03638063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025361|NCT03638063|Analgesics|analgesics|mesh-ancestor
25025362|NCT03638063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25025364|NCT03638063|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25025365|NCT03638063|Purinergic Agonists|purinergic agonists|mesh-ancestor
25025366|NCT03638063|Purinergic Agents|purinergic agents|mesh-ancestor
25025367|NCT03638063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25025368|NCT03638063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025369|NCT03638037|Vitamin D|vitamin d|mesh-list
25025370|NCT03638037|Vitamins|vitamins|mesh-ancestor
25025397|NCT03637582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25025398|NCT03637582|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25025399|NCT03637582|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25025400|NCT03637582|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25257479|NCT02476526|Antiviral Agents|antiviral agents|mesh-ancestor
25257480|NCT02476526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25257481|NCT02476526|Expectorants|expectorants|mesh-ancestor
25257482|NCT02476526|Respiratory System Agents|respiratory system agents|mesh-ancestor
25257483|NCT02476526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25257484|NCT02476526|Antioxidants|antioxidants|mesh-ancestor
25257485|NCT02476526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257486|NCT02476526|Protective Agents|protective agents|mesh-ancestor
25257487|NCT02476526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257488|NCT02476526|Antidotes|antidotes|mesh-ancestor
25257489|NCT02476773|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25257490|NCT02476773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24929161|NCT04115410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24929162|NCT04115410|Alkylating Agents|alkylating agents|mesh-ancestor
24929164|NCT04115462|Histamine|histamine|mesh-list
24929165|NCT04115462|Histamine phosphate|histamine phosphate|mesh-list
24929166|NCT04115462|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24929167|NCT04115462|Narcotics|narcotics|mesh-ancestor
24799157|NCT01967498|Respiratory System Agents|respiratory system agents|mesh-ancestor
25025401|NCT03637582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24590848|NCT00913965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25025408|NCT03637400|Doxycycline|doxycycline|mesh-list
24590373|NCT00912327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24590374|NCT00912327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24590375|NCT00912379|Chrysarobin|chrysarobin|mesh-list
25025441|NCT03637049|Midazolam|midazolam|mesh-list
25687923|NCT01938989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687924|NCT01938989|Adrenergic Agents|adrenergic agents|mesh-ancestor
25687925|NCT01938989|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25687926|NCT01938989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25687927|NCT01938989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25687928|NCT01938989|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25025442|NCT03637049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25025443|NCT03637049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25025444|NCT03637049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25025507|NCT03636555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025508|NCT03636542|Bupivacaine|bupivacaine|mesh-list
25025509|NCT03636542|Anesthetics, Local|anesthetics, local|mesh-ancestor
25025510|NCT03636542|Anesthetics|anesthetics|mesh-ancestor
25025511|NCT03636542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25025512|NCT03636542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025513|NCT03636542|Sensory System Agents|sensory system agents|mesh-ancestor
24590476|NCT00912678|Antitubercular Agents|antitubercular agents|mesh-ancestor
25025565|NCT03636048|Anesthetics, Local|anesthetics, local|mesh-ancestor
25025566|NCT03636048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25025567|NCT03636048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025642|NCT03635398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025644|NCT03635372|Hydrotalcite|hydrotalcite|mesh-list
25025645|NCT03635372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25025646|NCT03635372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25025661|NCT03635125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25025662|NCT03635125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025663|NCT03635125|Vasodilator Agents|vasodilator agents|mesh-ancestor
25025776|NCT03634137|alpha-MSH|alpha-msh|mesh-list
25025819|NCT03633747|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25025820|NCT03633747|Adrenergic Agents|adrenergic agents|mesh-ancestor
25025821|NCT03633747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25025822|NCT03633747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025823|NCT03633747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025824|NCT03633747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25025825|NCT03633747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25025826|NCT03633747|Vasodilator Agents|vasodilator agents|mesh-ancestor
25025827|NCT03633734|Folfirinox|folfirinox|mesh-list
25025828|NCT03633734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25025829|NCT03633630|Magnesium Oxide|magnesium oxide|mesh-list
25025875|NCT03633175|Progesterone|progesterone|mesh-list
25025876|NCT03633175|Progestins|progestins|mesh-ancestor
25025877|NCT03633175|Hormones|hormones|mesh-ancestor
25257491|NCT02476773|Immunologic Factors|immunologic factors|mesh-ancestor
25025921|NCT03632876|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25257492|NCT02476773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257493|NCT02476773|Antacids|antacids|mesh-ancestor
25257494|NCT02476773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257495|NCT02476773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25257496|NCT02476708|Curcumin|curcumin|mesh-list
25257497|NCT02476708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25257498|NCT02476708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25257499|NCT02476708|Analgesics|analgesics|mesh-ancestor
24929168|NCT04115462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24929169|NCT04115462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929170|NCT04115462|Analgesics|analgesics|mesh-ancestor
24929171|NCT04115462|Sensory System Agents|sensory system agents|mesh-ancestor
24929172|NCT04115462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24929173|NCT04115462|Histamine Agonists|histamine agonists|mesh-ancestor
24929174|NCT04115462|Histamine Agents|histamine agents|mesh-ancestor
24929175|NCT04115462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24505194|NCT00540280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505195|NCT00540345|Interferons|interferons|mesh-list
24528143|NCT00619944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25025922|NCT03632876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25027062|NCT03623087|Antiviral Agents|antiviral agents|mesh-ancestor
25025971|NCT03632642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25025972|NCT03632590|Magnesium Sulfate|magnesium sulfate|mesh-list
25025973|NCT03632590|Magnesium citrate|magnesium citrate|mesh-list
25025974|NCT03632590|Magnesium Oxide|magnesium oxide|mesh-list
25025975|NCT03632590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025976|NCT03632590|Analgesics|analgesics|mesh-ancestor
25025977|NCT03632590|Sensory System Agents|sensory system agents|mesh-ancestor
25025978|NCT03632590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25025979|NCT03632590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025980|NCT03632590|Anesthetics|anesthetics|mesh-ancestor
25025981|NCT03632590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25025982|NCT03632590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25025983|NCT03632590|Anticonvulsants|anticonvulsants|mesh-ancestor
25025984|NCT03632590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24751391|NCT01703910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24751393|NCT01703910|Topotecan|topotecan|mesh-list
25025985|NCT03632590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25025986|NCT03632590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25025987|NCT03632590|Tocolytic Agents|tocolytic agents|mesh-ancestor
25025988|NCT03632590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25025989|NCT03632590|Cathartics|cathartics|mesh-ancestor
25025990|NCT03632590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25025991|NCT03632590|Antacids|antacids|mesh-ancestor
25025992|NCT03632538|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25025993|NCT03632538|Protein C Inhibitor|protein c inhibitor|mesh-list
25025994|NCT03632538|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25025995|NCT03632538|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25025996|NCT03632538|Protease Inhibitors|protease inhibitors|mesh-ancestor
25025997|NCT03632538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24897290|NCT04426578|Vasodilator Agents|vasodilator agents|mesh-ancestor
24590978|NCT00914524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590979|NCT00914563|Lithium Carbonate|lithium carbonate|mesh-list
24590980|NCT00914563|Antidepressive Agents|antidepressive agents|mesh-ancestor
24591107|NCT00915200|Silybin|silybin|mesh-list
24591108|NCT00915200|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24983118|NCT02750540|Tenofovir|tenofovir|mesh-list
24983119|NCT02750540|Antiviral Agents|antiviral agents|mesh-ancestor
24983120|NCT02750540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24983121|NCT02750540|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24983122|NCT02750540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24983123|NCT02750540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257500|NCT02476708|Sensory System Agents|sensory system agents|mesh-ancestor
25257501|NCT02476708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25257502|NCT02476708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257503|NCT02476708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25257504|NCT02476708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25257505|NCT02476708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25257506|NCT02476708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257507|NCT02476708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257508|NCT02476760|Insulin|insulin|mesh-list
25257509|NCT02476760|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25257510|NCT02476760|Metformin|metformin|mesh-list
24528146|NCT00619996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528147|NCT00619996|Tubulin Modulators|tubulin modulators|mesh-ancestor
24528148|NCT00619996|Antimitotic Agents|antimitotic agents|mesh-ancestor
24528149|NCT00619996|Mitosis Modulators|mitosis modulators|mesh-ancestor
24528153|NCT00620100|Docetaxel|docetaxel|mesh-list
24587756|NCT00896831|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
24587757|NCT00896831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24587758|NCT00896831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24587759|NCT00896831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587770|NCT00896987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25026225|NCT03630796|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25026226|NCT03630796|Anesthetics, General|anesthetics, general|mesh-ancestor
25026227|NCT03630796|Anesthetics|anesthetics|mesh-ancestor
25026341|NCT03629522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026343|NCT03629522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25026344|NCT03629522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24917203|NCT04231864|Durvalumab|durvalumab|mesh-list
25026345|NCT03629522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25026346|NCT03629522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25026347|NCT03629418|Phenylephrine|phenylephrine|mesh-list
25026348|NCT03629418|Norepinephrine|norepinephrine|mesh-list
25026349|NCT03629418|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25026350|NCT03629418|Mydriatics|mydriatics|mesh-ancestor
25026351|NCT03629418|Autonomic Agents|autonomic agents|mesh-ancestor
25026448|NCT03628443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026450|NCT03628430|Epinephrine|epinephrine|mesh-list
25026451|NCT03628430|Anesthetics, Local|anesthetics, local|mesh-ancestor
24591503|NCT00917059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24591504|NCT00917059|Serotonin Agents|serotonin agents|mesh-ancestor
24591505|NCT00917059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591506|NCT00917059|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24591507|NCT00917059|Antidepressive Agents|antidepressive agents|mesh-ancestor
25026537|NCT03627546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25026538|NCT03627468|Bromides|bromides|mesh-list
25687929|NCT01938989|Hormones|hormones|mesh-ancestor
25687930|NCT01938989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25026539|NCT03627468|Anticonvulsants|anticonvulsants|mesh-ancestor
25026540|NCT03627390|Molybdenum|molybdenum|mesh-list
25026541|NCT03627390|Trace Elements|trace elements|mesh-ancestor
25026542|NCT03627390|Micronutrients|micronutrients|mesh-ancestor
24983449|NCT05186649|Anticoagulants|anticoagulants|mesh-ancestor
25257511|NCT02476760|Pioglitazone|pioglitazone|mesh-list
25257512|NCT02476760|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25257513|NCT02476760|Liraglutide|liraglutide|mesh-list
25257514|NCT02476760|Exenatide|exenatide|mesh-list
25257515|NCT02476760|Glimepiride|glimepiride|mesh-list
25257516|NCT02476760|Rosiglitazone|rosiglitazone|mesh-list
25257517|NCT02476760|Vildagliptin|vildagliptin|mesh-list
25257518|NCT02476760|Saxagliptin|saxagliptin|mesh-list
25257519|NCT02476760|Acarbose|acarbose|mesh-list
24983459|NCT05186363|Sulfadoxine|sulfadoxine|mesh-list
24983460|NCT05186363|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24983461|NCT05186363|Amodiaquine|amodiaquine|mesh-list
24983462|NCT05186363|Antimalarials|antimalarials|mesh-ancestor
24983463|NCT05186363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24983464|NCT05186363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24983465|NCT05186363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24983466|NCT05186363|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24983467|NCT05186363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24983468|NCT05186363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983469|NCT05186363|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24983470|NCT05186363|Renal Agents|renal agents|mesh-ancestor
24983471|NCT05186194|Vitamin D|vitamin d|mesh-list
25026577|NCT03626753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25026578|NCT03626753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25026580|NCT03626753|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25026581|NCT03626753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25026582|NCT03626753|Adrenergic Agents|adrenergic agents|mesh-ancestor
25026583|NCT03626753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25026584|NCT03626753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25026586|NCT03626727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25026610|NCT03626506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25026611|NCT03626506|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25026612|NCT03626506|Diuretics|diuretics|mesh-ancestor
25026613|NCT03626506|Natriuretic Agents|natriuretic agents|mesh-ancestor
25027392|NCT03620513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25026621|NCT03626454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026622|NCT03626454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026623|NCT03626454|Sympathomimetics|sympathomimetics|mesh-ancestor
25026624|NCT03626454|Autonomic Agents|autonomic agents|mesh-ancestor
25026625|NCT03626454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25026689|NCT03625739|Ethambutol|ethambutol|mesh-list
25026690|NCT03625739|Bedaquiline|bedaquiline|mesh-list
25026691|NCT03625739|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25026692|NCT03625739|Clofazimine|clofazimine|mesh-list
25026693|NCT03625739|Gatifloxacin|gatifloxacin|mesh-list
25026694|NCT03625739|Aminosalicylic Acid|aminosalicylic acid|mesh-list
25026695|NCT03625739|Streptomycin|streptomycin|mesh-list
25026696|NCT03625739|Kanamycin|kanamycin|mesh-list
25026697|NCT03625739|Ethionamide|ethionamide|mesh-list
25026698|NCT03625739|Capreomycin|capreomycin|mesh-list
25026699|NCT03625739|Thioacetazone|thioacetazone|mesh-list
24591715|NCT00918307|Cholinergic Agents|cholinergic agents|mesh-ancestor
25026700|NCT03625739|Antitubercular Agents|antitubercular agents|mesh-list
25026701|NCT03625739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25026702|NCT03625739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24897390|NCT04425590|Analgesics|analgesics|mesh-ancestor
25026726|NCT03625687|Antiviral Agents|antiviral agents|mesh-list
25026727|NCT03625687|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25026728|NCT03625687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25026729|NCT03625531|Letrozole|letrozole|mesh-list
24591753|NCT00918489|Vorinostat|vorinostat|mesh-list
25257520|NCT02476760|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25257521|NCT02476760|Repaglinide|repaglinide|mesh-list
25257522|NCT02476760|Gliclazide|gliclazide|mesh-list
25257523|NCT02476760|Glipizide|glipizide|mesh-list
24528175|NCT00620204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24528176|NCT00620204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24528177|NCT00620204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528178|NCT00620269|Irinotecan|irinotecan|mesh-list
24528179|NCT00620269|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25687931|NCT01939002|Interferons|interferons|mesh-list
24528180|NCT00620269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528181|NCT00620269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24619080|NCT01050699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24528182|NCT00620269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24528183|NCT00620269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24929176|NCT04115462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929178|NCT04115397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24929179|NCT04115397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929192|NCT04115163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24929193|NCT04115163|Antimetabolites|antimetabolites|mesh-ancestor
24591773|NCT00918554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591774|NCT00918554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591775|NCT00918554|Dermatologic Agents|dermatologic agents|mesh-ancestor
24591776|NCT00918554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25026730|NCT03625531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25026731|NCT03625531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25026732|NCT03625531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25026733|NCT03625531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591777|NCT00918554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25026734|NCT03625531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026735|NCT03625531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25026736|NCT03625531|Hormone Antagonists|hormone antagonists|mesh-ancestor
24587874|NCT00897975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24587876|NCT00898287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24587877|NCT00898287|Antimetabolites|antimetabolites|mesh-ancestor
24587879|NCT00898287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25026763|NCT03625167|Emollients|emollients|mesh-ancestor
25026764|NCT03625167|Dermatologic Agents|dermatologic agents|mesh-ancestor
25026765|NCT03625089|Atorvastatin|atorvastatin|mesh-list
25026766|NCT03625089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25026767|NCT03625089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25026768|NCT03625089|Antimetabolites|antimetabolites|mesh-ancestor
25026769|NCT03625089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026770|NCT03625089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25026771|NCT03625089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25026822|NCT03624985|Lidocaine|lidocaine|mesh-list
25026823|NCT03624985|Anesthetics, Local|anesthetics, local|mesh-ancestor
25026824|NCT03624985|Anesthetics|anesthetics|mesh-ancestor
25026825|NCT03624985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25026826|NCT03624985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257524|NCT02476760|Biguanides|biguanides|mesh-list
25257525|NCT02476760|Tolbutamide|tolbutamide|mesh-list
25257526|NCT02476760|Voglibose|voglibose|mesh-list
25257527|NCT02476760|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
25257528|NCT02476760|Nateglinide|nateglinide|mesh-list
25257529|NCT02476760|Miglitol|miglitol|mesh-list
25257530|NCT02476760|Troglitazone|troglitazone|mesh-list
25257531|NCT02476760|Meglitinide|meglitinide|mesh-list
25257532|NCT02476760|Acetohexamide|acetohexamide|mesh-list
25257533|NCT02476760|Chlorpropamide|chlorpropamide|mesh-list
25257534|NCT02476760|Phenformin|phenformin|mesh-list
25257535|NCT02476760|Buformin|buformin|mesh-list
25257536|NCT02476760|Glibornuride|glibornuride|mesh-list
25257537|NCT02476760|Tolazamide|tolazamide|mesh-list
25257538|NCT02476760|Carbutamide|carbutamide|mesh-list
25257539|NCT02476760|Gliquidone|gliquidone|mesh-list
24857598|NCT02292966|Asunaprevir|asunaprevir|mesh-list
25257540|NCT02476760|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25257541|NCT02476760|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
25257542|NCT02476760|Incretins|incretins|mesh-list
25257543|NCT02476760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257544|NCT02476760|Hormones|hormones|mesh-ancestor
24929195|NCT04115163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24505220|NCT00540410|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24657415|NCT01267305|PENTA|penta|mesh-list
25026827|NCT03624985|Sensory System Agents|sensory system agents|mesh-ancestor
25026828|NCT03624985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25026829|NCT03624985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25026830|NCT03624985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25026831|NCT03624985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25026832|NCT03624985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25026833|NCT03624985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026834|NCT03624959|Itraconazole|itraconazole|mesh-list
25026835|NCT03624959|Rifampin|rifampin|mesh-list
25687932|NCT01939002|Interferon-beta|interferon-beta|mesh-list
25026885|NCT03624322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026886|NCT03624322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25687933|NCT01939002|Interferon beta-1a|interferon beta-1a|mesh-list
25098096|NCT03199339|Anesthetics|anesthetics|mesh-ancestor
25026887|NCT03624322|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25026888|NCT03624322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25026889|NCT03624322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25026890|NCT03624322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25026891|NCT03624322|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25026910|NCT03624270|Ascorbic Acid|ascorbic acid|mesh-list
25026911|NCT03624270|Arsenic Trioxide|arsenic trioxide|mesh-list
25026912|NCT03624270|Antioxidants|antioxidants|mesh-ancestor
25026913|NCT03624270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026914|NCT03624270|Protective Agents|protective agents|mesh-ancestor
25026915|NCT03624270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026916|NCT03624270|Vitamins|vitamins|mesh-ancestor
25026917|NCT03624270|Micronutrients|micronutrients|mesh-ancestor
25026918|NCT03624270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25026920|NCT03624244|Exemestane|exemestane|mesh-list
25026921|NCT03624244|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25026922|NCT03624244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25026923|NCT03624244|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25026924|NCT03624244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25026925|NCT03624244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026926|NCT03624244|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25026927|NCT03624244|Hormone Antagonists|hormone antagonists|mesh-ancestor
25026928|NCT03624244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25026929|NCT03624244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592081|NCT00920153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24592082|NCT00920153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25026952|NCT03624166|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25026953|NCT03624166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25026954|NCT03624166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026956|NCT03624010|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25026957|NCT03624010|Vasodilator Agents|vasodilator agents|mesh-ancestor
25026958|NCT03624010|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25026959|NCT03624010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25026960|NCT03624010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25026961|NCT03624010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026962|NCT03624010|Protective Agents|protective agents|mesh-ancestor
25026963|NCT03624010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026964|NCT03623789|Tranylcypromine|tranylcypromine|mesh-list
25026965|NCT03623789|Tranexamic Acid|tranexamic acid|mesh-list
25026966|NCT03623789|Hemostatics|hemostatics|mesh-list
25026967|NCT03623789|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25026968|NCT03623789|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25112614|NCT03988205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25026969|NCT03623789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026980|NCT03623776|Pemetrexed|pemetrexed|mesh-list
24592128|NCT00920270|Colistin|colistin|mesh-list
24592129|NCT00920270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24592131|NCT00920283|Trace Elements|trace elements|mesh-ancestor
24592132|NCT00920283|Micronutrients|micronutrients|mesh-ancestor
25026999|NCT03623711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027000|NCT03623711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25027001|NCT03623711|Dopamine Agents|dopamine agents|mesh-ancestor
25257545|NCT02476760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25257546|NCT02476760|Protease Inhibitors|protease inhibitors|mesh-ancestor
25257547|NCT02476760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528184|NCT00620269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528185|NCT00620269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24528186|NCT00620295|Gemcitabine|gemcitabine|mesh-list
24528187|NCT00620295|Bortezomib|bortezomib|mesh-list
24528188|NCT00620295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24528189|NCT00620295|Antimetabolites|antimetabolites|mesh-ancestor
24528190|NCT00620295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027002|NCT03623711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25027003|NCT03623711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25027004|NCT03623711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25027005|NCT03623711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25027030|NCT03623256|Narcotics|narcotics|mesh-ancestor
25027031|NCT03623256|Analgesics|analgesics|mesh-ancestor
25027032|NCT03623256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25027033|NCT03623256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25027050|NCT03623087|Antiemetics|antiemetics|mesh-ancestor
25027051|NCT03623087|Autonomic Agents|autonomic agents|mesh-ancestor
25027052|NCT03623087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027053|NCT03623087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027054|NCT03623087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25027055|NCT03623087|Glucocorticoids|glucocorticoids|mesh-ancestor
25027056|NCT03623087|Hormones|hormones|mesh-ancestor
25027057|NCT03623087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25027058|NCT03623087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25027059|NCT03623087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25027060|NCT03623087|Antimetabolites|antimetabolites|mesh-ancestor
25027061|NCT03623087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027064|NCT03623087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25027070|NCT03623087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25027071|NCT03623087|Alkylating Agents|alkylating agents|mesh-ancestor
25027074|NCT03623048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25027075|NCT03623048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25027076|NCT03623048|Disinfectants|disinfectants|mesh-ancestor
25027077|NCT03622918|Rifampin|rifampin|mesh-list
25027078|NCT03622918|Colistin|colistin|mesh-list
25027079|NCT03622918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25027080|NCT03622918|Antitubercular Agents|antitubercular agents|mesh-ancestor
25027081|NCT03622918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25027082|NCT03622918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25027083|NCT03622918|Leprostatic Agents|leprostatic agents|mesh-ancestor
25027084|NCT03622918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25027085|NCT03622918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984000|NCT04943549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24984002|NCT04931667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24795919|NCT01946620|Respiratory System Agents|respiratory system agents|mesh-ancestor
24795941|NCT01946971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24795942|NCT01946971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24795943|NCT01946971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795944|NCT01946971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027093|NCT03622827|Endostar protein|endostar protein|mesh-list
25027133|NCT03622489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027134|NCT03622489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25027135|NCT03622489|Antipyretics|antipyretics|mesh-ancestor
25027136|NCT03622489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25027142|NCT03622450|Ciprofloxacin|ciprofloxacin|mesh-list
25257548|NCT02476760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257549|NCT02476760|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25257550|NCT02476760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25257551|NCT02476760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25257552|NCT02476760|Immunologic Factors|immunologic factors|mesh-ancestor
25257553|NCT02476552|Niraparib|niraparib|mesh-list
25257554|NCT02476552|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25257555|NCT02476552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528191|NCT00620295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528192|NCT00620295|Antiviral Agents|antiviral agents|mesh-ancestor
24528212|NCT00620438|Artemether|artemether|mesh-list
24917628|NCT04227912|Anesthetics|anesthetics|mesh-list
24592380|NCT00921531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25027199|NCT03621904|Antineoplastic Agents|antineoplastic agents|mesh-list
25027200|NCT03621904|Progesterone|progesterone|mesh-list
25027201|NCT03621904|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25027202|NCT03621904|Progestins|progestins|mesh-ancestor
25027203|NCT03621904|Hormones|hormones|mesh-ancestor
25027204|NCT03621904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25027205|NCT03621904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027206|NCT03621904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25027207|NCT03621904|Hormone Antagonists|hormone antagonists|mesh-ancestor
25027208|NCT03621904|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24817672|NCT02085018|Omeprazole|omeprazole|mesh-list
25112660|NCT03970746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112661|NCT03970746|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25112662|NCT03970746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25027219|NCT03621683|Protective Agents|protective agents|mesh-ancestor
25027220|NCT03621683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027222|NCT03621618|Norepinephrine|norepinephrine|mesh-list
25027223|NCT03621618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25027225|NCT03621618|Adrenergic Agents|adrenergic agents|mesh-ancestor
24592525|NCT00922506|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24592526|NCT00922506|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24592527|NCT00922506|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25027343|NCT03620760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027344|NCT03620760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027345|NCT03620760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25027386|NCT03620513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25027387|NCT03620513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25027388|NCT03620513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25027389|NCT03620513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25027390|NCT03620513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027391|NCT03620513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25027393|NCT03620513|Adrenergic Agents|adrenergic agents|mesh-ancestor
25027394|NCT03620513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25027395|NCT03620513|Sympathomimetics|sympathomimetics|mesh-ancestor
25027396|NCT03620513|Autonomic Agents|autonomic agents|mesh-ancestor
25027397|NCT03620513|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25027398|NCT03620513|Respiratory System Agents|respiratory system agents|mesh-ancestor
25027399|NCT03620513|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25027401|NCT03620513|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25027402|NCT03620513|Protective Agents|protective agents|mesh-ancestor
25027403|NCT03620513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24984232|NCT04714190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027426|NCT03620422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25027427|NCT03620422|Respiratory System Agents|respiratory system agents|mesh-ancestor
25027428|NCT03620422|Tocolytic Agents|tocolytic agents|mesh-ancestor
25027429|NCT03620422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25257556|NCT02476552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257557|NCT02476552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25257558|NCT02476136|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25257559|NCT02476136|Fluoxetine|fluoxetine|mesh-list
25257560|NCT02476136|Paroxetine|paroxetine|mesh-list
25257561|NCT02476136|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25257562|NCT02476136|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25257563|NCT02476136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25257564|NCT02476136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25257565|NCT02476136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929196|NCT04115163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24929197|NCT04115163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24929198|NCT04115163|Immunologic Factors|immunologic factors|mesh-ancestor
25027430|NCT03620422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25027431|NCT03620422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25027432|NCT03620422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25027433|NCT03620422|Adrenergic Agents|adrenergic agents|mesh-ancestor
25027434|NCT03620422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25027435|NCT03620422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027436|NCT03620422|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25027437|NCT03620422|Diuretics|diuretics|mesh-ancestor
25027438|NCT03620422|Natriuretic Agents|natriuretic agents|mesh-ancestor
25027439|NCT03620318|Crenolanib|crenolanib|mesh-list
25027440|NCT03620318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25027441|NCT03620292|Bevacizumab|bevacizumab|mesh-list
25027442|NCT03620292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25027443|NCT03620292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25027444|NCT03620292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25027445|NCT03620292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25027446|NCT03620292|Growth Substances|growth substances|mesh-ancestor
25027482|NCT03619876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027483|NCT03619876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25027484|NCT03619876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25027485|NCT03619876|Immunologic Factors|immunologic factors|mesh-ancestor
25027486|NCT03619876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027487|NCT03619824|Gemcitabine|gemcitabine|mesh-list
25027488|NCT03619824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25027489|NCT03619824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25112731|NCT03919526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112733|NCT03919526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25257577|NCT02476136|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25257578|NCT02476136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25257579|NCT02476136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257580|NCT02476123|Nivolumab|nivolumab|mesh-list
25257581|NCT02476123|Mogamulizumab|mogamulizumab|mesh-list
24929199|NCT04115163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929201|NCT04115020|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24929202|NCT04115020|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24929203|NCT04115020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929204|NCT04115020|Sensory System Agents|sensory system agents|mesh-ancestor
24929205|NCT04115020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24929206|NCT04115072|Praziquantel|praziquantel|mesh-list
24929207|NCT04115072|Anthelmintics|anthelmintics|mesh-ancestor
24929208|NCT04115072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24929209|NCT04115072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24929210|NCT04114643|Thrombin|thrombin|mesh-list
24929211|NCT04114643|Hemostatics|hemostatics|mesh-ancestor
24929212|NCT04114643|Coagulants|coagulants|mesh-ancestor
24929223|NCT04114383|Protective Agents|protective agents|mesh-ancestor
24929224|NCT04114383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929226|NCT04114526|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24929227|NCT04114526|Autonomic Agents|autonomic agents|mesh-ancestor
24929228|NCT04114526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24929229|NCT04114526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027500|NCT03619785|Ketorolac|ketorolac|mesh-list
25027501|NCT03619785|Fentanyl|fentanyl|mesh-list
25027502|NCT03619785|Ketamine|ketamine|mesh-list
25027503|NCT03619785|Morphine|morphine|mesh-list
25027504|NCT03619785|Gabapentin|gabapentin|mesh-list
25027505|NCT03619785|Hydromorphone|hydromorphone|mesh-list
24592892|NCT00926055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24592893|NCT00926055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25027536|NCT03619785|Antimanic Agents|antimanic agents|mesh-ancestor
25027537|NCT03619785|Antitussive Agents|antitussive agents|mesh-ancestor
25027538|NCT03619785|Respiratory System Agents|respiratory system agents|mesh-ancestor
25027539|NCT03619538|Nefopam|nefopam|mesh-list
25027540|NCT03619538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25027541|NCT03619538|Analgesics|analgesics|mesh-ancestor
25027542|NCT03619538|Sensory System Agents|sensory system agents|mesh-ancestor
25027543|NCT03619538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027544|NCT03619538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027545|NCT03619408|Antacids|antacids|mesh-list
25027546|NCT03619408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027547|NCT03619408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25027548|NCT03619330|Liraglutide|liraglutide|mesh-list
25027549|NCT03619330|Testosterone|testosterone|mesh-list
25027550|NCT03619330|Androgens|androgens|mesh-ancestor
25257582|NCT02476123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25257583|NCT02476123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25257584|NCT02476123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25257585|NCT02476123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275046|NCT02374567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25275047|NCT02374567|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25275048|NCT02374567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25275049|NCT02374567|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25275050|NCT02374567|Nootropic Agents|nootropic agents|mesh-ancestor
25275051|NCT02374567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25275052|NCT02374567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25275053|NCT02374567|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25275054|NCT02374567|Anesthetics, Local|anesthetics, local|mesh-ancestor
24917732|NCT04226885|Narcotics|narcotics|mesh-ancestor
25275055|NCT02374567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25275056|NCT02374567|Histamine Antagonists|histamine antagonists|mesh-ancestor
25275057|NCT02374567|Histamine Agents|histamine agents|mesh-ancestor
25275058|NCT02374567|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24929230|NCT04114526|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24929231|NCT04114526|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24929232|NCT04114526|Cholinergic Agents|cholinergic agents|mesh-ancestor
24528291|NCT00620646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24929233|NCT04114526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24929234|NCT04114526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929235|NCT04114461|Tofacitinib|tofacitinib|mesh-list
24929236|NCT04114461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027563|NCT03619057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027578|NCT03618797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25027579|NCT03618758|Paclitaxel|paclitaxel|mesh-list
25027580|NCT03618758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25027581|NCT03618758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25027582|NCT03618758|Tubulin Modulators|tubulin modulators|mesh-ancestor
25027583|NCT03618758|Antimitotic Agents|antimitotic agents|mesh-ancestor
25027584|NCT03618758|Mitosis Modulators|mitosis modulators|mesh-ancestor
25027585|NCT03618758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027639|NCT03618264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027640|NCT03618264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027641|NCT03618264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24752002|NCT01707732|Enoxaparin|enoxaparin|mesh-list
25027642|NCT03618264|Glucocorticoids|glucocorticoids|mesh-ancestor
25027643|NCT03618264|Hormones|hormones|mesh-ancestor
25027644|NCT03618264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25027645|NCT03618264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25027646|NCT03618264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25027647|NCT03618264|Anesthetics, Local|anesthetics, local|mesh-ancestor
25027648|NCT03618264|Anesthetics|anesthetics|mesh-ancestor
25027649|NCT03618264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25027650|NCT03618264|Sensory System Agents|sensory system agents|mesh-ancestor
25027652|NCT03618173|Dexamethasone acetate|dexamethasone acetate|mesh-list
25027656|NCT03618173|Autonomic Agents|autonomic agents|mesh-ancestor
25027657|NCT03618173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027658|NCT03618173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027659|NCT03618173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25027660|NCT03618173|Glucocorticoids|glucocorticoids|mesh-ancestor
25027661|NCT03618173|Hormones|hormones|mesh-ancestor
25027663|NCT03618173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25257588|NCT02476045|Oxaliplatin|oxaliplatin|mesh-list
25257589|NCT02476045|Panitumumab|panitumumab|mesh-list
25257590|NCT02476045|Levoleucovorin|levoleucovorin|mesh-list
25257591|NCT02476045|Antimetabolites|antimetabolites|mesh-ancestor
25257592|NCT02476045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257593|NCT02476045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25257594|NCT02476045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929239|NCT04114396|Antibodies|antibodies|mesh-list
24929240|NCT04114396|Immunologic Factors|immunologic factors|mesh-ancestor
24929241|NCT04114396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027695|NCT03617705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027721|NCT03617471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027722|NCT03617471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027723|NCT03617471|Antipyretics|antipyretics|mesh-ancestor
25027724|NCT03617432|Prednisone|prednisone|mesh-list
25027725|NCT03617432|Cyclophosphamide|cyclophosphamide|mesh-list
24593110|NCT00926900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027726|NCT03617432|Doxorubicin|doxorubicin|mesh-list
25027727|NCT03617432|Etoposide|etoposide|mesh-list
25027728|NCT03617432|Vincristine|vincristine|mesh-list
25027729|NCT03617432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25027730|NCT03617432|Immunologic Factors|immunologic factors|mesh-ancestor
25027731|NCT03617432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027732|NCT03617432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25027733|NCT03617432|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25027734|NCT03617432|Alkylating Agents|alkylating agents|mesh-ancestor
25027735|NCT03617432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027736|NCT03617432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25027737|NCT03617432|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25027738|NCT03617432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25027739|NCT03617432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24593154|NCT00927004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796121|NCT01948011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24796122|NCT01948011|Protease Inhibitors|protease inhibitors|mesh-ancestor
24796123|NCT01948011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25098750|NCT03195673|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25027745|NCT03617432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25027746|NCT03617432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25027747|NCT03617432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25027748|NCT03617432|Tubulin Modulators|tubulin modulators|mesh-ancestor
25027749|NCT03617432|Antimitotic Agents|antimitotic agents|mesh-ancestor
25027750|NCT03617432|Mitosis Modulators|mitosis modulators|mesh-ancestor
25027751|NCT03617289|Magnesium Sulfate|magnesium sulfate|mesh-list
25027752|NCT03617289|Analgesics|analgesics|mesh-ancestor
25027753|NCT03617289|Sensory System Agents|sensory system agents|mesh-ancestor
25027754|NCT03617289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027755|NCT03617289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027756|NCT03617289|Anesthetics|anesthetics|mesh-ancestor
25027887|NCT03616132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25027888|NCT03616132|Immunologic Factors|immunologic factors|mesh-ancestor
25027889|NCT03616132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112880|NCT03866174|Vitamins|vitamins|mesh-ancestor
25112881|NCT03866174|Micronutrients|micronutrients|mesh-ancestor
25112882|NCT03866174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112883|NCT03866174|Vitamin B Complex|vitamin b complex|mesh-ancestor
24752067|NCT01708044|Pramlintide|pramlintide|mesh-list
25112884|NCT03866174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25112885|NCT03866174|Antimetabolites|antimetabolites|mesh-ancestor
25112886|NCT03866174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112887|NCT03866174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25112888|NCT03866174|Vasodilator Agents|vasodilator agents|mesh-ancestor
24929250|NCT04114188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24929251|NCT04114188|Immunologic Factors|immunologic factors|mesh-ancestor
24929252|NCT04114188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929253|NCT04114188|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24929254|NCT04114188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24929255|NCT04114188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929256|NCT04114188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24929257|NCT04114188|Glucocorticoids|glucocorticoids|mesh-ancestor
24929258|NCT04114188|Hormones|hormones|mesh-ancestor
25098874|NCT03195023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929259|NCT04114188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24929260|NCT04114188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24929261|NCT04114188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929262|NCT04114188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24929263|NCT04114188|Dermatologic Agents|dermatologic agents|mesh-ancestor
24929264|NCT04114188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24929265|NCT04114149|Analgesics, Opioid|analgesics, opioid|mesh-list
24505316|NCT00540891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24929274|NCT04113772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929275|NCT04113863|Anastrozole|anastrozole|mesh-list
25112890|NCT03866174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25112891|NCT03842943|Pembrolizumab|pembrolizumab|mesh-list
25112892|NCT03842943|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25112893|NCT03842943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25027891|NCT03615950|Vitamins|vitamins|mesh-ancestor
25027892|NCT03615950|Micronutrients|micronutrients|mesh-ancestor
24984847|NCT03966339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24984849|NCT03948022|Progesterone|progesterone|mesh-list
24984850|NCT03948022|Dydrogesterone|dydrogesterone|mesh-list
24984851|NCT03948022|Progestins|progestins|mesh-ancestor
24984852|NCT03948022|Hormones|hormones|mesh-ancestor
24984853|NCT03948022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25027900|NCT03615833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25027901|NCT03615833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25027902|NCT03615768|Clindamycin|clindamycin|mesh-list
24593396|NCT00928798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24593397|NCT00928798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24593398|NCT00928798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24593399|NCT00928798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25257607|NCT02475876|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25257609|NCT02475876|Sulfamethoxazole|sulfamethoxazole|mesh-list
25257610|NCT02475876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25257611|NCT02475876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25257612|NCT02475876|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25257613|NCT02475876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257614|NCT02475876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257615|NCT02475876|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25257616|NCT02475876|Renal Agents|renal agents|mesh-ancestor
25257617|NCT02475876|Antimalarials|antimalarials|mesh-ancestor
25257618|NCT02475876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25257619|NCT02475876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25257620|NCT02475876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25257621|NCT02475876|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25257622|NCT02475876|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25257623|NCT02475876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25257624|NCT02475863|Warfarin|warfarin|mesh-list
25257625|NCT02475863|Anticoagulants|anticoagulants|mesh-ancestor
25257626|NCT02475915|Tenofovir|tenofovir|mesh-list
24929276|NCT04113863|Tretinoin|tretinoin|mesh-list
24929277|NCT04113863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25098970|NCT03194555|Antipyretics|antipyretics|mesh-ancestor
24929278|NCT04113863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24593401|NCT00928798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24593402|NCT00928798|Immunologic Factors|immunologic factors|mesh-ancestor
24635607|NCT01140425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25027905|NCT03615768|Adapalene|adapalene|mesh-list
24593439|NCT00929058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25687934|NCT01939002|Naproxen|naproxen|mesh-list
24752147|NCT01708642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24752148|NCT01708642|Respiratory System Agents|respiratory system agents|mesh-ancestor
24593440|NCT00929058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24593441|NCT00929058|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25027953|NCT03614832|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25027954|NCT03614832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25027955|NCT03614832|Purinergic Agents|purinergic agents|mesh-ancestor
25027956|NCT03614832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25027957|NCT03614832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027958|NCT03614832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027966|NCT03614715|Interferons|interferons|mesh-list
25027967|NCT03614715|Interferon-beta|interferon-beta|mesh-list
25027968|NCT03614715|Interferon beta-1a|interferon beta-1a|mesh-list
25027969|NCT03614715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25027970|NCT03614715|Antiviral Agents|antiviral agents|mesh-ancestor
25027971|NCT03614715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25027972|NCT03614715|Immunologic Factors|immunologic factors|mesh-ancestor
25027973|NCT03614715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027974|NCT03614715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25027975|NCT03614533|Vaccines|vaccines|mesh-list
24593479|NCT00929591|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24593480|NCT00929591|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25027998|NCT03614455|Posaconazole|posaconazole|mesh-list
24516804|NCT00603759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25112901|NCT03798080|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25112902|NCT03798080|Metformin|metformin|mesh-list
25112903|NCT03798080|Insulin Glargine|insulin glargine|mesh-list
25112904|NCT03798080|Lixisenatide|lixisenatide|mesh-list
25112905|NCT03798080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25112906|NCT03798080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112907|NCT03798054|Insulin|insulin|mesh-list
25112908|NCT03798054|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25112909|NCT03798054|Metformin|metformin|mesh-list
25112910|NCT03798054|Insulin Glargine|insulin glargine|mesh-list
25112911|NCT03798054|Lixisenatide|lixisenatide|mesh-list
25112912|NCT03798054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25112913|NCT03798054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25112914|NCT03798054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112915|NCT03798054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112923|NCT03787680|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25028049|NCT03614065|Endostar protein|endostar protein|mesh-list
25028050|NCT03614065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
25028051|NCT03614065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25028068|NCT03613974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25028069|NCT03613974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028070|NCT03613974|Sensory System Agents|sensory system agents|mesh-ancestor
25028071|NCT03613974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25028072|NCT03613974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25028073|NCT03613974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25028074|NCT03613974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25028075|NCT03613974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25028076|NCT03613974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028087|NCT03613857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25028088|NCT03613857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028089|NCT03613857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028090|NCT03613792|Fentanyl|fentanyl|mesh-list
25028091|NCT03613792|Midazolam|midazolam|mesh-list
25028092|NCT03613792|Ketamine|ketamine|mesh-list
25257627|NCT02475915|Emtricitabine|emtricitabine|mesh-list
25257628|NCT02475915|Efavirenz|efavirenz|mesh-list
25257629|NCT02475915|Maraviroc|maraviroc|mesh-list
25257630|NCT02475915|Darunavir|darunavir|mesh-list
24929279|NCT04113863|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24929280|NCT04113863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24929281|NCT04113863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25028115|NCT03613792|GABA Agents|gaba agents|mesh-ancestor
25028116|NCT03613753|Irinotecan|irinotecan|mesh-list
24593663|NCT00930488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24593664|NCT00930488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25028117|NCT03613753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25687935|NCT01939002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25687936|NCT01939002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25687937|NCT01939002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25687938|NCT01939002|Antiviral Agents|antiviral agents|mesh-ancestor
25028118|NCT03613753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25028119|NCT03613753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25028120|NCT03613753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028121|NCT03613753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028123|NCT03613597|Etoposide phosphate|etoposide phosphate|mesh-list
25028124|NCT03613597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028125|NCT03613597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25028126|NCT03613597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25028127|NCT03613597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25028128|NCT03613597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25028129|NCT03613597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985089|NCT03694002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985090|NCT03694002|Tubulin Modulators|tubulin modulators|mesh-ancestor
24985091|NCT03694002|Antimitotic Agents|antimitotic agents|mesh-ancestor
24985092|NCT03694002|Mitosis Modulators|mitosis modulators|mesh-ancestor
24985093|NCT03694002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985094|NCT03694002|Immunologic Factors|immunologic factors|mesh-ancestor
24985095|NCT03694002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985096|NCT03691727|Tirofiban|tirofiban|mesh-list
24985097|NCT03691727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25028160|NCT03613428|Tubulin Modulators|tubulin modulators|mesh-ancestor
25028161|NCT03613428|Antimitotic Agents|antimitotic agents|mesh-ancestor
25028162|NCT03613428|Mitosis Modulators|mitosis modulators|mesh-ancestor
25028163|NCT03613428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028164|NCT03613389|Vitamin E|vitamin e|mesh-list
25028165|NCT03613389|Vitamins|vitamins|mesh-ancestor
25028166|NCT03613389|Micronutrients|micronutrients|mesh-ancestor
25028167|NCT03613389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028168|NCT03613389|Antioxidants|antioxidants|mesh-ancestor
25028169|NCT03613389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028170|NCT03613389|Protective Agents|protective agents|mesh-ancestor
25028171|NCT03613259|Alovudine|alovudine|mesh-list
25028172|NCT03613259|Antiviral Agents|antiviral agents|mesh-ancestor
25028173|NCT03613259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25028174|NCT03613207|Lidocaine|lidocaine|mesh-list
25028175|NCT03613207|Prilocaine|prilocaine|mesh-list
25028176|NCT03613207|Anesthetics, Local|anesthetics, local|mesh-ancestor
25028197|NCT03612947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25028198|NCT03612947|Analgesics|analgesics|mesh-ancestor
25028199|NCT03612947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25028340|NCT03611595|Dermatologic Agents|dermatologic agents|mesh-ancestor
25028341|NCT03611530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25028342|NCT03611530|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25028343|NCT03611504|Hemostatics|hemostatics|mesh-list
25028344|NCT03611504|Coagulants|coagulants|mesh-ancestor
25028345|NCT03611491|Lidocaine|lidocaine|mesh-list
25028346|NCT03611491|Anesthetics, Local|anesthetics, local|mesh-ancestor
25099373|NCT03192059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25099374|NCT03192059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25028347|NCT03611491|Anesthetics|anesthetics|mesh-ancestor
25028348|NCT03611491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25028349|NCT03611491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028350|NCT03611491|Sensory System Agents|sensory system agents|mesh-ancestor
25028351|NCT03611491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25028352|NCT03611491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25028353|NCT03611491|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25028354|NCT03611491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25028399|NCT03610945|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25028400|NCT03610945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25028401|NCT03610945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25028402|NCT03610945|Adrenergic Agents|adrenergic agents|mesh-ancestor
25028403|NCT03610945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25028404|NCT03610945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25028406|NCT03610945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25028407|NCT03610945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25028408|NCT03610945|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25028409|NCT03610945|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25028462|NCT03610347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25028464|NCT03610347|Tubulin Modulators|tubulin modulators|mesh-ancestor
25028465|NCT03610347|Antimitotic Agents|antimitotic agents|mesh-ancestor
25028472|NCT03610282|Methylphenidate|methylphenidate|mesh-list
25028473|NCT03610282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25028474|NCT03610282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25028475|NCT03610282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028476|NCT03610282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25028477|NCT03610282|Anesthetics, General|anesthetics, general|mesh-ancestor
25687939|NCT01939002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24944506|NCT03959761|Nivolumab|nivolumab|mesh-list
25028478|NCT03610282|Anesthetics|anesthetics|mesh-ancestor
25028479|NCT03610282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24985452|NCT03341078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24594162|NCT00932880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24985453|NCT03341078|Respiratory System Agents|respiratory system agents|mesh-ancestor
24594163|NCT00932880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594164|NCT00932880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24985454|NCT03341078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24985455|NCT03341078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257635|NCT02475915|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25257636|NCT02475915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25257637|NCT02475915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257638|NCT02475915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257639|NCT02475915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25257640|NCT02475915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25257641|NCT02475915|Antimalarials|antimalarials|mesh-ancestor
24949084|NCT05282940|Levonorgestrel|levonorgestrel|mesh-list
24949085|NCT05282940|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24949088|NCT05282940|Estradiol|estradiol|mesh-list
25257642|NCT02475915|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25257643|NCT02475915|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24847306|NCT02246049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24847307|NCT02246049|Growth Substances|growth substances|mesh-ancestor
24929293|NCT04113954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24929294|NCT04113954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929295|NCT04113954|Sensory System Agents|sensory system agents|mesh-ancestor
24929296|NCT04113954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24528292|NCT00620646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24528295|NCT00620646|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24528296|NCT00620646|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24528297|NCT00620646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24528298|NCT00620646|Purinergic Agents|purinergic agents|mesh-ancestor
24528299|NCT00620646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24528300|NCT00620646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24528301|NCT00620646|Autonomic Agents|autonomic agents|mesh-ancestor
24528302|NCT00620646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24528303|NCT00620646|Respiratory System Agents|respiratory system agents|mesh-ancestor
24528304|NCT00620646|Vasodilator Agents|vasodilator agents|mesh-ancestor
24528305|NCT00620646|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25028490|NCT03610230|Trace Elements|trace elements|mesh-ancestor
25028543|NCT03609892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028544|NCT03609892|Antacids|antacids|mesh-ancestor
25028545|NCT03609892|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25028546|NCT03609892|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25028610|NCT03609359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25028611|NCT03609359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028612|NCT03609359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25028613|NCT03609359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25028614|NCT03609359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028615|NCT03609307|Bevacizumab|bevacizumab|mesh-list
25028616|NCT03609307|Propranolol|propranolol|mesh-list
24897778|NCT04422184|Expectorants|expectorants|mesh-ancestor
24594368|NCT00933582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25028701|NCT03608618|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25099485|NCT03190694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25257651|NCT02475915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25257652|NCT02475915|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25257653|NCT02475915|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25257654|NCT02475915|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25257655|NCT02475915|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25257656|NCT02475915|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25257657|NCT02475915|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25257658|NCT02475915|Protease Inhibitors|protease inhibitors|mesh-ancestor
24528306|NCT00620646|Protective Agents|protective agents|mesh-ancestor
24528307|NCT00620646|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24528308|NCT00620646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24528309|NCT00620724|Nifedipine|nifedipine|mesh-list
24528310|NCT00620724|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24528311|NCT00620724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25687940|NCT01939002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24761352|NCT01762319|Oxytocics|oxytocics|mesh-ancestor
25687941|NCT01939002|Analgesics|analgesics|mesh-ancestor
24528312|NCT00620724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528313|NCT00620724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24528314|NCT00620724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528315|NCT00620724|Vasodilator Agents|vasodilator agents|mesh-ancestor
24528316|NCT00620724|Tocolytic Agents|tocolytic agents|mesh-ancestor
25028726|NCT03608501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25028727|NCT03608501|Growth Substances|growth substances|mesh-ancestor
25028728|NCT03608501|Growth Inhibitors|growth inhibitors|mesh-ancestor
25028729|NCT03608501|Protease Inhibitors|protease inhibitors|mesh-ancestor
25028730|NCT03608501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25028731|NCT03608306|Methamphetamine|methamphetamine|mesh-list
25028732|NCT03608306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25028733|NCT03608306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028734|NCT03608306|Sympathomimetics|sympathomimetics|mesh-ancestor
25028735|NCT03608306|Autonomic Agents|autonomic agents|mesh-ancestor
25028736|NCT03608306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25028737|NCT03608306|Dopamine Agents|dopamine agents|mesh-ancestor
25028738|NCT03608306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25028739|NCT03608306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028740|NCT03608306|Adrenergic Agents|adrenergic agents|mesh-ancestor
25028741|NCT03608306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24594481|NCT00934154|Glucocorticoids|glucocorticoids|mesh-ancestor
24594482|NCT00934154|Hormones|hormones|mesh-ancestor
25028783|NCT03608007|Ensartinib|ensartinib|mesh-list
25028784|NCT03608007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028785|NCT03608007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25028786|NCT03608007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25028787|NCT03608007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028788|NCT03607955|Paclitaxel|paclitaxel|mesh-list
25028789|NCT03607955|Carboplatin|carboplatin|mesh-list
25028790|NCT03607955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25028791|NCT03607955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028792|NCT03607955|Tubulin Modulators|tubulin modulators|mesh-ancestor
25028793|NCT03607955|Antimitotic Agents|antimitotic agents|mesh-ancestor
25028794|NCT03607955|Mitosis Modulators|mitosis modulators|mesh-ancestor
25028795|NCT03607955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028796|NCT03607916|Morphine|morphine|mesh-list
25028797|NCT03607916|Prilocaine|prilocaine|mesh-list
25029037|NCT03606057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25029038|NCT03606057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25029039|NCT03606057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25029040|NCT03606057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25029041|NCT03606057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25029042|NCT03606057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029043|NCT03606057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029044|NCT03606057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25029045|NCT03606057|Contraceptive Agents|contraceptive agents|mesh-ancestor
25029046|NCT03606057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25029047|NCT03606057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257659|NCT02475824|Midazolam|midazolam|mesh-list
25257660|NCT02475824|Meperidine|meperidine|mesh-list
25257661|NCT02475824|Dexmedetomidine|dexmedetomidine|mesh-list
25257662|NCT02475824|Propofol|propofol|mesh-list
25257663|NCT02475824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25257664|NCT02475824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25257665|NCT02475824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257666|NCT02475824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25257667|NCT02475824|Anesthetics, General|anesthetics, general|mesh-ancestor
25257668|NCT02475824|Anesthetics|anesthetics|mesh-ancestor
25257669|NCT02475824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25257670|NCT02475824|Analgesics|analgesics|mesh-ancestor
25257671|NCT02475824|Sensory System Agents|sensory system agents|mesh-ancestor
25275059|NCT02374567|Antipruritics|antipruritics|mesh-ancestor
24929297|NCT04113915|Cyclosporine|cyclosporine|mesh-list
24929298|NCT04113915|Dexamethasone|dexamethasone|mesh-list
24929299|NCT04113915|Cyclosporins|cyclosporins|mesh-list
24929300|NCT04113915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929301|NCT04113915|Immunologic Factors|immunologic factors|mesh-ancestor
24929302|NCT04113915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929303|NCT04113915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24929304|NCT04113915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24929305|NCT04113915|Antiemetics|antiemetics|mesh-ancestor
24929306|NCT04113915|Autonomic Agents|autonomic agents|mesh-ancestor
24929307|NCT04113915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24929308|NCT04113915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24929309|NCT04113915|Glucocorticoids|glucocorticoids|mesh-ancestor
25404234|NCT03678675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24929311|NCT04113915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24799269|NCT01968005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25029051|NCT03606018|Insulin|insulin|mesh-list
25029093|NCT03605433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029094|NCT03605433|Anticoagulants|anticoagulants|mesh-ancestor
25029095|NCT03605199|Denosumab|denosumab|mesh-list
25029096|NCT03605199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25029097|NCT03605199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029098|NCT03605173|Vitamin D|vitamin d|mesh-list
25029099|NCT03605173|Ergocalciferols|ergocalciferols|mesh-list
25029100|NCT03605173|Cholecalciferol|cholecalciferol|mesh-list
25029101|NCT03605173|Vitamins|vitamins|mesh-list
25029102|NCT03605173|Micronutrients|micronutrients|mesh-ancestor
25029103|NCT03605173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029104|NCT03605173|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25029105|NCT03605173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25029106|NCT03605095|Nitroglycerin|nitroglycerin|mesh-list
25029107|NCT03605095|Vasodilator Agents|vasodilator agents|mesh-ancestor
25029108|NCT03605056|Dexamethasone|dexamethasone|mesh-list
25029109|NCT03605056|Lenalidomide|lenalidomide|mesh-list
25029110|NCT03605056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25029112|NCT03605056|Autonomic Agents|autonomic agents|mesh-ancestor
25029113|NCT03605056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25029114|NCT03605056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029115|NCT03605056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25029116|NCT03605056|Glucocorticoids|glucocorticoids|mesh-ancestor
25029117|NCT03605056|Hormones|hormones|mesh-ancestor
24594874|NCT00935805|Natriuretic Agents|natriuretic agents|mesh-ancestor
24594875|NCT00935805|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24594876|NCT00935805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24594877|NCT00935805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24594878|NCT00935805|Adrenergic Agents|adrenergic agents|mesh-ancestor
25113090|NCT03546582|Pembrolizumab|pembrolizumab|mesh-list
24594923|NCT00936182|Antifungal Agents|antifungal agents|mesh-ancestor
24594924|NCT00936182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25029133|NCT03604757|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25029134|NCT03604757|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25029135|NCT03604757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029136|NCT03604744|Psilocybin|psilocybin|mesh-list
25029137|NCT03604744|Hallucinogens|hallucinogens|mesh-ancestor
25257675|NCT02475824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25257676|NCT02475824|Adrenergic Agents|adrenergic agents|mesh-ancestor
25257677|NCT02475824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25257678|NCT02475824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257679|NCT02475824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25257680|NCT02475824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25257681|NCT02475824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25257682|NCT02475824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25257683|NCT02475824|GABA Modulators|gaba modulators|mesh-ancestor
25257684|NCT02475824|GABA Agents|gaba agents|mesh-ancestor
25257685|NCT02475824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25257686|NCT02475824|Narcotics|narcotics|mesh-ancestor
24929312|NCT04113915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24929313|NCT04113915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24929314|NCT04113915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029181|NCT03604354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029182|NCT03604354|Anticonvulsants|anticonvulsants|mesh-ancestor
25029183|NCT03604354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25029184|NCT03604354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25029185|NCT03604354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029186|NCT03604354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24897860|NCT04421079|Resveratrol|resveratrol|mesh-list
25029195|NCT03604354|Adrenergic Agents|adrenergic agents|mesh-ancestor
25029196|NCT03604354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25029235|NCT03603899|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25029236|NCT03603899|Anesthetics, General|anesthetics, general|mesh-ancestor
25029237|NCT03603899|Anesthetics|anesthetics|mesh-ancestor
25030818|NCT03592537|GABA Agents|gaba agents|mesh-ancestor
25029238|NCT03603899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25029239|NCT03603899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029240|NCT03603834|Leucovorin|leucovorin|mesh-list
25029241|NCT03603834|Fluorouracil|fluorouracil|mesh-list
25029242|NCT03603834|Oxaliplatin|oxaliplatin|mesh-list
25029243|NCT03603834|Irinotecan|irinotecan|mesh-list
25029244|NCT03603834|Antimetabolites|antimetabolites|mesh-ancestor
25029245|NCT03603834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029246|NCT03603834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25029247|NCT03603834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029248|NCT03603834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25029249|NCT03603834|Immunologic Factors|immunologic factors|mesh-ancestor
25029250|NCT03603834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029296|NCT03603418|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25029297|NCT03603418|BB 1101|bb 1101|mesh-list
25029298|NCT03603418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25029299|NCT03603418|Antiemetics|antiemetics|mesh-ancestor
25029300|NCT03603418|Autonomic Agents|autonomic agents|mesh-ancestor
25029301|NCT03603418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24595072|NCT00936767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24595073|NCT00936767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029358|NCT03603119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029359|NCT03603119|Antipruritics|antipruritics|mesh-ancestor
24929315|NCT04113915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24929316|NCT04113915|Antifungal Agents|antifungal agents|mesh-ancestor
24929317|NCT04113915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24929318|NCT04113915|Dermatologic Agents|dermatologic agents|mesh-ancestor
24929319|NCT04113915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24929320|NCT04113889|Acetylcarnitine|acetylcarnitine|mesh-list
24929321|NCT04113889|Metformin|metformin|mesh-list
24929322|NCT04113889|Pioglitazone|pioglitazone|mesh-list
24929323|NCT04113889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24929328|NCT04113889|Nootropic Agents|nootropic agents|mesh-ancestor
24929329|NCT04113928|Mechlorethamine|mechlorethamine|mesh-list
24929330|NCT04113928|Alkylating Agents|alkylating agents|mesh-ancestor
24929331|NCT04113928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929332|NCT04113928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25049696|NCT00578474|Ofloxacin|ofloxacin|mesh-list
25113183|NCT03401398|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24986295|NCT01978938|Ofloxacin|ofloxacin|mesh-list
24986296|NCT01978938|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24986297|NCT01978938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24986298|NCT01978938|Renal Agents|renal agents|mesh-ancestor
25029501|NCT03602430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029502|NCT03602430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25029503|NCT03602430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25029505|NCT03602378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25029506|NCT03602287|Lidocaine|lidocaine|mesh-list
25029507|NCT03602287|Anesthetics, Local|anesthetics, local|mesh-ancestor
25029508|NCT03602287|Anesthetics|anesthetics|mesh-ancestor
25029548|NCT03602131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25029549|NCT03602131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25029551|NCT03602118|Anticonvulsants|anticonvulsants|mesh-ancestor
25029552|NCT03602118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25029553|NCT03602118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25029554|NCT03602118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029555|NCT03602118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25029614|NCT03601871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25029615|NCT03601871|Growth Substances|growth substances|mesh-ancestor
25029616|NCT03601871|Growth Inhibitors|growth inhibitors|mesh-ancestor
25029617|NCT03601871|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25029727|NCT03600961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25029728|NCT03600961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25029729|NCT03600961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25029730|NCT03600961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029731|NCT03600961|Antifungal Agents|antifungal agents|mesh-ancestor
25029732|NCT03600961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25029733|NCT03600961|Immunologic Factors|immunologic factors|mesh-ancestor
25029734|NCT03600961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029791|NCT03600727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25029792|NCT03600727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25029794|NCT03600727|Adrenergic Agents|adrenergic agents|mesh-ancestor
25029795|NCT03600727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25029796|NCT03600727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029797|NCT03600623|Gemcitabine|gemcitabine|mesh-list
25029798|NCT03600623|Paclitaxel|paclitaxel|mesh-list
25029799|NCT03600623|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25029800|NCT03600623|Fluorouracil|fluorouracil|mesh-list
25029801|NCT03600623|Oxaliplatin|oxaliplatin|mesh-list
25029803|NCT03600623|Folfirinox|folfirinox|mesh-list
25029804|NCT03600623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25257691|NCT02475746|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25257692|NCT02475746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25687942|NCT01939002|Sensory System Agents|sensory system agents|mesh-ancestor
24752709|NCT01711671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24752710|NCT01711671|Antiemetics|antiemetics|mesh-ancestor
24752711|NCT01711671|Autonomic Agents|autonomic agents|mesh-ancestor
24598355|NCT00955630|Ranibizumab|ranibizumab|mesh-list
24417308|NCT00206167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25257693|NCT02475746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257694|NCT02475746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257695|NCT02475746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25257696|NCT02475746|Hormone Antagonists|hormone antagonists|mesh-ancestor
25257697|NCT02475746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25257698|NCT02475746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257699|NCT02475746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25257700|NCT02475746|GABA Modulators|gaba modulators|mesh-ancestor
25257701|NCT02475746|GABA Agents|gaba agents|mesh-ancestor
25257702|NCT02475746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25257703|NCT02475499|Metformin|metformin|mesh-list
24929333|NCT04113928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929334|NCT04114097|Betamethasone|betamethasone|mesh-list
24929335|NCT04114097|Betamethasone Valerate|betamethasone valerate|mesh-list
24929336|NCT04114097|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24929337|NCT04114097|Betamethasone benzoate|betamethasone benzoate|mesh-list
24929338|NCT04114097|Tacrolimus|tacrolimus|mesh-list
24929339|NCT04114097|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24929340|NCT04114097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24929341|NCT04114097|Immunologic Factors|immunologic factors|mesh-ancestor
24929342|NCT04114097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929343|NCT04114097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24929344|NCT04114097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24929345|NCT04114097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029805|NCT03600623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029806|NCT03600623|Tubulin Modulators|tubulin modulators|mesh-ancestor
25029807|NCT03600623|Antimitotic Agents|antimitotic agents|mesh-ancestor
25029808|NCT03600623|Mitosis Modulators|mitosis modulators|mesh-ancestor
25029809|NCT03600623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029810|NCT03600623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25029811|NCT03600623|Antimetabolites|antimetabolites|mesh-ancestor
25029812|NCT03600623|Antiviral Agents|antiviral agents|mesh-ancestor
25029813|NCT03600623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25029814|NCT03600623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25029836|NCT03600493|Lidocaine|lidocaine|mesh-list
25029843|NCT03600493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25029844|NCT03600493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25029845|NCT03600493|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25029846|NCT03600493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25029847|NCT03600493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25029848|NCT03600493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029849|NCT03600493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25029850|NCT03600493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25029851|NCT03600493|Analgesics|analgesics|mesh-ancestor
25029852|NCT03600493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25029853|NCT03600493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25029854|NCT03600493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25029855|NCT03600493|Adrenergic Agents|adrenergic agents|mesh-ancestor
25029856|NCT03600493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25029857|NCT03600467|Seviteronel|seviteronel|mesh-list
25029858|NCT03600467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029859|NCT03600467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25029860|NCT03600467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25029894|NCT03600064|Abortifacient Agents|abortifacient agents|mesh-ancestor
25029895|NCT03600064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25029896|NCT03600064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029897|NCT03600064|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25029898|NCT03600064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25029899|NCT03600064|Oxytocics|oxytocics|mesh-ancestor
25029900|NCT03599973|Plasma-lyte 148|plasma-lyte 148|mesh-list
25029901|NCT03599973|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25687943|NCT01939002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25687944|NCT01939002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687945|NCT01939002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25687946|NCT01939002|Gout Suppressants|gout suppressants|mesh-ancestor
25687947|NCT01939002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25029902|NCT03599973|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25029904|NCT03599778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029905|NCT03599778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25257718|NCT02475499|Tolbutamide|tolbutamide|mesh-list
25257719|NCT02475499|Voglibose|voglibose|mesh-list
25257720|NCT02475499|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
24929346|NCT04114097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24929347|NCT04114097|Glucocorticoids|glucocorticoids|mesh-ancestor
24929348|NCT04114097|Hormones|hormones|mesh-ancestor
24929349|NCT04114097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24929350|NCT04114097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24929351|NCT04114097|Respiratory System Agents|respiratory system agents|mesh-ancestor
24929352|NCT04113941|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24929353|NCT04113941|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24929354|NCT04113941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24929355|NCT04113941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929356|NCT04113941|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25113230|NCT03215524|Thalidomide|thalidomide|mesh-list
24595975|NCT00941096|Timolol|timolol|mesh-list
25030022|NCT03598959|Tofacitinib|tofacitinib|mesh-list
25030023|NCT03598959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25030024|NCT03598959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25030025|NCT03598959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030026|NCT03598868|Vortioxetine|vortioxetine|mesh-list
25030027|NCT03598868|Antidepressive Agents|antidepressive agents|mesh-ancestor
25030028|NCT03598868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25030029|NCT03598868|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25030030|NCT03598868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25030033|NCT03598868|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24587915|NCT00898573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24587916|NCT00898573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587917|NCT00898573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587918|NCT00898794|Bevacizumab|bevacizumab|mesh-list
24596086|NCT00941499|Antibodies|antibodies|mesh-list
25030072|NCT03598673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25030073|NCT03598673|Adrenergic Agents|adrenergic agents|mesh-ancestor
25030074|NCT03598673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25030075|NCT03598673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030076|NCT03598673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030078|NCT03598634|Vitamin B Complex|vitamin b complex|mesh-ancestor
25030079|NCT03598634|Vitamins|vitamins|mesh-ancestor
25030080|NCT03598634|Micronutrients|micronutrients|mesh-ancestor
25030180|NCT03597945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25030181|NCT03597945|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25030182|NCT03597945|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25030183|NCT03597945|Autonomic Agents|autonomic agents|mesh-ancestor
25030184|NCT03597945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25030190|NCT03597945|Anticonvulsants|anticonvulsants|mesh-ancestor
25030191|NCT03597945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25030192|NCT03597945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25030193|NCT03597945|Tocolytic Agents|tocolytic agents|mesh-ancestor
25030194|NCT03597945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25257721|NCT02475499|Nateglinide|nateglinide|mesh-list
25257722|NCT02475499|Miglitol|miglitol|mesh-list
25257723|NCT02475499|Troglitazone|troglitazone|mesh-list
25257724|NCT02475499|Meglitinide|meglitinide|mesh-list
25257725|NCT02475499|Acetohexamide|acetohexamide|mesh-list
25257726|NCT02475499|Chlorpropamide|chlorpropamide|mesh-list
25257727|NCT02475499|Phenformin|phenformin|mesh-list
25257728|NCT02475499|Buformin|buformin|mesh-list
25257729|NCT02475499|Glibornuride|glibornuride|mesh-list
25257730|NCT02475499|Tolazamide|tolazamide|mesh-list
25257731|NCT02475499|Carbutamide|carbutamide|mesh-list
25257732|NCT02475499|Gliquidone|gliquidone|mesh-list
25257733|NCT02475499|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25257734|NCT02475499|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
25687948|NCT01939002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687949|NCT01939002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687950|NCT01939002|Immunologic Factors|immunologic factors|mesh-ancestor
24929357|NCT04113941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24929358|NCT04113941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030195|NCT03597919|Vaccines|vaccines|mesh-list
25030196|NCT03597919|Immunologic Factors|immunologic factors|mesh-ancestor
25030197|NCT03597919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030198|NCT03597893|Oxytocin|oxytocin|mesh-list
25030199|NCT03597893|Oxytocics|oxytocics|mesh-ancestor
24752830|NCT01712295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752831|NCT01712295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25030200|NCT03597893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25030201|NCT03597893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030202|NCT03597867|Diclofenac|diclofenac|mesh-list
25113263|NCT03215524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25113264|NCT03215524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24596341|NCT00943137|Antimetabolites|antimetabolites|mesh-ancestor
24588046|NCT00900445|Protective Agents|protective agents|mesh-ancestor
24588047|NCT00900445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24588048|NCT00900445|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24588049|NCT00900445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24588050|NCT00900445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588051|NCT00900510|Trimethoprim|trimethoprim|mesh-list
24588052|NCT00900510|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24588053|NCT00900510|Sulfamethoxazole|sulfamethoxazole|mesh-list
24588054|NCT00900510|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24588068|NCT00900744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24588069|NCT00900744|Hormone Antagonists|hormone antagonists|mesh-ancestor
25030229|NCT03597594|Fludarabine|fludarabine|mesh-list
25030230|NCT03597594|Busulfan|busulfan|mesh-list
25030231|NCT03597594|Thiotepa|thiotepa|mesh-list
25030232|NCT03597594|Thymoglobulin|thymoglobulin|mesh-list
25030233|NCT03597594|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25030234|NCT03597594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25030235|NCT03597594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030236|NCT03597594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25030237|NCT03597594|Immunologic Factors|immunologic factors|mesh-ancestor
25030264|NCT03597308|Ibuprofen|ibuprofen|mesh-list
25030272|NCT03597308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24596390|NCT00943345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25030273|NCT03597308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25030274|NCT03597308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25030275|NCT03597308|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25030289|NCT03597282|Immunologic Factors|immunologic factors|mesh-ancestor
25030290|NCT03597282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030292|NCT03597087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25030293|NCT03597087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030294|NCT03597035|Spironolactone|spironolactone|mesh-list
25030300|NCT03597035|Diuretics|diuretics|mesh-ancestor
25030319|NCT03596892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25030320|NCT03596892|Alkylating Agents|alkylating agents|mesh-ancestor
25030321|NCT03596892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030322|NCT03596892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25030323|NCT03596892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25030324|NCT03596892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25030325|NCT03596892|Antimetabolites|antimetabolites|mesh-ancestor
24596494|NCT00943930|Hormones|hormones|mesh-ancestor
25030376|NCT03596281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25030377|NCT03596281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030378|NCT03596125|Acetylcysteine|acetylcysteine|mesh-list
25030379|NCT03596125|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25030380|NCT03596125|Antiviral Agents|antiviral agents|mesh-ancestor
25030381|NCT03596125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25030382|NCT03596125|Expectorants|expectorants|mesh-ancestor
25030383|NCT03596125|Respiratory System Agents|respiratory system agents|mesh-ancestor
25030384|NCT03596125|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25030385|NCT03596125|Antioxidants|antioxidants|mesh-ancestor
25257735|NCT02475499|Incretins|incretins|mesh-list
25257736|NCT02475499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257737|NCT02475499|Hormones|hormones|mesh-ancestor
25275060|NCT02374567|Dermatologic Agents|dermatologic agents|mesh-ancestor
24929359|NCT04113941|Cholinergic Agents|cholinergic agents|mesh-ancestor
24929360|NCT04113941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24929365|NCT04113993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24624738|NCT01077999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24505406|NCT00541086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24528328|NCT00620789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24528329|NCT00620789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24528330|NCT00620789|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25155504|NCT05353140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24528331|NCT00620789|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24528332|NCT00620789|Parasympatholytics|parasympatholytics|mesh-ancestor
25687951|NCT01939002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25687952|NCT01939028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24528333|NCT00620789|Autonomic Agents|autonomic agents|mesh-ancestor
24528334|NCT00620789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24528335|NCT00620789|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24528336|NCT00620789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24528337|NCT00620789|Cholinergic Agents|cholinergic agents|mesh-ancestor
24528338|NCT00620802|Clopidogrel|clopidogrel|mesh-list
24528339|NCT00620802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25049725|NCT00576667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25030386|NCT03596125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030387|NCT03596125|Protective Agents|protective agents|mesh-ancestor
25030388|NCT03596125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030389|NCT03596125|Antidotes|antidotes|mesh-ancestor
25030390|NCT03596099|Acetic Acid|acetic acid|mesh-list
25030391|NCT03596099|Retinol acetate|retinol acetate|mesh-list
25030392|NCT03596099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25030393|NCT03596099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24929619|NCT04110808|Adrenergic Agents|adrenergic agents|mesh-ancestor
25030394|NCT03596099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25030395|NCT03596099|Immunologic Factors|immunologic factors|mesh-ancestor
25030396|NCT03596099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030397|NCT03596099|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25030398|NCT03596099|Protective Agents|protective agents|mesh-ancestor
25030429|NCT03595930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25030430|NCT03595852|Cefazolin|cefazolin|mesh-list
25030431|NCT03595852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25030432|NCT03595852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25113336|NCT02968810|Simvastatin|simvastatin|mesh-list
25113337|NCT02968810|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25113338|NCT02968810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25030447|NCT03595514|Hormones|hormones|mesh-ancestor
25030448|NCT03595514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25030449|NCT03595514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25030450|NCT03595514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25030451|NCT03595514|Anesthetics, Local|anesthetics, local|mesh-ancestor
25030452|NCT03595514|Anesthetics|anesthetics|mesh-ancestor
25030453|NCT03595514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25030454|NCT03595514|Sensory System Agents|sensory system agents|mesh-ancestor
25030506|NCT03595254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25030507|NCT03595254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030508|NCT03595254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25030509|NCT03595254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25030510|NCT03595254|Cholinergic Agents|cholinergic agents|mesh-ancestor
25257738|NCT02475499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25257739|NCT02475499|Protease Inhibitors|protease inhibitors|mesh-ancestor
25257740|NCT02475499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257741|NCT02475499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257742|NCT02475499|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25257743|NCT02475499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25257744|NCT02475499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25257745|NCT02475499|Immunologic Factors|immunologic factors|mesh-ancestor
25257746|NCT02475421|Glucagon|glucagon|mesh-list
25257747|NCT02475421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25257748|NCT02475421|Hormones|hormones|mesh-ancestor
25257749|NCT02475421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25257750|NCT02475421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257751|NCT02475681|Obinutuzumab|obinutuzumab|mesh-list
25257752|NCT02475681|Acalabrutinib|acalabrutinib|mesh-list
25257753|NCT02475681|Chlorambucil|chlorambucil|mesh-list
25257754|NCT02475681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25257755|NCT02475681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25257756|NCT02475681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24528340|NCT00620802|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24528341|NCT00620802|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25100437|NCT03183076|Anticonvulsants|anticonvulsants|mesh-list
24528342|NCT00620802|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24528343|NCT00620802|Purinergic Agents|purinergic agents|mesh-ancestor
24528344|NCT00620802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25030511|NCT03595254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25030512|NCT03595254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030514|NCT03595189|Protease Inhibitors|protease inhibitors|mesh-ancestor
25030515|NCT03595189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25030517|NCT03595163|Folic Acid|folic acid|mesh-list
25030570|NCT03594604|Norethindrone Acetate|norethindrone acetate|mesh-list
25030571|NCT03594604|Contraceptives, Oral|contraceptives, oral|mesh-list
25030572|NCT03594604|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
24752962|NCT01712997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25030573|NCT03594604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25030574|NCT03594604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030575|NCT03594604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25030576|NCT03594604|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25030577|NCT03594604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25030578|NCT03594604|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25030579|NCT03594591|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25030580|NCT03594591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030581|NCT03594565|Fluticasone|fluticasone|mesh-list
25030582|NCT03594565|Xhance|xhance|mesh-list
24588159|NCT00901381|Lenograstim|lenograstim|mesh-list
24588160|NCT00901381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24588161|NCT00901381|Immunologic Factors|immunologic factors|mesh-ancestor
24588162|NCT00901381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588163|NCT00901407|Lamotrigine|lamotrigine|mesh-list
24588164|NCT00901407|Paroxetine|paroxetine|mesh-list
24588165|NCT00901407|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24588204|NCT00901537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24588218|NCT00901550|Dermatologic Agents|dermatologic agents|mesh-ancestor
24588219|NCT00901550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25030583|NCT03594565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25030584|NCT03594565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25030631|NCT03594396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030633|NCT03594240|Vitamin B Complex|vitamin b complex|mesh-list
25030634|NCT03594240|Vitamins|vitamins|mesh-ancestor
25030635|NCT03594240|Micronutrients|micronutrients|mesh-ancestor
25030636|NCT03594240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030637|NCT03594240|Hematinics|hematinics|mesh-ancestor
25030638|NCT03594214|Vitamin D|vitamin d|mesh-list
25030639|NCT03594214|Vitamins|vitamins|mesh-ancestor
25030640|NCT03594214|Micronutrients|micronutrients|mesh-ancestor
25030641|NCT03594214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030642|NCT03594214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25030749|NCT03593044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030750|NCT03593044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25030751|NCT03593044|Respiratory System Agents|respiratory system agents|mesh-ancestor
25030752|NCT03593044|Mydriatics|mydriatics|mesh-ancestor
25030753|NCT03593044|Parasympatholytics|parasympatholytics|mesh-ancestor
25030754|NCT03593044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25030755|NCT03593044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25030756|NCT03593044|Cholinergic Agents|cholinergic agents|mesh-ancestor
25030803|NCT03592537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25030804|NCT03592537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030805|NCT03592537|Sensory System Agents|sensory system agents|mesh-ancestor
25030806|NCT03592537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25030807|NCT03592537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25030808|NCT03592537|Narcotics|narcotics|mesh-ancestor
25030809|NCT03592537|Analgesics|analgesics|mesh-ancestor
25030810|NCT03592537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24987552|NCT00591318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25030811|NCT03592537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25030812|NCT03592537|Anesthetics, General|anesthetics, general|mesh-ancestor
25030813|NCT03592537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25257757|NCT02475681|Alkylating Agents|alkylating agents|mesh-ancestor
25257758|NCT02475681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257759|NCT02475382|Nivolumab|nivolumab|mesh-list
25257760|NCT02475382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25257761|NCT02475382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528370|NCT00620971|Bevacizumab|bevacizumab|mesh-list
24528371|NCT00620971|Cisplatin|cisplatin|mesh-list
24528372|NCT00620971|Docetaxel|docetaxel|mesh-list
24624740|NCT01077999|Tubulin Modulators|tubulin modulators|mesh-ancestor
24624741|NCT01077999|Antimitotic Agents|antimitotic agents|mesh-ancestor
24624742|NCT01077999|Mitosis Modulators|mitosis modulators|mesh-ancestor
24624743|NCT01077999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624744|NCT01077999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24624746|NCT01078038|Everolimus|everolimus|mesh-list
24624760|NCT01078142|Immunologic Factors|immunologic factors|mesh-ancestor
24624761|NCT01078142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624762|NCT01078142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24624763|NCT01078142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24624764|NCT01078142|Alkylating Agents|alkylating agents|mesh-ancestor
24624765|NCT01078142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624766|NCT01078142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24528413|NCT00621036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528414|NCT00621036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528415|NCT00621036|Dermatologic Agents|dermatologic agents|mesh-ancestor
24528416|NCT00621036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528417|NCT00621036|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24528418|NCT00621036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24528419|NCT00621036|Immunologic Factors|immunologic factors|mesh-ancestor
24528420|NCT00621036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25030814|NCT03592537|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25030815|NCT03592537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25030816|NCT03592537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25030817|NCT03592537|GABA Modulators|gaba modulators|mesh-ancestor
25030819|NCT03592537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25030820|NCT03592537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030821|NCT03592498|Sulfadiazine|sulfadiazine|mesh-list
25030822|NCT03592498|Silver Sulfadiazine|silver sulfadiazine|mesh-list
25030823|NCT03592498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25030824|NCT03592498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25030825|NCT03592498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25030868|NCT03592199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25030869|NCT03592199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030870|NCT03592082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25030871|NCT03592082|Bismuth|bismuth|mesh-list
25030872|NCT03592082|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
25030873|NCT03592082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25030874|NCT03592082|Antacids|antacids|mesh-ancestor
25257762|NCT02475382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25257763|NCT02475382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257764|NCT02475304|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25257765|NCT02475304|Dermatologic Agents|dermatologic agents|mesh-ancestor
25257766|NCT02475304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25257767|NCT02475304|Immunologic Factors|immunologic factors|mesh-ancestor
25257768|NCT02475304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257769|NCT02475343|Riboflavin|riboflavin|mesh-list
25257770|NCT02475343|Vitamin B Complex|vitamin b complex|mesh-ancestor
25257771|NCT02475343|Vitamins|vitamins|mesh-ancestor
25257772|NCT02475343|Micronutrients|micronutrients|mesh-ancestor
25257773|NCT02475343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257774|NCT02475343|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25257787|NCT02475135|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25257789|NCT02475135|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
24528421|NCT00621036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24528422|NCT00621036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24528423|NCT00621036|Alkylating Agents|alkylating agents|mesh-ancestor
24528424|NCT00621036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24528426|NCT00621101|Ezetimibe|ezetimibe|mesh-list
24528427|NCT00621101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24528428|NCT00621101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24528429|NCT00621101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24528430|NCT00621101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528431|NCT00621101|Antifungal Agents|antifungal agents|mesh-ancestor
24624767|NCT01078142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24624768|NCT01078142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24624769|NCT01078142|Antifungal Agents|antifungal agents|mesh-ancestor
25030875|NCT03592082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030876|NCT03592082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25030877|NCT03592082|Antidiarrheals|antidiarrheals|mesh-ancestor
25030878|NCT03592069|Amoxicillin|amoxicillin|mesh-list
25030879|NCT03592069|Metronidazole|metronidazole|mesh-list
25030880|NCT03592069|Clarithromycin|clarithromycin|mesh-list
25030881|NCT03592069|Esomeprazole|esomeprazole|mesh-list
25030930|NCT03591744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24597226|NCT00947843|Analgesics|analgesics|mesh-ancestor
25030931|NCT03591744|Glucocorticoids|glucocorticoids|mesh-ancestor
25030932|NCT03591744|Hormones|hormones|mesh-ancestor
25030933|NCT03591744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25030934|NCT03591744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25030935|NCT03591744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25030936|NCT03591744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25030937|NCT03591744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25030948|NCT03591679|Oxytocin|oxytocin|mesh-list
25030994|NCT03591471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25030995|NCT03591471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24597288|NCT00948220|Antimetabolites|antimetabolites|mesh-ancestor
25030996|NCT03591471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030997|NCT03591471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25031009|NCT03591341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25031010|NCT03591289|Bromides|bromides|mesh-list
25031049|NCT03590912|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25031050|NCT03590912|Histamine Agents|histamine agents|mesh-ancestor
25031051|NCT03590912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25031052|NCT03590912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031053|NCT03590912|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25031054|NCT03590912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25031055|NCT03590912|Adrenergic Agents|adrenergic agents|mesh-ancestor
25031056|NCT03590912|Sympathomimetics|sympathomimetics|mesh-ancestor
25031057|NCT03590912|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25031058|NCT03590912|Respiratory System Agents|respiratory system agents|mesh-ancestor
24597423|NCT00949247|Growth Substances|growth substances|mesh-ancestor
25257801|NCT02475135|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24624770|NCT01078142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24624772|NCT01078428|Emollients|emollients|mesh-ancestor
24624773|NCT01078428|Dermatologic Agents|dermatologic agents|mesh-ancestor
24624774|NCT01078519|Anesthetics|anesthetics|mesh-list
24624775|NCT01078519|Anesthetics, Local|anesthetics, local|mesh-list
24624776|NCT01078519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24630855|NCT01114100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24630981|NCT01115426|Protease Inhibitors|protease inhibitors|mesh-ancestor
24624777|NCT01078519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624778|NCT01078519|Sensory System Agents|sensory system agents|mesh-ancestor
24624779|NCT01078519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24624780|NCT01078610|Adalimumab|adalimumab|mesh-list
24624781|NCT01078610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24753674|NCT01716767|Antipruritics|antipruritics|mesh-ancestor
24929369|NCT04113668|BMS-986165|bms-986165|mesh-list
24929370|NCT04113668|Dermatologic Agents|dermatologic agents|mesh-ancestor
24929371|NCT04113668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24929405|NCT04113226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929407|NCT04113226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25045348|NCT00966953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24597474|NCT00949494|Immunologic Factors|immunologic factors|mesh-ancestor
24597475|NCT00949546|Etanercept|etanercept|mesh-list
24597476|NCT00949546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25031095|NCT03590431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25031096|NCT03590431|Trace Elements|trace elements|mesh-ancestor
25031097|NCT03590431|Micronutrients|micronutrients|mesh-ancestor
25031098|NCT03590431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031099|NCT03590275|Folfirinox|folfirinox|mesh-list
25031100|NCT03590275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597477|NCT00949546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25031101|NCT03590262|Metformin|metformin|mesh-list
25031102|NCT03590262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25031103|NCT03590262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031104|NCT03590210|Nivolumab|nivolumab|mesh-list
25031135|NCT03590080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25031136|NCT03590080|Glucocorticoids|glucocorticoids|mesh-ancestor
25031138|NCT03590080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25257802|NCT02475135|Protease Inhibitors|protease inhibitors|mesh-ancestor
25257803|NCT02475135|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25257804|NCT02475135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25257805|NCT02475135|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25257806|NCT02475161|Rabeprazole|rabeprazole|mesh-list
25257807|NCT02475161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25257808|NCT02475161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25257809|NCT02475161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25257810|NCT02475161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257811|NCT02475161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257812|NCT02475213|Pembrolizumab|pembrolizumab|mesh-list
25257813|NCT02475213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25257814|NCT02475213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25257815|NCT02475109|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25257816|NCT02475109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25257817|NCT02475317|Volixibat|volixibat|mesh-list
25257818|NCT02475317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25257819|NCT02474953|Curcumin|curcumin|mesh-list
25257820|NCT02474953|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25257821|NCT02474953|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25257822|NCT02474953|Analgesics|analgesics|mesh-ancestor
25257823|NCT02474953|Sensory System Agents|sensory system agents|mesh-ancestor
25257824|NCT02474953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24753073|NCT01713647|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24753074|NCT01713647|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25257825|NCT02474953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257826|NCT02474953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25257827|NCT02474953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24929470|NCT04112498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24929471|NCT04112498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929472|NCT04112498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24929473|NCT04112498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929474|NCT04112394|Anesthetics|anesthetics|mesh-list
24929475|NCT04112394|Anesthetics, Local|anesthetics, local|mesh-list
24929476|NCT04112394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24929477|NCT04112394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929478|NCT04112394|Sensory System Agents|sensory system agents|mesh-ancestor
24929479|NCT04112394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24929480|NCT04111822|Tranexamic Acid|tranexamic acid|mesh-list
24929481|NCT04111822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25100971|NCT03178396|Antioxidants|antioxidants|mesh-ancestor
24929482|NCT04111822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24929518|NCT04111328|Adrenergic Agents|adrenergic agents|mesh-ancestor
24929519|NCT04111328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24929520|NCT04111328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929521|NCT04111328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24929522|NCT04111328|Narcotics|narcotics|mesh-ancestor
24929523|NCT04111328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24929524|NCT04111328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24929525|NCT04111328|Anesthetics, General|anesthetics, general|mesh-ancestor
24929526|NCT04111328|Anesthetics|anesthetics|mesh-ancestor
24929528|NCT04111159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24929529|NCT04111159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24929530|NCT04111159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929532|NCT04111159|Anesthetics, General|anesthetics, general|mesh-ancestor
24929533|NCT04111159|Anesthetics|anesthetics|mesh-ancestor
24929534|NCT04111302|Dezocine|dezocine|mesh-list
24597525|NCT00949728|Coagulants|coagulants|mesh-ancestor
25031205|NCT03589430|Anticoagulants|anticoagulants|mesh-ancestor
25031206|NCT03589430|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25031207|NCT03589430|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25031208|NCT03589222|Dexamethasone|dexamethasone|mesh-list
25031209|NCT03589222|Bortezomib|bortezomib|mesh-list
25031210|NCT03589222|Daratumumab|daratumumab|mesh-list
25031218|NCT03589222|Hormones|hormones|mesh-ancestor
24597630|NCT00950391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597631|NCT00950391|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24597632|NCT00950391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597633|NCT00950391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257828|NCT02474953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25257829|NCT02474953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257830|NCT02474953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257831|NCT02474914|Octreotide|octreotide|mesh-list
25257832|NCT02474914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25257833|NCT02474914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25257834|NCT02474914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25257835|NCT02475057|Hormones|hormones|mesh-list
25257836|NCT02475057|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25257837|NCT02475057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25257838|NCT02475057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257839|NCT02474667|Mitogens|mitogens|mesh-list
25257840|NCT02474667|Mitosis Modulators|mitosis modulators|mesh-ancestor
25257841|NCT02474667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257842|NCT02474654|Ketorolac|ketorolac|mesh-list
25257843|NCT02474654|Epinephrine|epinephrine|mesh-list
25257844|NCT02474654|Racepinephrine|racepinephrine|mesh-list
25257845|NCT02474654|Fentanyl|fentanyl|mesh-list
25257846|NCT02474654|Bupivacaine|bupivacaine|mesh-list
25257847|NCT02474654|Epinephryl borate|epinephryl borate|mesh-list
25257854|NCT02474654|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25257855|NCT02474654|Narcotics|narcotics|mesh-ancestor
25687953|NCT01939158|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25687954|NCT01939158|Immunologic Factors|immunologic factors|mesh-ancestor
25257856|NCT02474654|Analgesics|analgesics|mesh-ancestor
25687955|NCT01939158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257857|NCT02474654|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24929535|NCT04111302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24929536|NCT04111302|Narcotics|narcotics|mesh-ancestor
24929537|NCT04111302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24929538|NCT04111302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929539|NCT04111302|Analgesics|analgesics|mesh-ancestor
24929540|NCT04111302|Sensory System Agents|sensory system agents|mesh-ancestor
25101046|NCT03177824|Sildenafil Citrate|sildenafil citrate|mesh-list
24929541|NCT04111302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24929548|NCT04111848|Ketamine|ketamine|mesh-list
24929563|NCT04111367|Antiviral Agents|antiviral agents|mesh-ancestor
24929564|NCT04111367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24929565|NCT04111003|Anesthetics|anesthetics|mesh-list
24929566|NCT04111003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24929567|NCT04111003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929568|NCT04110665|Acetaminophen|acetaminophen|mesh-list
24929569|NCT04110665|Morphine|morphine|mesh-list
24597634|NCT00950404|Sildenafil Citrate|sildenafil citrate|mesh-list
24597635|NCT00950404|Vasodilator Agents|vasodilator agents|mesh-ancestor
25031251|NCT03589027|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25031252|NCT03589027|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25031253|NCT03589027|Protease Inhibitors|protease inhibitors|mesh-ancestor
25113505|NCT02723955|Gemcitabine|gemcitabine|mesh-list
25113506|NCT02723955|Paclitaxel|paclitaxel|mesh-list
24597680|NCT00950794|Autonomic Agents|autonomic agents|mesh-ancestor
24597681|NCT00950794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25031307|NCT03588715|Interferon alpha-2|interferon alpha-2|mesh-list
25031308|NCT03588715|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25031309|NCT03588715|Antibodies, Blocking|antibodies, blocking|mesh-list
25031310|NCT03588715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031311|NCT03588715|Antiviral Agents|antiviral agents|mesh-ancestor
25031315|NCT03588689|Ropivacaine|ropivacaine|mesh-list
25031376|NCT03588338|Acetaminophen|acetaminophen|mesh-list
25031377|NCT03588338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25031378|NCT03588338|Analgesics|analgesics|mesh-ancestor
25031379|NCT03588338|Sensory System Agents|sensory system agents|mesh-ancestor
25031380|NCT03588338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25031381|NCT03588338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031382|NCT03588338|Antipyretics|antipyretics|mesh-ancestor
25031383|NCT03588273|Amoxicillin|amoxicillin|mesh-list
25031384|NCT03588273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25031385|NCT03588273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25031386|NCT03588091|Docetaxel|docetaxel|mesh-list
25031387|NCT03588091|Trastuzumab|trastuzumab|mesh-list
25031388|NCT03588091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031389|NCT03588091|Tubulin Modulators|tubulin modulators|mesh-ancestor
25031390|NCT03588091|Antimitotic Agents|antimitotic agents|mesh-ancestor
25031391|NCT03588091|Mitosis Modulators|mitosis modulators|mesh-ancestor
25031392|NCT03588091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031393|NCT03588091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25031394|NCT03588078|Azacitidine|azacitidine|mesh-list
25257858|NCT02474654|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25257859|NCT02474654|Anesthetics, General|anesthetics, general|mesh-ancestor
25257860|NCT02474654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25257861|NCT02474654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25257862|NCT02474654|Adrenergic Agents|adrenergic agents|mesh-ancestor
25257863|NCT02474654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25257864|NCT02474654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257865|NCT02474654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25257866|NCT02474654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25257867|NCT02474654|Autonomic Agents|autonomic agents|mesh-ancestor
25257868|NCT02474654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25257869|NCT02474654|Respiratory System Agents|respiratory system agents|mesh-ancestor
25257871|NCT02474654|Sympathomimetics|sympathomimetics|mesh-ancestor
25257872|NCT02474654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25257873|NCT02474654|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25257874|NCT02474654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25257875|NCT02474654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25257876|NCT02474654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25257877|NCT02474654|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25257878|NCT02474654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257879|NCT02474706|Imipenem|imipenem|mesh-list
24929571|NCT04110665|Tramadol|tramadol|mesh-list
24929572|NCT04110665|Nefopam|nefopam|mesh-list
24929573|NCT04110665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24929574|NCT04110665|Narcotics|narcotics|mesh-ancestor
24929575|NCT04110665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24929576|NCT04110665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929577|NCT04110665|Analgesics|analgesics|mesh-ancestor
24929578|NCT04110665|Sensory System Agents|sensory system agents|mesh-ancestor
24929579|NCT04110665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24929580|NCT04110665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24929582|NCT04110873|Ubiquinone|ubiquinone|mesh-list
24929583|NCT04110873|Micronutrients|micronutrients|mesh-ancestor
24929584|NCT04110873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929585|NCT04110834|Itraconazole|itraconazole|mesh-list
24929586|NCT04110834|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
24929587|NCT04110834|Antifungal Agents|antifungal agents|mesh-ancestor
24593226|NCT00927537|Telmisartan|telmisartan|mesh-list
24597850|NCT00952094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24597851|NCT00952159|Tramadol|tramadol|mesh-list
25031433|NCT03587662|Antiviral Agents|antiviral agents|mesh-ancestor
25031434|NCT03587662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25031435|NCT03587662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25031436|NCT03587662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25031437|NCT03587662|Immunologic Factors|immunologic factors|mesh-ancestor
25031438|NCT03587662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031439|NCT03587662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25031448|NCT03587558|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25031449|NCT03587558|Adrenergic Agents|adrenergic agents|mesh-ancestor
25031450|NCT03587558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25031452|NCT03587558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988282|NCT03513250|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24988283|NCT03513250|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24988285|NCT03513250|Autonomic Agents|autonomic agents|mesh-ancestor
24988286|NCT03513250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24988287|NCT03513250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988288|NCT03513250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24988289|NCT03513250|Mydriatics|mydriatics|mesh-ancestor
25031525|NCT03587194|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25031526|NCT03587194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25031527|NCT03587194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25031528|NCT03587194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031529|NCT03587129|Apatinib|apatinib|mesh-list
25031530|NCT03587129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031531|NCT03587129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25031532|NCT03587129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25031533|NCT03587129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031534|NCT03587077|Isosorbide|isosorbide|mesh-list
25031535|NCT03587077|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25031536|NCT03587077|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25031537|NCT03587077|Misoprostol|misoprostol|mesh-list
25031538|NCT03587077|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25031539|NCT03587077|Abortifacient Agents|abortifacient agents|mesh-ancestor
25031540|NCT03587077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25031541|NCT03587077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031542|NCT03587077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25031543|NCT03587077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25257880|NCT02474706|Cefoxitin|cefoxitin|mesh-list
25257881|NCT02474706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25257882|NCT02474706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25257883|NCT02474810|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25257884|NCT02474810|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25257885|NCT02474810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25257886|NCT02474810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257887|NCT02474563|Prednisone|prednisone|mesh-list
25257888|NCT02474563|Bortezomib|bortezomib|mesh-list
25257889|NCT02474563|Melphalan|melphalan|mesh-list
25257890|NCT02474563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25257891|NCT02474563|Glucocorticoids|glucocorticoids|mesh-ancestor
25257892|NCT02474563|Hormones|hormones|mesh-ancestor
25257893|NCT02474563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25257894|NCT02474563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257895|NCT02474563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25257896|NCT02474563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929588|NCT04110834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24929589|NCT04110834|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25155505|NCT05353140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24929590|NCT04110834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24929591|NCT04110834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24929593|NCT04110834|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24929599|NCT04110860|Antifungal Agents|antifungal agents|mesh-ancestor
24929600|NCT04110860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24929601|NCT04110860|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24929602|NCT04110860|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24929603|NCT04110860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24929604|NCT04110860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929605|NCT04110860|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24929606|NCT04110860|Hormone Antagonists|hormone antagonists|mesh-ancestor
24929607|NCT04110860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24929608|NCT04110860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929609|NCT04110860|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24929611|NCT04110808|Antihypertensive Agents|antihypertensive agents|mesh-list
24929612|NCT04110808|Nitroglycerin|nitroglycerin|mesh-list
24929613|NCT04110808|Anesthetics|anesthetics|mesh-list
24929614|NCT04110808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24929615|NCT04110808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929616|NCT04110808|Vasodilator Agents|vasodilator agents|mesh-ancestor
24929617|NCT04110808|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24929618|NCT04110808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24929629|NCT04111380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929631|NCT04111289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24528432|NCT00621101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24528433|NCT00621101|Immunologic Factors|immunologic factors|mesh-ancestor
24528434|NCT00621101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257897|NCT02474563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25257898|NCT02474563|Alkylating Agents|alkylating agents|mesh-ancestor
25257899|NCT02474563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257900|NCT02474563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25257901|NCT02474563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25257902|NCT02474563|Immunologic Factors|immunologic factors|mesh-ancestor
25257903|NCT02474511|Anesthetics|anesthetics|mesh-list
25257904|NCT02474511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25257905|NCT02474511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257906|NCT02474628|Calcium Carbonate|calcium carbonate|mesh-list
25257907|NCT02474628|Calcium|calcium|mesh-list
25257908|NCT02474628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25257909|NCT02474628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257910|NCT02474628|Antacids|antacids|mesh-ancestor
25257911|NCT02474628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257912|NCT02474628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25257913|NCT02474433|Misoprostol|misoprostol|mesh-list
25257914|NCT02474433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25257915|NCT02474433|Abortifacient Agents|abortifacient agents|mesh-ancestor
25257916|NCT02474433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25257917|NCT02474433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257918|NCT02474433|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25257919|NCT02474433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25257920|NCT02474433|Oxytocics|oxytocics|mesh-ancestor
25275061|NCT02374567|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25275062|NCT02374567|GABA Agonists|gaba agonists|mesh-ancestor
25275063|NCT02374567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25275064|NCT02374567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25275065|NCT02374567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25275066|NCT02374567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25275067|NCT02374567|Adrenergic Agents|adrenergic agents|mesh-ancestor
25275068|NCT02374567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25275069|NCT02374567|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25275070|NCT02374567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25275071|NCT02374567|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25275072|NCT02374567|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25275073|NCT02374567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24929635|NCT04110535|Midazolam|midazolam|mesh-list
24929636|NCT04110535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24929637|NCT04110535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24929638|NCT04110535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24929639|NCT04110535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929640|NCT04110535|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24929641|NCT04110535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24624782|NCT01078610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24624783|NCT01078714|Bumetanide|bumetanide|mesh-list
24624784|NCT01078714|Diuretics|diuretics|mesh-ancestor
24624785|NCT01078714|Natriuretic Agents|natriuretic agents|mesh-ancestor
24624786|NCT01078714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624787|NCT01078714|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24624788|NCT01078714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24624789|NCT01078714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624790|NCT01078779|Chloroquine|chloroquine|mesh-list
24624791|NCT01078779|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24624792|NCT01078779|Amebicides|amebicides|mesh-ancestor
24624793|NCT01078779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24624794|NCT01078779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24624795|NCT01078779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24624796|NCT01078779|Antimalarials|antimalarials|mesh-ancestor
24624797|NCT01078779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24624798|NCT01078779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24624799|NCT01078779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24624800|NCT01078779|Analgesics|analgesics|mesh-ancestor
24624801|NCT01078779|Sensory System Agents|sensory system agents|mesh-ancestor
24624802|NCT01078779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24624803|NCT01078779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624804|NCT01078779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24528436|NCT00621101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24528437|NCT00621101|Antimetabolites|antimetabolites|mesh-ancestor
25031544|NCT03587077|Oxytocics|oxytocics|mesh-ancestor
25031545|NCT03587077|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25031546|NCT03587077|Diuretics|diuretics|mesh-ancestor
25031547|NCT03587077|Natriuretic Agents|natriuretic agents|mesh-ancestor
25031548|NCT03587077|Vasodilator Agents|vasodilator agents|mesh-ancestor
25031549|NCT03587077|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25031550|NCT03587077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031551|NCT03587025|Amitriptyline|amitriptyline|mesh-list
25031572|NCT03586947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25031573|NCT03586947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25031574|NCT03586934|Acetaminophen|acetaminophen|mesh-list
25102764|NCT03166787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257921|NCT02474303|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25257922|NCT02474303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25257923|NCT02474303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25257924|NCT02474303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257925|NCT02474303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257926|NCT02474303|Antiviral Agents|antiviral agents|mesh-ancestor
25257927|NCT02474303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25257928|NCT02474303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25257929|NCT02474303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25257930|NCT02474290|Sorafenib|sorafenib|mesh-list
25257931|NCT02474290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25257932|NCT02474290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25257933|NCT02474290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257934|NCT02474290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257935|NCT02474212|Enoxaparin|enoxaparin|mesh-list
25257936|NCT02474212|Anticoagulants|anticoagulants|mesh-ancestor
25257937|NCT02474212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25257938|NCT02474212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25257939|NCT02474212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257940|NCT02474225|Bevacizumab|bevacizumab|mesh-list
25257941|NCT02474225|Ranibizumab|ranibizumab|mesh-list
25257942|NCT02474225|Endothelial Growth Factors|endothelial growth factors|mesh-list
25257943|NCT02474225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25257944|NCT02474225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25257945|NCT02474225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25257946|NCT02474225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25257947|NCT02474225|Growth Substances|growth substances|mesh-ancestor
25257948|NCT02474225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257949|NCT02474225|Growth Inhibitors|growth inhibitors|mesh-ancestor
25257950|NCT02474446|Vitamin D|vitamin d|mesh-list
25257951|NCT02474446|Vitamins|vitamins|mesh-ancestor
24528438|NCT00621101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528439|NCT00621101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24528440|NCT00621166|Ritonavir|ritonavir|mesh-list
24528441|NCT00621166|Lopinavir|lopinavir|mesh-list
24528442|NCT00621166|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24624805|NCT01078779|Filaricides|filaricides|mesh-ancestor
24624806|NCT01078779|Antinematodal Agents|antinematodal agents|mesh-ancestor
24624807|NCT01078779|Anthelmintics|anthelmintics|mesh-ancestor
24624808|NCT01078818|Ferrous fumarate|ferrous fumarate|mesh-list
24624809|NCT01078818|Trace Elements|trace elements|mesh-ancestor
24624810|NCT01078818|Micronutrients|micronutrients|mesh-ancestor
24753483|NCT01715597|Vitamins|vitamins|mesh-ancestor
24624811|NCT01078818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624812|NCT01078870|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24624813|NCT01078870|Citalopram|citalopram|mesh-list
24929649|NCT04110535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929651|NCT04110418|Methylene Blue|methylene blue|mesh-list
24929652|NCT04110418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24929653|NCT04110418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929654|NCT04110418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24929655|NCT04110418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25031575|NCT03586934|Celecoxib|celecoxib|mesh-list
25031576|NCT03586934|Ketorolac|ketorolac|mesh-list
25031646|NCT03586817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25031647|NCT03586817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25031648|NCT03586817|Serotonin Agents|serotonin agents|mesh-ancestor
25031649|NCT03586817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25031650|NCT03586817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031651|NCT03586817|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25031652|NCT03586791|Anesthetics|anesthetics|mesh-list
25031653|NCT03586791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25031654|NCT03586791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031708|NCT03586154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25031831|NCT03585673|Oxaliplatin|oxaliplatin|mesh-list
25031832|NCT03585673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031833|NCT03585673|Tubulin Modulators|tubulin modulators|mesh-ancestor
25031834|NCT03585673|Antimitotic Agents|antimitotic agents|mesh-ancestor
25031835|NCT03585673|Mitosis Modulators|mitosis modulators|mesh-ancestor
25031836|NCT03585673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031837|NCT03585569|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25031838|NCT03585569|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25031839|NCT03585569|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25031840|NCT03585569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25031841|NCT03585569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031842|NCT03585569|Cholinergic Agents|cholinergic agents|mesh-ancestor
25031843|NCT03585569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25031844|NCT03585569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031845|NCT03585569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25031846|NCT03585569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25257952|NCT02474446|Micronutrients|micronutrients|mesh-ancestor
25257953|NCT02474446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257954|NCT02474446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25257955|NCT02474316|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25257956|NCT02474316|Antiviral Agents|antiviral agents|mesh-ancestor
25257957|NCT02474316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25257958|NCT02474420|Amlodipine|amlodipine|mesh-list
25257959|NCT02474420|Deferasirox|deferasirox|mesh-list
25257960|NCT02474420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25257961|NCT02474420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25257962|NCT02474420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25257963|NCT02474420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257964|NCT02474420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25257965|NCT02474420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257966|NCT02474420|Vasodilator Agents|vasodilator agents|mesh-ancestor
25257967|NCT02474420|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25257968|NCT02474420|Chelating Agents|chelating agents|mesh-ancestor
25257969|NCT02474420|Sequestering Agents|sequestering agents|mesh-ancestor
25257970|NCT02474134|Interferons|interferons|mesh-list
24929656|NCT04110587|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24929657|NCT04110587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24929659|NCT04110587|Hyaluronic Acid|hyaluronic acid|mesh-list
24929660|NCT04110587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24929661|NCT04110587|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24929662|NCT04110587|Immunologic Factors|immunologic factors|mesh-ancestor
24929663|NCT04110587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929664|NCT04110587|Viscosupplements|viscosupplements|mesh-ancestor
24528443|NCT00621166|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24528444|NCT00621166|Protease Inhibitors|protease inhibitors|mesh-ancestor
24528445|NCT00621166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528446|NCT00621166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929665|NCT04110587|Protective Agents|protective agents|mesh-ancestor
24929666|NCT04110587|Sensory System Agents|sensory system agents|mesh-ancestor
24929667|NCT04110587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24929668|NCT04110132|Bupivacaine|bupivacaine|mesh-list
25687956|NCT01939197|Ritonavir|ritonavir|mesh-list
24929669|NCT04110132|Anesthetics, Local|anesthetics, local|mesh-ancestor
24929670|NCT04110132|Anesthetics|anesthetics|mesh-ancestor
24929671|NCT04110132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24929672|NCT04110132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929673|NCT04110132|Sensory System Agents|sensory system agents|mesh-ancestor
24929674|NCT04110132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24929675|NCT04110028|Niacinamide|niacinamide|mesh-list
24929676|NCT04110028|Niacin|niacin|mesh-list
24929677|NCT04110028|Nicotinic Acids|nicotinic acids|mesh-list
25257974|NCT02474134|Antiviral Agents|antiviral agents|mesh-ancestor
25257975|NCT02474134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25257976|NCT02474134|Immunologic Factors|immunologic factors|mesh-ancestor
25257977|NCT02474134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25257978|NCT02474134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25257979|NCT02474186|Paclitaxel|paclitaxel|mesh-list
25257980|NCT02474186|Docetaxel|docetaxel|mesh-list
25257981|NCT02474186|Capecitabine|capecitabine|mesh-list
25257982|NCT02474186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25257983|NCT02474186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25257984|NCT02474186|Tubulin Modulators|tubulin modulators|mesh-ancestor
25257985|NCT02474186|Antimitotic Agents|antimitotic agents|mesh-ancestor
25257986|NCT02474186|Mitosis Modulators|mitosis modulators|mesh-ancestor
25257987|NCT02474186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257988|NCT02474186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25257989|NCT02474186|Antimetabolites|antimetabolites|mesh-ancestor
25257990|NCT02473900|Oseltamivir|oseltamivir|mesh-list
25257991|NCT02473900|Antiviral Agents|antiviral agents|mesh-ancestor
25257992|NCT02473900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25257993|NCT02473900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25257994|NCT02473900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25257995|NCT02473887|Ondansetron|ondansetron|mesh-list
25257996|NCT02473887|Antiemetics|antiemetics|mesh-ancestor
25257997|NCT02473887|Autonomic Agents|autonomic agents|mesh-ancestor
25257998|NCT02473887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25257999|NCT02473887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258000|NCT02473887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25258001|NCT02473887|Antipruritics|antipruritics|mesh-ancestor
25258002|NCT02473887|Dermatologic Agents|dermatologic agents|mesh-ancestor
25258003|NCT02473887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25258004|NCT02473887|Serotonin Agents|serotonin agents|mesh-ancestor
25258005|NCT02473887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25258006|NCT02473887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258007|NCT02473887|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25258008|NCT02473887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24528527|NCT00621452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25031848|NCT03585556|Ranibizumab|ranibizumab|mesh-list
25031849|NCT03585556|Aflibercept|aflibercept|mesh-list
25031850|NCT03585556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031851|NCT03585556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25031852|NCT03585556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24598322|NCT00955240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598323|NCT00955240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24598325|NCT00955240|Immunologic Factors|immunologic factors|mesh-ancestor
24598326|NCT00955240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598327|NCT00955240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24598328|NCT00955318|Apomorphine|apomorphine|mesh-list
25113603|NCT02477202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25113605|NCT02477202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25113606|NCT02477202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988629|NCT02143063|Anesthetics|anesthetics|mesh-ancestor
25113607|NCT02477202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25031900|NCT03585179|Tranexamic Acid|tranexamic acid|mesh-list
25031902|NCT03585179|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25031903|NCT03585179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25031904|NCT03585179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031905|NCT03585179|Hemostatics|hemostatics|mesh-ancestor
25031923|NCT03585140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031940|NCT03585036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25031942|NCT03585036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25031943|NCT03585036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031945|NCT03585036|Sensory System Agents|sensory system agents|mesh-ancestor
25031946|NCT03585036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25031947|NCT03585036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25031948|NCT03585036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25031949|NCT03585036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25031950|NCT03585036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25031951|NCT03584984|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
25031952|NCT03584984|Hemostatics|hemostatics|mesh-ancestor
25031953|NCT03584984|Coagulants|coagulants|mesh-ancestor
25031954|NCT03584919|Doxycycline|doxycycline|mesh-list
25031955|NCT03584919|Cefuroxime|cefuroxime|mesh-list
25031956|NCT03584919|Cefuroxime axetil|cefuroxime axetil|mesh-list
25031957|NCT03584919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25031958|NCT03584919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25031959|NCT03584919|Antimalarials|antimalarials|mesh-ancestor
25031960|NCT03584919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25031961|NCT03584919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25031962|NCT03584893|Dehydrocholesterols|dehydrocholesterols|mesh-list
25031963|NCT03584893|Provitamins|provitamins|mesh-ancestor
25031964|NCT03584893|Vitamins|vitamins|mesh-ancestor
25031965|NCT03584893|Micronutrients|micronutrients|mesh-ancestor
25031966|NCT03584893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031967|NCT03584854|Methylergonovine|methylergonovine|mesh-list
25031968|NCT03584854|Carboprost|carboprost|mesh-list
25031969|NCT03584854|Dinoprost|dinoprost|mesh-list
25031970|NCT03584854|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
24598488|NCT00956267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598489|NCT00956267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24598490|NCT00956267|Hormone Antagonists|hormone antagonists|mesh-ancestor
24598492|NCT00956267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258009|NCT02473887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25258010|NCT02473887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25258011|NCT02473887|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25258012|NCT02473809|Liraglutide|liraglutide|mesh-list
25258013|NCT02473809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25258014|NCT02473809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258015|NCT02473809|Incretins|incretins|mesh-ancestor
25258016|NCT02473809|Hormones|hormones|mesh-ancestor
25258017|NCT02473809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25258018|NCT02473562|Varenicline|varenicline|mesh-list
24929683|NCT04110028|Antimetabolites|antimetabolites|mesh-ancestor
24929684|NCT04110028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929685|NCT04110028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24929686|NCT04110028|Vasodilator Agents|vasodilator agents|mesh-ancestor
24929687|NCT04110210|Morphine|morphine|mesh-list
24929688|NCT04110210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24929689|NCT04110210|Narcotics|narcotics|mesh-ancestor
24929690|NCT04110210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24929691|NCT04110210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929692|NCT04110210|Analgesics|analgesics|mesh-ancestor
24929693|NCT04110210|Sensory System Agents|sensory system agents|mesh-ancestor
25079786|NCT03345004|Vitamin D|vitamin d|mesh-list
24929694|NCT04110210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24929740|NCT04110119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24929741|NCT04110119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24929742|NCT04110119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24929743|NCT04110119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929744|NCT04109872|Lenalidomide|lenalidomide|mesh-list
24929745|NCT04109872|Immunologic Factors|immunologic factors|mesh-ancestor
24929746|NCT04109872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929747|NCT04109872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24799416|NCT01969019|Prednisone|prednisone|mesh-list
25031988|NCT03584698|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25031989|NCT03584698|Abortifacient Agents|abortifacient agents|mesh-ancestor
25031990|NCT03584698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25031991|NCT03584698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031992|NCT03584698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25032049|NCT03584360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24898325|NCT04415476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988826|NCT00033293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24988828|NCT00033293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24988829|NCT00033293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24988830|NCT00033293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25032105|NCT03583892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25032106|NCT03583892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032107|NCT03583892|Antimanic Agents|antimanic agents|mesh-ancestor
25032113|NCT03583749|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25032114|NCT03583749|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25032115|NCT03583749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25032116|NCT03583749|Antitubercular Agents|antitubercular agents|mesh-ancestor
25258019|NCT02473562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25258020|NCT02473562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25258021|NCT02473562|Cholinergic Agents|cholinergic agents|mesh-ancestor
25258022|NCT02473562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25258023|NCT02473562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258024|NCT02473562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258025|NCT02473575|Caffeine|caffeine|mesh-list
25258026|NCT02473575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25258027|NCT02473575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258028|NCT02473575|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25258029|NCT02473575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25258030|NCT02473575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258031|NCT02473575|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25258032|NCT02473575|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25258033|NCT02473575|Purinergic Agents|purinergic agents|mesh-ancestor
25258034|NCT02473575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25258035|NCT02473627|Pioglitazone|pioglitazone|mesh-list
25258036|NCT02473627|Tolbutamide|tolbutamide|mesh-list
25258037|NCT02473627|DS-1971a|ds-1971a|mesh-list
24438377|NCT00275652|Antiviral Agents|antiviral agents|mesh-ancestor
25258038|NCT02473627|Midazolam|midazolam|mesh-list
25258039|NCT02473627|Omeprazole|omeprazole|mesh-list
25258040|NCT02473627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25258041|NCT02473627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25258042|NCT02473627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25258043|NCT02473627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258044|NCT02473627|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25258045|NCT02473627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24929748|NCT04109872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24929749|NCT04109872|Growth Substances|growth substances|mesh-ancestor
25032119|NCT03583567|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
25032120|NCT03583567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25032121|NCT03583567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25032122|NCT03583567|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25032123|NCT03583567|Histamine Antagonists|histamine antagonists|mesh-ancestor
24598655|NCT00957177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24598656|NCT00957177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24598657|NCT00957190|Timolol|timolol|mesh-list
24598658|NCT00957190|Dorzolamide|dorzolamide|mesh-list
24598659|NCT00957190|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24598660|NCT00957190|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25032153|NCT03583476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25032154|NCT03583476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25032155|NCT03583476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25032156|NCT03583476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25032157|NCT03583476|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25032158|NCT03583476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25032159|NCT03583476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032160|NCT03583476|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24598704|NCT00957346|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24598705|NCT00957346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24598706|NCT00957346|Contraceptive Agents|contraceptive agents|mesh-ancestor
24598707|NCT00957346|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24598708|NCT00957346|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25032206|NCT03583229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24598709|NCT00957346|Hormone Antagonists|hormone antagonists|mesh-ancestor
25032264|NCT03582605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25032265|NCT03582605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24598782|NCT00958100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598783|NCT00958100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598784|NCT00958100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25032290|NCT03582280|Calcium Carbonate|calcium carbonate|mesh-list
25032291|NCT03582280|Calcium|calcium|mesh-list
25032292|NCT03582280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25032293|NCT03582280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598838|NCT00958451|Micronutrients|micronutrients|mesh-ancestor
24598839|NCT00958451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25113612|NCT02474173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25113614|NCT02474173|Tubulin Modulators|tubulin modulators|mesh-ancestor
25032440|NCT03580733|Miconazole|miconazole|mesh-list
25032441|NCT03580733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25032442|NCT03580733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25032443|NCT03580733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032444|NCT03580733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25032445|NCT03580733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25032453|NCT03580694|Cemiplimab|cemiplimab|mesh-list
24599128|NCT05178550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753753|NCT01717599|Diclofenac|diclofenac|mesh-list
24599129|NCT05119894|Brexpiprazole|brexpiprazole|mesh-list
24599130|NCT05119894|Serotonin Agents|serotonin agents|mesh-ancestor
24599131|NCT05119894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25032503|NCT03580291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25032504|NCT03580291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25032505|NCT03580291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25032506|NCT03580291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032507|NCT03580239|Everolimus|everolimus|mesh-list
24898397|NCT04414800|Anesthetics|anesthetics|mesh-ancestor
25032565|NCT03579927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032566|NCT03579927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25032567|NCT03579927|Antimetabolites|antimetabolites|mesh-ancestor
25258046|NCT02473627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25258047|NCT02473627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25258048|NCT02473627|Anesthetics, General|anesthetics, general|mesh-ancestor
25258049|NCT02473627|Anesthetics|anesthetics|mesh-ancestor
25258050|NCT02473627|GABA Modulators|gaba modulators|mesh-ancestor
24929753|NCT04109742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24929784|NCT04109534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24929791|NCT04109534|Cholinergic Agents|cholinergic agents|mesh-ancestor
24929792|NCT04109534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24929793|NCT04109534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032568|NCT03579927|Antiviral Agents|antiviral agents|mesh-ancestor
25032569|NCT03579927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25032570|NCT03579927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24599224|NCT04966663|Pemetrexed|pemetrexed|mesh-list
24599225|NCT04966663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599226|NCT04966663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24599227|NCT04966663|Antimetabolites|antimetabolites|mesh-ancestor
25032578|NCT03579927|Antimitotic Agents|antimitotic agents|mesh-ancestor
25032579|NCT03579927|Mitosis Modulators|mitosis modulators|mesh-ancestor
25032580|NCT03579888|Cyclophosphamide|cyclophosphamide|mesh-list
25032581|NCT03579888|Fludarabine|fludarabine|mesh-list
25032582|NCT03579888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24599228|NCT04966663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032583|NCT03579888|Immunologic Factors|immunologic factors|mesh-ancestor
25032584|NCT03579888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032585|NCT03579888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25032586|NCT03579888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25032633|NCT03579784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25032634|NCT03579784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032635|NCT03579784|Tubulin Modulators|tubulin modulators|mesh-ancestor
25032636|NCT03579784|Antimitotic Agents|antimitotic agents|mesh-ancestor
25032637|NCT03579784|Mitosis Modulators|mitosis modulators|mesh-ancestor
25032638|NCT03579784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032639|NCT03579784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25032640|NCT03579784|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24599374|NCT04687800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24599377|NCT04678089|Bortezomib|bortezomib|mesh-list
25032696|NCT03579589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25032697|NCT03579576|Ribavirin|ribavirin|mesh-list
25032698|NCT03579576|Sofosbuvir|sofosbuvir|mesh-list
25032699|NCT03579576|Velpatasvir|velpatasvir|mesh-list
25032700|NCT03579576|Antimetabolites|antimetabolites|mesh-ancestor
25102765|NCT03166787|Protective Agents|protective agents|mesh-ancestor
25032701|NCT03579576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032702|NCT03579576|Antiviral Agents|antiviral agents|mesh-ancestor
25032703|NCT03579576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25113637|NCT02428192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599426|NCT04588948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25113678|NCT02392429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25113679|NCT02392429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25113680|NCT02392429|Immunologic Factors|immunologic factors|mesh-ancestor
25113681|NCT02392429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032748|NCT03578900|Sequestering Agents|sequestering agents|mesh-ancestor
25258051|NCT02473627|GABA Agents|gaba agents|mesh-ancestor
25258052|NCT02473627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25258053|NCT02473627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258054|NCT02473627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25258055|NCT02473627|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25258056|NCT02473627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25258057|NCT02473627|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25258058|NCT02473627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25258059|NCT02473627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25258060|NCT02473627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25258061|NCT02473627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25258062|NCT02473601|Mivacurium|mivacurium|mesh-list
24929794|NCT04108845|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24929796|NCT04108845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929797|NCT04108468|Golimumab|golimumab|mesh-list
24929805|NCT04108468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929807|NCT04108468|Dermatologic Agents|dermatologic agents|mesh-ancestor
24929808|NCT04108468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24929809|NCT04108468|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24929810|NCT04108468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24929811|NCT04108468|Immunologic Factors|immunologic factors|mesh-ancestor
24929823|NCT04108637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24929824|NCT04108637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24929825|NCT04108013|Paclitaxel|paclitaxel|mesh-list
24929826|NCT04108013|Carboplatin|carboplatin|mesh-list
24799453|NCT01969032|Antimetabolites|antimetabolites|mesh-ancestor
25032749|NCT03578900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032751|NCT03578874|Oxaliplatin|oxaliplatin|mesh-list
25032752|NCT03578874|Sorafenib|sorafenib|mesh-list
25032753|NCT03578874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25032754|NCT03578874|Antimetabolites|antimetabolites|mesh-ancestor
25032755|NCT03578874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032756|NCT03578874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032803|NCT03578354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25032805|NCT03578263|Carbetocin|carbetocin|mesh-list
25032806|NCT03578263|Ergonovine|ergonovine|mesh-list
25032807|NCT03578263|Oxytocics|oxytocics|mesh-ancestor
25032808|NCT03578263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25032809|NCT03578263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032810|NCT03578042|Losartan|losartan|mesh-list
25032811|NCT03578042|Amlodipine|amlodipine|mesh-list
25032812|NCT03578042|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25032813|NCT03578042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25032814|NCT03578042|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25032823|NCT03578042|Diuretics|diuretics|mesh-ancestor
25113695|NCT02352948|Gemcitabine|gemcitabine|mesh-list
25032871|NCT03577652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25258063|NCT02473601|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25258064|NCT02473601|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25258065|NCT02473601|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25258066|NCT02473601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25258067|NCT02473601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258068|NCT02473328|Ritonavir|ritonavir|mesh-list
25258069|NCT02473328|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25258070|NCT02473328|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25258071|NCT02473328|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25258072|NCT02473328|Protease Inhibitors|protease inhibitors|mesh-ancestor
25258073|NCT02473328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25258074|NCT02473328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258075|NCT02473328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25258076|NCT02473328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25258077|NCT02473328|Antiviral Agents|antiviral agents|mesh-ancestor
25258078|NCT02473328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25258079|NCT02473328|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25258080|NCT02473328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25258081|NCT02473302|Tocopherols|tocopherols|mesh-list
25258082|NCT02473302|Vitamin E|vitamin e|mesh-list
25258083|NCT02473302|Tocotrienols|tocotrienols|mesh-list
25258084|NCT02473302|alpha-Tocopherol|alpha-tocopherol|mesh-list
25258085|NCT02473302|Antioxidants|antioxidants|mesh-ancestor
24929827|NCT04108013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24929832|NCT04108013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929835|NCT04107896|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24929837|NCT04107896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24929838|NCT04107896|Adrenergic Agents|adrenergic agents|mesh-ancestor
24929839|NCT04107896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24929840|NCT04107896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929841|NCT04107896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929842|NCT04107896|Urological Agents|urological agents|mesh-ancestor
24929843|NCT04107805|Midazolam|midazolam|mesh-list
24929844|NCT04107805|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25404235|NCT03678675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753828|NCT01717963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24929845|NCT04107805|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24929846|NCT04107805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24929847|NCT04107805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929848|NCT04107805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24929849|NCT04107805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24929850|NCT04107805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24929851|NCT04107805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24505913|NCT00543205|Oblimersen|oblimersen|mesh-list
24528531|NCT00621478|Antiemetics|antiemetics|mesh-ancestor
25155506|NCT05353140|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24528532|NCT00621478|Autonomic Agents|autonomic agents|mesh-ancestor
25102521|NCT03168035|NC-4016|nc-4016|mesh-list
24528533|NCT00621478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24528534|NCT00621478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528535|NCT00621478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24528536|NCT00621478|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24799462|NCT01969071|Dobutamine|dobutamine|mesh-list
25032872|NCT03577652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032873|NCT03577652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032874|NCT03577626|Hemay005|hemay005|mesh-list
25032875|NCT03577626|Dermatologic Agents|dermatologic agents|mesh-ancestor
25032876|NCT03577626|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25032877|NCT03577626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25032878|NCT03577626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25032879|NCT03577626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032880|NCT03577574|Anesthetics|anesthetics|mesh-list
24599727|NCT03940729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24898486|NCT04413864|Analgesics|analgesics|mesh-ancestor
25032937|NCT03576820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25032938|NCT03576820|Anesthetics, Local|anesthetics, local|mesh-ancestor
25032939|NCT03576820|Anesthetics|anesthetics|mesh-ancestor
25258086|NCT02473302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258087|NCT02473302|Protective Agents|protective agents|mesh-ancestor
25258088|NCT02473302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258089|NCT02473302|Vitamins|vitamins|mesh-ancestor
25258090|NCT02473302|Micronutrients|micronutrients|mesh-ancestor
25258091|NCT02473406|Thymalfasin|thymalfasin|mesh-list
25258092|NCT02473406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25258093|NCT02473406|Immunologic Factors|immunologic factors|mesh-ancestor
25258094|NCT02473406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258095|NCT02473354|Remifentanil|remifentanil|mesh-list
25258096|NCT02473354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25258097|NCT02473354|Narcotics|narcotics|mesh-ancestor
25258098|NCT02473354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25258099|NCT02473354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258100|NCT02473354|Analgesics|analgesics|mesh-ancestor
25258101|NCT02473354|Sensory System Agents|sensory system agents|mesh-ancestor
25258102|NCT02473354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25258103|NCT02473263|Ceftriaxone|ceftriaxone|mesh-list
25258104|NCT02473263|Tazobactam|tazobactam|mesh-list
25258105|NCT02473263|Piperacillin|piperacillin|mesh-list
25258106|NCT02473263|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25258107|NCT02473263|Hydrocortisone|hydrocortisone|mesh-list
25258108|NCT02473263|Norepinephrine|norepinephrine|mesh-list
25258109|NCT02473263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25258110|NCT02473263|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25258111|NCT02473263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25258112|NCT02473263|Adrenergic Agents|adrenergic agents|mesh-ancestor
25258113|NCT02473263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25258114|NCT02473263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258115|NCT02473263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528537|NCT00621478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24528538|NCT00621478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24528539|NCT00621478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24528540|NCT00621478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24528541|NCT00621478|GABA Modulators|gaba modulators|mesh-ancestor
24528542|NCT00621478|GABA Agents|gaba agents|mesh-ancestor
24528543|NCT00621478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24528544|NCT00621478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929852|NCT04107805|Anesthetics, General|anesthetics, general|mesh-ancestor
24929853|NCT04107805|Anesthetics|anesthetics|mesh-ancestor
24929854|NCT04107805|GABA Modulators|gaba modulators|mesh-ancestor
24929855|NCT04107805|GABA Agents|gaba agents|mesh-ancestor
25687957|NCT01939197|Ribavirin|ribavirin|mesh-list
25687958|NCT01939197|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24929856|NCT04107805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24929857|NCT04107805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929858|NCT04107740|TA 0910|ta 0910|mesh-list
24929859|NCT04107740|Nootropic Agents|nootropic agents|mesh-ancestor
24929860|NCT04107428|Somatostatin|somatostatin|mesh-list
24929861|NCT04107428|Hormones|hormones|mesh-ancestor
24929862|NCT04107428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24929863|NCT04107428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929864|NCT04107779|Menthol|menthol|mesh-list
24929865|NCT04107779|Nicotine|nicotine|mesh-list
24929866|NCT04107779|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24929867|NCT04107779|Autonomic Agents|autonomic agents|mesh-ancestor
24929868|NCT04107779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24929869|NCT04107779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929870|NCT04107779|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24929871|NCT04107779|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24799497|NCT01969227|Anesthetics|anesthetics|mesh-ancestor
25032942|NCT03576820|Sensory System Agents|sensory system agents|mesh-ancestor
25032980|NCT03576664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25032981|NCT03576664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25032982|NCT03576664|Adrenergic Agents|adrenergic agents|mesh-ancestor
25032983|NCT03576664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25032984|NCT03576664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032985|NCT03576664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032986|NCT03576664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25032987|NCT03576664|Antioxidants|antioxidants|mesh-ancestor
25032988|NCT03576664|Protective Agents|protective agents|mesh-ancestor
25032989|NCT03576664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24599768|NCT03913559|Autonomic Agents|autonomic agents|mesh-ancestor
24588221|NCT00901550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24588222|NCT00901550|Immunologic Factors|immunologic factors|mesh-ancestor
24599816|NCT03824561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24599817|NCT03741101|Trametinib|trametinib|mesh-list
24599818|NCT03741101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588223|NCT00901550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25258116|NCT02473263|Sympathomimetics|sympathomimetics|mesh-ancestor
25258117|NCT02473263|Autonomic Agents|autonomic agents|mesh-ancestor
25258118|NCT02473263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25258119|NCT02473263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25258120|NCT02473263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25258121|NCT02473263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25258122|NCT02473263|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25258123|NCT02473263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25258124|NCT02473237|Tiotropium Bromide|tiotropium bromide|mesh-list
25258125|NCT02473237|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25258126|NCT02473237|Autonomic Agents|autonomic agents|mesh-ancestor
25258127|NCT02473237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25258128|NCT02473237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258129|NCT02473237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25258130|NCT02473237|Respiratory System Agents|respiratory system agents|mesh-ancestor
25258131|NCT02473237|Parasympatholytics|parasympatholytics|mesh-ancestor
25258132|NCT02473237|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25258133|NCT02473237|Cholinergic Agents|cholinergic agents|mesh-ancestor
25258134|NCT02473237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25258135|NCT02473237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258136|NCT02473211|Sofosbuvir|sofosbuvir|mesh-list
25258137|NCT02473211|Antiviral Agents|antiviral agents|mesh-ancestor
25258138|NCT02473211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25258139|NCT02473185|Methylphenidate|methylphenidate|mesh-list
25258140|NCT02473185|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25258141|NCT02473185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258142|NCT02473185|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25258143|NCT02473185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24929872|NCT04107779|Cholinergic Agents|cholinergic agents|mesh-ancestor
25102692|NCT03167112|Protective Agents|protective agents|mesh-ancestor
24929873|NCT04107779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24929874|NCT04107779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929875|NCT04107779|Antipruritics|antipruritics|mesh-ancestor
24929876|NCT04107779|Dermatologic Agents|dermatologic agents|mesh-ancestor
24929877|NCT04107480|Dopamine|dopamine|mesh-list
24929879|NCT04107480|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24929880|NCT04107480|Sympathomimetics|sympathomimetics|mesh-ancestor
24528545|NCT00621478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24528546|NCT00621478|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24528547|NCT00621478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24929882|NCT04107480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24929883|NCT04107480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929884|NCT04107480|Dopamine Agents|dopamine agents|mesh-ancestor
24929885|NCT04107480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24978728|NCT03106415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929886|NCT04107480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929887|NCT04107480|Protective Agents|protective agents|mesh-ancestor
24929888|NCT04106999|Dexmedetomidine|dexmedetomidine|mesh-list
24929889|NCT04106999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24929890|NCT04106999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24929891|NCT04106999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929892|NCT04106999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24929893|NCT04106999|Analgesics|analgesics|mesh-ancestor
24929894|NCT04106999|Sensory System Agents|sensory system agents|mesh-ancestor
24929895|NCT04106999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24929896|NCT04106999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24929897|NCT04106999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24929898|NCT04106999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24929899|NCT04106999|Adrenergic Agents|adrenergic agents|mesh-ancestor
24929900|NCT04106999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24929901|NCT04106999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929902|NCT04107194|Amoxicillin|amoxicillin|mesh-list
24929903|NCT04107194|Metronidazole|metronidazole|mesh-list
24929904|NCT04107194|Clarithromycin|clarithromycin|mesh-list
25258144|NCT02473185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25258145|NCT02473185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258146|NCT02473185|Dopamine Agents|dopamine agents|mesh-ancestor
25258147|NCT02473185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25258148|NCT02473198|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25258149|NCT02473198|Morphine|morphine|mesh-list
25258150|NCT02473198|Bupivacaine|bupivacaine|mesh-list
25258151|NCT02473198|Anesthetics, Local|anesthetics, local|mesh-ancestor
25258152|NCT02473198|Anesthetics|anesthetics|mesh-ancestor
25258153|NCT02473198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25258154|NCT02473198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258155|NCT02473198|Sensory System Agents|sensory system agents|mesh-ancestor
25258156|NCT02473198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25258157|NCT02473198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25258158|NCT02473198|Narcotics|narcotics|mesh-ancestor
25258159|NCT02473198|Analgesics|analgesics|mesh-ancestor
25258160|NCT02473198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25258161|NCT02473198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25258162|NCT02473198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25258163|NCT02473198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25258164|NCT02473198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25258165|NCT02473198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25258166|NCT02473198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258167|NCT02473146|Gemtuzumab|gemtuzumab|mesh-list
25258168|NCT02473146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25258169|NCT02473146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25258170|NCT02472873|Ethanol|ethanol|mesh-list
25258171|NCT02472873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25258172|NCT02472873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25258173|NCT02472873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25258174|NCT02472873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258175|NCT02473094|Metformin|metformin|mesh-list
25258176|NCT02473094|Capecitabine|capecitabine|mesh-list
25258177|NCT02473094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25258178|NCT02473094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258179|NCT02473094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25258180|NCT02473094|Antimetabolites|antimetabolites|mesh-ancestor
24929905|NCT04107194|Levofloxacin|levofloxacin|mesh-list
24929906|NCT04107194|Tetracycline|tetracycline|mesh-list
24929907|NCT04107194|Rifabutin|rifabutin|mesh-list
24929908|NCT04107194|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
24929909|NCT04107194|Pantoprazole|pantoprazole|mesh-list
24929910|NCT04107194|Bismuth|bismuth|mesh-list
24929911|NCT04107194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24929912|NCT04107194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24528554|NCT00621556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24528555|NCT00621556|Hormones|hormones|mesh-ancestor
24528556|NCT00621556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24528557|NCT00621556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528558|NCT00621647|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24929913|NCT04107194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24406044|NCT00169039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24929924|NCT04107194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929925|NCT04107194|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24929926|NCT04107194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24929927|NCT04107194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24929928|NCT04107194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24929929|NCT04107194|Antacids|antacids|mesh-ancestor
24929930|NCT04107194|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24929931|NCT04107194|Antitubercular Agents|antitubercular agents|mesh-ancestor
24929932|NCT04107220|Valsartan|valsartan|mesh-list
24929933|NCT04107220|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24929934|NCT04107220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24929935|NCT04107220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24929936|NCT04107220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24929937|NCT04107220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588224|NCT00901550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24588225|NCT00901550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24588227|NCT00901615|Immunologic Factors|immunologic factors|mesh-ancestor
25258181|NCT02473094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258182|NCT02473094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25258183|NCT02472938|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25258184|NCT02472938|Dermatologic Agents|dermatologic agents|mesh-ancestor
25258185|NCT02472938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25258186|NCT02472938|Immunologic Factors|immunologic factors|mesh-ancestor
25258187|NCT02472938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258188|NCT02472782|Teriparatide|teriparatide|mesh-list
25258189|NCT02472782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25258190|NCT02472782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258191|NCT02472782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25258192|NCT02472717|Liraglutide|liraglutide|mesh-list
25258193|NCT02472717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25258194|NCT02472717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258195|NCT02472717|Incretins|incretins|mesh-ancestor
25258196|NCT02472717|Hormones|hormones|mesh-ancestor
25258197|NCT02472717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25258198|NCT02472691|Lenalidomide|lenalidomide|mesh-list
25258199|NCT02472691|Azacitidine|azacitidine|mesh-list
25258200|NCT02472691|Immunologic Factors|immunologic factors|mesh-ancestor
25258201|NCT02472691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780498|NCT01884623|Antimetabolites|antimetabolites|mesh-ancestor
25258202|NCT02472691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25258203|NCT02472691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25258204|NCT02472691|Growth Substances|growth substances|mesh-ancestor
25258205|NCT02472691|Growth Inhibitors|growth inhibitors|mesh-ancestor
25258206|NCT02472691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25258207|NCT02472691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25258208|NCT02472691|Antimetabolites|antimetabolites|mesh-ancestor
25258209|NCT02472691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258210|NCT02472691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25258211|NCT02472613|Fluoxetine|fluoxetine|mesh-list
25258212|NCT02472613|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25258213|NCT02472613|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25258214|NCT02472613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25275074|NCT02374567|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24929939|NCT04107103|Pemetrexed|pemetrexed|mesh-list
24929940|NCT04107103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24506002|NCT00543686|Dermatologic Agents|dermatologic agents|mesh-ancestor
24528596|NCT00621816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528597|NCT00621868|Ipragliflozin|ipragliflozin|mesh-list
24528598|NCT00621868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25258264|NCT02472626|Vitamins|vitamins|mesh-ancestor
24528599|NCT00621868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528600|NCT00621868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24528601|NCT00621868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528605|NCT00621907|Levobupivacaine|levobupivacaine|mesh-list
24528606|NCT00621907|Anesthetics, Local|anesthetics, local|mesh-ancestor
24929941|NCT04107103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929942|NCT04107103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24929943|NCT04107103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929944|NCT04107103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24929945|NCT04107103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24929946|NCT04107103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24929996|NCT04106557|GABA Agonists|gaba agonists|mesh-ancestor
24929997|NCT04106557|GABA Agents|gaba agents|mesh-ancestor
24929998|NCT04106557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24930012|NCT04106362|Cisplatin|cisplatin|mesh-list
24930013|NCT04106362|Cetuximab|cetuximab|mesh-list
24930014|NCT04106362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24930015|NCT04106362|Antibodies|antibodies|mesh-list
24930016|NCT04106362|Immunoglobulins|immunoglobulins|mesh-list
24930017|NCT04106362|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24930018|NCT04106362|Immunologic Factors|immunologic factors|mesh-ancestor
24930019|NCT04106362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258215|NCT02472613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258216|NCT02472613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25258217|NCT02472613|Serotonin Agents|serotonin agents|mesh-ancestor
25258218|NCT02472613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258219|NCT02472613|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25258220|NCT02472613|Antidepressive Agents|antidepressive agents|mesh-ancestor
25258221|NCT02472613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25258222|NCT02472613|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25258223|NCT02472613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25258224|NCT02472613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25258225|NCT02472509|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25258226|NCT02472509|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25258227|NCT02472509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25275075|NCT02374567|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25275076|NCT02374567|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25275077|NCT02374567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25275078|NCT02374567|GABA Antagonists|gaba antagonists|mesh-ancestor
25275079|NCT02374567|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25275080|NCT02374567|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25275081|NCT02374567|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25275082|NCT02374567|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25275083|NCT02374567|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25275084|NCT02374567|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25275085|NCT02374567|Vasodilator Agents|vasodilator agents|mesh-ancestor
25275682|NCT02370433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25275683|NCT02370069|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25275684|NCT02370069|Immunologic Factors|immunologic factors|mesh-ancestor
25275685|NCT02370069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275686|NCT02369978|Benzonidazole|benzonidazole|mesh-list
25275687|NCT02369978|Nifurtimox|nifurtimox|mesh-list
25275688|NCT02369978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25275689|NCT02369978|Immunologic Factors|immunologic factors|mesh-ancestor
25275690|NCT02369978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275691|NCT02369978|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25275692|NCT02369978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25275693|NCT02369978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24930022|NCT04105985|Tetracaine|tetracaine|mesh-list
24930023|NCT04105985|Carticaine|carticaine|mesh-list
24930024|NCT04105985|Anesthetics, Local|anesthetics, local|mesh-ancestor
24930025|NCT04105985|Anesthetics|anesthetics|mesh-ancestor
24930026|NCT04105985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24761884|NCT01765023|Metformin|metformin|mesh-list
24930027|NCT04105985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930028|NCT04105985|Sensory System Agents|sensory system agents|mesh-ancestor
24930029|NCT04105985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24930030|NCT04105985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24930031|NCT04105985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24930032|NCT04105985|Adrenergic Agents|adrenergic agents|mesh-ancestor
24930034|NCT04105985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930038|NCT04105985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24930039|NCT04105985|Respiratory System Agents|respiratory system agents|mesh-ancestor
24930040|NCT04106011|Gabapentin|gabapentin|mesh-list
24930041|NCT04106011|Analgesics|analgesics|mesh-ancestor
24930043|NCT04106011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24624815|NCT01078870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24624816|NCT01078870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24588228|NCT00901615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588229|NCT00901615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24588230|NCT00901615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24588232|NCT00901615|Growth Inhibitors|growth inhibitors|mesh-ancestor
24588233|NCT00901615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588234|NCT00901654|Vaccines|vaccines|mesh-list
24588235|NCT00901654|Immunologic Factors|immunologic factors|mesh-ancestor
25033112|NCT03576378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25033113|NCT03576378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25033114|NCT03576378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25033117|NCT03576378|Sensory System Agents|sensory system agents|mesh-ancestor
25033118|NCT03576378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25033119|NCT03576287|Apremilast|apremilast|mesh-list
25033120|NCT03576287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25103145|NCT03163914|Mydriatics|mydriatics|mesh-ancestor
25033121|NCT03576287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25033122|NCT03576287|Analgesics|analgesics|mesh-ancestor
25033123|NCT03576287|Sensory System Agents|sensory system agents|mesh-ancestor
25033124|NCT03576287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25033125|NCT03576287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25113754|NCT02278315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25113755|NCT02278315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25113756|NCT02271919|Nicotine|nicotine|mesh-list
25258228|NCT02472600|Colistin|colistin|mesh-list
25258229|NCT02472600|Polymyxins|polymyxins|mesh-list
25258230|NCT02472600|Neomycin|neomycin|mesh-list
25258231|NCT02472600|Omeprazole|omeprazole|mesh-list
25258232|NCT02472600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25258233|NCT02472600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25258234|NCT02472600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25258235|NCT02472600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25258236|NCT02472600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258237|NCT02472600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25258238|NCT02472600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25258239|NCT02472600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25258240|NCT02472574|Plasminogen|plasminogen|mesh-list
25258241|NCT02472574|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25258242|NCT02472574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25258243|NCT02472574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25258244|NCT02472574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258245|NCT02472626|Thioctic Acid|thioctic acid|mesh-list
25258246|NCT02472626|Cytarabine|cytarabine|mesh-list
25258247|NCT02472626|Daunorubicin|daunorubicin|mesh-list
25258248|NCT02472626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25258249|NCT02472626|Antimetabolites|antimetabolites|mesh-ancestor
25258250|NCT02472626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258251|NCT02472626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25258252|NCT02472626|Antiviral Agents|antiviral agents|mesh-ancestor
24624817|NCT01078870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624818|NCT01078870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24624819|NCT01078870|Serotonin Agents|serotonin agents|mesh-ancestor
24624820|NCT01078870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624821|NCT01078870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24624822|NCT01078870|Antidepressive Agents|antidepressive agents|mesh-ancestor
24624823|NCT01078870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24624824|NCT01078870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24624825|NCT01078870|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25113757|NCT02271919|Varenicline|varenicline|mesh-list
24990094|NCT03869866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033359|NCT03574090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25033360|NCT03574090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113809|NCT02167945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25113810|NCT02167945|Antimetabolites|antimetabolites|mesh-ancestor
25033361|NCT03574064|Glucagon|glucagon|mesh-list
25033362|NCT03574064|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
25033363|NCT03574064|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25033364|NCT03574064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25033365|NCT03574064|Hormones|hormones|mesh-ancestor
25033366|NCT03574064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25033367|NCT03574064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033368|NCT03574064|Incretins|incretins|mesh-ancestor
25033369|NCT03573999|Mannitol|mannitol|mesh-list
25033370|NCT03573999|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25033371|NCT03573999|Diuretics|diuretics|mesh-ancestor
25033372|NCT03573999|Natriuretic Agents|natriuretic agents|mesh-ancestor
25404310|NCT03675737|Immunologic Factors|immunologic factors|mesh-ancestor
25033373|NCT03573999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033375|NCT03573986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25033376|NCT03573986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25033377|NCT03573986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25258253|NCT02472626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25258254|NCT02472626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25258255|NCT02472626|Immunologic Factors|immunologic factors|mesh-ancestor
25258256|NCT02472626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258257|NCT02472626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25258258|NCT02472626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25258259|NCT02472626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25258260|NCT02472626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25258261|NCT02472626|Antioxidants|antioxidants|mesh-ancestor
25258262|NCT02472626|Protective Agents|protective agents|mesh-ancestor
25258263|NCT02472626|Vitamin B Complex|vitamin b complex|mesh-ancestor
24624826|NCT01078870|Analgesics|analgesics|mesh-ancestor
24624827|NCT01078870|Sensory System Agents|sensory system agents|mesh-ancestor
24930044|NCT04106011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930046|NCT04106011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24930047|NCT04106011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24930048|NCT04106011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24930059|NCT04106050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930060|NCT04106050|Sensory System Agents|sensory system agents|mesh-ancestor
24930061|NCT04106050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24930062|NCT04106050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24930063|NCT04106050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24930064|NCT04106050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24930065|NCT04106050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25033473|NCT03573050|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25033474|NCT03573050|Protective Agents|protective agents|mesh-ancestor
25033475|NCT03573037|Anticoagulants|anticoagulants|mesh-list
25033476|NCT03572959|Triamcinolone|triamcinolone|mesh-list
25033477|NCT03572959|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25033478|NCT03572959|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25033479|NCT03572959|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25033480|NCT03572959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25033481|NCT03572959|Glucocorticoids|glucocorticoids|mesh-ancestor
25033528|NCT03572790|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
25033529|NCT03572790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25033530|NCT03572790|Serotonin Agents|serotonin agents|mesh-ancestor
25033531|NCT03572790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25033548|NCT03572686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25033549|NCT03572686|Protease Inhibitors|protease inhibitors|mesh-ancestor
25033550|NCT03572686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25033551|NCT03572686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033576|NCT03572400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25033577|NCT03572400|Antimetabolites|antimetabolites|mesh-ancestor
25033578|NCT03572400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033579|NCT03572400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25033580|NCT03572400|Antiviral Agents|antiviral agents|mesh-ancestor
25033581|NCT03572400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25033582|NCT03572400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25033583|NCT03572400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25033584|NCT03572400|Immunologic Factors|immunologic factors|mesh-ancestor
25033585|NCT03572400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600513|NCT00959218|Sensory System Agents|sensory system agents|mesh-ancestor
24600514|NCT00959218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25258265|NCT02472626|Micronutrients|micronutrients|mesh-ancestor
25258266|NCT02472392|Cyclophosphamide|cyclophosphamide|mesh-list
25258267|NCT02472392|Melphalan|melphalan|mesh-list
25258268|NCT02472392|Busulfan|busulfan|mesh-list
25258269|NCT02472392|Fludarabine|fludarabine|mesh-list
25258270|NCT02472392|Thymoglobulin|thymoglobulin|mesh-list
25258271|NCT02472392|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25258272|NCT02472392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25258273|NCT02472392|Immunologic Factors|immunologic factors|mesh-ancestor
25258274|NCT02472392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258275|NCT02472392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25258276|NCT02472392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25258277|NCT02472392|Alkylating Agents|alkylating agents|mesh-ancestor
25258278|NCT02472392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258279|NCT02472392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25258280|NCT02472392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25258281|NCT02472054|Cyclosporine|cyclosporine|mesh-list
24930107|NCT04105374|Antimetabolites|antimetabolites|mesh-ancestor
24930108|NCT04105426|Antioxidants|antioxidants|mesh-list
24930109|NCT04105426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930110|NCT04105426|Protective Agents|protective agents|mesh-ancestor
24930111|NCT04105426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930112|NCT04105140|Oxytocin|oxytocin|mesh-list
24930113|NCT04105140|Oxytocics|oxytocics|mesh-ancestor
24930114|NCT04105140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25103539|NCT03160729|Hormones|hormones|mesh-ancestor
24930115|NCT04105140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930116|NCT04105231|Cannabidiol|cannabidiol|mesh-list
24930117|NCT04105231|Risperidone|risperidone|mesh-list
24930118|NCT04105231|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24930124|NCT04105231|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24930125|NCT04105231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24930126|NCT04105231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24930127|NCT04105231|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24930128|NCT04105231|Dopamine Agents|dopamine agents|mesh-ancestor
24930129|NCT04105231|Anticonvulsants|anticonvulsants|mesh-ancestor
24930130|NCT04105205|Apramycin|apramycin|mesh-list
24776393|NCT01857921|Trimetazidine|trimetazidine|mesh-list
25033652|NCT03571737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033653|NCT03571737|Sensory System Agents|sensory system agents|mesh-ancestor
25033654|NCT03571737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25033655|NCT03571737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25033656|NCT03571737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25033657|NCT03571737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25033658|NCT03571737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25033659|NCT03571737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033660|NCT03571737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25033661|NCT03571737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25033662|NCT03571737|Analgesics|analgesics|mesh-ancestor
25033663|NCT03571737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25033664|NCT03571737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25033665|NCT03571737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25033666|NCT03571737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25258282|NCT02472054|Prednisolone|prednisolone|mesh-list
25258283|NCT02472054|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25258284|NCT02472054|Methylprednisolone|methylprednisolone|mesh-list
25258285|NCT02472054|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25258286|NCT02472054|Prednisolone acetate|prednisolone acetate|mesh-list
25258287|NCT02472054|Alemtuzumab|alemtuzumab|mesh-list
25258288|NCT02472054|Cyclosporins|cyclosporins|mesh-list
25258289|NCT02472054|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25258290|NCT02472054|Prednisolone phosphate|prednisolone phosphate|mesh-list
25258291|NCT02472054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25258292|NCT02472054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258293|NCT02472054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25258294|NCT02472054|Immunologic Factors|immunologic factors|mesh-ancestor
25258295|NCT02472054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258296|NCT02472054|Antifungal Agents|antifungal agents|mesh-ancestor
25258297|NCT02472054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25258298|NCT02472054|Dermatologic Agents|dermatologic agents|mesh-ancestor
25258299|NCT02472054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25258300|NCT02472054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25258301|NCT02472054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25258302|NCT02472054|Glucocorticoids|glucocorticoids|mesh-ancestor
25258303|NCT02472054|Hormones|hormones|mesh-ancestor
25258304|NCT02472054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25258305|NCT02472054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25258306|NCT02472054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25258307|NCT02472054|Antiemetics|antiemetics|mesh-ancestor
25258308|NCT02472054|Autonomic Agents|autonomic agents|mesh-ancestor
24930131|NCT04105205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25155507|NCT05353140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24930132|NCT04105205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24930133|NCT04105283|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
24930134|NCT04105283|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24930148|NCT04105023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24930150|NCT04104893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24930151|NCT04104893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24930153|NCT04104867|Antiemetics|antiemetics|mesh-ancestor
24930154|NCT04104867|Autonomic Agents|autonomic agents|mesh-ancestor
24930155|NCT04104867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24930156|NCT04104867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930157|NCT04104867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24930158|NCT04104867|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24930159|NCT04104867|Dopamine Agents|dopamine agents|mesh-ancestor
24930160|NCT04104867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24930161|NCT04104867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930162|NCT04104984|Tocolytic Agents|tocolytic agents|mesh-list
24930163|NCT04104984|Progesterone|progesterone|mesh-list
24930164|NCT04104984|Progestins|progestins|mesh-ancestor
24930165|NCT04104984|Hormones|hormones|mesh-ancestor
24930166|NCT04104984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24930167|NCT04104984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930168|NCT04104984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24930169|NCT04104789|Oxymetazoline|oxymetazoline|mesh-list
24930170|NCT04104789|Tetracaine|tetracaine|mesh-list
25033667|NCT03571711|Meropenem|meropenem|mesh-list
25033684|NCT03571438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25033691|NCT03571438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033692|NCT03571438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25033693|NCT03571438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25033694|NCT03571438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25033695|NCT03571438|Antifungal Agents|antifungal agents|mesh-ancestor
25033696|NCT03571438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25033697|NCT03571438|Immunologic Factors|immunologic factors|mesh-ancestor
25033698|NCT03571321|Cytarabine|cytarabine|mesh-list
25033699|NCT03571321|Dexamethasone|dexamethasone|mesh-list
25033700|NCT03571321|Cyclophosphamide|cyclophosphamide|mesh-list
25033701|NCT03571321|Rituximab|rituximab|mesh-list
25033702|NCT03571321|Doxorubicin|doxorubicin|mesh-list
25033703|NCT03571321|Methotrexate|methotrexate|mesh-list
25033704|NCT03571321|Vincristine|vincristine|mesh-list
25033705|NCT03571321|Mercaptopurine|mercaptopurine|mesh-list
25033706|NCT03571321|Pegaspargase|pegaspargase|mesh-list
25033707|NCT03571321|Thioguanine|thioguanine|mesh-list
25033708|NCT03571321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25033709|NCT03571321|Immunologic Factors|immunologic factors|mesh-ancestor
25033710|NCT03571321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033711|NCT03571321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25258309|NCT02472054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25258310|NCT02472054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25258311|NCT02472054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25258312|NCT02472054|Protective Agents|protective agents|mesh-ancestor
25258313|NCT02472054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25258314|NCT02472158|Chlorhexidine|chlorhexidine|mesh-list
25258315|NCT02472158|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25258316|NCT02472158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25258317|NCT02472158|Disinfectants|disinfectants|mesh-ancestor
25258318|NCT02472080|Gemcitabine|gemcitabine|mesh-list
25258319|NCT02472080|Oxaliplatin|oxaliplatin|mesh-list
25258320|NCT02472080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25258321|NCT02472080|Antimetabolites|antimetabolites|mesh-ancestor
25258322|NCT02472080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258323|NCT02472080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25258324|NCT02472080|Antiviral Agents|antiviral agents|mesh-ancestor
25258325|NCT02472080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25258326|NCT02472080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25258327|NCT02472080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25258328|NCT02472080|Immunologic Factors|immunologic factors|mesh-ancestor
25258329|NCT02472080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258330|NCT02472249|Norepinephrine|norepinephrine|mesh-list
25258331|NCT02472249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25258332|NCT02472249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25258333|NCT02472249|Adrenergic Agents|adrenergic agents|mesh-ancestor
25258334|NCT02472249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25258335|NCT02472249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930171|NCT04104789|Carticaine|carticaine|mesh-list
24528616|NCT00621998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24528617|NCT00621998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528618|NCT00621998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528619|NCT00621998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24528620|NCT00621998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24528621|NCT00621998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24528622|NCT00621998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24528623|NCT00621998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24528624|NCT00621998|Dopamine Agents|dopamine agents|mesh-ancestor
24528625|NCT00621998|Antiemetics|antiemetics|mesh-ancestor
24528626|NCT00621998|Autonomic Agents|autonomic agents|mesh-ancestor
24528628|NCT00621998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24528638|NCT00622011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528639|NCT00622011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24528640|NCT00622011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24930172|NCT04104789|Anesthetics, Local|anesthetics, local|mesh-ancestor
24930186|NCT04104789|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24930187|NCT04104789|Respiratory System Agents|respiratory system agents|mesh-ancestor
24930189|NCT04104204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24930190|NCT04104204|Narcotics|narcotics|mesh-ancestor
24930191|NCT04104204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24930192|NCT04104204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930193|NCT04104204|Analgesics|analgesics|mesh-ancestor
25033712|NCT03571321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25033713|NCT03571321|Alkylating Agents|alkylating agents|mesh-ancestor
25033714|NCT03571321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033715|NCT03571321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25033716|NCT03571321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25033717|NCT03571321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25033719|NCT03571321|Antiemetics|antiemetics|mesh-ancestor
25033738|NCT03571321|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25033739|NCT03571321|Antiviral Agents|antiviral agents|mesh-ancestor
25033740|NCT03571321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25033741|NCT03571321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25033742|NCT03571321|Tubulin Modulators|tubulin modulators|mesh-ancestor
25033743|NCT03571321|Antimitotic Agents|antimitotic agents|mesh-ancestor
25033744|NCT03571321|Mitosis Modulators|mitosis modulators|mesh-ancestor
25033746|NCT03571308|Cyclophosphamide|cyclophosphamide|mesh-list
25033747|NCT03571308|Doxorubicin|doxorubicin|mesh-list
24600736|NCT00960310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600738|NCT00960336|Doxorubicin|doxorubicin|mesh-list
24600739|NCT00960336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24600740|NCT00960336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24600741|NCT00960336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600766|NCT00960479|Antimetabolites|antimetabolites|mesh-ancestor
24600767|NCT00960479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600768|NCT00960479|Antiviral Agents|antiviral agents|mesh-ancestor
25033840|NCT03570645|Dexamethasone|dexamethasone|mesh-list
25033841|NCT03570645|Dexmedetomidine|dexmedetomidine|mesh-list
25033842|NCT03570645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25258336|NCT02472249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258337|NCT02472249|Sympathomimetics|sympathomimetics|mesh-ancestor
25258338|NCT02472249|Autonomic Agents|autonomic agents|mesh-ancestor
25258339|NCT02472249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25258340|NCT02472249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25067133|NCT03446872|Fluorouracil|fluorouracil|mesh-list
25258341|NCT02472210|Botulinum Toxins|botulinum toxins|mesh-list
25258342|NCT02472210|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25258343|NCT02472210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25258344|NCT02472210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258345|NCT02472210|Cholinergic Agents|cholinergic agents|mesh-ancestor
25258346|NCT02472210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25258347|NCT02472210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258348|NCT02472275|Ascorbic Acid|ascorbic acid|mesh-list
25258349|NCT02472275|Methyltestosterone|methyltestosterone|mesh-list
25258350|NCT02472275|Hormones|hormones|mesh-list
25258351|NCT02472275|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25258352|NCT02472275|Androgens|androgens|mesh-list
25258353|NCT02472275|Androgen Antagonists|androgen antagonists|mesh-list
25258354|NCT02472275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25258355|NCT02472275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258356|NCT02472275|Antioxidants|antioxidants|mesh-ancestor
25258357|NCT02472275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258358|NCT02472275|Protective Agents|protective agents|mesh-ancestor
24930195|NCT04104204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24930197|NCT04104334|Desflurane|desflurane|mesh-list
24506278|NCT00544570|Melphalan|melphalan|mesh-list
24528641|NCT00622011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24528642|NCT00622011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24528736|NCT00622570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24528737|NCT00622570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528738|NCT00622570|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24528739|NCT00622570|Anesthetics, General|anesthetics, general|mesh-ancestor
24528741|NCT00622570|GABA Modulators|gaba modulators|mesh-ancestor
24528742|NCT00622570|GABA Agents|gaba agents|mesh-ancestor
24528743|NCT00622570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24528744|NCT00622570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528746|NCT00622622|Gemcitabine|gemcitabine|mesh-list
24528747|NCT00622622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24528748|NCT00622622|Antimetabolites|antimetabolites|mesh-ancestor
24528750|NCT00622622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528781|NCT00622817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24528782|NCT00622817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25033843|NCT03570645|Antiemetics|antiemetics|mesh-ancestor
25033844|NCT03570645|Autonomic Agents|autonomic agents|mesh-ancestor
25033845|NCT03570645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25033846|NCT03570645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033847|NCT03570645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25033848|NCT03570645|Glucocorticoids|glucocorticoids|mesh-ancestor
25033849|NCT03570645|Hormones|hormones|mesh-ancestor
25033850|NCT03570645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25033865|NCT03570541|Morphine|morphine|mesh-list
25033894|NCT03570320|Narcotics|narcotics|mesh-ancestor
25033895|NCT03570320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25033896|NCT03570320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033897|NCT03570320|Analgesics|analgesics|mesh-ancestor
25033898|NCT03570320|Sensory System Agents|sensory system agents|mesh-ancestor
25033899|NCT03570320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25033901|NCT03570294|Hormone Antagonists|hormone antagonists|mesh-ancestor
25033902|NCT03570294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25033903|NCT03570294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033904|NCT03570294|Tocolytic Agents|tocolytic agents|mesh-ancestor
25033905|NCT03570294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25033906|NCT03570281|Enoxaparin|enoxaparin|mesh-list
25033907|NCT03570281|Edoxaban|edoxaban|mesh-list
24600888|NCT00960973|Menatetrenone|menatetrenone|mesh-list
24600889|NCT00960973|Hemostatics|hemostatics|mesh-ancestor
24600890|NCT00960973|Coagulants|coagulants|mesh-ancestor
25033956|NCT03569696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25033957|NCT03569696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25258359|NCT02472275|Vitamins|vitamins|mesh-ancestor
25258360|NCT02472275|Micronutrients|micronutrients|mesh-ancestor
25258361|NCT02472275|Estrogens|estrogens|mesh-ancestor
25258362|NCT02472275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25258363|NCT02472275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25258364|NCT02472275|Anabolic Agents|anabolic agents|mesh-ancestor
25258365|NCT02472275|Hormone Antagonists|hormone antagonists|mesh-ancestor
25258366|NCT02472236|Digoxin|digoxin|mesh-list
25258367|NCT02472236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25258368|NCT02472236|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25258369|NCT02472236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25258370|NCT02472236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258371|NCT02472236|Protective Agents|protective agents|mesh-ancestor
25258372|NCT02472236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258373|NCT02471963|Empagliflozin|empagliflozin|mesh-list
25258374|NCT02471963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25258375|NCT02471963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258376|NCT02471963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25258377|NCT02471963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258378|NCT02471820|Dexamethasone|dexamethasone|mesh-list
25258379|NCT02471820|Dexamethasone acetate|dexamethasone acetate|mesh-list
25258380|NCT02471820|Lenalidomide|lenalidomide|mesh-list
25258381|NCT02471820|Doxorubicin|doxorubicin|mesh-list
25258382|NCT02471820|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25258383|NCT02471820|BB 1101|bb 1101|mesh-list
24528783|NCT00622817|Adrenergic Agents|adrenergic agents|mesh-ancestor
24528784|NCT00622817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24930198|NCT04104334|Anesthetics|anesthetics|mesh-ancestor
24930199|NCT04104334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24930200|NCT04104334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930201|NCT04104334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24930202|NCT04104334|Narcotics|narcotics|mesh-ancestor
24930203|NCT04104334|Analgesics|analgesics|mesh-ancestor
24930204|NCT04104334|Sensory System Agents|sensory system agents|mesh-ancestor
24930205|NCT04104334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24930206|NCT04104334|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24930207|NCT04104334|Anesthetics, General|anesthetics, general|mesh-ancestor
24930208|NCT04103684|Dexamethasone|dexamethasone|mesh-list
24930209|NCT04103684|Methylprednisolone|methylprednisolone|mesh-list
24930210|NCT04103684|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24406303|NCT00169585|Ofloxacin|ofloxacin|mesh-list
24624849|NCT01079065|Famotidine|famotidine|mesh-list
24624850|NCT01079065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24624851|NCT01079065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24600981|NCT00961480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24600982|NCT00961480|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24600983|NCT00961480|Protease Inhibitors|protease inhibitors|mesh-ancestor
24600984|NCT00961480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034003|NCT03568968|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25034004|NCT03568968|Antimetabolites|antimetabolites|mesh-ancestor
25034005|NCT03568968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034006|NCT03568968|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25034007|NCT03568968|Vasodilator Agents|vasodilator agents|mesh-ancestor
25034008|NCT03568916|Rivaroxaban|rivaroxaban|mesh-list
25034009|NCT03568916|Apixaban|apixaban|mesh-list
25034010|NCT03568916|Dabigatran|dabigatran|mesh-list
25034011|NCT03568916|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25034051|NCT03568513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24601013|NCT00961857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034052|NCT03568513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25034053|NCT03568513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25034054|NCT03568513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034055|NCT03568513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034056|NCT03568474|Fluorides|fluorides|mesh-list
25034057|NCT03568474|Cariostatic Agents|cariostatic agents|mesh-ancestor
25034058|NCT03568474|Protective Agents|protective agents|mesh-ancestor
25034059|NCT03568474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25113932|NCT01991977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113933|NCT01991977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25258384|NCT02471820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25258385|NCT02471820|Antiemetics|antiemetics|mesh-ancestor
25258386|NCT02471820|Autonomic Agents|autonomic agents|mesh-ancestor
25258387|NCT02471820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25258388|NCT02471820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258389|NCT02471820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25258390|NCT02471820|Glucocorticoids|glucocorticoids|mesh-ancestor
25258391|NCT02471820|Hormones|hormones|mesh-ancestor
25258392|NCT02471820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25258393|NCT02471820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25258394|NCT02471820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25258395|NCT02471820|Protease Inhibitors|protease inhibitors|mesh-ancestor
25258396|NCT02471820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25258397|NCT02471820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258398|NCT02471820|Immunologic Factors|immunologic factors|mesh-ancestor
25258399|NCT02471820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25258400|NCT02471820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25258401|NCT02471820|Growth Substances|growth substances|mesh-ancestor
25258402|NCT02471820|Growth Inhibitors|growth inhibitors|mesh-ancestor
24624853|NCT01079065|Histamine Antagonists|histamine antagonists|mesh-ancestor
24624854|NCT01079065|Histamine Agents|histamine agents|mesh-ancestor
24624855|NCT01079065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24624856|NCT01079065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624857|NCT01079065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624858|NCT01079078|Acetaminophen|acetaminophen|mesh-list
24624859|NCT01079078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24624860|NCT01079078|Analgesics|analgesics|mesh-ancestor
24631634|NCT01119157|Vaccines|vaccines|mesh-list
24624861|NCT01079078|Sensory System Agents|sensory system agents|mesh-ancestor
24624862|NCT01079078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24624863|NCT01079078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624865|NCT01079117|Morphine|morphine|mesh-list
24624866|NCT01079117|Methadone|methadone|mesh-list
24624867|NCT01079117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24624868|NCT01079117|Narcotics|narcotics|mesh-ancestor
24624869|NCT01079117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24624870|NCT01079117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624871|NCT01079117|Analgesics|analgesics|mesh-ancestor
24990851|NCT03873675|Parathyroid Hormone|parathyroid hormone|mesh-list
24990852|NCT03873675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24990853|NCT03873675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990854|NCT03873675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24588323|NCT00902057|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24588324|NCT00902057|Natriuretic Agents|natriuretic agents|mesh-ancestor
24588325|NCT00902057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588327|NCT00902070|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24588328|NCT00902070|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25034089|NCT03567681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25034090|NCT03567681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25034091|NCT03567655|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25258403|NCT02471820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25258404|NCT02471820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25258405|NCT02471820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25258407|NCT02471950|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25258408|NCT02471950|Anesthetics, General|anesthetics, general|mesh-ancestor
25258409|NCT02471950|Anesthetics|anesthetics|mesh-ancestor
25258410|NCT02471950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25258411|NCT02471950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258412|NCT02471690|Oritavancin|oritavancin|mesh-list
25258413|NCT02471690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25258414|NCT02471690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25258415|NCT02471677|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25258416|NCT02471677|Hormones|hormones|mesh-ancestor
25258417|NCT02471677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25258418|NCT02471677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258419|NCT02471846|Atezolizumab|atezolizumab|mesh-list
25258420|NCT02471846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25258421|NCT02471560|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25258422|NCT02471560|Dermatologic Agents|dermatologic agents|mesh-ancestor
25258423|NCT02471560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25258424|NCT02471560|Immunologic Factors|immunologic factors|mesh-ancestor
25258425|NCT02471560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258426|NCT02471547|Mitomycins|mitomycins|mesh-list
25258427|NCT02471547|Mitomycin|mitomycin|mesh-list
25258428|NCT02471547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24624879|NCT01079286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24930229|NCT04103905|Antibodies|antibodies|mesh-list
24930230|NCT04103905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24930231|NCT04103905|Immunologic Factors|immunologic factors|mesh-ancestor
24930232|NCT04103905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930233|NCT04103697|Capecitabine|capecitabine|mesh-list
24930234|NCT04103697|Oxaliplatin|oxaliplatin|mesh-list
24930235|NCT04103697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24930236|NCT04103697|Antimetabolites|antimetabolites|mesh-ancestor
24930237|NCT04103697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930238|NCT04103697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24930239|NCT04103489|Eculizumab|eculizumab|mesh-list
24930240|NCT04103489|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24930241|NCT04103489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24930242|NCT04103489|Immunologic Factors|immunologic factors|mesh-ancestor
24930243|NCT04103489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930244|NCT04103398|Sorafenib|sorafenib|mesh-list
24930245|NCT04103398|Chlorotrianisene|chlorotrianisene|mesh-list
24930246|NCT04103398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24930247|NCT04103398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24930248|NCT04103398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034092|NCT03567655|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25034093|NCT03567655|Contraceptive Agents|contraceptive agents|mesh-ancestor
25034094|NCT03567655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25034095|NCT03567655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034096|NCT03567655|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25034097|NCT03567655|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25034098|NCT03567655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25034099|NCT03567655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25034100|NCT03567629|Calcium, Dietary|calcium, dietary|mesh-list
25034102|NCT03567629|Bevacizumab|bevacizumab|mesh-list
25034104|NCT03567629|Fluorouracil|fluorouracil|mesh-list
25034105|NCT03567629|Capecitabine|capecitabine|mesh-list
25034106|NCT03567629|Oxaliplatin|oxaliplatin|mesh-list
25034107|NCT03567629|Irinotecan|irinotecan|mesh-list
25034108|NCT03567629|Calcium|calcium|mesh-list
25034109|NCT03567629|Levoleucovorin|levoleucovorin|mesh-list
25034110|NCT03567629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25034111|NCT03567629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25034112|NCT03567629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25034143|NCT03567408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25034144|NCT03567408|Protease Inhibitors|protease inhibitors|mesh-ancestor
25034145|NCT03567408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034146|NCT03567408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687959|NCT01939197|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25687960|NCT01939197|Protease Inhibitors|protease inhibitors|mesh-ancestor
25034147|NCT03567408|Anticoagulants|anticoagulants|mesh-ancestor
25034148|NCT03567395|Melatonin|melatonin|mesh-list
24857895|NCT02294344|Alkylating Agents|alkylating agents|mesh-ancestor
24857896|NCT02294344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034149|NCT03567395|Antioxidants|antioxidants|mesh-ancestor
25034150|NCT03567395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034151|NCT03567395|Protective Agents|protective agents|mesh-ancestor
25034152|NCT03567395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034153|NCT03567395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25034154|NCT03567369|Dexamethasone|dexamethasone|mesh-list
25034155|NCT03567369|Dexamethasone acetate|dexamethasone acetate|mesh-list
25034156|NCT03567369|BB 1101|bb 1101|mesh-list
25034157|NCT03567369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25258429|NCT02471547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25258430|NCT02471547|Alkylating Agents|alkylating agents|mesh-ancestor
25258431|NCT02471547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258432|NCT02471547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25258433|NCT02471547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25258434|NCT02471274|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25258435|NCT02471274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25258436|NCT02471274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258437|NCT02471274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25258438|NCT02471274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258439|NCT02471209|Sevoflurane|sevoflurane|mesh-list
25258440|NCT02471209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25258441|NCT02471209|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25258442|NCT02471209|Anesthetics, General|anesthetics, general|mesh-ancestor
25258443|NCT02471209|Anesthetics|anesthetics|mesh-ancestor
25258444|NCT02471209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25258445|NCT02471209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930249|NCT04103398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930255|NCT04103398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24930257|NCT04103125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24930258|NCT04103125|Immunologic Factors|immunologic factors|mesh-ancestor
24930259|NCT04103125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930260|NCT04103125|Viscosupplements|viscosupplements|mesh-ancestor
24930261|NCT04103125|Protective Agents|protective agents|mesh-ancestor
24930263|NCT04102995|Anesthetics|anesthetics|mesh-ancestor
24930264|NCT04102995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24930265|NCT04102995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930266|NCT04102878|Anesthetics|anesthetics|mesh-list
24930276|NCT04102670|Viscosupplements|viscosupplements|mesh-ancestor
25045350|NCT00966953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24799753|NCT01971047|Insulin|insulin|mesh-list
25034158|NCT03567369|Antiemetics|antiemetics|mesh-ancestor
25034159|NCT03567369|Autonomic Agents|autonomic agents|mesh-ancestor
25034160|NCT03567369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25034161|NCT03567369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034162|NCT03567369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25104559|NCT03152149|Fluticasone|fluticasone|mesh-list
25034163|NCT03567369|Glucocorticoids|glucocorticoids|mesh-ancestor
25034179|NCT03567304|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25034180|NCT03567304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034181|NCT03567304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034182|NCT03567304|Antiviral Agents|antiviral agents|mesh-ancestor
25034183|NCT03567304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25034184|NCT03567304|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25034185|NCT03567304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25034186|NCT03567135|Temozolomide|temozolomide|mesh-list
25034187|NCT03567135|Apatinib|apatinib|mesh-list
25034188|NCT03567135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25034189|NCT03567135|Alkylating Agents|alkylating agents|mesh-ancestor
25034190|NCT03567135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034191|NCT03567135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25034192|NCT03567135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25034193|NCT03567135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034194|NCT03566966|Antiviral Agents|antiviral agents|mesh-list
25034195|NCT03566966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25034196|NCT03566914|Tadalafil|tadalafil|mesh-list
25034197|NCT03566914|Vasodilator Agents|vasodilator agents|mesh-ancestor
25034198|NCT03566914|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25687961|NCT01939197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25687962|NCT01939197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034199|NCT03566914|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25034200|NCT03566914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034201|NCT03566914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034202|NCT03566914|Urological Agents|urological agents|mesh-ancestor
25034204|NCT03566576|Pemetrexed|pemetrexed|mesh-list
25034205|NCT03566576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25034206|NCT03566576|Tubulin Modulators|tubulin modulators|mesh-ancestor
25034207|NCT03566576|Antimitotic Agents|antimitotic agents|mesh-ancestor
25034208|NCT03566576|Mitosis Modulators|mitosis modulators|mesh-ancestor
25034209|NCT03566576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034210|NCT03566576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034211|NCT03566576|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25034212|NCT03566576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25034213|NCT03566394|Gabapentin|gabapentin|mesh-list
25034214|NCT03566394|Analgesics|analgesics|mesh-ancestor
25034215|NCT03566394|Sensory System Agents|sensory system agents|mesh-ancestor
25034216|NCT03566394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25034217|NCT03566394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258446|NCT02471105|Bimatoprost|bimatoprost|mesh-list
25258447|NCT02471105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25258448|NCT02470832|Itraconazole|itraconazole|mesh-list
25258449|NCT02470832|Antifungal Agents|antifungal agents|mesh-ancestor
25258450|NCT02470832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25258451|NCT02470832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25258452|NCT02470832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25258453|NCT02470832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25258454|NCT02470832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258455|NCT02470832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25258456|NCT02470832|Hormone Antagonists|hormone antagonists|mesh-ancestor
25258457|NCT02470832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25258458|NCT02470832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930277|NCT04102670|Protective Agents|protective agents|mesh-ancestor
24930278|NCT04102943|Tacrolimus|tacrolimus|mesh-list
24930279|NCT04102943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24930280|NCT04102943|Immunologic Factors|immunologic factors|mesh-ancestor
24930281|NCT04102943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930282|NCT04102943|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24930283|NCT04102943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24930284|NCT04102943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930285|NCT04102592|Permethrin|permethrin|mesh-list
24930286|NCT04102592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24930287|NCT04102592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930288|NCT04102267|Epinephrine|epinephrine|mesh-list
24930289|NCT04102267|Bupivacaine|bupivacaine|mesh-list
24930290|NCT04102267|Anesthetics, Local|anesthetics, local|mesh-ancestor
24930291|NCT04102267|Anesthetics|anesthetics|mesh-ancestor
24930292|NCT04102267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24930293|NCT04102267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930294|NCT04102267|Sensory System Agents|sensory system agents|mesh-ancestor
24930295|NCT04102267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24930296|NCT04102267|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24930297|NCT04102267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24930298|NCT04102267|Adrenergic Agents|adrenergic agents|mesh-ancestor
24930299|NCT04102267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24528840|NCT00623116|Testosterone|testosterone|mesh-list
24930300|NCT04102267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799768|NCT01971242|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25034219|NCT03566394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25034220|NCT03566394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25034221|NCT03566394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25034222|NCT03566394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25034223|NCT03566394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25113983|NCT01552434|Bevacizumab|bevacizumab|mesh-list
25113984|NCT01552434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25113986|NCT01552434|Valproic Acid|valproic acid|mesh-list
25113987|NCT01552434|Endothelial Growth Factors|endothelial growth factors|mesh-list
25113988|NCT01552434|Antibodies|antibodies|mesh-list
25113989|NCT01552434|Immunoglobulins|immunoglobulins|mesh-list
25113990|NCT01552434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25113991|NCT01552434|Immunoglobulin G|immunoglobulin g|mesh-list
25113992|NCT01552434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25114007|NCT01552434|GABA Agents|gaba agents|mesh-ancestor
25034259|NCT03566316|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25034260|NCT03566316|Antimetabolites|antimetabolites|mesh-ancestor
24754767|NCT01722656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24754768|NCT01722656|Growth Substances|growth substances|mesh-ancestor
24754769|NCT01722656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754770|NCT01722656|Growth Inhibitors|growth inhibitors|mesh-ancestor
24944899|NCT03956212|Antimalarials|antimalarials|mesh-ancestor
24944900|NCT03956212|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25034261|NCT03566316|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25034262|NCT03566316|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25034263|NCT03566316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034264|NCT03566316|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25034265|NCT03566316|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25258459|NCT02470832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25258460|NCT02470923|Nicotine|nicotine|mesh-list
25258461|NCT02470923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25258462|NCT02470923|Autonomic Agents|autonomic agents|mesh-ancestor
25258463|NCT02470923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25258464|NCT02470923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258465|NCT02470923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25258466|NCT02470923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25258467|NCT02470923|Cholinergic Agents|cholinergic agents|mesh-ancestor
25258468|NCT02470923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25258469|NCT02470923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258470|NCT02470858|Sofosbuvir|sofosbuvir|mesh-list
25258471|NCT02470858|Asunaprevir|asunaprevir|mesh-list
25258472|NCT02470858|Antiviral Agents|antiviral agents|mesh-ancestor
25258473|NCT02470858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25258474|NCT02470858|Protease Inhibitors|protease inhibitors|mesh-ancestor
25258475|NCT02470858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25258476|NCT02470858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258477|NCT02470780|Rifaximin|rifaximin|mesh-list
25258478|NCT02470780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25258479|NCT02470780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25258480|NCT02470780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25258481|NCT02470767|Anticoagulants|anticoagulants|mesh-list
25258482|NCT02470611|Alendronate|alendronate|mesh-list
25258483|NCT02470611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25258484|NCT02470611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258485|NCT02470559|Aldesleukin|aldesleukin|mesh-list
24930302|NCT04102267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24754639|NCT01722201|Risperidone|risperidone|mesh-list
24930303|NCT04102267|Autonomic Agents|autonomic agents|mesh-ancestor
24930304|NCT04102267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24506438|NCT00545311|Glycopyrrolate|glycopyrrolate|mesh-list
24420378|NCT00215826|Immunologic Factors|immunologic factors|mesh-ancestor
24528785|NCT00622817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528786|NCT00622817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528787|NCT00622817|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24528819|NCT00623064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24528820|NCT00623077|Etoposide|etoposide|mesh-list
24528821|NCT00623077|Melphalan|melphalan|mesh-list
24528822|NCT00623077|Busulfan|busulfan|mesh-list
24528823|NCT00623077|Ifosfamide|ifosfamide|mesh-list
25034266|NCT03566303|Vitamin K|vitamin k|mesh-list
25034267|NCT03566303|Warfarin|warfarin|mesh-list
25034268|NCT03566303|Rivaroxaban|rivaroxaban|mesh-list
25034269|NCT03566303|Vitamins|vitamins|mesh-ancestor
25034270|NCT03566303|Micronutrients|micronutrients|mesh-ancestor
25034271|NCT03566303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034272|NCT03566303|Anticoagulants|anticoagulants|mesh-ancestor
25034273|NCT03566303|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25034274|NCT03566303|Antithrombins|antithrombins|mesh-ancestor
25034275|NCT03566303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25034276|NCT03566303|Protease Inhibitors|protease inhibitors|mesh-ancestor
25034277|NCT03566303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528841|NCT00623116|Estrogens|estrogens|mesh-list
25687963|NCT01939197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25687964|NCT01939197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25687965|NCT01939197|Antiviral Agents|antiviral agents|mesh-ancestor
25687966|NCT01939197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25687967|NCT01939197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25687968|NCT01939197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25687969|NCT01939197|Antimetabolites|antimetabolites|mesh-ancestor
25687970|NCT01939301|Nitric Oxide|nitric oxide|mesh-list
25034278|NCT03566303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034279|NCT03566303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25034280|NCT03566303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25034281|NCT03566303|Hemostatics|hemostatics|mesh-ancestor
25034282|NCT03566303|Coagulants|coagulants|mesh-ancestor
25034283|NCT03566225|Metformin|metformin|mesh-list
25034284|NCT03566225|Pioglitazone|pioglitazone|mesh-list
25034285|NCT03566225|Clomiphene|clomiphene|mesh-list
25034286|NCT03566225|Enclomiphene|enclomiphene|mesh-list
25034287|NCT03566225|Zuclomiphene|zuclomiphene|mesh-list
25034288|NCT03566225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25034289|NCT03566225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034290|NCT03566225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25034291|NCT03566225|Hormone Antagonists|hormone antagonists|mesh-ancestor
25034292|NCT03566225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25034312|NCT03566030|Antiviral Agents|antiviral agents|mesh-ancestor
25034313|NCT03566030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25034314|NCT03566030|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25034315|NCT03566030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25034316|NCT03566030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034317|NCT03566030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034318|NCT03566030|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25034319|NCT03566030|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25034320|NCT03565536|Sorafenib|sorafenib|mesh-list
25034321|NCT03565536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25034322|NCT03565536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25034323|NCT03565536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034324|NCT03565536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034325|NCT03565458|Dapagliflozin|dapagliflozin|mesh-list
25034326|NCT03565458|Empagliflozin|empagliflozin|mesh-list
25034327|NCT03565458|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25034328|NCT03565458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034346|NCT03565302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25034347|NCT03565302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034348|NCT03565302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25034349|NCT03565302|Respiratory System Agents|respiratory system agents|mesh-ancestor
25104798|NCT03151005|Metformin|metformin|mesh-list
25034350|NCT03565302|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25034351|NCT03565302|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25034352|NCT03565302|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25258486|NCT02470559|Interleukin-2|interleukin-2|mesh-list
25258487|NCT02470559|Sargramostim|sargramostim|mesh-list
25258488|NCT02470559|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25258489|NCT02470559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25258490|NCT02470559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25258491|NCT02470559|Analgesics|analgesics|mesh-ancestor
25258492|NCT02470559|Sensory System Agents|sensory system agents|mesh-ancestor
25258493|NCT02470559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25258494|NCT02470559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258495|NCT02470559|Immunologic Factors|immunologic factors|mesh-ancestor
25258496|NCT02470559|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25258497|NCT02470559|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25258498|NCT02470559|Antiviral Agents|antiviral agents|mesh-ancestor
24528824|NCT00623077|Thiotepa|thiotepa|mesh-list
24528825|NCT00623077|Sargramostim|sargramostim|mesh-list
24528827|NCT00623077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24528828|NCT00623077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528829|NCT00623077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24930305|NCT04102267|Respiratory System Agents|respiratory system agents|mesh-ancestor
25034353|NCT03565302|Adrenergic Agents|adrenergic agents|mesh-ancestor
25034354|NCT03565302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25034355|NCT03565302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034356|NCT03565302|Sympathomimetics|sympathomimetics|mesh-ancestor
25034357|NCT03565302|Tocolytic Agents|tocolytic agents|mesh-ancestor
25034358|NCT03565302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24588339|NCT00902135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588340|NCT00902135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24588341|NCT00902187|Fesoterodine|fesoterodine|mesh-list
24588342|NCT00902187|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24588343|NCT00902187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24588344|NCT00902187|Cholinergic Agents|cholinergic agents|mesh-ancestor
24588345|NCT00902187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24634198|NCT01132404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24634202|NCT01132417|Tigecycline|tigecycline|mesh-list
24588379|NCT00902421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588380|NCT00902421|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24588385|NCT00902460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24588414|NCT00902525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588416|NCT00902603|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24588465|NCT00902772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588468|NCT00902811|Antimalarials|antimalarials|mesh-ancestor
24588469|NCT00902811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24588470|NCT00902811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24588471|NCT00902811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24588472|NCT00902811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588473|NCT00902811|Antiviral Agents|antiviral agents|mesh-ancestor
24588474|NCT00902811|Schistosomicides|schistosomicides|mesh-ancestor
24588475|NCT00902811|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24588476|NCT00902811|Anthelmintics|anthelmintics|mesh-ancestor
24588477|NCT00902837|Oxycodone|oxycodone|mesh-list
24588478|NCT00902837|Naloxone|naloxone|mesh-list
24588479|NCT00902837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24634255|NCT01132599|Antimetabolites|antimetabolites|mesh-ancestor
24634256|NCT01132599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634257|NCT01132599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24634258|NCT01132599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25034396|NCT03564795|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24634259|NCT01132599|Nootropic Agents|nootropic agents|mesh-ancestor
24588558|NCT00903188|Prednisolone|prednisolone|mesh-list
24588559|NCT00903188|Prednisolone acetate|prednisolone acetate|mesh-list
24588560|NCT00903188|Everolimus|everolimus|mesh-list
24588561|NCT00903188|Cyclosporins|cyclosporins|mesh-list
25034397|NCT03564795|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25034398|NCT03564795|Coccidiostats|coccidiostats|mesh-ancestor
25034399|NCT03564795|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25034421|NCT03564704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25034422|NCT03564704|Alkylating Agents|alkylating agents|mesh-ancestor
25034423|NCT03564704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034424|NCT03564704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25034425|NCT03564704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25034426|NCT03564704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25034427|NCT03564704|Antiemetics|antiemetics|mesh-ancestor
25034428|NCT03564704|Autonomic Agents|autonomic agents|mesh-ancestor
25258499|NCT02470559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25258500|NCT02470637|Insulin|insulin|mesh-list
25258501|NCT02470637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25258502|NCT02470637|Insulin Lispro|insulin lispro|mesh-list
25258503|NCT02470637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25258504|NCT02470637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258505|NCT02470650|Ritonavir|ritonavir|mesh-list
25258506|NCT02470650|Darunavir|darunavir|mesh-list
24930306|NCT04102267|Mydriatics|mydriatics|mesh-ancestor
24930307|NCT04102267|Sympathomimetics|sympathomimetics|mesh-ancestor
24930308|NCT04102267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24930310|NCT04102449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24930311|NCT04102449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24930312|NCT04102449|Analgesics|analgesics|mesh-ancestor
24930313|NCT04102449|Sensory System Agents|sensory system agents|mesh-ancestor
24930323|NCT04102566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24930325|NCT04102566|Analgesics|analgesics|mesh-ancestor
24930326|NCT04102566|Sensory System Agents|sensory system agents|mesh-ancestor
24930327|NCT04102566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24930328|NCT04102566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930329|NCT04102566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24930330|NCT04102566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24528830|NCT00623077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24528831|NCT00623077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528832|NCT00623077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528833|NCT00623077|Immunologic Factors|immunologic factors|mesh-ancestor
24528834|NCT00623077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528835|NCT00623077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24528836|NCT00623077|Alkylating Agents|alkylating agents|mesh-ancestor
24528837|NCT00623077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24528838|NCT00623077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24528839|NCT00623077|Protective Agents|protective agents|mesh-ancestor
24528842|NCT00623116|Androgens|androgens|mesh-ancestor
24528843|NCT00623116|Hormones|hormones|mesh-ancestor
25155508|NCT05353140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528844|NCT00623116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24528845|NCT00623116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034429|NCT03564704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25034430|NCT03564704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25034431|NCT03564704|Glucocorticoids|glucocorticoids|mesh-ancestor
25034432|NCT03564704|Hormones|hormones|mesh-ancestor
25404311|NCT03675737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034433|NCT03564704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25034434|NCT03564704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25034435|NCT03564704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25034436|NCT03564704|Abortifacient Agents|abortifacient agents|mesh-ancestor
25034453|NCT03564652|Azithromycin|azithromycin|mesh-list
25258507|NCT02470650|Tenofovir|tenofovir|mesh-list
25258508|NCT02470650|Lamivudine|lamivudine|mesh-list
25258509|NCT02470650|Emtricitabine|emtricitabine|mesh-list
25258510|NCT02470650|Abacavir|abacavir|mesh-list
25258511|NCT02470650|Cobicistat|cobicistat|mesh-list
25258512|NCT02470650|Rilpivirine|rilpivirine|mesh-list
25258513|NCT02470650|Elvitegravir|elvitegravir|mesh-list
25258514|NCT02470650|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25258515|NCT02470650|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25258517|NCT02470650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25258518|NCT02470650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258519|NCT02470650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25258520|NCT02470650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25258521|NCT02470650|Antiviral Agents|antiviral agents|mesh-ancestor
25258522|NCT02470650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25258523|NCT02470650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25258524|NCT02470650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25258525|NCT02470650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25258526|NCT02470650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25258527|NCT02470650|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25258528|NCT02470702|Oritavancin|oritavancin|mesh-list
25258529|NCT02470702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25258530|NCT02470702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25275086|NCT02374047|Atorvastatin|atorvastatin|mesh-list
25275087|NCT02374047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25275088|NCT02374047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25275089|NCT02374047|Antimetabolites|antimetabolites|mesh-ancestor
25275090|NCT02374047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275091|NCT02374047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25275092|NCT02374047|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25275093|NCT02374047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275094|NCT02373943|Carotenoids|carotenoids|mesh-list
24528846|NCT00623155|Pyrimethamine|pyrimethamine|mesh-list
24528847|NCT00623155|Sulfadoxine|sulfadoxine|mesh-list
24528848|NCT00623155|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24528849|NCT00623155|Antimalarials|antimalarials|mesh-ancestor
24522201|NCT04111926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24930331|NCT04102566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24930332|NCT04102566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24930333|NCT04102566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930334|NCT04102176|Tin Fluorides|tin fluorides|mesh-list
24930335|NCT04102176|Cariostatic Agents|cariostatic agents|mesh-ancestor
24951084|NCT03908528|Antioxidants|antioxidants|mesh-ancestor
25034454|NCT03564652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25034458|NCT03564574|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25034459|NCT03564574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24991289|NCT05196256|Anesthetics|anesthetics|mesh-ancestor
25034504|NCT03564106|Autonomic Agents|autonomic agents|mesh-ancestor
25034505|NCT03564106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25034506|NCT03564106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034507|NCT03564106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25034508|NCT03564106|Glucocorticoids|glucocorticoids|mesh-ancestor
25034510|NCT03564106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25034511|NCT03564106|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25034512|NCT03564106|Protective Agents|protective agents|mesh-ancestor
25034513|NCT03564106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25034514|NCT03564106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25034515|NCT03563963|Lidocaine|lidocaine|mesh-list
25034516|NCT03563963|Ropivacaine|ropivacaine|mesh-list
25034517|NCT03563963|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25034518|NCT03563963|Anesthetics, Local|anesthetics, local|mesh-ancestor
25034523|NCT03563963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25034525|NCT03563963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25034526|NCT03563963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25034527|NCT03563963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25034528|NCT03563963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034529|NCT03563950|Rifampin|rifampin|mesh-list
25034530|NCT03563950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25034531|NCT03563950|Antitubercular Agents|antitubercular agents|mesh-ancestor
25034546|NCT03563937|Edoxaban|edoxaban|mesh-list
25034547|NCT03563937|Phenprocoumon|phenprocoumon|mesh-list
25034548|NCT03563937|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25034549|NCT03563937|Antithrombins|antithrombins|mesh-ancestor
25034550|NCT03563937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25034551|NCT03563937|Protease Inhibitors|protease inhibitors|mesh-ancestor
25034552|NCT03563937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034553|NCT03563937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034554|NCT03563937|Anticoagulants|anticoagulants|mesh-ancestor
25034555|NCT03563833|Anesthetics|anesthetics|mesh-list
25034623|NCT03563235|Calcitriol|calcitriol|mesh-list
25034624|NCT03563235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25034625|NCT03563235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034626|NCT03563235|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25034627|NCT03563235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25034628|NCT03563235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258531|NCT02470676|Progesterone|progesterone|mesh-list
25258532|NCT02470676|Progestins|progestins|mesh-ancestor
25258533|NCT02470676|Hormones|hormones|mesh-ancestor
25258534|NCT02470676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25258535|NCT02470676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258536|NCT02470442|Sevoflurane|sevoflurane|mesh-list
25258537|NCT02470442|Desflurane|desflurane|mesh-list
25258538|NCT02470442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25258539|NCT02470442|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25258540|NCT02470442|Anesthetics, General|anesthetics, general|mesh-ancestor
25258541|NCT02470442|Anesthetics|anesthetics|mesh-ancestor
25275095|NCT02373943|Antioxidants|antioxidants|mesh-ancestor
24930337|NCT04102176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930339|NCT04101929|Apatinib|apatinib|mesh-list
24930340|NCT04101929|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24930341|NCT04101929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24930342|NCT04101929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24930343|NCT04101929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930344|NCT04101929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24930345|NCT04101929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24930346|NCT04102072|Dobutamine|dobutamine|mesh-list
24930347|NCT04102072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24930348|NCT04102072|Sympathomimetics|sympathomimetics|mesh-ancestor
24930349|NCT04102072|Autonomic Agents|autonomic agents|mesh-ancestor
24930350|NCT04102072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24930351|NCT04102072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930352|NCT04102072|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24930353|NCT04102072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25034629|NCT03563235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25034630|NCT03563235|Vitamins|vitamins|mesh-ancestor
25034631|NCT03563235|Micronutrients|micronutrients|mesh-ancestor
25034632|NCT03563235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25034633|NCT03563170|Leucovorin|leucovorin|mesh-list
25034634|NCT03563170|Paclitaxel|paclitaxel|mesh-list
25034635|NCT03563170|Cyclophosphamide|cyclophosphamide|mesh-list
25034636|NCT03563170|Fluorouracil|fluorouracil|mesh-list
25034644|NCT03563170|Antimitotic Agents|antimitotic agents|mesh-ancestor
25034645|NCT03563170|Mitosis Modulators|mitosis modulators|mesh-ancestor
25105259|NCT03147092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25034646|NCT03563170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034647|NCT03563170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25034648|NCT03563170|Immunologic Factors|immunologic factors|mesh-ancestor
25034649|NCT03563170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034650|NCT03563170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25034651|NCT03563170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25034652|NCT03563170|Alkylating Agents|alkylating agents|mesh-ancestor
25034653|NCT03563170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25034675|NCT03563144|Tubulin Modulators|tubulin modulators|mesh-ancestor
25034676|NCT03563144|Antimitotic Agents|antimitotic agents|mesh-ancestor
25034677|NCT03563144|Mitosis Modulators|mitosis modulators|mesh-ancestor
25034685|NCT03563144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25034686|NCT03563144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25034687|NCT03563144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25034688|NCT03563144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25034689|NCT03563144|Growth Substances|growth substances|mesh-ancestor
25034690|NCT03563144|Growth Inhibitors|growth inhibitors|mesh-ancestor
25034691|NCT03563144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25034692|NCT03563144|Antimetabolites|antimetabolites|mesh-ancestor
25034693|NCT03563144|Antiviral Agents|antiviral agents|mesh-ancestor
25034694|NCT03563144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25034695|NCT03563144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034696|NCT03563144|Antidotes|antidotes|mesh-ancestor
25034697|NCT03563144|Protective Agents|protective agents|mesh-ancestor
25034698|NCT03563144|Vitamin B Complex|vitamin b complex|mesh-ancestor
25034700|NCT03563144|Micronutrients|micronutrients|mesh-ancestor
25034701|NCT03563040|Methoxsalen|methoxsalen|mesh-list
25034702|NCT03563040|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25034703|NCT03563040|Dermatologic Agents|dermatologic agents|mesh-ancestor
25034704|NCT03563014|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25034705|NCT03563014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25258542|NCT02470442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25258543|NCT02470442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258544|NCT02470455|Atorvastatin|atorvastatin|mesh-list
25258545|NCT02470455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25258546|NCT02470455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25258551|NCT02470455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25258553|NCT02470546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25258554|NCT02470546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258555|NCT02470663|Calcium Carbonate|calcium carbonate|mesh-list
25258556|NCT02470663|Calcium|calcium|mesh-list
25258557|NCT02470663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24930354|NCT04102072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24930355|NCT04102072|Adrenergic Agents|adrenergic agents|mesh-ancestor
24528862|NCT00623168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25034706|NCT03563001|Budesonide|budesonide|mesh-list
25034707|NCT03563001|Formoterol Fumarate|formoterol fumarate|mesh-list
25034708|NCT03563001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25034709|NCT03563001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25034710|NCT03563001|Autonomic Agents|autonomic agents|mesh-ancestor
25034711|NCT03563001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25034712|NCT03563001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034713|NCT03563001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25034714|NCT03563001|Respiratory System Agents|respiratory system agents|mesh-ancestor
25034715|NCT03563001|Glucocorticoids|glucocorticoids|mesh-ancestor
25034716|NCT03563001|Hormones|hormones|mesh-ancestor
25034717|NCT03563001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25034718|NCT03563001|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25034739|NCT03562780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25034740|NCT03562780|Analgesics|analgesics|mesh-ancestor
25034741|NCT03562780|Sensory System Agents|sensory system agents|mesh-ancestor
25034742|NCT03562780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25034743|NCT03562780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034744|NCT03562780|Antipyretics|antipyretics|mesh-ancestor
24522280|NCT04017247|Oxytocin|oxytocin|mesh-list
24991510|NCT05150652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991511|NCT05150652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24991512|NCT05150652|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24991514|NCT05150652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24588562|NCT00903188|Basiliximab|basiliximab|mesh-list
24588563|NCT00903188|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24588572|NCT00903188|Dermatologic Agents|dermatologic agents|mesh-ancestor
24588575|NCT00903188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588576|NCT00903188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24588577|NCT00903188|Antiemetics|antiemetics|mesh-ancestor
24588578|NCT00903188|Autonomic Agents|autonomic agents|mesh-ancestor
24588579|NCT00903188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588580|NCT00903188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24588581|NCT00903188|Glucocorticoids|glucocorticoids|mesh-ancestor
24588582|NCT00903188|Hormones|hormones|mesh-ancestor
24588583|NCT00903188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24588584|NCT00903188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24588585|NCT00903188|Protective Agents|protective agents|mesh-ancestor
24588586|NCT00903188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24588587|NCT00903188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24588588|NCT00903188|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24588589|NCT00903188|Antitubercular Agents|antitubercular agents|mesh-ancestor
24588590|NCT00903188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24588591|NCT00903214|Riluzole|riluzole|mesh-list
24588592|NCT00903214|Anticonvulsants|anticonvulsants|mesh-ancestor
24588593|NCT00903214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24588594|NCT00903214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24588595|NCT00903214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24588596|NCT00903214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588597|NCT00903214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588598|NCT00903214|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24588599|NCT00903214|Protective Agents|protective agents|mesh-ancestor
24588600|NCT00903227|Fluticasone|fluticasone|mesh-list
24588602|NCT00903227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24588603|NCT00903227|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24588604|NCT00903227|Autonomic Agents|autonomic agents|mesh-ancestor
25258558|NCT02470663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258560|NCT02470663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258561|NCT02470663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25258562|NCT02470299|Ketorolac|ketorolac|mesh-list
25258563|NCT02470299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25258564|NCT02470299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25258565|NCT02470299|Analgesics|analgesics|mesh-ancestor
24930364|NCT04101812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24930365|NCT04101812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24930366|NCT04101812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930367|NCT04101500|Aminophylline|aminophylline|mesh-list
24930368|NCT04101500|Bromides|bromides|mesh-list
24930369|NCT04101500|Ipratropium|ipratropium|mesh-list
24930370|NCT04101500|Anticonvulsants|anticonvulsants|mesh-ancestor
24930371|NCT04101500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24930372|NCT04101500|Autonomic Agents|autonomic agents|mesh-ancestor
24930373|NCT04101500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24930374|NCT04101500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930375|NCT04101500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24930376|NCT04101500|Respiratory System Agents|respiratory system agents|mesh-ancestor
24588605|NCT00903227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588606|NCT00903227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588607|NCT00903227|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24601874|NCT00966316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24588639|NCT00903747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588640|NCT00903747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588641|NCT00903747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588642|NCT00903747|Laxatives|laxatives|mesh-ancestor
25034756|NCT03562611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034757|NCT03562611|Analgesics|analgesics|mesh-ancestor
25034758|NCT03562611|Sensory System Agents|sensory system agents|mesh-ancestor
25034759|NCT03562611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25034767|NCT03562585|Antibodies|antibodies|mesh-list
25034777|NCT03562533|Tubulin Modulators|tubulin modulators|mesh-ancestor
25034778|NCT03562533|Antimitotic Agents|antimitotic agents|mesh-ancestor
25034779|NCT03562533|Mitosis Modulators|mitosis modulators|mesh-ancestor
25034780|NCT03562533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034781|NCT03562533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25034782|NCT03562533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25034783|NCT03562533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25034784|NCT03562533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034785|NCT03562507|Nivolumab|nivolumab|mesh-list
25034786|NCT03562507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25034787|NCT03562507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25034788|NCT03562507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25034789|NCT03562507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034790|NCT03562468|Niacinamide|niacinamide|mesh-list
25034791|NCT03562468|Niacin|niacin|mesh-list
25034792|NCT03562468|Nicotinic Acids|nicotinic acids|mesh-list
25034793|NCT03562468|Vitamin B Complex|vitamin b complex|mesh-ancestor
25034794|NCT03562468|Vitamins|vitamins|mesh-ancestor
25034795|NCT03562468|Micronutrients|micronutrients|mesh-ancestor
25034796|NCT03562468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034797|NCT03562468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25034798|NCT03562468|Antimetabolites|antimetabolites|mesh-ancestor
25034799|NCT03562468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034800|NCT03562468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25034801|NCT03562468|Vasodilator Agents|vasodilator agents|mesh-ancestor
25034802|NCT03562416|Nintedanib|nintedanib|mesh-list
25034803|NCT03562416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25034804|NCT03562416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25034805|NCT03562416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034806|NCT03562416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034807|NCT03562390|Irinotecan|irinotecan|mesh-list
25034808|NCT03562390|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25258566|NCT02470299|Sensory System Agents|sensory system agents|mesh-ancestor
25258567|NCT02470299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25258568|NCT02470299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258569|NCT02470299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25258570|NCT02470299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25258571|NCT02470299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25258572|NCT02470299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24930460|NCT04101578|Protective Agents|protective agents|mesh-ancestor
25404312|NCT03675256|Vaccines|vaccines|mesh-list
24755373|NCT01726205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755374|NCT01726205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24755375|NCT01726205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24755376|NCT01726205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24755377|NCT01726205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24755378|NCT01726283|Riboflavin|riboflavin|mesh-list
24755379|NCT01726283|Vitamin B Complex|vitamin b complex|mesh-ancestor
24945041|NCT03954639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24770199|NCT01818973|Oxaliplatin|oxaliplatin|mesh-list
24945042|NCT03954756|Apatinib|apatinib|mesh-list
25258575|NCT02470117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258576|NCT02470117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25258577|NCT02470065|Afatinib|afatinib|mesh-list
25258578|NCT02470065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24754677|NCT01722305|Glucocorticoids|glucocorticoids|mesh-ancestor
24930377|NCT04101500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24930378|NCT04101500|Cholinergic Agents|cholinergic agents|mesh-ancestor
24930379|NCT04101500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24930380|NCT04101500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930381|NCT04101500|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24930382|NCT04101500|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24930383|NCT04101500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24930384|NCT04101500|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24930385|NCT04101500|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24930386|NCT04101500|Purinergic Agents|purinergic agents|mesh-ancestor
24930387|NCT04101500|Protective Agents|protective agents|mesh-ancestor
24930389|NCT04101474|Analgesics|analgesics|mesh-ancestor
24930390|NCT04101474|Sensory System Agents|sensory system agents|mesh-ancestor
24930391|NCT04101474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24930392|NCT04101474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930393|NCT04101474|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24930394|NCT04101474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24930395|NCT04101474|Anesthetics, General|anesthetics, general|mesh-ancestor
24930396|NCT04101474|Anesthetics|anesthetics|mesh-ancestor
24930397|NCT04101474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25034819|NCT03562169|Autonomic Agents|autonomic agents|mesh-ancestor
25034820|NCT03562169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25034821|NCT03562169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034822|NCT03562169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25034823|NCT03562169|Glucocorticoids|glucocorticoids|mesh-ancestor
25034825|NCT03562169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25034826|NCT03562169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25034827|NCT03562169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25034828|NCT03562169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25034829|NCT03562169|Immunologic Factors|immunologic factors|mesh-ancestor
25034830|NCT03562169|Leprostatic Agents|leprostatic agents|mesh-ancestor
25034831|NCT03562169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25034832|NCT03562169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25034833|NCT03562169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25034834|NCT03562169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24991590|NCT05123170|Analgesics|analgesics|mesh-ancestor
25034835|NCT03562169|Growth Substances|growth substances|mesh-ancestor
25034836|NCT03562169|Growth Inhibitors|growth inhibitors|mesh-ancestor
25034837|NCT03562169|Protease Inhibitors|protease inhibitors|mesh-ancestor
25034838|NCT03562169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034839|NCT03562169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034840|NCT03562169|Glycine Agents|glycine agents|mesh-ancestor
25034842|NCT03562143|Iron|iron|mesh-list
25034850|NCT03562130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034851|NCT03561935|Propafenone|propafenone|mesh-list
25034852|NCT03561935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25258579|NCT02470065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25258580|NCT02470065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25258581|NCT02470065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25687971|NCT01939301|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25687972|NCT01939301|Autonomic Agents|autonomic agents|mesh-ancestor
25687973|NCT01939301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25687974|NCT01939301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687975|NCT01939301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25687976|NCT01939301|Respiratory System Agents|respiratory system agents|mesh-ancestor
25687977|NCT01939301|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25687978|NCT01939301|Antioxidants|antioxidants|mesh-ancestor
25687979|NCT01939301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755447|NCT01726582|Irinotecan|irinotecan|mesh-list
24755448|NCT01726582|Cisplatin|cisplatin|mesh-list
24755449|NCT01726582|Folfirinox|folfirinox|mesh-list
24755450|NCT01726582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24755451|NCT01726582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755452|NCT01726582|Tubulin Modulators|tubulin modulators|mesh-ancestor
24755453|NCT01726582|Antimitotic Agents|antimitotic agents|mesh-ancestor
24755454|NCT01726582|Mitosis Modulators|mitosis modulators|mesh-ancestor
25258582|NCT02470026|Yohimbine|yohimbine|mesh-list
25258583|NCT02470026|Mydriatics|mydriatics|mesh-ancestor
25258584|NCT02470026|Autonomic Agents|autonomic agents|mesh-ancestor
25258585|NCT02470026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25258586|NCT02470026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258587|NCT02470026|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25258588|NCT02470026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25258589|NCT02470026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25258590|NCT02470026|Adrenergic Agents|adrenergic agents|mesh-ancestor
25258591|NCT02470026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25258592|NCT02470026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258593|NCT02470026|Urological Agents|urological agents|mesh-ancestor
25258594|NCT02469948|Botulinum Toxins|botulinum toxins|mesh-list
25258595|NCT02469948|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25258596|NCT02469948|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25258597|NCT02469948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25258600|NCT02469948|Cholinergic Agents|cholinergic agents|mesh-ancestor
24528902|NCT00623285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24930398|NCT04101474|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24930399|NCT04101474|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24930400|NCT04101474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24930401|NCT04101474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930402|NCT04101682|Bupivacaine|bupivacaine|mesh-list
24930403|NCT04101682|Anesthetics, Local|anesthetics, local|mesh-ancestor
24930404|NCT04101682|Anesthetics|anesthetics|mesh-ancestor
24930421|NCT04101578|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24930422|NCT04101578|Antibodies|antibodies|mesh-list
24799862|NCT01971658|Bortezomib|bortezomib|mesh-list
25034853|NCT03561935|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25034854|NCT03561935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25034855|NCT03561935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25034856|NCT03561935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034857|NCT03561740|Capecitabine|capecitabine|mesh-list
25034858|NCT03561740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25034859|NCT03561740|Antimetabolites|antimetabolites|mesh-ancestor
25034860|NCT03561740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034861|NCT03561740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25034862|NCT03561675|Acetazolamide|acetazolamide|mesh-list
25034863|NCT03561675|Anticonvulsants|anticonvulsants|mesh-ancestor
25034864|NCT03561675|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25034865|NCT03561675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034906|NCT03561402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25034907|NCT03561402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25034908|NCT03561402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25034915|NCT03561233|Omeprazole|omeprazole|mesh-list
25034916|NCT03561233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25034917|NCT03561233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25034918|NCT03561233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25034919|NCT03561233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034920|NCT03561233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034978|NCT03560583|Dopamine Agents|dopamine agents|mesh-ancestor
25034979|NCT03560583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25034980|NCT03560583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034981|NCT03560440|Vancomycin|vancomycin|mesh-list
25034982|NCT03560440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25034983|NCT03560440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25687980|NCT01939301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25687981|NCT01939301|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25687982|NCT01939301|Vasodilator Agents|vasodilator agents|mesh-ancestor
25687983|NCT01939301|Gasotransmitters|gasotransmitters|mesh-ancestor
25687984|NCT01939301|Protective Agents|protective agents|mesh-ancestor
25692615|NCT02002884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692616|NCT02002884|Cholinergic Agents|cholinergic agents|mesh-ancestor
25692617|NCT02002884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24755528|NCT01726933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24755529|NCT01726933|Immunologic Factors|immunologic factors|mesh-ancestor
24755530|NCT01726933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755531|NCT01727050|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24945066|NCT03953989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24726961|NCT01607086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24755532|NCT01727050|Hemostatics|hemostatics|mesh-ancestor
25034984|NCT03560427|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25034985|NCT03560427|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25258601|NCT02469948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25258602|NCT02469948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258603|NCT02469948|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25258604|NCT02469948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25258605|NCT02469974|Busulfan|busulfan|mesh-list
25258606|NCT02469974|Immunologic Factors|immunologic factors|mesh-ancestor
25258607|NCT02469974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258608|NCT02469974|Alkylating Agents|alkylating agents|mesh-ancestor
25258609|NCT02469974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258610|NCT02469974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25258611|NCT02469974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25258612|NCT02469974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25258613|NCT02469974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25258614|NCT02469831|Rocuronium|rocuronium|mesh-list
24930423|NCT04101578|gamma-Globulins|gamma-globulins|mesh-list
24930424|NCT04101578|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24930425|NCT04101578|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
24930426|NCT04101578|Immunologic Factors|immunologic factors|mesh-ancestor
24930427|NCT04101578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930445|NCT04101578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24930446|NCT04101578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24930447|NCT04101578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24799875|NCT01971658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25034986|NCT03560427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25105389|NCT03146247|Apremilast|apremilast|mesh-list
25034989|NCT03560427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25035032|NCT03560349|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25035033|NCT03560349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25035034|NCT03560349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035035|NCT03560336|Liraglutide|liraglutide|mesh-list
25035036|NCT03560336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25035037|NCT03560336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035038|NCT03560336|Incretins|incretins|mesh-ancestor
25035039|NCT03560336|Hormones|hormones|mesh-ancestor
25035040|NCT03560336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25035041|NCT03560310|Ticagrelor|ticagrelor|mesh-list
25035042|NCT03560310|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25035043|NCT03560310|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25035044|NCT03560310|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25035045|NCT03560310|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25035046|NCT03560310|Purinergic Agents|purinergic agents|mesh-ancestor
25035047|NCT03560310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25035048|NCT03560310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035049|NCT03560310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035050|NCT03560232|Clindamycin|clindamycin|mesh-list
25035051|NCT03560232|Gentamicins|gentamicins|mesh-list
25035052|NCT03560232|Cefazolin|cefazolin|mesh-list
25035053|NCT03560232|Ceftriaxone|ceftriaxone|mesh-list
25035054|NCT03560232|Tazobactam|tazobactam|mesh-list
25035055|NCT03560232|Piperacillin|piperacillin|mesh-list
25035056|NCT03560232|Ampicillin|ampicillin|mesh-list
25035058|NCT03560232|Sulbactam|sulbactam|mesh-list
25035080|NCT03559985|Sensory System Agents|sensory system agents|mesh-ancestor
25035081|NCT03559985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25035082|NCT03559985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035083|NCT03559985|Antipyretics|antipyretics|mesh-ancestor
25035097|NCT03559790|Antiviral Agents|antiviral agents|mesh-ancestor
25687985|NCT01939314|Bupivacaine|bupivacaine|mesh-list
25687986|NCT01939314|Anesthetics, Local|anesthetics, local|mesh-ancestor
25687987|NCT01939314|Anesthetics|anesthetics|mesh-ancestor
25687988|NCT01939314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25687989|NCT01939314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25687990|NCT01939314|Sensory System Agents|sensory system agents|mesh-ancestor
25687991|NCT01939314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25687992|NCT01939366|Pregabalin|pregabalin|mesh-list
24755593|NCT01727427|Antipyretics|antipyretics|mesh-ancestor
25035098|NCT03559790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25035099|NCT03559790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25035100|NCT03559790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25035101|NCT03559790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25035102|NCT03559790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035103|NCT03559790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25035104|NCT03559790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25035105|NCT03559751|Nicotine|nicotine|mesh-list
25035106|NCT03559751|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25035107|NCT03559751|Autonomic Agents|autonomic agents|mesh-ancestor
24602351|NCT00968435|Cetuximab|cetuximab|mesh-list
25035128|NCT03559673|Lacosamide|lacosamide|mesh-list
25035129|NCT03559673|Anticonvulsants|anticonvulsants|mesh-ancestor
25035130|NCT03559673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25035131|NCT03559673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25035132|NCT03559673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25035133|NCT03559673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035134|NCT03559504|Sevoflurane|sevoflurane|mesh-list
25035135|NCT03559504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25035136|NCT03559504|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25035137|NCT03559504|Anesthetics, General|anesthetics, general|mesh-ancestor
25035138|NCT03559504|Anesthetics|anesthetics|mesh-ancestor
25035139|NCT03559504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25258615|NCT02469831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25258616|NCT02469831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25258617|NCT02469831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25258618|NCT02469831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25258619|NCT02469831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258620|NCT02469740|Clopidogrel|clopidogrel|mesh-list
25258621|NCT02469740|Ticagrelor|ticagrelor|mesh-list
25258622|NCT02469740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25258623|NCT02469740|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24930448|NCT04101578|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24930449|NCT04101578|Antifungal Agents|antifungal agents|mesh-ancestor
24754755|NCT01722630|Dopamine|dopamine|mesh-list
24930450|NCT04101578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24930451|NCT04101578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24930452|NCT04101578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24930453|NCT04101578|Antitubercular Agents|antitubercular agents|mesh-ancestor
24930454|NCT04101578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24930455|NCT04101578|Antiemetics|antiemetics|mesh-ancestor
24930456|NCT04101578|Autonomic Agents|autonomic agents|mesh-ancestor
24930457|NCT04101578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24930458|NCT04101578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24930459|NCT04101578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24930461|NCT04101578|Anticonvulsants|anticonvulsants|mesh-ancestor
24930462|NCT04101578|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24930463|NCT04101578|Cholinergic Agents|cholinergic agents|mesh-ancestor
24930464|NCT04101578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24930465|NCT04101708|Amoxicillin|amoxicillin|mesh-list
24930466|NCT04101708|Clarithromycin|clarithromycin|mesh-list
24930467|NCT04101708|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
24930468|NCT04101708|Lansoprazole|lansoprazole|mesh-list
24930469|NCT04101708|Dexlansoprazole|dexlansoprazole|mesh-list
24930471|NCT04101708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24799886|NCT01971658|Growth Substances|growth substances|mesh-ancestor
25035140|NCT03559504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035141|NCT03559413|Imiquimod|imiquimod|mesh-list
25035142|NCT03559413|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25035143|NCT03559413|Immunologic Factors|immunologic factors|mesh-ancestor
24991846|NCT04871360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24991847|NCT04860804|Aspirin|aspirin|mesh-list
24991848|NCT04860804|Ketamine|ketamine|mesh-list
24991849|NCT04860804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24991850|NCT04860804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24991851|NCT04860804|Analgesics|analgesics|mesh-ancestor
24991852|NCT04860804|Sensory System Agents|sensory system agents|mesh-ancestor
24991853|NCT04860804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24991854|NCT04860804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991855|NCT04860804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24991856|NCT04860804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24991874|NCT04856488|Hemostatics|hemostatics|mesh-ancestor
24991875|NCT04856488|Coagulants|coagulants|mesh-ancestor
25258624|NCT02469740|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25258625|NCT02469740|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25687993|NCT01939366|Analgesics|analgesics|mesh-ancestor
25258626|NCT02469740|Purinergic Agents|purinergic agents|mesh-ancestor
25258627|NCT02469740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25258628|NCT02469740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258629|NCT02469740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258630|NCT02469545|Citalopram|citalopram|mesh-list
25258631|NCT02469545|Sertraline|sertraline|mesh-list
25258632|NCT02469545|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25258633|NCT02469545|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25258634|NCT02469545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25258635|NCT02469545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258636|NCT02469545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25258637|NCT02469545|Serotonin Agents|serotonin agents|mesh-ancestor
25258638|NCT02469545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258639|NCT02469545|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25258640|NCT02469545|Antidepressive Agents|antidepressive agents|mesh-ancestor
25258641|NCT02469545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25258642|NCT02469259|Oxytocin|oxytocin|mesh-list
25258643|NCT02469259|Oxytocics|oxytocics|mesh-ancestor
25258644|NCT02469259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25258645|NCT02469259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258646|NCT02469311|Chlorhexidine|chlorhexidine|mesh-list
25258647|NCT02469311|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24930472|NCT04101708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24930473|NCT04101708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24930474|NCT04101708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24930475|NCT04101708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930476|NCT04101708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24930477|NCT04101708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24930487|NCT04101370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24930488|NCT04101370|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24930489|NCT04101370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930516|NCT04101019|Anesthetics, Local|anesthetics, local|mesh-ancestor
24624891|NCT01079286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24624892|NCT01079286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24624893|NCT01079286|Antiviral Agents|antiviral agents|mesh-ancestor
24624895|NCT01079312|Remifentanil|remifentanil|mesh-list
24624896|NCT01079312|Propofol|propofol|mesh-list
24624897|NCT01079312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
24624898|NCT01079312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24624899|NCT01079312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624900|NCT01079312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24624901|NCT01079312|Anesthetics, General|anesthetics, general|mesh-ancestor
24624902|NCT01079312|Anesthetics|anesthetics|mesh-ancestor
24455771|NCT00328939|PENTA|penta|mesh-list
24588652|NCT00903825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035168|NCT03559140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25035169|NCT03559114|Dalteparin|dalteparin|mesh-list
25035170|NCT03559114|Tinzaparin|tinzaparin|mesh-list
25035171|NCT03559114|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25035172|NCT03559114|Anticoagulants|anticoagulants|mesh-ancestor
25035173|NCT03559114|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25035174|NCT03559114|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25035175|NCT03559114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035176|NCT03559049|Carboplatin|carboplatin|mesh-list
25035177|NCT03559049|Pembrolizumab|pembrolizumab|mesh-list
25035178|NCT03559049|Pemetrexed|pemetrexed|mesh-list
25035219|NCT03558750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25035220|NCT03558750|Growth Substances|growth substances|mesh-ancestor
25035221|NCT03558750|Growth Inhibitors|growth inhibitors|mesh-ancestor
25035222|NCT03558477|Esomeprazole|esomeprazole|mesh-list
25035223|NCT03558477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25035224|NCT03558477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25035225|NCT03558477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25035226|NCT03558477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25258648|NCT02469311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25258649|NCT02469311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25258650|NCT02469311|Disinfectants|disinfectants|mesh-ancestor
25258651|NCT02468999|Insulin|insulin|mesh-list
25258652|NCT02468999|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25258653|NCT02468999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25258654|NCT02468999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258655|NCT02469012|Ribavirin|ribavirin|mesh-list
25258656|NCT02469012|Sofosbuvir|sofosbuvir|mesh-list
25258657|NCT02469012|Ledipasvir|ledipasvir|mesh-list
25258658|NCT02469012|Antimetabolites|antimetabolites|mesh-ancestor
25258659|NCT02469012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258660|NCT02469012|Antiviral Agents|antiviral agents|mesh-ancestor
25258661|NCT02469012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25258662|NCT02468856|Modafinil|modafinil|mesh-list
25258663|NCT02468856|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25258664|NCT02468856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258665|NCT02468856|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25258666|NCT02468856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25258667|NCT02468856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25258668|NCT02468856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258669|NCT02468908|Molgramostim|molgramostim|mesh-list
25258670|NCT02468908|Sargramostim|sargramostim|mesh-list
24624904|NCT01079312|Narcotics|narcotics|mesh-ancestor
24624906|NCT01079312|Sensory System Agents|sensory system agents|mesh-ancestor
24624907|NCT01079312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24624908|NCT01079312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24624909|NCT01079338|Caffeine|caffeine|mesh-list
24624910|NCT01079338|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25045351|NCT00963885|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24624911|NCT01079338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624912|NCT01079338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24624913|NCT01079338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24624914|NCT01079338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624915|NCT01079338|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24624916|NCT01079338|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24624917|NCT01079338|Purinergic Agents|purinergic agents|mesh-ancestor
24624918|NCT01079338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24624919|NCT01079351|Carbamazepine|carbamazepine|mesh-list
24930517|NCT04101019|Anesthetics|anesthetics|mesh-ancestor
24930518|NCT04101019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24930519|NCT04101019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930520|NCT04101019|Sensory System Agents|sensory system agents|mesh-ancestor
24930521|NCT04101019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24930522|NCT04101019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24930528|NCT04100759|Vasodilator Agents|vasodilator agents|mesh-ancestor
24930529|NCT04100759|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24930530|NCT04100759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24930531|NCT04100759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24930532|NCT04100759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930533|NCT04100759|Urological Agents|urological agents|mesh-ancestor
24930543|NCT04100655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930545|NCT04100655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24930546|NCT04101383|Insulin|insulin|mesh-list
24930547|NCT04101383|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24930548|NCT04101383|Insulin Glargine|insulin glargine|mesh-list
24930549|NCT04101383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25035281|NCT03557437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24930550|NCT04101383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258671|NCT02468908|Immunologic Factors|immunologic factors|mesh-ancestor
25258672|NCT02468908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258673|NCT02468908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25258674|NCT02468791|Rituximab|rituximab|mesh-list
25258675|NCT02468791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25258676|NCT02468791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25258677|NCT02468791|Immunologic Factors|immunologic factors|mesh-ancestor
25258678|NCT02468791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258679|NCT02468791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25275096|NCT02373943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275097|NCT02373943|Protective Agents|protective agents|mesh-ancestor
25275098|NCT02373943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275099|NCT02374008|Dexamethasone|dexamethasone|mesh-list
25275100|NCT02374008|Ketorolac|ketorolac|mesh-list
25275101|NCT02374008|Ropivacaine|ropivacaine|mesh-list
25275102|NCT02374008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25275103|NCT02374008|Antiemetics|antiemetics|mesh-ancestor
25275104|NCT02374008|Autonomic Agents|autonomic agents|mesh-ancestor
25275105|NCT02374008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275106|NCT02374008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275107|NCT02374008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25275108|NCT02374008|Glucocorticoids|glucocorticoids|mesh-ancestor
25275109|NCT02374008|Hormones|hormones|mesh-ancestor
25275110|NCT02374008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25275111|NCT02374008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25275112|NCT02374008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25275113|NCT02374008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275114|NCT02374008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755877|NCT01729767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25275115|NCT02374008|Anesthetics, Local|anesthetics, local|mesh-ancestor
25275116|NCT02374008|Anesthetics|anesthetics|mesh-ancestor
25275117|NCT02374008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25275118|NCT02374008|Sensory System Agents|sensory system agents|mesh-ancestor
25275119|NCT02374008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25275120|NCT02374008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25275121|NCT02374008|Analgesics|analgesics|mesh-ancestor
25275122|NCT02374008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24930551|NCT04100824|Nimodipine|nimodipine|mesh-list
24930552|NCT04100824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24930553|NCT04100824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24930554|NCT04100824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24930555|NCT04100824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930556|NCT04100824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24930557|NCT04100824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930558|NCT04100824|Vasodilator Agents|vasodilator agents|mesh-ancestor
24930559|NCT04100330|Cytarabine|cytarabine|mesh-list
24930560|NCT04100330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24930561|NCT04100330|Antimetabolites|antimetabolites|mesh-ancestor
24930564|NCT04100330|Antiviral Agents|antiviral agents|mesh-ancestor
24930568|NCT04100330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930569|NCT04100473|Insulin|insulin|mesh-list
24930570|NCT04100473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24930571|NCT04100473|Insulin Lispro|insulin lispro|mesh-list
24930572|NCT04100473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24930573|NCT04100473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930574|NCT04100226|Vitamin D|vitamin d|mesh-list
24930575|NCT04100226|Cholecalciferol|cholecalciferol|mesh-list
24930576|NCT04100226|Calcium Carbonate|calcium carbonate|mesh-list
24930577|NCT04100226|Vitamins|vitamins|mesh-ancestor
24930578|NCT04100226|Micronutrients|micronutrients|mesh-ancestor
24622229|NCT01066247|Analgesics|analgesics|mesh-ancestor
25035227|NCT03558477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035228|NCT03558412|Decitabine|decitabine|mesh-list
25035229|NCT03558412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25035230|NCT03558412|Antimetabolites|antimetabolites|mesh-ancestor
25035231|NCT03558412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035232|NCT03558412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25035272|NCT03557437|Metronidazole|metronidazole|mesh-list
25035273|NCT03557437|Potassium Citrate|potassium citrate|mesh-list
25035274|NCT03557437|Esomeprazole|esomeprazole|mesh-list
25035275|NCT03557437|Bismuth|bismuth|mesh-list
25035276|NCT03557437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035277|NCT03557437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25035278|NCT03557437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25035279|NCT03557437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25035280|NCT03557437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25035282|NCT03557437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25035283|NCT03557437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25035284|NCT03557437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25035285|NCT03557437|Antacids|antacids|mesh-ancestor
25035286|NCT03557437|Diuretics|diuretics|mesh-ancestor
25035287|NCT03557437|Natriuretic Agents|natriuretic agents|mesh-ancestor
25035288|NCT03557437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258683|NCT02468661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25258684|NCT02468661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258686|NCT02468518|Vitamins|vitamins|mesh-ancestor
25258687|NCT02468518|Micronutrients|micronutrients|mesh-ancestor
25258688|NCT02468518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258689|NCT02468518|Antioxidants|antioxidants|mesh-ancestor
25258690|NCT02468518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258691|NCT02468518|Protective Agents|protective agents|mesh-ancestor
25258693|NCT02468531|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25258694|NCT02468531|Anesthetics, General|anesthetics, general|mesh-ancestor
25258695|NCT02468531|Anesthetics|anesthetics|mesh-ancestor
25258696|NCT02468531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25258697|NCT02468531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258698|NCT02468323|Ondansetron|ondansetron|mesh-list
25258699|NCT02468323|Palonosetron|palonosetron|mesh-list
25258700|NCT02468323|Antiemetics|antiemetics|mesh-ancestor
25258701|NCT02468323|Autonomic Agents|autonomic agents|mesh-ancestor
25258702|NCT02468323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24930579|NCT04100226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930580|NCT04100226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25687994|NCT01939366|Sensory System Agents|sensory system agents|mesh-ancestor
24755938|NCT01730222|Immunologic Factors|immunologic factors|mesh-ancestor
24546336|NCT00697775|Vaccines|vaccines|mesh-list
24930581|NCT04100226|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24930583|NCT04100226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930584|NCT04100226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24930585|NCT04100447|Tranexamic Acid|tranexamic acid|mesh-list
24930586|NCT04100447|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24930587|NCT04100447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24930588|NCT04100447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930589|NCT04100447|Hemostatics|hemostatics|mesh-ancestor
24930590|NCT04100447|Coagulants|coagulants|mesh-ancestor
24930591|NCT04100434|Evolocumab|evolocumab|mesh-list
24624920|NCT01079351|Anticonvulsants|anticonvulsants|mesh-ancestor
24930592|NCT04100434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24930593|NCT04100434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24930594|NCT04100434|Antimetabolites|antimetabolites|mesh-ancestor
24930595|NCT04100434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930596|NCT04100434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24930597|NCT04100083|Spironolactone|spironolactone|mesh-list
24930599|NCT04100083|Hormone Antagonists|hormone antagonists|mesh-ancestor
25155509|NCT05353140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25045352|NCT00963885|Lactams|lactams|mesh-list
25045353|NCT00963885|Antiviral Agents|antiviral agents|mesh-ancestor
25045354|NCT00963885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25045355|NCT00963885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24930611|NCT04099771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24930612|NCT04099771|Anesthetics, General|anesthetics, general|mesh-ancestor
25035294|NCT03557255|Simendan|simendan|mesh-list
25035295|NCT03557255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25035296|NCT03557255|Vasodilator Agents|vasodilator agents|mesh-ancestor
25035297|NCT03557255|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25035298|NCT03557255|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25035299|NCT03557255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25035300|NCT03557255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035301|NCT03557255|Protective Agents|protective agents|mesh-ancestor
25035302|NCT03557255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035352|NCT03556839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991969|NCT04703101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991970|NCT04703101|Antidotes|antidotes|mesh-ancestor
25258703|NCT02468323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258704|NCT02468323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25258705|NCT02468323|Antipruritics|antipruritics|mesh-ancestor
25258706|NCT02468323|Dermatologic Agents|dermatologic agents|mesh-ancestor
25258707|NCT02468323|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25258708|NCT02468323|Serotonin Agents|serotonin agents|mesh-ancestor
25258709|NCT02468323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25258710|NCT02468323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258711|NCT02468323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25258712|NCT02468323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25258713|NCT02468323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25258715|NCT02468323|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25258716|NCT02468323|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25258717|NCT02468297|Ibuprofen|ibuprofen|mesh-list
25258718|NCT02468297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25258719|NCT02468297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25258720|NCT02468297|Analgesics|analgesics|mesh-ancestor
25258721|NCT02468297|Sensory System Agents|sensory system agents|mesh-ancestor
25258722|NCT02468297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25258723|NCT02468297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258724|NCT02468297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25258725|NCT02468297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25258726|NCT02468297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25258727|NCT02468297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25258728|NCT02468297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258729|NCT02468375|Mirabegron|mirabegron|mesh-list
24930613|NCT04099771|Anesthetics|anesthetics|mesh-ancestor
24930614|NCT04099771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24930615|NCT04099771|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24930616|NCT04099771|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24930617|NCT04099771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24930622|NCT04099563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930624|NCT04099732|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25687995|NCT01939366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25687996|NCT01939366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755984|NCT01730612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24755985|NCT01730612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755986|NCT01730612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930625|NCT04099732|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24930626|NCT04099732|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24930627|NCT04099732|Antimetabolites|antimetabolites|mesh-ancestor
24930628|NCT04099732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930629|NCT04099732|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24930630|NCT04099732|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24930631|NCT04099732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991971|NCT04703101|Protective Agents|protective agents|mesh-ancestor
24991972|NCT04703101|Vitamin B Complex|vitamin b complex|mesh-ancestor
24991974|NCT04703101|Micronutrients|micronutrients|mesh-ancestor
24991975|NCT04690023|Ropivacaine|ropivacaine|mesh-list
25035355|NCT03556839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25035356|NCT03556839|Growth Substances|growth substances|mesh-ancestor
25035357|NCT03556839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035358|NCT03556839|Growth Inhibitors|growth inhibitors|mesh-ancestor
25035359|NCT03556592|Metoprolol|metoprolol|mesh-list
25035360|NCT03556592|Midazolam|midazolam|mesh-list
25035361|NCT03556592|Caffeine|caffeine|mesh-list
25035362|NCT03556592|Omeprazole|omeprazole|mesh-list
25035363|NCT03556592|Warfarin|warfarin|mesh-list
25035364|NCT03556592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25035365|NCT03556592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25035366|NCT03556592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25035367|NCT03556592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035368|NCT03556592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25035369|NCT03556592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25035370|NCT03556592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25035371|NCT03556592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25035372|NCT03556592|Anesthetics, General|anesthetics, general|mesh-ancestor
25035373|NCT03556592|Anesthetics|anesthetics|mesh-ancestor
25035374|NCT03556592|GABA Modulators|gaba modulators|mesh-ancestor
25035375|NCT03556592|GABA Agents|gaba agents|mesh-ancestor
25035376|NCT03556592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25035378|NCT03556592|Anticoagulants|anticoagulants|mesh-ancestor
25035385|NCT03556592|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25035386|NCT03556592|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25035387|NCT03556592|Purinergic Agents|purinergic agents|mesh-ancestor
25035388|NCT03556592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25035389|NCT03556592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25035390|NCT03556592|Sympatholytics|sympatholytics|mesh-ancestor
25035391|NCT03556592|Autonomic Agents|autonomic agents|mesh-ancestor
25035392|NCT03556592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25035393|NCT03556592|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25035394|NCT03556592|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25035395|NCT03556592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25035396|NCT03556592|Adrenergic Agents|adrenergic agents|mesh-ancestor
25035397|NCT03556384|Temozolomide|temozolomide|mesh-list
25035398|NCT03556384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25035399|NCT03556384|Alkylating Agents|alkylating agents|mesh-ancestor
25035400|NCT03556384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035401|NCT03556384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25258730|NCT02468375|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25258731|NCT02468375|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25258732|NCT02468375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24976019|NCT02088112|Durvalumab|durvalumab|mesh-list
25258733|NCT02468375|Adrenergic Agents|adrenergic agents|mesh-ancestor
25258734|NCT02468375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25258735|NCT02468375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258736|NCT02468375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258737|NCT02468375|Urological Agents|urological agents|mesh-ancestor
25258738|NCT02468232|Enalapril|enalapril|mesh-list
25258739|NCT02468232|Enalaprilat|enalaprilat|mesh-list
25258740|NCT02468232|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25258741|NCT02468232|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25258742|NCT02468232|Protease Inhibitors|protease inhibitors|mesh-ancestor
25258743|NCT02468232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275123|NCT02374008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24930633|NCT04099732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25687997|NCT01939366|Anticonvulsants|anticonvulsants|mesh-ancestor
25687998|NCT01939366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25687999|NCT01939366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24756071|NCT01731132|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24930634|NCT04099732|Protease Inhibitors|protease inhibitors|mesh-ancestor
24930635|NCT04099732|Anticoagulants|anticoagulants|mesh-ancestor
24930637|NCT04099407|Analgesics|analgesics|mesh-ancestor
24930638|NCT04099407|Sensory System Agents|sensory system agents|mesh-ancestor
24930639|NCT04099407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24930640|NCT04099407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930641|NCT04099407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24930642|NCT04099407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24930643|NCT04099407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24930644|NCT04099407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24930645|NCT04099407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24930646|NCT04099238|Warfarin|warfarin|mesh-list
24528903|NCT00623376|Dronabinol|dronabinol|mesh-list
24528904|NCT00623376|Nabilone|nabilone|mesh-list
24528905|NCT00623376|Antiemetics|antiemetics|mesh-ancestor
24930648|NCT04099238|Dabigatran|dabigatran|mesh-list
24930649|NCT04099238|Apixaban|apixaban|mesh-list
24930650|NCT04099238|Edoxaban|edoxaban|mesh-list
24930651|NCT04099238|Anticoagulants|anticoagulants|mesh-list
24930652|NCT04099238|Acenocoumarol|acenocoumarol|mesh-list
24930653|NCT04099238|Phenindione|phenindione|mesh-list
24930654|NCT04099238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24930655|NCT04099238|Antithrombins|antithrombins|mesh-ancestor
24930656|NCT04099238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24930657|NCT04099238|Protease Inhibitors|protease inhibitors|mesh-ancestor
24930658|NCT04099238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24930659|NCT04099238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930660|NCT04099069|Anesthetics|anesthetics|mesh-list
24930661|NCT04099069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24930662|NCT04099069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930663|NCT04099303|Vaccines|vaccines|mesh-list
24930664|NCT04099303|Immunologic Factors|immunologic factors|mesh-ancestor
24930665|NCT04099303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035402|NCT03556371|Acetylcysteine|acetylcysteine|mesh-list
25035403|NCT03556371|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25035404|NCT03556371|Antiviral Agents|antiviral agents|mesh-ancestor
25035405|NCT03556371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25035406|NCT03556371|Expectorants|expectorants|mesh-ancestor
25035407|NCT03556371|Respiratory System Agents|respiratory system agents|mesh-ancestor
25035408|NCT03556371|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25035409|NCT03556371|Antioxidants|antioxidants|mesh-ancestor
25035410|NCT03556371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035411|NCT03556371|Protective Agents|protective agents|mesh-ancestor
25258744|NCT02468232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258745|NCT02468232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25258746|NCT02468232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25258747|NCT02468206|Polidocanol|polidocanol|mesh-list
25258748|NCT02468206|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25258749|NCT02468206|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25258750|NCT02468128|Nalbuphine|nalbuphine|mesh-list
25258751|NCT02468128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25258762|NCT02468063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25258763|NCT02468063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25258764|NCT02468063|Adrenergic Agents|adrenergic agents|mesh-ancestor
25258765|NCT02468063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25258766|NCT02468063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258767|NCT02468063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258768|NCT02468063|Sympathomimetics|sympathomimetics|mesh-ancestor
25258769|NCT02468063|Autonomic Agents|autonomic agents|mesh-ancestor
25258770|NCT02468063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25258771|NCT02468102|Rivaroxaban|rivaroxaban|mesh-list
25258772|NCT02468102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25258773|NCT02468102|Antithrombins|antithrombins|mesh-ancestor
25258774|NCT02468102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25258775|NCT02468102|Protease Inhibitors|protease inhibitors|mesh-ancestor
24930666|NCT04098861|Timolol|timolol|mesh-list
24930667|NCT04098861|Latanoprost|latanoprost|mesh-list
24930668|NCT04098861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24930669|NCT04098861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24930670|NCT04098861|Adrenergic Agents|adrenergic agents|mesh-ancestor
24930671|NCT04098861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24930672|NCT04098861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930673|NCT04098861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692618|NCT02002884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930674|NCT04098861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24930675|NCT04098861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25155510|NCT05353140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25688000|NCT01939366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688001|NCT01939366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25155511|NCT05353140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25155512|NCT05353140|Antipyretics|antipyretics|mesh-ancestor
25155513|NCT05353140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24930704|NCT04098796|Antibodies|antibodies|mesh-list
24930705|NCT04098796|Immunologic Factors|immunologic factors|mesh-ancestor
24930706|NCT04098796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930711|NCT04098081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035412|NCT03556371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035413|NCT03556371|Antidotes|antidotes|mesh-ancestor
25035414|NCT03556098|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
25035428|NCT03555994|Incretins|incretins|mesh-ancestor
25035429|NCT03555994|Hormones|hormones|mesh-ancestor
25035430|NCT03555994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25035431|NCT03555929|Dexamethasone|dexamethasone|mesh-list
25035432|NCT03555929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25035433|NCT03555929|Antiemetics|antiemetics|mesh-ancestor
25035434|NCT03555929|Autonomic Agents|autonomic agents|mesh-ancestor
25035435|NCT03555929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25035436|NCT03555929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035437|NCT03555929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25035438|NCT03555929|Glucocorticoids|glucocorticoids|mesh-ancestor
25035439|NCT03555929|Hormones|hormones|mesh-ancestor
25035440|NCT03555929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25035441|NCT03555929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25035458|NCT03555526|Levofloxacin|levofloxacin|mesh-list
25258776|NCT02468102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25258777|NCT02468102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258778|NCT02468102|Anticoagulants|anticoagulants|mesh-ancestor
25258779|NCT02468167|Polidocanol|polidocanol|mesh-list
25258780|NCT02468167|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25258781|NCT02468167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25258782|NCT02467907|Paclitaxel|paclitaxel|mesh-list
25258783|NCT02467907|Bevacizumab|bevacizumab|mesh-list
25258784|NCT02467907|Carboplatin|carboplatin|mesh-list
25258785|NCT02467907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25258786|NCT02467907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25258787|NCT02467907|Tubulin Modulators|tubulin modulators|mesh-ancestor
25258788|NCT02467907|Antimitotic Agents|antimitotic agents|mesh-ancestor
25258789|NCT02467907|Mitosis Modulators|mitosis modulators|mesh-ancestor
25258790|NCT02467907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258791|NCT02467907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25258792|NCT02467907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25258793|NCT02467907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25258794|NCT02467907|Growth Substances|growth substances|mesh-ancestor
25258795|NCT02467907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258796|NCT02467907|Growth Inhibitors|growth inhibitors|mesh-ancestor
25258797|NCT02467920|Exenatide|exenatide|mesh-list
25258798|NCT02467920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25258799|NCT02467920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258800|NCT02467920|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25258801|NCT02467920|Incretins|incretins|mesh-ancestor
25258802|NCT02467920|Hormones|hormones|mesh-ancestor
25258803|NCT02467920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24930712|NCT04098081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24930713|NCT04098081|Antiviral Agents|antiviral agents|mesh-ancestor
24930714|NCT04098081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24930715|NCT04098081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24930716|NCT04098081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24930717|NCT04098081|Immunologic Factors|immunologic factors|mesh-ancestor
24930718|NCT04098081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930719|NCT04097847|Clodronic Acid|clodronic acid|mesh-list
24930720|NCT04097847|Tocopherols|tocopherols|mesh-list
24930722|NCT04097847|Tocotrienols|tocotrienols|mesh-list
24930723|NCT04097847|alpha-Tocopherol|alpha-tocopherol|mesh-list
24930724|NCT04097847|Pentoxifylline|pentoxifylline|mesh-list
24930725|NCT04097847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24930738|NCT04097899|Anti-Infective Agents|anti-infective agents|mesh-list
24930739|NCT04097899|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24930740|NCT04097613|Povidone-Iodine|povidone-iodine|mesh-list
24930741|NCT04097613|Budesonide|budesonide|mesh-list
24930742|NCT04097613|Povidone|povidone|mesh-list
24930743|NCT04097613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24930744|NCT04097613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24930745|NCT04097613|Autonomic Agents|autonomic agents|mesh-ancestor
24930746|NCT04097613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24930747|NCT04097613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035459|NCT03555526|Ofloxacin|ofloxacin|mesh-list
25035460|NCT03555526|Tetracycline|tetracycline|mesh-list
25035461|NCT03555526|Esomeprazole|esomeprazole|mesh-list
25035462|NCT03555526|Bismuth|bismuth|mesh-list
25035463|NCT03555526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25035467|NCT03555526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25035468|NCT03555526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25035469|NCT03555526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25035470|NCT03555526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25035471|NCT03555526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035472|NCT03555526|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25035473|NCT03555526|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25035474|NCT03555526|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25035475|NCT03555526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25035476|NCT03555526|Renal Agents|renal agents|mesh-ancestor
25035477|NCT03555526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25035478|NCT03555526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25035479|NCT03555526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25035481|NCT03555526|Antacids|antacids|mesh-ancestor
25035507|NCT03555188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25035508|NCT03555188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24602840|NCT00971152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602841|NCT00971165|Losartan|losartan|mesh-list
25035509|NCT03555136|Vortioxetine|vortioxetine|mesh-list
25035510|NCT03555136|Antidepressive Agents|antidepressive agents|mesh-ancestor
25035511|NCT03555136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25035512|NCT03555136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25035513|NCT03555136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25035514|NCT03555136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25035515|NCT03555136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035516|NCT03555136|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25258804|NCT02467647|Thalidomide|thalidomide|mesh-list
25258805|NCT02467647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25258807|NCT02467647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258808|NCT02467647|Leprostatic Agents|leprostatic agents|mesh-ancestor
25258809|NCT02467647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25258810|NCT02467647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25258811|NCT02467647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25258812|NCT02467647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25258813|NCT02467647|Growth Substances|growth substances|mesh-ancestor
25258814|NCT02467647|Growth Inhibitors|growth inhibitors|mesh-ancestor
25258815|NCT02467647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25258816|NCT02467426|Mitoxantrone|mitoxantrone|mesh-list
25258817|NCT02467426|Analgesics|analgesics|mesh-ancestor
25258818|NCT02467426|Sensory System Agents|sensory system agents|mesh-ancestor
25258819|NCT02467426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25258820|NCT02467426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258821|NCT02467426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25258822|NCT02467426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25258823|NCT02467426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25258824|NCT02467426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275124|NCT02373735|Mannitol|mannitol|mesh-list
24930748|NCT04097613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24930749|NCT04097613|Respiratory System Agents|respiratory system agents|mesh-ancestor
24930750|NCT04097613|Glucocorticoids|glucocorticoids|mesh-ancestor
24930751|NCT04097613|Hormones|hormones|mesh-ancestor
24930752|NCT04097613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24930753|NCT04097613|Plasma Substitutes|plasma substitutes|mesh-ancestor
24930754|NCT04097613|Blood Substitutes|blood substitutes|mesh-ancestor
24930755|NCT04097613|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24930756|NCT04097613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24930757|NCT04097574|Menthol|menthol|mesh-list
24930758|NCT04097574|Antipruritics|antipruritics|mesh-ancestor
24506917|NCT00547547|Selenium|selenium|mesh-list
24528906|NCT00623376|Autonomic Agents|autonomic agents|mesh-ancestor
24528907|NCT00623376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24528908|NCT00623376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528909|NCT00623376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24528910|NCT00623376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24528911|NCT00623376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24528912|NCT00623376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24528913|NCT00623376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24528937|NCT00623558|Docetaxel|docetaxel|mesh-list
24528938|NCT00623558|Cetuximab|cetuximab|mesh-list
24528939|NCT00623558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528940|NCT00623558|Tubulin Modulators|tubulin modulators|mesh-ancestor
24528941|NCT00623558|Antimitotic Agents|antimitotic agents|mesh-ancestor
24756436|NCT01733342|Anesthetics|anesthetics|mesh-list
24528942|NCT00623558|Mitosis Modulators|mitosis modulators|mesh-ancestor
24528943|NCT00623558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528944|NCT00623558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24528945|NCT00623688|Imidacloprid|imidacloprid|mesh-list
24528946|NCT00623688|Cholinergic Agents|cholinergic agents|mesh-ancestor
24528947|NCT00623688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24528948|NCT00623688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528949|NCT00623688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528950|NCT00623740|Hydrocortisone|hydrocortisone|mesh-list
24528951|NCT00623740|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24528952|NCT00623740|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25035517|NCT03555136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25035518|NCT03555136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25258825|NCT02467426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258826|NCT02467478|Linagliptin|linagliptin|mesh-list
25258827|NCT02467478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25258828|NCT02467478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258829|NCT02467478|Incretins|incretins|mesh-ancestor
25258830|NCT02467478|Hormones|hormones|mesh-ancestor
25258831|NCT02467478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25258832|NCT02467478|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25258833|NCT02467478|Protease Inhibitors|protease inhibitors|mesh-ancestor
25258834|NCT02467478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25258835|NCT02467478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258836|NCT02467556|Morphine|morphine|mesh-list
25258837|NCT02467556|Memantine|memantine|mesh-list
25258838|NCT02467556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25258839|NCT02467556|Narcotics|narcotics|mesh-ancestor
25258840|NCT02467556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25258864|NCT02467595|Narcotics|narcotics|mesh-ancestor
25258841|NCT02467556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258842|NCT02467556|Analgesics|analgesics|mesh-ancestor
25258843|NCT02467556|Sensory System Agents|sensory system agents|mesh-ancestor
25258844|NCT02467556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25258845|NCT02467556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25258846|NCT02467556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25258847|NCT02467556|Dopamine Agents|dopamine agents|mesh-ancestor
25258848|NCT02467556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25258849|NCT02467556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258850|NCT02467556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25258851|NCT02467556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25258852|NCT02467595|Fentanyl|fentanyl|mesh-list
25258853|NCT02467595|Bromides|bromides|mesh-list
25258854|NCT02467595|Propofol|propofol|mesh-list
25258855|NCT02467595|Sevoflurane|sevoflurane|mesh-list
25258856|NCT02467595|Rocuronium|rocuronium|mesh-list
25258857|NCT02467595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25258858|NCT02467595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25258859|NCT02467595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258860|NCT02467595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24528953|NCT00623740|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24528954|NCT00623740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24528955|NCT00623857|Vitamins|vitamins|mesh-list
24528957|NCT00623857|Micronutrients|micronutrients|mesh-ancestor
24528958|NCT00623857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528959|NCT00623857|Trace Elements|trace elements|mesh-ancestor
24528960|NCT00623987|Warfarin|warfarin|mesh-list
24406806|NCT00171366|Benazepril|benazepril|mesh-list
24930762|NCT04097444|Fluorouracil|fluorouracil|mesh-list
24930763|NCT04097444|Capecitabine|capecitabine|mesh-list
24930764|NCT04097444|Oxaliplatin|oxaliplatin|mesh-list
24930765|NCT04097444|Irinotecan|irinotecan|mesh-list
24762501|NCT01768377|Narcotics|narcotics|mesh-ancestor
24930766|NCT04097444|Calcium|calcium|mesh-list
24930767|NCT04097444|Levoleucovorin|levoleucovorin|mesh-list
24930768|NCT04097444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24930769|NCT04097444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24930770|NCT04097444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24930771|NCT04097444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24930772|NCT04097444|Growth Substances|growth substances|mesh-ancestor
24930773|NCT04097444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930774|NCT04097444|Growth Inhibitors|growth inhibitors|mesh-ancestor
24799999|NCT01972711|Dopamine Agents|dopamine agents|mesh-ancestor
25035519|NCT03555136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035520|NCT03555136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25688002|NCT01939366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24756554|NCT01734057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24756555|NCT01734057|Antiemetics|antiemetics|mesh-ancestor
24756556|NCT01734057|Autonomic Agents|autonomic agents|mesh-ancestor
25035521|NCT03555136|Serotonin Agents|serotonin agents|mesh-ancestor
25035522|NCT03555136|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25035523|NCT03555136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25035524|NCT03555136|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25035525|NCT03555136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24992210|NCT04168112|Protective Agents|protective agents|mesh-ancestor
24992211|NCT04165122|Valacyclovir|valacyclovir|mesh-list
24992212|NCT04165122|Antiviral Agents|antiviral agents|mesh-ancestor
24588765|NCT00904202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588767|NCT00904202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24588784|NCT00904280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588785|NCT00904280|Analgesics|analgesics|mesh-ancestor
24588786|NCT00904280|Sensory System Agents|sensory system agents|mesh-ancestor
24588787|NCT00904280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588788|NCT00904280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24588790|NCT00904293|Anticoagulants|anticoagulants|mesh-ancestor
24588792|NCT00904306|Picolinic acid|picolinic acid|mesh-list
24588793|NCT00904306|Trace Elements|trace elements|mesh-ancestor
24588794|NCT00904306|Micronutrients|micronutrients|mesh-ancestor
24588795|NCT00904306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588796|NCT00904306|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24588797|NCT00904306|Chelating Agents|chelating agents|mesh-ancestor
24588798|NCT00904306|Sequestering Agents|sequestering agents|mesh-ancestor
24588799|NCT00904306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588800|NCT00904397|Celecoxib|celecoxib|mesh-list
24588801|NCT00904397|Lidocaine|lidocaine|mesh-list
24588802|NCT00904397|Anesthetics, Local|anesthetics, local|mesh-ancestor
24588803|NCT00904397|Anesthetics|anesthetics|mesh-ancestor
24588804|NCT00904397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24588805|NCT00904397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258861|NCT02467595|Anesthetics, General|anesthetics, general|mesh-ancestor
25258862|NCT02467595|Anesthetics|anesthetics|mesh-ancestor
25258863|NCT02467595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25258870|NCT02467595|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25258871|NCT02467595|Anticonvulsants|anticonvulsants|mesh-ancestor
25258872|NCT02467595|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25258873|NCT02467595|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25258874|NCT02467595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25258875|NCT02467543|Ethanol|ethanol|mesh-list
25258876|NCT02467543|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25258877|NCT02467543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25258878|NCT02467543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24976404|NCT03629873|Cytarabine|cytarabine|mesh-list
25258879|NCT02467543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258880|NCT02467686|Tamoxifen|tamoxifen|mesh-list
25258881|NCT02467686|Exemestane|exemestane|mesh-list
25258882|NCT02467686|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24930775|NCT04097444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24930776|NCT04097444|Antimetabolites|antimetabolites|mesh-ancestor
24930777|NCT04097444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800017|NCT01972880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25035567|NCT03554590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25035568|NCT03554590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035569|NCT03554447|Pentoxifylline|pentoxifylline|mesh-list
25035570|NCT03554447|Dexetimide|dexetimide|mesh-list
25035571|NCT03554447|Citalopram|citalopram|mesh-list
25035572|NCT03554447|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25035573|NCT03554447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25035574|NCT03554447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25035575|NCT03554447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035576|NCT03554447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25035577|NCT03554447|Serotonin Agents|serotonin agents|mesh-ancestor
25035578|NCT03554447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035581|NCT03554447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25035582|NCT03554447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25035583|NCT03554447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25035584|NCT03554447|Parasympatholytics|parasympatholytics|mesh-ancestor
25035585|NCT03554447|Autonomic Agents|autonomic agents|mesh-ancestor
24517834|NCT00610142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25688003|NCT01939366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25688004|NCT01939366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25035632|NCT03554291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035633|NCT03554291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688005|NCT01939366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25688006|NCT01939496|Canagliflozin|canagliflozin|mesh-list
25035635|NCT03554200|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25035636|NCT03554200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035637|NCT03554200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25035638|NCT03554200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035639|NCT03554109|Leucovorin|leucovorin|mesh-list
25035640|NCT03554109|Paclitaxel|paclitaxel|mesh-list
25035641|NCT03554109|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25035642|NCT03554109|Cyclophosphamide|cyclophosphamide|mesh-list
25035643|NCT03554109|Doxorubicin|doxorubicin|mesh-list
25035644|NCT03554109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24992214|NCT04103554|Valsartan|valsartan|mesh-list
25035645|NCT03554109|Fluorouracil|fluorouracil|mesh-list
25035646|NCT03554109|Avelumab|avelumab|mesh-list
25035647|NCT03554109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25035648|NCT03554109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25035649|NCT03554109|Tubulin Modulators|tubulin modulators|mesh-ancestor
25035650|NCT03554109|Antimitotic Agents|antimitotic agents|mesh-ancestor
25035651|NCT03554109|Mitosis Modulators|mitosis modulators|mesh-ancestor
25035652|NCT03554109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035653|NCT03554109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25035654|NCT03554109|Immunologic Factors|immunologic factors|mesh-ancestor
25035655|NCT03554109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035684|NCT03553628|Chlorhexidine|chlorhexidine|mesh-list
25035685|NCT03553628|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25035686|NCT03553628|Propolis|propolis|mesh-list
25035687|NCT03553628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25035688|NCT03553628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25035689|NCT03553628|Disinfectants|disinfectants|mesh-ancestor
25035721|NCT03553537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25258883|NCT02467686|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25258884|NCT02467686|Hormone Antagonists|hormone antagonists|mesh-ancestor
25258885|NCT02467686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25258886|NCT02467686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930778|NCT04097444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24930779|NCT04097444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24930780|NCT04097444|Immunologic Factors|immunologic factors|mesh-ancestor
24930781|NCT04097444|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24930782|NCT04097444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24930783|NCT04097444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24930784|NCT04097444|Antidotes|antidotes|mesh-ancestor
24930785|NCT04097444|Protective Agents|protective agents|mesh-ancestor
24930786|NCT04097444|Vitamin B Complex|vitamin b complex|mesh-ancestor
24930787|NCT04097444|Vitamins|vitamins|mesh-ancestor
24930788|NCT04097444|Micronutrients|micronutrients|mesh-ancestor
24930789|NCT04097288|Dexetimide|dexetimide|mesh-list
24930790|NCT04097288|Citalopram|citalopram|mesh-list
24930791|NCT04097288|Reboxetine|reboxetine|mesh-list
24930792|NCT04097288|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25035722|NCT03553537|Antimetabolites|antimetabolites|mesh-ancestor
25114148|NCT01236547|Paclitaxel|paclitaxel|mesh-list
25114149|NCT01236547|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25114150|NCT01236547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25114151|NCT01236547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25114152|NCT01236547|Tubulin Modulators|tubulin modulators|mesh-ancestor
25114153|NCT01236547|Antimitotic Agents|antimitotic agents|mesh-ancestor
25114154|NCT01236547|Mitosis Modulators|mitosis modulators|mesh-ancestor
25114185|NCT01191697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25114186|NCT01191697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25114187|NCT01191697|Growth Substances|growth substances|mesh-ancestor
25114188|NCT01191697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25114189|NCT01191697|Growth Inhibitors|growth inhibitors|mesh-ancestor
25114190|NCT01191697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25114191|NCT01191697|Antimetabolites|antimetabolites|mesh-ancestor
25114192|NCT01191697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588806|NCT00904397|Sensory System Agents|sensory system agents|mesh-ancestor
24588807|NCT00904397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588808|NCT00904397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25035734|NCT03553433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25035767|NCT03553238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25688007|NCT01939496|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24603292|NCT00973193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25035768|NCT03553238|Antiemetics|antiemetics|mesh-ancestor
25035769|NCT03553238|Autonomic Agents|autonomic agents|mesh-ancestor
25035770|NCT03553238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25258887|NCT02467686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25258888|NCT02467686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25258889|NCT02467686|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25258890|NCT02467686|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25258891|NCT02467686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25258892|NCT02467686|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25258893|NCT02467686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25258894|NCT02467686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258895|NCT02467335|Fostemsavir|fostemsavir|mesh-list
25258896|NCT02467335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25258897|NCT02467335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25258898|NCT02467335|Antiviral Agents|antiviral agents|mesh-ancestor
25258899|NCT02467335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24930803|NCT04097288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24930804|NCT04097288|Parasympatholytics|parasympatholytics|mesh-ancestor
24930805|NCT04097288|Autonomic Agents|autonomic agents|mesh-ancestor
24930806|NCT04097288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24930807|NCT04097288|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24930808|NCT04097288|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24930809|NCT04097288|Cholinergic Agents|cholinergic agents|mesh-ancestor
24930810|NCT04097288|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24930811|NCT04097288|Adrenergic Agents|adrenergic agents|mesh-ancestor
24930812|NCT04096768|Dexmedetomidine|dexmedetomidine|mesh-list
24930813|NCT04096768|Ketamine|ketamine|mesh-list
24930814|NCT04096768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24930815|NCT04096768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24594059|NCT00932217|Lenograstim|lenograstim|mesh-list
25035771|NCT03553238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25035772|NCT03553238|Glucocorticoids|glucocorticoids|mesh-ancestor
25035774|NCT03553238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25035775|NCT03553238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25035776|NCT03553238|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25035777|NCT03553238|Abortifacient Agents|abortifacient agents|mesh-ancestor
25035778|NCT03553238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25035779|NCT03553238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25035780|NCT03553238|Antimetabolites|antimetabolites|mesh-ancestor
25035781|NCT03553238|Dermatologic Agents|dermatologic agents|mesh-ancestor
25035782|NCT03553238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25035783|NCT03553238|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25035784|NCT03553238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25035785|NCT03553238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25035786|NCT03553238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25035787|NCT03553238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25035816|NCT03553173|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25035817|NCT03553173|Cholinergic Agents|cholinergic agents|mesh-ancestor
25035818|NCT03553108|Olaparib|olaparib|mesh-list
25035819|NCT03553108|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25035820|NCT03553108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25035821|NCT03553108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035822|NCT03553108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25035823|NCT03553082|Propofol|propofol|mesh-list
25035824|NCT03553082|Sevoflurane|sevoflurane|mesh-list
25035825|NCT03553082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25035826|NCT03553082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25035827|NCT03553082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035828|NCT03553082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25035829|NCT03553082|Anesthetics, General|anesthetics, general|mesh-ancestor
25035831|NCT03553082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25035832|NCT03553082|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25035833|NCT03552770|Bevacizumab|bevacizumab|mesh-list
25035834|NCT03552770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25035835|NCT03552770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25035846|NCT03552705|Coagulants|coagulants|mesh-ancestor
25035847|NCT03552666|Vitamin D|vitamin d|mesh-list
25035848|NCT03552666|Cholecalciferol|cholecalciferol|mesh-list
25035849|NCT03552666|Vitamins|vitamins|mesh-ancestor
25035850|NCT03552666|Micronutrients|micronutrients|mesh-ancestor
25035851|NCT03552666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035852|NCT03552666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24603345|NCT00973310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036036|NCT03551067|Anesthetics|anesthetics|mesh-ancestor
25035853|NCT03552666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24756800|NCT01735825|Everolimus|everolimus|mesh-list
25035855|NCT03552653|Ergocalciferols|ergocalciferols|mesh-list
25035856|NCT03552653|Cholecalciferol|cholecalciferol|mesh-list
25035857|NCT03552653|Vitamins|vitamins|mesh-list
25258900|NCT02467335|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25258901|NCT02467335|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25258902|NCT02467335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258903|NCT02467400|Propranolol|propranolol|mesh-list
25258904|NCT02467400|Atenolol|atenolol|mesh-list
25258905|NCT02467400|Nebivolol|nebivolol|mesh-list
25258906|NCT02467400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25258907|NCT02467400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25258908|NCT02467400|Adrenergic Agents|adrenergic agents|mesh-ancestor
25258909|NCT02467400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25258910|NCT02467400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258911|NCT02467400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258912|NCT02467400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24930816|NCT04096768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930817|NCT04096768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24930818|NCT04096768|Analgesics|analgesics|mesh-ancestor
24930819|NCT04096768|Sensory System Agents|sensory system agents|mesh-ancestor
24930820|NCT04096768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24930821|NCT04096768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24930822|NCT04096768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24930823|NCT04096768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24930824|NCT04096768|Adrenergic Agents|adrenergic agents|mesh-ancestor
24930825|NCT04096768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24930826|NCT04096768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930827|NCT04096768|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24930828|NCT04096768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24930829|NCT04096768|Anesthetics, General|anesthetics, general|mesh-ancestor
24930830|NCT04096768|Anesthetics|anesthetics|mesh-ancestor
25035858|NCT03552653|Micronutrients|micronutrients|mesh-ancestor
25035859|NCT03552653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035860|NCT03552653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25035861|NCT03552653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25035862|NCT03552601|Methamphetamine|methamphetamine|mesh-list
25035863|NCT03552601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25035864|NCT03552601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035865|NCT03552601|Sympathomimetics|sympathomimetics|mesh-ancestor
25035866|NCT03552601|Autonomic Agents|autonomic agents|mesh-ancestor
25035867|NCT03552601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25035868|NCT03552601|Dopamine Agents|dopamine agents|mesh-ancestor
25035869|NCT03552601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25035870|NCT03552601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035871|NCT03552601|Adrenergic Agents|adrenergic agents|mesh-ancestor
25035872|NCT03552601|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25035873|NCT03552601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25035874|NCT03552601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25035875|NCT03552601|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25035876|NCT03552575|Valsartan|valsartan|mesh-list
25035877|NCT03552575|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25035878|NCT03552575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25035879|NCT03552575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25035880|NCT03552575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25035882|NCT03552406|Cetuximab|cetuximab|mesh-list
25035895|NCT03552315|Micronutrients|micronutrients|mesh-ancestor
25035896|NCT03552315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035897|NCT03552211|Biotin|biotin|mesh-list
25035898|NCT03552211|Vitamin B Complex|vitamin b complex|mesh-ancestor
25035899|NCT03552211|Vitamins|vitamins|mesh-ancestor
25035900|NCT03552211|Micronutrients|micronutrients|mesh-ancestor
25035901|NCT03552211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035902|NCT03552146|Dexmedetomidine|dexmedetomidine|mesh-list
25035903|NCT03552146|Propofol|propofol|mesh-list
25035904|NCT03552146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25035905|NCT03552146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25035906|NCT03552146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035907|NCT03552146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25035908|NCT03552146|Anesthetics, General|anesthetics, general|mesh-ancestor
25035910|NCT03552146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25035911|NCT03552146|Analgesics|analgesics|mesh-ancestor
25035912|NCT03552146|Sensory System Agents|sensory system agents|mesh-ancestor
25258921|NCT02467400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25692619|NCT02002884|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24757012|NCT01737177|Growth Inhibitors|growth inhibitors|mesh-ancestor
24757013|NCT01737177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24757014|NCT01737177|Alkylating Agents|alkylating agents|mesh-ancestor
24757015|NCT01737177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258922|NCT02467517|Magnesium Sulfate|magnesium sulfate|mesh-list
25258924|NCT02467517|Analgesics|analgesics|mesh-ancestor
25258925|NCT02467517|Sensory System Agents|sensory system agents|mesh-ancestor
25258926|NCT02467517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25258927|NCT02467517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258928|NCT02467517|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24930831|NCT04096768|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24930832|NCT04096768|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24930834|NCT04096599|Cariostatic Agents|cariostatic agents|mesh-ancestor
24930835|NCT04096599|Protective Agents|protective agents|mesh-ancestor
24930836|NCT04096599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930837|NCT04096742|Tretinoin|tretinoin|mesh-list
24930846|NCT04096690|Immunologic Factors|immunologic factors|mesh-ancestor
24930847|NCT04096690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930848|NCT04096690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24930849|NCT04096547|Rivaroxaban|rivaroxaban|mesh-list
25035970|NCT03551561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25035971|NCT03551561|Disinfectants|disinfectants|mesh-ancestor
25035972|NCT03551561|Dermatologic Agents|dermatologic agents|mesh-ancestor
25035973|NCT03551548|Spironolactone|spironolactone|mesh-list
25035974|NCT03551548|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25035975|NCT03551548|Hormone Antagonists|hormone antagonists|mesh-ancestor
25035976|NCT03551548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25035977|NCT03551548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035978|NCT03551548|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25035979|NCT03551548|Diuretics|diuretics|mesh-ancestor
25035980|NCT03551548|Natriuretic Agents|natriuretic agents|mesh-ancestor
25035981|NCT03551210|Levofloxacin|levofloxacin|mesh-list
25035982|NCT03551210|Ofloxacin|ofloxacin|mesh-list
25035983|NCT03551210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25035984|NCT03551210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25035985|NCT03551210|Renal Agents|renal agents|mesh-ancestor
25035986|NCT03551210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25035987|NCT03551210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25035988|NCT03551210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25035989|NCT03551210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25035990|NCT03551210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035991|NCT03551210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25035992|NCT03551210|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25035993|NCT03551210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25035994|NCT03551197|Budesonide|budesonide|mesh-list
25035995|NCT03551197|Formoterol Fumarate|formoterol fumarate|mesh-list
25035996|NCT03551197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25035997|NCT03551197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25035998|NCT03551197|Autonomic Agents|autonomic agents|mesh-ancestor
25035999|NCT03551197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25036000|NCT03551197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036001|NCT03551197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25036002|NCT03551197|Respiratory System Agents|respiratory system agents|mesh-ancestor
25036003|NCT03551197|Glucocorticoids|glucocorticoids|mesh-ancestor
25036004|NCT03551197|Hormones|hormones|mesh-ancestor
24603530|NCT00974272|Exenatide|exenatide|mesh-list
24899413|NCT04403724|Fentanyl|fentanyl|mesh-list
25036035|NCT03551067|Anesthetics, General|anesthetics, general|mesh-ancestor
25036037|NCT03551067|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25036038|NCT03551067|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25036039|NCT03551067|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25036040|NCT03551067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25036041|NCT03551067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25258929|NCT02467517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25688008|NCT01939496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688009|NCT01939496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25688010|NCT01939496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688011|NCT01939899|Ixazomib|ixazomib|mesh-list
25688012|NCT01939899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688013|NCT01939899|Protease Inhibitors|protease inhibitors|mesh-ancestor
25688014|NCT01939899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25258930|NCT02467517|Anesthetics, General|anesthetics, general|mesh-ancestor
25404313|NCT03675256|Immunologic Factors|immunologic factors|mesh-ancestor
25258932|NCT02467517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25258933|NCT02467517|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25258934|NCT02467517|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25258935|NCT02467517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25258936|NCT02467517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258937|NCT02467517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25258938|NCT02467517|Anticonvulsants|anticonvulsants|mesh-ancestor
24930850|NCT04096547|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24930851|NCT04096547|Antithrombins|antithrombins|mesh-ancestor
24930852|NCT04096547|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24930853|NCT04096547|Protease Inhibitors|protease inhibitors|mesh-ancestor
24930854|NCT04096547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24930855|NCT04096547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930856|NCT04096547|Anticoagulants|anticoagulants|mesh-ancestor
24930857|NCT04096157|Isavuconazole|isavuconazole|mesh-list
24624921|NCT01079351|Antimanic Agents|antimanic agents|mesh-ancestor
25155514|NCT05353140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24624922|NCT01079351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24624923|NCT01079351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24800022|NCT01972906|Analgesics|analgesics|mesh-ancestor
25036042|NCT03551067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25036043|NCT03551067|GABA Modulators|gaba modulators|mesh-ancestor
25036044|NCT03551067|GABA Agents|gaba agents|mesh-ancestor
24603691|NCT00974987|Temozolomide|temozolomide|mesh-list
25036078|NCT03550677|Anesthetics|anesthetics|mesh-list
25036079|NCT03550677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25036080|NCT03550677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036081|NCT03550651|Chlorhexidine|chlorhexidine|mesh-list
25036082|NCT03550651|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25036083|NCT03550651|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25036084|NCT03550651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25036085|NCT03550651|Disinfectants|disinfectants|mesh-ancestor
25036086|NCT03550651|Dermatologic Agents|dermatologic agents|mesh-ancestor
25036103|NCT03549975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036104|NCT03549975|Cholinergic Agents|cholinergic agents|mesh-ancestor
25036105|NCT03549975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25036106|NCT03549975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036107|NCT03549975|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25036108|NCT03549975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25036109|NCT03549923|Esmolol|esmolol|mesh-list
25036110|NCT03549923|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25036111|NCT03549923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25036112|NCT03549923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25036113|NCT03549923|Adrenergic Agents|adrenergic agents|mesh-ancestor
25036114|NCT03549923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25036115|NCT03549923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036116|NCT03549923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036117|NCT03549897|Albuterol|albuterol|mesh-list
25036118|NCT03549897|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25036151|NCT03549741|Clomiphene|clomiphene|mesh-list
25036152|NCT03549741|Enclomiphene|enclomiphene|mesh-list
25036153|NCT03549741|Zuclomiphene|zuclomiphene|mesh-list
25036154|NCT03549741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036155|NCT03549741|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25036156|NCT03549741|Hormone Antagonists|hormone antagonists|mesh-ancestor
25036157|NCT03549741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25036158|NCT03549741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036159|NCT03549741|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25036160|NCT03549741|Fertility Agents|fertility agents|mesh-ancestor
25036161|NCT03549741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25036162|NCT03549741|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25036163|NCT03549741|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25036164|NCT03549741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25036165|NCT03549741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25036166|NCT03549741|Dopamine Agonists|dopamine agonists|mesh-ancestor
25036167|NCT03549741|Dopamine Agents|dopamine agents|mesh-ancestor
25036168|NCT03549741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25036169|NCT03549728|Lenograstim|lenograstim|mesh-list
25036170|NCT03549728|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25258939|NCT02467517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25258940|NCT02467517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25258941|NCT02467517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25258942|NCT02467517|Tocolytic Agents|tocolytic agents|mesh-ancestor
25258943|NCT02467517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25258944|NCT02467673|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25258945|NCT02467673|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25258946|NCT02467673|Estradiol|estradiol|mesh-list
25258947|NCT02467673|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25258948|NCT02467673|Progesterone|progesterone|mesh-list
25258949|NCT02467673|Estrogens|estrogens|mesh-ancestor
25258950|NCT02467673|Hormones|hormones|mesh-ancestor
25258951|NCT02467673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24624924|NCT01079351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624925|NCT01079351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24624926|NCT01079351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24624927|NCT01079351|Analgesics|analgesics|mesh-ancestor
24624928|NCT01079351|Sensory System Agents|sensory system agents|mesh-ancestor
24624929|NCT01079351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24624930|NCT01079351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24624931|NCT01079351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24624932|NCT01079351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624933|NCT01079351|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24624934|NCT01079351|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24624936|NCT01079364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24624937|NCT01079364|Insulin Glargine|insulin glargine|mesh-list
25036171|NCT03549728|Immunologic Factors|immunologic factors|mesh-ancestor
25036172|NCT03549728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036173|NCT03549702|Povidone-Iodine|povidone-iodine|mesh-list
25036174|NCT03549702|Povidone|povidone|mesh-list
25036175|NCT03549702|Plasma Substitutes|plasma substitutes|mesh-ancestor
25036176|NCT03549702|Blood Substitutes|blood substitutes|mesh-ancestor
25036177|NCT03549702|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25036178|NCT03549702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25036179|NCT03549689|Tenofovir|tenofovir|mesh-list
25036180|NCT03549689|Lamivudine|lamivudine|mesh-list
24817817|NCT02085655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25036255|NCT03549221|Epinephrine|epinephrine|mesh-list
25036256|NCT03549221|Levobupivacaine|levobupivacaine|mesh-list
25036257|NCT03549221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25036258|NCT03549221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25036259|NCT03549221|Adrenergic Agents|adrenergic agents|mesh-ancestor
25036260|NCT03549221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25036261|NCT03549221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036262|NCT03549221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036263|NCT03549221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25036264|NCT03549221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25036265|NCT03549221|Autonomic Agents|autonomic agents|mesh-ancestor
25036266|NCT03549221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25036267|NCT03549221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25036268|NCT03549221|Respiratory System Agents|respiratory system agents|mesh-ancestor
25036269|NCT03549221|Mydriatics|mydriatics|mesh-ancestor
25036270|NCT03549221|Sympathomimetics|sympathomimetics|mesh-ancestor
25036271|NCT03549221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25036272|NCT03549221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25036273|NCT03549221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25036274|NCT03549221|Analgesics|analgesics|mesh-ancestor
25036275|NCT03549221|Sensory System Agents|sensory system agents|mesh-ancestor
25036276|NCT03549221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25036277|NCT03549221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25036278|NCT03549221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25036279|NCT03549221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036280|NCT03549221|Anesthetics, Local|anesthetics, local|mesh-ancestor
25036281|NCT03549221|Anesthetics|anesthetics|mesh-ancestor
25036284|NCT03549208|Immunologic Factors|immunologic factors|mesh-ancestor
25036296|NCT03549026|Antidepressive Agents|antidepressive agents|mesh-ancestor
25036297|NCT03549026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25036298|NCT03549026|Dopamine Agents|dopamine agents|mesh-ancestor
25036299|NCT03548948|Iron|iron|mesh-list
25036300|NCT03548948|Trace Elements|trace elements|mesh-ancestor
25036301|NCT03548948|Micronutrients|micronutrients|mesh-ancestor
25036302|NCT03548948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036303|NCT03548818|Interferons|interferons|mesh-list
25036304|NCT03548818|Interferon-gamma|interferon-gamma|mesh-list
24930892|NCT04095312|Pancrelipase|pancrelipase|mesh-list
25036305|NCT03548818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25036306|NCT03548818|Antiviral Agents|antiviral agents|mesh-ancestor
25258952|NCT02467673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258953|NCT02467673|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25258954|NCT02467673|Contraceptive Agents|contraceptive agents|mesh-ancestor
25258955|NCT02467673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25258956|NCT02467673|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25692620|NCT02002884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25258957|NCT02467673|Progestins|progestins|mesh-ancestor
25258959|NCT02467023|Fentanyl|fentanyl|mesh-list
25258960|NCT02467023|Midazolam|midazolam|mesh-list
25258961|NCT02467023|Anesthetics, Local|anesthetics, local|mesh-ancestor
25258962|NCT02467023|Anesthetics|anesthetics|mesh-ancestor
25258963|NCT02467023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25258964|NCT02467023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258965|NCT02467023|Sensory System Agents|sensory system agents|mesh-ancestor
25275125|NCT02373735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24624952|NCT01079455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24624953|NCT01079455|Immunologic Factors|immunologic factors|mesh-ancestor
24624954|NCT01079455|Viscosupplements|viscosupplements|mesh-ancestor
24624955|NCT01079455|Protective Agents|protective agents|mesh-ancestor
24624956|NCT01079455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24624957|NCT01079481|Everolimus|everolimus|mesh-list
24624958|NCT01079481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624960|NCT01079481|Immunologic Factors|immunologic factors|mesh-ancestor
24624961|NCT01079481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624962|NCT01079559|Tobramycin|tobramycin|mesh-list
24624963|NCT01079559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24624964|NCT01079559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24624965|NCT01079624|Glucagon|glucagon|mesh-list
24624966|NCT01079624|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24624967|NCT01079624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24528964|NCT00624000|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25036328|NCT03548493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25036329|NCT03548493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036338|NCT03548493|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25036339|NCT03548493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25036341|NCT03548493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25036342|NCT03548493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25036343|NCT03548493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036344|NCT03548493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25036345|NCT03548493|Tocolytic Agents|tocolytic agents|mesh-ancestor
25036346|NCT03548493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25036347|NCT03548311|Vitamin B 12|vitamin b 12|mesh-list
25036348|NCT03548311|Vitamin B Complex|vitamin b complex|mesh-ancestor
25036349|NCT03548311|Vitamins|vitamins|mesh-ancestor
25036350|NCT03548311|Micronutrients|micronutrients|mesh-ancestor
25036351|NCT03548311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603944|NCT00976261|Incretins|incretins|mesh-ancestor
25258966|NCT02467023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25258967|NCT02467023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25258968|NCT02467023|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25258969|NCT02467023|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25258970|NCT02467023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25258971|NCT02467023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25258972|NCT02467023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25258973|NCT02467023|Narcotics|narcotics|mesh-ancestor
25258974|NCT02467023|Analgesics|analgesics|mesh-ancestor
25258975|NCT02467023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25258976|NCT02467023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25258977|NCT02467023|Anesthetics, General|anesthetics, general|mesh-ancestor
25258978|NCT02467023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25258979|NCT02467023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25258980|NCT02467023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25258981|NCT02467023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25258982|NCT02467023|GABA Modulators|gaba modulators|mesh-ancestor
25258983|NCT02467023|GABA Agents|gaba agents|mesh-ancestor
24414707|NCT00198523|Tobramycin|tobramycin|mesh-list
25258984|NCT02467023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25258985|NCT02467127|Vitamin D|vitamin d|mesh-list
25258986|NCT02467127|Vitamins|vitamins|mesh-ancestor
25258987|NCT02467127|Micronutrients|micronutrients|mesh-ancestor
24507113|NCT00548704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528997|NCT00624143|Amphotericin B|amphotericin b|mesh-list
24603988|NCT00976690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24899446|NCT04403555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25036389|NCT03547895|Coagulants|coagulants|mesh-ancestor
25036390|NCT03547895|Antioxidants|antioxidants|mesh-ancestor
25036391|NCT03547895|Protective Agents|protective agents|mesh-ancestor
25036393|NCT03547830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25036394|NCT03547830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25036395|NCT03547830|Antiviral Agents|antiviral agents|mesh-ancestor
25036396|NCT03547830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25036397|NCT03547804|Apatinib|apatinib|mesh-list
25036398|NCT03547804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604079|NCT00977054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036444|NCT03547505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036446|NCT03547375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25036447|NCT03547375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25036448|NCT03547375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036449|NCT03547375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036450|NCT03547362|Caseins|caseins|mesh-list
25036451|NCT03547362|Chelating Agents|chelating agents|mesh-ancestor
25036452|NCT03547362|Sequestering Agents|sequestering agents|mesh-ancestor
25036453|NCT03547362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036454|NCT03547232|Indomethacin|indomethacin|mesh-list
25036455|NCT03547232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25036457|NCT03547232|Analgesics|analgesics|mesh-ancestor
25036458|NCT03547232|Sensory System Agents|sensory system agents|mesh-ancestor
25036459|NCT03547232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25036460|NCT03547232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036461|NCT03547232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25036462|NCT03547232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25036463|NCT03547232|Gout Suppressants|gout suppressants|mesh-ancestor
25036464|NCT03547232|Tocolytic Agents|tocolytic agents|mesh-ancestor
25036465|NCT03547232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25036466|NCT03547232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25036467|NCT03547232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036468|NCT03547232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036469|NCT03547219|Citalopram|citalopram|mesh-list
25036470|NCT03547219|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25036489|NCT03547024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25258989|NCT02467127|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25258990|NCT02466984|Metoclopramide|metoclopramide|mesh-list
25258991|NCT02466984|Antiemetics|antiemetics|mesh-ancestor
25258992|NCT02466984|Autonomic Agents|autonomic agents|mesh-ancestor
25258993|NCT02466984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25258994|NCT02466984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25258995|NCT02466984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25258996|NCT02466984|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25258997|NCT02466984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25258998|NCT02466984|Dopamine Agents|dopamine agents|mesh-ancestor
25258999|NCT02466984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25275126|NCT02373735|Diuretics|diuretics|mesh-ancestor
24528998|NCT00624143|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24529003|NCT00624143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529005|NCT00624143|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24529015|NCT00624182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24529016|NCT00624182|Antimetabolites|antimetabolites|mesh-ancestor
24529017|NCT00624182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529018|NCT00624182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24529019|NCT00624182|Antiviral Agents|antiviral agents|mesh-ancestor
24529020|NCT00624182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24529021|NCT00624182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529022|NCT00624182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24529023|NCT00624182|Immunologic Factors|immunologic factors|mesh-ancestor
24624968|NCT01079624|Hormones|hormones|mesh-ancestor
24624969|NCT01079624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24624970|NCT01079624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930858|NCT04096157|Antifungal Agents|antifungal agents|mesh-ancestor
25036490|NCT03547024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25036491|NCT03547024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036492|NCT03547024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25036493|NCT03547024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25036494|NCT03547024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25036495|NCT03547024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25036496|NCT03547024|Anesthetics, General|anesthetics, general|mesh-ancestor
25036547|NCT03546530|Antiviral Agents|antiviral agents|mesh-ancestor
25036548|NCT03546530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25036549|NCT03546530|Antioxidants|antioxidants|mesh-ancestor
25036550|NCT03546530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036551|NCT03546530|Protective Agents|protective agents|mesh-ancestor
25036552|NCT03546530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036553|NCT03546530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036554|NCT03546530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25036555|NCT03546426|Pembrolizumab|pembrolizumab|mesh-list
25036556|NCT03546426|Interleukin-2|interleukin-2|mesh-list
24945144|NCT03953326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945145|NCT03953235|Nivolumab|nivolumab|mesh-list
24945146|NCT03953235|Ipilimumab|ipilimumab|mesh-list
25036557|NCT03546426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25036558|NCT03546426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25036559|NCT03546426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25036560|NCT03546426|Analgesics|analgesics|mesh-ancestor
25036598|NCT03545997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25036599|NCT03545997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036600|NCT03545997|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25036601|NCT03545997|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25036602|NCT03545997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036603|NCT03545711|Irinotecan|irinotecan|mesh-list
25036604|NCT03545711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25036605|NCT03545711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25036606|NCT03545711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036607|NCT03545711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036608|NCT03545711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25036609|NCT03545516|Dexmedetomidine|dexmedetomidine|mesh-list
25036610|NCT03545516|Bupivacaine|bupivacaine|mesh-list
25036611|NCT03545516|Anesthetics, Local|anesthetics, local|mesh-ancestor
25036612|NCT03545516|Anesthetics|anesthetics|mesh-ancestor
25036613|NCT03545516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25036614|NCT03545516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259000|NCT02466984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259001|NCT02466997|Tacrolimus|tacrolimus|mesh-list
25259002|NCT02466997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25259003|NCT02466997|Immunologic Factors|immunologic factors|mesh-ancestor
24977027|NCT04666688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25259004|NCT02466997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259005|NCT02466997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25259006|NCT02466997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25259007|NCT02466997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275127|NCT02373735|Natriuretic Agents|natriuretic agents|mesh-ancestor
25275128|NCT02373735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275129|NCT02373449|Ketamine|ketamine|mesh-list
25275130|NCT02373449|Analgesics|analgesics|mesh-ancestor
25275131|NCT02373449|Sensory System Agents|sensory system agents|mesh-ancestor
25275132|NCT02373449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275133|NCT02373449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275134|NCT02373449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25275135|NCT02373449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24930859|NCT04096157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24930860|NCT04096144|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
24930861|NCT04096144|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24930862|NCT04096144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24930863|NCT04096144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930864|NCT04095754|Dexmedetomidine|dexmedetomidine|mesh-list
24930873|NCT04095754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24930874|NCT04095754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24930875|NCT04095754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24930876|NCT04095754|Adrenergic Agents|adrenergic agents|mesh-ancestor
24930877|NCT04095754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24930878|NCT04095754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930882|NCT04096027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24930883|NCT04096027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24930884|NCT04096027|Dopamine Agonists|dopamine agonists|mesh-ancestor
25036615|NCT03545516|Sensory System Agents|sensory system agents|mesh-ancestor
25036617|NCT03545516|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25036638|NCT03545347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25036639|NCT03545308|Rocuronium|rocuronium|mesh-list
25036640|NCT03545308|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25036641|NCT03545308|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25036642|NCT03545308|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25036643|NCT03545308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25036644|NCT03545308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036645|NCT03545243|Pantoprazole|pantoprazole|mesh-list
25036646|NCT03545243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25036647|NCT03545243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25036659|NCT03544827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25688015|NCT01939899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688016|NCT01939977|Calcifediol|calcifediol|mesh-list
25688017|NCT01939977|Vitamins|vitamins|mesh-ancestor
25036688|NCT03544710|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
25036689|NCT03544710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25259008|NCT02467010|Dexamethasone|dexamethasone|mesh-list
25259009|NCT02467010|Cyclophosphamide|cyclophosphamide|mesh-list
24977224|NCT03085056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977225|NCT03085056|Tubulin Modulators|tubulin modulators|mesh-ancestor
25259010|NCT02467010|Bortezomib|bortezomib|mesh-list
25259011|NCT02467010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25259012|NCT02467010|Immunologic Factors|immunologic factors|mesh-ancestor
25259013|NCT02467010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259014|NCT02467010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25259015|NCT02467010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25259016|NCT02467010|Alkylating Agents|alkylating agents|mesh-ancestor
25259017|NCT02467010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259018|NCT02467010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25259019|NCT02467010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25259020|NCT02467010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25259021|NCT02467010|Antiemetics|antiemetics|mesh-ancestor
25259022|NCT02467010|Autonomic Agents|autonomic agents|mesh-ancestor
25259023|NCT02467010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25259024|NCT02467010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25259025|NCT02467010|Glucocorticoids|glucocorticoids|mesh-ancestor
25259026|NCT02467010|Hormones|hormones|mesh-ancestor
25259027|NCT02467010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25259028|NCT02467010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25259029|NCT02466828|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25259030|NCT02466828|Hematinics|hematinics|mesh-ancestor
25259031|NCT02466828|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25259032|NCT02466828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25259033|NCT02466919|Amoxicillin|amoxicillin|mesh-list
24930885|NCT04096027|Dopamine Agents|dopamine agents|mesh-ancestor
24930886|NCT04096027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24930887|NCT04096027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930888|NCT04096027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930889|NCT04095832|Anesthetics|anesthetics|mesh-list
24930904|NCT04095390|Hormone Antagonists|hormone antagonists|mesh-ancestor
24930905|NCT04095390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25036691|NCT03544671|Vitamins|vitamins|mesh-ancestor
25036692|NCT03544671|Micronutrients|micronutrients|mesh-ancestor
25036693|NCT03544671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036694|NCT03544671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25036716|NCT03544229|Maleic acid|maleic acid|mesh-list
25036717|NCT03544229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036719|NCT03544125|Durvalumab|durvalumab|mesh-list
25259034|NCT02466919|Metronidazole|metronidazole|mesh-list
25259035|NCT02466919|Clarithromycin|clarithromycin|mesh-list
25259036|NCT02466919|Levofloxacin|levofloxacin|mesh-list
25259037|NCT02466919|Ofloxacin|ofloxacin|mesh-list
25259038|NCT02466919|Pantoprazole|pantoprazole|mesh-list
25259039|NCT02466919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25259040|NCT02466919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25259041|NCT02466919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25259042|NCT02466919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25259043|NCT02466919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25688018|NCT01939977|Micronutrients|micronutrients|mesh-ancestor
25688019|NCT01939977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688020|NCT01939977|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25688021|NCT01940276|Prednisone|prednisone|mesh-list
25688022|NCT01940276|Abiraterone Acetate|abiraterone acetate|mesh-list
25688023|NCT01940276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25688024|NCT01940276|Glucocorticoids|glucocorticoids|mesh-ancestor
25688025|NCT01940276|Hormones|hormones|mesh-ancestor
25688026|NCT01940276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25688027|NCT01940276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688028|NCT01940276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25259044|NCT02466919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25259045|NCT02466919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259046|NCT02466919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25259047|NCT02466919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25259048|NCT02466919|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25259049|NCT02466919|Renal Agents|renal agents|mesh-ancestor
25259050|NCT02466919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25259051|NCT02466919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25259052|NCT02466919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25259053|NCT02466919|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24930906|NCT04095390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930907|NCT04095455|Ketamine|ketamine|mesh-list
24930908|NCT04095455|Analgesics|analgesics|mesh-ancestor
24930909|NCT04095455|Sensory System Agents|sensory system agents|mesh-ancestor
24407041|NCT00171756|Valsartan|valsartan|mesh-list
24930913|NCT04095455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24930914|NCT04095455|Anesthetics, General|anesthetics, general|mesh-ancestor
24507112|NCT00548704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25036778|NCT03543683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036779|NCT03543683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25036793|NCT03543306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25036794|NCT03543306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25036795|NCT03543306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036796|NCT03543306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036797|NCT03543254|Botulinum Toxins|botulinum toxins|mesh-list
25036798|NCT03543254|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25036799|NCT03543254|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25036800|NCT03543254|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24977271|NCT02861183|Protective Agents|protective agents|mesh-ancestor
25036801|NCT03543254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25036802|NCT03543254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036803|NCT03543254|Cholinergic Agents|cholinergic agents|mesh-ancestor
25036804|NCT03543254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25036805|NCT03543254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036806|NCT03543254|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24604488|NCT00979706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24604489|NCT00979706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25036813|NCT03543072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036815|NCT03542955|Analgesics|analgesics|mesh-list
25036816|NCT03542955|Sensory System Agents|sensory system agents|mesh-ancestor
25036817|NCT03542955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25036818|NCT03542955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036819|NCT03542955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25036820|NCT03542955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25036821|NCT03542955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25036822|NCT03542955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25036823|NCT03542955|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25036824|NCT03542955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25036825|NCT03542955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036826|NCT03542955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259054|NCT02466919|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25259055|NCT02466919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25259056|NCT02466919|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25259057|NCT02466802|Sildenafil Citrate|sildenafil citrate|mesh-list
25259058|NCT02466802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259059|NCT02466802|Vasodilator Agents|vasodilator agents|mesh-ancestor
25259060|NCT02466802|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25259061|NCT02466802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25259062|NCT02466802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25259063|NCT02466802|Urological Agents|urological agents|mesh-ancestor
25259064|NCT02466503|Fluticasone|fluticasone|mesh-list
25259065|NCT02466503|Xhance|xhance|mesh-list
25259066|NCT02466503|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25259067|NCT02466503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24529028|NCT00624208|Autonomic Agents|autonomic agents|mesh-ancestor
24529029|NCT00624208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24529030|NCT00624208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529031|NCT00624208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24529032|NCT00624208|Antipruritics|antipruritics|mesh-ancestor
24529033|NCT00624208|Dermatologic Agents|dermatologic agents|mesh-ancestor
24529034|NCT00624208|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24529035|NCT00624208|Serotonin Agents|serotonin agents|mesh-ancestor
24529037|NCT00624208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529039|NCT00624208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24529055|NCT00624312|Hematinics|hematinics|mesh-ancestor
24529056|NCT00624325|Interferons|interferons|mesh-list
24529057|NCT00624325|Interferon-alpha|interferon-alpha|mesh-list
24529058|NCT00624325|Interferon alpha-2|interferon alpha-2|mesh-list
24977339|NCT01974609|Narcotics|narcotics|mesh-list
24529059|NCT00624325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24529060|NCT00624325|Antiviral Agents|antiviral agents|mesh-ancestor
24529061|NCT00624325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24930915|NCT04095455|Anesthetics|anesthetics|mesh-ancestor
24930916|NCT04095455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24930917|NCT04095455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24951442|NCT03904732|Aspirin|aspirin|mesh-list
24993450|NCT04783233|Chelating Agents|chelating agents|mesh-ancestor
24993461|NCT04707183|Lidocaine|lidocaine|mesh-list
24588820|NCT00904397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588822|NCT00904436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24588823|NCT00904436|Autonomic Agents|autonomic agents|mesh-ancestor
24588824|NCT00904436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588825|NCT00904436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588826|NCT00904436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24588827|NCT00904436|Respiratory System Agents|respiratory system agents|mesh-ancestor
24588839|NCT00904449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588840|NCT00904449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25036838|NCT03542825|Trace Elements|trace elements|mesh-ancestor
25036839|NCT03542825|Micronutrients|micronutrients|mesh-ancestor
25036840|NCT03542825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036841|NCT03542825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25036842|NCT03542825|Chelating Agents|chelating agents|mesh-ancestor
25036843|NCT03542825|Sequestering Agents|sequestering agents|mesh-ancestor
25036844|NCT03542825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036845|NCT03542760|Methylene Blue|methylene blue|mesh-list
25036846|NCT03542760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036847|NCT03542760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036870|NCT03542552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25036871|NCT03542552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25036872|NCT03542552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036874|NCT03542552|Tocolytic Agents|tocolytic agents|mesh-ancestor
25036933|NCT03542149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036934|NCT03542149|Protective Agents|protective agents|mesh-ancestor
25259068|NCT02466503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25259069|NCT02466503|Autonomic Agents|autonomic agents|mesh-ancestor
25259070|NCT02466503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25259071|NCT02466503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259072|NCT02466503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25259073|NCT02466503|Respiratory System Agents|respiratory system agents|mesh-ancestor
25259074|NCT02466503|Dermatologic Agents|dermatologic agents|mesh-ancestor
25259075|NCT02466503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25259076|NCT02466503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25259077|NCT02466503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25259078|NCT02466503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25259079|NCT02466503|Adrenergic Agents|adrenergic agents|mesh-ancestor
25259080|NCT02466503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25259081|NCT02466503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259082|NCT02466568|Nivolumab|nivolumab|mesh-list
25259083|NCT02466568|Vaccines|vaccines|mesh-list
25259084|NCT02466568|Immunologic Factors|immunologic factors|mesh-ancestor
25259085|NCT02466568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259086|NCT02466568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25259087|NCT02466568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25259088|NCT02466568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25259089|NCT02466568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930918|NCT04095455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24930919|NCT04095455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24930920|NCT04095455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930921|NCT04095182|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
24930922|NCT04095182|Anticonvulsants|anticonvulsants|mesh-ancestor
24930923|NCT04095182|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24930924|NCT04095182|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24930927|NCT04095299|Capecitabine|capecitabine|mesh-list
24951456|NCT03904732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036935|NCT03542149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036937|NCT03542149|Micronutrients|micronutrients|mesh-ancestor
25036938|NCT03542058|Carvedilol|carvedilol|mesh-list
25036939|NCT03542058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25036940|NCT03542058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25036941|NCT03542058|Adrenergic Agents|adrenergic agents|mesh-ancestor
25036942|NCT03542058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25036943|NCT03542058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036944|NCT03542058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036945|NCT03542058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25036946|NCT03542058|Antioxidants|antioxidants|mesh-ancestor
25036947|NCT03542058|Protective Agents|protective agents|mesh-ancestor
25036948|NCT03542058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25036949|NCT03542058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25036950|NCT03542058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25036951|NCT03542058|Vasodilator Agents|vasodilator agents|mesh-ancestor
25036952|NCT03542058|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25036953|NCT03542058|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25036954|NCT03542006|Brinzolamide|brinzolamide|mesh-list
25036955|NCT03542006|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25036956|NCT03542006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036978|NCT03541928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25036979|NCT03541915|Magnesium Sulfate|magnesium sulfate|mesh-list
25036980|NCT03541915|Analgesics|analgesics|mesh-ancestor
25036981|NCT03541915|Sensory System Agents|sensory system agents|mesh-ancestor
25036982|NCT03541915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25036983|NCT03541915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036984|NCT03541915|Anesthetics|anesthetics|mesh-ancestor
25036985|NCT03541915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25036986|NCT03541915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25036987|NCT03541915|Anticonvulsants|anticonvulsants|mesh-ancestor
25036988|NCT03541915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24993551|NCT05416762|Vortioxetine|vortioxetine|mesh-list
24993622|NCT05415917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993623|NCT05415917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993624|NCT05415917|Antiviral Agents|antiviral agents|mesh-ancestor
24993625|NCT05415917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24993626|NCT05415917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24518438|NCT05059626|Hormones|hormones|mesh-ancestor
24604778|NCT00981721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604779|NCT00981773|Maraviroc|maraviroc|mesh-list
24604780|NCT00981773|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24588883|NCT00904605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588884|NCT00904605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24588885|NCT00904605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24588886|NCT00904605|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24588887|NCT00904605|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25259090|NCT02466490|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25259091|NCT02466490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25259092|NCT02466490|Diuretics|diuretics|mesh-ancestor
25259093|NCT02466490|Natriuretic Agents|natriuretic agents|mesh-ancestor
25259094|NCT02466490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259095|NCT02466490|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25259096|NCT02466490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25259097|NCT02466490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259098|NCT02466542|Esmolol|esmolol|mesh-list
25259099|NCT02466542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25259100|NCT02466542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25102790|NCT03166306|Growth Inhibitors|growth inhibitors|mesh-ancestor
24930928|NCT04095299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24930929|NCT04095299|Antimetabolites|antimetabolites|mesh-ancestor
24930930|NCT04095299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930931|NCT04095299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24930932|NCT04095169|Complement System Proteins|complement system proteins|mesh-list
24930933|NCT04095169|Complement C3|complement c3|mesh-list
24588923|NCT00904657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24588924|NCT00904657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588925|NCT00904657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588926|NCT00904709|Tranexamic Acid|tranexamic acid|mesh-list
24588927|NCT00904709|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24588928|NCT00904709|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25037016|NCT03541681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037018|NCT03541681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25037019|NCT03541668|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25037020|NCT03541668|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25037021|NCT03541668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25692621|NCT02002975|Pioglitazone|pioglitazone|mesh-list
25037022|NCT03541668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037023|NCT03541603|Simendan|simendan|mesh-list
25037024|NCT03541603|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25037025|NCT03541603|Vasodilator Agents|vasodilator agents|mesh-ancestor
25037026|NCT03541603|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25037027|NCT03541603|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25037028|NCT03541603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25259101|NCT02466542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25259102|NCT02466542|Adrenergic Agents|adrenergic agents|mesh-ancestor
25259103|NCT02466542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25259104|NCT02466542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259105|NCT02466542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259106|NCT02466698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25259107|NCT02466698|Metronidazole|metronidazole|mesh-list
25259108|NCT02466698|Vancomycin|vancomycin|mesh-list
25259109|NCT02466698|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25259110|NCT02466698|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25259111|NCT02466698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25259112|NCT02466698|Antitubercular Agents|antitubercular agents|mesh-ancestor
25259113|NCT02466698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25259114|NCT02466698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25259115|NCT02466698|Laxatives|laxatives|mesh-ancestor
25259116|NCT02466698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25259117|NCT02466477|Psychotropic Drugs|psychotropic drugs|mesh-list
25259118|NCT02466464|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
25259119|NCT02466464|Hemostatics|hemostatics|mesh-ancestor
25259120|NCT02466464|Coagulants|coagulants|mesh-ancestor
24930951|NCT04095013|Dexmedetomidine|dexmedetomidine|mesh-list
24930952|NCT04095013|Bupivacaine|bupivacaine|mesh-list
24930953|NCT04095013|Anesthetics, Local|anesthetics, local|mesh-ancestor
24930954|NCT04095013|Anesthetics|anesthetics|mesh-ancestor
24930955|NCT04095013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24930970|NCT04095013|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24930971|NCT04095013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24930972|NCT04095013|Anesthetics, General|anesthetics, general|mesh-ancestor
25037031|NCT03541603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037050|NCT03541031|Micronutrients|micronutrients|mesh-list
25037051|NCT03541031|Trace Elements|trace elements|mesh-list
25037052|NCT03541031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037088|NCT03540810|Antimalarials|antimalarials|mesh-ancestor
25037089|NCT03540810|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25037090|NCT03540810|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25037091|NCT03540810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25037092|NCT03540810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037093|NCT03540810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037094|NCT03540810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25037095|NCT03540628|Ascorbic Acid|ascorbic acid|mesh-list
25037096|NCT03540628|Thiamine|thiamine|mesh-list
25037097|NCT03540628|Vitamins|vitamins|mesh-ancestor
25037098|NCT03540628|Micronutrients|micronutrients|mesh-ancestor
25037099|NCT03540628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037149|NCT03539887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25037150|NCT03539887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037151|NCT03539887|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25037152|NCT03539887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25037154|NCT03539887|Anesthetics|anesthetics|mesh-ancestor
25037155|NCT03539887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25037156|NCT03539887|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25037157|NCT03539887|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25037160|NCT03539731|Piperazine|piperazine|mesh-list
24993863|NCT05335655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24993864|NCT05335655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259129|NCT02466373|Clonidine|clonidine|mesh-list
25259130|NCT02466373|Analgesics|analgesics|mesh-ancestor
25259131|NCT02466373|Sensory System Agents|sensory system agents|mesh-ancestor
25259132|NCT02466373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25259133|NCT02466373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259134|NCT02466373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25259135|NCT02466373|Sympatholytics|sympatholytics|mesh-ancestor
25259136|NCT02466373|Autonomic Agents|autonomic agents|mesh-ancestor
25259137|NCT02466373|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25259138|NCT02466373|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25259139|NCT02466373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25259140|NCT02466373|Adrenergic Agents|adrenergic agents|mesh-ancestor
24529066|NCT00624364|Biphasic Insulins|biphasic insulins|mesh-list
24529067|NCT00624364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24529068|NCT00624364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422472|NCT00222547|Anticestodal Agents|anticestodal agents|mesh-ancestor
24529069|NCT00624429|Budesonide|budesonide|mesh-list
24529070|NCT00624429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24529071|NCT00624429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24529072|NCT00624429|Autonomic Agents|autonomic agents|mesh-ancestor
24529073|NCT00624429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24993865|NCT05328336|Paclitaxel|paclitaxel|mesh-list
25037223|NCT03539328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25037224|NCT03539328|Tubulin Modulators|tubulin modulators|mesh-ancestor
25037225|NCT03539328|Antimitotic Agents|antimitotic agents|mesh-ancestor
25037236|NCT03539328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25037237|NCT03539328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25037238|NCT03539328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25037239|NCT03539328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25037276|NCT03539003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25037277|NCT03539003|Narcotics|narcotics|mesh-ancestor
25037278|NCT03539003|Analgesics|analgesics|mesh-ancestor
25037279|NCT03539003|Sensory System Agents|sensory system agents|mesh-ancestor
25037280|NCT03539003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25037282|NCT03538704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25037283|NCT03538704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977630|NCT02560298|Paclitaxel|paclitaxel|mesh-list
25037284|NCT03538691|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25037285|NCT03538691|Dexetimide|dexetimide|mesh-list
25037286|NCT03538691|Citalopram|citalopram|mesh-list
25037287|NCT03538691|Fluoxetine|fluoxetine|mesh-list
25037288|NCT03538691|Paroxetine|paroxetine|mesh-list
25037289|NCT03538691|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25037290|NCT03538691|Sertraline|sertraline|mesh-list
25037291|NCT03538691|Brexpiprazole|brexpiprazole|mesh-list
25037292|NCT03538691|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25037293|NCT03538691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25037294|NCT03538691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25037295|NCT03538691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037296|NCT03538691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25037297|NCT03538691|Serotonin Agents|serotonin agents|mesh-ancestor
25037300|NCT03538691|Antidepressive Agents|antidepressive agents|mesh-ancestor
25259141|NCT02466373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25259142|NCT02466373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259143|NCT02466347|Fluticasone|fluticasone|mesh-list
25259144|NCT02466347|Xhance|xhance|mesh-list
25259145|NCT02466347|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25259146|NCT02466347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25259147|NCT02466347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25259148|NCT02466347|Autonomic Agents|autonomic agents|mesh-ancestor
25275136|NCT02373449|Anesthetics, General|anesthetics, general|mesh-ancestor
24529074|NCT00624429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529075|NCT00624429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24529076|NCT00624429|Respiratory System Agents|respiratory system agents|mesh-ancestor
24529077|NCT00624429|Glucocorticoids|glucocorticoids|mesh-ancestor
24529078|NCT00624429|Hormones|hormones|mesh-ancestor
24529079|NCT00624429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24529080|NCT00624455|Gabapentin|gabapentin|mesh-list
24529081|NCT00624455|Analgesics|analgesics|mesh-ancestor
24529082|NCT00624455|Sensory System Agents|sensory system agents|mesh-ancestor
24930978|NCT04094805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24930979|NCT04094805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930980|NCT04094805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24930981|NCT04094805|Glucocorticoids|glucocorticoids|mesh-ancestor
24930982|NCT04094805|Hormones|hormones|mesh-ancestor
24800136|NCT01973751|Autonomic Agents|autonomic agents|mesh-ancestor
25037329|NCT03538483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037330|NCT03538483|Sensory System Agents|sensory system agents|mesh-ancestor
25037331|NCT03538483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25037332|NCT03538327|Silybin|silybin|mesh-list
25037333|NCT03538327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25037334|NCT03538327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25037335|NCT03538327|Protective Agents|protective agents|mesh-ancestor
25037336|NCT03538327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037337|NCT03538171|Exemestane|exemestane|mesh-list
25037338|NCT03538171|Entinostat|entinostat|mesh-list
25037339|NCT03538171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25037340|NCT03538171|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25037341|NCT03538171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25037342|NCT03538171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037343|NCT03538171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688029|NCT01940276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25037344|NCT03538171|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25037345|NCT03538171|Hormone Antagonists|hormone antagonists|mesh-ancestor
24899764|NCT04400188|Alkylating Agents|alkylating agents|mesh-ancestor
25037387|NCT03537768|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25037388|NCT03537612|Clonidine|clonidine|mesh-list
25037389|NCT03537612|Morphine|morphine|mesh-list
25037390|NCT03537612|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25037391|NCT03537612|Narcotics|narcotics|mesh-ancestor
25037394|NCT03537612|Analgesics|analgesics|mesh-ancestor
25037443|NCT03537443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25037445|NCT03537326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25037447|NCT03537326|Autonomic Agents|autonomic agents|mesh-ancestor
25037458|NCT03537287|Hormones|hormones|mesh-ancestor
24795248|NCT03464292|Capsaicin|capsaicin|mesh-list
25037459|NCT03537287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25037460|NCT03537287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037461|NCT03537196|Ribavirin|ribavirin|mesh-list
25037462|NCT03537196|Sofosbuvir|sofosbuvir|mesh-list
25037463|NCT03537196|Antimetabolites|antimetabolites|mesh-ancestor
25037464|NCT03537196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037465|NCT03537196|Antiviral Agents|antiviral agents|mesh-ancestor
25037466|NCT03537196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25037467|NCT03537157|Rifaximin|rifaximin|mesh-list
25037468|NCT03537157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25037469|NCT03537157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25037470|NCT03537157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25037471|NCT03537144|Acetaminophen|acetaminophen|mesh-list
25037472|NCT03537144|Indomethacin|indomethacin|mesh-list
25037473|NCT03537144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25037474|NCT03537144|Analgesics|analgesics|mesh-ancestor
25037475|NCT03537144|Sensory System Agents|sensory system agents|mesh-ancestor
25037476|NCT03537144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25037477|NCT03537144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259149|NCT02466347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25259150|NCT02466347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259151|NCT02466347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25259152|NCT02466347|Respiratory System Agents|respiratory system agents|mesh-ancestor
25259153|NCT02466347|Dermatologic Agents|dermatologic agents|mesh-ancestor
25259154|NCT02466347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25259155|NCT02466347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25259156|NCT02466347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25259157|NCT02466347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25259158|NCT02466347|Adrenergic Agents|adrenergic agents|mesh-ancestor
25259159|NCT02466347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25259160|NCT02466347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259161|NCT02466438|Tazobactam|tazobactam|mesh-list
25259162|NCT02466438|Piperacillin|piperacillin|mesh-list
24930983|NCT04094805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24930984|NCT04094805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24930985|NCT04094805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24930986|NCT04094805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24930987|NCT04094805|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24930988|NCT04094805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25037478|NCT03537144|Antipyretics|antipyretics|mesh-ancestor
25037479|NCT03537144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25037519|NCT03536780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25037521|NCT03536780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037522|NCT03536780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25037523|NCT03536780|Antiviral Agents|antiviral agents|mesh-ancestor
25037524|NCT03536780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25037525|NCT03536780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037526|NCT03536780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25037527|NCT03536780|Immunologic Factors|immunologic factors|mesh-ancestor
25037528|NCT03536780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037529|NCT03536780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25037530|NCT03536741|Anesthetics|anesthetics|mesh-list
25037565|NCT03536494|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25037566|NCT03536494|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25037567|NCT03536494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25037568|NCT03536494|Adrenergic Agents|adrenergic agents|mesh-ancestor
25037636|NCT03535961|Etoposide|etoposide|mesh-list
25037637|NCT03535961|Apatinib|apatinib|mesh-list
25037638|NCT03535961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25037639|NCT03535961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25037640|NCT03535961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25037641|NCT03535961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25037642|NCT03535961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037643|NCT03535961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037644|NCT03535961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25037645|NCT03535883|Anticoagulants|anticoagulants|mesh-list
25037646|NCT03535883|Coagulants|coagulants|mesh-list
25037647|NCT03535870|Fluticasone|fluticasone|mesh-list
25037648|NCT03535870|Xhance|xhance|mesh-list
25037649|NCT03535870|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25037650|NCT03535870|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25037651|NCT03535870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25037652|NCT03535870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25037653|NCT03535870|Autonomic Agents|autonomic agents|mesh-ancestor
25037654|NCT03535870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25037655|NCT03535870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037656|NCT03535870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25037660|NCT03535870|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25037661|NCT03535870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25259163|NCT02466438|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25259164|NCT02466438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25259165|NCT02466438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25259166|NCT02466438|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25259167|NCT02466438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25259168|NCT02466438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259169|NCT02466191|Gabapentin|gabapentin|mesh-list
24930989|NCT04094805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930991|NCT04094805|Vitamins|vitamins|mesh-ancestor
24930992|NCT04094805|Micronutrients|micronutrients|mesh-ancestor
24930993|NCT04094805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24930994|NCT04094909|Paclitaxel|paclitaxel|mesh-list
24931001|NCT04094909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931002|NCT04094909|Tubulin Modulators|tubulin modulators|mesh-ancestor
24931003|NCT04094909|Antimitotic Agents|antimitotic agents|mesh-ancestor
24931004|NCT04094909|Mitosis Modulators|mitosis modulators|mesh-ancestor
24931005|NCT04094909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931007|NCT04094909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24931008|NCT04094909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24931009|NCT04094909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25037662|NCT03535870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25037663|NCT03535870|Adrenergic Agents|adrenergic agents|mesh-ancestor
25037664|NCT03535870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25037665|NCT03535870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037666|NCT03535870|Glucocorticoids|glucocorticoids|mesh-ancestor
25037667|NCT03535870|Hormones|hormones|mesh-ancestor
25259353|NCT02464722|Propofol|propofol|mesh-list
25037668|NCT03535870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25037669|NCT03535870|Sympathomimetics|sympathomimetics|mesh-ancestor
25037670|NCT03535792|Fentanyl|fentanyl|mesh-list
25037671|NCT03535792|Nalbuphine|nalbuphine|mesh-list
25037672|NCT03535792|Bupivacaine|bupivacaine|mesh-list
25037673|NCT03535792|Anesthetics, Local|anesthetics, local|mesh-ancestor
25037674|NCT03535792|Anesthetics|anesthetics|mesh-ancestor
25037675|NCT03535792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25037685|NCT03535753|Decitabine|decitabine|mesh-list
25037686|NCT03535753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25037687|NCT03535753|Antimetabolites|antimetabolites|mesh-ancestor
25037688|NCT03535753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037689|NCT03535753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25037690|NCT03535753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037691|NCT03535701|Paclitaxel|paclitaxel|mesh-list
25037692|NCT03535701|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25037693|NCT03535701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25037694|NCT03535701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25037695|NCT03535701|Tubulin Modulators|tubulin modulators|mesh-ancestor
25037696|NCT03535701|Antimitotic Agents|antimitotic agents|mesh-ancestor
25037698|NCT03535701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037699|NCT03535662|Itraconazole|itraconazole|mesh-list
25037700|NCT03535662|Antifungal Agents|antifungal agents|mesh-ancestor
25037701|NCT03535662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25037702|NCT03535662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25037703|NCT03535662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24994332|NCT04535362|Nicotine|nicotine|mesh-list
25037704|NCT03535662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037705|NCT03535662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037706|NCT03535662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25037707|NCT03535662|Hormone Antagonists|hormone antagonists|mesh-ancestor
25037708|NCT03535662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25037709|NCT03535662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037710|NCT03535662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25037711|NCT03535558|Azithromycin|azithromycin|mesh-list
25259170|NCT02466191|Memantine|memantine|mesh-list
25259171|NCT02466191|Analgesics|analgesics|mesh-ancestor
25259172|NCT02466191|Sensory System Agents|sensory system agents|mesh-ancestor
25259173|NCT02466191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25259174|NCT02466191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259175|NCT02466191|Anticonvulsants|anticonvulsants|mesh-ancestor
25259176|NCT02466191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25259177|NCT02466191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25259178|NCT02466191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25259179|NCT02466191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25259180|NCT02466191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25259181|NCT02466191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25259182|NCT02466191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25259183|NCT02466191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259184|NCT02466191|Antimanic Agents|antimanic agents|mesh-ancestor
25259185|NCT02466191|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24931010|NCT04094909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25037712|NCT03535558|Fluoroquinolones|fluoroquinolones|mesh-list
25037713|NCT03535558|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25037714|NCT03535558|Trimethoprim|trimethoprim|mesh-list
25037715|NCT03535558|Sulfamethoxazole|sulfamethoxazole|mesh-list
25037716|NCT03535558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25037717|NCT03535558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25037746|NCT03535480|Lenograstim|lenograstim|mesh-list
25037747|NCT03535480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25037748|NCT03535480|Immunologic Factors|immunologic factors|mesh-ancestor
25037749|NCT03535480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037814|NCT03535220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25037815|NCT03535220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25259186|NCT02466191|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24931018|NCT04094727|Antimalarials|antimalarials|mesh-ancestor
24931019|NCT04094727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24931020|NCT04094727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24931021|NCT04094727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24931028|NCT04094597|Lactoferrin|lactoferrin|mesh-list
24931029|NCT04094597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24931030|NCT04094532|Bupivacaine|bupivacaine|mesh-list
24931031|NCT04094532|Anesthetics, Local|anesthetics, local|mesh-ancestor
24931033|NCT04094532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24931034|NCT04094532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931040|NCT04094467|Fertility Agents|fertility agents|mesh-ancestor
24931041|NCT04094467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24931042|NCT04094467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529083|NCT00624455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25037816|NCT03535220|Antiviral Agents|antiviral agents|mesh-ancestor
25037817|NCT03535220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25037818|NCT03535168|Midazolam|midazolam|mesh-list
25037819|NCT03535168|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25037820|NCT03535168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25037821|NCT03535168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25037822|NCT03535168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037823|NCT03535168|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25037824|NCT03535168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25037825|NCT03535168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25037826|NCT03535168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25037827|NCT03535168|Anesthetics, General|anesthetics, general|mesh-ancestor
25037828|NCT03535168|Anesthetics|anesthetics|mesh-ancestor
25037834|NCT03535103|Hormones|hormones|mesh-ancestor
25037842|NCT03535090|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25037843|NCT03535090|Prednisolone phosphate|prednisolone phosphate|mesh-list
25037844|NCT03535090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25037845|NCT03535090|Antiemetics|antiemetics|mesh-ancestor
25037846|NCT03535090|Autonomic Agents|autonomic agents|mesh-ancestor
25037847|NCT03535090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25037848|NCT03535090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037849|NCT03535090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25037850|NCT03535090|Glucocorticoids|glucocorticoids|mesh-ancestor
25037851|NCT03535090|Hormones|hormones|mesh-ancestor
25259187|NCT02466191|Dopamine Agents|dopamine agents|mesh-ancestor
25259188|NCT02466204|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25259189|NCT02466204|Hormones|hormones|mesh-ancestor
25259190|NCT02466204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24619918|NCT01054508|Nicotinic Acids|nicotinic acids|mesh-list
25259191|NCT02466204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259192|NCT02466022|Fentanyl|fentanyl|mesh-list
25259193|NCT02466022|Midazolam|midazolam|mesh-list
25259194|NCT02466022|Dexmedetomidine|dexmedetomidine|mesh-list
25259195|NCT02466022|Bupivacaine|bupivacaine|mesh-list
25259196|NCT02466022|Anesthetics, Local|anesthetics, local|mesh-ancestor
25259197|NCT02466022|Anesthetics|anesthetics|mesh-ancestor
25259198|NCT02466022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25259199|NCT02466022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259200|NCT02466022|Sensory System Agents|sensory system agents|mesh-ancestor
25259201|NCT02466022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25259202|NCT02466022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25259203|NCT02466022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25259204|NCT02466022|Analgesics|analgesics|mesh-ancestor
25259205|NCT02466022|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25259206|NCT02466022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25259207|NCT02466022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25259208|NCT02466022|Adrenergic Agents|adrenergic agents|mesh-ancestor
25259209|NCT02466022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25259210|NCT02466022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259211|NCT02466022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25259212|NCT02466022|Narcotics|narcotics|mesh-ancestor
24529084|NCT00624455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529085|NCT00624455|Anticonvulsants|anticonvulsants|mesh-ancestor
24529086|NCT00624455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24529087|NCT00624455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24394228|NCT00132600|Bacitracin|bacitracin|mesh-list
24800187|NCT01973868|Cetuximab|cetuximab|mesh-list
25037852|NCT03535090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25037853|NCT03535090|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25037854|NCT03535090|Protective Agents|protective agents|mesh-ancestor
25037855|NCT03535090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25037856|NCT03535090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25037903|NCT03534674|Vitamins|vitamins|mesh-ancestor
25037904|NCT03534674|Micronutrients|micronutrients|mesh-ancestor
25037905|NCT03534674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037906|NCT03534674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25037907|NCT03534674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25037908|NCT03534661|Teduglutide|teduglutide|mesh-list
25037909|NCT03534661|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
25037910|NCT03534661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037911|NCT03534661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037912|NCT03534661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25037913|NCT03534661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25037914|NCT03534661|Protective Agents|protective agents|mesh-ancestor
25037915|NCT03534661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037916|NCT03534505|Ketorolac|ketorolac|mesh-list
25037917|NCT03534505|Bupivacaine|bupivacaine|mesh-list
25037947|NCT03534310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25037948|NCT03534310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037949|NCT03534310|Incretins|incretins|mesh-ancestor
25037950|NCT03534310|Hormones|hormones|mesh-ancestor
25037951|NCT03534310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25037952|NCT03534297|Dapansutrile|dapansutrile|mesh-list
25037953|NCT03534297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25037954|NCT03534102|Analgesics, Opioid|analgesics, opioid|mesh-list
25037955|NCT03534102|Narcotics|narcotics|mesh-ancestor
25037956|NCT03534102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25037957|NCT03534102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037958|NCT03534102|Analgesics|analgesics|mesh-ancestor
25037959|NCT03534102|Sensory System Agents|sensory system agents|mesh-ancestor
25037960|NCT03534102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25037961|NCT03534037|Febuxostat|febuxostat|mesh-list
25037962|NCT03534037|Benzbromarone|benzbromarone|mesh-list
25105717|NCT05143970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25037963|NCT03534037|Gout Suppressants|gout suppressants|mesh-ancestor
25037964|NCT03534037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25037965|NCT03534037|Uricosuric Agents|uricosuric agents|mesh-ancestor
25037966|NCT03534037|Renal Agents|renal agents|mesh-ancestor
25037967|NCT03534024|Curcumin|curcumin|mesh-list
25037968|NCT03534024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25037969|NCT03534024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25037999|NCT03533699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038000|NCT03533699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038001|NCT03533699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25692622|NCT02002975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25051320|NCT00417118|Citalopram|citalopram|mesh-list
25038002|NCT03533699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25038003|NCT03533699|Vasodilator Agents|vasodilator agents|mesh-ancestor
25038004|NCT03533556|Caffeine|caffeine|mesh-list
25038005|NCT03533556|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25038006|NCT03533556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038007|NCT03533556|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25038008|NCT03533556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038009|NCT03533556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259213|NCT02466022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25259214|NCT02466022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25259215|NCT02466022|Anesthetics, General|anesthetics, general|mesh-ancestor
25259216|NCT02466022|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25259217|NCT02466022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25259218|NCT02466022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25259219|NCT02466022|GABA Modulators|gaba modulators|mesh-ancestor
25259220|NCT02466022|GABA Agents|gaba agents|mesh-ancestor
25259221|NCT02466035|Caseins|caseins|mesh-list
25259222|NCT02466035|Chelating Agents|chelating agents|mesh-ancestor
25259223|NCT02466035|Sequestering Agents|sequestering agents|mesh-ancestor
24529090|NCT00624455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24529091|NCT00624455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24529092|NCT00624455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24529093|NCT00624455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529094|NCT00624455|Antimanic Agents|antimanic agents|mesh-ancestor
24529095|NCT00624481|Teriparatide|teriparatide|mesh-list
24529096|NCT00624481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24529097|NCT00624481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529098|NCT00624481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24529099|NCT00624546|Lansoprazole|lansoprazole|mesh-list
24529100|NCT00624546|Dexlansoprazole|dexlansoprazole|mesh-list
24529101|NCT00624546|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24529102|NCT00624546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24529103|NCT00624546|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24931056|NCT04094142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931057|NCT04094142|Immunologic Factors|immunologic factors|mesh-ancestor
24931058|NCT04094142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259354|NCT02464722|Rocuronium|rocuronium|mesh-list
25038010|NCT03533556|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25038011|NCT03533556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25038012|NCT03533556|Purinergic Agents|purinergic agents|mesh-ancestor
25038013|NCT03533556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25038049|NCT03533231|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25038050|NCT03533231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25038052|NCT03533179|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25038053|NCT03533179|Esmolol|esmolol|mesh-list
25038054|NCT03533179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25038055|NCT03533179|Hormones|hormones|mesh-ancestor
25038056|NCT03533179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25038057|NCT03533179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038058|NCT03533179|Incretins|incretins|mesh-ancestor
24589041|NCT00905333|Candesartan cilexetil|candesartan cilexetil|mesh-list
24589042|NCT00905333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24516970|NCT00605098|Ritonavir|ritonavir|mesh-list
24589043|NCT00905333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24589044|NCT00905333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24589045|NCT00905333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589046|NCT00905333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24589047|NCT00905333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24589048|NCT00905333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24589049|NCT00905333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25259224|NCT02466035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259225|NCT02465814|Ulipristal acetate|ulipristal acetate|mesh-list
25259226|NCT02465814|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25259227|NCT02465814|Contraceptive Agents|contraceptive agents|mesh-ancestor
25259228|NCT02465814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25259229|NCT02465814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259230|NCT02465814|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25259231|NCT02465827|Ropivacaine|ropivacaine|mesh-list
25259232|NCT02465827|Anesthetics, Local|anesthetics, local|mesh-ancestor
25259233|NCT02465827|Anesthetics|anesthetics|mesh-ancestor
25259234|NCT02465827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25259235|NCT02465827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259236|NCT02465827|Sensory System Agents|sensory system agents|mesh-ancestor
25259237|NCT02465827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25259238|NCT02465983|Cyclophosphamide|cyclophosphamide|mesh-list
25259239|NCT02465983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25259240|NCT02465983|Immunologic Factors|immunologic factors|mesh-ancestor
25259241|NCT02465983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259242|NCT02465983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25259243|NCT02465983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25259244|NCT02465983|Alkylating Agents|alkylating agents|mesh-ancestor
25259245|NCT02465983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931059|NCT04094142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24931060|NCT04094142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24931061|NCT04094142|Growth Substances|growth substances|mesh-ancestor
24931062|NCT04094142|Growth Inhibitors|growth inhibitors|mesh-ancestor
24931063|NCT04093895|Taurolidine|taurolidine|mesh-list
24931064|NCT04093895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24931065|NCT04093895|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24931066|NCT04093895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931068|NCT04093518|Estrogens|estrogens|mesh-ancestor
24931069|NCT04093518|Hormones|hormones|mesh-ancestor
24931091|NCT04093206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931092|NCT04093206|Antioxidants|antioxidants|mesh-ancestor
24931093|NCT04093206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931094|NCT04093206|Protective Agents|protective agents|mesh-ancestor
24931095|NCT04093271|Diphenhydramine|diphenhydramine|mesh-list
24931096|NCT04093271|Promethazine|promethazine|mesh-list
24931097|NCT04093271|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24931098|NCT04093271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24931099|NCT04093271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24931100|NCT04093271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931101|NCT04093271|Anesthetics, Local|anesthetics, local|mesh-ancestor
24931103|NCT04093271|Sensory System Agents|sensory system agents|mesh-ancestor
24931104|NCT04093271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24931105|NCT04093271|Antiemetics|antiemetics|mesh-ancestor
24931106|NCT04093271|Autonomic Agents|autonomic agents|mesh-ancestor
24931107|NCT04093271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24931108|NCT04093271|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24931109|NCT04093271|Histamine Antagonists|histamine antagonists|mesh-ancestor
24931110|NCT04093271|Histamine Agents|histamine agents|mesh-ancestor
24931112|NCT04093271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931113|NCT04093271|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24931114|NCT04093271|Antipruritics|antipruritics|mesh-ancestor
24800224|NCT01974037|Capsaicin|capsaicin|mesh-list
24589050|NCT00905333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589051|NCT00905333|Vasodilator Agents|vasodilator agents|mesh-ancestor
24589052|NCT00905502|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24589054|NCT00905528|Ramipril|ramipril|mesh-list
24589055|NCT00905528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25259246|NCT02465983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25259247|NCT02465983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25259248|NCT02465749|Vitamins|vitamins|mesh-list
25259249|NCT02465749|Micronutrients|micronutrients|mesh-ancestor
25259250|NCT02465749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259251|NCT02465736|Cisplatin|cisplatin|mesh-list
25259252|NCT02465736|Docetaxel|docetaxel|mesh-list
25259253|NCT02465736|Vinorelbine|vinorelbine|mesh-list
25259254|NCT02465736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25259255|NCT02465736|Tubulin Modulators|tubulin modulators|mesh-ancestor
25259256|NCT02465736|Antimitotic Agents|antimitotic agents|mesh-ancestor
25259257|NCT02465736|Mitosis Modulators|mitosis modulators|mesh-ancestor
25259258|NCT02465736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259259|NCT02465736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25259260|NCT02465801|Lenograstim|lenograstim|mesh-list
25259261|NCT02465801|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25259262|NCT02465801|Immunologic Factors|immunologic factors|mesh-ancestor
25259263|NCT02465801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259264|NCT02465645|Carvedilol|carvedilol|mesh-list
25259265|NCT02465645|Simvastatin|simvastatin|mesh-list
25259266|NCT02465645|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24415931|NCT00201539|Morphine|morphine|mesh-list
25259267|NCT02465645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25259268|NCT02465645|Antimetabolites|antimetabolites|mesh-ancestor
25259269|NCT02465645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259270|NCT02465645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25259271|NCT02465645|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25259272|NCT02465645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25259273|NCT02465645|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25259274|NCT02465645|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25259275|NCT02465645|Adrenergic Agents|adrenergic agents|mesh-ancestor
25259276|NCT02465645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25259277|NCT02465645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259278|NCT02465645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25259279|NCT02465645|Antioxidants|antioxidants|mesh-ancestor
25259280|NCT02465645|Protective Agents|protective agents|mesh-ancestor
24931115|NCT04093271|Dermatologic Agents|dermatologic agents|mesh-ancestor
24931116|NCT04093050|Vasopressins|vasopressins|mesh-list
24931117|NCT04093050|Hemostatics|hemostatics|mesh-ancestor
24931118|NCT04093050|Coagulants|coagulants|mesh-ancestor
24931119|NCT04093050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24931120|NCT04093050|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24931121|NCT04093050|Natriuretic Agents|natriuretic agents|mesh-ancestor
24507304|NCT00549666|Serotonin Agents|serotonin agents|mesh-ancestor
24529105|NCT00624546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529106|NCT00624663|Rivastigmine|rivastigmine|mesh-list
24529172|NCT00624871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24529173|NCT00624871|Analgesics|analgesics|mesh-ancestor
24529174|NCT00624871|Sensory System Agents|sensory system agents|mesh-ancestor
24529175|NCT00624871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24529176|NCT00624871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24529177|NCT00624871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24529178|NCT00624871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24529179|NCT00624871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24931138|NCT04092621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931139|NCT04092621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24931140|NCT04092621|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24931141|NCT04092621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24931142|NCT04092621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24931143|NCT04092621|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24931144|NCT04092621|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24800254|NCT01974375|Fluconazole|fluconazole|mesh-list
24589056|NCT00905528|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24476992|NCT00416910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25038117|NCT03532854|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25038118|NCT03532841|Tramadol|tramadol|mesh-list
25038119|NCT03532841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25038120|NCT03532841|Narcotics|narcotics|mesh-ancestor
25038121|NCT03532841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25038122|NCT03532841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038126|NCT03532802|Metoprolol|metoprolol|mesh-list
25038173|NCT03532698|Aspirin|aspirin|mesh-list
25038174|NCT03532698|Osimertinib|osimertinib|mesh-list
25038175|NCT03532698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25038176|NCT03532698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25038177|NCT03532698|Analgesics|analgesics|mesh-ancestor
25038178|NCT03532698|Sensory System Agents|sensory system agents|mesh-ancestor
25038179|NCT03532698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25038180|NCT03532698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259281|NCT02465645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25259282|NCT02465645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25259283|NCT02465645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25259284|NCT02465645|Vasodilator Agents|vasodilator agents|mesh-ancestor
25259285|NCT02465645|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25259286|NCT02465645|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25259287|NCT02465853|Hyaluronic Acid|hyaluronic acid|mesh-list
25259288|NCT02465853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25259289|NCT02465853|Immunologic Factors|immunologic factors|mesh-ancestor
25259290|NCT02465853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259291|NCT02465853|Viscosupplements|viscosupplements|mesh-ancestor
25259292|NCT02465853|Protective Agents|protective agents|mesh-ancestor
25259293|NCT02465385|Linaclotide|linaclotide|mesh-list
25259294|NCT02465385|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25259295|NCT02465385|Enzyme Activators|enzyme activators|mesh-ancestor
25259296|NCT02465385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259297|NCT02465385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25259298|NCT02465359|Immunoglobulins|immunoglobulins|mesh-list
25259299|NCT02465359|Antibodies|antibodies|mesh-list
25259300|NCT02465359|gamma-Globulins|gamma-globulins|mesh-list
25259301|NCT02465359|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25259302|NCT02465359|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25259303|NCT02465359|Immunologic Factors|immunologic factors|mesh-ancestor
25259304|NCT02465359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259305|NCT02465320|Lidocaine|lidocaine|mesh-list
25259306|NCT02465320|Anesthetics, Local|anesthetics, local|mesh-ancestor
25259307|NCT02465320|Anesthetics|anesthetics|mesh-ancestor
25259308|NCT02465320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25259309|NCT02465320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931145|NCT04092621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24624975|NCT01079676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624976|NCT01079702|Capecitabine|capecitabine|mesh-list
24624977|NCT01079702|Everolimus|everolimus|mesh-list
24624978|NCT01079702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24624979|NCT01079702|Antimetabolites|antimetabolites|mesh-ancestor
24624980|NCT01079702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624981|NCT01079702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624982|NCT01079702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24624983|NCT01079702|Immunologic Factors|immunologic factors|mesh-ancestor
24624984|NCT01079702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624985|NCT01079715|Propranolol|propranolol|mesh-list
24624986|NCT01079715|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24624987|NCT01079715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24624988|NCT01079715|Adrenergic Agents|adrenergic agents|mesh-ancestor
24624989|NCT01079715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24624990|NCT01079715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529180|NCT00624871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529181|NCT00624871|Antioxidants|antioxidants|mesh-ancestor
25038181|NCT03532698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25038182|NCT03532698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25038183|NCT03532698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25038184|NCT03532698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25038185|NCT03532698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038186|NCT03532698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25038187|NCT03532698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25038188|NCT03532698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038189|NCT03532698|Antipyretics|antipyretics|mesh-ancestor
25038190|NCT03532698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038191|NCT03532698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24931265|NCT04091009|Analgesics|analgesics|mesh-ancestor
25038222|NCT05262608|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25038224|NCT05262608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038225|NCT05262608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038226|NCT05262465|Azacitidine|azacitidine|mesh-list
25038227|NCT05262465|Venetoclax|venetoclax|mesh-list
25038228|NCT05262465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25038229|NCT05262465|Antimetabolites|antimetabolites|mesh-ancestor
25038230|NCT05262465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259310|NCT02465320|Sensory System Agents|sensory system agents|mesh-ancestor
25259311|NCT02465320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25259312|NCT02465320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25259313|NCT02465320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25259314|NCT02465320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25259315|NCT02465320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25259316|NCT02465320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259317|NCT02465008|Levobupivacaine|levobupivacaine|mesh-list
25259318|NCT02465008|Anesthetics, Local|anesthetics, local|mesh-ancestor
25259319|NCT02465008|Anesthetics|anesthetics|mesh-ancestor
25259320|NCT02465008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25259321|NCT02465008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259322|NCT02465008|Sensory System Agents|sensory system agents|mesh-ancestor
25259323|NCT02465008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25259324|NCT02465164|Oxytocin|oxytocin|mesh-list
25259325|NCT02465164|Oxytocics|oxytocics|mesh-ancestor
25259326|NCT02465164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25259327|NCT02465164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259328|NCT02465255|Acetaminophen|acetaminophen|mesh-list
25259329|NCT02465255|Ketorolac|ketorolac|mesh-list
25259330|NCT02465255|Tramadol|tramadol|mesh-list
25259331|NCT02465255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25259332|NCT02465255|Analgesics|analgesics|mesh-ancestor
25259333|NCT02465255|Sensory System Agents|sensory system agents|mesh-ancestor
25259334|NCT02465255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24529182|NCT00624871|Protective Agents|protective agents|mesh-ancestor
24529183|NCT00624936|Bortezomib|bortezomib|mesh-list
24529184|NCT00624936|Azacitidine|azacitidine|mesh-list
24529185|NCT00624936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24529186|NCT00624936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24529187|NCT00624936|Antimetabolites|antimetabolites|mesh-ancestor
25688030|NCT01940276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24529188|NCT00624936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529189|NCT00624936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529190|NCT00625014|Haloperidol|haloperidol|mesh-list
24529191|NCT00625014|Haloperidol decanoate|haloperidol decanoate|mesh-list
24529192|NCT00625014|Antiemetics|antiemetics|mesh-ancestor
24529193|NCT00625014|Autonomic Agents|autonomic agents|mesh-ancestor
24624997|NCT01079754|Narcotics|narcotics|mesh-ancestor
25114567|NCT00594334|Risedronic Acid|risedronic acid|mesh-list
25114568|NCT00594334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25114569|NCT00594334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25114570|NCT00594334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25114571|NCT00594334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25114572|NCT00594334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25114573|NCT00594334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25038274|NCT05261997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038275|NCT05261997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25038277|NCT05261971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25038278|NCT05261971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25038279|NCT05261971|Analgesics|analgesics|mesh-ancestor
25038280|NCT05261971|Sensory System Agents|sensory system agents|mesh-ancestor
25038292|NCT05261581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25038293|NCT05261581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038299|NCT05241496|Lidocaine|lidocaine|mesh-list
25038323|NCT05224401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25102791|NCT03166605|Simethicone|simethicone|mesh-list
24795284|NCT03229538|Antiemetics|antiemetics|mesh-ancestor
24795285|NCT03229538|Autonomic Agents|autonomic agents|mesh-ancestor
24795286|NCT03229538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24795287|NCT03229538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259335|NCT02465255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259337|NCT02465255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25259338|NCT02465255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25259339|NCT02465255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25259340|NCT02465255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25259341|NCT02465255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25259342|NCT02465255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259343|NCT02465255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25259344|NCT02465255|Narcotics|narcotics|mesh-ancestor
25259345|NCT02465255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25275137|NCT02373449|Anesthetics|anesthetics|mesh-ancestor
25275138|NCT02373449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25275139|NCT02373449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25275140|NCT02373449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25275141|NCT02373449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25275142|NCT02373449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275143|NCT02373722|Petrolatum|petrolatum|mesh-list
25275144|NCT02373722|Mineral Oil|mineral oil|mesh-list
25275145|NCT02373722|Emollients|emollients|mesh-ancestor
25275146|NCT02373722|Dermatologic Agents|dermatologic agents|mesh-ancestor
25275147|NCT02373514|Acetaminophen|acetaminophen|mesh-list
25275148|NCT02373514|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
25275149|NCT02373514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25275150|NCT02373514|Analgesics|analgesics|mesh-ancestor
24931167|NCT04092205|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
24931168|NCT04092205|Chelating Agents|chelating agents|mesh-ancestor
24931169|NCT04092205|Sequestering Agents|sequestering agents|mesh-ancestor
24931170|NCT04092205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688031|NCT01940276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688032|NCT01940276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688033|NCT01940276|Hormone Antagonists|hormone antagonists|mesh-ancestor
25688034|NCT01940276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25688035|NCT01940484|Epoetin Alfa|epoetin alfa|mesh-list
25688036|NCT01940484|Hematinics|hematinics|mesh-ancestor
25688037|NCT01940497|Paclitaxel|paclitaxel|mesh-list
25688038|NCT01940497|Docetaxel|docetaxel|mesh-list
24931172|NCT04092309|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24931173|NCT04092309|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24931174|NCT04092309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24931175|NCT04092309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24931176|NCT04092309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24931177|NCT04092309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931178|NCT04092309|Protease Inhibitors|protease inhibitors|mesh-ancestor
24931179|NCT04092309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416574|NCT00203450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24416575|NCT00203450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24416576|NCT00203450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416577|NCT00203450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24416579|NCT00203463|Topiramate|topiramate|mesh-list
24931180|NCT04091971|Ketamine|ketamine|mesh-list
24931181|NCT04091971|Analgesics|analgesics|mesh-ancestor
24931182|NCT04091971|Sensory System Agents|sensory system agents|mesh-ancestor
24931183|NCT04091971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24931184|NCT04091971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931185|NCT04091971|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24931186|NCT04091971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24931187|NCT04091971|Anesthetics, General|anesthetics, general|mesh-ancestor
24931188|NCT04091971|Anesthetics|anesthetics|mesh-ancestor
24931189|NCT04091971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24931190|NCT04091971|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24507407|NCT00550329|Glipizide|glipizide|mesh-list
24529218|NCT00625092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25049963|NCT00553306|Analgesics|analgesics|mesh-ancestor
25259346|NCT02464709|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25259347|NCT02464709|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
25259348|NCT02464709|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25259349|NCT02464709|Dermatologic Agents|dermatologic agents|mesh-ancestor
25259350|NCT02464722|Epinephrine|epinephrine|mesh-list
25259351|NCT02464722|Dexmedetomidine|dexmedetomidine|mesh-list
25259352|NCT02464722|Remifentanil|remifentanil|mesh-list
25259355|NCT02464722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25259356|NCT02464722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25259357|NCT02464722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259358|NCT02464722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25259359|NCT02464722|Anesthetics, General|anesthetics, general|mesh-ancestor
25259360|NCT02464722|Anesthetics|anesthetics|mesh-ancestor
25259361|NCT02464722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25259362|NCT02464722|Analgesics|analgesics|mesh-ancestor
25259363|NCT02464722|Sensory System Agents|sensory system agents|mesh-ancestor
25259364|NCT02464722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25102792|NCT03166605|Antifoaming Agents|antifoaming agents|mesh-ancestor
24977964|NCT01140867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977965|NCT01137773|Insulin|insulin|mesh-list
25259365|NCT02464722|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25259366|NCT02464722|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25259367|NCT02464722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25259368|NCT02464722|Adrenergic Agents|adrenergic agents|mesh-ancestor
25259369|NCT02464722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25259370|NCT02464722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259371|NCT02464722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25259372|NCT02464722|Narcotics|narcotics|mesh-ancestor
25259373|NCT02464722|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25259374|NCT02464722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25259375|NCT02464722|Autonomic Agents|autonomic agents|mesh-ancestor
25259376|NCT02464722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25259377|NCT02464722|Respiratory System Agents|respiratory system agents|mesh-ancestor
25259378|NCT02464722|Mydriatics|mydriatics|mesh-ancestor
25259379|NCT02464722|Sympathomimetics|sympathomimetics|mesh-ancestor
25259380|NCT02464722|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25259381|NCT02464722|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25259382|NCT02464722|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24758598|NCT01746992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259384|NCT02464761|Verteporfin|verteporfin|mesh-list
24529249|NCT00625170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24529250|NCT00625170|Dopamine Agents|dopamine agents|mesh-ancestor
24529251|NCT00625170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24529252|NCT00625196|Fluticasone|fluticasone|mesh-list
24416699|NCT00203775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24416700|NCT00203775|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24931235|NCT04091412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24931236|NCT04091412|Protective Agents|protective agents|mesh-ancestor
25038324|NCT05224401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25038325|NCT05224401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25038326|NCT05224401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038327|NCT05224401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038328|NCT05224401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038329|NCT05224401|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25038330|NCT05224401|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25038331|NCT05224401|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25038333|NCT05224401|Antimalarials|antimalarials|mesh-ancestor
25038334|NCT05224401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25038335|NCT05224401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25038336|NCT05224401|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25038379|NCT05195775|Urological Agents|urological agents|mesh-ancestor
25038381|NCT05190315|Chlorpromazine|chlorpromazine|mesh-list
25038382|NCT05190315|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25038383|NCT05190315|Alkylating Agents|alkylating agents|mesh-ancestor
25038384|NCT05190315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038385|NCT05190315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038386|NCT05190315|Antiemetics|antiemetics|mesh-ancestor
25259385|NCT02464761|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25259386|NCT02464761|Dermatologic Agents|dermatologic agents|mesh-ancestor
25259407|NCT02464865|Thiamine|thiamine|mesh-list
25259408|NCT02464865|Vitamin B Complex|vitamin b complex|mesh-ancestor
25259409|NCT02464865|Vitamins|vitamins|mesh-ancestor
25259410|NCT02464865|Micronutrients|micronutrients|mesh-ancestor
25259411|NCT02464865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259412|NCT02464813|Pregabalin|pregabalin|mesh-list
24931237|NCT04091412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931239|NCT04091204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24931240|NCT04091204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24931241|NCT04091204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931242|NCT04091204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931244|NCT04091074|Ticagrelor|ticagrelor|mesh-list
24931245|NCT04091074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24931246|NCT04091074|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24931247|NCT04091074|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24416701|NCT00203775|Dopamine Agents|dopamine agents|mesh-ancestor
24931248|NCT04091074|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24931249|NCT04091074|Purinergic Agents|purinergic agents|mesh-ancestor
24931250|NCT04091074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24931251|NCT04091074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931252|NCT04091074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931253|NCT04091178|Vitamin D|vitamin d|mesh-list
24931254|NCT04091178|Vitamins|vitamins|mesh-ancestor
24931255|NCT04091178|Micronutrients|micronutrients|mesh-ancestor
24931256|NCT04091178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038387|NCT05190315|Autonomic Agents|autonomic agents|mesh-ancestor
25038388|NCT05190315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25038389|NCT05190315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038390|NCT05190315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25038391|NCT05190315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25038392|NCT05190315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25038393|NCT05190315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25038394|NCT05190315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25038395|NCT05190315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25038396|NCT05190315|Dopamine Agents|dopamine agents|mesh-ancestor
25038397|NCT05190315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25688039|NCT01940497|Doxorubicin|doxorubicin|mesh-list
25688040|NCT01940497|Trastuzumab|trastuzumab|mesh-list
25688041|NCT01940497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25688042|NCT01940497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688043|NCT01940497|Tubulin Modulators|tubulin modulators|mesh-ancestor
25688044|NCT01940497|Antimitotic Agents|antimitotic agents|mesh-ancestor
24619983|NCT01055041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619984|NCT01055041|Antitussive Agents|antitussive agents|mesh-ancestor
24619985|NCT01055041|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24619986|NCT01055041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24619987|NCT01055145|Moxifloxacin|moxifloxacin|mesh-list
24619988|NCT01055145|Levofloxacin|levofloxacin|mesh-list
24619999|NCT01055145|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24620002|NCT01055236|Antipruritics|antipruritics|mesh-ancestor
25038398|NCT05186129|Clopidogrel|clopidogrel|mesh-list
25038399|NCT05186129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25038400|NCT05186129|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25038401|NCT05186129|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25038402|NCT05186129|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25038403|NCT05186129|Purinergic Agents|purinergic agents|mesh-ancestor
25038404|NCT05186129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25038405|NCT05186129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038406|NCT05186129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038407|NCT05175001|Betamethasone|betamethasone|mesh-list
25038408|NCT05175001|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
25038409|NCT05175001|Ropivacaine|ropivacaine|mesh-list
24818011|NCT02086474|Anesthetics|anesthetics|mesh-ancestor
25114655|NCT00390325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25114656|NCT00390325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25114657|NCT00390325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25114658|NCT00390325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25114659|NCT00365157|Halichondrin B|halichondrin b|mesh-list
25114660|NCT00365157|Tubulin Modulators|tubulin modulators|mesh-ancestor
25114661|NCT00365157|Antimitotic Agents|antimitotic agents|mesh-ancestor
25114662|NCT00365157|Mitosis Modulators|mitosis modulators|mesh-ancestor
25259413|NCT02464813|Oxycodone|oxycodone|mesh-list
25259414|NCT02464813|Analgesics|analgesics|mesh-ancestor
25259415|NCT02464813|Sensory System Agents|sensory system agents|mesh-ancestor
25259416|NCT02464813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25259417|NCT02464813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259418|NCT02464813|Anticonvulsants|anticonvulsants|mesh-ancestor
25259419|NCT02464813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25259420|NCT02464813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24977984|NCT01127256|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25259421|NCT02464813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259422|NCT02464813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25259423|NCT02464813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25259424|NCT02464813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25259425|NCT02464813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25259426|NCT02464813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25259427|NCT02464813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25259428|NCT02464813|Narcotics|narcotics|mesh-ancestor
25259429|NCT02464631|Ribavirin|ribavirin|mesh-list
25259430|NCT02464631|Sofosbuvir|sofosbuvir|mesh-list
25259431|NCT02464631|Antimetabolites|antimetabolites|mesh-ancestor
25259432|NCT02464631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259433|NCT02464631|Antiviral Agents|antiviral agents|mesh-ancestor
24931257|NCT04091178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24931259|NCT04091009|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
24931260|NCT04091009|Naloxone|naloxone|mesh-list
24931261|NCT04091009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24931262|NCT04091009|Narcotics|narcotics|mesh-ancestor
24931263|NCT04091009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24931264|NCT04091009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931266|NCT04091009|Sensory System Agents|sensory system agents|mesh-ancestor
24931267|NCT04091009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24931268|NCT04091009|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24407679|NCT00175032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24931288|NCT04090801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24931289|NCT04090801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24931290|NCT04090801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25688045|NCT01940497|Mitosis Modulators|mitosis modulators|mesh-ancestor
25688046|NCT01940497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688047|NCT01940497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25688048|NCT01940497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25688049|NCT01940497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25688050|NCT01940497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688051|NCT01940497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25688052|NCT01940510|Rifampin|rifampin|mesh-list
24758772|NCT01747707|Docetaxel|docetaxel|mesh-list
24931291|NCT04090801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931292|NCT04090801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24931293|NCT04090801|Vasodilator Agents|vasodilator agents|mesh-ancestor
24664644|NCT01308177|Ecabet|ecabet|mesh-list
25114663|NCT00365157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25114664|NCT00365157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038429|NCT05162976|Azacitidine|azacitidine|mesh-list
25038430|NCT05162976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25038431|NCT05162976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038432|NCT05162976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25038433|NCT05162976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038434|NCT05162976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25038435|NCT05162976|Antimetabolites|antimetabolites|mesh-ancestor
25038456|NCT05140148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038457|NCT05140148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038458|NCT05140148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25038459|NCT05140148|Analgesics|analgesics|mesh-ancestor
25038460|NCT05140148|Sensory System Agents|sensory system agents|mesh-ancestor
25038461|NCT05140148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25038462|NCT05092841|Naltrexone|naltrexone|mesh-list
25038463|NCT05092841|Baclofen|baclofen|mesh-list
25038464|NCT05092841|Sorbitol|sorbitol|mesh-list
25038465|NCT05092841|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25038466|NCT05092841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25038467|NCT05092841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038468|NCT05092841|Sensory System Agents|sensory system agents|mesh-ancestor
25038469|NCT05092841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25038470|NCT05092841|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25038471|NCT05092841|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25038472|NCT05092841|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25038473|NCT05092841|GABA Agonists|gaba agonists|mesh-ancestor
24995268|NCT05416957|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24995269|NCT05416957|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24995270|NCT05416957|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24995271|NCT05416190|Anticoagulants|anticoagulants|mesh-list
24995272|NCT05416190|Lupus Coagulation Inhibitor|lupus coagulation inhibitor|mesh-list
25259434|NCT02464631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25259435|NCT02464683|Vitamin D|vitamin d|mesh-list
25259436|NCT02464683|Vitamins|vitamins|mesh-ancestor
25259437|NCT02464683|Micronutrients|micronutrients|mesh-ancestor
25259438|NCT02464683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259439|NCT02464683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25259440|NCT02464501|Paclitaxel|paclitaxel|mesh-list
25259441|NCT02464501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25259442|NCT02464501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25259443|NCT02464501|Tubulin Modulators|tubulin modulators|mesh-ancestor
25259444|NCT02464501|Antimitotic Agents|antimitotic agents|mesh-ancestor
25259445|NCT02464501|Mitosis Modulators|mitosis modulators|mesh-ancestor
25259446|NCT02464501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259447|NCT02464228|Tipifarnib|tipifarnib|mesh-list
25259448|NCT02464228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25259449|NCT02464462|Vitamin D|vitamin d|mesh-list
25259450|NCT02464462|Cholecalciferol|cholecalciferol|mesh-list
25259451|NCT02464462|Calcium|calcium|mesh-list
25259452|NCT02464462|Vitamins|vitamins|mesh-ancestor
25259453|NCT02464462|Micronutrients|micronutrients|mesh-ancestor
25259454|NCT02464462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259455|NCT02464462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24931295|NCT04090112|Anesthetics, Local|anesthetics, local|mesh-ancestor
24931296|NCT04090112|Anesthetics|anesthetics|mesh-ancestor
25155515|NCT05353140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24931297|NCT04090112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24931298|NCT04090112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931299|NCT04090112|Sensory System Agents|sensory system agents|mesh-ancestor
24931300|NCT04090112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24529289|NCT00625339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24931302|NCT04090112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24931303|NCT04090112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24931304|NCT04090112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25688053|NCT01940510|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24931305|NCT04090112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931306|NCT04090047|Itraconazole|itraconazole|mesh-list
24931307|NCT04090047|PF-06700841|pf-06700841|mesh-list
24931308|NCT04090047|Antifungal Agents|antifungal agents|mesh-ancestor
24931309|NCT04090047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24931310|NCT04090047|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24931311|NCT04090047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24755628|NCT01727778|Antibodies|antibodies|mesh-list
24931312|NCT04090047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24931313|NCT04090047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995273|NCT05416190|Immunologic Factors|immunologic factors|mesh-ancestor
24995274|NCT05416190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933169|NCT04074122|Adenosine|adenosine|mesh-list
24589077|NCT00905723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589078|NCT00905762|Moxifloxacin|moxifloxacin|mesh-list
24589079|NCT00905762|Gatifloxacin|gatifloxacin|mesh-list
24589080|NCT00905762|Besifloxacin|besifloxacin|mesh-list
24589081|NCT00905762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24589082|NCT00905762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25259456|NCT02464462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25259464|NCT02464306|Fidaxomicin|fidaxomicin|mesh-list
25259465|NCT02464306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25259466|NCT02464306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25259467|NCT02463929|Diphenhydramine|diphenhydramine|mesh-list
25259468|NCT02463929|Promethazine|promethazine|mesh-list
25259469|NCT02463929|Ketamine|ketamine|mesh-list
25259470|NCT02463929|Bupivacaine|bupivacaine|mesh-list
25259471|NCT02463929|Sevoflurane|sevoflurane|mesh-list
25259472|NCT02463929|Anesthetics, Local|anesthetics, local|mesh-ancestor
25259473|NCT02463929|Anesthetics|anesthetics|mesh-ancestor
25259474|NCT02463929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25259475|NCT02463929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259476|NCT02463929|Sensory System Agents|sensory system agents|mesh-ancestor
25259477|NCT02463929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25259478|NCT02463929|Analgesics|analgesics|mesh-ancestor
25259479|NCT02463929|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25259480|NCT02463929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25259481|NCT02463929|Anesthetics, General|anesthetics, general|mesh-ancestor
25259482|NCT02463929|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25259483|NCT02463929|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25259484|NCT02463929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25259485|NCT02463929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259486|NCT02463929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25259487|NCT02463929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25259488|NCT02463929|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24931314|NCT04090047|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24931315|NCT04090047|Hormone Antagonists|hormone antagonists|mesh-ancestor
24931316|NCT04090047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24931317|NCT04090047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931318|NCT04090047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24931319|NCT04090047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24931320|NCT04090021|Amoxicillin|amoxicillin|mesh-list
24931321|NCT04090021|Metronidazole|metronidazole|mesh-list
24931322|NCT04090021|Clarithromycin|clarithromycin|mesh-list
24931324|NCT04090021|Ofloxacin|ofloxacin|mesh-list
24931325|NCT04090021|Rifabutin|rifabutin|mesh-list
24931326|NCT04090021|Esomeprazole|esomeprazole|mesh-list
24931327|NCT04090021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24931328|NCT04090021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24931329|NCT04090021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24931330|NCT04090021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24931331|NCT04090021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24407764|NCT00175396|Flutamide|flutamide|mesh-list
24625000|NCT01079754|Analgesics|analgesics|mesh-ancestor
24625001|NCT01079754|Sensory System Agents|sensory system agents|mesh-ancestor
24625002|NCT01079754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24625003|NCT01079767|Sirolimus|sirolimus|mesh-list
24625004|NCT01079767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24625005|NCT01079767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24625006|NCT01079767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24625007|NCT01079767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24625008|NCT01079767|Antifungal Agents|antifungal agents|mesh-ancestor
24625036|NCT01080027|Antiviral Agents|antiviral agents|mesh-ancestor
24589083|NCT00905762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24589084|NCT00905762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24589085|NCT00905762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900430|NCT04394377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25038508|NCT05055713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25038509|NCT05055713|Adrenergic Agents|adrenergic agents|mesh-ancestor
25038510|NCT05055713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25038511|NCT05055713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038512|NCT05055713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038514|NCT05055713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25038516|NCT05042791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25038517|NCT05042791|Antimetabolites|antimetabolites|mesh-ancestor
25038518|NCT05042791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417249|NCT00206089|Melagatran|melagatran|mesh-list
25038519|NCT05042791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038520|NCT05041062|Nivolumab|nivolumab|mesh-list
25038521|NCT05041062|Ipilimumab|ipilimumab|mesh-list
25038522|NCT05041062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25038523|NCT05041062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25259489|NCT02463929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25259490|NCT02463929|Antiemetics|antiemetics|mesh-ancestor
25259491|NCT02463929|Autonomic Agents|autonomic agents|mesh-ancestor
25259492|NCT02463929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25259493|NCT02463929|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25259494|NCT02463929|Histamine Antagonists|histamine antagonists|mesh-ancestor
25259495|NCT02463929|Histamine Agents|histamine agents|mesh-ancestor
25259496|NCT02463929|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25259497|NCT02463929|Antipruritics|antipruritics|mesh-ancestor
25259498|NCT02463929|Dermatologic Agents|dermatologic agents|mesh-ancestor
25259499|NCT02463825|Pimozide|pimozide|mesh-list
25259500|NCT02463825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25259501|NCT02463825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25259502|NCT02463825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25259503|NCT02463825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259504|NCT02463825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25259505|NCT02463825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25259506|NCT02463825|Dopamine Agents|dopamine agents|mesh-ancestor
25259507|NCT02463825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25259508|NCT02463825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259509|NCT02463825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25259510|NCT02463994|Atezolizumab|atezolizumab|mesh-list
25259511|NCT02463994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25259512|NCT02464020|Vancomycin|vancomycin|mesh-list
25259513|NCT02464020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25259514|NCT02464020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25259515|NCT02463747|Vancomycin|vancomycin|mesh-list
25259516|NCT02463747|Meropenem|meropenem|mesh-list
25259517|NCT02463747|Tazobactam|tazobactam|mesh-list
24625009|NCT01079767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24625010|NCT01079767|Immunologic Factors|immunologic factors|mesh-ancestor
24625011|NCT01079767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625013|NCT01079884|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24625014|NCT01079884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24625015|NCT01079884|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24625016|NCT01079884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625017|NCT01079884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625018|NCT01079897|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
24931419|NCT04089345|Ustekinumab|ustekinumab|mesh-list
24625019|NCT01079897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24625021|NCT01079910|Cariostatic Agents|cariostatic agents|mesh-ancestor
24625022|NCT01079910|Protective Agents|protective agents|mesh-ancestor
24625023|NCT01079910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625024|NCT01079923|Vitamin D|vitamin d|mesh-list
24625025|NCT01079923|Ergocalciferols|ergocalciferols|mesh-list
24625026|NCT01079923|Cholecalciferol|cholecalciferol|mesh-list
24625027|NCT01079923|Vitamins|vitamins|mesh-list
24625028|NCT01079923|Micronutrients|micronutrients|mesh-ancestor
24763082|NCT01771302|Calcium|calcium|mesh-list
24625029|NCT01079923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625030|NCT01079923|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24625031|NCT01079923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24625032|NCT01080027|Interferons|interferons|mesh-list
24625033|NCT01080027|Interferon-beta|interferon-beta|mesh-list
24625034|NCT01080027|Interferon beta-1a|interferon beta-1a|mesh-list
24529301|NCT00625352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24529302|NCT00625352|Antiviral Agents|antiviral agents|mesh-ancestor
24625035|NCT01080027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038524|NCT05041062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25038526|NCT05030519|Trastuzumab|trastuzumab|mesh-list
25038545|NCT04961619|Dabrafenib|dabrafenib|mesh-list
25038546|NCT04961619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038547|NCT04961619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25038548|NCT04961619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038549|NCT04961619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038550|NCT04947007|Bupivacaine|bupivacaine|mesh-list
25038551|NCT04947007|Anesthetics, Local|anesthetics, local|mesh-ancestor
25038552|NCT04947007|Anesthetics|anesthetics|mesh-ancestor
25038553|NCT04947007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25038554|NCT04947007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038555|NCT04947007|Sensory System Agents|sensory system agents|mesh-ancestor
25038556|NCT04947007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25038557|NCT04943445|Paclitaxel|paclitaxel|mesh-list
25038558|NCT04943445|Carboplatin|carboplatin|mesh-list
25259518|NCT02463747|Piperacillin|piperacillin|mesh-list
25259519|NCT02463747|Ceftazidime|ceftazidime|mesh-list
25259520|NCT02463747|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25259521|NCT02463747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25259522|NCT02463747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25259523|NCT02463747|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25259524|NCT02463747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25259525|NCT02463747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259526|NCT02464124|Nitazoxanide|nitazoxanide|mesh-list
25259527|NCT02464124|Lactulose|lactulose|mesh-list
25259528|NCT02464124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25259529|NCT02464124|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25259530|NCT02464124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25259531|NCT02463591|Thrombin|thrombin|mesh-list
25259532|NCT02463591|Hemostatics|hemostatics|mesh-ancestor
25259533|NCT02463591|Coagulants|coagulants|mesh-ancestor
25259534|NCT02463552|Naproxen|naproxen|mesh-list
25259535|NCT02463552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25259536|NCT02463552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25259537|NCT02463552|Analgesics|analgesics|mesh-ancestor
25259538|NCT02463552|Sensory System Agents|sensory system agents|mesh-ancestor
25259539|NCT02463552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25259540|NCT02463552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259541|NCT02463552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25259542|NCT02463552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25259543|NCT02463552|Gout Suppressants|gout suppressants|mesh-ancestor
25259544|NCT02463552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25259545|NCT02463552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25259546|NCT02463552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259547|NCT02463643|Rabeprazole|rabeprazole|mesh-list
24625038|NCT01080027|Immunologic Factors|immunologic factors|mesh-ancestor
24625039|NCT01080027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625040|NCT01080027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24625042|NCT01080066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24625043|NCT01080066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24625044|NCT01080079|Terbinafine|terbinafine|mesh-list
24407896|NCT00175838|Aspirin|aspirin|mesh-list
24625057|NCT01080417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24625058|NCT01080417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24625059|NCT01080417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24529306|NCT00625352|Immunologic Factors|immunologic factors|mesh-ancestor
24529307|NCT00625352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529326|NCT00625456|Sargramostim|sargramostim|mesh-list
24529327|NCT00625456|Immunologic Factors|immunologic factors|mesh-ancestor
24529328|NCT00625456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529329|NCT00625456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24529330|NCT00625469|Bosentan|bosentan|mesh-list
24529331|NCT00625469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24529332|NCT00625469|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24529333|NCT00625469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259548|NCT02463643|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25259549|NCT02463643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25259550|NCT02463643|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25259551|NCT02463643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25259552|NCT02463643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259553|NCT02463682|Insulin|insulin|mesh-list
25259554|NCT02463682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25259555|NCT02463682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259556|NCT02463942|Doxycycline|doxycycline|mesh-list
25259557|NCT02463942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25259558|NCT02463942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25259559|NCT02463942|Antimalarials|antimalarials|mesh-ancestor
25259560|NCT02463942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25259561|NCT02463942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25259562|NCT02463812|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25259563|NCT02463812|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25259565|NCT02463812|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25259568|NCT02463175|Plasma-lyte 148|plasma-lyte 148|mesh-list
25259569|NCT02463175|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25259570|NCT02463175|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25259572|NCT02463383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25259573|NCT02463383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25259574|NCT02463383|Analgesics|analgesics|mesh-ancestor
25259575|NCT02463383|Sensory System Agents|sensory system agents|mesh-ancestor
25259576|NCT02463383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25259577|NCT02463383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259578|NCT02463383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25259579|NCT02463383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25259580|NCT02463383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25259581|NCT02463383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25259582|NCT02463383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275151|NCT02373514|Sensory System Agents|sensory system agents|mesh-ancestor
25275152|NCT02373514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275153|NCT02373514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275154|NCT02373514|Antipyretics|antipyretics|mesh-ancestor
25275155|NCT02373514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25275156|NCT02373514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25275157|NCT02373514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25275158|NCT02373384|Allopurinol|allopurinol|mesh-list
24931341|NCT04090021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24931342|NCT04090021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24931343|NCT04090021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931344|NCT04090021|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24931345|NCT04090021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24931346|NCT04090021|Antitubercular Agents|antitubercular agents|mesh-ancestor
24931348|NCT04089657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931349|NCT04089657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24931350|NCT04089657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24931351|NCT04089657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931352|NCT04089722|Deoxycholic Acid|deoxycholic acid|mesh-list
24931420|NCT04089345|Dermatologic Agents|dermatologic agents|mesh-ancestor
24931374|NCT04089631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038559|NCT04943445|Pembrolizumab|pembrolizumab|mesh-list
25038560|NCT04943445|Immunologic Factors|immunologic factors|mesh-list
25038562|NCT04943445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038602|NCT04873583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25038604|NCT04873583|Autonomic Agents|autonomic agents|mesh-ancestor
25038605|NCT04873583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25038606|NCT04873583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038607|NCT04873583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25038619|NCT04831619|Antimetabolites|antimetabolites|mesh-ancestor
25038620|NCT04831619|Antiviral Agents|antiviral agents|mesh-ancestor
25038621|NCT04831619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25259583|NCT02463513|Vitamins|vitamins|mesh-list
25259584|NCT02463513|Riboflavin|riboflavin|mesh-list
25259585|NCT02463513|Vitamin B Complex|vitamin b complex|mesh-list
25259586|NCT02463513|Micronutrients|micronutrients|mesh-ancestor
25259587|NCT02463513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259588|NCT02463513|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25259589|NCT02463513|Dermatologic Agents|dermatologic agents|mesh-ancestor
25259590|NCT02463318|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25259591|NCT02463318|Melatonin|melatonin|mesh-list
25259592|NCT02463318|Antioxidants|antioxidants|mesh-ancestor
25259593|NCT02463318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259594|NCT02463318|Protective Agents|protective agents|mesh-ancestor
25259595|NCT02463318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259596|NCT02463318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25259597|NCT02463318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25259598|NCT02463318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25259599|NCT02463110|Sertraline|sertraline|mesh-list
25259600|NCT02463110|Antidepressive Agents|antidepressive agents|mesh-ancestor
25259601|NCT02463110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25259603|NCT02463110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25259604|NCT02463110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25259605|NCT02463110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259606|NCT02463110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25259607|NCT02463110|Serotonin Agents|serotonin agents|mesh-ancestor
25259608|NCT02463110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259609|NCT02462772|Cabotegravir|cabotegravir|mesh-list
25259610|NCT02462772|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24931375|NCT04089631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931376|NCT04089605|Dexamethasone|dexamethasone|mesh-list
24931377|NCT04089605|Dexamethasone acetate|dexamethasone acetate|mesh-list
24931378|NCT04089605|Ranibizumab|ranibizumab|mesh-list
24931380|NCT04089605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24931381|NCT04089605|Antiemetics|antiemetics|mesh-ancestor
24931382|NCT04089605|Autonomic Agents|autonomic agents|mesh-ancestor
24931383|NCT04089605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24931384|NCT04089605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931385|NCT04089605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24931386|NCT04089605|Glucocorticoids|glucocorticoids|mesh-ancestor
24931387|NCT04089605|Hormones|hormones|mesh-ancestor
24931421|NCT04089163|Flucytosine|flucytosine|mesh-list
24931388|NCT04089605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24931390|NCT04089605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931391|NCT04089605|Protease Inhibitors|protease inhibitors|mesh-ancestor
24931392|NCT04089605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24931393|NCT04089605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931394|NCT04089605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24931395|NCT04089605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24931396|NCT04089605|Growth Substances|growth substances|mesh-ancestor
24931397|NCT04089605|Growth Inhibitors|growth inhibitors|mesh-ancestor
24931398|NCT04089592|Fentanyl|fentanyl|mesh-list
24931399|NCT04089592|Dexmedetomidine|dexmedetomidine|mesh-list
24931400|NCT04089592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24931401|NCT04089592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24931402|NCT04089592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931403|NCT04089592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24931404|NCT04089592|Analgesics|analgesics|mesh-ancestor
24931406|NCT04089592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24931407|NCT04089592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24935285|NCT04052269|Tadalafil|tadalafil|mesh-list
25038672|NCT04747236|Gemcitabine|gemcitabine|mesh-list
25038673|NCT04747236|Azacitidine|azacitidine|mesh-list
25038674|NCT04747236|Romidepsin|romidepsin|mesh-list
25038675|NCT04747236|Belinostat|belinostat|mesh-list
25038676|NCT04747236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25038677|NCT04747236|Antimetabolites|antimetabolites|mesh-ancestor
25038678|NCT04747236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038679|NCT04747236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038680|NCT04747236|Antiviral Agents|antiviral agents|mesh-ancestor
25038681|NCT04747236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25259611|NCT02462772|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25259612|NCT02462772|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25259613|NCT02462772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25259614|NCT02462772|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25259615|NCT02462772|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25259616|NCT02462772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25259617|NCT02462772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259618|NCT02462772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25259619|NCT02462772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25259620|NCT02462772|Antiviral Agents|antiviral agents|mesh-ancestor
25259621|NCT02462772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25259622|NCT02462889|Aflibercept|aflibercept|mesh-list
25259623|NCT02462889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25259624|NCT02462889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25259625|NCT02462889|Growth Substances|growth substances|mesh-ancestor
25259626|NCT02462889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259627|NCT02462889|Growth Inhibitors|growth inhibitors|mesh-ancestor
25259628|NCT02462889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25259629|NCT02463019|Tenofovir|tenofovir|mesh-list
25259630|NCT02463019|Antiviral Agents|antiviral agents|mesh-ancestor
25259631|NCT02463019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25259632|NCT02463019|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25259633|NCT02463019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25259634|NCT02463019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25259636|NCT02463019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25259637|NCT02463019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25259638|NCT02463006|Methamphetamine|methamphetamine|mesh-list
25259639|NCT02463006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24417483|NCT00206570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259640|NCT02463006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259641|NCT02463006|Sympathomimetics|sympathomimetics|mesh-ancestor
25259642|NCT02463006|Autonomic Agents|autonomic agents|mesh-ancestor
24931408|NCT04089592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24931409|NCT04089592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24931410|NCT04089592|Adrenergic Agents|adrenergic agents|mesh-ancestor
24931411|NCT04089592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24931412|NCT04089592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931413|NCT04089592|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24931414|NCT04089592|Narcotics|narcotics|mesh-ancestor
24931415|NCT04089592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24931416|NCT04089592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24931417|NCT04089592|Anesthetics, General|anesthetics, general|mesh-ancestor
24931418|NCT04089592|Anesthetics|anesthetics|mesh-ancestor
25038687|NCT04747236|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25038689|NCT04676555|Ocrelizumab|ocrelizumab|mesh-list
25038690|NCT04676555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038693|NCT04634799|Plasminogen|plasminogen|mesh-list
25038717|NCT04624776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25038718|NCT04624776|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25038719|NCT04624776|Protective Agents|protective agents|mesh-ancestor
25038720|NCT04624776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25038721|NCT04624776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038725|NCT04581473|Paclitaxel|paclitaxel|mesh-list
25038726|NCT04581473|Irinotecan|irinotecan|mesh-list
25038727|NCT04581473|Apatinib|apatinib|mesh-list
25038728|NCT04581473|Antibodies|antibodies|mesh-list
25259643|NCT02463006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25259644|NCT02463006|Dopamine Agents|dopamine agents|mesh-ancestor
25259645|NCT02463006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25259646|NCT02463006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259647|NCT02463006|Adrenergic Agents|adrenergic agents|mesh-ancestor
25259648|NCT02463006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25259649|NCT02463006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25259650|NCT02463006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25259651|NCT02463006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25259652|NCT02462941|Adenosine|adenosine|mesh-list
25259653|NCT02462941|Analgesics|analgesics|mesh-ancestor
25259654|NCT02462941|Sensory System Agents|sensory system agents|mesh-ancestor
25259655|NCT02462941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25259656|NCT02462941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259657|NCT02462941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25259658|NCT02462941|Vasodilator Agents|vasodilator agents|mesh-ancestor
25259659|NCT02462941|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25259660|NCT02462941|Purinergic Agonists|purinergic agonists|mesh-ancestor
25259661|NCT02462941|Purinergic Agents|purinergic agents|mesh-ancestor
25259662|NCT02462941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25259663|NCT02462941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259664|NCT02462915|Lidocaine|lidocaine|mesh-list
25259665|NCT02462915|Fentanyl|fentanyl|mesh-list
25259666|NCT02462915|Propofol|propofol|mesh-list
25259667|NCT02462915|Cisatracurium|cisatracurium|mesh-list
25259668|NCT02462915|Anesthetics, Local|anesthetics, local|mesh-ancestor
25259669|NCT02462915|Anesthetics|anesthetics|mesh-ancestor
24529348|NCT00625547|Dopamine Agonists|dopamine agonists|mesh-ancestor
24529349|NCT00625560|Lamivudine|lamivudine|mesh-list
24931446|NCT04089176|Oxytocin|oxytocin|mesh-list
24931447|NCT04089176|Carbetocin|carbetocin|mesh-list
24931449|NCT04089176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24931450|NCT04089176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931451|NCT04088851|Metformin|metformin|mesh-list
24931452|NCT04088851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24931453|NCT04088851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931454|NCT04088903|Daratumumab|daratumumab|mesh-list
24931455|NCT04088903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931456|NCT04088604|Fluorouracil|fluorouracil|mesh-list
24931457|NCT04088604|Irinotecan|irinotecan|mesh-list
24931458|NCT04088604|Antimetabolites|antimetabolites|mesh-ancestor
24931459|NCT04088604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931460|NCT04088604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24931461|NCT04088604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931462|NCT04088604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24931463|NCT04088604|Immunologic Factors|immunologic factors|mesh-ancestor
24931464|NCT04088604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931465|NCT04088604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24931466|NCT04088604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24931467|NCT04088604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038729|NCT04581473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25038730|NCT04581473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038731|NCT04581473|Tubulin Modulators|tubulin modulators|mesh-ancestor
25038732|NCT04581473|Antimitotic Agents|antimitotic agents|mesh-ancestor
25038733|NCT04581473|Mitosis Modulators|mitosis modulators|mesh-ancestor
25038734|NCT04581473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038735|NCT04581473|Immunologic Factors|immunologic factors|mesh-ancestor
25038736|NCT04581473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038773|NCT04530383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25259670|NCT02462915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25259671|NCT02462915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259672|NCT02462915|Sensory System Agents|sensory system agents|mesh-ancestor
25259673|NCT02462915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25259674|NCT02462915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25259675|NCT02462915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25259676|NCT02462915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25259677|NCT02462915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25259678|NCT02462915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259679|NCT02462915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25259680|NCT02462915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25259681|NCT02462915|Anesthetics, General|anesthetics, general|mesh-ancestor
25259682|NCT02462915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25259683|NCT02462915|Narcotics|narcotics|mesh-ancestor
25259684|NCT02462915|Analgesics|analgesics|mesh-ancestor
25259685|NCT02462915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25259686|NCT02462915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25259687|NCT02462915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25259688|NCT02462837|Mirabegron|mirabegron|mesh-list
25259689|NCT02462837|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25259690|NCT02462837|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25259691|NCT02462837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25259692|NCT02462837|Adrenergic Agents|adrenergic agents|mesh-ancestor
25259693|NCT02462837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25259694|NCT02462837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259695|NCT02462837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259696|NCT02462837|Urological Agents|urological agents|mesh-ancestor
25259697|NCT02462525|Dexamethasone|dexamethasone|mesh-list
25259698|NCT02462525|Pomalidomide|pomalidomide|mesh-list
25259699|NCT02462525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25259700|NCT02462525|Antiemetics|antiemetics|mesh-ancestor
25259701|NCT02462525|Autonomic Agents|autonomic agents|mesh-ancestor
24931469|NCT04088461|Linagliptin|linagliptin|mesh-list
24931470|NCT04088461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24931471|NCT04088461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931472|NCT04088461|Incretins|incretins|mesh-ancestor
24931476|NCT04088461|Protease Inhibitors|protease inhibitors|mesh-ancestor
24931477|NCT04088461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050010|NCT00547651|Topotecan|topotecan|mesh-list
24900566|NCT04392427|Antiviral Agents|antiviral agents|mesh-ancestor
24995488|NCT05134363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24995489|NCT05134363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24995490|NCT05134363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995491|NCT05134363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24995492|NCT05134363|Analgesics|analgesics|mesh-ancestor
25038780|NCT04528563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25038783|NCT04528563|Sensory System Agents|sensory system agents|mesh-ancestor
25038784|NCT04528563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25038785|NCT04528563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25038786|NCT04528563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25038787|NCT04528563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25688054|NCT01940510|Antitubercular Agents|antitubercular agents|mesh-ancestor
25688055|NCT01940510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25688056|NCT01940510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25688057|NCT01940510|Leprostatic Agents|leprostatic agents|mesh-ancestor
25688058|NCT01940510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25688059|NCT01940510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688060|NCT01940510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688061|NCT01940510|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25038788|NCT04528563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25038789|NCT04528563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25038790|NCT04528563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038791|NCT04528563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038794|NCT04521335|Trace Elements|trace elements|mesh-ancestor
25038795|NCT04521335|Micronutrients|micronutrients|mesh-ancestor
25038839|NCT04459286|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25038840|NCT04459286|Nitazoxanide|nitazoxanide|mesh-list
25038841|NCT04459286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25038842|NCT04459286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25038843|NCT04459286|Protease Inhibitors|protease inhibitors|mesh-ancestor
25038844|NCT04459286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038845|NCT04459286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038846|NCT04459286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25038847|NCT04459286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25038848|NCT04459286|Antiviral Agents|antiviral agents|mesh-ancestor
25038849|NCT04459286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25038850|NCT04459286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25038851|NCT04459286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25038897|NCT04378114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038898|NCT04378114|Antipyretics|antipyretics|mesh-ancestor
25038899|NCT04349124|Antihypertensive Agents|antihypertensive agents|mesh-list
25038901|NCT04349124|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25038902|NCT04349124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25038903|NCT04349124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038904|NCT04349124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25038905|NCT04349124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038906|NCT04349124|Vasodilator Agents|vasodilator agents|mesh-ancestor
25038959|NCT04259086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25038960|NCT04259086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038961|NCT04259086|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25038962|NCT04259086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24795345|NCT02971761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24795347|NCT02959697|Lidocaine|lidocaine|mesh-list
25038963|NCT04259086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038964|NCT04259086|Cholinergic Agents|cholinergic agents|mesh-ancestor
25038965|NCT04259086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25039021|NCT04209296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25039022|NCT04209296|Anesthetics, General|anesthetics, general|mesh-ancestor
25039023|NCT04209296|Anesthetics|anesthetics|mesh-ancestor
25039024|NCT04209296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25039025|NCT04209296|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25039026|NCT04209296|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25039027|NCT04209296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25259702|NCT02462525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25259703|NCT02462525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259704|NCT02462525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25259705|NCT02462525|Glucocorticoids|glucocorticoids|mesh-ancestor
25259706|NCT02462525|Hormones|hormones|mesh-ancestor
25259707|NCT02462525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24931478|NCT04088461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931480|NCT04088448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24931481|NCT04088448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931482|NCT04088292|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24931483|NCT04088292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24408143|NCT00176670|GABA Agents|gaba agents|mesh-ancestor
24931491|NCT04088266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931492|NCT04088266|Analgesics|analgesics|mesh-ancestor
24931493|NCT04088266|Sensory System Agents|sensory system agents|mesh-ancestor
24931494|NCT04088266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24931495|NCT04088266|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24931496|NCT04088032|Durvalumab|durvalumab|mesh-list
24931497|NCT04088032|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24931498|NCT04088032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24931499|NCT04088032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931500|NCT04088032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24931501|NCT04088032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24931502|NCT04088032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931503|NCT04088032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24931521|NCT04087915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24931522|NCT04087915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24931523|NCT04087915|Antimetabolites|antimetabolites|mesh-ancestor
24945549|NCT03949842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945550|NCT03949842|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24945551|NCT03949517|Piperidine|piperidine|mesh-list
24945552|NCT03949517|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
24945553|NCT03949517|Bombesin|bombesin|mesh-list
24945554|NCT03949517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945555|NCT03949517|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24945556|NCT03949517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24945557|NCT03949517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931524|NCT04087915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931525|NCT04087915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24931527|NCT04088084|Analgesics|analgesics|mesh-ancestor
24931528|NCT04088084|Sensory System Agents|sensory system agents|mesh-ancestor
24931529|NCT04088084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24931530|NCT04088084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931531|NCT04088084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24931532|NCT04088084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24931533|NCT04088084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24931534|NCT04088084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24931535|NCT04088084|Antiviral Agents|antiviral agents|mesh-ancestor
24931536|NCT04088084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25039028|NCT04209296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259708|NCT02462525|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25259709|NCT02462525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25259710|NCT02462525|Immunologic Factors|immunologic factors|mesh-ancestor
25259711|NCT02462525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25259712|NCT02462525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25259713|NCT02462525|Growth Substances|growth substances|mesh-ancestor
25259714|NCT02462525|Growth Inhibitors|growth inhibitors|mesh-ancestor
25259715|NCT02462577|Morphine|morphine|mesh-list
25259716|NCT02462577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25259717|NCT02462577|Narcotics|narcotics|mesh-ancestor
25259718|NCT02462577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25259719|NCT02462577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259720|NCT02462577|Analgesics|analgesics|mesh-ancestor
25259721|NCT02462577|Sensory System Agents|sensory system agents|mesh-ancestor
25259722|NCT02462577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25259723|NCT02462447|Choline|choline|mesh-list
25259724|NCT02462447|Lipotropic Agents|lipotropic agents|mesh-ancestor
25259725|NCT02462447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25259726|NCT02462447|Antimetabolites|antimetabolites|mesh-ancestor
25259727|NCT02462447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259728|NCT02462447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25259729|NCT02462447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25259730|NCT02462447|Nootropic Agents|nootropic agents|mesh-ancestor
25259731|NCT02462681|Ketamine|ketamine|mesh-list
25259732|NCT02462681|Analgesics|analgesics|mesh-ancestor
25259733|NCT02462681|Sensory System Agents|sensory system agents|mesh-ancestor
25259734|NCT02462681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25259735|NCT02462681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259736|NCT02462681|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25259737|NCT02462681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25259738|NCT02462681|Anesthetics, General|anesthetics, general|mesh-ancestor
25259739|NCT02462681|Anesthetics|anesthetics|mesh-ancestor
25259740|NCT02462681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25259741|NCT02462681|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25259742|NCT02462681|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25259743|NCT02462681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24931537|NCT04088084|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24931538|NCT04088084|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24931539|NCT04088084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24931540|NCT04088084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931541|NCT04088084|Hormones|hormones|mesh-ancestor
24931542|NCT04088084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25688062|NCT01940510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25688063|NCT01940510|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25688064|NCT01940510|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25688065|NCT01940510|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25688066|NCT01940510|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25688067|NCT01940523|Tranexamic Acid|tranexamic acid|mesh-list
25688068|NCT01940523|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25688069|NCT01940523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24394735|NCT00134069|Sorafenib|sorafenib|mesh-list
24931543|NCT04088110|Trastuzumab|trastuzumab|mesh-list
24931544|NCT04088110|Letrozole|letrozole|mesh-list
24931545|NCT04088110|Anastrozole|anastrozole|mesh-list
24931546|NCT04088110|Exemestane|exemestane|mesh-list
24931547|NCT04088110|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24931548|NCT04088110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24931549|NCT04088110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931550|NCT04088110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24931551|NCT04088110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039035|NCT04174612|Daunorubicin|daunorubicin|mesh-list
25039036|NCT04174612|Midostaurin|midostaurin|mesh-list
25039068|NCT04163185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25039069|NCT04163185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25039070|NCT04163185|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25039071|NCT04163185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25039072|NCT04163185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039073|NCT04163185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039074|NCT04163185|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25039075|NCT04163185|Serotonin Agents|serotonin agents|mesh-ancestor
25039076|NCT04163185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25039078|NCT04161456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25039079|NCT04161456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25039080|NCT04161456|Analgesics|analgesics|mesh-ancestor
24589174|NCT00906048|Antitubercular Agents|antitubercular agents|mesh-ancestor
24589175|NCT00906048|Leprostatic Agents|leprostatic agents|mesh-ancestor
24589176|NCT00906048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24589177|NCT00906048|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25039090|NCT04145297|Hydroxychloroquine|hydroxychloroquine|mesh-list
25039091|NCT04145297|Antimalarials|antimalarials|mesh-ancestor
25039092|NCT04145297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25039093|NCT04145297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25039094|NCT04145297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25039095|NCT04145297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039096|NCT04145297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039097|NCT04145297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25039098|NCT04144582|Docetaxel|docetaxel|mesh-list
25039099|NCT04144582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25039100|NCT04144582|Tubulin Modulators|tubulin modulators|mesh-ancestor
25039101|NCT04144582|Antimitotic Agents|antimitotic agents|mesh-ancestor
25039102|NCT04144582|Mitosis Modulators|mitosis modulators|mesh-ancestor
25039103|NCT04144582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259744|NCT02462681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259745|NCT02462499|Eplerenone|eplerenone|mesh-list
25259746|NCT02462499|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25259747|NCT02462499|Hormone Antagonists|hormone antagonists|mesh-ancestor
25259748|NCT02462499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25259749|NCT02462499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259750|NCT02462499|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25259751|NCT02462499|Diuretics|diuretics|mesh-ancestor
25259752|NCT02462499|Natriuretic Agents|natriuretic agents|mesh-ancestor
25259753|NCT02462499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25259754|NCT02462369|Glimepiride|glimepiride|mesh-list
25259755|NCT02462369|Saxagliptin|saxagliptin|mesh-list
25259756|NCT02462369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25259757|NCT02462369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25259758|NCT02462369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259759|NCT02462369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24931552|NCT04088110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931553|NCT04088110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24931560|NCT04087746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24931561|NCT04087746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24931562|NCT04087746|Growth Substances|growth substances|mesh-ancestor
24931563|NCT04087746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931564|NCT04087746|Growth Inhibitors|growth inhibitors|mesh-ancestor
24931565|NCT04087746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931566|NCT04088006|Hyaluronic Acid|hyaluronic acid|mesh-list
24931567|NCT04088006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24931568|NCT04088006|Immunologic Factors|immunologic factors|mesh-ancestor
24931569|NCT04088006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931570|NCT04088006|Viscosupplements|viscosupplements|mesh-ancestor
25039186|NCT04029610|Racepinephrine|racepinephrine|mesh-list
25039187|NCT04029610|Epinephryl borate|epinephryl borate|mesh-list
25039237|NCT03949673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25039238|NCT03949673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25039239|NCT03949673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039240|NCT03949673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039241|NCT03949673|Gout Suppressants|gout suppressants|mesh-ancestor
25039243|NCT03948646|Anticonvulsants|anticonvulsants|mesh-ancestor
25039244|NCT03943147|Mycophenolic Acid|mycophenolic acid|mesh-list
25039245|NCT03943147|BMS-986165|bms-986165|mesh-list
24818031|NCT02086656|Growth Substances|growth substances|mesh-ancestor
25039255|NCT03943147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25259760|NCT02462369|Immunologic Factors|immunologic factors|mesh-ancestor
25259761|NCT02462369|Incretins|incretins|mesh-ancestor
25259762|NCT02462369|Hormones|hormones|mesh-ancestor
25259763|NCT02462369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25259764|NCT02462369|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25259765|NCT02462369|Protease Inhibitors|protease inhibitors|mesh-ancestor
25259766|NCT02462369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25259767|NCT02462369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259768|NCT02462304|Bevacizumab|bevacizumab|mesh-list
25259769|NCT02462304|Ranibizumab|ranibizumab|mesh-list
25259770|NCT02462304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25259771|NCT02462304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25259772|NCT02462304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24931571|NCT04088006|Protective Agents|protective agents|mesh-ancestor
24625062|NCT01080417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24625070|NCT01080443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24625072|NCT01080443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625073|NCT01080443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625075|NCT01080456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24625076|NCT01080456|Immunologic Factors|immunologic factors|mesh-ancestor
24529350|NCT00625560|Entecavir|entecavir|mesh-list
24529351|NCT00625560|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24529352|NCT00625560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24529353|NCT00625560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529354|NCT00625560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529355|NCT00625560|Antiviral Agents|antiviral agents|mesh-ancestor
24529356|NCT00625560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24529360|NCT00625573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25039294|NCT03916042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25039295|NCT03916042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25039296|NCT03915067|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25039297|NCT03915067|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25039298|NCT03915067|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25039299|NCT03915067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039300|NCT03915067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039350|NCT03879863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25039351|NCT03879863|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25039352|NCT03879408|Acetaminophen|acetaminophen|mesh-list
25039354|NCT03879408|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25039355|NCT03879408|Hydrocodone|hydrocodone|mesh-list
25039356|NCT03879408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25039357|NCT03879408|Analgesics|analgesics|mesh-ancestor
25039358|NCT03879408|Sensory System Agents|sensory system agents|mesh-ancestor
25039359|NCT03879408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039360|NCT03879408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039361|NCT03879408|Antipyretics|antipyretics|mesh-ancestor
25039362|NCT03879408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25039363|NCT03879408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25039364|NCT03879408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25039401|NCT03857646|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25039402|NCT03857646|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25039403|NCT03857646|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25039404|NCT03857646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25039405|NCT03856047|Liraglutide|liraglutide|mesh-list
25039406|NCT03856047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24996073|NCT04306900|Gemcitabine|gemcitabine|mesh-list
25039407|NCT03856047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039408|NCT03856047|Incretins|incretins|mesh-ancestor
25259773|NCT02462304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25259774|NCT02462304|Growth Substances|growth substances|mesh-ancestor
25259775|NCT02462304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259776|NCT02462304|Growth Inhibitors|growth inhibitors|mesh-ancestor
25259777|NCT02462317|Baclofen|baclofen|mesh-list
25259778|NCT02462317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25259779|NCT02462317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25259780|NCT02462317|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25259781|NCT02462317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259782|NCT02462317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25259783|NCT02462317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25259784|NCT02462317|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25259785|NCT02462317|GABA Agonists|gaba agonists|mesh-ancestor
25259786|NCT02462317|GABA Agents|gaba agents|mesh-ancestor
25259787|NCT02462317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25259788|NCT02462317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259789|NCT02462317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25259790|NCT02462317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25259791|NCT02462317|Cholinergic Agents|cholinergic agents|mesh-ancestor
25259792|NCT02462109|Lorazepam|lorazepam|mesh-list
25259793|NCT02462109|Anticonvulsants|anticonvulsants|mesh-ancestor
24529363|NCT00625677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529364|NCT00625781|Insulin|insulin|mesh-list
24529365|NCT00625781|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24529366|NCT00625781|Insulin Aspart|insulin aspart|mesh-list
24529367|NCT00625781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24529368|NCT00625781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529369|NCT00625794|Nicotine|nicotine|mesh-list
24625077|NCT01080456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625078|NCT01080456|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24625079|NCT01080456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625080|NCT01080456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625082|NCT01080469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24625083|NCT01080469|Immunologic Factors|immunologic factors|mesh-ancestor
24625084|NCT01080469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625085|NCT01080469|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24625086|NCT01080469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625097|NCT01080534|Immunologic Factors|immunologic factors|mesh-ancestor
24625098|NCT01080534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625099|NCT01080534|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24625100|NCT01080534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759918|NCT01755494|Metformin|metformin|mesh-list
25039410|NCT03856047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25039461|NCT03832179|Hormones|hormones|mesh-ancestor
25039462|NCT03832179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25039463|NCT03832179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25039464|NCT03827018|Prednisone|prednisone|mesh-list
25039465|NCT03827018|Mavrilimumab|mavrilimumab|mesh-list
25039466|NCT03827018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25039467|NCT03827018|Glucocorticoids|glucocorticoids|mesh-ancestor
25039468|NCT03827018|Hormones|hormones|mesh-ancestor
25039469|NCT03827018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25039470|NCT03827018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259794|NCT02462109|Antiemetics|antiemetics|mesh-ancestor
25259795|NCT02462109|Autonomic Agents|autonomic agents|mesh-ancestor
25259796|NCT02462109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25259797|NCT02462109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259798|NCT02462109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25259799|NCT02462109|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25259800|NCT02462109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25259801|NCT02462109|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25259802|NCT02462109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25259803|NCT02462109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25259804|NCT02462109|GABA Modulators|gaba modulators|mesh-ancestor
25259805|NCT02462109|GABA Agents|gaba agents|mesh-ancestor
25259806|NCT02462109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25259807|NCT02462109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259808|NCT02462161|Insulin|insulin|mesh-list
25259809|NCT02462161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25259810|NCT02462161|Insulin Aspart|insulin aspart|mesh-list
25259811|NCT02462161|Insulin, Long-Acting|insulin, long-acting|mesh-list
25259812|NCT02462161|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25259813|NCT02462161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25259814|NCT02462161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259815|NCT02462174|Ketamine|ketamine|mesh-list
25259816|NCT02462174|Bupivacaine|bupivacaine|mesh-list
25259817|NCT02462174|Anesthetics, Local|anesthetics, local|mesh-ancestor
25259818|NCT02462174|Anesthetics|anesthetics|mesh-ancestor
25259819|NCT02462174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25259820|NCT02462174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259821|NCT02462174|Sensory System Agents|sensory system agents|mesh-ancestor
25259822|NCT02462174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24395891|NCT00137098|Caffeine|caffeine|mesh-list
24395971|NCT00137462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395972|NCT00137462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25259823|NCT02462174|Analgesics|analgesics|mesh-ancestor
25259824|NCT02462174|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25259825|NCT02462174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24625101|NCT01080534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931587|NCT04087967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24408365|NCT00177567|Lamotrigine|lamotrigine|mesh-list
24931606|NCT04087460|Vaccines|vaccines|mesh-list
24931607|NCT04087460|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24931608|NCT04087460|Immunologic Factors|immunologic factors|mesh-ancestor
24931609|NCT04087460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931610|NCT04087668|Anesthetics|anesthetics|mesh-list
24931611|NCT04087668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24931612|NCT04087668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931613|NCT04087759|Bedaquiline|bedaquiline|mesh-list
24931614|NCT04087759|Diarylquinolines|diarylquinolines|mesh-list
24931615|NCT04087759|Antitubercular Agents|antitubercular agents|mesh-ancestor
24931616|NCT04087759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24931617|NCT04087759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24931618|NCT04087421|Glycerol|glycerol|mesh-list
24931619|NCT04087421|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24931620|NCT04087421|Protective Agents|protective agents|mesh-ancestor
24931621|NCT04087421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931622|NCT04087239|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24931623|NCT04087239|Antiviral Agents|antiviral agents|mesh-ancestor
24931624|NCT04087239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24931625|NCT04086940|Esmolol|esmolol|mesh-list
25259826|NCT02462174|Anesthetics, General|anesthetics, general|mesh-ancestor
24931626|NCT04086940|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25259827|NCT02462174|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25259828|NCT02462174|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25259829|NCT02462174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25259830|NCT02462174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259831|NCT02462252|Cyclosporine|cyclosporine|mesh-list
25259832|NCT02462252|Methylprednisolone|methylprednisolone|mesh-list
25259833|NCT02462252|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25259834|NCT02462252|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25259835|NCT02462252|Cyclosporins|cyclosporins|mesh-list
25259836|NCT02462252|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24418359|NCT00209313|Acyclovir|acyclovir|mesh-list
25259837|NCT02462252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25259838|NCT02462252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259839|NCT02462252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25259840|NCT02462252|Immunologic Factors|immunologic factors|mesh-ancestor
25259841|NCT02462252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259842|NCT02462252|Antifungal Agents|antifungal agents|mesh-ancestor
25259843|NCT02462252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25259844|NCT02462252|Dermatologic Agents|dermatologic agents|mesh-ancestor
25259845|NCT02462252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25259846|NCT02462252|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25259847|NCT02462252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25259848|NCT02462252|Antiemetics|antiemetics|mesh-ancestor
25259849|NCT02462252|Autonomic Agents|autonomic agents|mesh-ancestor
25259850|NCT02462252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25259851|NCT02462252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25259852|NCT02462252|Glucocorticoids|glucocorticoids|mesh-ancestor
25259853|NCT02462252|Hormones|hormones|mesh-ancestor
25259854|NCT02462252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25259855|NCT02462252|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25259856|NCT02462252|Protective Agents|protective agents|mesh-ancestor
25259857|NCT02462252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25259858|NCT02462252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25259859|NCT02462265|Mitoxantrone|mitoxantrone|mesh-list
25259860|NCT02462265|Antineoplastic Agents|antineoplastic agents|mesh-list
25259861|NCT02462265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259862|NCT02462265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259863|NCT02462265|Analgesics|analgesics|mesh-ancestor
25259864|NCT02462265|Sensory System Agents|sensory system agents|mesh-ancestor
24931632|NCT04086940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931633|NCT04087317|Acetaminophen|acetaminophen|mesh-list
25688070|NCT01940523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688071|NCT01940523|Hemostatics|hemostatics|mesh-ancestor
25688072|NCT01940523|Coagulants|coagulants|mesh-ancestor
25688073|NCT01940887|Bevacizumab|bevacizumab|mesh-list
24931634|NCT04087317|Ibuprofen|ibuprofen|mesh-list
24931635|NCT04087317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24931636|NCT04087317|Analgesics|analgesics|mesh-ancestor
24931637|NCT04087317|Sensory System Agents|sensory system agents|mesh-ancestor
24931638|NCT04087317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24931639|NCT04087317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931640|NCT04087317|Antipyretics|antipyretics|mesh-ancestor
24931641|NCT04087317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24931642|NCT04087317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24931643|NCT04087317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24931644|NCT04087317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25039471|NCT03827018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25039472|NCT03827018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25039473|NCT03827018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25039474|NCT03824587|Calcium, Dietary|calcium, dietary|mesh-list
25039475|NCT03824587|Calcium Carbonate|calcium carbonate|mesh-list
25039646|NCT03729362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25039647|NCT03729362|Antiviral Agents|antiviral agents|mesh-ancestor
25039648|NCT03729362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25039649|NCT03729362|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25039650|NCT03729362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25039651|NCT03729362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039652|NCT03727022|Lorecivivint|lorecivivint|mesh-list
25039653|NCT03727022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25039654|NCT03724825|Testosterone|testosterone|mesh-list
25039655|NCT03724825|Androgens|androgens|mesh-ancestor
25039657|NCT03724825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25039658|NCT03724825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039659|NCT03721965|Prednisone|prednisone|mesh-list
25039660|NCT03721965|Methylprednisolone|methylprednisolone|mesh-list
25039661|NCT03721965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25039662|NCT03721965|Glucocorticoids|glucocorticoids|mesh-ancestor
25039664|NCT03721965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25039703|NCT03706521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25039704|NCT03704584|Methylprednisolone|methylprednisolone|mesh-list
25039705|NCT03704584|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25039706|NCT03704584|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25259865|NCT02462265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25259866|NCT02462265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25259867|NCT02462265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25259868|NCT02462265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25259869|NCT02462044|Iodine|iodine|mesh-list
25259870|NCT02462044|Cadexomer iodine|cadexomer iodine|mesh-list
25259871|NCT02462044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25259872|NCT02462044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25259873|NCT02462044|Trace Elements|trace elements|mesh-ancestor
25259874|NCT02462044|Micronutrients|micronutrients|mesh-ancestor
25259875|NCT02462044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259876|NCT02461706|Cannabidiol|cannabidiol|mesh-list
25259877|NCT02461706|Anticonvulsants|anticonvulsants|mesh-ancestor
25259878|NCT02461836|Gemcitabine|gemcitabine|mesh-list
24931645|NCT04087317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24931646|NCT04087317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931647|NCT04086537|Hepcidins|hepcidins|mesh-list
24931648|NCT04086537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24931649|NCT04086719|Pyrimethamine|pyrimethamine|mesh-list
24931650|NCT04086719|BMS-986165|bms-986165|mesh-list
24931651|NCT04086719|Antimalarials|antimalarials|mesh-ancestor
24931669|NCT04086264|Azacitidine|azacitidine|mesh-list
24931670|NCT04086264|Decitabine|decitabine|mesh-list
24931671|NCT04086264|Venetoclax|venetoclax|mesh-list
24931672|NCT04086264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24931673|NCT04086264|Antimetabolites|antimetabolites|mesh-ancestor
24931674|NCT04086264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931675|NCT04086264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931676|NCT04086264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24931677|NCT04086186|Bupivacaine|bupivacaine|mesh-list
24931687|NCT04086238|Antimetabolites|antimetabolites|mesh-ancestor
24931688|NCT04086238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931689|NCT04086238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935483|NCT04049916|Artesunate|artesunate|mesh-list
25039711|NCT03704584|Prednisolone phosphate|prednisolone phosphate|mesh-list
25039712|NCT03704584|Anesthetics, Local|anesthetics, local|mesh-ancestor
25039713|NCT03704584|Anesthetics|anesthetics|mesh-ancestor
25688074|NCT01940887|Aflibercept|aflibercept|mesh-list
24996389|NCT03568708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25039780|NCT03660878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25039782|NCT03659929|Amphetamine|amphetamine|mesh-list
25039783|NCT03659929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25039784|NCT03659929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039785|NCT03659929|Sympathomimetics|sympathomimetics|mesh-ancestor
25039786|NCT03659929|Autonomic Agents|autonomic agents|mesh-ancestor
25039787|NCT03659929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039807|NCT03647592|Gefitinib|gefitinib|mesh-list
25039844|NCT03626545|Mitosis Modulators|mitosis modulators|mesh-ancestor
25039845|NCT03626545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039846|NCT03624127|Apremilast|apremilast|mesh-list
25039847|NCT03624127|BMS-986165|bms-986165|mesh-list
25039848|NCT03624127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25039849|NCT03624127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25039850|NCT03624127|Analgesics|analgesics|mesh-ancestor
25039851|NCT03624127|Sensory System Agents|sensory system agents|mesh-ancestor
25039852|NCT03624127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039853|NCT03624127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039905|NCT03608397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039906|NCT03608397|Cholinergic Agents|cholinergic agents|mesh-ancestor
25039907|NCT03608397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25039909|NCT03603288|Antioxidants|antioxidants|mesh-ancestor
25039910|NCT03603288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039911|NCT03603288|Protective Agents|protective agents|mesh-ancestor
25039912|NCT03603288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259879|NCT02461836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25259880|NCT02461836|Antimetabolites|antimetabolites|mesh-ancestor
25259881|NCT02461836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259882|NCT02461836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25259883|NCT02461836|Antiviral Agents|antiviral agents|mesh-ancestor
25259884|NCT02461836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25259885|NCT02461836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25259886|NCT02461836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25259887|NCT02461836|Immunologic Factors|immunologic factors|mesh-ancestor
25259888|NCT02461836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259889|NCT02461888|Dexamethasone|dexamethasone|mesh-list
25259890|NCT02461888|Cyclophosphamide|cyclophosphamide|mesh-list
25259891|NCT02461888|Ixazomib|ixazomib|mesh-list
25259892|NCT02461888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25259893|NCT02461888|Immunologic Factors|immunologic factors|mesh-ancestor
25259894|NCT02461888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259895|NCT02461888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25259896|NCT02461888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25259897|NCT02461888|Alkylating Agents|alkylating agents|mesh-ancestor
24931690|NCT04086238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24931691|NCT04085913|Lidocaine|lidocaine|mesh-list
24931692|NCT04085913|Epinephrine|epinephrine|mesh-list
24931693|NCT04085913|Racepinephrine|racepinephrine|mesh-list
24931694|NCT04085913|Bupivacaine|bupivacaine|mesh-list
24931695|NCT04085913|Epinephryl borate|epinephryl borate|mesh-list
24931696|NCT04085913|Anesthetics, Local|anesthetics, local|mesh-ancestor
24931697|NCT04085913|Anesthetics|anesthetics|mesh-ancestor
24931698|NCT04085913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24931699|NCT04085913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931701|NCT04085913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24931702|NCT04085913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24931710|NCT04085913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24931711|NCT04085913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25039967|NCT03542669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25039968|NCT03542669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25039969|NCT03542669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039970|NCT03542669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039971|NCT03541655|Celecoxib|celecoxib|mesh-list
25039972|NCT03541655|Bupivacaine|bupivacaine|mesh-list
25040054|NCT03471767|Bupropion|bupropion|mesh-list
25040055|NCT03471767|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25040106|NCT03423147|Disinfectants|disinfectants|mesh-ancestor
25040107|NCT03423147|Dermatologic Agents|dermatologic agents|mesh-ancestor
25040110|NCT03412890|Norethindrone|norethindrone|mesh-list
25040111|NCT03412890|Norethindrone Acetate|norethindrone acetate|mesh-list
25259898|NCT02461888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259899|NCT02461888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25259900|NCT02461888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25259901|NCT02461888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25259903|NCT02461888|Autonomic Agents|autonomic agents|mesh-ancestor
25259904|NCT02461888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25259905|NCT02461888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25259906|NCT02461888|Glucocorticoids|glucocorticoids|mesh-ancestor
25259907|NCT02461888|Hormones|hormones|mesh-ancestor
25259908|NCT02461888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25259909|NCT02461888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25259910|NCT02461888|Protease Inhibitors|protease inhibitors|mesh-ancestor
24931712|NCT04085913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24931713|NCT04085913|Autonomic Agents|autonomic agents|mesh-ancestor
24931714|NCT04085913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24931715|NCT04085913|Respiratory System Agents|respiratory system agents|mesh-ancestor
24931716|NCT04085913|Mydriatics|mydriatics|mesh-ancestor
24931717|NCT04085913|Sympathomimetics|sympathomimetics|mesh-ancestor
24931718|NCT04085913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24931719|NCT04085562|Amlodipine|amlodipine|mesh-list
24931720|NCT04085562|Bisoprolol|bisoprolol|mesh-list
24931721|NCT04085562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24931722|NCT04085562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24931723|NCT04085562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24931724|NCT04085562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931725|NCT04085562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24931726|NCT04085562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931727|NCT04085562|Vasodilator Agents|vasodilator agents|mesh-ancestor
24931728|NCT04085562|Sympatholytics|sympatholytics|mesh-ancestor
25040118|NCT03412890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25040228|NCT03301051|Immunologic Factors|immunologic factors|mesh-ancestor
25040229|NCT03301051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040230|NCT03288454|Apixaban|apixaban|mesh-list
25040231|NCT03288454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25040232|NCT03288454|Antithrombins|antithrombins|mesh-ancestor
25040233|NCT03288454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25040234|NCT03288454|Protease Inhibitors|protease inhibitors|mesh-ancestor
25040235|NCT03288454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25259911|NCT02461888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25259912|NCT02461875|Cabergoline|cabergoline|mesh-list
25259913|NCT02461875|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25259914|NCT02461875|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25259915|NCT02461875|Dopamine Agonists|dopamine agonists|mesh-ancestor
25259916|NCT02461875|Dopamine Agents|dopamine agents|mesh-ancestor
25259917|NCT02461875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25259918|NCT02461875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259919|NCT02461875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259920|NCT02461719|Cyclosporine|cyclosporine|mesh-list
25259921|NCT02461719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25259922|NCT02461719|Cyclosporins|cyclosporins|mesh-list
25259923|NCT02461719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25259924|NCT02461719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259925|NCT02461719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25259926|NCT02461719|Immunologic Factors|immunologic factors|mesh-ancestor
25259927|NCT02461719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259928|NCT02461719|Antifungal Agents|antifungal agents|mesh-ancestor
25259929|NCT02461719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25259930|NCT02461719|Dermatologic Agents|dermatologic agents|mesh-ancestor
25259931|NCT02461719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25259932|NCT02461719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24931733|NCT04085562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24931734|NCT04085562|Adrenergic Agents|adrenergic agents|mesh-ancestor
24931735|NCT04085562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24931736|NCT04085744|Mometasone Furoate|mometasone furoate|mesh-list
24931737|NCT04085744|Lidocaine|lidocaine|mesh-list
24931738|NCT04085744|Anesthetics, Local|anesthetics, local|mesh-ancestor
24931739|NCT04085744|Anesthetics|anesthetics|mesh-ancestor
24931740|NCT04085744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24931741|NCT04085744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931742|NCT04085744|Sensory System Agents|sensory system agents|mesh-ancestor
24931743|NCT04085744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24529370|NCT00625794|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24529371|NCT00625794|Autonomic Agents|autonomic agents|mesh-ancestor
24529372|NCT00625794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25040278|NCT03215277|Certolizumab Pegol|certolizumab pegol|mesh-list
24398047|NCT00143299|Cholinergic Agents|cholinergic agents|mesh-ancestor
24398048|NCT00143299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25040279|NCT03215277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25040280|NCT03215277|Immunologic Factors|immunologic factors|mesh-ancestor
25040281|NCT03215277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040282|NCT03215277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25040309|NCT03187834|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25040310|NCT03187834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25040311|NCT03187834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25040378|NCT03137407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25040379|NCT03137407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25040380|NCT03137407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040382|NCT03137407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25040383|NCT03137407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040384|NCT03137407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25040385|NCT03137407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25040386|NCT03131154|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25040387|NCT03131154|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25259933|NCT02461719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25259934|NCT02461914|Warfarin|warfarin|mesh-list
25259935|NCT02461914|Anticoagulants|anticoagulants|mesh-ancestor
25259936|NCT02461667|Alendronate|alendronate|mesh-list
25259937|NCT02461667|Metformin|metformin|mesh-list
25259938|NCT02461667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25259939|NCT02461667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259940|NCT02461667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25259941|NCT02461329|Polygeline|polygeline|mesh-list
25259942|NCT02461329|Plasma Substitutes|plasma substitutes|mesh-ancestor
25259943|NCT02461329|Blood Substitutes|blood substitutes|mesh-ancestor
25259944|NCT02461368|Triamcinolone|triamcinolone|mesh-list
25259945|NCT02461368|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25259946|NCT02461368|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25259947|NCT02461368|Lidocaine|lidocaine|mesh-list
25259948|NCT02461368|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25259949|NCT02461368|Anesthetics, Local|anesthetics, local|mesh-ancestor
25259950|NCT02461368|Anesthetics|anesthetics|mesh-ancestor
25259951|NCT02461368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24931744|NCT04085744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24931761|NCT04085757|Oxytocics|oxytocics|mesh-ancestor
24931762|NCT04085757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24931763|NCT04085757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931764|NCT04085575|Tranexamic Acid|tranexamic acid|mesh-list
24931765|NCT04085575|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24931766|NCT04085575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24931767|NCT04085575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931768|NCT04085575|Hemostatics|hemostatics|mesh-ancestor
24931769|NCT04085575|Coagulants|coagulants|mesh-ancestor
24931770|NCT04085627|Amlodipine|amlodipine|mesh-list
24931771|NCT04085627|Valsartan|valsartan|mesh-list
25040392|NCT03123783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040393|NCT03118570|Vitamin D|vitamin d|mesh-list
25040394|NCT03118570|Zoledronic Acid|zoledronic acid|mesh-list
25040395|NCT03118570|Calcium|calcium|mesh-list
25040396|NCT03118570|Vitamins|vitamins|mesh-ancestor
25040397|NCT03118570|Micronutrients|micronutrients|mesh-ancestor
25040398|NCT03118570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040399|NCT03118570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25040445|NCT03070951|OBE2109|obe2109|mesh-list
25040446|NCT03070951|Hormone Antagonists|hormone antagonists|mesh-ancestor
25040447|NCT03070951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25040448|NCT03070951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040449|NCT03070899|OBE2109|obe2109|mesh-list
25040450|NCT03070899|Hormone Antagonists|hormone antagonists|mesh-ancestor
25040451|NCT03070899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25040452|NCT03070899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040453|NCT03065556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25040455|NCT03062540|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25040471|NCT03060980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25040472|NCT03060980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25040473|NCT03060980|Immunologic Factors|immunologic factors|mesh-ancestor
25040474|NCT03060980|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25040475|NCT03060980|Incretins|incretins|mesh-ancestor
25040476|NCT03060980|Hormones|hormones|mesh-ancestor
25688075|NCT01940887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25688076|NCT01940887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24398388|NCT00144274|Expectorants|expectorants|mesh-ancestor
24398389|NCT00144274|Respiratory System Agents|respiratory system agents|mesh-ancestor
24398420|NCT00144352|Antimalarials|antimalarials|mesh-ancestor
24398421|NCT00144352|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24398422|NCT00144352|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24398423|NCT00144352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24398424|NCT00144352|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24398425|NCT00144352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398426|NCT00144352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398427|NCT00144352|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24524124|NCT05252923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24945831|NCT03945955|Melatonin|melatonin|mesh-list
24945832|NCT03945955|Antioxidants|antioxidants|mesh-ancestor
24961662|NCT03806036|Vitamin D|vitamin d|mesh-list
24945833|NCT03945955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945834|NCT03945955|Protective Agents|protective agents|mesh-ancestor
24945835|NCT03945955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945836|NCT03945955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24945837|NCT03945539|Itraconazole|itraconazole|mesh-list
25040477|NCT03060980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25040478|NCT03060772|Pioglitazone|pioglitazone|mesh-list
25040479|NCT03060772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25040480|NCT03060772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259952|NCT02461368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259953|NCT02461368|Sensory System Agents|sensory system agents|mesh-ancestor
25259954|NCT02461368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25259955|NCT02461368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25259956|NCT02461368|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25259957|NCT02461368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25259958|NCT02461368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25259959|NCT02461368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259960|NCT02461368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25259961|NCT02461368|Glucocorticoids|glucocorticoids|mesh-ancestor
25259962|NCT02461368|Hormones|hormones|mesh-ancestor
25259963|NCT02461368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25259964|NCT02461368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25259965|NCT02461368|Immunologic Factors|immunologic factors|mesh-ancestor
25259966|NCT02461368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275159|NCT02373384|Potassium Citrate|potassium citrate|mesh-list
24508079|NCT00554164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24529376|NCT00625794|Cholinergic Agents|cholinergic agents|mesh-ancestor
24529377|NCT00625794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24529378|NCT00625794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529379|NCT00625859|Bupropion|bupropion|mesh-list
24529380|NCT00625859|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24529381|NCT00625859|Antidepressive Agents|antidepressive agents|mesh-ancestor
24931776|NCT04085627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931777|NCT04085627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24607466|NCT04558281|Anesthetics, Local|anesthetics, local|mesh-ancestor
24931781|NCT04085627|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24931784|NCT04085393|Autonomic Agents|autonomic agents|mesh-ancestor
24931785|NCT04085393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25688077|NCT01940887|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25688078|NCT01940887|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25688079|NCT01940887|Growth Substances|growth substances|mesh-ancestor
25688080|NCT01940887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688081|NCT01940887|Growth Inhibitors|growth inhibitors|mesh-ancestor
25688082|NCT01940900|Ranibizumab|ranibizumab|mesh-list
25688083|NCT01940900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25688084|NCT01940900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25688085|NCT01940900|Growth Substances|growth substances|mesh-ancestor
25688086|NCT01940900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688087|NCT01940900|Growth Inhibitors|growth inhibitors|mesh-ancestor
25688088|NCT01940900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688089|NCT01941095|Hydroxychloroquine|hydroxychloroquine|mesh-list
25688090|NCT01941095|Chloroquine|chloroquine|mesh-list
25688091|NCT01941095|Sulfasalazine|sulfasalazine|mesh-list
25688092|NCT01941095|Methotrexate|methotrexate|mesh-list
25688093|NCT01941095|Azathioprine|azathioprine|mesh-list
25688094|NCT01941095|Leflunomide|leflunomide|mesh-list
25688095|NCT01941095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25688096|NCT01941095|Abortifacient Agents|abortifacient agents|mesh-ancestor
24931786|NCT04085393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931787|NCT04085393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24931788|NCT04085393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24931789|NCT04085393|Serotonin Agents|serotonin agents|mesh-ancestor
24931790|NCT04085393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24931791|NCT04085393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931792|NCT04085640|Ropivacaine|ropivacaine|mesh-list
24931793|NCT04085640|Anesthetics, Local|anesthetics, local|mesh-ancestor
24931830|NCT04085120|Dexamethasone|dexamethasone|mesh-list
24931831|NCT04085120|Dexamethasone acetate|dexamethasone acetate|mesh-list
24931832|NCT04085120|Lidocaine|lidocaine|mesh-list
24931833|NCT04085120|Ropivacaine|ropivacaine|mesh-list
24931834|NCT04085120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24931835|NCT04085120|Antiemetics|antiemetics|mesh-ancestor
24931836|NCT04085120|Autonomic Agents|autonomic agents|mesh-ancestor
24931837|NCT04085120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25259967|NCT02461186|Piperaquine|piperaquine|mesh-list
25259968|NCT02461186|Artenimol|artenimol|mesh-list
25259969|NCT02461186|Antimalarials|antimalarials|mesh-ancestor
25259970|NCT02461186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25259971|NCT02461186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25259972|NCT02461186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25259973|NCT02461004|Ezetimibe|ezetimibe|mesh-list
25259974|NCT02461004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25259975|NCT02461004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25259976|NCT02461004|Antimetabolites|antimetabolites|mesh-ancestor
25259977|NCT02461004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259978|NCT02461004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25259979|NCT02461056|Ibuprofen|ibuprofen|mesh-list
25259980|NCT02461056|Hydromorphone|hydromorphone|mesh-list
25259981|NCT02461056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25259982|NCT02461056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25259983|NCT02461056|Analgesics|analgesics|mesh-ancestor
25259984|NCT02461056|Sensory System Agents|sensory system agents|mesh-ancestor
25259985|NCT02461056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25259986|NCT02461056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25259987|NCT02461056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25259988|NCT02461056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25259989|NCT02461056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25259990|NCT02461056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25259991|NCT02461056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25259992|NCT02461056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25259993|NCT02461056|Narcotics|narcotics|mesh-ancestor
25259994|NCT02461056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25259995|NCT02461121|Cyclosporine|cyclosporine|mesh-list
25259996|NCT02461121|Mycophenolic Acid|mycophenolic acid|mesh-list
25259997|NCT02461121|Cyclophosphamide|cyclophosphamide|mesh-list
25259998|NCT02461121|Fludarabine|fludarabine|mesh-list
25259999|NCT02461121|Cyclosporins|cyclosporins|mesh-list
25260000|NCT02461121|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25260001|NCT02461121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25260002|NCT02461121|Immunologic Factors|immunologic factors|mesh-ancestor
25260003|NCT02461121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260004|NCT02461121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25260005|NCT02461121|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24931838|NCT04085120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931839|NCT04085120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24931840|NCT04085120|Glucocorticoids|glucocorticoids|mesh-ancestor
24931841|NCT04085120|Hormones|hormones|mesh-ancestor
24931842|NCT04085120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24931843|NCT04085120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24931844|NCT04085120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931845|NCT04085120|Anesthetics, Local|anesthetics, local|mesh-ancestor
24931846|NCT04085120|Anesthetics|anesthetics|mesh-ancestor
24931847|NCT04085120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24931848|NCT04085120|Sensory System Agents|sensory system agents|mesh-ancestor
25040556|NCT03009019|Celecoxib|celecoxib|mesh-list
25040557|NCT03009019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25040558|NCT03009019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25040559|NCT03009019|Analgesics|analgesics|mesh-ancestor
24901111|NCT04388904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25260006|NCT02461121|Alkylating Agents|alkylating agents|mesh-ancestor
25260007|NCT02461121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260008|NCT02461121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25260009|NCT02461121|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25260010|NCT02461121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25260011|NCT02461121|Antifungal Agents|antifungal agents|mesh-ancestor
25260012|NCT02461121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25260013|NCT02461121|Dermatologic Agents|dermatologic agents|mesh-ancestor
25260014|NCT02461121|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25260015|NCT02461121|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25260016|NCT02461121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25260017|NCT02461121|Antitubercular Agents|antitubercular agents|mesh-ancestor
25260018|NCT02461121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25260020|NCT02461043|Cisplatin|cisplatin|mesh-list
25260021|NCT02461043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25260022|NCT02461043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25260023|NCT02461043|Tubulin Modulators|tubulin modulators|mesh-ancestor
24849300|NCT01309191|Minoxidil|minoxidil|mesh-list
24849301|NCT01309191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24931852|NCT04085120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24534163|NCT00646204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24534164|NCT00646204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24931856|NCT04085250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931857|NCT04085250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24607091|NCT05239624|Pembrolizumab|pembrolizumab|mesh-list
24607092|NCT05239624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24607093|NCT05239624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607094|NCT05219942|Insulin|insulin|mesh-list
24607095|NCT05219942|Insulin Glargine|insulin glargine|mesh-list
24607096|NCT05219942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24607097|NCT05219942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607143|NCT05177263|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24607165|NCT05123092|Morphine|morphine|mesh-list
24607166|NCT05123092|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24607167|NCT05123092|Narcotics|narcotics|mesh-ancestor
24607168|NCT05123092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24607169|NCT05123092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607189|NCT05072093|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24607190|NCT05072093|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24607226|NCT04994561|Vitamins|vitamins|mesh-ancestor
24607245|NCT04941443|Sensory System Agents|sensory system agents|mesh-ancestor
24607246|NCT04941443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24607247|NCT04941443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607248|NCT04941443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24607249|NCT04941443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24607250|NCT04941443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24607251|NCT04941443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24607252|NCT04941443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607253|NCT04941443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24477914|NCT00420797|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24607340|NCT04764942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24607341|NCT04764942|Glucocorticoids|glucocorticoids|mesh-ancestor
25260024|NCT02461043|Antimitotic Agents|antimitotic agents|mesh-ancestor
25260025|NCT02461043|Mitosis Modulators|mitosis modulators|mesh-ancestor
25260026|NCT02461043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260027|NCT02461069|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25260028|NCT02461069|Dermatologic Agents|dermatologic agents|mesh-ancestor
25260029|NCT02461069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25260030|NCT02461069|Immunologic Factors|immunologic factors|mesh-ancestor
25260031|NCT02461069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260032|NCT02461030|Listerine|listerine|mesh-list
25260033|NCT02461030|Sodium Fluoride|sodium fluoride|mesh-list
25260034|NCT02461030|Cariostatic Agents|cariostatic agents|mesh-ancestor
25260035|NCT02461030|Protective Agents|protective agents|mesh-ancestor
25260036|NCT02461030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260037|NCT02461030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25260038|NCT02461030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25260039|NCT02460913|Morphine|morphine|mesh-list
25260040|NCT02460913|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24931858|NCT04085250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607467|NCT04558281|Anesthetics|anesthetics|mesh-ancestor
24931883|NCT04084912|Antiemetics|antiemetics|mesh-ancestor
24931884|NCT04084912|Autonomic Agents|autonomic agents|mesh-ancestor
24931885|NCT04084912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24931886|NCT04084912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966093|NCT03771768|Hormones|hormones|mesh-ancestor
24640798|NCT01170130|Lidocaine|lidocaine|mesh-list
24607342|NCT04764942|Hormones|hormones|mesh-ancestor
24607343|NCT04764942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24607344|NCT04764942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24607345|NCT04764942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607359|NCT04761198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609513|NCT00997022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24853503|NCT02268565|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24607395|NCT04710628|Pembrolizumab|pembrolizumab|mesh-list
24607396|NCT04710628|Lenvatinib|lenvatinib|mesh-list
24607421|NCT04649229|Antiemetics|antiemetics|mesh-ancestor
24607423|NCT04649229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24607424|NCT04649229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607425|NCT04649229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24607426|NCT04649229|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24607427|NCT04649229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24607428|NCT04649229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671266|NCT01324596|Methylprednisolone|methylprednisolone|mesh-list
24671267|NCT01324596|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24671268|NCT01324596|Prednisolone acetate|prednisolone acetate|mesh-list
24671269|NCT01324596|Cyclophosphamide|cyclophosphamide|mesh-list
25260041|NCT02460913|Narcotics|narcotics|mesh-ancestor
25260042|NCT02460913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25260043|NCT02460913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260044|NCT02460913|Analgesics|analgesics|mesh-ancestor
25260045|NCT02460913|Sensory System Agents|sensory system agents|mesh-ancestor
25260046|NCT02460913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25260050|NCT02460497|Minoxidil|minoxidil|mesh-list
25260051|NCT02460497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25260052|NCT02460497|Vasodilator Agents|vasodilator agents|mesh-ancestor
25260053|NCT02460510|Mannitol|mannitol|mesh-list
25260054|NCT02460510|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25260055|NCT02460510|Diuretics|diuretics|mesh-ancestor
25260056|NCT02460510|Natriuretic Agents|natriuretic agents|mesh-ancestor
25260057|NCT02460510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260058|NCT02460627|Lidocaine|lidocaine|mesh-list
25260059|NCT02460627|Anesthetics, Local|anesthetics, local|mesh-ancestor
25260060|NCT02460627|Anesthetics|anesthetics|mesh-ancestor
25260061|NCT02460627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24931887|NCT04084912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24931888|NCT04084912|Glucocorticoids|glucocorticoids|mesh-ancestor
24931889|NCT04084912|Hormones|hormones|mesh-ancestor
24931890|NCT04084912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24931892|NCT04084912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931893|NCT04084912|Protease Inhibitors|protease inhibitors|mesh-ancestor
24931894|NCT04084912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24931895|NCT04084912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931896|NCT04084496|Folfirinox|folfirinox|mesh-list
24931897|NCT04084496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931898|NCT04084158|Paclitaxel|paclitaxel|mesh-list
24931899|NCT04084158|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24931900|NCT04084158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24931901|NCT04084158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931902|NCT04084158|Tubulin Modulators|tubulin modulators|mesh-ancestor
24931903|NCT04084158|Antimitotic Agents|antimitotic agents|mesh-ancestor
24931904|NCT04084158|Mitosis Modulators|mitosis modulators|mesh-ancestor
24931905|NCT04084158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931906|NCT04084171|Insulin|insulin|mesh-list
24508223|NCT00554632|Ortho Evra|ortho evra|mesh-list
24529405|NCT00625898|Alkylating Agents|alkylating agents|mesh-ancestor
24529406|NCT00625898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529407|NCT00625898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24529408|NCT00625898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24529409|NCT00625898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24529410|NCT00625898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24529411|NCT00625898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24529412|NCT00625898|Growth Substances|growth substances|mesh-ancestor
24529413|NCT00625898|Growth Inhibitors|growth inhibitors|mesh-ancestor
24529414|NCT00625898|Tubulin Modulators|tubulin modulators|mesh-ancestor
24529415|NCT00625898|Antimitotic Agents|antimitotic agents|mesh-ancestor
24529416|NCT00625898|Mitosis Modulators|mitosis modulators|mesh-ancestor
24671270|NCT01324596|Rituximab|rituximab|mesh-list
24671271|NCT01324596|Doxorubicin|doxorubicin|mesh-list
24671272|NCT01324596|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24400386|NCT00150436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24671285|NCT01324596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24671286|NCT01324596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24671287|NCT01324596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24671288|NCT01324596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25260062|NCT02460627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260063|NCT02460627|Sensory System Agents|sensory system agents|mesh-ancestor
25260064|NCT02460627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25260065|NCT02460627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25260066|NCT02460627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25260067|NCT02460627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25260068|NCT02460627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25260069|NCT02460627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260070|NCT02460692|Dronabinol|dronabinol|mesh-list
25260071|NCT02460692|Hallucinogens|hallucinogens|mesh-ancestor
25260072|NCT02460692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260073|NCT02460692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25260074|NCT02460692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25260075|NCT02460692|Analgesics|analgesics|mesh-ancestor
25260076|NCT02460692|Sensory System Agents|sensory system agents|mesh-ancestor
25260077|NCT02460692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25260078|NCT02460692|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25260079|NCT02460692|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25260080|NCT02460692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25260081|NCT02460692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260082|NCT02460692|Hormones|hormones|mesh-ancestor
25260083|NCT02460692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25260084|NCT02460640|Morphine|morphine|mesh-list
25260085|NCT02460640|Ropivacaine|ropivacaine|mesh-list
25260086|NCT02460640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25260087|NCT02460640|Narcotics|narcotics|mesh-ancestor
25260088|NCT02460640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25260089|NCT02460640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260090|NCT02460640|Analgesics|analgesics|mesh-ancestor
25260091|NCT02460640|Sensory System Agents|sensory system agents|mesh-ancestor
25260092|NCT02460640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25260093|NCT02460640|Anesthetics, Local|anesthetics, local|mesh-ancestor
25260094|NCT02460640|Anesthetics|anesthetics|mesh-ancestor
24529444|NCT00625937|Antimitotic Agents|antimitotic agents|mesh-ancestor
24529445|NCT00625937|Mitosis Modulators|mitosis modulators|mesh-ancestor
24529446|NCT00625937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529447|NCT00625937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24529448|NCT00625937|Antimetabolites|antimetabolites|mesh-ancestor
24931913|NCT04083911|Cytarabine|cytarabine|mesh-list
24931914|NCT04083911|Decitabine|decitabine|mesh-list
24625108|NCT01080560|Cyclosporine|cyclosporine|mesh-list
24625109|NCT01080560|Cyclosporins|cyclosporins|mesh-list
24625110|NCT01080560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625111|NCT01080560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625112|NCT01080560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24625113|NCT01080560|Immunologic Factors|immunologic factors|mesh-ancestor
24625114|NCT01080560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625115|NCT01080560|Antifungal Agents|antifungal agents|mesh-ancestor
24625116|NCT01080560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24625117|NCT01080560|Dermatologic Agents|dermatologic agents|mesh-ancestor
24625118|NCT01080560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24625119|NCT01080560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24625120|NCT01080586|Cyclosporine|cyclosporine|mesh-list
24625121|NCT01080586|Cyclosporins|cyclosporins|mesh-list
24625122|NCT01080586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24931925|NCT04083911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625124|NCT01080586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24625125|NCT01080586|Immunologic Factors|immunologic factors|mesh-ancestor
25050101|NCT00542633|Insulin|insulin|mesh-list
24671289|NCT01324596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24671290|NCT01324596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24607460|NCT04561063|Sofosbuvir|sofosbuvir|mesh-list
24607461|NCT04561063|Nitazoxanide|nitazoxanide|mesh-list
24607462|NCT04561063|Antiviral Agents|antiviral agents|mesh-ancestor
24607463|NCT04561063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24607464|NCT04561063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25260095|NCT02460419|Capecitabine|capecitabine|mesh-list
25688097|NCT01941095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25260096|NCT02460419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25260098|NCT02460419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260099|NCT02460419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25260100|NCT02460276|Rituximab|rituximab|mesh-list
25260101|NCT02460276|Lenalidomide|lenalidomide|mesh-list
25260102|NCT02460276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25260103|NCT02460276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25260104|NCT02460276|Immunologic Factors|immunologic factors|mesh-ancestor
25260105|NCT02460276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260106|NCT02460276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25260107|NCT02460276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25260108|NCT02460276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25260109|NCT02460276|Growth Substances|growth substances|mesh-ancestor
25260110|NCT02460276|Growth Inhibitors|growth inhibitors|mesh-ancestor
25260111|NCT02460432|Paclitaxel|paclitaxel|mesh-list
25260112|NCT02460432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25260113|NCT02460432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25260114|NCT02460432|Tubulin Modulators|tubulin modulators|mesh-ancestor
25260115|NCT02460432|Antimitotic Agents|antimitotic agents|mesh-ancestor
25260116|NCT02460432|Mitosis Modulators|mitosis modulators|mesh-ancestor
25260117|NCT02460432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260118|NCT02460289|Minoxidil|minoxidil|mesh-list
25260119|NCT02460289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25260120|NCT02460289|Vasodilator Agents|vasodilator agents|mesh-ancestor
25260121|NCT02460393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25260122|NCT02460393|Antibodies|antibodies|mesh-list
25260123|NCT02460393|Immunoglobulins|immunoglobulins|mesh-list
25260124|NCT02460393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25260125|NCT02460393|Immunologic Factors|immunologic factors|mesh-ancestor
25260126|NCT02460393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625126|NCT01080586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625127|NCT01080586|Antifungal Agents|antifungal agents|mesh-ancestor
24625128|NCT01080586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24625129|NCT01080586|Dermatologic Agents|dermatologic agents|mesh-ancestor
24625130|NCT01080586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24625131|NCT01080586|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24625133|NCT01080612|Analgesics|analgesics|mesh-ancestor
24625134|NCT01080612|Sensory System Agents|sensory system agents|mesh-ancestor
25155517|NCT05353140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25045357|NCT00961675|Povidone-Iodine|povidone-iodine|mesh-list
24529490|NCT00626262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607465|NCT04558281|Ropivacaine|ropivacaine|mesh-list
24607539|NCT04424264|Efavirenz|efavirenz|mesh-list
24675134|NCT03004131|Azelastine|azelastine|mesh-list
24607541|NCT04424264|Rifampin|rifampin|mesh-list
24607603|NCT04230954|Pembrolizumab|pembrolizumab|mesh-list
24607604|NCT04230954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24607624|NCT04217694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24607625|NCT04217694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853538|NCT02268773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853540|NCT02268773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24853541|NCT02268773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24853542|NCT02268773|Antipyretics|antipyretics|mesh-ancestor
24853543|NCT02268773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24853544|NCT02268773|Vasodilator Agents|vasodilator agents|mesh-ancestor
24607776|NCT03675139|Medroxyprogesterone|medroxyprogesterone|mesh-list
24607777|NCT03675139|Dydrogesterone|dydrogesterone|mesh-list
24607778|NCT03675139|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24607779|NCT03675139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24607780|NCT03675139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24607781|NCT03675139|Contraceptive Agents|contraceptive agents|mesh-ancestor
24607782|NCT03675139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24607796|NCT03646474|Hemostatics|hemostatics|mesh-ancestor
24607797|NCT03646474|Coagulants|coagulants|mesh-ancestor
25260127|NCT02460393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25260129|NCT02460354|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25260130|NCT02460354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260131|NCT02460367|Docetaxel|docetaxel|mesh-list
25260132|NCT02460367|Tryptophan|tryptophan|mesh-list
25260133|NCT02460367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25260134|NCT02460367|Tubulin Modulators|tubulin modulators|mesh-ancestor
25260135|NCT02460367|Antimitotic Agents|antimitotic agents|mesh-ancestor
25260136|NCT02460367|Mitosis Modulators|mitosis modulators|mesh-ancestor
25260137|NCT02460367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260138|NCT02460367|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24529492|NCT00626288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24529493|NCT00626288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24529504|NCT00626509|Sunitinib|sunitinib|mesh-list
24529505|NCT00626509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24529506|NCT00626509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24756314|NCT01732250|Meropenem|meropenem|mesh-list
24931915|NCT04083911|Homoharringtonine|homoharringtonine|mesh-list
24931916|NCT04083911|Aclarubicin|aclarubicin|mesh-list
24931917|NCT04083911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24931918|NCT04083911|Antimetabolites|antimetabolites|mesh-ancestor
24935653|NCT04048226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24607799|NCT03612466|Calcium Carbonate|calcium carbonate|mesh-list
24607800|NCT03612466|Calcium|calcium|mesh-list
24607801|NCT03612466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24607920|NCT03185208|Antidepressive Agents|antidepressive agents|mesh-ancestor
24607921|NCT03185208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24607922|NCT03185208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24607929|NCT03179449|Hematinics|hematinics|mesh-ancestor
24607972|NCT03077698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24607973|NCT03077698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607974|NCT03077698|Appetite Stimulants|appetite stimulants|mesh-ancestor
24607975|NCT03077698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24901251|NCT04386876|Antiviral Agents|antiviral agents|mesh-ancestor
24608093|NCT02360280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24608094|NCT02360280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24608095|NCT02360280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24608096|NCT02360280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24608097|NCT02360280|GABA Modulators|gaba modulators|mesh-ancestor
24608098|NCT02360280|GABA Agents|gaba agents|mesh-ancestor
24608099|NCT02315326|Rituximab|rituximab|mesh-list
24608100|NCT02315326|Methotrexate|methotrexate|mesh-list
24608101|NCT02315326|Procarbazine|procarbazine|mesh-list
24608102|NCT02315326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24853603|NCT02269176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853604|NCT02269202|Midazolam|midazolam|mesh-list
24853605|NCT02269202|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24853606|NCT02269202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24853607|NCT02269202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24853608|NCT02269202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853609|NCT02269202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24853610|NCT02269202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24608103|NCT02315326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608104|NCT02315326|Immunologic Factors|immunologic factors|mesh-ancestor
24608105|NCT02315326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260139|NCT02460367|Antidepressive Agents|antidepressive agents|mesh-ancestor
25260140|NCT02460367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25260141|NCT02460211|Vitamin D|vitamin d|mesh-list
25260142|NCT02460211|Cholecalciferol|cholecalciferol|mesh-list
25260143|NCT02460211|Vitamins|vitamins|mesh-ancestor
25260144|NCT02460211|Micronutrients|micronutrients|mesh-ancestor
25260145|NCT02460211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260146|NCT02460211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25260147|NCT02460211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25260148|NCT02460341|Ondansetron|ondansetron|mesh-list
25260149|NCT02460341|Antiemetics|antiemetics|mesh-ancestor
25260150|NCT02460341|Autonomic Agents|autonomic agents|mesh-ancestor
24931919|NCT04083911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931920|NCT04083911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931922|NCT04083911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24931923|NCT04083911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24931924|NCT04083911|Immunologic Factors|immunologic factors|mesh-ancestor
24931926|NCT04083911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24931927|NCT04083911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24931928|NCT04083911|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24931942|NCT04083833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24931943|NCT04083833|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24931944|NCT04083833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24931945|NCT04083833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931946|NCT04083755|Ferric Compounds|ferric compounds|mesh-list
24931947|NCT04083755|Hematinics|hematinics|mesh-ancestor
24931949|NCT04083651|Methylnaltrexone|methylnaltrexone|mesh-list
24608106|NCT02315326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24608107|NCT02315326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24608108|NCT02315326|Abortifacient Agents|abortifacient agents|mesh-ancestor
24608111|NCT02315326|Antimetabolites|antimetabolites|mesh-ancestor
24608145|NCT02096588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24608146|NCT02096588|Immunologic Factors|immunologic factors|mesh-ancestor
24608148|NCT02096588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24608149|NCT02096588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24608150|NCT02096588|Alkylating Agents|alkylating agents|mesh-ancestor
24608151|NCT02096588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608152|NCT02096588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608153|NCT02096588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24608154|NCT02096588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24608155|NCT02096588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24608156|NCT02096588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24608157|NCT02096588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608158|NCT02096588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24608159|NCT02096588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24608160|NCT02096588|Antimetabolites|antimetabolites|mesh-ancestor
24608161|NCT02096588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24608162|NCT02096588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24608164|NCT02044497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24608166|NCT02044497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24608167|NCT02044497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608168|NCT02044497|Analgesics|analgesics|mesh-ancestor
24608169|NCT02044497|Sensory System Agents|sensory system agents|mesh-ancestor
24853611|NCT02269202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24853612|NCT02269202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24608192|NCT01965704|Autonomic Agents|autonomic agents|mesh-ancestor
24608193|NCT01965704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24608204|NCT01965704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24608205|NCT01965704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24608206|NCT01965704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24608207|NCT01664182|Bevacizumab|bevacizumab|mesh-list
24608208|NCT01664182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24608209|NCT01664182|Sunitinib|sunitinib|mesh-list
24608210|NCT01664182|Trebananib|trebananib|mesh-list
24608211|NCT01664182|Sorafenib|sorafenib|mesh-list
25260151|NCT02460341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25260152|NCT02460341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260153|NCT02460341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25260154|NCT02460341|Antipruritics|antipruritics|mesh-ancestor
25260155|NCT02460341|Dermatologic Agents|dermatologic agents|mesh-ancestor
25260156|NCT02460341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25260157|NCT02460341|Serotonin Agents|serotonin agents|mesh-ancestor
25260158|NCT02460341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25260159|NCT02460341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260160|NCT02460341|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25260161|NCT02460341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25260162|NCT02460341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25260163|NCT02460341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25260164|NCT02460341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25260165|NCT02460107|Botulinum Toxins|botulinum toxins|mesh-list
25260166|NCT02460107|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25260167|NCT02460107|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24529507|NCT00626509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24529508|NCT00626509|Growth Substances|growth substances|mesh-ancestor
24529509|NCT00626509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529510|NCT00626509|Growth Inhibitors|growth inhibitors|mesh-ancestor
24931950|NCT04083651|Anticonvulsants|anticonvulsants|mesh-ancestor
24931951|NCT04083651|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24931952|NCT04083651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931953|NCT04083651|Sensory System Agents|sensory system agents|mesh-ancestor
24931954|NCT04083651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24931955|NCT04083417|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24931956|NCT04083417|Penicillins|penicillins|mesh-list
24931957|NCT04083417|Penicillin V|penicillin v|mesh-list
24931958|NCT04083417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24931959|NCT04083664|Hepcidins|hepcidins|mesh-list
24931960|NCT04083664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24931961|NCT04083625|Carbetocin|carbetocin|mesh-list
24931962|NCT04083625|Oxytocics|oxytocics|mesh-ancestor
24931963|NCT04083625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24931964|NCT04083625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756354|NCT01732666|Remifentanil|remifentanil|mesh-list
24931965|NCT04083105|Midazolam|midazolam|mesh-list
24931966|NCT04083105|Nitrous Oxide|nitrous oxide|mesh-list
24935696|NCT04048070|Sufentanil|sufentanil|mesh-list
24608260|NCT01621568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608261|NCT01621568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24608262|NCT01621568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24608263|NCT01621568|Growth Substances|growth substances|mesh-ancestor
24608264|NCT01621568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608265|NCT01621568|Growth Inhibitors|growth inhibitors|mesh-ancestor
24608266|NCT01621568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24608267|NCT01621568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608268|NCT01621568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608269|NCT01416636|Treprostinil|treprostinil|mesh-list
24608270|NCT01416636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24608271|NCT00788684|Rituximab|rituximab|mesh-list
24608272|NCT00788684|Navitoclax|navitoclax|mesh-list
24608273|NCT00788684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24608274|NCT00788684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608275|NCT00788684|Immunologic Factors|immunologic factors|mesh-ancestor
24608276|NCT00788684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608277|NCT00788684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24608278|NCT00775684|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24608279|NCT00775684|Exenatide|exenatide|mesh-list
24608280|NCT00775684|Glimepiride|glimepiride|mesh-list
24608281|NCT00775684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24608284|NCT00775684|Hormones|hormones|mesh-ancestor
24608336|NCT00991848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608337|NCT00991926|Orlistat|orlistat|mesh-list
24608338|NCT00991926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608339|NCT00991926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608357|NCT00992004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608359|NCT00992030|Doxorubicin|doxorubicin|mesh-list
24608360|NCT00992030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24608361|NCT00992030|Dacarbazine|dacarbazine|mesh-list
24608362|NCT00992030|Bleomycin|bleomycin|mesh-list
24608363|NCT00992030|Vinblastine|vinblastine|mesh-list
25260168|NCT02460107|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25260169|NCT02460107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25260170|NCT02460107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260171|NCT02460107|Cholinergic Agents|cholinergic agents|mesh-ancestor
25260172|NCT02460107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25260173|NCT02460107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260174|NCT02460107|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25260175|NCT02460107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25260176|NCT02460133|Ritonavir|ritonavir|mesh-list
25260177|NCT02460133|Ribavirin|ribavirin|mesh-list
25260178|NCT02460133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25260179|NCT02460133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25260180|NCT02460133|Protease Inhibitors|protease inhibitors|mesh-ancestor
25260181|NCT02460133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25260182|NCT02460133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260183|NCT02460133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25260184|NCT02460133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25260185|NCT02460133|Antiviral Agents|antiviral agents|mesh-ancestor
25260186|NCT02460133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25260187|NCT02460133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25260188|NCT02460133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24931967|NCT04083105|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24931968|NCT04083105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24931969|NCT04083105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24931970|NCT04083105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931971|NCT04083105|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24931972|NCT04083105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24931973|NCT04083105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24931974|NCT04083105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24931976|NCT04083105|Anesthetics|anesthetics|mesh-ancestor
24932000|NCT04083066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932002|NCT04083066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24932003|NCT04083066|Antiemetics|antiemetics|mesh-ancestor
24932004|NCT04083066|Autonomic Agents|autonomic agents|mesh-ancestor
24932005|NCT04083066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24932006|NCT04083066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24932007|NCT04083066|Glucocorticoids|glucocorticoids|mesh-ancestor
24932008|NCT04083066|Hormones|hormones|mesh-ancestor
24932009|NCT04083066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24932010|NCT04083066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24932011|NCT04083066|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24932012|NCT04083066|Abortifacient Agents|abortifacient agents|mesh-ancestor
24529511|NCT00626509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25155518|NCT05353140|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24637137|NCT01148992|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24608364|NCT00992030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24608365|NCT00992030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608366|NCT00992030|Immunologic Factors|immunologic factors|mesh-ancestor
24608367|NCT00992030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608368|NCT00992030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24608369|NCT00992030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24608370|NCT00992030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24608371|NCT00992030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24608372|NCT00992030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608373|NCT00992030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608374|NCT00992030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24608380|NCT00992069|Efavirenz|efavirenz|mesh-list
24608401|NCT00992082|Analgesics|analgesics|mesh-ancestor
24608402|NCT00992082|Sensory System Agents|sensory system agents|mesh-ancestor
24608410|NCT00992082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608411|NCT00992082|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24608412|NCT00992082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24608414|NCT00992082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24608415|NCT00992082|Respiratory System Agents|respiratory system agents|mesh-ancestor
24608416|NCT00992082|Mydriatics|mydriatics|mesh-ancestor
24608417|NCT00992082|Sympathomimetics|sympathomimetics|mesh-ancestor
24608418|NCT00992082|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25260189|NCT02460133|Antimetabolites|antimetabolites|mesh-ancestor
25260190|NCT02460146|CXA-10|cxa-10|mesh-list
25260191|NCT02460146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25260192|NCT02460302|Progesterone|progesterone|mesh-list
25260193|NCT02460302|Progestins|progestins|mesh-ancestor
25260194|NCT02460302|Hormones|hormones|mesh-ancestor
25260195|NCT02460302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25260196|NCT02460302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260197|NCT02460068|Nivolumab|nivolumab|mesh-list
25260198|NCT02460068|Ipilimumab|ipilimumab|mesh-list
25260199|NCT02460068|Fotemustine|fotemustine|mesh-list
25260200|NCT02460068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25260201|NCT02460068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25260202|NCT02460068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25260203|NCT02460068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260204|NCT02459977|Basiliximab|basiliximab|mesh-list
25260205|NCT02459977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25260206|NCT02459977|Immunologic Factors|immunologic factors|mesh-ancestor
25260207|NCT02459977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260208|NCT02459938|Glucagon|glucagon|mesh-list
25260209|NCT02459938|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25260210|NCT02459938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25260211|NCT02459938|Hormones|hormones|mesh-ancestor
25260212|NCT02459938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25260213|NCT02459938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260214|NCT02459938|Incretins|incretins|mesh-ancestor
24932027|NCT04083118|Cariostatic Agents|cariostatic agents|mesh-ancestor
24932028|NCT04083118|Protective Agents|protective agents|mesh-ancestor
24608443|NCT00992134|Rituximab|rituximab|mesh-list
24608444|NCT00992134|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24608445|NCT00992134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24608446|NCT00992134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608447|NCT00992134|Immunologic Factors|immunologic factors|mesh-ancestor
25688098|NCT01941095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688099|NCT01941095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25688100|NCT01941095|Antimetabolites|antimetabolites|mesh-ancestor
25688101|NCT01941095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688102|NCT01941095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688103|NCT01941095|Dermatologic Agents|dermatologic agents|mesh-ancestor
25688104|NCT01941095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688105|NCT01941095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25688106|NCT01941095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24404204|NCT00162734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24404205|NCT00162734|Antiviral Agents|antiviral agents|mesh-ancestor
25688107|NCT01941095|Immunologic Factors|immunologic factors|mesh-ancestor
24608448|NCT00992134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608449|NCT00992134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24608450|NCT00992134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24608460|NCT00992160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24608461|NCT00992160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608491|NCT00992329|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24608492|NCT00992355|Tobramycin|tobramycin|mesh-list
24608493|NCT00992355|Dexamethasone|dexamethasone|mesh-list
24608494|NCT00992355|Dexamethasone acetate|dexamethasone acetate|mesh-list
24608495|NCT00992355|Ketorolac|ketorolac|mesh-list
24608496|NCT00992355|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24608497|NCT00992355|BB 1101|bb 1101|mesh-list
24608498|NCT00992355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24608499|NCT00992355|Antiemetics|antiemetics|mesh-ancestor
24608500|NCT00992355|Autonomic Agents|autonomic agents|mesh-ancestor
24608501|NCT00992355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24608502|NCT00992355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608503|NCT00992355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24608504|NCT00992355|Glucocorticoids|glucocorticoids|mesh-ancestor
25260215|NCT02460055|Dexamethasone|dexamethasone|mesh-list
25260216|NCT02460055|Fentanyl|fentanyl|mesh-list
25260217|NCT02460055|Nitrous Oxide|nitrous oxide|mesh-list
25260218|NCT02460055|Ondansetron|ondansetron|mesh-list
25260219|NCT02460055|Propofol|propofol|mesh-list
25260220|NCT02460055|Sevoflurane|sevoflurane|mesh-list
25260221|NCT02460055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25260222|NCT02460055|Antiemetics|antiemetics|mesh-ancestor
25260223|NCT02460055|Autonomic Agents|autonomic agents|mesh-ancestor
25260224|NCT02460055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25260225|NCT02460055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260226|NCT02460055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25260227|NCT02460055|Glucocorticoids|glucocorticoids|mesh-ancestor
25260228|NCT02460055|Hormones|hormones|mesh-ancestor
25260229|NCT02460055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25260230|NCT02460055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25260231|NCT02460055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25260232|NCT02460055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25260233|NCT02460055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25260234|NCT02460055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25260235|NCT02460055|Anesthetics, General|anesthetics, general|mesh-ancestor
24932029|NCT04083118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932030|NCT04083118|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24932031|NCT04083118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24451007|NCT00321360|Anesthetics|anesthetics|mesh-ancestor
24529544|NCT00626613|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24529545|NCT00626613|Autonomic Agents|autonomic agents|mesh-ancestor
24529559|NCT00626678|Hormones|hormones|mesh-ancestor
24529560|NCT00626678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24529561|NCT00626678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529562|NCT00626678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24608505|NCT00992355|Hormones|hormones|mesh-ancestor
24608506|NCT00992355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24608507|NCT00992355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24608508|NCT00992355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25260236|NCT02460055|Anesthetics|anesthetics|mesh-ancestor
25260237|NCT02460055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25260238|NCT02460055|Narcotics|narcotics|mesh-ancestor
25260239|NCT02460055|Analgesics|analgesics|mesh-ancestor
25260240|NCT02460055|Sensory System Agents|sensory system agents|mesh-ancestor
25260241|NCT02460055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25260242|NCT02460055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25260243|NCT02460055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25260244|NCT02460055|Antipruritics|antipruritics|mesh-ancestor
25260245|NCT02460055|Dermatologic Agents|dermatologic agents|mesh-ancestor
25260246|NCT02460055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25688108|NCT01941095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25688109|NCT01941095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25688110|NCT01941095|Antimalarials|antimalarials|mesh-ancestor
25260247|NCT02460055|Serotonin Agents|serotonin agents|mesh-ancestor
25260248|NCT02460055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25688111|NCT01941095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25688112|NCT01941095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25688113|NCT01941095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25260249|NCT02460055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260250|NCT02460055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25260251|NCT02460055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25260252|NCT02460055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25260253|NCT02460055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25260254|NCT02460055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25260262|NCT02459782|Anesthetics|anesthetics|mesh-list
25260263|NCT02459782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25260264|NCT02459782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275160|NCT02373384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275161|NCT02373384|Antimetabolites|antimetabolites|mesh-ancestor
25275162|NCT02373384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275163|NCT02373384|Gout Suppressants|gout suppressants|mesh-ancestor
25275164|NCT02373384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25275165|NCT02373384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24529563|NCT00626678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24529565|NCT00626678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529566|NCT00626678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24529567|NCT00626678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24529568|NCT00626678|Immunologic Factors|immunologic factors|mesh-ancestor
24529569|NCT00626678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24529570|NCT00626717|Riboflavin|riboflavin|mesh-list
24529571|NCT00626717|Vitamin B Complex|vitamin b complex|mesh-ancestor
24608624|NCT00992797|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24608625|NCT00992797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24608627|NCT00992823|Trace Elements|trace elements|mesh-ancestor
24608628|NCT00992823|Micronutrients|micronutrients|mesh-ancestor
24608629|NCT00992823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608630|NCT00992849|Bevacizumab|bevacizumab|mesh-list
24608631|NCT00992849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24608632|NCT00992849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608640|NCT00992862|Protease Inhibitors|protease inhibitors|mesh-ancestor
24608641|NCT00992862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608642|NCT00992862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608643|NCT00992862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24853676|NCT02269514|Nicotine|nicotine|mesh-list
24853677|NCT02269514|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24608681|NCT00993070|Dermatologic Agents|dermatologic agents|mesh-ancestor
24608682|NCT00993070|Sensory System Agents|sensory system agents|mesh-ancestor
24608683|NCT00993070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24608684|NCT00993070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608685|NCT00993096|Insulin|insulin|mesh-list
24608686|NCT00993096|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24608687|NCT00993096|Insulin Aspart|insulin aspart|mesh-list
24608688|NCT00993096|Insulin, Long-Acting|insulin, long-acting|mesh-list
24682366|NCT01386164|Vaccines|vaccines|mesh-list
24608689|NCT00993096|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24608690|NCT00993096|Biphasic Insulins|biphasic insulins|mesh-list
24608691|NCT00993096|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24608692|NCT00993096|Insulin, Isophane|insulin, isophane|mesh-list
24608693|NCT00993096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24608694|NCT00993096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608695|NCT00993109|Valsartan|valsartan|mesh-list
24608696|NCT00993109|Nifedipine|nifedipine|mesh-list
24608697|NCT00993109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24608698|NCT00993109|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24608699|NCT00993109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24608700|NCT00993109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608701|NCT00993109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24608702|NCT00993109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24608703|NCT00993109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24608705|NCT00993109|Vasodilator Agents|vasodilator agents|mesh-ancestor
24608815|NCT00993746|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24608816|NCT00993746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24608817|NCT00993746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25260265|NCT02460016|Ziresovir|ziresovir|mesh-list
25260266|NCT02460016|Antiviral Agents|antiviral agents|mesh-ancestor
25260267|NCT02460016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25260268|NCT02459600|Cyclopentolate|cyclopentolate|mesh-list
25260269|NCT02459600|Mydriatics|mydriatics|mesh-ancestor
25260270|NCT02459600|Autonomic Agents|autonomic agents|mesh-ancestor
25260271|NCT02459600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25260272|NCT02459600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260273|NCT02459600|Parasympatholytics|parasympatholytics|mesh-ancestor
24407513|NCT00174642|Insulin glulisine|insulin glulisine|mesh-list
25260274|NCT02459600|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25260275|NCT02459600|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25260276|NCT02459600|Cholinergic Agents|cholinergic agents|mesh-ancestor
24932059|NCT04082949|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24932060|NCT04082949|Hemostatics|hemostatics|mesh-ancestor
24932061|NCT04082949|Coagulants|coagulants|mesh-ancestor
24932062|NCT04082962|Dexamethasone|dexamethasone|mesh-list
24932063|NCT04082962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24932064|NCT04082962|Antiemetics|antiemetics|mesh-ancestor
24608818|NCT00993746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608819|NCT00993863|Ibuprofen|ibuprofen|mesh-list
24608820|NCT00993863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24608821|NCT00993863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24608822|NCT00993863|Analgesics|analgesics|mesh-ancestor
24608823|NCT00993863|Sensory System Agents|sensory system agents|mesh-ancestor
24608824|NCT00993863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24608825|NCT00993863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608826|NCT00993863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24608853|NCT00994071|Temozolomide|temozolomide|mesh-list
24608854|NCT00994071|Veliparib|veliparib|mesh-list
24608855|NCT00994071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24608856|NCT00994071|Alkylating Agents|alkylating agents|mesh-ancestor
24608857|NCT00994071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608858|NCT00994071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608871|NCT00994097|Immunologic Factors|immunologic factors|mesh-ancestor
24608893|NCT00994305|Antioxidants|antioxidants|mesh-ancestor
24608894|NCT00994305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608895|NCT00994305|Protective Agents|protective agents|mesh-ancestor
24608896|NCT00994305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608897|NCT00994305|Antidotes|antidotes|mesh-ancestor
24608899|NCT00994344|Lopinavir|lopinavir|mesh-list
24608958|NCT00994617|Losartan|losartan|mesh-list
24608959|NCT00994617|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24608960|NCT00994617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24853687|NCT02269540|Sertraline|sertraline|mesh-list
24853688|NCT02269540|Citalopram|citalopram|mesh-list
24853689|NCT02269540|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24609053|NCT00994916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24609054|NCT00994916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24609055|NCT00994916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609056|NCT00994916|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24609057|NCT00994916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24609214|NCT00995397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609216|NCT00995397|Antipruritics|antipruritics|mesh-ancestor
24609217|NCT00995397|Dermatologic Agents|dermatologic agents|mesh-ancestor
24682554|NCT01386710|Carboplatin|carboplatin|mesh-list
24609218|NCT00995397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24609219|NCT00995423|Paclitaxel|paclitaxel|mesh-list
24609220|NCT00995423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24609221|NCT00995423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609266|NCT00995800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24609267|NCT00995800|Respiratory System Agents|respiratory system agents|mesh-ancestor
24609268|NCT00995800|Dermatologic Agents|dermatologic agents|mesh-ancestor
24609269|NCT00995800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24609270|NCT00995800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24609271|NCT00995800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25260277|NCT02459600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25260278|NCT02459600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260279|NCT02459509|Dexmedetomidine|dexmedetomidine|mesh-list
25260280|NCT02459509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25260281|NCT02459509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25260282|NCT02459509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260283|NCT02459509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25260284|NCT02459509|Analgesics|analgesics|mesh-ancestor
25260285|NCT02459509|Sensory System Agents|sensory system agents|mesh-ancestor
25260286|NCT02459509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25260287|NCT02459509|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24932065|NCT04082962|Autonomic Agents|autonomic agents|mesh-ancestor
24932113|NCT04082858|Analgesics|analgesics|mesh-ancestor
24932066|NCT04082962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24932067|NCT04082962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932068|NCT04082962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25688114|NCT01941095|Amebicides|amebicides|mesh-ancestor
24932069|NCT04082962|Glucocorticoids|glucocorticoids|mesh-ancestor
24408117|NCT00176618|Curcumin|curcumin|mesh-list
24932071|NCT04082962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24932072|NCT04082962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24932073|NCT04082962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24932074|NCT04082988|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24932075|NCT04082988|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24932076|NCT04082988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529572|NCT00626717|Vitamins|vitamins|mesh-ancestor
24529573|NCT00626717|Micronutrients|micronutrients|mesh-ancestor
24932087|NCT04082715|Celecoxib|celecoxib|mesh-list
24932088|NCT04082715|Levodopa|levodopa|mesh-list
24932089|NCT04082715|Carbidopa|carbidopa|mesh-list
24609272|NCT00995800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24609273|NCT00995800|Adrenergic Agents|adrenergic agents|mesh-ancestor
24609274|NCT00995800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24609275|NCT00995800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609276|NCT00995826|Laninamivir|laninamivir|mesh-list
24609277|NCT00995826|Antiviral Agents|antiviral agents|mesh-ancestor
24609278|NCT00995826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24609279|NCT00995839|Terlipressin|terlipressin|mesh-list
24609302|NCT00996021|Dolutegravir|dolutegravir|mesh-list
24609303|NCT00996021|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24609304|NCT00996021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24609305|NCT00996021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24609306|NCT00996021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24609307|NCT00996021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24609308|NCT00996021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609310|NCT00996021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609357|NCT00996177|Anesthetics, General|anesthetics, general|mesh-ancestor
24609358|NCT00996177|Anesthetics|anesthetics|mesh-ancestor
24609359|NCT00996190|Phenylephrine|phenylephrine|mesh-list
24609360|NCT00996190|Oxymetazoline|oxymetazoline|mesh-list
24609361|NCT00996190|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24609362|NCT00996190|Mydriatics|mydriatics|mesh-ancestor
24609363|NCT00996190|Autonomic Agents|autonomic agents|mesh-ancestor
24609364|NCT00996190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24609365|NCT00996190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609366|NCT00996190|Sympathomimetics|sympathomimetics|mesh-ancestor
24609367|NCT00996190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24609368|NCT00996190|Nasal Decongestants|nasal decongestants|mesh-ancestor
24901466|NCT04384380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24609446|NCT00996697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25260288|NCT02459509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25260289|NCT02459509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25260290|NCT02459509|Adrenergic Agents|adrenergic agents|mesh-ancestor
25260291|NCT02459509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25260292|NCT02459509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260294|NCT02459613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25260295|NCT02459613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260296|NCT02459756|Ascorbic Acid|ascorbic acid|mesh-list
25260297|NCT02459756|Citric Acid|citric acid|mesh-list
25260298|NCT02459756|Sodium Citrate|sodium citrate|mesh-list
25260299|NCT02459756|Vitamins|vitamins|mesh-ancestor
25260300|NCT02459756|Micronutrients|micronutrients|mesh-ancestor
25260301|NCT02459756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260302|NCT02459756|Antioxidants|antioxidants|mesh-ancestor
25260303|NCT02459756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260304|NCT02459756|Protective Agents|protective agents|mesh-ancestor
25260305|NCT02459756|Anticoagulants|anticoagulants|mesh-ancestor
25260306|NCT02459756|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25260307|NCT02459756|Chelating Agents|chelating agents|mesh-ancestor
25260308|NCT02459756|Sequestering Agents|sequestering agents|mesh-ancestor
25260309|NCT02459574|Amiodarone|amiodarone|mesh-list
25260310|NCT02459574|Sotalol|sotalol|mesh-list
25260311|NCT02459574|Flecainide|flecainide|mesh-list
25260312|NCT02459574|Propafenone|propafenone|mesh-list
24932090|NCT04082715|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24932091|NCT04082715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24932092|NCT04082715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24932093|NCT04082715|Analgesics|analgesics|mesh-ancestor
24932094|NCT04082715|Sensory System Agents|sensory system agents|mesh-ancestor
24932095|NCT04082715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25688115|NCT01941095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24932096|NCT04082715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932097|NCT04082715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25688116|NCT01941095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24408265|NCT00177060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24609447|NCT00996697|Cholinergic Agents|cholinergic agents|mesh-ancestor
24609448|NCT00996723|Dasatinib|dasatinib|mesh-list
24609449|NCT00996723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609450|NCT00996723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24609451|NCT00996723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609452|NCT00996723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609453|NCT00996762|Lapatinib|lapatinib|mesh-list
24609454|NCT00996762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609455|NCT00996762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24609456|NCT00996762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609457|NCT00996762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609458|NCT00996788|Rebamipide|rebamipide|mesh-list
24609459|NCT00996788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24609460|NCT00996788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24609461|NCT00996788|Antioxidants|antioxidants|mesh-ancestor
24609463|NCT00996788|Protective Agents|protective agents|mesh-ancestor
24609546|NCT00997191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24609547|NCT00997191|Growth Substances|growth substances|mesh-ancestor
24609581|NCT00997399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609582|NCT00997399|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24609583|NCT00997399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609584|NCT00997399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609585|NCT00997412|Mycophenolic Acid|mycophenolic acid|mesh-list
24609586|NCT00997412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24853724|NCT02269696|Sympatholytics|sympatholytics|mesh-ancestor
24609602|NCT00997477|Respiratory System Agents|respiratory system agents|mesh-ancestor
24609603|NCT00997477|Glucocorticoids|glucocorticoids|mesh-ancestor
24609605|NCT00997477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24609625|NCT00997581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24609627|NCT00997581|Sensory System Agents|sensory system agents|mesh-ancestor
24609628|NCT00997581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24609629|NCT00997581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609630|NCT00997581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24609631|NCT00997581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24609632|NCT00997581|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24609633|NCT00997581|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24609634|NCT00997581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609635|NCT00997581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609685|NCT00997815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24609686|NCT00997815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24609688|NCT00997828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609689|NCT00997828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24609690|NCT00997828|Immunologic Factors|immunologic factors|mesh-ancestor
24609691|NCT00997828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609692|NCT00997880|Calcium, Dietary|calcium, dietary|mesh-list
24609693|NCT00997880|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24609695|NCT00997880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24609696|NCT00997880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609697|NCT00997880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24609698|NCT00997880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24609699|NCT00997880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24609700|NCT00997880|Antimetabolites|antimetabolites|mesh-ancestor
24609701|NCT00997880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609702|NCT00997880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24609703|NCT00997880|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25260313|NCT02459574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
25260314|NCT02459574|Calcium Channel Blockers|calcium channel blockers|mesh-list
25260315|NCT02459574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25260316|NCT02459574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260317|NCT02459574|Vasodilator Agents|vasodilator agents|mesh-ancestor
25260318|NCT02459574|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25260319|NCT02459574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25688117|NCT01941095|Analgesics|analgesics|mesh-ancestor
25688118|NCT01941095|Sensory System Agents|sensory system agents|mesh-ancestor
25688119|NCT01941095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275166|NCT02373384|Antioxidants|antioxidants|mesh-ancestor
24932098|NCT04082715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24932099|NCT04082715|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24529590|NCT00626834|Vigabatrin|vigabatrin|mesh-list
24529591|NCT00626834|Anticonvulsants|anticonvulsants|mesh-ancestor
24529592|NCT00626834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609704|NCT00997880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609820|NCT00998322|Antimetabolites|antimetabolites|mesh-ancestor
24609821|NCT00998322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609822|NCT00998322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609823|NCT00998322|Antiviral Agents|antiviral agents|mesh-ancestor
24609824|NCT00998322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24609825|NCT00998322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609826|NCT00998322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24609827|NCT00998322|Immunologic Factors|immunologic factors|mesh-ancestor
24609828|NCT00998322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609830|NCT00998439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24609831|NCT00998439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609832|NCT00998439|Tubulin Modulators|tubulin modulators|mesh-ancestor
24609833|NCT00998439|Antimitotic Agents|antimitotic agents|mesh-ancestor
24609834|NCT00998439|Mitosis Modulators|mitosis modulators|mesh-ancestor
24853742|NCT02269748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24853743|NCT02269748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853744|NCT02269800|Benzalkonium Compounds|benzalkonium compounds|mesh-list
24853745|NCT02269800|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24853746|NCT02269800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24853747|NCT02269904|Fluorouracil|fluorouracil|mesh-list
24609835|NCT00998439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609836|NCT00998504|Resveratrol|resveratrol|mesh-list
24609881|NCT00998686|Protease Inhibitors|protease inhibitors|mesh-ancestor
24609882|NCT00998686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609883|NCT00998686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609884|NCT00998816|Pregabalin|pregabalin|mesh-list
24609885|NCT00998816|Analgesics|analgesics|mesh-ancestor
24609886|NCT00998816|Sensory System Agents|sensory system agents|mesh-ancestor
24609887|NCT00998816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24609888|NCT00998816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609889|NCT00998816|Anticonvulsants|anticonvulsants|mesh-ancestor
24609890|NCT00998816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24609891|NCT00998816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24609892|NCT00998816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609893|NCT00998816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25260320|NCT02459574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260321|NCT02459574|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25260322|NCT02459574|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25260323|NCT02459574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25260324|NCT02459574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25260325|NCT02459574|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25260326|NCT02459574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25260327|NCT02459574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25260328|NCT02459574|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25260329|NCT02459574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25260330|NCT02459574|Adrenergic Agents|adrenergic agents|mesh-ancestor
25260331|NCT02459574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24529593|NCT00626834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529595|NCT00626834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24529596|NCT00626834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529597|NCT00626977|Clonidine|clonidine|mesh-list
24529598|NCT00626977|Ropivacaine|ropivacaine|mesh-list
24529599|NCT00626977|Anesthetics, Local|anesthetics, local|mesh-ancestor
24529600|NCT00626977|Anesthetics|anesthetics|mesh-ancestor
24529601|NCT00626977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24529602|NCT00626977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529603|NCT00626977|Sensory System Agents|sensory system agents|mesh-ancestor
24529604|NCT00626977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24529605|NCT00626977|Analgesics|analgesics|mesh-ancestor
24529606|NCT00626977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25045358|NCT00961675|Dexamethasone|dexamethasone|mesh-list
25045359|NCT00961675|Dexamethasone acetate|dexamethasone acetate|mesh-list
24409400|NCT00181935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24409401|NCT00181935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409430|NCT00181987|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24409474|NCT00182104|Warfarin|warfarin|mesh-list
25045360|NCT00961675|Povidone|povidone|mesh-list
25045361|NCT00961675|BB 1101|bb 1101|mesh-list
25045362|NCT00961675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25045363|NCT00961675|Antiemetics|antiemetics|mesh-ancestor
24609894|NCT00998816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24609895|NCT00998816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24609896|NCT00998816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24609904|NCT00998920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609905|NCT00998933|Testosterone|testosterone|mesh-list
24609906|NCT00998933|Androgens|androgens|mesh-ancestor
24609934|NCT00999180|Cholinergic Agents|cholinergic agents|mesh-ancestor
24609935|NCT00999180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24901743|NCT04381858|Antibodies|antibodies|mesh-list
24610019|NCT00999479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24610021|NCT00999479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24610022|NCT00999479|Contraceptive Agents|contraceptive agents|mesh-ancestor
24610023|NCT00999479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24610032|NCT00999505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24610033|NCT00999505|Antiviral Agents|antiviral agents|mesh-ancestor
24610034|NCT00999505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24610035|NCT00999505|Dopamine Agents|dopamine agents|mesh-ancestor
24610036|NCT00999505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24610037|NCT00999505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610038|NCT00999505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610039|NCT00999505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24610041|NCT00999505|Sensory System Agents|sensory system agents|mesh-ancestor
24610055|NCT00999700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610057|NCT00999700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24610058|NCT00999700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24610059|NCT00999700|Immunologic Factors|immunologic factors|mesh-ancestor
24610124|NCT00999869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24610125|NCT00999869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610126|NCT00999869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24671383|NCT01325298|Micronutrients|micronutrients|mesh-ancestor
25260332|NCT02459574|Sympatholytics|sympatholytics|mesh-ancestor
25260333|NCT02459574|Autonomic Agents|autonomic agents|mesh-ancestor
25260334|NCT02459574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25260335|NCT02459574|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25260336|NCT02459288|Clopidogrel|clopidogrel|mesh-list
25260337|NCT02459288|Ticagrelor|ticagrelor|mesh-list
25260338|NCT02459288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25260339|NCT02459288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25260340|NCT02459288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25260341|NCT02459288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25260342|NCT02459288|Purinergic Agents|purinergic agents|mesh-ancestor
25260343|NCT02459288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25260344|NCT02459288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260345|NCT02459288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260346|NCT02459353|Dapagliflozin|dapagliflozin|mesh-list
25260347|NCT02459353|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25260348|NCT02459353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260349|NCT02459353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25260350|NCT02459353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260351|NCT02458963|Menotropins|menotropins|mesh-list
25045364|NCT00961675|Autonomic Agents|autonomic agents|mesh-ancestor
25045365|NCT00961675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045366|NCT00961675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045367|NCT00961675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25045368|NCT00961675|Glucocorticoids|glucocorticoids|mesh-ancestor
25045369|NCT00961675|Hormones|hormones|mesh-ancestor
25045370|NCT00961675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25045371|NCT00961675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25045372|NCT00961675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045373|NCT00961675|Protease Inhibitors|protease inhibitors|mesh-ancestor
25045374|NCT00961675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688120|NCT01941095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25688121|NCT01941095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25688122|NCT01941537|Fezakinumab|fezakinumab|mesh-list
25688123|NCT01941537|Dermatologic Agents|dermatologic agents|mesh-ancestor
25688124|NCT01941628|Rocuronium|rocuronium|mesh-list
24409995|NCT00183989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409999|NCT00184015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045375|NCT00961675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045376|NCT00961675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25045377|NCT00961675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25050138|NCT00537043|Carvedilol|carvedilol|mesh-list
24671384|NCT01325298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671385|NCT01325298|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24671386|NCT01325298|Dermatologic Agents|dermatologic agents|mesh-ancestor
24671387|NCT01325415|Moxifloxacin|moxifloxacin|mesh-list
24671388|NCT01325415|Naloxegol|naloxegol|mesh-list
24671389|NCT01325415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24671390|NCT01325415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24671391|NCT01325415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24671392|NCT01325415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24637328|NCT01149902|Antimitotic Agents|antimitotic agents|mesh-ancestor
24637329|NCT01149902|Mitosis Modulators|mitosis modulators|mesh-ancestor
24671448|NCT01325935|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24610128|NCT00999869|Hormones|hormones|mesh-ancestor
24610186|NCT01000441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24610187|NCT01000441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24610189|NCT01000441|Sensory System Agents|sensory system agents|mesh-ancestor
24610190|NCT01000441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24610191|NCT01000441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24610192|NCT01000441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24812566|NCT02053558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24812567|NCT02053558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24812568|NCT02053558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812569|NCT02053597|Paclitaxel|paclitaxel|mesh-list
24610342|NCT01001364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24610343|NCT01001364|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24610344|NCT01001364|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24610345|NCT01001364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24610346|NCT01001364|Adrenergic Agents|adrenergic agents|mesh-ancestor
24610347|NCT01001364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24610348|NCT01001364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610349|NCT01001585|Sevoflurane|sevoflurane|mesh-list
24610350|NCT01001585|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24610351|NCT01001585|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24610352|NCT01001585|Anesthetics, General|anesthetics, general|mesh-ancestor
24610353|NCT01001585|Anesthetics|anesthetics|mesh-ancestor
24610354|NCT01001585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24610355|NCT01001585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610356|NCT01001624|Hydroquinone|hydroquinone|mesh-list
24610357|NCT01001624|Antioxidants|antioxidants|mesh-ancestor
24671514|NCT01326325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24671515|NCT01326325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25260352|NCT02458963|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25260353|NCT02458963|Fertility Agents|fertility agents|mesh-ancestor
25260354|NCT02458963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25260355|NCT02458963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260356|NCT02458742|Morphine|morphine|mesh-list
25260357|NCT02458742|Bupivacaine|bupivacaine|mesh-list
25260358|NCT02458742|Anesthetics, Local|anesthetics, local|mesh-ancestor
25260359|NCT02458742|Anesthetics|anesthetics|mesh-ancestor
25260360|NCT02458742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25260361|NCT02458742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260362|NCT02458742|Sensory System Agents|sensory system agents|mesh-ancestor
25260363|NCT02458742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25260364|NCT02458742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25260365|NCT02458742|Narcotics|narcotics|mesh-ancestor
25260366|NCT02458742|Analgesics|analgesics|mesh-ancestor
25260367|NCT02458755|Atorvastatin|atorvastatin|mesh-list
25260368|NCT02458755|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24998418|NCT02881957|Micronutrients|micronutrients|mesh-ancestor
24932105|NCT04082715|Dopamine Agents|dopamine agents|mesh-ancestor
24932106|NCT04082715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24932107|NCT04082715|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24932108|NCT04082715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25688125|NCT01941628|Succinylcholine|succinylcholine|mesh-list
25688126|NCT01941628|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24932109|NCT04082715|Immunologic Factors|immunologic factors|mesh-ancestor
24932110|NCT04082715|Dopamine Agonists|dopamine agonists|mesh-ancestor
24932112|NCT04082858|Ketamine|ketamine|mesh-list
24410416|NCT00185224|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24410417|NCT00185224|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24410418|NCT00185224|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24410419|NCT00185224|Contraceptive Agents|contraceptive agents|mesh-ancestor
24410420|NCT00185224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24410421|NCT00185224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932114|NCT04082858|Sensory System Agents|sensory system agents|mesh-ancestor
24932115|NCT04082858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24932116|NCT04082858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932117|NCT04082858|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24932129|NCT04082858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24932130|NCT04082858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24932131|NCT04082858|GABA Modulators|gaba modulators|mesh-ancestor
24932132|NCT04082858|GABA Agents|gaba agents|mesh-ancestor
24932133|NCT04082793|Diclofenac|diclofenac|mesh-list
24932134|NCT04082793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24932135|NCT04082793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24625135|NCT01080612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24625136|NCT01080612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625137|NCT01080612|Anticonvulsants|anticonvulsants|mesh-ancestor
24625138|NCT01080612|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24508450|NCT00555607|Prednisolone|prednisolone|mesh-list
24671521|NCT01326403|Tranexamic Acid|tranexamic acid|mesh-list
24671522|NCT01326403|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25260369|NCT02458755|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25260370|NCT02458755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25260371|NCT02458755|Antimetabolites|antimetabolites|mesh-ancestor
25260372|NCT02458755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260373|NCT02458755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25260374|NCT02458755|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25260375|NCT02458755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25260376|NCT02458924|Niacin|niacin|mesh-list
25260377|NCT02458924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25260378|NCT02458924|Antimetabolites|antimetabolites|mesh-ancestor
25260379|NCT02458924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260380|NCT02458924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25260381|NCT02458924|Vasodilator Agents|vasodilator agents|mesh-ancestor
25260382|NCT02458924|Vitamin B Complex|vitamin b complex|mesh-ancestor
25260383|NCT02458924|Vitamins|vitamins|mesh-ancestor
25260384|NCT02458924|Micronutrients|micronutrients|mesh-ancestor
25260385|NCT02458924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260386|NCT02459158|Arbekacin|arbekacin|mesh-list
25260387|NCT02459158|Dibekacin|dibekacin|mesh-list
25260388|NCT02459158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25260389|NCT02459158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25260390|NCT02459158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25260391|NCT02458716|Leuprolide|leuprolide|mesh-list
25260392|NCT02458716|Bicalutamide|bicalutamide|mesh-list
25260393|NCT02458716|Androgens|androgens|mesh-list
25260394|NCT02458716|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
25260395|NCT02458716|Hormones|hormones|mesh-ancestor
25260396|NCT02458716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25260397|NCT02458716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260398|NCT02458716|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25260399|NCT02458716|Fertility Agents|fertility agents|mesh-ancestor
25260400|NCT02458716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25260401|NCT02458716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25260402|NCT02458716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25155520|NCT05353140|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25155521|NCT05353140|Protease Inhibitors|protease inhibitors|mesh-ancestor
25155522|NCT05353140|Anticoagulants|anticoagulants|mesh-ancestor
24671523|NCT01326403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24671524|NCT01326403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671525|NCT01326403|Hemostatics|hemostatics|mesh-ancestor
24671526|NCT01326403|Coagulants|coagulants|mesh-ancestor
24671607|NCT01326754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688127|NCT01941628|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25688128|NCT01941628|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25688129|NCT01941628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25688130|NCT01941628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688131|NCT01941628|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
25688132|NCT01941927|Trametinib|trametinib|mesh-list
24671608|NCT01326754|Antiviral Agents|antiviral agents|mesh-ancestor
24671609|NCT01326754|Schistosomicides|schistosomicides|mesh-ancestor
25688133|NCT01941927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626040|NCT01085383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24671610|NCT01326754|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24671611|NCT01326754|Anthelmintics|anthelmintics|mesh-ancestor
24671612|NCT01326767|Paclitaxel|paclitaxel|mesh-list
24724908|NCT01595685|Entecavir|entecavir|mesh-list
24853832|NCT02270437|Sympathomimetics|sympathomimetics|mesh-ancestor
24853833|NCT02270437|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24703612|NCT01472796|Vitamin D|vitamin d|mesh-list
24671688|NCT01327118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24671689|NCT01327118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671690|NCT01327118|Oxytocics|oxytocics|mesh-ancestor
24671691|NCT01327144|Acyclovir|acyclovir|mesh-list
24671692|NCT01327144|Famciclovir|famciclovir|mesh-list
24671693|NCT01327144|Antiviral Agents|antiviral agents|mesh-ancestor
24671694|NCT01327144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24671695|NCT01327144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24671696|NCT01327144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671724|NCT01327326|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24671725|NCT01327326|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24671726|NCT01327326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671727|NCT01327326|Sensory System Agents|sensory system agents|mesh-ancestor
24671728|NCT01327326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24671729|NCT01327469|Albendazole|albendazole|mesh-list
24671730|NCT01327469|Mebendazole|mebendazole|mesh-list
24671731|NCT01327469|Piperazine|piperazine|mesh-list
24671732|NCT01327469|Piperazine citrate|piperazine citrate|mesh-list
24671733|NCT01327469|Pyrantel|pyrantel|mesh-list
24671734|NCT01327469|Oxantel|oxantel|mesh-list
24671735|NCT01327469|DMP 777|dmp 777|mesh-list
24671736|NCT01327469|Anthelmintics|anthelmintics|mesh-ancestor
24671737|NCT01327469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24671738|NCT01327469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24671739|NCT01327469|Anticestodal Agents|anticestodal agents|mesh-ancestor
24671741|NCT01327469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24671768|NCT01327521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25260403|NCT02458716|Androgen Antagonists|androgen antagonists|mesh-ancestor
25260404|NCT02458716|Hormone Antagonists|hormone antagonists|mesh-ancestor
25260405|NCT02458911|Paclitaxel|paclitaxel|mesh-list
25260406|NCT02458911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25260407|NCT02458911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25260408|NCT02458911|Tubulin Modulators|tubulin modulators|mesh-ancestor
25260409|NCT02458911|Antimitotic Agents|antimitotic agents|mesh-ancestor
25260410|NCT02458911|Mitosis Modulators|mitosis modulators|mesh-ancestor
25260411|NCT02458911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260412|NCT02458781|Metronidazole|metronidazole|mesh-list
25260413|NCT02458781|Ciprofloxacin|ciprofloxacin|mesh-list
25260414|NCT02458781|Fluoroquinolones|fluoroquinolones|mesh-list
25260415|NCT02458781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25260416|NCT02458781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25260417|NCT02458781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25260418|NCT02458781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25260419|NCT02458781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24932138|NCT04082793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24932139|NCT04082793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932140|NCT04082793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24932141|NCT04082793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24932142|NCT04082793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24671769|NCT01327521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24671770|NCT01327521|Immunologic Factors|immunologic factors|mesh-ancestor
24671771|NCT01327521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671772|NCT01327521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24671773|NCT01327521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24610390|NCT01001780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24610391|NCT01001780|Immunologic Factors|immunologic factors|mesh-ancestor
24610392|NCT01001780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610393|NCT01001780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24610394|NCT01001780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24671807|NCT01327859|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24853848|NCT02270606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24853849|NCT02270606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24456614|NCT00331825|Risperidone|risperidone|mesh-list
24456615|NCT00331825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24456616|NCT00331825|Serotonin Agents|serotonin agents|mesh-ancestor
25688134|NCT01941927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24671836|NCT01328145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671838|NCT01328145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24671839|NCT01328145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24671840|NCT01328145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24671841|NCT01328145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671889|NCT01328301|Autonomic Agents|autonomic agents|mesh-ancestor
24671890|NCT01328301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24671891|NCT01328301|Dopamine Agents|dopamine agents|mesh-ancestor
24671892|NCT01328301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24671893|NCT01328301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671894|NCT01328301|Adrenergic Agents|adrenergic agents|mesh-ancestor
24671895|NCT01328301|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24671896|NCT01328301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24853859|NCT02270749|Micronutrients|micronutrients|mesh-ancestor
24853860|NCT02270749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853861|NCT02270749|Vitamin B Complex|vitamin b complex|mesh-ancestor
24853862|NCT02270749|Hematinics|hematinics|mesh-ancestor
24853864|NCT02270788|Cytarabine|cytarabine|mesh-list
24853865|NCT02270788|Hydrocortisone|hydrocortisone|mesh-list
24853866|NCT02270788|Methotrexate|methotrexate|mesh-list
24671928|NCT01328457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671930|NCT01328470|Clopidogrel|clopidogrel|mesh-list
24671931|NCT01328470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24671932|NCT01328470|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24671933|NCT01328470|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24671934|NCT01328470|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24671935|NCT01328470|Purinergic Agents|purinergic agents|mesh-ancestor
25260420|NCT02458781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25260421|NCT02458781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25260422|NCT02458781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260423|NCT02458781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25260424|NCT02458781|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25260425|NCT02458781|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25260426|NCT02458781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25260427|NCT02458729|Tranylcypromine|tranylcypromine|mesh-list
25260428|NCT02458729|Rivaroxaban|rivaroxaban|mesh-list
25260429|NCT02458729|Tranexamic Acid|tranexamic acid|mesh-list
24932143|NCT04082793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24932144|NCT04082793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853871|NCT02270788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24853872|NCT02270788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853873|NCT02270788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24853874|NCT02270788|Antimetabolites|antimetabolites|mesh-ancestor
24456627|NCT00331825|Autonomic Agents|autonomic agents|mesh-ancestor
24671945|NCT01328470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24671946|NCT01328470|Vasodilator Agents|vasodilator agents|mesh-ancestor
24637451|NCT01150344|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
24637452|NCT01150344|Antimalarials|antimalarials|mesh-ancestor
24637453|NCT01150344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24671973|NCT01328834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671974|NCT01328834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24671975|NCT01328834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671976|NCT01328834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671977|NCT01328886|Omalizumab|omalizumab|mesh-list
24671978|NCT01328886|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24671979|NCT01328886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24671980|NCT01328886|Respiratory System Agents|respiratory system agents|mesh-ancestor
24671981|NCT01328925|Nitazoxanide|nitazoxanide|mesh-list
24671982|NCT01328925|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24671983|NCT01328925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24671984|NCT01328990|Pyrimethamine|pyrimethamine|mesh-list
24671985|NCT01328990|Sulfadoxine|sulfadoxine|mesh-list
25260430|NCT02458729|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25260431|NCT02458729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25260432|NCT02458729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260433|NCT02458729|Hemostatics|hemostatics|mesh-ancestor
25260434|NCT02458729|Coagulants|coagulants|mesh-ancestor
25260435|NCT02458729|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25260436|NCT02458729|Antithrombins|antithrombins|mesh-ancestor
25260437|NCT02458729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24946596|NCT03936907|Nabiximols|nabiximols|mesh-list
25260438|NCT02458729|Protease Inhibitors|protease inhibitors|mesh-ancestor
25260439|NCT02458729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25260440|NCT02458729|Anticoagulants|anticoagulants|mesh-ancestor
25260441|NCT02458729|Antidepressive Agents|antidepressive agents|mesh-ancestor
25260442|NCT02458729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25260443|NCT02458729|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25260444|NCT02458729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25260445|NCT02458729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25260446|NCT02458729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25260447|NCT02458729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260448|NCT02458547|Bupivacaine|bupivacaine|mesh-list
25260449|NCT02458547|Propofol|propofol|mesh-list
25260450|NCT02458547|Desflurane|desflurane|mesh-list
24529625|NCT00627003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24529626|NCT00627003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932176|NCT04082598|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24932177|NCT04082598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24932178|NCT04082598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932179|NCT04082559|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24932180|NCT04082559|Metronidazole|metronidazole|mesh-list
24932181|NCT04082559|Doxycycline|doxycycline|mesh-list
24932182|NCT04082559|Ciprofloxacin|ciprofloxacin|mesh-list
24932183|NCT04082559|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24932184|NCT04082559|Complement Factor H|complement factor h|mesh-list
24932185|NCT04082559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24932186|NCT04082559|Antitubercular Agents|antitubercular agents|mesh-ancestor
24932187|NCT04082559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24932188|NCT04082559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24932189|NCT04082559|Antimalarials|antimalarials|mesh-ancestor
24932190|NCT04082559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24935903|NCT04046861|Antioxidants|antioxidants|mesh-ancestor
24671986|NCT01328990|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24671987|NCT01328990|Amodiaquine|amodiaquine|mesh-list
24671988|NCT01328990|Antimalarials|antimalarials|mesh-ancestor
24671989|NCT01328990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24671990|NCT01328990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24671991|NCT01328990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24672025|NCT01329289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24672027|NCT01329289|Autonomic Agents|autonomic agents|mesh-ancestor
24672028|NCT01329289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24902013|NCT04378972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24672045|NCT01329406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24672046|NCT01329406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24672047|NCT01329406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24672048|NCT01329406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672080|NCT01329627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24637479|NCT01150630|Gemcitabine|gemcitabine|mesh-list
24672125|NCT01329770|Tocopherols|tocopherols|mesh-list
24672126|NCT01329770|alpha-Tocopherol|alpha-tocopherol|mesh-list
24672127|NCT01329770|Micronutrients|micronutrients|mesh-ancestor
24637485|NCT01150630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672128|NCT01329770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672129|NCT01329770|Antioxidants|antioxidants|mesh-ancestor
24672130|NCT01329770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853884|NCT02270788|Antiviral Agents|antiviral agents|mesh-ancestor
24853885|NCT02270788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24853886|NCT02270788|Antidotes|antidotes|mesh-ancestor
24853887|NCT02270788|Protective Agents|protective agents|mesh-ancestor
25260451|NCT02458547|Anesthetics, Local|anesthetics, local|mesh-ancestor
25260452|NCT02458547|Anesthetics|anesthetics|mesh-ancestor
25260453|NCT02458547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25260454|NCT02458547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260455|NCT02458547|Sensory System Agents|sensory system agents|mesh-ancestor
25260456|NCT02458547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25260457|NCT02458547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25260458|NCT02458547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25260459|NCT02458547|Anesthetics, General|anesthetics, general|mesh-ancestor
25260460|NCT02458547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25260462|NCT02458625|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25260463|NCT02458625|Trace Elements|trace elements|mesh-ancestor
25260464|NCT02458625|Micronutrients|micronutrients|mesh-ancestor
25260465|NCT02458625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260466|NCT02458625|Hematinics|hematinics|mesh-ancestor
25260467|NCT02458482|Albuterol|albuterol|mesh-list
25260468|NCT02458482|Ipratropium|ipratropium|mesh-list
25260469|NCT02458482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25260470|NCT02458482|Autonomic Agents|autonomic agents|mesh-ancestor
25260471|NCT02458482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25260472|NCT02458482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260473|NCT02458482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25260474|NCT02458482|Respiratory System Agents|respiratory system agents|mesh-ancestor
24932191|NCT04082559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24932192|NCT04082559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24932193|NCT04082559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932194|NCT04082559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24932213|NCT04081909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24932215|NCT04081909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24932216|NCT04081909|Analgesics|analgesics|mesh-ancestor
24932217|NCT04081909|Sensory System Agents|sensory system agents|mesh-ancestor
24853888|NCT02270788|Vitamin B Complex|vitamin b complex|mesh-ancestor
24853890|NCT02270788|Micronutrients|micronutrients|mesh-ancestor
24853891|NCT02270788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24853892|NCT02270788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24456645|NCT00331851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24456646|NCT00331851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456647|NCT00331851|Incretins|incretins|mesh-ancestor
24672131|NCT01329770|Protective Agents|protective agents|mesh-ancestor
24672133|NCT01329783|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24672134|NCT01329783|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24672135|NCT01329783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672136|NCT01329783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24672137|NCT01329783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24672138|NCT01329783|Antiviral Agents|antiviral agents|mesh-ancestor
24672139|NCT01329783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24672140|NCT01329783|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24672181|NCT01330472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672182|NCT01330524|Triamcinolone|triamcinolone|mesh-list
24672183|NCT01330524|Bevacizumab|bevacizumab|mesh-list
24672184|NCT01330524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24672185|NCT01330524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672186|NCT01330524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24610425|NCT01001962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610426|NCT01001962|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24610427|NCT01001962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610428|NCT01002079|Rifampin|rifampin|mesh-list
24610429|NCT01002079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24610430|NCT01002079|Antitubercular Agents|antitubercular agents|mesh-ancestor
24610431|NCT01002079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24610432|NCT01002079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24610433|NCT01002079|Leprostatic Agents|leprostatic agents|mesh-ancestor
24610434|NCT01002079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24610435|NCT01002079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610436|NCT01002079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610437|NCT01002079|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24853901|NCT02270827|Respiratory System Agents|respiratory system agents|mesh-ancestor
24853903|NCT02270827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24853904|NCT02270827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24853907|NCT02270827|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24610439|NCT01002079|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24610440|NCT01002079|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24610452|NCT01002157|Vitamin MK 7|vitamin mk 7|mesh-list
24610453|NCT01002157|Vitamins|vitamins|mesh-ancestor
24610454|NCT01002157|Micronutrients|micronutrients|mesh-ancestor
24610455|NCT01002157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610456|NCT01002157|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24610457|NCT01002157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24610468|NCT01002534|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24610469|NCT01002534|Vasodilator Agents|vasodilator agents|mesh-ancestor
24637509|NCT01150877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637510|NCT01150877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24672372|NCT01331785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25404314|NCT03675256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688135|NCT01941927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672373|NCT01331785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672374|NCT01331902|Nicorandil|nicorandil|mesh-list
25260475|NCT02458482|Tocolytic Agents|tocolytic agents|mesh-ancestor
25260476|NCT02458482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25260477|NCT02458482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25260478|NCT02458482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25260479|NCT02458482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25260480|NCT02458482|Adrenergic Agents|adrenergic agents|mesh-ancestor
25260481|NCT02458482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25260482|NCT02458482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932218|NCT04081909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24932219|NCT04081909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24932220|NCT04081909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24932221|NCT04081909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24932222|NCT04081909|Adrenergic Agents|adrenergic agents|mesh-ancestor
24932223|NCT04081909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24935930|NCT04046029|Antithrombins|antithrombins|mesh-ancestor
24672375|NCT01331902|Adenosine|adenosine|mesh-list
24672376|NCT01331902|Analgesics|analgesics|mesh-ancestor
24672377|NCT01331902|Sensory System Agents|sensory system agents|mesh-ancestor
24672378|NCT01331902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24672379|NCT01331902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672394|NCT01331928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672395|NCT01331928|Tubulin Modulators|tubulin modulators|mesh-ancestor
24672396|NCT01331928|Antimitotic Agents|antimitotic agents|mesh-ancestor
24672397|NCT01331928|Mitosis Modulators|mitosis modulators|mesh-ancestor
24672398|NCT01331928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672411|NCT01331941|Growth Substances|growth substances|mesh-ancestor
24672513|NCT01332409|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24456574|NCT00331708|Renal Agents|renal agents|mesh-ancestor
24672514|NCT01332409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24672515|NCT01332409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24672516|NCT01332409|Adrenergic Agents|adrenergic agents|mesh-ancestor
24672517|NCT01332409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24672519|NCT01332409|Glucocorticoids|glucocorticoids|mesh-ancestor
24672565|NCT01332565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672566|NCT01332565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672567|NCT01332565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24672568|NCT01332565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24672569|NCT01332565|Antiviral Agents|antiviral agents|mesh-ancestor
24672570|NCT01332565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24672571|NCT01332604|Bevacizumab|bevacizumab|mesh-list
24672626|NCT01332734|Sensory System Agents|sensory system agents|mesh-ancestor
24672627|NCT01332734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24672628|NCT01332734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672630|NCT01332734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24672631|NCT01332734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24672632|NCT01332734|Anticonvulsants|anticonvulsants|mesh-ancestor
24672633|NCT01332734|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24672634|NCT01332734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24672635|NCT01332734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672636|NCT01332734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24672637|NCT01332734|Tocolytic Agents|tocolytic agents|mesh-ancestor
24672638|NCT01332734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24672639|NCT01332747|Atorvastatin|atorvastatin|mesh-list
24455820|NCT00329134|Analgesics|analgesics|mesh-ancestor
24672761|NCT01333514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853956|NCT02271191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853957|NCT02271191|Vasodilator Agents|vasodilator agents|mesh-ancestor
24853958|NCT02271204|Ibandronic Acid|ibandronic acid|mesh-list
24672762|NCT01333631|Valproic Acid|valproic acid|mesh-list
24672763|NCT01333631|Anticonvulsants|anticonvulsants|mesh-ancestor
24672764|NCT01333631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672765|NCT01333631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672766|NCT01333631|GABA Agents|gaba agents|mesh-ancestor
24672767|NCT01333631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24672768|NCT01333631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672769|NCT01333631|Antimanic Agents|antimanic agents|mesh-ancestor
24672770|NCT01333631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24672771|NCT01333631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24672772|NCT01333631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24672773|NCT01333670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24672774|NCT01333696|Pemetrexed|pemetrexed|mesh-list
24672775|NCT01333696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672776|NCT01333696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412875|NCT00192608|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24412877|NCT00192621|Lamivudine|lamivudine|mesh-list
24672777|NCT01333696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672778|NCT01333696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25260483|NCT02458482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25260484|NCT02458482|Cholinergic Agents|cholinergic agents|mesh-ancestor
25260485|NCT02458339|Methotrexate|methotrexate|mesh-list
25260486|NCT02458339|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25260487|NCT02458339|Abortifacient Agents|abortifacient agents|mesh-ancestor
25260488|NCT02458339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25260489|NCT02458339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932224|NCT04081909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932225|NCT04081909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24932226|NCT04081909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24932227|NCT04081909|Anesthetics, General|anesthetics, general|mesh-ancestor
24932228|NCT04081909|Anesthetics|anesthetics|mesh-ancestor
24932229|NCT04081909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24932230|NCT04081909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24932231|NCT04081909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24932232|NCT04081909|Narcotics|narcotics|mesh-ancestor
24932233|NCT04081909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24932234|NCT04081805|Estradiol|estradiol|mesh-list
24932235|NCT04081805|Estrogens|estrogens|mesh-ancestor
24932236|NCT04081805|Hormones|hormones|mesh-ancestor
24932237|NCT04081805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24932238|NCT04081805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932296|NCT04081012|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24932297|NCT04081012|Antioxidants|antioxidants|mesh-ancestor
24932299|NCT04081012|Protective Agents|protective agents|mesh-ancestor
24932300|NCT04081012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932301|NCT04081012|Antidotes|antidotes|mesh-ancestor
24932302|NCT04081077|Moxifloxacin|moxifloxacin|mesh-list
24932303|NCT04081077|Linezolid|linezolid|mesh-list
24932304|NCT04081077|Bedaquiline|bedaquiline|mesh-list
24932305|NCT04081077|Clofazimine|clofazimine|mesh-list
24932306|NCT04081077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24932307|NCT04081077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24932308|NCT04081077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24932309|NCT04081077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24932310|NCT04081077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24932311|NCT04081077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672779|NCT01333696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24672780|NCT01333709|Folfirinox|folfirinox|mesh-list
24672781|NCT01333709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672782|NCT01333774|Acarbose|acarbose|mesh-list
24853973|NCT02271295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24673007|NCT01334762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673009|NCT01334762|Hormone Antagonists|hormone antagonists|mesh-ancestor
24673010|NCT01334762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24673011|NCT01334762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673012|NCT01334879|Ranibizumab|ranibizumab|mesh-list
25260490|NCT02458339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25260491|NCT02458339|Antimetabolites|antimetabolites|mesh-ancestor
25260492|NCT02458339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260493|NCT02458339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25260494|NCT02458339|Dermatologic Agents|dermatologic agents|mesh-ancestor
25260495|NCT02458339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25260496|NCT02458339|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25260497|NCT02458339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25260498|NCT02458339|Immunologic Factors|immunologic factors|mesh-ancestor
25260499|NCT02458339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25260500|NCT02458339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25260501|NCT02458209|Bococizumab|bococizumab|mesh-list
25260502|NCT02458209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25260503|NCT02458209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25260504|NCT02458209|Antimetabolites|antimetabolites|mesh-ancestor
25260505|NCT02458209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260506|NCT02458209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25260507|NCT02458183|Vaccines|vaccines|mesh-list
25260508|NCT02458183|Immunologic Factors|immunologic factors|mesh-ancestor
25260509|NCT02458183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260510|NCT02458274|Dimercaprol|dimercaprol|mesh-list
25260511|NCT02458274|Chelating Agents|chelating agents|mesh-ancestor
25688136|NCT01941927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688137|NCT01942148|Aripiprazole|aripiprazole|mesh-list
24962583|NCT03797508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24962584|NCT03797508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788471|NCT01931514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24788472|NCT01931514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788473|NCT01931514|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24946775|NCT03935074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25260512|NCT02458274|Sequestering Agents|sequestering agents|mesh-ancestor
25260513|NCT02458274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260514|NCT02458196|Mycophenolic Acid|mycophenolic acid|mesh-list
25260515|NCT02458196|Prednisone|prednisone|mesh-list
25260516|NCT02458196|Prednisolone|prednisolone|mesh-list
25260517|NCT02458196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25260518|NCT02458196|Glucocorticoids|glucocorticoids|mesh-ancestor
25260519|NCT02458196|Hormones|hormones|mesh-ancestor
25260520|NCT02458196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25260521|NCT02458196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932321|NCT04080518|Dapagliflozin|dapagliflozin|mesh-list
24932322|NCT04080518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24932323|NCT04080518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932324|NCT04080518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24932325|NCT04080518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932326|NCT04080726|Esomeprazole|esomeprazole|mesh-list
24932327|NCT04080726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24932328|NCT04080726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24932329|NCT04080726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24932330|NCT04080726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529634|NCT00627081|Sensory System Agents|sensory system agents|mesh-ancestor
24935963|NCT04046302|Dinoprostone|dinoprostone|mesh-list
24673013|NCT01334879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24849735|NCT02249936|Omeprazole|omeprazole|mesh-list
24673014|NCT01334879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24673015|NCT01334879|Growth Substances|growth substances|mesh-ancestor
24673016|NCT01334879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673017|NCT01334879|Growth Inhibitors|growth inhibitors|mesh-ancestor
24673018|NCT01334879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673019|NCT01334892|Cyclosporine|cyclosporine|mesh-list
24673020|NCT01334892|Cyclosporins|cyclosporins|mesh-list
24673021|NCT01334892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673040|NCT01335035|Deferasirox|deferasirox|mesh-list
24673041|NCT01335035|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24673042|NCT01335035|Chelating Agents|chelating agents|mesh-ancestor
24673043|NCT01335035|Sequestering Agents|sequestering agents|mesh-ancestor
24673044|NCT01335035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673045|NCT01335048|Clopidogrel|clopidogrel|mesh-list
24673046|NCT01335048|Atorvastatin|atorvastatin|mesh-list
24673061|NCT01335074|Sirolimus|sirolimus|mesh-list
24673070|NCT01335074|Antifungal Agents|antifungal agents|mesh-ancestor
24673071|NCT01335074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24673072|NCT01335074|Immunologic Factors|immunologic factors|mesh-ancestor
24673073|NCT01335074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673074|NCT01335126|Lubricant Eye Drops|lubricant eye drops|mesh-list
24673075|NCT01335126|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24673104|NCT01335334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673106|NCT01335334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24673107|NCT01335360|Nevirapine|nevirapine|mesh-list
24673108|NCT01335360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24673109|NCT01335360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24673110|NCT01335360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24853980|NCT02271360|Calcium|calcium|mesh-list
24673185|NCT01336010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673187|NCT01336049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24673188|NCT01336049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688138|NCT01942148|Antidepressive Agents|antidepressive agents|mesh-ancestor
25688139|NCT01942148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25688140|NCT01942148|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25688141|NCT01942148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25688142|NCT01942148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25688143|NCT01942148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688144|NCT01942148|Dopamine Agonists|dopamine agonists|mesh-ancestor
24673189|NCT01336062|Paclitaxel|paclitaxel|mesh-list
25688145|NCT01942148|Dopamine Agents|dopamine agents|mesh-ancestor
24673190|NCT01336062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24673191|NCT01336062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24673192|NCT01336062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673193|NCT01336062|Tubulin Modulators|tubulin modulators|mesh-ancestor
24673194|NCT01336062|Antimitotic Agents|antimitotic agents|mesh-ancestor
24673195|NCT01336062|Mitosis Modulators|mitosis modulators|mesh-ancestor
24902566|NCT04371874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24673389|NCT01337466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673390|NCT01337466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24673391|NCT01337466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673392|NCT01337466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673393|NCT01337492|Sorafenib|sorafenib|mesh-list
24673394|NCT01337492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673395|NCT01337492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24673396|NCT01337492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25260522|NCT02458196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25260523|NCT02458196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25260524|NCT02458196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25260525|NCT02458196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25260526|NCT02458196|Antitubercular Agents|antitubercular agents|mesh-ancestor
25260527|NCT02458196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25260528|NCT02458196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25260529|NCT02458196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25260530|NCT02458196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260531|NCT02458157|Furosemide|furosemide|mesh-list
25260532|NCT02458157|Diuretics|diuretics|mesh-ancestor
25260533|NCT02458157|Natriuretic Agents|natriuretic agents|mesh-ancestor
25260534|NCT02458157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529635|NCT00627081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24529637|NCT00627133|Anticonvulsants|anticonvulsants|mesh-ancestor
24529638|NCT00627133|Nootropic Agents|nootropic agents|mesh-ancestor
24529639|NCT00627354|Prednisone|prednisone|mesh-list
24932331|NCT04080726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932332|NCT04080375|Dinoprostone|dinoprostone|mesh-list
24932333|NCT04080375|Oxytocics|oxytocics|mesh-ancestor
24932334|NCT04080375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24932335|NCT04080375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932336|NCT04080388|Diuretics|diuretics|mesh-list
24932337|NCT04080388|Natriuretic Agents|natriuretic agents|mesh-ancestor
24932338|NCT04080388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932339|NCT04080713|Budesonide|budesonide|mesh-list
24932340|NCT04080713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24673397|NCT01337492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673399|NCT01337518|Hormones|hormones|mesh-ancestor
24673400|NCT01337518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24673401|NCT01337518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673408|NCT01337570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673409|NCT01337583|Dapivirine|dapivirine|mesh-list
24673410|NCT01337583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24673411|NCT01337583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24818252|NCT02087579|Olanzapine|olanzapine|mesh-list
24673499|NCT01338441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24673500|NCT01338441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673501|NCT01338441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24673502|NCT01338441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24673503|NCT01338441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673504|NCT01338441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673598|NCT01339039|Antiviral Agents|antiviral agents|mesh-ancestor
24673599|NCT01339039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673601|NCT01339065|Analgesics|analgesics|mesh-ancestor
24673602|NCT01339065|Sensory System Agents|sensory system agents|mesh-ancestor
24673603|NCT01339065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24673604|NCT01339065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673605|NCT01339065|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24673606|NCT01339065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24854002|NCT02271399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24534874|NCT00648193|Paroxetine|paroxetine|mesh-list
24534883|NCT00648193|Antidepressive Agents|antidepressive agents|mesh-ancestor
24854003|NCT02271399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854004|NCT02271399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24854005|NCT02271399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24673698|NCT01339663|Sensory System Agents|sensory system agents|mesh-ancestor
24673699|NCT01339663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24673701|NCT01339663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24673702|NCT01339663|Antiviral Agents|antiviral agents|mesh-ancestor
24673703|NCT01339663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673704|NCT01339676|Vitamin D|vitamin d|mesh-list
24673705|NCT01339676|Cholecalciferol|cholecalciferol|mesh-list
24673706|NCT01339676|Vitamins|vitamins|mesh-ancestor
24673707|NCT01339676|Micronutrients|micronutrients|mesh-ancestor
24673708|NCT01339676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673709|NCT01339676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24854014|NCT02271412|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24854015|NCT02271412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24854016|NCT02271412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24673710|NCT01339676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24674011|NCT01341405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260535|NCT02458157|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25260536|NCT02458157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25260537|NCT02458157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275167|NCT02373384|Protective Agents|protective agents|mesh-ancestor
25275168|NCT02373384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275169|NCT02373384|Diuretics|diuretics|mesh-ancestor
25275170|NCT02373384|Natriuretic Agents|natriuretic agents|mesh-ancestor
25275171|NCT02373384|Expectorants|expectorants|mesh-ancestor
25275172|NCT02373384|Respiratory System Agents|respiratory system agents|mesh-ancestor
25275173|NCT02373579|Methotrexate|methotrexate|mesh-list
25275174|NCT02373579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25275175|NCT02373579|Abortifacient Agents|abortifacient agents|mesh-ancestor
25275176|NCT02373579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24932342|NCT04080713|Autonomic Agents|autonomic agents|mesh-ancestor
24932343|NCT04080713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24932344|NCT04080713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932345|NCT04080713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24932346|NCT04080713|Respiratory System Agents|respiratory system agents|mesh-ancestor
24932347|NCT04080713|Glucocorticoids|glucocorticoids|mesh-ancestor
24932348|NCT04080713|Hormones|hormones|mesh-ancestor
24529640|NCT00627354|Etoposide|etoposide|mesh-list
24529641|NCT00627354|Vinorelbine|vinorelbine|mesh-list
24529642|NCT00627354|Mitoxantrone|mitoxantrone|mesh-list
24529643|NCT00627354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24529644|NCT00627354|Glucocorticoids|glucocorticoids|mesh-ancestor
24529645|NCT00627354|Hormones|hormones|mesh-ancestor
24674012|NCT01341496|Celecoxib|celecoxib|mesh-list
24674014|NCT01341496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24674015|NCT01341496|Immunologic Factors|immunologic factors|mesh-ancestor
24674016|NCT01341496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674017|NCT01341496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24674018|NCT01341496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24674019|NCT01341496|Alkylating Agents|alkylating agents|mesh-ancestor
24637664|NCT01152242|Insulin Glargine|insulin glargine|mesh-list
24674026|NCT01341496|Sensory System Agents|sensory system agents|mesh-ancestor
24674027|NCT01341496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24674028|NCT01341496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24674029|NCT01341496|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24674030|NCT01341496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24674031|NCT01341496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674032|NCT01341717|Metformin|metformin|mesh-list
24674033|NCT01341717|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24674034|NCT01341717|Glimepiride|glimepiride|mesh-list
24674035|NCT01341717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24674036|NCT01341717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674037|NCT01341717|Incretins|incretins|mesh-ancestor
24674053|NCT01341743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24674054|NCT01341743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674072|NCT01341938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674073|NCT01341938|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24854026|NCT02271438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24854027|NCT02271438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24854028|NCT02271438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854029|NCT02271438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854030|NCT02271438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24854031|NCT02271438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24854032|NCT02271438|Contraceptive Agents|contraceptive agents|mesh-ancestor
24854033|NCT02271438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24674074|NCT01341938|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24674075|NCT01341938|Cholinergic Agents|cholinergic agents|mesh-ancestor
24674076|NCT01341938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24674077|NCT01341938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674078|NCT01341951|Lenograstim|lenograstim|mesh-list
24674079|NCT01341951|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24674080|NCT01341951|Immunologic Factors|immunologic factors|mesh-ancestor
24674081|NCT01341951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674083|NCT01341964|Clopidogrel|clopidogrel|mesh-list
24674084|NCT01341964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24674085|NCT01341964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24674086|NCT01341964|Analgesics|analgesics|mesh-ancestor
24674087|NCT01341964|Sensory System Agents|sensory system agents|mesh-ancestor
24674088|NCT01341964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24674089|NCT01341964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674090|NCT01341964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25260538|NCT02457975|Ranibizumab|ranibizumab|mesh-list
25260539|NCT02457975|Aflibercept|aflibercept|mesh-list
25260540|NCT02457975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25260541|NCT02457975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25260542|NCT02457975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25260543|NCT02457975|Growth Substances|growth substances|mesh-ancestor
25260544|NCT02457975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260545|NCT02457975|Growth Inhibitors|growth inhibitors|mesh-ancestor
25260546|NCT02458118|Secretin|secretin|mesh-list
25260547|NCT02458118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25260548|NCT02458118|Hormones|hormones|mesh-ancestor
25260549|NCT02458118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24529646|NCT00627354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24529647|NCT00627354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674091|NCT01341964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24674105|NCT01342016|Tacrolimus|tacrolimus|mesh-list
24674106|NCT01342016|Leflunomide|leflunomide|mesh-list
24674107|NCT01342016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24674108|NCT01342016|Glucocorticoids|glucocorticoids|mesh-ancestor
24674109|NCT01342016|Hormones|hormones|mesh-ancestor
24674110|NCT01342016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24674111|NCT01342016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674122|NCT01342185|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
24674123|NCT01342185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24674215|NCT01342328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24674266|NCT01342692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24674267|NCT01342692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24674268|NCT01342692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24674269|NCT01342731|Tigecycline|tigecycline|mesh-list
24674270|NCT01342731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24674271|NCT01342731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24674272|NCT01342731|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24674273|NCT01342731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456767|NCT00332176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456768|NCT00332176|Antiviral Agents|antiviral agents|mesh-ancestor
24456769|NCT00332176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24456770|NCT00332228|Naltrexone|naltrexone|mesh-list
24456771|NCT00332228|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24539993|NCT00666185|Fluconazole|fluconazole|mesh-list
24539994|NCT00666185|Micafungin|micafungin|mesh-list
24539995|NCT00666185|Antifungal Agents|antifungal agents|mesh-ancestor
24539996|NCT00666185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24539997|NCT00666185|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24540078|NCT00666484|Glucocorticoids|glucocorticoids|mesh-ancestor
24540079|NCT00666484|Hormones|hormones|mesh-ancestor
24540081|NCT00666484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24674350|NCT05250752|Dapagliflozin|dapagliflozin|mesh-list
24674351|NCT05250752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24674352|NCT05250752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610505|NCT01002703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610506|NCT01002729|Oseltamivir|oseltamivir|mesh-list
24854047|NCT02271464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854048|NCT02271464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24854049|NCT02271464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25260550|NCT02458118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260551|NCT02458079|Pentoxifylline|pentoxifylline|mesh-list
25260552|NCT02458079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24414972|NCT00199017|Cyclophosphamide|cyclophosphamide|mesh-list
24414973|NCT00199017|Methotrexate|methotrexate|mesh-list
24414975|NCT00199017|Doxorubicin|doxorubicin|mesh-list
24414976|NCT00199017|Daunorubicin|daunorubicin|mesh-list
24414980|NCT00199017|Cladribine|cladribine|mesh-list
24415034|NCT00199043|Protective Agents|protective agents|mesh-ancestor
24415101|NCT00199069|Immunologic Factors|immunologic factors|mesh-ancestor
24415102|NCT00199069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415103|NCT00199069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25260553|NCT02458079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529648|NCT00627354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24529649|NCT00627354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24529650|NCT00627354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24529651|NCT00627354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24529652|NCT00627354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24529653|NCT00627354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529655|NCT00627354|Tubulin Modulators|tubulin modulators|mesh-ancestor
24935999|NCT04045821|Plerixafor|plerixafor|mesh-list
24854050|NCT02271464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24936042|NCT04044976|Caffeine citrate|caffeine citrate|mesh-list
24674470|NCT05193396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24674580|NCT05073250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24674581|NCT05073250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24674582|NCT05073250|Immunologic Factors|immunologic factors|mesh-ancestor
24674583|NCT05073250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674584|NCT05073250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24610572|NCT01003483|Orlistat|orlistat|mesh-list
24610573|NCT01003483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610574|NCT01003483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674614|NCT05027919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24674631|NCT05027048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674633|NCT04999228|Infliximab|infliximab|mesh-list
24674634|NCT04999228|Dermatologic Agents|dermatologic agents|mesh-ancestor
24674635|NCT04999228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24674636|NCT04999228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24674637|NCT04999228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24674638|NCT04999228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24674639|NCT04999228|Analgesics|analgesics|mesh-ancestor
24674640|NCT04999228|Sensory System Agents|sensory system agents|mesh-ancestor
24674641|NCT04999228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24674642|NCT04999228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674643|NCT04999228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24610594|NCT01003613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24610595|NCT01003613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24610596|NCT01003613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674673|NCT04920331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674674|NCT04861987|Capecitabine|capecitabine|mesh-list
24704444|NCT01478282|Anticoagulants|anticoagulants|mesh-ancestor
24674675|NCT04861987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24674676|NCT04861987|Antimetabolites|antimetabolites|mesh-ancestor
24674677|NCT04861987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260554|NCT02458079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260555|NCT02458079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25260556|NCT02458079|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25260557|NCT02458079|Protective Agents|protective agents|mesh-ancestor
25260558|NCT02458079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260559|NCT02458079|Vasodilator Agents|vasodilator agents|mesh-ancestor
25260560|NCT02458079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25260561|NCT02458079|Antioxidants|antioxidants|mesh-ancestor
25260562|NCT02457650|Cyclophosphamide|cyclophosphamide|mesh-list
25260563|NCT02457650|Fludarabine|fludarabine|mesh-list
25688146|NCT01942148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25688147|NCT01942148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688148|NCT01942148|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25688149|NCT01942148|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25688150|NCT01942148|Serotonin Agents|serotonin agents|mesh-ancestor
25688151|NCT01942148|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25688152|NCT01942148|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25688153|NCT01942148|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25260564|NCT02457650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24529664|NCT00627432|Antimetabolites|antimetabolites|mesh-ancestor
24529665|NCT00627432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529666|NCT00627432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24529667|NCT00627432|Antiviral Agents|antiviral agents|mesh-ancestor
24529710|NCT00627666|Methotrexate|methotrexate|mesh-list
24932349|NCT04080713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24932350|NCT04080622|Selenium|selenium|mesh-list
24932351|NCT04080622|Antioxidants|antioxidants|mesh-ancestor
24932352|NCT04080622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932353|NCT04080622|Protective Agents|protective agents|mesh-ancestor
24932354|NCT04080622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932355|NCT04080622|Trace Elements|trace elements|mesh-ancestor
24932356|NCT04080622|Micronutrients|micronutrients|mesh-ancestor
24932357|NCT04080349|Misoprostol|misoprostol|mesh-list
24932358|NCT04080349|Dinoprostone|dinoprostone|mesh-list
24936005|NCT04045548|Oxytocics|oxytocics|mesh-ancestor
24674678|NCT04861987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24674679|NCT04832438|Carboplatin|carboplatin|mesh-list
24674680|NCT04832438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24674681|NCT04832087|Teduglutide|teduglutide|mesh-list
24674682|NCT04832087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24674764|NCT04541108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24674766|NCT04541108|Tubulin Modulators|tubulin modulators|mesh-ancestor
24674767|NCT04541108|Antimitotic Agents|antimitotic agents|mesh-ancestor
24854068|NCT02271555|Anesthetics, General|anesthetics, general|mesh-ancestor
24854069|NCT02271555|Anesthetics|anesthetics|mesh-ancestor
24854070|NCT02271555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24854071|NCT02271555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854072|NCT02271555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24854073|NCT02271555|Narcotics|narcotics|mesh-ancestor
24674782|NCT04490993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674808|NCT04409964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24674809|NCT04409964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24674810|NCT04409964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24674811|NCT04409964|Adrenergic Agents|adrenergic agents|mesh-ancestor
24674812|NCT04409964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24674813|NCT04409964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24674814|NCT04409964|Narcotics|narcotics|mesh-ancestor
24674815|NCT04377997|Heparin|heparin|mesh-list
24674816|NCT04377997|Calcium heparin|calcium heparin|mesh-list
24674817|NCT04377997|Enoxaparin|enoxaparin|mesh-list
24674818|NCT04377997|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24674819|NCT04377997|Tinzaparin|tinzaparin|mesh-list
24674820|NCT04377997|Dalteparin|dalteparin|mesh-list
24674821|NCT04377997|Anticoagulants|anticoagulants|mesh-ancestor
24854090|NCT02271893|Dextromethorphan|dextromethorphan|mesh-list
24854091|NCT02271893|Antitussive Agents|antitussive agents|mesh-ancestor
25260565|NCT02457650|Immunologic Factors|immunologic factors|mesh-ancestor
25260566|NCT02457650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260567|NCT02457650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25260568|NCT02457650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25260569|NCT02457650|Alkylating Agents|alkylating agents|mesh-ancestor
25260570|NCT02457650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260571|NCT02457650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25260572|NCT02457650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25260574|NCT02457806|Oxymetazoline|oxymetazoline|mesh-list
25260575|NCT02457806|Tetracaine|tetracaine|mesh-list
25260576|NCT02457806|Anesthetics, Local|anesthetics, local|mesh-ancestor
25260577|NCT02457806|Anesthetics|anesthetics|mesh-ancestor
25260578|NCT02457806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25260579|NCT02457806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260580|NCT02457806|Sensory System Agents|sensory system agents|mesh-ancestor
25260581|NCT02457806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25260582|NCT02457806|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25260583|NCT02457806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25260584|NCT02457806|Adrenergic Agents|adrenergic agents|mesh-ancestor
25260585|NCT02457806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25260586|NCT02457806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260587|NCT02457806|Sympathomimetics|sympathomimetics|mesh-ancestor
24932359|NCT04080349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24932360|NCT04080349|Abortifacient Agents|abortifacient agents|mesh-ancestor
24932361|NCT04080349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24416118|NCT00202020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24416119|NCT00202020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24416120|NCT00202020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416121|NCT00202020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24416123|NCT00202020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24932362|NCT04080349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932363|NCT04080349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24932364|NCT04080349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24932366|NCT04080323|Dinoprostone|dinoprostone|mesh-list
24932367|NCT04080323|Oxytocics|oxytocics|mesh-ancestor
24932368|NCT04080323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24932369|NCT04080323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854092|NCT02271893|Respiratory System Agents|respiratory system agents|mesh-ancestor
24674822|NCT04377997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24674823|NCT04377997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24667343|NCT05459441|Pemetrexed|pemetrexed|mesh-list
24674824|NCT04377997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674877|NCT04091022|Diclofenac|diclofenac|mesh-list
24674962|NCT03740958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674963|NCT03740958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674964|NCT03740958|Anticoagulants|anticoagulants|mesh-ancestor
24674965|NCT03740958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24674966|NCT03711318|Buprenorphine|buprenorphine|mesh-list
24674967|NCT03711318|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
24674968|NCT03711318|Naloxone|naloxone|mesh-list
24674969|NCT03711318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24674970|NCT03711318|Narcotics|narcotics|mesh-ancestor
24674971|NCT03711318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24674972|NCT03711318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674973|NCT03711318|Analgesics|analgesics|mesh-ancestor
24674974|NCT03711318|Sensory System Agents|sensory system agents|mesh-ancestor
24674975|NCT03711318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24674976|NCT03711318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24674977|NCT03685188|Sufentanil|sufentanil|mesh-list
24854100|NCT02271958|Abortifacient Agents|abortifacient agents|mesh-ancestor
24854101|NCT02271958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24854102|NCT02271958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854103|NCT02271958|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24854104|NCT02271958|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24854105|NCT02271958|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24854106|NCT02271958|Contraceptive Agents|contraceptive agents|mesh-ancestor
24854107|NCT02271958|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24854108|NCT02271958|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24812573|NCT02053597|Tubulin Modulators|tubulin modulators|mesh-ancestor
24675148|NCT03004131|Histamine Agents|histamine agents|mesh-ancestor
24675149|NCT03004131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24675150|NCT03004131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675151|NCT03004131|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24675152|NCT03004131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675153|NCT02959944|Prednisone|prednisone|mesh-list
24675154|NCT02959944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24675197|NCT02855697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675198|NCT02855697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24675199|NCT02855697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24675200|NCT02710097|Ethanol|ethanol|mesh-list
24675201|NCT02710097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24675220|NCT02709954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675222|NCT02709954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24675223|NCT02681549|Bevacizumab|bevacizumab|mesh-list
24675224|NCT02681549|Pembrolizumab|pembrolizumab|mesh-list
24675225|NCT02681549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24675226|NCT02681549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24675236|NCT02562599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24675237|NCT02562599|Antimetabolites|antimetabolites|mesh-ancestor
25260588|NCT02457806|Autonomic Agents|autonomic agents|mesh-ancestor
25260589|NCT02457806|Nasal Decongestants|nasal decongestants|mesh-ancestor
25260590|NCT02457806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25688154|NCT01942148|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25688155|NCT01942161|Aripiprazole|aripiprazole|mesh-list
25688156|NCT01942161|Antidepressive Agents|antidepressive agents|mesh-ancestor
25688157|NCT01942161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25688158|NCT01942161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25688159|NCT01942161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24801233|NCT01981941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24416527|NCT00203359|Analgesics|analgesics|mesh-ancestor
24416528|NCT00203359|Sensory System Agents|sensory system agents|mesh-ancestor
24416529|NCT00203359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24416530|NCT00203359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416531|NCT00203359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24416532|NCT00203359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24416713|NCT00203788|Dopamine Agents|dopamine agents|mesh-ancestor
24416715|NCT00203801|Lumefantrine|lumefantrine|mesh-list
24416716|NCT00203801|Artemether|artemether|mesh-list
24687860|NCT03620942|Ephedrine|ephedrine|mesh-list
25260591|NCT02457806|Respiratory System Agents|respiratory system agents|mesh-ancestor
25260592|NCT02457806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25260593|NCT02457806|Mydriatics|mydriatics|mesh-ancestor
25260594|NCT02457806|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25260595|NCT02457806|Protective Agents|protective agents|mesh-ancestor
25260596|NCT02457585|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
25260597|NCT02457585|Infliximab|infliximab|mesh-list
25260598|NCT02457585|Dermatologic Agents|dermatologic agents|mesh-ancestor
25260599|NCT02457585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24932370|NCT04080336|Misoprostol|misoprostol|mesh-list
24932371|NCT04080336|Dinoprostone|dinoprostone|mesh-list
24932372|NCT04080336|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24932373|NCT04080336|Abortifacient Agents|abortifacient agents|mesh-ancestor
24932374|NCT04080336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24932375|NCT04080336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932376|NCT04080336|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24932377|NCT04080336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24936035|NCT04045093|Anticoagulants|anticoagulants|mesh-ancestor
24936036|NCT04045093|Antithrombins|antithrombins|mesh-ancestor
24936037|NCT04045093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24936038|NCT04045093|Protease Inhibitors|protease inhibitors|mesh-ancestor
24936039|NCT04045093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24936040|NCT04045093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936041|NCT04044976|Caffeine|caffeine|mesh-list
24667344|NCT05459441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24667345|NCT05459441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675238|NCT02562599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675274|NCT01431508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24675275|NCT01431508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24637773|NCT01152931|Anthelmintics|anthelmintics|mesh-ancestor
24675276|NCT01431508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24675277|NCT01431508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24675278|NCT01431508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675279|NCT00871351|Atorvastatin|atorvastatin|mesh-list
24675280|NCT00871351|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24675281|NCT00871351|Ezetimibe|ezetimibe|mesh-list
24675282|NCT00871351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24675284|NCT00871351|Antimetabolites|antimetabolites|mesh-ancestor
24675285|NCT00871351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675286|NCT00871351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24675287|NCT00871351|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24675288|NCT00871351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675289|NCT00832455|Montelukast|montelukast|mesh-list
24675290|NCT00832455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24675291|NCT00832455|Respiratory System Agents|respiratory system agents|mesh-ancestor
24610655|NCT01004380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610656|NCT01004419|Fulvestrant|fulvestrant|mesh-list
24812579|NCT02053597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24610719|NCT01004601|Antimitotic Agents|antimitotic agents|mesh-ancestor
24610720|NCT01004601|Mitosis Modulators|mitosis modulators|mesh-ancestor
24675292|NCT00832455|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24675293|NCT00832455|Hormone Antagonists|hormone antagonists|mesh-ancestor
24675294|NCT00832455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24675295|NCT00832455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688160|NCT01942161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25688161|NCT01942161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688162|NCT01942161|Dopamine Agonists|dopamine agonists|mesh-ancestor
25688163|NCT01942161|Dopamine Agents|dopamine agents|mesh-ancestor
25688164|NCT01942161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25688165|NCT01942161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688166|NCT01942161|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25688167|NCT01942161|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24946934|NCT03933787|Saxagliptin|saxagliptin|mesh-list
24946935|NCT03933787|Incretins|incretins|mesh-ancestor
24946936|NCT03933787|Hormones|hormones|mesh-ancestor
24418081|NCT00208546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24418082|NCT00208546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24418983|NCT00210756|Epoetin Alfa|epoetin alfa|mesh-list
24675296|NCT00832455|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24675297|NCT00832455|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24675298|NCT00832455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675299|NCT00812006|Rizatriptan|rizatriptan|mesh-list
24675300|NCT00812006|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24675301|NCT00812006|Serotonin Agents|serotonin agents|mesh-ancestor
24675325|NCT00654628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675326|NCT00604812|Rizatriptan|rizatriptan|mesh-list
25260600|NCT02457585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25260601|NCT02457585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25260603|NCT02457507|Hydroxocobalamin|hydroxocobalamin|mesh-list
25260604|NCT02457507|Vitamins|vitamins|mesh-ancestor
25260605|NCT02457507|Micronutrients|micronutrients|mesh-ancestor
25260606|NCT02457507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260607|NCT02457507|Vitamin B Complex|vitamin b complex|mesh-ancestor
25260608|NCT02457507|Hematinics|hematinics|mesh-ancestor
25260609|NCT02457286|Metformin|metformin|mesh-list
25260610|NCT02457286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25260611|NCT02457286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260612|NCT02457351|Itraconazole|itraconazole|mesh-list
25260613|NCT02457351|Antifungal Agents|antifungal agents|mesh-ancestor
25260614|NCT02457351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25260615|NCT02457351|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25260616|NCT02457351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25260617|NCT02457351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25260618|NCT02457351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932378|NCT04080336|Oxytocics|oxytocics|mesh-ancestor
24932380|NCT04080310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
24932381|NCT04080310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24932382|NCT04080310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24932383|NCT04080310|Antimetabolites|antimetabolites|mesh-ancestor
24932391|NCT04080869|Keratolytic Agents|keratolytic agents|mesh-ancestor
24932392|NCT04080869|Dermatologic Agents|dermatologic agents|mesh-ancestor
24932394|NCT04080869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932395|NCT04080869|Protective Agents|protective agents|mesh-ancestor
24932396|NCT04080869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932397|NCT04080869|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24932398|NCT04080869|Vitamins|vitamins|mesh-ancestor
24932399|NCT04080869|Micronutrients|micronutrients|mesh-ancestor
24932400|NCT04079933|Nicotine|nicotine|mesh-list
24932401|NCT04079933|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24932402|NCT04079933|Autonomic Agents|autonomic agents|mesh-ancestor
24932405|NCT04079933|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24932406|NCT04079933|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24675327|NCT00604812|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24675328|NCT00604812|Serotonin Agents|serotonin agents|mesh-ancestor
24675329|NCT00604812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24675330|NCT00604812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675331|NCT00604812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675332|NCT00536380|Loratadine|loratadine|mesh-list
24675333|NCT00536380|Desloratadine|desloratadine|mesh-list
24675382|NCT00442897|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24675383|NCT00442897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675384|NCT00423579|Simvastatin|simvastatin|mesh-list
24675385|NCT00423579|Ezetimibe|ezetimibe|mesh-list
24675386|NCT00423579|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
24675387|NCT00423579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24675388|NCT00423579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24675389|NCT00423579|Antimetabolites|antimetabolites|mesh-ancestor
24675390|NCT00423579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675391|NCT00423579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25688168|NCT01942161|Serotonin Agents|serotonin agents|mesh-ancestor
25688169|NCT01942161|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25688170|NCT01942161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25688171|NCT01942161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25688172|NCT01942161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24675392|NCT00423579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24812586|NCT02053675|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24812587|NCT02053675|Natriuretic Agents|natriuretic agents|mesh-ancestor
25404315|NCT03674242|Gemcitabine|gemcitabine|mesh-list
24812588|NCT02053675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812590|NCT02053727|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24675396|NCT00394355|Mometasone Furoate|mometasone furoate|mesh-list
24675397|NCT00394355|Montelukast|montelukast|mesh-list
24675398|NCT00394355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24675399|NCT00394355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24675444|NCT01343186|Antiviral Agents|antiviral agents|mesh-ancestor
24675445|NCT01343186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24675446|NCT01343186|Immunologic Factors|immunologic factors|mesh-ancestor
24675447|NCT01343186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675448|NCT01343225|Ritonavir|ritonavir|mesh-list
24675449|NCT01343225|Darunavir|darunavir|mesh-list
24675450|NCT01343225|Raltegravir Potassium|raltegravir potassium|mesh-list
24675451|NCT01343225|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25260619|NCT02457351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25260620|NCT02457351|Hormone Antagonists|hormone antagonists|mesh-ancestor
25260621|NCT02457351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25260622|NCT02457351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260625|NCT02457442|Propofol|propofol|mesh-list
25260626|NCT02457442|Sevoflurane|sevoflurane|mesh-list
25260627|NCT02457442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25260628|NCT02457442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25260629|NCT02457442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260630|NCT02457442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25260631|NCT02457442|Anesthetics, General|anesthetics, general|mesh-ancestor
25260632|NCT02457442|Anesthetics|anesthetics|mesh-ancestor
25260633|NCT02457442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25260634|NCT02457442|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25260635|NCT02457442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25260636|NCT02457442|Narcotics|narcotics|mesh-ancestor
25260637|NCT02457442|Analgesics|analgesics|mesh-ancestor
25260638|NCT02457442|Sensory System Agents|sensory system agents|mesh-ancestor
24932408|NCT04079933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24932409|NCT04079933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625144|NCT01080612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24625146|NCT01080638|polysaccharide-K|polysaccharide-k|mesh-list
24625147|NCT01080638|Abciximab|abciximab|mesh-list
24625148|NCT01080638|Anticoagulants|anticoagulants|mesh-ancestor
24625149|NCT01080638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24625150|NCT01080638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24625151|NCT01080638|Immunologic Factors|immunologic factors|mesh-ancestor
24529711|NCT00627666|Fludarabine phosphate|fludarabine phosphate|mesh-list
24529712|NCT00627666|Fludarabine|fludarabine|mesh-list
24529714|NCT00627666|Calcium|calcium|mesh-list
24529715|NCT00627666|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24529716|NCT00627666|Levoleucovorin|levoleucovorin|mesh-list
24625152|NCT01080638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625153|NCT01080638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24625154|NCT01080638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24625155|NCT01080638|Antiviral Agents|antiviral agents|mesh-ancestor
24625157|NCT01080638|Interferon Inducers|interferon inducers|mesh-ancestor
24625158|NCT01080638|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24625159|NCT01080638|Protective Agents|protective agents|mesh-ancestor
24625160|NCT01080651|Voriconazole|voriconazole|mesh-list
24625161|NCT01080651|Antifungal Agents|antifungal agents|mesh-ancestor
24625162|NCT01080651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24625163|NCT01080651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24932418|NCT04079517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24932419|NCT04079517|Hormone Antagonists|hormone antagonists|mesh-ancestor
24932420|NCT04079517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24932421|NCT04079517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675452|NCT01343225|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24675453|NCT01343225|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24675454|NCT01343225|Protease Inhibitors|protease inhibitors|mesh-ancestor
24675455|NCT01343225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675481|NCT01343303|Gout Suppressants|gout suppressants|mesh-ancestor
24675482|NCT01343303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24675483|NCT01343303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675536|NCT01343862|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24675537|NCT01343862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24675538|NCT01343862|Renal Agents|renal agents|mesh-ancestor
24675539|NCT01343862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24675540|NCT01343862|Antitubercular Agents|antitubercular agents|mesh-ancestor
25260639|NCT02457442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25260640|NCT02457312|Letrozole|letrozole|mesh-list
25260641|NCT02457312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420474|NCT00216138|Docetaxel|docetaxel|mesh-list
25260642|NCT02457312|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25260643|NCT02457312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25260644|NCT02457312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25260645|NCT02457312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857634|NCT02293148|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24857635|NCT02293148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25260646|NCT02457312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25260647|NCT02457312|Hormone Antagonists|hormone antagonists|mesh-ancestor
25260648|NCT02457312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25260649|NCT02457312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260650|NCT02457208|Rifampin|rifampin|mesh-list
25260651|NCT02457208|Isoniazid|isoniazid|mesh-list
25260652|NCT02457208|Pyrazinamide|pyrazinamide|mesh-list
25260653|NCT02457208|Ethambutol|ethambutol|mesh-list
25260654|NCT02457208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25260655|NCT02457208|Antitubercular Agents|antitubercular agents|mesh-ancestor
25260656|NCT02457208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25260657|NCT02457208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25260658|NCT02457208|Leprostatic Agents|leprostatic agents|mesh-ancestor
25260659|NCT02457208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25260660|NCT02457208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25260661|NCT02457208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260662|NCT02457208|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25260663|NCT02457208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25260664|NCT02457208|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25260665|NCT02457208|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25260666|NCT02457208|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25260667|NCT02457208|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24932422|NCT04079517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24932423|NCT04079517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24932424|NCT04079517|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24932425|NCT04079517|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24932426|NCT04079517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24932430|NCT04079582|Dialysis Solutions|dialysis solutions|mesh-list
24932431|NCT04079582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24675542|NCT01343862|Antimetabolites|antimetabolites|mesh-ancestor
24675543|NCT01343862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675544|NCT01344031|Fulvestrant|fulvestrant|mesh-list
24675545|NCT01344031|Anastrozole|anastrozole|mesh-list
24675546|NCT01344031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24675547|NCT01344031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24675548|NCT01344031|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24675549|NCT01344031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24675550|NCT01344031|Hormone Antagonists|hormone antagonists|mesh-ancestor
24675551|NCT01344031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24675552|NCT01344031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675553|NCT01344031|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24675554|NCT01344031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24675555|NCT01344031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812608|NCT02053766|Sensory System Agents|sensory system agents|mesh-ancestor
24812609|NCT02053766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812610|NCT02053766|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24812611|NCT02053766|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24812612|NCT02053766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24812613|NCT02053766|Adrenergic Agents|adrenergic agents|mesh-ancestor
24812614|NCT02053766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24675607|NCT01344213|Celecoxib|celecoxib|mesh-list
24675654|NCT01344304|Fosaprepitant|fosaprepitant|mesh-list
24675655|NCT01344304|Antiemetics|antiemetics|mesh-ancestor
24675656|NCT01344304|Autonomic Agents|autonomic agents|mesh-ancestor
24675657|NCT01344304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24675658|NCT01344304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675659|NCT01344304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24675660|NCT01344304|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24675661|NCT01344304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24675662|NCT01344304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610742|NCT01004731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260668|NCT02457208|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25688173|NCT01942590|Clenbuterol|clenbuterol|mesh-list
25260669|NCT02457208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25260670|NCT02457208|Antimetabolites|antimetabolites|mesh-ancestor
25260671|NCT02457208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25260672|NCT02456961|Riboflavin|riboflavin|mesh-list
25260673|NCT02456961|Vitamin B Complex|vitamin b complex|mesh-ancestor
25260674|NCT02456961|Vitamins|vitamins|mesh-ancestor
25260675|NCT02456961|Micronutrients|micronutrients|mesh-ancestor
25260676|NCT02456961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260677|NCT02456961|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25260678|NCT02456961|Dermatologic Agents|dermatologic agents|mesh-ancestor
25260679|NCT02456974|Amoxicillin|amoxicillin|mesh-list
25260680|NCT02456974|Vancomycin|vancomycin|mesh-list
25260681|NCT02456974|Ciprofloxacin|ciprofloxacin|mesh-list
25260682|NCT02456974|Meropenem|meropenem|mesh-list
25260683|NCT02456974|Tazobactam|tazobactam|mesh-list
25260684|NCT02456974|Clavulanic Acid|clavulanic acid|mesh-list
25260685|NCT02456974|Amikacin|amikacin|mesh-list
25260686|NCT02456974|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25260687|NCT02456974|Teicoplanin|teicoplanin|mesh-list
25260688|NCT02456974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25260689|NCT02456974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24932450|NCT04079426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932471|NCT04079374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24610743|NCT01004731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24610745|NCT01004809|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24610746|NCT01004809|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24610747|NCT01004809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610748|NCT01004809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610749|NCT01004809|Hormone Antagonists|hormone antagonists|mesh-ancestor
24675698|NCT01344512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24675699|NCT01344512|Hormone Antagonists|hormone antagonists|mesh-ancestor
24675700|NCT01344512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24675701|NCT01344512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675702|NCT01344512|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24535040|NCT00648440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24675704|NCT01344564|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24675706|NCT01344564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24812616|NCT02053766|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24675707|NCT01344564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675814|NCT01345448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24675815|NCT01345448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675816|NCT01345448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675817|NCT01345604|Ropivacaine|ropivacaine|mesh-list
24675818|NCT01345604|Anesthetics, Local|anesthetics, local|mesh-ancestor
24675819|NCT01345604|Anesthetics|anesthetics|mesh-ancestor
24675820|NCT01345604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24675843|NCT01345708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24675844|NCT01345708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24675845|NCT01345734|Liraglutide|liraglutide|mesh-list
24675846|NCT01345734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24675847|NCT01345734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675848|NCT01345734|Incretins|incretins|mesh-ancestor
24675850|NCT01345734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24675851|NCT01345851|Paclitaxel|paclitaxel|mesh-list
24675853|NCT01345851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24675854|NCT01345851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812617|NCT02053766|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24812618|NCT02053779|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24675855|NCT01345851|Tubulin Modulators|tubulin modulators|mesh-ancestor
24675856|NCT01345851|Antimitotic Agents|antimitotic agents|mesh-ancestor
24675857|NCT01345851|Mitosis Modulators|mitosis modulators|mesh-ancestor
24675905|NCT01346137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25260690|NCT02456974|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25260691|NCT02456974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25260692|NCT02456974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25260693|NCT02456974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260694|NCT02456974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25260695|NCT02456974|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25260696|NCT02456974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25260697|NCT02456974|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25260698|NCT02457130|Clopidogrel|clopidogrel|mesh-list
25260699|NCT02457130|Ticagrelor|ticagrelor|mesh-list
25260700|NCT02457130|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25260701|NCT02457130|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25260702|NCT02457130|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25260703|NCT02457130|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25260704|NCT02457130|Purinergic Agents|purinergic agents|mesh-ancestor
24932474|NCT04079374|Sensory System Agents|sensory system agents|mesh-ancestor
24932475|NCT04079374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24932476|NCT04079374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932478|NCT04079374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24932495|NCT04079088|Immunologic Factors|immunologic factors|mesh-ancestor
24756871|NCT01736371|Propofol|propofol|mesh-list
24932496|NCT04079088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932497|NCT04079088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24932498|NCT04079088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24932499|NCT04079088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24932500|NCT04079140|Dinoprostone|dinoprostone|mesh-list
24932501|NCT04079140|Oxytocics|oxytocics|mesh-ancestor
24932502|NCT04079140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24932503|NCT04079140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050177|NCT00535366|Hormones|hormones|mesh-ancestor
24675906|NCT01346137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675907|NCT01346215|Heparin|heparin|mesh-list
24675908|NCT01346215|Calcium heparin|calcium heparin|mesh-list
24675909|NCT01346215|Anticoagulants|anticoagulants|mesh-ancestor
24675910|NCT01346215|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24675911|NCT01346215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24675912|NCT01346215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675913|NCT01346254|Pioglitazone|pioglitazone|mesh-list
24675914|NCT01346254|Vildagliptin|vildagliptin|mesh-list
24675915|NCT01346254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24675916|NCT01346254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903624|NCT04362332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24675945|NCT01346826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24675946|NCT01346826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24675947|NCT01346865|Cilostazol|cilostazol|mesh-list
24675948|NCT01346865|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24675949|NCT01346865|Autonomic Agents|autonomic agents|mesh-ancestor
24675950|NCT01346865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24675951|NCT01346865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675952|NCT01346865|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24812619|NCT02053779|Luteolytic Agents|luteolytic agents|mesh-ancestor
24812620|NCT02053779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24854109|NCT02271958|Hormone Antagonists|hormone antagonists|mesh-ancestor
24675959|NCT01346865|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24675960|NCT01346865|Protective Agents|protective agents|mesh-ancestor
24675961|NCT01346865|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24675962|NCT01346865|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24675963|NCT01346865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675964|NCT01346917|Lidocaine|lidocaine|mesh-list
24675965|NCT01346917|Anesthetics, Local|anesthetics, local|mesh-ancestor
24675966|NCT01346917|Anesthetics|anesthetics|mesh-ancestor
24675967|NCT01346917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24675968|NCT01346917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675969|NCT01346917|Sensory System Agents|sensory system agents|mesh-ancestor
24675970|NCT01346917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24675971|NCT01346917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24675972|NCT01346917|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24675973|NCT01346917|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24675974|NCT01346917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24675975|NCT01346917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675976|NCT01346930|Macitentan|macitentan|mesh-list
24675978|NCT01346930|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24676027|NCT01347853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24676028|NCT01347853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25260705|NCT02457130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25260706|NCT02457130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260707|NCT02457130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260708|NCT02456935|Esomeprazole|esomeprazole|mesh-list
25260709|NCT02456935|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25404316|NCT03674242|Carboplatin|carboplatin|mesh-list
24422565|NCT00222976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25260710|NCT02456935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25260711|NCT02456935|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25260712|NCT02456935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25260713|NCT02456935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260714|NCT02457039|Cyclophosphamide|cyclophosphamide|mesh-list
25260715|NCT02457039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25260716|NCT02457039|Immunologic Factors|immunologic factors|mesh-ancestor
25260717|NCT02457039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260718|NCT02457039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24932504|NCT04078724|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
24932505|NCT04078724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24932506|NCT04078724|Antidepressive Agents|antidepressive agents|mesh-ancestor
24932507|NCT04078724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24932509|NCT04078711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24932511|NCT04078711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24932512|NCT04078711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24932513|NCT04078711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676030|NCT01347853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676031|NCT01347853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676033|NCT01347944|Immunologic Factors|immunologic factors|mesh-ancestor
24676045|NCT01347957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24676046|NCT01347957|Respiratory System Agents|respiratory system agents|mesh-ancestor
24676047|NCT01347957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24676048|NCT01347957|Antioxidants|antioxidants|mesh-ancestor
24676049|NCT01347957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676050|NCT01347957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24676051|NCT01347957|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24903723|NCT04361279|Rituximab|rituximab|mesh-list
24610779|NCT01005121|Mitosis Modulators|mitosis modulators|mesh-ancestor
24610780|NCT01005121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610781|NCT01005121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610782|NCT01005147|Tranexamic Acid|tranexamic acid|mesh-list
24610783|NCT01005147|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24610784|NCT01005147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24676137|NCT01348321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24676138|NCT01348321|Immunologic Factors|immunologic factors|mesh-ancestor
24676139|NCT01348321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676140|NCT01348321|Antinematodal Agents|antinematodal agents|mesh-ancestor
24676141|NCT01348321|Anthelmintics|anthelmintics|mesh-ancestor
24676142|NCT01348321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24676143|NCT01348321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24676144|NCT01348321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24676145|NCT01348412|Oxaliplatin|oxaliplatin|mesh-list
24676146|NCT01348412|Raltitrexed|raltitrexed|mesh-list
24676147|NCT01348412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24676148|NCT01348412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24676149|NCT01348412|Antimetabolites|antimetabolites|mesh-ancestor
24676150|NCT01348412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676151|NCT01348412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24676152|NCT01348412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676153|NCT01348503|Lenalidomide|lenalidomide|mesh-list
24676154|NCT01348503|Sorafenib|sorafenib|mesh-list
24676155|NCT01348503|Immunologic Factors|immunologic factors|mesh-ancestor
24676156|NCT01348503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676157|NCT01348503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24676202|NCT01349088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24676203|NCT01349088|Antimetabolites|antimetabolites|mesh-ancestor
24676204|NCT01349088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676205|NCT01349088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24676206|NCT01349088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24676207|NCT01349088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676208|NCT01349088|Vitamin B Complex|vitamin b complex|mesh-ancestor
24676209|NCT01349088|Vitamins|vitamins|mesh-ancestor
24676210|NCT01349088|Micronutrients|micronutrients|mesh-ancestor
24676211|NCT01349088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676212|NCT01349127|Calcium, Dietary|calcium, dietary|mesh-list
24676213|NCT01349127|Vitamin D|vitamin d|mesh-list
24676214|NCT01349127|Ergocalciferols|ergocalciferols|mesh-list
25260719|NCT02457039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25260720|NCT02457039|Alkylating Agents|alkylating agents|mesh-ancestor
25688174|NCT01942590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25688175|NCT01942590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24423085|NCT00224588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25260721|NCT02457039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260722|NCT02457039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25260723|NCT02457039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25260724|NCT02457026|Triamcinolone|triamcinolone|mesh-list
25260725|NCT02457026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25260726|NCT02457026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25260727|NCT02457026|Aflibercept|aflibercept|mesh-list
25260728|NCT02457026|Verteporfin|verteporfin|mesh-list
24932515|NCT04078659|Magnesium Sulfate|magnesium sulfate|mesh-list
24932516|NCT04078659|Fentanyl|fentanyl|mesh-list
24932517|NCT04078659|Propofol|propofol|mesh-list
24932518|NCT04078659|Atracurium|atracurium|mesh-list
24932519|NCT04078659|Anesthetics, Local|anesthetics, local|mesh-ancestor
24932520|NCT04078659|Anesthetics|anesthetics|mesh-ancestor
24763999|NCT01778842|Clopidogrel|clopidogrel|mesh-list
24676216|NCT01349127|Vitamins|vitamins|mesh-list
24676217|NCT01349127|Calcium|calcium|mesh-list
24676312|NCT01349452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854128|NCT02272049|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24854129|NCT02272049|Anesthetics, General|anesthetics, general|mesh-ancestor
24676314|NCT01349452|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24676315|NCT01349556|Tretinoin|tretinoin|mesh-list
24676316|NCT01349556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24676381|NCT01349777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676410|NCT01350024|Mydriatics|mydriatics|mesh-ancestor
24676411|NCT01350024|Sympathomimetics|sympathomimetics|mesh-ancestor
24676412|NCT01350024|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24676413|NCT01350037|Remifentanil|remifentanil|mesh-list
24676414|NCT01350037|Alfentanil|alfentanil|mesh-list
24676415|NCT01350037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24676416|NCT01350037|Narcotics|narcotics|mesh-ancestor
24676417|NCT01350037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24676418|NCT01350037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676419|NCT01350037|Analgesics|analgesics|mesh-ancestor
24676420|NCT01350037|Sensory System Agents|sensory system agents|mesh-ancestor
24676421|NCT01350037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24676422|NCT01350037|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24676506|NCT01350622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676507|NCT01350622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676508|NCT01350713|Povidone-Iodine|povidone-iodine|mesh-list
24676509|NCT01350713|Povidone|povidone|mesh-list
24676510|NCT01350713|Plasma Substitutes|plasma substitutes|mesh-ancestor
24676511|NCT01350713|Blood Substitutes|blood substitutes|mesh-ancestor
24637865|NCT01153568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24676512|NCT01350713|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24676513|NCT01350713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24676514|NCT01350817|Docetaxel|docetaxel|mesh-list
24676515|NCT01350817|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24676516|NCT01350817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610795|NCT01005199|Immunologic Factors|immunologic factors|mesh-ancestor
24610796|NCT01005199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610797|NCT01005199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24676543|NCT01350882|Chelating Agents|chelating agents|mesh-ancestor
24676544|NCT01350882|Sequestering Agents|sequestering agents|mesh-ancestor
24676545|NCT01350882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676546|NCT01350921|Ticagrelor|ticagrelor|mesh-list
24676547|NCT01350921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24676548|NCT01350921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24676549|NCT01350921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24676550|NCT01350921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24676551|NCT01350921|Purinergic Agents|purinergic agents|mesh-ancestor
24676552|NCT01350921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24676553|NCT01350921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676554|NCT01350921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676555|NCT01351038|Capecitabine|capecitabine|mesh-list
24676556|NCT01351038|Oxaliplatin|oxaliplatin|mesh-list
24676557|NCT01351038|Panitumumab|panitumumab|mesh-list
24676558|NCT01351038|Epirubicin|epirubicin|mesh-list
24676559|NCT01351038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24676560|NCT01351038|Antimetabolites|antimetabolites|mesh-ancestor
24676561|NCT01351038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676562|NCT01351038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688176|NCT01942590|Adrenergic Agents|adrenergic agents|mesh-ancestor
24676563|NCT01351038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24903971|NCT04359615|Antimalarials|antimalarials|mesh-ancestor
24854136|NCT02272101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260729|NCT02457026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25260730|NCT02457026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25260731|NCT02457026|Glucocorticoids|glucocorticoids|mesh-ancestor
25260732|NCT02457026|Hormones|hormones|mesh-ancestor
25260733|NCT02457026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25260734|NCT02457026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932521|NCT04078659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24932522|NCT04078659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932523|NCT04078659|Sensory System Agents|sensory system agents|mesh-ancestor
24932524|NCT04078659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24932525|NCT04078659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24932526|NCT04078659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24932527|NCT04078659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24932536|NCT04078659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24932537|NCT04078659|Anticonvulsants|anticonvulsants|mesh-ancestor
24932538|NCT04078659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24932539|NCT04078659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24932540|NCT04078659|Tocolytic Agents|tocolytic agents|mesh-ancestor
24932541|NCT04078659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24932542|NCT04078659|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24932543|NCT04078659|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24932544|NCT04078659|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24932545|NCT04078659|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24932546|NCT04078659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24932547|NCT04078659|Cholinergic Agents|cholinergic agents|mesh-ancestor
24932548|NCT04078659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24932549|NCT04078880|Ascorbic Acid|ascorbic acid|mesh-list
24932550|NCT04078880|Antioxidants|antioxidants|mesh-ancestor
24932551|NCT04078880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932552|NCT04078880|Protective Agents|protective agents|mesh-ancestor
24932553|NCT04078880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932554|NCT04078880|Vitamins|vitamins|mesh-ancestor
24932564|NCT04078399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508894|NCT00557700|Tiotropium Bromide|tiotropium bromide|mesh-list
24508895|NCT00557700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24508896|NCT00557700|Autonomic Agents|autonomic agents|mesh-ancestor
24508897|NCT00557700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24508898|NCT00557700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854137|NCT02272101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24854139|NCT02272166|Sevoflurane|sevoflurane|mesh-list
24854140|NCT02272166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24854141|NCT02272166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24854142|NCT02272166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854143|NCT02272166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24676597|NCT01351285|Sensory System Agents|sensory system agents|mesh-ancestor
24676598|NCT01351285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25260735|NCT02457026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25260736|NCT02457026|Immunologic Factors|immunologic factors|mesh-ancestor
25260737|NCT02457026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25260738|NCT02457026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260739|NCT02457026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25260740|NCT02457026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25260741|NCT02457026|Growth Substances|growth substances|mesh-ancestor
25260742|NCT02457026|Growth Inhibitors|growth inhibitors|mesh-ancestor
25260743|NCT02457026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25260744|NCT02457026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25260745|NCT02457026|Dermatologic Agents|dermatologic agents|mesh-ancestor
25260746|NCT02456948|Minocycline|minocycline|mesh-list
25260747|NCT02456948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25260748|NCT02456948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25260749|NCT02456844|Leucovorin|leucovorin|mesh-list
25260750|NCT02456844|Flurbiprofen|flurbiprofen|mesh-list
24535370|NCT00649051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24535371|NCT00649051|Diuretics|diuretics|mesh-ancestor
24705253|NCT01483274|Immunologic Factors|immunologic factors|mesh-ancestor
24705255|NCT01483300|Cisplatin|cisplatin|mesh-list
25260751|NCT02456844|Methotrexate|methotrexate|mesh-list
25260752|NCT02456844|Digoxin|digoxin|mesh-list
25260753|NCT02456844|Midazolam|midazolam|mesh-list
25260754|NCT02456844|Pravastatin|pravastatin|mesh-list
25260755|NCT02456844|Montelukast|montelukast|mesh-list
25260756|NCT02456844|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25260757|NCT02456844|Abortifacient Agents|abortifacient agents|mesh-ancestor
25260758|NCT02456844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25260759|NCT02456844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404317|NCT03674242|Asparaginase|asparaginase|mesh-list
25260760|NCT02456844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25260761|NCT02456844|Antimetabolites|antimetabolites|mesh-ancestor
25260762|NCT02456844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260763|NCT02456844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25260764|NCT02456844|Dermatologic Agents|dermatologic agents|mesh-ancestor
25260765|NCT02456844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25260766|NCT02456844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25260767|NCT02456844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25260768|NCT02456844|Immunologic Factors|immunologic factors|mesh-ancestor
24508899|NCT00557700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24508901|NCT00557700|Parasympatholytics|parasympatholytics|mesh-ancestor
24932565|NCT04078425|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
24932566|NCT04078425|Hormone Antagonists|hormone antagonists|mesh-ancestor
24625518|NCT01082289|Dopamine Agents|dopamine agents|mesh-ancestor
24676600|NCT01351298|Xylometazoline|xylometazoline|mesh-list
24676601|NCT01351298|Anesthetics, Local|anesthetics, local|mesh-ancestor
24676602|NCT01351298|Anesthetics|anesthetics|mesh-ancestor
24676603|NCT01351298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24676604|NCT01351298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676605|NCT01351298|Sensory System Agents|sensory system agents|mesh-ancestor
24676606|NCT01351298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24676607|NCT01351298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24676635|NCT01351493|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24676636|NCT01351493|Vasodilator Agents|vasodilator agents|mesh-ancestor
24676658|NCT01351792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24676659|NCT01351792|Respiratory System Agents|respiratory system agents|mesh-ancestor
24676661|NCT01351818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24676662|NCT01351818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676663|NCT01351948|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24676664|NCT01351948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24676665|NCT01351948|Immunologic Factors|immunologic factors|mesh-ancestor
24676666|NCT01351948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676767|NCT01352494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24676768|NCT01352494|Immunologic Factors|immunologic factors|mesh-ancestor
24676769|NCT01352494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676770|NCT01352494|Tubulin Modulators|tubulin modulators|mesh-ancestor
24676771|NCT01352494|Antimitotic Agents|antimitotic agents|mesh-ancestor
24676772|NCT01352494|Mitosis Modulators|mitosis modulators|mesh-ancestor
24676773|NCT01352559|Milnacipran|milnacipran|mesh-list
24676774|NCT01352559|Mirtazapine|mirtazapine|mesh-list
24676775|NCT01352559|Sertraline|sertraline|mesh-list
24676776|NCT01352559|Fluoxetine|fluoxetine|mesh-list
24676777|NCT01352559|Paroxetine|paroxetine|mesh-list
24676778|NCT01352559|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24676779|NCT01352559|Nortriptyline|nortriptyline|mesh-list
24676780|NCT01352559|Antidepressive Agents|antidepressive agents|mesh-ancestor
24676781|NCT01352559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24904106|NCT04358796|Perflubron|perflubron|mesh-list
24854172|NCT02272517|Citalopram|citalopram|mesh-list
24854173|NCT02272517|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24854174|NCT02272517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24854175|NCT02272517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24456869|NCT00332436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24456872|NCT00332540|Timolol|timolol|mesh-list
24676805|NCT01352559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24676806|NCT01352559|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24676807|NCT01352559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24676808|NCT01352559|Analgesics|analgesics|mesh-ancestor
24676809|NCT01352559|Sensory System Agents|sensory system agents|mesh-ancestor
24676810|NCT01352559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24676811|NCT01352559|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24676812|NCT01352559|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24676813|NCT01352572|Milnacipran|milnacipran|mesh-list
24676814|NCT01352572|Mirtazapine|mirtazapine|mesh-list
24676815|NCT01352572|Sertraline|sertraline|mesh-list
24676816|NCT01352572|Fluoxetine|fluoxetine|mesh-list
24676817|NCT01352572|Paroxetine|paroxetine|mesh-list
24676818|NCT01352572|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24854176|NCT02272517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854177|NCT02272517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24854178|NCT02272517|Serotonin Agents|serotonin agents|mesh-ancestor
24676834|NCT01352572|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24676836|NCT01352572|Histamine Antagonists|histamine antagonists|mesh-ancestor
24676837|NCT01352572|Histamine Agents|histamine agents|mesh-ancestor
24676838|NCT01352572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24676839|NCT01352572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24424971|NCT00231517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24676840|NCT01352572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24676841|NCT01352572|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24676842|NCT01352572|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25260769|NCT02456844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25260770|NCT02456844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25260772|NCT02456844|Protective Agents|protective agents|mesh-ancestor
25260773|NCT02456844|Vitamin B Complex|vitamin b complex|mesh-ancestor
25260774|NCT02456844|Vitamins|vitamins|mesh-ancestor
24932567|NCT04078425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24932568|NCT04078425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932569|NCT04078425|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24932570|NCT04078425|Diuretics|diuretics|mesh-ancestor
24932571|NCT04078425|Natriuretic Agents|natriuretic agents|mesh-ancestor
24932572|NCT04078204|3-n-butylphthalide|3-n-butylphthalide|mesh-list
24932573|NCT04078204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24932574|NCT04078204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24932575|NCT04078204|Protective Agents|protective agents|mesh-ancestor
24932576|NCT04078204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932577|NCT04078048|Vitamins|vitamins|mesh-list
24932578|NCT04078048|Ascorbic Acid|ascorbic acid|mesh-list
24932579|NCT04078048|Vitamin E|vitamin e|mesh-list
24932580|NCT04078048|Antioxidants|antioxidants|mesh-list
24932581|NCT04078048|Micronutrients|micronutrients|mesh-ancestor
24932582|NCT04078048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932583|NCT04078048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936075|NCT04044417|Curcumin|curcumin|mesh-list
24676843|NCT01352572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24676844|NCT01352572|Adrenergic Agents|adrenergic agents|mesh-ancestor
24676865|NCT01352650|Decitabine|decitabine|mesh-list
24676866|NCT01352650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24676977|NCT01353599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24676978|NCT01353599|Dermatologic Agents|dermatologic agents|mesh-ancestor
24676979|NCT01353599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24676980|NCT01353716|Dolutegravir|dolutegravir|mesh-list
24676981|NCT01353716|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24676982|NCT01353716|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24676983|NCT01353716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676984|NCT01353716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676985|NCT01353716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24676986|NCT01353716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24676987|NCT01353716|Antiviral Agents|antiviral agents|mesh-ancestor
24676988|NCT01353716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24676989|NCT01353729|Moxifloxacin|moxifloxacin|mesh-list
24854183|NCT02272517|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24676991|NCT01353729|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24676992|NCT01353729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24676993|NCT01353729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24677044|NCT01353846|Luteolytic Agents|luteolytic agents|mesh-ancestor
24677045|NCT01353846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24677046|NCT01353846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24677047|NCT01353924|Aluminum sulfate|aluminum sulfate|mesh-list
24677048|NCT01353924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24677049|NCT01353924|Immunologic Factors|immunologic factors|mesh-ancestor
24677050|NCT01353924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677051|NCT01353937|Plerixafor|plerixafor|mesh-list
24677131|NCT01354483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24677132|NCT01354483|Antiemetics|antiemetics|mesh-ancestor
24677133|NCT01354483|Autonomic Agents|autonomic agents|mesh-ancestor
24677134|NCT01354483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24677135|NCT01354483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677136|NCT01354483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24677137|NCT01354483|Glucocorticoids|glucocorticoids|mesh-ancestor
24677138|NCT01354483|Hormones|hormones|mesh-ancestor
24677139|NCT01354483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24677140|NCT01354483|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24677141|NCT01354483|Protective Agents|protective agents|mesh-ancestor
25260775|NCT02456844|Micronutrients|micronutrients|mesh-ancestor
25260776|NCT02456844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25260777|NCT02456844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25260778|NCT02456844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25260779|NCT02456844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25260780|NCT02456844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25260781|NCT02456844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25688177|NCT01942590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25260782|NCT02456844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25260783|NCT02456844|Anesthetics, General|anesthetics, general|mesh-ancestor
25260784|NCT02456844|Anesthetics|anesthetics|mesh-ancestor
25260785|NCT02456844|GABA Modulators|gaba modulators|mesh-ancestor
25260786|NCT02456844|GABA Agents|gaba agents|mesh-ancestor
25260787|NCT02456844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25260788|NCT02456844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25260789|NCT02456844|Respiratory System Agents|respiratory system agents|mesh-ancestor
25260790|NCT02456844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25260791|NCT02456844|Hormone Antagonists|hormone antagonists|mesh-ancestor
25275177|NCT02373579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932584|NCT04078048|Protective Agents|protective agents|mesh-ancestor
24932585|NCT04077853|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
24932586|NCT04077853|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
24932587|NCT04077853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24932590|NCT04077853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932591|NCT04077853|Progestins|progestins|mesh-ancestor
24932592|NCT04077853|Hormones|hormones|mesh-ancestor
24932593|NCT04077827|Propofol|propofol|mesh-list
24932610|NCT04077957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24932612|NCT04077957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932613|NCT04077957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24932614|NCT04077957|Dermatologic Agents|dermatologic agents|mesh-ancestor
24936080|NCT04044417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936081|NCT04044417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24936082|NCT04044417|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24936083|NCT04044417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24936113|NCT04043897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24677142|NCT01354483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24677143|NCT01354483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24677144|NCT01354483|Antidepressive Agents|antidepressive agents|mesh-ancestor
24677145|NCT01354483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24677146|NCT01354483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24677175|NCT01354613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24677176|NCT01354613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24677177|NCT01354613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24677178|NCT01354613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677179|NCT01354613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24677180|NCT01354613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677181|NCT01354613|Vasodilator Agents|vasodilator agents|mesh-ancestor
24677182|NCT01354613|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24677183|NCT01354613|Sympathomimetics|sympathomimetics|mesh-ancestor
24677199|NCT01354665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677200|NCT01354665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24677202|NCT01354704|Anticoagulants|anticoagulants|mesh-ancestor
24677203|NCT01354704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24677204|NCT01354704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24677205|NCT01354704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677206|NCT01354743|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24677207|NCT01354743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24677208|NCT01354743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24677209|NCT01354743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677210|NCT01354743|Cholinergic Agents|cholinergic agents|mesh-ancestor
24677211|NCT01354743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24677212|NCT01354743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677213|NCT01354860|Lobeline|lobeline|mesh-list
24677214|NCT01354860|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24677215|NCT01354860|Autonomic Agents|autonomic agents|mesh-ancestor
24677216|NCT01354860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24677217|NCT01354860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260792|NCT02456844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25260793|NCT02456844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25260794|NCT02456844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25260795|NCT02456844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25260796|NCT02456844|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25260797|NCT02456844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25260798|NCT02456844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24425573|NCT00233662|Dermatologic Agents|dermatologic agents|mesh-ancestor
24425574|NCT00233662|Immunologic Factors|immunologic factors|mesh-ancestor
24425575|NCT00233662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425577|NCT00233675|Anticonvulsants|anticonvulsants|mesh-ancestor
24425578|NCT00233675|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
24425579|NCT00233675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24425580|NCT00233675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24425581|NCT00233675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425582|NCT00233675|GABA Agents|gaba agents|mesh-ancestor
24425583|NCT00233675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24425584|NCT00233675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425585|NCT00233714|Sirolimus|sirolimus|mesh-list
24425586|NCT00233714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25260799|NCT02456844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25260800|NCT02456844|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25260801|NCT02456844|Analgesics|analgesics|mesh-ancestor
25260802|NCT02456844|Sensory System Agents|sensory system agents|mesh-ancestor
25260803|NCT02456844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25260804|NCT02456844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25260805|NCT02456844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25260806|NCT02456844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25260807|NCT02456844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24932615|NCT04077957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24932616|NCT04077957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24932617|NCT04077957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24932618|NCT04077957|Immunologic Factors|immunologic factors|mesh-ancestor
24932619|NCT04077957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24677232|NCT01355120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24677233|NCT01355120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24677234|NCT01355120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24677235|NCT01355120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677236|NCT01355198|Acetylcysteine|acetylcysteine|mesh-list
24677237|NCT01355198|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24677238|NCT01355198|Glycine|glycine|mesh-list
24677261|NCT01355276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24677262|NCT01355276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24677263|NCT01355276|Dopamine Agents|dopamine agents|mesh-ancestor
24677264|NCT01355276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24677265|NCT01355276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677294|NCT01355445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24677295|NCT01355445|Tubulin Modulators|tubulin modulators|mesh-ancestor
24677296|NCT01355445|Antimitotic Agents|antimitotic agents|mesh-ancestor
24677297|NCT01355445|Mitosis Modulators|mitosis modulators|mesh-ancestor
24677298|NCT01355445|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24677299|NCT01355445|Alkylating Agents|alkylating agents|mesh-ancestor
24677300|NCT01355562|Interleukin-2|interleukin-2|mesh-list
24677301|NCT01355562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24677302|NCT01355562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24677303|NCT01355562|Analgesics|analgesics|mesh-ancestor
24677319|NCT01355757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24677350|NCT01355991|Adrenergic Agents|adrenergic agents|mesh-ancestor
24677351|NCT01356017|Amlodipine|amlodipine|mesh-list
24677352|NCT01356017|Telmisartan|telmisartan|mesh-list
24677353|NCT01356017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25688178|NCT01942590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688179|NCT01942590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688180|NCT01942590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25688181|NCT01942590|Autonomic Agents|autonomic agents|mesh-ancestor
25688182|NCT01942590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25688183|NCT01942590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25688184|NCT01942590|Respiratory System Agents|respiratory system agents|mesh-ancestor
25688185|NCT01942590|Sympathomimetics|sympathomimetics|mesh-ancestor
25688186|NCT01942668|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25688187|NCT01942668|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25688188|NCT01942668|Estradiol|estradiol|mesh-list
25688189|NCT01942668|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25688190|NCT01942668|Progesterone|progesterone|mesh-list
25688191|NCT01942668|Estrogens|estrogens|mesh-ancestor
25688192|NCT01942668|Hormones|hormones|mesh-ancestor
25688193|NCT01942668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24425804|NCT00234403|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24425806|NCT00234403|Hormone Antagonists|hormone antagonists|mesh-ancestor
24677354|NCT01356017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24677355|NCT01356017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24677356|NCT01356017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610864|NCT01005537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610865|NCT01005537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613638|NCT01020162|Antimanic Agents|antimanic agents|mesh-ancestor
24491207|NCT00481624|Epoetin Alfa|epoetin alfa|mesh-list
24705355|NCT01484327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24705356|NCT01484327|Vasodilator Agents|vasodilator agents|mesh-ancestor
24610866|NCT01005537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24610867|NCT01005537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24610868|NCT01005537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24610885|NCT01005641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610887|NCT01005641|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24610888|NCT01005641|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24610889|NCT01005641|Hormone Antagonists|hormone antagonists|mesh-ancestor
24610890|NCT01005641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24677379|NCT01356043|Micronutrients|micronutrients|mesh-ancestor
24677380|NCT01356121|Midazolam|midazolam|mesh-list
24677381|NCT01356121|Propofol|propofol|mesh-list
24677382|NCT01356121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24677383|NCT01356121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24677384|NCT01356121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677385|NCT01356121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25260819|NCT02456597|Lidocaine|lidocaine|mesh-list
25260820|NCT02456597|Anesthetics, Local|anesthetics, local|mesh-ancestor
25260821|NCT02456597|Anesthetics|anesthetics|mesh-ancestor
25260866|NCT02456701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24932625|NCT04077957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24932626|NCT04077957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24932628|NCT04077957|Sensory System Agents|sensory system agents|mesh-ancestor
24932629|NCT04077957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24409256|NCT00181636|Galantamine|galantamine|mesh-list
24932641|NCT04077892|Glucocorticoids|glucocorticoids|mesh-ancestor
24677386|NCT01356121|Anesthetics, General|anesthetics, general|mesh-ancestor
24677387|NCT01356121|Anesthetics|anesthetics|mesh-ancestor
24677388|NCT01356121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24677389|NCT01356121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24677410|NCT01356225|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24677411|NCT01356225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24677412|NCT01356225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24677413|NCT01356225|Analgesics|analgesics|mesh-ancestor
24677414|NCT01356225|Sensory System Agents|sensory system agents|mesh-ancestor
24677418|NCT01356225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24677466|NCT01356472|Protease Inhibitors|protease inhibitors|mesh-ancestor
24677467|NCT01356472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24677468|NCT01356472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677475|NCT01356511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24677545|NCT01356745|Nitrous Oxide|nitrous oxide|mesh-list
24677546|NCT01356745|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24677547|NCT01356745|Anesthetics, General|anesthetics, general|mesh-ancestor
24677548|NCT01356745|Anesthetics|anesthetics|mesh-ancestor
24677549|NCT01356745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24467967|NCT00379405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24467968|NCT00379405|Antiviral Agents|antiviral agents|mesh-ancestor
24467969|NCT00379405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24467970|NCT00379405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24467971|NCT00379405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24677642|NCT01357317|Sequestering Agents|sequestering agents|mesh-ancestor
24677643|NCT01357317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677644|NCT01357486|Sorafenib|sorafenib|mesh-list
24677645|NCT01357486|Pravastatin|pravastatin|mesh-list
24677646|NCT01357486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24677647|NCT01357486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24677648|NCT01357486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24677649|NCT01357486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677650|NCT01357486|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25688194|NCT01942668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688195|NCT01942668|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24677651|NCT01357486|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24677652|NCT01357486|Antimetabolites|antimetabolites|mesh-ancestor
24677718|NCT01358045|Sensory System Agents|sensory system agents|mesh-ancestor
24677719|NCT01358045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24677720|NCT01358045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677721|NCT01358045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24677722|NCT01358045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24677723|NCT01358045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24677724|NCT01358045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24677802|NCT01358344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24677803|NCT01358344|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24677804|NCT01358344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24677805|NCT01358344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677806|NCT01358344|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24677832|NCT01358396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24677833|NCT01358409|Nebivolol|nebivolol|mesh-list
24677834|NCT01358409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24677835|NCT01358409|Vasodilator Agents|vasodilator agents|mesh-ancestor
24677836|NCT01358409|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24677837|NCT01358409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24677838|NCT01358409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25260822|NCT02456597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25260823|NCT02456597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260825|NCT02456597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25260826|NCT02456597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25260827|NCT02456597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24529717|NCT00627666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24529718|NCT00627666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529719|NCT00627666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24529720|NCT00627666|Abortifacient Agents|abortifacient agents|mesh-ancestor
24529721|NCT00627666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24529722|NCT00627666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24529723|NCT00627666|Antimetabolites|antimetabolites|mesh-ancestor
24529724|NCT00627666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529725|NCT00627666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24932642|NCT04077892|Hormones|hormones|mesh-ancestor
24932643|NCT04077892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24932644|NCT04077892|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24932645|NCT04077892|Hormone Antagonists|hormone antagonists|mesh-ancestor
24932646|NCT04077892|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24932647|NCT04077892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24932648|NCT04077892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932649|NCT04077866|Temozolomide|temozolomide|mesh-list
24677839|NCT01358409|Adrenergic Agents|adrenergic agents|mesh-ancestor
24677840|NCT01358409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24677850|NCT01358500|Fentanyl|fentanyl|mesh-list
24677922|NCT01359098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24677923|NCT01359098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854249|NCT02272738|Antimetabolites|antimetabolites|mesh-ancestor
24854250|NCT02272738|Antiviral Agents|antiviral agents|mesh-ancestor
24904509|NCT04355429|Captopril|captopril|mesh-list
24677994|NCT01359462|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24677995|NCT01359462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677997|NCT01359462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677998|NCT01359488|Hormones|hormones|mesh-list
24678002|NCT01359514|Pregabalin|pregabalin|mesh-list
24678053|NCT01359657|Antiemetics|antiemetics|mesh-ancestor
24678054|NCT01359657|Autonomic Agents|autonomic agents|mesh-ancestor
24678055|NCT01359657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24678056|NCT01359657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678057|NCT01359657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24678058|NCT01359657|Glucocorticoids|glucocorticoids|mesh-ancestor
24678060|NCT01359657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24678061|NCT01359657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24678062|NCT01359657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24678063|NCT01359657|Protease Inhibitors|protease inhibitors|mesh-ancestor
24678064|NCT01359657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678065|NCT01359657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678066|NCT01359657|Immunologic Factors|immunologic factors|mesh-ancestor
24678067|NCT01359657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24678155|NCT01360034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24678156|NCT01360034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24678157|NCT01360034|Analgesics|analgesics|mesh-ancestor
24678158|NCT01360034|Sensory System Agents|sensory system agents|mesh-ancestor
24678159|NCT01360034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24678160|NCT01360034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24678161|NCT01360034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25260828|NCT02456597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25260829|NCT02456597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25260830|NCT02456597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260831|NCT02456714|Folfirinox|folfirinox|mesh-list
25260832|NCT02456714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25260833|NCT02456454|Valproic Acid|valproic acid|mesh-list
25260834|NCT02456454|Risperidone|risperidone|mesh-list
25260835|NCT02456454|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25260836|NCT02456454|Serotonin Agents|serotonin agents|mesh-ancestor
25260837|NCT02456454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25260838|NCT02456454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260841|NCT02456454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25260842|NCT02456454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25260843|NCT02456454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25260844|NCT02456454|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25260846|NCT02456454|Anticonvulsants|anticonvulsants|mesh-ancestor
25260847|NCT02456454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24932650|NCT04077866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24932651|NCT04077866|Alkylating Agents|alkylating agents|mesh-ancestor
24932652|NCT04077866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932653|NCT04077866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24932654|NCT04077983|Gemcitabine|gemcitabine|mesh-list
24932655|NCT04077983|Paclitaxel|paclitaxel|mesh-list
24932656|NCT04077983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24932657|NCT04077983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24932658|NCT04077983|Tubulin Modulators|tubulin modulators|mesh-ancestor
24932659|NCT04077983|Antimitotic Agents|antimitotic agents|mesh-ancestor
24932660|NCT04077983|Mitosis Modulators|mitosis modulators|mesh-ancestor
24932661|NCT04077983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932662|NCT04077983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24932663|NCT04077983|Antimetabolites|antimetabolites|mesh-ancestor
24932664|NCT04077983|Antiviral Agents|antiviral agents|mesh-ancestor
24932665|NCT04077983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24932666|NCT04077983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24932667|NCT04077983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24529752|NCT00627731|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24529753|NCT00627731|Prednisolone|prednisolone|mesh-list
24529754|NCT00627731|Prednisolone acetate|prednisolone acetate|mesh-list
24529755|NCT00627731|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24529756|NCT00627731|Prednisolone phosphate|prednisolone phosphate|mesh-list
24529757|NCT00627731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24678162|NCT01360034|Gout Suppressants|gout suppressants|mesh-ancestor
24678163|NCT01360034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24678164|NCT01360034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678165|NCT01360060|Magnesium Sulfate|magnesium sulfate|mesh-list
24678166|NCT01360060|Analgesics|analgesics|mesh-ancestor
24678179|NCT01360060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24678180|NCT01360086|Leucovorin|leucovorin|mesh-list
24678181|NCT01360086|Fluorouracil|fluorouracil|mesh-list
24678182|NCT01360086|Cetuximab|cetuximab|mesh-list
24610923|NCT01005758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24610924|NCT01005758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24610925|NCT01005758|Glucocorticoids|glucocorticoids|mesh-ancestor
24610927|NCT01005758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24610928|NCT01005758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24610929|NCT01005758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24610930|NCT01005758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24610931|NCT01005758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24610932|NCT01005758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610933|NCT01005758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24610934|NCT01005758|Abortifacient Agents|abortifacient agents|mesh-ancestor
25260848|NCT02456454|GABA Agents|gaba agents|mesh-ancestor
25260849|NCT02456454|Antimanic Agents|antimanic agents|mesh-ancestor
25688196|NCT01942668|Contraceptive Agents|contraceptive agents|mesh-ancestor
25260850|NCT02456584|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25260851|NCT02456584|Medroxyprogesterone|medroxyprogesterone|mesh-list
25260852|NCT02456584|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25260853|NCT02456584|Contraceptive Agents|contraceptive agents|mesh-ancestor
25260854|NCT02456584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25260855|NCT02456584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260856|NCT02456584|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25260857|NCT02456584|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25260858|NCT02456584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25260859|NCT02456584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25260860|NCT02456584|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25260861|NCT02456584|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25260862|NCT02456584|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25260863|NCT02456701|Vemurafenib|vemurafenib|mesh-list
25260864|NCT02456701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25260865|NCT02456701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25260867|NCT02456701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260868|NCT02456558|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25260869|NCT02456558|Deferiprone|deferiprone|mesh-list
25260870|NCT02456558|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25260871|NCT02456558|Chelating Agents|chelating agents|mesh-ancestor
25260872|NCT02456558|Sequestering Agents|sequestering agents|mesh-ancestor
25260873|NCT02456558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529759|NCT00627731|Autonomic Agents|autonomic agents|mesh-ancestor
24529760|NCT00627731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24529761|NCT00627731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529762|NCT00627731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24529763|NCT00627731|Glucocorticoids|glucocorticoids|mesh-ancestor
24932671|NCT04077905|Doxorubicin|doxorubicin|mesh-list
24932672|NCT04077905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24932673|NCT04077905|Etoposide|etoposide|mesh-list
24932674|NCT04077905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24932675|NCT04077905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24932676|NCT04077905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24932677|NCT04077905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24932678|NCT04077905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24932679|NCT04077905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932680|NCT04077905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24932681|NCT04077905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24625164|NCT01080651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24625165|NCT01080651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24936159|NCT04043520|Estrogens|estrogens|mesh-list
24678721|NCT01363648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24610935|NCT01005758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24610936|NCT01005758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24610953|NCT01005784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24610954|NCT01005784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610955|NCT01005784|Hormone Antagonists|hormone antagonists|mesh-ancestor
24462721|NCT00357318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24678253|NCT01360476|Cholecalciferol|cholecalciferol|mesh-list
24678255|NCT01360476|Micronutrients|micronutrients|mesh-ancestor
24678289|NCT01360749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24678290|NCT01360749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678291|NCT01360788|Albuterol|albuterol|mesh-list
24678312|NCT01360827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24678313|NCT01360827|Antimetabolites|antimetabolites|mesh-ancestor
24854275|NCT02272829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24854276|NCT02272855|Ipilimumab|ipilimumab|mesh-list
24854277|NCT02272855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24854278|NCT02272855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24854279|NCT02272855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24854280|NCT02272855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678374|NCT01361425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24678375|NCT01361425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678377|NCT01361516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24678378|NCT01361516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678379|NCT01361542|Etanercept|etanercept|mesh-list
24678380|NCT01361542|Infliximab|infliximab|mesh-list
24678381|NCT01361542|Dermatologic Agents|dermatologic agents|mesh-ancestor
24678382|NCT01361542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24535650|NCT00649519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24535677|NCT00649558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24678384|NCT01361542|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24678385|NCT01361542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24678386|NCT01361542|Analgesics|analgesics|mesh-ancestor
24678387|NCT01361542|Sensory System Agents|sensory system agents|mesh-ancestor
25260874|NCT02456428|Insulin|insulin|mesh-list
25260875|NCT02456428|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25260876|NCT02456428|Metformin|metformin|mesh-list
25260877|NCT02456428|Pioglitazone|pioglitazone|mesh-list
25260878|NCT02456428|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25260879|NCT02456428|Liraglutide|liraglutide|mesh-list
25260880|NCT02456428|Exenatide|exenatide|mesh-list
25260881|NCT02456428|Glimepiride|glimepiride|mesh-list
25260882|NCT02456428|Rosiglitazone|rosiglitazone|mesh-list
25260883|NCT02456428|Vildagliptin|vildagliptin|mesh-list
25260884|NCT02456428|Saxagliptin|saxagliptin|mesh-list
25260885|NCT02456428|Acarbose|acarbose|mesh-list
25260886|NCT02456428|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25260887|NCT02456428|Repaglinide|repaglinide|mesh-list
25260888|NCT02456428|Gliclazide|gliclazide|mesh-list
25260889|NCT02456428|Glipizide|glipizide|mesh-list
25260890|NCT02456428|Biguanides|biguanides|mesh-list
25260893|NCT02456428|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
25260894|NCT02456428|Nateglinide|nateglinide|mesh-list
25260895|NCT02456428|Miglitol|miglitol|mesh-list
25260896|NCT02456428|Troglitazone|troglitazone|mesh-list
25260897|NCT02456428|Meglitinide|meglitinide|mesh-list
25260898|NCT02456428|Acetohexamide|acetohexamide|mesh-list
25260899|NCT02456428|Chlorpropamide|chlorpropamide|mesh-list
24625166|NCT01080651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625167|NCT01080651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24625169|NCT01080651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24625170|NCT01080651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625172|NCT01080729|Hormones|hormones|mesh-list
24625196|NCT01080820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24625197|NCT01080820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24625198|NCT01080846|Misoprostol|misoprostol|mesh-list
24625199|NCT01080846|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24625200|NCT01080846|Abortifacient Agents|abortifacient agents|mesh-ancestor
24625201|NCT01080846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24678388|NCT01361542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24678389|NCT01361542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678390|NCT01361542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24678391|NCT01361542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24678480|NCT01362218|Sensory System Agents|sensory system agents|mesh-ancestor
24678481|NCT01362218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24678482|NCT01362218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678483|NCT01362218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24678494|NCT01362309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24678495|NCT01362309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24678496|NCT01362309|Renal Agents|renal agents|mesh-ancestor
24678497|NCT01362309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24678498|NCT01362309|Antitubercular Agents|antitubercular agents|mesh-ancestor
24678499|NCT01362309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24678500|NCT01362309|Antimetabolites|antimetabolites|mesh-ancestor
24678501|NCT01362309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678502|NCT01362361|Nintedanib|nintedanib|mesh-list
24678503|NCT01362361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24678504|NCT01362361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24678505|NCT01362361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678506|NCT01362361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678507|NCT01362400|Docetaxel|docetaxel|mesh-list
24678508|NCT01362400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610979|NCT01005979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24610981|NCT01005979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24610982|NCT01005979|Growth Substances|growth substances|mesh-ancestor
24610983|NCT01005979|Growth Inhibitors|growth inhibitors|mesh-ancestor
24610984|NCT01006031|Interferons|interferons|mesh-list
24610985|NCT01006031|Ribavirin|ribavirin|mesh-list
24610986|NCT01006031|Interferon-alpha|interferon-alpha|mesh-list
24610987|NCT01006031|Interferon alpha-2|interferon alpha-2|mesh-list
24854286|NCT02272868|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24854287|NCT02272868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854288|NCT02272868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610988|NCT01006031|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24610989|NCT01006031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610990|NCT01006031|Antiviral Agents|antiviral agents|mesh-ancestor
24610991|NCT01006031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24610992|NCT01006031|Antimetabolites|antimetabolites|mesh-ancestor
24610993|NCT01006031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678664|NCT01363323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24678665|NCT01363323|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24678666|NCT01363336|Nifedipine|nifedipine|mesh-list
24678667|NCT01363336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25260900|NCT02456428|Phenformin|phenformin|mesh-list
25260901|NCT02456428|Buformin|buformin|mesh-list
25260902|NCT02456428|Glibornuride|glibornuride|mesh-list
25260903|NCT02456428|Tolazamide|tolazamide|mesh-list
25260904|NCT02456428|Carbutamide|carbutamide|mesh-list
25260905|NCT02456428|Gliquidone|gliquidone|mesh-list
25260906|NCT02456428|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25260907|NCT02456428|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
25260908|NCT02456428|Incretins|incretins|mesh-list
25260909|NCT02456428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260910|NCT02456428|Hormones|hormones|mesh-ancestor
25260911|NCT02456428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25260912|NCT02456428|Protease Inhibitors|protease inhibitors|mesh-ancestor
25260913|NCT02456428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625202|NCT01080846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625203|NCT01080846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24625204|NCT01080846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24932683|NCT04077905|Autonomic Agents|autonomic agents|mesh-ancestor
24932684|NCT04077905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24932685|NCT04077905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932687|NCT04077905|Glucocorticoids|glucocorticoids|mesh-ancestor
24932689|NCT04077905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24932690|NCT04077905|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24932691|NCT04077905|Protective Agents|protective agents|mesh-ancestor
24932692|NCT04077736|Aldesleukin|aldesleukin|mesh-list
24932693|NCT04077736|Interleukin-2|interleukin-2|mesh-list
24932694|NCT04077736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24932695|NCT04077736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24932696|NCT04077736|Analgesics|analgesics|mesh-ancestor
24932697|NCT04077736|Sensory System Agents|sensory system agents|mesh-ancestor
24932698|NCT04077736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24936192|NCT04043494|Thioguanine|thioguanine|mesh-list
24678668|NCT01363336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24678669|NCT01363336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904781|NCT04352959|Betadex|betadex|mesh-list
24678687|NCT01363544|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24678688|NCT01363544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678720|NCT01363648|Lipotropic Agents|lipotropic agents|mesh-ancestor
24678722|NCT01363648|Antimetabolites|antimetabolites|mesh-ancestor
24678723|NCT01363648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678724|NCT01363648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24678725|NCT01363648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24857710|NCT02293668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678726|NCT01363648|Nootropic Agents|nootropic agents|mesh-ancestor
24678727|NCT01363752|Mycophenolic Acid|mycophenolic acid|mesh-list
24678729|NCT01363752|Tacrolimus|tacrolimus|mesh-list
24678730|NCT01363752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24678731|NCT01363752|Immunologic Factors|immunologic factors|mesh-ancestor
24678732|NCT01363752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678733|NCT01363752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24678734|NCT01363752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678735|NCT01363752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678736|NCT01363752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24678737|NCT01363752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24678738|NCT01363752|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24678739|NCT01363752|Antitubercular Agents|antitubercular agents|mesh-ancestor
24678740|NCT01363752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24678741|NCT01363752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24678742|NCT01363752|Antifungal Agents|antifungal agents|mesh-ancestor
24678783|NCT01364194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24678784|NCT01364220|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24854293|NCT02272998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24854294|NCT02272998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24854295|NCT02272998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854296|NCT02272998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854297|NCT02273102|Tretinoin|tretinoin|mesh-list
24854298|NCT02273102|Tranylcypromine|tranylcypromine|mesh-list
25260914|NCT02456428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260915|NCT02456428|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25260916|NCT02456428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25260917|NCT02456428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25260918|NCT02456428|Immunologic Factors|immunologic factors|mesh-ancestor
25260919|NCT02456350|Cyclophosphamide|cyclophosphamide|mesh-list
25260920|NCT02456350|Fludarabine|fludarabine|mesh-list
25260921|NCT02456350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25260922|NCT02456350|Immunologic Factors|immunologic factors|mesh-ancestor
25260923|NCT02456350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260924|NCT02456350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25260925|NCT02456350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25260926|NCT02456350|Alkylating Agents|alkylating agents|mesh-ancestor
25260927|NCT02456350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260928|NCT02456350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25260929|NCT02456350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25275178|NCT02373579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25275179|NCT02373579|Antimetabolites|antimetabolites|mesh-ancestor
24529792|NCT00627848|Rivastigmine|rivastigmine|mesh-list
24529793|NCT00627848|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24529794|NCT00627848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529795|NCT00627848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529796|NCT00627848|Cholinergic Agents|cholinergic agents|mesh-ancestor
24529797|NCT00627848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24529798|NCT00627848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529799|NCT00627848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24529800|NCT00627848|Protective Agents|protective agents|mesh-ancestor
24529801|NCT00627887|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24529802|NCT00627887|Antidepressive Agents|antidepressive agents|mesh-ancestor
24529803|NCT00627887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24936202|NCT04043494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24854299|NCT02273102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24854300|NCT02273102|Keratolytic Agents|keratolytic agents|mesh-ancestor
24854301|NCT02273102|Dermatologic Agents|dermatologic agents|mesh-ancestor
24854302|NCT02273102|Antidepressive Agents|antidepressive agents|mesh-ancestor
24854303|NCT02273102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24678839|NCT01364675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678840|NCT01364675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24678841|NCT01364675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24678850|NCT01364688|Alfacalcidol|alfacalcidol|mesh-list
24678851|NCT01364688|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
24638229|NCT01155453|Trametinib|trametinib|mesh-list
24678852|NCT01364688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24678853|NCT01364688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678854|NCT01364688|Vitamins|vitamins|mesh-ancestor
24678855|NCT01364688|Micronutrients|micronutrients|mesh-ancestor
24678857|NCT01364701|Tadalafil|tadalafil|mesh-list
24678909|NCT01364987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678910|NCT01364987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24678911|NCT01364987|Immunologic Factors|immunologic factors|mesh-ancestor
24678912|NCT01364987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678913|NCT01365000|Naloxegol|naloxegol|mesh-list
24678914|NCT01365000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24678915|NCT01365000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678916|NCT01365000|Sensory System Agents|sensory system agents|mesh-ancestor
24678917|NCT01365000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24678918|NCT01365065|Vorinostat|vorinostat|mesh-list
24678919|NCT01365065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24678920|NCT01365065|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24678921|NCT01365065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678923|NCT01365104|Deferoxamine|deferoxamine|mesh-list
24678966|NCT01365598|Antimalarials|antimalarials|mesh-ancestor
24678967|NCT01365598|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24678968|NCT01365598|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24678969|NCT01365598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24678971|NCT01365676|Antidepressive Agents|antidepressive agents|mesh-ancestor
24678972|NCT01365676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24679003|NCT01365923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24679004|NCT01365923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24679005|NCT01365923|Adrenergic Agents|adrenergic agents|mesh-ancestor
24679006|NCT01365923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24679007|NCT01365923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679008|NCT01365923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24679009|NCT01365923|Narcotics|narcotics|mesh-ancestor
24679010|NCT01365936|Menotropins|menotropins|mesh-list
24679011|NCT01365936|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24679026|NCT01366118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24679027|NCT01366183|Paclitaxel|paclitaxel|mesh-list
25260930|NCT02456363|Sulfasalazine|sulfasalazine|mesh-list
25260931|NCT02456363|Adalimumab|adalimumab|mesh-list
25260932|NCT02456363|Etanercept|etanercept|mesh-list
25260933|NCT02456363|Golimumab|golimumab|mesh-list
25260934|NCT02456363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25260935|NCT02456363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25260936|NCT02456363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25260937|NCT02456363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25260938|NCT02456363|Analgesics|analgesics|mesh-ancestor
25260939|NCT02456363|Sensory System Agents|sensory system agents|mesh-ancestor
25260940|NCT02456363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25260941|NCT02456363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260942|NCT02456363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25260943|NCT02456363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25260944|NCT02456363|Immunologic Factors|immunologic factors|mesh-ancestor
24529807|NCT00627887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24529808|NCT00627887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24932700|NCT04077736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24932701|NCT04077736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24932702|NCT04077736|Antiviral Agents|antiviral agents|mesh-ancestor
24932703|NCT04077736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24932704|NCT04077944|Trace Elements|trace elements|mesh-list
24932705|NCT04077944|Micronutrients|micronutrients|mesh-list
24932706|NCT04077944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936210|NCT04043494|Hormones|hormones|mesh-ancestor
24936216|NCT04043494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24679028|NCT01366183|Carboplatin|carboplatin|mesh-list
24679029|NCT01366183|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24679030|NCT01366183|Lenograstim|lenograstim|mesh-list
24679031|NCT01366183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24679032|NCT01366183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24679033|NCT01366183|Tubulin Modulators|tubulin modulators|mesh-ancestor
24679034|NCT01366183|Antimitotic Agents|antimitotic agents|mesh-ancestor
24679035|NCT01366183|Mitosis Modulators|mitosis modulators|mesh-ancestor
24679036|NCT01366183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812622|NCT02053779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24812623|NCT02053779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679037|NCT01366183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24678090|NCT01359709|Nicotine|nicotine|mesh-list
24679054|NCT01366235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24679055|NCT01366235|Filaricides|filaricides|mesh-ancestor
24679056|NCT01366235|Antinematodal Agents|antinematodal agents|mesh-ancestor
24679057|NCT01366235|Anthelmintics|anthelmintics|mesh-ancestor
24679058|NCT01366300|Lidocaine|lidocaine|mesh-list
24679059|NCT01366300|Propofol|propofol|mesh-list
24679060|NCT01366300|Anesthetics, Local|anesthetics, local|mesh-ancestor
24679061|NCT01366300|Anesthetics|anesthetics|mesh-ancestor
24679091|NCT01366326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679124|NCT01366547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24679125|NCT01366547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24679126|NCT01366547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24812624|NCT02053779|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24679127|NCT01366547|Antimetabolites|antimetabolites|mesh-ancestor
24679128|NCT01366547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24679129|NCT01366547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24679130|NCT01366651|Doripenem|doripenem|mesh-list
24679147|NCT01367054|Metformin|metformin|mesh-list
24679148|NCT01367054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24679149|NCT01367054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679150|NCT01367210|Maraviroc|maraviroc|mesh-list
24679251|NCT01367561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679252|NCT01367561|Sensory System Agents|sensory system agents|mesh-ancestor
24679253|NCT01367561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679255|NCT01367574|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24679256|NCT01367574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679257|NCT01367574|Sensory System Agents|sensory system agents|mesh-ancestor
24679258|NCT01367574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679259|NCT01367587|Methylnaltrexone|methylnaltrexone|mesh-list
24679260|NCT01367587|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24679261|NCT01367587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431854|NCT00253136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24679262|NCT01367587|Sensory System Agents|sensory system agents|mesh-ancestor
25260945|NCT02456363|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25260946|NCT02456363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25260947|NCT02456142|Morphine|morphine|mesh-list
25260948|NCT02456142|Bupivacaine|bupivacaine|mesh-list
25260949|NCT02456142|Anesthetics, Local|anesthetics, local|mesh-ancestor
25260950|NCT02456142|Anesthetics|anesthetics|mesh-ancestor
25260951|NCT02456142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25260952|NCT02456142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260953|NCT02456142|Sensory System Agents|sensory system agents|mesh-ancestor
25260954|NCT02456142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25260955|NCT02456142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25260956|NCT02456142|Narcotics|narcotics|mesh-ancestor
24932709|NCT04077346|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
24932710|NCT04077346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24932711|NCT04077346|Immunologic Factors|immunologic factors|mesh-ancestor
24932712|NCT04077346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679331|NCT01367912|Hormones|hormones|mesh-ancestor
24679332|NCT01367912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24679333|NCT01367912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679334|NCT01367912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24679335|NCT01367912|Contraceptive Agents|contraceptive agents|mesh-ancestor
24679347|NCT01367990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24679348|NCT01367990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24679349|NCT01367990|Adrenergic Agents|adrenergic agents|mesh-ancestor
24679350|NCT01367990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24679351|NCT01367990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679352|NCT01367990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679353|NCT01367990|Sympathomimetics|sympathomimetics|mesh-ancestor
24679354|NCT01367990|Autonomic Agents|autonomic agents|mesh-ancestor
24679419|NCT01368419|Endostar protein|endostar protein|mesh-list
24679420|NCT01368419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24679421|NCT01368419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24679422|NCT01368419|Growth Substances|growth substances|mesh-ancestor
24679423|NCT01368419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679424|NCT01368419|Growth Inhibitors|growth inhibitors|mesh-ancestor
24679425|NCT01368419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24679426|NCT01368445|Azelastine|azelastine|mesh-list
24679427|NCT01368445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24679428|NCT01368445|Autonomic Agents|autonomic agents|mesh-ancestor
24611042|NCT01006551|Ziprasidone|ziprasidone|mesh-list
24611054|NCT01006668|Propofol|propofol|mesh-list
25261016|NCT02455908|Aldesleukin|aldesleukin|mesh-list
24854325|NCT02273154|Antidepressive Agents|antidepressive agents|mesh-ancestor
24854326|NCT02273154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24854327|NCT02273154|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24854328|NCT02273154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24854329|NCT02273154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854330|NCT02273154|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24854331|NCT02273154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24854332|NCT02273154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24854333|NCT02273154|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24854334|NCT02273258|Insulin|insulin|mesh-list
24854335|NCT02273258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24611062|NCT01006668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24611063|NCT01006668|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24611064|NCT01006681|Vaccines|vaccines|mesh-list
24611065|NCT01006681|MF59 oil emulsion|mf59 oil emulsion|mesh-list
24611066|NCT01006681|Immunologic Factors|immunologic factors|mesh-ancestor
24611067|NCT01006681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611068|NCT01006681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24679484|NCT01368848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24679485|NCT01368848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24679486|NCT01368848|Growth Substances|growth substances|mesh-ancestor
24679487|NCT01368848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260961|NCT02456194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260962|NCT02456194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25260963|NCT02456129|Itraconazole|itraconazole|mesh-list
25260964|NCT02456129|Antifungal Agents|antifungal agents|mesh-ancestor
25260965|NCT02456129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25688197|NCT01942668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25260966|NCT02456129|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25260967|NCT02456129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25260968|NCT02456129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25260969|NCT02456129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260999|NCT02455726|Analgesics|analgesics|mesh-ancestor
25260972|NCT02456129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24932723|NCT04077580|Methenamine hippurate|methenamine hippurate|mesh-list
24932724|NCT04077580|Methenamine mandelate|methenamine mandelate|mesh-list
24932725|NCT04077580|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24932726|NCT04077580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24932728|NCT04077580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24932730|NCT04077684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24932731|NCT04077684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24932732|NCT04077684|Analgesics|analgesics|mesh-ancestor
24679488|NCT01368848|Growth Inhibitors|growth inhibitors|mesh-ancestor
24679489|NCT01368848|Tubulin Modulators|tubulin modulators|mesh-ancestor
24679503|NCT01368887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679504|NCT01368887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24679505|NCT01368887|Vasodilator Agents|vasodilator agents|mesh-ancestor
24679506|NCT01368887|Dermatologic Agents|dermatologic agents|mesh-ancestor
24679507|NCT01369017|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24679508|NCT01369017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24679509|NCT01369043|Vitamins|vitamins|mesh-list
24535994|NCT00650156|Adalimumab|adalimumab|mesh-list
24679510|NCT01369043|Ascorbic Acid|ascorbic acid|mesh-list
24679511|NCT01369043|Vitamin E|vitamin e|mesh-list
24679512|NCT01369043|Micronutrients|micronutrients|mesh-ancestor
24679513|NCT01369043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679514|NCT01369043|Antioxidants|antioxidants|mesh-ancestor
24679515|NCT01369043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679516|NCT01369043|Protective Agents|protective agents|mesh-ancestor
24679517|NCT01369082|Cyclosporine|cyclosporine|mesh-list
24679518|NCT01369082|Sirolimus|sirolimus|mesh-list
24679519|NCT01369082|Mycophenolic Acid|mycophenolic acid|mesh-list
24679520|NCT01369082|Tacrolimus|tacrolimus|mesh-list
24854358|NCT02273453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24854359|NCT02273453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24854360|NCT02273453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854361|NCT02273453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24854362|NCT02273453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24854363|NCT02273453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24854364|NCT02273453|GABA Modulators|gaba modulators|mesh-ancestor
24679527|NCT01369082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679528|NCT01369082|Antifungal Agents|antifungal agents|mesh-ancestor
24679529|NCT01369082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24679530|NCT01369082|Dermatologic Agents|dermatologic agents|mesh-ancestor
24679531|NCT01369082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24679532|NCT01369082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24679533|NCT01369082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24679534|NCT01369082|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24679535|NCT01369082|Antitubercular Agents|antitubercular agents|mesh-ancestor
24679536|NCT01369082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24679575|NCT01369277|Micronutrients|micronutrients|mesh-ancestor
24679576|NCT01369277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679577|NCT01369290|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24679578|NCT01369290|Citalopram|citalopram|mesh-list
24679579|NCT01369290|Bupropion|bupropion|mesh-list
24679580|NCT01369290|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24679586|NCT01369290|Serotonin Agents|serotonin agents|mesh-ancestor
24679652|NCT01369667|Vitamin D|vitamin d|mesh-list
24679653|NCT01369667|Cholecalciferol|cholecalciferol|mesh-list
24679654|NCT01369667|Vitamins|vitamins|mesh-ancestor
24679655|NCT01369667|Micronutrients|micronutrients|mesh-ancestor
24679656|NCT01369667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260973|NCT02456129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260974|NCT02456129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25260975|NCT02456207|Rituximab|rituximab|mesh-list
25260976|NCT02456207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25260977|NCT02456207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25260978|NCT02456207|Immunologic Factors|immunologic factors|mesh-ancestor
25260979|NCT02456207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260980|NCT02456207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25260981|NCT02456116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
24433080|NCT00257465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260982|NCT02456116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25260983|NCT02456116|Analgesics|analgesics|mesh-ancestor
24854378|NCT02273466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24854379|NCT02273466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854380|NCT02273479|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
24854381|NCT02273479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24679692|NCT01370096|Coagulants|coagulants|mesh-ancestor
24679693|NCT01370096|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24679700|NCT01370135|Ranibizumab|ranibizumab|mesh-list
24679705|NCT01370135|Growth Inhibitors|growth inhibitors|mesh-ancestor
24679706|NCT01370135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24679707|NCT01370148|Conivaptan|conivaptan|mesh-list
24679708|NCT01370148|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24679709|NCT01370148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679710|NCT01370148|Natriuretic Agents|natriuretic agents|mesh-ancestor
24679711|NCT01370148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679712|NCT01370161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24679713|NCT01370161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24679726|NCT01370187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24679727|NCT01370187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679729|NCT01370291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24679730|NCT01370291|Serotonin Agents|serotonin agents|mesh-ancestor
24679731|NCT01370291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24679732|NCT01370291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679733|NCT01370291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679734|NCT01370291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24854389|NCT02273505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24854390|NCT02273505|Antifungal Agents|antifungal agents|mesh-ancestor
24854391|NCT02273505|Keratolytic Agents|keratolytic agents|mesh-ancestor
24854392|NCT02273505|Dermatologic Agents|dermatologic agents|mesh-ancestor
24854393|NCT02273505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24854395|NCT02273505|Analgesics|analgesics|mesh-ancestor
24679743|NCT01370304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24679744|NCT01370304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679745|NCT01370304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24679746|NCT01370304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679747|NCT01370304|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24679748|NCT01370304|Antidepressive Agents|antidepressive agents|mesh-ancestor
24679749|NCT01370304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24679750|NCT01370343|Nicotinic Acids|nicotinic acids|mesh-list
24679751|NCT01370343|Cyclosporine|cyclosporine|mesh-list
24679752|NCT01370343|Cyclosporins|cyclosporins|mesh-list
24679813|NCT01370889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679814|NCT01370889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24679815|NCT01370889|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24679818|NCT01370915|Micronutrients|micronutrients|mesh-ancestor
24932783|NCT04076436|beta-Lactams|beta-lactams|mesh-list
24679819|NCT01370915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679820|NCT01370915|Analgesics|analgesics|mesh-ancestor
24638553|NCT01157000|Canagliflozin|canagliflozin|mesh-list
25260986|NCT02456116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25260987|NCT02456116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25260988|NCT02456116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25260989|NCT02456025|Tacrolimus|tacrolimus|mesh-list
25260990|NCT02456025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25260991|NCT02456025|Immunologic Factors|immunologic factors|mesh-ancestor
24932733|NCT04077684|Sensory System Agents|sensory system agents|mesh-ancestor
24932734|NCT04077684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24932735|NCT04077684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679910|NCT01371461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24679911|NCT01371461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24679913|NCT01371474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24679914|NCT01371474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24679915|NCT01371474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24679916|NCT01371474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679917|NCT01371474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24679918|NCT01371474|Serotonin Agents|serotonin agents|mesh-ancestor
24679919|NCT01371474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679920|NCT01371474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25688198|NCT01942668|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24947258|NCT03930875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679935|NCT01371604|Ribavirin|ribavirin|mesh-list
24854458|NCT02273622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24854459|NCT02273622|Antioxidants|antioxidants|mesh-ancestor
24854460|NCT02273622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854461|NCT02273622|Protective Agents|protective agents|mesh-ancestor
24854464|NCT02273635|Andrographolide|andrographolide|mesh-list
24679973|NCT01372280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679974|NCT01372280|Nootropic Agents|nootropic agents|mesh-ancestor
24679975|NCT01372293|Contraceptive Agents|contraceptive agents|mesh-list
24679976|NCT01372293|Contraceptives, Oral|contraceptives, oral|mesh-list
24679977|NCT01372293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
24679978|NCT01372293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24679979|NCT01372293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680008|NCT01372449|Dopamine Agents|dopamine agents|mesh-ancestor
24680100|NCT01373008|Glucocorticoids|glucocorticoids|mesh-ancestor
24680101|NCT01373008|Hormones|hormones|mesh-ancestor
24680102|NCT01373008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24680103|NCT01373008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680104|NCT01373008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24680105|NCT01373008|Respiratory System Agents|respiratory system agents|mesh-ancestor
24680106|NCT01373021|Fentanyl|fentanyl|mesh-list
24680107|NCT01373021|Dexmedetomidine|dexmedetomidine|mesh-list
24680108|NCT01373021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24680109|NCT01373021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24680164|NCT01373333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680165|NCT01373333|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24680166|NCT01373333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24680167|NCT01373333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680168|NCT01373359|Misoprostol|misoprostol|mesh-list
24680169|NCT01373359|Oxytocin|oxytocin|mesh-list
24611092|NCT01006863|Sympathomimetics|sympathomimetics|mesh-ancestor
24611093|NCT01006863|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24611094|NCT01006863|Nasal Decongestants|nasal decongestants|mesh-ancestor
24611095|NCT01006863|Respiratory System Agents|respiratory system agents|mesh-ancestor
24611096|NCT01006863|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24611097|NCT01006863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24611104|NCT01006876|Warfarin|warfarin|mesh-list
24680179|NCT01373372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24680212|NCT01373541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680213|NCT01373554|Oltipraz|oltipraz|mesh-list
24680214|NCT01373554|Antiviral Agents|antiviral agents|mesh-ancestor
24680215|NCT01373554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24680216|NCT01373554|Schistosomicides|schistosomicides|mesh-ancestor
24680217|NCT01373554|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24680218|NCT01373554|Anthelmintics|anthelmintics|mesh-ancestor
24680219|NCT01373554|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24680220|NCT01373554|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24680237|NCT01373593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24680238|NCT01373593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25260994|NCT02456025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24932784|NCT04076436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25260995|NCT02456025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25260996|NCT02455726|Pregabalin|pregabalin|mesh-list
25260997|NCT02455726|Oxycodone|oxycodone|mesh-list
25260998|NCT02455726|Magnesium Oxide|magnesium oxide|mesh-list
24932737|NCT04077398|Anesthetics, Local|anesthetics, local|mesh-ancestor
24932738|NCT04077398|Anesthetics|anesthetics|mesh-ancestor
24932739|NCT04077398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24932740|NCT04077398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932741|NCT04077398|Sensory System Agents|sensory system agents|mesh-ancestor
24932742|NCT04077398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24932743|NCT04076930|Enzyme Inhibitors|enzyme inhibitors|mesh-list
24932744|NCT04076930|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24932745|NCT04076930|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24932746|NCT04076930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932747|NCT04076930|Protease Inhibitors|protease inhibitors|mesh-ancestor
24932757|NCT04076865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24932758|NCT04076865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24932781|NCT04076436|Fosfomycin|fosfomycin|mesh-list
24932782|NCT04076436|Lactams|lactams|mesh-list
24680239|NCT01373593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688199|NCT01942668|Progestins|progestins|mesh-ancestor
24680241|NCT01373606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24680242|NCT01373606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24680243|NCT01373632|Sirolimus|sirolimus|mesh-list
24680244|NCT01373632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24680245|NCT01373632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24680246|NCT01373632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24680247|NCT01373632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680248|NCT01373632|Antifungal Agents|antifungal agents|mesh-ancestor
24680249|NCT01373632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24680250|NCT01373632|Immunologic Factors|immunologic factors|mesh-ancestor
24680251|NCT01373632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680252|NCT01373684|Tenofovir|tenofovir|mesh-list
24680253|NCT01373684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24680254|NCT01373684|Entecavir|entecavir|mesh-list
24680255|NCT01373684|Adefovir|adefovir|mesh-list
24680256|NCT01373684|Antiviral Agents|antiviral agents|mesh-ancestor
24905309|NCT04348786|Antimalarials|antimalarials|mesh-ancestor
24680272|NCT01373697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24680273|NCT01373697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24854494|NCT02273713|Paclitaxel|paclitaxel|mesh-list
24854495|NCT02273713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24854496|NCT02273713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680274|NCT01373697|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24680282|NCT01373736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680283|NCT01373736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680284|NCT01373736|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24680286|NCT01373749|Vasodilator Agents|vasodilator agents|mesh-ancestor
24680287|NCT01373749|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24680335|NCT01374282|Protective Agents|protective agents|mesh-ancestor
24680336|NCT01374282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680337|NCT01374282|Chelating Agents|chelating agents|mesh-ancestor
24680338|NCT01374282|Sequestering Agents|sequestering agents|mesh-ancestor
24680361|NCT01374581|Artemether|artemether|mesh-list
24680362|NCT01374581|Amodiaquine|amodiaquine|mesh-list
24680363|NCT01374581|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24680364|NCT01374581|Quinine|quinine|mesh-list
24680365|NCT01374581|Clindamycin|clindamycin|mesh-list
24680366|NCT01374581|Clindamycin palmitate|clindamycin palmitate|mesh-list
24680367|NCT01374581|Clindamycin phosphate|clindamycin phosphate|mesh-list
24680368|NCT01374581|Antimalarials|antimalarials|mesh-ancestor
25261000|NCT02455726|Sensory System Agents|sensory system agents|mesh-ancestor
25261001|NCT02455726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25261002|NCT02455726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261003|NCT02455726|Anticonvulsants|anticonvulsants|mesh-ancestor
25261004|NCT02455726|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25261005|NCT02455726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25261006|NCT02455726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261007|NCT02455726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25261008|NCT02455726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25261009|NCT02455726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25261010|NCT02455726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25261011|NCT02455726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25261012|NCT02455726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25261013|NCT02455726|Narcotics|narcotics|mesh-ancestor
25261014|NCT02455726|Antacids|antacids|mesh-ancestor
25261015|NCT02455726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24932785|NCT04076436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24932787|NCT04076709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24932788|NCT04076709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932789|NCT04076826|Midazolam|midazolam|mesh-list
24932790|NCT04076826|Dexmedetomidine|dexmedetomidine|mesh-list
24680369|NCT01374581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24680370|NCT01374581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24680371|NCT01374581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24680372|NCT01374581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24854497|NCT02273713|Tubulin Modulators|tubulin modulators|mesh-ancestor
24680427|NCT01374737|Dexmedetomidine|dexmedetomidine|mesh-list
24680428|NCT01374737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24680429|NCT01374737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24680430|NCT01374737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680431|NCT01374737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24680432|NCT01374737|Analgesics|analgesics|mesh-ancestor
24680433|NCT01374737|Sensory System Agents|sensory system agents|mesh-ancestor
24680434|NCT01374737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24680435|NCT01374737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24434268|NCT00261820|Hormones|hormones|mesh-ancestor
24434269|NCT00261820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24434270|NCT00261820|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24434271|NCT00261820|Protective Agents|protective agents|mesh-ancestor
24434272|NCT00261820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24434273|NCT00261872|Methylphenidate|methylphenidate|mesh-list
24434299|NCT00262015|Immunologic Factors|immunologic factors|mesh-ancestor
24434301|NCT00262054|Heparin|heparin|mesh-list
24680456|NCT01374750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24680457|NCT01374750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680459|NCT01374763|Naloxone|naloxone|mesh-list
24680460|NCT01374763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24680461|NCT01374763|Narcotics|narcotics|mesh-ancestor
24680462|NCT01374763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24680464|NCT01374763|Analgesics|analgesics|mesh-ancestor
24680487|NCT01374841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24680488|NCT01374841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24680489|NCT01374841|Alkylating Agents|alkylating agents|mesh-ancestor
24680503|NCT01375023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24680504|NCT01375088|Propolis|propolis|mesh-list
24680505|NCT01375088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24680506|NCT01375101|Quercetin|quercetin|mesh-list
24680507|NCT01375101|Antioxidants|antioxidants|mesh-ancestor
24680508|NCT01375101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680509|NCT01375101|Protective Agents|protective agents|mesh-ancestor
24680510|NCT01375101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680511|NCT01375244|Lisinopril|lisinopril|mesh-list
24680512|NCT01375244|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24680513|NCT01375244|Protease Inhibitors|protease inhibitors|mesh-ancestor
24854510|NCT02273765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854512|NCT02273765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24680531|NCT01375322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680532|NCT01375322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24680533|NCT01375322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680534|NCT01375322|Vasodilator Agents|vasodilator agents|mesh-ancestor
24680535|NCT01375322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24680536|NCT01375322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24680537|NCT01375322|Diuretics|diuretics|mesh-ancestor
24680538|NCT01375322|Natriuretic Agents|natriuretic agents|mesh-ancestor
24680539|NCT01375322|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24680540|NCT01375322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24680541|NCT01375322|Protease Inhibitors|protease inhibitors|mesh-ancestor
24680542|NCT01375322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680543|NCT01375335|Dobutamine|dobutamine|mesh-list
24680544|NCT01375335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24680545|NCT01375335|Sympathomimetics|sympathomimetics|mesh-ancestor
24680579|NCT01375387|Lacosamide|lacosamide|mesh-list
24680590|NCT01375400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24680591|NCT01375400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680592|NCT01375400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24680593|NCT01375400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24680594|NCT01375400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25261017|NCT02455908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25261018|NCT02455908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25261019|NCT02455908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25261020|NCT02455908|Antiviral Agents|antiviral agents|mesh-ancestor
25261021|NCT02455908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25261022|NCT02455869|Alendronate|alendronate|mesh-list
25261023|NCT02455869|Atorvastatin|atorvastatin|mesh-list
25261024|NCT02455869|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25261025|NCT02455869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24932791|NCT04076826|Propofol|propofol|mesh-list
24932792|NCT04076826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24932793|NCT04076826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24932794|NCT04076826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688200|NCT01942733|Brexpiprazole|brexpiprazole|mesh-list
25688201|NCT01942733|Serotonin Agents|serotonin agents|mesh-ancestor
25688202|NCT01942733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25688203|NCT01942733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688204|NCT01942733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688205|NCT01942733|Dopamine Agonists|dopamine agonists|mesh-ancestor
25688206|NCT01942733|Dopamine Agents|dopamine agents|mesh-ancestor
25688207|NCT01942785|Brexpiprazole|brexpiprazole|mesh-list
24932795|NCT04076826|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25688208|NCT01942785|Serotonin Agents|serotonin agents|mesh-ancestor
24434509|NCT00262561|Aspirin|aspirin|mesh-list
24932796|NCT04076826|Anesthetics, General|anesthetics, general|mesh-ancestor
24932798|NCT04076826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24932800|NCT04076826|Sensory System Agents|sensory system agents|mesh-ancestor
24932801|NCT04076826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24680595|NCT01375400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24680596|NCT01375400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680597|NCT01375400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24680598|NCT01375400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24680599|NCT01375400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680600|NCT01375400|Antipyretics|antipyretics|mesh-ancestor
24680601|NCT01375426|Amoxicillin|amoxicillin|mesh-list
24680602|NCT01375426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24680603|NCT01375426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24680605|NCT01375452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680606|NCT01375452|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24680607|NCT01375452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24680608|NCT01375452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680609|NCT01375452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680634|NCT01375634|GABA Agents|gaba agents|mesh-ancestor
24680635|NCT01375634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24854530|NCT02273791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24854531|NCT02273791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854532|NCT02273791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24680732|NCT01376076|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24680733|NCT01376076|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24680734|NCT01376076|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24680735|NCT01376076|Serotonin Agents|serotonin agents|mesh-ancestor
24854539|NCT02273791|Fertility Agents|fertility agents|mesh-ancestor
24854540|NCT02273791|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24854541|NCT02273791|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24854542|NCT02273804|Topiramate|topiramate|mesh-list
24854543|NCT02273804|Anticonvulsants|anticonvulsants|mesh-ancestor
24854544|NCT02273804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24680736|NCT01376076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24680737|NCT01376076|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24680738|NCT01376076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24680787|NCT01376180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24680788|NCT01376180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24680789|NCT01376193|Naratriptan|naratriptan|mesh-list
24680790|NCT01376193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24680791|NCT01376193|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24680792|NCT01376193|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24447252|NCT00307671|Protective Agents|protective agents|mesh-ancestor
24680824|NCT01376258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680825|NCT01376258|Hormone Antagonists|hormone antagonists|mesh-ancestor
24680826|NCT01376258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24680827|NCT01376258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680828|NCT01376258|Urological Agents|urological agents|mesh-ancestor
24680874|NCT01376440|Sodium Hypochlorite|sodium hypochlorite|mesh-list
24536542|NCT00651599|Natriuretic Agents|natriuretic agents|mesh-ancestor
24536543|NCT00651612|Timolol|timolol|mesh-list
24680877|NCT01376440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24680878|NCT01376453|Fluorouracil|fluorouracil|mesh-list
24680879|NCT01376453|Sorafenib|sorafenib|mesh-list
24680880|NCT01376453|Antimetabolites|antimetabolites|mesh-ancestor
24680881|NCT01376453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680882|NCT01376453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25261026|NCT02455869|Antimetabolites|antimetabolites|mesh-ancestor
25261027|NCT02455869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261028|NCT02455869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25261029|NCT02455869|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25261030|NCT02455869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261031|NCT02455869|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25261032|NCT02455869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261033|NCT02455856|Itraconazole|itraconazole|mesh-list
25261034|NCT02455856|Antifungal Agents|antifungal agents|mesh-ancestor
25261035|NCT02455856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24932802|NCT04076826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24932803|NCT04076826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24932804|NCT04076826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24932805|NCT04076826|Adrenergic Agents|adrenergic agents|mesh-ancestor
24932806|NCT04076826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24932807|NCT04076826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932830|NCT04076371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24932831|NCT04076371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24932832|NCT04076371|Dopamine Agents|dopamine agents|mesh-ancestor
24932833|NCT04076371|Antiemetics|antiemetics|mesh-ancestor
24932834|NCT04076371|Autonomic Agents|autonomic agents|mesh-ancestor
24932835|NCT04076371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24932836|NCT04076371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24932837|NCT04076371|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24932838|NCT04076371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24932839|NCT04076371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24680883|NCT01376453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680884|NCT01376453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24680885|NCT01376453|Immunologic Factors|immunologic factors|mesh-ancestor
24680886|NCT01376453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680887|NCT01376453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24680888|NCT01376453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680889|NCT01376505|Vaccines|vaccines|mesh-list
24680890|NCT01376505|Immunologic Factors|immunologic factors|mesh-ancestor
24680891|NCT01376505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680924|NCT01376999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680925|NCT01377025|Sorafenib|sorafenib|mesh-list
24680926|NCT01377025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680927|NCT01377025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24680928|NCT01377025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680929|NCT01377025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680930|NCT01377051|Maleic acid|maleic acid|mesh-list
24457144|NCT00333164|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24457145|NCT00333164|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24680966|NCT01377285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680967|NCT01377285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24680968|NCT01377285|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24680969|NCT01377285|Protective Agents|protective agents|mesh-ancestor
24680970|NCT01377285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680971|NCT01377285|Vasodilator Agents|vasodilator agents|mesh-ancestor
24680972|NCT01377285|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24680973|NCT01377285|Antioxidants|antioxidants|mesh-ancestor
24680974|NCT01377324|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24681041|NCT01377961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24681042|NCT01377961|Antioxidants|antioxidants|mesh-ancestor
24681043|NCT01377961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681044|NCT01377961|Protective Agents|protective agents|mesh-ancestor
24681045|NCT01377961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681046|NCT01377961|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24681047|NCT01377961|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24681048|NCT01377961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681049|NCT01377974|Miltefosine|miltefosine|mesh-list
24681050|NCT01377974|Meglumine Antimoniate|meglumine antimoniate|mesh-list
24681051|NCT01377974|Antifungal Agents|antifungal agents|mesh-ancestor
24681052|NCT01377974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24681053|NCT01377974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681054|NCT01377974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25261036|NCT02455856|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25261037|NCT02455856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25261038|NCT02455856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261039|NCT02455856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261040|NCT02455856|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25261041|NCT02455856|Hormone Antagonists|hormone antagonists|mesh-ancestor
25261042|NCT02455856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25261043|NCT02455856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261044|NCT02455856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25261045|NCT02455921|Atropine|atropine|mesh-list
25261046|NCT02455921|Neostigmine|neostigmine|mesh-list
25261047|NCT02455921|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25261048|NCT02455921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25261049|NCT02455921|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25261050|NCT02455921|Autonomic Agents|autonomic agents|mesh-ancestor
24932840|NCT04076371|Antidepressive Agents|antidepressive agents|mesh-ancestor
24932841|NCT04076371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24932842|NCT04076371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24932844|NCT04076098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24932845|NCT04076098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24932846|NCT04076137|Decitabine|decitabine|mesh-list
24932847|NCT04076137|Antibodies|antibodies|mesh-list
24932848|NCT04076137|Antibodies, Bispecific|antibodies, bispecific|mesh-list
24932849|NCT04076137|Immunologic Factors|immunologic factors|mesh-ancestor
24932850|NCT04076137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932851|NCT04076137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24932852|NCT04076137|Antimetabolites|antimetabolites|mesh-ancestor
24760903|NCT01760278|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24854581|NCT02273986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24457156|NCT00333255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24611190|NCT01007695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24611191|NCT01007773|Fentanyl|fentanyl|mesh-list
24681123|NCT01378533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854582|NCT02273986|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24854583|NCT02273986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854584|NCT02273986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854585|NCT02273986|Protective Agents|protective agents|mesh-ancestor
24854586|NCT02273986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854587|NCT02274012|Paclitaxel|paclitaxel|mesh-list
24854588|NCT02274012|Afatinib|afatinib|mesh-list
24854589|NCT02274012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24854590|NCT02274012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24854591|NCT02274012|Tubulin Modulators|tubulin modulators|mesh-ancestor
24854592|NCT02274012|Antimitotic Agents|antimitotic agents|mesh-ancestor
24854593|NCT02274012|Mitosis Modulators|mitosis modulators|mesh-ancestor
24854594|NCT02274012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457163|NCT00333255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24681124|NCT01378533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24681125|NCT01378533|Immunologic Factors|immunologic factors|mesh-ancestor
24681126|NCT01378533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681127|NCT01378533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24681128|NCT01378533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24681129|NCT01378533|Alkylating Agents|alkylating agents|mesh-ancestor
24681130|NCT01378533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24681154|NCT01378650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24681155|NCT01378650|Protective Agents|protective agents|mesh-ancestor
24681156|NCT01378650|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24681157|NCT01378650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24681158|NCT01378650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681159|NCT01378715|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24681160|NCT01378715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24681161|NCT01378715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24681172|NCT01378741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24681173|NCT01378741|Anesthetics, General|anesthetics, general|mesh-ancestor
24681174|NCT01378741|Anesthetics|anesthetics|mesh-ancestor
24681175|NCT01378741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24681177|NCT01378741|Sensory System Agents|sensory system agents|mesh-ancestor
24681178|NCT01378741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24681179|NCT01378741|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24681202|NCT01378845|Urological Agents|urological agents|mesh-ancestor
24681203|NCT01378884|Domperidone|domperidone|mesh-list
24681215|NCT01378949|Anesthetics, Local|anesthetics, local|mesh-ancestor
24681216|NCT01378949|Anesthetics|anesthetics|mesh-ancestor
24681217|NCT01378949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24681225|NCT01379001|Donepezil|donepezil|mesh-list
24681268|NCT01379157|Imipenem|imipenem|mesh-list
25261051|NCT02455921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25261052|NCT02455921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261053|NCT02455921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25261054|NCT02455921|Respiratory System Agents|respiratory system agents|mesh-ancestor
25261055|NCT02455921|Mydriatics|mydriatics|mesh-ancestor
25261056|NCT02455921|Parasympatholytics|parasympatholytics|mesh-ancestor
25261057|NCT02455921|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25261058|NCT02455921|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25261059|NCT02455921|Cholinergic Agents|cholinergic agents|mesh-ancestor
25261060|NCT02455921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24932885|NCT04075721|Hormones|hormones|mesh-ancestor
24932886|NCT04075721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24932887|NCT04075721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24932888|NCT04075721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681269|NCT01379157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24681270|NCT01379157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24681272|NCT01379196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24681273|NCT01379196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24681274|NCT01379300|Rivaroxaban|rivaroxaban|mesh-list
24681275|NCT01379300|Dabigatran|dabigatran|mesh-list
24681276|NCT01379300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24681277|NCT01379300|Antithrombins|antithrombins|mesh-ancestor
24681278|NCT01379300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24681279|NCT01379300|Protease Inhibitors|protease inhibitors|mesh-ancestor
24681283|NCT01379326|Mebendazole|mebendazole|mesh-list
24681334|NCT01379807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24681336|NCT01379846|Immunologic Factors|immunologic factors|mesh-ancestor
24681337|NCT01379846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681338|NCT01379898|Doxazosin|doxazosin|mesh-list
24681339|NCT01379898|Phenoxybenzamine|phenoxybenzamine|mesh-list
24681340|NCT01379898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24681341|NCT01379898|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24681342|NCT01379898|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24681343|NCT01379898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24681344|NCT01379898|Adrenergic Agents|adrenergic agents|mesh-ancestor
24681345|NCT01379898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24681346|NCT01379898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681347|NCT01379898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681349|NCT01379976|Acetylcarnitine|acetylcarnitine|mesh-list
24681362|NCT01380015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24681363|NCT01380015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24681364|NCT01380015|Antioxidants|antioxidants|mesh-ancestor
24681365|NCT01380015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681366|NCT01380015|Protective Agents|protective agents|mesh-ancestor
24681367|NCT01380015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24681382|NCT01380275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681383|NCT01380288|Rivastigmine|rivastigmine|mesh-list
24681384|NCT01380288|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24681385|NCT01380288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681386|NCT01380288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681387|NCT01380288|Cholinergic Agents|cholinergic agents|mesh-ancestor
24681388|NCT01380288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24681451|NCT01380496|Doxycycline|doxycycline|mesh-list
24681452|NCT01380496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24681453|NCT01380496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24681454|NCT01380496|Antimalarials|antimalarials|mesh-ancestor
25261064|NCT02455921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24529883|NCT00628225|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24529884|NCT00628225|Autonomic Agents|autonomic agents|mesh-ancestor
24529885|NCT00628225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24529886|NCT00628225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529887|NCT00628225|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24681455|NCT01380496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24681456|NCT01380496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24681457|NCT01380509|Metronidazole|metronidazole|mesh-list
24681458|NCT01380509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24681459|NCT01380509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24681460|NCT01380509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24681461|NCT01380509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24681462|NCT01380522|Metronidazole|metronidazole|mesh-list
24466068|NCT00371735|Leprostatic Agents|leprostatic agents|mesh-ancestor
24466069|NCT00371735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24466070|NCT00371735|Antimetabolites|antimetabolites|mesh-ancestor
24466071|NCT00371813|Varenicline|varenicline|mesh-list
24466072|NCT00371813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24466073|NCT00371813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24681463|NCT01380522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24681464|NCT01380522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24681483|NCT01380678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24681485|NCT01380678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24681486|NCT01380678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24681494|NCT01380717|Calcium|calcium|mesh-list
24681498|NCT01380717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681499|NCT01380717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24681501|NCT01380717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24681502|NCT01380717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681503|NCT01380717|Protease Inhibitors|protease inhibitors|mesh-ancestor
24681504|NCT01380717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681505|NCT01380717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24436515|NCT00270335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24436516|NCT00270335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436517|NCT00270335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24436518|NCT00270335|Anesthetics, General|anesthetics, general|mesh-ancestor
24436519|NCT00270335|Anesthetics|anesthetics|mesh-ancestor
24681506|NCT01380808|Capecitabine|capecitabine|mesh-list
24681507|NCT01380808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24681508|NCT01380808|Antimetabolites|antimetabolites|mesh-ancestor
24681509|NCT01380808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681510|NCT01380808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681511|NCT01380912|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24681512|NCT01380912|Methylprednisolone|methylprednisolone|mesh-list
24681513|NCT01380912|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24681514|NCT01380912|Prednisolone|prednisolone|mesh-list
24681515|NCT01380912|Prednisolone acetate|prednisolone acetate|mesh-list
24681516|NCT01380912|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24681517|NCT01380912|Prednisolone phosphate|prednisolone phosphate|mesh-list
24681518|NCT01380912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24681519|NCT01380912|Antiemetics|antiemetics|mesh-ancestor
24681520|NCT01380912|Autonomic Agents|autonomic agents|mesh-ancestor
24681521|NCT01380912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24611218|NCT01007799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261089|NCT02455362|Morphine|morphine|mesh-list
25261090|NCT02455362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25261091|NCT02455362|Narcotics|narcotics|mesh-ancestor
25261092|NCT02455362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25261093|NCT02455362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261094|NCT02455362|Analgesics|analgesics|mesh-ancestor
24529888|NCT00628225|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24529889|NCT00628225|Cholinergic Agents|cholinergic agents|mesh-ancestor
24529915|NCT00628290|Anticonvulsants|anticonvulsants|mesh-ancestor
24529916|NCT00628290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24529917|NCT00628290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24529918|NCT00628290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24529919|NCT00628290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529920|NCT00628290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24529921|NCT00628290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24529922|NCT00628290|Dopamine Agents|dopamine agents|mesh-ancestor
24529923|NCT00628290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24529924|NCT00628290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529925|NCT00628290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24529926|NCT00628290|Antidepressive Agents|antidepressive agents|mesh-ancestor
24529927|NCT00628316|Caffeine|caffeine|mesh-list
24529928|NCT00628316|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24529929|NCT00628316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529930|NCT00628316|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24529931|NCT00628316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24936360|NCT04041791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936361|NCT04041791|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24611219|NCT01007799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24611220|NCT01007799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24681556|NCT01381185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24681557|NCT01381185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24681558|NCT01381185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24681559|NCT01381185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24681560|NCT01381185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681623|NCT01381393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24681624|NCT01381393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681625|NCT01381432|Azathioprine|azathioprine|mesh-list
24681626|NCT01381432|Antimetabolites|antimetabolites|mesh-ancestor
24681627|NCT01381432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681628|NCT01381432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24681629|NCT01381432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681630|NCT01381432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24681631|NCT01381432|Immunologic Factors|immunologic factors|mesh-ancestor
24681632|NCT01381432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681633|NCT01381432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24681634|NCT01381445|Clobetasol|clobetasol|mesh-list
25688209|NCT01942785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25688210|NCT01942785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688211|NCT01942785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688212|NCT01942785|Dopamine Agonists|dopamine agonists|mesh-ancestor
25688213|NCT01942785|Dopamine Agents|dopamine agents|mesh-ancestor
24436720|NCT00271063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24436721|NCT00271063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24436722|NCT00271206|Progesterone|progesterone|mesh-list
24436723|NCT00271206|Progestins|progestins|mesh-ancestor
24436724|NCT00271206|Hormones|hormones|mesh-ancestor
24436762|NCT00271323|Antimitotic Agents|antimitotic agents|mesh-ancestor
24436763|NCT00271323|Mitosis Modulators|mitosis modulators|mesh-ancestor
24436776|NCT00271349|Budesonide|budesonide|mesh-list
24436777|NCT00271349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24436778|NCT00271349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24436779|NCT00271349|Autonomic Agents|autonomic agents|mesh-ancestor
24681635|NCT01381445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24681636|NCT01381445|Glucocorticoids|glucocorticoids|mesh-ancestor
24681637|NCT01381445|Hormones|hormones|mesh-ancestor
24681638|NCT01381445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24681639|NCT01381445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681640|NCT01381497|Naproxen|naproxen|mesh-list
24681641|NCT01381497|Sumatriptan|sumatriptan|mesh-list
24681642|NCT01381497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24681643|NCT01381497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24681644|NCT01381497|Analgesics|analgesics|mesh-ancestor
25261095|NCT02455362|Sensory System Agents|sensory system agents|mesh-ancestor
25261096|NCT02455362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25261097|NCT02455609|Dexmedetomidine|dexmedetomidine|mesh-list
25261098|NCT02455609|Ketamine|ketamine|mesh-list
25261099|NCT02455609|Bupivacaine|bupivacaine|mesh-list
25261100|NCT02455609|Anesthetics, Local|anesthetics, local|mesh-ancestor
25261101|NCT02455609|Anesthetics|anesthetics|mesh-ancestor
25261102|NCT02455609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25261103|NCT02455609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261104|NCT02455609|Sensory System Agents|sensory system agents|mesh-ancestor
25261105|NCT02455609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25261106|NCT02455609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25261107|NCT02455609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25261108|NCT02455609|Analgesics|analgesics|mesh-ancestor
25261109|NCT02455609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25261110|NCT02455609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25261111|NCT02455609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25261112|NCT02455609|Adrenergic Agents|adrenergic agents|mesh-ancestor
25261113|NCT02455609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25261114|NCT02455609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261115|NCT02455609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25261116|NCT02455609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24932889|NCT04075760|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24932890|NCT04075760|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24932891|NCT04075760|Adrenergic Agents|adrenergic agents|mesh-ancestor
24932892|NCT04075760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24932901|NCT04075578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24932902|NCT04075578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932903|NCT04075578|Cholinergic Agents|cholinergic agents|mesh-ancestor
24932904|NCT04075578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24932906|NCT04075474|Fluorides|fluorides|mesh-list
24932907|NCT04075474|Sodium Fluoride|sodium fluoride|mesh-list
24681645|NCT01381497|Sensory System Agents|sensory system agents|mesh-ancestor
24681646|NCT01381497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24681647|NCT01381497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854668|NCT02274506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24854669|NCT02274506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24854670|NCT02274506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24681648|NCT01381497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24681650|NCT01381497|Gout Suppressants|gout suppressants|mesh-ancestor
24681651|NCT01381497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24681664|NCT01381510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688215|NCT01942993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688216|NCT01942993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25688217|NCT01942993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688218|NCT01942993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688219|NCT01943435|Acetaminophen|acetaminophen|mesh-list
25688220|NCT01943435|Ibuprofen|ibuprofen|mesh-list
25688221|NCT01943435|Celecoxib|celecoxib|mesh-list
25688222|NCT01943435|Diclofenac|diclofenac|mesh-list
25688223|NCT01943435|Gabapentin|gabapentin|mesh-list
25688224|NCT01943435|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25688225|NCT01943435|Tramadol|tramadol|mesh-list
25688226|NCT01943435|Analgesics|analgesics|mesh-list
25688227|NCT01943435|Mirtazapine|mirtazapine|mesh-list
24947359|NCT03929744|Antimetabolites|antimetabolites|mesh-ancestor
24947385|NCT03929094|Paclitaxel|paclitaxel|mesh-list
24681665|NCT01381510|Hormone Antagonists|hormone antagonists|mesh-ancestor
24681666|NCT01381510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24681667|NCT01381510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681668|NCT01381510|Urological Agents|urological agents|mesh-ancestor
24681677|NCT01381523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24681678|NCT01381523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24681679|NCT01381523|Gout Suppressants|gout suppressants|mesh-ancestor
24681680|NCT01381523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24681718|NCT01381627|Dexmedetomidine|dexmedetomidine|mesh-list
24854671|NCT02274506|Antimetabolites|antimetabolites|mesh-ancestor
24854672|NCT02274506|Antiviral Agents|antiviral agents|mesh-ancestor
24854673|NCT02274506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24854674|NCT02274545|Vaccines|vaccines|mesh-list
24854675|NCT02274545|Immunologic Factors|immunologic factors|mesh-ancestor
24854676|NCT02274545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854677|NCT02274610|Docetaxel|docetaxel|mesh-list
24854678|NCT02274610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681763|NCT01381835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681764|NCT01381848|Doripenem|doripenem|mesh-list
24681765|NCT01381848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24681766|NCT01381848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24681767|NCT01381887|Canagliflozin|canagliflozin|mesh-list
24681768|NCT01381887|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24681769|NCT01381887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681770|NCT01381887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24681771|NCT01381887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681772|NCT01382004|Azithromycin|azithromycin|mesh-list
24681773|NCT01382004|Penicillins|penicillins|mesh-list
24681774|NCT01382004|Penicillin G|penicillin g|mesh-list
24681775|NCT01382004|Penicillin G Benzathine|penicillin g benzathine|mesh-list
24681776|NCT01382004|Penicillin G Procaine|penicillin g procaine|mesh-list
24681777|NCT01382004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24933068|NCT04074317|Pramlintide|pramlintide|mesh-list
24681780|NCT01382017|Carbamazepine|carbamazepine|mesh-list
24681781|NCT01382017|Anticonvulsants|anticonvulsants|mesh-ancestor
24681782|NCT01382017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24681783|NCT01382017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24681784|NCT01382017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24681785|NCT01382017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681786|NCT01382017|Antimanic Agents|antimanic agents|mesh-ancestor
24681787|NCT01382017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24681801|NCT01382134|Analgesics|analgesics|mesh-ancestor
24681820|NCT01382147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25261117|NCT02455609|Anesthetics, General|anesthetics, general|mesh-ancestor
25261118|NCT02455609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25261119|NCT02455609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25261120|NCT02455401|Remifentanil|remifentanil|mesh-list
25261121|NCT02455401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25261122|NCT02455401|Narcotics|narcotics|mesh-ancestor
25261123|NCT02455401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25261124|NCT02455401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261125|NCT02455401|Analgesics|analgesics|mesh-ancestor
25261126|NCT02455401|Sensory System Agents|sensory system agents|mesh-ancestor
24932908|NCT04075474|Cariostatic Agents|cariostatic agents|mesh-ancestor
24932911|NCT04075474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24932912|NCT04075474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24932913|NCT04075227|Loteprednol Etabonate|loteprednol etabonate|mesh-list
24932914|NCT04075227|Dexamethasone|dexamethasone|mesh-list
24932915|NCT04075227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24932916|NCT04075227|Antiemetics|antiemetics|mesh-ancestor
24932917|NCT04075227|Autonomic Agents|autonomic agents|mesh-ancestor
24932918|NCT04075227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24932919|NCT04075227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932920|NCT04075227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24932921|NCT04075227|Glucocorticoids|glucocorticoids|mesh-ancestor
24932922|NCT04075227|Hormones|hormones|mesh-ancestor
24932923|NCT04075227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24529932|NCT00628316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529933|NCT00628316|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24932924|NCT04075227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24932925|NCT04075227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688228|NCT01943435|Trazodone|trazodone|mesh-list
25688229|NCT01943435|Sertraline|sertraline|mesh-list
25688230|NCT01943435|Nortriptyline|nortriptyline|mesh-list
24437260|NCT00273247|Antiviral Agents|antiviral agents|mesh-ancestor
24932926|NCT04075227|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24932927|NCT04075006|Ketamine|ketamine|mesh-list
24932928|NCT04075006|Analgesics|analgesics|mesh-ancestor
24932929|NCT04075006|Sensory System Agents|sensory system agents|mesh-ancestor
24932930|NCT04075006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24932931|NCT04075006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932932|NCT04075006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24932933|NCT04075006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24932934|NCT04075006|Anesthetics, General|anesthetics, general|mesh-ancestor
24932935|NCT04075006|Anesthetics|anesthetics|mesh-ancestor
24932936|NCT04075006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24932937|NCT04075006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24932938|NCT04075006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25261127|NCT02455401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25261128|NCT02455596|Interferons|interferons|mesh-list
25261129|NCT02455596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25261130|NCT02455596|Antiviral Agents|antiviral agents|mesh-ancestor
25261131|NCT02455596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25261132|NCT02455440|Propofol|propofol|mesh-list
25261133|NCT02455440|Sevoflurane|sevoflurane|mesh-list
25261134|NCT02455440|Esmolol|esmolol|mesh-list
25261135|NCT02455440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25261136|NCT02455440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25261137|NCT02455440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261138|NCT02455440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25261139|NCT02455440|Anesthetics, General|anesthetics, general|mesh-ancestor
25261140|NCT02455440|Anesthetics|anesthetics|mesh-ancestor
25261141|NCT02455440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25261142|NCT02455440|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25261143|NCT02455440|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25261144|NCT02455440|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25261145|NCT02455440|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25261146|NCT02455440|Adrenergic Agents|adrenergic agents|mesh-ancestor
25261147|NCT02455440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25261148|NCT02455440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261150|NCT02455271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25261151|NCT02455271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25261152|NCT02455271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261153|NCT02455232|Lidocaine|lidocaine|mesh-list
25261154|NCT02455232|Anesthetics, Local|anesthetics, local|mesh-ancestor
25261155|NCT02455232|Anesthetics|anesthetics|mesh-ancestor
25261156|NCT02455232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25261157|NCT02455232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261158|NCT02455232|Sensory System Agents|sensory system agents|mesh-ancestor
25261159|NCT02455232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25261160|NCT02455232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25261161|NCT02455232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25261162|NCT02455232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25261163|NCT02455232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25261164|NCT02455232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261165|NCT02455245|Carboplatin|carboplatin|mesh-list
25261166|NCT02455245|Vincristine|vincristine|mesh-list
24625230|NCT01081002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625232|NCT01081158|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24625233|NCT01081158|Interferon-alpha|interferon-alpha|mesh-list
24625234|NCT01081158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24625235|NCT01081158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24932981|NCT04075188|Growth Inhibitors|growth inhibitors|mesh-ancestor
24932982|NCT04075188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24932983|NCT04075188|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24932984|NCT04075188|Dermatologic Agents|dermatologic agents|mesh-ancestor
24529962|NCT00628550|Sympathomimetics|sympathomimetics|mesh-ancestor
24529963|NCT00628550|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24681821|NCT01382147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681822|NCT01382147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24681823|NCT01382147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24681824|NCT01382147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854702|NCT02274974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24854703|NCT02274974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854704|NCT02274974|Sensory System Agents|sensory system agents|mesh-ancestor
24854705|NCT02274974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24854706|NCT02274974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25688231|NCT01943435|Antidepressive Agents|antidepressive agents|mesh-list
24854707|NCT02274974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24854708|NCT02274974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24854709|NCT02274974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24457262|NCT00333632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24457263|NCT00333632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457264|NCT00333632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24457265|NCT00333632|Narcotics|narcotics|mesh-ancestor
24457266|NCT00333632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24905900|NCT04344288|Hormones|hormones|mesh-ancestor
24681920|NCT01383044|Carvedilol|carvedilol|mesh-list
24681921|NCT01383044|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24854728|NCT02275013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854729|NCT02275013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854730|NCT02275013|Protective Agents|protective agents|mesh-ancestor
25261167|NCT02455245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25261168|NCT02455245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25261169|NCT02455245|Tubulin Modulators|tubulin modulators|mesh-ancestor
25261170|NCT02455245|Antimitotic Agents|antimitotic agents|mesh-ancestor
25261171|NCT02455245|Mitosis Modulators|mitosis modulators|mesh-ancestor
25261172|NCT02455245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261173|NCT02454894|Lidocaine|lidocaine|mesh-list
25261174|NCT02454894|Anesthetics, Local|anesthetics, local|mesh-ancestor
25261175|NCT02454894|Anesthetics|anesthetics|mesh-ancestor
25261176|NCT02454894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25261177|NCT02454894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261178|NCT02454894|Sensory System Agents|sensory system agents|mesh-ancestor
25261179|NCT02454894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25261180|NCT02454894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25261181|NCT02454894|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25261182|NCT02454894|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25261183|NCT02454894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25261184|NCT02454894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261185|NCT02455154|Letrozole|letrozole|mesh-list
25261186|NCT02455154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25261187|NCT02455154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25261188|NCT02455154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25261189|NCT02455154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275694|NCT02369978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24529964|NCT00628550|Hemostatics|hemostatics|mesh-ancestor
24529965|NCT00628550|Coagulants|coagulants|mesh-ancestor
24529966|NCT00628550|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24933009|NCT04074473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933010|NCT04074473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933011|NCT04074473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24933012|NCT04074473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24933013|NCT04074473|Vasodilator Agents|vasodilator agents|mesh-ancestor
24933015|NCT04074603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24933016|NCT04074603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933017|NCT04074564|Apatinib|apatinib|mesh-list
24933018|NCT04074564|Antibodies|antibodies|mesh-list
24933019|NCT04074564|Immunologic Factors|immunologic factors|mesh-ancestor
24933020|NCT04074564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933024|NCT04074564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933026|NCT04074551|Amlodipine|amlodipine|mesh-list
24933027|NCT04074551|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24933028|NCT04074551|Ezetimibe|ezetimibe|mesh-list
24933029|NCT04074551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24933030|NCT04074551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24933031|NCT04074551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24933032|NCT04074551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261190|NCT02455154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261191|NCT02455154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25261192|NCT02455154|Hormone Antagonists|hormone antagonists|mesh-ancestor
25261193|NCT02455154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25261194|NCT02455154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261195|NCT02455180|Ascorbic Acid|ascorbic acid|mesh-list
25261196|NCT02455180|Vitamins|vitamins|mesh-ancestor
25261197|NCT02455180|Micronutrients|micronutrients|mesh-ancestor
25261198|NCT02455180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261199|NCT02455180|Antioxidants|antioxidants|mesh-ancestor
25688232|NCT01943435|Misoprostol|misoprostol|mesh-list
25688233|NCT01943435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24438560|NCT00276172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438561|NCT00276185|Botulinum Toxins|botulinum toxins|mesh-list
24438562|NCT00276185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24438563|NCT00276185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24438564|NCT00276185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438565|NCT00276185|Cholinergic Agents|cholinergic agents|mesh-ancestor
24438566|NCT00276185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24438567|NCT00276185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438568|NCT00276198|Vitamin D|vitamin d|mesh-list
25261200|NCT02455180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261201|NCT02455180|Protective Agents|protective agents|mesh-ancestor
25261202|NCT02454881|Dexmedetomidine|dexmedetomidine|mesh-list
25261203|NCT02454881|Oxycodone|oxycodone|mesh-list
25261204|NCT02454881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25261205|NCT02454881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25261206|NCT02454881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261207|NCT02454881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25261208|NCT02454881|Analgesics|analgesics|mesh-ancestor
25261209|NCT02454881|Sensory System Agents|sensory system agents|mesh-ancestor
25261210|NCT02454881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25261211|NCT02454881|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25261212|NCT02454881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25261213|NCT02454881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25261214|NCT02454881|Adrenergic Agents|adrenergic agents|mesh-ancestor
25261215|NCT02454881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25261216|NCT02454881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261217|NCT02454881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25261218|NCT02454881|Narcotics|narcotics|mesh-ancestor
25261219|NCT02455115|Chromium|chromium|mesh-list
25261220|NCT02455115|Norepinephrine|norepinephrine|mesh-list
25261221|NCT02455115|Edetic Acid|edetic acid|mesh-list
25261222|NCT02455115|Pentetic Acid|pentetic acid|mesh-list
25261223|NCT02455115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25261224|NCT02455115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25261225|NCT02455115|Adrenergic Agents|adrenergic agents|mesh-ancestor
25261226|NCT02455115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25261227|NCT02455115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933035|NCT04074551|Vasodilator Agents|vasodilator agents|mesh-ancestor
24933036|NCT04074551|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24933053|NCT04074213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933054|NCT04074213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933055|NCT04074213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24933056|NCT04074213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24933058|NCT04074213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24933065|NCT04073953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24933067|NCT04074317|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24933069|NCT04074317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24933070|NCT04074317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933071|NCT04073849|Epoetin Alfa|epoetin alfa|mesh-list
24933072|NCT04073849|Hematinics|hematinics|mesh-ancestor
24933073|NCT04073758|Dexmedetomidine|dexmedetomidine|mesh-list
24933074|NCT04073758|Remifentanil|remifentanil|mesh-list
24933075|NCT04073758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24933076|NCT04073758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24933077|NCT04073758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933078|NCT04073758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24933079|NCT04073758|Analgesics|analgesics|mesh-ancestor
24933080|NCT04073758|Sensory System Agents|sensory system agents|mesh-ancestor
24509517|NCT00560638|Loteprednol Etabonate|loteprednol etabonate|mesh-list
24509518|NCT00560638|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24854731|NCT02275013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854732|NCT02275039|Gemcitabine|gemcitabine|mesh-list
24611311|NCT01008566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24681953|NCT01383148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25688234|NCT01943435|Sensory System Agents|sensory system agents|mesh-ancestor
25688235|NCT01943435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25688236|NCT01943435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688237|NCT01943435|Antipyretics|antipyretics|mesh-ancestor
25688238|NCT01943435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25688239|NCT01943435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25688240|NCT01943435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25688241|NCT01943435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25688242|NCT01943435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681954|NCT01383148|Immunologic Factors|immunologic factors|mesh-ancestor
24681955|NCT01383148|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24438810|NCT00276770|Protective Agents|protective agents|mesh-ancestor
24438811|NCT00276770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438812|NCT00276783|Pemetrexed|pemetrexed|mesh-list
24438813|NCT00276783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438814|NCT00276783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438815|NCT00276783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438889|NCT00276848|Cyclophosphamide|cyclophosphamide|mesh-list
24438890|NCT00276848|Fludarabine|fludarabine|mesh-list
24438891|NCT00276848|Fludarabine phosphate|fludarabine phosphate|mesh-list
24438892|NCT00276848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24438893|NCT00276848|Immunologic Factors|immunologic factors|mesh-ancestor
24681956|NCT01383148|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24681957|NCT01383330|Megestrol Acetate|megestrol acetate|mesh-list
24854739|NCT02275039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24854740|NCT02275039|Antiviral Agents|antiviral agents|mesh-ancestor
24854741|NCT02275039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24854742|NCT02275039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854743|NCT02275039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24854744|NCT02275130|Calcium, Dietary|calcium, dietary|mesh-list
24854745|NCT02275130|Calcium|calcium|mesh-list
24854746|NCT02275130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24854747|NCT02275130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905994|NCT04343963|Bromides|bromides|mesh-list
24682020|NCT01383395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24682021|NCT01383395|Vasodilator Agents|vasodilator agents|mesh-ancestor
24682022|NCT01383395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24682023|NCT01383395|Protective Agents|protective agents|mesh-ancestor
24682071|NCT01383668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682072|NCT01383668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24682073|NCT01383694|Piperine|piperine|mesh-list
24682074|NCT01383694|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24682075|NCT01383694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261228|NCT02455115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261229|NCT02455115|Sympathomimetics|sympathomimetics|mesh-ancestor
25261230|NCT02455115|Autonomic Agents|autonomic agents|mesh-ancestor
25261231|NCT02455115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25261232|NCT02455115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25261233|NCT02455115|Trace Elements|trace elements|mesh-ancestor
25261234|NCT02455115|Micronutrients|micronutrients|mesh-ancestor
25261235|NCT02455115|Anticoagulants|anticoagulants|mesh-ancestor
25261236|NCT02455115|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25261237|NCT02455115|Chelating Agents|chelating agents|mesh-ancestor
25261238|NCT02455115|Sequestering Agents|sequestering agents|mesh-ancestor
25261239|NCT02455115|Antidotes|antidotes|mesh-ancestor
25261240|NCT02455115|Protective Agents|protective agents|mesh-ancestor
25261241|NCT02455115|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25261242|NCT02455011|Volagidemab|volagidemab|mesh-list
25261243|NCT02455011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25261244|NCT02455011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261245|NCT02454868|Remifentanil|remifentanil|mesh-list
25261246|NCT02454868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25261247|NCT02454868|Narcotics|narcotics|mesh-ancestor
25261248|NCT02454868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25261249|NCT02454868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261250|NCT02454868|Analgesics|analgesics|mesh-ancestor
25261251|NCT02454868|Sensory System Agents|sensory system agents|mesh-ancestor
25261252|NCT02454868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24509519|NCT00560690|Metformin|metformin|mesh-list
24509520|NCT00560690|Interferons|interferons|mesh-list
24509521|NCT00560690|Ribavirin|ribavirin|mesh-list
24537901|NCT00656695|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24537903|NCT00656747|Moxifloxacin|moxifloxacin|mesh-list
24537904|NCT00656747|Clavulanic Acids|clavulanic acids|mesh-list
24509525|NCT00560690|Antiviral Agents|antiviral agents|mesh-ancestor
24642256|NCT01178645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25688243|NCT01943435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688244|NCT01943435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25688245|NCT01943435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25688246|NCT01943435|Abortifacient Agents|abortifacient agents|mesh-ancestor
25688247|NCT01943435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25688248|NCT01943435|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25688249|NCT01943435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25688250|NCT01943435|Oxytocics|oxytocics|mesh-ancestor
25688251|NCT01943435|Anticonvulsants|anticonvulsants|mesh-ancestor
25688252|NCT01943435|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24529997|NCT00628706|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24529998|NCT00628706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25404318|NCT03674242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439035|NCT00277225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439036|NCT00277225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439037|NCT00277225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24439038|NCT00277225|Immunologic Factors|immunologic factors|mesh-ancestor
24439039|NCT00277225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529999|NCT00628706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530001|NCT00628706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24530003|NCT00628719|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24530004|NCT00628719|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
24530005|NCT00628719|Deoxycholic Acid|deoxycholic acid|mesh-list
24530006|NCT00628719|Amebicides|amebicides|mesh-ancestor
24530007|NCT00628719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24530008|NCT00628719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24530009|NCT00628719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24530011|NCT00628719|Antifungal Agents|antifungal agents|mesh-ancestor
24933094|NCT04073797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933095|NCT04073797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24933096|NCT04073550|Topotecan|topotecan|mesh-list
24933097|NCT04073550|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24757484|NCT01740336|Paclitaxel|paclitaxel|mesh-list
24764538|NCT01782560|Omeprazole|omeprazole|mesh-list
24933098|NCT04073550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24933100|NCT04073550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933101|NCT04073550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24933102|NCT04073537|Paclitaxel|paclitaxel|mesh-list
24933103|NCT04073537|Carboplatin|carboplatin|mesh-list
24509527|NCT00560690|Antimetabolites|antimetabolites|mesh-ancestor
24530054|NCT00628810|Micronutrients|micronutrients|mesh-ancestor
24530055|NCT00628914|Dexetimide|dexetimide|mesh-list
24530056|NCT00628914|Eszopiclone|eszopiclone|mesh-list
24530057|NCT00628914|Citalopram|citalopram|mesh-list
24936463|NCT04039854|Sevoflurane|sevoflurane|mesh-list
24682076|NCT01383694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682077|NCT01383785|Abciximab|abciximab|mesh-list
24682078|NCT01383785|Anticoagulants|anticoagulants|mesh-ancestor
24682079|NCT01383785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24682080|NCT01384214|Botulinum Toxins|botulinum toxins|mesh-list
24682081|NCT01384214|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24682082|NCT01384214|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24682083|NCT01384214|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24682084|NCT01384214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24682106|NCT01384058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25261253|NCT02454764|Interferons|interferons|mesh-list
25261254|NCT02454764|Tenofovir|tenofovir|mesh-list
25261255|NCT02454764|Interferon-alpha|interferon-alpha|mesh-list
25261256|NCT02454764|Interferon alpha-2|interferon alpha-2|mesh-list
25261257|NCT02454764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25261258|NCT02454764|Antiviral Agents|antiviral agents|mesh-ancestor
25261259|NCT02454764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25261260|NCT02454764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25261261|NCT02454764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25261262|NCT02454764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261263|NCT02454764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261264|NCT02454764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25261265|NCT02454764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25261266|NCT02454764|Immunologic Factors|immunologic factors|mesh-ancestor
25261267|NCT02454764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261268|NCT02454751|Fentanyl|fentanyl|mesh-list
25261269|NCT02454751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25261270|NCT02454751|Narcotics|narcotics|mesh-ancestor
25261271|NCT02454751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25261272|NCT02454751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261273|NCT02454751|Analgesics|analgesics|mesh-ancestor
25261274|NCT02454751|Sensory System Agents|sensory system agents|mesh-ancestor
25261275|NCT02454751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25261276|NCT02454751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25261277|NCT02454751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25688253|NCT01943435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25688254|NCT01943435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25688255|NCT01943435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25688256|NCT01943435|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25688257|NCT01943435|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25261278|NCT02454751|Anesthetics, General|anesthetics, general|mesh-ancestor
25261279|NCT02454751|Anesthetics|anesthetics|mesh-ancestor
25261280|NCT02454712|Naltrexone|naltrexone|mesh-list
25261281|NCT02454712|Oxycodone|oxycodone|mesh-list
25261282|NCT02454712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25261283|NCT02454712|Narcotics|narcotics|mesh-ancestor
25261284|NCT02454712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25261285|NCT02454712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530058|NCT00628914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24530075|NCT00628914|Cholinergic Agents|cholinergic agents|mesh-ancestor
24530076|NCT00628914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24530276|NCT00629681|Analgesics|analgesics|mesh-ancestor
24530077|NCT00628914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24530078|NCT00628953|Esomeprazole|esomeprazole|mesh-list
24933110|NCT04073719|Acetic Acid|acetic acid|mesh-list
24933111|NCT04073719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24933112|NCT04073719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24933113|NCT04073602|Trastuzumab|trastuzumab|mesh-list
24933114|NCT04073602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24933115|NCT04073602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24933117|NCT04073680|Serabelisib|serabelisib|mesh-list
24933118|NCT04073680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24933119|NCT04073680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933120|NCT04073680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24933121|NCT04073680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933122|NCT04073680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933123|NCT04073173|Analgesics, Opioid|analgesics, opioid|mesh-list
24933125|NCT04073173|Narcotics|narcotics|mesh-ancestor
24933126|NCT04073173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24933127|NCT04073173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933128|NCT04073173|Sensory System Agents|sensory system agents|mesh-ancestor
24933129|NCT04073173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24933130|NCT04074265|Ketorolac|ketorolac|mesh-list
24933131|NCT04074265|Epinephrine|epinephrine|mesh-list
24933132|NCT04074265|Ropivacaine|ropivacaine|mesh-list
24933133|NCT04074265|Anesthetics, Local|anesthetics, local|mesh-ancestor
24933161|NCT04073160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24933162|NCT04073160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24933163|NCT04073134|Evolocumab|evolocumab|mesh-list
24933164|NCT04073134|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24933165|NCT04073134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24625280|NCT01081535|Analgesics|analgesics|mesh-ancestor
25261286|NCT02454712|Analgesics|analgesics|mesh-ancestor
25261287|NCT02454712|Sensory System Agents|sensory system agents|mesh-ancestor
25261288|NCT02454712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25261289|NCT02454712|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25261290|NCT02454712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25261291|NCT02454491|Verapamil|verapamil|mesh-list
25261292|NCT02454491|Heparin|heparin|mesh-list
25261293|NCT02454491|Anticoagulants|anticoagulants|mesh-ancestor
25261294|NCT02454491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25261295|NCT02454491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25261296|NCT02454491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261297|NCT02454491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25261298|NCT02454491|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25261299|NCT02454491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25261300|NCT02454491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25261301|NCT02454491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261302|NCT02454491|Vasodilator Agents|vasodilator agents|mesh-ancestor
25275180|NCT02373579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275181|NCT02373579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25275182|NCT02373579|Dermatologic Agents|dermatologic agents|mesh-ancestor
25275183|NCT02373579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538280|NCT00658268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25275184|NCT02373579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25275185|NCT02373579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25275186|NCT02373579|Immunologic Factors|immunologic factors|mesh-ancestor
25275187|NCT02373579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25275188|NCT02373579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25275189|NCT02373410|Bupivacaine|bupivacaine|mesh-list
25275190|NCT02373410|Anesthetics, Local|anesthetics, local|mesh-ancestor
25275191|NCT02373410|Anesthetics|anesthetics|mesh-ancestor
25275192|NCT02373410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25275193|NCT02373410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275194|NCT02373410|Sensory System Agents|sensory system agents|mesh-ancestor
25275195|NCT02373410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275196|NCT02373462|Olmesartan|olmesartan|mesh-list
25275197|NCT02373462|Antihypertensive Agents|antihypertensive agents|mesh-list
25275198|NCT02373462|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25275199|NCT02373462|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25275200|NCT02373462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275201|NCT02373215|Nalbuphine|nalbuphine|mesh-list
25275202|NCT02373215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24933198|NCT04073927|Histamine Agents|histamine agents|mesh-ancestor
24933199|NCT04073927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24933237|NCT04072640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24530106|NCT00629148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24530107|NCT00629148|Antimetabolites|antimetabolites|mesh-ancestor
24530108|NCT00629148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25155543|NCT05346601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24966139|NCT03770936|Ramipril|ramipril|mesh-list
24933211|NCT04073056|Bupivacaine|bupivacaine|mesh-list
24933212|NCT04073056|Anesthetics, Local|anesthetics, local|mesh-ancestor
24933213|NCT04073056|Anesthetics|anesthetics|mesh-ancestor
24682107|NCT01384058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24682108|NCT01384058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682110|NCT01384279|Topiramate|topiramate|mesh-list
24682111|NCT01384279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24682112|NCT01384279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682113|NCT01384279|Anticonvulsants|anticonvulsants|mesh-ancestor
24682114|NCT01384331|NuvaRing|nuvaring|mesh-list
24682123|NCT01384331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25261303|NCT02454504|Neostigmine|neostigmine|mesh-list
25261304|NCT02454504|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25261305|NCT02454504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261306|NCT02454504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261307|NCT02454504|Cholinergic Agents|cholinergic agents|mesh-ancestor
25261308|NCT02454504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25261309|NCT02454504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261310|NCT02454504|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25261311|NCT02454504|Autonomic Agents|autonomic agents|mesh-ancestor
25261312|NCT02454504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25261313|NCT02454556|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25261314|NCT02454556|Hormones|hormones|mesh-ancestor
25261315|NCT02454556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25261316|NCT02454556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261317|NCT02454426|Vortioxetine|vortioxetine|mesh-list
25261318|NCT02454426|Antidepressive Agents|antidepressive agents|mesh-ancestor
25261319|NCT02454426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25261320|NCT02454426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25261321|NCT02454426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25261322|NCT02454426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25261323|NCT02454426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261324|NCT02454426|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25261325|NCT02454426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25261326|NCT02454426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25261327|NCT02454426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261328|NCT02454426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25261329|NCT02454426|Serotonin Agents|serotonin agents|mesh-ancestor
25261330|NCT02454426|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25261331|NCT02454426|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25261332|NCT02454426|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25261333|NCT02454426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24530115|NCT00629187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24530116|NCT00629187|Alkylating Agents|alkylating agents|mesh-ancestor
24933238|NCT04072640|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24530117|NCT00629187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530118|NCT00629187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530120|NCT00629200|Interferon-alpha|interferon-alpha|mesh-list
24530133|NCT00629213|Acarbose|acarbose|mesh-list
24530141|NCT00629226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530149|NCT00629252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530151|NCT00629252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24530152|NCT00629252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24530153|NCT00629252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24530154|NCT00629252|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24530155|NCT00629252|Dopamine Agents|dopamine agents|mesh-ancestor
24933230|NCT04072640|Hormone Antagonists|hormone antagonists|mesh-ancestor
24933231|NCT04072640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25050204|NCT00532038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24682124|NCT01384331|Progestins|progestins|mesh-ancestor
24682125|NCT01384331|Hormones|hormones|mesh-ancestor
24682126|NCT01384331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24682127|NCT01384448|Dobutamine|dobutamine|mesh-list
24682128|NCT01384448|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24682129|NCT01384448|Sympathomimetics|sympathomimetics|mesh-ancestor
24682130|NCT01384448|Autonomic Agents|autonomic agents|mesh-ancestor
24682131|NCT01384448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24854786|NCT02275299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24854787|NCT02275416|Ipilimumab|ipilimumab|mesh-list
24854788|NCT02275416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24854789|NCT02275416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24854790|NCT02275416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24682201|NCT01384695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24682202|NCT01384695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24682203|NCT01384708|Proflavine|proflavine|mesh-list
24682204|NCT01384708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24682205|NCT01384708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24682206|NCT01384773|Riboflavin|riboflavin|mesh-list
24682290|NCT01385527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682291|NCT01385631|Ezetimibe|ezetimibe|mesh-list
24682292|NCT01385631|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24682293|NCT01385631|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24682294|NCT01385631|Antimetabolites|antimetabolites|mesh-ancestor
24682302|NCT01385683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682303|NCT01385683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682304|NCT01385683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24682305|NCT01385683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24682307|NCT01385683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24682308|NCT01385683|Protease Inhibitors|protease inhibitors|mesh-ancestor
24682309|NCT01385683|Anticoagulants|anticoagulants|mesh-ancestor
24682310|NCT01385735|Rasagiline|rasagiline|mesh-list
24682311|NCT01385735|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24682312|NCT01385735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682313|NCT01385735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261334|NCT02454348|Vasopressins|vasopressins|mesh-list
25261335|NCT02454348|Arginine Vasopressin|arginine vasopressin|mesh-list
25261336|NCT02454348|Norepinephrine|norepinephrine|mesh-list
25261337|NCT02454348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25261338|NCT02454348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25261339|NCT02454348|Adrenergic Agents|adrenergic agents|mesh-ancestor
25261340|NCT02454348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25261341|NCT02454348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261342|NCT02454348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261343|NCT02454348|Sympathomimetics|sympathomimetics|mesh-ancestor
25261344|NCT02454348|Autonomic Agents|autonomic agents|mesh-ancestor
25261345|NCT02454348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25261346|NCT02454348|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25261347|NCT02454348|Hemostatics|hemostatics|mesh-ancestor
25261348|NCT02454348|Coagulants|coagulants|mesh-ancestor
25261349|NCT02454348|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25261350|NCT02454348|Natriuretic Agents|natriuretic agents|mesh-ancestor
25261351|NCT02454205|Moxifloxacin|moxifloxacin|mesh-list
25261352|NCT02454205|Levofloxacin|levofloxacin|mesh-list
25261353|NCT02454205|Ofloxacin|ofloxacin|mesh-list
25261354|NCT02454205|Isoniazid|isoniazid|mesh-list
24933232|NCT04072640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933233|NCT04072640|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24933234|NCT04072640|Amebicides|amebicides|mesh-ancestor
24933235|NCT04072640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24933236|NCT04072640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24933239|NCT04072640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24933240|NCT04072900|Imiquimod|imiquimod|mesh-list
24933241|NCT04072900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24933242|NCT04072900|Immunologic Factors|immunologic factors|mesh-ancestor
24933243|NCT04072900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933244|NCT04072900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688258|NCT01943435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25688259|NCT01943435|Antimanic Agents|antimanic agents|mesh-ancestor
24933289|NCT04072198|Irinotecan|irinotecan|mesh-list
24933290|NCT04072198|Fluorouracil|fluorouracil|mesh-list
25050208|NCT00531622|Citalopram|citalopram|mesh-list
24682314|NCT01385735|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24682315|NCT01385735|Protective Agents|protective agents|mesh-ancestor
24682316|NCT01385735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682317|NCT01385826|Antibodies|antibodies|mesh-list
24682318|NCT01385826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24682319|NCT01385826|Immunologic Factors|immunologic factors|mesh-ancestor
24682320|NCT01385826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466901|NCT00375557|Antimanic Agents|antimanic agents|mesh-ancestor
24466902|NCT00375583|Albendazole|albendazole|mesh-list
24466903|NCT00375583|Anthelmintics|anthelmintics|mesh-ancestor
24466904|NCT00375583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24466905|NCT00375583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24682321|NCT01385891|Etoposide|etoposide|mesh-list
24682322|NCT01385891|Clofarabine|clofarabine|mesh-list
24682323|NCT01385891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24682324|NCT01385891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611313|NCT01008566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24611315|NCT01008566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611316|NCT01008566|Immunologic Factors|immunologic factors|mesh-ancestor
24611317|NCT01008566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611318|NCT01008592|Levocetirizine|levocetirizine|mesh-list
24611319|NCT01008592|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24611320|NCT01008592|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24611321|NCT01008592|Histamine Antagonists|histamine antagonists|mesh-ancestor
24611322|NCT01008592|Histamine Agents|histamine agents|mesh-ancestor
24611323|NCT01008592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24611324|NCT01008592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611325|NCT01008592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611326|NCT01008631|Sodium thiosulfate|sodium thiosulfate|mesh-list
24611347|NCT01008761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24611348|NCT01008813|Vaccines|vaccines|mesh-list
24611349|NCT01008813|Immunologic Factors|immunologic factors|mesh-ancestor
24611350|NCT01008813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682431|NCT01386346|Azacitidine|azacitidine|mesh-list
24682432|NCT01386346|Oxaliplatin|oxaliplatin|mesh-list
24682433|NCT01386346|Epirubicin|epirubicin|mesh-list
24812666|NCT02053974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24854808|NCT02275702|Dexamethasone|dexamethasone|mesh-list
24682434|NCT01386346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24682435|NCT01386346|Antimetabolites|antimetabolites|mesh-ancestor
24682436|NCT01386346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682437|NCT01386346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24682438|NCT01386346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261355|NCT02454205|Linezolid|linezolid|mesh-list
25261356|NCT02454205|Pyrazinamide|pyrazinamide|mesh-list
25261357|NCT02454205|Bedaquiline|bedaquiline|mesh-list
25261358|NCT02454205|Kanamycin|kanamycin|mesh-list
25261359|NCT02454205|Ethionamide|ethionamide|mesh-list
25261360|NCT02454205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25261361|NCT02454205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25261362|NCT02454205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25261363|NCT02454205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25261364|NCT02454205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261365|NCT02454205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261366|NCT02454205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25261367|NCT02454205|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25261368|NCT02454205|Renal Agents|renal agents|mesh-ancestor
25261369|NCT02454205|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25261370|NCT02454205|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24933291|NCT04072198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24933292|NCT04072198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530243|NCT00629512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688260|NCT01943435|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25688261|NCT01943435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25688262|NCT01943435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25688263|NCT01943435|Dopamine Agents|dopamine agents|mesh-ancestor
25688264|NCT01943435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24530244|NCT00629564|Esomeprazole|esomeprazole|mesh-list
25688265|NCT01943435|Narcotics|narcotics|mesh-ancestor
24933318|NCT04072328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24933319|NCT04072328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933320|NCT04072328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24933321|NCT04072328|Anesthetics, General|anesthetics, general|mesh-ancestor
24757715|NCT01742247|Antiviral Agents|antiviral agents|mesh-ancestor
24933322|NCT04072328|Anesthetics|anesthetics|mesh-ancestor
24933323|NCT04072328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24933324|NCT04072328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24933325|NCT04072328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24933326|NCT04072328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24933327|NCT04072328|GABA Modulators|gaba modulators|mesh-ancestor
24933328|NCT04072328|GABA Agents|gaba agents|mesh-ancestor
24933329|NCT04072328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24933330|NCT04072328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933331|NCT04071639|Ubiquinone|ubiquinone|mesh-list
24933332|NCT04071639|Haloperidol|haloperidol|mesh-list
24933333|NCT04071639|Risperidone|risperidone|mesh-list
24933334|NCT04071639|Haloperidol decanoate|haloperidol decanoate|mesh-list
24933335|NCT04071639|Sertraline|sertraline|mesh-list
24933337|NCT04071639|Idebenone|idebenone|mesh-list
24933358|NCT04071639|Antioxidants|antioxidants|mesh-ancestor
24933359|NCT04071639|Protective Agents|protective agents|mesh-ancestor
24933360|NCT04071639|Micronutrients|micronutrients|mesh-ancestor
24933361|NCT04071639|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24933362|NCT04071639|Adrenergic Agents|adrenergic agents|mesh-ancestor
24933363|NCT04071574|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24933364|NCT04071574|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24933365|NCT04071574|Cetrorelix|cetrorelix|mesh-list
24933366|NCT04071574|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25261371|NCT02454205|Antitubercular Agents|antitubercular agents|mesh-ancestor
25261372|NCT02454205|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25261373|NCT02454205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25261374|NCT02454205|Antimetabolites|antimetabolites|mesh-ancestor
25261375|NCT02454205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25261376|NCT02454205|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25261377|NCT02454088|Calcium, Dietary|calcium, dietary|mesh-list
25261378|NCT02454088|Triamcinolone|triamcinolone|mesh-list
25261379|NCT02454088|Calcium|calcium|mesh-list
25261380|NCT02454088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25261381|NCT02454088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261382|NCT02454088|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25261383|NCT02454088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25261384|NCT02454088|Glucocorticoids|glucocorticoids|mesh-ancestor
25261385|NCT02454088|Hormones|hormones|mesh-ancestor
25261386|NCT02454088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25261387|NCT02453867|Tacrolimus|tacrolimus|mesh-list
25261388|NCT02453867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25261389|NCT02453867|Immunologic Factors|immunologic factors|mesh-ancestor
25261390|NCT02453867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261391|NCT02453867|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25261392|NCT02453867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261393|NCT02453867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261394|NCT02453932|Donepezil|donepezil|mesh-list
25261395|NCT02453932|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25261396|NCT02453932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261397|NCT02453932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261398|NCT02453932|Cholinergic Agents|cholinergic agents|mesh-ancestor
25261399|NCT02453932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25261400|NCT02453932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261401|NCT02453932|Nootropic Agents|nootropic agents|mesh-ancestor
25261402|NCT02453698|Methylphenidate|methylphenidate|mesh-list
25261403|NCT02453698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25261404|NCT02453698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261405|NCT02453698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25261406|NCT02453698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25261407|NCT02453698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25261408|NCT02453698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261409|NCT02453698|Dopamine Agents|dopamine agents|mesh-ancestor
25261410|NCT02453698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24933445|NCT04070495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24933446|NCT04070495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24933447|NCT04070495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24645770|NCT01199757|Mometasone Furoate|mometasone furoate|mesh-list
24933448|NCT04070495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440753|NCT00284583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24440754|NCT00284583|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24933449|NCT04070495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24933450|NCT04070495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24933452|NCT04070495|Antitubercular Agents|antitubercular agents|mesh-ancestor
24933453|NCT04070495|Leprostatic Agents|leprostatic agents|mesh-ancestor
24933454|NCT04070495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24933455|NCT04070495|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24933456|NCT04070495|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24933457|NCT04070495|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24933458|NCT04070495|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24933459|NCT04070495|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24933460|NCT04070495|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24933461|NCT04070469|Amoxicillin|amoxicillin|mesh-list
24933462|NCT04070469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24933463|NCT04070469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24933464|NCT04070391|Vitamin B 6|vitamin b 6|mesh-list
24933465|NCT04070391|Pyridoxal|pyridoxal|mesh-list
24933466|NCT04070391|Pyridoxine|pyridoxine|mesh-list
24933467|NCT04070391|Vitamins|vitamins|mesh-ancestor
24933468|NCT04070391|Micronutrients|micronutrients|mesh-ancestor
24933469|NCT04070391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933500|NCT04070001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933501|NCT04069949|Sorafenib|sorafenib|mesh-list
24933502|NCT04069949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24933503|NCT04069949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24933504|NCT04069949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933505|NCT04069949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261411|NCT02453659|Nicotine|nicotine|mesh-list
25261412|NCT02453659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25261413|NCT02453659|Autonomic Agents|autonomic agents|mesh-ancestor
25261414|NCT02453659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25261415|NCT02453659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261416|NCT02453659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25261417|NCT02453659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25261418|NCT02453659|Cholinergic Agents|cholinergic agents|mesh-ancestor
25261419|NCT02453659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25261420|NCT02453659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261421|NCT02453893|Risperidone|risperidone|mesh-list
25261422|NCT02453893|Iloperidone|iloperidone|mesh-list
25261423|NCT02453893|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25261424|NCT02453893|Serotonin Agents|serotonin agents|mesh-ancestor
25261425|NCT02453893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25261426|NCT02453893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261427|NCT02453893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261428|NCT02453893|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25261429|NCT02453893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25261430|NCT02453893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25261431|NCT02453893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25261432|NCT02453893|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25261433|NCT02453893|Dopamine Agents|dopamine agents|mesh-ancestor
25261434|NCT02453776|Infliximab|infliximab|mesh-list
25261435|NCT02453776|Dermatologic Agents|dermatologic agents|mesh-ancestor
25261436|NCT02453776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25261437|NCT02453776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25261438|NCT02453607|Infliximab|infliximab|mesh-list
25261439|NCT02453607|Dermatologic Agents|dermatologic agents|mesh-ancestor
25261440|NCT02453607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25261441|NCT02453607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25261442|NCT02453529|Nafithromycin|nafithromycin|mesh-list
25261443|NCT02453529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25261444|NCT02453529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25261445|NCT02453529|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25261446|NCT02453529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261447|NCT02453529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261448|NCT02453802|Tranylcypromine|tranylcypromine|mesh-list
25261449|NCT02453802|Rivaroxaban|rivaroxaban|mesh-list
25261450|NCT02453802|Tranexamic Acid|tranexamic acid|mesh-list
25261451|NCT02453802|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25261452|NCT02453802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25688266|NCT01943435|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25688267|NCT01943435|Serotonin Agents|serotonin agents|mesh-ancestor
24530269|NCT00629642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530270|NCT00629642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530271|NCT00629642|Urological Agents|urological agents|mesh-ancestor
24530272|NCT00629642|Parasympatholytics|parasympatholytics|mesh-ancestor
24530273|NCT00629642|Autonomic Agents|autonomic agents|mesh-ancestor
24530274|NCT00629642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24530277|NCT00629681|Sensory System Agents|sensory system agents|mesh-ancestor
24933541|NCT04069169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24933542|NCT04069169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933543|NCT04069169|Sensory System Agents|sensory system agents|mesh-ancestor
24933544|NCT04069169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24933545|NCT04069169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24933546|NCT04069169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24933547|NCT04069169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24933548|NCT04069169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24933549|NCT04069169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933551|NCT04069208|Idarubicin|idarubicin|mesh-list
24530282|NCT00629681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24530296|NCT00629720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933572|NCT04069429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933573|NCT04069286|Amoxicillin|amoxicillin|mesh-list
24933574|NCT04069286|Omeprazole|omeprazole|mesh-list
24933575|NCT04069286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24933576|NCT04069286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24933582|NCT04069078|Scopolamine|scopolamine|mesh-list
25261453|NCT02453802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261454|NCT02453802|Hemostatics|hemostatics|mesh-ancestor
25261455|NCT02453802|Coagulants|coagulants|mesh-ancestor
25261456|NCT02453802|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25261457|NCT02453802|Antithrombins|antithrombins|mesh-ancestor
25261458|NCT02453802|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25261459|NCT02453802|Protease Inhibitors|protease inhibitors|mesh-ancestor
25261460|NCT02453802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261461|NCT02453802|Anticoagulants|anticoagulants|mesh-ancestor
25261462|NCT02453802|Antidepressive Agents|antidepressive agents|mesh-ancestor
25261463|NCT02453802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25261464|NCT02453802|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25261465|NCT02453802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25261466|NCT02453802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25261467|NCT02453802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25261468|NCT02453802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261469|NCT02453516|Epinephrine|epinephrine|mesh-list
25261470|NCT02453516|Ropivacaine|ropivacaine|mesh-list
25261471|NCT02453516|Anesthetics, Local|anesthetics, local|mesh-ancestor
25261472|NCT02453516|Anesthetics|anesthetics|mesh-ancestor
25261473|NCT02453516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25261474|NCT02453516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261475|NCT02453516|Sensory System Agents|sensory system agents|mesh-ancestor
25261476|NCT02453516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25261477|NCT02453516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25261478|NCT02453516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25261479|NCT02453516|Adrenergic Agents|adrenergic agents|mesh-ancestor
25261480|NCT02453516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25261481|NCT02453516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261482|NCT02453516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25261483|NCT02453516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25261484|NCT02453516|Autonomic Agents|autonomic agents|mesh-ancestor
25261485|NCT02453516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25261486|NCT02453516|Respiratory System Agents|respiratory system agents|mesh-ancestor
25261487|NCT02453516|Mydriatics|mydriatics|mesh-ancestor
25261488|NCT02453516|Sympathomimetics|sympathomimetics|mesh-ancestor
25261489|NCT02453516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25261490|NCT02453503|Triamcinolone|triamcinolone|mesh-list
25261491|NCT02453503|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25261492|NCT02453503|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25261493|NCT02453503|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25261494|NCT02453503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25261495|NCT02453503|Glucocorticoids|glucocorticoids|mesh-ancestor
24933589|NCT04069078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24933590|NCT04069078|Mydriatics|mydriatics|mesh-ancestor
24933591|NCT04069078|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24933629|NCT04068974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933644|NCT04068948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24933645|NCT04068948|Anesthetics, General|anesthetics, general|mesh-ancestor
24933646|NCT04068948|Anesthetics|anesthetics|mesh-ancestor
24933647|NCT04068948|GABA Modulators|gaba modulators|mesh-ancestor
24933648|NCT04068948|GABA Agents|gaba agents|mesh-ancestor
24933649|NCT04068948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24539172|NCT00662610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24539173|NCT00662610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24933660|NCT04068948|Histamine Agents|histamine agents|mesh-ancestor
24758014|NCT01743300|Anesthetics|anesthetics|mesh-ancestor
24682439|NCT01386346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24682440|NCT01386346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24682441|NCT01386346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24682442|NCT01386372|Tolvaptan|tolvaptan|mesh-list
24682443|NCT01386372|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24682444|NCT01386372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682445|NCT01386372|Natriuretic Agents|natriuretic agents|mesh-ancestor
24682446|NCT01386372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682447|NCT01386398|Bortezomib|bortezomib|mesh-list
24682448|NCT01386398|Vorinostat|vorinostat|mesh-list
24682449|NCT01386398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24682450|NCT01386398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24682451|NCT01386398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682488|NCT01386580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24682489|NCT01386580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24682490|NCT01386580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24682721|NCT01388075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24906410|NCT04340869|Theobromine|theobromine|mesh-list
25261496|NCT02453503|Hormones|hormones|mesh-ancestor
25261497|NCT02453503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25261498|NCT02453503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261499|NCT02453503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25261500|NCT02453503|Immunologic Factors|immunologic factors|mesh-ancestor
25261501|NCT02453503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261502|NCT02453503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261504|NCT02453490|Raltitrexed|raltitrexed|mesh-list
25261505|NCT02453490|Antimetabolites|antimetabolites|mesh-ancestor
25261506|NCT02453490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261507|NCT02453490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25261508|NCT02453490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25261509|NCT02453490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25261510|NCT02453490|Immunologic Factors|immunologic factors|mesh-ancestor
25261511|NCT02453490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261512|NCT02453490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25261513|NCT02453490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261514|NCT02453464|Leucovorin|leucovorin|mesh-list
25261515|NCT02453464|Irinotecan|irinotecan|mesh-list
25261516|NCT02453464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25261517|NCT02453464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25261518|NCT02453464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261519|NCT02453464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261520|NCT02453464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25261521|NCT02453464|Antidotes|antidotes|mesh-ancestor
25261522|NCT02453464|Protective Agents|protective agents|mesh-ancestor
25261523|NCT02453464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539270|NCT00662987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24539271|NCT00662987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24933711|NCT04067817|Phenylephrine|phenylephrine|mesh-list
24933712|NCT04067817|Oxymetazoline|oxymetazoline|mesh-list
24933713|NCT04067817|Norepinephrine|norepinephrine|mesh-list
24933714|NCT04067817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
24933715|NCT04067817|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24933716|NCT04067817|Mydriatics|mydriatics|mesh-ancestor
24933717|NCT04067817|Autonomic Agents|autonomic agents|mesh-ancestor
24933728|NCT04067817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933729|NCT04067817|Protective Agents|protective agents|mesh-ancestor
24933730|NCT04067856|Dexamethasone|dexamethasone|mesh-list
24933731|NCT04067856|Bevacizumab|bevacizumab|mesh-list
24933732|NCT04067856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24933733|NCT04067856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24933734|NCT04067856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24933735|NCT04067856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24933736|NCT04067856|Growth Substances|growth substances|mesh-ancestor
24933737|NCT04067856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933738|NCT04067856|Growth Inhibitors|growth inhibitors|mesh-ancestor
24933741|NCT04067856|Autonomic Agents|autonomic agents|mesh-ancestor
24933742|NCT04067856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24854870|NCT02275975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24854872|NCT02275975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24854873|NCT02275975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854874|NCT02275975|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24854875|NCT02275975|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25261524|NCT02453464|Vitamin B Complex|vitamin b complex|mesh-ancestor
25261525|NCT02453464|Vitamins|vitamins|mesh-ancestor
25261526|NCT02453464|Micronutrients|micronutrients|mesh-ancestor
25261527|NCT02453425|Norepinephrine|norepinephrine|mesh-list
25261528|NCT02453425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25261529|NCT02453425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25261530|NCT02453425|Adrenergic Agents|adrenergic agents|mesh-ancestor
25261531|NCT02453425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25261532|NCT02453425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261533|NCT02453425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261534|NCT02453425|Sympathomimetics|sympathomimetics|mesh-ancestor
25261535|NCT02453425|Autonomic Agents|autonomic agents|mesh-ancestor
25261536|NCT02453425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25261537|NCT02453425|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25261538|NCT02453087|Rituximab|rituximab|mesh-list
25261539|NCT02453087|Obinutuzumab|obinutuzumab|mesh-list
25261540|NCT02453087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25261541|NCT02453087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25261542|NCT02453087|Immunologic Factors|immunologic factors|mesh-ancestor
24540282|NCT00667147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443927|NCT00296205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443928|NCT00296205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24443929|NCT00296205|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24540394|NCT00667797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443931|NCT00296218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25261543|NCT02453087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261544|NCT02453087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25261545|NCT02452905|Nitazoxanide|nitazoxanide|mesh-list
25261546|NCT02452905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25261547|NCT02452905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25261548|NCT02453022|Omeprazole|omeprazole|mesh-list
25261549|NCT02453022|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25261550|NCT02453022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25261551|NCT02453022|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25261552|NCT02453022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261553|NCT02453022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261554|NCT02452970|Gemcitabine|gemcitabine|mesh-list
25261555|NCT02452970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25261556|NCT02452970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24933745|NCT04067856|Hormones|hormones|mesh-ancestor
24933746|NCT04067856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24933747|NCT04067856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24933748|NCT04067531|Clindamycin|clindamycin|mesh-list
24933749|NCT04067531|Clindamycin palmitate|clindamycin palmitate|mesh-list
24933792|NCT04067024|Anesthetics|anesthetics|mesh-list
24410609|NCT00186706|Protective Agents|protective agents|mesh-ancestor
24625329|NCT01081652|Hormones|hormones|mesh-ancestor
24625330|NCT01081652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24625331|NCT01081652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625332|NCT01081691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24625333|NCT01081691|Immunologic Factors|immunologic factors|mesh-ancestor
24625334|NCT01081691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625335|NCT01081704|Ustekinumab|ustekinumab|mesh-list
24625336|NCT01081704|Dermatologic Agents|dermatologic agents|mesh-ancestor
24625337|NCT01081717|Golimumab|golimumab|mesh-list
24530340|NCT00629928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24530341|NCT00629928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24530342|NCT00629928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530343|NCT00629928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530344|NCT00629967|Interferons|interferons|mesh-list
24530345|NCT00629967|Ribavirin|ribavirin|mesh-list
24530346|NCT00629967|Interferon-alpha|interferon-alpha|mesh-list
24530347|NCT00629967|Interferon alpha-2|interferon alpha-2|mesh-list
24530348|NCT00629967|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24530349|NCT00629967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758243|NCT01744444|Antimanic Agents|antimanic agents|mesh-ancestor
24442535|NCT00291382|Adrenergic Agents|adrenergic agents|mesh-ancestor
24442536|NCT00291382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24933805|NCT04067102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261559|NCT02452970|Antiviral Agents|antiviral agents|mesh-ancestor
24445583|NCT00301899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24540508|NCT00668135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540509|NCT00668135|Urological Agents|urological agents|mesh-ancestor
24540510|NCT00668239|Triamcinolone|triamcinolone|mesh-list
25261560|NCT02452970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25261561|NCT02452970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261562|NCT02452970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25261563|NCT02452970|Immunologic Factors|immunologic factors|mesh-ancestor
25261564|NCT02452970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261565|NCT02452918|Oritavancin|oritavancin|mesh-list
25261566|NCT02452918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25261567|NCT02452918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25261568|NCT02452879|Solifenacin Succinate|solifenacin succinate|mesh-list
25261569|NCT02452879|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25261570|NCT02452879|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25261571|NCT02452879|Cholinergic Agents|cholinergic agents|mesh-ancestor
25261572|NCT02452879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25261573|NCT02452879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261574|NCT02452879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261575|NCT02452879|Urological Agents|urological agents|mesh-ancestor
25261576|NCT02453009|Prednisone|prednisone|mesh-list
25261577|NCT02453009|Docetaxel|docetaxel|mesh-list
25261578|NCT02453009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25261579|NCT02453009|Tubulin Modulators|tubulin modulators|mesh-ancestor
25261580|NCT02453009|Antimitotic Agents|antimitotic agents|mesh-ancestor
25261581|NCT02453009|Mitosis Modulators|mitosis modulators|mesh-ancestor
25261582|NCT02453009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261583|NCT02453009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25261584|NCT02453009|Glucocorticoids|glucocorticoids|mesh-ancestor
25261585|NCT02453009|Hormones|hormones|mesh-ancestor
24505097|NCT00539799|Prednisolone|prednisolone|mesh-list
25261586|NCT02453009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25261587|NCT02453009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261588|NCT02453009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25261590|NCT02452775|Poly ICLC|poly iclc|mesh-list
25261591|NCT02452775|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25261592|NCT02452775|Immunologic Factors|immunologic factors|mesh-ancestor
25261660|NCT02452125|Autonomic Agents|autonomic agents|mesh-ancestor
25261593|NCT02452775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261594|NCT02452775|Interferon Inducers|interferon inducers|mesh-ancestor
25275203|NCT02373215|Narcotics|narcotics|mesh-ancestor
25275204|NCT02373215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25275205|NCT02373215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540762|NCT00669643|Clofazimine|clofazimine|mesh-list
24540763|NCT00669643|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24540764|NCT00669643|Antitubercular Agents|antitubercular agents|mesh-ancestor
24540765|NCT00669643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24540766|NCT00669643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24540767|NCT00669643|Leprostatic Agents|leprostatic agents|mesh-ancestor
24857838|NCT02294266|Autonomic Agents|autonomic agents|mesh-ancestor
25275206|NCT02373215|Analgesics|analgesics|mesh-ancestor
24510257|NCT00564031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24510258|NCT00564031|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24530351|NCT00629967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24530352|NCT00629967|Antimetabolites|antimetabolites|mesh-ancestor
24530353|NCT00629967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530354|NCT00629967|Immunologic Factors|immunologic factors|mesh-ancestor
24530355|NCT00629967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530356|NCT00630019|Moxifloxacin|moxifloxacin|mesh-list
24530357|NCT00630019|Levofloxacin|levofloxacin|mesh-list
24530358|NCT00630019|Ofloxacin|ofloxacin|mesh-list
24530381|NCT00630045|Oxaliplatin|oxaliplatin|mesh-list
24530382|NCT00630045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24530383|NCT00630045|Antimetabolites|antimetabolites|mesh-ancestor
24530384|NCT00630045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688268|NCT01943435|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25688269|NCT01943435|Histamine Antagonists|histamine antagonists|mesh-ancestor
24530385|NCT00630045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24933831|NCT04067037|Alkylating Agents|alkylating agents|mesh-ancestor
24933832|NCT04066803|Folic Acid|folic acid|mesh-list
24933833|NCT04066803|Hematinics|hematinics|mesh-ancestor
24933834|NCT04066803|Vitamin B Complex|vitamin b complex|mesh-ancestor
24933835|NCT04066803|Vitamins|vitamins|mesh-ancestor
24933836|NCT04066803|Micronutrients|micronutrients|mesh-ancestor
24933837|NCT04066803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933838|NCT04066790|Paclitaxel|paclitaxel|mesh-list
24933839|NCT04066790|Trastuzumab|trastuzumab|mesh-list
24933840|NCT04066790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24933841|NCT04066790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24933842|NCT04066790|Tubulin Modulators|tubulin modulators|mesh-ancestor
24933843|NCT04066790|Antimitotic Agents|antimitotic agents|mesh-ancestor
24933844|NCT04066790|Mitosis Modulators|mitosis modulators|mesh-ancestor
24933845|NCT04066790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530389|NCT00630084|Interferon alpha-2|interferon alpha-2|mesh-list
24530390|NCT00630084|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25261595|NCT02452632|Ipragliflozin|ipragliflozin|mesh-list
25261596|NCT02452632|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25261597|NCT02452632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261598|NCT02452632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25261599|NCT02452632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261600|NCT02452515|Fulacimstat|fulacimstat|mesh-list
25261601|NCT02452515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261602|NCT02452515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261603|NCT02452684|Eszopiclone|eszopiclone|mesh-list
25261604|NCT02452684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25261605|NCT02452684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25261606|NCT02452684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261607|NCT02452437|Oxycodone|oxycodone|mesh-list
25261608|NCT02452437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25261609|NCT02452437|Narcotics|narcotics|mesh-ancestor
25261610|NCT02452437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24541401|NCT00672659|Pipamperone|pipamperone|mesh-list
25261611|NCT02452437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261612|NCT02452437|Analgesics|analgesics|mesh-ancestor
25261613|NCT02452437|Sensory System Agents|sensory system agents|mesh-ancestor
25261614|NCT02452437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25261615|NCT02452606|Levodopa|levodopa|mesh-list
25261616|NCT02452606|Carbidopa|carbidopa|mesh-list
25261617|NCT02452606|Entacapone|entacapone|mesh-list
25261618|NCT02452606|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25261619|NCT02452606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25261620|NCT02452606|Dopamine Agents|dopamine agents|mesh-ancestor
25261624|NCT02452606|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25261626|NCT02452606|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25261627|NCT02452502|Atorvastatin|atorvastatin|mesh-list
25261628|NCT02452502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25261629|NCT02452502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25261630|NCT02452502|Antimetabolites|antimetabolites|mesh-ancestor
25261631|NCT02452502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261632|NCT02452502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25261633|NCT02452502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25261634|NCT02452502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261635|NCT02452385|Vorolanib|vorolanib|mesh-list
25261636|NCT02452385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24933862|NCT04066881|Vaccines|vaccines|mesh-list
24933863|NCT04066881|Immunologic Factors|immunologic factors|mesh-ancestor
24933864|NCT04066881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933865|NCT04066621|Ceftriaxone|ceftriaxone|mesh-list
24933866|NCT04066621|Sulbactam|sulbactam|mesh-list
24933867|NCT04066621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24933868|NCT04066621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24933869|NCT04066621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24933870|NCT04066621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933871|NCT04066621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933872|NCT04066452|Immunoglobulins|immunoglobulins|mesh-list
24933873|NCT04066452|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24933874|NCT04066452|Antibodies|antibodies|mesh-list
24933875|NCT04066452|Immunologic Factors|immunologic factors|mesh-ancestor
24933876|NCT04066452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933877|NCT04066179|Prednisolone|prednisolone|mesh-list
24933878|NCT04066179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25688270|NCT01943435|Histamine Agents|histamine agents|mesh-ancestor
24933879|NCT04066179|Glucocorticoids|glucocorticoids|mesh-ancestor
24933880|NCT04066179|Hormones|hormones|mesh-ancestor
24933881|NCT04066179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24933882|NCT04066179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933883|NCT04066179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24933884|NCT04066179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24933922|NCT04066660|Fucoidan|fucoidan|mesh-list
24933923|NCT04066660|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24933924|NCT04066660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24933925|NCT04066660|Anticoagulants|anticoagulants|mesh-ancestor
24933926|NCT04066660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24933927|NCT04066088|Guanfacine|guanfacine|mesh-list
24933928|NCT04066088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24933929|NCT04066088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25261637|NCT02452385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261638|NCT02452385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261639|NCT02452450|Acetaminophen|acetaminophen|mesh-list
25261640|NCT02452450|Ibuprofen|ibuprofen|mesh-list
25261641|NCT02452450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25261642|NCT02452450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25261643|NCT02452450|Analgesics|analgesics|mesh-ancestor
25261644|NCT02452450|Sensory System Agents|sensory system agents|mesh-ancestor
25261645|NCT02452450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25261646|NCT02452450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261647|NCT02452450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25261648|NCT02452450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25261649|NCT02452450|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25261650|NCT02452450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261651|NCT02452450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261652|NCT02452450|Antipyretics|antipyretics|mesh-ancestor
25261653|NCT02452281|Ipilimumab|ipilimumab|mesh-list
25261654|NCT02452281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25261655|NCT02452281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25261656|NCT02452281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25261657|NCT02452281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261658|NCT02452125|Nicotine|nicotine|mesh-list
25261659|NCT02452125|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25261661|NCT02452125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25261662|NCT02452125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261663|NCT02452125|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25261664|NCT02452125|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25261665|NCT02452125|Cholinergic Agents|cholinergic agents|mesh-ancestor
25261666|NCT02452125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25261667|NCT02452125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261668|NCT02452307|Imiquimod|imiquimod|mesh-list
25261669|NCT02452307|Molgramostim|molgramostim|mesh-list
25261670|NCT02452307|Protamines|protamines|mesh-list
25261671|NCT02452307|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25261672|NCT02452307|Sargramostim|sargramostim|mesh-list
25261673|NCT02452307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25261674|NCT02452307|Immunologic Factors|immunologic factors|mesh-ancestor
25261675|NCT02452307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261676|NCT02452307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24933950|NCT04065919|Anesthetics, Local|anesthetics, local|mesh-ancestor
24933951|NCT04065919|Anesthetics|anesthetics|mesh-ancestor
24933952|NCT04065919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24933953|NCT04065919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933954|NCT04065919|Sensory System Agents|sensory system agents|mesh-ancestor
24933964|NCT04065919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24933965|NCT04065919|Respiratory System Agents|respiratory system agents|mesh-ancestor
24933967|NCT04065919|Sympathomimetics|sympathomimetics|mesh-ancestor
24530425|NCT00630175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24530426|NCT00630175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530427|NCT00630214|Calcium, Dietary|calcium, dietary|mesh-list
24530428|NCT00630214|Vitamin D|vitamin d|mesh-list
24530429|NCT00630214|Ergocalciferols|ergocalciferols|mesh-list
24530430|NCT00630214|Cholecalciferol|cholecalciferol|mesh-list
24541326|NCT00672295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688271|NCT01943435|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24530431|NCT00630214|Vitamins|vitamins|mesh-list
24530432|NCT00630214|Calcium Carbonate|calcium carbonate|mesh-list
24530433|NCT00630214|Calcium|calcium|mesh-list
24530434|NCT00630214|Micronutrients|micronutrients|mesh-ancestor
24530435|NCT00630214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530436|NCT00630214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24530437|NCT00630214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24530438|NCT00630214|Antacids|antacids|mesh-ancestor
24530439|NCT00630214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530440|NCT00630214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24530441|NCT00630357|Levetiracetam|levetiracetam|mesh-list
24530444|NCT00630370|ATI 7505|ati 7505|mesh-list
24854877|NCT02275988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24662141|NCT01292993|Metformin|metformin|mesh-list
24854878|NCT02275988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24611412|NCT01009476|Piracetam|piracetam|mesh-list
24682895|NCT01389063|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24682896|NCT01389063|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24682897|NCT01389063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682898|NCT01389063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24682899|NCT01389063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24682900|NCT01389063|Antiviral Agents|antiviral agents|mesh-ancestor
24682901|NCT01389063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24682902|NCT01389063|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24682903|NCT01389167|Naltrexone|naltrexone|mesh-list
24682904|NCT01389167|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24682905|NCT01389167|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24682907|NCT01389167|Sensory System Agents|sensory system agents|mesh-ancestor
24854924|NCT02276300|Interferon Inducers|interferon inducers|mesh-ancestor
24854925|NCT02276365|Pioglitazone|pioglitazone|mesh-list
24854926|NCT02276365|Empagliflozin|empagliflozin|mesh-list
24854927|NCT02276365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24854928|NCT02276365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854929|NCT02276365|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24854932|NCT02276378|Telmisartan|telmisartan|mesh-list
24854950|NCT02276495|Ropivacaine|ropivacaine|mesh-list
24854951|NCT02276495|Anesthetics, Local|anesthetics, local|mesh-ancestor
24683261|NCT01390935|Hormone Antagonists|hormone antagonists|mesh-ancestor
25261677|NCT02452307|Interferon Inducers|interferon inducers|mesh-ancestor
25261678|NCT02452307|Heparin Antagonists|heparin antagonists|mesh-ancestor
25261679|NCT02452307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261680|NCT02452307|Coagulants|coagulants|mesh-ancestor
24541402|NCT00672659|Citalopram|citalopram|mesh-list
24541403|NCT00672659|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24541404|NCT00672659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24541405|NCT00672659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25261681|NCT02452151|Infliximab|infliximab|mesh-list
25261682|NCT02452151|Dermatologic Agents|dermatologic agents|mesh-ancestor
25261683|NCT02452151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25261684|NCT02452151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25261685|NCT02452177|Vitamin D|vitamin d|mesh-list
25261686|NCT02452177|Vitamins|vitamins|mesh-ancestor
25261687|NCT02452177|Micronutrients|micronutrients|mesh-ancestor
25261688|NCT02452177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261689|NCT02452177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25261690|NCT02452255|Propranolol|propranolol|mesh-list
25688272|NCT01943435|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25688273|NCT01943435|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25688274|NCT01943435|Adrenergic Agents|adrenergic agents|mesh-ancestor
25688275|NCT01943435|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25688276|NCT01943435|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25688277|NCT01943435|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25688278|NCT01943435|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25688279|NCT01943435|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25688280|NCT01943435|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25688281|NCT01943461|Avelumab|avelumab|mesh-list
25261691|NCT02452255|Metoprolol|metoprolol|mesh-list
25261692|NCT02452255|Fenofibrate|fenofibrate|mesh-list
24460473|NCT00348452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25261693|NCT02452255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25261694|NCT02452255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25261696|NCT02452255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25261697|NCT02452255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261698|NCT02452255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261699|NCT02452255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25261700|NCT02452255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25261701|NCT02452255|Vasodilator Agents|vasodilator agents|mesh-ancestor
25261702|NCT02452255|Sympatholytics|sympatholytics|mesh-ancestor
25261703|NCT02452255|Autonomic Agents|autonomic agents|mesh-ancestor
24530464|NCT00630474|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24530465|NCT00630474|Respiratory System Agents|respiratory system agents|mesh-ancestor
24530466|NCT00630500|Memantine|memantine|mesh-list
24530467|NCT00630500|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24530468|NCT00630500|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24530469|NCT00630500|Dopamine Agents|dopamine agents|mesh-ancestor
24530470|NCT00630500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24933968|NCT04065919|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24933969|NCT04065932|BMS-986165|bms-986165|mesh-list
24933970|NCT04065932|Famotidine|famotidine|mesh-list
24933971|NCT04065932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24933972|NCT04065932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24933973|NCT04065932|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24933974|NCT04065932|Histamine Antagonists|histamine antagonists|mesh-ancestor
24933975|NCT04065932|Histamine Agents|histamine agents|mesh-ancestor
24933976|NCT04065932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24933977|NCT04065932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933978|NCT04065932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933979|NCT04065932|Dermatologic Agents|dermatologic agents|mesh-ancestor
24933980|NCT04065932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24933981|NCT04065932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933983|NCT04065529|Trace Elements|trace elements|mesh-ancestor
24933984|NCT04065529|Micronutrients|micronutrients|mesh-ancestor
24933985|NCT04065529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934006|NCT04065581|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24934007|NCT04065581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683262|NCT01390935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24683263|NCT01390935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683264|NCT01390935|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25261704|NCT02452255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25261705|NCT02452255|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25261706|NCT02452255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25261707|NCT02452255|Antimetabolites|antimetabolites|mesh-ancestor
25261708|NCT02452255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25261709|NCT02452216|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25261710|NCT02452216|Hematinics|hematinics|mesh-ancestor
25261711|NCT02452216|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25261712|NCT02452216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25688282|NCT01943461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25688283|NCT01943461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25688284|NCT01943461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688285|NCT01943461|Immunologic Factors|immunologic factors|mesh-ancestor
25688286|NCT01943461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688287|NCT01943552|Bromides|bromides|mesh-list
25688288|NCT01943552|Ipratropium|ipratropium|mesh-list
25688289|NCT01943552|Anticonvulsants|anticonvulsants|mesh-ancestor
25688290|NCT01943552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25688291|NCT01943552|Autonomic Agents|autonomic agents|mesh-ancestor
25688292|NCT01943552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25688293|NCT01943552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688294|NCT01943552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25261713|NCT02452112|Lidocaine|lidocaine|mesh-list
25261714|NCT02452112|Anesthetics, Local|anesthetics, local|mesh-ancestor
25261715|NCT02452112|Anesthetics|anesthetics|mesh-ancestor
25261716|NCT02452112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25261717|NCT02452112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261718|NCT02452112|Sensory System Agents|sensory system agents|mesh-ancestor
25261719|NCT02452112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25261720|NCT02452112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25261721|NCT02452112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25261722|NCT02452112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25261723|NCT02452112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25261724|NCT02452112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261725|NCT02452099|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
25261726|NCT02452099|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25261727|NCT02452099|Protective Agents|protective agents|mesh-ancestor
25261728|NCT02452099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261729|NCT02452099|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25261730|NCT02452099|Antioxidants|antioxidants|mesh-ancestor
25261731|NCT02452099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261732|NCT02451956|Paclitaxel|paclitaxel|mesh-list
25261733|NCT02451956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25261734|NCT02451956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25261735|NCT02451956|Tubulin Modulators|tubulin modulators|mesh-ancestor
25261736|NCT02451956|Antimitotic Agents|antimitotic agents|mesh-ancestor
25261737|NCT02451956|Mitosis Modulators|mitosis modulators|mesh-ancestor
24934008|NCT04065581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934010|NCT04065230|Antiviral Agents|antiviral agents|mesh-ancestor
24934011|NCT04065230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24934012|NCT04065230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24934013|NCT04065230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24934015|NCT04065230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934016|NCT04065230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24934017|NCT04065230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24934019|NCT04065165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934020|NCT04065308|Daratumumab|daratumumab|mesh-list
24934021|NCT04065308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934022|NCT04065282|Capecitabine|capecitabine|mesh-list
24934023|NCT04065282|Oxaliplatin|oxaliplatin|mesh-list
24934024|NCT04065282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24934025|NCT04065282|Antimetabolites|antimetabolites|mesh-ancestor
24934026|NCT04065282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934027|NCT04065282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934028|NCT04065269|Olaparib|olaparib|mesh-list
25688295|NCT01943552|Respiratory System Agents|respiratory system agents|mesh-ancestor
25688296|NCT01943552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25688297|NCT01943552|Cholinergic Agents|cholinergic agents|mesh-ancestor
25688298|NCT01943552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25688299|NCT01943552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688300|NCT01943565|Hydromorphone|hydromorphone|mesh-list
25688301|NCT01943565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25688302|NCT01943565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688303|NCT01943565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25688304|NCT01943565|Narcotics|narcotics|mesh-ancestor
25688305|NCT01943565|Analgesics|analgesics|mesh-ancestor
25688306|NCT01943565|Sensory System Agents|sensory system agents|mesh-ancestor
25688307|NCT01943565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25688308|NCT01943864|Trametinib|trametinib|mesh-list
25688309|NCT01943864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24443194|NCT00293917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443195|NCT00293930|Tacrolimus|tacrolimus|mesh-list
24443196|NCT00293930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24934029|NCT04065269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24934030|NCT04065269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24934031|NCT04065269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934032|NCT04065269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934033|NCT04065035|Sunscreening Agents|sunscreening agents|mesh-list
24934034|NCT04065035|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24410877|NCT00187083|Dexamethasone|dexamethasone|mesh-list
24541574|NCT00674011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934055|NCT04064632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24625338|NCT01081717|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24625339|NCT01081717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24625340|NCT01081717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24625341|NCT01081717|Immunologic Factors|immunologic factors|mesh-ancestor
24625342|NCT01081717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625344|NCT01081730|Dermatologic Agents|dermatologic agents|mesh-ancestor
24683265|NCT01390935|Diuretics|diuretics|mesh-ancestor
24683266|NCT01390935|Natriuretic Agents|natriuretic agents|mesh-ancestor
24683267|NCT01390961|Pheniramine|pheniramine|mesh-list
24683268|NCT01390961|Naphazoline|naphazoline|mesh-list
24683284|NCT01391052|Norethindrone|norethindrone|mesh-list
24683320|NCT01391221|Analgesics|analgesics|mesh-ancestor
24639740|NCT01164059|Antiemetics|antiemetics|mesh-ancestor
24683512|NCT01392755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261738|NCT02451956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261739|NCT02451865|Docetaxel|docetaxel|mesh-list
25261740|NCT02451865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25261741|NCT02451865|Tubulin Modulators|tubulin modulators|mesh-ancestor
25261742|NCT02451865|Antimitotic Agents|antimitotic agents|mesh-ancestor
25261743|NCT02451865|Mitosis Modulators|mitosis modulators|mesh-ancestor
25261744|NCT02451865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261745|NCT02451787|Vitamin D|vitamin d|mesh-list
25261746|NCT02451787|Cholecalciferol|cholecalciferol|mesh-list
25261747|NCT02451787|Vitamins|vitamins|mesh-ancestor
25261748|NCT02451787|Micronutrients|micronutrients|mesh-ancestor
25261749|NCT02451787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261750|NCT02451787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25261751|NCT02451787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25261753|NCT02451774|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25261754|NCT02451774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261755|NCT02451774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261756|NCT02451774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25261757|NCT02451774|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25261758|NCT02451774|Protective Agents|protective agents|mesh-ancestor
25261759|NCT02451774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261760|NCT02451774|Vasodilator Agents|vasodilator agents|mesh-ancestor
25261761|NCT02451774|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25261762|NCT02451774|Antioxidants|antioxidants|mesh-ancestor
25261763|NCT02451826|Ulipristal acetate|ulipristal acetate|mesh-list
25261764|NCT02451826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25261765|NCT02451826|Contraceptive Agents|contraceptive agents|mesh-ancestor
25261766|NCT02451826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25261767|NCT02451826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261768|NCT02451826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25261769|NCT02451852|Osimertinib|osimertinib|mesh-list
25261770|NCT02451852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24625345|NCT01081756|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24625346|NCT01081756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24625347|NCT01081756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625349|NCT01081847|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
24625350|NCT01081847|Freund's Adjuvant|freund's adjuvant|mesh-list
25688310|NCT01943864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25688311|NCT01943864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688312|NCT01943864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688313|NCT01944046|Oxytocin|oxytocin|mesh-list
25688314|NCT01944046|Oxytocics|oxytocics|mesh-ancestor
25688315|NCT01944046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25688316|NCT01944046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625355|NCT01081847|Diuretics|diuretics|mesh-ancestor
24460484|NCT00348491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24460485|NCT00348491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24625365|NCT01081964|Fluoroquinolones|fluoroquinolones|mesh-list
24764870|NCT01784562|Riociguat|riociguat|mesh-list
24625366|NCT01081964|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24934056|NCT04064632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24934057|NCT04064632|Antiviral Agents|antiviral agents|mesh-ancestor
24934058|NCT04064632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24934059|NCT04064632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24934060|NCT04064632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24934061|NCT04064632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24934062|NCT04064632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24934063|NCT04064190|Durvalumab|durvalumab|mesh-list
24934064|NCT04064190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24934065|NCT04064190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934066|NCT04064125|Minocycline|minocycline|mesh-list
24410920|NCT00187122|Cytarabine|cytarabine|mesh-list
24934088|NCT04063904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24934095|NCT04063904|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24934096|NCT04063904|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24934097|NCT04063904|Hormone Antagonists|hormone antagonists|mesh-ancestor
24934098|NCT04063904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24934099|NCT04063904|Luteolytic Agents|luteolytic agents|mesh-ancestor
24934100|NCT04063904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24934101|NCT04063904|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24934102|NCT04063865|Everolimus|everolimus|mesh-list
24934103|NCT04063865|Tacrolimus|tacrolimus|mesh-list
24936631|NCT04038034|Coenzyme Q10|coenzyme q10|mesh-list
24683513|NCT01392755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683514|NCT01392755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24683515|NCT01392755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24683516|NCT01392755|Antiviral Agents|antiviral agents|mesh-ancestor
24683517|NCT01392755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24683544|NCT01392807|Sensory System Agents|sensory system agents|mesh-ancestor
24683545|NCT01392807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24683564|NCT01392833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25261771|NCT02451852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25261772|NCT02451852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261773|NCT02451852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261774|NCT02451748|Hydroxychloroquine|hydroxychloroquine|mesh-list
25261775|NCT02451748|Sulfasalazine|sulfasalazine|mesh-list
25261776|NCT02451748|Prednisone|prednisone|mesh-list
25261777|NCT02451748|Triamcinolone|triamcinolone|mesh-list
25261778|NCT02451748|Naproxen|naproxen|mesh-list
25261779|NCT02451748|Methotrexate|methotrexate|mesh-list
25261780|NCT02451748|Certolizumab Pegol|certolizumab pegol|mesh-list
25261787|NCT02451748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25261788|NCT02451748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25261789|NCT02451748|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25261790|NCT02451748|Abortifacient Agents|abortifacient agents|mesh-ancestor
25261791|NCT02451748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25261792|NCT02451748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25261793|NCT02451748|Antimetabolites|antimetabolites|mesh-ancestor
25261794|NCT02451748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688317|NCT01944098|Lidocaine|lidocaine|mesh-list
25688318|NCT01944098|Anesthetics, Local|anesthetics, local|mesh-ancestor
25688319|NCT01944098|Anesthetics|anesthetics|mesh-ancestor
25688320|NCT01944098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25688321|NCT01944098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688322|NCT01944098|Sensory System Agents|sensory system agents|mesh-ancestor
25688323|NCT01944098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25688324|NCT01944098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25688325|NCT01944098|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25688326|NCT01944098|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25688327|NCT01944098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24801696|NCT01985061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24801697|NCT01985061|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25261795|NCT02451748|Dermatologic Agents|dermatologic agents|mesh-ancestor
25261796|NCT02451748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261797|NCT02451748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25261798|NCT02451748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25261799|NCT02451748|Immunologic Factors|immunologic factors|mesh-ancestor
25261800|NCT02451748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25261801|NCT02451748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25261802|NCT02451748|Antimalarials|antimalarials|mesh-ancestor
25261803|NCT02451748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24934104|NCT04063865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24934105|NCT04063865|Immunologic Factors|immunologic factors|mesh-ancestor
24934106|NCT04063865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934107|NCT04063865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24934108|NCT04063865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24934109|NCT04063865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934110|NCT04063865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934112|NCT04063683|Cisplatin|cisplatin|mesh-list
24934113|NCT04063683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24934114|NCT04063683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934115|NCT04063683|Tubulin Modulators|tubulin modulators|mesh-ancestor
24934116|NCT04063683|Antimitotic Agents|antimitotic agents|mesh-ancestor
24934117|NCT04063683|Mitosis Modulators|mitosis modulators|mesh-ancestor
24934118|NCT04063683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934119|NCT04063527|Paclitaxel|paclitaxel|mesh-list
24934161|NCT04063358|Growth Inhibitors|growth inhibitors|mesh-ancestor
24934162|NCT04063358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934163|NCT04063189|Clarithromycin|clarithromycin|mesh-list
24934164|NCT04063189|Dexamethasone|dexamethasone|mesh-list
24934165|NCT04063189|Lenalidomide|lenalidomide|mesh-list
24934166|NCT04063189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24934167|NCT04063189|Antiemetics|antiemetics|mesh-ancestor
24934168|NCT04063189|Autonomic Agents|autonomic agents|mesh-ancestor
24934169|NCT04063189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24934170|NCT04063189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934171|NCT04063189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24934172|NCT04063189|Glucocorticoids|glucocorticoids|mesh-ancestor
24934173|NCT04063189|Hormones|hormones|mesh-ancestor
24934179|NCT04063189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24934180|NCT04063189|Growth Substances|growth substances|mesh-ancestor
24934181|NCT04063189|Growth Inhibitors|growth inhibitors|mesh-ancestor
25261804|NCT02451748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25261805|NCT02451748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25261806|NCT02451748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25261807|NCT02451748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25261808|NCT02451748|Analgesics|analgesics|mesh-ancestor
25261809|NCT02451748|Sensory System Agents|sensory system agents|mesh-ancestor
25261810|NCT02451748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25261811|NCT02451748|Gout Suppressants|gout suppressants|mesh-ancestor
25261812|NCT02451748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25261813|NCT02451748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25261814|NCT02451527|Digoxin|digoxin|mesh-list
25261815|NCT02451527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25261816|NCT02451527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25261817|NCT02451527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261818|NCT02451527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261819|NCT02451527|Protective Agents|protective agents|mesh-ancestor
25261820|NCT02451527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261821|NCT02451605|Analgesics|analgesics|mesh-list
25261822|NCT02451605|Ropivacaine|ropivacaine|mesh-list
25261823|NCT02451605|Anesthetics, Local|anesthetics, local|mesh-ancestor
25688328|NCT01944098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688329|NCT01944293|Midazolam|midazolam|mesh-list
25688330|NCT01944293|Ketamine|ketamine|mesh-list
25688331|NCT01944293|Analgesics|analgesics|mesh-ancestor
25688332|NCT01944293|Sensory System Agents|sensory system agents|mesh-ancestor
25688333|NCT01944293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25688334|NCT01944293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688335|NCT01944293|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25261824|NCT02451605|Anesthetics|anesthetics|mesh-ancestor
25261830|NCT02451579|Histamine Antagonists|histamine antagonists|mesh-list
25261831|NCT02451579|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25261832|NCT02451579|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25261833|NCT02451579|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25261834|NCT02451579|Histamine Agents|histamine agents|mesh-ancestor
25261835|NCT02451579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25261836|NCT02451579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261837|NCT02451579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261838|NCT02451475|Amitriptyline|amitriptyline|mesh-list
25261839|NCT02451475|Paroxetine|paroxetine|mesh-list
25261840|NCT02451475|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24934182|NCT04063189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24934183|NCT04063189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24934184|NCT04063189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24934185|NCT04063189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24934186|NCT04063189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934187|NCT04063189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24934188|NCT04063189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24966223|NCT03770000|Tenalisib|tenalisib|mesh-list
24934197|NCT04063046|Anesthetics|anesthetics|mesh-list
24934198|NCT04063046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24934199|NCT04063046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934200|NCT04062760|Diuretics|diuretics|mesh-list
24934201|NCT04062760|Natriuretic Agents|natriuretic agents|mesh-ancestor
24934202|NCT04062760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934203|NCT04062890|Vigabatrin|vigabatrin|mesh-list
24934204|NCT04062890|Anticonvulsants|anticonvulsants|mesh-ancestor
24934205|NCT04062890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24934206|NCT04062890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934207|NCT04062890|GABA Agents|gaba agents|mesh-ancestor
24934208|NCT04062890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24934232|NCT04062656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25688336|NCT01944293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25688337|NCT01944293|Anesthetics, General|anesthetics, general|mesh-ancestor
25688338|NCT01944293|Anesthetics|anesthetics|mesh-ancestor
25688339|NCT01944293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25688340|NCT01944293|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25688341|NCT01944293|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25688342|NCT01944293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25688343|NCT01944293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688344|NCT01944293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25688345|NCT01944293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25688346|NCT01944293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25688347|NCT01944293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25688348|NCT01944293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25688349|NCT01944293|GABA Modulators|gaba modulators|mesh-ancestor
25688350|NCT01944293|GABA Agents|gaba agents|mesh-ancestor
24443370|NCT00294606|Respiratory System Agents|respiratory system agents|mesh-ancestor
24443371|NCT00294606|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24443372|NCT00294606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25688351|NCT01944319|Meropenem|meropenem|mesh-list
24443374|NCT00294606|Adrenergic Agents|adrenergic agents|mesh-ancestor
24934233|NCT04062656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24934234|NCT04062656|Antidotes|antidotes|mesh-ancestor
24934235|NCT04062656|Protective Agents|protective agents|mesh-ancestor
24683565|NCT01392833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24683566|NCT01392833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24855007|NCT02276859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24683567|NCT01392833|Protective Agents|protective agents|mesh-ancestor
24683569|NCT01392833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611466|NCT01009697|Narcotics|narcotics|mesh-ancestor
24611467|NCT01009697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24611468|NCT01009697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611469|NCT01009697|Analgesics|analgesics|mesh-ancestor
24611470|NCT01009697|Sensory System Agents|sensory system agents|mesh-ancestor
25261841|NCT02451475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25261842|NCT02451475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25261843|NCT02451475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25261844|NCT02451475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261845|NCT02451475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25261846|NCT02451475|Serotonin Agents|serotonin agents|mesh-ancestor
25261847|NCT02451475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261848|NCT02451475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25261849|NCT02451475|Antidepressive Agents|antidepressive agents|mesh-ancestor
25261850|NCT02451475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24684160|NCT01395849|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25261851|NCT02451475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25261852|NCT02451475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25261853|NCT02451475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261854|NCT02451475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25261855|NCT02451475|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25261856|NCT02451475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25261857|NCT02451475|Analgesics|analgesics|mesh-ancestor
25261858|NCT02451475|Sensory System Agents|sensory system agents|mesh-ancestor
25261859|NCT02451475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25261860|NCT02451475|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25261861|NCT02451475|Adrenergic Agents|adrenergic agents|mesh-ancestor
25261862|NCT02451462|Zoledronic Acid|zoledronic acid|mesh-list
25261863|NCT02451462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24530543|NCT00630929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261864|NCT02451462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261865|NCT02451306|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25261866|NCT02451306|Antidepressive Agents|antidepressive agents|mesh-ancestor
25261867|NCT02451306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25261868|NCT02451306|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25261869|NCT02451306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25261870|NCT02451306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24934236|NCT04062656|Vitamin B Complex|vitamin b complex|mesh-ancestor
24934237|NCT04062656|Vitamins|vitamins|mesh-ancestor
24934238|NCT04062656|Micronutrients|micronutrients|mesh-ancestor
24934239|NCT04062656|Hematinics|hematinics|mesh-ancestor
24934240|NCT04062175|Azithromycin|azithromycin|mesh-list
24934241|NCT04062175|Cephalosporins|cephalosporins|mesh-list
24934242|NCT04062175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24934243|NCT04062175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24934244|NCT04062591|Piroxicam|piroxicam|mesh-list
24934245|NCT04062591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24934246|NCT04062591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24934247|NCT04062591|Analgesics|analgesics|mesh-ancestor
24934248|NCT04062591|Sensory System Agents|sensory system agents|mesh-ancestor
24934249|NCT04062591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24934250|NCT04062591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688352|NCT01944319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25688353|NCT01944319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25688354|NCT01944371|Disulfiram|disulfiram|mesh-list
25688355|NCT01944371|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25688356|NCT01944371|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25688357|NCT01944371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692623|NCT02002975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934251|NCT04062591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24530502|NCT00630695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530504|NCT00630695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24934252|NCT04062591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24934253|NCT04062591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24611471|NCT01009697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24611472|NCT01009697|Antitussive Agents|antitussive agents|mesh-ancestor
24611473|NCT01009697|Respiratory System Agents|respiratory system agents|mesh-ancestor
24611474|NCT01009788|Temozolomide|temozolomide|mesh-list
24611475|NCT01009788|Veliparib|veliparib|mesh-list
24611476|NCT01009788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24611477|NCT01009788|Alkylating Agents|alkylating agents|mesh-ancestor
24855008|NCT02276859|Insulin Aspart|insulin aspart|mesh-list
24855009|NCT02276859|Insulin Lispro|insulin lispro|mesh-list
24855010|NCT02276859|Insulin glulisine|insulin glulisine|mesh-list
24855011|NCT02276859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24855012|NCT02276859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855014|NCT02276911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24855015|NCT02276911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24855016|NCT02276911|Analgesics|analgesics|mesh-ancestor
24683796|NCT01394224|Nootropic Agents|nootropic agents|mesh-ancestor
24683797|NCT01394263|Goserelin|goserelin|mesh-list
24683798|NCT01394263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24683799|NCT01394263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24683800|NCT01394341|Liraglutide|liraglutide|mesh-list
24683801|NCT01394341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24683825|NCT01394354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683829|NCT01394406|Analgesics|analgesics|mesh-ancestor
24683907|NCT01394679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683908|NCT01394679|Antimetabolites|antimetabolites|mesh-ancestor
24683909|NCT01394679|Antiviral Agents|antiviral agents|mesh-ancestor
24906633|NCT04338919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683990|NCT01394913|Analgesics|analgesics|mesh-ancestor
24683991|NCT01394913|Sensory System Agents|sensory system agents|mesh-ancestor
24683992|NCT01394913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24683993|NCT01394913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683994|NCT01394913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24683995|NCT01394913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25261871|NCT02451306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261873|NCT02451293|Antioxidants|antioxidants|mesh-ancestor
25261874|NCT02451293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261875|NCT02451293|Protective Agents|protective agents|mesh-ancestor
25261876|NCT02451293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261877|NCT02451293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25261878|NCT02451072|Ketanserin|ketanserin|mesh-list
25261879|NCT02451072|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
25261880|NCT02451072|Hallucinogens|hallucinogens|mesh-ancestor
25261881|NCT02451072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261882|NCT02451072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25261883|NCT02451072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25261884|NCT02451072|Serotonin Agents|serotonin agents|mesh-ancestor
25261885|NCT02451072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25261886|NCT02451072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261887|NCT02451072|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25261888|NCT02451072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25261889|NCT02451072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25261890|NCT02451033|Hormones|hormones|mesh-list
24934254|NCT04062591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24934255|NCT04062591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934256|NCT04062565|Treprostinil|treprostinil|mesh-list
24934257|NCT04062565|Riociguat|riociguat|mesh-list
24934258|NCT04062565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24934321|NCT04061824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24934325|NCT04061772|Prednisone|prednisone|mesh-list
24510771|NCT00565591|Respiratory System Agents|respiratory system agents|mesh-ancestor
24934336|NCT04061772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934337|NCT04061772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934338|NCT04061772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24934339|NCT04061772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24934340|NCT04061772|Glucocorticoids|glucocorticoids|mesh-ancestor
24934342|NCT04061772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24934343|NCT04061772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24934344|NCT04061772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25051528|NCT00397254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051529|NCT00397254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051531|NCT00396357|Vildagliptin|vildagliptin|mesh-list
25051532|NCT00396357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25051533|NCT00396357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934345|NCT04061772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24683996|NCT01394913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24683997|NCT01394913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24683998|NCT01394913|Immunologic Factors|immunologic factors|mesh-ancestor
24683999|NCT01395069|Ketorolac|ketorolac|mesh-list
24684000|NCT01395069|Nepafenac|nepafenac|mesh-list
24684001|NCT01395069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24489959|NCT00476073|Xhance|xhance|mesh-list
24684048|NCT01395290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684049|NCT01395290|Vitamins|vitamins|mesh-ancestor
24684050|NCT01395290|Micronutrients|micronutrients|mesh-ancestor
24684051|NCT01395290|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24684052|NCT01395381|Albendazole|albendazole|mesh-list
24684053|NCT01395381|Anthelmintics|anthelmintics|mesh-ancestor
24684054|NCT01395381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24684055|NCT01395381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24684056|NCT01395381|Anticestodal Agents|anticestodal agents|mesh-ancestor
24684057|NCT01395381|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24684058|NCT01395381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24684059|NCT01395381|Tubulin Modulators|tubulin modulators|mesh-ancestor
24684060|NCT01395381|Antimitotic Agents|antimitotic agents|mesh-ancestor
24684061|NCT01395381|Mitosis Modulators|mitosis modulators|mesh-ancestor
24684062|NCT01395381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684063|NCT01395381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684064|NCT01395420|Ceftazidime|ceftazidime|mesh-list
24684065|NCT01395420|Avibactam|avibactam|mesh-list
24684066|NCT01395420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24611507|NCT01009879|Sensory System Agents|sensory system agents|mesh-ancestor
24611508|NCT01009879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24611509|NCT01009879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684129|NCT01395667|Oxaliplatin|oxaliplatin|mesh-list
24684130|NCT01395667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684131|NCT01395667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684132|NCT01395667|Antimetabolites|antimetabolites|mesh-ancestor
24684156|NCT01395849|Dermatologic Agents|dermatologic agents|mesh-ancestor
24684157|NCT01395849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24684158|NCT01395849|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24684159|NCT01395849|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25261891|NCT02451033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25261892|NCT02451033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261893|NCT02450994|Dexamethasone|dexamethasone|mesh-list
25261894|NCT02450994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25261895|NCT02450994|Antiemetics|antiemetics|mesh-ancestor
25261896|NCT02450994|Autonomic Agents|autonomic agents|mesh-ancestor
25261897|NCT02450994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25261898|NCT02450994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261899|NCT02450994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25261900|NCT02450994|Glucocorticoids|glucocorticoids|mesh-ancestor
25261901|NCT02450994|Hormones|hormones|mesh-ancestor
25261902|NCT02450994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25261903|NCT02450994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25261904|NCT02450994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25261905|NCT02450981|Bevacizumab|bevacizumab|mesh-list
25261906|NCT02450981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25261907|NCT02450981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25275695|NCT02369861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24934350|NCT04062019|Interleukin-2|interleukin-2|mesh-list
24934351|NCT04062019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934352|NCT04062019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24934353|NCT04062019|Analgesics|analgesics|mesh-ancestor
24934354|NCT04062019|Sensory System Agents|sensory system agents|mesh-ancestor
24934355|NCT04062019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24934381|NCT04062006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24934382|NCT04062006|Analgesics|analgesics|mesh-ancestor
25688358|NCT01944371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688359|NCT01944423|Cycloserine|cycloserine|mesh-list
25688360|NCT01944423|Nicotine|nicotine|mesh-list
25688361|NCT01944423|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25688362|NCT01944423|Autonomic Agents|autonomic agents|mesh-ancestor
25688363|NCT01944423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24934384|NCT04062006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24934385|NCT04062006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155545|NCT05346601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934431|NCT04061265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24934432|NCT04061265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934433|NCT04061265|Sensory System Agents|sensory system agents|mesh-ancestor
24934434|NCT04061265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24934435|NCT04061265|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24934436|NCT04061265|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24934437|NCT04061265|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24510831|NCT00565708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510832|NCT00565708|Antipyretics|antipyretics|mesh-ancestor
24530525|NCT00630890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24530526|NCT00630890|Antimetabolites|antimetabolites|mesh-ancestor
24684161|NCT01395849|Adrenergic Agents|adrenergic agents|mesh-ancestor
24906773|NCT04337450|Lamivudine|lamivudine|mesh-list
24684179|NCT01395862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24684180|NCT01395862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24684200|NCT01395875|Respiratory System Agents|respiratory system agents|mesh-ancestor
24684201|NCT01395875|Dermatologic Agents|dermatologic agents|mesh-ancestor
24684202|NCT01395875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25261908|NCT02450981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25261909|NCT02450981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25261910|NCT02450981|Growth Substances|growth substances|mesh-ancestor
25261911|NCT02450981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261912|NCT02450981|Growth Inhibitors|growth inhibitors|mesh-ancestor
25275207|NCT02373215|Sensory System Agents|sensory system agents|mesh-ancestor
25275208|NCT02373215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275209|NCT02373254|Acetaminophen|acetaminophen|mesh-list
25275210|NCT02373254|Ibuprofen|ibuprofen|mesh-list
25275211|NCT02373254|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25275212|NCT02373254|Hydrocodone|hydrocodone|mesh-list
25275213|NCT02373254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25275214|NCT02373254|Analgesics|analgesics|mesh-ancestor
25275215|NCT02373254|Sensory System Agents|sensory system agents|mesh-ancestor
25275216|NCT02373254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275217|NCT02373254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275218|NCT02373254|Antipyretics|antipyretics|mesh-ancestor
25275219|NCT02373254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25275220|NCT02373254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25275221|NCT02373254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25275222|NCT02373254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25275223|NCT02373254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262022|NCT02450175|Hormone Antagonists|hormone antagonists|mesh-ancestor
25275224|NCT02373254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275225|NCT02373254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25275226|NCT02373254|Narcotics|narcotics|mesh-ancestor
25275227|NCT02373254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25275228|NCT02373254|Antitussive Agents|antitussive agents|mesh-ancestor
25275229|NCT02373254|Respiratory System Agents|respiratory system agents|mesh-ancestor
25275230|NCT02373046|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25275231|NCT02373046|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25275232|NCT02373046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530544|NCT00630929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530545|NCT00630929|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24530546|NCT00630942|Minocycline|minocycline|mesh-list
24530547|NCT00630942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24530548|NCT00630942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24530549|NCT00630968|Levetiracetam|levetiracetam|mesh-list
24530550|NCT00630968|Anticonvulsants|anticonvulsants|mesh-ancestor
24934458|NCT04061538|Dermatologic Agents|dermatologic agents|mesh-ancestor
24934459|NCT04061473|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24934460|NCT04061473|Empagliflozin|empagliflozin|mesh-list
24934461|NCT04061473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24934462|NCT04061473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934463|NCT04061473|Incretins|incretins|mesh-ancestor
24530586|NCT00631124|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24934470|NCT04061473|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24934471|NCT04061200|Empagliflozin|empagliflozin|mesh-list
24934472|NCT04061200|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24934473|NCT04061200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934474|NCT04061200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24934475|NCT04061200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510872|NCT00566124|Insulin Detemir|insulin detemir|mesh-list
24510873|NCT00566124|Isophane Insulin, Human|isophane insulin, human|mesh-list
24530638|NCT00631527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24530651|NCT00631527|Hormone Antagonists|hormone antagonists|mesh-ancestor
24530653|NCT00631579|Rasburicase|rasburicase|mesh-list
25261913|NCT02450968|Dexamethasone|dexamethasone|mesh-list
25261914|NCT02450968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25261915|NCT02450968|Antiemetics|antiemetics|mesh-ancestor
25261916|NCT02450968|Autonomic Agents|autonomic agents|mesh-ancestor
25261917|NCT02450968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25261918|NCT02450968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261919|NCT02450968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25261920|NCT02450968|Glucocorticoids|glucocorticoids|mesh-ancestor
25261922|NCT02450968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25261923|NCT02450968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25261924|NCT02450968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25261925|NCT02451098|Atorvastatin|atorvastatin|mesh-list
25261926|NCT02451098|Ezetimibe|ezetimibe|mesh-list
25261927|NCT02451098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25261928|NCT02451098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25261929|NCT02451098|Antimetabolites|antimetabolites|mesh-ancestor
25261930|NCT02451098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261931|NCT02451098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25261932|NCT02451098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25261933|NCT02451098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261934|NCT02450786|Donepezil|donepezil|mesh-list
25261935|NCT02450786|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25261936|NCT02450786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261937|NCT02450786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261938|NCT02450786|Cholinergic Agents|cholinergic agents|mesh-ancestor
25261939|NCT02450786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25261940|NCT02450786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261941|NCT02450786|Nootropic Agents|nootropic agents|mesh-ancestor
25261942|NCT02450838|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25261943|NCT02450838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25261944|NCT02450838|Immunologic Factors|immunologic factors|mesh-ancestor
25261945|NCT02450838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25261946|NCT02450838|Antacids|antacids|mesh-ancestor
24934499|NCT04061057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24934500|NCT04061057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24934501|NCT04061057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24543163|NCT00682136|Sensory System Agents|sensory system agents|mesh-ancestor
24934502|NCT04061057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24934503|NCT04061057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765120|NCT01786070|Budesonide|budesonide|mesh-list
24530675|NCT00631631|Mifamurtide|mifamurtide|mesh-list
24530676|NCT00631631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24530677|NCT00631631|Immunologic Factors|immunologic factors|mesh-ancestor
24530678|NCT00631631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530679|NCT00631722|Haloperidol|haloperidol|mesh-list
24530680|NCT00631722|Haloperidol decanoate|haloperidol decanoate|mesh-list
24530681|NCT00631722|Antiemetics|antiemetics|mesh-ancestor
24934528|NCT04060914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934530|NCT04060771|Dexamethasone|dexamethasone|mesh-list
25261955|NCT02450773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261956|NCT02450877|Azacitidine|azacitidine|mesh-list
25261957|NCT02450877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25261958|NCT02450877|Antimetabolites|antimetabolites|mesh-ancestor
25261959|NCT02450877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261960|NCT02450877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25261961|NCT02450877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261962|NCT02450682|Warfarin|warfarin|mesh-list
25261963|NCT02450682|Apixaban|apixaban|mesh-list
25261964|NCT02450682|Anticoagulants|anticoagulants|mesh-ancestor
25261966|NCT02450682|Antithrombins|antithrombins|mesh-ancestor
25261967|NCT02450682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25261968|NCT02450682|Protease Inhibitors|protease inhibitors|mesh-ancestor
25261969|NCT02450682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261970|NCT02450682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261971|NCT02450656|Docetaxel|docetaxel|mesh-list
25261972|NCT02450656|Afatinib|afatinib|mesh-list
25261973|NCT02450656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25261974|NCT02450656|Tubulin Modulators|tubulin modulators|mesh-ancestor
25261975|NCT02450656|Antimitotic Agents|antimitotic agents|mesh-ancestor
25261976|NCT02450656|Mitosis Modulators|mitosis modulators|mesh-ancestor
25261977|NCT02450656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261978|NCT02450656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25261979|NCT02450656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261980|NCT02450513|Adalimumab|adalimumab|mesh-list
25261981|NCT02450513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25261982|NCT02450513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25261983|NCT02450188|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
25261984|NCT02450188|Vasodilator Agents|vasodilator agents|mesh-ancestor
25261985|NCT02450188|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25261986|NCT02450188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25261987|NCT02450188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25261988|NCT02450188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261989|NCT02450188|Urological Agents|urological agents|mesh-ancestor
25261990|NCT02450253|Tadalafil|tadalafil|mesh-list
25261991|NCT02450253|Vasodilator Agents|vasodilator agents|mesh-ancestor
25261992|NCT02450253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25261993|NCT02450253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25261994|NCT02450253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275233|NCT02373046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24934539|NCT04060771|Hormones|hormones|mesh-ancestor
24934540|NCT04060771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24934541|NCT04060771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24934542|NCT04060771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934543|NCT04060771|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24934544|NCT04060771|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24934545|NCT04060771|Serotonin Agents|serotonin agents|mesh-ancestor
24934546|NCT04060771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24934547|NCT04060771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934548|NCT04061213|Technetium Tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid|technetium tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid|mesh-list
24934549|NCT04061213|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24934550|NCT04061213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934551|NCT04060979|Nitric Oxide|nitric oxide|mesh-list
24934552|NCT04060979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24934553|NCT04060979|Autonomic Agents|autonomic agents|mesh-ancestor
24934554|NCT04060979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24934555|NCT04060979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934556|NCT04060979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24934557|NCT04060979|Respiratory System Agents|respiratory system agents|mesh-ancestor
24934558|NCT04060979|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24934559|NCT04060979|Antioxidants|antioxidants|mesh-ancestor
24934560|NCT04060979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934561|NCT04060979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24934562|NCT04060979|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24934563|NCT04060979|Vasodilator Agents|vasodilator agents|mesh-ancestor
24934564|NCT04060979|Gasotransmitters|gasotransmitters|mesh-ancestor
24934565|NCT04060979|Protective Agents|protective agents|mesh-ancestor
24934566|NCT04060836|Factor VIII|factor viii|mesh-list
24934567|NCT04060836|Coagulants|coagulants|mesh-ancestor
24934568|NCT04060719|Rifampin|rifampin|mesh-list
24934569|NCT04060719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24934570|NCT04060719|Antitubercular Agents|antitubercular agents|mesh-ancestor
24934571|NCT04060719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24934572|NCT04060719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24934573|NCT04060719|Leprostatic Agents|leprostatic agents|mesh-ancestor
25261995|NCT02450253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25261996|NCT02450253|Urological Agents|urological agents|mesh-ancestor
25261998|NCT02450214|Analgesics|analgesics|mesh-ancestor
25261999|NCT02450214|Sensory System Agents|sensory system agents|mesh-ancestor
25262000|NCT02450214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25262001|NCT02450214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262002|NCT02450214|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25262003|NCT02450214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25262004|NCT02450214|Anesthetics, General|anesthetics, general|mesh-ancestor
25262005|NCT02450214|Anesthetics|anesthetics|mesh-ancestor
25262006|NCT02450214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25262007|NCT02450214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25262008|NCT02450214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25262009|NCT02450214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25262010|NCT02450214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262011|NCT02450175|Everolimus|everolimus|mesh-list
25262012|NCT02450175|Letrozole|letrozole|mesh-list
25262013|NCT02450175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262014|NCT02450175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25262015|NCT02450175|Immunologic Factors|immunologic factors|mesh-ancestor
24543477|NCT00683943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543478|NCT00683956|Propofol|propofol|mesh-list
25262016|NCT02450175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262017|NCT02450175|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25262018|NCT02450175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25262019|NCT02450175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262020|NCT02450175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262021|NCT02450175|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25262023|NCT02450175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25262024|NCT02450279|Edetic Acid|edetic acid|mesh-list
25262025|NCT02450279|Pentetic Acid|pentetic acid|mesh-list
25262026|NCT02450279|Antidotes|antidotes|mesh-ancestor
25262027|NCT02450279|Protective Agents|protective agents|mesh-ancestor
25262028|NCT02450279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262029|NCT02450279|Chelating Agents|chelating agents|mesh-ancestor
25262030|NCT02450279|Sequestering Agents|sequestering agents|mesh-ancestor
25275234|NCT02373046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934574|NCT04060719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24934608|NCT04060381|Sympathomimetics|sympathomimetics|mesh-ancestor
24934609|NCT04060381|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24934610|NCT04060381|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24934611|NCT04060381|Dopamine Agents|dopamine agents|mesh-ancestor
24934612|NCT04060381|Protective Agents|protective agents|mesh-ancestor
24934613|NCT04060472|Paclitaxel|paclitaxel|mesh-list
24934614|NCT04060472|Oxaliplatin|oxaliplatin|mesh-list
24934615|NCT04060472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24934616|NCT04060472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24934617|NCT04060472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25155546|NCT05345613|Epinephrine|epinephrine|mesh-list
24934618|NCT04060472|Tubulin Modulators|tubulin modulators|mesh-ancestor
24934619|NCT04060472|Antimitotic Agents|antimitotic agents|mesh-ancestor
24934620|NCT04060472|Mitosis Modulators|mitosis modulators|mesh-ancestor
24934621|NCT04060472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934622|NCT04060459|Paclitaxel|paclitaxel|mesh-list
24934623|NCT04060459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24934624|NCT04060459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934625|NCT04060459|Tubulin Modulators|tubulin modulators|mesh-ancestor
24934626|NCT04060459|Antimitotic Agents|antimitotic agents|mesh-ancestor
24934627|NCT04060459|Mitosis Modulators|mitosis modulators|mesh-ancestor
24934628|NCT04060459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934629|NCT04060407|Nivolumab|nivolumab|mesh-list
24934630|NCT04060407|Ipilimumab|ipilimumab|mesh-list
24934631|NCT04060407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24934632|NCT04060407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934633|NCT04060407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24511010|NCT00566904|Analgesics|analgesics|mesh-ancestor
24530684|NCT00631722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530685|NCT00631722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24530686|NCT00631722|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24530713|NCT00631943|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24530714|NCT00631943|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24934634|NCT04060407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934635|NCT04060264|Eculizumab|eculizumab|mesh-list
24934637|NCT04060264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25262031|NCT02450279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262032|NCT02450279|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25262033|NCT02450279|Anticoagulants|anticoagulants|mesh-ancestor
25262034|NCT02450279|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25262035|NCT02450149|Sorafenib|sorafenib|mesh-list
25262036|NCT02450149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262037|NCT02450149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25262038|NCT02450149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543479|NCT00683956|Anesthetics|anesthetics|mesh-ancestor
25262039|NCT02450149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262040|NCT02450084|Fentanyl|fentanyl|mesh-list
25262041|NCT02450084|Ropivacaine|ropivacaine|mesh-list
25262042|NCT02450084|Anesthetics, Local|anesthetics, local|mesh-ancestor
25262043|NCT02450084|Anesthetics|anesthetics|mesh-ancestor
25262044|NCT02450084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25262045|NCT02450084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262046|NCT02450084|Sensory System Agents|sensory system agents|mesh-ancestor
25262047|NCT02450084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25262048|NCT02450084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25262049|NCT02450084|Narcotics|narcotics|mesh-ancestor
25262050|NCT02450084|Analgesics|analgesics|mesh-ancestor
25262051|NCT02450084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25262052|NCT02450084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25262053|NCT02450084|Anesthetics, General|anesthetics, general|mesh-ancestor
25262054|NCT02450045|Bupivacaine|bupivacaine|mesh-list
25262055|NCT02450045|Ropivacaine|ropivacaine|mesh-list
25262056|NCT02450045|Anesthetics, Local|anesthetics, local|mesh-list
25262057|NCT02450045|Anesthetics|anesthetics|mesh-list
25262058|NCT02450045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25262059|NCT02450045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262068|NCT02449954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25262069|NCT02449954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934638|NCT04060264|Immunologic Factors|immunologic factors|mesh-ancestor
24934639|NCT04060264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934640|NCT04060550|Omalizumab|omalizumab|mesh-list
24934641|NCT04060550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24934642|NCT04060550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24934643|NCT04060550|Respiratory System Agents|respiratory system agents|mesh-ancestor
24934644|NCT04059770|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24934645|NCT04059770|Amphotericin B|amphotericin b|mesh-list
24934646|NCT04059770|Antifungal Agents|antifungal agents|mesh-ancestor
24934647|NCT04059770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24934648|NCT04059770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24934649|NCT04059770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24934650|NCT04059770|Amebicides|amebicides|mesh-ancestor
24934651|NCT04059770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24635095|NCT01136941|Analgesics|analgesics|mesh-ancestor
24934652|NCT04060043|Goserelin|goserelin|mesh-list
24934653|NCT04060043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24934654|NCT04060043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934655|NCT04060095|Anesthetics|anesthetics|mesh-list
24934656|NCT04060095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24530729|NCT00632086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24530731|NCT00632086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24934670|NCT04059887|Atezolizumab|atezolizumab|mesh-list
24934671|NCT04059887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934672|NCT04059978|Remifentanil|remifentanil|mesh-list
24934673|NCT04059978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25262070|NCT02449954|Analgesics|analgesics|mesh-ancestor
25262071|NCT02449954|Sensory System Agents|sensory system agents|mesh-ancestor
25262072|NCT02449954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25262073|NCT02449954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25262074|NCT02449954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25262075|NCT02449954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25262076|NCT02449954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25262077|NCT02449954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25262078|NCT02449954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262079|NCT02449954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262080|NCT02449941|Rabeprazole|rabeprazole|mesh-list
25262081|NCT02449941|Pantoprazole|pantoprazole|mesh-list
25262082|NCT02449941|Lansoprazole|lansoprazole|mesh-list
25262083|NCT02449941|Dexlansoprazole|dexlansoprazole|mesh-list
25262084|NCT02449941|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25262085|NCT02449941|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25262086|NCT02449941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25262087|NCT02449941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262088|NCT02449941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262089|NCT02449811|Amlodipine|amlodipine|mesh-list
25262090|NCT02449811|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25262091|NCT02449811|Olmesartan|olmesartan|mesh-list
25262092|NCT02449811|Perindopril|perindopril|mesh-list
25262093|NCT02449811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25262094|NCT02449811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25262095|NCT02449811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25262096|NCT02449811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262097|NCT02449811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25262098|NCT02449811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262099|NCT02449811|Vasodilator Agents|vasodilator agents|mesh-ancestor
25262100|NCT02449811|Diuretics|diuretics|mesh-ancestor
24934679|NCT04059978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24934693|NCT04059679|Rivaroxaban|rivaroxaban|mesh-list
24934694|NCT04059679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24934695|NCT04059679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24934696|NCT04059679|Analgesics|analgesics|mesh-ancestor
24934697|NCT04059679|Sensory System Agents|sensory system agents|mesh-ancestor
24934698|NCT04059679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24934699|NCT04059679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934700|NCT04059679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24934701|NCT04059679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24934702|NCT04059679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24934703|NCT04059679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24934704|NCT04059679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934705|NCT04059679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24934706|NCT04059679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24934707|NCT04059679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24934708|NCT04059679|Antipyretics|antipyretics|mesh-ancestor
24934709|NCT04059679|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24934710|NCT04059679|Antithrombins|antithrombins|mesh-ancestor
24934711|NCT04059679|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24934712|NCT04059679|Protease Inhibitors|protease inhibitors|mesh-ancestor
24934713|NCT04059679|Anticoagulants|anticoagulants|mesh-ancestor
24684203|NCT01395875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24684204|NCT01395875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25262108|NCT02449733|Tenofovir|tenofovir|mesh-list
25262109|NCT02449733|Emtricitabine|emtricitabine|mesh-list
25262110|NCT02449733|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25262111|NCT02449733|Antiviral Agents|antiviral agents|mesh-ancestor
25262112|NCT02449733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25262113|NCT02449733|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25262114|NCT02449733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25262115|NCT02449733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262116|NCT02449733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262117|NCT02449733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25262118|NCT02449733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25262119|NCT02449746|Immunoglobulins|immunoglobulins|mesh-list
25262120|NCT02449746|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25262121|NCT02449746|Antibodies|antibodies|mesh-list
25262122|NCT02449746|gamma-Globulins|gamma-globulins|mesh-list
25262123|NCT02449746|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25262124|NCT02449746|Immunologic Factors|immunologic factors|mesh-ancestor
25262125|NCT02449746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262126|NCT02449538|Everolimus|everolimus|mesh-list
25262127|NCT02449538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262128|NCT02449538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25262129|NCT02449538|Immunologic Factors|immunologic factors|mesh-ancestor
25262130|NCT02449538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262131|NCT02449564|Sirolimus|sirolimus|mesh-list
25262132|NCT02449564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25262133|NCT02449564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25262134|NCT02449564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25262135|NCT02449564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262136|NCT02449564|Antifungal Agents|antifungal agents|mesh-ancestor
25262137|NCT02449564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25262138|NCT02449564|Immunologic Factors|immunologic factors|mesh-ancestor
25262140|NCT02449720|Ropivacaine|ropivacaine|mesh-list
25262141|NCT02449720|Anesthetics, Local|anesthetics, local|mesh-ancestor
25262142|NCT02449720|Anesthetics|anesthetics|mesh-ancestor
25262143|NCT02449720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24934811|NCT04057755|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24625367|NCT01081964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24625368|NCT01081964|Renal Agents|renal agents|mesh-ancestor
24936717|NCT04037085|Anesthetics|anesthetics|mesh-ancestor
25262144|NCT02449720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262145|NCT02449720|Sensory System Agents|sensory system agents|mesh-ancestor
25262146|NCT02449720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25262147|NCT02449603|Insulin Aspart|insulin aspart|mesh-list
25262148|NCT02449603|Exenatide|exenatide|mesh-list
25262149|NCT02449603|Biphasic Insulins|biphasic insulins|mesh-list
25262150|NCT02449603|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
25262151|NCT02449603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25262152|NCT02449603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262153|NCT02449603|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25262154|NCT02449603|Incretins|incretins|mesh-ancestor
25262155|NCT02449603|Hormones|hormones|mesh-ancestor
25262156|NCT02449603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25262157|NCT02450058|Paclitaxel|paclitaxel|mesh-list
25262158|NCT02450058|Cyclophosphamide|cyclophosphamide|mesh-list
25262159|NCT02450058|Fluorouracil|fluorouracil|mesh-list
25262160|NCT02450058|Epirubicin|epirubicin|mesh-list
25262161|NCT02450058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25262162|NCT02450058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262163|NCT02450058|Tubulin Modulators|tubulin modulators|mesh-ancestor
25262164|NCT02450058|Antimitotic Agents|antimitotic agents|mesh-ancestor
25262165|NCT02450058|Mitosis Modulators|mitosis modulators|mesh-ancestor
25262166|NCT02450058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262167|NCT02450058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25262168|NCT02450058|Immunologic Factors|immunologic factors|mesh-ancestor
25262169|NCT02450058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262170|NCT02450058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25262171|NCT02450058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25262172|NCT02450058|Alkylating Agents|alkylating agents|mesh-ancestor
25262173|NCT02450058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25262174|NCT02450058|Antimetabolites|antimetabolites|mesh-ancestor
25262175|NCT02450058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25262176|NCT02450058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25262177|NCT02450058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25262178|NCT02450058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25262179|NCT02450058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262180|NCT02449655|Paclitaxel|paclitaxel|mesh-list
25262181|NCT02449655|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25262182|NCT02449655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25262183|NCT02449655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262184|NCT02449655|Tubulin Modulators|tubulin modulators|mesh-ancestor
24530876|NCT00632762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24530877|NCT00632762|Dopamine Agents|dopamine agents|mesh-ancestor
24530878|NCT00632762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24530880|NCT00632762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530881|NCT00632762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24625369|NCT01081964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24625370|NCT01081964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24625371|NCT01081964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24625372|NCT01081964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635341|NCT01138553|Hormone Antagonists|hormone antagonists|mesh-ancestor
24625373|NCT01081964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625375|NCT01081964|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24625376|NCT01081964|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24625377|NCT01081964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24625378|NCT01081990|Cyclobenzaprine|cyclobenzaprine|mesh-list
24625379|NCT01081990|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24625380|NCT01081990|Antidepressive Agents|antidepressive agents|mesh-ancestor
24625381|NCT01081990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24625382|NCT01081990|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24934998|NCT04056143|Thromboplastin|thromboplastin|mesh-list
24625386|NCT01081990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24934826|NCT04057989|Analgesics|analgesics|mesh-ancestor
24684208|NCT01395875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684210|NCT01395927|Canagliflozin|canagliflozin|mesh-list
24684212|NCT01395927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24684213|NCT01395927|Antitubercular Agents|antitubercular agents|mesh-ancestor
24684214|NCT01395927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24684215|NCT01395927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24684216|NCT01395927|Leprostatic Agents|leprostatic agents|mesh-ancestor
24684217|NCT01395927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24684218|NCT01395927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24684219|NCT01395927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684220|NCT01395927|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25688364|NCT01944423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688365|NCT01944423|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25688366|NCT01944423|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24551058|NCT00723866|Cholinergic Agents|cholinergic agents|mesh-ancestor
24551059|NCT00723866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24551061|NCT00723879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24551062|NCT00723879|Antimetabolites|antimetabolites|mesh-ancestor
24684221|NCT01395927|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24684227|NCT01395927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25262185|NCT02449655|Antimitotic Agents|antimitotic agents|mesh-ancestor
25262186|NCT02449655|Mitosis Modulators|mitosis modulators|mesh-ancestor
25262187|NCT02449655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262188|NCT02449486|Ropivacaine|ropivacaine|mesh-list
25262189|NCT02449486|Anesthetics, Local|anesthetics, local|mesh-ancestor
25262190|NCT02449486|Anesthetics|anesthetics|mesh-ancestor
25262191|NCT02449486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25262192|NCT02449486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262193|NCT02449486|Sensory System Agents|sensory system agents|mesh-ancestor
25262194|NCT02449486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25262196|NCT02449265|Cyclophosphamide|cyclophosphamide|mesh-list
25262197|NCT02449265|Doxorubicin|doxorubicin|mesh-list
25262198|NCT02449265|Vincristine|vincristine|mesh-list
25262199|NCT02449265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25262200|NCT02449265|Immunologic Factors|immunologic factors|mesh-ancestor
25262201|NCT02449265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262202|NCT02449265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25262203|NCT02449265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25262204|NCT02449265|Alkylating Agents|alkylating agents|mesh-ancestor
25262205|NCT02449265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262206|NCT02449265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262207|NCT02449265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25262208|NCT02449265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25262209|NCT02449265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25262210|NCT02449265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25262211|NCT02449265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262212|NCT02449265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25262213|NCT02449265|Glucocorticoids|glucocorticoids|mesh-ancestor
25262214|NCT02449265|Hormones|hormones|mesh-ancestor
24934827|NCT04057989|Sensory System Agents|sensory system agents|mesh-ancestor
24934828|NCT04057989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24934829|NCT04057989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934830|NCT04057989|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24934831|NCT04057989|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24934832|NCT04057989|Anesthetics, General|anesthetics, general|mesh-ancestor
24934833|NCT04057989|Anesthetics|anesthetics|mesh-ancestor
24934861|NCT04057300|Aspirin|aspirin|mesh-list
24934862|NCT04057300|Clopidogrel|clopidogrel|mesh-list
24934863|NCT04057300|Ticagrelor|ticagrelor|mesh-list
24934864|NCT04057300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24934865|NCT04057300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24934866|NCT04057300|Analgesics|analgesics|mesh-ancestor
24934867|NCT04057300|Sensory System Agents|sensory system agents|mesh-ancestor
24934868|NCT04057300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24934869|NCT04057300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934870|NCT04057300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24934871|NCT04057300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24934872|NCT04057300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24934873|NCT04057300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24934898|NCT04056949|Antimitotic Agents|antimitotic agents|mesh-ancestor
24934899|NCT04056949|Mitosis Modulators|mitosis modulators|mesh-ancestor
24934900|NCT04056949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934901|NCT04056897|Teriflunomide|teriflunomide|mesh-list
24934902|NCT04056897|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24934903|NCT04056897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24934904|NCT04056897|Analgesics|analgesics|mesh-ancestor
24934936|NCT04056845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24934937|NCT04056845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688367|NCT01944423|Cholinergic Agents|cholinergic agents|mesh-ancestor
25688368|NCT01944423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25688369|NCT01944423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688370|NCT01944423|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25688371|NCT01944423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24551751|NCT05065567|Droperidol|droperidol|mesh-list
24551752|NCT05065567|Haloperidol|haloperidol|mesh-list
24551753|NCT05065567|Ondansetron|ondansetron|mesh-list
24551754|NCT05065567|Haloperidol decanoate|haloperidol decanoate|mesh-list
24551755|NCT05065567|Antiemetics|antiemetics|mesh-ancestor
24551756|NCT05065567|Autonomic Agents|autonomic agents|mesh-ancestor
24551807|NCT04956627|Itraconazole|itraconazole|mesh-list
24551809|NCT04956627|Gemfibrozil|gemfibrozil|mesh-list
24551810|NCT04956627|Antifungal Agents|antifungal agents|mesh-ancestor
24551811|NCT04956627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24934938|NCT04056845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934939|NCT04056845|Antipyretics|antipyretics|mesh-ancestor
24934940|NCT04056650|Caffeine|caffeine|mesh-list
24934941|NCT04056650|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24934944|NCT04056650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24934960|NCT04056754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262215|NCT02449265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25262216|NCT02449265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25262217|NCT02449265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25262218|NCT02449265|Tubulin Modulators|tubulin modulators|mesh-ancestor
25262219|NCT02449265|Antimitotic Agents|antimitotic agents|mesh-ancestor
25262220|NCT02449265|Mitosis Modulators|mitosis modulators|mesh-ancestor
25262221|NCT02449187|Calcium, Dietary|calcium, dietary|mesh-list
25262222|NCT02449187|Metformin|metformin|mesh-list
25262223|NCT02449187|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25262224|NCT02449187|Calcium|calcium|mesh-list
25262225|NCT02449187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25262226|NCT02449187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262227|NCT02449187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25262228|NCT02449187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25262229|NCT02449187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25262230|NCT02449187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25262231|NCT02449187|Antimetabolites|antimetabolites|mesh-ancestor
25262232|NCT02449187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262233|NCT02449187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25262234|NCT02449187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25262235|NCT02449187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275235|NCT02373033|Folic Acid|folic acid|mesh-list
25275236|NCT02373033|Vitamin B Complex|vitamin b complex|mesh-list
25275237|NCT02373033|Hematinics|hematinics|mesh-ancestor
25275238|NCT02373033|Vitamins|vitamins|mesh-ancestor
25275239|NCT02373033|Micronutrients|micronutrients|mesh-ancestor
25275240|NCT02373033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275241|NCT02373085|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25275242|NCT02373085|Anti-Infective Agents|anti-infective agents|mesh-list
25275243|NCT02373072|Trimethobenzamide|trimethobenzamide|mesh-list
25275244|NCT02373072|Antiemetics|antiemetics|mesh-ancestor
25275245|NCT02373072|Autonomic Agents|autonomic agents|mesh-ancestor
25275246|NCT02373072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275247|NCT02373072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275248|NCT02373072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25275249|NCT02373280|Amoxicillin|amoxicillin|mesh-list
25275250|NCT02373280|Moxifloxacin|moxifloxacin|mesh-list
25275251|NCT02373280|Metronidazole|metronidazole|mesh-list
24934961|NCT04056754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934962|NCT04056754|Hormone Antagonists|hormone antagonists|mesh-ancestor
24934976|NCT04056702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934977|NCT04056741|Pulmonary Surfactants|pulmonary surfactants|mesh-list
24934978|NCT04056741|Respiratory System Agents|respiratory system agents|mesh-ancestor
24934979|NCT04056039|Colchicine|colchicine|mesh-list
24934980|NCT04056039|Atorvastatin|atorvastatin|mesh-list
24934981|NCT04056039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24934982|NCT04056039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24934983|NCT04056039|Antimetabolites|antimetabolites|mesh-ancestor
24934984|NCT04056039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934985|NCT04056039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24934986|NCT04056039|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24934987|NCT04056039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688372|NCT01944423|Renal Agents|renal agents|mesh-ancestor
25688373|NCT01944423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25688374|NCT01944423|Antitubercular Agents|antitubercular agents|mesh-ancestor
25688375|NCT01944423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25688376|NCT01944423|Antimetabolites|antimetabolites|mesh-ancestor
25688377|NCT01944462|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25688378|NCT01944462|Immunologic Factors|immunologic factors|mesh-ancestor
25688379|NCT01944462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688380|NCT01944774|Moxifloxacin|moxifloxacin|mesh-list
24552072|NCT04209543|Progesterone|progesterone|mesh-list
24552073|NCT04209543|Progestins|progestins|mesh-ancestor
24552074|NCT04209543|Hormones|hormones|mesh-ancestor
24552075|NCT04209543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24552076|NCT04209543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552083|NCT04183062|Antiviral Agents|antiviral agents|mesh-ancestor
24552084|NCT04183062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24934988|NCT04056039|Gout Suppressants|gout suppressants|mesh-ancestor
24934989|NCT04056039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24934990|NCT04056039|Tubulin Modulators|tubulin modulators|mesh-ancestor
24934991|NCT04056039|Antimitotic Agents|antimitotic agents|mesh-ancestor
24934992|NCT04056039|Mitosis Modulators|mitosis modulators|mesh-ancestor
24934993|NCT04056039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934994|NCT04056143|Rivaroxaban|rivaroxaban|mesh-list
24934996|NCT04056143|Edoxaban|edoxaban|mesh-list
24934997|NCT04056143|Dabigatran|dabigatran|mesh-list
24934999|NCT04056143|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24935000|NCT04056143|Antithrombins|antithrombins|mesh-ancestor
24935001|NCT04056143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24935002|NCT04056143|Protease Inhibitors|protease inhibitors|mesh-ancestor
24935003|NCT04056143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935004|NCT04056143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935035|NCT04055506|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24935036|NCT04055506|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24935037|NCT04055506|Protease Inhibitors|protease inhibitors|mesh-ancestor
24935038|NCT04055506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24684318|NCT01396707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262237|NCT02449369|Oxycodone|oxycodone|mesh-list
25262238|NCT02449369|Hydromorphone|hydromorphone|mesh-list
25262239|NCT02449369|Orphenadrine|orphenadrine|mesh-list
25262240|NCT02449369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25262241|NCT02449369|Analgesics|analgesics|mesh-ancestor
25262242|NCT02449369|Sensory System Agents|sensory system agents|mesh-ancestor
25262243|NCT02449369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25262244|NCT02449369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262245|NCT02449369|Antipyretics|antipyretics|mesh-ancestor
25262246|NCT02449369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25262247|NCT02449369|Narcotics|narcotics|mesh-ancestor
25262248|NCT02449369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25262249|NCT02449369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25262250|NCT02449369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25262251|NCT02449369|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25262252|NCT02449369|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25262253|NCT02449369|Parasympatholytics|parasympatholytics|mesh-ancestor
25262254|NCT02449369|Autonomic Agents|autonomic agents|mesh-ancestor
25262255|NCT02449369|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25262256|NCT02449369|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25262257|NCT02449369|Cholinergic Agents|cholinergic agents|mesh-ancestor
25262258|NCT02449369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25262259|NCT02449369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262260|NCT02449369|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
25262261|NCT02449369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25262262|NCT02449369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262263|NCT02449252|Prednisone|prednisone|mesh-list
25262264|NCT02449252|Cyclophosphamide|cyclophosphamide|mesh-list
25262265|NCT02449252|Doxorubicin|doxorubicin|mesh-list
25262266|NCT02449252|Vincristine|vincristine|mesh-list
25262267|NCT02449252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25262268|NCT02449252|Immunologic Factors|immunologic factors|mesh-ancestor
25262269|NCT02449252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262270|NCT02449252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24857991|NCT02294617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25262271|NCT02449252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25262272|NCT02449252|Alkylating Agents|alkylating agents|mesh-ancestor
25275252|NCT02373280|Clarithromycin|clarithromycin|mesh-list
24935040|NCT04055506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24935041|NCT04055506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24935042|NCT04055506|Antiviral Agents|antiviral agents|mesh-ancestor
25688381|NCT01944774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25688382|NCT01944774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25688383|NCT01944774|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25688384|NCT01944774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25688385|NCT01944774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688386|NCT01944774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688387|NCT01944774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935043|NCT04055506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24935044|NCT04055506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24552284|NCT03655821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552285|NCT03655821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24552286|NCT03655821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552287|NCT03655821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24547207|NCT00702975|Antimitotic Agents|antimitotic agents|mesh-ancestor
24552288|NCT03655821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24552290|NCT03635164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24552291|NCT03635164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552292|NCT03613116|Vitamin D|vitamin d|mesh-list
24552293|NCT03613116|Cholecalciferol|cholecalciferol|mesh-list
24552294|NCT03613116|Vitamins|vitamins|mesh-ancestor
24552295|NCT03613116|Micronutrients|micronutrients|mesh-ancestor
24552296|NCT03613116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552297|NCT03613116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24552298|NCT03613116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24552304|NCT03583957|Caffeine|caffeine|mesh-list
24552305|NCT03583957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24552306|NCT03583957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461989|NCT00354458|Rolofylline|rolofylline|mesh-list
24552307|NCT03583957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24552308|NCT03583957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935045|NCT04055506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24935046|NCT04055506|Dermatologic Agents|dermatologic agents|mesh-ancestor
24935047|NCT04055506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24935048|NCT04055623|Aldesleukin|aldesleukin|mesh-list
24935049|NCT04055623|Interleukin-2|interleukin-2|mesh-list
24935050|NCT04055623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530892|NCT00632840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24530893|NCT00632840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530894|NCT00632866|Hydroxychloroquine|hydroxychloroquine|mesh-list
24530895|NCT00632866|Antimalarials|antimalarials|mesh-ancestor
24935051|NCT04055623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24935052|NCT04055623|Analgesics|analgesics|mesh-ancestor
24530941|NCT00633373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530942|NCT00633373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530943|NCT00633373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24530944|NCT00633373|Immunologic Factors|immunologic factors|mesh-ancestor
24530945|NCT00633373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530946|NCT00633373|Antifungal Agents|antifungal agents|mesh-ancestor
24530947|NCT00633373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24530948|NCT00633373|Dermatologic Agents|dermatologic agents|mesh-ancestor
24530949|NCT00633373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24530950|NCT00633373|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24530951|NCT00633386|Celecoxib|celecoxib|mesh-list
24530952|NCT00633386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24530953|NCT00633386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25262273|NCT02449252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262274|NCT02449252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262275|NCT02449252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25262276|NCT02449252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25262369|NCT02448316|Prednisolone phosphate|prednisolone phosphate|mesh-list
25262277|NCT02449252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25688388|NCT01944839|Ranibizumab|ranibizumab|mesh-list
25688389|NCT01944839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25688390|NCT01944839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25688391|NCT01944839|Growth Substances|growth substances|mesh-ancestor
25688392|NCT01944839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688393|NCT01944839|Growth Inhibitors|growth inhibitors|mesh-ancestor
25688394|NCT01944839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688395|NCT01944969|Brexpiprazole|brexpiprazole|mesh-list
25688396|NCT01944969|Serotonin Agents|serotonin agents|mesh-ancestor
25688397|NCT01944969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25688398|NCT01944969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688399|NCT01944969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688400|NCT01944969|Dopamine Agonists|dopamine agonists|mesh-ancestor
25688401|NCT01944969|Dopamine Agents|dopamine agents|mesh-ancestor
25688402|NCT01945086|Ustekinumab|ustekinumab|mesh-list
25688403|NCT01945086|Dermatologic Agents|dermatologic agents|mesh-ancestor
25688404|NCT01945138|Insulin|insulin|mesh-list
25688405|NCT01945138|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25688406|NCT01945138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25688407|NCT01945138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688408|NCT01945216|Alogliptin|alogliptin|mesh-list
25688409|NCT01945216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25688410|NCT01945216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552457|NCT02916862|Calcium, Dietary|calcium, dietary|mesh-list
24552458|NCT02916862|Calcium|calcium|mesh-list
24947779|NCT03925818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552523|NCT02704156|Gemcitabine|gemcitabine|mesh-list
24552524|NCT02704156|Pembrolizumab|pembrolizumab|mesh-list
24552525|NCT02704156|Trametinib|trametinib|mesh-list
24552526|NCT02704156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24552527|NCT02704156|Antimetabolites|antimetabolites|mesh-ancestor
24552528|NCT02704156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552529|NCT02704156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552530|NCT02704156|Antiviral Agents|antiviral agents|mesh-ancestor
24552531|NCT02704156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24552548|NCT02688530|Hormones|hormones|mesh-ancestor
25262278|NCT02449252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25262279|NCT02449252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262280|NCT02449252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25262281|NCT02449252|Glucocorticoids|glucocorticoids|mesh-ancestor
25262282|NCT02449252|Hormones|hormones|mesh-ancestor
25262283|NCT02449252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25262284|NCT02449252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25262285|NCT02449252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25262286|NCT02449252|Tubulin Modulators|tubulin modulators|mesh-ancestor
25262287|NCT02449252|Antimitotic Agents|antimitotic agents|mesh-ancestor
25262288|NCT02449252|Mitosis Modulators|mitosis modulators|mesh-ancestor
25262289|NCT02449070|Nicorandil|nicorandil|mesh-list
25262290|NCT02449070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25262291|NCT02449070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25262292|NCT02449070|Vasodilator Agents|vasodilator agents|mesh-ancestor
25262293|NCT02449070|Vitamin B Complex|vitamin b complex|mesh-ancestor
25262294|NCT02449070|Vitamins|vitamins|mesh-ancestor
25262295|NCT02449070|Micronutrients|micronutrients|mesh-ancestor
25262296|NCT02449070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262297|NCT02449278|Prednisone|prednisone|mesh-list
25262298|NCT02449278|Cyclophosphamide|cyclophosphamide|mesh-list
25262299|NCT02449278|Doxorubicin|doxorubicin|mesh-list
25262300|NCT02449278|Vincristine|vincristine|mesh-list
25262301|NCT02449278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25262302|NCT02449278|Immunologic Factors|immunologic factors|mesh-ancestor
25262303|NCT02449278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262304|NCT02449278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25262305|NCT02449278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25262306|NCT02449278|Alkylating Agents|alkylating agents|mesh-ancestor
25262307|NCT02449278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262308|NCT02449278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262309|NCT02449278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25262310|NCT02449278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25262311|NCT02449278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25262312|NCT02449278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24530978|NCT00633425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24530979|NCT00633425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24530980|NCT00633425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530981|NCT00633425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24625439|NCT01082237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24625452|NCT01082250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24625453|NCT01082250|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24625454|NCT01082250|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24625455|NCT01082250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24625456|NCT01082250|Adrenergic Agents|adrenergic agents|mesh-ancestor
24625457|NCT01082250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25688411|NCT01945216|Incretins|incretins|mesh-ancestor
25688412|NCT01945216|Hormones|hormones|mesh-ancestor
25688413|NCT01945216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25688414|NCT01945216|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25688415|NCT01945216|Protease Inhibitors|protease inhibitors|mesh-ancestor
25688416|NCT01945216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688417|NCT01945216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688418|NCT01945242|Alogliptin|alogliptin|mesh-list
25688419|NCT01945242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25688420|NCT01945242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688421|NCT01945242|Incretins|incretins|mesh-ancestor
25688422|NCT01945242|Hormones|hormones|mesh-ancestor
25688423|NCT01945242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25688424|NCT01945242|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24625458|NCT01082250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625459|NCT01082250|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25045378|NCT00961675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24625460|NCT01082250|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24625461|NCT01082250|Serotonin Agents|serotonin agents|mesh-ancestor
24531012|NCT00633542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24531013|NCT00633542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24531014|NCT00633542|Growth Substances|growth substances|mesh-ancestor
24531015|NCT00633542|Growth Inhibitors|growth inhibitors|mesh-ancestor
24531017|NCT00633568|Docetaxel|docetaxel|mesh-list
24935069|NCT04054960|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24935070|NCT04054960|Dopamine Agents|dopamine agents|mesh-ancestor
24935071|NCT04054960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24935072|NCT04054960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935117|NCT04054687|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24935118|NCT04054687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935120|NCT04054687|Coagulants|coagulants|mesh-ancestor
24935121|NCT04054635|Fluorides|fluorides|mesh-list
24935122|NCT04054635|Cariostatic Agents|cariostatic agents|mesh-ancestor
24935142|NCT04054362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24935143|NCT04054362|Immunologic Factors|immunologic factors|mesh-ancestor
24935144|NCT04054362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935145|NCT04054284|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24935149|NCT04054206|Autonomic Agents|autonomic agents|mesh-ancestor
25262313|NCT02449278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262314|NCT02449278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25262315|NCT02449278|Glucocorticoids|glucocorticoids|mesh-ancestor
25262316|NCT02449278|Hormones|hormones|mesh-ancestor
24511983|NCT00571935|Insulin|insulin|mesh-list
25262317|NCT02449278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25262318|NCT02449278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25262319|NCT02449278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25262320|NCT02449278|Tubulin Modulators|tubulin modulators|mesh-ancestor
25262321|NCT02449278|Antimitotic Agents|antimitotic agents|mesh-ancestor
25262322|NCT02449278|Mitosis Modulators|mitosis modulators|mesh-ancestor
25262323|NCT02448797|Vinorelbine|vinorelbine|mesh-list
25262324|NCT02448797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25262325|NCT02448797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262326|NCT02448797|Tubulin Modulators|tubulin modulators|mesh-ancestor
25262327|NCT02448797|Antimitotic Agents|antimitotic agents|mesh-ancestor
25262328|NCT02448797|Mitosis Modulators|mitosis modulators|mesh-ancestor
25262329|NCT02448797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262330|NCT02448784|Donepezil|donepezil|mesh-list
25262331|NCT02448784|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25262332|NCT02448784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262333|NCT02448784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262334|NCT02448784|Cholinergic Agents|cholinergic agents|mesh-ancestor
25262335|NCT02448784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25262336|NCT02448784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262337|NCT02448784|Nootropic Agents|nootropic agents|mesh-ancestor
25262338|NCT02448901|Edoxaban|edoxaban|mesh-list
25262339|NCT02448901|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25262340|NCT02448901|Antithrombins|antithrombins|mesh-ancestor
25262341|NCT02448901|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25262342|NCT02448901|Protease Inhibitors|protease inhibitors|mesh-ancestor
25262343|NCT02448901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262344|NCT02448901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262345|NCT02448901|Anticoagulants|anticoagulants|mesh-ancestor
25262346|NCT02448407|Hyaluronic Acid|hyaluronic acid|mesh-list
25262347|NCT02448407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25262348|NCT02448407|Immunologic Factors|immunologic factors|mesh-ancestor
25262349|NCT02448407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935150|NCT04054206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24935151|NCT04054206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935152|NCT04054206|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24935153|NCT04054206|Respiratory System Agents|respiratory system agents|mesh-ancestor
24935154|NCT04054206|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24935155|NCT04054206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935156|NCT04054206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935157|NCT04054206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24935158|NCT04054206|Vasodilator Agents|vasodilator agents|mesh-ancestor
24935160|NCT04054024|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
24935161|NCT04054024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935163|NCT04054024|Sensory System Agents|sensory system agents|mesh-ancestor
24935164|NCT04054024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24935194|NCT04053972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935195|NCT04053972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935196|NCT04054115|Alprostadil|alprostadil|mesh-list
24935197|NCT04054115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24511651|NCT00569985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531018|NCT00633568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531019|NCT00633568|Tubulin Modulators|tubulin modulators|mesh-ancestor
24531020|NCT00633568|Antimitotic Agents|antimitotic agents|mesh-ancestor
24531021|NCT00633568|Mitosis Modulators|mitosis modulators|mesh-ancestor
24531022|NCT00633568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262350|NCT02448407|Viscosupplements|viscosupplements|mesh-ancestor
25262351|NCT02448407|Protective Agents|protective agents|mesh-ancestor
25262352|NCT02448550|Heparin|heparin|mesh-list
25262353|NCT02448550|Calcium heparin|calcium heparin|mesh-list
25262354|NCT02448550|Bivalirudin|bivalirudin|mesh-list
25262355|NCT02448550|Anticoagulants|anticoagulants|mesh-ancestor
25262358|NCT02448550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262360|NCT02448550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25262361|NCT02448550|Protease Inhibitors|protease inhibitors|mesh-ancestor
25262362|NCT02448550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262363|NCT02448316|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25262364|NCT02448316|Methylprednisolone|methylprednisolone|mesh-list
25262365|NCT02448316|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25262366|NCT02448316|Prednisolone|prednisolone|mesh-list
25262367|NCT02448316|Prednisolone acetate|prednisolone acetate|mesh-list
25262368|NCT02448316|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25262371|NCT02448316|Antiemetics|antiemetics|mesh-ancestor
25262372|NCT02448316|Autonomic Agents|autonomic agents|mesh-ancestor
25262373|NCT02448316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25262374|NCT02448316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262375|NCT02448316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25262376|NCT02448316|Glucocorticoids|glucocorticoids|mesh-ancestor
25262377|NCT02448316|Hormones|hormones|mesh-ancestor
25262378|NCT02448316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25262379|NCT02448316|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25262380|NCT02448316|Protective Agents|protective agents|mesh-ancestor
25262381|NCT02448316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25262382|NCT02448316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262383|NCT02448264|Berotralstat|berotralstat|mesh-list
25262384|NCT02448264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262385|NCT02448264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262386|NCT02448290|Docetaxel|docetaxel|mesh-list
25262387|NCT02448290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262388|NCT02448290|Tubulin Modulators|tubulin modulators|mesh-ancestor
25262389|NCT02448290|Antimitotic Agents|antimitotic agents|mesh-ancestor
25262390|NCT02448290|Mitosis Modulators|mitosis modulators|mesh-ancestor
25262391|NCT02448290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262392|NCT02448251|Abivertinib|abivertinib|mesh-list
25262393|NCT02448251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25262394|NCT02448251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262395|NCT02448251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262396|NCT02448199|Meloxicam|meloxicam|mesh-list
25262397|NCT02448199|Antirheumatic Agents|antirheumatic agents|mesh-list
24456304|NCT00330824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412130|NCT00190866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155547|NCT05345613|Tranexamic Acid|tranexamic acid|mesh-list
25155548|NCT05345613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24668488|NCT04892706|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
24668489|NCT04892706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24668490|NCT04892706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24668492|NCT04892706|Sensory System Agents|sensory system agents|mesh-ancestor
24668493|NCT04892706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24668494|NCT04892706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24668495|NCT04892706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24668496|NCT04892706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24412183|NCT00190918|Pemetrexed|pemetrexed|mesh-list
24531167|NCT00634348|Serotonin Agents|serotonin agents|mesh-ancestor
24531168|NCT00634348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24531169|NCT00634348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24531170|NCT00634348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24668509|NCT04889547|Dexamethasone acetate|dexamethasone acetate|mesh-list
24668510|NCT04889547|BB 1101|bb 1101|mesh-list
24668511|NCT04889547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24668512|NCT04889547|Antiemetics|antiemetics|mesh-ancestor
24668513|NCT04889547|Autonomic Agents|autonomic agents|mesh-ancestor
25262412|NCT02448069|Antithrombins|antithrombins|mesh-ancestor
25262413|NCT02448069|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25262414|NCT02448069|Protease Inhibitors|protease inhibitors|mesh-ancestor
25262415|NCT02448069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262416|NCT02448069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262417|NCT02448069|Anticoagulants|anticoagulants|mesh-ancestor
25262418|NCT02448069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25262419|NCT02447965|Bupivacaine|bupivacaine|mesh-list
25262420|NCT02447965|Anesthetics, Local|anesthetics, local|mesh-ancestor
25262421|NCT02447965|Anesthetics|anesthetics|mesh-ancestor
25262422|NCT02447965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25262423|NCT02447965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262424|NCT02447965|Sensory System Agents|sensory system agents|mesh-ancestor
25262425|NCT02447965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25262426|NCT02447939|Trametinib|trametinib|mesh-list
25262427|NCT02447939|Dabrafenib|dabrafenib|mesh-list
25262428|NCT02447939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262430|NCT02447939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262431|NCT02447939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531212|NCT00634491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531213|NCT00634491|Diuretics|diuretics|mesh-ancestor
24531214|NCT00634491|Natriuretic Agents|natriuretic agents|mesh-ancestor
24531215|NCT00634491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531217|NCT00634556|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
24668560|NCT04837716|Bevacizumab|bevacizumab|mesh-list
24668561|NCT04837716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25262432|NCT02447809|Aspirin|aspirin|mesh-list
25262433|NCT02447809|Clopidogrel|clopidogrel|mesh-list
25262434|NCT02447809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25262435|NCT02447809|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25262436|NCT02447809|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25262439|NCT02447809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25262440|NCT02447809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262441|NCT02447809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262442|NCT02447809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25262443|NCT02447809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25262444|NCT02447809|Analgesics|analgesics|mesh-ancestor
25262445|NCT02447809|Sensory System Agents|sensory system agents|mesh-ancestor
25262446|NCT02447809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25262447|NCT02447809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25262448|NCT02447809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25262449|NCT02447809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25262450|NCT02447809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25262451|NCT02447809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25262452|NCT02447809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262453|NCT02447809|Antipyretics|antipyretics|mesh-ancestor
25262454|NCT02447822|Thymoglobulin|thymoglobulin|mesh-list
25262455|NCT02447822|Immunologic Factors|immunologic factors|mesh-ancestor
25262456|NCT02447822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262457|NCT02447822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25262458|NCT02447757|Remifentanil|remifentanil|mesh-list
25262459|NCT02447757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25262460|NCT02447757|Narcotics|narcotics|mesh-ancestor
25262461|NCT02447757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25262462|NCT02447757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262463|NCT02447757|Analgesics|analgesics|mesh-ancestor
25262464|NCT02447757|Sensory System Agents|sensory system agents|mesh-ancestor
25262465|NCT02447757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25262466|NCT02447705|Telbivudine|telbivudine|mesh-list
25262467|NCT02447705|Antiviral Agents|antiviral agents|mesh-ancestor
25262468|NCT02447705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25262469|NCT02447705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25262470|NCT02447705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262471|NCT02447705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262472|NCT02447835|Olanzapine|olanzapine|mesh-list
25262473|NCT02447835|Antiemetics|antiemetics|mesh-ancestor
25262474|NCT02447835|Autonomic Agents|autonomic agents|mesh-ancestor
25262475|NCT02447835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24668599|NCT04734080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24668600|NCT04734080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24668601|NCT04734080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24668603|NCT04734080|Sensory System Agents|sensory system agents|mesh-ancestor
24668604|NCT04734080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24668605|NCT04734080|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24668606|NCT04734080|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24668607|NCT04734080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24668608|NCT04734080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24668609|NCT04734080|Hormones|hormones|mesh-ancestor
24668610|NCT04734080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24668611|NCT04725331|Pembrolizumab|pembrolizumab|mesh-list
24668612|NCT04725331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24668613|NCT04725331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511827|NCT00571142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24511833|NCT00571142|GABA Agents|gaba agents|mesh-ancestor
24531219|NCT00634556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24531220|NCT00634556|Dopamine Agents|dopamine agents|mesh-ancestor
24531221|NCT00634556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24531222|NCT00634556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531223|NCT00634556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531224|NCT00634595|Paclitaxel|paclitaxel|mesh-list
24531225|NCT00634595|Cisplatin|cisplatin|mesh-list
24531227|NCT00634595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262476|NCT02447835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262477|NCT02447835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25262478|NCT02447835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25262479|NCT02447835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25262480|NCT02447835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25262481|NCT02447835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25262482|NCT02447835|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25262483|NCT02447835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25262484|NCT02447835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25262488|NCT02447796|Dexmedetomidine|dexmedetomidine|mesh-list
25262489|NCT02447796|Propofol|propofol|mesh-list
25262490|NCT02447796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25262491|NCT02447796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25262492|NCT02447796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262493|NCT02447796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25262494|NCT02447796|Anesthetics, General|anesthetics, general|mesh-ancestor
25262495|NCT02447796|Anesthetics|anesthetics|mesh-ancestor
25262496|NCT02447796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25262497|NCT02447796|Analgesics|analgesics|mesh-ancestor
25262498|NCT02447796|Sensory System Agents|sensory system agents|mesh-ancestor
25262499|NCT02447796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25262500|NCT02447796|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25262501|NCT02447796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25262502|NCT02447796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25262503|NCT02447796|Adrenergic Agents|adrenergic agents|mesh-ancestor
25262504|NCT02447796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25262505|NCT02447796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262506|NCT02447666|Azacitidine|azacitidine|mesh-list
25262507|NCT02447666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25262508|NCT02447666|Antimetabolites|antimetabolites|mesh-ancestor
25262509|NCT02447666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262510|NCT02447666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262511|NCT02447666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262512|NCT02447679|Tegafur|tegafur|mesh-list
25262513|NCT02447679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25262514|NCT02447679|Antimetabolites|antimetabolites|mesh-ancestor
25262515|NCT02447679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262516|NCT02447679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262517|NCT02447601|Simvastatin|simvastatin|mesh-list
25262518|NCT02447601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25262519|NCT02447601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25262520|NCT02447601|Antimetabolites|antimetabolites|mesh-ancestor
24531259|NCT00634725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24531260|NCT00634725|Antimetabolites|antimetabolites|mesh-ancestor
24531261|NCT00634725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531262|NCT00634725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531263|NCT00634725|Antiviral Agents|antiviral agents|mesh-ancestor
24554130|NCT00734448|Vitamin B Complex|vitamin b complex|mesh-ancestor
24554131|NCT00734448|Vitamins|vitamins|mesh-ancestor
24531276|NCT00634790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24531277|NCT00634790|GABA Modulators|gaba modulators|mesh-ancestor
24531302|NCT00634959|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24668779|NCT04609514|Cholinergic Agents|cholinergic agents|mesh-ancestor
24668780|NCT04609514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24668781|NCT04609514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24668786|NCT04596033|Cyclophosphamide|cyclophosphamide|mesh-list
24668787|NCT04596033|Fludarabine|fludarabine|mesh-list
24668788|NCT04596033|Interleukin-2|interleukin-2|mesh-list
24668789|NCT04596033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24668790|NCT04596033|Immunologic Factors|immunologic factors|mesh-ancestor
24668795|NCT04596033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24668796|NCT04596033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24668797|NCT04596033|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24668798|NCT04596033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24668799|NCT04596033|Analgesics|analgesics|mesh-ancestor
24668800|NCT04596033|Sensory System Agents|sensory system agents|mesh-ancestor
24668801|NCT04596033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24668803|NCT04591353|Anesthetics, Local|anesthetics, local|mesh-ancestor
24668804|NCT04591353|Anesthetics|anesthetics|mesh-ancestor
24668805|NCT04591353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24511982|NCT00571870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24511985|NCT00571935|Insulin Aspart|insulin aspart|mesh-list
24684325|NCT01396720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684346|NCT01396733|Micronutrients|micronutrients|mesh-ancestor
24684347|NCT01397006|Pregabalin|pregabalin|mesh-list
24684348|NCT01397006|Analgesics|analgesics|mesh-ancestor
24684349|NCT01397006|Sensory System Agents|sensory system agents|mesh-ancestor
25262543|NCT02447289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25262544|NCT02447289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262545|NCT02447289|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25262546|NCT02447289|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25262547|NCT02447289|Anesthetics, General|anesthetics, general|mesh-ancestor
25262548|NCT02447289|Anesthetics|anesthetics|mesh-ancestor
25262549|NCT02447289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25262550|NCT02447289|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25262551|NCT02447289|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25262552|NCT02447289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25262553|NCT02447289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531320|NCT00635037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531321|NCT00635037|Sensory System Agents|sensory system agents|mesh-ancestor
24668806|NCT04591353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456318|NCT00330902|Sulfadoxine|sulfadoxine|mesh-list
24412502|NCT00191516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24668841|NCT04551131|Dexamethasone|dexamethasone|mesh-list
24668842|NCT04551131|Etoposide|etoposide|mesh-list
24668843|NCT04551131|Etoposide phosphate|etoposide phosphate|mesh-list
24668844|NCT04551131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24668845|NCT04551131|Antiemetics|antiemetics|mesh-ancestor
24668846|NCT04551131|Autonomic Agents|autonomic agents|mesh-ancestor
24684351|NCT01397006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684352|NCT01397006|Anticonvulsants|anticonvulsants|mesh-ancestor
24684353|NCT01397006|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24684354|NCT01397006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25262559|NCT02447289|GABA Modulators|gaba modulators|mesh-ancestor
25262560|NCT02447289|GABA Agents|gaba agents|mesh-ancestor
25275253|NCT02373280|Esomeprazole|esomeprazole|mesh-list
25275255|NCT02373280|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25275256|NCT02373280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25275257|NCT02373280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25275258|NCT02373280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25275259|NCT02373280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25275260|NCT02373280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275261|NCT02373280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688425|NCT01945242|Protease Inhibitors|protease inhibitors|mesh-ancestor
25688426|NCT01945242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688427|NCT01945242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688428|NCT01945281|Amphotericin B|amphotericin b|mesh-list
25275263|NCT02373280|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25275264|NCT02373280|Contraceptive Agents|contraceptive agents|mesh-ancestor
25275265|NCT02373280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25275266|NCT02373280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275267|NCT02373280|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25275268|NCT02373280|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25275269|NCT02373280|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25275270|NCT02373280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25275271|NCT02373280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25275272|NCT02373280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25275273|NCT02373280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25275274|NCT02373280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25275275|NCT02373280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25275276|NCT02373280|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25275277|NCT02373280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25275278|NCT02373280|Antacids|antacids|mesh-ancestor
25275279|NCT02372942|Progesterone|progesterone|mesh-list
25275280|NCT02372942|Progestins|progestins|mesh-ancestor
24668847|NCT04551131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24668848|NCT04551131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24668849|NCT04551131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24668851|NCT04551131|Hormones|hormones|mesh-ancestor
24668852|NCT04551131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24668853|NCT04551131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24412549|NCT00191581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24668878|NCT04543968|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24668879|NCT04543968|Disinfectants|disinfectants|mesh-ancestor
24456356|NCT00330993|Mifepristone|mifepristone|mesh-list
24456357|NCT00330993|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24456358|NCT00330993|Abortifacient Agents|abortifacient agents|mesh-ancestor
24456359|NCT00330993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24531332|NCT00635076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24531333|NCT00635076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531334|NCT00635258|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24668922|NCT04512066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24668923|NCT04512066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24668924|NCT04512066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24668925|NCT04512066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24668926|NCT04512066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24668927|NCT04512066|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24668928|NCT04512066|Dopamine Agents|dopamine agents|mesh-ancestor
24531364|NCT00635323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24531365|NCT00635323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24531367|NCT00635401|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24684355|NCT01397006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519503|NCT05333159|Empagliflozin|empagliflozin|mesh-list
24684511|NCT05243251|Olanzapine|olanzapine|mesh-list
24684580|NCT05054439|Paclitaxel|paclitaxel|mesh-list
24684581|NCT05054439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24684582|NCT05054439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684583|NCT05054439|Tubulin Modulators|tubulin modulators|mesh-ancestor
25262572|NCT02447315|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25262573|NCT02447315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25262574|NCT02447315|Cholinergic Agents|cholinergic agents|mesh-ancestor
25262575|NCT02447315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25262576|NCT02447315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262577|NCT02447224|Metronidazole|metronidazole|mesh-list
25262578|NCT02447224|Ertapenem|ertapenem|mesh-list
25262579|NCT02447224|Cefdinir|cefdinir|mesh-list
25262580|NCT02447224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25262581|NCT02447224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25262582|NCT02447224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25262583|NCT02447224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25262584|NCT02447211|Doxepin|doxepin|mesh-list
25262585|NCT02447211|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25262586|NCT02447211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25262587|NCT02447211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25262588|NCT02447211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262589|NCT02447211|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25262590|NCT02447211|Antidepressive Agents|antidepressive agents|mesh-ancestor
25262591|NCT02447211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25275281|NCT02372942|Hormones|hormones|mesh-ancestor
24531368|NCT00635401|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24531369|NCT00635401|Cholinergic Agents|cholinergic agents|mesh-ancestor
24531370|NCT00635401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24531371|NCT00635401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531372|NCT00635401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531373|NCT00635414|Esomeprazole|esomeprazole|mesh-list
24531374|NCT00635414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24531375|NCT00635414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24531376|NCT00635414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24531377|NCT00635414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24531378|NCT00635414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531379|NCT00635531|Alprazolam|alprazolam|mesh-list
24531380|NCT00635531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24531401|NCT00635713|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24456360|NCT00330993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456362|NCT00330993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24456363|NCT00330993|Oxytocics|oxytocics|mesh-ancestor
24456364|NCT00330993|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24456365|NCT00330993|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24937020|NCT04033471|Narcotics|narcotics|mesh-ancestor
24684588|NCT05038592|Decitabine|decitabine|mesh-list
24684589|NCT05038592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24684590|NCT05038592|Antimetabolites|antimetabolites|mesh-ancestor
24684591|NCT05038592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684592|NCT05038592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684593|NCT05038592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24684594|NCT05009355|Ascorbic Acid|ascorbic acid|mesh-list
25262600|NCT02447185|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25262601|NCT02447185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25262602|NCT02447185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24544621|NCT00689715|Ethanol|ethanol|mesh-list
25262603|NCT02447185|Growth Substances|growth substances|mesh-ancestor
25262604|NCT02447185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262605|NCT02447185|Growth Inhibitors|growth inhibitors|mesh-ancestor
25262606|NCT02447185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262607|NCT02447185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25262608|NCT02447185|Glucocorticoids|glucocorticoids|mesh-ancestor
25262609|NCT02447185|Hormones|hormones|mesh-ancestor
25262610|NCT02447185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25262611|NCT02447185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25262612|NCT02447185|Immunologic Factors|immunologic factors|mesh-ancestor
25262613|NCT02447185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262614|NCT02447185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262615|NCT02446977|Riboflavin|riboflavin|mesh-list
25262616|NCT02446977|Vitamins|vitamins|mesh-ancestor
25262617|NCT02446977|Micronutrients|micronutrients|mesh-ancestor
25262618|NCT02446977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262619|NCT02446977|Vitamin B Complex|vitamin b complex|mesh-ancestor
25262620|NCT02446977|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25262621|NCT02446977|Dermatologic Agents|dermatologic agents|mesh-ancestor
25262622|NCT02447016|Tenofovir|tenofovir|mesh-list
25262623|NCT02447016|Emtricitabine|emtricitabine|mesh-list
25262624|NCT02447016|Efavirenz|efavirenz|mesh-list
25262625|NCT02447016|Rilpivirine|rilpivirine|mesh-list
25262626|NCT02447016|Antiviral Agents|antiviral agents|mesh-ancestor
24456368|NCT00330993|Contraceptive Agents|contraceptive agents|mesh-ancestor
24512210|NCT00573599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24512211|NCT00573599|Histamine Antagonists|histamine antagonists|mesh-ancestor
24531458|NCT00635960|Hormones|hormones|mesh-list
24531459|NCT00635960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24531460|NCT00635960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531461|NCT00635973|Gefitinib|gefitinib|mesh-list
24531462|NCT00635973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531463|NCT00635973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24531464|NCT00635973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24531465|NCT00635973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531466|NCT00635986|Fentanyl|fentanyl|mesh-list
24531467|NCT00635986|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24531468|NCT00635986|Narcotics|narcotics|mesh-ancestor
24531469|NCT00635986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24531470|NCT00635986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412765|NCT00191997|Olanzapine|olanzapine|mesh-list
24512220|NCT00573599|Dopamine Agents|dopamine agents|mesh-ancestor
25262627|NCT02447016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25262628|NCT02447016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24554793|NCT00738192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554795|NCT00738192|Sensory System Agents|sensory system agents|mesh-ancestor
24554796|NCT00738192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24554797|NCT00738192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24554798|NCT00738192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24554799|NCT00738192|Anesthetics, General|anesthetics, general|mesh-ancestor
24554800|NCT00738192|Anesthetics|anesthetics|mesh-ancestor
24554801|NCT00738192|Anticoagulants|anticoagulants|mesh-ancestor
24554802|NCT00738192|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24554803|NCT00738192|Chelating Agents|chelating agents|mesh-ancestor
24554804|NCT00738192|Sequestering Agents|sequestering agents|mesh-ancestor
24554805|NCT00738192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554806|NCT00738192|Antitussive Agents|antitussive agents|mesh-ancestor
24554807|NCT00738192|Respiratory System Agents|respiratory system agents|mesh-ancestor
24947929|NCT03925090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262629|NCT02447016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25262630|NCT02447016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262631|NCT02447016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262632|NCT02447016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25262633|NCT02447016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25262634|NCT02447016|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25262794|NCT02446353|Appetite Stimulants|appetite stimulants|mesh-ancestor
25262635|NCT02447016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25262636|NCT02447016|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25262637|NCT02447016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25262638|NCT02447016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25262639|NCT02447016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25262640|NCT02447055|Mycophenolic Acid|mycophenolic acid|mesh-list
25262641|NCT02447055|Cyclophosphamide|cyclophosphamide|mesh-list
25262642|NCT02447055|Melphalan|melphalan|mesh-list
25262643|NCT02447055|Fludarabine|fludarabine|mesh-list
25262644|NCT02447055|Fludarabine phosphate|fludarabine phosphate|mesh-list
25262645|NCT02447055|Tacrolimus|tacrolimus|mesh-list
25262646|NCT02447055|Lenograstim|lenograstim|mesh-list
25262647|NCT02447055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25262648|NCT02447055|Immunologic Factors|immunologic factors|mesh-ancestor
25262649|NCT02447055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262650|NCT02447055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25262651|NCT02447055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25262652|NCT02447055|Alkylating Agents|alkylating agents|mesh-ancestor
25262653|NCT02447055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262654|NCT02447055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262655|NCT02447055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25262656|NCT02447055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25262657|NCT02447055|Antimetabolites|antimetabolites|mesh-ancestor
25262658|NCT02447055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25262659|NCT02447055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262660|NCT02447055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25262661|NCT02447055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25262662|NCT02447055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24531502|NCT00636116|Immunologic Factors|immunologic factors|mesh-ancestor
24531503|NCT00636116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531504|NCT00636142|Infliximab|infliximab|mesh-list
24531505|NCT00636142|Dermatologic Agents|dermatologic agents|mesh-ancestor
24531506|NCT00636142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24531513|NCT00636246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24531514|NCT00636246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25688429|NCT01945281|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25688430|NCT01945281|Caspofungin|caspofungin|mesh-list
25688431|NCT01945281|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
25688432|NCT01945281|Deoxycholic Acid|deoxycholic acid|mesh-list
25688433|NCT01945281|Amebicides|amebicides|mesh-ancestor
25688434|NCT01945281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25688435|NCT01945281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25688436|NCT01945281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25688437|NCT01945281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25688438|NCT01945281|Antifungal Agents|antifungal agents|mesh-ancestor
25688439|NCT01945281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688440|NCT01945281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688441|NCT01945281|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25688442|NCT01945281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25688443|NCT01945294|Interferons|interferons|mesh-list
25688444|NCT01945294|Ribavirin|ribavirin|mesh-list
24531515|NCT00636246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531516|NCT00636246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24531517|NCT00636246|Serotonin Agents|serotonin agents|mesh-ancestor
24531518|NCT00636246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531519|NCT00636246|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24531520|NCT00636246|Adrenergic Agents|adrenergic agents|mesh-ancestor
24531521|NCT00636259|Bicalutamide|bicalutamide|mesh-list
24531522|NCT00636259|Androgen Antagonists|androgen antagonists|mesh-ancestor
24531523|NCT00636259|Hormone Antagonists|hormone antagonists|mesh-ancestor
24531524|NCT00636259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24531525|NCT00636259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531526|NCT00636259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531527|NCT00636285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24531528|NCT00636285|Immunologic Factors|immunologic factors|mesh-ancestor
24531529|NCT00636285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531530|NCT00636298|Bevacizumab|bevacizumab|mesh-list
24412814|NCT00192088|Pemetrexed|pemetrexed|mesh-list
24456369|NCT00330993|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24456370|NCT00330993|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24456372|NCT00330993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24456373|NCT00330993|Luteolytic Agents|luteolytic agents|mesh-ancestor
24456374|NCT00330993|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24456375|NCT00330993|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24456377|NCT00331045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24937062|NCT04033029|Ceftolozane|ceftolozane|mesh-list
24684595|NCT05009355|Vitamins|vitamins|mesh-ancestor
24684596|NCT05009355|Micronutrients|micronutrients|mesh-ancestor
24684597|NCT05009355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855064|NCT02277067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855065|NCT02277067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24855066|NCT02277067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24855067|NCT02277067|Oxytocics|oxytocics|mesh-ancestor
24684649|NCT04893096|Immunologic Factors|immunologic factors|mesh-ancestor
25262663|NCT02447055|Antitubercular Agents|antitubercular agents|mesh-ancestor
25262664|NCT02447055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25262665|NCT02447055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25262666|NCT02447094|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25262667|NCT02447094|Plasminogen|plasminogen|mesh-list
25262668|NCT02447094|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25262671|NCT02446860|Nivolumab|nivolumab|mesh-list
25262672|NCT02446860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25262673|NCT02446860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262674|NCT02446860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25262675|NCT02446860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262676|NCT02446730|Clopidogrel|clopidogrel|mesh-list
25262677|NCT02446730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25262678|NCT02446730|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25262679|NCT02446730|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25262680|NCT02446730|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25262681|NCT02446730|Purinergic Agents|purinergic agents|mesh-ancestor
25262682|NCT02446730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25262683|NCT02446730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262684|NCT02446730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262685|NCT02446652|Paclitaxel|paclitaxel|mesh-list
25262686|NCT02446652|Carboplatin|carboplatin|mesh-list
25262687|NCT02446652|Hydralazine|hydralazine|mesh-list
25262688|NCT02446652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25262689|NCT02446652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262690|NCT02446652|Tubulin Modulators|tubulin modulators|mesh-ancestor
25262691|NCT02446652|Antimitotic Agents|antimitotic agents|mesh-ancestor
25262692|NCT02446652|Mitosis Modulators|mitosis modulators|mesh-ancestor
25262693|NCT02446652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262694|NCT02446652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24405005|NCT00165295|Sildenafil Citrate|sildenafil citrate|mesh-list
24456378|NCT00331058|Prednisolone|prednisolone|mesh-list
24456379|NCT00331058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24456380|NCT00331058|Glucocorticoids|glucocorticoids|mesh-ancestor
24531571|NCT00636428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531572|NCT00636428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24531573|NCT00636428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24531574|NCT00636428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24531575|NCT00636428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24531576|NCT00636428|Anesthetics, General|anesthetics, general|mesh-ancestor
24531578|NCT00636428|GABA Modulators|gaba modulators|mesh-ancestor
24531579|NCT00636428|GABA Agents|gaba agents|mesh-ancestor
24531580|NCT00636428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24531581|NCT00636428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531600|NCT00636740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24531601|NCT00636740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531603|NCT00636766|Rosiglitazone|rosiglitazone|mesh-list
24531604|NCT00636766|Rimonabant|rimonabant|mesh-list
24531605|NCT00636766|Atorvastatin|atorvastatin|mesh-list
24531606|NCT00636766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24531607|NCT00636766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531608|NCT00636766|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24531609|NCT00636766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24531610|NCT00636766|Antimetabolites|antimetabolites|mesh-ancestor
24531611|NCT00636766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531612|NCT00636766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24531613|NCT00636766|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24531614|NCT00636766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262695|NCT02446652|Vasodilator Agents|vasodilator agents|mesh-ancestor
25262696|NCT02446782|Clindamycin|clindamycin|mesh-list
25262697|NCT02446782|Cefazolin|cefazolin|mesh-list
25262698|NCT02446782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25262699|NCT02446782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25262700|NCT02446782|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25262701|NCT02446782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262702|NCT02446782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262703|NCT02446795|Sunitinib|sunitinib|mesh-list
25262704|NCT02446795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262705|NCT02446795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25262706|NCT02446795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25262707|NCT02446795|Growth Substances|growth substances|mesh-ancestor
25262708|NCT02446795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262709|NCT02446795|Growth Inhibitors|growth inhibitors|mesh-ancestor
25262710|NCT02446795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25262711|NCT02446795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262725|NCT02446574|Antimitotic Agents|antimitotic agents|mesh-ancestor
25262726|NCT02446574|Mitosis Modulators|mitosis modulators|mesh-ancestor
25262727|NCT02446574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262729|NCT02446704|Olaparib|olaparib|mesh-list
25262730|NCT02446704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25262731|NCT02446704|Alkylating Agents|alkylating agents|mesh-ancestor
25262732|NCT02446704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262733|NCT02446704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262734|NCT02446704|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25262735|NCT02446704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262736|NCT02446548|Losartan|losartan|mesh-list
25262737|NCT02446548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24531759|NCT00637078|Natriuretic Agents|natriuretic agents|mesh-ancestor
24531761|NCT00637091|Cetuximab|cetuximab|mesh-list
24531762|NCT00637091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24531763|NCT00637091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24531764|NCT00637091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456386|NCT00331071|Contraceptive Agents|contraceptive agents|mesh-list
24669058|NCT04296305|Hydromorphone|hydromorphone|mesh-list
24669059|NCT04296305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24669060|NCT04296305|Narcotics|narcotics|mesh-ancestor
24669061|NCT04296305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24669062|NCT04296305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24669063|NCT04296305|Analgesics|analgesics|mesh-ancestor
24669064|NCT04296305|Sensory System Agents|sensory system agents|mesh-ancestor
24669065|NCT04296305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24669066|NCT04292457|Propofol|propofol|mesh-list
24669067|NCT04292457|Sevoflurane|sevoflurane|mesh-list
24669068|NCT04292457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24669069|NCT04292457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24669070|NCT04292457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24669071|NCT04292457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24669072|NCT04292457|Anesthetics, General|anesthetics, general|mesh-ancestor
24669073|NCT04292457|Anesthetics|anesthetics|mesh-ancestor
24669074|NCT04292457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24669075|NCT04292457|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24669109|NCT04258410|Quercetin|quercetin|mesh-list
24669110|NCT04258410|Antioxidants|antioxidants|mesh-ancestor
25404319|NCT03674242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25051579|NCT00393991|Fluticasone|fluticasone|mesh-list
24669111|NCT04258410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512350|NCT00574470|Infliximab|infliximab|mesh-list
24531765|NCT00637091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531766|NCT00637091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531840|NCT00637442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262738|NCT02446548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25262739|NCT02446548|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25262740|NCT02446548|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25262741|NCT02446548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262761|NCT02446431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25262762|NCT02446431|Immunologic Factors|immunologic factors|mesh-ancestor
25262763|NCT02446431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262764|NCT02446431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25262765|NCT02446431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25262766|NCT02446431|Alkylating Agents|alkylating agents|mesh-ancestor
25262767|NCT02446431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262768|NCT02446431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262769|NCT02446431|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25262770|NCT02446431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25262771|NCT02446431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25262772|NCT02446431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25262773|NCT02446431|Growth Substances|growth substances|mesh-ancestor
25262774|NCT02446431|Growth Inhibitors|growth inhibitors|mesh-ancestor
25262775|NCT02446431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25262776|NCT02446431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25262777|NCT02446431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25262778|NCT02446431|Antifungal Agents|antifungal agents|mesh-ancestor
24531959|NCT00637663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24531961|NCT00637663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531962|NCT00637663|Antiviral Agents|antiviral agents|mesh-ancestor
24531963|NCT00637663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24531964|NCT00637663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24531965|NCT00637663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24531966|NCT00637715|Alfuzosin|alfuzosin|mesh-list
24531967|NCT00637715|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24456412|NCT00331084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456413|NCT00331084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24456414|NCT00331084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24456415|NCT00331084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24456416|NCT00331084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24456417|NCT00331084|Contraceptive Agents|contraceptive agents|mesh-ancestor
25045379|NCT00961675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25045380|NCT00961675|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25045381|NCT00961675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25045382|NCT00961675|Plasma Substitutes|plasma substitutes|mesh-ancestor
25045383|NCT00961675|Blood Substitutes|blood substitutes|mesh-ancestor
25045384|NCT00961675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25045385|NCT00961090|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25045386|NCT00961090|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25045387|NCT00961090|Dermatologic Agents|dermatologic agents|mesh-ancestor
25045388|NCT00959036|Methotrexate|methotrexate|mesh-list
25045389|NCT00959036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25045390|NCT00959036|Abortifacient Agents|abortifacient agents|mesh-ancestor
25045391|NCT00959036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25045392|NCT00959036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045393|NCT00959036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25045394|NCT00959036|Antimetabolites|antimetabolites|mesh-ancestor
25045395|NCT00959036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045396|NCT00959036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045397|NCT00959036|Dermatologic Agents|dermatologic agents|mesh-ancestor
25262779|NCT02446431|Anticonvulsants|anticonvulsants|mesh-ancestor
25262783|NCT02446431|Antimanic Agents|antimanic agents|mesh-ancestor
25262784|NCT02446431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25262785|NCT02446431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25262786|NCT02446431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25262787|NCT02446379|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25262788|NCT02446379|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25262789|NCT02446379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262790|NCT02446353|Megestrol Acetate|megestrol acetate|mesh-list
25688445|NCT01945294|Interferon-alpha|interferon-alpha|mesh-list
24555581|NCT00742092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555582|NCT00742144|Ofatumumab|ofatumumab|mesh-list
24555583|NCT00742144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24555584|NCT00742157|Hormones|hormones|mesh-list
25262791|NCT02446353|Megestrol|megestrol|mesh-list
25262792|NCT02446353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25262793|NCT02446353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262797|NCT02446353|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25262798|NCT02446353|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25262799|NCT02446353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25262800|NCT02446353|Contraceptive Agents|contraceptive agents|mesh-ancestor
25262801|NCT02446353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25262802|NCT02446353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25262803|NCT02446353|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25262804|NCT02446158|Chlorhexidine|chlorhexidine|mesh-list
25262805|NCT02446158|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25262806|NCT02446158|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25262807|NCT02446158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25262808|NCT02446158|Disinfectants|disinfectants|mesh-ancestor
25262809|NCT02446158|Dermatologic Agents|dermatologic agents|mesh-ancestor
25262810|NCT02446301|Nalbuphine|nalbuphine|mesh-list
25262811|NCT02446301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25262812|NCT02446301|Narcotics|narcotics|mesh-ancestor
25262813|NCT02446301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25262814|NCT02446301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262815|NCT02446301|Analgesics|analgesics|mesh-ancestor
25262816|NCT02446301|Sensory System Agents|sensory system agents|mesh-ancestor
25262817|NCT02446301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045400|NCT00959036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25045401|NCT00959036|Immunologic Factors|immunologic factors|mesh-ancestor
25045402|NCT00959036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25045403|NCT00959036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25045404|NCT00957918|Nicotine|nicotine|mesh-list
25045405|NCT00957918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25045406|NCT00957918|Autonomic Agents|autonomic agents|mesh-ancestor
25045407|NCT00957918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045414|NCT00955981|Lesinurad|lesinurad|mesh-list
25155549|NCT05345613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25155550|NCT05345613|Adrenergic Agents|adrenergic agents|mesh-ancestor
25155551|NCT05345613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25155552|NCT05345613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25155553|NCT05345613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155554|NCT05345613|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25155555|NCT05345613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25155556|NCT05345613|Autonomic Agents|autonomic agents|mesh-ancestor
25155557|NCT05345613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25155558|NCT05345613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25155559|NCT05345613|Respiratory System Agents|respiratory system agents|mesh-ancestor
25155560|NCT05345613|Mydriatics|mydriatics|mesh-ancestor
25155561|NCT05345613|Sympathomimetics|sympathomimetics|mesh-ancestor
25155562|NCT05345613|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25155563|NCT05345613|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25155564|NCT05345613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25155565|NCT05345613|Hemostatics|hemostatics|mesh-ancestor
25155566|NCT05345613|Coagulants|coagulants|mesh-ancestor
24937128|NCT04032834|Budesonide|budesonide|mesh-list
24684650|NCT04893096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684651|NCT04835129|Dexamethasone|dexamethasone|mesh-list
24684652|NCT04835129|Pomalidomide|pomalidomide|mesh-list
24684653|NCT04835129|Elotuzumab|elotuzumab|mesh-list
24684654|NCT04835129|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24684655|NCT04835129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24684656|NCT04835129|Antiemetics|antiemetics|mesh-ancestor
24684657|NCT04835129|Autonomic Agents|autonomic agents|mesh-ancestor
24684658|NCT04835129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24684659|NCT04835129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684660|NCT04835129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24684661|NCT04835129|Glucocorticoids|glucocorticoids|mesh-ancestor
25262818|NCT02445976|Seviteronel|seviteronel|mesh-list
24549593|NCT00716183|beta-Lactams|beta-lactams|mesh-list
25262819|NCT02445976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262820|NCT02445976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25688446|NCT01945294|Interferon alpha-2|interferon alpha-2|mesh-list
25688447|NCT01945294|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25688448|NCT01945294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688449|NCT01945294|Antiviral Agents|antiviral agents|mesh-ancestor
25262821|NCT02445976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262822|NCT02445976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262840|NCT02446002|Adrenergic Agents|adrenergic agents|mesh-ancestor
25262841|NCT02446002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25262842|NCT02446002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262843|NCT02446002|Analgesics|analgesics|mesh-ancestor
25262844|NCT02446002|Sympatholytics|sympatholytics|mesh-ancestor
25262845|NCT02446002|Autonomic Agents|autonomic agents|mesh-ancestor
25155585|NCT05340374|177Lu-PSMA-617|177lu-psma-617|mesh-list
25155586|NCT05340374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25155587|NCT05340374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24669264|NCT04145258|Aspirin|aspirin|mesh-list
24669265|NCT04145258|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24669266|NCT04145258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24669267|NCT04145258|Analgesics|analgesics|mesh-ancestor
24669268|NCT04145258|Sensory System Agents|sensory system agents|mesh-ancestor
24669269|NCT04145258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24669270|NCT04145258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512558|NCT00575627|Ribavirin|ribavirin|mesh-list
25262846|NCT02445898|Methylprednisolone|methylprednisolone|mesh-list
25262847|NCT02445898|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25262848|NCT02445898|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25262849|NCT02445898|Prednisolone|prednisolone|mesh-list
25262850|NCT02445898|Prednisolone acetate|prednisolone acetate|mesh-list
25262851|NCT02445898|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25262852|NCT02445898|Prednisolone phosphate|prednisolone phosphate|mesh-list
25262853|NCT02445898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25262854|NCT02445898|Antiemetics|antiemetics|mesh-ancestor
25262855|NCT02445898|Autonomic Agents|autonomic agents|mesh-ancestor
25262856|NCT02445898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25262857|NCT02445898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262858|NCT02445898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25262859|NCT02445898|Glucocorticoids|glucocorticoids|mesh-ancestor
25262860|NCT02445898|Hormones|hormones|mesh-ancestor
25262861|NCT02445898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25262862|NCT02445898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24544954|NCT00691158|Pramlintide|pramlintide|mesh-list
25262863|NCT02445898|Protective Agents|protective agents|mesh-ancestor
25262864|NCT02445898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25262865|NCT02445898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262866|NCT02445872|Dexamethasone|dexamethasone|mesh-list
25262867|NCT02445872|Aprepitant|aprepitant|mesh-list
25262868|NCT02445872|Palonosetron|palonosetron|mesh-list
25262869|NCT02445872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25262870|NCT02445872|Antiemetics|antiemetics|mesh-ancestor
25262871|NCT02445872|Autonomic Agents|autonomic agents|mesh-ancestor
25262872|NCT02445872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25262873|NCT02445872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262874|NCT02445872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25262875|NCT02445872|Glucocorticoids|glucocorticoids|mesh-ancestor
25262876|NCT02445872|Hormones|hormones|mesh-ancestor
25262877|NCT02445872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25262878|NCT02445872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25262879|NCT02445872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262880|NCT02445872|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25262881|NCT02445872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25262882|NCT02445872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262883|NCT02445872|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25262884|NCT02445872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24456424|NCT00331097|Fluorouracil|fluorouracil|mesh-list
24456425|NCT00331097|Methotrexate|methotrexate|mesh-list
24456426|NCT00331097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24456427|NCT00331097|Immunologic Factors|immunologic factors|mesh-ancestor
24669274|NCT04145258|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24669275|NCT04145258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24669421|NCT04005053|Protective Agents|protective agents|mesh-ancestor
24669276|NCT04145258|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24669277|NCT04145258|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24669278|NCT04145258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24669279|NCT04145258|Antipyretics|antipyretics|mesh-ancestor
24669280|NCT04132505|Hydroxychloroquine|hydroxychloroquine|mesh-list
24669281|NCT04132505|Antimalarials|antimalarials|mesh-ancestor
24669282|NCT04132505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24669283|NCT04132505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24669284|NCT04132505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24556087|NCT00744913|Autonomic Agents|autonomic agents|mesh-ancestor
24556088|NCT00744913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24411436|NCT00189007|Diuretics|diuretics|mesh-ancestor
24556117|NCT00745043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556118|NCT00745043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24556140|NCT00745173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24669285|NCT04132505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24669286|NCT04132505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24669287|NCT04132505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24669288|NCT04116112|Labetalol|labetalol|mesh-list
24669289|NCT04116112|Hydralazine|hydralazine|mesh-list
24669290|NCT04116112|Nicardipine|nicardipine|mesh-list
24669291|NCT04116112|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24669292|NCT04116112|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24669293|NCT04116112|Adrenergic Agents|adrenergic agents|mesh-ancestor
24669294|NCT04116112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24669295|NCT04116112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456428|NCT00331097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456429|NCT00331097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24456430|NCT00331097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24456431|NCT00331097|Alkylating Agents|alkylating agents|mesh-ancestor
24456432|NCT00331097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456433|NCT00331097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24456434|NCT00331097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24456435|NCT00331097|Tubulin Modulators|tubulin modulators|mesh-ancestor
24456436|NCT00331097|Antimitotic Agents|antimitotic agents|mesh-ancestor
24456437|NCT00331097|Mitosis Modulators|mitosis modulators|mesh-ancestor
25262885|NCT02445872|Serotonin Agents|serotonin agents|mesh-ancestor
25262886|NCT02446093|Valacyclovir|valacyclovir|mesh-list
25262887|NCT02446093|Antiviral Agents|antiviral agents|mesh-ancestor
25262888|NCT02446093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25262889|NCT02445820|Plasma-lyte 148|plasma-lyte 148|mesh-list
25262890|NCT02445820|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25262891|NCT02445820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25262892|NCT02445599|Dipyrone|dipyrone|mesh-list
25262893|NCT02445599|Diclofenac|diclofenac|mesh-list
25262894|NCT02445599|Atropine|atropine|mesh-list
25262895|NCT02445599|Fentanyl|fentanyl|mesh-list
25262896|NCT02445599|Midazolam|midazolam|mesh-list
25262897|NCT02445599|Tramadol|tramadol|mesh-list
25262898|NCT02445599|Nalbuphine|nalbuphine|mesh-list
25262899|NCT02445599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25262900|NCT02445599|Narcotics|narcotics|mesh-ancestor
25262901|NCT02445599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25262902|NCT02445599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262903|NCT02445599|Analgesics|analgesics|mesh-ancestor
25262904|NCT02445599|Sensory System Agents|sensory system agents|mesh-ancestor
25262905|NCT02445599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25262913|NCT02445599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25262914|NCT02445599|GABA Modulators|gaba modulators|mesh-ancestor
25262915|NCT02445599|GABA Agents|gaba agents|mesh-ancestor
25262916|NCT02445599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25262917|NCT02445599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262918|NCT02445599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25262919|NCT02445599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25262920|NCT02445599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25262921|NCT02445599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25262922|NCT02445599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25262923|NCT02445599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262924|NCT02445599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24532020|NCT00637871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24532021|NCT00637871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532194|NCT00638482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532195|NCT00638482|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24456441|NCT00331097|Abortifacient Agents|abortifacient agents|mesh-ancestor
24456442|NCT00331097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24669415|NCT04005053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25688450|NCT01945294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25688451|NCT01945294|Antimetabolites|antimetabolites|mesh-ancestor
25688452|NCT01945294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688453|NCT01945294|Immunologic Factors|immunologic factors|mesh-ancestor
25688454|NCT01945294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688455|NCT01945489|Botulinum Toxins|botulinum toxins|mesh-list
24669416|NCT04005053|Expectorants|expectorants|mesh-ancestor
24556348|NCT00747279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24669417|NCT04005053|Respiratory System Agents|respiratory system agents|mesh-ancestor
24669418|NCT04005053|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24669419|NCT04005053|Antioxidants|antioxidants|mesh-ancestor
24669420|NCT04005053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24669422|NCT04005053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24669423|NCT04005053|Antidotes|antidotes|mesh-ancestor
24669424|NCT04003285|Pregnanolone|pregnanolone|mesh-list
24669425|NCT04003285|Anesthetics|anesthetics|mesh-ancestor
24669426|NCT04003285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24669427|NCT04003285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684777|NCT04385992|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
24684778|NCT04385992|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24684779|NCT04385992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684780|NCT04182373|Antithrombins|antithrombins|mesh-list
24684781|NCT04182373|Antithrombin III|antithrombin iii|mesh-list
24684782|NCT04182373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24684873|NCT03481556|Dexamethasone|dexamethasone|mesh-list
24684874|NCT03481556|Dexamethasone acetate|dexamethasone acetate|mesh-list
24684875|NCT03481556|Bortezomib|bortezomib|mesh-list
24684876|NCT03481556|Melphalan|melphalan|mesh-list
24684877|NCT03481556|Daratumumab|daratumumab|mesh-list
24684878|NCT03481556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24684879|NCT03481556|Antiemetics|antiemetics|mesh-ancestor
24684880|NCT03481556|Autonomic Agents|autonomic agents|mesh-ancestor
24640358|NCT01167738|Antiviral Agents|antiviral agents|mesh-ancestor
25262925|NCT02445599|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25262926|NCT02445599|Autonomic Agents|autonomic agents|mesh-ancestor
25262927|NCT02445599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25262928|NCT02445599|Respiratory System Agents|respiratory system agents|mesh-ancestor
25262929|NCT02445599|Mydriatics|mydriatics|mesh-ancestor
25262930|NCT02445599|Parasympatholytics|parasympatholytics|mesh-ancestor
25262931|NCT02445599|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25262932|NCT02445599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25262933|NCT02445599|Cholinergic Agents|cholinergic agents|mesh-ancestor
25262934|NCT02445599|Antipyretics|antipyretics|mesh-ancestor
25262935|NCT02445703|Vaccines|vaccines|mesh-list
25262936|NCT02445703|Immunologic Factors|immunologic factors|mesh-ancestor
25262937|NCT02445703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262938|NCT02445716|Methyltestosterone|methyltestosterone|mesh-list
25262939|NCT02445716|Testosterone|testosterone|mesh-list
25262945|NCT02445716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25262946|NCT02445716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262947|NCT02445716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25262948|NCT02445716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262949|NCT02445716|Anabolic Agents|anabolic agents|mesh-ancestor
25262950|NCT02445547|Hormones|hormones|mesh-list
25262951|NCT02445547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25262952|NCT02445547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262953|NCT02445508|Cholecystokinin|cholecystokinin|mesh-list
25262954|NCT02445508|Sevelamer|sevelamer|mesh-list
25262955|NCT02445508|Chelating Agents|chelating agents|mesh-ancestor
24669433|NCT03919617|Volagidemab|volagidemab|mesh-list
24669434|NCT03919617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24669435|NCT03919617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512739|NCT00576433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24532196|NCT00638482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24532214|NCT00638638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24532215|NCT00638677|Sorbitol|sorbitol|mesh-list
24532246|NCT00638742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24394230|NCT00132600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24532247|NCT00638781|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
24532248|NCT00638781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24532249|NCT00638781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24532250|NCT00638781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532251|NCT00638807|Celecoxib|celecoxib|mesh-list
24532252|NCT00638807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24532253|NCT00638807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24532254|NCT00638807|Analgesics|analgesics|mesh-ancestor
24532255|NCT00638807|Sensory System Agents|sensory system agents|mesh-ancestor
24532256|NCT00638807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25688456|NCT01945489|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25688457|NCT01945489|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25688458|NCT01945489|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25688459|NCT01945489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24556556|NCT00748150|Vaccines|vaccines|mesh-list
24669448|NCT03917446|Propofol|propofol|mesh-list
24669449|NCT03917446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24684881|NCT03481556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24684882|NCT03481556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684883|NCT03481556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24684884|NCT03481556|Glucocorticoids|glucocorticoids|mesh-ancestor
24684885|NCT03481556|Hormones|hormones|mesh-ancestor
24684886|NCT03481556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24684887|NCT03481556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24684888|NCT03481556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684889|NCT03481556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24684890|NCT03481556|Alkylating Agents|alkylating agents|mesh-ancestor
24684891|NCT03481556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684892|NCT03481556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25262956|NCT02445508|Sequestering Agents|sequestering agents|mesh-ancestor
25262957|NCT02445508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262958|NCT02445508|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25262959|NCT02445508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25275282|NCT02372942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25275283|NCT02372942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275285|NCT02373163|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25275286|NCT02373163|Telmisartan|telmisartan|mesh-list
25275287|NCT02373163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25275288|NCT02373163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25275289|NCT02373163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25275290|NCT02373163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275291|NCT02373163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25275297|NCT02373163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25275298|NCT02373163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25275300|NCT02372903|Analgesics|analgesics|mesh-ancestor
25275301|NCT02372903|Sensory System Agents|sensory system agents|mesh-ancestor
25275302|NCT02372903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275303|NCT02372903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275304|NCT02372903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25275305|NCT02372903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24669450|NCT03917446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24669451|NCT03917446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456443|NCT00331097|Dermatologic Agents|dermatologic agents|mesh-ancestor
25045424|NCT00953420|Antiemetics|antiemetics|mesh-ancestor
24456444|NCT00331097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456445|NCT00331097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24456446|NCT00331097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24456447|NCT00331123|Testosterone|testosterone|mesh-list
24456448|NCT00331123|Androgens|androgens|mesh-ancestor
24456449|NCT00331123|Hormones|hormones|mesh-ancestor
24669452|NCT03917446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24669453|NCT03917446|Anesthetics, General|anesthetics, general|mesh-ancestor
24669454|NCT03917446|Anesthetics|anesthetics|mesh-ancestor
24512758|NCT00576459|Hormones|hormones|mesh-ancestor
24532257|NCT00638807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532258|NCT00638807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24532259|NCT00638807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24532260|NCT00638807|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24532261|NCT00638807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24532262|NCT00638807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532263|NCT00638807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532264|NCT00638833|Memantine|memantine|mesh-list
24532265|NCT00638833|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24532266|NCT00638833|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24532267|NCT00638833|Dopamine Agents|dopamine agents|mesh-ancestor
24684893|NCT03481556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24684920|NCT03283384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684921|NCT03283384|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24684922|NCT03283384|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24684923|NCT03283384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24684924|NCT03283384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684925|NCT03283384|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24684926|NCT03283384|Hormone Antagonists|hormone antagonists|mesh-ancestor
24684927|NCT03283384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25692624|NCT02003014|Pioglitazone|pioglitazone|mesh-list
24684928|NCT03283384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684966|NCT03121534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684967|NCT03121534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24684968|NCT03121534|Glucocorticoids|glucocorticoids|mesh-ancestor
24684970|NCT03121534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24684971|NCT03121534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24684973|NCT03116997|Glycopyrrolate|glycopyrrolate|mesh-list
24684974|NCT03116997|Neostigmine|neostigmine|mesh-list
24684975|NCT03116997|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25262960|NCT02445352|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25262961|NCT02445352|Ezetimibe|ezetimibe|mesh-list
25262962|NCT02445352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25262963|NCT02445352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25262964|NCT02445352|Antimetabolites|antimetabolites|mesh-ancestor
25262965|NCT02445352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262966|NCT02445352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25262967|NCT02445352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25262968|NCT02445352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25262977|NCT02445339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25262978|NCT02445404|Dexamethasone|dexamethasone|mesh-list
25262980|NCT02445404|Cyclophosphamide|cyclophosphamide|mesh-list
25262981|NCT02445404|Ifosfamide|ifosfamide|mesh-list
25262982|NCT02445404|Carboplatin|carboplatin|mesh-list
25262983|NCT02445404|Etoposide|etoposide|mesh-list
25262984|NCT02445404|Vincristine|vincristine|mesh-list
25262985|NCT02445404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24532268|NCT00638833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24532269|NCT00638833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532295|NCT00639015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532296|NCT00639015|Protective Agents|protective agents|mesh-ancestor
24532298|NCT00639119|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24532299|NCT00639119|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24669493|NCT03891524|Enoxaparin|enoxaparin|mesh-list
24669494|NCT03891524|Anticoagulants|anticoagulants|mesh-ancestor
24669495|NCT03891524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24669496|NCT03891524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24669497|NCT03891524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24669498|NCT03884101|Paclitaxel|paclitaxel|mesh-list
24669499|NCT03884101|Carboplatin|carboplatin|mesh-list
24669500|NCT03884101|Pembrolizumab|pembrolizumab|mesh-list
24669501|NCT03884101|Lenvatinib|lenvatinib|mesh-list
24669502|NCT03884101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24669503|NCT03884101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24669504|NCT03884101|Tubulin Modulators|tubulin modulators|mesh-ancestor
24669505|NCT03884101|Antimitotic Agents|antimitotic agents|mesh-ancestor
24669506|NCT03884101|Mitosis Modulators|mitosis modulators|mesh-ancestor
24532300|NCT00639119|Dopamine Agonists|dopamine agonists|mesh-ancestor
25262986|NCT02445404|Immunologic Factors|immunologic factors|mesh-ancestor
25262987|NCT02445404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25262988|NCT02445404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25262989|NCT02445404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25262990|NCT02445404|Alkylating Agents|alkylating agents|mesh-ancestor
25262991|NCT02445404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25262992|NCT02445404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25262993|NCT02445404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25262994|NCT02445404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25262995|NCT02445404|Antiemetics|antiemetics|mesh-ancestor
25262996|NCT02445404|Autonomic Agents|autonomic agents|mesh-ancestor
25262997|NCT02445404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25262998|NCT02445404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25262999|NCT02445404|Glucocorticoids|glucocorticoids|mesh-ancestor
25263000|NCT02445404|Hormones|hormones|mesh-ancestor
25263001|NCT02445404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25263002|NCT02445404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25263003|NCT02445404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25263004|NCT02445404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25263005|NCT02445404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25263006|NCT02445404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25692625|NCT02003014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25263007|NCT02445404|Tubulin Modulators|tubulin modulators|mesh-ancestor
25263008|NCT02445404|Antimitotic Agents|antimitotic agents|mesh-ancestor
25263009|NCT02445404|Mitosis Modulators|mitosis modulators|mesh-ancestor
25263010|NCT02445391|Cisplatin|cisplatin|mesh-list
25263012|NCT02445391|Capecitabine|capecitabine|mesh-list
25263013|NCT02445391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25263014|NCT02445391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25263015|NCT02445391|Antimetabolites|antimetabolites|mesh-ancestor
24532384|NCT00639743|Tenecteplase|tenecteplase|mesh-list
24532388|NCT00639756|Allopurinol|allopurinol|mesh-list
25263029|NCT02444949|Growth Substances|growth substances|mesh-ancestor
25263030|NCT02444949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263031|NCT02444949|Growth Inhibitors|growth inhibitors|mesh-ancestor
25263032|NCT02445053|Ivacaftor|ivacaftor|mesh-list
25263033|NCT02445053|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25263034|NCT02445053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25263035|NCT02445053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263036|NCT02444767|Bimatoprost|bimatoprost|mesh-list
25263037|NCT02444767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25263038|NCT02444897|Fentanyl|fentanyl|mesh-list
25263039|NCT02444897|Nefopam|nefopam|mesh-list
25263040|NCT02444897|Ramosetron|ramosetron|mesh-list
25263041|NCT02444897|Ropivacaine|ropivacaine|mesh-list
25263042|NCT02444897|Anesthetics, Local|anesthetics, local|mesh-ancestor
25263043|NCT02444897|Anesthetics|anesthetics|mesh-ancestor
25263044|NCT02444897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25263045|NCT02444897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263046|NCT02444897|Sensory System Agents|sensory system agents|mesh-ancestor
25263047|NCT02444897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25263048|NCT02444897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25263049|NCT02444897|Narcotics|narcotics|mesh-ancestor
25263050|NCT02444897|Analgesics|analgesics|mesh-ancestor
25263051|NCT02444897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25263052|NCT02444897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25263053|NCT02444897|Anesthetics, General|anesthetics, general|mesh-ancestor
25263054|NCT02444897|Antiemetics|antiemetics|mesh-ancestor
25263055|NCT02444897|Autonomic Agents|autonomic agents|mesh-ancestor
25263056|NCT02444897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25263057|NCT02444897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25263058|NCT02444897|Serotonin Agents|serotonin agents|mesh-ancestor
25263059|NCT02444897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25263060|NCT02444897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263061|NCT02444897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25263062|NCT02444611|Vaccines|vaccines|mesh-list
25263063|NCT02444611|BCG Vaccine|bcg vaccine|mesh-list
25263064|NCT02444611|Immunologic Factors|immunologic factors|mesh-ancestor
25263065|NCT02444611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263073|NCT02444637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263074|NCT02444637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25263075|NCT02444637|Protective Agents|protective agents|mesh-ancestor
25263076|NCT02444585|Denosumab|denosumab|mesh-list
24669604|NCT03777982|Prednisone|prednisone|mesh-list
24669605|NCT03777982|Abiraterone Acetate|abiraterone acetate|mesh-list
24669606|NCT03777982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24669607|NCT03777982|Glucocorticoids|glucocorticoids|mesh-ancestor
24669608|NCT03777982|Hormones|hormones|mesh-ancestor
24669609|NCT03777982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25263077|NCT02444585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25263078|NCT02444585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263079|NCT02444507|Esomeprazole|esomeprazole|mesh-list
25263080|NCT02444507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25263081|NCT02444507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25263082|NCT02444507|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25263083|NCT02444507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25263084|NCT02444507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263085|NCT02444481|Polymyxins|polymyxins|mesh-list
25263086|NCT02444481|Nystatin|nystatin|mesh-list
25263087|NCT02444481|Neomycin|neomycin|mesh-list
25263088|NCT02444481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25263089|NCT02444481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25263090|NCT02444481|Antifungal Agents|antifungal agents|mesh-ancestor
25263091|NCT02444481|Ionophores|ionophores|mesh-ancestor
25263092|NCT02444481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25263093|NCT02444481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263094|NCT02444481|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25263095|NCT02444481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25263096|NCT02444572|Enoxaparin|enoxaparin|mesh-list
25263097|NCT02444572|Anticoagulants|anticoagulants|mesh-ancestor
25688460|NCT01945489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557020|NCT00751049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24557022|NCT00751049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24557023|NCT00751049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557024|NCT00751049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557025|NCT00751049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25263098|NCT02444572|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25263099|NCT02444572|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25263100|NCT02444572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263104|NCT02444559|Clonidine|clonidine|mesh-list
25263105|NCT02444559|Ropivacaine|ropivacaine|mesh-list
25263106|NCT02444559|Anesthetics, Local|anesthetics, local|mesh-ancestor
25263107|NCT02444559|Anesthetics|anesthetics|mesh-ancestor
25263110|NCT02444559|Sensory System Agents|sensory system agents|mesh-ancestor
25263120|NCT02444559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24532394|NCT00639756|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24532395|NCT00639756|Antioxidants|antioxidants|mesh-ancestor
24532396|NCT00639756|Protective Agents|protective agents|mesh-ancestor
24513047|NCT00578370|Antifungal Agents|antifungal agents|mesh-ancestor
24532402|NCT00639873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24532403|NCT00639873|Antimalarials|antimalarials|mesh-ancestor
24532404|NCT00639873|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24532405|NCT00639873|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24532406|NCT00639873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24532407|NCT00639873|Antiviral Agents|antiviral agents|mesh-ancestor
24532408|NCT00639873|Schistosomicides|schistosomicides|mesh-ancestor
24532409|NCT00639873|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24532410|NCT00639873|Anthelmintics|anthelmintics|mesh-ancestor
24532411|NCT00639873|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24532413|NCT00639873|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24532428|NCT00639925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532430|NCT00639938|Immunoglobulins|immunoglobulins|mesh-list
24532431|NCT00639938|Antibodies|antibodies|mesh-list
24532478|NCT00640081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532480|NCT00640081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532481|NCT00640081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24532482|NCT00640081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24532491|NCT00640094|Melatonin|melatonin|mesh-list
24532492|NCT00640094|Antioxidants|antioxidants|mesh-ancestor
24532493|NCT00640094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532494|NCT00640094|Protective Agents|protective agents|mesh-ancestor
24684976|NCT03116997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24684977|NCT03116997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684978|NCT03116997|Cholinergic Agents|cholinergic agents|mesh-ancestor
24684979|NCT03116997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24684980|NCT03116997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684981|NCT03116997|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24684982|NCT03116997|Autonomic Agents|autonomic agents|mesh-ancestor
24684983|NCT03116997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24684984|NCT03116997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24855096|NCT02277223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24855097|NCT02277223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24685217|NCT01175356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24685270|NCT05274139|Dexamethasone|dexamethasone|mesh-list
24685271|NCT05274139|Temozolomide|temozolomide|mesh-list
24685272|NCT05274139|Fotemustine|fotemustine|mesh-list
24685273|NCT05274139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24685274|NCT05274139|Antiemetics|antiemetics|mesh-ancestor
24685275|NCT05274139|Autonomic Agents|autonomic agents|mesh-ancestor
25263121|NCT02444559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263128|NCT03810911|Darbepoetin alfa|darbepoetin alfa|mesh-list
25263129|NCT03810911|Hematinics|hematinics|mesh-ancestor
25263130|NCT03808025|Analgesics, Opioid|analgesics, opioid|mesh-list
25263131|NCT03808025|Narcotics|narcotics|mesh-ancestor
25263132|NCT03808025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25263133|NCT03808025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688461|NCT01945489|Cholinergic Agents|cholinergic agents|mesh-ancestor
25688462|NCT01945489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25688463|NCT01945489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688464|NCT01945489|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25688465|NCT01945489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25263134|NCT03808025|Analgesics|analgesics|mesh-ancestor
25263135|NCT03808025|Sensory System Agents|sensory system agents|mesh-ancestor
25263136|NCT03808025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24557178|NCT00751556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557179|NCT00751556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557181|NCT00751699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24669733|NCT03691376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24669734|NCT03691376|Alkylating Agents|alkylating agents|mesh-ancestor
24669735|NCT03691376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24669736|NCT03691376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24669737|NCT03691376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24669738|NCT03691376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24685276|NCT05274139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812667|NCT02053974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812669|NCT02053974|Diuretics|diuretics|mesh-ancestor
24812670|NCT02053974|Natriuretic Agents|natriuretic agents|mesh-ancestor
24812672|NCT02054000|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24812673|NCT02054000|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25263181|NCT03572283|Bethanechol|bethanechol|mesh-list
24812674|NCT02054000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812675|NCT02054000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24812676|NCT02054052|Bevacizumab|bevacizumab|mesh-list
24812677|NCT02054052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24685277|NCT05274139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685278|NCT05274139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24685279|NCT05274139|Glucocorticoids|glucocorticoids|mesh-ancestor
24685309|NCT05274113|Sensory System Agents|sensory system agents|mesh-ancestor
24685310|NCT05274100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24685311|NCT05274100|Immunologic Factors|immunologic factors|mesh-ancestor
24685312|NCT05274100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685313|NCT05273944|Doxorubicin|doxorubicin|mesh-list
24611589|NCT01010048|Anticonvulsants|anticonvulsants|mesh-ancestor
24611590|NCT01010048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24685314|NCT05273944|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24685315|NCT05273944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24685316|NCT05273944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24907034|NCT04334005|Vitamins|vitamins|mesh-ancestor
24457579|NCT00334685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24685323|NCT05273775|Digoxin|digoxin|mesh-list
24685324|NCT05273775|Midazolam|midazolam|mesh-list
24685325|NCT05273775|Omeprazole|omeprazole|mesh-list
24685326|NCT05273775|Warfarin|warfarin|mesh-list
24685327|NCT05273775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24685351|NCT05273775|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24685352|NCT05273775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25263154|NCT03716934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
25263155|NCT03651804|Acetaminophen|acetaminophen|mesh-list
25263156|NCT03651804|Diphosphonates|diphosphonates|mesh-list
25263157|NCT03651804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25263158|NCT03651804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25263159|NCT03651804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25263160|NCT03651804|Analgesics|analgesics|mesh-ancestor
25263161|NCT03651804|Sensory System Agents|sensory system agents|mesh-ancestor
25263162|NCT03651804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25263163|NCT03651804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263164|NCT03651804|Antipyretics|antipyretics|mesh-ancestor
24669741|NCT03691376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24456487|NCT00331305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24456488|NCT00331305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24532512|NCT00640198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24532513|NCT00640198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532514|NCT00640198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532515|NCT00640198|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24532516|NCT00640198|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24532517|NCT00640237|Calcifediol|calcifediol|mesh-list
24532518|NCT00640237|Vitamins|vitamins|mesh-ancestor
24532519|NCT00640237|Micronutrients|micronutrients|mesh-ancestor
24532520|NCT00640237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532521|NCT00640237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24532522|NCT00640263|Ritonavir|ritonavir|mesh-list
24532523|NCT00640263|Lopinavir|lopinavir|mesh-list
24532524|NCT00640263|Lamivudine|lamivudine|mesh-list
25688466|NCT01945593|Factor VIII|factor viii|mesh-list
25688467|NCT01945593|BAX 855|bax 855|mesh-list
25688468|NCT01945593|Coagulants|coagulants|mesh-ancestor
25688469|NCT01945866|Dexamethasone|dexamethasone|mesh-list
25688470|NCT01945866|Ranibizumab|ranibizumab|mesh-list
25688471|NCT01945866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24557238|NCT00751907|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25688473|NCT01945866|Autonomic Agents|autonomic agents|mesh-ancestor
24532525|NCT00640263|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24532526|NCT00640263|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24532527|NCT00640263|Protease Inhibitors|protease inhibitors|mesh-ancestor
24532528|NCT00640263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532529|NCT00640263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532530|NCT00640263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24685353|NCT05273775|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24685354|NCT05273775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24685355|NCT05273775|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24685356|NCT05273775|Protective Agents|protective agents|mesh-ancestor
24685357|NCT05273775|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24685358|NCT05273775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24685359|NCT05273775|Hemostatics|hemostatics|mesh-ancestor
24685360|NCT05273775|Coagulants|coagulants|mesh-ancestor
25263172|NCT03608163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25263173|NCT03608163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25263174|NCT03608163|Vasodilator Agents|vasodilator agents|mesh-ancestor
25263175|NCT03578198|Rituximab|rituximab|mesh-list
25263176|NCT03578198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25263177|NCT03578198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25263178|NCT03578198|Immunologic Factors|immunologic factors|mesh-ancestor
25263179|NCT03578198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263180|NCT03578198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25263182|NCT03572283|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25263183|NCT03572283|Autonomic Agents|autonomic agents|mesh-ancestor
25263184|NCT03572283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25263185|NCT03572283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263186|NCT03572283|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25263187|NCT03572283|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25263188|NCT03572283|Cholinergic Agents|cholinergic agents|mesh-ancestor
25263189|NCT03572283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25263190|NCT03572283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263191|NCT03512197|Midostaurin|midostaurin|mesh-list
25263192|NCT03512197|Staurosporine|staurosporine|mesh-list
25263193|NCT03512197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25263194|NCT03512197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25263195|NCT03512197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25263196|NCT03512197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532550|NCT00640432|Celecoxib|celecoxib|mesh-list
24532551|NCT00640432|Diclofenac|diclofenac|mesh-list
24532552|NCT00640432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24532553|NCT00640432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24532554|NCT00640432|Analgesics|analgesics|mesh-ancestor
24532555|NCT00640432|Sensory System Agents|sensory system agents|mesh-ancestor
24685374|NCT05273528|Vaccines|vaccines|mesh-list
24685429|NCT05272865|Hallucinogens|hallucinogens|mesh-ancestor
24685430|NCT05272865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685431|NCT05272865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24685432|NCT05272865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24685433|NCT05272865|Analgesics|analgesics|mesh-ancestor
24685434|NCT05272865|Sensory System Agents|sensory system agents|mesh-ancestor
24685435|NCT05272865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24685436|NCT05272865|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24685437|NCT05272865|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24685438|NCT05272865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24685439|NCT05272865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685440|NCT05272865|Hormones|hormones|mesh-ancestor
24685441|NCT05272865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24685442|NCT05272839|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24685443|NCT05272839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685495|NCT05271448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24685496|NCT05271448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24685497|NCT05271448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24685498|NCT05271448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685500|NCT05271448|Protease Inhibitors|protease inhibitors|mesh-ancestor
24685515|NCT05271253|Anesthetics, Local|anesthetics, local|mesh-ancestor
24685516|NCT05271253|Anesthetics|anesthetics|mesh-ancestor
25688474|NCT01945866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25688475|NCT01945866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688476|NCT01945866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25688477|NCT01945866|Glucocorticoids|glucocorticoids|mesh-ancestor
24685558|NCT05271058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24685560|NCT05271058|Hormones|hormones|mesh-ancestor
24685561|NCT05271058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24685579|NCT05270434|Meperidine|meperidine|mesh-list
24685580|NCT05270434|Morphine|morphine|mesh-list
24685581|NCT05270434|Buprenorphine|buprenorphine|mesh-list
24685582|NCT05270434|Analgesics|analgesics|mesh-list
24685583|NCT05270434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24685584|NCT05270434|Narcotics|narcotics|mesh-ancestor
24685585|NCT05270434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24685586|NCT05270434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685587|NCT05270434|Sensory System Agents|sensory system agents|mesh-ancestor
24685588|NCT05270434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24685589|NCT05270434|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24685590|NCT05270434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24685591|NCT05270434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24685592|NCT05270434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24685593|NCT05270434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24685594|NCT05270434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25263203|NCT03388788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25263204|NCT03388788|Adrenergic Agents|adrenergic agents|mesh-ancestor
25263205|NCT03388788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25263206|NCT03388788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263207|NCT03388788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263208|NCT03388788|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24685667|NCT05248724|Epinephryl borate|epinephryl borate|mesh-list
24685668|NCT05248724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24685669|NCT05248724|Narcotics|narcotics|mesh-ancestor
24812701|NCT02054182|Vitamins|vitamins|mesh-ancestor
24685709|NCT05243199|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24685710|NCT05243199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24685711|NCT05243199|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24685712|NCT05243199|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24685713|NCT05243199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685714|NCT05242705|Cystatins|cystatins|mesh-list
24685715|NCT05242705|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
24685716|NCT05242705|Protease Inhibitors|protease inhibitors|mesh-ancestor
24685717|NCT05242705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24685718|NCT05242705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640640|NCT01169415|Dexamethasone|dexamethasone|mesh-list
24685719|NCT05241470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24685720|NCT05241470|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24685721|NCT05238155|Antimetabolites|antimetabolites|mesh-list
24685722|NCT05238155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685723|NCT05235737|Pembrolizumab|pembrolizumab|mesh-list
24812712|NCT02054299|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24812713|NCT02054299|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24812714|NCT02054299|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24812715|NCT02054299|Serotonin Agents|serotonin agents|mesh-ancestor
24611604|NCT01010048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24611605|NCT01010048|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24611606|NCT01010048|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24611607|NCT01010048|Cholinergic Agents|cholinergic agents|mesh-ancestor
24611608|NCT01010087|Oseltamivir|oseltamivir|mesh-list
24611609|NCT01010087|Antiviral Agents|antiviral agents|mesh-ancestor
24611610|NCT01010087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24611611|NCT01010087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24685756|NCT05226325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263212|NCT03369717|Clavulanic Acids|clavulanic acids|mesh-list
25263213|NCT03369717|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25263214|NCT03369717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25263215|NCT03369717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263216|NCT03369717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25263217|NCT03369717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25275306|NCT02372903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25275307|NCT02372903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24532596|NCT00640575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24532597|NCT00640575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452826|NCT05420402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25404320|NCT03674242|Antimetabolites|antimetabolites|mesh-ancestor
24452827|NCT05420402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452828|NCT05420402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24452829|NCT05420402|Anesthetics, General|anesthetics, general|mesh-ancestor
24450050|NCT00317733|Ketoprofen|ketoprofen|mesh-list
24669789|NCT03613181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24937330|NCT04030572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24685793|NCT05207280|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24685794|NCT05207280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24685795|NCT05207280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24685796|NCT05207280|Adrenergic Agents|adrenergic agents|mesh-ancestor
24685910|NCT05142267|Narcotics|narcotics|mesh-ancestor
24685911|NCT05142267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24685912|NCT05142267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685913|NCT05142267|Analgesics|analgesics|mesh-ancestor
24685914|NCT05142267|Sensory System Agents|sensory system agents|mesh-ancestor
24685915|NCT05142267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24685916|NCT05142267|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24685918|NCT05142072|Cholecalciferol|cholecalciferol|mesh-list
24686013|NCT05087771|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24686014|NCT05087771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24686015|NCT05087771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686016|NCT05087771|Sensory System Agents|sensory system agents|mesh-ancestor
24686017|NCT05087771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24686018|NCT05087030|Denosumab|denosumab|mesh-list
24686019|NCT05087030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24686020|NCT05087030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611627|NCT01010139|Antitussive Agents|antitussive agents|mesh-ancestor
24611628|NCT01010139|Respiratory System Agents|respiratory system agents|mesh-ancestor
24686089|NCT05063097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24686090|NCT05063097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686093|NCT05052528|Cyclophosphamide|cyclophosphamide|mesh-list
24686094|NCT05052528|Rituximab|rituximab|mesh-list
24686187|NCT05002738|Hormones|hormones|mesh-ancestor
24686188|NCT05002738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24686189|NCT05002738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686190|NCT05002738|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24686191|NCT05002738|Contraceptive Agents|contraceptive agents|mesh-ancestor
24686192|NCT05002738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24686193|NCT05002738|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24686194|NCT05002738|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24686195|NCT05002738|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24686196|NCT05002738|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24686197|NCT05002738|Progestins|progestins|mesh-ancestor
24686198|NCT05001724|Docetaxel|docetaxel|mesh-list
24686199|NCT05001724|Lenvatinib|lenvatinib|mesh-list
25263218|NCT03365908|Ropivacaine|ropivacaine|mesh-list
25263219|NCT03365908|Anesthetics, Local|anesthetics, local|mesh-ancestor
25263220|NCT03365908|Anesthetics|anesthetics|mesh-ancestor
25263221|NCT03365908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25263222|NCT03365908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263223|NCT03365908|Sensory System Agents|sensory system agents|mesh-ancestor
25263224|NCT03365908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25263233|NCT03295240|Rituximab|rituximab|mesh-list
25263234|NCT03295240|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24456489|NCT00331305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24532608|NCT00640588|Antiviral Agents|antiviral agents|mesh-ancestor
24532609|NCT00640588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24532610|NCT00640588|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24456490|NCT00331305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456492|NCT00331305|Serotonin Agents|serotonin agents|mesh-ancestor
24669791|NCT03613181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24669792|NCT03613181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24669793|NCT03613181|Dermatologic Agents|dermatologic agents|mesh-ancestor
24669794|NCT03613181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24669796|NCT03613181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24669797|NCT03613181|Immunologic Factors|immunologic factors|mesh-ancestor
24669798|NCT03613181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24669799|NCT03613181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24669801|NCT03611010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24669802|NCT03611010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24532630|NCT00640640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24532646|NCT00640705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24532647|NCT00640705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24532648|NCT00640705|Analgesics|analgesics|mesh-ancestor
24532649|NCT00640705|Sensory System Agents|sensory system agents|mesh-ancestor
24532650|NCT00640705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24532651|NCT00640705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532652|NCT00640705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24532653|NCT00640705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24532654|NCT00640705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24937375|NCT04029636|Xenon|xenon|mesh-list
24686200|NCT05001724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24686201|NCT05001724|Tubulin Modulators|tubulin modulators|mesh-ancestor
24640769|NCT01169922|Ethanol|ethanol|mesh-list
25263236|NCT03295240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25263237|NCT03295240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25263238|NCT03295240|Immunologic Factors|immunologic factors|mesh-ancestor
25263239|NCT03295240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263240|NCT03295240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25263241|NCT03295240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25263242|NCT03295240|Alkylating Agents|alkylating agents|mesh-ancestor
25263243|NCT03295240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263244|NCT03279471|Sertraline|sertraline|mesh-list
25263245|NCT03279471|Antidepressive Agents|antidepressive agents|mesh-ancestor
25263246|NCT03279471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25263247|NCT03279471|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25263248|NCT03279471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25263249|NCT03279471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25263250|NCT03279471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263251|NCT03279471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25263252|NCT03279471|Serotonin Agents|serotonin agents|mesh-ancestor
25263253|NCT03279471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263254|NCT03241940|Cyclophosphamide|cyclophosphamide|mesh-list
25263255|NCT03241940|Fludarabine|fludarabine|mesh-list
25263256|NCT03241940|Fludarabine phosphate|fludarabine phosphate|mesh-list
25263257|NCT03241940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25263258|NCT03241940|Immunologic Factors|immunologic factors|mesh-ancestor
25263259|NCT03241940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263260|NCT03241940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25263261|NCT03241940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25263262|NCT03241940|Alkylating Agents|alkylating agents|mesh-ancestor
25263263|NCT03241940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263264|NCT03241940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25263265|NCT03241940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25263266|NCT03241940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25263267|NCT03241940|Antimetabolites|antimetabolites|mesh-ancestor
25263268|NCT03109964|Hemostatics|hemostatics|mesh-list
25263269|NCT03109964|Surgiflo|surgiflo|mesh-list
25263270|NCT03109964|Coagulants|coagulants|mesh-ancestor
24686206|NCT05001724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24686241|NCT04968522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24686242|NCT04961801|Methotrexate|methotrexate|mesh-list
24686243|NCT04961801|Acalabrutinib|acalabrutinib|mesh-list
24686244|NCT04961801|Tacrolimus|tacrolimus|mesh-list
24686245|NCT04961801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24686246|NCT04961801|Abortifacient Agents|abortifacient agents|mesh-ancestor
24686247|NCT04961801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24686248|NCT04961801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686249|NCT04961801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24686250|NCT04961801|Antimetabolites|antimetabolites|mesh-ancestor
25263271|NCT03099486|Leucovorin|leucovorin|mesh-list
25263272|NCT03099486|Antidotes|antidotes|mesh-ancestor
25263273|NCT03099486|Protective Agents|protective agents|mesh-ancestor
25263274|NCT03099486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263275|NCT03099486|Vitamin B Complex|vitamin b complex|mesh-ancestor
25263276|NCT03099486|Vitamins|vitamins|mesh-ancestor
25263277|NCT03099486|Micronutrients|micronutrients|mesh-ancestor
25263278|NCT03022903|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25263279|NCT03022903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25263280|NCT03022903|Dermatologic Agents|dermatologic agents|mesh-ancestor
25263281|NCT03017820|Iodine|iodine|mesh-list
25263282|NCT03017820|Interferons|interferons|mesh-list
25263283|NCT03017820|Interferon-beta|interferon-beta|mesh-list
25263284|NCT03017820|Cyclophosphamide|cyclophosphamide|mesh-list
25263285|NCT03017820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25263286|NCT03017820|Immunologic Factors|immunologic factors|mesh-ancestor
25263287|NCT03017820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263288|NCT03017820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25263289|NCT03017820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25263290|NCT03017820|Alkylating Agents|alkylating agents|mesh-ancestor
25263291|NCT03017820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263292|NCT03017820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25263293|NCT03017820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24858363|NCT02296671|Oxaliplatin|oxaliplatin|mesh-list
25263294|NCT03017820|Antiviral Agents|antiviral agents|mesh-ancestor
25263295|NCT03017820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25263296|NCT03017820|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25263297|NCT03017820|Trace Elements|trace elements|mesh-ancestor
25263298|NCT03017820|Micronutrients|micronutrients|mesh-ancestor
24669874|NCT03476798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24669875|NCT03476798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686254|NCT04961801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24686255|NCT04961801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24611689|NCT01010308|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24611690|NCT01010308|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24611691|NCT01010308|Adrenergic Agents|adrenergic agents|mesh-ancestor
24611692|NCT01010308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24611693|NCT01010308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611694|NCT01010308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611695|NCT01010308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24611696|NCT01010308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24611697|NCT01010308|Sympatholytics|sympatholytics|mesh-ancestor
24611698|NCT01010308|Autonomic Agents|autonomic agents|mesh-ancestor
24686482|NCT04767022|Paclitaxel|paclitaxel|mesh-list
24686485|NCT04767022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24686487|NCT04767022|Antimitotic Agents|antimitotic agents|mesh-ancestor
24686488|NCT04767022|Mitosis Modulators|mitosis modulators|mesh-ancestor
24669894|NCT03414034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24669895|NCT03414034|Glucocorticoids|glucocorticoids|mesh-ancestor
24669896|NCT03414034|Hormones|hormones|mesh-ancestor
24532753|NCT00640991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24532744|NCT00640939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24532745|NCT00640939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24532746|NCT00640939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24686489|NCT04767022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686490|NCT04760912|Bromides|bromides|mesh-list
24686491|NCT04760912|Anesthetics|anesthetics|mesh-list
24686492|NCT04760912|Rocuronium|rocuronium|mesh-list
24686493|NCT04760912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24471434|NCT00395252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24471435|NCT00395252|Antiviral Agents|antiviral agents|mesh-ancestor
24471442|NCT00395369|Aprotinin|aprotinin|mesh-list
24686494|NCT04760912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686495|NCT04760912|Anticonvulsants|anticonvulsants|mesh-ancestor
24686496|NCT04760912|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24686529|NCT04745299|Anticonvulsants|anticonvulsants|mesh-ancestor
24686530|NCT04745299|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24532747|NCT00640939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532748|NCT00640952|Acamprosate|acamprosate|mesh-list
24532749|NCT00640952|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24532750|NCT00640991|Insulin|insulin|mesh-list
24532752|NCT00640991|Insulin glulisine|insulin glulisine|mesh-list
24532759|NCT00641004|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24532760|NCT00641004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532761|NCT00641004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532762|NCT00641004|Antioxidants|antioxidants|mesh-ancestor
24532763|NCT00641004|Protective Agents|protective agents|mesh-ancestor
24532764|NCT00641004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532765|NCT00641030|Melphalan|melphalan|mesh-list
24532766|NCT00641030|Clofarabine|clofarabine|mesh-list
24532767|NCT00641030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24532768|NCT00641030|Alkylating Agents|alkylating agents|mesh-ancestor
24532769|NCT00641030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532770|NCT00641030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24532771|NCT00641030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24452961|NCT05378113|Lidocaine|lidocaine|mesh-list
25404396|NCT03670810|Lasmiditan|lasmiditan|mesh-list
24557793|NCT00753909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24532772|NCT00641030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24532773|NCT00641030|Immunologic Factors|immunologic factors|mesh-ancestor
24532777|NCT00641082|Adefovir|adefovir|mesh-list
25263359|NCT02648698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25263360|NCT02648698|Levofloxacin|levofloxacin|mesh-list
25263361|NCT02648698|Tinidazole|tinidazole|mesh-list
25263362|NCT02648698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25263363|NCT02648698|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25263364|NCT02648698|Renal Agents|renal agents|mesh-ancestor
25263365|NCT02648698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25263366|NCT02648698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25263367|NCT02648698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25263368|NCT02648698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263369|NCT02648698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25263370|NCT02648698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25263371|NCT02648698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25263372|NCT02648698|Alkylating Agents|alkylating agents|mesh-ancestor
25263373|NCT02648698|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25263374|NCT02648698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25263375|NCT02648698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25263376|NCT02600897|Rituximab|rituximab|mesh-list
25263377|NCT02600897|Obinutuzumab|obinutuzumab|mesh-list
25263378|NCT02600897|Lenalidomide|lenalidomide|mesh-list
25263379|NCT02600897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25263380|NCT02600897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25263381|NCT02600897|Immunologic Factors|immunologic factors|mesh-ancestor
25263382|NCT02600897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263383|NCT02600897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25263384|NCT02600897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25263385|NCT02600897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25263386|NCT02600897|Growth Substances|growth substances|mesh-ancestor
25263387|NCT02600897|Growth Inhibitors|growth inhibitors|mesh-ancestor
25263388|NCT02532257|Rituximab|rituximab|mesh-list
25263389|NCT02532257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25263390|NCT02532257|Lenalidomide|lenalidomide|mesh-list
25263391|NCT02532257|Antibodies|antibodies|mesh-list
25263392|NCT02532257|Immunoglobulins|immunoglobulins|mesh-list
25263393|NCT02532257|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25263394|NCT02532257|Immunologic Factors|immunologic factors|mesh-ancestor
25263395|NCT02532257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263396|NCT02532257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25263397|NCT02532257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25263398|NCT02532257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25263399|NCT02532257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25263400|NCT02532257|Growth Substances|growth substances|mesh-ancestor
24532837|NCT00641212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24532839|NCT00641264|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24532843|NCT00641264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532845|NCT00641329|Analgesics|analgesics|mesh-ancestor
24532846|NCT00641329|Sensory System Agents|sensory system agents|mesh-ancestor
24532847|NCT00641329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24532848|NCT00641329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532857|NCT00641329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532858|NCT00641407|Insulin|insulin|mesh-list
24532859|NCT00641407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24532860|NCT00641407|Insulin Glargine|insulin glargine|mesh-list
24532879|NCT00641446|Glucocorticoids|glucocorticoids|mesh-ancestor
24532882|NCT00641472|Budesonide|budesonide|mesh-list
24686531|NCT04745299|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24686532|NCT04745299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24686533|NCT04745299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686534|NCT04745299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686535|NCT04745299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24686536|NCT04745299|Protective Agents|protective agents|mesh-ancestor
24686537|NCT04710641|Sorafenib|sorafenib|mesh-list
24686538|NCT04710641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24686539|NCT04710641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24686596|NCT04697719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24686597|NCT04697719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24686598|NCT04697719|Antipyretics|antipyretics|mesh-ancestor
24686599|NCT04690686|Paclitaxel|paclitaxel|mesh-list
25688478|NCT01945866|Hormones|hormones|mesh-ancestor
25688479|NCT01945866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24686600|NCT04690686|Atezolizumab|atezolizumab|mesh-list
24686601|NCT04690686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24686602|NCT04690686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24686603|NCT04690686|Tubulin Modulators|tubulin modulators|mesh-ancestor
24686634|NCT04674514|Glucocorticoids|glucocorticoids|mesh-ancestor
24686635|NCT04674514|Hormones|hormones|mesh-ancestor
24640950|NCT01170780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24686636|NCT04674514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25263401|NCT02532257|Growth Inhibitors|growth inhibitors|mesh-ancestor
25263402|NCT02320292|Rituximab|rituximab|mesh-list
25263403|NCT02320292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25263404|NCT02320292|Antibodies|antibodies|mesh-list
25263405|NCT02320292|Immunoglobulins|immunoglobulins|mesh-list
25263406|NCT02320292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25263407|NCT02320292|Immunologic Factors|immunologic factors|mesh-ancestor
25263408|NCT02320292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263409|NCT02320292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25263410|NCT02320292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25263411|NCT02317783|Deoxyglucose|deoxyglucose|mesh-list
25263412|NCT02317783|Flutemetamol|flutemetamol|mesh-list
25263413|NCT02317783|Antimetabolites|antimetabolites|mesh-ancestor
25263414|NCT02317783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263415|NCT02317783|Antiviral Agents|antiviral agents|mesh-ancestor
25263416|NCT02317783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25263417|NCT02317783|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25263418|NCT02232191|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25263419|NCT02232191|Immunologic Factors|immunologic factors|mesh-ancestor
25263420|NCT02232191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532925|NCT00641654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532926|NCT00641680|Fluticasone|fluticasone|mesh-list
24532928|NCT00641680|Budesonide|budesonide|mesh-list
24532929|NCT00641680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24532930|NCT00641680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24532931|NCT00641680|Autonomic Agents|autonomic agents|mesh-ancestor
24532932|NCT00641680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24532933|NCT00641680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532934|NCT00641680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24532935|NCT00641680|Respiratory System Agents|respiratory system agents|mesh-ancestor
24456508|NCT00331500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24456509|NCT00331500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456510|NCT00331500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24513338|NCT00580814|Methylphenidate|methylphenidate|mesh-list
24513345|NCT00580814|Dopamine Agents|dopamine agents|mesh-ancestor
24532968|NCT00641810|Purinergic Agents|purinergic agents|mesh-ancestor
24532969|NCT00641810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24532970|NCT00641914|Budesonide|budesonide|mesh-list
24532971|NCT00641914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24532972|NCT00641914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24532973|NCT00641914|Autonomic Agents|autonomic agents|mesh-ancestor
24532974|NCT00641914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24532975|NCT00641914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263430|NCT02008656|Leucovorin|leucovorin|mesh-list
25263431|NCT02008656|Fluorouracil|fluorouracil|mesh-list
25263432|NCT02008656|Capecitabine|capecitabine|mesh-list
25263433|NCT02008656|Oxaliplatin|oxaliplatin|mesh-list
25263434|NCT02008656|Antimetabolites|antimetabolites|mesh-ancestor
25263435|NCT02008656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263436|NCT02008656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25263437|NCT02008656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25263438|NCT02008656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25263439|NCT02008656|Immunologic Factors|immunologic factors|mesh-ancestor
25263440|NCT02008656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263441|NCT02008656|Antidotes|antidotes|mesh-ancestor
25263442|NCT02008656|Protective Agents|protective agents|mesh-ancestor
25263443|NCT02008656|Vitamin B Complex|vitamin b complex|mesh-ancestor
25263444|NCT02008656|Vitamins|vitamins|mesh-ancestor
25263445|NCT02008656|Micronutrients|micronutrients|mesh-ancestor
25263446|NCT02000882|Capecitabine|capecitabine|mesh-list
25263447|NCT02000882|Trastuzumab|trastuzumab|mesh-list
25263448|NCT02000882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25263449|NCT02000882|Antimetabolites|antimetabolites|mesh-ancestor
25263450|NCT02000882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263451|NCT02000882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25263452|NCT02000882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25263453|NCT01877837|Vidarabine|vidarabine|mesh-list
25263454|NCT01877837|Fludarabine|fludarabine|mesh-list
24558218|NCT00755859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263455|NCT01877837|Fludarabine phosphate|fludarabine phosphate|mesh-list
25263456|NCT01877837|Melphalan|melphalan|mesh-list
25263457|NCT01877837|Alemtuzumab|alemtuzumab|mesh-list
25263458|NCT01877837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25263459|NCT01877837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25263460|NCT01877837|Antimetabolites|antimetabolites|mesh-ancestor
25263461|NCT01877837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263462|NCT01877837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25263463|NCT01877837|Immunologic Factors|immunologic factors|mesh-ancestor
25263464|NCT01877837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263465|NCT01877837|Antiviral Agents|antiviral agents|mesh-ancestor
25263466|NCT01877837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25263467|NCT01877837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24456516|NCT00331500|Histamine Agents|histamine agents|mesh-ancestor
24456517|NCT00331500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24533100|NCT00642291|Emtricitabine|emtricitabine|mesh-list
24533101|NCT00642291|Antiviral Agents|antiviral agents|mesh-ancestor
24533102|NCT00642291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24533103|NCT00642291|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24533104|NCT00642291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24533105|NCT00642291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533106|NCT00642291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533115|NCT00642330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533116|NCT00642330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24686637|NCT04674514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24686638|NCT04674514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24686640|NCT04674514|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24686641|NCT04674514|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24686642|NCT04674514|Growth Substances|growth substances|mesh-ancestor
24686643|NCT04674514|Growth Inhibitors|growth inhibitors|mesh-ancestor
24686683|NCT04640636|Anesthetics, General|anesthetics, general|mesh-ancestor
24907523|NCT04329611|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25263468|NCT01877837|Alkylating Agents|alkylating agents|mesh-ancestor
25263469|NCT01877837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25263470|NCT01877837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25263484|NCT01642004|Docetaxel|docetaxel|mesh-list
25263485|NCT01642004|Nivolumab|nivolumab|mesh-list
25263486|NCT01642004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25263487|NCT01642004|Tubulin Modulators|tubulin modulators|mesh-ancestor
25263488|NCT01642004|Antimitotic Agents|antimitotic agents|mesh-ancestor
24533117|NCT00642330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24533118|NCT00642330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24533126|NCT00642421|Octreotide|octreotide|mesh-list
24533188|NCT00642512|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24533189|NCT00642512|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24686932|NCT04515628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24686933|NCT04515628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24686934|NCT04515628|Antimetabolites|antimetabolites|mesh-ancestor
24686935|NCT04515628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686936|NCT04515628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24686937|NCT04515628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24686938|NCT04515628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24686939|NCT04515628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24687143|NCT04324021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24687275|NCT04148937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24687276|NCT04148937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24687386|NCT04011150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25263489|NCT01642004|Mitosis Modulators|mitosis modulators|mesh-ancestor
25263490|NCT01642004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263491|NCT01642004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25263492|NCT01642004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25688480|NCT01945866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25263493|NCT01453179|Diclofenac|diclofenac|mesh-list
25263494|NCT01453179|Imiquimod|imiquimod|mesh-list
25688481|NCT01945866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688482|NCT01945866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25688483|NCT01945866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25688484|NCT01945866|Growth Substances|growth substances|mesh-ancestor
25688485|NCT01945866|Growth Inhibitors|growth inhibitors|mesh-ancestor
25688486|NCT01946152|Dexamethasone|dexamethasone|mesh-list
25263495|NCT01453179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25263497|NCT01453179|Analgesics|analgesics|mesh-ancestor
25263498|NCT01453179|Sensory System Agents|sensory system agents|mesh-ancestor
25263499|NCT01453179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24702648|NCT01467115|Leucovorin|leucovorin|mesh-list
25263500|NCT01453179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263501|NCT01453179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25263502|NCT01453179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25263503|NCT01453179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25263504|NCT01453179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25263505|NCT01453179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263506|NCT01453179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24533237|NCT00642733|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24533238|NCT00642733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24533239|NCT00642733|Antimetabolites|antimetabolites|mesh-ancestor
24533240|NCT00642733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24669995|NCT03395080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24669996|NCT03395080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24669997|NCT03395080|Tubulin Modulators|tubulin modulators|mesh-ancestor
24669998|NCT03395080|Antimitotic Agents|antimitotic agents|mesh-ancestor
24456518|NCT00331500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456520|NCT00331513|Idarubicin|idarubicin|mesh-list
24456521|NCT00331513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25263511|NCT01336530|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25263512|NCT01336530|Antacids|antacids|mesh-list
25263513|NCT01336530|Magnesium Hydroxide|magnesium hydroxide|mesh-list
25263514|NCT01336530|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25263515|NCT01336530|Immunologic Factors|immunologic factors|mesh-ancestor
25263516|NCT01336530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263517|NCT01336530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263518|NCT01336530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25263519|NCT01336530|Anesthetics, Local|anesthetics, local|mesh-ancestor
25263520|NCT01336530|Anesthetics|anesthetics|mesh-ancestor
25263521|NCT01336530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25263522|NCT01336530|Sensory System Agents|sensory system agents|mesh-ancestor
25263523|NCT01336530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25263532|NCT01244815|Asenapine|asenapine|mesh-list
25263533|NCT01244815|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25263534|NCT01244815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25263535|NCT01244815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25263536|NCT01244815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263537|NCT01244815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25263538|NCT01194622|Fluticasone|fluticasone|mesh-list
25263539|NCT01194622|Xhance|xhance|mesh-list
25263540|NCT01194622|Azelastine|azelastine|mesh-list
25263541|NCT01194622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25263542|NCT01194622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25263543|NCT01194622|Autonomic Agents|autonomic agents|mesh-ancestor
25263544|NCT01194622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25263545|NCT01194622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263546|NCT01194622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25263547|NCT01194622|Respiratory System Agents|respiratory system agents|mesh-ancestor
25263548|NCT01194622|Dermatologic Agents|dermatologic agents|mesh-ancestor
25263549|NCT01194622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25263550|NCT01194622|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25263551|NCT01194622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533250|NCT00642798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24533251|NCT00642798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533252|NCT00642798|Incretins|incretins|mesh-ancestor
24533253|NCT00642798|Hormones|hormones|mesh-ancestor
24670082|NCT03300947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24670084|NCT03300947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24670085|NCT03300947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25688487|NCT01946152|Dexamethasone acetate|dexamethasone acetate|mesh-list
25688488|NCT01946152|Pomalidomide|pomalidomide|mesh-list
25688489|NCT01946152|Ichthammol|ichthammol|mesh-list
25688490|NCT01946152|Lenograstim|lenograstim|mesh-list
25688491|NCT01946152|BB 1101|bb 1101|mesh-list
25688492|NCT01946152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25688493|NCT01946152|Antiemetics|antiemetics|mesh-ancestor
25688494|NCT01946152|Autonomic Agents|autonomic agents|mesh-ancestor
25688495|NCT01946152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25688496|NCT01946152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687530|NCT03932318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24687561|NCT03897439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24687562|NCT03897439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687563|NCT03897439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24687564|NCT03897439|Antidepressive Agents|antidepressive agents|mesh-ancestor
24687565|NCT03897439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24687566|NCT03897439|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24687567|NCT03897439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24687568|NCT03897439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24687569|NCT03897439|Dopamine Agents|dopamine agents|mesh-ancestor
24687570|NCT03897439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24687571|NCT03897439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24687572|NCT03897439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24687573|NCT03883412|Liraglutide|liraglutide|mesh-list
24687574|NCT03883412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24687575|NCT03883412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687576|NCT03883412|Incretins|incretins|mesh-ancestor
24472656|NCT00400088|Lithium Carbonate|lithium carbonate|mesh-list
24472657|NCT00400088|Paroxetine|paroxetine|mesh-list
24472658|NCT00400088|Antidepressive Agents|antidepressive agents|mesh-ancestor
24472659|NCT00400088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24472660|NCT00400088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24472661|NCT00400088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263552|NCT01194622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263553|NCT01194622|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25263554|NCT01194622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25263555|NCT01194622|Histamine Antagonists|histamine antagonists|mesh-ancestor
25263556|NCT01194622|Histamine Agents|histamine agents|mesh-ancestor
25263557|NCT01194622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25263558|NCT01190852|Fluticasone|fluticasone|mesh-list
25263559|NCT01190852|Azelastine|azelastine|mesh-list
25263560|NCT01190852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25263561|NCT01190852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25263562|NCT01190852|Autonomic Agents|autonomic agents|mesh-ancestor
25263563|NCT01190852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25263564|NCT01190852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263565|NCT01190852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25263566|NCT01190852|Respiratory System Agents|respiratory system agents|mesh-ancestor
25263567|NCT01190852|Dermatologic Agents|dermatologic agents|mesh-ancestor
25263568|NCT01190852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24670090|NCT03300947|GABA Agents|gaba agents|mesh-ancestor
24670091|NCT03300947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24670092|NCT03300947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24670093|NCT03300947|Hallucinogens|hallucinogens|mesh-ancestor
24670099|NCT03263767|Cyclophosphamide|cyclophosphamide|mesh-list
24670100|NCT03263767|Fludarabine|fludarabine|mesh-list
24670101|NCT03263767|Clofarabine|clofarabine|mesh-list
24687655|NCT03845270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687657|NCT03836651|Antioxidants|antioxidants|mesh-list
24687658|NCT03836651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687659|NCT03836651|Protective Agents|protective agents|mesh-ancestor
24687660|NCT03836651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687661|NCT03807921|Aspirin|aspirin|mesh-list
24687662|NCT03807921|Warfarin|warfarin|mesh-list
24687768|NCT03704285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24687769|NCT03704285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24687770|NCT03704285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687771|NCT03704285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24687776|NCT03696537|Fludarabine|fludarabine|mesh-list
24687777|NCT03696537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24687811|NCT03661996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24687812|NCT03661996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24687813|NCT03661996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24687892|NCT03618550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687893|NCT03618550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24687895|NCT03618550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24472899|NCT00401115|Sirolimus|sirolimus|mesh-list
24558550|NCT00757835|Adrenergic Agents|adrenergic agents|mesh-ancestor
24558551|NCT00757835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24558555|NCT00757835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24558556|NCT00757835|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24558557|NCT00757835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24558558|NCT00757874|Clobetasol|clobetasol|mesh-list
24558559|NCT00757874|Tacrolimus|tacrolimus|mesh-list
24558560|NCT00757874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24564017|NCT00774735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24687896|NCT03618550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24687897|NCT03618550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24687898|NCT03618550|Immunologic Factors|immunologic factors|mesh-ancestor
24687899|NCT03618550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687900|NCT03618550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24687901|NCT03618550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24687902|NCT03618550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25263569|NCT01190852|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25263570|NCT01190852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25263571|NCT01190852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263572|NCT01190852|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25263573|NCT01190852|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25263574|NCT01190852|Histamine Antagonists|histamine antagonists|mesh-ancestor
25263575|NCT01190852|Histamine Agents|histamine agents|mesh-ancestor
25263576|NCT01190852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25263577|NCT01142596|Asenapine|asenapine|mesh-list
25263578|NCT01142596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25263579|NCT01142596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25263580|NCT01142596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25263581|NCT01142596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263582|NCT01142596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25263583|NCT01098110|Asenapine|asenapine|mesh-list
25263584|NCT01098110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25263585|NCT01098110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25263586|NCT01098110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25263587|NCT01098110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533262|NCT00642824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24533263|NCT00642824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24533264|NCT00642824|Growth Substances|growth substances|mesh-ancestor
24533265|NCT00642824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263588|NCT01098110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25263589|NCT01028716|Vidarabine|vidarabine|mesh-list
25263590|NCT01028716|Mycophenolic Acid|mycophenolic acid|mesh-list
25263591|NCT01028716|Cyclophosphamide|cyclophosphamide|mesh-list
25263592|NCT01028716|Fludarabine|fludarabine|mesh-list
25263593|NCT01028716|Fludarabine phosphate|fludarabine phosphate|mesh-list
25263594|NCT01028716|Tacrolimus|tacrolimus|mesh-list
25263595|NCT01028716|Lenograstim|lenograstim|mesh-list
25263596|NCT01028716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25263597|NCT01028716|Immunologic Factors|immunologic factors|mesh-ancestor
25263598|NCT01028716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688497|NCT01946152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25688498|NCT01946152|Glucocorticoids|glucocorticoids|mesh-ancestor
25688499|NCT01946152|Hormones|hormones|mesh-ancestor
25688500|NCT01946152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25688501|NCT01946152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25688502|NCT01946152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688503|NCT01946152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25688504|NCT01946152|Immunologic Factors|immunologic factors|mesh-ancestor
25688505|NCT01946152|Protease Inhibitors|protease inhibitors|mesh-ancestor
25688506|NCT01946152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25263599|NCT01028716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25263600|NCT01028716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25263601|NCT01028716|Alkylating Agents|alkylating agents|mesh-ancestor
25263602|NCT01028716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263603|NCT01028716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25263604|NCT01028716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25263605|NCT01028716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25263606|NCT01028716|Antimetabolites|antimetabolites|mesh-ancestor
25263607|NCT01028716|Antiviral Agents|antiviral agents|mesh-ancestor
25263608|NCT01028716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25263609|NCT01028716|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25263610|NCT01028716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25263611|NCT01028716|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25263612|NCT01028716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25263613|NCT01028716|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25263614|NCT01028716|Antitubercular Agents|antitubercular agents|mesh-ancestor
25263615|NCT01028716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25263616|NCT01006265|Ponesimod|ponesimod|mesh-list
25263617|NCT01006265|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25263618|NCT01006265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263619|NCT01006265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25263620|NCT01006265|Immunologic Factors|immunologic factors|mesh-ancestor
25263621|NCT01006265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263622|NCT00977483|Thioctic Acid|thioctic acid|mesh-list
25263623|NCT00977483|Antioxidants|antioxidants|mesh-ancestor
25263624|NCT00977483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263625|NCT00977483|Protective Agents|protective agents|mesh-ancestor
25263626|NCT00977483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263627|NCT00977483|Vitamin B Complex|vitamin b complex|mesh-ancestor
25263628|NCT00977483|Vitamins|vitamins|mesh-ancestor
25263629|NCT00977483|Micronutrients|micronutrients|mesh-ancestor
25263630|NCT00972309|Vaccines|vaccines|mesh-list
24670118|NCT03251326|Adrenergic Agents|adrenergic agents|mesh-ancestor
24670119|NCT03251326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24513547|NCT00583271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24513548|NCT00583271|Glucocorticoids|glucocorticoids|mesh-ancestor
24670129|NCT03251326|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24453032|NCT05354258|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24453033|NCT05354258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24687903|NCT03618550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24688052|NCT03489018|Vaccines|vaccines|mesh-list
24688053|NCT03489018|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24688212|NCT03276533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688213|NCT03276533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24688214|NCT03276533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24688216|NCT03276533|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24688217|NCT03276533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24688218|NCT03276533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24688219|NCT03276533|Adrenergic Agents|adrenergic agents|mesh-ancestor
24688220|NCT03276533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24855182|NCT02277847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24855183|NCT02277847|Immunologic Factors|immunologic factors|mesh-ancestor
25263631|NCT00972309|Immunologic Factors|immunologic factors|mesh-ancestor
25263632|NCT00972309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263633|NCT00777348|Reproterol|reproterol|mesh-list
25263634|NCT00777348|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25263635|NCT00777348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25263636|NCT00777348|Adrenergic Agents|adrenergic agents|mesh-ancestor
25263637|NCT00777348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25263638|NCT00777348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263639|NCT00777348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263640|NCT00777348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25263641|NCT00777348|Autonomic Agents|autonomic agents|mesh-ancestor
25263642|NCT00777348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25263643|NCT00777348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25263644|NCT00777348|Respiratory System Agents|respiratory system agents|mesh-ancestor
25263645|NCT00777127|Diclofenac|diclofenac|mesh-list
25692626|NCT02003014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558580|NCT00758004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24558581|NCT00758004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24558582|NCT00758004|Antimetabolites|antimetabolites|mesh-ancestor
25263646|NCT00777127|Imiquimod|imiquimod|mesh-list
25263647|NCT00777127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25263648|NCT00777127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24453034|NCT05354258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24453035|NCT05354258|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24453036|NCT05354258|Renal Agents|renal agents|mesh-ancestor
24533273|NCT00642837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533274|NCT00642837|Antipyretics|antipyretics|mesh-ancestor
24533275|NCT00642837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24453042|NCT05354258|Mitosis Modulators|mitosis modulators|mesh-ancestor
24513577|NCT00583518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513578|NCT00583518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24453043|NCT05354258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24453062|NCT05339087|Riociguat|riociguat|mesh-list
24688320|NCT03141671|Hormone Antagonists|hormone antagonists|mesh-ancestor
24688321|NCT03137173|Vancomycin|vancomycin|mesh-list
24688322|NCT03137173|Aztreonam|aztreonam|mesh-list
24688360|NCT03081052|Nitric Oxide|nitric oxide|mesh-list
24688388|NCT03078855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688389|NCT03078855|Immunologic Factors|immunologic factors|mesh-ancestor
24688390|NCT03078855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24641443|NCT01173562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24688391|NCT03078855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24688392|NCT03078855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24688393|NCT03071601|Lidocaine|lidocaine|mesh-list
24688394|NCT03071601|Epinephrine|epinephrine|mesh-list
24688395|NCT03071601|Prilocaine|prilocaine|mesh-list
24688396|NCT03071601|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24688397|NCT03071601|Anesthetics, Local|anesthetics, local|mesh-ancestor
25263649|NCT00777127|Analgesics|analgesics|mesh-ancestor
25263650|NCT00777127|Sensory System Agents|sensory system agents|mesh-ancestor
25263651|NCT00777127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25263652|NCT00777127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263653|NCT00777127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25263654|NCT00777127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25263655|NCT00777127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25263656|NCT00777127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25263657|NCT00777127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263658|NCT00777127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25263659|NCT00777127|Immunologic Factors|immunologic factors|mesh-ancestor
25263660|NCT00777127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25263661|NCT00777127|Interferon Inducers|interferon inducers|mesh-ancestor
25263662|NCT00761371|Imiquimod|imiquimod|mesh-list
25263663|NCT00761371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25263664|NCT00761371|Immunologic Factors|immunologic factors|mesh-ancestor
25263665|NCT00761371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263666|NCT00761371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25263667|NCT00761371|Interferon Inducers|interferon inducers|mesh-ancestor
25263668|NCT00591227|Insulin|insulin|mesh-list
25263669|NCT00591227|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25263670|NCT00591227|Insulin Aspart|insulin aspart|mesh-list
25263671|NCT00591227|Insulin Detemir|insulin detemir|mesh-list
25263672|NCT00591227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25263673|NCT00591227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263674|NCT00534976|Montelukast|montelukast|mesh-list
25263675|NCT00534976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25263676|NCT00534976|Respiratory System Agents|respiratory system agents|mesh-ancestor
24414705|NCT00198445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24688398|NCT03071601|Anesthetics|anesthetics|mesh-ancestor
24688399|NCT03071601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24688400|NCT03071601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688401|NCT03071601|Sensory System Agents|sensory system agents|mesh-ancestor
24688497|NCT03012672|Cytarabine|cytarabine|mesh-list
24688498|NCT03012672|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
25688507|NCT01946152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688508|NCT01946152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25688509|NCT01946152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24688535|NCT03011775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25688510|NCT01946152|Growth Substances|growth substances|mesh-ancestor
25688511|NCT01946152|Growth Inhibitors|growth inhibitors|mesh-ancestor
25688512|NCT01946152|Dermatologic Agents|dermatologic agents|mesh-ancestor
25688513|NCT01946165|Prednisone|prednisone|mesh-list
25688514|NCT01946165|Abiraterone Acetate|abiraterone acetate|mesh-list
24465621|NCT00370318|Immunologic Factors|immunologic factors|mesh-ancestor
24688536|NCT03011775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24688537|NCT03011775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24688572|NCT02960997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688573|NCT02960997|Antifungal Agents|antifungal agents|mesh-ancestor
24688574|NCT02960997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24688575|NCT02960997|Immunologic Factors|immunologic factors|mesh-ancestor
24688576|NCT02960997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688604|NCT02889900|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24688605|NCT02889900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24688606|NCT02889900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688607|NCT02889900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688608|NCT02889900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24688625|NCT02873819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24611831|NCT01010958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611832|NCT01010958|GABA Agents|gaba agents|mesh-ancestor
24611833|NCT01010958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24611834|NCT01010958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611835|NCT01010958|Antimanic Agents|antimanic agents|mesh-ancestor
24611836|NCT01010958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24688690|NCT02740699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688691|NCT02740699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24855185|NCT02277847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24855186|NCT02277847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24688791|NCT02666794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24688792|NCT02666794|Anesthetics, General|anesthetics, general|mesh-ancestor
24688793|NCT02656550|Thymoglobulin|thymoglobulin|mesh-list
24688794|NCT02656550|Immunologic Factors|immunologic factors|mesh-ancestor
24688795|NCT02656550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688796|NCT02656550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24688798|NCT02642094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24688799|NCT02642094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24688800|NCT02642094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24688801|NCT02642094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688802|NCT02642094|Antifungal Agents|antifungal agents|mesh-ancestor
24688803|NCT02642094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24688804|NCT02642094|Immunologic Factors|immunologic factors|mesh-ancestor
24688805|NCT02642094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688806|NCT02636569|Diclofenac|diclofenac|mesh-list
24688807|NCT02636569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24688809|NCT02636569|Analgesics|analgesics|mesh-ancestor
24688897|NCT02578368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688898|NCT02578368|Tubulin Modulators|tubulin modulators|mesh-ancestor
24688899|NCT02578368|Antimitotic Agents|antimitotic agents|mesh-ancestor
24688900|NCT02578368|Mitosis Modulators|mitosis modulators|mesh-ancestor
24688901|NCT02578368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688902|NCT02578368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688903|NCT02578368|Antimetabolites|antimetabolites|mesh-ancestor
24688904|NCT02578368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24688905|NCT02578368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24688906|NCT02578368|Immunologic Factors|immunologic factors|mesh-ancestor
24688907|NCT02578368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24688909|NCT02578368|Protective Agents|protective agents|mesh-ancestor
24688937|NCT02551991|Oxaliplatin|oxaliplatin|mesh-list
24688938|NCT02551991|Antimetabolites|antimetabolites|mesh-ancestor
25688515|NCT01946165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25688516|NCT01946165|Glucocorticoids|glucocorticoids|mesh-ancestor
25688517|NCT01946165|Hormones|hormones|mesh-ancestor
25688518|NCT01946165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25688519|NCT01946165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688520|NCT01946165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25688521|NCT01946165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688522|NCT01946165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25688523|NCT01946165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24558750|NCT05435378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558751|NCT05435378|Hematinics|hematinics|mesh-ancestor
24558763|NCT05435235|Dapagliflozin|dapagliflozin|mesh-list
24558767|NCT05435235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558814|NCT05434377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24558815|NCT05434377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24462660|NCT00357188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24688939|NCT02551991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263677|NCT00534976|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25263678|NCT00534976|Hormone Antagonists|hormone antagonists|mesh-ancestor
25263679|NCT00534976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24670223|NCT03181100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24670224|NCT03181100|Endothelial Growth Factors|endothelial growth factors|mesh-list
24670225|NCT03181100|Antibodies|antibodies|mesh-list
24670226|NCT03181100|Immunoglobulins|immunoglobulins|mesh-list
24670227|NCT03181100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24670228|NCT03181100|Immunoglobulin G|immunoglobulin g|mesh-list
24670229|NCT03181100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24670230|NCT03181100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24670231|NCT03181100|Tubulin Modulators|tubulin modulators|mesh-ancestor
24670232|NCT03181100|Antimitotic Agents|antimitotic agents|mesh-ancestor
24670233|NCT03181100|Mitosis Modulators|mitosis modulators|mesh-ancestor
24670235|NCT03181100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25263680|NCT00534976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263681|NCT00534976|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25263682|NCT00534976|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24461208|NCT00351364|Montelukast|montelukast|mesh-list
25263683|NCT00534976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263684|NCT00492999|Leucovorin|leucovorin|mesh-list
25263685|NCT00492999|Dexamethasone|dexamethasone|mesh-list
25263686|NCT00492999|Fluorouracil|fluorouracil|mesh-list
25263687|NCT00492999|Oxaliplatin|oxaliplatin|mesh-list
25263688|NCT00492999|Irinotecan|irinotecan|mesh-list
25263689|NCT00492999|Floxuridine|floxuridine|mesh-list
25263690|NCT00492999|Calcium|calcium|mesh-list
25263691|NCT00492999|Levoleucovorin|levoleucovorin|mesh-list
25263692|NCT00492999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25263693|NCT00492999|Antiemetics|antiemetics|mesh-ancestor
25263694|NCT00492999|Autonomic Agents|autonomic agents|mesh-ancestor
25263695|NCT00492999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25263696|NCT00492999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263697|NCT00492999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25263698|NCT00492999|Glucocorticoids|glucocorticoids|mesh-ancestor
25263699|NCT00492999|Hormones|hormones|mesh-ancestor
25263700|NCT00492999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25263701|NCT00492999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25263702|NCT00492999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25263703|NCT00492999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25688524|NCT01946165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688525|NCT01946165|Hormone Antagonists|hormone antagonists|mesh-ancestor
25688526|NCT01946165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25688527|NCT01946412|Ivacaftor|ivacaftor|mesh-list
25688528|NCT01946412|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25688529|NCT01946412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25688530|NCT01946412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688531|NCT01946425|Vaccines|vaccines|mesh-list
25688532|NCT01946425|Immunologic Factors|immunologic factors|mesh-ancestor
25263704|NCT00492999|Antimetabolites|antimetabolites|mesh-ancestor
24558871|NCT05424796|Hemostatics|hemostatics|mesh-list
24773584|NCT01840774|Analgesics|analgesics|mesh-list
24773585|NCT01840774|Sensory System Agents|sensory system agents|mesh-ancestor
24773586|NCT01840774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773587|NCT01840774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773588|NCT01840774|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24773591|NCT01840774|Anesthetics|anesthetics|mesh-ancestor
25263705|NCT00492999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263706|NCT00492999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25263707|NCT00492999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25263708|NCT00492999|Immunologic Factors|immunologic factors|mesh-ancestor
25263709|NCT00492999|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25263710|NCT00492999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25263711|NCT00492999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25263712|NCT00492999|Antidotes|antidotes|mesh-ancestor
25263713|NCT00492999|Protective Agents|protective agents|mesh-ancestor
25263714|NCT00492999|Vitamin B Complex|vitamin b complex|mesh-ancestor
25263715|NCT00492999|Vitamins|vitamins|mesh-ancestor
25263716|NCT00492999|Micronutrients|micronutrients|mesh-ancestor
25263717|NCT00408473|Flecainide|flecainide|mesh-list
25263718|NCT00408473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25263719|NCT00408473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25263720|NCT00408473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25263721|NCT00408473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24456553|NCT00331695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24670269|NCT03117049|Growth Substances|growth substances|mesh-ancestor
24670270|NCT03117049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24670271|NCT03117049|Growth Inhibitors|growth inhibitors|mesh-ancestor
24670272|NCT03117049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24670274|NCT03101748|Cyclophosphamide|cyclophosphamide|mesh-list
24670275|NCT03101748|Doxorubicin|doxorubicin|mesh-list
24670276|NCT03101748|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24670277|NCT03101748|Trastuzumab|trastuzumab|mesh-list
24670278|NCT03101748|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24670279|NCT03101748|Daunorubicin|daunorubicin|mesh-list
24670280|NCT03101748|Pertuzumab|pertuzumab|mesh-list
24670281|NCT03101748|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
24670282|NCT03101748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24670283|NCT03101748|Antibodies|antibodies|mesh-list
24670284|NCT03101748|Immunoglobulins|immunoglobulins|mesh-list
24670285|NCT03101748|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24670289|NCT03101748|Antimitotic Agents|antimitotic agents|mesh-ancestor
24670290|NCT03101748|Mitosis Modulators|mitosis modulators|mesh-ancestor
24670291|NCT03101748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513733|NCT00584662|Sympathomimetics|sympathomimetics|mesh-ancestor
24689094|NCT02299999|Cyclophosphamide|cyclophosphamide|mesh-list
25263722|NCT00408473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263723|NCT00337675|Montelukast|montelukast|mesh-list
25263724|NCT00337675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25263725|NCT00337675|Respiratory System Agents|respiratory system agents|mesh-ancestor
25263726|NCT00337675|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25263727|NCT00337675|Hormone Antagonists|hormone antagonists|mesh-ancestor
25263728|NCT00337675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25263729|NCT00337675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263730|NCT00337675|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25263731|NCT00337675|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25263732|NCT00337675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263733|NCT00328601|Thioctic Acid|thioctic acid|mesh-list
25263734|NCT00328601|Antioxidants|antioxidants|mesh-ancestor
25688533|NCT01946425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688534|NCT01946438|Vaccines|vaccines|mesh-list
25688535|NCT01946438|Immunologic Factors|immunologic factors|mesh-ancestor
25688536|NCT01946438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692627|NCT02003365|Triamcinolone|triamcinolone|mesh-list
25692628|NCT02003365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25692629|NCT02003365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25692631|NCT02003365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24559011|NCT05343156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24559012|NCT05343156|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24559029|NCT05319730|Paclitaxel|paclitaxel|mesh-list
24559030|NCT05319730|Pembrolizumab|pembrolizumab|mesh-list
24559031|NCT05319730|Irinotecan|irinotecan|mesh-list
24559032|NCT05319730|Lenvatinib|lenvatinib|mesh-list
24559033|NCT05319730|Immunoglobulins|immunoglobulins|mesh-list
24559034|NCT05319730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24559035|NCT05319730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24559036|NCT05319730|Tubulin Modulators|tubulin modulators|mesh-ancestor
25263735|NCT00328601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263736|NCT00328601|Protective Agents|protective agents|mesh-ancestor
25263737|NCT00328601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263738|NCT00328601|Vitamin B Complex|vitamin b complex|mesh-ancestor
25263739|NCT00328601|Vitamins|vitamins|mesh-ancestor
25263740|NCT00328601|Micronutrients|micronutrients|mesh-ancestor
25263741|NCT00317772|Topotecan|topotecan|mesh-list
25263742|NCT00317772|Gefitinib|gefitinib|mesh-list
25263743|NCT00317772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25263744|NCT00317772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25263745|NCT00317772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25263746|NCT00317772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263748|NCT00317772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25263749|NCT00294320|Imiquimod|imiquimod|mesh-list
25263750|NCT00294320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25263751|NCT00294320|Immunologic Factors|immunologic factors|mesh-ancestor
25263752|NCT00294320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24670300|NCT03101748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24670301|NCT03101748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24670302|NCT03101748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24513759|NCT00584779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24689095|NCT02299999|Bevacizumab|bevacizumab|mesh-list
24689096|NCT02299999|Cisplatin|cisplatin|mesh-list
24689097|NCT02299999|Carboplatin|carboplatin|mesh-list
24689098|NCT02299999|Doxorubicin|doxorubicin|mesh-list
24855197|NCT02277938|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24855198|NCT02277938|Antiviral Agents|antiviral agents|mesh-ancestor
24689295|NCT01829958|Hormones|hormones|mesh-ancestor
24689296|NCT01829958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24689304|NCT01779557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24689355|NCT01622998|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24689356|NCT01622998|Autonomic Agents|autonomic agents|mesh-ancestor
24689384|NCT01591629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689385|NCT01591629|Sensory System Agents|sensory system agents|mesh-ancestor
25688537|NCT01946880|Mycophenolic Acid|mycophenolic acid|mesh-list
25688538|NCT01946880|Hydroxychloroquine|hydroxychloroquine|mesh-list
25688539|NCT01946880|Chloroquine|chloroquine|mesh-list
25688540|NCT01946880|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
25688541|NCT01946880|Prednisone|prednisone|mesh-list
25688542|NCT01946880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25688543|NCT01946880|Glucocorticoids|glucocorticoids|mesh-ancestor
25688544|NCT01946880|Hormones|hormones|mesh-ancestor
25688545|NCT01946880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25688546|NCT01946880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688547|NCT01946880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25688548|NCT01946880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689386|NCT01591629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24689387|NCT01591629|Hallucinogens|hallucinogens|mesh-ancestor
24689388|NCT01591629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24559268|NCT05122221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24689389|NCT01591629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24689390|NCT01591629|Analgesics|analgesics|mesh-ancestor
24689391|NCT01591629|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25263753|NCT00294320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25263754|NCT00294320|Interferon Inducers|interferon inducers|mesh-ancestor
25263755|NCT00291486|Capecitabine|capecitabine|mesh-list
25263756|NCT00291486|Antibodies|antibodies|mesh-list
25263757|NCT00291486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25263758|NCT00291486|Immunologic Factors|immunologic factors|mesh-ancestor
25263759|NCT00291486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263760|NCT00291486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25263761|NCT00291486|Antimetabolites|antimetabolites|mesh-ancestor
25263762|NCT00291486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263763|NCT00291486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25263764|NCT00284856|Fluticasone|fluticasone|mesh-list
25263765|NCT00284856|Montelukast|montelukast|mesh-list
25263766|NCT00284856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25263767|NCT00284856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25263768|NCT00284856|Autonomic Agents|autonomic agents|mesh-ancestor
25263769|NCT00284856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25263770|NCT00284856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263771|NCT00284856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25263772|NCT00284856|Respiratory System Agents|respiratory system agents|mesh-ancestor
25263773|NCT00284856|Dermatologic Agents|dermatologic agents|mesh-ancestor
25263774|NCT00284856|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24456555|NCT00331695|Progestins|progestins|mesh-ancestor
24456556|NCT00331695|Hormones|hormones|mesh-ancestor
24456557|NCT00331708|Artesunate|artesunate|mesh-list
24689392|NCT01591629|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24689393|NCT01591629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24689394|NCT01591629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689396|NCT01591629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24689397|NCT01564537|Dexamethasone|dexamethasone|mesh-list
24689398|NCT01564537|Lenalidomide|lenalidomide|mesh-list
24689399|NCT01564537|Ixazomib|ixazomib|mesh-list
24689400|NCT01564537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24689652|NCT00785525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689653|NCT00768820|Risperidone|risperidone|mesh-list
24689654|NCT00768820|Methylphenidate|methylphenidate|mesh-list
24689655|NCT00768820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24689656|NCT00768820|Serotonin Agents|serotonin agents|mesh-ancestor
24689657|NCT00768820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24689663|NCT00768820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24689664|NCT00768820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24689665|NCT00768820|Dopamine Agents|dopamine agents|mesh-ancestor
24689666|NCT00768820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24689667|NCT00768820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24689668|NCT00768820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24689669|NCT00768820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24689670|NCT00682318|Ethanol|ethanol|mesh-list
24689671|NCT00682318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24689672|NCT00682318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24611896|NCT01011166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611898|NCT01011166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24611899|NCT01011205|Mycophenolic Acid|mycophenolic acid|mesh-list
24611900|NCT01011205|Methylprednisolone|methylprednisolone|mesh-list
24611901|NCT01011205|Tacrolimus|tacrolimus|mesh-list
25263775|NCT00284856|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25263776|NCT00284856|Hormone Antagonists|hormone antagonists|mesh-ancestor
25263777|NCT00284856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25263778|NCT00284856|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25688549|NCT01946880|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25688550|NCT01946880|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25263779|NCT00284856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25263780|NCT00284856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688551|NCT01946880|Antitubercular Agents|antitubercular agents|mesh-ancestor
25688552|NCT01946880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25688553|NCT01946880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25688554|NCT01946880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688555|NCT01946880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539930|NCT00666042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948257|NCT03920813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948258|NCT03920813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24948259|NCT03920813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24948260|NCT03920813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24948261|NCT03920813|Immunologic Factors|immunologic factors|mesh-ancestor
24448502|NCT00312013|Nadroparin|nadroparin|mesh-list
25263781|NCT00189319|Flecainide|flecainide|mesh-list
25263782|NCT00189319|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25263783|NCT00189319|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25263784|NCT00189319|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25263785|NCT00189319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25263786|NCT00189319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275310|NCT02372903|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25275311|NCT02372903|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25275312|NCT02372903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25275313|NCT02372903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275314|NCT02372903|Hormones|hormones|mesh-ancestor
24533296|NCT00642915|Immunologic Factors|immunologic factors|mesh-ancestor
24533297|NCT00642967|Epoetin Alfa|epoetin alfa|mesh-list
24670344|NCT02936622|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24670345|NCT02936622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24937634|NCT04027283|Erythritol|erythritol|mesh-list
24611902|NCT01011205|Basiliximab|basiliximab|mesh-list
24611903|NCT01011205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24611904|NCT01011205|Immunologic Factors|immunologic factors|mesh-ancestor
24611905|NCT01011205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264060|NCT02442817|Linagliptin|linagliptin|mesh-list
24611906|NCT01011205|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24611907|NCT01011205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689694|NCT00600015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689717|NCT00447122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24689719|NCT00430040|Lisinopril|lisinopril|mesh-list
24689720|NCT00430040|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24689721|NCT00430040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25263787|NCT00189293|Imiquimod|imiquimod|mesh-list
25263797|NCT00189267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688556|NCT01946880|Antimalarials|antimalarials|mesh-ancestor
25688557|NCT01946880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25688558|NCT01946880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25688559|NCT01946880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25688560|NCT01946880|Amebicides|amebicides|mesh-ancestor
25688561|NCT01946880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25688562|NCT01946880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25688563|NCT01946880|Analgesics|analgesics|mesh-ancestor
25688564|NCT01946880|Sensory System Agents|sensory system agents|mesh-ancestor
25688565|NCT01946880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25688566|NCT01946880|Filaricides|filaricides|mesh-ancestor
25688567|NCT01946880|Antinematodal Agents|antinematodal agents|mesh-ancestor
25688568|NCT01946880|Anthelmintics|anthelmintics|mesh-ancestor
25688569|NCT01947153|Metformin|metformin|mesh-list
25688570|NCT01947153|Linagliptin|linagliptin|mesh-list
25688571|NCT01947153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25688572|NCT01947153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688573|NCT01947153|Incretins|incretins|mesh-ancestor
25688574|NCT01947153|Hormones|hormones|mesh-ancestor
25688575|NCT01947153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25688576|NCT01947153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25688577|NCT01947153|Protease Inhibitors|protease inhibitors|mesh-ancestor
25688578|NCT01947153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25263798|NCT00189267|Interferon Inducers|interferon inducers|mesh-ancestor
25263800|NCT00189254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25263801|NCT00189254|Immunologic Factors|immunologic factors|mesh-ancestor
25263802|NCT00189254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263803|NCT00189254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25263804|NCT00189254|Interferon Inducers|interferon inducers|mesh-ancestor
25263805|NCT00189241|Imiquimod|imiquimod|mesh-list
25263806|NCT00189241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25263807|NCT00189241|Immunologic Factors|immunologic factors|mesh-ancestor
25263808|NCT00189241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263809|NCT00189241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25263810|NCT00189241|Interferon Inducers|interferon inducers|mesh-ancestor
25263811|NCT00070707|Mometasone Furoate|mometasone furoate|mesh-list
25263812|NCT00070707|Albuterol|albuterol|mesh-list
25263813|NCT00070707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25263814|NCT00070707|Autonomic Agents|autonomic agents|mesh-ancestor
25263815|NCT00070707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25263816|NCT00070707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263817|NCT00070707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25263818|NCT00070707|Respiratory System Agents|respiratory system agents|mesh-ancestor
25263819|NCT00070707|Tocolytic Agents|tocolytic agents|mesh-ancestor
24670348|NCT02936622|Antimitotic Agents|antimitotic agents|mesh-ancestor
24670349|NCT02936622|Mitosis Modulators|mitosis modulators|mesh-ancestor
24670350|NCT02936622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513806|NCT00585260|Mannitol|mannitol|mesh-list
24689722|NCT00430040|Adrenergic Agents|adrenergic agents|mesh-ancestor
24689723|NCT00430040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24689724|NCT00430040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689725|NCT00430040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689726|NCT00430040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24689727|NCT00430040|Antioxidants|antioxidants|mesh-ancestor
24689728|NCT00430040|Protective Agents|protective agents|mesh-ancestor
24689729|NCT00430040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24689730|NCT00430040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24689788|NCT00309985|Docetaxel|docetaxel|mesh-list
24689789|NCT00309985|Androgens|androgens|mesh-list
24689790|NCT00309985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689791|NCT00309985|Tubulin Modulators|tubulin modulators|mesh-ancestor
24689792|NCT00309985|Antimitotic Agents|antimitotic agents|mesh-ancestor
24689793|NCT00309985|Mitosis Modulators|mitosis modulators|mesh-ancestor
25263820|NCT00070707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25263821|NCT00070707|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25263822|NCT00070707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25263823|NCT00070707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25263824|NCT00070707|Adrenergic Agents|adrenergic agents|mesh-ancestor
25263825|NCT00070707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25263826|NCT00070707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263827|NCT00070707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25263828|NCT00070707|Dermatologic Agents|dermatologic agents|mesh-ancestor
25263829|NCT00070707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25692632|NCT02003365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24671011|NCT01323244|Antiviral Agents|antiviral agents|mesh-ancestor
24671012|NCT01323244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24671013|NCT01323244|Protease Inhibitors|protease inhibitors|mesh-ancestor
24671014|NCT01323244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469611|NCT00386529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469613|NCT00386529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24469615|NCT00386529|Antipyretics|antipyretics|mesh-ancestor
24469617|NCT00386555|Axitinib|axitinib|mesh-list
24469832|NCT00387504|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25263830|NCT02444169|Hyaluronic Acid|hyaluronic acid|mesh-list
25263831|NCT02444169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25263832|NCT02444169|Immunologic Factors|immunologic factors|mesh-ancestor
25263833|NCT02444169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263834|NCT02444169|Viscosupplements|viscosupplements|mesh-ancestor
25263835|NCT02444169|Protective Agents|protective agents|mesh-ancestor
25263836|NCT02444364|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25263837|NCT02444364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25263838|NCT02444364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263839|NCT02444364|Incretins|incretins|mesh-ancestor
25263840|NCT02444364|Hormones|hormones|mesh-ancestor
25263841|NCT02444364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25263842|NCT02444364|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25263843|NCT02444364|Protease Inhibitors|protease inhibitors|mesh-ancestor
24533301|NCT00642980|Clindamycin phosphate|clindamycin phosphate|mesh-list
24533302|NCT00642980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24533303|NCT00642980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24670378|NCT02842086|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24670379|NCT02842086|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
24670380|NCT02842086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24670381|NCT02842086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24670382|NCT02842086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24670383|NCT02842086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24670384|NCT02842086|Antiviral Agents|antiviral agents|mesh-ancestor
24513824|NCT00585455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24533304|NCT00642980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24533305|NCT00642980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533306|NCT00642980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966432|NCT03768258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689823|NCT00055731|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25688579|NCT01947153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688580|NCT01947855|Empagliflozin|empagliflozin|mesh-list
25688581|NCT01947855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25688582|NCT01947855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688583|NCT01947855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25688584|NCT01947855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688585|NCT01947907|Hormones|hormones|mesh-list
25688586|NCT01947907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25688587|NCT01947907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688588|NCT01947946|Benralizumab|benralizumab|mesh-list
25688589|NCT01947946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24948295|NCT03920839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24948296|NCT03920839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24948297|NCT03920839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24948298|NCT03920839|Immunologic Factors|immunologic factors|mesh-ancestor
24948299|NCT03920839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24560219|NCT03205137|Diuretics|diuretics|mesh-ancestor
24689824|NCT00055731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25263844|NCT02444364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25263845|NCT02444364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263846|NCT02444351|Botulinum Toxins|botulinum toxins|mesh-list
25263847|NCT02444351|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25263848|NCT02444351|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25263849|NCT02444351|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25263850|NCT02444351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25263851|NCT02444351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263852|NCT02444351|Cholinergic Agents|cholinergic agents|mesh-ancestor
25263853|NCT02444351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25263854|NCT02444351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263855|NCT02444351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25263856|NCT02444351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25263857|NCT02444091|Cyclophosphamide|cyclophosphamide|mesh-list
25263858|NCT02444091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25263859|NCT02444091|Immunologic Factors|immunologic factors|mesh-ancestor
25263860|NCT02444091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263861|NCT02444091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25263862|NCT02444091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25263863|NCT02444091|Alkylating Agents|alkylating agents|mesh-ancestor
25263864|NCT02444091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263865|NCT02444091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25263866|NCT02444091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25263867|NCT02444260|Lidocaine|lidocaine|mesh-list
25263868|NCT02444260|Midazolam|midazolam|mesh-list
25263869|NCT02444260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25263870|NCT02444260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25263871|NCT02444260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25263872|NCT02444260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800394|NCT01975441|Ivermectin|ivermectin|mesh-list
25263873|NCT02444260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25263874|NCT02444260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25263875|NCT02444260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25263876|NCT02444260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25263877|NCT02444260|Anesthetics, General|anesthetics, general|mesh-ancestor
25263878|NCT02444260|Anesthetics|anesthetics|mesh-ancestor
24670386|NCT02842086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24670387|NCT02842086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24670395|NCT02748018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24670396|NCT02748018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533309|NCT00643071|Immunologic Factors|immunologic factors|mesh-ancestor
24533310|NCT00643071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533311|NCT00643071|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24533312|NCT00643071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688590|NCT01947946|Respiratory System Agents|respiratory system agents|mesh-ancestor
25688591|NCT01948141|Nintedanib|nintedanib|mesh-list
25688592|NCT01948141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688593|NCT01948141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25688594|NCT01948141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688595|NCT01948141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688596|NCT01948310|Ranolazine|ranolazine|mesh-list
25688597|NCT01948310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25688598|NCT01948310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25688599|NCT01948310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560301|NCT02981979|Prednisone|prednisone|mesh-list
24560302|NCT02981979|Leflunomide|leflunomide|mesh-list
24560303|NCT02981979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24560304|NCT02981979|Glucocorticoids|glucocorticoids|mesh-ancestor
24560305|NCT02981979|Hormones|hormones|mesh-ancestor
24560307|NCT02981979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24560397|NCT02726997|Immunoglobulin G|immunoglobulin g|mesh-list
24560398|NCT02726997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24560399|NCT02726997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24560400|NCT02726997|Tubulin Modulators|tubulin modulators|mesh-ancestor
24560401|NCT02726997|Antimitotic Agents|antimitotic agents|mesh-ancestor
24560402|NCT02726997|Mitosis Modulators|mitosis modulators|mesh-ancestor
24560403|NCT02726997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560405|NCT02726997|Immunologic Factors|immunologic factors|mesh-ancestor
24533318|NCT00643136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533319|NCT00643136|Anticonvulsants|anticonvulsants|mesh-ancestor
24670398|NCT02663622|Tacrolimus|tacrolimus|mesh-list
24689826|NCT00055731|Sensory System Agents|sensory system agents|mesh-ancestor
24689827|NCT00055731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24689828|NCT00055731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689829|NCT00055731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24689830|NCT00055731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24689831|NCT00055731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24689832|NCT00055731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24689833|NCT00055731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24689879|NCT01397994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24689880|NCT01397994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263879|NCT02444260|GABA Modulators|gaba modulators|mesh-ancestor
25263880|NCT02444260|GABA Agents|gaba agents|mesh-ancestor
25263881|NCT02444260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25263882|NCT02444260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263883|NCT02444260|Anesthetics, Local|anesthetics, local|mesh-ancestor
25263884|NCT02444260|Sensory System Agents|sensory system agents|mesh-ancestor
25263885|NCT02444260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25263886|NCT02444260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25263887|NCT02444260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25263888|NCT02444260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25263891|NCT02443935|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25263892|NCT02443935|Immunologic Factors|immunologic factors|mesh-ancestor
25263893|NCT02443935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263895|NCT02443727|Oxytocics|oxytocics|mesh-ancestor
25263896|NCT02443727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25263897|NCT02443727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263898|NCT02443818|Sirolimus|sirolimus|mesh-list
25263899|NCT02443818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25263900|NCT02443818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25263901|NCT02443818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25263902|NCT02443818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25263903|NCT02443818|Antifungal Agents|antifungal agents|mesh-ancestor
25263904|NCT02443818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25263905|NCT02443818|Immunologic Factors|immunologic factors|mesh-ancestor
25263906|NCT02443818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263908|NCT02444013|Uric Acid|uric acid|mesh-list
25263909|NCT02444013|Hematinics|hematinics|mesh-ancestor
25263910|NCT02444013|Vitamin B Complex|vitamin b complex|mesh-ancestor
25263911|NCT02444013|Vitamins|vitamins|mesh-ancestor
25688600|NCT01948388|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25688601|NCT01948388|Hormones|hormones|mesh-ancestor
25688602|NCT01948388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25688603|NCT01948388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688604|NCT01948518|Sildenafil Citrate|sildenafil citrate|mesh-list
25688605|NCT01948518|Vasodilator Agents|vasodilator agents|mesh-ancestor
25688606|NCT01948518|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25688607|NCT01948518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25688608|NCT01948518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688609|NCT01948518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688610|NCT01948518|Urological Agents|urological agents|mesh-ancestor
25688611|NCT01948791|Rivastigmine|rivastigmine|mesh-list
25688612|NCT01948791|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24948311|NCT03920644|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24948312|NCT03920644|Cholinergic Agents|cholinergic agents|mesh-ancestor
24948313|NCT03920644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24948314|NCT03920644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452040|NCT00325806|Ramipril|ramipril|mesh-list
24560484|NCT02476279|Indomethacin|indomethacin|mesh-list
24560494|NCT02476279|Tocolytic Agents|tocolytic agents|mesh-ancestor
24560495|NCT02476279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24670400|NCT02663622|Abortifacient Agents|abortifacient agents|mesh-ancestor
24670401|NCT02663622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24670402|NCT02663622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24670403|NCT02663622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24670404|NCT02663622|Antimetabolites|antimetabolites|mesh-ancestor
24670405|NCT02663622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24670406|NCT02663622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513897|NCT00586118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24513898|NCT00586118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533320|NCT00643136|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24855221|NCT02278172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24855222|NCT02278172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24689881|NCT01397994|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24689882|NCT01397994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24689883|NCT01397994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24689884|NCT01397994|Adrenergic Agents|adrenergic agents|mesh-ancestor
24689885|NCT01397994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24689886|NCT01397994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689887|NCT01397994|Vasodilator Agents|vasodilator agents|mesh-ancestor
24689888|NCT01397994|Vitamin B Complex|vitamin b complex|mesh-ancestor
24689889|NCT01397994|Vitamins|vitamins|mesh-ancestor
24689890|NCT01397994|Micronutrients|micronutrients|mesh-ancestor
24689891|NCT01398033|Paclitaxel|paclitaxel|mesh-list
25263912|NCT02444013|Micronutrients|micronutrients|mesh-ancestor
25263913|NCT02444013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263914|NCT02444013|Antioxidants|antioxidants|mesh-ancestor
25263915|NCT02444013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263916|NCT02444013|Protective Agents|protective agents|mesh-ancestor
25263917|NCT02443844|Tamsulosin|tamsulosin|mesh-list
25263918|NCT02443844|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24546819|NCT00700583|Terazosin|terazosin|mesh-list
25263919|NCT02443844|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25263920|NCT02443844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25263921|NCT02443844|Adrenergic Agents|adrenergic agents|mesh-ancestor
25263922|NCT02443844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25275329|NCT02372526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25263933|NCT02443922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25263934|NCT02443922|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25688613|NCT01948791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688614|NCT01948791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688615|NCT01948791|Cholinergic Agents|cholinergic agents|mesh-ancestor
25688616|NCT01948791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25688617|NCT01948791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688618|NCT01948791|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25688619|NCT01948791|Protective Agents|protective agents|mesh-ancestor
25688620|NCT01948830|Ranibizumab|ranibizumab|mesh-list
25688621|NCT01948830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25688622|NCT01948830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25688623|NCT01948830|Growth Substances|growth substances|mesh-ancestor
24560584|NCT02303028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24560585|NCT02303028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24560586|NCT02303028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560587|NCT02303028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24560588|NCT02292238|Benphothiamine|benphothiamine|mesh-list
24560589|NCT02292238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24560590|NCT02292238|Immunologic Factors|immunologic factors|mesh-ancestor
24560591|NCT02292238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263935|NCT02443922|Protease Inhibitors|protease inhibitors|mesh-ancestor
25263936|NCT02443922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25263937|NCT02443922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263938|NCT02443922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25263939|NCT02443922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25263940|NCT02443922|Immunologic Factors|immunologic factors|mesh-ancestor
25263941|NCT02443714|Insulin|insulin|mesh-list
24670477|NCT02516241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24456563|NCT00331708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24456564|NCT00331708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24456565|NCT00331708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514130|NCT00588016|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24670729|NCT01998971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24670731|NCT01998971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24670732|NCT01998971|Glucocorticoids|glucocorticoids|mesh-ancestor
24670733|NCT01998971|Hormones|hormones|mesh-ancestor
24670734|NCT01998971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24689892|NCT01398033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24689893|NCT01398033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689894|NCT01398033|Tubulin Modulators|tubulin modulators|mesh-ancestor
24689895|NCT01398033|Antimitotic Agents|antimitotic agents|mesh-ancestor
24689896|NCT01398033|Mitosis Modulators|mitosis modulators|mesh-ancestor
24689897|NCT01398033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689974|NCT01398293|Moxifloxacin|moxifloxacin|mesh-list
24689975|NCT01398293|Lactams|lactams|mesh-list
24689976|NCT01398293|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24689977|NCT01398293|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24689978|NCT01398293|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24689979|NCT01398293|Protease Inhibitors|protease inhibitors|mesh-ancestor
24689980|NCT01398293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689981|NCT01398293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689982|NCT01398293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24689983|NCT01398293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24690078|NCT01399086|Hormone Antagonists|hormone antagonists|mesh-ancestor
25263942|NCT02443714|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25263943|NCT02443714|Insulin Lispro|insulin lispro|mesh-list
25263944|NCT02443714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25263945|NCT02443714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263946|NCT02443545|Deferiprone|deferiprone|mesh-list
25263947|NCT02443545|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25263948|NCT02443545|Chelating Agents|chelating agents|mesh-ancestor
25263949|NCT02443545|Sequestering Agents|sequestering agents|mesh-ancestor
25263950|NCT02443545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263951|NCT02443285|Ceftriaxone|ceftriaxone|mesh-list
25263952|NCT02443285|Cefotaxime|cefotaxime|mesh-list
25263953|NCT02443285|Cefoxitin|cefoxitin|mesh-list
25264161|NCT02442492|Urological Agents|urological agents|mesh-ancestor
25263970|NCT02443311|Glucocorticoids|glucocorticoids|mesh-ancestor
24670735|NCT01998971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24670736|NCT01998971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24670737|NCT01998971|Immunologic Factors|immunologic factors|mesh-ancestor
24670738|NCT01998971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25688625|NCT01948830|Growth Inhibitors|growth inhibitors|mesh-ancestor
25688626|NCT01948830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688627|NCT01948908|Midazolam|midazolam|mesh-list
25688628|NCT01948908|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25688629|NCT01948908|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25688630|NCT01948908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25688631|NCT01948908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688632|NCT01948908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25688633|NCT01948908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24560916|NCT01177540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24560918|NCT01177540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560919|NCT01177540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24560920|NCT01177540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24561007|NCT00662792|Tiotropium Bromide|tiotropium bromide|mesh-list
24561008|NCT00662792|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24561009|NCT00662792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24670739|NCT01998971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24670740|NCT01998971|Growth Substances|growth substances|mesh-ancestor
24415283|NCT00199160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456595|NCT00331786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456596|NCT00331786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24547069|NCT00702182|Vinorelbine|vinorelbine|mesh-list
24456597|NCT00331786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24456598|NCT00331786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456599|NCT00331786|Antipyretics|antipyretics|mesh-ancestor
24456600|NCT00331786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25263972|NCT02443311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25263973|NCT02443311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25263974|NCT02443311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25263975|NCT02443311|Respiratory System Agents|respiratory system agents|mesh-ancestor
25263976|NCT02443311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25263977|NCT02443311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25263978|NCT02443311|Analgesics|analgesics|mesh-ancestor
25263979|NCT02443311|Sensory System Agents|sensory system agents|mesh-ancestor
25263980|NCT02443311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25263981|NCT02443311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25263982|NCT02443311|Dermatologic Agents|dermatologic agents|mesh-ancestor
25263983|NCT02443311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25263984|NCT02443311|Immunologic Factors|immunologic factors|mesh-ancestor
25263985|NCT02443311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25263986|NCT02443311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25263987|NCT02443311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25263988|NCT02443194|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25263989|NCT02443194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25263990|NCT02443194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24705744|NCT01486511|Liver Extracts|liver extracts|mesh-list
25263991|NCT02443194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25264001|NCT02443012|Nepafenac|nepafenac|mesh-list
25264002|NCT02443012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25264003|NCT02443012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25264004|NCT02443012|Analgesics|analgesics|mesh-ancestor
25264005|NCT02443012|Sensory System Agents|sensory system agents|mesh-ancestor
25264006|NCT02443012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25264007|NCT02443012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24670838|NCT01759459|Anesthetics, Local|anesthetics, local|mesh-ancestor
24670839|NCT01759459|Anesthetics|anesthetics|mesh-ancestor
24611955|NCT01011452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24611957|NCT01011452|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24611958|NCT01011452|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24690088|NCT01399151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24690089|NCT01399216|Fucoidan|fucoidan|mesh-list
25688634|NCT01948908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25688635|NCT01948908|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25688636|NCT01948908|Anesthetics, General|anesthetics, general|mesh-ancestor
25688637|NCT01948908|Anesthetics|anesthetics|mesh-ancestor
25688638|NCT01948908|GABA Modulators|gaba modulators|mesh-ancestor
25688639|NCT01948908|GABA Agents|gaba agents|mesh-ancestor
25688640|NCT01948908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25688641|NCT01948908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688642|NCT01948986|Ertugliflozin|ertugliflozin|mesh-list
24561324|NCT00759421|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24561325|NCT00759421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24561326|NCT00759421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24690090|NCT01399216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24690281|NCT01400685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24690308|NCT01400750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24690309|NCT01400750|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24690310|NCT01400750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24690311|NCT01400789|Insulin Lispro|insulin lispro|mesh-list
24690312|NCT01400789|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
24690313|NCT01400789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24690314|NCT01400789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690315|NCT01400802|Insulin Lispro|insulin lispro|mesh-list
24690316|NCT01400802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24690317|NCT01400802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690318|NCT01400828|Desloratadine|desloratadine|mesh-list
24690319|NCT01400828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24676854|NCT01352611|Baclofen|baclofen|mesh-list
24855247|NCT02278419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24908680|NCT04317872|Glucocorticoids|glucocorticoids|mesh-ancestor
24690515|NCT01402245|Vaccines|vaccines|mesh-list
24690516|NCT01402245|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24690517|NCT01402245|Immunologic Factors|immunologic factors|mesh-ancestor
24690518|NCT01402245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690519|NCT01402271|Paclitaxel|paclitaxel|mesh-list
24690549|NCT01402336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24690550|NCT01402336|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24690551|NCT01402336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24690552|NCT01402336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24690553|NCT01402336|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25264008|NCT02443012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25264009|NCT02443012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25264010|NCT02443064|Vancomycin|vancomycin|mesh-list
25264011|NCT02443064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25264012|NCT02443064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25264013|NCT02443142|Acetaminophen|acetaminophen|mesh-list
25264014|NCT02443142|Ibuprofen|ibuprofen|mesh-list
25264015|NCT02443142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25264016|NCT02443142|Analgesics|analgesics|mesh-ancestor
25264029|NCT02442921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25264030|NCT02442921|Tubulin Modulators|tubulin modulators|mesh-ancestor
25264031|NCT02442921|Antimitotic Agents|antimitotic agents|mesh-ancestor
25264032|NCT02442921|Mitosis Modulators|mitosis modulators|mesh-ancestor
25264033|NCT02442921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264034|NCT02442921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25264035|NCT02442791|Exenatide|exenatide|mesh-list
25264036|NCT02442791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25264037|NCT02442791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264038|NCT02442791|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25264039|NCT02442791|Incretins|incretins|mesh-ancestor
25264040|NCT02442791|Hormones|hormones|mesh-ancestor
25264041|NCT02442791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25275315|NCT02372903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25275316|NCT02372955|Dapagliflozin|dapagliflozin|mesh-list
25275317|NCT02372955|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25275318|NCT02372955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275319|NCT02372955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25275320|NCT02372955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275321|NCT02372916|Ranibizumab|ranibizumab|mesh-list
25275322|NCT02372916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25275323|NCT02372916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25275324|NCT02372916|Growth Substances|growth substances|mesh-ancestor
25275325|NCT02372916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275326|NCT02372916|Growth Inhibitors|growth inhibitors|mesh-ancestor
25275327|NCT02372916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25275328|NCT02372526|Orlistat|orlistat|mesh-list
25275331|NCT02372526|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25275332|NCT02372526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25688643|NCT01948986|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25688644|NCT01948986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688645|NCT01948986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24533329|NCT00643149|Azithromycin|azithromycin|mesh-list
24533330|NCT00643149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24533331|NCT00643149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24533332|NCT00643227|Azithromycin|azithromycin|mesh-list
24533333|NCT00643227|Clarithromycin|clarithromycin|mesh-list
24533334|NCT00643227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24533335|NCT00643227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24533336|NCT00643227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24514401|NCT00590174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25045427|NCT00953420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045429|NCT00953420|Glucocorticoids|glucocorticoids|mesh-ancestor
25045430|NCT00953420|Hormones|hormones|mesh-ancestor
25264042|NCT02442713|Fluvoxamine|fluvoxamine|mesh-list
25264043|NCT02442713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25264044|NCT02442713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25264045|NCT02442713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25264046|NCT02442713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264047|NCT02442713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25264048|NCT02442713|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25264049|NCT02442713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25264050|NCT02442713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25264051|NCT02442713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264052|NCT02442713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25264053|NCT02442713|Serotonin Agents|serotonin agents|mesh-ancestor
25264054|NCT02442713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25264055|NCT02442713|Antidepressive Agents|antidepressive agents|mesh-ancestor
25264056|NCT02442713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25264057|NCT02442713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25264058|NCT02442713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264059|NCT02442713|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25264061|NCT02442817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25264062|NCT02442817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264063|NCT02442817|Incretins|incretins|mesh-ancestor
25264064|NCT02442817|Hormones|hormones|mesh-ancestor
25264065|NCT02442817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25264066|NCT02442817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25264067|NCT02442817|Protease Inhibitors|protease inhibitors|mesh-ancestor
25264068|NCT02442817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264069|NCT02442817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264070|NCT02442674|Tolvaptan|tolvaptan|mesh-list
25264071|NCT02442674|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25264162|NCT02442063|Paclitaxel|paclitaxel|mesh-list
25264072|NCT02442674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264073|NCT02442674|Natriuretic Agents|natriuretic agents|mesh-ancestor
25264074|NCT02442674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688646|NCT01948986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688647|NCT01949051|Levocabastine|levocabastine|mesh-list
25688648|NCT01949051|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25688649|NCT01949051|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25688650|NCT01949051|Histamine Antagonists|histamine antagonists|mesh-ancestor
25688651|NCT01949051|Histamine Agents|histamine agents|mesh-ancestor
25688652|NCT01949051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25692633|NCT02003365|Glucocorticoids|glucocorticoids|mesh-ancestor
24855264|NCT02278510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24855265|NCT02278510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457758|NCT00335166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24690560|NCT01402479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690561|NCT01402479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24690562|NCT01402583|Ribavirin|ribavirin|mesh-list
24448748|NCT00313001|Insulin Aspart|insulin aspart|mesh-list
24690590|NCT01402674|Phentermine|phentermine|mesh-list
24611994|NCT01011621|Antiemetics|antiemetics|mesh-ancestor
24611995|NCT01011621|Autonomic Agents|autonomic agents|mesh-ancestor
25264079|NCT02442648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264080|NCT02442648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25264081|NCT02442752|Dexlansoprazole|dexlansoprazole|mesh-list
25264082|NCT02442752|Lansoprazole|lansoprazole|mesh-list
25264083|NCT02442752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25264084|NCT02442752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25264085|NCT02442752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25264086|NCT02442752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264087|NCT02442752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264088|NCT02442362|Paclitaxel|paclitaxel|mesh-list
25264089|NCT02442362|Fluorouracil|fluorouracil|mesh-list
25264090|NCT02442362|Oxaliplatin|oxaliplatin|mesh-list
25264091|NCT02442362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25264092|NCT02442362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25264093|NCT02442362|Tubulin Modulators|tubulin modulators|mesh-ancestor
25688653|NCT01949051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688654|NCT01949051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264094|NCT02442362|Antimitotic Agents|antimitotic agents|mesh-ancestor
25264095|NCT02442362|Mitosis Modulators|mitosis modulators|mesh-ancestor
25264096|NCT02442362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264097|NCT02442362|Antimetabolites|antimetabolites|mesh-ancestor
25264098|NCT02442362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25264099|NCT02442362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25264113|NCT02442739|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25264114|NCT02442739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25264115|NCT02442739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264116|NCT02442453|Turmeric extract|turmeric extract|mesh-list
25264117|NCT02442453|Antioxidants|antioxidants|mesh-ancestor
25264118|NCT02442453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264119|NCT02442453|Protective Agents|protective agents|mesh-ancestor
25264120|NCT02442453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264121|NCT02442531|Docetaxel|docetaxel|mesh-list
25264122|NCT02442531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25264123|NCT02442531|Tubulin Modulators|tubulin modulators|mesh-ancestor
25264124|NCT02442531|Antimitotic Agents|antimitotic agents|mesh-ancestor
25264125|NCT02442531|Mitosis Modulators|mitosis modulators|mesh-ancestor
25264126|NCT02442531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264128|NCT02442466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25264129|NCT02442466|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25264130|NCT02442466|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25264131|NCT02442466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264132|NCT02442440|Anisodamine|anisodamine|mesh-list
25264133|NCT02442440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25264134|NCT02442440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25264135|NCT02442440|Adrenergic Agents|adrenergic agents|mesh-ancestor
25264136|NCT02442440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25264137|NCT02442440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264138|NCT02442440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264139|NCT02442440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25264140|NCT02442440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25264141|NCT02442440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25264142|NCT02442440|Analgesics|analgesics|mesh-ancestor
25264143|NCT02442440|Sensory System Agents|sensory system agents|mesh-ancestor
25264144|NCT02442440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25264145|NCT02442440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25688655|NCT01949116|Folic Acid|folic acid|mesh-list
25688656|NCT01949116|Methotrexate|methotrexate|mesh-list
25688657|NCT01949116|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25688658|NCT01949116|Abortifacient Agents|abortifacient agents|mesh-ancestor
25688659|NCT01949116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25688660|NCT01949116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688661|NCT01949116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25688662|NCT01949116|Antimetabolites|antimetabolites|mesh-ancestor
25688663|NCT01949116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688664|NCT01949116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688665|NCT01949116|Dermatologic Agents|dermatologic agents|mesh-ancestor
25688666|NCT01949116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688667|NCT01949116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25688668|NCT01949116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24690596|NCT01402674|Autonomic Agents|autonomic agents|mesh-ancestor
24690597|NCT01402674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24690598|NCT01402674|Adrenergic Agents|adrenergic agents|mesh-ancestor
24690599|NCT01402674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24690600|NCT01402674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690601|NCT01402843|Valsartan|valsartan|mesh-list
24690602|NCT01402843|Pitavastatin|pitavastatin|mesh-list
24690603|NCT01402843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24690604|NCT01402843|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24690605|NCT01402843|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24690606|NCT01402843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690607|NCT01402843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24690608|NCT01402843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24457761|NCT00335166|Dopamine Agents|dopamine agents|mesh-ancestor
24457763|NCT00335179|Imiquimod|imiquimod|mesh-list
24690698|NCT01403415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24690699|NCT01403415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24690700|NCT01403415|Antimetabolites|antimetabolites|mesh-ancestor
24690701|NCT01403415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690702|NCT01403415|Dermatologic Agents|dermatologic agents|mesh-ancestor
24690940|NCT01404468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24690941|NCT01404468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24690942|NCT01404468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24690943|NCT01404468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24690944|NCT01404468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690946|NCT01404507|Anticoagulants|anticoagulants|mesh-ancestor
24691015|NCT01404715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691016|NCT01404715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24691017|NCT01404715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691022|NCT01404741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691024|NCT01404741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264148|NCT02442440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25688672|NCT01949116|Hematinics|hematinics|mesh-ancestor
25688673|NCT01949116|Vitamin B Complex|vitamin b complex|mesh-ancestor
25688674|NCT01949116|Vitamins|vitamins|mesh-ancestor
25688675|NCT01949116|Micronutrients|micronutrients|mesh-ancestor
25688676|NCT01949844|Regadenoson|regadenoson|mesh-list
25688677|NCT01949844|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25688678|NCT01949844|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25264149|NCT02442440|Parasympatholytics|parasympatholytics|mesh-ancestor
25264155|NCT02442492|Sildenafil Citrate|sildenafil citrate|mesh-list
25264156|NCT02442492|Vasodilator Agents|vasodilator agents|mesh-ancestor
25264157|NCT02442492|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25264158|NCT02442492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25264159|NCT02442492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264160|NCT02442492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514508|NCT00591162|Tetracycline|tetracycline|mesh-list
24691027|NCT01404767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24691028|NCT01404767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24691029|NCT01404767|Sympatholytics|sympatholytics|mesh-ancestor
24691030|NCT01404767|Autonomic Agents|autonomic agents|mesh-ancestor
24691031|NCT01404767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24691032|NCT01404767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691039|NCT01404793|Rocuronium|rocuronium|mesh-list
24691072|NCT01404871|Analgesics|analgesics|mesh-ancestor
24691073|NCT01404871|Sensory System Agents|sensory system agents|mesh-ancestor
24691074|NCT01404871|Dopamine Agents|dopamine agents|mesh-ancestor
24691075|NCT01404871|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24691076|NCT01405079|Vinorelbine|vinorelbine|mesh-list
24691078|NCT01405079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691079|NCT01405079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24691080|NCT01405079|Tubulin Modulators|tubulin modulators|mesh-ancestor
24691081|NCT01405079|Antimitotic Agents|antimitotic agents|mesh-ancestor
24691082|NCT01405079|Mitosis Modulators|mitosis modulators|mesh-ancestor
24691083|NCT01405079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691113|NCT01405144|Fluorouracil|fluorouracil|mesh-list
24691114|NCT01405144|Antimetabolites|antimetabolites|mesh-ancestor
24691115|NCT01405144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691116|NCT01405144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24691117|NCT01405144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25264167|NCT02442063|Antimitotic Agents|antimitotic agents|mesh-ancestor
25264168|NCT02442063|Mitosis Modulators|mitosis modulators|mesh-ancestor
25264169|NCT02442063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264170|NCT02442427|Palivizumab|palivizumab|mesh-list
25264171|NCT02442427|Antiviral Agents|antiviral agents|mesh-ancestor
25264172|NCT02442427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24691119|NCT01405144|Immunologic Factors|immunologic factors|mesh-ancestor
24691233|NCT01405586|Immunologic Factors|immunologic factors|mesh-ancestor
24691234|NCT01405586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612055|NCT01011751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24612056|NCT01011751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24612057|NCT01011751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691393|NCT01406392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691394|NCT01406392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24691395|NCT01406392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24691396|NCT01406392|Oxytocics|oxytocics|mesh-ancestor
24691398|NCT01406431|Pitavastatin|pitavastatin|mesh-list
24691399|NCT01406431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24691427|NCT01406522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691429|NCT01406522|Autonomic Agents|autonomic agents|mesh-ancestor
24691430|NCT01406522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24691431|NCT01406522|Nootropic Agents|nootropic agents|mesh-ancestor
24691432|NCT01406535|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24691433|NCT01406535|Vasodilator Agents|vasodilator agents|mesh-ancestor
24691434|NCT01406535|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24691435|NCT01406535|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24691442|NCT01406600|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24691443|NCT01406600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24691524|NCT01407484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24691525|NCT01407484|Glucocorticoids|glucocorticoids|mesh-ancestor
24691526|NCT01407484|Hormones|hormones|mesh-ancestor
24691527|NCT01407484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24691528|NCT01407484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691529|NCT01407484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24691530|NCT01407484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691531|NCT01407497|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24691540|NCT01407679|Alitretinoin|alitretinoin|mesh-list
24691541|NCT01407679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691542|NCT01407679|Dermatologic Agents|dermatologic agents|mesh-ancestor
24691632|NCT01408186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24691633|NCT01408186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855308|NCT02278861|Dermatologic Agents|dermatologic agents|mesh-ancestor
24855309|NCT02278861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855310|NCT02278861|Keratolytic Agents|keratolytic agents|mesh-ancestor
25264192|NCT02442128|Propofol|propofol|mesh-list
25264193|NCT02442128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25264194|NCT02442128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25264195|NCT02442128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264196|NCT02442128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25264197|NCT02442128|Anesthetics, General|anesthetics, general|mesh-ancestor
25264198|NCT02442128|Anesthetics|anesthetics|mesh-ancestor
25264199|NCT02442128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25264200|NCT02442128|Narcotics|narcotics|mesh-ancestor
25264201|NCT02442128|Analgesics|analgesics|mesh-ancestor
25264202|NCT02442128|Sensory System Agents|sensory system agents|mesh-ancestor
24456648|NCT00331851|Hormones|hormones|mesh-ancestor
24706487|NCT01490255|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24456649|NCT00331851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24456650|NCT00331851|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24456651|NCT00331851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24456652|NCT00331851|Immunologic Factors|immunologic factors|mesh-ancestor
24691634|NCT01408186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691635|NCT01408186|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24691636|NCT01408186|Histamine Antagonists|histamine antagonists|mesh-ancestor
24691638|NCT01408186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24691705|NCT01408797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691707|NCT01408810|Dermatologic Agents|dermatologic agents|mesh-ancestor
24691708|NCT01408810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24691717|NCT01408836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24691718|NCT01408836|Glucocorticoids|glucocorticoids|mesh-ancestor
24691720|NCT01408836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24691801|NCT01409148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24691802|NCT01409148|Immunologic Factors|immunologic factors|mesh-ancestor
24691803|NCT01409148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691804|NCT01409174|Interferons|interferons|mesh-list
24691805|NCT01409174|Interferon-alpha|interferon-alpha|mesh-list
24691806|NCT01409174|Interferon alpha-2|interferon alpha-2|mesh-list
24448844|NCT00313261|Clevudine|clevudine|mesh-list
24691836|NCT01409187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24691837|NCT01409187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24691838|NCT01409187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24691839|NCT01409187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691840|NCT01409187|Immunologic Factors|immunologic factors|mesh-ancestor
24691841|NCT01409187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691842|NCT01409187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24691843|NCT01409187|Analgesics|analgesics|mesh-ancestor
24691844|NCT01409187|Sensory System Agents|sensory system agents|mesh-ancestor
24691845|NCT01409187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24691846|NCT01409187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24691847|NCT01409187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24691848|NCT01409278|Ropivacaine|ropivacaine|mesh-list
24691849|NCT01409278|Anesthetics, Local|anesthetics, local|mesh-ancestor
24691850|NCT01409278|Anesthetics|anesthetics|mesh-ancestor
24691851|NCT01409278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24691880|NCT01409499|Sorafenib|sorafenib|mesh-list
24855311|NCT02278861|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24691951|NCT01409694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691952|NCT01409694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24691953|NCT01409694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24691955|NCT01409733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24691956|NCT01409733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691957|NCT01409733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24691958|NCT01409733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24691959|NCT01409733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264203|NCT02442128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25264204|NCT02442128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25264205|NCT02441933|Carboplatin|carboplatin|mesh-list
25264206|NCT02441933|Taxane|taxane|mesh-list
25264207|NCT02441933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25264208|NCT02441907|Aflibercept|aflibercept|mesh-list
25264209|NCT02441907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25264211|NCT02441907|Growth Substances|growth substances|mesh-ancestor
25264212|NCT02441907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767261|NCT01799486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24514524|NCT00591188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691960|NCT01409733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691961|NCT01409772|Ethanol|ethanol|mesh-list
24691962|NCT01409772|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24691963|NCT01409772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24692098|NCT01411176|Antipruritics|antipruritics|mesh-ancestor
25688679|NCT01949844|Purinergic Agonists|purinergic agonists|mesh-ancestor
25688680|NCT01949844|Purinergic Agents|purinergic agents|mesh-ancestor
25688681|NCT01949844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25688682|NCT01949844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688683|NCT01949844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688684|NCT01949870|Gemcitabine|gemcitabine|mesh-list
25688685|NCT01949870|Cisplatin|cisplatin|mesh-list
25688686|NCT01949870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688687|NCT01949870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25688688|NCT01949870|Antimetabolites|antimetabolites|mesh-ancestor
24562176|NCT00764907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24562177|NCT00764907|Antiemetics|antiemetics|mesh-ancestor
24562178|NCT00764907|Autonomic Agents|autonomic agents|mesh-ancestor
24562179|NCT00764907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24562180|NCT00764907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24692099|NCT01411176|Dermatologic Agents|dermatologic agents|mesh-ancestor
24692100|NCT01411189|Menthol|menthol|mesh-list
24692101|NCT01411189|Antipruritics|antipruritics|mesh-ancestor
24692102|NCT01411189|Dermatologic Agents|dermatologic agents|mesh-ancestor
24692103|NCT01411202|Doxycycline|doxycycline|mesh-list
24692104|NCT01411202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24908983|NCT04314193|Dermatologic Agents|dermatologic agents|mesh-ancestor
24692132|NCT01411410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692133|NCT01411410|Tubulin Modulators|tubulin modulators|mesh-ancestor
24692134|NCT01411410|Antimitotic Agents|antimitotic agents|mesh-ancestor
24692135|NCT01411410|Mitosis Modulators|mitosis modulators|mesh-ancestor
24692136|NCT01411410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692137|NCT01411423|Sorafenib|sorafenib|mesh-list
24692138|NCT01411423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612135|NCT01012141|Mitosis Modulators|mitosis modulators|mesh-ancestor
24612136|NCT01012141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612137|NCT01012193|Cilostazol|cilostazol|mesh-list
24612138|NCT01012193|Clopidogrel|clopidogrel|mesh-list
24612139|NCT01012193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24612140|NCT01012193|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24612141|NCT01012193|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24612143|NCT01012193|Purinergic Agents|purinergic agents|mesh-ancestor
24612144|NCT01012193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24612145|NCT01012193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264213|NCT02441907|Growth Inhibitors|growth inhibitors|mesh-ancestor
25264214|NCT02441907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25264215|NCT02441842|Atenolol|atenolol|mesh-list
25264216|NCT02441842|Lisinopril|lisinopril|mesh-list
25264217|NCT02441842|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25264218|NCT02441842|Protease Inhibitors|protease inhibitors|mesh-ancestor
25264219|NCT02441842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264220|NCT02441842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264221|NCT02441842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25264222|NCT02441842|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25264223|NCT02441842|Protective Agents|protective agents|mesh-ancestor
25264224|NCT02441842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264225|NCT02441842|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25264226|NCT02441842|Sympatholytics|sympatholytics|mesh-ancestor
25264227|NCT02441842|Autonomic Agents|autonomic agents|mesh-ancestor
25264228|NCT02441842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25264229|NCT02441842|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25264230|NCT02441842|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25264231|NCT02441842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25264232|NCT02441842|Adrenergic Agents|adrenergic agents|mesh-ancestor
24692224|NCT01412073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24692225|NCT01412073|Abortifacient Agents|abortifacient agents|mesh-ancestor
24692226|NCT01412073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24692227|NCT01412073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24855314|NCT02278913|Insulin|insulin|mesh-list
24855315|NCT02278913|Insulin Glargine|insulin glargine|mesh-list
25688689|NCT01949870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688690|NCT01949870|Antiviral Agents|antiviral agents|mesh-ancestor
25688691|NCT01949870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25688692|NCT01949870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688693|NCT01949870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25688694|NCT01949870|Immunologic Factors|immunologic factors|mesh-ancestor
25688695|NCT01949870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688696|NCT01950039|Betaine|betaine|mesh-list
25688697|NCT01950039|Glycine|glycine|mesh-list
25688698|NCT01950039|Glycine Agents|glycine agents|mesh-ancestor
25688699|NCT01950039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24457788|NCT00335231|Gatifloxacin|gatifloxacin|mesh-list
24692315|NCT01412840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24692316|NCT01412840|Analgesics|analgesics|mesh-ancestor
25692634|NCT02003365|Hormones|hormones|mesh-ancestor
24562386|NCT00766246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562388|NCT00766285|Immunologic Factors|immunologic factors|mesh-ancestor
24692317|NCT01412840|Sensory System Agents|sensory system agents|mesh-ancestor
24692318|NCT01412840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24692319|NCT01412840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692320|NCT01412840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24692321|NCT01412840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24692352|NCT01413048|Adrenergic Agents|adrenergic agents|mesh-ancestor
24692353|NCT01413048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24692354|NCT01413048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692355|NCT01413048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692356|NCT01413048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24640726|NCT01169805|Ondansetron|ondansetron|mesh-list
24692417|NCT01413711|GABA Agents|gaba agents|mesh-ancestor
24692418|NCT01413711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24692419|NCT01413711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692420|NCT01413763|Imiquimod|imiquimod|mesh-list
24692421|NCT01413763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24692485|NCT01414569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24692486|NCT01414569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24692521|NCT01414881|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24692522|NCT01414881|Antimetabolites|antimetabolites|mesh-ancestor
24692523|NCT01414881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692524|NCT01414881|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24692525|NCT01414972|Vitamin A|vitamin a|mesh-list
24692526|NCT01414972|Vitamins|vitamins|mesh-ancestor
24692527|NCT01414972|Micronutrients|micronutrients|mesh-ancestor
24692528|NCT01414972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692529|NCT01414998|Nicotine|nicotine|mesh-list
24692530|NCT01414998|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24692729|NCT01416038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24692730|NCT01416116|Lidocaine|lidocaine|mesh-list
24692731|NCT01416116|Tramadol|tramadol|mesh-list
24692732|NCT01416116|Capsaicin|capsaicin|mesh-list
24692733|NCT01416116|Anesthetics, Local|anesthetics, local|mesh-ancestor
24692734|NCT01416116|Anesthetics|anesthetics|mesh-ancestor
24692735|NCT01416116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24692736|NCT01416116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692737|NCT01416116|Sensory System Agents|sensory system agents|mesh-ancestor
24692738|NCT01416116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24692739|NCT01416116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24692740|NCT01416116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24692771|NCT01416220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24692773|NCT01416220|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24692774|NCT01416220|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25264236|NCT02441894|Dexamethasone|dexamethasone|mesh-list
25264237|NCT02441894|Prednisolone|prednisolone|mesh-list
25264238|NCT02441894|Ondansetron|ondansetron|mesh-list
25264239|NCT02441894|Metoclopramide|metoclopramide|mesh-list
24692775|NCT01416220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24692776|NCT01416246|Anti-Infective Agents|anti-infective agents|mesh-list
24612201|NCT01012479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24612202|NCT01012479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612203|NCT01012479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24612204|NCT01012479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24612205|NCT01012544|Clopidogrel|clopidogrel|mesh-list
24612206|NCT01012544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24612207|NCT01012544|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24612208|NCT01012544|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24612209|NCT01012544|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24612210|NCT01012544|Purinergic Agents|purinergic agents|mesh-ancestor
24612211|NCT01012544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24612212|NCT01012544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612213|NCT01012544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688700|NCT01950039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688701|NCT01950039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562459|NCT00766545|Cilostazol|cilostazol|mesh-list
24612214|NCT01012570|Adalimumab|adalimumab|mesh-list
24612215|NCT01012570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24612217|NCT01012687|Perindopril|perindopril|mesh-list
24612218|NCT01012687|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24612219|NCT01012687|Protease Inhibitors|protease inhibitors|mesh-ancestor
24612220|NCT01012687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612221|NCT01012687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612222|NCT01012687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24692964|NCT01417494|Oxaliplatin|oxaliplatin|mesh-list
24692965|NCT01417494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24692966|NCT01417494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692967|NCT01417494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24692968|NCT01417494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24692969|NCT01417494|Growth Substances|growth substances|mesh-ancestor
24693001|NCT01417754|Hormone Antagonists|hormone antagonists|mesh-ancestor
24693048|NCT01418118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24693168|NCT01418586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24693169|NCT01418586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693170|NCT01418586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693171|NCT01418586|Urological Agents|urological agents|mesh-ancestor
24693173|NCT01418599|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24693174|NCT01418599|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24693175|NCT01418599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24693176|NCT01418599|Adrenergic Agents|adrenergic agents|mesh-ancestor
24693177|NCT01418599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24693178|NCT01418599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693179|NCT01418599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693234|NCT01418794|Antifungal Agents|antifungal agents|mesh-ancestor
24693235|NCT01418794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24693236|NCT01418794|Immunologic Factors|immunologic factors|mesh-ancestor
24693237|NCT01418794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693238|NCT01419041|Crizotinib|crizotinib|mesh-list
24693239|NCT01419041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24693240|NCT01419041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24693241|NCT01419041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693242|NCT01419041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693243|NCT01419119|Cholecalciferol|cholecalciferol|mesh-list
24693244|NCT01419119|Vitamin D|vitamin d|mesh-list
24693245|NCT01419119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25264240|NCT02441894|Granisetron|granisetron|mesh-list
25264241|NCT02441894|Ranitidine|ranitidine|mesh-list
25264242|NCT02441894|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
25264243|NCT02441894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25264244|NCT02441894|Antiemetics|antiemetics|mesh-ancestor
25264245|NCT02441894|Autonomic Agents|autonomic agents|mesh-ancestor
25264246|NCT02441894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25264247|NCT02441894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264248|NCT02441894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24455510|NCT00327587|Diuretics|diuretics|mesh-ancestor
24455511|NCT00327587|Natriuretic Agents|natriuretic agents|mesh-ancestor
24455512|NCT00327587|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24455550|NCT00327756|Micronutrients|micronutrients|mesh-ancestor
24455551|NCT00327756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855329|NCT02278978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693246|NCT01419119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24693247|NCT01419119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693248|NCT01419119|Vitamins|vitamins|mesh-ancestor
24693249|NCT01419119|Micronutrients|micronutrients|mesh-ancestor
24693250|NCT01419119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24693371|NCT01420094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24693373|NCT01420094|Sensory System Agents|sensory system agents|mesh-ancestor
24693374|NCT01420094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24693375|NCT01420094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693376|NCT01420094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24693377|NCT01420094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24693378|NCT01420094|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24693379|NCT01420094|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24693380|NCT01420094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693381|NCT01420094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25688702|NCT01950039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25688703|NCT01950039|Lipotropic Agents|lipotropic agents|mesh-ancestor
24448577|NCT00312260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24448578|NCT00312260|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24448579|NCT00312260|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24448580|NCT00312260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24448581|NCT00312260|Adrenergic Agents|adrenergic agents|mesh-ancestor
24562609|NCT00767286|Cobalt|cobalt|mesh-list
24562610|NCT00767286|Goserelin|goserelin|mesh-list
24693382|NCT01420094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24693383|NCT01420094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693384|NCT01420094|Antipyretics|antipyretics|mesh-ancestor
24693385|NCT01420159|Methoxyflurane|methoxyflurane|mesh-list
24693386|NCT01420159|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24693387|NCT01420159|Anesthetics, General|anesthetics, general|mesh-ancestor
24693388|NCT01420159|Anesthetics|anesthetics|mesh-ancestor
24693389|NCT01420159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24693390|NCT01420159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693392|NCT01420250|Hormones|hormones|mesh-list
24612292|NCT01013272|Entecavir|entecavir|mesh-list
24612293|NCT01013272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24612294|NCT01013272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24612295|NCT01013272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612296|NCT01013272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264249|NCT02441894|Glucocorticoids|glucocorticoids|mesh-ancestor
25264250|NCT02441894|Hormones|hormones|mesh-ancestor
25264251|NCT02441894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25264252|NCT02441894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25264253|NCT02441894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25264254|NCT02441894|Antipruritics|antipruritics|mesh-ancestor
25264255|NCT02441894|Dermatologic Agents|dermatologic agents|mesh-ancestor
25264256|NCT02441894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25264257|NCT02441894|Serotonin Agents|serotonin agents|mesh-ancestor
25264258|NCT02441894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25264259|NCT02441894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264260|NCT02441894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25264261|NCT02441894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25264262|NCT02441894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25264263|NCT02441894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25264264|NCT02441894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25264265|NCT02441894|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25264266|NCT02441894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25264267|NCT02441894|Anesthetics, Local|anesthetics, local|mesh-ancestor
25264268|NCT02441894|Anesthetics|anesthetics|mesh-ancestor
25264269|NCT02441894|Sensory System Agents|sensory system agents|mesh-ancestor
24455552|NCT00327756|Vitamins|vitamins|mesh-ancestor
24453526|NCT04942340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24453527|NCT04942340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24453528|NCT04942340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24453529|NCT04942340|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24453530|NCT04942340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24453531|NCT04942340|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24612297|NCT01013272|Antiviral Agents|antiviral agents|mesh-ancestor
24612298|NCT01013272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24612299|NCT01013272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24612300|NCT01013272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24612301|NCT01013402|Insulin|insulin|mesh-list
24612302|NCT01013402|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24612303|NCT01013402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24612304|NCT01013402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693496|NCT01420822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24693497|NCT01420822|Respiratory System Agents|respiratory system agents|mesh-ancestor
24693498|NCT01420822|Dermatologic Agents|dermatologic agents|mesh-ancestor
24693541|NCT01421069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24693542|NCT01421069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693543|NCT01421069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25688704|NCT01950039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25688705|NCT01950039|Antimetabolites|antimetabolites|mesh-ancestor
25688706|NCT01950039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25688707|NCT01950169|Vitamin D|vitamin d|mesh-list
25688708|NCT01950169|Cholecalciferol|cholecalciferol|mesh-list
25688709|NCT01950169|Risedronic Acid|risedronic acid|mesh-list
25688710|NCT01950169|Diphosphonates|diphosphonates|mesh-list
25688711|NCT01950169|Calcium|calcium|mesh-list
25688712|NCT01950169|Vitamins|vitamins|mesh-ancestor
24693545|NCT01421069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24693546|NCT01421069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24693547|NCT01421069|Immunologic Factors|immunologic factors|mesh-ancestor
24693548|NCT01421121|Vaccines|vaccines|mesh-list
24693549|NCT01421121|Immunologic Factors|immunologic factors|mesh-ancestor
24693550|NCT01421121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693551|NCT01421160|Citric Acid|citric acid|mesh-list
24693552|NCT01421160|Sodium Citrate|sodium citrate|mesh-list
24693589|NCT01421173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24693590|NCT01421173|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24855332|NCT02279121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24693981|NCT01423240|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24612345|NCT01013532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24612346|NCT01013532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24612347|NCT01013532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24612348|NCT01013532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24612349|NCT01013532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612350|NCT01013532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24612351|NCT01013532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24612352|NCT01013532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612354|NCT01013532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24612355|NCT01013532|Autonomic Agents|autonomic agents|mesh-ancestor
24612356|NCT01013532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24612357|NCT01013532|Respiratory System Agents|respiratory system agents|mesh-ancestor
24612358|NCT01013532|Vasodilator Agents|vasodilator agents|mesh-ancestor
24612359|NCT01013532|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24909452|NCT04308850|Vitamin D|vitamin d|mesh-list
24855337|NCT02279134|Nedaplatin|nedaplatin|mesh-list
24855338|NCT02279134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24855339|NCT02279134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855340|NCT02279134|Tubulin Modulators|tubulin modulators|mesh-ancestor
24694068|NCT01423708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694069|NCT01423708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24694113|NCT01423864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694115|NCT01423864|Protective Agents|protective agents|mesh-ancestor
24694116|NCT01423864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24694117|NCT01423864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694118|NCT01423864|Antiemetics|antiemetics|mesh-ancestor
24694119|NCT01423864|Autonomic Agents|autonomic agents|mesh-ancestor
24694120|NCT01423864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24694121|NCT01423864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24694122|NCT01423955|Epoetin Alfa|epoetin alfa|mesh-list
24694123|NCT01423955|Hematinics|hematinics|mesh-ancestor
24694124|NCT01424046|Insulin Glargine|insulin glargine|mesh-list
24694125|NCT01424046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25264270|NCT02441894|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25264271|NCT02441894|Histamine Antagonists|histamine antagonists|mesh-ancestor
25264272|NCT02441894|Histamine Agents|histamine agents|mesh-ancestor
25264273|NCT02441894|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25264274|NCT02441894|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25264275|NCT02441894|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25264276|NCT02441894|Dopamine Agents|dopamine agents|mesh-ancestor
25264277|NCT02441894|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25264278|NCT02441894|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24453532|NCT04942340|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24453533|NCT04942340|Purinergic Agents|purinergic agents|mesh-ancestor
24455565|NCT00327769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455567|NCT00327808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24455568|NCT00327808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24455570|NCT00327808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24455571|NCT00327808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455572|NCT00327808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24455573|NCT00327808|Respiratory System Agents|respiratory system agents|mesh-ancestor
24455576|NCT00327808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25155620|NCT05323552|Curare|curare|mesh-list
24455589|NCT00327847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24455593|NCT00327990|Alendronate|alendronate|mesh-list
24455594|NCT00327990|Ibandronic Acid|ibandronic acid|mesh-list
25688713|NCT01950169|Micronutrients|micronutrients|mesh-ancestor
25688714|NCT01950169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688715|NCT01950169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24562676|NCT00767689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455595|NCT00327990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24694126|NCT01424046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694127|NCT01424111|Citalopram|citalopram|mesh-list
24694128|NCT01424111|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24694129|NCT01424111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24694130|NCT01424111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24694131|NCT01424111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694132|NCT01424111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24694143|NCT01424124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24694144|NCT01424124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694145|NCT01424124|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24694146|NCT01424124|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24694147|NCT01424124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694148|NCT01424137|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24694149|NCT01424137|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24694150|NCT01424137|Autonomic Agents|autonomic agents|mesh-ancestor
24694151|NCT01424137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24694152|NCT01424137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694153|NCT01424137|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24694306|NCT01424839|Alkylating Agents|alkylating agents|mesh-ancestor
24694307|NCT01424891|Simvastatin|simvastatin|mesh-list
24696255|NCT01428388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696372|NCT01429025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696374|NCT01429090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24696400|NCT01429337|Midostaurin|midostaurin|mesh-list
24696401|NCT01429337|Staurosporine|staurosporine|mesh-list
24696402|NCT01429337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24696403|NCT01429337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24696404|NCT01429337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264279|NCT02441660|Capsaicin|capsaicin|mesh-list
25264280|NCT02441660|Antipruritics|antipruritics|mesh-ancestor
25264281|NCT02441660|Dermatologic Agents|dermatologic agents|mesh-ancestor
25264282|NCT02441660|Sensory System Agents|sensory system agents|mesh-ancestor
25264283|NCT02441660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25264284|NCT02441660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264285|NCT02441673|Ephedrine|ephedrine|mesh-list
25264286|NCT02441673|Meperidine|meperidine|mesh-list
25264287|NCT02441673|Tramadol|tramadol|mesh-list
25264288|NCT02441673|Nefopam|nefopam|mesh-list
25264289|NCT02441673|Metoclopramide|metoclopramide|mesh-list
25264290|NCT02441673|Ranitidine|ranitidine|mesh-list
25264291|NCT02441673|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
25264292|NCT02441673|Oxytocin|oxytocin|mesh-list
25264293|NCT02441673|Oxytocics|oxytocics|mesh-ancestor
25264294|NCT02441673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25264295|NCT02441673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264296|NCT02441673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25264297|NCT02441673|Narcotics|narcotics|mesh-ancestor
25264298|NCT02441673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25264299|NCT02441673|Analgesics|analgesics|mesh-ancestor
25264300|NCT02441673|Sensory System Agents|sensory system agents|mesh-ancestor
25264301|NCT02441673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25264302|NCT02441673|Antiemetics|antiemetics|mesh-ancestor
24455596|NCT00327990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455599|NCT00328029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455600|NCT00328029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24455601|NCT00328029|Immunologic Factors|immunologic factors|mesh-ancestor
24455602|NCT00328029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455603|NCT00328029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24455604|NCT00328029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24455605|NCT00328029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24455606|NCT00328107|Hemagglutinins|hemagglutinins|mesh-list
24455607|NCT00328107|Agglutinins|agglutinins|mesh-ancestor
24455640|NCT00328367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24455641|NCT00328367|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24455642|NCT00328367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24455644|NCT00328380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24455645|NCT00328380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24455646|NCT00328380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24455648|NCT00328393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24455649|NCT00328393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548468|NCT00709644|Contraceptive Agents|contraceptive agents|mesh-ancestor
24455651|NCT00328432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24455652|NCT00328432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24455653|NCT00328432|Analgesics|analgesics|mesh-ancestor
24455654|NCT00328432|Sensory System Agents|sensory system agents|mesh-ancestor
24696405|NCT01429337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696406|NCT01429402|Botulinum Toxins|botulinum toxins|mesh-list
24696408|NCT01429402|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24855347|NCT02279147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855348|NCT02279147|Cholinergic Agents|cholinergic agents|mesh-ancestor
24696493|NCT01429714|Adrenergic Agents|adrenergic agents|mesh-ancestor
24696494|NCT01429714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24696495|NCT01429714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612663|NCT01014858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612665|NCT01014858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24612666|NCT01014858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612667|NCT01014858|Nootropic Agents|nootropic agents|mesh-ancestor
24612668|NCT01015040|Solifenacin Succinate|solifenacin succinate|mesh-list
24612669|NCT01015040|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24612670|NCT01015040|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24612702|NCT01015196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612703|NCT01015196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24612704|NCT01015196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24612705|NCT01015196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612706|NCT01015196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696575|NCT01430052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24696576|NCT01430052|Immunologic Factors|immunologic factors|mesh-ancestor
24696577|NCT01430052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696578|NCT01430065|Tacrolimus|tacrolimus|mesh-list
25264303|NCT02441673|Autonomic Agents|autonomic agents|mesh-ancestor
25264304|NCT02441673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25264305|NCT02441673|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25264306|NCT02441673|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25264307|NCT02441673|Dopamine Agents|dopamine agents|mesh-ancestor
25264308|NCT02441673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25264309|NCT02441673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264310|NCT02441673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25264311|NCT02441673|Sympathomimetics|sympathomimetics|mesh-ancestor
25264312|NCT02441673|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25264313|NCT02441673|Adrenergic Agents|adrenergic agents|mesh-ancestor
25264314|NCT02441673|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25264315|NCT02441673|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25264316|NCT02441673|Histamine Antagonists|histamine antagonists|mesh-ancestor
25264317|NCT02441673|Histamine Agents|histamine agents|mesh-ancestor
25264318|NCT02441673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25264319|NCT02441673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25264320|NCT02441803|Cytarabine|cytarabine|mesh-list
25264321|NCT02441803|Mycophenolic Acid|mycophenolic acid|mesh-list
25264322|NCT02441803|Cyclophosphamide|cyclophosphamide|mesh-list
25264323|NCT02441803|Busulfan|busulfan|mesh-list
25264324|NCT02441803|Fludarabine|fludarabine|mesh-list
25264325|NCT02441803|Fludarabine phosphate|fludarabine phosphate|mesh-list
25264326|NCT02441803|Decitabine|decitabine|mesh-list
25264327|NCT02441803|Idarubicin|idarubicin|mesh-list
24455655|NCT00328432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24455656|NCT00328432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455658|NCT00328432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24455659|NCT00328432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24455660|NCT00328432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24455661|NCT00328432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24455662|NCT00328432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455663|NCT00328458|Epothilones|epothilones|mesh-list
24455664|NCT00328458|Epothilone B|epothilone b|mesh-list
24514824|NCT00593099|Bupropion|bupropion|mesh-list
24455666|NCT00328458|Antimitotic Agents|antimitotic agents|mesh-ancestor
24533363|NCT00643357|Sensory System Agents|sensory system agents|mesh-ancestor
24696579|NCT01430065|Peficitinib|peficitinib|mesh-list
24696661|NCT01430793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696662|NCT01430793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24696663|NCT01430793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24696664|NCT01430806|Dronedarone|dronedarone|mesh-list
24696666|NCT01430910|Ceftazidime|ceftazidime|mesh-list
24696704|NCT01431092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24696705|NCT01431118|Camphor|camphor|mesh-list
24696706|NCT01431118|Salicylates|salicylates|mesh-list
24696707|NCT01431118|Methyl salicylate|methyl salicylate|mesh-list
24696708|NCT01431118|Menthol|menthol|mesh-list
24696709|NCT01431118|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24696710|NCT01431118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24696711|NCT01431118|Antipruritics|antipruritics|mesh-ancestor
24696712|NCT01431118|Dermatologic Agents|dermatologic agents|mesh-ancestor
24696713|NCT01431118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24696714|NCT01431118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24696715|NCT01431118|Analgesics|analgesics|mesh-ancestor
24696939|NCT01431924|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24696940|NCT01431924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24696941|NCT01431924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24697329|NCT01434160|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24697391|NCT01434303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24697392|NCT01434303|Trastuzumab|trastuzumab|mesh-list
24697394|NCT01434303|Entinostat|entinostat|mesh-list
24697395|NCT01434303|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
24697396|NCT01434303|Antibodies|antibodies|mesh-list
24697397|NCT01434303|Immunoglobulins|immunoglobulins|mesh-list
24697398|NCT01434303|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24697399|NCT01434303|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
24697400|NCT01434303|Immunologic Factors|immunologic factors|mesh-ancestor
24697401|NCT01434303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697406|NCT01434381|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24697961|NCT01438021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24699721|NCT01448720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24697962|NCT01438021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24697964|NCT01438086|Growth Substances|growth substances|mesh-ancestor
24697965|NCT01438086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697966|NCT01438112|Gemcitabine|gemcitabine|mesh-list
24697967|NCT01438112|Interferons|interferons|mesh-list
24697968|NCT01438112|Mitomycins|mitomycins|mesh-list
24697969|NCT01438112|Mitomycin|mitomycin|mesh-list
24697970|NCT01438112|Valrubicin|valrubicin|mesh-list
24697971|NCT01438112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24697972|NCT01438112|Antimetabolites|antimetabolites|mesh-ancestor
24698317|NCT01440582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24698318|NCT01440582|Growth Substances|growth substances|mesh-ancestor
25264328|NCT02441803|Clofarabine|clofarabine|mesh-list
25264329|NCT02441803|Tacrolimus|tacrolimus|mesh-list
25264330|NCT02441803|Thymoglobulin|thymoglobulin|mesh-list
25264331|NCT02441803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25264332|NCT02441803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25264333|NCT02441803|Immunologic Factors|immunologic factors|mesh-ancestor
25264334|NCT02441803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264335|NCT02441803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25264336|NCT02441803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25264337|NCT02441803|Alkylating Agents|alkylating agents|mesh-ancestor
25264338|NCT02441803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264339|NCT02441803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25264340|NCT02441803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25264341|NCT02441803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25264342|NCT02441803|Antimetabolites|antimetabolites|mesh-ancestor
24455761|NCT00328900|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24455762|NCT00328900|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24455763|NCT00328900|Cholinergic Agents|cholinergic agents|mesh-ancestor
24455769|NCT00328913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24455772|NCT00328939|Fondaparinux|fondaparinux|mesh-list
24455773|NCT00328939|Anticoagulants|anticoagulants|mesh-ancestor
24455774|NCT00328939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24455775|NCT00328939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24937935|NCT04023760|Apixaban|apixaban|mesh-list
24698319|NCT01440582|Growth Inhibitors|growth inhibitors|mesh-ancestor
24698320|NCT01440582|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24698321|NCT01440582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698323|NCT01440608|Albendazole|albendazole|mesh-list
24855359|NCT02279186|Coagulants|coagulants|mesh-ancestor
24855360|NCT02279316|Vitamin D|vitamin d|mesh-list
24524764|NCT04377204|Lidocaine|lidocaine|mesh-list
24562862|NCT00768638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698486|NCT01441427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24698487|NCT01441427|Immunologic Factors|immunologic factors|mesh-ancestor
24698523|NCT01441531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24698524|NCT01441531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698525|NCT01441531|Antimanic Agents|antimanic agents|mesh-ancestor
24698526|NCT01441557|Amifampridine|amifampridine|mesh-list
24698527|NCT01441557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24698528|NCT01441557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24698644|NCT01442428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24698645|NCT01442428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698646|NCT01442428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24698647|NCT01442428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24698648|NCT01442428|Analgesics|analgesics|mesh-ancestor
24698649|NCT01442428|Sensory System Agents|sensory system agents|mesh-ancestor
24698650|NCT01442428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24698651|NCT01442428|Gout Suppressants|gout suppressants|mesh-ancestor
24698652|NCT01442428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24698653|NCT01442519|Mitomycins|mitomycins|mesh-list
24698654|NCT01442519|Mitomycin|mitomycin|mesh-list
24698655|NCT01442519|BCG Vaccine|bcg vaccine|mesh-list
24698656|NCT01442519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24698657|NCT01442519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698694|NCT01442610|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24698721|NCT01442727|Sodium Selenite|sodium selenite|mesh-list
24698883|NCT01443247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698884|NCT01443325|Lidocaine|lidocaine|mesh-list
24698885|NCT01443325|Anesthetics, Local|anesthetics, local|mesh-ancestor
24698886|NCT01443325|Anesthetics|anesthetics|mesh-ancestor
24698887|NCT01443325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24698888|NCT01443325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698889|NCT01443325|Sensory System Agents|sensory system agents|mesh-ancestor
24698890|NCT01443325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24698891|NCT01443325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24698892|NCT01443325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24698893|NCT01443325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24698894|NCT01443325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24698926|NCT01443572|Desflurane|desflurane|mesh-list
25264343|NCT02441803|Antiviral Agents|antiviral agents|mesh-ancestor
25264344|NCT02441803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25264345|NCT02441803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25264346|NCT02441803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264347|NCT02441803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25264348|NCT02441803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25264349|NCT02441803|Antitubercular Agents|antitubercular agents|mesh-ancestor
25264350|NCT02441803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25264351|NCT02441803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25264352|NCT02441803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25264353|NCT02441816|Aflibercept|aflibercept|mesh-list
25264354|NCT02441816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24801203|NCT01981746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24548860|NCT00712452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25264355|NCT02441816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25264356|NCT02441816|Growth Substances|growth substances|mesh-ancestor
25264357|NCT02441816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455776|NCT00328939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455777|NCT00328939|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24698927|NCT01443572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24698930|NCT01443572|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24698982|NCT01444118|Alkylating Agents|alkylating agents|mesh-ancestor
24698983|NCT01444118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698984|NCT01444118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698985|NCT01444118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24698986|NCT01444118|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24698987|NCT01444131|Nicotine|nicotine|mesh-list
24698988|NCT01444131|Varenicline|varenicline|mesh-list
24698989|NCT01444131|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24698990|NCT01444131|Autonomic Agents|autonomic agents|mesh-ancestor
24698991|NCT01444131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24699074|NCT01444807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688716|NCT01950169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24699075|NCT01444807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24699077|NCT01444807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699078|NCT01444833|Candesartan|candesartan|mesh-list
24699079|NCT01444833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24699080|NCT01444833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24699081|NCT01444833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24699082|NCT01444833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699083|NCT01444846|Ebselen|ebselen|mesh-list
24699084|NCT01444846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24699085|NCT01444846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24699086|NCT01444846|Analgesics|analgesics|mesh-ancestor
24699087|NCT01444846|Sensory System Agents|sensory system agents|mesh-ancestor
24699088|NCT01444846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24699089|NCT01444846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699090|NCT01444846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24699091|NCT01444846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24699092|NCT01444846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24699093|NCT01444846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24699094|NCT01444846|Antioxidants|antioxidants|mesh-ancestor
24699095|NCT01444846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855373|NCT02279381|Disinfectants|disinfectants|mesh-ancestor
24699099|NCT01444846|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24699100|NCT01444885|Amlodipine|amlodipine|mesh-list
24699101|NCT01444885|Nitroglycerin|nitroglycerin|mesh-list
24699102|NCT01444885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24699103|NCT01444885|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24699104|NCT01444885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24699105|NCT01444885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699112|NCT01444976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699113|NCT01444976|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24699114|NCT01444976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24699115|NCT01444976|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24699146|NCT01445223|Efavirenz|efavirenz|mesh-list
24699147|NCT01445223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24699148|NCT01445223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24699149|NCT01445223|Protease Inhibitors|protease inhibitors|mesh-ancestor
24699150|NCT01445223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699151|NCT01445223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699152|NCT01445223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24699153|NCT01445223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24699154|NCT01445223|Antiviral Agents|antiviral agents|mesh-ancestor
24699155|NCT01445223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24548861|NCT00712452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24699156|NCT01445223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24699157|NCT01445223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24699158|NCT01445223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24699159|NCT01445223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24699160|NCT01445223|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24699200|NCT01445392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24699201|NCT01445392|Immunologic Factors|immunologic factors|mesh-ancestor
24699202|NCT01445392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699259|NCT01445756|Anesthetics|anesthetics|mesh-ancestor
25264358|NCT02441816|Growth Inhibitors|growth inhibitors|mesh-ancestor
25264359|NCT02441816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25264360|NCT02441439|Iron|iron|mesh-list
24455779|NCT00328939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24455781|NCT00328939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24455782|NCT00328965|Lacidipine|lacidipine|mesh-list
24455783|NCT00328965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24455784|NCT00328965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24455785|NCT00328965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24455788|NCT00328965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416467|NCT00203138|Rasagiline|rasagiline|mesh-list
24455839|NCT00329147|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24455840|NCT00329147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24455841|NCT00329147|Adrenergic Agents|adrenergic agents|mesh-ancestor
24455842|NCT00329173|Atorvastatin|atorvastatin|mesh-list
24455843|NCT00329173|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24455844|NCT00329173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24455845|NCT00329173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24455846|NCT00329173|Antimetabolites|antimetabolites|mesh-ancestor
24455847|NCT00329173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455848|NCT00329173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24937950|NCT04023617|Docetaxel|docetaxel|mesh-list
24699260|NCT01445756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24699261|NCT01445756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699262|NCT01445756|Sensory System Agents|sensory system agents|mesh-ancestor
24699263|NCT01445756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24699264|NCT01445756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24699265|NCT01445756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24699266|NCT01445756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24699267|NCT01445756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24699268|NCT01445756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699270|NCT01445860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24699271|NCT01445860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24699272|NCT01445860|Antimetabolites|antimetabolites|mesh-ancestor
24699273|NCT01445860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699274|NCT01445860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24699305|NCT01446107|Cariostatic Agents|cariostatic agents|mesh-ancestor
24699306|NCT01446107|Protective Agents|protective agents|mesh-ancestor
24699307|NCT01446107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699308|NCT01446120|Insulin|insulin|mesh-list
24855384|NCT02279394|Hormones|hormones|mesh-ancestor
24699317|NCT01446211|Methotrexate|methotrexate|mesh-list
24699354|NCT01446328|Antiemetics|antiemetics|mesh-ancestor
24699386|NCT01446445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699388|NCT01446458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24699389|NCT01446484|Cyclosporine|cyclosporine|mesh-list
24699390|NCT01446484|Sirolimus|sirolimus|mesh-list
24699391|NCT01446484|Mycophenolic Acid|mycophenolic acid|mesh-list
24699392|NCT01446484|Everolimus|everolimus|mesh-list
24699393|NCT01446484|Alemtuzumab|alemtuzumab|mesh-list
24699394|NCT01446484|Tacrolimus|tacrolimus|mesh-list
24699395|NCT01446484|Cyclosporins|cyclosporins|mesh-list
24612985|NCT01016158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24699407|NCT01446484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24699408|NCT01446484|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24699409|NCT01446484|Antitubercular Agents|antitubercular agents|mesh-ancestor
24699434|NCT01446679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708658|NCT01501916|Vitamin D|vitamin d|mesh-list
25264361|NCT02441439|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25264362|NCT02441439|Trace Elements|trace elements|mesh-ancestor
25264363|NCT02441439|Micronutrients|micronutrients|mesh-ancestor
25264364|NCT02441439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264365|NCT02441439|Hematinics|hematinics|mesh-ancestor
25264366|NCT02441465|Vemurafenib|vemurafenib|mesh-list
25264367|NCT02441465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25264368|NCT02441465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25264369|NCT02441465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264370|NCT02441465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264371|NCT02441530|Vitamin D|vitamin d|mesh-list
25264372|NCT02441530|Vitamins|vitamins|mesh-list
25264373|NCT02441530|Vitamin E|vitamin e|mesh-list
25264374|NCT02441530|Ibuprofen|ibuprofen|mesh-list
25264375|NCT02441530|Micronutrients|micronutrients|mesh-ancestor
25264376|NCT02441530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264377|NCT02441530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25264378|NCT02441530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25264379|NCT02441530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25264380|NCT02441530|Analgesics|analgesics|mesh-ancestor
24455849|NCT00329173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24455850|NCT00329173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24455865|NCT00329264|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24455866|NCT00329264|Antidepressive Agents|antidepressive agents|mesh-ancestor
24455867|NCT00329264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24699436|NCT01446679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24909670|NCT04306276|Dienogest|dienogest|mesh-list
24699507|NCT01447212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24699508|NCT01447212|Narcotics|narcotics|mesh-ancestor
24699509|NCT01447212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24699541|NCT01447485|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24699542|NCT01447485|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24699543|NCT01447485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699545|NCT01447550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24699546|NCT01447550|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24699547|NCT01447550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699628|NCT01448174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563087|NCT00770042|Ketoconazole|ketoconazole|mesh-list
24699629|NCT01448174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24699630|NCT01448174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24699632|NCT01448239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24699633|NCT01448239|Immunologic Factors|immunologic factors|mesh-ancestor
24699634|NCT01448239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699635|NCT01448291|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24855396|NCT02279511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24855397|NCT02279511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855398|NCT02279511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24855399|NCT02279511|Vasodilator Agents|vasodilator agents|mesh-ancestor
24855400|NCT02279511|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24855401|NCT02279511|Purinergic Agonists|purinergic agonists|mesh-ancestor
24855402|NCT02279511|Purinergic Agents|purinergic agents|mesh-ancestor
24855403|NCT02279511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24855404|NCT02279511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855405|NCT02279537|Aflibercept|aflibercept|mesh-list
24699636|NCT01448291|Etonogestrel|etonogestrel|mesh-list
24699637|NCT01448291|NuvaRing|nuvaring|mesh-list
24801224|NCT01981889|Glucocorticoids|glucocorticoids|mesh-ancestor
24699638|NCT01448291|Contraceptive Agents|contraceptive agents|mesh-list
24699639|NCT01448291|Estradiol|estradiol|mesh-list
24699640|NCT01448291|Estrogens|estrogens|mesh-ancestor
24699641|NCT01448291|Hormones|hormones|mesh-ancestor
24699642|NCT01448291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24699714|NCT01448720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24699715|NCT01448720|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24699716|NCT01448720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24699717|NCT01448720|Serotonin Agents|serotonin agents|mesh-ancestor
24699718|NCT01448720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24699719|NCT01448720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699720|NCT01448720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24699723|NCT01448733|Clindamycin|clindamycin|mesh-list
24699724|NCT01448733|Clindamycin palmitate|clindamycin palmitate|mesh-list
24699725|NCT01448733|Clindamycin phosphate|clindamycin phosphate|mesh-list
24699727|NCT01448733|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24699728|NCT01448733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24699729|NCT01448733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24699730|NCT01448733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24699731|NCT01448733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613035|NCT01016639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24699741|NCT01448746|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24699742|NCT01448746|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24699743|NCT01448746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699744|NCT01448772|Dronabinol|dronabinol|mesh-list
24699745|NCT01448772|Hallucinogens|hallucinogens|mesh-ancestor
24699746|NCT01448772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699747|NCT01448772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25264381|NCT02441530|Sensory System Agents|sensory system agents|mesh-ancestor
25264382|NCT02441530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25264383|NCT02441530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25264384|NCT02441530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25264385|NCT02441530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25264386|NCT02441530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24455869|NCT00329264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24455870|NCT00329264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24455871|NCT00329264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699748|NCT01448772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24699749|NCT01448772|Analgesics|analgesics|mesh-ancestor
24699750|NCT01448772|Sensory System Agents|sensory system agents|mesh-ancestor
24699751|NCT01448772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24699766|NCT01448837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24699767|NCT01448837|Adrenergic Agents|adrenergic agents|mesh-ancestor
24699796|NCT01449110|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24699797|NCT01449123|Mannitol|mannitol|mesh-list
24699798|NCT01449123|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25688717|NCT01950169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25688718|NCT01950169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25688719|NCT01950169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688720|NCT01950260|Hormones|hormones|mesh-list
24699801|NCT01449123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699802|NCT01449136|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24699803|NCT01449136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24699804|NCT01449188|Moxifloxacin|moxifloxacin|mesh-list
24699805|NCT01449188|Ondansetron|ondansetron|mesh-list
24699806|NCT01449188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24699807|NCT01449188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24699808|NCT01449188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24699809|NCT01449188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24699810|NCT01449188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699811|NCT01449188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699812|NCT01449188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24699813|NCT01449188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699835|NCT01449253|Urological Agents|urological agents|mesh-ancestor
24699836|NCT01449253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24909779|NCT04304807|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24699863|NCT01449344|Antiviral Agents|antiviral agents|mesh-ancestor
24699864|NCT01449344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24699865|NCT01449344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24699866|NCT01449357|Zalutumumab|zalutumumab|mesh-list
24699867|NCT01449357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24699868|NCT01449357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24699869|NCT01449435|Methacholine Chloride|methacholine chloride|mesh-list
24699894|NCT01449448|Sensory System Agents|sensory system agents|mesh-ancestor
24699895|NCT01449448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24699946|NCT01449799|Autonomic Agents|autonomic agents|mesh-ancestor
24699947|NCT01449799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24699948|NCT01449799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699949|NCT01449799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24699950|NCT01449799|Respiratory System Agents|respiratory system agents|mesh-ancestor
24699951|NCT01449799|Dermatologic Agents|dermatologic agents|mesh-ancestor
24699952|NCT01449799|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24699953|NCT01449825|Bevacizumab|bevacizumab|mesh-list
24699954|NCT01449825|Sunitinib|sunitinib|mesh-list
24699955|NCT01449825|Sorafenib|sorafenib|mesh-list
24699956|NCT01449825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24699957|NCT01449825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24699958|NCT01449825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24699959|NCT01449825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24699960|NCT01449825|Growth Substances|growth substances|mesh-ancestor
25264387|NCT02441530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264388|NCT02441530|Antioxidants|antioxidants|mesh-ancestor
25264389|NCT02441530|Protective Agents|protective agents|mesh-ancestor
25264390|NCT02441387|Antidepressive Agents|antidepressive agents|mesh-list
25264391|NCT02441387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24549106|NCT00713440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549107|NCT00713440|Antiemetics|antiemetics|mesh-ancestor
25264392|NCT02441270|Cyclophosphamide|cyclophosphamide|mesh-list
25264393|NCT02441270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25264394|NCT02441270|Immunologic Factors|immunologic factors|mesh-ancestor
25264395|NCT02441270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264396|NCT02441270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25264397|NCT02441270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25264398|NCT02441270|Alkylating Agents|alkylating agents|mesh-ancestor
24455889|NCT00329355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24455890|NCT00329355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456700|NCT00332033|Pirfenidone|pirfenidone|mesh-list
24456701|NCT00332033|Analgesics|analgesics|mesh-ancestor
24699961|NCT01449825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699962|NCT01449825|Growth Inhibitors|growth inhibitors|mesh-ancestor
24699963|NCT01449825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24699964|NCT01449825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448686|NCT00312598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24448687|NCT00312598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613066|NCT01016821|Sensory System Agents|sensory system agents|mesh-ancestor
24613067|NCT01016821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24613069|NCT01016860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24700094|NCT01450462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24700096|NCT01450514|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24700097|NCT01450514|Serotonin Agents|serotonin agents|mesh-ancestor
24700098|NCT01450514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24700099|NCT01450514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700100|NCT01450514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700101|NCT01450514|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24700102|NCT01450514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24700103|NCT01450514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24700104|NCT01450514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24700105|NCT01450566|Lidocaine|lidocaine|mesh-list
24700106|NCT01450566|Anesthetics, Local|anesthetics, local|mesh-ancestor
24855419|NCT02279563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855420|NCT02279563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24855421|NCT02279563|Respiratory System Agents|respiratory system agents|mesh-ancestor
24855422|NCT02279563|Dermatologic Agents|dermatologic agents|mesh-ancestor
24909910|NCT04304040|Antibodies|antibodies|mesh-list
24700191|NCT01451229|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24700192|NCT01451229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24700193|NCT01451229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24700194|NCT01451229|Protective Agents|protective agents|mesh-ancestor
24700195|NCT01451268|Panobinostat|panobinostat|mesh-list
24700196|NCT01451268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24700219|NCT01451294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24700221|NCT01451320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24700222|NCT01451320|Streptokinase|streptokinase|mesh-list
24700223|NCT01451320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24700224|NCT01451320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25264399|NCT02441270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264400|NCT02441270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25264401|NCT02441270|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25264402|NCT02441075|Ethanol|ethanol|mesh-list
25264403|NCT02441075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25264404|NCT02441075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25264405|NCT02441075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25264406|NCT02441075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264407|NCT02441088|Octreotide|octreotide|mesh-list
25264408|NCT02441088|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
25264409|NCT02441088|Edotreotide|edotreotide|mesh-list
25264410|NCT02441088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25264411|NCT02441088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25264412|NCT02441088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25264413|NCT02441088|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25275697|NCT02369861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24937989|NCT04023344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24937990|NCT04023344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264414|NCT02441088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264415|NCT02441088|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25264416|NCT02441088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25275340|NCT02372656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275341|NCT02372656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24456702|NCT00332033|Sensory System Agents|sensory system agents|mesh-ancestor
24456703|NCT00332033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24455898|NCT00329355|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24700225|NCT01451320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700226|NCT01451333|Efavirenz|efavirenz|mesh-list
24449497|NCT00315861|Pemetrexed|pemetrexed|mesh-list
24700554|NCT01453062|Ofatumumab|ofatumumab|mesh-list
25688721|NCT01950260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25688722|NCT01950260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688723|NCT01950273|Rituximab|rituximab|mesh-list
25688724|NCT01950273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24563494|NCT00772057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24563496|NCT00772057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700555|NCT01453062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24700556|NCT01453192|Raltegravir Potassium|raltegravir potassium|mesh-list
24700558|NCT01453192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24700559|NCT01453192|Antiviral Agents|antiviral agents|mesh-ancestor
24700560|NCT01453192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24700561|NCT01453192|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24700562|NCT01453192|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24700563|NCT01453192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700564|NCT01453192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700565|NCT01453283|Trabectedin|trabectedin|mesh-list
24700566|NCT01453283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24700567|NCT01453283|Alkylating Agents|alkylating agents|mesh-ancestor
24700568|NCT01453283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700569|NCT01453283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24700570|NCT01453400|Aspirin|aspirin|mesh-list
24700571|NCT01453400|Acetaminophen|acetaminophen|mesh-list
24700572|NCT01453400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24700573|NCT01453400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24700574|NCT01453400|Analgesics|analgesics|mesh-ancestor
24700575|NCT01453400|Sensory System Agents|sensory system agents|mesh-ancestor
24700576|NCT01453400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24700577|NCT01453400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700578|NCT01453400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24700589|NCT01453426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24700727|NCT01454609|Adrenergic Agents|adrenergic agents|mesh-ancestor
24700770|NCT01455025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24700772|NCT01455103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24700773|NCT01455103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24700774|NCT01455103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24700775|NCT01455103|Immunologic Factors|immunologic factors|mesh-ancestor
24700776|NCT01455103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700801|NCT01455233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24700802|NCT01455233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700803|NCT01455233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700804|NCT01455233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24700805|NCT01455233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25275342|NCT02372656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25275343|NCT02372656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275344|NCT02372591|Buprenorphine|buprenorphine|mesh-list
25275345|NCT02372591|Hydromorphone|hydromorphone|mesh-list
25275346|NCT02372591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25275347|NCT02372591|Narcotics|narcotics|mesh-ancestor
25275348|NCT02372591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25275698|NCT02369965|Ritonavir|ritonavir|mesh-list
25264417|NCT02440880|Dexamethasone|dexamethasone|mesh-list
25264418|NCT02440880|Dexamethasone acetate|dexamethasone acetate|mesh-list
25264419|NCT02440880|BB 1101|bb 1101|mesh-list
25264420|NCT02440880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25264421|NCT02440880|Antiemetics|antiemetics|mesh-ancestor
25264422|NCT02440880|Autonomic Agents|autonomic agents|mesh-ancestor
25264423|NCT02440880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24938003|NCT04023292|Tamoxifen|tamoxifen|mesh-list
24938004|NCT04023292|Letrozole|letrozole|mesh-list
24938005|NCT04023292|Exemestane|exemestane|mesh-list
24938006|NCT04023292|Anastrozole|anastrozole|mesh-list
24938007|NCT04023292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622300|NCT01066559|Protective Agents|protective agents|mesh-ancestor
24938008|NCT04023292|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24938009|NCT04023292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24453933|NCT04646395|Acalabrutinib|acalabrutinib|mesh-list
24455899|NCT00329355|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24533381|NCT00643500|Nootropic Agents|nootropic agents|mesh-ancestor
24533383|NCT00643539|Amoxicillin|amoxicillin|mesh-list
24533384|NCT00643539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24533385|NCT00643539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24533387|NCT00643643|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24455900|NCT00329355|Serotonin Agents|serotonin agents|mesh-ancestor
24455901|NCT00329355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24455904|NCT00329368|Interferons|interferons|mesh-list
24455905|NCT00329368|Interferon-alpha|interferon-alpha|mesh-list
25688725|NCT01950273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688726|NCT01950273|Immunologic Factors|immunologic factors|mesh-ancestor
24455906|NCT00329368|Interleukin-2|interleukin-2|mesh-list
25264424|NCT02440880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264425|NCT02440880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25264426|NCT02440880|Glucocorticoids|glucocorticoids|mesh-ancestor
25264427|NCT02440880|Hormones|hormones|mesh-ancestor
25264428|NCT02440880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25264429|NCT02440880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25264430|NCT02440880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25264431|NCT02440880|Protease Inhibitors|protease inhibitors|mesh-ancestor
25264432|NCT02440880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264433|NCT02440880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455907|NCT00329368|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
25264434|NCT02440750|Dienogest|dienogest|mesh-list
25264435|NCT02440750|Ulipristal acetate|ulipristal acetate|mesh-list
25264436|NCT02440750|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25264437|NCT02440750|Contraceptive Agents|contraceptive agents|mesh-ancestor
25264438|NCT02440750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25264439|NCT02440750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264440|NCT02440750|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25264441|NCT02440750|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25264442|NCT02440750|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25264443|NCT02440750|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25264444|NCT02440750|Hormone Antagonists|hormone antagonists|mesh-ancestor
25264445|NCT02440750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25264446|NCT02440750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25264447|NCT02440750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25264448|NCT02440958|Folfirinox|folfirinox|mesh-list
25264449|NCT02440958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25264450|NCT02440841|Itraconazole|itraconazole|mesh-list
25264451|NCT02440841|Rifampin|rifampin|mesh-list
25264452|NCT02440841|Antifungal Agents|antifungal agents|mesh-ancestor
25264453|NCT02440841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25264454|NCT02440841|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25264455|NCT02440841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25264456|NCT02440841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264457|NCT02440841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264458|NCT02440841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25264459|NCT02440841|Hormone Antagonists|hormone antagonists|mesh-ancestor
25264460|NCT02440841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25264461|NCT02440841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455925|NCT00329381|Respiratory System Agents|respiratory system agents|mesh-ancestor
24455926|NCT00329381|Immunologic Factors|immunologic factors|mesh-ancestor
24515069|NCT00594269|Antidepressive Agents|antidepressive agents|mesh-ancestor
24455931|NCT00329394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24455932|NCT00329394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455933|NCT00329394|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24455934|NCT00329394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24700806|NCT01455233|Contraceptive Agents|contraceptive agents|mesh-ancestor
24700807|NCT01455233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24700808|NCT01455233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700809|NCT01455233|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24700810|NCT01455233|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24700811|NCT01455233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24700826|NCT01455337|Protective Agents|protective agents|mesh-ancestor
24700859|NCT01455506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700864|NCT01455506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24700865|NCT01455506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24700866|NCT01455506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700867|NCT01455532|Gemcitabine|gemcitabine|mesh-list
24700868|NCT01455532|Carboplatin|carboplatin|mesh-list
24700869|NCT01455532|Doxorubicin|doxorubicin|mesh-list
24700870|NCT01455532|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24486512|NCT00458263|Hormones|hormones|mesh-list
24700906|NCT01455649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24700907|NCT01455649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24700908|NCT01455831|Tinzaparin|tinzaparin|mesh-list
24855429|NCT02279563|Histamine Antagonists|histamine antagonists|mesh-ancestor
24855431|NCT02279563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24855432|NCT02279576|Paclitaxel|paclitaxel|mesh-list
24855433|NCT02279576|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24700909|NCT01455831|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24700910|NCT01455831|Dalteparin|dalteparin|mesh-list
24700911|NCT01455831|Anticoagulants|anticoagulants|mesh-ancestor
24613188|NCT01017640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24701183|NCT01457508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701184|NCT01457508|Chelating Agents|chelating agents|mesh-ancestor
24701185|NCT01457508|Sequestering Agents|sequestering agents|mesh-ancestor
24701186|NCT01457508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701187|NCT01457508|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24701188|NCT01457508|Anticoagulants|anticoagulants|mesh-ancestor
24701189|NCT01457508|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24701190|NCT01457547|Edetic Acid|edetic acid|mesh-list
24701191|NCT01457547|Vaccines|vaccines|mesh-list
24701192|NCT01457547|Pentetic Acid|pentetic acid|mesh-list
24701193|NCT01457547|Immunologic Factors|immunologic factors|mesh-ancestor
24701194|NCT01457547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701195|NCT01457547|Antidotes|antidotes|mesh-ancestor
24701196|NCT01457547|Protective Agents|protective agents|mesh-ancestor
24701197|NCT01457547|Chelating Agents|chelating agents|mesh-ancestor
24701198|NCT01457547|Sequestering Agents|sequestering agents|mesh-ancestor
24701199|NCT01457547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701200|NCT01457547|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24701201|NCT01457547|Anticoagulants|anticoagulants|mesh-ancestor
24701202|NCT01457547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24701203|NCT01457690|Tocopherols|tocopherols|mesh-list
24701237|NCT01457820|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24701238|NCT01457820|Antioxidants|antioxidants|mesh-ancestor
24701239|NCT01457820|Protective Agents|protective agents|mesh-ancestor
24701240|NCT01457820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701242|NCT01457859|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24855434|NCT02279576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24633764|NCT01131026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24633765|NCT01131026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24633766|NCT01131026|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24633767|NCT01131039|Gemcitabine|gemcitabine|mesh-list
25264462|NCT02440841|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25264463|NCT02440841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25264464|NCT02440841|Antitubercular Agents|antitubercular agents|mesh-ancestor
25264465|NCT02440841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25264466|NCT02440841|Leprostatic Agents|leprostatic agents|mesh-ancestor
25264467|NCT02440841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25264468|NCT02440841|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24455935|NCT00329394|Anesthetics, General|anesthetics, general|mesh-ancestor
24455937|NCT00329394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24455938|NCT00329394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24455939|NCT00329394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24456707|NCT00332033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24456708|NCT00332033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24456709|NCT00332033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24456710|NCT00332046|Casopitant|casopitant|mesh-list
24633768|NCT01131039|Bevacizumab|bevacizumab|mesh-list
24633769|NCT01131039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24633770|NCT01131039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633798|NCT01131195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24633800|NCT01131195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24633801|NCT01131195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24633819|NCT01131247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633820|NCT01131247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633821|NCT01131247|Immunologic Factors|immunologic factors|mesh-ancestor
24633822|NCT01131247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633827|NCT01131273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24633828|NCT01131273|Narcotics|narcotics|mesh-ancestor
24633829|NCT01131273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24633830|NCT01131273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633831|NCT01131273|Analgesics|analgesics|mesh-ancestor
24633832|NCT01131273|Sensory System Agents|sensory system agents|mesh-ancestor
24633833|NCT01131273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24633834|NCT01131273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24633835|NCT01131273|Antitussive Agents|antitussive agents|mesh-ancestor
24633836|NCT01131273|Respiratory System Agents|respiratory system agents|mesh-ancestor
24633837|NCT01131364|Doxorubicin|doxorubicin|mesh-list
24633838|NCT01131364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24633856|NCT01131429|Tubulin Modulators|tubulin modulators|mesh-ancestor
24633857|NCT01131429|Antimitotic Agents|antimitotic agents|mesh-ancestor
24633858|NCT01131429|Mitosis Modulators|mitosis modulators|mesh-ancestor
24633860|NCT01131429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24633861|NCT01131429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633862|NCT01131468|Acetylcysteine|acetylcysteine|mesh-list
24633876|NCT01131546|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24633877|NCT01131546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24633878|NCT01131546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633879|NCT01131546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24633880|NCT01131546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633881|NCT01131546|Vasodilator Agents|vasodilator agents|mesh-ancestor
24633882|NCT01131559|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
24633883|NCT01131559|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24633884|NCT01131559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633888|NCT01131559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633890|NCT01131559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24633891|NCT01131572|Acetylcysteine|acetylcysteine|mesh-list
24633892|NCT01131572|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24633893|NCT01131572|Antiviral Agents|antiviral agents|mesh-ancestor
24633894|NCT01131572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24633895|NCT01131572|Expectorants|expectorants|mesh-ancestor
24633896|NCT01131572|Respiratory System Agents|respiratory system agents|mesh-ancestor
24633897|NCT01131572|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24633898|NCT01131572|Antioxidants|antioxidants|mesh-ancestor
24633899|NCT01131572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633900|NCT01131572|Protective Agents|protective agents|mesh-ancestor
24633901|NCT01131572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633904|NCT01131689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812740|NCT02054299|Autonomic Agents|autonomic agents|mesh-ancestor
24633912|NCT01131702|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25264469|NCT02440841|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25264470|NCT02440841|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25264471|NCT02440841|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25264472|NCT02440841|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25264473|NCT02440841|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25264474|NCT02440581|Alendronate|alendronate|mesh-list
25264475|NCT02440581|Teriparatide|teriparatide|mesh-list
25264476|NCT02440581|Cinacalcet|cinacalcet|mesh-list
25275699|NCT02369965|Lopinavir|lopinavir|mesh-list
24456712|NCT00332046|Autonomic Agents|autonomic agents|mesh-ancestor
24456713|NCT00332046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24455940|NCT00329394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24455961|NCT00329459|Analgesics|analgesics|mesh-ancestor
24455962|NCT00329459|Sensory System Agents|sensory system agents|mesh-ancestor
24455963|NCT00329459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24938087|NCT04022525|Immunologic Factors|immunologic factors|mesh-ancestor
24633913|NCT01131702|Histamine Antagonists|histamine antagonists|mesh-ancestor
24633914|NCT01131702|Histamine Agents|histamine agents|mesh-ancestor
24633915|NCT01131702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24633916|NCT01131702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633917|NCT01131702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633918|NCT01131728|Naproxen|naproxen|mesh-list
24633919|NCT01131728|Pseudoephedrine|pseudoephedrine|mesh-list
24633920|NCT01131728|Ephedrine|ephedrine|mesh-list
24633921|NCT01131728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24633922|NCT01131728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24633923|NCT01131728|Analgesics|analgesics|mesh-ancestor
24665648|NCT01313845|Amantadine|amantadine|mesh-list
24633924|NCT01131728|Sensory System Agents|sensory system agents|mesh-ancestor
24910089|NCT04302116|Prednisolone acetate|prednisolone acetate|mesh-list
24633956|NCT01131741|Mydriatics|mydriatics|mesh-ancestor
24633957|NCT01131741|Sympathomimetics|sympathomimetics|mesh-ancestor
24633958|NCT01131741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24633960|NCT01131754|Anticoagulants|anticoagulants|mesh-ancestor
24633961|NCT01131754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24812748|NCT02054299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24633967|NCT01131767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24633968|NCT01131767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24633975|NCT01131767|Gout Suppressants|gout suppressants|mesh-ancestor
24633976|NCT01131767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24633977|NCT01131767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633978|NCT01131767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633979|NCT01131767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25688727|NCT01950273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633981|NCT01131767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24633982|NCT01131767|Respiratory System Agents|respiratory system agents|mesh-ancestor
24633983|NCT01131767|Nasal Decongestants|nasal decongestants|mesh-ancestor
24633984|NCT01131767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24634017|NCT01131806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24634018|NCT01131806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24634019|NCT01131806|Autonomic Agents|autonomic agents|mesh-ancestor
24634020|NCT01131806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24634021|NCT01131806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634022|NCT01131806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24634023|NCT01131806|Respiratory System Agents|respiratory system agents|mesh-ancestor
24634024|NCT01131806|Dermatologic Agents|dermatologic agents|mesh-ancestor
24634025|NCT01131806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24634026|NCT01131806|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24634027|NCT01131806|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24634028|NCT01131806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24634029|NCT01131806|Adrenergic Agents|adrenergic agents|mesh-ancestor
24634030|NCT01131806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24634031|NCT01131806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264477|NCT02440581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24634038|NCT01131897|Levetiracetam|levetiracetam|mesh-list
24634071|NCT01131949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24812742|NCT02054299|Respiratory System Agents|respiratory system agents|mesh-ancestor
24812744|NCT02054299|Tocolytic Agents|tocolytic agents|mesh-ancestor
25264478|NCT02440581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264479|NCT02440581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25264480|NCT02440581|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25264481|NCT02440581|Hormone Antagonists|hormone antagonists|mesh-ancestor
25264482|NCT02440581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25264483|NCT02440828|Tobramycin|tobramycin|mesh-list
25264484|NCT02440828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25264485|NCT02440828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24812745|NCT02054299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24634073|NCT01131962|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24634075|NCT01131975|Anticonvulsants|anticonvulsants|mesh-ancestor
24634076|NCT01131975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24634078|NCT01131975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634079|NCT01131975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24634081|NCT01131975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24687980|NCT03555877|Letrozole|letrozole|mesh-list
24688018|NCT03522584|Ipilimumab|ipilimumab|mesh-list
24688019|NCT03522584|Tremelimumab|tremelimumab|mesh-list
24634206|NCT01132417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634207|NCT01132417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634208|NCT01132443|Clindamycin|clindamycin|mesh-list
24634209|NCT01132443|Clindamycin palmitate|clindamycin palmitate|mesh-list
24634210|NCT01132443|Clindamycin phosphate|clindamycin phosphate|mesh-list
24634211|NCT01132443|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24634213|NCT01132443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24634214|NCT01132443|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24634215|NCT01132443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634216|NCT01132443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812746|NCT02054299|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24812747|NCT02054299|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24634219|NCT01132521|Trypsin Inhibitors|trypsin inhibitors|mesh-list
24634220|NCT01132521|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24634221|NCT01132521|Protease Inhibitors|protease inhibitors|mesh-ancestor
24634222|NCT01132521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634223|NCT01132521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634224|NCT01132573|Clofarabine|clofarabine|mesh-list
24634226|NCT01132573|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
24634300|NCT01132768|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24634301|NCT01132768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24634302|NCT01132768|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24634303|NCT01132768|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24634304|NCT01132768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634322|NCT01132781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24484836|NCT00450203|Bevacizumab|bevacizumab|mesh-list
24634484|NCT01133548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634485|NCT01133548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24964099|NCT03785613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24634486|NCT01133548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24634487|NCT01133548|Anabolic Agents|anabolic agents|mesh-ancestor
24634488|NCT01133600|Vancomycin|vancomycin|mesh-list
24634489|NCT01133600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24634490|NCT01133600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24634491|NCT01133743|Thalidomide|thalidomide|mesh-list
24634492|NCT01133743|Dexamethasone|dexamethasone|mesh-list
24634493|NCT01133743|Lenalidomide|lenalidomide|mesh-list
24634494|NCT01133743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24634495|NCT01133743|Antiemetics|antiemetics|mesh-ancestor
24634496|NCT01133743|Autonomic Agents|autonomic agents|mesh-ancestor
24634497|NCT01133743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24634498|NCT01133743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634499|NCT01133743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24634500|NCT01133743|Glucocorticoids|glucocorticoids|mesh-ancestor
24634501|NCT01133743|Hormones|hormones|mesh-ancestor
24634502|NCT01133743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24634503|NCT01133743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24634504|NCT01133743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24634505|NCT01133743|Immunologic Factors|immunologic factors|mesh-ancestor
24634506|NCT01133743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24634507|NCT01133743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24634524|NCT01133795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24634525|NCT01133795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634527|NCT01133873|Levopropoxyphene|levopropoxyphene|mesh-list
24634528|NCT01133873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25264486|NCT02440347|Anesthetics|anesthetics|mesh-list
24455964|NCT00329459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455965|NCT00329459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24455966|NCT00329459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24455967|NCT00329459|Gout Suppressants|gout suppressants|mesh-ancestor
24455968|NCT00329459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24938097|NCT04022161|Antioxidants|antioxidants|mesh-ancestor
24634529|NCT01133873|Narcotics|narcotics|mesh-ancestor
24634629|NCT01134432|Prednisolone phosphate|prednisolone phosphate|mesh-list
24634630|NCT01134432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24634631|NCT01134432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24634632|NCT01134432|Immunologic Factors|immunologic factors|mesh-ancestor
24634633|NCT01134432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634634|NCT01134432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24634635|NCT01134432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24634636|NCT01134432|Glucocorticoids|glucocorticoids|mesh-ancestor
24634637|NCT01134432|Hormones|hormones|mesh-ancestor
24634638|NCT01134432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24634639|NCT01134432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24634666|NCT01134484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24634667|NCT01134484|Growth Substances|growth substances|mesh-ancestor
24634668|NCT01134484|Growth Inhibitors|growth inhibitors|mesh-ancestor
24634669|NCT01134523|Paclitaxel|paclitaxel|mesh-list
24634670|NCT01134523|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24634671|NCT01134523|Epirubicin|epirubicin|mesh-list
24634672|NCT01134523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24634673|NCT01134523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24634674|NCT01134523|Tubulin Modulators|tubulin modulators|mesh-ancestor
24634675|NCT01134523|Antimitotic Agents|antimitotic agents|mesh-ancestor
24634676|NCT01134523|Mitosis Modulators|mitosis modulators|mesh-ancestor
24634677|NCT01134523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634678|NCT01134523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24634679|NCT01134523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24634680|NCT01134523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24634681|NCT01134523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634683|NCT01134536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24634684|NCT01134536|Narcotics|narcotics|mesh-ancestor
24634685|NCT01134536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24634686|NCT01134536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634687|NCT01134536|Analgesics|analgesics|mesh-ancestor
24634688|NCT01134536|Sensory System Agents|sensory system agents|mesh-ancestor
24634789|NCT01135212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25688728|NCT01950273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25688729|NCT01950299|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25688730|NCT01950299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25688731|NCT01950364|Rifampin|rifampin|mesh-list
24634790|NCT01135212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24634791|NCT01135212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24634792|NCT01135212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812756|NCT02054442|Abortifacient Agents|abortifacient agents|mesh-ancestor
24855435|NCT02279576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528002|NCT00619203|Acetaminophen|acetaminophen|mesh-list
24634794|NCT01135290|Emollients|emollients|mesh-ancestor
24634795|NCT01135290|Dermatologic Agents|dermatologic agents|mesh-ancestor
24635089|NCT01136863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24635090|NCT01136863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635091|NCT01136863|Vasodilator Agents|vasodilator agents|mesh-ancestor
24635139|NCT01137253|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24635140|NCT01137253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24635141|NCT01137253|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
24635142|NCT01137253|Autonomic Agents|autonomic agents|mesh-ancestor
24635143|NCT01137253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24635144|NCT01137253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635145|NCT01137253|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25264487|NCT02440347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25264488|NCT02440347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264489|NCT02440230|Anastrozole|anastrozole|mesh-list
25264490|NCT02440230|Exemestane|exemestane|mesh-list
25264491|NCT02440230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25264492|NCT02440230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24455969|NCT00329459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24455970|NCT00329459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455971|NCT00329459|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24455972|NCT00329459|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24455973|NCT00329459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24455974|NCT00329459|Serotonin Agents|serotonin agents|mesh-ancestor
24455975|NCT00329459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24455977|NCT00329472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24455978|NCT00329472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24455979|NCT00329472|Antimetabolites|antimetabolites|mesh-ancestor
24455980|NCT00329472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455981|NCT00329472|Antiviral Agents|antiviral agents|mesh-ancestor
24455982|NCT00329472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24455983|NCT00329472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24455984|NCT00329472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24455985|NCT00329472|Immunologic Factors|immunologic factors|mesh-ancestor
24533395|NCT00643734|Azithromycin|azithromycin|mesh-list
24533396|NCT00643734|Levofloxacin|levofloxacin|mesh-list
24533397|NCT00643734|Ofloxacin|ofloxacin|mesh-list
24635146|NCT01137253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24635147|NCT01137253|Cholinergic Agents|cholinergic agents|mesh-ancestor
24635148|NCT01137253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24635149|NCT01137253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635187|NCT01137695|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
24635188|NCT01137695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24635212|NCT01137903|Ciprofloxacin|ciprofloxacin|mesh-list
24635213|NCT01137903|Clavulanic Acid|clavulanic acid|mesh-list
24635214|NCT01137903|Clavulanic Acids|clavulanic acids|mesh-list
24635215|NCT01137903|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24635216|NCT01137903|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24635217|NCT01137903|Trimethoprim|trimethoprim|mesh-list
24635218|NCT01137903|Sulfamethoxazole|sulfamethoxazole|mesh-list
24635219|NCT01137903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24635220|NCT01137903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24635222|NCT01137903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24635223|NCT01137903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635224|NCT01137903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635225|NCT01137903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24635226|NCT01137903|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24635227|NCT01137903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24635228|NCT01137903|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24635239|NCT01137916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24635271|NCT01137994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635273|NCT01138072|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25264493|NCT02440230|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25264494|NCT02440230|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25264495|NCT02440230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264496|NCT02440230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264497|NCT02440230|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25264498|NCT02440230|Hormone Antagonists|hormone antagonists|mesh-ancestor
25264499|NCT02440230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25264500|NCT02440230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264501|NCT02440399|Acetaminophen|acetaminophen|mesh-list
25264502|NCT02440399|Diclofenac|diclofenac|mesh-list
25264503|NCT02440399|Morphine|morphine|mesh-list
25264504|NCT02440399|Oxycodone|oxycodone|mesh-list
25264505|NCT02440399|Tramadol|tramadol|mesh-list
25264506|NCT02440399|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25264507|NCT02440399|Narcotics|narcotics|mesh-ancestor
25264508|NCT02440399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25264509|NCT02440399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264510|NCT02440399|Analgesics|analgesics|mesh-ancestor
25264511|NCT02440399|Sensory System Agents|sensory system agents|mesh-ancestor
25264512|NCT02440399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25264513|NCT02440399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25264514|NCT02440399|Antipyretics|antipyretics|mesh-ancestor
25264515|NCT02440399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25264516|NCT02440399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24938123|NCT04022317|Insulin|insulin|mesh-list
24635274|NCT01138072|Simvastatin|simvastatin|mesh-list
24635275|NCT01138072|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24635276|NCT01138072|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24635277|NCT01138072|Antimetabolites|antimetabolites|mesh-ancestor
24635278|NCT01138072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635279|NCT01138072|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24635325|NCT01138449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635326|NCT01138488|Insulin|insulin|mesh-list
24635327|NCT01138488|Insulin Aspart|insulin aspart|mesh-list
24635328|NCT01138488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24635329|NCT01138488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635330|NCT01138553|Mifepristone|mifepristone|mesh-list
24635331|NCT01138553|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24635332|NCT01138553|Abortifacient Agents|abortifacient agents|mesh-ancestor
24635333|NCT01138553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24910397|NCT04298684|Incretins|incretins|mesh-ancestor
24635375|NCT01138839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635376|NCT01138839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24635377|NCT01138839|Glucocorticoids|glucocorticoids|mesh-ancestor
24635378|NCT01138839|Hormones|hormones|mesh-ancestor
24635379|NCT01138839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24635380|NCT01138839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24635381|NCT01138839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24635382|NCT01138852|Ampicillin|ampicillin|mesh-list
24635383|NCT01138852|Cefuroxime|cefuroxime|mesh-list
24635384|NCT01138852|Cefuroxime axetil|cefuroxime axetil|mesh-list
24635385|NCT01138852|Sulbactam|sulbactam|mesh-list
24635413|NCT01139138|Panitumumab|panitumumab|mesh-list
24635414|NCT01139138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25688732|NCT01950364|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25688733|NCT01950364|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25688734|NCT01950364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25688735|NCT01950364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688736|NCT01950364|Immunologic Factors|immunologic factors|mesh-ancestor
25688737|NCT01950364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688738|NCT01950364|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25688739|NCT01950364|Antitubercular Agents|antitubercular agents|mesh-ancestor
25688740|NCT01950364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25688741|NCT01950364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25688742|NCT01950364|Leprostatic Agents|leprostatic agents|mesh-ancestor
24635415|NCT01139138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24635416|NCT01139138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264517|NCT02440399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25264518|NCT02440399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25264519|NCT02440399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264520|NCT02440399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264521|NCT02440243|Vaccines|vaccines|mesh-list
25264522|NCT02440243|Immunologic Factors|immunologic factors|mesh-ancestor
25264523|NCT02440243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264524|NCT02440256|Analgesics, Opioid|analgesics, opioid|mesh-list
25264525|NCT02440256|Narcotics|narcotics|mesh-ancestor
25264526|NCT02440256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25264527|NCT02440256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264528|NCT02440256|Analgesics|analgesics|mesh-ancestor
25264529|NCT02440256|Sensory System Agents|sensory system agents|mesh-ancestor
25264530|NCT02440256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25264531|NCT02440100|Midazolam|midazolam|mesh-list
25264532|NCT02440100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25264533|NCT02440100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25264534|NCT02440100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25264535|NCT02440100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264536|NCT02440100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24533399|NCT00643734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24533400|NCT00643734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24533402|NCT00643734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24533403|NCT00643734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24533404|NCT00643734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533405|NCT00643734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635417|NCT01139138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635418|NCT01139138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24635422|NCT01139138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24635423|NCT01139151|Cytarabine|cytarabine|mesh-list
24635424|NCT01139151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24635425|NCT01139151|Antimetabolites|antimetabolites|mesh-ancestor
24635426|NCT01139151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635427|NCT01139151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24635428|NCT01139151|Antiviral Agents|antiviral agents|mesh-ancestor
24635429|NCT01139151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24635430|NCT01139151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24635458|NCT01139463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24635459|NCT01139463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24910450|NCT04297215|Chelating Agents|chelating agents|mesh-ancestor
24635478|NCT01139671|Remifentanil|remifentanil|mesh-list
24635481|NCT01139671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24635576|NCT01140399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635578|NCT01140399|Sympathomimetics|sympathomimetics|mesh-ancestor
24635579|NCT01140399|Autonomic Agents|autonomic agents|mesh-ancestor
24635580|NCT01140399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24635581|NCT01140399|Dopamine Agents|dopamine agents|mesh-ancestor
24446953|NCT00306735|Autonomic Agents|autonomic agents|mesh-ancestor
24635587|NCT01140412|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24635588|NCT01140412|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24635589|NCT01140412|Protease Inhibitors|protease inhibitors|mesh-ancestor
24635611|NCT01140425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24635612|NCT01140425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24635613|NCT01140425|Antiviral Agents|antiviral agents|mesh-ancestor
24635614|NCT01140438|Metformin|metformin|mesh-list
24635615|NCT01140438|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24635616|NCT01140438|Repaglinide|repaglinide|mesh-list
24635617|NCT01140438|Insulin, Isophane|insulin, isophane|mesh-list
24635618|NCT01140438|Isophane Insulin, Human|isophane insulin, human|mesh-list
24635619|NCT01140438|Isophane insulin, beef|isophane insulin, beef|mesh-list
24635620|NCT01140438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24855444|NCT02279615|Mirabegron|mirabegron|mesh-list
24635636|NCT01140529|Analgesics|analgesics|mesh-ancestor
24635637|NCT01140529|Sensory System Agents|sensory system agents|mesh-ancestor
24635639|NCT01140529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24635640|NCT01140529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24635641|NCT01140529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24635642|NCT01140529|Adrenergic Agents|adrenergic agents|mesh-ancestor
24635668|NCT01140620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24635669|NCT01140620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24666012|NCT01316744|Anesthetics, General|anesthetics, general|mesh-ancestor
25264537|NCT02440100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25264538|NCT02440100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25264539|NCT02440100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25264540|NCT02440100|Anesthetics, General|anesthetics, general|mesh-ancestor
25264541|NCT02440100|Anesthetics|anesthetics|mesh-ancestor
25264542|NCT02440100|GABA Modulators|gaba modulators|mesh-ancestor
25264543|NCT02440100|GABA Agents|gaba agents|mesh-ancestor
25264544|NCT02440100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24549673|NCT00716846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25264545|NCT02440100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264546|NCT02439944|Nicotine|nicotine|mesh-list
25264547|NCT02439944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24688626|NCT02873819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24688627|NCT02873819|Alkylating Agents|alkylating agents|mesh-ancestor
24688628|NCT02873819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688629|NCT02873819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24635675|NCT01140620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24635676|NCT01140620|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24635677|NCT01140620|Dopamine Agents|dopamine agents|mesh-ancestor
24635695|NCT01140893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24635697|NCT01140932|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24635698|NCT01140932|Methylprednisolone|methylprednisolone|mesh-list
24635699|NCT01140932|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24635700|NCT01140932|Prednisolone acetate|prednisolone acetate|mesh-list
24635701|NCT01140932|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24635702|NCT01140932|Prednisolone phosphate|prednisolone phosphate|mesh-list
24635703|NCT01140932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24635704|NCT01140932|Glucocorticoids|glucocorticoids|mesh-ancestor
24635705|NCT01140932|Hormones|hormones|mesh-ancestor
24635706|NCT01140932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24635707|NCT01140932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635708|NCT01140932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24635709|NCT01140932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24635710|NCT01140932|Antiemetics|antiemetics|mesh-ancestor
24635711|NCT01140932|Autonomic Agents|autonomic agents|mesh-ancestor
24635712|NCT01140932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24635713|NCT01140932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24635769|NCT01141127|Coagulants|coagulants|mesh-ancestor
24635771|NCT01141153|Acenocoumarol|acenocoumarol|mesh-list
24635772|NCT01141153|Clopidogrel|clopidogrel|mesh-list
24635773|NCT01141153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24635774|NCT01141153|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24635775|NCT01141153|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24635777|NCT01141153|Purinergic Agents|purinergic agents|mesh-ancestor
24635778|NCT01141153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25264548|NCT02439944|Autonomic Agents|autonomic agents|mesh-ancestor
25264549|NCT02439944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25264550|NCT02439944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264551|NCT02439944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25264552|NCT02439944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25264553|NCT02439944|Cholinergic Agents|cholinergic agents|mesh-ancestor
25264554|NCT02439944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25264555|NCT02439944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635781|NCT01141153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24635782|NCT01141153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24635783|NCT01141153|Analgesics|analgesics|mesh-ancestor
24635784|NCT01141153|Sensory System Agents|sensory system agents|mesh-ancestor
24635785|NCT01141153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24635786|NCT01141153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24635787|NCT01141153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24635788|NCT01141153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24635789|NCT01141153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24635890|NCT01141556|Protective Agents|protective agents|mesh-ancestor
24635891|NCT01141556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635892|NCT01141556|Trace Elements|trace elements|mesh-ancestor
24635893|NCT01141556|Micronutrients|micronutrients|mesh-ancestor
24635895|NCT01141855|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24855452|NCT02279615|Urological Agents|urological agents|mesh-ancestor
24529014|NCT00624182|Gemcitabine|gemcitabine|mesh-list
24636033|NCT01142492|Immunologic Factors|immunologic factors|mesh-ancestor
24636034|NCT01142492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636037|NCT01142505|Montelukast|montelukast|mesh-list
24636038|NCT01142505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24636039|NCT01142505|Respiratory System Agents|respiratory system agents|mesh-ancestor
24636040|NCT01142505|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24636041|NCT01142505|Hormone Antagonists|hormone antagonists|mesh-ancestor
24636042|NCT01142505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24636043|NCT01142505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636044|NCT01142505|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24636045|NCT01142505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24636046|NCT01142505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636066|NCT01142557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636067|NCT01142557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24636068|NCT01142622|Ropivacaine|ropivacaine|mesh-list
24636084|NCT01142648|Neostigmine|neostigmine|mesh-list
24636122|NCT01142934|Chlorhexidine|chlorhexidine|mesh-list
24636123|NCT01142934|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24636124|NCT01142934|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24636125|NCT01142934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24636126|NCT01142934|Disinfectants|disinfectants|mesh-ancestor
24636127|NCT01142934|Dermatologic Agents|dermatologic agents|mesh-ancestor
24636143|NCT01143129|Hormones|hormones|mesh-ancestor
24636144|NCT01143129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24636145|NCT01143129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24636146|NCT01143129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24636147|NCT01143545|Celecoxib|celecoxib|mesh-list
24636148|NCT01143545|Cyclophosphamide|cyclophosphamide|mesh-list
25264556|NCT02439905|Dexmedetomidine|dexmedetomidine|mesh-list
25264557|NCT02439905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24549776|NCT00717561|Moxifloxacin|moxifloxacin|mesh-list
25264558|NCT02439905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25264559|NCT02439905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264560|NCT02439905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25264561|NCT02439905|Analgesics|analgesics|mesh-ancestor
25264562|NCT02439905|Sensory System Agents|sensory system agents|mesh-ancestor
25264563|NCT02439905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24456032|NCT00329680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456033|NCT00329680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456034|NCT00329680|Protective Agents|protective agents|mesh-ancestor
24515156|NCT00595140|Octreotide|octreotide|mesh-list
24533407|NCT00643734|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24533408|NCT00643734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24533409|NCT00643799|Celecoxib|celecoxib|mesh-list
24533410|NCT00643799|Naproxen|naproxen|mesh-list
24938180|NCT04021433|Ketamine|ketamine|mesh-list
24636149|NCT01143545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24636150|NCT01143545|Immunologic Factors|immunologic factors|mesh-ancestor
24636151|NCT01143545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636152|NCT01143545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25264564|NCT02439905|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25264565|NCT02439905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25264566|NCT02439905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25264567|NCT02439905|Adrenergic Agents|adrenergic agents|mesh-ancestor
25264568|NCT02439905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25264569|NCT02439905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264570|NCT02439866|Methylprednisolone|methylprednisolone|mesh-list
25264571|NCT02439866|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25264572|NCT02439866|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25264573|NCT02439866|Prednisolone|prednisolone|mesh-list
25264574|NCT02439866|Prednisolone acetate|prednisolone acetate|mesh-list
25264575|NCT02439866|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25264576|NCT02439866|Prednisolone phosphate|prednisolone phosphate|mesh-list
25264577|NCT02439866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25264578|NCT02439866|Antiemetics|antiemetics|mesh-ancestor
25264579|NCT02439866|Autonomic Agents|autonomic agents|mesh-ancestor
25264580|NCT02439866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25264581|NCT02439866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264582|NCT02439866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25264583|NCT02439866|Glucocorticoids|glucocorticoids|mesh-ancestor
25264584|NCT02439866|Hormones|hormones|mesh-ancestor
25264585|NCT02439866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25264586|NCT02439866|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25264587|NCT02439866|Protective Agents|protective agents|mesh-ancestor
25264588|NCT02439866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25264589|NCT02439866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25264590|NCT02439996|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25264591|NCT02439996|gamma-Globulins|gamma-globulins|mesh-list
25264592|NCT02439996|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25264593|NCT02439996|Immunologic Factors|immunologic factors|mesh-ancestor
25264594|NCT02439996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264595|NCT02440009|Itraconazole|itraconazole|mesh-list
25264596|NCT02440009|Glucocorticoids|glucocorticoids|mesh-list
25264597|NCT02440009|Antifungal Agents|antifungal agents|mesh-ancestor
25264598|NCT02440009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24456039|NCT00329680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24456042|NCT00329680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24456043|NCT00329680|Antimetabolites|antimetabolites|mesh-ancestor
24456044|NCT00329680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24456045|NCT00329680|Dermatologic Agents|dermatologic agents|mesh-ancestor
24456046|NCT00329693|Quinagolide|quinagolide|mesh-list
24636153|NCT01143545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24636154|NCT01143545|Alkylating Agents|alkylating agents|mesh-ancestor
24636156|NCT01143545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24636157|NCT01143545|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24636158|NCT01143545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24636159|NCT01143545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24636161|NCT01143545|Sensory System Agents|sensory system agents|mesh-ancestor
24636198|NCT01143831|Coagulants|coagulants|mesh-ancestor
24636199|NCT01143857|Varenicline|varenicline|mesh-list
24636200|NCT01143857|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24636315|NCT01144702|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24636316|NCT01144702|Anthelmintics|anthelmintics|mesh-ancestor
24636317|NCT01144728|Metformin|metformin|mesh-list
24636318|NCT01144728|Glimepiride|glimepiride|mesh-list
24636319|NCT01144728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24855453|NCT02279615|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24636356|NCT01144923|Anticonvulsants|anticonvulsants|mesh-ancestor
24636357|NCT01144923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24636380|NCT01144988|Growth Inhibitors|growth inhibitors|mesh-ancestor
24636381|NCT01144988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24636382|NCT01144988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24636383|NCT01144988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636384|NCT01144988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636386|NCT01145079|Everolimus|everolimus|mesh-list
24636387|NCT01145079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24636388|NCT01145079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24636389|NCT01145079|Immunologic Factors|immunologic factors|mesh-ancestor
24636390|NCT01145079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636393|NCT01145079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24636394|NCT01145079|Antifungal Agents|antifungal agents|mesh-ancestor
24636395|NCT01145144|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24636396|NCT01145144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24636397|NCT01145144|Immunologic Factors|immunologic factors|mesh-ancestor
24636398|NCT01145144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636399|NCT01145170|Nimotuzumab|nimotuzumab|mesh-list
24855459|NCT02279628|Narcotics|narcotics|mesh-ancestor
25264599|NCT02440009|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25264600|NCT02440009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25264601|NCT02440009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264602|NCT02440009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264603|NCT02440009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25264604|NCT02440009|Hormone Antagonists|hormone antagonists|mesh-ancestor
25264605|NCT02440009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25264606|NCT02440009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264607|NCT02440009|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25264608|NCT02440009|Hormones|hormones|mesh-ancestor
25264609|NCT02439788|Cyclophosphamide|cyclophosphamide|mesh-list
24762949|NCT01770236|Acetaminophen|acetaminophen|mesh-list
24636521|NCT01145950|Immunologic Factors|immunologic factors|mesh-ancestor
24636522|NCT01145976|Cyclophosphamide|cyclophosphamide|mesh-list
24636523|NCT01145976|Fludarabine|fludarabine|mesh-list
24485324|NCT00452582|Sildenafil Citrate|sildenafil citrate|mesh-list
24636587|NCT01146106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24636589|NCT01146106|Antimetabolites|antimetabolites|mesh-ancestor
24636590|NCT01146106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636591|NCT01146106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24636592|NCT01146106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24636593|NCT01146106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636596|NCT01146145|Analgesics|analgesics|mesh-ancestor
24636597|NCT01146145|Sensory System Agents|sensory system agents|mesh-ancestor
24636598|NCT01146145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24636599|NCT01146145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636600|NCT01146145|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24636621|NCT01146431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24636622|NCT01146431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636623|NCT01146483|Pantoprazole|pantoprazole|mesh-list
24636624|NCT01146483|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24636625|NCT01146483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24636626|NCT01146483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24636627|NCT01146483|Antimetabolites|antimetabolites|mesh-ancestor
24549929|NCT00718146|Vaccines|vaccines|mesh-list
24636628|NCT01146483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636666|NCT01146548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636667|NCT01146626|Vitamin D|vitamin d|mesh-list
24636668|NCT01146626|Ribavirin|ribavirin|mesh-list
24636669|NCT01146626|Vitamins|vitamins|mesh-ancestor
24636670|NCT01146626|Micronutrients|micronutrients|mesh-ancestor
24636672|NCT01146626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24636674|NCT01146626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636675|NCT01146626|Antiviral Agents|antiviral agents|mesh-ancestor
24855462|NCT02279628|Analgesics|analgesics|mesh-ancestor
24855463|NCT02279628|Sensory System Agents|sensory system agents|mesh-ancestor
24636676|NCT01146626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25264610|NCT02439788|Fludarabine|fludarabine|mesh-list
25264611|NCT02439788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25264612|NCT02439788|Immunologic Factors|immunologic factors|mesh-ancestor
25264613|NCT02439788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264614|NCT02439788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25264615|NCT02439788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25264616|NCT02439788|Alkylating Agents|alkylating agents|mesh-ancestor
25264617|NCT02439788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264618|NCT02439788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25264619|NCT02439788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25264620|NCT02439697|Darbepoetin alfa|darbepoetin alfa|mesh-list
25264621|NCT02439697|Hematinics|hematinics|mesh-ancestor
25264622|NCT02439632|Levofloxacin|levofloxacin|mesh-list
25264623|NCT02439632|Ofloxacin|ofloxacin|mesh-list
24515191|NCT00595374|Isophane insulin, beef|isophane insulin, beef|mesh-list
24515192|NCT00595374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24515193|NCT00595374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275349|NCT02372591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456055|NCT00329758|Antimetabolites|antimetabolites|mesh-ancestor
24456056|NCT00329758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515194|NCT00595543|Diclofenac|diclofenac|mesh-list
25275350|NCT02372591|Analgesics|analgesics|mesh-ancestor
24636677|NCT01146678|Insulin Glargine|insulin glargine|mesh-list
24636678|NCT01146678|Lixisenatide|lixisenatide|mesh-list
24636679|NCT01146678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24636680|NCT01146678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910724|NCT04294836|Analgesics|analgesics|mesh-ancestor
24636731|NCT01147133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636733|NCT01147146|Midazolam|midazolam|mesh-list
24636734|NCT01147146|Bupivacaine|bupivacaine|mesh-list
24636735|NCT01147146|Propofol|propofol|mesh-list
25264632|NCT02439632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264633|NCT02439632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264634|NCT02439632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25264635|NCT02439632|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25264636|NCT02439632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25264637|NCT02439632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25264648|NCT02439489|Carboplatin|carboplatin|mesh-list
25264649|NCT02439489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25275351|NCT02372591|Sensory System Agents|sensory system agents|mesh-ancestor
25275352|NCT02372591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275353|NCT02372591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25275701|NCT02369965|Lamivudine|lamivudine|mesh-list
25275702|NCT02369965|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24456061|NCT00329810|Antidepressive Agents|antidepressive agents|mesh-ancestor
24456062|NCT00329810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24456063|NCT00329810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24456064|NCT00329810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24456065|NCT00329810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24456066|NCT00329810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456067|NCT00329810|Dopamine Agonists|dopamine agonists|mesh-ancestor
24456068|NCT00329810|Dopamine Agents|dopamine agents|mesh-ancestor
24456069|NCT00329810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24456070|NCT00329810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515203|NCT00595543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24550102|NCT00719095|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24666373|NCT01318837|Urological Agents|urological agents|mesh-ancestor
24636739|NCT01147146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24636740|NCT01147146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636741|NCT01147146|Sensory System Agents|sensory system agents|mesh-ancestor
24636742|NCT01147146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24636743|NCT01147146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24636744|NCT01147146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24636745|NCT01147146|Anesthetics, General|anesthetics, general|mesh-ancestor
24636746|NCT01147146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24636747|NCT01147146|Narcotics|narcotics|mesh-ancestor
24636779|NCT01147289|Analgesics|analgesics|mesh-ancestor
24636872|NCT01147718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636873|NCT01147718|Protective Agents|protective agents|mesh-ancestor
24636874|NCT01147718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636876|NCT01147718|Hormones|hormones|mesh-ancestor
24636989|NCT01148277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24636877|NCT01147718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24636878|NCT01147731|Warfarin|warfarin|mesh-list
24636879|NCT01147731|rGLP-1 protein|rglp-1 protein|mesh-list
24636880|NCT01147731|Anticoagulants|anticoagulants|mesh-ancestor
24636881|NCT01147731|Incretins|incretins|mesh-ancestor
24636882|NCT01147731|Hormones|hormones|mesh-ancestor
24636908|NCT01148004|Antiviral Agents|antiviral agents|mesh-ancestor
24636909|NCT01148004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24636910|NCT01148004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24636911|NCT01148004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24636912|NCT01148004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24636913|NCT01148004|Antimetabolites|antimetabolites|mesh-ancestor
25264650|NCT02439190|Aspirin|aspirin|mesh-list
25264651|NCT02439190|Clopidogrel|clopidogrel|mesh-list
25264652|NCT02439190|BMS-986120|bms-986120|mesh-list
25264653|NCT02439190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25264654|NCT02439190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25264655|NCT02439190|Analgesics|analgesics|mesh-ancestor
25264656|NCT02439190|Sensory System Agents|sensory system agents|mesh-ancestor
25264657|NCT02439190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25264658|NCT02439190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264659|NCT02439190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25264660|NCT02439190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25264661|NCT02439190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25264662|NCT02439190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25264663|NCT02439190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264664|NCT02439190|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25264665|NCT02439190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25264666|NCT02439190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264667|NCT02439190|Antipyretics|antipyretics|mesh-ancestor
25264668|NCT02439190|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25264669|NCT02439190|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25264670|NCT02439190|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25264671|NCT02439190|Purinergic Agents|purinergic agents|mesh-ancestor
25264672|NCT02439190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25264673|NCT02439411|Trametinib|trametinib|mesh-list
24938278|NCT04020380|Azithromycin|azithromycin|mesh-list
24569073|NCT00798954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569074|NCT00798954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24636914|NCT01148004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24636915|NCT01148030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
24636916|NCT01148030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24636917|NCT01148043|Hydroxychloroquine|hydroxychloroquine|mesh-list
24636918|NCT01148043|Antimalarials|antimalarials|mesh-ancestor
24636919|NCT01148043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24636920|NCT01148043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24636921|NCT01148043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24636922|NCT01148043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24910775|NCT04294992|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24636949|NCT01148173|Ifosfamide|ifosfamide|mesh-list
24636950|NCT01148173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24636952|NCT01148173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636953|NCT01148173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24636955|NCT01148264|Metoclopramide|metoclopramide|mesh-list
24636956|NCT01148264|Antiemetics|antiemetics|mesh-ancestor
24636957|NCT01148264|Autonomic Agents|autonomic agents|mesh-ancestor
24636958|NCT01148264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24636959|NCT01148264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636960|NCT01148264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24636961|NCT01148264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24636962|NCT01148264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24636963|NCT01148264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24636964|NCT01148264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24636965|NCT01148264|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24636966|NCT01148264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24636967|NCT01148264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24636968|NCT01148264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636985|NCT01148277|Analgesics|analgesics|mesh-ancestor
24636986|NCT01148277|Sensory System Agents|sensory system agents|mesh-ancestor
24636987|NCT01148277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24636988|NCT01148277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24636990|NCT01148277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24636991|NCT01148277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24637002|NCT01148303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637010|NCT01148316|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24637011|NCT01148316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24637012|NCT01148316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24637013|NCT01148316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637014|NCT01148316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24637016|NCT01148316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264674|NCT02439411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25264675|NCT02439411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25264676|NCT02439411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264677|NCT02439411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264679|NCT02439125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25264680|NCT02439125|Serotonin Agents|serotonin agents|mesh-ancestor
25264681|NCT02439125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25264682|NCT02439125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264683|NCT02439125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264684|NCT02439034|Acetaminophen|acetaminophen|mesh-list
25264685|NCT02439034|Ketoprofen|ketoprofen|mesh-list
25264686|NCT02439034|Codeine|codeine|mesh-list
25264687|NCT02439034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24446794|NCT00305903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24446795|NCT00305903|Protective Agents|protective agents|mesh-ancestor
24456076|NCT00329810|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24456078|NCT00329823|Etanercept|etanercept|mesh-list
24456079|NCT00329823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24456080|NCT00329823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24456081|NCT00329823|Analgesics|analgesics|mesh-ancestor
25688743|NCT01950364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25688744|NCT01950364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456083|NCT00329823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24456084|NCT00329823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456086|NCT00329823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24456087|NCT00329823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24938287|NCT04020328|Leflunomide|leflunomide|mesh-list
24637068|NCT01148472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24637069|NCT01148472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637071|NCT01148472|Serotonin Agents|serotonin agents|mesh-ancestor
24637072|NCT01148472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637073|NCT01148472|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24637074|NCT01148472|Antidepressive Agents|antidepressive agents|mesh-ancestor
24637075|NCT01148472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24637076|NCT01148472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24637077|NCT01148472|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24637078|NCT01148472|Analgesics|analgesics|mesh-ancestor
24637079|NCT01148472|Sensory System Agents|sensory system agents|mesh-ancestor
24637080|NCT01148472|Dopamine Agents|dopamine agents|mesh-ancestor
24637081|NCT01148576|Vitamin E|vitamin e|mesh-list
24637082|NCT01148576|Entecavir|entecavir|mesh-list
24637084|NCT01148576|Vitamins|vitamins|mesh-ancestor
24637085|NCT01148576|Micronutrients|micronutrients|mesh-ancestor
24637086|NCT01148576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637087|NCT01148576|Antiviral Agents|antiviral agents|mesh-ancestor
24637088|NCT01148576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24637089|NCT01148576|Antioxidants|antioxidants|mesh-ancestor
24637090|NCT01148576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637116|NCT01148628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25264688|NCT02439034|Analgesics|analgesics|mesh-ancestor
25264689|NCT02439034|Sensory System Agents|sensory system agents|mesh-ancestor
25264690|NCT02439034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25264691|NCT02439034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264692|NCT02439034|Antipyretics|antipyretics|mesh-ancestor
25264693|NCT02439034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25264694|NCT02439034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25264695|NCT02439034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25264696|NCT02439034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25264697|NCT02439034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264698|NCT02439034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264699|NCT02439034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25264700|NCT02439034|Narcotics|narcotics|mesh-ancestor
25264701|NCT02439034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25264702|NCT02439034|Antitussive Agents|antitussive agents|mesh-ancestor
25264703|NCT02439034|Respiratory System Agents|respiratory system agents|mesh-ancestor
25264704|NCT02438982|Rituximab|rituximab|mesh-list
25264705|NCT02438982|Tacrolimus|tacrolimus|mesh-list
25264706|NCT02438982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
25264707|NCT02438982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25264708|NCT02438982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25264709|NCT02438982|Immunologic Factors|immunologic factors|mesh-ancestor
25264710|NCT02438982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264711|NCT02438982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25264712|NCT02438982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25264713|NCT02438982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533426|NCT00643825|Alkylating Agents|alkylating agents|mesh-ancestor
24533427|NCT00643825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533428|NCT00643825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24533429|NCT00643877|Oxaliplatin|oxaliplatin|mesh-list
24456115|NCT00330135|Viscosupplements|viscosupplements|mesh-ancestor
24456117|NCT00330148|Eflornithine|eflornithine|mesh-list
24456125|NCT00330148|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
24456127|NCT00330148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515285|NCT00596154|Immunologic Factors|immunologic factors|mesh-ancestor
24637117|NCT01148628|Immunologic Factors|immunologic factors|mesh-ancestor
24637118|NCT01148628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637119|NCT01148667|Caseins|caseins|mesh-list
24637133|NCT01148992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637134|NCT01148992|Sensory System Agents|sensory system agents|mesh-ancestor
24637135|NCT01148992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24855481|NCT02279875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637311|NCT01149798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637312|NCT01149824|Salvinorin A|salvinorin a|mesh-list
24637313|NCT01149824|Hallucinogens|hallucinogens|mesh-ancestor
24637314|NCT01149824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264714|NCT02438982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264715|NCT02438709|Etoricoxib|etoricoxib|mesh-list
25264716|NCT02438709|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
25264717|NCT02438709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25264718|NCT02438709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25264719|NCT02438709|Analgesics|analgesics|mesh-ancestor
25264720|NCT02438709|Sensory System Agents|sensory system agents|mesh-ancestor
25264721|NCT02438709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25264722|NCT02438709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264723|NCT02438709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25264724|NCT02438709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25264725|NCT02438709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25264726|NCT02438709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264727|NCT02438709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264728|NCT02438761|Gedatolisib|gedatolisib|mesh-list
25264729|NCT02438761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25264730|NCT02438761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264731|NCT02438761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264732|NCT02438683|BI 409306|bi 409306|mesh-list
25264733|NCT02438683|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25264734|NCT02438683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264735|NCT02438683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264736|NCT02438852|Ropivacaine|ropivacaine|mesh-list
25264737|NCT02438852|Anesthetics, Local|anesthetics, local|mesh-ancestor
25264738|NCT02438852|Anesthetics|anesthetics|mesh-ancestor
25264739|NCT02438852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25264740|NCT02438852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264741|NCT02438852|Sensory System Agents|sensory system agents|mesh-ancestor
25264742|NCT02438852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24456129|NCT00330239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24456130|NCT00330239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24456131|NCT00330239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24456132|NCT00330239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456133|NCT00330239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24533435|NCT00644020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533436|NCT00644020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24533438|NCT00644020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24533439|NCT00644020|Immunologic Factors|immunologic factors|mesh-ancestor
24533440|NCT00644020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533441|NCT00644020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24782158|NCT01894451|Bevacizumab|bevacizumab|mesh-list
24417171|NCT00205751|Prednisone|prednisone|mesh-list
24637421|NCT01150162|Protective Agents|protective agents|mesh-ancestor
25264744|NCT02438657|Epinephrine|epinephrine|mesh-list
25264745|NCT02438657|Anesthetics, Local|anesthetics, local|mesh-ancestor
25264746|NCT02438657|Anesthetics|anesthetics|mesh-ancestor
25264747|NCT02438657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25264748|NCT02438657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264749|NCT02438657|Sensory System Agents|sensory system agents|mesh-ancestor
25264750|NCT02438657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25264751|NCT02438657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25264752|NCT02438657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25264753|NCT02438657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25264754|NCT02438657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25264755|NCT02438657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264756|NCT02438657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25264757|NCT02438657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25264758|NCT02438657|Adrenergic Agents|adrenergic agents|mesh-ancestor
25264759|NCT02438657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25264760|NCT02438657|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25264761|NCT02438657|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25264762|NCT02438657|Autonomic Agents|autonomic agents|mesh-ancestor
25264763|NCT02438657|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25264764|NCT02438657|Respiratory System Agents|respiratory system agents|mesh-ancestor
25264765|NCT02438657|Mydriatics|mydriatics|mesh-ancestor
25264766|NCT02438657|Sympathomimetics|sympathomimetics|mesh-ancestor
25264767|NCT02438657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25264768|NCT02438865|Epirubicin|epirubicin|mesh-list
25264769|NCT02438865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25264770|NCT02438865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25264772|NCT02438865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25264773|NCT02438865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264774|NCT02438865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264775|NCT02438566|Tranexamic Acid|tranexamic acid|mesh-list
25264776|NCT02438566|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25264777|NCT02438566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25264778|NCT02438566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456172|NCT00330317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456173|NCT00330317|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24456174|NCT00330317|Hormone Antagonists|hormone antagonists|mesh-ancestor
24456175|NCT00330317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24456176|NCT00330317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456178|NCT00330395|Antifungal Agents|antifungal agents|mesh-ancestor
24456179|NCT00330395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24456180|NCT00330395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456181|NCT00330395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456182|NCT00330486|Acamprosate|acamprosate|mesh-list
24456183|NCT00330486|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24456184|NCT00330499|Cisplatin|cisplatin|mesh-list
24456185|NCT00330499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637422|NCT01150162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637424|NCT01150201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24637425|NCT01150201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24637426|NCT01150201|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24637427|NCT01150201|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24637428|NCT01150201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637429|NCT01150266|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24637430|NCT01150266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24637431|NCT01150266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24637432|NCT01150266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637434|NCT01150318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24637436|NCT01150318|Trace Elements|trace elements|mesh-ancestor
24637437|NCT01150318|Micronutrients|micronutrients|mesh-ancestor
24485583|NCT00453804|Naltrexone|naltrexone|mesh-list
24637625|NCT01151865|Dexmedetomidine|dexmedetomidine|mesh-list
24637626|NCT01151865|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24637647|NCT01151943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24637650|NCT01152047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24637651|NCT01152047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637653|NCT01152203|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24637654|NCT01152203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24637723|NCT01152749|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24637724|NCT01152749|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24637725|NCT01152749|Cholinergic Agents|cholinergic agents|mesh-ancestor
24637726|NCT01152749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24637759|NCT01152931|Micronutrients|micronutrients|mesh-ancestor
24637761|NCT01152931|Trace Elements|trace elements|mesh-ancestor
24637791|NCT01153191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24637792|NCT01153191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24637811|NCT01153217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24637812|NCT01153217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24855498|NCT02279914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532037|NCT00637897|Paclitaxel|paclitaxel|mesh-list
24637813|NCT01153217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25264779|NCT02438566|Hemostatics|hemostatics|mesh-ancestor
25264780|NCT02438566|Coagulants|coagulants|mesh-ancestor
25264781|NCT02438345|Leronlimab|leronlimab|mesh-list
25264782|NCT02438345|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25264783|NCT02438345|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25264784|NCT02438345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264785|NCT02438345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25264786|NCT02438345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25264787|NCT02438345|Antiviral Agents|antiviral agents|mesh-ancestor
25264788|NCT02438345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25264789|NCT02438397|Insulin|insulin|mesh-list
25264790|NCT02438397|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25264791|NCT02438397|Metformin|metformin|mesh-list
25264792|NCT02438397|Acarbose|acarbose|mesh-list
25264793|NCT02438397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25264794|NCT02438397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264795|NCT02438397|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25264796|NCT02438397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264797|NCT02438397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456186|NCT00330525|Sibutramine|sibutramine|mesh-list
24456187|NCT00330525|Antidepressive Agents|antidepressive agents|mesh-ancestor
24456188|NCT00330525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24456189|NCT00330525|Appetite Depressants|appetite depressants|mesh-ancestor
24456190|NCT00330525|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24456191|NCT00330577|Timolol|timolol|mesh-list
24456192|NCT00330577|Latanoprost|latanoprost|mesh-list
24456193|NCT00330577|Lubricant Eye Drops|lubricant eye drops|mesh-list
24456194|NCT00330577|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24456195|NCT00330577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24456196|NCT00330577|Adrenergic Agents|adrenergic agents|mesh-ancestor
24456197|NCT00330577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24637814|NCT01153217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637815|NCT01153217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637817|NCT01153217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24637818|NCT01153243|Vitamin D|vitamin d|mesh-list
24637819|NCT01153243|Ergocalciferols|ergocalciferols|mesh-list
24637820|NCT01153243|Vitamins|vitamins|mesh-ancestor
24637821|NCT01153243|Micronutrients|micronutrients|mesh-ancestor
24637822|NCT01153243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637823|NCT01153243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25264798|NCT02438098|Rivaroxaban|rivaroxaban|mesh-list
25264799|NCT02438098|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25264800|NCT02438098|Antithrombins|antithrombins|mesh-ancestor
25264801|NCT02438098|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25264802|NCT02438098|Protease Inhibitors|protease inhibitors|mesh-ancestor
25264803|NCT02438098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264804|NCT02438098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264805|NCT02438098|Anticoagulants|anticoagulants|mesh-ancestor
25264806|NCT02437825|Octreotide|octreotide|mesh-list
25264807|NCT02437825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25264808|NCT02437825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25264809|NCT02437825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25264810|NCT02438072|Fexofenadine|fexofenadine|mesh-list
25264811|NCT02438072|Flurbiprofen|flurbiprofen|mesh-list
25264812|NCT02438072|Midazolam|midazolam|mesh-list
25264813|NCT02438072|Dextromethorphan|dextromethorphan|mesh-list
25264814|NCT02438072|Caffeine|caffeine|mesh-list
25264815|NCT02438072|Bupropion|bupropion|mesh-list
25264816|NCT02438072|Omeprazole|omeprazole|mesh-list
25264817|NCT02438072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25264818|NCT02438072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25264819|NCT02438072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25264820|NCT02438072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264821|NCT02438072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25264822|NCT02438072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25264823|NCT02438072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25264824|NCT02438072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25264825|NCT02438072|Anesthetics, General|anesthetics, general|mesh-ancestor
25264826|NCT02438072|Anesthetics|anesthetics|mesh-ancestor
25264827|NCT02438072|GABA Modulators|gaba modulators|mesh-ancestor
25264828|NCT02438072|GABA Agents|gaba agents|mesh-ancestor
25264829|NCT02438072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25264847|NCT02438072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25264831|NCT02438072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25264832|NCT02438072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25155621|NCT05323552|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24713739|NCT01527305|Dopamine Agents|dopamine agents|mesh-ancestor
24767746|NCT01802931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24767747|NCT01802931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767748|NCT01802931|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24767750|NCT01802944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24767751|NCT01802944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767753|NCT01802970|Vinorelbine|vinorelbine|mesh-list
24637824|NCT01153243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24637825|NCT01153256|Magnesium Sulfate|magnesium sulfate|mesh-list
24637827|NCT01153256|Sensory System Agents|sensory system agents|mesh-ancestor
24637883|NCT01153802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24637884|NCT01153802|Adrenergic Agents|adrenergic agents|mesh-ancestor
24637885|NCT01153802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637886|NCT01153802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637887|NCT01153802|Sympathomimetics|sympathomimetics|mesh-ancestor
24637888|NCT01153802|Autonomic Agents|autonomic agents|mesh-ancestor
24637889|NCT01153802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24637890|NCT01153802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24637892|NCT01153802|Dopamine Agents|dopamine agents|mesh-ancestor
24637893|NCT01153802|Protective Agents|protective agents|mesh-ancestor
24637894|NCT01153802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24637895|NCT01153802|Serotonin Agents|serotonin agents|mesh-ancestor
24637896|NCT01153828|Mupirocin|mupirocin|mesh-list
24637897|NCT01153828|Retapamulin|retapamulin|mesh-list
24638057|NCT01154738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638058|NCT01154764|Ketoconazole|ketoconazole|mesh-list
24638059|NCT01154764|Antifungal Agents|antifungal agents|mesh-ancestor
24638073|NCT01154790|Analgesics|analgesics|mesh-ancestor
25264833|NCT02438072|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25264834|NCT02438072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264835|NCT02438072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25264836|NCT02438072|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25264837|NCT02438072|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25264838|NCT02438072|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25264839|NCT02438072|Purinergic Agents|purinergic agents|mesh-ancestor
25264840|NCT02438072|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25264841|NCT02438072|Antidepressive Agents|antidepressive agents|mesh-ancestor
25264842|NCT02438072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25264843|NCT02438072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25264844|NCT02438072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25264845|NCT02438072|Dopamine Agents|dopamine agents|mesh-ancestor
25264846|NCT02438072|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25264848|NCT02438072|Antitussive Agents|antitussive agents|mesh-ancestor
25264849|NCT02438072|Respiratory System Agents|respiratory system agents|mesh-ancestor
24456211|NCT00330655|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25264850|NCT02438072|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25264851|NCT02438072|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25264852|NCT02438072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25264854|NCT02438072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25264855|NCT02438072|Histamine Antagonists|histamine antagonists|mesh-ancestor
25264856|NCT02438072|Histamine Agents|histamine agents|mesh-ancestor
25264857|NCT02438072|Analgesics|analgesics|mesh-ancestor
25264858|NCT02438072|Sensory System Agents|sensory system agents|mesh-ancestor
25264859|NCT02438072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25264860|NCT02438072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25264861|NCT02438072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25264862|NCT02438072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25264863|NCT02438072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25264864|NCT02438072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25264865|NCT02438020|Metformin|metformin|mesh-list
25264866|NCT02438020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25264867|NCT02438020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264868|NCT02437812|Metformin|metformin|mesh-list
25264869|NCT02437812|Paclitaxel|paclitaxel|mesh-list
25264870|NCT02437812|Carboplatin|carboplatin|mesh-list
25264871|NCT02437812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25264872|NCT02437812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25264873|NCT02437812|Tubulin Modulators|tubulin modulators|mesh-ancestor
25264874|NCT02437812|Antimitotic Agents|antimitotic agents|mesh-ancestor
25264875|NCT02437812|Mitosis Modulators|mitosis modulators|mesh-ancestor
25264876|NCT02437812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264877|NCT02437812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25264878|NCT02437812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264879|NCT02437955|Ferrous fumarate|ferrous fumarate|mesh-list
25264880|NCT02437955|Trace Elements|trace elements|mesh-ancestor
25264881|NCT02437955|Micronutrients|micronutrients|mesh-ancestor
25264882|NCT02437955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275354|NCT02372786|Lidocaine|lidocaine|mesh-list
25275355|NCT02372786|Tetracaine|tetracaine|mesh-list
25275356|NCT02372786|Prilocaine|prilocaine|mesh-list
25275357|NCT02372786|Anesthetics, Local|anesthetics, local|mesh-ancestor
25275358|NCT02372786|Anesthetics|anesthetics|mesh-ancestor
25275359|NCT02372786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25155622|NCT05323552|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25155623|NCT05323552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25155624|NCT05323552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25050343|NCT00517153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24638074|NCT01154790|Sensory System Agents|sensory system agents|mesh-ancestor
24638075|NCT01154790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24638076|NCT01154790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638077|NCT01154790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24638078|NCT01154790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24638079|NCT01154790|Gout Suppressants|gout suppressants|mesh-ancestor
24638080|NCT01154790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24638081|NCT01154790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24638082|NCT01154790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638083|NCT01154803|Micronutrients|micronutrients|mesh-list
24638084|NCT01154803|Trace Elements|trace elements|mesh-list
24638107|NCT01154881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24638168|NCT01155102|Hormone Antagonists|hormone antagonists|mesh-ancestor
24638169|NCT01155102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24638170|NCT01155102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638172|NCT01155115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24638173|NCT01155115|Autonomic Agents|autonomic agents|mesh-ancestor
24638174|NCT01155115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24855512|NCT02279953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855513|NCT02279953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24855514|NCT02279953|Serotonin Agents|serotonin agents|mesh-ancestor
24855515|NCT02279953|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24855516|NCT02279953|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24911039|NCT04291287|Fibrinolytic Agents|fibrinolytic agents|mesh-list
24638181|NCT01155115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24638184|NCT01155115|Gasotransmitters|gasotransmitters|mesh-ancestor
24638185|NCT01155115|Protective Agents|protective agents|mesh-ancestor
24638197|NCT01155232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24638198|NCT01155245|Teriparatide|teriparatide|mesh-list
24638199|NCT01155245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24638212|NCT01155258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24638213|NCT01155258|Tubulin Modulators|tubulin modulators|mesh-ancestor
24638214|NCT01155258|Antimitotic Agents|antimitotic agents|mesh-ancestor
24638215|NCT01155258|Mitosis Modulators|mitosis modulators|mesh-ancestor
24638216|NCT01155258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638218|NCT01155440|Anesthetics, Local|anesthetics, local|mesh-ancestor
24638219|NCT01155440|Anesthetics|anesthetics|mesh-ancestor
24638220|NCT01155440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24638221|NCT01155440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638222|NCT01155440|Sensory System Agents|sensory system agents|mesh-ancestor
24638223|NCT01155440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24638224|NCT01155440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24638225|NCT01155440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25264883|NCT02437461|Triamcinolone|triamcinolone|mesh-list
25264884|NCT02437461|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25264885|NCT02437461|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25264886|NCT02437461|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25264887|NCT02437461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25264888|NCT02437461|Glucocorticoids|glucocorticoids|mesh-ancestor
25264889|NCT02437461|Hormones|hormones|mesh-ancestor
25264890|NCT02437461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25264891|NCT02437461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264892|NCT02437461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25264893|NCT02437461|Immunologic Factors|immunologic factors|mesh-ancestor
25264894|NCT02437461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25155626|NCT05323552|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25155627|NCT05323552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25155629|NCT05323552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24621155|NCT01060891|Colistin|colistin|mesh-list
24638226|NCT01155440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24638227|NCT01155440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24638228|NCT01155440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638230|NCT01155453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638231|NCT01155453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24638232|NCT01155453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24638258|NCT01155700|Omalizumab|omalizumab|mesh-list
24638259|NCT01155700|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24638260|NCT01155700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24638261|NCT01155700|Respiratory System Agents|respiratory system agents|mesh-ancestor
24638334|NCT01155947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24638335|NCT01155947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638390|NCT01156350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24638394|NCT01156389|Pyronaridine|pyronaridine|mesh-list
24638395|NCT01156389|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24638396|NCT01156389|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24638397|NCT01156389|Protease Inhibitors|protease inhibitors|mesh-ancestor
24638398|NCT01156389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24638399|NCT01156389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638400|NCT01156389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24638401|NCT01156389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24638402|NCT01156389|Antiviral Agents|antiviral agents|mesh-ancestor
24911099|NCT04291066|Acetylcysteine|acetylcysteine|mesh-list
24638489|NCT01156883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24638490|NCT01156883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24638491|NCT01156883|Antiemetics|antiemetics|mesh-ancestor
24638492|NCT01156883|Autonomic Agents|autonomic agents|mesh-ancestor
24638493|NCT01156883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24572753|NCT00816543|Docetaxel|docetaxel|mesh-list
24638494|NCT01156883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24638495|NCT01156883|Glucocorticoids|glucocorticoids|mesh-ancestor
24638496|NCT01156883|Hormones|hormones|mesh-ancestor
24638609|NCT01157312|Sequestering Agents|sequestering agents|mesh-ancestor
24638610|NCT01157312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638611|NCT01157312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24638612|NCT01157312|Hormone Antagonists|hormone antagonists|mesh-ancestor
24638613|NCT01157312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24911172|NCT04290429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24638722|NCT01157754|Levonorgestrel|levonorgestrel|mesh-list
24638744|NCT01157858|Immunologic Factors|immunologic factors|mesh-ancestor
24638746|NCT01157858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24638750|NCT01157936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638751|NCT01157936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24638752|NCT01157936|Gout Suppressants|gout suppressants|mesh-ancestor
24638753|NCT01157936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25264895|NCT02437461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264896|NCT02437721|Folic Acid|folic acid|mesh-list
25264897|NCT02437721|Vitamin B Complex|vitamin b complex|mesh-list
25264898|NCT02437721|Hematinics|hematinics|mesh-ancestor
25264899|NCT02437721|Vitamins|vitamins|mesh-ancestor
25264900|NCT02437721|Micronutrients|micronutrients|mesh-ancestor
25264901|NCT02437721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264902|NCT02437565|Salicylic Acid|salicylic acid|mesh-list
25264903|NCT02437565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25264904|NCT02437565|Antifungal Agents|antifungal agents|mesh-ancestor
25264905|NCT02437565|Keratolytic Agents|keratolytic agents|mesh-ancestor
24456216|NCT00330707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24456217|NCT00330707|Antiviral Agents|antiviral agents|mesh-ancestor
24456218|NCT00330707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24456219|NCT00330707|Immunologic Factors|immunologic factors|mesh-ancestor
24456220|NCT00330707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404777|NCT00164801|Diltiazem|diltiazem|mesh-list
24456221|NCT00330707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24456223|NCT00330746|Cetuximab|cetuximab|mesh-list
24456224|NCT00330746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24456225|NCT00330746|Antimetabolites|antimetabolites|mesh-ancestor
25050367|NCT00514267|Hormones|hormones|mesh-ancestor
24638754|NCT01157936|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24638756|NCT01157936|Protective Agents|protective agents|mesh-ancestor
24638757|NCT01157936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638758|NCT01157949|Thymoglobulin|thymoglobulin|mesh-list
24638759|NCT01157949|Immunologic Factors|immunologic factors|mesh-ancestor
24638760|NCT01157949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638761|NCT01157949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24638764|NCT01157975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24638765|NCT01157975|Glucocorticoids|glucocorticoids|mesh-ancestor
24638766|NCT01157975|Hormones|hormones|mesh-ancestor
24638767|NCT01157975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24638768|NCT01157975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638769|NCT01157975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24638770|NCT01157975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638771|NCT01157975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24638851|NCT01158755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24638852|NCT01158755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24638853|NCT01158755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24638854|NCT01158755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24638856|NCT01158755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638857|NCT01158755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638858|NCT01158846|Bivalirudin|bivalirudin|mesh-list
24638860|NCT01158846|Clopidogrel|clopidogrel|mesh-list
24638861|NCT01158846|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24638862|NCT01158846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24638863|NCT01158846|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24638893|NCT01159080|Tacrolimus|tacrolimus|mesh-list
24638894|NCT01159080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24638895|NCT01159080|Immunologic Factors|immunologic factors|mesh-ancestor
24638896|NCT01159080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638897|NCT01159080|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24638898|NCT01159080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24638899|NCT01159080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638900|NCT01159080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24638901|NCT01159080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638902|NCT01159080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24638903|NCT01159080|Antitubercular Agents|antitubercular agents|mesh-ancestor
24638904|NCT01159080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24638905|NCT01159080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24638906|NCT01159132|Raltegravir Potassium|raltegravir potassium|mesh-list
24638907|NCT01159132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24638908|NCT01159132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24638909|NCT01159132|Antiviral Agents|antiviral agents|mesh-ancestor
24638910|NCT01159132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25264906|NCT02437565|Dermatologic Agents|dermatologic agents|mesh-ancestor
25264907|NCT02437591|Fidaxomicin|fidaxomicin|mesh-list
25264908|NCT02437591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25264909|NCT02437591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25264910|NCT02437656|Metformin|metformin|mesh-list
25264911|NCT02437656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25264912|NCT02437656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264913|NCT02437045|Meropenem|meropenem|mesh-list
25264914|NCT02437045|Tazobactam|tazobactam|mesh-list
25264915|NCT02437045|Piperacillin|piperacillin|mesh-list
25264916|NCT02437045|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25264917|NCT02437045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25264918|NCT02437045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25264919|NCT02437045|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24394237|NCT00132639|Tubulin Modulators|tubulin modulators|mesh-ancestor
24638911|NCT01159132|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24638912|NCT01159132|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24638913|NCT01159132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24638945|NCT01159236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24638946|NCT01159236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24638947|NCT01159236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24638948|NCT01159236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24638949|NCT01159236|Growth Substances|growth substances|mesh-ancestor
24638950|NCT01159236|Growth Inhibitors|growth inhibitors|mesh-ancestor
24638951|NCT01159236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24855526|NCT02279966|Serotonin Agents|serotonin agents|mesh-ancestor
24855527|NCT02279966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855528|NCT02279966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24638952|NCT01159236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24638953|NCT01159236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24638954|NCT01159236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24638955|NCT01159236|Antimetabolites|antimetabolites|mesh-ancestor
24638956|NCT01159236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24638957|NCT01159275|Lopinavir|lopinavir|mesh-list
24638958|NCT01159275|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24638959|NCT01159275|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24638960|NCT01159275|Protease Inhibitors|protease inhibitors|mesh-ancestor
24638961|NCT01159275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688745|NCT01950364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638962|NCT01159275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638963|NCT01159275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24638964|NCT01159275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25688746|NCT01950364|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25688747|NCT01950364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25688748|NCT01950364|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25688749|NCT01950364|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24638965|NCT01159275|Antiviral Agents|antiviral agents|mesh-ancestor
24638966|NCT01159275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24638969|NCT01159301|Sorafenib|sorafenib|mesh-list
24638971|NCT01159301|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
24638972|NCT01159301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638973|NCT01159301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24638975|NCT01159301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638976|NCT01159327|Sorafenib|sorafenib|mesh-list
25264920|NCT02437045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264921|NCT02437045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264922|NCT02436993|Paclitaxel|paclitaxel|mesh-list
25264923|NCT02436993|Bevacizumab|bevacizumab|mesh-list
25264924|NCT02436993|Carboplatin|carboplatin|mesh-list
25264925|NCT02436993|Trastuzumab|trastuzumab|mesh-list
25264926|NCT02436993|Pertuzumab|pertuzumab|mesh-list
25264927|NCT02436993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25264928|NCT02436993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25264929|NCT02436993|Tubulin Modulators|tubulin modulators|mesh-ancestor
25264930|NCT02436993|Antimitotic Agents|antimitotic agents|mesh-ancestor
25264931|NCT02436993|Mitosis Modulators|mitosis modulators|mesh-ancestor
25264932|NCT02436993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264933|NCT02436993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25264934|NCT02436993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25264935|NCT02436993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25264936|NCT02436993|Growth Substances|growth substances|mesh-ancestor
25264937|NCT02436993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456237|NCT00330772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24456240|NCT00330772|Sensory System Agents|sensory system agents|mesh-ancestor
24456241|NCT00330772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24456242|NCT00330772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456243|NCT00330772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24456244|NCT00330772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24456245|NCT00330772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24456246|NCT00330772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24456247|NCT00330772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638977|NCT01159327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638978|NCT01159327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24638979|NCT01159327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24638980|NCT01159327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638993|NCT01159418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24638994|NCT01159418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638996|NCT01159418|Antimitotic Agents|antimitotic agents|mesh-ancestor
24855531|NCT02279966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24855532|NCT02279966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24855533|NCT02279966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639066|NCT01159847|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24639067|NCT01159847|Protease Inhibitors|protease inhibitors|mesh-ancestor
24639068|NCT01159847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639211|NCT01160627|Antidotes|antidotes|mesh-ancestor
24639069|NCT01159847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639071|NCT01160029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24639072|NCT01160029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639073|NCT01160042|Metformin|metformin|mesh-list
24639074|NCT01160042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24639075|NCT01160042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639076|NCT01160068|Metformin|metformin|mesh-list
24639077|NCT01160068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24639078|NCT01160068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639079|NCT01160172|Vaccines|vaccines|mesh-list
24639080|NCT01160172|Immunologic Factors|immunologic factors|mesh-ancestor
24639081|NCT01160172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639082|NCT01160185|Paclitaxel|paclitaxel|mesh-list
24639083|NCT01160185|Topotecan|topotecan|mesh-list
24639084|NCT01160185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24639085|NCT01160185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639109|NCT01160276|Antimitotic Agents|antimitotic agents|mesh-ancestor
24639110|NCT01160276|Mitosis Modulators|mitosis modulators|mesh-ancestor
24639111|NCT01160276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639132|NCT01160315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24639135|NCT01160315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24639160|NCT01160341|Anabolic Agents|anabolic agents|mesh-ancestor
24639161|NCT01160419|Leucovorin|leucovorin|mesh-list
24639162|NCT01160419|Folic Acid|folic acid|mesh-list
24639163|NCT01160419|Docetaxel|docetaxel|mesh-list
24639164|NCT01160419|Oxaliplatin|oxaliplatin|mesh-list
24639165|NCT01160419|Levoleucovorin|levoleucovorin|mesh-list
24639166|NCT01160419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639167|NCT01160419|Tubulin Modulators|tubulin modulators|mesh-ancestor
24639168|NCT01160419|Antimitotic Agents|antimitotic agents|mesh-ancestor
24639169|NCT01160419|Mitosis Modulators|mitosis modulators|mesh-ancestor
24639170|NCT01160419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264938|NCT02436993|Growth Inhibitors|growth inhibitors|mesh-ancestor
25264939|NCT02436980|Midazolam|midazolam|mesh-list
25264940|NCT02436980|Tramadol|tramadol|mesh-list
25264941|NCT02436980|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25264942|NCT02436980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25264943|NCT02436980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25264944|NCT02436980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264945|NCT02436980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25264946|NCT02436980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25264947|NCT02436980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25264948|NCT02436980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25264949|NCT02436980|Anesthetics, General|anesthetics, general|mesh-ancestor
25264950|NCT02436980|Anesthetics|anesthetics|mesh-ancestor
24533460|NCT00644085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24639171|NCT01160419|Antidotes|antidotes|mesh-ancestor
24639172|NCT01160419|Protective Agents|protective agents|mesh-ancestor
24639173|NCT01160419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639174|NCT01160419|Vitamin B Complex|vitamin b complex|mesh-ancestor
24639175|NCT01160419|Vitamins|vitamins|mesh-ancestor
24855534|NCT02279966|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24855535|NCT02279966|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24855536|NCT02279966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24639205|NCT01160627|Respiratory System Agents|respiratory system agents|mesh-ancestor
24639206|NCT01160627|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24639207|NCT01160627|Antioxidants|antioxidants|mesh-ancestor
24639208|NCT01160627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639209|NCT01160627|Protective Agents|protective agents|mesh-ancestor
24639210|NCT01160627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639212|NCT01160666|Belimumab|belimumab|mesh-list
24639213|NCT01160666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24639214|NCT01160666|Immunologic Factors|immunologic factors|mesh-ancestor
24639215|NCT01160666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639216|NCT01160705|Docetaxel|docetaxel|mesh-list
24639217|NCT01160705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639218|NCT01160705|Tubulin Modulators|tubulin modulators|mesh-ancestor
24639219|NCT01160705|Antimitotic Agents|antimitotic agents|mesh-ancestor
24666996|NCT01321827|Hormones|hormones|mesh-ancestor
24639220|NCT01160705|Mitosis Modulators|mitosis modulators|mesh-ancestor
24639221|NCT01160705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639222|NCT01160718|Fulvestrant|fulvestrant|mesh-list
24855548|NCT02279992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855549|NCT02279992|Urological Agents|urological agents|mesh-ancestor
24855550|NCT02280031|Aspirin|aspirin|mesh-list
24639261|NCT01160952|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24639262|NCT01160952|Hormone Antagonists|hormone antagonists|mesh-ancestor
24964366|NCT03783754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964367|NCT03783754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24964372|NCT03783754|Diuretics|diuretics|mesh-ancestor
24948809|NCT05402189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24948810|NCT05402189|Narcotics|narcotics|mesh-ancestor
24948811|NCT05402189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24948812|NCT05402189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948813|NCT05402189|Analgesics|analgesics|mesh-ancestor
24639263|NCT01160952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24639264|NCT01160952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264951|NCT02436980|GABA Modulators|gaba modulators|mesh-ancestor
25264952|NCT02436980|GABA Agents|gaba agents|mesh-ancestor
25264953|NCT02436980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25264954|NCT02436980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264955|NCT02436980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25264956|NCT02436980|Narcotics|narcotics|mesh-ancestor
25264957|NCT02436980|Analgesics|analgesics|mesh-ancestor
25264958|NCT02436980|Sensory System Agents|sensory system agents|mesh-ancestor
25264959|NCT02436980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25264960|NCT02437032|Menotropins|menotropins|mesh-list
25264961|NCT02437032|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25264962|NCT02437032|Fertility Agents|fertility agents|mesh-ancestor
25264963|NCT02437032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25264964|NCT02437032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264965|NCT02436928|Vaccines|vaccines|mesh-list
25264966|NCT02436928|Immunologic Factors|immunologic factors|mesh-ancestor
25264967|NCT02436928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264968|NCT02436902|Sorafenib|sorafenib|mesh-list
25264969|NCT02436902|Chlorotrianisene|chlorotrianisene|mesh-list
25264970|NCT02436902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25264971|NCT02436902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24456248|NCT00330772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24456249|NCT00330772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24533458|NCT00644085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24533459|NCT00644085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24533461|NCT00644085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24533462|NCT00644085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533463|NCT00644085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24533464|NCT00644085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24533465|NCT00644085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456735|NCT00332072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456736|NCT00332072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639265|NCT01160952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24639267|NCT01160965|Levobupivacaine|levobupivacaine|mesh-list
24639268|NCT01160965|Anesthetics, Local|anesthetics, local|mesh-ancestor
24639269|NCT01160965|Anesthetics|anesthetics|mesh-ancestor
24639270|NCT01160965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24639271|NCT01160965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639272|NCT01160965|Sensory System Agents|sensory system agents|mesh-ancestor
24639303|NCT01161017|Topiramate|topiramate|mesh-list
24639356|NCT01161147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688750|NCT01950364|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25688751|NCT01950364|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25688752|NCT01950741|Aflibercept|aflibercept|mesh-list
25688753|NCT01950741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25688754|NCT01950741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25688755|NCT01950741|Growth Substances|growth substances|mesh-ancestor
25688756|NCT01950741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688757|NCT01950741|Growth Inhibitors|growth inhibitors|mesh-ancestor
25688758|NCT01950741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688759|NCT01950819|Cyclosporine|cyclosporine|mesh-list
24948939|NCT05401032|Tamsulosin|tamsulosin|mesh-list
24639357|NCT01161147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639358|NCT01161186|Gemcitabine|gemcitabine|mesh-list
24639374|NCT01161186|Immunologic Factors|immunologic factors|mesh-ancestor
24639375|NCT01161186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855558|NCT02280031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24855559|NCT02280031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24855560|NCT02280031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24855561|NCT02280031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457948|NCT00335699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639377|NCT01161277|Aripiprazole|aripiprazole|mesh-list
24639378|NCT01161277|Haloperidol decanoate|haloperidol decanoate|mesh-list
24639379|NCT01161277|Antidepressive Agents|antidepressive agents|mesh-ancestor
24639380|NCT01161277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24639381|NCT01161277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24639382|NCT01161277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25264972|NCT02436902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25264973|NCT02436902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264974|NCT02436902|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25264975|NCT02436902|Estrogens|estrogens|mesh-ancestor
25264976|NCT02436902|Hormones|hormones|mesh-ancestor
24801578|NCT01984099|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25264977|NCT02436902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25264978|NCT02436902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264979|NCT02436902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25264980|NCT02436538|Hormones|hormones|mesh-list
25264981|NCT02436538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25264982|NCT02436538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264983|NCT02436798|Ondansetron|ondansetron|mesh-list
25264984|NCT02436798|Antiemetics|antiemetics|mesh-ancestor
25264985|NCT02436798|Autonomic Agents|autonomic agents|mesh-ancestor
25264986|NCT02436798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25264987|NCT02436798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25264988|NCT02436798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25264989|NCT02436798|Antipruritics|antipruritics|mesh-ancestor
25264990|NCT02436798|Dermatologic Agents|dermatologic agents|mesh-ancestor
25264991|NCT02436798|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25264992|NCT02436798|Serotonin Agents|serotonin agents|mesh-ancestor
25264993|NCT02436798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25264994|NCT02436798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25264995|NCT02436798|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24456297|NCT00330824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24456298|NCT00330824|Glucocorticoids|glucocorticoids|mesh-ancestor
24533466|NCT00644085|Antipyretics|antipyretics|mesh-ancestor
24533467|NCT00644111|Hydromorphone|hydromorphone|mesh-list
24533468|NCT00644111|Bupivacaine|bupivacaine|mesh-list
24533469|NCT00644111|Anesthetics, Local|anesthetics, local|mesh-ancestor
24456300|NCT00330824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24456301|NCT00330824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24456302|NCT00330824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24456303|NCT00330824|Protease Inhibitors|protease inhibitors|mesh-ancestor
24535716|NCT00649610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24535717|NCT00649610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535718|NCT00649610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24535719|NCT00649610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24763172|NCT01771874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24639407|NCT01161368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639408|NCT01161368|Tubulin Modulators|tubulin modulators|mesh-ancestor
24639409|NCT01161368|Antimitotic Agents|antimitotic agents|mesh-ancestor
24639410|NCT01161368|Mitosis Modulators|mitosis modulators|mesh-ancestor
24639411|NCT01161368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639412|NCT01161368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24639413|NCT01161368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639414|NCT01161459|Prednisone|prednisone|mesh-list
24639415|NCT01161459|Tacrolimus|tacrolimus|mesh-list
24639416|NCT01161459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24639417|NCT01161459|Glucocorticoids|glucocorticoids|mesh-ancestor
24639418|NCT01161459|Hormones|hormones|mesh-ancestor
24639419|NCT01161459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25688760|NCT01950819|Prednisone|prednisone|mesh-list
25688761|NCT01950819|Methylprednisolone|methylprednisolone|mesh-list
25688762|NCT01950819|Tacrolimus|tacrolimus|mesh-list
25688763|NCT01950819|Thymoglobulin|thymoglobulin|mesh-list
25688764|NCT01950819|Cyclosporins|cyclosporins|mesh-list
24948982|NCT05400889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24948983|NCT05400889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24948984|NCT05400889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948988|NCT05400148|Bupivacaine|bupivacaine|mesh-list
24639439|NCT01161550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24639440|NCT01161550|Immunologic Factors|immunologic factors|mesh-ancestor
24639441|NCT01161550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639442|NCT01161550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24639443|NCT01161550|Keratolytic Agents|keratolytic agents|mesh-ancestor
24639444|NCT01161550|Dermatologic Agents|dermatologic agents|mesh-ancestor
24639445|NCT01161550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24855562|NCT02280031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24855563|NCT02280031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24855564|NCT02280031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855565|NCT02280031|Antipyretics|antipyretics|mesh-ancestor
24855566|NCT02280057|Metformin|metformin|mesh-list
24855567|NCT02280057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24855568|NCT02280057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855569|NCT02280070|Leucovorin|leucovorin|mesh-list
24855570|NCT02280070|Fluorouracil|fluorouracil|mesh-list
24855571|NCT02280070|Tegafur|tegafur|mesh-list
24639456|NCT01161667|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25264996|NCT02436798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25264997|NCT02436798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25264998|NCT02436798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25264999|NCT02436798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25265000|NCT02436694|Dexamethasone|dexamethasone|mesh-list
25265001|NCT02436694|Dexamethasone acetate|dexamethasone acetate|mesh-list
25265002|NCT02436694|Ropivacaine|ropivacaine|mesh-list
25265003|NCT02436694|Anesthetics, Local|anesthetics, local|mesh-list
25265004|NCT02436694|Anesthetics|anesthetics|mesh-list
25265005|NCT02436694|BB 1101|bb 1101|mesh-list
25265006|NCT02436694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25265007|NCT02436694|Antiemetics|antiemetics|mesh-ancestor
25265008|NCT02436694|Autonomic Agents|autonomic agents|mesh-ancestor
25265009|NCT02436694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25265010|NCT02436694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265011|NCT02436694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25265012|NCT02436694|Glucocorticoids|glucocorticoids|mesh-ancestor
25265013|NCT02436694|Hormones|hormones|mesh-ancestor
25265014|NCT02436694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25265015|NCT02436694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25265016|NCT02436694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265017|NCT02436694|Protease Inhibitors|protease inhibitors|mesh-ancestor
25265018|NCT02436694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639457|NCT01161667|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24639458|NCT01161667|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24639460|NCT01161667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25688765|NCT01950819|Basiliximab|basiliximab|mesh-list
25688766|NCT01950819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25688767|NCT01950819|Glucocorticoids|glucocorticoids|mesh-ancestor
25688768|NCT01950819|Hormones|hormones|mesh-ancestor
25688769|NCT01950819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25688770|NCT01950819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688771|NCT01950819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25688772|NCT01950819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639461|NCT01161667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639462|NCT01161667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688773|NCT01950819|Antiemetics|antiemetics|mesh-ancestor
24574648|NCT00826657|Vitamins|vitamins|mesh-ancestor
24574649|NCT00826657|Micronutrients|micronutrients|mesh-ancestor
24574650|NCT00826657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574651|NCT00826657|Vitamin B Complex|vitamin b complex|mesh-ancestor
24574652|NCT00826657|Hematinics|hematinics|mesh-ancestor
24574653|NCT00826722|Levetiracetam|levetiracetam|mesh-list
24574654|NCT00826722|Anticonvulsants|anticonvulsants|mesh-ancestor
24574655|NCT00826722|Nootropic Agents|nootropic agents|mesh-ancestor
24639463|NCT01161836|Iniparib|iniparib|mesh-list
24639464|NCT01161836|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24639465|NCT01161836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639466|NCT01161836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639467|NCT01161836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639468|NCT01161888|Imiquimod|imiquimod|mesh-list
24639469|NCT01161888|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24639470|NCT01161888|Immunologic Factors|immunologic factors|mesh-ancestor
24855585|NCT02280070|Vitamin B Complex|vitamin b complex|mesh-ancestor
24855587|NCT02280070|Micronutrients|micronutrients|mesh-ancestor
24855588|NCT02280083|Botulinum Toxins|botulinum toxins|mesh-list
24855589|NCT02280083|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24855590|NCT02280083|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24639606|NCT01162967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24639607|NCT01162967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639609|NCT01162967|Immunologic Factors|immunologic factors|mesh-ancestor
24639610|NCT01163201|Cyclophosphamide|cyclophosphamide|mesh-list
24639612|NCT01163201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24639613|NCT01163201|Immunologic Factors|immunologic factors|mesh-ancestor
24639614|NCT01163201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639615|NCT01163201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24639616|NCT01163201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24639617|NCT01163201|Alkylating Agents|alkylating agents|mesh-ancestor
24639618|NCT01163201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639619|NCT01163201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639620|NCT01163201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24639621|NCT01163396|Leucovorin|leucovorin|mesh-list
24639622|NCT01163396|Bevacizumab|bevacizumab|mesh-list
24639623|NCT01163396|Fluorouracil|fluorouracil|mesh-list
24639714|NCT01164046|Tinzaparin|tinzaparin|mesh-list
24639715|NCT01164046|Dalteparin|dalteparin|mesh-list
24639716|NCT01164046|Nadroparin|nadroparin|mesh-list
24639717|NCT01164046|Reviparin|reviparin|mesh-list
24855591|NCT02280083|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24855592|NCT02280083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24855593|NCT02280083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855594|NCT02280083|Cholinergic Agents|cholinergic agents|mesh-ancestor
24855595|NCT02280083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24639718|NCT01164046|Warfarin|warfarin|mesh-list
24639719|NCT01164046|Phenprocoumon|phenprocoumon|mesh-list
24639720|NCT01164046|Acenocoumarol|acenocoumarol|mesh-list
24639721|NCT01164046|Bemiparin|bemiparin|mesh-list
24639722|NCT01164046|Certoparin|certoparin|mesh-list
24639723|NCT01164046|Vitamins|vitamins|mesh-ancestor
24639724|NCT01164046|Micronutrients|micronutrients|mesh-ancestor
24639761|NCT01164059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24639762|NCT01164059|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24639795|NCT01164215|Fluorouracil|fluorouracil|mesh-list
24639796|NCT01164215|Oxaliplatin|oxaliplatin|mesh-list
24639797|NCT01164215|Levoleucovorin|levoleucovorin|mesh-list
24639798|NCT01164215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639799|NCT01164215|Antimetabolites|antimetabolites|mesh-ancestor
25688774|NCT01950819|Autonomic Agents|autonomic agents|mesh-ancestor
25688775|NCT01950819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25688776|NCT01950819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25688777|NCT01950819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25688778|NCT01950819|Protective Agents|protective agents|mesh-ancestor
25688779|NCT01950819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25688780|NCT01950819|Immunologic Factors|immunologic factors|mesh-ancestor
25688781|NCT01950819|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24639800|NCT01164215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639801|NCT01164215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24639802|NCT01164215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639821|NCT01164306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24639822|NCT01164306|Cholinergic Agents|cholinergic agents|mesh-ancestor
24639855|NCT01164540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24949171|NCT05189457|Fertility Agents|fertility agents|mesh-ancestor
24639856|NCT01164540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639857|NCT01164605|Raltegravir Potassium|raltegravir potassium|mesh-list
25265019|NCT02436694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265020|NCT02436694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25265021|NCT02436694|Sensory System Agents|sensory system agents|mesh-ancestor
24639858|NCT01164605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24639859|NCT01164605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24639860|NCT01164605|Antiviral Agents|antiviral agents|mesh-ancestor
24639861|NCT01164605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24639879|NCT01164761|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24639881|NCT01164761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639882|NCT01164761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639883|NCT01164761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24639884|NCT01164774|Ramipril|ramipril|mesh-list
24855596|NCT02280083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855598|NCT02280083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24855599|NCT02280109|Tenofovir|tenofovir|mesh-list
24855600|NCT02280109|Antiviral Agents|antiviral agents|mesh-ancestor
24855601|NCT02280109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24639889|NCT01164774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24639890|NCT01164787|Trandolapril|trandolapril|mesh-list
24639891|NCT01164787|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24639892|NCT01164787|Protease Inhibitors|protease inhibitors|mesh-ancestor
24639893|NCT01164787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639894|NCT01164787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639895|NCT01164787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24639896|NCT01164800|Trandolapril|trandolapril|mesh-list
24639897|NCT01164800|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24639898|NCT01164800|Protease Inhibitors|protease inhibitors|mesh-ancestor
24639899|NCT01164800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639900|NCT01164800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639901|NCT01164800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24639902|NCT01164813|Nabumetone|nabumetone|mesh-list
24640008|NCT01165567|Sarpogrelate|sarpogrelate|mesh-list
24639903|NCT01164813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24639904|NCT01164813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24639905|NCT01164813|Analgesics|analgesics|mesh-ancestor
24639906|NCT01164813|Sensory System Agents|sensory system agents|mesh-ancestor
24639907|NCT01164813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24639908|NCT01164813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639909|NCT01164813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24639910|NCT01164813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24639911|NCT01164813|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24639912|NCT01164813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24639913|NCT01164813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639914|NCT01164813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639933|NCT01164943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24639934|NCT01164943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639935|NCT01164969|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24855610|NCT02280148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24855612|NCT02280148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24855613|NCT02280148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24855614|NCT02280148|Anesthetics, General|anesthetics, general|mesh-ancestor
24855615|NCT02280174|Linagliptin|linagliptin|mesh-list
24855616|NCT02280174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24458004|NCT00336219|Pantoprazole|pantoprazole|mesh-list
24639943|NCT01165060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24639944|NCT01165125|Ketoconazole|ketoconazole|mesh-list
24639945|NCT01165125|Antifungal Agents|antifungal agents|mesh-ancestor
24639946|NCT01165125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24639947|NCT01165125|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24639948|NCT01165125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24639949|NCT01165125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688782|NCT01950819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688783|NCT01950819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688784|NCT01950819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24964702|NCT03781063|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24964703|NCT03781063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24964704|NCT03781063|Hormone Antagonists|hormone antagonists|mesh-ancestor
24964705|NCT03781063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24964706|NCT03781063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583169|NCT00873509|Serotonin Agents|serotonin agents|mesh-ancestor
24575196|NCT00830193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24575197|NCT00830193|Expectorants|expectorants|mesh-ancestor
24575198|NCT00830193|Respiratory System Agents|respiratory system agents|mesh-ancestor
24800218|NCT01974024|Hormones|hormones|mesh-ancestor
24949190|NCT05161156|Bromides|bromides|mesh-list
24949191|NCT05161156|Tiotropium Bromide|tiotropium bromide|mesh-list
24949192|NCT05161156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24639950|NCT01165125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639951|NCT01165125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24639952|NCT01165125|Hormone Antagonists|hormone antagonists|mesh-ancestor
24639953|NCT01165125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24639954|NCT01165125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639955|NCT01165125|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24639956|NCT01165164|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25265022|NCT02436486|Moxifloxacin|moxifloxacin|mesh-list
25265023|NCT02436486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25265024|NCT02436486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24536447|NCT00651300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24639957|NCT01165164|Lubricant Eye Drops|lubricant eye drops|mesh-list
24639958|NCT01165164|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24639959|NCT01165255|Bupropion|bupropion|mesh-list
24639960|NCT01165255|Antidepressive Agents|antidepressive agents|mesh-list
24639961|NCT01165255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24639962|NCT01165255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24639988|NCT01165294|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24639989|NCT01165294|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24639990|NCT01165294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24639991|NCT01165294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639992|NCT01165372|Artesunate|artesunate|mesh-list
24639993|NCT01165372|Piperaquine|piperaquine|mesh-list
24639994|NCT01165372|Artenimol|artenimol|mesh-list
24639995|NCT01165372|Antimalarials|antimalarials|mesh-ancestor
24639996|NCT01165372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24639997|NCT01165372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24639998|NCT01165372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24639999|NCT01165372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640000|NCT01165372|Antiviral Agents|antiviral agents|mesh-ancestor
24640001|NCT01165372|Schistosomicides|schistosomicides|mesh-ancestor
24640002|NCT01165372|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24640003|NCT01165372|Anthelmintics|anthelmintics|mesh-ancestor
24640004|NCT01165385|Cisplatin|cisplatin|mesh-list
24640005|NCT01165385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640006|NCT01165476|Treprostinil|treprostinil|mesh-list
24640007|NCT01165476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24640016|NCT01165567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640017|NCT01165580|Valganciclovir|valganciclovir|mesh-list
24640018|NCT01165580|Antiviral Agents|antiviral agents|mesh-ancestor
24640058|NCT01165866|Dermatologic Agents|dermatologic agents|mesh-ancestor
24640059|NCT01165866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25688785|NCT01950819|Antifungal Agents|antifungal agents|mesh-ancestor
25688786|NCT01950819|Dermatologic Agents|dermatologic agents|mesh-ancestor
25688787|NCT01950819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25688788|NCT01951066|Dexamethasone|dexamethasone|mesh-list
25688789|NCT01951066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25688790|NCT01951066|Antiemetics|antiemetics|mesh-ancestor
25688791|NCT01951066|Autonomic Agents|autonomic agents|mesh-ancestor
25688792|NCT01951066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25688793|NCT01951066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688794|NCT01951066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25688795|NCT01951066|Glucocorticoids|glucocorticoids|mesh-ancestor
25688796|NCT01951066|Hormones|hormones|mesh-ancestor
25688797|NCT01951066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24640060|NCT01165866|Serotonin Agents|serotonin agents|mesh-ancestor
24949312|NCT04982146|Respiratory System Agents|respiratory system agents|mesh-ancestor
24949314|NCT04982146|Antioxidants|antioxidants|mesh-ancestor
24949315|NCT04982146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640061|NCT01165866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24640062|NCT01165866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640063|NCT01165866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24640064|NCT01165866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24640065|NCT01165866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24640066|NCT01165866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24640067|NCT01165866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24640095|NCT01166035|Immunologic Factors|immunologic factors|mesh-ancestor
24640096|NCT01166035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640097|NCT01166035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24640098|NCT01166035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24640099|NCT01166035|Growth Substances|growth substances|mesh-ancestor
25265025|NCT02436486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25265026|NCT02436486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25265027|NCT02436486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265028|NCT02436486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265029|NCT02436486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265030|NCT02436499|Botulinum Toxins|botulinum toxins|mesh-list
24537349|NCT00654303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537351|NCT00654303|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24537352|NCT00654303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640100|NCT01166035|Growth Inhibitors|growth inhibitors|mesh-ancestor
24640101|NCT01166035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640102|NCT01166035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24640104|NCT01166048|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24640105|NCT01166048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24640106|NCT01166048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24640107|NCT01166048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855634|NCT02280447|Vaccines|vaccines|mesh-list
24640147|NCT01166165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640149|NCT01166165|Micronutrients|micronutrients|mesh-ancestor
24640150|NCT01166165|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24640151|NCT01166425|Lithium Carbonate|lithium carbonate|mesh-list
24640152|NCT01166425|Antidepressive Agents|antidepressive agents|mesh-ancestor
24640153|NCT01166425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24640154|NCT01166425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640155|NCT01166425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640156|NCT01166425|Antimanic Agents|antimanic agents|mesh-ancestor
24640157|NCT01166425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24640158|NCT01166425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24640159|NCT01166425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640162|NCT01166451|Micronutrients|micronutrients|mesh-ancestor
24640184|NCT01166542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640185|NCT01166594|Bevacizumab|bevacizumab|mesh-list
24640186|NCT01166594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24640187|NCT01166594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640188|NCT01166594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24640189|NCT01166594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24640212|NCT01166789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24640213|NCT01166789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640214|NCT01166815|Zinc Sulfate|zinc sulfate|mesh-list
25688798|NCT01951066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25688799|NCT01951066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688800|NCT01951105|Naproxen|naproxen|mesh-list
25688801|NCT01951105|Levodopa|levodopa|mesh-list
25688802|NCT01951105|Carbidopa|carbidopa|mesh-list
25688803|NCT01951105|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24626161|NCT01085721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24626162|NCT01085721|Appetite Depressants|appetite depressants|mesh-ancestor
24626163|NCT01085721|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24949349|NCT04958746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24949350|NCT04958746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24949351|NCT04958746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949352|NCT04958746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24640216|NCT01166815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640240|NCT01167010|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24640241|NCT01167010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24640242|NCT01167010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24640243|NCT01167010|Adrenergic Agents|adrenergic agents|mesh-ancestor
24640244|NCT01167010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24640245|NCT01167010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640246|NCT01167049|Capecitabine|capecitabine|mesh-list
24640247|NCT01167049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24640248|NCT01167049|Antimetabolites|antimetabolites|mesh-ancestor
24640249|NCT01167049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640250|NCT01167049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640251|NCT01167062|Tamsulosin|tamsulosin|mesh-list
24640252|NCT01167062|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24640253|NCT01167062|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24640264|NCT01167101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24640265|NCT01167101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265031|NCT02436499|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25265032|NCT02436499|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25265033|NCT02436499|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25265034|NCT02436499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25265035|NCT02436499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265036|NCT02436499|Cholinergic Agents|cholinergic agents|mesh-ancestor
25265037|NCT02436499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25265038|NCT02436499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265039|NCT02436499|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24537353|NCT00654394|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24537354|NCT00654394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24537355|NCT00654394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24537356|NCT00654394|Antimetabolites|antimetabolites|mesh-ancestor
24537357|NCT00654394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537358|NCT00654394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24537359|NCT00654394|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24640266|NCT01167101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640287|NCT01167465|Dermatologic Agents|dermatologic agents|mesh-ancestor
24640288|NCT01167465|Sunscreening Agents|sunscreening agents|mesh-ancestor
24640289|NCT01167465|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24640290|NCT01167465|Protective Agents|protective agents|mesh-ancestor
24640291|NCT01167465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640292|NCT01167478|Caffeine|caffeine|mesh-list
24640293|NCT01167478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24640294|NCT01167478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640295|NCT01167478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24640296|NCT01167478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640297|NCT01167478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855653|NCT02280525|Cyclophosphamide|cyclophosphamide|mesh-list
24855654|NCT02280525|Rituximab|rituximab|mesh-list
24855655|NCT02280525|Fludarabine|fludarabine|mesh-list
24855656|NCT02280525|Fludarabine phosphate|fludarabine phosphate|mesh-list
24855657|NCT02280525|Lenalidomide|lenalidomide|mesh-list
24855658|NCT02280525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24855659|NCT02280525|Immunologic Factors|immunologic factors|mesh-ancestor
24640351|NCT01167738|Gemcitabine|gemcitabine|mesh-list
24640352|NCT01167738|Capecitabine|capecitabine|mesh-list
25688804|NCT01951105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25688805|NCT01951105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25688806|NCT01951105|Analgesics|analgesics|mesh-ancestor
25688807|NCT01951105|Sensory System Agents|sensory system agents|mesh-ancestor
25688808|NCT01951105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25688809|NCT01951105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688810|NCT01951105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24640353|NCT01167738|Epirubicin|epirubicin|mesh-list
24640354|NCT01167738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519963|NCT04333407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24640469|NCT01168440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24855677|NCT02280538|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24855678|NCT02280538|Immunologic Factors|immunologic factors|mesh-ancestor
24855679|NCT02280538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855680|NCT02280538|Viscosupplements|viscosupplements|mesh-ancestor
24855681|NCT02280538|Protective Agents|protective agents|mesh-ancestor
24855682|NCT02280590|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24855683|NCT02280590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24855684|NCT02280590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24640526|NCT01168791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24640527|NCT01168791|Isophosphamide mustard|isophosphamide mustard|mesh-list
24640528|NCT01168791|Ifosfamide|ifosfamide|mesh-list
24640529|NCT01168791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24640530|NCT01168791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640531|NCT01168791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24640532|NCT01168791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24640533|NCT01168791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640534|NCT01168791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640535|NCT01168791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24640536|NCT01168791|Alkylating Agents|alkylating agents|mesh-ancestor
24640537|NCT01168804|Dexamethasone|dexamethasone|mesh-list
24640538|NCT01168804|Bortezomib|bortezomib|mesh-list
24640539|NCT01168804|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24640540|NCT01168804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24640541|NCT01168804|Antiemetics|antiemetics|mesh-ancestor
24640542|NCT01168804|Autonomic Agents|autonomic agents|mesh-ancestor
25265040|NCT02436499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25265041|NCT02436512|Nitric Oxide|nitric oxide|mesh-list
25265042|NCT02436512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25265043|NCT02436512|Autonomic Agents|autonomic agents|mesh-ancestor
25265044|NCT02436512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25265045|NCT02436512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265046|NCT02436512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25265047|NCT02436512|Respiratory System Agents|respiratory system agents|mesh-ancestor
25265048|NCT02436512|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25265049|NCT02436512|Antioxidants|antioxidants|mesh-ancestor
24537367|NCT00654407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537368|NCT00654407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24537403|NCT00654524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24640562|NCT01168895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24640563|NCT01168895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24640564|NCT01168895|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24640565|NCT01168895|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24640566|NCT01168895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640567|NCT01168895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640568|NCT01168895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640569|NCT01168895|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24640570|NCT01168895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24640572|NCT01169012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24640574|NCT01169012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640575|NCT01169012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640576|NCT01169025|Fentanyl|fentanyl|mesh-list
24640577|NCT01169025|Ketamine|ketamine|mesh-list
24640578|NCT01169025|Analgesics|analgesics|mesh-ancestor
24640579|NCT01169025|Sensory System Agents|sensory system agents|mesh-ancestor
24640580|NCT01169025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24640581|NCT01169025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640582|NCT01169025|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24855686|NCT02280590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855687|NCT02280590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24855688|NCT02280590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24855689|NCT02280590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855690|NCT02280603|Minoxidil|minoxidil|mesh-list
25051842|NCT00370383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051843|NCT00370383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051844|NCT00369473|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25051845|NCT00369473|Immunologic Factors|immunologic factors|mesh-ancestor
25051846|NCT00369473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051847|NCT00369070|Paclitaxel|paclitaxel|mesh-list
25051848|NCT00369070|Bevacizumab|bevacizumab|mesh-list
25051849|NCT00369070|Carboplatin|carboplatin|mesh-list
25051850|NCT00369070|Motesanib diphosphate|motesanib diphosphate|mesh-list
25051851|NCT00369070|Imetelstat|imetelstat|mesh-list
24803600|NCT01997294|Atorvastatin|atorvastatin|mesh-list
24631353|NCT01117129|Rituximab|rituximab|mesh-list
24855691|NCT02280603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24855692|NCT02280603|Vasodilator Agents|vasodilator agents|mesh-ancestor
24855693|NCT02280616|Budesonide|budesonide|mesh-list
24855694|NCT02280616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24855695|NCT02280616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24855696|NCT02280616|Autonomic Agents|autonomic agents|mesh-ancestor
24855697|NCT02280616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24855698|NCT02280616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855699|NCT02280616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24855700|NCT02280616|Respiratory System Agents|respiratory system agents|mesh-ancestor
24855701|NCT02280616|Glucocorticoids|glucocorticoids|mesh-ancestor
24812757|NCT02054442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24812758|NCT02054442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812759|NCT02054442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24812760|NCT02054442|Antimetabolites|antimetabolites|mesh-ancestor
24812762|NCT02054442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265050|NCT02436512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265051|NCT02436512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25265052|NCT02436512|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25265053|NCT02436512|Vasodilator Agents|vasodilator agents|mesh-ancestor
25265054|NCT02436512|Gasotransmitters|gasotransmitters|mesh-ancestor
25265055|NCT02436512|Protective Agents|protective agents|mesh-ancestor
25265056|NCT02436395|Povidone-Iodine|povidone-iodine|mesh-list
25265057|NCT02436395|Povidone|povidone|mesh-list
25265058|NCT02436395|Plasma Substitutes|plasma substitutes|mesh-ancestor
24449556|NCT00315965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24812763|NCT02054442|Dermatologic Agents|dermatologic agents|mesh-ancestor
24812764|NCT02054442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640583|NCT01169025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24640584|NCT01169025|Anesthetics, General|anesthetics, general|mesh-ancestor
24640585|NCT01169025|Anesthetics|anesthetics|mesh-ancestor
24911806|NCT04283747|Antibodies|antibodies|mesh-list
24640673|NCT01169571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24640674|NCT01169571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640675|NCT01169584|Molgramostim|molgramostim|mesh-list
24640676|NCT01169584|Sargramostim|sargramostim|mesh-list
24640677|NCT01169584|Immunologic Factors|immunologic factors|mesh-ancestor
24640678|NCT01169584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640679|NCT01169584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640681|NCT01169597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24640682|NCT01169597|Glucocorticoids|glucocorticoids|mesh-ancestor
24640684|NCT01169597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24640685|NCT01169597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812765|NCT02054442|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24812766|NCT02054442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24812767|NCT02054442|Immunologic Factors|immunologic factors|mesh-ancestor
24812768|NCT02054442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24812769|NCT02054442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25688811|NCT01951105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25688812|NCT01951105|Gout Suppressants|gout suppressants|mesh-ancestor
25688813|NCT01951105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25688814|NCT01951105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688815|NCT01951105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688816|NCT01951105|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25688817|NCT01951105|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25688818|NCT01951105|Dopamine Agents|dopamine agents|mesh-ancestor
25688819|NCT01951105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25688820|NCT01951105|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24640692|NCT01169688|Mydriatics|mydriatics|mesh-ancestor
24640693|NCT01169688|Autonomic Agents|autonomic agents|mesh-ancestor
24949624|NCT04006288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24949626|NCT04006288|Analgesics|analgesics|mesh-ancestor
24949627|NCT04006288|Sensory System Agents|sensory system agents|mesh-ancestor
24949628|NCT04006288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24949629|NCT04006288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949630|NCT04006288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24701788|NCT01460979|Immunologic Factors|immunologic factors|mesh-ancestor
24640694|NCT01169688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24640695|NCT01169688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640696|NCT01169688|Sympathomimetics|sympathomimetics|mesh-ancestor
24640697|NCT01169688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24640698|NCT01169688|Nasal Decongestants|nasal decongestants|mesh-ancestor
24640699|NCT01169688|Respiratory System Agents|respiratory system agents|mesh-ancestor
24640700|NCT01169688|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24640701|NCT01169688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24640702|NCT01169688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24640723|NCT01169792|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24640724|NCT01169792|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24640725|NCT01169792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24640727|NCT01169805|Palonosetron|palonosetron|mesh-list
24640728|NCT01169805|Ramosetron|ramosetron|mesh-list
24640729|NCT01169805|Antiemetics|antiemetics|mesh-ancestor
24640730|NCT01169805|Autonomic Agents|autonomic agents|mesh-ancestor
24640731|NCT01169805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24640733|NCT01169805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24640734|NCT01169805|Antipruritics|antipruritics|mesh-ancestor
24640735|NCT01169805|Dermatologic Agents|dermatologic agents|mesh-ancestor
24640736|NCT01169805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24640737|NCT01169805|Serotonin Agents|serotonin agents|mesh-ancestor
24640818|NCT01170169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640819|NCT01170182|Omeprazole|omeprazole|mesh-list
24640820|NCT01170182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24812775|NCT02054468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24812776|NCT02054468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812778|NCT02054468|Anesthetics, General|anesthetics, general|mesh-ancestor
24812779|NCT02054468|Anesthetics|anesthetics|mesh-ancestor
24812780|NCT02054468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24812781|NCT02054468|Narcotics|narcotics|mesh-ancestor
24812782|NCT02054468|Analgesics|analgesics|mesh-ancestor
24812783|NCT02054468|Sensory System Agents|sensory system agents|mesh-ancestor
24812788|NCT02054637|Lanreotide|lanreotide|mesh-list
24812789|NCT02054637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812790|NCT02054663|Clopidogrel|clopidogrel|mesh-list
24812791|NCT02054663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25688821|NCT01951105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25688822|NCT01951105|Immunologic Factors|immunologic factors|mesh-ancestor
25688823|NCT01951105|Dopamine Agonists|dopamine agonists|mesh-ancestor
25688824|NCT01951118|Donepezil|donepezil|mesh-list
25688825|NCT01951118|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25688826|NCT01951118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688827|NCT01951118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688828|NCT01951118|Cholinergic Agents|cholinergic agents|mesh-ancestor
25688829|NCT01951118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25688830|NCT01951118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688831|NCT01951118|Nootropic Agents|nootropic agents|mesh-ancestor
25688832|NCT01951157|Gemcitabine|gemcitabine|mesh-list
25688833|NCT01951157|Docetaxel|docetaxel|mesh-list
25688834|NCT01951157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25688835|NCT01951157|Antimetabolites|antimetabolites|mesh-ancestor
25688836|NCT01951157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688837|NCT01951157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688838|NCT01951157|Antiviral Agents|antiviral agents|mesh-ancestor
25688839|NCT01951157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24803702|NCT01998113|Insulin|insulin|mesh-list
24949800|NCT03585465|Nivolumab|nivolumab|mesh-list
24949801|NCT03585465|Vinblastine|vinblastine|mesh-list
24949802|NCT03585465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24949803|NCT03585465|Immunologic Factors|immunologic factors|mesh-ancestor
24949804|NCT03585465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949805|NCT03585465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24949806|NCT03585465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24949807|NCT03585465|Alkylating Agents|alkylating agents|mesh-ancestor
24949808|NCT03585465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949809|NCT03585465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24949810|NCT03585465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24949811|NCT03585465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24949812|NCT03585465|Antimetabolites|antimetabolites|mesh-ancestor
24949813|NCT03585465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24949814|NCT03585465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24949815|NCT03585465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24640821|NCT01170182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24612097|NCT01011920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24612098|NCT01011920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25265059|NCT02436395|Blood Substitutes|blood substitutes|mesh-ancestor
25265060|NCT02436395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25265061|NCT02436395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25265062|NCT02436226|Citric Acid|citric acid|mesh-list
25265063|NCT02436226|Sodium Citrate|sodium citrate|mesh-list
24449557|NCT00315965|Autonomic Agents|autonomic agents|mesh-ancestor
24449558|NCT00315965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24449570|NCT00315965|Antimetabolites|antimetabolites|mesh-ancestor
24449572|NCT00316030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449573|NCT00316095|Telmisartan|telmisartan|mesh-list
24449574|NCT00316095|Simvastatin|simvastatin|mesh-list
24449575|NCT00316095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24449576|NCT00316095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24449577|NCT00316095|Antimetabolites|antimetabolites|mesh-ancestor
24938468|NCT04018417|Amebicides|amebicides|mesh-ancestor
24612099|NCT01011920|Antiviral Agents|antiviral agents|mesh-ancestor
24640873|NCT01170429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640876|NCT01170442|Cholecalciferol|cholecalciferol|mesh-list
24640877|NCT01170442|Vitamins|vitamins|mesh-list
24640878|NCT01170442|Micronutrients|micronutrients|mesh-ancestor
24640879|NCT01170442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640880|NCT01170442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24640881|NCT01170442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24640882|NCT01170468|Vitamin D|vitamin d|mesh-list
24640883|NCT01170468|Cholecalciferol|cholecalciferol|mesh-list
24640884|NCT01170468|Vitamins|vitamins|mesh-ancestor
24640931|NCT01170637|Nasal Decongestants|nasal decongestants|mesh-ancestor
24640932|NCT01170637|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24640933|NCT01170637|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24640934|NCT01170637|Sympathomimetics|sympathomimetics|mesh-ancestor
24640935|NCT01170637|Adrenergic Agents|adrenergic agents|mesh-ancestor
24640936|NCT01170637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24640937|NCT01170767|Bevacizumab|bevacizumab|mesh-list
24640938|NCT01170767|Ranibizumab|ranibizumab|mesh-list
24640939|NCT01170767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24640940|NCT01170767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640941|NCT01170767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25688840|NCT01951157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688841|NCT01951157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25688842|NCT01951157|Immunologic Factors|immunologic factors|mesh-ancestor
25688843|NCT01951157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688844|NCT01951157|Tubulin Modulators|tubulin modulators|mesh-ancestor
25688845|NCT01951157|Antimitotic Agents|antimitotic agents|mesh-ancestor
25688846|NCT01951157|Mitosis Modulators|mitosis modulators|mesh-ancestor
25688847|NCT01951339|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25688848|NCT01951339|Glimepiride|glimepiride|mesh-list
25688849|NCT01951339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25688850|NCT01951339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688851|NCT01951339|Incretins|incretins|mesh-ancestor
25688852|NCT01951339|Hormones|hormones|mesh-ancestor
25688853|NCT01951339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25688854|NCT01951339|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25688855|NCT01951339|Protease Inhibitors|protease inhibitors|mesh-ancestor
25688856|NCT01951339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640942|NCT01170767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24640943|NCT01170767|Growth Substances|growth substances|mesh-ancestor
24575906|NCT00835393|Pantoprazole|pantoprazole|mesh-list
24575949|NCT00835848|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24575950|NCT00835848|Incretins|incretins|mesh-ancestor
24575951|NCT00835848|Hormones|hormones|mesh-ancestor
24575952|NCT00835848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24575953|NCT00835939|Lidocaine|lidocaine|mesh-list
24575954|NCT00835939|Anesthetics, Local|anesthetics, local|mesh-ancestor
24575955|NCT00835939|Anesthetics|anesthetics|mesh-ancestor
24631720|NCT01119638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24640944|NCT01170767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640945|NCT01170767|Growth Inhibitors|growth inhibitors|mesh-ancestor
24640946|NCT01170780|Dexamethasone|dexamethasone|mesh-list
24640947|NCT01170780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24640948|NCT01170780|Antiemetics|antiemetics|mesh-ancestor
24640949|NCT01170780|Autonomic Agents|autonomic agents|mesh-ancestor
24640951|NCT01170780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640952|NCT01170780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24812792|NCT02054663|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24812793|NCT02054663|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24812794|NCT02054663|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24812800|NCT02054676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24640964|NCT01170819|Oxytocics|oxytocics|mesh-ancestor
24640965|NCT01170819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24640966|NCT01170819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640967|NCT01170845|Sivelestat|sivelestat|mesh-list
24640968|NCT01170845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24640969|NCT01170845|Protease Inhibitors|protease inhibitors|mesh-ancestor
24640970|NCT01170845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640971|NCT01170845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640972|NCT01170858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24640973|NCT01170858|Icodextrin|icodextrin|mesh-list
24640974|NCT01170858|Dialysis Solutions|dialysis solutions|mesh-ancestor
24640975|NCT01170871|Pemetrexed|pemetrexed|mesh-list
24640976|NCT01170871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640977|NCT01170871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641004|NCT01171209|Interferon beta-1b|interferon beta-1b|mesh-list
24641005|NCT01171209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641006|NCT01171209|Antiviral Agents|antiviral agents|mesh-ancestor
24641007|NCT01171209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24641008|NCT01171209|Immunologic Factors|immunologic factors|mesh-ancestor
24641009|NCT01171209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265064|NCT02436226|Clomiphene|clomiphene|mesh-list
25265065|NCT02436226|Enclomiphene|enclomiphene|mesh-list
25265066|NCT02436226|Zuclomiphene|zuclomiphene|mesh-list
25265067|NCT02436226|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25265068|NCT02436226|Anticoagulants|anticoagulants|mesh-ancestor
25265069|NCT02436226|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25265070|NCT02436226|Chelating Agents|chelating agents|mesh-ancestor
25265071|NCT02436226|Sequestering Agents|sequestering agents|mesh-ancestor
25265072|NCT02436226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265073|NCT02436226|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25265074|NCT02436226|Hormone Antagonists|hormone antagonists|mesh-ancestor
24449578|NCT00316095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449579|NCT00316095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24449580|NCT00316095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24449581|NCT00316095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449582|NCT00316095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24449583|NCT00316095|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24449595|NCT00316160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25688857|NCT01951339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688858|NCT01951339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25688859|NCT01951339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25688860|NCT01951339|Immunologic Factors|immunologic factors|mesh-ancestor
25688861|NCT01951391|Benzalkonium Compounds|benzalkonium compounds|mesh-list
25688862|NCT01951391|Triclocarban|triclocarban|mesh-list
25688863|NCT01951391|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25688864|NCT01951391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25688865|NCT01951586|Zoledronic Acid|zoledronic acid|mesh-list
25688866|NCT01951586|Denosumab|denosumab|mesh-list
24949899|NCT03412643|Mitosis Modulators|mitosis modulators|mesh-ancestor
24949900|NCT03412643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949901|NCT03412643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24949902|NCT03412643|Immunologic Factors|immunologic factors|mesh-ancestor
24449596|NCT00316160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449597|NCT00316160|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24641010|NCT01171209|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24641011|NCT01171300|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24812806|NCT02054676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24812807|NCT02054676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24812808|NCT02054676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24812809|NCT02054676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812810|NCT02054676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812811|NCT02054793|Itraconazole|itraconazole|mesh-list
24812812|NCT02054793|Antifungal Agents|antifungal agents|mesh-ancestor
24641012|NCT01171300|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24641013|NCT01171300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641014|NCT01171326|Minocycline|minocycline|mesh-list
24641015|NCT01171326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24641016|NCT01171326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24641017|NCT01171365|Ciclesonide|ciclesonide|mesh-list
24641018|NCT01171365|Glucocorticoids|glucocorticoids|mesh-ancestor
24641020|NCT01171365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24641021|NCT01171365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641022|NCT01171365|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24641068|NCT01171755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641070|NCT01171781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641071|NCT01171807|Dexamethasone|dexamethasone|mesh-list
24641072|NCT01171807|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24641162|NCT01172223|Mitosis Modulators|mitosis modulators|mesh-ancestor
24641163|NCT01172223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641164|NCT01172223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24641165|NCT01172223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24641166|NCT01172223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24641167|NCT01172223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641168|NCT01172223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24641170|NCT01172236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24641171|NCT01172392|Interferons|interferons|mesh-list
24641172|NCT01172392|Interferon-alpha|interferon-alpha|mesh-list
24641173|NCT01172392|Interferon alpha-2|interferon alpha-2|mesh-list
24641174|NCT01172392|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24641175|NCT01172392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641176|NCT01172392|Antiviral Agents|antiviral agents|mesh-ancestor
24641177|NCT01172392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24641178|NCT01172392|Immunologic Factors|immunologic factors|mesh-ancestor
24641179|NCT01172392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420533|NCT00216216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265075|NCT02436226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25265076|NCT02436226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265077|NCT02436226|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25265078|NCT02436226|Fertility Agents|fertility agents|mesh-ancestor
25265079|NCT02436226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25265080|NCT02436226|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25265081|NCT02436226|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25265082|NCT02436083|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25265084|NCT02436083|Cefuroxime axetil|cefuroxime axetil|mesh-list
25265085|NCT02436083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25265086|NCT02436044|Leucovorin|leucovorin|mesh-list
25265087|NCT02436044|Fluorouracil|fluorouracil|mesh-list
25265088|NCT02436044|Oxaliplatin|oxaliplatin|mesh-list
25265089|NCT02436044|Levoleucovorin|levoleucovorin|mesh-list
25265090|NCT02436044|Antimetabolites|antimetabolites|mesh-ancestor
25265091|NCT02436044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449611|NCT00316238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24449612|NCT00316238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449613|NCT00316238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24449614|NCT00316238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24449615|NCT00316238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25688867|NCT01951586|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25688868|NCT01951586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688869|NCT01951651|Exenatide|exenatide|mesh-list
25688870|NCT01951651|Glipizide|glipizide|mesh-list
24449616|NCT00316238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24537479|NCT00654758|Antimitotic Agents|antimitotic agents|mesh-ancestor
24950017|NCT03015896|Growth Substances|growth substances|mesh-ancestor
24950018|NCT03015896|Growth Inhibitors|growth inhibitors|mesh-ancestor
24950020|NCT02938923|Androgens|androgens|mesh-ancestor
24950021|NCT02938923|Hormones|hormones|mesh-ancestor
24950022|NCT02938923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24950023|NCT02938923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950024|NCT02890784|Dasatinib|dasatinib|mesh-list
24950025|NCT02890784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950026|NCT02890784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24950027|NCT02890784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641181|NCT01172405|Caffeine|caffeine|mesh-list
24641182|NCT01172405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24641183|NCT01172405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24641184|NCT01172405|Analgesics|analgesics|mesh-ancestor
24641185|NCT01172405|Sensory System Agents|sensory system agents|mesh-ancestor
24641186|NCT01172405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24641187|NCT01172405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641188|NCT01172405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24641233|NCT01172496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24641235|NCT01172509|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24641241|NCT01172509|GABA Agents|gaba agents|mesh-ancestor
24641295|NCT01172769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24641296|NCT01172769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24641297|NCT01172769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24641298|NCT01172769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641300|NCT01172769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24641301|NCT01172769|Immunologic Factors|immunologic factors|mesh-ancestor
24641302|NCT01172769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641303|NCT01172769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855723|NCT02280694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855724|NCT02280694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855725|NCT02280694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24855726|NCT02280694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24855727|NCT02280694|Antimetabolites|antimetabolites|mesh-ancestor
24855728|NCT02280694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24855729|NCT02280694|Abortifacient Agents|abortifacient agents|mesh-ancestor
24855730|NCT02280694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24855731|NCT02280694|Dermatologic Agents|dermatologic agents|mesh-ancestor
24855732|NCT02280694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855733|NCT02280694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24458163|NCT00336882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24458164|NCT00336882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458165|NCT00336882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24641386|NCT01173107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641388|NCT01173172|Boron|boron|mesh-list
24641389|NCT01173172|Trace Elements|trace elements|mesh-ancestor
24641390|NCT01173172|Micronutrients|micronutrients|mesh-ancestor
24641391|NCT01173172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641392|NCT01173237|Pulmonary Surfactants|pulmonary surfactants|mesh-list
24641393|NCT01173237|Respiratory System Agents|respiratory system agents|mesh-ancestor
24641394|NCT01173263|Propofol|propofol|mesh-list
24641395|NCT01173263|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24641459|NCT01173640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24641460|NCT01173640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24641461|NCT01173640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641462|NCT01173640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24641463|NCT01173640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24641464|NCT01173640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24641465|NCT01173640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24641466|NCT01173640|Anesthetics, General|anesthetics, general|mesh-ancestor
24641467|NCT01173640|Anesthetics|anesthetics|mesh-ancestor
24641468|NCT01173640|GABA Modulators|gaba modulators|mesh-ancestor
24641470|NCT01173640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25265092|NCT02436044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25688871|NCT01951651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25688872|NCT01951651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688873|NCT01951651|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25688874|NCT01951651|Incretins|incretins|mesh-ancestor
25688875|NCT01951651|Hormones|hormones|mesh-ancestor
25688876|NCT01951651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25688877|NCT01951768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25688878|NCT01951768|Gentamicins|gentamicins|mesh-list
25688879|NCT01951768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25688880|NCT01951768|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25265093|NCT02436044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265094|NCT02436044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25265095|NCT02436044|Immunologic Factors|immunologic factors|mesh-ancestor
25265096|NCT02436044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265097|NCT02436044|Antidotes|antidotes|mesh-ancestor
25265098|NCT02436044|Protective Agents|protective agents|mesh-ancestor
25265099|NCT02436044|Vitamin B Complex|vitamin b complex|mesh-ancestor
25265100|NCT02436044|Vitamins|vitamins|mesh-ancestor
25265101|NCT02436044|Micronutrients|micronutrients|mesh-ancestor
24641471|NCT01173640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641472|NCT01173640|Antioxidants|antioxidants|mesh-ancestor
24641473|NCT01173640|Protective Agents|protective agents|mesh-ancestor
24641474|NCT01173640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641475|NCT01173640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24641476|NCT01173809|Amiodarone|amiodarone|mesh-list
24641477|NCT01173809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24641479|NCT01173809|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24641480|NCT01173809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24641481|NCT01173809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641482|NCT01173809|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24641483|NCT01173809|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24641484|NCT01173809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24641485|NCT01173809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641486|NCT01173809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24912232|NCT04278287|Paclitaxel|paclitaxel|mesh-list
24855744|NCT02280720|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24855746|NCT02280720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24855747|NCT02280772|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
24855748|NCT02280772|Cathartics|cathartics|mesh-ancestor
24855749|NCT02280772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24855750|NCT02280785|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24855751|NCT02280785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24641498|NCT01173939|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24641499|NCT01173939|Pravastatin|pravastatin|mesh-list
24641500|NCT01173939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24641501|NCT01173939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24641502|NCT01173939|Antimetabolites|antimetabolites|mesh-ancestor
24641503|NCT01173939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641504|NCT01173939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24641505|NCT01173939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24641506|NCT01173939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641507|NCT01173978|Prednisolone|prednisolone|mesh-list
24641508|NCT01173978|Hormones|hormones|mesh-list
24641509|NCT01173978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24641510|NCT01173978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691699|NCT01408680|Ubiquinone|ubiquinone|mesh-list
24641538|NCT01174056|Hormone Antagonists|hormone antagonists|mesh-ancestor
24641539|NCT01174056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24641540|NCT01174056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641541|NCT01174056|Antisickling Agents|antisickling agents|mesh-ancestor
24641542|NCT01174056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24641543|NCT01174199|Sirolimus|sirolimus|mesh-list
24641544|NCT01174199|Vorinostat|vorinostat|mesh-list
24641545|NCT01174199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24641546|NCT01174199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24641547|NCT01174199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24641548|NCT01174199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641549|NCT01174199|Antifungal Agents|antifungal agents|mesh-ancestor
24641550|NCT01174199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24641551|NCT01174199|Immunologic Factors|immunologic factors|mesh-ancestor
24641552|NCT01174199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641553|NCT01174199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24641554|NCT01174199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641555|NCT01174199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641556|NCT01174212|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24641557|NCT01174212|Vancomycin|vancomycin|mesh-list
24641558|NCT01174212|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24855752|NCT02280785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855754|NCT02280850|Vasodilator Agents|vasodilator agents|mesh-ancestor
24855755|NCT02280876|Andrographolide|andrographolide|mesh-list
25265102|NCT02435927|Leucovorin|leucovorin|mesh-list
25265103|NCT02435927|Fluorouracil|fluorouracil|mesh-list
25265104|NCT02435927|Capecitabine|capecitabine|mesh-list
25265105|NCT02435927|Oxaliplatin|oxaliplatin|mesh-list
25265106|NCT02435927|Antimetabolites|antimetabolites|mesh-ancestor
25275360|NCT02372786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537483|NCT00654758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24537485|NCT00654758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537486|NCT00654758|Growth Inhibitors|growth inhibitors|mesh-ancestor
24537487|NCT00654758|Immunologic Factors|immunologic factors|mesh-ancestor
24537488|NCT00654888|Mitomycins|mitomycins|mesh-list
24537489|NCT00654888|Mitomycin|mitomycin|mesh-list
24537490|NCT00654888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24537491|NCT00654888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24537492|NCT00654888|Alkylating Agents|alkylating agents|mesh-ancestor
24537493|NCT00654888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537494|NCT00654888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24537495|NCT00654888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641567|NCT01174290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24641568|NCT01174290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24641569|NCT01174290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24641570|NCT01174290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24641571|NCT01174290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24641572|NCT01174290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24641573|NCT01174290|Dopamine Agents|dopamine agents|mesh-ancestor
24641604|NCT01174420|Alkylating Agents|alkylating agents|mesh-ancestor
24641616|NCT01174524|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24641617|NCT01174524|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24641619|NCT01174524|Femovan|femovan|mesh-list
24641620|NCT01174524|Contraceptive Agents|contraceptive agents|mesh-list
24641621|NCT01174524|Contraceptives, Oral|contraceptives, oral|mesh-list
24641622|NCT01174524|Estradiol|estradiol|mesh-list
24641623|NCT01174524|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24641624|NCT01174524|Estrogens|estrogens|mesh-ancestor
24641625|NCT01174524|Hormones|hormones|mesh-ancestor
24641640|NCT01174693|Clopidogrel|clopidogrel|mesh-list
24641641|NCT01174693|Triflusal|triflusal|mesh-list
24641642|NCT01174693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24641643|NCT01174693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24641644|NCT01174693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24641645|NCT01174693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24641646|NCT01174693|Purinergic Agents|purinergic agents|mesh-ancestor
24641647|NCT01174693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24912369|NCT04276480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855792|NCT02281006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24855793|NCT02281006|Chelating Agents|chelating agents|mesh-ancestor
24855794|NCT02281006|Sequestering Agents|sequestering agents|mesh-ancestor
24855796|NCT02281045|Sodium Citrate|sodium citrate|mesh-list
24855797|NCT02281045|Anticoagulants|anticoagulants|mesh-ancestor
24855798|NCT02281045|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24641676|NCT01174888|Antiviral Agents|antiviral agents|mesh-ancestor
24641677|NCT01174888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24641678|NCT01174888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24641679|NCT01174888|Immunologic Factors|immunologic factors|mesh-ancestor
24641680|NCT01174888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641681|NCT01174888|Analgesics|analgesics|mesh-ancestor
24641682|NCT01174888|Sensory System Agents|sensory system agents|mesh-ancestor
24641710|NCT01174914|Sensory System Agents|sensory system agents|mesh-ancestor
24641711|NCT01174914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24641714|NCT01174914|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24641715|NCT01174914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24641716|NCT01174914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24641717|NCT01174914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25265107|NCT02435927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265108|NCT02435927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25265110|NCT02435927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25265111|NCT02435927|Immunologic Factors|immunologic factors|mesh-ancestor
25265112|NCT02435927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265113|NCT02435927|Antidotes|antidotes|mesh-ancestor
25265114|NCT02435927|Protective Agents|protective agents|mesh-ancestor
25265115|NCT02435927|Vitamin B Complex|vitamin b complex|mesh-ancestor
25265116|NCT02435927|Vitamins|vitamins|mesh-ancestor
25265117|NCT02435927|Micronutrients|micronutrients|mesh-ancestor
25265118|NCT02435797|Nicorandil|nicorandil|mesh-list
25265119|NCT02435797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25265120|NCT02435797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24641718|NCT01174914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24641780|NCT01175291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24641781|NCT01175291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641782|NCT01175291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24641783|NCT01175291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24641784|NCT01175291|Growth Substances|growth substances|mesh-ancestor
24641785|NCT01175291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641786|NCT01175291|Growth Inhibitors|growth inhibitors|mesh-ancestor
24641787|NCT01175291|Antimetabolites|antimetabolites|mesh-ancestor
24641788|NCT01175291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641789|NCT01175291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24641790|NCT01175291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24641791|NCT01175291|Immunologic Factors|immunologic factors|mesh-ancestor
24641792|NCT01175291|Antidotes|antidotes|mesh-ancestor
24641793|NCT01175291|Protective Agents|protective agents|mesh-ancestor
24641794|NCT01175291|Vitamin B Complex|vitamin b complex|mesh-ancestor
24641795|NCT01175291|Vitamins|vitamins|mesh-ancestor
24641796|NCT01175291|Micronutrients|micronutrients|mesh-ancestor
24855799|NCT02281045|Chelating Agents|chelating agents|mesh-ancestor
24855800|NCT02281045|Sequestering Agents|sequestering agents|mesh-ancestor
24912420|NCT04275414|Growth Substances|growth substances|mesh-ancestor
24855808|NCT02281058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855809|NCT02281058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24855810|NCT02281201|Thrombin|thrombin|mesh-list
24641797|NCT01175330|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24641798|NCT01175330|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24641799|NCT01175330|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24641800|NCT01175330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24641801|NCT01175460|Nedaplatin|nedaplatin|mesh-list
24641802|NCT01175460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641803|NCT01175486|Pioglitazone|pioglitazone|mesh-list
24641804|NCT01175486|Acarbose|acarbose|mesh-list
24641805|NCT01175486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24641806|NCT01175486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641807|NCT01175486|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24641808|NCT01175486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641809|NCT01175486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641810|NCT01175512|Naltrexone|naltrexone|mesh-list
24641811|NCT01175512|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24641812|NCT01175512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24641813|NCT01175512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641814|NCT01175512|Sensory System Agents|sensory system agents|mesh-ancestor
24641815|NCT01175512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24641865|NCT01175772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24855811|NCT02281201|Hemostatics|hemostatics|mesh-ancestor
24855812|NCT02281201|Coagulants|coagulants|mesh-ancestor
24855813|NCT02281240|Oprelvekin|oprelvekin|mesh-list
24855814|NCT02281240|Heparin|heparin|mesh-list
25265121|NCT02435797|Vasodilator Agents|vasodilator agents|mesh-ancestor
25265122|NCT02435797|Vitamin B Complex|vitamin b complex|mesh-ancestor
25265123|NCT02435797|Vitamins|vitamins|mesh-ancestor
25265124|NCT02435797|Micronutrients|micronutrients|mesh-ancestor
25265125|NCT02435797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265126|NCT02435771|Ergocalciferols|ergocalciferols|mesh-list
25265127|NCT02435771|Vitamin D|vitamin d|mesh-list
24576572|NCT00839345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24576573|NCT00839345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24576574|NCT00839345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24950235|NCT01883297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24950236|NCT01883297|Immunologic Factors|immunologic factors|mesh-ancestor
24950237|NCT01883297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950238|NCT01883297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24950292|NCT01862315|Hormones|hormones|mesh-ancestor
24938527|NCT04018313|Omalizumab|omalizumab|mesh-list
24855815|NCT02281240|Anticoagulants|anticoagulants|mesh-ancestor
24855816|NCT02281240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24855817|NCT02281240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24855818|NCT02281240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855819|NCT02281240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855820|NCT02281266|Entecavir|entecavir|mesh-list
24855821|NCT02281266|Thymalfasin|thymalfasin|mesh-list
24855822|NCT02281266|Antiviral Agents|antiviral agents|mesh-ancestor
24855823|NCT02281266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24855824|NCT02281266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24641908|NCT01176669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641909|NCT01176669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24641910|NCT01176669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641911|NCT01176669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641913|NCT01176708|Protease Inhibitors|protease inhibitors|mesh-ancestor
24641917|NCT01176708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641918|NCT01176747|Formoterol Fumarate|formoterol fumarate|mesh-list
24641919|NCT01176747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24641945|NCT01176799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24641946|NCT01176799|Alkylating Agents|alkylating agents|mesh-ancestor
24855836|NCT02281279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24641947|NCT01176799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641948|NCT01176799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641950|NCT01176799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24641951|NCT01176799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24641952|NCT01176799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24641953|NCT01176799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641954|NCT01176799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24641955|NCT01176799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24641956|NCT01176799|Growth Substances|growth substances|mesh-ancestor
24641957|NCT01176799|Growth Inhibitors|growth inhibitors|mesh-ancestor
24641958|NCT01176799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24641960|NCT01176851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24641961|NCT01176851|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24641962|NCT01176851|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24641963|NCT01176851|Cholinergic Agents|cholinergic agents|mesh-ancestor
24641964|NCT01176851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24641988|NCT01177176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641989|NCT01177176|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24855825|NCT02281266|Immunologic Factors|immunologic factors|mesh-ancestor
24855826|NCT02281266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265128|NCT02435771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25265129|NCT02435771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265130|NCT02435771|Vitamins|vitamins|mesh-ancestor
25265131|NCT02435771|Micronutrients|micronutrients|mesh-ancestor
25688881|NCT01951768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688882|NCT01951768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688883|NCT01951820|Lidocaine|lidocaine|mesh-list
25688884|NCT01951820|Tetracaine|tetracaine|mesh-list
25688885|NCT01951820|Carticaine|carticaine|mesh-list
25688886|NCT01951820|Benzocaine|benzocaine|mesh-list
25688887|NCT01951820|Anesthetics, Local|anesthetics, local|mesh-ancestor
25688888|NCT01951820|Anesthetics|anesthetics|mesh-ancestor
25688889|NCT01951820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25688890|NCT01951820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950377|NCT03916679|Immunologic Factors|immunologic factors|mesh-ancestor
24950378|NCT03916679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950379|NCT03916679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24950380|NCT03916679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24950381|NCT03916679|Alkylating Agents|alkylating agents|mesh-ancestor
24950382|NCT03916679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950383|NCT03916679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950384|NCT03916679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24950385|NCT03916640|Insulin Lispro|insulin lispro|mesh-list
24950386|NCT03916640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24950387|NCT03916640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950389|NCT03916250|PF-06700841|pf-06700841|mesh-list
24950390|NCT03916250|Emollients|emollients|mesh-ancestor
25265133|NCT02435732|Heparin|heparin|mesh-list
25265134|NCT02435732|Anticoagulants|anticoagulants|mesh-ancestor
25265135|NCT02435732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25265136|NCT02435732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25265137|NCT02435732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265138|NCT02435654|Olanzapine|olanzapine|mesh-list
25265139|NCT02435654|Antiemetics|antiemetics|mesh-ancestor
25265140|NCT02435654|Autonomic Agents|autonomic agents|mesh-ancestor
25265141|NCT02435654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25265142|NCT02435654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265143|NCT02435654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24537653|NCT00655616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537654|NCT00655616|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24537655|NCT00655616|Hormone Antagonists|hormone antagonists|mesh-ancestor
24537837|NCT00656435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24537838|NCT00656435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24537839|NCT00656435|Growth Substances|growth substances|mesh-ancestor
24855827|NCT02281279|Rituximab|rituximab|mesh-list
24855828|NCT02281279|Lenalidomide|lenalidomide|mesh-list
24641999|NCT01177176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24642000|NCT01177176|Dopamine Agents|dopamine agents|mesh-ancestor
24642001|NCT01177176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24642002|NCT01177176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24642003|NCT01177176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642005|NCT01177306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24642006|NCT01177306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24642007|NCT01177306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24642008|NCT01177306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24642027|NCT01177371|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24642028|NCT01177371|Prednisolone|prednisolone|mesh-list
24642029|NCT01177371|Prednisolone acetate|prednisolone acetate|mesh-list
24642030|NCT01177371|Cyclophosphamide|cyclophosphamide|mesh-list
24642031|NCT01177371|Busulfan|busulfan|mesh-list
24642032|NCT01177371|Methotrexate|methotrexate|mesh-list
24642033|NCT01177371|Cyclosporins|cyclosporins|mesh-list
24642034|NCT01177371|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24642035|NCT01177371|Prednisolone phosphate|prednisolone phosphate|mesh-list
24642036|NCT01177371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24642037|NCT01177371|Immunologic Factors|immunologic factors|mesh-ancestor
24642038|NCT01177371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642039|NCT01177371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24642047|NCT01177371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24642048|NCT01177371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24855837|NCT02281279|Growth Substances|growth substances|mesh-ancestor
24855838|NCT02281279|Growth Inhibitors|growth inhibitors|mesh-ancestor
25688891|NCT01951820|Sensory System Agents|sensory system agents|mesh-ancestor
25688892|NCT01951820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25688893|NCT01951820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25688894|NCT01951820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25688895|NCT01951820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25688896|NCT01951820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25688897|NCT01951820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688898|NCT01951950|Nicardipine|nicardipine|mesh-list
25688899|NCT01951950|Esmolol|esmolol|mesh-list
25688900|NCT01951950|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25688901|NCT01951950|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25688902|NCT01951950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24855839|NCT02281279|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24855841|NCT02281292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24855842|NCT02281292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24642049|NCT01177371|Antimetabolites|antimetabolites|mesh-ancestor
24642050|NCT01177371|Dermatologic Agents|dermatologic agents|mesh-ancestor
24642051|NCT01177371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642052|NCT01177371|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24642053|NCT01177371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24642054|NCT01177371|Antifungal Agents|antifungal agents|mesh-ancestor
24642055|NCT01177371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24642056|NCT01177371|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24642057|NCT01177371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24642058|NCT01177371|Antiemetics|antiemetics|mesh-ancestor
24642059|NCT01177371|Autonomic Agents|autonomic agents|mesh-ancestor
24642146|NCT01177852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24642147|NCT01177852|Antipruritics|antipruritics|mesh-ancestor
24642148|NCT01177852|Dermatologic Agents|dermatologic agents|mesh-ancestor
24642149|NCT01177852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24642150|NCT01177852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24642151|NCT01177852|Respiratory System Agents|respiratory system agents|mesh-ancestor
24642152|NCT01177852|Nasal Decongestants|nasal decongestants|mesh-ancestor
25265144|NCT02435654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25265145|NCT02435654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25265146|NCT02435654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25265151|NCT02435654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265152|NCT02435654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25265153|NCT02435654|Serotonin Agents|serotonin agents|mesh-ancestor
25275361|NCT02372786|Sensory System Agents|sensory system agents|mesh-ancestor
24537840|NCT00656435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537841|NCT00656435|Growth Inhibitors|growth inhibitors|mesh-ancestor
24537843|NCT00656526|Anesthetics, Local|anesthetics, local|mesh-ancestor
24537844|NCT00656526|Anesthetics|anesthetics|mesh-ancestor
24642153|NCT01177852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24642154|NCT01177852|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24642155|NCT01177852|Sympathomimetics|sympathomimetics|mesh-ancestor
24642156|NCT01177852|Adrenergic Agents|adrenergic agents|mesh-ancestor
24642157|NCT01177852|Antitussive Agents|antitussive agents|mesh-ancestor
24642158|NCT01177904|Progesterone|progesterone|mesh-list
24642159|NCT01177904|Progestins|progestins|mesh-ancestor
24642161|NCT01177904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24642162|NCT01177904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855843|NCT02281292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24855844|NCT02281292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24855845|NCT02281292|Growth Substances|growth substances|mesh-ancestor
24855846|NCT02281292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855847|NCT02281292|Growth Inhibitors|growth inhibitors|mesh-ancestor
24855848|NCT02281292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855849|NCT02281305|Colchicine|colchicine|mesh-list
24642169|NCT01178021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24642170|NCT01178021|Antimalarials|antimalarials|mesh-ancestor
24642171|NCT01178021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24642172|NCT01178021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24642173|NCT01178021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24642174|NCT01178021|Analgesics|analgesics|mesh-ancestor
24642175|NCT01178021|Sensory System Agents|sensory system agents|mesh-ancestor
24642176|NCT01178021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24642201|NCT01178151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642202|NCT01178203|Naproxen|naproxen|mesh-list
24642203|NCT01178203|Tramadol|tramadol|mesh-list
24642204|NCT01178203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24642205|NCT01178203|Narcotics|narcotics|mesh-ancestor
24642206|NCT01178203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24642207|NCT01178203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642208|NCT01178203|Analgesics|analgesics|mesh-ancestor
24642209|NCT01178203|Sensory System Agents|sensory system agents|mesh-ancestor
24642210|NCT01178203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24642211|NCT01178203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24642212|NCT01178203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24642213|NCT01178203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24642214|NCT01178203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24642216|NCT01178203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24642217|NCT01178203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642218|NCT01178203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642220|NCT01178320|Niacinamide|niacinamide|mesh-list
24642221|NCT01178320|Nicotinic Acids|nicotinic acids|mesh-list
25265154|NCT02435563|Ritonavir|ritonavir|mesh-list
25265155|NCT02435563|Ticagrelor|ticagrelor|mesh-list
25265156|NCT02435563|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25265157|NCT02435563|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25265158|NCT02435563|Protease Inhibitors|protease inhibitors|mesh-ancestor
25265159|NCT02435563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265160|NCT02435563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265161|NCT02435563|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25265162|NCT02435563|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25265163|NCT02435563|Antiviral Agents|antiviral agents|mesh-ancestor
25265165|NCT02435563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25265166|NCT02435563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25265167|NCT02435563|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24642222|NCT01178320|Simvastatin|simvastatin|mesh-list
24642264|NCT01178658|Etoposide|etoposide|mesh-list
24855854|NCT02281305|Mitosis Modulators|mitosis modulators|mesh-ancestor
24855855|NCT02281305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855856|NCT02281305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855857|NCT02281370|Cyclosporine|cyclosporine|mesh-list
24855858|NCT02281370|Cyclosporins|cyclosporins|mesh-list
24855859|NCT02281370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855860|NCT02281370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855861|NCT02281370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24855862|NCT02281370|Immunologic Factors|immunologic factors|mesh-ancestor
24855863|NCT02281370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855864|NCT02281370|Antifungal Agents|antifungal agents|mesh-ancestor
24458294|NCT00337389|Leucovorin|leucovorin|mesh-list
24642270|NCT01178658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24642271|NCT01178658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642272|NCT01178658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642273|NCT01178658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24642274|NCT01178658|Antimetabolites|antimetabolites|mesh-ancestor
24642275|NCT01178658|Antiviral Agents|antiviral agents|mesh-ancestor
24642276|NCT01178658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24642277|NCT01178658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24642278|NCT01178658|Immunologic Factors|immunologic factors|mesh-ancestor
24642279|NCT01178658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642280|NCT01178658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24642290|NCT01178697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24642292|NCT01178697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24642293|NCT01178697|Immunologic Factors|immunologic factors|mesh-ancestor
24855865|NCT02281370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24855866|NCT02281370|Dermatologic Agents|dermatologic agents|mesh-ancestor
24855867|NCT02281370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24855868|NCT02281370|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24855869|NCT02281396|Vaccines|vaccines|mesh-list
24855870|NCT02281396|Immunologic Factors|immunologic factors|mesh-ancestor
24642326|NCT01178996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24642327|NCT01178996|Immunologic Factors|immunologic factors|mesh-ancestor
24642549|NCT01180075|Ritonavir|ritonavir|mesh-list
24642328|NCT01178996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642329|NCT01179009|Clonidine|clonidine|mesh-list
24642330|NCT01179009|Scopolamine|scopolamine|mesh-list
24642331|NCT01179009|Ketamine|ketamine|mesh-list
24642332|NCT01179009|Lorazepam|lorazepam|mesh-list
24642333|NCT01179009|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24642334|NCT01179009|Analgesics|analgesics|mesh-ancestor
24642335|NCT01179009|Sensory System Agents|sensory system agents|mesh-ancestor
24642336|NCT01179009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24642337|NCT01179009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642338|NCT01179009|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24642339|NCT01179009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24642340|NCT01179009|Anesthetics, General|anesthetics, general|mesh-ancestor
24692234|NCT01412294|Capecitabine|capecitabine|mesh-list
25688903|NCT01951950|Adrenergic Agents|adrenergic agents|mesh-ancestor
24642342|NCT01179009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24642343|NCT01179009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24642344|NCT01179009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24642345|NCT01179009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24642346|NCT01179009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642367|NCT01179009|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24642368|NCT01179009|Parasympatholytics|parasympatholytics|mesh-ancestor
24642369|NCT01179100|Lidocaine|lidocaine|mesh-list
24642370|NCT01179100|Anesthetics, Local|anesthetics, local|mesh-ancestor
25265168|NCT02435563|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25265169|NCT02435563|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25265170|NCT02435563|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25265171|NCT02435563|Purinergic Agents|purinergic agents|mesh-ancestor
25265172|NCT02435563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25265173|NCT02435563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938572|NCT04017741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24642371|NCT01179100|Anesthetics|anesthetics|mesh-ancestor
24642372|NCT01179100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24642373|NCT01179100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642374|NCT01179100|Sensory System Agents|sensory system agents|mesh-ancestor
24642375|NCT01179100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24458310|NCT00337389|Protective Agents|protective agents|mesh-ancestor
24458311|NCT00337389|Vitamin B Complex|vitamin b complex|mesh-ancestor
24458312|NCT00337389|Vitamins|vitamins|mesh-ancestor
24458313|NCT00337389|Micronutrients|micronutrients|mesh-ancestor
24458314|NCT00337441|Epoetin Alfa|epoetin alfa|mesh-list
24403936|NCT00162201|Abatacept|abatacept|mesh-list
24642423|NCT01179269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642424|NCT01179308|Anesthetics|anesthetics|mesh-list
24642425|NCT01179308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24642426|NCT01179308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642428|NCT01179412|Cadexomer iodine|cadexomer iodine|mesh-list
24642429|NCT01179412|Povidone-Iodine|povidone-iodine|mesh-list
24642430|NCT01179412|Povidone|povidone|mesh-list
24642431|NCT01179412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24642432|NCT01179412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24642433|NCT01179412|Trace Elements|trace elements|mesh-ancestor
24642434|NCT01179412|Micronutrients|micronutrients|mesh-ancestor
24642435|NCT01179412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642436|NCT01179412|Plasma Substitutes|plasma substitutes|mesh-ancestor
24642450|NCT01179438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24642451|NCT01179438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642452|NCT01179464|Simvastatin|simvastatin|mesh-list
24642453|NCT01179464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24642454|NCT01179464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24642455|NCT01179464|Antimetabolites|antimetabolites|mesh-ancestor
24642456|NCT01179464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642457|NCT01179464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24855884|NCT02281669|Anthelmintics|anthelmintics|mesh-ancestor
24855885|NCT02281682|Fluorouracil|fluorouracil|mesh-list
24855887|NCT02281682|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
24855888|NCT02281682|Antimetabolites|antimetabolites|mesh-ancestor
24855890|NCT02281682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24642547|NCT01180062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24642548|NCT01180062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24642550|NCT01180075|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24855903|NCT02281708|Tubulin Modulators|tubulin modulators|mesh-ancestor
24642644|NCT01180413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24642645|NCT01180413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24642646|NCT01180413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24642647|NCT01180413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642648|NCT01180413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24642649|NCT01180413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642650|NCT01180413|Vasodilator Agents|vasodilator agents|mesh-ancestor
24642651|NCT01180413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24642652|NCT01180413|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24642653|NCT01180413|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24642654|NCT01180413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24642665|NCT01180569|Growth Substances|growth substances|mesh-ancestor
24642666|NCT01180569|Growth Inhibitors|growth inhibitors|mesh-ancestor
24642667|NCT01180569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642670|NCT01180621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642671|NCT01180725|Psyllium|psyllium|mesh-list
25265174|NCT02435537|Dexmedetomidine|dexmedetomidine|mesh-list
24642672|NCT01180725|Cathartics|cathartics|mesh-ancestor
24642673|NCT01180725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25265175|NCT02435537|Morphine|morphine|mesh-list
25265176|NCT02435537|Bupivacaine|bupivacaine|mesh-list
25265177|NCT02435537|Anesthetics, Local|anesthetics, local|mesh-ancestor
25265178|NCT02435537|Anesthetics|anesthetics|mesh-ancestor
24537845|NCT00656526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24537846|NCT00656526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537847|NCT00656526|Sensory System Agents|sensory system agents|mesh-ancestor
24537848|NCT00656526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24537849|NCT00656526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24448000|NCT00310011|Antimitotic Agents|antimitotic agents|mesh-ancestor
24537850|NCT00656526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24537851|NCT00656526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24537852|NCT00656526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24537853|NCT00656526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642674|NCT01180751|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24642675|NCT01180751|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24642676|NCT01180751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642677|NCT01180816|Temozolomide|temozolomide|mesh-list
24642689|NCT01180946|Ergocalciferols|ergocalciferols|mesh-list
24642690|NCT01180946|Vitamins|vitamins|mesh-ancestor
24642691|NCT01180946|Micronutrients|micronutrients|mesh-ancestor
24448059|NCT00310128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25265181|NCT02435537|Sensory System Agents|sensory system agents|mesh-ancestor
25265182|NCT02435537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25265183|NCT02435537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25265184|NCT02435537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25265185|NCT02435537|Analgesics|analgesics|mesh-ancestor
25265186|NCT02435537|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25265187|NCT02435537|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25265188|NCT02435537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25265189|NCT02435537|Adrenergic Agents|adrenergic agents|mesh-ancestor
25265190|NCT02435537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25265191|NCT02435537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265192|NCT02435537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25265193|NCT02435537|Narcotics|narcotics|mesh-ancestor
25265194|NCT02435459|Calcium|calcium|mesh-list
25265195|NCT02435459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25265196|NCT02435459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265197|NCT02435368|Mycophenolic Acid|mycophenolic acid|mesh-list
25265198|NCT02435368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25265199|NCT02435368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688904|NCT01951950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25688905|NCT01951950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688906|NCT01951950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265200|NCT02435368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24965899|NCT03773367|Oxaliplatin|oxaliplatin|mesh-list
24965900|NCT03773367|Irinotecan|irinotecan|mesh-list
25265201|NCT02435368|Antitubercular Agents|antitubercular agents|mesh-ancestor
25265202|NCT02435368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25265203|NCT02435368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25265204|NCT02435368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265205|NCT02435368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265206|NCT02435303|Sildenafil Citrate|sildenafil citrate|mesh-list
25265207|NCT02435303|Vasodilator Agents|vasodilator agents|mesh-ancestor
25265208|NCT02435303|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24812338|NCT02051569|Tryptophan|tryptophan|mesh-list
24448060|NCT00310128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24642698|NCT01180959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642699|NCT01180959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24642700|NCT01180959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24642702|NCT01180959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642703|NCT01180959|Growth Inhibitors|growth inhibitors|mesh-ancestor
24642704|NCT01180959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24642705|NCT01180959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642706|NCT01180959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642707|NCT01181063|Budesonide|budesonide|mesh-list
24642708|NCT01181063|Formoterol Fumarate|formoterol fumarate|mesh-list
24642709|NCT01181063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24642710|NCT01181063|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24642711|NCT01181063|Autonomic Agents|autonomic agents|mesh-ancestor
24642712|NCT01181063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24642714|NCT01181063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24642715|NCT01181063|Respiratory System Agents|respiratory system agents|mesh-ancestor
24642716|NCT01181063|Glucocorticoids|glucocorticoids|mesh-ancestor
24642717|NCT01181063|Hormones|hormones|mesh-ancestor
24642718|NCT01181063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24855904|NCT02281708|Antimitotic Agents|antimitotic agents|mesh-ancestor
24855905|NCT02281708|Mitosis Modulators|mitosis modulators|mesh-ancestor
24855906|NCT02281708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642719|NCT01181063|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24642720|NCT01181063|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24642721|NCT01181063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24612169|NCT01012284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24642730|NCT01181115|Antiviral Agents|antiviral agents|mesh-ancestor
24642731|NCT01181115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24642733|NCT01181154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24642734|NCT01181154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642735|NCT01181154|Immunologic Factors|immunologic factors|mesh-ancestor
25265211|NCT02435303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265212|NCT02435303|Urological Agents|urological agents|mesh-ancestor
25265213|NCT02435095|Antipsychotic Agents|antipsychotic agents|mesh-list
25265214|NCT02435095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25265215|NCT02435095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25265216|NCT02435095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265217|NCT02435095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25265218|NCT02435186|Paclitaxel|paclitaxel|mesh-list
25688907|NCT01951950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25688908|NCT01951950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25688909|NCT01951950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25265219|NCT02435186|Cisplatin|cisplatin|mesh-list
25265220|NCT02435186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25688910|NCT01951950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25688911|NCT01951950|Vasodilator Agents|vasodilator agents|mesh-ancestor
25688912|NCT01951963|Ketamine|ketamine|mesh-list
25688913|NCT01951963|Morphine|morphine|mesh-list
25688914|NCT01951963|Analgesics|analgesics|mesh-ancestor
25688915|NCT01951963|Sensory System Agents|sensory system agents|mesh-ancestor
24515631|NCT00598533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24537861|NCT00656552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537862|NCT00656552|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24537886|NCT00656643|Antifungal Agents|antifungal agents|mesh-ancestor
24537887|NCT00656643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24456752|NCT00332124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456753|NCT00332124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24456754|NCT00332124|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24642736|NCT01181154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642737|NCT01181154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24642738|NCT01181193|Vitamin D|vitamin d|mesh-list
24642740|NCT01181193|Temozolomide|temozolomide|mesh-list
24642741|NCT01181193|Vitamins|vitamins|mesh-ancestor
24642742|NCT01181193|Micronutrients|micronutrients|mesh-ancestor
25265222|NCT02435186|Tubulin Modulators|tubulin modulators|mesh-ancestor
25265223|NCT02435186|Antimitotic Agents|antimitotic agents|mesh-ancestor
25265224|NCT02435186|Mitosis Modulators|mitosis modulators|mesh-ancestor
25265225|NCT02435186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265226|NCT02435108|Crizotinib|crizotinib|mesh-list
25265227|NCT02435108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265231|NCT02434952|Piperaquine|piperaquine|mesh-list
25265232|NCT02434952|Primaquine|primaquine|mesh-list
25265233|NCT02434952|Artenimol|artenimol|mesh-list
25265234|NCT02434952|Antimalarials|antimalarials|mesh-ancestor
25265235|NCT02434952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25265236|NCT02434952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25265237|NCT02434952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25265238|NCT02434861|Sulfasalazine|sulfasalazine|mesh-list
25265239|NCT02434861|Digoxin|digoxin|mesh-list
25265240|NCT02434861|Rolapitant|rolapitant|mesh-list
25265241|NCT02434861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25265242|NCT02434861|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25265243|NCT02434861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265244|NCT02434861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265245|NCT02434861|Protective Agents|protective agents|mesh-ancestor
25265246|NCT02434861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265247|NCT02434861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25265248|NCT02434861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25265249|NCT02434861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25265250|NCT02434861|Analgesics|analgesics|mesh-ancestor
25265251|NCT02434861|Sensory System Agents|sensory system agents|mesh-ancestor
25265252|NCT02434861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25265253|NCT02434861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25265254|NCT02434861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25265255|NCT02434861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25265256|NCT02434861|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25404397|NCT03670810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25051979|NCT00356681|Bevacizumab|bevacizumab|mesh-list
25051980|NCT00356681|Motesanib diphosphate|motesanib diphosphate|mesh-list
25051981|NCT00356681|Imetelstat|imetelstat|mesh-list
25051983|NCT00356681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24938650|NCT04017624|Cholinergic Agents|cholinergic agents|mesh-ancestor
24642743|NCT01181193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642744|NCT01181193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24642745|NCT01181193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24642746|NCT01181193|Alkylating Agents|alkylating agents|mesh-ancestor
24642747|NCT01181193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642762|NCT01181310|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24642763|NCT01181310|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24642764|NCT01181310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642765|NCT01181310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642766|NCT01181310|Cholinergic Agents|cholinergic agents|mesh-ancestor
24642767|NCT01181310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24462848|NCT00357682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24642780|NCT01181388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24642781|NCT01181388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24642782|NCT01181388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642783|NCT01181388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24642784|NCT01181401|Cisplatin|cisplatin|mesh-list
24642785|NCT01181401|Docetaxel|docetaxel|mesh-list
24642786|NCT01181401|Cetuximab|cetuximab|mesh-list
24642787|NCT01181401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642788|NCT01181401|Tubulin Modulators|tubulin modulators|mesh-ancestor
24642789|NCT01181401|Antimitotic Agents|antimitotic agents|mesh-ancestor
24642834|NCT01181570|Sequestering Agents|sequestering agents|mesh-ancestor
24642835|NCT01181570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642836|NCT01181570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24642837|NCT01181570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24642838|NCT01181570|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24642839|NCT01181570|Diuretics|diuretics|mesh-ancestor
24642840|NCT01181570|Natriuretic Agents|natriuretic agents|mesh-ancestor
24642841|NCT01181570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642843|NCT01181765|Dermatologic Agents|dermatologic agents|mesh-ancestor
24642844|NCT01181765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24642845|NCT01181765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24642847|NCT01181882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24642848|NCT01181882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24642849|NCT01181882|Analgesics|analgesics|mesh-ancestor
24642850|NCT01181882|Sensory System Agents|sensory system agents|mesh-ancestor
24642851|NCT01181882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25265257|NCT02434861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25265258|NCT02434549|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25265259|NCT02434549|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25265260|NCT02434549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25265261|NCT02434549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265262|NCT02434549|Cholinergic Agents|cholinergic agents|mesh-ancestor
25265263|NCT02434549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25265264|NCT02434549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265265|NCT02434822|Vaccines|vaccines|mesh-list
25265266|NCT02434822|Immunologic Factors|immunologic factors|mesh-ancestor
25265267|NCT02434822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265268|NCT02434757|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25265269|NCT02434757|Hormones|hormones|mesh-ancestor
25265270|NCT02434757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25265271|NCT02434757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265272|NCT02434653|Chrysarobin|chrysarobin|mesh-list
25688916|NCT01951963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25688917|NCT01951963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688918|NCT01951963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24576904|NCT00840918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24576906|NCT00840918|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24576907|NCT00840918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24576908|NCT00840918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24576909|NCT00840918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576910|NCT00840931|Lenalidomide|lenalidomide|mesh-list
24576911|NCT00840931|Immunologic Factors|immunologic factors|mesh-ancestor
24950969|NCT03909529|Digoxin|digoxin|mesh-list
24538064|NCT00657410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24538065|NCT00657410|Antiemetics|antiemetics|mesh-ancestor
24538066|NCT00657410|Autonomic Agents|autonomic agents|mesh-ancestor
24538067|NCT00657410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24782562|NCT01896609|Interferons|interferons|mesh-list
24538068|NCT00657410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538069|NCT00657410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24538070|NCT00657410|Glucocorticoids|glucocorticoids|mesh-ancestor
24763440|NCT01773616|Hormones|hormones|mesh-ancestor
24642852|NCT01181882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642853|NCT01181882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24642854|NCT01181882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24642855|NCT01181882|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24642856|NCT01181882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24642857|NCT01181882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642858|NCT01181882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24642859|NCT01181882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24642860|NCT01181882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642861|NCT01181882|Antipyretics|antipyretics|mesh-ancestor
24642862|NCT01181934|Nicotine|nicotine|mesh-list
24642863|NCT01181934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24642864|NCT01181934|Autonomic Agents|autonomic agents|mesh-ancestor
24642865|NCT01181934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24819243|NCT02094287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24642901|NCT01182077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24642902|NCT01182077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24855913|NCT02281799|Antimetabolites|antimetabolites|mesh-ancestor
24855914|NCT02281799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642903|NCT01182077|Anesthetics, General|anesthetics, general|mesh-ancestor
24642904|NCT01182077|Anesthetics|anesthetics|mesh-ancestor
24448181|NCT00310596|Moxifloxacin|moxifloxacin|mesh-list
24642905|NCT01182077|GABA Modulators|gaba modulators|mesh-ancestor
24642906|NCT01182077|GABA Agents|gaba agents|mesh-ancestor
24642907|NCT01182077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24642908|NCT01182077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642909|NCT01182077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642910|NCT01182077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24642911|NCT01182077|Immunologic Factors|immunologic factors|mesh-ancestor
24642912|NCT01182129|Nicotine|nicotine|mesh-list
24642940|NCT01182246|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24642941|NCT01182246|Protective Agents|protective agents|mesh-ancestor
24642942|NCT01182246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642979|NCT01182662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24642981|NCT01182662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642982|NCT01182662|Antifungal Agents|antifungal agents|mesh-ancestor
24642983|NCT01182662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24642984|NCT01182662|Dermatologic Agents|dermatologic agents|mesh-ancestor
24642985|NCT01182662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24642986|NCT01182662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24642987|NCT01182792|Ascorbic Acid|ascorbic acid|mesh-list
24642988|NCT01182792|Vitamins|vitamins|mesh-ancestor
25265273|NCT02434653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25688919|NCT01951963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25688920|NCT01951963|Anesthetics, General|anesthetics, general|mesh-ancestor
25688921|NCT01951963|Anesthetics|anesthetics|mesh-ancestor
25688922|NCT01951963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25688923|NCT01951963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25688924|NCT01951963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25688925|NCT01951963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25688926|NCT01951963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265274|NCT02434653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24951031|NCT03908944|Narcotics|narcotics|mesh-ancestor
24951032|NCT03908944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25265275|NCT02434653|Analgesics|analgesics|mesh-ancestor
25265276|NCT02434653|Sensory System Agents|sensory system agents|mesh-ancestor
25265277|NCT02434653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25265278|NCT02434653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265279|NCT02434653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25265280|NCT02434653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25265281|NCT02434276|Hemagglutinins|hemagglutinins|mesh-list
25265282|NCT02434276|Immunologic Factors|immunologic factors|mesh-ancestor
25265283|NCT02434276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265284|NCT02434276|Agglutinins|agglutinins|mesh-ancestor
25265285|NCT02434614|Cisplatin|cisplatin|mesh-list
25265286|NCT02434614|Docetaxel|docetaxel|mesh-list
25265287|NCT02434614|Fluorouracil|fluorouracil|mesh-list
25265288|NCT02434614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538072|NCT00657410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24538074|NCT00657410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538075|NCT00657423|Cisplatin|cisplatin|mesh-list
24538076|NCT00657423|Docetaxel|docetaxel|mesh-list
24538077|NCT00657423|Endostar protein|endostar protein|mesh-list
24538078|NCT00657423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538079|NCT00657423|Tubulin Modulators|tubulin modulators|mesh-ancestor
24538080|NCT00657423|Antimitotic Agents|antimitotic agents|mesh-ancestor
24538081|NCT00657423|Mitosis Modulators|mitosis modulators|mesh-ancestor
24538082|NCT00657423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538083|NCT00657423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24515657|NCT00598624|Treosulfan|treosulfan|mesh-list
24642989|NCT01182792|Micronutrients|micronutrients|mesh-ancestor
24642990|NCT01182792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642991|NCT01182792|Antioxidants|antioxidants|mesh-ancestor
24642992|NCT01182792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642993|NCT01182792|Protective Agents|protective agents|mesh-ancestor
24642994|NCT01182883|Sirolimus|sirolimus|mesh-list
24642995|NCT01182883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24642996|NCT01182883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24642997|NCT01182883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25265289|NCT02434614|Tubulin Modulators|tubulin modulators|mesh-ancestor
25265290|NCT02434614|Antimitotic Agents|antimitotic agents|mesh-ancestor
25265291|NCT02434614|Mitosis Modulators|mitosis modulators|mesh-ancestor
25265292|NCT02434614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265293|NCT02434614|Antimetabolites|antimetabolites|mesh-ancestor
25265294|NCT02434614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25265295|NCT02434614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25265296|NCT02434614|Immunologic Factors|immunologic factors|mesh-ancestor
25265297|NCT02434614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265298|NCT02433860|Nicotine|nicotine|mesh-list
25265299|NCT02433860|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25265300|NCT02433860|Autonomic Agents|autonomic agents|mesh-ancestor
25265301|NCT02433860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25265302|NCT02433860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265303|NCT02433860|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25265304|NCT02433860|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25265305|NCT02433860|Cholinergic Agents|cholinergic agents|mesh-ancestor
25265306|NCT02433860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25265307|NCT02433860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688927|NCT01951963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25688928|NCT01951963|Narcotics|narcotics|mesh-ancestor
25688929|NCT01952054|Denosumab|denosumab|mesh-list
25275362|NCT02372786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275363|NCT02372786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25275364|NCT02372786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25275365|NCT02372786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25275366|NCT02372786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25275367|NCT02372786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275368|NCT02372487|Sildenafil Citrate|sildenafil citrate|mesh-list
25275369|NCT02372487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275370|NCT02372487|Vasodilator Agents|vasodilator agents|mesh-ancestor
25275371|NCT02372487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25275372|NCT02372487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25275373|NCT02372487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538114|NCT00657488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24538115|NCT00657488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24538116|NCT00657488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24538117|NCT00657488|Growth Substances|growth substances|mesh-ancestor
24538118|NCT00657488|Growth Inhibitors|growth inhibitors|mesh-ancestor
24449621|NCT00316238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449622|NCT00316238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24449623|NCT00316238|Serotonin Agents|serotonin agents|mesh-ancestor
24449624|NCT00316329|Artesunate|artesunate|mesh-list
24449625|NCT00316329|Amodiaquine|amodiaquine|mesh-list
24449626|NCT00316329|Antimalarials|antimalarials|mesh-ancestor
24449627|NCT00316329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24642998|NCT01182883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642999|NCT01182883|Antifungal Agents|antifungal agents|mesh-ancestor
24643000|NCT01182883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24643001|NCT01182883|Immunologic Factors|immunologic factors|mesh-ancestor
24643002|NCT01182883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643003|NCT01182974|Acetaminophen|acetaminophen|mesh-list
24643004|NCT01182974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24643005|NCT01182974|Analgesics|analgesics|mesh-ancestor
24643161|NCT01184196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24643162|NCT01184235|Antipsychotic Agents|antipsychotic agents|mesh-list
24643163|NCT01184235|Antidepressive Agents|antidepressive agents|mesh-list
24643164|NCT01184235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24643165|NCT01184235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24643166|NCT01184235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24643167|NCT01184235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643169|NCT01184287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24643195|NCT01184443|Antiemetics|antiemetics|mesh-ancestor
24643196|NCT01184443|Autonomic Agents|autonomic agents|mesh-ancestor
24643197|NCT01184443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24643198|NCT01184443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643199|NCT01184443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24643200|NCT01184443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24643201|NCT01184443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25265308|NCT02433847|Mosapride|mosapride|mesh-list
25265309|NCT02433847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25265310|NCT02433847|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25265311|NCT02433847|Serotonin Agents|serotonin agents|mesh-ancestor
25265312|NCT02433847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25265313|NCT02433847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265314|NCT02433847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265315|NCT02433808|Neostigmine|neostigmine|mesh-list
25265316|NCT02433808|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25265317|NCT02433808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265318|NCT02433808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265319|NCT02433808|Cholinergic Agents|cholinergic agents|mesh-ancestor
25265320|NCT02433808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25265321|NCT02433808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265322|NCT02433808|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25265323|NCT02433808|Autonomic Agents|autonomic agents|mesh-ancestor
25265324|NCT02433808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25265325|NCT02433899|Chlorhexidine|chlorhexidine|mesh-list
25265326|NCT02433899|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25265327|NCT02433899|Dexamethasone|dexamethasone|mesh-list
25265328|NCT02433899|Epinephrine|epinephrine|mesh-list
25265329|NCT02433899|Mepivacaine|mepivacaine|mesh-list
25265330|NCT02433899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25265331|NCT02433899|Antiemetics|antiemetics|mesh-ancestor
25265332|NCT02433899|Autonomic Agents|autonomic agents|mesh-ancestor
25265333|NCT02433899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25265334|NCT02433899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643202|NCT01184443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24643203|NCT01184443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24643213|NCT01184482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24643214|NCT01184482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24643215|NCT01184482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643230|NCT01184638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24643231|NCT01184638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24643232|NCT01184638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643233|NCT01184638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24643234|NCT01184638|Anesthetics, General|anesthetics, general|mesh-ancestor
24643235|NCT01184638|Anesthetics|anesthetics|mesh-ancestor
24643236|NCT01184638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24643237|NCT01184638|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24643238|NCT01184664|Nicotine|nicotine|mesh-list
24643239|NCT01184664|Varenicline|varenicline|mesh-list
24643240|NCT01184664|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24643241|NCT01184664|Autonomic Agents|autonomic agents|mesh-ancestor
24643242|NCT01184664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24643243|NCT01184664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643244|NCT01184664|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24520051|NCT03980769|Fludarabine|fludarabine|mesh-list
24677533|NCT01356732|Sufentanil|sufentanil|mesh-list
24855928|NCT02281929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24855929|NCT02281929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24855930|NCT02281929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25265335|NCT02433899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25265336|NCT02433899|Glucocorticoids|glucocorticoids|mesh-ancestor
25265337|NCT02433899|Hormones|hormones|mesh-ancestor
25265361|NCT02434029|Budesonide|budesonide|mesh-list
25265338|NCT02433899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25265339|NCT02433899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25265340|NCT02433899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265341|NCT02433899|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25265342|NCT02433899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25265343|NCT02433899|Disinfectants|disinfectants|mesh-ancestor
25265344|NCT02433899|Dermatologic Agents|dermatologic agents|mesh-ancestor
25265345|NCT02433899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25265346|NCT02433899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25265347|NCT02433899|Adrenergic Agents|adrenergic agents|mesh-ancestor
25265348|NCT02433899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25265349|NCT02433899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265350|NCT02433899|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25265351|NCT02433899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25265352|NCT02433899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25265353|NCT02433899|Respiratory System Agents|respiratory system agents|mesh-ancestor
25265354|NCT02433899|Mydriatics|mydriatics|mesh-ancestor
25265355|NCT02433899|Sympathomimetics|sympathomimetics|mesh-ancestor
25265356|NCT02433899|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25265357|NCT02433899|Anesthetics, Local|anesthetics, local|mesh-ancestor
25265358|NCT02433899|Anesthetics|anesthetics|mesh-ancestor
24538132|NCT00657566|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24538133|NCT00657566|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24538134|NCT00657566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24538135|NCT00657566|Antitubercular Agents|antitubercular agents|mesh-ancestor
24538136|NCT00657579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24538137|NCT00657579|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24538138|NCT00657644|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24538208|NCT00657878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538209|NCT00657878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24538210|NCT00657878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24538211|NCT00657878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24538212|NCT00657878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24458345|NCT00337506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24458346|NCT00337506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24458348|NCT00337519|Alemtuzumab|alemtuzumab|mesh-list
24458349|NCT00337519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24458350|NCT00337519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458351|NCT00337545|Everolimus|everolimus|mesh-list
24458352|NCT00337545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458353|NCT00337545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24458354|NCT00337545|Immunologic Factors|immunologic factors|mesh-ancestor
24458355|NCT00337545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643246|NCT01184664|Cholinergic Agents|cholinergic agents|mesh-ancestor
24643247|NCT01184664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24643248|NCT01184664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643249|NCT01184716|Vitamin D|vitamin d|mesh-list
24643250|NCT01184716|Vitamins|vitamins|mesh-ancestor
24643251|NCT01184716|Micronutrients|micronutrients|mesh-ancestor
24643252|NCT01184716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643253|NCT01184716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24643254|NCT01184794|Levobupivacaine|levobupivacaine|mesh-list
24643255|NCT01184794|Anesthetics, Local|anesthetics, local|mesh-ancestor
24643256|NCT01184794|Anesthetics|anesthetics|mesh-ancestor
24643257|NCT01184794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25265359|NCT02433899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25265360|NCT02433899|Sensory System Agents|sensory system agents|mesh-ancestor
25265362|NCT02434029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25265363|NCT02434029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25265364|NCT02434029|Autonomic Agents|autonomic agents|mesh-ancestor
25265365|NCT02434029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25265366|NCT02434029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265367|NCT02434029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25265368|NCT02434029|Respiratory System Agents|respiratory system agents|mesh-ancestor
25265369|NCT02434029|Glucocorticoids|glucocorticoids|mesh-ancestor
25265370|NCT02434029|Hormones|hormones|mesh-ancestor
25265371|NCT02434029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25265372|NCT02433925|Resveratrol|resveratrol|mesh-list
25265373|NCT02433925|Antioxidants|antioxidants|mesh-ancestor
25265374|NCT02433925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265375|NCT02433925|Protective Agents|protective agents|mesh-ancestor
25265376|NCT02433925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265377|NCT02433925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265378|NCT02433925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25265379|NCT02433717|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25265380|NCT02433717|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25265381|NCT02433717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24643437|NCT01185678|Hormones|hormones|mesh-ancestor
24643258|NCT01184794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643259|NCT01184794|Sensory System Agents|sensory system agents|mesh-ancestor
24643260|NCT01184794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24643261|NCT01184820|Factor VIII|factor viii|mesh-list
24643262|NCT01184820|Coagulants|coagulants|mesh-ancestor
24643263|NCT01184833|Interferons|interferons|mesh-list
24643264|NCT01184833|Interferon-beta|interferon-beta|mesh-list
24643265|NCT01184833|Interferon beta-1b|interferon beta-1b|mesh-list
24643267|NCT01184833|Antiviral Agents|antiviral agents|mesh-ancestor
24855936|NCT02281929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24643274|NCT01184911|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24643275|NCT01184911|Antimalarials|antimalarials|mesh-ancestor
24643276|NCT01184911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24643277|NCT01184911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24643278|NCT01184911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24643279|NCT01184911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24643341|NCT01185223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643342|NCT01185223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643343|NCT01185236|Atorvastatin|atorvastatin|mesh-list
24643360|NCT01185262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24643361|NCT01185262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24643363|NCT01185262|Growth Inhibitors|growth inhibitors|mesh-ancestor
24643364|NCT01185405|Voriconazole|voriconazole|mesh-list
24420534|NCT00216216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24643373|NCT01185405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24643374|NCT01185405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643375|NCT01185405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24643377|NCT01185418|Risperidone|risperidone|mesh-list
24643414|NCT01185470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643415|NCT01185470|Analgesics|analgesics|mesh-ancestor
24643416|NCT01185470|Sensory System Agents|sensory system agents|mesh-ancestor
24643417|NCT01185470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24643418|NCT01185535|Anesthetics|anesthetics|mesh-list
24643421|NCT01185574|Vitamin D|vitamin d|mesh-list
24643426|NCT01185678|Contraceptive Agents|contraceptive agents|mesh-list
24643427|NCT01185678|Desogestrel|desogestrel|mesh-list
24643428|NCT01185678|Contraceptives, Oral|contraceptives, oral|mesh-list
25265382|NCT02433717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25265383|NCT02433717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265384|NCT02433717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25265385|NCT02433717|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25265386|NCT02433717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25265387|NCT02433717|Serotonin Agents|serotonin agents|mesh-ancestor
25265388|NCT02433717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25265389|NCT02433717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265390|NCT02433717|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25265391|NCT02433717|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25265392|NCT02433717|Dopamine Agents|dopamine agents|mesh-ancestor
25265393|NCT02433652|Vaccines|vaccines|mesh-list
25265394|NCT02433652|Immunologic Factors|immunologic factors|mesh-ancestor
25265395|NCT02433652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265396|NCT02433626|Cisplatin|cisplatin|mesh-list
25265397|NCT02433626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265398|NCT02433587|Aspirin|aspirin|mesh-list
25265399|NCT02433587|Clopidogrel|clopidogrel|mesh-list
25265400|NCT02433587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24538213|NCT00657891|Omalizumab|omalizumab|mesh-list
24538214|NCT00657891|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24538215|NCT00657891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24538216|NCT00657891|Respiratory System Agents|respiratory system agents|mesh-ancestor
24538217|NCT00657904|Bicalutamide|bicalutamide|mesh-list
24538218|NCT00657904|Androgen Antagonists|androgen antagonists|mesh-ancestor
24538219|NCT00657904|Hormone Antagonists|hormone antagonists|mesh-ancestor
24643429|NCT01185678|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
24643430|NCT01185678|Progestins|progestins|mesh-list
24643431|NCT01185678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24643432|NCT01185678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643433|NCT01185678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24643434|NCT01185678|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24448465|NCT00311896|Bemiparin|bemiparin|mesh-list
24643435|NCT01185678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24643436|NCT01185678|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24643438|NCT01185678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24643441|NCT01185743|Antiemetics|antiemetics|mesh-ancestor
24643442|NCT01185743|Autonomic Agents|autonomic agents|mesh-ancestor
24643443|NCT01185743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24643444|NCT01185743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643445|NCT01185743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24643446|NCT01185743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24643447|NCT01185743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24855937|NCT02281929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855938|NCT02281929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643644|NCT01186471|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24643668|NCT01186549|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24643670|NCT01186549|Autonomic Agents|autonomic agents|mesh-ancestor
24643671|NCT01186549|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24643673|NCT01186549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24643674|NCT01186549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24643675|NCT01186549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24643676|NCT01186549|Respiratory System Agents|respiratory system agents|mesh-ancestor
24643677|NCT01186549|Nasal Decongestants|nasal decongestants|mesh-ancestor
24643678|NCT01186588|Canagliflozin|canagliflozin|mesh-list
24643679|NCT01186588|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24643680|NCT01186588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643681|NCT01186588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24643682|NCT01186588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643683|NCT01186653|Fluticasone|fluticasone|mesh-list
24643685|NCT01186653|Formoterol Fumarate|formoterol fumarate|mesh-list
24643686|NCT01186653|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24643687|NCT01186653|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24643688|NCT01186653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24643689|NCT01186653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24855945|NCT02281968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24643904|NCT01187862|Adrenergic Agents|adrenergic agents|mesh-ancestor
24643778|NCT01187264|Abortifacient Agents|abortifacient agents|mesh-ancestor
24643779|NCT01187264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24643780|NCT01187264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643781|NCT01187264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25265401|NCT02433587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25265403|NCT02433587|Sensory System Agents|sensory system agents|mesh-ancestor
25265404|NCT02433587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25265405|NCT02433587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265406|NCT02433587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25265407|NCT02433587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25265408|NCT02433587|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25265409|NCT02433587|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25265410|NCT02433587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265411|NCT02433587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24538220|NCT00657904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24538221|NCT00657904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538222|NCT00657904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538224|NCT00657930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24538225|NCT00657930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938742|NCT04016233|Antiviral Agents|antiviral agents|mesh-ancestor
24643783|NCT01187264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643784|NCT01187264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24643785|NCT01187264|Dermatologic Agents|dermatologic agents|mesh-ancestor
24643786|NCT01187264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643787|NCT01187264|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24643788|NCT01187264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24643789|NCT01187264|Immunologic Factors|immunologic factors|mesh-ancestor
24643790|NCT01187264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24643791|NCT01187264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24643793|NCT01187303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24643794|NCT01187459|Vitamin D|vitamin d|mesh-list
24643795|NCT01187459|Ergocalciferols|ergocalciferols|mesh-list
24643796|NCT01187459|Cholecalciferol|cholecalciferol|mesh-list
24643797|NCT01187459|Vitamins|vitamins|mesh-list
24643798|NCT01187459|Micronutrients|micronutrients|mesh-ancestor
24643799|NCT01187459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643800|NCT01187459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24643801|NCT01187459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24643802|NCT01187485|Methyltestosterone|methyltestosterone|mesh-list
24643803|NCT01187485|Testosterone|testosterone|mesh-list
24643804|NCT01187485|Testosterone undecanoate|testosterone undecanoate|mesh-list
24643807|NCT01187485|Androgens|androgens|mesh-ancestor
24643816|NCT01187537|Anesthetics|anesthetics|mesh-ancestor
24643817|NCT01187537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24643867|NCT01187862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24643868|NCT01187862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24643893|NCT01187862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24643894|NCT01187862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24643895|NCT01187862|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24643896|NCT01187862|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24643897|NCT01187862|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24643899|NCT01187862|Autonomic Agents|autonomic agents|mesh-ancestor
24643900|NCT01187862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24643901|NCT01187862|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24643902|NCT01187862|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24643903|NCT01187862|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25265412|NCT02433587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25265413|NCT02433587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265414|NCT02433587|Antipyretics|antipyretics|mesh-ancestor
25265415|NCT02433587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25265416|NCT02433587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25265417|NCT02433587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25265418|NCT02433587|Purinergic Agents|purinergic agents|mesh-ancestor
25265419|NCT02433587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25265420|NCT02433704|Cefazolin|cefazolin|mesh-list
25265421|NCT02433704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25265422|NCT02433704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25265423|NCT02433457|Omeprazole|omeprazole|mesh-list
25265424|NCT02433457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25265425|NCT02433457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24643941|NCT01188005|Gout Suppressants|gout suppressants|mesh-ancestor
24693069|NCT01418131|Tacrolimus|tacrolimus|mesh-list
24644116|NCT01189097|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24644117|NCT01189097|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24644118|NCT01189097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24644119|NCT01189097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644120|NCT01189097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644122|NCT01189214|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24644123|NCT01189214|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24644124|NCT01189214|Dopamine Agents|dopamine agents|mesh-ancestor
24644125|NCT01189214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24644126|NCT01189214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644127|NCT01189214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644128|NCT01189214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24644129|NCT01189214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24644130|NCT01189253|Doxorubicin|doxorubicin|mesh-list
24644131|NCT01189253|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24644132|NCT01189253|Trabectedin|trabectedin|mesh-list
24644133|NCT01189253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24644134|NCT01189253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855952|NCT02281968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855954|NCT02282059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855955|NCT02282059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24855956|NCT02282059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24855957|NCT02282059|Growth Substances|growth substances|mesh-ancestor
24538226|NCT00657943|Insulin|insulin|mesh-list
24538227|NCT00657943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24538228|NCT00657943|Metformin|metformin|mesh-list
24538229|NCT00657943|Insulin Aspart|insulin aspart|mesh-list
24538230|NCT00657943|Insulin, Long-Acting|insulin, long-acting|mesh-list
24538231|NCT00657943|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24538266|NCT00658255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24448962|NCT00313625|Alkylating Agents|alkylating agents|mesh-ancestor
24693130|NCT01418430|Daclizumab|daclizumab|mesh-list
24644184|NCT01189656|Immunologic Factors|immunologic factors|mesh-ancestor
24644185|NCT01189656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644187|NCT01189695|Lopinavir|lopinavir|mesh-list
24644188|NCT01189695|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25265436|NCT02433535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265437|NCT02433522|Rituximab|rituximab|mesh-list
25265438|NCT02433522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25265439|NCT02433522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265440|NCT02433522|Immunologic Factors|immunologic factors|mesh-ancestor
25265441|NCT02433522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265442|NCT02433522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25265443|NCT02433418|Diclofenac|diclofenac|mesh-list
25265444|NCT02433418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25265445|NCT02433418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25265446|NCT02433418|Analgesics|analgesics|mesh-ancestor
25265447|NCT02433418|Sensory System Agents|sensory system agents|mesh-ancestor
25265448|NCT02433418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25265453|NCT02433418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265454|NCT02433418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265455|NCT02433314|Brexanolone|brexanolone|mesh-list
25265456|NCT02433314|Neurosteroids|neurosteroids|mesh-ancestor
25265457|NCT02433314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25265458|NCT02433314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265459|NCT02433314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265460|NCT02433314|GABA Modulators|gaba modulators|mesh-ancestor
25265461|NCT02433314|GABA Agents|gaba agents|mesh-ancestor
25265462|NCT02433353|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24776986|NCT01860833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632955|NCT01126450|Lenalidomide|lenalidomide|mesh-list
24449636|NCT00316407|Carboplatin|carboplatin|mesh-list
24449637|NCT00316407|Lapatinib|lapatinib|mesh-list
24449638|NCT00316407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24644189|NCT01189695|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24644204|NCT01189721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24644206|NCT01189721|Anesthetics|anesthetics|mesh-ancestor
24644242|NCT01189864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24644243|NCT01189864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24644244|NCT01189864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420535|NCT00216216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24644245|NCT01189864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644246|NCT01189864|Antiemetics|antiemetics|mesh-ancestor
24644286|NCT01190241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644312|NCT01190293|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24644314|NCT01190293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24644315|NCT01190293|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24644401|NCT01190722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644402|NCT01190722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24644403|NCT01190722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24644404|NCT01190722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24644405|NCT01190722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644406|NCT01190722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644407|NCT01190722|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24644409|NCT01190735|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24644410|NCT01190735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644411|NCT01190735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24644412|NCT01190735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644413|NCT01190735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644414|NCT01190735|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24644415|NCT01190735|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24644416|NCT01190735|Purinergic Agents|purinergic agents|mesh-ancestor
24644417|NCT01190735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24644419|NCT01190748|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24644420|NCT01190748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265463|NCT02433353|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25265464|NCT02433353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25265465|NCT02433353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25265466|NCT02433353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265467|NCT02433353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25265468|NCT02433353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265469|NCT02433353|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25265470|NCT02433353|Antidepressive Agents|antidepressive agents|mesh-ancestor
25265471|NCT02433353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25265472|NCT02433730|Testosterone|testosterone|mesh-list
25265473|NCT02433730|Androgens|androgens|mesh-ancestor
25265474|NCT02433730|Hormones|hormones|mesh-ancestor
25265475|NCT02433730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25265476|NCT02433730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265477|NCT02433912|Acetaminophen|acetaminophen|mesh-list
25265478|NCT02433912|Chlorhexidine|chlorhexidine|mesh-list
25265479|NCT02433912|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25265480|NCT02433912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25265481|NCT02433912|Analgesics|analgesics|mesh-ancestor
24449639|NCT00316407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688930|NCT01952054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25688931|NCT01952054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584391|NCT00880243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24584392|NCT00880243|Antimetabolites|antimetabolites|mesh-ancestor
24584393|NCT00880243|Antiviral Agents|antiviral agents|mesh-ancestor
24449640|NCT00316407|Tubulin Modulators|tubulin modulators|mesh-ancestor
24449641|NCT00316407|Antimitotic Agents|antimitotic agents|mesh-ancestor
24538362|NCT00659022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538363|NCT00659022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25155630|NCT05323552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538364|NCT00659022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24538365|NCT00659022|Growth Substances|growth substances|mesh-ancestor
24538366|NCT00659022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538367|NCT00659022|Growth Inhibitors|growth inhibitors|mesh-ancestor
24538368|NCT00659022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24538369|NCT00659022|Antimetabolites|antimetabolites|mesh-ancestor
24538370|NCT00659022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538371|NCT00659048|Ciclesonide|ciclesonide|mesh-list
24538403|NCT00659100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24538404|NCT00659100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24538405|NCT00659100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24538406|NCT00659100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24538407|NCT00659100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644421|NCT01190748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644422|NCT01190748|Cholinergic Agents|cholinergic agents|mesh-ancestor
24644423|NCT01190748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24644424|NCT01190748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644425|NCT01190748|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24644426|NCT01190748|Autonomic Agents|autonomic agents|mesh-ancestor
24644427|NCT01190748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24644445|NCT01190982|Mitosis Modulators|mitosis modulators|mesh-ancestor
24644446|NCT01190982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644468|NCT01191060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644491|NCT01191216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644507|NCT01191424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644509|NCT01191450|Amiloride|amiloride|mesh-list
24644510|NCT01191450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24644511|NCT01191450|Diuretics|diuretics|mesh-ancestor
24644512|NCT01191450|Natriuretic Agents|natriuretic agents|mesh-ancestor
24644513|NCT01191450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644514|NCT01191450|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24644515|NCT01191450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24644516|NCT01191450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644517|NCT01191450|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24644518|NCT01191450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24644519|NCT01191450|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24644520|NCT01191450|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24644521|NCT01191554|Tranexamic Acid|tranexamic acid|mesh-list
24644522|NCT01191554|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24644523|NCT01191554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24644525|NCT01191554|Hemostatics|hemostatics|mesh-ancestor
25265482|NCT02433912|Sensory System Agents|sensory system agents|mesh-ancestor
25265483|NCT02433912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25265484|NCT02433912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265485|NCT02433912|Antipyretics|antipyretics|mesh-ancestor
25265486|NCT02433912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25265487|NCT02433912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25265488|NCT02433912|Disinfectants|disinfectants|mesh-ancestor
25265489|NCT02433912|Dermatologic Agents|dermatologic agents|mesh-ancestor
25265490|NCT02433184|Hydroxychloroquine|hydroxychloroquine|mesh-list
25265491|NCT02433184|Sulfasalazine|sulfasalazine|mesh-list
25265493|NCT02433184|Methotrexate|methotrexate|mesh-list
24645955|NCT01200901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25265494|NCT02433184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25265495|NCT02433184|Abortifacient Agents|abortifacient agents|mesh-ancestor
25265496|NCT02433184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25265497|NCT02433184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404398|NCT03670810|Serotonin Agents|serotonin agents|mesh-ancestor
25688932|NCT01952080|Teduglutide|teduglutide|mesh-list
25688933|NCT01952080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25688934|NCT01952080|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24585692|NCT00886717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585693|NCT00886860|Misoprostol|misoprostol|mesh-list
24585694|NCT00886860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24585700|NCT00886860|Oxytocics|oxytocics|mesh-ancestor
25265498|NCT02433184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25265499|NCT02433184|Antimetabolites|antimetabolites|mesh-ancestor
25265500|NCT02433184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265501|NCT02433184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265502|NCT02433184|Dermatologic Agents|dermatologic agents|mesh-ancestor
25265503|NCT02433184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538408|NCT00659100|Antimanic Agents|antimanic agents|mesh-ancestor
24538410|NCT00659113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449642|NCT00316407|Mitosis Modulators|mitosis modulators|mesh-ancestor
24449643|NCT00316407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449644|NCT00316407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24449645|NCT00316407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449646|NCT00316420|Gemcitabine|gemcitabine|mesh-list
24449647|NCT00316420|Capecitabine|capecitabine|mesh-list
24449648|NCT00316420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24449649|NCT00316420|Antimetabolites|antimetabolites|mesh-ancestor
24449650|NCT00316420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449651|NCT00316420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449652|NCT00316420|Antiviral Agents|antiviral agents|mesh-ancestor
24449653|NCT00316420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24449654|NCT00316420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449655|NCT00316420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24449656|NCT00316420|Immunologic Factors|immunologic factors|mesh-ancestor
24449657|NCT00316420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538523|NCT00659685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24538525|NCT00659685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24538560|NCT00659919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24938831|NCT04015414|Varenicline|varenicline|mesh-list
24644580|NCT01191892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644581|NCT01191892|Antiviral Agents|antiviral agents|mesh-ancestor
24644582|NCT01191892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24644583|NCT01191892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644584|NCT01191892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24644585|NCT01191892|Immunologic Factors|immunologic factors|mesh-ancestor
24644586|NCT01191892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644587|NCT01191918|Lithium Carbonate|lithium carbonate|mesh-list
24644588|NCT01191918|Donepezil|donepezil|mesh-list
24644589|NCT01191918|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24913480|NCT04264130|Artesunate|artesunate|mesh-list
24644603|NCT01191957|Fludarabine|fludarabine|mesh-list
24644604|NCT01191957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24644605|NCT01191957|Immunologic Factors|immunologic factors|mesh-ancestor
24644606|NCT01191957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644607|NCT01191957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24644608|NCT01191957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24644734|NCT01192724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24644785|NCT01193166|Antiemetics|antiemetics|mesh-ancestor
24644786|NCT01193166|Autonomic Agents|autonomic agents|mesh-ancestor
24644787|NCT01193166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24644788|NCT01193166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24644789|NCT01193166|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24644973|NCT01194336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24644974|NCT01194336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24644975|NCT01194336|Protective Agents|protective agents|mesh-ancestor
24644976|NCT01194700|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24644977|NCT01194700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24644978|NCT01194700|Autonomic Agents|autonomic agents|mesh-ancestor
24644979|NCT01194700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25265504|NCT02433184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25265505|NCT02433184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25265506|NCT02433184|Immunologic Factors|immunologic factors|mesh-ancestor
25265507|NCT02433184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25265508|NCT02433184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25265509|NCT02433184|Antimalarials|antimalarials|mesh-ancestor
25265510|NCT02433184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25265511|NCT02433184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25265512|NCT02433184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25688935|NCT01952080|Protective Agents|protective agents|mesh-ancestor
25688936|NCT01952080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688937|NCT01952145|Insulin|insulin|mesh-list
25688938|NCT01952145|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24805480|NCT02009540|Cholinergic Agents|cholinergic agents|mesh-ancestor
24586113|NCT00889343|Leucovorin|leucovorin|mesh-list
24586114|NCT00889343|Fluorouracil|fluorouracil|mesh-list
24586115|NCT00889343|Oxaliplatin|oxaliplatin|mesh-list
24586116|NCT00889343|Irinotecan|irinotecan|mesh-list
24586117|NCT00889343|Sorafenib|sorafenib|mesh-list
24586128|NCT00889343|Antidotes|antidotes|mesh-ancestor
25265513|NCT02433184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25265515|NCT02433184|Analgesics|analgesics|mesh-ancestor
25265516|NCT02433184|Sensory System Agents|sensory system agents|mesh-ancestor
25265520|NCT02432885|Enalapril|enalapril|mesh-list
25265521|NCT02432885|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25265522|NCT02432885|Protease Inhibitors|protease inhibitors|mesh-ancestor
25265523|NCT02432885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265524|NCT02432885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265525|NCT02432885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24538562|NCT00659919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24538585|NCT00659997|Immunologic Factors|immunologic factors|mesh-ancestor
24538586|NCT00659997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538587|NCT00659997|Antinematodal Agents|antinematodal agents|mesh-ancestor
24538588|NCT00659997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24538589|NCT00660036|Etoposide|etoposide|mesh-list
24538590|NCT00660036|Mitoxantrone|mitoxantrone|mesh-list
24538591|NCT00660036|Gemtuzumab|gemtuzumab|mesh-list
24538592|NCT00660036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24538593|NCT00660036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538594|NCT00660036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24538595|NCT00660036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24538596|NCT00660036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539632|NCT00664781|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24539633|NCT00664781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644980|NCT01194700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644981|NCT01194700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24644982|NCT01194700|Respiratory System Agents|respiratory system agents|mesh-ancestor
24644983|NCT01194700|Glucocorticoids|glucocorticoids|mesh-ancestor
24644984|NCT01194700|Hormones|hormones|mesh-ancestor
24644985|NCT01194700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24644986|NCT01194700|Sympathomimetics|sympathomimetics|mesh-ancestor
24855973|NCT02282085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855974|NCT02282085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855975|NCT02282085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24855976|NCT02282085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24855977|NCT02282085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24855978|NCT02282085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24855979|NCT02282085|Dopamine Agents|dopamine agents|mesh-ancestor
24855980|NCT02282085|Antiemetics|antiemetics|mesh-ancestor
24644988|NCT01194778|Vitamin K|vitamin k|mesh-list
24644989|NCT01194778|Vitamin K 2|vitamin k 2|mesh-list
24644990|NCT01194778|Vitamin K 1|vitamin k 1|mesh-list
24644991|NCT01194778|Micronutrients|micronutrients|mesh-ancestor
24644992|NCT01194778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644993|NCT01194778|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24645064|NCT01195324|Anticoagulants|anticoagulants|mesh-ancestor
24645065|NCT01195324|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24645067|NCT01195324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25265526|NCT02432911|Cytarabine|cytarabine|mesh-list
25265527|NCT02432911|Aclacinomycins|aclacinomycins|mesh-list
25265528|NCT02432911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25265529|NCT02432911|Antimetabolites|antimetabolites|mesh-ancestor
25265530|NCT02432911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265531|NCT02432911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265532|NCT02432911|Antiviral Agents|antiviral agents|mesh-ancestor
25265533|NCT02432911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25265534|NCT02432911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25265535|NCT02432911|Immunologic Factors|immunologic factors|mesh-ancestor
25688939|NCT01952145|Insulin Glargine|insulin glargine|mesh-list
25688940|NCT01952145|Liraglutide|liraglutide|mesh-list
25688941|NCT01952145|Xultophy|xultophy|mesh-list
25688942|NCT01952145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25688943|NCT01952145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688944|NCT01952145|Incretins|incretins|mesh-ancestor
25265536|NCT02432911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265537|NCT02432911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25265538|NCT02432911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25265539|NCT02433041|Ketamine|ketamine|mesh-list
25265540|NCT02433041|Haloperidol|haloperidol|mesh-list
25265541|NCT02433041|Haloperidol decanoate|haloperidol decanoate|mesh-list
25265542|NCT02433041|Analgesics|analgesics|mesh-ancestor
25265543|NCT02433041|Sensory System Agents|sensory system agents|mesh-ancestor
25265549|NCT02433041|Anesthetics|anesthetics|mesh-ancestor
25265550|NCT02433041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25275374|NCT02372487|Urological Agents|urological agents|mesh-ancestor
24418140|NCT00208715|Modafinil|modafinil|mesh-list
24645068|NCT01195324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645104|NCT01195766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24645107|NCT01195805|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24645108|NCT01195805|Hormone Antagonists|hormone antagonists|mesh-ancestor
24645109|NCT01195805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24645183|NCT01196481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24645184|NCT01196481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24645185|NCT01196481|Vasodilator Agents|vasodilator agents|mesh-ancestor
24645206|NCT01196546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24645207|NCT01196546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801724|NCT01985373|Immunologic Factors|immunologic factors|mesh-ancestor
24645208|NCT01196546|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24645209|NCT01196546|Protease Inhibitors|protease inhibitors|mesh-ancestor
24645210|NCT01196546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24645211|NCT01196546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645212|NCT01196559|Gemcitabine|gemcitabine|mesh-list
24645213|NCT01196559|Vinorelbine|vinorelbine|mesh-list
24645214|NCT01196559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24645215|NCT01196559|Antimetabolites|antimetabolites|mesh-ancestor
24645223|NCT01196559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645224|NCT01196559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24645225|NCT01196559|Tubulin Modulators|tubulin modulators|mesh-ancestor
24645226|NCT01196559|Antimitotic Agents|antimitotic agents|mesh-ancestor
24645227|NCT01196559|Mitosis Modulators|mitosis modulators|mesh-ancestor
24645228|NCT01196715|Darbepoetin alfa|darbepoetin alfa|mesh-list
24645229|NCT01196715|Hematinics|hematinics|mesh-ancestor
24645230|NCT01196754|Sevoflurane|sevoflurane|mesh-list
24645231|NCT01196754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24645232|NCT01196754|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24855981|NCT02282085|Autonomic Agents|autonomic agents|mesh-ancestor
24855982|NCT02282085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24855983|NCT02282085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24855984|NCT02282085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24855985|NCT02282085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24855986|NCT02282085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24855987|NCT02282085|Antidepressive Agents|antidepressive agents|mesh-ancestor
24855988|NCT02282085|Dopamine Agonists|dopamine agonists|mesh-ancestor
24855989|NCT02282085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24855990|NCT02282085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24855991|NCT02282085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24458401|NCT00337766|Coagulants|coagulants|mesh-ancestor
24458402|NCT00337766|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24645382|NCT01198106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24645383|NCT01198106|Histamine Antagonists|histamine antagonists|mesh-ancestor
24645385|NCT01198184|Sirolimus|sirolimus|mesh-list
24645386|NCT01198184|R04929097|r04929097|mesh-list
24645387|NCT01198184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24645388|NCT01198184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24645389|NCT01198184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24645390|NCT01198184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24645391|NCT01198184|Antifungal Agents|antifungal agents|mesh-ancestor
24645411|NCT01198210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24645412|NCT01198210|Protease Inhibitors|protease inhibitors|mesh-ancestor
24645413|NCT01198210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265551|NCT02433041|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25265552|NCT02433041|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25265553|NCT02433041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25265555|NCT02433041|Antiemetics|antiemetics|mesh-ancestor
25265556|NCT02433041|Autonomic Agents|autonomic agents|mesh-ancestor
25265557|NCT02433041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25265558|NCT02433041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25265559|NCT02433041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25155631|NCT05317364|Estradiol|estradiol|mesh-list
24782807|NCT01898169|Nicotine|nicotine|mesh-list
24938877|NCT04015778|Paclitaxel|paclitaxel|mesh-list
24645414|NCT01198210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645415|NCT01198210|Analgesics|analgesics|mesh-ancestor
24645416|NCT01198210|Sensory System Agents|sensory system agents|mesh-ancestor
24645417|NCT01198210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24645418|NCT01198210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24645490|NCT01198379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24645491|NCT01198379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24645492|NCT01198379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24645493|NCT01198379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645494|NCT01198379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24645495|NCT01198379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24645496|NCT01198379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24645497|NCT01198379|Antipyretics|antipyretics|mesh-ancestor
24645499|NCT01198392|Tegafur|tegafur|mesh-list
24645500|NCT01198392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24645501|NCT01198392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24645502|NCT01198392|Antimetabolites|antimetabolites|mesh-ancestor
24645503|NCT01198392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645504|NCT01198444|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
24645505|NCT01198444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24645506|NCT01198444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645507|NCT01198457|Clodronic Acid|clodronic acid|mesh-list
24645508|NCT01198457|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24645509|NCT01198457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645511|NCT01198496|Amlodipine|amlodipine|mesh-list
24645513|NCT01198496|Telmisartan|telmisartan|mesh-list
24645514|NCT01198496|Candesartan|candesartan|mesh-list
24645515|NCT01198496|Candesartan cilexetil|candesartan cilexetil|mesh-list
24645516|NCT01198496|Olmesartan|olmesartan|mesh-list
24645517|NCT01198496|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24645518|NCT01198496|Spironolactone|spironolactone|mesh-list
24645519|NCT01198496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24645520|NCT01198496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24645521|NCT01198496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24645522|NCT01198496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645523|NCT01198496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24645524|NCT01198496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645525|NCT01198496|Vasodilator Agents|vasodilator agents|mesh-ancestor
24645526|NCT01198496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24645561|NCT01198665|Vincristine|vincristine|mesh-list
24645565|NCT01198665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24645566|NCT01198665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24645621|NCT01198938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645623|NCT01198938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645624|NCT01198938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24855992|NCT02282085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24855993|NCT02282085|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24855994|NCT02282085|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24855995|NCT02282085|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24645625|NCT01199029|Prednisone|prednisone|mesh-list
24645626|NCT01199029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24645627|NCT01199029|Glucocorticoids|glucocorticoids|mesh-ancestor
24645628|NCT01199029|Hormones|hormones|mesh-ancestor
24645629|NCT01199029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24645630|NCT01199029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645631|NCT01199029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24645797|NCT01200004|Immunologic Factors|immunologic factors|mesh-ancestor
24645798|NCT01200004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645799|NCT01200004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24645813|NCT01200056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24645814|NCT01200056|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24645817|NCT01200108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24856003|NCT02282098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856004|NCT02282098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24856005|NCT02282137|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
24856006|NCT02282137|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24856007|NCT02282137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856008|NCT02282150|Hydrocortisone|hydrocortisone|mesh-list
24856009|NCT02282150|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24856010|NCT02282150|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24856011|NCT02282150|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24812815|NCT02054793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24812816|NCT02054793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812817|NCT02054793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812818|NCT02054793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24812819|NCT02054793|Hormone Antagonists|hormone antagonists|mesh-ancestor
24812820|NCT02054793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25265574|NCT02432807|Vancomycin|vancomycin|mesh-list
25265575|NCT02432807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25265576|NCT02432807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25265577|NCT02432976|Insulin|insulin|mesh-list
25265578|NCT02432976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25265579|NCT02432976|Exenatide|exenatide|mesh-list
25265580|NCT02432976|Insulin Lispro|insulin lispro|mesh-list
25265581|NCT02432976|Incretins|incretins|mesh-list
25265582|NCT02432976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25275375|NCT02372669|Chitosan|chitosan|mesh-list
24539684|NCT00665041|Dopamine Agonists|dopamine agonists|mesh-ancestor
24539685|NCT00665041|Dopamine Agents|dopamine agents|mesh-ancestor
24539686|NCT00665041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24539687|NCT00665041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539688|NCT00665041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539689|NCT00665054|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24539690|NCT00665054|Vasodilator Agents|vasodilator agents|mesh-ancestor
24539691|NCT00665054|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24812821|NCT02054793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812822|NCT02054793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24812823|NCT02054806|Pembrolizumab|pembrolizumab|mesh-list
24812824|NCT02054806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24812848|NCT02054949|Respiratory System Agents|respiratory system agents|mesh-ancestor
24812849|NCT02054949|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24812851|NCT02054949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458474|NCT00338091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24645818|NCT01200108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24645819|NCT01200108|Autonomic Agents|autonomic agents|mesh-ancestor
24645820|NCT01200108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24645821|NCT01200108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645822|NCT01200108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24645823|NCT01200108|Respiratory System Agents|respiratory system agents|mesh-ancestor
24645825|NCT01200108|Hormones|hormones|mesh-ancestor
24645826|NCT01200108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24645828|NCT01200121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25265583|NCT02432976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265585|NCT02432976|Hormones|hormones|mesh-ancestor
25265586|NCT02432976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25265587|NCT02432833|Tacrolimus|tacrolimus|mesh-list
25265588|NCT02432833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25265589|NCT02432833|Immunologic Factors|immunologic factors|mesh-ancestor
25265590|NCT02432833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265591|NCT02432833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25265592|NCT02432833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265593|NCT02432833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265594|NCT02432872|Cytarabine|cytarabine|mesh-list
25265595|NCT02432872|Daunorubicin|daunorubicin|mesh-list
25265596|NCT02432872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25265597|NCT02432872|Antimetabolites|antimetabolites|mesh-ancestor
25265598|NCT02432872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265599|NCT02432872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265600|NCT02432872|Antiviral Agents|antiviral agents|mesh-ancestor
24539692|NCT00665054|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24515835|NCT00599573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515836|NCT00599573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24515837|NCT00599573|Antipruritics|antipruritics|mesh-ancestor
24645829|NCT01200121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24645830|NCT01200121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24645831|NCT01200121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24645832|NCT01200121|Growth Substances|growth substances|mesh-ancestor
24645833|NCT01200121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645834|NCT01200121|Growth Inhibitors|growth inhibitors|mesh-ancestor
24645835|NCT01200186|Progestins|progestins|mesh-list
24645836|NCT01200186|Hormones|hormones|mesh-ancestor
24913743|NCT04261517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856016|NCT02282241|Melatonin|melatonin|mesh-list
24856017|NCT02282241|Antioxidants|antioxidants|mesh-ancestor
24645899|NCT01200641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24645900|NCT01200641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24645951|NCT01200901|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24645952|NCT01200901|Antidepressive Agents|antidepressive agents|mesh-ancestor
24645953|NCT01200901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24645954|NCT01200901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24645956|NCT01200901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24645957|NCT01200901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645959|NCT01200914|Anticoagulants|anticoagulants|mesh-ancestor
24645960|NCT01200914|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24645961|NCT01200914|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24856059|NCT02282384|Calcium Carbonate|calcium carbonate|mesh-list
24646040|NCT01201551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24646043|NCT01201551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24856077|NCT02282683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856078|NCT02282683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24856079|NCT02282683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24856080|NCT02282709|Asunaprevir|asunaprevir|mesh-list
24856081|NCT02282709|Protease Inhibitors|protease inhibitors|mesh-ancestor
24856082|NCT02282709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856083|NCT02282709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856084|NCT02282774|Lidocaine|lidocaine|mesh-list
24856085|NCT02282774|Bupivacaine|bupivacaine|mesh-list
24856086|NCT02282774|Anesthetics, Local|anesthetics, local|mesh-ancestor
25265601|NCT02432872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25265602|NCT02432872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25265603|NCT02432872|Immunologic Factors|immunologic factors|mesh-ancestor
25265604|NCT02432872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265605|NCT02432872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25265606|NCT02432872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25265607|NCT02432872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25265608|NCT02432872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265610|NCT02432781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25265611|NCT02432781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265612|NCT02432599|Choline|choline|mesh-list
25265613|NCT02432599|Lipotropic Agents|lipotropic agents|mesh-ancestor
25265614|NCT02432599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25265615|NCT02432599|Antimetabolites|antimetabolites|mesh-ancestor
25265616|NCT02432599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265617|NCT02432599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25265618|NCT02432599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24539694|NCT00665054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539696|NCT00665093|Insulin|insulin|mesh-list
24539697|NCT00665093|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24539698|NCT00665093|Insulin Aspart|insulin aspart|mesh-list
24539699|NCT00665093|Insulin Detemir|insulin detemir|mesh-list
24856090|NCT02282774|Sensory System Agents|sensory system agents|mesh-ancestor
24856091|NCT02282774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24856092|NCT02282774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24856097|NCT02282787|Dexmedetomidine|dexmedetomidine|mesh-list
24856108|NCT02282787|Adrenergic Agents|adrenergic agents|mesh-ancestor
24856109|NCT02282787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24856110|NCT02282787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856111|NCT02282800|Vitamin D|vitamin d|mesh-list
24856112|NCT02282800|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
24856113|NCT02282800|Vitamins|vitamins|mesh-ancestor
24856114|NCT02282800|Micronutrients|micronutrients|mesh-ancestor
24856115|NCT02282800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856116|NCT02282800|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24856117|NCT02282826|Acyclovir|acyclovir|mesh-list
24856118|NCT02282826|Antiviral Agents|antiviral agents|mesh-ancestor
24856119|NCT02282826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24856120|NCT02282891|Ketamine|ketamine|mesh-list
24856121|NCT02282891|Propofol|propofol|mesh-list
24856123|NCT02282891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24856124|NCT02282891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856126|NCT02282891|Anesthetics, General|anesthetics, general|mesh-ancestor
24856127|NCT02282891|Anesthetics|anesthetics|mesh-ancestor
24856128|NCT02282891|Analgesics|analgesics|mesh-ancestor
24856129|NCT02282891|Sensory System Agents|sensory system agents|mesh-ancestor
24856130|NCT02282891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24856131|NCT02282891|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24856132|NCT02282891|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25265619|NCT02432599|Nootropic Agents|nootropic agents|mesh-ancestor
25265620|NCT02432534|Atorvastatin|atorvastatin|mesh-list
25265621|NCT02432534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25265622|NCT02432534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25265623|NCT02432534|Antimetabolites|antimetabolites|mesh-ancestor
25265624|NCT02432534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265625|NCT02432534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25265626|NCT02432534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25265627|NCT02432534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265628|NCT02432612|Nabiximols|nabiximols|mesh-list
25265636|NCT02432677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25265637|NCT02432677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265638|NCT02432677|Analgesics|analgesics|mesh-ancestor
24539700|NCT00665093|Biphasic Insulins|biphasic insulins|mesh-list
24515845|NCT00599573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25155632|NCT05317364|Estrogens|estrogens|mesh-ancestor
24856133|NCT02282891|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24856182|NCT02283060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24856183|NCT02283060|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24646074|NCT01201694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646076|NCT01201902|Immunologic Factors|immunologic factors|mesh-ancestor
24856192|NCT02283177|Cytarabine|cytarabine|mesh-list
24856193|NCT02283177|Daunorubicin|daunorubicin|mesh-list
24856202|NCT02283177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24856203|NCT02283177|Immunologic Factors|immunologic factors|mesh-ancestor
24856204|NCT02283177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646077|NCT01201902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646078|NCT01201928|Insulin|insulin|mesh-list
24646079|NCT01201928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24646080|NCT01201928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646081|NCT01202032|Bevacizumab|bevacizumab|mesh-list
24646082|NCT01202032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24646083|NCT01202032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24646084|NCT01202032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24646085|NCT01202032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24646086|NCT01202032|Growth Substances|growth substances|mesh-ancestor
24646087|NCT01202032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646168|NCT01202240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24646170|NCT01202331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24646171|NCT01202331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24646172|NCT01202370|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
24646173|NCT01202370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24646174|NCT01202370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265640|NCT02432677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25265641|NCT02432651|Xanthohumol|xanthohumol|mesh-list
25265642|NCT02432651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265643|NCT02432651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25265644|NCT02432651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25265645|NCT02432651|Growth Substances|growth substances|mesh-ancestor
25265646|NCT02432651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265647|NCT02432651|Growth Inhibitors|growth inhibitors|mesh-ancestor
25265648|NCT02433795|Rituximab|rituximab|mesh-list
25265649|NCT02433795|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25265650|NCT02433795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25265651|NCT02433795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265652|NCT02433795|Immunologic Factors|immunologic factors|mesh-ancestor
25265653|NCT02433795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646177|NCT01202422|Sensory System Agents|sensory system agents|mesh-ancestor
24646178|NCT01202422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24805733|NCT02011906|alpha-Tocopherol|alpha-tocopherol|mesh-list
24805734|NCT02011906|Micronutrients|micronutrients|mesh-ancestor
24805735|NCT02011906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805736|NCT02011906|Antioxidants|antioxidants|mesh-ancestor
24589234|NCT00906139|GABA Agents|gaba agents|mesh-ancestor
24646179|NCT01202422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646180|NCT01202422|Anticonvulsants|anticonvulsants|mesh-ancestor
24646216|NCT01202487|Sensory System Agents|sensory system agents|mesh-ancestor
24646217|NCT01202487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24646218|NCT01202487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24646233|NCT01202487|Sympathomimetics|sympathomimetics|mesh-ancestor
24913930|NCT04259333|Acetaminophen|acetaminophen|mesh-list
24694006|NCT01423305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24646247|NCT01202734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24646248|NCT01202734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646249|NCT01202734|Dopamine Agents|dopamine agents|mesh-ancestor
24646250|NCT01202734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24646251|NCT01202799|Diclofenac|diclofenac|mesh-list
24646252|NCT01202799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24646253|NCT01202799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24646254|NCT01202799|Analgesics|analgesics|mesh-ancestor
24646255|NCT01202799|Sensory System Agents|sensory system agents|mesh-ancestor
24646256|NCT01202799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24646257|NCT01202799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646258|NCT01202799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24646259|NCT01202799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24646260|NCT01202799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24646261|NCT01202799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646262|NCT01202799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646263|NCT01202825|Simeprevir|simeprevir|mesh-list
24646264|NCT01202825|Antiviral Agents|antiviral agents|mesh-ancestor
24646265|NCT01202825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24646266|NCT01202825|Protease Inhibitors|protease inhibitors|mesh-ancestor
24646267|NCT01202825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646268|NCT01202825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646269|NCT01202890|Bevacizumab|bevacizumab|mesh-list
24646270|NCT01202890|Lenalidomide|lenalidomide|mesh-list
24646271|NCT01202890|Doxorubicin|doxorubicin|mesh-list
24856217|NCT02283203|Antipyretics|antipyretics|mesh-ancestor
24646290|NCT01203020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24646291|NCT01203020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24646292|NCT01203020|Antimetabolites|antimetabolites|mesh-ancestor
24646293|NCT01203020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646294|NCT01203020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24646301|NCT01203020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24646303|NCT01203111|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24646304|NCT01203111|Insulin Glargine|insulin glargine|mesh-list
24646305|NCT01203111|Insulin glulisine|insulin glulisine|mesh-list
24646306|NCT01203111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24646307|NCT01203111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646308|NCT01203202|Clomipramine|clomipramine|mesh-list
24646309|NCT01203202|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24646310|NCT01203202|Antidepressive Agents|antidepressive agents|mesh-ancestor
25265655|NCT02433795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25265657|NCT02433795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265658|NCT02432664|Midazolam|midazolam|mesh-list
25265659|NCT02432664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25265660|NCT02432664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25265661|NCT02432664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25265662|NCT02432664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539702|NCT00665093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24539766|NCT00665522|Sensory System Agents|sensory system agents|mesh-ancestor
24539767|NCT00665522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24539768|NCT00665522|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24646315|NCT01203202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688945|NCT01952145|Hormones|hormones|mesh-ancestor
25688946|NCT01952145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25688947|NCT01952444|Ciprofloxacin|ciprofloxacin|mesh-list
25688948|NCT01952444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24646316|NCT01203202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24646317|NCT01203202|Serotonin Agents|serotonin agents|mesh-ancestor
24646318|NCT01203202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646320|NCT01203228|Busulfan|busulfan|mesh-list
24646321|NCT01203228|Fludarabine phosphate|fludarabine phosphate|mesh-list
24646322|NCT01203228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24646323|NCT01203228|Immunologic Factors|immunologic factors|mesh-ancestor
24646324|NCT01203228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646325|NCT01203228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24646326|NCT01203228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24646327|NCT01203228|Alkylating Agents|alkylating agents|mesh-ancestor
24646328|NCT01203228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646329|NCT01203228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24646330|NCT01203228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24646331|NCT01203228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24646332|NCT01203228|Antimetabolites|antimetabolites|mesh-ancestor
24856264|NCT02283424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856265|NCT02283476|Gemcitabine|gemcitabine|mesh-list
24856266|NCT02283476|Endostar protein|endostar protein|mesh-list
24856267|NCT02283476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24856268|NCT02283476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24856269|NCT02283476|Antimetabolites|antimetabolites|mesh-ancestor
24856270|NCT02283476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856271|NCT02283476|Antiviral Agents|antiviral agents|mesh-ancestor
24856272|NCT02283476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24856273|NCT02283476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856274|NCT02283476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25265663|NCT02432664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25265664|NCT02432664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25265665|NCT02432664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25265666|NCT02432664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25265667|NCT02432664|Anesthetics, General|anesthetics, general|mesh-ancestor
25265668|NCT02432664|Anesthetics|anesthetics|mesh-ancestor
25265669|NCT02432664|GABA Modulators|gaba modulators|mesh-ancestor
25265670|NCT02432664|GABA Agents|gaba agents|mesh-ancestor
25265671|NCT02432664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25265672|NCT02432664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265673|NCT02432339|Mycophenolic Acid|mycophenolic acid|mesh-list
25265674|NCT02432339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25265675|NCT02432339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265676|NCT02432339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24856277|NCT02283476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24856288|NCT02283489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856290|NCT02283489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24856291|NCT02283489|Growth Substances|growth substances|mesh-ancestor
24856292|NCT02283489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856293|NCT02283489|Growth Inhibitors|growth inhibitors|mesh-ancestor
24856303|NCT02283554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24856304|NCT02283554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856305|NCT02283645|Minoxidil|minoxidil|mesh-list
24856306|NCT02283645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24856307|NCT02283645|Vasodilator Agents|vasodilator agents|mesh-ancestor
24812874|NCT02055014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24812875|NCT02055014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812876|NCT02055014|Incretins|incretins|mesh-ancestor
24812877|NCT02055014|Hormones|hormones|mesh-ancestor
24420537|NCT00216268|Antimetabolites|antimetabolites|mesh-ancestor
24812878|NCT02055014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24812879|NCT02055079|Sirolimus|sirolimus|mesh-list
24812880|NCT02055079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24812881|NCT02055079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24812882|NCT02055079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24812883|NCT02055079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812884|NCT02055079|Antifungal Agents|antifungal agents|mesh-ancestor
24812895|NCT02055131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24812896|NCT02055131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24812897|NCT02055131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24458752|NCT00339118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24646397|NCT01203488|Micronutrients|micronutrients|mesh-ancestor
24646398|NCT01203488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646399|NCT01203514|Epoetin Alfa|epoetin alfa|mesh-list
24646400|NCT01203514|Hematinics|hematinics|mesh-ancestor
24646401|NCT01203540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24646402|NCT01203540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24646403|NCT01203592|Albuterol|albuterol|mesh-list
24646404|NCT01203592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24646405|NCT01203592|Autonomic Agents|autonomic agents|mesh-ancestor
25265677|NCT02432339|Antitubercular Agents|antitubercular agents|mesh-ancestor
25265678|NCT02432339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25265679|NCT02432339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25265680|NCT02432339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265681|NCT02432339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265682|NCT02432248|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25265683|NCT02432248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25265684|NCT02432248|Immunologic Factors|immunologic factors|mesh-ancestor
24515856|NCT00599651|Pulmonary Surfactants|pulmonary surfactants|mesh-list
24515864|NCT00599807|Vitamin D|vitamin d|mesh-list
24646406|NCT01203592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24646407|NCT01203592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646408|NCT01203592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24646409|NCT01203592|Respiratory System Agents|respiratory system agents|mesh-ancestor
24646410|NCT01203592|Tocolytic Agents|tocolytic agents|mesh-ancestor
24646411|NCT01203592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24812898|NCT02055131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24812899|NCT02055131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812900|NCT02055131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24812901|NCT02055131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24812902|NCT02055131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812903|NCT02055131|Antipyretics|antipyretics|mesh-ancestor
24812904|NCT02055170|Finasteride|finasteride|mesh-list
24812905|NCT02055170|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24812906|NCT02055170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24812907|NCT02055170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265685|NCT02432248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275376|NCT02372669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25275377|NCT02372669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25275378|NCT02372669|Antimetabolites|antimetabolites|mesh-ancestor
25275379|NCT02372669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275380|NCT02372669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25275381|NCT02372669|Chelating Agents|chelating agents|mesh-ancestor
25275382|NCT02372669|Sequestering Agents|sequestering agents|mesh-ancestor
25275383|NCT02372669|Hemostatics|hemostatics|mesh-ancestor
25275384|NCT02372669|Coagulants|coagulants|mesh-ancestor
25275385|NCT02372760|Lidocaine|lidocaine|mesh-list
25275386|NCT02372760|Anesthetics|anesthetics|mesh-list
25275387|NCT02372760|Anesthetics, Local|anesthetics, local|mesh-ancestor
25275388|NCT02372760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25275389|NCT02372760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275390|NCT02372760|Sensory System Agents|sensory system agents|mesh-ancestor
25275391|NCT02372760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275392|NCT02372760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25275394|NCT02372760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25275395|NCT02372760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25275396|NCT02372760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275398|NCT02372461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25275399|NCT02372461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25275400|NCT02372812|Dexamethasone|dexamethasone|mesh-list
25275401|NCT02372812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25275402|NCT02372812|Antiemetics|antiemetics|mesh-ancestor
24856321|NCT02283775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24856322|NCT02283775|Antiemetics|antiemetics|mesh-ancestor
24856323|NCT02283775|Autonomic Agents|autonomic agents|mesh-ancestor
24856324|NCT02283775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24458779|NCT00339196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24646412|NCT01203592|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24646413|NCT01203592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24646414|NCT01203592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24646415|NCT01203592|Adrenergic Agents|adrenergic agents|mesh-ancestor
24646416|NCT01203592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24646417|NCT01203592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646418|NCT01203618|Farletuzumab|farletuzumab|mesh-list
24646419|NCT01203618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24646479|NCT01204112|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24694235|NCT01424449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24694236|NCT01424449|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24694237|NCT01424449|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24694238|NCT01424618|Leuprolide|leuprolide|mesh-list
24694239|NCT01424618|Ganirelix|ganirelix|mesh-list
24646481|NCT01204112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24646482|NCT01204112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24646483|NCT01204112|Leprostatic Agents|leprostatic agents|mesh-ancestor
24646484|NCT01204112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24646485|NCT01204112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646486|NCT01204112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646487|NCT01204112|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24856325|NCT02283775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856326|NCT02283775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24856327|NCT02283775|Glucocorticoids|glucocorticoids|mesh-ancestor
24856328|NCT02283775|Hormones|hormones|mesh-ancestor
24856483|NCT02284529|Vitamin B Complex|vitamin b complex|mesh-ancestor
24856330|NCT02283775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24856332|NCT02283775|Immunologic Factors|immunologic factors|mesh-ancestor
24856340|NCT02283801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24856341|NCT02283801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24856342|NCT02283801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914221|NCT04257032|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24856378|NCT02284035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24856380|NCT02284035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24856381|NCT02284035|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25265686|NCT02432365|Paclitaxel|paclitaxel|mesh-list
25265687|NCT02432365|Cisplatin|cisplatin|mesh-list
25265688|NCT02432365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25265689|NCT02432365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265690|NCT02432365|Tubulin Modulators|tubulin modulators|mesh-ancestor
25265691|NCT02432365|Antimitotic Agents|antimitotic agents|mesh-ancestor
25265692|NCT02432365|Mitosis Modulators|mitosis modulators|mesh-ancestor
25265693|NCT02432365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265694|NCT02432053|Tacrolimus|tacrolimus|mesh-list
25155633|NCT05317364|Hormones|hormones|mesh-ancestor
24418337|NCT00209222|Tubulin Modulators|tubulin modulators|mesh-ancestor
24539983|NCT00666159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539984|NCT00666159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938945|NCT04014101|Apatinib|apatinib|mesh-list
24856382|NCT02284035|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24856383|NCT02284035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856384|NCT02284035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856385|NCT02284035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24856386|NCT02284035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24856388|NCT02284048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24856389|NCT02284048|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24856390|NCT02284048|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24856391|NCT02284048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24856392|NCT02284048|Purinergic Agents|purinergic agents|mesh-ancestor
24856393|NCT02284048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24856394|NCT02284048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856395|NCT02284048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856396|NCT02284204|Midazolam|midazolam|mesh-list
24856397|NCT02284204|Ketamine|ketamine|mesh-list
24856407|NCT02284204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24856408|NCT02284204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24856409|NCT02284204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24856411|NCT02284204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856412|NCT02284204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24856413|NCT02284204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24856414|NCT02284204|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24856415|NCT02284204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24856416|NCT02284204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24856417|NCT02284204|GABA Modulators|gaba modulators|mesh-ancestor
24856418|NCT02284204|GABA Agents|gaba agents|mesh-ancestor
24856419|NCT02284204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24856420|NCT02284204|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24856421|NCT02284230|Liraglutide|liraglutide|mesh-list
24856422|NCT02284230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24856429|NCT02284269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24856430|NCT02284269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856431|NCT02284282|Lidocaine|lidocaine|mesh-list
24856432|NCT02284282|Morphine|morphine|mesh-list
24856433|NCT02284282|Bupivacaine|bupivacaine|mesh-list
24856434|NCT02284282|Anesthetics, Local|anesthetics, local|mesh-ancestor
24856435|NCT02284282|Anesthetics|anesthetics|mesh-ancestor
24856436|NCT02284282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24856437|NCT02284282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856438|NCT02284282|Sensory System Agents|sensory system agents|mesh-ancestor
24856439|NCT02284282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24856440|NCT02284282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24646520|NCT01204164|Autonomic Agents|autonomic agents|mesh-ancestor
24646521|NCT01204164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24646522|NCT01204164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646523|NCT01204164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24646524|NCT01204164|Glucocorticoids|glucocorticoids|mesh-ancestor
24646526|NCT01204164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24646527|NCT01204164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24694364|NCT01425216|Sorafenib|sorafenib|mesh-list
25265695|NCT02432053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25265696|NCT02432053|Immunologic Factors|immunologic factors|mesh-ancestor
25265697|NCT02432053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265698|NCT02432053|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25265699|NCT02432053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265700|NCT02432053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265701|NCT02432027|Betamethasone|betamethasone|mesh-list
25265702|NCT02432027|Calcipotriene|calcipotriene|mesh-list
25265703|NCT02432027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25265704|NCT02432027|Glucocorticoids|glucocorticoids|mesh-ancestor
25265705|NCT02432027|Hormones|hormones|mesh-ancestor
24539986|NCT00666159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24539988|NCT00666159|Sensory System Agents|sensory system agents|mesh-ancestor
24539989|NCT00666159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24539990|NCT00666159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24539991|NCT00666159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24646528|NCT01204164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24646529|NCT01204177|Sorafenib|sorafenib|mesh-list
24646530|NCT01204177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24646531|NCT01204177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24646532|NCT01204177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646533|NCT01204177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646534|NCT01204190|Gestodene|gestodene|mesh-list
24646535|NCT01204190|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24646537|NCT01204190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24646538|NCT01204190|Contraceptive Agents|contraceptive agents|mesh-ancestor
24646539|NCT01204190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24646552|NCT01204268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24646553|NCT01204268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24646570|NCT01204320|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24646571|NCT01204320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24646572|NCT01204320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24646573|NCT01204320|Tubulin Modulators|tubulin modulators|mesh-ancestor
24646574|NCT01204320|Antimitotic Agents|antimitotic agents|mesh-ancestor
24646575|NCT01204320|Mitosis Modulators|mitosis modulators|mesh-ancestor
24646576|NCT01204320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646578|NCT01204333|Anticoagulants|anticoagulants|mesh-ancestor
24646579|NCT01204333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24646580|NCT01204333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24646581|NCT01204333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646582|NCT01204346|Psychotropic Drugs|psychotropic drugs|mesh-list
24646583|NCT01204372|Gemcitabine|gemcitabine|mesh-list
24646584|NCT01204372|Trastuzumab|trastuzumab|mesh-list
24646585|NCT01204372|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24646586|NCT01204372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24856441|NCT02284282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24856442|NCT02284282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24856443|NCT02284282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24856444|NCT02284282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856445|NCT02284282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24856446|NCT02284282|Narcotics|narcotics|mesh-ancestor
24856447|NCT02284282|Analgesics|analgesics|mesh-ancestor
24856448|NCT02284412|Neostigmine|neostigmine|mesh-list
24856452|NCT02284412|Cholinergic Agents|cholinergic agents|mesh-ancestor
24856453|NCT02284412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24856454|NCT02284412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856455|NCT02284412|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25265706|NCT02432027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25265707|NCT02432027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265708|NCT02432027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25265709|NCT02432027|Respiratory System Agents|respiratory system agents|mesh-ancestor
25265710|NCT02432027|Dermatologic Agents|dermatologic agents|mesh-ancestor
25265711|NCT02432261|Methyltestosterone|methyltestosterone|mesh-list
25265712|NCT02432261|ST 1435|st 1435|mesh-list
25265713|NCT02432261|Testosterone|testosterone|mesh-list
25275403|NCT02372812|Autonomic Agents|autonomic agents|mesh-ancestor
25275404|NCT02372812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275405|NCT02372812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694395|NCT01425320|Leprostatic Agents|leprostatic agents|mesh-ancestor
24646590|NCT01204372|Antiviral Agents|antiviral agents|mesh-ancestor
24646591|NCT01204372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24646592|NCT01204372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646593|NCT01204372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24646594|NCT01204372|Immunologic Factors|immunologic factors|mesh-ancestor
24646595|NCT01204372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646596|NCT01204372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24646597|NCT01204372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24646598|NCT01204411|Artesunate|artesunate|mesh-list
24646599|NCT01204411|Amodiaquine|amodiaquine|mesh-list
24646600|NCT01204411|Antimalarials|antimalarials|mesh-ancestor
24646601|NCT01204411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24646602|NCT01204411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24646603|NCT01204411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24646604|NCT01204411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24646605|NCT01204411|Antiviral Agents|antiviral agents|mesh-ancestor
24646606|NCT01204411|Schistosomicides|schistosomicides|mesh-ancestor
24646607|NCT01204411|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24646608|NCT01204411|Anthelmintics|anthelmintics|mesh-ancestor
24646609|NCT01204437|Paclitaxel|paclitaxel|mesh-list
24646610|NCT01204437|Cyclophosphamide|cyclophosphamide|mesh-list
24646611|NCT01204437|Capecitabine|capecitabine|mesh-list
24646678|NCT01204593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24646679|NCT01204593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646680|NCT01204723|Aprepitant|aprepitant|mesh-list
24646681|NCT01204723|Fosaprepitant|fosaprepitant|mesh-list
24646682|NCT01204723|Antiemetics|antiemetics|mesh-ancestor
24646683|NCT01204723|Autonomic Agents|autonomic agents|mesh-ancestor
24694428|NCT01425476|Analgesics|analgesics|mesh-ancestor
24646684|NCT01204723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24646685|NCT01204723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646686|NCT01204723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24646687|NCT01204723|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24856480|NCT02284529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856481|NCT02284529|Antidotes|antidotes|mesh-ancestor
25265716|NCT02432261|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25265717|NCT02432261|Androgens|androgens|mesh-ancestor
25265718|NCT02432261|Hormones|hormones|mesh-ancestor
25265719|NCT02432261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25265720|NCT02432261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265721|NCT02432261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25265722|NCT02432261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265723|NCT02432261|Anabolic Agents|anabolic agents|mesh-ancestor
25265724|NCT02432261|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24540158|NCT00666783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24938968|NCT04014361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856484|NCT02284529|Vitamins|vitamins|mesh-ancestor
24856485|NCT02284529|Micronutrients|micronutrients|mesh-ancestor
24856486|NCT02284672|Dexmedetomidine|dexmedetomidine|mesh-list
24856487|NCT02284672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24856488|NCT02284672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24646694|NCT01204801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24646703|NCT01204996|Docetaxel|docetaxel|mesh-list
24646704|NCT01204996|Carboplatin|carboplatin|mesh-list
24646705|NCT01204996|Doxorubicin|doxorubicin|mesh-list
24646706|NCT01204996|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24646707|NCT01204996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24646708|NCT01204996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24646709|NCT01204996|Tubulin Modulators|tubulin modulators|mesh-ancestor
24646716|NCT01204996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24646717|NCT01204996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646718|NCT01204996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24646719|NCT01204996|Immunologic Factors|immunologic factors|mesh-ancestor
24646720|NCT01204996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646721|NCT01204996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24646722|NCT01204996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24646723|NCT01204996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24646724|NCT01205009|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24646726|NCT01205009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646728|NCT01205022|Leucovorin|leucovorin|mesh-list
24646729|NCT01205022|Bevacizumab|bevacizumab|mesh-list
24646730|NCT01205022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24646731|NCT01205022|Fluorouracil|fluorouracil|mesh-list
24646732|NCT01205022|Irinotecan|irinotecan|mesh-list
24646733|NCT01205022|Camptothecin|camptothecin|mesh-list
24646734|NCT01205022|Antibodies|antibodies|mesh-list
24646735|NCT01205022|Immunoglobulins|immunoglobulins|mesh-list
24646736|NCT01205022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24646737|NCT01205022|Calcium|calcium|mesh-list
24646738|NCT01205022|Levoleucovorin|levoleucovorin|mesh-list
24646739|NCT01205022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24646740|NCT01205022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24646741|NCT01205022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24646742|NCT01205022|Growth Substances|growth substances|mesh-ancestor
24646743|NCT01205022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646744|NCT01205022|Growth Inhibitors|growth inhibitors|mesh-ancestor
24646745|NCT01205022|Immunologic Factors|immunologic factors|mesh-ancestor
24646746|NCT01205022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24646747|NCT01205022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24646748|NCT01205022|Antimetabolites|antimetabolites|mesh-ancestor
24646749|NCT01205022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646750|NCT01205022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24646751|NCT01205022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24646752|NCT01205022|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24646753|NCT01205022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24646754|NCT01205022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646755|NCT01205022|Antidotes|antidotes|mesh-ancestor
25265725|NCT02432261|Contraceptive Agents|contraceptive agents|mesh-ancestor
25265726|NCT02432261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25265727|NCT02432261|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25265728|NCT02432066|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
25265729|NCT02432066|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25265730|NCT02432066|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25265731|NCT02432066|Cholinergic Agents|cholinergic agents|mesh-ancestor
24646756|NCT01205022|Protective Agents|protective agents|mesh-ancestor
24646757|NCT01205022|Vitamin B Complex|vitamin b complex|mesh-ancestor
24646758|NCT01205022|Vitamins|vitamins|mesh-ancestor
24646759|NCT01205022|Micronutrients|micronutrients|mesh-ancestor
24646760|NCT01205022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24646761|NCT01205074|Ethanol|ethanol|mesh-list
24646762|NCT01205074|Propranolol|propranolol|mesh-list
24646789|NCT01205139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24856512|NCT02284984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856513|NCT02284984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24458964|NCT00343239|Mitosis Modulators|mitosis modulators|mesh-ancestor
24646800|NCT01205178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24646801|NCT01205204|Clonidine|clonidine|mesh-list
24646802|NCT01205204|Fentanyl|fentanyl|mesh-list
24646803|NCT01205204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24646804|NCT01205204|Narcotics|narcotics|mesh-ancestor
24646805|NCT01205204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24669016|NCT04332653|Pembrolizumab|pembrolizumab|mesh-list
24646806|NCT01205204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646807|NCT01205204|Analgesics|analgesics|mesh-ancestor
24646808|NCT01205204|Sensory System Agents|sensory system agents|mesh-ancestor
24646809|NCT01205204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24646810|NCT01205204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24646811|NCT01205204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24646812|NCT01205204|Anesthetics, General|anesthetics, general|mesh-ancestor
24646836|NCT01205217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594492|NCT00934167|Heparin|heparin|mesh-list
24646837|NCT01205217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24646838|NCT01205217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25265732|NCT02432066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25265733|NCT02432066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265734|NCT02432066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265736|NCT02431988|Fludarabine|fludarabine|mesh-list
25265737|NCT02431988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25265738|NCT02431988|Immunologic Factors|immunologic factors|mesh-ancestor
25265739|NCT02431988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265740|NCT02431988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25265741|NCT02431988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25265742|NCT02431988|Alkylating Agents|alkylating agents|mesh-ancestor
25265743|NCT02431988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265744|NCT02431988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265745|NCT02431988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25265746|NCT02431975|Ritonavir|ritonavir|mesh-list
25265747|NCT02431975|Lopinavir|lopinavir|mesh-list
25265748|NCT02431975|Lamivudine|lamivudine|mesh-list
25265749|NCT02431975|Zidovudine|zidovudine|mesh-list
25265750|NCT02431975|Nevirapine|nevirapine|mesh-list
25265751|NCT02431975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24646839|NCT01205217|Alkylating Agents|alkylating agents|mesh-ancestor
24646840|NCT01205217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24646851|NCT01205243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646852|NCT01205243|Antiviral Agents|antiviral agents|mesh-ancestor
24646853|NCT01205243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24646854|NCT01205243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24646855|NCT01205243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24646857|NCT01205256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24646858|NCT01205256|Narcotics|narcotics|mesh-ancestor
24856514|NCT02284984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24856515|NCT02285036|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24856516|NCT02285036|Immunologic Factors|immunologic factors|mesh-ancestor
24856517|NCT02285036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856518|NCT02285075|Temocillin|temocillin|mesh-list
24856519|NCT02285075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24856520|NCT02285075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24678170|NCT01360060|Anesthetics|anesthetics|mesh-ancestor
24646880|NCT01205347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24646881|NCT01205347|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24646882|NCT01205347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265752|NCT02431975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25265753|NCT02431975|Protease Inhibitors|protease inhibitors|mesh-ancestor
25265754|NCT02431975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265755|NCT02431975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265756|NCT02431975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25265757|NCT02431975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25265758|NCT02431975|Antiviral Agents|antiviral agents|mesh-ancestor
25265759|NCT02431975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25265760|NCT02431975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25265761|NCT02431975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25265762|NCT02431975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25265763|NCT02431975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25265764|NCT02431975|Antimetabolites|antimetabolites|mesh-ancestor
25265766|NCT02431975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24939008|NCT04013620|Immunologic Factors|immunologic factors|mesh-ancestor
24646884|NCT01205360|Bupivacaine|bupivacaine|mesh-list
24646885|NCT01205360|Anesthetics, Local|anesthetics, local|mesh-ancestor
24594975|NCT00936390|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24594976|NCT00936390|Flutamide|flutamide|mesh-list
24594977|NCT00936390|Bicalutamide|bicalutamide|mesh-list
24594978|NCT00936390|Buserelin|buserelin|mesh-list
24594979|NCT00936390|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25052112|NCT00332657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24646886|NCT01205360|Anesthetics|anesthetics|mesh-ancestor
24646887|NCT01205360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24646888|NCT01205360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694614|NCT05385744|Teriflunomide|teriflunomide|mesh-list
24694615|NCT05385744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24694616|NCT05385744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24694617|NCT05385744|Analgesics|analgesics|mesh-ancestor
24694618|NCT05385744|Sensory System Agents|sensory system agents|mesh-ancestor
24694619|NCT05385744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24914743|NCT04252274|Cobicistat|cobicistat|mesh-list
24646915|NCT01205516|Analgesics|analgesics|mesh-ancestor
24694642|NCT05385406|Acetic Acid|acetic acid|mesh-list
24646924|NCT01205711|Fluorouracil|fluorouracil|mesh-list
24646925|NCT01205711|Irinotecan|irinotecan|mesh-list
24646926|NCT01205711|Calcium|calcium|mesh-list
24646949|NCT01205737|Immunologic Factors|immunologic factors|mesh-ancestor
24646950|NCT01205737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646951|NCT01205737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24646952|NCT01205750|Insulin|insulin|mesh-list
24646953|NCT01205750|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24646954|NCT01205750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24646955|NCT01205750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856521|NCT02285101|BCT-100|bct-100|mesh-list
24856522|NCT02285101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24856523|NCT02285309|Enoximone|enoximone|mesh-list
24856524|NCT02285309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24856525|NCT02285309|Vasodilator Agents|vasodilator agents|mesh-ancestor
24856526|NCT02285309|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24856527|NCT02285309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24856528|NCT02285309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856529|NCT02285309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856530|NCT02285309|Protective Agents|protective agents|mesh-ancestor
24856531|NCT02285309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856532|NCT02285374|Tenofovir|tenofovir|mesh-list
24694663|NCT05385094|Cystatins|cystatins|mesh-list
24694664|NCT05385094|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
24694665|NCT05385094|Protease Inhibitors|protease inhibitors|mesh-ancestor
24856552|NCT02285374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24856553|NCT02285413|Cisplatin|cisplatin|mesh-list
24856554|NCT02285413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449043|NCT00313976|Interferon-beta|interferon-beta|mesh-list
25265778|NCT02431832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25265779|NCT02431832|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25265780|NCT02431832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265781|NCT02431832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265782|NCT02431728|Melatonin|melatonin|mesh-list
25688949|NCT01952444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25688950|NCT01952444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25688951|NCT01952444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25688952|NCT01952444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856565|NCT02285647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856567|NCT02285699|Fluvoxamine|fluvoxamine|mesh-list
24856568|NCT02285699|Citalopram|citalopram|mesh-list
24595759|NCT00940524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24856569|NCT02285699|Fluoxetine|fluoxetine|mesh-list
24856570|NCT02285699|Paroxetine|paroxetine|mesh-list
24856571|NCT02285699|Sertraline|sertraline|mesh-list
24856572|NCT02285699|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24856573|NCT02285699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24856578|NCT02285699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646978|NCT01205932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646979|NCT01205932|Anticoagulants|anticoagulants|mesh-ancestor
24647006|NCT01205984|Glucocorticoids|glucocorticoids|mesh-ancestor
24647007|NCT01205984|Hormones|hormones|mesh-ancestor
24647008|NCT01205984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24647009|NCT01205984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24647010|NCT01205984|Protective Agents|protective agents|mesh-ancestor
24856579|NCT02285699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24856580|NCT02285699|Antidepressive Agents|antidepressive agents|mesh-ancestor
24856581|NCT02285699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24856582|NCT02285699|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24856583|NCT02285699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24856584|NCT02285699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856585|NCT02285699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24856586|NCT02285699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24856587|NCT02285699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24856588|NCT02285699|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25265787|NCT02431728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25265788|NCT02431663|Ketamine|ketamine|mesh-list
25265789|NCT02431663|Analgesics|analgesics|mesh-ancestor
25265790|NCT02431663|Sensory System Agents|sensory system agents|mesh-ancestor
25265791|NCT02431663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25265792|NCT02431663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265793|NCT02431663|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25265794|NCT02431663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25265795|NCT02431663|Anesthetics, General|anesthetics, general|mesh-ancestor
25265796|NCT02431663|Anesthetics|anesthetics|mesh-ancestor
25265797|NCT02431663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25265798|NCT02431663|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25265799|NCT02431663|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24546554|NCT00699049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546557|NCT00699049|Adrenergic Agents|adrenergic agents|mesh-ancestor
24694748|NCT05370040|Immunologic Factors|immunologic factors|mesh-ancestor
24856589|NCT02285699|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24856590|NCT02285738|Aspirin|aspirin|mesh-list
24856591|NCT02285738|Simvastatin|simvastatin|mesh-list
24459051|NCT00343408|Protective Agents|protective agents|mesh-ancestor
24647011|NCT01205984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24647012|NCT01205984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647013|NCT01205984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24647014|NCT01205984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24647015|NCT01205984|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24647016|NCT01205984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24647017|NCT01205984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647020|NCT01205997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24647021|NCT01205997|Narcotics|narcotics|mesh-ancestor
24647022|NCT01205997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24647023|NCT01205997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647024|NCT01205997|Analgesics|analgesics|mesh-ancestor
24647025|NCT01205997|Sensory System Agents|sensory system agents|mesh-ancestor
24647048|NCT01206036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647049|NCT01206036|Tubulin Modulators|tubulin modulators|mesh-ancestor
24647050|NCT01206036|Antimitotic Agents|antimitotic agents|mesh-ancestor
24647051|NCT01206036|Mitosis Modulators|mitosis modulators|mesh-ancestor
24647052|NCT01206036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647053|NCT01206036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24647054|NCT01206036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24647055|NCT01206036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24694768|NCT05316220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24694769|NCT05316220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25265800|NCT02431663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25265801|NCT02431663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952088|NCT03898011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24596397|NCT00943410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24596398|NCT00943410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265802|NCT02431429|Miltefosine|miltefosine|mesh-list
25265803|NCT02431429|Antifungal Agents|antifungal agents|mesh-ancestor
25265804|NCT02431429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25265805|NCT02431429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265806|NCT02431429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25265807|NCT02431429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25265808|NCT02431416|Hormones|hormones|mesh-list
25265809|NCT02431416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25265810|NCT02431416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520458|NCT01497509|Fentanyl|fentanyl|mesh-list
24647072|NCT01206049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24647073|NCT01206049|Antimetabolites|antimetabolites|mesh-ancestor
24647074|NCT01206049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647075|NCT01206049|Antiviral Agents|antiviral agents|mesh-ancestor
25265811|NCT02431403|Imatinib Mesylate|imatinib mesylate|mesh-list
25265812|NCT02431403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265813|NCT02431403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25265814|NCT02431403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265815|NCT02431403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265816|NCT02431325|Teduglutide|teduglutide|mesh-list
25265817|NCT02431325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25265818|NCT02431325|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25265819|NCT02431325|Protective Agents|protective agents|mesh-ancestor
24647077|NCT01206049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856592|NCT02285738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24856594|NCT02285738|Analgesics|analgesics|mesh-ancestor
24856595|NCT02285738|Sensory System Agents|sensory system agents|mesh-ancestor
24856596|NCT02285738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24856597|NCT02285738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856598|NCT02285738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24856599|NCT02285738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24856600|NCT02285738|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24856601|NCT02285738|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24694801|NCT05244525|Epinephrine|epinephrine|mesh-list
24546733|NCT00699946|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25265820|NCT02431325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265821|NCT02431286|Dexamethasone|dexamethasone|mesh-list
25265822|NCT02431286|Aprepitant|aprepitant|mesh-list
25265823|NCT02431286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25265824|NCT02431286|Antiemetics|antiemetics|mesh-ancestor
25265825|NCT02431286|Autonomic Agents|autonomic agents|mesh-ancestor
25265826|NCT02431286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25265827|NCT02431286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688953|NCT01952444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688954|NCT01952444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688955|NCT01952444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25688956|NCT01952444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25688957|NCT01952834|Vancomycin|vancomycin|mesh-list
25688958|NCT01952834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25688959|NCT01952834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24598091|NCT00953641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24598455|NCT00956189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24598456|NCT00956189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24598457|NCT00956189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598458|NCT00956189|Dopamine Agonists|dopamine agonists|mesh-ancestor
24598459|NCT00956189|Dopamine Agents|dopamine agents|mesh-ancestor
24952129|NCT03897452|Anesthetics, General|anesthetics, general|mesh-ancestor
24915278|NCT03568994|Cytarabine|cytarabine|mesh-list
24856632|NCT02285751|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24856633|NCT02285751|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24856634|NCT02285751|Purinergic Agents|purinergic agents|mesh-ancestor
24856635|NCT02285751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24694836|NCT05176379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265828|NCT02431286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25265829|NCT02431286|Glucocorticoids|glucocorticoids|mesh-ancestor
25265830|NCT02431286|Hormones|hormones|mesh-ancestor
25265831|NCT02431286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25265832|NCT02431286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25265833|NCT02431286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265834|NCT02431286|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25265835|NCT02431286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25265836|NCT02431286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265837|NCT02431221|Perhexiline|perhexiline|mesh-list
25265838|NCT02431221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25265839|NCT02431221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25265840|NCT02431221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265841|NCT02431221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25265842|NCT02431221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265843|NCT02431221|Vasodilator Agents|vasodilator agents|mesh-ancestor
25265844|NCT02431208|Dexamethasone|dexamethasone|mesh-list
24812908|NCT02055170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647131|NCT01206530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24647132|NCT01206530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647133|NCT01206530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25265859|NCT02431208|Hormones|hormones|mesh-ancestor
24647135|NCT01206530|Growth Substances|growth substances|mesh-ancestor
24647136|NCT01206530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647137|NCT01206530|Growth Inhibitors|growth inhibitors|mesh-ancestor
24647138|NCT01206530|Antimetabolites|antimetabolites|mesh-ancestor
24647139|NCT01206530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647153|NCT01206530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24647154|NCT01206569|Tacrolimus|tacrolimus|mesh-list
24647155|NCT01206569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24647156|NCT01206569|Immunologic Factors|immunologic factors|mesh-ancestor
24647157|NCT01206569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647158|NCT01206569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25265845|NCT02431208|Lenalidomide|lenalidomide|mesh-list
25265846|NCT02431208|Atezolizumab|atezolizumab|mesh-list
25265847|NCT02431208|Daratumumab|daratumumab|mesh-list
25265848|NCT02431208|Pomalidomide|pomalidomide|mesh-list
25265849|NCT02431208|Antibodies|antibodies|mesh-list
25265850|NCT02431208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25265851|NCT02431208|Immunologic Factors|immunologic factors|mesh-ancestor
25265852|NCT02431208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265853|NCT02431208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25265854|NCT02431208|Antiemetics|antiemetics|mesh-ancestor
25265855|NCT02431208|Autonomic Agents|autonomic agents|mesh-ancestor
24647161|NCT01206647|Metformin|metformin|mesh-list
24647162|NCT01206647|Saxagliptin|saxagliptin|mesh-list
24647163|NCT01206647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25688960|NCT01953003|Capecitabine|capecitabine|mesh-list
25688961|NCT01953003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25688962|NCT01953003|Antimetabolites|antimetabolites|mesh-ancestor
25688963|NCT01953003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688964|NCT01953003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25688965|NCT01953081|Metoclopramide|metoclopramide|mesh-list
25688966|NCT01953081|Antiemetics|antiemetics|mesh-ancestor
24647164|NCT01206647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600205|NCT01696734|Autonomic Agents|autonomic agents|mesh-ancestor
24600206|NCT01696734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24600207|NCT01696734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600208|NCT01696734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24856655|NCT02285972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24856656|NCT02285972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856657|NCT02285972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856659|NCT02285985|Incretins|incretins|mesh-ancestor
24856669|NCT02286206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24856670|NCT02286206|Serotonin Agents|serotonin agents|mesh-ancestor
24856671|NCT02286206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24856672|NCT02286206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856673|NCT02286206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647165|NCT01206647|Incretins|incretins|mesh-ancestor
24647166|NCT01206647|Hormones|hormones|mesh-ancestor
24647167|NCT01206647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24647168|NCT01206647|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25265856|NCT02431208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25265857|NCT02431208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25265858|NCT02431208|Glucocorticoids|glucocorticoids|mesh-ancestor
25265860|NCT02431208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25265861|NCT02431208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25265862|NCT02431208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265863|NCT02431208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24546730|NCT00699946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24546731|NCT00699946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546732|NCT00699946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25045447|NCT00948961|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25045449|NCT00948961|Interferon Inducers|interferon inducers|mesh-ancestor
25045450|NCT00948961|Immunologic Factors|immunologic factors|mesh-ancestor
25045451|NCT00948961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045452|NCT00948961|Laxatives|laxatives|mesh-ancestor
25045453|NCT00948961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24647169|NCT01206647|Protease Inhibitors|protease inhibitors|mesh-ancestor
24647170|NCT01206647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24647171|NCT01206647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647173|NCT01206803|Hormone Antagonists|hormone antagonists|mesh-ancestor
24856674|NCT02286206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24856675|NCT02286206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24856676|NCT02286206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24856677|NCT02286206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24856686|NCT02286258|Calcium|calcium|mesh-list
24856687|NCT02286258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24856688|NCT02286258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856689|NCT02286258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24856690|NCT02286258|Chelating Agents|chelating agents|mesh-ancestor
24856691|NCT02286258|Sequestering Agents|sequestering agents|mesh-ancestor
24856692|NCT02286258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856693|NCT02286258|Anticoagulants|anticoagulants|mesh-ancestor
24856694|NCT02286258|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24856695|NCT02286388|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24856696|NCT02286388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24856697|NCT02286453|Diclofenac|diclofenac|mesh-list
24856698|NCT02286453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24856699|NCT02286453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24856700|NCT02286453|Analgesics|analgesics|mesh-ancestor
24856701|NCT02286453|Sensory System Agents|sensory system agents|mesh-ancestor
24856702|NCT02286453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25265864|NCT02431208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25265865|NCT02431208|Growth Substances|growth substances|mesh-ancestor
25265866|NCT02431208|Growth Inhibitors|growth inhibitors|mesh-ancestor
25265867|NCT02431143|Miltefosine|miltefosine|mesh-list
25265868|NCT02431143|Antifungal Agents|antifungal agents|mesh-ancestor
25265869|NCT02431143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25688967|NCT01953081|Autonomic Agents|autonomic agents|mesh-ancestor
25688968|NCT01953081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25688969|NCT01953081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688970|NCT01953081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24863126|NCT03065244|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24863127|NCT03065244|Immunologic Factors|immunologic factors|mesh-ancestor
24863128|NCT03065244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265870|NCT02431143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265871|NCT02431143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25265872|NCT02431143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25265874|NCT02431013|Simvastatin|simvastatin|mesh-list
25265875|NCT02431013|Pravastatin|pravastatin|mesh-list
25265876|NCT02431013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25265877|NCT02431013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25265878|NCT02431013|Antimetabolites|antimetabolites|mesh-ancestor
25265879|NCT02431013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265880|NCT02431013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25265881|NCT02431013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25265882|NCT02431013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265883|NCT02431013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24647208|NCT01206946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24647211|NCT01206946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24647212|NCT01206946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647213|NCT01206946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24856709|NCT02286544|Atorvastatin|atorvastatin|mesh-list
24856710|NCT02286544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24856720|NCT02286596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24856721|NCT02286596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24856722|NCT02286596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856723|NCT02286596|Plasma Substitutes|plasma substitutes|mesh-ancestor
24459176|NCT00343811|Modafinil|modafinil|mesh-list
24459179|NCT00343811|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24647220|NCT01206972|Protease Inhibitors|protease inhibitors|mesh-ancestor
24647221|NCT01206972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265884|NCT02431013|Autonomic Agents|autonomic agents|mesh-ancestor
25265885|NCT02431013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25265886|NCT02431013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265887|NCT02431013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25265888|NCT02431013|Respiratory System Agents|respiratory system agents|mesh-ancestor
25265889|NCT02431013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25265890|NCT02431013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25265891|NCT02431013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25265892|NCT02431013|Vasodilator Agents|vasodilator agents|mesh-ancestor
25265893|NCT02431013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25045464|NCT00948753|Maraviroc|maraviroc|mesh-list
25045465|NCT00948753|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25155634|NCT05317364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25155635|NCT05317364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155636|NCT05312151|Psilocybin|psilocybin|mesh-list
25155637|NCT05312151|Hallucinogens|hallucinogens|mesh-ancestor
25155638|NCT05312151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155639|NCT05312151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24647257|NCT01207206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647287|NCT01207622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24647288|NCT01207622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647289|NCT01207622|Adrenergic Agents|adrenergic agents|mesh-ancestor
24647290|NCT01207622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24647291|NCT01207622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647293|NCT01207739|Doxycycline|doxycycline|mesh-list
25688971|NCT01953081|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25688972|NCT01953081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25688973|NCT01953081|Dopamine Agents|dopamine agents|mesh-ancestor
25688974|NCT01953081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25688975|NCT01953081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25688976|NCT01953211|Contraceptive Agents|contraceptive agents|mesh-list
25688977|NCT01953211|Norinyl|norinyl|mesh-list
25688978|NCT01953211|Contraceptives, Oral|contraceptives, oral|mesh-list
24863223|NCT02590094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24863224|NCT02590094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24863225|NCT02590094|Growth Substances|growth substances|mesh-ancestor
24647342|NCT01208363|Sequestering Agents|sequestering agents|mesh-ancestor
24856724|NCT02286596|Blood Substitutes|blood substitutes|mesh-ancestor
24856726|NCT02286609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24856727|NCT02286609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24856739|NCT02286635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24856740|NCT02286635|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24856741|NCT02286635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856742|NCT02286635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856743|NCT02286635|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24647343|NCT01208363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647344|NCT01208441|Letrozole|letrozole|mesh-list
24647345|NCT01208441|R04929097|r04929097|mesh-list
24647346|NCT01208441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647347|NCT01208441|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24647348|NCT01208441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24647361|NCT01208454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265894|NCT02431013|Protective Agents|protective agents|mesh-ancestor
25265895|NCT02431013|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25265896|NCT02431013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25265897|NCT02431039|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25265898|NCT02431039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25265899|NCT02431065|Ropivacaine|ropivacaine|mesh-list
25265900|NCT02431065|Anesthetics, Local|anesthetics, local|mesh-ancestor
25265901|NCT02431065|Anesthetics|anesthetics|mesh-ancestor
24647365|NCT01208454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647367|NCT01208454|Dermatologic Agents|dermatologic agents|mesh-ancestor
24647369|NCT01208480|Docetaxel|docetaxel|mesh-list
24647370|NCT01208480|Bevacizumab|bevacizumab|mesh-list
24647371|NCT01208480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647372|NCT01208480|Tubulin Modulators|tubulin modulators|mesh-ancestor
24647373|NCT01208480|Antimitotic Agents|antimitotic agents|mesh-ancestor
24647374|NCT01208480|Mitosis Modulators|mitosis modulators|mesh-ancestor
24647375|NCT01208480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647376|NCT01208480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24647377|NCT01208480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25265902|NCT02431065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25265903|NCT02431065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265904|NCT02431065|Sensory System Agents|sensory system agents|mesh-ancestor
25155674|NCT05292755|Lubricant Eye Drops|lubricant eye drops|mesh-list
25155675|NCT05292755|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24647378|NCT01208480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24647379|NCT01208480|Growth Substances|growth substances|mesh-ancestor
24647380|NCT01208480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647388|NCT01208649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24647390|NCT01208701|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24856744|NCT02286635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24856745|NCT02286635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24856746|NCT02286635|Antitubercular Agents|antitubercular agents|mesh-ancestor
24856747|NCT02286635|Leprostatic Agents|leprostatic agents|mesh-ancestor
24856748|NCT02286635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24856749|NCT02286635|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24856750|NCT02286635|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24856751|NCT02286635|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24856752|NCT02286635|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24856753|NCT02286635|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24856754|NCT02286635|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24856755|NCT02286635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24856756|NCT02286635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25265917|NCT02430896|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25688979|NCT01953211|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25688980|NCT01953211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25688981|NCT01953211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688982|NCT01953211|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25265919|NCT02430896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265920|NCT02430896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25265921|NCT02430896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25265922|NCT02430896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25265923|NCT02430896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265925|NCT02430896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25265926|NCT02430896|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25265927|NCT02430896|Adrenergic Agents|adrenergic agents|mesh-ancestor
25265928|NCT02430545|Rifampin|rifampin|mesh-list
25265929|NCT02430545|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25265930|NCT02430545|Antitubercular Agents|antitubercular agents|mesh-ancestor
25265931|NCT02430545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25265932|NCT02430545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25265933|NCT02430545|Leprostatic Agents|leprostatic agents|mesh-ancestor
25265934|NCT02430545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25265935|NCT02430545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25155682|NCT05288907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25155683|NCT05288907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25155684|NCT05288907|Sensory System Agents|sensory system agents|mesh-ancestor
24546736|NCT00699946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24546737|NCT00699946|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24546738|NCT00699946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24546739|NCT00699946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24856757|NCT02286635|Immunologic Factors|immunologic factors|mesh-ancestor
24856758|NCT02286635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856759|NCT02286687|Talazoparib|talazoparib|mesh-list
24856760|NCT02286687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24856761|NCT02286687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24647399|NCT01208740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647400|NCT01208766|Dexamethasone|dexamethasone|mesh-list
24647402|NCT01208766|Lenalidomide|lenalidomide|mesh-list
24647403|NCT01208766|Bortezomib|bortezomib|mesh-list
24647404|NCT01208766|Melphalan|melphalan|mesh-list
24647405|NCT01208766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24647406|NCT01208766|Antiemetics|antiemetics|mesh-ancestor
24647407|NCT01208766|Autonomic Agents|autonomic agents|mesh-ancestor
24647408|NCT01208766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24647409|NCT01208766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265937|NCT02430545|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25265938|NCT02430545|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25265939|NCT02430545|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25265940|NCT02430545|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25265941|NCT02430545|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25265942|NCT02430545|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25265944|NCT02430272|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25265945|NCT02430272|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25265946|NCT02430272|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25265947|NCT02430272|Cholinergic Agents|cholinergic agents|mesh-ancestor
24856774|NCT02286752|Autonomic Agents|autonomic agents|mesh-ancestor
24856775|NCT02286752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24856777|NCT02286934|Isoproterenol|isoproterenol|mesh-list
24695094|NCT04622020|Anesthetics|anesthetics|mesh-list
24695095|NCT04622020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24695099|NCT04560556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856778|NCT02286934|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24856779|NCT02286934|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24856780|NCT02286934|Adrenergic Agents|adrenergic agents|mesh-ancestor
24856781|NCT02286934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24856782|NCT02286934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856783|NCT02286934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052271|NCT00313196|Bosentan|bosentan|mesh-list
24856784|NCT02286934|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24856785|NCT02286934|Antioxidants|antioxidants|mesh-ancestor
24856786|NCT02286934|Protective Agents|protective agents|mesh-ancestor
24856787|NCT02286934|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24647459|NCT01208935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25265952|NCT02430298|Antioxidants|antioxidants|mesh-ancestor
25265953|NCT02430298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25265954|NCT02430298|Protective Agents|protective agents|mesh-ancestor
25265955|NCT02430298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647465|NCT01209026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24647466|NCT01209026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24647468|NCT01209026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24647469|NCT01209026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647470|NCT01209026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24647471|NCT01209026|Respiratory System Agents|respiratory system agents|mesh-ancestor
24647472|NCT01209026|Dermatologic Agents|dermatologic agents|mesh-ancestor
24647507|NCT01209130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647508|NCT01209130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24647509|NCT01209208|Budesonide|budesonide|mesh-list
24647510|NCT01209208|Mesalamine|mesalamine|mesh-list
24647511|NCT01209208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24647512|NCT01209208|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25265956|NCT02430298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25265957|NCT02430259|Isoniazid|isoniazid|mesh-list
25265958|NCT02430259|Rifapentine|rifapentine|mesh-list
25265959|NCT02430259|Antitubercular Agents|antitubercular agents|mesh-ancestor
25265960|NCT02430259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25265961|NCT02430259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25265962|NCT02430259|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25265963|NCT02430259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25265964|NCT02430259|Antimetabolites|antimetabolites|mesh-ancestor
24856788|NCT02286934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24856789|NCT02286934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24856790|NCT02286934|Vasodilator Agents|vasodilator agents|mesh-ancestor
24856791|NCT02286934|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24856792|NCT02286934|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24856793|NCT02286934|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24856794|NCT02286934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24856795|NCT02286934|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24856796|NCT02286934|Autonomic Agents|autonomic agents|mesh-ancestor
24856797|NCT02286934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24856798|NCT02286934|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24856799|NCT02286934|Respiratory System Agents|respiratory system agents|mesh-ancestor
24856800|NCT02286934|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24856801|NCT02286934|Sympathomimetics|sympathomimetics|mesh-ancestor
24856802|NCT02286973|Tranexamic Acid|tranexamic acid|mesh-list
24856803|NCT02286973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24856804|NCT02286973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24856805|NCT02286973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856806|NCT02286973|Hemostatics|hemostatics|mesh-ancestor
24695147|NCT04425902|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25265967|NCT02430259|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25265968|NCT02430259|Leprostatic Agents|leprostatic agents|mesh-ancestor
25275406|NCT02372812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25275407|NCT02372812|Glucocorticoids|glucocorticoids|mesh-ancestor
25275408|NCT02372812|Hormones|hormones|mesh-ancestor
25688983|NCT01953211|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25688984|NCT01953211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25688985|NCT01953328|Atorvastatin|atorvastatin|mesh-list
25688986|NCT01953328|Evolocumab|evolocumab|mesh-list
25688987|NCT01953328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25688988|NCT01953328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25688989|NCT01953328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25688990|NCT01953328|Antimetabolites|antimetabolites|mesh-ancestor
25688991|NCT01953328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813713|NCT02060006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24813714|NCT02060006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609381|NCT00996229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609383|NCT00996229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24609384|NCT00996385|Oxaliplatin|oxaliplatin|mesh-list
24863519|NCT04743570|Sensory System Agents|sensory system agents|mesh-ancestor
24863521|NCT04708613|Corticosterone|corticosterone|mesh-list
25275409|NCT02372812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25275410|NCT02372812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25275411|NCT02372812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25275413|NCT02372604|Levocetirizine|levocetirizine|mesh-list
25275414|NCT02372604|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24546849|NCT00700687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24763822|NCT01777477|Antiviral Agents|antiviral agents|mesh-ancestor
24695173|NCT04421677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24695174|NCT04370093|Pioglitazone|pioglitazone|mesh-list
24695175|NCT04370093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24695176|NCT04370093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622480|NCT01067274|Cytarabine|cytarabine|mesh-list
24647558|NCT01209416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916248|NCT04243109|Hormones|hormones|mesh-ancestor
24856819|NCT02287129|Capecitabine|capecitabine|mesh-list
24856820|NCT02287129|Oxaliplatin|oxaliplatin|mesh-list
24856822|NCT02287129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24695189|NCT04246762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695190|NCT04246762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24695191|NCT04246762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24695193|NCT04246762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25265969|NCT02430181|Interferons|interferons|mesh-list
25265970|NCT02430181|Ritonavir|ritonavir|mesh-list
25265971|NCT02430181|Interferon-alpha|interferon-alpha|mesh-list
25265972|NCT02430181|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25265973|NCT02430181|Lonafarnib|lonafarnib|mesh-list
25265974|NCT02430181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265975|NCT02430181|Antiviral Agents|antiviral agents|mesh-ancestor
25265976|NCT02430181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25265977|NCT02430181|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25265978|NCT02430181|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25265979|NCT02430181|Protease Inhibitors|protease inhibitors|mesh-ancestor
25265980|NCT02430181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25265981|NCT02430181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547060|NCT00702156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24459289|NCT00344201|Hemostatics|hemostatics|mesh-ancestor
24647606|NCT01209715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24647607|NCT01209715|Adrenergic Agents|adrenergic agents|mesh-ancestor
24647630|NCT01209806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24647631|NCT01209806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24647632|NCT01209806|Immunologic Factors|immunologic factors|mesh-ancestor
24647633|NCT01209806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647635|NCT01209806|Protective Agents|protective agents|mesh-ancestor
24647636|NCT01209845|Ketamine|ketamine|mesh-list
25688993|NCT01953328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25688994|NCT01953328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25688995|NCT01953328|Immunologic Factors|immunologic factors|mesh-ancestor
25688996|NCT01953328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25688997|NCT01953432|Doxazosin|doxazosin|mesh-list
25688998|NCT01953432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25688999|NCT01953432|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24863655|NCT04002037|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24863656|NCT04002037|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24647646|NCT01209845|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24647647|NCT01209845|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25265982|NCT02430181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25265983|NCT02430181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25265984|NCT02430181|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25265985|NCT02430181|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25265986|NCT02430181|Immunologic Factors|immunologic factors|mesh-ancestor
25265987|NCT02430181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265988|NCT02430194|Interferons|interferons|mesh-list
25265989|NCT02430194|Ritonavir|ritonavir|mesh-list
25265990|NCT02430194|Interferon-alpha|interferon-alpha|mesh-list
25265991|NCT02430194|Interferon alpha-2|interferon alpha-2|mesh-list
25265992|NCT02430194|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25265993|NCT02430194|Lonafarnib|lonafarnib|mesh-list
25265994|NCT02430194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25265995|NCT02430194|Antiviral Agents|antiviral agents|mesh-ancestor
25265996|NCT02430194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25265997|NCT02430194|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24547702|NCT00705315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547703|NCT00705315|Growth Inhibitors|growth inhibitors|mesh-ancestor
24547704|NCT00705315|Tubulin Modulators|tubulin modulators|mesh-ancestor
24547878|NCT00706277|Remifentanil|remifentanil|mesh-list
24547879|NCT00706277|Nitrous Oxide|nitrous oxide|mesh-list
24547880|NCT00706277|Propofol|propofol|mesh-list
24856827|NCT02287129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856828|NCT02287129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24856829|NCT02287129|Antimetabolites|antimetabolites|mesh-ancestor
24856830|NCT02287129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24856831|NCT02287129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24856832|NCT02287129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24856833|NCT02287129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856834|NCT02287181|Remifentanil|remifentanil|mesh-list
24856835|NCT02287181|Propofol|propofol|mesh-list
24856836|NCT02287181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24856837|NCT02287181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24856838|NCT02287181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25265998|NCT02430194|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25265999|NCT02430194|Protease Inhibitors|protease inhibitors|mesh-ancestor
25266000|NCT02430194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25266001|NCT02430194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266002|NCT02430194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25266003|NCT02430194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25266004|NCT02430194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25266005|NCT02430194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25266006|NCT02430194|Immunologic Factors|immunologic factors|mesh-ancestor
25266007|NCT02430194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856839|NCT02287181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24856840|NCT02287181|Anesthetics, General|anesthetics, general|mesh-ancestor
24856842|NCT02287181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24856843|NCT02287181|Narcotics|narcotics|mesh-ancestor
24856844|NCT02287181|Analgesics|analgesics|mesh-ancestor
24856845|NCT02287181|Sensory System Agents|sensory system agents|mesh-ancestor
24647764|NCT01210521|Vitamins|vitamins|mesh-ancestor
24647684|NCT01210040|Hematinics|hematinics|mesh-ancestor
24647686|NCT01210040|Micronutrients|micronutrients|mesh-ancestor
24647687|NCT01210040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647688|NCT01210066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
24647689|NCT01210066|Fentanyl|fentanyl|mesh-list
24647690|NCT01210066|Analgesics, Opioid|analgesics, opioid|mesh-list
24647691|NCT01210066|Narcotics|narcotics|mesh-ancestor
24647692|NCT01210066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24647693|NCT01210066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647705|NCT01210287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647707|NCT01210287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24647708|NCT01210287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24647709|NCT01210287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24647710|NCT01210339|Esomeprazole|esomeprazole|mesh-list
25689000|NCT01953432|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25689001|NCT01953432|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24647711|NCT01210339|Clopidogrel|clopidogrel|mesh-list
25689002|NCT01953432|Adrenergic Agents|adrenergic agents|mesh-ancestor
25689003|NCT01953432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24647712|NCT01210339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24647713|NCT01210339|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24647714|NCT01210339|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24647715|NCT01210339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24647716|NCT01210339|Purinergic Agents|purinergic agents|mesh-ancestor
24647717|NCT01210339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24647718|NCT01210339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647742|NCT01210456|Acetylcysteine|acetylcysteine|mesh-list
24647743|NCT01210456|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25266008|NCT02430350|Edaravone|edaravone|mesh-list
24647744|NCT01210456|Antiviral Agents|antiviral agents|mesh-ancestor
25266009|NCT02430350|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25266010|NCT02430350|Antioxidants|antioxidants|mesh-ancestor
25266011|NCT02430350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266012|NCT02430350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25266013|NCT02430350|Protective Agents|protective agents|mesh-ancestor
24647748|NCT01210456|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24647750|NCT01210456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647751|NCT01210456|Protective Agents|protective agents|mesh-ancestor
24647752|NCT01210456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647753|NCT01210456|Antidotes|antidotes|mesh-ancestor
24647755|NCT01210482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24448467|NCT00311961|Prednisolone|prednisolone|mesh-list
24647756|NCT01210482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24647757|NCT01210482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24647758|NCT01210482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647759|NCT01210482|Antifungal Agents|antifungal agents|mesh-ancestor
24647760|NCT01210482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24647761|NCT01210482|Immunologic Factors|immunologic factors|mesh-ancestor
24647762|NCT01210482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647763|NCT01210521|Vitamin D|vitamin d|mesh-list
24647767|NCT01210521|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24647769|NCT01210599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24647770|NCT01210599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647771|NCT01210625|Psyllium|psyllium|mesh-list
24647772|NCT01210625|Cathartics|cathartics|mesh-ancestor
24647773|NCT01210625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24647814|NCT01210911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24647842|NCT01211080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24647844|NCT01211080|Vasodilator Agents|vasodilator agents|mesh-ancestor
24647846|NCT01211158|Propofol|propofol|mesh-list
24647847|NCT01211158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24647848|NCT01211158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25266014|NCT02430350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266015|NCT02430363|Pembrolizumab|pembrolizumab|mesh-list
25266016|NCT02430363|Dactolisib|dactolisib|mesh-list
25266017|NCT02430363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25266018|NCT02430363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266019|NCT02430233|Progesterone|progesterone|mesh-list
25266020|NCT02430233|Progestins|progestins|mesh-ancestor
25266021|NCT02430233|Hormones|hormones|mesh-ancestor
25275415|NCT02372604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25275416|NCT02372604|Histamine Antagonists|histamine antagonists|mesh-ancestor
25275417|NCT02372604|Histamine Agents|histamine agents|mesh-ancestor
25275418|NCT02372604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24559721|NCT04459598|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24449708|NCT00316745|Antimetabolites|antimetabolites|mesh-ancestor
24939160|NCT04012606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24647849|NCT01211158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647850|NCT01211158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24647851|NCT01211158|Anesthetics, General|anesthetics, general|mesh-ancestor
25689004|NCT01953432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647852|NCT01211158|Anesthetics|anesthetics|mesh-ancestor
24647853|NCT01211158|Analgesics|analgesics|mesh-ancestor
24647854|NCT01211158|Sensory System Agents|sensory system agents|mesh-ancestor
24678476|NCT01362218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612489|NCT01014234|Cyclosporine|cyclosporine|mesh-list
24812910|NCT02055170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24812911|NCT02055170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812912|NCT02055170|Urological Agents|urological agents|mesh-ancestor
24812914|NCT02055183|Botulinum Antitoxin|botulinum antitoxin|mesh-list
24812915|NCT02055183|Immunologic Factors|immunologic factors|mesh-ancestor
24812916|NCT02055183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812917|NCT02055196|Irinotecan|irinotecan|mesh-list
24812918|NCT02055196|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24812919|NCT02055196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24812920|NCT02055196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812921|NCT02055196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812922|NCT02055196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812923|NCT02055274|Rotigotine|rotigotine|mesh-list
24812924|NCT02055274|Dopamine Agonists|dopamine agonists|mesh-ancestor
24812925|NCT02055274|Dopamine Agents|dopamine agents|mesh-ancestor
24812926|NCT02055274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24812927|NCT02055274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812928|NCT02055274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812946|NCT02055378|Respiratory System Agents|respiratory system agents|mesh-ancestor
24812947|NCT02055378|Mydriatics|mydriatics|mesh-ancestor
24812948|NCT02055378|Parasympatholytics|parasympatholytics|mesh-ancestor
24647901|NCT01211327|Cyclosporine|cyclosporine|mesh-list
24647902|NCT01211327|Dexamethasone|dexamethasone|mesh-list
24647903|NCT01211327|Cyclosporins|cyclosporins|mesh-list
24647904|NCT01211327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24647906|NCT01211327|Autonomic Agents|autonomic agents|mesh-ancestor
24647907|NCT01211327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812974|NCT02055664|Anesthetics|anesthetics|mesh-ancestor
24812975|NCT02055664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25266022|NCT02430233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25266023|NCT02430233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266024|NCT02430103|Goserelin|goserelin|mesh-list
25266025|NCT02430103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25266026|NCT02430103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266027|NCT02429973|Gemcitabine|gemcitabine|mesh-list
25266028|NCT02429973|Sirolimus|sirolimus|mesh-list
25266029|NCT02429973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25266030|NCT02429973|Antimetabolites|antimetabolites|mesh-ancestor
24647937|NCT01211496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647940|NCT01211496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24647941|NCT01211496|Dopamine Agents|dopamine agents|mesh-ancestor
24647942|NCT01211496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24647943|NCT01211496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647944|NCT01211496|Adrenergic Agents|adrenergic agents|mesh-ancestor
25266034|NCT02429973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25266035|NCT02429973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25266036|NCT02429973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25266037|NCT02429973|Immunologic Factors|immunologic factors|mesh-ancestor
25266038|NCT02429973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266039|NCT02429973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25266041|NCT02429973|Antifungal Agents|antifungal agents|mesh-ancestor
25266042|NCT02429960|Remifentanil|remifentanil|mesh-list
25266044|NCT02429960|Narcotics|narcotics|mesh-ancestor
25266045|NCT02429960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25266046|NCT02429960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266047|NCT02429960|Analgesics|analgesics|mesh-ancestor
25266048|NCT02429960|Sensory System Agents|sensory system agents|mesh-ancestor
25266049|NCT02429960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25266050|NCT02429921|Selenium|selenium|mesh-list
25266051|NCT02429921|Antioxidants|antioxidants|mesh-ancestor
25266052|NCT02429921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266053|NCT02429921|Protective Agents|protective agents|mesh-ancestor
25266054|NCT02429921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266055|NCT02429921|Trace Elements|trace elements|mesh-ancestor
25266056|NCT02429921|Micronutrients|micronutrients|mesh-ancestor
24647945|NCT01211496|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24916783|NCT04237493|Metformin|metformin|mesh-list
24856901|NCT02287558|Pomalidomide|pomalidomide|mesh-list
24648029|NCT01211860|Diazoxide|diazoxide|mesh-list
24648030|NCT01211860|Choline|choline|mesh-list
24648031|NCT01211860|Lipotropic Agents|lipotropic agents|mesh-ancestor
24648032|NCT01211860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24648033|NCT01211860|Antimetabolites|antimetabolites|mesh-ancestor
24648068|NCT01212133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648069|NCT01212133|Incretins|incretins|mesh-ancestor
24648070|NCT01212133|Hormones|hormones|mesh-ancestor
24648071|NCT01212133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24648101|NCT01212367|Antiviral Agents|antiviral agents|mesh-ancestor
24648102|NCT01212367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24648103|NCT01212367|Immunologic Factors|immunologic factors|mesh-ancestor
24648104|NCT01212367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648105|NCT01212406|Vitamin D|vitamin d|mesh-list
24856864|NCT02287246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24856865|NCT02287259|Olanzapine|olanzapine|mesh-list
24856866|NCT02287259|Antiemetics|antiemetics|mesh-ancestor
25266057|NCT02429804|Listerine|listerine|mesh-list
25266058|NCT02429804|Deoxyglucose|deoxyglucose|mesh-list
25266059|NCT02429804|Fluorides|fluorides|mesh-list
25266060|NCT02429804|Sodium Fluoride|sodium fluoride|mesh-list
25266061|NCT02429804|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25266062|NCT02429804|Cariostatic Agents|cariostatic agents|mesh-ancestor
25266063|NCT02429804|Protective Agents|protective agents|mesh-ancestor
25266064|NCT02429804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266065|NCT02429804|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25266066|NCT02429804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266067|NCT02429804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25266068|NCT02429804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25266069|NCT02429804|Antimetabolites|antimetabolites|mesh-ancestor
25266070|NCT02429804|Antiviral Agents|antiviral agents|mesh-ancestor
25266071|NCT02429726|Cisplatin|cisplatin|mesh-list
25266072|NCT02429726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266073|NCT02429700|Paclitaxel|paclitaxel|mesh-list
25266074|NCT02429700|Etoposide|etoposide|mesh-list
25266075|NCT02429700|Carboplatin|carboplatin|mesh-list
24939188|NCT04012268|Aspirin|aspirin|mesh-list
24856867|NCT02287259|Autonomic Agents|autonomic agents|mesh-ancestor
24856868|NCT02287259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24856869|NCT02287259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856870|NCT02287259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24856871|NCT02287259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24856872|NCT02287259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24856873|NCT02287259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24856874|NCT02287259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24856875|NCT02287259|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24802058|NCT01986998|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24648113|NCT01212523|Propofol|propofol|mesh-list
24648114|NCT01212523|Isoflurane|isoflurane|mesh-list
24648193|NCT01212913|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24648195|NCT01212913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648196|NCT01212965|Selenium|selenium|mesh-list
25266076|NCT02429700|Bleomycin|bleomycin|mesh-list
25266077|NCT02429700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25266078|NCT02429700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266079|NCT02429700|Tubulin Modulators|tubulin modulators|mesh-ancestor
25266080|NCT02429700|Antimitotic Agents|antimitotic agents|mesh-ancestor
25266081|NCT02429700|Mitosis Modulators|mitosis modulators|mesh-ancestor
25266082|NCT02429700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266083|NCT02429700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25266084|NCT02429700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24648197|NCT01212965|Antioxidants|antioxidants|mesh-ancestor
24648198|NCT01212965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648199|NCT01212965|Protective Agents|protective agents|mesh-ancestor
24856902|NCT02287558|Immunologic Factors|immunologic factors|mesh-ancestor
24648241|NCT01213238|Growth Substances|growth substances|mesh-ancestor
24648242|NCT01213238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648243|NCT01213238|Growth Inhibitors|growth inhibitors|mesh-ancestor
24648362|NCT01213784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648363|NCT01213849|Fluticasone|fluticasone|mesh-list
24648365|NCT01213849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24648366|NCT01213849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24648367|NCT01213849|Autonomic Agents|autonomic agents|mesh-ancestor
25266085|NCT02429700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25266086|NCT02429700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25266087|NCT02429713|Oxymetazoline|oxymetazoline|mesh-list
25266088|NCT02429713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25266089|NCT02429713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25266090|NCT02429713|Adrenergic Agents|adrenergic agents|mesh-ancestor
25266091|NCT02429713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25266092|NCT02429713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266093|NCT02429713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550263|NCT00719823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25155685|NCT05288907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25155686|NCT05288907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24648368|NCT01213849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24856877|NCT02287259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24856878|NCT02287259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856879|NCT02287259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24856880|NCT02287259|Serotonin Agents|serotonin agents|mesh-ancestor
24856882|NCT02287272|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24856883|NCT02287272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24856884|NCT02287272|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24856885|NCT02287272|Histamine Antagonists|histamine antagonists|mesh-ancestor
24856886|NCT02287272|Histamine Agents|histamine agents|mesh-ancestor
24856887|NCT02287272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24856888|NCT02287272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856889|NCT02287272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856890|NCT02287272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24856891|NCT02287272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24856892|NCT02287272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856893|NCT02287389|Mitomycins|mitomycins|mesh-list
24856894|NCT02287389|Mitomycin|mitomycin|mesh-list
24856895|NCT02287389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24856896|NCT02287389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24856897|NCT02287389|Alkylating Agents|alkylating agents|mesh-ancestor
24856898|NCT02287389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695479|NCT03417154|Nivolumab|nivolumab|mesh-list
24481010|NCT00433121|Risperidone|risperidone|mesh-list
24695480|NCT03417154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24695481|NCT03417154|Immunologic Factors|immunologic factors|mesh-ancestor
24695482|NCT03417154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695483|NCT03417154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24695484|NCT03417154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24695485|NCT03417154|Alkylating Agents|alkylating agents|mesh-ancestor
24695486|NCT03417154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689005|NCT01953432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695491|NCT03375203|Zolpidem|zolpidem|mesh-list
24856899|NCT02287389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24812982|NCT02055703|Itraconazole|itraconazole|mesh-list
25266101|NCT02429817|Pentetic Acid|pentetic acid|mesh-list
25266102|NCT02429817|Antidotes|antidotes|mesh-ancestor
25266103|NCT02429817|Protective Agents|protective agents|mesh-ancestor
25266104|NCT02429817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266105|NCT02429817|Chelating Agents|chelating agents|mesh-ancestor
24516143|NCT00600639|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24939209|NCT04012047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856905|NCT02287558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24856906|NCT02287558|Growth Substances|growth substances|mesh-ancestor
24695494|NCT03375203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24695495|NCT03375203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695496|NCT03375203|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24695497|NCT03375203|GABA Agonists|gaba agonists|mesh-ancestor
24695498|NCT03375203|GABA Agents|gaba agents|mesh-ancestor
24695499|NCT03375203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24856907|NCT02287558|Growth Inhibitors|growth inhibitors|mesh-ancestor
24856908|NCT02287558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24856909|NCT02287792|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24856910|NCT02287792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24856911|NCT02287792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856912|NCT02287857|Tenofovir|tenofovir|mesh-list
24856913|NCT02287857|Antiviral Agents|antiviral agents|mesh-ancestor
25266106|NCT02429817|Sequestering Agents|sequestering agents|mesh-ancestor
25266107|NCT02429817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266108|NCT02429817|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25266109|NCT02429817|Anticoagulants|anticoagulants|mesh-ancestor
25266110|NCT02429817|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25266111|NCT02429882|Brodalumab|brodalumab|mesh-list
25266112|NCT02429882|Dermatologic Agents|dermatologic agents|mesh-ancestor
25266113|NCT02429765|Formoterol Fumarate|formoterol fumarate|mesh-list
25266114|NCT02429765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25266115|NCT02429765|Autonomic Agents|autonomic agents|mesh-ancestor
25266116|NCT02429765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25266117|NCT02429765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266118|NCT02429765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25266119|NCT02429765|Respiratory System Agents|respiratory system agents|mesh-ancestor
25266120|NCT02429765|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25266121|NCT02429765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25266122|NCT02429765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25266123|NCT02429765|Adrenergic Agents|adrenergic agents|mesh-ancestor
25266124|NCT02429765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25266125|NCT02429765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266126|NCT02429687|Paclitaxel|paclitaxel|mesh-list
24856921|NCT02287870|Lidocaine|lidocaine|mesh-list
24856922|NCT02287870|Chloroprocaine|chloroprocaine|mesh-list
24856923|NCT02287870|Procaine|procaine|mesh-list
24856924|NCT02287870|Anesthetics, Local|anesthetics, local|mesh-ancestor
24856925|NCT02287870|Anesthetics|anesthetics|mesh-ancestor
24856926|NCT02287870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24856927|NCT02287870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648394|NCT01213992|Hematinics|hematinics|mesh-ancestor
24648396|NCT01214122|Anticoagulants|anticoagulants|mesh-ancestor
24648397|NCT01214226|Pentoxifylline|pentoxifylline|mesh-list
24648398|NCT01214226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24648399|NCT01214226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648400|NCT01214226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648401|NCT01214226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24648402|NCT01214226|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24648403|NCT01214226|Protective Agents|protective agents|mesh-ancestor
24648404|NCT01214226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856930|NCT02287870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25689007|NCT01953692|Lenalidomide|lenalidomide|mesh-list
25689008|NCT01953692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24813884|NCT02060734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24544162|NCT00687648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24544163|NCT00687648|Alkylating Agents|alkylating agents|mesh-ancestor
24864251|NCT05116800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24864252|NCT05116800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864253|NCT05116800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24856931|NCT02287870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24856932|NCT02287870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24695549|NCT03142035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25266127|NCT02429687|Etoposide|etoposide|mesh-list
25266128|NCT02429687|Carboplatin|carboplatin|mesh-list
25266129|NCT02429687|Bleomycin|bleomycin|mesh-list
25266130|NCT02429687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25266131|NCT02429687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266132|NCT02429687|Tubulin Modulators|tubulin modulators|mesh-ancestor
25266133|NCT02429687|Antimitotic Agents|antimitotic agents|mesh-ancestor
25266134|NCT02429687|Mitosis Modulators|mitosis modulators|mesh-ancestor
25266135|NCT02429687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266136|NCT02429687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25266137|NCT02429687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24939226|NCT04011930|Calcitriol|calcitriol|mesh-list
24856933|NCT02287870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24856934|NCT02287870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856935|NCT02288000|Memantine|memantine|mesh-list
24856936|NCT02288000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24856937|NCT02288000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24856938|NCT02288000|Dopamine Agents|dopamine agents|mesh-ancestor
24856939|NCT02288000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24648421|NCT01214343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648422|NCT01214382|Sertraline|sertraline|mesh-list
24648423|NCT01214382|Antidepressive Agents|antidepressive agents|mesh-ancestor
24648424|NCT01214382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24648425|NCT01214382|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24695564|NCT02926833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266138|NCT02429687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25266139|NCT02429687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25266140|NCT02429622|Paclitaxel|paclitaxel|mesh-list
25266141|NCT02429622|Nedaplatin|nedaplatin|mesh-list
25266142|NCT02429622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25266143|NCT02429622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266144|NCT02429622|Tubulin Modulators|tubulin modulators|mesh-ancestor
24724050|NCT01590836|Insulin|insulin|mesh-list
25266145|NCT02429622|Antimitotic Agents|antimitotic agents|mesh-ancestor
25689009|NCT01953692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25689010|NCT01953692|Immunologic Factors|immunologic factors|mesh-ancestor
25689011|NCT01953692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689012|NCT01953692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25689013|NCT01953692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25689014|NCT01953692|Growth Substances|growth substances|mesh-ancestor
25689015|NCT01953692|Growth Inhibitors|growth inhibitors|mesh-ancestor
25689016|NCT01953783|Ixazomib|ixazomib|mesh-list
25266146|NCT02429622|Mitosis Modulators|mitosis modulators|mesh-ancestor
24445192|NCT00300768|Anthelmintics|anthelmintics|mesh-ancestor
25266147|NCT02429622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266148|NCT02429596|Lamotrigine|lamotrigine|mesh-list
25266149|NCT02429596|Carbamazepine|carbamazepine|mesh-list
24648426|NCT01214382|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24648427|NCT01214382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24648428|NCT01214382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648429|NCT01214382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24648430|NCT01214382|Serotonin Agents|serotonin agents|mesh-ancestor
24648431|NCT01214382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648432|NCT01214408|Pantoprazole|pantoprazole|mesh-list
24648433|NCT01214408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24648434|NCT01214408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24648435|NCT01214408|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24648436|NCT01214408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648441|NCT01214486|Antiviral Agents|antiviral agents|mesh-ancestor
24648442|NCT01214486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24648443|NCT01214486|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24648444|NCT01214486|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24648445|NCT01214486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856971|NCT02288208|Tenofovir|tenofovir|mesh-list
24648466|NCT01214928|Micronutrients|micronutrients|mesh-ancestor
25266150|NCT02429596|Anticonvulsants|anticonvulsants|mesh-ancestor
25266151|NCT02429596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25266152|NCT02429596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25266153|NCT02429596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266154|NCT02429596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25266155|NCT02429596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266156|NCT02429596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25266157|NCT02429596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24648647|NCT01216111|Alkylating Agents|alkylating agents|mesh-ancestor
25266158|NCT02429596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25266159|NCT02429596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25266160|NCT02429596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24939262|NCT04011345|Folic Acid|folic acid|mesh-list
24648467|NCT01214928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648517|NCT01215136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648519|NCT01215136|Immunologic Factors|immunologic factors|mesh-ancestor
24648520|NCT01215136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648522|NCT01215149|Immunologic Factors|immunologic factors|mesh-ancestor
24648523|NCT01215149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648524|NCT01215214|Midazolam|midazolam|mesh-list
24856973|NCT02288208|Antiviral Agents|antiviral agents|mesh-list
24856974|NCT02288208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24856975|NCT02288208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24856976|NCT02288208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24856977|NCT02288208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856978|NCT02288208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856979|NCT02288208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24856980|NCT02288208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24856981|NCT02288234|Telavancin|telavancin|mesh-list
24856982|NCT02288234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24856983|NCT02288234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24856984|NCT02288286|Vaccines|vaccines|mesh-list
24856985|NCT02288286|Immunologic Factors|immunologic factors|mesh-ancestor
25689018|NCT01953783|Protease Inhibitors|protease inhibitors|mesh-ancestor
25689019|NCT01953783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689020|NCT01953783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689021|NCT01953913|Afatinib|afatinib|mesh-list
25689022|NCT01953913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25689023|NCT01953913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25266167|NCT02429596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25266169|NCT02429219|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25266170|NCT02429219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25266171|NCT02429219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25266172|NCT02429219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266173|NCT02429193|Prednisone|prednisone|mesh-list
25266174|NCT02429193|Abiraterone Acetate|abiraterone acetate|mesh-list
25266175|NCT02429193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25266176|NCT02429193|Glucocorticoids|glucocorticoids|mesh-ancestor
25266177|NCT02429193|Hormones|hormones|mesh-ancestor
25266178|NCT02429193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24516176|NCT00600847|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24516177|NCT00600847|Histamine Antagonists|histamine antagonists|mesh-ancestor
24648531|NCT01215214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24648532|NCT01215214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24648533|NCT01215214|Anesthetics, General|anesthetics, general|mesh-ancestor
25266179|NCT02429193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266180|NCT02429193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25266181|NCT02429193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266182|NCT02429193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25266183|NCT02429193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25266184|NCT02429193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266185|NCT02429193|Hormone Antagonists|hormone antagonists|mesh-ancestor
25266186|NCT02429193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25266187|NCT02429271|Clopidogrel|clopidogrel|mesh-list
25266188|NCT02429271|Ticagrelor|ticagrelor|mesh-list
25266189|NCT02429271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25266190|NCT02429271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25266191|NCT02429271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25266192|NCT02429271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25266193|NCT02429271|Purinergic Agents|purinergic agents|mesh-ancestor
25266194|NCT02429271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25266195|NCT02429271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266196|NCT02429271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266197|NCT02429466|Guadecitabine|guadecitabine|mesh-list
25266198|NCT02429466|Azacitidine|azacitidine|mesh-list
25689024|NCT01953913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689025|NCT01953913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689026|NCT01954056|Hydrocortisone|hydrocortisone|mesh-list
25689027|NCT01954056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25689028|NCT01954082|Inositol|inositol|mesh-list
25689029|NCT01954082|Vitamin B Complex|vitamin b complex|mesh-ancestor
25689030|NCT01954082|Vitamins|vitamins|mesh-ancestor
25689031|NCT01954082|Micronutrients|micronutrients|mesh-ancestor
25689032|NCT01954082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689034|NCT01954121|Levetiracetam|levetiracetam|mesh-list
24864683|NCT02799641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24864689|NCT02799641|Anticonvulsants|anticonvulsants|mesh-ancestor
24544568|NCT00689559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24544569|NCT00689559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544571|NCT00689559|Dopamine Agents|dopamine agents|mesh-ancestor
24544572|NCT00689559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24648535|NCT01215214|GABA Modulators|gaba modulators|mesh-ancestor
24648536|NCT01215214|GABA Agents|gaba agents|mesh-ancestor
24648537|NCT01215214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24648538|NCT01215214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648539|NCT01215266|Sorafenib|sorafenib|mesh-list
24648540|NCT01215266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648541|NCT01215266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24648542|NCT01215266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648543|NCT01215266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648544|NCT01215331|Insulin|insulin|mesh-list
24648545|NCT01215331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24648546|NCT01215331|Metformin|metformin|mesh-list
24648547|NCT01215331|Glyburide|glyburide|mesh-list
24648579|NCT01215578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648581|NCT01215669|Immunologic Factors|immunologic factors|mesh-ancestor
24648582|NCT01215669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648583|NCT01215682|Vitamin D|vitamin d|mesh-list
24648584|NCT01215682|Vitamins|vitamins|mesh-ancestor
24648585|NCT01215682|Micronutrients|micronutrients|mesh-ancestor
24648646|NCT01216111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24857001|NCT02288507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24857003|NCT02288507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857005|NCT02288741|Dexamethasone acetate|dexamethasone acetate|mesh-list
24857006|NCT02288741|Melphalan|melphalan|mesh-list
24857007|NCT02288741|BB 1101|bb 1101|mesh-list
25266205|NCT02429531|Immunologic Factors|immunologic factors|mesh-ancestor
25266206|NCT02429531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266207|NCT02429505|Miltefosine|miltefosine|mesh-list
25266208|NCT02429505|Antifungal Agents|antifungal agents|mesh-ancestor
25266209|NCT02429505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25266210|NCT02429505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266211|NCT02429505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24520726|NCT05333809|Pembrolizumab|pembrolizumab|mesh-list
24857018|NCT02288741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648657|NCT01216124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648658|NCT01216124|Tubulin Modulators|tubulin modulators|mesh-ancestor
24648659|NCT01216124|Antimitotic Agents|antimitotic agents|mesh-ancestor
24648660|NCT01216124|Mitosis Modulators|mitosis modulators|mesh-ancestor
24648661|NCT01216124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648663|NCT01216267|Dexlansoprazole|dexlansoprazole|mesh-list
24648664|NCT01216267|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24648665|NCT01216267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24648698|NCT01216371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24648699|NCT01216371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648700|NCT01216371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648701|NCT01216449|Citalopram|citalopram|mesh-list
24857029|NCT02288923|Morphine|morphine|mesh-list
24857030|NCT02288923|Antiemetics|antiemetics|mesh-list
24857031|NCT02288923|Anesthetics|anesthetics|mesh-list
24857032|NCT02288923|Emetics|emetics|mesh-list
24857033|NCT02288923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24857034|NCT02288923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857035|NCT02288923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24857036|NCT02288923|Narcotics|narcotics|mesh-ancestor
25689035|NCT01954121|Anticonvulsants|anticonvulsants|mesh-ancestor
25689036|NCT01954121|Nootropic Agents|nootropic agents|mesh-ancestor
25689037|NCT01954121|Antimanic Agents|antimanic agents|mesh-ancestor
25689038|NCT01954121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25689039|NCT01954121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25689040|NCT01954121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689041|NCT01954121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25052982|NCT00117650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052983|NCT00117650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24857038|NCT02288923|Sensory System Agents|sensory system agents|mesh-ancestor
24857039|NCT02288923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857040|NCT02288923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24857041|NCT02288923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24459544|NCT00344994|Pramipexole|pramipexole|mesh-list
24648702|NCT01216449|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24648703|NCT01216449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24649424|NCT01219764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24648735|NCT01216644|Fluorouracil|fluorouracil|mesh-list
24648736|NCT01216644|Oxaliplatin|oxaliplatin|mesh-list
24648737|NCT01216644|Epirubicin|epirubicin|mesh-list
24648738|NCT01216644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648739|NCT01216644|Tubulin Modulators|tubulin modulators|mesh-ancestor
24648740|NCT01216644|Antimitotic Agents|antimitotic agents|mesh-ancestor
25266212|NCT02429505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25266213|NCT02429388|Sodium Channel Blockers|sodium channel blockers|mesh-list
25266214|NCT02429388|Spironolactone|spironolactone|mesh-list
25266215|NCT02429388|Diuretics|diuretics|mesh-list
25266216|NCT02429388|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
25266219|NCT02429388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25266220|NCT02429388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857054|NCT02288962|Dopamine Agents|dopamine agents|mesh-ancestor
24857055|NCT02288962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24857056|NCT02288962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857057|NCT02288962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857059|NCT02289027|Immunologic Factors|immunologic factors|mesh-ancestor
24857060|NCT02289027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857061|NCT02289144|Ceritinib|ceritinib|mesh-list
24857062|NCT02289144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24857063|NCT02289144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24857064|NCT02289144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857065|NCT02289144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857066|NCT02289248|Ketamine|ketamine|mesh-list
24648784|NCT01216839|Everolimus|everolimus|mesh-list
24648785|NCT01216839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648786|NCT01216839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24648787|NCT01216839|Immunologic Factors|immunologic factors|mesh-ancestor
24648788|NCT01216839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648789|NCT01216852|Losartan|losartan|mesh-list
24648790|NCT01216852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24648791|NCT01216852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24857072|NCT02289248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24857073|NCT02289248|Anesthetics, General|anesthetics, general|mesh-ancestor
24857074|NCT02289248|Anesthetics|anesthetics|mesh-ancestor
25266221|NCT02429388|Natriuretic Agents|natriuretic agents|mesh-ancestor
25266222|NCT02429388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25266223|NCT02429388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266224|NCT02429232|Pioglitazone|pioglitazone|mesh-list
25266225|NCT02429232|Linagliptin|linagliptin|mesh-list
25266226|NCT02429232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25266227|NCT02429232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266228|NCT02429232|Incretins|incretins|mesh-ancestor
25266229|NCT02429232|Hormones|hormones|mesh-ancestor
24857075|NCT02289248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24857076|NCT02289248|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24857077|NCT02289248|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24857078|NCT02289248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24857079|NCT02289248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857080|NCT02289261|Dexmedetomidine|dexmedetomidine|mesh-list
24857081|NCT02289261|Morphine|morphine|mesh-list
24857082|NCT02289261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24857083|NCT02289261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24857084|NCT02289261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689042|NCT01954121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25689043|NCT01954121|Analgesics|analgesics|mesh-ancestor
24857085|NCT02289261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24917494|NCT04229264|Antithrombins|antithrombins|mesh-ancestor
24857094|NCT02289261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857096|NCT02289261|Narcotics|narcotics|mesh-ancestor
24857097|NCT02289274|Aceclofenac|aceclofenac|mesh-list
24857098|NCT02289274|Eperisone|eperisone|mesh-list
24857099|NCT02289274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24648836|NCT01217086|Dermatologic Agents|dermatologic agents|mesh-ancestor
24648837|NCT01217086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24648838|NCT01217086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24648839|NCT01217099|Azithromycin|azithromycin|mesh-list
24648840|NCT01217099|Methylprednisolone|methylprednisolone|mesh-list
24648841|NCT01217099|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24648842|NCT01217099|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24648843|NCT01217099|Prednisolone|prednisolone|mesh-list
24648844|NCT01217099|Prednisolone acetate|prednisolone acetate|mesh-list
24648845|NCT01217099|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24917597|NCT04227886|Capecitabine|capecitabine|mesh-list
24648922|NCT01217398|Growth Substances|growth substances|mesh-ancestor
24648923|NCT01217398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648924|NCT01217398|Growth Inhibitors|growth inhibitors|mesh-ancestor
24648925|NCT01217398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24648999|NCT01218022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649001|NCT01218035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24649002|NCT01218035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649003|NCT01218217|Rifampin|rifampin|mesh-list
24857111|NCT02289274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24857112|NCT02289274|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24857113|NCT02289274|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24857114|NCT02289274|Parasympatholytics|parasympatholytics|mesh-ancestor
24857115|NCT02289274|Autonomic Agents|autonomic agents|mesh-ancestor
24857116|NCT02289274|Vasodilator Agents|vasodilator agents|mesh-ancestor
24678717|NCT01363609|Hormones|hormones|mesh-ancestor
24857117|NCT02289378|Docetaxel|docetaxel|mesh-list
24857118|NCT02289378|Oxaliplatin|oxaliplatin|mesh-list
24857119|NCT02289378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24857120|NCT02289378|Tubulin Modulators|tubulin modulators|mesh-ancestor
24695872|NCT01426087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24695873|NCT01426087|Hormones|hormones|mesh-ancestor
24695874|NCT01426087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24695875|NCT01426087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857122|NCT02289378|Mitosis Modulators|mitosis modulators|mesh-ancestor
24857123|NCT02289378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857124|NCT02289391|Anesthetics|anesthetics|mesh-list
25266230|NCT02429232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25266231|NCT02429232|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25266232|NCT02429232|Protease Inhibitors|protease inhibitors|mesh-ancestor
25266233|NCT02429232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857127|NCT02289430|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24459672|NCT00345761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24459673|NCT00345761|Growth Substances|growth substances|mesh-ancestor
24459674|NCT00345761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459675|NCT00345761|Growth Inhibitors|growth inhibitors|mesh-ancestor
24857155|NCT02289495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695901|NCT01426256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24857156|NCT02289495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24857157|NCT02289495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24857158|NCT02289495|Antiviral Agents|antiviral agents|mesh-ancestor
24857159|NCT02289495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24857160|NCT02289495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24857161|NCT02289495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24857162|NCT02289547|Capecitabine|capecitabine|mesh-list
24857163|NCT02289547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24857164|NCT02289547|Antimetabolites|antimetabolites|mesh-ancestor
24857165|NCT02289547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857166|NCT02289547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24857167|NCT02289586|Fentanyl|fentanyl|mesh-list
24857168|NCT02289586|Midazolam|midazolam|mesh-list
24857169|NCT02289586|Remifentanil|remifentanil|mesh-list
24857170|NCT02289586|Dezocine|dezocine|mesh-list
24857171|NCT02289586|Propofol|propofol|mesh-list
24857172|NCT02289586|Rocuronium|rocuronium|mesh-list
24857173|NCT02289586|Anesthetics|anesthetics|mesh-ancestor
24857174|NCT02289586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25689044|NCT01954121|Sensory System Agents|sensory system agents|mesh-ancestor
25689045|NCT01954121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25053107|NCT00106340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25053108|NCT00106340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25053109|NCT00106340|Immunologic Factors|immunologic factors|mesh-ancestor
25053110|NCT00106340|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25053111|NCT00106340|Protease Inhibitors|protease inhibitors|mesh-ancestor
25053112|NCT00106340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053113|NCT00106340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053122|NCT00102466|Protease Inhibitors|protease inhibitors|mesh-ancestor
25053123|NCT00102466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053125|NCT00101595|Dasatinib|dasatinib|mesh-list
24457975|NCT00335933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266234|NCT02429232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266235|NCT02429323|Sevoflurane|sevoflurane|mesh-list
25266236|NCT02429323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25266237|NCT02429323|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25266238|NCT02429323|Anesthetics, General|anesthetics, general|mesh-ancestor
25266239|NCT02429323|Anesthetics|anesthetics|mesh-ancestor
25266240|NCT02429323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25266241|NCT02429323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649034|NCT01218386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649035|NCT01218386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24649036|NCT01218386|Contraceptive Agents|contraceptive agents|mesh-ancestor
24649037|NCT01218386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24649038|NCT01218386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24649039|NCT01218425|Levodopa|levodopa|mesh-list
24649040|NCT01218425|Carbidopa|carbidopa|mesh-list
24649041|NCT01218425|Domperidone|domperidone|mesh-list
24649042|NCT01218425|Methylphenidate|methylphenidate|mesh-list
24649043|NCT01218425|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24649044|NCT01218425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649046|NCT01218425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24649047|NCT01218425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24649048|NCT01218425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649049|NCT01218425|Dopamine Agents|dopamine agents|mesh-ancestor
24649050|NCT01218425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24649051|NCT01218425|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24649052|NCT01218425|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24649053|NCT01218425|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24649055|NCT01218425|Antiemetics|antiemetics|mesh-ancestor
24649056|NCT01218425|Autonomic Agents|autonomic agents|mesh-ancestor
24649057|NCT01218425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24649059|NCT01218425|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24649060|NCT01218451|Vaccines|vaccines|mesh-list
24649061|NCT01218451|Immunologic Factors|immunologic factors|mesh-ancestor
24649062|NCT01218451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649063|NCT01218529|Lapatinib|lapatinib|mesh-list
24649064|NCT01218529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649872|NCT01222312|Docetaxel|docetaxel|mesh-list
24649065|NCT01218529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24649066|NCT01218529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24649100|NCT01218620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24649101|NCT01218620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24649102|NCT01218620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24649103|NCT01218620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24649104|NCT01218620|Anesthetics, General|anesthetics, general|mesh-ancestor
24649105|NCT01218620|Anesthetics|anesthetics|mesh-ancestor
24649108|NCT01218620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24649109|NCT01218620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649138|NCT01218698|Losartan|losartan|mesh-list
24649139|NCT01218698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24649140|NCT01218698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24649141|NCT01218698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25689046|NCT01954121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25689047|NCT01954121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25689048|NCT01954121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689049|NCT01954121|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25689050|NCT01954121|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25689051|NCT01954251|Vaccines|vaccines|mesh-list
25689052|NCT01954251|Immunologic Factors|immunologic factors|mesh-ancestor
25689053|NCT01954251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689054|NCT01954927|Gabapentin|gabapentin|mesh-list
25689055|NCT01954927|Analgesics|analgesics|mesh-ancestor
25689057|NCT01954927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25689058|NCT01954927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649142|NCT01218698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24649143|NCT01218698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649145|NCT01218711|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24649146|NCT01218711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24649220|NCT01219023|Vasodilator Agents|vasodilator agents|mesh-ancestor
24649221|NCT01219023|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24649222|NCT01219023|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24649223|NCT01219023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24649224|NCT01219023|Urological Agents|urological agents|mesh-ancestor
24649226|NCT01219036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24649227|NCT01219036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24649229|NCT01219036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24649267|NCT01219101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649359|NCT01219582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649412|NCT01219751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649413|NCT01219751|Growth Inhibitors|growth inhibitors|mesh-ancestor
24649414|NCT01219751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24649415|NCT01219751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24649416|NCT01219751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649418|NCT01219764|Metronidazole|metronidazole|mesh-list
24649419|NCT01219764|Clarithromycin|clarithromycin|mesh-list
24649420|NCT01219764|Rabeprazole|rabeprazole|mesh-list
24649421|NCT01219764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24649422|NCT01219764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24649425|NCT01219764|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24649426|NCT01219764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24649427|NCT01219764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857212|NCT02289768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649428|NCT01219764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25266246|NCT02429440|Immunologic Factors|immunologic factors|mesh-ancestor
25266247|NCT02429440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266248|NCT02429440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266249|NCT02429453|Thrombin|thrombin|mesh-list
25266250|NCT02429453|Hemostatics|hemostatics|mesh-ancestor
25266251|NCT02429453|Coagulants|coagulants|mesh-ancestor
25266252|NCT02429518|Miltefosine|miltefosine|mesh-list
25266253|NCT02429518|Antifungal Agents|antifungal agents|mesh-ancestor
25266254|NCT02429518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25266255|NCT02429518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649429|NCT01219764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24649430|NCT01219764|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24649431|NCT01219764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24649437|NCT01219907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24649438|NCT01219907|Immunologic Factors|immunologic factors|mesh-ancestor
24649439|NCT01219907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649440|NCT01219907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24649503|NCT01220219|Sensory System Agents|sensory system agents|mesh-ancestor
24649504|NCT01220219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24649505|NCT01220219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649506|NCT01220219|Anticonvulsants|anticonvulsants|mesh-ancestor
24649507|NCT01220219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24649508|NCT01220219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24649509|NCT01220219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649510|NCT01220219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24649511|NCT01220219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25689059|NCT01954927|Anticonvulsants|anticonvulsants|mesh-ancestor
25689060|NCT01954927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25689061|NCT01954927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25689062|NCT01954927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25689063|NCT01954927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24649512|NCT01220219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24649513|NCT01220219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24649514|NCT01220219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24649570|NCT01220375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649571|NCT01220375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24649572|NCT01220375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24649573|NCT01220375|Antiviral Agents|antiviral agents|mesh-ancestor
24917939|NCT04224649|Lidocaine|lidocaine|mesh-list
24649582|NCT01220440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649584|NCT01220440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24649585|NCT01220518|Infliximab|infliximab|mesh-list
24649586|NCT01220518|Dermatologic Agents|dermatologic agents|mesh-ancestor
24649587|NCT01220518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24649588|NCT01220518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24649589|NCT01220570|Sirolimus|sirolimus|mesh-list
24649590|NCT01220570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24649591|NCT01220570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24649592|NCT01220570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24649593|NCT01220570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24649594|NCT01220570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649595|NCT01220570|Antifungal Agents|antifungal agents|mesh-ancestor
24649596|NCT01220570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24649597|NCT01220570|Immunologic Factors|immunologic factors|mesh-ancestor
24649598|NCT01220570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649599|NCT01220596|Interferons|interferons|mesh-list
24649600|NCT01220596|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24649601|NCT01220596|Interferon-alpha|interferon-alpha|mesh-list
24649602|NCT01220596|Entecavir|entecavir|mesh-list
24649603|NCT01220596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649604|NCT01220596|Antiviral Agents|antiviral agents|mesh-ancestor
24649605|NCT01220596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24649606|NCT01220596|Immunologic Factors|immunologic factors|mesh-ancestor
24612644|NCT01014650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612645|NCT01014793|Cabergoline|cabergoline|mesh-list
24612646|NCT01014793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24612647|NCT01014793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24643104|NCT01183663|Vitamins|vitamins|mesh-ancestor
24612648|NCT01014793|Dopamine Agonists|dopamine agonists|mesh-ancestor
24612649|NCT01014793|Dopamine Agents|dopamine agents|mesh-ancestor
24612650|NCT01014793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24612651|NCT01014793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612652|NCT01014793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649607|NCT01220596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649684|NCT01221337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649685|NCT01221376|Imatinib Mesylate|imatinib mesylate|mesh-list
24649686|NCT01221376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649687|NCT01221376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24649689|NCT01221376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649690|NCT01221402|Niacin|niacin|mesh-list
24649691|NCT01221402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24649692|NCT01221402|Antimetabolites|antimetabolites|mesh-ancestor
24457983|NCT00335998|Cisplatin|cisplatin|mesh-list
25266256|NCT02429518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25266257|NCT02429518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25266258|NCT02428751|Prednisone|prednisone|mesh-list
24649693|NCT01221402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649694|NCT01221402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24649695|NCT01221402|Vasodilator Agents|vasodilator agents|mesh-ancestor
24649726|NCT01221740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24649727|NCT01221740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649728|NCT01221740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24649730|NCT01221740|Sensory System Agents|sensory system agents|mesh-ancestor
24649731|NCT01221740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24649732|NCT01221740|Antidepressive Agents|antidepressive agents|mesh-ancestor
24649733|NCT01221740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24649734|NCT01221792|Carvedilol|carvedilol|mesh-list
24649735|NCT01221792|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24649736|NCT01221792|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24649737|NCT01221792|Adrenergic Agents|adrenergic agents|mesh-ancestor
24649738|NCT01221792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24649739|NCT01221792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649740|NCT01221792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649766|NCT01221831|Hormone Antagonists|hormone antagonists|mesh-ancestor
24649767|NCT01221831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24649768|NCT01221831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649770|NCT01221883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24649771|NCT01221883|Anticonvulsants|anticonvulsants|mesh-ancestor
24649785|NCT01221883|Anesthetics, General|anesthetics, general|mesh-ancestor
24649787|NCT01221883|GABA Modulators|gaba modulators|mesh-ancestor
24649822|NCT01222026|Micronutrients|micronutrients|mesh-ancestor
24857215|NCT02289768|Keratolytic Agents|keratolytic agents|mesh-ancestor
24857216|NCT02289768|Dermatologic Agents|dermatologic agents|mesh-ancestor
24649823|NCT01222026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649824|NCT01222026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24649825|NCT01222052|Cyclophosphamide|cyclophosphamide|mesh-list
24649846|NCT01222052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24649847|NCT01222169|Propofol|propofol|mesh-list
24649848|NCT01222169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24649849|NCT01222169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24649850|NCT01222169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649851|NCT01222169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24649852|NCT01222169|Anesthetics, General|anesthetics, general|mesh-ancestor
24649853|NCT01222169|Anesthetics|anesthetics|mesh-ancestor
24649854|NCT01222182|Atorvastatin|atorvastatin|mesh-list
24649855|NCT01222182|Simvastatin|simvastatin|mesh-list
24649856|NCT01222182|Pravastatin|pravastatin|mesh-list
24696133|NCT01427478|Afatinib|afatinib|mesh-list
24649873|NCT01222312|Oxaliplatin|oxaliplatin|mesh-list
24649874|NCT01222312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649875|NCT01222312|Tubulin Modulators|tubulin modulators|mesh-ancestor
24649876|NCT01222312|Antimitotic Agents|antimitotic agents|mesh-ancestor
24649877|NCT01222312|Mitosis Modulators|mitosis modulators|mesh-ancestor
24649905|NCT01222611|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24649906|NCT01222611|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24649907|NCT01222611|Protease Inhibitors|protease inhibitors|mesh-ancestor
24649908|NCT01222611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24649909|NCT01222611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649910|NCT01222611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25266259|NCT02428751|Rituximab|rituximab|mesh-list
24649915|NCT01222650|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24649916|NCT01222650|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24696159|NCT01427686|Protective Agents|protective agents|mesh-ancestor
24649963|NCT01222923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24650026|NCT01223339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24650027|NCT01223339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696196|NCT01427985|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24696197|NCT01427985|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24696198|NCT01427985|Cholinergic Agents|cholinergic agents|mesh-ancestor
24696199|NCT01427985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24696200|NCT01427985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696204|NCT01428037|Misoprostol|misoprostol|mesh-list
24857217|NCT02289768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24857218|NCT02289768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24650028|NCT01223443|Paclitaxel|paclitaxel|mesh-list
24650029|NCT01223443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24650030|NCT01223443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650031|NCT01223443|Tubulin Modulators|tubulin modulators|mesh-ancestor
24650032|NCT01223443|Antimitotic Agents|antimitotic agents|mesh-ancestor
24650033|NCT01223443|Mitosis Modulators|mitosis modulators|mesh-ancestor
24650034|NCT01223443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650035|NCT01223534|Isoniazid|isoniazid|mesh-list
24650036|NCT01223534|Antitubercular Agents|antitubercular agents|mesh-ancestor
24650037|NCT01223534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25689064|NCT01954927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25689065|NCT01954927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25689066|NCT01954927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24814087|NCT02062255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24814089|NCT02062255|Antipyretics|antipyretics|mesh-ancestor
24650038|NCT01223534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24650039|NCT01223534|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24650040|NCT01223534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24918218|NCT04221971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24650077|NCT01223742|Vitamin B Complex|vitamin b complex|mesh-ancestor
24650078|NCT01223742|Vitamins|vitamins|mesh-ancestor
24650079|NCT01223742|Micronutrients|micronutrients|mesh-ancestor
24650085|NCT01223755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24650086|NCT01223755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650088|NCT01223755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24650089|NCT01223755|Immunologic Factors|immunologic factors|mesh-ancestor
24650090|NCT01223755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650091|NCT01223768|Acetylcarnitine|acetylcarnitine|mesh-list
24650092|NCT01223768|Vitamin B Complex|vitamin b complex|mesh-ancestor
24650093|NCT01223768|Vitamins|vitamins|mesh-ancestor
24650094|NCT01223768|Micronutrients|micronutrients|mesh-ancestor
24650129|NCT01224093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25266260|NCT02428751|Doxorubicin|doxorubicin|mesh-list
25266261|NCT02428751|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25266262|NCT02428751|Vincristine|vincristine|mesh-list
25266263|NCT02428751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25266264|NCT02428751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650130|NCT01224197|Simeprevir|simeprevir|mesh-list
24650131|NCT01224197|Antiviral Agents|antiviral agents|mesh-ancestor
24650201|NCT01224470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650202|NCT01224509|Mifepristone|mifepristone|mesh-list
24650203|NCT01224509|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24650204|NCT01224509|Abortifacient Agents|abortifacient agents|mesh-ancestor
24650252|NCT01224769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650253|NCT01224769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24650254|NCT01224769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24650255|NCT01224769|Alkylating Agents|alkylating agents|mesh-ancestor
24696256|NCT01428388|Growth Inhibitors|growth inhibitors|mesh-ancestor
24696257|NCT01428414|Paclitaxel|paclitaxel|mesh-list
24696258|NCT01428414|Carboplatin|carboplatin|mesh-list
24696259|NCT01428414|Trastuzumab|trastuzumab|mesh-list
24696260|NCT01428414|Epirubicin|epirubicin|mesh-list
24696261|NCT01428414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24696262|NCT01428414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24696263|NCT01428414|Tubulin Modulators|tubulin modulators|mesh-ancestor
24918273|NCT04221256|Antidepressive Agents|antidepressive agents|mesh-ancestor
24650294|NCT01224964|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24650295|NCT01224964|Hormone Antagonists|hormone antagonists|mesh-ancestor
24650296|NCT01224964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24650297|NCT01224964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650298|NCT01224964|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24650299|NCT01224964|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24669870|NCT03476798|Growth Substances|growth substances|mesh-ancestor
24650300|NCT01224964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650301|NCT01224977|Azithromycin|azithromycin|mesh-list
24650302|NCT01224977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24650303|NCT01224977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24650304|NCT01225081|Pioglitazone|pioglitazone|mesh-list
24650305|NCT01225081|Ipragliflozin|ipragliflozin|mesh-list
24696277|NCT01428427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24696288|NCT01428492|Bortezomib|bortezomib|mesh-list
24650306|NCT01225081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25266265|NCT02428751|Immunologic Factors|immunologic factors|mesh-ancestor
25266266|NCT02428751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689067|NCT01954927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689068|NCT01954927|Antimanic Agents|antimanic agents|mesh-ancestor
25266267|NCT02428751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25266268|NCT02428751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25053537|NCT00005918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053539|NCT00005918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24865296|NCT03962894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865320|NCT03832010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865321|NCT03733132|Metformin|metformin|mesh-list
24865322|NCT03733132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24865323|NCT03733132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053563|NCT00005608|Antidotes|antidotes|mesh-ancestor
25266269|NCT02428751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25266270|NCT02428751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25266271|NCT02428751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24650307|NCT01225081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650308|NCT01225081|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24651275|NCT01230983|Doxorubicin|doxorubicin|mesh-list
24442398|NCT00290849|Anticoagulants|anticoagulants|mesh-ancestor
24650309|NCT01225081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650337|NCT01225237|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24650338|NCT01225237|Serotonin Agents|serotonin agents|mesh-ancestor
24650339|NCT01225237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24650340|NCT01225237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650341|NCT01225302|Paclitaxel|paclitaxel|mesh-list
24650342|NCT01225302|Carboplatin|carboplatin|mesh-list
24650343|NCT01225302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24650344|NCT01225302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650345|NCT01225302|Tubulin Modulators|tubulin modulators|mesh-ancestor
24650346|NCT01225302|Antimitotic Agents|antimitotic agents|mesh-ancestor
24650347|NCT01225302|Mitosis Modulators|mitosis modulators|mesh-ancestor
24918324|NCT04220892|Pembrolizumab|pembrolizumab|mesh-list
24650429|NCT01225744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650430|NCT01225744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24650431|NCT01225744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24650432|NCT01225744|Antimetabolites|antimetabolites|mesh-ancestor
24650433|NCT01225874|Cytarabine|cytarabine|mesh-list
24650507|NCT01226056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24650508|NCT01226056|Immunologic Factors|immunologic factors|mesh-ancestor
24650569|NCT01226602|Purinergic Agents|purinergic agents|mesh-ancestor
24650570|NCT01226602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24650571|NCT01226602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650572|NCT01226602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650573|NCT01226667|Pregabalin|pregabalin|mesh-list
24650574|NCT01226667|Analgesics|analgesics|mesh-ancestor
24650575|NCT01226667|Sensory System Agents|sensory system agents|mesh-ancestor
24650576|NCT01226667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24650610|NCT01226849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24650611|NCT01226849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24650612|NCT01226849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24650613|NCT01226849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650614|NCT01226849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24650615|NCT01226849|Alkylating Agents|alkylating agents|mesh-ancestor
24650616|NCT01226901|Niraparib|niraparib|mesh-list
24650649|NCT01227174|Anesthetics, General|anesthetics, general|mesh-ancestor
24650650|NCT01227174|Anesthetics|anesthetics|mesh-ancestor
24650652|NCT01227200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25689070|NCT01955382|Amodiaquine|amodiaquine|mesh-list
25689071|NCT01955382|Charcoal|charcoal|mesh-list
25689072|NCT01955382|Antimalarials|antimalarials|mesh-ancestor
25689073|NCT01955382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25689074|NCT01955382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25689075|NCT01955382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25689076|NCT01955382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25689077|NCT01955382|Antiviral Agents|antiviral agents|mesh-ancestor
25689078|NCT01955382|Schistosomicides|schistosomicides|mesh-ancestor
25689079|NCT01955382|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25689080|NCT01955382|Anthelmintics|anthelmintics|mesh-ancestor
24650653|NCT01227200|Narcotics|narcotics|mesh-ancestor
24650654|NCT01227200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24650936|NCT01228552|Ketoprofen|ketoprofen|mesh-list
24650949|NCT01228565|OTD70DERM|otd70derm|mesh-list
24650950|NCT01228565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24650951|NCT01228565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650952|NCT01228565|Protective Agents|protective agents|mesh-ancestor
24650953|NCT01228565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651126|NCT01229605|Antimitotic Agents|antimitotic agents|mesh-ancestor
24651127|NCT01229605|Mitosis Modulators|mitosis modulators|mesh-ancestor
24651128|NCT01229761|Trimethoprim|trimethoprim|mesh-list
24651129|NCT01229761|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24651130|NCT01229761|Sulfamethoxazole|sulfamethoxazole|mesh-list
24651162|NCT01229813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651163|NCT01229813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24651164|NCT01229813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24651165|NCT01229813|Growth Substances|growth substances|mesh-ancestor
24651166|NCT01229813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651167|NCT01229813|Growth Inhibitors|growth inhibitors|mesh-ancestor
25275703|NCT02369965|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24651267|NCT01230775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24651271|NCT01230983|Hydrocortisone|hydrocortisone|mesh-list
24696422|NCT01429415|Anesthetics|anesthetics|mesh-ancestor
24651272|NCT01230983|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24651273|NCT01230983|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24651274|NCT01230983|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24651276|NCT01230983|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24651277|NCT01230983|Dexrazoxane|dexrazoxane|mesh-list
24651278|NCT01230983|Methotrexate|methotrexate|mesh-list
24651279|NCT01230983|Vincristine|vincristine|mesh-list
24651280|NCT01230983|Asparaginase|asparaginase|mesh-list
24651281|NCT01230983|Mercaptopurine|mercaptopurine|mesh-list
24651282|NCT01230983|Razoxane|razoxane|mesh-list
24651283|NCT01230983|Levoleucovorin|levoleucovorin|mesh-list
24651284|NCT01230983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24651285|NCT01230983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651286|NCT01230983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24651287|NCT01230983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24651288|NCT01230983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651289|NCT01230983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651290|NCT01230983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651291|NCT01230983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24651292|NCT01230983|Glucocorticoids|glucocorticoids|mesh-ancestor
24651293|NCT01230983|Hormones|hormones|mesh-ancestor
24651934|NCT01234740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651296|NCT01230983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24651297|NCT01230983|Abortifacient Agents|abortifacient agents|mesh-ancestor
24651298|NCT01230983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24651299|NCT01230983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24651300|NCT01230983|Antimetabolites|antimetabolites|mesh-ancestor
24651330|NCT01231113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24651331|NCT01231113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24651341|NCT01231126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651343|NCT01231126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24651344|NCT01231126|Oxytocics|oxytocics|mesh-ancestor
24651345|NCT01231139|Acetaminophen|acetaminophen|mesh-list
24651346|NCT01231139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24651347|NCT01231139|Analgesics|analgesics|mesh-ancestor
24651348|NCT01231139|Sensory System Agents|sensory system agents|mesh-ancestor
24520908|NCT05243940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24651507|NCT01231854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651508|NCT01231854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24651509|NCT01231854|Immunologic Factors|immunologic factors|mesh-ancestor
24651510|NCT01231854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651511|NCT01231854|Antifungal Agents|antifungal agents|mesh-ancestor
25689081|NCT01955382|Antidotes|antidotes|mesh-ancestor
24651512|NCT01231854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24651513|NCT01231854|Dermatologic Agents|dermatologic agents|mesh-ancestor
24651514|NCT01231854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24651515|NCT01231854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25266272|NCT02428751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266274|NCT02428751|Glucocorticoids|glucocorticoids|mesh-ancestor
25266275|NCT02428751|Hormones|hormones|mesh-ancestor
24939355|NCT04010929|Pemetrexed|pemetrexed|mesh-list
24651516|NCT01231854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651517|NCT01231880|Piperaquine|piperaquine|mesh-list
24651518|NCT01231880|Artenimol|artenimol|mesh-list
24651519|NCT01231880|Antimalarials|antimalarials|mesh-ancestor
24651520|NCT01231880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24651521|NCT01231880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24651527|NCT01231997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651528|NCT01232010|Mirodenafil|mirodenafil|mesh-list
24651529|NCT01232010|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24651530|NCT01232010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24651531|NCT01232010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651532|NCT01232010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651533|NCT01232023|Indobufen|indobufen|mesh-list
24651676|NCT01233206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24651535|NCT01232023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24651536|NCT01232023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651537|NCT01232023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696526|NCT01429831|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24696527|NCT01429831|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24696528|NCT01429844|Cyclosporine|cyclosporine|mesh-list
24696529|NCT01429844|Tacrolimus|tacrolimus|mesh-list
24643331|NCT01185197|Hormones|hormones|mesh-ancestor
24696530|NCT01429844|Cyclosporins|cyclosporins|mesh-list
24608514|NCT00992355|Analgesics|analgesics|mesh-ancestor
24651538|NCT01232023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24651539|NCT01232023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24651540|NCT01232023|Analgesics|analgesics|mesh-ancestor
24651541|NCT01232023|Sensory System Agents|sensory system agents|mesh-ancestor
24651542|NCT01232023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24651543|NCT01232023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725608|NCT01598558|Rituximab|rituximab|mesh-list
24651544|NCT01232023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24651545|NCT01232023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24651546|NCT01232036|Metformin|metformin|mesh-list
24651547|NCT01232036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24651548|NCT01232036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651549|NCT01232075|Letrozole|letrozole|mesh-list
24651550|NCT01232075|Citric Acid|citric acid|mesh-list
24651551|NCT01232075|Sodium Citrate|sodium citrate|mesh-list
24651552|NCT01232075|Clomiphene|clomiphene|mesh-list
25689082|NCT01955382|Protective Agents|protective agents|mesh-ancestor
25689083|NCT01955382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689084|NCT01955434|Cyclophosphamide|cyclophosphamide|mesh-list
25689085|NCT01955434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25689086|NCT01955434|Immunologic Factors|immunologic factors|mesh-ancestor
25689087|NCT01955434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651553|NCT01232075|Enclomiphene|enclomiphene|mesh-list
24651554|NCT01232075|Zuclomiphene|zuclomiphene|mesh-list
24651555|NCT01232075|Anticoagulants|anticoagulants|mesh-ancestor
25689088|NCT01955434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25689089|NCT01955434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25689090|NCT01955434|Alkylating Agents|alkylating agents|mesh-ancestor
25053731|NCT00004231|Cyclophosphamide|cyclophosphamide|mesh-list
25053732|NCT00004231|Busulfan|busulfan|mesh-list
25053733|NCT00004231|Doxorubicin|doxorubicin|mesh-list
24651556|NCT01232075|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24651558|NCT01232075|Sequestering Agents|sequestering agents|mesh-ancestor
24651559|NCT01232075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651611|NCT01232400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651612|NCT01232413|Ipragliflozin|ipragliflozin|mesh-list
25266276|NCT02428751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25266277|NCT02428751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25266278|NCT02428751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25266279|NCT02428751|Tubulin Modulators|tubulin modulators|mesh-ancestor
25266280|NCT02428751|Antimitotic Agents|antimitotic agents|mesh-ancestor
24651613|NCT01232413|Moxifloxacin|moxifloxacin|mesh-list
24651614|NCT01232413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24651615|NCT01232413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24651616|NCT01232413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24651617|NCT01232413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24651618|NCT01232413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651619|NCT01232413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651620|NCT01232413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651621|NCT01232413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651622|NCT01232413|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24651629|NCT01232647|Vitamins|vitamins|mesh-list
24651630|NCT01232647|Vitamin K|vitamin k|mesh-list
24651631|NCT01232647|Vitamin K 2|vitamin k 2|mesh-list
24651644|NCT01232660|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24651645|NCT01232660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24651646|NCT01232660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651647|NCT01232660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651648|NCT01232660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24651674|NCT01233167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651677|NCT01233206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651678|NCT01233219|Morphine|morphine|mesh-list
24651679|NCT01233219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24651680|NCT01233219|Narcotics|narcotics|mesh-ancestor
24651681|NCT01233219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24651682|NCT01233219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651683|NCT01233219|Analgesics|analgesics|mesh-ancestor
24651684|NCT01233219|Sensory System Agents|sensory system agents|mesh-ancestor
24651685|NCT01233219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24651686|NCT01233245|Interferons|interferons|mesh-list
24651687|NCT01233245|Interferon-beta|interferon-beta|mesh-list
24651695|NCT01233362|Vaccines|vaccines|mesh-list
24651736|NCT01233583|Analgesics|analgesics|mesh-ancestor
24651825|NCT01234116|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24651827|NCT01234116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24651828|NCT01234116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24651829|NCT01234116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24651830|NCT01234116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24696581|NCT01430065|Immunologic Factors|immunologic factors|mesh-ancestor
24696582|NCT01430065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696583|NCT01430065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24696584|NCT01430065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24696585|NCT01430065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266281|NCT02428751|Mitosis Modulators|mitosis modulators|mesh-ancestor
25266282|NCT02428764|Gemcitabine|gemcitabine|mesh-list
25266283|NCT02428764|Carboplatin|carboplatin|mesh-list
25266284|NCT02428764|Nimotuzumab|nimotuzumab|mesh-list
25266285|NCT02428764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25689091|NCT01955434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689092|NCT01955434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25689093|NCT01955434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25689094|NCT01955629|Capecitabine|capecitabine|mesh-list
25689095|NCT01955629|Oxaliplatin|oxaliplatin|mesh-list
25689096|NCT01955629|Aflibercept|aflibercept|mesh-list
25689097|NCT01955629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25689098|NCT01955629|Antimetabolites|antimetabolites|mesh-ancestor
25689099|NCT01955629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689100|NCT01955629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25689101|NCT01955629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25689102|NCT01955629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25266286|NCT02428764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25266287|NCT02428764|Antimetabolites|antimetabolites|mesh-ancestor
25275704|NCT02369965|Protease Inhibitors|protease inhibitors|mesh-ancestor
24651835|NCT01234129|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24651836|NCT01234129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24670115|NCT03251326|Nabilone|nabilone|mesh-list
24651839|NCT01234142|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24651840|NCT01234142|Cholinergic Agents|cholinergic agents|mesh-ancestor
24651841|NCT01234142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24651842|NCT01234142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651843|NCT01234142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651844|NCT01234194|Remifentanil|remifentanil|mesh-list
24651845|NCT01234194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24812993|NCT02055703|Antifungal Agents|antifungal agents|mesh-ancestor
24812994|NCT02055703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24651846|NCT01234194|Narcotics|narcotics|mesh-ancestor
24651847|NCT01234194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24651848|NCT01234194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651849|NCT01234194|Analgesics|analgesics|mesh-ancestor
24651850|NCT01234194|Sensory System Agents|sensory system agents|mesh-ancestor
24651851|NCT01234194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24651852|NCT01234272|Morphine|morphine|mesh-list
24651853|NCT01234272|Ropivacaine|ropivacaine|mesh-list
24651854|NCT01234272|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24651855|NCT01234272|Narcotics|narcotics|mesh-ancestor
24651856|NCT01234272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24651857|NCT01234272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651858|NCT01234272|Analgesics|analgesics|mesh-ancestor
24651859|NCT01234272|Sensory System Agents|sensory system agents|mesh-ancestor
24651860|NCT01234272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24651861|NCT01234272|Anesthetics, Local|anesthetics, local|mesh-ancestor
24651862|NCT01234272|Anesthetics|anesthetics|mesh-ancestor
24651863|NCT01234285|Heparin|heparin|mesh-list
24651864|NCT01234285|Calcium heparin|calcium heparin|mesh-list
24696594|NCT01430078|Vitamins|vitamins|mesh-ancestor
24651906|NCT01234454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24651907|NCT01234454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24651908|NCT01234454|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24651927|NCT01234597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651928|NCT01234623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24651929|NCT01234623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24651931|NCT01234701|Hematinics|hematinics|mesh-ancestor
24651932|NCT01234740|Bafetinib|bafetinib|mesh-list
24651933|NCT01234740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24651935|NCT01234740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651937|NCT01234792|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24651938|NCT01234792|Autonomic Agents|autonomic agents|mesh-ancestor
24651939|NCT01234792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24651940|NCT01234792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651941|NCT01234792|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24651942|NCT01234792|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24651943|NCT01234792|Cholinergic Agents|cholinergic agents|mesh-ancestor
24651944|NCT01234792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24651946|NCT01234818|Levonorgestrel|levonorgestrel|mesh-list
24651957|NCT01234857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651959|NCT01234857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24651960|NCT01234857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651961|NCT01234857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651962|NCT01234857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24651963|NCT01234857|Hormone Antagonists|hormone antagonists|mesh-ancestor
24812995|NCT02055703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25266288|NCT02428764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266289|NCT02428764|Antiviral Agents|antiviral agents|mesh-ancestor
25266290|NCT02428764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25266291|NCT02428764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24802248|NCT01989052|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
24651964|NCT01234857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24651965|NCT01234857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651967|NCT01234857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24651968|NCT01234857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24652020|NCT01235143|Desflurane|desflurane|mesh-list
24652021|NCT01235143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24652022|NCT01235143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24652023|NCT01235143|Anesthetics, General|anesthetics, general|mesh-ancestor
24652024|NCT01235143|Anesthetics|anesthetics|mesh-ancestor
24652025|NCT01235143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24652026|NCT01235143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652027|NCT01235221|4-Aminopyridine|4-aminopyridine|mesh-list
24652028|NCT01235221|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24652029|NCT01235221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24652030|NCT01235221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652031|NCT01235260|Becaplermin|becaplermin|mesh-list
24652032|NCT01235260|Anticoagulants|anticoagulants|mesh-ancestor
24652055|NCT01235455|Interferon-beta|interferon-beta|mesh-list
24652064|NCT01235637|Alfentanil|alfentanil|mesh-list
24652076|NCT01235819|Insulin|insulin|mesh-list
24652077|NCT01235819|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24652078|NCT01235819|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24652079|NCT01235819|Exenatide|exenatide|mesh-list
24652080|NCT01235819|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24918645|NCT04217447|Aspirin|aspirin|mesh-list
24652211|NCT01237067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652212|NCT01237067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652213|NCT01237119|Liraglutide|liraglutide|mesh-list
24652214|NCT01237119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24652215|NCT01237119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652216|NCT01237119|Incretins|incretins|mesh-ancestor
24652217|NCT01237119|Hormones|hormones|mesh-ancestor
24652218|NCT01237119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24652219|NCT01237249|Dexamethasone|dexamethasone|mesh-list
24652220|NCT01237249|Prednisone|prednisone|mesh-list
24652221|NCT01237249|Melphalan|melphalan|mesh-list
24652222|NCT01237249|Lenalidomide|lenalidomide|mesh-list
24652223|NCT01237249|Bortezomib|bortezomib|mesh-list
24652226|NCT01237249|Autonomic Agents|autonomic agents|mesh-ancestor
25266292|NCT02428764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25266293|NCT02428764|Immunologic Factors|immunologic factors|mesh-ancestor
25266294|NCT02428764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266295|NCT02428764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25266296|NCT02428933|Bromocriptine|bromocriptine|mesh-list
25266297|NCT02428933|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25266298|NCT02428933|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25266299|NCT02428933|Hormone Antagonists|hormone antagonists|mesh-ancestor
25266300|NCT02428933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25266301|NCT02428933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266302|NCT02428933|Dopamine Agonists|dopamine agonists|mesh-ancestor
25266303|NCT02428933|Dopamine Agents|dopamine agents|mesh-ancestor
25266304|NCT02428933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25266305|NCT02428933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266306|NCT02428777|Diclofenac|diclofenac|mesh-list
25689104|NCT01955629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689105|NCT01955629|Growth Inhibitors|growth inhibitors|mesh-ancestor
25689106|NCT01955707|Natalizumab|natalizumab|mesh-list
24545592|NCT00693966|Vaccines|vaccines|mesh-list
25266307|NCT02428777|Tramadol|tramadol|mesh-list
25275705|NCT02369965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652227|NCT01237249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812996|NCT02055703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24812997|NCT02055703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24812998|NCT02055703|Hormone Antagonists|hormone antagonists|mesh-ancestor
24812999|NCT02055703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24813000|NCT02055703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24652228|NCT01237249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652229|NCT01237249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24652230|NCT01237249|Glucocorticoids|glucocorticoids|mesh-ancestor
24652231|NCT01237249|Hormones|hormones|mesh-ancestor
24652232|NCT01237249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24652233|NCT01237249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24652268|NCT01237275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652269|NCT01237275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24652270|NCT01237275|Serotonin Agents|serotonin agents|mesh-ancestor
24652271|NCT01237275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652272|NCT01237275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24652300|NCT01237522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652301|NCT01237535|Progesterone|progesterone|mesh-list
24652302|NCT01237535|Estrogens|estrogens|mesh-list
24652303|NCT01237535|Progestins|progestins|mesh-ancestor
24652304|NCT01237535|Hormones|hormones|mesh-ancestor
24652357|NCT01237977|Cholinergic Agents|cholinergic agents|mesh-ancestor
24652385|NCT01238055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652386|NCT01238055|Growth Inhibitors|growth inhibitors|mesh-ancestor
24652387|NCT01238055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24652388|NCT01238055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652389|NCT01238094|Simvastatin|simvastatin|mesh-list
24652390|NCT01238094|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24652391|NCT01238094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24652392|NCT01238094|Antimetabolites|antimetabolites|mesh-ancestor
24652918|NCT01240928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24652393|NCT01238094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652394|NCT01238094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24652395|NCT01238094|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24652396|NCT01238094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652398|NCT01238133|Carboplatin|carboplatin|mesh-list
24652399|NCT01238133|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24652400|NCT01238133|R04929097|r04929097|mesh-list
24652401|NCT01238133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24652402|NCT01238133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652403|NCT01238133|Tubulin Modulators|tubulin modulators|mesh-ancestor
24652418|NCT01238146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652419|NCT01238146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652421|NCT01238185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24652422|NCT01238185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24652425|NCT01238185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24652447|NCT01238276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24652448|NCT01238276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24652449|NCT01238328|Thymoglobulin|thymoglobulin|mesh-list
24652450|NCT01238328|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24652451|NCT01238328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24652452|NCT01238328|Immunologic Factors|immunologic factors|mesh-ancestor
24652453|NCT01238328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652454|NCT01238367|Factor VIII|factor viii|mesh-list
24652455|NCT01238367|Coagulants|coagulants|mesh-ancestor
24652456|NCT01238393|Ranibizumab|ranibizumab|mesh-list
24652461|NCT01238393|Growth Inhibitors|growth inhibitors|mesh-ancestor
24652462|NCT01238393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652489|NCT01238692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652490|NCT01238692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24652491|NCT01238692|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24652492|NCT01238692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652493|NCT01238692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652495|NCT01238705|Felodipine|felodipine|mesh-list
24652496|NCT01238705|Irbesartan|irbesartan|mesh-list
24652500|NCT01238705|Autonomic Agents|autonomic agents|mesh-ancestor
24652501|NCT01238705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24652502|NCT01238705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652503|NCT01238705|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24652504|NCT01238705|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24652505|NCT01238705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24652506|NCT01238705|Adrenergic Agents|adrenergic agents|mesh-ancestor
24696858|NCT01431430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696859|NCT01431430|Vitamins|vitamins|mesh-ancestor
24696860|NCT01431430|Micronutrients|micronutrients|mesh-ancestor
24652507|NCT01238705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24652508|NCT01238705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652509|NCT01238705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24652579|NCT01238978|Protease Inhibitors|protease inhibitors|mesh-ancestor
24652580|NCT01238978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652581|NCT01238978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652582|NCT01239004|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
24652583|NCT01239004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24652637|NCT01239459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652639|NCT01239485|Irinotecan|irinotecan|mesh-list
24652640|NCT01239485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24652641|NCT01239485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24652642|NCT01239485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813004|NCT02055703|Leprostatic Agents|leprostatic agents|mesh-ancestor
24813005|NCT02055703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25266311|NCT02428777|Sensory System Agents|sensory system agents|mesh-ancestor
25266312|NCT02428777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25266313|NCT02428777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266314|NCT02428777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24660644|NCT01284907|Vitamin D|vitamin d|mesh-list
24813006|NCT02055703|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24652643|NCT01239485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652644|NCT01239485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24696879|NCT01431456|Anticoagulants|anticoagulants|mesh-ancestor
24696880|NCT01431456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24652647|NCT01239498|Racepinephrine|racepinephrine|mesh-list
24652648|NCT01239498|Anesthetics|anesthetics|mesh-list
24652649|NCT01239498|Epinephryl borate|epinephryl borate|mesh-list
24652650|NCT01239498|Anesthetics, Local|anesthetics, local|mesh-ancestor
24652651|NCT01239498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24652652|NCT01239498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652653|NCT01239498|Sensory System Agents|sensory system agents|mesh-ancestor
24652654|NCT01239498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24652655|NCT01239498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24652656|NCT01239498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24652657|NCT01239498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24652658|NCT01239498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24652659|NCT01239498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652660|NCT01239498|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24652661|NCT01239498|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24652662|NCT01239498|Adrenergic Agents|adrenergic agents|mesh-ancestor
24652663|NCT01239498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24652664|NCT01239498|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24652665|NCT01239498|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24652900|NCT01240850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24652902|NCT01240889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24652903|NCT01240889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24652904|NCT01240889|Autonomic Agents|autonomic agents|mesh-ancestor
24652905|NCT01240889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24652906|NCT01240889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652907|NCT01240889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24652908|NCT01240889|Respiratory System Agents|respiratory system agents|mesh-ancestor
24652909|NCT01240889|Dermatologic Agents|dermatologic agents|mesh-ancestor
24652910|NCT01240889|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24652912|NCT01240928|Goserelin|goserelin|mesh-list
24652913|NCT01240928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652914|NCT01240928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24652915|NCT01240928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24652916|NCT01240928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652917|NCT01240928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813035|NCT02056210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24813036|NCT02056210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24813037|NCT02056210|Antiviral Agents|antiviral agents|mesh-ancestor
24813038|NCT02056210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24409086|NCT00180895|Rituximab|rituximab|mesh-list
24652920|NCT01240928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24652921|NCT01240928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696945|NCT01431924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25266315|NCT02428777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25266316|NCT02428777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25266317|NCT02428777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652929|NCT01240941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652931|NCT01240941|Hormone Antagonists|hormone antagonists|mesh-ancestor
24652932|NCT01240941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24652933|NCT01240941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652934|NCT01240941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24653024|NCT01241422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653025|NCT01241487|Amlodipine|amlodipine|mesh-list
24653026|NCT01241487|Valsartan|valsartan|mesh-list
24653027|NCT01241487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24653028|NCT01241487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24653029|NCT01241487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24918976|NCT04214938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24653053|NCT01241734|Lenalidomide|lenalidomide|mesh-list
24653054|NCT01241734|Immunologic Factors|immunologic factors|mesh-ancestor
24653055|NCT01241734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653056|NCT01241734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24653057|NCT01241734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24653058|NCT01241734|Growth Substances|growth substances|mesh-ancestor
24653059|NCT01241734|Growth Inhibitors|growth inhibitors|mesh-ancestor
24653060|NCT01241734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653061|NCT01241773|Efavirenz|efavirenz|mesh-list
24653062|NCT01241773|Raltegravir Potassium|raltegravir potassium|mesh-list
24653063|NCT01241773|Simeprevir|simeprevir|mesh-list
24865785|NCT04940572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24865786|NCT04940572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865787|NCT04940572|Antimanic Agents|antimanic agents|mesh-ancestor
24653065|NCT01241773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24653066|NCT01241773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653067|NCT01241773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653068|NCT01241773|Antiviral Agents|antiviral agents|mesh-ancestor
24653069|NCT01241773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24653070|NCT01241773|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24653071|NCT01241773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24653072|NCT01241773|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24653073|NCT01241773|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24653074|NCT01241773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24653075|NCT01241773|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24653076|NCT01241773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25266318|NCT02428777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266319|NCT02428777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25266320|NCT02428777|Narcotics|narcotics|mesh-ancestor
25266321|NCT02428777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25266322|NCT02428959|Amyl Nitrite|amyl nitrite|mesh-list
24653077|NCT01241773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24653078|NCT01241773|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24653079|NCT01241773|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24653080|NCT01241773|Protease Inhibitors|protease inhibitors|mesh-ancestor
24653190|NCT01242306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24653191|NCT01242306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653192|NCT01242306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653195|NCT01242332|Sensory System Agents|sensory system agents|mesh-ancestor
24653196|NCT01242332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24653197|NCT01242332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653198|NCT01242332|Anticonvulsants|anticonvulsants|mesh-ancestor
24653199|NCT01242332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24653200|NCT01242332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24653201|NCT01242332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653202|NCT01242332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24653203|NCT01242332|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24653204|NCT01242332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24653233|NCT01242579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653234|NCT01242579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24653235|NCT01242579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24653236|NCT01242579|Antiviral Agents|antiviral agents|mesh-ancestor
24653237|NCT01242579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24653238|NCT01242579|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24653239|NCT01242592|Antitubercular Agents|antitubercular agents|mesh-list
24653240|NCT01242592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24653241|NCT01242592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24653242|NCT01242605|Gemcitabine|gemcitabine|mesh-list
24653243|NCT01242605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653244|NCT01242605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24653245|NCT01242605|Antimetabolites|antimetabolites|mesh-ancestor
24653246|NCT01242605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653247|NCT01242605|Antiviral Agents|antiviral agents|mesh-ancestor
25266323|NCT02428959|Vasodilator Agents|vasodilator agents|mesh-ancestor
25689109|NCT01956123|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25689110|NCT01956123|Hormones|hormones|mesh-ancestor
25689111|NCT01956123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25689112|NCT01956123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689113|NCT01957150|Fluticasone|fluticasone|mesh-list
25689114|NCT01957150|Xhance|xhance|mesh-list
25689115|NCT01957150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25689116|NCT01957150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25689117|NCT01957150|Autonomic Agents|autonomic agents|mesh-ancestor
25689118|NCT01957150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25689119|NCT01957150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689120|NCT01957150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24865848|NCT04761887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865849|NCT04761887|Sensory System Agents|sensory system agents|mesh-ancestor
24865850|NCT04761887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25266325|NCT02429037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266326|NCT02429076|Propofol|propofol|mesh-list
25266327|NCT02429076|Sevoflurane|sevoflurane|mesh-list
25266328|NCT02429076|Methylphenidate|methylphenidate|mesh-list
25266329|NCT02429076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24764115|NCT01779479|Paclitaxel|paclitaxel|mesh-list
24653248|NCT01242605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24653249|NCT01242605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653312|NCT01243359|Sunitinib|sunitinib|mesh-list
24653326|NCT01243385|Metformin|metformin|mesh-list
24653327|NCT01243385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24653328|NCT01243385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653329|NCT01243437|Ciprofloxacin|ciprofloxacin|mesh-list
24653330|NCT01243437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24653331|NCT01243437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24813041|NCT02056223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24813042|NCT02056223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24653533|NCT01244217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653535|NCT01244230|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24653536|NCT01244230|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24653537|NCT01244230|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24653538|NCT01244230|Histamine Antagonists|histamine antagonists|mesh-ancestor
24653566|NCT01244256|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24653568|NCT01244269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24653569|NCT01244269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653570|NCT01244269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24653571|NCT01244269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24653572|NCT01244269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24653573|NCT01244269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653574|NCT01244269|Dopamine Agents|dopamine agents|mesh-ancestor
24697038|NCT01432249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24697039|NCT01432249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24697040|NCT01432249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24697041|NCT01432249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24697042|NCT01432249|Immunologic Factors|immunologic factors|mesh-ancestor
24653575|NCT01244269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24653576|NCT01244334|Prednisolone|prednisolone|mesh-list
24653577|NCT01244334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24653578|NCT01244334|Methylprednisolone|methylprednisolone|mesh-list
24653579|NCT01244334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24919195|NCT04213781|Sufentanil|sufentanil|mesh-list
24653624|NCT01244659|Tacrolimus|tacrolimus|mesh-list
24653625|NCT01244659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24653626|NCT01244659|Immunologic Factors|immunologic factors|mesh-ancestor
24653627|NCT01244659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653628|NCT01244659|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24653654|NCT01244880|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24653655|NCT01244880|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24653656|NCT01244880|Anesthetics, General|anesthetics, general|mesh-ancestor
24697067|NCT01432522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24697069|NCT01432522|Mydriatics|mydriatics|mesh-ancestor
25266330|NCT02429076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25266331|NCT02429076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266332|NCT02429076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25266333|NCT02429076|Anesthetics, General|anesthetics, general|mesh-ancestor
25266334|NCT02429076|Anesthetics|anesthetics|mesh-ancestor
25689121|NCT01957150|Respiratory System Agents|respiratory system agents|mesh-ancestor
25689122|NCT01957150|Dermatologic Agents|dermatologic agents|mesh-ancestor
25689123|NCT01957150|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25689124|NCT01957202|Levocabastine|levocabastine|mesh-list
25689125|NCT01957202|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24713807|NCT01527591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865896|NCT04558866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24697926|NCT01437982|Prednisolone|prednisolone|mesh-list
24865897|NCT04558866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865898|NCT04558866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24865899|NCT04558866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865900|NCT04558866|Anabolic Agents|anabolic agents|mesh-ancestor
24865901|NCT04556370|Norepinephrine|norepinephrine|mesh-list
24865902|NCT04556370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24865903|NCT04556370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24764119|NCT01779479|Antimitotic Agents|antimitotic agents|mesh-ancestor
24653657|NCT01244880|Anesthetics|anesthetics|mesh-ancestor
24653658|NCT01244880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24653659|NCT01244880|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24653661|NCT01244880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24653662|NCT01244880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653663|NCT01244932|Bupivacaine|bupivacaine|mesh-list
24653664|NCT01244932|Anesthetics, Local|anesthetics, local|mesh-ancestor
24653665|NCT01244932|Anesthetics|anesthetics|mesh-ancestor
24653666|NCT01244932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24653667|NCT01244932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653668|NCT01244932|Sensory System Agents|sensory system agents|mesh-ancestor
24653669|NCT01244932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24653671|NCT01244958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24653672|NCT01244958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653673|NCT01244958|Immunologic Factors|immunologic factors|mesh-ancestor
24653674|NCT01244958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653675|NCT01244958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24653676|NCT01244971|Acarbose|acarbose|mesh-list
24653696|NCT01245205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24653698|NCT01245205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653699|NCT01245244|Morphine|morphine|mesh-list
24653700|NCT01245244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24653701|NCT01245244|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24653702|NCT01245244|Narcotics|narcotics|mesh-ancestor
24653703|NCT01245244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24653704|NCT01245244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653707|NCT01245244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24653708|NCT01245361|Infliximab|infliximab|mesh-list
24653709|NCT01245361|Dermatologic Agents|dermatologic agents|mesh-ancestor
24653710|NCT01245361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24653711|NCT01245361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24653712|NCT01245452|Methotrexate|methotrexate|mesh-list
24653713|NCT01245452|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24653714|NCT01245452|Abortifacient Agents|abortifacient agents|mesh-ancestor
24653715|NCT01245452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24653716|NCT01245452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653837|NCT01245946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24653838|NCT01245946|Antimalarials|antimalarials|mesh-ancestor
24653839|NCT01245946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24653840|NCT01245946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24653841|NCT01245946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24653842|NCT01245946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24653843|NCT01245946|Analgesics|analgesics|mesh-ancestor
24653844|NCT01245946|Sensory System Agents|sensory system agents|mesh-ancestor
24653845|NCT01245946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24653846|NCT01245946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653847|NCT01245946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24653848|NCT01245946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24653849|NCT01245946|Dermatologic Agents|dermatologic agents|mesh-ancestor
24653851|NCT01245959|Docetaxel|docetaxel|mesh-list
24653852|NCT01245959|Fluorouracil|fluorouracil|mesh-list
24653853|NCT01245959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25689126|NCT01957202|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25689127|NCT01957202|Histamine Antagonists|histamine antagonists|mesh-ancestor
25689128|NCT01957202|Histamine Agents|histamine agents|mesh-ancestor
25689129|NCT01957202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25689130|NCT01957202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689131|NCT01957202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689132|NCT01957215|Indomethacin|indomethacin|mesh-list
25689133|NCT01957215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25689134|NCT01957215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25689135|NCT01957215|Analgesics|analgesics|mesh-ancestor
25054109|NCT03531970|Sympathomimetics|sympathomimetics|mesh-ancestor
25054110|NCT03531970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25054112|NCT03531931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25054113|NCT03531931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25054114|NCT03531931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25054115|NCT03531931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054117|NCT03531918|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
25054118|NCT03531918|Mitoxantrone|mitoxantrone|mesh-list
25054119|NCT03531918|Cladribine|cladribine|mesh-list
25054120|NCT03531918|Gemtuzumab|gemtuzumab|mesh-list
25054121|NCT03531918|Calicheamicins|calicheamicins|mesh-list
25054122|NCT03531918|Lenograstim|lenograstim|mesh-list
25054123|NCT03531918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25054124|NCT03531918|Antimetabolites|antimetabolites|mesh-ancestor
25054125|NCT03531918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054126|NCT03531918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25054127|NCT03531918|Antiviral Agents|antiviral agents|mesh-ancestor
25054128|NCT03531918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25054129|NCT03531918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25054130|NCT03531918|Immunologic Factors|immunologic factors|mesh-ancestor
25054131|NCT03531918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054132|NCT03531918|Analgesics|analgesics|mesh-ancestor
24653854|NCT01245959|Tubulin Modulators|tubulin modulators|mesh-ancestor
25266335|NCT02429076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25266336|NCT02429076|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25266337|NCT02429076|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25266338|NCT02429076|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25266339|NCT02429076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25266340|NCT02429076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24653855|NCT01245959|Antimitotic Agents|antimitotic agents|mesh-ancestor
24653856|NCT01245959|Mitosis Modulators|mitosis modulators|mesh-ancestor
24653857|NCT01245959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653858|NCT01245959|Antimetabolites|antimetabolites|mesh-ancestor
24653918|NCT01246232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653919|NCT01246232|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24653923|NCT01246284|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24653924|NCT01246284|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24653925|NCT01246284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24653926|NCT01246284|Glucocorticoids|glucocorticoids|mesh-ancestor
24653927|NCT01246284|Hormones|hormones|mesh-ancestor
24653928|NCT01246284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25689136|NCT01957215|Sensory System Agents|sensory system agents|mesh-ancestor
25689137|NCT01957215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25689138|NCT01957215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689139|NCT01957215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25689140|NCT01957215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25689141|NCT01957215|Gout Suppressants|gout suppressants|mesh-ancestor
25689142|NCT01957215|Tocolytic Agents|tocolytic agents|mesh-ancestor
25689143|NCT01957215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25689144|NCT01957215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25689145|NCT01957215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689146|NCT01957215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689147|NCT01957410|Ketamine|ketamine|mesh-list
25689148|NCT01957410|Analgesics|analgesics|mesh-ancestor
25689149|NCT01957410|Sensory System Agents|sensory system agents|mesh-ancestor
25689150|NCT01957410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25689151|NCT01957410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689152|NCT01957410|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25689153|NCT01957410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25689154|NCT01957410|Anesthetics, General|anesthetics, general|mesh-ancestor
25689155|NCT01957410|Anesthetics|anesthetics|mesh-ancestor
25689156|NCT01957410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24814199|NCT02063139|Hormones|hormones|mesh-ancestor
24653929|NCT01246284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653930|NCT01246284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24653931|NCT01246284|Immunologic Factors|immunologic factors|mesh-ancestor
24653932|NCT01246284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653933|NCT01246284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653934|NCT01246323|Fentanyl|fentanyl|mesh-list
24653935|NCT01246323|Morphine|morphine|mesh-list
24919261|NCT04213573|Fluorides|fluorides|mesh-list
24654049|NCT01247311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654050|NCT01247311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24654051|NCT01247311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24654052|NCT01247337|Gemcitabine|gemcitabine|mesh-list
24654053|NCT01247337|Capecitabine|capecitabine|mesh-list
24654054|NCT01247337|Oxaliplatin|oxaliplatin|mesh-list
24654056|NCT01247337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24654057|NCT01247337|Antimetabolites|antimetabolites|mesh-ancestor
24654058|NCT01247337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654059|NCT01247337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654060|NCT01247337|Antiviral Agents|antiviral agents|mesh-ancestor
24654061|NCT01247337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24654062|NCT01247337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654063|NCT01247337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24654064|NCT01247337|Immunologic Factors|immunologic factors|mesh-ancestor
24654065|NCT01247337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654066|NCT01247337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24654067|NCT01247493|Cytarabine|cytarabine|mesh-list
24654068|NCT01247493|Fludarabine|fludarabine|mesh-list
24654069|NCT01247493|Idarubicin|idarubicin|mesh-list
25266341|NCT02429076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266342|NCT02429076|Dopamine Agents|dopamine agents|mesh-ancestor
25266343|NCT02429076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25266344|NCT02429050|Morphine|morphine|mesh-list
25266345|NCT02429050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25266346|NCT02429050|Narcotics|narcotics|mesh-ancestor
25266347|NCT02429050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25266359|NCT02428972|Anesthetics|anesthetics|mesh-ancestor
25266348|NCT02429050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266349|NCT02429050|Analgesics|analgesics|mesh-ancestor
25266350|NCT02429050|Sensory System Agents|sensory system agents|mesh-ancestor
25266351|NCT02429050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25266353|NCT02428972|Sevoflurane|sevoflurane|mesh-list
24654070|NCT01247493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654071|NCT01247493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24654072|NCT01247493|Antimetabolites|antimetabolites|mesh-ancestor
24654073|NCT01247493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654074|NCT01247493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24654075|NCT01247493|Immunologic Factors|immunologic factors|mesh-ancestor
24654076|NCT01247493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654077|NCT01247493|Antiviral Agents|antiviral agents|mesh-ancestor
24654110|NCT01247701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24654112|NCT01247714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24654113|NCT01247714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654114|NCT01247714|Appetite Depressants|appetite depressants|mesh-ancestor
24654115|NCT01247714|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24654116|NCT01247714|Sympathomimetics|sympathomimetics|mesh-ancestor
24654117|NCT01247714|Autonomic Agents|autonomic agents|mesh-ancestor
24654118|NCT01247714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24654260|NCT01248338|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24654261|NCT01248338|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24654262|NCT01248338|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24654265|NCT01248403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24654300|NCT01248611|Narcotics|narcotics|mesh-ancestor
24654301|NCT01248611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24866018|NCT03948867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866019|NCT03948867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866020|NCT03948867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24866027|NCT03930498|Antibodies|antibodies|mesh-list
24866028|NCT03930498|Antibodies, Blocking|antibodies, blocking|mesh-list
24866029|NCT03930498|Immunologic Factors|immunologic factors|mesh-ancestor
24866030|NCT03930498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654302|NCT01248611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654384|NCT01249339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654385|NCT01249339|Respiratory System Agents|respiratory system agents|mesh-ancestor
24654387|NCT01249352|Nimotuzumab|nimotuzumab|mesh-list
24654388|NCT01249352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654435|NCT01249521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654437|NCT01249547|Axitinib|axitinib|mesh-list
24654438|NCT01249547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654439|NCT01249547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24654440|NCT01249547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654479|NCT01249690|Protease Inhibitors|protease inhibitors|mesh-ancestor
24654480|NCT01249690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654481|NCT01249690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654510|NCT01249937|Growth Substances|growth substances|mesh-ancestor
24654511|NCT01249937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654512|NCT01249937|Growth Inhibitors|growth inhibitors|mesh-ancestor
24654513|NCT01249937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654514|NCT01249937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24654516|NCT01249937|Hormones|hormones|mesh-ancestor
24654517|NCT01249937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24654518|NCT01249937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24654519|NCT01249937|Immunologic Factors|immunologic factors|mesh-ancestor
24654520|NCT01249937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654521|NCT01249937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654522|NCT01250236|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24654523|NCT01250236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25266354|NCT02428972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25266355|NCT02428972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25266356|NCT02428972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266357|NCT02428972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25266358|NCT02428972|Anesthetics, General|anesthetics, general|mesh-ancestor
25266362|NCT02428946|Bromocriptine|bromocriptine|mesh-list
25266363|NCT02428946|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25689157|NCT01957410|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25689158|NCT01957410|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25689159|NCT01957410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25689160|NCT01957410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689161|NCT01957644|Azacitidine|azacitidine|mesh-list
25689162|NCT01957644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25689163|NCT01957644|Antimetabolites|antimetabolites|mesh-ancestor
24939404|NCT04010071|Axitinib|axitinib|mesh-list
24654524|NCT01250236|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24654525|NCT01250236|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24654526|NCT01250236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24654734|NCT01251107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24654735|NCT01251107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24654736|NCT01251107|Tubulin Modulators|tubulin modulators|mesh-ancestor
24654737|NCT01251107|Antimitotic Agents|antimitotic agents|mesh-ancestor
24654738|NCT01251107|Mitosis Modulators|mitosis modulators|mesh-ancestor
24654739|NCT01251133|Vaccines|vaccines|mesh-list
24654844|NCT01251822|Serotonin Agents|serotonin agents|mesh-ancestor
24654903|NCT01252056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24654904|NCT01252056|Autonomic Agents|autonomic agents|mesh-ancestor
24654905|NCT01252056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24654962|NCT01252420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654963|NCT01252524|Calcium polycarbophil|calcium polycarbophil|mesh-list
24654966|NCT01252524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25266364|NCT02428946|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25266365|NCT02428946|Hormone Antagonists|hormone antagonists|mesh-ancestor
25266366|NCT02428946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25266367|NCT02428946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266368|NCT02428946|Dopamine Agonists|dopamine agonists|mesh-ancestor
25266369|NCT02428946|Dopamine Agents|dopamine agents|mesh-ancestor
25266370|NCT02428946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25266371|NCT02428946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266372|NCT02428881|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25266373|NCT02428881|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25266374|NCT02428881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25266375|NCT02428881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25266376|NCT02428881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266377|NCT02428881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25266378|NCT02428881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25266379|NCT02428881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266380|NCT02428881|Cholinergic Agents|cholinergic agents|mesh-ancestor
25266381|NCT02428881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25275419|NCT02372604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275420|NCT02372604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275421|NCT02372604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25275422|NCT02372110|Caffeine|caffeine|mesh-list
25275423|NCT02372110|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25275424|NCT02372110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654967|NCT01252524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654968|NCT01252524|Antidiarrheals|antidiarrheals|mesh-ancestor
24654969|NCT01252524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24654971|NCT01252680|Vaccines|vaccines|mesh-list
24654972|NCT01252680|Immunologic Factors|immunologic factors|mesh-ancestor
24654973|NCT01252680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655067|NCT01254071|Urological Agents|urological agents|mesh-ancestor
24655068|NCT01254071|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24655069|NCT01254071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24655070|NCT01254071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24655071|NCT01254071|Hormone Antagonists|hormone antagonists|mesh-ancestor
24806080|NCT02013492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655072|NCT01254071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24655074|NCT01254123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24655075|NCT01254123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655076|NCT01254123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24655077|NCT01254123|Incretins|incretins|mesh-ancestor
24655078|NCT01254123|Hormones|hormones|mesh-ancestor
24655079|NCT01254123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24655081|NCT01254175|Immunologic Factors|immunologic factors|mesh-ancestor
24655112|NCT01254513|Antimitotic Agents|antimitotic agents|mesh-ancestor
24655113|NCT01254513|Mitosis Modulators|mitosis modulators|mesh-ancestor
24655114|NCT01254513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655115|NCT01254513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24655116|NCT01254513|Glucocorticoids|glucocorticoids|mesh-ancestor
24655118|NCT01254513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24655119|NCT01254513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655120|NCT01254513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24655121|NCT01254526|Paclitaxel|paclitaxel|mesh-list
24655122|NCT01254526|Bevacizumab|bevacizumab|mesh-list
24655123|NCT01254526|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24655283|NCT01255579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24655284|NCT01255579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24655350|NCT01255956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24655351|NCT01255956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24655352|NCT01255956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24655373|NCT01256151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24655374|NCT01256151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24655377|NCT01256151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24655378|NCT01256151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655379|NCT01256268|Paclitaxel|paclitaxel|mesh-list
24655380|NCT01256268|Carboplatin|carboplatin|mesh-list
24655381|NCT01256268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24655382|NCT01256268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655383|NCT01256268|Tubulin Modulators|tubulin modulators|mesh-ancestor
24655384|NCT01256268|Antimitotic Agents|antimitotic agents|mesh-ancestor
24655385|NCT01256268|Mitosis Modulators|mitosis modulators|mesh-ancestor
24655386|NCT01256268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655387|NCT01256359|Docetaxel|docetaxel|mesh-list
24655388|NCT01256359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655389|NCT01256359|Tubulin Modulators|tubulin modulators|mesh-ancestor
24655390|NCT01256359|Antimitotic Agents|antimitotic agents|mesh-ancestor
24655391|NCT01256359|Mitosis Modulators|mitosis modulators|mesh-ancestor
24655392|NCT01256359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655393|NCT01256489|Infliximab|infliximab|mesh-list
24655394|NCT01256489|Dermatologic Agents|dermatologic agents|mesh-ancestor
24655395|NCT01256489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24655396|NCT01256489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24655397|NCT01256541|Lactulose|lactulose|mesh-list
24655398|NCT01256541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24655399|NCT01256580|Dexamethasone|dexamethasone|mesh-list
24655401|NCT01256580|Verteporfin|verteporfin|mesh-list
25266382|NCT02428868|Tranexamic Acid|tranexamic acid|mesh-list
25266383|NCT02428868|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24655402|NCT01256580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24655403|NCT01256580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655404|NCT01256580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24655405|NCT01256580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24655406|NCT01256580|Growth Substances|growth substances|mesh-ancestor
24655471|NCT01256866|Analgesics|analgesics|mesh-ancestor
24655472|NCT01256866|Sensory System Agents|sensory system agents|mesh-ancestor
24655473|NCT01256866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24655474|NCT01256866|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24655475|NCT01256866|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24655476|NCT01256866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24655477|NCT01256866|Adrenergic Agents|adrenergic agents|mesh-ancestor
24655478|NCT01256866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24655512|NCT01257048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24655547|NCT01257139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655548|NCT01257165|Ethanol|ethanol|mesh-list
24655549|NCT01257165|Zopiclone|zopiclone|mesh-list
24655550|NCT01257165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24655552|NCT01257165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24655553|NCT01257165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655612|NCT01257399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655614|NCT01257399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24655615|NCT01257412|Dapagliflozin|dapagliflozin|mesh-list
25689168|NCT01957709|Interferon-gamma|interferon-gamma|mesh-list
25689169|NCT01957709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866258|NCT02269917|Protease Inhibitors|protease inhibitors|mesh-list
24866259|NCT02269917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24494441|NCT00495287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655658|NCT01257516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24655659|NCT01257516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655695|NCT01257672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24655696|NCT01257672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655697|NCT01257672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24655698|NCT01257672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24655699|NCT01257672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24655738|NCT01257815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655769|NCT01257893|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24655770|NCT01257893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655771|NCT01257893|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24655772|NCT01257893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24655773|NCT01257893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24655774|NCT01257893|Antipyretics|antipyretics|mesh-ancestor
24655775|NCT01257906|Tretinoin|tretinoin|mesh-list
24655776|NCT01257906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655777|NCT01257906|Keratolytic Agents|keratolytic agents|mesh-ancestor
24655778|NCT01257906|Dermatologic Agents|dermatologic agents|mesh-ancestor
24655779|NCT01257919|Azelaic acid|azelaic acid|mesh-list
24655891|NCT01258634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24670924|NCT01116648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266384|NCT02428868|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25266385|NCT02428868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266386|NCT02428868|Hemostatics|hemostatics|mesh-ancestor
25266387|NCT02428868|Coagulants|coagulants|mesh-ancestor
25266388|NCT02428686|Epoetin Alfa|epoetin alfa|mesh-list
25266389|NCT02428686|Hematinics|hematinics|mesh-ancestor
25266390|NCT02428543|Cytarabine|cytarabine|mesh-list
25266391|NCT02428543|Ponatinib|ponatinib|mesh-list
25266392|NCT02428543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25266393|NCT02428543|Antimetabolites|antimetabolites|mesh-ancestor
24655925|NCT01258712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24655926|NCT01258764|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24802421|NCT01990079|Bupropion|bupropion|mesh-list
24655927|NCT01258764|Lisinopril|lisinopril|mesh-list
24655928|NCT01258764|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24655929|NCT01258764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24655930|NCT01258764|Diuretics|diuretics|mesh-ancestor
24655931|NCT01258764|Natriuretic Agents|natriuretic agents|mesh-ancestor
24655932|NCT01258764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655999|NCT01259193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656000|NCT01259193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24656001|NCT01259193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656003|NCT01259219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24656004|NCT01259219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24656005|NCT01259219|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24656006|NCT01259219|Antitubercular Agents|antitubercular agents|mesh-ancestor
25689170|NCT01957709|Antiviral Agents|antiviral agents|mesh-ancestor
25689171|NCT01957709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25689172|NCT01957930|Insulin|insulin|mesh-list
25689173|NCT01957930|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25689174|NCT01957930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24656007|NCT01259323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24656034|NCT01259362|Dopamine Agents|dopamine agents|mesh-ancestor
24919471|NCT04211805|Antiviral Agents|antiviral agents|mesh-ancestor
24656041|NCT01259531|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24656043|NCT01259531|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24656044|NCT01259531|Adrenergic Agents|adrenergic agents|mesh-ancestor
24656045|NCT01259531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25266394|NCT02428543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266395|NCT02428543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266396|NCT02428543|Antiviral Agents|antiviral agents|mesh-ancestor
25266397|NCT02428543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25266398|NCT02428543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25266399|NCT02428543|Immunologic Factors|immunologic factors|mesh-ancestor
25266400|NCT02428543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266401|NCT02428543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25266402|NCT02428543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25266403|NCT02428439|Lamotrigine|lamotrigine|mesh-list
25266404|NCT02428439|Bupropion|bupropion|mesh-list
25266405|NCT02428439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25266406|NCT02428439|Antidepressive Agents|antidepressive agents|mesh-ancestor
24656046|NCT01259531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656047|NCT01259531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656048|NCT01259531|Urological Agents|urological agents|mesh-ancestor
24656049|NCT01259557|Botulinum Toxins|botulinum toxins|mesh-list
24656050|NCT01259557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24656051|NCT01259557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24656052|NCT01259557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24656080|NCT01259817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24656082|NCT01259817|Antipyretics|antipyretics|mesh-ancestor
24656083|NCT01259817|Immunologic Factors|immunologic factors|mesh-ancestor
24656084|NCT01259830|Etoricoxib|etoricoxib|mesh-list
24656085|NCT01259830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24656086|NCT01259830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24656087|NCT01259830|Analgesics|analgesics|mesh-ancestor
24656088|NCT01259830|Sensory System Agents|sensory system agents|mesh-ancestor
24656089|NCT01259830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24656090|NCT01259830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656091|NCT01259830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24656092|NCT01259830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24656093|NCT01259830|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24919524|NCT04211168|Lenvatinib|lenvatinib|mesh-list
24656097|NCT01259934|Interferons|interferons|mesh-list
24656098|NCT01259934|Interferon-alpha|interferon-alpha|mesh-list
24656099|NCT01259934|Interferon alpha-2|interferon alpha-2|mesh-list
24656135|NCT01260025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24656136|NCT01260025|Growth Substances|growth substances|mesh-ancestor
24656206|NCT01260558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24656373|NCT01261234|Autonomic Agents|autonomic agents|mesh-ancestor
24656374|NCT01261234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24656375|NCT01261234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656376|NCT01261234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24656377|NCT01261234|Respiratory System Agents|respiratory system agents|mesh-ancestor
24656378|NCT01261234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24656379|NCT01261234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24656429|NCT01261689|Anesthetics|anesthetics|mesh-ancestor
24656430|NCT01261689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24656431|NCT01261689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656432|NCT01261689|Sensory System Agents|sensory system agents|mesh-ancestor
25689175|NCT01957930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689176|NCT01958073|Estradiol|estradiol|mesh-list
25266421|NCT02428439|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24768960|NCT01811615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24449722|NCT00316745|Micronutrients|micronutrients|mesh-ancestor
24449723|NCT00316758|Metformin|metformin|mesh-list
24449724|NCT00316758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24449725|NCT00316758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449726|NCT00316810|Alemtuzumab|alemtuzumab|mesh-list
24449727|NCT00316810|Thymoglobulin|thymoglobulin|mesh-list
24802441|NCT01990079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25266422|NCT02428439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25689177|NCT01958073|Estrogens|estrogens|mesh-list
25689178|NCT01958073|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25689179|NCT01958073|Hormones|hormones|mesh-ancestor
25689180|NCT01958073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25689181|NCT01958073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689182|NCT01958112|Trametinib|trametinib|mesh-list
25689183|NCT01958112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25689184|NCT01958112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25689185|NCT01958112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25266435|NCT02428374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266436|NCT02428374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266437|NCT02428374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25266438|NCT02428374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25266439|NCT02428374|Antimetabolites|antimetabolites|mesh-ancestor
25266440|NCT02428374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25266441|NCT02428374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25266442|NCT02428374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25266443|NCT02428322|Vitamin D|vitamin d|mesh-list
25266444|NCT02428322|Cholecalciferol|cholecalciferol|mesh-list
25266445|NCT02428322|Vitamins|vitamins|mesh-ancestor
25266446|NCT02428322|Micronutrients|micronutrients|mesh-ancestor
25266447|NCT02428322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266448|NCT02428322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25266449|NCT02428322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25266450|NCT02428257|Ephedrine|ephedrine|mesh-list
25266451|NCT02428257|Bupivacaine|bupivacaine|mesh-list
25266452|NCT02428257|Anesthetics, Local|anesthetics, local|mesh-ancestor
25266453|NCT02428257|Anesthetics|anesthetics|mesh-ancestor
24656507|NCT01262196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24656508|NCT01262196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24656509|NCT01262274|Anastrozole|anastrozole|mesh-list
24656510|NCT01262274|Tegafur|tegafur|mesh-list
24656511|NCT01262274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24656512|NCT01262274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266454|NCT02428257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25266455|NCT02428257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689186|NCT01958112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689187|NCT01958164|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25689188|NCT01958164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25689189|NCT01958164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25689190|NCT01958164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689191|NCT01958281|Sofosbuvir|sofosbuvir|mesh-list
25689192|NCT01958281|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25266457|NCT02428257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25266458|NCT02428257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25266460|NCT02428257|Autonomic Agents|autonomic agents|mesh-ancestor
25266461|NCT02428257|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24656730|NCT01263652|Cholinergic Agents|cholinergic agents|mesh-ancestor
24656731|NCT01263652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24656732|NCT01263652|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
24656733|NCT01263652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24656735|NCT01263808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24656736|NCT01263808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24656737|NCT01263808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24656738|NCT01263808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24656739|NCT01263808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656814|NCT01264302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656816|NCT01264302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24656817|NCT01264302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656818|NCT01264302|Urological Agents|urological agents|mesh-ancestor
24656819|NCT01264315|Lenalidomide|lenalidomide|mesh-list
24656820|NCT01264315|Immunologic Factors|immunologic factors|mesh-ancestor
24857224|NCT02289768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24857225|NCT02289768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857226|NCT02289807|Cisplatin|cisplatin|mesh-list
24857227|NCT02289807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656834|NCT01264328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656835|NCT01264328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24656869|NCT01264432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656870|NCT01264445|Vaccines|vaccines|mesh-list
24656871|NCT01264445|Immunologic Factors|immunologic factors|mesh-ancestor
24656872|NCT01264445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656873|NCT01264484|Imidacloprid|imidacloprid|mesh-list
24656874|NCT01264484|Cholinergic Agents|cholinergic agents|mesh-ancestor
24656951|NCT01264692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656952|NCT01264692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24656953|NCT01264692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656954|NCT01264692|Vasodilator Agents|vasodilator agents|mesh-ancestor
24656955|NCT01264731|Imiquimod|imiquimod|mesh-list
24656956|NCT01264731|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24656957|NCT01264731|Immunologic Factors|immunologic factors|mesh-ancestor
24656958|NCT01264731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656959|NCT01264731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656960|NCT01264731|Interferon Inducers|interferon inducers|mesh-ancestor
25266462|NCT02428257|Adrenergic Agents|adrenergic agents|mesh-ancestor
25266463|NCT02428257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25266464|NCT02428257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266465|NCT02428283|Remifentanil|remifentanil|mesh-list
25266466|NCT02428283|Ropivacaine|ropivacaine|mesh-list
25266467|NCT02428283|Sevoflurane|sevoflurane|mesh-list
24857228|NCT02289924|Aflibercept|aflibercept|mesh-list
24857229|NCT02289924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24657129|NCT01265888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25689193|NCT01958281|Antiviral Agents|antiviral agents|mesh-ancestor
25689194|NCT01958281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25689195|NCT01958476|Morphine|morphine|mesh-list
25689196|NCT01958476|Methadone|methadone|mesh-list
25689197|NCT01958476|Phenobarbital|phenobarbital|mesh-list
25054908|NCT03526224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25054909|NCT03526224|Analgesics|analgesics|mesh-ancestor
25054910|NCT03526224|Sensory System Agents|sensory system agents|mesh-ancestor
25054911|NCT03526224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25054912|NCT03526224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25054931|NCT03526107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25054934|NCT03526107|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24657130|NCT01265888|Autonomic Agents|autonomic agents|mesh-ancestor
24657131|NCT01265888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24657155|NCT01265940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657157|NCT01266005|Clevudine|clevudine|mesh-list
24657158|NCT01266005|Antiviral Agents|antiviral agents|mesh-ancestor
24657159|NCT01266005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24657160|NCT01266031|Bevacizumab|bevacizumab|mesh-list
24657161|NCT01266031|Vorinostat|vorinostat|mesh-list
24657162|NCT01266031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24657163|NCT01266031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657164|NCT01266031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24657165|NCT01266031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24657175|NCT01266057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24657176|NCT01266057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24657177|NCT01266057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25266468|NCT02428283|Anesthetics, Local|anesthetics, local|mesh-ancestor
25266469|NCT02428283|Anesthetics|anesthetics|mesh-ancestor
25266470|NCT02428283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25266471|NCT02428283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266472|NCT02428283|Sensory System Agents|sensory system agents|mesh-ancestor
24657180|NCT01266057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24657181|NCT01266057|Immunologic Factors|immunologic factors|mesh-ancestor
24657182|NCT01266057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657183|NCT01266057|Antimalarials|antimalarials|mesh-ancestor
24657184|NCT01266057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24657372|NCT01266837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657373|NCT01266928|Ascorbic Acid|ascorbic acid|mesh-list
24657375|NCT01266928|Micronutrients|micronutrients|mesh-ancestor
24657376|NCT01266928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657377|NCT01266928|Antioxidants|antioxidants|mesh-ancestor
24657378|NCT01266928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657379|NCT01266928|Protective Agents|protective agents|mesh-ancestor
24657380|NCT01267058|Vaccines|vaccines|mesh-list
24657381|NCT01267058|Immunologic Factors|immunologic factors|mesh-ancestor
24657382|NCT01267058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657383|NCT01267084|Ketoconazole|ketoconazole|mesh-list
24657384|NCT01267084|Dexamethasone|dexamethasone|mesh-list
24657385|NCT01267084|Trabectedin|trabectedin|mesh-list
24657386|NCT01267084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24657387|NCT01267084|Antiemetics|antiemetics|mesh-ancestor
25689198|NCT01958476|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25689199|NCT01958476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25689200|NCT01958476|Narcotics|narcotics|mesh-ancestor
25689201|NCT01958476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25689202|NCT01958476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689203|NCT01958476|Analgesics|analgesics|mesh-ancestor
25689204|NCT01958476|Sensory System Agents|sensory system agents|mesh-ancestor
25689205|NCT01958476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25689206|NCT01958476|Antitussive Agents|antitussive agents|mesh-ancestor
25689207|NCT01958476|Respiratory System Agents|respiratory system agents|mesh-ancestor
25689208|NCT01958476|Anticonvulsants|anticonvulsants|mesh-ancestor
24657388|NCT01267084|Autonomic Agents|autonomic agents|mesh-ancestor
25689209|NCT01958476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24657392|NCT01267084|Glucocorticoids|glucocorticoids|mesh-ancestor
24657394|NCT01267084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24657395|NCT01267084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24657396|NCT01267084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657397|NCT01267084|Antifungal Agents|antifungal agents|mesh-ancestor
24657398|NCT01267084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24657399|NCT01267084|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24657400|NCT01267084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25266473|NCT02428283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25266474|NCT02428283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25266475|NCT02428283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25266476|NCT02428283|Anesthetics, General|anesthetics, general|mesh-ancestor
24939482|NCT04009317|Crizotinib|crizotinib|mesh-list
24657401|NCT01267084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657402|NCT01267084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857230|NCT02289924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24857231|NCT02289924|Growth Substances|growth substances|mesh-ancestor
24657484|NCT01267487|Heparin Antagonists|heparin antagonists|mesh-ancestor
24657518|NCT01267734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24657519|NCT01267734|Purinergic Agents|purinergic agents|mesh-ancestor
24657520|NCT01267734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24657521|NCT01267734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657522|NCT01267760|Dialysis Solutions|dialysis solutions|mesh-list
24657523|NCT01267760|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24657525|NCT01267903|Immunologic Factors|immunologic factors|mesh-ancestor
24657526|NCT01267903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657527|NCT01267942|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24657528|NCT01267942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24657546|NCT01268176|Cholecalciferol|cholecalciferol|mesh-list
24697790|NCT01437306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24697801|NCT01437371|Ramipril|ramipril|mesh-list
24919816|NCT04208516|Hormones|hormones|mesh-ancestor
24657558|NCT01268202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24657560|NCT01268215|Budesonide|budesonide|mesh-list
24657561|NCT01268215|Calfactant|calfactant|mesh-list
24657562|NCT01268215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24657563|NCT01268215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24657564|NCT01268215|Autonomic Agents|autonomic agents|mesh-ancestor
24657565|NCT01268215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24657566|NCT01268215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657567|NCT01268215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24657568|NCT01268215|Respiratory System Agents|respiratory system agents|mesh-ancestor
24657569|NCT01268215|Glucocorticoids|glucocorticoids|mesh-ancestor
24657570|NCT01268215|Hormones|hormones|mesh-ancestor
24657571|NCT01268215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24697821|NCT01437462|Anesthetics|anesthetics|mesh-ancestor
25266483|NCT02428218|Immunologic Factors|immunologic factors|mesh-ancestor
25266484|NCT02428218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266485|NCT02428062|Phenylephrine|phenylephrine|mesh-list
25266486|NCT02428062|Dopamine|dopamine|mesh-list
25266487|NCT02428062|Epinephrine|epinephrine|mesh-list
25266488|NCT02428062|Oxymetazoline|oxymetazoline|mesh-list
25266489|NCT02428062|Norepinephrine|norepinephrine|mesh-list
25266490|NCT02428062|Ephedrine|ephedrine|mesh-list
25266491|NCT02428062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25266492|NCT02428062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266493|NCT02428062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24657643|NCT01268709|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24657644|NCT01268709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24657645|NCT01268709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24657646|NCT01268709|Histamine Antagonists|histamine antagonists|mesh-ancestor
24657647|NCT01268709|Histamine Agents|histamine agents|mesh-ancestor
24657649|NCT01268735|Lubricant Eye Drops|lubricant eye drops|mesh-list
24657650|NCT01268735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24657651|NCT01268761|Cetrorelix|cetrorelix|mesh-list
24657652|NCT01268761|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24657653|NCT01268761|Fertility Agents|fertility agents|mesh-ancestor
24657654|NCT01268761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24857232|NCT02289924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857233|NCT02289924|Growth Inhibitors|growth inhibitors|mesh-ancestor
24657806|NCT01269294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24657807|NCT01269294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24657808|NCT01269294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657868|NCT01269437|Respiratory System Agents|respiratory system agents|mesh-ancestor
24657870|NCT01269437|Hormones|hormones|mesh-ancestor
24657871|NCT01269437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24657872|NCT01269450|Progesterone|progesterone|mesh-list
24657873|NCT01269450|Progestins|progestins|mesh-ancestor
24657874|NCT01269450|Hormones|hormones|mesh-ancestor
24657875|NCT01269450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24657876|NCT01269450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266495|NCT02428062|Adrenergic Agents|adrenergic agents|mesh-ancestor
25266496|NCT02428062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25266497|NCT02428062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266498|NCT02428062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25266499|NCT02428062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25689210|NCT01958476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25689211|NCT01958476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25689212|NCT01958476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25689213|NCT01958476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689214|NCT01958476|GABA Modulators|gaba modulators|mesh-ancestor
25689215|NCT01958476|GABA Agents|gaba agents|mesh-ancestor
25689216|NCT01958476|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25689217|NCT01958476|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25155688|NCT05288907|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25155689|NCT05288907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25155690|NCT05288907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657911|NCT01269528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24623833|NCT01073748|Antipyretics|antipyretics|mesh-ancestor
24657949|NCT01269606|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24657982|NCT01269788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657984|NCT01269788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24657985|NCT01269788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24657986|NCT01269788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24657987|NCT01269788|Serotonin Agents|serotonin agents|mesh-ancestor
24657988|NCT01269788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657989|NCT01269788|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24657990|NCT01269788|Antidepressive Agents|antidepressive agents|mesh-ancestor
24657991|NCT01269788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24657992|NCT01269788|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24657993|NCT01269788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24658052|NCT01270165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24658082|NCT01270386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24658083|NCT01270386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658085|NCT01270412|Hyaluronic Acid|hyaluronic acid|mesh-list
25266505|NCT02428062|Sympathomimetics|sympathomimetics|mesh-ancestor
25266506|NCT02428062|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25266507|NCT02428062|Nasal Decongestants|nasal decongestants|mesh-ancestor
25266508|NCT02428062|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25266509|NCT02428062|Protective Agents|protective agents|mesh-ancestor
25266510|NCT02428062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25266511|NCT02428062|Dopamine Agents|dopamine agents|mesh-ancestor
25266512|NCT02427932|Gentamicins|gentamicins|mesh-list
25266513|NCT02427932|Ampicillin|ampicillin|mesh-list
25689218|NCT01958476|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25689219|NCT01958489|Pravastatin|pravastatin|mesh-list
25689220|NCT01958489|Evacetrapib|evacetrapib|mesh-list
25689221|NCT01958489|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25689222|NCT01958489|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25689223|NCT01958489|Antimetabolites|antimetabolites|mesh-ancestor
25689224|NCT01958489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689225|NCT01958489|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24548222|NCT00708357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548224|NCT00708396|Citalopram|citalopram|mesh-list
24868256|NCT01489813|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25266514|NCT02427932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25266515|NCT02427932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25266516|NCT02427932|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25266517|NCT02427932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25266518|NCT02427932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266519|NCT02427919|Lenograstim|lenograstim|mesh-list
24658086|NCT01270412|Mitosis Modulators|mitosis modulators|mesh-ancestor
24658087|NCT01270412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658178|NCT01270776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24658179|NCT01270776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24658198|NCT01270815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24658199|NCT01270815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24658200|NCT01270815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24658201|NCT01270815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24658202|NCT01270815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24658224|NCT01270932|Immunologic Factors|immunologic factors|mesh-ancestor
24658225|NCT01270932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24658245|NCT01270997|Immunologic Factors|immunologic factors|mesh-ancestor
24658247|NCT01271023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24658248|NCT01271023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658249|NCT01271088|Acetylcysteine|acetylcysteine|mesh-list
24658250|NCT01271088|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24658251|NCT01271088|Antiviral Agents|antiviral agents|mesh-ancestor
24658252|NCT01271088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24658253|NCT01271088|Expectorants|expectorants|mesh-ancestor
24658254|NCT01271088|Respiratory System Agents|respiratory system agents|mesh-ancestor
24658255|NCT01271088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24658256|NCT01271088|Antioxidants|antioxidants|mesh-ancestor
24658257|NCT01271088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658258|NCT01271088|Protective Agents|protective agents|mesh-ancestor
24658259|NCT01271088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658271|NCT01271114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658272|NCT01271114|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24658273|NCT01271114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24658274|NCT01271140|Insulin|insulin|mesh-list
24658275|NCT01271140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24857237|NCT02289937|Anesthetics|anesthetics|mesh-ancestor
24857238|NCT02289937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24658276|NCT01271140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658277|NCT01271153|Dobutamine|dobutamine|mesh-list
24658335|NCT01271179|Protective Agents|protective agents|mesh-ancestor
24658336|NCT01271179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24658338|NCT01271231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24658339|NCT01271231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24658340|NCT01271257|Misoprostol|misoprostol|mesh-list
24658341|NCT01271257|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24658342|NCT01271257|Abortifacient Agents|abortifacient agents|mesh-ancestor
24658343|NCT01271257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24658344|NCT01271257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658345|NCT01271257|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24658346|NCT01271257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24658347|NCT01271257|Oxytocics|oxytocics|mesh-ancestor
24658348|NCT01271283|Lenalidomide|lenalidomide|mesh-list
25266520|NCT02427919|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25689226|NCT01958489|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25689227|NCT01958489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689228|NCT01958619|Artefenomel|artefenomel|mesh-list
25689229|NCT01958619|Antimalarials|antimalarials|mesh-ancestor
25689230|NCT01958619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25689231|NCT01958619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25689232|NCT01958619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25689233|NCT01958671|Metformin|metformin|mesh-list
25689234|NCT01958671|Glimepiride|glimepiride|mesh-list
25689235|NCT01958671|Ertugliflozin|ertugliflozin|mesh-list
24868432|NCT04778618|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24868433|NCT04778618|Immunologic Factors|immunologic factors|mesh-ancestor
24868434|NCT04778618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868435|NCT04778618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24868456|NCT04645602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868458|NCT04560725|Lipotropic Agents|lipotropic agents|mesh-ancestor
24868459|NCT04560725|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24868460|NCT04560725|Antimetabolites|antimetabolites|mesh-ancestor
25266521|NCT02427919|Immunologic Factors|immunologic factors|mesh-ancestor
25266522|NCT02427919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266523|NCT02427893|Vemurafenib|vemurafenib|mesh-list
24658349|NCT01271283|Immunologic Factors|immunologic factors|mesh-ancestor
24658350|NCT01271283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698004|NCT01438515|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24698005|NCT01438515|Doxycycline|doxycycline|mesh-list
24698006|NCT01438515|Rifampin|rifampin|mesh-list
24698007|NCT01438515|Mupirocin|mupirocin|mesh-list
24698008|NCT01438515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24658357|NCT01271348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24658419|NCT01271517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658420|NCT01271556|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24658421|NCT01271556|Bronchodilator Agents|bronchodilator agents|mesh-list
24658422|NCT01271556|Autonomic Agents|autonomic agents|mesh-ancestor
24658678|NCT01273506|Narcotics|narcotics|mesh-ancestor
24658426|NCT01271556|Respiratory System Agents|respiratory system agents|mesh-ancestor
24658427|NCT01271556|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24658428|NCT01271556|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24658429|NCT01271556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24658430|NCT01271556|Adrenergic Agents|adrenergic agents|mesh-ancestor
24658431|NCT01271556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24658432|NCT01271556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658498|NCT01272089|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24658499|NCT01272089|Histamine Antagonists|histamine antagonists|mesh-ancestor
24658500|NCT01272089|Histamine Agents|histamine agents|mesh-ancestor
24658501|NCT01272089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24658502|NCT01272089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658503|NCT01272128|Interferons|interferons|mesh-list
24658504|NCT01272128|Interferon-beta|interferon-beta|mesh-list
24658505|NCT01272128|Interferon beta-1a|interferon beta-1a|mesh-list
24658506|NCT01272128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24658507|NCT01272128|Antiviral Agents|antiviral agents|mesh-ancestor
24658508|NCT01272128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25266524|NCT02427893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266525|NCT02427893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25266526|NCT02427893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25266527|NCT02427893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266528|NCT02427880|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25266529|NCT02427880|Furosemide|furosemide|mesh-list
25266530|NCT02427880|Acetazolamide|acetazolamide|mesh-list
25266531|NCT02427880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25689236|NCT01958671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25689237|NCT01958671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689238|NCT01958671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25689239|NCT01958671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25689240|NCT01958671|Immunologic Factors|immunologic factors|mesh-ancestor
25689241|NCT01958671|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25689242|NCT01958671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689243|NCT01958827|Adalimumab|adalimumab|mesh-list
25689244|NCT01958827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25266532|NCT02427880|Diuretics|diuretics|mesh-ancestor
25266533|NCT02427880|Natriuretic Agents|natriuretic agents|mesh-ancestor
24658511|NCT01272128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24658512|NCT01272258|Leronlimab|leronlimab|mesh-list
24658513|NCT01272258|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24658514|NCT01272258|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24658551|NCT01272531|Anticonvulsants|anticonvulsants|mesh-ancestor
24658552|NCT01272531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24658553|NCT01272531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658554|NCT01272531|GABA Agents|gaba agents|mesh-ancestor
24658555|NCT01272531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24658586|NCT01272778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24521633|NCT04627142|Irinotecan|irinotecan|mesh-list
24658600|NCT01272856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24658602|NCT01272856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658637|NCT01273402|Antibodies, Bispecific|antibodies, bispecific|mesh-list
24658639|NCT01273402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658641|NCT01273441|Metronidazole|metronidazole|mesh-list
24658642|NCT01273441|Clarithromycin|clarithromycin|mesh-list
24658643|NCT01273441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24658644|NCT01273441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24658675|NCT01273493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658683|NCT01273506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658684|NCT01273506|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24658685|NCT01273506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24658686|NCT01273506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24658687|NCT01273506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658725|NCT01273662|Axitinib|axitinib|mesh-list
24658726|NCT01273662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24658727|NCT01273662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24658728|NCT01273662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24658729|NCT01273662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658730|NCT01273727|Dexamethasone|dexamethasone|mesh-list
24658731|NCT01273727|Dexamethasone acetate|dexamethasone acetate|mesh-list
24658732|NCT01273727|BB 1101|bb 1101|mesh-list
24658760|NCT01273831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658761|NCT01273844|Bortezomib|bortezomib|mesh-list
24658762|NCT01273844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24658763|NCT01273948|Interferons|interferons|mesh-list
24658764|NCT01273948|Bavituximab|bavituximab|mesh-list
24658765|NCT01273948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698103|NCT01438866|Fluorides|fluorides|mesh-list
24658766|NCT01273948|Antiviral Agents|antiviral agents|mesh-ancestor
24658796|NCT01274039|Natriuretic Agents|natriuretic agents|mesh-ancestor
24658797|NCT01274039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658798|NCT01274104|Vitamin D|vitamin d|mesh-list
24658799|NCT01274104|Cholecalciferol|cholecalciferol|mesh-list
24658800|NCT01274104|Vitamins|vitamins|mesh-ancestor
24658801|NCT01274104|Micronutrients|micronutrients|mesh-ancestor
24658802|NCT01274104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266534|NCT02427880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266535|NCT02427880|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25266536|NCT02427880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24658804|NCT01274104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24658806|NCT01274130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24658807|NCT01274130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658808|NCT01274195|Busulfan|busulfan|mesh-list
24658809|NCT01274195|Alkylating Agents|alkylating agents|mesh-ancestor
24658810|NCT01274195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658812|NCT01274195|Immunologic Factors|immunologic factors|mesh-ancestor
24658813|NCT01274195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658814|NCT01274195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24658815|NCT01274195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24857240|NCT02289937|Sensory System Agents|sensory system agents|mesh-ancestor
24857241|NCT02289937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658816|NCT01274195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24658817|NCT01274221|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
24658818|NCT01274221|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24658819|NCT01274221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658820|NCT01274221|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24658821|NCT01274221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24658825|NCT01274221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24658827|NCT01274247|Anesthetics, Local|anesthetics, local|mesh-ancestor
24658858|NCT01274273|Interleukin-2|interleukin-2|mesh-list
24521740|NCT04553536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24658859|NCT01274273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24658861|NCT01274273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24658862|NCT01274273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24698150|NCT01439191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659129|NCT01275859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25266538|NCT02427880|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25266539|NCT02427880|Anticonvulsants|anticonvulsants|mesh-ancestor
25266540|NCT02427880|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25266541|NCT02427880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25266542|NCT02427529|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25266543|NCT02427529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24658864|NCT01274273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658865|NCT01274273|Growth Inhibitors|growth inhibitors|mesh-ancestor
24658866|NCT01274273|Antiviral Agents|antiviral agents|mesh-ancestor
24658867|NCT01274273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24658868|NCT01274273|Immunologic Factors|immunologic factors|mesh-ancestor
24658869|NCT01274273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24658870|NCT01274273|Analgesics|analgesics|mesh-ancestor
24658871|NCT01274273|Sensory System Agents|sensory system agents|mesh-ancestor
24658872|NCT01274273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658873|NCT01274273|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24658874|NCT01274273|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24658909|NCT01274481|Iloprost|iloprost|mesh-list
24658910|NCT01274481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24658911|NCT01274481|Vasodilator Agents|vasodilator agents|mesh-ancestor
24658912|NCT01274624|Leucovorin|leucovorin|mesh-list
24658913|NCT01274624|Bevacizumab|bevacizumab|mesh-list
24658914|NCT01274624|Fluorouracil|fluorouracil|mesh-list
24658915|NCT01274624|Irinotecan|irinotecan|mesh-list
24658976|NCT01275014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658977|NCT01275014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24658978|NCT01275014|Glucocorticoids|glucocorticoids|mesh-ancestor
24463951|NCT00362869|Levofloxacin|levofloxacin|mesh-list
24463952|NCT00362869|Ofloxacin|ofloxacin|mesh-list
24658979|NCT01275014|Hormones|hormones|mesh-ancestor
24698177|NCT01439399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24659019|NCT01275287|Eculizumab|eculizumab|mesh-list
24659020|NCT01275287|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24659021|NCT01275287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25689245|NCT01958827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24659022|NCT01275287|Immunologic Factors|immunologic factors|mesh-ancestor
24659023|NCT01275287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659024|NCT01275352|Eplerenone|eplerenone|mesh-list
25689246|NCT01958918|Ranibizumab|ranibizumab|mesh-list
25689247|NCT01958918|Aflibercept|aflibercept|mesh-list
25689248|NCT01958918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25689249|NCT01958918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25689250|NCT01958918|Growth Substances|growth substances|mesh-ancestor
24869060|NCT04947592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24659050|NCT01275521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25266544|NCT02427529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266545|NCT02427295|Octreotide|octreotide|mesh-list
25266546|NCT02427295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25266547|NCT02427295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25266548|NCT02427295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659051|NCT01275521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659052|NCT01275521|Cholinergic Agents|cholinergic agents|mesh-ancestor
24659053|NCT01275521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24659054|NCT01275547|Midazolam|midazolam|mesh-list
24659055|NCT01275547|Ketamine|ketamine|mesh-list
24659056|NCT01275547|Morphine|morphine|mesh-list
24698198|NCT01439542|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24698201|NCT01439750|Rituximab|rituximab|mesh-list
24659057|NCT01275547|Esketamine|esketamine|mesh-list
24659058|NCT01275547|Analgesics|analgesics|mesh-ancestor
24857242|NCT02290002|Calcium Dobesilate|calcium dobesilate|mesh-list
24857243|NCT02290002|Calcium|calcium|mesh-list
24857244|NCT02290002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24659059|NCT01275547|Sensory System Agents|sensory system agents|mesh-ancestor
24659060|NCT01275547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24659061|NCT01275547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659062|NCT01275547|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24659063|NCT01275547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24659064|NCT01275547|Anesthetics, General|anesthetics, general|mesh-ancestor
24659065|NCT01275547|Anesthetics|anesthetics|mesh-ancestor
24659066|NCT01275547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24659067|NCT01275547|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24659068|NCT01275547|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24659069|NCT01275547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24659070|NCT01275547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659071|NCT01275547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24659072|NCT01275547|Narcotics|narcotics|mesh-ancestor
24659073|NCT01275547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24659074|NCT01275547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24659075|NCT01275547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24659076|NCT01275547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24920078|NCT04205240|Melphalan|melphalan|mesh-list
24659114|NCT01275638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24659115|NCT01275638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24659116|NCT01275638|Protective Agents|protective agents|mesh-ancestor
24659117|NCT01275729|Furosemide|furosemide|mesh-list
24659118|NCT01275729|Diuretics|diuretics|mesh-ancestor
24659119|NCT01275729|Natriuretic Agents|natriuretic agents|mesh-ancestor
24659120|NCT01275729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659121|NCT01275729|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24659122|NCT01275729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25266579|NCT02427308|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24659123|NCT01275729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659124|NCT01275859|Letrozole|letrozole|mesh-list
24659125|NCT01275859|Lapatinib|lapatinib|mesh-list
24659126|NCT01275859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659127|NCT01275859|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24659128|NCT01275859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24659133|NCT01275859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25266549|NCT02427334|Dienogest|dienogest|mesh-list
25266550|NCT02427334|Fluoxetine|fluoxetine|mesh-list
25266551|NCT02427334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25266552|NCT02427334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24939522|NCT04008784|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24939523|NCT04008784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24939524|NCT04008784|Glucocorticoids|glucocorticoids|mesh-ancestor
24939525|NCT04008784|Hormones|hormones|mesh-ancestor
24541394|NCT00672568|Capsaicin|capsaicin|mesh-list
24659134|NCT01275859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659135|NCT01275859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25689251|NCT01958918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689252|NCT01958918|Growth Inhibitors|growth inhibitors|mesh-ancestor
24659164|NCT01275976|Complement C1s|complement c1s|mesh-list
24659165|NCT01275976|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
24698264|NCT01440140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698265|NCT01440270|Cetuximab|cetuximab|mesh-list
24698266|NCT01440270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24659166|NCT01275976|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
24659167|NCT01275976|Immunologic Factors|immunologic factors|mesh-ancestor
24659168|NCT01275976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659169|NCT01275976|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24698268|NCT01440309|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25266553|NCT02427334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24452547|NCT05458180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266554|NCT02427334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266555|NCT02427334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25266556|NCT02427334|Serotonin Agents|serotonin agents|mesh-ancestor
25266557|NCT02427334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266558|NCT02427334|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25266559|NCT02427334|Antidepressive Agents|antidepressive agents|mesh-ancestor
25266560|NCT02427334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24598045|NCT00953459|Sunitinib|sunitinib|mesh-list
24659259|NCT01276613|Gemcitabine|gemcitabine|mesh-list
24659260|NCT01276613|Losartan|losartan|mesh-list
24659261|NCT01276613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24659262|NCT01276613|Antimetabolites|antimetabolites|mesh-ancestor
24659263|NCT01276613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659265|NCT01276613|Antiviral Agents|antiviral agents|mesh-ancestor
24659291|NCT01276704|Secoisolariciresinol|secoisolariciresinol|mesh-list
24659386|NCT01277289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24659387|NCT01277289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659388|NCT01277289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24659389|NCT01277289|Glucocorticoids|glucocorticoids|mesh-ancestor
24659390|NCT01277289|Hormones|hormones|mesh-ancestor
24659391|NCT01277289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24857248|NCT02290054|Anesthetics|anesthetics|mesh-list
24857249|NCT02290054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24857250|NCT02290054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857251|NCT02290132|Thymoglobulin|thymoglobulin|mesh-list
24857252|NCT02290132|Immunologic Factors|immunologic factors|mesh-ancestor
24857253|NCT02290132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857254|NCT02290132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24659392|NCT01277289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24659393|NCT01277289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659394|NCT01277315|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24659395|NCT01277315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24659396|NCT01277484|Decitabine|decitabine|mesh-list
24869490|NCT03287050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24659397|NCT01277484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24659398|NCT01277484|Antimetabolites|antimetabolites|mesh-ancestor
24659399|NCT01277484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659400|NCT01277484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659425|NCT01277627|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24659426|NCT01277627|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24659427|NCT01277627|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24659429|NCT01277640|Dapivirine|dapivirine|mesh-list
24659439|NCT01277731|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24659441|NCT01277731|Prednisolone acetate|prednisolone acetate|mesh-list
24659442|NCT01277731|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24659443|NCT01277731|Prednisolone phosphate|prednisolone phosphate|mesh-list
24659444|NCT01277731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24659445|NCT01277731|Antiemetics|antiemetics|mesh-ancestor
24659446|NCT01277731|Autonomic Agents|autonomic agents|mesh-ancestor
24659447|NCT01277731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24659488|NCT01278056|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24659489|NCT01278056|Chelating Agents|chelating agents|mesh-ancestor
24659490|NCT01278056|Sequestering Agents|sequestering agents|mesh-ancestor
24659491|NCT01278056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659492|NCT01278082|Budesonide|budesonide|mesh-list
24659493|NCT01278082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24659494|NCT01278082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24659495|NCT01278082|Autonomic Agents|autonomic agents|mesh-ancestor
24659496|NCT01278082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24659602|NCT01278784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659603|NCT01278784|Antidotes|antidotes|mesh-ancestor
24659633|NCT01279096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659634|NCT01279096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24659635|NCT01279096|Glucocorticoids|glucocorticoids|mesh-ancestor
24659636|NCT01279096|Hormones|hormones|mesh-ancestor
24659637|NCT01279096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24659638|NCT01279096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24659639|NCT01279096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659640|NCT01279096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25266564|NCT02427334|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25266565|NCT02427334|Contraceptive Agents|contraceptive agents|mesh-ancestor
25266566|NCT02427334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24456787|NCT00332293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659644|NCT01279096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24659673|NCT01279252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24659674|NCT01279252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24659675|NCT01279252|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24659676|NCT01279252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464147|NCT00363519|Protease Inhibitors|protease inhibitors|mesh-ancestor
24659677|NCT01279252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689253|NCT01958918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25689254|NCT01959035|Aripiprazole|aripiprazole|mesh-list
25689255|NCT01959035|Antidepressive Agents|antidepressive agents|mesh-ancestor
25689256|NCT01959035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25689257|NCT01959035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25689258|NCT01959035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25689259|NCT01959035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25689260|NCT01959035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689261|NCT01959035|Dopamine Agonists|dopamine agonists|mesh-ancestor
25689262|NCT01959035|Dopamine Agents|dopamine agents|mesh-ancestor
24659678|NCT01279252|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24659679|NCT01279252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24659680|NCT01279252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24659681|NCT01279252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24659682|NCT01279252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659683|NCT01279252|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24659710|NCT01279434|Vitamin E|vitamin e|mesh-list
24659711|NCT01279434|Tocopherols|tocopherols|mesh-list
24659712|NCT01279434|Tocotrienols|tocotrienols|mesh-list
24659713|NCT01279434|alpha-Tocopherol|alpha-tocopherol|mesh-list
24659714|NCT01279434|Micronutrients|micronutrients|mesh-ancestor
24698420|NCT01441128|Crizotinib|crizotinib|mesh-list
24659715|NCT01279434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659729|NCT01279499|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24659730|NCT01279499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24659731|NCT01279499|Narcotics|narcotics|mesh-ancestor
24659732|NCT01279499|Analgesics|analgesics|mesh-ancestor
24659733|NCT01279499|Sensory System Agents|sensory system agents|mesh-ancestor
24659734|NCT01279499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24659735|NCT01279512|Metformin|metformin|mesh-list
24659758|NCT01279629|Dermatologic Agents|dermatologic agents|mesh-ancestor
24659759|NCT01279629|Keratolytic Agents|keratolytic agents|mesh-ancestor
24659760|NCT01279668|Montelukast|montelukast|mesh-list
24659761|NCT01279668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24659762|NCT01279668|Respiratory System Agents|respiratory system agents|mesh-ancestor
24659763|NCT01279668|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24659764|NCT01279668|Hormone Antagonists|hormone antagonists|mesh-ancestor
24659765|NCT01279668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25266567|NCT02427334|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25266568|NCT02427334|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25266569|NCT02427334|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25266570|NCT02427334|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25266571|NCT02427334|Hormone Antagonists|hormone antagonists|mesh-ancestor
25266572|NCT02427334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25266573|NCT02427334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25266574|NCT02427334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266575|NCT02427308|Miltefosine|miltefosine|mesh-list
25266576|NCT02427308|Antifungal Agents|antifungal agents|mesh-ancestor
25266577|NCT02427308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25266578|NCT02427308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266580|NCT02427308|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24659766|NCT01279668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659767|NCT01279668|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24659768|NCT01279668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24659769|NCT01279668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857257|NCT02290327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24857258|NCT02290327|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24659772|NCT01279694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24659774|NCT01279694|Hormones|hormones|mesh-ancestor
24659775|NCT01279694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24659776|NCT01279694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659785|NCT01279707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24659786|NCT01279707|Epratuzumab|epratuzumab|mesh-list
24659787|NCT01279707|Veltuzumab|veltuzumab|mesh-list
24659813|NCT01279876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659814|NCT01279876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24659815|NCT01279902|Rituximab|rituximab|mesh-list
24659816|NCT01279902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24659817|NCT01279902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659818|NCT01279902|Immunologic Factors|immunologic factors|mesh-ancestor
24659819|NCT01279902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659820|NCT01279902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24659821|NCT01279915|Linaclotide|linaclotide|mesh-list
24659822|NCT01279915|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
24659823|NCT01279915|Enzyme Activators|enzyme activators|mesh-ancestor
24659860|NCT01280071|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24809601|NCT02035072|Gemcitabine|gemcitabine|mesh-list
24809602|NCT02035072|Oxaliplatin|oxaliplatin|mesh-list
24809603|NCT02035072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24809604|NCT02035072|Antimetabolites|antimetabolites|mesh-ancestor
24869711|NCT00563576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24869712|NCT00563576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24869713|NCT00563576|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24659862|NCT01280071|Purinergic Agents|purinergic agents|mesh-ancestor
24659863|NCT01280071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24659864|NCT01280071|Protective Agents|protective agents|mesh-ancestor
24659865|NCT01280149|Substance P|substance p|mesh-list
24659866|NCT01280149|Neurokinin A|neurokinin a|mesh-list
24659867|NCT01280149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24659868|NCT01280149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659869|NCT01280149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659871|NCT01280162|Artenimol|artenimol|mesh-list
24659872|NCT01280162|Antimalarials|antimalarials|mesh-ancestor
24659873|NCT01280162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24659874|NCT01280162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24659875|NCT01280162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24659876|NCT01280175|Charcoal|charcoal|mesh-list
24659877|NCT01280175|Antidotes|antidotes|mesh-ancestor
24659878|NCT01280175|Protective Agents|protective agents|mesh-ancestor
24659879|NCT01280175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659880|NCT01280188|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24659881|NCT01280188|Hemostatics|hemostatics|mesh-ancestor
24659882|NCT01280188|Coagulants|coagulants|mesh-ancestor
24698529|NCT01441557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698530|NCT01441557|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24698531|NCT01441557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25266581|NCT02427412|Tranexamic Acid|tranexamic acid|mesh-list
25266582|NCT02427412|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25266583|NCT02427412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25266584|NCT02427412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659883|NCT01280188|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24659884|NCT01280188|Natriuretic Agents|natriuretic agents|mesh-ancestor
24659885|NCT01280188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659886|NCT01280214|Triamcinolone|triamcinolone|mesh-list
24659887|NCT01280214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24659888|NCT01280214|Glucocorticoids|glucocorticoids|mesh-ancestor
24659889|NCT01280214|Hormones|hormones|mesh-ancestor
24659924|NCT01280734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659925|NCT01280734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24659926|NCT01280929|Ranibizumab|ranibizumab|mesh-list
24659927|NCT01280929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24659959|NCT01281150|Paclitaxel|paclitaxel|mesh-list
24660038|NCT01281579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660040|NCT01281605|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24660041|NCT01281605|Insulin Detemir|insulin detemir|mesh-list
24660042|NCT01281605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24660043|NCT01281605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660044|NCT01281657|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24660184|NCT01281943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660185|NCT01281943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660186|NCT01281943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24698552|NCT01441869|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24698553|NCT01441869|Protease Inhibitors|protease inhibitors|mesh-ancestor
25689263|NCT01959035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25689264|NCT01959035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689265|NCT01959035|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25689266|NCT01959035|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25689267|NCT01959035|Serotonin Agents|serotonin agents|mesh-ancestor
25689268|NCT01959035|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25689269|NCT01959035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25055508|NCT03520543|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25055509|NCT03520543|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25055510|NCT03520543|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24660187|NCT01281943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24660188|NCT01281943|Antifungal Agents|antifungal agents|mesh-ancestor
24660189|NCT01281943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24660319|NCT01282697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660320|NCT01282697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24660348|NCT01282879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660349|NCT01282879|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24660350|NCT01283048|Bevacizumab|bevacizumab|mesh-list
24660351|NCT01283048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24660352|NCT01283048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660353|NCT01283048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24660354|NCT01283048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25266585|NCT02427412|Hemostatics|hemostatics|mesh-ancestor
24452737|NCT05455944|Pregabalin|pregabalin|mesh-list
25266586|NCT02427412|Coagulants|coagulants|mesh-ancestor
25266587|NCT02427386|Estradiol|estradiol|mesh-list
25266588|NCT02427386|Estrogens|estrogens|mesh-list
25266589|NCT02427386|Hormones|hormones|mesh-ancestor
25266590|NCT02427386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25266591|NCT02427386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266592|NCT02427165|Albuterol|albuterol|mesh-list
25266593|NCT02427165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25266594|NCT02427165|Autonomic Agents|autonomic agents|mesh-ancestor
25045494|NCT00945802|Glucocorticoids|glucocorticoids|mesh-ancestor
24660355|NCT01283048|Growth Substances|growth substances|mesh-ancestor
24660356|NCT01283048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660357|NCT01283048|Growth Inhibitors|growth inhibitors|mesh-ancestor
24660358|NCT01283061|Zafirlukast|zafirlukast|mesh-list
24660359|NCT01283061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24660360|NCT01283061|Respiratory System Agents|respiratory system agents|mesh-ancestor
24660361|NCT01283061|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24660362|NCT01283061|Hormone Antagonists|hormone antagonists|mesh-ancestor
24455598|NCT00328029|Alkylating Agents|alkylating agents|mesh-ancestor
24660390|NCT01283204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660392|NCT01283204|Protective Agents|protective agents|mesh-ancestor
24660393|NCT01283204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660394|NCT01283204|Vitamin B Complex|vitamin b complex|mesh-ancestor
24660395|NCT01283204|Vitamins|vitamins|mesh-ancestor
24660396|NCT01283204|Micronutrients|micronutrients|mesh-ancestor
24660397|NCT01283217|Cisplatin|cisplatin|mesh-list
24660403|NCT01283217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660405|NCT01283256|Anticonvulsants|anticonvulsants|mesh-ancestor
24660406|NCT01283256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24660407|NCT01283256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24660408|NCT01283256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660409|NCT01283256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24660442|NCT01283646|Protective Agents|protective agents|mesh-ancestor
25689270|NCT01959035|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25689271|NCT01959035|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25689272|NCT01959230|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25689273|NCT01959230|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25689274|NCT01959230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25689275|NCT01959230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25689276|NCT01959230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24870040|NCT04274361|Anesthetics, General|anesthetics, general|mesh-ancestor
24870042|NCT04274361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24870043|NCT04274361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24870044|NCT04274361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25055605|NCT03519386|Travoprost|travoprost|mesh-list
25055606|NCT03519386|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25055607|NCT03519386|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25055608|NCT03519386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24809844|NCT02036489|Prednisone|prednisone|mesh-list
24857259|NCT02290327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857260|NCT02290327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857261|NCT02290431|Dexamethasone|dexamethasone|mesh-list
24660443|NCT01283646|Hematinics|hematinics|mesh-ancestor
24660445|NCT01283724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24660446|NCT01283724|Contraceptive Agents|contraceptive agents|mesh-ancestor
24660478|NCT01283789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660479|NCT01283789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24660480|NCT01283789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660481|NCT01283789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660482|NCT01283841|Mycophenolic Acid|mycophenolic acid|mesh-list
24660483|NCT01283841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24660484|NCT01283841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660485|NCT01283841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24660486|NCT01283841|Antitubercular Agents|antitubercular agents|mesh-ancestor
24660596|NCT01284647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24660597|NCT01284647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660598|NCT01284725|Mycophenolic Acid|mycophenolic acid|mesh-list
25266595|NCT02427165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25266596|NCT02427165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266597|NCT02427165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25266598|NCT02427165|Respiratory System Agents|respiratory system agents|mesh-ancestor
25266599|NCT02427165|Tocolytic Agents|tocolytic agents|mesh-ancestor
25266600|NCT02427165|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25266601|NCT02427165|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25266602|NCT02427165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25266603|NCT02427165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25266604|NCT02427165|Adrenergic Agents|adrenergic agents|mesh-ancestor
25266605|NCT02427165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25275425|NCT02372110|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24660634|NCT01284868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24660635|NCT01284868|Vasodilator Agents|vasodilator agents|mesh-ancestor
24660636|NCT01284868|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24660637|NCT01284868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24660638|NCT01284868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24660639|NCT01284868|Urological Agents|urological agents|mesh-ancestor
24660640|NCT01284868|Sympatholytics|sympatholytics|mesh-ancestor
24660641|NCT01284868|Autonomic Agents|autonomic agents|mesh-ancestor
24660642|NCT01284868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24660643|NCT01284868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24660645|NCT01284907|Cholecalciferol|cholecalciferol|mesh-list
24660646|NCT01284907|Vitamins|vitamins|mesh-ancestor
24660647|NCT01284907|Micronutrients|micronutrients|mesh-ancestor
24660648|NCT01284907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660674|NCT01285141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24660675|NCT01285141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660676|NCT01285141|Antiviral Agents|antiviral agents|mesh-ancestor
24660677|NCT01285141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24660678|NCT01285141|Interferon Inducers|interferon inducers|mesh-ancestor
24660690|NCT01285271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24660691|NCT01285271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24660692|NCT01285271|Anesthetics, General|anesthetics, general|mesh-ancestor
24857262|NCT02290431|Bortezomib|bortezomib|mesh-list
24857263|NCT02290431|Panobinostat|panobinostat|mesh-list
25689277|NCT01959230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25689278|NCT01959230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25689279|NCT01959230|Adrenergic Agents|adrenergic agents|mesh-ancestor
25689280|NCT01959230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25689281|NCT01959230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689282|NCT01959230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689283|NCT01959243|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25689284|NCT01959243|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25689285|NCT01959243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25689286|NCT01959243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24857267|NCT02290431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857268|NCT02290431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857269|NCT02290431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24660693|NCT01285271|Anesthetics|anesthetics|mesh-ancestor
24660731|NCT01285466|Mitosis Modulators|mitosis modulators|mesh-ancestor
24660766|NCT01285661|Micronutrients|micronutrients|mesh-ancestor
24660767|NCT01285661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660768|NCT01285661|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24660769|NCT01285661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25266606|NCT02427165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266607|NCT02427243|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25266608|NCT02427243|Immunologic Factors|immunologic factors|mesh-ancestor
25266609|NCT02427243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266610|NCT02426840|Calcium, Dietary|calcium, dietary|mesh-list
25266611|NCT02426840|Vitamin D|vitamin d|mesh-list
25266612|NCT02426840|Ergocalciferols|ergocalciferols|mesh-list
25266613|NCT02426840|Cholecalciferol|cholecalciferol|mesh-list
25266614|NCT02426840|Vitamins|vitamins|mesh-list
24660791|NCT01285817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24660792|NCT01285817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24660793|NCT01285817|Alkylating Agents|alkylating agents|mesh-ancestor
24660794|NCT01285817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660795|NCT01285817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660796|NCT01285817|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24660816|NCT01285817|Antimitotic Agents|antimitotic agents|mesh-ancestor
24660817|NCT01285817|Mitosis Modulators|mitosis modulators|mesh-ancestor
24660818|NCT01285934|Insulin|insulin|mesh-list
24660819|NCT01285934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24660820|NCT01285934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660821|NCT01286051|Ganirelix|ganirelix|mesh-list
24660822|NCT01286051|Hormone Antagonists|hormone antagonists|mesh-ancestor
24660823|NCT01286051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24660824|NCT01286051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660858|NCT01286584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660861|NCT01286688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24660862|NCT01286688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25266615|NCT02426840|Calcium|calcium|mesh-list
25266616|NCT02426840|Micronutrients|micronutrients|mesh-ancestor
25266617|NCT02426840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266618|NCT02426840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25266619|NCT02426840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25266620|NCT02426905|Trientine|trientine|mesh-list
25689287|NCT01959243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25689288|NCT01959243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25689289|NCT01959243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25689290|NCT01959243|Adrenergic Agents|adrenergic agents|mesh-ancestor
25689291|NCT01959243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25689292|NCT01959243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689293|NCT01959243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689294|NCT01959334|Glucagon|glucagon|mesh-list
24496755|NCT00506545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496763|NCT00506623|Capecitabine|capecitabine|mesh-list
25055813|NCT03517930|Respiratory System Agents|respiratory system agents|mesh-ancestor
25055814|NCT03517930|Nasal Decongestants|nasal decongestants|mesh-ancestor
25266621|NCT02426905|Chelating Agents|chelating agents|mesh-ancestor
25266622|NCT02426905|Sequestering Agents|sequestering agents|mesh-ancestor
25266623|NCT02426905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266625|NCT02426866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25266626|NCT02426866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25266627|NCT02426866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25266628|NCT02426866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266629|NCT02426866|Antiviral Agents|antiviral agents|mesh-ancestor
24660863|NCT01286688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660864|NCT01286701|Terbinafine|terbinafine|mesh-list
24660865|NCT01286701|Antifungal Agents|antifungal agents|mesh-ancestor
24660898|NCT01286909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660900|NCT01286948|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24660901|NCT01286948|Contraceptive Agents|contraceptive agents|mesh-ancestor
24660902|NCT01286948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24660903|NCT01286948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660904|NCT01286948|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24660905|NCT01286948|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24660906|NCT01286948|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24660907|NCT01287052|Nitrous Oxide|nitrous oxide|mesh-list
24660908|NCT01287052|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24660909|NCT01287052|Anesthetics, General|anesthetics, general|mesh-ancestor
24660910|NCT01287052|Anesthetics|anesthetics|mesh-ancestor
24660911|NCT01287052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24660912|NCT01287052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660913|NCT01287052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24660914|NCT01287052|Analgesics|analgesics|mesh-ancestor
24660915|NCT01287052|Sensory System Agents|sensory system agents|mesh-ancestor
24660916|NCT01287052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24660917|NCT01287091|Rabeprazole|rabeprazole|mesh-list
24660918|NCT01287091|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24660919|NCT01287091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24660920|NCT01287091|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24660921|NCT01287091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660922|NCT01287091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660924|NCT01287130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24660925|NCT01287130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660926|NCT01287247|Botulinum Toxins|botulinum toxins|mesh-list
24660927|NCT01287247|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24660928|NCT01287247|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24660929|NCT01287247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24660930|NCT01287247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660931|NCT01287247|Cholinergic Agents|cholinergic agents|mesh-ancestor
24660932|NCT01287247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24660948|NCT01287338|Analgesics|analgesics|mesh-ancestor
24660951|NCT01287338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660952|NCT01287338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24660953|NCT01287338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24660954|NCT01287338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24660955|NCT01287338|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24660956|NCT01287338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24660957|NCT01287338|Histamine Antagonists|histamine antagonists|mesh-ancestor
24660958|NCT01287338|Histamine Agents|histamine agents|mesh-ancestor
24660968|NCT01287351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660969|NCT01287351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24660970|NCT01287351|Respiratory System Agents|respiratory system agents|mesh-ancestor
24660971|NCT01287351|Dermatologic Agents|dermatologic agents|mesh-ancestor
24660972|NCT01287351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24660973|NCT01287351|Glucocorticoids|glucocorticoids|mesh-ancestor
25689295|NCT01959334|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25689296|NCT01959334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25689297|NCT01959334|Hormones|hormones|mesh-ancestor
25055906|NCT03517020|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25055907|NCT03517020|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24870371|NCT01471444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24870372|NCT01471444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24870373|NCT05162872|Niraparib|niraparib|mesh-list
24870375|NCT05162872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24870397|NCT05162430|Propofol|propofol|mesh-list
24870398|NCT05162430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24870399|NCT05162430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24870400|NCT05162430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660974|NCT01287351|Hormones|hormones|mesh-ancestor
24660975|NCT01287351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24660976|NCT01287455|Vitamin D|vitamin d|mesh-list
24660977|NCT01287455|Cholecalciferol|cholecalciferol|mesh-list
24660978|NCT01287455|Vitamins|vitamins|mesh-ancestor
24660979|NCT01287455|Micronutrients|micronutrients|mesh-ancestor
24660980|NCT01287455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660982|NCT01287455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24464705|NCT00366067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660984|NCT01287494|Antidepressive Agents|antidepressive agents|mesh-ancestor
24660985|NCT01287494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25266630|NCT02426866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25266631|NCT02426866|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25266632|NCT02426866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25266633|NCT02426866|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25266634|NCT02426866|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24660986|NCT01287494|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24661001|NCT01287546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24661002|NCT01287546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661003|NCT01287546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661004|NCT01287598|Rosiglitazone|rosiglitazone|mesh-list
24661005|NCT01287598|Midazolam|midazolam|mesh-list
24661006|NCT01287598|Omeprazole|omeprazole|mesh-list
24661008|NCT01287598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24661009|NCT01287598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24661010|NCT01287598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24661011|NCT01287598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661012|NCT01287598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24661013|NCT01287598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24661014|NCT01287598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24661015|NCT01287598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24661016|NCT01287598|Anesthetics, General|anesthetics, general|mesh-ancestor
24661017|NCT01287598|Anesthetics|anesthetics|mesh-ancestor
24661018|NCT01287598|GABA Modulators|gaba modulators|mesh-ancestor
24661019|NCT01287598|GABA Agents|gaba agents|mesh-ancestor
24661020|NCT01287598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24661021|NCT01287598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661022|NCT01287598|Anticoagulants|anticoagulants|mesh-ancestor
24661023|NCT01287598|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24661024|NCT01287598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24661025|NCT01287598|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24661026|NCT01287598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661027|NCT01287598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24661028|NCT01287624|Gemcitabine|gemcitabine|mesh-list
24661029|NCT01287624|Paclitaxel|paclitaxel|mesh-list
24661030|NCT01287624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24661031|NCT01287624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24857277|NCT02290431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450282|NCT00318513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25689298|NCT01959334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25689299|NCT01959334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689300|NCT01959334|Incretins|incretins|mesh-ancestor
25689301|NCT01959490|Paclitaxel|paclitaxel|mesh-list
25689302|NCT01959490|Docetaxel|docetaxel|mesh-list
25689303|NCT01959490|Cyclophosphamide|cyclophosphamide|mesh-list
25689304|NCT01959490|Bevacizumab|bevacizumab|mesh-list
25689305|NCT01959490|Carboplatin|carboplatin|mesh-list
25689306|NCT01959490|Doxorubicin|doxorubicin|mesh-list
25689307|NCT01959490|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25689308|NCT01959490|Trastuzumab|trastuzumab|mesh-list
25689309|NCT01959490|Pertuzumab|pertuzumab|mesh-list
25689310|NCT01959490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24870748|NCT04017442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25689311|NCT01959490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870750|NCT04017442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24870751|NCT04017442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870752|NCT04017442|Analgesics|analgesics|mesh-ancestor
24870753|NCT04017442|Sensory System Agents|sensory system agents|mesh-ancestor
24870771|NCT03942224|Dexamethasone|dexamethasone|mesh-list
24870778|NCT03942224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24870779|NCT03942224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870780|NCT03942224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24870852|NCT03296033|Enoxaparin sodium|enoxaparin sodium|mesh-list
24870853|NCT03296033|Anticoagulants|anticoagulants|mesh-ancestor
24661041|NCT01287624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24464742|NCT00366470|Vitamin D|vitamin d|mesh-list
24661042|NCT01287624|Immunologic Factors|immunologic factors|mesh-ancestor
24661043|NCT01287624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661045|NCT01287663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661046|NCT01287663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661047|NCT01287689|Immunoglobulins|immunoglobulins|mesh-list
24661066|NCT01287741|Cyclophosphamide|cyclophosphamide|mesh-list
24661069|NCT01287741|Vincristine|vincristine|mesh-list
24661070|NCT01287741|Obinutuzumab|obinutuzumab|mesh-list
24661071|NCT01287741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24661072|NCT01287741|Immunologic Factors|immunologic factors|mesh-ancestor
24661073|NCT01287741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661074|NCT01287741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24661075|NCT01287741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24661076|NCT01287741|Alkylating Agents|alkylating agents|mesh-ancestor
24661077|NCT01287741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661078|NCT01287741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661079|NCT01287741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24661095|NCT01287780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24661096|NCT01287780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24661097|NCT01287780|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24661098|NCT01287780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661099|NCT01287780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661100|NCT01287793|Moxifloxacin|moxifloxacin|mesh-list
24661101|NCT01287793|Tigecycline|tigecycline|mesh-list
24661291|NCT01288794|Natriuretic Agents|natriuretic agents|mesh-ancestor
24661102|NCT01287793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24661103|NCT01287793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24661104|NCT01287793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24661131|NCT01288131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24661132|NCT01288131|Alkylating Agents|alkylating agents|mesh-ancestor
24661133|NCT01288131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661134|NCT01288131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266635|NCT02426866|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25266636|NCT02426866|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25266637|NCT02426697|Fentanyl|fentanyl|mesh-list
25266638|NCT02426697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25266639|NCT02426697|Narcotics|narcotics|mesh-ancestor
24456788|NCT00332293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24764354|NCT01780883|Antioxidants|antioxidants|mesh-ancestor
24661135|NCT01288131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25689312|NCT01959490|Tubulin Modulators|tubulin modulators|mesh-ancestor
25689313|NCT01959490|Antimitotic Agents|antimitotic agents|mesh-ancestor
25689314|NCT01959490|Mitosis Modulators|mitosis modulators|mesh-ancestor
25689315|NCT01959490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689316|NCT01959490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25689317|NCT01959490|Immunologic Factors|immunologic factors|mesh-ancestor
25689318|NCT01959490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689319|NCT01959490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25689320|NCT01959490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25689321|NCT01959490|Alkylating Agents|alkylating agents|mesh-ancestor
25689322|NCT01959490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25689323|NCT01959490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25689324|NCT01959490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24870968|NCT00893789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24870969|NCT00893789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661136|NCT01288131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661137|NCT01288131|Antifungal Agents|antifungal agents|mesh-ancestor
24661138|NCT01288131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24661139|NCT01288131|Dermatologic Agents|dermatologic agents|mesh-ancestor
24661140|NCT01288131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24661141|NCT01288131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24661142|NCT01288131|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24661143|NCT01288131|Antitubercular Agents|antitubercular agents|mesh-ancestor
24661144|NCT01288131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24661146|NCT01288157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24920480|NCT04202406|Antipyretics|antipyretics|mesh-ancestor
24661228|NCT01288547|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24661229|NCT01288547|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24661230|NCT01288547|Purinergic Agents|purinergic agents|mesh-ancestor
24661231|NCT01288547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24661232|NCT01288547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24661233|NCT01288547|Autonomic Agents|autonomic agents|mesh-ancestor
24661247|NCT01288664|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24661249|NCT01288664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661251|NCT01288716|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24661252|NCT01288716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661253|NCT01288716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24661254|NCT01288716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24661255|NCT01288716|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24661256|NCT01288716|GABA Agonists|gaba agonists|mesh-ancestor
24661257|NCT01288716|GABA Agents|gaba agents|mesh-ancestor
24661258|NCT01288716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24661259|NCT01288716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661261|NCT01288742|Digoxin|digoxin|mesh-list
24661262|NCT01288742|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24661263|NCT01288742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24661264|NCT01288742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24661265|NCT01288742|Antimetabolites|antimetabolites|mesh-ancestor
24661266|NCT01288742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661267|NCT01288742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24661268|NCT01288742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24661269|NCT01288742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661273|NCT01288742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661274|NCT01288742|Antiviral Agents|antiviral agents|mesh-ancestor
24661275|NCT01288742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24661276|NCT01288742|Protease Inhibitors|protease inhibitors|mesh-ancestor
24661277|NCT01288755|Raltegravir Potassium|raltegravir potassium|mesh-list
24661278|NCT01288755|Rilpivirine|rilpivirine|mesh-list
24661279|NCT01288755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24661280|NCT01288755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24661281|NCT01288755|Antiviral Agents|antiviral agents|mesh-ancestor
24661282|NCT01288755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24661283|NCT01288755|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24661284|NCT01288755|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24661285|NCT01288755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661286|NCT01288755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661287|NCT01288755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24661288|NCT01288755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24661289|NCT01288794|Furosemide|furosemide|mesh-list
24661290|NCT01288794|Diuretics|diuretics|mesh-list
24661292|NCT01288794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464881|NCT00367211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24464882|NCT00367211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24464883|NCT00367211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24464884|NCT00367211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24802585|NCT01991119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24661293|NCT01288794|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24661294|NCT01288794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24661295|NCT01288794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266640|NCT02426697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25689325|NCT01959490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25689326|NCT01959490|Growth Substances|growth substances|mesh-ancestor
24871270|NCT04218786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871271|NCT04206813|Vaccines|vaccines|mesh-list
24871272|NCT04206813|Immunologic Factors|immunologic factors|mesh-ancestor
24871273|NCT04206813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871292|NCT04002362|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24871293|NCT04002362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24871294|NCT04002362|Glucocorticoids|glucocorticoids|mesh-ancestor
24661322|NCT01288898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25266641|NCT02426697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266642|NCT02426697|Analgesics|analgesics|mesh-ancestor
25266643|NCT02426697|Sensory System Agents|sensory system agents|mesh-ancestor
24456790|NCT00332293|Contraceptive Agents|contraceptive agents|mesh-ancestor
24456791|NCT00332293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24661332|NCT01288924|Sensory System Agents|sensory system agents|mesh-ancestor
24661333|NCT01288924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24661334|NCT01288924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661335|NCT01288924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24661336|NCT01288924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24661338|NCT01288950|Ergocalciferols|ergocalciferols|mesh-list
24661339|NCT01288950|Cholecalciferol|cholecalciferol|mesh-list
24661340|NCT01288950|Vitamins|vitamins|mesh-list
24661341|NCT01288950|Micronutrients|micronutrients|mesh-ancestor
24661342|NCT01288950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661343|NCT01288950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24661344|NCT01288950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24661345|NCT01288963|Aldesleukin|aldesleukin|mesh-list
24661414|NCT01289327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24661415|NCT01289327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24661416|NCT01289327|GABA Modulators|gaba modulators|mesh-ancestor
24661417|NCT01289327|GABA Agents|gaba agents|mesh-ancestor
24661418|NCT01289327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24661527|NCT01289769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24661528|NCT01289769|Analgesics|analgesics|mesh-ancestor
24661529|NCT01289769|Sensory System Agents|sensory system agents|mesh-ancestor
24661530|NCT01289769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24661531|NCT01289769|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24661532|NCT01289769|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24661537|NCT01289925|Selenium|selenium|mesh-list
24661585|NCT01290003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661586|NCT01290003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661587|NCT01290042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24661588|NCT01290042|Immunologic Factors|immunologic factors|mesh-ancestor
24661589|NCT01290042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661641|NCT01290211|Protease Inhibitors|protease inhibitors|mesh-ancestor
24661642|NCT01290211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661643|NCT01290211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661644|NCT01290211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24661645|NCT01290211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24661646|NCT01290211|Antiviral Agents|antiviral agents|mesh-ancestor
24661647|NCT01290211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24661648|NCT01290211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24661649|NCT01290211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24661650|NCT01290211|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24661651|NCT01290211|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25689327|NCT01959490|Growth Inhibitors|growth inhibitors|mesh-ancestor
25689328|NCT01959490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25689329|NCT01959490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25689330|NCT01959490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25689331|NCT01959490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689332|NCT01959503|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
25689333|NCT01959503|Hemostatics|hemostatics|mesh-ancestor
25689334|NCT01959503|Coagulants|coagulants|mesh-ancestor
24661652|NCT01290211|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24661653|NCT01290276|Ondansetron|ondansetron|mesh-list
24857279|NCT02290470|Dexamethasone acetate|dexamethasone acetate|mesh-list
25689335|NCT01959516|Glycopyrrolate|glycopyrrolate|mesh-list
24871460|NCT02492867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24661655|NCT01290276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24661656|NCT01290276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661657|NCT01290276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24661669|NCT01290276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24661670|NCT01290276|Serotonin Agents|serotonin agents|mesh-ancestor
24661671|NCT01290276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24661672|NCT01290276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24661673|NCT01290276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24661674|NCT01290276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25266644|NCT02426697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25266645|NCT02426697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25266646|NCT02426697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25266647|NCT02426697|Anesthetics, General|anesthetics, general|mesh-ancestor
25266648|NCT02426697|Anesthetics|anesthetics|mesh-ancestor
25266649|NCT02426983|Dextromethorphan|dextromethorphan|mesh-list
25266650|NCT02426983|Antitussive Agents|antitussive agents|mesh-ancestor
24939626|NCT04008186|GABA Agents|gaba agents|mesh-ancestor
24661675|NCT01290276|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24661676|NCT01290302|Azacitidine|azacitidine|mesh-list
24661677|NCT01290302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24661678|NCT01290302|Antimetabolites|antimetabolites|mesh-ancestor
24661679|NCT01290302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661680|NCT01290302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661681|NCT01290302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661738|NCT01290549|Rituximab|rituximab|mesh-list
24661739|NCT01290549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24661740|NCT01290549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661741|NCT01290549|Immunologic Factors|immunologic factors|mesh-ancestor
24661742|NCT01290549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661743|NCT01290549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24661744|NCT01290692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
24661745|NCT01290692|Immunologic Factors|immunologic factors|mesh-ancestor
24661746|NCT01290692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661747|NCT01290744|Clofazimine|clofazimine|mesh-list
24661748|NCT01290744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24661749|NCT01290744|Leprostatic Agents|leprostatic agents|mesh-ancestor
24661750|NCT01290744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24661751|NCT01290744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24661752|NCT01290783|Irinotecan|irinotecan|mesh-list
24661753|NCT01290783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24661754|NCT01290783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24662029|NCT01291979|Anesthetics|anesthetics|mesh-ancestor
24662030|NCT01291979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24662031|NCT01291979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662032|NCT01291979|Sensory System Agents|sensory system agents|mesh-ancestor
24662033|NCT01291979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24662034|NCT01291979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24455759|NCT00328900|Mydriatics|mydriatics|mesh-ancestor
24662035|NCT01291979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24662036|NCT01291979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24662037|NCT01291979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24662038|NCT01291979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662039|NCT01292031|Meropenem|meropenem|mesh-list
24662040|NCT01292031|Colistin|colistin|mesh-list
24662043|NCT01292083|Azacitidine|azacitidine|mesh-list
24662082|NCT01292343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24662083|NCT01292356|Cetuximab|cetuximab|mesh-list
24662120|NCT01292694|Captopril|captopril|mesh-list
24662121|NCT01292694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24662122|NCT01292694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24662123|NCT01292694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24662124|NCT01292694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24662125|NCT01292694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662126|NCT01292694|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24662127|NCT01292694|Protease Inhibitors|protease inhibitors|mesh-ancestor
24662128|NCT01292694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689336|NCT01959516|Tiotropium Bromide|tiotropium bromide|mesh-list
24662129|NCT01292720|Vitamin D|vitamin d|mesh-list
24662130|NCT01292720|Cholecalciferol|cholecalciferol|mesh-list
24662131|NCT01292720|Vitamins|vitamins|mesh-ancestor
24662132|NCT01292720|Micronutrients|micronutrients|mesh-ancestor
25266652|NCT02426983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25266653|NCT02426983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25266654|NCT02426983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25266655|NCT02426983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266656|NCT02426983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275426|NCT02372110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419694|NCT00213291|Darbepoetin alfa|darbepoetin alfa|mesh-list
24662135|NCT01292720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24662136|NCT01292785|Hormones|hormones|mesh-list
24662140|NCT01292863|Dialysis Solutions|dialysis solutions|mesh-list
24662179|NCT01293149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24662180|NCT01293149|Analgesics|analgesics|mesh-ancestor
24662181|NCT01293149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24662182|NCT01293149|Sympatholytics|sympatholytics|mesh-ancestor
24662205|NCT01293266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24662206|NCT01293266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662207|NCT01293266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24662208|NCT01293266|Anesthetics, General|anesthetics, general|mesh-ancestor
24662209|NCT01293266|Anesthetics|anesthetics|mesh-ancestor
24662210|NCT01293292|Teriparatide|teriparatide|mesh-list
24662211|NCT01293292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24662212|NCT01293292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662213|NCT01293292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24662214|NCT01293422|Rifampin|rifampin|mesh-list
24662215|NCT01293422|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24662216|NCT01293422|Antitubercular Agents|antitubercular agents|mesh-ancestor
24662217|NCT01293422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24662218|NCT01293422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24662219|NCT01293422|Leprostatic Agents|leprostatic agents|mesh-ancestor
24662220|NCT01293422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24662221|NCT01293422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24662222|NCT01293422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662223|NCT01293422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24857287|NCT02290470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24857288|NCT02290470|Tubulin Modulators|tubulin modulators|mesh-ancestor
24857289|NCT02290470|Antimitotic Agents|antimitotic agents|mesh-ancestor
24857290|NCT02290470|Mitosis Modulators|mitosis modulators|mesh-ancestor
24699203|NCT01445405|Cetuximab|cetuximab|mesh-list
24522359|NCT03927378|Ketamine|ketamine|mesh-list
24662255|NCT01293643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662256|NCT01293643|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24662258|NCT01293643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24662259|NCT01293643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24662260|NCT01293734|Budesonide|budesonide|mesh-list
24662261|NCT01293734|Theophylline|theophylline|mesh-list
24662262|NCT01293734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24662263|NCT01293734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24662264|NCT01293734|Autonomic Agents|autonomic agents|mesh-ancestor
24662265|NCT01293734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24662266|NCT01293734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662425|NCT01294826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662426|NCT01294852|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25266658|NCT02426723|Lenalidomide|lenalidomide|mesh-list
25266659|NCT02426723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25266660|NCT02426723|Antiemetics|antiemetics|mesh-ancestor
25266661|NCT02426723|Autonomic Agents|autonomic agents|mesh-ancestor
25266662|NCT02426723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24871781|NCT04527289|Antiviral Agents|antiviral agents|mesh-ancestor
24871782|NCT04527289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24871783|NCT04527289|Dopamine Agents|dopamine agents|mesh-ancestor
24871784|NCT04527289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24871785|NCT04527289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871791|NCT04525898|Methadone|methadone|mesh-list
24871824|NCT04282070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25266663|NCT02426723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266664|NCT02426723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25266665|NCT02426723|Glucocorticoids|glucocorticoids|mesh-ancestor
25266666|NCT02426723|Hormones|hormones|mesh-ancestor
25266667|NCT02426723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25266668|NCT02426723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25266669|NCT02426723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266670|NCT02426723|Immunologic Factors|immunologic factors|mesh-ancestor
25266671|NCT02426723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24955742|NCT03862079|Ionophores|ionophores|mesh-ancestor
24857295|NCT02290470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857296|NCT02290470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662427|NCT01294852|Respiratory System Agents|respiratory system agents|mesh-ancestor
24662429|NCT01294878|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24662430|NCT01294878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24662431|NCT01294878|Respiratory System Agents|respiratory system agents|mesh-ancestor
24662432|NCT01294956|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24662433|NCT01294956|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24662434|NCT01294956|Lubricant Eye Drops|lubricant eye drops|mesh-list
24662435|NCT01294956|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24662436|NCT01294956|Laxatives|laxatives|mesh-ancestor
24662437|NCT01294956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24662438|NCT01294969|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
24662478|NCT01295073|Sequestering Agents|sequestering agents|mesh-ancestor
24450283|NCT00318513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24662479|NCT01295073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662481|NCT01295086|Capecitabine|capecitabine|mesh-list
24662482|NCT01295086|Oxaliplatin|oxaliplatin|mesh-list
24662483|NCT01295086|Trastuzumab|trastuzumab|mesh-list
24662484|NCT01295086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662485|NCT01295086|Tubulin Modulators|tubulin modulators|mesh-ancestor
24662486|NCT01295086|Antimitotic Agents|antimitotic agents|mesh-ancestor
24662487|NCT01295086|Mitosis Modulators|mitosis modulators|mesh-ancestor
24662488|NCT01295086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662489|NCT01295086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24662490|NCT01295086|Antimetabolites|antimetabolites|mesh-ancestor
24662491|NCT01295086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24662492|NCT01295099|Triamcinolone|triamcinolone|mesh-list
24662493|NCT01295099|Fluorouracil|fluorouracil|mesh-list
24662516|NCT01295151|Immunologic Factors|immunologic factors|mesh-ancestor
24662517|NCT01295151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662518|NCT01295151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24662519|NCT01295151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24662520|NCT01295151|Dermatologic Agents|dermatologic agents|mesh-ancestor
24662521|NCT01295151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24662522|NCT01295151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24662523|NCT01295151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24662524|NCT01295151|Analgesics|analgesics|mesh-ancestor
25689337|NCT01959516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25689338|NCT01959516|Autonomic Agents|autonomic agents|mesh-ancestor
25689339|NCT01959516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25689340|NCT01959516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689341|NCT01959516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25689342|NCT01959516|Respiratory System Agents|respiratory system agents|mesh-ancestor
25689343|NCT01959516|Parasympatholytics|parasympatholytics|mesh-ancestor
25689344|NCT01959516|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24872019|NCT05400603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872020|NCT05400603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872021|NCT05400603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24872022|NCT05400603|Alkylating Agents|alkylating agents|mesh-ancestor
24872023|NCT05400603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24872064|NCT05399576|Vasodilator Agents|vasodilator agents|mesh-ancestor
24662582|NCT01295502|Paclitaxel|paclitaxel|mesh-list
24662583|NCT01295502|Cisplatin|cisplatin|mesh-list
24857297|NCT02290470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24857298|NCT02290470|Glucocorticoids|glucocorticoids|mesh-ancestor
24857299|NCT02290470|Hormones|hormones|mesh-ancestor
24857300|NCT02290470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24857301|NCT02290470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24857302|NCT02290470|Protease Inhibitors|protease inhibitors|mesh-ancestor
24857303|NCT02290470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857304|NCT02290470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25266672|NCT02426723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25266673|NCT02426723|Growth Substances|growth substances|mesh-ancestor
25266674|NCT02426723|Growth Inhibitors|growth inhibitors|mesh-ancestor
25266675|NCT02426736|Dexamethasone|dexamethasone|mesh-list
25266676|NCT02426736|Bupivacaine|bupivacaine|mesh-list
25266677|NCT02426736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25266678|NCT02426736|Antiemetics|antiemetics|mesh-ancestor
25266679|NCT02426736|Autonomic Agents|autonomic agents|mesh-ancestor
25266680|NCT02426736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25266681|NCT02426736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266682|NCT02426736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25266683|NCT02426736|Glucocorticoids|glucocorticoids|mesh-ancestor
25266684|NCT02426736|Hormones|hormones|mesh-ancestor
25266685|NCT02426736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24857305|NCT02290470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24857306|NCT02290470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24857307|NCT02290470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24662612|NCT01295593|Immunologic Factors|immunologic factors|mesh-ancestor
24662613|NCT01295606|Cefazolin|cefazolin|mesh-list
24662614|NCT01295606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24662615|NCT01295606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24662616|NCT01295736|Sildenafil Citrate|sildenafil citrate|mesh-list
24662617|NCT01295736|Vasodilator Agents|vasodilator agents|mesh-ancestor
24662670|NCT01296178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662671|NCT01296178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24662672|NCT01296178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24662673|NCT01296178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24662676|NCT01296204|Immunologic Factors|immunologic factors|mesh-ancestor
24662732|NCT01296503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24662733|NCT01296503|Glucocorticoids|glucocorticoids|mesh-ancestor
24662734|NCT01296503|Hormones|hormones|mesh-ancestor
24662735|NCT01296503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24662736|NCT01296503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24662737|NCT01296503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662738|NCT01296503|Protease Inhibitors|protease inhibitors|mesh-ancestor
24662739|NCT01296503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24662755|NCT01296555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24662756|NCT01296555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662757|NCT01296555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25689345|NCT01959516|Cholinergic Agents|cholinergic agents|mesh-ancestor
25689346|NCT01959516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25689347|NCT01959516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689348|NCT01959516|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25689349|NCT01959516|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25689350|NCT01959529|Insulin|insulin|mesh-list
25689351|NCT01959529|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25689352|NCT01959529|Insulin Glargine|insulin glargine|mesh-list
25689353|NCT01959529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24662774|NCT01296555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24662775|NCT01296555|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24857308|NCT02290470|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24857312|NCT02290470|Serotonin Agents|serotonin agents|mesh-ancestor
24662777|NCT01296802|Dexfenfluramine|dexfenfluramine|mesh-list
24662778|NCT01296802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24662779|NCT01296802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24662780|NCT01296802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24662781|NCT01296802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662782|NCT01296802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24662783|NCT01296802|Serotonin Agents|serotonin agents|mesh-ancestor
24662784|NCT01296802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662785|NCT01296802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24662786|NCT01296958|Niclosamide|niclosamide|mesh-list
24662787|NCT01296958|Anticestodal Agents|anticestodal agents|mesh-ancestor
24662788|NCT01296958|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24662789|NCT01296958|Anthelmintics|anthelmintics|mesh-ancestor
24662790|NCT01296958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24662791|NCT01296958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24662793|NCT01296971|Ribavirin|ribavirin|mesh-list
24662794|NCT01296971|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24662795|NCT01296971|Antimetabolites|antimetabolites|mesh-ancestor
24455805|NCT00329095|Travoprost|travoprost|mesh-list
24662797|NCT01296971|Antiviral Agents|antiviral agents|mesh-ancestor
25266686|NCT02426736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25266687|NCT02426736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266688|NCT02426736|Anesthetics, Local|anesthetics, local|mesh-ancestor
25266689|NCT02426736|Anesthetics|anesthetics|mesh-ancestor
25266690|NCT02426736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25266691|NCT02426736|Sensory System Agents|sensory system agents|mesh-ancestor
25266692|NCT02426619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25266693|NCT02426619|Fluorides|fluorides|mesh-list
24449741|NCT00316849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24449742|NCT00316849|Antifungal Agents|antifungal agents|mesh-ancestor
24449743|NCT00316849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24449744|NCT00316849|Immunologic Factors|immunologic factors|mesh-ancestor
24449745|NCT00316849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449746|NCT00316875|Doxorubicin|doxorubicin|mesh-list
24449747|NCT00316875|Lapatinib|lapatinib|mesh-list
24662798|NCT01296971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24662800|NCT01296997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24662908|NCT01297634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24662909|NCT01297634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24662910|NCT01297634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662911|NCT01297634|Cholinergic Agents|cholinergic agents|mesh-ancestor
24662912|NCT01297634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24662913|NCT01297634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662914|NCT01297634|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24857314|NCT02290470|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24662949|NCT01297764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24662951|NCT01297764|Growth Inhibitors|growth inhibitors|mesh-ancestor
24662952|NCT01297764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24662958|NCT01297803|Mitomycins|mitomycins|mesh-list
24663046|NCT01298011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24663047|NCT01298011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663048|NCT01298011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24663049|NCT01298011|Immunologic Factors|immunologic factors|mesh-ancestor
24663175|NCT01298843|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
24663176|NCT01298843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24663177|NCT01298843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24663178|NCT01298882|Diacetylrhein|diacetylrhein|mesh-list
24663179|NCT01298882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24663180|NCT01298934|Panobinostat|panobinostat|mesh-list
24663181|NCT01298934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663182|NCT01298934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24663204|NCT01299194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24663205|NCT01299194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24663206|NCT01299194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663207|NCT01299220|Acitretin|acitretin|mesh-list
24663208|NCT01299220|Keratolytic Agents|keratolytic agents|mesh-ancestor
24663209|NCT01299220|Dermatologic Agents|dermatologic agents|mesh-ancestor
24663210|NCT01299298|Mipomersen|mipomersen|mesh-list
24663211|NCT01299298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24663212|NCT01299298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24663213|NCT01299298|Antimetabolites|antimetabolites|mesh-ancestor
24663214|NCT01299298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663227|NCT01299558|Dermatologic Agents|dermatologic agents|mesh-ancestor
24663228|NCT01299558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24663229|NCT01299597|Atorvastatin|atorvastatin|mesh-list
24663230|NCT01299597|Simvastatin|simvastatin|mesh-list
24663231|NCT01299597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24663232|NCT01299597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24663233|NCT01299597|Antimetabolites|antimetabolites|mesh-ancestor
24663264|NCT01299922|Antifungal Agents|antifungal agents|mesh-ancestor
24663265|NCT01299922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24663266|NCT01299922|Dermatologic Agents|dermatologic agents|mesh-ancestor
25266694|NCT02426619|Sodium Fluoride|sodium fluoride|mesh-list
25266695|NCT02426619|Fluorides, Topical|fluorides, topical|mesh-list
25266696|NCT02426619|Cariostatic Agents|cariostatic agents|mesh-ancestor
25266697|NCT02426619|Protective Agents|protective agents|mesh-ancestor
25266698|NCT02426619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266699|NCT02426502|Cyclosporine|cyclosporine|mesh-list
25266700|NCT02426502|Mycophenolic Acid|mycophenolic acid|mesh-list
25266701|NCT02426502|Prednisone|prednisone|mesh-list
25266702|NCT02426502|Azathioprine|azathioprine|mesh-list
25266703|NCT02426502|Antihypertensive Agents|antihypertensive agents|mesh-list
24449749|NCT00316875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449750|NCT00316875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24449751|NCT00316875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24663267|NCT01299922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24663268|NCT01299922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24663269|NCT01299922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24663270|NCT01299922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663271|NCT01299922|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24621254|NCT01061216|Insulin|insulin|mesh-list
24663420|NCT01301040|Alkylating Agents|alkylating agents|mesh-ancestor
24663421|NCT01301040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663422|NCT01301040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663423|NCT01301040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24663424|NCT01301040|Tubulin Modulators|tubulin modulators|mesh-ancestor
24663425|NCT01301040|Antimitotic Agents|antimitotic agents|mesh-ancestor
24663480|NCT01301716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24663481|NCT01301716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663482|NCT01301716|Tubulin Modulators|tubulin modulators|mesh-ancestor
25689354|NCT01959529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692635|NCT02003365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25692636|NCT02003365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692637|NCT02003365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24872538|NCT05325580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24872539|NCT05325580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872540|NCT05325580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24872542|NCT05325580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24872543|NCT05315479|Meloxicam|meloxicam|mesh-list
24872544|NCT05315479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24663483|NCT01301716|Antimitotic Agents|antimitotic agents|mesh-ancestor
24663484|NCT01301716|Mitosis Modulators|mitosis modulators|mesh-ancestor
24663485|NCT01301716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663486|NCT01301716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24663487|NCT01301716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24663488|NCT01301716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24663489|NCT01301716|Growth Substances|growth substances|mesh-ancestor
24663490|NCT01301716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663491|NCT01301716|Growth Inhibitors|growth inhibitors|mesh-ancestor
24663492|NCT01301716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663493|NCT01301716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24663494|NCT01301716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24857317|NCT02290717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24663495|NCT01301820|Lenalidomide|lenalidomide|mesh-list
24663496|NCT01301820|Azacitidine|azacitidine|mesh-list
24663497|NCT01301820|Immunologic Factors|immunologic factors|mesh-ancestor
24663498|NCT01301820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663499|NCT01301820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24663500|NCT01301820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24663576|NCT01302275|Anticonvulsants|anticonvulsants|mesh-ancestor
24663577|NCT01302275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24663578|NCT01302275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24663579|NCT01302275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24663580|NCT01302275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663581|NCT01302275|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24663582|NCT01302275|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24663584|NCT01302340|Hallucinogens|hallucinogens|mesh-ancestor
24663585|NCT01302340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663586|NCT01302340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24663587|NCT01302340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24663588|NCT01302340|Analgesics|analgesics|mesh-ancestor
24663589|NCT01302340|Sensory System Agents|sensory system agents|mesh-ancestor
24663621|NCT01302587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24663622|NCT01302587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663714|NCT01303497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24663715|NCT01303497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663716|NCT01303497|Tubulin Modulators|tubulin modulators|mesh-ancestor
24663717|NCT01303497|Antimitotic Agents|antimitotic agents|mesh-ancestor
24920914|NCT04196608|Relebactam|relebactam|mesh-list
24663755|NCT01303601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663756|NCT01303601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663758|NCT01303601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24663759|NCT01303601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25689356|NCT01959672|Leucovorin|leucovorin|mesh-list
25689357|NCT01959672|Folic Acid|folic acid|mesh-list
25689358|NCT01959672|Gemcitabine|gemcitabine|mesh-list
25689359|NCT01959672|Nelfinavir|nelfinavir|mesh-list
25689360|NCT01959672|Fluorouracil|fluorouracil|mesh-list
25689361|NCT01959672|Oregovomab|oregovomab|mesh-list
25689362|NCT01959672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25689363|NCT01959672|Antibodies|antibodies|mesh-list
25689364|NCT01959672|Immunoglobulins|immunoglobulins|mesh-list
25689365|NCT01959672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25689366|NCT01959672|Calcium|calcium|mesh-list
25689367|NCT01959672|Levoleucovorin|levoleucovorin|mesh-list
25689368|NCT01959672|Immunologic Factors|immunologic factors|mesh-ancestor
25689369|NCT01959672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872727|NCT05232734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24872728|NCT05232734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24872729|NCT05232734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24663760|NCT01303601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25266704|NCT02426502|Cyclosporins|cyclosporins|mesh-list
25266706|NCT02426502|Glucocorticoids|glucocorticoids|mesh-ancestor
25266707|NCT02426502|Hormones|hormones|mesh-ancestor
24449752|NCT00316875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419823|NCT00214214|Alemtuzumab|alemtuzumab|mesh-list
24663761|NCT01303601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24663762|NCT01303601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24857318|NCT02290717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24857319|NCT02290717|Autonomic Agents|autonomic agents|mesh-ancestor
24396988|NCT00140530|Sirolimus|sirolimus|mesh-list
24663763|NCT01303601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24663764|NCT01303601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24663765|NCT01303601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663766|NCT01303601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24663767|NCT01303601|Serotonin Agents|serotonin agents|mesh-ancestor
24663768|NCT01303614|Lidocaine|lidocaine|mesh-list
24663769|NCT01303614|Prilocaine|prilocaine|mesh-list
24663770|NCT01303614|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24663771|NCT01303614|Anesthetics, Local|anesthetics, local|mesh-ancestor
24663772|NCT01303614|Anesthetics|anesthetics|mesh-ancestor
24663773|NCT01303614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24663899|NCT01304069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663900|NCT01304069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24663901|NCT01304069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24663902|NCT01304069|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24663903|NCT01304069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24663904|NCT01304069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663905|NCT01304069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663906|NCT01304095|Ranolazine|ranolazine|mesh-list
24663907|NCT01304095|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24663908|NCT01304095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24663909|NCT01304095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663910|NCT01304134|Morphine|morphine|mesh-list
24663911|NCT01304134|Oxycodone|oxycodone|mesh-list
24663912|NCT01304134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24663913|NCT01304134|Narcotics|narcotics|mesh-ancestor
24663914|NCT01304134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24663915|NCT01304134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663916|NCT01304134|Analgesics|analgesics|mesh-ancestor
24663917|NCT01304134|Sensory System Agents|sensory system agents|mesh-ancestor
24663918|NCT01304134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663919|NCT01304212|Ketorolac|ketorolac|mesh-list
24663920|NCT01304212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24663921|NCT01304212|Epinephrine|epinephrine|mesh-list
25689370|NCT01959672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25689371|NCT01959672|Antimetabolites|antimetabolites|mesh-ancestor
25689372|NCT01959672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689373|NCT01959672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25689374|NCT01959672|Antiviral Agents|antiviral agents|mesh-ancestor
25689375|NCT01959672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25689376|NCT01959672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689377|NCT01959672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25689378|NCT01959672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25689379|NCT01959672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25689380|NCT01959672|Antidotes|antidotes|mesh-ancestor
24872870|NCT05439577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24663922|NCT01304212|Racepinephrine|racepinephrine|mesh-list
24663923|NCT01304212|Morphine|morphine|mesh-list
24663924|NCT01304212|Ropivacaine|ropivacaine|mesh-list
24663925|NCT01304212|Epinephryl borate|epinephryl borate|mesh-list
24663926|NCT01304212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24663927|NCT01304212|Narcotics|narcotics|mesh-ancestor
24663928|NCT01304212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24663929|NCT01304212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663930|NCT01304212|Analgesics|analgesics|mesh-ancestor
24663931|NCT01304212|Sensory System Agents|sensory system agents|mesh-ancestor
24664190|NCT01305707|Imipramine|imipramine|mesh-list
24465156|NCT00368030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664353|NCT01306318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24664354|NCT01306318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24664355|NCT01306318|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24664356|NCT01306318|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24664357|NCT01306318|Parasympatholytics|parasympatholytics|mesh-ancestor
24664359|NCT01306318|Vasodilator Agents|vasodilator agents|mesh-ancestor
24664360|NCT01306357|Hormones|hormones|mesh-list
24664361|NCT01306357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25266708|NCT02426502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25266709|NCT02426502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266710|NCT02426502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25266711|NCT02426502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266712|NCT02426502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25266713|NCT02426502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266714|NCT02426502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25266715|NCT02426502|Immunologic Factors|immunologic factors|mesh-ancestor
24939658|NCT04008433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24664362|NCT01306357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664363|NCT01306370|Tranexamic Acid|tranexamic acid|mesh-list
24664364|NCT01306370|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24664365|NCT01306370|Hemostatics|hemostatics|mesh-list
24664589|NCT01307865|Diuretics|diuretics|mesh-ancestor
24664591|NCT01307865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664593|NCT01307969|Epinephrine|epinephrine|mesh-list
24664595|NCT01307969|Ropivacaine|ropivacaine|mesh-list
24664596|NCT01307969|Epinephryl borate|epinephryl borate|mesh-list
24664597|NCT01307969|Anesthetics, Local|anesthetics, local|mesh-ancestor
24664598|NCT01307969|Anesthetics|anesthetics|mesh-ancestor
24664599|NCT01307969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24664600|NCT01307969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664601|NCT01307969|Sensory System Agents|sensory system agents|mesh-ancestor
24664602|NCT01307969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24664603|NCT01307969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24664604|NCT01307969|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24664605|NCT01307969|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24664606|NCT01307969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24664607|NCT01307969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664608|NCT01307969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24664655|NCT01308203|Niacin|niacin|mesh-list
24664777|NCT01308632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664780|NCT01308658|Darunavir|darunavir|mesh-list
25689381|NCT01959672|Protective Agents|protective agents|mesh-ancestor
25689382|NCT01959672|Vitamin B Complex|vitamin b complex|mesh-ancestor
25689383|NCT01959672|Vitamins|vitamins|mesh-ancestor
25689384|NCT01959672|Micronutrients|micronutrients|mesh-ancestor
25689385|NCT01959672|Hematinics|hematinics|mesh-ancestor
25689386|NCT01959672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25689387|NCT01959672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25689388|NCT01959672|Protease Inhibitors|protease inhibitors|mesh-ancestor
25689389|NCT01959672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24664842|NCT01309009|Respiratory System Agents|respiratory system agents|mesh-ancestor
24664844|NCT01309022|Sirolimus|sirolimus|mesh-list
24664845|NCT01309022|Tacrolimus|tacrolimus|mesh-list
24664846|NCT01309022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24664847|NCT01309022|Immunologic Factors|immunologic factors|mesh-ancestor
24664848|NCT01309022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664849|NCT01309022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24664850|NCT01309022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24664907|NCT01309178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664909|NCT01309178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24664968|NCT01309542|Antidepressive Agents|antidepressive agents|mesh-ancestor
24664969|NCT01309542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24664970|NCT01309607|Paclitaxel|paclitaxel|mesh-list
24665073|NCT01309984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24665074|NCT01309984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24665075|NCT01309984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665076|NCT01309984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24665077|NCT01309984|Anesthetics, General|anesthetics, general|mesh-ancestor
24665078|NCT01309984|Anesthetics|anesthetics|mesh-ancestor
24665079|NCT01310101|Dexamethasone|dexamethasone|mesh-list
24665080|NCT01310101|Ofatumumab|ofatumumab|mesh-list
24665081|NCT01310101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24665082|NCT01310101|Antiemetics|antiemetics|mesh-ancestor
24665083|NCT01310101|Autonomic Agents|autonomic agents|mesh-ancestor
24665084|NCT01310101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24665085|NCT01310101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665086|NCT01310101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24665087|NCT01310101|Glucocorticoids|glucocorticoids|mesh-ancestor
25266716|NCT02426502|Antifungal Agents|antifungal agents|mesh-ancestor
24665088|NCT01310101|Hormones|hormones|mesh-ancestor
24665684|NCT01314144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24665089|NCT01310101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24665090|NCT01310101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24465251|NCT00368342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24665091|NCT01310101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266717|NCT02426502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25266718|NCT02426502|Dermatologic Agents|dermatologic agents|mesh-ancestor
25266719|NCT02426502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24665092|NCT01310166|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24665093|NCT01310166|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24665119|NCT01310283|Cariostatic Agents|cariostatic agents|mesh-ancestor
24459845|NCT00346580|Protease Inhibitors|protease inhibitors|mesh-ancestor
24398107|NCT00143481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665120|NCT01310283|Protective Agents|protective agents|mesh-ancestor
24665121|NCT01310283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665124|NCT01310296|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24665144|NCT01310361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24665173|NCT01310673|Allopurinol|allopurinol|mesh-list
24665174|NCT01310673|Antimetabolites|antimetabolites|mesh-ancestor
24665175|NCT01310673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665176|NCT01310673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689390|NCT01959672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25689391|NCT01959685|Enclomiphene|enclomiphene|mesh-list
25689392|NCT01959685|Clomiphene|clomiphene|mesh-list
25689393|NCT01959685|Zuclomiphene|zuclomiphene|mesh-list
25689394|NCT01959685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25689395|NCT01959685|Hormone Antagonists|hormone antagonists|mesh-ancestor
25056148|NCT03515200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25056149|NCT03515187|Bromides|bromides|mesh-list
25056150|NCT03515187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25056151|NCT03515187|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25056152|NCT03515187|Hyaluronic Acid|hyaluronic acid|mesh-list
25056153|NCT03515187|Anticonvulsants|anticonvulsants|mesh-ancestor
25056154|NCT03515187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25056155|NCT03515187|Immunologic Factors|immunologic factors|mesh-ancestor
24605694|NCT00986778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24873028|NCT05430893|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24873029|NCT05430893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24873030|NCT05430893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24873031|NCT05430893|Cholinergic Agents|cholinergic agents|mesh-ancestor
24873032|NCT05430893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665177|NCT01310673|Gout Suppressants|gout suppressants|mesh-ancestor
24665178|NCT01310673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24665179|NCT01310673|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24665180|NCT01310673|Antioxidants|antioxidants|mesh-ancestor
24665181|NCT01310673|Protective Agents|protective agents|mesh-ancestor
24665182|NCT01310673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665183|NCT01310712|Oxybutynin|oxybutynin|mesh-list
24665184|NCT01310712|Parasympatholytics|parasympatholytics|mesh-ancestor
24665185|NCT01310712|Autonomic Agents|autonomic agents|mesh-ancestor
24665450|NCT01312363|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24665451|NCT01312363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24665452|NCT01312363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857341|NCT02291094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412483|NCT00191503|Pemetrexed|pemetrexed|mesh-list
24665453|NCT01312363|Cholinergic Agents|cholinergic agents|mesh-ancestor
24665454|NCT01312363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665455|NCT01312363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665456|NCT01312363|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24665457|NCT01312363|Protective Agents|protective agents|mesh-ancestor
24665459|NCT01312376|Bevacizumab|bevacizumab|mesh-list
24665460|NCT01312376|Fludarabine|fludarabine|mesh-list
24665461|NCT01312376|Vaccines|vaccines|mesh-list
24665462|NCT01312376|Immunologic Factors|immunologic factors|mesh-ancestor
24465256|NCT00368381|Hydrocortisone|hydrocortisone|mesh-list
24665463|NCT01312376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665464|NCT01312376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24665466|NCT01312376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24665467|NCT01312376|Alkylating Agents|alkylating agents|mesh-ancestor
24665524|NCT01313143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665525|NCT01313143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665557|NCT01313403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24665559|NCT01313429|Cyclophosphamide|cyclophosphamide|mesh-list
24665560|NCT01313429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24665561|NCT01313429|Immunologic Factors|immunologic factors|mesh-ancestor
24665562|NCT01313429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665563|NCT01313429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24665564|NCT01313429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25689396|NCT01959685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25689397|NCT01959685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689398|NCT01959685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25689399|NCT01959685|Fertility Agents|fertility agents|mesh-ancestor
25689400|NCT01959685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25689401|NCT01959685|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25689402|NCT01959685|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25689403|NCT01959841|Valacyclovir|valacyclovir|mesh-list
25689404|NCT01959841|Antiviral Agents|antiviral agents|mesh-ancestor
25689405|NCT01959841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25689406|NCT01959919|Factor VIII|factor viii|mesh-list
25689407|NCT01959919|Coagulants|coagulants|mesh-ancestor
25689408|NCT01959945|Vaccines|vaccines|mesh-list
25689409|NCT01959945|Hemagglutinins|hemagglutinins|mesh-list
25689410|NCT01959945|Immunologic Factors|immunologic factors|mesh-ancestor
25689411|NCT01959945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689412|NCT01959945|Agglutinins|agglutinins|mesh-ancestor
24665565|NCT01313429|Alkylating Agents|alkylating agents|mesh-ancestor
25689413|NCT01960075|Fosphenytoin|fosphenytoin|mesh-list
24815137|NCT02068287|Adrenergic Agents|adrenergic agents|mesh-ancestor
24815138|NCT02068287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24815139|NCT02068287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24873198|NCT05328154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24873199|NCT05328154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665566|NCT01313429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665567|NCT01313429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665568|NCT01313429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24665605|NCT01313611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24665606|NCT01313611|Alkylating Agents|alkylating agents|mesh-ancestor
24621947|NCT01064986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665682|NCT01314144|Anesthetics, Local|anesthetics, local|mesh-ancestor
24665683|NCT01314144|Anesthetics|anesthetics|mesh-ancestor
24666644|NCT01320254|Cisplatin|cisplatin|mesh-list
24665685|NCT01314144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665686|NCT01314144|Sensory System Agents|sensory system agents|mesh-ancestor
24665710|NCT01314300|Lidocaine|lidocaine|mesh-list
25266720|NCT02426502|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25266721|NCT02426502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25266722|NCT02426502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25266723|NCT02426502|Antitubercular Agents|antitubercular agents|mesh-ancestor
24456798|NCT00332306|Nevirapine|nevirapine|mesh-list
24456799|NCT00332306|Didanosine|didanosine|mesh-list
24456800|NCT00332306|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24665711|NCT01314300|Anesthetics, Local|anesthetics, local|mesh-ancestor
24665712|NCT01314300|Anesthetics|anesthetics|mesh-ancestor
24465272|NCT00368602|Timolol|timolol|mesh-list
24665713|NCT01314300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24665714|NCT01314300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665715|NCT01314300|Sensory System Agents|sensory system agents|mesh-ancestor
24665716|NCT01314300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24665717|NCT01314300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24665770|NCT01314781|Cholinergic Agents|cholinergic agents|mesh-ancestor
24665771|NCT01314781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24459852|NCT00346619|Nelfinavir|nelfinavir|mesh-list
24398779|NCT00145639|Ifosfamide|ifosfamide|mesh-list
24665772|NCT01314781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665773|NCT01314781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665774|NCT01314781|Urological Agents|urological agents|mesh-ancestor
24665778|NCT01314833|Fluorouracil|fluorouracil|mesh-list
24665779|NCT01314833|Epirubicin|epirubicin|mesh-list
24665812|NCT01314898|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24665813|NCT01314898|Hormone Antagonists|hormone antagonists|mesh-ancestor
24665814|NCT01314898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24665815|NCT01314898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665816|NCT01314898|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24665882|NCT01315470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665883|NCT01315496|Immunoglobulins|immunoglobulins|mesh-list
24665884|NCT01315496|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24665885|NCT01315496|Antibodies|antibodies|mesh-list
25689414|NCT01960075|Levetiracetam|levetiracetam|mesh-list
25689415|NCT01960075|Valproic Acid|valproic acid|mesh-list
25689416|NCT01960075|Anticonvulsants|anticonvulsants|mesh-ancestor
25689417|NCT01960075|Nootropic Agents|nootropic agents|mesh-ancestor
25689418|NCT01960075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689419|NCT01960075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689420|NCT01960075|GABA Agents|gaba agents|mesh-ancestor
25689421|NCT01960075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665886|NCT01315496|Immunoglobulin G|immunoglobulin g|mesh-list
25689422|NCT01960075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689423|NCT01960075|Antimanic Agents|antimanic agents|mesh-ancestor
24665888|NCT01315496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665889|NCT01315691|Amikacin|amikacin|mesh-list
24665898|NCT01315795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665899|NCT01315886|Fentanyl|fentanyl|mesh-list
24665900|NCT01315886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24665901|NCT01315886|Narcotics|narcotics|mesh-ancestor
24665902|NCT01315886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24665903|NCT01315886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665905|NCT01315886|Sensory System Agents|sensory system agents|mesh-ancestor
24665906|NCT01315886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24665907|NCT01315886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24665908|NCT01315886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24665909|NCT01315886|Anesthetics, General|anesthetics, general|mesh-ancestor
24665910|NCT01315886|Anesthetics|anesthetics|mesh-ancestor
24665911|NCT01315912|Letrozole|letrozole|mesh-list
24665912|NCT01315912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665913|NCT01315912|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24665914|NCT01315912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24665915|NCT01315912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24665916|NCT01315912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266724|NCT02426502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25266725|NCT02426502|Antimetabolites|antimetabolites|mesh-ancestor
25266726|NCT02426502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25266727|NCT02426463|Oxycodone|oxycodone|mesh-list
25266728|NCT02426463|Propofol|propofol|mesh-list
25266729|NCT02426463|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25266730|NCT02426463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24666645|NCT01320254|Panitumumab|panitumumab|mesh-list
25266733|NCT02426463|Anesthetics, General|anesthetics, general|mesh-ancestor
25266734|NCT02426463|Anesthetics|anesthetics|mesh-ancestor
25266735|NCT02426463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25266736|NCT02426463|Narcotics|narcotics|mesh-ancestor
25266737|NCT02426463|Analgesics|analgesics|mesh-ancestor
24451527|NCT00324051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451528|NCT00324051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24451529|NCT00324051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24665917|NCT01315912|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24665952|NCT01316081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665953|NCT01316081|Antioxidants|antioxidants|mesh-ancestor
24666001|NCT01316718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24666002|NCT01316718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666003|NCT01316718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24666004|NCT01316718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24666006|NCT01316744|Analgesics|analgesics|mesh-ancestor
24666007|NCT01316744|Sensory System Agents|sensory system agents|mesh-ancestor
24666008|NCT01316744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24666009|NCT01316744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666010|NCT01316744|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24666011|NCT01316744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24666013|NCT01316744|Anesthetics|anesthetics|mesh-ancestor
25689424|NCT01960075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25689425|NCT01960075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25689426|NCT01960075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25689427|NCT01960075|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25689428|NCT01960075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25689429|NCT01960114|Acetaminophen|acetaminophen|mesh-list
25689430|NCT01960114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25689431|NCT01960114|Analgesics|analgesics|mesh-ancestor
25689432|NCT01960114|Sensory System Agents|sensory system agents|mesh-ancestor
25689433|NCT01960114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24666088|NCT01317212|Carboplatin|carboplatin|mesh-list
24666089|NCT01317212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24666090|NCT01317225|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
25056205|NCT03514667|Curcumin|curcumin|mesh-list
25056206|NCT03514667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25056207|NCT03514667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25056208|NCT03514667|Analgesics|analgesics|mesh-ancestor
25056209|NCT03514667|Sensory System Agents|sensory system agents|mesh-ancestor
24666091|NCT01317225|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
24666092|NCT01317225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24666093|NCT01317225|Hormone Antagonists|hormone antagonists|mesh-ancestor
24666094|NCT01317225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24666095|NCT01317225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666096|NCT01317225|Progestins|progestins|mesh-ancestor
25689434|NCT01960114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689435|NCT01960114|Antipyretics|antipyretics|mesh-ancestor
24666097|NCT01317225|Hormones|hormones|mesh-ancestor
24666098|NCT01317368|Ropivacaine|ropivacaine|mesh-list
24666099|NCT01317368|Anesthetics, Local|anesthetics, local|mesh-ancestor
24666100|NCT01317368|Anesthetics|anesthetics|mesh-ancestor
24666101|NCT01317368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24666105|NCT01317433|Doxycycline|doxycycline|mesh-list
24666106|NCT01317433|Cetuximab|cetuximab|mesh-list
24666107|NCT01317433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24666108|NCT01317433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24666109|NCT01317433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24666110|NCT01317433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24666111|NCT01317433|Antimalarials|antimalarials|mesh-ancestor
24666112|NCT01317433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24666113|NCT01317433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24666114|NCT01317446|Fluorides|fluorides|mesh-list
24666115|NCT01317446|Tin Fluorides|tin fluorides|mesh-list
24666116|NCT01317446|Cariostatic Agents|cariostatic agents|mesh-ancestor
24666117|NCT01317446|Protective Agents|protective agents|mesh-ancestor
24666156|NCT01317849|Pyridoxal|pyridoxal|mesh-list
24666157|NCT01317849|Vitamin B 6|vitamin b 6|mesh-list
24666193|NCT01317992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666194|NCT01317992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666195|NCT01317992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24666196|NCT01317992|Vasodilator Agents|vasodilator agents|mesh-ancestor
24666197|NCT01318005|Contraceptive Agents|contraceptive agents|mesh-list
24666227|NCT01318096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666228|NCT01318096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266738|NCT02426463|Sensory System Agents|sensory system agents|mesh-ancestor
25266739|NCT02426463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25266740|NCT02426294|Pioglitazone|pioglitazone|mesh-list
25266741|NCT02426294|Glimepiride|glimepiride|mesh-list
25266742|NCT02426294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25266743|NCT02426294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266744|NCT02426294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24939667|NCT04008316|Antimitotic Agents|antimitotic agents|mesh-ancestor
25689436|NCT01960140|Simvastatin|simvastatin|mesh-list
25689437|NCT01960140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25689438|NCT01960140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25689439|NCT01960140|Antimetabolites|antimetabolites|mesh-ancestor
25689440|NCT01960140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689441|NCT01960140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24815155|NCT02068339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815156|NCT02068404|Nifedipine|nifedipine|mesh-list
24815157|NCT02068404|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24815158|NCT02068404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24939668|NCT04008316|Mitosis Modulators|mitosis modulators|mesh-ancestor
24939669|NCT04008316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939670|NCT04008316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24666230|NCT01318096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24666231|NCT01318096|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24666232|NCT01318096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24857350|NCT02291341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24857351|NCT02291341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857352|NCT02291341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24857353|NCT02291341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857355|NCT02291341|Sensory System Agents|sensory system agents|mesh-ancestor
24857356|NCT02291341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857357|NCT02291341|Antidepressive Agents|antidepressive agents|mesh-ancestor
24857358|NCT02291341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24666233|NCT01318096|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24666234|NCT01318096|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24666236|NCT01318096|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24666344|NCT01318655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24666345|NCT01318668|Vaccines|vaccines|mesh-list
24666346|NCT01318668|Immunologic Factors|immunologic factors|mesh-ancestor
24666347|NCT01318668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666348|NCT01318681|Fluticasone|fluticasone|mesh-list
24666349|NCT01318681|Xhance|xhance|mesh-list
24666350|NCT01318681|Cetirizine|cetirizine|mesh-list
24666351|NCT01318681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24666405|NCT01319188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24666441|NCT01319279|Hydrocodone|hydrocodone|mesh-list
24666442|NCT01319279|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24666472|NCT01319357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24700311|NCT01451840|Narcotics|narcotics|mesh-ancestor
24666473|NCT01319357|Protease Inhibitors|protease inhibitors|mesh-ancestor
24666474|NCT01319357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666475|NCT01319357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666476|NCT01319357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24666478|NCT01319370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24666479|NCT01319370|Vasodilator Agents|vasodilator agents|mesh-ancestor
24666480|NCT01319448|Artesunate|artesunate|mesh-list
24666481|NCT01319448|Pyrimethamine|pyrimethamine|mesh-list
25266745|NCT02426294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25266746|NCT02426294|Immunologic Factors|immunologic factors|mesh-ancestor
25266747|NCT02426450|Leucovorin|leucovorin|mesh-list
25266748|NCT02426450|Fluorouracil|fluorouracil|mesh-list
25266749|NCT02426450|Oxaliplatin|oxaliplatin|mesh-list
25266750|NCT02426450|Antimetabolites|antimetabolites|mesh-ancestor
25266751|NCT02426450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266752|NCT02426450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25266753|NCT02426450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266754|NCT02426450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25266755|NCT02426450|Immunologic Factors|immunologic factors|mesh-ancestor
25266756|NCT02426450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266757|NCT02426450|Antidotes|antidotes|mesh-ancestor
25266758|NCT02426450|Protective Agents|protective agents|mesh-ancestor
25266759|NCT02426450|Vitamin B Complex|vitamin b complex|mesh-ancestor
25266760|NCT02426450|Vitamins|vitamins|mesh-ancestor
25266761|NCT02426450|Micronutrients|micronutrients|mesh-ancestor
25266762|NCT02426229|Dabigatran|dabigatran|mesh-list
25689442|NCT01960140|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25689443|NCT01960140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689444|NCT01960296|Clopidogrel|clopidogrel|mesh-list
25689445|NCT01960296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25689446|NCT01960296|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25689447|NCT01960296|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25689448|NCT01960296|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25689449|NCT01960296|Purinergic Agents|purinergic agents|mesh-ancestor
25266763|NCT02426229|Antithrombins|antithrombins|mesh-ancestor
24744845|NCT04123314|Psilocybin|psilocybin|mesh-list
24666564|NCT01319942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666621|NCT01320007|Diuretics|diuretics|mesh-ancestor
24666622|NCT01320007|Natriuretic Agents|natriuretic agents|mesh-ancestor
24666623|NCT01320007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666624|NCT01320007|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24666625|NCT01320007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24666626|NCT01320007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666627|NCT01320020|Catumaxomab|catumaxomab|mesh-list
24666628|NCT01320020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24666629|NCT01320111|Paclitaxel|paclitaxel|mesh-list
24666630|NCT01320111|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24666631|NCT01320111|Sorafenib|sorafenib|mesh-list
24666632|NCT01320111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24666633|NCT01320111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24666634|NCT01320111|Tubulin Modulators|tubulin modulators|mesh-ancestor
24666635|NCT01320111|Antimitotic Agents|antimitotic agents|mesh-ancestor
24666636|NCT01320111|Mitosis Modulators|mitosis modulators|mesh-ancestor
24666637|NCT01320111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666638|NCT01320111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24666639|NCT01320111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666640|NCT01320176|Vaccines|vaccines|mesh-list
24666641|NCT01320176|Immunologic Factors|immunologic factors|mesh-ancestor
24666642|NCT01320176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666643|NCT01320254|Gemcitabine|gemcitabine|mesh-list
25266765|NCT02426229|Protease Inhibitors|protease inhibitors|mesh-ancestor
25689451|NCT01960296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689452|NCT01960296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689453|NCT01960387|Cytarabine|cytarabine|mesh-list
25689454|NCT01960387|Clofarabine|clofarabine|mesh-list
25689455|NCT01960387|Antimetabolites|antimetabolites|mesh-list
25689456|NCT01960387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25689457|NCT01960387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689458|NCT01960387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25689459|NCT01960387|Antiviral Agents|antiviral agents|mesh-ancestor
25266766|NCT02426229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25266767|NCT02426229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266768|NCT02426229|Anticoagulants|anticoagulants|mesh-ancestor
25266769|NCT02426333|Abiraterone Acetate|abiraterone acetate|mesh-list
25266770|NCT02426333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266771|NCT02426333|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25266772|NCT02426333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25266773|NCT02426333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266774|NCT02426333|Hormone Antagonists|hormone antagonists|mesh-ancestor
25266775|NCT02426333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25266776|NCT02426333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266777|NCT02426333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25266778|NCT02426177|Labetalol|labetalol|mesh-list
25266779|NCT02426177|Nifedipine|nifedipine|mesh-list
24465472|NCT00369811|Analgesics|analgesics|mesh-ancestor
24666675|NCT01320436|Sensory System Agents|sensory system agents|mesh-ancestor
24666676|NCT01320436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24666677|NCT01320436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666678|NCT01320436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24700380|NCT01452217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24700381|NCT01452217|Hormones|hormones|mesh-ancestor
24700382|NCT01452217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24700383|NCT01452217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666679|NCT01320436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24666680|NCT01320436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24666681|NCT01320436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666682|NCT01320436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666683|NCT01320436|Antitubercular Agents|antitubercular agents|mesh-ancestor
24666684|NCT01320436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24666685|NCT01320436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24666686|NCT01320449|Epoetin Alfa|epoetin alfa|mesh-list
24666722|NCT01320592|Palbociclib|palbociclib|mesh-list
24666723|NCT01320592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24666724|NCT01320592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24666725|NCT01320592|Tubulin Modulators|tubulin modulators|mesh-ancestor
24666726|NCT01320592|Antimitotic Agents|antimitotic agents|mesh-ancestor
24666727|NCT01320592|Mitosis Modulators|mitosis modulators|mesh-ancestor
24666728|NCT01320592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666737|NCT01320709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666738|NCT01320709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24666739|NCT01320709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24666740|NCT01320709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25689461|NCT01960387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25689462|NCT01960387|Immunologic Factors|immunologic factors|mesh-ancestor
25689463|NCT01960387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689464|NCT01960413|Hydroxyurea|hydroxyurea|mesh-list
25689465|NCT01960413|Montelukast|montelukast|mesh-list
25689466|NCT01960413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25689467|NCT01960413|Respiratory System Agents|respiratory system agents|mesh-ancestor
25689468|NCT01960413|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25689469|NCT01960413|Hormone Antagonists|hormone antagonists|mesh-ancestor
25689470|NCT01960413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25692638|NCT02003365|Immunologic Factors|immunologic factors|mesh-ancestor
25056313|NCT03513549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056314|NCT03513549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25056315|NCT03513549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25056316|NCT03513549|Dopamine Agents|dopamine agents|mesh-ancestor
25056317|NCT03513549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25056318|NCT03513549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810539|NCT02040662|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24810540|NCT02040662|Narcotics|narcotics|mesh-ancestor
24810541|NCT02040662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24810542|NCT02040662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666741|NCT01320709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666845|NCT01321125|Blood Substitutes|blood substitutes|mesh-ancestor
24666883|NCT01321268|Carotenoids|carotenoids|mesh-list
24666884|NCT01321268|Antioxidants|antioxidants|mesh-ancestor
24666885|NCT01321268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266786|NCT02426177|Tocolytic Agents|tocolytic agents|mesh-ancestor
25266787|NCT02426177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25266788|NCT02426177|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24667020|NCT01321931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24667021|NCT01321931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700454|NCT01452607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24667035|NCT01321944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24667036|NCT01321944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24667037|NCT01321957|Bevacizumab|bevacizumab|mesh-list
24667038|NCT01321957|Oxaliplatin|oxaliplatin|mesh-list
24667040|NCT01321957|Fluorouracil|fluorouracil|mesh-list
24667041|NCT01321957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24667042|NCT01321957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24667043|NCT01321957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24667044|NCT01321957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24667109|NCT01322204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24667110|NCT01322204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459872|NCT00346749|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25689474|NCT01960413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689475|NCT01960413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25689476|NCT01960413|Antisickling Agents|antisickling agents|mesh-ancestor
25689477|NCT01960413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689478|NCT01960413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25689479|NCT01960842|Levodopa|levodopa|mesh-list
25689480|NCT01960842|Carbidopa|carbidopa|mesh-list
25689481|NCT01960842|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25689482|NCT01960842|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25689483|NCT01960842|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25689484|NCT01960842|Dopamine Agents|dopamine agents|mesh-ancestor
25689485|NCT01960842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25689486|NCT01960842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689487|NCT01960842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692639|NCT02003365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24874274|NCT04856189|Pembrolizumab|pembrolizumab|mesh-list
24874275|NCT04856189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24874276|NCT04856189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056323|NCT03513484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056324|NCT03513484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056325|NCT03513484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25056326|NCT03513484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24810555|NCT02040818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24874337|NCT04812535|Pembrolizumab|pembrolizumab|mesh-list
24700479|NCT01452685|Relugolix|relugolix|mesh-list
24700480|NCT01452685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24700481|NCT01452685|Fertility Agents|fertility agents|mesh-ancestor
24700482|NCT01452685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24667195|NCT05461092|Analgesics|analgesics|mesh-ancestor
24667227|NCT05460858|Respiratory System Agents|respiratory system agents|mesh-ancestor
24667228|NCT05460858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24667230|NCT05460858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24667231|NCT05460858|Protective Agents|protective agents|mesh-ancestor
24667232|NCT05460858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667233|NCT05460858|Antidotes|antidotes|mesh-ancestor
24667368|NCT05455697|Immunoglobulins|immunoglobulins|mesh-list
24667369|NCT05455697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25266789|NCT02426177|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25266790|NCT02426177|Adrenergic Agents|adrenergic agents|mesh-ancestor
25266791|NCT02426177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25266792|NCT02426177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25266793|NCT02426177|Sympathomimetics|sympathomimetics|mesh-ancestor
25266794|NCT02426177|Autonomic Agents|autonomic agents|mesh-ancestor
25266795|NCT02426177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25266796|NCT02426177|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25266797|NCT02426177|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25266798|NCT02426164|Methylprednisolone|methylprednisolone|mesh-list
25266799|NCT02426164|Epinephrine|epinephrine|mesh-list
25266801|NCT02426164|Bupivacaine|bupivacaine|mesh-list
25266802|NCT02426164|Anesthetics, Local|anesthetics, local|mesh-ancestor
24667370|NCT05455697|Immunologic Factors|immunologic factors|mesh-ancestor
24667371|NCT05455697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667373|NCT05455697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24667374|NCT05455697|Alkylating Agents|alkylating agents|mesh-ancestor
24667375|NCT05455697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24667698|NCT05323214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24667699|NCT05323214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667700|NCT05323214|Sensory System Agents|sensory system agents|mesh-ancestor
24667900|NCT05249478|Fentanyl|fentanyl|mesh-list
24667901|NCT05249478|Bupivacaine|bupivacaine|mesh-list
24667902|NCT05249478|Anesthetics, Local|anesthetics, local|mesh-ancestor
24857366|NCT02291367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667903|NCT05249478|Anesthetics|anesthetics|mesh-ancestor
24622512|NCT01067365|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24667904|NCT05249478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24667905|NCT05249478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667906|NCT05249478|Sensory System Agents|sensory system agents|mesh-ancestor
24667907|NCT05249478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24667908|NCT05249478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24667909|NCT05249478|Narcotics|narcotics|mesh-ancestor
24667910|NCT05249478|Analgesics|analgesics|mesh-ancestor
24667911|NCT05249478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24667912|NCT05249478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24667913|NCT05249478|Anesthetics, General|anesthetics, general|mesh-ancestor
25689488|NCT01960842|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25689489|NCT01960842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689490|NCT01960842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25689491|NCT01960842|Immunologic Factors|immunologic factors|mesh-ancestor
25689492|NCT01960842|Dopamine Agonists|dopamine agonists|mesh-ancestor
25689493|NCT01960855|Upadacitinib|upadacitinib|mesh-list
25689494|NCT01960855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25689495|NCT01960855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25689496|NCT01960855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25266805|NCT02426164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266806|NCT02426164|Sensory System Agents|sensory system agents|mesh-ancestor
25266807|NCT02426164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24667934|NCT05242484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266810|NCT02426164|Analgesics|analgesics|mesh-ancestor
25266811|NCT02426164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25266812|NCT02426164|Antiemetics|antiemetics|mesh-ancestor
25266813|NCT02426164|Autonomic Agents|autonomic agents|mesh-ancestor
25266814|NCT02426164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25266815|NCT02426164|Glucocorticoids|glucocorticoids|mesh-ancestor
25266816|NCT02426164|Hormones|hormones|mesh-ancestor
25266818|NCT02426164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25266819|NCT02426164|Protective Agents|protective agents|mesh-ancestor
25266820|NCT02426164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25266821|NCT02426164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25266822|NCT02426164|Adrenergic Agents|adrenergic agents|mesh-ancestor
25266823|NCT02426164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24544612|NCT00689637|Warfarin|warfarin|mesh-list
24622379|NCT01066767|Fexofenadine|fexofenadine|mesh-list
24857368|NCT02291367|Sensory System Agents|sensory system agents|mesh-ancestor
24400709|NCT00151203|Dexamethasone|dexamethasone|mesh-list
24668114|NCT05084378|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25266826|NCT02426164|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25266827|NCT02426164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25266828|NCT02426164|Respiratory System Agents|respiratory system agents|mesh-ancestor
25689497|NCT01960855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689498|NCT01960855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25689499|NCT01961271|Buprenorphine|buprenorphine|mesh-list
25689500|NCT01961271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25689501|NCT01961271|Narcotics|narcotics|mesh-ancestor
25689502|NCT01961271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25689503|NCT01961271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689504|NCT01961271|Analgesics|analgesics|mesh-ancestor
24874970|NCT04488978|Irbesartan|irbesartan|mesh-list
24874971|NCT04488978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24874972|NCT04488978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24874973|NCT04488978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24874974|NCT04488978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24874975|NCT04488978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24874976|NCT04488978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456291|NCT00330824|BB 1101|bb 1101|mesh-list
24533481|NCT00644124|Growth Substances|growth substances|mesh-ancestor
24533482|NCT00644124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533483|NCT00644124|Growth Inhibitors|growth inhibitors|mesh-ancestor
24533484|NCT00644124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24533485|NCT00644137|Pregabalin|pregabalin|mesh-list
24533486|NCT00644137|Analgesics|analgesics|mesh-ancestor
24533487|NCT00644137|Sensory System Agents|sensory system agents|mesh-ancestor
24533488|NCT00644137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24533510|NCT00644293|Azithromycin|azithromycin|mesh-list
24533511|NCT00644293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25266829|NCT02426164|Mydriatics|mydriatics|mesh-ancestor
25266830|NCT02426164|Sympathomimetics|sympathomimetics|mesh-ancestor
25266831|NCT02426164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25266832|NCT02426099|Antihypertensive Agents|antihypertensive agents|mesh-list
25266833|NCT02426099|Spironolactone|spironolactone|mesh-list
25266834|NCT02426099|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25266835|NCT02426099|Hormone Antagonists|hormone antagonists|mesh-ancestor
25266836|NCT02426099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25266837|NCT02426099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420085|NCT00215163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24769301|NCT01813643|Risperidone|risperidone|mesh-list
25689505|NCT01961271|Sensory System Agents|sensory system agents|mesh-ancestor
25689506|NCT01961271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25689507|NCT01961271|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25689508|NCT01961297|Sodium Oxybate|sodium oxybate|mesh-list
25689509|NCT01961297|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25689510|NCT01961297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25689511|NCT01961297|Anesthetics, General|anesthetics, general|mesh-ancestor
25689512|NCT01961297|Anesthetics|anesthetics|mesh-ancestor
25689513|NCT01961297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25689514|NCT01961297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689515|NCT01961323|Nebivolol|nebivolol|mesh-list
25056433|NCT03512834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056434|NCT03512834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25056436|NCT03512821|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25056437|NCT03512821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25056438|NCT03512808|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25056439|NCT03512808|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25056440|NCT03512808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24533519|NCT00644306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24394238|NCT00132639|Antimitotic Agents|antimitotic agents|mesh-ancestor
24857374|NCT02291380|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24857375|NCT02291380|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24857376|NCT02291380|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24533525|NCT00644306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533526|NCT00644306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24533527|NCT00644306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25266838|NCT02426099|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25266839|NCT02426099|Diuretics|diuretics|mesh-ancestor
25266840|NCT02426099|Natriuretic Agents|natriuretic agents|mesh-ancestor
25266841|NCT02426060|Warfarin|warfarin|mesh-list
25266842|NCT02426060|Anticoagulants|anticoagulants|mesh-ancestor
25266843|NCT02426021|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25266844|NCT02426021|Immunologic Factors|immunologic factors|mesh-ancestor
25266845|NCT02426021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266846|NCT02426008|Mitogens|mitogens|mesh-list
25266847|NCT02426008|Mitosis Modulators|mitosis modulators|mesh-ancestor
25266848|NCT02426008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266849|NCT02425813|Methylprednisolone|methylprednisolone|mesh-list
25266850|NCT02425813|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25266851|NCT02425813|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24516544|NCT00602381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24516545|NCT00602381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689516|NCT01961323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25689517|NCT01961323|Vasodilator Agents|vasodilator agents|mesh-ancestor
25689518|NCT01961323|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25689519|NCT01961323|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25689520|NCT01961323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25689521|NCT01961323|Adrenergic Agents|adrenergic agents|mesh-ancestor
25689522|NCT01961323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25689523|NCT01961323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689524|NCT01961323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24875326|NCT04222595|Immunologic Factors|immunologic factors|mesh-ancestor
24875327|NCT04222595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24875328|NCT04220827|Paclitaxel|paclitaxel|mesh-list
24875329|NCT04220827|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24875330|NCT04220827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24617594|NCT01044225|Cetuximab|cetuximab|mesh-list
24875331|NCT04220827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24875332|NCT04220827|Tubulin Modulators|tubulin modulators|mesh-ancestor
24875333|NCT04220827|Antimitotic Agents|antimitotic agents|mesh-ancestor
24875334|NCT04220827|Mitosis Modulators|mitosis modulators|mesh-ancestor
24875421|NCT04181333|Trastuzumab|trastuzumab|mesh-list
24875423|NCT04181333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24875474|NCT04163978|Budesonide|budesonide|mesh-list
24875475|NCT04163978|Nitric Oxide|nitric oxide|mesh-list
24875476|NCT04163978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25056451|NCT03512574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25056452|NCT03512574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25056453|NCT03512574|Adrenergic Agents|adrenergic agents|mesh-ancestor
25056454|NCT03512574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25056455|NCT03512574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875538|NCT04088591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875539|NCT04088591|Protective Agents|protective agents|mesh-ancestor
24875540|NCT04088591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689525|NCT01961349|Propofol|propofol|mesh-list
24875541|NCT04088591|Vitamins|vitamins|mesh-ancestor
24875542|NCT04088591|Micronutrients|micronutrients|mesh-ancestor
24875543|NCT04080271|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24875544|NCT04080271|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24875546|NCT04079712|Nivolumab|nivolumab|mesh-list
25404399|NCT03670810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25689526|NCT01961349|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25689527|NCT01961349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25689528|NCT01961349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25689529|NCT01961349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689530|NCT01961349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25689531|NCT01961349|Anesthetics, General|anesthetics, general|mesh-ancestor
25689532|NCT01961349|Anesthetics|anesthetics|mesh-ancestor
25689533|NCT01961349|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25689534|NCT01961349|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25689535|NCT01961349|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25689536|NCT01962103|Paclitaxel|paclitaxel|mesh-list
25689537|NCT01962103|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25689538|NCT01962103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25689539|NCT01962103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25689540|NCT01962103|Tubulin Modulators|tubulin modulators|mesh-ancestor
25689541|NCT01962103|Antimitotic Agents|antimitotic agents|mesh-ancestor
25689542|NCT01962103|Mitosis Modulators|mitosis modulators|mesh-ancestor
25689543|NCT01962103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689544|NCT01962298|Rocuronium|rocuronium|mesh-list
25689545|NCT01962298|Neostigmine|neostigmine|mesh-list
25689546|NCT01962298|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25689547|NCT01962298|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25689548|NCT01962298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25689549|NCT01962298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25689550|NCT01962298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689551|NCT01962298|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24875703|NCT03907475|Mitosis Modulators|mitosis modulators|mesh-ancestor
24875704|NCT03907475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875705|NCT03907475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24875706|NCT03907475|Antimetabolites|antimetabolites|mesh-ancestor
24875707|NCT03907475|Antiviral Agents|antiviral agents|mesh-ancestor
24875708|NCT03907475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24875709|NCT03907475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24875710|NCT03907475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24815354|NCT02069808|Hormone Antagonists|hormone antagonists|mesh-ancestor
24875830|NCT03819465|Paclitaxel|paclitaxel|mesh-list
24465998|NCT00371501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25266852|NCT02425813|Prednisolone|prednisolone|mesh-list
25266853|NCT02425813|Prednisolone acetate|prednisolone acetate|mesh-list
25266854|NCT02425813|Budesonide|budesonide|mesh-list
25266855|NCT02425813|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25266856|NCT02425813|Prednisolone phosphate|prednisolone phosphate|mesh-list
25266857|NCT02425813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25266858|NCT02425813|Antiemetics|antiemetics|mesh-ancestor
25266859|NCT02425813|Autonomic Agents|autonomic agents|mesh-ancestor
24955872|NCT03860129|Anesthetics|anesthetics|mesh-ancestor
24533569|NCT00644449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24533570|NCT00644449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533571|NCT00644449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465999|NCT00371501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466000|NCT00371501|Antipyretics|antipyretics|mesh-ancestor
24466001|NCT00371501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24466002|NCT00371501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24533572|NCT00644449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25689552|NCT01962298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689553|NCT01962298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689554|NCT01962298|Cholinergic Agents|cholinergic agents|mesh-ancestor
25689555|NCT01962298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25689556|NCT01962298|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25689557|NCT01962298|Autonomic Agents|autonomic agents|mesh-ancestor
25689558|NCT01962428|Ticagrelor|ticagrelor|mesh-list
25689559|NCT01962428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25689560|NCT01962428|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25689561|NCT01962428|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25689562|NCT01962428|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24815371|NCT02069977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815372|NCT02069977|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24815373|NCT02069977|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24815374|NCT02069977|Serotonin Agents|serotonin agents|mesh-ancestor
24815375|NCT02069977|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24815376|NCT02069977|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24815377|NCT02069977|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24815378|NCT02069977|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24815379|NCT02069990|Cholecalciferol|cholecalciferol|mesh-list
24815380|NCT02069990|Vitamin D|vitamin d|mesh-list
24815381|NCT02069990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24815382|NCT02069990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815383|NCT02069990|Vitamins|vitamins|mesh-ancestor
24876160|NCT03704298|Immunologic Factors|immunologic factors|mesh-ancestor
24876161|NCT03704298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24876162|NCT03704298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24876163|NCT03704298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24876164|NCT03704298|Alkylating Agents|alkylating agents|mesh-ancestor
24876165|NCT03704298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24876249|NCT03646123|Nivolumab|nivolumab|mesh-list
24533573|NCT00644449|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24533581|NCT00644475|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24533583|NCT00644475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533584|NCT00644540|Vaccines|vaccines|mesh-list
24533585|NCT00644540|Immunologic Factors|immunologic factors|mesh-ancestor
24533586|NCT00644540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533587|NCT00644553|Amoxicillin|amoxicillin|mesh-list
24486667|NCT00459173|Hormones|hormones|mesh-ancestor
25266874|NCT02425852|Hydrocortisone|hydrocortisone|mesh-list
25689563|NCT01962428|Purinergic Agents|purinergic agents|mesh-ancestor
25689564|NCT01962428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25689565|NCT01962428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689566|NCT01962428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689567|NCT01962441|Sofosbuvir|sofosbuvir|mesh-list
25689568|NCT01962441|Antiviral Agents|antiviral agents|mesh-ancestor
25689569|NCT01962441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25689570|NCT01962493|Chlorhexidine|chlorhexidine|mesh-list
25689571|NCT01962493|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25689572|NCT01962493|Listerine|listerine|mesh-list
25689573|NCT01962493|Fluorides|fluorides|mesh-list
25689574|NCT01962493|Sodium Fluoride|sodium fluoride|mesh-list
25689575|NCT01962493|Cariostatic Agents|cariostatic agents|mesh-ancestor
25689576|NCT01962493|Protective Agents|protective agents|mesh-ancestor
25689577|NCT01962493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689578|NCT01962493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25689579|NCT01962493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25689580|NCT01962493|Disinfectants|disinfectants|mesh-ancestor
25689581|NCT01962493|Dermatologic Agents|dermatologic agents|mesh-ancestor
25689582|NCT01962688|Diuretics|diuretics|mesh-list
25689583|NCT01962688|Natriuretic Agents|natriuretic agents|mesh-ancestor
25689584|NCT01962688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689585|NCT01962870|Vasopressins|vasopressins|mesh-list
24876419|NCT03555916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24876420|NCT03555916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266860|NCT02425813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25266861|NCT02425813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266862|NCT02425813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25266863|NCT02425813|Glucocorticoids|glucocorticoids|mesh-ancestor
24803254|NCT01995331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25266864|NCT02425813|Hormones|hormones|mesh-ancestor
24857379|NCT02291380|Cholinergic Agents|cholinergic agents|mesh-ancestor
24857380|NCT02291380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24533619|NCT00644631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25266865|NCT02425813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25266866|NCT02425813|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25266867|NCT02425813|Protective Agents|protective agents|mesh-ancestor
25266868|NCT02425813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25266869|NCT02425813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266870|NCT02425813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25266871|NCT02425813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25266872|NCT02425813|Respiratory System Agents|respiratory system agents|mesh-ancestor
25266873|NCT02425852|Prednisolone|prednisolone|mesh-list
24939776|NCT04006873|Ivacaftor|ivacaftor|mesh-list
25689586|NCT01962870|Arginine Vasopressin|arginine vasopressin|mesh-list
25689587|NCT01962870|Hemostatics|hemostatics|mesh-ancestor
25689588|NCT01962870|Coagulants|coagulants|mesh-ancestor
25689589|NCT01962870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25689590|NCT01962870|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25689591|NCT01962870|Natriuretic Agents|natriuretic agents|mesh-ancestor
25689592|NCT01962870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689593|NCT01962896|Sirolimus|sirolimus|mesh-list
25689594|NCT01962896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25689595|NCT01962896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25689596|NCT01962896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24815400|NCT02070120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815401|NCT02070133|Simvastatin|simvastatin|mesh-list
24815402|NCT02070133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24815403|NCT02070133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24815404|NCT02070133|Antimetabolites|antimetabolites|mesh-ancestor
24737344|NCT01668498|Doxycycline|doxycycline|mesh-list
24815405|NCT02070133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815406|NCT02070133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24815407|NCT02070133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24815408|NCT02070133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815409|NCT02070159|Clopidogrel|clopidogrel|mesh-list
24815410|NCT02070159|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24701204|NCT01457690|Vitamin E|vitamin e|mesh-list
24857382|NCT02291380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24857383|NCT02291380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24404192|NCT00162721|Ifosfamide|ifosfamide|mesh-list
25266875|NCT02425852|Azathioprine|azathioprine|mesh-list
25266876|NCT02425852|Infliximab|infliximab|mesh-list
25266877|NCT02425852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25266878|NCT02425852|Glucocorticoids|glucocorticoids|mesh-ancestor
25266879|NCT02425852|Hormones|hormones|mesh-ancestor
25266880|NCT02425852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25266881|NCT02425852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533701|NCT00644891|Amoxicillin|amoxicillin|mesh-list
25266884|NCT02425852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25266885|NCT02425852|Dermatologic Agents|dermatologic agents|mesh-ancestor
25266886|NCT02425852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25266887|NCT02425852|Antimetabolites|antimetabolites|mesh-ancestor
25266888|NCT02425852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266889|NCT02425852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25689597|NCT01962896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689598|NCT01962896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689599|NCT01962896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25689600|NCT01962896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25689601|NCT01962896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25689602|NCT01962896|Antifungal Agents|antifungal agents|mesh-ancestor
25689603|NCT01962896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25689604|NCT01962896|Immunologic Factors|immunologic factors|mesh-ancestor
25689605|NCT01962896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689606|NCT01962922|Tacrolimus|tacrolimus|mesh-list
25689607|NCT01962922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25689608|NCT01962922|Immunologic Factors|immunologic factors|mesh-ancestor
25689609|NCT01962922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689610|NCT01962922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24623387|NCT01071174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24623388|NCT01071174|Antiviral Agents|antiviral agents|mesh-ancestor
24623389|NCT01071174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24623390|NCT01071187|Varenicline|varenicline|mesh-list
24623391|NCT01071187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24623392|NCT01071187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24623401|NCT01071291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623402|NCT01071291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24623403|NCT01071291|Vasodilator Agents|vasodilator agents|mesh-ancestor
25266890|NCT02425852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25266891|NCT02425852|Immunologic Factors|immunologic factors|mesh-ancestor
24939793|NCT04006470|Fluorides|fluorides|mesh-list
24701322|NCT01458301|Androgen Antagonists|androgen antagonists|mesh-ancestor
24533712|NCT00644904|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24533713|NCT00644943|Amoxicillin|amoxicillin|mesh-list
24533714|NCT00644943|Cefdinir|cefdinir|mesh-list
25266892|NCT02425878|Ulipristal acetate|ulipristal acetate|mesh-list
25266893|NCT02425878|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25266894|NCT02425878|Contraceptive Agents|contraceptive agents|mesh-ancestor
25266895|NCT02425878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25266896|NCT02425878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266897|NCT02425878|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25266898|NCT02425722|Linaclotide|linaclotide|mesh-list
25266899|NCT02425722|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25266900|NCT02425722|Enzyme Activators|enzyme activators|mesh-ancestor
25266901|NCT02425722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266910|NCT02425774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266911|NCT02425774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266912|NCT02425930|Oxaliplatin|oxaliplatin|mesh-list
25266913|NCT02425930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266914|NCT02425943|Mannitol|mannitol|mesh-list
25266915|NCT02425943|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25266916|NCT02425943|Diuretics|diuretics|mesh-ancestor
25266917|NCT02425943|Natriuretic Agents|natriuretic agents|mesh-ancestor
25266918|NCT02425943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266919|NCT02425709|Diclofenac|diclofenac|mesh-list
25266920|NCT02425709|Tramadol|tramadol|mesh-list
25689611|NCT01962922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689612|NCT01962922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689613|NCT01962961|Acetylcysteine|acetylcysteine|mesh-list
25689614|NCT01962961|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25689615|NCT01962961|Antiviral Agents|antiviral agents|mesh-ancestor
25689616|NCT01962961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25689617|NCT01962961|Expectorants|expectorants|mesh-ancestor
25689618|NCT01962961|Respiratory System Agents|respiratory system agents|mesh-ancestor
25689619|NCT01962961|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25689620|NCT01962961|Antioxidants|antioxidants|mesh-ancestor
25689621|NCT01962961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689622|NCT01962961|Protective Agents|protective agents|mesh-ancestor
24877023|NCT02998645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24877024|NCT02998645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24877025|NCT02998645|Immunologic Factors|immunologic factors|mesh-ancestor
24877026|NCT02998645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24877027|NCT02998645|Antifungal Agents|antifungal agents|mesh-ancestor
24877028|NCT02998645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24877029|NCT02998645|Dermatologic Agents|dermatologic agents|mesh-ancestor
24877030|NCT02998645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24877031|NCT02998645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24877040|NCT02974621|Bevacizumab|bevacizumab|mesh-list
24815503|NCT02070653|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24815504|NCT02070653|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24815505|NCT02070653|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24815506|NCT02070653|Purinergic Agents|purinergic agents|mesh-ancestor
24815507|NCT02070653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24815516|NCT02070679|Antioxidants|antioxidants|mesh-ancestor
25266921|NCT02425709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25266922|NCT02425709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25266923|NCT02425709|Analgesics|analgesics|mesh-ancestor
25266924|NCT02425709|Sensory System Agents|sensory system agents|mesh-ancestor
25266925|NCT02425709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25266926|NCT02425709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266927|NCT02425709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25266928|NCT02425709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24857391|NCT02291536|Anticonvulsants|anticonvulsants|mesh-ancestor
24701426|NCT01458964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701428|NCT01458977|Emtricitabine|emtricitabine|mesh-list
25266929|NCT02425709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25689623|NCT01962961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689624|NCT01962961|Antidotes|antidotes|mesh-ancestor
25689625|NCT01962987|Diclofenac|diclofenac|mesh-list
25689626|NCT01962987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25689627|NCT01962987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25689628|NCT01962987|Analgesics|analgesics|mesh-ancestor
25689629|NCT01962987|Sensory System Agents|sensory system agents|mesh-ancestor
25689630|NCT01962987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25689631|NCT01962987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689632|NCT01962987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25689633|NCT01962987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25689634|NCT01962987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25689635|NCT01962987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689636|NCT01962987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689637|NCT01963078|Oxytocin|oxytocin|mesh-list
25689638|NCT01963078|Oxytocics|oxytocics|mesh-ancestor
25689639|NCT01963078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25689640|NCT01963078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689641|NCT01963091|Oxytocin|oxytocin|mesh-list
24940047|NCT04004234|Trace Elements|trace elements|mesh-ancestor
25056574|NCT03511391|Pembrolizumab|pembrolizumab|mesh-list
25056575|NCT03511391|Nivolumab|nivolumab|mesh-list
25056576|NCT03511391|Atezolizumab|atezolizumab|mesh-list
25056577|NCT03511391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24877369|NCT02798471|Protease Inhibitors|protease inhibitors|mesh-ancestor
24877370|NCT02798471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815559|NCT02071069|Irinotecan|irinotecan|mesh-list
24877421|NCT02692339|Dexamethasone|dexamethasone|mesh-list
24877422|NCT02692339|Lenalidomide|lenalidomide|mesh-list
24877423|NCT02692339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24877424|NCT02692339|Antiemetics|antiemetics|mesh-ancestor
24877425|NCT02692339|Autonomic Agents|autonomic agents|mesh-ancestor
24877432|NCT02692339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25266930|NCT02425709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25266931|NCT02425709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266932|NCT02425709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25266933|NCT02425709|Narcotics|narcotics|mesh-ancestor
25266934|NCT02425709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24533756|NCT00645073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24857392|NCT02291536|Hallucinogens|hallucinogens|mesh-ancestor
24857393|NCT02291536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533757|NCT00645073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24922479|NCT04179500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533758|NCT00645073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533759|NCT00645073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689642|NCT01963091|Oxytocics|oxytocics|mesh-ancestor
25689643|NCT01963091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25689644|NCT01963091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689645|NCT01963143|gamma-Globulins|gamma-globulins|mesh-list
25689646|NCT01963143|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25689647|NCT01963143|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25689648|NCT01963143|Immunologic Factors|immunologic factors|mesh-ancestor
25689649|NCT01963143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689650|NCT01963481|Cyclophosphamide|cyclophosphamide|mesh-list
25689651|NCT01963481|Exemestane|exemestane|mesh-list
25689652|NCT01963481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25689653|NCT01963481|Immunologic Factors|immunologic factors|mesh-ancestor
25689654|NCT01963481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689655|NCT01963481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25689656|NCT01963481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24877495|NCT02620150|Citalopram|citalopram|mesh-list
24877496|NCT02620150|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25056581|NCT03511261|Curcumin|curcumin|mesh-list
24877554|NCT02535325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24877555|NCT02535325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24877581|NCT02529852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24877582|NCT02529852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24877583|NCT02529852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24877584|NCT02529852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24701534|NCT01459445|Metformin|metformin|mesh-list
24857394|NCT02291536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24857395|NCT02291536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25266950|NCT02425488|Coal Tar|coal tar|mesh-list
25266951|NCT02425488|Keratolytic Agents|keratolytic agents|mesh-ancestor
25266952|NCT02425488|Dermatologic Agents|dermatologic agents|mesh-ancestor
25266953|NCT02425605|Sorafenib|sorafenib|mesh-list
25266954|NCT02425605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266955|NCT02425605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25266956|NCT02425605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25266957|NCT02425605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266958|NCT02425579|Carbon Monoxide|carbon monoxide|mesh-list
24803895|NCT01999413|Cytarabine|cytarabine|mesh-list
25689657|NCT01963481|Alkylating Agents|alkylating agents|mesh-ancestor
25689658|NCT01963481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689659|NCT01963481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25689660|NCT01963481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25689661|NCT01963481|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25689662|NCT01963481|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25689663|NCT01963481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689664|NCT01963481|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25689665|NCT01963481|Hormone Antagonists|hormone antagonists|mesh-ancestor
25266959|NCT02425579|Antimetabolites|antimetabolites|mesh-ancestor
25266960|NCT02425579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266961|NCT02425579|Gasotransmitters|gasotransmitters|mesh-ancestor
25266962|NCT02425579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25266963|NCT02425579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266964|NCT02426112|Azithromycin|azithromycin|mesh-list
25266965|NCT02426112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25689667|NCT01963611|Glatiramer Acetate|glatiramer acetate|mesh-list
25689668|NCT01963611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25689669|NCT01963611|Immunologic Factors|immunologic factors|mesh-ancestor
25689670|NCT01963611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689671|NCT01963611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25689672|NCT01963611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25689673|NCT01963793|Aprepitant|aprepitant|mesh-list
25689674|NCT01963793|Fosaprepitant|fosaprepitant|mesh-list
25689675|NCT01963793|Antiemetics|antiemetics|mesh-ancestor
24952609|NCT03892525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24952610|NCT03892928|Dexmedetomidine|dexmedetomidine|mesh-list
24815649|NCT02071407|GABA Modulators|gaba modulators|mesh-ancestor
24815650|NCT02071407|GABA Agents|gaba agents|mesh-ancestor
24815651|NCT02071407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24815652|NCT02071407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815654|NCT02071433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24815655|NCT02071433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24456805|NCT00332306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24955956|NCT03859102|Autonomic Agents|autonomic agents|mesh-ancestor
24458357|NCT00337558|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24458358|NCT00337558|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24466269|NCT00372801|Ibuprofen|ibuprofen|mesh-list
25266966|NCT02426112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25266967|NCT02425865|Golimumab|golimumab|mesh-list
25266968|NCT02425865|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25266969|NCT02425865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25266970|NCT02425865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25266971|NCT02425865|Immunologic Factors|immunologic factors|mesh-ancestor
25266972|NCT02425865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266973|NCT02425462|Dienogest|dienogest|mesh-list
25266974|NCT02425462|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25266975|NCT02425462|Contraceptive Agents|contraceptive agents|mesh-ancestor
25266976|NCT02425462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25266977|NCT02425462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266978|NCT02425462|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25266979|NCT02425462|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25266980|NCT02425462|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25266981|NCT02425462|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25689676|NCT01963793|Autonomic Agents|autonomic agents|mesh-ancestor
25689677|NCT01963793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25689678|NCT01963793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689679|NCT01963793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25689680|NCT01963793|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25689681|NCT01963793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25689682|NCT01963793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689683|NCT01963845|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24533893|NCT00645372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24533901|NCT00645398|Anticonvulsants|anticonvulsants|mesh-ancestor
24533902|NCT00645398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24533903|NCT00645398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25689684|NCT01963845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25689685|NCT01963845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689686|NCT01963845|Incretins|incretins|mesh-ancestor
25689687|NCT01963845|Hormones|hormones|mesh-ancestor
25689688|NCT01963845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25689689|NCT01963845|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25689690|NCT01963845|Protease Inhibitors|protease inhibitors|mesh-ancestor
25689691|NCT01963845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689692|NCT01963845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689693|NCT01964300|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25689694|NCT01964300|Antiviral Agents|antiviral agents|mesh-ancestor
25689695|NCT01964300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25689696|NCT01964326|Atorvastatin|atorvastatin|mesh-list
25689697|NCT01964326|Calcium|calcium|mesh-list
25689698|NCT01964326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25689699|NCT01964326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739659|NCT01683188|Vemurafenib|vemurafenib|mesh-list
24624112|NCT01074853|Propranolol|propranolol|mesh-list
25266983|NCT02425462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25266984|NCT02425462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25266985|NCT02425462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25266986|NCT02425501|Aflibercept|aflibercept|mesh-list
25266987|NCT02425501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25266988|NCT02425501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25266989|NCT02425501|Growth Substances|growth substances|mesh-ancestor
25266990|NCT02425501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25266991|NCT02425501|Growth Inhibitors|growth inhibitors|mesh-ancestor
25266992|NCT02425501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466380|NCT00373412|Vaccines|vaccines|mesh-list
25689701|NCT01964326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25689702|NCT01964326|Antimetabolites|antimetabolites|mesh-ancestor
25689703|NCT01964326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689704|NCT01964326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25689705|NCT01964326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25689706|NCT01964326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689707|NCT01964352|Tiotropium Bromide|tiotropium bromide|mesh-list
25689708|NCT01964352|Olodaterol|olodaterol|mesh-list
25689709|NCT01964352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25689710|NCT01964352|Autonomic Agents|autonomic agents|mesh-ancestor
24878793|NCT00828854|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24878811|NCT00753545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689711|NCT01964352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24878812|NCT00753545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450262|NCT00318422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24450263|NCT00318422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450264|NCT00318422|Incretins|incretins|mesh-ancestor
24450265|NCT00318422|Hormones|hormones|mesh-ancestor
24450266|NCT00318422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24450267|NCT00318422|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24450268|NCT00318422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24450269|NCT00318422|Immunologic Factors|immunologic factors|mesh-ancestor
24450270|NCT00318448|Zolpidem|zolpidem|mesh-list
24450271|NCT00318448|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24450272|NCT00318448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24450273|NCT00318448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24450277|NCT00318448|GABA Agents|gaba agents|mesh-ancestor
24450278|NCT00318448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24458361|NCT00337558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458363|NCT00337558|Urological Agents|urological agents|mesh-ancestor
25689712|NCT01964352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689713|NCT01964352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25689714|NCT01964352|Respiratory System Agents|respiratory system agents|mesh-ancestor
25689715|NCT01964352|Parasympatholytics|parasympatholytics|mesh-ancestor
25689716|NCT01964352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25689717|NCT01964352|Cholinergic Agents|cholinergic agents|mesh-ancestor
24815703|NCT02071615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815704|NCT02071615|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24815705|NCT02071615|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24815706|NCT02071615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24815707|NCT02071615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25266996|NCT02425137|Gemcitabine|gemcitabine|mesh-list
25266997|NCT02425137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25266998|NCT02425137|Antimetabolites|antimetabolites|mesh-ancestor
25266999|NCT02425137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533979|NCT00645580|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25689718|NCT01964352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25689719|NCT01964352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689720|NCT01964378|Morphine|morphine|mesh-list
25689721|NCT01964378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25689722|NCT01964378|Narcotics|narcotics|mesh-ancestor
25689723|NCT01964378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25689724|NCT01964378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689725|NCT01964378|Analgesics|analgesics|mesh-ancestor
25689726|NCT01964378|Sensory System Agents|sensory system agents|mesh-ancestor
25689727|NCT01964378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25689728|NCT01964547|Nabiximols|nabiximols|mesh-list
25689729|NCT01964547|Analgesics|analgesics|mesh-ancestor
24428976|NCT00242164|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24428977|NCT00242177|Pioglitazone|pioglitazone|mesh-list
24428978|NCT00242177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24428979|NCT00242177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267000|NCT02425137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267001|NCT02425137|Antiviral Agents|antiviral agents|mesh-ancestor
25267002|NCT02425137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25267003|NCT02425137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25267004|NCT02425137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25267005|NCT02425137|Immunologic Factors|immunologic factors|mesh-ancestor
25267006|NCT02425137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267007|NCT02425176|Botulinum Toxins|botulinum toxins|mesh-list
25267008|NCT02425176|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25267009|NCT02425176|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25267010|NCT02425176|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25267011|NCT02425176|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25267012|NCT02425176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25267013|NCT02425176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267014|NCT02425176|Cholinergic Agents|cholinergic agents|mesh-ancestor
25267015|NCT02425176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25267016|NCT02425176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267017|NCT02425176|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24939860|NCT04006054|Analgesics|analgesics|mesh-ancestor
24428980|NCT00242190|Gemcitabine|gemcitabine|mesh-list
24428981|NCT00242190|Oxaliplatin|oxaliplatin|mesh-list
24824918|NCT02126137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428984|NCT00242190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429036|NCT00242411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24429037|NCT00242411|Respiratory System Agents|respiratory system agents|mesh-ancestor
24429040|NCT00242411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24429041|NCT00242411|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24429042|NCT00242411|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24429043|NCT00242411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24429044|NCT00242411|Adrenergic Agents|adrenergic agents|mesh-ancestor
24429045|NCT00242411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24429046|NCT00242411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429048|NCT00242437|Hemostatics|hemostatics|mesh-list
24429049|NCT00242437|Coagulants|coagulants|mesh-ancestor
24429050|NCT00242450|Metoclopramide|metoclopramide|mesh-list
25689730|NCT01964547|Sensory System Agents|sensory system agents|mesh-ancestor
25689731|NCT01964547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25689732|NCT01964547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689733|NCT01964716|Vaccines|vaccines|mesh-list
25689734|NCT01964716|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25689735|NCT01964716|Immunologic Factors|immunologic factors|mesh-ancestor
25689736|NCT01964716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689737|NCT01964755|Leucovorin|leucovorin|mesh-list
25689738|NCT01964755|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
24429051|NCT00242450|Antiemetics|antiemetics|mesh-ancestor
24429052|NCT00242450|Autonomic Agents|autonomic agents|mesh-ancestor
24429053|NCT00242450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24429054|NCT00242450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429055|NCT00242450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24429056|NCT00242450|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24429057|NCT00242450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24429058|NCT00242450|Dopamine Agents|dopamine agents|mesh-ancestor
24429059|NCT00242450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24824920|NCT02126267|Chlorhexidine|chlorhexidine|mesh-list
24429093|NCT00242606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24429094|NCT00242606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24429095|NCT00242606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24429096|NCT00242606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24429141|NCT00242775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24429142|NCT00242775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429143|NCT00242788|Capecitabine|capecitabine|mesh-list
24429144|NCT00242788|Gefitinib|gefitinib|mesh-list
24429145|NCT00242788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24429146|NCT00242788|Antimetabolites|antimetabolites|mesh-ancestor
24429147|NCT00242788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429148|NCT00242788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429149|NCT00242788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24429150|NCT00242788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429151|NCT00242801|Gefitinib|gefitinib|mesh-list
24429152|NCT00242801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429153|NCT00242801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24429154|NCT00242801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429156|NCT00242814|Amlodipine|amlodipine|mesh-list
24548291|NCT00708799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24429199|NCT00242918|Mitosis Modulators|mitosis modulators|mesh-ancestor
24429200|NCT00242918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429201|NCT00242918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24824933|NCT02126332|Sufentanil|sufentanil|mesh-list
24824934|NCT02126332|Nefopam|nefopam|mesh-list
24429202|NCT00242918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429203|NCT00242944|Atorvastatin|atorvastatin|mesh-list
24429204|NCT00242944|Pitavastatin|pitavastatin|mesh-list
24429205|NCT00242944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25267018|NCT02425176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267019|NCT02425202|Ketamine|ketamine|mesh-list
25267020|NCT02425202|Analgesics|analgesics|mesh-ancestor
25267021|NCT02425202|Sensory System Agents|sensory system agents|mesh-ancestor
25267022|NCT02425202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267023|NCT02425202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429208|NCT00242944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429209|NCT00242944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24429210|NCT00242944|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24429211|NCT00242944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429212|NCT00242996|Cyclophosphamide|cyclophosphamide|mesh-list
24429213|NCT00242996|Carmustine|carmustine|mesh-list
24429214|NCT00242996|Rituximab|rituximab|mesh-list
24429215|NCT00242996|Etoposide|etoposide|mesh-list
24429216|NCT00242996|Sargramostim|sargramostim|mesh-list
24429217|NCT00242996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24429218|NCT00242996|Immunologic Factors|immunologic factors|mesh-ancestor
24429219|NCT00242996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429220|NCT00242996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24429222|NCT00242996|Alkylating Agents|alkylating agents|mesh-ancestor
24600657|NCT00959725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25689739|NCT01964755|Tetrahydrofolates|tetrahydrofolates|mesh-list
25689740|NCT01964755|Zidovudine|zidovudine|mesh-list
25689741|NCT01964755|Rituximab|rituximab|mesh-list
25689742|NCT01964755|Doxorubicin|doxorubicin|mesh-list
25689743|NCT01964755|Methotrexate|methotrexate|mesh-list
24429344|NCT00243672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25689744|NCT01964755|Hydroxyurea|hydroxyurea|mesh-list
25689745|NCT01964755|Levoleucovorin|levoleucovorin|mesh-list
24879766|NCT04439799|Testosterone|testosterone|mesh-list
24429345|NCT00243711|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24429346|NCT00243711|Glycerol|glycerol|mesh-list
24429347|NCT00243711|Laxatives|laxatives|mesh-ancestor
24429348|NCT00243711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24429349|NCT00243711|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24429350|NCT00243711|Protective Agents|protective agents|mesh-ancestor
24429351|NCT00243711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429370|NCT00243750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24429381|NCT00243750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24429383|NCT00243750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24429384|NCT00243750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24429385|NCT00243789|Pentoxifylline|pentoxifylline|mesh-list
24429386|NCT00243789|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24429387|NCT00243789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429388|NCT00243789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429389|NCT00243789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24429390|NCT00243789|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24429391|NCT00243789|Protective Agents|protective agents|mesh-ancestor
24600776|NCT00960518|Antiviral Agents|antiviral agents|mesh-ancestor
24429443|NCT00244023|Testosterone enanthate|testosterone enanthate|mesh-list
24429444|NCT00244023|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24429445|NCT00244023|Androgens|androgens|mesh-ancestor
24429447|NCT00244023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24429448|NCT00244023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429449|NCT00244023|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24429450|NCT00244023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429451|NCT00244023|Anabolic Agents|anabolic agents|mesh-ancestor
24429452|NCT00244075|Hormones|hormones|mesh-list
24429453|NCT00244075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24429483|NCT00244153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24429484|NCT00244153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429485|NCT00244153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24429486|NCT00244153|Glucocorticoids|glucocorticoids|mesh-ancestor
24429490|NCT00244153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429492|NCT00244153|Narcotics|narcotics|mesh-ancestor
24429493|NCT00244153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24429494|NCT00244153|Analgesics|analgesics|mesh-ancestor
24429495|NCT00244153|Sensory System Agents|sensory system agents|mesh-ancestor
24429514|NCT00244192|Dermatologic Agents|dermatologic agents|mesh-ancestor
24429515|NCT00244192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24429516|NCT00244192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24429517|NCT00244283|Sevoflurane|sevoflurane|mesh-list
24429518|NCT00244283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24429519|NCT00244283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24429520|NCT00244283|Anesthetics, General|anesthetics, general|mesh-ancestor
24429521|NCT00244283|Anesthetics|anesthetics|mesh-ancestor
24429522|NCT00244283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24429523|NCT00244283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267024|NCT02425202|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25267025|NCT02425202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25267026|NCT02425202|Anesthetics, General|anesthetics, general|mesh-ancestor
25267027|NCT02425202|Anesthetics|anesthetics|mesh-ancestor
25689746|NCT01964755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25689747|NCT01964755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25689748|NCT01964755|Immunologic Factors|immunologic factors|mesh-ancestor
25689749|NCT01964755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689750|NCT01964755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25689751|NCT01964755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25689752|NCT01964755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25689753|NCT01964755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24602936|NCT00971724|Hormones|hormones|mesh-ancestor
24824946|NCT02126332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25056914|NCT03508869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25056923|NCT03508817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25056924|NCT03508817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056925|NCT03508817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25056926|NCT03508817|Respiratory System Agents|respiratory system agents|mesh-ancestor
25056927|NCT03508817|Mydriatics|mydriatics|mesh-ancestor
25056928|NCT03508817|Parasympatholytics|parasympatholytics|mesh-ancestor
25056934|NCT03508804|Lidocaine|lidocaine|mesh-list
24824947|NCT02126332|Narcotics|narcotics|mesh-ancestor
24824948|NCT02126332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24824949|NCT02126332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24824950|NCT02126332|Anesthetics, General|anesthetics, general|mesh-ancestor
24824951|NCT02126358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24824977|NCT02126527|Immunologic Factors|immunologic factors|mesh-ancestor
24429596|NCT00244452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429597|NCT00244452|Hormone Antagonists|hormone antagonists|mesh-ancestor
24429607|NCT00244517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429614|NCT00244517|Sensory System Agents|sensory system agents|mesh-ancestor
24429615|NCT00244517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24429616|NCT00244530|Nifedipine|nifedipine|mesh-list
24429617|NCT00244530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24429618|NCT00244530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24429619|NCT00244530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429620|NCT00244530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24429621|NCT00244530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429622|NCT00244530|Vasodilator Agents|vasodilator agents|mesh-ancestor
24429623|NCT00244530|Tocolytic Agents|tocolytic agents|mesh-ancestor
24429624|NCT00244530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24636488|NCT01145846|Idarubicin|idarubicin|mesh-list
24429753|NCT00244972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429808|NCT00245115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24429809|NCT00245141|Dactinomycin|dactinomycin|mesh-list
24429872|NCT00245258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429873|NCT00245258|Vasodilator Agents|vasodilator agents|mesh-ancestor
24429874|NCT00245258|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24429875|NCT00245258|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24429876|NCT00245258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429877|NCT00245258|Urological Agents|urological agents|mesh-ancestor
24429878|NCT00245297|Factor VIII|factor viii|mesh-list
24429879|NCT00245297|Coagulants|coagulants|mesh-ancestor
24429880|NCT00245336|Thrombin|thrombin|mesh-list
24429881|NCT00245336|Hemostatics|hemostatics|mesh-ancestor
24429882|NCT00245336|Coagulants|coagulants|mesh-ancestor
24429883|NCT00245375|Acetaminophen|acetaminophen|mesh-list
24429884|NCT00245375|Ibuprofen|ibuprofen|mesh-list
24429885|NCT00245375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24429886|NCT00245375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24824997|NCT02126683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24824998|NCT02126761|Vaccines|vaccines|mesh-list
24824999|NCT02126761|Immunologic Factors|immunologic factors|mesh-ancestor
24698053|NCT01438580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24429887|NCT00245375|Analgesics|analgesics|mesh-ancestor
24429888|NCT00245375|Sensory System Agents|sensory system agents|mesh-ancestor
24429889|NCT00245375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24429910|NCT00245414|Immunologic Factors|immunologic factors|mesh-ancestor
24429911|NCT00245414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429912|NCT00245427|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24429913|NCT00245427|Lactams|lactams|mesh-list
24429914|NCT00245427|beta-Lactams|beta-lactams|mesh-list
24429915|NCT00245427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24429916|NCT00245427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24429917|NCT00245427|Antitubercular Agents|antitubercular agents|mesh-ancestor
25267028|NCT02425202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25267029|NCT02425202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25267030|NCT02425202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25689754|NCT01964755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689755|NCT01964755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689756|NCT01964755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25689757|NCT01964755|Abortifacient Agents|abortifacient agents|mesh-ancestor
25689758|NCT01964755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25689759|NCT01964755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25689760|NCT01964755|Antimetabolites|antimetabolites|mesh-ancestor
25267031|NCT02425202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25689761|NCT01964755|Dermatologic Agents|dermatologic agents|mesh-ancestor
24880287|NCT03897998|Sensory System Agents|sensory system agents|mesh-ancestor
25689762|NCT01964755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25689763|NCT01964755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24880360|NCT03829371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24880362|NCT03829371|Growth Inhibitors|growth inhibitors|mesh-ancestor
24880379|NCT03809637|Pemetrexed|pemetrexed|mesh-list
24880380|NCT03809637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880381|NCT03809637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24880382|NCT03809637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880383|NCT03809637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24880384|NCT03809637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24880385|NCT03802071|Doxorubicin|doxorubicin|mesh-list
24880386|NCT03802071|Durvalumab|durvalumab|mesh-list
24880387|NCT03802071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24429931|NCT00245453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24429933|NCT00245505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24429934|NCT00245505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24429935|NCT00245505|Analgesics|analgesics|mesh-ancestor
24429936|NCT00245505|Sensory System Agents|sensory system agents|mesh-ancestor
24429953|NCT00245609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429955|NCT00245609|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24429956|NCT00245609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24429957|NCT00245609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430075|NCT00246103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24430077|NCT00246142|Botulinum Toxins|botulinum toxins|mesh-list
24825013|NCT02126917|Respiratory System Agents|respiratory system agents|mesh-ancestor
24825014|NCT02126943|Macitentan|macitentan|mesh-list
24825015|NCT02126943|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
24825016|NCT02126943|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24825017|NCT02126943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825018|NCT02126943|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
24430093|NCT00246155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733026|NCT01642979|Levamisole|levamisole|mesh-list
24430094|NCT00246155|Cholinergic Agents|cholinergic agents|mesh-ancestor
24430168|NCT00246272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24430169|NCT00246272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24430170|NCT00246272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24430171|NCT00246272|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24825027|NCT02127034|Digoxin|digoxin|mesh-list
24825028|NCT02127034|Solifenacin Succinate|solifenacin succinate|mesh-list
24825029|NCT02127034|Mirabegron|mirabegron|mesh-list
24698291|NCT01440400|Anesthetics|anesthetics|mesh-list
24430212|NCT00246415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430235|NCT00246610|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24430236|NCT00246610|Protease Inhibitors|protease inhibitors|mesh-ancestor
24636549|NCT01146028|Anticonvulsants|anticonvulsants|mesh-ancestor
24825036|NCT02127034|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24430308|NCT00247052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430309|NCT00247052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24430310|NCT00247052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25689764|NCT01964755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25689765|NCT01964755|Antidotes|antidotes|mesh-ancestor
25689766|NCT01964755|Protective Agents|protective agents|mesh-ancestor
25689767|NCT01964755|Vitamin B Complex|vitamin b complex|mesh-ancestor
25689768|NCT01964755|Vitamins|vitamins|mesh-ancestor
25689769|NCT01964755|Micronutrients|micronutrients|mesh-ancestor
25689770|NCT01964755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25689771|NCT01964755|Antiviral Agents|antiviral agents|mesh-ancestor
25689772|NCT01964755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25689773|NCT01964755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25689774|NCT01964755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25689775|NCT01964755|Antisickling Agents|antisickling agents|mesh-ancestor
25689776|NCT01964898|Nicotine|nicotine|mesh-list
25689777|NCT01964898|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24880519|NCT03608358|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24880614|NCT03560934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24880615|NCT03560934|Analgesics|analgesics|mesh-ancestor
24880616|NCT03560934|Sensory System Agents|sensory system agents|mesh-ancestor
24880617|NCT03560934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24880659|NCT03525002|Hormone Antagonists|hormone antagonists|mesh-ancestor
24880660|NCT03525002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24880661|NCT03525002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880662|NCT03525002|Dopamine Agonists|dopamine agonists|mesh-ancestor
24880663|NCT03525002|Dopamine Agents|dopamine agents|mesh-ancestor
24880664|NCT03525002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24600314|NCT01026220|Etoposide|etoposide|mesh-list
24880743|NCT03398135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880744|NCT03395314|Midazolam|midazolam|mesh-list
24430311|NCT00247052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25267032|NCT02425202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267033|NCT02425254|Acetaminophen|acetaminophen|mesh-list
25689778|NCT01964898|Autonomic Agents|autonomic agents|mesh-ancestor
25689779|NCT01964898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267034|NCT02425254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25267035|NCT02425254|Analgesics|analgesics|mesh-ancestor
25267036|NCT02425254|Sensory System Agents|sensory system agents|mesh-ancestor
25267037|NCT02425254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267038|NCT02425254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430312|NCT00247052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430313|NCT00247052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430315|NCT00247078|Immunologic Factors|immunologic factors|mesh-ancestor
24430316|NCT00247078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430317|NCT00247117|Metformin|metformin|mesh-list
24430318|NCT00247117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24804707|NCT02004652|Prucalopride|prucalopride|mesh-list
24430324|NCT00247130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24430365|NCT00247481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430366|NCT00247481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24430368|NCT00247494|Mycophenolic Acid|mycophenolic acid|mesh-list
24601622|NCT00965042|Ceftobiprole|ceftobiprole|mesh-list
24581600|NCT00865540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24825052|NCT02127047|Protease Inhibitors|protease inhibitors|mesh-ancestor
24825053|NCT02127047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430647|NCT00248729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24430648|NCT00248729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24430649|NCT00248729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24430650|NCT00248729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430651|NCT00248729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24430652|NCT00248729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24430653|NCT00248729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24430654|NCT00248729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24430655|NCT00248729|Anesthetics, General|anesthetics, general|mesh-ancestor
24430656|NCT00248729|Anesthetics|anesthetics|mesh-ancestor
24430711|NCT00249132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430712|NCT00249132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25689780|NCT01964898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689781|NCT01964898|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25689782|NCT01964898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25689783|NCT01964898|Cholinergic Agents|cholinergic agents|mesh-ancestor
25689784|NCT01964898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25689785|NCT01964898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689786|NCT01964924|Trametinib|trametinib|mesh-list
25689787|NCT01964924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25689788|NCT01964924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25689789|NCT01964924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689790|NCT01964924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689791|NCT01964963|Alogliptin|alogliptin|mesh-list
25689792|NCT01964963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25689793|NCT01964963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689794|NCT01964963|Incretins|incretins|mesh-ancestor
24825089|NCT02127320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24880911|NCT03179904|Trastuzumab|trastuzumab|mesh-list
24880912|NCT03179904|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24880914|NCT03179904|Fulvestrant|fulvestrant|mesh-list
24880915|NCT03179904|Anastrozole|anastrozole|mesh-list
24880916|NCT03179904|Exemestane|exemestane|mesh-list
24880968|NCT03174275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24880970|NCT03174275|Tubulin Modulators|tubulin modulators|mesh-ancestor
24825090|NCT02127320|Antimetabolites|antimetabolites|mesh-ancestor
24825091|NCT02127320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825092|NCT02127320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24430760|NCT00249197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24430843|NCT00249431|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25267039|NCT02425254|Antipyretics|antipyretics|mesh-ancestor
25267040|NCT02424656|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25267041|NCT02424656|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25267042|NCT02424656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267043|NCT02424552|Vitamin D|vitamin d|mesh-list
25267044|NCT02424552|Cholecalciferol|cholecalciferol|mesh-list
25267045|NCT02424552|Vitamins|vitamins|mesh-ancestor
25267046|NCT02424552|Micronutrients|micronutrients|mesh-ancestor
25267047|NCT02424552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267048|NCT02424552|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25267049|NCT02424552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25267051|NCT02424695|Analgesics|analgesics|mesh-ancestor
25267052|NCT02424695|Sensory System Agents|sensory system agents|mesh-ancestor
25267053|NCT02424695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267054|NCT02424695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267055|NCT02424695|Anticonvulsants|anticonvulsants|mesh-ancestor
25267056|NCT02424695|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25267057|NCT02424695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25267058|NCT02424695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25267059|NCT02424695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24466548|NCT00373802|Protective Agents|protective agents|mesh-ancestor
24430844|NCT00249431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24430845|NCT00249431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24430846|NCT00249431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430847|NCT00249431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430848|NCT00249431|Serotonin Agents|serotonin agents|mesh-ancestor
24430849|NCT00249431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430850|NCT00249483|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24430851|NCT00249483|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24430852|NCT00249483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24431090|NCT00250315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431091|NCT00250315|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24431092|NCT00250315|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24431093|NCT00250315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24431094|NCT00250315|Adrenergic Agents|adrenergic agents|mesh-ancestor
24431095|NCT00250315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431096|NCT00250315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431097|NCT00250315|Protective Agents|protective agents|mesh-ancestor
24431098|NCT00250354|Risperidone|risperidone|mesh-list
24431100|NCT00250354|Serotonin Agents|serotonin agents|mesh-ancestor
24431130|NCT00250536|Nandrolone Decanoate|nandrolone decanoate|mesh-list
24431132|NCT00250536|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
24431133|NCT00250536|Androgens|androgens|mesh-ancestor
24825102|NCT02127489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24825104|NCT02127489|Sensory System Agents|sensory system agents|mesh-ancestor
24825105|NCT02127489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24431248|NCT00250952|Cholinergic Agents|cholinergic agents|mesh-ancestor
24431249|NCT00250952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24601843|NCT00966160|Efavirenz|efavirenz|mesh-list
24431404|NCT00251602|Autonomic Agents|autonomic agents|mesh-ancestor
24431428|NCT00251706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25689795|NCT01964963|Hormones|hormones|mesh-ancestor
25689796|NCT01964963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25689797|NCT01964963|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25689798|NCT01964963|Protease Inhibitors|protease inhibitors|mesh-ancestor
25689799|NCT01964963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689800|NCT01964963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881181|NCT02944019|Protease Inhibitors|protease inhibitors|mesh-ancestor
24881182|NCT02944019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881183|NCT02944019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881184|NCT02944019|Anticoagulants|anticoagulants|mesh-ancestor
24881212|NCT02921893|Ixazomib|ixazomib|mesh-list
24881240|NCT02900443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24881241|NCT02900443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881242|NCT02900443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24881243|NCT02900443|Antitubercular Agents|antitubercular agents|mesh-ancestor
24881244|NCT02900443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24881245|NCT02900443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24431447|NCT00251732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431448|NCT00251732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431449|NCT00251732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24431450|NCT00251732|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24431451|NCT00251732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24431452|NCT00251732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24431453|NCT00251732|Adrenergic Agents|adrenergic agents|mesh-ancestor
24431454|NCT00251732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431455|NCT00251732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431520|NCT00251992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24431521|NCT00251992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24431522|NCT00251992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431523|NCT00251992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431524|NCT00252044|Pergolide|pergolide|mesh-list
24431525|NCT00252044|Dopamine Agonists|dopamine agonists|mesh-ancestor
24804828|NCT02005523|Analgesics|analgesics|mesh-ancestor
24431696|NCT00252785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24431697|NCT00252785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24431698|NCT00252785|Autonomic Agents|autonomic agents|mesh-ancestor
24431699|NCT00252785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24431700|NCT00252785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431701|NCT00252785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24431702|NCT00252785|Respiratory System Agents|respiratory system agents|mesh-ancestor
24431703|NCT00252785|Glucocorticoids|glucocorticoids|mesh-ancestor
24431758|NCT00252863|Formoterol Fumarate|formoterol fumarate|mesh-list
24431759|NCT00252863|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24431760|NCT00252863|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24431761|NCT00252863|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24431762|NCT00252863|Montelukast|montelukast|mesh-list
24431763|NCT00252863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24431764|NCT00252863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24431765|NCT00252863|Autonomic Agents|autonomic agents|mesh-ancestor
25267060|NCT02424695|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25267061|NCT02424695|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24625635|NCT01082731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24625636|NCT01082731|Antiviral Agents|antiviral agents|mesh-ancestor
24431872|NCT00253149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24431873|NCT00253149|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24431874|NCT00253149|Dopamine Agents|dopamine agents|mesh-ancestor
24431875|NCT00253162|Risperidone|risperidone|mesh-list
24431876|NCT00253162|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25689801|NCT01965002|Aspirin|aspirin|mesh-list
25689802|NCT01965002|Enoxaparin|enoxaparin|mesh-list
25689803|NCT01965002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25689804|NCT01965002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25689805|NCT01965002|Analgesics|analgesics|mesh-ancestor
25689806|NCT01965002|Sensory System Agents|sensory system agents|mesh-ancestor
25689807|NCT01965002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25689808|NCT01965002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689809|NCT01965002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25689810|NCT01965002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25689811|NCT01965002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24431883|NCT00253162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24431884|NCT00253162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24431885|NCT00253162|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24466723|NCT00374764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431886|NCT00253162|Dopamine Agents|dopamine agents|mesh-ancestor
24431962|NCT00253318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432180|NCT00253929|Purinergic Agents|purinergic agents|mesh-ancestor
24432181|NCT00253929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24432183|NCT00253929|Sensory System Agents|sensory system agents|mesh-ancestor
24432184|NCT00253929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24432185|NCT00253929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24432186|NCT00253929|Vasodilator Agents|vasodilator agents|mesh-ancestor
24432187|NCT00253929|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24432188|NCT00253929|Purinergic Agonists|purinergic agonists|mesh-ancestor
24432189|NCT00253929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25267068|NCT02424318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267069|NCT02424214|Ionophores|ionophores|mesh-list
25267070|NCT02424214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25267071|NCT02424214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804915|NCT02005770|Anesthetics|anesthetics|mesh-ancestor
24432223|NCT00254020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24432224|NCT00254020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24432225|NCT00254020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432365|NCT00254618|Sensory System Agents|sensory system agents|mesh-ancestor
24432366|NCT00254618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24432367|NCT00254618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432368|NCT00254618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24432369|NCT00254618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24432446|NCT00254800|Estrogens|estrogens|mesh-ancestor
24432447|NCT00254800|Hormones|hormones|mesh-ancestor
24432456|NCT00254800|Incretins|incretins|mesh-ancestor
24432475|NCT00254865|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24432842|NCT00256347|Analgesics|analgesics|mesh-ancestor
24432843|NCT00256347|Sensory System Agents|sensory system agents|mesh-ancestor
24432844|NCT00256347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267072|NCT02424201|Ascorbic Acid|ascorbic acid|mesh-list
25267073|NCT02424201|Misoprostol|misoprostol|mesh-list
25267074|NCT02424201|Vitamins|vitamins|mesh-ancestor
25267075|NCT02424201|Micronutrients|micronutrients|mesh-ancestor
25267076|NCT02424201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267077|NCT02424201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25267078|NCT02424201|Abortifacient Agents|abortifacient agents|mesh-ancestor
25267079|NCT02424201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25267080|NCT02424201|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25267088|NCT02424461|Levofloxacin|levofloxacin|mesh-list
25267089|NCT02424461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25267090|NCT02424461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25267091|NCT02424461|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24432918|NCT00257023|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24432919|NCT00257023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24432920|NCT00257023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24432921|NCT00257023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432922|NCT00257023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24432967|NCT00257062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432968|NCT00257062|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24432969|NCT00257062|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24432971|NCT00257075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24432974|NCT00257075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432975|NCT00257075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432976|NCT00257075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24433091|NCT00257530|Interferon Inducers|interferon inducers|mesh-ancestor
24433092|NCT00257569|Cetirizine|cetirizine|mesh-list
24433093|NCT00257569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24443202|NCT00293969|Morphine|morphine|mesh-list
24433094|NCT00257569|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24433095|NCT00257569|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24433096|NCT00257569|Histamine Antagonists|histamine antagonists|mesh-ancestor
24433097|NCT00257569|Histamine Agents|histamine agents|mesh-ancestor
24433098|NCT00257569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24433099|NCT00257569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433100|NCT00257569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433101|NCT00257582|Cetirizine|cetirizine|mesh-list
24433102|NCT00257582|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24433103|NCT00257582|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24433104|NCT00257582|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24433105|NCT00257582|Histamine Antagonists|histamine antagonists|mesh-ancestor
24433106|NCT00257582|Histamine Agents|histamine agents|mesh-ancestor
24433107|NCT00257582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24433108|NCT00257582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433109|NCT00257582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433110|NCT00257595|Cetirizine|cetirizine|mesh-list
24433111|NCT00257595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25267097|NCT02424461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267098|NCT02424461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25267099|NCT02424461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25267100|NCT02424435|Methylprednisolone|methylprednisolone|mesh-list
25267101|NCT02424435|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25267102|NCT02424435|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25267103|NCT02424435|Prednisolone|prednisolone|mesh-list
25267104|NCT02424435|Prednisolone acetate|prednisolone acetate|mesh-list
25267105|NCT02424435|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25267106|NCT02424435|Prednisolone phosphate|prednisolone phosphate|mesh-list
24456809|NCT00332306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24939895|NCT04005768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24433395|NCT00258258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433397|NCT00258271|Imatinib Mesylate|imatinib mesylate|mesh-list
24433398|NCT00258271|Cladribine|cladribine|mesh-list
24433399|NCT00258271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24433400|NCT00258271|Antimetabolites|antimetabolites|mesh-ancestor
24881534|NCT02101853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24405896|NCT00168740|Immunologic Factors|immunologic factors|mesh-ancestor
25689812|NCT01965002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24741259|NCT01693081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24741260|NCT01693081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24741269|NCT01693276|Paclitaxel|paclitaxel|mesh-list
24433401|NCT00258271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433402|NCT00258271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433403|NCT00258271|Antiviral Agents|antiviral agents|mesh-ancestor
24433404|NCT00258271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24433405|NCT00258271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24433406|NCT00258271|Immunologic Factors|immunologic factors|mesh-ancestor
24433681|NCT00259701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433683|NCT00259714|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24433684|NCT00259766|Budesonide|budesonide|mesh-list
24433685|NCT00259766|Terbutaline|terbutaline|mesh-list
24433686|NCT00259766|Formoterol Fumarate|formoterol fumarate|mesh-list
24433687|NCT00259766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24433688|NCT00259766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24433689|NCT00259766|Autonomic Agents|autonomic agents|mesh-ancestor
24433690|NCT00259766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24433691|NCT00259766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433692|NCT00259766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24433693|NCT00259766|Respiratory System Agents|respiratory system agents|mesh-ancestor
24433694|NCT00259766|Glucocorticoids|glucocorticoids|mesh-ancestor
24433695|NCT00259766|Hormones|hormones|mesh-ancestor
24433696|NCT00259766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24433697|NCT00259766|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24433698|NCT00259766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24433700|NCT00259766|Adrenergic Agents|adrenergic agents|mesh-ancestor
24433836|NCT00260247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433837|NCT00260247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24433838|NCT00260247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24433839|NCT00260247|Analgesics|analgesics|mesh-ancestor
24433840|NCT00260247|Sensory System Agents|sensory system agents|mesh-ancestor
24433841|NCT00260247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24434047|NCT00261300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434049|NCT00261313|Hematinics|hematinics|mesh-ancestor
24434050|NCT00261326|Simvastatin|simvastatin|mesh-list
24434051|NCT00261326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24434052|NCT00261326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24434053|NCT00261326|Antimetabolites|antimetabolites|mesh-ancestor
24434146|NCT00261586|Celecoxib|celecoxib|mesh-list
24434147|NCT00261586|Naproxen|naproxen|mesh-list
24434148|NCT00261586|Rofecoxib|rofecoxib|mesh-list
24434149|NCT00261586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24434150|NCT00261586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24434151|NCT00261586|Analgesics|analgesics|mesh-ancestor
24434802|NCT00263718|Betamethasone Valerate|betamethasone valerate|mesh-list
24434153|NCT00261586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24825258|NCT02127866|Glucocorticoids|glucocorticoids|mesh-ancestor
24825259|NCT02127866|Hormones|hormones|mesh-ancestor
24825260|NCT02127866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24825261|NCT02127918|Clobazam|clobazam|mesh-list
24825262|NCT02127918|Anticonvulsants|anticonvulsants|mesh-ancestor
24825263|NCT02127918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25267107|NCT02424435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25267108|NCT02424435|Antiemetics|antiemetics|mesh-ancestor
25267109|NCT02424435|Autonomic Agents|autonomic agents|mesh-ancestor
25267110|NCT02424435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267111|NCT02424435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267112|NCT02424435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25267113|NCT02424435|Glucocorticoids|glucocorticoids|mesh-ancestor
25267114|NCT02424435|Hormones|hormones|mesh-ancestor
25267115|NCT02424435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25689813|NCT01965002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689814|NCT01965002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25689815|NCT01965002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25689816|NCT01965002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689817|NCT01965002|Antipyretics|antipyretics|mesh-ancestor
24825264|NCT02127918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24434375|NCT00262327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24434376|NCT00262327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25689818|NCT01965002|Anticoagulants|anticoagulants|mesh-ancestor
25689819|NCT01965327|Interferons|interferons|mesh-list
25689820|NCT01965327|Interferon-gamma|interferon-gamma|mesh-list
25689821|NCT01965327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24434377|NCT00262327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25689822|NCT01965327|Antiviral Agents|antiviral agents|mesh-ancestor
25689823|NCT01965327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25689824|NCT01965366|Dexamethasone|dexamethasone|mesh-list
24434378|NCT00262327|Growth Substances|growth substances|mesh-ancestor
24434379|NCT00262327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434380|NCT00262327|Growth Inhibitors|growth inhibitors|mesh-ancestor
24434382|NCT00262379|Hematinics|hematinics|mesh-ancestor
24434383|NCT00262392|Pamidronate|pamidronate|mesh-list
24434384|NCT00262392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24603482|NCT00974012|Valproic Acid|valproic acid|mesh-list
24825298|NCT02128100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825299|NCT02128100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24825300|NCT02128100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825301|NCT02128100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24825302|NCT02128100|Immunologic Factors|immunologic factors|mesh-ancestor
24825303|NCT02128100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825304|NCT02128100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24825306|NCT02128100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825314|NCT02128126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825317|NCT02128178|Anticoagulants|anticoagulants|mesh-ancestor
24825318|NCT02128178|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24825319|NCT02128178|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24825320|NCT02128178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467194|NCT00376493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24825322|NCT02128191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24825323|NCT02128191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24825324|NCT02128191|Analgesics|analgesics|mesh-ancestor
24825347|NCT02128243|Docetaxel|docetaxel|mesh-list
24825348|NCT02128243|Fluorouracil|fluorouracil|mesh-list
24825349|NCT02128243|Capecitabine|capecitabine|mesh-list
24825350|NCT02128243|Oxaliplatin|oxaliplatin|mesh-list
24825351|NCT02128243|Epirubicin|epirubicin|mesh-list
24825352|NCT02128243|Levoleucovorin|levoleucovorin|mesh-list
24825353|NCT02128243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825354|NCT02128243|Tubulin Modulators|tubulin modulators|mesh-ancestor
24825355|NCT02128243|Antimitotic Agents|antimitotic agents|mesh-ancestor
24825356|NCT02128243|Mitosis Modulators|mitosis modulators|mesh-ancestor
24825394|NCT02128308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24825407|NCT02128308|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24825409|NCT02128308|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24825410|NCT02128308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24825411|NCT02128308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24825412|NCT02128308|Antitubercular Agents|antitubercular agents|mesh-ancestor
24825413|NCT02128308|Antimetabolites|antimetabolites|mesh-ancestor
24434796|NCT00263705|Capecitabine|capecitabine|mesh-list
24434797|NCT00263705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24434798|NCT00263705|Antimetabolites|antimetabolites|mesh-ancestor
24434799|NCT00263705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434800|NCT00263705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24434801|NCT00263718|Betamethasone|betamethasone|mesh-list
24434804|NCT00263718|Betamethasone benzoate|betamethasone benzoate|mesh-list
24434805|NCT00263718|Calcipotriene|calcipotriene|mesh-list
24434806|NCT00263718|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24434807|NCT00263718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24434808|NCT00263718|Glucocorticoids|glucocorticoids|mesh-ancestor
24434809|NCT00263718|Hormones|hormones|mesh-ancestor
24434811|NCT00263718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549732|NCT00717379|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24549733|NCT00717379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434824|NCT00263796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25689825|NCT01965366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25689826|NCT01965366|Antiemetics|antiemetics|mesh-ancestor
25267116|NCT02424435|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25267117|NCT02424435|Protective Agents|protective agents|mesh-ancestor
25267118|NCT02424435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24434826|NCT00263822|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24434827|NCT00263822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24434828|NCT00263822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24434829|NCT00263822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434830|NCT00263822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434831|NCT00263965|Metformin|metformin|mesh-list
24434832|NCT00263965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24434833|NCT00263965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434834|NCT00263978|Defibrotide|defibrotide|mesh-list
24434835|NCT00263978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24434878|NCT00264186|Adrenergic Agents|adrenergic agents|mesh-ancestor
24434879|NCT00264186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24549760|NCT00717470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24434880|NCT00264186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434881|NCT00264186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434882|NCT00264186|Sympathomimetics|sympathomimetics|mesh-ancestor
24434883|NCT00264186|Autonomic Agents|autonomic agents|mesh-ancestor
24434884|NCT00264186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24434885|NCT00264186|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24434886|NCT00264186|Vasodilator Agents|vasodilator agents|mesh-ancestor
24434887|NCT00264186|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24603921|NCT00976105|GABA Agents|gaba agents|mesh-ancestor
24825433|NCT02128334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24825434|NCT02128334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825435|NCT02128334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24825436|NCT02128334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825437|NCT02128360|Letrozole|letrozole|mesh-list
24701046|NCT01456507|Narcotics|narcotics|mesh-ancestor
24435034|NCT00264901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435036|NCT00264914|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24435037|NCT00264914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435038|NCT00264914|Natriuretic Agents|natriuretic agents|mesh-ancestor
24435039|NCT00264914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825439|NCT02128360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24825440|NCT02128360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24825441|NCT02128360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825442|NCT02128360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825443|NCT02128360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24825444|NCT02128360|Hormone Antagonists|hormone antagonists|mesh-ancestor
24701107|NCT01456689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24435209|NCT00265551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24435259|NCT00265772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24467362|NCT00377325|Cyclosporine|cyclosporine|mesh-list
24435260|NCT00265772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604099|NCT00977145|Interferon-gamma|interferon-gamma|mesh-list
24825466|NCT02128425|Micronutrients|micronutrients|mesh-ancestor
25267122|NCT02424136|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25267124|NCT02424136|Immunologic Factors|immunologic factors|mesh-ancestor
25689827|NCT01965366|Autonomic Agents|autonomic agents|mesh-ancestor
25689828|NCT01965366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25689829|NCT01965366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689830|NCT01965366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25689831|NCT01965366|Glucocorticoids|glucocorticoids|mesh-ancestor
25689832|NCT01965366|Hormones|hormones|mesh-ancestor
25689833|NCT01965366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25689834|NCT01965366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25267127|NCT02424136|Autonomic Agents|autonomic agents|mesh-ancestor
24516678|NCT00602706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24516679|NCT00602706|Analgesics|analgesics|mesh-ancestor
24516680|NCT00602706|Sensory System Agents|sensory system agents|mesh-ancestor
24516681|NCT00602706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24825468|NCT02128451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24825469|NCT02128451|Narcotics|narcotics|mesh-ancestor
24825470|NCT02128451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24825471|NCT02128451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825472|NCT02128451|Analgesics|analgesics|mesh-ancestor
24701177|NCT01457495|Anticoagulants|anticoagulants|mesh-ancestor
24435303|NCT00265915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435304|NCT00265915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24435306|NCT00265928|Bortezomib|bortezomib|mesh-list
24435307|NCT00265928|Antibodies|antibodies|mesh-list
24435321|NCT00265967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435322|NCT00265993|Enoxaparin|enoxaparin|mesh-list
24435323|NCT00265993|Anticoagulants|anticoagulants|mesh-ancestor
24435324|NCT00265993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24435325|NCT00265993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24435326|NCT00265993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435327|NCT00266058|Ritonavir|ritonavir|mesh-list
24435328|NCT00266058|Lopinavir|lopinavir|mesh-list
24435329|NCT00266058|Efavirenz|efavirenz|mesh-list
24435330|NCT00266058|Lumefantrine|lumefantrine|mesh-list
24549814|NCT00717652|Triamcinolone|triamcinolone|mesh-list
24435332|NCT00266058|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24435333|NCT00266058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24435334|NCT00266058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24435335|NCT00266058|Protease Inhibitors|protease inhibitors|mesh-ancestor
24435336|NCT00266058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435337|NCT00266058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435338|NCT00266058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24435339|NCT00266058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24435340|NCT00266058|Antiviral Agents|antiviral agents|mesh-ancestor
24435341|NCT00266058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24435342|NCT00266058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24435343|NCT00266058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24435428|NCT00266253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435429|NCT00266318|Interferons|interferons|mesh-list
24435430|NCT00266318|Ribavirin|ribavirin|mesh-list
24435431|NCT00266318|Interferon alfacon-1|interferon alfacon-1|mesh-list
24435432|NCT00266318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435433|NCT00266318|Antiviral Agents|antiviral agents|mesh-ancestor
24435434|NCT00266318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24435435|NCT00266318|Antimetabolites|antimetabolites|mesh-ancestor
24435436|NCT00266318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435438|NCT00266344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25267128|NCT02424136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267129|NCT02424136|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25267130|NCT02424136|Respiratory System Agents|respiratory system agents|mesh-ancestor
25267131|NCT02424136|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25267132|NCT02424136|Antioxidants|antioxidants|mesh-ancestor
25267133|NCT02424136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267134|NCT02424136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24516682|NCT00602719|Zolpidem|zolpidem|mesh-list
24882184|NCT02735707|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24882185|NCT02735707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24882186|NCT02735707|Antimetabolites|antimetabolites|mesh-ancestor
24435439|NCT00266344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435440|NCT00266344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435506|NCT00266578|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24435508|NCT00266591|Anticonvulsants|anticonvulsants|mesh-ancestor
24435509|NCT00266591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24435510|NCT00266591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435511|NCT00266604|Topiramate|topiramate|mesh-list
24435512|NCT00266604|Anticonvulsants|anticonvulsants|mesh-ancestor
24435513|NCT00266604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24435514|NCT00266604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435515|NCT00266617|Epoetin Alfa|epoetin alfa|mesh-list
24435516|NCT00266617|Hematinics|hematinics|mesh-ancestor
24435517|NCT00266643|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24467389|NCT00377468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24435518|NCT00266643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24435519|NCT00266643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24435520|NCT00266643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24435521|NCT00266643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435522|NCT00266643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24436220|NCT00269555|Genistein|genistein|mesh-list
24436221|NCT00269555|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24436222|NCT00269555|Protective Agents|protective agents|mesh-ancestor
24436353|NCT00269776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24436354|NCT00269776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436355|NCT00269776|Dopamine Agents|dopamine agents|mesh-ancestor
24436356|NCT00269776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24436357|NCT00269789|Methylphenidate|methylphenidate|mesh-list
24436358|NCT00269789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24436359|NCT00269789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436410|NCT00269854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436411|NCT00269854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24436413|NCT00269854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24436414|NCT00269854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24436445|NCT00269932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24436446|NCT00269932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24436447|NCT00269932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24436448|NCT00269932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436449|NCT00269932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24436450|NCT00269932|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24604913|NCT00982332|Hormones|hormones|mesh-ancestor
24436625|NCT00270582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24436626|NCT00270582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24436632|NCT00270647|Vitamins|vitamins|mesh-list
24605034|NCT00983034|Amoxicillin|amoxicillin|mesh-list
24436747|NCT00271271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436748|NCT00271271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24436750|NCT00271271|Antimitotic Agents|antimitotic agents|mesh-ancestor
24436751|NCT00271271|Mitosis Modulators|mitosis modulators|mesh-ancestor
24436752|NCT00271284|Insulin|insulin|mesh-list
24436753|NCT00271284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24436754|NCT00271284|Insulin Glargine|insulin glargine|mesh-list
24605199|NCT00983788|Bezafibrate|bezafibrate|mesh-list
24436825|NCT00271453|Anesthetics, General|anesthetics, general|mesh-ancestor
24436827|NCT00271466|Fentanyl|fentanyl|mesh-list
24436828|NCT00271466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24436829|NCT00271466|Narcotics|narcotics|mesh-ancestor
24436830|NCT00271466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25689835|NCT01965366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25689836|NCT01965431|Moxifloxacin|moxifloxacin|mesh-list
25689837|NCT01965431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25689838|NCT01965431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24882415|NCT05171400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882421|NCT05171309|Apatinib|apatinib|mesh-list
24882422|NCT05171309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882423|NCT05171309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24882424|NCT05171309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24882425|NCT05171309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882426|NCT05171179|Lidocaine|lidocaine|mesh-list
24882427|NCT05171179|Bupivacaine|bupivacaine|mesh-list
24882428|NCT05171179|Anesthetics, Local|anesthetics, local|mesh-ancestor
24882429|NCT05171179|Anesthetics|anesthetics|mesh-ancestor
24436831|NCT00271466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267135|NCT02424136|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25267136|NCT02424136|Vasodilator Agents|vasodilator agents|mesh-ancestor
25267137|NCT02424136|Gasotransmitters|gasotransmitters|mesh-ancestor
25267138|NCT02424136|Protective Agents|protective agents|mesh-ancestor
25267139|NCT02423928|Cyclophosphamide|cyclophosphamide|mesh-list
25267140|NCT02423928|Ipilimumab|ipilimumab|mesh-list
25267141|NCT02423928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24436832|NCT00271466|Analgesics|analgesics|mesh-ancestor
24436833|NCT00271466|Sensory System Agents|sensory system agents|mesh-ancestor
24436834|NCT00271466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24436835|NCT00271466|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24436836|NCT00271466|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24436837|NCT00271466|Anesthetics, General|anesthetics, general|mesh-ancestor
24436838|NCT00271466|Anesthetics|anesthetics|mesh-ancestor
24436839|NCT00271492|Atrasentan|atrasentan|mesh-list
24436840|NCT00271492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550335|NCT00720304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550336|NCT00720304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24436843|NCT00271492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436844|NCT00271518|Hormones|hormones|mesh-list
24436845|NCT00271518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24436846|NCT00271518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436847|NCT00271557|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24436848|NCT00271557|Natriuretic Agents|natriuretic agents|mesh-ancestor
24550337|NCT00720304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550338|NCT00720408|Mycophenolic Acid|mycophenolic acid|mesh-list
24550340|NCT00720408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24436850|NCT00271583|Levonorgestrel|levonorgestrel|mesh-list
24436910|NCT00272051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24436911|NCT00272051|Serotonin Agents|serotonin agents|mesh-ancestor
24436912|NCT00272051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24436913|NCT00272051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436914|NCT00272051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825597|NCT02129231|Antacids|antacids|mesh-ancestor
24825598|NCT02129231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24825599|NCT02129257|Leucovorin|leucovorin|mesh-list
25689839|NCT01965431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25689840|NCT01965431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25689841|NCT01965431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689842|NCT01965431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689843|NCT01965431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25689844|NCT01965535|Sofosbuvir|sofosbuvir|mesh-list
25689845|NCT01965535|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25689846|NCT01965535|Ledipasvir|ledipasvir|mesh-list
25689847|NCT01965535|Antiviral Agents|antiviral agents|mesh-ancestor
24825600|NCT02129257|Folic Acid|folic acid|mesh-list
24825604|NCT02129257|Levoleucovorin|levoleucovorin|mesh-list
24825605|NCT02129257|Antimetabolites|antimetabolites|mesh-ancestor
24825606|NCT02129257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825607|NCT02129257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24825608|NCT02129257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825609|NCT02129257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24825610|NCT02129257|Immunologic Factors|immunologic factors|mesh-ancestor
24825611|NCT02129257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825613|NCT02129257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24436936|NCT00272116|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25267142|NCT02423928|Immunologic Factors|immunologic factors|mesh-ancestor
25267145|NCT02423928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25267146|NCT02423928|Alkylating Agents|alkylating agents|mesh-ancestor
25267147|NCT02423928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267148|NCT02423928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267149|NCT02423928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24467588|NCT00378144|Autonomic Agents|autonomic agents|mesh-ancestor
25267150|NCT02423928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25267151|NCT02423928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25267153|NCT02424071|Antioxidants|antioxidants|mesh-ancestor
25267154|NCT02424071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939967|NCT04005417|Tin Fluorides|tin fluorides|mesh-list
24436937|NCT00272116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24436938|NCT00272207|Nabilone|nabilone|mesh-list
24436939|NCT00272207|Antiemetics|antiemetics|mesh-ancestor
24437067|NCT00272597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550374|NCT00720447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550375|NCT00720447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24550376|NCT00720447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24437068|NCT00272597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437069|NCT00272597|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24437070|NCT00272597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24437071|NCT00272597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24437072|NCT00272597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24437073|NCT00272597|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24437074|NCT00272597|Dopamine Agents|dopamine agents|mesh-ancestor
24437077|NCT00272610|Micronutrients|micronutrients|mesh-ancestor
24437078|NCT00272610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437079|NCT00272636|Amiodarone|amiodarone|mesh-list
24437080|NCT00272636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24437111|NCT00272714|Afimoxifene|afimoxifene|mesh-list
24437112|NCT00272714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24437138|NCT00272753|Hormones|hormones|mesh-ancestor
24437139|NCT00272753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24437668|NCT00274105|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24437669|NCT00274105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437670|NCT00274118|Telmisartan|telmisartan|mesh-list
24437672|NCT00274118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24437673|NCT00274118|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24437674|NCT00274118|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24437675|NCT00274118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437676|NCT00274118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24437716|NCT00274274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437718|NCT00274326|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24437719|NCT00274326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437720|NCT00274326|Natriuretic Agents|natriuretic agents|mesh-ancestor
24437721|NCT00274326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437722|NCT00274339|Lansoprazole|lansoprazole|mesh-list
24437723|NCT00274339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24437724|NCT00274339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24882769|NCT05002244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24437725|NCT00274339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24437726|NCT00274339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825622|NCT02129257|Vitamins|vitamins|mesh-ancestor
24550429|NCT00720538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550431|NCT00720564|Arsenic Trioxide|arsenic trioxide|mesh-list
24550432|NCT00720564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24550433|NCT00720564|Alkylating Agents|alkylating agents|mesh-ancestor
24437728|NCT00274352|Adalimumab|adalimumab|mesh-list
24437729|NCT00274352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25267163|NCT02423954|Antimetabolites|antimetabolites|mesh-ancestor
24437731|NCT00274391|Amiloride|amiloride|mesh-list
24825630|NCT02129270|Sensory System Agents|sensory system agents|mesh-ancestor
24825631|NCT02129270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24825632|NCT02129270|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24825633|NCT02129270|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24825634|NCT02129270|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24825635|NCT02129270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24825636|NCT02129270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438354|NCT00275600|Micronutrients|micronutrients|mesh-ancestor
24438355|NCT00275600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438356|NCT00275600|Antioxidants|antioxidants|mesh-ancestor
24438357|NCT00275600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438358|NCT00275600|Protective Agents|protective agents|mesh-ancestor
24438359|NCT00275613|Rituximab|rituximab|mesh-list
24438360|NCT00275613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24438361|NCT00275613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438362|NCT00275613|Immunologic Factors|immunologic factors|mesh-ancestor
24438363|NCT00275613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438364|NCT00275613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24438365|NCT00275639|Losartan|losartan|mesh-list
24438366|NCT00275639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24438367|NCT00275639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24438368|NCT00275639|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24438369|NCT00275639|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24438370|NCT00275639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438372|NCT00275652|Telbivudine|telbivudine|mesh-list
24438396|NCT00275730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24438397|NCT00275730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438398|NCT00275730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438399|NCT00275756|Timolol|timolol|mesh-list
24825644|NCT02129400|Xenon|xenon|mesh-list
24825645|NCT02129400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24825646|NCT02129400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267164|NCT02423954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267165|NCT02423954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25689855|NCT01965834|Antimetabolites|antimetabolites|mesh-ancestor
25689856|NCT01965834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267168|NCT02423954|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25267169|NCT02423954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25267170|NCT02423954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25267171|NCT02423954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25267172|NCT02423954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25267173|NCT02423954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25267174|NCT02423954|Antifungal Agents|antifungal agents|mesh-ancestor
24825647|NCT02129400|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24825648|NCT02129400|Anesthetics, General|anesthetics, general|mesh-ancestor
24825649|NCT02129582|Methotrexate|methotrexate|mesh-list
24825650|NCT02129582|Fludarabine phosphate|fludarabine phosphate|mesh-list
24825651|NCT02129582|Fludarabine|fludarabine|mesh-list
24825652|NCT02129582|Busulfan|busulfan|mesh-list
24825653|NCT02129582|Tacrolimus|tacrolimus|mesh-list
24825654|NCT02129582|Thymoglobulin|thymoglobulin|mesh-list
24825655|NCT02129582|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24438521|NCT00276081|Analgesics|analgesics|mesh-ancestor
24438522|NCT00276081|Sensory System Agents|sensory system agents|mesh-ancestor
24438523|NCT00276081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24439117|NCT00277602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439118|NCT00277602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439119|NCT00277602|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24825678|NCT02129595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825679|NCT02129595|Protective Agents|protective agents|mesh-ancestor
24825680|NCT02129595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825681|NCT02129595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825682|NCT02129595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24606111|NCT00988897|Vitamins|vitamins|mesh-ancestor
24439183|NCT00277862|Ribavirin|ribavirin|mesh-list
24439184|NCT00277862|Interferon-alpha|interferon-alpha|mesh-list
24439185|NCT00277862|Interferon alpha-2|interferon alpha-2|mesh-list
24439186|NCT00277862|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
24439187|NCT00277862|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24439208|NCT00278083|Respiratory System Agents|respiratory system agents|mesh-ancestor
24439209|NCT00278083|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24439210|NCT00278083|Antioxidants|antioxidants|mesh-ancestor
24439211|NCT00278083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692640|NCT02003365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692641|NCT02003391|Timolol|timolol|mesh-list
25692642|NCT02003391|Travoprost|travoprost|mesh-list
25692643|NCT02003391|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25692644|NCT02003391|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25692645|NCT02003391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25692646|NCT02003391|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25057320|NCT03506178|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24439300|NCT00278278|Vincristine|vincristine|mesh-list
24439302|NCT00278278|Lomustine|lomustine|mesh-list
24439303|NCT00278278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439304|NCT00278278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24439305|NCT00278278|Glucocorticoids|glucocorticoids|mesh-ancestor
24439306|NCT00278278|Hormones|hormones|mesh-ancestor
24439307|NCT00278278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24439374|NCT00278408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24825688|NCT02129621|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24439376|NCT00278408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439377|NCT00278408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439378|NCT00278408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24439379|NCT00278408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24439380|NCT00278408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24439381|NCT00278408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24439382|NCT00278408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24439383|NCT00278408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24439384|NCT00278408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25267176|NCT02423954|Immunologic Factors|immunologic factors|mesh-ancestor
25267177|NCT02423954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267179|NCT02423915|Mycophenolic Acid|mycophenolic acid|mesh-list
25267180|NCT02423915|Sirolimus|sirolimus|mesh-list
25267181|NCT02423915|Cyclophosphamide|cyclophosphamide|mesh-list
25267182|NCT02423915|Rituximab|rituximab|mesh-list
24439387|NCT00278408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24439388|NCT00278408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24439389|NCT00278408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24439390|NCT00278408|Tubulin Modulators|tubulin modulators|mesh-ancestor
24439415|NCT00278421|Hormones|hormones|mesh-ancestor
24439496|NCT00279045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439515|NCT00279123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24439516|NCT00279123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439518|NCT00279162|Calcipotriene|calcipotriene|mesh-list
24439519|NCT00279162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24439520|NCT00279162|Glucocorticoids|glucocorticoids|mesh-ancestor
24439522|NCT00279162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24439523|NCT00279162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439524|NCT00279162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24439525|NCT00279162|Respiratory System Agents|respiratory system agents|mesh-ancestor
24606490|NCT00990678|Vitamin D|vitamin d|mesh-list
24825697|NCT02129634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825698|NCT02129673|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24825699|NCT02129673|Latanoprost|latanoprost|mesh-list
24703043|NCT01469468|Simvastatin|simvastatin|mesh-list
24439982|NCT00281125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25689861|NCT01966003|Carboplatin|carboplatin|mesh-list
25689862|NCT01966003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25689863|NCT01966003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25689864|NCT01966003|Tubulin Modulators|tubulin modulators|mesh-ancestor
25689865|NCT01966003|Antimitotic Agents|antimitotic agents|mesh-ancestor
25689866|NCT01966003|Mitosis Modulators|mitosis modulators|mesh-ancestor
25692647|NCT02003391|Adrenergic Agents|adrenergic agents|mesh-ancestor
24883314|NCT03991403|Tubulin Modulators|tubulin modulators|mesh-ancestor
24883315|NCT03991403|Antimitotic Agents|antimitotic agents|mesh-ancestor
24883316|NCT03991403|Mitosis Modulators|mitosis modulators|mesh-ancestor
24440108|NCT00281710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24440109|NCT00281710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440111|NCT00281788|Carboplatin|carboplatin|mesh-list
24440112|NCT00281788|Capecitabine|capecitabine|mesh-list
24440113|NCT00281788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24440114|NCT00281788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440115|NCT00281788|Tubulin Modulators|tubulin modulators|mesh-ancestor
24440116|NCT00281788|Antimitotic Agents|antimitotic agents|mesh-ancestor
24440395|NCT00282932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440396|NCT00282932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440397|NCT00282932|Urological Agents|urological agents|mesh-ancestor
24440399|NCT00282945|Rosiglitazone|rosiglitazone|mesh-list
24440400|NCT00282945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24440401|NCT00282945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440402|NCT00282958|Botulinum Toxins|botulinum toxins|mesh-list
24440403|NCT00282958|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24440404|NCT00282958|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24440405|NCT00282958|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25267183|NCT02423915|Fludarabine|fludarabine|mesh-list
25267185|NCT02423915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25267186|NCT02423915|Immunologic Factors|immunologic factors|mesh-ancestor
24825739|NCT02129985|Exenatide|exenatide|mesh-list
24825740|NCT02129985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24825741|NCT02129985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825742|NCT02129985|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24703297|NCT01470937|Acarbose|acarbose|mesh-list
24440461|NCT00283179|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24440777|NCT00284765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440793|NCT00284791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24606886|NCT05407467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24825760|NCT02130167|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24825761|NCT02130167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24825762|NCT02130167|Cholinergic Agents|cholinergic agents|mesh-ancestor
24825763|NCT02130167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24440921|NCT00285376|Serotonin Agents|serotonin agents|mesh-ancestor
24703491|NCT01471925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703493|NCT01471964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703494|NCT01471964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24703495|NCT01471964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703496|NCT01471964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703497|NCT01471990|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
24441099|NCT00286117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441100|NCT00286117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24441101|NCT00286117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441102|NCT00286117|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24441103|NCT00286117|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24441104|NCT00286117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24441106|NCT00286117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24441107|NCT00286117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689867|NCT01966003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689868|NCT01966003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25689869|NCT01966003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25689870|NCT01966003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25689871|NCT01966003|Growth Substances|growth substances|mesh-ancestor
25689872|NCT01966003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689873|NCT01966003|Growth Inhibitors|growth inhibitors|mesh-ancestor
25689874|NCT01966107|Bromides|bromides|mesh-list
24883384|NCT03926624|Antiviral Agents|antiviral agents|mesh-ancestor
24441108|NCT00286117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442634|NCT00291850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442796|NCT00292734|GABA Agents|gaba agents|mesh-ancestor
24607706|NCT03971409|Avelumab|avelumab|mesh-list
24442820|NCT00292760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442821|NCT00292799|Metformin|metformin|mesh-list
24442822|NCT00292799|Orlistat|orlistat|mesh-list
24442829|NCT00292838|Fluticasone|fluticasone|mesh-list
24442875|NCT00293111|Analgesics|analgesics|mesh-ancestor
24442876|NCT00293111|Sensory System Agents|sensory system agents|mesh-ancestor
24442877|NCT00293111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24442878|NCT00293111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442879|NCT00293111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24442880|NCT00293111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24442881|NCT00293111|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24442882|NCT00293111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24442883|NCT00293111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442884|NCT00293111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442885|NCT00293124|Imatinib Mesylate|imatinib mesylate|mesh-list
25267191|NCT02423915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267192|NCT02423915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267196|NCT02423915|Antimetabolites|antimetabolites|mesh-ancestor
24442888|NCT00293124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442889|NCT00293124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825866|NCT02130817|Autonomic Agents|autonomic agents|mesh-ancestor
24825867|NCT02130817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25689875|NCT01966107|Anticonvulsants|anticonvulsants|mesh-ancestor
25689876|NCT01966120|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25689877|NCT01966120|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25689878|NCT01966120|Dermatologic Agents|dermatologic agents|mesh-ancestor
25689879|NCT01966419|Phenylacetic acid|phenylacetic acid|mesh-list
25689880|NCT01966419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25689881|NCT01966419|Antimetabolites|antimetabolites|mesh-ancestor
25689882|NCT01966419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267201|NCT02423915|Antitubercular Agents|antitubercular agents|mesh-ancestor
25267202|NCT02423915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25267203|NCT02423915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25267204|NCT02423915|Antifungal Agents|antifungal agents|mesh-ancestor
24443169|NCT00293826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825982|NCT02131350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24825983|NCT02131350|Growth Substances|growth substances|mesh-ancestor
25267221|NCT02424045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267223|NCT02423837|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25267224|NCT02423837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25267225|NCT02423837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267226|NCT02423837|Immunologic Factors|immunologic factors|mesh-ancestor
24469302|NCT00385411|Valproic Acid|valproic acid|mesh-list
24825995|NCT02131480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24610311|NCT01001247|Antiviral Agents|antiviral agents|mesh-ancestor
24471960|NCT00397657|Niacin|niacin|mesh-list
24826019|NCT02131688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826020|NCT02131688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24826021|NCT02131688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24826022|NCT02131688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443204|NCT00293969|Narcotics|narcotics|mesh-ancestor
25267227|NCT02423837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267228|NCT02423837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25689883|NCT01966419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25689884|NCT01966718|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25689885|NCT01966718|Hormones|hormones|mesh-ancestor
25689886|NCT01966718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25689887|NCT01966718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689888|NCT01966809|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
25689889|NCT01966809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25689890|NCT01966809|Dermatologic Agents|dermatologic agents|mesh-ancestor
24883615|NCT05237323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24883616|NCT05237323|Antitubercular Agents|antitubercular agents|mesh-ancestor
24443208|NCT00293969|Sensory System Agents|sensory system agents|mesh-ancestor
24826033|NCT02131948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24826051|NCT02132091|Ascorbic Acid|ascorbic acid|mesh-list
24826052|NCT02132091|Vitamin E|vitamin e|mesh-list
24826053|NCT02132091|Micronutrients|micronutrients|mesh-ancestor
24826054|NCT02132091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826055|NCT02132091|Antioxidants|antioxidants|mesh-ancestor
24826056|NCT02132091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826057|NCT02132091|Protective Agents|protective agents|mesh-ancestor
24826058|NCT02132104|Hormones|hormones|mesh-list
25267229|NCT02423837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25267230|NCT02423837|Alkylating Agents|alkylating agents|mesh-ancestor
25267231|NCT02423837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267232|NCT02423863|Pembrolizumab|pembrolizumab|mesh-list
25267233|NCT02423863|Nivolumab|nivolumab|mesh-list
25267234|NCT02423863|Durvalumab|durvalumab|mesh-list
25267235|NCT02423863|Cemiplimab|cemiplimab|mesh-list
25267236|NCT02423863|Atezolizumab|atezolizumab|mesh-list
25267237|NCT02423863|Poly ICLC|poly iclc|mesh-list
25267238|NCT02423863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25689891|NCT01966809|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25689892|NCT01966978|Insulin|insulin|mesh-list
25689893|NCT01966978|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25689894|NCT01966978|Metformin|metformin|mesh-list
25689895|NCT01966978|Insulin Aspart|insulin aspart|mesh-list
25689896|NCT01966978|Insulin, Long-Acting|insulin, long-acting|mesh-list
25689897|NCT01966978|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25689898|NCT01966978|Liraglutide|liraglutide|mesh-list
25689899|NCT01966978|Insulin Detemir|insulin detemir|mesh-list
25689900|NCT01966978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25689901|NCT01966978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689902|NCT01966978|Incretins|incretins|mesh-ancestor
25689903|NCT01966978|Hormones|hormones|mesh-ancestor
25689904|NCT01966978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25689905|NCT01967147|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25689906|NCT01967147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25689907|NCT01967173|Fluticasone|fluticasone|mesh-list
25689908|NCT01967173|Xhance|xhance|mesh-list
25689909|NCT01967173|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24443211|NCT00294008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24443212|NCT00294008|Serotonin Agents|serotonin agents|mesh-ancestor
24443213|NCT00294008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24443214|NCT00294008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826108|NCT02132403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826111|NCT02132416|Diclofenac|diclofenac|mesh-list
24826112|NCT02132416|Morphine|morphine|mesh-list
24826113|NCT02132416|Oxycodone|oxycodone|mesh-list
24443225|NCT00294086|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24443226|NCT00294086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443227|NCT00294099|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24443228|NCT00294099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24443229|NCT00294099|Immunologic Factors|immunologic factors|mesh-ancestor
25267239|NCT02423863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267240|NCT02423863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25267241|NCT02423863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267242|NCT02423863|Interferon Inducers|interferon inducers|mesh-ancestor
25267243|NCT02423863|Immunologic Factors|immunologic factors|mesh-ancestor
25267244|NCT02423863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267245|NCT02423811|Fursultiamin|fursultiamin|mesh-list
25267246|NCT02423811|Vitamin B Complex|vitamin b complex|mesh-ancestor
25267247|NCT02423811|Vitamins|vitamins|mesh-ancestor
25267248|NCT02423811|Micronutrients|micronutrients|mesh-ancestor
25267249|NCT02423811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267250|NCT02423759|Ciprofloxacin|ciprofloxacin|mesh-list
25267251|NCT02423759|Gentamicins|gentamicins|mesh-list
25267252|NCT02423759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25267253|NCT02423759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25267255|NCT02423759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25267256|NCT02423759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25267257|NCT02423759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267258|NCT02423759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267259|NCT02423759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25267260|NCT02423759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24672115|NCT01329731|Olaflur|olaflur|mesh-list
25267265|NCT02423694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25267266|NCT02423694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24826160|NCT02132897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24826161|NCT02132897|Analgesics|analgesics|mesh-ancestor
24826162|NCT02132897|Sensory System Agents|sensory system agents|mesh-ancestor
24826163|NCT02132897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24826164|NCT02132897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24826165|NCT02132897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24470102|NCT00388778|Antimalarials|antimalarials|mesh-ancestor
24826166|NCT02132897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826167|NCT02132897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24707494|NCT01496196|Hemostatics|hemostatics|mesh-ancestor
24826179|NCT02133053|Glucocorticoids|glucocorticoids|mesh-ancestor
24826180|NCT02133053|Hormones|hormones|mesh-ancestor
24826181|NCT02133053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24826182|NCT02133053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826183|NCT02133053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24826184|NCT02133053|Respiratory System Agents|respiratory system agents|mesh-ancestor
25689914|NCT01967173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25689915|NCT01967173|Respiratory System Agents|respiratory system agents|mesh-ancestor
25689916|NCT01967173|Glucocorticoids|glucocorticoids|mesh-ancestor
25689917|NCT01967173|Hormones|hormones|mesh-ancestor
25692648|NCT02003391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25267268|NCT02423694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25267269|NCT02423694|Serotonin Agents|serotonin agents|mesh-ancestor
25267270|NCT02423694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267271|NCT02423694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25267272|NCT02423694|Antidepressive Agents|antidepressive agents|mesh-ancestor
25267273|NCT02423694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25267274|NCT02423694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24470272|NCT00389428|Antimetabolites|antimetabolites|mesh-ancestor
24826323|NCT02134002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826324|NCT02134002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826326|NCT02134067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24826327|NCT02134067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826328|NCT02134067|Tubulin Modulators|tubulin modulators|mesh-ancestor
24826329|NCT02134067|Antimitotic Agents|antimitotic agents|mesh-ancestor
24826330|NCT02134067|Mitosis Modulators|mitosis modulators|mesh-ancestor
24826331|NCT02134067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826332|NCT02134093|Midazolam|midazolam|mesh-list
24826333|NCT02134093|Sufentanil|sufentanil|mesh-list
24826334|NCT02134093|Dexmedetomidine|dexmedetomidine|mesh-list
24826335|NCT02134093|Remifentanil|remifentanil|mesh-list
24826336|NCT02134093|Anesthetics|anesthetics|mesh-list
24826337|NCT02134093|Propofol|propofol|mesh-list
24826338|NCT02134093|Etomidate|etomidate|mesh-list
24448006|NCT00310011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24448007|NCT00310011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448008|NCT00310011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24826368|NCT02134093|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24826369|NCT02134093|Cholinergic Agents|cholinergic agents|mesh-ancestor
24826370|NCT02134106|Polymyxins|polymyxins|mesh-list
24826371|NCT02134106|Doripenem|doripenem|mesh-list
24826372|NCT02134106|Polymyxin B|polymyxin b|mesh-list
24826373|NCT02134106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24826374|NCT02134106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24826375|NCT02134249|Cabergoline|cabergoline|mesh-list
24826376|NCT02134249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25267275|NCT02423694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25267276|NCT02423694|Parasympatholytics|parasympatholytics|mesh-ancestor
25267277|NCT02423694|Autonomic Agents|autonomic agents|mesh-ancestor
25267278|NCT02423694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267279|NCT02423694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25267280|NCT02423694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25267281|NCT02423694|Cholinergic Agents|cholinergic agents|mesh-ancestor
25267282|NCT02423590|Gemcitabine|gemcitabine|mesh-list
25267283|NCT02423590|Carboplatin|carboplatin|mesh-list
25267284|NCT02423590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267285|NCT02423590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25267286|NCT02423590|Antimetabolites|antimetabolites|mesh-ancestor
25267287|NCT02423590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267288|NCT02423590|Antiviral Agents|antiviral agents|mesh-ancestor
25267289|NCT02423590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24826377|NCT02134249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25689918|NCT01967173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25689920|NCT01967173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24826397|NCT02134288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24826398|NCT02134288|Immunologic Factors|immunologic factors|mesh-ancestor
24826400|NCT02134288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24826406|NCT02134327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24826407|NCT02134327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826408|NCT02134327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24826409|NCT02134327|Analgesics|analgesics|mesh-ancestor
24826410|NCT02134327|Sensory System Agents|sensory system agents|mesh-ancestor
24826412|NCT02134327|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24826414|NCT02134327|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24826415|NCT02134327|Adrenergic Agents|adrenergic agents|mesh-ancestor
24826416|NCT02134327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24826421|NCT02134327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24826422|NCT02134327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24826423|NCT02134327|Anesthetics, General|anesthetics, general|mesh-ancestor
24826425|NCT02134327|GABA Modulators|gaba modulators|mesh-ancestor
24826426|NCT02134327|GABA Agents|gaba agents|mesh-ancestor
24826435|NCT02134366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24826436|NCT02134366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24826438|NCT02134366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24826439|NCT02134366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24826440|NCT02134366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24826441|NCT02134366|GABA Modulators|gaba modulators|mesh-ancestor
24826442|NCT02134366|GABA Agents|gaba agents|mesh-ancestor
24826443|NCT02134366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25267290|NCT02423590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25267291|NCT02423590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25267292|NCT02423590|Immunologic Factors|immunologic factors|mesh-ancestor
25267293|NCT02423590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267294|NCT02423642|Heparin|heparin|mesh-list
25267295|NCT02423642|Anticoagulants|anticoagulants|mesh-ancestor
25267296|NCT02423642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267297|NCT02423642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24826481|NCT02134470|Hormones|hormones|mesh-ancestor
24826482|NCT02134470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25689921|NCT01967173|Dermatologic Agents|dermatologic agents|mesh-ancestor
25689922|NCT01967173|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25689923|NCT01967225|Linezolid|linezolid|mesh-list
25689924|NCT01967225|Tedizolid|tedizolid|mesh-list
25689925|NCT01967225|Tedizolid phosphate|tedizolid phosphate|mesh-list
25267301|NCT02423603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267302|NCT02423603|Tubulin Modulators|tubulin modulators|mesh-ancestor
25267303|NCT02423603|Antimitotic Agents|antimitotic agents|mesh-ancestor
25267304|NCT02423603|Mitosis Modulators|mitosis modulators|mesh-ancestor
25267305|NCT02423603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275427|NCT02372110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443382|NCT00294736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24443383|NCT00294736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24826493|NCT02134626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24826494|NCT02134626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826495|NCT02134639|Edotreotide|edotreotide|mesh-list
24826496|NCT02134639|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24826497|NCT02134639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826498|NCT02134717|Maraviroc|maraviroc|mesh-list
24826499|NCT02134717|Dimercaprol|dimercaprol|mesh-list
24826500|NCT02134717|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24470527|NCT00390403|Alkylating Agents|alkylating agents|mesh-ancestor
24673851|NCT01340820|Immunologic Factors|immunologic factors|mesh-ancestor
24516753|NCT00603109|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24516754|NCT00603109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24443578|NCT00295464|Hormones|hormones|mesh-ancestor
24470728|NCT00391248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24805390|NCT02009280|Sevoflurane|sevoflurane|mesh-list
24805391|NCT02009280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24443614|NCT00295542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24443615|NCT00295542|Protease Inhibitors|protease inhibitors|mesh-ancestor
24443616|NCT00295542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443617|NCT00295542|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24674194|NCT01342289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24674444|NCT05220319|Antiemetics|antiemetics|mesh-ancestor
24443645|NCT00295607|Antibodies|antibodies|mesh-list
24443646|NCT00295607|Tacrolimus|tacrolimus|mesh-list
24443647|NCT00295607|Immunologic Factors|immunologic factors|mesh-ancestor
24443648|NCT00295607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267317|NCT02423395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25267318|NCT02423395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267319|NCT02423395|Parasympatholytics|parasympatholytics|mesh-ancestor
25267320|NCT02423395|Autonomic Agents|autonomic agents|mesh-ancestor
25267321|NCT02423395|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25689927|NCT01967225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25267322|NCT02423395|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25267324|NCT02423395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25267325|NCT02423395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267326|NCT02423395|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
25050606|NCT00484419|Antimetabolites|antimetabolites|mesh-ancestor
24674728|NCT04721132|Antibodies|antibodies|mesh-list
24709903|NCT01507519|Sirolimus|sirolimus|mesh-list
24805395|NCT02009280|Anesthetics, General|anesthetics, general|mesh-ancestor
24674943|NCT03785249|Afatinib|afatinib|mesh-list
24443716|NCT00295893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24443717|NCT00295893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826654|NCT02135510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826655|NCT02135510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24826656|NCT02135510|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24826657|NCT02135510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24826658|NCT02135510|Serotonin Agents|serotonin agents|mesh-ancestor
24826659|NCT02135510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24826660|NCT02135510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826661|NCT02135510|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24826662|NCT02135510|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24826663|NCT02135510|Dopamine Agents|dopamine agents|mesh-ancestor
25267329|NCT02423278|Oxaliplatin|oxaliplatin|mesh-list
25267330|NCT02423278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267331|NCT02423265|Ranolazine|ranolazine|mesh-list
25267332|NCT02423265|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25267333|NCT02423265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25267334|NCT02423265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267335|NCT02423239|Gemcitabine|gemcitabine|mesh-list
25267336|NCT02423239|Paclitaxel|paclitaxel|mesh-list
25267337|NCT02423239|Sorafenib|sorafenib|mesh-list
25267338|NCT02423239|HU 211|hu 211|mesh-list
25689928|NCT01967225|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25689929|NCT01967225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689930|NCT01967225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689931|NCT01967433|Diphenhydramine|diphenhydramine|mesh-list
25689932|NCT01967433|Promethazine|promethazine|mesh-list
25689933|NCT01967433|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25689934|NCT01967433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25689935|NCT01967433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25689936|NCT01967433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689937|NCT01967433|Anesthetics, Local|anesthetics, local|mesh-ancestor
25689938|NCT01967433|Anesthetics|anesthetics|mesh-ancestor
25689939|NCT01967433|Sensory System Agents|sensory system agents|mesh-ancestor
24826664|NCT02135588|Plasminogen|plasminogen|mesh-list
24610686|NCT01004497|Antiemetics|antiemetics|mesh-ancestor
25267339|NCT02423239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25267340|NCT02423239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25267341|NCT02423239|Tubulin Modulators|tubulin modulators|mesh-ancestor
25267342|NCT02423239|Antimitotic Agents|antimitotic agents|mesh-ancestor
25267343|NCT02423239|Mitosis Modulators|mitosis modulators|mesh-ancestor
25267344|NCT02423239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636047|NCT01142505|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25689940|NCT01967433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25689941|NCT01967433|Antiemetics|antiemetics|mesh-ancestor
25689942|NCT01967433|Autonomic Agents|autonomic agents|mesh-ancestor
25689943|NCT01967433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25689944|NCT01967433|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25689945|NCT01967433|Histamine Antagonists|histamine antagonists|mesh-ancestor
25689946|NCT01967433|Histamine Agents|histamine agents|mesh-ancestor
25689947|NCT01967433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24636048|NCT01142505|Diuretics|diuretics|mesh-ancestor
24443778|NCT00295971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24443779|NCT00295971|Immunologic Factors|immunologic factors|mesh-ancestor
24443780|NCT00295971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443781|NCT00295971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24443782|NCT00295971|Alkylating Agents|alkylating agents|mesh-ancestor
24443784|NCT00295984|Nicotine|nicotine|mesh-list
24883967|NCT03987919|Hormones|hormones|mesh-ancestor
24883968|NCT03987919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24745983|NCT03460379|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25689948|NCT01967433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805471|NCT02009514|Dialysis Solutions|dialysis solutions|mesh-list
24805473|NCT02009514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24805474|NCT02009540|Botulinum Toxins|botulinum toxins|mesh-list
24805475|NCT02009540|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24471798|NCT00396760|Coagulants|coagulants|mesh-ancestor
24471799|NCT00396760|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25267363|NCT02423239|Protective Agents|protective agents|mesh-ancestor
25267364|NCT02422784|Vitamin D|vitamin d|mesh-list
25267365|NCT02422784|Ergocalciferols|ergocalciferols|mesh-list
25267366|NCT02422784|Cholecalciferol|cholecalciferol|mesh-list
25267367|NCT02422784|Vitamins|vitamins|mesh-list
25267368|NCT02422784|Micronutrients|micronutrients|mesh-ancestor
25267369|NCT02422784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625667|NCT01082848|Aripiprazole|aripiprazole|mesh-list
24826756|NCT02135887|Oxaliplatin|oxaliplatin|mesh-list
24826757|NCT02135887|Levoleucovorin|levoleucovorin|mesh-list
24443808|NCT00295997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443809|NCT00295997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24443810|NCT00295997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24443811|NCT00295997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24443813|NCT00295997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24443814|NCT00295997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24443815|NCT00295997|Antimetabolites|antimetabolites|mesh-ancestor
24443816|NCT00295997|Dermatologic Agents|dermatologic agents|mesh-ancestor
24443817|NCT00295997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443818|NCT00295997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24443819|NCT00295997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24443820|NCT00295997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24443821|NCT00295997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24443822|NCT00295997|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24443823|NCT00295997|Antitubercular Agents|antitubercular agents|mesh-ancestor
24443830|NCT00296010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24443831|NCT00296010|Immunologic Factors|immunologic factors|mesh-ancestor
24443832|NCT00296010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443833|NCT00296010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24443834|NCT00296010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24443835|NCT00296010|Alkylating Agents|alkylating agents|mesh-ancestor
24443836|NCT00296010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443837|NCT00296010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24443841|NCT00296010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24443842|NCT00296010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826766|NCT02135887|Protective Agents|protective agents|mesh-ancestor
24826767|NCT02135887|Vitamin B Complex|vitamin b complex|mesh-ancestor
25689949|NCT01967433|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25689950|NCT01967433|Antipruritics|antipruritics|mesh-ancestor
25689951|NCT01967433|Dermatologic Agents|dermatologic agents|mesh-ancestor
25689952|NCT01967550|Diclofenac|diclofenac|mesh-list
25689953|NCT01967550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25689954|NCT01967550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25689955|NCT01967550|Analgesics|analgesics|mesh-ancestor
25689956|NCT01967550|Sensory System Agents|sensory system agents|mesh-ancestor
25689957|NCT01967550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25689958|NCT01967550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267372|NCT02422836|Sunscreening Agents|sunscreening agents|mesh-list
25267373|NCT02422836|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25267374|NCT02422836|Protective Agents|protective agents|mesh-ancestor
25267375|NCT02422836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267376|NCT02422836|Dermatologic Agents|dermatologic agents|mesh-ancestor
25267378|NCT02422901|Vitamins|vitamins|mesh-ancestor
25267379|NCT02422901|Micronutrients|micronutrients|mesh-ancestor
25267380|NCT02422901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267381|NCT02422901|Antioxidants|antioxidants|mesh-ancestor
25267382|NCT02422901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443881|NCT00296062|Capecitabine|capecitabine|mesh-list
24443882|NCT00296062|Oxaliplatin|oxaliplatin|mesh-list
25267385|NCT02422966|Ibuprofen|ibuprofen|mesh-list
25267386|NCT02422966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25267387|NCT02422966|Analgesics|analgesics|mesh-ancestor
25267388|NCT02422966|Sensory System Agents|sensory system agents|mesh-ancestor
25267389|NCT02422966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25267390|NCT02422966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267391|NCT02422966|Antipyretics|antipyretics|mesh-ancestor
25267392|NCT02422966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25267393|NCT02422966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25267394|NCT02422966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25267395|NCT02422966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25267396|NCT02422966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826846|NCT02136589|Travoprost|travoprost|mesh-list
24826847|NCT02136589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24443960|NCT00296348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24443961|NCT00296361|Tacrolimus|tacrolimus|mesh-list
24443962|NCT00296361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24677320|NCT01355939|Zinc Oxide|zinc oxide|mesh-list
24443981|NCT00296465|Zuclomiphene|zuclomiphene|mesh-list
24443982|NCT00296465|Hormones|hormones|mesh-list
24443983|NCT00296465|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24443984|NCT00296465|Anticoagulants|anticoagulants|mesh-ancestor
24443985|NCT00296465|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24443986|NCT00296465|Chelating Agents|chelating agents|mesh-ancestor
24443987|NCT00296465|Sequestering Agents|sequestering agents|mesh-ancestor
25267397|NCT02422966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25267398|NCT02422953|Micronutrients|micronutrients|mesh-list
25267399|NCT02422953|Trace Elements|trace elements|mesh-list
25267400|NCT02422953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25267401|NCT02422888|Ticagrelor|ticagrelor|mesh-list
25267402|NCT02422888|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25267403|NCT02422888|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25267404|NCT02422888|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25011008|NCT02424851|Bortezomib|bortezomib|mesh-list
25011009|NCT02424851|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25011010|NCT02424851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25011011|NCT02424851|Antiemetics|antiemetics|mesh-ancestor
25011012|NCT02424851|Autonomic Agents|autonomic agents|mesh-ancestor
25105760|NCT04935476|Dapsone|dapsone|mesh-list
25689959|NCT01967550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25689960|NCT01967550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25689961|NCT01967550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24634534|NCT01133873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24634535|NCT01133873|Antitussive Agents|antitussive agents|mesh-ancestor
24634587|NCT01134224|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24634588|NCT01134224|Insulin Aspart|insulin aspart|mesh-list
24634589|NCT01134224|Insulin, Long-Acting|insulin, long-acting|mesh-list
25689962|NCT01967550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634591|NCT01134224|Biphasic Insulins|biphasic insulins|mesh-list
24634592|NCT01134224|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24634593|NCT01134224|Insulin, Isophane|insulin, isophane|mesh-list
24634594|NCT01134224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24634640|NCT01134432|Antiemetics|antiemetics|mesh-ancestor
24634641|NCT01134432|Autonomic Agents|autonomic agents|mesh-ancestor
24634642|NCT01134432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24634643|NCT01134432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24634644|NCT01134432|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24634645|NCT01134432|Protective Agents|protective agents|mesh-ancestor
24634646|NCT01134484|Thalidomide|thalidomide|mesh-list
24634723|NCT01134718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634724|NCT01134848|Morphine|morphine|mesh-list
24634725|NCT01134848|Secretin|secretin|mesh-list
24634774|NCT01135056|Sorafenib|sorafenib|mesh-list
24634775|NCT01135056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24634776|NCT01135056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24634777|NCT01135056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634778|NCT01135056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634780|NCT01135199|Immunologic Factors|immunologic factors|mesh-ancestor
24634781|NCT01135199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634782|NCT01135199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24634783|NCT01135199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24634784|NCT01135199|Growth Substances|growth substances|mesh-ancestor
24634785|NCT01135199|Growth Inhibitors|growth inhibitors|mesh-ancestor
25011020|NCT02424851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011021|NCT02424851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25011022|NCT02424851|Alkylating Agents|alkylating agents|mesh-ancestor
25011023|NCT02424851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011024|NCT02424851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25011025|NCT02424851|Immunologic Factors|immunologic factors|mesh-ancestor
25011026|NCT02424851|Leprostatic Agents|leprostatic agents|mesh-ancestor
25011027|NCT02424851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25011028|NCT02424851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25011029|NCT02424851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24634788|NCT01135212|Candesartan cilexetil|candesartan cilexetil|mesh-list
24634793|NCT01135290|Petrolatum|petrolatum|mesh-list
24634843|NCT01135563|Mitosis Modulators|mitosis modulators|mesh-ancestor
24634844|NCT01135563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634845|NCT01135589|Micafungin|micafungin|mesh-list
24634846|NCT01135589|Antifungal Agents|antifungal agents|mesh-ancestor
24634847|NCT01135589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24634848|NCT01135602|Topiramate|topiramate|mesh-list
24634849|NCT01135602|Anticonvulsants|anticonvulsants|mesh-ancestor
24634850|NCT01135602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24634854|NCT01135615|Calcium acetate|calcium acetate|mesh-list
24634855|NCT01135615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25689963|NCT01967550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634856|NCT01135615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634857|NCT01135615|Chelating Agents|chelating agents|mesh-ancestor
24634858|NCT01135615|Sequestering Agents|sequestering agents|mesh-ancestor
24634859|NCT01135615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011035|NCT02423876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011036|NCT02423876|Sensory System Agents|sensory system agents|mesh-ancestor
25011037|NCT02423876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24634983|NCT01136278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24634985|NCT01136317|Rabeprazole|rabeprazole|mesh-list
24634986|NCT01136317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24634987|NCT01136317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24634988|NCT01136317|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24634989|NCT01136317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634990|NCT01136317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634991|NCT01136395|Rituximab|rituximab|mesh-list
24634992|NCT01136395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24665776|NCT01314833|Docetaxel|docetaxel|mesh-list
24634994|NCT01136395|Immunologic Factors|immunologic factors|mesh-ancestor
24634995|NCT01136395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634996|NCT01136395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24634997|NCT01136421|Magnesium Sulfate|magnesium sulfate|mesh-list
24634998|NCT01136421|Bromides|bromides|mesh-list
24634999|NCT01136421|Ipratropium|ipratropium|mesh-list
24635000|NCT01136421|Anticonvulsants|anticonvulsants|mesh-ancestor
24635001|NCT01136421|Analgesics|analgesics|mesh-ancestor
24635002|NCT01136421|Sensory System Agents|sensory system agents|mesh-ancestor
24635003|NCT01136421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24635007|NCT01136421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24635020|NCT01136421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24635021|NCT01136499|Panobinostat|panobinostat|mesh-list
24635022|NCT01136499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24635023|NCT01136499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24635042|NCT01136590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24635043|NCT01136590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24635044|NCT01136590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635046|NCT01136590|Coagulants|coagulants|mesh-ancestor
24635165|NCT01137591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24635166|NCT01137591|Analgesics|analgesics|mesh-ancestor
24635167|NCT01137591|Sensory System Agents|sensory system agents|mesh-ancestor
24635168|NCT01137591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24635206|NCT01137708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635207|NCT01137708|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24635209|NCT01137708|Hormones|hormones|mesh-ancestor
24635210|NCT01137708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24635240|NCT01137916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635241|NCT01137916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635242|NCT01137942|Metronidazole|metronidazole|mesh-list
24635243|NCT01137942|Clarithromycin|clarithromycin|mesh-list
24635244|NCT01137942|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24635245|NCT01137942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24635246|NCT01137942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24635247|NCT01137942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24635248|NCT01137942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24635249|NCT01137942|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24635250|NCT01137942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635251|NCT01137942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635254|NCT01137955|Rifaximin|rifaximin|mesh-list
25011038|NCT02423876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25011039|NCT02423876|Narcotics|narcotics|mesh-ancestor
25011040|NCT02423876|Analgesics|analgesics|mesh-ancestor
25011063|NCT02176863|Immunoglobulins|immunoglobulins|mesh-list
25011064|NCT02176863|gamma-Globulins|gamma-globulins|mesh-list
25011065|NCT02176863|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25689965|NCT01967576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25689966|NCT01967576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25689967|NCT01967576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25689968|NCT01967576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011066|NCT02176863|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25011067|NCT02176863|Immunologic Factors|immunologic factors|mesh-ancestor
25011068|NCT02176863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011069|NCT02073968|Paclitaxel|paclitaxel|mesh-list
25011070|NCT02073968|Carboplatin|carboplatin|mesh-list
25011071|NCT02073968|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25011072|NCT02073968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25011073|NCT02073968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011074|NCT02073968|Tubulin Modulators|tubulin modulators|mesh-ancestor
25011075|NCT02073968|Antimitotic Agents|antimitotic agents|mesh-ancestor
25011076|NCT02073968|Mitosis Modulators|mitosis modulators|mesh-ancestor
25011077|NCT02073968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011079|NCT01971970|Infliximab|infliximab|mesh-list
25011080|NCT01971970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25011081|NCT01971970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25011082|NCT01971970|Dermatologic Agents|dermatologic agents|mesh-ancestor
25011083|NCT01971970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25011084|NCT01969409|Rituximab|rituximab|mesh-list
25011085|NCT01969409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25011086|NCT01969409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011087|NCT01969409|Immunologic Factors|immunologic factors|mesh-ancestor
25011088|NCT01969409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011089|NCT01969409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25011090|NCT01942122|Mefenamic Acid|mefenamic acid|mesh-list
25011091|NCT01942122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25011092|NCT01942122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25011093|NCT01942122|Analgesics|analgesics|mesh-ancestor
24635299|NCT01138137|Respiratory System Agents|respiratory system agents|mesh-ancestor
24635300|NCT01138137|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24635449|NCT01139437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635451|NCT01139463|Olanzapine|olanzapine|mesh-list
24635452|NCT01139463|Haloperidol decanoate|haloperidol decanoate|mesh-list
24635453|NCT01139463|Antiemetics|antiemetics|mesh-ancestor
24635454|NCT01139463|Autonomic Agents|autonomic agents|mesh-ancestor
25011094|NCT01942122|Sensory System Agents|sensory system agents|mesh-ancestor
25011095|NCT01942122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25011096|NCT01942122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011097|NCT01942122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25011098|NCT01942122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25011099|NCT01942122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25011116|NCT01869829|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25011117|NCT01869829|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25011118|NCT01869829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25011119|NCT01869829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011120|NCT01869829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011121|NCT01869829|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25011122|NCT01869829|Hormone Antagonists|hormone antagonists|mesh-ancestor
25011123|NCT01869829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25011124|NCT01869829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011125|NCT01869829|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25011126|NCT01869829|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24635455|NCT01139463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24635456|NCT01139463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635457|NCT01139463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24635484|NCT01139671|Sensory System Agents|sensory system agents|mesh-ancestor
24635485|NCT01139671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24635518|NCT01139840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635519|NCT01139840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24635520|NCT01139840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24635522|NCT01139905|Lopinavir|lopinavir|mesh-list
24635523|NCT01139905|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24635524|NCT01139905|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24635525|NCT01139905|Protease Inhibitors|protease inhibitors|mesh-ancestor
24635526|NCT01139905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635527|NCT01139905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635528|NCT01139905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24635529|NCT01139905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24635569|NCT01140399|Dopamine|dopamine|mesh-list
24635570|NCT01140399|Furosemide|furosemide|mesh-list
24635598|NCT01140412|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24635599|NCT01140412|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24635652|NCT01140529|Dopamine Agents|dopamine agents|mesh-ancestor
24635653|NCT01140529|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24635654|NCT01140581|Dronedarone|dronedarone|mesh-list
24635655|NCT01140581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24635656|NCT01140620|Ketamine|ketamine|mesh-list
24635657|NCT01140620|Risperidone|risperidone|mesh-list
24635658|NCT01140620|Analgesics|analgesics|mesh-ancestor
24635659|NCT01140620|Sensory System Agents|sensory system agents|mesh-ancestor
24635660|NCT01140620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24635661|NCT01140620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635662|NCT01140620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25011128|NCT01860937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25011129|NCT01860937|Immunologic Factors|immunologic factors|mesh-ancestor
25011130|NCT01860937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011131|NCT01860937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25011132|NCT01860937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25011133|NCT01860937|Alkylating Agents|alkylating agents|mesh-ancestor
25011134|NCT01860937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011135|NCT01860937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24635663|NCT01140620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24635678|NCT01140737|Axitinib|axitinib|mesh-list
24635763|NCT01141036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635764|NCT01141127|Tranexamic Acid|tranexamic acid|mesh-list
24635765|NCT01141127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24635766|NCT01141127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24635767|NCT01141127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635768|NCT01141127|Hemostatics|hemostatics|mesh-ancestor
24635770|NCT01141153|Aspirin|aspirin|mesh-list
24635795|NCT01141192|Cholecalciferol|cholecalciferol|mesh-list
24635809|NCT01141244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24635810|NCT01141244|Alkylating Agents|alkylating agents|mesh-ancestor
24635811|NCT01141244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24635812|NCT01141244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24635813|NCT01141244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24968053|NCT03754959|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24635815|NCT01141244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24635816|NCT01141244|Immunologic Factors|immunologic factors|mesh-ancestor
24635817|NCT01141244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635819|NCT01141296|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24635831|NCT01141439|Autonomic Agents|autonomic agents|mesh-ancestor
24635832|NCT01141439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24635833|NCT01141439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635834|NCT01141439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24635839|NCT01141439|Hormones|hormones|mesh-ancestor
24635858|NCT01141465|Budesonide|budesonide|mesh-list
24635859|NCT01141465|Formoterol Fumarate|formoterol fumarate|mesh-list
24635860|NCT01141465|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24635861|NCT01141465|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24635865|NCT01141465|Autonomic Agents|autonomic agents|mesh-ancestor
24635887|NCT01141556|Selenium|selenium|mesh-list
24635888|NCT01141556|Antioxidants|antioxidants|mesh-ancestor
24635889|NCT01141556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635907|NCT01141881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24635908|NCT01141881|Growth Substances|growth substances|mesh-ancestor
24635909|NCT01141881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635910|NCT01141881|Growth Inhibitors|growth inhibitors|mesh-ancestor
25011136|NCT01860937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25011138|NCT01754779|Potassium Citrate|potassium citrate|mesh-list
25011139|NCT01754779|Citric Acid|citric acid|mesh-list
25011140|NCT01754779|Sodium Citrate|sodium citrate|mesh-list
25011141|NCT01754779|Anticoagulants|anticoagulants|mesh-ancestor
25011142|NCT01754779|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24635911|NCT01141881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24635912|NCT01141881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25689969|NCT01967628|Vitamin D|vitamin d|mesh-list
24635914|NCT01141894|Phenylephrine|phenylephrine|mesh-list
24636015|NCT01142414|Immunologic Factors|immunologic factors|mesh-ancestor
24636016|NCT01142414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636017|NCT01142414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24636018|NCT01142453|Interferons|interferons|mesh-list
24636019|NCT01142453|Interferon-beta|interferon-beta|mesh-list
24636020|NCT01142453|Interferon beta-1a|interferon beta-1a|mesh-list
24636021|NCT01142453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24636022|NCT01142453|Antiviral Agents|antiviral agents|mesh-ancestor
24805535|NCT02010723|Polidocanol|polidocanol|mesh-list
24636023|NCT01142453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24636024|NCT01142453|Immunologic Factors|immunologic factors|mesh-ancestor
24636025|NCT01142453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636026|NCT01142453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24636027|NCT01142492|Interferons|interferons|mesh-list
24636028|NCT01142492|Interferon-beta|interferon-beta|mesh-list
24636029|NCT01142492|Interferon beta-1a|interferon beta-1a|mesh-list
24636030|NCT01142492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24636031|NCT01142492|Antiviral Agents|antiviral agents|mesh-ancestor
24636032|NCT01142492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24636050|NCT01142518|Interferons|interferons|mesh-list
24636179|NCT01143584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24636180|NCT01143584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24636181|NCT01143662|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24636296|NCT01144650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24636297|NCT01144650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636298|NCT01144650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636299|NCT01144650|Leprostatic Agents|leprostatic agents|mesh-ancestor
24636300|NCT01144650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24636302|NCT01144676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24636303|NCT01144676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24636508|NCT01145859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011144|NCT01754779|Sequestering Agents|sequestering agents|mesh-ancestor
25011145|NCT01754779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011146|NCT01754779|Diuretics|diuretics|mesh-ancestor
25011147|NCT01754779|Natriuretic Agents|natriuretic agents|mesh-ancestor
25011148|NCT01754779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011149|NCT01754779|Expectorants|expectorants|mesh-ancestor
25011150|NCT01754779|Respiratory System Agents|respiratory system agents|mesh-ancestor
24636510|NCT01145950|Etanercept|etanercept|mesh-list
24636511|NCT01145950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24636512|NCT01145950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24636513|NCT01145950|Analgesics|analgesics|mesh-ancestor
24636514|NCT01145950|Sensory System Agents|sensory system agents|mesh-ancestor
24636515|NCT01145950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24636655|NCT01146548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24636656|NCT01146548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24636657|NCT01146548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636658|NCT01146548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24636659|NCT01146548|Serotonin Agents|serotonin agents|mesh-ancestor
24636660|NCT01146548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636705|NCT01147016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636706|NCT01147016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24636707|NCT01147016|Immunologic Factors|immunologic factors|mesh-ancestor
24636708|NCT01147016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636709|NCT01147016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24636710|NCT01147016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24636711|NCT01147016|Alkylating Agents|alkylating agents|mesh-ancestor
24636713|NCT01147016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24636714|NCT01147016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24636715|NCT01147016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24636716|NCT01147016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636717|NCT01147029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
24636798|NCT01147432|Antipruritics|antipruritics|mesh-ancestor
24636799|NCT01147432|Dermatologic Agents|dermatologic agents|mesh-ancestor
24636800|NCT01147432|Sensory System Agents|sensory system agents|mesh-ancestor
24636853|NCT01147692|Incretins|incretins|mesh-ancestor
24636854|NCT01147692|Hormones|hormones|mesh-ancestor
24636855|NCT01147692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24636856|NCT01147692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636884|NCT01147731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636886|NCT01147757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24636887|NCT01147757|Narcotics|narcotics|mesh-ancestor
24636893|NCT01147770|Progesterone|progesterone|mesh-list
24637093|NCT01148576|Immunologic Factors|immunologic factors|mesh-ancestor
24637251|NCT01149408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24637253|NCT01149408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637255|NCT01149408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637256|NCT01149499|Valacyclovir|valacyclovir|mesh-list
24637257|NCT01149499|Antiviral Agents|antiviral agents|mesh-ancestor
25011151|NCT01754779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25011152|NCT01754779|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25011153|NCT01754779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25011178|NCT01218555|Lenalidomide|lenalidomide|mesh-list
25011179|NCT01218555|Everolimus|everolimus|mesh-list
25011180|NCT01218555|Immunologic Factors|immunologic factors|mesh-ancestor
25011181|NCT01218555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011182|NCT01218555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25011183|NCT01218555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25011184|NCT01218555|Growth Substances|growth substances|mesh-ancestor
25011185|NCT01218555|Growth Inhibitors|growth inhibitors|mesh-ancestor
25011186|NCT01218555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011187|NCT01218555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24419064|NCT00210925|Topiramate|topiramate|mesh-list
24637258|NCT01149499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24637259|NCT01149564|Ibuprofen|ibuprofen|mesh-list
24637260|NCT01149564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24637261|NCT01149564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24637262|NCT01149564|Analgesics|analgesics|mesh-ancestor
24637469|NCT01150448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637470|NCT01150448|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24637471|NCT01150448|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24637472|NCT01150448|Dopamine Agents|dopamine agents|mesh-ancestor
24637473|NCT01150617|Insulin|insulin|mesh-list
24637474|NCT01150617|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24637475|NCT01150617|Insulin Glargine|insulin glargine|mesh-list
24637476|NCT01150617|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24637489|NCT01150630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24637490|NCT01150630|Immunologic Factors|immunologic factors|mesh-ancestor
24637505|NCT01150786|Micronutrients|micronutrients|mesh-ancestor
24637506|NCT01150877|Vitamin D|vitamin d|mesh-list
24637507|NCT01150877|Vitamins|vitamins|mesh-ancestor
24637508|NCT01150877|Micronutrients|micronutrients|mesh-ancestor
24637798|NCT01153204|Anticoagulants|anticoagulants|mesh-ancestor
24637799|NCT01153204|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24637800|NCT01153204|Chelating Agents|chelating agents|mesh-ancestor
24637801|NCT01153204|Sequestering Agents|sequestering agents|mesh-ancestor
24637802|NCT01153204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637803|NCT01153204|Vasodilator Agents|vasodilator agents|mesh-ancestor
24637804|NCT01153204|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24637805|NCT01153204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24637806|NCT01153204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637807|NCT01153204|Urological Agents|urological agents|mesh-ancestor
24637808|NCT01153217|Tenofovir|tenofovir|mesh-list
24637810|NCT01153217|Antiviral Agents|antiviral agents|mesh-ancestor
24637848|NCT01153373|Ethanol|ethanol|mesh-list
24637849|NCT01153373|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24637913|NCT01153880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24637914|NCT01153880|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24637915|NCT01153880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637916|NCT01153880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637919|NCT01153919|Interferon-alpha|interferon-alpha|mesh-list
24637920|NCT01153919|Interferon alpha-2|interferon alpha-2|mesh-list
24505745|NCT00542165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24884189|NCT02744742|Lenograstim|lenograstim|mesh-list
25011188|NCT01161394|Pioglitazone|pioglitazone|mesh-list
25011189|NCT01161394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25011190|NCT01161394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011191|NCT01141712|Cytarabine|cytarabine|mesh-list
25011192|NCT01141712|Etoposide|etoposide|mesh-list
25011193|NCT01141712|Melphalan|melphalan|mesh-list
25011194|NCT01141712|Carmustine|carmustine|mesh-list
25011195|NCT01141712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25011196|NCT01141712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011197|NCT01141712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25011198|NCT01141712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25011199|NCT01141712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011200|NCT01141712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011201|NCT01141712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25011202|NCT01141712|Antimetabolites|antimetabolites|mesh-ancestor
25011203|NCT01141712|Antiviral Agents|antiviral agents|mesh-ancestor
24637921|NCT01153919|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24637922|NCT01153919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637923|NCT01153919|Antiviral Agents|antiviral agents|mesh-ancestor
24638000|NCT01154439|Antimetabolites|antimetabolites|mesh-ancestor
24638001|NCT01154439|Antiviral Agents|antiviral agents|mesh-ancestor
24638002|NCT01154439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24638003|NCT01154439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24638004|NCT01154439|Immunologic Factors|immunologic factors|mesh-ancestor
24638005|NCT01154439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638095|NCT01154829|Dopamine Agents|dopamine agents|mesh-ancestor
24638096|NCT01154829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24638097|NCT01154829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638098|NCT01154829|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24638099|NCT01154829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24638101|NCT01154829|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24638102|NCT01154829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24638103|NCT01154829|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24638104|NCT01154829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24638105|NCT01154829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24447014|NCT00307138|Plasma Substitutes|plasma substitutes|mesh-ancestor
24638135|NCT01154959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24638136|NCT01154959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24638137|NCT01154959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24638138|NCT01154959|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24638139|NCT01154959|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24638140|NCT01154959|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24638141|NCT01154959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24638142|NCT01154959|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24638143|NCT01154959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24638144|NCT01154959|Antimetabolites|antimetabolites|mesh-ancestor
24638235|NCT01155505|Immunologic Factors|immunologic factors|mesh-ancestor
24638236|NCT01155505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638237|NCT01155505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24638238|NCT01155505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25011210|NCT01141712|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25011211|NCT01111305|Diethylcarbamazine|diethylcarbamazine|mesh-list
25011231|NCT00792831|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25011233|NCT00792831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011234|NCT00659646|Levofloxacin|levofloxacin|mesh-list
25011235|NCT00659646|Ofloxacin|ofloxacin|mesh-list
25011236|NCT00659646|Gentamicins|gentamicins|mesh-list
25689970|NCT01967628|Cholecalciferol|cholecalciferol|mesh-list
25689971|NCT01967628|Vitamins|vitamins|mesh-ancestor
25689972|NCT01967628|Micronutrients|micronutrients|mesh-ancestor
25689973|NCT01967628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689974|NCT01967628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25689975|NCT01967628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25689976|NCT01967641|Buprenorphine|buprenorphine|mesh-list
25011237|NCT00659646|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25011238|NCT00659646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24638358|NCT01155986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24638359|NCT01155986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638360|NCT01155986|Sensory System Agents|sensory system agents|mesh-ancestor
24638361|NCT01155986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24638362|NCT01155986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24638376|NCT01156246|Metformin|metformin|mesh-list
24638419|NCT01156584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638420|NCT01156636|Sildenafil Citrate|sildenafil citrate|mesh-list
24638421|NCT01156636|Vasodilator Agents|vasodilator agents|mesh-ancestor
24638422|NCT01156636|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24638423|NCT01156636|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24638424|NCT01156636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24638425|NCT01156636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406047|NCT00169039|Antiemetics|antiemetics|mesh-ancestor
24638511|NCT01156883|Antiviral Agents|antiviral agents|mesh-ancestor
24638512|NCT01156883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24638513|NCT01156883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24638514|NCT01156883|Tubulin Modulators|tubulin modulators|mesh-ancestor
24638515|NCT01156883|Antimitotic Agents|antimitotic agents|mesh-ancestor
24638516|NCT01156883|Mitosis Modulators|mitosis modulators|mesh-ancestor
24638520|NCT01156909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24638521|NCT01156909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638523|NCT01156909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638524|NCT01156909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24638525|NCT01156922|Rituximab|rituximab|mesh-list
24638526|NCT01156922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24638527|NCT01156922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638571|NCT01157026|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25011243|NCT00659646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011244|NCT00659646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011245|NCT00659646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011246|NCT00659646|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25011247|NCT00659646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25011248|NCT00659646|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25011249|NCT00496431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25011250|NCT00496431|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
25011251|NCT00496431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011252|NCT00496431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011253|NCT00477412|Cytarabine|cytarabine|mesh-list
25011254|NCT00477412|Dexamethasone|dexamethasone|mesh-list
25011255|NCT00477412|Dexamethasone acetate|dexamethasone acetate|mesh-list
25011256|NCT00477412|Cyclophosphamide|cyclophosphamide|mesh-list
25011257|NCT00477412|Rituximab|rituximab|mesh-list
25011258|NCT00477412|Doxorubicin|doxorubicin|mesh-list
25011259|NCT00477412|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25011260|NCT00477412|Methotrexate|methotrexate|mesh-list
25011261|NCT00477412|Vincristine|vincristine|mesh-list
25011262|NCT00477412|Bortezomib|bortezomib|mesh-list
25011263|NCT00477412|Daunorubicin|daunorubicin|mesh-list
25011264|NCT00477412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25011265|NCT00477412|Antibodies|antibodies|mesh-list
25011266|NCT00477412|Immunoglobulins|immunoglobulins|mesh-list
24638572|NCT01157026|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24638573|NCT01157026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24638574|NCT01157026|Antioxidants|antioxidants|mesh-ancestor
24638575|NCT01157026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638576|NCT01157026|Protective Agents|protective agents|mesh-ancestor
24638577|NCT01157026|Vitamins|vitamins|mesh-ancestor
24638578|NCT01157026|Micronutrients|micronutrients|mesh-ancestor
24638579|NCT01157052|Capecitabine|capecitabine|mesh-list
24638580|NCT01157052|Oxaliplatin|oxaliplatin|mesh-list
24638581|NCT01157052|Calcium|calcium|mesh-list
24638582|NCT01157052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24638583|NCT01157052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638630|NCT01157455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638631|NCT01157455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24638632|NCT01157455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24638633|NCT01157455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24444640|NCT00298675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444641|NCT00298675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25058166|NCT03498963|Sequestering Agents|sequestering agents|mesh-ancestor
24444642|NCT00298675|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24473038|NCT00401609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24638634|NCT01157455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25011267|NCT00477412|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25011288|NCT00477412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25011289|NCT00477412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25011290|NCT00477412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011291|NCT00477412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25011292|NCT00477412|Abortifacient Agents|abortifacient agents|mesh-ancestor
25011293|NCT00477412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25011294|NCT00477412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25011295|NCT00477412|Antimetabolites|antimetabolites|mesh-ancestor
25011296|NCT00477412|Dermatologic Agents|dermatologic agents|mesh-ancestor
25011297|NCT00477412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24736018|NCT01659775|Ondansetron|ondansetron|mesh-list
25011298|NCT00477412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25011299|NCT00477412|Antiviral Agents|antiviral agents|mesh-ancestor
24968050|NCT03754959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24968051|NCT03754959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24968052|NCT03754959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968055|NCT03754959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24968056|NCT03754959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24968057|NCT03754959|Anesthetics, General|anesthetics, general|mesh-ancestor
24968058|NCT03754959|Anesthetics|anesthetics|mesh-ancestor
24968059|NCT03754959|GABA Modulators|gaba modulators|mesh-ancestor
24968060|NCT03754959|GABA Agents|gaba agents|mesh-ancestor
24968061|NCT03754959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24968062|NCT03754959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968063|NCT03754842|Niacinamide|niacinamide|mesh-list
24968064|NCT03754842|Niacin|niacin|mesh-list
24968065|NCT03754842|Nicotinic Acids|nicotinic acids|mesh-list
24968066|NCT03754842|Vitamin B Complex|vitamin b complex|mesh-ancestor
24968067|NCT03754842|Vitamins|vitamins|mesh-ancestor
24968068|NCT03754842|Micronutrients|micronutrients|mesh-ancestor
24968069|NCT03754842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638635|NCT01157455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638636|NCT01157455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24638637|NCT01157455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24638638|NCT01157455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24572458|NCT00815022|Bupivacaine|bupivacaine|mesh-list
24586090|NCT00889148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24586091|NCT00889148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24586092|NCT00889148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24586093|NCT00889148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24586094|NCT00889148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24586095|NCT00889148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24473188|NCT00402350|Anesthetics, General|anesthetics, general|mesh-ancestor
24586096|NCT00889148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586097|NCT00889148|Antimanic Agents|antimanic agents|mesh-ancestor
24586119|NCT00889343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586120|NCT00889343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24586121|NCT00889343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586122|NCT00889343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24586123|NCT00889343|Immunologic Factors|immunologic factors|mesh-ancestor
24586124|NCT00889343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586125|NCT00889343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24638684|NCT01157559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24638685|NCT01157559|Serotonin Agents|serotonin agents|mesh-ancestor
24638686|NCT01157559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24638687|NCT01157559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506217|NCT00544349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24506218|NCT00544349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506219|NCT00544349|Antimetabolites|antimetabolites|mesh-ancestor
24638688|NCT01157559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638689|NCT01157559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24638714|NCT01157585|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24638715|NCT01157585|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24638716|NCT01157585|Serotonin Agents|serotonin agents|mesh-ancestor
24638723|NCT01157754|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24638724|NCT01157754|Contraceptive Agents|contraceptive agents|mesh-ancestor
24638725|NCT01157754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24638882|NCT01158859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24638883|NCT01158859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638884|NCT01158859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24639020|NCT01159548|Autonomic Agents|autonomic agents|mesh-ancestor
24639021|NCT01159548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24639022|NCT01159587|Factor VIII|factor viii|mesh-list
24639023|NCT01159587|Coagulants|coagulants|mesh-ancestor
24639024|NCT01159639|Clopidogrel|clopidogrel|mesh-list
24639040|NCT01159652|GABA Agonists|gaba agonists|mesh-ancestor
24639041|NCT01159652|GABA Agents|gaba agents|mesh-ancestor
24639042|NCT01159652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24639043|NCT01159652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639044|NCT01159652|Anticonvulsants|anticonvulsants|mesh-ancestor
24639045|NCT01159652|GABA Modulators|gaba modulators|mesh-ancestor
24639047|NCT01159821|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24639048|NCT01159821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24639049|NCT01159821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24639050|NCT01159821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011300|NCT00477412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25011301|NCT00477412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25011302|NCT00477412|Tubulin Modulators|tubulin modulators|mesh-ancestor
25011303|NCT00477412|Antimitotic Agents|antimitotic agents|mesh-ancestor
25011304|NCT00477412|Mitosis Modulators|mitosis modulators|mesh-ancestor
25011305|NCT00477412|Protease Inhibitors|protease inhibitors|mesh-ancestor
25011308|NCT00369317|Daunorubicin|daunorubicin|mesh-list
25011309|NCT00369317|Etoposide phosphate|etoposide phosphate|mesh-list
25011310|NCT00369317|Asparaginase|asparaginase|mesh-list
24903447|NCT04364113|Benzocaine|benzocaine|mesh-list
25011311|NCT00369317|Thioguanine|thioguanine|mesh-list
25011312|NCT00369317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25011313|NCT00369317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011314|NCT00369317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25011315|NCT00369317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25011316|NCT00369317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011317|NCT00369317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011318|NCT00369317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25011319|NCT00369317|Antimetabolites|antimetabolites|mesh-ancestor
25011320|NCT00369317|Antiviral Agents|antiviral agents|mesh-ancestor
25011321|NCT00369317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25011322|NCT00369317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25011323|NCT00369317|Immunologic Factors|immunologic factors|mesh-ancestor
25011346|NCT05216237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25011347|NCT05216237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011348|NCT05216237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011349|NCT05216237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25011350|NCT05216237|Antimetabolites|antimetabolites|mesh-ancestor
24639051|NCT01159821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24639052|NCT01159821|Serotonin Agents|serotonin agents|mesh-ancestor
24406983|NCT00171665|Analgesics|analgesics|mesh-ancestor
24639108|NCT01160276|Tubulin Modulators|tubulin modulators|mesh-ancestor
24639137|NCT01160315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24639138|NCT01160328|Leuprolide|leuprolide|mesh-list
24639139|NCT01160328|Testosterone|testosterone|mesh-list
24639140|NCT01160328|Androgens|androgens|mesh-ancestor
24639141|NCT01160328|Hormones|hormones|mesh-ancestor
24639233|NCT01160731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639234|NCT01160731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24639235|NCT01160731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24639236|NCT01160731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25689977|NCT01967641|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25689978|NCT01967641|Naloxone|naloxone|mesh-list
25689979|NCT01967641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25689980|NCT01967641|Narcotics|narcotics|mesh-ancestor
24511491|NCT00568984|Metformin|metformin|mesh-list
24639237|NCT01160731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639238|NCT01160731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639239|NCT01160731|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24639240|NCT01160900|Bivalirudin|bivalirudin|mesh-list
24639323|NCT01161069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24639324|NCT01161069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639360|NCT01161186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24639361|NCT01161186|Capecitabine|capecitabine|mesh-list
24639362|NCT01161186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24639363|NCT01161186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639364|NCT01161186|Tubulin Modulators|tubulin modulators|mesh-ancestor
24639365|NCT01161186|Antimitotic Agents|antimitotic agents|mesh-ancestor
24639366|NCT01161186|Mitosis Modulators|mitosis modulators|mesh-ancestor
24639367|NCT01161186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639368|NCT01161186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24639369|NCT01161186|Antimetabolites|antimetabolites|mesh-ancestor
24639370|NCT01161186|Antiviral Agents|antiviral agents|mesh-ancestor
24639371|NCT01161186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24639372|NCT01161186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639373|NCT01161186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24639420|NCT01161459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639421|NCT01161459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24639422|NCT01161459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639489|NCT01161940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24639490|NCT01161940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639491|NCT01161940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639492|NCT01161966|Zonisamide|zonisamide|mesh-list
24639493|NCT01161966|Anticonvulsants|anticonvulsants|mesh-ancestor
24450284|NCT00318513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24639496|NCT01161966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639497|NCT01161966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24639564|NCT01162889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639566|NCT01162902|Diltiazem|diltiazem|mesh-list
24639577|NCT01162902|Sympatholytics|sympatholytics|mesh-ancestor
24639578|NCT01162902|Autonomic Agents|autonomic agents|mesh-ancestor
24639579|NCT01162902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24639580|NCT01162902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24639581|NCT01162902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24639582|NCT01162902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24639583|NCT01162902|Adrenergic Agents|adrenergic agents|mesh-ancestor
24639584|NCT01162902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24639650|NCT01163435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24639651|NCT01163435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24639652|NCT01163435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639653|NCT01163435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639654|NCT01163435|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24639655|NCT01163435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25011355|NCT05215743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25011356|NCT05215743|Expectorants|expectorants|mesh-ancestor
25011357|NCT05215743|Respiratory System Agents|respiratory system agents|mesh-ancestor
25011358|NCT05215743|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24968154|NCT03753685|Ensartinib|ensartinib|mesh-list
25011379|NCT05215366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25011380|NCT05215366|Natriuretic Agents|natriuretic agents|mesh-ancestor
25011381|NCT05215366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639656|NCT01163435|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24639657|NCT01163435|Renal Agents|renal agents|mesh-ancestor
24639658|NCT01163435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24639659|NCT01163435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24639660|NCT01163435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639661|NCT01163435|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24639662|NCT01163500|Ubiquinone|ubiquinone|mesh-list
24639663|NCT01163500|Coenzyme Q10|coenzyme q10|mesh-list
24639664|NCT01163500|Micronutrients|micronutrients|mesh-ancestor
24639665|NCT01163500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639666|NCT01163500|Vitamins|vitamins|mesh-ancestor
24639667|NCT01163630|Esomeprazole|esomeprazole|mesh-list
24639668|NCT01163630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24639669|NCT01163630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24639670|NCT01163630|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24639671|NCT01163630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639672|NCT01163630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639673|NCT01163734|Ranolazine|ranolazine|mesh-list
24639702|NCT01163929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639704|NCT01163994|Ceftriaxone|ceftriaxone|mesh-list
24639706|NCT01163994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24639707|NCT01163994|Antimalarials|antimalarials|mesh-ancestor
24639708|NCT01163994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24639709|NCT01163994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24639725|NCT01164046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639726|NCT01164046|Anticoagulants|anticoagulants|mesh-ancestor
24639727|NCT01164046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24639728|NCT01164046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24639729|NCT01164046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639730|NCT01164046|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24639732|NCT01164046|Coagulants|coagulants|mesh-ancestor
24639733|NCT01164059|Haloperidol|haloperidol|mesh-list
24639734|NCT01164059|Olanzapine|olanzapine|mesh-list
24639735|NCT01164059|Aripiprazole|aripiprazole|mesh-list
24639776|NCT01164085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640080|NCT01165905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24640081|NCT01165905|Immunologic Factors|immunologic factors|mesh-ancestor
24640082|NCT01165905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640083|NCT01165905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24640084|NCT01165931|Riociguat|riociguat|mesh-list
24423318|NCT00225485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24473579|NCT00403338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24473580|NCT00403338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24473581|NCT00403338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473582|NCT00403338|Antifungal Agents|antifungal agents|mesh-ancestor
24473583|NCT00403338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24805717|NCT02011841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640085|NCT01165931|Enzyme Activators|enzyme activators|mesh-ancestor
24640086|NCT01165931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640087|NCT01165944|Pramlintide|pramlintide|mesh-list
24640088|NCT01165944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24640089|NCT01165944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640090|NCT01165970|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24640176|NCT01166477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25011383|NCT05215106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25011384|NCT05215106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011385|NCT05214911|Loratadine|loratadine|mesh-list
25011386|NCT05214911|Prednisolone|prednisolone|mesh-list
25011387|NCT05214911|Desloratadine|desloratadine|mesh-list
25011388|NCT05214911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25011389|NCT05214911|Glucocorticoids|glucocorticoids|mesh-ancestor
25011390|NCT05214911|Hormones|hormones|mesh-ancestor
25011391|NCT05214911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25011392|NCT05214911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011393|NCT05214911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25011394|NCT05214911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011395|NCT05214911|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25011396|NCT05214911|Cholinergic Agents|cholinergic agents|mesh-ancestor
25011397|NCT05214911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25011398|NCT05214911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011399|NCT05214911|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25011400|NCT05214911|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25011401|NCT05214911|Histamine Antagonists|histamine antagonists|mesh-ancestor
25011402|NCT05214911|Histamine Agents|histamine agents|mesh-ancestor
25011403|NCT05214911|Antipruritics|antipruritics|mesh-ancestor
25011404|NCT05214911|Dermatologic Agents|dermatologic agents|mesh-ancestor
25011405|NCT05214911|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25011406|NCT05214872|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25011407|NCT05214872|Calcium|calcium|mesh-list
25011408|NCT05214872|Mitogens|mitogens|mesh-list
25011409|NCT05214872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25011410|NCT05214872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968197|NCT03753477|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24968198|NCT03753477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24968199|NCT03753477|Antimetabolites|antimetabolites|mesh-ancestor
24968200|NCT03753477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24586126|NCT00889343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25011412|NCT05214872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011415|NCT05214820|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
24473624|NCT00403533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011443|NCT05130788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25011444|NCT05130788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011445|NCT05130788|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25011446|NCT05130788|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25011447|NCT05130788|Cholinergic Agents|cholinergic agents|mesh-ancestor
25011448|NCT05130788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25011449|NCT05130788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011450|NCT05114915|Docetaxel|docetaxel|mesh-list
25011451|NCT05114915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978396|NCT04555811|Rituximab|rituximab|mesh-list
24640178|NCT01166542|Carboplatin|carboplatin|mesh-list
24640179|NCT01166542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24640180|NCT01166542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640181|NCT01166542|Tubulin Modulators|tubulin modulators|mesh-ancestor
24640182|NCT01166542|Antimitotic Agents|antimitotic agents|mesh-ancestor
24640217|NCT01166815|Dermatologic Agents|dermatologic agents|mesh-ancestor
24640218|NCT01166932|Amoxicillin|amoxicillin|mesh-list
24640219|NCT01166932|Ceftriaxone|ceftriaxone|mesh-list
24640220|NCT01166932|Clavulanic Acids|clavulanic acids|mesh-list
24640221|NCT01166932|Clavulanic Acid|clavulanic acid|mesh-list
24640222|NCT01166932|Oxacillin|oxacillin|mesh-list
24640223|NCT01166932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24640224|NCT01166932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24640227|NCT01166932|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24640229|NCT01167010|Formoterol Fumarate|formoterol fumarate|mesh-list
24640230|NCT01167010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24640231|NCT01167010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24640232|NCT01167010|Autonomic Agents|autonomic agents|mesh-ancestor
24640233|NCT01167010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24640234|NCT01167010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640235|NCT01167010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24640238|NCT01167010|Hormones|hormones|mesh-ancestor
24408527|NCT00178113|Lycopene|lycopene|mesh-list
24640476|NCT01168492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640477|NCT01168492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24640478|NCT01168492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24640480|NCT01168492|Anesthetics|anesthetics|mesh-ancestor
24640481|NCT01168492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24640499|NCT01168531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24640592|NCT01169025|Narcotics|narcotics|mesh-ancestor
24640593|NCT01169025|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24640594|NCT01169090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24640595|NCT01169090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24640596|NCT01169090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640597|NCT01169090|Incretins|incretins|mesh-ancestor
24640598|NCT01169090|Hormones|hormones|mesh-ancestor
25011452|NCT05114915|Tubulin Modulators|tubulin modulators|mesh-ancestor
25011453|NCT05114915|Antimitotic Agents|antimitotic agents|mesh-ancestor
25011454|NCT05114915|Mitosis Modulators|mitosis modulators|mesh-ancestor
25011455|NCT05114915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011456|NCT04992013|Niraparib|niraparib|mesh-list
25011457|NCT04992013|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25011458|NCT04992013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011459|NCT04992013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011460|NCT04992013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011461|NCT04967079|Trametinib|trametinib|mesh-list
25011462|NCT04967079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011463|NCT04967079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25011464|NCT04967079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011465|NCT04967079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011466|NCT04964193|Cyproterone Acetate|cyproterone acetate|mesh-list
25011467|NCT04964193|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24640599|NCT01169090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24640600|NCT01169090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24640601|NCT01169090|Protease Inhibitors|protease inhibitors|mesh-ancestor
24640602|NCT01169090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640603|NCT01169090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640604|NCT01169142|Vitamin D|vitamin d|mesh-list
24640605|NCT01169142|Ergocalciferols|ergocalciferols|mesh-list
24640606|NCT01169142|Cholecalciferol|cholecalciferol|mesh-list
24640607|NCT01169142|Vitamins|vitamins|mesh-list
24640608|NCT01169142|Micronutrients|micronutrients|mesh-ancestor
24640609|NCT01169142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058372|NCT03497702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25058374|NCT03497702|Fertility Agents|fertility agents|mesh-ancestor
25058375|NCT03497702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25058376|NCT03497702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25058377|NCT03497442|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24820434|NCT02099604|Vitamin D|vitamin d|mesh-list
24447492|NCT00308594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640610|NCT01169142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24640611|NCT01169142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24640646|NCT01169415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24640647|NCT01169415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640648|NCT01169415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25110294|NCT05464433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25110295|NCT05464433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25110296|NCT05464433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011495|NCT04899986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25011497|NCT04896320|Tucatinib|tucatinib|mesh-list
25011498|NCT04896320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011499|NCT04896320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25011500|NCT04896320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011501|NCT04896320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011502|NCT04865796|Lactoferrin|lactoferrin|mesh-list
25011503|NCT04865796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25011514|NCT04844528|Niacinamide|niacinamide|mesh-list
25011516|NCT04844528|Nicotinic Acids|nicotinic acids|mesh-list
25011517|NCT04844528|Vitamin B Complex|vitamin b complex|mesh-ancestor
25011519|NCT04844528|Micronutrients|micronutrients|mesh-ancestor
24978467|NCT04297605|Mitosis Modulators|mitosis modulators|mesh-ancestor
24640649|NCT01169415|Glucocorticoids|glucocorticoids|mesh-ancestor
24640650|NCT01169415|Hormones|hormones|mesh-ancestor
24640651|NCT01169415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24640652|NCT01169415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24409007|NCT00180310|Paclitaxel|paclitaxel|mesh-list
24640853|NCT01170351|Immunologic Factors|immunologic factors|mesh-ancestor
24409409|NCT00181935|Antiemetics|antiemetics|mesh-ancestor
24641104|NCT01171885|Anesthetics, Local|anesthetics, local|mesh-ancestor
24641105|NCT01171885|Anesthetics|anesthetics|mesh-ancestor
24641106|NCT01171885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24641107|NCT01171885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641108|NCT01171885|Sensory System Agents|sensory system agents|mesh-ancestor
25011623|NCT04557449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25011624|NCT04557449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25011625|NCT04530409|Dexamethasone|dexamethasone|mesh-list
25011626|NCT04530409|Methylprednisolone|methylprednisolone|mesh-list
25011627|NCT04530409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25011628|NCT04530409|Antiemetics|antiemetics|mesh-ancestor
25011629|NCT04530409|Autonomic Agents|autonomic agents|mesh-ancestor
25011630|NCT04530409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25011631|NCT04530409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011632|NCT04530409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25011633|NCT04530409|Glucocorticoids|glucocorticoids|mesh-ancestor
24641109|NCT01171885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24641110|NCT01171911|Nicardipine|nicardipine|mesh-list
24641111|NCT01171911|Calcium Channel Blockers|calcium channel blockers|mesh-list
24641116|NCT01171911|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24641117|NCT01171911|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24641118|NCT01171911|Adrenergic Agents|adrenergic agents|mesh-ancestor
25689981|NCT01967641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25689982|NCT01967641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689983|NCT01967641|Analgesics|analgesics|mesh-ancestor
25689984|NCT01967641|Sensory System Agents|sensory system agents|mesh-ancestor
25689985|NCT01967641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25689986|NCT01967641|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24641119|NCT01171911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25689987|NCT01967862|Listerine|listerine|mesh-list
25689988|NCT01967862|Fluorides|fluorides|mesh-list
24884470|NCT00496730|Simvastatin|simvastatin|mesh-list
24884471|NCT00496730|Ezetimibe|ezetimibe|mesh-list
24641120|NCT01171911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447611|NCT00309218|Prednisolone|prednisolone|mesh-list
24641121|NCT01171911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24641122|NCT01171911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24641123|NCT01171911|Vasodilator Agents|vasodilator agents|mesh-ancestor
24641124|NCT01172002|Azathioprine|azathioprine|mesh-list
24641125|NCT01172002|Leflunomide|leflunomide|mesh-list
24641126|NCT01172002|Antimetabolites|antimetabolites|mesh-ancestor
24641127|NCT01172002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641266|NCT01172652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24641267|NCT01172652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24641268|NCT01172652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24641269|NCT01172652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24641270|NCT01172652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24641271|NCT01172652|Dopamine Agents|dopamine agents|mesh-ancestor
24641272|NCT01172691|Nitric Oxide|nitric oxide|mesh-list
24641273|NCT01172691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24641274|NCT01172691|Autonomic Agents|autonomic agents|mesh-ancestor
24641284|NCT01172691|Vasodilator Agents|vasodilator agents|mesh-ancestor
24641322|NCT01172912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641323|NCT01172912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24641324|NCT01172912|Glucocorticoids|glucocorticoids|mesh-ancestor
24641326|NCT01172912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24641327|NCT01172912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24641328|NCT01172912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24641329|NCT01172912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24641330|NCT01172912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24641331|NCT01172912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011634|NCT04530409|Hormones|hormones|mesh-ancestor
25011635|NCT04530409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25011636|NCT04530409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24968687|NCT03749408|Natriuretic Agents|natriuretic agents|mesh-ancestor
25011637|NCT04530409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011638|NCT04530409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25011639|NCT04530409|Protective Agents|protective agents|mesh-ancestor
24968467|NCT03751059|Glucocorticoids|glucocorticoids|mesh-ancestor
24968469|NCT03751059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24968470|NCT03751059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24968471|NCT03751059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24968472|NCT03751059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24968473|NCT03751059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24445540|NCT00301795|Immunologic Factors|immunologic factors|mesh-ancestor
24968474|NCT03751059|Analgesics|analgesics|mesh-ancestor
24968475|NCT03751059|Sensory System Agents|sensory system agents|mesh-ancestor
24968476|NCT03751059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24586127|NCT00889343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24586129|NCT00889343|Protective Agents|protective agents|mesh-ancestor
24641332|NCT01172912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641333|NCT01172912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24641334|NCT01172912|Alkylating Agents|alkylating agents|mesh-ancestor
24641335|NCT01172925|Tiotropium Bromide|tiotropium bromide|mesh-list
24641411|NCT01173510|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24641412|NCT01173510|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24641528|NCT01174056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24641598|NCT01174394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24641599|NCT01174394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641602|NCT01174420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24641626|NCT01174524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24641627|NCT01174524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641628|NCT01174524|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24641630|NCT01174524|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24641631|NCT01174524|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24641632|NCT01174524|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24641633|NCT01174524|Progestins|progestins|mesh-ancestor
24641634|NCT01174524|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24641635|NCT01174563|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25689989|NCT01967862|Sodium Fluoride|sodium fluoride|mesh-list
25689990|NCT01967862|Cariostatic Agents|cariostatic agents|mesh-ancestor
24641636|NCT01174563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641637|NCT01174563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24641751|NCT01175109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24641752|NCT01175109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641753|NCT01175109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641754|NCT01175109|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24641756|NCT01175161|Trace Elements|trace elements|mesh-ancestor
24641757|NCT01175161|Micronutrients|micronutrients|mesh-ancestor
24641758|NCT01175161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641759|NCT01175200|Lansoprazole|lansoprazole|mesh-list
24641760|NCT01175200|Dexlansoprazole|dexlansoprazole|mesh-list
24641761|NCT01175200|Clopidogrel|clopidogrel|mesh-list
24452352|NCT00327197|Hormones|hormones|mesh-ancestor
24586130|NCT00889343|Vitamin B Complex|vitamin b complex|mesh-ancestor
24586131|NCT00889343|Vitamins|vitamins|mesh-ancestor
24586132|NCT00889343|Micronutrients|micronutrients|mesh-ancestor
24586133|NCT00889343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24586134|NCT00889356|Clindamycin|clindamycin|mesh-list
24586135|NCT00889356|Clindamycin palmitate|clindamycin palmitate|mesh-list
24633885|NCT01131559|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24633886|NCT01131559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24633887|NCT01131559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24633889|NCT01131559|Dopamine Agents|dopamine agents|mesh-ancestor
24586136|NCT00889356|Clindamycin phosphate|clindamycin phosphate|mesh-list
24586137|NCT00889356|Amphotericin B|amphotericin b|mesh-list
24586167|NCT00889369|Antidepressive Agents|antidepressive agents|mesh-ancestor
24586168|NCT00889369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24586169|NCT00889369|Dopamine Agents|dopamine agents|mesh-ancestor
24586170|NCT00889434|Tocotrienols|tocotrienols|mesh-list
24586171|NCT00889434|Vitamin E|vitamin e|mesh-list
24586172|NCT00889434|Tocopherols|tocopherols|mesh-list
24586173|NCT00889434|Antioxidants|antioxidants|mesh-ancestor
24641883|NCT01176175|Progesterone|progesterone|mesh-list
24641884|NCT01176175|Progestins|progestins|mesh-ancestor
24641886|NCT01176175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24641887|NCT01176175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641888|NCT01176318|Erdosteine|erdosteine|mesh-list
24641889|NCT01176318|Expectorants|expectorants|mesh-ancestor
24641890|NCT01176318|Respiratory System Agents|respiratory system agents|mesh-ancestor
24641891|NCT01176344|Vitamin D|vitamin d|mesh-list
24641938|NCT01176799|Doxorubicin|doxorubicin|mesh-list
24641939|NCT01176799|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24641940|NCT01176799|Sunitinib|sunitinib|mesh-list
24641941|NCT01176799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24641942|NCT01176799|Immunologic Factors|immunologic factors|mesh-ancestor
24641943|NCT01176799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641944|NCT01176799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24641959|NCT01176851|Glycopyrrolate|glycopyrrolate|mesh-list
24641965|NCT01176851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641966|NCT01176851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641967|NCT01176903|Glycopyrrolate|glycopyrrolate|mesh-list
24641968|NCT01176903|Tiotropium Bromide|tiotropium bromide|mesh-list
24641969|NCT01176903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24641970|NCT01176903|Autonomic Agents|autonomic agents|mesh-ancestor
24633902|NCT01131572|Antidotes|antidotes|mesh-ancestor
24586174|NCT00889434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586175|NCT00889434|Protective Agents|protective agents|mesh-ancestor
24586176|NCT00889434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586177|NCT00889434|Vitamins|vitamins|mesh-ancestor
25011673|NCT04431375|Tenofovir|tenofovir|mesh-list
25011674|NCT04431375|Antiviral Agents|antiviral agents|mesh-ancestor
24583974|NCT00877955|GABA Agents|gaba agents|mesh-ancestor
25011675|NCT04431375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25011676|NCT04431375|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25011677|NCT04431375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25011678|NCT04431375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011679|NCT04431375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011680|NCT04431375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25011681|NCT04431375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25011682|NCT04410913|Psilocybin|psilocybin|mesh-list
25011683|NCT04410913|Hallucinogens|hallucinogens|mesh-ancestor
25011684|NCT04410913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011685|NCT04410913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25011686|NCT04369664|Atorvastatin|atorvastatin|mesh-list
25011687|NCT04369664|Ezetimibe|ezetimibe|mesh-list
25011688|NCT04369664|Evolocumab|evolocumab|mesh-list
25011689|NCT04369664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25011690|NCT04369664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25011691|NCT04369664|Antimetabolites|antimetabolites|mesh-ancestor
25011692|NCT04369664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978585|NCT03849443|Ascorbic Acid|ascorbic acid|mesh-list
24641971|NCT01176903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24641972|NCT01176903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011701|NCT04304144|Bortezomib|bortezomib|mesh-list
25011702|NCT04304144|Daratumumab|daratumumab|mesh-list
25011703|NCT04304144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25011704|NCT04304144|Immunologic Factors|immunologic factors|mesh-ancestor
25011705|NCT04304144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011706|NCT04304144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25110308|NCT05464303|gamma-Globulins|gamma-globulins|mesh-list
25011739|NCT04231084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011740|NCT04231084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25011741|NCT04231084|Respiratory System Agents|respiratory system agents|mesh-ancestor
25011742|NCT04231084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25011743|NCT04231084|Antioxidants|antioxidants|mesh-ancestor
25011744|NCT04231084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105798|NCT04861064|Sirolimus|sirolimus|mesh-list
24641974|NCT01176903|Respiratory System Agents|respiratory system agents|mesh-ancestor
24641975|NCT01176903|Parasympatholytics|parasympatholytics|mesh-ancestor
24641976|NCT01176903|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24642103|NCT01177566|Immunologic Factors|immunologic factors|mesh-ancestor
24642104|NCT01177566|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24642105|NCT01177566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642112|NCT01177683|Bortezomib|bortezomib|mesh-list
24642122|NCT01177696|Psychotropic Drugs|psychotropic drugs|mesh-list
24642123|NCT01177852|Diphenhydramine|diphenhydramine|mesh-list
24642124|NCT01177852|Promethazine|promethazine|mesh-list
24642125|NCT01177852|Brompheniramine|brompheniramine|mesh-list
24642126|NCT01177852|Pseudoephedrine|pseudoephedrine|mesh-list
24642127|NCT01177852|Brompheniramine, pseudoephedrine drug combination|brompheniramine, pseudoephedrine drug combination|mesh-list
24642128|NCT01177852|Ephedrine|ephedrine|mesh-list
24642129|NCT01177852|Dipropizine|dipropizine|mesh-list
24642130|NCT01177852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642131|NCT01177852|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24642132|NCT01177852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24642135|NCT01177852|Anesthetics, Local|anesthetics, local|mesh-ancestor
24968688|NCT03749356|Tacrolimus|tacrolimus|mesh-list
24642178|NCT01178021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24642179|NCT01178021|Filaricides|filaricides|mesh-ancestor
24642180|NCT01178021|Antinematodal Agents|antinematodal agents|mesh-ancestor
24943028|NCT03975166|Hormones|hormones|mesh-ancestor
24642181|NCT01178021|Anthelmintics|anthelmintics|mesh-ancestor
24642183|NCT01178034|Anticoagulants|anticoagulants|mesh-ancestor
24642184|NCT01178047|Rasagiline|rasagiline|mesh-list
24642185|NCT01178047|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24642186|NCT01178047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642187|NCT01178047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642188|NCT01178047|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24642189|NCT01178047|Protective Agents|protective agents|mesh-ancestor
24642190|NCT01178047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011745|NCT04231084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25011746|NCT04231084|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25011747|NCT04231084|Gasotransmitters|gasotransmitters|mesh-ancestor
25011748|NCT04231084|Protective Agents|protective agents|mesh-ancestor
25110318|NCT05464264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25110320|NCT05464264|Anesthetics|anesthetics|mesh-ancestor
25110321|NCT05464264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25110322|NCT05464264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25110323|NCT05464264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25110324|NCT05464264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25110325|NCT05464264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968693|NCT03749356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011789|NCT03790111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25011790|NCT03790111|Antimetabolites|antimetabolites|mesh-ancestor
25011791|NCT03790111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011792|NCT03790111|Antiviral Agents|antiviral agents|mesh-ancestor
25011793|NCT03790111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25011794|NCT03790111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011795|NCT03790111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25011796|NCT03790111|Immunologic Factors|immunologic factors|mesh-ancestor
25011797|NCT03790111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011799|NCT03771586|Analgesics|analgesics|mesh-ancestor
24978603|NCT03810417|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24642191|NCT01178112|Carboplatin|carboplatin|mesh-list
24642192|NCT01178112|Trientine|trientine|mesh-list
24642193|NCT01178112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642194|NCT01178112|Chelating Agents|chelating agents|mesh-ancestor
24642195|NCT01178112|Sequestering Agents|sequestering agents|mesh-ancestor
24642350|NCT01179009|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24642351|NCT01179009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24642352|NCT01179009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24642353|NCT01179009|Adrenergic Agents|adrenergic agents|mesh-ancestor
24642354|NCT01179009|Anticonvulsants|anticonvulsants|mesh-ancestor
24642356|NCT01179009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24642629|NCT01180348|Botulinum Toxins|botulinum toxins|mesh-list
24642630|NCT01180348|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24642631|NCT01180348|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24642632|NCT01180348|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24642633|NCT01180348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24642634|NCT01180348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642635|NCT01180348|Cholinergic Agents|cholinergic agents|mesh-ancestor
24805809|NCT02012088|Glucocorticoids|glucocorticoids|mesh-ancestor
24642636|NCT01180348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24642749|NCT01181193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24642750|NCT01181232|Zolpidem|zolpidem|mesh-list
24642751|NCT01181232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24642752|NCT01181232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24642753|NCT01181232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24642754|NCT01181232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642755|NCT01181232|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24642756|NCT01181232|GABA Agonists|gaba agonists|mesh-ancestor
24642757|NCT01181232|GABA Agents|gaba agents|mesh-ancestor
24642758|NCT01181232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25011800|NCT03771586|Sensory System Agents|sensory system agents|mesh-ancestor
25011801|NCT03771586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25011802|NCT03771586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011803|NCT03771586|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25011804|NCT03771586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25011805|NCT03771586|Anesthetics, General|anesthetics, general|mesh-ancestor
25011806|NCT03771586|Anesthetics|anesthetics|mesh-ancestor
24573189|NCT00818350|Sunitinib|sunitinib|mesh-list
24968684|NCT03749408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24968685|NCT03749408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24968686|NCT03749408|Diuretics|diuretics|mesh-ancestor
24968689|NCT03749356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24968690|NCT03749356|Immunologic Factors|immunologic factors|mesh-ancestor
24968691|NCT03749356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968692|NCT03749356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24586190|NCT00889525|Cabergoline|cabergoline|mesh-list
24586191|NCT00889525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24586192|NCT00889525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24586199|NCT00889590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24586200|NCT00889590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586201|NCT00889616|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24586202|NCT00889616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24586203|NCT00889616|Immunologic Factors|immunologic factors|mesh-ancestor
24586204|NCT00889616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586206|NCT00889616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586207|NCT00889616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24586208|NCT00889629|Vitamin D|vitamin d|mesh-list
24642759|NCT01181232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642760|NCT01181310|Scopolamine|scopolamine|mesh-list
24642761|NCT01181310|Donepezil|donepezil|mesh-list
24642805|NCT01181414|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24642806|NCT01181414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24642808|NCT01181414|Adrenergic Agents|adrenergic agents|mesh-ancestor
24642809|NCT01181414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24642810|NCT01181414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642811|NCT01181427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-list
24642812|NCT01181427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642813|NCT01181427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643041|NCT01183455|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
24643042|NCT01183455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24586211|NCT00889629|Ergocalciferols|ergocalciferols|mesh-list
24586212|NCT00889629|Vitamins|vitamins|mesh-ancestor
25011835|NCT03560960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643043|NCT01183455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643044|NCT01183455|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24643045|NCT01183455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24643047|NCT01183494|Bevacizumab|bevacizumab|mesh-list
25689991|NCT01967862|Protective Agents|protective agents|mesh-ancestor
25058737|NCT03493269|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24754144|NCT01719302|Docetaxel|docetaxel|mesh-list
24754145|NCT01719302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24754146|NCT01719302|Antimetabolites|antimetabolites|mesh-ancestor
24754147|NCT01719302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754149|NCT01719302|Antiviral Agents|antiviral agents|mesh-ancestor
25058738|NCT03493269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25058739|NCT03493269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24643048|NCT01183494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24643073|NCT01183585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24643074|NCT01183585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643076|NCT01183611|Immunologic Factors|immunologic factors|mesh-ancestor
24446015|NCT00303589|Lactams|lactams|mesh-list
24643077|NCT01183611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643137|NCT01183806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24643138|NCT01183806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643139|NCT01183806|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24643140|NCT01183806|Protective Agents|protective agents|mesh-ancestor
24643141|NCT01183910|Calcium Carbonate|calcium carbonate|mesh-list
24643143|NCT01183910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24643144|NCT01183910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410268|NCT00184977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24643392|NCT01185418|Antidepressive Agents|antidepressive agents|mesh-ancestor
24643393|NCT01185418|Dopamine Agonists|dopamine agonists|mesh-ancestor
24643394|NCT01185418|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24643395|NCT01185418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24643397|NCT01185418|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24643398|NCT01185418|Antiemetics|antiemetics|mesh-ancestor
24643399|NCT01185418|Autonomic Agents|autonomic agents|mesh-ancestor
24643400|NCT01185418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24736647|NCT01664013|Cholinergic Agents|cholinergic agents|mesh-ancestor
24643401|NCT01185418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24643508|NCT01185873|Protease Inhibitors|protease inhibitors|mesh-ancestor
24643509|NCT01185873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643510|NCT01185873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643511|NCT01185873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24643547|NCT01185977|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24643548|NCT01185977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643549|NCT01186029|Aprepitant|aprepitant|mesh-list
24643550|NCT01186029|Antiemetics|antiemetics|mesh-ancestor
24643551|NCT01186029|Autonomic Agents|autonomic agents|mesh-ancestor
24643552|NCT01186029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24643556|NCT01186029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24643582|NCT01186146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24643585|NCT01186146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24643586|NCT01186146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643587|NCT01186146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24643588|NCT01186146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24643589|NCT01186146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011868|NCT03284853|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25011869|NCT03284853|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25011870|NCT03206463|Dronabinol|dronabinol|mesh-list
25011871|NCT03206463|Hallucinogens|hallucinogens|mesh-ancestor
25011872|NCT03206463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011873|NCT03206463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25011874|NCT03206463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25011875|NCT03206463|Analgesics|analgesics|mesh-ancestor
25011876|NCT03206463|Sensory System Agents|sensory system agents|mesh-ancestor
25011877|NCT03206463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25011878|NCT03206463|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25011879|NCT03206463|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25011880|NCT03206463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25011881|NCT03206463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25689992|NCT01967862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25689993|NCT01967862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25689994|NCT01967862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25689995|NCT01967940|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25689996|NCT01967940|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25689997|NCT01967940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24643611|NCT01186172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24643612|NCT01186172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24643613|NCT01186172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24643614|NCT01186172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643616|NCT01186185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24643617|NCT01186224|Plerixafor|plerixafor|mesh-list
24643618|NCT01186224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24643619|NCT01186224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24643620|NCT01186224|Antiviral Agents|antiviral agents|mesh-ancestor
24643621|NCT01186224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24643622|NCT01186289|Atorvastatin|atorvastatin|mesh-list
24643623|NCT01186289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24643624|NCT01186289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24643625|NCT01186289|Antimetabolites|antimetabolites|mesh-ancestor
24410491|NCT00185510|Hormones|hormones|mesh-ancestor
24643746|NCT01187108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24643747|NCT01187108|Expectorants|expectorants|mesh-ancestor
24643748|NCT01187108|Respiratory System Agents|respiratory system agents|mesh-ancestor
24643749|NCT01187108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24643751|NCT01187108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643752|NCT01187108|Protective Agents|protective agents|mesh-ancestor
24643753|NCT01187108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643755|NCT01187108|Anticonvulsants|anticonvulsants|mesh-ancestor
24643756|NCT01187108|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25011885|NCT03166761|Triamcinolone|triamcinolone|mesh-list
25011886|NCT03166761|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25011887|NCT03166761|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25011888|NCT03166761|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25011889|NCT03166761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25011912|NCT03153410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011913|NCT03153410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011914|NCT03153410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25011915|NCT03153410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25011916|NCT03072147|Teriparatide|teriparatide|mesh-list
24643845|NCT01187719|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24643846|NCT01187719|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24643847|NCT01187719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24643920|NCT01187992|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24643921|NCT01187992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643923|NCT01188005|Vitamin E|vitamin e|mesh-list
24643924|NCT01188005|Vitamin A|vitamin a|mesh-list
24643925|NCT01188005|Acetylcysteine|acetylcysteine|mesh-list
24643926|NCT01188005|Allopurinol|allopurinol|mesh-list
24643927|NCT01188005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24643928|NCT01188005|Micronutrients|micronutrients|mesh-ancestor
24643929|NCT01188005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643972|NCT01188148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24643973|NCT01188148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24643974|NCT01188174|Clofarabine|clofarabine|mesh-list
24643975|NCT01188174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24643976|NCT01188174|Antimetabolites|antimetabolites|mesh-ancestor
24643977|NCT01188174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643978|NCT01188174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24643979|NCT01188213|Dimethyl sulfone|dimethyl sulfone|mesh-list
24643980|NCT01188213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24644072|NCT01188824|Vasodilator Agents|vasodilator agents|mesh-ancestor
24644073|NCT01188824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24644074|NCT01188824|Protective Agents|protective agents|mesh-ancestor
24644075|NCT01188824|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24644077|NCT01188824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644078|NCT01188863|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
24644079|NCT01188863|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25011917|NCT03072147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25011918|NCT03072147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011919|NCT03072147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25011920|NCT03032250|Hydrocortisone|hydrocortisone|mesh-list
25011921|NCT03032250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25011922|NCT03011814|Lenalidomide|lenalidomide|mesh-list
25011923|NCT03011814|Durvalumab|durvalumab|mesh-list
25011924|NCT03011814|Immunoglobulins|immunoglobulins|mesh-list
25011925|NCT03011814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25011926|NCT03011814|Immunoglobulin G|immunoglobulin g|mesh-list
25011927|NCT03011814|Immunologic Factors|immunologic factors|mesh-ancestor
25011928|NCT03011814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011929|NCT03011814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25011930|NCT03011814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25011931|NCT03011814|Growth Substances|growth substances|mesh-ancestor
25011932|NCT03011814|Growth Inhibitors|growth inhibitors|mesh-ancestor
24644103|NCT01189006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24644104|NCT01189006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644105|NCT01189006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644106|NCT01189019|Ranibizumab|ranibizumab|mesh-list
24644107|NCT01189019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24644108|NCT01189019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24644109|NCT01189019|Growth Substances|growth substances|mesh-ancestor
24644110|NCT01189019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644111|NCT01189019|Growth Inhibitors|growth inhibitors|mesh-ancestor
24644146|NCT01189318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24644147|NCT01189318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644148|NCT01189448|Pyrimethamine|pyrimethamine|mesh-list
24644149|NCT01189448|Sulfadiazine|sulfadiazine|mesh-list
24644203|NCT01189721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644248|NCT01189864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24644251|NCT01189864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24644252|NCT01189864|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24644253|NCT01189864|Protective Agents|protective agents|mesh-ancestor
24644254|NCT01189864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24644255|NCT01189864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644257|NCT01189929|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24644258|NCT01189929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24644259|NCT01189929|Antimetabolites|antimetabolites|mesh-ancestor
24644260|NCT01189929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644261|NCT01189929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644262|NCT01189929|Antiviral Agents|antiviral agents|mesh-ancestor
24644263|NCT01189929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24644264|NCT01189929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644265|NCT01189929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24644266|NCT01189929|Immunologic Factors|immunologic factors|mesh-ancestor
24644267|NCT01189929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644268|NCT01190137|Cholecalciferol|cholecalciferol|mesh-list
24644270|NCT01190137|Ergocalciferols|ergocalciferols|mesh-list
24644271|NCT01190137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24644272|NCT01190137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644299|NCT01190293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24644300|NCT01190293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24644301|NCT01190293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011974|NCT02721069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25011975|NCT02721069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24449034|NCT00313963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24449035|NCT00313963|Anticonvulsants|anticonvulsants|mesh-ancestor
24644302|NCT01190293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508212|NCT00554528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24508213|NCT00554528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24508214|NCT00554528|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25058869|NCT03492593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058876|NCT03492593|Vitamins|vitamins|mesh-ancestor
24644303|NCT01190293|Antiviral Agents|antiviral agents|mesh-ancestor
24644304|NCT01190293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24644305|NCT01190293|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24644306|NCT01190293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24644307|NCT01190293|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24644308|NCT01190293|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24644635|NCT01192165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24410768|NCT00187031|Topotecan|topotecan|mesh-list
24644804|NCT01193270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644806|NCT01193270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644807|NCT01193270|Protective Agents|protective agents|mesh-ancestor
24644808|NCT01193296|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24644809|NCT01193296|Vildagliptin|vildagliptin|mesh-list
24644810|NCT01193296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24644811|NCT01193296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644812|NCT01193296|Incretins|incretins|mesh-ancestor
24644813|NCT01193296|Hormones|hormones|mesh-ancestor
24644814|NCT01193296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24644815|NCT01193296|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24644816|NCT01193296|Protease Inhibitors|protease inhibitors|mesh-ancestor
24644817|NCT01193296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644818|NCT01193296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644819|NCT01193387|Insulin|insulin|mesh-list
24410999|NCT00187174|Everolimus|everolimus|mesh-list
24644853|NCT01193478|Ledipasvir|ledipasvir|mesh-list
24644881|NCT01193504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24644882|NCT01193504|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24644883|NCT01193504|Protective Agents|protective agents|mesh-ancestor
24646186|NCT01202422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24644910|NCT01193621|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25011979|NCT02721069|GABA Modulators|gaba modulators|mesh-ancestor
25011980|NCT02721069|GABA Agents|gaba agents|mesh-ancestor
25011981|NCT02721069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24644911|NCT01193816|Loxapine|loxapine|mesh-list
24644962|NCT01194336|Donepezil|donepezil|mesh-list
24644964|NCT01194336|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24644965|NCT01194336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644966|NCT01194336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644967|NCT01194336|Cholinergic Agents|cholinergic agents|mesh-ancestor
24644968|NCT01194336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24644969|NCT01194336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644970|NCT01194336|Nootropic Agents|nootropic agents|mesh-ancestor
24644971|NCT01194336|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24645035|NCT01194934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24645036|NCT01194934|Immunologic Factors|immunologic factors|mesh-ancestor
24645037|NCT01194934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645038|NCT01195181|Ribavirin|ribavirin|mesh-list
24645039|NCT01195181|Antimetabolites|antimetabolites|mesh-ancestor
24645040|NCT01195181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645041|NCT01195181|Antiviral Agents|antiviral agents|mesh-ancestor
24645042|NCT01195181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24645043|NCT01195246|Vaccines|vaccines|mesh-list
24645044|NCT01195246|Immunologic Factors|immunologic factors|mesh-ancestor
24645045|NCT01195246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645046|NCT01195259|Metformin|metformin|mesh-list
24645047|NCT01195259|Rosiglitazone|rosiglitazone|mesh-list
24645048|NCT01195259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24645049|NCT01195259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645050|NCT01195298|Bevacizumab|bevacizumab|mesh-list
24645051|NCT01195298|Capecitabine|capecitabine|mesh-list
24645052|NCT01195298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25689998|NCT01967940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25689999|NCT01967940|Protease Inhibitors|protease inhibitors|mesh-ancestor
25690000|NCT01967940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25690001|NCT01967940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690002|NCT01967940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25690003|NCT01967940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25058974|NCT03492047|Antimitotic Agents|antimitotic agents|mesh-ancestor
25058975|NCT03492047|Mitosis Modulators|mitosis modulators|mesh-ancestor
25058976|NCT03492047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645053|NCT01195298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24645054|NCT01195298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24645055|NCT01195298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24645056|NCT01195298|Growth Substances|growth substances|mesh-ancestor
24645057|NCT01195298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645058|NCT01195298|Growth Inhibitors|growth inhibitors|mesh-ancestor
24645059|NCT01195298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24645091|NCT01195649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24645092|NCT01195649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645093|NCT01195714|Ofatumumab|ofatumumab|mesh-list
24645094|NCT01195714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24645095|NCT01195727|Apixaban|apixaban|mesh-list
24474061|NCT00404794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474062|NCT00404794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24645127|NCT01196065|Memantine|memantine|mesh-list
24645128|NCT01196065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24645129|NCT01196065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24645130|NCT01196065|Dopamine Agents|dopamine agents|mesh-ancestor
24645131|NCT01196065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24645132|NCT01196065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645133|NCT01196065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645134|NCT01196065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25012019|NCT02389465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25012020|NCT02389465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012021|NCT02389465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25012022|NCT02389465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25012023|NCT02389465|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25012024|NCT02389465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25012025|NCT02389465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25012026|NCT02389465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012027|NCT02389465|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25012028|NCT02389465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24645135|NCT01196065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24645136|NCT01196169|Vancomycin|vancomycin|mesh-list
24645137|NCT01196169|Daptomycin|daptomycin|mesh-list
24645146|NCT01196234|Gefitinib|gefitinib|mesh-list
24645159|NCT01196260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645160|NCT01196260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24645161|NCT01196455|Capecitabine|capecitabine|mesh-list
24645162|NCT01196455|Mitomycins|mitomycins|mesh-list
24645163|NCT01196455|Mitomycin|mitomycin|mesh-list
24645164|NCT01196455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24645165|NCT01196455|Antimetabolites|antimetabolites|mesh-ancestor
24645166|NCT01196455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645167|NCT01196455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24645168|NCT01196455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24645170|NCT01196455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24645171|NCT01196455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25012029|NCT02389465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25012030|NCT02389465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25012031|NCT02389465|Serotonin Agents|serotonin agents|mesh-ancestor
25012032|NCT02389465|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25012033|NCT02389465|Antidepressive Agents|antidepressive agents|mesh-ancestor
25012034|NCT02389465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25012035|NCT02389465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25012036|NCT02389465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25012037|NCT02389465|Parasympatholytics|parasympatholytics|mesh-ancestor
25012038|NCT02389465|Autonomic Agents|autonomic agents|mesh-ancestor
25012039|NCT02389465|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24446359|NCT00304551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25012040|NCT02389465|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25012041|NCT02389465|Cholinergic Agents|cholinergic agents|mesh-ancestor
25012043|NCT02335060|Dronabinol|dronabinol|mesh-list
25012059|NCT02335060|Sensory System Agents|sensory system agents|mesh-ancestor
25012060|NCT02335060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25690004|NCT01967940|Antiviral Agents|antiviral agents|mesh-ancestor
25690005|NCT01967940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25690006|NCT01968031|Istradefylline|istradefylline|mesh-list
25690007|NCT01968031|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
25690008|NCT01968031|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25690009|NCT01968031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25690010|NCT01968031|Purinergic Agents|purinergic agents|mesh-ancestor
24645173|NCT01196481|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24645175|NCT01196481|Adrenergic Agents|adrenergic agents|mesh-ancestor
24645186|NCT01196481|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24645187|NCT01196481|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24645189|NCT01196507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24645191|NCT01196507|Adrenergic Agents|adrenergic agents|mesh-ancestor
24645254|NCT01197001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24645255|NCT01197001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24645258|NCT01197014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24645259|NCT01197014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24645271|NCT01197040|Glucocorticoids|glucocorticoids|mesh-ancestor
24645272|NCT01197040|Hormones|hormones|mesh-ancestor
24449677|NCT00316498|Miglustat|miglustat|mesh-list
24645288|NCT01197157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24645289|NCT01197157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24645292|NCT01197170|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24645293|NCT01197170|Sorafenib|sorafenib|mesh-list
24645294|NCT01197170|Anastrozole|anastrozole|mesh-list
24645295|NCT01197170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24645296|NCT01197170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24645297|NCT01197170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24645298|NCT01197170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24645299|NCT01197170|Growth Substances|growth substances|mesh-ancestor
24645306|NCT01197170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645307|NCT01197170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24645308|NCT01197170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24645309|NCT01197170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24645310|NCT01197170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24645311|NCT01197170|Hormone Antagonists|hormone antagonists|mesh-ancestor
24645313|NCT01197235|Darbepoetin alfa|darbepoetin alfa|mesh-list
24645352|NCT01197846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24645353|NCT01197846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24645354|NCT01197846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645356|NCT01198054|Immunologic Factors|immunologic factors|mesh-ancestor
24645357|NCT01198054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645358|NCT01198054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24645359|NCT01198054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24645360|NCT01198054|Growth Substances|growth substances|mesh-ancestor
24645362|NCT01198054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25012061|NCT02335060|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25012062|NCT02335060|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25012063|NCT02335060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25012064|NCT02335060|Hormones|hormones|mesh-ancestor
25012065|NCT02335060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25012066|NCT02297438|Letrozole|letrozole|mesh-list
25012067|NCT02297438|Palbociclib|palbociclib|mesh-list
25012068|NCT02297438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25012069|NCT02297438|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25012070|NCT02297438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25012071|NCT02297438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25012072|NCT02297438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012074|NCT02297438|Hormone Antagonists|hormone antagonists|mesh-ancestor
24645363|NCT01198106|Cinnarizine|cinnarizine|mesh-list
24645473|NCT01198353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24645474|NCT01198353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645475|NCT01198353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645482|NCT01198379|Aspirin|aspirin|mesh-list
24645547|NCT01198639|Propofol|propofol|mesh-list
24645548|NCT01198639|Anesthetics|anesthetics|mesh-list
24645549|NCT01198639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24645550|NCT01198639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25690011|NCT01968031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25690012|NCT01968031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690013|NCT01968031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645551|NCT01198639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645552|NCT01198639|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24645553|NCT01198639|Anesthetics, General|anesthetics, general|mesh-ancestor
25690014|NCT01968057|Cyclosporine|cyclosporine|mesh-list
25690015|NCT01968057|Cyclosporins|cyclosporins|mesh-list
25059109|NCT03491085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059110|NCT03491072|Fentanyl|fentanyl|mesh-list
24508491|NCT00555984|Remifentanil|remifentanil|mesh-list
24508492|NCT00555984|Propofol|propofol|mesh-list
24884766|NCT03618134|Immunoglobulin G|immunoglobulin g|mesh-list
24884767|NCT03618134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25038418|NCT05175001|Hormones|hormones|mesh-ancestor
24645554|NCT01198639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24645555|NCT01198639|Narcotics|narcotics|mesh-ancestor
24645556|NCT01198639|Analgesics|analgesics|mesh-ancestor
24645557|NCT01198639|Sensory System Agents|sensory system agents|mesh-ancestor
24645558|NCT01198639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24645559|NCT01198665|Prednisolone|prednisolone|mesh-list
24645560|NCT01198665|Doxorubicin|doxorubicin|mesh-list
24645570|NCT01198665|Tubulin Modulators|tubulin modulators|mesh-ancestor
24645571|NCT01198665|Antimitotic Agents|antimitotic agents|mesh-ancestor
24645572|NCT01198665|Mitosis Modulators|mitosis modulators|mesh-ancestor
24645573|NCT01198665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24645574|NCT01198665|Immunologic Factors|immunologic factors|mesh-ancestor
24645575|NCT01198665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645659|NCT01199276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24645660|NCT01199276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645662|NCT01199328|Esomeprazole|esomeprazole|mesh-list
24645663|NCT01199328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24645665|NCT01199328|Analgesics|analgesics|mesh-ancestor
24645666|NCT01199328|Sensory System Agents|sensory system agents|mesh-ancestor
24645667|NCT01199328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24645668|NCT01199328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645669|NCT01199328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24645670|NCT01199328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24645671|NCT01199328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24645672|NCT01199328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24645726|NCT01199458|Narcotics|narcotics|mesh-ancestor
24645727|NCT01199458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24645728|NCT01199458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645730|NCT01199458|Sensory System Agents|sensory system agents|mesh-ancestor
24645731|NCT01199458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24645732|NCT01199458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24645734|NCT01199458|Anesthetics|anesthetics|mesh-ancestor
25012075|NCT02297438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25012076|NCT02297438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012077|NCT02297438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25012078|NCT02297412|Minocycline|minocycline|mesh-list
25012079|NCT02297412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25012080|NCT02297412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25012081|NCT02292758|Bevacizumab|bevacizumab|mesh-list
24420800|NCT00216827|Hormones|hormones|mesh-ancestor
24645745|NCT01199523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645746|NCT01199523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24645747|NCT01199523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645748|NCT01199523|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24645749|NCT01199523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24645904|NCT01200641|Antimanic Agents|antimanic agents|mesh-ancestor
24645905|NCT01200641|Antioxidants|antioxidants|mesh-ancestor
24645906|NCT01200641|Protective Agents|protective agents|mesh-ancestor
24645907|NCT01200654|Linezolid|linezolid|mesh-list
24645908|NCT01200654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24645909|NCT01200654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24645910|NCT01200654|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24645911|NCT01200654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24645912|NCT01200654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645913|NCT01200693|Sirolimus|sirolimus|mesh-list
24645914|NCT01200693|Everolimus|everolimus|mesh-list
24645915|NCT01200693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24645916|NCT01200693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24645917|NCT01200693|Immunologic Factors|immunologic factors|mesh-ancestor
24645918|NCT01200693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690016|NCT01968057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25690017|NCT01968057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690018|NCT01968057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25690019|NCT01968057|Immunologic Factors|immunologic factors|mesh-ancestor
25690020|NCT01968057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690021|NCT01968057|Antifungal Agents|antifungal agents|mesh-ancestor
24645920|NCT01200693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24645921|NCT01200693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24645922|NCT01200693|Antifungal Agents|antifungal agents|mesh-ancestor
24645923|NCT01200706|Amoxicillin|amoxicillin|mesh-list
24645934|NCT01200745|Antipruritics|antipruritics|mesh-ancestor
24645935|NCT01200745|Dermatologic Agents|dermatologic agents|mesh-ancestor
24645936|NCT01200745|Sensory System Agents|sensory system agents|mesh-ancestor
24645937|NCT01200745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24645938|NCT01200745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645939|NCT01200784|Niacinamide|niacinamide|mesh-list
24645941|NCT01200784|Nicotinic Acids|nicotinic acids|mesh-list
24645942|NCT01200784|Vitamin B Complex|vitamin b complex|mesh-ancestor
24645943|NCT01200784|Vitamins|vitamins|mesh-ancestor
24645944|NCT01200784|Micronutrients|micronutrients|mesh-ancestor
24645945|NCT01200784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645946|NCT01200784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24646061|NCT01201642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24646062|NCT01201642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24646064|NCT01201694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24646065|NCT01201694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24646067|NCT01201694|Sensory System Agents|sensory system agents|mesh-ancestor
24646093|NCT01202058|Immunologic Factors|immunologic factors|mesh-ancestor
24411694|NCT00189722|Tacrolimus|tacrolimus|mesh-list
24646161|NCT01202240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646176|NCT01202422|Analgesics|analgesics|mesh-ancestor
24646181|NCT01202422|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24646182|NCT01202422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24646183|NCT01202422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646184|NCT01202422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24646185|NCT01202422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24646187|NCT01202422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24646188|NCT01202422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24646189|NCT01202435|Pregabalin|pregabalin|mesh-list
24646190|NCT01202435|Analgesics|analgesics|mesh-ancestor
24646191|NCT01202435|Sensory System Agents|sensory system agents|mesh-ancestor
25012082|NCT02292758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25012083|NCT02292758|Cetuximab|cetuximab|mesh-list
25012084|NCT02292758|Irinotecan|irinotecan|mesh-list
25012085|NCT02292758|Endothelial Growth Factors|endothelial growth factors|mesh-list
25012086|NCT02292758|Antibodies|antibodies|mesh-list
25012087|NCT02292758|Immunoglobulins|immunoglobulins|mesh-list
25012088|NCT02292758|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25012089|NCT02292758|Immunoglobulin G|immunoglobulin g|mesh-list
25012090|NCT02292758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25012091|NCT02292758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25012092|NCT02292758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25012093|NCT02292758|Growth Substances|growth substances|mesh-ancestor
25012094|NCT02292758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012095|NCT02292758|Growth Inhibitors|growth inhibitors|mesh-ancestor
24646194|NCT01202435|Anticonvulsants|anticonvulsants|mesh-ancestor
24646214|NCT01202487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24646215|NCT01202487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646219|NCT01202487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24646220|NCT01202487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24646221|NCT01202487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24646222|NCT01202487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646223|NCT01202487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24646370|NCT01203371|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24646371|NCT01203371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24646372|NCT01203371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24646373|NCT01203371|Adrenergic Agents|adrenergic agents|mesh-ancestor
24646374|NCT01203371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24646375|NCT01203371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646376|NCT01203371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646377|NCT01203371|Urological Agents|urological agents|mesh-ancestor
24646378|NCT01203371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24646379|NCT01203371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24646420|NCT01203696|Amlodipine|amlodipine|mesh-list
24646435|NCT01203709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646437|NCT01203709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24646438|NCT01203709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24646439|NCT01203709|Antitubercular Agents|antitubercular agents|mesh-ancestor
24646440|NCT01203709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24646441|NCT01203709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24646442|NCT01203735|Valproic Acid|valproic acid|mesh-list
24646443|NCT01203735|Anticonvulsants|anticonvulsants|mesh-ancestor
24646444|NCT01203735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646445|NCT01203735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646446|NCT01203735|GABA Agents|gaba agents|mesh-ancestor
24646447|NCT01203735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24646448|NCT01203735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646449|NCT01203735|Antimanic Agents|antimanic agents|mesh-ancestor
24646450|NCT01203735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24646451|NCT01203735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24646452|NCT01203735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24646507|NCT01204138|Analgesics|analgesics|mesh-ancestor
24646508|NCT01204138|Sensory System Agents|sensory system agents|mesh-ancestor
24646509|NCT01204138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24646510|NCT01204138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646511|NCT01204138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24646647|NCT01204450|Immunologic Factors|immunologic factors|mesh-ancestor
25012096|NCT02292758|Immunologic Factors|immunologic factors|mesh-ancestor
25012097|NCT02292758|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25012098|NCT02292758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25012099|NCT02292758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25012100|NCT02292758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646648|NCT01204450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646649|NCT01204450|Anticonvulsants|anticonvulsants|mesh-ancestor
24646650|NCT01204450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646651|NCT01204450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646652|NCT01204450|GABA Agents|gaba agents|mesh-ancestor
24646653|NCT01204450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24646777|NCT01205087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24646778|NCT01205087|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24646779|NCT01205087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646780|NCT01205087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646781|NCT01205139|Simeprevir|simeprevir|mesh-list
24646782|NCT01205139|Rilpivirine|rilpivirine|mesh-list
24646783|NCT01205139|Antiviral Agents|antiviral agents|mesh-ancestor
24646784|NCT01205139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24646785|NCT01205139|Protease Inhibitors|protease inhibitors|mesh-ancestor
24646813|NCT01205204|Anesthetics|anesthetics|mesh-ancestor
24646814|NCT01205204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24646815|NCT01205204|Sympatholytics|sympatholytics|mesh-ancestor
24646816|NCT01205204|Autonomic Agents|autonomic agents|mesh-ancestor
24646817|NCT01205204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24646818|NCT01205204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24646819|NCT01205204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24646820|NCT01205204|Adrenergic Agents|adrenergic agents|mesh-ancestor
24646933|NCT01205711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24646934|NCT01205711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24646935|NCT01205711|Immunologic Factors|immunologic factors|mesh-ancestor
24646936|NCT01205711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24647090|NCT01206205|Immunologic Factors|immunologic factors|mesh-ancestor
24647091|NCT01206205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647189|NCT01206881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24647190|NCT01206881|Tubulin Modulators|tubulin modulators|mesh-ancestor
24647192|NCT01206881|Mitosis Modulators|mitosis modulators|mesh-ancestor
24647193|NCT01206881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24647194|NCT01206881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24647195|NCT01206881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24647196|NCT01206881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24647197|NCT01206881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24647198|NCT01206907|Oxymorphone|oxymorphone|mesh-list
24647199|NCT01206907|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24647201|NCT01206907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24647203|NCT01206907|Analgesics|analgesics|mesh-ancestor
24647268|NCT01207297|Alkylating Agents|alkylating agents|mesh-ancestor
24647269|NCT01207297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647270|NCT01207297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647271|NCT01207297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24647272|NCT01207297|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24647273|NCT01207297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24647275|NCT01207310|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24647276|NCT01207310|Autonomic Agents|autonomic agents|mesh-ancestor
24647277|NCT01207310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24647278|NCT01207310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647279|NCT01207310|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24647280|NCT01207310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24647281|NCT01207310|Cholinergic Agents|cholinergic agents|mesh-ancestor
24647282|NCT01207310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24647351|NCT01208441|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24647424|NCT01208766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24647425|NCT01208766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24647427|NCT01208818|Dexamethasone acetate|dexamethasone acetate|mesh-list
24647429|NCT01208818|Bortezomib|bortezomib|mesh-list
24647430|NCT01208818|BB 1101|bb 1101|mesh-list
25012101|NCT02250326|Paclitaxel|paclitaxel|mesh-list
25012102|NCT02250326|Azacitidine|azacitidine|mesh-list
24584266|NCT00879242|Chelating Agents|chelating agents|mesh-ancestor
25012111|NCT02250326|Antimetabolites|antimetabolites|mesh-ancestor
25012112|NCT02250326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24647431|NCT01208818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24647432|NCT01208818|Immunologic Factors|immunologic factors|mesh-ancestor
24647433|NCT01208818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647434|NCT01208818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24647435|NCT01208818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24647436|NCT01208818|Alkylating Agents|alkylating agents|mesh-ancestor
24647437|NCT01208818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647438|NCT01208818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647439|NCT01208818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24647440|NCT01208818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24647441|NCT01208818|Antiemetics|antiemetics|mesh-ancestor
24647442|NCT01208818|Autonomic Agents|autonomic agents|mesh-ancestor
24647517|NCT01209208|Respiratory System Agents|respiratory system agents|mesh-ancestor
24647518|NCT01209208|Glucocorticoids|glucocorticoids|mesh-ancestor
24647519|NCT01209208|Hormones|hormones|mesh-ancestor
24647520|NCT01209208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24647521|NCT01209208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24647587|NCT01209650|Afatinib|afatinib|mesh-list
24647588|NCT01209650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647589|NCT01209650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24647590|NCT01209650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24647591|NCT01209650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647592|NCT01209715|Fluticasone|fluticasone|mesh-list
24647593|NCT01209715|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24647594|NCT01209715|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24647595|NCT01209715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24647596|NCT01209715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24647597|NCT01209715|Autonomic Agents|autonomic agents|mesh-ancestor
24647608|NCT01209715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24647609|NCT01209715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647610|NCT01209715|Glucocorticoids|glucocorticoids|mesh-ancestor
24647612|NCT01209715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24647736|NCT01210430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24647737|NCT01210430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24647738|NCT01210430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24647739|NCT01210430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647741|NCT01210430|Protective Agents|protective agents|mesh-ancestor
24647754|NCT01210482|Sirolimus|sirolimus|mesh-list
24647775|NCT01210638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24647776|NCT01210638|Narcotics|narcotics|mesh-ancestor
24647777|NCT01210638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24647778|NCT01210638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647780|NCT01210638|Sensory System Agents|sensory system agents|mesh-ancestor
24647781|NCT01210638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24647782|NCT01210638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24647783|NCT01210677|Prednisone|prednisone|mesh-list
24647786|NCT01210677|Hormones|hormones|mesh-ancestor
24647836|NCT01211080|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24647837|NCT01211080|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24647838|NCT01211080|Adrenergic Agents|adrenergic agents|mesh-ancestor
24647839|NCT01211080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412091|NCT00190814|Dopamine Agents|dopamine agents|mesh-ancestor
24647962|NCT01211561|Protective Agents|protective agents|mesh-ancestor
24648503|NCT01215019|Diuretics|diuretics|mesh-ancestor
24647963|NCT01211561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647964|NCT01211561|Trace Elements|trace elements|mesh-ancestor
24968866|NCT03747536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968867|NCT03747523|Vitamin D|vitamin d|mesh-list
24968868|NCT03747523|Ergocalciferols|ergocalciferols|mesh-list
24968869|NCT03747523|Vitamins|vitamins|mesh-ancestor
24821664|NCT02107170|Remifentanil|remifentanil|mesh-list
24968870|NCT03747523|Micronutrients|micronutrients|mesh-ancestor
24968871|NCT03747523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474282|NCT00405418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968872|NCT03747523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24968873|NCT03747523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24968874|NCT03747341|Fentanyl|fentanyl|mesh-list
24968875|NCT03747341|Oxycodone|oxycodone|mesh-list
24968876|NCT03747341|Buprenorphine|buprenorphine|mesh-list
24647965|NCT01211561|Micronutrients|micronutrients|mesh-ancestor
24647966|NCT01211691|Antibodies|antibodies|mesh-list
24647967|NCT01211691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24647968|NCT01211691|Immunologic Factors|immunologic factors|mesh-ancestor
24647986|NCT01211795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24647988|NCT01211795|Sensory System Agents|sensory system agents|mesh-ancestor
24647990|NCT01211795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647991|NCT01211795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24647993|NCT01211795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24647994|NCT01211795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24647995|NCT01211795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647997|NCT01211808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24647998|NCT01211808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24647999|NCT01211808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24648000|NCT01211808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648001|NCT01211808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24648053|NCT01211925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968877|NCT03747341|Ondansetron|ondansetron|mesh-list
25012157|NCT01856270|Amitriptyline|amitriptyline|mesh-list
25039932|NCT03588884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24648055|NCT01211925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24648056|NCT01211925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24648057|NCT01211925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24648058|NCT01211925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648059|NCT01211925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24648061|NCT01211925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648062|NCT01211925|Antipyretics|antipyretics|mesh-ancestor
24648063|NCT01211938|Cetuximab|cetuximab|mesh-list
24648064|NCT01211938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24648065|NCT01211938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648066|NCT01212133|Liraglutide|liraglutide|mesh-list
24648067|NCT01212133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24648073|NCT01212250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24648074|NCT01212250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24648075|NCT01212250|Adrenergic Agents|adrenergic agents|mesh-ancestor
24648076|NCT01212250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24648121|NCT01212523|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24648122|NCT01212653|Golimumab|golimumab|mesh-list
24648123|NCT01212653|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24648124|NCT01212653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24648125|NCT01212653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24648126|NCT01212653|Immunologic Factors|immunologic factors|mesh-ancestor
24648127|NCT01212653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648128|NCT01212666|Ropivacaine|ropivacaine|mesh-list
24648129|NCT01212666|Anesthetics, Local|anesthetics, local|mesh-ancestor
24648130|NCT01212666|Anesthetics|anesthetics|mesh-ancestor
24648131|NCT01212666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24648132|NCT01212666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648133|NCT01212666|Sensory System Agents|sensory system agents|mesh-ancestor
24648134|NCT01212666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24648135|NCT01212679|Mitogens|mitogens|mesh-list
24648136|NCT01212679|Mitosis Modulators|mitosis modulators|mesh-ancestor
25012183|NCT01503515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25012184|NCT01503515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012185|NCT01503515|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25012190|NCT01491893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012192|NCT01180374|Cannabidiol|cannabidiol|mesh-list
25012193|NCT01180374|Anticonvulsants|anticonvulsants|mesh-ancestor
25012194|NCT01180374|Hallucinogens|hallucinogens|mesh-ancestor
25690022|NCT01968057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25690023|NCT01968057|Dermatologic Agents|dermatologic agents|mesh-ancestor
25690024|NCT01968057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25012197|NCT01180374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24648137|NCT01212679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648139|NCT01212809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24648140|NCT01212809|Immunologic Factors|immunologic factors|mesh-ancestor
24648142|NCT01212809|Viscosupplements|viscosupplements|mesh-ancestor
24648190|NCT01212913|Insulin Glargine|insulin glargine|mesh-list
24648191|NCT01212913|Insulin Aspart|insulin aspart|mesh-list
24648192|NCT01212913|Insulin glulisine|insulin glulisine|mesh-list
24648266|NCT01213368|Dronedarone|dronedarone|mesh-list
24648267|NCT01213368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24648268|NCT01213381|Gemcitabine|gemcitabine|mesh-list
24648269|NCT01213381|Carboplatin|carboplatin|mesh-list
24648270|NCT01213381|Iniparib|iniparib|mesh-list
24648271|NCT01213381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648272|NCT01213381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24648273|NCT01213381|Antimetabolites|antimetabolites|mesh-ancestor
24648274|NCT01213381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648275|NCT01213381|Antiviral Agents|antiviral agents|mesh-ancestor
24648276|NCT01213381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24648277|NCT01213381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648278|NCT01213381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24648412|NCT01214291|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24648413|NCT01214291|Hormone Antagonists|hormone antagonists|mesh-ancestor
24648414|NCT01214291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24648415|NCT01214291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648416|NCT01214291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24648417|NCT01214343|Sorafenib|sorafenib|mesh-list
24648418|NCT01214343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648419|NCT01214343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24648468|NCT01214928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24450438|NCT00319072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648469|NCT01214928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24648471|NCT01214941|Ticlopidine|ticlopidine|mesh-list
25012198|NCT01180374|Analgesics|analgesics|mesh-ancestor
25012199|NCT01180374|Sensory System Agents|sensory system agents|mesh-ancestor
25012200|NCT01180374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25012201|NCT01180374|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25012202|NCT01180374|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25012203|NCT01180374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25012231|NCT00357565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25012232|NCT00357565|Alkylating Agents|alkylating agents|mesh-ancestor
25012233|NCT00357565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25012234|NCT00284986|Remestemcel-l|remestemcel-l|mesh-list
25012235|NCT00284986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25012236|NCT00284986|Antiviral Agents|antiviral agents|mesh-ancestor
24648495|NCT01214993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648496|NCT01214993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648497|NCT01214993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24648498|NCT01214993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24648499|NCT01214993|Antiviral Agents|antiviral agents|mesh-ancestor
24648500|NCT01214993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24648501|NCT01215019|Mannitol|mannitol|mesh-list
24648502|NCT01215019|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24648505|NCT01215019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648506|NCT01215084|4-Aminopyridine|4-aminopyridine|mesh-list
24648507|NCT01215084|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24648580|NCT01215669|Vaccines|vaccines|mesh-list
24648586|NCT01215682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648587|NCT01215682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24648588|NCT01215708|Tamsulosin|tamsulosin|mesh-list
24648589|NCT01215708|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24648590|NCT01215708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24648591|NCT01215708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24648592|NCT01215708|Adrenergic Agents|adrenergic agents|mesh-ancestor
24509379|NCT00560092|Analgesics|analgesics|mesh-ancestor
24648593|NCT01215708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24648666|NCT01216267|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24648667|NCT01216267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648668|NCT01216267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648669|NCT01216293|Esomeprazole|esomeprazole|mesh-list
24648670|NCT01216293|Dexlansoprazole|dexlansoprazole|mesh-list
24648671|NCT01216293|Lansoprazole|lansoprazole|mesh-list
24648672|NCT01216293|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24648673|NCT01216293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24648697|NCT01216371|Growth Inhibitors|growth inhibitors|mesh-ancestor
24648705|NCT01216449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648859|NCT01217099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648860|NCT01217099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24648861|NCT01217099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24648862|NCT01217125|Sirolimus|sirolimus|mesh-list
24648863|NCT01217125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24648864|NCT01217125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24648865|NCT01217125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24648866|NCT01217125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648867|NCT01217125|Antifungal Agents|antifungal agents|mesh-ancestor
24648868|NCT01217125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24648869|NCT01217125|Immunologic Factors|immunologic factors|mesh-ancestor
24648870|NCT01217125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648871|NCT01217138|Epinephrine|epinephrine|mesh-list
24648872|NCT01217138|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24648873|NCT01217138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24648874|NCT01217138|Adrenergic Agents|adrenergic agents|mesh-ancestor
24648875|NCT01217138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25012237|NCT00284986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25012238|NCT00245960|Etanercept|etanercept|mesh-list
25012239|NCT00245960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25012240|NCT00245960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25012241|NCT00245960|Analgesics|analgesics|mesh-ancestor
25012242|NCT00245960|Sensory System Agents|sensory system agents|mesh-ancestor
25012243|NCT00245960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25012244|NCT00245960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012245|NCT00245960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25012246|NCT00245960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25012247|NCT00245960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25012248|NCT00245960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25012249|NCT00245960|Immunologic Factors|immunologic factors|mesh-ancestor
25012250|NCT00136903|Cyclosporine|cyclosporine|mesh-list
25012251|NCT00136903|Mycophenolic Acid|mycophenolic acid|mesh-list
24648953|NCT01217671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648954|NCT01217671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648955|NCT01217671|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24648956|NCT01217671|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24648958|NCT01217697|Prednisolone|prednisolone|mesh-list
24648959|NCT01217697|Abiraterone Acetate|abiraterone acetate|mesh-list
24648960|NCT01217697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24648961|NCT01217697|Glucocorticoids|glucocorticoids|mesh-ancestor
24648962|NCT01217697|Hormones|hormones|mesh-ancestor
24648963|NCT01217697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24648964|NCT01217697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648965|NCT01217697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24648966|NCT01217697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648967|NCT01217697|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24648968|NCT01217697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648969|NCT01217697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648970|NCT01217697|Hormone Antagonists|hormone antagonists|mesh-ancestor
24648971|NCT01217697|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24648973|NCT01217723|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24648974|NCT01217723|Immunologic Factors|immunologic factors|mesh-ancestor
24648975|NCT01217723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648976|NCT01217723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24648977|NCT01217879|Telmisartan|telmisartan|mesh-list
24648978|NCT01217879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24648979|NCT01217879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25690025|NCT01968057|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25690026|NCT01968070|Celecoxib|celecoxib|mesh-list
25690027|NCT01968070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24509570|NCT00561067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24509575|NCT00561067|Hematinics|hematinics|mesh-ancestor
24648980|NCT01217879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24648990|NCT01217970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648991|NCT01217970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648992|NCT01217970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24648993|NCT01217970|Vasodilator Agents|vasodilator agents|mesh-ancestor
24648994|NCT01218022|Losartan|losartan|mesh-list
25012281|NCT00136903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25012282|NCT00136903|Protective Agents|protective agents|mesh-ancestor
25012283|NCT00136903|Antiviral Agents|antiviral agents|mesh-ancestor
24737636|NCT01670084|Leucovorin|leucovorin|mesh-list
25110365|NCT05463822|Botulinum Toxins|botulinum toxins|mesh-list
25110366|NCT05463822|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25110367|NCT05463822|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25110368|NCT05463822|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25110369|NCT05463822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25012285|NCT05218915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24573699|NCT00821574|Valsartan|valsartan|mesh-list
25012309|NCT05218616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012310|NCT05218616|Growth Inhibitors|growth inhibitors|mesh-ancestor
25012311|NCT05218616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25012312|NCT05218616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039933|NCT03588884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648995|NCT01218022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24648996|NCT01218022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24412631|NCT00191685|Analgesics|analgesics|mesh-ancestor
24649091|NCT01218620|Ketoconazole|ketoconazole|mesh-list
24649092|NCT01218620|Midazolam|midazolam|mesh-list
24649093|NCT01218620|Dextromethorphan|dextromethorphan|mesh-list
24649094|NCT01218620|Omeprazole|omeprazole|mesh-list
24649099|NCT01218620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649110|NCT01218620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24649111|NCT01218620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24649112|NCT01218620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24649162|NCT01218724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649164|NCT01218724|Natriuretic Agents|natriuretic agents|mesh-ancestor
24649165|NCT01218724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474381|NCT00405847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24474382|NCT00405847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24474383|NCT00405847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24474384|NCT00405847|Adrenergic Agents|adrenergic agents|mesh-ancestor
24649166|NCT01218724|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24649167|NCT01218724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24649168|NCT01218737|Gatifloxacin|gatifloxacin|mesh-list
24649169|NCT01218737|Prednisolone|prednisolone|mesh-list
24649322|NCT01219400|Vildagliptin|vildagliptin|mesh-list
25012314|NCT05218577|Selenium|selenium|mesh-list
25012315|NCT05218577|Antioxidants|antioxidants|mesh-ancestor
25012316|NCT05218577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012317|NCT05218577|Protective Agents|protective agents|mesh-ancestor
25012318|NCT05218577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012319|NCT05218577|Trace Elements|trace elements|mesh-ancestor
25012320|NCT05218577|Micronutrients|micronutrients|mesh-ancestor
25012323|NCT05218161|Dexmedetomidine|dexmedetomidine|mesh-list
25012324|NCT05218161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24649347|NCT01219569|Sevoflurane|sevoflurane|mesh-list
24649348|NCT01219569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24649349|NCT01219569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24649350|NCT01219569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649351|NCT01219569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24649352|NCT01219569|Anesthetics, General|anesthetics, general|mesh-ancestor
24649353|NCT01219569|Anesthetics|anesthetics|mesh-ancestor
24649354|NCT01219569|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24649355|NCT01219569|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24649357|NCT01219582|Acarbose|acarbose|mesh-list
24649358|NCT01219582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24649360|NCT01219582|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24649361|NCT01219582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24649362|NCT01219582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649396|NCT01219699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24649398|NCT01219712|Simendan|simendan|mesh-list
24649399|NCT01219712|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25690028|NCT01968070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25690029|NCT01968070|Analgesics|analgesics|mesh-ancestor
25690030|NCT01968070|Sensory System Agents|sensory system agents|mesh-ancestor
24509807|NCT00562185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509808|NCT00562198|Carbidopa|carbidopa|mesh-list
24509810|NCT00562198|Entacapone|entacapone|mesh-list
24649400|NCT01219712|Vasodilator Agents|vasodilator agents|mesh-ancestor
24649401|NCT01219712|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24649402|NCT01219712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24649403|NCT01219712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24649404|NCT01219712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649405|NCT01219712|Protective Agents|protective agents|mesh-ancestor
24649406|NCT01219712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649407|NCT01219751|Sunitinib|sunitinib|mesh-list
24649408|NCT01219751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450540|NCT00319514|Docetaxel|docetaxel|mesh-list
24649409|NCT01219751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24649410|NCT01219751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24649411|NCT01219751|Growth Substances|growth substances|mesh-ancestor
24649417|NCT01219764|Amoxicillin|amoxicillin|mesh-list
24649441|NCT01219907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24649442|NCT01219907|Alkylating Agents|alkylating agents|mesh-ancestor
24649522|NCT01220232|Antiviral Agents|antiviral agents|mesh-ancestor
24649523|NCT01220232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24805978|NCT02013115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649525|NCT01220232|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24649526|NCT01220232|Antimetabolites|antimetabolites|mesh-ancestor
24649611|NCT01220622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24649612|NCT01220622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649613|NCT01220622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24649614|NCT01220622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649615|NCT01220622|Vasodilator Agents|vasodilator agents|mesh-ancestor
24649616|NCT01220648|Interferons|interferons|mesh-list
24649618|NCT01220648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25012325|NCT05218161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25012326|NCT05218161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012327|NCT05218161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25012328|NCT05218161|Analgesics|analgesics|mesh-ancestor
25012329|NCT05218161|Sensory System Agents|sensory system agents|mesh-ancestor
25012330|NCT05218161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25012331|NCT05218161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25012332|NCT05218161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24649619|NCT01220648|Antiviral Agents|antiviral agents|mesh-ancestor
24649620|NCT01220648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24649621|NCT01220648|Immunologic Factors|immunologic factors|mesh-ancestor
24649622|NCT01220648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649623|NCT01220661|Cefotetan|cefotetan|mesh-list
24649624|NCT01220661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24649625|NCT01220661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24649626|NCT01220791|Progesterone|progesterone|mesh-list
24649627|NCT01220791|Progestins|progestins|mesh-ancestor
24649628|NCT01220791|Hormones|hormones|mesh-ancestor
24649629|NCT01220791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24649630|NCT01220791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649631|NCT01220843|Sevelamer|sevelamer|mesh-list
24649632|NCT01220843|Chelating Agents|chelating agents|mesh-ancestor
24649633|NCT01220843|Sequestering Agents|sequestering agents|mesh-ancestor
24649634|NCT01220843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649635|NCT01221025|Parecoxib|parecoxib|mesh-list
24649636|NCT01221025|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24649637|NCT01221025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24412977|NCT00192777|Capecitabine|capecitabine|mesh-list
24649662|NCT01221103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649663|NCT01221103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24649664|NCT01221103|Alkylating Agents|alkylating agents|mesh-ancestor
24649665|NCT01221103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649667|NCT01221116|Simendan|simendan|mesh-list
24649668|NCT01221116|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24649669|NCT01221116|Vasodilator Agents|vasodilator agents|mesh-ancestor
24649670|NCT01221116|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24649722|NCT01221740|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25690031|NCT01968070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25690032|NCT01968070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649741|NCT01221792|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24649743|NCT01221792|Protective Agents|protective agents|mesh-ancestor
24649744|NCT01221792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24649845|NCT01222052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24649878|NCT01222312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649879|NCT01222442|Moxifloxacin|moxifloxacin|mesh-list
24649880|NCT01222442|AZD-3199|azd-3199|mesh-list
24649881|NCT01222442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24649882|NCT01222442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24649883|NCT01222442|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24649884|NCT01222442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24649885|NCT01222442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24649889|NCT01222442|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24649891|NCT01222442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24740830|NCT01690364|Anesthetics|anesthetics|mesh-list
24649892|NCT01222442|Adrenergic Agents|adrenergic agents|mesh-ancestor
24649893|NCT01222442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24649894|NCT01222468|Nabilone|nabilone|mesh-list
24649895|NCT01222468|Antiemetics|antiemetics|mesh-ancestor
24649896|NCT01222468|Autonomic Agents|autonomic agents|mesh-ancestor
24649897|NCT01222468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24649898|NCT01222468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649899|NCT01222468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24649900|NCT01222468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24649901|NCT01222468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24649903|NCT01222468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24649971|NCT01222936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012333|NCT05218161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25012334|NCT05218161|Adrenergic Agents|adrenergic agents|mesh-ancestor
25012335|NCT05218161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24573738|NCT00821782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584463|NCT00880477|Edetic Acid|edetic acid|mesh-list
25012353|NCT05217355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012355|NCT05217355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25012356|NCT05217355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012357|NCT05217355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25012358|NCT05217355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25012360|NCT05217342|Natriuretic Agents|natriuretic agents|mesh-ancestor
25012361|NCT05217342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012362|NCT05217238|Remifentanil|remifentanil|mesh-list
25012363|NCT05217238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25012364|NCT05217238|Narcotics|narcotics|mesh-ancestor
25012365|NCT05217238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25012366|NCT05217238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012367|NCT05217238|Analgesics|analgesics|mesh-ancestor
25012368|NCT05217238|Sensory System Agents|sensory system agents|mesh-ancestor
25012369|NCT05217238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25012370|NCT05217160|Morphine|morphine|mesh-list
25105862|NCT04844905|Ivermectin|ivermectin|mesh-list
24649972|NCT01222975|Risperidone|risperidone|mesh-list
24649973|NCT01222975|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24649974|NCT01222975|Serotonin Agents|serotonin agents|mesh-ancestor
24649975|NCT01222975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24649976|NCT01222975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649977|NCT01222975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649978|NCT01222975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24649979|NCT01222975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24649980|NCT01222975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24649981|NCT01222975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24649982|NCT01222975|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24649983|NCT01222975|Dopamine Agents|dopamine agents|mesh-ancestor
24649984|NCT01223040|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24649985|NCT01223040|Lubricant Eye Drops|lubricant eye drops|mesh-list
24649986|NCT01223040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24649987|NCT01223053|Ketoprofen|ketoprofen|mesh-list
24649988|NCT01223053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24649989|NCT01223053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24649990|NCT01223053|Analgesics|analgesics|mesh-ancestor
24649991|NCT01223053|Sensory System Agents|sensory system agents|mesh-ancestor
24649992|NCT01223053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24649994|NCT01223053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24649995|NCT01223053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24649996|NCT01223053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24649997|NCT01223053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24649998|NCT01223053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650000|NCT01223079|Hormones|hormones|mesh-ancestor
24650006|NCT01223131|Insulin, Isophane|insulin, isophane|mesh-list
25105881|NCT04824274|Anesthetics|anesthetics|mesh-ancestor
25105885|NCT04771923|Epinephrine|epinephrine|mesh-list
25012371|NCT05217160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25012372|NCT05217160|Narcotics|narcotics|mesh-ancestor
25012373|NCT05217160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25012374|NCT05217160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012375|NCT05217160|Analgesics|analgesics|mesh-ancestor
25012376|NCT05217160|Sensory System Agents|sensory system agents|mesh-ancestor
25012377|NCT05217160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25012378|NCT05217069|Leucovorin|leucovorin|mesh-list
25012379|NCT05217069|Folic Acid|folic acid|mesh-list
25012380|NCT05217069|Irinotecan|irinotecan|mesh-list
25012381|NCT05217069|Cetuximab|cetuximab|mesh-list
25012382|NCT05217069|Avelumab|avelumab|mesh-list
25012383|NCT05217069|Levoleucovorin|levoleucovorin|mesh-list
25012384|NCT05217069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25012385|NCT05217069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25012386|NCT05217069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25012387|NCT05217069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012388|NCT05217069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650101|NCT01223820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24650102|NCT01223820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650103|NCT01224028|Tacrolimus|tacrolimus|mesh-list
24650104|NCT01224028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24650105|NCT01224028|Immunologic Factors|immunologic factors|mesh-ancestor
24650106|NCT01224028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650107|NCT01224028|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24650108|NCT01224028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24650166|NCT01224405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650168|NCT01224418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24650169|NCT01224418|Immunologic Factors|immunologic factors|mesh-ancestor
24650170|NCT01224418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650171|NCT01224418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24650172|NCT01224418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24650173|NCT01224418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650174|NCT01224457|Phenobarbital|phenobarbital|mesh-list
24650175|NCT01224457|Anticonvulsants|anticonvulsants|mesh-ancestor
24650244|NCT01224756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740941|NCT01690767|Lidocaine|lidocaine|mesh-list
24650245|NCT01224756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24650246|NCT01224756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24650247|NCT01224769|Rituximab|rituximab|mesh-list
24650248|NCT01224769|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24650249|NCT01224769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24650250|NCT01224769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650251|NCT01224769|Immunologic Factors|immunologic factors|mesh-ancestor
24650267|NCT01224847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24650269|NCT01224847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24650270|NCT01224847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012391|NCT05217069|Protective Agents|protective agents|mesh-ancestor
25012392|NCT05217069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012423|NCT05192460|Vaccines|vaccines|mesh-list
25012424|NCT05192460|Immunologic Factors|immunologic factors|mesh-ancestor
25012425|NCT05192460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012426|NCT05186779|Progestins|progestins|mesh-list
25012427|NCT05186779|Hormones|hormones|mesh-ancestor
25012428|NCT05186779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25110373|NCT05463822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110374|NCT05463822|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24573833|NCT00822263|Antiviral Agents|antiviral agents|mesh-ancestor
24650271|NCT01224847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24650272|NCT01224847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24650273|NCT01224847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24650274|NCT01224847|Dopamine Agents|dopamine agents|mesh-ancestor
24943804|NCT03966560|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25059874|NCT03484507|Plasma Substitutes|plasma substitutes|mesh-ancestor
25059875|NCT03484507|Blood Substitutes|blood substitutes|mesh-ancestor
25059877|NCT03484416|Calcium Carbonate|calcium carbonate|mesh-list
25059878|NCT03484416|Calcium|calcium|mesh-list
25059879|NCT03484416|Vitamins|vitamins|mesh-ancestor
25059880|NCT03484416|Micronutrients|micronutrients|mesh-ancestor
25059881|NCT03484416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650275|NCT01224847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24650277|NCT01224860|Telmisartan|telmisartan|mesh-list
24650278|NCT01224860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24650279|NCT01224860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24650280|NCT01224860|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24650281|NCT01224860|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24650282|NCT01224860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650484|NCT01225913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24650513|NCT01226069|Magnesium Sulfate|magnesium sulfate|mesh-list
25012466|NCT05146232|Anesthetics|anesthetics|mesh-list
25012467|NCT05146232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25012468|NCT05146232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012470|NCT05141305|Clopidogrel|clopidogrel|mesh-list
25012471|NCT05141305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25012472|NCT05141305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25012473|NCT05141305|Analgesics|analgesics|mesh-ancestor
25105918|NCT04754230|Hemostatics|hemostatics|mesh-ancestor
24650515|NCT01226069|Analgesics|analgesics|mesh-ancestor
24650516|NCT01226069|Sensory System Agents|sensory system agents|mesh-ancestor
24650517|NCT01226069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24650518|NCT01226069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650519|NCT01226069|Anesthetics|anesthetics|mesh-ancestor
24650520|NCT01226069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24650521|NCT01226069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24650522|NCT01226069|Anticonvulsants|anticonvulsants|mesh-ancestor
24650523|NCT01226069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24650524|NCT01226069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24650525|NCT01226069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650526|NCT01226069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24650527|NCT01226069|Tocolytic Agents|tocolytic agents|mesh-ancestor
24650528|NCT01226069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24650529|NCT01226069|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24650530|NCT01226069|Protective Agents|protective agents|mesh-ancestor
24650531|NCT01226186|Morphine|morphine|mesh-list
24650532|NCT01226186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24650533|NCT01226186|Narcotics|narcotics|mesh-ancestor
24650545|NCT01226212|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24650546|NCT01226303|Tretinoin|tretinoin|mesh-list
24650547|NCT01226303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650548|NCT01226303|Keratolytic Agents|keratolytic agents|mesh-ancestor
24650549|NCT01226303|Dermatologic Agents|dermatologic agents|mesh-ancestor
24650550|NCT01226355|Sirolimus|sirolimus|mesh-list
24650551|NCT01226355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24650552|NCT01226355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25012474|NCT05141305|Sensory System Agents|sensory system agents|mesh-ancestor
25012475|NCT05141305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25012476|NCT05141305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012477|NCT05141305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25012478|NCT05141305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25012479|NCT05141305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25012480|NCT05141305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25012481|NCT05141305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012482|NCT05141305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25012483|NCT05141305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25012484|NCT05141305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25012517|NCT05052970|Protease Inhibitors|protease inhibitors|mesh-ancestor
25012518|NCT05052970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404477|NCT03665038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25690033|NCT01968070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25690034|NCT01968070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25690035|NCT01968070|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25690036|NCT01968070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25690037|NCT01968070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25690038|NCT01968070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690039|NCT01968135|Contraceptive Agents|contraceptive agents|mesh-list
24510447|NCT00564603|BB 1101|bb 1101|mesh-list
24510448|NCT00564603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24510449|NCT00564603|Antiemetics|antiemetics|mesh-ancestor
24510450|NCT00564603|Autonomic Agents|autonomic agents|mesh-ancestor
24510451|NCT00564603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25012519|NCT05052970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413505|NCT00194064|Olanzapine|olanzapine|mesh-list
24650609|NCT01226849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24650617|NCT01226901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24650618|NCT01226901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24650619|NCT01226901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650620|NCT01226901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650621|NCT01226966|Liraglutide|liraglutide|mesh-list
24650622|NCT01226966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24650623|NCT01226966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650624|NCT01226966|Incretins|incretins|mesh-ancestor
24650625|NCT01226966|Hormones|hormones|mesh-ancestor
24650626|NCT01226966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24650627|NCT01226992|Vancomycin|vancomycin|mesh-list
24650628|NCT01226992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24650629|NCT01226992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24650630|NCT01227135|Hydroxychloroquine|hydroxychloroquine|mesh-list
24650631|NCT01227135|Imatinib Mesylate|imatinib mesylate|mesh-list
24650632|NCT01227135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650633|NCT01227135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24650634|NCT01227135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24650635|NCT01227135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650636|NCT01227135|Antimalarials|antimalarials|mesh-ancestor
24650637|NCT01227135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24650638|NCT01227135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24650639|NCT01227135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24650640|NCT01227135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24650642|NCT01227148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24650643|NCT01227148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650645|NCT01227174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24650646|NCT01227174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24650647|NCT01227174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650648|NCT01227174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24650661|NCT01227226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24650665|NCT01227356|Imatinib Mesylate|imatinib mesylate|mesh-list
24650666|NCT01227356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650667|NCT01227356|Antiviral Agents|antiviral agents|mesh-ancestor
24650668|NCT01227356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24650669|NCT01227356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25012520|NCT05052970|Analgesics|analgesics|mesh-ancestor
25012521|NCT05052970|Sensory System Agents|sensory system agents|mesh-ancestor
24573933|NCT00822614|Fentanyl|fentanyl|mesh-list
25012559|NCT04903210|Vasodilator Agents|vasodilator agents|mesh-ancestor
25012592|NCT04742023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110375|NCT05463822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25110376|NCT05463809|Oxycodone|oxycodone|mesh-list
25110377|NCT05463809|Analgesics|analgesics|mesh-list
25110378|NCT05463809|Ropivacaine|ropivacaine|mesh-list
25110379|NCT05463809|Anesthetics, Local|anesthetics, local|mesh-ancestor
25110380|NCT05463809|Anesthetics|anesthetics|mesh-ancestor
25110381|NCT05463809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25110382|NCT05463809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110383|NCT05463809|Sensory System Agents|sensory system agents|mesh-ancestor
25110384|NCT05463809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25110385|NCT05463809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25110386|NCT05463809|Narcotics|narcotics|mesh-ancestor
25110418|NCT05463601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25110420|NCT05463601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25110422|NCT05463601|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24969299|NCT03744091|Hormones|hormones|mesh-ancestor
25110423|NCT05463601|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24650670|NCT01227356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24650671|NCT01227356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650713|NCT01227590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25690040|NCT01968135|Contraceptives, Oral|contraceptives, oral|mesh-list
25690041|NCT01968135|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25690042|NCT01968135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25690043|NCT01968135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510641|NCT00565227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510642|NCT00565227|Tubulin Modulators|tubulin modulators|mesh-ancestor
25110426|NCT05463588|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25110427|NCT05463588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012610|NCT04724252|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25012612|NCT04724252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650741|NCT01227759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24650742|NCT01227759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24650743|NCT01227759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24650745|NCT01227798|Interferon alfacon-1|interferon alfacon-1|mesh-list
24650746|NCT01227798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650747|NCT01227798|Antiviral Agents|antiviral agents|mesh-ancestor
24806037|NCT02013427|Omeprazole|omeprazole|mesh-list
24650748|NCT01227798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24650749|NCT01227811|Darifenacin|darifenacin|mesh-list
24650750|NCT01227811|Muscarinic Antagonists|muscarinic antagonists|mesh-list
24650751|NCT01227811|Cholinergic Agents|cholinergic agents|mesh-list
24650752|NCT01227811|Cholinergic Antagonists|cholinergic antagonists|mesh-list
24650753|NCT01227811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24650754|NCT01227811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650755|NCT01227811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650756|NCT01227811|Urological Agents|urological agents|mesh-ancestor
24650757|NCT01227863|Dexamethasone, neomycin, polymyxin B drug combination|dexamethasone, neomycin, polymyxin b drug combination|mesh-list
24650758|NCT01227863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24650759|NCT01227863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24650906|NCT01228357|Adrenergic Agents|adrenergic agents|mesh-ancestor
24650907|NCT01228357|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24650908|NCT01228357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24650909|NCT01228357|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24651029|NCT01228994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24651030|NCT01228994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651031|NCT01229046|Clavulanic Acids|clavulanic acids|mesh-list
24651032|NCT01229046|Clavulanic Acid|clavulanic acid|mesh-list
24651033|NCT01229046|Ticarcillin|ticarcillin|mesh-list
24651034|NCT01229046|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
24651035|NCT01229046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24651036|NCT01229046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24651037|NCT01229046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651038|NCT01229046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651068|NCT01229202|Bevacizumab|bevacizumab|mesh-list
24651073|NCT01229202|Growth Substances|growth substances|mesh-ancestor
24651131|NCT01229761|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25690044|NCT01968135|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25690045|NCT01968317|Metformin|metformin|mesh-list
25690046|NCT01968317|Megestrol|megestrol|mesh-list
25690047|NCT01968317|Megestrol Acetate|megestrol acetate|mesh-list
25690048|NCT01968317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25690049|NCT01968317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690050|NCT01968317|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25690051|NCT01968317|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24651132|NCT01229761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24651133|NCT01229761|Renal Agents|renal agents|mesh-ancestor
24651134|NCT01229761|Antimalarials|antimalarials|mesh-ancestor
24651135|NCT01229761|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25012615|NCT04719208|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25012616|NCT04719208|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25012617|NCT04719208|Povidone-Iodine|povidone-iodine|mesh-list
25012618|NCT04719208|Listerine|listerine|mesh-list
25012619|NCT04719208|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25012620|NCT04719208|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25012621|NCT04719208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25012622|NCT04719208|Disinfectants|disinfectants|mesh-ancestor
25012623|NCT04719208|Dermatologic Agents|dermatologic agents|mesh-ancestor
24651464|NCT01231685|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24651465|NCT01231685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24651467|NCT01231685|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24806038|NCT02013427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24806041|NCT02013427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474615|NCT00406913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474631|NCT00406978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24530477|NCT00630513|Sulbactam|sulbactam|mesh-list
24651469|NCT01231698|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24651470|NCT01231698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24651471|NCT01231698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24651487|NCT01231802|Eniluracil|eniluracil|mesh-list
24651563|NCT01232075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651564|NCT01232075|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24651565|NCT01232075|Hormone Antagonists|hormone antagonists|mesh-ancestor
24651566|NCT01232075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24651567|NCT01232075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651568|NCT01232075|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24651569|NCT01232075|Fertility Agents|fertility agents|mesh-ancestor
24651662|NCT01232803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651663|NCT01232803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651664|NCT01232803|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24651665|NCT01232803|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24651666|NCT01233167|Clopidogrel|clopidogrel|mesh-list
24651667|NCT01233167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24651668|NCT01233167|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24651669|NCT01233167|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24670086|NCT03300947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24651671|NCT01233167|Purinergic Agents|purinergic agents|mesh-ancestor
24651672|NCT01233167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24651673|NCT01233167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651675|NCT01233206|Metformin|metformin|mesh-list
24651698|NCT01233453|Umirolimus|umirolimus|mesh-list
24651731|NCT01233583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24651732|NCT01233583|Dermatologic Agents|dermatologic agents|mesh-ancestor
24651733|NCT01233583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24651737|NCT01233583|Sensory System Agents|sensory system agents|mesh-ancestor
24651738|NCT01233583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24651739|NCT01233583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012627|NCT04706715|Cemiplimab|cemiplimab|mesh-list
25012628|NCT04706715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25012629|NCT04706715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25012630|NCT04701190|Norepinephrine|norepinephrine|mesh-list
25012631|NCT04701190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012632|NCT04701190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25012633|NCT04701190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25012634|NCT04701190|Adrenergic Agents|adrenergic agents|mesh-ancestor
25012635|NCT04701190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25012636|NCT04701190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651742|NCT01233583|Keratolytic Agents|keratolytic agents|mesh-ancestor
24651744|NCT01233622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24651745|NCT01233622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651746|NCT01233622|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24651747|NCT01233622|Protease Inhibitors|protease inhibitors|mesh-ancestor
24651748|NCT01233622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651749|NCT01233622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060122|NCT03482362|Mitosis Modulators|mitosis modulators|mesh-ancestor
24822509|NCT02112292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24822510|NCT02112292|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24510965|NCT00566761|Growth Inhibitors|growth inhibitors|mesh-ancestor
24510966|NCT00566761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24510967|NCT00566761|Glucocorticoids|glucocorticoids|mesh-ancestor
24510969|NCT00566761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24511022|NCT00567034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511023|NCT00567034|Sensory System Agents|sensory system agents|mesh-ancestor
24885480|NCT05172115|Heparin|heparin|mesh-list
25060124|NCT03482232|Acetaminophen|acetaminophen|mesh-list
24651750|NCT01233635|Losartan|losartan|mesh-list
24651756|NCT01233752|Morphine|morphine|mesh-list
24651794|NCT01233843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651796|NCT01233895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474649|NCT00406978|Growth Substances|growth substances|mesh-ancestor
24474650|NCT00406978|Growth Inhibitors|growth inhibitors|mesh-ancestor
24651797|NCT01233934|Chlorpheniramine|chlorpheniramine|mesh-list
24651798|NCT01233934|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
24651799|NCT01233934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24651800|NCT01233934|Histamine Antagonists|histamine antagonists|mesh-ancestor
24651801|NCT01233934|Histamine Agents|histamine agents|mesh-ancestor
24651802|NCT01233934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24651803|NCT01233934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414192|NCT00196586|Analgesics|analgesics|mesh-ancestor
24652054|NCT01235455|Interferons|interferons|mesh-list
24652089|NCT01235819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24652091|NCT01236040|Immunologic Factors|immunologic factors|mesh-ancestor
24652092|NCT01236040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652093|NCT01236144|Plerixafor|plerixafor|mesh-list
24652094|NCT01236144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24652095|NCT01236144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24652096|NCT01236144|Antiviral Agents|antiviral agents|mesh-ancestor
24652097|NCT01236144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24652098|NCT01236482|Oxytocin|oxytocin|mesh-list
24652099|NCT01236482|Ergonovine|ergonovine|mesh-list
24652100|NCT01236482|Oxytocics|oxytocics|mesh-ancestor
24652101|NCT01236482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24652200|NCT01237028|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24652201|NCT01237028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24652202|NCT01237028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652274|NCT01237275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24652276|NCT01237444|Ritonavir|ritonavir|mesh-list
24652277|NCT01237444|Lopinavir|lopinavir|mesh-list
24652278|NCT01237444|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24652354|NCT01237977|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24652355|NCT01237977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24652356|NCT01237977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652358|NCT01237977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25012637|NCT04701190|Sympathomimetics|sympathomimetics|mesh-ancestor
25012638|NCT04701190|Autonomic Agents|autonomic agents|mesh-ancestor
25012639|NCT04701190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25012640|NCT04701190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25012662|NCT04666454|Protease Inhibitors|protease inhibitors|mesh-ancestor
25012663|NCT04666454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25110432|NCT05463588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25012664|NCT04666454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012665|NCT04666454|Anticoagulants|anticoagulants|mesh-ancestor
25012667|NCT04666454|Sensory System Agents|sensory system agents|mesh-ancestor
25012668|NCT04666454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24652365|NCT01238029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24652366|NCT01238029|Antimetabolites|antimetabolites|mesh-ancestor
24652367|NCT01238029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690052|NCT01968317|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25690053|NCT01968317|Contraceptive Agents|contraceptive agents|mesh-ancestor
25690054|NCT01968317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25690055|NCT01968317|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25690056|NCT01968317|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25690057|NCT01968317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25690058|NCT01968317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25690059|NCT01968317|Appetite Stimulants|appetite stimulants|mesh-ancestor
25690060|NCT01968317|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25690061|NCT01968356|Ethanol|ethanol|mesh-list
25690062|NCT01968356|Chlorhexidine|chlorhexidine|mesh-list
24885709|NCT04671030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885728|NCT04660890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25060183|NCT03481998|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25060184|NCT03481998|Hormone Antagonists|hormone antagonists|mesh-ancestor
24652476|NCT01238627|Autonomic Agents|autonomic agents|mesh-ancestor
24652477|NCT01238627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24652478|NCT01238627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652479|NCT01238627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24652480|NCT01238627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24652481|NCT01238627|Cholinergic Agents|cholinergic agents|mesh-ancestor
24652482|NCT01238627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24652483|NCT01238627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652484|NCT01238692|Rituximab|rituximab|mesh-list
24652485|NCT01238692|Panobinostat|panobinostat|mesh-list
24652486|NCT01238692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24652487|NCT01238692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652488|NCT01238692|Immunologic Factors|immunologic factors|mesh-ancestor
24652510|NCT01238705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24652511|NCT01238705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24652512|NCT01238705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24652513|NCT01238705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24652514|NCT01238705|Vasodilator Agents|vasodilator agents|mesh-ancestor
24652515|NCT01238718|Lidocaine|lidocaine|mesh-list
24652516|NCT01238718|Anesthetics, Local|anesthetics, local|mesh-ancestor
24652517|NCT01238718|Anesthetics|anesthetics|mesh-ancestor
24652518|NCT01238718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24652519|NCT01238718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652520|NCT01238718|Sensory System Agents|sensory system agents|mesh-ancestor
24652521|NCT01238718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24652522|NCT01238718|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24652523|NCT01238718|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24652537|NCT01238796|Telavancin|telavancin|mesh-list
24652556|NCT01238965|Panobinostat|panobinostat|mesh-list
24652557|NCT01238965|Calcium|calcium|mesh-list
24652558|NCT01238965|Levoleucovorin|levoleucovorin|mesh-list
24652594|NCT01239030|Methylphenidate|methylphenidate|mesh-list
24652595|NCT01239030|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24652596|NCT01239030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652597|NCT01239030|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24652598|NCT01239030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24652599|NCT01239030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25012671|NCT04666454|Vasodilator Agents|vasodilator agents|mesh-ancestor
25012672|NCT04666454|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25012673|NCT04666454|Purinergic Agonists|purinergic agonists|mesh-ancestor
25012674|NCT04666454|Purinergic Agents|purinergic agents|mesh-ancestor
25012675|NCT04666454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25012676|NCT04666454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25012677|NCT04666454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25012684|NCT04600921|Ertugliflozin|ertugliflozin|mesh-list
25012715|NCT04546126|Glucocorticoids|glucocorticoids|mesh-ancestor
25012716|NCT04546126|Hormones|hormones|mesh-ancestor
25012717|NCT04546126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25012718|NCT04546126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25012719|NCT04546126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25012720|NCT04538352|Insulin|insulin|mesh-list
25012721|NCT04538352|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25012722|NCT04538352|Insulin Aspart|insulin aspart|mesh-list
25012723|NCT04538352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25012724|NCT04538352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012725|NCT04531176|Liraglutide|liraglutide|mesh-list
25012726|NCT04531176|Topiramate|topiramate|mesh-list
25012728|NCT04531176|Phentermine|phentermine|mesh-list
25012729|NCT04531176|Naltrexone|naltrexone|mesh-list
25012730|NCT04531176|Bupropion|bupropion|mesh-list
25690063|NCT01968356|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25690064|NCT01968356|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25690065|NCT01968356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25690066|NCT01968356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25690067|NCT01968356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690068|NCT01968356|Disinfectants|disinfectants|mesh-ancestor
25012758|NCT04531176|Autonomic Agents|autonomic agents|mesh-ancestor
25012759|NCT04531176|Adrenergic Agents|adrenergic agents|mesh-ancestor
25012761|NCT04496362|Anticoagulants|anticoagulants|mesh-ancestor
25690069|NCT01968356|Dermatologic Agents|dermatologic agents|mesh-ancestor
25690070|NCT01968421|Broncho-Vaxom|broncho-vaxom|mesh-list
25012762|NCT04496362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25012763|NCT04496362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25012764|NCT04496362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012765|NCT04465266|Tolperisone|tolperisone|mesh-list
24652600|NCT01239030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652601|NCT01239030|Dopamine Agents|dopamine agents|mesh-ancestor
24652602|NCT01239030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25012766|NCT04465266|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25012767|NCT04465266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012768|NCT04465266|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25012769|NCT04465266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25012770|NCT04437108|Solifenacin Succinate|solifenacin succinate|mesh-list
25012771|NCT04437108|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25012772|NCT04437108|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25012773|NCT04437108|Cholinergic Agents|cholinergic agents|mesh-ancestor
25012774|NCT04437108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25012775|NCT04437108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012797|NCT04423588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012798|NCT04407377|Cyclobenzaprine|cyclobenzaprine|mesh-list
25012799|NCT04407377|Tolperisone|tolperisone|mesh-list
25012800|NCT04407377|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25012801|NCT04407377|Antidepressive Agents|antidepressive agents|mesh-ancestor
25012802|NCT04407377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25012803|NCT04407377|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25012804|NCT04407377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012805|NCT04407377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25012806|NCT04407377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25012807|NCT04407377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25012808|NCT04407377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25012809|NCT04318015|Hydroxychloroquine|hydroxychloroquine|mesh-list
25012811|NCT04318015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25012812|NCT04318015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25012813|NCT04318015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25012814|NCT04318015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25012816|NCT04318015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25012817|NCT04315896|Hydroxychloroquine|hydroxychloroquine|mesh-list
25012818|NCT04315896|Antimalarials|antimalarials|mesh-ancestor
25012819|NCT04315896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25012820|NCT04315896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24652603|NCT01239173|Propranolol|propranolol|mesh-list
24652604|NCT01239173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24652684|NCT01239719|BB 1101|bb 1101|mesh-list
24652685|NCT01239719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24652686|NCT01239719|Antiemetics|antiemetics|mesh-ancestor
24652687|NCT01239719|Autonomic Agents|autonomic agents|mesh-ancestor
25012821|NCT04315896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25012822|NCT04315896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25012831|NCT04307797|Incretins|incretins|mesh-ancestor
25012832|NCT04307797|Hormones|hormones|mesh-ancestor
25012833|NCT04307797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25012834|NCT04307797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25012835|NCT04297150|Rivaroxaban|rivaroxaban|mesh-list
25012836|NCT04297150|Apixaban|apixaban|mesh-list
25012837|NCT04297150|Edoxaban|edoxaban|mesh-list
25012838|NCT04297150|Dabigatran|dabigatran|mesh-list
25012839|NCT04297150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25012840|NCT04297150|Antithrombins|antithrombins|mesh-ancestor
25012841|NCT04297150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25012842|NCT04297150|Protease Inhibitors|protease inhibitors|mesh-ancestor
24652688|NCT01239719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24652689|NCT01239719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652690|NCT01239719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24652691|NCT01239719|Glucocorticoids|glucocorticoids|mesh-ancestor
24652692|NCT01239719|Hormones|hormones|mesh-ancestor
24652693|NCT01239719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24652694|NCT01239719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24652695|NCT01239719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652696|NCT01239719|Protease Inhibitors|protease inhibitors|mesh-ancestor
24652745|NCT01239940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652747|NCT01239940|Immunologic Factors|immunologic factors|mesh-ancestor
24652748|NCT01239940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652749|NCT01239953|Paclitaxel|paclitaxel|mesh-list
24652750|NCT01239953|Everolimus|everolimus|mesh-list
24652751|NCT01239953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24652752|NCT01239953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652753|NCT01239953|Tubulin Modulators|tubulin modulators|mesh-ancestor
24652754|NCT01239953|Antimitotic Agents|antimitotic agents|mesh-ancestor
24652755|NCT01239953|Mitosis Modulators|mitosis modulators|mesh-ancestor
24652756|NCT01239953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652757|NCT01239953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24652758|NCT01239953|Immunologic Factors|immunologic factors|mesh-ancestor
24652805|NCT01240213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652806|NCT01240213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24652807|NCT01240226|Ketoconazole|ketoconazole|mesh-list
24652808|NCT01240226|Antifungal Agents|antifungal agents|mesh-ancestor
24652809|NCT01240226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24652810|NCT01240226|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24652819|NCT01240252|Insulin|insulin|mesh-list
24652847|NCT01240629|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24652848|NCT01240629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24652849|NCT01240629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652850|NCT01240629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24652851|NCT01240629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24652852|NCT01240629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652853|NCT01240629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652854|NCT01240642|Vadimezan|vadimezan|mesh-list
24652855|NCT01240642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652856|NCT01240655|Paclitaxel|paclitaxel|mesh-list
24652857|NCT01240655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24652859|NCT01240655|Tubulin Modulators|tubulin modulators|mesh-ancestor
24652860|NCT01240655|Antimitotic Agents|antimitotic agents|mesh-ancestor
24652861|NCT01240655|Mitosis Modulators|mitosis modulators|mesh-ancestor
24652862|NCT01240655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652863|NCT01240824|Aminophylline|aminophylline|mesh-list
25012844|NCT04297150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012846|NCT04249323|Prednisone|prednisone|mesh-list
25012847|NCT04249323|Cortisone|cortisone|mesh-list
25012851|NCT04249323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25012852|NCT04249323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012853|NCT04249323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25012854|NCT04249323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25012855|NCT04227821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25012856|NCT04227327|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25012857|NCT04227327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24787088|NCT01923623|Sensory System Agents|sensory system agents|mesh-ancestor
25109098|NCT03127189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24787090|NCT01923649|Lanreotide|lanreotide|mesh-list
25012858|NCT04227327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25012859|NCT04227327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012860|NCT04227327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24652864|NCT01240824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24652865|NCT01240824|Autonomic Agents|autonomic agents|mesh-ancestor
24652866|NCT01240824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24652867|NCT01240824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652870|NCT01240824|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24652943|NCT01241006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24652945|NCT01241006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24652946|NCT01241006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24652947|NCT01241006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652948|NCT01241019|Topiramate|topiramate|mesh-list
24652949|NCT01241019|Anticonvulsants|anticonvulsants|mesh-ancestor
24652950|NCT01241019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24652951|NCT01241019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652981|NCT01241110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652982|NCT01241110|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24652983|NCT01241110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24652993|NCT01241175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24652994|NCT01241175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652996|NCT01241175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24652997|NCT01241175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24652998|NCT01241175|Anticonvulsants|anticonvulsants|mesh-ancestor
24652999|NCT01241175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24653021|NCT01241422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653022|NCT01241422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24653023|NCT01241422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24885970|NCT03857542|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24885971|NCT03857542|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24885972|NCT03857542|Cholinergic Agents|cholinergic agents|mesh-ancestor
24885973|NCT03857542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24885981|NCT03835013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885982|NCT03835013|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24885983|NCT03835013|Incretins|incretins|mesh-ancestor
24885984|NCT03835013|Hormones|hormones|mesh-ancestor
24885985|NCT03835013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24885986|NCT03835013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24885987|NCT03810807|Osimertinib|osimertinib|mesh-list
24885988|NCT03810807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885989|NCT03810807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24885990|NCT03810807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885991|NCT03810807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653030|NCT01241487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653031|NCT01241487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24653032|NCT01241487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653033|NCT01241487|Vasodilator Agents|vasodilator agents|mesh-ancestor
25012862|NCT04227327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25012863|NCT04227327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012864|NCT04218357|Probenecid|probenecid|mesh-list
25012865|NCT04218357|Uricosuric Agents|uricosuric agents|mesh-ancestor
25012866|NCT04218357|Gout Suppressants|gout suppressants|mesh-ancestor
25012867|NCT04218357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25012868|NCT04218357|Renal Agents|renal agents|mesh-ancestor
25110433|NCT05463588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110434|NCT05463588|Adrenergic Agents|adrenergic agents|mesh-ancestor
25110435|NCT05463588|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25110436|NCT05463588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25110437|NCT05463588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25110438|NCT05463588|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25110439|NCT05463393|Xanthohumol|xanthohumol|mesh-list
24979113|NCT05181852|Pregabalin|pregabalin|mesh-list
24653034|NCT01241487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24653035|NCT01241487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24653037|NCT01241500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653038|NCT01241500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24653039|NCT01241500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653040|NCT01241500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653041|NCT01241682|Cyclophosphamide|cyclophosphamide|mesh-list
24653118|NCT01242098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653119|NCT01242098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24653120|NCT01242098|Respiratory System Agents|respiratory system agents|mesh-ancestor
24653121|NCT01242098|Dermatologic Agents|dermatologic agents|mesh-ancestor
24653122|NCT01242098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24653123|NCT01242098|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24653124|NCT01242098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24653125|NCT01242098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24653126|NCT01242098|Adrenergic Agents|adrenergic agents|mesh-ancestor
24653127|NCT01242098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24653128|NCT01242098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653129|NCT01242098|Glucocorticoids|glucocorticoids|mesh-ancestor
24653130|NCT01242098|Hormones|hormones|mesh-ancestor
25404550|NCT03661411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25690071|NCT01968421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25690072|NCT01968421|Immunologic Factors|immunologic factors|mesh-ancestor
25690073|NCT01968421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690074|NCT01968434|Carbocysteine|carbocysteine|mesh-list
25690075|NCT01968434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25690076|NCT01968434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25690077|NCT01968434|Expectorants|expectorants|mesh-ancestor
25690078|NCT01968434|Respiratory System Agents|respiratory system agents|mesh-ancestor
25690079|NCT01968551|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25690080|NCT01968551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25690081|NCT01968551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25690082|NCT01968551|Antiviral Agents|antiviral agents|mesh-ancestor
25690083|NCT01968551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25690084|NCT01968694|Diphenhydramine|diphenhydramine|mesh-list
24653131|NCT01242098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24653177|NCT01242267|Immunologic Factors|immunologic factors|mesh-ancestor
24653178|NCT01242267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653179|NCT01242267|Leprostatic Agents|leprostatic agents|mesh-ancestor
24653180|NCT01242267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24653363|NCT01243658|Oxytocin|oxytocin|mesh-list
24653365|NCT01243658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24653366|NCT01243658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653367|NCT01243697|Desogestrel|desogestrel|mesh-list
24653368|NCT01243697|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25110440|NCT05463393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25110441|NCT05463393|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25110442|NCT05463393|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25110443|NCT05463393|Growth Substances|growth substances|mesh-ancestor
25110444|NCT05463393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110445|NCT05463393|Growth Inhibitors|growth inhibitors|mesh-ancestor
25110446|NCT05463367|Acetaminophen|acetaminophen|mesh-list
25110447|NCT05463367|Naproxen|naproxen|mesh-list
25110448|NCT05463367|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25110449|NCT05463367|Oxymorphone|oxymorphone|mesh-list
25110450|NCT05463367|Morphine|morphine|mesh-list
25110451|NCT05463367|Oxycodone|oxycodone|mesh-list
25110452|NCT05463367|Tramadol|tramadol|mesh-list
25110453|NCT05463367|Hydrocodone|hydrocodone|mesh-list
25110454|NCT05463367|Codeine|codeine|mesh-list
24574352|NCT00825058|Antidepressive Agents|antidepressive agents|mesh-ancestor
24969671|NCT03741244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969672|NCT03741244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653402|NCT01243736|Dermatologic Agents|dermatologic agents|mesh-ancestor
24653443|NCT01243827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24653444|NCT01243827|Antioxidants|antioxidants|mesh-ancestor
24653445|NCT01243827|Protective Agents|protective agents|mesh-ancestor
24653446|NCT01243827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24653447|NCT01243827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24653448|NCT01243827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24905949|NCT04343768|Ritonavir|ritonavir|mesh-list
24653449|NCT01243827|Vasodilator Agents|vasodilator agents|mesh-ancestor
24653450|NCT01243827|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24653451|NCT01243827|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24653452|NCT01243827|Sympatholytics|sympatholytics|mesh-ancestor
24653453|NCT01243827|Autonomic Agents|autonomic agents|mesh-ancestor
24653495|NCT01244100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24653496|NCT01244100|Analgesics|analgesics|mesh-ancestor
24653501|NCT01244100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24653581|NCT01244334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24653582|NCT01244334|Prednisolone phosphate|prednisolone phosphate|mesh-list
24653583|NCT01244334|Difluprednate|difluprednate|mesh-list
24653584|NCT01244334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24653585|NCT01244334|Glucocorticoids|glucocorticoids|mesh-ancestor
24653586|NCT01244334|Hormones|hormones|mesh-ancestor
24653587|NCT01244334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24653588|NCT01244334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653589|NCT01244334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24653591|NCT01244334|Antiemetics|antiemetics|mesh-ancestor
24653682|NCT01245166|Metformin|metformin|mesh-list
24653683|NCT01245166|Acarbose|acarbose|mesh-list
24653684|NCT01245166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24739106|NCT01679106|Fentanyl|fentanyl|mesh-list
24653685|NCT01245166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653686|NCT01245166|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24653687|NCT01245166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653688|NCT01245166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653689|NCT01245179|Panobinostat|panobinostat|mesh-list
25690085|NCT01968694|Promethazine|promethazine|mesh-list
25690086|NCT01968694|Lidocaine|lidocaine|mesh-list
25690087|NCT01968694|Anesthetics, Local|anesthetics, local|mesh-ancestor
25690088|NCT01968694|Anesthetics|anesthetics|mesh-ancestor
25690089|NCT01968694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25690090|NCT01968694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690091|NCT01968694|Sensory System Agents|sensory system agents|mesh-ancestor
24417006|NCT00204659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417007|NCT00204659|Immunologic Factors|immunologic factors|mesh-ancestor
24417009|NCT00204659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24511398|NCT00568529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24511399|NCT00568529|Antimetabolites|antimetabolites|mesh-ancestor
24653690|NCT01245179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24969673|NCT03741244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24969674|NCT03741244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24969675|NCT03741075|Tranexamic Acid|tranexamic acid|mesh-list
24969676|NCT03741075|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24969677|NCT03741075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24969678|NCT03741075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969679|NCT03741075|Hemostatics|hemostatics|mesh-ancestor
24969680|NCT03741075|Coagulants|coagulants|mesh-ancestor
24969681|NCT03740945|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24969682|NCT03740945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24969683|NCT03740945|Immunologic Factors|immunologic factors|mesh-ancestor
24969684|NCT03740945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586213|NCT00889629|Micronutrients|micronutrients|mesh-ancestor
24586214|NCT00889629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586215|NCT00889629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24586216|NCT00889629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24586217|NCT00889642|Lidocaine|lidocaine|mesh-list
24586218|NCT00889642|Epinephrine|epinephrine|mesh-list
24586219|NCT00889642|Racepinephrine|racepinephrine|mesh-list
24586220|NCT00889642|Epinephryl borate|epinephryl borate|mesh-list
24586221|NCT00889642|Anesthetics, Local|anesthetics, local|mesh-ancestor
24586222|NCT00889642|Anesthetics|anesthetics|mesh-ancestor
24586223|NCT00889642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24586224|NCT00889642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586225|NCT00889642|Sensory System Agents|sensory system agents|mesh-ancestor
24906312|NCT04341727|Analgesics|analgesics|mesh-ancestor
24653691|NCT01245179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24653763|NCT01245582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653764|NCT01245582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653765|NCT01245582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24653766|NCT01245582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653767|NCT01245660|Lapatinib|lapatinib|mesh-list
24653768|NCT01245660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653769|NCT01245660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24653770|NCT01245660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653771|NCT01245660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653772|NCT01245725|Tirofiban|tirofiban|mesh-list
24653773|NCT01245725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24653774|NCT01245725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24653775|NCT01245725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653776|NCT01245725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24653777|NCT01245803|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24653778|NCT01245803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24653780|NCT01245803|Antimetabolites|antimetabolites|mesh-ancestor
24653781|NCT01245803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653782|NCT01245803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24653786|NCT01245816|Sulindac|sulindac|mesh-list
24653805|NCT01245855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24586226|NCT00889642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24586227|NCT00889642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24586228|NCT00889642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24586229|NCT00889642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24586230|NCT00889642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25012869|NCT04190056|Tamoxifen|tamoxifen|mesh-list
25012870|NCT04190056|Pembrolizumab|pembrolizumab|mesh-list
25012871|NCT04190056|Vorinostat|vorinostat|mesh-list
24739120|NCT01679327|Bevacizumab|bevacizumab|mesh-list
25012872|NCT04190056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25012873|NCT04190056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25012874|NCT04190056|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25012875|NCT04190056|Hormone Antagonists|hormone antagonists|mesh-ancestor
25012876|NCT04190056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25012877|NCT04190056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690092|NCT01968694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25690093|NCT01968694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25690094|NCT01968694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25690095|NCT01968694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25012878|NCT04190056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25012879|NCT04190056|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25012880|NCT04190056|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25012899|NCT04136366|Abortifacient Agents|abortifacient agents|mesh-ancestor
24906313|NCT04341727|Sensory System Agents|sensory system agents|mesh-ancestor
25012900|NCT04136366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24653806|NCT01245855|Vasodilator Agents|vasodilator agents|mesh-ancestor
24653807|NCT01245855|Urological Agents|urological agents|mesh-ancestor
24653809|NCT01245868|Bupivacaine|bupivacaine|mesh-list
24653810|NCT01245868|Anesthetics, Local|anesthetics, local|mesh-ancestor
24653811|NCT01245868|Anesthetics|anesthetics|mesh-ancestor
24653871|NCT01246037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24653872|NCT01246037|Sympatholytics|sympatholytics|mesh-ancestor
24653873|NCT01246037|Autonomic Agents|autonomic agents|mesh-ancestor
24653874|NCT01246037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24653875|NCT01246037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653876|NCT01246037|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24653877|NCT01246037|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24653878|NCT01246037|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24653879|NCT01246037|Adrenergic Agents|adrenergic agents|mesh-ancestor
24653880|NCT01246037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24653881|NCT01246037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653882|NCT01246089|Ranibizumab|ranibizumab|mesh-list
24653883|NCT01246089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24653884|NCT01246089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24653885|NCT01246089|Growth Substances|growth substances|mesh-ancestor
24653886|NCT01246089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653887|NCT01246089|Growth Inhibitors|growth inhibitors|mesh-ancestor
24653888|NCT01246089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653889|NCT01246180|Diclofenac|diclofenac|mesh-list
24653890|NCT01246180|Amiloride|amiloride|mesh-list
24653915|NCT01246232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24653916|NCT01246232|Dopamine Agents|dopamine agents|mesh-ancestor
24653941|NCT01246323|Analgesics|analgesics|mesh-ancestor
24653961|NCT01246440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24653962|NCT01246453|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25012902|NCT04136366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25012903|NCT04136366|Antimetabolites|antimetabolites|mesh-ancestor
25012904|NCT04136366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012905|NCT04136366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25012906|NCT04136366|Dermatologic Agents|dermatologic agents|mesh-ancestor
25012907|NCT04136366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25012908|NCT04136366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25012909|NCT04136366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25012910|NCT04136366|Immunologic Factors|immunologic factors|mesh-ancestor
25012911|NCT04136366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25012912|NCT04136366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25012914|NCT04112641|Niacin|niacin|mesh-list
25012915|NCT04112641|Nicotinic Acids|nicotinic acids|mesh-list
25012916|NCT04112641|Vitamin B Complex|vitamin b complex|mesh-ancestor
25012917|NCT04112641|Vitamins|vitamins|mesh-ancestor
25012918|NCT04112641|Micronutrients|micronutrients|mesh-ancestor
25012919|NCT04112641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012920|NCT04112641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25012921|NCT04112641|Antimetabolites|antimetabolites|mesh-ancestor
25012922|NCT04112641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012923|NCT04112641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25012924|NCT04112641|Vasodilator Agents|vasodilator agents|mesh-ancestor
25012925|NCT04108962|Benralizumab|benralizumab|mesh-list
25012926|NCT04108962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25012927|NCT04108962|Respiratory System Agents|respiratory system agents|mesh-ancestor
25012928|NCT04090684|Ciprofloxacin|ciprofloxacin|mesh-list
25012929|NCT04090684|Celecoxib|celecoxib|mesh-list
25012930|NCT04090684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24653963|NCT01246453|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24906374|NCT04341038|Antiemetics|antiemetics|mesh-ancestor
24653964|NCT01246453|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24653966|NCT01246557|Dexamethasone|dexamethasone|mesh-list
24654016|NCT01246804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654021|NCT01246817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24654022|NCT01246817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25012931|NCT04090684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25012932|NCT04090684|Analgesics|analgesics|mesh-ancestor
25012933|NCT04090684|Sensory System Agents|sensory system agents|mesh-ancestor
25012934|NCT04090684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25012935|NCT04090684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012936|NCT04090684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25012958|NCT04045301|Immunologic Factors|immunologic factors|mesh-ancestor
25012959|NCT04045301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012960|NCT04033107|Ascorbic Acid|ascorbic acid|mesh-list
25012961|NCT04033107|Metformin|metformin|mesh-list
25012962|NCT04033107|Vitamins|vitamins|mesh-ancestor
25012963|NCT04033107|Micronutrients|micronutrients|mesh-ancestor
25012964|NCT04033107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012965|NCT04033107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24969685|NCT03740893|Durvalumab|durvalumab|mesh-list
25012966|NCT04033107|Antioxidants|antioxidants|mesh-ancestor
25012967|NCT04033107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012968|NCT04033107|Protective Agents|protective agents|mesh-ancestor
25012969|NCT03950245|Glucagon|glucagon|mesh-list
25012970|NCT03950245|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25012971|NCT03950245|Incretins|incretins|mesh-ancestor
25012972|NCT03950245|Hormones|hormones|mesh-ancestor
25012973|NCT03950245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25012974|NCT03950245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012975|NCT03950245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25012976|NCT03939104|Artesunate|artesunate|mesh-list
25012977|NCT03939104|Lumefantrine|lumefantrine|mesh-list
25012978|NCT03939104|Artemether|artemether|mesh-list
25012979|NCT03939104|Piperaquine|piperaquine|mesh-list
25012980|NCT03939104|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25012981|NCT03939104|Amodiaquine|amodiaquine|mesh-list
25012982|NCT03939104|Mefloquine|mefloquine|mesh-list
25012983|NCT03939104|Antimalarials|antimalarials|mesh-ancestor
24654092|NCT01247688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24654093|NCT01247688|Immunologic Factors|immunologic factors|mesh-ancestor
24654094|NCT01247688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654095|NCT01247688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24654096|NCT01247688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24654097|NCT01247688|Alkylating Agents|alkylating agents|mesh-ancestor
24654098|NCT01247688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24654099|NCT01247701|Cyclophosphamide|cyclophosphamide|mesh-list
25012984|NCT03939104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25012985|NCT03939104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25012986|NCT03939104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25012987|NCT03939104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25012988|NCT03939104|Antiviral Agents|antiviral agents|mesh-ancestor
25012989|NCT03939104|Schistosomicides|schistosomicides|mesh-ancestor
24818704|NCT02090348|Immunologic Factors|immunologic factors|mesh-ancestor
25012990|NCT03939104|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25013010|NCT03858322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25013011|NCT03858322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013012|NCT03858322|Tubulin Modulators|tubulin modulators|mesh-ancestor
25013013|NCT03858322|Antimitotic Agents|antimitotic agents|mesh-ancestor
25013014|NCT03858322|Mitosis Modulators|mitosis modulators|mesh-ancestor
25013015|NCT03858322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013016|NCT03858322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25013017|NCT03858322|Immunologic Factors|immunologic factors|mesh-ancestor
25013018|NCT03858322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013019|NCT03858322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25013020|NCT03858322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25013021|NCT03858322|Alkylating Agents|alkylating agents|mesh-ancestor
24654101|NCT01247701|Fludarabine|fludarabine|mesh-list
24654102|NCT01247701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24654103|NCT01247701|Immunologic Factors|immunologic factors|mesh-ancestor
24654104|NCT01247701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654105|NCT01247701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24654106|NCT01247701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24654107|NCT01247701|Alkylating Agents|alkylating agents|mesh-ancestor
24739316|NCT01680471|Midazolam|midazolam|mesh-list
24654108|NCT01247701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654171|NCT01247961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654289|NCT01248494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654290|NCT01248494|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24654291|NCT01248494|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24654292|NCT01248494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25013029|NCT03822637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013030|NCT03822637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25013031|NCT03822637|Respiratory System Agents|respiratory system agents|mesh-ancestor
25013032|NCT03822637|Tocolytic Agents|tocolytic agents|mesh-ancestor
25013033|NCT03822637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25013034|NCT03822637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25013035|NCT03822637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25013036|NCT03822637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25013037|NCT03822637|Adrenergic Agents|adrenergic agents|mesh-ancestor
25013038|NCT03822637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25013065|NCT03752307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25013066|NCT03752307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013068|NCT03752307|Autonomic Agents|autonomic agents|mesh-ancestor
25013069|NCT03752307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25013070|NCT03752307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25013071|NCT03752307|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24654293|NCT01248494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654294|NCT01248494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24654295|NCT01248494|Hormone Antagonists|hormone antagonists|mesh-ancestor
24654296|NCT01248494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24654297|NCT01248494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654299|NCT01248611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24654303|NCT01248611|Analgesics|analgesics|mesh-ancestor
24654304|NCT01248611|Sensory System Agents|sensory system agents|mesh-ancestor
24654305|NCT01248611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24654306|NCT01248611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24654307|NCT01248611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24654308|NCT01248611|Anesthetics, General|anesthetics, general|mesh-ancestor
24654309|NCT01248611|Anesthetics|anesthetics|mesh-ancestor
24654310|NCT01248819|Ropivacaine|ropivacaine|mesh-list
24654311|NCT01248819|Anesthetics, Local|anesthetics, local|mesh-ancestor
24654312|NCT01248819|Anesthetics|anesthetics|mesh-ancestor
24654313|NCT01248819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24654314|NCT01248819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654315|NCT01248819|Sensory System Agents|sensory system agents|mesh-ancestor
24654316|NCT01248819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24654317|NCT01248858|Trametinib|trametinib|mesh-list
24654318|NCT01248858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654319|NCT01248858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24654320|NCT01248858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654321|NCT01248858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654322|NCT01248871|Sufentanil|sufentanil|mesh-list
24654430|NCT01249521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24654508|NCT01249937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25013073|NCT03752307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25013074|NCT03752307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25013075|NCT03752307|Adrenergic Agents|adrenergic agents|mesh-ancestor
25013076|NCT03752307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25013077|NCT03752307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013079|NCT03752307|Vasodilator Agents|vasodilator agents|mesh-ancestor
25013080|NCT03752307|Tocolytic Agents|tocolytic agents|mesh-ancestor
25013081|NCT03752307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25013082|NCT03740334|Dexamethasone|dexamethasone|mesh-list
25013083|NCT03740334|Everolimus|everolimus|mesh-list
25013084|NCT03740334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25013085|NCT03740334|Antiemetics|antiemetics|mesh-ancestor
25013086|NCT03740334|Autonomic Agents|autonomic agents|mesh-ancestor
25013087|NCT03740334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25013105|NCT03627897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25013106|NCT03627897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013107|NCT03627897|Sensory System Agents|sensory system agents|mesh-ancestor
25013108|NCT03627897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25013109|NCT03603184|Paclitaxel|paclitaxel|mesh-list
25013110|NCT03603184|Carboplatin|carboplatin|mesh-list
25690096|NCT01968694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25690097|NCT01968694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690098|NCT01968694|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25690099|NCT01968694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24512092|NCT00572689|Exenatide|exenatide|mesh-list
25013111|NCT03603184|Atezolizumab|atezolizumab|mesh-list
25013112|NCT03603184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25013117|NCT03603184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979272|NCT04855526|Dronabinol|dronabinol|mesh-list
24654611|NCT01250548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654612|NCT01250548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24654613|NCT01250548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24654614|NCT01250548|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24415263|NCT00199147|Fludarabine|fludarabine|mesh-list
24654662|NCT01250808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24654663|NCT01250808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654664|NCT01250808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24654665|NCT01250808|Glucocorticoids|glucocorticoids|mesh-ancestor
24654666|NCT01250808|Hormones|hormones|mesh-ancestor
24654689|NCT01250951|Deferasirox|deferasirox|mesh-list
24654690|NCT01250951|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24654691|NCT01250951|Chelating Agents|chelating agents|mesh-ancestor
24654692|NCT01250951|Sequestering Agents|sequestering agents|mesh-ancestor
24654693|NCT01250951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654694|NCT01251029|Acetylcysteine|acetylcysteine|mesh-list
24654695|NCT01251029|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24654696|NCT01251029|Antiviral Agents|antiviral agents|mesh-ancestor
24654697|NCT01251029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25013145|NCT03452111|Hormones|hormones|mesh-ancestor
25013161|NCT03439293|Dexamethasone|dexamethasone|mesh-list
25013162|NCT03439293|Daratumumab|daratumumab|mesh-list
25013163|NCT03439293|Ixazomib|ixazomib|mesh-list
25013164|NCT03439293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25013165|NCT03439293|Antiemetics|antiemetics|mesh-ancestor
25013166|NCT03439293|Autonomic Agents|autonomic agents|mesh-ancestor
25013167|NCT03439293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25013168|NCT03439293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013169|NCT03439293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24654760|NCT01251211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654761|NCT01251211|Cholinergic Agents|cholinergic agents|mesh-ancestor
24654762|NCT01251211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24654763|NCT01251211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654764|NCT01251211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24654765|NCT01251211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24654766|NCT01251263|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24654767|NCT01251263|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24654769|NCT01251263|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24654770|NCT01251263|Estrogens|estrogens|mesh-ancestor
24654771|NCT01251263|Hormones|hormones|mesh-ancestor
24654815|NCT01251640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654816|NCT01251640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654817|NCT01251640|Antiviral Agents|antiviral agents|mesh-ancestor
24654818|NCT01251640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24654819|NCT01251640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654820|NCT01251640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24654821|NCT01251640|Immunologic Factors|immunologic factors|mesh-ancestor
24654822|NCT01251640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654824|NCT01251718|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24654825|NCT01251718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654826|NCT01251718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654827|NCT01251718|Cholinergic Agents|cholinergic agents|mesh-ancestor
24654828|NCT01251718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24654829|NCT01251718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654873|NCT01251848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24654874|NCT01251848|Antiviral Agents|antiviral agents|mesh-ancestor
24654875|NCT01251848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24654876|NCT01251848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24654877|NCT01251848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24654878|NCT01251848|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24654880|NCT01251874|Carboplatin|carboplatin|mesh-list
24654881|NCT01251874|Veliparib|veliparib|mesh-list
24654882|NCT01251874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654883|NCT01251874|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24654884|NCT01251874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654885|NCT01251874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690100|NCT01968694|Antiemetics|antiemetics|mesh-ancestor
25690101|NCT01968694|Autonomic Agents|autonomic agents|mesh-ancestor
24415437|NCT00199472|Diuretics|diuretics|mesh-list
24654986|NCT01252758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24654987|NCT01252758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25013172|NCT03439293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25013173|NCT03439293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25013174|NCT03439293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013175|NCT03439293|Protease Inhibitors|protease inhibitors|mesh-ancestor
25013176|NCT03439293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25013177|NCT03439293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013178|NCT03438526|Melatonin|melatonin|mesh-list
24787103|NCT01923818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24787104|NCT01923818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787105|NCT01923818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24787106|NCT01923818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24787107|NCT01923818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787109|NCT01923818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24787110|NCT01923818|Antithrombins|antithrombins|mesh-ancestor
24787111|NCT01923818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24655050|NCT01253928|Pioglitazone|pioglitazone|mesh-list
24415527|NCT00199784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24655127|NCT01254526|Mitosis Modulators|mitosis modulators|mesh-ancestor
24655130|NCT01254526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24655189|NCT01254825|Sensory System Agents|sensory system agents|mesh-ancestor
24655190|NCT01254825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24655191|NCT00660218|Paclitaxel|paclitaxel|mesh-list
24655192|NCT00660218|Cetuximab|cetuximab|mesh-list
24655193|NCT00660218|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
24655194|NCT00660218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24655195|NCT00660218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655196|NCT00660218|Tubulin Modulators|tubulin modulators|mesh-ancestor
24655197|NCT00660218|Antimitotic Agents|antimitotic agents|mesh-ancestor
24655198|NCT00660218|Mitosis Modulators|mitosis modulators|mesh-ancestor
24655199|NCT00660218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655200|NCT00660218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24655201|NCT01254929|Frovatriptan|frovatriptan|mesh-list
24655202|NCT01254929|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24655203|NCT01254929|Serotonin Agents|serotonin agents|mesh-ancestor
24655204|NCT01254929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24655205|NCT01254929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655207|NCT01254994|Entecavir|entecavir|mesh-list
24655210|NCT01255046|Donepezil|donepezil|mesh-list
24655211|NCT01255046|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24655212|NCT01255046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24655213|NCT01255046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655214|NCT01255046|Cholinergic Agents|cholinergic agents|mesh-ancestor
24655243|NCT01255358|Glucocorticoids|glucocorticoids|mesh-ancestor
24655244|NCT01255358|Hormones|hormones|mesh-ancestor
24655245|NCT01255358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24655246|NCT01255358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24655247|NCT01255358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655248|NCT01255358|Protease Inhibitors|protease inhibitors|mesh-ancestor
24655249|NCT01255358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24655250|NCT01255358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655251|NCT01255371|Lopinavir|lopinavir|mesh-list
24655252|NCT01255371|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24655253|NCT01255371|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24787112|NCT01923818|Protease Inhibitors|protease inhibitors|mesh-ancestor
24655254|NCT01255371|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25690102|NCT01968694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25060591|NCT03478436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25060593|NCT03478423|Hydromorphone|hydromorphone|mesh-list
25060594|NCT03478423|Codeine|codeine|mesh-list
24655255|NCT01255371|Protease Inhibitors|protease inhibitors|mesh-ancestor
24655256|NCT01255371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24979307|NCT04812951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24979308|NCT04772313|Methotrexate|methotrexate|mesh-list
24979309|NCT04772313|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24979310|NCT04772313|Abortifacient Agents|abortifacient agents|mesh-ancestor
24979311|NCT04772313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24979312|NCT04772313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979314|NCT04772313|Antimetabolites|antimetabolites|mesh-ancestor
25013179|NCT03438526|Antioxidants|antioxidants|mesh-ancestor
25013180|NCT03438526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013181|NCT03438526|Protective Agents|protective agents|mesh-ancestor
25013182|NCT03438526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013183|NCT03438526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25013184|NCT03416179|Cytarabine|cytarabine|mesh-list
25013185|NCT03416179|Azacitidine|azacitidine|mesh-list
25013186|NCT03416179|Daunorubicin|daunorubicin|mesh-list
25013187|NCT03416179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25013188|NCT03416179|Antimetabolites|antimetabolites|mesh-ancestor
25013189|NCT03416179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013190|NCT03416179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013191|NCT03416179|Antiviral Agents|antiviral agents|mesh-ancestor
25013192|NCT03416179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25013196|NCT03416179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24969851|NCT03739541|Benzonidazole|benzonidazole|mesh-list
24969929|NCT03738800|Trifarotene|trifarotene|mesh-list
24969930|NCT03738800|Dermatologic Agents|dermatologic agents|mesh-ancestor
24655257|NCT01255371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655309|NCT01255774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655407|NCT01256580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655408|NCT01256580|Growth Inhibitors|growth inhibitors|mesh-ancestor
24655409|NCT01256580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24655412|NCT01256580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24655413|NCT01256580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24655414|NCT01256580|Glucocorticoids|glucocorticoids|mesh-ancestor
24655416|NCT01256580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24969931|NCT03738579|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24586240|NCT00889642|Respiratory System Agents|respiratory system agents|mesh-ancestor
24586241|NCT00889642|Mydriatics|mydriatics|mesh-ancestor
24586242|NCT00889642|Sympathomimetics|sympathomimetics|mesh-ancestor
24586243|NCT00889642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24586244|NCT00889655|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24586245|NCT00889655|Laxatives|laxatives|mesh-ancestor
24586246|NCT00889655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24586247|NCT00889694|Sulfasalazine|sulfasalazine|mesh-list
24586248|NCT00889694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24586249|NCT00889694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24655417|NCT01256580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24655418|NCT01256580|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24655419|NCT01256580|Dermatologic Agents|dermatologic agents|mesh-ancestor
24655421|NCT01256619|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24655422|NCT01256619|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24655423|NCT01256619|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24655424|NCT01256619|Contraceptive Agents|contraceptive agents|mesh-ancestor
24655425|NCT01256619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24655426|NCT01256619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655427|NCT01256619|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24655428|NCT01256619|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24655429|NCT01256619|Progestins|progestins|mesh-ancestor
24655430|NCT01256619|Hormones|hormones|mesh-ancestor
24655431|NCT01256619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24655453|NCT01256775|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
24655454|NCT01256775|Protease Inhibitors|protease inhibitors|mesh-ancestor
24655455|NCT01256775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25690103|NCT01968694|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25690104|NCT01968694|Histamine Antagonists|histamine antagonists|mesh-ancestor
25690105|NCT01968694|Histamine Agents|histamine agents|mesh-ancestor
24655456|NCT01256775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24655457|NCT01256775|Antipyretics|antipyretics|mesh-ancestor
24512278|NCT00573950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24512279|NCT00573950|Respiratory System Agents|respiratory system agents|mesh-ancestor
24655458|NCT01256801|Interleukin-2|interleukin-2|mesh-list
24655459|NCT01256801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655460|NCT01256801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24655461|NCT01256801|Analgesics|analgesics|mesh-ancestor
24655462|NCT01256801|Sensory System Agents|sensory system agents|mesh-ancestor
24655463|NCT01256801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24655464|NCT01256801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655466|NCT01256866|Dexmedetomidine|dexmedetomidine|mesh-list
24655467|NCT01256866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24655468|NCT01256866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24655469|NCT01256866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655470|NCT01256866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24655479|NCT01256866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655480|NCT01256866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24655481|NCT01256866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24655482|NCT01256866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24655483|NCT01256866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24655484|NCT01256866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24655485|NCT01256866|Anesthetics, General|anesthetics, general|mesh-ancestor
24655487|NCT01256866|GABA Modulators|gaba modulators|mesh-ancestor
24655503|NCT01257009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24655504|NCT01257035|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
24655505|NCT01257035|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24415733|NCT00200564|Ketamine|ketamine|mesh-list
24655520|NCT01257048|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24655522|NCT01257048|Adrenergic Agents|adrenergic agents|mesh-ancestor
24655523|NCT01257048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24655524|NCT01257048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655525|NCT01257074|Acyclovir|acyclovir|mesh-list
24655526|NCT01257074|Penciclovir|penciclovir|mesh-list
24655527|NCT01257074|Antiviral Agents|antiviral agents|mesh-ancestor
24979345|NCT04707625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24979346|NCT04707625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24979347|NCT04707625|Growth Substances|growth substances|mesh-ancestor
24979348|NCT04707625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979349|NCT04707625|Growth Inhibitors|growth inhibitors|mesh-ancestor
24586250|NCT00889694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24633972|NCT01131767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633973|NCT01131767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24633974|NCT01131767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24586252|NCT00889694|Sensory System Agents|sensory system agents|mesh-ancestor
24586253|NCT00889694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24586254|NCT00889694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586255|NCT00889694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24586256|NCT00889694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24586257|NCT00889694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24425912|NCT00234819|Hormones|hormones|mesh-ancestor
24655528|NCT01257074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24655529|NCT01257126|Diclofenac|diclofenac|mesh-list
24655530|NCT01257126|Nimesulide|nimesulide|mesh-list
24655531|NCT01257126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24655532|NCT01257126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24655533|NCT01257126|Analgesics|analgesics|mesh-ancestor
24655534|NCT01257126|Sensory System Agents|sensory system agents|mesh-ancestor
24655535|NCT01257126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24655536|NCT01257126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655538|NCT01257126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24655546|NCT01257139|Mitosis Modulators|mitosis modulators|mesh-ancestor
24655554|NCT01257165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24655555|NCT01257243|Potassium iodate|potassium iodate|mesh-list
24655556|NCT01257243|Phenylpropanolamine|phenylpropanolamine|mesh-list
24655558|NCT01257243|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
24655559|NCT01257243|Expectorants|expectorants|mesh-ancestor
24655560|NCT01257243|Respiratory System Agents|respiratory system agents|mesh-ancestor
24655561|NCT01257243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24655562|NCT01257243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25690106|NCT01968694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25690107|NCT01968694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25690108|NCT01968694|Antipruritics|antipruritics|mesh-ancestor
24512369|NCT00574483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512370|NCT00574509|Tositumomab I-131|tositumomab i-131|mesh-list
24512371|NCT00574509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512372|NCT00574600|Vaccines|vaccines|mesh-list
24512373|NCT00574600|Immunologic Factors|immunologic factors|mesh-ancestor
24512374|NCT00574600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886826|NCT04522297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24886829|NCT04521868|Sulforaphane|sulforaphane|mesh-list
24655563|NCT01257243|Adrenergic Agents|adrenergic agents|mesh-ancestor
24655564|NCT01257243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24655565|NCT01257243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655606|NCT01257399|Mesalamine|mesalamine|mesh-list
24655607|NCT01257399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24655608|NCT01257399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24655610|NCT01257399|Sensory System Agents|sensory system agents|mesh-ancestor
24655611|NCT01257399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24655624|NCT01257451|Protease Inhibitors|protease inhibitors|mesh-ancestor
24655625|NCT01257451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24655626|NCT01257451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655627|NCT01257464|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24655628|NCT01257464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24655629|NCT01257464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24907265|NCT04331418|Analgesics|analgesics|mesh-ancestor
24482682|NCT00440219|Prednisone|prednisone|mesh-list
24655630|NCT01257464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586259|NCT00889733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586260|NCT00889837|Loxapine|loxapine|mesh-list
24586261|NCT00889837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24586262|NCT00889837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24586263|NCT00889837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24586264|NCT00889837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586265|NCT00889837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24586266|NCT00889837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24586267|NCT00889837|Dopamine Agents|dopamine agents|mesh-ancestor
24586268|NCT00889837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24586269|NCT00889837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586271|NCT00889850|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24586272|NCT00889850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24426111|NCT00235079|Colchicine|colchicine|mesh-list
24655632|NCT01257464|Hormones|hormones|mesh-ancestor
24655633|NCT01257464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24655634|NCT01257464|Protease Inhibitors|protease inhibitors|mesh-ancestor
24655635|NCT01257464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24655636|NCT01257464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655688|NCT01257672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24655689|NCT01257672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655690|NCT01257672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24655691|NCT01257672|Antipruritics|antipruritics|mesh-ancestor
24655692|NCT01257672|Dermatologic Agents|dermatologic agents|mesh-ancestor
24655693|NCT01257672|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24655694|NCT01257672|Serotonin Agents|serotonin agents|mesh-ancestor
24655700|NCT01257672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24655701|NCT01257672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24655702|NCT01257672|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24655730|NCT00077285|Antimitotic Agents|antimitotic agents|mesh-ancestor
24655731|NCT00077285|Mitosis Modulators|mitosis modulators|mesh-ancestor
24655732|NCT00077285|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24655733|NCT00077285|Protective Agents|protective agents|mesh-ancestor
24655734|NCT01257815|Ranibizumab|ranibizumab|mesh-list
24655735|NCT01257815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24655736|NCT01257815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24655737|NCT01257815|Growth Substances|growth substances|mesh-ancestor
24655739|NCT01257815|Growth Inhibitors|growth inhibitors|mesh-ancestor
24655740|NCT01257815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655742|NCT01257828|Anticonvulsants|anticonvulsants|mesh-ancestor
25690109|NCT01968694|Dermatologic Agents|dermatologic agents|mesh-ancestor
25690110|NCT01968707|Ethanol|ethanol|mesh-list
25690111|NCT01968707|Chlorhexidine|chlorhexidine|mesh-list
25690112|NCT01968707|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25690113|NCT01968707|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25690114|NCT01968707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25690115|NCT01968707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25690116|NCT01968707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655746|NCT01257828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655747|NCT01257828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655748|NCT01257828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24655796|NCT01258192|Paclitaxel|paclitaxel|mesh-list
24655797|NCT01258192|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24655798|NCT01258192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24655799|NCT01258192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655800|NCT01258192|Tubulin Modulators|tubulin modulators|mesh-ancestor
24655801|NCT01258192|Antimitotic Agents|antimitotic agents|mesh-ancestor
24655802|NCT01258192|Mitosis Modulators|mitosis modulators|mesh-ancestor
24655803|NCT01258192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655804|NCT01258296|Fentanyl|fentanyl|mesh-list
24655805|NCT01258296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24655806|NCT01258296|Narcotics|narcotics|mesh-ancestor
24586273|NCT00889850|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24586274|NCT00889850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039934|NCT03588884|Vitamins|vitamins|mesh-ancestor
24655947|NCT01258868|Celecoxib|celecoxib|mesh-list
24655949|NCT01258868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24656012|NCT01259336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24656013|NCT01259336|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24656014|NCT01259336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24656015|NCT01259336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656016|NCT01259336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656118|NCT01259973|Dopamine Agents|dopamine agents|mesh-ancestor
24656119|NCT01259973|Antiemetics|antiemetics|mesh-ancestor
24656120|NCT01259973|Autonomic Agents|autonomic agents|mesh-ancestor
24656121|NCT01259973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24656122|NCT01259973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24656123|NCT01259973|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24656124|NCT01260012|Praziquantel|praziquantel|mesh-list
24656125|NCT01260012|Antioxidants|antioxidants|mesh-list
24656126|NCT01260012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656127|NCT01260012|Protective Agents|protective agents|mesh-ancestor
24656128|NCT01260012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656129|NCT01260012|Anthelmintics|anthelmintics|mesh-ancestor
24656130|NCT01260012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24656131|NCT01260012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24656132|NCT01260025|Endostatins|endostatins|mesh-list
24656133|NCT01260025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656134|NCT01260025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24656137|NCT01260025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656138|NCT01260025|Growth Inhibitors|growth inhibitors|mesh-ancestor
24656140|NCT01260103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24656141|NCT01260103|Alkylating Agents|alkylating agents|mesh-ancestor
24656142|NCT01260103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656143|NCT01260103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656144|NCT01260129|Silodosin|silodosin|mesh-list
24656170|NCT01260246|Protease Inhibitors|protease inhibitors|mesh-ancestor
24656171|NCT01260246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656172|NCT01260246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656173|NCT01260285|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24656174|NCT01260285|Vasodilator Agents|vasodilator agents|mesh-ancestor
24656175|NCT01260285|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24656259|NCT01260714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656260|NCT01260714|Keratolytic Agents|keratolytic agents|mesh-ancestor
24656261|NCT01260714|Dermatologic Agents|dermatologic agents|mesh-ancestor
24656262|NCT01260714|Tubulin Modulators|tubulin modulators|mesh-ancestor
24656263|NCT01260714|Antimitotic Agents|antimitotic agents|mesh-ancestor
24512491|NCT00575406|Glucocorticoids|glucocorticoids|mesh-ancestor
24656264|NCT01260714|Mitosis Modulators|mitosis modulators|mesh-ancestor
24656266|NCT01260727|Immunologic Factors|immunologic factors|mesh-ancestor
24656267|NCT01260727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656291|NCT01260857|Natriuretic Agents|natriuretic agents|mesh-ancestor
24656324|NCT01261078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656325|NCT01261078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656326|NCT01261078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24656327|NCT01261078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24656381|NCT01261234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24656382|NCT01261234|Vasodilator Agents|vasodilator agents|mesh-ancestor
24586275|NCT00889850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586276|NCT00889876|Metformin|metformin|mesh-list
24586277|NCT00889876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24586278|NCT00889876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586279|NCT00890110|Sunitinib|sunitinib|mesh-list
24656383|NCT01261234|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24656384|NCT01261234|Protective Agents|protective agents|mesh-ancestor
24656385|NCT01261234|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24656386|NCT01261234|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24656387|NCT01261234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656388|NCT01261286|Verapamil|verapamil|mesh-list
24656389|NCT01261286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24656390|NCT01261286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24656391|NCT01261286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24656392|NCT01261286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656410|NCT01261546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24405304|NCT00166465|Leucovorin|leucovorin|mesh-list
24656411|NCT01261546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656412|NCT01261546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24656413|NCT01261546|Glucocorticoids|glucocorticoids|mesh-ancestor
24656414|NCT01261546|Hormones|hormones|mesh-ancestor
24907740|NCT04328272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24656415|NCT01261546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24656416|NCT01261546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24656417|NCT01261546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656418|NCT01261637|Ropivacaine|ropivacaine|mesh-list
24656419|NCT01261637|Anesthetics, Local|anesthetics, local|mesh-ancestor
24656420|NCT01261637|Anesthetics|anesthetics|mesh-ancestor
24656421|NCT01261637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24656425|NCT01261689|Sufentanil|sufentanil|mesh-list
24656523|NCT01262391|Solifenacin Succinate|solifenacin succinate|mesh-list
24656524|NCT01262391|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24656525|NCT01262391|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24656526|NCT01262391|Cholinergic Agents|cholinergic agents|mesh-ancestor
24656527|NCT01262391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24656528|NCT01262391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656529|NCT01262391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656573|NCT01262742|Carbetocin|carbetocin|mesh-list
24656574|NCT01262742|Oxytocin|oxytocin|mesh-list
24656575|NCT01262742|Oxytocics|oxytocics|mesh-ancestor
24656576|NCT01262742|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24656577|NCT01262742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656578|NCT01262859|Bevacizumab|bevacizumab|mesh-list
24656579|NCT01262859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24656580|NCT01262859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656581|NCT01262859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24656582|NCT01262859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24656583|NCT01262859|Growth Substances|growth substances|mesh-ancestor
24656584|NCT01262859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656585|NCT01262859|Growth Inhibitors|growth inhibitors|mesh-ancestor
24656586|NCT01262924|Vaccines|vaccines|mesh-list
24656637|NCT01263158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690117|NCT01968707|Disinfectants|disinfectants|mesh-ancestor
24656639|NCT01263171|Fluorouracil|fluorouracil|mesh-list
24426954|NCT00236912|Ofloxacin|ofloxacin|mesh-list
24656698|NCT01263574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24656699|NCT01263574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24656700|NCT01263574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24656701|NCT01263574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656702|NCT01263652|Dipyrone|dipyrone|mesh-list
24656703|NCT01263652|Diclofenac|diclofenac|mesh-list
24656704|NCT01263652|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
24656705|NCT01263652|Tramadol|tramadol|mesh-list
24656706|NCT01263652|Orphenadrine|orphenadrine|mesh-list
24656707|NCT01263652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24656709|NCT01263652|Analgesics|analgesics|mesh-ancestor
24656762|NCT01263860|Antiviral Agents|antiviral agents|mesh-ancestor
24656763|NCT01263860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24656895|NCT01264575|Adrenergic Agents|adrenergic agents|mesh-ancestor
24656896|NCT01264575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24656897|NCT01264575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656898|NCT01264575|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24656899|NCT01264575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24656900|NCT01264575|Autonomic Agents|autonomic agents|mesh-ancestor
24656945|NCT01264653|Sympathomimetics|sympathomimetics|mesh-ancestor
24656946|NCT01264653|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24656948|NCT01264692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24656949|NCT01264692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24656966|NCT01264783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24656967|NCT01264783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657010|NCT01265017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24657067|NCT01265576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24657068|NCT01265576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657069|NCT01265576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657070|NCT01265576|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24657071|NCT01265576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24657072|NCT01265576|Adrenergic Agents|adrenergic agents|mesh-ancestor
24657073|NCT01265576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24657074|NCT01265576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657075|NCT01265576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24657076|NCT01265576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24657077|NCT01265576|Vasodilator Agents|vasodilator agents|mesh-ancestor
24657078|NCT01265576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24657079|NCT01265576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24657080|NCT01265576|Analgesics|analgesics|mesh-ancestor
25110486|NCT05463354|Immunologic Factors|immunologic factors|mesh-ancestor
25110487|NCT05463354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690118|NCT01968707|Dermatologic Agents|dermatologic agents|mesh-ancestor
25690119|NCT01968954|Bococizumab|bococizumab|mesh-list
25690120|NCT01968954|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25690121|NCT01968954|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25690122|NCT01968954|Antimetabolites|antimetabolites|mesh-ancestor
25013257|NCT03173456|Sensory System Agents|sensory system agents|mesh-ancestor
25013260|NCT03173456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25013261|NCT03173456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25013262|NCT03173456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25013263|NCT03173456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657145|NCT01265927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24657146|NCT01265927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657147|NCT01265927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657148|NCT01265927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657149|NCT01265940|Vinblastine|vinblastine|mesh-list
24657150|NCT01265940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24657151|NCT01265940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657152|NCT01265940|Tubulin Modulators|tubulin modulators|mesh-ancestor
24657153|NCT01265940|Antimitotic Agents|antimitotic agents|mesh-ancestor
24657154|NCT01265940|Mitosis Modulators|mitosis modulators|mesh-ancestor
24657185|NCT01266057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24657186|NCT01266057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657278|NCT01266681|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24657279|NCT01266681|Vasodilator Agents|vasodilator agents|mesh-ancestor
24657280|NCT01266681|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24657281|NCT01266681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24657282|NCT01266681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657283|NCT01266681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24657284|NCT01266681|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24657285|NCT01266681|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24657286|NCT01266681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657287|NCT01266681|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24657288|NCT01266681|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24657290|NCT01266694|Colchicine|colchicine|mesh-list
24657309|NCT01266720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24657311|NCT01266720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657312|NCT01266720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013264|NCT03173456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013265|NCT03173456|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25013266|NCT03173456|Narcotics|narcotics|mesh-ancestor
25013267|NCT03173456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25013268|NCT03173456|Antipyretics|antipyretics|mesh-ancestor
25013269|NCT03173456|Antitussive Agents|antitussive agents|mesh-ancestor
24657313|NCT01266720|Antiviral Agents|antiviral agents|mesh-ancestor
24657314|NCT01266720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24657315|NCT01266720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657316|NCT01266720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24657317|NCT01266759|NuvaRing|nuvaring|mesh-list
24657318|NCT01266759|Norethindrone|norethindrone|mesh-list
24657319|NCT01266759|Norethindrone Acetate|norethindrone acetate|mesh-list
24657320|NCT01266759|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24657321|NCT01266759|Contraceptive Agents|contraceptive agents|mesh-ancestor
24908178|NCT04322955|Nivolumab|nivolumab|mesh-list
24657322|NCT01266759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24657323|NCT01266759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657324|NCT01266759|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24657325|NCT01266759|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24657326|NCT01266759|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24657339|NCT01266772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24657340|NCT01266772|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24657341|NCT01266772|Hormone Antagonists|hormone antagonists|mesh-ancestor
24657342|NCT01266772|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24657343|NCT01266772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24657344|NCT01266772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657345|NCT01266785|Infliximab|infliximab|mesh-list
24657346|NCT01266785|Dermatologic Agents|dermatologic agents|mesh-ancestor
24657347|NCT01266785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24657424|NCT01267305|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24657425|NCT01267305|Protease Inhibitors|protease inhibitors|mesh-ancestor
24657445|NCT01267383|Sertraline|sertraline|mesh-list
24657450|NCT01267383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25013454|NCT02575144|Dexamethasone|dexamethasone|mesh-list
24657453|NCT01267383|Serotonin Agents|serotonin agents|mesh-ancestor
25013270|NCT03173456|Respiratory System Agents|respiratory system agents|mesh-ancestor
25013294|NCT03101566|Gemcitabine|gemcitabine|mesh-list
24969986|NCT03737968|Durvalumab|durvalumab|mesh-list
25013296|NCT03101566|Ipilimumab|ipilimumab|mesh-list
25013297|NCT03101566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013298|NCT03101566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25013300|NCT03101566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013301|NCT03101566|Antiviral Agents|antiviral agents|mesh-ancestor
24657454|NCT01267383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657455|NCT01267396|Sertraline|sertraline|mesh-list
24657504|NCT01267695|Imatinib Mesylate|imatinib mesylate|mesh-list
24657505|NCT01267695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657506|NCT01267695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24657507|NCT01267695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657508|NCT01267695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657511|NCT01267734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657512|NCT01267734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24657513|NCT01267734|Immunologic Factors|immunologic factors|mesh-ancestor
24657514|NCT01267734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657515|NCT01267734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24657516|NCT01267734|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24657517|NCT01267734|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24657524|NCT01267903|Vaccines|vaccines|mesh-list
24657529|NCT01267942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24657530|NCT01267942|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24657531|NCT01267942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657532|NCT01267942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657533|NCT01268033|Rituximab|rituximab|mesh-list
24657534|NCT01268033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24657608|NCT01268631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24657609|NCT01268631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24657610|NCT01268631|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24657611|NCT01268631|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24657612|NCT01268631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24657613|NCT01268631|Antidepressive Agents|antidepressive agents|mesh-ancestor
24657614|NCT01268631|Dopamine Agents|dopamine agents|mesh-ancestor
24657624|NCT01268670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24657625|NCT01268670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24657626|NCT01268670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657627|NCT01268670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657629|NCT01268670|Narcotics|narcotics|mesh-ancestor
25690123|NCT01968954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690124|NCT01968954|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25690125|NCT01968967|Bococizumab|bococizumab|mesh-list
25690126|NCT01968967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24657669|NCT01268839|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24657670|NCT01268839|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24657671|NCT01268839|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24657672|NCT01268839|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24657673|NCT01268839|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24657674|NCT01268904|Valproic Acid|valproic acid|mesh-list
24657675|NCT01268904|Anticonvulsants|anticonvulsants|mesh-ancestor
24657676|NCT01268904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657677|NCT01268904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013302|NCT03101566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25013304|NCT03101566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25013305|NCT03101566|Immunologic Factors|immunologic factors|mesh-ancestor
25013306|NCT03101566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013307|NCT03101566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25013308|NCT03101566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25013321|NCT03006068|Upadacitinib|upadacitinib|mesh-list
25013322|NCT03006068|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25013323|NCT03006068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25013324|NCT03006068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657710|NCT01268995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657711|NCT01268995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657712|NCT01268995|Antifungal Agents|antifungal agents|mesh-ancestor
24657713|NCT01268995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24657714|NCT01268995|Dermatologic Agents|dermatologic agents|mesh-ancestor
24657715|NCT01268995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24657716|NCT01269021|Mycophenolic Acid|mycophenolic acid|mesh-list
24657717|NCT01269021|Prednisone|prednisone|mesh-list
24657718|NCT01269021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24657719|NCT01269021|Glucocorticoids|glucocorticoids|mesh-ancestor
24657720|NCT01269021|Hormones|hormones|mesh-ancestor
24657721|NCT01269021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24657722|NCT01269021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657723|NCT01269021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24657724|NCT01269021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657732|NCT01269099|Fentanyl|fentanyl|mesh-list
24657741|NCT01269099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24657742|NCT01269099|Anesthetics, General|anesthetics, general|mesh-ancestor
24657743|NCT01269099|Anesthetics|anesthetics|mesh-ancestor
24657744|NCT01269112|Citric Acid|citric acid|mesh-list
24657745|NCT01269112|Sodium Citrate|sodium citrate|mesh-list
24657746|NCT01269112|Anticoagulants|anticoagulants|mesh-ancestor
24657747|NCT01269112|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24657748|NCT01269112|Chelating Agents|chelating agents|mesh-ancestor
24657749|NCT01269112|Sequestering Agents|sequestering agents|mesh-ancestor
24657750|NCT01269112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657751|NCT01269138|Thrombin|thrombin|mesh-list
24657752|NCT01269138|Hemostatics|hemostatics|mesh-ancestor
24657753|NCT01269138|Coagulants|coagulants|mesh-ancestor
24908866|NCT04315584|Antimetabolites|antimetabolites|mesh-ancestor
24970057|NCT03736980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25013362|NCT02992015|Gemcitabine|gemcitabine|mesh-list
25039935|NCT03588884|Micronutrients|micronutrients|mesh-ancestor
24787190|NCT01923948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24787191|NCT01923948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24909037|NCT04313270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24909038|NCT04313270|Antimetabolites|antimetabolites|mesh-ancestor
24657794|NCT01269281|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24657795|NCT01269281|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24657796|NCT01269281|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24657797|NCT01269281|Serotonin Agents|serotonin agents|mesh-ancestor
24657798|NCT01269281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24657802|NCT01269294|Simeprevir|simeprevir|mesh-list
24657849|NCT01269333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25690127|NCT01968967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25690128|NCT01968967|Antimetabolites|antimetabolites|mesh-ancestor
25690129|NCT01968967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690130|NCT01968967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25690131|NCT01968980|Bococizumab|bococizumab|mesh-list
25690132|NCT01968980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25690133|NCT01968980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25690134|NCT01968980|Antimetabolites|antimetabolites|mesh-ancestor
25060833|NCT03476044|Antioxidants|antioxidants|mesh-ancestor
25060834|NCT03476044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060835|NCT03476044|Protective Agents|protective agents|mesh-ancestor
24823229|NCT02115763|Caffeine|caffeine|mesh-list
24823231|NCT02115763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657850|NCT01269333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24657851|NCT01269333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24657852|NCT01269333|Serotonin Agents|serotonin agents|mesh-ancestor
24657853|NCT01269333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24657854|NCT01269333|Antidepressive Agents|antidepressive agents|mesh-ancestor
24657855|NCT01269333|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24657856|NCT01269333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24657857|NCT01269333|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24657858|NCT01269411|R04929097|r04929097|mesh-list
24657859|NCT01269411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657860|NCT01269411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657861|NCT01269437|Budesonide|budesonide|mesh-list
24657862|NCT01269437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24657863|NCT01269437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24657864|NCT01269437|Autonomic Agents|autonomic agents|mesh-ancestor
24657865|NCT01269437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24451362|NCT00323323|Hormones|hormones|mesh-ancestor
24657913|NCT01269528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24657914|NCT01269528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657915|NCT01269528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25013366|NCT02992015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013368|NCT02992015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25013389|NCT02918370|Serotonin Agents|serotonin agents|mesh-ancestor
25013390|NCT02918370|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25013391|NCT02918370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25013392|NCT02918370|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25013393|NCT02918370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25013394|NCT02891824|Bevacizumab|bevacizumab|mesh-list
25013395|NCT02891824|Atezolizumab|atezolizumab|mesh-list
25013396|NCT02891824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25013397|NCT02891824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013398|NCT02891824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25013399|NCT02891824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25013400|NCT02891824|Growth Substances|growth substances|mesh-ancestor
25013401|NCT02891824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013402|NCT02891824|Growth Inhibitors|growth inhibitors|mesh-ancestor
25109222|NCT03126708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24484046|NCT00446368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484073|NCT00446433|Immunologic Factors|immunologic factors|mesh-ancestor
24909334|NCT04310280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013455|NCT02575144|Lenalidomide|lenalidomide|mesh-list
24658007|NCT01269853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013419|NCT02845323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25013420|NCT02845323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25039936|NCT03588884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24658008|NCT01269853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24658009|NCT01269853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24658011|NCT01269853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658012|NCT01269853|Growth Inhibitors|growth inhibitors|mesh-ancestor
24658013|NCT01269866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24658037|NCT01270074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24658038|NCT01270074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24658039|NCT01270087|Adalimumab|adalimumab|mesh-list
24658040|NCT01270087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24658041|NCT01270087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24658043|NCT01270152|Antioxidants|antioxidants|mesh-ancestor
25404551|NCT03661411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25690135|NCT01968980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690136|NCT01968980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25690137|NCT01969058|Isotretinoin|isotretinoin|mesh-list
25690138|NCT01969058|Dermatologic Agents|dermatologic agents|mesh-ancestor
25690139|NCT01969084|Linagliptin|linagliptin|mesh-list
25690140|NCT01969084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24658125|NCT01270490|Antiviral Agents|antiviral agents|mesh-ancestor
24658126|NCT01270490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24658128|NCT01270672|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
24658129|NCT01270672|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24658130|NCT01270672|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24658131|NCT01270672|Adrenergic Agents|adrenergic agents|mesh-ancestor
24658132|NCT01270672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24658134|NCT01270672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658139|NCT01270672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24658140|NCT01270672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24658141|NCT01270672|Vasodilator Agents|vasodilator agents|mesh-ancestor
24658142|NCT01270672|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24658143|NCT01270672|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24658144|NCT01270672|Hallucinogens|hallucinogens|mesh-ancestor
24658145|NCT01270672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24658196|NCT01270815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24658197|NCT01270815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658227|NCT01270932|Growth Substances|growth substances|mesh-ancestor
24658228|NCT01270932|Growth Inhibitors|growth inhibitors|mesh-ancestor
24658229|NCT01270984|Imatinib Mesylate|imatinib mesylate|mesh-list
24658230|NCT01270984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013449|NCT02609737|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
25013451|NCT02609737|Sequestering Agents|sequestering agents|mesh-ancestor
25013452|NCT02609737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013453|NCT02575144|Clarithromycin|clarithromycin|mesh-list
25013460|NCT02575144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013461|NCT02575144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24658231|NCT01270984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24658232|NCT01270984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24658233|NCT01270984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658243|NCT01270997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24658244|NCT01270997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24658305|NCT01271166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24658306|NCT01271166|Immunologic Factors|immunologic factors|mesh-ancestor
24658308|NCT01271166|Protective Agents|protective agents|mesh-ancestor
24658309|NCT01271166|Vitamin B Complex|vitamin b complex|mesh-ancestor
24658311|NCT01271166|Micronutrients|micronutrients|mesh-ancestor
24658312|NCT01271166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24658313|NCT01271166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24658314|NCT01271179|Insulin|insulin|mesh-list
24658315|NCT01271179|Allopurinol|allopurinol|mesh-list
24658316|NCT01271179|Adenosine|adenosine|mesh-list
24658317|NCT01271179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24658318|NCT01271179|Analgesics|analgesics|mesh-ancestor
24658319|NCT01271179|Sensory System Agents|sensory system agents|mesh-ancestor
24658320|NCT01271179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658321|NCT01271179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658322|NCT01271179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24658323|NCT01271179|Vasodilator Agents|vasodilator agents|mesh-ancestor
24658368|NCT01271348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658369|NCT01271361|Sirolimus|sirolimus|mesh-list
24658370|NCT01271361|Umirolimus|umirolimus|mesh-list
24658371|NCT01271361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24658372|NCT01271361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24658373|NCT01271361|Immunologic Factors|immunologic factors|mesh-ancestor
24658374|NCT01271361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658375|NCT01271361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24658376|NCT01271361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24658377|NCT01271361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25690141|NCT01969084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658378|NCT01271361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24658379|NCT01271361|Antifungal Agents|antifungal agents|mesh-ancestor
24658380|NCT01271374|Losartan|losartan|mesh-list
24888653|NCT04501809|Oxytocics|oxytocics|mesh-ancestor
24658381|NCT01271374|Amlodipine|amlodipine|mesh-list
24658382|NCT01271374|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24658383|NCT01271374|Olmesartan|olmesartan|mesh-list
24658384|NCT01271374|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
25013462|NCT02575144|Glucocorticoids|glucocorticoids|mesh-ancestor
25013463|NCT02575144|Hormones|hormones|mesh-ancestor
25013464|NCT02575144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25013465|NCT02575144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24658385|NCT01271374|Spironolactone|spironolactone|mesh-list
24658386|NCT01271374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24658387|NCT01271374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24658388|NCT01271374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24658389|NCT01271374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658390|NCT01271374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24658414|NCT01271478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24658415|NCT01271517|Insulin, Isophane|insulin, isophane|mesh-list
24658416|NCT01271517|Isophane Insulin, Human|isophane insulin, human|mesh-list
24658417|NCT01271517|Isophane insulin, beef|isophane insulin, beef|mesh-list
24658418|NCT01271517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24658433|NCT01271569|Fospropofol|fospropofol|mesh-list
24658434|NCT01271569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24658435|NCT01271569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24658445|NCT01271582|Protective Agents|protective agents|mesh-ancestor
24658446|NCT01271582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658447|NCT01271582|Vitamin B Complex|vitamin b complex|mesh-ancestor
24658448|NCT01271582|Vitamins|vitamins|mesh-ancestor
24658449|NCT01271582|Micronutrients|micronutrients|mesh-ancestor
24658450|NCT01271660|Pregabalin|pregabalin|mesh-list
24658451|NCT01271660|Analgesics|analgesics|mesh-ancestor
24658452|NCT01271660|Sensory System Agents|sensory system agents|mesh-ancestor
24658453|NCT01271660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658454|NCT01271660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658455|NCT01271660|Anticonvulsants|anticonvulsants|mesh-ancestor
24658456|NCT01271660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24658474|NCT01271894|Antiviral Agents|antiviral agents|mesh-ancestor
24658475|NCT01271894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24658476|NCT01271894|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24658477|NCT01271894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24658478|NCT01271894|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24658479|NCT01271894|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24910284|NCT04301375|Paclitaxel|paclitaxel|mesh-list
24658480|NCT01271894|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24658481|NCT01271894|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24658482|NCT01271998|Tedizolid phosphate|tedizolid phosphate|mesh-list
24658483|NCT01271998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24658484|NCT01271998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24658485|NCT01272089|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
24658486|NCT01272089|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24658487|NCT01272089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24658488|NCT01272089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24658489|NCT01272089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24658491|NCT01272089|Sensory System Agents|sensory system agents|mesh-ancestor
24658492|NCT01272089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658547|NCT01272414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24658548|NCT01272414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658550|NCT01272531|Lithium Carbonate|lithium carbonate|mesh-list
24658556|NCT01272531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658557|NCT01272531|Antimanic Agents|antimanic agents|mesh-ancestor
24658558|NCT01272531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24658559|NCT01272531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24658560|NCT01272531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24658561|NCT01272531|Antidepressive Agents|antidepressive agents|mesh-ancestor
24658562|NCT01272557|Doxorubicin|doxorubicin|mesh-list
24658564|NCT01272557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24658565|NCT01272557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24658566|NCT01272557|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25690142|NCT01969084|Incretins|incretins|mesh-ancestor
25690143|NCT01969084|Hormones|hormones|mesh-ancestor
24658567|NCT01272557|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24658568|NCT01272557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24658569|NCT01272557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060867|NCT03475693|Magnesium Oxide|magnesium oxide|mesh-list
25060868|NCT03475693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24435766|NCT00268177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25060869|NCT03475693|Analgesics|analgesics|mesh-ancestor
25060870|NCT03475693|Sensory System Agents|sensory system agents|mesh-ancestor
25060871|NCT03475693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060872|NCT03475693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060873|NCT03475693|Antipyretics|antipyretics|mesh-ancestor
24658570|NCT01272557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24658571|NCT01272609|Timolol|timolol|mesh-list
24658572|NCT01272609|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24658573|NCT01272609|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25013466|NCT02575144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013467|NCT02575144|Immunologic Factors|immunologic factors|mesh-ancestor
25013468|NCT02575144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25013469|NCT02575144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25013470|NCT02575144|Growth Substances|growth substances|mesh-ancestor
25013483|NCT02574286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25013484|NCT02542956|Bupivacaine|bupivacaine|mesh-list
24658575|NCT01272609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24658576|NCT01272609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658577|NCT01272609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658578|NCT01272609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24658579|NCT01272609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24658580|NCT01272778|Lorazepam|lorazepam|mesh-list
24658629|NCT01273298|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24658631|NCT01273298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24658633|NCT01273298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24658635|NCT01273402|Antibodies|antibodies|mesh-list
24658701|NCT01273532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658702|NCT01273532|Adrenergic Agents|adrenergic agents|mesh-ancestor
24658703|NCT01273532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24658704|NCT01273558|Canagliflozin|canagliflozin|mesh-list
24819042|NCT02092766|Quinine|quinine|mesh-list
24658705|NCT01273558|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24658706|NCT01273558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658707|NCT01273558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24658716|NCT01273584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24658717|NCT01273584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658733|NCT01273727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24658734|NCT01273727|Antiemetics|antiemetics|mesh-ancestor
24658735|NCT01273727|Autonomic Agents|autonomic agents|mesh-ancestor
24658736|NCT01273727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658737|NCT01273727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658739|NCT01273727|Glucocorticoids|glucocorticoids|mesh-ancestor
24658751|NCT01273831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24658752|NCT01273831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24658753|NCT01273831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658754|NCT01273831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658755|NCT01273831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24658756|NCT01273831|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24658757|NCT01273831|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24658758|NCT01273831|Cholinergic Agents|cholinergic agents|mesh-ancestor
24417385|NCT00206388|Cyclophosphamide|cyclophosphamide|mesh-list
24658786|NCT01274026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658787|NCT01274026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24658788|NCT01274026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658790|NCT01274039|Acetazolamide|acetazolamide|mesh-list
24658849|NCT01274260|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24658850|NCT01274260|Protective Agents|protective agents|mesh-ancestor
24658851|NCT01274260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24658852|NCT01274260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24658853|NCT01274273|Interferons|interferons|mesh-list
24658854|NCT01274273|Interferon-alpha|interferon-alpha|mesh-list
25013487|NCT02542956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24485519|NCT00453414|Iloprost|iloprost|mesh-list
25690144|NCT01969084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25690145|NCT01969084|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25690146|NCT01969084|Protease Inhibitors|protease inhibitors|mesh-ancestor
25690147|NCT01969084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25690148|NCT01969084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690149|NCT01969201|Hormones|hormones|mesh-list
25690150|NCT01969201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25013495|NCT02471144|Analgesics|analgesics|mesh-ancestor
25013496|NCT02471144|Sensory System Agents|sensory system agents|mesh-ancestor
24658855|NCT01274273|Interferon alpha-2|interferon alpha-2|mesh-list
24658856|NCT01274273|Aldesleukin|aldesleukin|mesh-list
24658857|NCT01274273|Bevacizumab|bevacizumab|mesh-list
24658875|NCT01274325|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24658876|NCT01274325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24658878|NCT01274325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658879|NCT01274325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658880|NCT01274325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24658881|NCT01274325|Respiratory System Agents|respiratory system agents|mesh-ancestor
24658882|NCT01274325|Glucocorticoids|glucocorticoids|mesh-ancestor
24658883|NCT01274325|Hormones|hormones|mesh-ancestor
24658884|NCT01274325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24658885|NCT01274325|Sympathomimetics|sympathomimetics|mesh-ancestor
24658887|NCT01274403|Prednisone|prednisone|mesh-list
24658888|NCT01274403|Melphalan|melphalan|mesh-list
24658889|NCT01274403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24658890|NCT01274403|Glucocorticoids|glucocorticoids|mesh-ancestor
24658891|NCT01274403|Hormones|hormones|mesh-ancestor
24658892|NCT01274403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24658893|NCT01274403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658894|NCT01274403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24658895|NCT01274403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24658896|NCT01274403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24658897|NCT01274403|Alkylating Agents|alkylating agents|mesh-ancestor
24658898|NCT01274403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658899|NCT01274403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24658900|NCT01274403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24658901|NCT01274403|Immunologic Factors|immunologic factors|mesh-ancestor
24658902|NCT01274403|Leprostatic Agents|leprostatic agents|mesh-ancestor
24658903|NCT01274403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24658904|NCT01274403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24658905|NCT01274403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24658906|NCT01274403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24658907|NCT01274403|Growth Substances|growth substances|mesh-ancestor
24658908|NCT01274403|Growth Inhibitors|growth inhibitors|mesh-ancestor
24658957|NCT01274793|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24658959|NCT01274793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24658960|NCT01274793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658961|NCT01274988|Methadone|methadone|mesh-list
24658962|NCT01274988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24658963|NCT01274988|Narcotics|narcotics|mesh-ancestor
24658964|NCT01274988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25013497|NCT02471144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25013498|NCT02471144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911405|NCT04288349|Epinephrine|epinephrine|mesh-list
25013499|NCT02471144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25013500|NCT02471144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25013501|NCT02471144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25013502|NCT02471144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24658965|NCT01274988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658966|NCT01274988|Analgesics|analgesics|mesh-ancestor
24658967|NCT01274988|Sensory System Agents|sensory system agents|mesh-ancestor
24658968|NCT01274988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658969|NCT01274988|Antitussive Agents|antitussive agents|mesh-ancestor
24658971|NCT01275014|Dexamethasone|dexamethasone|mesh-list
24659035|NCT01275443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24659036|NCT01275443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24659037|NCT01275443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659038|NCT01275443|Antiviral Agents|antiviral agents|mesh-ancestor
24659039|NCT01275443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24659092|NCT01275599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659154|NCT01275911|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24659155|NCT01275911|Adrenergic Agents|adrenergic agents|mesh-ancestor
24659156|NCT01275911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24659157|NCT01275911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659158|NCT01275937|Esomeprazole|esomeprazole|mesh-list
24659159|NCT01275937|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24659160|NCT01275937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24659174|NCT01276015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24659175|NCT01276015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24659176|NCT01276015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659177|NCT01276015|Cholinergic Agents|cholinergic agents|mesh-ancestor
24659178|NCT01276015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24659189|NCT01276067|Nootropic Agents|nootropic agents|mesh-ancestor
24659199|NCT01276093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24659200|NCT01276093|Vasodilator Agents|vasodilator agents|mesh-ancestor
24659201|NCT01276093|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24659202|NCT01276093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24659203|NCT01276093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659204|NCT01276093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24659205|NCT01276093|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24659206|NCT01276093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24659207|NCT01276093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24659208|NCT01276093|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24659209|NCT01276093|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24659210|NCT01276093|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24659212|NCT01276210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659213|NCT01276210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24659214|NCT01276210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24659215|NCT01276210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659216|NCT01276262|Contraceptive Agents|contraceptive agents|mesh-list
24659217|NCT01276262|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25013503|NCT02471144|Immunologic Factors|immunologic factors|mesh-ancestor
25013504|NCT02440464|Fludarabine|fludarabine|mesh-list
25013505|NCT02440464|Bortezomib|bortezomib|mesh-list
25013506|NCT02440464|Melphalan|melphalan|mesh-list
25013507|NCT02440464|Ixazomib|ixazomib|mesh-list
25013508|NCT02440464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013509|NCT02440464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013510|NCT02440464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25013511|NCT02440464|Immunologic Factors|immunologic factors|mesh-ancestor
25013512|NCT02440464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013513|NCT02440464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25013514|NCT02440464|Alkylating Agents|alkylating agents|mesh-ancestor
25013515|NCT02440464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25013516|NCT02440464|Protease Inhibitors|protease inhibitors|mesh-ancestor
24659218|NCT01276262|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
24659219|NCT01276262|Contraceptives, Oral|contraceptives, oral|mesh-list
24659220|NCT01276262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24659221|NCT01276262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659222|NCT01276262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24659223|NCT01276262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24659224|NCT01276262|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24659225|NCT01276262|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25061020|NCT03474614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061021|NCT03474614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061022|NCT03474614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25061023|NCT03474614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25061024|NCT03474614|Vasodilator Agents|vasodilator agents|mesh-ancestor
25061025|NCT03474601|Hormones|hormones|mesh-list
25061026|NCT03474601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24659226|NCT01276262|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24659227|NCT01276262|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
24659228|NCT01276262|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24659231|NCT01276431|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24659318|NCT01276769|Mitosis Modulators|mitosis modulators|mesh-ancestor
24659319|NCT01276769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659320|NCT01276769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24659321|NCT01276769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24659322|NCT01276769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24659323|NCT01276769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24659324|NCT01276834|Everolimus|everolimus|mesh-list
24659325|NCT01276834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659326|NCT01276834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24659422|NCT01277627|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24659457|NCT01277770|Thymoglobulin|thymoglobulin|mesh-list
24659520|NCT01278238|Respiratory System Agents|respiratory system agents|mesh-ancestor
24659521|NCT01278238|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24659522|NCT01278238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24659524|NCT01278238|Adrenergic Agents|adrenergic agents|mesh-ancestor
24659525|NCT01278238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24659526|NCT01278238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659527|NCT01278238|Protective Agents|protective agents|mesh-ancestor
24659528|NCT01278264|Ropivacaine|ropivacaine|mesh-list
24659529|NCT01278264|Anesthetics, Local|anesthetics, local|mesh-ancestor
25013519|NCT02366728|Basiliximab|basiliximab|mesh-list
25013520|NCT02366728|Immunologic Factors|immunologic factors|mesh-ancestor
25013521|NCT02366728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013522|NCT02366728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25013523|NCT02366728|Alkylating Agents|alkylating agents|mesh-ancestor
25013524|NCT02366728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013525|NCT02366728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013526|NCT02366728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25013527|NCT02313870|Clobetasol|clobetasol|mesh-list
25013528|NCT02313870|Methotrexate|methotrexate|mesh-list
25013529|NCT02313870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24659580|NCT01278576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24659581|NCT01278602|Rituximab|rituximab|mesh-list
24659582|NCT01278602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24659583|NCT01278602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659584|NCT01278602|Immunologic Factors|immunologic factors|mesh-ancestor
24659585|NCT01278602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659586|NCT01278602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24659587|NCT01278758|Vadimezan|vadimezan|mesh-list
24659588|NCT01278758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659589|NCT01278784|Acetylcysteine|acetylcysteine|mesh-list
24659590|NCT01278784|Chitosan|chitosan|mesh-list
24659591|NCT01278784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24659592|NCT01278784|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24659593|NCT01278784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24659594|NCT01278784|Antiviral Agents|antiviral agents|mesh-ancestor
24659595|NCT01278784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24659596|NCT01278784|Expectorants|expectorants|mesh-ancestor
24659597|NCT01278784|Respiratory System Agents|respiratory system agents|mesh-ancestor
24659598|NCT01278784|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25690151|NCT01969201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690152|NCT01969435|Cytarabine|cytarabine|mesh-list
25690153|NCT01969435|Etoposide|etoposide|mesh-list
25690154|NCT01969435|Melphalan|melphalan|mesh-list
25690155|NCT01969435|Carmustine|carmustine|mesh-list
25690156|NCT01969435|Etoposide phosphate|etoposide phosphate|mesh-list
25690157|NCT01969435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25690158|NCT01969435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25690159|NCT01969435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24659606|NCT01278784|Antimetabolites|antimetabolites|mesh-ancestor
24659607|NCT01278784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24659608|NCT01278784|Chelating Agents|chelating agents|mesh-ancestor
24659649|NCT01279213|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24659650|NCT01279213|Clozapine|clozapine|mesh-list
24659651|NCT01279213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24659652|NCT01279213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24659653|NCT01279213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24659654|NCT01279213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659655|NCT01279213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24659656|NCT01279213|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24659657|NCT01279213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24659739|NCT01279512|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24659740|NCT01279512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24659741|NCT01279512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659743|NCT01279551|Nitroglycerin|nitroglycerin|mesh-list
24659744|NCT01279551|Anesthetics, Local|anesthetics, local|mesh-ancestor
24659745|NCT01279551|Anesthetics|anesthetics|mesh-ancestor
24659746|NCT01279551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24659747|NCT01279551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659749|NCT01279551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24659750|NCT01279551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24659755|NCT01279551|Vasodilator Agents|vasodilator agents|mesh-ancestor
25013530|NCT02313870|Abortifacient Agents|abortifacient agents|mesh-ancestor
25013531|NCT02313870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25013532|NCT02313870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013550|NCT02243709|Mifepristone|mifepristone|mesh-list
25013551|NCT02243709|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25013552|NCT02243709|Abortifacient Agents|abortifacient agents|mesh-ancestor
25013553|NCT02243709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25013554|NCT02243709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013555|NCT02243709|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25013556|NCT02243709|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25013557|NCT02243709|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25013558|NCT02243709|Contraceptive Agents|contraceptive agents|mesh-ancestor
25013559|NCT02243709|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25013560|NCT02243709|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25013561|NCT02243709|Hormone Antagonists|hormone antagonists|mesh-ancestor
25013562|NCT02243709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25013563|NCT02243709|Luteolytic Agents|luteolytic agents|mesh-ancestor
25013564|NCT02243709|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25013565|NCT02243709|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25013567|NCT02236806|Bisoprolol|bisoprolol|mesh-list
25013568|NCT02236806|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25013569|NCT02236806|Protease Inhibitors|protease inhibitors|mesh-ancestor
25013570|NCT02236806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25013571|NCT02236806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013572|NCT02236806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25013573|NCT02236806|Sympatholytics|sympatholytics|mesh-ancestor
25013574|NCT02236806|Autonomic Agents|autonomic agents|mesh-ancestor
24659844|NCT01280006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24659845|NCT01280006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659846|NCT01280006|Gout Suppressants|gout suppressants|mesh-ancestor
24659847|NCT01280006|Tocolytic Agents|tocolytic agents|mesh-ancestor
24659848|NCT01280006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24659850|NCT01280071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24659851|NCT01280071|Autonomic Agents|autonomic agents|mesh-ancestor
24659852|NCT01280071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24659853|NCT01280071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659854|NCT01280071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24659855|NCT01280071|Respiratory System Agents|respiratory system agents|mesh-ancestor
24659856|NCT01280071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24659857|NCT01280071|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24659858|NCT01280071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24659861|NCT01280071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24979502|NCT04133623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24889447|NCT04493463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889457|NCT04493463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24889458|NCT04493463|Protective Agents|protective agents|mesh-ancestor
25061229|NCT03472963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979503|NCT04133623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24979504|NCT04133623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24979505|NCT04133623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24979506|NCT04133623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013575|NCT02236806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25013576|NCT02236806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013577|NCT02236806|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25013578|NCT02236806|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25013579|NCT02236806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24970328|NCT03734302|Serotonin Agents|serotonin agents|mesh-ancestor
24970329|NCT03734302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24659894|NCT01280305|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
24659928|NCT01280929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24659930|NCT01280929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659931|NCT01280929|Growth Inhibitors|growth inhibitors|mesh-ancestor
24659932|NCT01280929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659934|NCT01280994|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24659935|NCT01280994|Anesthetics, General|anesthetics, general|mesh-ancestor
24659936|NCT01280994|Anesthetics|anesthetics|mesh-ancestor
24659937|NCT01280994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24659938|NCT01280994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659939|NCT01281111|Aspirin|aspirin|mesh-list
24659940|NCT01281111|Dimethyl Fumarate|dimethyl fumarate|mesh-list
24659941|NCT01281111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24659942|NCT01281111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24615785|NCT01031901|Sirolimus|sirolimus|mesh-list
24660023|NCT01281553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24660024|NCT01281553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660028|NCT01281566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24660029|NCT01281566|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24660031|NCT01281566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24660032|NCT01281566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660033|NCT01281566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660034|NCT01281579|Canagliflozin|canagliflozin|mesh-list
24660035|NCT01281579|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24660036|NCT01281579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970335|NCT03734159|Anesthetics, Local|anesthetics, local|mesh-ancestor
25013581|NCT02236806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25013583|NCT02236572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013584|NCT02236572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25013585|NCT02236572|Immunologic Factors|immunologic factors|mesh-ancestor
25013586|NCT02236572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013587|NCT02220452|Anesthetics|anesthetics|mesh-list
25013588|NCT02220452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25013589|NCT02220452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013592|NCT02083354|Trametinib|trametinib|mesh-list
25013593|NCT02083354|Dabrafenib|dabrafenib|mesh-list
25013594|NCT02083354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013595|NCT02083354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25013596|NCT02083354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25013597|NCT02083354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621921|NCT01064726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660039|NCT01281605|Insulin|insulin|mesh-list
25690160|NCT01969435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25690161|NCT01969435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25690162|NCT01969435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690163|NCT01969435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25690164|NCT01969435|Antimetabolites|antimetabolites|mesh-ancestor
25690165|NCT01969435|Antiviral Agents|antiviral agents|mesh-ancestor
25690166|NCT01969435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25690167|NCT01969435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25690168|NCT01969435|Immunologic Factors|immunologic factors|mesh-ancestor
25690169|NCT01969435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690170|NCT01969435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24914648|NCT04253132|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
24660070|NCT01281696|Immunologic Factors|immunologic factors|mesh-ancestor
25013598|NCT02065635|Propofol|propofol|mesh-list
25013599|NCT02065635|Sevoflurane|sevoflurane|mesh-list
25013600|NCT02065635|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25013601|NCT02065635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25013602|NCT02065635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013603|NCT02065635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25013605|NCT02065635|Anesthetics|anesthetics|mesh-ancestor
25013606|NCT02065635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25013607|NCT02065635|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25013608|NCT02061514|Propofol|propofol|mesh-list
25013609|NCT02061514|Desflurane|desflurane|mesh-list
25013610|NCT02061514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25013611|NCT02061514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25013612|NCT02061514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013613|NCT02061514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25013644|NCT01399918|Growth Substances|growth substances|mesh-ancestor
24979525|NCT04042831|Olaparib|olaparib|mesh-list
24914649|NCT04253132|Hormone Antagonists|hormone antagonists|mesh-ancestor
25109297|NCT03125980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24914650|NCT04253132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24914726|NCT04252456|Vitamins|vitamins|mesh-ancestor
24914760|NCT04252300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660078|NCT01281748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24660079|NCT01281748|Prednisolone|prednisolone|mesh-list
24660080|NCT01281748|Prednisolone acetate|prednisolone acetate|mesh-list
24660081|NCT01281748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24660082|NCT01281748|Prednisolone phosphate|prednisolone phosphate|mesh-list
24660083|NCT01281748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24660084|NCT01281748|Antiemetics|antiemetics|mesh-ancestor
24660085|NCT01281748|Autonomic Agents|autonomic agents|mesh-ancestor
24660086|NCT01281748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24660087|NCT01281748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660088|NCT01281748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24660089|NCT01281748|Glucocorticoids|glucocorticoids|mesh-ancestor
24660091|NCT01281748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24660092|NCT01281748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24660100|NCT01281761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24660102|NCT01281761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660103|NCT01281761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660104|NCT01281761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25690171|NCT01969435|Alkylating Agents|alkylating agents|mesh-ancestor
25690172|NCT01969435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25690173|NCT01969708|Bevacizumab|bevacizumab|mesh-list
25690174|NCT01969708|Aflibercept|aflibercept|mesh-list
25690175|NCT01969708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25690176|NCT01969708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25690177|NCT01969708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24744227|NCT04430517|Antimetabolites|antimetabolites|mesh-ancestor
25690178|NCT01969708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25690179|NCT01969708|Growth Substances|growth substances|mesh-ancestor
25061343|NCT03472144|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25061344|NCT03472144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25061345|NCT03472144|Antitubercular Agents|antitubercular agents|mesh-ancestor
25061346|NCT03472144|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25061347|NCT03472144|Renal Agents|renal agents|mesh-ancestor
25061348|NCT03472144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24660105|NCT01281761|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24660112|NCT01281787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24660117|NCT01281787|Sympatholytics|sympatholytics|mesh-ancestor
24660201|NCT01282073|Mycophenolic Acid|mycophenolic acid|mesh-list
24660202|NCT01282073|Cyclosporins|cyclosporins|mesh-list
24660203|NCT01282073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660204|NCT01282073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660276|NCT01282541|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24660277|NCT01282541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24660278|NCT01282541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660279|NCT01282541|Cholinergic Agents|cholinergic agents|mesh-ancestor
24660280|NCT01282541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24660281|NCT01282541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660282|NCT01282541|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24814453|NCT02064556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814454|NCT02064556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24660284|NCT01282619|Huperzine A|huperzine a|mesh-list
24660285|NCT01282619|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24660286|NCT01282619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660287|NCT01282619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660288|NCT01282619|Cholinergic Agents|cholinergic agents|mesh-ancestor
24660289|NCT01282619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25013653|NCT01078454|Antiemetics|antiemetics|mesh-ancestor
25013654|NCT01078454|Autonomic Agents|autonomic agents|mesh-ancestor
25013655|NCT01078454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25013656|NCT01078454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013657|NCT01078454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25013658|NCT01078454|Glucocorticoids|glucocorticoids|mesh-ancestor
24585549|NCT00886028|Doxorubicin|doxorubicin|mesh-list
25013659|NCT01078454|Hormones|hormones|mesh-ancestor
24575385|NCT00830895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013676|NCT00458536|Immunologic Factors|immunologic factors|mesh-ancestor
25013677|NCT00458536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013678|NCT00458536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013679|NCT00112840|Bevacizumab|bevacizumab|mesh-list
25013680|NCT00112840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25013681|NCT00112840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013682|NCT00112840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25013683|NCT00112840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25013684|NCT00112840|Growth Substances|growth substances|mesh-ancestor
25690180|NCT01969708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690181|NCT01969708|Growth Inhibitors|growth inhibitors|mesh-ancestor
25690182|NCT01969721|Fluticasone|fluticasone|mesh-list
25690183|NCT01969721|Xhance|xhance|mesh-list
25690184|NCT01969721|Tiotropium Bromide|tiotropium bromide|mesh-list
25690185|NCT01969721|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25690186|NCT01969721|Olodaterol|olodaterol|mesh-list
25690187|NCT01969721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25690188|NCT01969721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25690189|NCT01969721|Autonomic Agents|autonomic agents|mesh-ancestor
25690190|NCT01969721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25690191|NCT01969721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690192|NCT01969721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25061371|NCT03471819|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25061372|NCT03471819|Serotonin Agents|serotonin agents|mesh-ancestor
25061376|NCT03471585|Dronabinol|dronabinol|mesh-list
25013685|NCT00112840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013686|NCT00112840|Growth Inhibitors|growth inhibitors|mesh-ancestor
25013687|NCT05223244|Triamcinolone|triamcinolone|mesh-list
25013688|NCT05223244|Heparin|heparin|mesh-list
25013689|NCT05223244|Bupivacaine|bupivacaine|mesh-list
25013690|NCT05223244|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
25013691|NCT05223244|Anesthetics, Local|anesthetics, local|mesh-ancestor
25013692|NCT05223244|Anesthetics|anesthetics|mesh-ancestor
24660290|NCT01282619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744503|NCT04262687|Antimetabolites|antimetabolites|mesh-ancestor
24660291|NCT01282619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24418102|NCT00208572|Citalopram|citalopram|mesh-list
24660327|NCT01282762|Vaccines|vaccines|mesh-list
24660329|NCT01282762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660330|NCT01282840|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24660331|NCT01282840|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24915004|NCT05251766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915005|NCT05251662|Bevacizumab|bevacizumab|mesh-list
24660332|NCT01282840|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24660333|NCT01282840|Cholinergic Agents|cholinergic agents|mesh-ancestor
24660334|NCT01282840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24660335|NCT01282840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660336|NCT01282840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660337|NCT01282840|Urological Agents|urological agents|mesh-ancestor
24660338|NCT01282879|Itraconazole|itraconazole|mesh-list
24660339|NCT01282879|Antifungal Agents|antifungal agents|mesh-ancestor
24660343|NCT01282879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660376|NCT01283178|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24660377|NCT01283178|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24660378|NCT01283178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660380|NCT01283204|Paclitaxel|paclitaxel|mesh-list
24660381|NCT01283204|Docetaxel|docetaxel|mesh-list
24660382|NCT01283204|Cisplatin|cisplatin|mesh-list
24660383|NCT01283204|Oxaliplatin|oxaliplatin|mesh-list
24660384|NCT01283204|Levoleucovorin|levoleucovorin|mesh-list
24660385|NCT01283204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25013693|NCT05223244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25013694|NCT05223244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013695|NCT05223244|Sensory System Agents|sensory system agents|mesh-ancestor
25013696|NCT05223244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25013697|NCT05223244|Anticoagulants|anticoagulants|mesh-ancestor
25013698|NCT05223244|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25013699|NCT05223244|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25013700|NCT05223244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013701|NCT05223244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24660386|NCT01283204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660388|NCT01283204|Antimitotic Agents|antimitotic agents|mesh-ancestor
24660389|NCT01283204|Mitosis Modulators|mitosis modulators|mesh-ancestor
24660391|NCT01283204|Antidotes|antidotes|mesh-ancestor
24660411|NCT01283360|Tenofovir|tenofovir|mesh-list
24660412|NCT01283360|Antiviral Agents|antiviral agents|mesh-ancestor
24660413|NCT01283360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24660414|NCT01283360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24660415|NCT01283360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24660416|NCT01283360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660417|NCT01283360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660418|NCT01283360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24660419|NCT01283360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24660453|NCT01283724|Hormone Antagonists|hormone antagonists|mesh-ancestor
24660454|NCT01283724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24660455|NCT01283724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24660456|NCT01283724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660457|NCT01283763|Imiquimod|imiquimod|mesh-list
24660458|NCT01283763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24660459|NCT01283763|Immunologic Factors|immunologic factors|mesh-ancestor
24660460|NCT01283763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660461|NCT01283763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660476|NCT01283789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24660477|NCT01283789|Immunologic Factors|immunologic factors|mesh-ancestor
24660490|NCT01283841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690193|NCT01969721|Respiratory System Agents|respiratory system agents|mesh-ancestor
25690194|NCT01969721|Dermatologic Agents|dermatologic agents|mesh-ancestor
24660491|NCT01283867|Mycophenolic Acid|mycophenolic acid|mesh-list
24660492|NCT01283867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24660493|NCT01283867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660494|NCT01283867|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24660495|NCT01283867|Antitubercular Agents|antitubercular agents|mesh-ancestor
24660496|NCT01283867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24660497|NCT01283867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24660498|NCT01283867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660499|NCT01283867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660500|NCT01283919|Pantoprazole|pantoprazole|mesh-list
24660509|NCT01283932|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24660510|NCT01283932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660511|NCT01283932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660512|NCT01284049|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25013705|NCT05223244|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25013706|NCT05223244|Protective Agents|protective agents|mesh-ancestor
25013707|NCT05223244|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25013709|NCT05223088|Oxaliplatin|oxaliplatin|mesh-list
25013710|NCT05223088|Apatinib|apatinib|mesh-list
24660539|NCT01284309|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24660540|NCT01284309|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24660541|NCT01284309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24418212|NCT00208923|Busulfan|busulfan|mesh-list
24660605|NCT01284725|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24660606|NCT01284725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24660607|NCT01284725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660608|NCT01284725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660609|NCT01284725|Antimetabolites|antimetabolites|mesh-ancestor
24660610|NCT01284725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24660611|NCT01284725|Immunologic Factors|immunologic factors|mesh-ancestor
24660612|NCT01284725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660613|NCT01284725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24660614|NCT01284764|Mosapride|mosapride|mesh-list
24660615|NCT01284764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24660616|NCT01284764|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24660650|NCT01284907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24660651|NCT01284946|Deferasirox|deferasirox|mesh-list
24660652|NCT01284946|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24660653|NCT01284946|Chelating Agents|chelating agents|mesh-ancestor
24660654|NCT01284946|Sequestering Agents|sequestering agents|mesh-ancestor
24660655|NCT01284946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660656|NCT01285037|Gemcitabine|gemcitabine|mesh-list
24660657|NCT01285037|Cetuximab|cetuximab|mesh-list
24660658|NCT01285037|Ramucirumab|ramucirumab|mesh-list
24660659|NCT01285037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660660|NCT01285037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24660661|NCT01285037|Antimetabolites|antimetabolites|mesh-ancestor
24660662|NCT01285037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660663|NCT01285037|Antiviral Agents|antiviral agents|mesh-ancestor
24660664|NCT01285037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24660665|NCT01285037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660666|NCT01285037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25013711|NCT05223088|Tegafur|tegafur|mesh-list
25013712|NCT05223088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013713|NCT05223088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25013714|NCT05223088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25013715|NCT05223088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013716|NCT05223088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25013717|NCT05223088|Antimetabolites|antimetabolites|mesh-ancestor
25110535|NCT05460338|Cholecalciferol|cholecalciferol|mesh-list
25110536|NCT05460338|Vitamin D|vitamin d|mesh-list
25110537|NCT05460338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25110538|NCT05460338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110539|NCT05460338|Vitamins|vitamins|mesh-ancestor
25110540|NCT05460338|Micronutrients|micronutrients|mesh-ancestor
25110541|NCT05460338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24660717|NCT01285414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24660718|NCT01285414|Alkylating Agents|alkylating agents|mesh-ancestor
24660720|NCT01285414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660722|NCT01285453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660723|NCT01285466|Paclitaxel|paclitaxel|mesh-list
24660724|NCT01285466|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24890098|NCT04485780|Cholinergic Agents|cholinergic agents|mesh-ancestor
24660725|NCT01285466|Trastuzumab|trastuzumab|mesh-list
24660726|NCT01285466|Dactolisib|dactolisib|mesh-list
24660727|NCT01285466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24660728|NCT01285466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660729|NCT01285466|Tubulin Modulators|tubulin modulators|mesh-ancestor
24660730|NCT01285466|Antimitotic Agents|antimitotic agents|mesh-ancestor
24660732|NCT01285466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660733|NCT01285466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24660735|NCT01285505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24660736|NCT01285505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25110550|NCT05456269|Decitabine|decitabine|mesh-list
25110551|NCT05456269|Bisantrene|bisantrene|mesh-list
25110552|NCT05456269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25110553|NCT05456269|Antimetabolites|antimetabolites|mesh-ancestor
25110554|NCT05456269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110555|NCT05456269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25110556|NCT05456269|Antiviral Agents|antiviral agents|mesh-ancestor
25110557|NCT05456269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25110558|NCT05456269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25110559|NCT05456269|Immunologic Factors|immunologic factors|mesh-ancestor
25110560|NCT05456269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110561|NCT05456269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25110562|NCT05456269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25110571|NCT05451550|Anesthetics|anesthetics|mesh-list
25110572|NCT05451550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25013718|NCT05223010|Sevoflurane|sevoflurane|mesh-list
25013719|NCT05223010|Melatonin|melatonin|mesh-list
25013720|NCT05223010|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25013721|NCT05223010|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25013722|NCT05223010|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24660737|NCT01285505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013736|NCT05222646|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25013737|NCT05222646|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25013738|NCT05222646|Dopamine Agents|dopamine agents|mesh-ancestor
25013739|NCT05222646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24661596|NCT01290120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25013741|NCT05222633|Ranibizumab|ranibizumab|mesh-list
25013742|NCT05222633|Aflibercept|aflibercept|mesh-list
25013743|NCT05222633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25013744|NCT05222633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25013745|NCT05222633|Growth Substances|growth substances|mesh-ancestor
25013746|NCT05222633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013747|NCT05222633|Growth Inhibitors|growth inhibitors|mesh-ancestor
25013748|NCT05222633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013749|NCT05222607|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25013750|NCT05222607|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25013751|NCT05222607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25013752|NCT05222607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013753|NCT05222607|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25013754|NCT05222607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24660738|NCT01285505|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24660739|NCT01285505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24660740|NCT01285505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24660741|NCT01285505|GABA Modulators|gaba modulators|mesh-ancestor
24660742|NCT01285505|GABA Agents|gaba agents|mesh-ancestor
24660759|NCT01285596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660760|NCT01285596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660761|NCT01285596|Urological Agents|urological agents|mesh-ancestor
24660763|NCT01285661|Warfarin|warfarin|mesh-list
24660764|NCT01285661|Anticoagulants|anticoagulants|mesh-list
24660765|NCT01285661|Vitamins|vitamins|mesh-ancestor
24660770|NCT01285661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660771|NCT01285661|Hemostatics|hemostatics|mesh-ancestor
25690195|NCT01969721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25690196|NCT01969721|Parasympatholytics|parasympatholytics|mesh-ancestor
25690197|NCT01969721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25690198|NCT01969721|Cholinergic Agents|cholinergic agents|mesh-ancestor
25690199|NCT01969721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25690200|NCT01969721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061630|NCT03469544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25061631|NCT03469544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660772|NCT01285661|Coagulants|coagulants|mesh-ancestor
24660829|NCT01286090|Serotonin Agents|serotonin agents|mesh-ancestor
24660830|NCT01286090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24660831|NCT01286090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660832|NCT01286090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660833|NCT01286103|Canagliflozin|canagliflozin|mesh-list
24660834|NCT01286103|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24660835|NCT01286103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660836|NCT01286103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24660837|NCT01286103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660838|NCT01286194|Rabeprazole|rabeprazole|mesh-list
24660839|NCT01286194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24660840|NCT01286194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24660841|NCT01286194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24660842|NCT01286194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660843|NCT01286194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660844|NCT01286233|Metformin|metformin|mesh-list
25013755|NCT05222607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013756|NCT05222607|Cholinergic Agents|cholinergic agents|mesh-ancestor
25013757|NCT05222607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25013758|NCT05222334|Bupivacaine|bupivacaine|mesh-list
25013759|NCT05222334|Anesthetics, Local|anesthetics, local|mesh-ancestor
25013760|NCT05222334|Anesthetics|anesthetics|mesh-ancestor
25013761|NCT05222334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25013762|NCT05222334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013763|NCT05222334|Sensory System Agents|sensory system agents|mesh-ancestor
25013764|NCT05222334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25013765|NCT05222243|Calcium|calcium|mesh-list
25013766|NCT05222243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25013767|NCT05222243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013768|NCT05222204|Gemcitabine|gemcitabine|mesh-list
25013769|NCT05222204|Paclitaxel|paclitaxel|mesh-list
25013770|NCT05222204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25013771|NCT05222204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013772|NCT05222204|Tubulin Modulators|tubulin modulators|mesh-ancestor
25013773|NCT05222204|Antimitotic Agents|antimitotic agents|mesh-ancestor
25013774|NCT05222204|Mitosis Modulators|mitosis modulators|mesh-ancestor
25013775|NCT05222204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013776|NCT05222204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25013777|NCT05222204|Antimetabolites|antimetabolites|mesh-ancestor
25013778|NCT05222204|Antiviral Agents|antiviral agents|mesh-ancestor
24660987|NCT01287494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24660989|NCT01287494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660990|NCT01287494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24660991|NCT01287494|Serotonin Agents|serotonin agents|mesh-ancestor
24660992|NCT01287494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660993|NCT01287507|Lactoferrin|lactoferrin|mesh-list
24660994|NCT01287507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24660995|NCT01287533|Ibandronic Acid|ibandronic acid|mesh-list
24660996|NCT01287533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24660997|NCT01287533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660998|NCT01287546|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24660999|NCT01287546|Trametinib|trametinib|mesh-list
24661000|NCT01287546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661237|NCT01288547|Vasodilator Agents|vasodilator agents|mesh-ancestor
24661239|NCT01288573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24661240|NCT01288573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24661241|NCT01288573|Antiviral Agents|antiviral agents|mesh-ancestor
24661242|NCT01288573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24661243|NCT01288664|Tacrolimus|tacrolimus|mesh-list
24661244|NCT01288664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24661245|NCT01288664|Immunologic Factors|immunologic factors|mesh-ancestor
25690201|NCT01969721|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25690202|NCT01969721|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25690203|NCT01969721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24513341|NCT00580814|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24890479|NCT04482881|Misoprostol|misoprostol|mesh-list
24661246|NCT01288664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661248|NCT01288664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661296|NCT01288820|Artesunate|artesunate|mesh-list
24661297|NCT01288820|Piperaquine|piperaquine|mesh-list
24661298|NCT01288820|Primaquine|primaquine|mesh-list
25013781|NCT05222204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24575542|NCT00832364|Etanercept|etanercept|mesh-list
25013806|NCT05221892|Pyridoxine|pyridoxine|mesh-list
25013807|NCT05221892|Vitamin B 12|vitamin b 12|mesh-list
25013808|NCT05221892|Hydroxocobalamin|hydroxocobalamin|mesh-list
25013809|NCT05221892|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
25013810|NCT05221892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013811|NCT05221892|Vitamin B Complex|vitamin b complex|mesh-ancestor
25013812|NCT05221892|Vitamins|vitamins|mesh-ancestor
25013813|NCT05221892|Micronutrients|micronutrients|mesh-ancestor
25013814|NCT05221892|Hematinics|hematinics|mesh-ancestor
25013815|NCT05221892|GABA Agents|gaba agents|mesh-ancestor
25013816|NCT05221892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25013817|NCT05221892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013818|NCT05221879|Enoxaparin|enoxaparin|mesh-list
25013819|NCT05221879|Anticoagulants|anticoagulants|mesh-ancestor
24661299|NCT01288820|Amodiaquine|amodiaquine|mesh-list
24661300|NCT01288820|Artenimol|artenimol|mesh-list
24661301|NCT01288820|Antimalarials|antimalarials|mesh-ancestor
24661302|NCT01288820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24661303|NCT01288820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24661304|NCT01288820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24661305|NCT01288820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661306|NCT01288820|Antiviral Agents|antiviral agents|mesh-ancestor
24661307|NCT01288820|Schistosomicides|schistosomicides|mesh-ancestor
24661308|NCT01288820|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24661309|NCT01288820|Anthelmintics|anthelmintics|mesh-ancestor
24819692|NCT02096913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24819693|NCT02096913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819694|NCT02096913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24819720|NCT02097004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24819725|NCT02097017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819726|NCT02097017|Sensory System Agents|sensory system agents|mesh-ancestor
24819727|NCT02097017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24819728|NCT02097017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24819729|NCT02097017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24819730|NCT02097017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24819731|NCT02097017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24739386|NCT01680952|Mycophenolic Acid|mycophenolic acid|mesh-list
24661361|NCT01289132|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24661362|NCT01289132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661363|NCT01289171|Glycolic acid|glycolic acid|mesh-list
24661364|NCT01289171|Keratolytic Agents|keratolytic agents|mesh-ancestor
24661365|NCT01289171|Dermatologic Agents|dermatologic agents|mesh-ancestor
24661366|NCT01289223|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24661369|NCT01289223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661371|NCT01289236|Milnacipran|milnacipran|mesh-list
24661372|NCT01289236|Levomilnacipran|levomilnacipran|mesh-list
24661373|NCT01289236|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24661374|NCT01289236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24661375|NCT01289236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24661376|NCT01289236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661377|NCT01289236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24661459|NCT01289561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24661460|NCT01289561|Antimalarials|antimalarials|mesh-ancestor
24661461|NCT01289561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24661462|NCT01289561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24661463|NCT01289561|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24661464|NCT01289561|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24661465|NCT01289561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24661466|NCT01289561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24661467|NCT01289561|Analgesics|analgesics|mesh-ancestor
24661468|NCT01289561|Sensory System Agents|sensory system agents|mesh-ancestor
24661469|NCT01289730|Etanercept|etanercept|mesh-list
25013820|NCT05221879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25013821|NCT05221879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25690204|NCT01969721|Adrenergic Agents|adrenergic agents|mesh-ancestor
25690205|NCT01969747|Empagliflozin|empagliflozin|mesh-list
25013822|NCT05221879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013824|NCT05221775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661470|NCT01289730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24661485|NCT01289743|Sensory System Agents|sensory system agents|mesh-ancestor
24661486|NCT01289743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24661487|NCT01289743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661488|NCT01289743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24661489|NCT01289743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24745197|NCT03922451|Cefazolin|cefazolin|mesh-list
24661490|NCT01289743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24661491|NCT01289743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24661492|NCT01289743|Immunologic Factors|immunologic factors|mesh-ancestor
24661494|NCT01289756|Paroxetine|paroxetine|mesh-list
24661495|NCT01289756|Clomiphene|clomiphene|mesh-list
24661517|NCT01289756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24661518|NCT01289756|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24661519|NCT01289756|Fertility Agents|fertility agents|mesh-ancestor
24661520|NCT01289756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24661521|NCT01289756|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24661522|NCT01289756|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24661523|NCT01289769|Dexmedetomidine|dexmedetomidine|mesh-list
24661524|NCT01289769|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24661525|NCT01289769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24661526|NCT01289769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661543|NCT01289925|Micronutrients|micronutrients|mesh-ancestor
24661544|NCT01289938|Diphenhydramine|diphenhydramine|mesh-list
24661545|NCT01289938|Promethazine|promethazine|mesh-list
24661546|NCT01289938|Metoclopramide|metoclopramide|mesh-list
24661547|NCT01289938|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24661548|NCT01289938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24661549|NCT01289938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24661550|NCT01289938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661551|NCT01289938|Anesthetics, Local|anesthetics, local|mesh-ancestor
24661552|NCT01289938|Anesthetics|anesthetics|mesh-ancestor
24661555|NCT01289938|Antiemetics|antiemetics|mesh-ancestor
24661595|NCT01290120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661599|NCT01290120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24916187|NCT04243850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490970|NCT00480649|Autonomic Agents|autonomic agents|mesh-ancestor
24916213|NCT04243434|Alkylating Agents|alkylating agents|mesh-ancestor
24916215|NCT04243434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661600|NCT01290120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661601|NCT01290120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661603|NCT01290133|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24661604|NCT01290133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24661605|NCT01290133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661606|NCT01290133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661607|NCT01290146|Simendan|simendan|mesh-list
24661608|NCT01290146|Diuretics|diuretics|mesh-list
24661609|NCT01290146|Natriuretic Agents|natriuretic agents|mesh-ancestor
24661610|NCT01290146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661611|NCT01290146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24661612|NCT01290146|Vasodilator Agents|vasodilator agents|mesh-ancestor
24661613|NCT01290146|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24661614|NCT01290146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24661615|NCT01290146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661616|NCT01290146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013825|NCT05221775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25013826|NCT05221775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25013827|NCT05221775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013832|NCT05221736|Ethanol|ethanol|mesh-list
24575588|NCT00832442|Sympathomimetics|sympathomimetics|mesh-ancestor
25013848|NCT05221645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25013849|NCT05221645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25013850|NCT05221645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24891458|NCT04470557|Fibrin fragment D|fibrin fragment d|mesh-list
24891459|NCT04470557|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24891460|NCT04470557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24891462|NCT04470557|Hemostatics|hemostatics|mesh-ancestor
25013851|NCT05221645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013852|NCT05221645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25013853|NCT05221645|Alkylating Agents|alkylating agents|mesh-ancestor
25013854|NCT05221593|Lithium Carbonate|lithium carbonate|mesh-list
25013855|NCT05221593|Antidepressive Agents|antidepressive agents|mesh-ancestor
25013856|NCT05221593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25013857|NCT05221593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25013858|NCT05221593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013859|NCT05221593|Antimanic Agents|antimanic agents|mesh-ancestor
25013860|NCT05221593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25013861|NCT05221593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25013862|NCT05221593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661686|NCT01290354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24661687|NCT01290354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661688|NCT01290354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661690|NCT01290367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24661691|NCT01290367|Immunologic Factors|immunologic factors|mesh-ancestor
24661692|NCT01290367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661693|NCT01290367|Viscosupplements|viscosupplements|mesh-ancestor
24661694|NCT01290367|Protective Agents|protective agents|mesh-ancestor
24916264|NCT04242914|Anesthetics|anesthetics|mesh-ancestor
24661695|NCT01290380|Vadimezan|vadimezan|mesh-list
24661709|NCT01290432|Hematinics|hematinics|mesh-ancestor
24661710|NCT01290432|Vitamin B Complex|vitamin b complex|mesh-ancestor
24661711|NCT01290432|Vitamins|vitamins|mesh-ancestor
24661721|NCT01290458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661722|NCT01290458|Protective Agents|protective agents|mesh-ancestor
24661724|NCT01290471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24661729|NCT01290497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661730|NCT01290497|Viscosupplements|viscosupplements|mesh-ancestor
24970581|NCT03732105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970582|NCT03732105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24970583|NCT03732105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24970584|NCT03732105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970585|NCT03732105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24970586|NCT03732105|Growth Substances|growth substances|mesh-ancestor
24970587|NCT03732105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970588|NCT03732105|Growth Inhibitors|growth inhibitors|mesh-ancestor
24794150|NCT05413863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24586288|NCT00890110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24586289|NCT00890110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24586290|NCT00890110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586292|NCT00890175|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24586293|NCT00890175|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24661731|NCT01290497|Protective Agents|protective agents|mesh-ancestor
24661732|NCT01290510|Hyaluronic Acid|hyaluronic acid|mesh-list
24661733|NCT01290510|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24661734|NCT01290510|Immunologic Factors|immunologic factors|mesh-ancestor
24661735|NCT01290510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661736|NCT01290510|Viscosupplements|viscosupplements|mesh-ancestor
24661737|NCT01290510|Protective Agents|protective agents|mesh-ancestor
24661769|NCT01290900|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24661770|NCT01290926|Sorafenib|sorafenib|mesh-list
25690206|NCT01969747|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25690207|NCT01969747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690208|NCT01969747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25690209|NCT01969747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690210|NCT01969799|Amikacin|amikacin|mesh-list
25690211|NCT01969799|Fosfomycin|fosfomycin|mesh-list
25690212|NCT01969799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25690213|NCT01969799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24892044|NCT04465916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24892045|NCT04465916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661771|NCT01290926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661772|NCT01290926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24661773|NCT01290926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661774|NCT01290926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661776|NCT01290939|Lomustine|lomustine|mesh-list
24661777|NCT01290939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24661795|NCT01291095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661796|NCT01291121|Ranibizumab|ranibizumab|mesh-list
24661797|NCT01291121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24661798|NCT01291121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24661853|NCT01291316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418799|NCT00210210|Ketamine|ketamine|mesh-list
24661917|NCT01291511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586294|NCT00890175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24586295|NCT00890175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586297|NCT00890175|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24586310|NCT00890188|Growth Substances|growth substances|mesh-ancestor
24586311|NCT00890188|Growth Inhibitors|growth inhibitors|mesh-ancestor
24586312|NCT00890188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586313|NCT00890214|Epoprostenol|epoprostenol|mesh-list
24586375|NCT00890487|Viscosupplements|viscosupplements|mesh-ancestor
24586376|NCT00890487|Protective Agents|protective agents|mesh-ancestor
24586377|NCT00890500|Sirolimus|sirolimus|mesh-list
24586378|NCT00890500|Fludarabine|fludarabine|mesh-list
24586379|NCT00890500|Melphalan|melphalan|mesh-list
24586380|NCT00890500|Tacrolimus|tacrolimus|mesh-list
24586381|NCT00890500|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24586382|NCT00890500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013944|NCT05219669|Sensory System Agents|sensory system agents|mesh-ancestor
24661922|NCT01291524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24661923|NCT01291524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661925|NCT01291524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24661926|NCT01291524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24661927|NCT01291524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661966|NCT01291602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24661967|NCT01291602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24661969|NCT01291615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24661970|NCT01291615|Antimetabolites|antimetabolites|mesh-ancestor
24661971|NCT01291615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661972|NCT01291615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661992|NCT01291641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24661993|NCT01291641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24661994|NCT01291641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661995|NCT01291641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24661996|NCT01291641|Vasodilator Agents|vasodilator agents|mesh-ancestor
24451486|NCT00323934|Mocetinostat|mocetinostat|mesh-list
24661997|NCT01291641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24661998|NCT01291641|Protective Agents|protective agents|mesh-ancestor
24661999|NCT01291641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24662000|NCT01291641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24662098|NCT01292460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24662099|NCT01292460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662100|NCT01292460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662101|NCT01292460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24662102|NCT01292460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24662104|NCT01292525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24662105|NCT01292525|Immunologic Factors|immunologic factors|mesh-ancestor
25690214|NCT01969851|Lacosamide|lacosamide|mesh-list
25690215|NCT01969851|Anticonvulsants|anticonvulsants|mesh-ancestor
25690216|NCT01969851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25690217|NCT01969851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25690218|NCT01969851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25690219|NCT01969851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690220|NCT01969916|Regadenoson|regadenoson|mesh-list
25690221|NCT01969916|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
24662106|NCT01292525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455766|NCT00328913|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
24662107|NCT01292525|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24586405|NCT00890539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24586406|NCT00890539|Cholinergic Agents|cholinergic agents|mesh-ancestor
24586407|NCT00890539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24586408|NCT00890539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586409|NCT00890565|Granisetron|granisetron|mesh-list
24586410|NCT00890565|Antiemetics|antiemetics|mesh-ancestor
25013883|NCT05221411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013884|NCT05221411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25013885|NCT05221411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013886|NCT05221411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25013887|NCT05221411|Antitubercular Agents|antitubercular agents|mesh-ancestor
25013888|NCT05221411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25013889|NCT05221411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25013893|NCT05221190|Lidocaine|lidocaine|mesh-list
25013895|NCT05221190|Anesthetics|anesthetics|mesh-ancestor
25013896|NCT05221190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25013897|NCT05221190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013898|NCT05221190|Sensory System Agents|sensory system agents|mesh-ancestor
25013899|NCT05221190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25013900|NCT05221190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25013901|NCT05221190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25013902|NCT05221190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25013903|NCT05221190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24662108|NCT01292525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24662109|NCT01292525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662111|NCT01292551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24662112|NCT01292551|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24662113|NCT01292551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662114|NCT01292616|Antirheumatic Agents|antirheumatic agents|mesh-list
24662115|NCT01292668|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25013904|NCT05221190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013905|NCT05221164|Aspirin|aspirin|mesh-list
25013906|NCT05221164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25013907|NCT05221164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25013908|NCT05221164|Analgesics|analgesics|mesh-ancestor
25013909|NCT05221164|Sensory System Agents|sensory system agents|mesh-ancestor
24916642|NCT04238884|Hormone Antagonists|hormone antagonists|mesh-ancestor
25013910|NCT05221164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25013911|NCT05221164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013912|NCT05221164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25013913|NCT05221164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24662116|NCT01292668|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
24662117|NCT01292668|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24662144|NCT01292993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662174|NCT01293149|Anesthetics, Local|anesthetics, local|mesh-ancestor
24662175|NCT01293149|Anesthetics|anesthetics|mesh-ancestor
24662176|NCT01293149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24662177|NCT01293149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662178|NCT01293149|Sensory System Agents|sensory system agents|mesh-ancestor
24662253|NCT01293643|Hormone Antagonists|hormone antagonists|mesh-ancestor
24662254|NCT01293643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24662283|NCT01293747|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24662284|NCT01293747|Progesterone|progesterone|mesh-list
24662285|NCT01293747|Estrogens|estrogens|mesh-ancestor
24662286|NCT01293747|Hormones|hormones|mesh-ancestor
24662287|NCT01293747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24662288|NCT01293747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662289|NCT01293747|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24662290|NCT01293747|Contraceptive Agents|contraceptive agents|mesh-ancestor
24662291|NCT01293747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24662292|NCT01293747|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24662293|NCT01293747|Progestins|progestins|mesh-ancestor
24662294|NCT01293838|Citalopram|citalopram|mesh-list
24662295|NCT01293838|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24662296|NCT01293838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24662298|NCT01293838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662299|NCT01293838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24662300|NCT01293838|Serotonin Agents|serotonin agents|mesh-ancestor
24662301|NCT01293838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662302|NCT01293838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24662303|NCT01293838|Antidepressive Agents|antidepressive agents|mesh-ancestor
24662304|NCT01293838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24662305|NCT01293942|Bevacizumab|bevacizumab|mesh-list
24662306|NCT01293942|Capecitabine|capecitabine|mesh-list
24662307|NCT01293942|Oxaliplatin|oxaliplatin|mesh-list
24662308|NCT01293942|Irinotecan|irinotecan|mesh-list
24662326|NCT01294059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24662327|NCT01294059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662328|NCT01294059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24662329|NCT01294059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662330|NCT01294059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24662331|NCT01294059|Analgesics|analgesics|mesh-ancestor
24662332|NCT01294059|Sensory System Agents|sensory system agents|mesh-ancestor
24662333|NCT01294059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24662334|NCT01294059|Antidepressive Agents|antidepressive agents|mesh-ancestor
24662335|NCT01294059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25013914|NCT05221164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25013915|NCT05221164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25013916|NCT05221164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013917|NCT05221164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25013918|NCT05221164|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25013919|NCT05221164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25013920|NCT05221164|Antipyretics|antipyretics|mesh-ancestor
25013921|NCT05220527|Triamcinolone|triamcinolone|mesh-list
25013922|NCT05220527|Hyaluronic Acid|hyaluronic acid|mesh-list
25013923|NCT05220527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25013924|NCT05220527|Glucocorticoids|glucocorticoids|mesh-ancestor
25013925|NCT05220527|Hormones|hormones|mesh-ancestor
25013926|NCT05220527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25106044|NCT04630938|Narcotics|narcotics|mesh-ancestor
24662337|NCT01294072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24662338|NCT01294072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24662389|NCT01294605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662390|NCT01294605|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24662391|NCT01294605|Anticoagulants|anticoagulants|mesh-ancestor
24662392|NCT01294605|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24662393|NCT01294618|Interferons|interferons|mesh-list
24662397|NCT01294631|Canagliflozin|canagliflozin|mesh-list
24662398|NCT01294631|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24662399|NCT01294631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662400|NCT01294631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24662401|NCT01294631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662402|NCT01294735|Temozolomide|temozolomide|mesh-list
24662403|NCT01294735|Niraparib|niraparib|mesh-list
24662404|NCT01294735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24662405|NCT01294735|Alkylating Agents|alkylating agents|mesh-ancestor
24662406|NCT01294735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662407|NCT01294735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662408|NCT01294735|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24662409|NCT01294735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24662410|NCT01294761|Raltegravir Potassium|raltegravir potassium|mesh-list
24662411|NCT01294761|Darunavir|darunavir|mesh-list
24662412|NCT01294761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24662413|NCT01294761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24662414|NCT01294761|Antiviral Agents|antiviral agents|mesh-ancestor
24662415|NCT01294761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24662416|NCT01294761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24662449|NCT01294969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24662450|NCT01294969|Histamine Antagonists|histamine antagonists|mesh-ancestor
24662452|NCT01294969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24662453|NCT01294969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662454|NCT01295047|Atenolol|atenolol|mesh-list
24662455|NCT01295047|Verapamil|verapamil|mesh-list
24662456|NCT01295047|Perindopril|perindopril|mesh-list
24662457|NCT01295047|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25690222|NCT01969916|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24946202|NCT03942289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24946203|NCT03942289|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25690223|NCT01969916|Purinergic Agonists|purinergic agonists|mesh-ancestor
24662458|NCT01295047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24662459|NCT01295047|Sympatholytics|sympatholytics|mesh-ancestor
24662460|NCT01295047|Autonomic Agents|autonomic agents|mesh-ancestor
24662461|NCT01295047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24662462|NCT01295047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662463|NCT01295047|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24662464|NCT01295047|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24662465|NCT01295047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24662466|NCT01295047|Adrenergic Agents|adrenergic agents|mesh-ancestor
24662467|NCT01295047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25013927|NCT05220527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013928|NCT05220527|Immunologic Factors|immunologic factors|mesh-ancestor
25013929|NCT05220527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25013930|NCT05220527|Viscosupplements|viscosupplements|mesh-ancestor
25013931|NCT05220527|Protective Agents|protective agents|mesh-ancestor
25110573|NCT05451550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110574|NCT05442580|Cyclophosphamide|cyclophosphamide|mesh-list
25013935|NCT05220228|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
25013936|NCT05220228|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25013937|NCT05220228|Serotonin Agents|serotonin agents|mesh-ancestor
25013938|NCT05220228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25013939|NCT05220228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013940|NCT05220228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013942|NCT05219669|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25013943|NCT05219669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014017|NCT05168644|Antinematodal Agents|antinematodal agents|mesh-ancestor
25013945|NCT05219669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25013946|NCT05219656|Cyclosporine|cyclosporine|mesh-list
25013947|NCT05219656|Cyclosporins|cyclosporins|mesh-list
25013948|NCT05219656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25013949|NCT05219656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013950|NCT05219656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25013951|NCT05219656|Immunologic Factors|immunologic factors|mesh-ancestor
25106049|NCT04594746|Amiodarone|amiodarone|mesh-list
24662468|NCT01295047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662469|NCT01295047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24662470|NCT01295047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24662471|NCT01295047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24662472|NCT01295047|Vasodilator Agents|vasodilator agents|mesh-ancestor
24662473|NCT01295047|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24662474|NCT01295047|Protease Inhibitors|protease inhibitors|mesh-ancestor
24662475|NCT01295047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24662477|NCT01295073|Chelating Agents|chelating agents|mesh-ancestor
24662480|NCT01295086|Docetaxel|docetaxel|mesh-list
24662555|NCT01295294|Analgesics|analgesics|mesh-ancestor
24662556|NCT01295294|Sensory System Agents|sensory system agents|mesh-ancestor
24662557|NCT01295294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24662558|NCT01295294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24662559|NCT01295294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24662560|NCT01295294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24662561|NCT01295294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24662562|NCT01295307|Clofarabine|clofarabine|mesh-list
24662596|NCT01295567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24662597|NCT01295567|Vasodilator Agents|vasodilator agents|mesh-ancestor
24662598|NCT01295593|Cladribine|cladribine|mesh-list
24662599|NCT01295593|Valproic Acid|valproic acid|mesh-list
24662600|NCT01295593|Anticonvulsants|anticonvulsants|mesh-ancestor
24662601|NCT01295593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25013952|NCT05219656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013954|NCT05219656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25013955|NCT05219656|Dermatologic Agents|dermatologic agents|mesh-ancestor
25013956|NCT05219656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25013957|NCT05219656|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25013958|NCT05219266|Midostaurin|midostaurin|mesh-list
25013959|NCT05219266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013960|NCT05219266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25013961|NCT05219266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25013962|NCT05219266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690224|NCT01969916|Purinergic Agents|purinergic agents|mesh-ancestor
25690225|NCT01969916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24893373|NCT04450576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24893374|NCT04450576|Analgesics|analgesics|mesh-ancestor
24893375|NCT04450576|Sensory System Agents|sensory system agents|mesh-ancestor
24893376|NCT04450576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953148|NCT03888144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24953149|NCT03888144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25013963|NCT05197374|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25013964|NCT05197374|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25013965|NCT05197374|Estradiol|estradiol|mesh-list
25013966|NCT05197374|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24575815|NCT00834470|Mydriatics|mydriatics|mesh-ancestor
25013988|NCT05189028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24662602|NCT01295593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662603|NCT01295593|GABA Agents|gaba agents|mesh-ancestor
24662604|NCT01295593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24662605|NCT01295593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662606|NCT01295593|Antimanic Agents|antimanic agents|mesh-ancestor
24662607|NCT01295593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24662608|NCT01295593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24662609|NCT01295593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24662610|NCT01295593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662611|NCT01295593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24662618|NCT01295736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24662619|NCT01295736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24662620|NCT01295736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24662621|NCT01295736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662622|NCT01295736|Urological Agents|urological agents|mesh-ancestor
24662624|NCT01295775|Anticoagulants|anticoagulants|mesh-ancestor
24662641|NCT01295866|Antioxidants|antioxidants|mesh-ancestor
24662687|NCT01296269|Arginine Vasopressin|arginine vasopressin|mesh-list
24662688|NCT01296269|Oxytocin|oxytocin|mesh-list
24662689|NCT01296269|Oxytocics|oxytocics|mesh-ancestor
24662690|NCT01296269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24662691|NCT01296269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662692|NCT01296269|Hemostatics|hemostatics|mesh-ancestor
24662693|NCT01296269|Coagulants|coagulants|mesh-ancestor
24662694|NCT01296269|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24662695|NCT01296269|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24662696|NCT01296269|Natriuretic Agents|natriuretic agents|mesh-ancestor
24662697|NCT01296334|Morphine|morphine|mesh-list
25013989|NCT05189028|Antimetabolites|antimetabolites|mesh-ancestor
25013990|NCT05189028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013991|NCT05189028|Antiviral Agents|antiviral agents|mesh-ancestor
25013992|NCT05189028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25013993|NCT05189028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25013994|NCT05189028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25013995|NCT05189028|Immunologic Factors|immunologic factors|mesh-ancestor
25013996|NCT05189028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014000|NCT05179499|Norepinephrine|norepinephrine|mesh-list
25014001|NCT05179499|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25014002|NCT05179499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25014003|NCT05179499|Adrenergic Agents|adrenergic agents|mesh-ancestor
24970664|NCT03731741|Protective Agents|protective agents|mesh-ancestor
25014004|NCT05179499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25014005|NCT05179499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014006|NCT05179499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662698|NCT01296334|Buprenorphine|buprenorphine|mesh-list
24662699|NCT01296334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24662700|NCT01296334|Narcotics|narcotics|mesh-ancestor
24662701|NCT01296334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25690226|NCT01969916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690227|NCT01969916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690228|NCT01970176|Tadalafil|tadalafil|mesh-list
25690229|NCT01970176|Vasodilator Agents|vasodilator agents|mesh-ancestor
25690230|NCT01970176|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25690231|NCT01970176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25690232|NCT01970176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25690233|NCT01970176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893645|NCT04447560|Anesthetics, Local|anesthetics, local|mesh-ancestor
24893658|NCT04447092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662702|NCT01296334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662703|NCT01296334|Analgesics|analgesics|mesh-ancestor
24662704|NCT01296334|Sensory System Agents|sensory system agents|mesh-ancestor
24662705|NCT01296334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24662706|NCT01296334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24662715|NCT01296464|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24662716|NCT01296464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24662718|NCT01296464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24662719|NCT01296464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662720|NCT01296464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662721|NCT01296464|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24662723|NCT01296503|Thalidomide|thalidomide|mesh-list
24662724|NCT01296503|Dexamethasone|dexamethasone|mesh-list
24662725|NCT01296503|Dexamethasone acetate|dexamethasone acetate|mesh-list
24662726|NCT01296503|BB 1101|bb 1101|mesh-list
24662727|NCT01296503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24662728|NCT01296503|Antiemetics|antiemetics|mesh-ancestor
24662729|NCT01296503|Autonomic Agents|autonomic agents|mesh-ancestor
24662730|NCT01296503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25014012|NCT05168644|Anticestodal Agents|anticestodal agents|mesh-ancestor
25014013|NCT05168644|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25014014|NCT05168644|Anthelmintics|anthelmintics|mesh-ancestor
25014015|NCT05168644|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25014016|NCT05168644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25014038|NCT05126264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014039|NCT05126264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25014040|NCT05126264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25014041|NCT05126264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24662731|NCT01296503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662845|NCT01297166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24662846|NCT01297166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662847|NCT01297166|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24662848|NCT01297166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24662849|NCT01297166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662850|NCT01297166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24662851|NCT01297166|Vitamins|vitamins|mesh-ancestor
24662852|NCT01297166|Micronutrients|micronutrients|mesh-ancestor
24662853|NCT01297166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24662854|NCT01297179|Levonorgestrel|levonorgestrel|mesh-list
24662855|NCT01297179|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24662856|NCT01297179|Mirabegron|mirabegron|mesh-list
24662857|NCT01297179|Estradiol|estradiol|mesh-list
24662858|NCT01297179|Estrogens|estrogens|mesh-ancestor
25690234|NCT01970176|Urological Agents|urological agents|mesh-ancestor
25690235|NCT01970241|Insulin|insulin|mesh-list
25690236|NCT01970241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25690237|NCT01970241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25690238|NCT01970241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690239|NCT01970371|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25690240|NCT01970371|Meropenem|meropenem|mesh-list
25690241|NCT01970371|Colistin|colistin|mesh-list
25690242|NCT01970371|Tigecycline|tigecycline|mesh-list
25690243|NCT01970371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25690244|NCT01970371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24470970|NCT00392691|Antimitotic Agents|antimitotic agents|mesh-ancestor
24470971|NCT00392691|Mitosis Modulators|mitosis modulators|mesh-ancestor
24553241|NCT00730054|Analgesics|analgesics|mesh-ancestor
24893847|NCT04445948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24893848|NCT04445948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893849|NCT04445948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061939|NCT05389813|Analgesics|analgesics|mesh-ancestor
25061940|NCT05389813|Sensory System Agents|sensory system agents|mesh-ancestor
25061941|NCT05389813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25061942|NCT05389813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824447|NCT02123498|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24824448|NCT02123498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24824449|NCT02123498|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24824450|NCT02123498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824451|NCT02123498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893971|NCT04445636|Morphine|morphine|mesh-list
24893972|NCT04445636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25061945|NCT05389813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25061946|NCT05389813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061947|NCT05389813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25061948|NCT05389813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24662859|NCT01297179|Hormones|hormones|mesh-ancestor
24662860|NCT01297179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24662861|NCT01297179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662878|NCT01297192|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24662879|NCT01297192|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24662880|NCT01297192|Cholinergic Agents|cholinergic agents|mesh-ancestor
24662881|NCT01297192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25014042|NCT05126264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25014043|NCT05126264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110596|NCT05437835|Ropivacaine|ropivacaine|mesh-list
25110597|NCT05437835|Anesthetics, Local|anesthetics, local|mesh-ancestor
25110598|NCT05437835|Anesthetics|anesthetics|mesh-ancestor
25110599|NCT05437835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25110600|NCT05437835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110601|NCT05437835|Sensory System Agents|sensory system agents|mesh-ancestor
25110602|NCT05437835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24575894|NCT00835107|Ziprasidone|ziprasidone|mesh-list
24618571|NCT01049022|Moxifloxacin|moxifloxacin|mesh-list
25014056|NCT05095311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014057|NCT05095311|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
25690245|NCT01970371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25690246|NCT01970371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690247|NCT01970397|Hyaluronic Acid|hyaluronic acid|mesh-list
25690248|NCT01970397|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25690249|NCT01970397|Immunologic Factors|immunologic factors|mesh-ancestor
25690250|NCT01970397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690251|NCT01970397|Viscosupplements|viscosupplements|mesh-ancestor
25690252|NCT01970397|Protective Agents|protective agents|mesh-ancestor
25690253|NCT01970475|Adalimumab|adalimumab|mesh-list
25690254|NCT01970475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25690255|NCT01970475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25690256|NCT01970488|Adalimumab|adalimumab|mesh-list
25690257|NCT01970488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25690258|NCT01970488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25690259|NCT01970527|Ipilimumab|ipilimumab|mesh-list
25690260|NCT01970527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25690261|NCT01970527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25690262|NCT01970527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25690263|NCT01970527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690264|NCT01970540|Doxorubicin|doxorubicin|mesh-list
25690265|NCT01970540|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25690266|NCT01970540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894037|NCT04444726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24894038|NCT04444726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014059|NCT05095311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25014060|NCT05095311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24662882|NCT01297192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662883|NCT01297192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662884|NCT01297192|Urological Agents|urological agents|mesh-ancestor
24662885|NCT01297192|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24662934|NCT01297764|Antiemetics|antiemetics|mesh-ancestor
24662935|NCT01297764|Autonomic Agents|autonomic agents|mesh-ancestor
24662936|NCT01297764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663009|NCT01297907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663010|NCT01297907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663011|NCT01297907|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24663012|NCT01297907|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
24663013|NCT01297907|Respiratory System Agents|respiratory system agents|mesh-ancestor
24663014|NCT01297907|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24663015|NCT01297907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24663523|NCT01302028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663070|NCT01298180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24663130|NCT01298401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663132|NCT01298401|Antiviral Agents|antiviral agents|mesh-ancestor
24663133|NCT01298401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24663134|NCT01298401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663135|NCT01298401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24663136|NCT01298401|Immunologic Factors|immunologic factors|mesh-ancestor
25014061|NCT05095311|Respiratory System Agents|respiratory system agents|mesh-ancestor
25014079|NCT05081375|Anticoagulants|anticoagulants|mesh-ancestor
25014080|NCT05081375|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25014081|NCT05081375|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25014082|NCT05081375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014088|NCT05052827|Caseins|caseins|mesh-list
25014089|NCT05052827|Chelating Agents|chelating agents|mesh-ancestor
25014090|NCT05052827|Sequestering Agents|sequestering agents|mesh-ancestor
25014091|NCT05052827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014092|NCT05049278|Phenylephrine|phenylephrine|mesh-list
25014108|NCT05049278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25014109|NCT05049278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014110|NCT05049278|Protective Agents|protective agents|mesh-ancestor
25014117|NCT05011357|Phenylephrine|phenylephrine|mesh-list
25014118|NCT05011357|Oxymetazoline|oxymetazoline|mesh-list
25014119|NCT05011357|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25014120|NCT05011357|Mydriatics|mydriatics|mesh-ancestor
25014121|NCT05011357|Autonomic Agents|autonomic agents|mesh-ancestor
25014122|NCT05011357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25014123|NCT05011357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014124|NCT05011357|Sympathomimetics|sympathomimetics|mesh-ancestor
25014125|NCT05011357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25014126|NCT05011357|Nasal Decongestants|nasal decongestants|mesh-ancestor
25014127|NCT05011357|Respiratory System Agents|respiratory system agents|mesh-ancestor
25014128|NCT05011357|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25014130|NCT05011357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25014131|NCT05011357|Adrenergic Agents|adrenergic agents|mesh-ancestor
25014132|NCT05011357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25014133|NCT05011357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014134|NCT05011357|Protective Agents|protective agents|mesh-ancestor
25014177|NCT04963816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25014178|NCT04963816|Sensory System Agents|sensory system agents|mesh-ancestor
25014180|NCT04933240|Estradiol|estradiol|mesh-list
25014181|NCT04933240|Estrogens|estrogens|mesh-ancestor
25014182|NCT04933240|Hormones|hormones|mesh-ancestor
25014183|NCT04933240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25014184|NCT04933240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014185|NCT04933240|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24663193|NCT01299181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25690267|NCT01970540|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25690268|NCT01970540|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25690269|NCT01970540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25690270|NCT01970540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690271|NCT01970878|Bromides|bromides|mesh-list
24663197|NCT01299181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24663199|NCT01299194|Atorvastatin|atorvastatin|mesh-list
24663296|NCT01300312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24663297|NCT01300312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24663298|NCT01300312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663299|NCT01300312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663300|NCT01300312|Anticonvulsants|anticonvulsants|mesh-ancestor
24663301|NCT01300312|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24663452|NCT01301469|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24663454|NCT01301586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24663455|NCT01301586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24663456|NCT01301586|Antimalarials|antimalarials|mesh-ancestor
24663515|NCT01301937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24663517|NCT01302002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24663518|NCT01302002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663519|NCT01302028|Ipragliflozin|ipragliflozin|mesh-list
24663520|NCT01302028|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24663521|NCT01302028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663522|NCT01302028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24663608|NCT01302587|Albuterol|albuterol|mesh-list
24663609|NCT01302587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24663610|NCT01302587|Autonomic Agents|autonomic agents|mesh-ancestor
24663611|NCT01302587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663612|NCT01302587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663613|NCT01302587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24663614|NCT01302587|Respiratory System Agents|respiratory system agents|mesh-ancestor
24663615|NCT01302587|Tocolytic Agents|tocolytic agents|mesh-ancestor
25014186|NCT04933240|Hormone Antagonists|hormone antagonists|mesh-ancestor
25014187|NCT04933240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25014188|NCT04933240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25014189|NCT04933240|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24663616|NCT01302587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24663619|NCT01302587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24663654|NCT01302951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663655|NCT01302951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663656|NCT01302951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109446|NCT03124082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24496116|NCT00503516|Megestrol|megestrol|mesh-list
24621267|NCT01061320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621268|NCT01061320|Antioxidants|antioxidants|mesh-ancestor
24621269|NCT01061320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419307|NCT00211679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24663872|NCT01303926|Pemetrexed|pemetrexed|mesh-list
24663982|NCT01304342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24663983|NCT01304342|Narcotics|narcotics|mesh-ancestor
24663984|NCT01304342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24663985|NCT01304342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663986|NCT01304342|Analgesics|analgesics|mesh-ancestor
24663987|NCT01304342|Sensory System Agents|sensory system agents|mesh-ancestor
24663988|NCT01304342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663989|NCT01304342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24663990|NCT01304342|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24663991|NCT01304342|Anesthetics, General|anesthetics, general|mesh-ancestor
24664053|NCT01304797|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24664054|NCT01304797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24664055|NCT01304797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24664056|NCT01304797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24664057|NCT01304836|Mycophenolic Acid|mycophenolic acid|mesh-list
24664058|NCT01304836|Methylprednisolone|methylprednisolone|mesh-list
24664059|NCT01304836|Prednisolone|prednisolone|mesh-list
24664060|NCT01304836|Tacrolimus|tacrolimus|mesh-list
24664061|NCT01304836|Basiliximab|basiliximab|mesh-list
24513805|NCT00585156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817155|NCT02081391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24817156|NCT02081391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817157|NCT02081391|Analgesics|analgesics|mesh-ancestor
24817158|NCT02081391|Sensory System Agents|sensory system agents|mesh-ancestor
24817159|NCT02081391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25062004|NCT05389514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25062005|NCT05389514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25062007|NCT05389176|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25062014|NCT05389150|Pregabalin|pregabalin|mesh-list
24771684|NCT01828736|Antiviral Agents|antiviral agents|mesh-ancestor
25062088|NCT05323149|Hemostatics|hemostatics|mesh-ancestor
24664095|NCT01304927|Vitamin D|vitamin d|mesh-list
24664175|NCT01305707|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
24664177|NCT01305707|Olanzapine|olanzapine|mesh-list
24664178|NCT01305707|Risperidone|risperidone|mesh-list
24664179|NCT01305707|Aripiprazole|aripiprazole|mesh-list
24419402|NCT00212043|Gemcitabine|gemcitabine|mesh-list
24664397|NCT01306630|Capecitabine|capecitabine|mesh-list
24664398|NCT01306630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24664399|NCT01306630|Antimetabolites|antimetabolites|mesh-ancestor
24664408|NCT01306708|Sensory System Agents|sensory system agents|mesh-ancestor
25014190|NCT04933240|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25014191|NCT04933240|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25014193|NCT04915768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25014194|NCT04915768|Immunologic Factors|immunologic factors|mesh-ancestor
25014195|NCT04915768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014196|NCT04915768|Antacids|antacids|mesh-ancestor
25014197|NCT04915768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014198|NCT04915768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24970888|NCT03730181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24970889|NCT03730181|Antimetabolites|antimetabolites|mesh-ancestor
24970890|NCT03730181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970891|NCT03730181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24970892|NCT03730181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24970893|NCT03730181|Leprostatic Agents|leprostatic agents|mesh-ancestor
24794247|NCT05352178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24794249|NCT05352178|Antioxidants|antioxidants|mesh-ancestor
24794250|NCT05352178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794251|NCT05352178|Protective Agents|protective agents|mesh-ancestor
24794252|NCT05352178|Vitamins|vitamins|mesh-ancestor
24586411|NCT00890565|Autonomic Agents|autonomic agents|mesh-ancestor
24586412|NCT00890565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24586413|NCT00890565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586414|NCT00890565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24664459|NCT01306773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664460|NCT01306851|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24664461|NCT01306851|Hemostatics|hemostatics|mesh-ancestor
24664462|NCT01306851|Coagulants|coagulants|mesh-ancestor
24664463|NCT01306864|Hemostatics|hemostatics|mesh-list
24664464|NCT01306864|Coagulants|coagulants|mesh-ancestor
24664465|NCT01306981|Ranibizumab|ranibizumab|mesh-list
24664466|NCT01306981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24664467|NCT01306981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24664468|NCT01306981|Growth Substances|growth substances|mesh-ancestor
24664469|NCT01306981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690272|NCT01970878|Tiotropium Bromide|tiotropium bromide|mesh-list
25690273|NCT01970878|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25690274|NCT01970878|Autonomic Agents|autonomic agents|mesh-ancestor
25690275|NCT01970878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25690276|NCT01970878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690277|NCT01970878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25690278|NCT01970878|Respiratory System Agents|respiratory system agents|mesh-ancestor
25690279|NCT01970878|Parasympatholytics|parasympatholytics|mesh-ancestor
25690280|NCT01970878|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25690281|NCT01970878|Cholinergic Agents|cholinergic agents|mesh-ancestor
25690282|NCT01970878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25690283|NCT01970878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664756|NCT01308541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664814|NCT01308723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664815|NCT01308944|Propranolol|propranolol|mesh-list
24664816|NCT01308944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24664817|NCT01308944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24664818|NCT01308944|Adrenergic Agents|adrenergic agents|mesh-ancestor
24664819|NCT01308944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24664821|NCT01308944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664882|NCT01309139|Tiotropium Bromide|tiotropium bromide|mesh-list
24664883|NCT01309139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24664884|NCT01309139|Autonomic Agents|autonomic agents|mesh-ancestor
24664885|NCT01309139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24664886|NCT01309139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664887|NCT01309139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24664888|NCT01309139|Respiratory System Agents|respiratory system agents|mesh-ancestor
24664889|NCT01309139|Parasympatholytics|parasympatholytics|mesh-ancestor
24664890|NCT01309139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24665253|NCT01311076|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24665254|NCT01311076|Insulin Lispro|insulin lispro|mesh-list
24665255|NCT01311076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24665256|NCT01311076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665258|NCT01311141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24665259|NCT01311141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24665260|NCT01311167|Dexamethasone|dexamethasone|mesh-list
24665268|NCT01311167|Hormones|hormones|mesh-ancestor
24665306|NCT01311622|Warfarin|warfarin|mesh-list
24665308|NCT01311700|Metoprolol|metoprolol|mesh-list
24665309|NCT01311700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24665310|NCT01311700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24665311|NCT01311700|Sympatholytics|sympatholytics|mesh-ancestor
24665312|NCT01311700|Autonomic Agents|autonomic agents|mesh-ancestor
24665384|NCT01312064|Thymoglobulin|thymoglobulin|mesh-list
24665385|NCT01312064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24665386|NCT01312064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921838|NCT04186897|Keratolytic Agents|keratolytic agents|mesh-ancestor
24921871|NCT04186026|Hormones|hormones|mesh-ancestor
24665425|NCT01312311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665426|NCT01312324|Docetaxel|docetaxel|mesh-list
24665427|NCT01312324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665428|NCT01312324|Tubulin Modulators|tubulin modulators|mesh-ancestor
24665429|NCT01312324|Antimitotic Agents|antimitotic agents|mesh-ancestor
24665430|NCT01312324|Mitosis Modulators|mitosis modulators|mesh-ancestor
24665431|NCT01312324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665432|NCT01312337|Gefitinib|gefitinib|mesh-list
24665433|NCT01312337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665434|NCT01312337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24665543|NCT01313377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25690284|NCT01970878|Anticonvulsants|anticonvulsants|mesh-ancestor
25690285|NCT01970995|Menthol|menthol|mesh-list
25690286|NCT01970995|Antipruritics|antipruritics|mesh-ancestor
25690287|NCT01970995|Dermatologic Agents|dermatologic agents|mesh-ancestor
25690288|NCT01971203|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25690289|NCT01971203|Antidepressive Agents|antidepressive agents|mesh-ancestor
25690290|NCT01971203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25690291|NCT01971203|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25690292|NCT01971203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25690293|NCT01971203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25690294|NCT01971203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513913|NCT00586274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513914|NCT00586274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24824783|NCT02125344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24824784|NCT02125344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824785|NCT02125344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24894634|NCT04438850|Ivermectin|ivermectin|mesh-list
24665707|NCT01314274|Growth Substances|growth substances|mesh-ancestor
24665708|NCT01314274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665709|NCT01314274|Growth Inhibitors|growth inhibitors|mesh-ancestor
24665733|NCT01314352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24665810|NCT01314859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24665818|NCT01314898|Natriuretic Agents|natriuretic agents|mesh-ancestor
24665935|NCT01316068|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
24665936|NCT01316068|Anticoagulants|anticoagulants|mesh-ancestor
24665937|NCT01316068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24665938|NCT01316068|Antimetabolites|antimetabolites|mesh-ancestor
25014244|NCT04887792|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25014245|NCT04887792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25014246|NCT04887792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014247|NCT04887792|Diuretics|diuretics|mesh-ancestor
25014248|NCT04887792|Natriuretic Agents|natriuretic agents|mesh-ancestor
25014249|NCT04887792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014250|NCT04873375|Cemiplimab|cemiplimab|mesh-list
25014251|NCT04873375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25014252|NCT04873375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25014253|NCT04814433|Lidocaine|lidocaine|mesh-list
25014254|NCT04814433|Epinephrine|epinephrine|mesh-list
25014255|NCT04814433|Racepinephrine|racepinephrine|mesh-list
25014256|NCT04814433|Bupivacaine|bupivacaine|mesh-list
25010693|NCT03382301|Immunologic Factors|immunologic factors|mesh-ancestor
24665939|NCT01316068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666084|NCT01317069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24666085|NCT01317069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24666086|NCT01317069|Immunologic Factors|immunologic factors|mesh-ancestor
24666087|NCT01317069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666118|NCT01317446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666120|NCT01317511|Chelating Agents|chelating agents|mesh-ancestor
24666121|NCT01317511|Sequestering Agents|sequestering agents|mesh-ancestor
24666123|NCT01317563|Vitamin A|vitamin a|mesh-list
24666180|NCT01317966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24666181|NCT01317966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24666182|NCT01317966|Immunologic Factors|immunologic factors|mesh-ancestor
24666183|NCT01317966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666184|NCT01317966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24666185|NCT01317992|Ibudilast|ibudilast|mesh-list
24666186|NCT01317992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24666187|NCT01317992|Autonomic Agents|autonomic agents|mesh-ancestor
24666188|NCT01317992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24666268|NCT01318265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24666310|NCT01318460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24666311|NCT01318460|Vasodilator Agents|vasodilator agents|mesh-ancestor
24666312|NCT01318460|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24666313|NCT01318460|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24666314|NCT01318460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666342|NCT01318655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666343|NCT01318655|Sensory System Agents|sensory system agents|mesh-ancestor
24666366|NCT01318837|Solifenacin Succinate|solifenacin succinate|mesh-list
25014257|NCT04814433|Tranexamic Acid|tranexamic acid|mesh-list
25690295|NCT01971346|Etanercept|etanercept|mesh-list
25690296|NCT01971346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25690297|NCT01971346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25690298|NCT01971346|Analgesics|analgesics|mesh-ancestor
25690299|NCT01971346|Sensory System Agents|sensory system agents|mesh-ancestor
25014258|NCT04814433|Aminocaproic Acid|aminocaproic acid|mesh-list
25014259|NCT04814433|Thrombin|thrombin|mesh-list
25690300|NCT01971346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25690301|NCT01971346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690302|NCT01971346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24894779|NCT05387876|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24894780|NCT05387681|Endostatins|endostatins|mesh-list
24894781|NCT05387681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894782|NCT05387681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24894783|NCT05387681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24894784|NCT05387681|Growth Substances|growth substances|mesh-ancestor
24894785|NCT05387681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894786|NCT05387681|Growth Inhibitors|growth inhibitors|mesh-ancestor
24894819|NCT05387187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894908|NCT05375084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894909|NCT05374057|Ibuprofen|ibuprofen|mesh-list
24894910|NCT05374057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24894911|NCT05374057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24514090|NCT00587873|Leucovorin|leucovorin|mesh-list
25014260|NCT04814433|Epinephryl borate|epinephryl borate|mesh-list
25014261|NCT04814433|Anesthetics, Local|anesthetics, local|mesh-ancestor
25014262|NCT04814433|Anesthetics|anesthetics|mesh-ancestor
25014263|NCT04814433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24979931|NCT04933383|Autonomic Agents|autonomic agents|mesh-ancestor
24666430|NCT01319240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24666431|NCT01319266|Hydrocodone|hydrocodone|mesh-list
24666432|NCT01319266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24666433|NCT01319266|Narcotics|narcotics|mesh-ancestor
24666434|NCT01319266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24666435|NCT01319266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666436|NCT01319266|Analgesics|analgesics|mesh-ancestor
24666437|NCT01319266|Sensory System Agents|sensory system agents|mesh-ancestor
24666438|NCT01319266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24666506|NCT01319461|Viscosupplements|viscosupplements|mesh-ancestor
24666507|NCT01319461|Protective Agents|protective agents|mesh-ancestor
24666508|NCT01319487|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24666509|NCT01319487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24666510|NCT01319682|Lidocaine|lidocaine|mesh-list
24666511|NCT01319682|Anesthetics, Local|anesthetics, local|mesh-ancestor
24666661|NCT01320345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666662|NCT01320345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24666663|NCT01320397|Losartan|losartan|mesh-list
24666664|NCT01320397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24666665|NCT01320397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24419871|NCT00214318|Vasodilator Agents|vasodilator agents|mesh-ancestor
24666779|NCT01320982|Dopamine Agonists|dopamine agonists|mesh-ancestor
24666780|NCT01320982|Dopamine Agents|dopamine agents|mesh-ancestor
24666781|NCT01320982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24666847|NCT01321138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24666848|NCT01321138|Narcotics|narcotics|mesh-ancestor
24666849|NCT01321138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24666850|NCT01321138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666904|NCT01321346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24666905|NCT01321346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24666906|NCT01321346|Immunologic Factors|immunologic factors|mesh-ancestor
25014264|NCT04814433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014265|NCT04814433|Sensory System Agents|sensory system agents|mesh-ancestor
25014266|NCT04814433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25014267|NCT04814433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24576142|NCT00837135|Vaccines|vaccines|mesh-list
24497881|NCT00512291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25110624|NCT05434663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110625|NCT05434663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25690303|NCT01971346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25690304|NCT01971346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25690305|NCT01971346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25690306|NCT01971346|Immunologic Factors|immunologic factors|mesh-ancestor
25690307|NCT01971385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25690308|NCT01971385|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
25690309|NCT01971385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25690310|NCT01971385|Immunologic Factors|immunologic factors|mesh-ancestor
25690311|NCT01971385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692649|NCT02003391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692650|NCT02003391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692651|NCT02003391|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25692652|NCT02003391|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25692653|NCT02003534|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25692654|NCT02003534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24514338|NCT00589927|Respiratory System Agents|respiratory system agents|mesh-ancestor
24514339|NCT00589927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24514340|NCT00589927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24746797|NCT03485287|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
24514341|NCT00589927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110626|NCT05434663|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25110627|NCT05434663|Serotonin Agents|serotonin agents|mesh-ancestor
25110628|NCT05434663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25110629|NCT05434663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110630|NCT05429489|Morphine|morphine|mesh-list
25110631|NCT05429489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25110632|NCT05429489|Narcotics|narcotics|mesh-ancestor
25110633|NCT05429489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25110634|NCT05429489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110635|NCT05429489|Analgesics|analgesics|mesh-ancestor
25110636|NCT05429489|Sensory System Agents|sensory system agents|mesh-ancestor
25110637|NCT05429489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970894|NCT03730064|Acetylcysteine|acetylcysteine|mesh-list
24666907|NCT01321346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666908|NCT01321346|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24666909|NCT01321346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666994|NCT01321827|Glucocorticoids|glucocorticoids|mesh-list
25014291|NCT04789499|Theophylline|theophylline|mesh-list
25014292|NCT04789499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25014293|NCT04789499|Autonomic Agents|autonomic agents|mesh-ancestor
25014294|NCT04789499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24666995|NCT01321827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24667065|NCT01322100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24667066|NCT01322139|Moxifloxacin|moxifloxacin|mesh-list
24667067|NCT01322139|Nabiximols|nabiximols|mesh-list
24667074|NCT01322139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24667116|NCT01322282|Cetirizine|cetirizine|mesh-list
24667118|NCT01322282|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24667119|NCT01322282|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24667120|NCT01322282|Histamine Antagonists|histamine antagonists|mesh-ancestor
24667121|NCT01322282|Histamine Agents|histamine agents|mesh-ancestor
24667122|NCT01322282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24667125|NCT01322308|Pioglitazone|pioglitazone|mesh-list
24667197|NCT05461053|Anesthetics, Local|anesthetics, local|mesh-ancestor
24667198|NCT05461053|Anesthetics|anesthetics|mesh-ancestor
24667199|NCT05461053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24667200|NCT05461053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667201|NCT05461053|Sensory System Agents|sensory system agents|mesh-ancestor
24667202|NCT05461053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24667203|NCT05461053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24667204|NCT05461053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24667205|NCT05461053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24667206|NCT05461053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25690312|NCT01971580|Ambrisentan|ambrisentan|mesh-list
25690313|NCT01971580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25690314|NCT01971593|Eplerenone|eplerenone|mesh-list
25690315|NCT01971593|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25690316|NCT01971593|Hormone Antagonists|hormone antagonists|mesh-ancestor
25690317|NCT01971593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25690318|NCT01971593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690319|NCT01971593|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25690320|NCT01971593|Diuretics|diuretics|mesh-ancestor
24895055|NCT05184712|Pemetrexed|pemetrexed|mesh-list
24979967|NCT04834024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24667924|NCT05247619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24667925|NCT05247619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24667927|NCT05247619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667928|NCT05247619|Growth Inhibitors|growth inhibitors|mesh-ancestor
24456239|NCT00330772|Analgesics|analgesics|mesh-ancestor
24667931|NCT05242484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24668183|NCT05050305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24668184|NCT05050305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24668185|NCT05050305|Immunologic Factors|immunologic factors|mesh-ancestor
24668186|NCT05050305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24668187|NCT05050305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24668188|NCT05050305|Growth Substances|growth substances|mesh-ancestor
24747159|NCT01746173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24668349|NCT04943341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24668350|NCT04943341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24668351|NCT04943341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24668352|NCT04943341|Immunologic Factors|immunologic factors|mesh-ancestor
24668353|NCT04943341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24668354|NCT04943341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24668355|NCT04936763|Hyaluronic Acid|hyaluronic acid|mesh-list
24668457|NCT04918147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24668458|NCT04918147|Protective Agents|protective agents|mesh-ancestor
24668459|NCT04918147|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24668460|NCT04918147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24668461|NCT04918147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24668462|NCT04918147|Anesthetics, Local|anesthetics, local|mesh-ancestor
24668463|NCT04918147|Anesthetics|anesthetics|mesh-ancestor
24533471|NCT00644111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24533472|NCT00644111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533473|NCT00644111|Sensory System Agents|sensory system agents|mesh-ancestor
24533474|NCT00644111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24533475|NCT00644111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24533476|NCT00644111|Narcotics|narcotics|mesh-ancestor
24533477|NCT00644111|Analgesics|analgesics|mesh-ancestor
24533478|NCT00644124|Aflibercept|aflibercept|mesh-list
24533479|NCT00644124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24533480|NCT00644124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25014329|NCT04717765|Vitamin E|vitamin e|mesh-list
25014330|NCT04717765|alpha-Tocopherol|alpha-tocopherol|mesh-list
25014331|NCT04717765|Tocopherols|tocopherols|mesh-list
25014332|NCT04717765|Antioxidants|antioxidants|mesh-ancestor
25014333|NCT04717765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690322|NCT01971593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25690323|NCT01971645|Dexamethasone|dexamethasone|mesh-list
25690324|NCT01971645|Ropivacaine|ropivacaine|mesh-list
25690325|NCT01971645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25690326|NCT01971645|Antiemetics|antiemetics|mesh-ancestor
25690327|NCT01971645|Autonomic Agents|autonomic agents|mesh-ancestor
25404552|NCT03661411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25690328|NCT01971645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25690329|NCT01971645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062343|NCT04923659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25062344|NCT04923659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24533610|NCT00644618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923968|NCT04165174|Antibodies|antibodies|mesh-list
24923969|NCT04165174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24923977|NCT04164823|Sensory System Agents|sensory system agents|mesh-ancestor
24923978|NCT04164823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24745650|NCT03662919|Dermatologic Agents|dermatologic agents|mesh-ancestor
25014365|NCT04671355|Adrenergic Agents|adrenergic agents|mesh-ancestor
25014366|NCT04671355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25014367|NCT04671355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014368|NCT04671355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25014369|NCT04671355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25014370|NCT04671355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25014371|NCT04671355|Cholinergic Agents|cholinergic agents|mesh-ancestor
25014372|NCT04671355|Glucocorticoids|glucocorticoids|mesh-ancestor
25690330|NCT01971645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25690331|NCT01971645|Glucocorticoids|glucocorticoids|mesh-ancestor
25690332|NCT01971645|Hormones|hormones|mesh-ancestor
25690333|NCT01971645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25690334|NCT01971645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25690335|NCT01971645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25690336|NCT01971645|Anesthetics, Local|anesthetics, local|mesh-ancestor
25014373|NCT04671355|Hormones|hormones|mesh-ancestor
25014374|NCT04671355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25014375|NCT04625088|Atropine|atropine|mesh-list
25014376|NCT04625088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25014377|NCT04625088|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25014378|NCT04625088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25014379|NCT04625088|Autonomic Agents|autonomic agents|mesh-ancestor
25014380|NCT04625088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25014381|NCT04625088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014382|NCT04625088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24747754|NCT03110432|Niacin|niacin|mesh-list
24420573|NCT00216359|Enfuvirtide|enfuvirtide|mesh-list
25690337|NCT01971645|Anesthetics|anesthetics|mesh-ancestor
25690338|NCT01971645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25690339|NCT01971645|Sensory System Agents|sensory system agents|mesh-ancestor
25690340|NCT01972074|Memantine|memantine|mesh-list
25690341|NCT01972074|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25690342|NCT01972074|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25690343|NCT01972074|Dopamine Agents|dopamine agents|mesh-ancestor
25690344|NCT01972074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24895404|NCT04278053|Vitamin B Complex|vitamin b complex|mesh-ancestor
24895405|NCT04278053|Vitamins|vitamins|mesh-ancestor
24895406|NCT04278053|Micronutrients|micronutrients|mesh-ancestor
25690345|NCT01972074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514868|NCT00593164|Anticonvulsants|anticonvulsants|mesh-ancestor
24514869|NCT00593164|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24514878|NCT00593255|Insulin|insulin|mesh-list
24514912|NCT00593463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24514954|NCT00593619|Dextrans|dextrans|mesh-list
24420675|NCT00216554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24533707|NCT00644904|Cholecalciferol|cholecalciferol|mesh-list
25014392|NCT04597671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25014393|NCT04597671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25014394|NCT04564898|Trifluridine|trifluridine|mesh-list
25014395|NCT04564898|Bevacizumab|bevacizumab|mesh-list
25014396|NCT04564898|Capecitabine|capecitabine|mesh-list
25014397|NCT04564898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25014398|NCT04564898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25014399|NCT04564898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25014400|NCT04564898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25014401|NCT04564898|Growth Substances|growth substances|mesh-ancestor
25014402|NCT04564898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014413|NCT04562779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25014414|NCT04562779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014415|NCT04562779|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25014416|NCT04562779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25014417|NCT04562779|Anesthetics, General|anesthetics, general|mesh-ancestor
24533708|NCT00644904|Vitamins|vitamins|mesh-list
24533709|NCT00644904|Micronutrients|micronutrients|mesh-ancestor
24533710|NCT00644904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014420|NCT04562779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25014421|NCT04562779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25014422|NCT04562779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25014423|NCT04562779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014424|NCT04562779|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25014425|NCT04562779|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25014426|NCT04556838|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25014427|NCT04556838|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25014428|NCT04547790|Psyllium|psyllium|mesh-list
25014429|NCT04547790|Cathartics|cathartics|mesh-ancestor
25014430|NCT04547790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25014431|NCT04523363|Metformin|metformin|mesh-list
25014432|NCT04523363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25690346|NCT01972074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690347|NCT01972074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25690348|NCT01972074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25690349|NCT01972152|Glucagon|glucagon|mesh-list
25690350|NCT01972152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25690351|NCT01972152|Hormones|hormones|mesh-ancestor
25690352|NCT01972152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25014434|NCT04517435|Prednisone|prednisone|mesh-list
25014435|NCT04517435|Cyclophosphamide|cyclophosphamide|mesh-list
25014436|NCT04517435|Rituximab|rituximab|mesh-list
25014437|NCT04517435|Doxorubicin|doxorubicin|mesh-list
25014438|NCT04517435|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25014439|NCT04517435|Vincristine|vincristine|mesh-list
25014440|NCT04517435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25014441|NCT04517435|Immunologic Factors|immunologic factors|mesh-ancestor
25014442|NCT04517435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014443|NCT04517435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25014444|NCT04517435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25014445|NCT04517435|Alkylating Agents|alkylating agents|mesh-ancestor
25014446|NCT04517435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014447|NCT04517435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25014448|NCT04517435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24533820|NCT00645242|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25690353|NCT01972152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690354|NCT01972464|Progesterone|progesterone|mesh-list
25690355|NCT01972464|Progestins|progestins|mesh-ancestor
25690356|NCT01972464|Hormones|hormones|mesh-ancestor
25690357|NCT01972464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25690358|NCT01972464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690359|NCT01972659|Magnesium Sulfate|magnesium sulfate|mesh-list
25690360|NCT01972659|Analgesics|analgesics|mesh-ancestor
25014460|NCT04517435|Tubulin Modulators|tubulin modulators|mesh-ancestor
25014461|NCT04517435|Antimitotic Agents|antimitotic agents|mesh-ancestor
25014462|NCT04517435|Mitosis Modulators|mitosis modulators|mesh-ancestor
25014464|NCT04509050|Elexacaftor|elexacaftor|mesh-list
25014465|NCT04509050|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25014466|NCT04509050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24745940|NCT03500549|Eculizumab|eculizumab|mesh-list
24533904|NCT00645398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925340|NCT04150965|BB 1101|bb 1101|mesh-list
24533935|NCT00645502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533936|NCT00645502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533939|NCT00645502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24533940|NCT00645502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24533941|NCT00645502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24533942|NCT00645502|Dopamine Agents|dopamine agents|mesh-ancestor
24533943|NCT00645515|Risperidone|risperidone|mesh-list
24533949|NCT00645515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533950|NCT00645515|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24533951|NCT00645515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24533952|NCT00645515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24533953|NCT00645515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24533962|NCT00645554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110647|NCT05414240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25110648|NCT05414240|Autonomic Agents|autonomic agents|mesh-ancestor
24534057|NCT00645918|Clopidogrel|clopidogrel|mesh-list
25690361|NCT01972659|Sensory System Agents|sensory system agents|mesh-ancestor
25690362|NCT01972659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25690363|NCT01972659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690364|NCT01972659|Anesthetics|anesthetics|mesh-ancestor
25690365|NCT01972659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25690366|NCT01972659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25690367|NCT01972659|Anticonvulsants|anticonvulsants|mesh-ancestor
24534059|NCT00645918|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24534060|NCT00645918|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24534061|NCT00645918|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24534062|NCT00645918|Purinergic Agents|purinergic agents|mesh-ancestor
24534063|NCT00645918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24534064|NCT00645918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534089|NCT00646009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24534092|NCT00646009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534093|NCT00646009|Tocolytic Agents|tocolytic agents|mesh-ancestor
24534094|NCT00646009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24534095|NCT00646009|Sympathomimetics|sympathomimetics|mesh-ancestor
24534122|NCT00646087|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24534123|NCT00646087|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24534124|NCT00646087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24624382|NCT01075906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624383|NCT01075945|Lumefantrine|lumefantrine|mesh-list
24925931|NCT04146155|Hormones|hormones|mesh-ancestor
24925932|NCT04146155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24746052|NCT03435185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24746053|NCT03435185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24926086|NCT04144933|Ketamine|ketamine|mesh-list
24534125|NCT00646087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534126|NCT00646126|Artesunate|artesunate|mesh-list
24534127|NCT00646126|Pyrimethamine|pyrimethamine|mesh-list
24534128|NCT00646126|Sulfadoxine|sulfadoxine|mesh-list
24534129|NCT00646126|Antimalarials|antimalarials|mesh-ancestor
24534130|NCT00646126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24534131|NCT00646126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25690368|NCT01972659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25690369|NCT01972659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25690370|NCT01972659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690371|NCT01972659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25690372|NCT01972659|Tocolytic Agents|tocolytic agents|mesh-ancestor
25690373|NCT01972659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25690374|NCT01972724|Metformin|metformin|mesh-list
25690375|NCT01972724|Pioglitazone|pioglitazone|mesh-list
24817375|NCT02083276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24817376|NCT02083315|Morphine|morphine|mesh-list
24817377|NCT02083315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24817378|NCT02083315|Narcotics|narcotics|mesh-ancestor
24817381|NCT02083315|Analgesics|analgesics|mesh-ancestor
24971124|NCT03728244|Hyaluronic Acid|hyaluronic acid|mesh-list
24534261|NCT00646594|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24534262|NCT00646594|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24534263|NCT00646594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24421414|NCT00218569|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24534338|NCT00646737|Mycophenolic Acid|mycophenolic acid|mesh-list
24534339|NCT00646737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24534340|NCT00646737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24534341|NCT00646737|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24971148|NCT03728153|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24971149|NCT03728153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25690376|NCT01972724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25690377|NCT01972724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690378|NCT01972789|Ranibizumab|ranibizumab|mesh-list
25690379|NCT01972789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25690380|NCT01972789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25690381|NCT01972789|Growth Substances|growth substances|mesh-ancestor
25690382|NCT01972789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690383|NCT01972789|Growth Inhibitors|growth inhibitors|mesh-ancestor
24534419|NCT00646945|Nitrous Oxide|nitrous oxide|mesh-list
24451023|NCT00321490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24451024|NCT00321490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451025|NCT00321490|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24451026|NCT00321490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24586424|NCT00890604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24586425|NCT00890604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783940|NCT01904981|Autonomic Agents|autonomic agents|mesh-ancestor
24421883|NCT00220480|Citalopram|citalopram|mesh-list
24534488|NCT00647166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24534489|NCT00647166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24534490|NCT00647166|Immunologic Factors|immunologic factors|mesh-ancestor
24534491|NCT00647166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534492|NCT00647166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24534560|NCT00647621|Anticonvulsants|anticonvulsants|mesh-ancestor
24534561|NCT00647621|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24534604|NCT00647673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534605|NCT00647673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24534606|NCT00647673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534607|NCT00647673|Vasodilator Agents|vasodilator agents|mesh-ancestor
24534608|NCT00647686|Fentanyl|fentanyl|mesh-list
24534609|NCT00647686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24534610|NCT00647686|Narcotics|narcotics|mesh-ancestor
24534611|NCT00647686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24534612|NCT00647686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534613|NCT00647686|Analgesics|analgesics|mesh-ancestor
24534819|NCT00648063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25014522|NCT04390945|Capecitabine|capecitabine|mesh-list
25014556|NCT04337827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014557|NCT04337827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25014558|NCT04322669|Pidotimod|pidotimod|mesh-list
24534866|NCT00648154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24534867|NCT00648154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534869|NCT00648180|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24534877|NCT00648193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24534878|NCT00648193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534879|NCT00648193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24534880|NCT00648193|Serotonin Agents|serotonin agents|mesh-ancestor
24515661|NCT00598624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24515662|NCT00598637|Everolimus|everolimus|mesh-list
24515663|NCT00598637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24515664|NCT00598637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25014595|NCT04230161|Milbemycin oxime|milbemycin oxime|mesh-list
25014596|NCT04230161|Anthelmintics|anthelmintics|mesh-ancestor
25014597|NCT04230161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24444491|NCT00298194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534940|NCT00648310|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24534942|NCT00648310|Hormones|hormones|mesh-ancestor
25014600|NCT04214691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25014602|NCT04214691|Sensory System Agents|sensory system agents|mesh-ancestor
25014603|NCT04214691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25014604|NCT04214691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014605|NCT04214691|Antipyretics|antipyretics|mesh-ancestor
25014606|NCT04204941|Doxorubicin|doxorubicin|mesh-list
25014626|NCT04198116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014627|NCT04198116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404553|NCT03661411|Purinergic Agents|purinergic agents|mesh-ancestor
25690384|NCT01972789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25690385|NCT01972841|Solifenacin Succinate|solifenacin succinate|mesh-list
25690386|NCT01972841|Mirabegron|mirabegron|mesh-list
25690387|NCT01972841|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25690388|NCT01972841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25690389|NCT01972841|Cholinergic Agents|cholinergic agents|mesh-ancestor
25690390|NCT01972841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25692655|NCT02003534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24534967|NCT00648336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534975|NCT00648349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014634|NCT04183452|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
25014635|NCT04183452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24535037|NCT00648440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535038|NCT00648440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24535044|NCT00648440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535045|NCT00648453|Clopidogrel|clopidogrel|mesh-list
24535046|NCT00648453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24535047|NCT00648453|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24535048|NCT00648453|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24535049|NCT00648453|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24535050|NCT00648453|Purinergic Agents|purinergic agents|mesh-ancestor
24535051|NCT00648453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535052|NCT00648453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535053|NCT00648453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535055|NCT00648466|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24535056|NCT00648466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24535057|NCT00648466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24535058|NCT00648466|Serotonin Agents|serotonin agents|mesh-ancestor
24535059|NCT00648466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535060|NCT00648466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014646|NCT04155710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25014647|NCT04155710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25014648|NCT04155710|Analgesics|analgesics|mesh-ancestor
25062642|NCT04231877|Etoposide|etoposide|mesh-list
25014649|NCT04155710|Sensory System Agents|sensory system agents|mesh-ancestor
25014650|NCT04155710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25014651|NCT04155710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014652|NCT04095208|Nivolumab|nivolumab|mesh-list
24535061|NCT00648466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535062|NCT00648492|Metformin|metformin|mesh-list
24535063|NCT00648492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24535065|NCT00648505|Metformin|metformin|mesh-list
24929973|NCT04106700|Apixaban|apixaban|mesh-list
24535137|NCT00648622|Adrenergic Agents|adrenergic agents|mesh-ancestor
24535138|NCT00648622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535139|NCT00648622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535140|NCT00648622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535141|NCT00648622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24535142|NCT00648622|Antioxidants|antioxidants|mesh-ancestor
24535143|NCT00648622|Protective Agents|protective agents|mesh-ancestor
24535144|NCT00648622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24535145|NCT00648622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24535146|NCT00648622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24535147|NCT00648622|Vasodilator Agents|vasodilator agents|mesh-ancestor
24535148|NCT00648622|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24535149|NCT00648622|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25690391|NCT01972841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690392|NCT01972841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690393|NCT01972841|Urological Agents|urological agents|mesh-ancestor
24535163|NCT00648661|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24535164|NCT00648661|Parasympatholytics|parasympatholytics|mesh-ancestor
24535166|NCT00648661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24535167|NCT00648661|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24535168|NCT00648661|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24535169|NCT00648661|Cholinergic Agents|cholinergic agents|mesh-ancestor
24535183|NCT00648726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24535184|NCT00648726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24535185|NCT00648726|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24535186|NCT00648726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535187|NCT00648726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535189|NCT00648765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24535190|NCT00648765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25014684|NCT04042077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535225|NCT00648804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24535248|NCT00648843|Autonomic Agents|autonomic agents|mesh-ancestor
24535249|NCT00648843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24422948|NCT00224185|Dimercaprol|dimercaprol|mesh-list
24535259|NCT00648856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24535278|NCT00648921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24535279|NCT00648921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25014731|NCT03995017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014732|NCT03995017|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25014733|NCT03995017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787570|NCT01925898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014734|NCT03980314|Nivolumab|nivolumab|mesh-list
25014735|NCT03980314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25014736|NCT03980314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25014737|NCT03980314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24535280|NCT00648921|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24535296|NCT00648947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535297|NCT00648947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535299|NCT00648960|Clarithromycin|clarithromycin|mesh-list
25690394|NCT01972841|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25690395|NCT01972841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25690396|NCT01972841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25690397|NCT01972841|Adrenergic Agents|adrenergic agents|mesh-ancestor
25690398|NCT01973036|Oxytocin|oxytocin|mesh-list
25690399|NCT01973036|Oxytocics|oxytocics|mesh-ancestor
25690400|NCT01973036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25014744|NCT03926299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25014745|NCT03926299|Glucocorticoids|glucocorticoids|mesh-ancestor
24535380|NCT00649064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535382|NCT00649064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535386|NCT00649064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25014747|NCT03926299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25014811|NCT03814200|Rifampin|rifampin|mesh-list
25014769|NCT03893903|Avelumab|avelumab|mesh-list
25014770|NCT03893903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25014771|NCT03893903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980187|NCT05440864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24535387|NCT00649064|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24535388|NCT00649064|Dopamine Agents|dopamine agents|mesh-ancestor
24535389|NCT00649077|Meloxicam|meloxicam|mesh-list
24535390|NCT00649077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24535391|NCT00649077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24535392|NCT00649077|Analgesics|analgesics|mesh-ancestor
24535393|NCT00649077|Sensory System Agents|sensory system agents|mesh-ancestor
24535394|NCT00649077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25014786|NCT03868956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014787|NCT03868956|Hemostatics|hemostatics|mesh-ancestor
25014788|NCT03868956|Coagulants|coagulants|mesh-ancestor
25014789|NCT03861793|Pembrolizumab|pembrolizumab|mesh-list
25014790|NCT03861793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25014791|NCT03861793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980210|NCT05440578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535395|NCT00649077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535396|NCT00649077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24535397|NCT00649077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24535413|NCT00649103|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24535414|NCT00649103|Protease Inhibitors|protease inhibitors|mesh-ancestor
25690401|NCT01973036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690402|NCT01973205|Aspirin|aspirin|mesh-list
25690403|NCT01973205|Acetaminophen|acetaminophen|mesh-list
25690404|NCT01973205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25690405|NCT01973205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25690406|NCT01973205|Analgesics|analgesics|mesh-ancestor
25690407|NCT01973205|Sensory System Agents|sensory system agents|mesh-ancestor
25690408|NCT01973205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24535415|NCT00649103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535416|NCT00649103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535417|NCT00649103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24535419|NCT00649116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24535423|NCT00649116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24535424|NCT00649116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535425|NCT00649116|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24535426|NCT00649116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24535427|NCT00649116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24535428|NCT00649116|Adrenergic Agents|adrenergic agents|mesh-ancestor
24535429|NCT00649116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25014795|NCT03841097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014796|NCT03841097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25014797|NCT03841097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25014798|NCT03841097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014802|NCT03814356|Methylphenidate|methylphenidate|mesh-list
25014803|NCT03814356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25014804|NCT03814356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014805|NCT03814356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24980219|NCT05431075|Bismuth|bismuth|mesh-list
24535430|NCT00649116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535432|NCT00649129|Parasympatholytics|parasympatholytics|mesh-ancestor
24535433|NCT00649129|Autonomic Agents|autonomic agents|mesh-ancestor
24535448|NCT00649155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014810|NCT03814356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24787583|NCT01925898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25014885|NCT03705845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014887|NCT03705845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014888|NCT03705845|Vitamins|vitamins|mesh-ancestor
25014889|NCT03705845|Micronutrients|micronutrients|mesh-ancestor
25014963|NCT03589729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25014964|NCT03589729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25014965|NCT03589729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25014966|NCT03589729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24980242|NCT05420467|Paclitaxel|paclitaxel|mesh-list
25015002|NCT03520491|Nivolumab|nivolumab|mesh-list
25015003|NCT03520491|Ipilimumab|ipilimumab|mesh-list
25015004|NCT03520491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25015005|NCT03520491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015006|NCT03520491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25015007|NCT03520491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015008|NCT03495388|Oxycodone|oxycodone|mesh-list
25015009|NCT03495388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25015010|NCT03495388|Narcotics|narcotics|mesh-ancestor
24971613|NCT03723941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971614|NCT03723941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24586427|NCT00890604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24586428|NCT00890604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24586429|NCT00890604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24586430|NCT00890604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24515984|NCT00600158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586431|NCT00890604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625193|NCT01080820|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
24625194|NCT01080820|Antiviral Agents|antiviral agents|mesh-ancestor
24625195|NCT01080820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24535583|NCT00649402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24535584|NCT00649402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535586|NCT00649402|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24535587|NCT00649402|Protease Inhibitors|protease inhibitors|mesh-ancestor
24535588|NCT00649402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535589|NCT00649415|Valdecoxib|valdecoxib|mesh-list
24535590|NCT00649415|Piroxicam|piroxicam|mesh-list
24535592|NCT00649415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24535593|NCT00649415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24586433|NCT00890630|Oxytocin|oxytocin|mesh-list
24586446|NCT00890708|Voriconazole|voriconazole|mesh-list
24586447|NCT00890708|Antifungal Agents|antifungal agents|mesh-ancestor
24586448|NCT00890708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24586449|NCT00890708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24586450|NCT00890708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24577046|NCT00841841|Dipyrone|dipyrone|mesh-list
24586473|NCT00890786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24795603|NCT01498458|Capecitabine|capecitabine|mesh-list
24932824|NCT04076371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25690409|NCT01973205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516017|NCT00600301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25062725|NCT04099836|Bevacizumab|bevacizumab|mesh-list
25062726|NCT04099836|Atezolizumab|atezolizumab|mesh-list
24423843|NCT00227084|Hemostatics|hemostatics|mesh-list
24535669|NCT00649532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24535670|NCT00649532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24586475|NCT00890786|Growth Substances|growth substances|mesh-ancestor
24586476|NCT00890786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586477|NCT00890786|Growth Inhibitors|growth inhibitors|mesh-ancestor
24586478|NCT00890786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24586479|NCT00890786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24586480|NCT00890786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24586481|NCT00890786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586482|NCT00890786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24586483|NCT00890786|Alkylating Agents|alkylating agents|mesh-ancestor
24586512|NCT00891072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24586513|NCT00891072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586514|NCT00891072|Tubulin Modulators|tubulin modulators|mesh-ancestor
24586515|NCT00891072|Antimitotic Agents|antimitotic agents|mesh-ancestor
24586516|NCT00891072|Mitosis Modulators|mitosis modulators|mesh-ancestor
24980282|NCT05420454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24980283|NCT05420454|Immunologic Factors|immunologic factors|mesh-ancestor
24535672|NCT00649532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24535673|NCT00649545|Adalimumab|adalimumab|mesh-list
24535674|NCT00649545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24535675|NCT00649545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24535676|NCT00649558|Pioglitazone|pioglitazone|mesh-list
24535679|NCT00649571|Doxycycline|doxycycline|mesh-list
24535680|NCT00649571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24535681|NCT00649571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24535682|NCT00649571|Antimalarials|antimalarials|mesh-ancestor
24535683|NCT00649571|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24535684|NCT00649571|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24618633|NCT01049425|Docetaxel|docetaxel|mesh-list
24933267|NCT04072263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535727|NCT00649623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25690410|NCT01973205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25690411|NCT01973205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25690412|NCT01973205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25015026|NCT03476330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015027|NCT03476330|Protective Agents|protective agents|mesh-ancestor
25015028|NCT03476330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015029|NCT03473977|Benralizumab|benralizumab|mesh-list
25015030|NCT03473977|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25015031|NCT03473977|Respiratory System Agents|respiratory system agents|mesh-ancestor
25015032|NCT03461445|Tacrolimus|tacrolimus|mesh-list
25015033|NCT03461445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25015034|NCT03461445|Immunologic Factors|immunologic factors|mesh-ancestor
25015035|NCT03461445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015036|NCT03461445|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25015037|NCT03461445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25015038|NCT03461445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015039|NCT03451006|Metformin|metformin|mesh-list
25015040|NCT03451006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25015041|NCT03451006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015042|NCT03437421|Vitamin D|vitamin d|mesh-list
25015043|NCT03437421|Cholecalciferol|cholecalciferol|mesh-list
24579908|NCT00858676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579910|NCT00858676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621403|NCT01062152|Immunologic Factors|immunologic factors|mesh-ancestor
24621404|NCT01062152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621405|NCT01062152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24535798|NCT00649727|Oxybutynin|oxybutynin|mesh-list
24535799|NCT00649727|Parasympatholytics|parasympatholytics|mesh-ancestor
24535800|NCT00649727|Autonomic Agents|autonomic agents|mesh-ancestor
24535801|NCT00649727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24535802|NCT00649727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015045|NCT03437421|Micronutrients|micronutrients|mesh-ancestor
25015046|NCT03437421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015047|NCT03437421|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25015048|NCT03437421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25015049|NCT03420950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25015050|NCT03420950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25015051|NCT03420950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015052|NCT03396211|Nivolumab|nivolumab|mesh-list
25015053|NCT03396211|Apatinib|apatinib|mesh-list
25015054|NCT03396211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25015055|NCT03396211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015056|NCT03396211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25015057|NCT03396211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015058|NCT03396211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25015059|NCT03396211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621428|NCT01062360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24621429|NCT01062360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24621430|NCT01062360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24621431|NCT01062360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24621432|NCT01062360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621433|NCT01062360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24621434|NCT01062360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24621435|NCT01062360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004569|NCT02795988|Fluorouracil|fluorouracil|mesh-list
25015090|NCT03205761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015127|NCT03126968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25015128|NCT03126968|Respiratory System Agents|respiratory system agents|mesh-ancestor
25015129|NCT03126968|Mydriatics|mydriatics|mesh-ancestor
25015130|NCT03126968|Sympathomimetics|sympathomimetics|mesh-ancestor
24424331|NCT00228878|Insulin|insulin|mesh-list
24535827|NCT00649779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577200|NCT00842491|Growth Inhibitors|growth inhibitors|mesh-ancestor
25015179|NCT03033225|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25015180|NCT03033225|Dermatologic Agents|dermatologic agents|mesh-ancestor
25015181|NCT03011034|Daratumumab|daratumumab|mesh-list
25015182|NCT03011034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25004570|NCT02795988|Capecitabine|capecitabine|mesh-list
24535829|NCT00649805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24535830|NCT00649805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24535831|NCT00649805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24535832|NCT00649805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535833|NCT00649805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24535834|NCT00649805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535835|NCT00649805|Vasodilator Agents|vasodilator agents|mesh-ancestor
24535837|NCT00649818|Anticonvulsants|anticonvulsants|mesh-ancestor
24535838|NCT00649818|Antiemetics|antiemetics|mesh-ancestor
24535839|NCT00649818|Autonomic Agents|autonomic agents|mesh-ancestor
24535840|NCT00649818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24535841|NCT00649818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535842|NCT00649818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24971838|NCT03722173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24971840|NCT03722173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24971842|NCT03721991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24971843|NCT03721991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535888|NCT00649896|Hormones|hormones|mesh-ancestor
24535889|NCT00649896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24535890|NCT00649896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535891|NCT00649922|Adalimumab|adalimumab|mesh-list
24535892|NCT00649922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24971844|NCT03721991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971845|NCT03721991|Histamine Antagonists|histamine antagonists|mesh-ancestor
24971846|NCT03721991|Histamine Agents|histamine agents|mesh-ancestor
24971847|NCT03721900|Ketamine|ketamine|mesh-list
24971848|NCT03721900|Analgesics|analgesics|mesh-ancestor
24971849|NCT03721900|Sensory System Agents|sensory system agents|mesh-ancestor
24971850|NCT03721900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24971851|NCT03721900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971852|NCT03721900|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24971853|NCT03721900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24971854|NCT03721900|Anesthetics, General|anesthetics, general|mesh-ancestor
24971855|NCT03721900|Anesthetics|anesthetics|mesh-ancestor
24971856|NCT03721900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24971857|NCT03721900|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24971858|NCT03721900|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24971859|NCT03721900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24933725|NCT04067817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24971860|NCT03721900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690413|NCT01973205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25690414|NCT01973205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586557|NCT00891267|Vasodilator Agents|vasodilator agents|mesh-ancestor
24586558|NCT00891267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24586559|NCT00891267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24586561|NCT00891306|Mycophenolic Acid|mycophenolic acid|mesh-list
24586562|NCT00891306|Methylprednisolone|methylprednisolone|mesh-list
24577318|NCT00842998|Lapatinib|lapatinib|mesh-list
24980451|NCT05263921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24980452|NCT05263921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980453|NCT05263921|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24980454|NCT05263921|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24980455|NCT05263921|Antiviral Agents|antiviral agents|mesh-ancestor
24980456|NCT05263921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25015282|NCT02734290|Paclitaxel|paclitaxel|mesh-list
25015283|NCT02734290|Pembrolizumab|pembrolizumab|mesh-list
25015284|NCT02734290|Capecitabine|capecitabine|mesh-list
25015285|NCT02734290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25015286|NCT02734290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015296|NCT02630368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25015297|NCT02630368|Immunologic Factors|immunologic factors|mesh-ancestor
25015298|NCT02630368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015299|NCT02630368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25015300|NCT02630368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25015301|NCT02630368|Alkylating Agents|alkylating agents|mesh-ancestor
25015302|NCT02630368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015303|NCT02630368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015304|NCT02630368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25015305|NCT02630368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25015306|NCT02613416|Denosumab|denosumab|mesh-list
25015307|NCT02613416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25015308|NCT02613416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015309|NCT02601014|Nivolumab|nivolumab|mesh-list
25015310|NCT02601014|Ipilimumab|ipilimumab|mesh-list
25015311|NCT02601014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25015312|NCT02601014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015313|NCT02601014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25015315|NCT02598999|Lactoferrin|lactoferrin|mesh-list
24826110|NCT02132416|Ibuprofen|ibuprofen|mesh-list
24980487|NCT05224089|Dexamethasone|dexamethasone|mesh-list
24980488|NCT05224089|Epinephrine|epinephrine|mesh-list
24980489|NCT05224089|Bupivacaine|bupivacaine|mesh-list
24980490|NCT05224089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24980491|NCT05224089|Antiemetics|antiemetics|mesh-ancestor
24980492|NCT05224089|Autonomic Agents|autonomic agents|mesh-ancestor
24980493|NCT05224089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25015316|NCT02598999|Hypothiocyanite ion|hypothiocyanite ion|mesh-list
25015317|NCT02598999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25015318|NCT02588651|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25015319|NCT02588651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25015320|NCT02588651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015321|NCT02581787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25015322|NCT02581787|Antibodies|antibodies|mesh-list
25015323|NCT02581787|Immunoglobulins|immunoglobulins|mesh-list
25015324|NCT02581787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25015325|NCT02581787|Immunoglobulin G|immunoglobulin g|mesh-list
25015326|NCT02581787|Immunologic Factors|immunologic factors|mesh-ancestor
25015327|NCT02581787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015328|NCT02581787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015329|NCT02581085|Tocotrienols|tocotrienols|mesh-list
25015330|NCT02581085|Vitamin E|vitamin e|mesh-list
25015331|NCT02581085|Tocopherols|tocopherols|mesh-list
25015332|NCT02581085|Antioxidants|antioxidants|mesh-ancestor
24577432|NCT00844142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25015358|NCT02527200|Incretins|incretins|mesh-ancestor
25015366|NCT02516696|Autonomic Agents|autonomic agents|mesh-ancestor
25015367|NCT02516696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25690415|NCT01973205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25690416|NCT01973205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25690417|NCT01973205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25690418|NCT01973205|Antipyretics|antipyretics|mesh-ancestor
25690419|NCT01973218|Vaccines|vaccines|mesh-list
25015368|NCT02516696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015369|NCT02516696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25690420|NCT01973218|Immunologic Factors|immunologic factors|mesh-ancestor
25690421|NCT01973218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690422|NCT01973231|Liraglutide|liraglutide|mesh-list
25062891|NCT03530995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25015376|NCT02516696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25015377|NCT02516696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25015378|NCT02516696|Growth Substances|growth substances|mesh-ancestor
25015379|NCT02516696|Growth Inhibitors|growth inhibitors|mesh-ancestor
25015380|NCT02516696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25015381|NCT02516696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25015382|NCT02516696|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25015383|NCT02516696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25015406|NCT02476058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24535934|NCT00650013|Adrenergic Agents|adrenergic agents|mesh-ancestor
24535935|NCT00650013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535972|NCT00650117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24535973|NCT00650117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535974|NCT00650117|Analgesics|analgesics|mesh-ancestor
24535975|NCT00650117|Sensory System Agents|sensory system agents|mesh-ancestor
24535976|NCT00650117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24535977|NCT00650117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24535998|NCT00650169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24535999|NCT00650169|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24536000|NCT00650169|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24536001|NCT00650169|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24536002|NCT00650169|Purinergic Agents|purinergic agents|mesh-ancestor
24536003|NCT00650169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24536004|NCT00650169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015408|NCT02476058|Autonomic Agents|autonomic agents|mesh-ancestor
25015409|NCT02476058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25015410|NCT02476058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25015411|NCT02476058|Histamine Antagonists|histamine antagonists|mesh-ancestor
25015412|NCT02476058|Histamine Agents|histamine agents|mesh-ancestor
25015413|NCT02476058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25015414|NCT02476058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015415|NCT02476058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25015416|NCT02476058|Antipruritics|antipruritics|mesh-ancestor
25015417|NCT02476058|Dermatologic Agents|dermatologic agents|mesh-ancestor
25015419|NCT02432209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25015420|NCT02432209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015421|NCT02432209|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25015422|NCT02432209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25690423|NCT01973231|Lixisenatide|lixisenatide|mesh-list
24536058|NCT00650247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536059|NCT00650247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536060|NCT00650273|Azithromycin|azithromycin|mesh-list
24536061|NCT00650273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24536062|NCT00650273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24536063|NCT00650286|Modafinil|modafinil|mesh-list
25015451|NCT02392637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25015452|NCT02392637|Immunologic Factors|immunologic factors|mesh-ancestor
25015453|NCT02392637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015455|NCT02372630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25015459|NCT02372630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015460|NCT02372630|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25015461|NCT02372630|Protease Inhibitors|protease inhibitors|mesh-ancestor
25015462|NCT02372630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25015463|NCT02372630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015464|NCT02341014|Lenalidomide|lenalidomide|mesh-list
25015465|NCT02341014|Romidepsin|romidepsin|mesh-list
25015466|NCT02341014|Immunologic Factors|immunologic factors|mesh-ancestor
25015467|NCT02341014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015468|NCT02341014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25015469|NCT02341014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25015470|NCT02341014|Growth Substances|growth substances|mesh-ancestor
25015471|NCT02341014|Growth Inhibitors|growth inhibitors|mesh-ancestor
25015472|NCT02341014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980518|NCT05199324|Ciprofloxacin|ciprofloxacin|mesh-list
24536064|NCT00650286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24536089|NCT00650325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24536090|NCT00650325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536091|NCT00650325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24536092|NCT00650325|Serotonin Agents|serotonin agents|mesh-ancestor
24536093|NCT00650325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536094|NCT00650338|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24536095|NCT00650338|Latanoprost|latanoprost|mesh-list
24536096|NCT00650338|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24451213|NCT00322660|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24451214|NCT00322660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24451215|NCT00322660|Adrenergic Agents|adrenergic agents|mesh-ancestor
24451216|NCT00322660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24451217|NCT00322660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015473|NCT02341014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24536183|NCT00650442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24536184|NCT00650442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24536193|NCT00650455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24536194|NCT00650455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24536195|NCT00650455|Gout Suppressants|gout suppressants|mesh-ancestor
24536196|NCT00650455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24536197|NCT00650455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536198|NCT00650455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536199|NCT00650455|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25690425|NCT01973231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690426|NCT01973231|Incretins|incretins|mesh-ancestor
25690427|NCT01973231|Hormones|hormones|mesh-ancestor
24536200|NCT00650468|Mycophenolic Acid|mycophenolic acid|mesh-list
24536201|NCT00650468|Prednisone|prednisone|mesh-list
25015518|NCT02164643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015520|NCT02155920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24972116|NCT03720041|Dexamethasone acetate|dexamethasone acetate|mesh-list
24972117|NCT03720041|Lenalidomide|lenalidomide|mesh-list
24972119|NCT03720041|BB 1101|bb 1101|mesh-list
24972120|NCT03720041|Glycine|glycine|mesh-list
24536268|NCT00650611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536269|NCT00650611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536270|NCT00650611|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24536271|NCT00650611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24536272|NCT00650611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24536292|NCT00650637|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
24536294|NCT00650637|Calcium Carbonate|calcium carbonate|mesh-list
25690428|NCT01973231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25690429|NCT01973283|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25690430|NCT01973283|Citalopram|citalopram|mesh-list
25690431|NCT01973283|Antidepressive Agents|antidepressive agents|mesh-list
24972121|NCT03720041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24972123|NCT03720041|Autonomic Agents|autonomic agents|mesh-ancestor
24972124|NCT03720041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24972125|NCT03720041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972126|NCT03720041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24972127|NCT03720041|Glucocorticoids|glucocorticoids|mesh-ancestor
24972129|NCT03720041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24972130|NCT03720041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24577634|NCT00845338|Darifenacin|darifenacin|mesh-list
24586581|NCT00891306|Antiemetics|antiemetics|mesh-ancestor
24586582|NCT00891306|Autonomic Agents|autonomic agents|mesh-ancestor
24536315|NCT00650754|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24536316|NCT00650754|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24536317|NCT00650754|Immunologic Factors|immunologic factors|mesh-ancestor
24536318|NCT00650754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536319|NCT00650793|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24536320|NCT00650793|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24536321|NCT00650793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24536322|NCT00650793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24536323|NCT00650793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536324|NCT00650793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24536325|NCT00650793|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24536326|NCT00650793|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24536327|NCT00650793|Serotonin Agents|serotonin agents|mesh-ancestor
24536349|NCT00650897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536350|NCT00650897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24536351|NCT00650897|Antidepressive Agents|antidepressive agents|mesh-ancestor
24536352|NCT00650897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24536353|NCT00650910|Lapatinib|lapatinib|mesh-list
24536354|NCT00650910|Digoxin|digoxin|mesh-list
24586584|NCT00891306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24586585|NCT00891306|Glucocorticoids|glucocorticoids|mesh-ancestor
24586586|NCT00891306|Hormones|hormones|mesh-ancestor
24749031|NCT01857115|Alkylating Agents|alkylating agents|mesh-ancestor
24586587|NCT00891306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24586588|NCT00891306|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24586589|NCT00891306|Protective Agents|protective agents|mesh-ancestor
24586590|NCT00891306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24586592|NCT00891332|Antidotes|antidotes|mesh-ancestor
24586593|NCT00891332|Protective Agents|protective agents|mesh-ancestor
25015521|NCT02155920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25015522|NCT02155920|Immunologic Factors|immunologic factors|mesh-ancestor
25015523|NCT02155920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015524|NCT02130492|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25015525|NCT02130492|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25015526|NCT02130492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015527|NCT02123823|Everolimus|everolimus|mesh-list
25015528|NCT02123823|Exemestane|exemestane|mesh-list
25015529|NCT02123823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015530|NCT02123823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25015531|NCT02123823|Immunologic Factors|immunologic factors|mesh-ancestor
25015532|NCT02123823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015533|NCT02123823|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25015534|NCT02123823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25015535|NCT02123823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577680|NCT00845559|Exenatide|exenatide|mesh-list
25015562|NCT01656434|Ferrous fumarate|ferrous fumarate|mesh-list
25015563|NCT01656434|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25015564|NCT01656434|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25015565|NCT01656434|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25015566|NCT01656434|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25015567|NCT01656434|Contraceptive Agents|contraceptive agents|mesh-ancestor
25015570|NCT01656434|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25015572|NCT01656434|Hormones|hormones|mesh-ancestor
25015573|NCT01656434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015574|NCT01656434|Trace Elements|trace elements|mesh-ancestor
25015575|NCT01656434|Micronutrients|micronutrients|mesh-ancestor
25015576|NCT01601522|Ranitidine|ranitidine|mesh-list
25015577|NCT01601522|Desloratadine|desloratadine|mesh-list
25015578|NCT01601522|Histamine Antagonists|histamine antagonists|mesh-list
25015579|NCT01601522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25015580|NCT01601522|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25015581|NCT01601522|Cholinergic Agents|cholinergic agents|mesh-ancestor
25015582|NCT01601522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25015607|NCT01415674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015608|NCT01415674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25015609|NCT01415674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25015610|NCT01415674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015614|NCT01350934|Vitamin D|vitamin d|mesh-list
25015615|NCT01350934|Cholecalciferol|cholecalciferol|mesh-list
25015616|NCT01350934|Alendronate|alendronate|mesh-list
25015617|NCT01350934|Calcitriol|calcitriol|mesh-list
25015618|NCT01350934|Calcium|calcium|mesh-list
25015619|NCT01350934|Vitamins|vitamins|mesh-ancestor
24972142|NCT03719989|Azacitidine|azacitidine|mesh-list
24536374|NCT00650923|Growth Inhibitors|growth inhibitors|mesh-ancestor
24536375|NCT00651066|Ritonavir|ritonavir|mesh-list
24536376|NCT00651066|Lopinavir|lopinavir|mesh-list
24536377|NCT00651066|Rifabutin|rifabutin|mesh-list
24536378|NCT00651066|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24536379|NCT00651066|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24536380|NCT00651066|Protease Inhibitors|protease inhibitors|mesh-ancestor
24536381|NCT00651066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536382|NCT00651066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536384|NCT00651066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25015620|NCT01350934|Micronutrients|micronutrients|mesh-ancestor
25015621|NCT01350934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015622|NCT01350934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25015623|NCT01350934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25015624|NCT01350934|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25015625|NCT01350934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25690432|NCT01973283|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25690433|NCT01973283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25690434|NCT01973283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25015626|NCT01350934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015629|NCT01304511|Hormone Antagonists|hormone antagonists|mesh-ancestor
25015630|NCT01304511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015650|NCT01146418|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25015651|NCT01146418|Hormones|hormones|mesh-ancestor
25015652|NCT01146418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015653|NCT01146418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536389|NCT00651066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24536399|NCT00651131|Daptomycin|daptomycin|mesh-list
24536400|NCT00651131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24536401|NCT00651131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24536402|NCT00651209|Tenofovir|tenofovir|mesh-list
24536403|NCT00651209|Antiviral Agents|antiviral agents|mesh-ancestor
24536404|NCT00651209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24536423|NCT00651235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536424|NCT00651235|Vasodilator Agents|vasodilator agents|mesh-ancestor
24536425|NCT00651235|Sympatholytics|sympatholytics|mesh-ancestor
24536426|NCT00651235|Autonomic Agents|autonomic agents|mesh-ancestor
24536427|NCT00651235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24536428|NCT00651235|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24536430|NCT00651287|Quinapril|quinapril|mesh-list
24536431|NCT00651287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24536432|NCT00651287|Diuretics|diuretics|mesh-ancestor
24536473|NCT00651326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24536474|NCT00651352|Nicotine|nicotine|mesh-list
24536475|NCT00651352|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24536515|NCT00651547|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24536516|NCT00651547|Adrenergic Agents|adrenergic agents|mesh-ancestor
25015656|NCT01144416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015657|NCT01144416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015658|NCT01077817|Alendronate|alendronate|mesh-list
25015659|NCT01077817|Risedronic Acid|risedronic acid|mesh-list
25015660|NCT01077817|Ibandronic Acid|ibandronic acid|mesh-list
25015661|NCT01077817|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25015662|NCT01077817|Etidronic Acid|etidronic acid|mesh-list
25015663|NCT01077817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25015664|NCT01077817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015665|NCT01077817|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25015666|NCT01077817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25015667|NCT01077817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015668|NCT01077817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24980681|NCT05027100|Irinotecan|irinotecan|mesh-list
24536517|NCT00651547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25690435|NCT01973283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690436|NCT01973283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25690437|NCT01973283|Serotonin Agents|serotonin agents|mesh-ancestor
25690438|NCT01973283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690439|NCT01973283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25690440|NCT01973283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25063069|NCT03225417|Protease Inhibitors|protease inhibitors|mesh-ancestor
25063070|NCT03217071|Pembrolizumab|pembrolizumab|mesh-list
25063071|NCT03217071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25063073|NCT03204812|Durvalumab|durvalumab|mesh-list
24536518|NCT00651547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536519|NCT00651586|Ciprofloxacin|ciprofloxacin|mesh-list
24536520|NCT00651586|Gatifloxacin|gatifloxacin|mesh-list
24536521|NCT00651586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24536522|NCT00651586|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24536523|NCT00651586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24536524|NCT00651586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24536525|NCT00651586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24536526|NCT00651586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24536527|NCT00651586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536528|NCT00651586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536529|NCT00651586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24536530|NCT00651586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24536569|NCT00651651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24536573|NCT00651651|Adrenergic Agents|adrenergic agents|mesh-ancestor
25015670|NCT01077817|Hormone Antagonists|hormone antagonists|mesh-ancestor
25015671|NCT01077817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015672|NCT01077817|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25015673|NCT01077817|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25015675|NCT01065779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25015676|NCT01065779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015677|NCT01056159|Albuterol|albuterol|mesh-list
25015678|NCT01056159|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25015679|NCT01056159|Autonomic Agents|autonomic agents|mesh-ancestor
25015680|NCT01056159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24980683|NCT05027100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24980684|NCT05027100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24980685|NCT05027100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980686|NCT05027100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980687|NCT05024214|Sunitinib|sunitinib|mesh-list
24536574|NCT00651651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24536575|NCT00651651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536622|NCT00651768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24536637|NCT00651846|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
24536638|NCT00651846|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24536639|NCT00651846|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24536640|NCT00651859|Bimatoprost|bimatoprost|mesh-list
24536641|NCT00651859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24536642|NCT00651859|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24536643|NCT00651859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24536644|NCT00651885|Treprostinil|treprostinil|mesh-list
24536645|NCT00651885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24536646|NCT00651911|Rasburicase|rasburicase|mesh-list
24536647|NCT00651911|Gout Suppressants|gout suppressants|mesh-ancestor
24536648|NCT00651911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24536649|NCT00651976|Letrozole|letrozole|mesh-list
25690441|NCT01973283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25690442|NCT01973283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25690443|NCT01973283|Analgesics|analgesics|mesh-ancestor
25690444|NCT01973283|Sensory System Agents|sensory system agents|mesh-ancestor
25690445|NCT01973283|Dopamine Agents|dopamine agents|mesh-ancestor
25690446|NCT01973335|Spironolactone|spironolactone|mesh-list
25690447|NCT01973335|Acetazolamide|acetazolamide|mesh-list
25690448|NCT01973335|Bumetanide|bumetanide|mesh-list
25690449|NCT01973335|Diuretics|diuretics|mesh-list
25015681|NCT01056159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110781|NCT05370326|Sensory System Agents|sensory system agents|mesh-ancestor
25110782|NCT05370326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25110783|NCT05360576|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25110784|NCT05360576|Etonogestrel|etonogestrel|mesh-list
25110786|NCT05360576|Estradiol|estradiol|mesh-list
25110787|NCT05360576|Estrogens|estrogens|mesh-ancestor
25110788|NCT05360576|Hormones|hormones|mesh-ancestor
24536683|NCT00652041|Leprostatic Agents|leprostatic agents|mesh-ancestor
24536684|NCT00652041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24536884|NCT00652808|Analgesics|analgesics|mesh-ancestor
24536700|NCT00652106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24446356|NCT00304551|Antimetabolites|antimetabolites|mesh-ancestor
24536702|NCT00652106|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24536703|NCT00652106|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24536704|NCT00652106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24536706|NCT00652119|Bevacizumab|bevacizumab|mesh-list
24536707|NCT00652119|Carboplatin|carboplatin|mesh-list
24536708|NCT00652119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24536709|NCT00652119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24536762|NCT00652288|Insulin Lispro|insulin lispro|mesh-list
24536763|NCT00652288|Insulin Detemir|insulin detemir|mesh-list
24536764|NCT00652288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24536765|NCT00652288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536766|NCT00652379|Octreotide|octreotide|mesh-list
24536767|NCT00652379|Lanreotide|lanreotide|mesh-list
24536768|NCT00652379|Somatostatin|somatostatin|mesh-list
24536769|NCT00652379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24536770|NCT00652379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24536771|NCT00652379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25110789|NCT05360576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24577859|NCT00846131|Sorafenib|sorafenib|mesh-list
25015696|NCT00974571|Cetirizine|cetirizine|mesh-list
25015697|NCT00974571|Montelukast|montelukast|mesh-list
25015698|NCT00974571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25015699|NCT00974571|Respiratory System Agents|respiratory system agents|mesh-ancestor
25015700|NCT00974571|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25015701|NCT00974571|Hormone Antagonists|hormone antagonists|mesh-ancestor
25015702|NCT00974571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25690450|NCT01973335|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
24897241|NCT04426734|Methylprednisolone|methylprednisolone|mesh-list
24897242|NCT04426734|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24897243|NCT04426734|Prednisolone acetate|prednisolone acetate|mesh-list
25015703|NCT00974571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015704|NCT00974571|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25015705|NCT00974571|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25015706|NCT00974571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015707|NCT00974571|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25015708|NCT00974571|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24980720|NCT04992260|Vaccines|vaccines|mesh-list
24536786|NCT00652392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24536787|NCT00652392|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24536788|NCT00652392|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24536789|NCT00652392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24536790|NCT00652392|Adrenergic Agents|adrenergic agents|mesh-ancestor
24536791|NCT00652392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24536792|NCT00652392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536793|NCT00652483|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24536794|NCT00652483|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25015709|NCT00974571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25015710|NCT00974571|Histamine Antagonists|histamine antagonists|mesh-ancestor
25015711|NCT00974571|Histamine Agents|histamine agents|mesh-ancestor
25015712|NCT00974571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25015713|NCT00972738|Loratadine|loratadine|mesh-list
25015714|NCT00972738|Montelukast|montelukast|mesh-list
25015715|NCT00972738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25015716|NCT00972738|Respiratory System Agents|respiratory system agents|mesh-ancestor
24577887|NCT00846248|Chromium|chromium|mesh-list
25015744|NCT00968149|Respiratory System Agents|respiratory system agents|mesh-ancestor
25015745|NCT00968149|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25015746|NCT00968149|Hormone Antagonists|hormone antagonists|mesh-ancestor
25015747|NCT00968149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015748|NCT00968149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015749|NCT00968149|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25015750|NCT00968149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25015751|NCT00968149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015752|NCT00963469|Loratadine|loratadine|mesh-list
24536795|NCT00652483|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24536796|NCT00652483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24536856|NCT00652704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24536857|NCT00652704|Antimalarials|antimalarials|mesh-ancestor
24536858|NCT00652704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24536859|NCT00652704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24536860|NCT00652730|Buspirone|buspirone|mesh-list
24536861|NCT00652730|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24536862|NCT00652730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24536863|NCT00652730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24536864|NCT00652730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536865|NCT00652730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24549911|NCT00717951|Antimitotic Agents|antimitotic agents|mesh-ancestor
25690451|NCT01973335|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25690452|NCT01973335|Hormone Antagonists|hormone antagonists|mesh-ancestor
25690453|NCT01973335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25690454|NCT01973335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690455|NCT01973335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24536875|NCT00652795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24536876|NCT00652795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24536877|NCT00652795|Antimalarials|antimalarials|mesh-ancestor
24536878|NCT00652795|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24536879|NCT00652795|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24536881|NCT00652808|Valdecoxib|valdecoxib|mesh-list
24536882|NCT00652808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24536883|NCT00652808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24972402|NCT03718273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972403|NCT03718273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972404|NCT03718273|Protective Agents|protective agents|mesh-ancestor
24972405|NCT03718273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536886|NCT00652808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24536887|NCT00652808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536935|NCT00652912|Clonazepam|clonazepam|mesh-list
24536889|NCT00652808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24536890|NCT00652808|Gout Suppressants|gout suppressants|mesh-ancestor
24536891|NCT00652808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24536892|NCT00652808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972415|NCT03718182|Cholecalciferol|cholecalciferol|mesh-list
24972416|NCT03718182|Vitamin D|vitamin d|mesh-list
24972417|NCT03718182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24972418|NCT03718182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972419|NCT03718182|Vitamins|vitamins|mesh-ancestor
24972420|NCT03718182|Micronutrients|micronutrients|mesh-ancestor
24972421|NCT03718182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24972422|NCT03718039|Aprepitant|aprepitant|mesh-list
24972423|NCT03718039|Antiemetics|antiemetics|mesh-ancestor
24972424|NCT03718039|Autonomic Agents|autonomic agents|mesh-ancestor
24972425|NCT03718039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25690456|NCT01973335|Natriuretic Agents|natriuretic agents|mesh-ancestor
24474493|NCT00406237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536933|NCT00652886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536934|NCT00652886|Anabolic Agents|anabolic agents|mesh-ancestor
24536936|NCT00652912|Anticonvulsants|anticonvulsants|mesh-ancestor
24536937|NCT00652912|GABA Modulators|gaba modulators|mesh-ancestor
24536938|NCT00652912|GABA Agents|gaba agents|mesh-ancestor
24536939|NCT00652912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24536940|NCT00652912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536941|NCT00652912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536942|NCT00652925|Celecoxib|celecoxib|mesh-list
24536943|NCT00652925|Naproxen|naproxen|mesh-list
24536944|NCT00652925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24536945|NCT00652925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25015774|NCT00960141|Respiratory System Agents|respiratory system agents|mesh-ancestor
25015775|NCT00960141|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25015776|NCT00960141|Hormone Antagonists|hormone antagonists|mesh-ancestor
24577978|NCT00846612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015796|NCT00943683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015797|NCT00943683|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25015798|NCT00943683|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25015799|NCT00943683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015801|NCT00943397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25015802|NCT00943397|Respiratory System Agents|respiratory system agents|mesh-ancestor
25015803|NCT00943397|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25015804|NCT00943397|Hormone Antagonists|hormone antagonists|mesh-ancestor
25015805|NCT00943397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015806|NCT00943397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015807|NCT00943397|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25690457|NCT01973335|Anticonvulsants|anticonvulsants|mesh-ancestor
25690458|NCT01973335|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24474526|NCT00406380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474527|NCT00406380|Growth Inhibitors|growth inhibitors|mesh-ancestor
24474528|NCT00406432|Paroxetine|paroxetine|mesh-list
24474529|NCT00406432|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24474530|NCT00406432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24474531|NCT00406432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24536987|NCT00653120|Propranolol|propranolol|mesh-list
25015810|NCT00911547|Beclomethasone|beclomethasone|mesh-list
25015811|NCT00911547|Montelukast|montelukast|mesh-list
25015812|NCT00911547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25015813|NCT00911547|Respiratory System Agents|respiratory system agents|mesh-ancestor
25015814|NCT00911547|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25015815|NCT00911547|Hormone Antagonists|hormone antagonists|mesh-ancestor
25015816|NCT00911547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015817|NCT00911547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980764|NCT04958486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25004922|NCT05202275|Serotonin Agents|serotonin agents|mesh-ancestor
24456914|NCT00332631|Antiviral Agents|antiviral agents|mesh-ancestor
24537011|NCT00653250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24537012|NCT00653250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24537013|NCT00653250|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24537032|NCT00653341|Isophane Insulin, Human|isophane insulin, human|mesh-list
24537033|NCT00653341|Insulin, Isophane|insulin, isophane|mesh-list
24537034|NCT00653341|Isophane insulin, beef|isophane insulin, beef|mesh-list
24537037|NCT00653354|Valdecoxib|valdecoxib|mesh-list
24537039|NCT00653354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24537040|NCT00653354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537041|NCT00653354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537042|NCT00653354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24537043|NCT00653354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24537044|NCT00653354|Analgesics|analgesics|mesh-ancestor
24537045|NCT00653354|Sensory System Agents|sensory system agents|mesh-ancestor
24537046|NCT00653354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24537047|NCT00653354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537048|NCT00653354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24537049|NCT00653354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24537050|NCT00653380|Doxycycline|doxycycline|mesh-list
25690459|NCT01973335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25690460|NCT01973335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690461|NCT01973335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25690462|NCT01973348|Methamphetamine|methamphetamine|mesh-list
25690463|NCT01973348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25690464|NCT01973348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690465|NCT01973348|Sympathomimetics|sympathomimetics|mesh-ancestor
25690466|NCT01973348|Autonomic Agents|autonomic agents|mesh-ancestor
25063250|NCT02477826|Antimitotic Agents|antimitotic agents|mesh-ancestor
25063251|NCT02477826|Mitosis Modulators|mitosis modulators|mesh-ancestor
24825765|NCT02130323|Imiquimod|imiquimod|mesh-list
25015818|NCT00911547|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25015819|NCT00911547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25015820|NCT00911547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015822|NCT00911547|Glucocorticoids|glucocorticoids|mesh-ancestor
25015823|NCT00911547|Hormones|hormones|mesh-ancestor
25015824|NCT00899379|Rizatriptan|rizatriptan|mesh-list
25015849|NCT00897104|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25015850|NCT00897104|Serotonin Agents|serotonin agents|mesh-ancestor
25015851|NCT00897104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25015852|NCT00897104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015853|NCT00897104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015854|NCT00817817|Mometasone Furoate|mometasone furoate|mesh-list
25015855|NCT00817817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24467860|NCT00378976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25015856|NCT00817817|Dermatologic Agents|dermatologic agents|mesh-ancestor
24537071|NCT00653406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537072|NCT00653406|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24537073|NCT00653406|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24537074|NCT00653406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24537075|NCT00653406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24537076|NCT00653406|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24537077|NCT00653406|Dopamine Agents|dopamine agents|mesh-ancestor
24537078|NCT00653419|Buspirone|buspirone|mesh-list
24537079|NCT00653419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24537080|NCT00653419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24537081|NCT00653419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24537082|NCT00653419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537083|NCT00653419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24428232|NCT00239993|(T,G)-A-L|(t,g)-a-l|mesh-list
25015859|NCT00803790|Ergocalciferols|ergocalciferols|mesh-list
25015860|NCT00803790|Cholecalciferol|cholecalciferol|mesh-list
25015861|NCT00803790|Alendronate|alendronate|mesh-list
25015862|NCT00803790|Vitamins|vitamins|mesh-list
25015863|NCT00803790|Micronutrients|micronutrients|mesh-ancestor
25015864|NCT00803790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015865|NCT00803790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25015866|NCT00803790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25015867|NCT00792506|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25015868|NCT00792506|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
25015869|NCT00792506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25015870|NCT00792506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015871|NCT00745108|Tibolone|tibolone|mesh-list
25015872|NCT00745108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015903|NCT00725374|Anabolic Agents|anabolic agents|mesh-ancestor
25690467|NCT01973348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25690468|NCT01973348|Dopamine Agents|dopamine agents|mesh-ancestor
25690469|NCT01973348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25690470|NCT01973348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690471|NCT01973348|Adrenergic Agents|adrenergic agents|mesh-ancestor
25690472|NCT01973348|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25690473|NCT01973348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25690474|NCT01973348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24532861|NCT00641407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24947734|NCT03926377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24947735|NCT03926377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947736|NCT03926403|Anesthetics|anesthetics|mesh-list
24474742|NCT00407225|Glucocorticoids|glucocorticoids|mesh-ancestor
24474743|NCT00407225|Hormones|hormones|mesh-ancestor
25015904|NCT00725374|Hormones|hormones|mesh-ancestor
25015905|NCT00724789|Ganirelix|ganirelix|mesh-list
24537108|NCT00653458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537109|NCT00653458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24537110|NCT00653458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24537111|NCT00653458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24451236|NCT00322751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25015911|NCT00711607|Hormones|hormones|mesh-ancestor
25015912|NCT00711607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015947|NCT00702624|Hormone Antagonists|hormone antagonists|mesh-ancestor
25015949|NCT00702546|Progesterone|progesterone|mesh-list
25015950|NCT00702546|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25015951|NCT00702546|Ganirelix|ganirelix|mesh-list
25015967|NCT00702520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015968|NCT00702338|Hormones|hormones|mesh-list
25015969|NCT00702338|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24451240|NCT00322803|1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one|1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one|mesh-list
24451241|NCT00322803|Anticonvulsants|anticonvulsants|mesh-ancestor
24451242|NCT00322803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24451243|NCT00322803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24451245|NCT00322803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451246|NCT00322803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25690475|NCT01973348|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25690476|NCT01973387|Rituximab|rituximab|mesh-list
25690477|NCT01973387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25690478|NCT01973387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25690479|NCT01973387|Immunologic Factors|immunologic factors|mesh-ancestor
25690480|NCT01973387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690481|NCT01973387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25690482|NCT01973413|Insulin|insulin|mesh-list
25690483|NCT01973413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24897748|NCT04422392|Carboplatin|carboplatin|mesh-list
24537154|NCT00653744|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24537155|NCT00653744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24537156|NCT00653744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24537157|NCT00653744|Antimetabolites|antimetabolites|mesh-ancestor
24537158|NCT00653744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537159|NCT00653744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25015970|NCT00702338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015971|NCT00702338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015973|NCT00702273|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25015974|NCT00702273|Ganirelix|ganirelix|mesh-list
25015975|NCT00702273|Progestins|progestins|mesh-ancestor
25015976|NCT00702273|Hormones|hormones|mesh-ancestor
25015977|NCT00702273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015978|NCT00702273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015979|NCT00702273|Hormone Antagonists|hormone antagonists|mesh-ancestor
25015980|NCT00702234|Progesterone|progesterone|mesh-list
25015981|NCT00702234|Progestins|progestins|mesh-ancestor
25015982|NCT00702234|Hormones|hormones|mesh-ancestor
25015983|NCT00702234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015984|NCT00702234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015985|NCT00702195|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25015986|NCT00702195|Hormones|hormones|mesh-ancestor
25015987|NCT00702195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015988|NCT00702195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015989|NCT00697255|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25015990|NCT00697255|Hormones|hormones|mesh-list
25015991|NCT00697255|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25015992|NCT00697255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015993|NCT00697255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015994|NCT00697255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25015995|NCT00696878|Progesterone|progesterone|mesh-list
25015996|NCT00696878|Progestins|progestins|mesh-ancestor
25015997|NCT00696878|Hormones|hormones|mesh-ancestor
25015998|NCT00696878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015999|NCT00696878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016000|NCT00696800|Progesterone|progesterone|mesh-list
24980823|NCT04874610|Methylprednisolone|methylprednisolone|mesh-list
24537160|NCT00653744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24537161|NCT00653744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537162|NCT00653757|Leuprolide|leuprolide|mesh-list
24537163|NCT00653757|Goserelin|goserelin|mesh-list
24537164|NCT00653757|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24537165|NCT00653757|Fertility Agents|fertility agents|mesh-ancestor
25004927|NCT05201560|Butorphanol|butorphanol|mesh-list
25016001|NCT00696800|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25016002|NCT00696800|Ganirelix|ganirelix|mesh-list
25016003|NCT00696800|Progestins|progestins|mesh-ancestor
25016004|NCT00696800|Hormones|hormones|mesh-ancestor
25016005|NCT00696800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25016006|NCT00696800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016007|NCT00696800|Hormone Antagonists|hormone antagonists|mesh-ancestor
25016037|NCT00616967|Mitosis Modulators|mitosis modulators|mesh-ancestor
25016038|NCT00616967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016039|NCT00616967|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25016040|NCT00616967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25016041|NCT00598208|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25016042|NCT00598208|Hormones|hormones|mesh-ancestor
25016043|NCT00598208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25016044|NCT00598208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016045|NCT00519857|Tibolone|tibolone|mesh-list
24474859|NCT00407771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24474860|NCT00407784|Eplerenone|eplerenone|mesh-list
24474861|NCT00407784|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24474862|NCT00407784|Hormone Antagonists|hormone antagonists|mesh-ancestor
25016046|NCT00519857|Androgen Antagonists|androgen antagonists|mesh-ancestor
25016047|NCT00519857|Hormone Antagonists|hormone antagonists|mesh-ancestor
25016048|NCT00519857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24537166|NCT00653757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24537167|NCT00653757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537168|NCT00653757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24537169|NCT00653757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24537170|NCT00653822|Alefacept|alefacept|mesh-list
24537171|NCT00653822|Dermatologic Agents|dermatologic agents|mesh-ancestor
24537172|NCT00653822|Immunologic Factors|immunologic factors|mesh-ancestor
24537173|NCT00653822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537174|NCT00653848|Docetaxel|docetaxel|mesh-list
24537175|NCT00653848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24537176|NCT00653848|Tubulin Modulators|tubulin modulators|mesh-ancestor
24445522|NCT00301782|Etoposide|etoposide|mesh-list
25016080|NCT00446056|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25016081|NCT00446056|Antipruritics|antipruritics|mesh-ancestor
25016082|NCT00446056|Dermatologic Agents|dermatologic agents|mesh-ancestor
25016083|NCT00446056|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25016084|NCT00446056|Histamine Antagonists|histamine antagonists|mesh-ancestor
25016085|NCT00446056|Histamine Agents|histamine agents|mesh-ancestor
25016086|NCT00446056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25016087|NCT00442338|Aminophylline|aminophylline|mesh-list
25016088|NCT00442338|Theophylline|theophylline|mesh-list
25016089|NCT00442338|Montelukast|montelukast|mesh-list
25016090|NCT00442338|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25016091|NCT00442338|Respiratory System Agents|respiratory system agents|mesh-ancestor
24578326|NCT00848562|Vitamins|vitamins|mesh-ancestor
25016101|NCT00442338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25016102|NCT00442338|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25016103|NCT00442338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25016104|NCT00442338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25016105|NCT00442338|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25016106|NCT00442338|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25016107|NCT00442338|Purinergic Agents|purinergic agents|mesh-ancestor
25016108|NCT00442338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25016109|NCT00442338|Protective Agents|protective agents|mesh-ancestor
25016110|NCT00442338|Vasodilator Agents|vasodilator agents|mesh-ancestor
25016111|NCT00431093|Tibolone|tibolone|mesh-list
25016112|NCT00431093|Estradiol|estradiol|mesh-list
25016113|NCT00431093|Estrogens|estrogens|mesh-ancestor
25016114|NCT00431093|Hormones|hormones|mesh-ancestor
25016115|NCT00431093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25016127|NCT00398606|Alendronate|alendronate|mesh-list
25016128|NCT00398606|Calcium Carbonate|calcium carbonate|mesh-list
25690484|NCT01973413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690485|NCT01973439|Abacavir|abacavir|mesh-list
25690486|NCT01973439|Dideoxynucleosides|dideoxynucleosides|mesh-list
25690487|NCT01973439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25016129|NCT00398606|Calcium|calcium|mesh-list
25016130|NCT00398606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24897795|NCT04421716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897796|NCT04421716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24897797|NCT04421716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24897798|NCT04421716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24897799|NCT04421911|Diclofenac|diclofenac|mesh-list
25690488|NCT01973439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25016131|NCT00398606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016132|NCT00398606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016133|NCT00398606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25016134|NCT00398606|Antacids|antacids|mesh-ancestor
25016135|NCT00398606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25016136|NCT00395408|Beclomethasone|beclomethasone|mesh-list
25016137|NCT00395408|Montelukast|montelukast|mesh-list
25016138|NCT00395408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016139|NCT00395408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016141|NCT00395408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25016142|NCT00395408|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25016143|NCT00395408|Hormone Antagonists|hormone antagonists|mesh-ancestor
25016144|NCT00395408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25016145|NCT00395408|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25016146|NCT00395408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25016147|NCT00395408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25016148|NCT00395408|Glucocorticoids|glucocorticoids|mesh-ancestor
25016149|NCT00395408|Hormones|hormones|mesh-ancestor
25016150|NCT00394069|Montelukast|montelukast|mesh-list
25016151|NCT00394069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25016152|NCT00394069|Respiratory System Agents|respiratory system agents|mesh-ancestor
25016164|NCT00389740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25016166|NCT00389740|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25016167|NCT00389740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25016168|NCT00289874|Montelukast|montelukast|mesh-list
25106103|NCT04469959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25016169|NCT00289874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25016170|NCT00289874|Respiratory System Agents|respiratory system agents|mesh-ancestor
25016171|NCT00289874|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25016178|NCT00250458|Rizatriptan|rizatriptan|mesh-list
25016179|NCT00250458|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25016180|NCT00250458|Serotonin Agents|serotonin agents|mesh-ancestor
25016181|NCT00250458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25016182|NCT00250458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016183|NCT00250458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016184|NCT00245570|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25016185|NCT00245570|Montelukast|montelukast|mesh-list
25016186|NCT00245570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25016187|NCT00245570|Autonomic Agents|autonomic agents|mesh-ancestor
25016188|NCT00245570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25016189|NCT00245570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016190|NCT00245570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25016191|NCT00245570|Respiratory System Agents|respiratory system agents|mesh-ancestor
25016192|NCT00245570|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24980874|NCT04783857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24428805|NCT00241241|Interferons|interferons|mesh-list
24537203|NCT00653926|Mydriatics|mydriatics|mesh-ancestor
24537204|NCT00653926|Sympathomimetics|sympathomimetics|mesh-ancestor
24537205|NCT00653926|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25690489|NCT01973439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25690490|NCT01973439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690491|NCT01973439|Antiviral Agents|antiviral agents|mesh-ancestor
25690492|NCT01973439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25690493|NCT01973439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25690494|NCT01973439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24897874|NCT04421105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690495|NCT01973439|Antimetabolites|antimetabolites|mesh-ancestor
24897883|NCT04420871|Capecitabine|capecitabine|mesh-list
24537207|NCT00653952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24537208|NCT00653952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446375|NCT00304616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24537209|NCT00653952|Tubulin Modulators|tubulin modulators|mesh-ancestor
24537210|NCT00653952|Antimitotic Agents|antimitotic agents|mesh-ancestor
24537211|NCT00653952|Mitosis Modulators|mitosis modulators|mesh-ancestor
25016198|NCT00245570|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25016199|NCT00245570|Hormone Antagonists|hormone antagonists|mesh-ancestor
25016200|NCT00245570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25016201|NCT00245570|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25016202|NCT00245570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25016203|NCT00229970|Montelukast|montelukast|mesh-list
25016204|NCT00229970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25016205|NCT00229970|Respiratory System Agents|respiratory system agents|mesh-ancestor
25016206|NCT00229970|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25016207|NCT00229970|Hormone Antagonists|hormone antagonists|mesh-ancestor
25016222|NCT00140946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25016224|NCT00140881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25016225|NCT00140881|Respiratory System Agents|respiratory system agents|mesh-ancestor
24537212|NCT00653952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537217|NCT00653965|Antimetabolites|antimetabolites|mesh-ancestor
24537240|NCT00654056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446376|NCT00304616|Dopamine Agents|dopamine agents|mesh-ancestor
25016227|NCT00140881|Hormone Antagonists|hormone antagonists|mesh-ancestor
25016228|NCT00140881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24972794|NCT03715296|Lenalidomide|lenalidomide|mesh-list
25016229|NCT00140881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016230|NCT00140881|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25016231|NCT00140881|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25016232|NCT00140881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016233|NCT00111722|Rizatriptan|rizatriptan|mesh-list
25016234|NCT00111722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25016235|NCT00111722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016236|NCT00111722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016237|NCT00111722|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25016238|NCT00111722|Serotonin Agents|serotonin agents|mesh-ancestor
25016239|NCT00111709|Rizatriptan|rizatriptan|mesh-list
24537241|NCT00654082|Sildenafil Citrate|sildenafil citrate|mesh-list
24537242|NCT00654082|Vasodilator Agents|vasodilator agents|mesh-ancestor
24537243|NCT00654082|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24537244|NCT00654082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24537245|NCT00654082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537246|NCT00654082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537247|NCT00654082|Urological Agents|urological agents|mesh-ancestor
24537248|NCT00654108|Ascorbic Acid|ascorbic acid|mesh-list
24537249|NCT00654108|Ciprofloxacin|ciprofloxacin|mesh-list
24537290|NCT00654173|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24537291|NCT00654173|Simvastatin|simvastatin|mesh-list
24537292|NCT00654173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25690496|NCT01973569|Denosumab|denosumab|mesh-list
25690497|NCT01973569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25690498|NCT01973569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537293|NCT00654173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25690499|NCT01974141|Dapsone|dapsone|mesh-list
25690500|NCT01974141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24897960|NCT04419662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897961|NCT04419662|Protective Agents|protective agents|mesh-ancestor
24897963|NCT04419493|Calcium heparin|calcium heparin|mesh-list
24897964|NCT04419493|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24897965|NCT04419493|Anticoagulants|anticoagulants|mesh-ancestor
24897966|NCT04419493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24897967|NCT04419493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25063314|NCT02097121|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25063315|NCT02097121|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25063316|NCT02097121|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25063317|NCT02097121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24825865|NCT02130817|Antiemetics|antiemetics|mesh-ancestor
24537294|NCT00654173|Antimetabolites|antimetabolites|mesh-ancestor
24537295|NCT00654173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537296|NCT00654173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24537297|NCT00654173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24537298|NCT00654173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481729|NCT00436709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24481730|NCT00436709|Immunologic Factors|immunologic factors|mesh-ancestor
25016242|NCT00111709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016243|NCT00111709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25016244|NCT00111709|Serotonin Agents|serotonin agents|mesh-ancestor
25016245|NCT00095004|Rizatriptan|rizatriptan|mesh-list
25016246|NCT00095004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25016247|NCT00095004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537344|NCT00654290|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24537345|NCT00654303|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24537369|NCT00654407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24537370|NCT00654407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537371|NCT00654446|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25690501|NCT01974141|Antimalarials|antimalarials|mesh-ancestor
25690502|NCT01974141|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25690503|NCT01974141|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25690504|NCT01974141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25690505|NCT01974141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25690506|NCT01974141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690507|NCT01974141|Leprostatic Agents|leprostatic agents|mesh-ancestor
25690508|NCT01974141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25690509|NCT01974245|Cholecalciferol|cholecalciferol|mesh-list
25690510|NCT01974245|Vitamin D|vitamin d|mesh-list
25690511|NCT01974245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25690512|NCT01974245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475153|NCT00409227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475154|NCT00409227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475156|NCT00409253|Nicardipine|nicardipine|mesh-list
24537372|NCT00654446|Simvastatin|simvastatin|mesh-list
24537373|NCT00654446|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24537374|NCT00654446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24537375|NCT00654446|Antimetabolites|antimetabolites|mesh-ancestor
24537376|NCT00654446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537377|NCT00654446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24537378|NCT00654446|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24537379|NCT00654446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446391|NCT00304629|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24537380|NCT00654459|Policosanol|policosanol|mesh-list
24537381|NCT00654459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24537382|NCT00654459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24537383|NCT00654459|Antimetabolites|antimetabolites|mesh-ancestor
24537384|NCT00654459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537385|NCT00654459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24537431|NCT00654576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24537446|NCT00654589|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24537448|NCT00654589|Sequestering Agents|sequestering agents|mesh-ancestor
24537449|NCT00654589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537450|NCT00654602|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24537451|NCT00654602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25016250|NCT00095004|Serotonin Agents|serotonin agents|mesh-ancestor
25016251|NCT00092963|Rizatriptan|rizatriptan|mesh-list
25016252|NCT00092963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25016253|NCT00092963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016254|NCT00092963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016255|NCT00092963|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25016256|NCT00092963|Serotonin Agents|serotonin agents|mesh-ancestor
25016257|NCT00092885|Montelukast|montelukast|mesh-list
25016258|NCT00092885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25016274|NCT00092131|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25016275|NCT00092131|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25016276|NCT00092131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016277|NCT00092118|Montelukast|montelukast|mesh-list
25016278|NCT00092118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24980949|NCT04718155|Atorvastatin|atorvastatin|mesh-list
24537452|NCT00654602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24537453|NCT00654602|Antimetabolites|antimetabolites|mesh-ancestor
24429504|NCT00244179|Interferons|interferons|mesh-list
24537461|NCT00654667|Protective Agents|protective agents|mesh-ancestor
24537506|NCT00655018|alpha-Tocopherol|alpha-tocopherol|mesh-list
24537508|NCT00655018|Micronutrients|micronutrients|mesh-ancestor
24537509|NCT00655018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537510|NCT00655018|Antioxidants|antioxidants|mesh-ancestor
24537511|NCT00655018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537512|NCT00655018|Protective Agents|protective agents|mesh-ancestor
24537518|NCT00655109|Lubricant Eye Drops|lubricant eye drops|mesh-list
24537519|NCT00655109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24537520|NCT00655109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24537521|NCT00655109|Autonomic Agents|autonomic agents|mesh-ancestor
25016280|NCT00092118|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25016281|NCT00092118|Hormone Antagonists|hormone antagonists|mesh-ancestor
25016282|NCT00092118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25016283|NCT00092118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016284|NCT00092118|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25016285|NCT00092118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25016286|NCT00092118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016287|NCT00092105|Montelukast|montelukast|mesh-list
25016288|NCT00092105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25016289|NCT00092105|Respiratory System Agents|respiratory system agents|mesh-ancestor
25016290|NCT00092105|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25690513|NCT01974245|Vitamins|vitamins|mesh-ancestor
25690514|NCT01974245|Micronutrients|micronutrients|mesh-ancestor
25690515|NCT01974245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25690516|NCT01974323|Dapsone|dapsone|mesh-list
24475236|NCT00409591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016291|NCT00092105|Hormone Antagonists|hormone antagonists|mesh-ancestor
25016292|NCT00092105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25016293|NCT00092105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968457|NCT03751111|Sensory System Agents|sensory system agents|mesh-ancestor
24968460|NCT03751059|Bromfenac|bromfenac|mesh-list
24980995|NCT04634409|Bamlanivimab|bamlanivimab|mesh-list
24537551|NCT00655148|Immunologic Factors|immunologic factors|mesh-ancestor
24537552|NCT00655148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537553|NCT00655174|Fluvoxamine|fluvoxamine|mesh-list
24537554|NCT00655174|Sertraline|sertraline|mesh-list
24537556|NCT00655174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24537557|NCT00655174|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24537558|NCT00655174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25016294|NCT00092105|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25016295|NCT00092105|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24972817|NCT03715023|Antiviral Agents|antiviral agents|mesh-ancestor
24972891|NCT03714555|Immunologic Factors|immunologic factors|mesh-ancestor
24972892|NCT03714555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972893|NCT03714555|Trace Elements|trace elements|mesh-ancestor
24972894|NCT03714555|Micronutrients|micronutrients|mesh-ancestor
24972895|NCT03714555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24972896|NCT03714555|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
24972897|NCT03714490|Capecitabine|capecitabine|mesh-list
24972898|NCT03714490|Oxaliplatin|oxaliplatin|mesh-list
24972899|NCT03714490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24972900|NCT03714490|Antimetabolites|antimetabolites|mesh-ancestor
24972901|NCT03714490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972902|NCT03714490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24972903|NCT03714360|Tranexamic Acid|tranexamic acid|mesh-list
24972904|NCT03714360|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24586598|NCT00891384|Lenalidomide|lenalidomide|mesh-list
24586599|NCT00891384|Immunologic Factors|immunologic factors|mesh-ancestor
24586600|NCT00891384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586601|NCT00891384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24586602|NCT00891384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24586603|NCT00891384|Growth Substances|growth substances|mesh-ancestor
24586604|NCT00891384|Growth Inhibitors|growth inhibitors|mesh-ancestor
24586605|NCT00891384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24537559|NCT00655174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24537560|NCT00655174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537561|NCT00655174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24537562|NCT00655174|Serotonin Agents|serotonin agents|mesh-ancestor
24537563|NCT00655174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690517|NCT01974323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25690518|NCT01974323|Antimalarials|antimalarials|mesh-ancestor
25690519|NCT01974323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25690520|NCT01974323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24586607|NCT00891397|Analgesics|analgesics|mesh-ancestor
24586608|NCT00891397|Sensory System Agents|sensory system agents|mesh-ancestor
24586609|NCT00891397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24586610|NCT00891397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586611|NCT00891397|Anticonvulsants|anticonvulsants|mesh-ancestor
24586612|NCT00891397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24586613|NCT00891397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24586614|NCT00891397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586615|NCT00891397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24586616|NCT00891397|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24586617|NCT00891397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24586618|NCT00891397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24586619|NCT00891397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24586620|NCT00891423|Meropenem|meropenem|mesh-list
24586621|NCT00891423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24586622|NCT00891423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24586623|NCT00891475|Interferons|interferons|mesh-list
24586625|NCT00891475|Sunitinib|sunitinib|mesh-list
24586626|NCT00891475|Maleic acid|maleic acid|mesh-list
24586627|NCT00891475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586628|NCT00891475|Antiviral Agents|antiviral agents|mesh-ancestor
24586629|NCT00891475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24586630|NCT00891475|Immunologic Factors|immunologic factors|mesh-ancestor
24586631|NCT00891475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457502|NCT00334594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457503|NCT00334594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24537584|NCT00655265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537586|NCT00655330|Valsartan|valsartan|mesh-list
24537587|NCT00655330|Probucol|probucol|mesh-list
24537588|NCT00655330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24537589|NCT00655330|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24537590|NCT00655330|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24537591|NCT00655330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537592|NCT00655330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24537593|NCT00655330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24537594|NCT00655330|Antimetabolites|antimetabolites|mesh-ancestor
24537595|NCT00655330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24537596|NCT00655330|Antioxidants|antioxidants|mesh-ancestor
24586633|NCT00891475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24586634|NCT00891475|Growth Substances|growth substances|mesh-ancestor
25016296|NCT00092105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016298|NCT00092092|Montelukast|montelukast|mesh-list
25016299|NCT00092092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25016300|NCT00092092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25016301|NCT00092092|Autonomic Agents|autonomic agents|mesh-ancestor
25016302|NCT00092092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25016303|NCT00092092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457504|NCT00334594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24485212|NCT00451997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24485213|NCT00451997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25690521|NCT01974323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25690522|NCT01974323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25690523|NCT01974323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690524|NCT01974323|Leprostatic Agents|leprostatic agents|mesh-ancestor
25690525|NCT01974323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24898306|NCT04415385|Apatinib|apatinib|mesh-list
25016331|NCT00092040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25016332|NCT00092040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25016334|NCT00092027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016335|NCT00092027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25016336|NCT00092014|Vitamin D|vitamin d|mesh-list
25016337|NCT00092014|Alendronate|alendronate|mesh-list
25016338|NCT00092014|Risedronic Acid|risedronic acid|mesh-list
25016339|NCT00092014|Calcium|calcium|mesh-list
25016340|NCT00092014|Vitamins|vitamins|mesh-ancestor
25016341|NCT00092014|Micronutrients|micronutrients|mesh-ancestor
25016342|NCT00092014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016343|NCT00092014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25016344|NCT00092014|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25016345|NCT00092014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25016346|NCT00092014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25016347|NCT00092014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981048|NCT04512261|Pembrolizumab|pembrolizumab|mesh-list
24537597|NCT00655330|Protective Agents|protective agents|mesh-ancestor
24537598|NCT00655330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537600|NCT00655408|Trace Elements|trace elements|mesh-ancestor
24537601|NCT00655408|Micronutrients|micronutrients|mesh-ancestor
25016372|NCT00043108|Tubulin Modulators|tubulin modulators|mesh-ancestor
25016375|NCT00043108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016376|NCT05225597|Carbachol|carbachol|mesh-list
25016377|NCT05225597|Epinephrine|epinephrine|mesh-list
25016378|NCT05225597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25016379|NCT05225597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25016380|NCT05225597|Adrenergic Agents|adrenergic agents|mesh-ancestor
25016381|NCT05225597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25016382|NCT05225597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016383|NCT05225597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972910|NCT03714165|Defensins|defensins|mesh-list
25016384|NCT05225597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25016385|NCT05225597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24537607|NCT00655421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537609|NCT00655512|Pimecrolimus|pimecrolimus|mesh-list
24537610|NCT00655512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24537611|NCT00655512|Glucocorticoids|glucocorticoids|mesh-ancestor
24537612|NCT00655512|Hormones|hormones|mesh-ancestor
24537613|NCT00655512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24537614|NCT00655512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537618|NCT00655512|Sensory System Agents|sensory system agents|mesh-ancestor
24537619|NCT00655512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24485509|NCT00453323|Antimetabolites|antimetabolites|mesh-ancestor
24537641|NCT00655616|Montelukast|montelukast|mesh-list
24537642|NCT00655616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24537643|NCT00655616|Autonomic Agents|autonomic agents|mesh-ancestor
24537657|NCT00655616|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24537658|NCT00655616|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24537659|NCT00655655|Everolimus|everolimus|mesh-list
24537660|NCT00655655|Vatalanib|vatalanib|mesh-list
24537661|NCT00655655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24537662|NCT00655655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24537663|NCT00655655|Immunologic Factors|immunologic factors|mesh-ancestor
25690526|NCT01974687|Itraconazole|itraconazole|mesh-list
25690527|NCT01974687|Uprifosbuvir|uprifosbuvir|mesh-list
25690528|NCT01974687|Antifungal Agents|antifungal agents|mesh-ancestor
25690529|NCT01974687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25690530|NCT01974687|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25690531|NCT01974687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25690532|NCT01974687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537664|NCT00655655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537665|NCT00655655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25016386|NCT05225597|Autonomic Agents|autonomic agents|mesh-ancestor
25016387|NCT05225597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25016388|NCT05225597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25016389|NCT05225597|Respiratory System Agents|respiratory system agents|mesh-ancestor
25016390|NCT05225597|Mydriatics|mydriatics|mesh-ancestor
25016391|NCT05225597|Sympathomimetics|sympathomimetics|mesh-ancestor
25016392|NCT05225597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25016393|NCT05225597|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25110837|NCT05341323|Anesthetics, Local|anesthetics, local|mesh-ancestor
25110838|NCT05341323|Anesthetics|anesthetics|mesh-ancestor
25110839|NCT05341323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25110840|NCT05341323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110841|NCT05341323|Sensory System Agents|sensory system agents|mesh-ancestor
25110842|NCT05341323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25110843|NCT05341323|Analgesics|analgesics|mesh-ancestor
25110844|NCT05341323|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25110845|NCT05341323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25110846|NCT05341323|Anesthetics, General|anesthetics, general|mesh-ancestor
25110847|NCT05341323|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25110848|NCT05341323|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25110849|NCT05341323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25110850|NCT05341323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110852|NCT05336266|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25110853|NCT05336266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25110854|NCT05336266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25110855|NCT05336266|Analgesics|analgesics|mesh-ancestor
25110856|NCT05336266|Sensory System Agents|sensory system agents|mesh-ancestor
25110857|NCT05336266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25110858|NCT05336266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110861|NCT05336266|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25110862|NCT05336266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25110863|NCT05336266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972985|NCT03713346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972986|NCT03713216|Morphine|morphine|mesh-list
24972987|NCT03713216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24972988|NCT03713216|Narcotics|narcotics|mesh-ancestor
24972989|NCT03713216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24972990|NCT03713216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972991|NCT03713216|Analgesics|analgesics|mesh-ancestor
24972992|NCT03713216|Sensory System Agents|sensory system agents|mesh-ancestor
24578749|NCT00851513|Anesthetics, Local|anesthetics, local|mesh-ancestor
25016423|NCT05224388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25016424|NCT05224388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016426|NCT05224336|Psilocybin|psilocybin|mesh-list
25016427|NCT05224336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25016428|NCT05224336|Antimetabolites|antimetabolites|mesh-ancestor
25016429|NCT05224336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016430|NCT05224336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25016431|NCT05224336|Vasodilator Agents|vasodilator agents|mesh-ancestor
25016432|NCT05224336|Vitamin B Complex|vitamin b complex|mesh-ancestor
25016433|NCT05224336|Vitamins|vitamins|mesh-ancestor
25016434|NCT05224336|Micronutrients|micronutrients|mesh-ancestor
25016435|NCT05224336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016436|NCT05224336|Hallucinogens|hallucinogens|mesh-ancestor
25016437|NCT05224336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25016438|NCT05224167|Melatonin|melatonin|mesh-list
25016439|NCT05224167|Hydroxyzine|hydroxyzine|mesh-list
25016440|NCT05224167|Antioxidants|antioxidants|mesh-ancestor
25016441|NCT05224167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016442|NCT05224167|Protective Agents|protective agents|mesh-ancestor
25016443|NCT05224167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016444|NCT05224167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25063387|NCT01733888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25063388|NCT01709981|Colchicine|colchicine|mesh-list
25063389|NCT01709981|Gout Suppressants|gout suppressants|mesh-ancestor
25063390|NCT01709981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25063391|NCT01709981|Tubulin Modulators|tubulin modulators|mesh-ancestor
24898546|NCT04412850|Magnesium Sulfate|magnesium sulfate|mesh-list
24898547|NCT04412850|Analgesics|analgesics|mesh-ancestor
24898548|NCT04412850|Sensory System Agents|sensory system agents|mesh-ancestor
24898549|NCT04412850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24898550|NCT04412850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898551|NCT04412850|Anesthetics|anesthetics|mesh-ancestor
25016445|NCT05224167|Antipruritics|antipruritics|mesh-ancestor
25016446|NCT05224167|Dermatologic Agents|dermatologic agents|mesh-ancestor
25016467|NCT05223647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25016468|NCT05223647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25016469|NCT05223647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25016470|NCT05223647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25016471|NCT05223647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25016472|NCT05223647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016473|NCT05223647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25016475|NCT05223400|Clindamycin palmitate|clindamycin palmitate|mesh-list
25016476|NCT05223400|Clindamycin phosphate|clindamycin phosphate|mesh-list
24537677|NCT00655785|Antimetabolites|antimetabolites|mesh-ancestor
24537678|NCT00655785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537679|NCT00655785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24537680|NCT00655785|Antiviral Agents|antiviral agents|mesh-ancestor
24537681|NCT00655785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24537682|NCT00655785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537683|NCT00655785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24537684|NCT00655785|Immunologic Factors|immunologic factors|mesh-ancestor
24537707|NCT00655915|Betamethasone|betamethasone|mesh-list
25016478|NCT05223400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25016479|NCT05223400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25016480|NCT05223400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25016481|NCT05223400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016482|NCT05202002|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25016483|NCT05202002|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
25016484|NCT05202002|beta-Endorphin|beta-endorphin|mesh-list
25016485|NCT05202002|Hormones|hormones|mesh-ancestor
25016486|NCT05202002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25016487|NCT05202002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016488|NCT05202002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25016489|NCT05202002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016490|NCT05194124|alpha-MSH|alpha-msh|mesh-list
25016491|NCT05194124|Hormones|hormones|mesh-ancestor
25690533|NCT01974687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690534|NCT01974687|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24750637|NCT01699802|Anesthetics|anesthetics|mesh-list
25690535|NCT01974687|Hormone Antagonists|hormone antagonists|mesh-ancestor
25690536|NCT01974687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25690537|NCT01974687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690538|NCT01974687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25690539|NCT01974687|Antiviral Agents|antiviral agents|mesh-ancestor
25690540|NCT01974700|Levetiracetam|levetiracetam|mesh-list
25690541|NCT01974700|Anticonvulsants|anticonvulsants|mesh-ancestor
25690542|NCT01974700|Nootropic Agents|nootropic agents|mesh-ancestor
25690543|NCT01974752|Dacarbazine|dacarbazine|mesh-list
25690544|NCT01974752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24537715|NCT00655915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24537716|NCT00655915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24537717|NCT00655915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24537718|NCT00655915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24537719|NCT00655915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537720|NCT00655915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24537721|NCT00655915|Glucocorticoids|glucocorticoids|mesh-ancestor
24537722|NCT00655915|Hormones|hormones|mesh-ancestor
24537723|NCT00655915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24537724|NCT00655915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24537725|NCT00655915|Respiratory System Agents|respiratory system agents|mesh-ancestor
24537726|NCT00655967|Acamprosate|acamprosate|mesh-list
24537727|NCT00655967|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24537728|NCT00656006|Ribavirin|ribavirin|mesh-list
24537729|NCT00656006|Antimetabolites|antimetabolites|mesh-ancestor
24537730|NCT00656006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537731|NCT00656006|Antiviral Agents|antiviral agents|mesh-ancestor
24537732|NCT00656006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24537733|NCT00656032|Cinacalcet|cinacalcet|mesh-list
24537734|NCT00656032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24537735|NCT00656032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537736|NCT00656032|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24537737|NCT00656032|Hormone Antagonists|hormone antagonists|mesh-ancestor
24537738|NCT00656032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24537739|NCT00656110|Ethanol|ethanol|mesh-list
24537740|NCT00656110|Methylprednisolone|methylprednisolone|mesh-list
24537741|NCT00656110|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24537742|NCT00656110|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24537744|NCT00656110|Prednisolone acetate|prednisolone acetate|mesh-list
24537745|NCT00656110|Lidocaine|lidocaine|mesh-list
24537746|NCT00656110|Bupivacaine|bupivacaine|mesh-list
24537747|NCT00656110|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25016492|NCT05194124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25016493|NCT05194124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016495|NCT05183308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24973081|NCT03712540|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24973082|NCT03712540|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24490619|NCT00479206|Antimalarials|antimalarials|mesh-ancestor
24973083|NCT03712540|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24973084|NCT03712540|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24973099|NCT03712423|Docetaxel|docetaxel|mesh-list
24973102|NCT03712423|Antimitotic Agents|antimitotic agents|mesh-ancestor
24973103|NCT03712423|Mitosis Modulators|mitosis modulators|mesh-ancestor
24973104|NCT03712423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973105|NCT03712397|Irinotecan|irinotecan|mesh-list
24973106|NCT03712397|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24973107|NCT03712397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25016496|NCT05183308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016497|NCT05169866|Amiodarone|amiodarone|mesh-list
25016498|NCT05169866|Nifekalant|nifekalant|mesh-list
25016499|NCT05169866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25016500|NCT05169866|Vasodilator Agents|vasodilator agents|mesh-ancestor
24537754|NCT00656110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24537755|NCT00656110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24537756|NCT00656110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24537757|NCT00656110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24537758|NCT00656110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24537759|NCT00656110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537760|NCT00656110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24537761|NCT00656110|Antiemetics|antiemetics|mesh-ancestor
24537762|NCT00656110|Autonomic Agents|autonomic agents|mesh-ancestor
24537763|NCT00656110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24537764|NCT00656110|Glucocorticoids|glucocorticoids|mesh-ancestor
24537765|NCT00656110|Hormones|hormones|mesh-ancestor
24537766|NCT00656110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24537767|NCT00656110|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24537768|NCT00656110|Protective Agents|protective agents|mesh-ancestor
25690545|NCT01974752|Alkylating Agents|alkylating agents|mesh-ancestor
24898744|NCT04411212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898745|NCT04411069|Droperidol|droperidol|mesh-list
24898746|NCT04411069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24898747|NCT04411069|Antiemetics|antiemetics|mesh-ancestor
24537771|NCT00656110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24537772|NCT00656110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446406|NCT00304655|Aripiprazole|aripiprazole|mesh-list
24537773|NCT00656123|Cyclophosphamide|cyclophosphamide|mesh-list
25016501|NCT05169866|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25016502|NCT05169866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25016503|NCT05169866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016504|NCT05169866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25016505|NCT05169866|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25016506|NCT05169866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25016507|NCT05169866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25106140|NCT04356638|Anesthetics|anesthetics|mesh-ancestor
24537774|NCT00656123|Molgramostim|molgramostim|mesh-list
24537775|NCT00656123|Sargramostim|sargramostim|mesh-list
24537776|NCT00656123|Immunologic Factors|immunologic factors|mesh-ancestor
24537777|NCT00656123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537778|NCT00656123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24537779|NCT00656123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24432129|NCT00253617|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
24537808|NCT00656266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24537809|NCT00656266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24537810|NCT00656266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537811|NCT00656266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537812|NCT00656318|Contraceptive Agents|contraceptive agents|mesh-list
25016510|NCT05169866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25016511|NCT05153395|Insulin|insulin|mesh-list
25016512|NCT05153395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25016513|NCT05153395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25016514|NCT05153395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690546|NCT01974752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690547|NCT01974752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25690548|NCT01974817|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25690549|NCT01974817|Immunologic Factors|immunologic factors|mesh-ancestor
25690550|NCT01974817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690551|NCT01975220|Metformin|metformin|mesh-list
25690552|NCT01975220|Empagliflozin|empagliflozin|mesh-list
24898817|NCT04409912|Sirolimus|sirolimus|mesh-list
25016515|NCT05137600|Clarithromycin|clarithromycin|mesh-list
25016516|NCT05137600|Midazolam|midazolam|mesh-list
25016517|NCT05137600|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25016518|NCT05137600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25016519|NCT05137600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25016520|NCT05137600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016521|NCT05137600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25016522|NCT05137600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25016523|NCT05137600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25016524|NCT05137600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25016525|NCT05137600|Anesthetics, General|anesthetics, general|mesh-ancestor
25016526|NCT05137600|Anesthetics|anesthetics|mesh-ancestor
25016527|NCT05137600|GABA Modulators|gaba modulators|mesh-ancestor
25106154|NCT04327310|Meplazumab|meplazumab|mesh-list
24537813|NCT00656318|Contraceptives, Oral|contraceptives, oral|mesh-list
24537814|NCT00656318|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
24537815|NCT00656318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24537879|NCT00656591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24537880|NCT00656591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24537882|NCT00656643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24537883|NCT00656643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24537884|NCT00656643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24537885|NCT00656643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24537890|NCT00656695|Cyclosporine|cyclosporine|mesh-list
24537896|NCT00656695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537897|NCT00656695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24537902|NCT00656747|Amoxicillin|amoxicillin|mesh-list
25016547|NCT05091294|Anesthetics, Local|anesthetics, local|mesh-list
25016548|NCT05091294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25016549|NCT05091294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016550|NCT05091294|Sensory System Agents|sensory system agents|mesh-ancestor
25110888|NCT05329779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25110889|NCT05329779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110890|NCT05329779|GABA Modulators|gaba modulators|mesh-ancestor
25110891|NCT05329779|GABA Agents|gaba agents|mesh-ancestor
25110892|NCT05323656|Pembrolizumab|pembrolizumab|mesh-list
25110893|NCT05323656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25110894|NCT05323656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25110912|NCT05305794|Insulin|insulin|mesh-list
25106181|NCT04229095|Suvorexant|suvorexant|mesh-list
24537921|NCT00656747|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24432418|NCT00254774|Valproic Acid|valproic acid|mesh-list
24537987|NCT00657059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25110913|NCT05305794|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25110914|NCT05305794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25110915|NCT05305794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016563|NCT05072704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25016564|NCT05072704|Adrenergic Agents|adrenergic agents|mesh-ancestor
25016565|NCT05072704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25016566|NCT05072704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016567|NCT05072704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25016568|NCT05072704|Narcotics|narcotics|mesh-ancestor
25016569|NCT05072704|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25016570|NCT05072704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25016571|NCT05072704|Anesthetics, General|anesthetics, general|mesh-ancestor
24898893|NCT04409431|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24475909|NCT00411996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24475910|NCT00411996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25016572|NCT05072704|Anesthetics|anesthetics|mesh-ancestor
25016573|NCT05041426|Valganciclovir|valganciclovir|mesh-list
25016575|NCT05041426|Antiviral Agents|antiviral agents|mesh-ancestor
25016576|NCT05041426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25016577|NCT05041426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25016578|NCT05041426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25016579|NCT05041426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493589|NCT00491582|Hormones|hormones|mesh-list
25016580|NCT05041426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25016581|NCT04987372|Lidocaine|lidocaine|mesh-list
25016582|NCT04987372|Magnesium Sulfate|magnesium sulfate|mesh-list
25016583|NCT04987372|Pregabalin|pregabalin|mesh-list
25016584|NCT04987372|Dexmedetomidine|dexmedetomidine|mesh-list
25016585|NCT04987372|Ketamine|ketamine|mesh-list
25016586|NCT04987372|Anesthetics, Local|anesthetics, local|mesh-ancestor
25016587|NCT04987372|Anesthetics|anesthetics|mesh-ancestor
25016588|NCT04987372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25016589|NCT04987372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016590|NCT04987372|Sensory System Agents|sensory system agents|mesh-ancestor
24981241|NCT04216017|Glucocorticoids|glucocorticoids|mesh-ancestor
24537992|NCT00657059|Autonomic Agents|autonomic agents|mesh-ancestor
24537993|NCT00657059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24537994|NCT00657059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25016591|NCT04987372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25016592|NCT04987372|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25016593|NCT04987372|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25016594|NCT04987372|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25016595|NCT04987372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25016596|NCT04987372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016597|NCT04987372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25016598|NCT04987372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25016613|NCT04987372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25016614|NCT04987372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25016615|NCT04987372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25016616|NCT04987372|Tocolytic Agents|tocolytic agents|mesh-ancestor
25016617|NCT04987372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25016618|NCT04981067|Ropivacaine|ropivacaine|mesh-list
25016619|NCT04981067|Anesthetics, Local|anesthetics, local|mesh-ancestor
25016620|NCT04981067|Anesthetics|anesthetics|mesh-ancestor
25016621|NCT04981067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25016622|NCT04981067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016623|NCT04981067|Sensory System Agents|sensory system agents|mesh-ancestor
25016624|NCT04981067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24973200|NCT03711240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25016625|NCT04964050|Captopril, hydrochlorothiazide drug combination|captopril, hydrochlorothiazide drug combination|mesh-list
24493941|NCT00493116|Immunologic Factors|immunologic factors|mesh-ancestor
24751143|NCT01702389|Remifentanil|remifentanil|mesh-list
24538005|NCT00657137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538006|NCT00657137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24538007|NCT00657137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538008|NCT00657163|Fluoxetine|fluoxetine|mesh-list
25690553|NCT01975220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25690554|NCT01975220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690555|NCT01975220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24538041|NCT00657319|Insulin Aspart|insulin aspart|mesh-list
24538042|NCT00657319|Biphasic Insulins|biphasic insulins|mesh-list
24538043|NCT00657319|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24538051|NCT00657384|Coagulants|coagulants|mesh-ancestor
24538052|NCT00657397|Methadone|methadone|mesh-list
24538053|NCT00657397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24538054|NCT00657397|Narcotics|narcotics|mesh-ancestor
24538055|NCT00657397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24538056|NCT00657397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538057|NCT00657397|Analgesics|analgesics|mesh-ancestor
24538058|NCT00657397|Sensory System Agents|sensory system agents|mesh-ancestor
25016626|NCT04964050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25016627|NCT04964050|Protease Inhibitors|protease inhibitors|mesh-ancestor
25016628|NCT04964050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25016629|NCT04964050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016630|NCT04964050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25016631|NCT04964050|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25016632|NCT04964050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25016633|NCT04964050|Diuretics|diuretics|mesh-ancestor
25016634|NCT04964050|Natriuretic Agents|natriuretic agents|mesh-ancestor
25016635|NCT04964050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016636|NCT04905862|Antipyretics|antipyretics|mesh-list
25016638|NCT04905862|Sensory System Agents|sensory system agents|mesh-ancestor
25016639|NCT04905862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25016640|NCT04905862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016641|NCT04898309|Complement C1s|complement c1s|mesh-list
25016642|NCT04898309|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25016643|NCT04898309|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
25016644|NCT04898309|Immunologic Factors|immunologic factors|mesh-ancestor
25016645|NCT04898309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016646|NCT04898309|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25016647|NCT04898309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25016649|NCT04895202|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25016650|NCT04895202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016651|NCT04895202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25016652|NCT04895202|Immunologic Factors|immunologic factors|mesh-ancestor
25016653|NCT04895202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538059|NCT00657397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24538060|NCT00657397|Antitussive Agents|antitussive agents|mesh-ancestor
24538062|NCT00657410|Dexamethasone|dexamethasone|mesh-list
24538091|NCT00657449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24538092|NCT00657449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432641|NCT00255567|Paromomycin|paromomycin|mesh-list
25016654|NCT04840264|Docetaxel|docetaxel|mesh-list
25016674|NCT04808973|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25016675|NCT04808973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25016676|NCT04808973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25016677|NCT04808973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016678|NCT04808973|Antiviral Agents|antiviral agents|mesh-ancestor
25016679|NCT04808973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25016680|NCT04808973|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25016681|NCT04808973|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25016682|NCT04808973|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25016683|NCT04808973|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25016684|NCT04804007|Etoposide|etoposide|mesh-list
25016685|NCT04804007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25016686|NCT04804007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25016687|NCT04804007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25016688|NCT04804007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25016689|NCT04804007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24919376|NCT04211896|Nivolumab|nivolumab|mesh-list
25690556|NCT01975220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690558|NCT01975246|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24751264|NCT01703104|Antimalarials|antimalarials|mesh-ancestor
24538182|NCT00657852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538183|NCT00657865|Ramipril|ramipril|mesh-list
24538184|NCT00657865|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24538185|NCT00657865|Protease Inhibitors|protease inhibitors|mesh-ancestor
24538186|NCT00657865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538187|NCT00657865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538188|NCT00657865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24538189|NCT00657878|Gemcitabine|gemcitabine|mesh-list
24538190|NCT00657878|Paclitaxel|paclitaxel|mesh-list
24538191|NCT00657878|Carboplatin|carboplatin|mesh-list
24538192|NCT00657878|Doxorubicin|doxorubicin|mesh-list
24538237|NCT00657943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538239|NCT00657982|Everolimus|everolimus|mesh-list
24538240|NCT00657982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538257|NCT00658177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24538258|NCT00658177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538259|NCT00658177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538260|NCT00658177|Urological Agents|urological agents|mesh-ancestor
24538262|NCT00658255|Formoterol Fumarate|formoterol fumarate|mesh-list
24538301|NCT00658580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24538302|NCT00658580|Alkylating Agents|alkylating agents|mesh-ancestor
24538303|NCT00658593|Gemcitabine|gemcitabine|mesh-list
24538304|NCT00658593|Capecitabine|capecitabine|mesh-list
24538305|NCT00658593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24538306|NCT00658593|Antimetabolites|antimetabolites|mesh-ancestor
24538307|NCT00658593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538308|NCT00658593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538309|NCT00658593|Antiviral Agents|antiviral agents|mesh-ancestor
24538310|NCT00658593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24538311|NCT00658593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538312|NCT00658593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25690559|NCT01975246|Telmisartan|telmisartan|mesh-list
25690560|NCT01975246|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
25690561|NCT01975246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25690562|NCT01975246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25690563|NCT01975246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25690564|NCT01975246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690565|NCT01975246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24517672|NCT00609180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690566|NCT01975246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063445|NCT00753532|Vitamins|vitamins|mesh-ancestor
24538313|NCT00658593|Immunologic Factors|immunologic factors|mesh-ancestor
24538314|NCT00658593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538315|NCT00658645|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24538316|NCT00658645|Antidepressive Agents|antidepressive agents|mesh-ancestor
24538317|NCT00658645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24538318|NCT00658645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24973319|NCT03710304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24586635|NCT00891475|Growth Inhibitors|growth inhibitors|mesh-ancestor
24586636|NCT00891475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24586660|NCT00891605|Mitosis Modulators|mitosis modulators|mesh-ancestor
24586661|NCT00891605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586662|NCT00891670|Aspirin|aspirin|mesh-list
24538319|NCT00658645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24538320|NCT00658645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24538321|NCT00658645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538340|NCT00658931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538341|NCT00658931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24538380|NCT00659074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24538381|NCT00659074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538383|NCT00659074|Antipruritics|antipruritics|mesh-ancestor
24538384|NCT00659074|Dermatologic Agents|dermatologic agents|mesh-ancestor
24538418|NCT00659178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24538419|NCT00659178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24538421|NCT00659178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538422|NCT00659282|Insulin Aspart|insulin aspart|mesh-list
24538423|NCT00659282|Biphasic Insulins|biphasic insulins|mesh-list
24538424|NCT00659282|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24538425|NCT00659282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24538426|NCT00659282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538427|NCT00659321|Nicotine|nicotine|mesh-list
24538428|NCT00659321|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24538429|NCT00659321|Autonomic Agents|autonomic agents|mesh-ancestor
24538430|NCT00659321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24538431|NCT00659321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538432|NCT00659321|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24538433|NCT00659321|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24538434|NCT00659321|Cholinergic Agents|cholinergic agents|mesh-ancestor
25690568|NCT01975246|Diuretics|diuretics|mesh-ancestor
25690569|NCT01975246|Natriuretic Agents|natriuretic agents|mesh-ancestor
25690570|NCT01975246|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24538440|NCT00659386|gamma-Globulins|gamma-globulins|mesh-list
24538441|NCT00659386|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24586728|NCT00891761|Dermatologic Agents|dermatologic agents|mesh-ancestor
24586729|NCT00891761|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24586730|NCT00891761|Serotonin Agents|serotonin agents|mesh-ancestor
24586731|NCT00891761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24586732|NCT00891761|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24586733|NCT00891761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24586734|NCT00891761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24586735|NCT00891761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24586736|NCT00891761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24586737|NCT00891761|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24586758|NCT00892125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586759|NCT00892125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24586760|NCT00892125|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24634060|NCT01131949|Lamotrigine|lamotrigine|mesh-list
24586761|NCT00892125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24586762|NCT00892125|Serotonin Agents|serotonin agents|mesh-ancestor
24586763|NCT00892125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24586764|NCT00892125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538442|NCT00659386|Immunologic Factors|immunologic factors|mesh-ancestor
24538443|NCT00659386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538444|NCT00659399|PENTA|penta|mesh-list
24538445|NCT00659399|Fondaparinux|fondaparinux|mesh-list
24538446|NCT00659399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24538447|NCT00659399|Antithrombins|antithrombins|mesh-ancestor
24538448|NCT00659399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24586765|NCT00892125|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24586766|NCT00892125|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24586767|NCT00892125|Dopamine Agents|dopamine agents|mesh-ancestor
24586768|NCT00892125|Anticonvulsants|anticonvulsants|mesh-ancestor
24586769|NCT00892125|Antimanic Agents|antimanic agents|mesh-ancestor
24586770|NCT00892125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24586771|NCT00892125|Analgesics|analgesics|mesh-ancestor
24586796|NCT00892242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586797|NCT00892307|Adenosine|adenosine|mesh-list
24586798|NCT00892307|Analgesics|analgesics|mesh-ancestor
24586799|NCT00892307|Sensory System Agents|sensory system agents|mesh-ancestor
24586800|NCT00892307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24586801|NCT00892307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586802|NCT00892307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24586803|NCT00892307|Vasodilator Agents|vasodilator agents|mesh-ancestor
24586804|NCT00892307|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24586805|NCT00892307|Purinergic Agonists|purinergic agonists|mesh-ancestor
24586806|NCT00892307|Purinergic Agents|purinergic agents|mesh-ancestor
24586807|NCT00892307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24499243|NCT00518375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25016727|NCT04661137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24981435|NCT03367715|Nivolumab|nivolumab|mesh-list
24476208|NCT00413452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24476209|NCT00413452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24476210|NCT00413452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24899272|NCT04405154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24899273|NCT04405245|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24899275|NCT04405245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24899278|NCT04405011|Entecavir|entecavir|mesh-list
24538456|NCT00659412|Alefacept|alefacept|mesh-list
24538457|NCT00659412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24538458|NCT00659412|Abortifacient Agents|abortifacient agents|mesh-ancestor
24538459|NCT00659412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24538460|NCT00659412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538461|NCT00659412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24538462|NCT00659412|Antimetabolites|antimetabolites|mesh-ancestor
24538463|NCT00659412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538464|NCT00659412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538465|NCT00659412|Dermatologic Agents|dermatologic agents|mesh-ancestor
24538466|NCT00659412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538467|NCT00659412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24538468|NCT00659412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24538469|NCT00659412|Immunologic Factors|immunologic factors|mesh-ancestor
24538470|NCT00659412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24538471|NCT00659412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24538473|NCT00659451|Amlodipine|amlodipine|mesh-list
24538474|NCT00659451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25016740|NCT04633889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016756|NCT04510207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016758|NCT04509115|Narcotics|narcotics|mesh-ancestor
25016763|NCT04509115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25016765|NCT04497987|Antiviral Agents|antiviral agents|mesh-ancestor
25016766|NCT04497987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25016767|NCT04484701|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25016768|NCT04484701|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25016937|NCT03837977|Vitamins|vitamins|mesh-ancestor
25016771|NCT04479566|Calcium Carbonate|calcium carbonate|mesh-list
25016772|NCT04479566|Calcium|calcium|mesh-list
25016773|NCT04479566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25016774|NCT04479566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016775|NCT04479566|Antidepressive Agents|antidepressive agents|mesh-ancestor
24827112|NCT02137434|Calcium, Dietary|calcium, dietary|mesh-list
24538475|NCT00659451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24538479|NCT00659451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538480|NCT00659451|Vasodilator Agents|vasodilator agents|mesh-ancestor
24538481|NCT00659451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24538482|NCT00659451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24538483|NCT00659451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24538484|NCT00659477|Insulin Glargine|insulin glargine|mesh-list
25690571|NCT01975246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25690572|NCT01975246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25690573|NCT01975285|Dexamethasone|dexamethasone|mesh-list
25690574|NCT01975285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25690575|NCT01975285|Antiemetics|antiemetics|mesh-ancestor
25690576|NCT01975285|Autonomic Agents|autonomic agents|mesh-ancestor
25690577|NCT01975285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25690578|NCT01975285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063497|NCT03468348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063498|NCT03468348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25063499|NCT03468348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063500|NCT03468348|Analgesics|analgesics|mesh-ancestor
25063501|NCT03468348|Sensory System Agents|sensory system agents|mesh-ancestor
25063502|NCT03468348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25063503|NCT03468348|Antidepressive Agents|antidepressive agents|mesh-ancestor
24538485|NCT00659477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24538486|NCT00659477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538487|NCT00659503|Ciclesonide|ciclesonide|mesh-list
24538488|NCT00659503|Glucocorticoids|glucocorticoids|mesh-ancestor
25016777|NCT04479566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25016778|NCT04479566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016779|NCT04479566|Antimanic Agents|antimanic agents|mesh-ancestor
25016780|NCT04479566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25016781|NCT04479566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25016783|NCT04479566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25016790|NCT04356495|Ciclesonide|ciclesonide|mesh-list
25016791|NCT04356495|Interferons|interferons|mesh-list
25016792|NCT04356495|Interferon-beta|interferon-beta|mesh-list
25016793|NCT04356495|Telmisartan|telmisartan|mesh-list
25016794|NCT04356495|Interferon beta-1b|interferon beta-1b|mesh-list
25016795|NCT04356495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016796|NCT04356495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25016797|NCT04356495|Antiviral Agents|antiviral agents|mesh-ancestor
25016798|NCT04356495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25016799|NCT04356495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25016800|NCT04356495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24981475|NCT03132454|Autonomic Agents|autonomic agents|mesh-ancestor
24538489|NCT00659503|Hormones|hormones|mesh-ancestor
24538490|NCT00659503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24538491|NCT00659503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538493|NCT00659555|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24538494|NCT00659555|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24538495|NCT00659568|Metformin|metformin|mesh-list
24538496|NCT00659568|Sirolimus|sirolimus|mesh-list
25016801|NCT04356495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25016809|NCT04200963|Nivolumab|nivolumab|mesh-list
25016810|NCT04200963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25016811|NCT04200963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25016812|NCT04200963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25016813|NCT04200963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016814|NCT04200911|Sirolimus|sirolimus|mesh-list
25016815|NCT04200911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25016816|NCT04200911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25016817|NCT04200911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25016818|NCT04200911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25016819|NCT04200911|Antifungal Agents|antifungal agents|mesh-ancestor
25016820|NCT04200911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25016821|NCT04200911|Immunologic Factors|immunologic factors|mesh-ancestor
25016848|NCT04104178|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25016849|NCT04104178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25016850|NCT04104178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690579|NCT01975285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25690580|NCT01975285|Glucocorticoids|glucocorticoids|mesh-ancestor
25690581|NCT01975285|Hormones|hormones|mesh-ancestor
25690582|NCT01975285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25690583|NCT01975285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25690584|NCT01975285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25690585|NCT01975376|Bococizumab|bococizumab|mesh-list
24817825|NCT02085655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24817826|NCT02085655|Leprostatic Agents|leprostatic agents|mesh-ancestor
24817827|NCT02085655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24817828|NCT02085655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24476348|NCT00414323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24476349|NCT00414323|Serotonin Agents|serotonin agents|mesh-ancestor
24476350|NCT00414323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538497|NCT00659568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24538498|NCT00659568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538499|NCT00659568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24538500|NCT00659568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24538501|NCT00659568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24538502|NCT00659568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538521|NCT00659685|Antipruritics|antipruritics|mesh-ancestor
24538526|NCT00659685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538527|NCT00659685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24538528|NCT00659685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24538529|NCT00659685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24538537|NCT00659750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24538538|NCT00659750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538581|NCT00659997|Mitosis Modulators|mitosis modulators|mesh-ancestor
24538582|NCT00659997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538583|NCT00659997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538584|NCT00659997|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25016868|NCT03918915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25016869|NCT03918915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25016870|NCT03918915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25016896|NCT03843008|Melatonin|melatonin|mesh-list
25016897|NCT03843008|Antioxidants|antioxidants|mesh-ancestor
25016898|NCT03843008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016899|NCT03843008|Protective Agents|protective agents|mesh-ancestor
25016900|NCT03843008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016901|NCT03843008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25016902|NCT03840616|Fluconazole|fluconazole|mesh-list
25016903|NCT03840616|Antifungal Agents|antifungal agents|mesh-ancestor
24538614|NCT00660062|Antidepressive Agents|antidepressive agents|mesh-ancestor
24538615|NCT00660062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24538616|NCT00660062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24538617|NCT00660062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24538618|NCT00660062|Parasympatholytics|parasympatholytics|mesh-ancestor
24538619|NCT00660062|Autonomic Agents|autonomic agents|mesh-ancestor
24538620|NCT00660062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24538621|NCT00660062|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24538622|NCT00660062|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24538623|NCT00660062|Cholinergic Agents|cholinergic agents|mesh-ancestor
24538624|NCT00660062|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24538625|NCT00660062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24538646|NCT00660231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24538647|NCT00660231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25690586|NCT01975376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25690587|NCT01975376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25690588|NCT01975376|Antimetabolites|antimetabolites|mesh-ancestor
25690589|NCT01975376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690590|NCT01975376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25690591|NCT01975389|Bococizumab|bococizumab|mesh-list
25690592|NCT01975389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25690593|NCT01975389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24538648|NCT00660231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24538649|NCT00660231|Immunologic Factors|immunologic factors|mesh-ancestor
24538652|NCT00660244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24538653|NCT00660244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538654|NCT00660244|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24538655|NCT00660244|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24538656|NCT00660244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538657|NCT00660244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538658|NCT00660244|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24538659|NCT00660244|Hormone Antagonists|hormone antagonists|mesh-ancestor
24538660|NCT00660244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24538664|NCT00660257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538665|NCT00660270|Gemcitabine|gemcitabine|mesh-list
24538666|NCT00660270|Interferons|interferons|mesh-list
24538667|NCT00660270|Interferon-alpha|interferon-alpha|mesh-list
24538668|NCT00660270|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
24538669|NCT00660270|Fluorouracil|fluorouracil|mesh-list
25016905|NCT03840616|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25016906|NCT03840616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25016907|NCT03840616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25016908|NCT03840616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016909|NCT03840616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25016910|NCT03840616|Hormone Antagonists|hormone antagonists|mesh-ancestor
25016911|NCT03840616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25016912|NCT03840616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016913|NCT03840616|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25016914|NCT03840616|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25016915|NCT03837977|Leucovorin|leucovorin|mesh-list
25016916|NCT03837977|Folic Acid|folic acid|mesh-list
25016917|NCT03837977|Docetaxel|docetaxel|mesh-list
25016918|NCT03837977|Fluorouracil|fluorouracil|mesh-list
25016924|NCT03837977|Mitosis Modulators|mitosis modulators|mesh-ancestor
25016925|NCT03837977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538670|NCT00660270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538671|NCT00660270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24538672|NCT00660270|Antimetabolites|antimetabolites|mesh-ancestor
24538673|NCT00660270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538674|NCT00660270|Antiviral Agents|antiviral agents|mesh-ancestor
24538675|NCT00660270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24538676|NCT00660270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538683|NCT00660283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538684|NCT00660283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538686|NCT00660335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24538687|NCT00660335|Hormones|hormones|mesh-ancestor
24538688|NCT00660335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25016932|NCT03837977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25016933|NCT03837977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25016934|NCT03837977|Antidotes|antidotes|mesh-ancestor
25016935|NCT03837977|Protective Agents|protective agents|mesh-ancestor
25016936|NCT03837977|Vitamin B Complex|vitamin b complex|mesh-ancestor
25016939|NCT03837977|Hematinics|hematinics|mesh-ancestor
25016940|NCT03787654|Solifenacin Succinate|solifenacin succinate|mesh-list
24590307|NCT00911716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590308|NCT00911716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24634872|NCT01135641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590452|NCT00912574|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
24476451|NCT00415090|Antiviral Agents|antiviral agents|mesh-ancestor
24899558|NCT04402580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24899560|NCT04402580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899562|NCT04402671|Disinfectants|disinfectants|mesh-ancestor
24899563|NCT04402671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24899564|NCT04402723|Cytarabine|cytarabine|mesh-list
24899565|NCT04402723|Daunorubicin|daunorubicin|mesh-list
25063568|NCT03468010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063569|NCT03467984|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25063570|NCT03467984|Immunologic Factors|immunologic factors|mesh-ancestor
25016941|NCT03787654|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25016942|NCT03787654|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25016943|NCT03787654|Cholinergic Agents|cholinergic agents|mesh-ancestor
25016944|NCT03787654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24981546|NCT02725177|Hormones|hormones|mesh-ancestor
24538730|NCT00660621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24451273|NCT00322972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24451274|NCT00322985|Lenalidomide|lenalidomide|mesh-list
24457659|NCT00334867|Dexrazoxane|dexrazoxane|mesh-list
24406324|NCT00169624|Metformin|metformin|mesh-list
24538770|NCT00660764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24538772|NCT00660764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016959|NCT03772353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25016960|NCT03772353|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25016962|NCT03697720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25016963|NCT03697720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25016965|NCT03697720|Sensory System Agents|sensory system agents|mesh-ancestor
25016966|NCT03697720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25016967|NCT03697720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016968|NCT03697720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25690594|NCT01975389|Antimetabolites|antimetabolites|mesh-ancestor
25690595|NCT01975389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690596|NCT01975389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25690597|NCT01975519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25690598|NCT01975519|Immunologic Factors|immunologic factors|mesh-ancestor
25690599|NCT01975519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690600|NCT01975675|Sofosbuvir|sofosbuvir|mesh-list
25690601|NCT01975675|Antiviral Agents|antiviral agents|mesh-ancestor
25690602|NCT01975675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25690603|NCT01975701|Infigratinib|infigratinib|mesh-list
25690604|NCT01975701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25690605|NCT01975831|Durvalumab|durvalumab|mesh-list
25690606|NCT01975831|Tremelimumab|tremelimumab|mesh-list
25690607|NCT01975831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25690608|NCT01975831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25690609|NCT01975935|Amlexanox|amlexanox|mesh-list
24899618|NCT04402047|Analgesics|analgesics|mesh-ancestor
24899619|NCT04402047|Sensory System Agents|sensory system agents|mesh-ancestor
24899620|NCT04402047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24899621|NCT04402047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899622|NCT04402047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24899623|NCT04402047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25016969|NCT03697720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24538773|NCT00660764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24538774|NCT00660764|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24538775|NCT00660764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538776|NCT00660803|Fulvestrant|fulvestrant|mesh-list
24538777|NCT00660803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24538778|NCT00660803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538779|NCT00660803|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24538780|NCT00660803|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24538781|NCT00660803|Hormone Antagonists|hormone antagonists|mesh-ancestor
24538782|NCT00660803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24538783|NCT00660803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538784|NCT00660842|Paclitaxel|paclitaxel|mesh-list
24538785|NCT00660842|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24538786|NCT00660842|Carboplatin|carboplatin|mesh-list
24538787|NCT00660842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24538788|NCT00660842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538789|NCT00660842|Tubulin Modulators|tubulin modulators|mesh-ancestor
24538790|NCT00660842|Antimitotic Agents|antimitotic agents|mesh-ancestor
24538791|NCT00660842|Mitosis Modulators|mitosis modulators|mesh-ancestor
24457660|NCT00334867|Razoxane|razoxane|mesh-list
24457661|NCT00334867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24538792|NCT00660842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538793|NCT00660855|Parecoxib|parecoxib|mesh-list
24538794|NCT00660855|Valdecoxib|valdecoxib|mesh-list
24538795|NCT00660855|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24538808|NCT00660868|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24538809|NCT00660868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538818|NCT00660894|Leucovorin|leucovorin|mesh-list
24538831|NCT00660894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016970|NCT03697720|Gout Suppressants|gout suppressants|mesh-ancestor
25016971|NCT03697720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25016972|NCT03697720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25016973|NCT03697720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016974|NCT03649633|Vitamins|vitamins|mesh-list
25016975|NCT03649633|Ascorbic Acid|ascorbic acid|mesh-list
25016976|NCT03649633|Hydrocortisone|hydrocortisone|mesh-list
25016977|NCT03649633|Micronutrients|micronutrients|mesh-ancestor
25016978|NCT03649633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016979|NCT03649633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25016980|NCT03649633|Antioxidants|antioxidants|mesh-ancestor
25016981|NCT03649633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016982|NCT03649633|Protective Agents|protective agents|mesh-ancestor
25016983|NCT03623373|Cytarabine|cytarabine|mesh-list
25016984|NCT03623373|Rituximab|rituximab|mesh-list
25016985|NCT03623373|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25016986|NCT03623373|Acalabrutinib|acalabrutinib|mesh-list
25690610|NCT01975935|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25690611|NCT01976312|Ranibizumab|ranibizumab|mesh-list
25690612|NCT01976312|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25690613|NCT01976312|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25690614|NCT01976312|Growth Substances|growth substances|mesh-ancestor
25690615|NCT01976312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016987|NCT03623373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25016988|NCT03623373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25016989|NCT03623373|Immunologic Factors|immunologic factors|mesh-ancestor
25016990|NCT03623373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016991|NCT03623373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25063595|NCT03467620|Cannabidiol|cannabidiol|mesh-list
24899671|NCT04401488|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24899672|NCT04401488|Immunologic Factors|immunologic factors|mesh-ancestor
25016992|NCT03623373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25016993|NCT03623373|Antimetabolites|antimetabolites|mesh-ancestor
25016994|NCT03623373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016995|NCT03623373|Antiviral Agents|antiviral agents|mesh-ancestor
25016996|NCT03623373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25016997|NCT03623373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25017002|NCT03583528|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25017003|NCT03583528|Edotreotide|edotreotide|mesh-list
25017004|NCT03583528|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25017005|NCT03583528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017006|NCT03582774|Edetic Acid|edetic acid|mesh-list
25017007|NCT03582774|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25017008|NCT03582774|Chelating Agents|chelating agents|mesh-ancestor
25017009|NCT03582774|Sequestering Agents|sequestering agents|mesh-ancestor
25017010|NCT03582774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017011|NCT03582774|Anticoagulants|anticoagulants|mesh-ancestor
25017012|NCT03582774|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24579639|NCT00856687|Montelukast|montelukast|mesh-list
25017032|NCT03198689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25017033|NCT03198689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25017034|NCT03073941|Cimetidine|cimetidine|mesh-list
25017035|NCT03073941|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25017036|NCT03073941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25017037|NCT03073941|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25017038|NCT03073941|Histamine Antagonists|histamine antagonists|mesh-ancestor
25017039|NCT03073941|Histamine Agents|histamine agents|mesh-ancestor
25017040|NCT03073941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25017041|NCT03073941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017042|NCT03073941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017043|NCT03073941|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25017044|NCT03073941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25017058|NCT02668822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25017099|NCT02616146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25017100|NCT02616146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017101|NCT02616146|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25017103|NCT02616146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25017104|NCT02616146|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25017105|NCT02616146|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25017107|NCT02616146|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25017108|NCT02616146|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25017120|NCT02489942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005105|NCT04856176|Tubulin Modulators|tubulin modulators|mesh-ancestor
25017130|NCT02409342|Gemcitabine|gemcitabine|mesh-list
25017131|NCT02409342|Carboplatin|carboplatin|mesh-list
25017132|NCT02409342|Pemetrexed|pemetrexed|mesh-list
25017133|NCT02409342|Atezolizumab|atezolizumab|mesh-list
25017134|NCT02409342|Antibodies|antibodies|mesh-list
25017135|NCT02409342|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24579802|NCT00857870|Metformin|metformin|mesh-list
25690616|NCT01976312|Growth Inhibitors|growth inhibitors|mesh-ancestor
25690617|NCT01976312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25690618|NCT01976338|Ranibizumab|ranibizumab|mesh-list
25690619|NCT01976338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25690620|NCT01976338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25690621|NCT01976338|Growth Substances|growth substances|mesh-ancestor
25690622|NCT01976338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690623|NCT01976338|Growth Inhibitors|growth inhibitors|mesh-ancestor
25690624|NCT01976338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657214|NCT01266213|Anastrozole|anastrozole|mesh-list
24576165|NCT00837239|Gemcitabine|gemcitabine|mesh-list
24538892|NCT00661102|Capecitabine|capecitabine|mesh-list
24538893|NCT00661102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24538894|NCT00661102|Antimetabolites|antimetabolites|mesh-ancestor
24538895|NCT00661102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538896|NCT00661102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538897|NCT00661115|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24446043|NCT00303745|Irinotecan|irinotecan|mesh-list
24507913|NCT00553137|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25017209|NCT02275546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25017210|NCT02275546|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25017212|NCT02131597|Guadecitabine|guadecitabine|mesh-list
25017213|NCT02131597|Azacitidine|azacitidine|mesh-list
25017214|NCT02131597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25017215|NCT02131597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25017216|NCT02131597|Antimetabolites|antimetabolites|mesh-ancestor
24509055|NCT00558181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25017217|NCT02131597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017218|NCT02131597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25017219|NCT02077166|Rituximab|rituximab|mesh-list
25017220|NCT02077166|Lenalidomide|lenalidomide|mesh-list
24538919|NCT00661206|Clopidogrel|clopidogrel|mesh-list
24538922|NCT00661206|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24538923|NCT00661206|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24538924|NCT00661206|Purinergic Agents|purinergic agents|mesh-ancestor
24538925|NCT00661206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25690625|NCT01976364|Methotrexate|methotrexate|mesh-list
25690626|NCT01976364|Tofacitinib|tofacitinib|mesh-list
25690627|NCT01976364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25690628|NCT01976364|Abortifacient Agents|abortifacient agents|mesh-ancestor
25690629|NCT01976364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25690630|NCT01976364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690631|NCT01976364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25063627|NCT03467178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899978|NCT04398290|Respiratory System Agents|respiratory system agents|mesh-ancestor
24899979|NCT04398290|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24899980|NCT04398290|Antioxidants|antioxidants|mesh-ancestor
24899981|NCT04398290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899990|NCT04398316|Anesthetics|anesthetics|mesh-ancestor
24899991|NCT04398316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24899992|NCT04398316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017228|NCT02077166|Growth Substances|growth substances|mesh-ancestor
25017229|NCT02077166|Growth Inhibitors|growth inhibitors|mesh-ancestor
25017230|NCT02027935|Aldesleukin|aldesleukin|mesh-list
25017231|NCT02027935|Cyclophosphamide|cyclophosphamide|mesh-list
25017232|NCT02027935|Ipilimumab|ipilimumab|mesh-list
25017233|NCT02027935|Interleukin-2|interleukin-2|mesh-list
25017234|NCT02027935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25017235|NCT02027935|Immunologic Factors|immunologic factors|mesh-ancestor
25017236|NCT02027935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017237|NCT02027935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25017238|NCT02027935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25017239|NCT02027935|Alkylating Agents|alkylating agents|mesh-ancestor
25017240|NCT02027935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017241|NCT02027935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751975|NCT01707407|Analgesics|analgesics|mesh-ancestor
25017242|NCT02027935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25017243|NCT02027935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25017244|NCT02027935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25017245|NCT02027935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25017246|NCT02027935|Analgesics|analgesics|mesh-ancestor
25017247|NCT02027935|Sensory System Agents|sensory system agents|mesh-ancestor
25017251|NCT02027935|Antiviral Agents|antiviral agents|mesh-ancestor
25017252|NCT02027935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25017253|NCT01965132|Adalimumab|adalimumab|mesh-list
25017270|NCT01965132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25017272|NCT01965132|Sensory System Agents|sensory system agents|mesh-ancestor
25017273|NCT01965132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25017274|NCT01965132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25017275|NCT01965132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25017276|NCT01965132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017277|NCT01965132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25017278|NCT01965132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25017279|NCT01965132|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25017280|NCT01965132|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25017282|NCT01891344|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25690632|NCT01976364|Antimetabolites|antimetabolites|mesh-ancestor
25690633|NCT01976364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690634|NCT01976364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25690635|NCT01976364|Dermatologic Agents|dermatologic agents|mesh-ancestor
25690636|NCT01976364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25690637|NCT01976364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25690638|NCT01976364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25690639|NCT01976364|Immunologic Factors|immunologic factors|mesh-ancestor
25690640|NCT01976364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25690641|NCT01976364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25017283|NCT01891344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25017284|NCT01891344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017285|NCT01891344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25017286|NCT01847274|Niraparib|niraparib|mesh-list
25017287|NCT01847274|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25017288|NCT01847274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25017289|NCT01847274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017290|NCT01847274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25017291|NCT01764191|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25017292|NCT01764191|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25017293|NCT01764191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017294|NCT01670656|Ibuprofen|ibuprofen|mesh-list
25017295|NCT01670656|Contraceptive Agents|contraceptive agents|mesh-list
25017296|NCT01670656|Etonogestrel|etonogestrel|mesh-list
25017297|NCT01670656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25017298|NCT01670656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25017299|NCT01670656|Analgesics|analgesics|mesh-ancestor
25017300|NCT01670656|Sensory System Agents|sensory system agents|mesh-ancestor
25017301|NCT01670656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24451447|NCT00323791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24451449|NCT00323791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451450|NCT00323791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24451453|NCT00323804|Antimetabolites|antimetabolites|mesh-ancestor
25017302|NCT01670656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017304|NCT01670656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25017305|NCT01670656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25017306|NCT01670656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25017307|NCT01670656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017308|NCT01670656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25017309|NCT01670656|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25017310|NCT01670656|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25017311|NCT01648751|Estrogens|estrogens|mesh-list
25017312|NCT01648751|Hormones|hormones|mesh-ancestor
25017313|NCT01648751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25017332|NCT01498770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017334|NCT01498770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25017335|NCT01498770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25017336|NCT01498770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25017337|NCT01498770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24510213|NCT00563875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24510214|NCT00563875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017338|NCT01498770|Dopamine Agents|dopamine agents|mesh-ancestor
25017339|NCT01498770|Antiemetics|antiemetics|mesh-ancestor
25017340|NCT01498770|Autonomic Agents|autonomic agents|mesh-ancestor
24973870|NCT03706287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25017341|NCT01498770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25017342|NCT01498770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25017343|NCT01498770|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25017344|NCT01498770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25017345|NCT01498770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24451454|NCT00323804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451455|NCT00323804|Antiviral Agents|antiviral agents|mesh-ancestor
24451456|NCT00323804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24451457|NCT00323817|Z 338|z 338|mesh-list
25017347|NCT01498770|Dopamine Agonists|dopamine agonists|mesh-ancestor
25017348|NCT01498770|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25017349|NCT01498770|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25017350|NCT01498770|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25017351|NCT01498770|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25017352|NCT01498770|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25017353|NCT01498770|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25017354|NCT01498770|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25017355|NCT01498770|Adrenergic Agents|adrenergic agents|mesh-ancestor
25017356|NCT01498770|GABA Antagonists|gaba antagonists|mesh-ancestor
25017358|NCT01498770|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25017400|NCT01244828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25017401|NCT01047540|Pritelivir|pritelivir|mesh-list
25017402|NCT01047540|Antiviral Agents|antiviral agents|mesh-ancestor
25017403|NCT01047540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25017404|NCT01047540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25017405|NCT01047540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017406|NCT01044056|Contraceptive Agents|contraceptive agents|mesh-list
25017407|NCT01044056|Levonorgestrel|levonorgestrel|mesh-list
25017408|NCT01044056|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25017410|NCT01044056|NuvaRing|nuvaring|mesh-list
25017411|NCT01044056|Contraceptives, Oral|contraceptives, oral|mesh-list
25017412|NCT01044056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25017413|NCT01044056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017414|NCT01044056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24974018|NCT05176548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24981776|NCT01832402|Analgesics|analgesics|mesh-ancestor
24538964|NCT00661349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538966|NCT00661349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24974019|NCT05176548|Myeloma Proteins|myeloma proteins|mesh-list
24974020|NCT05176548|Paraproteins|paraproteins|mesh-list
24974021|NCT05176548|Immunologic Factors|immunologic factors|mesh-ancestor
24974022|NCT05176548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587930|NCT00898846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587931|NCT00898950|Aspirin|aspirin|mesh-list
24587932|NCT00898950|Salicylic Acid|salicylic acid|mesh-list
24587933|NCT00898950|Salicylates|salicylates|mesh-list
24587934|NCT00898950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24587935|NCT00898950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24587936|NCT00898950|Analgesics|analgesics|mesh-ancestor
24587937|NCT00898950|Sensory System Agents|sensory system agents|mesh-ancestor
24587938|NCT00898950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24580100|NCT00860275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24586815|NCT00892320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24586825|NCT00892346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24586833|NCT00892346|Leprostatic Agents|leprostatic agents|mesh-ancestor
24538967|NCT00661349|Antiviral Agents|antiviral agents|mesh-ancestor
24394245|NCT00132652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444848|NCT00299364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25017417|NCT01044056|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25017418|NCT01044056|Estrogens|estrogens|mesh-ancestor
25017419|NCT01044056|Hormones|hormones|mesh-ancestor
25017422|NCT01005056|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25017423|NCT01005056|Desogestrel|desogestrel|mesh-list
25017424|NCT01005056|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25017425|NCT01005056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25017426|NCT01005056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25017427|NCT01005056|Contraceptive Agents|contraceptive agents|mesh-ancestor
24539068|NCT00662233|Immunologic Factors|immunologic factors|mesh-ancestor
24539069|NCT00662233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539070|NCT00662233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24539072|NCT00662233|Alkylating Agents|alkylating agents|mesh-ancestor
24539080|NCT00662233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25017430|NCT01005056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25017432|NCT01005056|Hormones|hormones|mesh-ancestor
25017433|NCT01005056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24580181|NCT00860964|Estradiol|estradiol|mesh-list
25017443|NCT00967746|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25017444|NCT00967746|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25017445|NCT00967746|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25017446|NCT00967746|Progestins|progestins|mesh-ancestor
25017447|NCT00967746|Hormones|hormones|mesh-ancestor
25017448|NCT00967746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25017449|NCT00944216|Emollients|emollients|mesh-list
25017450|NCT00944216|Dermatologic Agents|dermatologic agents|mesh-ancestor
25017451|NCT00920634|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25017452|NCT00920634|Hormones|hormones|mesh-ancestor
24539081|NCT00662233|Tubulin Modulators|tubulin modulators|mesh-ancestor
24539082|NCT00662233|Antimitotic Agents|antimitotic agents|mesh-ancestor
24539083|NCT00662233|Mitosis Modulators|mitosis modulators|mesh-ancestor
24539084|NCT00662272|Vaccines|vaccines|mesh-list
24539085|NCT00662272|Immunologic Factors|immunologic factors|mesh-ancestor
24539086|NCT00662272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539087|NCT00662337|Diphenhydramine|diphenhydramine|mesh-list
24443673|NCT00295776|Anticonvulsants|anticonvulsants|mesh-ancestor
24443674|NCT00295776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24443677|NCT00295776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24443688|NCT00295789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24443689|NCT00295789|Tubulin Modulators|tubulin modulators|mesh-ancestor
24443690|NCT00295789|Antimitotic Agents|antimitotic agents|mesh-ancestor
24443691|NCT00295789|Mitosis Modulators|mitosis modulators|mesh-ancestor
24443692|NCT00295789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443694|NCT00295815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24443695|NCT00295815|Alkylating Agents|alkylating agents|mesh-ancestor
24443696|NCT00295815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443697|NCT00295815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24539161|NCT00662519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539163|NCT00662571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24539196|NCT00662779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24539197|NCT00662779|Respiratory System Agents|respiratory system agents|mesh-ancestor
24539198|NCT00662779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25017453|NCT00920634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25017454|NCT00920634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017455|NCT00920361|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25017457|NCT00920361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25017458|NCT00920361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017459|NCT00886691|Bevacizumab|bevacizumab|mesh-list
25017460|NCT00886691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25017461|NCT00886691|Everolimus|everolimus|mesh-list
25017462|NCT00886691|Endothelial Growth Factors|endothelial growth factors|mesh-list
25017463|NCT00886691|Antibodies|antibodies|mesh-list
25017464|NCT00886691|Immunoglobulins|immunoglobulins|mesh-list
25017465|NCT00886691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25017466|NCT00886691|Immunoglobulin G|immunoglobulin g|mesh-list
25017467|NCT00886691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25017468|NCT00886691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25017469|NCT00886691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25017470|NCT00886691|Growth Substances|growth substances|mesh-ancestor
25017471|NCT00886691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017474|NCT00886691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25017475|NCT00878462|Asenapine|asenapine|mesh-list
25017476|NCT00878462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25017477|NCT00878462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25017478|NCT00878462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25017479|NCT00878462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017480|NCT00878462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25017481|NCT00778999|Desogestrel|desogestrel|mesh-list
25017482|NCT00778999|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25017483|NCT00778999|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25017484|NCT00778999|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25017485|NCT00778999|Contraceptive Agents|contraceptive agents|mesh-ancestor
25017486|NCT00778999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24539199|NCT00662779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24446526|NCT00305201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24539200|NCT00662779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25017489|NCT00778999|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25017490|NCT00778999|Progestins|progestins|mesh-ancestor
25017491|NCT00778999|Hormones|hormones|mesh-ancestor
25017492|NCT00778999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25017493|NCT00725413|Etonogestrel|etonogestrel|mesh-list
25017494|NCT00725413|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25017495|NCT00725413|Contraceptive Agents|contraceptive agents|mesh-ancestor
25017598|NCT00159796|Olanzapine|olanzapine|mesh-list
24539227|NCT00662844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24539228|NCT00662844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24539229|NCT00662883|Mometasone Furoate|mometasone furoate|mesh-list
24539231|NCT00662883|Analgesics|analgesics|mesh-ancestor
24539232|NCT00662883|Sensory System Agents|sensory system agents|mesh-ancestor
24539233|NCT00662883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24539234|NCT00662883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580220|NCT00861029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25017518|NCT00620035|Etonogestrel|etonogestrel|mesh-list
25017519|NCT00620035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25017520|NCT00620035|Contraceptive Agents|contraceptive agents|mesh-ancestor
25017521|NCT00620035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25017522|NCT00620035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017523|NCT00620035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25017524|NCT00541684|Atenolol|atenolol|mesh-list
25017525|NCT00541684|Adrenergic Agents|adrenergic agents|mesh-ancestor
25017526|NCT00541684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25017527|NCT00541684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017528|NCT00541684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017529|NCT00541684|Autonomic Agents|autonomic agents|mesh-ancestor
25017530|NCT00541684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25017531|NCT00541684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25017532|NCT00541684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25017533|NCT00541684|Sympatholytics|sympatholytics|mesh-ancestor
25017534|NCT00541684|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25017535|NCT00541684|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25017536|NCT00541684|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25017537|NCT00431431|Tibolone|tibolone|mesh-list
25017538|NCT00431431|Androgen Antagonists|androgen antagonists|mesh-ancestor
25017539|NCT00431431|Hormone Antagonists|hormone antagonists|mesh-ancestor
25017599|NCT00159796|Asenapine|asenapine|mesh-list
25017540|NCT00431431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25017541|NCT00431431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017542|NCT00431431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25017543|NCT00431431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25017544|NCT00431431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25017545|NCT00431431|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25017558|NCT00413764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25017572|NCT00408863|Hormone Antagonists|hormone antagonists|mesh-ancestor
25017573|NCT00408863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25017574|NCT00408863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017575|NCT00408863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25017576|NCT00408863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25017577|NCT00408863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25017578|NCT00408863|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25017579|NCT00408863|Anabolic Agents|anabolic agents|mesh-ancestor
25017580|NCT00408863|Hormones|hormones|mesh-ancestor
24477499|NCT00418860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24477500|NCT00418860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24477501|NCT00418860|Analgesics|analgesics|mesh-ancestor
25063822|NCT03465579|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25063823|NCT03465579|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25063824|NCT03465579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063825|NCT03465488|Albendazole|albendazole|mesh-list
25063826|NCT03465488|Anthelmintics|anthelmintics|mesh-ancestor
24752277|NCT01709682|Flecainide|flecainide|mesh-list
25063827|NCT03465488|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25063829|NCT03465488|Anticestodal Agents|anticestodal agents|mesh-ancestor
25017581|NCT00403793|Methyltestosterone|methyltestosterone|mesh-list
25017582|NCT00403793|Etonogestrel|etonogestrel|mesh-list
25017583|NCT00403793|Testosterone|testosterone|mesh-list
25017584|NCT00403793|Testosterone undecanoate|testosterone undecanoate|mesh-list
25017585|NCT00403793|Testosterone enanthate|testosterone enanthate|mesh-list
24514284|NCT00589316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539235|NCT00662883|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24539236|NCT00662883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24539237|NCT00662883|Anesthetics, General|anesthetics, general|mesh-ancestor
24539244|NCT00662883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24539245|NCT00662883|Dermatologic Agents|dermatologic agents|mesh-ancestor
24539246|NCT00662883|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24539247|NCT00662896|Ibuprofen|ibuprofen|mesh-list
24539248|NCT00662896|Naproxen|naproxen|mesh-list
24539249|NCT00662896|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
24539250|NCT00662896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24539251|NCT00662896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24539252|NCT00662896|Analgesics|analgesics|mesh-ancestor
24539256|NCT00662896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24539257|NCT00662896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24539258|NCT00662896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24539303|NCT00663195|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25017586|NCT00403793|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24974098|NCT05175066|Sympatholytics|sympatholytics|mesh-ancestor
25017587|NCT00403793|Androgens|androgens|mesh-ancestor
25017588|NCT00403793|Hormones|hormones|mesh-ancestor
25017589|NCT00403793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25017590|NCT00403793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017591|NCT00403793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25017592|NCT00403793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25017593|NCT00403793|Anabolic Agents|anabolic agents|mesh-ancestor
25012577|NCT04896658|Hormones|hormones|mesh-ancestor
25017594|NCT00403793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25017595|NCT00403793|Contraceptive Agents|contraceptive agents|mesh-ancestor
25017596|NCT00403793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25017597|NCT00403793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25017601|NCT00159796|Autonomic Agents|autonomic agents|mesh-ancestor
25017602|NCT00159796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25690642|NCT01976364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25690643|NCT01976390|Sirolimus|sirolimus|mesh-list
25690644|NCT01976390|Everolimus|everolimus|mesh-list
25690645|NCT01976390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25690646|NCT01976390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25690647|NCT01976390|Immunologic Factors|immunologic factors|mesh-ancestor
25690648|NCT01976390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690649|NCT01976390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25690650|NCT01976390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25690651|NCT01976390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24900747|NCT04391569|Ganaxolone|ganaxolone|mesh-list
25017603|NCT00159796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017604|NCT00159796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25017605|NCT00159796|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25017606|NCT00159796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25017607|NCT00159796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25017608|NCT00159796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24580336|NCT00861406|Antiviral Agents|antiviral agents|mesh-ancestor
24974177|NCT05148637|Sevoflurane|sevoflurane|mesh-list
24974179|NCT05148637|Anesthetics, Local|anesthetics, local|mesh-ancestor
24539305|NCT00663195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24539306|NCT00663195|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24539307|NCT00663221|Vitamin D|vitamin d|mesh-list
24974181|NCT05148637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974182|NCT05148637|Sensory System Agents|sensory system agents|mesh-ancestor
24974183|NCT05148637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24974184|NCT05148637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24974185|NCT05148637|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24974186|NCT05148637|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24974187|NCT05148637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24974188|NCT05148637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974190|NCT05148637|Narcotics|narcotics|mesh-ancestor
24974191|NCT05148637|Analgesics|analgesics|mesh-ancestor
24974192|NCT05148637|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25017616|NCT00159744|Asenapine|asenapine|mesh-list
25017617|NCT00159744|Antiemetics|antiemetics|mesh-ancestor
25017618|NCT00159744|Autonomic Agents|autonomic agents|mesh-ancestor
25017619|NCT00159744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25017620|NCT00159744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017621|NCT00159744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25017622|NCT00159744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24539341|NCT00663338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517268|NCT00607035|Diuretics|diuretics|mesh-ancestor
24539343|NCT00663377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25017627|NCT00159744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25017628|NCT00159744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25017629|NCT00159744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017631|NCT00159744|Serotonin Agents|serotonin agents|mesh-ancestor
25017632|NCT00143182|Olanzapine|olanzapine|mesh-list
25017633|NCT00143182|Asenapine|asenapine|mesh-list
25017634|NCT00143182|Antiemetics|antiemetics|mesh-ancestor
25017635|NCT00143182|Autonomic Agents|autonomic agents|mesh-ancestor
25017636|NCT00143182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25017637|NCT00143182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017638|NCT00143182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25017639|NCT00143182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25017640|NCT00143182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25017641|NCT00143182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25017642|NCT00143182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25017671|NCT03705351|Temozolomide|temozolomide|mesh-list
25017672|NCT03705351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25017673|NCT03705351|Alkylating Agents|alkylating agents|mesh-ancestor
25017682|NCT03705065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25017683|NCT03705065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017685|NCT03705065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25111020|NCT05278065|Nicotine|nicotine|mesh-list
25690652|NCT01976390|Antifungal Agents|antifungal agents|mesh-ancestor
25690653|NCT01976416|Hydroxyurea|hydroxyurea|mesh-list
25690654|NCT01976416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25690655|NCT01976416|Antisickling Agents|antisickling agents|mesh-ancestor
25690656|NCT01976416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25690657|NCT01976416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690658|NCT01976416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25690659|NCT01976507|Dabigatran|dabigatran|mesh-list
24900871|NCT04391439|Prednisolone acetate|prednisolone acetate|mesh-list
24900872|NCT04391439|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24900873|NCT04391439|Prednisolone phosphate|prednisolone phosphate|mesh-list
25111021|NCT05278065|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25111022|NCT05278065|Autonomic Agents|autonomic agents|mesh-ancestor
25111023|NCT05278065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25111024|NCT05278065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25111025|NCT05278065|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25111026|NCT05278065|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25111027|NCT05278065|Cholinergic Agents|cholinergic agents|mesh-ancestor
24539350|NCT00663442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539352|NCT00663442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24539353|NCT00663442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24539354|NCT00663442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539355|NCT00663442|Dopamine Agents|dopamine agents|mesh-ancestor
24539356|NCT00663442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24539357|NCT00663455|Cyclosporine|cyclosporine|mesh-list
24539358|NCT00663455|Cyclosporins|cyclosporins|mesh-list
24539359|NCT00663455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539361|NCT00663455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25017704|NCT03704909|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25017705|NCT03704909|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24519613|NCT05332106|Androgens|androgens|mesh-ancestor
24539414|NCT00663806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24539415|NCT00663806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24539416|NCT00663806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24539417|NCT00663806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24539418|NCT00663806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539419|NCT00663806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539420|NCT00663806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24539421|NCT00663806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24539422|NCT00663806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24539423|NCT00663832|Panobinostat|panobinostat|mesh-list
24539424|NCT00663832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24539425|NCT00663832|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24539438|NCT00663884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539439|NCT00663884|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24539440|NCT00663884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539441|NCT00663884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539443|NCT00663897|Dexlansoprazole|dexlansoprazole|mesh-list
25017764|NCT03704623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25690660|NCT01976507|Antithrombins|antithrombins|mesh-ancestor
25690661|NCT01976507|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25690662|NCT01976507|Protease Inhibitors|protease inhibitors|mesh-ancestor
25690663|NCT01976507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25690664|NCT01976507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690665|NCT01976507|Anticoagulants|anticoagulants|mesh-ancestor
25690666|NCT01976572|Candesartan|candesartan|mesh-list
25690667|NCT01976572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25690668|NCT01976572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25063893|NCT03464968|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24723983|NCT01590342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24900940|NCT04390061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24900941|NCT04389866|Hyaluronic Acid|hyaluronic acid|mesh-list
24539449|NCT00663897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539450|NCT00663897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24539451|NCT00663897|Serotonin Agents|serotonin agents|mesh-ancestor
24539452|NCT00663897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24539453|NCT00663897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539454|NCT00663910|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24539455|NCT00663910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24539456|NCT00663910|Dermatologic Agents|dermatologic agents|mesh-ancestor
24539458|NCT00663949|Pentoxifylline|pentoxifylline|mesh-list
24539459|NCT00663949|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24446263|NCT00304252|Interferons|interferons|mesh-list
25005214|NCT04368559|Posaconazole|posaconazole|mesh-list
25017795|NCT03704181|Gout Suppressants|gout suppressants|mesh-ancestor
25017796|NCT03704181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25017797|NCT03704181|Tubulin Modulators|tubulin modulators|mesh-ancestor
25017798|NCT03704181|Antimitotic Agents|antimitotic agents|mesh-ancestor
25017799|NCT03704181|Mitosis Modulators|mitosis modulators|mesh-ancestor
25017800|NCT03704181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539472|NCT00664001|Antioxidants|antioxidants|mesh-list
24539473|NCT00664001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539474|NCT00664001|Protective Agents|protective agents|mesh-ancestor
25017814|NCT03704077|Nivolumab|nivolumab|mesh-list
25017815|NCT03704077|Ramucirumab|ramucirumab|mesh-list
25017816|NCT03704077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25017817|NCT03704077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25017818|NCT03704077|Tubulin Modulators|tubulin modulators|mesh-ancestor
25690669|NCT01976572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25690670|NCT01976572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690671|NCT01976624|Timolol|timolol|mesh-list
25690672|NCT01976624|Bimatoprost|bimatoprost|mesh-list
25690673|NCT01976624|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25690674|NCT01976624|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25690675|NCT01976624|Adrenergic Agents|adrenergic agents|mesh-ancestor
24901036|NCT04389359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901037|NCT04389359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24477800|NCT00420277|Plasma Substitutes|plasma substitutes|mesh-ancestor
24477801|NCT00420277|Blood Substitutes|blood substitutes|mesh-ancestor
24901065|NCT04389229|Fludarabine|fludarabine|mesh-list
24901066|NCT04389229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24901067|NCT04389229|Immunologic Factors|immunologic factors|mesh-ancestor
24901099|NCT04388904|Tenofovir|tenofovir|mesh-list
25690676|NCT01976624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25690677|NCT01976624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017819|NCT03704077|Antimitotic Agents|antimitotic agents|mesh-ancestor
25017820|NCT03704077|Mitosis Modulators|mitosis modulators|mesh-ancestor
25017821|NCT03704077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017822|NCT03704077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25017824|NCT03703960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25017825|NCT03703960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25017826|NCT03703960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017827|NCT03703596|Docetaxel|docetaxel|mesh-list
25017828|NCT03703596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25017829|NCT03703596|Tubulin Modulators|tubulin modulators|mesh-ancestor
25017830|NCT03703596|Antimitotic Agents|antimitotic agents|mesh-ancestor
24982025|NCT04454411|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24443756|NCT00295945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539500|NCT00664053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539502|NCT00664144|Gout Suppressants|gout suppressants|mesh-ancestor
25690678|NCT01976624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690679|NCT01976624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25690680|NCT01976624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25690681|NCT01976650|Dexamethasone|dexamethasone|mesh-list
25690682|NCT01976650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25690683|NCT01976650|Antiemetics|antiemetics|mesh-ancestor
25690684|NCT01976650|Autonomic Agents|autonomic agents|mesh-ancestor
25690685|NCT01976650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25690686|NCT01976650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539503|NCT00664144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24539505|NCT00664170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24539506|NCT00664170|Tubulin Modulators|tubulin modulators|mesh-ancestor
24539507|NCT00664170|Antimitotic Agents|antimitotic agents|mesh-ancestor
24539508|NCT00664170|Mitosis Modulators|mitosis modulators|mesh-ancestor
24974408|NCT04735913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974409|NCT04735913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24586835|NCT00892346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24539509|NCT00664170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539510|NCT00664196|Hormones|hormones|mesh-list
24539511|NCT00664196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24539516|NCT00664222|Natriuretic Agents|natriuretic agents|mesh-ancestor
24539517|NCT00664222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539518|NCT00664222|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24539519|NCT00664222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24539520|NCT00664222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446592|NCT00305422|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24539565|NCT00664586|Masoprocol|masoprocol|mesh-list
24539566|NCT00664586|Antioxidants|antioxidants|mesh-ancestor
24539567|NCT00664586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539568|NCT00664586|Protective Agents|protective agents|mesh-ancestor
24621513|NCT01062906|Narcotics|narcotics|mesh-ancestor
24525139|NCT03893617|Propranolol|propranolol|mesh-list
24525140|NCT03893617|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24518850|NCT04145076|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24518851|NCT04145076|Antidepressive Agents|antidepressive agents|mesh-ancestor
24518852|NCT04145076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24525141|NCT03893617|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24525142|NCT03893617|Adrenergic Agents|adrenergic agents|mesh-ancestor
24539602|NCT00664690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24539604|NCT00664690|Analgesics|analgesics|mesh-ancestor
24539605|NCT00664690|Sensory System Agents|sensory system agents|mesh-ancestor
24539606|NCT00664690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24539620|NCT00664703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24539621|NCT00664703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539628|NCT00664703|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24539629|NCT00664703|Cholinergic Agents|cholinergic agents|mesh-ancestor
24539630|NCT00664703|Respiratory System Agents|respiratory system agents|mesh-ancestor
24586857|NCT00892424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24586858|NCT00892424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25017857|NCT03703349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25017859|NCT03703310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25017861|NCT03703154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25017862|NCT03703154|Immunologic Factors|immunologic factors|mesh-ancestor
25017863|NCT03703154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017864|NCT03703154|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25017865|NCT03703154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25017866|NCT03703154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017867|NCT03703089|Gemcitabine|gemcitabine|mesh-list
25017868|NCT03703089|Paclitaxel|paclitaxel|mesh-list
24784127|NCT01906411|Dopamine|dopamine|mesh-list
24784128|NCT01906411|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25106262|NCT03651206|Niraparib|niraparib|mesh-list
24539642|NCT00664833|Urological Agents|urological agents|mesh-ancestor
24539643|NCT00664846|Aspirin|aspirin|mesh-list
24539644|NCT00664846|Clopidogrel|clopidogrel|mesh-list
24539645|NCT00664846|Atorvastatin|atorvastatin|mesh-list
24539646|NCT00664846|Simvastatin|simvastatin|mesh-list
24539647|NCT00664846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24539648|NCT00664846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24539649|NCT00664846|Analgesics|analgesics|mesh-ancestor
24539650|NCT00664846|Sensory System Agents|sensory system agents|mesh-ancestor
24539651|NCT00664846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24539652|NCT00664846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690687|NCT01976650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25690688|NCT01976650|Glucocorticoids|glucocorticoids|mesh-ancestor
25690689|NCT01976650|Hormones|hormones|mesh-ancestor
25690690|NCT01976650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25690691|NCT01976650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25690692|NCT01976650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25690693|NCT01976728|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25690694|NCT01976728|Hormones|hormones|mesh-ancestor
25692656|NCT02003534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24901214|NCT04387539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901216|NCT04387565|Trace Elements|trace elements|mesh-ancestor
24901217|NCT04387565|Micronutrients|micronutrients|mesh-ancestor
24901218|NCT04387565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901219|NCT04387526|Sofosbuvir|sofosbuvir|mesh-list
24901246|NCT04386876|Protease Inhibitors|protease inhibitors|mesh-ancestor
24901247|NCT04386876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901248|NCT04386876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901249|NCT04386876|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24542921|NCT00680940|Cisplatin|cisplatin|mesh-list
24542922|NCT00680940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24901271|NCT04386850|Calcifediol|calcifediol|mesh-list
24901272|NCT04386850|Vitamins|vitamins|mesh-ancestor
24901273|NCT04386850|Micronutrients|micronutrients|mesh-ancestor
24901274|NCT04386850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539653|NCT00664846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24539654|NCT00664846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24539655|NCT00664846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24539656|NCT00664846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25017874|NCT03703089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017875|NCT03703089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25017876|NCT03703089|Antimetabolites|antimetabolites|mesh-ancestor
25017877|NCT03703089|Antiviral Agents|antiviral agents|mesh-ancestor
24525472|NCT03326791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25111050|NCT05265650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25111062|NCT05261386|Sequestering Agents|sequestering agents|mesh-ancestor
25111063|NCT05261386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25111084|NCT05183126|Paclitaxel|paclitaxel|mesh-list
25111085|NCT05183126|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25111086|NCT05183126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25111087|NCT05183126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25111088|NCT05183126|Tubulin Modulators|tubulin modulators|mesh-ancestor
25111089|NCT05183126|Antimitotic Agents|antimitotic agents|mesh-ancestor
25111090|NCT05183126|Mitosis Modulators|mitosis modulators|mesh-ancestor
25111091|NCT05183126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017883|NCT03703063|Leucovorin|leucovorin|mesh-list
25017884|NCT03703063|Gemcitabine|gemcitabine|mesh-list
25017885|NCT03703063|Paclitaxel|paclitaxel|mesh-list
24443757|NCT00295945|Sensory System Agents|sensory system agents|mesh-ancestor
25690695|NCT01976728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25690696|NCT01976728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690697|NCT01976806|Aspirin|aspirin|mesh-list
25690698|NCT01976806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25690699|NCT01976806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25690700|NCT01976806|Analgesics|analgesics|mesh-ancestor
25690701|NCT01976806|Sensory System Agents|sensory system agents|mesh-ancestor
25690702|NCT01976806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25690703|NCT01976806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690704|NCT01976806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25690705|NCT01976806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25690706|NCT01976806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25690707|NCT01976806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25690708|NCT01976806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692657|NCT02003534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25690709|NCT01976806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25690710|NCT01976806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25690711|NCT01976806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25690712|NCT01976806|Antipyretics|antipyretics|mesh-ancestor
25690713|NCT01976845|Midazolam|midazolam|mesh-list
25017894|NCT03703063|Antiviral Agents|antiviral agents|mesh-ancestor
25017886|NCT03703063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25017887|NCT03703063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25017888|NCT03703063|Tubulin Modulators|tubulin modulators|mesh-ancestor
24539660|NCT00664846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539662|NCT00664846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24539663|NCT00664846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24539665|NCT00664846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24539671|NCT00664846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24539673|NCT00664898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24539674|NCT00664963|Sirolimus|sirolimus|mesh-list
24539703|NCT00665093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539704|NCT00665119|Remifentanil|remifentanil|mesh-list
24539705|NCT00665119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24539706|NCT00665119|Narcotics|narcotics|mesh-ancestor
24539707|NCT00665119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24539708|NCT00665119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539709|NCT00665119|Analgesics|analgesics|mesh-ancestor
24438111|NCT00275015|Hormones|hormones|mesh-ancestor
25017889|NCT03703063|Antimitotic Agents|antimitotic agents|mesh-ancestor
25690714|NCT01976845|Propofol|propofol|mesh-list
25690715|NCT01976845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25690716|NCT01976845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25064007|NCT03463967|Lycopene|lycopene|mesh-list
25017890|NCT03703063|Mitosis Modulators|mitosis modulators|mesh-ancestor
25017891|NCT03703063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017892|NCT03703063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25017893|NCT03703063|Antimetabolites|antimetabolites|mesh-ancestor
25017896|NCT03703063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25017897|NCT03703063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25017898|NCT03703063|Immunologic Factors|immunologic factors|mesh-ancestor
25017899|NCT03703063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017900|NCT03703063|Antidotes|antidotes|mesh-ancestor
25017901|NCT03703063|Protective Agents|protective agents|mesh-ancestor
25017924|NCT03702959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25017925|NCT03702959|Respiratory System Agents|respiratory system agents|mesh-ancestor
25017926|NCT03702946|Oxytocin|oxytocin|mesh-list
25017927|NCT03702946|Oxytocics|oxytocics|mesh-ancestor
25017928|NCT03702946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24526030|NCT01999569|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25017929|NCT03702946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017930|NCT03702894|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24982076|NCT04266665|Analgesics|analgesics|mesh-ancestor
24539713|NCT00665314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24539714|NCT00665314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24539715|NCT00665314|Antiviral Agents|antiviral agents|mesh-ancestor
25017933|NCT03702894|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25017934|NCT03702894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25017935|NCT03702894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017936|NCT03702855|Tetrabenazine|tetrabenazine|mesh-list
25017937|NCT03702855|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25017938|NCT03702855|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25017939|NCT03702855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25017940|NCT03702855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017941|NCT03702855|Adrenergic Agents|adrenergic agents|mesh-ancestor
25017942|NCT03702855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24982107|NCT04245748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24539716|NCT00665314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24539717|NCT00665327|Moxifloxacin|moxifloxacin|mesh-list
24539718|NCT00665327|Levofloxacin|levofloxacin|mesh-list
24539719|NCT00665327|Ofloxacin|ofloxacin|mesh-list
24526334|NCT00611195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24526335|NCT00611195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25692658|NCT02003534|Adrenergic Agents|adrenergic agents|mesh-ancestor
25692659|NCT02003534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25692660|NCT02003534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692661|NCT02003534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539735|NCT00665327|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24539737|NCT00665327|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24539738|NCT00665327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24539740|NCT00665340|Vasodilator Agents|vasodilator agents|mesh-ancestor
24539741|NCT00665340|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24539742|NCT00665340|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25017943|NCT03702855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017945|NCT03702803|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25017946|NCT03702803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25017947|NCT03702803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017948|NCT03702803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25017949|NCT03702803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25017950|NCT03702803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25017951|NCT03702803|GABA Modulators|gaba modulators|mesh-ancestor
25017952|NCT03702803|GABA Agents|gaba agents|mesh-ancestor
25017968|NCT03702647|Anesthetics, Local|anesthetics, local|mesh-ancestor
25017969|NCT03702647|Anesthetics|anesthetics|mesh-ancestor
25017970|NCT03702647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25017971|NCT03702647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017972|NCT03702647|Sensory System Agents|sensory system agents|mesh-ancestor
25017973|NCT03702647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25017974|NCT03702621|Bupivacaine|bupivacaine|mesh-list
25017975|NCT03702621|Anesthetics, Local|anesthetics, local|mesh-ancestor
25017976|NCT03702621|Anesthetics|anesthetics|mesh-ancestor
25017977|NCT03702621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25017978|NCT03702621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017979|NCT03702621|Sensory System Agents|sensory system agents|mesh-ancestor
25017980|NCT03702621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25017981|NCT03702582|Warfarin|warfarin|mesh-list
25017982|NCT03702582|Rivaroxaban|rivaroxaban|mesh-list
24539743|NCT00665340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539744|NCT00665340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539745|NCT00665340|Urological Agents|urological agents|mesh-ancestor
24539746|NCT00665418|Sevoflurane|sevoflurane|mesh-list
24539747|NCT00665418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24539748|NCT00665418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24539749|NCT00665418|Anesthetics, General|anesthetics, general|mesh-ancestor
24539750|NCT00665418|Anesthetics|anesthetics|mesh-ancestor
24438263|NCT00275236|Rotigotine|rotigotine|mesh-list
24539787|NCT00665600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539788|NCT00665639|Caspofungin|caspofungin|mesh-list
25017989|NCT03702582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017990|NCT03702530|Albendazole|albendazole|mesh-list
25690717|NCT01976845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690718|NCT01976845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25690719|NCT01976845|Anesthetics, General|anesthetics, general|mesh-ancestor
25690720|NCT01976845|Anesthetics|anesthetics|mesh-ancestor
25690721|NCT01976845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25690722|NCT01976845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25690723|NCT01976845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25690724|NCT01976845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25690725|NCT01976845|GABA Modulators|gaba modulators|mesh-ancestor
24901490|NCT04384133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901491|NCT04384133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24901492|NCT04384133|Respiratory System Agents|respiratory system agents|mesh-ancestor
24901493|NCT04384133|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24901535|NCT04383717|Azithromycin|azithromycin|mesh-list
24901536|NCT04383717|Hydroxychloroquine|hydroxychloroquine|mesh-list
24901538|NCT04383717|Inosine Pranobex|inosine pranobex|mesh-list
25017991|NCT03702530|Anthelmintics|anthelmintics|mesh-ancestor
25017992|NCT03702530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25017993|NCT03702530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25017994|NCT03702530|Anticestodal Agents|anticestodal agents|mesh-ancestor
25017995|NCT03702530|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25017996|NCT03702530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25017997|NCT03702530|Tubulin Modulators|tubulin modulators|mesh-ancestor
25017998|NCT03702530|Antimitotic Agents|antimitotic agents|mesh-ancestor
25017999|NCT03702530|Mitosis Modulators|mitosis modulators|mesh-ancestor
25018000|NCT03702530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018001|NCT03702530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018027|NCT03702400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018028|NCT03702400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018029|NCT03702400|Sympathomimetics|sympathomimetics|mesh-ancestor
25018030|NCT03702400|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24539789|NCT00665639|Micafungin|micafungin|mesh-list
24539790|NCT00665639|Antifungal Agents|antifungal agents|mesh-ancestor
24539791|NCT00665639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24539792|NCT00665639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539845|NCT00665808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24539846|NCT00665808|Insulin Detemir|insulin detemir|mesh-list
24539847|NCT00665808|Isophane Insulin, Human|isophane insulin, human|mesh-list
24539848|NCT00665808|Insulin, Isophane|insulin, isophane|mesh-list
24539849|NCT00665808|Isophane insulin, beef|isophane insulin, beef|mesh-list
24539850|NCT00665808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24539851|NCT00665808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539852|NCT00665834|Atorvastatin|atorvastatin|mesh-list
24539854|NCT00665834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25018031|NCT03702400|Nasal Decongestants|nasal decongestants|mesh-ancestor
25018032|NCT03702400|Respiratory System Agents|respiratory system agents|mesh-ancestor
25018033|NCT03702400|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25018034|NCT03702400|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25018035|NCT03702400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25018036|NCT03702400|Adrenergic Agents|adrenergic agents|mesh-ancestor
25018037|NCT03702400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25018038|NCT03702400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018039|NCT03702400|Protective Agents|protective agents|mesh-ancestor
25018041|NCT03702387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25018042|NCT03702387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018043|NCT03702218|Antiviral Agents|antiviral agents|mesh-list
25018044|NCT03702218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25018045|NCT03702205|Betaine|betaine|mesh-list
25018046|NCT03702205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25018047|NCT03702205|Lipotropic Agents|lipotropic agents|mesh-ancestor
25018048|NCT03702205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25018049|NCT03702205|Antimetabolites|antimetabolites|mesh-ancestor
25018050|NCT03702205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018051|NCT03702205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25018075|NCT03701984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690726|NCT01976845|GABA Agents|gaba agents|mesh-ancestor
25690727|NCT01976845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25690728|NCT01976845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690729|NCT01976871|Rotigotine|rotigotine|mesh-list
25690730|NCT01976871|Dopamine Agonists|dopamine agonists|mesh-ancestor
25690731|NCT01976871|Dopamine Agents|dopamine agents|mesh-ancestor
25690732|NCT01976871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25690733|NCT01976871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018077|NCT03701984|Narcotics|narcotics|mesh-ancestor
25018078|NCT03701984|Analgesics|analgesics|mesh-ancestor
25018079|NCT03701919|Botulinum Toxins|botulinum toxins|mesh-list
25018080|NCT03701919|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24539855|NCT00665834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24539856|NCT00665834|Antimetabolites|antimetabolites|mesh-ancestor
24539870|NCT00665873|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24539872|NCT00665951|Lopinavir|lopinavir|mesh-list
24539873|NCT00665951|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24539874|NCT00665951|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24539888|NCT00665977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24539889|NCT00665977|Glucocorticoids|glucocorticoids|mesh-ancestor
24539890|NCT00665977|Hormones|hormones|mesh-ancestor
24539891|NCT00665977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24539892|NCT00665977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539893|NCT00665977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24539894|NCT00665977|Immunologic Factors|immunologic factors|mesh-ancestor
24539895|NCT00665977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539896|NCT00665977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539897|NCT00665990|Cyclophosphamide|cyclophosphamide|mesh-list
24539898|NCT00665990|Bevacizumab|bevacizumab|mesh-list
24539899|NCT00665990|Sorafenib|sorafenib|mesh-list
25018082|NCT03701919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25018083|NCT03701919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018084|NCT03701919|Cholinergic Agents|cholinergic agents|mesh-ancestor
25018085|NCT03701919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25018086|NCT03701919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018087|NCT03701919|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25018088|NCT03701919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018089|NCT03701880|Bisoprolol|bisoprolol|mesh-list
25018090|NCT03701880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25018091|NCT03701880|Sympatholytics|sympatholytics|mesh-ancestor
25018092|NCT03701880|Autonomic Agents|autonomic agents|mesh-ancestor
24539900|NCT00665990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24539901|NCT00665990|Immunologic Factors|immunologic factors|mesh-ancestor
24539902|NCT00665990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539903|NCT00665990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24539904|NCT00665990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24539905|NCT00665990|Alkylating Agents|alkylating agents|mesh-ancestor
25018180|NCT03701321|Hormones|hormones|mesh-ancestor
24901956|NCT04379180|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24519200|NCT03007329|Dapagliflozin|dapagliflozin|mesh-list
24519201|NCT03007329|Exenatide|exenatide|mesh-list
24901963|NCT04379271|Calcium|calcium|mesh-list
25018093|NCT03701880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018094|NCT03701880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018095|NCT03701880|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25018096|NCT03701880|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25018097|NCT03701880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25018098|NCT03701880|Adrenergic Agents|adrenergic agents|mesh-ancestor
25018117|NCT03701698|Prednisolone phosphate|prednisolone phosphate|mesh-list
25018118|NCT03701698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25018120|NCT03701698|Autonomic Agents|autonomic agents|mesh-ancestor
25018121|NCT03701698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018122|NCT03701698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018123|NCT03701698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24539931|NCT00666042|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24539932|NCT00666042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24539933|NCT00666042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24539935|NCT00666055|Lopinavir|lopinavir|mesh-list
24539936|NCT00666055|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24539937|NCT00666055|Tenofovir|tenofovir|mesh-list
24539938|NCT00666055|Lamivudine|lamivudine|mesh-list
24539939|NCT00666055|Zidovudine|zidovudine|mesh-list
24539940|NCT00666055|Emtricitabine|emtricitabine|mesh-list
24539941|NCT00666055|Raltegravir Potassium|raltegravir potassium|mesh-list
24539942|NCT00666055|Maraviroc|maraviroc|mesh-list
24539943|NCT00666055|Efavirenz|efavirenz|mesh-list
24539944|NCT00666055|Etravirine|etravirine|mesh-list
24539945|NCT00666055|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24539946|NCT00666055|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24539947|NCT00666055|Protease Inhibitors|protease inhibitors|mesh-ancestor
24539948|NCT00666055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018440|NCT03699254|Antiviral Agents|antiviral agents|mesh-ancestor
24539951|NCT00666055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24539952|NCT00666055|Antiviral Agents|antiviral agents|mesh-ancestor
24539953|NCT00666055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24539954|NCT00666055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24539955|NCT00666055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25018125|NCT03701698|Hormones|hormones|mesh-ancestor
25018126|NCT03701698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25018127|NCT03701698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25018128|NCT03701698|Protective Agents|protective agents|mesh-ancestor
25018129|NCT03701698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25018130|NCT03701698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25012897|NCT04136366|Methotrexate|methotrexate|mesh-list
25018131|NCT03701672|Analgesics, Opioid|analgesics, opioid|mesh-list
25018132|NCT03701672|Analgesics|analgesics|mesh-list
25690734|NCT01976871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690735|NCT01976988|Heparin|heparin|mesh-list
25690736|NCT01976988|Anticoagulants|anticoagulants|mesh-ancestor
25018133|NCT03701672|Narcotics|narcotics|mesh-ancestor
25018134|NCT03701672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24539960|NCT00666055|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24539961|NCT00666055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25690737|NCT01976988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25690738|NCT01976988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25690739|NCT01976988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690740|NCT01977352|Bupivacaine|bupivacaine|mesh-list
25690741|NCT01977352|Anesthetics, Local|anesthetics, local|mesh-ancestor
25690742|NCT01977352|Anesthetics|anesthetics|mesh-ancestor
25690743|NCT01977352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25690744|NCT01977352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901996|NCT04378972|Micronutrients|micronutrients|mesh-ancestor
24901997|NCT04378972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018143|NCT03701529|Propofol|propofol|mesh-list
25018144|NCT03701529|Sevoflurane|sevoflurane|mesh-list
25018145|NCT03701529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25018146|NCT03701529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018147|NCT03701529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25018148|NCT03701529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25018149|NCT03701529|Anesthetics, General|anesthetics, general|mesh-ancestor
25018179|NCT03701321|Glucocorticoids|glucocorticoids|mesh-ancestor
25018187|NCT03701321|Dermatologic Agents|dermatologic agents|mesh-ancestor
24581087|NCT00864396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540133|NCT00666692|Growth Substances|growth substances|mesh-ancestor
25111136|NCT05134792|gamma-Globulins|gamma-globulins|mesh-list
25111137|NCT05134792|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25111138|NCT05134792|Immunologic Factors|immunologic factors|mesh-ancestor
25111139|NCT05134792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25111140|NCT05128734|Temozolomide|temozolomide|mesh-list
25111141|NCT05128734|Olaparib|olaparib|mesh-list
25111142|NCT05128734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25111143|NCT05128734|Alkylating Agents|alkylating agents|mesh-ancestor
25111144|NCT05128734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25111145|NCT05128734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25111146|NCT05128734|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25111147|NCT05128734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25111148|NCT05120960|Osimertinib|osimertinib|mesh-list
25111149|NCT05120960|Tepotinib|tepotinib|mesh-list
25111150|NCT05120960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25111151|NCT05120960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25111152|NCT05120960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25111153|NCT05120960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690745|NCT01977352|Sensory System Agents|sensory system agents|mesh-ancestor
25690746|NCT01977352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25690747|NCT01977456|Eptifibatide|eptifibatide|mesh-list
25690748|NCT01977456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25690749|NCT01977625|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25690750|NCT01977625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25690751|NCT01977625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902143|NCT04376970|Cyclosporins|cyclosporins|mesh-list
24902144|NCT04376970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902146|NCT04376970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25064092|NCT03463252|Progesterone|progesterone|mesh-list
24540145|NCT00666770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24586861|NCT00892450|Darifenacin|darifenacin|mesh-list
24586862|NCT00892450|Parasympatholytics|parasympatholytics|mesh-ancestor
24586863|NCT00892450|Autonomic Agents|autonomic agents|mesh-ancestor
24586864|NCT00892450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24586865|NCT00892450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586867|NCT00892450|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24586868|NCT00892450|Cholinergic Agents|cholinergic agents|mesh-ancestor
24586869|NCT00892450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24586887|NCT00892489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24586889|NCT00892489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24586890|NCT00892489|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24586891|NCT00892489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24586893|NCT00892489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24586899|NCT00892502|Antacids|antacids|mesh-ancestor
24586900|NCT00892502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586901|NCT00892502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24586902|NCT00892541|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24586903|NCT00892541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24619244|NCT01051531|Dopamine Agents|dopamine agents|mesh-ancestor
24586904|NCT00892541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24586905|NCT00892541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24586906|NCT00892541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586907|NCT00892541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24586908|NCT00892541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24586909|NCT00892541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24586910|NCT00892541|Serotonin Agents|serotonin agents|mesh-ancestor
24586911|NCT00892541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24586937|NCT00892892|Nitrendipine|nitrendipine|mesh-list
24586938|NCT00892892|Rilmenidine|rilmenidine|mesh-list
25018208|NCT03701087|Micronutrients|micronutrients|mesh-ancestor
25018209|NCT03701087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018210|NCT03701087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25018211|NCT03701022|Apatinib|apatinib|mesh-list
25018212|NCT03701022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018213|NCT03701022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25018214|NCT03701022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018215|NCT03701022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018216|NCT03700905|Nivolumab|nivolumab|mesh-list
25018217|NCT03700905|Ipilimumab|ipilimumab|mesh-list
25018218|NCT03700905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25018219|NCT03700905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018220|NCT03700905|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25018221|NCT03700905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018253|NCT03700749|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25018255|NCT03700749|Povidone-Iodine|povidone-iodine|mesh-list
25018256|NCT03700749|Povidone|povidone|mesh-list
25018257|NCT03700749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25018258|NCT03700749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25018259|NCT03700749|Disinfectants|disinfectants|mesh-ancestor
25018260|NCT03700749|Dermatologic Agents|dermatologic agents|mesh-ancestor
25018261|NCT03700749|Trace Elements|trace elements|mesh-ancestor
25018262|NCT03700749|Micronutrients|micronutrients|mesh-ancestor
25018263|NCT03700749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018264|NCT03700749|Plasma Substitutes|plasma substitutes|mesh-ancestor
24581275|NCT00864825|Allopurinol|allopurinol|mesh-list
24540184|NCT00666809|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24540215|NCT00667043|Midazolam|midazolam|mesh-list
24540216|NCT00667043|Remifentanil|remifentanil|mesh-list
24540217|NCT00667043|Propofol|propofol|mesh-list
24540218|NCT00667043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24444993|NCT00299923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540219|NCT00667043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25690752|NCT01977625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25690753|NCT01977625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25690754|NCT01977625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25692662|NCT02003573|Decitabine|decitabine|mesh-list
24902343|NCT04374318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902435|NCT04374006|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25690755|NCT01977625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690756|NCT01977625|Dopamine Agents|dopamine agents|mesh-ancestor
24902462|NCT04373967|Incretins|incretins|mesh-ancestor
24540220|NCT00667043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540221|NCT00667043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24540222|NCT00667043|Anesthetics, General|anesthetics, general|mesh-ancestor
24540223|NCT00667043|Anesthetics|anesthetics|mesh-ancestor
24540224|NCT00667043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24540225|NCT00667043|Narcotics|narcotics|mesh-ancestor
25018287|NCT03700450|Immunologic Factors|immunologic factors|mesh-ancestor
25018288|NCT03700450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018289|NCT03700450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25018290|NCT03700450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24445014|NCT00300014|Hormones|hormones|mesh-ancestor
24445015|NCT00300014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24445016|NCT00300014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445017|NCT00300040|Chrysarobin|chrysarobin|mesh-list
24445018|NCT00300040|HBOC 201|hboc 201|mesh-list
24528482|NCT00621387|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25018292|NCT03700450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018293|NCT03700450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018294|NCT03700450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25018296|NCT03700359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25018297|NCT03700359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018298|NCT03700359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25018299|NCT03700359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25018300|NCT03700359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018301|NCT03700359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018303|NCT03700333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018304|NCT03700333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018305|NCT03700333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018306|NCT03700333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25018307|NCT03700333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25018309|NCT03700229|Bortezomib|bortezomib|mesh-list
25018310|NCT03700229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25018311|NCT03700229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106364|NCT02919683|Nivolumab|nivolumab|mesh-list
24440343|NCT00282451|Biphasic Insulins|biphasic insulins|mesh-list
25018312|NCT03700229|Immunologic Factors|immunologic factors|mesh-ancestor
25018322|NCT03700177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25018323|NCT03700177|Glucocorticoids|glucocorticoids|mesh-ancestor
25018324|NCT03700177|Hormones|hormones|mesh-ancestor
25018325|NCT03700177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25690757|NCT01977625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25690758|NCT01977677|Plerixafor|plerixafor|mesh-list
25690759|NCT01977677|Temozolomide|temozolomide|mesh-list
25690760|NCT01977677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25690761|NCT01977677|Alkylating Agents|alkylating agents|mesh-ancestor
25690762|NCT01977677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690763|NCT01977677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24902733|NCT04371146|Dopamine Agents|dopamine agents|mesh-ancestor
25018326|NCT03700177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25018327|NCT03700177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018328|NCT03700177|Anesthetics, Local|anesthetics, local|mesh-ancestor
25018329|NCT03700177|Anesthetics|anesthetics|mesh-ancestor
25018341|NCT03699956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25018342|NCT03699956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25018343|NCT03699956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25018344|NCT03699956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018345|NCT03699956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018346|NCT03699904|Valacyclovir|valacyclovir|mesh-list
24974850|NCT05207709|Tubulin Modulators|tubulin modulators|mesh-ancestor
24974851|NCT05207709|Antimitotic Agents|antimitotic agents|mesh-ancestor
24974852|NCT05207709|Mitosis Modulators|mitosis modulators|mesh-ancestor
24974853|NCT05207709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974854|NCT05207709|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24974855|NCT05207709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24974856|NCT05207709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24974857|NCT05207709|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24974858|NCT05207709|Hormone Antagonists|hormone antagonists|mesh-ancestor
24974859|NCT05207709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24974860|NCT05207709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013142|NCT03452111|ST 1435|st 1435|mesh-list
25018367|NCT03699696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25018368|NCT03699696|Anesthetics, General|anesthetics, general|mesh-ancestor
25018369|NCT03699696|Anesthetics|anesthetics|mesh-ancestor
25111181|NCT05102721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25111182|NCT05102721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018370|NCT03699449|Paclitaxel|paclitaxel|mesh-list
25018371|NCT03699449|Durvalumab|durvalumab|mesh-list
25018372|NCT03699449|Olaparib|olaparib|mesh-list
25018373|NCT03699449|Tremelimumab|tremelimumab|mesh-list
25018374|NCT03699449|Cediranib|cediranib|mesh-list
25018376|NCT03699449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25018377|NCT03699449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018378|NCT03699449|Tubulin Modulators|tubulin modulators|mesh-ancestor
25018379|NCT03699449|Antimitotic Agents|antimitotic agents|mesh-ancestor
25018380|NCT03699449|Mitosis Modulators|mitosis modulators|mesh-ancestor
25018381|NCT03699449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018382|NCT03699449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25018383|NCT03699449|Immunologic Factors|immunologic factors|mesh-ancestor
25018384|NCT03699449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018385|NCT03699449|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25018386|NCT03699449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018397|NCT03699423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25018398|NCT03699423|Respiratory System Agents|respiratory system agents|mesh-ancestor
25018399|NCT03699423|Mydriatics|mydriatics|mesh-ancestor
25018400|NCT03699423|Parasympatholytics|parasympatholytics|mesh-ancestor
25018401|NCT03699423|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25018402|NCT03699423|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25018403|NCT03699423|Cholinergic Agents|cholinergic agents|mesh-ancestor
25018404|NCT03699423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25018405|NCT03699423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018407|NCT03699384|Avelumab|avelumab|mesh-list
25018408|NCT03699384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25018409|NCT03699384|Antimetabolites|antimetabolites|mesh-ancestor
25018410|NCT03699384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018411|NCT03699384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018432|NCT03699293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25018433|NCT03699293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018435|NCT03699293|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25018436|NCT03699293|Gout Suppressants|gout suppressants|mesh-ancestor
25018437|NCT03699254|Valganciclovir|valganciclovir|mesh-list
25018438|NCT03699254|Ganciclovir|ganciclovir|mesh-list
25018439|NCT03699254|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25018441|NCT03699254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25018442|NCT03699254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25018443|NCT03699254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018444|NCT03699254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018445|NCT03699215|Simendan|simendan|mesh-list
25018446|NCT03699215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25018447|NCT03699215|Vasodilator Agents|vasodilator agents|mesh-ancestor
25018448|NCT03699215|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25690764|NCT01977677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25018449|NCT03699215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25018480|NCT03698851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018481|NCT03698851|Sympathomimetics|sympathomimetics|mesh-ancestor
25018482|NCT03698851|Autonomic Agents|autonomic agents|mesh-ancestor
25018484|NCT03698851|Dopamine Agents|dopamine agents|mesh-ancestor
25018560|NCT03698617|Propofol|propofol|mesh-list
25018561|NCT03698617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25018562|NCT03698617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25018563|NCT03698617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018564|NCT03698617|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25018565|NCT03698617|Anesthetics, General|anesthetics, general|mesh-ancestor
25018566|NCT03698617|Anesthetics|anesthetics|mesh-ancestor
25018567|NCT03698513|Aspirin|aspirin|mesh-list
25018568|NCT03698513|Clopidogrel|clopidogrel|mesh-list
25018569|NCT03698513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25018570|NCT03698513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25018571|NCT03698513|Analgesics|analgesics|mesh-ancestor
25018572|NCT03698513|Sensory System Agents|sensory system agents|mesh-ancestor
25018573|NCT03698513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018574|NCT03698513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018575|NCT03698513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25018576|NCT03698513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25018577|NCT03698513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25018578|NCT03698513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25018579|NCT03698513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982529|NCT02382406|Paclitaxel|paclitaxel|mesh-list
25018580|NCT03698513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25018581|NCT03698513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25018582|NCT03698513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018583|NCT03698513|Antipyretics|antipyretics|mesh-ancestor
25018584|NCT03698513|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25018585|NCT03698513|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25018586|NCT03698513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25018587|NCT03698513|Purinergic Agents|purinergic agents|mesh-ancestor
25018588|NCT03698513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25018589|NCT03698474|Ascorbic Acid|ascorbic acid|mesh-list
25018590|NCT03698474|Magnesium Sulfate|magnesium sulfate|mesh-list
25018591|NCT03698474|Picosulfate sodium|picosulfate sodium|mesh-list
25018592|NCT03698474|Magnesium citrate|magnesium citrate|mesh-list
25018593|NCT03698474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018594|NCT03698474|Analgesics|analgesics|mesh-ancestor
25018595|NCT03698474|Sensory System Agents|sensory system agents|mesh-ancestor
25018596|NCT03698474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018597|NCT03698474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018620|NCT03698435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018622|NCT03698383|Gedatolisib|gedatolisib|mesh-list
25018631|NCT03698292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018632|NCT03698292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982562|NCT02121184|Oxytocin|oxytocin|mesh-list
25690765|NCT01977677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25690766|NCT01977677|Antiviral Agents|antiviral agents|mesh-ancestor
25690767|NCT01977677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25690768|NCT01977781|Methylprednisolone|methylprednisolone|mesh-list
25690769|NCT01977781|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25690770|NCT01977781|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25690771|NCT01977781|Prednisolone|prednisolone|mesh-list
25690772|NCT01977781|Prednisolone acetate|prednisolone acetate|mesh-list
25690773|NCT01977781|Tacrolimus|tacrolimus|mesh-list
25690774|NCT01977781|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25018633|NCT03698292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25018634|NCT03698292|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25018635|NCT03698292|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25018636|NCT03698292|Dopamine Agents|dopamine agents|mesh-ancestor
25018637|NCT03698292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25018638|NCT03698292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018639|NCT03698227|Doxorubicin|doxorubicin|mesh-list
25018640|NCT03698227|Dexrazoxane|dexrazoxane|mesh-list
25018641|NCT03698227|Razoxane|razoxane|mesh-list
25018642|NCT03698227|Olaratumab|olaratumab|mesh-list
25018643|NCT03698227|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25018644|NCT03698227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018645|NCT03698227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25018646|NCT03698227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25018647|NCT03698227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018648|NCT03698227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018649|NCT03698227|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25018650|NCT03698227|Protective Agents|protective agents|mesh-ancestor
25018666|NCT03697889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25018667|NCT03697889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018668|NCT03697889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018669|NCT03697824|Cyclophosphamide|cyclophosphamide|mesh-list
25018670|NCT03697824|Pembrolizumab|pembrolizumab|mesh-list
25018671|NCT03697824|Fludarabine|fludarabine|mesh-list
25018672|NCT03697824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25018673|NCT03697824|Immunologic Factors|immunologic factors|mesh-ancestor
24540309|NCT00667303|Immunologic Factors|immunologic factors|mesh-ancestor
25018676|NCT03697824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25018677|NCT03697824|Alkylating Agents|alkylating agents|mesh-ancestor
25018678|NCT03697824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018679|NCT03697824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018680|NCT03697824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25018681|NCT03697824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24445241|NCT00300924|Antipyretics|antipyretics|mesh-ancestor
24540323|NCT00667407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24540324|NCT00667407|Adrenergic Agents|adrenergic agents|mesh-ancestor
24540325|NCT00667407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24540326|NCT00667407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540327|NCT00667433|Tenofovir|tenofovir|mesh-list
24540328|NCT00667433|Emtricitabine|emtricitabine|mesh-list
24540329|NCT00667433|Raltegravir Potassium|raltegravir potassium|mesh-list
25018694|NCT03697746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25018695|NCT03697746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25018696|NCT03697746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018697|NCT03697746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018705|NCT03697668|Piperaquine|piperaquine|mesh-list
25018707|NCT03697668|Imatinib Mesylate|imatinib mesylate|mesh-list
25018708|NCT03697668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018709|NCT03697668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24445275|NCT00301054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445276|NCT00301054|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24441626|NCT00287950|Cyclophosphamide|cyclophosphamide|mesh-list
25018713|NCT03697668|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25018714|NCT03697668|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25018715|NCT03697668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25018727|NCT03697564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25018728|NCT03697564|Antimetabolites|antimetabolites|mesh-ancestor
25018729|NCT03697564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018730|NCT03697564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018731|NCT03697564|Antiviral Agents|antiviral agents|mesh-ancestor
25018732|NCT03697564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25018733|NCT03697564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018734|NCT03697564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25018735|NCT03697564|Immunologic Factors|immunologic factors|mesh-ancestor
24540330|NCT00667433|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24540332|NCT00667433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24540333|NCT00667433|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25018736|NCT03697564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690775|NCT01977781|Prednisolone phosphate|prednisolone phosphate|mesh-list
25690776|NCT01977781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25690777|NCT01977781|Immunologic Factors|immunologic factors|mesh-ancestor
25690778|NCT01977781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690779|NCT01977781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25690780|NCT01977781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25690781|NCT01977781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690782|NCT01977781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25690783|NCT01977781|Antiemetics|antiemetics|mesh-ancestor
25690784|NCT01977781|Autonomic Agents|autonomic agents|mesh-ancestor
25690785|NCT01977781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24903393|NCT04364321|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25018737|NCT03697564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25018738|NCT03697564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25018741|NCT03697265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25018742|NCT03697265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018743|NCT03697239|Ascorbic Acid|ascorbic acid|mesh-list
25018744|NCT03697239|Gemcitabine|gemcitabine|mesh-list
25018745|NCT03697239|Paclitaxel|paclitaxel|mesh-list
25018746|NCT03697239|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25018747|NCT03697239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25018748|NCT03697239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018749|NCT03697239|Tubulin Modulators|tubulin modulators|mesh-ancestor
25018750|NCT03697239|Antimitotic Agents|antimitotic agents|mesh-ancestor
25018751|NCT03697239|Mitosis Modulators|mitosis modulators|mesh-ancestor
25018752|NCT03697239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018753|NCT03697239|Vitamins|vitamins|mesh-ancestor
25018754|NCT03697239|Micronutrients|micronutrients|mesh-ancestor
25018755|NCT03697239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018756|NCT03697239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25018757|NCT03697239|Antimetabolites|antimetabolites|mesh-ancestor
25018758|NCT03697239|Antiviral Agents|antiviral agents|mesh-ancestor
25018759|NCT03697239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25018760|NCT03697239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018761|NCT03697239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25018762|NCT03697239|Immunologic Factors|immunologic factors|mesh-ancestor
25018763|NCT03697239|Antioxidants|antioxidants|mesh-ancestor
25018764|NCT03697239|Protective Agents|protective agents|mesh-ancestor
25018765|NCT03697161|Gaboxadol|gaboxadol|mesh-list
25018766|NCT03697161|Analgesics|analgesics|mesh-ancestor
25018767|NCT03697161|Sensory System Agents|sensory system agents|mesh-ancestor
25018768|NCT03697161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018769|NCT03697161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018799|NCT03696940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25018800|NCT03696940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018802|NCT03696901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25018803|NCT03696901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25018804|NCT03696641|Lithium Carbonate|lithium carbonate|mesh-list
25018805|NCT03696641|Antidepressive Agents|antidepressive agents|mesh-ancestor
25018806|NCT03696641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25018807|NCT03696641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018808|NCT03696641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018809|NCT03696641|Antimanic Agents|antimanic agents|mesh-ancestor
25018810|NCT03696641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25018811|NCT03696641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25018812|NCT03696641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018813|NCT03696459|Moxifloxacin|moxifloxacin|mesh-list
25018814|NCT03696459|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25018815|NCT03696459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25018816|NCT03696459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24540335|NCT00667433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540336|NCT00667433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540337|NCT00667433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24540338|NCT00667433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24540339|NCT00667433|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24540343|NCT00667472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24445365|NCT00301405|Immunologic Factors|immunologic factors|mesh-ancestor
24445366|NCT00301405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018817|NCT03696459|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25018818|NCT03696459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25018819|NCT03696459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018820|NCT03696459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018821|NCT03696459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018822|NCT03696459|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25018823|NCT03696459|Contraceptive Agents|contraceptive agents|mesh-ancestor
25018824|NCT03696459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25018825|NCT03696459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018826|NCT03696459|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25018827|NCT03696459|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25690786|NCT01977781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25690787|NCT01977781|Glucocorticoids|glucocorticoids|mesh-ancestor
25690788|NCT01977781|Hormones|hormones|mesh-ancestor
25690789|NCT01977781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25018828|NCT03696459|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25018829|NCT03696329|Tetrabenazine|tetrabenazine|mesh-list
25018830|NCT03696329|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25018831|NCT03696329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25018832|NCT03696329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25018833|NCT03696329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018834|NCT03696329|Adrenergic Agents|adrenergic agents|mesh-ancestor
25018852|NCT03696186|GABA Modulators|gaba modulators|mesh-ancestor
25018853|NCT03696186|GABA Agents|gaba agents|mesh-ancestor
25018854|NCT03696186|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24540344|NCT00667472|Growth Substances|growth substances|mesh-ancestor
24540345|NCT00667472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540346|NCT00667472|Growth Inhibitors|growth inhibitors|mesh-ancestor
24540347|NCT00667472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24540349|NCT00667485|Bevacizumab|bevacizumab|mesh-list
24540350|NCT00667485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24540351|NCT00667485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24540352|NCT00667485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24540353|NCT00667485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24442162|NCT00290121|Serotonin Agents|serotonin agents|mesh-ancestor
25018859|NCT03696121|Coagulants|coagulants|mesh-ancestor
25018860|NCT03696121|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25018861|NCT03696121|Natriuretic Agents|natriuretic agents|mesh-ancestor
25018862|NCT03696121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018863|NCT03696095|Ropivacaine|ropivacaine|mesh-list
25018864|NCT03696095|Anesthetics, Local|anesthetics, local|mesh-ancestor
25018865|NCT03696095|Anesthetics|anesthetics|mesh-ancestor
25018866|NCT03696095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25018867|NCT03696095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018868|NCT03696095|Sensory System Agents|sensory system agents|mesh-ancestor
25018869|NCT03696095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018870|NCT03695952|Pembrolizumab|pembrolizumab|mesh-list
25018872|NCT03695952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24975467|NCT03593811|Ondansetron|ondansetron|mesh-list
24975346|NCT04080804|Immunoglobulins|immunoglobulins|mesh-list
24975347|NCT04080804|Immunologic Factors|immunologic factors|mesh-ancestor
24975348|NCT04080804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944625|NCT03959124|Dopamine Agents|dopamine agents|mesh-ancestor
24975349|NCT04080804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24975350|NCT04080804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018905|NCT03695744|Antiemetics|antiemetics|mesh-ancestor
24445408|NCT00301522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540367|NCT00667537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24540369|NCT00667641|Bortezomib|bortezomib|mesh-list
24529661|NCT00627432|Gemcitabine|gemcitabine|mesh-list
24540370|NCT00667641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25018906|NCT03695744|Autonomic Agents|autonomic agents|mesh-ancestor
25018907|NCT03695744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018908|NCT03695744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018909|NCT03695744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25018910|NCT03695744|Glucocorticoids|glucocorticoids|mesh-ancestor
25018911|NCT03695744|Hormones|hormones|mesh-ancestor
25018912|NCT03695744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25018926|NCT03695705|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25111225|NCT05031026|Sensory System Agents|sensory system agents|mesh-ancestor
25111226|NCT05031026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25111227|NCT05031026|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25111228|NCT05031026|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25111229|NCT05031026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25111230|NCT05031026|Adrenergic Agents|adrenergic agents|mesh-ancestor
25111231|NCT05031026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25111232|NCT05031026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25111254|NCT05020028|Cannabidiol|cannabidiol|mesh-list
25111255|NCT05020028|Anticonvulsants|anticonvulsants|mesh-ancestor
25111256|NCT05016297|Hydroxychloroquine|hydroxychloroquine|mesh-list
24903756|NCT04361370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24903757|NCT04361370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24953241|NCT03887169|Vitamin B 12|vitamin b 12|mesh-list
24953242|NCT03887169|Hydroxocobalamin|hydroxocobalamin|mesh-list
24953243|NCT03887169|Vitamins|vitamins|mesh-ancestor
24953244|NCT03887169|Micronutrients|micronutrients|mesh-ancestor
24953245|NCT03887169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953246|NCT03887169|Vitamin B Complex|vitamin b complex|mesh-ancestor
25111257|NCT05016297|Antimalarials|antimalarials|mesh-ancestor
25111258|NCT05016297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25111259|NCT05016297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25111260|NCT05016297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25111261|NCT05016297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25111262|NCT05016297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25111263|NCT05016297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25018946|NCT03695445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24540371|NCT00667641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018947|NCT03695445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018948|NCT03695445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018951|NCT03695445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018952|NCT03695445|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25018953|NCT03695107|Nifedipine|nifedipine|mesh-list
25018954|NCT03695107|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25018955|NCT03695107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25018956|NCT03695107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018957|NCT03695107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25018958|NCT03695107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018959|NCT03695107|Vasodilator Agents|vasodilator agents|mesh-ancestor
25018960|NCT03695107|Tocolytic Agents|tocolytic agents|mesh-ancestor
25018961|NCT03695107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25018962|NCT03695029|Tenofovir|tenofovir|mesh-list
25018963|NCT03695029|Antiviral Agents|antiviral agents|mesh-ancestor
24975466|NCT03593811|Cyproheptadine|cyproheptadine|mesh-list
24975470|NCT03593811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24540378|NCT00667758|Fertility Agents|fertility agents|mesh-ancestor
24540379|NCT00667758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24540380|NCT00667758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540381|NCT00667758|Hormone Antagonists|hormone antagonists|mesh-ancestor
24443795|NCT00295997|Cyclophosphamide|cyclophosphamide|mesh-list
24443796|NCT00295997|Busulfan|busulfan|mesh-list
24443797|NCT00295997|Methotrexate|methotrexate|mesh-list
24443798|NCT00295997|Fludarabine|fludarabine|mesh-list
24443799|NCT00295997|Fludarabine phosphate|fludarabine phosphate|mesh-list
24443800|NCT00295997|Tacrolimus|tacrolimus|mesh-list
24443801|NCT00295997|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24443803|NCT00295997|Immunologic Factors|immunologic factors|mesh-ancestor
24444021|NCT00296530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25690790|NCT01977781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25690791|NCT01977781|Protective Agents|protective agents|mesh-ancestor
25690792|NCT01977781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25690793|NCT01977781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25692663|NCT02003573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25692664|NCT02003573|Antimetabolites|antimetabolites|mesh-ancestor
25692665|NCT02003573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586993|NCT00893009|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24540449|NCT00668018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24540450|NCT00668018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540451|NCT00668018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540454|NCT00668031|Hemostatics|hemostatics|mesh-ancestor
24540480|NCT00668096|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24540481|NCT00668096|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24540482|NCT00668096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540483|NCT00668096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540484|NCT00668096|Urological Agents|urological agents|mesh-ancestor
24540485|NCT00668109|Tadalafil|tadalafil|mesh-list
24540486|NCT00668109|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24540487|NCT00668109|Vasodilator Agents|vasodilator agents|mesh-ancestor
24540488|NCT00668109|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24540489|NCT00668109|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24540490|NCT00668109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540491|NCT00668109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540492|NCT00668109|Urological Agents|urological agents|mesh-ancestor
24587029|NCT00893100|Vasodilator Agents|vasodilator agents|mesh-ancestor
25018985|NCT03694873|Celecoxib|celecoxib|mesh-list
25018986|NCT03694873|Tramadol|tramadol|mesh-list
24582224|NCT00868738|Vitamin D|vitamin d|mesh-list
25018995|NCT03694873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25018996|NCT03694873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25018997|NCT03694873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25019000|NCT03694873|Narcotics|narcotics|mesh-ancestor
25019001|NCT03694873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25019003|NCT03694587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25019004|NCT03694587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25019005|NCT03694587|Analgesics|analgesics|mesh-ancestor
25019006|NCT03694587|Sensory System Agents|sensory system agents|mesh-ancestor
25019007|NCT03694587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25019008|NCT03694587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019009|NCT03694587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25019010|NCT03694587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24540618|NCT00668642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540619|NCT00668642|Hormone Antagonists|hormone antagonists|mesh-ancestor
24540620|NCT00668642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24540621|NCT00668642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019011|NCT03694587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25019012|NCT03694587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25019013|NCT03694587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019014|NCT03694535|Mitomycins|mitomycins|mesh-list
25019015|NCT03694535|Mitomycin|mitomycin|mesh-list
25019016|NCT03694535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25019017|NCT03694535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019018|NCT03694535|Alkylating Agents|alkylating agents|mesh-ancestor
25019019|NCT03694535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019020|NCT03694535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25019021|NCT03694535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25019022|NCT03694236|Durvalumab|durvalumab|mesh-list
25019023|NCT03694236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25019024|NCT03694236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019025|NCT03694119|Phenelzine|phenelzine|mesh-list
25019026|NCT03694119|Ozanimod|ozanimod|mesh-list
25019027|NCT03694119|Tyramine|tyramine|mesh-list
25019028|NCT03694119|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25019029|NCT03694119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019030|NCT03694119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25019031|NCT03694119|Immunologic Factors|immunologic factors|mesh-ancestor
25111286|NCT04975919|Decitabine|decitabine|mesh-list
24818398|NCT02088502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24818399|NCT02088515|Docetaxel|docetaxel|mesh-list
24818400|NCT02088515|Nedaplatin|nedaplatin|mesh-list
25111287|NCT04975919|Venetoclax|venetoclax|mesh-list
25111288|NCT04975919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25111289|NCT04975919|Antimetabolites|antimetabolites|mesh-ancestor
25111290|NCT04975919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25111291|NCT04975919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25111292|NCT04975919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25019108|NCT03693573|Growth Substances|growth substances|mesh-ancestor
25019109|NCT03693573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019110|NCT03693573|Growth Inhibitors|growth inhibitors|mesh-ancestor
25019111|NCT03693560|Metformin|metformin|mesh-list
25019112|NCT03693560|Glimepiride|glimepiride|mesh-list
25019113|NCT03693560|Vildagliptin|vildagliptin|mesh-list
25019114|NCT03693560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25019148|NCT03693391|Fluorides|fluorides|mesh-list
25019149|NCT03693391|Cariostatic Agents|cariostatic agents|mesh-ancestor
25019150|NCT03693391|Protective Agents|protective agents|mesh-ancestor
25019152|NCT03693326|Spartalizumab|spartalizumab|mesh-list
25019153|NCT03693326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25019154|NCT03693326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019155|NCT03693326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019156|NCT03693248|Paclitaxel|paclitaxel|mesh-list
25019157|NCT03693248|Carboplatin|carboplatin|mesh-list
25019158|NCT03693248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25019159|NCT03693248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019160|NCT03693248|Tubulin Modulators|tubulin modulators|mesh-ancestor
25019161|NCT03693248|Antimitotic Agents|antimitotic agents|mesh-ancestor
25019162|NCT03693248|Mitosis Modulators|mitosis modulators|mesh-ancestor
25019163|NCT03693248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019165|NCT03693222|Tramadol|tramadol|mesh-list
25019166|NCT03693222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25019167|NCT03693222|Narcotics|narcotics|mesh-ancestor
24582440|NCT00869752|Etoposide|etoposide|mesh-list
25019185|NCT03693183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019189|NCT03693131|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
25019190|NCT03693131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25019191|NCT03693131|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25019192|NCT03693066|Chlorhexidine|chlorhexidine|mesh-list
24540674|NCT00668967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540676|NCT00669149|Aspirin|aspirin|mesh-list
25690794|NCT01977794|Amlodipine|amlodipine|mesh-list
25690795|NCT01977794|Bisoprolol|bisoprolol|mesh-list
25690796|NCT01977794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25690797|NCT01977794|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25690798|NCT01977794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25692666|NCT02003573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904315|NCT04356508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24904316|NCT04356508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25064198|NCT03462329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25064199|NCT03462329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25064200|NCT03462212|Paclitaxel|paclitaxel|mesh-list
25064201|NCT03462212|Bevacizumab|bevacizumab|mesh-list
25064202|NCT03462212|Carboplatin|carboplatin|mesh-list
24540677|NCT00669149|Heparin|heparin|mesh-list
24540678|NCT00669149|Enoxaparin|enoxaparin|mesh-list
24540679|NCT00669149|Bivalirudin|bivalirudin|mesh-list
24540680|NCT00669149|Clopidogrel|clopidogrel|mesh-list
24540681|NCT00669149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25019195|NCT03693066|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25019196|NCT03693066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25019197|NCT03693066|Dermatologic Agents|dermatologic agents|mesh-ancestor
25019201|NCT03692819|Amoxicillin|amoxicillin|mesh-list
25019202|NCT03692819|Metronidazole|metronidazole|mesh-list
25019203|NCT03692819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25019204|NCT03692819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25019205|NCT03692819|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25019206|NCT03692819|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25019207|NCT03692754|Calcium, Dietary|calcium, dietary|mesh-list
25019208|NCT03692754|Dexamethasone|dexamethasone|mesh-list
25019209|NCT03692754|Atorvastatin|atorvastatin|mesh-list
25019211|NCT03692754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25019212|NCT03692754|Antiemetics|antiemetics|mesh-ancestor
25019213|NCT03692754|Autonomic Agents|autonomic agents|mesh-ancestor
25019214|NCT03692754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25019215|NCT03692754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019216|NCT03692754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25019217|NCT03692754|Glucocorticoids|glucocorticoids|mesh-ancestor
25019218|NCT03692754|Hormones|hormones|mesh-ancestor
25019221|NCT03692754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019222|NCT03692754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25019223|NCT03692754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24582496|NCT00870038|Paclitaxel|paclitaxel|mesh-list
24540682|NCT00669149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24540690|NCT00669149|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24540691|NCT00669149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540692|NCT00669149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24540693|NCT00669149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25019294|NCT03692065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019295|NCT03692065|Anticoagulants|anticoagulants|mesh-ancestor
25690799|NCT01977794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690800|NCT01977794|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25690801|NCT01977794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690802|NCT01977794|Vasodilator Agents|vasodilator agents|mesh-ancestor
25690803|NCT01977794|Sympatholytics|sympatholytics|mesh-ancestor
25690804|NCT01977794|Autonomic Agents|autonomic agents|mesh-ancestor
25690805|NCT01977794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24530836|NCT00632645|Tetrabenazine|tetrabenazine|mesh-list
24531866|NCT00637468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25019297|NCT03692026|Hyaluronic Acid|hyaluronic acid|mesh-list
24904468|NCT04355637|Hormones|hormones|mesh-ancestor
25019298|NCT03692026|Antioxidants|antioxidants|mesh-ancestor
24982874|NCT00379288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24540768|NCT00669643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25019364|NCT03691688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25019303|NCT03692026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25019304|NCT03692026|Immunologic Factors|immunologic factors|mesh-ancestor
25019305|NCT03692026|Viscosupplements|viscosupplements|mesh-ancestor
25019306|NCT03692013|Losartan|losartan|mesh-list
25013703|NCT05223244|Hormones|hormones|mesh-ancestor
25019307|NCT03692013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25019308|NCT03692013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25019309|NCT03692013|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25019310|NCT03692013|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25019311|NCT03692013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019312|NCT03691935|Ropivacaine|ropivacaine|mesh-list
25019313|NCT03691935|Anesthetics|anesthetics|mesh-list
25019314|NCT03691935|Anesthetics, Local|anesthetics, local|mesh-ancestor
25019338|NCT03691922|Respiratory System Agents|respiratory system agents|mesh-ancestor
24540769|NCT00669643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24406550|NCT00170768|Oxybutynin|oxybutynin|mesh-list
24540775|NCT00669643|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25019340|NCT03691922|Sympathomimetics|sympathomimetics|mesh-ancestor
25019341|NCT03691922|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25019342|NCT03691896|Cholecalciferol|cholecalciferol|mesh-list
25019343|NCT03691896|Vitamin D|vitamin d|mesh-list
25019344|NCT03691896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25019345|NCT03691896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019346|NCT03691896|Vitamins|vitamins|mesh-ancestor
25019347|NCT03691896|Micronutrients|micronutrients|mesh-ancestor
25019348|NCT03691896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25019349|NCT03691818|Ibuprofen|ibuprofen|mesh-list
25019350|NCT03691818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25019351|NCT03691818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25019352|NCT03691818|Analgesics|analgesics|mesh-ancestor
25019353|NCT03691818|Sensory System Agents|sensory system agents|mesh-ancestor
25019354|NCT03691818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25019355|NCT03691818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019356|NCT03691818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25019357|NCT03691818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25019358|NCT03691818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25019359|NCT03691818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25019360|NCT03691818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019361|NCT03691688|Aspirin|aspirin|mesh-list
25019362|NCT03691688|Clopidogrel|clopidogrel|mesh-list
25019363|NCT03691688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25019365|NCT03691688|Analgesics|analgesics|mesh-ancestor
25692667|NCT02003573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692668|NCT02003625|Meloxicam|meloxicam|mesh-list
25692669|NCT02003625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25692670|NCT02003625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25692671|NCT02003625|Analgesics|analgesics|mesh-ancestor
25692672|NCT02003625|Sensory System Agents|sensory system agents|mesh-ancestor
25692673|NCT02003625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25692674|NCT02003625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692675|NCT02003625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25692676|NCT02003625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25692677|NCT02003625|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25692678|NCT02003625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25692679|NCT02003625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692680|NCT02003625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692681|NCT02003638|Niacin|niacin|mesh-list
24904547|NCT04355026|Bromhexine|bromhexine|mesh-list
24904558|NCT04355052|Hydroxychloroquine|hydroxychloroquine|mesh-list
24904559|NCT04355052|Camostat|camostat|mesh-list
24904560|NCT04355052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24904561|NCT04355052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24904562|NCT04355052|Antimalarials|antimalarials|mesh-ancestor
24904563|NCT04355052|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24904571|NCT04354961|Paclitaxel|paclitaxel|mesh-list
24904577|NCT04354961|Mitosis Modulators|mitosis modulators|mesh-ancestor
25019378|NCT03691688|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25019379|NCT03691688|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25019381|NCT03691688|Purinergic Agents|purinergic agents|mesh-ancestor
25019382|NCT03691688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25019384|NCT03691662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25019385|NCT03691662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24540783|NCT00669656|Cholecalciferol|cholecalciferol|mesh-list
24540784|NCT00669656|Vitamins|vitamins|mesh-list
24540785|NCT00669656|Vitamin E|vitamin e|mesh-list
24540786|NCT00669656|Tocopherols|tocopherols|mesh-list
24540787|NCT00669656|alpha-Tocopherol|alpha-tocopherol|mesh-list
24540788|NCT00669656|Selenium|selenium|mesh-list
24540789|NCT00669656|Lycopene|lycopene|mesh-list
24540790|NCT00669656|Daidzein|daidzein|mesh-list
24540791|NCT00669656|Micronutrients|micronutrients|mesh-ancestor
24541076|NCT00670722|Insulin Detemir|insulin detemir|mesh-list
25019386|NCT03691662|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25019387|NCT03691662|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25019389|NCT03691662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25019390|NCT03691662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019391|NCT03691662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019392|NCT03691662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25019393|NCT03691662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25019395|NCT03691649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25019396|NCT03691649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25019397|NCT03691649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25019398|NCT03691649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25019399|NCT03691649|Adrenergic Agents|adrenergic agents|mesh-ancestor
25019400|NCT03691649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25019401|NCT03691649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019402|NCT03691649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019403|NCT03691649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25019404|NCT03691649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25019405|NCT03691636|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25019486|NCT03691038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25019487|NCT03691038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019488|NCT03691038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25019489|NCT03691038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25019490|NCT03691038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25019491|NCT03691038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25019492|NCT03691038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24975972|NCT02274662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24975973|NCT02274662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975974|NCT02274662|Antifungal Agents|antifungal agents|mesh-ancestor
24975975|NCT02274662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24975976|NCT02274662|Dermatologic Agents|dermatologic agents|mesh-ancestor
24975977|NCT02274662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24975978|NCT02243878|Ranibizumab|ranibizumab|mesh-list
24975979|NCT02243878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24975980|NCT02243878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24975981|NCT02243878|Growth Substances|growth substances|mesh-ancestor
24975982|NCT02243878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975983|NCT02243878|Growth Inhibitors|growth inhibitors|mesh-ancestor
24975984|NCT02243878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019493|NCT03690947|Ranibizumab|ranibizumab|mesh-list
25019494|NCT03690947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25019500|NCT03690778|Metformin|metformin|mesh-list
25690806|NCT01977794|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25690807|NCT01977794|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25690808|NCT01977794|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25690809|NCT01977794|Adrenergic Agents|adrenergic agents|mesh-ancestor
25690810|NCT01977794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25690811|NCT01977898|Morphine|morphine|mesh-list
25690812|NCT01977898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25690813|NCT01977898|Narcotics|narcotics|mesh-ancestor
25690814|NCT01977898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24544138|NCT00687388|Adrenergic Agents|adrenergic agents|mesh-ancestor
24445038|NCT00300118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064229|NCT03461718|Sensory System Agents|sensory system agents|mesh-ancestor
25690815|NCT01977898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690816|NCT01977898|Analgesics|analgesics|mesh-ancestor
25690817|NCT01977898|Sensory System Agents|sensory system agents|mesh-ancestor
25690818|NCT01977898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25064230|NCT03461718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25064231|NCT03461718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064232|NCT03461718|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25064233|NCT03461718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25064235|NCT03461718|Anesthetics|anesthetics|mesh-ancestor
25019543|NCT03690622|Sensory System Agents|sensory system agents|mesh-ancestor
25019544|NCT03690622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25019545|NCT03690622|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25019546|NCT03690622|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25019547|NCT03690622|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25019548|NCT03690622|Adrenergic Agents|adrenergic agents|mesh-ancestor
25019549|NCT03690622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25019550|NCT03690622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019551|NCT03690583|Zinc|zinc|mesh-list
25019552|NCT03690583|Zinc Sulfate|zinc sulfate|mesh-list
25019553|NCT03690583|Trace Elements|trace elements|mesh-ancestor
25019554|NCT03690583|Micronutrients|micronutrients|mesh-ancestor
25019555|NCT03690583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019556|NCT03690583|Astringents|astringents|mesh-ancestor
25019557|NCT03690583|Dermatologic Agents|dermatologic agents|mesh-ancestor
25019558|NCT03690414|Atropine|atropine|mesh-list
25019560|NCT03690414|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25019561|NCT03690414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25019562|NCT03690414|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25019563|NCT03690414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25019564|NCT03690414|Autonomic Agents|autonomic agents|mesh-ancestor
25019565|NCT03690414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24540792|NCT00669656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540901|NCT00669890|Alkylating Agents|alkylating agents|mesh-ancestor
24540902|NCT00669890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540903|NCT00669890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019605|NCT03689998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019606|NCT03689998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25019607|NCT03689972|Natalizumab|natalizumab|mesh-list
25019608|NCT03689972|Immunologic Factors|immunologic factors|mesh-ancestor
25019609|NCT03689972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019610|NCT03689894|Rituximab|rituximab|mesh-list
25019611|NCT03689894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25019652|NCT03689114|Sensory System Agents|sensory system agents|mesh-ancestor
25019653|NCT03689114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25019654|NCT03689114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019655|NCT03689114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25019656|NCT03689114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25690819|NCT01977937|Gabapentin|gabapentin|mesh-list
25690820|NCT01977937|Analgesics|analgesics|mesh-ancestor
25690821|NCT01977937|Sensory System Agents|sensory system agents|mesh-ancestor
25690822|NCT01977937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25690823|NCT01977937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690824|NCT01977937|Anticonvulsants|anticonvulsants|mesh-ancestor
25690825|NCT01977937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25690826|NCT01977937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25690827|NCT01977937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25690828|NCT01977937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24904834|NCT04352686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24904835|NCT04352686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856074|NCT02282683|Glucocorticoids|glucocorticoids|mesh-ancestor
25019657|NCT03689114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25019658|NCT03689114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25019662|NCT03689114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019663|NCT03689114|Antimanic Agents|antimanic agents|mesh-ancestor
25019664|NCT03689114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25019665|NCT03689114|Nootropic Agents|nootropic agents|mesh-ancestor
25019666|NCT03689114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25019667|NCT03689114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25019668|NCT03689114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25019669|NCT03689114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25019670|NCT03689114|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25019671|NCT03689114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25019672|NCT03689114|GABA Agents|gaba agents|mesh-ancestor
25019673|NCT03689114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25019674|NCT03689114|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25019675|NCT03689114|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25019676|NCT03689114|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25019698|NCT03688971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24401754|NCT00153972|Levodopa|levodopa|mesh-list
25019701|NCT03688958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25019702|NCT03688958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25019703|NCT03688958|Trace Elements|trace elements|mesh-ancestor
25019704|NCT03688958|Micronutrients|micronutrients|mesh-ancestor
25019705|NCT03688958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019716|NCT03688568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019717|NCT03688568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25019719|NCT03688568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019720|NCT03688464|Diphenhydramine|diphenhydramine|mesh-list
25019721|NCT03688464|Promethazine|promethazine|mesh-list
25019722|NCT03688464|Melatonin|melatonin|mesh-list
25019723|NCT03688464|Antioxidants|antioxidants|mesh-ancestor
25019724|NCT03688464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019725|NCT03688464|Protective Agents|protective agents|mesh-ancestor
25019726|NCT03688464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019727|NCT03688464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25019760|NCT03688269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976321|NCT04154800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24976322|NCT04154800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24976323|NCT04154800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540958|NCT00670293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24540959|NCT00670293|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24540960|NCT00670319|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
24540961|NCT00670319|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24540962|NCT00670319|Hormone Antagonists|hormone antagonists|mesh-ancestor
24540963|NCT00670319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24540964|NCT00670319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540965|NCT00670319|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24540966|NCT00670319|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25111441|NCT04823065|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25111442|NCT04823065|Antiemetics|antiemetics|mesh-ancestor
25111443|NCT04823065|Autonomic Agents|autonomic agents|mesh-ancestor
25111444|NCT04823065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25111445|NCT04823065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25111446|NCT04823065|Mydriatics|mydriatics|mesh-ancestor
24795822|NCT01946373|Interleukin-2|interleukin-2|mesh-list
24541074|NCT00670722|Insulin, Long-Acting|insulin, long-acting|mesh-list
24541075|NCT00670722|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24541105|NCT00670813|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24541106|NCT00670813|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24541107|NCT00670813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541109|NCT00670878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24541110|NCT00670878|Antimetabolites|antimetabolites|mesh-ancestor
25019806|NCT03687606|Menotropins|menotropins|mesh-list
25690829|NCT01977937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25690830|NCT01977937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25692682|NCT02003638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25690831|NCT01977937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25690832|NCT01977937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690833|NCT01977937|Antimanic Agents|antimanic agents|mesh-ancestor
25690834|NCT01978093|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25690835|NCT01978093|Immunologic Factors|immunologic factors|mesh-ancestor
25690836|NCT01978093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690837|NCT01978184|Gemcitabine|gemcitabine|mesh-list
25019807|NCT03687606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25019808|NCT03687606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019809|NCT03687606|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25019810|NCT03687606|Fertility Agents|fertility agents|mesh-ancestor
25019811|NCT03687515|Prednisone|prednisone|mesh-list
25019812|NCT03687515|Budesonide|budesonide|mesh-list
25019813|NCT03687515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25019814|NCT03687515|Glucocorticoids|glucocorticoids|mesh-ancestor
25019815|NCT03687515|Hormones|hormones|mesh-ancestor
25019816|NCT03687515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25019817|NCT03687515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019818|NCT03687515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25019819|NCT03687515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019820|NCT03687515|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25019821|NCT03687515|Autonomic Agents|autonomic agents|mesh-ancestor
25019822|NCT03687515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25019823|NCT03687515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25019824|NCT03687515|Respiratory System Agents|respiratory system agents|mesh-ancestor
25019825|NCT03687463|Decitabine|decitabine|mesh-list
25019840|NCT03687255|Enmetazobactam|enmetazobactam|mesh-list
25019843|NCT03687255|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25019844|NCT03687255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25019846|NCT03687229|Insulin|insulin|mesh-list
25019869|NCT03686787|Tranexamic Acid|tranexamic acid|mesh-list
25019870|NCT03686787|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25019871|NCT03686787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25019872|NCT03686787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019873|NCT03686787|Hemostatics|hemostatics|mesh-ancestor
25019874|NCT03686787|Coagulants|coagulants|mesh-ancestor
25019875|NCT03686774|Memantine|memantine|mesh-list
25019876|NCT03686774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25019877|NCT03686774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25019878|NCT03686774|Dopamine Agents|dopamine agents|mesh-ancestor
25019879|NCT03686774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25019880|NCT03686774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019881|NCT03686774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019882|NCT03686774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25019883|NCT03686774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25019884|NCT03686722|Metformin|metformin|mesh-list
24583270|NCT00873886|Oseltamivir|oseltamivir|mesh-list
25019899|NCT03686657|Valsartan|valsartan|mesh-list
25019900|NCT03686657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25019901|NCT03686657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019902|NCT03686657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25019903|NCT03686657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25019904|NCT03686657|Analgesics|analgesics|mesh-ancestor
25019905|NCT03686657|Sensory System Agents|sensory system agents|mesh-ancestor
25019906|NCT03686657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25019907|NCT03686657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25019908|NCT03686657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25019909|NCT03686657|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24541254|NCT00671645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24541255|NCT00671645|Antimetabolites|antimetabolites|mesh-ancestor
24541256|NCT00671645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541258|NCT00671697|Arsenic Trioxide|arsenic trioxide|mesh-list
24541259|NCT00671697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25019977|NCT03685084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25019978|NCT03685084|Antitubercular Agents|antitubercular agents|mesh-ancestor
25019979|NCT03685084|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25019980|NCT03685084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25019981|NCT03685084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690838|NCT01978184|Hydroxychloroquine|hydroxychloroquine|mesh-list
25019983|NCT03685032|Ondansetron|ondansetron|mesh-list
25019984|NCT03685032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25019985|NCT03685032|Antiemetics|antiemetics|mesh-ancestor
25019986|NCT03685032|Autonomic Agents|autonomic agents|mesh-ancestor
25019987|NCT03685032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24458062|NCT00336414|Cyclophosphamide|cyclophosphamide|mesh-list
25019988|NCT03685032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019989|NCT03685032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25019990|NCT03685032|Glucocorticoids|glucocorticoids|mesh-ancestor
25019991|NCT03685032|Hormones|hormones|mesh-ancestor
25019992|NCT03685032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25019993|NCT03685032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25019994|NCT03685032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25019995|NCT03685032|Antipruritics|antipruritics|mesh-ancestor
24976584|NCT03164655|Protective Agents|protective agents|mesh-ancestor
24976585|NCT03164655|Vitamin B Complex|vitamin b complex|mesh-ancestor
24976586|NCT03164655|Vitamins|vitamins|mesh-ancestor
24976587|NCT03164655|Micronutrients|micronutrients|mesh-ancestor
24583368|NCT00874315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24587041|NCT00893256|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24587042|NCT00893256|Serotonin Agents|serotonin agents|mesh-ancestor
24587043|NCT00893256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24587052|NCT00893256|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24587053|NCT00893256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24587054|NCT00893256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24587055|NCT00893256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24587056|NCT00893256|Antidepressive Agents|antidepressive agents|mesh-ancestor
24587057|NCT00893269|Zolpidem|zolpidem|mesh-list
24587058|NCT00893269|Eszopiclone|eszopiclone|mesh-list
24587059|NCT00893269|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24587060|NCT00893269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24587061|NCT00893269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24587062|NCT00893269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587063|NCT00893269|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24587064|NCT00893269|GABA Agonists|gaba agonists|mesh-ancestor
24587065|NCT00893269|GABA Agents|gaba agents|mesh-ancestor
24587066|NCT00893269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24587067|NCT00893269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587068|NCT00893373|Sorafenib|sorafenib|mesh-list
24587069|NCT00893373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587070|NCT00893373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24587071|NCT00893373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587072|NCT00893373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587073|NCT00893399|Gemtuzumab|gemtuzumab|mesh-list
24587074|NCT00893399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24587075|NCT00893399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587076|NCT00893412|Tramadol|tramadol|mesh-list
24587077|NCT00893412|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24587078|NCT00893412|Narcotics|narcotics|mesh-ancestor
24587079|NCT00893412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24587080|NCT00893412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020005|NCT03685032|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25020006|NCT03684993|Chlorhexidine|chlorhexidine|mesh-list
25020008|NCT03684993|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25020009|NCT03684993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25020010|NCT03684993|Disinfectants|disinfectants|mesh-ancestor
25020011|NCT03684993|Dermatologic Agents|dermatologic agents|mesh-ancestor
25020012|NCT03684876|Diuretics|diuretics|mesh-list
25020013|NCT03684876|Natriuretic Agents|natriuretic agents|mesh-ancestor
25020014|NCT03684876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020015|NCT03684863|Capecitabine|capecitabine|mesh-list
24458064|NCT00336414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24458065|NCT00336414|Immunologic Factors|immunologic factors|mesh-ancestor
24402582|NCT00157872|Gout Suppressants|gout suppressants|mesh-ancestor
25020016|NCT03684863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25020017|NCT03684863|Antimetabolites|antimetabolites|mesh-ancestor
25020018|NCT03684863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020019|NCT03684863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25020020|NCT03684837|Vitamin D|vitamin d|mesh-list
25020021|NCT03684837|Vitamins|vitamins|mesh-ancestor
25020026|NCT03684824|Luteolytic Agents|luteolytic agents|mesh-ancestor
25020027|NCT03684824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25020028|NCT03684824|Contraceptive Agents|contraceptive agents|mesh-ancestor
25020029|NCT03684824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25020030|NCT03684824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020031|NCT03684824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25020032|NCT03684824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25020033|NCT03684824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25020035|NCT03684772|Furosemide|furosemide|mesh-list
25020036|NCT03684772|Diuretics|diuretics|mesh-ancestor
25020037|NCT03684772|Natriuretic Agents|natriuretic agents|mesh-ancestor
25020038|NCT03684772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020039|NCT03684772|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25020040|NCT03684772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25020041|NCT03684772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020042|NCT03684772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25020043|NCT03684772|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25020044|NCT03684772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25020045|NCT03684772|Protective Agents|protective agents|mesh-ancestor
25020054|NCT03684564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25020072|NCT03684395|Apixaban|apixaban|mesh-list
25020073|NCT03684395|Anticoagulants|anticoagulants|mesh-ancestor
25020074|NCT03684395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25020075|NCT03684395|Antithrombins|antithrombins|mesh-ancestor
25020076|NCT03684395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25020077|NCT03684395|Protease Inhibitors|protease inhibitors|mesh-ancestor
25020078|NCT03684395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25111455|NCT04814875|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25111456|NCT04814875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25111457|NCT04814875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25111458|NCT04814875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25111459|NCT04814875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25111460|NCT04814875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25020080|NCT03684330|Vitamin D|vitamin d|mesh-list
25020081|NCT03684330|Vitamins|vitamins|mesh-ancestor
25020082|NCT03684330|Micronutrients|micronutrients|mesh-ancestor
25020083|NCT03684330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020084|NCT03684330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25020085|NCT03683914|Dinoprostone|dinoprostone|mesh-list
25020086|NCT03683914|Oxytocics|oxytocics|mesh-ancestor
25020087|NCT03683914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25020088|NCT03683914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020093|NCT03683667|Azithromycin|azithromycin|mesh-list
25020094|NCT03683667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25020095|NCT03683667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25020096|NCT03683563|Citric Acid|citric acid|mesh-list
25020097|NCT03683563|Sodium Citrate|sodium citrate|mesh-list
24976675|NCT05275777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25020157|NCT03682952|Alprostadil|alprostadil|mesh-list
25020158|NCT03682952|Beraprost|beraprost|mesh-list
25020159|NCT03682952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25020160|NCT03682952|Vasodilator Agents|vasodilator agents|mesh-ancestor
25020161|NCT03682952|Urological Agents|urological agents|mesh-ancestor
25020162|NCT03682939|Vaccines|vaccines|mesh-list
25020163|NCT03682939|Immunologic Factors|immunologic factors|mesh-ancestor
25020179|NCT03682653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25020181|NCT03682640|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25020182|NCT03682640|Insulin Lispro|insulin lispro|mesh-list
25020183|NCT03682640|Azithromycin|azithromycin|mesh-list
25020184|NCT03682640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25020185|NCT03682640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020186|NCT03682640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25020187|NCT03682640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25111461|NCT04814875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794230|NCT05356936|Vitamins|vitamins|mesh-list
25111470|NCT04809766|Cyclophosphamide|cyclophosphamide|mesh-list
25111471|NCT04809766|Fludarabine|fludarabine|mesh-list
24474689|NCT00407017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25020192|NCT03682497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020193|NCT03682497|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25020195|NCT03682497|Natriuretic Agents|natriuretic agents|mesh-ancestor
25020196|NCT03682471|Deoxycholic Acid|deoxycholic acid|mesh-list
25020197|NCT03682471|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25020198|NCT03682471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25020199|NCT03682276|Nivolumab|nivolumab|mesh-list
24944689|NCT03958123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25020200|NCT03682276|Ipilimumab|ipilimumab|mesh-list
24784480|NCT01908257|Renal Agents|renal agents|mesh-ancestor
25020210|NCT03682211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020211|NCT03682211|Analgesics|analgesics|mesh-ancestor
25020212|NCT03682211|Sensory System Agents|sensory system agents|mesh-ancestor
25020213|NCT03682211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25020214|NCT03682211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25020215|NCT03682211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25020216|NCT03682211|Anesthetics, General|anesthetics, general|mesh-ancestor
25020217|NCT03682211|Anesthetics|anesthetics|mesh-ancestor
24806068|NCT02013453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020265|NCT03681639|Chromium|chromium|mesh-list
25020266|NCT03681639|Trace Elements|trace elements|mesh-ancestor
25020267|NCT03681639|Micronutrients|micronutrients|mesh-ancestor
25020268|NCT03681639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020269|NCT03681613|Pyrantel|pyrantel|mesh-list
24541439|NCT00672776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020271|NCT03681613|Antinematodal Agents|antinematodal agents|mesh-ancestor
25020272|NCT03681613|Anthelmintics|anthelmintics|mesh-ancestor
25020273|NCT03681613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25020274|NCT03681613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25020275|NCT03681613|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
25020276|NCT03681613|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25020277|NCT03681613|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25020278|NCT03681613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25020279|NCT03681613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541556|NCT00673621|Miotics|miotics|mesh-ancestor
24541557|NCT00673621|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25064300|NCT03461302|Keratolytic Agents|keratolytic agents|mesh-ancestor
25064301|NCT03461302|Dermatologic Agents|dermatologic agents|mesh-ancestor
25064302|NCT03461185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
24541584|NCT00674050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24541585|NCT00674050|Autonomic Agents|autonomic agents|mesh-ancestor
24541586|NCT00674050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24541587|NCT00674050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24541588|NCT00674050|Respiratory System Agents|respiratory system agents|mesh-ancestor
25020289|NCT03681548|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25020292|NCT03681548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020293|NCT03681509|Pramipexole|pramipexole|mesh-list
25020294|NCT03681509|Antioxidants|antioxidants|mesh-ancestor
25020295|NCT03681509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690839|NCT01978184|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25690840|NCT01978184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25690841|NCT01978184|Antimetabolites|antimetabolites|mesh-ancestor
25690842|NCT01978184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690843|NCT01978184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25690844|NCT01978184|Antiviral Agents|antiviral agents|mesh-ancestor
25690845|NCT01978184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25020313|NCT03681431|Ceftriaxone|ceftriaxone|mesh-list
25020314|NCT03681431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25020315|NCT03681431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25020316|NCT03681275|Tofacitinib|tofacitinib|mesh-list
24541904|NCT00675714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24541905|NCT00675740|Rosiglitazone|rosiglitazone|mesh-list
24541906|NCT00675740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24541907|NCT00675740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541909|NCT00675779|Contraceptive Agents|contraceptive agents|mesh-list
24541910|NCT00675779|Contraceptives, Oral|contraceptives, oral|mesh-list
24541911|NCT00675779|Dacuronium|dacuronium|mesh-list
24541912|NCT00675779|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24541913|NCT00675779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24541914|NCT00675779|Antimetabolites|antimetabolites|mesh-ancestor
25020317|NCT03681275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25020318|NCT03681275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25020319|NCT03681275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020320|NCT03681197|Metformin|metformin|mesh-list
25020321|NCT03681197|Clomiphene|clomiphene|mesh-list
24541946|NCT00676039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690846|NCT01978184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25690847|NCT01978184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25690848|NCT01978184|Immunologic Factors|immunologic factors|mesh-ancestor
25690849|NCT01978184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690850|NCT01978184|Antimalarials|antimalarials|mesh-ancestor
25690851|NCT01978184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25690852|NCT01978184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25690853|NCT01978184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24905475|NCT04347512|Azithromycin|azithromycin|mesh-list
24905488|NCT04347252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24905489|NCT04347252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905490|NCT04346901|Methimazole|methimazole|mesh-list
24905491|NCT04346901|Antithyroid Agents|antithyroid agents|mesh-ancestor
24905492|NCT04346901|Hormone Antagonists|hormone antagonists|mesh-ancestor
24905493|NCT04346901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24905494|NCT04346901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905495|NCT04347031|Azithromycin|azithromycin|mesh-list
24905496|NCT04347031|Hydroxychloroquine|hydroxychloroquine|mesh-list
24905498|NCT04347031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24905499|NCT04347031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905500|NCT04347031|Antimalarials|antimalarials|mesh-ancestor
24905501|NCT04347031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24905502|NCT04347031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24905503|NCT04347031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905505|NCT04347031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24542008|NCT00676416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784495|NCT01908296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24795883|NCT01946555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24983472|NCT05186194|Calcium|calcium|mesh-list
24983473|NCT05186194|Vitamins|vitamins|mesh-ancestor
24983474|NCT05186194|Micronutrients|micronutrients|mesh-ancestor
24983475|NCT05186194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983476|NCT05186194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25020328|NCT03681197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25020329|NCT03681197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25020330|NCT03681197|Fertility Agents|fertility agents|mesh-ancestor
25020331|NCT03681197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25020332|NCT03681197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25020333|NCT03681197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25020335|NCT03680976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25020336|NCT03680885|Lidocaine|lidocaine|mesh-list
25020337|NCT03680885|Anesthetics, Local|anesthetics, local|mesh-ancestor
25020338|NCT03680885|Anesthetics|anesthetics|mesh-ancestor
25020339|NCT03680885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25020340|NCT03680885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020341|NCT03680885|Sensory System Agents|sensory system agents|mesh-ancestor
25020342|NCT03680885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25020343|NCT03680885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25020344|NCT03680885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25020345|NCT03680885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25020346|NCT03680885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25020347|NCT03680885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690854|NCT01978236|Trametinib|trametinib|mesh-list
25690855|NCT01978236|Dabrafenib|dabrafenib|mesh-list
25690856|NCT01978236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25690857|NCT01978236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25690858|NCT01978236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25690859|NCT01978236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690860|NCT01978600|Timolol|timolol|mesh-list
25690861|NCT01978600|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25690862|NCT01978600|Brinzolamide|brinzolamide|mesh-list
25690863|NCT01978600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25690864|NCT01978600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25690865|NCT01978600|Adrenergic Agents|adrenergic agents|mesh-ancestor
25690866|NCT01978600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25690867|NCT01978600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690868|NCT01978600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690869|NCT01978600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25690870|NCT01978600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25690871|NCT01978600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542245|NCT00677755|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24542247|NCT00677755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24542248|NCT00677755|Contraceptive Agents|contraceptive agents|mesh-ancestor
24542249|NCT00677755|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24542404|NCT00678522|Atorvastatin|atorvastatin|mesh-list
25020351|NCT03680716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25020352|NCT03680716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020353|NCT03680716|Sensory System Agents|sensory system agents|mesh-ancestor
24542408|NCT00678522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542765|NCT00680329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24542767|NCT00680329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24542839|NCT00680511|Methamphetamine|methamphetamine|mesh-list
24542974|NCT00681213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24542984|NCT00681226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24542986|NCT00681343|Thymoglobulin|thymoglobulin|mesh-list
24542988|NCT00681343|Immunologic Factors|immunologic factors|mesh-ancestor
24542989|NCT00681343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543011|NCT00681525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24543012|NCT00681525|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24543013|NCT00681525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543014|NCT00681603|Bevacizumab|bevacizumab|mesh-list
24543015|NCT00681603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24543016|NCT00681603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543017|NCT00681603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24976904|NCT04893915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24976906|NCT04817189|Ondansetron|ondansetron|mesh-list
24976907|NCT04817189|Palonosetron|palonosetron|mesh-list
24976908|NCT04817189|Granisetron|granisetron|mesh-list
24976909|NCT04817189|Tropisetron|tropisetron|mesh-list
24976910|NCT04817189|Dolasetron|dolasetron|mesh-list
24976911|NCT04817189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24976912|NCT04817189|Antiemetics|antiemetics|mesh-ancestor
24543029|NCT00681720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543031|NCT00681733|Pentoxifylline|pentoxifylline|mesh-list
24543032|NCT00681733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24543033|NCT00681733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543034|NCT00681733|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25690872|NCT01978600|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25690873|NCT01978600|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25690874|NCT01978600|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25690875|NCT01978600|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25690876|NCT01978743|Raltegravir Potassium|raltegravir potassium|mesh-list
25690877|NCT01978743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25690878|NCT01978743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24905631|NCT04346095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543035|NCT00681733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702577|NCT01466543|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24418854|NCT00210379|Rituximab|rituximab|mesh-list
24702578|NCT01466543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702580|NCT01466608|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24543159|NCT00682136|Anesthetics, Local|anesthetics, local|mesh-ancestor
24543362|NCT00683306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24543363|NCT00683306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543364|NCT00683306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543366|NCT00683319|Carboplatin|carboplatin|mesh-list
24543386|NCT00683319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24543387|NCT00683319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24976916|NCT04817189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24976917|NCT04817189|Glucocorticoids|glucocorticoids|mesh-ancestor
24976918|NCT04817189|Hormones|hormones|mesh-ancestor
24976919|NCT04817189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24976920|NCT04817189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24976922|NCT04817189|Antipruritics|antipruritics|mesh-ancestor
25020383|NCT03680573|Gout Suppressants|gout suppressants|mesh-ancestor
25020384|NCT03680573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25020385|NCT03680573|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25020386|NCT03680573|Antioxidants|antioxidants|mesh-ancestor
25020387|NCT03680573|Protective Agents|protective agents|mesh-ancestor
25020388|NCT03680573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020389|NCT03680573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25020390|NCT03680573|Vasodilator Agents|vasodilator agents|mesh-ancestor
24543408|NCT00683514|Vinorelbine|vinorelbine|mesh-list
24543409|NCT00683514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543410|NCT00683514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24543411|NCT00683514|Tubulin Modulators|tubulin modulators|mesh-ancestor
24543412|NCT00683514|Antimitotic Agents|antimitotic agents|mesh-ancestor
24543413|NCT00683514|Mitosis Modulators|mitosis modulators|mesh-ancestor
24543414|NCT00683514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543415|NCT00683670|Cyclophosphamide|cyclophosphamide|mesh-list
24543416|NCT00683670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24543438|NCT00683865|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24543439|NCT00683865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24543440|NCT00683865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24543441|NCT00683865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24543535|NCT00684164|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24543558|NCT00684216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543559|NCT00684216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543560|NCT00684216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24543566|NCT00684216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543567|NCT00684216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24543568|NCT00684216|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25020394|NCT03680560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25020416|NCT03680495|Protective Agents|protective agents|mesh-ancestor
25020417|NCT03680495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25020418|NCT03680495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25020419|NCT03680404|Allopurinol|allopurinol|mesh-list
24983531|NCT05184530|Evolocumab|evolocumab|mesh-list
25690879|NCT01978743|Antiviral Agents|antiviral agents|mesh-ancestor
25690880|NCT01978743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25690881|NCT01978743|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25690882|NCT01978743|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25690883|NCT01978743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25690884|NCT01978743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690885|NCT01979016|Emollients|emollients|mesh-list
25690886|NCT01979016|Dermatologic Agents|dermatologic agents|mesh-ancestor
25690887|NCT01979185|Simvastatin|simvastatin|mesh-list
25690888|NCT01979185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25690889|NCT01979185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25690890|NCT01979185|Antimetabolites|antimetabolites|mesh-ancestor
25690891|NCT01979185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543569|NCT00684216|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24543570|NCT00684216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24543571|NCT00684229|Anesthetics|anesthetics|mesh-list
24543574|NCT00684268|Silybin|silybin|mesh-list
24543575|NCT00684268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24543576|NCT00684268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543577|NCT00684268|Protective Agents|protective agents|mesh-ancestor
24543578|NCT00684268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543579|NCT00684346|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24543580|NCT00684346|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24543581|NCT00684346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543582|NCT00684372|Leflunomide|leflunomide|mesh-list
24543629|NCT00684632|Anesthetics, General|anesthetics, general|mesh-ancestor
24543630|NCT00684632|Anesthetics|anesthetics|mesh-ancestor
24543632|NCT00684827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24543633|NCT00684827|Autonomic Agents|autonomic agents|mesh-ancestor
24543634|NCT00684827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24543635|NCT00684827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543636|NCT00684827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24543637|NCT00684827|Respiratory System Agents|respiratory system agents|mesh-ancestor
24543638|NCT00684827|Tocolytic Agents|tocolytic agents|mesh-ancestor
24543639|NCT00684827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24543640|NCT00684827|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24543641|NCT00684827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24543642|NCT00684827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24543643|NCT00684827|Adrenergic Agents|adrenergic agents|mesh-ancestor
24543716|NCT00685100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24543717|NCT00685100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543719|NCT00685126|Albuterol|albuterol|mesh-list
24543748|NCT00685269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24543749|NCT00685269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446654|NCT00305552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24543751|NCT00685347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24543752|NCT00685347|Autonomic Agents|autonomic agents|mesh-ancestor
24543753|NCT00685347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24543754|NCT00685347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543755|NCT00685347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25020420|NCT03680404|Phenylephrine|phenylephrine|mesh-list
25020421|NCT03680404|Oxymetazoline|oxymetazoline|mesh-list
25020423|NCT03680404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25020424|NCT03680404|Mydriatics|mydriatics|mesh-ancestor
25020425|NCT03680404|Autonomic Agents|autonomic agents|mesh-ancestor
25020426|NCT03680404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25020427|NCT03680404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020428|NCT03680404|Sympathomimetics|sympathomimetics|mesh-ancestor
24754409|NCT01720459|Antioxidants|antioxidants|mesh-ancestor
25020429|NCT03680404|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25020430|NCT03680404|Nasal Decongestants|nasal decongestants|mesh-ancestor
25020438|NCT03680404|Protective Agents|protective agents|mesh-ancestor
25020440|NCT03680404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25020441|NCT03680404|Gout Suppressants|gout suppressants|mesh-ancestor
24983549|NCT05184465|Anesthetics|anesthetics|mesh-list
24543756|NCT00685347|Respiratory System Agents|respiratory system agents|mesh-ancestor
24543757|NCT00685347|Tocolytic Agents|tocolytic agents|mesh-ancestor
24543765|NCT00685425|Albuterol|albuterol|mesh-list
24543779|NCT00685425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543781|NCT00685464|Anticoagulants|anticoagulants|mesh-ancestor
24543894|NCT00685854|Growth Inhibitors|growth inhibitors|mesh-ancestor
24543895|NCT00685854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25690892|NCT01979185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25690893|NCT01979185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24543896|NCT00685906|Ticagrelor|ticagrelor|mesh-list
25690894|NCT01979185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25690895|NCT01979276|Dexamethasone|dexamethasone|mesh-list
25690896|NCT01979276|Pomalidomide|pomalidomide|mesh-list
25690897|NCT01979276|Romidepsin|romidepsin|mesh-list
25690898|NCT01979276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24447025|NCT00307203|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24543923|NCT00685906|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24543924|NCT00685958|Enoxaparin|enoxaparin|mesh-list
24543925|NCT00685958|Anticoagulants|anticoagulants|mesh-ancestor
24543926|NCT00685958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24543927|NCT00685958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24543928|NCT00685958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543929|NCT00685971|Cholecalciferol|cholecalciferol|mesh-list
24543930|NCT00685971|Vitamin D|vitamin d|mesh-list
24543931|NCT00685971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24447026|NCT00307203|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24447027|NCT00307203|Cholinergic Agents|cholinergic agents|mesh-ancestor
24702627|NCT01466959|Chelating Agents|chelating agents|mesh-ancestor
25020451|NCT03680339|Misoprostol|misoprostol|mesh-list
24543932|NCT00685971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543992|NCT00686322|Tubulin Modulators|tubulin modulators|mesh-ancestor
24543993|NCT00686322|Antimitotic Agents|antimitotic agents|mesh-ancestor
24543995|NCT00686322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020485|NCT03679546|Vedolizumab|vedolizumab|mesh-list
25020486|NCT03679546|Dermatologic Agents|dermatologic agents|mesh-ancestor
25020487|NCT03679546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25020488|NCT03679546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25020489|NCT03679481|Tranexamic Acid|tranexamic acid|mesh-list
25020490|NCT03679481|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25020491|NCT03679481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25020492|NCT03679481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020493|NCT03679481|Hemostatics|hemostatics|mesh-ancestor
25020494|NCT03679481|Coagulants|coagulants|mesh-ancestor
25020495|NCT03679455|Obinutuzumab|obinutuzumab|mesh-list
25020496|NCT03679455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25020497|NCT03679455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25020498|NCT03679442|Acetylcysteine|acetylcysteine|mesh-list
25020531|NCT03679182|Autonomic Agents|autonomic agents|mesh-ancestor
25020532|NCT03679182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25020533|NCT03679182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020534|NCT03679182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25020535|NCT03679182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25020536|NCT03679182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25020537|NCT03679182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24983569|NCT05184101|Heparin|heparin|mesh-list
24446662|NCT00305552|Growth Substances|growth substances|mesh-ancestor
24446663|NCT00305552|Growth Inhibitors|growth inhibitors|mesh-ancestor
24446664|NCT00305552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446665|NCT00305591|N-Methylaspartate|n-methylaspartate|mesh-list
24544402|NCT00688896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24544403|NCT00688896|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24544404|NCT00688896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25020561|NCT03679065|Protease Inhibitors|protease inhibitors|mesh-ancestor
25020562|NCT03679065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25020563|NCT03679065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020564|NCT03679065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25020566|NCT03679065|Sensory System Agents|sensory system agents|mesh-ancestor
25020567|NCT03679065|Antipyretics|antipyretics|mesh-ancestor
25020568|NCT03679052|Clonidine|clonidine|mesh-list
24545143|NCT00692055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545144|NCT00692120|Vitamin D|vitamin d|mesh-list
24545145|NCT00692120|Ergocalciferols|ergocalciferols|mesh-list
24545146|NCT00692120|Cholecalciferol|cholecalciferol|mesh-list
25020570|NCT03679052|Analgesics|analgesics|mesh-ancestor
25020571|NCT03679052|Sensory System Agents|sensory system agents|mesh-ancestor
25020572|NCT03679052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25020573|NCT03679052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020574|NCT03679052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25020575|NCT03679052|Sympatholytics|sympatholytics|mesh-ancestor
25020576|NCT03679052|Autonomic Agents|autonomic agents|mesh-ancestor
25020577|NCT03679052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25064386|NCT03460808|Antiviral Agents|antiviral agents|mesh-ancestor
25064387|NCT03460808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25064388|NCT03460808|Expectorants|expectorants|mesh-ancestor
24545275|NCT00692757|Povidone-Iodine|povidone-iodine|mesh-list
24545276|NCT00692757|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24545277|NCT00692757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24545279|NCT00692900|Oxaliplatin|oxaliplatin|mesh-list
24545280|NCT00692900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24545281|NCT00692900|Tubulin Modulators|tubulin modulators|mesh-ancestor
24545338|NCT00693069|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24545339|NCT00693069|Purinergic Agents|purinergic agents|mesh-ancestor
24545340|NCT00693069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24545341|NCT00693069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545342|NCT00693069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703042|NCT01469416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703507|NCT01472016|Docetaxel|docetaxel|mesh-list
24703508|NCT01472016|Cetuximab|cetuximab|mesh-list
24754388|NCT01720290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24754389|NCT01720290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545473|NCT00693446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24545474|NCT00693446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24545475|NCT00693446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24545476|NCT00693446|Antifungal Agents|antifungal agents|mesh-ancestor
24545489|NCT00693524|Immunologic Factors|immunologic factors|mesh-ancestor
25690899|NCT01979276|Antiemetics|antiemetics|mesh-ancestor
25690900|NCT01979276|Autonomic Agents|autonomic agents|mesh-ancestor
25690901|NCT01979276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24545534|NCT00693680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545535|NCT00693680|Adrenergic Agents|adrenergic agents|mesh-ancestor
24545536|NCT00693680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25690902|NCT01979276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690903|NCT01979276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25690904|NCT01979276|Glucocorticoids|glucocorticoids|mesh-ancestor
25690905|NCT01979276|Hormones|hormones|mesh-ancestor
25690906|NCT01979276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25064400|NCT03460782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25064401|NCT03460782|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24545628|NCT00694148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25020585|NCT03679052|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25020586|NCT03679052|Histamine Antagonists|histamine antagonists|mesh-ancestor
25020587|NCT03679052|Histamine Agents|histamine agents|mesh-ancestor
25020588|NCT03679052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25020589|NCT03679052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25020590|NCT03679052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25020591|NCT03679052|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25020592|NCT03679052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25020593|NCT03679052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25020594|NCT03679052|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24983623|NCT05183334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24983624|NCT05183334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545686|NCT00694408|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24545687|NCT00694408|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24545688|NCT00694408|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24545689|NCT00694408|Prednisolone phosphate|prednisolone phosphate|mesh-list
24545690|NCT00694408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24545692|NCT00694408|Autonomic Agents|autonomic agents|mesh-ancestor
24447373|NCT00308334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24545780|NCT00694837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24447397|NCT00308373|Metformin|metformin|mesh-list
24447398|NCT00308373|Pioglitazone|pioglitazone|mesh-list
24447399|NCT00308373|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
24447400|NCT00308373|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24447401|NCT00308373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447402|NCT00308425|Mycophenolic Acid|mycophenolic acid|mesh-list
24703842|NCT01474902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703843|NCT01474967|Metformin|metformin|mesh-list
24703844|NCT01474967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24703845|NCT01474967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404554|NCT03661411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25690907|NCT01979276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25690908|NCT01979276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25690909|NCT01979276|Immunologic Factors|immunologic factors|mesh-ancestor
25690910|NCT01979276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25690911|NCT01979276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25690912|NCT01979276|Growth Substances|growth substances|mesh-ancestor
25690913|NCT01979276|Growth Inhibitors|growth inhibitors|mesh-ancestor
25692683|NCT02003638|Antimetabolites|antimetabolites|mesh-ancestor
25064414|NCT03460678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826863|NCT02136641|Sensory System Agents|sensory system agents|mesh-ancestor
24614377|NCT01024075|Dexamethasone|dexamethasone|mesh-list
24545970|NCT00696098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545972|NCT00696111|Progesterone|progesterone|mesh-list
24545973|NCT00696111|Estrogens|estrogens|mesh-list
24545974|NCT00696111|Progestins|progestins|mesh-ancestor
24545975|NCT00696111|Hormones|hormones|mesh-ancestor
24545976|NCT00696111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24545978|NCT00696111|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24546200|NCT00697086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24546201|NCT00697125|Vaccines|vaccines|mesh-list
24546202|NCT00697125|Immunologic Factors|immunologic factors|mesh-ancestor
24546203|NCT00697125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546204|NCT00697138|Amphetamine|amphetamine|mesh-list
24546205|NCT00697138|Dextroamphetamine|dextroamphetamine|mesh-list
24546206|NCT00697138|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24546207|NCT00697138|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25020601|NCT03679013|Analgesics|analgesics|mesh-ancestor
25020602|NCT03679013|Sensory System Agents|sensory system agents|mesh-ancestor
25020612|NCT03679013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24703949|NCT01475617|Vitamin B 12|vitamin b 12|mesh-list
24754495|NCT01720875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020613|NCT03679013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25020614|NCT03679013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020615|NCT03679013|Antimanic Agents|antimanic agents|mesh-ancestor
25020616|NCT03678987|Mycophenolic Acid|mycophenolic acid|mesh-list
25020617|NCT03678987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25020618|NCT03678987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25020619|NCT03678987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25020622|NCT03678987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25020623|NCT03678987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24546267|NCT00697437|Antifungal Agents|antifungal agents|mesh-ancestor
24546268|NCT00697437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24546269|NCT00697437|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24546270|NCT00697437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24546271|NCT00697437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24546272|NCT00697437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24546273|NCT00697437|Hormone Antagonists|hormone antagonists|mesh-ancestor
24546275|NCT00697437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446754|NCT00305812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24446755|NCT00305825|Bevacizumab|bevacizumab|mesh-list
25690914|NCT01979276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25690915|NCT01979445|Clopidogrel|clopidogrel|mesh-list
25690916|NCT01979445|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25690917|NCT01979445|Cangrelor|cangrelor|mesh-list
25690918|NCT01979445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25690919|NCT01979445|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25690920|NCT01979445|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25690921|NCT01979445|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25690922|NCT01979445|Purinergic Agents|purinergic agents|mesh-ancestor
25690923|NCT01979445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25690924|NCT01979445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447438|NCT00308477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24447439|NCT00308477|Glucocorticoids|glucocorticoids|mesh-ancestor
24447441|NCT00308477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24447442|NCT00308477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24447443|NCT00308477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447444|NCT00308490|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25690925|NCT01979445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690926|NCT01979523|Trametinib|trametinib|mesh-list
25690927|NCT01979523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25690928|NCT01979523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25690929|NCT01979523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25690930|NCT01979523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447445|NCT00308490|Hematinics|hematinics|mesh-ancestor
24977137|NCT03439033|N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid|n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid|mesh-list
24977139|NCT03439033|Sequestering Agents|sequestering agents|mesh-ancestor
24977140|NCT03439033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977141|NCT03439033|Anticoagulants|anticoagulants|mesh-ancestor
24977142|NCT03439033|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24977143|NCT03396874|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
24977144|NCT03396874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24977145|NCT03396874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977152|NCT03362099|Bupropion|bupropion|mesh-list
24977153|NCT03362099|Varenicline|varenicline|mesh-list
24977154|NCT03362099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24977155|NCT03362099|Antidepressive Agents|antidepressive agents|mesh-ancestor
24546748|NCT00700024|Androgens|androgens|mesh-ancestor
24546750|NCT00700024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24546751|NCT00700024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546752|NCT00700024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24546753|NCT00700024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24546754|NCT00700024|Anabolic Agents|anabolic agents|mesh-ancestor
24546755|NCT00700037|Atorvastatin|atorvastatin|mesh-list
24546756|NCT00700037|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24546757|NCT00700037|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24546758|NCT00700037|Antimetabolites|antimetabolites|mesh-ancestor
24546759|NCT00700037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546760|NCT00700037|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24546761|NCT00700037|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24546762|NCT00700037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24546763|NCT00700128|Frovatriptan|frovatriptan|mesh-list
24546765|NCT00700128|Serotonin Agents|serotonin agents|mesh-ancestor
24546800|NCT00700466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546801|NCT00700466|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24546956|NCT00701337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546957|NCT00701337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24546959|NCT00701337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24546960|NCT00701337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24546961|NCT00701428|Losartan|losartan|mesh-list
24546962|NCT00701428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24546963|NCT00701428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24546964|NCT00701428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24547025|NCT00701961|Antimalarials|antimalarials|mesh-ancestor
24547026|NCT00701961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24977157|NCT03362099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24977158|NCT03362099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24547031|NCT00701961|Schistosomicides|schistosomicides|mesh-ancestor
24547510|NCT00704314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547511|NCT00704314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24547512|NCT00704314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24547513|NCT00704314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547514|NCT00704366|Saracatinib|saracatinib|mesh-list
24547515|NCT00704366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547516|NCT00704366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25690931|NCT01979952|Nintedanib|nintedanib|mesh-list
25690932|NCT01979952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547653|NCT00704990|Micronutrients|micronutrients|mesh-ancestor
24547654|NCT00704990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977166|NCT03362099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547863|NCT00706186|Anesthetics, General|anesthetics, general|mesh-ancestor
24547864|NCT00706186|Anesthetics|anesthetics|mesh-ancestor
24547865|NCT00706186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24547866|NCT00706186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547867|NCT00706225|Bazedoxifene|bazedoxifene|mesh-list
24547976|NCT00707083|Mercaptopurine|mercaptopurine|mesh-list
24547977|NCT00707083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24547978|NCT00707083|Antiemetics|antiemetics|mesh-ancestor
24547979|NCT00707083|Autonomic Agents|autonomic agents|mesh-ancestor
24547981|NCT00707083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547982|NCT00707083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25690933|NCT01979952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25404555|NCT03661307|Decitabine|decitabine|mesh-list
25690934|NCT01979952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25690935|NCT01979952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690936|NCT01980485|Carbon Monoxide|carbon monoxide|mesh-list
25690937|NCT01980485|Antimetabolites|antimetabolites|mesh-ancestor
25690938|NCT01980485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690939|NCT01980485|Gasotransmitters|gasotransmitters|mesh-ancestor
25690940|NCT01980485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25690941|NCT01980485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690942|NCT01980524|Acipimox|acipimox|mesh-list
25690943|NCT01980524|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25690944|NCT01980524|Antimetabolites|antimetabolites|mesh-ancestor
25690945|NCT01980524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690946|NCT01980524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25690947|NCT01980589|Dexamethasone|dexamethasone|mesh-list
25690948|NCT01980589|Cyclophosphamide|cyclophosphamide|mesh-list
24548194|NCT00708266|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24548195|NCT00708266|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24548218|NCT00708344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977167|NCT03362099|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24977168|NCT03362099|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24977169|NCT03362099|Cholinergic Agents|cholinergic agents|mesh-ancestor
24915148|NCT04539873|Colchicine|colchicine|mesh-list
24587108|NCT00893490|Alkylating Agents|alkylating agents|mesh-ancestor
24587109|NCT00893490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020624|NCT03678987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020625|NCT03678792|Morphine|morphine|mesh-list
25020635|NCT03678792|Sensory System Agents|sensory system agents|mesh-ancestor
25020636|NCT03678792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25020637|NCT03678792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25111512|NCT04791475|Dexamethasone|dexamethasone|mesh-list
25111513|NCT04791475|Dexmedetomidine|dexmedetomidine|mesh-list
25111514|NCT04791475|Bupivacaine|bupivacaine|mesh-list
25111515|NCT04791475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25111516|NCT04791475|Antiemetics|antiemetics|mesh-ancestor
25111517|NCT04791475|Autonomic Agents|autonomic agents|mesh-ancestor
25111518|NCT04791475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24983693|NCT05177939|Methylprednisolone|methylprednisolone|mesh-list
24548657|NCT00711204|Cholinergic Agents|cholinergic agents|mesh-ancestor
24548658|NCT00711204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25111519|NCT04791475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25111520|NCT04791475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25111521|NCT04791475|Glucocorticoids|glucocorticoids|mesh-ancestor
25111522|NCT04791475|Hormones|hormones|mesh-ancestor
25111523|NCT04791475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25111524|NCT04791475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25111525|NCT04791475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25111526|NCT04791475|Anesthetics, Local|anesthetics, local|mesh-ancestor
25111527|NCT04791475|Anesthetics|anesthetics|mesh-ancestor
25111528|NCT04791475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25020651|NCT03678649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25020652|NCT03678649|Antimetabolites|antimetabolites|mesh-ancestor
24548922|NCT00712595|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24548923|NCT00712595|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24548924|NCT00712595|Hormone Antagonists|hormone antagonists|mesh-ancestor
24548925|NCT00712595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24548926|NCT00712595|Luteolytic Agents|luteolytic agents|mesh-ancestor
24548927|NCT00712595|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24548928|NCT00712595|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24548929|NCT00712647|Beta Carotene|beta carotene|mesh-list
24548930|NCT00712647|Vitamin A|vitamin a|mesh-list
24548941|NCT00712660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24548942|NCT00712660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548944|NCT00712686|Olanzapine|olanzapine|mesh-list
24447664|NCT00309361|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24549169|NCT00713739|Doxazosin|doxazosin|mesh-list
24549170|NCT00713739|Nifedipine|nifedipine|mesh-list
24549171|NCT00713739|Alfuzosin|alfuzosin|mesh-list
24549172|NCT00713739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25020653|NCT03678649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020654|NCT03678649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25020656|NCT03678610|Calcium Ionophores|calcium ionophores|mesh-ancestor
25020657|NCT03678610|Ionophores|ionophores|mesh-ancestor
25020658|NCT03678610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24704580|NCT01479023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704581|NCT01479036|Docetaxel|docetaxel|mesh-list
24704582|NCT01479036|Epirubicin|epirubicin|mesh-list
24704583|NCT01479036|Endostatins|endostatins|mesh-list
24704584|NCT01479036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24704585|NCT01479036|Tubulin Modulators|tubulin modulators|mesh-ancestor
25020661|NCT03678532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25020662|NCT03678532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25020663|NCT03678532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25020664|NCT03678532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020665|NCT03678532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25020666|NCT03678532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25020667|NCT03678532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25020668|NCT03678532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25020686|NCT03678428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020687|NCT03678428|Antidotes|antidotes|mesh-ancestor
25020688|NCT03678428|Protective Agents|protective agents|mesh-ancestor
25020689|NCT03678428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106662|NCT00799396|Analgesics|analgesics|mesh-ancestor
24549173|NCT00713739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24549344|NCT00714779|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24549345|NCT00714779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24549346|NCT00714779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24549349|NCT00714779|Serotonin Agents|serotonin agents|mesh-ancestor
24447706|NCT00309478|Hormone Antagonists|hormone antagonists|mesh-ancestor
24447707|NCT00309478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24447708|NCT00309478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24447712|NCT00309491|Tamoxifen|tamoxifen|mesh-list
25020693|NCT03678428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25020694|NCT03678428|Antimetabolites|antimetabolites|mesh-ancestor
25020695|NCT03678233|Testosterone|testosterone|mesh-list
25020696|NCT03678233|Androgens|androgens|mesh-ancestor
25020697|NCT03678233|Hormones|hormones|mesh-ancestor
24704805|NCT01480492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549670|NCT00716846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24549671|NCT00716846|Antimetabolites|antimetabolites|mesh-ancestor
24549672|NCT00716846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404556|NCT03661307|Venetoclax|venetoclax|mesh-list
24549687|NCT00716924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24550257|NCT00719823|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24550258|NCT00719823|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24550259|NCT00719823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550260|NCT00719823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24550261|NCT00719823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24550262|NCT00719823|Antiviral Agents|antiviral agents|mesh-ancestor
24550267|NCT00719875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550268|NCT00719875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550269|NCT00719875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550270|NCT00720018|Sumatriptan|sumatriptan|mesh-list
24550271|NCT00720018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25020704|NCT03678142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25020706|NCT03678116|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25020707|NCT03678116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020708|NCT03678116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25020709|NCT03678116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25020771|NCT03677323|Narcotics|narcotics|mesh-ancestor
24550434|NCT00720564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550435|NCT00720564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25690949|NCT01980589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25690950|NCT01980589|Immunologic Factors|immunologic factors|mesh-ancestor
25690951|NCT01980589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690952|NCT01980589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25690953|NCT01980589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25690954|NCT01980589|Alkylating Agents|alkylating agents|mesh-ancestor
25690955|NCT01980589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25690956|NCT01980589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25690957|NCT01980589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25690958|NCT01980589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25690968|NCT01980654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25020764|NCT03677323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25020765|NCT03677323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25020766|NCT03677323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020767|NCT03677323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25020768|NCT03677323|Anesthetics, General|anesthetics, general|mesh-ancestor
25020770|NCT03677323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25020773|NCT03677323|Sensory System Agents|sensory system agents|mesh-ancestor
25020774|NCT03677323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25020775|NCT03677323|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25020776|NCT03677323|Antiemetics|antiemetics|mesh-ancestor
25020777|NCT03677323|Autonomic Agents|autonomic agents|mesh-ancestor
25020778|NCT03677323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25020779|NCT03677323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25020780|NCT03677323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25020781|NCT03677323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25020782|NCT03677323|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25020783|NCT03677323|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25020798|NCT03677258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020799|NCT03677258|Viscosupplements|viscosupplements|mesh-ancestor
25020800|NCT03677258|Protective Agents|protective agents|mesh-ancestor
25690969|NCT01980654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25020832|NCT03676621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25020833|NCT03676621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020834|NCT03676621|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25020836|NCT03676621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25020837|NCT03676621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25690973|NCT01980706|Baclofen|baclofen|mesh-list
25690974|NCT01980706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25690975|NCT01980706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25690976|NCT01980706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25690977|NCT01980706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25690978|NCT01980706|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25690979|NCT01980706|GABA Agonists|gaba agonists|mesh-ancestor
25690980|NCT01980706|GABA Agents|gaba agents|mesh-ancestor
25690997|NCT01981473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25691001|NCT01981616|Immunologic Factors|immunologic factors|mesh-ancestor
25691002|NCT01981616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691003|NCT01981616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25691004|NCT01981759|Cycloserine|cycloserine|mesh-list
25691005|NCT01981759|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25691006|NCT01981759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25691007|NCT01981759|Renal Agents|renal agents|mesh-ancestor
25020952|NCT03676036|Dermatologic Agents|dermatologic agents|mesh-ancestor
25020953|NCT03676036|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25020954|NCT03676023|Tranexamic Acid|tranexamic acid|mesh-list
25020955|NCT03676023|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25020956|NCT03676023|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25020957|NCT03676023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020958|NCT03676023|Hemostatics|hemostatics|mesh-ancestor
25020959|NCT03676023|Coagulants|coagulants|mesh-ancestor
25020960|NCT03675854|Cefazolin|cefazolin|mesh-list
25020961|NCT03675854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25020962|NCT03675854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25020963|NCT03675841|Carbamide Peroxide|carbamide peroxide|mesh-list
25020964|NCT03675841|Pazufloxacin|pazufloxacin|mesh-list
25020965|NCT03675841|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25020966|NCT03675841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25020967|NCT03675841|Antitubercular Agents|antitubercular agents|mesh-ancestor
25020968|NCT03675841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25020970|NCT03675841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25020971|NCT03675841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25020972|NCT03675841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020976|NCT03675815|Tenofovir|tenofovir|mesh-list
25020977|NCT03675815|Lamivudine|lamivudine|mesh-list
25020978|NCT03675815|Emtricitabine|emtricitabine|mesh-list
25020979|NCT03675815|Dolutegravir|dolutegravir|mesh-list
25020980|NCT03675815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
24443890|NCT00296062|Growth Inhibitors|growth inhibitors|mesh-ancestor
25020997|NCT03675802|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25020998|NCT03675802|Abortifacient Agents|abortifacient agents|mesh-ancestor
24448435|NCT00311818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448437|NCT00311857|Temozolomide|temozolomide|mesh-list
24448438|NCT00311857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24448439|NCT00311857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448440|NCT00311857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25691008|NCT01981759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25691009|NCT01981759|Antitubercular Agents|antitubercular agents|mesh-ancestor
25691010|NCT01981759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25691011|NCT01981759|Antimetabolites|antimetabolites|mesh-ancestor
25691012|NCT01981759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691013|NCT01981772|Lidocaine|lidocaine|mesh-list
25691014|NCT01981772|Epinephrine|epinephrine|mesh-list
25691015|NCT01981772|Racepinephrine|racepinephrine|mesh-list
25691016|NCT01981772|Epinephryl borate|epinephryl borate|mesh-list
25691017|NCT01981772|Anesthetics, Local|anesthetics, local|mesh-ancestor
25691018|NCT01981772|Anesthetics|anesthetics|mesh-ancestor
25691019|NCT01981772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25020999|NCT03675802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25021000|NCT03675802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021001|NCT03675802|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25021002|NCT03675802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25021003|NCT03675802|Oxytocics|oxytocics|mesh-ancestor
25021004|NCT03675646|Morphine|morphine|mesh-list
25021005|NCT03675646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25021006|NCT03675646|Narcotics|narcotics|mesh-ancestor
25021007|NCT03675646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25021008|NCT03675646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021009|NCT03675646|Analgesics|analgesics|mesh-ancestor
25021010|NCT03675646|Sensory System Agents|sensory system agents|mesh-ancestor
25021011|NCT03675646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25021013|NCT03675594|Chromium|chromium|mesh-list
25021014|NCT03675594|Trace Elements|trace elements|mesh-ancestor
25021015|NCT03675594|Micronutrients|micronutrients|mesh-ancestor
25021016|NCT03675594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021017|NCT03675555|Dexamethasone|dexamethasone|mesh-list
25021018|NCT03675555|Mirtazapine|mirtazapine|mesh-list
25021019|NCT03675555|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24977502|NCT02987530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977503|NCT02987530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24977504|NCT02987530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24977505|NCT02987530|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24977506|NCT02987530|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24977507|NCT02987530|Protease Inhibitors|protease inhibitors|mesh-ancestor
24977508|NCT02987530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24977509|NCT02987530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25021029|NCT03675555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25021030|NCT03675555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25021055|NCT03675191|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25021057|NCT03675191|Appetite Depressants|appetite depressants|mesh-ancestor
25021058|NCT03675191|Sympathomimetics|sympathomimetics|mesh-ancestor
25021059|NCT03675191|Autonomic Agents|autonomic agents|mesh-ancestor
25021060|NCT03675191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25021061|NCT03675191|Adrenergic Agents|adrenergic agents|mesh-ancestor
25021062|NCT03675191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25021063|NCT03675178|Ceftriaxone|ceftriaxone|mesh-list
25021064|NCT03675178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25021065|NCT03675178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25111566|NCT04780568|Osimertinib|osimertinib|mesh-list
25111567|NCT04780568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25111568|NCT04780568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25111569|NCT04780568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25111570|NCT04780568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021077|NCT03674671|Analgesics|analgesics|mesh-ancestor
25021078|NCT03674671|Sensory System Agents|sensory system agents|mesh-ancestor
25021079|NCT03674671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25021080|NCT03674671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021081|NCT03674671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24983908|NCT05089643|Capecitabine|capecitabine|mesh-list
24584749|NCT00881556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709998|NCT01507974|Cefuroxime|cefuroxime|mesh-list
24709999|NCT01507974|Nitrofurantoin|nitrofurantoin|mesh-list
25021115|NCT03674541|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25021117|NCT03674541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021118|NCT03674541|Cholinergic Agents|cholinergic agents|mesh-ancestor
25691022|NCT01981772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25021134|NCT03674411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021135|NCT03674411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25021136|NCT03674411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25021141|NCT03674411|Antitubercular Agents|antitubercular agents|mesh-ancestor
25021142|NCT03674411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25021143|NCT03674411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25021144|NCT03674411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24710002|NCT01507974|Trimethoprim|trimethoprim|mesh-list
24505116|NCT00539968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25021619|NCT03669757|Hormones|hormones|mesh-ancestor
25021154|NCT03674385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021155|NCT03674385|Antioxidants|antioxidants|mesh-ancestor
25021156|NCT03674385|Protective Agents|protective agents|mesh-ancestor
25021157|NCT03674385|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25021158|NCT03674385|Hormone Antagonists|hormone antagonists|mesh-ancestor
25404557|NCT03661307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25691025|NCT01981772|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25691026|NCT01981772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25691027|NCT01981772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691028|NCT01981772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25691029|NCT01981772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24907493|NCT04330677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907494|NCT04330677|Hormones|hormones|mesh-ancestor
24907495|NCT04330677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24907496|NCT04330027|Mitogens|mitogens|mesh-list
24907497|NCT04330027|Mitosis Modulators|mitosis modulators|mesh-ancestor
24907498|NCT04330027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021159|NCT03674385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25021160|NCT03674385|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25021161|NCT03674385|Fertility Agents|fertility agents|mesh-ancestor
25021162|NCT03674385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25021163|NCT03674385|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25021164|NCT03674385|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25021165|NCT03674333|Folic Acid|folic acid|mesh-list
25021166|NCT03674333|Hematinics|hematinics|mesh-ancestor
25021167|NCT03674333|Vitamin B Complex|vitamin b complex|mesh-ancestor
25021168|NCT03674333|Vitamins|vitamins|mesh-ancestor
25021169|NCT03674333|Micronutrients|micronutrients|mesh-ancestor
25021170|NCT03674333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021171|NCT03674294|Dexamethasone|dexamethasone|mesh-list
25021172|NCT03674294|Aprepitant|aprepitant|mesh-list
25021173|NCT03674294|Palonosetron|palonosetron|mesh-list
25021174|NCT03674294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25021175|NCT03674294|Antiemetics|antiemetics|mesh-ancestor
25021176|NCT03674294|Autonomic Agents|autonomic agents|mesh-ancestor
25021177|NCT03674294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24584751|NCT00881556|Immunologic Factors|immunologic factors|mesh-ancestor
25021187|NCT03674294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021188|NCT03674294|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25021189|NCT03674294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25021190|NCT03674294|Serotonin Agents|serotonin agents|mesh-ancestor
25021212|NCT03674099|Imatinib Mesylate|imatinib mesylate|mesh-list
24977712|NCT02338921|Metformin|metformin|mesh-list
25021213|NCT03674099|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25021214|NCT03674099|Prednisolone phosphate|prednisolone phosphate|mesh-list
25021215|NCT03674099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25021216|NCT03674099|Antiemetics|antiemetics|mesh-ancestor
25021217|NCT03674099|Autonomic Agents|autonomic agents|mesh-ancestor
25021218|NCT03674099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25021219|NCT03674099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021220|NCT03674099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25021221|NCT03674099|Glucocorticoids|glucocorticoids|mesh-ancestor
25021222|NCT03674099|Hormones|hormones|mesh-ancestor
25021223|NCT03674099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25021224|NCT03674099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25021225|NCT03674099|Protective Agents|protective agents|mesh-ancestor
25021226|NCT03674099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25021227|NCT03674099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25021228|NCT03674099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25021229|NCT03674099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25021230|NCT03674099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021231|NCT03674073|Vaccines|vaccines|mesh-list
25691030|NCT01981772|Adrenergic Agents|adrenergic agents|mesh-ancestor
25691031|NCT01981772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25691032|NCT01981772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25691033|NCT01981772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25691034|NCT01981772|Autonomic Agents|autonomic agents|mesh-ancestor
25691035|NCT01981772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25691036|NCT01981772|Respiratory System Agents|respiratory system agents|mesh-ancestor
25691037|NCT01981772|Mydriatics|mydriatics|mesh-ancestor
25691038|NCT01981772|Sympathomimetics|sympathomimetics|mesh-ancestor
25021234|NCT03674060|Sorafenib|sorafenib|mesh-list
25021235|NCT03674060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25021236|NCT03674060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25021237|NCT03674060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25021238|NCT03674060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021239|NCT03674008|Propofol|propofol|mesh-list
25021240|NCT03674008|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25021264|NCT03673501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784598|NCT01909063|Antioxidants|antioxidants|mesh-ancestor
24448668|NCT00312546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24448670|NCT00312546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24448674|NCT00312546|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25021266|NCT03673501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25021270|NCT03673501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25021271|NCT03673501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25021272|NCT03673501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021273|NCT03673384|Fluticasone|fluticasone|mesh-list
25021275|NCT03673384|Histamine|histamine|mesh-list
25021276|NCT03673384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25021277|NCT03673384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25021278|NCT03673384|Autonomic Agents|autonomic agents|mesh-ancestor
25021279|NCT03673384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25021280|NCT03673384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691039|NCT01981772|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25691040|NCT01981863|Aminocaproic Acid|aminocaproic acid|mesh-list
25691041|NCT01981863|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25691042|NCT01981863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25691043|NCT01981863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691044|NCT01981863|Hemostatics|hemostatics|mesh-ancestor
25691045|NCT01981863|Coagulants|coagulants|mesh-ancestor
25691046|NCT01981954|Solifenacin Succinate|solifenacin succinate|mesh-list
25691047|NCT01981954|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25691048|NCT01981954|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25691049|NCT01981954|Cholinergic Agents|cholinergic agents|mesh-ancestor
25691050|NCT01981954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25021290|NCT03673332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021291|NCT03673332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25111678|NCT04727307|Immunologic Factors|immunologic factors|mesh-ancestor
25021300|NCT03673163|Lidocaine|lidocaine|mesh-list
25021301|NCT03673163|Anesthetics, Local|anesthetics, local|mesh-ancestor
25021302|NCT03673163|Anesthetics|anesthetics|mesh-ancestor
25021303|NCT03673163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25021304|NCT03673163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021305|NCT03673163|Sensory System Agents|sensory system agents|mesh-ancestor
25021306|NCT03673163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25021307|NCT03673163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25021308|NCT03673163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25021309|NCT03673163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24447237|NCT00307671|Antimetabolites|antimetabolites|mesh-ancestor
24448877|NCT00313482|Hormones|hormones|mesh-ancestor
25691051|NCT01981954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691052|NCT01981954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691053|NCT01981954|Urological Agents|urological agents|mesh-ancestor
25691054|NCT01981967|Vaccines|vaccines|mesh-list
25691055|NCT01981967|Immunologic Factors|immunologic factors|mesh-ancestor
25691056|NCT01981967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691057|NCT01982123|Edetic Acid|edetic acid|mesh-list
25691058|NCT01982123|Pentetic Acid|pentetic acid|mesh-list
25021316|NCT03673137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25021317|NCT03673137|Antiviral Agents|antiviral agents|mesh-ancestor
25021318|NCT03673137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25021319|NCT03673137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25021320|NCT03673137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25021321|NCT03673137|Immunologic Factors|immunologic factors|mesh-ancestor
25021322|NCT03673137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021345|NCT03672435|Sensory System Agents|sensory system agents|mesh-ancestor
25021346|NCT03672435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25021347|NCT03672357|Liver Extracts|liver extracts|mesh-list
25021348|NCT03672357|Hematinics|hematinics|mesh-ancestor
25021350|NCT03672149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25021351|NCT03672149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25021353|NCT03672071|Pseudoephedrine|pseudoephedrine|mesh-list
25021354|NCT03672071|Norepinephrine|norepinephrine|mesh-list
25021355|NCT03672071|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25021356|NCT03672071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021357|NCT03672071|Sympathomimetics|sympathomimetics|mesh-ancestor
25021358|NCT03672071|Autonomic Agents|autonomic agents|mesh-ancestor
25021360|NCT03672071|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25021361|NCT03672071|Adrenergic Agents|adrenergic agents|mesh-ancestor
25021362|NCT03672071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25021363|NCT03672071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106749|NCT03145025|Glucocorticoids|glucocorticoids|mesh-ancestor
24393909|NCT00131261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021364|NCT03672071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25021365|NCT03672071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25021366|NCT03672071|Respiratory System Agents|respiratory system agents|mesh-ancestor
25021367|NCT03672071|Nasal Decongestants|nasal decongestants|mesh-ancestor
25021368|NCT03672071|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25021369|NCT03672071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24710698|NCT01511562|Antimetabolites|antimetabolites|mesh-ancestor
24710699|NCT01511562|Antiviral Agents|antiviral agents|mesh-ancestor
24710700|NCT01511562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24710701|NCT01511562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24710702|NCT01511562|Immunologic Factors|immunologic factors|mesh-ancestor
24710703|NCT01511562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710704|NCT01511562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25021371|NCT03672045|Oxytocics|oxytocics|mesh-ancestor
25021372|NCT03672045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25021373|NCT03672045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977928|NCT01332266|Cetuximab|cetuximab|mesh-list
25021374|NCT03671941|Ticagrelor|ticagrelor|mesh-list
25021411|NCT03671733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021413|NCT03671733|Hormones|hormones|mesh-ancestor
25021414|NCT03671733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25021415|NCT03671733|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25021416|NCT03671707|Nicotine|nicotine|mesh-list
25021417|NCT03671707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25021418|NCT03671707|Autonomic Agents|autonomic agents|mesh-ancestor
25021419|NCT03671707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25021420|NCT03671707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021421|NCT03671707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25021422|NCT03671707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25021423|NCT03671707|Cholinergic Agents|cholinergic agents|mesh-ancestor
25021424|NCT03671707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25021425|NCT03671707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021426|NCT03671655|Paclitaxel|paclitaxel|mesh-list
25021427|NCT03671655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24984083|NCT04838223|Proxymetacaine|proxymetacaine|mesh-list
24394068|NCT00131963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24394069|NCT00131963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978041|NCT00038675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587110|NCT00893490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24587112|NCT00893542|Mycophenolic Acid|mycophenolic acid|mesh-list
24587113|NCT00893542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24587114|NCT00893542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587115|NCT00893542|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24587116|NCT00893542|Antitubercular Agents|antitubercular agents|mesh-ancestor
24587117|NCT00893542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24587118|NCT00893542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24587119|NCT00893542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587120|NCT00893542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587121|NCT00893555|Voriconazole|voriconazole|mesh-list
24587162|NCT00893607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24587163|NCT00893607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587164|NCT00893607|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24587165|NCT00893607|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24587166|NCT00893607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24587167|NCT00893607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24587186|NCT00893724|Acetylcysteine|acetylcysteine|mesh-list
24587188|NCT00893724|Vitamins|vitamins|mesh-ancestor
24587189|NCT00893724|Micronutrients|micronutrients|mesh-ancestor
25021439|NCT03671265|Apatinib|apatinib|mesh-list
25021440|NCT03671265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25021441|NCT03671265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25021442|NCT03671265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25021443|NCT03671265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021444|NCT03671174|Aspirin|aspirin|mesh-list
25021445|NCT03671174|Hydroxychloroquine|hydroxychloroquine|mesh-list
25021446|NCT03671174|Prednisone|prednisone|mesh-list
25021447|NCT03671174|Heparin|heparin|mesh-list
25021448|NCT03671174|Enoxaparin|enoxaparin|mesh-list
25021449|NCT03671174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25021450|NCT03671174|Tinzaparin|tinzaparin|mesh-list
25021451|NCT03671174|Dalteparin|dalteparin|mesh-list
25021452|NCT03671174|Nadroparin|nadroparin|mesh-list
25021453|NCT03671174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25021454|NCT03671174|Glucocorticoids|glucocorticoids|mesh-ancestor
25021455|NCT03671174|Hormones|hormones|mesh-ancestor
25021456|NCT03671174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25021457|NCT03671174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021458|NCT03671174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25021459|NCT03671174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25021460|NCT03671174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25021461|NCT03671174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25021509|NCT03671057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25021510|NCT03671057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25021511|NCT03671057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24463207|NCT00359333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463208|NCT00359333|Antiviral Agents|antiviral agents|mesh-ancestor
24463209|NCT00359333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25021512|NCT03671057|Anesthetics, General|anesthetics, general|mesh-ancestor
25021513|NCT03671057|Anesthetics|anesthetics|mesh-ancestor
25021514|NCT03671057|GABA Modulators|gaba modulators|mesh-ancestor
25021515|NCT03671057|GABA Agents|gaba agents|mesh-ancestor
25021516|NCT03671057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25021517|NCT03671057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021518|NCT03671044|Docetaxel|docetaxel|mesh-list
25021519|NCT03671044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25021520|NCT03671044|Tubulin Modulators|tubulin modulators|mesh-ancestor
25021521|NCT03671044|Antimitotic Agents|antimitotic agents|mesh-ancestor
25021522|NCT03671044|Mitosis Modulators|mitosis modulators|mesh-ancestor
25021523|NCT03671044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021524|NCT03670953|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25015171|NCT03039673|Anticonvulsants|anticonvulsants|mesh-ancestor
25021525|NCT03670953|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25021526|NCT03670953|Immunologic Factors|immunologic factors|mesh-ancestor
25021527|NCT03670953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021528|NCT03670953|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25021529|NCT03670953|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25021530|NCT03670953|Dopamine Agonists|dopamine agonists|mesh-ancestor
25021531|NCT03670953|Dopamine Agents|dopamine agents|mesh-ancestor
24978042|NCT05179525|Risperidone|risperidone|mesh-list
25021532|NCT03670953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25021533|NCT03670953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021577|NCT03670212|Urological Agents|urological agents|mesh-ancestor
25021578|NCT03670095|Memantine|memantine|mesh-list
25021579|NCT03670095|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25021580|NCT03670095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25021581|NCT03670095|Dopamine Agents|dopamine agents|mesh-ancestor
25021582|NCT03670095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25021583|NCT03670095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021584|NCT03670095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021585|NCT03670095|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25021586|NCT03670095|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25021587|NCT03670043|Metformin|metformin|mesh-list
25021588|NCT03670043|Psyllium|psyllium|mesh-list
25021589|NCT03670043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25021590|NCT03670043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021591|NCT03670043|Cathartics|cathartics|mesh-ancestor
25021592|NCT03670043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25021593|NCT03669783|Dactinomycin|dactinomycin|mesh-list
25021594|NCT03669783|Carboplatin|carboplatin|mesh-list
25021595|NCT03669783|Doxorubicin|doxorubicin|mesh-list
25021596|NCT03669783|Etoposide|etoposide|mesh-list
25021614|NCT03669757|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25021615|NCT03669757|Betamethasone benzoate|betamethasone benzoate|mesh-list
25021616|NCT03669757|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25021617|NCT03669757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25021618|NCT03669757|Glucocorticoids|glucocorticoids|mesh-ancestor
25021622|NCT03669757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25021623|NCT03669757|Respiratory System Agents|respiratory system agents|mesh-ancestor
25021624|NCT03669601|Gemcitabine|gemcitabine|mesh-list
25021625|NCT03669601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25021626|NCT03669601|Antimetabolites|antimetabolites|mesh-ancestor
25021627|NCT03669601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021628|NCT03669601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25021629|NCT03669601|Antiviral Agents|antiviral agents|mesh-ancestor
24971829|NCT03722173|Itraconazole|itraconazole|mesh-list
25021630|NCT03669601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25021631|NCT03669601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25021632|NCT03669601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25021633|NCT03669601|Immunologic Factors|immunologic factors|mesh-ancestor
25021634|NCT03669601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021635|NCT03669562|Alprostadil|alprostadil|mesh-list
25021636|NCT03669562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25021637|NCT03669562|Vasodilator Agents|vasodilator agents|mesh-ancestor
25021638|NCT03669562|Urological Agents|urological agents|mesh-ancestor
25111689|NCT04718805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25111690|NCT04718805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25111691|NCT04718805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25111692|NCT04718805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25111693|NCT04718805|Antiviral Agents|antiviral agents|mesh-ancestor
25111694|NCT04718805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25111695|NCT04718805|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25111696|NCT04718805|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24806070|NCT02013453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25111713|NCT04677049|Nicotinic Acids|nicotinic acids|mesh-list
25111715|NCT04677049|Micronutrients|micronutrients|mesh-ancestor
25111716|NCT04677049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25111717|NCT04677049|Vitamin B Complex|vitamin b complex|mesh-ancestor
25111718|NCT04677049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25111719|NCT04677049|Antimetabolites|antimetabolites|mesh-ancestor
25111720|NCT04677049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25111721|NCT04677049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25021645|NCT03669484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021646|NCT03669484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25021648|NCT03669484|Anesthetics|anesthetics|mesh-ancestor
25021649|NCT03669484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25021650|NCT03669484|Narcotics|narcotics|mesh-ancestor
25021664|NCT03669445|Antiemetics|antiemetics|mesh-ancestor
25021665|NCT03669445|Autonomic Agents|autonomic agents|mesh-ancestor
24463297|NCT00359853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463298|NCT00359853|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24463299|NCT00359853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24463301|NCT00359879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24463302|NCT00359879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463339|NCT00360178|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24463351|NCT00360191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25021666|NCT03669445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25021667|NCT03669445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021668|NCT03669445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25021669|NCT03669445|Glucocorticoids|glucocorticoids|mesh-ancestor
25021682|NCT03669328|Anesthetics|anesthetics|mesh-list
25021683|NCT03669328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25021684|NCT03669328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021686|NCT03669263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25021687|NCT03669263|Narcotics|narcotics|mesh-ancestor
25021688|NCT03669263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25021689|NCT03669263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021690|NCT03669263|Analgesics|analgesics|mesh-ancestor
25021691|NCT03669263|Sensory System Agents|sensory system agents|mesh-ancestor
25021692|NCT03669263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25021693|NCT03669263|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25021694|NCT03669263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25021695|NCT03669263|Anesthetics, General|anesthetics, general|mesh-ancestor
25005867|NCT01821690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25021696|NCT03669263|Anesthetics|anesthetics|mesh-ancestor
25021697|NCT03669224|Chlorhexidine|chlorhexidine|mesh-list
25021698|NCT03669224|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25021699|NCT03669224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25021700|NCT03669224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25021701|NCT03669224|Disinfectants|disinfectants|mesh-ancestor
25021702|NCT03669224|Dermatologic Agents|dermatologic agents|mesh-ancestor
25021704|NCT03669029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25021705|NCT03669029|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25021706|NCT03669029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25021707|NCT03669029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25691059|NCT01982123|Technetium Tc 99m Pentetate|technetium tc 99m pentetate|mesh-list
24868454|NCT04645602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24868455|NCT04645602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908338|NCT04321616|Antiviral Agents|antiviral agents|mesh-ancestor
24908351|NCT04321837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24623685|NCT01073189|Diuretics|diuretics|mesh-ancestor
24623686|NCT01073189|Natriuretic Agents|natriuretic agents|mesh-ancestor
24623687|NCT01073189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623688|NCT01073189|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24623689|NCT01073189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24623690|NCT01073189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021708|NCT03669029|Immunologic Factors|immunologic factors|mesh-ancestor
25021709|NCT03669029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021725|NCT03668964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25021726|NCT03668964|Antioxidants|antioxidants|mesh-ancestor
25021727|NCT03668964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021728|NCT03668964|Protective Agents|protective agents|mesh-ancestor
25021729|NCT03668964|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25021730|NCT03668964|Dermatologic Agents|dermatologic agents|mesh-ancestor
25021731|NCT03668860|Dexamethasone|dexamethasone|mesh-list
25021732|NCT03668860|Dexamethasone acetate|dexamethasone acetate|mesh-list
25021756|NCT03668860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25021757|NCT03668730|Paclitaxel|paclitaxel|mesh-list
25021758|NCT03668730|Fluorouracil|fluorouracil|mesh-list
25021759|NCT03668730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25021760|NCT03668730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25021761|NCT03668730|Tubulin Modulators|tubulin modulators|mesh-ancestor
25021762|NCT03668730|Antimitotic Agents|antimitotic agents|mesh-ancestor
25021763|NCT03668730|Mitosis Modulators|mitosis modulators|mesh-ancestor
25021764|NCT03668730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021765|NCT03668730|Antimetabolites|antimetabolites|mesh-ancestor
25021766|NCT03668730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25021767|NCT03668730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25021768|NCT03668730|Immunologic Factors|immunologic factors|mesh-ancestor
25021769|NCT03668730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021770|NCT03668665|Hyaluronic Acid|hyaluronic acid|mesh-list
25021771|NCT03668665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25021772|NCT03668665|Immunologic Factors|immunologic factors|mesh-ancestor
25021773|NCT03668665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021774|NCT03668665|Viscosupplements|viscosupplements|mesh-ancestor
25021775|NCT03668665|Protective Agents|protective agents|mesh-ancestor
25021807|NCT03668262|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25021808|NCT03668262|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25021810|NCT03668262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25021811|NCT03668262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021813|NCT03668262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25021814|NCT03668262|Cholinergic Agents|cholinergic agents|mesh-ancestor
25021815|NCT03668262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25021816|NCT03668262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021818|NCT03668054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25021819|NCT03668054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25021820|NCT03668054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25021821|NCT03668054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25021822|NCT03668054|Growth Substances|growth substances|mesh-ancestor
25021823|NCT03668054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021824|NCT03668054|Growth Inhibitors|growth inhibitors|mesh-ancestor
25021825|NCT03668015|Sorbitol|sorbitol|mesh-list
25021826|NCT03668015|Cathartics|cathartics|mesh-ancestor
25021827|NCT03668015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25021828|NCT03667963|Lactulose|lactulose|mesh-list
25021829|NCT03667963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25021830|NCT03667937|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25021831|NCT03667937|Laxatives|laxatives|mesh-ancestor
25691060|NCT01982123|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
25691061|NCT01982123|Antidotes|antidotes|mesh-ancestor
25691062|NCT01982123|Protective Agents|protective agents|mesh-ancestor
25691063|NCT01982123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691064|NCT01982123|Chelating Agents|chelating agents|mesh-ancestor
25691065|NCT01982123|Sequestering Agents|sequestering agents|mesh-ancestor
25691066|NCT01982123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691067|NCT01982123|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25691068|NCT01982123|Anticoagulants|anticoagulants|mesh-ancestor
25691069|NCT01982123|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25691070|NCT01982123|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25691071|NCT01982240|Bisacodyl|bisacodyl|mesh-list
25021847|NCT03667677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021848|NCT03667677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25021849|NCT03667677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021850|NCT03667677|Vasodilator Agents|vasodilator agents|mesh-ancestor
25021851|NCT03667677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25021852|NCT03667677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25021855|NCT03667677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25021856|NCT03667677|Serotonin Agents|serotonin agents|mesh-ancestor
25021857|NCT03667677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25021859|NCT03667352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25021860|NCT03667352|Narcotics|narcotics|mesh-ancestor
25021861|NCT03667352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25021862|NCT03667352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021863|NCT03667352|Analgesics|analgesics|mesh-ancestor
25021864|NCT03667352|Sensory System Agents|sensory system agents|mesh-ancestor
25021865|NCT03667352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25021866|NCT03667352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25021867|NCT03667352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25021868|NCT03667352|Anesthetics, General|anesthetics, general|mesh-ancestor
25021869|NCT03667352|Anesthetics|anesthetics|mesh-ancestor
25021870|NCT03667326|Aspirin|aspirin|mesh-list
25111770|NCT04631029|Entinostat|entinostat|mesh-list
25021871|NCT03667326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25021872|NCT03667326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25021873|NCT03667326|Analgesics|analgesics|mesh-ancestor
25021874|NCT03667326|Sensory System Agents|sensory system agents|mesh-ancestor
25021875|NCT03667326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25021897|NCT03667313|Antifungal Agents|antifungal agents|mesh-ancestor
25021898|NCT03667313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25021899|NCT03667313|Immunologic Factors|immunologic factors|mesh-ancestor
25021900|NCT03667313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021901|NCT03667300|Linagliptin|linagliptin|mesh-list
25021902|NCT03667300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25021903|NCT03667300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021904|NCT03667300|Incretins|incretins|mesh-ancestor
25021905|NCT03667300|Hormones|hormones|mesh-ancestor
25021906|NCT03667300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25021907|NCT03667300|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25021915|NCT03667222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25021916|NCT03667222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25021917|NCT03667131|Enalapril|enalapril|mesh-list
25021927|NCT03667066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25021946|NCT03666949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25021947|NCT03666949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021948|NCT03666884|Cyclosporine|cyclosporine|mesh-list
25021949|NCT03666884|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24984404|NCT04552535|Afatinib|afatinib|mesh-list
25021974|NCT03666715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25021975|NCT03666715|Dopamine Agents|dopamine agents|mesh-ancestor
25021976|NCT03666650|Edoxaban|edoxaban|mesh-list
25015447|NCT02392637|Antimetabolites|antimetabolites|mesh-ancestor
25021977|NCT03666650|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25021978|NCT03666650|Antithrombins|antithrombins|mesh-ancestor
25005891|NCT01502085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25005892|NCT01502085|Antiemetics|antiemetics|mesh-ancestor
25005893|NCT01502085|Autonomic Agents|autonomic agents|mesh-ancestor
25005894|NCT01502085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25005895|NCT01502085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021979|NCT03666650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24585758|NCT00887003|Hormones|hormones|mesh-ancestor
25022005|NCT03666494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022006|NCT03666494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25022007|NCT03666494|Anesthetics, General|anesthetics, general|mesh-ancestor
25022008|NCT03666494|Anesthetics|anesthetics|mesh-ancestor
25022009|NCT03666494|Analgesics|analgesics|mesh-ancestor
25022010|NCT03666494|Sensory System Agents|sensory system agents|mesh-ancestor
25022011|NCT03666494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25022012|NCT03666494|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25022013|NCT03666494|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25022014|NCT03666494|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25022015|NCT03666494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24984475|NCT04503668|Dexamethasone|dexamethasone|mesh-list
24452407|NCT00327418|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24448524|NCT00312130|Vildagliptin|vildagliptin|mesh-list
24463583|NCT00361452|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24463586|NCT00361517|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
24463587|NCT00361517|Deoxycholic Acid|deoxycholic acid|mesh-list
24463588|NCT00361517|Amebicides|amebicides|mesh-ancestor
24463589|NCT00361517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24463590|NCT00361517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24463591|NCT00361517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25022016|NCT03666494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022019|NCT03666494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25022020|NCT03666390|Midazolam|midazolam|mesh-list
25022021|NCT03666390|Ketamine|ketamine|mesh-list
25022022|NCT03666390|Analgesics|analgesics|mesh-ancestor
25022023|NCT03666390|Sensory System Agents|sensory system agents|mesh-ancestor
25022024|NCT03666390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25022025|NCT03666390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022026|NCT03666390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25404558|NCT03661307|Antimetabolites|antimetabolites|mesh-ancestor
25022065|NCT03666299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25022066|NCT03666299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022067|NCT03666299|Sensory System Agents|sensory system agents|mesh-ancestor
25022068|NCT03666299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25022069|NCT03666299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25022070|NCT03666299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25022071|NCT03666299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25022072|NCT03666299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25022073|NCT03666299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022074|NCT03666221|Nimotuzumab|nimotuzumab|mesh-list
25022075|NCT03666221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25022076|NCT03666221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25022077|NCT03666208|Sirolimus|sirolimus|mesh-list
25022078|NCT03666208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25022079|NCT03666208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25022080|NCT03666208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25022081|NCT03666208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25022082|NCT03666208|Antifungal Agents|antifungal agents|mesh-ancestor
25022083|NCT03666208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25022084|NCT03666208|Immunologic Factors|immunologic factors|mesh-ancestor
25022085|NCT03666208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022086|NCT03666195|Titanium dioxide|titanium dioxide|mesh-list
25022087|NCT03666195|Sunscreening Agents|sunscreening agents|mesh-ancestor
25022088|NCT03666195|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25022089|NCT03666195|Protective Agents|protective agents|mesh-ancestor
25022090|NCT03666195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978670|NCT03432741|Antiviral Agents|antiviral agents|mesh-ancestor
24978671|NCT03432741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24978672|NCT03432741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978673|NCT03432741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25022127|NCT03665753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25022128|NCT03665753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022129|NCT03665753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25022130|NCT03665753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25022131|NCT03665753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25022132|NCT03665753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022133|NCT03665753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022134|NCT03665740|Resveratrol|resveratrol|mesh-list
25022135|NCT03665740|Antioxidants|antioxidants|mesh-ancestor
25022170|NCT03665454|Dopamine Agents|dopamine agents|mesh-ancestor
25022171|NCT03665454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25022172|NCT03665454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022200|NCT03665428|Bismuth|bismuth|mesh-list
25022201|NCT03665428|Antacids|antacids|mesh-ancestor
25022202|NCT03665428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022203|NCT03665428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25022204|NCT03665402|Isoniazid|isoniazid|mesh-list
25022205|NCT03665402|Antitubercular Agents|antitubercular agents|mesh-ancestor
25022206|NCT03665402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25022211|NCT03665402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022212|NCT03665402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25022213|NCT03665350|Insulin|insulin|mesh-list
25022214|NCT03665350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25022215|NCT03665350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022216|NCT03665181|Bismuth|bismuth|mesh-list
25022217|NCT03665181|Antacids|antacids|mesh-ancestor
25022218|NCT03665181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022219|NCT03665181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25022220|NCT03664986|Bupivacaine|bupivacaine|mesh-list
25022221|NCT03664986|Anesthetics, Local|anesthetics, local|mesh-ancestor
25022222|NCT03664986|Anesthetics|anesthetics|mesh-ancestor
25404635|NCT03656536|Gemcitabine|gemcitabine|mesh-list
25022241|NCT03664622|Ketamine|ketamine|mesh-list
25022242|NCT03664622|Morphine|morphine|mesh-list
25022243|NCT03664622|Analgesics|analgesics|mesh-ancestor
25022244|NCT03664622|Sensory System Agents|sensory system agents|mesh-ancestor
24978749|NCT02995252|Tenofovir|tenofovir|mesh-list
25022245|NCT03664622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25022246|NCT03664622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022247|NCT03664622|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25022248|NCT03664622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25022249|NCT03664622|Anesthetics, General|anesthetics, general|mesh-ancestor
25022250|NCT03664622|Anesthetics|anesthetics|mesh-ancestor
25022251|NCT03664622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25022299|NCT03664375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022300|NCT03664375|Cholinergic Agents|cholinergic agents|mesh-ancestor
25022301|NCT03664375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25022302|NCT03664375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022303|NCT03664375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25022304|NCT03664375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24978818|NCT02774265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022305|NCT03664115|Itraconazole|itraconazole|mesh-list
25022306|NCT03664115|Antifungal Agents|antifungal agents|mesh-ancestor
25022307|NCT03664115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25022308|NCT03664115|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25022318|NCT03664063|Ivermectin|ivermectin|mesh-list
25022319|NCT03664063|Albendazole|albendazole|mesh-list
25022320|NCT03664063|Diethylcarbamazine|diethylcarbamazine|mesh-list
25022321|NCT03664063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25022322|NCT03664063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25022323|NCT03664063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25022324|NCT03664063|Anthelmintics|anthelmintics|mesh-ancestor
25022325|NCT03664063|Anticestodal Agents|anticestodal agents|mesh-ancestor
25022326|NCT03664063|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25022327|NCT03664063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25022328|NCT03664063|Tubulin Modulators|tubulin modulators|mesh-ancestor
25022329|NCT03664063|Antimitotic Agents|antimitotic agents|mesh-ancestor
25022330|NCT03664063|Mitosis Modulators|mitosis modulators|mesh-ancestor
25022331|NCT03664063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022332|NCT03664063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25022333|NCT03664063|Filaricides|filaricides|mesh-ancestor
25022334|NCT03664063|Antinematodal Agents|antinematodal agents|mesh-ancestor
25022335|NCT03664063|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25022336|NCT03664063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022337|NCT03664050|Letrozole|letrozole|mesh-list
25022338|NCT03664050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25022339|NCT03664050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24984572|NCT04385433|Pravastatin|pravastatin|mesh-list
24463614|NCT00361621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24463615|NCT00361621|Alkylating Agents|alkylating agents|mesh-ancestor
24463616|NCT00361621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463617|NCT00361621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25022341|NCT03664050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022345|NCT03664050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25022347|NCT03664037|Dexamethasone|dexamethasone|mesh-list
25022348|NCT03664037|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25022349|NCT03664037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25022350|NCT03664037|Antiemetics|antiemetics|mesh-ancestor
25022351|NCT03664037|Autonomic Agents|autonomic agents|mesh-ancestor
25022352|NCT03664037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25022353|NCT03664037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022354|NCT03664037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25022355|NCT03664037|Glucocorticoids|glucocorticoids|mesh-ancestor
25022356|NCT03664037|Hormones|hormones|mesh-ancestor
25022357|NCT03664037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25691074|NCT01982240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25691075|NCT01982240|Laxatives|laxatives|mesh-ancestor
25691076|NCT01982240|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25022358|NCT03664037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25404636|NCT03656536|Cisplatin|cisplatin|mesh-list
24713441|NCT01526122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25022390|NCT03663114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022393|NCT03662984|Antimetabolites|antimetabolites|mesh-ancestor
25022394|NCT03662984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022395|NCT03662984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25022396|NCT03662971|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25022397|NCT03662971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25022398|NCT03662958|Leuprolide|leuprolide|mesh-list
25022399|NCT03662958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25022400|NCT03662958|Fertility Agents|fertility agents|mesh-ancestor
25022401|NCT03662958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25022402|NCT03662958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022403|NCT03662958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25022404|NCT03662958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25022405|NCT03662893|Muscarinic Antagonists|muscarinic antagonists|mesh-list
25022406|NCT03662893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25022407|NCT03662893|Cholinergic Agents|cholinergic agents|mesh-ancestor
25022408|NCT03662893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25022409|NCT03662893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022410|NCT03662893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022411|NCT03662763|Guanfacine|guanfacine|mesh-list
25022412|NCT03662763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25022413|NCT03662763|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25022414|NCT03662763|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25022415|NCT03662763|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24984643|NCT04291599|Ketorolac|ketorolac|mesh-list
24463833|NCT00362323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463834|NCT00362323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25022416|NCT03662763|Adrenergic Agents|adrenergic agents|mesh-ancestor
25022417|NCT03662763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25022418|NCT03662763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022419|NCT03662763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022421|NCT03662724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25022422|NCT03662711|Bronchodilator Agents|bronchodilator agents|mesh-list
25022423|NCT03662711|Olodaterol|olodaterol|mesh-list
25022424|NCT03662711|Autonomic Agents|autonomic agents|mesh-ancestor
25022425|NCT03662711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25022426|NCT03662711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691086|NCT01982435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691087|NCT01982435|Growth Inhibitors|growth inhibitors|mesh-ancestor
25691088|NCT01982435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25691089|NCT01982539|Diclofenac|diclofenac|mesh-list
25691090|NCT01982539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25691091|NCT01982539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25691092|NCT01982539|Analgesics|analgesics|mesh-ancestor
24463853|NCT00362531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24463854|NCT00362531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463855|NCT00362544|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24463888|NCT00362687|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25022453|NCT03662568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25022454|NCT03662568|Antiviral Agents|antiviral agents|mesh-ancestor
25022455|NCT03662568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25022456|NCT03662568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25691094|NCT01982539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25691095|NCT01982539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691096|NCT01982539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25691097|NCT01982539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25691098|NCT01982539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25691099|NCT01982539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691100|NCT01982539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691101|NCT01982643|Naltrexone|naltrexone|mesh-list
25691102|NCT01982643|Bupropion|bupropion|mesh-list
25691103|NCT01982643|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25691104|NCT01982643|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25691105|NCT01982643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022460|NCT03662516|Levonorgestrel|levonorgestrel|mesh-list
25022461|NCT03662516|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25022462|NCT03662516|Contraceptive Agents|contraceptive agents|mesh-list
25022463|NCT03662516|Contraceptives, Oral|contraceptives, oral|mesh-list
25022465|NCT03662516|Abrocitinib|abrocitinib|mesh-list
25022466|NCT03662516|Estrogens|estrogens|mesh-ancestor
25022467|NCT03662516|Hormones|hormones|mesh-ancestor
25022468|NCT03662516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25022469|NCT03662516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022470|NCT03662516|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25022471|NCT03662516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24463925|NCT00362752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24448684|NCT00312598|Dopamine Agonists|dopamine agonists|mesh-ancestor
24463945|NCT00362804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24463946|NCT00362804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24463947|NCT00362804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463949|NCT00362804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24463950|NCT00362804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463956|NCT00362869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24463957|NCT00362869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24463958|NCT00362869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24463959|NCT00362869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022472|NCT03662516|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25022473|NCT03662516|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25022474|NCT03662516|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25022475|NCT03662516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25022476|NCT03662516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022477|NCT03662516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25111827|NCT04608474|Evolocumab|evolocumab|mesh-list
25111828|NCT04608474|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
25111829|NCT04608474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24979098|NCT00688376|Cholinergic Agents|cholinergic agents|mesh-ancestor
24979099|NCT00688376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24979100|NCT00688376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979101|NCT00688376|Nootropic Agents|nootropic agents|mesh-ancestor
24463960|NCT00362869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463961|NCT00362869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25691106|NCT01982643|Sensory System Agents|sensory system agents|mesh-ancestor
25691107|NCT01982643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25691108|NCT01982643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25691109|NCT01982643|Antidepressive Agents|antidepressive agents|mesh-ancestor
25691110|NCT01982643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25691111|NCT01982643|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25691112|NCT01982643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25691113|NCT01982643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24452511|NCT05458479|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24587192|NCT00893724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587193|NCT00893724|Protective Agents|protective agents|mesh-ancestor
24587194|NCT00893724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24587195|NCT00893724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24587196|NCT00893724|Antiviral Agents|antiviral agents|mesh-ancestor
24634098|NCT01132027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634099|NCT01132027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634101|NCT01132040|Anticonvulsants|anticonvulsants|mesh-ancestor
24587228|NCT00893854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587229|NCT00893854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587230|NCT00893854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587231|NCT00893854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24587232|NCT00893854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24587233|NCT00893854|Analgesics|analgesics|mesh-ancestor
24587234|NCT00893854|Sensory System Agents|sensory system agents|mesh-ancestor
24587235|NCT00893854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24587236|NCT00893854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24452512|NCT05458479|Antidepressive Agents|antidepressive agents|mesh-ancestor
24452550|NCT05458180|Glucocorticoids|glucocorticoids|mesh-ancestor
24452551|NCT05458180|Hormones|hormones|mesh-ancestor
24452552|NCT05458180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24452553|NCT05458180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24714225|NCT01529476|Levofloxacin|levofloxacin|mesh-list
24452554|NCT05458180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25691114|NCT01982643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691115|NCT01982643|Dopamine Agents|dopamine agents|mesh-ancestor
25691116|NCT01982643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25691117|NCT01982643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25691118|NCT01982643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25691119|NCT01982643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022481|NCT03662425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022484|NCT03662412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25022515|NCT03662113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022516|NCT03662113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25022517|NCT03662113|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25022518|NCT03662113|Dopamine Agents|dopamine agents|mesh-ancestor
25022519|NCT03662113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25022520|NCT03662113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022521|NCT03662113|Antifoaming Agents|antifoaming agents|mesh-ancestor
25022522|NCT03662113|Emollients|emollients|mesh-ancestor
25022523|NCT03662113|Dermatologic Agents|dermatologic agents|mesh-ancestor
25022524|NCT03662100|Mirikizumab|mirikizumab|mesh-list
25022525|NCT03662100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25022526|NCT03662100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25022527|NCT03662100|Analgesics|analgesics|mesh-ancestor
25022528|NCT03662100|Sensory System Agents|sensory system agents|mesh-ancestor
25022529|NCT03662100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25022558|NCT03661788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022559|NCT03661788|Adrenergic Agents|adrenergic agents|mesh-ancestor
25022560|NCT03661788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25022561|NCT03661788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022562|NCT03661775|Magnesium Sulfate|magnesium sulfate|mesh-list
25022569|NCT03661775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25022570|NCT03661775|Anticonvulsants|anticonvulsants|mesh-ancestor
25022571|NCT03661775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25022572|NCT03661775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24979184|NCT05152888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24979185|NCT05152888|Antimetabolites|antimetabolites|mesh-ancestor
24979186|NCT05152888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979187|NCT05152888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24979188|NCT05152017|Vaccines|vaccines|mesh-list
24979189|NCT05152017|Immunologic Factors|immunologic factors|mesh-ancestor
24979190|NCT05152017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979191|NCT05142735|Acetylcysteine|acetylcysteine|mesh-list
24979192|NCT05142735|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24979193|NCT05142735|Antiviral Agents|antiviral agents|mesh-ancestor
24784734|NCT01910155|Hormones|hormones|mesh-ancestor
24448834|NCT00313235|Vaccines|vaccines|mesh-list
25691127|NCT01982682|Alkylating Agents|alkylating agents|mesh-ancestor
25691128|NCT01982682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691129|NCT01982682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25691130|NCT01982682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25691131|NCT01982682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25691132|NCT01982682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25691133|NCT01982682|Antitubercular Agents|antitubercular agents|mesh-ancestor
25691134|NCT01982682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25022577|NCT03661684|Prednisone|prednisone|mesh-list
25022578|NCT03661684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25022579|NCT03661684|Glucocorticoids|glucocorticoids|mesh-ancestor
25022580|NCT03661684|Hormones|hormones|mesh-ancestor
25022581|NCT03661684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25022582|NCT03661684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022583|NCT03661684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25022584|NCT03661684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25022585|NCT03661567|Methylprednisolone|methylprednisolone|mesh-list
25022586|NCT03661567|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25022587|NCT03661567|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24788946|NCT01934816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24453210|NCT05238831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24453212|NCT05238831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25106861|NCT03144401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25106862|NCT03144401|Oxytocics|oxytocics|mesh-ancestor
25106863|NCT03144115|Oxytocin|oxytocin|mesh-list
25106864|NCT03144115|Oxytocics|oxytocics|mesh-ancestor
25106865|NCT03144115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25106866|NCT03144115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106867|NCT03144128|Vitamin D|vitamin d|mesh-list
25022588|NCT03661567|Prednisolone|prednisolone|mesh-list
25022589|NCT03661567|Prednisolone acetate|prednisolone acetate|mesh-list
25022590|NCT03661567|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25022591|NCT03661567|Prednisolone phosphate|prednisolone phosphate|mesh-list
25022592|NCT03661567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25022593|NCT03661567|Antiemetics|antiemetics|mesh-ancestor
25022594|NCT03661567|Autonomic Agents|autonomic agents|mesh-ancestor
25022595|NCT03661567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25022596|NCT03661567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022597|NCT03661567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25022598|NCT03661567|Glucocorticoids|glucocorticoids|mesh-ancestor
25022599|NCT03661567|Hormones|hormones|mesh-ancestor
25022600|NCT03661567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25022601|NCT03661567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25022602|NCT03661567|Protective Agents|protective agents|mesh-ancestor
25022603|NCT03661567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25022604|NCT03661567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25022605|NCT03661515|Cytarabine|cytarabine|mesh-list
25022606|NCT03661515|Fludarabine|fludarabine|mesh-list
25691138|NCT01982695|Lisinopril|lisinopril|mesh-list
25691139|NCT01982695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25691140|NCT01982695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25691141|NCT01982695|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25691142|NCT01982695|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25691143|NCT01982695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022607|NCT03661515|Idarubicin|idarubicin|mesh-list
25022608|NCT03661515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25022636|NCT03661463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25022649|NCT03661385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25022650|NCT03661385|Respiratory System Agents|respiratory system agents|mesh-ancestor
25022651|NCT03661385|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25022652|NCT03661385|Antioxidants|antioxidants|mesh-ancestor
25022653|NCT03661385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25111871|NCT04569747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25111872|NCT04569747|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25111873|NCT04569747|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24465174|NCT00368121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465175|NCT00368121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24465176|NCT00368134|Vildagliptin|vildagliptin|mesh-list
24465177|NCT00368134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24465178|NCT00368134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465179|NCT00368134|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24465180|NCT00368134|Protease Inhibitors|protease inhibitors|mesh-ancestor
24465187|NCT00368160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465188|NCT00368238|Aspirin|aspirin|mesh-list
24465486|NCT00369863|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24465487|NCT00369863|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24465490|NCT00369863|Glucocorticoids|glucocorticoids|mesh-ancestor
24715005|NCT01533740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715006|NCT01533740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24715007|NCT01533740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24757372|NCT01739556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25022701|NCT03660436|BMS-986165|bms-986165|mesh-list
25022702|NCT03660436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25022703|NCT03660436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25022704|NCT03660436|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25022705|NCT03660436|Antitubercular Agents|antitubercular agents|mesh-ancestor
25022706|NCT03660436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25022707|NCT03660436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24465780|NCT00370721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465788|NCT00370734|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24465789|NCT00370734|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24465790|NCT00370734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25022708|NCT03660436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022709|NCT03660436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022710|NCT03660436|Dermatologic Agents|dermatologic agents|mesh-ancestor
25022711|NCT03660436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25022712|NCT03660397|Antihypertensive Agents|antihypertensive agents|mesh-list
25022713|NCT03660306|Analgesics, Opioid|analgesics, opioid|mesh-list
25022714|NCT03660306|Anesthetics|anesthetics|mesh-list
25022742|NCT03660267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24465832|NCT00370760|Antimitotic Agents|antimitotic agents|mesh-ancestor
24465833|NCT00370760|Mitosis Modulators|mitosis modulators|mesh-ancestor
24465834|NCT00370786|Bevacizumab|bevacizumab|mesh-list
24465835|NCT00370786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24465836|NCT00370786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465876|NCT00371007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465877|NCT00371007|Incretins|incretins|mesh-ancestor
24465878|NCT00371007|Hormones|hormones|mesh-ancestor
24465879|NCT00371007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24465880|NCT00371007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24465896|NCT00371033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465897|NCT00371033|Anticonvulsants|anticonvulsants|mesh-ancestor
25022758|NCT03660020|Anesthetics|anesthetics|mesh-list
25022759|NCT03660020|Anesthetics, Local|anesthetics, local|mesh-list
25022760|NCT03660020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25022761|NCT03660020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979435|NCT04338828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24979436|NCT04338828|Respiratory System Agents|respiratory system agents|mesh-ancestor
24979437|NCT04338828|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24979438|NCT04338828|Antioxidants|antioxidants|mesh-ancestor
24979439|NCT04338828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979440|NCT04338828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24979441|NCT04338828|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24979442|NCT04338828|Vasodilator Agents|vasodilator agents|mesh-ancestor
24979443|NCT04338828|Gasotransmitters|gasotransmitters|mesh-ancestor
24979444|NCT04338828|Protective Agents|protective agents|mesh-ancestor
24917387|NCT04230330|Autonomic Agents|autonomic agents|mesh-ancestor
24587287|NCT00894010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24587288|NCT00894010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24587289|NCT00894010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587290|NCT00894010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24587291|NCT00894010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24587292|NCT00894023|Abciximab|abciximab|mesh-list
24587293|NCT00894023|Anticoagulants|anticoagulants|mesh-ancestor
24587294|NCT00894023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24587295|NCT00894062|Everolimus|everolimus|mesh-list
24465898|NCT00371033|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24587348|NCT00894569|Cetuximab|cetuximab|mesh-list
24587349|NCT00894569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24756151|NCT01731275|Immunologic Factors|immunologic factors|mesh-ancestor
24587350|NCT00894569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587351|NCT00894569|Tubulin Modulators|tubulin modulators|mesh-ancestor
24587352|NCT00894569|Antimitotic Agents|antimitotic agents|mesh-ancestor
24587353|NCT00894569|Mitosis Modulators|mitosis modulators|mesh-ancestor
24587368|NCT00894621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24587369|NCT00894621|Adrenergic Agents|adrenergic agents|mesh-ancestor
24587370|NCT00894621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24587371|NCT00894621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587372|NCT00894621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587373|NCT00894621|Sympathomimetics|sympathomimetics|mesh-ancestor
24587374|NCT00894621|Autonomic Agents|autonomic agents|mesh-ancestor
24587375|NCT00894621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24587376|NCT00894621|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24587377|NCT00894634|Brompheniramine|brompheniramine|mesh-list
24587378|NCT00894634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022762|NCT03660020|Sensory System Agents|sensory system agents|mesh-ancestor
25022763|NCT03660020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25022764|NCT03659851|Simendan|simendan|mesh-list
25022765|NCT03659851|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25022766|NCT03659851|Vasodilator Agents|vasodilator agents|mesh-ancestor
25022767|NCT03659851|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25022768|NCT03659851|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25022794|NCT03659292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022795|NCT03659162|Antifungal Agents|antifungal agents|mesh-list
25022796|NCT03659162|Clotrimazole|clotrimazole|mesh-list
25022797|NCT03659162|Miconazole|miconazole|mesh-list
25022798|NCT03659162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25022799|NCT03659162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25022800|NCT03659162|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24465901|NCT00371033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24465953|NCT00371319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465954|NCT00371319|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24465955|NCT00371319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24909683|NCT04306471|Evolocumab|evolocumab|mesh-list
24465956|NCT00371319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465957|NCT00371319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24465958|NCT00371319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25022802|NCT03659162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022803|NCT03659162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022804|NCT03659162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25022805|NCT03659162|Hormone Antagonists|hormone antagonists|mesh-ancestor
25022806|NCT03659162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25022807|NCT03659162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022808|NCT03659162|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25022809|NCT03659162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25022811|NCT03659084|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25022812|NCT03659084|Chelating Agents|chelating agents|mesh-ancestor
25022813|NCT03659084|Sequestering Agents|sequestering agents|mesh-ancestor
24586916|NCT00892658|Sorafenib|sorafenib|mesh-list
25022836|NCT03658850|Diuretics|diuretics|mesh-ancestor
25022837|NCT03658850|Natriuretic Agents|natriuretic agents|mesh-ancestor
25022838|NCT03658850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022839|NCT03658850|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25022840|NCT03658850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24466078|NCT00371878|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24466080|NCT00371878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466081|NCT00371904|Rituximab|rituximab|mesh-list
24788963|NCT01934933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24788964|NCT01934933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24788965|NCT01934933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24788966|NCT01934933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24788968|NCT01934933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466082|NCT00371904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24466083|NCT00371904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466084|NCT00371904|Immunologic Factors|immunologic factors|mesh-ancestor
24466085|NCT00371904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466086|NCT00371904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24466118|NCT00372099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466119|NCT00372099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24466120|NCT00372099|Vasodilator Agents|vasodilator agents|mesh-ancestor
24466122|NCT00372138|Hemostatics|hemostatics|mesh-ancestor
24466123|NCT00372138|Coagulants|coagulants|mesh-ancestor
24466124|NCT00372177|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
24466125|NCT00372177|Immunologic Factors|immunologic factors|mesh-ancestor
24466126|NCT00372177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466145|NCT00372294|Clindamycin palmitate|clindamycin palmitate|mesh-list
24466146|NCT00372294|Clindamycin phosphate|clindamycin phosphate|mesh-list
24466147|NCT00372294|Sulfadiazine|sulfadiazine|mesh-list
24466148|NCT00372294|Pyrimethamine|pyrimethamine|mesh-list
24466149|NCT00372294|Dexamethasone|dexamethasone|mesh-list
24466150|NCT00372294|Prednisolone|prednisolone|mesh-list
24466151|NCT00372294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24466152|NCT00372294|Antiemetics|antiemetics|mesh-ancestor
24466153|NCT00372294|Autonomic Agents|autonomic agents|mesh-ancestor
24466230|NCT00372658|Lidocaine|lidocaine|mesh-list
24466232|NCT00372658|Anesthetics|anesthetics|mesh-ancestor
25022844|NCT03658785|Fludarabine|fludarabine|mesh-list
25022845|NCT03658785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25022846|NCT03658785|Immunologic Factors|immunologic factors|mesh-ancestor
25022847|NCT03658785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022848|NCT03658785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25022849|NCT03658785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25022850|NCT03658785|Alkylating Agents|alkylating agents|mesh-ancestor
25022851|NCT03658785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022852|NCT03658785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25022853|NCT03658785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25022854|NCT03658785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25022855|NCT03658785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25022856|NCT03658785|Antiviral Agents|antiviral agents|mesh-ancestor
25022857|NCT03658785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25691145|NCT01982695|Protease Inhibitors|protease inhibitors|mesh-ancestor
25691146|NCT01982695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691147|NCT01982695|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24466319|NCT00373061|Omalizumab|omalizumab|mesh-list
24466320|NCT00373061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24466567|NCT00373906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466568|NCT00373919|Erythromycin|erythromycin|mesh-list
24466569|NCT00373919|Erythromycin Estolate|erythromycin estolate|mesh-list
24466570|NCT00373919|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24466571|NCT00373919|Erythromycin stearate|erythromycin stearate|mesh-list
24466572|NCT00373919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24466573|NCT00373919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24466648|NCT00374426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24466650|NCT00374426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466651|NCT00374465|Verapamil|verapamil|mesh-list
24466652|NCT00374465|Carvedilol|carvedilol|mesh-list
24466653|NCT00374465|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24466654|NCT00374465|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24466655|NCT00374465|Adrenergic Agents|adrenergic agents|mesh-ancestor
25022885|NCT03658746|Antacids|antacids|mesh-ancestor
25022886|NCT03658746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25022887|NCT03658746|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25022888|NCT03658746|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25022889|NCT03658746|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25022890|NCT03658746|Alkylating Agents|alkylating agents|mesh-ancestor
25022891|NCT03658733|Amoxicillin|amoxicillin|mesh-list
25022892|NCT03658733|Tetracycline|tetracycline|mesh-list
25022893|NCT03658733|Furazolidone|furazolidone|mesh-list
25022894|NCT03658733|Esomeprazole|esomeprazole|mesh-list
25022895|NCT03658733|Rabeprazole|rabeprazole|mesh-list
25022896|NCT03658733|Bismuth|bismuth|mesh-list
25022897|NCT03658733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25022898|NCT03658733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25022899|NCT03658733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24466671|NCT00374478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24466672|NCT00374478|Antiemetics|antiemetics|mesh-ancestor
25691148|NCT01982695|Protective Agents|protective agents|mesh-ancestor
25691149|NCT01982695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691150|NCT01982812|Levetiracetam|levetiracetam|mesh-list
25691151|NCT01982812|Anticonvulsants|anticonvulsants|mesh-ancestor
25691152|NCT01982812|Nootropic Agents|nootropic agents|mesh-ancestor
25691153|NCT01982942|Ibudilast|ibudilast|mesh-list
25691154|NCT01982942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25691155|NCT01982942|Autonomic Agents|autonomic agents|mesh-ancestor
24466673|NCT00374478|Autonomic Agents|autonomic agents|mesh-ancestor
24415962|NCT00201682|Analgesics|analgesics|mesh-ancestor
24466751|NCT00374855|Natriuretic Agents|natriuretic agents|mesh-ancestor
24909836|NCT04304209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064709|NCT03457597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24909838|NCT04304157|Dexmedetomidine|dexmedetomidine|mesh-list
24466752|NCT00374855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466753|NCT00374855|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24466754|NCT00374855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25022900|NCT03658733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25022901|NCT03658733|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25022902|NCT03658733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022903|NCT03658733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022930|NCT03658590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022931|NCT03658590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25022932|NCT03658590|Glucocorticoids|glucocorticoids|mesh-ancestor
25022933|NCT03658590|Hormones|hormones|mesh-ancestor
25022934|NCT03658590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25022935|NCT03658590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25022936|NCT03658590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25022938|NCT03658473|Rabeprazole|rabeprazole|mesh-list
25022939|NCT03658473|Rebamipide|rebamipide|mesh-list
25022940|NCT03658473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25022941|NCT03658473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25022942|NCT03658473|Analgesics|analgesics|mesh-ancestor
25022943|NCT03658473|Sensory System Agents|sensory system agents|mesh-ancestor
25022944|NCT03658473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25022945|NCT03658473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022946|NCT03658473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25022947|NCT03658473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25022948|NCT03658473|Gout Suppressants|gout suppressants|mesh-ancestor
25022949|NCT03658473|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24985001|NCT03772951|Clozapine|clozapine|mesh-list
24466755|NCT00374855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466757|NCT00374881|Oxymetazoline|oxymetazoline|mesh-list
24466758|NCT00374881|Morphine|morphine|mesh-list
24466759|NCT00374881|Sorbitol|sorbitol|mesh-list
24466817|NCT00375232|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24466818|NCT00375232|Hormone Antagonists|hormone antagonists|mesh-ancestor
24466819|NCT00375232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24466820|NCT00375232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466821|NCT00375232|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24466822|NCT00375232|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24466823|NCT00375232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466824|NCT00375245|Sirolimus|sirolimus|mesh-list
24466841|NCT00375284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466842|NCT00375284|Protective Agents|protective agents|mesh-ancestor
24466843|NCT00375284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022950|NCT03658473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022951|NCT03658473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022952|NCT03658473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25022953|NCT03658473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25022954|NCT03658473|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25022984|NCT03658330|Sensory System Agents|sensory system agents|mesh-ancestor
25022985|NCT03658330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25022986|NCT03658330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022987|NCT03658330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25022988|NCT03658330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25022989|NCT03658330|Anesthetics, General|anesthetics, general|mesh-ancestor
25022991|NCT03658330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25691156|NCT01982942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25691157|NCT01982942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691158|NCT01982942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25691159|NCT01982942|Respiratory System Agents|respiratory system agents|mesh-ancestor
25691160|NCT01982942|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25691161|NCT01982942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022993|NCT03658330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25022994|NCT03658330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25022995|NCT03658330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985012|NCT03772951|GABA Agents|gaba agents|mesh-ancestor
24466844|NCT00375284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24466977|NCT00375843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24466984|NCT00375843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24466985|NCT00375843|Antidepressive Agents|antidepressive agents|mesh-ancestor
24466990|NCT00375895|Cyclosporins|cyclosporins|mesh-list
24466991|NCT00375895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466992|NCT00375895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467001|NCT00376012|Rifampin|rifampin|mesh-list
24467006|NCT00376012|Antitubercular Agents|antitubercular agents|mesh-ancestor
24467007|NCT00376012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24467008|NCT00376012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24467009|NCT00376012|Leprostatic Agents|leprostatic agents|mesh-ancestor
24467010|NCT00376012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24467429|NCT00377559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24467430|NCT00377559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467431|NCT00377624|Hyaluronic Acid|hyaluronic acid|mesh-list
24467435|NCT00377624|Viscosupplements|viscosupplements|mesh-ancestor
24467472|NCT00377806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24467473|NCT00377806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467474|NCT00377806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467475|NCT00377910|Lidocaine|lidocaine|mesh-list
24467476|NCT00377910|Polidocanol|polidocanol|mesh-list
24467477|NCT00377910|Anesthetics, Local|anesthetics, local|mesh-ancestor
25022996|NCT03658330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25022997|NCT03658330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25022998|NCT03658317|Uric Acid|uric acid|mesh-list
25022999|NCT03658317|Antioxidants|antioxidants|mesh-ancestor
24979715|NCT02968602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24979716|NCT02946047|Ixazomib|ixazomib|mesh-list
24979717|NCT02946047|Glycine|glycine|mesh-list
24979718|NCT02946047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979719|NCT02946047|Protease Inhibitors|protease inhibitors|mesh-ancestor
24979720|NCT02946047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24979721|NCT02946047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979722|NCT02946047|Glycine Agents|glycine agents|mesh-ancestor
24979723|NCT02946047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24979724|NCT02946047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587379|NCT00894634|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24587380|NCT00894634|Histamine Antagonists|histamine antagonists|mesh-ancestor
24587381|NCT00894634|Histamine Agents|histamine agents|mesh-ancestor
24587382|NCT00894634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24587383|NCT00894634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587384|NCT00894634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24587385|NCT00894660|Amodiaquine|amodiaquine|mesh-list
24587386|NCT00894660|Antimalarials|antimalarials|mesh-ancestor
24587387|NCT00894660|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24587388|NCT00894660|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24715835|NCT01538693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24757670|NCT01741623|Bisoprolol|bisoprolol|mesh-list
24587389|NCT00894660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24587391|NCT00894673|Calcium heparin|calcium heparin|mesh-list
24587392|NCT00894673|Anticoagulants|anticoagulants|mesh-ancestor
24587393|NCT00894673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24587394|NCT00894673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25691162|NCT01982942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691163|NCT01982942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25691164|NCT01982942|Vasodilator Agents|vasodilator agents|mesh-ancestor
25691165|NCT01983020|Lidocaine|lidocaine|mesh-list
24587399|NCT00894712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023025|NCT03658109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023026|NCT03658109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25023028|NCT03658109|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25023029|NCT03658109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25023030|NCT03658109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023032|NCT03658057|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25023033|NCT03658057|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25023035|NCT03658057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023036|NCT03658057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023037|NCT03658031|Dapagliflozin|dapagliflozin|mesh-list
25023038|NCT03658031|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25023039|NCT03658031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023040|NCT03658031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25023041|NCT03658031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023059|NCT03657966|Antimetabolites|antimetabolites|mesh-ancestor
25023060|NCT03657966|Antiviral Agents|antiviral agents|mesh-ancestor
24619700|NCT01053390|Hormones|hormones|mesh-ancestor
25023061|NCT03657966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25023062|NCT03657966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25023063|NCT03657966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25023064|NCT03657966|Immunologic Factors|immunologic factors|mesh-ancestor
25023065|NCT03657966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106897|NCT03143972|Remifentanil|remifentanil|mesh-list
24467752|NCT00378638|Growth Substances|growth substances|mesh-ancestor
24467753|NCT00378638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467754|NCT00378638|Growth Inhibitors|growth inhibitors|mesh-ancestor
24467756|NCT00378677|Cyclosporins|cyclosporins|mesh-list
24467757|NCT00378677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24468524|NCT00382057|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24467758|NCT00378677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467759|NCT00378677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24467760|NCT00378677|Immunologic Factors|immunologic factors|mesh-ancestor
24467761|NCT00378677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467762|NCT00378677|Antifungal Agents|antifungal agents|mesh-ancestor
24467763|NCT00378677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24467764|NCT00378677|Dermatologic Agents|dermatologic agents|mesh-ancestor
24467893|NCT00379028|Dermatologic Agents|dermatologic agents|mesh-ancestor
24468153|NCT00380224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24468154|NCT00380224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468155|NCT00380224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24468163|NCT00380224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023067|NCT03657862|Cariostatic Agents|cariostatic agents|mesh-ancestor
25023068|NCT03657862|Protective Agents|protective agents|mesh-ancestor
25023069|NCT03657862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023070|NCT03657836|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25023071|NCT03657836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25023072|NCT03657758|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25023073|NCT03657758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25023074|NCT03657758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25023076|NCT03657758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023077|NCT03657758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25023078|NCT03657758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24468164|NCT00380224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24468165|NCT00380224|Serotonin Agents|serotonin agents|mesh-ancestor
25691166|NCT01983020|Ketamine|ketamine|mesh-list
24716146|NCT01540110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468375|NCT00381199|Antiemetics|antiemetics|mesh-ancestor
24468376|NCT00381199|Autonomic Agents|autonomic agents|mesh-ancestor
24468377|NCT00381199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24468378|NCT00381199|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24468379|NCT00381199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24468380|NCT00381199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24468442|NCT00381537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24468443|NCT00381537|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24468444|NCT00381537|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24468445|NCT00381537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24468446|NCT00381537|GABA Modulators|gaba modulators|mesh-ancestor
25023087|NCT03657602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023088|NCT03657602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25023089|NCT03657602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25023090|NCT03657602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25023093|NCT03657550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25023094|NCT03657550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25023095|NCT03657550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25023096|NCT03657550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023097|NCT03657550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25023128|NCT03657420|Dexamethasone|dexamethasone|mesh-list
24979801|NCT05241054|Narcotics|narcotics|mesh-ancestor
24979802|NCT05241054|Analgesics|analgesics|mesh-ancestor
24979803|NCT05241054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24979804|NCT05241054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24979805|NCT05241054|Antipyretics|antipyretics|mesh-ancestor
24985022|NCT03735420|Growth Substances|growth substances|mesh-ancestor
24468447|NCT00381537|GABA Agents|gaba agents|mesh-ancestor
24468448|NCT00381537|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25691167|NCT01983020|Anesthetics, Local|anesthetics, local|mesh-ancestor
25691168|NCT01983020|Anesthetics|anesthetics|mesh-ancestor
25691169|NCT01983020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25691170|NCT01983020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691171|NCT01983020|Sensory System Agents|sensory system agents|mesh-ancestor
24561443|NCT00760448|Insulin|insulin|mesh-list
25691172|NCT01983020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25691173|NCT01983020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24468449|NCT00381589|Bromides|bromides|mesh-list
24468480|NCT00381758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468482|NCT00381758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24468483|NCT00381836|Darbepoetin alfa|darbepoetin alfa|mesh-list
24468484|NCT00381836|Hematinics|hematinics|mesh-ancestor
24468485|NCT00381875|Sargramostim|sargramostim|mesh-list
24979809|NCT05241054|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24979810|NCT05241054|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24979812|NCT05241054|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24979813|NCT05241054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24979814|NCT05241054|Cholinergic Agents|cholinergic agents|mesh-ancestor
24979815|NCT05241054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25023137|NCT03657420|Hormones|hormones|mesh-ancestor
25023138|NCT03657420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24985049|NCT03715153|Bumetanide|bumetanide|mesh-list
24468486|NCT00381875|Freund's Adjuvant|freund's adjuvant|mesh-list
24468487|NCT00381875|Immunologic Factors|immunologic factors|mesh-ancestor
24468489|NCT00381875|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24468490|NCT00381901|Trastuzumab|trastuzumab|mesh-list
24468491|NCT00381901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24468492|NCT00381901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468493|NCT00381914|Vitamin D|vitamin d|mesh-list
24468494|NCT00381914|Ergocalciferols|ergocalciferols|mesh-list
24468495|NCT00381914|Cholecalciferol|cholecalciferol|mesh-list
24468496|NCT00381914|Vitamins|vitamins|mesh-list
24468497|NCT00381914|Micronutrients|micronutrients|mesh-ancestor
24468498|NCT00381914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468499|NCT00381914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24788996|NCT01935115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24788997|NCT01935115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468500|NCT00381914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24468501|NCT00381953|Interferons|interferons|mesh-list
24468502|NCT00381953|Ribavirin|ribavirin|mesh-list
24468503|NCT00381953|Interferon-alpha|interferon-alpha|mesh-list
24468516|NCT00382057|Goserelin|goserelin|mesh-list
24468517|NCT00382057|Testosterone|testosterone|mesh-list
24468518|NCT00382057|Androgens|androgens|mesh-ancestor
24468519|NCT00382057|Hormones|hormones|mesh-ancestor
24468520|NCT00382057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24468521|NCT00382057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468522|NCT00382057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24468523|NCT00382057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468527|NCT00382057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468529|NCT00382057|Hormone Antagonists|hormone antagonists|mesh-ancestor
24468530|NCT00382083|Acetaminophen|acetaminophen|mesh-list
24468531|NCT00382083|Ibuprofen|ibuprofen|mesh-list
24468532|NCT00382083|Lidocaine|lidocaine|mesh-list
24468543|NCT00382083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468544|NCT00382083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24468545|NCT00382083|Analgesics|analgesics|mesh-ancestor
24468546|NCT00382083|Antipyretics|antipyretics|mesh-ancestor
24468547|NCT00382083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24468548|NCT00382083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24468549|NCT00382083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24468550|NCT00382083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25023139|NCT03657420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25023140|NCT03657420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023141|NCT03657420|Immunologic Factors|immunologic factors|mesh-ancestor
25023142|NCT03657420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25023143|NCT03657420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25023144|NCT03657420|Growth Substances|growth substances|mesh-ancestor
25023145|NCT03657420|Growth Inhibitors|growth inhibitors|mesh-ancestor
25023146|NCT03657381|Antibodies|antibodies|mesh-list
25023147|NCT03657381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25023148|NCT03657381|Immunologic Factors|immunologic factors|mesh-ancestor
25023149|NCT03657381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023150|NCT03657355|Zolpidem|zolpidem|mesh-list
25023151|NCT03657355|Suvorexant|suvorexant|mesh-list
25023152|NCT03657355|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25023153|NCT03657355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24985062|NCT03711838|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24468551|NCT00382083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24468552|NCT00382135|Tadalafil|tadalafil|mesh-list
24468553|NCT00382135|Vasodilator Agents|vasodilator agents|mesh-ancestor
25064756|NCT03457025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25064757|NCT03456947|Pregabalin|pregabalin|mesh-list
25064758|NCT03456947|Analgesics|analgesics|mesh-ancestor
25064759|NCT03456947|Sensory System Agents|sensory system agents|mesh-ancestor
24870630|NCT04821284|Vitamins|vitamins|mesh-ancestor
25064760|NCT03456947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25064761|NCT03456947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064762|NCT03456947|Anticonvulsants|anticonvulsants|mesh-ancestor
24827186|NCT02137733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468574|NCT00382330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24468577|NCT00382343|Sulfamethoxazole|sulfamethoxazole|mesh-list
24468595|NCT00382356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468597|NCT00382356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24468598|NCT00382356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468600|NCT00382421|Amlodipine|amlodipine|mesh-list
24468601|NCT00382421|Bisoprolol|bisoprolol|mesh-list
24468602|NCT00382421|Molsidomine|molsidomine|mesh-list
24468603|NCT00382421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24468604|NCT00382421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24468605|NCT00382421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24468606|NCT00382421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757761|NCT01742390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757762|NCT01742390|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24757763|NCT01742390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24757765|NCT01742390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24468607|NCT00382421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24468608|NCT00382421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468609|NCT00382421|Vasodilator Agents|vasodilator agents|mesh-ancestor
24468610|NCT00382421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24468611|NCT00382421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24468655|NCT00382538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24468657|NCT00382538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24468658|NCT00382538|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24468659|NCT00382629|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
24468660|NCT00382629|Antioxidants|antioxidants|mesh-ancestor
24468661|NCT00382629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468662|NCT00382629|Protective Agents|protective agents|mesh-ancestor
24468663|NCT00382629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468664|NCT00382642|Ondansetron|ondansetron|mesh-list
24468665|NCT00382642|Antiemetics|antiemetics|mesh-ancestor
24468666|NCT00382642|Autonomic Agents|autonomic agents|mesh-ancestor
24468688|NCT00382694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468689|NCT00382837|Epratuzumab|epratuzumab|mesh-list
24468690|NCT00382837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24468691|NCT00382837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468692|NCT00382889|Beclomethasone|beclomethasone|mesh-list
24468693|NCT00382889|Albuterol|albuterol|mesh-list
24468694|NCT00382889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25023154|NCT03657355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25023155|NCT03657355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023156|NCT03657355|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25023157|NCT03657355|GABA Agonists|gaba agonists|mesh-ancestor
25023158|NCT03657355|GABA Agents|gaba agents|mesh-ancestor
25023159|NCT03657355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25023160|NCT03657355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691174|NCT01983020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25691175|NCT01983020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25691176|NCT01983020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25691177|NCT01983020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691178|NCT01983020|Analgesics|analgesics|mesh-ancestor
25691179|NCT01983020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25691180|NCT01983020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25691181|NCT01983020|Anesthetics, General|anesthetics, general|mesh-ancestor
24468695|NCT00382889|Autonomic Agents|autonomic agents|mesh-ancestor
24468696|NCT00382889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24468697|NCT00382889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468698|NCT00382889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24468699|NCT00382889|Respiratory System Agents|respiratory system agents|mesh-ancestor
24468700|NCT00382889|Tocolytic Agents|tocolytic agents|mesh-ancestor
24468701|NCT00382889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24468702|NCT00382889|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24468703|NCT00382889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24468704|NCT00382889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24468705|NCT00382889|Adrenergic Agents|adrenergic agents|mesh-ancestor
24468709|NCT00382889|Glucocorticoids|glucocorticoids|mesh-ancestor
24468711|NCT00382889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24468712|NCT00382954|Bortezomib|bortezomib|mesh-list
24468713|NCT00382954|Idarubicin|idarubicin|mesh-list
24468714|NCT00382954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468759|NCT00383136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24468760|NCT00383136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468761|NCT00383214|Epratuzumab|epratuzumab|mesh-list
24468762|NCT00383214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24468763|NCT00383214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468764|NCT00383357|Zolpidem|zolpidem|mesh-list
24468765|NCT00383357|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24468766|NCT00383357|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24468767|NCT00383357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24468768|NCT00383357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468769|NCT00383357|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24468770|NCT00383357|GABA Agonists|gaba agonists|mesh-ancestor
24468771|NCT00383357|GABA Agents|gaba agents|mesh-ancestor
24468772|NCT00383357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24468773|NCT00383357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468774|NCT00383370|Aflibercept|aflibercept|mesh-list
24468775|NCT00383370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24469632|NCT00386581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24468937|NCT00383929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468939|NCT00383929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24468940|NCT00383994|Rituximab|rituximab|mesh-list
24468941|NCT00383994|Sargramostim|sargramostim|mesh-list
24468944|NCT00383994|Immunologic Factors|immunologic factors|mesh-ancestor
24468949|NCT00384020|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24469088|NCT00384566|Sympatholytics|sympatholytics|mesh-ancestor
24469089|NCT00384566|Autonomic Agents|autonomic agents|mesh-ancestor
24469090|NCT00384566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24469091|NCT00384566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469092|NCT00384566|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24469093|NCT00384566|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24469094|NCT00384566|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24469095|NCT00384566|Adrenergic Agents|adrenergic agents|mesh-ancestor
24469098|NCT00384566|Antioxidants|antioxidants|mesh-ancestor
24469105|NCT00384566|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24469452|NCT00385931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469453|NCT00385931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24469454|NCT00385931|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24469455|NCT00385931|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25016163|NCT00389740|Hormone Antagonists|hormone antagonists|mesh-ancestor
25023161|NCT03657355|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25023162|NCT03657212|Zolpidem|zolpidem|mesh-list
25023163|NCT03657212|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25023164|NCT03657212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25023165|NCT03657212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25023166|NCT03657212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023167|NCT03657212|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25023168|NCT03657212|GABA Agonists|gaba agonists|mesh-ancestor
25023169|NCT03657212|GABA Agents|gaba agents|mesh-ancestor
25023170|NCT03657212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25023171|NCT03657212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023199|NCT03656679|Trace Elements|trace elements|mesh-ancestor
25023200|NCT03656679|Micronutrients|micronutrients|mesh-ancestor
25023201|NCT03656679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023202|NCT03656666|Thalidomide|thalidomide|mesh-list
25023203|NCT03656666|Apremilast|apremilast|mesh-list
25023208|NCT03656666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023209|NCT03656666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023210|NCT03656666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25023211|NCT03656666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24985104|NCT03647852|Prednisolone|prednisolone|mesh-list
24469457|NCT00385957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24469458|NCT00385957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24716492|NCT01541956|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24716493|NCT01541956|Protease Inhibitors|protease inhibitors|mesh-ancestor
24716494|NCT01541956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716495|NCT01541956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716496|NCT01542047|Carboplatin|carboplatin|mesh-list
24716497|NCT01542047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469459|NCT00385957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469553|NCT00386282|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24469554|NCT00386282|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24469555|NCT00386282|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24469556|NCT00386282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24469557|NCT00386282|Contraceptive Agents|contraceptive agents|mesh-ancestor
24469558|NCT00386282|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24469559|NCT00386282|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24469560|NCT00386282|Hormone Antagonists|hormone antagonists|mesh-ancestor
24469561|NCT00386282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24469562|NCT00386282|Luteolytic Agents|luteolytic agents|mesh-ancestor
24469654|NCT00386659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24979890|NCT04984083|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24979891|NCT04984083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24979892|NCT04984083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979895|NCT04976777|Dexamethasone|dexamethasone|mesh-list
24979897|NCT04976777|BB 1101|bb 1101|mesh-list
25023235|NCT03656614|Cholinergic Agents|cholinergic agents|mesh-ancestor
25023236|NCT03656614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25023237|NCT03656614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023238|NCT03656614|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25023239|NCT03656614|Autonomic Agents|autonomic agents|mesh-ancestor
24469655|NCT00386659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24469656|NCT00386659|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24469657|NCT00386659|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24469659|NCT00386659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24469660|NCT00386659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24469662|NCT00386672|Calcium, Dietary|calcium, dietary|mesh-list
24469663|NCT00386672|Vitamin D|vitamin d|mesh-list
24469664|NCT00386672|Ergocalciferols|ergocalciferols|mesh-list
24469665|NCT00386672|Cholecalciferol|cholecalciferol|mesh-list
25691182|NCT01983020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25691183|NCT01983020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25691184|NCT01983020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25691185|NCT01983111|Acetaminophen|acetaminophen|mesh-list
25691186|NCT01983111|Buprenorphine|buprenorphine|mesh-list
25691187|NCT01983111|Tramadol|tramadol|mesh-list
25691188|NCT01983111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25691189|NCT01983111|Analgesics|analgesics|mesh-ancestor
25691190|NCT01983111|Sensory System Agents|sensory system agents|mesh-ancestor
25691191|NCT01983111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24446827|NCT00306137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469759|NCT00387114|Ascorbic Acid|ascorbic acid|mesh-list
24469760|NCT00387114|Vitamins|vitamins|mesh-ancestor
24469761|NCT00387114|Micronutrients|micronutrients|mesh-ancestor
24469762|NCT00387114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469763|NCT00387114|Antioxidants|antioxidants|mesh-ancestor
24469764|NCT00387114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469765|NCT00387114|Protective Agents|protective agents|mesh-ancestor
24469766|NCT00387179|Melatonin|melatonin|mesh-list
24469767|NCT00387179|Antioxidants|antioxidants|mesh-ancestor
24469769|NCT00387179|Protective Agents|protective agents|mesh-ancestor
24469808|NCT00387400|Immunologic Factors|immunologic factors|mesh-ancestor
24469809|NCT00387400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469811|NCT00387400|Alkylating Agents|alkylating agents|mesh-ancestor
24757283|NCT01738945|Amlodipine|amlodipine|mesh-list
24469838|NCT00387530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24469839|NCT00387530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469840|NCT00387556|Ondansetron|ondansetron|mesh-list
24469841|NCT00387556|Antiemetics|antiemetics|mesh-ancestor
24469842|NCT00387556|Autonomic Agents|autonomic agents|mesh-ancestor
24469843|NCT00387556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24469844|NCT00387556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469846|NCT00387556|Antipruritics|antipruritics|mesh-ancestor
24469847|NCT00387556|Dermatologic Agents|dermatologic agents|mesh-ancestor
24469848|NCT00387556|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24469849|NCT00387556|Serotonin Agents|serotonin agents|mesh-ancestor
24469850|NCT00387556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24469851|NCT00387556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469852|NCT00387556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24469853|NCT00387556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24806071|NCT02013453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25023271|NCT03656484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25023272|NCT03656484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25023273|NCT03656484|Immunologic Factors|immunologic factors|mesh-ancestor
25023274|NCT03656484|Viscosupplements|viscosupplements|mesh-ancestor
25023275|NCT03656484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25023276|NCT03656484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25023277|NCT03656445|Tranexamic Acid|tranexamic acid|mesh-list
25023278|NCT03656445|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25023279|NCT03656445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25023280|NCT03656445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023281|NCT03656445|Hemostatics|hemostatics|mesh-ancestor
25023282|NCT03656445|Coagulants|coagulants|mesh-ancestor
25023283|NCT03656432|Fluorides|fluorides|mesh-list
25023284|NCT03656432|Cariostatic Agents|cariostatic agents|mesh-ancestor
25023285|NCT03656432|Protective Agents|protective agents|mesh-ancestor
25023286|NCT03656432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023287|NCT03656393|Carboplatin|carboplatin|mesh-list
25023288|NCT03656393|Vinorelbine|vinorelbine|mesh-list
25023289|NCT03656393|Gefitinib|gefitinib|mesh-list
25023290|NCT03656393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023291|NCT03656393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25023292|NCT03656393|Tubulin Modulators|tubulin modulators|mesh-ancestor
25023293|NCT03656393|Antimitotic Agents|antimitotic agents|mesh-ancestor
25023294|NCT03656393|Mitosis Modulators|mitosis modulators|mesh-ancestor
25023295|NCT03656393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023296|NCT03656393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25023297|NCT03656393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25023298|NCT03656289|Etonogestrel|etonogestrel|mesh-list
25023299|NCT03656289|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25023300|NCT03656289|Contraceptive Agents|contraceptive agents|mesh-ancestor
25023301|NCT03656289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24469915|NCT00387920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24716584|NCT01542489|Insulin|insulin|mesh-list
24469916|NCT00387920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469917|NCT00387920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469918|NCT00387933|Imatinib Mesylate|imatinib mesylate|mesh-list
24469919|NCT00387933|Hydroxyurea|hydroxyurea|mesh-list
24469920|NCT00387933|Vatalanib|vatalanib|mesh-list
24469921|NCT00387933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469922|NCT00387933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24469923|NCT00387933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469924|NCT00387933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469925|NCT00387933|Antisickling Agents|antisickling agents|mesh-ancestor
25023302|NCT03656289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023303|NCT03656289|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25023304|NCT03656172|Chrysarobin|chrysarobin|mesh-list
25023305|NCT03656172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25023306|NCT03656172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25023307|NCT03656172|Analgesics|analgesics|mesh-ancestor
25023308|NCT03656172|Sensory System Agents|sensory system agents|mesh-ancestor
25023309|NCT03656172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023310|NCT03656172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023311|NCT03656172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25023312|NCT03656172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25023313|NCT03656094|Docetaxel|docetaxel|mesh-list
25023333|NCT03655964|Antihypertensive Agents|antihypertensive agents|mesh-list
25023334|NCT03655964|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25023335|NCT03655964|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25023336|NCT03655964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023338|NCT03655964|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25023339|NCT03655964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25023340|NCT03655964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25023341|NCT03655964|Adrenergic Agents|adrenergic agents|mesh-ancestor
25023342|NCT03655964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25023343|NCT03655964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985168|NCT03592693|Vitamins|vitamins|mesh-list
24469926|NCT00387933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24469927|NCT00388011|Morphine|morphine|mesh-list
24469928|NCT00388011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24469929|NCT00388011|Narcotics|narcotics|mesh-ancestor
24469943|NCT00388076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469944|NCT00388076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24469945|NCT00388076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469946|NCT00388089|Bortezomib|bortezomib|mesh-list
24469947|NCT00388089|Topotecan|topotecan|mesh-list
25023345|NCT03655847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25023346|NCT03655847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25023347|NCT03655847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023348|NCT03655847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25023349|NCT03655847|Analgesics|analgesics|mesh-ancestor
25023350|NCT03655847|Sensory System Agents|sensory system agents|mesh-ancestor
25023351|NCT03655847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023352|NCT03655847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25023353|NCT03655847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25023354|NCT03655847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25023355|NCT03655847|Adrenergic Agents|adrenergic agents|mesh-ancestor
25023356|NCT03655847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25023357|NCT03655847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023358|NCT03655834|Pemetrexed|pemetrexed|mesh-list
25023359|NCT03655834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023360|NCT03655834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25023361|NCT03655834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023362|NCT03655834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25023363|NCT03655834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25023364|NCT03655730|Psychotropic Drugs|psychotropic drugs|mesh-list
25023409|NCT03655392|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25023410|NCT03655392|Antioxidants|antioxidants|mesh-ancestor
25023411|NCT03655392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023412|NCT03655392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25023413|NCT03655392|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25023414|NCT03655392|Vasodilator Agents|vasodilator agents|mesh-ancestor
25023415|NCT03655392|Gasotransmitters|gasotransmitters|mesh-ancestor
25023416|NCT03655392|Protective Agents|protective agents|mesh-ancestor
25112065|NCT04491695|Tirofiban|tirofiban|mesh-list
25112066|NCT04491695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25112067|NCT04491695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25112068|NCT04491695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112069|NCT04491695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25112070|NCT04491084|Antibodies|antibodies|mesh-list
25112071|NCT04491084|Flt3 ligand protein|flt3 ligand protein|mesh-list
25112072|NCT04491084|Immunologic Factors|immunologic factors|mesh-ancestor
24469951|NCT00388089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469952|NCT00388089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469953|NCT00388128|Caffeine|caffeine|mesh-list
24469954|NCT00388128|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24469955|NCT00388128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419478|NCT00212186|Selenium|selenium|mesh-list
24469956|NCT00388128|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24469957|NCT00388128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24470014|NCT00388427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25112109|NCT04415840|Acetic Acid|acetic acid|mesh-list
25112110|NCT04415840|Retinol acetate|retinol acetate|mesh-list
24980141|NCT05441410|Pyronaridine|pyronaridine|mesh-list
24980142|NCT05441410|Antimalarials|antimalarials|mesh-ancestor
24980143|NCT05441410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24980144|NCT05441410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24980145|NCT05441410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24980146|NCT05441410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470015|NCT00388427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24470016|NCT00388427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691192|NCT01983111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470017|NCT00388479|Alvimopan|alvimopan|mesh-list
25691193|NCT01983111|Antipyretics|antipyretics|mesh-ancestor
25691194|NCT01983111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25691195|NCT01983111|Narcotics|narcotics|mesh-ancestor
25691196|NCT01983111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24872445|NCT05385705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24470067|NCT00388700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470068|NCT00388700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24470069|NCT00388700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24470070|NCT00388700|Immunologic Factors|immunologic factors|mesh-ancestor
24470072|NCT00388700|Protective Agents|protective agents|mesh-ancestor
24470073|NCT00388700|Vitamin B Complex|vitamin b complex|mesh-ancestor
24470074|NCT00388700|Vitamins|vitamins|mesh-ancestor
24470077|NCT00388739|Budesonide|budesonide|mesh-list
24470078|NCT00388739|Albuterol|albuterol|mesh-list
24470079|NCT00388739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24470080|NCT00388739|Glucocorticoids|glucocorticoids|mesh-ancestor
24470081|NCT00388739|Hormones|hormones|mesh-ancestor
24470082|NCT00388739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24470083|NCT00388739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470176|NCT00389038|Adrenergic Agents|adrenergic agents|mesh-ancestor
24470177|NCT00389038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24470178|NCT00389051|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24470179|NCT00389051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24470180|NCT00389051|Alkylating Agents|alkylating agents|mesh-ancestor
24470181|NCT00389051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470182|NCT00389051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470184|NCT00389090|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
24980149|NCT05441410|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24980150|NCT05441410|Anthelmintics|anthelmintics|mesh-ancestor
24795593|NCT01503632|Mercaptopurine|mercaptopurine|mesh-list
24587437|NCT00894959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587438|NCT00894985|Heparin|heparin|mesh-list
24587439|NCT00894985|Calcium heparin|calcium heparin|mesh-list
24587443|NCT00894985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587527|NCT00895362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587530|NCT00895505|Anticoagulants|anticoagulants|mesh-ancestor
24470187|NCT00389090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470188|NCT00389090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470189|NCT00389090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24470190|NCT00389129|Aspirin|aspirin|mesh-list
24470191|NCT00389129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24470192|NCT00389129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24470193|NCT00389129|Analgesics|analgesics|mesh-ancestor
24470194|NCT00389129|Sensory System Agents|sensory system agents|mesh-ancestor
24470195|NCT00389129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24470196|NCT00389129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470197|NCT00389129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25691197|NCT01983111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25691198|NCT01983566|Omeprazole|omeprazole|mesh-list
25691199|NCT01983566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24470198|NCT00389129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24470199|NCT00389129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25691200|NCT01983566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24470281|NCT00389428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24470282|NCT00389428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24470283|NCT00389428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24470286|NCT00389506|Fludarabine phosphate|fludarabine phosphate|mesh-list
24470287|NCT00389506|Immunotoxins|immunotoxins|mesh-list
24470346|NCT00389909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470347|NCT00389909|Respiratory System Agents|respiratory system agents|mesh-ancestor
24470348|NCT00389922|Vinorelbine|vinorelbine|mesh-list
24470349|NCT00389922|Lapatinib|lapatinib|mesh-list
24470350|NCT00389922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24470351|NCT00389922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470352|NCT00389922|Tubulin Modulators|tubulin modulators|mesh-ancestor
24470353|NCT00389922|Antimitotic Agents|antimitotic agents|mesh-ancestor
24470354|NCT00389922|Mitosis Modulators|mitosis modulators|mesh-ancestor
24470355|NCT00389922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470365|NCT00389935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24470366|NCT00389935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24470367|NCT00389935|Growth Substances|growth substances|mesh-ancestor
24470368|NCT00389935|Growth Inhibitors|growth inhibitors|mesh-ancestor
24910539|NCT04296578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910540|NCT04296578|Hormone Antagonists|hormone antagonists|mesh-ancestor
24910541|NCT04296578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24717635|NCT01549093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24717666|NCT01549236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24504442|NCT00536276|Vitamin D|vitamin d|mesh-list
25023439|NCT03654612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023441|NCT03654365|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25023442|NCT03654365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023443|NCT03654365|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25023444|NCT03654365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25023445|NCT03654365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023446|NCT03654365|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25023447|NCT03654365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25023448|NCT03654365|Purinergic Agents|purinergic agents|mesh-ancestor
25023449|NCT03654365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25023450|NCT03654170|BI 425809|bi 425809|mesh-list
25023451|NCT03654170|Nootropic Agents|nootropic agents|mesh-ancestor
25023452|NCT03654144|Dienogest|dienogest|mesh-list
25023499|NCT03653845|Epinephrine|epinephrine|mesh-list
25023500|NCT03653845|Racepinephrine|racepinephrine|mesh-list
25023501|NCT03653845|Epinephryl borate|epinephryl borate|mesh-list
25023502|NCT03653845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25023503|NCT03653845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24470408|NCT00390065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470409|NCT00390065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24470410|NCT00390065|Respiratory System Agents|respiratory system agents|mesh-ancestor
24470411|NCT00390065|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24470412|NCT00390065|Antioxidants|antioxidants|mesh-ancestor
24470413|NCT00390065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470414|NCT00390065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24470415|NCT00390065|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24717668|NCT01549301|Lenograstim|lenograstim|mesh-list
24470416|NCT00390065|Vasodilator Agents|vasodilator agents|mesh-ancestor
24470417|NCT00390065|Gasotransmitters|gasotransmitters|mesh-ancestor
24470418|NCT00390065|Protective Agents|protective agents|mesh-ancestor
24470419|NCT00390091|Abetimus|abetimus|mesh-list
24470420|NCT00390091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24470421|NCT00390091|Immunologic Factors|immunologic factors|mesh-ancestor
24470577|NCT00390728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24470579|NCT00390793|Cytarabine|cytarabine|mesh-list
24470603|NCT00390793|Autonomic Agents|autonomic agents|mesh-ancestor
24470604|NCT00390793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24470605|NCT00390793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24470606|NCT00390793|Glucocorticoids|glucocorticoids|mesh-ancestor
24470607|NCT00390793|Hormones|hormones|mesh-ancestor
24470608|NCT00390793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24470614|NCT00390793|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24470615|NCT00390793|Abortifacient Agents|abortifacient agents|mesh-ancestor
24470616|NCT00390793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24470617|NCT00390793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24470618|NCT00390793|Antimetabolites|antimetabolites|mesh-ancestor
24470619|NCT00390793|Dermatologic Agents|dermatologic agents|mesh-ancestor
24470620|NCT00390793|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24470621|NCT00390793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24470622|NCT00390793|Antiviral Agents|antiviral agents|mesh-ancestor
24470623|NCT00390793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24470624|NCT00390793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24470675|NCT00390923|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24470676|NCT00390923|Protective Agents|protective agents|mesh-ancestor
24470678|NCT00390975|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25023504|NCT03653845|Adrenergic Agents|adrenergic agents|mesh-ancestor
25023505|NCT03653845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25023506|NCT03653845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023507|NCT03653845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023508|NCT03653845|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25023509|NCT03653845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25023510|NCT03653845|Autonomic Agents|autonomic agents|mesh-ancestor
25691201|NCT01983566|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25691202|NCT01983566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757520|NCT01740921|Liraglutide|liraglutide|mesh-list
25691203|NCT01983566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691204|NCT01983683|Vancomycin|vancomycin|mesh-list
24910586|NCT04296175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25023511|NCT03653845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023512|NCT03653845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25023513|NCT03653845|Respiratory System Agents|respiratory system agents|mesh-ancestor
25023514|NCT03653845|Mydriatics|mydriatics|mesh-ancestor
25023515|NCT03653845|Sympathomimetics|sympathomimetics|mesh-ancestor
25023516|NCT03653845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25023542|NCT03653520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25023543|NCT03653520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25023544|NCT03653520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25023545|NCT03653520|Narcotics|narcotics|mesh-ancestor
25023546|NCT03653520|Analgesics|analgesics|mesh-ancestor
24985286|NCT03514121|Pembrolizumab|pembrolizumab|mesh-list
24470679|NCT00390975|Serotonin Agents|serotonin agents|mesh-ancestor
24470680|NCT00390975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24470681|NCT00390975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470682|NCT00390975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470683|NCT00391014|Amphotericin B|amphotericin b|mesh-list
24470684|NCT00391014|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24470685|NCT00391014|Amebicides|amebicides|mesh-ancestor
24470753|NCT00391534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470754|NCT00391534|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24470755|NCT00391534|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24470756|NCT00391638|Interferons|interferons|mesh-list
24470758|NCT00391638|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24470759|NCT00391638|Emtricitabine|emtricitabine|mesh-list
24470760|NCT00391638|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24470807|NCT00392028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24470808|NCT00392028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24470809|NCT00392067|Calcipotriene|calcipotriene|mesh-list
24470810|NCT00392067|Dermatologic Agents|dermatologic agents|mesh-ancestor
24470811|NCT00392080|Naproxen|naproxen|mesh-list
24470812|NCT00392080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24470813|NCT00392080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24470814|NCT00392080|Analgesics|analgesics|mesh-ancestor
24470815|NCT00392080|Sensory System Agents|sensory system agents|mesh-ancestor
24470940|NCT00392522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24471274|NCT00394368|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24471275|NCT00394368|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24471276|NCT00394368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24471283|NCT00394394|Enalapril|enalapril|mesh-list
24471284|NCT00394394|Amiloride|amiloride|mesh-list
24471285|NCT00394394|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25691205|NCT01983683|Oxazolidinones|oxazolidinones|mesh-list
25691206|NCT01983683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25691207|NCT01983683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25691208|NCT01983683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25691209|NCT01983683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691210|NCT01983683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691211|NCT01983878|Ramucirumab|ramucirumab|mesh-list
25691212|NCT01983878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24471289|NCT00394394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25691213|NCT01983969|Pyridoxine|pyridoxine|mesh-list
25691214|NCT01983969|Gemcitabine|gemcitabine|mesh-list
25691215|NCT01983969|Dexamethasone|dexamethasone|mesh-list
25691216|NCT01983969|Rituximab|rituximab|mesh-list
25691217|NCT01983969|Azacitidine|azacitidine|mesh-list
24485278|NCT00452322|Testosterone enanthate|testosterone enanthate|mesh-list
24485279|NCT00452322|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24485280|NCT00452322|Androgens|androgens|mesh-ancestor
25064871|NCT03456401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064873|NCT03456154|Salicylic Acid|salicylic acid|mesh-list
24471438|NCT00395252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24471439|NCT00395252|Immunologic Factors|immunologic factors|mesh-ancestor
24471440|NCT00395252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471441|NCT00395252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24471443|NCT00395369|Hemostatics|hemostatics|mesh-ancestor
24471444|NCT00395369|Coagulants|coagulants|mesh-ancestor
25023557|NCT03653520|GABA Agents|gaba agents|mesh-ancestor
25023559|NCT03653260|Anesthetics, Local|anesthetics, local|mesh-ancestor
25023560|NCT03653260|Anesthetics|anesthetics|mesh-ancestor
25023561|NCT03653260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25023562|NCT03653260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023563|NCT03653260|Sensory System Agents|sensory system agents|mesh-ancestor
25023564|NCT03653260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023565|NCT03653260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25023566|NCT03653260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25023567|NCT03653260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24980304|NCT05406102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24980305|NCT05406102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980306|NCT05406102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24980307|NCT05406102|Anesthetics, General|anesthetics, general|mesh-ancestor
24980308|NCT05406102|Anesthetics|anesthetics|mesh-ancestor
24587542|NCT00895570|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24587543|NCT00895570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471471|NCT00395434|Growth Substances|growth substances|mesh-ancestor
24471477|NCT00395434|Mitosis Modulators|mitosis modulators|mesh-ancestor
24471478|NCT00395434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471479|NCT00395499|Risperidone|risperidone|mesh-list
24471480|NCT00395499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24471481|NCT00395499|Serotonin Agents|serotonin agents|mesh-ancestor
24471482|NCT00395499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24471483|NCT00395499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471484|NCT00395499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471485|NCT00395499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24471486|NCT00395499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24471487|NCT00395499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24471488|NCT00395499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24471489|NCT00395499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24471490|NCT00395499|Dopamine Agents|dopamine agents|mesh-ancestor
24471491|NCT00395551|Ranibizumab|ranibizumab|mesh-list
24471492|NCT00395551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24471493|NCT00395551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24471494|NCT00395551|Growth Substances|growth substances|mesh-ancestor
24471495|NCT00395551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471496|NCT00395551|Growth Inhibitors|growth inhibitors|mesh-ancestor
24587545|NCT00895570|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24587546|NCT00895570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25691218|NCT01983969|Melphalan|melphalan|mesh-list
25691219|NCT01983969|Busulfan|busulfan|mesh-list
25691220|NCT01983969|Vorinostat|vorinostat|mesh-list
25691221|NCT01983969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25691222|NCT01983969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25691223|NCT01983969|Immunologic Factors|immunologic factors|mesh-ancestor
25691224|NCT01983969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691225|NCT01983969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25691226|NCT01983969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25064892|NCT03455426|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24827293|NCT02138084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24827294|NCT02138084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24587547|NCT00895570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587548|NCT00895609|Neostigmine|neostigmine|mesh-list
24587582|NCT00895739|Cyclosporine|cyclosporine|mesh-list
24587583|NCT00895739|Alemtuzumab|alemtuzumab|mesh-list
24587584|NCT00895739|Cyclosporins|cyclosporins|mesh-list
24471517|NCT00395681|Anesthetics, General|anesthetics, general|mesh-ancestor
25023598|NCT03652870|Nortriptyline|nortriptyline|mesh-list
25023599|NCT03652870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25023600|NCT03652870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25023601|NCT03652870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25023602|NCT03652870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023603|NCT03652870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25023604|NCT03652870|Serotonin Agents|serotonin agents|mesh-ancestor
25023605|NCT03652870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023606|NCT03652870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25023607|NCT03652870|Antidepressive Agents|antidepressive agents|mesh-ancestor
24471565|NCT00395915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24471566|NCT00395915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471567|NCT00395915|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24471568|NCT00395915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24471569|NCT00395915|Serotonin Agents|serotonin agents|mesh-ancestor
24471570|NCT00395915|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24471571|NCT00395915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24471572|NCT00395915|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24471573|NCT00395915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24471574|NCT00395941|Pioglitazone|pioglitazone|mesh-list
24471576|NCT00395941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24471577|NCT00395941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471578|NCT00395941|Keratolytic Agents|keratolytic agents|mesh-ancestor
24471579|NCT00395941|Dermatologic Agents|dermatologic agents|mesh-ancestor
24471580|NCT00396045|Lenalidomide|lenalidomide|mesh-list
25691227|NCT01983969|Antiemetics|antiemetics|mesh-ancestor
25691228|NCT01983969|Autonomic Agents|autonomic agents|mesh-ancestor
25691229|NCT01983969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25691230|NCT01983969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25691231|NCT01983969|Glucocorticoids|glucocorticoids|mesh-ancestor
25691232|NCT01983969|Hormones|hormones|mesh-ancestor
25691233|NCT01983969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25691234|NCT01983969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25691235|NCT01983969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24471611|NCT00396227|Pioglitazone|pioglitazone|mesh-list
24471613|NCT00396227|Vildagliptin|vildagliptin|mesh-list
24471614|NCT00396227|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
24471615|NCT00396227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24471616|NCT00396227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471617|NCT00396227|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24471629|NCT00396344|Hydrocortisone|hydrocortisone|mesh-list
24471652|NCT00396487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24471653|NCT00396487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24471654|NCT00396487|Immunologic Factors|immunologic factors|mesh-ancestor
24471655|NCT00396487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471656|NCT00396487|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24471657|NCT00396487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24471658|NCT00396487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24471659|NCT00396500|Vitamin A|vitamin a|mesh-list
24471678|NCT00396513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471679|NCT00396513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24471680|NCT00396513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25023726|NCT03652233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25023727|NCT03652233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023728|NCT03652233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24980386|NCT05303727|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24980387|NCT05303727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24980388|NCT05303727|Immunologic Factors|immunologic factors|mesh-ancestor
24980389|NCT05303727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980390|NCT05303727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24980391|NCT05303727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24980392|NCT05303727|Alkylating Agents|alkylating agents|mesh-ancestor
24980393|NCT05303727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980394|NCT05303727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980395|NCT05303727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24980396|NCT05303727|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24980397|NCT05303727|Abortifacient Agents|abortifacient agents|mesh-ancestor
24980398|NCT05303727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24980399|NCT05303727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24980400|NCT05303727|Antimetabolites|antimetabolites|mesh-ancestor
25023730|NCT03652233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25023731|NCT03652233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25023733|NCT03652142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25023734|NCT03652142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023735|NCT03652142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24860520|NCT02310360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24471682|NCT00396513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471683|NCT00396513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25691236|NCT01983969|Antimetabolites|antimetabolites|mesh-ancestor
25691237|NCT01983969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691238|NCT01983969|Antiviral Agents|antiviral agents|mesh-ancestor
25691239|NCT01983969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25691240|NCT01983969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691241|NCT01983969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24715912|NCT01539018|Tegafur|tegafur|mesh-list
24471684|NCT00396513|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24471685|NCT00396513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24471686|NCT00396526|Amoxicillin|amoxicillin|mesh-list
24471687|NCT00396526|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25023736|NCT03652142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023775|NCT03651726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023776|NCT03651726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25023777|NCT03651726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25023778|NCT03651726|Analgesics|analgesics|mesh-ancestor
25023779|NCT03651726|Sensory System Agents|sensory system agents|mesh-ancestor
25023798|NCT03651674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25023799|NCT03651674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25023800|NCT03651674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25023801|NCT03651674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25023802|NCT03651674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25023803|NCT03651674|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25023804|NCT03651674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25023805|NCT03651674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25023806|NCT03651674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023807|NCT03651674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25023808|NCT03651674|Serotonin Agents|serotonin agents|mesh-ancestor
25023809|NCT03651674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24471688|NCT00396526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24471689|NCT00396526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24471690|NCT00396526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24471691|NCT00396526|Renal Agents|renal agents|mesh-ancestor
24471692|NCT00396526|Antimalarials|antimalarials|mesh-ancestor
24471693|NCT00396526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24471694|NCT00396526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24471702|NCT00396604|Maleic acid|maleic acid|mesh-list
24471703|NCT00396604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24471704|NCT00396604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471727|NCT00396682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023810|NCT03651674|GABA Antagonists|gaba antagonists|mesh-ancestor
25023811|NCT03651674|GABA Agents|gaba agents|mesh-ancestor
25023812|NCT03651661|Insulin|insulin|mesh-list
25023820|NCT03651557|Sensory System Agents|sensory system agents|mesh-ancestor
25023821|NCT03651557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023822|NCT03651557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023823|NCT03651557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25023824|NCT03651557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25023825|NCT03651557|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25023826|NCT03651557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691242|NCT01983969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25691243|NCT01983969|Alkylating Agents|alkylating agents|mesh-ancestor
25691244|NCT01983969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25691245|NCT01983969|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25691246|NCT01983969|Vitamin B Complex|vitamin b complex|mesh-ancestor
25691247|NCT01983969|Vitamins|vitamins|mesh-ancestor
25691248|NCT01983969|Micronutrients|micronutrients|mesh-ancestor
25691249|NCT01984164|Candesartan|candesartan|mesh-list
25691250|NCT01984164|Lisinopril|lisinopril|mesh-list
24472027|NCT00397761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24472030|NCT00397787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472031|NCT00397787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24472032|NCT00397787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24472033|NCT00397787|Growth Substances|growth substances|mesh-ancestor
24472034|NCT00397787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472035|NCT00397787|Growth Inhibitors|growth inhibitors|mesh-ancestor
25023827|NCT03651557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023828|NCT03651531|Metformin|metformin|mesh-list
25023829|NCT03651531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25023830|NCT03651531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023831|NCT03651427|Estradiol|estradiol|mesh-list
25023832|NCT03651427|Estrogens|estrogens|mesh-ancestor
25023833|NCT03651427|Hormones|hormones|mesh-ancestor
25023834|NCT03651427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24980611|NCT05097326|Hormone Antagonists|hormone antagonists|mesh-ancestor
24980612|NCT05097326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24980613|NCT05097326|Luteolytic Agents|luteolytic agents|mesh-ancestor
24980614|NCT05097326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24980615|NCT05097326|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25023869|NCT03650738|Tubulin Modulators|tubulin modulators|mesh-ancestor
25023870|NCT03650738|Antimitotic Agents|antimitotic agents|mesh-ancestor
25023871|NCT03650738|Mitosis Modulators|mitosis modulators|mesh-ancestor
24472074|NCT00398008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24421713|NCT00220051|Capecitabine|capecitabine|mesh-list
24789220|NCT01935908|Levetiracetam|levetiracetam|mesh-list
24719092|NCT01559142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25023878|NCT03650582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25023880|NCT03650582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25023881|NCT03650582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023882|NCT03650543|Amoxicillin|amoxicillin|mesh-list
25023883|NCT03650543|Clarithromycin|clarithromycin|mesh-list
25023884|NCT03650543|Omeprazole|omeprazole|mesh-list
25023885|NCT03650543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25023886|NCT03650543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25023887|NCT03650543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25023888|NCT03650543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25023889|NCT03650543|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25023890|NCT03650543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25023891|NCT03650543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023892|NCT03650543|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25023893|NCT03650543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25023894|NCT03650543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25023895|NCT03650361|Adapalene|adapalene|mesh-list
25023929|NCT03650270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25023930|NCT03650270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25023931|NCT03650270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25023932|NCT03650270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25023933|NCT03650270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25023934|NCT03650257|Temozolomide|temozolomide|mesh-list
25023935|NCT03650257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25023936|NCT03650257|Alkylating Agents|alkylating agents|mesh-ancestor
25023970|NCT03649763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25023971|NCT03649763|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25023972|NCT03649763|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25023974|NCT03649763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634260|NCT01132638|Esomeprazole|esomeprazole|mesh-list
25023990|NCT03649711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023992|NCT03649711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25023993|NCT03649711|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25023994|NCT03649711|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25023995|NCT03649711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023996|NCT03649711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25112168|NCT04335201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25112169|NCT04335201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25024011|NCT03649334|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25024018|NCT03649334|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25024019|NCT03649334|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25024020|NCT03649334|Anesthetics, General|anesthetics, general|mesh-ancestor
25024021|NCT03649334|Anesthetics|anesthetics|mesh-ancestor
25024022|NCT03649334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25024023|NCT03649334|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25024024|NCT03649334|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25024050|NCT03649230|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25024051|NCT03649230|Serotonin Agents|serotonin agents|mesh-ancestor
25024052|NCT03649230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25024053|NCT03649230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024054|NCT03649165|Acetaminophen|acetaminophen|mesh-list
25024055|NCT03649165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25024056|NCT03649165|Analgesics|analgesics|mesh-ancestor
25024057|NCT03649165|Sensory System Agents|sensory system agents|mesh-ancestor
25024058|NCT03649165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024059|NCT03649165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024060|NCT03649165|Antipyretics|antipyretics|mesh-ancestor
25691251|NCT01984164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25024116|NCT03648684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024139|NCT03648528|Cholecalciferol|cholecalciferol|mesh-list
25024140|NCT03648528|Vitamin D|vitamin d|mesh-list
25024141|NCT03648528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25024142|NCT03648528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024143|NCT03648528|Vitamins|vitamins|mesh-ancestor
25024144|NCT03648528|Micronutrients|micronutrients|mesh-ancestor
25024145|NCT03648528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25024146|NCT03648437|Acetaminophen|acetaminophen|mesh-list
25024147|NCT03648437|Ibuprofen|ibuprofen|mesh-list
25024148|NCT03648437|Indomethacin|indomethacin|mesh-list
25024149|NCT03648437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25024164|NCT03648437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25024165|NCT03648346|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25024167|NCT03648333|Amlodipine|amlodipine|mesh-list
25024168|NCT03648333|Valsartan|valsartan|mesh-list
25024169|NCT03648333|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
25024202|NCT03648034|Ropivacaine|ropivacaine|mesh-list
25024203|NCT03648034|Anesthetics, Local|anesthetics, local|mesh-ancestor
25024204|NCT03648034|Anesthetics|anesthetics|mesh-ancestor
25024205|NCT03648034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25024206|NCT03648034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024207|NCT03648034|Sensory System Agents|sensory system agents|mesh-ancestor
25024208|NCT03648034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024209|NCT03648008|Morphine|morphine|mesh-list
25024210|NCT03648008|Hydromorphone|hydromorphone|mesh-list
24588746|NCT00904176|Dapagliflozin|dapagliflozin|mesh-list
25024226|NCT03647982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25024233|NCT03647956|Bevacizumab|bevacizumab|mesh-list
24980965|NCT04668859|Midodrine|midodrine|mesh-list
24980966|NCT04668859|Sympathomimetics|sympathomimetics|mesh-ancestor
24980967|NCT04668859|Autonomic Agents|autonomic agents|mesh-ancestor
24980968|NCT04668859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24980969|NCT04668859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980970|NCT04668859|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24980971|NCT04668859|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24980972|NCT04668859|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24980973|NCT04668859|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24980984|NCT04641351|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24980985|NCT04641351|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24980986|NCT04641351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24980987|NCT04641351|Glucocorticoids|glucocorticoids|mesh-ancestor
24980988|NCT04641351|Hormones|hormones|mesh-ancestor
24980989|NCT04641351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24980990|NCT04641351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980991|NCT04641351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24980992|NCT04641351|Immunologic Factors|immunologic factors|mesh-ancestor
24980993|NCT04641351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24980994|NCT04641351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587592|NCT00895739|Dermatologic Agents|dermatologic agents|mesh-ancestor
24587593|NCT00895739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24587594|NCT00895739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24587595|NCT00895739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25024241|NCT03647956|Growth Substances|growth substances|mesh-ancestor
25024242|NCT03647956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024243|NCT03647956|Growth Inhibitors|growth inhibitors|mesh-ancestor
25024244|NCT03647956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024245|NCT03647956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024246|NCT03647956|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25024247|NCT03647956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25024248|NCT03647839|Nivolumab|nivolumab|mesh-list
25024249|NCT03647839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25106966|NCT03143244|Analgesics|analgesics|mesh-ancestor
25024250|NCT03647839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25024251|NCT03647839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25024252|NCT03647839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024253|NCT03647670|Midazolam|midazolam|mesh-list
25024254|NCT03647670|Abrocitinib|abrocitinib|mesh-list
25024255|NCT03647670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25024256|NCT03647670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25024257|NCT03647670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25024258|NCT03647670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024259|NCT03647670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25024260|NCT03647670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25024261|NCT03647670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25024262|NCT03647670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25024263|NCT03647670|Anesthetics, General|anesthetics, general|mesh-ancestor
25024264|NCT03647670|Anesthetics|anesthetics|mesh-ancestor
25024265|NCT03647670|GABA Modulators|gaba modulators|mesh-ancestor
25024266|NCT03647670|GABA Agents|gaba agents|mesh-ancestor
25024267|NCT03647670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25024268|NCT03647670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024269|NCT03647670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25024270|NCT03647670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024271|NCT03647579|Midazolam|midazolam|mesh-list
25024272|NCT03647579|Dexmedetomidine|dexmedetomidine|mesh-list
25024273|NCT03647579|Ketamine|ketamine|mesh-list
25024274|NCT03647579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25024275|NCT03647579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25024276|NCT03647579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472917|NCT00401128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25024277|NCT03647579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25024279|NCT03647579|Sensory System Agents|sensory system agents|mesh-ancestor
25024280|NCT03647579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024281|NCT03647579|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25024282|NCT03647579|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25024283|NCT03647579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25024284|NCT03647579|Adrenergic Agents|adrenergic agents|mesh-ancestor
25024285|NCT03647579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25024286|NCT03647579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024287|NCT03647579|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25024288|NCT03647579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25024289|NCT03647579|Anesthetics, General|anesthetics, general|mesh-ancestor
25024291|NCT03647579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24588832|NCT00904449|Oxymorphone|oxymorphone|mesh-list
25112190|NCT04318704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25112191|NCT04318704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25112193|NCT04310540|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25112194|NCT04310540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112195|NCT04307329|Trastuzumab|trastuzumab|mesh-list
25112196|NCT04307329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25112197|NCT04307329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806072|NCT02013453|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25024310|NCT03647423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024311|NCT03647423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25024312|NCT03647423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25024313|NCT03647423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25024314|NCT03647280|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25024315|NCT03647280|Epirubicin|epirubicin|mesh-list
25024316|NCT03647280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25024317|NCT03647280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024318|NCT03647280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25024323|NCT03647150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25024324|NCT03647150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25024325|NCT03647072|Famotidine|famotidine|mesh-list
25024326|NCT03647072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25024327|NCT03647072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25024328|NCT03647072|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25024329|NCT03647072|Histamine Antagonists|histamine antagonists|mesh-ancestor
25024330|NCT03647072|Histamine Agents|histamine agents|mesh-ancestor
25024331|NCT03647072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25024332|NCT03647072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024333|NCT03647072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024334|NCT03646916|Dexamethasone|dexamethasone|mesh-list
25024335|NCT03646916|Dexamethasone acetate|dexamethasone acetate|mesh-list
25024336|NCT03646916|BB 1101|bb 1101|mesh-list
25024337|NCT03646916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25024338|NCT03646916|Antiemetics|antiemetics|mesh-ancestor
25024339|NCT03646916|Autonomic Agents|autonomic agents|mesh-ancestor
25024340|NCT03646916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024341|NCT03646916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024342|NCT03646916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25024343|NCT03646916|Glucocorticoids|glucocorticoids|mesh-ancestor
25024344|NCT03646916|Hormones|hormones|mesh-ancestor
25024345|NCT03646916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25024346|NCT03646916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25024347|NCT03646916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25024348|NCT03646916|Protease Inhibitors|protease inhibitors|mesh-ancestor
25024349|NCT03646916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024350|NCT03646916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691252|NCT01984164|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25691253|NCT01984164|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24910839|NCT04293419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24910840|NCT04293419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910841|NCT04293081|Maleic acid|maleic acid|mesh-list
24910842|NCT04293081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24910843|NCT04293081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910844|NCT04293172|Ticagrelor|ticagrelor|mesh-list
24910845|NCT04293172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24910846|NCT04293172|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24910847|NCT04293172|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24910848|NCT04293172|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24910849|NCT04293172|Purinergic Agents|purinergic agents|mesh-ancestor
24827393|NCT02138773|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24827395|NCT02138773|Adrenergic Agents|adrenergic agents|mesh-ancestor
25024351|NCT03646825|Antioxidants|antioxidants|mesh-list
24472918|NCT00401128|Immunologic Factors|immunologic factors|mesh-ancestor
24472963|NCT00401323|Tubulin Modulators|tubulin modulators|mesh-ancestor
24472964|NCT00401323|Antimitotic Agents|antimitotic agents|mesh-ancestor
24472965|NCT00401323|Mitosis Modulators|mitosis modulators|mesh-ancestor
24444187|NCT00296933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24472988|NCT00401440|Misoprostol|misoprostol|mesh-list
25024373|NCT03646526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024375|NCT03646526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25024376|NCT03646526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25024377|NCT03646526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024379|NCT03646526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25024380|NCT03646500|Remifentanil|remifentanil|mesh-list
25024381|NCT03646500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25024382|NCT03646500|Narcotics|narcotics|mesh-ancestor
25024383|NCT03646500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25024384|NCT03646500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024385|NCT03646500|Analgesics|analgesics|mesh-ancestor
25024386|NCT03646500|Sensory System Agents|sensory system agents|mesh-ancestor
25024387|NCT03646500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024388|NCT03646396|Sofosbuvir|sofosbuvir|mesh-list
25024389|NCT03646396|Antiviral Agents|antiviral agents|mesh-ancestor
24472989|NCT00401440|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24472990|NCT00401440|Abortifacient Agents|abortifacient agents|mesh-ancestor
24444191|NCT00296933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24444192|NCT00296933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444212|NCT00296972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24444290|NCT00297362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024390|NCT03646396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25024391|NCT03646370|Tenofovir|tenofovir|mesh-list
25024392|NCT03646370|Antiviral Agents|antiviral agents|mesh-ancestor
25691254|NCT01984164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691255|NCT01984164|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25691256|NCT01984164|Protease Inhibitors|protease inhibitors|mesh-ancestor
25691257|NCT01984164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691258|NCT01984164|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25691259|NCT01984164|Protective Agents|protective agents|mesh-ancestor
25691260|NCT01984164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691261|NCT01984229|Posaconazole|posaconazole|mesh-list
25691262|NCT01984229|Antifungal Agents|antifungal agents|mesh-ancestor
25691263|NCT01984229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25691264|NCT01984229|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25691265|NCT01984229|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25691266|NCT01984229|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25691267|NCT01984229|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25691268|NCT01984229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25691269|NCT01984229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600328|NCT01026220|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25024393|NCT03646370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25024394|NCT03646370|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25024395|NCT03646370|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25024396|NCT03646370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024397|NCT03646370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024398|NCT03646370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25024399|NCT03646370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25024400|NCT03646357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25024401|NCT03646357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25024402|NCT03646357|Adrenergic Agents|adrenergic agents|mesh-ancestor
25016726|NCT04661137|Hormones|hormones|mesh-ancestor
25024403|NCT03646357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25024404|NCT03646357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024405|NCT03646357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024406|NCT03646318|Ketanserin|ketanserin|mesh-list
25024407|NCT03646318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25024408|NCT03646318|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25024409|NCT03646318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25024410|NCT03646318|Serotonin Agents|serotonin agents|mesh-ancestor
25024411|NCT03646318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25024412|NCT03646318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024413|NCT03646318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024419|NCT03646292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024421|NCT03646266|Rocuronium|rocuronium|mesh-list
25024422|NCT03646266|Anticonvulsants|anticonvulsants|mesh-ancestor
25024423|NCT03646266|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25024424|NCT03646266|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25024425|NCT03646266|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25024426|NCT03646266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024427|NCT03646266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981125|NCT04414722|Amoxicillin|amoxicillin|mesh-list
24981126|NCT04414722|Clavulanic Acid|clavulanic acid|mesh-list
24981127|NCT04414722|Clavulanic Acids|clavulanic acids|mesh-list
24981128|NCT04414722|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24981129|NCT04414722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24981130|NCT04414722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24981131|NCT04414722|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24981132|NCT04414722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24981133|NCT04414722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981149|NCT04377451|Metformin|metformin|mesh-list
24981150|NCT04377451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24981151|NCT04377451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981152|NCT04373369|Atezolizumab|atezolizumab|mesh-list
24981153|NCT04373369|Vorolanib|vorolanib|mesh-list
24981154|NCT04373369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25024440|NCT03646006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024441|NCT03646006|Sensory System Agents|sensory system agents|mesh-ancestor
25024442|NCT03646006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024444|NCT03645980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25024445|NCT03645980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25024446|NCT03645980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024447|NCT03645980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024448|NCT03645876|Capecitabine|capecitabine|mesh-list
25024449|NCT03645876|Oxaliplatin|oxaliplatin|mesh-list
25024450|NCT03645876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25024451|NCT03645876|Antimetabolites|antimetabolites|mesh-ancestor
24860789|NCT02312661|Metformin|metformin|mesh-list
24860790|NCT02312661|Paclitaxel|paclitaxel|mesh-list
24860791|NCT02312661|Carboplatin|carboplatin|mesh-list
24860792|NCT02312661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24860793|NCT02312661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985726|NCT02818868|Apixaban|apixaban|mesh-list
25024458|NCT03645668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25024459|NCT03645642|Midodrine|midodrine|mesh-list
25024460|NCT03645642|Diuretics|diuretics|mesh-list
25024461|NCT03645642|Natriuretic Agents|natriuretic agents|mesh-ancestor
25024462|NCT03645642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024463|NCT03645642|Sympathomimetics|sympathomimetics|mesh-ancestor
25024464|NCT03645642|Autonomic Agents|autonomic agents|mesh-ancestor
25024465|NCT03645642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024476|NCT03645304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25024477|NCT03645304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691270|NCT01984229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024478|NCT03645304|Sensory System Agents|sensory system agents|mesh-ancestor
25024479|NCT03645304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024480|NCT03645200|Apatinib|apatinib|mesh-list
25024481|NCT03645200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25024482|NCT03645200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25024483|NCT03645200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024484|NCT03645200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024485|NCT03645187|Celecoxib|celecoxib|mesh-list
25024502|NCT03645109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024503|NCT03645109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25024504|NCT03645109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25024506|NCT03645057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25024507|NCT03645057|Immunologic Factors|immunologic factors|mesh-ancestor
25024508|NCT03645057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024509|NCT03645057|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25024510|NCT03645057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024511|NCT03645057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860797|NCT02312661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860799|NCT02312661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985781|NCT02748616|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24985782|NCT02748616|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24985783|NCT02748616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25024520|NCT03644706|Expectorants|expectorants|mesh-ancestor
25024521|NCT03644706|Respiratory System Agents|respiratory system agents|mesh-ancestor
25024522|NCT03644667|Mycophenolic Acid|mycophenolic acid|mesh-list
25024523|NCT03644667|Prednisone|prednisone|mesh-list
25024524|NCT03644667|Methylprednisolone|methylprednisolone|mesh-list
25024525|NCT03644667|Tacrolimus|tacrolimus|mesh-list
25024526|NCT03644667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
25024527|NCT03644667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25024528|NCT03644667|Glucocorticoids|glucocorticoids|mesh-ancestor
25024529|NCT03644667|Hormones|hormones|mesh-ancestor
25024530|NCT03644667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25024531|NCT03644667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024532|NCT03644667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25024533|NCT03644667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25024534|NCT03644667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25024535|NCT03644667|Immunologic Factors|immunologic factors|mesh-ancestor
25024536|NCT03644667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024537|NCT03644667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981271|NCT04022876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24981272|NCT04022876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981273|NCT04022876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24981274|NCT04022876|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25024538|NCT03644667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25024555|NCT03644641|Anesthetics, General|anesthetics, general|mesh-ancestor
25024556|NCT03644641|Anesthetics|anesthetics|mesh-ancestor
25024557|NCT03644641|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25024558|NCT03644589|Pembrolizumab|pembrolizumab|mesh-list
25024559|NCT03644589|Immunoglobulins|immunoglobulins|mesh-list
25024560|NCT03644589|Immunoglobulin G|immunoglobulin g|mesh-list
25024561|NCT03644589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24444291|NCT00297362|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25024563|NCT03644589|Immunologic Factors|immunologic factors|mesh-ancestor
25024564|NCT03644589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024565|NCT03644576|Pseudoephedrine|pseudoephedrine|mesh-list
25024566|NCT03644576|Ephedrine|ephedrine|mesh-list
25024567|NCT03644576|Ozanimod|ozanimod|mesh-list
25024568|NCT03644576|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25024569|NCT03644576|Autonomic Agents|autonomic agents|mesh-ancestor
25024570|NCT03644576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024571|NCT03644576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024572|NCT03644576|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25024573|NCT03644576|Respiratory System Agents|respiratory system agents|mesh-ancestor
25024574|NCT03644576|Nasal Decongestants|nasal decongestants|mesh-ancestor
25024575|NCT03644576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25024820|NCT03642600|Vitamins|vitamins|mesh-ancestor
25024576|NCT03644576|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25024577|NCT03644576|Sympathomimetics|sympathomimetics|mesh-ancestor
25024578|NCT03644576|Adrenergic Agents|adrenergic agents|mesh-ancestor
25024579|NCT03644576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25024580|NCT03644576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024581|NCT03644576|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25024582|NCT03644576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25024584|NCT03644511|Sorafenib|sorafenib|mesh-list
25024585|NCT03644511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25024586|NCT03644511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25024587|NCT03644511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024588|NCT03644511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024589|NCT03644446|Bisoprolol|bisoprolol|mesh-list
25024590|NCT03644446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24444292|NCT00297362|Autonomic Agents|autonomic agents|mesh-ancestor
24444293|NCT00297362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24444294|NCT00297362|Nootropic Agents|nootropic agents|mesh-ancestor
24444295|NCT00297375|Acetaminophen|acetaminophen|mesh-list
24444341|NCT00297544|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24444342|NCT00297544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24444343|NCT00297544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444344|NCT00297544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444345|NCT00297544|Urological Agents|urological agents|mesh-ancestor
24444346|NCT00297570|Interferons|interferons|mesh-list
24444347|NCT00297570|Imatinib Mesylate|imatinib mesylate|mesh-list
24444348|NCT00297570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473004|NCT00401492|Gemcitabine|gemcitabine|mesh-list
24473005|NCT00401492|Vinorelbine|vinorelbine|mesh-list
24473006|NCT00401492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473007|NCT00401492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24473008|NCT00401492|Antimetabolites|antimetabolites|mesh-ancestor
24473009|NCT00401492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024594|NCT03644446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024624|NCT03643900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25024625|NCT03643900|Gout Suppressants|gout suppressants|mesh-ancestor
25024626|NCT03643900|Tocolytic Agents|tocolytic agents|mesh-ancestor
25024627|NCT03643900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25024628|NCT03643900|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25024629|NCT03643900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024630|NCT03643900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024632|NCT03643874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25024633|NCT03643874|Autonomic Agents|autonomic agents|mesh-ancestor
25024634|NCT03643874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024635|NCT03643874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473011|NCT00401492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24444474|NCT00298168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24444549|NCT00298415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444550|NCT00298415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24444551|NCT00298415|Immunologic Factors|immunologic factors|mesh-ancestor
24444643|NCT00298688|Gefitinib|gefitinib|mesh-list
24444644|NCT00298688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24444645|NCT00298688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24444646|NCT00298688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444647|NCT00298688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444648|NCT00298714|Losartan|losartan|mesh-list
25112270|NCT04239339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25112271|NCT04239339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25112272|NCT04239339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112273|NCT04239339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25112274|NCT04239339|Serotonin Agents|serotonin agents|mesh-ancestor
25112275|NCT04239339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112276|NCT04239339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25112277|NCT04239339|Antidepressive Agents|antidepressive agents|mesh-ancestor
25112278|NCT04239339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24981417|NCT03472365|Apatinib|apatinib|mesh-list
25024646|NCT03643757|Bupivacaine|bupivacaine|mesh-list
25024664|NCT03643666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25024665|NCT03643666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24444649|NCT00298714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24444650|NCT00298714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24444651|NCT00298714|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24444652|NCT00298714|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24444653|NCT00298714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444654|NCT00298779|Bortezomib|bortezomib|mesh-list
24444655|NCT00298779|Omeprazole|omeprazole|mesh-list
24444656|NCT00298779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24444657|NCT00298779|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24911340|NCT04289467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24911341|NCT04289467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24473471|NCT00403000|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24473472|NCT00403000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24473474|NCT00403000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473475|NCT00403000|Hormone Antagonists|hormone antagonists|mesh-ancestor
24473476|NCT00403000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24985844|NCT02658812|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
24985845|NCT02658812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24985846|NCT02658812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24860879|NCT02313337|Analgesics|analgesics|mesh-ancestor
24505845|NCT00542802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25024666|NCT03643666|Analgesics|analgesics|mesh-ancestor
25024667|NCT03643666|Sensory System Agents|sensory system agents|mesh-ancestor
25024668|NCT03643666|Anesthetics|anesthetics|mesh-ancestor
25024669|NCT03643666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25024670|NCT03643666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25024671|NCT03643666|Anticonvulsants|anticonvulsants|mesh-ancestor
25024672|NCT03643666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25024673|NCT03643666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25024674|NCT03643666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024685|NCT03643549|Bortezomib|bortezomib|mesh-list
25024687|NCT03643549|Alkylating Agents|alkylating agents|mesh-ancestor
25024688|NCT03643549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024689|NCT03643549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25024690|NCT03643497|Meropenem|meropenem|mesh-list
25024691|NCT03643497|Linezolid|linezolid|mesh-list
25024692|NCT03643497|Anti-Infective Agents|anti-infective agents|mesh-list
25024693|NCT03643497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25024694|NCT03643497|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25024695|NCT03643497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473477|NCT00403000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473478|NCT00403013|Anesthetics|anesthetics|mesh-list
24473479|NCT00403013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24473576|NCT00403325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473578|NCT00403338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24985865|NCT02626715|Vidarabine|vidarabine|mesh-list
24985866|NCT02626715|Fludarabine phosphate|fludarabine phosphate|mesh-list
24985867|NCT02626715|Fludarabine|fludarabine|mesh-list
24985868|NCT02626715|Alemtuzumab|alemtuzumab|mesh-list
24985869|NCT02626715|Thiotepa|thiotepa|mesh-list
24985870|NCT02626715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24985871|NCT02626715|Antimetabolites|antimetabolites|mesh-ancestor
25024696|NCT03643497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024697|NCT03643276|Cytarabine|cytarabine|mesh-list
25024698|NCT03643276|Dexamethasone|dexamethasone|mesh-list
25024699|NCT03643276|Prednisone|prednisone|mesh-list
25024700|NCT03643276|Prednisolone|prednisolone|mesh-list
25024701|NCT03643276|Cyclophosphamide|cyclophosphamide|mesh-list
25024702|NCT03643276|Ifosfamide|ifosfamide|mesh-list
25024703|NCT03643276|Doxorubicin|doxorubicin|mesh-list
25024704|NCT03643276|Methotrexate|methotrexate|mesh-list
25024705|NCT03643276|Fludarabine|fludarabine|mesh-list
25024716|NCT03643276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25024718|NCT03643276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024719|NCT03643276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25024720|NCT03643276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25024721|NCT03643276|Alkylating Agents|alkylating agents|mesh-ancestor
25024722|NCT03643276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024723|NCT03643276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25024724|NCT03643276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25024725|NCT03643276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25024726|NCT03643276|Antiemetics|antiemetics|mesh-ancestor
25024727|NCT03643276|Autonomic Agents|autonomic agents|mesh-ancestor
25024728|NCT03643276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024821|NCT03642600|Micronutrients|micronutrients|mesh-ancestor
24473655|NCT00403715|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24473697|NCT00403806|Protease Inhibitors|protease inhibitors|mesh-ancestor
25691271|NCT01984229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25691272|NCT01984229|Hormone Antagonists|hormone antagonists|mesh-ancestor
24473698|NCT00403806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24519872|NCT04542278|Prednisone|prednisone|mesh-list
24519873|NCT04542278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24519874|NCT04542278|Glucocorticoids|glucocorticoids|mesh-ancestor
24519875|NCT04542278|Hormones|hormones|mesh-ancestor
24420538|NCT00216268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519876|NCT04542278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24519877|NCT04542278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911437|NCT04288219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24911438|NCT04288219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473699|NCT00403806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473700|NCT00403819|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24473701|NCT00403819|Laxatives|laxatives|mesh-ancestor
24473720|NCT00403949|Dermatologic Agents|dermatologic agents|mesh-ancestor
24473721|NCT00403962|Paroxetine|paroxetine|mesh-list
24473722|NCT00403962|Vestipitant|vestipitant|mesh-list
24473723|NCT00403962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24473782|NCT00404183|Respiratory System Agents|respiratory system agents|mesh-ancestor
24473820|NCT00404261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24473821|NCT00404261|Adrenergic Agents|adrenergic agents|mesh-ancestor
24473845|NCT00404326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24473846|NCT00404326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473847|NCT00404326|Antimanic Agents|antimanic agents|mesh-ancestor
25024767|NCT03642990|Vitamin B Complex|vitamin b complex|mesh-ancestor
25024769|NCT03642990|Micronutrients|micronutrients|mesh-ancestor
25024770|NCT03642990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024771|NCT03642990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25024772|NCT03642990|Antimetabolites|antimetabolites|mesh-ancestor
25024773|NCT03642990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024792|NCT03642665|Progestins|progestins|mesh-ancestor
25024793|NCT03642626|Vidarabine|vidarabine|mesh-list
25024794|NCT03642626|Cyclophosphamide|cyclophosphamide|mesh-list
25024795|NCT03642626|Fludarabine|fludarabine|mesh-list
25024796|NCT03642626|Fludarabine phosphate|fludarabine phosphate|mesh-list
25024797|NCT03642626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25024798|NCT03642626|Immunologic Factors|immunologic factors|mesh-ancestor
25024799|NCT03642626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024800|NCT03642626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25024801|NCT03642626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25024802|NCT03642626|Alkylating Agents|alkylating agents|mesh-ancestor
25024803|NCT03642626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024804|NCT03642626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25024805|NCT03642626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25024806|NCT03642626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25024807|NCT03642626|Antimetabolites|antimetabolites|mesh-ancestor
25024808|NCT03642626|Antiviral Agents|antiviral agents|mesh-ancestor
25024809|NCT03642626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25024810|NCT03642600|Folic Acid|folic acid|mesh-list
25024811|NCT03642600|Inositol|inositol|mesh-list
25024812|NCT03642600|Liraglutide|liraglutide|mesh-list
25024813|NCT03642600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25024814|NCT03642600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024815|NCT03642600|Incretins|incretins|mesh-ancestor
25024816|NCT03642600|Hormones|hormones|mesh-ancestor
24473848|NCT00404326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24473849|NCT00404326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24473850|NCT00404326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24473851|NCT00404326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24473852|NCT00404326|Vasodilator Agents|vasodilator agents|mesh-ancestor
24473853|NCT00404378|Ketoconazole|ketoconazole|mesh-list
24473855|NCT00404378|Antifungal Agents|antifungal agents|mesh-ancestor
25024830|NCT03642509|Antithrombins|antithrombins|mesh-ancestor
25024831|NCT03642509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25024832|NCT03642509|Protease Inhibitors|protease inhibitors|mesh-ancestor
25691273|NCT01984229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25691274|NCT01984229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691275|NCT01984242|Bevacizumab|bevacizumab|mesh-list
25691276|NCT01984242|Sunitinib|sunitinib|mesh-list
25691277|NCT01984242|Atezolizumab|atezolizumab|mesh-list
25691278|NCT01984242|Antibodies|antibodies|mesh-list
25691279|NCT01984242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25691280|NCT01984242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24446141|NCT00303836|Fludarabine|fludarabine|mesh-list
25691281|NCT01984242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880505|NCT03621553|Micronutrients|micronutrients|mesh-ancestor
24420539|NCT00216268|Antiviral Agents|antiviral agents|mesh-ancestor
24880506|NCT03621553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880507|NCT03621553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24880508|NCT03621553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24911472|NCT04287842|Sevoflurane|sevoflurane|mesh-list
25024855|NCT03642184|Incretins|incretins|mesh-ancestor
25024856|NCT03642184|Hormones|hormones|mesh-ancestor
25024857|NCT03642184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25024858|NCT03642184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25024859|NCT03642184|Protease Inhibitors|protease inhibitors|mesh-ancestor
25024860|NCT03642184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024861|NCT03642145|Deflazacort|deflazacort|mesh-list
25024862|NCT03642145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25024863|NCT03642145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25024864|NCT03642145|Immunologic Factors|immunologic factors|mesh-ancestor
25024865|NCT03642145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981633|NCT02260193|Glycine|glycine|mesh-list
24721028|NCT01571921|Protective Agents|protective agents|mesh-ancestor
24587630|NCT00895960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587631|NCT00895960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587632|NCT00895960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24587633|NCT00895960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587635|NCT00896077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24587636|NCT00896077|Immunologic Factors|immunologic factors|mesh-ancestor
24587637|NCT00896077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587638|NCT00896077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24587639|NCT00896077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24587640|NCT00896077|Analgesics|analgesics|mesh-ancestor
24587641|NCT00896077|Sensory System Agents|sensory system agents|mesh-ancestor
24587642|NCT00896077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24587643|NCT00896077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24587644|NCT00896077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24587645|NCT00896077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24587646|NCT00896155|Tamoxifen|tamoxifen|mesh-list
24587647|NCT00896155|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24587648|NCT00896155|Hormone Antagonists|hormone antagonists|mesh-ancestor
24587649|NCT00896155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24587650|NCT00896155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587651|NCT00896155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24587652|NCT00896155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587653|NCT00896155|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24587654|NCT00896155|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25024866|NCT03641950|Botulinum Toxins|botulinum toxins|mesh-list
25024867|NCT03641950|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25024868|NCT03641950|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25024869|NCT03641950|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25024870|NCT03641950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25024871|NCT03641950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024873|NCT03641950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25024874|NCT03641950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985985|NCT02422368|Autonomic Agents|autonomic agents|mesh-ancestor
25024876|NCT03641950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024899|NCT03641456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25024901|NCT03641456|Protease Inhibitors|protease inhibitors|mesh-ancestor
25024904|NCT03641456|Immunologic Factors|immunologic factors|mesh-ancestor
25024905|NCT03641456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25024906|NCT03641456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25024907|NCT03641456|Growth Substances|growth substances|mesh-ancestor
25024908|NCT03641456|Growth Inhibitors|growth inhibitors|mesh-ancestor
25024909|NCT03641404|Ergothioneine|ergothioneine|mesh-list
25024910|NCT03641404|Antioxidants|antioxidants|mesh-ancestor
25024911|NCT03641404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024912|NCT03641404|Protective Agents|protective agents|mesh-ancestor
25691282|NCT01984242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25691283|NCT01984242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25691284|NCT01984242|Growth Substances|growth substances|mesh-ancestor
25691285|NCT01984242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691286|NCT01984242|Growth Inhibitors|growth inhibitors|mesh-ancestor
25024913|NCT03641404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024915|NCT03641209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25024916|NCT03641209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25024917|NCT03641209|Analgesics|analgesics|mesh-ancestor
25024918|NCT03641209|Sensory System Agents|sensory system agents|mesh-ancestor
24758442|NCT01745770|Mesalamine|mesalamine|mesh-list
25024919|NCT03641209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024920|NCT03641209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024921|NCT03641209|Antipyretics|antipyretics|mesh-ancestor
25024922|NCT03641053|Iodine|iodine|mesh-list
25024923|NCT03641053|Povidone-Iodine|povidone-iodine|mesh-list
25024924|NCT03641053|Povidone|povidone|mesh-list
25024925|NCT03641053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25024926|NCT03641053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25024927|NCT03641053|Trace Elements|trace elements|mesh-ancestor
25024928|NCT03641053|Micronutrients|micronutrients|mesh-ancestor
25024929|NCT03641053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024930|NCT03641053|Plasma Substitutes|plasma substitutes|mesh-ancestor
25024931|NCT03641053|Blood Substitutes|blood substitutes|mesh-ancestor
25024959|NCT03640468|Ketamine|ketamine|mesh-list
25024960|NCT03640468|Anesthetics, Local|anesthetics, local|mesh-ancestor
25024961|NCT03640468|Anesthetics|anesthetics|mesh-ancestor
24474029|NCT00404781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24474030|NCT00404781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24474031|NCT00404781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024965|NCT03640468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024966|NCT03640468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25024967|NCT03640468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25024968|NCT03640468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25024969|NCT03640468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25024970|NCT03640468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024971|NCT03640468|Analgesics|analgesics|mesh-ancestor
25024972|NCT03640468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25024973|NCT03640468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25024974|NCT03640468|Anesthetics, General|anesthetics, general|mesh-ancestor
25024975|NCT03640468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25024976|NCT03640468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25024977|NCT03640468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25024978|NCT03640468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25024979|NCT03640468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25025003|NCT03640390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25025004|NCT03640390|Analgesics|analgesics|mesh-ancestor
25025005|NCT03640390|Sensory System Agents|sensory system agents|mesh-ancestor
25025006|NCT03640390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25025007|NCT03640390|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25025008|NCT03640390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25025009|NCT03640390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25025010|NCT03640390|Adrenergic Agents|adrenergic agents|mesh-ancestor
25025011|NCT03640390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25025012|NCT03640390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025013|NCT03640390|Anesthetics|anesthetics|mesh-ancestor
25025014|NCT03640390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24474032|NCT00404781|Antipyretics|antipyretics|mesh-ancestor
24474033|NCT00404781|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25025031|NCT03640273|Dermatologic Agents|dermatologic agents|mesh-ancestor
25025032|NCT03640273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25025033|NCT03640273|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25025034|NCT03640273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24589780|NCT00908986|Rituximab|rituximab|mesh-list
25025049|NCT03640247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25025050|NCT03640247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025051|NCT03640247|Antipyretics|antipyretics|mesh-ancestor
25025052|NCT03640247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25025054|NCT03640247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25025055|NCT03640247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25025056|NCT03640247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25025057|NCT03640247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025058|NCT03640247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24911530|NCT04286711|Paclitaxel|paclitaxel|mesh-list
24911531|NCT04286711|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25112299|NCT04195139|Nivolumab|nivolumab|mesh-list
25112300|NCT04195139|Temozolomide|temozolomide|mesh-list
24446345|NCT00304499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24474119|NCT00404937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24474120|NCT00405015|Rosiglitazone|rosiglitazone|mesh-list
24474121|NCT00405015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24474122|NCT00405015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474123|NCT00405080|Rifampin|rifampin|mesh-list
24474124|NCT00405080|Casopitant|casopitant|mesh-list
24474125|NCT00405080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25112301|NCT04195139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25112302|NCT04195139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25112303|NCT04195139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25112304|NCT04195139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112305|NCT04195139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25025086|NCT03639922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25025087|NCT03639922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25025088|NCT03639922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025089|NCT03639896|Dexmedetomidine|dexmedetomidine|mesh-list
25025090|NCT03639896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25025091|NCT03639896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25025092|NCT03639896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025093|NCT03639896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25025094|NCT03639896|Analgesics|analgesics|mesh-ancestor
25025095|NCT03639896|Sensory System Agents|sensory system agents|mesh-ancestor
24986073|NCT02333162|Fludarabine phosphate|fludarabine phosphate|mesh-list
25025096|NCT03639896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25025097|NCT03639896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25025098|NCT03639896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25025099|NCT03639896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25025100|NCT03639896|Adrenergic Agents|adrenergic agents|mesh-ancestor
25025103|NCT03639740|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25025104|NCT03639740|Immunologic Factors|immunologic factors|mesh-ancestor
25025105|NCT03639740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025106|NCT03639727|Mannitol|mannitol|mesh-list
25025107|NCT03639727|Citric Acid|citric acid|mesh-list
25025108|NCT03639727|Sodium Citrate|sodium citrate|mesh-list
25691287|NCT01984242|Immunologic Factors|immunologic factors|mesh-ancestor
25691288|NCT01984242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25691289|NCT01984242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25025109|NCT03639727|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25025110|NCT03639727|Diuretics|diuretics|mesh-ancestor
25025111|NCT03639727|Natriuretic Agents|natriuretic agents|mesh-ancestor
25025112|NCT03639727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691290|NCT01984242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691291|NCT01984294|Ribavirin|ribavirin|mesh-list
25691292|NCT01984294|Antiviral Agents|antiviral agents|mesh-ancestor
25691293|NCT01984294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25691294|NCT01984294|Antimetabolites|antimetabolites|mesh-ancestor
25691295|NCT01984294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691296|NCT01984398|Citric Acid|citric acid|mesh-list
25691297|NCT01984398|Sodium Citrate|sodium citrate|mesh-list
25691298|NCT01984398|Enclomiphene|enclomiphene|mesh-list
25691299|NCT01984398|Clomiphene|clomiphene|mesh-list
25691300|NCT01984398|Zuclomiphene|zuclomiphene|mesh-list
25691301|NCT01984398|Anticoagulants|anticoagulants|mesh-ancestor
24911602|NCT04285775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24911603|NCT04285775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24911605|NCT04286152|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24911606|NCT04286152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24911607|NCT04286152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24911608|NCT04286152|Adrenergic Agents|adrenergic agents|mesh-ancestor
24911609|NCT04286152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24911610|NCT04286152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025113|NCT03639727|Anticoagulants|anticoagulants|mesh-ancestor
25025114|NCT03639727|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25025140|NCT03639545|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25025141|NCT03639545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025143|NCT03639532|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25025144|NCT03639532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25025145|NCT03639532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025146|NCT03639532|Cholinergic Agents|cholinergic agents|mesh-ancestor
25025147|NCT03639532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25025148|NCT03639532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025149|NCT03639532|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25025150|NCT03639532|Autonomic Agents|autonomic agents|mesh-ancestor
25025151|NCT03639532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25025152|NCT03639532|Nootropic Agents|nootropic agents|mesh-ancestor
25025153|NCT03639519|Ascorbic Acid|ascorbic acid|mesh-list
25025192|NCT03639467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025193|NCT03639467|Antiviral Agents|antiviral agents|mesh-ancestor
25025194|NCT03639467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25025195|NCT03639467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25025196|NCT03639467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25025197|NCT03639467|Immunologic Factors|immunologic factors|mesh-ancestor
25025198|NCT03639467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025199|NCT03639428|Midazolam|midazolam|mesh-list
25025200|NCT03639428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25025201|NCT03639428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25025202|NCT03639428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25025203|NCT03639428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025275|NCT03638726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25025276|NCT03638726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25025277|NCT03638726|Autonomic Agents|autonomic agents|mesh-ancestor
25025278|NCT03638726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25025279|NCT03638726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25025280|NCT03638726|Respiratory System Agents|respiratory system agents|mesh-ancestor
25025281|NCT03638726|Mydriatics|mydriatics|mesh-ancestor
25025282|NCT03638726|Sympathomimetics|sympathomimetics|mesh-ancestor
25025283|NCT03638726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25025284|NCT03638726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25025285|NCT03638726|Nasal Decongestants|nasal decongestants|mesh-ancestor
24590029|NCT00910416|Anesthetics, General|anesthetics, general|mesh-ancestor
24587662|NCT00896285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24587663|NCT00896285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24587664|NCT00896285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24587665|NCT00896285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24587667|NCT00896285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24587668|NCT00896311|Nitroglycerin|nitroglycerin|mesh-list
24587670|NCT00896376|Trastuzumab|trastuzumab|mesh-list
24587698|NCT00896519|Vincristine|vincristine|mesh-list
24587699|NCT00896519|Sargramostim|sargramostim|mesh-list
24587700|NCT00896519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24587701|NCT00896519|Immunologic Factors|immunologic factors|mesh-ancestor
24587702|NCT00896519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587703|NCT00896519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24590071|NCT00910598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24587715|NCT00896519|Glucocorticoids|glucocorticoids|mesh-ancestor
25691302|NCT01984398|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25691303|NCT01984398|Chelating Agents|chelating agents|mesh-ancestor
25691304|NCT01984398|Sequestering Agents|sequestering agents|mesh-ancestor
25691305|NCT01984398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691306|NCT01984398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25691307|NCT01984398|Hormone Antagonists|hormone antagonists|mesh-ancestor
25691308|NCT01984398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25691309|NCT01984398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691310|NCT01984398|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24587718|NCT00896519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24474344|NCT00405730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24474345|NCT00405730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24474346|NCT00405730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24474348|NCT00405730|Sensory System Agents|sensory system agents|mesh-ancestor
24474349|NCT00405730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24474350|NCT00405730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474351|NCT00405730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24474352|NCT00405730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24474353|NCT00405730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24872576|NCT05311033|Hemostatics|hemostatics|mesh-ancestor
25112370|NCT04157751|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25112371|NCT04157751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112372|NCT04157751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25112373|NCT04157751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025334|NCT03638297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025335|NCT03638297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24474535|NCT00406432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474537|NCT00406432|Antidepressive Agents|antidepressive agents|mesh-ancestor
24474562|NCT00406601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25025336|NCT03638297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25025337|NCT03638297|Analgesics|analgesics|mesh-ancestor
25025338|NCT03638297|Sensory System Agents|sensory system agents|mesh-ancestor
25025339|NCT03638297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25025340|NCT03638297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25025341|NCT03638297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25025342|NCT03638076|Ritonavir|ritonavir|mesh-list
25025343|NCT03638076|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25025344|NCT03638076|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25025345|NCT03638076|Protease Inhibitors|protease inhibitors|mesh-ancestor
25025346|NCT03638076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25025347|NCT03638076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025348|NCT03638076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25025349|NCT03638076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25025380|NCT03637790|Leprostatic Agents|leprostatic agents|mesh-ancestor
25025381|NCT03637790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25025382|NCT03637790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25025383|NCT03637790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025384|NCT03637790|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25025385|NCT03637790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25025386|NCT03637790|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25025387|NCT03637790|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25025388|NCT03637790|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25025389|NCT03637790|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25025390|NCT03637790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25025391|NCT03637582|Lidocaine|lidocaine|mesh-list
25025392|NCT03637582|Anesthetics, Local|anesthetics, local|mesh-ancestor
25025407|NCT03637543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025410|NCT03637400|Sulfamethoxazole|sulfamethoxazole|mesh-list
25025411|NCT03637400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25691311|NCT01984398|Fertility Agents|fertility agents|mesh-ancestor
25691312|NCT01984398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25025421|NCT03637400|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25025422|NCT03637400|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25025423|NCT03637400|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25025425|NCT03637361|D-methadone|d-methadone|mesh-list
25025426|NCT03637361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25025427|NCT03637361|Narcotics|narcotics|mesh-ancestor
25025428|NCT03637361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25025429|NCT03637361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025430|NCT03637361|Analgesics|analgesics|mesh-ancestor
25025431|NCT03637361|Sensory System Agents|sensory system agents|mesh-ancestor
25025432|NCT03637361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25025433|NCT03637361|Antitussive Agents|antitussive agents|mesh-ancestor
25025434|NCT03637361|Respiratory System Agents|respiratory system agents|mesh-ancestor
25025435|NCT03637361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25025436|NCT03637335|Carboplatin|carboplatin|mesh-list
25025437|NCT03637335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24590339|NCT00912171|Budesonide|budesonide|mesh-list
24590376|NCT00912379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24590377|NCT00912379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25025445|NCT03637049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025446|NCT03637049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25025447|NCT03637049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25025448|NCT03637049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25025449|NCT03637049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25025450|NCT03637049|Anesthetics, General|anesthetics, general|mesh-ancestor
25025451|NCT03637049|Anesthetics|anesthetics|mesh-ancestor
25025452|NCT03637049|GABA Modulators|gaba modulators|mesh-ancestor
25025453|NCT03637049|GABA Agents|gaba agents|mesh-ancestor
25025454|NCT03637049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25025455|NCT03637049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025457|NCT03636971|Sorbitol|sorbitol|mesh-list
25025458|NCT03636971|Hyaluronic Acid|hyaluronic acid|mesh-list
24982256|NCT03326492|Antivenins|antivenins|mesh-list
25025459|NCT03636971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25025460|NCT03636971|Immunologic Factors|immunologic factors|mesh-ancestor
25025461|NCT03636971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025463|NCT03636971|Protective Agents|protective agents|mesh-ancestor
25025464|NCT03636971|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25025465|NCT03636971|Diuretics|diuretics|mesh-ancestor
25025466|NCT03636971|Natriuretic Agents|natriuretic agents|mesh-ancestor
25025467|NCT03636971|Cathartics|cathartics|mesh-ancestor
25025468|NCT03636971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25025469|NCT03636932|Acetylcysteine|acetylcysteine|mesh-list
25025475|NCT03636932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25025476|NCT03636932|Antioxidants|antioxidants|mesh-ancestor
25025477|NCT03636932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025478|NCT03636932|Protective Agents|protective agents|mesh-ancestor
25025479|NCT03636932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025480|NCT03636932|Antidotes|antidotes|mesh-ancestor
25025481|NCT03636711|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25025482|NCT03636711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25025483|NCT03636685|Paclitaxel|paclitaxel|mesh-list
25025484|NCT03636685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25025485|NCT03636685|Carboplatin|carboplatin|mesh-list
25025486|NCT03636685|Pemetrexed|pemetrexed|mesh-list
25025487|NCT03636685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25025489|NCT03636685|Tubulin Modulators|tubulin modulators|mesh-ancestor
25025490|NCT03636685|Antimitotic Agents|antimitotic agents|mesh-ancestor
25025491|NCT03636685|Mitosis Modulators|mitosis modulators|mesh-ancestor
25025492|NCT03636685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025493|NCT03636685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474563|NCT00406601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474565|NCT00406679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24474566|NCT00406679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24474567|NCT00406679|Analgesics|analgesics|mesh-ancestor
24474568|NCT00406679|Sensory System Agents|sensory system agents|mesh-ancestor
24474569|NCT00406679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24474570|NCT00406679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474616|NCT00406913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691313|NCT01984398|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25691314|NCT01984398|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25691315|NCT01984424|Atorvastatin|atorvastatin|mesh-list
25691316|NCT01984424|Ezetimibe|ezetimibe|mesh-list
24474617|NCT00406952|Sertraline|sertraline|mesh-list
24474618|NCT00406952|Antidepressive Agents|antidepressive agents|mesh-ancestor
24474619|NCT00406952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25025654|NCT03635125|Autonomic Agents|autonomic agents|mesh-ancestor
25025496|NCT03636659|Amphotericin B|amphotericin b|mesh-list
25025497|NCT03636659|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25025498|NCT03636659|Amebicides|amebicides|mesh-ancestor
25025499|NCT03636659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25025500|NCT03636659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25025501|NCT03636659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25025502|NCT03636659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25025503|NCT03636659|Antifungal Agents|antifungal agents|mesh-ancestor
25025504|NCT03636555|Oxytocin|oxytocin|mesh-list
25025505|NCT03636555|Oxytocics|oxytocics|mesh-ancestor
25025506|NCT03636555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24590477|NCT00912678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24590478|NCT00912678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24590480|NCT00912756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24590481|NCT00912756|Autonomic Agents|autonomic agents|mesh-ancestor
24590482|NCT00912756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24590484|NCT00912756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25025514|NCT03636542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25025515|NCT03636477|Nivolumab|nivolumab|mesh-list
25025516|NCT03636477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25025517|NCT03636477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25025518|NCT03636477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25025519|NCT03636477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025520|NCT03636373|Triamcinolone|triamcinolone|mesh-list
25025521|NCT03636373|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25025522|NCT03636373|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24474621|NCT00406952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24474622|NCT00406952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24474623|NCT00406952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474624|NCT00406952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24474625|NCT00406952|Serotonin Agents|serotonin agents|mesh-ancestor
25025535|NCT03636373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25025537|NCT03636373|Sensory System Agents|sensory system agents|mesh-ancestor
25025538|NCT03636373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25025539|NCT03636373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25025540|NCT03636373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25025541|NCT03636308|Gemcitabine|gemcitabine|mesh-list
25025542|NCT03636308|Paclitaxel|paclitaxel|mesh-list
25025543|NCT03636308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25025544|NCT03636308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24474626|NCT00406952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474627|NCT00406978|Thalidomide|thalidomide|mesh-list
24474628|NCT00406978|Prednisone|prednisone|mesh-list
24474629|NCT00406978|Melphalan|melphalan|mesh-list
24474630|NCT00406978|Defibrotide|defibrotide|mesh-list
24474661|NCT00406991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474662|NCT00406991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24474688|NCT00407017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395444|NCT00135967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474663|NCT00406991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24474664|NCT00406991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25025546|NCT03636308|Tubulin Modulators|tubulin modulators|mesh-ancestor
25025547|NCT03636308|Antimitotic Agents|antimitotic agents|mesh-ancestor
25025548|NCT03636308|Mitosis Modulators|mitosis modulators|mesh-ancestor
25025550|NCT03636308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25025551|NCT03636308|Antimetabolites|antimetabolites|mesh-ancestor
25025552|NCT03636308|Antiviral Agents|antiviral agents|mesh-ancestor
25691317|NCT01984424|Evolocumab|evolocumab|mesh-list
25025553|NCT03636308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25025554|NCT03636308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25025555|NCT03636308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25025556|NCT03636308|Immunologic Factors|immunologic factors|mesh-ancestor
25691318|NCT01984424|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25691319|NCT01984424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25691320|NCT01984424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25691321|NCT01984424|Antimetabolites|antimetabolites|mesh-ancestor
25691322|NCT01984424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691323|NCT01984424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25691324|NCT01984424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24827526|NCT02140047|Vaccines|vaccines|mesh-list
24953413|NCT03885388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25691325|NCT01984424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24953416|NCT03885388|Antimetabolites|antimetabolites|mesh-ancestor
25025557|NCT03636308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025558|NCT03636178|Daminozide|daminozide|mesh-list
25025559|NCT03636178|Plant Growth Regulators|plant growth regulators|mesh-ancestor
25025560|NCT03636178|Growth Substances|growth substances|mesh-ancestor
25025561|NCT03636178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025562|NCT03636048|Bupivacaine|bupivacaine|mesh-list
25025563|NCT03636048|Anesthetics|anesthetics|mesh-list
25025564|NCT03636048|Propofol|propofol|mesh-list
25025570|NCT03636048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25025571|NCT03636048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25025572|NCT03636048|Anesthetics, General|anesthetics, general|mesh-ancestor
24590522|NCT00913029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24590523|NCT00913029|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24590524|NCT00913029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24590526|NCT00913055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25025573|NCT03635931|Mitogens|mitogens|mesh-list
25025574|NCT03635931|Mitosis Modulators|mitosis modulators|mesh-ancestor
24590527|NCT00913055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25025575|NCT03635931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025576|NCT03635905|Gabapentin|gabapentin|mesh-list
25025577|NCT03635905|Analgesics|analgesics|mesh-ancestor
25025578|NCT03635905|Sensory System Agents|sensory system agents|mesh-ancestor
25025579|NCT03635905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25025580|NCT03635905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025581|NCT03635905|Anticonvulsants|anticonvulsants|mesh-ancestor
24986407|NCT01665794|Hormones|hormones|mesh-ancestor
25025586|NCT03635905|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25025587|NCT03635905|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25025588|NCT03635905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25025589|NCT03635905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025590|NCT03635905|Antimanic Agents|antimanic agents|mesh-ancestor
25025592|NCT03635827|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25025593|NCT03635827|Anesthetics, General|anesthetics, general|mesh-ancestor
25025594|NCT03635827|Anesthetics|anesthetics|mesh-ancestor
25025595|NCT03635827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25025596|NCT03635827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025597|NCT03635684|Acetaminophen|acetaminophen|mesh-list
25025598|NCT03635684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25025599|NCT03635684|Analgesics|analgesics|mesh-ancestor
25025600|NCT03635684|Sensory System Agents|sensory system agents|mesh-ancestor
25025601|NCT03635684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25025602|NCT03635684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025603|NCT03635684|Antipyretics|antipyretics|mesh-ancestor
25025604|NCT03635437|Alprazolam|alprazolam|mesh-list
25025605|NCT03635437|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
25025606|NCT03635437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25025607|NCT03635437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25025608|NCT03635437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025609|NCT03635437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25025610|NCT03635437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25025611|NCT03635437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25691326|NCT01984424|Immunologic Factors|immunologic factors|mesh-ancestor
25691327|NCT01984424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691328|NCT01984684|Vancomycin|vancomycin|mesh-list
25691329|NCT01984684|Aztreonam|aztreonam|mesh-list
25691330|NCT01984684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25691331|NCT01984684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25691332|NCT01984892|Poly ICLC|poly iclc|mesh-list
25691333|NCT01984892|Interferon Inducers|interferon inducers|mesh-ancestor
25691334|NCT01984892|Immunologic Factors|immunologic factors|mesh-ancestor
25691335|NCT01984892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691336|NCT01985126|Acetaminophen|acetaminophen|mesh-list
25025612|NCT03635437|GABA Modulators|gaba modulators|mesh-ancestor
25017516|NCT00620464|Hormones|hormones|mesh-ancestor
25025613|NCT03635437|GABA Agents|gaba agents|mesh-ancestor
25025614|NCT03635437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24911860|NCT04283435|Estradiol|estradiol|mesh-list
25025615|NCT03635437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025616|NCT03635411|Niacinamide|niacinamide|mesh-list
24590528|NCT00913055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24590529|NCT00913107|Lamotrigine|lamotrigine|mesh-list
25025648|NCT03635372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025649|NCT03635125|Metoprolol|metoprolol|mesh-list
24590592|NCT00913276|Anesthetics|anesthetics|mesh-ancestor
24590593|NCT00913276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24590594|NCT00913276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24590595|NCT00913315|Tamsulosin|tamsulosin|mesh-list
25025668|NCT03634917|Acamprosate|acamprosate|mesh-list
25025669|NCT03634917|Calcium Carbonate|calcium carbonate|mesh-list
25025670|NCT03634917|Calcium|calcium|mesh-list
25025671|NCT03634917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25025672|NCT03634917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025701|NCT03634852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25025702|NCT03634852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474744|NCT00407225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24474788|NCT00407394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24474789|NCT00407394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24474931|NCT00408187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24474932|NCT00408187|Immunologic Factors|immunologic factors|mesh-ancestor
24474933|NCT00408187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025730|NCT03634605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24474956|NCT00408239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24474957|NCT00408239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24474958|NCT00408239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475007|NCT00408525|Donepezil|donepezil|mesh-list
24475167|NCT00409253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24475168|NCT00409253|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25025731|NCT03634605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25025732|NCT03634605|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25025733|NCT03634605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25025734|NCT03634514|Hormones|hormones|mesh-list
25025735|NCT03634514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25025736|NCT03634514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025737|NCT03634345|Fluconazole|fluconazole|mesh-list
25025738|NCT03634345|Fluvoxamine|fluvoxamine|mesh-list
25025739|NCT03634345|Abrocitinib|abrocitinib|mesh-list
25025740|NCT03634345|Antifungal Agents|antifungal agents|mesh-ancestor
25025741|NCT03634345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25691337|NCT01985126|Diphenhydramine|diphenhydramine|mesh-list
25691338|NCT01985126|Promethazine|promethazine|mesh-list
25691339|NCT01985126|Methylprednisolone|methylprednisolone|mesh-list
25691340|NCT01985126|Daratumumab|daratumumab|mesh-list
25691341|NCT01985126|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25691342|NCT01985126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25691343|NCT01985126|Analgesics|analgesics|mesh-ancestor
25691344|NCT01985126|Sensory System Agents|sensory system agents|mesh-ancestor
25691345|NCT01985126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25691346|NCT01985126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065234|NCT03451734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25065235|NCT03451734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065236|NCT03451734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25065237|NCT03451734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25065238|NCT03451734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25065240|NCT03451695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25065241|NCT03451695|Narcotics|narcotics|mesh-ancestor
24827550|NCT02140242|Daunorubicin|daunorubicin|mesh-list
24912000|NCT04282200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25025742|NCT03634345|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25025750|NCT03634345|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25025751|NCT03634345|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25025753|NCT03634345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25025754|NCT03634345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24784919|NCT01910987|Antiemetics|antiemetics|mesh-ancestor
24475169|NCT00409253|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24446695|NCT00305708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446696|NCT00305708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24475278|NCT00409721|Memantine|memantine|mesh-list
25025755|NCT03634345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25025756|NCT03634345|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25025757|NCT03634345|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25025758|NCT03634345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25025759|NCT03634345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25025760|NCT03634345|Serotonin Agents|serotonin agents|mesh-ancestor
25025761|NCT03634345|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25025762|NCT03634345|Antidepressive Agents|antidepressive agents|mesh-ancestor
25025763|NCT03634345|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25025764|NCT03634345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25025772|NCT03634202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25025773|NCT03634189|Cannabidiol|cannabidiol|mesh-list
25025774|NCT03634189|Anticonvulsants|anticonvulsants|mesh-ancestor
25025775|NCT03634137|Afamelanotide|afamelanotide|mesh-list
24590679|NCT00913549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24590680|NCT00913562|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24590681|NCT00913562|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25025777|NCT03634137|Dermatologic Agents|dermatologic agents|mesh-ancestor
25025778|NCT03634137|Hormones|hormones|mesh-ancestor
25025779|NCT03634137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25025780|NCT03634137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025781|NCT03634111|Morphine|morphine|mesh-list
25025782|NCT03634111|Ropivacaine|ropivacaine|mesh-list
25025783|NCT03634111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25025784|NCT03634111|Narcotics|narcotics|mesh-ancestor
25025785|NCT03634111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25025786|NCT03634111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025787|NCT03634111|Analgesics|analgesics|mesh-ancestor
25025788|NCT03634111|Sensory System Agents|sensory system agents|mesh-ancestor
24982588|NCT01485874|Nintedanib|nintedanib|mesh-list
25025789|NCT03634111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25025802|NCT03634020|Antifungal Agents|antifungal agents|mesh-ancestor
25025803|NCT03634020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25025804|NCT03634020|Immunologic Factors|immunologic factors|mesh-ancestor
25025805|NCT03634020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025806|NCT03633994|Heparin|heparin|mesh-list
25025812|NCT03633812|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25025813|NCT03633812|Adrenergic Agents|adrenergic agents|mesh-ancestor
25025814|NCT03633812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25025815|NCT03633812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025816|NCT03633812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025817|NCT03633747|Propranolol|propranolol|mesh-list
25025818|NCT03633747|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25691347|NCT01985126|Antipyretics|antipyretics|mesh-ancestor
25691348|NCT01985126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25691349|NCT01985126|Antiemetics|antiemetics|mesh-ancestor
25691350|NCT01985126|Autonomic Agents|autonomic agents|mesh-ancestor
25691351|NCT01985126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25691352|NCT01985126|Glucocorticoids|glucocorticoids|mesh-ancestor
25691353|NCT01985126|Hormones|hormones|mesh-ancestor
25691354|NCT01985126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25691355|NCT01985126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25691356|NCT01985126|Protective Agents|protective agents|mesh-ancestor
24912148|NCT04279379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24912149|NCT04279379|Antimetabolites|antimetabolites|mesh-ancestor
24912150|NCT04279379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912151|NCT04279379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24819170|NCT02093910|Dexamethasone|dexamethasone|mesh-list
24819171|NCT02093910|Bortezomib|bortezomib|mesh-list
24819172|NCT02093910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24912179|NCT04278859|Antibodies|antibodies|mesh-list
24912180|NCT04278859|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24912181|NCT04278859|Immunologic Factors|immunologic factors|mesh-ancestor
24912182|NCT04278859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912184|NCT04278703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24912185|NCT04278703|Narcotics|narcotics|mesh-ancestor
24590682|NCT00913562|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24723039|NCT01584492|Beclomethasone|beclomethasone|mesh-list
24475519|NCT00410657|Prednisone|prednisone|mesh-list
24475520|NCT00410657|Methylprednisolone|methylprednisolone|mesh-list
24475521|NCT00410657|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24475522|NCT00410657|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25025832|NCT03633630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25025833|NCT03633604|HBOC 201|hboc 201|mesh-list
25025834|NCT03633604|Blood Substitutes|blood substitutes|mesh-ancestor
25025835|NCT03633591|Tolcapone|tolcapone|mesh-list
25025836|NCT03633591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25025837|NCT03633591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25025838|NCT03633591|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25025839|NCT03633591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25025840|NCT03633591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025841|NCT03633565|Prednisolone|prednisolone|mesh-list
25025842|NCT03633565|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25025843|NCT03633565|Methylprednisolone|methylprednisolone|mesh-list
25025844|NCT03633565|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25025845|NCT03633565|Prednisolone acetate|prednisolone acetate|mesh-list
25025846|NCT03633565|Sildenafil Citrate|sildenafil citrate|mesh-list
24986557|NCT00193219|Vitamins|vitamins|mesh-ancestor
24475523|NCT00410657|Prednisolone|prednisolone|mesh-list
24475683|NCT00411125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24475684|NCT00411125|Vasodilator Agents|vasodilator agents|mesh-ancestor
24475685|NCT00411164|Hydromorphone|hydromorphone|mesh-list
24475686|NCT00411164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24475687|NCT00411164|Narcotics|narcotics|mesh-ancestor
24475688|NCT00411164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24475689|NCT00411164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475690|NCT00411164|Analgesics|analgesics|mesh-ancestor
25691357|NCT01985126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25691358|NCT01985126|Immunologic Factors|immunologic factors|mesh-ancestor
25691359|NCT01985126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25691360|NCT01985126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25691361|NCT01985126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25691362|NCT01985126|Anesthetics, Local|anesthetics, local|mesh-ancestor
25691363|NCT01985126|Anesthetics|anesthetics|mesh-ancestor
25691364|NCT01985126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25691365|NCT01985126|Histamine Antagonists|histamine antagonists|mesh-ancestor
25691366|NCT01985126|Histamine Agents|histamine agents|mesh-ancestor
25691367|NCT01985126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25691368|NCT01985126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691369|NCT01985126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25691370|NCT01985126|Antipruritics|antipruritics|mesh-ancestor
25691371|NCT01985126|Dermatologic Agents|dermatologic agents|mesh-ancestor
25691372|NCT01985321|Ethanol|ethanol|mesh-list
25691373|NCT01985321|Glycolic acid|glycolic acid|mesh-list
24912439|NCT04275388|Ritonavir|ritonavir|mesh-list
24912440|NCT04275388|Lopinavir|lopinavir|mesh-list
24912441|NCT04275388|Interferon-alpha|interferon-alpha|mesh-list
24912442|NCT04275388|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
24912443|NCT04275388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912444|NCT04275388|Antiviral Agents|antiviral agents|mesh-ancestor
24912445|NCT04275388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24912446|NCT04275388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24475807|NCT00411437|Cholinergic Agents|cholinergic agents|mesh-ancestor
25025854|NCT03633565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025855|NCT03633565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25025856|NCT03633565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25025857|NCT03633565|Antiemetics|antiemetics|mesh-ancestor
25025858|NCT03633565|Autonomic Agents|autonomic agents|mesh-ancestor
25025859|NCT03633565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24476086|NCT00412802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25025860|NCT03633565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25025861|NCT03633565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25025863|NCT03633565|Vasodilator Agents|vasodilator agents|mesh-ancestor
25025864|NCT03633565|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25025865|NCT03633565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25025866|NCT03633565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025867|NCT03633565|Urological Agents|urological agents|mesh-ancestor
25025869|NCT03633552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25025870|NCT03633552|Alkylating Agents|alkylating agents|mesh-ancestor
25025871|NCT03633552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691374|NCT01985321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25691375|NCT01985321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25691376|NCT01985321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25691377|NCT01985321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691378|NCT01985321|Keratolytic Agents|keratolytic agents|mesh-ancestor
25691379|NCT01985321|Dermatologic Agents|dermatologic agents|mesh-ancestor
25691380|NCT01985334|Glycopyrrolate|glycopyrrolate|mesh-list
25691381|NCT01985334|Bromides|bromides|mesh-list
24912556|NCT04274257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912557|NCT04274257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24912576|NCT04273997|Metronidazole|metronidazole|mesh-list
24735646|NCT01657929|Antacids|antacids|mesh-ancestor
24912602|NCT04273763|Bromhexine|bromhexine|mesh-list
24912603|NCT04273763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912604|NCT04273763|Antiviral Agents|antiviral agents|mesh-ancestor
24912605|NCT04273763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24912627|NCT04273529|Thalidomide|thalidomide|mesh-list
24912628|NCT04273529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24882358|NCT01111565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24912629|NCT04273529|Immunologic Factors|immunologic factors|mesh-ancestor
24912630|NCT04273529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912631|NCT04273529|Leprostatic Agents|leprostatic agents|mesh-ancestor
24912632|NCT04273529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24912633|NCT04273529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24912634|NCT04273529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24912635|NCT04273529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25025872|NCT03633552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25039941|NCT03571568|Rituximab|rituximab|mesh-list
24476087|NCT00412802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691382|NCT01985334|Anticonvulsants|anticonvulsants|mesh-ancestor
25691383|NCT01985334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691384|NCT01985334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25691385|NCT01985334|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25691386|NCT01985334|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25691387|NCT01985334|Cholinergic Agents|cholinergic agents|mesh-ancestor
25691388|NCT01985334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25691389|NCT01985334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691390|NCT01985425|Colchicine|colchicine|mesh-list
25691391|NCT01985425|Gout Suppressants|gout suppressants|mesh-ancestor
25691392|NCT01985425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25691393|NCT01985425|Tubulin Modulators|tubulin modulators|mesh-ancestor
25691394|NCT01985425|Antimitotic Agents|antimitotic agents|mesh-ancestor
25691395|NCT01985425|Mitosis Modulators|mitosis modulators|mesh-ancestor
25691396|NCT01985425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691397|NCT01985425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25691398|NCT01985581|Guanfacine|guanfacine|mesh-list
24912727|NCT04272567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25065277|NCT03451500|Carbidopa|carbidopa|mesh-list
25025873|NCT03633292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
25025874|NCT03633292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25025910|NCT03632915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25025911|NCT03632915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25025912|NCT03632915|GABA Modulators|gaba modulators|mesh-ancestor
25025913|NCT03632915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25025914|NCT03632915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25025915|NCT03632876|Vitamin A|vitamin a|mesh-list
25025938|NCT03632772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025940|NCT03632772|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25025941|NCT03632772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25025942|NCT03632772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25025943|NCT03632772|Adrenergic Agents|adrenergic agents|mesh-ancestor
25025944|NCT03632733|Tetracycline|tetracycline|mesh-list
25025945|NCT03632733|Clotrimazole|clotrimazole|mesh-list
25025946|NCT03632733|Miconazole|miconazole|mesh-list
25025947|NCT03632733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24723633|NCT01588704|Pemetrexed|pemetrexed|mesh-list
25025948|NCT03632733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25025949|NCT03632733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25025950|NCT03632733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24986587|NCT00070018|Immunologic Factors|immunologic factors|mesh-ancestor
24476143|NCT00413257|Nefopam|nefopam|mesh-list
24476150|NCT00413296|Anticonvulsants|anticonvulsants|mesh-ancestor
24476151|NCT00413296|Nootropic Agents|nootropic agents|mesh-ancestor
24476152|NCT00413322|Fluorouracil|fluorouracil|mesh-list
24476153|NCT00413322|Belinostat|belinostat|mesh-list
24476154|NCT00413322|Antimetabolites|antimetabolites|mesh-ancestor
24476155|NCT00413322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476156|NCT00413322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24476157|NCT00413322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476158|NCT00413322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25025951|NCT03632733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025953|NCT03632733|Antifungal Agents|antifungal agents|mesh-ancestor
25025954|NCT03632733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25025955|NCT03632733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25025956|NCT03632733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25025957|NCT03632733|Hormone Antagonists|hormone antagonists|mesh-ancestor
25025958|NCT03632733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25025959|NCT03632733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025960|NCT03632733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25025961|NCT03632733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24476159|NCT00413322|Immunologic Factors|immunologic factors|mesh-ancestor
25026049|NCT03632317|Panobinostat|panobinostat|mesh-list
24476163|NCT00413361|Hydroxychloroquine|hydroxychloroquine|mesh-list
24476164|NCT00413361|Antimalarials|antimalarials|mesh-ancestor
24476165|NCT00413361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24476166|NCT00413361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24476167|NCT00413361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24476168|NCT00413361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691399|NCT01985581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25691400|NCT01985581|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25691401|NCT01985581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25691402|NCT01985581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25691403|NCT01985581|Adrenergic Agents|adrenergic agents|mesh-ancestor
25691404|NCT01985581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25691405|NCT01985581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912893|NCT04270487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476169|NCT00413361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476229|NCT00413608|Purinergic Agents|purinergic agents|mesh-ancestor
24476384|NCT00414531|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24476385|NCT00414531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25025962|NCT03632681|Insulin|insulin|mesh-list
25025963|NCT03632681|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25025964|NCT03632681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25025965|NCT03632681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025966|NCT03632642|Floxacillin|floxacillin|mesh-list
25025967|NCT03632642|Penicillin G|penicillin g|mesh-list
25025968|NCT03632642|Penicillin G Benzathine|penicillin g benzathine|mesh-list
25025969|NCT03632642|Penicillin G Procaine|penicillin g procaine|mesh-list
25025970|NCT03632642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24590850|NCT00914004|Desipramine|desipramine|mesh-list
24478501|NCT00423215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25025998|NCT03632538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025999|NCT03632460|Dexmedetomidine|dexmedetomidine|mesh-list
25026000|NCT03632460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24986641|NCT05189184|Antimitotic Agents|antimitotic agents|mesh-ancestor
24476438|NCT00415064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24476439|NCT00415064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24476441|NCT00415064|Immunologic Factors|immunologic factors|mesh-ancestor
24476442|NCT00415064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24476739|NCT00416377|Glucocorticoids|glucocorticoids|mesh-ancestor
24476741|NCT00416377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25691406|NCT01985581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691407|NCT01985685|Thiamine|thiamine|mesh-list
25691408|NCT01985685|Vitamin B Complex|vitamin b complex|mesh-ancestor
25691409|NCT01985685|Vitamins|vitamins|mesh-ancestor
25691410|NCT01985685|Micronutrients|micronutrients|mesh-ancestor
25691411|NCT01985685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691412|NCT01985763|Genistein|genistein|mesh-list
25691413|NCT01985763|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25691414|NCT01985763|Protective Agents|protective agents|mesh-ancestor
24476742|NCT00416377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476743|NCT00416377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24476744|NCT00416377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24476745|NCT00416377|Alkylating Agents|alkylating agents|mesh-ancestor
24476807|NCT00416533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24476846|NCT00416676|Antimitotic Agents|antimitotic agents|mesh-ancestor
24477100|NCT00417183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24477102|NCT00417222|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24477161|NCT00417677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477162|NCT00417677|Growth Inhibitors|growth inhibitors|mesh-ancestor
25026008|NCT03632460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25026009|NCT03632460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25026010|NCT03632460|Adrenergic Agents|adrenergic agents|mesh-ancestor
25026011|NCT03632460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25026012|NCT03632460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026014|NCT03632408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24477163|NCT00417677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24477164|NCT00417677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477166|NCT00417677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24477181|NCT00417716|Growth Substances|growth substances|mesh-ancestor
24477182|NCT00417716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477183|NCT00417716|Growth Inhibitors|growth inhibitors|mesh-ancestor
24477185|NCT00417729|Glyburide|glyburide|mesh-list
24477509|NCT00418860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477510|NCT00418860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24477637|NCT00419549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24478231|NCT00421915|Immunologic Factors|immunologic factors|mesh-ancestor
24478233|NCT00421967|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24478234|NCT00421967|Epinephrine|epinephrine|mesh-list
24478235|NCT00421967|Racepinephrine|racepinephrine|mesh-list
24478236|NCT00421967|Ropivacaine|ropivacaine|mesh-list
24478237|NCT00421967|Epinephryl borate|epinephryl borate|mesh-list
24478238|NCT00421967|Anesthetics, Local|anesthetics, local|mesh-ancestor
24478351|NCT00422526|Progestins|progestins|mesh-ancestor
24478394|NCT00422617|Alefacept|alefacept|mesh-list
24478419|NCT00422682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24478420|NCT00422682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478422|NCT00422682|Immunologic Factors|immunologic factors|mesh-ancestor
24478500|NCT00423215|Insulin Glargine|insulin glargine|mesh-list
24478502|NCT00423215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478503|NCT00423228|Donepezil|donepezil|mesh-list
24478504|NCT00423228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24478505|NCT00423228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478506|NCT00423228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026050|NCT03632317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25026051|NCT03632317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25026052|NCT03632317|Immunologic Factors|immunologic factors|mesh-ancestor
25026053|NCT03632317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026054|NCT03632317|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25026062|NCT03632213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25026063|NCT03632213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25026064|NCT03632213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25026065|NCT03632213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026067|NCT03632161|Bupivacaine|bupivacaine|mesh-list
25026068|NCT03632161|Anesthetics, Local|anesthetics, local|mesh-ancestor
25026069|NCT03632161|Anesthetics|anesthetics|mesh-ancestor
25026070|NCT03632161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25026071|NCT03632161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026072|NCT03632161|Sensory System Agents|sensory system agents|mesh-ancestor
25026073|NCT03632161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25691415|NCT01985763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691416|NCT01985763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25691417|NCT01985763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25691418|NCT01985763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691419|NCT01985763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691420|NCT01985763|Phytoestrogens|phytoestrogens|mesh-ancestor
24913063|NCT04268602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24913064|NCT04268602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913065|NCT04268602|Sensory System Agents|sensory system agents|mesh-ancestor
25026074|NCT03632161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25026075|NCT03632161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25026076|NCT03632161|Analgesics|analgesics|mesh-ancestor
25026077|NCT03632161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25026078|NCT03632161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25026079|NCT03632161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25026080|NCT03632161|Adrenergic Agents|adrenergic agents|mesh-ancestor
25026081|NCT03632161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25026082|NCT03632161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026083|NCT03631966|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25026084|NCT03631966|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25026085|NCT03631966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25026086|NCT03631966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026087|NCT03631966|Cholinergic Agents|cholinergic agents|mesh-ancestor
25026088|NCT03631966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25026094|NCT03631953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026096|NCT03631901|Melatonin|melatonin|mesh-list
25026097|NCT03631901|Antioxidants|antioxidants|mesh-ancestor
25026098|NCT03631901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026099|NCT03631901|Protective Agents|protective agents|mesh-ancestor
25026100|NCT03631901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026101|NCT03631901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25026102|NCT03631901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25026109|NCT03631901|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25026110|NCT03631901|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25026111|NCT03631901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25026112|NCT03631901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25026113|NCT03631901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25026114|NCT03631901|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25026115|NCT03631901|Anesthetics, General|anesthetics, general|mesh-ancestor
25026116|NCT03631901|Anesthetics|anesthetics|mesh-ancestor
25026117|NCT03631901|GABA Modulators|gaba modulators|mesh-ancestor
25026118|NCT03631901|GABA Agents|gaba agents|mesh-ancestor
25026119|NCT03631901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25026120|NCT03631875|Ketamine|ketamine|mesh-list
25026121|NCT03631875|Propofol|propofol|mesh-list
25026122|NCT03631875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25026123|NCT03631875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25026124|NCT03631875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026125|NCT03631875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25026126|NCT03631875|Anesthetics, General|anesthetics, general|mesh-ancestor
25026127|NCT03631875|Anesthetics|anesthetics|mesh-ancestor
25026147|NCT03631836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25026148|NCT03631836|Growth Substances|growth substances|mesh-ancestor
25026149|NCT03631836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026150|NCT03631836|Growth Inhibitors|growth inhibitors|mesh-ancestor
25026151|NCT03631836|Immunologic Factors|immunologic factors|mesh-ancestor
25026182|NCT03631563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026184|NCT03631316|Antiviral Agents|antiviral agents|mesh-ancestor
25026185|NCT03631316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25026186|NCT03631277|Calcium|calcium|mesh-list
25026187|NCT03631277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25026188|NCT03631277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026189|NCT03631147|Rifaximin|rifaximin|mesh-list
25026190|NCT03631147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25026191|NCT03631147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25026219|NCT03630952|Growth Substances|growth substances|mesh-ancestor
25026220|NCT03630952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026221|NCT03630952|Growth Inhibitors|growth inhibitors|mesh-ancestor
25026222|NCT03630952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24615906|NCT01032499|Oxytetracycline|oxytetracycline|mesh-list
24587842|NCT00897520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587843|NCT00897520|Antiviral Agents|antiviral agents|mesh-ancestor
24587844|NCT00897520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24587845|NCT00897520|Immunologic Factors|immunologic factors|mesh-ancestor
24587846|NCT00897520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587847|NCT00897871|Cyclophosphamide|cyclophosphamide|mesh-list
25691421|NCT01985763|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25691422|NCT01985763|Estrogens|estrogens|mesh-ancestor
25691423|NCT01985763|Hormones|hormones|mesh-ancestor
24587848|NCT00897871|Carboplatin|carboplatin|mesh-list
24587861|NCT00897871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24587862|NCT00897871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25026223|NCT03630796|Sevoflurane|sevoflurane|mesh-list
25026224|NCT03630796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24591170|NCT00915408|Hormones|hormones|mesh-ancestor
25026241|NCT03630367|Dexamethasone|dexamethasone|mesh-list
25026242|NCT03630367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25026243|NCT03630367|Antiemetics|antiemetics|mesh-ancestor
25026244|NCT03630367|Autonomic Agents|autonomic agents|mesh-ancestor
25026245|NCT03630367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25026246|NCT03630367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026247|NCT03630367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25026248|NCT03630367|Glucocorticoids|glucocorticoids|mesh-ancestor
25026249|NCT03630367|Hormones|hormones|mesh-ancestor
25026250|NCT03630367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25026251|NCT03630367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25026252|NCT03630367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25026253|NCT03630341|Clomiphene|clomiphene|mesh-list
25026254|NCT03630341|Enclomiphene|enclomiphene|mesh-list
25026255|NCT03630341|Zuclomiphene|zuclomiphene|mesh-list
25026256|NCT03630341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25026257|NCT03630341|Hormone Antagonists|hormone antagonists|mesh-ancestor
25026258|NCT03630341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25026291|NCT03630042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026292|NCT03630042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25026293|NCT03630029|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25026295|NCT03629847|Everolimus|everolimus|mesh-list
25026296|NCT03629847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986839|NCT05124509|Vaccines|vaccines|mesh-list
24478516|NCT00423371|Protective Agents|protective agents|mesh-ancestor
24478517|NCT00423384|Ibandronic Acid|ibandronic acid|mesh-list
24478518|NCT00423384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24478519|NCT00423384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478520|NCT00423397|Interferons|interferons|mesh-list
24478521|NCT00423397|Interferon-alpha|interferon-alpha|mesh-list
24478522|NCT00423397|Interferon alpha-2|interferon alpha-2|mesh-list
24478561|NCT00423514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24478654|NCT00423826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24478655|NCT00423826|Antitubercular Agents|antitubercular agents|mesh-ancestor
25026297|NCT03629847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25026299|NCT03629847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026300|NCT03629717|Vitamin D|vitamin d|mesh-list
25026301|NCT03629717|Denosumab|denosumab|mesh-list
25026302|NCT03629717|Calcium|calcium|mesh-list
25026303|NCT03629717|Vitamins|vitamins|mesh-ancestor
25026304|NCT03629717|Micronutrients|micronutrients|mesh-ancestor
25026305|NCT03629717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026306|NCT03629717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25026307|NCT03629717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25026308|NCT03629639|Metformin|metformin|mesh-list
25026309|NCT03629639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25026310|NCT03629639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026315|NCT03629600|Indomethacin|indomethacin|mesh-list
25026316|NCT03629600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25026317|NCT03629600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25026318|NCT03629600|Analgesics|analgesics|mesh-ancestor
25026319|NCT03629600|Sensory System Agents|sensory system agents|mesh-ancestor
25026328|NCT03629600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25026329|NCT03629600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026367|NCT03629379|Dermatologic Agents|dermatologic agents|mesh-ancestor
25026368|NCT03629379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25026409|NCT03629093|Anesthetics, General|anesthetics, general|mesh-list
25026410|NCT03629093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25026411|NCT03629093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112516|NCT04029038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25112517|NCT04029038|Alkylating Agents|alkylating agents|mesh-ancestor
25112518|NCT04029038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112519|NCT04029038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25112520|NCT04029038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24725236|NCT01596803|Protective Agents|protective agents|mesh-ancestor
25112544|NCT04025216|Cyclophosphamide|cyclophosphamide|mesh-list
25112545|NCT04025216|Fludarabine|fludarabine|mesh-list
25112546|NCT04025216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24478656|NCT00423826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24478657|NCT00423826|Alkylating Agents|alkylating agents|mesh-ancestor
24478658|NCT00423826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24478659|NCT00423826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24478660|NCT00423865|Everolimus|everolimus|mesh-list
24478661|NCT00423865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25112547|NCT04025216|Immunologic Factors|immunologic factors|mesh-ancestor
25112548|NCT04025216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112549|NCT04025216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25112550|NCT04025216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25107042|NCT03142776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107043|NCT03142776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107044|NCT03142776|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24861452|NCT02317861|Verinurad|verinurad|mesh-list
25112551|NCT04025216|Alkylating Agents|alkylating agents|mesh-ancestor
25112552|NCT04025216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112553|NCT04025216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25112554|NCT04025216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25112555|NCT04024254|Folic Acid|folic acid|mesh-list
25112556|NCT04024254|Hematinics|hematinics|mesh-ancestor
25112557|NCT04024254|Vitamin B Complex|vitamin b complex|mesh-ancestor
25112558|NCT04024254|Vitamins|vitamins|mesh-ancestor
25112559|NCT04024254|Micronutrients|micronutrients|mesh-ancestor
25112560|NCT04024254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112561|NCT04001647|Ascorbic Acid|ascorbic acid|mesh-list
25112562|NCT04001647|Nitroprusside|nitroprusside|mesh-list
25112563|NCT04001647|Acetylcholine|acetylcholine|mesh-list
25026458|NCT03628430|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25026459|NCT03628430|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25026460|NCT03628430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25026461|NCT03628430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026463|NCT03628430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25026464|NCT03628430|Adrenergic Agents|adrenergic agents|mesh-ancestor
25026465|NCT03628430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25026466|NCT03628430|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24591508|NCT00917059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25026543|NCT03627390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026544|NCT03627260|Sunscreening Agents|sunscreening agents|mesh-list
25026545|NCT03627260|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25026546|NCT03627260|Protective Agents|protective agents|mesh-ancestor
25026547|NCT03627260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026548|NCT03627260|Dermatologic Agents|dermatologic agents|mesh-ancestor
25112574|NCT04001647|Cholinergic Agents|cholinergic agents|mesh-ancestor
25112575|NCT04001647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25026558|NCT03626831|Evolocumab|evolocumab|mesh-list
25026559|NCT03626831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25026560|NCT03626831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25026561|NCT03626831|Antimetabolites|antimetabolites|mesh-ancestor
25026562|NCT03626831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026563|NCT03626831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24478714|NCT00424151|Immunologic Factors|immunologic factors|mesh-ancestor
24478715|NCT00424151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478716|NCT00424151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24478717|NCT00424164|Tamoxifen|tamoxifen|mesh-list
25026564|NCT03626753|Acetaminophen|acetaminophen|mesh-list
25026565|NCT03626753|Piroxicam|piroxicam|mesh-list
25026566|NCT03626753|Nefopam|nefopam|mesh-list
25026567|NCT03626753|Proroxan|proroxan|mesh-list
24913334|NCT04266288|Ketamine|ketamine|mesh-list
24913335|NCT04266288|Analgesics|analgesics|mesh-ancestor
24913341|NCT04266288|Anesthetics, General|anesthetics, general|mesh-ancestor
25026568|NCT03626753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25026569|NCT03626753|Analgesics|analgesics|mesh-ancestor
25026570|NCT03626753|Sensory System Agents|sensory system agents|mesh-ancestor
25026571|NCT03626753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25026572|NCT03626753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026573|NCT03626753|Antipyretics|antipyretics|mesh-ancestor
25026574|NCT03626753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25026575|NCT03626753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25026576|NCT03626753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25026587|NCT03626727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25026588|NCT03626727|Anesthetics, General|anesthetics, general|mesh-ancestor
25026589|NCT03626727|Anesthetics|anesthetics|mesh-ancestor
25026590|NCT03626727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25026591|NCT03626727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026592|NCT03626571|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25026593|NCT03626571|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25026594|NCT03626571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026595|NCT03626519|Menthol|menthol|mesh-list
25026596|NCT03626519|Antipruritics|antipruritics|mesh-ancestor
25026598|NCT03626506|Amlodipine|amlodipine|mesh-list
24478719|NCT00424164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478720|NCT00424164|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24478721|NCT00424164|Hormone Antagonists|hormone antagonists|mesh-ancestor
24478722|NCT00424164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24478723|NCT00424164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478724|NCT00424164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24478725|NCT00424164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478726|NCT00424164|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24478727|NCT00424164|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24478728|NCT00424164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24478729|NCT00424164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24478730|NCT00424164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478731|NCT00424203|Cyclophosphamide|cyclophosphamide|mesh-list
24478732|NCT00424203|Doxorubicin|doxorubicin|mesh-list
24478733|NCT00424203|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24478734|NCT00424203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24478735|NCT00424203|Immunologic Factors|immunologic factors|mesh-ancestor
24478736|NCT00424203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478737|NCT00424203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24796516|NCT01950507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24796517|NCT01950507|Autonomic Agents|autonomic agents|mesh-ancestor
24796518|NCT01950507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25026600|NCT03626506|Spironolactone|spironolactone|mesh-list
25026601|NCT03626506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25026602|NCT03626506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25026603|NCT03626506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25026604|NCT03626506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026605|NCT03626506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25026606|NCT03626506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026607|NCT03626506|Vasodilator Agents|vasodilator agents|mesh-ancestor
25026608|NCT03626506|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25026609|NCT03626506|Hormone Antagonists|hormone antagonists|mesh-ancestor
25026631|NCT03626298|Vitamin B Complex|vitamin b complex|mesh-ancestor
25026632|NCT03626298|Vitamins|vitamins|mesh-ancestor
25026633|NCT03626298|Micronutrients|micronutrients|mesh-ancestor
25026634|NCT03626298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026635|NCT03626298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25026636|NCT03626298|Antimetabolites|antimetabolites|mesh-ancestor
25026637|NCT03626298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026638|NCT03626298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25026639|NCT03626298|Vasodilator Agents|vasodilator agents|mesh-ancestor
25026640|NCT03626298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25026641|NCT03626298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25691424|NCT01985763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25692684|NCT02003638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692685|NCT02003638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25026642|NCT03626298|Analgesics|analgesics|mesh-ancestor
24913458|NCT04264026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25065305|NCT03451435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065306|NCT03451435|Protective Agents|protective agents|mesh-ancestor
25026643|NCT03626298|Sensory System Agents|sensory system agents|mesh-ancestor
25026644|NCT03626298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25026645|NCT03626298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25026646|NCT03626298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25026659|NCT03626259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25026660|NCT03626064|Nicotine|nicotine|mesh-list
25026661|NCT03626064|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25026662|NCT03626064|Autonomic Agents|autonomic agents|mesh-ancestor
25026747|NCT03625310|Fluorides|fluorides|mesh-list
25026748|NCT03625310|Sodium Fluoride|sodium fluoride|mesh-list
24983575|NCT05184049|Vitamin B 12|vitamin b 12|mesh-list
25026749|NCT03625310|Cariostatic Agents|cariostatic agents|mesh-ancestor
25026750|NCT03625310|Protective Agents|protective agents|mesh-ancestor
25026751|NCT03625310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026752|NCT03625310|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24983629|NCT05183334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983631|NCT05183334|Sensory System Agents|sensory system agents|mesh-ancestor
24983632|NCT05183334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24983633|NCT05183204|Metformin|metformin|mesh-list
24983634|NCT05183204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24983635|NCT05183204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983636|NCT05182970|Metformin|metformin|mesh-list
24983637|NCT05182970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24983638|NCT05182970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983639|NCT05182957|Lenalidomide|lenalidomide|mesh-list
24983640|NCT05182957|Azacitidine|azacitidine|mesh-list
24983641|NCT05182957|Antibodies|antibodies|mesh-list
24983642|NCT05182957|Immunoglobulins|immunoglobulins|mesh-list
24983643|NCT05182957|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24983644|NCT05182957|Immunologic Factors|immunologic factors|mesh-list
24983645|NCT05182957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983646|NCT05182957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24983647|NCT05182957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24987053|NCT04447287|GABA Modulators|gaba modulators|mesh-ancestor
24987054|NCT04447287|GABA Agents|gaba agents|mesh-ancestor
24987059|NCT04416048|Antithrombins|antithrombins|mesh-ancestor
25112595|NCT03989609|Analgesics|analgesics|mesh-ancestor
25112596|NCT03989609|Sensory System Agents|sensory system agents|mesh-ancestor
25112597|NCT03989609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25112598|NCT03989609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25112599|NCT03989609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25112600|NCT03989609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25112601|NCT03989609|Adrenergic Agents|adrenergic agents|mesh-ancestor
25112602|NCT03989609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25112603|NCT03989609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112604|NCT03989609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25112605|NCT03989609|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25112607|NCT03989609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25112608|NCT03989609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25112609|NCT03989609|Anesthetics, General|anesthetics, general|mesh-ancestor
25112611|NCT03989609|GABA Modulators|gaba modulators|mesh-ancestor
25112612|NCT03989609|GABA Agents|gaba agents|mesh-ancestor
25112613|NCT03988205|Cytarabine|cytarabine|mesh-list
25026755|NCT03625219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25026756|NCT03625219|Glucocorticoids|glucocorticoids|mesh-ancestor
25026757|NCT03625219|Hormones|hormones|mesh-ancestor
25026758|NCT03625219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25026759|NCT03625219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026760|NCT03625219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25026761|NCT03625219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25026772|NCT03625089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25026773|NCT03625076|Lidocaine|lidocaine|mesh-list
25026774|NCT03625076|Propofol|propofol|mesh-list
25026775|NCT03625076|Etomidate|etomidate|mesh-list
25026776|NCT03625076|Anesthetics, Local|anesthetics, local|mesh-ancestor
25026777|NCT03625076|Anesthetics|anesthetics|mesh-ancestor
25026778|NCT03625076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25026779|NCT03625076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987094|NCT04175964|Metformin|metformin|mesh-list
24987095|NCT04175964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25691425|NCT01986010|Aluminum phosphate|aluminum phosphate|mesh-list
25691426|NCT01986010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25691427|NCT01986010|Immunologic Factors|immunologic factors|mesh-ancestor
25691428|NCT01986010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913514|NCT04263844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913515|NCT04263844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24913517|NCT04263844|Sensory System Agents|sensory system agents|mesh-ancestor
24913518|NCT04263844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24913519|NCT04263844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24913520|NCT04263844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24913521|NCT04263844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24913522|NCT04263844|Adrenergic Agents|adrenergic agents|mesh-ancestor
24913523|NCT04263844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24520102|NCT03897335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520103|NCT03897335|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24520105|NCT03897335|Purinergic Agents|purinergic agents|mesh-ancestor
24520106|NCT03897335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24913536|NCT04263519|Immunologic Factors|immunologic factors|mesh-ancestor
24913538|NCT04263519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24987096|NCT04175964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987097|NCT04175834|Cetirizine|cetirizine|mesh-list
24987098|NCT04175834|Histamine Antagonists|histamine antagonists|mesh-list
24987099|NCT04175834|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25026781|NCT03625076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25026782|NCT03625076|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25026783|NCT03625076|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25026784|NCT03625076|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25026785|NCT03625076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25026786|NCT03625076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026787|NCT03625076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25026788|NCT03625076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25026789|NCT03625076|Anesthetics, General|anesthetics, general|mesh-ancestor
25026790|NCT03625050|Celecoxib|celecoxib|mesh-list
25026861|NCT03624959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25026862|NCT03624959|Immunologic Factors|immunologic factors|mesh-ancestor
25026863|NCT03624959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25026864|NCT03624959|Antimetabolites|antimetabolites|mesh-ancestor
24591917|NCT00919542|Glucocorticoids|glucocorticoids|mesh-ancestor
25026895|NCT03624322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25026896|NCT03624322|Serotonin Agents|serotonin agents|mesh-ancestor
25026897|NCT03624309|Docetaxel|docetaxel|mesh-list
25026898|NCT03624309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25026899|NCT03624309|Tubulin Modulators|tubulin modulators|mesh-ancestor
25026900|NCT03624309|Antimitotic Agents|antimitotic agents|mesh-ancestor
25026901|NCT03624309|Mitosis Modulators|mitosis modulators|mesh-ancestor
25026902|NCT03624309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026903|NCT03624283|Betahistine|betahistine|mesh-list
25026904|NCT03624283|Vasodilator Agents|vasodilator agents|mesh-ancestor
25026905|NCT03624283|Histamine Agonists|histamine agonists|mesh-ancestor
25026906|NCT03624283|Histamine Agents|histamine agents|mesh-ancestor
25026930|NCT03624231|Durvalumab|durvalumab|mesh-list
25026931|NCT03624231|Tremelimumab|tremelimumab|mesh-list
25026932|NCT03624231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25026933|NCT03624231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25026934|NCT03624205|Paclitaxel|paclitaxel|mesh-list
25026935|NCT03624205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25026936|NCT03624205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25026937|NCT03624205|Tubulin Modulators|tubulin modulators|mesh-ancestor
25026938|NCT03624205|Antimitotic Agents|antimitotic agents|mesh-ancestor
25691429|NCT01986010|Antacids|antacids|mesh-ancestor
25691430|NCT01986010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691431|NCT01986010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25691432|NCT01986062|Amphetamine|amphetamine|mesh-list
25691433|NCT01986062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25691434|NCT01986062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691435|NCT01986062|Sympathomimetics|sympathomimetics|mesh-ancestor
25691436|NCT01986062|Autonomic Agents|autonomic agents|mesh-ancestor
25691437|NCT01986062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25691438|NCT01986062|Dopamine Agents|dopamine agents|mesh-ancestor
25691439|NCT01986062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25691440|NCT01986062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691441|NCT01986062|Adrenergic Agents|adrenergic agents|mesh-ancestor
25691442|NCT01986062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25691443|NCT01986062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25691444|NCT01986062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25691445|NCT01986062|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25691446|NCT01986231|Glucagon|glucagon|mesh-list
24913631|NCT04262765|Ramipril|ramipril|mesh-list
24913632|NCT04262765|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
24520141|NCT03879577|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24913634|NCT04262765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24913635|NCT04262765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24913636|NCT04262765|Antimetabolites|antimetabolites|mesh-ancestor
24913637|NCT04262765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065328|NCT03451318|Mometasone Furoate|mometasone furoate|mesh-list
24913661|NCT04262804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24913662|NCT04262804|Immunologic Factors|immunologic factors|mesh-ancestor
24913663|NCT04262804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520147|NCT03822871|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
24478842|NCT00424801|Natriuretic Agents|natriuretic agents|mesh-ancestor
24983808|NCT05150782|Analgesics|analgesics|mesh-ancestor
24983809|NCT05150782|Sensory System Agents|sensory system agents|mesh-ancestor
24983810|NCT05150782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25026939|NCT03624205|Mitosis Modulators|mitosis modulators|mesh-ancestor
25026940|NCT03624205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026941|NCT03624166|Ketamine|ketamine|mesh-list
25026942|NCT03624166|Anesthetics|anesthetics|mesh-list
25026943|NCT03624166|Anesthetics, General|anesthetics, general|mesh-list
25026944|NCT03624166|Analgesics|analgesics|mesh-ancestor
25026945|NCT03624166|Sensory System Agents|sensory system agents|mesh-ancestor
25026946|NCT03624166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25026947|NCT03624166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026948|NCT03624166|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25026949|NCT03624166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25026950|NCT03624166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25026951|NCT03624166|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25027015|NCT03623529|Protease Inhibitors|protease inhibitors|mesh-ancestor
25027016|NCT03623529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25027017|NCT03623529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112615|NCT03988205|Antimetabolites|antimetabolites|mesh-ancestor
24726371|NCT01602939|Immunologic Factors|immunologic factors|mesh-ancestor
25112616|NCT03988205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112617|NCT03988205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25112618|NCT03988205|Antiviral Agents|antiviral agents|mesh-ancestor
25112619|NCT03988205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25112620|NCT03988205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25112621|NCT03988205|Immunologic Factors|immunologic factors|mesh-ancestor
24478843|NCT00424801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478844|NCT00424801|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24478845|NCT00424801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24478846|NCT00424801|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24478847|NCT00424801|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24478848|NCT00424801|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24478849|NCT00424801|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24478850|NCT00424801|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24478851|NCT00424801|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24478852|NCT00424801|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24478853|NCT00424801|Adrenergic Agents|adrenergic agents|mesh-ancestor
24478854|NCT00424801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24478855|NCT00424801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24478856|NCT00424801|Vasodilator Agents|vasodilator agents|mesh-ancestor
24478919|NCT00424970|Acetazolamide|acetazolamide|mesh-list
24478920|NCT00424970|Anticonvulsants|anticonvulsants|mesh-ancestor
24478921|NCT00424970|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24478922|NCT00424970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691447|NCT01986231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25691448|NCT01986231|Hormones|hormones|mesh-ancestor
25691449|NCT01986231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25691450|NCT01986231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691451|NCT01986361|Flurbiprofen|flurbiprofen|mesh-list
25691452|NCT01986361|Analgesics|analgesics|mesh-ancestor
25691453|NCT01986361|Sensory System Agents|sensory system agents|mesh-ancestor
25691454|NCT01986361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25691455|NCT01986361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691456|NCT01986361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25691457|NCT01986361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25691458|NCT01986361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24478923|NCT00424970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478924|NCT00424970|Diuretics|diuretics|mesh-ancestor
24478925|NCT00424970|Natriuretic Agents|natriuretic agents|mesh-ancestor
24478926|NCT00424970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478927|NCT00424983|Zoledronic Acid|zoledronic acid|mesh-list
24478928|NCT00424983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24478929|NCT00424983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478946|NCT00425074|Sensory System Agents|sensory system agents|mesh-ancestor
24478947|NCT00425074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24478965|NCT00425152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24478966|NCT00425152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478967|NCT00425152|Antimetabolites|antimetabolites|mesh-ancestor
24478968|NCT00425152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478969|NCT00425152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24478970|NCT00425152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478973|NCT00425152|Antidotes|antidotes|mesh-ancestor
24478996|NCT00425191|Tubulin Modulators|tubulin modulators|mesh-ancestor
25112622|NCT03988205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112624|NCT03984955|Hyaluronic Acid|hyaluronic acid|mesh-list
25112625|NCT03984955|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25112626|NCT03984955|Diuretics|diuretics|mesh-ancestor
25112627|NCT03984955|Natriuretic Agents|natriuretic agents|mesh-ancestor
25112628|NCT03984955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112629|NCT03984955|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25112630|NCT03984955|Immunologic Factors|immunologic factors|mesh-ancestor
25112631|NCT03984955|Viscosupplements|viscosupplements|mesh-ancestor
25112632|NCT03984955|Protective Agents|protective agents|mesh-ancestor
25027018|NCT03623425|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25027019|NCT03623425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25027020|NCT03623425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027021|NCT03623256|Fentanyl|fentanyl|mesh-list
25027022|NCT03623256|Bupivacaine|bupivacaine|mesh-list
25027023|NCT03623256|Anesthetics, Local|anesthetics, local|mesh-ancestor
25027024|NCT03623256|Anesthetics|anesthetics|mesh-ancestor
25027025|NCT03623256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25027026|NCT03623256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027027|NCT03623256|Sensory System Agents|sensory system agents|mesh-ancestor
25027028|NCT03623256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24592133|NCT00920283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027063|NCT03623087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25027065|NCT03623087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25027066|NCT03623087|Immunologic Factors|immunologic factors|mesh-ancestor
25027067|NCT03623087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24795927|NCT01946815|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24795928|NCT01946815|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24795929|NCT01946815|Antimetabolites|antimetabolites|mesh-ancestor
24795930|NCT01946815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795931|NCT01946815|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24795932|NCT01946815|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24795933|NCT01946815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795934|NCT01946906|Rifaximin|rifaximin|mesh-list
24795935|NCT01946906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24795936|NCT01946906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24795937|NCT01946906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24795938|NCT01946971|Lansoprazole|lansoprazole|mesh-list
24795939|NCT01946971|Dexlansoprazole|dexlansoprazole|mesh-list
24795940|NCT01946971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25027120|NCT03622502|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25027121|NCT03622502|Narcotics|narcotics|mesh-ancestor
25027122|NCT03622489|Acetaminophen|acetaminophen|mesh-list
25027123|NCT03622489|Dipyrone|dipyrone|mesh-list
25027124|NCT03622489|Ibuprofen|ibuprofen|mesh-list
25027125|NCT03622489|Morphine|morphine|mesh-list
25027126|NCT03622489|Tramadol|tramadol|mesh-list
25027127|NCT03622489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25027128|NCT03622489|Narcotics|narcotics|mesh-ancestor
25027129|NCT03622489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25027130|NCT03622489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027137|NCT03622489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25027138|NCT03622489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25027139|NCT03622489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25027164|NCT03622060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25027165|NCT03622060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25027166|NCT03622060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027167|NCT03622060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25027168|NCT03622060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027169|NCT03622047|Sufentanil|sufentanil|mesh-list
25027170|NCT03622047|Dexmedetomidine|dexmedetomidine|mesh-list
25027171|NCT03622047|Ropivacaine|ropivacaine|mesh-list
25027172|NCT03622047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25027173|NCT03622047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25027174|NCT03622047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027175|NCT03622047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25027176|NCT03622047|Analgesics|analgesics|mesh-ancestor
25027177|NCT03622047|Sensory System Agents|sensory system agents|mesh-ancestor
25027178|NCT03622047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027179|NCT03622047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25027180|NCT03622047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25027181|NCT03622047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25112676|NCT03965962|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25112677|NCT03965962|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25112678|NCT03965962|Immunologic Factors|immunologic factors|mesh-ancestor
25112679|NCT03965962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112680|NCT03961919|Fludarabine|fludarabine|mesh-list
25112681|NCT03961919|Treosulfan|treosulfan|mesh-list
25112682|NCT03961919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25112683|NCT03961919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112684|NCT03961919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25112685|NCT03961919|Alkylating Agents|alkylating agents|mesh-ancestor
25112686|NCT03946969|Paclitaxel|paclitaxel|mesh-list
25112687|NCT03946969|Cisplatin|cisplatin|mesh-list
25112688|NCT03946969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25112689|NCT03946969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25112690|NCT03946969|Tubulin Modulators|tubulin modulators|mesh-ancestor
25112691|NCT03946969|Antimitotic Agents|antimitotic agents|mesh-ancestor
25112692|NCT03946969|Mitosis Modulators|mitosis modulators|mesh-ancestor
25112693|NCT03946969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112694|NCT03934905|Sulforaphane|sulforaphane|mesh-list
25112697|NCT03934905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112698|NCT03934905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25112699|NCT03928275|Aldesleukin|aldesleukin|mesh-list
25112700|NCT03928275|Interleukin-2|interleukin-2|mesh-list
25112701|NCT03928275|BCG Vaccine|bcg vaccine|mesh-list
25112702|NCT03928275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25027234|NCT03621618|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25027235|NCT03621618|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25027236|NCT03621618|Protective Agents|protective agents|mesh-ancestor
25027237|NCT03621527|Remifentanil|remifentanil|mesh-list
25027238|NCT03621527|Anesthetics|anesthetics|mesh-list
25027239|NCT03621527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25027240|NCT03621527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027241|NCT03621527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25027242|NCT03621527|Narcotics|narcotics|mesh-ancestor
25027243|NCT03621527|Analgesics|analgesics|mesh-ancestor
25027244|NCT03621527|Sensory System Agents|sensory system agents|mesh-ancestor
25027245|NCT03621527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027246|NCT03621514|Lidocaine|lidocaine|mesh-list
25027247|NCT03621514|Anesthetics, Local|anesthetics, local|mesh-ancestor
25027248|NCT03621514|Anesthetics|anesthetics|mesh-ancestor
25027249|NCT03621514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25027250|NCT03621514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027251|NCT03621514|Sensory System Agents|sensory system agents|mesh-ancestor
25027252|NCT03621514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027253|NCT03621514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25027254|NCT03621514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25027255|NCT03621514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25027256|NCT03621514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25027257|NCT03621514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027258|NCT03621163|Lithium Carbonate|lithium carbonate|mesh-list
25027259|NCT03621163|Antidepressive Agents|antidepressive agents|mesh-ancestor
25027260|NCT03621163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25027261|NCT03621163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25027262|NCT03621163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027263|NCT03621163|Antimanic Agents|antimanic agents|mesh-ancestor
25027289|NCT03621046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027290|NCT03620929|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25027291|NCT03620929|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25027292|NCT03620929|Estradiol|estradiol|mesh-list
24987351|NCT02403193|Spartalizumab|spartalizumab|mesh-list
24479161|NCT00425724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24479163|NCT00425724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24479164|NCT00425724|Protective Agents|protective agents|mesh-ancestor
24479165|NCT00425841|Gemcitabine|gemcitabine|mesh-list
24479166|NCT00425841|Oxaliplatin|oxaliplatin|mesh-list
24479392|NCT00426621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24479393|NCT00426621|Analgesics|analgesics|mesh-ancestor
24479394|NCT00426621|Sensory System Agents|sensory system agents|mesh-ancestor
24479395|NCT00426621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24479438|NCT00426933|Daptomycin|daptomycin|mesh-list
24479439|NCT00426933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24479441|NCT00426946|Reboxetine|reboxetine|mesh-list
24479443|NCT00426946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24479444|NCT00426946|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24479445|NCT00426946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24479446|NCT00426946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24479447|NCT00426946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479448|NCT00426946|Adrenergic Agents|adrenergic agents|mesh-ancestor
24479449|NCT00426946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24479629|NCT00427570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479630|NCT00427570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24479631|NCT00427570|Immunologic Factors|immunologic factors|mesh-ancestor
24479767|NCT00428311|Estrogens|estrogens|mesh-ancestor
24479768|NCT00428311|Hormones|hormones|mesh-ancestor
24479769|NCT00428311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25027293|NCT03620929|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25027294|NCT03620929|Dydrogesterone|dydrogesterone|mesh-list
25027296|NCT03620929|Hormones|hormones|mesh-ancestor
25027297|NCT03620929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25027298|NCT03620929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027299|NCT03620929|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25027300|NCT03620929|Contraceptive Agents|contraceptive agents|mesh-ancestor
25027301|NCT03620929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25027302|NCT03620929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25027303|NCT03620929|Progestins|progestins|mesh-ancestor
25027304|NCT03620916|Morphine|morphine|mesh-list
25027305|NCT03620916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25027306|NCT03620916|Narcotics|narcotics|mesh-ancestor
25027307|NCT03620916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25027308|NCT03620916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027309|NCT03620916|Analgesics|analgesics|mesh-ancestor
25027310|NCT03620916|Sensory System Agents|sensory system agents|mesh-ancestor
25027311|NCT03620916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027312|NCT03620838|Contraceptive Agents|contraceptive agents|mesh-list
25027313|NCT03620838|Contraceptives, Oral|contraceptives, oral|mesh-list
25027314|NCT03620838|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25027315|NCT03620838|Progesterone|progesterone|mesh-list
25027316|NCT03620838|Progestins|progestins|mesh-ancestor
24479895|NCT00428818|Antimalarials|antimalarials|mesh-ancestor
24479896|NCT00428818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24479897|NCT00428818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24479898|NCT00428818|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24479900|NCT00428818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24479901|NCT00428818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479902|NCT00428818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479903|NCT00428818|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24444576|NCT00298545|Calcium|calcium|mesh-list
24480137|NCT00429897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480138|NCT00429897|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24480139|NCT00429897|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24480189|NCT00430105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24480190|NCT00430105|Immunologic Factors|immunologic factors|mesh-ancestor
24480191|NCT00430105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691459|NCT01986361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24480192|NCT00430105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24480193|NCT00430105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24480194|NCT00430105|Alkylating Agents|alkylating agents|mesh-ancestor
24480195|NCT00430105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480196|NCT00430105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480197|NCT00430105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24480198|NCT00430118|Cytarabine|cytarabine|mesh-list
24480199|NCT00430118|Dexamethasone|dexamethasone|mesh-list
24480200|NCT00430118|Prednisone|prednisone|mesh-list
25027317|NCT03620838|Hormones|hormones|mesh-ancestor
25027318|NCT03620838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25027319|NCT03620838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027320|NCT03620838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25027321|NCT03620838|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25027322|NCT03620825|Indomethacin|indomethacin|mesh-list
25027323|NCT03620825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25027324|NCT03620825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25027325|NCT03620825|Analgesics|analgesics|mesh-ancestor
25027326|NCT03620825|Sensory System Agents|sensory system agents|mesh-ancestor
25027327|NCT03620825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027328|NCT03620825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027329|NCT03620825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25027346|NCT03620760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25027347|NCT03620760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25027348|NCT03620760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25027349|NCT03620760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027350|NCT03620760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25027351|NCT03620760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25027352|NCT03620760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25027353|NCT03620760|Antipyretics|antipyretics|mesh-ancestor
25027354|NCT03620760|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25027355|NCT03620760|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25027356|NCT03620760|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25027357|NCT03620760|Purinergic Agents|purinergic agents|mesh-ancestor
25027358|NCT03620760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25027359|NCT03620591|Lidocaine|lidocaine|mesh-list
25027360|NCT03620591|Anesthetics, Local|anesthetics, local|mesh-ancestor
25027377|NCT03620513|Nasal Decongestants|nasal decongestants|mesh-list
25027378|NCT03620513|Pseudoephedrine|pseudoephedrine|mesh-list
25027379|NCT03620513|Ephedrine|ephedrine|mesh-list
25027380|NCT03620513|Anesthetics|anesthetics|mesh-list
25027381|NCT03620513|Anesthetics, Local|anesthetics, local|mesh-ancestor
25027382|NCT03620513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25027383|NCT03620513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027384|NCT03620513|Sensory System Agents|sensory system agents|mesh-ancestor
25027385|NCT03620513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24984237|NCT04714190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24984238|NCT04704999|Chloroquine|chloroquine|mesh-list
24984239|NCT04704999|Lumefantrine|lumefantrine|mesh-list
24984240|NCT04704999|Artemether|artemether|mesh-list
24984241|NCT04704999|Tafenoquine|tafenoquine|mesh-list
24984242|NCT04704999|Amebicides|amebicides|mesh-ancestor
24984243|NCT04704999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24984244|NCT04704999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24984245|NCT04704999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24984246|NCT04704999|Antimalarials|antimalarials|mesh-ancestor
24984247|NCT04704999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24984248|NCT04702802|Hyaluronic Acid|hyaluronic acid|mesh-list
24984249|NCT04702802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25027404|NCT03620513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25027405|NCT03620513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25027406|NCT03620461|Gemcitabine|gemcitabine|mesh-list
25027407|NCT03620461|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25027408|NCT03620461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25027409|NCT03620461|Antimetabolites|antimetabolites|mesh-ancestor
25027410|NCT03620461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027495|NCT03619824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25027496|NCT03619824|Immunologic Factors|immunologic factors|mesh-ancestor
25027497|NCT03619824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112713|NCT03928275|Immunologic Factors|immunologic factors|mesh-ancestor
24592726|NCT00924222|Anesthetics, General|anesthetics, general|mesh-ancestor
25027576|NCT03618797|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25027577|NCT03618797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24592894|NCT00926055|Antimetabolites|antimetabolites|mesh-ancestor
25692686|NCT02003638|Vasodilator Agents|vasodilator agents|mesh-ancestor
25027599|NCT03618589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24914131|NCT04257851|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24914132|NCT04257851|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24914133|NCT04257851|Serotonin Agents|serotonin agents|mesh-ancestor
24914134|NCT04257851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24914138|NCT04257851|Autonomic Agents|autonomic agents|mesh-ancestor
25027600|NCT03618589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027601|NCT03618589|Anticonvulsants|anticonvulsants|mesh-ancestor
25027602|NCT03618589|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25027603|NCT03618589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25027604|NCT03618589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027605|NCT03618589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25027606|NCT03618589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25027607|NCT03618589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25027608|NCT03618589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25027609|NCT03618589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25027610|NCT03618472|Metformin|metformin|mesh-list
25027611|NCT03618472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25027612|NCT03618472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027613|NCT03618355|Sirolimus|sirolimus|mesh-list
25027614|NCT03618355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25027615|NCT03618355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25027622|NCT03618316|Cimetidine|cimetidine|mesh-list
25027625|NCT03618316|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25027626|NCT03618316|Histamine Antagonists|histamine antagonists|mesh-ancestor
25027627|NCT03618316|Histamine Agents|histamine agents|mesh-ancestor
25027628|NCT03618316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25027629|NCT03618316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027630|NCT03618316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592942|NCT00926419|Vaccines|vaccines|mesh-list
25027662|NCT03618173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25027664|NCT03618173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25027665|NCT03618173|Protease Inhibitors|protease inhibitors|mesh-ancestor
25027666|NCT03618173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25027667|NCT03618173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027670|NCT03618108|Rifabutin|rifabutin|mesh-list
25027671|NCT03618108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25027672|NCT03618108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25027673|NCT03618108|Antimalarials|antimalarials|mesh-ancestor
25027699|NCT03617575|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25027700|NCT03617575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25027701|NCT03617575|Cholinergic Agents|cholinergic agents|mesh-ancestor
25027702|NCT03617575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25027703|NCT03617575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027704|NCT03617575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027705|NCT03617575|Urological Agents|urological agents|mesh-ancestor
25027706|NCT03617510|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
25027707|NCT03617510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25027708|NCT03617510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25027709|NCT03617510|Analgesics|analgesics|mesh-ancestor
25027710|NCT03617510|Sensory System Agents|sensory system agents|mesh-ancestor
25027711|NCT03617510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027712|NCT03617510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027713|NCT03617510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25027714|NCT03617510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25027715|NCT03617484|Bortezomib|bortezomib|mesh-list
25027716|NCT03617484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25027717|NCT03617471|Acetaminophen|acetaminophen|mesh-list
25027718|NCT03617471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24480201|NCT00430118|Cyclophosphamide|cyclophosphamide|mesh-list
24480202|NCT00430118|Ifosfamide|ifosfamide|mesh-list
24480203|NCT00430118|Doxorubicin|doxorubicin|mesh-list
24480204|NCT00430118|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24480205|NCT00430118|Methotrexate|methotrexate|mesh-list
24480217|NCT00430118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24480218|NCT00430118|Alkylating Agents|alkylating agents|mesh-ancestor
24480219|NCT00430118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480220|NCT00430118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480221|NCT00430118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24480222|NCT00430118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25691460|NCT01986361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25691461|NCT01986361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691462|NCT01986361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691463|NCT01986855|Ertugliflozin|ertugliflozin|mesh-list
24914288|NCT04256200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24914289|NCT04256200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24914290|NCT04256200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914292|NCT04256057|Analgesics|analgesics|mesh-ancestor
24914293|NCT04256057|Sensory System Agents|sensory system agents|mesh-ancestor
24480223|NCT00430118|Antiemetics|antiemetics|mesh-ancestor
24480224|NCT00430118|Autonomic Agents|autonomic agents|mesh-ancestor
24480225|NCT00430118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24480226|NCT00430118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24480227|NCT00430118|Glucocorticoids|glucocorticoids|mesh-ancestor
24480228|NCT00430118|Hormones|hormones|mesh-ancestor
24480252|NCT00430144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25027740|NCT03617432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25027742|NCT03617432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25027743|NCT03617432|Glucocorticoids|glucocorticoids|mesh-ancestor
25027744|NCT03617432|Hormones|hormones|mesh-ancestor
24984670|NCT04270669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24984671|NCT04269356|Magnesium Oxide|magnesium oxide|mesh-list
24984672|NCT04269356|Magnesium Hydroxide|magnesium hydroxide|mesh-list
24984673|NCT04269356|Antacids|antacids|mesh-ancestor
24984674|NCT04269356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984675|NCT04269356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24984676|NCT04222504|Tenofovir|tenofovir|mesh-list
24984677|NCT04222504|Emtricitabine|emtricitabine|mesh-list
24984678|NCT04222504|Antiviral Agents|antiviral agents|mesh-ancestor
24984679|NCT04222504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24984680|NCT04222504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24984681|NCT04222504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24984682|NCT04222504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984683|NCT04222504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984684|NCT04222504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24480253|NCT00430144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480254|NCT00430144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480255|NCT00430157|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
24480256|NCT00430157|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24480257|NCT00430157|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24480258|NCT00430157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25027804|NCT03616639|Narcotics|narcotics|mesh-ancestor
24480259|NCT00430157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480261|NCT00430170|Caffeine|caffeine|mesh-list
24480262|NCT00430170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24480426|NCT00431080|Paclitaxel|paclitaxel|mesh-list
24480427|NCT00431080|Docetaxel|docetaxel|mesh-list
24480428|NCT00431080|Cyclophosphamide|cyclophosphamide|mesh-list
24480429|NCT00431080|Epirubicin|epirubicin|mesh-list
24480430|NCT00431080|Fluorouracil|fluorouracil|mesh-list
24480431|NCT00431080|Mitogens|mitogens|mesh-list
24984685|NCT04222504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24796110|NCT01947998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
24796111|NCT01947998|Anticoagulants|anticoagulants|mesh-ancestor
24796112|NCT01947998|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24796113|NCT01947998|Antithrombins|antithrombins|mesh-ancestor
24796114|NCT01947998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24796115|NCT01947998|Protease Inhibitors|protease inhibitors|mesh-ancestor
24796116|NCT01947998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796117|NCT01947998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796118|NCT01948011|Racecadotril|racecadotril|mesh-list
24796119|NCT01948011|Thiorphan|thiorphan|mesh-list
24796120|NCT01948011|Antidiarrheals|antidiarrheals|mesh-ancestor
25027771|NCT03617055|Protease Inhibitors|protease inhibitors|mesh-ancestor
25027772|NCT03617055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25027773|NCT03617055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027774|NCT03617029|Ethiodized Oil|ethiodized oil|mesh-list
25027775|NCT03617029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25027776|NCT03617016|Domperidone|domperidone|mesh-list
25691464|NCT01986855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25691465|NCT01986855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691466|NCT01986855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25691467|NCT01986855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691468|NCT01986907|Ranibizumab|ranibizumab|mesh-list
25027777|NCT03617016|Antiemetics|antiemetics|mesh-ancestor
25691469|NCT01986907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25691470|NCT01986907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25027778|NCT03617016|Autonomic Agents|autonomic agents|mesh-ancestor
24480432|NCT00431080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24480433|NCT00431080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480434|NCT00431080|Tubulin Modulators|tubulin modulators|mesh-ancestor
24480435|NCT00431080|Antimitotic Agents|antimitotic agents|mesh-ancestor
24480438|NCT00431080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24480439|NCT00431080|Immunologic Factors|immunologic factors|mesh-ancestor
24480440|NCT00431080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480441|NCT00431080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24480442|NCT00431080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24480443|NCT00431080|Alkylating Agents|alkylating agents|mesh-ancestor
24480444|NCT00431080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24480445|NCT00431080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24480481|NCT00431119|Immunologic Factors|immunologic factors|mesh-ancestor
24480482|NCT00431119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480483|NCT00431119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24480485|NCT00431145|Niacinamide|niacinamide|mesh-list
24480486|NCT00431145|Nicotinic Acids|nicotinic acids|mesh-list
24480487|NCT00431145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24480488|NCT00431145|Antimetabolites|antimetabolites|mesh-ancestor
24480489|NCT00431145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480490|NCT00431145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24480491|NCT00431145|Vasodilator Agents|vasodilator agents|mesh-ancestor
24480492|NCT00431145|Vitamin B Complex|vitamin b complex|mesh-ancestor
24480493|NCT00431145|Vitamins|vitamins|mesh-ancestor
24480494|NCT00431145|Micronutrients|micronutrients|mesh-ancestor
24480495|NCT00431145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027779|NCT03617016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027798|NCT03616691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027799|NCT03616691|Growth Inhibitors|growth inhibitors|mesh-ancestor
25027800|NCT03616691|Immunologic Factors|immunologic factors|mesh-ancestor
25027802|NCT03616639|Oxycodone|oxycodone|mesh-list
25027803|NCT03616639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25027805|NCT03616639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25027806|NCT03616639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027807|NCT03616639|Analgesics|analgesics|mesh-ancestor
25027808|NCT03616639|Sensory System Agents|sensory system agents|mesh-ancestor
25027809|NCT03616639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027811|NCT03616561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25027812|NCT03616561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25027813|NCT03616561|Analgesics|analgesics|mesh-ancestor
25027814|NCT03616561|Sensory System Agents|sensory system agents|mesh-ancestor
25027815|NCT03616561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027816|NCT03616561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027817|NCT03616561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25027818|NCT03616561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25027819|NCT03616561|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25027820|NCT03616561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25027821|NCT03616561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25027822|NCT03616561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027823|NCT03616509|Hormones|hormones|mesh-list
24625996|NCT01084980|Tacrolimus|tacrolimus|mesh-list
25027824|NCT03616509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25027825|NCT03616509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027860|NCT03616262|Anesthetics|anesthetics|mesh-ancestor
24984686|NCT04177706|Ketamine|ketamine|mesh-list
25027861|NCT03616262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25027862|NCT03616262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027863|NCT03616262|Sensory System Agents|sensory system agents|mesh-ancestor
25027864|NCT03616262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027865|NCT03616262|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25027866|NCT03616262|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25027867|NCT03616262|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25027868|NCT03616262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25027869|NCT03616262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027870|NCT03616236|Buprenorphine|buprenorphine|mesh-list
25027871|NCT03616236|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25027873|NCT03616236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25027874|NCT03616236|Narcotics|narcotics|mesh-ancestor
25027883|NCT03616132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25027884|NCT03616132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25027885|NCT03616132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25027886|NCT03616132|Antifungal Agents|antifungal agents|mesh-ancestor
24984854|NCT03948022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984855|NCT03946111|Naltrexone|naltrexone|mesh-list
24984856|NCT03946111|Bupropion|bupropion|mesh-list
24984857|NCT03946111|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24984858|NCT03946111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24984859|NCT03946111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984860|NCT03946111|Sensory System Agents|sensory system agents|mesh-ancestor
24984861|NCT03946111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24984862|NCT03946111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24984863|NCT03946111|Antidepressive Agents|antidepressive agents|mesh-ancestor
24984864|NCT03946111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24984865|NCT03946111|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24984866|NCT03946111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24984867|NCT03946111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24984868|NCT03946111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480496|NCT00431171|Lithium Carbonate|lithium carbonate|mesh-list
24480576|NCT00431340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24480630|NCT00431418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480631|NCT00431418|Urological Agents|urological agents|mesh-ancestor
24480682|NCT00431678|Levofloxacin|levofloxacin|mesh-list
24480683|NCT00431678|Ofloxacin|ofloxacin|mesh-list
24480684|NCT00431678|Ceftriaxone|ceftriaxone|mesh-list
24480685|NCT00431678|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24480686|NCT00431678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24480723|NCT00431795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24480725|NCT00431795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480767|NCT00432081|Indomethacin|indomethacin|mesh-list
24480768|NCT00432081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24480769|NCT00432081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24480770|NCT00432081|Analgesics|analgesics|mesh-ancestor
24480771|NCT00432081|Sensory System Agents|sensory system agents|mesh-ancestor
24480772|NCT00432081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24480821|NCT00432367|Artesunate|artesunate|mesh-list
24480822|NCT00432367|Pyrimethamine|pyrimethamine|mesh-list
24480823|NCT00432367|Sulfadoxine|sulfadoxine|mesh-list
24480824|NCT00432367|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24480825|NCT00432367|Amodiaquine|amodiaquine|mesh-list
24480826|NCT00432367|Antimalarials|antimalarials|mesh-ancestor
24480827|NCT00432367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25027908|NCT03615768|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25027909|NCT03615768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25027910|NCT03615768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027911|NCT03615768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25027912|NCT03615768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25027913|NCT03615768|Analgesics|analgesics|mesh-ancestor
25027914|NCT03615768|Sensory System Agents|sensory system agents|mesh-ancestor
25027915|NCT03615768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027916|NCT03615768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027917|NCT03615768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25027918|NCT03615768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25027919|NCT03615768|Dermatologic Agents|dermatologic agents|mesh-ancestor
25027920|NCT03615677|Esomeprazole|esomeprazole|mesh-list
25027921|NCT03615677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25027922|NCT03615677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25027923|NCT03615677|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25027924|NCT03615677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25027925|NCT03615677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027926|NCT03615430|Anesthetics|anesthetics|mesh-list
25027927|NCT03615430|Anesthetics, Local|anesthetics, local|mesh-list
25027928|NCT03615430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25027929|NCT03615430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027930|NCT03615430|Sensory System Agents|sensory system agents|mesh-ancestor
25027931|NCT03615430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027932|NCT03615417|Anesthetics|anesthetics|mesh-list
25691471|NCT01986907|Growth Substances|growth substances|mesh-ancestor
25027933|NCT03615417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24480845|NCT00432393|Dopamine Agents|dopamine agents|mesh-ancestor
24480846|NCT00432393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24480847|NCT00432393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480848|NCT00432393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480849|NCT00432393|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24480850|NCT00432393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480851|NCT00432393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24480852|NCT00432393|Immunologic Factors|immunologic factors|mesh-ancestor
24480853|NCT00432393|Dopamine Agonists|dopamine agonists|mesh-ancestor
24480855|NCT00432406|Infliximab|infliximab|mesh-list
24480856|NCT00432406|Dermatologic Agents|dermatologic agents|mesh-ancestor
24480857|NCT00432406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24480858|NCT00432406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24480859|NCT00432406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24480860|NCT00432406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25027934|NCT03615417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027946|NCT03615313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027947|NCT03615196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25027948|NCT03615196|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25027949|NCT03614832|Clopidogrel|clopidogrel|mesh-list
25027950|NCT03614832|Ticagrelor|ticagrelor|mesh-list
25027951|NCT03614832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25027952|NCT03614832|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25027976|NCT03614533|Immunologic Factors|immunologic factors|mesh-ancestor
25027977|NCT03614533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027978|NCT03614494|Piroxicam|piroxicam|mesh-list
25027979|NCT03614494|Levonorgestrel|levonorgestrel|mesh-list
25027980|NCT03614494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25027981|NCT03614494|Contraceptive Agents|contraceptive agents|mesh-ancestor
25027982|NCT03614494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25027983|NCT03614494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027984|NCT03614494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25027985|NCT03614494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25107112|NCT03142516|Irinotecan|irinotecan|mesh-list
24480865|NCT00432406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24480866|NCT00432406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24480867|NCT00432406|Immunologic Factors|immunologic factors|mesh-ancestor
24480869|NCT00432432|Dermatologic Agents|dermatologic agents|mesh-ancestor
24480870|NCT00432432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24480871|NCT00432432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24480872|NCT00432510|Complement C1s|complement c1s|mesh-list
24480873|NCT00432510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
24480874|NCT00432510|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
24480875|NCT00432510|Immunologic Factors|immunologic factors|mesh-ancestor
24480912|NCT00432614|Serotonin Agents|serotonin agents|mesh-ancestor
24480924|NCT00432627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480925|NCT00432653|Rituximab|rituximab|mesh-list
24480927|NCT00432653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480937|NCT00432757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24480987|NCT00433069|Pioglitazone|pioglitazone|mesh-list
24480988|NCT00433069|Interferons|interferons|mesh-list
24480990|NCT00433069|Interferon-alpha|interferon-alpha|mesh-list
24480991|NCT00433069|Interferon alpha-2|interferon alpha-2|mesh-list
24480992|NCT00433069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480993|NCT00433069|Antiviral Agents|antiviral agents|mesh-ancestor
25691472|NCT01986907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027991|NCT03614494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027992|NCT03614494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25027993|NCT03614494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25027994|NCT03614494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25027995|NCT03614494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25027996|NCT03614494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027997|NCT03614455|Itraconazole|itraconazole|mesh-list
24481231|NCT00433784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24481232|NCT00433784|Purinergic Agents|purinergic agents|mesh-ancestor
24481233|NCT00433784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24481235|NCT00433784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481241|NCT00433823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481242|NCT00433823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24481244|NCT00433823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481367|NCT00434135|Tubulin Modulators|tubulin modulators|mesh-ancestor
24481368|NCT00434135|Antimitotic Agents|antimitotic agents|mesh-ancestor
24481369|NCT00434135|Mitosis Modulators|mitosis modulators|mesh-ancestor
24481370|NCT00434135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481371|NCT00434135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24481372|NCT00434135|Antimetabolites|antimetabolites|mesh-ancestor
24481373|NCT00434135|Antiviral Agents|antiviral agents|mesh-ancestor
24481374|NCT00434135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24481375|NCT00434135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481378|NCT00434135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481381|NCT00434174|Pemetrexed|pemetrexed|mesh-list
24481382|NCT00434174|Everolimus|everolimus|mesh-list
24481383|NCT00434174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481384|NCT00434174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481391|NCT00434239|Lenalidomide|lenalidomide|mesh-list
25028028|NCT03614273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25028029|NCT03614273|Adrenergic Agents|adrenergic agents|mesh-ancestor
25028030|NCT03614273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25028031|NCT03614273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028032|NCT03614273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028033|NCT03614273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25028034|NCT03614273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25028035|NCT03614273|Autonomic Agents|autonomic agents|mesh-ancestor
25691473|NCT01986907|Growth Inhibitors|growth inhibitors|mesh-ancestor
25691474|NCT01986907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25691475|NCT01986946|Hydromorphone|hydromorphone|mesh-list
25691476|NCT01986946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25691477|NCT01986946|Narcotics|narcotics|mesh-ancestor
25691478|NCT01986946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25691479|NCT01986946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691480|NCT01986946|Analgesics|analgesics|mesh-ancestor
24914706|NCT04252365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446849|NCT00306254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481542|NCT00435331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481543|NCT00435331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24481544|NCT00435331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481545|NCT00435331|Vasodilator Agents|vasodilator agents|mesh-ancestor
25028036|NCT03614273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25028037|NCT03614273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25028038|NCT03614273|Respiratory System Agents|respiratory system agents|mesh-ancestor
25028039|NCT03614273|Mydriatics|mydriatics|mesh-ancestor
25028040|NCT03614273|Sympathomimetics|sympathomimetics|mesh-ancestor
25028041|NCT03614273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25028042|NCT03614221|Tacrolimus|tacrolimus|mesh-list
25028043|NCT03614221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25028044|NCT03614221|Immunologic Factors|immunologic factors|mesh-ancestor
25028045|NCT03614221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028046|NCT03614221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25028047|NCT03614221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25028048|NCT03614221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112894|NCT03842943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028052|NCT03614065|Growth Substances|growth substances|mesh-ancestor
25028053|NCT03614065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028054|NCT03614065|Growth Inhibitors|growth inhibitors|mesh-ancestor
25028055|NCT03614065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028056|NCT03614052|Tamsulosin|tamsulosin|mesh-list
25028057|NCT03614052|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25028058|NCT03614052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25028060|NCT03614052|Adrenergic Agents|adrenergic agents|mesh-ancestor
25028061|NCT03614052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25107163|NCT03142256|Antiviral Agents|antiviral agents|mesh-ancestor
24481546|NCT00435435|Disulfiram|disulfiram|mesh-list
24481547|NCT00435435|Acamprosate|acamprosate|mesh-list
24481548|NCT00435435|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24481549|NCT00435435|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
24481550|NCT00435435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481551|NCT00435435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481626|NCT00436033|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24481710|NCT00436579|Sorafenib|sorafenib|mesh-list
24481711|NCT00436579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481712|NCT00436579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24481713|NCT00436579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481714|NCT00436579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481715|NCT00436657|Cisplatin|cisplatin|mesh-list
24481716|NCT00436657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481717|NCT00436709|Paclitaxel|paclitaxel|mesh-list
24481718|NCT00436709|Cyclophosphamide|cyclophosphamide|mesh-list
24481719|NCT00436709|Bevacizumab|bevacizumab|mesh-list
25028062|NCT03614052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028063|NCT03614052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028064|NCT03614052|Urological Agents|urological agents|mesh-ancestor
25028066|NCT03613974|Anesthetics, Local|anesthetics, local|mesh-ancestor
25028067|NCT03613974|Anesthetics|anesthetics|mesh-ancestor
24593565|NCT00930072|Sympatholytics|sympatholytics|mesh-ancestor
25028093|NCT03613792|Remifentanil|remifentanil|mesh-list
25028094|NCT03613792|Analgesics|analgesics|mesh-ancestor
25028095|NCT03613792|Sensory System Agents|sensory system agents|mesh-ancestor
25028096|NCT03613792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25028097|NCT03613792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028098|NCT03613792|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25028099|NCT03613792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25028100|NCT03613792|Anesthetics, General|anesthetics, general|mesh-ancestor
25028101|NCT03613792|Anesthetics|anesthetics|mesh-ancestor
25028102|NCT03613792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25028103|NCT03613792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25691481|NCT01986946|Sensory System Agents|sensory system agents|mesh-ancestor
25692687|NCT02003638|Vitamin B Complex|vitamin b complex|mesh-ancestor
24819523|NCT02095834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24819524|NCT02095834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028104|NCT03613792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25028105|NCT03613792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25028106|NCT03613792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028107|NCT03613792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25028108|NCT03613792|Narcotics|narcotics|mesh-ancestor
25028109|NCT03613792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25028110|NCT03613792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24481720|NCT00436709|Doxorubicin|doxorubicin|mesh-list
24481721|NCT00436709|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24481738|NCT00436709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24481739|NCT00436709|Growth Substances|growth substances|mesh-ancestor
24481740|NCT00436709|Growth Inhibitors|growth inhibitors|mesh-ancestor
24481741|NCT00436709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24481742|NCT00436709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24481743|NCT00436709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24481744|NCT00436709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481745|NCT00436722|Immunoglobulins|immunoglobulins|mesh-list
24481746|NCT00436722|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24481747|NCT00436722|Immunologic Factors|immunologic factors|mesh-ancestor
24481748|NCT00436722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481749|NCT00436722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24481767|NCT00436761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24481768|NCT00436761|Antiemetics|antiemetics|mesh-ancestor
24481769|NCT00436761|Autonomic Agents|autonomic agents|mesh-ancestor
25028113|NCT03613792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25028130|NCT03613558|Dexmedetomidine|dexmedetomidine|mesh-list
25028131|NCT03613558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25028132|NCT03613558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25028133|NCT03613558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028134|NCT03613558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25028135|NCT03613558|Analgesics|analgesics|mesh-ancestor
25028136|NCT03613558|Sensory System Agents|sensory system agents|mesh-ancestor
25028137|NCT03613558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25028138|NCT03613558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25028139|NCT03613558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25028140|NCT03613558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25028141|NCT03613558|Adrenergic Agents|adrenergic agents|mesh-ancestor
24987686|NCT05167084|Hydrocortisone|hydrocortisone|mesh-list
24481782|NCT00436787|Fondaparinux|fondaparinux|mesh-list
24481783|NCT00436787|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24481784|NCT00436787|Antithrombins|antithrombins|mesh-ancestor
24481785|NCT00436787|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24481786|NCT00436787|Protease Inhibitors|protease inhibitors|mesh-ancestor
24481787|NCT00436787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481808|NCT00436826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481809|NCT00436826|Antiviral Agents|antiviral agents|mesh-ancestor
24481810|NCT00436826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24481811|NCT00436826|Immunologic Factors|immunologic factors|mesh-ancestor
24481812|NCT00436826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481813|NCT00436826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24481814|NCT00436826|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24481815|NCT00436839|Prednisone|prednisone|mesh-list
24481816|NCT00436839|Docetaxel|docetaxel|mesh-list
24481817|NCT00436839|Mitoxantrone|mitoxantrone|mesh-list
24481820|NCT00436839|Antimitotic Agents|antimitotic agents|mesh-ancestor
24481821|NCT00436839|Mitosis Modulators|mitosis modulators|mesh-ancestor
24481822|NCT00436839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028150|NCT03613428|Prednisone|prednisone|mesh-list
25028151|NCT03613428|Vincristine|vincristine|mesh-list
25028152|NCT03613428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25028153|NCT03613428|Glucocorticoids|glucocorticoids|mesh-ancestor
25028154|NCT03613428|Hormones|hormones|mesh-ancestor
25028155|NCT03613428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25028156|NCT03613428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028157|NCT03613428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25028158|NCT03613428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028159|NCT03613428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25691482|NCT01986946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25691483|NCT01987102|Leucovorin|leucovorin|mesh-list
24985078|NCT03706898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24985079|NCT03694002|Paclitaxel|paclitaxel|mesh-list
24985080|NCT03694002|Carboplatin|carboplatin|mesh-list
24833673|NCT02175017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24833674|NCT02175017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24833675|NCT02175017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24743342|NCT04871425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24833783|NCT02175589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985081|NCT03694002|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24985083|NCT03694002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24985084|NCT03694002|Antibodies|antibodies|mesh-list
24985085|NCT03694002|Immunoglobulins|immunoglobulins|mesh-list
24985086|NCT03694002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24985087|NCT03694002|Lexatumumab|lexatumumab|mesh-list
25028177|NCT03613207|Anesthetics|anesthetics|mesh-ancestor
25028178|NCT03613207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25028179|NCT03613207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028180|NCT03613207|Sensory System Agents|sensory system agents|mesh-ancestor
25028181|NCT03613207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25028182|NCT03613207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25028183|NCT03613207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25028184|NCT03613207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25028185|NCT03613207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25028186|NCT03613207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028187|NCT03613168|Trastuzumab|trastuzumab|mesh-list
24987706|NCT05154968|Diuretics|diuretics|mesh-ancestor
24481823|NCT00436839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24481824|NCT00436839|Glucocorticoids|glucocorticoids|mesh-ancestor
24481826|NCT00436839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24875184|NCT04345913|Halichondrin B|halichondrin b|mesh-list
24481852|NCT00436943|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24481853|NCT00436943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24481854|NCT00436943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24481855|NCT00436943|Dopamine Agents|dopamine agents|mesh-ancestor
24481856|NCT00436943|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25028214|NCT03612817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25028215|NCT03612817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25028216|NCT03612739|Azacitidine|azacitidine|mesh-list
25028217|NCT03612739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24481857|NCT00436943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24481858|NCT00436943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481859|NCT00436995|Darbepoetin alfa|darbepoetin alfa|mesh-list
24481860|NCT00436995|Hematinics|hematinics|mesh-ancestor
24481861|NCT00437008|Benphothiamine|benphothiamine|mesh-list
24481862|NCT00437008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24481863|NCT00437008|Immunologic Factors|immunologic factors|mesh-ancestor
24481864|NCT00437008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481865|NCT00437008|Chelating Agents|chelating agents|mesh-ancestor
24481866|NCT00437008|Sequestering Agents|sequestering agents|mesh-ancestor
24481867|NCT00437008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481868|NCT00437086|Bortezomib|bortezomib|mesh-list
24481869|NCT00437086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481870|NCT00437164|Insulin|insulin|mesh-list
24481871|NCT00437164|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25028218|NCT03612739|Antimetabolites|antimetabolites|mesh-ancestor
25028219|NCT03612739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028220|NCT03612739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481890|NCT00437229|Dexamethasone|dexamethasone|mesh-list
24481891|NCT00437229|Dexamethasone acetate|dexamethasone acetate|mesh-list
24481892|NCT00437229|Ondansetron|ondansetron|mesh-list
24481893|NCT00437229|Casopitant|casopitant|mesh-list
24481894|NCT00437229|BB 1101|bb 1101|mesh-list
24481895|NCT00437229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24481896|NCT00437229|Antiemetics|antiemetics|mesh-ancestor
24481897|NCT00437229|Autonomic Agents|autonomic agents|mesh-ancestor
25691484|NCT01987102|Calcium|calcium|mesh-list
25691485|NCT01987102|Levoleucovorin|levoleucovorin|mesh-list
25691486|NCT01987102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25691487|NCT01987102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691488|NCT01987102|Antidotes|antidotes|mesh-ancestor
24481898|NCT00437229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25691489|NCT01987102|Protective Agents|protective agents|mesh-ancestor
24834830|NCT02181309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835672|NCT02183194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24835673|NCT02183194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24835674|NCT02183194|Tubulin Modulators|tubulin modulators|mesh-ancestor
24835705|NCT02183272|Anesthetics, General|anesthetics, general|mesh-ancestor
24835706|NCT02183272|Anesthetics|anesthetics|mesh-ancestor
24835707|NCT02183272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24835708|NCT02183272|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24835709|NCT02183272|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24835710|NCT02183272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24835712|NCT02183298|Linagliptin|linagliptin|mesh-list
24481939|NCT00437307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481940|NCT00437307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481941|NCT00437320|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
24481942|NCT00437320|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24481943|NCT00437320|Dermatologic Agents|dermatologic agents|mesh-ancestor
24481944|NCT00437333|Metformin|metformin|mesh-list
24481945|NCT00437333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24481946|NCT00437333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481947|NCT00437359|Toremifene|toremifene|mesh-list
24481948|NCT00437359|Anastrozole|anastrozole|mesh-list
24481951|NCT00437359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481967|NCT00437372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481969|NCT00437372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24481970|NCT00437372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481971|NCT00437372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481972|NCT00437385|Lithium Carbonate|lithium carbonate|mesh-list
24481973|NCT00437385|Antidepressive Agents|antidepressive agents|mesh-ancestor
24481974|NCT00437385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24481975|NCT00437385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481988|NCT00437463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24481989|NCT00437476|Ribavirin|ribavirin|mesh-list
24481990|NCT00437476|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24481991|NCT00437476|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
24481992|NCT00437476|Antimetabolites|antimetabolites|mesh-ancestor
24481993|NCT00437476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481995|NCT00437476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24481996|NCT00437476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24481997|NCT00437476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481998|NCT00437502|Vaccines|vaccines|mesh-list
24481999|NCT00437502|Immunologic Factors|immunologic factors|mesh-ancestor
24482000|NCT00437502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482001|NCT00437554|Glimepiride|glimepiride|mesh-list
24482002|NCT00437554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24482003|NCT00437554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24482004|NCT00437554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482005|NCT00437554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24482006|NCT00437554|Immunologic Factors|immunologic factors|mesh-ancestor
24482007|NCT00437606|Ethanol|ethanol|mesh-list
24482043|NCT00437697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482044|NCT00437723|Epoetin Alfa|epoetin alfa|mesh-list
24482045|NCT00437723|Hematinics|hematinics|mesh-ancestor
25691490|NCT01987102|Vitamin B Complex|vitamin b complex|mesh-ancestor
25691491|NCT01987102|Vitamins|vitamins|mesh-ancestor
25691492|NCT01987102|Micronutrients|micronutrients|mesh-ancestor
25691493|NCT01987219|Bromides|bromides|mesh-list
25691494|NCT01987219|Albuterol|albuterol|mesh-list
25691495|NCT01987219|Ipratropium|ipratropium|mesh-list
25691496|NCT01987219|Anticonvulsants|anticonvulsants|mesh-ancestor
25691497|NCT01987219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25691498|NCT01987219|Autonomic Agents|autonomic agents|mesh-ancestor
25691499|NCT01987219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25691500|NCT01987219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691501|NCT01987219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25691502|NCT01987219|Respiratory System Agents|respiratory system agents|mesh-ancestor
25108305|NCT03132688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25108306|NCT03132688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836539|NCT02186145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24836540|NCT02186145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836541|NCT02186158|Ascorbic Acid|ascorbic acid|mesh-list
24836542|NCT02186158|Vitamins|vitamins|mesh-ancestor
24836543|NCT02186158|Micronutrients|micronutrients|mesh-ancestor
25028221|NCT03612739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25028222|NCT03612557|Penicillins|penicillins|mesh-list
25028223|NCT03612557|Penicillin G|penicillin g|mesh-list
24482113|NCT00437970|Pioglitazone|pioglitazone|mesh-list
24482114|NCT00437970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24482115|NCT00437970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482122|NCT00437996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482123|NCT00437996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24482124|NCT00437996|Sympatholytics|sympatholytics|mesh-ancestor
24482125|NCT00437996|Autonomic Agents|autonomic agents|mesh-ancestor
24482126|NCT00437996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24482127|NCT00437996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24482299|NCT00438386|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24482300|NCT00438386|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24482301|NCT00438477|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
24482302|NCT00438477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24482397|NCT00438841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24482398|NCT00438841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24482399|NCT00438841|Leprostatic Agents|leprostatic agents|mesh-ancestor
24482446|NCT00439049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482516|NCT00439361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24482517|NCT00439361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24482519|NCT00439361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24482520|NCT00439361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482521|NCT00439361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24482522|NCT00439361|Alkylating Agents|alkylating agents|mesh-ancestor
24482523|NCT00439400|Doxycycline|doxycycline|mesh-list
24482524|NCT00439400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24482525|NCT00439400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24482553|NCT00439530|Gout Suppressants|gout suppressants|mesh-ancestor
24482554|NCT00439530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24482560|NCT00439699|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24482561|NCT00439699|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24482562|NCT00439699|Dopamine Agents|dopamine agents|mesh-ancestor
24482563|NCT00439699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24482627|NCT00440102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24482628|NCT00440102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24482629|NCT00440102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25691503|NCT01987219|Tocolytic Agents|tocolytic agents|mesh-ancestor
25691504|NCT01987219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25691505|NCT01987219|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25691506|NCT01987219|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25691507|NCT01987219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25691508|NCT01987219|Adrenergic Agents|adrenergic agents|mesh-ancestor
25691509|NCT01987219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25692688|NCT02003638|Vitamins|vitamins|mesh-ancestor
24837666|NCT02192710|Midazolam|midazolam|mesh-list
24482630|NCT00440102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24482632|NCT00440102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24482655|NCT00440141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24482656|NCT00440141|Adrenergic Agents|adrenergic agents|mesh-ancestor
24482657|NCT00440141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24482658|NCT00440141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482659|NCT00440141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482660|NCT00440141|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24482661|NCT00440141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24482662|NCT00440154|Ezetimibe|ezetimibe|mesh-list
24482663|NCT00440154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24482664|NCT00440154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24482665|NCT00440154|Antimetabolites|antimetabolites|mesh-ancestor
24482667|NCT00440154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24482693|NCT00440245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24482694|NCT00440245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482709|NCT00440258|Dopamine Agents|dopamine agents|mesh-ancestor
24482813|NCT00440687|Respiratory System Agents|respiratory system agents|mesh-ancestor
24482814|NCT00440687|Dermatologic Agents|dermatologic agents|mesh-ancestor
24482829|NCT00440713|Serotonin Agents|serotonin agents|mesh-ancestor
25028237|NCT03612492|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25028238|NCT03612492|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25028239|NCT03612492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25028240|NCT03612492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729562|NCT01622439|Prednisone|prednisone|mesh-list
24729777|NCT01623921|Celecoxib|celecoxib|mesh-list
25028241|NCT03612492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25028242|NCT03612492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25028243|NCT03612492|Adrenergic Agents|adrenergic agents|mesh-ancestor
25028244|NCT03612492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25028245|NCT03612492|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25028246|NCT03612440|Dexmedetomidine|dexmedetomidine|mesh-list
25028247|NCT03612440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25028248|NCT03612440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25028249|NCT03612440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028251|NCT03612440|Analgesics|analgesics|mesh-ancestor
25028252|NCT03612440|Sensory System Agents|sensory system agents|mesh-ancestor
25028253|NCT03612440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24796684|NCT01951508|Modafinil|modafinil|mesh-list
24482830|NCT00440713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24482831|NCT00440713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24482832|NCT00440713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24482833|NCT00440713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24482834|NCT00440739|Etoricoxib|etoricoxib|mesh-list
24482835|NCT00440739|Flavoxate|flavoxate|mesh-list
24482837|NCT00440739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24482869|NCT00440843|Antiemetics|antiemetics|mesh-ancestor
24482870|NCT00440843|Autonomic Agents|autonomic agents|mesh-ancestor
25028315|NCT03612037|Micronutrients|micronutrients|mesh-ancestor
24483046|NCT00441532|Anesthetics, Local|anesthetics, local|mesh-ancestor
24729778|NCT01623921|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25028257|NCT03612440|Adrenergic Agents|adrenergic agents|mesh-ancestor
25028258|NCT03612440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25028278|NCT03612323|Sensory System Agents|sensory system agents|mesh-ancestor
25028279|NCT03612323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25028280|NCT03612323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25692689|NCT02003638|Micronutrients|micronutrients|mesh-ancestor
25692690|NCT02003638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692691|NCT02003898|Insulin|insulin|mesh-list
25692692|NCT02003898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25692693|NCT02003898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692694|NCT02003911|Azithromycin|azithromycin|mesh-list
25692695|NCT02003911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25692696|NCT02003911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25692697|NCT02004093|Gemcitabine|gemcitabine|mesh-list
24786304|NCT01918995|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25028281|NCT03612323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25028283|NCT03612323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25028284|NCT03612323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25028285|NCT03612323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25028286|NCT03612323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25028287|NCT03612323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028288|NCT03612297|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25028289|NCT03612297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25112924|NCT03787680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25112925|NCT03787680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112926|NCT03787680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796696|NCT01951560|Valproic Acid|valproic acid|mesh-list
24483047|NCT00441532|Anesthetics|anesthetics|mesh-ancestor
24483475|NCT00443716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24483478|NCT00443794|Atenolol|atenolol|mesh-list
24483479|NCT00443794|Ramipril|ramipril|mesh-list
24483480|NCT00443794|Simvastatin|simvastatin|mesh-list
24483481|NCT00443794|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
24483482|NCT00443794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24483549|NCT00443963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483550|NCT00443963|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24483551|NCT00443963|Histamine Antagonists|histamine antagonists|mesh-ancestor
24483577|NCT00444132|Purinergic Agents|purinergic agents|mesh-ancestor
24483578|NCT00444132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24483579|NCT00444132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483580|NCT00444132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483582|NCT00444171|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24483652|NCT00444379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24483653|NCT00444379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24483655|NCT00444379|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24483656|NCT00444379|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24483658|NCT00444418|Naloxone|naloxone|mesh-list
24483659|NCT00444418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24483660|NCT00444418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24483661|NCT00444418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483662|NCT00444418|Sensory System Agents|sensory system agents|mesh-ancestor
24483663|NCT00444418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24483664|NCT00444470|Tranexamic Acid|tranexamic acid|mesh-list
24483665|NCT00444470|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25691510|NCT01987219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691511|NCT01987219|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25691512|NCT01987219|Cholinergic Agents|cholinergic agents|mesh-ancestor
25691513|NCT01987232|Carboplatin|carboplatin|mesh-list
25691514|NCT01987232|Etoposide|etoposide|mesh-list
25691515|NCT01987232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25691516|NCT01987232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25691517|NCT01987232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24839864|NCT02206425|Antioxidants|antioxidants|mesh-ancestor
24839957|NCT02206789|Prednisolone|prednisolone|mesh-list
24593818|NCT00931073|Hormone Antagonists|hormone antagonists|mesh-ancestor
25028291|NCT03612219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028292|NCT03612219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25028293|NCT03612219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25028294|NCT03612219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028296|NCT03612180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25028297|NCT03612180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25028298|NCT03612180|Sympatholytics|sympatholytics|mesh-ancestor
25028299|NCT03612180|Autonomic Agents|autonomic agents|mesh-ancestor
25028300|NCT03612180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25028301|NCT03612180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028302|NCT03612180|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25028303|NCT03612180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25028304|NCT03612180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25028305|NCT03612180|Adrenergic Agents|adrenergic agents|mesh-ancestor
25028306|NCT03612180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25006677|NCT04785625|Anesthetics|anesthetics|mesh-ancestor
25028307|NCT03612180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028308|NCT03612037|Thioctic Acid|thioctic acid|mesh-list
25028309|NCT03612037|Antioxidants|antioxidants|mesh-ancestor
25028310|NCT03612037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028311|NCT03612037|Protective Agents|protective agents|mesh-ancestor
25028312|NCT03612037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028313|NCT03612037|Vitamin B Complex|vitamin b complex|mesh-ancestor
25028314|NCT03612037|Vitamins|vitamins|mesh-ancestor
24483680|NCT00444522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483691|NCT00444561|Pramlintide|pramlintide|mesh-list
24483692|NCT00444561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24483693|NCT00444561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483694|NCT00444574|Methylphenidate|methylphenidate|mesh-list
24483695|NCT00444574|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24483696|NCT00444574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483697|NCT00444574|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24483698|NCT00444574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24434294|NCT00261976|Infliximab|infliximab|mesh-list
24483699|NCT00444574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24483700|NCT00444574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483701|NCT00444574|Dopamine Agents|dopamine agents|mesh-ancestor
24483702|NCT00444574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24483703|NCT00444613|Vitamin B 12|vitamin b 12|mesh-list
24483704|NCT00444613|Vitamin B Complex|vitamin b complex|mesh-ancestor
24483705|NCT00444613|Vitamins|vitamins|mesh-ancestor
24483706|NCT00444613|Micronutrients|micronutrients|mesh-ancestor
24483707|NCT00444613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483708|NCT00444639|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25028317|NCT03611985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028318|NCT03611920|Tetracycline|tetracycline|mesh-list
25028319|NCT03611920|Dexamethasone|dexamethasone|mesh-list
25028320|NCT03611920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25028321|NCT03611920|Antiemetics|antiemetics|mesh-ancestor
25028322|NCT03611920|Autonomic Agents|autonomic agents|mesh-ancestor
25028323|NCT03611920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25028324|NCT03611920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028325|NCT03611920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25028326|NCT03611920|Glucocorticoids|glucocorticoids|mesh-ancestor
25028327|NCT03611920|Hormones|hormones|mesh-ancestor
24483735|NCT00444756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25028330|NCT03611920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028331|NCT03611920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25028332|NCT03611920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25028333|NCT03611920|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25028334|NCT03611920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25028335|NCT03611920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028336|NCT03611595|Tretinoin|tretinoin|mesh-list
25028337|NCT03611595|Isotretinoin|isotretinoin|mesh-list
25028338|NCT03611595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028339|NCT03611595|Keratolytic Agents|keratolytic agents|mesh-ancestor
25028355|NCT03611491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25028356|NCT03611491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483709|NCT00444639|Luteolytic Agents|luteolytic agents|mesh-ancestor
25691518|NCT01987232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24483710|NCT00444639|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24840434|NCT02210117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840435|NCT02210117|Growth Inhibitors|growth inhibitors|mesh-ancestor
24840436|NCT02210117|Immunologic Factors|immunologic factors|mesh-ancestor
24840437|NCT02210117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24483711|NCT00444639|Contraceptive Agents|contraceptive agents|mesh-ancestor
24483712|NCT00444639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24483722|NCT00444665|Travoprost|travoprost|mesh-list
24483724|NCT00444717|Pitavastatin|pitavastatin|mesh-list
24483725|NCT00444717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24483726|NCT00444717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25028357|NCT03611426|Thrombin|thrombin|mesh-list
25028358|NCT03611426|Hemostatics|hemostatics|mesh-ancestor
25028359|NCT03611426|Coagulants|coagulants|mesh-ancestor
25028360|NCT03611348|Latanoprost|latanoprost|mesh-list
25028361|NCT03611348|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25028362|NCT03611348|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25028364|NCT03611244|Anesthetics, Local|anesthetics, local|mesh-ancestor
25028365|NCT03611244|Anesthetics|anesthetics|mesh-ancestor
25028366|NCT03611244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25028367|NCT03611244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028368|NCT03611244|Sensory System Agents|sensory system agents|mesh-ancestor
25028369|NCT03611244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25028370|NCT03611179|Bevacizumab|bevacizumab|mesh-list
25028371|NCT03611179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25028372|NCT03611179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028373|NCT03611179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25028374|NCT03611179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25028375|NCT03611179|Growth Substances|growth substances|mesh-ancestor
25028376|NCT03611179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028377|NCT03611179|Growth Inhibitors|growth inhibitors|mesh-ancestor
25028378|NCT03611049|Vitamin D|vitamin d|mesh-list
25028379|NCT03611049|Ergocalciferols|ergocalciferols|mesh-list
25028380|NCT03611049|Cholecalciferol|cholecalciferol|mesh-list
25028381|NCT03611049|Vitamins|vitamins|mesh-list
25028382|NCT03611049|Micronutrients|micronutrients|mesh-ancestor
25028383|NCT03611049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028384|NCT03611049|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25028385|NCT03611049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25028386|NCT03610945|Fluconazole|fluconazole|mesh-list
25028387|NCT03610945|Quinidine|quinidine|mesh-list
24862299|NCT02324257|Obinutuzumab|obinutuzumab|mesh-list
24483727|NCT00444717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24483728|NCT00444717|Antimetabolites|antimetabolites|mesh-ancestor
24483729|NCT00444717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483730|NCT00444717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483731|NCT00444717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24483732|NCT00444756|Lidocaine|lidocaine|mesh-list
24483733|NCT00444756|Anesthetics, Local|anesthetics, local|mesh-ancestor
24483734|NCT00444756|Anesthetics|anesthetics|mesh-ancestor
25112979|NCT03778372|Analgesics|analgesics|mesh-ancestor
24483736|NCT00444756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483737|NCT00444756|Sensory System Agents|sensory system agents|mesh-ancestor
24483738|NCT00444756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24483739|NCT00444756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24483740|NCT00444756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25028390|NCT03610945|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25028391|NCT03610945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25691519|NCT01987232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691520|NCT01987232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691521|NCT01987427|Phentermine|phentermine|mesh-list
25691522|NCT01987427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25028392|NCT03610945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25028393|NCT03610945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028394|NCT03610945|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25691523|NCT01987427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691524|NCT01987427|Appetite Depressants|appetite depressants|mesh-ancestor
25691525|NCT01987427|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25691526|NCT01987427|Sympathomimetics|sympathomimetics|mesh-ancestor
25691527|NCT01987427|Autonomic Agents|autonomic agents|mesh-ancestor
25691528|NCT01987427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25691529|NCT01987427|Adrenergic Agents|adrenergic agents|mesh-ancestor
25691530|NCT01987427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25691531|NCT01987427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028395|NCT03610945|Hormone Antagonists|hormone antagonists|mesh-ancestor
25028396|NCT03610945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25028397|NCT03610945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028398|NCT03610945|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25028420|NCT03610932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028421|NCT03610932|Protective Agents|protective agents|mesh-ancestor
25028423|NCT03610893|Dexmedetomidine|dexmedetomidine|mesh-list
25028424|NCT03610893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25028425|NCT03610893|Antiemetics|antiemetics|mesh-ancestor
25028426|NCT03610893|Autonomic Agents|autonomic agents|mesh-ancestor
25028427|NCT03610893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24987827|NCT04939090|Appetite Stimulants|appetite stimulants|mesh-ancestor
24483741|NCT00444756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24483742|NCT00444756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25028430|NCT03610893|Glucocorticoids|glucocorticoids|mesh-ancestor
25028431|NCT03610893|Hormones|hormones|mesh-ancestor
25028432|NCT03610893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25028433|NCT03610893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25028434|NCT03610893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028435|NCT03610893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25028436|NCT03610893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25028437|NCT03610893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24796171|NCT01948336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25028438|NCT03610893|Analgesics|analgesics|mesh-ancestor
25028439|NCT03610893|Sensory System Agents|sensory system agents|mesh-ancestor
25028440|NCT03610893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25028441|NCT03610893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25028442|NCT03610893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25028443|NCT03610893|Adrenergic Agents|adrenergic agents|mesh-ancestor
25028447|NCT03610880|Antiviral Agents|antiviral agents|mesh-ancestor
25028448|NCT03610880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25028449|NCT03610685|Prednisolone|prednisolone|mesh-list
25028450|NCT03610685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25112974|NCT03778372|Methadone|methadone|mesh-list
25112975|NCT03778372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25112976|NCT03778372|Narcotics|narcotics|mesh-ancestor
25112977|NCT03778372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24483800|NCT00445055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24483801|NCT00445055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24483805|NCT00445081|Cyclosporine|cyclosporine|mesh-list
24483841|NCT00445250|Calcipotriene|calcipotriene|mesh-list
24730721|NCT01630018|Belotecan|belotecan|mesh-list
24483842|NCT00445250|Dermatologic Agents|dermatologic agents|mesh-ancestor
24483843|NCT00445276|Diacetylrhein|diacetylrhein|mesh-list
24483862|NCT00445497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483863|NCT00445497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483864|NCT00445497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24483872|NCT00445510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112978|NCT03778372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112982|NCT03778372|Antitussive Agents|antitussive agents|mesh-ancestor
25112983|NCT03778372|Respiratory System Agents|respiratory system agents|mesh-ancestor
25028480|NCT03610282|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25028481|NCT03610282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25028482|NCT03610282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24483878|NCT00445523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24483879|NCT00445523|Immunologic Factors|immunologic factors|mesh-ancestor
24483880|NCT00445523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483881|NCT00445575|Risedronic Acid|risedronic acid|mesh-list
24483882|NCT00445575|Etidronic Acid|etidronic acid|mesh-list
24483883|NCT00445575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24841352|NCT02215447|Carboplatin|carboplatin|mesh-list
24841353|NCT02215447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24841354|NCT02215447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841355|NCT02215447|Tubulin Modulators|tubulin modulators|mesh-ancestor
24841450|NCT02215993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24841451|NCT02215993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841452|NCT02215993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483884|NCT00445575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24483885|NCT00445575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483886|NCT00445575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24483887|NCT00445575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483888|NCT00445575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24483890|NCT00445796|Amodiaquine|amodiaquine|mesh-list
24483891|NCT00445796|Antimalarials|antimalarials|mesh-ancestor
24483918|NCT00445900|Thalidomide|thalidomide|mesh-list
24483937|NCT00445900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24483938|NCT00445900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24483945|NCT00445965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483946|NCT00446004|Imatinib Mesylate|imatinib mesylate|mesh-list
24483947|NCT00446004|Omeprazole|omeprazole|mesh-list
24483948|NCT00446004|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25028488|NCT03610230|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25028489|NCT03610230|Ferric Compounds|ferric compounds|mesh-list
24985437|NCT03365609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985438|NCT03365609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24985440|NCT03353675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24985441|NCT03353675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985442|NCT03353675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24985443|NCT03353675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985444|NCT03341156|Thrombin|thrombin|mesh-list
24985445|NCT03341156|Hemostatics|hemostatics|mesh-ancestor
24985446|NCT03341156|Coagulants|coagulants|mesh-ancestor
24985447|NCT03341078|Ibudilast|ibudilast|mesh-list
24985448|NCT03341078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24985449|NCT03341078|Autonomic Agents|autonomic agents|mesh-ancestor
24985450|NCT03341078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24985451|NCT03341078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410064|NCT00184106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24985456|NCT03341078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985457|NCT03341078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24483962|NCT00446017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24483963|NCT00446017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483964|NCT00446017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483965|NCT00446017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24483966|NCT00446017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24483968|NCT00446017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24483969|NCT00446017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24484098|NCT00446537|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24484099|NCT00446537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484100|NCT00446537|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24484101|NCT00446537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24484102|NCT00446537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24484103|NCT00446537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484139|NCT00446784|Dermatologic Agents|dermatologic agents|mesh-ancestor
25028495|NCT03610178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25028505|NCT03610100|Gemcitabine|gemcitabine|mesh-list
25691532|NCT01987453|Sofosbuvir|sofosbuvir|mesh-list
25691533|NCT01987453|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25691534|NCT01987453|Ledipasvir|ledipasvir|mesh-list
25691535|NCT01987453|Antiviral Agents|antiviral agents|mesh-ancestor
25691536|NCT01987453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25691537|NCT01987479|Methotrexate|methotrexate|mesh-list
25691538|NCT01987479|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25691539|NCT01987479|Abortifacient Agents|abortifacient agents|mesh-ancestor
25691540|NCT01987479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25108403|NCT03132142|Antipruritics|antipruritics|mesh-ancestor
25108404|NCT03132142|Dermatologic Agents|dermatologic agents|mesh-ancestor
25108412|NCT03132194|Dapsone|dapsone|mesh-list
25028506|NCT03610100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25107190|NCT03141658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25107191|NCT03141658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107192|NCT03141658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25107194|NCT03141658|Anesthetics, General|anesthetics, general|mesh-ancestor
24484302|NCT00447577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484303|NCT00447577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24484305|NCT00447577|Hormones|hormones|mesh-ancestor
24484306|NCT00447577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24484307|NCT00447577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25028508|NCT03610100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028509|NCT03610100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028510|NCT03610100|Antiviral Agents|antiviral agents|mesh-ancestor
25028511|NCT03610100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25028512|NCT03610100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25028513|NCT03610100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25028514|NCT03610100|Immunologic Factors|immunologic factors|mesh-ancestor
25028515|NCT03610100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028516|NCT03610035|Immunoglobulins|immunoglobulins|mesh-list
25028517|NCT03610035|Immunoglobulin G|immunoglobulin g|mesh-list
25028518|NCT03610035|Immunologic Factors|immunologic factors|mesh-ancestor
25028519|NCT03610035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028520|NCT03609996|Ranibizumab|ranibizumab|mesh-list
25028521|NCT03609996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25028522|NCT03609996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25028523|NCT03609996|Growth Substances|growth substances|mesh-ancestor
24484400|NCT00448149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24484401|NCT00448149|Immunologic Factors|immunologic factors|mesh-ancestor
24484402|NCT00448149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484403|NCT00448149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24484404|NCT00448149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484433|NCT00448292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484434|NCT00448292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484460|NCT00448461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484461|NCT00448461|Antithrombins|antithrombins|mesh-ancestor
25028769|NCT03608098|Autonomic Agents|autonomic agents|mesh-ancestor
24484538|NCT00449137|Fluorouracil|fluorouracil|mesh-list
24484539|NCT00449137|Arsenic Trioxide|arsenic trioxide|mesh-list
24484541|NCT00449137|Levoleucovorin|levoleucovorin|mesh-list
24484542|NCT00449137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24484543|NCT00449137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484544|NCT00449137|Antimetabolites|antimetabolites|mesh-ancestor
24484545|NCT00449137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484546|NCT00449137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24484547|NCT00449137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028524|NCT03609996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028525|NCT03609996|Growth Inhibitors|growth inhibitors|mesh-ancestor
25028526|NCT03609996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028527|NCT03609970|Vitamin D|vitamin d|mesh-list
25028528|NCT03609970|Vitamins|vitamins|mesh-ancestor
25028529|NCT03609970|Micronutrients|micronutrients|mesh-ancestor
25028530|NCT03609970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691541|NCT01987479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691542|NCT01987479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25691543|NCT01987479|Antimetabolites|antimetabolites|mesh-ancestor
25691544|NCT01987479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691545|NCT01987479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25691546|NCT01987479|Dermatologic Agents|dermatologic agents|mesh-ancestor
25691547|NCT01987479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691548|NCT01987479|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25691549|NCT01987479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24842641|NCT02222441|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24754980|NCT01724268|Prednisolone|prednisolone|mesh-list
24842673|NCT02222636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24842674|NCT02222636|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24873806|NCT05015387|Procyanidin|procyanidin|mesh-list
25028531|NCT03609970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25028532|NCT03609892|Amoxicillin|amoxicillin|mesh-list
25028533|NCT03609892|Tetracycline|tetracycline|mesh-list
25028534|NCT03609892|Furazolidone|furazolidone|mesh-list
25028535|NCT03609892|Esomeprazole|esomeprazole|mesh-list
25028536|NCT03609892|Bismuth|bismuth|mesh-list
25028537|NCT03609892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25028538|NCT03609892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25028539|NCT03609892|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24484548|NCT00449137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24484549|NCT00449137|Immunologic Factors|immunologic factors|mesh-ancestor
24484550|NCT00449137|Antidotes|antidotes|mesh-ancestor
24484551|NCT00449137|Protective Agents|protective agents|mesh-ancestor
24484552|NCT00449137|Vitamin B Complex|vitamin b complex|mesh-ancestor
24484553|NCT00449137|Vitamins|vitamins|mesh-ancestor
24484554|NCT00449137|Micronutrients|micronutrients|mesh-ancestor
24484571|NCT00449280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484579|NCT00449280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24484580|NCT00449280|Immunologic Factors|immunologic factors|mesh-ancestor
24484581|NCT00449280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484583|NCT00449319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24484584|NCT00449319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484585|NCT00449319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24484586|NCT00449319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24484628|NCT00449449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24484629|NCT00449449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24484630|NCT00449449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24484631|NCT00449449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24484632|NCT00449449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484633|NCT00449488|Epoetin Alfa|epoetin alfa|mesh-list
24484634|NCT00449488|Hematinics|hematinics|mesh-ancestor
24484636|NCT00449501|Formoterol Fumarate|formoterol fumarate|mesh-list
24484637|NCT00449501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24484638|NCT00449501|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24731247|NCT01633645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484639|NCT00449501|Autonomic Agents|autonomic agents|mesh-ancestor
24484640|NCT00449501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24484641|NCT00449501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484642|NCT00449501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24484643|NCT00449501|Respiratory System Agents|respiratory system agents|mesh-ancestor
24484644|NCT00449501|Glucocorticoids|glucocorticoids|mesh-ancestor
24484645|NCT00449501|Hormones|hormones|mesh-ancestor
24484664|NCT00449514|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24484665|NCT00449514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24484666|NCT00449514|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24484667|NCT00449514|Fertility Agents|fertility agents|mesh-ancestor
25028553|NCT03609827|Melphalan|melphalan|mesh-list
25028554|NCT03609827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25028555|NCT03609827|Alkylating Agents|alkylating agents|mesh-ancestor
24484768|NCT00449839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24484769|NCT00449839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484770|NCT00450008|Thalidomide|thalidomide|mesh-list
24484771|NCT00450008|Docetaxel|docetaxel|mesh-list
25691550|NCT01987479|Immunologic Factors|immunologic factors|mesh-ancestor
25691551|NCT01987479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25691552|NCT01987479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25691553|NCT01987505|Rituximab|rituximab|mesh-list
25691554|NCT01987505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25691555|NCT01987505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484827|NCT00450164|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24484828|NCT00450164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24843293|NCT02226913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24843295|NCT02226913|Sensory System Agents|sensory system agents|mesh-ancestor
24843296|NCT02226913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24843297|NCT02226913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25028557|NCT03609827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028558|NCT03609827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25028559|NCT03609827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25028561|NCT03609827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028562|NCT03609814|Fludarabine|fludarabine|mesh-list
25028563|NCT03609814|Clofarabine|clofarabine|mesh-list
25028564|NCT03609814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028565|NCT03609814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25028566|NCT03609814|Antimetabolites|antimetabolites|mesh-ancestor
25028567|NCT03609814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028568|NCT03609775|Ethanol|ethanol|mesh-list
25028569|NCT03609775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25028570|NCT03609775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24987902|NCT04713358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24484829|NCT00450164|Adrenergic Agents|adrenergic agents|mesh-ancestor
24484830|NCT00450164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24484837|NCT00450203|Capecitabine|capecitabine|mesh-list
24484838|NCT00450203|Epirubicin|epirubicin|mesh-list
24484839|NCT00450203|Lapatinib|lapatinib|mesh-list
24484840|NCT00450203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24484841|NCT00450203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484842|NCT00450203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24484843|NCT00450203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24484844|NCT00450203|Growth Substances|growth substances|mesh-ancestor
24484984|NCT00451061|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24484985|NCT00451061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24485038|NCT00451139|Sensory System Agents|sensory system agents|mesh-ancestor
24485039|NCT00451139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485497|NCT00453232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485498|NCT00453232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485499|NCT00453232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24485500|NCT00453323|Paclitaxel|paclitaxel|mesh-list
24485501|NCT00453323|Capecitabine|capecitabine|mesh-list
24485502|NCT00453323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24485503|NCT00453323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485504|NCT00453323|Tubulin Modulators|tubulin modulators|mesh-ancestor
24485505|NCT00453323|Antimitotic Agents|antimitotic agents|mesh-ancestor
24485612|NCT00453960|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25028597|NCT03609489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485615|NCT00453960|Contraceptive Agents|contraceptive agents|mesh-ancestor
24485616|NCT00453960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24485617|NCT00453960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485622|NCT00454168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485623|NCT00454233|Metformin|metformin|mesh-list
24485624|NCT00454233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24485625|NCT00454233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485626|NCT00454259|Fentanyl|fentanyl|mesh-list
24485672|NCT00454480|Arsenic Trioxide|arsenic trioxide|mesh-list
24485673|NCT00454480|Gemtuzumab|gemtuzumab|mesh-list
24485674|NCT00454480|Tipifarnib|tipifarnib|mesh-list
24436484|NCT00270153|Enalapril|enalapril|mesh-list
24485706|NCT00454545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24485707|NCT00454545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485708|NCT00454558|Riociguat|riociguat|mesh-list
24485709|NCT00454558|Enzyme Activators|enzyme activators|mesh-ancestor
25028599|NCT03609489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25028600|NCT03609489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25028602|NCT03609424|Spartalizumab|spartalizumab|mesh-list
25028603|NCT03609424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028604|NCT03609424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25028605|NCT03609424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25028606|NCT03609424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028637|NCT03609294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25691556|NCT01987505|Immunologic Factors|immunologic factors|mesh-ancestor
25691557|NCT01987505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691558|NCT01987505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25691559|NCT01987596|Lenograstim|lenograstim|mesh-list
25691560|NCT01987596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25691561|NCT01987596|Immunologic Factors|immunologic factors|mesh-ancestor
25028638|NCT03609294|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25028640|NCT03609294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25028641|NCT03609294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028642|NCT03609190|Ketamine|ketamine|mesh-list
25028643|NCT03609190|Analgesics|analgesics|mesh-ancestor
25028644|NCT03609190|Sensory System Agents|sensory system agents|mesh-ancestor
24862429|NCT02325180|Antimalarials|antimalarials|mesh-ancestor
24485710|NCT00454558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485711|NCT00454662|Amlodipine|amlodipine|mesh-list
24485712|NCT00454662|Olmesartan|olmesartan|mesh-list
24485713|NCT00454662|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24485714|NCT00454662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24485715|NCT00454662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24485716|NCT00454662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24485717|NCT00454662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485718|NCT00454662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24485760|NCT00454883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24485761|NCT00454883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24485762|NCT00454883|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24485763|NCT00454883|Dopamine Agents|dopamine agents|mesh-ancestor
24485764|NCT00454896|Solifenacin Succinate|solifenacin succinate|mesh-list
24485773|NCT00454961|Artemether|artemether|mesh-list
24485828|NCT00455234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485829|NCT00455234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25028646|NCT03609190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028647|NCT03609190|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25028649|NCT03609190|Anesthetics, General|anesthetics, general|mesh-ancestor
25028650|NCT03609190|Anesthetics|anesthetics|mesh-ancestor
25028651|NCT03609190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25028652|NCT03609190|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25028653|NCT03609190|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25028688|NCT03608761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028689|NCT03608761|Protective Agents|protective agents|mesh-ancestor
25028690|NCT03608761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028691|NCT03608761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25028692|NCT03608618|Cyclophosphamide|cyclophosphamide|mesh-list
25028693|NCT03608618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25028694|NCT03608618|Immunologic Factors|immunologic factors|mesh-ancestor
25028695|NCT03608618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028696|NCT03608618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24486431|NCT00457860|Immunologic Factors|immunologic factors|mesh-ancestor
24731985|NCT01637454|Terlipressin|terlipressin|mesh-list
25028711|NCT03608501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25028712|NCT03608501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028714|NCT03608501|Glucocorticoids|glucocorticoids|mesh-ancestor
25028715|NCT03608501|Hormones|hormones|mesh-ancestor
25028716|NCT03608501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25028717|NCT03608501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25028725|NCT03608501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25028742|NCT03608306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25028743|NCT03608306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24844682|NCT02233790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844684|NCT02233816|Immunologic Factors|immunologic factors|mesh-ancestor
24844685|NCT02233816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844686|NCT02233881|Ipratropium|ipratropium|mesh-list
24844687|NCT02233881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24844688|NCT02233881|Autonomic Agents|autonomic agents|mesh-ancestor
24844714|NCT02233920|Parasympatholytics|parasympatholytics|mesh-ancestor
25028744|NCT03608306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25028745|NCT03608293|Dimercaprol|dimercaprol|mesh-list
25028746|NCT03608293|Chelating Agents|chelating agents|mesh-ancestor
25028747|NCT03608293|Sequestering Agents|sequestering agents|mesh-ancestor
25028748|NCT03608293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028749|NCT03608241|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25028750|NCT03608241|Contraceptive Agents|contraceptive agents|mesh-list
25028751|NCT03608241|Contraceptives, Oral|contraceptives, oral|mesh-list
25028752|NCT03608241|Estradiol|estradiol|mesh-list
25028753|NCT03608241|Estrogens|estrogens|mesh-ancestor
25028754|NCT03608241|Hormones|hormones|mesh-ancestor
25028755|NCT03608241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25028756|NCT03608241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028757|NCT03608241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25028758|NCT03608241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25028759|NCT03608241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25028760|NCT03608241|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25028761|NCT03608098|Oxymetazoline|oxymetazoline|mesh-list
24988028|NCT04420455|Enoximone|enoximone|mesh-list
24485937|NCT00455442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24485938|NCT00455442|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24485939|NCT00455507|Istradefylline|istradefylline|mesh-list
25028765|NCT03608098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25028766|NCT03608098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028767|NCT03608098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028768|NCT03608098|Sympathomimetics|sympathomimetics|mesh-ancestor
25028770|NCT03608098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25028771|NCT03608098|Nasal Decongestants|nasal decongestants|mesh-ancestor
25028772|NCT03608098|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25028773|NCT03608098|Respiratory System Agents|respiratory system agents|mesh-ancestor
25028774|NCT03608046|Irinotecan|irinotecan|mesh-list
25028775|NCT03608046|Cetuximab|cetuximab|mesh-list
25028776|NCT03608046|Avelumab|avelumab|mesh-list
25028777|NCT03608046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25028778|NCT03608046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25028779|NCT03608046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039943|NCT03571568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485967|NCT00455585|Antimetabolites|antimetabolites|mesh-ancestor
24486145|NCT00456560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24486146|NCT00456560|Serotonin Agents|serotonin agents|mesh-ancestor
24486182|NCT00456794|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24486183|NCT00456794|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24486184|NCT00456794|Purinergic Agents|purinergic agents|mesh-ancestor
24486185|NCT00456794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24486432|NCT00457860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486186|NCT00456794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486187|NCT00456794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486189|NCT00456820|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24486190|NCT00456820|Antidepressive Agents|antidepressive agents|mesh-ancestor
24486191|NCT00456820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24486192|NCT00456820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24486193|NCT00456820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24486194|NCT00456820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24486195|NCT00456820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486196|NCT00456820|Dopamine Agents|dopamine agents|mesh-ancestor
24486197|NCT00456820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24486198|NCT00456820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691562|NCT01987596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691563|NCT01987752|Timolol|timolol|mesh-list
25691564|NCT01987752|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25691565|NCT01987752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25691566|NCT01987752|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
25691567|NCT01987752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25691568|NCT01987752|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25691569|NCT01987752|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25691570|NCT01987752|Adrenergic Agents|adrenergic agents|mesh-ancestor
25691571|NCT01987752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24757721|NCT01742247|Hormones|hormones|mesh-ancestor
24486199|NCT00456820|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24486200|NCT00456820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24486203|NCT00456833|Everolimus|everolimus|mesh-list
24486229|NCT00456898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486231|NCT00456898|Serotonin Agents|serotonin agents|mesh-ancestor
24486232|NCT00456898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486233|NCT00456898|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24486234|NCT00456898|Antidepressive Agents|antidepressive agents|mesh-ancestor
25028781|NCT03608046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028782|NCT03608046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25028798|NCT03607916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25028799|NCT03607916|Narcotics|narcotics|mesh-ancestor
25028800|NCT03607916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25028801|NCT03607916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028802|NCT03607916|Analgesics|analgesics|mesh-ancestor
25028803|NCT03607916|Sensory System Agents|sensory system agents|mesh-ancestor
25028804|NCT03607916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25028805|NCT03607916|Anesthetics, Local|anesthetics, local|mesh-ancestor
25028806|NCT03607916|Anesthetics|anesthetics|mesh-ancestor
25028807|NCT03607903|Adalimumab|adalimumab|mesh-list
25028808|NCT03607903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24988056|NCT04251715|Leucovorin|leucovorin|mesh-list
24486235|NCT00456898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24486264|NCT00456963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24486265|NCT00456963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486266|NCT00456963|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24486267|NCT00456963|Protease Inhibitors|protease inhibitors|mesh-ancestor
24486268|NCT00456963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486270|NCT00456976|Antidepressive Agents|antidepressive agents|mesh-ancestor
24486271|NCT00456976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24486272|NCT00456976|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24486347|NCT00457405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24486348|NCT00457405|Vasodilator Agents|vasodilator agents|mesh-ancestor
24486350|NCT00457470|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24486351|NCT00457470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486352|NCT00457470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486353|NCT00457470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486354|NCT00457483|Valsartan|valsartan|mesh-list
24486357|NCT00457483|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24486358|NCT00457483|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24486359|NCT00457483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486360|NCT00457483|Diuretics|diuretics|mesh-ancestor
24486361|NCT00457483|Natriuretic Agents|natriuretic agents|mesh-ancestor
24486362|NCT00457483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486418|NCT00457769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486419|NCT00457769|Nootropic Agents|nootropic agents|mesh-ancestor
24486421|NCT00457808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24486422|NCT00457808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24486423|NCT00457808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24486424|NCT00457808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486425|NCT00457808|Antifungal Agents|antifungal agents|mesh-ancestor
24486426|NCT00457808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24486427|NCT00457808|Immunologic Factors|immunologic factors|mesh-ancestor
24486428|NCT00457808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486429|NCT00457860|Immunotoxin HA22|immunotoxin ha22|mesh-list
24486430|NCT00457860|Immunotoxins|immunotoxins|mesh-list
24486433|NCT00457860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486442|NCT00457964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486443|NCT00457964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25028809|NCT03607903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25028811|NCT03607851|Anticonvulsants|anticonvulsants|mesh-ancestor
25028812|NCT03607851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25028813|NCT03607851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24985741|NCT02809131|Bacitracin|bacitracin|mesh-list
24985742|NCT02809131|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24985743|NCT02809131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25691572|NCT01987752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691573|NCT01987752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691574|NCT01987752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24985744|NCT02809131|Renal Agents|renal agents|mesh-ancestor
24985745|NCT02809131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24985746|NCT02809131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24985747|NCT02809131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24985748|NCT02809131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039944|NCT03571568|Immunologic Factors|immunologic factors|mesh-ancestor
24486444|NCT00457964|Immunologic Factors|immunologic factors|mesh-ancestor
24486445|NCT00457964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486446|NCT00458042|Treprostinil|treprostinil|mesh-list
24486447|NCT00458042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24486449|NCT00458055|Atorvastatin|atorvastatin|mesh-list
24486450|NCT00458055|Fenofibrate|fenofibrate|mesh-list
24486451|NCT00458055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24486476|NCT00458185|Sensory System Agents|sensory system agents|mesh-ancestor
24486481|NCT00458185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24486482|NCT00458185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24486483|NCT00458185|Immunologic Factors|immunologic factors|mesh-ancestor
24486484|NCT00458250|Cyclosporine|cyclosporine|mesh-list
24486485|NCT00458250|Cyclophosphamide|cyclophosphamide|mesh-list
24486487|NCT00458250|Methotrexate|methotrexate|mesh-list
24486628|NCT00458900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24486629|NCT00458900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24486630|NCT00458900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24486631|NCT00458900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486632|NCT00458900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486633|NCT00458900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486634|NCT00458913|Bortezomib|bortezomib|mesh-list
24486663|NCT00459173|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24486664|NCT00459173|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24486665|NCT00459173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24486666|NCT00459173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486668|NCT00459173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24486720|NCT00459615|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24486767|NCT00459992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486768|NCT00459992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486770|NCT00460057|Diphosphonates|diphosphonates|mesh-list
24486771|NCT00460057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24486772|NCT00460057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486773|NCT00460083|Pimecrolimus|pimecrolimus|mesh-list
24486774|NCT00460083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24446891|NCT00306462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24446892|NCT00306462|Anticonvulsants|anticonvulsants|mesh-ancestor
24446893|NCT00306462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24985749|NCT02809131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985750|NCT02809131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985751|NCT02809131|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24985752|NCT02809131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24985753|NCT02809131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24985754|NCT02809131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24446894|NCT00306462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24446895|NCT00306462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446896|NCT00306462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24486899|NCT00460486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24486903|NCT00460512|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24486904|NCT00460512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24486905|NCT00460512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24486906|NCT00460512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24486916|NCT00460512|Dopamine Agents|dopamine agents|mesh-ancestor
24486918|NCT00460616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24486919|NCT00460616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24486920|NCT00460616|Dopamine Agonists|dopamine agonists|mesh-ancestor
24486921|NCT00460616|Dopamine Agents|dopamine agents|mesh-ancestor
24486922|NCT00460616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24486923|NCT00460616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486924|NCT00460616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486926|NCT00460642|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24874461|NCT04750616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24874462|NCT04750616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24874463|NCT04750616|Antimetabolites|antimetabolites|mesh-ancestor
24874464|NCT04750616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24874465|NCT04750616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24874466|NCT04750616|Vasodilator Agents|vasodilator agents|mesh-ancestor
24486927|NCT00460642|Fertility Agents|fertility agents|mesh-ancestor
24486939|NCT00460707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24487059|NCT00461344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24487062|NCT00461396|Interferon beta-1b|interferon beta-1b|mesh-list
24487063|NCT00461396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487064|NCT00461396|Antiviral Agents|antiviral agents|mesh-ancestor
24487065|NCT00461396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24487066|NCT00461396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24487067|NCT00461396|Immunologic Factors|immunologic factors|mesh-ancestor
24487068|NCT00461396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487069|NCT00461422|Ganirelix|ganirelix|mesh-list
24487316|NCT00462618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487318|NCT00462631|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24487319|NCT00462631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24487320|NCT00462631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487321|NCT00462631|Tubulin Modulators|tubulin modulators|mesh-ancestor
24487322|NCT00462631|Antimitotic Agents|antimitotic agents|mesh-ancestor
24487323|NCT00462631|Mitosis Modulators|mitosis modulators|mesh-ancestor
24487324|NCT00462631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487325|NCT00462657|Dimercaprol|dimercaprol|mesh-list
24985755|NCT02785952|Nivolumab|nivolumab|mesh-list
24985756|NCT02785952|Ipilimumab|ipilimumab|mesh-list
24985757|NCT02785952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24985758|NCT02785952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028814|NCT03607851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25028815|NCT03607851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028817|NCT03607734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25028818|NCT03607734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25028819|NCT03607643|Leucovorin|leucovorin|mesh-list
25028820|NCT03607643|Gemcitabine|gemcitabine|mesh-list
25028821|NCT03607643|Bevacizumab|bevacizumab|mesh-list
25028822|NCT03607643|Oxaliplatin|oxaliplatin|mesh-list
25028832|NCT03607643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028833|NCT03607643|Growth Inhibitors|growth inhibitors|mesh-ancestor
25028834|NCT03607643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25028835|NCT03607643|Antimetabolites|antimetabolites|mesh-ancestor
25028836|NCT03607643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028837|NCT03607643|Antiviral Agents|antiviral agents|mesh-ancestor
25028838|NCT03607643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25028839|NCT03607643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25028840|NCT03607643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25028841|NCT03607643|Immunologic Factors|immunologic factors|mesh-ancestor
25028842|NCT03607643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25028843|NCT03607643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25028845|NCT03607643|Protective Agents|protective agents|mesh-ancestor
25691575|NCT01987752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25691576|NCT01987752|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25691577|NCT01987752|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25691578|NCT01987752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25691579|NCT01987765|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25691580|NCT01987765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25691581|NCT01987895|Vancomycin|vancomycin|mesh-list
25691582|NCT01987895|Oxazolidinones|oxazolidinones|mesh-list
25691583|NCT01987895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25691584|NCT01987895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25691585|NCT01987895|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25691586|NCT01987895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25028846|NCT03607643|Vitamin B Complex|vitamin b complex|mesh-ancestor
25028847|NCT03607643|Vitamins|vitamins|mesh-ancestor
25028848|NCT03607643|Micronutrients|micronutrients|mesh-ancestor
25028849|NCT03607643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25028850|NCT03607643|Alkylating Agents|alkylating agents|mesh-ancestor
25028851|NCT03607643|Anticonvulsants|anticonvulsants|mesh-ancestor
25028852|NCT03607578|Sunscreening Agents|sunscreening agents|mesh-list
25028853|NCT03607578|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24487326|NCT00462657|Chelating Agents|chelating agents|mesh-ancestor
24487327|NCT00462657|Sequestering Agents|sequestering agents|mesh-ancestor
24487328|NCT00462657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487330|NCT00462696|Epirubicin|epirubicin|mesh-list
24487331|NCT00462696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487332|NCT00462696|Tubulin Modulators|tubulin modulators|mesh-ancestor
24487333|NCT00462696|Antimitotic Agents|antimitotic agents|mesh-ancestor
25028854|NCT03607578|Protective Agents|protective agents|mesh-ancestor
25028855|NCT03607578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028856|NCT03607578|Dermatologic Agents|dermatologic agents|mesh-ancestor
25028857|NCT03607383|Red yeast rice|red yeast rice|mesh-list
25028858|NCT03607383|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25028859|NCT03607383|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25028860|NCT03607383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25028861|NCT03607383|Antimetabolites|antimetabolites|mesh-ancestor
25028862|NCT03607383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028863|NCT03607383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25028864|NCT03607383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25028865|NCT03607331|Citalopram|citalopram|mesh-list
25028866|NCT03607331|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25028867|NCT03607331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25028868|NCT03607331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25028869|NCT03607331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028870|NCT03607331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25028871|NCT03607331|Serotonin Agents|serotonin agents|mesh-ancestor
25028872|NCT03607331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028873|NCT03607331|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25028874|NCT03607331|Antidepressive Agents|antidepressive agents|mesh-ancestor
25028875|NCT03607331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25028876|NCT03607227|Levobupivacaine|levobupivacaine|mesh-list
25028877|NCT03607227|Anesthetics, Local|anesthetics, local|mesh-ancestor
25028878|NCT03607227|Anesthetics|anesthetics|mesh-ancestor
24594537|NCT00934323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594541|NCT00934414|Insulin|insulin|mesh-list
25028888|NCT03607175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25028889|NCT03607175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028891|NCT03607175|Immunologic Factors|immunologic factors|mesh-ancestor
25028892|NCT03607149|Pemetrexed|pemetrexed|mesh-list
25028893|NCT03607149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028898|NCT03607110|Fentanyl|fentanyl|mesh-list
25028904|NCT03607110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25028905|NCT03607110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25028906|NCT03607110|Anesthetics, General|anesthetics, general|mesh-ancestor
25028908|NCT03607110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24985796|NCT02730429|Letrozole|letrozole|mesh-list
25028909|NCT03607110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25028910|NCT03607110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25028911|NCT03607110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25028912|NCT03607110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028913|NCT03607110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25028914|NCT03607110|Narcotics|narcotics|mesh-ancestor
25028915|NCT03607110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25028916|NCT03607071|Prednisolone|prednisolone|mesh-list
25028917|NCT03607071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25028918|NCT03607071|Glucocorticoids|glucocorticoids|mesh-ancestor
25028919|NCT03607071|Hormones|hormones|mesh-ancestor
25039945|NCT03571568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487359|NCT00462787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487360|NCT00462787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487479|NCT00463320|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24487481|NCT00463359|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24487482|NCT00463359|Immunologic Factors|immunologic factors|mesh-ancestor
25692699|NCT02004093|Carboplatin|carboplatin|mesh-list
25692700|NCT02004093|Pertuzumab|pertuzumab|mesh-list
24459740|NCT00346255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24459742|NCT00346294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24409497|NCT00182312|Caffeine|caffeine|mesh-list
24450572|NCT00319618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450573|NCT00319618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24450574|NCT00319618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487483|NCT00463359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028920|NCT03607071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25028921|NCT03607071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028922|NCT03607071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25028923|NCT03607071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028924|NCT03606928|Leucovorin|leucovorin|mesh-list
25028925|NCT03606928|Docetaxel|docetaxel|mesh-list
25028926|NCT03606928|Oxaliplatin|oxaliplatin|mesh-list
25028927|NCT03606928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028928|NCT03606928|Tubulin Modulators|tubulin modulators|mesh-ancestor
25028929|NCT03606928|Antimitotic Agents|antimitotic agents|mesh-ancestor
25028930|NCT03606928|Mitosis Modulators|mitosis modulators|mesh-ancestor
25028931|NCT03606928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028932|NCT03606928|Antidotes|antidotes|mesh-ancestor
25028933|NCT03606928|Protective Agents|protective agents|mesh-ancestor
25028934|NCT03606928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028935|NCT03606928|Vitamin B Complex|vitamin b complex|mesh-ancestor
25028936|NCT03606928|Vitamins|vitamins|mesh-ancestor
25028937|NCT03606928|Micronutrients|micronutrients|mesh-ancestor
25028938|NCT03606902|Fentanyl|fentanyl|mesh-list
25028939|NCT03606902|Bupivacaine|bupivacaine|mesh-list
25028940|NCT03606902|Anesthetics, Local|anesthetics, local|mesh-ancestor
25028954|NCT03606824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25028955|NCT03606824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25028956|NCT03606824|Antimetabolites|antimetabolites|mesh-ancestor
25028957|NCT03606824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028958|NCT03606824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25028959|NCT03606824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24487492|NCT00463515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24487493|NCT00463515|Antimetabolites|antimetabolites|mesh-ancestor
24487596|NCT00463983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487598|NCT00464035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24487599|NCT00464035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487600|NCT00464165|Rimonabant|rimonabant|mesh-list
24487601|NCT00464165|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24487602|NCT00464165|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24487603|NCT00464165|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25113060|NCT03587311|Paclitaxel|paclitaxel|mesh-list
25113061|NCT03587311|Maytansine|maytansine|mesh-list
25113062|NCT03587311|Bevacizumab|bevacizumab|mesh-list
25113063|NCT03587311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25113064|NCT03587311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25113065|NCT03587311|Endothelial Growth Factors|endothelial growth factors|mesh-list
25113066|NCT03587311|Antibodies|antibodies|mesh-list
25113067|NCT03587311|Immunoglobulins|immunoglobulins|mesh-list
25113068|NCT03587311|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25113069|NCT03587311|Immunoglobulin G|immunoglobulin g|mesh-list
25113072|NCT03587311|Tubulin Modulators|tubulin modulators|mesh-ancestor
25028960|NCT03606681|Calcium, Dietary|calcium, dietary|mesh-list
25028961|NCT03606681|Calcium|calcium|mesh-list
25028962|NCT03606681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25028963|NCT03606681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028964|NCT03606681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25028965|NCT03606590|Sorafenib|sorafenib|mesh-list
25028966|NCT03606590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028967|NCT03606590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25028968|NCT03606590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691587|NCT01987895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691588|NCT01987960|Brexpiprazole|brexpiprazole|mesh-list
25691589|NCT01987960|Serotonin Agents|serotonin agents|mesh-ancestor
25691590|NCT01987960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25691591|NCT01987960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691592|NCT01987960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691593|NCT01987960|Dopamine Agonists|dopamine agonists|mesh-ancestor
25691594|NCT01987960|Dopamine Agents|dopamine agents|mesh-ancestor
24860359|NCT02309385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24860360|NCT02309385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24860361|NCT02309385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028976|NCT03606577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25028977|NCT03606577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028978|NCT03606577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25028979|NCT03606577|Glucocorticoids|glucocorticoids|mesh-ancestor
25028981|NCT03606577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24487604|NCT00464165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24487606|NCT00464165|Hormones|hormones|mesh-ancestor
24487608|NCT00464165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028982|NCT03606577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25028983|NCT03606577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028984|NCT03606577|Immunologic Factors|immunologic factors|mesh-ancestor
25028985|NCT03606577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25028986|NCT03606577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25028987|NCT03606577|Growth Substances|growth substances|mesh-ancestor
25028988|NCT03606577|Growth Inhibitors|growth inhibitors|mesh-ancestor
25028989|NCT03606473|Amphetamine|amphetamine|mesh-list
25028990|NCT03606473|Dextroamphetamine|dextroamphetamine|mesh-list
25028991|NCT03606473|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25028992|NCT03606473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028993|NCT03606473|Sympathomimetics|sympathomimetics|mesh-ancestor
25028994|NCT03606473|Autonomic Agents|autonomic agents|mesh-ancestor
25028995|NCT03606473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25028996|NCT03606473|Dopamine Agents|dopamine agents|mesh-ancestor
25028997|NCT03606473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25028998|NCT03606473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028999|NCT03606473|Adrenergic Agents|adrenergic agents|mesh-ancestor
25029000|NCT03606473|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25029001|NCT03606473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25029002|NCT03606473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25029003|NCT03606473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25029004|NCT03606369|Ondansetron|ondansetron|mesh-list
25029005|NCT03606369|Palonosetron|palonosetron|mesh-list
25029006|NCT03606369|Antiemetics|antiemetics|mesh-ancestor
24487610|NCT00464191|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24487611|NCT00464191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24487612|NCT00464191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24487613|NCT00464191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487614|NCT00464191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24487615|NCT00464191|Serotonin Agents|serotonin agents|mesh-ancestor
24487616|NCT00464191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487633|NCT00464256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487635|NCT00464256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25029026|NCT03606174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029027|NCT03606174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24732993|NCT01642771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25029028|NCT03606174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985901|NCT02556606|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25029048|NCT03606057|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25029049|NCT03606057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25029050|NCT03606057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25029052|NCT03606018|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25029053|NCT03606018|Insulin Lispro|insulin lispro|mesh-list
25029054|NCT03606018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25029055|NCT03606018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691595|NCT01988090|Vitamin D|vitamin d|mesh-list
25691596|NCT01988090|Ergocalciferols|ergocalciferols|mesh-list
25691597|NCT01988090|Cholecalciferol|cholecalciferol|mesh-list
25691598|NCT01988090|Vitamins|vitamins|mesh-list
25691599|NCT01988090|Micronutrients|micronutrients|mesh-ancestor
25691600|NCT01988090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691601|NCT01988090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25691602|NCT01988090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25691603|NCT01988103|Thalidomide|thalidomide|mesh-list
25691604|NCT01988103|Apremilast|apremilast|mesh-list
25691605|NCT01988103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25691606|NCT01988103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25691607|NCT01988103|Analgesics|analgesics|mesh-ancestor
25691608|NCT01988103|Sensory System Agents|sensory system agents|mesh-ancestor
24861670|NCT02319343|Glucocorticoids|glucocorticoids|mesh-ancestor
25029057|NCT03605940|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25029058|NCT03605940|Dermatologic Agents|dermatologic agents|mesh-ancestor
25029059|NCT03605758|Ivermectin|ivermectin|mesh-list
25029060|NCT03605758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25029061|NCT03605758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25029076|NCT03605589|Pembrolizumab|pembrolizumab|mesh-list
25029077|NCT03605589|Blinatumomab|blinatumomab|mesh-list
25029078|NCT03605589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25029079|NCT03605589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029080|NCT03605537|Mometasone Furoate|mometasone furoate|mesh-list
24988264|NCT03615664|Hormones|hormones|mesh-ancestor
24487710|NCT00464594|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24487733|NCT00464789|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24415111|NCT00199069|Autonomic Agents|autonomic agents|mesh-ancestor
24487734|NCT00464789|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24487735|NCT00464789|Hormone Antagonists|hormone antagonists|mesh-ancestor
24487736|NCT00464789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24487737|NCT00464854|Insulin Aspart|insulin aspart|mesh-list
24487738|NCT00464854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24487739|NCT00464854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487740|NCT00464893|Catumaxomab|catumaxomab|mesh-list
24487750|NCT00464919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487751|NCT00464919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24487752|NCT00464919|Antimetabolites|antimetabolites|mesh-ancestor
24487753|NCT00464932|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
24733172|NCT01643759|Buprenorphine|buprenorphine|mesh-list
25029081|NCT03605537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25029082|NCT03605537|Dermatologic Agents|dermatologic agents|mesh-ancestor
25029083|NCT03605537|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25029084|NCT03605511|Complement System Proteins|complement system proteins|mesh-list
25029085|NCT03605511|Immunologic Factors|immunologic factors|mesh-ancestor
25029086|NCT03605511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029087|NCT03605433|Rivaroxaban|rivaroxaban|mesh-list
25029088|NCT03605433|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25029089|NCT03605433|Antithrombins|antithrombins|mesh-ancestor
25029090|NCT03605433|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25029091|NCT03605433|Protease Inhibitors|protease inhibitors|mesh-ancestor
25029092|NCT03605433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594777|NCT00935506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25113075|NCT03587311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113076|NCT03587311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25113077|NCT03587311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25113078|NCT03587311|Growth Substances|growth substances|mesh-ancestor
25113079|NCT03587311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25113080|NCT03587311|Growth Inhibitors|growth inhibitors|mesh-ancestor
24594835|NCT00935571|Narcotics|narcotics|mesh-ancestor
24594879|NCT00935805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25113088|NCT03565900|Immunologic Factors|immunologic factors|mesh-ancestor
25113089|NCT03565900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25113091|NCT03546582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25113092|NCT03546582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25113093|NCT03517969|Carboplatin|carboplatin|mesh-list
25113094|NCT03517969|Docetaxel|docetaxel|mesh-list
25113095|NCT03517969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796821|NCT01952626|Ondansetron|ondansetron|mesh-list
24487754|NCT00464932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24487755|NCT00464932|Vasodilator Agents|vasodilator agents|mesh-ancestor
24487756|NCT00464932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24487757|NCT00464932|Protective Agents|protective agents|mesh-ancestor
24487758|NCT00464932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487759|NCT00464958|Tizanidine|tizanidine|mesh-list
24487760|NCT00464958|Analgesics|analgesics|mesh-ancestor
24487761|NCT00464958|Sensory System Agents|sensory system agents|mesh-ancestor
25691609|NCT01988103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24487762|NCT00464958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25691610|NCT01988103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691611|NCT01988103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25691612|NCT01988103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25691613|NCT01988103|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25691614|NCT01988103|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25691615|NCT01988103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24861989|NCT02321839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24861990|NCT02321839|Growth Substances|growth substances|mesh-ancestor
24861991|NCT02321839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861992|NCT02321839|Growth Inhibitors|growth inhibitors|mesh-ancestor
24487763|NCT00464958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487764|NCT00464958|Anticonvulsants|anticonvulsants|mesh-ancestor
24487765|NCT00464958|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25113097|NCT03517969|Antimitotic Agents|antimitotic agents|mesh-ancestor
25113098|NCT03517969|Mitosis Modulators|mitosis modulators|mesh-ancestor
25113099|NCT03517969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113105|NCT03511625|Methylprednisolone|methylprednisolone|mesh-list
25113106|NCT03511625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25113107|NCT03511625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25113109|NCT03511625|Prednisolone acetate|prednisolone acetate|mesh-list
25113110|NCT03511625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25113111|NCT03511625|Prednisolone phosphate|prednisolone phosphate|mesh-list
25113112|NCT03511625|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25113120|NCT03511625|Hormones|hormones|mesh-ancestor
25113121|NCT03511625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25113122|NCT03511625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25113123|NCT03511625|Protective Agents|protective agents|mesh-ancestor
25113124|NCT03511625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25113125|NCT03511625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029157|NCT03604627|Calcium|calcium|mesh-list
25029158|NCT03604627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25029159|NCT03604627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029160|NCT03604575|Insulin|insulin|mesh-list
25029161|NCT03604575|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25029162|NCT03604575|Insulin Lispro|insulin lispro|mesh-list
25029163|NCT03604575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25029164|NCT03604575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029165|NCT03604471|Atorvastatin|atorvastatin|mesh-list
25029166|NCT03604471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25029167|NCT03604471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25029168|NCT03604471|Antimetabolites|antimetabolites|mesh-ancestor
25029169|NCT03604471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029170|NCT03604471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25029171|NCT03604471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25029172|NCT03604471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25029173|NCT03604419|Metformin|metformin|mesh-list
25029174|NCT03604419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25029175|NCT03604419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029176|NCT03604354|Pregabalin|pregabalin|mesh-list
25029177|NCT03604354|Tapentadol|tapentadol|mesh-list
25029178|NCT03604354|Analgesics|analgesics|mesh-ancestor
25029179|NCT03604354|Sensory System Agents|sensory system agents|mesh-ancestor
25029180|NCT03604354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25029216|NCT03604016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25029217|NCT03604016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25029218|NCT03604016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25029219|NCT03604016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029220|NCT03604016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25029221|NCT03604016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25029222|NCT03604003|Losartan|losartan|mesh-list
25029223|NCT03604003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25029224|NCT03604003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25029225|NCT03604003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25029226|NCT03604003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25029227|NCT03604003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029228|NCT03603938|Losartan|losartan|mesh-list
25029229|NCT03603938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25029230|NCT03603938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25029231|NCT03603938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25029232|NCT03603938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25029233|NCT03603938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029251|NCT03603834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25029252|NCT03603834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25029253|NCT03603834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25029254|NCT03603834|Antidotes|antidotes|mesh-ancestor
25691616|NCT01988103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691617|NCT01988103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25691618|NCT01988103|Immunologic Factors|immunologic factors|mesh-ancestor
24544516|NCT00689208|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24814023|NCT02061800|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24814024|NCT02061800|Protective Agents|protective agents|mesh-ancestor
24814025|NCT02061800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24814026|NCT02061800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24814027|NCT02061878|Bexarotene|bexarotene|mesh-list
24546091|NCT00696644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24546093|NCT00696722|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24546094|NCT00696722|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24875495|NCT04156334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24875504|NCT04116320|Poly ICLC|poly iclc|mesh-list
25029255|NCT03603834|Protective Agents|protective agents|mesh-ancestor
25029256|NCT03603834|Vitamin B Complex|vitamin b complex|mesh-ancestor
25029257|NCT03603834|Vitamins|vitamins|mesh-ancestor
25029258|NCT03603834|Micronutrients|micronutrients|mesh-ancestor
25029259|NCT03603756|Paclitaxel|paclitaxel|mesh-list
25029260|NCT03603756|Irinotecan|irinotecan|mesh-list
25029261|NCT03603756|Apatinib|apatinib|mesh-list
25029262|NCT03603756|Nedaplatin|nedaplatin|mesh-list
25029263|NCT03603756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25029264|NCT03603756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487766|NCT00464958|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24487767|NCT00464958|Parasympatholytics|parasympatholytics|mesh-ancestor
24487768|NCT00464958|Autonomic Agents|autonomic agents|mesh-ancestor
24487769|NCT00464958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24487770|NCT00464958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24487772|NCT00464958|Adrenergic Agents|adrenergic agents|mesh-ancestor
24487773|NCT00464958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24487774|NCT00464958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029265|NCT03603756|Tubulin Modulators|tubulin modulators|mesh-ancestor
25029266|NCT03603756|Antimitotic Agents|antimitotic agents|mesh-ancestor
25029267|NCT03603756|Mitosis Modulators|mitosis modulators|mesh-ancestor
25029268|NCT03603756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029269|NCT03603756|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25029270|NCT03603756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25029271|NCT03603756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25029272|NCT03603756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25029273|NCT03603626|Pregabalin|pregabalin|mesh-list
25029274|NCT03603626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029275|NCT03603626|Analgesics|analgesics|mesh-ancestor
25029276|NCT03603626|Sensory System Agents|sensory system agents|mesh-ancestor
25029277|NCT03603626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25029278|NCT03603626|Anticonvulsants|anticonvulsants|mesh-ancestor
25029279|NCT03603626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25029280|NCT03603626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25029281|NCT03603626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617417|NCT01043172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617418|NCT01043172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029282|NCT03603626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25029283|NCT03603626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25029284|NCT03603626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25029285|NCT03603626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25029286|NCT03603626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25029287|NCT03603548|Tacrolimus|tacrolimus|mesh-list
25029288|NCT03603548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25029289|NCT03603548|Immunologic Factors|immunologic factors|mesh-ancestor
25029290|NCT03603548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029291|NCT03603548|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25029292|NCT03603548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25029293|NCT03603548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029294|NCT03603418|Dexamethasone|dexamethasone|mesh-list
24487849|NCT00465257|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24487850|NCT00465257|Anthelmintics|anthelmintics|mesh-ancestor
25691619|NCT01988103|Leprostatic Agents|leprostatic agents|mesh-ancestor
25691620|NCT01988103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25691621|NCT01988103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25691622|NCT01988103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25691623|NCT01988103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25691624|NCT01988103|Growth Substances|growth substances|mesh-ancestor
25691625|NCT01988103|Growth Inhibitors|growth inhibitors|mesh-ancestor
25691626|NCT01988103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25691627|NCT01988246|Aflibercept|aflibercept|mesh-list
25691628|NCT01988246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25691629|NCT01988246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25691630|NCT01988246|Growth Substances|growth substances|mesh-ancestor
25691631|NCT01988246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814398|NCT02064465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24814399|NCT02064465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24814400|NCT02064465|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24814401|NCT02064491|Paclitaxel|paclitaxel|mesh-list
24487852|NCT00465283|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24487853|NCT00465283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487854|NCT00465283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487948|NCT00465907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487950|NCT00465907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24487951|NCT00465907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487953|NCT00466063|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24487954|NCT00466063|Chelating Agents|chelating agents|mesh-ancestor
24487955|NCT00466063|Sequestering Agents|sequestering agents|mesh-ancestor
24595074|NCT00936767|Antiviral Agents|antiviral agents|mesh-ancestor
25029302|NCT03603418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029303|NCT03603418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25029306|NCT03603418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25029307|NCT03603418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25029308|NCT03603418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029309|NCT03603418|Protease Inhibitors|protease inhibitors|mesh-ancestor
25029310|NCT03603418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25029311|NCT03603418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029312|NCT03603366|Aspirin|aspirin|mesh-list
25029313|NCT03603366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25029314|NCT03603366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25029315|NCT03603366|Analgesics|analgesics|mesh-ancestor
25029332|NCT03603119|Dexamethasone|dexamethasone|mesh-list
25029333|NCT03603119|Midazolam|midazolam|mesh-list
25029334|NCT03603119|Ondansetron|ondansetron|mesh-list
25029345|NCT03603119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029346|NCT03603119|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25029347|NCT03603119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25029348|NCT03603119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25029349|NCT03603119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25029350|NCT03603119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25029351|NCT03603119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25029352|NCT03603119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25029353|NCT03603119|Anesthetics, General|anesthetics, general|mesh-ancestor
25029354|NCT03603119|Anesthetics|anesthetics|mesh-ancestor
25029355|NCT03603119|GABA Modulators|gaba modulators|mesh-ancestor
25029356|NCT03603119|GABA Agents|gaba agents|mesh-ancestor
25029357|NCT03603119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25019774|NCT03688191|Sirolimus|sirolimus|mesh-list
24587885|NCT00898287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587886|NCT00898417|Paclitaxel|paclitaxel|mesh-list
24587887|NCT00898417|Bevacizumab|bevacizumab|mesh-list
24587888|NCT00898417|Carboplatin|carboplatin|mesh-list
24587895|NCT00898417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24587897|NCT00898417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24587898|NCT00898417|Growth Substances|growth substances|mesh-ancestor
24587899|NCT00898417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587900|NCT00898417|Growth Inhibitors|growth inhibitors|mesh-ancestor
24587902|NCT00898508|Immunologic Factors|immunologic factors|mesh-ancestor
24587903|NCT00898508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587904|NCT00898534|Chrysarobin|chrysarobin|mesh-list
24587905|NCT00898534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24587906|NCT00898534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24733886|NCT01649284|Afatinib|afatinib|mesh-list
24587907|NCT00898534|Analgesics|analgesics|mesh-ancestor
24595209|NCT00937300|Vidarabine|vidarabine|mesh-list
25691632|NCT01988246|Growth Inhibitors|growth inhibitors|mesh-ancestor
25691633|NCT01988246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25691634|NCT01988402|Allopurinol|allopurinol|mesh-list
25691635|NCT01988402|Antimetabolites|antimetabolites|mesh-ancestor
25691636|NCT01988402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691637|NCT01988402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691638|NCT01988402|Gout Suppressants|gout suppressants|mesh-ancestor
25691639|NCT01988402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25691640|NCT01988402|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25691641|NCT01988402|Antioxidants|antioxidants|mesh-ancestor
25108631|NCT03131375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108632|NCT03131375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25108633|NCT03131375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25108634|NCT03131375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25108635|NCT03131375|Adrenergic Agents|adrenergic agents|mesh-ancestor
25108636|NCT03131375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25029377|NCT03602898|Cyclophosphamide|cyclophosphamide|mesh-list
25029379|NCT03602898|Methotrexate|methotrexate|mesh-list
24488081|NCT00466518|Hormones|hormones|mesh-ancestor
24488082|NCT00466518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25029380|NCT03602898|Fludarabine|fludarabine|mesh-list
25029381|NCT03602898|Fludarabine phosphate|fludarabine phosphate|mesh-list
25029382|NCT03602898|Tacrolimus|tacrolimus|mesh-list
25029383|NCT03602898|Cyclosporins|cyclosporins|mesh-list
25029384|NCT03602898|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25029385|NCT03602898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25029386|NCT03602898|Immunologic Factors|immunologic factors|mesh-ancestor
25029387|NCT03602898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029388|NCT03602898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25029389|NCT03602898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25029390|NCT03602898|Alkylating Agents|alkylating agents|mesh-ancestor
25029391|NCT03602898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029392|NCT03602898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029393|NCT03602898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25029394|NCT03602898|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25029395|NCT03602898|Abortifacient Agents|abortifacient agents|mesh-ancestor
25029396|NCT03602898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25029397|NCT03602898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25029399|NCT03602898|Dermatologic Agents|dermatologic agents|mesh-ancestor
25029400|NCT03602898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25029401|NCT03602898|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25029430|NCT03602690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029432|NCT03602690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25029434|NCT03602690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25029435|NCT03602690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25029436|NCT03602690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25029437|NCT03602690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25029438|NCT03602690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25029439|NCT03602638|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25029440|NCT03602638|Acarbose|acarbose|mesh-list
25029441|NCT03602638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25029442|NCT03602638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029443|NCT03602638|Incretins|incretins|mesh-ancestor
25029444|NCT03602638|Hormones|hormones|mesh-ancestor
25029445|NCT03602638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25029446|NCT03602638|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25029447|NCT03602638|Protease Inhibitors|protease inhibitors|mesh-ancestor
25029448|NCT03602638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25029451|NCT03602586|Pembrolizumab|pembrolizumab|mesh-list
25029476|NCT03602508|Parasympatholytics|parasympatholytics|mesh-ancestor
25029477|NCT03602508|Autonomic Agents|autonomic agents|mesh-ancestor
25029478|NCT03602508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25029479|NCT03602469|Bupivacaine|bupivacaine|mesh-list
25029480|NCT03602469|Propofol|propofol|mesh-list
25029481|NCT03602469|Sevoflurane|sevoflurane|mesh-list
25029482|NCT03602469|Rocuronium|rocuronium|mesh-list
25029483|NCT03602469|Anesthetics, Local|anesthetics, local|mesh-ancestor
25029484|NCT03602469|Anesthetics|anesthetics|mesh-ancestor
25029485|NCT03602469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25029486|NCT03602469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029487|NCT03602469|Sensory System Agents|sensory system agents|mesh-ancestor
25029488|NCT03602469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25029489|NCT03602469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25029490|NCT03602469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25029491|NCT03602469|Anesthetics, General|anesthetics, general|mesh-ancestor
25029492|NCT03602469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25029493|NCT03602469|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25029509|NCT03602287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25691642|NCT01988402|Protective Agents|protective agents|mesh-ancestor
25691643|NCT01988402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691644|NCT01988662|Ranibizumab|ranibizumab|mesh-list
25691645|NCT01988662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25691646|NCT01988662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25691647|NCT01988662|Growth Substances|growth substances|mesh-ancestor
24870517|NCT05063851|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24870661|NCT04577690|Anesthetics|anesthetics|mesh-ancestor
24870662|NCT04577690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24870663|NCT04577690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870664|NCT04577690|Sensory System Agents|sensory system agents|mesh-ancestor
24870665|NCT04577690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24610626|NCT01004068|Fertility Agents|fertility agents|mesh-ancestor
25029510|NCT03602287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029511|NCT03602287|Sensory System Agents|sensory system agents|mesh-ancestor
25029512|NCT03602287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25029513|NCT03602287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24488083|NCT00466518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24488084|NCT00466518|Protease Inhibitors|protease inhibitors|mesh-ancestor
24488085|NCT00466518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488087|NCT00466570|Moxifloxacin|moxifloxacin|mesh-list
24488120|NCT00466609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24488121|NCT00466609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488122|NCT00466609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24488123|NCT00466609|Serotonin Agents|serotonin agents|mesh-ancestor
24488124|NCT00466609|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24488138|NCT00466791|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24488139|NCT00466791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24734181|NCT01650961|Palonosetron|palonosetron|mesh-list
24734182|NCT01650961|Antiemetics|antiemetics|mesh-ancestor
24488140|NCT00466791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24488141|NCT00466791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488143|NCT00466791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24488144|NCT00466843|Prednisone|prednisone|mesh-list
24488145|NCT00466843|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24488146|NCT00466843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24488147|NCT00466843|Glucocorticoids|glucocorticoids|mesh-ancestor
24488148|NCT00466843|Hormones|hormones|mesh-ancestor
24488149|NCT00466843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25029514|NCT03602287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25029515|NCT03602287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25029516|NCT03602287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25029517|NCT03602287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029518|NCT03602248|Methamphetamine|methamphetamine|mesh-list
25029519|NCT03602248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25029520|NCT03602248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029521|NCT03602248|Sympathomimetics|sympathomimetics|mesh-ancestor
25029522|NCT03602248|Autonomic Agents|autonomic agents|mesh-ancestor
25029523|NCT03602248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25029524|NCT03602248|Dopamine Agents|dopamine agents|mesh-ancestor
25029525|NCT03602248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25029526|NCT03602248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029527|NCT03602248|Adrenergic Agents|adrenergic agents|mesh-ancestor
25029528|NCT03602248|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25029529|NCT03602248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25029530|NCT03602248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25029531|NCT03602248|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25029532|NCT03602209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25029533|NCT03602209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25029534|NCT03602131|Gemcitabine|gemcitabine|mesh-list
25029535|NCT03602131|Busulfan|busulfan|mesh-list
25029536|NCT03602131|Cladribine|cladribine|mesh-list
25029537|NCT03602131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25029538|NCT03602131|Antimetabolites|antimetabolites|mesh-ancestor
25029539|NCT03602131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029540|NCT03602131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986388|NCT01712789|Hormones|hormones|mesh-ancestor
25029566|NCT03602027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25029567|NCT03602027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691648|NCT01988662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691649|NCT01988662|Growth Inhibitors|growth inhibitors|mesh-ancestor
25691650|NCT01988662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25691651|NCT01988779|Levofloxacin|levofloxacin|mesh-list
25691652|NCT01988779|Ofloxacin|ofloxacin|mesh-list
25691653|NCT01988779|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25691654|NCT01988779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25691655|NCT01988779|Renal Agents|renal agents|mesh-ancestor
25691656|NCT01988779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24870928|NCT02513329|Sensory System Agents|sensory system agents|mesh-ancestor
24870929|NCT02513329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24870930|NCT02297139|Dasatinib|dasatinib|mesh-list
24870931|NCT02297139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870932|NCT02297139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24870933|NCT02297139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24870934|NCT02297139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871027|NCT05163704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24871028|NCT05163704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24511060|NCT00567177|Immunologic Factors|immunologic factors|mesh-ancestor
25029568|NCT03602027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029569|NCT03602014|Droxidopa|droxidopa|mesh-list
25029570|NCT03602014|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25029571|NCT03602014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25029572|NCT03601975|Gemcitabine|gemcitabine|mesh-list
25029573|NCT03601975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029574|NCT03601975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25029575|NCT03601975|Antimetabolites|antimetabolites|mesh-ancestor
25029576|NCT03601975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029577|NCT03601975|Antiviral Agents|antiviral agents|mesh-ancestor
25029578|NCT03601975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25029579|NCT03601975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25029580|NCT03601975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25029581|NCT03601975|Immunologic Factors|immunologic factors|mesh-ancestor
25029582|NCT03601975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029583|NCT03601897|Paclitaxel|paclitaxel|mesh-list
24734183|NCT01650961|Autonomic Agents|autonomic agents|mesh-ancestor
25029584|NCT03601897|Rebastinib|rebastinib|mesh-list
25029585|NCT03601897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25029586|NCT03601897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029587|NCT03601897|Tubulin Modulators|tubulin modulators|mesh-ancestor
25029588|NCT03601897|Antimitotic Agents|antimitotic agents|mesh-ancestor
25029589|NCT03601897|Mitosis Modulators|mitosis modulators|mesh-ancestor
25029590|NCT03601897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029591|NCT03601897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25029592|NCT03601897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25029593|NCT03601871|Thalidomide|thalidomide|mesh-list
25029594|NCT03601871|Dexamethasone|dexamethasone|mesh-list
25029595|NCT03601871|Palonosetron|palonosetron|mesh-list
25029596|NCT03601871|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
25029597|NCT03601871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25029598|NCT03601871|Antiemetics|antiemetics|mesh-ancestor
25029599|NCT03601871|Autonomic Agents|autonomic agents|mesh-ancestor
24988592|NCT02323659|Antiviral Agents|antiviral agents|mesh-ancestor
24488217|NCT00467181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488218|NCT00467181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488219|NCT00467194|Sirolimus|sirolimus|mesh-list
24488220|NCT00467194|Bevacizumab|bevacizumab|mesh-list
24488221|NCT00467194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25029600|NCT03601871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25029601|NCT03601871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029602|NCT03601871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25029603|NCT03601871|Glucocorticoids|glucocorticoids|mesh-ancestor
25029605|NCT03601871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25029606|NCT03601871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25029607|NCT03601871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029608|NCT03601871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25029609|NCT03601871|Immunologic Factors|immunologic factors|mesh-ancestor
25029610|NCT03601871|Leprostatic Agents|leprostatic agents|mesh-ancestor
25029611|NCT03601871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25029612|NCT03601871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25029613|NCT03601871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25029619|NCT03601871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25404637|NCT03656536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25691657|NCT01988779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25691658|NCT01988779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25691659|NCT01988779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691660|NCT01988779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691661|NCT01988779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25691662|NCT01988779|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25691663|NCT01988779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25691664|NCT01988922|Ketamine|ketamine|mesh-list
25691665|NCT01988922|Analgesics|analgesics|mesh-ancestor
25691666|NCT01988922|Sensory System Agents|sensory system agents|mesh-ancestor
24871917|NCT03594474|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24871918|NCT03594474|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
24871919|NCT03594474|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24871920|NCT03594474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24871954|NCT03465540|Antimetabolites|antimetabolites|mesh-ancestor
24871955|NCT03465540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871956|NCT03465540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25029620|NCT03601871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029621|NCT03601741|Anti-Infective Agents|anti-infective agents|mesh-list
25029622|NCT03601741|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25029623|NCT03601624|Dexamethasone|dexamethasone|mesh-list
25029624|NCT03601624|Cyclophosphamide|cyclophosphamide|mesh-list
25029625|NCT03601624|Pomalidomide|pomalidomide|mesh-list
25029626|NCT03601624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25029627|NCT03601624|Immunologic Factors|immunologic factors|mesh-ancestor
25029628|NCT03601624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029629|NCT03601624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25029630|NCT03601624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25029631|NCT03601624|Alkylating Agents|alkylating agents|mesh-ancestor
25029652|NCT03601611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25029653|NCT03601611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029654|NCT03601611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25029655|NCT03601611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029657|NCT03601533|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25029658|NCT03601533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25029659|NCT03601533|Disinfectants|disinfectants|mesh-ancestor
25029660|NCT03601533|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25029661|NCT03601533|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25029662|NCT03601338|Bemiparin|bemiparin|mesh-list
25029663|NCT03601338|Anticoagulants|anticoagulants|mesh-ancestor
25029664|NCT03601260|Allopurinol|allopurinol|mesh-list
25029665|NCT03601260|Antimetabolites|antimetabolites|mesh-ancestor
25029666|NCT03601260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488222|NCT00467194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488223|NCT00467194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24488224|NCT00467194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24488225|NCT00467194|Growth Substances|growth substances|mesh-ancestor
24488226|NCT00467194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488227|NCT00467194|Growth Inhibitors|growth inhibitors|mesh-ancestor
24488228|NCT00467194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24488242|NCT00467207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488243|NCT00467207|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24488244|NCT00467207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24488246|NCT00467246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24488247|NCT00467246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488249|NCT00467376|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24488250|NCT00467376|Insulin Glargine|insulin glargine|mesh-list
24488251|NCT00467376|Insulin glulisine|insulin glulisine|mesh-list
24488252|NCT00467376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24488253|NCT00467376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488254|NCT00467454|Naltrexone|naltrexone|mesh-list
24488255|NCT00467454|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24488256|NCT00467454|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24488257|NCT00467454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488258|NCT00467454|Sensory System Agents|sensory system agents|mesh-ancestor
24446907|NCT00306475|Antimanic Agents|antimanic agents|mesh-ancestor
24488291|NCT00467571|Clarithromycin|clarithromycin|mesh-list
24488292|NCT00467571|Lansoprazole|lansoprazole|mesh-list
24488293|NCT00467571|Dexlansoprazole|dexlansoprazole|mesh-list
24488301|NCT00467571|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24488322|NCT00467883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24488323|NCT00467883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24488324|NCT00467883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25691667|NCT01988922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25691668|NCT01988922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691669|NCT01988922|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25691670|NCT01988922|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25691671|NCT01988922|Anesthetics, General|anesthetics, general|mesh-ancestor
25691672|NCT01988922|Anesthetics|anesthetics|mesh-ancestor
25691673|NCT01988922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24488325|NCT00467883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24872662|NCT05293249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24872741|NCT05232461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24872742|NCT05232461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24886138|NCT02997358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24876322|NCT03597568|Antioxidants|antioxidants|mesh-ancestor
24488326|NCT00467883|Antifungal Agents|antifungal agents|mesh-ancestor
24488327|NCT00467909|Micronutrients|micronutrients|mesh-list
24488354|NCT00468091|Mydriatics|mydriatics|mesh-ancestor
24488355|NCT00468091|Parasympatholytics|parasympatholytics|mesh-ancestor
24488356|NCT00468091|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25029667|NCT03601260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25029668|NCT03601260|Gout Suppressants|gout suppressants|mesh-ancestor
25029669|NCT03601260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25029670|NCT03601260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25029671|NCT03601260|Antioxidants|antioxidants|mesh-ancestor
25029672|NCT03601260|Protective Agents|protective agents|mesh-ancestor
25029673|NCT03601260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25113184|NCT03401398|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25113185|NCT03401398|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25113186|NCT03401398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25113187|NCT03377049|Acetazolamide|acetazolamide|mesh-list
25113188|NCT03377049|Anticonvulsants|anticonvulsants|mesh-ancestor
25113189|NCT03377049|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25113190|NCT03377049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488514|NCT00469131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25113191|NCT03377049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113193|NCT03377049|Natriuretic Agents|natriuretic agents|mesh-ancestor
25113194|NCT03377049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029675|NCT03601091|Dexmedetomidine|dexmedetomidine|mesh-list
25029676|NCT03601091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24488357|NCT00468091|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24488358|NCT00468091|Cholinergic Agents|cholinergic agents|mesh-ancestor
24488359|NCT00468091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24488360|NCT00468091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488361|NCT00468182|Interferons|interferons|mesh-list
24488362|NCT00468182|Interferon-beta|interferon-beta|mesh-list
24488363|NCT00468182|Interferon beta-1b|interferon beta-1b|mesh-list
24488364|NCT00468182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488365|NCT00468182|Antiviral Agents|antiviral agents|mesh-ancestor
24488366|NCT00468182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24488373|NCT00468234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25029677|NCT03601091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25029678|NCT03601091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029679|NCT03601091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25029680|NCT03601091|Analgesics|analgesics|mesh-ancestor
25029681|NCT03601091|Sensory System Agents|sensory system agents|mesh-ancestor
25029682|NCT03601091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25029683|NCT03601091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25029684|NCT03601091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25029685|NCT03601091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25029686|NCT03601091|Adrenergic Agents|adrenergic agents|mesh-ancestor
25029687|NCT03601091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25029688|NCT03601091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029689|NCT03601091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25029690|NCT03601091|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25029691|NCT03601091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25029698|NCT03600974|Domperidone|domperidone|mesh-list
25029701|NCT03600974|Omeprazole|omeprazole|mesh-list
25029702|NCT03600974|Rabeprazole|rabeprazole|mesh-list
25029703|NCT03600974|Pantoprazole|pantoprazole|mesh-list
25691674|NCT01988922|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25691675|NCT01988922|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25691676|NCT01988922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25691677|NCT01988922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691678|NCT01989156|Menthol|menthol|mesh-list
25691679|NCT01989156|Antipruritics|antipruritics|mesh-ancestor
25691680|NCT01989156|Dermatologic Agents|dermatologic agents|mesh-ancestor
25691681|NCT01989169|Midazolam|midazolam|mesh-list
25029704|NCT03600974|Lansoprazole|lansoprazole|mesh-list
25029705|NCT03600974|Mosapride|mosapride|mesh-list
25691682|NCT01989169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24876471|NCT03512756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24876472|NCT03512756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24876473|NCT03512756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24876474|NCT03512756|Antifungal Agents|antifungal agents|mesh-ancestor
24876475|NCT03512756|Anticonvulsants|anticonvulsants|mesh-ancestor
24876476|NCT03512756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24876477|NCT03512756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25029706|NCT03600974|Neurotransmitter Agents|neurotransmitter agents|mesh-list
25029707|NCT03600974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25029708|NCT03600974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25029709|NCT03600974|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25029710|NCT03600974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25029711|NCT03600974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029712|NCT03600974|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25029713|NCT03600974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25029714|NCT03600974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25029720|NCT03600974|Autonomic Agents|autonomic agents|mesh-ancestor
25029721|NCT03600974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25029722|NCT03600974|Antiemetics|antiemetics|mesh-ancestor
25029723|NCT03600974|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25029724|NCT03600974|Dopamine Agents|dopamine agents|mesh-ancestor
25029725|NCT03600974|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25029726|NCT03600961|Sirolimus|sirolimus|mesh-list
25029735|NCT03600948|Sirolimus|sirolimus|mesh-list
25029736|NCT03600948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25029737|NCT03600948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25029738|NCT03600948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25029739|NCT03600948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029740|NCT03600948|Antifungal Agents|antifungal agents|mesh-ancestor
25029741|NCT03600948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25029742|NCT03600948|Immunologic Factors|immunologic factors|mesh-ancestor
25029743|NCT03600948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029744|NCT03600870|Midodrine|midodrine|mesh-list
25029745|NCT03600870|Sympathomimetics|sympathomimetics|mesh-ancestor
25029746|NCT03600870|Autonomic Agents|autonomic agents|mesh-ancestor
25029747|NCT03600870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25029748|NCT03600870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445274|NCT00301054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488480|NCT00468923|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24488482|NCT00468923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24488483|NCT00468923|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24488484|NCT00468923|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24488513|NCT00469131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24488517|NCT00469131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488518|NCT00469131|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24488519|NCT00469131|Antitubercular Agents|antitubercular agents|mesh-ancestor
24488520|NCT00469131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24488521|NCT00469131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25029750|NCT03600870|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25029751|NCT03600870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25029752|NCT03600870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25029753|NCT03600870|Adrenergic Agents|adrenergic agents|mesh-ancestor
25029754|NCT03600870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25029755|NCT03600870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029756|NCT03600857|Misoprostol|misoprostol|mesh-list
25029757|NCT03600857|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25029758|NCT03600857|Abortifacient Agents|abortifacient agents|mesh-ancestor
25029759|NCT03600857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25029760|NCT03600857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029771|NCT03600766|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25029772|NCT03600766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25029773|NCT03600766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24986686|NCT05188833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25029774|NCT03600766|Adrenergic Agents|adrenergic agents|mesh-ancestor
25029775|NCT03600766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25404638|NCT03656536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25691683|NCT01989169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25691684|NCT01989169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25691685|NCT01989169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691686|NCT01989169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25691687|NCT01989169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25691688|NCT01989169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25691689|NCT01989169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24875751|NCT03878095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25691690|NCT01989169|Anesthetics, General|anesthetics, general|mesh-ancestor
25691691|NCT01989169|Anesthetics|anesthetics|mesh-ancestor
25691692|NCT01989169|GABA Modulators|gaba modulators|mesh-ancestor
24875752|NCT03878095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24876274|NCT03623750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511606|NCT00569816|Sevoflurane|sevoflurane|mesh-list
24876275|NCT03623750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029776|NCT03600766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029777|NCT03600766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029778|NCT03600766|Urological Agents|urological agents|mesh-ancestor
25029779|NCT03600727|Dexmedetomidine|dexmedetomidine|mesh-list
24735402|NCT01656811|Autonomic Agents|autonomic agents|mesh-ancestor
25029781|NCT03600727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25029782|NCT03600727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25029783|NCT03600727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029784|NCT03600727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25029785|NCT03600727|Anesthetics, General|anesthetics, general|mesh-ancestor
25029787|NCT03600727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25029788|NCT03600727|Analgesics|analgesics|mesh-ancestor
25029789|NCT03600727|Sensory System Agents|sensory system agents|mesh-ancestor
25029790|NCT03600727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25029815|NCT03600623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25029816|NCT03600623|Immunologic Factors|immunologic factors|mesh-ancestor
25029817|NCT03600623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029818|NCT03600623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25029819|NCT03600623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25029820|NCT03600506|Dexmedetomidine|dexmedetomidine|mesh-list
25029821|NCT03600506|Sympatholytics|sympatholytics|mesh-list
25029822|NCT03600506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24988749|NCT00867178|Vitamin A|vitamin a|mesh-list
24488556|NCT00469352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24488557|NCT00469352|Growth Substances|growth substances|mesh-ancestor
24488561|NCT00469404|Buprenorphine|buprenorphine|mesh-list
24488590|NCT00469443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029823|NCT03600506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25029824|NCT03600506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029825|NCT03600506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25029827|NCT03600506|Sensory System Agents|sensory system agents|mesh-ancestor
25029828|NCT03600506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25029829|NCT03600506|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25029830|NCT03600506|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25029832|NCT03600506|Adrenergic Agents|adrenergic agents|mesh-ancestor
25029833|NCT03600506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25029834|NCT03600506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029835|NCT03600506|Autonomic Agents|autonomic agents|mesh-ancestor
25029837|NCT03600493|Dexmedetomidine|dexmedetomidine|mesh-list
25029838|NCT03600493|Anesthetics, Local|anesthetics, local|mesh-ancestor
25029839|NCT03600493|Anesthetics|anesthetics|mesh-ancestor
25029840|NCT03600493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25029841|NCT03600493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029861|NCT03600467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029862|NCT03600454|Anesthetics|anesthetics|mesh-list
25691693|NCT01989169|GABA Agents|gaba agents|mesh-ancestor
25691694|NCT01989169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25691695|NCT01989169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691696|NCT01989195|Manganese|manganese|mesh-list
25691697|NCT01989195|Trace Elements|trace elements|mesh-ancestor
25691698|NCT01989195|Micronutrients|micronutrients|mesh-ancestor
24815446|NCT02070406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815447|NCT02070406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24815448|NCT02070406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24815449|NCT02070406|Alkylating Agents|alkylating agents|mesh-ancestor
24815450|NCT02070406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815451|NCT02070406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815452|NCT02070406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24815453|NCT02070406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24815454|NCT02070406|Antimetabolites|antimetabolites|mesh-ancestor
24815455|NCT02070406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24815456|NCT02070406|Analgesics|analgesics|mesh-ancestor
24815490|NCT02070510|Lisinopril|lisinopril|mesh-list
25029863|NCT03600454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25029864|NCT03600454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029869|NCT03600363|Metformin|metformin|mesh-list
25029870|NCT03600363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25029871|NCT03600363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029872|NCT03600311|Vitamin D|vitamin d|mesh-list
24488591|NCT00469443|Growth Inhibitors|growth inhibitors|mesh-ancestor
24488593|NCT00469443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488594|NCT00469443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24488595|NCT00469443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24488596|NCT00469443|Immunologic Factors|immunologic factors|mesh-ancestor
24488597|NCT00469443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24488598|NCT00469443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24488599|NCT00469443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488600|NCT00469443|Antidotes|antidotes|mesh-ancestor
24488601|NCT00469443|Protective Agents|protective agents|mesh-ancestor
24488602|NCT00469443|Vitamin B Complex|vitamin b complex|mesh-ancestor
24488603|NCT00469443|Vitamins|vitamins|mesh-ancestor
25029873|NCT03600311|Calcium|calcium|mesh-list
25029874|NCT03600311|Vitamins|vitamins|mesh-ancestor
25029875|NCT03600311|Micronutrients|micronutrients|mesh-ancestor
25029876|NCT03600311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029877|NCT03600311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25029878|NCT03600311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25029879|NCT03600155|Nivolumab|nivolumab|mesh-list
25029880|NCT03600155|Ipilimumab|ipilimumab|mesh-list
25029881|NCT03600155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25029882|NCT03600155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029883|NCT03600155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25029884|NCT03600155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029885|NCT03600129|Ropivacaine|ropivacaine|mesh-list
25029886|NCT03600129|Anesthetics, Local|anesthetics, local|mesh-ancestor
25029887|NCT03600129|Anesthetics|anesthetics|mesh-ancestor
25029888|NCT03600129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25029889|NCT03600129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25029890|NCT03600129|Sensory System Agents|sensory system agents|mesh-ancestor
25029891|NCT03600129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25029892|NCT03600064|Misoprostol|misoprostol|mesh-list
25029893|NCT03600064|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25029906|NCT03599778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25029907|NCT03599778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029908|NCT03599726|Donepezil|donepezil|mesh-list
24488606|NCT00469469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24488622|NCT00469547|Dermatologic Agents|dermatologic agents|mesh-ancestor
24488623|NCT00469560|Deferasirox|deferasirox|mesh-list
24488624|NCT00469560|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24488625|NCT00469560|Chelating Agents|chelating agents|mesh-ancestor
24488678|NCT00469703|Growth Inhibitors|growth inhibitors|mesh-ancestor
25029918|NCT03599609|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25029919|NCT03599609|Antimetabolites|antimetabolites|mesh-ancestor
25691699|NCT01989195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691700|NCT01989208|Sodium sulfate|sodium sulfate|mesh-list
25691701|NCT01989208|Cathartics|cathartics|mesh-ancestor
25691702|NCT01989208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25691703|NCT01989221|Granisetron|granisetron|mesh-list
25691704|NCT01989221|Antiemetics|antiemetics|mesh-ancestor
25691705|NCT01989221|Autonomic Agents|autonomic agents|mesh-ancestor
25691706|NCT01989221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25691707|NCT01989221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691708|NCT01989221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25691709|NCT01989221|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25691710|NCT01989221|Serotonin Agents|serotonin agents|mesh-ancestor
25691711|NCT01989221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24880394|NCT03799835|Atezolizumab|atezolizumab|mesh-list
25029920|NCT03599609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029921|NCT03599609|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25029922|NCT03599609|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25029923|NCT03599609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25029924|NCT03599596|Pyrimethamine|pyrimethamine|mesh-list
25029925|NCT03599596|Sulfadoxine|sulfadoxine|mesh-list
25029926|NCT03599596|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25029927|NCT03599596|Antimalarials|antimalarials|mesh-ancestor
25029928|NCT03599596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25029929|NCT03599596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25029930|NCT03599596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25029931|NCT03599596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25029932|NCT03599596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420845|NCT00216892|Glucocorticoids|glucocorticoids|mesh-ancestor
25029933|NCT03599596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029934|NCT03599596|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25029935|NCT03599596|Renal Agents|renal agents|mesh-ancestor
25029937|NCT03599518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029938|NCT03599518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25029939|NCT03599518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25029940|NCT03599518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029941|NCT03599466|Lisinopril|lisinopril|mesh-list
25029942|NCT03599466|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25029943|NCT03599466|Protease Inhibitors|protease inhibitors|mesh-ancestor
25029944|NCT03599466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25029945|NCT03599466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029946|NCT03599466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24488680|NCT00469716|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24488681|NCT00469716|Plasma Substitutes|plasma substitutes|mesh-ancestor
24488682|NCT00469716|Blood Substitutes|blood substitutes|mesh-ancestor
24445402|NCT00301522|Paclitaxel|paclitaxel|mesh-list
25029947|NCT03599466|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25029948|NCT03599466|Protective Agents|protective agents|mesh-ancestor
25029949|NCT03599466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595806|NCT00940628|Orlistat|orlistat|mesh-list
25029986|NCT03599427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25029987|NCT03599427|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25029988|NCT03599427|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25029989|NCT03599427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25029990|NCT03599427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113208|NCT03245151|Everolimus|everolimus|mesh-list
25113209|NCT03245151|Lenvatinib|lenvatinib|mesh-list
25113211|NCT03245151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25113212|NCT03245151|Immunologic Factors|immunologic factors|mesh-ancestor
25113213|NCT03245151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25113214|NCT03245151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25113215|NCT03245151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25113216|NCT03245151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113217|NCT03240211|Pembrolizumab|pembrolizumab|mesh-list
25113218|NCT03240211|Decitabine|decitabine|mesh-list
24886735|NCT04523506|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24886736|NCT04523506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24886737|NCT04523506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886738|NCT04523506|Cholinergic Agents|cholinergic agents|mesh-ancestor
24886739|NCT04523506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24886740|NCT04523506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886741|NCT04523233|Vitamins|vitamins|mesh-list
24886742|NCT04523233|Micronutrients|micronutrients|mesh-ancestor
24886743|NCT04523233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886744|NCT04523272|Sunitinib|sunitinib|mesh-list
24886745|NCT04523272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886746|NCT04523272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24887154|NCT04519710|Rituximab|rituximab|mesh-list
24488725|NCT00469781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24488726|NCT00469781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24488727|NCT00469781|Protective Agents|protective agents|mesh-ancestor
24488728|NCT00469781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24488729|NCT00469781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488730|NCT00469846|Ascorbic Acid|ascorbic acid|mesh-list
24488731|NCT00469846|Vitamins|vitamins|mesh-ancestor
24488732|NCT00469846|Micronutrients|micronutrients|mesh-ancestor
24488733|NCT00469846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488734|NCT00469846|Antioxidants|antioxidants|mesh-ancestor
24488735|NCT00469846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488737|NCT00469885|Nicotine|nicotine|mesh-list
24488746|NCT00469885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488747|NCT00469924|Caffeine|caffeine|mesh-list
24488748|NCT00469924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24488749|NCT00469924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488750|NCT00469924|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24488751|NCT00469924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488752|NCT00469924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488753|NCT00469924|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24488754|NCT00469924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24488764|NCT00469937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24488765|NCT00469937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488767|NCT00469976|Bevacizumab|bevacizumab|mesh-list
24488768|NCT00469976|Carboplatin|carboplatin|mesh-list
24488769|NCT00469976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24488770|NCT00469976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488771|NCT00469976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24488772|NCT00469976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24488773|NCT00469976|Growth Substances|growth substances|mesh-ancestor
25113219|NCT03240211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25113220|NCT03240211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25113221|NCT03240211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25113223|NCT03240211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595860|NCT00940719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25113231|NCT03215524|Dexamethasone|dexamethasone|mesh-list
25113232|NCT03215524|Dexamethasone acetate|dexamethasone acetate|mesh-list
25113233|NCT03215524|Cyclophosphamide|cyclophosphamide|mesh-list
25691712|NCT01989221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691713|NCT01989455|Deferiprone|deferiprone|mesh-list
25691714|NCT01989455|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25691715|NCT01989455|Chelating Agents|chelating agents|mesh-ancestor
25691716|NCT01989455|Sequestering Agents|sequestering agents|mesh-ancestor
25691717|NCT01989455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691718|NCT01989468|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25691719|NCT01989468|Immunologic Factors|immunologic factors|mesh-ancestor
25691720|NCT01989468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691721|NCT01989546|Talazoparib|talazoparib|mesh-list
25691722|NCT01989546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25691723|NCT01989546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887306|NCT04517526|Durvalumab|durvalumab|mesh-list
24887307|NCT04517526|Carboplatin|carboplatin|mesh-list
24887392|NCT04517162|Povidone|povidone|mesh-list
24887425|NCT04516655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24887426|NCT04516655|Antimetabolites|antimetabolites|mesh-ancestor
24887427|NCT04516655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887428|NCT04516655|Dermatologic Agents|dermatologic agents|mesh-ancestor
24887429|NCT04516655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887430|NCT04516655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24887431|NCT04516655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25113234|NCT03215524|Daratumumab|daratumumab|mesh-list
25113235|NCT03215524|Pomalidomide|pomalidomide|mesh-list
25113236|NCT03215524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25113238|NCT03215524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25113239|NCT03215524|Immunologic Factors|immunologic factors|mesh-ancestor
25113240|NCT03215524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25113241|NCT03215524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25113242|NCT03215524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25113243|NCT03215524|Alkylating Agents|alkylating agents|mesh-ancestor
25113244|NCT03215524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113245|NCT03215524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25113246|NCT03215524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25113247|NCT03215524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25113248|NCT03215524|Antiemetics|antiemetics|mesh-ancestor
25113249|NCT03215524|Autonomic Agents|autonomic agents|mesh-ancestor
25113250|NCT03215524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25113251|NCT03215524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25113252|NCT03215524|Glucocorticoids|glucocorticoids|mesh-ancestor
25113253|NCT03215524|Hormones|hormones|mesh-ancestor
24488799|NCT00470041|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25113255|NCT03215524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25113257|NCT03215524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25113258|NCT03215524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25113259|NCT03215524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25030007|NCT03599284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25030008|NCT03599284|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25030009|NCT03599284|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25030010|NCT03599284|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25030011|NCT03599284|Purinergic Agents|purinergic agents|mesh-ancestor
25030012|NCT03599284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25030013|NCT03599284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030014|NCT03599284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030031|NCT03598868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25030032|NCT03598868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030034|NCT03598868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25030035|NCT03598868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25030036|NCT03598868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030037|NCT03598868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25030038|NCT03598868|Serotonin Agents|serotonin agents|mesh-ancestor
25030039|NCT03598868|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25030040|NCT03598868|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25030041|NCT03598868|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24736346|NCT01661439|Tinzaparin|tinzaparin|mesh-list
25404639|NCT03656536|Antimetabolites|antimetabolites|mesh-ancestor
25691724|NCT01989546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691725|NCT01989546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25691726|NCT01989572|Sargramostim|sargramostim|mesh-list
25691727|NCT01989572|Immunologic Factors|immunologic factors|mesh-ancestor
25691728|NCT01989572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691729|NCT01989689|Etanercept|etanercept|mesh-list
25691730|NCT01989689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25691731|NCT01989689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25691732|NCT01989689|Analgesics|analgesics|mesh-ancestor
24887818|NCT04511975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24887820|NCT04511975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887821|NCT04511975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887822|NCT04511975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24465902|NCT00371033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24816641|NCT02078089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24816642|NCT02078089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816643|NCT02078089|Analgesics|analgesics|mesh-ancestor
24488774|NCT00469976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488775|NCT00469976|Growth Inhibitors|growth inhibitors|mesh-ancestor
24488776|NCT00469976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24488789|NCT00470015|Sensory System Agents|sensory system agents|mesh-ancestor
24488790|NCT00470015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24488791|NCT00470015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488792|NCT00470015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24488793|NCT00470015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24488794|NCT00470015|Antiviral Agents|antiviral agents|mesh-ancestor
24488795|NCT00470015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24488796|NCT00470041|Lamivudine|lamivudine|mesh-list
24488797|NCT00470041|Zidovudine|zidovudine|mesh-list
24488798|NCT00470041|Antiviral Agents|antiviral agents|mesh-list
25030042|NCT03598868|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25030044|NCT03598816|Tremelimumab|tremelimumab|mesh-list
25030045|NCT03598816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25030046|NCT03598816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25030047|NCT03598738|Esomeprazole|esomeprazole|mesh-list
25030048|NCT03598738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25030049|NCT03598738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25030050|NCT03598738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25030051|NCT03598738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25030052|NCT03598738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030053|NCT03598725|Prednisone|prednisone|mesh-list
25030054|NCT03598725|Rituximab|rituximab|mesh-list
25030055|NCT03598725|Factor VIII|factor viii|mesh-list
25030056|NCT03598725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25030057|NCT03598725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25030058|NCT03598725|Immunologic Factors|immunologic factors|mesh-ancestor
25030059|NCT03598725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030060|NCT03598725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25030061|NCT03598725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24488862|NCT00470340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24488889|NCT00470483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24488890|NCT00470483|Serotonin Agents|serotonin agents|mesh-ancestor
24488891|NCT00470483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488892|NCT00470483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24736734|NCT01664845|Metformin|metformin|mesh-list
24587920|NCT00898794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587952|NCT00898950|Dermatologic Agents|dermatologic agents|mesh-ancestor
24587953|NCT00899197|Tamoxifen|tamoxifen|mesh-list
24587954|NCT00899197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24587955|NCT00899197|Hormone Antagonists|hormone antagonists|mesh-ancestor
24587956|NCT00899197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25039946|NCT03571568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24488909|NCT00470522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488955|NCT00470743|Indomethacin|indomethacin|mesh-list
24488956|NCT00470743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24488957|NCT00470743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25691733|NCT01989689|Sensory System Agents|sensory system agents|mesh-ancestor
25691734|NCT01989689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25691735|NCT01989689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691736|NCT01989689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25691737|NCT01989689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25691738|NCT01989689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25691739|NCT01989689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25691740|NCT01989689|Immunologic Factors|immunologic factors|mesh-ancestor
25691741|NCT01989754|Canagliflozin|canagliflozin|mesh-list
24877778|NCT02435212|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24877779|NCT02435212|Chelating Agents|chelating agents|mesh-ancestor
24877780|NCT02435212|Sequestering Agents|sequestering agents|mesh-ancestor
24877781|NCT02435212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815579|NCT02071212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24815580|NCT02071212|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24815581|NCT02071212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24488958|NCT00470743|Analgesics|analgesics|mesh-ancestor
24488959|NCT00470743|Sensory System Agents|sensory system agents|mesh-ancestor
24488960|NCT00470743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24488961|NCT00470743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489071|NCT00471393|Analgesics|analgesics|mesh-ancestor
24489072|NCT00471393|Sensory System Agents|sensory system agents|mesh-ancestor
24489073|NCT00471393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489074|NCT00471393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489075|NCT00471393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24489076|NCT00471393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24489085|NCT00471406|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24489087|NCT00471419|Rimexolone|rimexolone|mesh-list
24489088|NCT00471419|Glucocorticoids|glucocorticoids|mesh-ancestor
24489089|NCT00471419|Hormones|hormones|mesh-ancestor
24489090|NCT00471419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24489095|NCT00471432|Antimitotic Agents|antimitotic agents|mesh-ancestor
24489096|NCT00471432|Mitosis Modulators|mitosis modulators|mesh-ancestor
24489097|NCT00471432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489098|NCT00471471|Sargramostim|sargramostim|mesh-list
24489099|NCT00471471|Immunologic Factors|immunologic factors|mesh-ancestor
24489100|NCT00471471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489101|NCT00471484|Interferons|interferons|mesh-list
24489102|NCT00471484|Interferon-alpha|interferon-alpha|mesh-list
24489103|NCT00471484|Interferon alpha-2|interferon alpha-2|mesh-list
24489104|NCT00471484|Doxorubicin|doxorubicin|mesh-list
24489105|NCT00471484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24489106|NCT00471484|Fluorouracil|fluorouracil|mesh-list
24587957|NCT00899197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587958|NCT00899197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24587960|NCT00899197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24587961|NCT00899197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24587962|NCT00899197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24587963|NCT00899483|Insulin|insulin|mesh-list
24587964|NCT00899483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24587965|NCT00899483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587966|NCT00899587|Enalapril|enalapril|mesh-list
24587967|NCT00899587|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24587981|NCT00899821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24634161|NCT01132222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24489452|NCT00473460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634163|NCT01132222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24489118|NCT00471484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489120|NCT00471484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24489125|NCT00471523|Metformin|metformin|mesh-list
24489135|NCT00471523|Fertility Agents|fertility agents|mesh-ancestor
24489136|NCT00471523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24489137|NCT00471523|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24489138|NCT00471523|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24489139|NCT00471549|Simvastatin|simvastatin|mesh-list
24489140|NCT00471549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24489141|NCT00471549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24489151|NCT00471588|Amisulpride|amisulpride|mesh-list
24489182|NCT00471653|Temozolomide|temozolomide|mesh-list
24489183|NCT00471653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24489184|NCT00471653|Alkylating Agents|alkylating agents|mesh-ancestor
24489185|NCT00471653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489186|NCT00471653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25691742|NCT01989754|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25691743|NCT01989754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691744|NCT01989754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25691745|NCT01989754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691746|NCT01989793|Losartan|losartan|mesh-list
25691747|NCT01989793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25691748|NCT01989793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24888503|NCT04503850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466470|NCT00373607|Piperaquine|piperaquine|mesh-list
24888836|NCT04500678|Metformin|metformin|mesh-list
24888839|NCT04500002|Isoniazid|isoniazid|mesh-list
24888873|NCT04499898|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24888874|NCT04499898|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24888876|NCT04499885|Emollients|emollients|mesh-ancestor
24888943|NCT04499313|Dexamethasone|dexamethasone|mesh-list
24489187|NCT00471679|Ethanol|ethanol|mesh-list
24489188|NCT00471679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24489189|NCT00471679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24489190|NCT00471679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24489191|NCT00471679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489192|NCT00471744|Levetiracetam|levetiracetam|mesh-list
24489193|NCT00471744|Sulthiame|sulthiame|mesh-list
24489194|NCT00471744|Anticonvulsants|anticonvulsants|mesh-ancestor
24489195|NCT00471744|Nootropic Agents|nootropic agents|mesh-ancestor
24489196|NCT00471783|Chlorhexidine|chlorhexidine|mesh-list
24489197|NCT00471783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24489198|NCT00471783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24489199|NCT00471783|Disinfectants|disinfectants|mesh-ancestor
24489253|NCT00471965|Antimetabolites|antimetabolites|mesh-ancestor
24489257|NCT00471965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489258|NCT00471965|Antidotes|antidotes|mesh-ancestor
24489259|NCT00471965|Protective Agents|protective agents|mesh-ancestor
24489260|NCT00471965|Vitamin B Complex|vitamin b complex|mesh-ancestor
24489261|NCT00471965|Vitamins|vitamins|mesh-ancestor
24489262|NCT00471965|Micronutrients|micronutrients|mesh-ancestor
24489263|NCT00471991|Dienogest|dienogest|mesh-list
24402359|NCT00156897|Orlistat|orlistat|mesh-list
24489264|NCT00471991|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24489265|NCT00471991|Estradiol|estradiol|mesh-list
24489266|NCT00471991|Estrogens|estrogens|mesh-ancestor
24489267|NCT00471991|Hormones|hormones|mesh-ancestor
24489268|NCT00471991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24489269|NCT00471991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489271|NCT00471991|Contraceptive Agents|contraceptive agents|mesh-ancestor
24489443|NCT00473343|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
24489444|NCT00473343|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24587983|NCT00899821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24587984|NCT00899821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24587985|NCT00899821|Growth Substances|growth substances|mesh-ancestor
24587986|NCT00899821|Growth Inhibitors|growth inhibitors|mesh-ancestor
24587988|NCT00899951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24587989|NCT00899951|Narcotics|narcotics|mesh-ancestor
24587990|NCT00899951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24587991|NCT00899951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587992|NCT00899951|Analgesics|analgesics|mesh-ancestor
24587993|NCT00899951|Sensory System Agents|sensory system agents|mesh-ancestor
24587994|NCT00899951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24587995|NCT00899951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24587996|NCT00899951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24587997|NCT00899951|Anesthetics, General|anesthetics, general|mesh-ancestor
24587998|NCT00899951|Anesthetics|anesthetics|mesh-ancestor
24588000|NCT00900172|Bevacizumab|bevacizumab|mesh-list
24588001|NCT00900172|Carboplatin|carboplatin|mesh-list
24588002|NCT00900172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24588003|NCT00900172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25030062|NCT03598725|Glucocorticoids|glucocorticoids|mesh-ancestor
25030063|NCT03598725|Hormones|hormones|mesh-ancestor
25030064|NCT03598725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24489445|NCT00473343|Dermatologic Agents|dermatologic agents|mesh-ancestor
24489446|NCT00473460|Moxifloxacin|moxifloxacin|mesh-list
24489447|NCT00473460|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24489448|NCT00473460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25691749|NCT01989793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25691750|NCT01989793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25691751|NCT01989793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691752|NCT01989910|Efavirenz|efavirenz|mesh-list
25691753|NCT01989910|Raltegravir Potassium|raltegravir potassium|mesh-list
25691754|NCT01989910|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25691755|NCT01989910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24489449|NCT00473460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24489450|NCT00473460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24489467|NCT00473486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489468|NCT00473486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24889479|NCT04493099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24889486|NCT04493073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24889487|NCT04493073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889488|NCT04492774|Dexamethasone|dexamethasone|mesh-list
24889489|NCT04492774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24889490|NCT04492774|Antiemetics|antiemetics|mesh-ancestor
24889491|NCT04492774|Autonomic Agents|autonomic agents|mesh-ancestor
24889492|NCT04492774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24889493|NCT04492774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889495|NCT04492774|Glucocorticoids|glucocorticoids|mesh-ancestor
24489469|NCT00473486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24489470|NCT00473486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24489471|NCT00473551|Vidarabine|vidarabine|mesh-list
24489472|NCT00473551|Sirolimus|sirolimus|mesh-list
24489473|NCT00473551|Cyclophosphamide|cyclophosphamide|mesh-list
24489474|NCT00473551|Rituximab|rituximab|mesh-list
24489475|NCT00473551|Fludarabine|fludarabine|mesh-list
24489476|NCT00473551|Fludarabine phosphate|fludarabine phosphate|mesh-list
24489477|NCT00473551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24489478|NCT00473551|Immunologic Factors|immunologic factors|mesh-ancestor
24489710|NCT00475059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24489711|NCT00475059|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24489712|NCT00475059|Histamine Antagonists|histamine antagonists|mesh-ancestor
24489713|NCT00475059|Histamine Agents|histamine agents|mesh-ancestor
24489714|NCT00475059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25030065|NCT03598725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25030066|NCT03598725|Coagulants|coagulants|mesh-ancestor
25030067|NCT03598673|Nebivolol|nebivolol|mesh-list
25030068|NCT03598673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25030069|NCT03598673|Vasodilator Agents|vasodilator agents|mesh-ancestor
25030070|NCT03598673|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25030071|NCT03598673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25030104|NCT03598582|Epoetin Alfa|epoetin alfa|mesh-list
24489715|NCT00475059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489716|NCT00475059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489717|NCT00475059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24489718|NCT00475059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24489719|NCT00475059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24489720|NCT00475072|Ribavirin|ribavirin|mesh-list
24489721|NCT00475072|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24489722|NCT00475072|Antimetabolites|antimetabolites|mesh-ancestor
24489724|NCT00475072|Antiviral Agents|antiviral agents|mesh-ancestor
24489745|NCT00475189|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
24489748|NCT00475189|Norethindrone|norethindrone|mesh-list
24489749|NCT00475189|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24489750|NCT00475189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24489751|NCT00475189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24489752|NCT00475189|Contraceptive Agents|contraceptive agents|mesh-ancestor
24489753|NCT00475189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24489808|NCT00475514|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24489809|NCT00475514|Serotonin Agents|serotonin agents|mesh-ancestor
24489810|NCT00475514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24489811|NCT00475514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489812|NCT00475514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489813|NCT00475527|Amoxicillin|amoxicillin|mesh-list
24489814|NCT00475527|Metronidazole|metronidazole|mesh-list
24489815|NCT00475527|Clarithromycin|clarithromycin|mesh-list
24489816|NCT00475527|Omeprazole|omeprazole|mesh-list
24489817|NCT00475527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24489818|NCT00475527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24489821|NCT00475527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24489822|NCT00475527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24489823|NCT00475527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24489824|NCT00475527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404715|NCT03653247|Antiviral Agents|antiviral agents|mesh-ancestor
25691756|NCT01989910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691757|NCT01989910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691758|NCT01989910|Antiviral Agents|antiviral agents|mesh-ancestor
25691759|NCT01989910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25691760|NCT01989910|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25691761|NCT01989910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25691762|NCT01989910|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25691763|NCT01989910|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25691764|NCT01989910|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24890517|NCT04482712|Immunologic Factors|immunologic factors|mesh-ancestor
24890518|NCT04482712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890519|NCT04482764|Valproic Acid|valproic acid|mesh-list
24890520|NCT04482764|Anticonvulsants|anticonvulsants|mesh-ancestor
24890521|NCT04482764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24890522|NCT04482764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890523|NCT04482764|GABA Agents|gaba agents|mesh-ancestor
24713105|NCT01524094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890524|NCT04482764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24890525|NCT04482764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890822|NCT04479865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890823|NCT04479865|Cholinergic Agents|cholinergic agents|mesh-ancestor
24890904|NCT04478474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24890905|NCT04478474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890980|NCT04477642|Abatacept|abatacept|mesh-list
24891009|NCT04477317|Epinephrine|epinephrine|mesh-list
24489825|NCT00475527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489826|NCT00475527|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24489827|NCT00475527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24489828|NCT00475527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24489833|NCT00475553|Desogestrel|desogestrel|mesh-list
24489867|NCT00475696|Sensory System Agents|sensory system agents|mesh-ancestor
24489868|NCT00475696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489869|NCT00475696|Antidepressive Agents|antidepressive agents|mesh-ancestor
24489878|NCT00475800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24489879|NCT00475800|Analgesics|analgesics|mesh-ancestor
25030109|NCT03598556|Micronutrients|micronutrients|mesh-ancestor
25030110|NCT03598556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030111|NCT03598556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25030112|NCT03598556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25030113|NCT03598452|Ganciclovir|ganciclovir|mesh-list
25030114|NCT03598452|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25030115|NCT03598452|Antiviral Agents|antiviral agents|mesh-ancestor
25030116|NCT03598452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25030117|NCT03598452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25030118|NCT03598452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25030119|NCT03598452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030121|NCT03598374|Vitamin B Complex|vitamin b complex|mesh-list
25030123|NCT03598374|Hematinics|hematinics|mesh-ancestor
25030124|NCT03598374|Vitamins|vitamins|mesh-ancestor
25030125|NCT03598374|Micronutrients|micronutrients|mesh-ancestor
25030126|NCT03598374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030127|NCT03598348|Capecitabine|capecitabine|mesh-list
25030128|NCT03598348|Apatinib|apatinib|mesh-list
24785167|NCT01912573|Naloxone|naloxone|mesh-list
24489889|NCT00475813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24489890|NCT00475813|Autonomic Agents|autonomic agents|mesh-ancestor
24489891|NCT00475813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489892|NCT00475813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489895|NCT00475813|Dermatologic Agents|dermatologic agents|mesh-ancestor
24489926|NCT00475956|Cediranib|cediranib|mesh-list
24489927|NCT00475956|Saracatinib|saracatinib|mesh-list
24489928|NCT00475956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489930|NCT00475956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691765|NCT01989910|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25691766|NCT01989910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25691767|NCT01989910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25691768|NCT01989910|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25691769|NCT01989910|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25691770|NCT01990261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25691771|NCT01990261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25691772|NCT01990261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25691773|NCT01990261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691774|NCT01990261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691775|NCT01990300|Pioglitazone|pioglitazone|mesh-list
25691776|NCT01990300|Alogliptin|alogliptin|mesh-list
25691777|NCT01990300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25691778|NCT01990300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691779|NCT01990300|Incretins|incretins|mesh-ancestor
25691780|NCT01990300|Hormones|hormones|mesh-ancestor
25691781|NCT01990300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25691782|NCT01990300|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24891342|NCT04473144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891343|NCT04472910|Folfirinox|folfirinox|mesh-list
24891344|NCT04472910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24891355|NCT04472585|Ivermectin|ivermectin|mesh-list
24891361|NCT04472806|Growth Substances|growth substances|mesh-ancestor
24891381|NCT04472481|Vitamins|vitamins|mesh-ancestor
24891382|NCT04472481|Micronutrients|micronutrients|mesh-ancestor
24891383|NCT04472481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24891384|NCT04471922|Rabeprazole|rabeprazole|mesh-list
24878381|NCT01854775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24815659|NCT02071459|Droxidopa|droxidopa|mesh-list
24891400|NCT04471441|Mycophenolic Acid|mycophenolic acid|mesh-list
24489932|NCT00475969|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24490149|NCT00476710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24490151|NCT00476853|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24490152|NCT00476853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24490174|NCT00476983|Ritonavir|ritonavir|mesh-list
24490181|NCT00476983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490183|NCT00476983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24490184|NCT00476983|Antiviral Agents|antiviral agents|mesh-ancestor
24490185|NCT00476983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24490186|NCT00476983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25030129|NCT03598348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25030130|NCT03598348|Antimetabolites|antimetabolites|mesh-ancestor
25030131|NCT03598348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030132|NCT03598348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25030133|NCT03598348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25030134|NCT03598348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25030135|NCT03598192|Sufentanil|sufentanil|mesh-list
25030136|NCT03598192|Dsuvia|dsuvia|mesh-list
25030137|NCT03598192|Ropivacaine|ropivacaine|mesh-list
25030138|NCT03598192|Anesthetics, Local|anesthetics, local|mesh-ancestor
25030139|NCT03598192|Anesthetics|anesthetics|mesh-ancestor
25030140|NCT03598192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25030141|NCT03598192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030142|NCT03598192|Sensory System Agents|sensory system agents|mesh-ancestor
25030143|NCT03598192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25030144|NCT03598192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25030145|NCT03598192|Narcotics|narcotics|mesh-ancestor
25030146|NCT03598192|Analgesics|analgesics|mesh-ancestor
24490187|NCT00476983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24490188|NCT00476983|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24490189|NCT00476983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24490190|NCT00477035|Gemcitabine|gemcitabine|mesh-list
24490191|NCT00477035|Cyclophosphamide|cyclophosphamide|mesh-list
24490193|NCT00477035|Carmustine|carmustine|mesh-list
24490194|NCT00477035|Etoposide|etoposide|mesh-list
24490195|NCT00477035|Vinorelbine|vinorelbine|mesh-list
24490196|NCT00477035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24490197|NCT00477035|Immunologic Factors|immunologic factors|mesh-ancestor
24490198|NCT00477035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490199|NCT00477035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24490200|NCT00477035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24490201|NCT00477035|Alkylating Agents|alkylating agents|mesh-ancestor
24490277|NCT00477503|Antidotes|antidotes|mesh-ancestor
24490399|NCT00477984|Ethanol|ethanol|mesh-list
24490400|NCT00477984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24490401|NCT00477984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24490402|NCT00477984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24490403|NCT00477984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490404|NCT00477997|Hormones|hormones|mesh-list
24490405|NCT00477997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24490406|NCT00477997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490407|NCT00478049|Docetaxel|docetaxel|mesh-list
24490408|NCT00478049|Gefitinib|gefitinib|mesh-list
24490409|NCT00478049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25691783|NCT01990300|Protease Inhibitors|protease inhibitors|mesh-ancestor
25691784|NCT01990300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691785|NCT01990300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691786|NCT01990339|Lansoprazole|lansoprazole|mesh-list
25691787|NCT01990339|Dexlansoprazole|dexlansoprazole|mesh-list
25691788|NCT01990339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25691789|NCT01990339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25691790|NCT01990339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25691791|NCT01990339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691792|NCT01990339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691793|NCT01990534|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24891628|NCT04468711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24490423|NCT00478075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490424|NCT00478101|Fentanyl|fentanyl|mesh-list
24490425|NCT00478101|Oxycodone|oxycodone|mesh-list
24490426|NCT00478101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24490427|NCT00478101|Narcotics|narcotics|mesh-ancestor
24490428|NCT00478101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24490429|NCT00478101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490430|NCT00478101|Analgesics|analgesics|mesh-ancestor
24490431|NCT00478101|Sensory System Agents|sensory system agents|mesh-ancestor
24490432|NCT00478101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24490433|NCT00478101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24490518|NCT00478699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490519|NCT00478699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24490520|NCT00478699|Immunologic Factors|immunologic factors|mesh-ancestor
25030152|NCT03598075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030153|NCT03597997|Propofol|propofol|mesh-list
25030154|NCT03597997|Sevoflurane|sevoflurane|mesh-list
25030155|NCT03597997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25030156|NCT03597997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25030157|NCT03597997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030158|NCT03597997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25030159|NCT03597997|Anesthetics, General|anesthetics, general|mesh-ancestor
25030160|NCT03597997|Anesthetics|anesthetics|mesh-ancestor
25030161|NCT03597997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25030162|NCT03597997|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25030163|NCT03597945|Lidocaine|lidocaine|mesh-list
25030164|NCT03597945|Magnesium Sulfate|magnesium sulfate|mesh-list
25030165|NCT03597945|Epinephrine|epinephrine|mesh-list
25030166|NCT03597945|Anesthetics, Local|anesthetics, local|mesh-ancestor
24490521|NCT00478699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490522|NCT00478699|Tubulin Modulators|tubulin modulators|mesh-ancestor
24490523|NCT00478699|Antimitotic Agents|antimitotic agents|mesh-ancestor
24490524|NCT00478699|Mitosis Modulators|mitosis modulators|mesh-ancestor
24490525|NCT00478764|Triamcinolone|triamcinolone|mesh-list
24490526|NCT00478764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24490527|NCT00478764|Glucocorticoids|glucocorticoids|mesh-ancestor
24490539|NCT00478855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490540|NCT00478855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490678|NCT00479661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490679|NCT00479726|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24490680|NCT00479726|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24490681|NCT00479726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24490767|NCT00480064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24490769|NCT00480090|Cytarabine|cytarabine|mesh-list
24490770|NCT00480090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24490771|NCT00480090|Antimetabolites|antimetabolites|mesh-ancestor
24490772|NCT00480090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490773|NCT00480090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490775|NCT00480090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24490776|NCT00480090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24490777|NCT00480090|Immunologic Factors|immunologic factors|mesh-ancestor
24490778|NCT00480090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490779|NCT00480103|Mineral Oil|mineral oil|mesh-list
24490780|NCT00480103|Emollients|emollients|mesh-ancestor
24490781|NCT00480103|Dermatologic Agents|dermatologic agents|mesh-ancestor
24490782|NCT00480116|Vaccines|vaccines|mesh-list
24490783|NCT00480116|Immunologic Factors|immunologic factors|mesh-ancestor
24490986|NCT00480675|Prednisolone|prednisolone|mesh-list
24491008|NCT00480753|Nitroglycerin|nitroglycerin|mesh-list
24491009|NCT00480753|Vasodilator Agents|vasodilator agents|mesh-ancestor
25030167|NCT03597945|Anesthetics|anesthetics|mesh-ancestor
25030175|NCT03597945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25030176|NCT03597945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030177|NCT03597945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25030178|NCT03597945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25030179|NCT03597945|Adrenergic Agents|adrenergic agents|mesh-ancestor
24596141|NCT00941967|Immunologic Factors|immunologic factors|mesh-ancestor
25030211|NCT03597867|Sensory System Agents|sensory system agents|mesh-ancestor
25030212|NCT03597867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25030213|NCT03597867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030214|NCT03597867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25030215|NCT03597867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25691794|NCT01990534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25030216|NCT03597867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25030217|NCT03597867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25030218|NCT03597867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030219|NCT03597867|Gout Suppressants|gout suppressants|mesh-ancestor
24987030|NCT04498715|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24491011|NCT00480844|Sertindole|sertindole|mesh-list
24491012|NCT00480844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24491013|NCT00480844|Serotonin Agents|serotonin agents|mesh-ancestor
24491023|NCT00480870|Donepezil|donepezil|mesh-list
24491024|NCT00480870|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24491026|NCT00480870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491027|NCT00480870|Cholinergic Agents|cholinergic agents|mesh-ancestor
24491114|NCT00481312|Midazolam|midazolam|mesh-list
24491169|NCT00481455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24491170|NCT00481455|Alkylating Agents|alkylating agents|mesh-ancestor
24491171|NCT00481455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491202|NCT00481572|Hemostatics|hemostatics|mesh-ancestor
24491203|NCT00481572|Coagulants|coagulants|mesh-ancestor
24491204|NCT00481572|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24491205|NCT00481572|Natriuretic Agents|natriuretic agents|mesh-ancestor
24491294|NCT00481962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24491295|NCT00481962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491296|NCT00481962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491347|NCT00482209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24491348|NCT00482209|Luteolytic Agents|luteolytic agents|mesh-ancestor
24491395|NCT00482261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24491396|NCT00482261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24491397|NCT00482261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491398|NCT00482261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24491399|NCT00482261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24491400|NCT00482261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491402|NCT00482261|Immunologic Factors|immunologic factors|mesh-ancestor
24491403|NCT00482261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24491404|NCT00482261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24491405|NCT00482261|Growth Substances|growth substances|mesh-ancestor
24491406|NCT00482261|Growth Inhibitors|growth inhibitors|mesh-ancestor
24491407|NCT00482313|Methylphenidate|methylphenidate|mesh-list
24491408|NCT00482313|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24491409|NCT00482313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491410|NCT00482313|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25030221|NCT03597867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24987031|NCT04498715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987041|NCT04447287|Buprenorphine|buprenorphine|mesh-list
24987042|NCT04447287|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25113275|NCT03176472|Ricolinostat|ricolinostat|mesh-list
25113286|NCT03112590|Trastuzumab|trastuzumab|mesh-list
25113288|NCT03112590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25113289|NCT03112590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25113290|NCT03112590|Tubulin Modulators|tubulin modulators|mesh-ancestor
25113291|NCT03112590|Antimitotic Agents|antimitotic agents|mesh-ancestor
25113292|NCT03112590|Mitosis Modulators|mitosis modulators|mesh-ancestor
25113293|NCT03112590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113294|NCT03112590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25113295|NCT03112590|Antiviral Agents|antiviral agents|mesh-ancestor
25113296|NCT03112590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25113297|NCT03094247|Amoxicillin|amoxicillin|mesh-list
25113298|NCT03094247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25113299|NCT03094247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25113300|NCT03086343|Abatacept|abatacept|mesh-list
25113301|NCT03086343|Upadacitinib|upadacitinib|mesh-list
25113302|NCT03086343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25113304|NCT03086343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25113305|NCT03086343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25113306|NCT03086343|Immunologic Factors|immunologic factors|mesh-ancestor
24491716|NCT00483782|Bevacizumab|bevacizumab|mesh-list
25020551|NCT03679065|Antiemetics|antiemetics|mesh-ancestor
24987115|NCT04125745|CXA-10|cxa-10|mesh-list
24987116|NCT04125745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24491799|NCT00484003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24491801|NCT00484003|Dermatologic Agents|dermatologic agents|mesh-ancestor
24491802|NCT00484003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24491803|NCT00484003|Immunologic Factors|immunologic factors|mesh-ancestor
24491804|NCT00484003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24491805|NCT00484003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24892455|NCT04462614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892456|NCT04462822|Fluticasone|fluticasone|mesh-list
24892458|NCT04462822|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24892459|NCT04462822|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24892460|NCT04462822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24892489|NCT04462666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24892492|NCT04462666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24491806|NCT00484003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491807|NCT00484055|Gentamicins|gentamicins|mesh-list
24491808|NCT00484055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24491809|NCT00484055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24491810|NCT00484055|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24491811|NCT00484055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491812|NCT00484055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492149|NCT00485498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24492150|NCT00485498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24492154|NCT00485498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24492155|NCT00485498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24420540|NCT00216268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24492306|NCT00485862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492566|NCT00486772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492568|NCT00486785|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24492570|NCT00486785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24492571|NCT00486785|Adrenergic Agents|adrenergic agents|mesh-ancestor
24987122|NCT04042740|Ribavirin|ribavirin|mesh-list
24987123|NCT04042740|Antimetabolites|antimetabolites|mesh-ancestor
24987124|NCT04042740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987125|NCT04042740|Antiviral Agents|antiviral agents|mesh-ancestor
24987126|NCT04042740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24987127|NCT04039503|Tirzepatide|tirzepatide|mesh-list
24987128|NCT04039503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24987129|NCT04039503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987130|NCT04039503|Incretins|incretins|mesh-ancestor
24987131|NCT04039503|Hormones|hormones|mesh-ancestor
24987132|NCT04039503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24588004|NCT00900172|Tubulin Modulators|tubulin modulators|mesh-ancestor
24588005|NCT00900172|Antimitotic Agents|antimitotic agents|mesh-ancestor
24588006|NCT00900172|Mitosis Modulators|mitosis modulators|mesh-ancestor
24492572|NCT00486785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492573|NCT00486785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492822|NCT00488176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24492823|NCT00488176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492824|NCT00488176|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24492825|NCT00488176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24492826|NCT00488176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492827|NCT00488176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24492840|NCT00488189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492842|NCT00488215|Laxatives|laxatives|mesh-ancestor
24492843|NCT00488215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24492844|NCT00488215|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24492845|NCT00488215|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24492846|NCT00488215|Serotonin Agents|serotonin agents|mesh-ancestor
24493048|NCT00489164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493049|NCT00489190|Insulin glulisine|insulin glulisine|mesh-list
24493050|NCT00489190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24493051|NCT00489190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493052|NCT00489229|Rosiglitazone|rosiglitazone|mesh-list
24493054|NCT00489229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25691795|NCT01990534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25691796|NCT01990560|Mifepristone|mifepristone|mesh-list
25691797|NCT01990560|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25691798|NCT01990560|Abortifacient Agents|abortifacient agents|mesh-ancestor
25691799|NCT01990560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25691800|NCT01990560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691801|NCT01990560|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25691802|NCT01990560|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24890052|NCT04486430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24893008|NCT04455555|Dopamine Agonists|dopamine agonists|mesh-ancestor
24893009|NCT04455555|Dopamine Agents|dopamine agents|mesh-ancestor
25108792|NCT03130010|Nefopam|nefopam|mesh-list
25691803|NCT01990560|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24493182|NCT00489892|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24493183|NCT00489892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24493184|NCT00489892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24493185|NCT00489892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493187|NCT00489905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24493188|NCT00489905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493189|NCT00489944|Tamoxifen|tamoxifen|mesh-list
24493190|NCT00489944|Sunitinib|sunitinib|mesh-list
24493191|NCT00489944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493192|NCT00489944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588036|NCT00900445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24588037|NCT00900445|Tubulin Modulators|tubulin modulators|mesh-ancestor
24588038|NCT00900445|Antimitotic Agents|antimitotic agents|mesh-ancestor
24588039|NCT00900445|Mitosis Modulators|mitosis modulators|mesh-ancestor
24588040|NCT00900445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588042|NCT00900445|Autonomic Agents|autonomic agents|mesh-ancestor
24588044|NCT00900445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24588045|NCT00900445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25030238|NCT03597594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030239|NCT03597594|Alkylating Agents|alkylating agents|mesh-ancestor
25030240|NCT03597594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25030241|NCT03597594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25030242|NCT03597555|Sodium Oxybate|sodium oxybate|mesh-list
25030243|NCT03597555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24493297|NCT00490360|Gemcitabine|gemcitabine|mesh-list
24493307|NCT00490360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493309|NCT00490373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493310|NCT00490373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493311|NCT00490373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493314|NCT00490399|Gemcitabine|gemcitabine|mesh-list
24493322|NCT00490399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24493323|NCT00490399|Immunologic Factors|immunologic factors|mesh-ancestor
24493324|NCT00490399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493325|NCT00490412|Vitamin D|vitamin d|mesh-list
24493335|NCT00490464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24493336|NCT00490464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493337|NCT00490464|Vasodilator Agents|vasodilator agents|mesh-ancestor
24493338|NCT00490620|Antiviral Agents|antiviral agents|mesh-list
24493339|NCT00490620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493340|NCT00490633|Ethanol|ethanol|mesh-list
24493341|NCT00490633|Hand Sanitizers|hand sanitizers|mesh-list
24493521|NCT00491166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24493522|NCT00491166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24493524|NCT00491192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24493525|NCT00491192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24493526|NCT00491192|Analgesics|analgesics|mesh-ancestor
24493527|NCT00491192|Sensory System Agents|sensory system agents|mesh-ancestor
25030244|NCT03597555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25030246|NCT03597555|Anesthetics|anesthetics|mesh-ancestor
25030247|NCT03597555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25030248|NCT03597555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030249|NCT03597477|Dexmedetomidine|dexmedetomidine|mesh-list
25030250|NCT03597477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25030251|NCT03597477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25030253|NCT03597477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25030255|NCT03597477|Sensory System Agents|sensory system agents|mesh-ancestor
25030256|NCT03597477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25030257|NCT03597477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25030258|NCT03597477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25030259|NCT03597477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25691804|NCT01990560|Contraceptive Agents|contraceptive agents|mesh-ancestor
25691805|NCT01990560|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25691806|NCT01990560|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25691807|NCT01990560|Hormone Antagonists|hormone antagonists|mesh-ancestor
25691808|NCT01990560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25691809|NCT01990560|Luteolytic Agents|luteolytic agents|mesh-ancestor
25030260|NCT03597477|Adrenergic Agents|adrenergic agents|mesh-ancestor
25030261|NCT03597477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25030262|NCT03597477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030263|NCT03597308|Acetaminophen|acetaminophen|mesh-list
25030265|NCT03597308|Oxycodone|oxycodone|mesh-list
25030266|NCT03597308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25030267|NCT03597308|Analgesics|analgesics|mesh-ancestor
25030268|NCT03597308|Sensory System Agents|sensory system agents|mesh-ancestor
25030269|NCT03597308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25030270|NCT03597308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493528|NCT00491192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24493529|NCT00491192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493530|NCT00491192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24493564|NCT00491426|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24493565|NCT00491426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493566|NCT00491426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493567|NCT00491426|Amebicides|amebicides|mesh-ancestor
24493568|NCT00491426|Antifungal Agents|antifungal agents|mesh-ancestor
24493569|NCT00491426|Antiviral Agents|antiviral agents|mesh-ancestor
24493570|NCT00491478|Sertraline|sertraline|mesh-list
24493571|NCT00491478|Antidepressive Agents|antidepressive agents|mesh-ancestor
24493572|NCT00491478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24493573|NCT00491478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24493574|NCT00491478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24493684|NCT00491998|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24493686|NCT00491998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493687|NCT00492037|Conivaptan|conivaptan|mesh-list
24493688|NCT00492037|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24493689|NCT00492037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030271|NCT03597308|Antipyretics|antipyretics|mesh-ancestor
25030295|NCT03597035|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25030296|NCT03597035|Hormone Antagonists|hormone antagonists|mesh-ancestor
25030297|NCT03597035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25030298|NCT03597035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030299|NCT03597035|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25030301|NCT03597035|Natriuretic Agents|natriuretic agents|mesh-ancestor
25030302|NCT03596970|Everolimus|everolimus|mesh-list
25030303|NCT03596970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25030304|NCT03596970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25030305|NCT03596970|Immunologic Factors|immunologic factors|mesh-ancestor
25030306|NCT03596970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030307|NCT03596957|Tolvaptan|tolvaptan|mesh-list
25030308|NCT03596957|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25030309|NCT03596957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030310|NCT03596957|Natriuretic Agents|natriuretic agents|mesh-ancestor
25030311|NCT03596957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030312|NCT03596892|Cyclophosphamide|cyclophosphamide|mesh-list
25030313|NCT03596892|Busulfan|busulfan|mesh-list
25030314|NCT03596892|Decitabine|decitabine|mesh-list
25030315|NCT03596892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25030316|NCT03596892|Immunologic Factors|immunologic factors|mesh-ancestor
25030317|NCT03596892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030318|NCT03596892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25030326|NCT03596892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24987133|NCT03913195|Ibalizumab|ibalizumab|mesh-list
25030327|NCT03596775|Dexmedetomidine|dexmedetomidine|mesh-list
25030328|NCT03596775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25030329|NCT03596775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25030330|NCT03596775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030331|NCT03596775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24493690|NCT00492037|Natriuretic Agents|natriuretic agents|mesh-ancestor
24493691|NCT00492037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493692|NCT00492102|Montelukast|montelukast|mesh-list
24493693|NCT00492102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24493694|NCT00492102|Respiratory System Agents|respiratory system agents|mesh-ancestor
24493695|NCT00492102|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24493696|NCT00492102|Hormone Antagonists|hormone antagonists|mesh-ancestor
24493697|NCT00492102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24493698|NCT00492102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493699|NCT00492102|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25691810|NCT01990560|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24893723|NCT04446663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893725|NCT04446715|Meperidine|meperidine|mesh-list
24893819|NCT04446234|Dopamine Agents|dopamine agents|mesh-ancestor
24893820|NCT04446234|Antidepressive Agents|antidepressive agents|mesh-ancestor
24893821|NCT04446234|Dopamine Agonists|dopamine agonists|mesh-ancestor
24893822|NCT04446234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24893823|NCT04446234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25030333|NCT03596775|Sensory System Agents|sensory system agents|mesh-ancestor
25691811|NCT01990560|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25691812|NCT01990573|Methadone|methadone|mesh-list
25030334|NCT03596775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25030335|NCT03596775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25030336|NCT03596775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25030337|NCT03596775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25030338|NCT03596775|Adrenergic Agents|adrenergic agents|mesh-ancestor
25030339|NCT03596775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24420541|NCT00216281|Clozapine|clozapine|mesh-list
25030340|NCT03596775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030341|NCT03596749|Sevelamer|sevelamer|mesh-list
25030342|NCT03596749|Chelating Agents|chelating agents|mesh-ancestor
25030343|NCT03596749|Sequestering Agents|sequestering agents|mesh-ancestor
25030344|NCT03596749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030345|NCT03596502|Warfarin|warfarin|mesh-list
25030346|NCT03596502|Anticoagulants|anticoagulants|mesh-list
25030347|NCT03596294|Rifampin|rifampin|mesh-list
25030348|NCT03596294|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25030349|NCT03596294|Antitubercular Agents|antitubercular agents|mesh-ancestor
25030350|NCT03596294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25030351|NCT03596294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25030352|NCT03596294|Leprostatic Agents|leprostatic agents|mesh-ancestor
25030353|NCT03596294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25030354|NCT03596294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25030355|NCT03596294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030356|NCT03596294|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25030357|NCT03596294|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25030358|NCT03596294|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25030359|NCT03596294|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25030360|NCT03596294|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25030361|NCT03596294|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25030362|NCT03596281|Bevacizumab|bevacizumab|mesh-list
25030363|NCT03596281|Pembrolizumab|pembrolizumab|mesh-list
25030364|NCT03596281|Doxorubicin|doxorubicin|mesh-list
25030365|NCT03596281|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25030366|NCT03596281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25030367|NCT03596281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25030368|NCT03596281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25030369|NCT03596281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25030370|NCT03596281|Growth Substances|growth substances|mesh-ancestor
25030371|NCT03596281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030372|NCT03596281|Growth Inhibitors|growth inhibitors|mesh-ancestor
25030373|NCT03596281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25030374|NCT03596281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25030375|NCT03596281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24596441|NCT00943566|Narcotics|narcotics|mesh-ancestor
25030399|NCT03596099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25030400|NCT03596060|Fentanyl|fentanyl|mesh-list
25030401|NCT03596060|Morphine|morphine|mesh-list
25030402|NCT03596060|Propofol|propofol|mesh-list
25030403|NCT03596060|Rocuronium|rocuronium|mesh-list
25030404|NCT03596060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25030405|NCT03596060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25030406|NCT03596060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030407|NCT03596060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25030408|NCT03596060|Anesthetics, General|anesthetics, general|mesh-ancestor
25030409|NCT03596060|Anesthetics|anesthetics|mesh-ancestor
25691813|NCT01990573|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25691814|NCT01990573|Narcotics|narcotics|mesh-ancestor
25691815|NCT01990573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25691816|NCT01990573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691817|NCT01990573|Analgesics|analgesics|mesh-ancestor
25691818|NCT01990573|Sensory System Agents|sensory system agents|mesh-ancestor
25691819|NCT01990573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25691820|NCT01990573|Antitussive Agents|antitussive agents|mesh-ancestor
25691821|NCT01990573|Respiratory System Agents|respiratory system agents|mesh-ancestor
25691822|NCT01990677|Eplerenone|eplerenone|mesh-list
25030410|NCT03596060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25030411|NCT03596060|Narcotics|narcotics|mesh-ancestor
25030412|NCT03596060|Analgesics|analgesics|mesh-ancestor
25030413|NCT03596060|Sensory System Agents|sensory system agents|mesh-ancestor
25030414|NCT03596060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25030415|NCT03596060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25030416|NCT03596060|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25030417|NCT03596060|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25030418|NCT03596060|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25030419|NCT03595930|Fluticasone|fluticasone|mesh-list
25030420|NCT03595930|Xhance|xhance|mesh-list
25030421|NCT03595930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24493700|NCT00492102|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24493701|NCT00492102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493702|NCT00492128|Losartan|losartan|mesh-list
24493791|NCT00492466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24493792|NCT00492466|Antiemetics|antiemetics|mesh-ancestor
24493793|NCT00492466|Autonomic Agents|autonomic agents|mesh-ancestor
24493797|NCT00492466|Glucocorticoids|glucocorticoids|mesh-ancestor
24493857|NCT00492661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24493858|NCT00492661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493859|NCT00492661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493860|NCT00492687|Tamoxifen|tamoxifen|mesh-list
24493861|NCT00492687|Carboplatin|carboplatin|mesh-list
24493862|NCT00492687|Temozolomide|temozolomide|mesh-list
24493863|NCT00492687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25030422|NCT03595930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25030424|NCT03595930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25030425|NCT03595930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030426|NCT03595930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25030427|NCT03595930|Respiratory System Agents|respiratory system agents|mesh-ancestor
25113344|NCT02945852|Apatinib|apatinib|mesh-list
25113345|NCT02945852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25113346|NCT02945852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25113347|NCT02945852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25113348|NCT02945852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493865|NCT00492687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24493866|NCT00492687|Alkylating Agents|alkylating agents|mesh-ancestor
24493867|NCT00492687|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24493868|NCT00492687|Hormone Antagonists|hormone antagonists|mesh-ancestor
24493869|NCT00492687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24493870|NCT00492687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493871|NCT00492687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24493872|NCT00492687|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24493873|NCT00492687|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24493924|NCT00493116|Interferon-beta|interferon-beta|mesh-list
24493925|NCT00493116|Interferon beta-1a|interferon beta-1a|mesh-list
24493926|NCT00493116|Methylprednisolone|methylprednisolone|mesh-list
24493927|NCT00493116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493928|NCT00493116|Antiviral Agents|antiviral agents|mesh-ancestor
24493929|NCT00493116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493991|NCT00493233|Antidepressive Agents|antidepressive agents|mesh-ancestor
24493992|NCT00493233|GABA Antagonists|gaba antagonists|mesh-ancestor
24493993|NCT00493233|GABA Agents|gaba agents|mesh-ancestor
24493994|NCT00493298|Natalizumab|natalizumab|mesh-list
24493995|NCT00493298|Immunologic Factors|immunologic factors|mesh-ancestor
24493996|NCT00493298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493997|NCT00493324|Alefacept|alefacept|mesh-list
24493999|NCT00493324|Immunologic Factors|immunologic factors|mesh-ancestor
24494004|NCT00493363|Antimalarials|antimalarials|mesh-ancestor
24494005|NCT00493363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24494006|NCT00493363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24494007|NCT00493363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24494008|NCT00493363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494009|NCT00493363|Antiviral Agents|antiviral agents|mesh-ancestor
24494010|NCT00493363|Schistosomicides|schistosomicides|mesh-ancestor
24494011|NCT00493363|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24494012|NCT00493363|Anthelmintics|anthelmintics|mesh-ancestor
24494013|NCT00493389|Hormones|hormones|mesh-list
24494014|NCT00493389|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24494015|NCT00493389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24494016|NCT00493389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494017|NCT00493402|Chlorotrianisene|chlorotrianisene|mesh-list
24494018|NCT00493402|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24879141|NCT05016518|Anesthetics|anesthetics|mesh-ancestor
24879142|NCT05006599|Insulin|insulin|mesh-list
25108851|NCT03129646|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25108852|NCT03129646|Anthelmintics|anthelmintics|mesh-ancestor
25108853|NCT03129594|Glucagon|glucagon|mesh-list
25108854|NCT03129594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25108855|NCT03129594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25108856|NCT03129594|Hormones|hormones|mesh-ancestor
25108857|NCT03129594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24494019|NCT00493402|Estrogens|estrogens|mesh-ancestor
24494020|NCT00493402|Hormones|hormones|mesh-ancestor
24494026|NCT00493415|Vasodilator Agents|vasodilator agents|mesh-ancestor
24494029|NCT00493428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494031|NCT00493428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24494032|NCT00493428|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24494033|NCT00493428|GABA Agonists|gaba agonists|mesh-ancestor
24494034|NCT00493428|GABA Agents|gaba agents|mesh-ancestor
24494035|NCT00493428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25113373|NCT02893917|Olaparib|olaparib|mesh-list
25113374|NCT02893917|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25113375|NCT02893917|Cediranib|cediranib|mesh-list
25113376|NCT02893917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25030433|NCT03595683|Pembrolizumab|pembrolizumab|mesh-list
25030434|NCT03595683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25030435|NCT03595683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25030436|NCT03595514|Dexamethasone|dexamethasone|mesh-list
25030437|NCT03595514|Lidocaine|lidocaine|mesh-list
25030438|NCT03595514|Epinephrine|epinephrine|mesh-list
25030439|NCT03595514|Bupivacaine|bupivacaine|mesh-list
25030440|NCT03595514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25030441|NCT03595514|Antiemetics|antiemetics|mesh-ancestor
25030442|NCT03595514|Autonomic Agents|autonomic agents|mesh-ancestor
25030443|NCT03595514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25030455|NCT03595514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25030456|NCT03595514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25030457|NCT03595514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25030458|NCT03595514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25030459|NCT03595514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030460|NCT03595514|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25030461|NCT03595514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25030462|NCT03595514|Adrenergic Agents|adrenergic agents|mesh-ancestor
25030463|NCT03595514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25030464|NCT03595514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25030465|NCT03595514|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25030466|NCT03595514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25030467|NCT03595514|Respiratory System Agents|respiratory system agents|mesh-ancestor
25030468|NCT03595514|Mydriatics|mydriatics|mesh-ancestor
25030469|NCT03595514|Sympathomimetics|sympathomimetics|mesh-ancestor
25030470|NCT03595514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25030471|NCT03595397|Magnesium Sulfate|magnesium sulfate|mesh-list
25030472|NCT03595397|Fentanyl|fentanyl|mesh-list
25030473|NCT03595397|Bupivacaine|bupivacaine|mesh-list
24494036|NCT00493428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494207|NCT00494377|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24494208|NCT00494377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24494209|NCT00494377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24494210|NCT00494377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494211|NCT00494377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25030475|NCT03595397|Anesthetics|anesthetics|mesh-ancestor
25030476|NCT03595397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25030477|NCT03595397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030478|NCT03595397|Sensory System Agents|sensory system agents|mesh-ancestor
25030479|NCT03595397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25030480|NCT03595397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25030481|NCT03595397|Narcotics|narcotics|mesh-ancestor
25030482|NCT03595397|Analgesics|analgesics|mesh-ancestor
25030483|NCT03595397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25691823|NCT01990677|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25691824|NCT01990677|Hormone Antagonists|hormone antagonists|mesh-ancestor
25691825|NCT01990677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25691826|NCT01990677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691827|NCT01990677|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25691828|NCT01990677|Diuretics|diuretics|mesh-ancestor
25691829|NCT01990677|Natriuretic Agents|natriuretic agents|mesh-ancestor
25691830|NCT01990677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24894855|NCT05379855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25030484|NCT03595397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25030485|NCT03595397|Anesthetics, General|anesthetics, general|mesh-ancestor
25030486|NCT03595397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25030487|NCT03595397|Anticonvulsants|anticonvulsants|mesh-ancestor
25030488|NCT03595397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25030489|NCT03595397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25030490|NCT03595397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030491|NCT03595397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25030492|NCT03595397|Tocolytic Agents|tocolytic agents|mesh-ancestor
24494212|NCT00494377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494214|NCT00494377|Sensory System Agents|sensory system agents|mesh-ancestor
24494235|NCT00494468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24494236|NCT00494468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494237|NCT00494533|Treprostinil|treprostinil|mesh-list
24494238|NCT00494533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24494239|NCT00494559|Pioglitazone|pioglitazone|mesh-list
24494240|NCT00494559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24494252|NCT00494598|Sufentanil|sufentanil|mesh-list
24494253|NCT00494598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24494254|NCT00494598|Narcotics|narcotics|mesh-ancestor
24494255|NCT00494598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24494347|NCT00494897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494348|NCT00494897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494349|NCT00494897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24494350|NCT00494897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24494351|NCT00494897|Glucocorticoids|glucocorticoids|mesh-ancestor
24494352|NCT00494897|Hormones|hormones|mesh-ancestor
25030553|NCT03595046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494353|NCT00494897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24494354|NCT00494897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24494355|NCT00494897|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24494356|NCT00494897|Abortifacient Agents|abortifacient agents|mesh-ancestor
24494357|NCT00494897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24494358|NCT00494897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24494367|NCT00494897|Tubulin Modulators|tubulin modulators|mesh-ancestor
24494368|NCT00494897|Antimitotic Agents|antimitotic agents|mesh-ancestor
24494369|NCT00494897|Mitosis Modulators|mitosis modulators|mesh-ancestor
24494370|NCT00494897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24494371|NCT00494897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24494372|NCT00494897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24494373|NCT00494949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24494374|NCT00494988|Insulin|insulin|mesh-list
24494375|NCT00494988|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25030493|NCT03595397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25030495|NCT03595371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25030496|NCT03595319|Sevoflurane|sevoflurane|mesh-list
25030497|NCT03595319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25030498|NCT03595319|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25030499|NCT03595319|Anesthetics, General|anesthetics, general|mesh-ancestor
25030500|NCT03595319|Anesthetics|anesthetics|mesh-ancestor
25030501|NCT03595319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25030502|NCT03595319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030503|NCT03595254|Nicotine|nicotine|mesh-list
25030504|NCT03595254|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25030505|NCT03595254|Autonomic Agents|autonomic agents|mesh-ancestor
24987359|NCT02358681|Analgesics|analgesics|mesh-ancestor
25030516|NCT03595189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030518|NCT03595163|Vitamin B Complex|vitamin b complex|mesh-list
25030519|NCT03595163|Propofol|propofol|mesh-list
25030520|NCT03595163|Sevoflurane|sevoflurane|mesh-list
25030521|NCT03595163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25030522|NCT03595163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25030523|NCT03595163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030524|NCT03595163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25030525|NCT03595163|Anesthetics, General|anesthetics, general|mesh-ancestor
25030526|NCT03595163|Anesthetics|anesthetics|mesh-ancestor
25030527|NCT03595163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25030528|NCT03595163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25030529|NCT03595163|Hematinics|hematinics|mesh-ancestor
25030530|NCT03595163|Vitamins|vitamins|mesh-ancestor
25030531|NCT03595163|Micronutrients|micronutrients|mesh-ancestor
25691831|NCT01990703|Levonorgestrel|levonorgestrel|mesh-list
24898922|NCT04409483|Ritonavir|ritonavir|mesh-list
25030532|NCT03595085|Streptokinase|streptokinase|mesh-list
25030533|NCT03595085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25030534|NCT03595085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25039947|NCT03553498|Acetaminophen|acetaminophen|mesh-list
24494376|NCT00494988|Insulin Aspart|insulin aspart|mesh-list
24494377|NCT00494988|Isophane Insulin, Human|isophane insulin, human|mesh-list
24494461|NCT00495326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24494615|NCT00496093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494617|NCT00496158|Clevudine|clevudine|mesh-list
24494618|NCT00496158|Antiviral Agents|antiviral agents|mesh-ancestor
24494619|NCT00496158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24494623|NCT00496158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494625|NCT00496184|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24494626|NCT00496184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25030535|NCT03595085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030536|NCT03595046|Dexamethasone|dexamethasone|mesh-list
25030537|NCT03595046|Dexamethasone acetate|dexamethasone acetate|mesh-list
25030538|NCT03595046|Ropivacaine|ropivacaine|mesh-list
25030539|NCT03595046|BB 1101|bb 1101|mesh-list
25030540|NCT03595046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25030541|NCT03595046|Antiemetics|antiemetics|mesh-ancestor
25030542|NCT03595046|Autonomic Agents|autonomic agents|mesh-ancestor
25030543|NCT03595046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25030544|NCT03595046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030545|NCT03595046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25030546|NCT03595046|Glucocorticoids|glucocorticoids|mesh-ancestor
25030547|NCT03595046|Hormones|hormones|mesh-ancestor
25030548|NCT03595046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25030549|NCT03595046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25030550|NCT03595046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25030551|NCT03595046|Protease Inhibitors|protease inhibitors|mesh-ancestor
25030552|NCT03595046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25030554|NCT03595046|Anesthetics, Local|anesthetics, local|mesh-ancestor
25030556|NCT03595046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25030557|NCT03595046|Sensory System Agents|sensory system agents|mesh-ancestor
25030558|NCT03594968|Progesterone|progesterone|mesh-list
25030559|NCT03594968|Progestins|progestins|mesh-ancestor
25030560|NCT03594968|Hormones|hormones|mesh-ancestor
25030561|NCT03594968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25030562|NCT03594968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030563|NCT03594825|Valsartan|valsartan|mesh-list
24494627|NCT00496184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494628|NCT00496184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24494629|NCT00496184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494630|NCT00496184|Vasodilator Agents|vasodilator agents|mesh-ancestor
24494648|NCT00496275|Vinorelbine|vinorelbine|mesh-list
24494752|NCT00496704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494754|NCT00496704|Antiviral Agents|antiviral agents|mesh-ancestor
24494755|NCT00496704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24494756|NCT00496704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24494757|NCT00496704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24494758|NCT00496704|Immunologic Factors|immunologic factors|mesh-ancestor
24494759|NCT00496704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494760|NCT00497003|Metoprolol|metoprolol|mesh-list
24494761|NCT00497003|Carvedilol|carvedilol|mesh-list
24494762|NCT00497003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24494797|NCT00497107|Calcium|calcium|mesh-list
25030564|NCT03594825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25030565|NCT03594825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25030566|NCT03594825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25030567|NCT03594825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030568|NCT03594604|Contraceptive Agents|contraceptive agents|mesh-list
25030569|NCT03594604|Norethindrone|norethindrone|mesh-list
24987368|NCT02339168|Metformin|metformin|mesh-list
24987443|NCT01936480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24987444|NCT01936480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24987445|NCT01936480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24987446|NCT01936480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987447|NCT01936480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987449|NCT01880567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24987450|NCT01880567|Antibodies|antibodies|mesh-list
24987451|NCT01880567|Immunoglobulins|immunoglobulins|mesh-list
24987452|NCT01880567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24987453|NCT01880567|Immunologic Factors|immunologic factors|mesh-ancestor
24899155|NCT04406506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24899156|NCT04406506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24899157|NCT04406506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24899158|NCT04406506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24899159|NCT04406506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899160|NCT04406506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899162|NCT04406259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24899163|NCT04406259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24987454|NCT01880567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987455|NCT01880567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987456|NCT01880567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24588070|NCT00900744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24588071|NCT00900744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588072|NCT00900744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24588073|NCT00900744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588074|NCT00900744|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24588075|NCT00900744|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24588076|NCT00900744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24588078|NCT00900874|Formoterol Fumarate|formoterol fumarate|mesh-list
24588079|NCT00900874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24588080|NCT00900874|Autonomic Agents|autonomic agents|mesh-ancestor
24494850|NCT00497237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24494851|NCT00497250|Gefitinib|gefitinib|mesh-list
24494852|NCT00497250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494853|NCT00497250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24494854|NCT00497250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24494855|NCT00497250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494856|NCT00497315|Pemetrexed|pemetrexed|mesh-list
24494857|NCT00497315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588081|NCT00900874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588082|NCT00900874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588083|NCT00900874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24588084|NCT00900874|Respiratory System Agents|respiratory system agents|mesh-ancestor
24588085|NCT00900874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24588086|NCT00900874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24588087|NCT00900874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24588154|NCT00901368|Respiratory System Agents|respiratory system agents|mesh-ancestor
24588155|NCT00901368|Glucocorticoids|glucocorticoids|mesh-ancestor
24588157|NCT00901368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24588158|NCT00901368|Sympathomimetics|sympathomimetics|mesh-ancestor
25030585|NCT03594565|Autonomic Agents|autonomic agents|mesh-ancestor
25030586|NCT03594565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25030587|NCT03594565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030588|NCT03594565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25030589|NCT03594565|Respiratory System Agents|respiratory system agents|mesh-ancestor
25030590|NCT03594565|Dermatologic Agents|dermatologic agents|mesh-ancestor
25691832|NCT01990703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25691833|NCT01990703|Contraceptive Agents|contraceptive agents|mesh-ancestor
25691834|NCT01990703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25691835|NCT01990703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691836|NCT01990703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25691837|NCT01990703|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25691838|NCT01990703|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25691839|NCT01990768|Tranexamic Acid|tranexamic acid|mesh-list
25691840|NCT01990768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24494877|NCT00497341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25030597|NCT03594513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25030600|NCT03594513|Sensory System Agents|sensory system agents|mesh-ancestor
25030601|NCT03594513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25030602|NCT03594513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030603|NCT03594513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25030604|NCT03594513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25030605|NCT03594513|Antipyretics|antipyretics|mesh-ancestor
25030606|NCT03594461|Aflibercept|aflibercept|mesh-list
25107310|NCT03140553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25107311|NCT03140553|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25107312|NCT03140553|Tubulin Modulators|tubulin modulators|mesh-ancestor
25107313|NCT03140553|Antimitotic Agents|antimitotic agents|mesh-ancestor
24836598|NCT02186535|Vitamin D|vitamin d|mesh-list
24989385|NCT05322707|Autonomic Agents|autonomic agents|mesh-ancestor
24989386|NCT05322707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24494879|NCT00497354|Anesthetics, Local|anesthetics, local|mesh-list
24494886|NCT00497458|Hormones|hormones|mesh-ancestor
24494893|NCT00497471|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24494894|NCT00497471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24494895|NCT00497471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24494896|NCT00497471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24494897|NCT00497471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494898|NCT00497471|Leprostatic Agents|leprostatic agents|mesh-ancestor
24494899|NCT00497471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25030612|NCT03594461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25030614|NCT03594435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25030615|NCT03594435|Autonomic Agents|autonomic agents|mesh-ancestor
25030616|NCT03594435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25030617|NCT03594435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030618|NCT03594435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25030619|NCT03594435|Respiratory System Agents|respiratory system agents|mesh-ancestor
25030620|NCT03594435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25030621|NCT03594435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25030622|NCT03594435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030623|NCT03594435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25030624|NCT03594435|Vasodilator Agents|vasodilator agents|mesh-ancestor
25030625|NCT03594396|Durvalumab|durvalumab|mesh-list
25030626|NCT03594396|Olaparib|olaparib|mesh-list
25030627|NCT03594396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25030628|NCT03594396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494927|NCT00497523|Adrenergic Agents|adrenergic agents|mesh-ancestor
24494928|NCT00497523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24494929|NCT00497523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494930|NCT00497523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24494931|NCT00497523|Glucocorticoids|glucocorticoids|mesh-ancestor
24494977|NCT00497601|Antifungal Agents|antifungal agents|mesh-ancestor
24494981|NCT00497614|Adalimumab|adalimumab|mesh-list
24443110|NCT00293657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24495109|NCT00498342|Protective Agents|protective agents|mesh-ancestor
24495110|NCT00498342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495112|NCT00498537|Spironolactone|spironolactone|mesh-list
24495272|NCT00499018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24495273|NCT00499018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24495274|NCT00499018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24495275|NCT00499018|Tubulin Modulators|tubulin modulators|mesh-ancestor
24495276|NCT00499018|Antimitotic Agents|antimitotic agents|mesh-ancestor
24495277|NCT00499018|Mitosis Modulators|mitosis modulators|mesh-ancestor
24495278|NCT00499018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24495296|NCT00499265|Antimetabolites|antimetabolites|mesh-ancestor
24495297|NCT00499265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495298|NCT00499265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495299|NCT00499265|Antiviral Agents|antiviral agents|mesh-ancestor
24495300|NCT00499265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24817986|NCT02086292|Lidocaine|lidocaine|mesh-list
25030629|NCT03594396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25030630|NCT03594396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25030648|NCT03594149|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25030649|NCT03594149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25030650|NCT03594149|Renal Agents|renal agents|mesh-ancestor
25030651|NCT03594149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25030652|NCT03594149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25030653|NCT03594149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25030654|NCT03594149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25030655|NCT03594149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030656|NCT03594149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25030657|NCT03594149|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25030658|NCT03594149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25113377|NCT02893917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113378|NCT02893917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25113379|NCT02893917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25113380|NCT02888743|Durvalumab|durvalumab|mesh-list
25113381|NCT02888743|Ipilimumab|ipilimumab|mesh-list
25113382|NCT02888743|Tremelimumab|tremelimumab|mesh-list
24495301|NCT00499265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495425|NCT00500188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24495431|NCT00500253|Autonomic Agents|autonomic agents|mesh-ancestor
24495456|NCT00500279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495457|NCT00500279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24495458|NCT00500279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24495459|NCT00500279|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24436511|NCT00270322|Anesthetics|anesthetics|mesh-ancestor
24495460|NCT00500279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24495461|NCT00500279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495462|NCT00500279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495463|NCT00500344|Ranibizumab|ranibizumab|mesh-list
24495464|NCT00500344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24495465|NCT00500344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24495466|NCT00500344|Growth Substances|growth substances|mesh-ancestor
24495467|NCT00500344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495482|NCT00500422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495483|NCT00500422|Antiviral Agents|antiviral agents|mesh-ancestor
24495484|NCT00500422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24495485|NCT00500422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495486|NCT00500422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24495487|NCT00500422|Immunologic Factors|immunologic factors|mesh-ancestor
25113386|NCT02888743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25113387|NCT02888743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25113388|NCT02888743|Immunologic Factors|immunologic factors|mesh-ancestor
25113389|NCT02888743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030660|NCT03593954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25030661|NCT03593954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25030662|NCT03593954|Protease Inhibitors|protease inhibitors|mesh-ancestor
25030663|NCT03593954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25030664|NCT03593954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030665|NCT03593954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25030666|NCT03593954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25030667|NCT03593954|Antiviral Agents|antiviral agents|mesh-ancestor
25030668|NCT03593954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25030669|NCT03593954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25030670|NCT03593954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25030671|NCT03593707|Metformin|metformin|mesh-list
25030672|NCT03593707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25030673|NCT03593707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030674|NCT03593668|Metformin|metformin|mesh-list
25030675|NCT03593668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25030676|NCT03593668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745343|NCT03809923|Lidocaine|lidocaine|mesh-list
24495544|NCT00500864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495545|NCT00500864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24495546|NCT00500864|Tocolytic Agents|tocolytic agents|mesh-ancestor
25691841|NCT01990768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24900828|NCT04390789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24900829|NCT04390789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900831|NCT04390984|Gefitinib|gefitinib|mesh-list
24900832|NCT04390984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427586|NCT00238394|Cediranib|cediranib|mesh-list
24900866|NCT04390685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900867|NCT04391439|Methylprednisolone|methylprednisolone|mesh-list
24723912|NCT01589809|Niacin|niacin|mesh-list
24495547|NCT00500864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24495548|NCT00500955|Rosiglitazone|rosiglitazone|mesh-list
24495549|NCT00500955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24495550|NCT00500955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495551|NCT00501020|Rosiglitazone|rosiglitazone|mesh-list
24495552|NCT00501020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24495553|NCT00501020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495809|NCT00502073|Dermatologic Agents|dermatologic agents|mesh-ancestor
24495810|NCT00502073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24495811|NCT00502073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24495812|NCT00502099|Interferons|interferons|mesh-list
24495813|NCT00502099|Ribavirin|ribavirin|mesh-list
24495814|NCT00502099|Interferon-alpha|interferon-alpha|mesh-list
24495819|NCT00502099|Antiviral Agents|antiviral agents|mesh-ancestor
24495820|NCT00502099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24495822|NCT00502099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495823|NCT00502099|Immunologic Factors|immunologic factors|mesh-ancestor
24745418|NCT03782142|Tenofovir|tenofovir|mesh-list
24496111|NCT00503503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24496112|NCT00503503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24496113|NCT00503503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24496129|NCT00503516|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24496131|NCT00503542|Clindamycin|clindamycin|mesh-list
24496132|NCT00503542|Clindamycin palmitate|clindamycin palmitate|mesh-list
24496133|NCT00503542|Clindamycin phosphate|clindamycin phosphate|mesh-list
24496134|NCT00503542|Fluconazole|fluconazole|mesh-list
25030715|NCT03593304|Vitamins|vitamins|mesh-list
25030716|NCT03593304|Vitamin B 12|vitamin b 12|mesh-list
25030717|NCT03593304|Pyridoxine|pyridoxine|mesh-list
25030718|NCT03593304|Pyridoxal|pyridoxal|mesh-list
25030719|NCT03593304|Vitamin B 6|vitamin b 6|mesh-list
25030720|NCT03593304|Vitamin B Complex|vitamin b complex|mesh-list
25030721|NCT03593304|Micronutrients|micronutrients|mesh-ancestor
25030722|NCT03593304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030723|NCT03593291|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25030724|NCT03593291|Dalteparin|dalteparin|mesh-list
25030725|NCT03593291|Anticoagulants|anticoagulants|mesh-ancestor
25030726|NCT03593291|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25030727|NCT03593291|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25030728|NCT03593291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030729|NCT03593135|Metformin|metformin|mesh-list
25030730|NCT03593135|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25030731|NCT03593135|Acetic Acid|acetic acid|mesh-list
25030732|NCT03593135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25030733|NCT03593135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030734|NCT03593135|Incretins|incretins|mesh-ancestor
24987482|NCT01362374|Antidotes|antidotes|mesh-ancestor
25030735|NCT03593135|Hormones|hormones|mesh-ancestor
25030736|NCT03593135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25030737|NCT03593135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25691842|NCT01990768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691843|NCT01990768|Hemostatics|hemostatics|mesh-ancestor
25691844|NCT01990768|Coagulants|coagulants|mesh-ancestor
25691845|NCT01990859|Ipilimumab|ipilimumab|mesh-list
25691846|NCT01990859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25691847|NCT01990859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25691848|NCT01990859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25030738|NCT03593135|Protease Inhibitors|protease inhibitors|mesh-ancestor
25030739|NCT03593135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496135|NCT00503542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24496207|NCT00503659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25404716|NCT03653247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24901605|NCT04383275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496208|NCT00503659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496209|NCT00503763|Simvastatin|simvastatin|mesh-list
24496210|NCT00503763|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24496211|NCT00503763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24496212|NCT00503763|Antimetabolites|antimetabolites|mesh-ancestor
24496213|NCT00503763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496660|NCT00505843|Carbidopa|carbidopa|mesh-list
24496230|NCT00503828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24496231|NCT00503828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496232|NCT00503828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496233|NCT00503932|Capecitabine|capecitabine|mesh-list
24496234|NCT00503932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24496235|NCT00503932|Antimetabolites|antimetabolites|mesh-ancestor
24496236|NCT00503932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496237|NCT00503932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496238|NCT00503971|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24496239|NCT00503971|Vorinostat|vorinostat|mesh-list
24496458|NCT00504946|Hormones|hormones|mesh-ancestor
25030740|NCT03593135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030741|NCT03593135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24596931|NCT00946504|Glipizide|glipizide|mesh-list
25030757|NCT03593044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25030758|NCT03593044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030759|NCT03592992|Morphine|morphine|mesh-list
25030760|NCT03592992|Hydromorphone|hydromorphone|mesh-list
25030761|NCT03592992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25030762|NCT03592992|Narcotics|narcotics|mesh-ancestor
25030763|NCT03592992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25030764|NCT03592992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030765|NCT03592992|Analgesics|analgesics|mesh-ancestor
25030766|NCT03592992|Sensory System Agents|sensory system agents|mesh-ancestor
25030767|NCT03592992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25030768|NCT03592901|Anesthetics|anesthetics|mesh-list
25030769|NCT03592901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25030770|NCT03592901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030771|NCT03592836|Furosemide|furosemide|mesh-list
25030772|NCT03592836|Diuretics|diuretics|mesh-list
25030773|NCT03592836|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
25030774|NCT03592836|Natriuretic Agents|natriuretic agents|mesh-ancestor
25030775|NCT03592836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030776|NCT03592836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25030777|NCT03592836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030778|NCT03592823|Hydroxychloroquine|hydroxychloroquine|mesh-list
25030779|NCT03592823|Antimalarials|antimalarials|mesh-ancestor
25030780|NCT03592823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25030781|NCT03592823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25030782|NCT03592823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25030783|NCT03592823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039948|NCT03553498|Hydromorphone|hydromorphone|mesh-list
24496459|NCT00504946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24496460|NCT00504946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496461|NCT00504946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24496462|NCT00504946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496463|NCT00504946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24496581|NCT00505531|Autonomic Agents|autonomic agents|mesh-ancestor
24496582|NCT00505531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24496583|NCT00505531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24496584|NCT00505531|Histamine Antagonists|histamine antagonists|mesh-ancestor
24496585|NCT00505531|Histamine Agents|histamine agents|mesh-ancestor
24496586|NCT00505531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25030784|NCT03592823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030785|NCT03592823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25030786|NCT03592680|Ascorbic Acid|ascorbic acid|mesh-list
25030787|NCT03592680|Vitamins|vitamins|mesh-ancestor
25030788|NCT03592680|Micronutrients|micronutrients|mesh-ancestor
25030789|NCT03592680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030790|NCT03592680|Antioxidants|antioxidants|mesh-ancestor
25030791|NCT03592680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030792|NCT03592680|Protective Agents|protective agents|mesh-ancestor
25030793|NCT03592667|Dapagliflozin|dapagliflozin|mesh-list
25030794|NCT03592667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25691849|NCT01990859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691850|NCT01990898|Cyclosporine|cyclosporine|mesh-list
24901732|NCT04382014|Analgesics|analgesics|mesh-ancestor
24901876|NCT04380181|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24901877|NCT04380181|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24901878|NCT04380181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901879|NCT04380181|Protective Agents|protective agents|mesh-ancestor
24901880|NCT04380298|Ketorolac|ketorolac|mesh-list
24901881|NCT04380298|Epinephrine|epinephrine|mesh-list
24901882|NCT04380298|Ropivacaine|ropivacaine|mesh-list
25030795|NCT03592667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030796|NCT03592667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25030797|NCT03592667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030798|NCT03592537|Fentanyl|fentanyl|mesh-list
25030799|NCT03592537|Midazolam|midazolam|mesh-list
25030800|NCT03592537|Bupivacaine|bupivacaine|mesh-list
25030801|NCT03592537|Anesthetics, Local|anesthetics, local|mesh-ancestor
25030802|NCT03592537|Anesthetics|anesthetics|mesh-ancestor
24597027|NCT00946907|Aspirin|aspirin|mesh-list
25006936|NCT04472182|Calcium|calcium|mesh-list
24496658|NCT00505817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24497002|NCT00507793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24497003|NCT00507793|Immunologic Factors|immunologic factors|mesh-ancestor
24497004|NCT00507793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497005|NCT00507793|Antifungal Agents|antifungal agents|mesh-ancestor
24497006|NCT00507793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24497007|NCT00507793|Dermatologic Agents|dermatologic agents|mesh-ancestor
24497008|NCT00507793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24497009|NCT00507793|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24497013|NCT00507832|Hydrocortisone|hydrocortisone|mesh-list
24497295|NCT00509353|Mitosis Modulators|mitosis modulators|mesh-ancestor
24497297|NCT00509379|Rituximab|rituximab|mesh-list
24497527|NCT00510367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497528|NCT00510367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24497529|NCT00510367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24497530|NCT00510367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24497543|NCT00510406|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25030831|NCT03592485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25030832|NCT03592485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030833|NCT03592485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25030835|NCT03592485|Sensory System Agents|sensory system agents|mesh-ancestor
25030836|NCT03592485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25030837|NCT03592485|Antipyretics|antipyretics|mesh-ancestor
25030838|NCT03592485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25030839|NCT03592485|Narcotics|narcotics|mesh-ancestor
25030844|NCT03592342|Clobetasol|clobetasol|mesh-list
25030845|NCT03592342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25030846|NCT03592342|Glucocorticoids|glucocorticoids|mesh-ancestor
25030847|NCT03592342|Hormones|hormones|mesh-ancestor
25030848|NCT03592342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25030849|NCT03592342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987631|NCT05190341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24987632|NCT05190341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24987633|NCT05190341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989503|NCT05143762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24989504|NCT05143762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24989505|NCT05143762|Analgesics|analgesics|mesh-ancestor
25006968|NCT04409509|Antibodies|antibodies|mesh-list
24989506|NCT05143762|Sensory System Agents|sensory system agents|mesh-ancestor
24989507|NCT05143762|Antipyretics|antipyretics|mesh-ancestor
25691851|NCT01990898|Cyclosporins|cyclosporins|mesh-list
25691852|NCT01990898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691853|NCT01990898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691854|NCT01990898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25691855|NCT01990898|Immunologic Factors|immunologic factors|mesh-ancestor
25691856|NCT01990898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691857|NCT01990898|Antifungal Agents|antifungal agents|mesh-ancestor
24497544|NCT00510406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24497545|NCT00510406|Adrenergic Agents|adrenergic agents|mesh-ancestor
24498127|NCT00513266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24498233|NCT00513630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498235|NCT00513643|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24498236|NCT00513643|Insulin Aspart|insulin aspart|mesh-list
24498237|NCT00513643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25113419|NCT02832544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25030859|NCT03592199|Sunitinib|sunitinib|mesh-list
25030860|NCT03592199|Axitinib|axitinib|mesh-list
25030861|NCT03592199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25030862|NCT03592199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25030863|NCT03592199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25030864|NCT03592199|Growth Substances|growth substances|mesh-ancestor
25030865|NCT03592199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498246|NCT00513656|Sensory System Agents|sensory system agents|mesh-ancestor
24498275|NCT00513864|Respiratory System Agents|respiratory system agents|mesh-ancestor
24498276|NCT00513864|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24498278|NCT00513864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24498360|NCT00514163|Gemcitabine|gemcitabine|mesh-list
24498361|NCT00514163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24498362|NCT00514163|Antimetabolites|antimetabolites|mesh-ancestor
24498420|NCT00514475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498421|NCT00514488|Imatinib Mesylate|imatinib mesylate|mesh-list
24498422|NCT00514488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498423|NCT00514488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24498424|NCT00514488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25030866|NCT03592199|Growth Inhibitors|growth inhibitors|mesh-ancestor
24746824|NCT03424122|Rituximab|rituximab|mesh-list
25030867|NCT03592199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25030882|NCT03592069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25030883|NCT03592069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25030884|NCT03592069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25030885|NCT03592069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25030886|NCT03592069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25030887|NCT03592069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25021038|NCT03675555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25030888|NCT03592069|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25030889|NCT03592069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25030890|NCT03592069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030891|NCT03592069|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25030892|NCT03592069|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25030893|NCT03592069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25030894|NCT03591991|Empagliflozin|empagliflozin|mesh-list
25030895|NCT03591991|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25030896|NCT03591991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030897|NCT03591991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25030898|NCT03591991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030899|NCT03591913|Misoprostol|misoprostol|mesh-list
25030900|NCT03591913|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25030901|NCT03591913|Abortifacient Agents|abortifacient agents|mesh-ancestor
25030902|NCT03591913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25030903|NCT03591913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030904|NCT03591913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25030905|NCT03591913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25030906|NCT03591913|Oxytocics|oxytocics|mesh-ancestor
25030907|NCT03591900|Insulin|insulin|mesh-list
25030908|NCT03591900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25030909|NCT03591900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030911|NCT03591757|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24498425|NCT00514488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498426|NCT00514527|Oritavancin|oritavancin|mesh-list
24498427|NCT00514527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24498428|NCT00514527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24498429|NCT00514605|Antibodies|antibodies|mesh-list
24498430|NCT00514605|Immunoglobulins|immunoglobulins|mesh-list
24498431|NCT00514605|Immunologic Factors|immunologic factors|mesh-ancestor
25030912|NCT03591757|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25030913|NCT03591757|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25030914|NCT03591757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25030915|NCT03591757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030916|NCT03591744|Dexamethasone|dexamethasone|mesh-list
25030917|NCT03591744|Dexamethasone acetate|dexamethasone acetate|mesh-list
25030918|NCT03591744|Doxorubicin|doxorubicin|mesh-list
25030919|NCT03591744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25030920|NCT03591744|Lenalidomide|lenalidomide|mesh-list
25030921|NCT03591744|Bortezomib|bortezomib|mesh-list
25030922|NCT03591744|Daratumumab|daratumumab|mesh-list
25030923|NCT03591744|Ichthammol|ichthammol|mesh-list
25030924|NCT03591744|BB 1101|bb 1101|mesh-list
25030925|NCT03591744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25030926|NCT03591744|Antiemetics|antiemetics|mesh-ancestor
25030927|NCT03591744|Autonomic Agents|autonomic agents|mesh-ancestor
25030928|NCT03591744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25030929|NCT03591744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030938|NCT03591744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25030939|NCT03591744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25030940|NCT03591744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030941|NCT03591744|Immunologic Factors|immunologic factors|mesh-ancestor
25030942|NCT03591744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25030943|NCT03591744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25030944|NCT03591744|Growth Substances|growth substances|mesh-ancestor
24498481|NCT00514982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499111|NCT00517764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24499112|NCT00517764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24499349|NCT00519051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499350|NCT00519051|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24499351|NCT00519051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24499352|NCT00519051|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24499353|NCT00519051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24499354|NCT00519051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499356|NCT00519116|Tacrolimus|tacrolimus|mesh-list
24499357|NCT00519116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24499358|NCT00519116|Immunologic Factors|immunologic factors|mesh-ancestor
24499359|NCT00519116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499360|NCT00519116|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24499634|NCT00520325|Agglutinins|agglutinins|mesh-ancestor
24499771|NCT00521040|Histamine Agents|histamine agents|mesh-ancestor
24499772|NCT00521040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24499773|NCT00521040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499774|NCT00521040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499775|NCT00521092|Sunitinib|sunitinib|mesh-list
24499776|NCT00521092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24499777|NCT00521092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24499778|NCT00521092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25030945|NCT03591744|Growth Inhibitors|growth inhibitors|mesh-ancestor
25030946|NCT03591744|Protease Inhibitors|protease inhibitors|mesh-ancestor
25030947|NCT03591744|Dermatologic Agents|dermatologic agents|mesh-ancestor
25030949|NCT03591679|Oxytocics|oxytocics|mesh-ancestor
25030950|NCT03591679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25030951|NCT03591679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030952|NCT03591575|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25030953|NCT03591575|Deferiprone|deferiprone|mesh-list
24501956|NCT00531687|Antiviral Agents|antiviral agents|mesh-ancestor
25030965|NCT03591549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25030966|NCT03591549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030968|NCT03591536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25030969|NCT03591536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25030970|NCT03591536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499967|NCT00521859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24500583|NCT00525096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24500584|NCT00525096|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24500585|NCT00525096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24500586|NCT00525096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24500587|NCT00525096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500648|NCT00525382|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24500649|NCT00525382|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24500650|NCT00525382|Histamine Antagonists|histamine antagonists|mesh-ancestor
24501218|NCT00527449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25030971|NCT03591536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25030972|NCT03591536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25030974|NCT03591536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030975|NCT03591536|Vasodilator Agents|vasodilator agents|mesh-ancestor
25030976|NCT03591536|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25030977|NCT03591536|Antioxidants|antioxidants|mesh-ancestor
25030978|NCT03591471|Prednisone|prednisone|mesh-list
25030979|NCT03591471|Benazepril|benazepril|mesh-list
25030980|NCT03591471|Heparin|heparin|mesh-list
25030981|NCT03591471|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25030982|NCT03591471|Tinzaparin|tinzaparin|mesh-list
25030983|NCT03591471|Dalteparin|dalteparin|mesh-list
25030984|NCT03591471|Calcium heparin|calcium heparin|mesh-list
25030985|NCT03591471|Dipyridamole|dipyridamole|mesh-list
25030986|NCT03591471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030987|NCT03591471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25030988|NCT03591471|Glucocorticoids|glucocorticoids|mesh-ancestor
25030989|NCT03591471|Hormones|hormones|mesh-ancestor
24501220|NCT00527501|Brinzolamide|brinzolamide|mesh-list
24501221|NCT00527501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24501222|NCT00527501|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24501223|NCT00527501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501224|NCT00527501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501225|NCT00527540|Interferons|interferons|mesh-list
24501226|NCT00527540|Ribavirin|ribavirin|mesh-list
24501227|NCT00527540|Interferon-alpha|interferon-alpha|mesh-list
24501228|NCT00527540|Interferon alpha-2|interferon alpha-2|mesh-list
24501229|NCT00527540|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24501316|NCT00528060|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25030993|NCT03591471|Anticoagulants|anticoagulants|mesh-ancestor
25031011|NCT03591289|Rocuronium|rocuronium|mesh-list
25031012|NCT03591289|Anticonvulsants|anticonvulsants|mesh-ancestor
25031013|NCT03591289|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25031014|NCT03591289|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25031015|NCT03591289|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25031016|NCT03591289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25031017|NCT03591289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031018|NCT03591276|Antineoplastic Agents|antineoplastic agents|mesh-list
25031019|NCT03591172|Propolis|propolis|mesh-list
25031020|NCT03591172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25031021|NCT03591003|Antibodies|antibodies|mesh-list
25031022|NCT03591003|Antibodies, Blocking|antibodies, blocking|mesh-list
25031023|NCT03591003|Immunologic Factors|immunologic factors|mesh-ancestor
25031024|NCT03591003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031025|NCT03590912|Mometasone Furoate|mometasone furoate|mesh-list
25031026|NCT03590912|Cetirizine|cetirizine|mesh-list
25031027|NCT03590912|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25031028|NCT03590912|Cefpodoxime|cefpodoxime|mesh-list
25031029|NCT03590912|Prednisolone|prednisolone|mesh-list
25031030|NCT03590912|Phenylephrine|phenylephrine|mesh-list
25031031|NCT03590912|Oxymetazoline|oxymetazoline|mesh-list
24989641|NCT04969276|Vaccines|vaccines|mesh-list
24501410|NCT00528385|Natriuretic Agents|natriuretic agents|mesh-ancestor
24501411|NCT00528502|Lidocaine|lidocaine|mesh-list
24501412|NCT00528502|Anesthetics, Local|anesthetics, local|mesh-ancestor
24501413|NCT00528502|Anesthetics|anesthetics|mesh-ancestor
24501414|NCT00528502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24501415|NCT00528502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501416|NCT00528502|Sensory System Agents|sensory system agents|mesh-ancestor
24501417|NCT00528502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24501418|NCT00528502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24501528|NCT00529269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501529|NCT00529269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24501530|NCT00529269|Antitubercular Agents|antitubercular agents|mesh-ancestor
24501531|NCT00529269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24501535|NCT00529295|Misoprostol|misoprostol|mesh-list
24501546|NCT00529360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501562|NCT00529594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24501563|NCT00529594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24501564|NCT00529594|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24501565|NCT00529594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25031032|NCT03590912|Nasal Decongestants|nasal decongestants|mesh-list
25031034|NCT03590912|Histamine Antagonists|histamine antagonists|mesh-list
25031035|NCT03590912|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25031036|NCT03590912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25031037|NCT03590912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25031038|NCT03590912|Glucocorticoids|glucocorticoids|mesh-ancestor
25031039|NCT03590912|Hormones|hormones|mesh-ancestor
25031040|NCT03590912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25031041|NCT03590912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031042|NCT03590912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25031043|NCT03590912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031044|NCT03590912|Autonomic Agents|autonomic agents|mesh-ancestor
25031045|NCT03590912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25031046|NCT03590912|Protective Agents|protective agents|mesh-ancestor
25031047|NCT03590912|Dermatologic Agents|dermatologic agents|mesh-ancestor
25031048|NCT03590912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24748696|NCT02215980|Hormones|hormones|mesh-ancestor
24501703|NCT00530517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501704|NCT00530517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501707|NCT00530556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24501760|NCT00530907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24501761|NCT00530907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24501821|NCT00531193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501822|NCT00531193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501823|NCT00531245|Oxaliplatin|oxaliplatin|mesh-list
24501824|NCT00531245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501825|NCT00531271|Docetaxel|docetaxel|mesh-list
24501881|NCT00531362|Antipyretics|antipyretics|mesh-ancestor
24501882|NCT00531401|Farnesylthiosalicylic acid|farnesylthiosalicylic acid|mesh-list
24501883|NCT00531401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501905|NCT00531544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501906|NCT00531557|Ritonavir|ritonavir|mesh-list
24501907|NCT00531557|Darunavir|darunavir|mesh-list
24501908|NCT00531557|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24501909|NCT00531557|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24501910|NCT00531557|Protease Inhibitors|protease inhibitors|mesh-ancestor
24501911|NCT00531557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25031060|NCT03590912|Mydriatics|mydriatics|mesh-ancestor
25031061|NCT03590912|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25031062|NCT03590873|Vasopressins|vasopressins|mesh-list
25031063|NCT03590873|Arginine Vasopressin|arginine vasopressin|mesh-list
25031064|NCT03590873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031065|NCT03590873|Hemostatics|hemostatics|mesh-ancestor
25031066|NCT03590873|Coagulants|coagulants|mesh-ancestor
25031067|NCT03590873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25031068|NCT03590873|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25031069|NCT03590873|Natriuretic Agents|natriuretic agents|mesh-ancestor
25031070|NCT03590769|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25031071|NCT03590769|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25031072|NCT03590769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031073|NCT03590626|Dulaglutide|dulaglutide|mesh-list
25031074|NCT03590626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25031075|NCT03590626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031076|NCT03590587|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
24987782|NCT04989829|Omeprazole|omeprazole|mesh-list
25031077|NCT03590587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25031078|NCT03590587|Glucocorticoids|glucocorticoids|mesh-ancestor
25031080|NCT03590587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25031081|NCT03590587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501912|NCT00531557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501913|NCT00531557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24501914|NCT00531557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24501915|NCT00531557|Antiviral Agents|antiviral agents|mesh-ancestor
24501916|NCT00531557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24501917|NCT00531557|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24501918|NCT00531557|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24501928|NCT00531596|Protective Agents|protective agents|mesh-ancestor
24501952|NCT00531687|Mitosis Modulators|mitosis modulators|mesh-ancestor
24501953|NCT00531687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501954|NCT00531687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24501955|NCT00531687|Antimetabolites|antimetabolites|mesh-ancestor
25113427|NCT02832531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25113428|NCT02832531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25113429|NCT02832531|Analgesics|analgesics|mesh-ancestor
24787006|NCT01923064|Polidocanol|polidocanol|mesh-list
24579317|NCT00854451|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24579318|NCT00854451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24579319|NCT00854451|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24579320|NCT00854451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579321|NCT00854451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579322|NCT00854477|Capecitabine|capecitabine|mesh-list
24579323|NCT00854477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24579324|NCT00854477|Antimetabolites|antimetabolites|mesh-ancestor
24818305|NCT02087813|Antiemetics|antiemetics|mesh-ancestor
25113430|NCT02832531|Sensory System Agents|sensory system agents|mesh-ancestor
25113431|NCT02832531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25113432|NCT02832531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25113433|NCT02832531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25113434|NCT02832531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25113435|NCT02832531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25113436|NCT02832531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25113437|NCT02832531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113438|NCT02832531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25113439|NCT02832531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25113440|NCT02832531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24502093|NCT05319834|Antipyretics|antipyretics|mesh-ancestor
24502094|NCT05319756|Oxycodone|oxycodone|mesh-list
24502095|NCT05319756|Gabapentin|gabapentin|mesh-list
24433313|NCT00258115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24502096|NCT05319756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24502097|NCT05319756|Narcotics|narcotics|mesh-ancestor
24502100|NCT05319756|Analgesics|analgesics|mesh-ancestor
24502185|NCT05318248|Clonidine|clonidine|mesh-list
24502186|NCT05318248|Analgesics|analgesics|mesh-ancestor
24502187|NCT05318248|Sensory System Agents|sensory system agents|mesh-ancestor
24502249|NCT05317611|Antipruritics|antipruritics|mesh-ancestor
24502250|NCT05317611|Dermatologic Agents|dermatologic agents|mesh-ancestor
24502251|NCT05317611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24502252|NCT05317611|Serotonin Agents|serotonin agents|mesh-ancestor
25113443|NCT02832531|Antithrombins|antithrombins|mesh-ancestor
25113444|NCT02832531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25113445|NCT02832531|Protease Inhibitors|protease inhibitors|mesh-ancestor
25113446|NCT02832531|Anticoagulants|anticoagulants|mesh-ancestor
24806075|NCT02013492|Propranolol|propranolol|mesh-list
24502253|NCT05317611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24502254|NCT05317611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502255|NCT05317611|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24502256|NCT05317611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24502377|NCT05220722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502445|NCT05085067|Protective Agents|protective agents|mesh-ancestor
24502446|NCT05075980|Cisplatin|cisplatin|mesh-list
24502447|NCT05075980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25113488|NCT02759588|Bevacizumab|bevacizumab|mesh-list
25113489|NCT02759588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25113490|NCT02759588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031082|NCT03590496|Calcium|calcium|mesh-list
25031083|NCT03590496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25031084|NCT03590496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031085|NCT03590444|Ranibizumab|ranibizumab|mesh-list
25031106|NCT03590210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25031108|NCT03590210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25031109|NCT03590210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031110|NCT03590210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25031111|NCT03590210|Alkylating Agents|alkylating agents|mesh-ancestor
25691858|NCT01990898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25691859|NCT01990898|Dermatologic Agents|dermatologic agents|mesh-ancestor
25691860|NCT01990898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25691861|NCT01990898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25691862|NCT01991197|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25691863|NCT01991197|Gliclazide|gliclazide|mesh-list
25691864|NCT01991197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25691865|NCT01991197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691866|NCT01991197|Incretins|incretins|mesh-ancestor
25691867|NCT01991197|Hormones|hormones|mesh-ancestor
24502459|NCT05061654|Tazobactam|tazobactam|mesh-list
24502460|NCT05061654|Ceftolozane|ceftolozane|mesh-list
25691868|NCT01991197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24502461|NCT05061654|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
24502462|NCT05061654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24502463|NCT05061654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25031112|NCT03590197|Melatonin|melatonin|mesh-list
25031113|NCT03590197|Antioxidants|antioxidants|mesh-ancestor
25031114|NCT03590197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031115|NCT03590197|Protective Agents|protective agents|mesh-ancestor
25031116|NCT03590197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031117|NCT03590197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25031118|NCT03590171|Bortezomib|bortezomib|mesh-list
25031119|NCT03590171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031120|NCT03590119|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25031121|NCT03590119|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24987922|NCT04668950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24987923|NCT04668950|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24987924|NCT04668950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24987925|NCT04668950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24987926|NCT04668950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987927|NCT04668950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24987928|NCT04668950|Serotonin Agents|serotonin agents|mesh-ancestor
24987929|NCT04668950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24987930|NCT04668950|Antidepressive Agents|antidepressive agents|mesh-ancestor
24987931|NCT04668950|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24987932|NCT04668950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24987933|NCT04668950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24987934|NCT04668950|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24987935|NCT04631471|Ibudilast|ibudilast|mesh-list
24987936|NCT04631471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24987937|NCT04631471|Autonomic Agents|autonomic agents|mesh-ancestor
25031122|NCT03590119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502544|NCT04974684|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24502545|NCT04974684|Protease Inhibitors|protease inhibitors|mesh-ancestor
24502546|NCT04974684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24502547|NCT04974684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502548|NCT04974684|Anticoagulants|anticoagulants|mesh-ancestor
24502617|NCT04748172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031123|NCT03590080|Methylprednisolone|methylprednisolone|mesh-list
25113511|NCT02723955|Pemetrexed|pemetrexed|mesh-list
25031124|NCT03590080|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25031125|NCT03590080|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25031126|NCT03590080|Prednisolone|prednisolone|mesh-list
25031127|NCT03590080|Prednisolone acetate|prednisolone acetate|mesh-list
25031128|NCT03590080|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25031129|NCT03590080|Prednisolone phosphate|prednisolone phosphate|mesh-list
25031130|NCT03590080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25031131|NCT03590080|Antiemetics|antiemetics|mesh-ancestor
25031132|NCT03590080|Autonomic Agents|autonomic agents|mesh-ancestor
25031133|NCT03590080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25031134|NCT03590080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597526|NCT00949780|Chloral Hydrate|chloral hydrate|mesh-list
25031139|NCT03590080|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25031140|NCT03590080|Protective Agents|protective agents|mesh-ancestor
25031141|NCT03590080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25031142|NCT03590080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031143|NCT03589898|Gabapentin|gabapentin|mesh-list
25031144|NCT03589898|Analgesics|analgesics|mesh-ancestor
25031145|NCT03589898|Sensory System Agents|sensory system agents|mesh-ancestor
25031146|NCT03589898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25031147|NCT03589898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031148|NCT03589898|Anticonvulsants|anticonvulsants|mesh-ancestor
25031149|NCT03589898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25031150|NCT03589898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25031153|NCT03589898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25031154|NCT03589898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25031155|NCT03589898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25031156|NCT03589898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031158|NCT03589833|Methotrexate|methotrexate|mesh-list
25031159|NCT03589833|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24502703|NCT04630886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24502704|NCT04630886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502705|NCT04630886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25031160|NCT03589833|Abortifacient Agents|abortifacient agents|mesh-ancestor
24815935|NCT02072798|Cefuroxime|cefuroxime|mesh-list
24815936|NCT02072798|Cefuroxime axetil|cefuroxime axetil|mesh-list
24815939|NCT02072811|Cytarabine|cytarabine|mesh-list
25031161|NCT03589833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25031162|NCT03589833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031163|NCT03589833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25031164|NCT03589833|Antimetabolites|antimetabolites|mesh-ancestor
25031165|NCT03589833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031166|NCT03589833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031167|NCT03589833|Dermatologic Agents|dermatologic agents|mesh-ancestor
25031168|NCT03589833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25031169|NCT03589833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25031170|NCT03589833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25031171|NCT03589833|Immunologic Factors|immunologic factors|mesh-ancestor
25031172|NCT03589833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25031173|NCT03589833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25031174|NCT03589690|Thioctic Acid|thioctic acid|mesh-list
25031175|NCT03589690|Antioxidants|antioxidants|mesh-ancestor
25031176|NCT03589690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031177|NCT03589690|Protective Agents|protective agents|mesh-ancestor
25031178|NCT03589690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031179|NCT03589690|Vitamin B Complex|vitamin b complex|mesh-ancestor
25031180|NCT03589690|Vitamins|vitamins|mesh-ancestor
25031181|NCT03589690|Micronutrients|micronutrients|mesh-ancestor
25031182|NCT03589547|Durvalumab|durvalumab|mesh-list
25031183|NCT03589547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25031184|NCT03589547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031185|NCT03589495|Acetylcysteine|acetylcysteine|mesh-list
25031186|NCT03589495|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25031187|NCT03589495|Antiviral Agents|antiviral agents|mesh-ancestor
25031188|NCT03589495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25031189|NCT03589495|Expectorants|expectorants|mesh-ancestor
25031190|NCT03589495|Respiratory System Agents|respiratory system agents|mesh-ancestor
25031191|NCT03589495|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25031192|NCT03589495|Antioxidants|antioxidants|mesh-ancestor
24597527|NCT00949780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25031211|NCT03589222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25031212|NCT03589222|Antiemetics|antiemetics|mesh-ancestor
24502706|NCT04630886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24502803|NCT04380740|Immunologic Factors|immunologic factors|mesh-ancestor
24502804|NCT04380740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502805|NCT04380740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25031214|NCT03589222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25031215|NCT03589222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031401|NCT03588039|Pembrolizumab|pembrolizumab|mesh-list
25031223|NCT03589066|Dopamine Agonists|dopamine agonists|mesh-ancestor
25031224|NCT03589066|Dopamine Agents|dopamine agents|mesh-ancestor
25031225|NCT03589066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25031226|NCT03589066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031227|NCT03589066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031228|NCT03589040|Darunavir|darunavir|mesh-list
25031229|NCT03589040|Rilpivirine|rilpivirine|mesh-list
25031230|NCT03589040|Etonogestrel|etonogestrel|mesh-list
25031231|NCT03589040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25031232|NCT03589040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25031233|NCT03589040|Protease Inhibitors|protease inhibitors|mesh-ancestor
25031234|NCT03589040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25031240|NCT03589040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24989842|NCT04677959|Tocolytic Agents|tocolytic agents|mesh-ancestor
24502806|NCT04325685|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
24502808|NCT04288323|Diethylenetriamine|diethylenetriamine|mesh-list
24502866|NCT04137770|Analgesics|analgesics|mesh-ancestor
24502867|NCT04137770|Sensory System Agents|sensory system agents|mesh-ancestor
24502868|NCT04137770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24502869|NCT04137770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031241|NCT03589040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25031242|NCT03589040|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24751425|NCT01704092|Dexmedetomidine|dexmedetomidine|mesh-list
25031243|NCT03589040|Contraceptive Agents|contraceptive agents|mesh-ancestor
25031244|NCT03589040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25031245|NCT03589040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031246|NCT03589040|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25031247|NCT03589027|Ritonavir|ritonavir|mesh-list
25031248|NCT03589027|Darunavir|darunavir|mesh-list
25031249|NCT03589027|Rilpivirine|rilpivirine|mesh-list
25691869|NCT01991197|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25691870|NCT01991197|Protease Inhibitors|protease inhibitors|mesh-ancestor
25031250|NCT03589027|Levonorgestrel|levonorgestrel|mesh-list
24880948|NCT03177291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24597579|NCT00950105|Semapimod|semapimod|mesh-list
25031254|NCT03589027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25031255|NCT03589027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031256|NCT03589027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25031257|NCT03589027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25031258|NCT03589027|Antiviral Agents|antiviral agents|mesh-ancestor
25031259|NCT03589027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25031260|NCT03589027|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25031261|NCT03589027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25031262|NCT03589027|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25031263|NCT03589027|Contraceptive Agents|contraceptive agents|mesh-ancestor
25031264|NCT03589027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25031265|NCT03589027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031266|NCT03589027|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25031267|NCT03589027|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25031268|NCT03589027|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25031269|NCT03589027|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24989864|NCT04624984|Antimitotic Agents|antimitotic agents|mesh-ancestor
24502870|NCT04137770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24502871|NCT04137770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24751426|NCT01704092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24751461|NCT01704469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24751462|NCT01704482|Acetylcysteine|acetylcysteine|mesh-list
24751463|NCT01704482|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24751464|NCT01704482|Antiviral Agents|antiviral agents|mesh-ancestor
24415909|NCT00201422|Omeprazole|omeprazole|mesh-list
24751494|NCT01704638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24434310|NCT00262054|Protease Inhibitors|protease inhibitors|mesh-ancestor
24751495|NCT01704638|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24751496|NCT01704638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24751497|NCT01704638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751498|NCT01704638|Protective Agents|protective agents|mesh-ancestor
24502912|NCT04049084|Vasodilator Agents|vasodilator agents|mesh-ancestor
24502913|NCT04049084|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24502914|NCT04049084|Purinergic Agonists|purinergic agonists|mesh-ancestor
24502915|NCT04049084|Purinergic Agents|purinergic agents|mesh-ancestor
24502916|NCT04049084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24502917|NCT04049084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502918|NCT04033419|Memantine|memantine|mesh-list
24502930|NCT04020172|Autonomic Agents|autonomic agents|mesh-ancestor
25031270|NCT03589027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25031271|NCT03588988|Dexmedetomidine|dexmedetomidine|mesh-list
25031272|NCT03588988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25031273|NCT03588988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25031274|NCT03588988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031275|NCT03588988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25031276|NCT03588988|Analgesics|analgesics|mesh-ancestor
25031277|NCT03588988|Sensory System Agents|sensory system agents|mesh-ancestor
25031278|NCT03588988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25031279|NCT03588988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25031280|NCT03588988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25031281|NCT03588988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25031282|NCT03588988|Adrenergic Agents|adrenergic agents|mesh-ancestor
25031283|NCT03588988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25031284|NCT03588988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031285|NCT03588936|Nivolumab|nivolumab|mesh-list
25031286|NCT03588936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25031287|NCT03588936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031288|NCT03588936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25031289|NCT03588936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031291|NCT03588871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25031292|NCT03588871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25113491|NCT02759588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25113492|NCT02759588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25113493|NCT02759588|Growth Substances|growth substances|mesh-ancestor
24502948|NCT04000854|Calcium|calcium|mesh-list
24502949|NCT04000854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25691871|NCT01991197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691872|NCT01991197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691873|NCT01991548|Insulin|insulin|mesh-list
25691874|NCT01991548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25113497|NCT02740179|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25113498|NCT02740179|Hormone Antagonists|hormone antagonists|mesh-ancestor
25113499|NCT02740179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25113500|NCT02740179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415953|NCT00201682|Etanercept|etanercept|mesh-list
25113501|NCT02740179|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25113502|NCT02740179|Diuretics|diuretics|mesh-ancestor
25113503|NCT02740179|Natriuretic Agents|natriuretic agents|mesh-ancestor
25113504|NCT02740179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25113507|NCT02723955|Docetaxel|docetaxel|mesh-list
25113508|NCT02723955|Carboplatin|carboplatin|mesh-list
25113509|NCT02723955|Pembrolizumab|pembrolizumab|mesh-list
25113510|NCT02723955|Fluorouracil|fluorouracil|mesh-list
25113523|NCT02723955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25113524|NCT02723955|Immunologic Factors|immunologic factors|mesh-ancestor
25113525|NCT02723955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25113530|NCT02714881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25113531|NCT02714881|Immunologic Factors|immunologic factors|mesh-ancestor
25113532|NCT02714881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25113533|NCT02714881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24502959|NCT03981341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24502960|NCT03959423|Insulin|insulin|mesh-list
24502961|NCT03959423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24502962|NCT03959423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502963|NCT03950817|Ketamine|ketamine|mesh-list
24502964|NCT03950817|Analgesics|analgesics|mesh-ancestor
24502965|NCT03950817|Sensory System Agents|sensory system agents|mesh-ancestor
24502966|NCT03950817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25113547|NCT02657434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113555|NCT02636270|Mecasermin|mecasermin|mesh-list
25113556|NCT02636270|Growth Substances|growth substances|mesh-ancestor
25113557|NCT02636270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988074|NCT04251715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25031293|NCT03588767|Vitamin D|vitamin d|mesh-list
25031294|NCT03588767|Ergocalciferols|ergocalciferols|mesh-list
25031295|NCT03588767|Cholecalciferol|cholecalciferol|mesh-list
25031296|NCT03588767|Vitamins|vitamins|mesh-list
25031297|NCT03588767|Testosterone Congeners|testosterone congeners|mesh-list
25031298|NCT03588767|Micronutrients|micronutrients|mesh-ancestor
25031299|NCT03588767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031300|NCT03588767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25031301|NCT03588767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24503027|NCT03571802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503028|NCT03571802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24503029|NCT03571802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24503033|NCT03539614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24503034|NCT03539614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24503035|NCT03539614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24503036|NCT03539614|Adrenergic Agents|adrenergic agents|mesh-ancestor
24503037|NCT03539614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24503038|NCT03539614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503039|NCT03539614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503040|NCT03532022|Dexamethasone|dexamethasone|mesh-list
24503041|NCT03532022|Prednisone|prednisone|mesh-list
24503042|NCT03532022|Prednisolone|prednisolone|mesh-list
24503050|NCT03532022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24503051|NCT03532022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503052|NCT03532022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24503054|NCT03532022|Hormones|hormones|mesh-ancestor
24503055|NCT03532022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24503056|NCT03532022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24503057|NCT03532022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503058|NCT03481634|Aflibercept|aflibercept|mesh-list
24503059|NCT03481634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25031304|NCT03588767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25031312|NCT03588715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25031313|NCT03588715|Immunologic Factors|immunologic factors|mesh-ancestor
25031314|NCT03588715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031316|NCT03588689|Anesthetics, Local|anesthetics, local|mesh-ancestor
25031317|NCT03588689|Anesthetics|anesthetics|mesh-ancestor
25031325|NCT03588676|Protective Agents|protective agents|mesh-ancestor
25031326|NCT03588676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031327|NCT03588676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25031328|NCT03588611|Hirudins|hirudins|mesh-list
25031329|NCT03588611|Bivalirudin|bivalirudin|mesh-list
25031330|NCT03588611|Antithrombins|antithrombins|mesh-ancestor
25031331|NCT03588611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25031332|NCT03588611|Protease Inhibitors|protease inhibitors|mesh-ancestor
25031333|NCT03588611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25031334|NCT03588611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031335|NCT03588611|Anticoagulants|anticoagulants|mesh-ancestor
25107371|NCT03140488|Oxytocin|oxytocin|mesh-list
24503100|NCT03288545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24503101|NCT03288545|Immunologic Factors|immunologic factors|mesh-ancestor
24503102|NCT03288545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031336|NCT03588611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25031337|NCT03588611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25031338|NCT03588533|Capecitabine|capecitabine|mesh-list
25031339|NCT03588533|Trastuzumab|trastuzumab|mesh-list
25031340|NCT03588533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031341|NCT03588533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25031342|NCT03588533|Antimetabolites|antimetabolites|mesh-ancestor
25031343|NCT03588533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031344|NCT03588533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25031346|NCT03588494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25031347|NCT03588494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25031348|NCT03588494|Growth Substances|growth substances|mesh-ancestor
25031349|NCT03588494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031350|NCT03588494|Growth Inhibitors|growth inhibitors|mesh-ancestor
25031351|NCT03588494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031352|NCT03588429|Sevoflurane|sevoflurane|mesh-list
25031354|NCT03588429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25031355|NCT03588429|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25031356|NCT03588429|Anesthetics, General|anesthetics, general|mesh-ancestor
25031357|NCT03588429|Anesthetics|anesthetics|mesh-ancestor
25031430|NCT03587662|Antimetabolites|antimetabolites|mesh-ancestor
25691876|NCT01991743|Bupivacaine|bupivacaine|mesh-list
25691877|NCT01991743|Anesthetics, Local|anesthetics, local|mesh-ancestor
24892871|NCT04457609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892872|NCT04457648|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24892913|NCT04456985|Micronutrients|micronutrients|mesh-ancestor
25031365|NCT03588351|Disinfectants|disinfectants|mesh-ancestor
25031366|NCT03588351|Dermatologic Agents|dermatologic agents|mesh-ancestor
25031367|NCT03588351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25031368|NCT03588351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25031369|NCT03588351|Antimetabolites|antimetabolites|mesh-ancestor
25031370|NCT03588351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752390|NCT01710163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24503103|NCT03288545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24503104|NCT03283566|Hydroxychloroquine|hydroxychloroquine|mesh-list
24503105|NCT03283566|Antimalarials|antimalarials|mesh-ancestor
24503108|NCT03283566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24503109|NCT03283566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503110|NCT03283566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031371|NCT03588351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25031373|NCT03588351|Sequestering Agents|sequestering agents|mesh-ancestor
25031374|NCT03588351|Hemostatics|hemostatics|mesh-ancestor
25031375|NCT03588351|Coagulants|coagulants|mesh-ancestor
25031395|NCT03588078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25031396|NCT03588078|Antimetabolites|antimetabolites|mesh-ancestor
25031397|NCT03588078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031398|NCT03588078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031399|NCT03588078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25031406|NCT03588039|Mitosis Modulators|mitosis modulators|mesh-ancestor
25031407|NCT03588039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031408|NCT03588039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25031414|NCT03587779|Desflurane|desflurane|mesh-list
25031415|NCT03587779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25031416|NCT03587779|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25031417|NCT03587779|Anesthetics, General|anesthetics, general|mesh-ancestor
25031418|NCT03587779|Anesthetics|anesthetics|mesh-ancestor
25031419|NCT03587779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24503153|NCT03077685|Paclitaxel|paclitaxel|mesh-list
24503154|NCT03077685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24503155|NCT03077685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503156|NCT03077685|Tubulin Modulators|tubulin modulators|mesh-ancestor
24503157|NCT03077685|Antimitotic Agents|antimitotic agents|mesh-ancestor
24503158|NCT03077685|Mitosis Modulators|mitosis modulators|mesh-ancestor
24503159|NCT03077685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754198|NCT01719614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754199|NCT01719614|Antiviral Agents|antiviral agents|mesh-ancestor
24503160|NCT03074539|Riociguat|riociguat|mesh-list
24503161|NCT03074539|Enzyme Activators|enzyme activators|mesh-ancestor
24503162|NCT03074539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031420|NCT03587779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031421|NCT03587701|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25031422|NCT03587701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25031423|NCT03587662|Gemcitabine|gemcitabine|mesh-list
25031424|NCT03587662|Doxorubicin|doxorubicin|mesh-list
25031425|NCT03587662|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25031426|NCT03587662|Daunorubicin|daunorubicin|mesh-list
25031427|NCT03587662|Ixazomib|ixazomib|mesh-list
25031428|NCT03587662|Glycine|glycine|mesh-list
25031429|NCT03587662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25031453|NCT03587558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25031454|NCT03587558|Antioxidants|antioxidants|mesh-ancestor
25031455|NCT03587558|Protective Agents|protective agents|mesh-ancestor
25031456|NCT03587558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25031457|NCT03587558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25031458|NCT03587558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25031459|NCT03587558|Vasodilator Agents|vasodilator agents|mesh-ancestor
25031460|NCT03587558|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25031461|NCT03587558|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25691878|NCT01991743|Anesthetics|anesthetics|mesh-ancestor
25691879|NCT01991743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25691880|NCT01991743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691881|NCT01991743|Sensory System Agents|sensory system agents|mesh-ancestor
25031462|NCT03587558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25031463|NCT03587558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25031464|NCT03587558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25031465|NCT03587441|Neostigmine|neostigmine|mesh-list
25031466|NCT03587441|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25031467|NCT03587441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25031468|NCT03587441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503166|NCT02978391|Epinephrine|epinephrine|mesh-list
24503167|NCT02978391|Hemostatics|hemostatics|mesh-list
24503168|NCT02978391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24503169|NCT02978391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24503208|NCT02670252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503210|NCT02670252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24503211|NCT02670252|Alkylating Agents|alkylating agents|mesh-ancestor
25031469|NCT03587441|Cholinergic Agents|cholinergic agents|mesh-ancestor
25031470|NCT03587441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25031471|NCT03587441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031472|NCT03587441|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24988271|NCT03615664|Antiviral Agents|antiviral agents|mesh-ancestor
24988272|NCT03615664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24988273|NCT03615664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988274|NCT03615664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24988275|NCT03615664|Immunologic Factors|immunologic factors|mesh-ancestor
24988276|NCT03615664|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24988277|NCT03615664|Alkylating Agents|alkylating agents|mesh-ancestor
24988280|NCT03556345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988281|NCT03513250|Scopolamine|scopolamine|mesh-list
24988290|NCT03513250|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24988291|NCT03513250|Cholinergic Agents|cholinergic agents|mesh-ancestor
24988292|NCT03513250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24988293|NCT03513250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988294|NCT03513250|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25031473|NCT03587441|Autonomic Agents|autonomic agents|mesh-ancestor
25031474|NCT03587441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25031475|NCT03587324|Clopidogrel|clopidogrel|mesh-list
25031476|NCT03587324|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25031477|NCT03587324|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25031478|NCT03587324|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25031479|NCT03587324|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24503224|NCT02550470|Anesthetics|anesthetics|mesh-ancestor
24503225|NCT02550470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24503226|NCT02550470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031482|NCT03587324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031484|NCT03587285|Goserelin|goserelin|mesh-list
25031485|NCT03587285|Abiraterone Acetate|abiraterone acetate|mesh-list
25031486|NCT03587285|Bicalutamide|bicalutamide|mesh-list
25031487|NCT03587285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25031488|NCT03587285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031489|NCT03587285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25031490|NCT03587285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25031491|NCT03587285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031492|NCT03587285|Hormone Antagonists|hormone antagonists|mesh-ancestor
25031493|NCT03587285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25031494|NCT03587285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031495|NCT03587285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25691882|NCT01991743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24503240|NCT02503839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24503241|NCT02503839|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24503242|NCT02503839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24503243|NCT02503839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503244|NCT02503839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503246|NCT02384850|Folic Acid|folic acid|mesh-list
24503247|NCT02384850|Fluorouracil|fluorouracil|mesh-list
24503248|NCT02384850|Oxaliplatin|oxaliplatin|mesh-list
24503249|NCT02384850|Levoleucovorin|levoleucovorin|mesh-list
24503250|NCT02384850|Antimetabolites|antimetabolites|mesh-ancestor
24503251|NCT02384850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031895|NCT03585374|Anesthetics|anesthetics|mesh-ancestor
25031499|NCT03587220|Histamine|histamine|mesh-list
25031500|NCT03587220|Anesthetics, Local|anesthetics, local|mesh-ancestor
25031501|NCT03587220|Anesthetics|anesthetics|mesh-ancestor
25031502|NCT03587220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25031503|NCT03587220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031504|NCT03587220|Sensory System Agents|sensory system agents|mesh-ancestor
25031505|NCT03587220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25031506|NCT03587220|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25031507|NCT03587220|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25031508|NCT03587220|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25031509|NCT03587220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25031510|NCT03587220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031511|NCT03587220|Antipruritics|antipruritics|mesh-ancestor
25031512|NCT03587220|Dermatologic Agents|dermatologic agents|mesh-ancestor
25031513|NCT03587220|Histamine Agonists|histamine agonists|mesh-ancestor
25031514|NCT03587220|Histamine Agents|histamine agents|mesh-ancestor
25031515|NCT03587220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25031516|NCT03587194|Apremilast|apremilast|mesh-list
24989996|NCT04429880|Oxytocin|oxytocin|mesh-list
24443546|NCT00295386|Zopiclone|zopiclone|mesh-list
24503311|NCT02274779|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24503312|NCT02274779|Fertility Agents|fertility agents|mesh-ancestor
24503313|NCT02274779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24503314|NCT02274779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031517|NCT03587194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25031518|NCT03587194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25031519|NCT03587194|Analgesics|analgesics|mesh-ancestor
25031520|NCT03587194|Sensory System Agents|sensory system agents|mesh-ancestor
25031521|NCT03587194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25031522|NCT03587194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031523|NCT03587194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25031524|NCT03587194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25031552|NCT03587025|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25031553|NCT03587025|Antidepressive Agents|antidepressive agents|mesh-ancestor
25691883|NCT01991795|Ticagrelor|ticagrelor|mesh-list
25691884|NCT01991795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25691885|NCT01991795|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25691886|NCT01991795|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25691887|NCT01991795|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25691888|NCT01991795|Purinergic Agents|purinergic agents|mesh-ancestor
25691889|NCT01991795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25691890|NCT01991795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031554|NCT03587025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25031555|NCT03587025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25031556|NCT03587025|Analgesics|analgesics|mesh-ancestor
25031557|NCT03587025|Sensory System Agents|sensory system agents|mesh-ancestor
25031558|NCT03587025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25031559|NCT03587025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031560|NCT03587025|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25031561|NCT03587025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25031562|NCT03587025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25031563|NCT03587025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031564|NCT03587025|Adrenergic Agents|adrenergic agents|mesh-ancestor
24988322|NCT03229382|Obinutuzumab|obinutuzumab|mesh-list
25031565|NCT03587025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25031567|NCT03586947|Ergocalciferols|ergocalciferols|mesh-list
25031568|NCT03586947|Cholecalciferol|cholecalciferol|mesh-list
25031569|NCT03586947|Vitamins|vitamins|mesh-list
25031570|NCT03586947|Micronutrients|micronutrients|mesh-ancestor
24503315|NCT02274779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25031587|NCT03586934|Analgesics|analgesics|mesh-ancestor
25031588|NCT03586934|Sensory System Agents|sensory system agents|mesh-ancestor
25031589|NCT03586934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25031590|NCT03586934|Anesthetics, Local|anesthetics, local|mesh-ancestor
25031591|NCT03586934|Anesthetics|anesthetics|mesh-ancestor
25031592|NCT03586934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25031593|NCT03586934|Antipyretics|antipyretics|mesh-ancestor
25031594|NCT03586934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25031595|NCT03586934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25031596|NCT03586934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25031611|NCT03586869|Oxaliplatin|oxaliplatin|mesh-list
25031612|NCT03586869|Avelumab|avelumab|mesh-list
25031613|NCT03586869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25031614|NCT03586869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031615|NCT03586869|Tubulin Modulators|tubulin modulators|mesh-ancestor
24503404|NCT01582776|Growth Inhibitors|growth inhibitors|mesh-ancestor
25031616|NCT03586869|Antimitotic Agents|antimitotic agents|mesh-ancestor
25031617|NCT03586869|Mitosis Modulators|mitosis modulators|mesh-ancestor
25031618|NCT03586869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031619|NCT03586869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25031620|NCT03586869|Immunologic Factors|immunologic factors|mesh-ancestor
25031621|NCT03586869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031622|NCT03586869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25031623|NCT03586869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24998399|NCT02960646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031624|NCT03586869|Alkylating Agents|alkylating agents|mesh-ancestor
25031625|NCT03586869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25031626|NCT03586869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25031627|NCT03586869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25031628|NCT03586869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25031629|NCT03586869|Growth Substances|growth substances|mesh-ancestor
25031630|NCT03586869|Growth Inhibitors|growth inhibitors|mesh-ancestor
25031631|NCT03586869|Antimetabolites|antimetabolites|mesh-ancestor
25031632|NCT03586869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25031633|NCT03586869|Antidotes|antidotes|mesh-ancestor
25031634|NCT03586869|Protective Agents|protective agents|mesh-ancestor
25031635|NCT03586869|Vitamin B Complex|vitamin b complex|mesh-ancestor
25031636|NCT03586869|Vitamins|vitamins|mesh-ancestor
25031637|NCT03586869|Micronutrients|micronutrients|mesh-ancestor
25031638|NCT03586817|Palonosetron|palonosetron|mesh-list
25031639|NCT03586817|Fosaprepitant|fosaprepitant|mesh-list
25031640|NCT03586817|Aprepitant|aprepitant|mesh-list
25031641|NCT03586817|Antiemetics|antiemetics|mesh-ancestor
25031642|NCT03586817|Autonomic Agents|autonomic agents|mesh-ancestor
24503405|NCT01582776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031669|NCT03586466|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25031671|NCT03586466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25031672|NCT03586466|Narcotics|narcotics|mesh-ancestor
25031673|NCT03586466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25031674|NCT03586466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031675|NCT03586466|Analgesics|analgesics|mesh-ancestor
25031676|NCT03586466|Sensory System Agents|sensory system agents|mesh-ancestor
25031688|NCT03586323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25031689|NCT03586323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25031690|NCT03586323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25031691|NCT03586323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25031692|NCT03586323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25031693|NCT03586323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031696|NCT03586219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25031697|NCT03586219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031698|NCT03586219|Analgesics|analgesics|mesh-ancestor
25031699|NCT03586219|Sensory System Agents|sensory system agents|mesh-ancestor
25031700|NCT03586219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25031701|NCT03586154|Ketamine|ketamine|mesh-list
25031702|NCT03586154|Bupivacaine|bupivacaine|mesh-list
25031703|NCT03586154|Anesthetics, Local|anesthetics, local|mesh-ancestor
25031704|NCT03586154|Anesthetics|anesthetics|mesh-ancestor
25031705|NCT03586154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25031716|NCT03586154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031717|NCT03586141|Chrysarobin|chrysarobin|mesh-list
25031718|NCT03586141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25031719|NCT03586141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25031720|NCT03586141|Analgesics|analgesics|mesh-ancestor
25031721|NCT03586141|Sensory System Agents|sensory system agents|mesh-ancestor
25031722|NCT03586141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24797153|NCT01954043|Rifampin|rifampin|mesh-list
24503502|NCT00532116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24503503|NCT00532116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24503504|NCT00532116|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24503505|NCT00532116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503528|NCT00532168|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24503529|NCT00532168|Antiviral Agents|antiviral agents|mesh-ancestor
24503530|NCT00532168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24503531|NCT00532168|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24503622|NCT00532415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24503623|NCT00532415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503624|NCT00532415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24503625|NCT00532415|Immunologic Factors|immunologic factors|mesh-ancestor
24503626|NCT00532415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25031723|NCT03586141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031724|NCT03586141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25031725|NCT03586141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25031726|NCT03586089|Diazepam|diazepam|mesh-list
25031727|NCT03586089|Phenobarbital|phenobarbital|mesh-list
25031728|NCT03586089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25031729|NCT03586089|Anticonvulsants|anticonvulsants|mesh-ancestor
25031730|NCT03586089|Antiemetics|antiemetics|mesh-ancestor
25031731|NCT03586089|Autonomic Agents|autonomic agents|mesh-ancestor
25031732|NCT03586089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25031733|NCT03586089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031734|NCT03586089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25031735|NCT03586089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25031736|NCT03586089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25031737|NCT03586089|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25031738|NCT03586089|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25031739|NCT03586089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25031740|NCT03586089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25031741|NCT03586089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25031751|NCT03586089|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25031752|NCT03586089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25031753|NCT03586089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25031755|NCT03586024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25031756|NCT03586024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031757|NCT03585998|Cisplatin|cisplatin|mesh-list
25031758|NCT03585998|Etoposide|etoposide|mesh-list
25031759|NCT03585998|Durvalumab|durvalumab|mesh-list
25031763|NCT03585998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25031764|NCT03585998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25031765|NCT03585998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031766|NCT03585998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25031778|NCT03585894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25031779|NCT03585894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756360|NCT01732666|Analgesics|analgesics|mesh-ancestor
25031780|NCT03585894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25031781|NCT03585894|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25031782|NCT03585894|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25031783|NCT03585894|Serotonin Agents|serotonin agents|mesh-ancestor
25691891|NCT01991795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031784|NCT03585894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25031786|NCT03585829|Hydrocortisone|hydrocortisone|mesh-list
25031787|NCT03585829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25031788|NCT03585829|Glucocorticoids|glucocorticoids|mesh-ancestor
25031789|NCT03585829|Hormones|hormones|mesh-ancestor
25031790|NCT03585829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25031791|NCT03585829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031792|NCT03585829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25031793|NCT03585829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031794|NCT03585751|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25031795|NCT03585751|Simvastatin|simvastatin|mesh-list
25031796|NCT03585751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24503627|NCT00532415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503645|NCT00532454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24503695|NCT00532662|Analgesics|analgesics|mesh-ancestor
24503696|NCT00532662|Sensory System Agents|sensory system agents|mesh-ancestor
25031797|NCT03585751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25031798|NCT03585751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25031799|NCT03585751|Antimetabolites|antimetabolites|mesh-ancestor
25031800|NCT03585751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031801|NCT03585751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25031802|NCT03585751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25031803|NCT03585751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25031804|NCT03585738|Folic Acid|folic acid|mesh-list
25031805|NCT03585738|Vitamin B Complex|vitamin b complex|mesh-list
25031806|NCT03585738|Inositol|inositol|mesh-list
25031807|NCT03585738|Hematinics|hematinics|mesh-ancestor
25031808|NCT03585738|Vitamins|vitamins|mesh-ancestor
25031809|NCT03585738|Micronutrients|micronutrients|mesh-ancestor
25031810|NCT03585738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031811|NCT03585725|Ribavirin|ribavirin|mesh-list
25031812|NCT03585725|Antimetabolites|antimetabolites|mesh-ancestor
25031819|NCT03585686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25031820|NCT03585686|Antimetabolites|antimetabolites|mesh-ancestor
24756805|NCT01735825|Mitosis Modulators|mitosis modulators|mesh-ancestor
25031821|NCT03585686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031822|NCT03585686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031823|NCT03585686|Antiviral Agents|antiviral agents|mesh-ancestor
25031824|NCT03585686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25031825|NCT03585686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25031826|NCT03585686|Immunologic Factors|immunologic factors|mesh-ancestor
25031827|NCT03585686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031828|NCT03585686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25031829|NCT03585686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25031830|NCT03585673|Docetaxel|docetaxel|mesh-list
25031853|NCT03585556|Growth Substances|growth substances|mesh-ancestor
25031854|NCT03585556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990141|NCT03654768|Dasatinib|dasatinib|mesh-list
24503780|NCT00532857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503781|NCT00532857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25031855|NCT03585556|Growth Inhibitors|growth inhibitors|mesh-ancestor
25031856|NCT03585556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25031857|NCT03585556|Glucocorticoids|glucocorticoids|mesh-ancestor
25031858|NCT03585556|Hormones|hormones|mesh-ancestor
25031859|NCT03585556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25031860|NCT03585556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25031861|NCT03585530|Raltitrexed|raltitrexed|mesh-list
25031862|NCT03585530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25031863|NCT03585530|Antimetabolites|antimetabolites|mesh-ancestor
25031864|NCT03585530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031865|NCT03585530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031866|NCT03585530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25031867|NCT03585530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25031868|NCT03585426|Vancomycin|vancomycin|mesh-list
25031869|NCT03585426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25031870|NCT03585426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25031871|NCT03585413|Micronutrients|micronutrients|mesh-list
25031872|NCT03585413|Trace Elements|trace elements|mesh-list
25691892|NCT01991860|Amisulpride|amisulpride|mesh-list
25031877|NCT03585374|Methoxyflurane|methoxyflurane|mesh-list
25031878|NCT03585374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25691893|NCT01991860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25691894|NCT01991860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25691895|NCT01991860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25691896|NCT01991860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894932|NCT05373446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24894933|NCT05373433|Ritonavir|ritonavir|mesh-list
24894934|NCT05373433|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24471887|NCT00397332|Alefacept|alefacept|mesh-list
24521351|NCT04848597|Mitosis Modulators|mitosis modulators|mesh-ancestor
24514133|NCT00588016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031879|NCT03585374|Narcotics|narcotics|mesh-ancestor
24626088|NCT01085617|Daunorubicin|daunorubicin|mesh-list
25031880|NCT03585374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25031881|NCT03585374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031882|NCT03585374|Analgesics|analgesics|mesh-ancestor
25031883|NCT03585374|Sensory System Agents|sensory system agents|mesh-ancestor
24990165|NCT03584152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24503785|NCT00532857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503786|NCT00532857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24503787|NCT00532857|Immunologic Factors|immunologic factors|mesh-ancestor
24503788|NCT00532857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503789|NCT00532857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24503791|NCT00532909|Capecitabine|capecitabine|mesh-list
24503792|NCT00532909|Oxaliplatin|oxaliplatin|mesh-list
24503793|NCT00532909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24503794|NCT00532909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503795|NCT00532909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24503829|NCT00533026|Analgesics|analgesics|mesh-ancestor
25031887|NCT03585374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25031888|NCT03585374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25031889|NCT03585374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25031890|NCT03585374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25031891|NCT03585374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25031892|NCT03585374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031893|NCT03585374|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25031894|NCT03585374|Anesthetics, General|anesthetics, general|mesh-ancestor
25031897|NCT03585348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25031898|NCT03585348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25031899|NCT03585348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990207|NCT03521687|Apremilast|apremilast|mesh-list
24503862|NCT00533247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24503878|NCT00533299|GABA Agents|gaba agents|mesh-ancestor
24503879|NCT00533299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25113581|NCT02535312|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25113582|NCT02535312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25113583|NCT02520791|Antibodies|antibodies|mesh-list
25691897|NCT01991860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25691898|NCT01991860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25691899|NCT01991860|Dopamine Agents|dopamine agents|mesh-ancestor
25691900|NCT01991860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25691901|NCT01991860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691902|NCT01991860|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25691903|NCT01991860|Antidepressive Agents|antidepressive agents|mesh-ancestor
25691904|NCT01992016|Ranolazine|ranolazine|mesh-list
25691905|NCT01992016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25691906|NCT01992016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25691907|NCT01992016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692701|NCT02004093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25692703|NCT02004093|Tubulin Modulators|tubulin modulators|mesh-ancestor
25692704|NCT02004093|Antimitotic Agents|antimitotic agents|mesh-ancestor
24904296|NCT04356872|Ifosfamide|ifosfamide|mesh-list
25113584|NCT02520791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25113585|NCT02520791|Immunologic Factors|immunologic factors|mesh-ancestor
25113586|NCT02520791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990210|NCT03521687|Analgesics|analgesics|mesh-ancestor
24503900|NCT00533390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24503901|NCT00533390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24503902|NCT00533390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757980|NCT01743157|Growth Substances|growth substances|mesh-ancestor
25113602|NCT02477202|Levonorgestrel|levonorgestrel|mesh-list
25031925|NCT03585140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25031926|NCT03585140|Dermatologic Agents|dermatologic agents|mesh-ancestor
25031927|NCT03585101|Grazoprevir|grazoprevir|mesh-list
25031928|NCT03585101|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25031929|NCT03585101|Antiviral Agents|antiviral agents|mesh-ancestor
25031930|NCT03585101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25031931|NCT03585062|Paclitaxel|paclitaxel|mesh-list
25031932|NCT03585062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25031933|NCT03585062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25031934|NCT03585062|Tubulin Modulators|tubulin modulators|mesh-ancestor
25031935|NCT03585062|Antimitotic Agents|antimitotic agents|mesh-ancestor
25031936|NCT03585062|Mitosis Modulators|mitosis modulators|mesh-ancestor
25031937|NCT03585062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031938|NCT03585036|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
25031939|NCT03585036|Tramadol|tramadol|mesh-list
25031971|NCT03584854|Oxytocics|oxytocics|mesh-ancestor
25031972|NCT03584854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24990237|NCT03403205|Choline|choline|mesh-list
24504048|NCT00533923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504155|NCT00534378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504156|NCT00534378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24504193|NCT00534573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031973|NCT03584854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031974|NCT03584854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25031975|NCT03584854|Abortifacient Agents|abortifacient agents|mesh-ancestor
25031977|NCT03584841|Miotics|miotics|mesh-ancestor
25031978|NCT03584841|Autonomic Agents|autonomic agents|mesh-ancestor
25031979|NCT03584841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25031980|NCT03584841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031981|NCT03584841|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25031982|NCT03584841|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25031983|NCT03584841|Cholinergic Agents|cholinergic agents|mesh-ancestor
25031984|NCT03584841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25031985|NCT03584841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031986|NCT03584698|Evening primrose oil|evening primrose oil|mesh-list
25031987|NCT03584698|Misoprostol|misoprostol|mesh-list
25031993|NCT03584698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25031994|NCT03584698|Oxytocics|oxytocics|mesh-ancestor
25031995|NCT03584698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25031996|NCT03584698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25692705|NCT02004093|Mitosis Modulators|mitosis modulators|mesh-ancestor
25692706|NCT02004093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031997|NCT03584698|Analgesics|analgesics|mesh-ancestor
25031998|NCT03584698|Sensory System Agents|sensory system agents|mesh-ancestor
25031999|NCT03584698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25032000|NCT03584698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25032001|NCT03584698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25032002|NCT03584698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25032003|NCT03584698|Antimetabolites|antimetabolites|mesh-ancestor
25032004|NCT03584698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032005|NCT03584698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25032006|NCT03584698|Dermatologic Agents|dermatologic agents|mesh-ancestor
25032007|NCT03584529|Vitamin D|vitamin d|mesh-list
25032008|NCT03584529|Cholecalciferol|cholecalciferol|mesh-list
25032009|NCT03584529|Vitamins|vitamins|mesh-ancestor
25032010|NCT03584529|Micronutrients|micronutrients|mesh-ancestor
25032011|NCT03584529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032034|NCT03584360|Calcitriol|calcitriol|mesh-list
25032035|NCT03584360|Betamethasone|betamethasone|mesh-list
25032036|NCT03584360|Betamethasone Valerate|betamethasone valerate|mesh-list
25032037|NCT03584360|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25032038|NCT03584360|Betamethasone benzoate|betamethasone benzoate|mesh-list
25032039|NCT03584360|Calcipotriene|calcipotriene|mesh-list
25032040|NCT03584360|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25032041|NCT03584360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25032042|NCT03584360|Glucocorticoids|glucocorticoids|mesh-ancestor
25032043|NCT03584360|Hormones|hormones|mesh-ancestor
25032044|NCT03584360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25032045|NCT03584360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032046|NCT03584360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25032047|NCT03584360|Respiratory System Agents|respiratory system agents|mesh-ancestor
25032058|NCT03584178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25032059|NCT03584178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25032073|NCT03584074|Analgesics|analgesics|mesh-ancestor
25032074|NCT03584074|Sensory System Agents|sensory system agents|mesh-ancestor
25032075|NCT03584074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24758691|NCT01747278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758791|NCT01747746|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25032076|NCT03584074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032077|NCT03584074|Anticonvulsants|anticonvulsants|mesh-ancestor
25032078|NCT03584074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25032079|NCT03584074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25032080|NCT03584074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032081|NCT03584074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25032082|NCT03584074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25032083|NCT03584074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25032084|NCT03584074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25032085|NCT03584074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25032086|NCT03584074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25032087|NCT03584074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25032090|NCT03584074|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25032091|NCT03584074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25032092|NCT03584074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25032094|NCT03583892|Analgesics|analgesics|mesh-ancestor
25032095|NCT03583892|Sensory System Agents|sensory system agents|mesh-ancestor
25032096|NCT03583892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24785340|NCT01913847|Sildenafil Citrate|sildenafil citrate|mesh-list
24504194|NCT00534573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24504335|NCT00535379|Growth Substances|growth substances|mesh-ancestor
24504336|NCT00535379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504337|NCT00535379|Growth Inhibitors|growth inhibitors|mesh-ancestor
24504365|NCT00535574|Bexarotene|bexarotene|mesh-list
24504366|NCT00535574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504367|NCT00535665|Vaccines|vaccines|mesh-list
24504368|NCT00535665|Immunologic Factors|immunologic factors|mesh-ancestor
25691908|NCT01992172|Sunscreening Agents|sunscreening agents|mesh-list
25691909|NCT01992172|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25691910|NCT01992172|Protective Agents|protective agents|mesh-ancestor
25691911|NCT01992172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691912|NCT01992172|Dermatologic Agents|dermatologic agents|mesh-ancestor
25691913|NCT01992185|Sunscreening Agents|sunscreening agents|mesh-list
25691914|NCT01992185|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25691915|NCT01992185|Protective Agents|protective agents|mesh-ancestor
24504369|NCT00535665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504370|NCT00535691|Tacrolimus|tacrolimus|mesh-list
24504371|NCT00535691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24504372|NCT00535691|Immunologic Factors|immunologic factors|mesh-ancestor
24504431|NCT00536237|Niacinamide|niacinamide|mesh-list
25032097|NCT03583892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032098|NCT03583892|Anticonvulsants|anticonvulsants|mesh-ancestor
25032099|NCT03583892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25032100|NCT03583892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25032101|NCT03583892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25032102|NCT03583892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25032103|NCT03583892|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25032104|NCT03583892|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24988821|NCT00033293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24988822|NCT00033293|Alkylating Agents|alkylating agents|mesh-ancestor
24988823|NCT00033293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988824|NCT00033293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032124|NCT03583567|Histamine Agents|histamine agents|mesh-ancestor
25032125|NCT03583567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25032126|NCT03583567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032127|NCT03583567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032128|NCT03583567|Antipruritics|antipruritics|mesh-ancestor
25032129|NCT03583567|Dermatologic Agents|dermatologic agents|mesh-ancestor
25032130|NCT03583567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25032131|NCT03583567|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25032132|NCT03583489|Ondansetron|ondansetron|mesh-list
24504432|NCT00536237|Nicotinic Acids|nicotinic acids|mesh-list
24504433|NCT00536237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504434|NCT00536237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504435|NCT00536237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24504468|NCT00536614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24504469|NCT00536614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504470|NCT00536640|Gemcitabine|gemcitabine|mesh-list
24504610|NCT00537173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032133|NCT03583489|Antiemetics|antiemetics|mesh-ancestor
25032134|NCT03583489|Autonomic Agents|autonomic agents|mesh-ancestor
25032135|NCT03583489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25032136|NCT03583489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032137|NCT03583489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25032138|NCT03583489|Antipruritics|antipruritics|mesh-ancestor
25032139|NCT03583489|Dermatologic Agents|dermatologic agents|mesh-ancestor
25032140|NCT03583489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25032141|NCT03583489|Serotonin Agents|serotonin agents|mesh-ancestor
25032142|NCT03583489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25032143|NCT03583489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032144|NCT03583489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25032145|NCT03583489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25032146|NCT03583489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25032147|NCT03583489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25032148|NCT03583489|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25032149|NCT03583476|Amoxicillin|amoxicillin|mesh-list
25032150|NCT03583476|Metronidazole|metronidazole|mesh-list
25032151|NCT03583476|Clarithromycin|clarithromycin|mesh-list
25032152|NCT03583476|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24598599|NCT00956982|Interferons|interferons|mesh-list
25032161|NCT03583476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25032162|NCT03583424|Cytarabine|cytarabine|mesh-list
25032163|NCT03583424|Etoposide|etoposide|mesh-list
25032164|NCT03583424|Podophyllotoxin|podophyllotoxin|mesh-list
25032165|NCT03583424|Etoposide phosphate|etoposide phosphate|mesh-list
25032166|NCT03583424|Melphalan|melphalan|mesh-list
25032167|NCT03583424|Venetoclax|venetoclax|mesh-list
24504611|NCT00537173|Growth Inhibitors|growth inhibitors|mesh-ancestor
24504612|NCT00537251|Insulin Glargine|insulin glargine|mesh-list
24504613|NCT00537251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24504614|NCT00537251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504615|NCT00537355|Histamine|histamine|mesh-list
24504616|NCT00537355|Histamine Agonists|histamine agonists|mesh-ancestor
24504617|NCT00537355|Histamine Agents|histamine agents|mesh-ancestor
24504618|NCT00537355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24504619|NCT00537355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504627|NCT00537472|Anesthetics|anesthetics|mesh-list
24504641|NCT00537537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504675|NCT00537602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25032171|NCT03583424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25032172|NCT03583424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032173|NCT03583424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25032174|NCT03583424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25032175|NCT03583424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25032176|NCT03583424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032177|NCT03583424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25032178|NCT03583424|Antimetabolites|antimetabolites|mesh-ancestor
25032179|NCT03583424|Antiviral Agents|antiviral agents|mesh-ancestor
25032180|NCT03583424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25032181|NCT03583424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25032182|NCT03583424|Immunologic Factors|immunologic factors|mesh-ancestor
25032183|NCT03583424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032184|NCT03583424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24504676|NCT00537602|Antiviral Agents|antiviral agents|mesh-ancestor
24504677|NCT00537602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24504691|NCT00537836|Hormones|hormones|mesh-ancestor
24504692|NCT00537836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24504693|NCT00537836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504694|NCT00537862|Mycophenolic Acid|mycophenolic acid|mesh-list
24504695|NCT00537862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24504696|NCT00537862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504697|NCT00537862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24504752|NCT00537966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24504787|NCT00538096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504788|NCT00538109|Imatinib Mesylate|imatinib mesylate|mesh-list
24504789|NCT00538109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504790|NCT00538109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24504791|NCT00538109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504792|NCT00538109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504793|NCT00538148|Telithromycin|telithromycin|mesh-list
24504794|NCT00538148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24504795|NCT00538148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24504796|NCT00538174|Dapagliflozin|dapagliflozin|mesh-list
24504797|NCT00538174|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25032187|NCT03583424|Keratolytic Agents|keratolytic agents|mesh-ancestor
25032188|NCT03583424|Dermatologic Agents|dermatologic agents|mesh-ancestor
25032189|NCT03583424|Tubulin Modulators|tubulin modulators|mesh-ancestor
25032190|NCT03583424|Antimitotic Agents|antimitotic agents|mesh-ancestor
24988886|NCT05192681|Docetaxel|docetaxel|mesh-list
25032191|NCT03583424|Mitosis Modulators|mitosis modulators|mesh-ancestor
25032192|NCT03583242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
25032193|NCT03583242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25032194|NCT03583242|Growth Substances|growth substances|mesh-ancestor
25032195|NCT03583242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032196|NCT03583242|Growth Inhibitors|growth inhibitors|mesh-ancestor
25032197|NCT03583242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032198|NCT03583229|Aspirin|aspirin|mesh-list
25032199|NCT03583229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25032200|NCT03583229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25032201|NCT03583229|Analgesics|analgesics|mesh-ancestor
25032202|NCT03583229|Sensory System Agents|sensory system agents|mesh-ancestor
24504808|NCT00538239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24504809|NCT00538239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24504810|NCT00538239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504811|NCT00538239|Antifungal Agents|antifungal agents|mesh-ancestor
24504812|NCT00538239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24504813|NCT00538239|Immunologic Factors|immunologic factors|mesh-ancestor
24504814|NCT00538239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504817|NCT00538265|Thymoglobulin|thymoglobulin|mesh-list
24504818|NCT00538265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24504819|NCT00538265|Immunologic Factors|immunologic factors|mesh-ancestor
24504820|NCT00538265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504821|NCT00538265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24504822|NCT00538265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504920|NCT00538525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504921|NCT00538538|Ranibizumab|ranibizumab|mesh-list
24504922|NCT00538538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24504923|NCT00538538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24504924|NCT00538538|Growth Substances|growth substances|mesh-ancestor
24504925|NCT00538538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504926|NCT00538538|Growth Inhibitors|growth inhibitors|mesh-ancestor
24504953|NCT00538655|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25032208|NCT03583229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25032209|NCT03583229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032210|NCT03583229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25032211|NCT03583229|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25032212|NCT03583229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25032213|NCT03583229|Antipyretics|antipyretics|mesh-ancestor
25032217|NCT03583138|Buprenorphine|buprenorphine|mesh-list
25032218|NCT03583138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25032219|NCT03583138|Narcotics|narcotics|mesh-ancestor
25032220|NCT03583138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25032221|NCT03583138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032222|NCT03583138|Analgesics|analgesics|mesh-ancestor
25032223|NCT03583138|Sensory System Agents|sensory system agents|mesh-ancestor
25032224|NCT03583138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25032225|NCT03583138|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24505015|NCT00539071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24505016|NCT00539071|Serotonin Agents|serotonin agents|mesh-ancestor
24505017|NCT00539071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24505071|NCT00539565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24505077|NCT00539630|Tubulin Modulators|tubulin modulators|mesh-ancestor
24505078|NCT00539630|Antimitotic Agents|antimitotic agents|mesh-ancestor
24505079|NCT00539630|Mitosis Modulators|mitosis modulators|mesh-ancestor
24505080|NCT00539630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505082|NCT00539669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032236|NCT03582930|Calfactant|calfactant|mesh-list
25032237|NCT03582930|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
25032238|NCT03582930|Respiratory System Agents|respiratory system agents|mesh-ancestor
25032239|NCT03582878|Mycophenolic Acid|mycophenolic acid|mesh-list
25032240|NCT03582878|Sirolimus|sirolimus|mesh-list
25032241|NCT03582878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25032242|NCT03582878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032243|NCT03582878|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25032244|NCT03582878|Antitubercular Agents|antitubercular agents|mesh-ancestor
25032246|NCT03582878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25032247|NCT03582878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25032248|NCT03582878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032249|NCT03582878|Antifungal Agents|antifungal agents|mesh-ancestor
25032250|NCT03582878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25032251|NCT03582878|Immunologic Factors|immunologic factors|mesh-ancestor
24990350|NCT03186456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505084|NCT00539669|Antimitotic Agents|antimitotic agents|mesh-ancestor
24505085|NCT00539669|Mitosis Modulators|mitosis modulators|mesh-ancestor
24505086|NCT00539669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505087|NCT00539773|Interferons|interferons|mesh-list
24505088|NCT00539773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759030|NCT01749085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24759031|NCT01749085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759032|NCT01749085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24759033|NCT01749098|Ketamine|ketamine|mesh-list
24759034|NCT01749098|Analgesics|analgesics|mesh-ancestor
24759116|NCT01749371|Tocotrienols|tocotrienols|mesh-list
24759117|NCT01749371|alpha-Tocopherol|alpha-tocopherol|mesh-list
24759118|NCT01749371|Micronutrients|micronutrients|mesh-ancestor
24759119|NCT01749371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759120|NCT01749371|Antioxidants|antioxidants|mesh-ancestor
24759123|NCT01749384|Bevacizumab|bevacizumab|mesh-list
24759128|NCT01749384|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25032256|NCT03582865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25032258|NCT03582865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25032259|NCT03582865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032260|NCT03582865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25032261|NCT03582865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25032262|NCT03582865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25032263|NCT03582605|Amoxicillin|amoxicillin|mesh-list
24598786|NCT00958100|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24759130|NCT01749384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032272|NCT03582332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25032273|NCT03582332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032274|NCT03582332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25032275|NCT03582332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25032276|NCT03582332|Gout Suppressants|gout suppressants|mesh-ancestor
25032277|NCT03582332|Tocolytic Agents|tocolytic agents|mesh-ancestor
25032278|NCT03582332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25032279|NCT03582332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25032280|NCT03582332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25032281|NCT03582332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032286|NCT03582306|Chlorophyllin|chlorophyllin|mesh-list
25032287|NCT03582306|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25032288|NCT03582306|Protective Agents|protective agents|mesh-ancestor
25032289|NCT03582306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598840|NCT05352373|Calcium|calcium|mesh-list
24598841|NCT05352373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25032294|NCT03582280|Antacids|antacids|mesh-ancestor
25032295|NCT03582280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032296|NCT03582280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25032297|NCT03582098|Rituximab|rituximab|mesh-list
25032298|NCT03582098|Idelalisib|idelalisib|mesh-list
25032299|NCT03582098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25032300|NCT03582098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032301|NCT03582098|Immunologic Factors|immunologic factors|mesh-ancestor
25032302|NCT03582098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032303|NCT03582098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25032304|NCT03582098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25032305|NCT03582098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032306|NCT03582007|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25032307|NCT03582007|Murepavadin|murepavadin|mesh-list
25032308|NCT03582007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25032309|NCT03581968|Pancrelipase|pancrelipase|mesh-list
25032310|NCT03581968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25032311|NCT03581916|JNJ-64326067|jnj-64326067|mesh-list
25032312|NCT03581916|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25032338|NCT03581630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25032339|NCT03581630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25032340|NCT03581630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032342|NCT03581630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24623624|NCT01072890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24904980|NCT04351867|Capecitabine|capecitabine|mesh-list
25032343|NCT03581630|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25032344|NCT03581630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25032345|NCT03581630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24397271|NCT00141245|Pregabalin|pregabalin|mesh-list
25032346|NCT03581422|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25032347|NCT03581422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25032348|NCT03581422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25113608|NCT02477202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25113609|NCT02477202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25113610|NCT02474173|Paclitaxel|paclitaxel|mesh-list
25113611|NCT02474173|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25032551|NCT03579927|Podophyllotoxin|podophyllotoxin|mesh-list
25113634|NCT02428192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25113635|NCT02428192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25113636|NCT02428192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25032349|NCT03581149|Ascorbic Acid|ascorbic acid|mesh-list
25032350|NCT03581149|Picosulfate sodium|picosulfate sodium|mesh-list
25032351|NCT03581149|Magnesium citrate|magnesium citrate|mesh-list
25032352|NCT03581149|Laxatives|laxatives|mesh-list
25032353|NCT03581149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032354|NCT03581149|Antioxidants|antioxidants|mesh-ancestor
25032355|NCT03581149|Protective Agents|protective agents|mesh-ancestor
25032356|NCT03581149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032357|NCT03581149|Vitamins|vitamins|mesh-ancestor
25032358|NCT03581149|Micronutrients|micronutrients|mesh-ancestor
25032359|NCT03581149|Cathartics|cathartics|mesh-ancestor
25032360|NCT03581149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25032361|NCT03580980|Acetaminophen|acetaminophen|mesh-list
25032362|NCT03580980|Ketamine|ketamine|mesh-list
25032366|NCT03580980|Sensory System Agents|sensory system agents|mesh-ancestor
25032367|NCT03580980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24759204|NCT01749579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25032368|NCT03580980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032369|NCT03580980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25032370|NCT03580980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25032371|NCT03580980|Anesthetics, General|anesthetics, general|mesh-ancestor
25032373|NCT03580980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25032374|NCT03580980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25032375|NCT03580980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25032376|NCT03580980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25032377|NCT03580980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032378|NCT03580980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25032379|NCT03580980|Narcotics|narcotics|mesh-ancestor
25032380|NCT03580980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25032381|NCT03580980|Antipyretics|antipyretics|mesh-ancestor
25032382|NCT03580980|Anesthetics, Local|anesthetics, local|mesh-ancestor
25032394|NCT03580967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25032396|NCT03580967|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25032397|NCT03580967|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25032398|NCT03580967|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25032399|NCT03580967|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25032411|NCT03580889|Atropine|atropine|mesh-list
25032412|NCT03580889|Glycopyrrolate|glycopyrrolate|mesh-list
25032413|NCT03580889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25032414|NCT03580889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25032415|NCT03580889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24759148|NCT01749397|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24759149|NCT01749397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759150|NCT01749423|Botulinum Toxins|botulinum toxins|mesh-list
24759151|NCT01749423|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24759152|NCT01749423|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24759153|NCT01749423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24759154|NCT01749423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24759155|NCT01749423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759156|NCT01749423|Cholinergic Agents|cholinergic agents|mesh-ancestor
24759193|NCT01749579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24759194|NCT01749579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759195|NCT01749579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24759196|NCT01749579|Anesthetics, General|anesthetics, general|mesh-ancestor
24759197|NCT01749579|Anesthetics|anesthetics|mesh-ancestor
24759198|NCT01749579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25691916|NCT01992185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905135|NCT04350684|Interferon beta-1a|interferon beta-1a|mesh-list
24759199|NCT01749579|Narcotics|narcotics|mesh-ancestor
24759200|NCT01749579|Analgesics|analgesics|mesh-ancestor
24759201|NCT01749579|Sensory System Agents|sensory system agents|mesh-ancestor
24759202|NCT01749579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25032417|NCT03580889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25032418|NCT03580889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032419|NCT03580889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25032420|NCT03580889|Respiratory System Agents|respiratory system agents|mesh-ancestor
25032421|NCT03580889|Mydriatics|mydriatics|mesh-ancestor
25032422|NCT03580889|Parasympatholytics|parasympatholytics|mesh-ancestor
25032423|NCT03580889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25032424|NCT03580889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25032425|NCT03580889|Cholinergic Agents|cholinergic agents|mesh-ancestor
25032426|NCT03580889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25032479|NCT03580499|Pyridoxine|pyridoxine|mesh-list
25032480|NCT03580499|Vitamin B Complex|vitamin b complex|mesh-list
25032481|NCT03580499|Micronutrients|micronutrients|mesh-ancestor
25032482|NCT03580499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989222|NCT04245423|Analgesics|analgesics|mesh-ancestor
25032488|NCT03580395|Paclitaxel|paclitaxel|mesh-list
25032489|NCT03580395|Apatinib|apatinib|mesh-list
25032490|NCT03580395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25032491|NCT03580395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032492|NCT03580395|Tubulin Modulators|tubulin modulators|mesh-ancestor
25032493|NCT03580395|Antimitotic Agents|antimitotic agents|mesh-ancestor
25032494|NCT03580395|Mitosis Modulators|mitosis modulators|mesh-ancestor
25032495|NCT03580395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032496|NCT03580395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25032497|NCT03580395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25032498|NCT03580291|Mycophenolic Acid|mycophenolic acid|mesh-list
25032499|NCT03580291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25032500|NCT03580291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032501|NCT03580291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25032502|NCT03580291|Antitubercular Agents|antitubercular agents|mesh-ancestor
24759203|NCT01749579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24459870|NCT00346749|Fluticasone|fluticasone|mesh-list
24759205|NCT01749579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25032524|NCT03580135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25032525|NCT03580018|Tranexamic Acid|tranexamic acid|mesh-list
25032526|NCT03580018|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25032527|NCT03580018|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25032528|NCT03580018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032529|NCT03580018|Hemostatics|hemostatics|mesh-ancestor
25032530|NCT03580018|Coagulants|coagulants|mesh-ancestor
25032531|NCT03580005|Methylphenidate|methylphenidate|mesh-list
25032532|NCT03580005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25032533|NCT03580005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032534|NCT03580005|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25032535|NCT03580005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25032536|NCT03580005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25032537|NCT03580005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032538|NCT03580005|Dopamine Agents|dopamine agents|mesh-ancestor
25032539|NCT03580005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25032540|NCT03579979|Methylene Blue|methylene blue|mesh-list
25032541|NCT03579979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25032542|NCT03579979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032543|NCT03579927|Cytarabine|cytarabine|mesh-list
25032544|NCT03579927|Rituximab|rituximab|mesh-list
25032545|NCT03579927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25032547|NCT03579927|Etoposide phosphate|etoposide phosphate|mesh-list
25032548|NCT03579927|Melphalan|melphalan|mesh-list
25032549|NCT03579927|Mechlorethamine|mechlorethamine|mesh-list
25032550|NCT03579927|Carmustine|carmustine|mesh-list
25032552|NCT03579927|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25032554|NCT03579927|Immunoglobulins|immunoglobulins|mesh-list
24599133|NCT05119894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032571|NCT03579927|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24759206|NCT01749579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24759208|NCT01749579|GABA Agents|gaba agents|mesh-ancestor
24759213|NCT01750060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24759214|NCT01750060|Narcotics|narcotics|mesh-ancestor
24759215|NCT01750060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24759216|NCT01750060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032572|NCT03579927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25032573|NCT03579927|Alkylating Agents|alkylating agents|mesh-ancestor
25691917|NCT01992185|Dermatologic Agents|dermatologic agents|mesh-ancestor
25691918|NCT01992523|Ticagrelor|ticagrelor|mesh-list
25691919|NCT01992523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25691920|NCT01992523|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25691921|NCT01992523|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25691922|NCT01992523|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25691923|NCT01992523|Purinergic Agents|purinergic agents|mesh-ancestor
24989301|NCT05366101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400530|NCT00150761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400616|NCT00151008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24400617|NCT00151034|Gemcitabine|gemcitabine|mesh-list
24400618|NCT00151034|Paclitaxel|paclitaxel|mesh-list
24989302|NCT05365984|Carbon Monoxide|carbon monoxide|mesh-list
24989303|NCT05365984|Antimetabolites|antimetabolites|mesh-ancestor
24989304|NCT05365984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989305|NCT05365984|Gasotransmitters|gasotransmitters|mesh-ancestor
24989306|NCT05365984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24989307|NCT05365984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989309|NCT05365555|Ropivacaine|ropivacaine|mesh-list
24989310|NCT05365555|Anesthetics, Local|anesthetics, local|mesh-list
24989311|NCT05365555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24989312|NCT05365555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989313|NCT05365555|Sensory System Agents|sensory system agents|mesh-ancestor
24989314|NCT05365555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24989315|NCT05365464|Progesterone|progesterone|mesh-list
24989316|NCT05365464|Progestins|progestins|mesh-ancestor
25032603|NCT03579875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032604|NCT03579875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25032605|NCT03579875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25032606|NCT03579875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25032607|NCT03579875|Antiemetics|antiemetics|mesh-ancestor
25032608|NCT03579875|Autonomic Agents|autonomic agents|mesh-ancestor
25032609|NCT03579875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25032610|NCT03579875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25032611|NCT03579875|Glucocorticoids|glucocorticoids|mesh-ancestor
25032612|NCT03579875|Hormones|hormones|mesh-ancestor
25032613|NCT03579875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25032614|NCT03579875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25032615|NCT03579875|Protective Agents|protective agents|mesh-ancestor
25032616|NCT03579836|Gemcitabine|gemcitabine|mesh-list
25032617|NCT03579836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25032618|NCT03579836|Antimetabolites|antimetabolites|mesh-ancestor
25032619|NCT03579836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032620|NCT03579836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032621|NCT03579836|Antiviral Agents|antiviral agents|mesh-ancestor
25032622|NCT03579836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25032623|NCT03579836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25032624|NCT03579836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25032625|NCT03579836|Immunologic Factors|immunologic factors|mesh-ancestor
25032626|NCT03579836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032628|NCT03579823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25032629|NCT03579823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25032630|NCT03579784|Paclitaxel|paclitaxel|mesh-list
25032631|NCT03579784|Durvalumab|durvalumab|mesh-list
25032632|NCT03579784|Olaparib|olaparib|mesh-list
24599229|NCT04966663|Antiviral Agents|antiviral agents|mesh-ancestor
25032641|NCT03579784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25032642|NCT03579771|Gemcitabine|gemcitabine|mesh-list
25032643|NCT03579771|Paclitaxel|paclitaxel|mesh-list
25032644|NCT03579771|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25032645|NCT03579771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25032646|NCT03579771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759217|NCT01750060|Analgesics|analgesics|mesh-ancestor
24759218|NCT01750060|Sensory System Agents|sensory system agents|mesh-ancestor
24759328|NCT01750645|Botulinum Toxins|botulinum toxins|mesh-list
25032647|NCT03579771|Tubulin Modulators|tubulin modulators|mesh-ancestor
25032648|NCT03579771|Antimitotic Agents|antimitotic agents|mesh-ancestor
25032649|NCT03579771|Mitosis Modulators|mitosis modulators|mesh-ancestor
25032650|NCT03579771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032651|NCT03579771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25032655|NCT03579771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25032656|NCT03579771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25032657|NCT03579771|Immunologic Factors|immunologic factors|mesh-ancestor
25032658|NCT03579771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032660|NCT03579758|Capecitabine|capecitabine|mesh-list
25032661|NCT03579758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25691924|NCT01992523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25404717|NCT03652974|Valproic Acid|valproic acid|mesh-list
25032662|NCT03579758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25032663|NCT03579758|Antimetabolites|antimetabolites|mesh-ancestor
25032664|NCT03579758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032665|NCT03579758|Antiviral Agents|antiviral agents|mesh-ancestor
25032666|NCT03579758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25032667|NCT03579758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25032668|NCT03579758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25032669|NCT03579758|Immunologic Factors|immunologic factors|mesh-ancestor
25032670|NCT03579758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032671|NCT03579732|Aspirin|aspirin|mesh-list
25032672|NCT03579732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25032673|NCT03579732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25032674|NCT03579732|Analgesics|analgesics|mesh-ancestor
25032675|NCT03579732|Sensory System Agents|sensory system agents|mesh-ancestor
25032676|NCT03579732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25032690|NCT03579589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032691|NCT03579589|Cholinergic Agents|cholinergic agents|mesh-ancestor
25032692|NCT03579589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25032693|NCT03579589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022386|NCT03663114|Lenvatinib|lenvatinib|mesh-list
25032694|NCT03579589|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25032695|NCT03579589|Autonomic Agents|autonomic agents|mesh-ancestor
25113643|NCT02425891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25113644|NCT02425891|Tubulin Modulators|tubulin modulators|mesh-ancestor
25113645|NCT02425891|Antimitotic Agents|antimitotic agents|mesh-ancestor
25113646|NCT02425891|Mitosis Modulators|mitosis modulators|mesh-ancestor
25113647|NCT02425891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113648|NCT02425891|Immunologic Factors|immunologic factors|mesh-ancestor
25113649|NCT02425891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25113650|NCT02420847|Gemcitabine|gemcitabine|mesh-list
25113651|NCT02420847|Doxorubicin|doxorubicin|mesh-list
25113652|NCT02420847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25113653|NCT02420847|Ixazomib|ixazomib|mesh-list
25113654|NCT02420847|Glycine|glycine|mesh-list
25113655|NCT02420847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25113656|NCT02420847|Antimetabolites|antimetabolites|mesh-ancestor
25113657|NCT02420847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113658|NCT02420847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25113659|NCT02420847|Antiviral Agents|antiviral agents|mesh-ancestor
25113660|NCT02420847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25113661|NCT02420847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25113662|NCT02420847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25113663|NCT02420847|Immunologic Factors|immunologic factors|mesh-ancestor
25113664|NCT02420847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25113665|NCT02420847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25113666|NCT02420847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25113667|NCT02420847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25113668|NCT02420847|Protease Inhibitors|protease inhibitors|mesh-ancestor
25113669|NCT02420847|Glycine Agents|glycine agents|mesh-ancestor
25113670|NCT02420847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25113672|NCT02392429|Alovudine|alovudine|mesh-list
25039950|NCT03553498|Analgesics|analgesics|mesh-ancestor
25113673|NCT02392429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25032710|NCT03579082|Decitabine|decitabine|mesh-list
25032711|NCT03579082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25032712|NCT03579082|Antimetabolites|antimetabolites|mesh-ancestor
25032713|NCT03579082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032714|NCT03579082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032715|NCT03579082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25032716|NCT03579043|Cocaine|cocaine|mesh-list
25032717|NCT03579043|Anesthetics, Local|anesthetics, local|mesh-ancestor
25032718|NCT03579043|Anesthetics|anesthetics|mesh-ancestor
25032719|NCT03579043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25032720|NCT03579043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032721|NCT03579043|Sensory System Agents|sensory system agents|mesh-ancestor
25032722|NCT03579043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25032723|NCT03579043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25032724|NCT03579043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25032725|NCT03579043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25032726|NCT03579043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25032727|NCT03579043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032728|NCT03579043|Dopamine Agents|dopamine agents|mesh-ancestor
25032729|NCT03579043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25032730|NCT03579004|Paclitaxel|paclitaxel|mesh-list
25032731|NCT03579004|Fluorouracil|fluorouracil|mesh-list
25404718|NCT03652974|Clozapine|clozapine|mesh-list
25032732|NCT03579004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25032733|NCT03579004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032734|NCT03579004|Tubulin Modulators|tubulin modulators|mesh-ancestor
25032735|NCT03579004|Antimitotic Agents|antimitotic agents|mesh-ancestor
24759329|NCT01750645|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24759330|NCT01750645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24460672|NCT00349219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24460673|NCT00349219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460674|NCT00349219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24460676|NCT00349219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460677|NCT00349219|Antiviral Agents|antiviral agents|mesh-ancestor
24460678|NCT00349219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24460679|NCT00349219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460680|NCT00349219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25032736|NCT03579004|Mitosis Modulators|mitosis modulators|mesh-ancestor
25032737|NCT03579004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032738|NCT03579004|Antimetabolites|antimetabolites|mesh-ancestor
25032739|NCT03579004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25032740|NCT03579004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25032741|NCT03579004|Immunologic Factors|immunologic factors|mesh-ancestor
25032742|NCT03579004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032743|NCT03578900|Citric Acid|citric acid|mesh-list
25032744|NCT03578900|Sodium Citrate|sodium citrate|mesh-list
24460681|NCT00349219|Immunologic Factors|immunologic factors|mesh-ancestor
24460682|NCT00349219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460718|NCT00349310|Protective Agents|protective agents|mesh-ancestor
24460720|NCT00349310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24461515|NCT00352495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461516|NCT00352521|Bevacizumab|bevacizumab|mesh-list
24461518|NCT00352521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24404761|NCT00164775|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24404762|NCT00164775|Antidepressive Agents|antidepressive agents|mesh-ancestor
24404763|NCT00164775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24461519|NCT00352521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461520|NCT00352521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24461567|NCT00352677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461621|NCT00352859|Immunologic Factors|immunologic factors|mesh-ancestor
24461622|NCT00352859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461623|NCT00352859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24461685|NCT00353067|Sensory System Agents|sensory system agents|mesh-ancestor
24461686|NCT00353067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24461687|NCT00353067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461688|NCT00353067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24461689|NCT00353067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24461690|NCT00353067|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24461691|NCT00353067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461692|NCT00353067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664836|NCT01309009|MEN 11420|men 11420|mesh-list
24461693|NCT00353080|Risedronic Acid|risedronic acid|mesh-list
24461694|NCT00353080|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24461922|NCT00354367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461923|NCT00354367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24461924|NCT00354380|Artesunate|artesunate|mesh-list
24461925|NCT00354380|Amodiaquine|amodiaquine|mesh-list
24461926|NCT00354380|Methylene Blue|methylene blue|mesh-list
24461927|NCT00354380|Antimalarials|antimalarials|mesh-ancestor
24461928|NCT00354380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24461929|NCT00354380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24462161|NCT00355277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462163|NCT00355277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24462210|NCT00355524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24462211|NCT00355524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24462212|NCT00355524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24462240|NCT00355589|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24462241|NCT00355589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24462242|NCT00355589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462243|NCT00355589|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24462244|NCT00355589|Protease Inhibitors|protease inhibitors|mesh-ancestor
24462245|NCT00355589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462247|NCT00355602|Vancomycin|vancomycin|mesh-list
24462248|NCT00355602|Clarithromycin|clarithromycin|mesh-list
24462249|NCT00355602|Doxycycline|doxycycline|mesh-list
24462250|NCT00355602|Ciprofloxacin|ciprofloxacin|mesh-list
24462251|NCT00355602|Rifaximin|rifaximin|mesh-list
24462252|NCT00355602|Cefuroxime|cefuroxime|mesh-list
24462253|NCT00355602|Neomycin|neomycin|mesh-list
24462254|NCT00355602|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24462256|NCT00355602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24462299|NCT00355641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462300|NCT00355641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462301|NCT00355667|Furosemide|furosemide|mesh-list
24462302|NCT00355667|Azosemide|azosemide|mesh-list
25032745|NCT03578900|Anticoagulants|anticoagulants|mesh-ancestor
25032746|NCT03578900|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24599427|NCT04588948|Growth Substances|growth substances|mesh-ancestor
24405488|NCT00167375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24599428|NCT04588948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032757|NCT03578874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25032758|NCT03578874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25032759|NCT03578822|Aspirin|aspirin|mesh-list
25032760|NCT03578822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25032761|NCT03578822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25032762|NCT03578822|Analgesics|analgesics|mesh-ancestor
25032763|NCT03578822|Sensory System Agents|sensory system agents|mesh-ancestor
25032764|NCT03578822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24462303|NCT00355667|Diuretics|diuretics|mesh-ancestor
24462304|NCT00355667|Natriuretic Agents|natriuretic agents|mesh-ancestor
24462305|NCT00355667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462306|NCT00355667|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24462339|NCT00355771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24462340|NCT00355771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462341|NCT00355771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462342|NCT00355862|Cyclosporine|cyclosporine|mesh-list
24462343|NCT00355862|Sirolimus|sirolimus|mesh-list
24462344|NCT00355862|Prednisolone|prednisolone|mesh-list
24462345|NCT00355862|Azathioprine|azathioprine|mesh-list
24462346|NCT00355862|Tacrolimus|tacrolimus|mesh-list
24462347|NCT00355862|Cyclosporins|cyclosporins|mesh-list
24462348|NCT00355862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24462349|NCT00355862|Immunologic Factors|immunologic factors|mesh-ancestor
24462350|NCT00355862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462351|NCT00355862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24462352|NCT00355862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462432|NCT00356096|Protective Agents|protective agents|mesh-ancestor
24434594|NCT00262886|Antimetabolites|antimetabolites|mesh-ancestor
24462433|NCT00356096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462434|NCT00356096|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24462435|NCT00356096|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24462471|NCT00356395|Ramipril|ramipril|mesh-list
24462472|NCT00356395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24462473|NCT00356395|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24462474|NCT00356395|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24462475|NCT00356395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462476|NCT00356395|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24462478|NCT00356395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462479|NCT00356447|Estradiol|estradiol|mesh-list
24462480|NCT00356447|Estrogens|estrogens|mesh-ancestor
24462481|NCT00356447|Hormones|hormones|mesh-ancestor
24435117|NCT00265070|Gefitinib|gefitinib|mesh-list
24462482|NCT00356447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24462483|NCT00356447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462484|NCT00356460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24462486|NCT00356460|Immunoglobulins|immunoglobulins|mesh-list
24462487|NCT00356460|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24462636|NCT00357123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24462637|NCT00357123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24462638|NCT00357123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462640|NCT00357149|Docetaxel|docetaxel|mesh-list
24462641|NCT00357149|Fluorouracil|fluorouracil|mesh-list
24437251|NCT00273065|Neosaxitoxin|neosaxitoxin|mesh-list
24462642|NCT00357149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24462643|NCT00357149|Tubulin Modulators|tubulin modulators|mesh-ancestor
24462644|NCT00357149|Antimitotic Agents|antimitotic agents|mesh-ancestor
24462645|NCT00357149|Mitosis Modulators|mitosis modulators|mesh-ancestor
24411585|NCT00189501|Cinacalcet|cinacalcet|mesh-list
24437395|NCT00273520|Telithromycin|telithromycin|mesh-list
24989442|NCT05224050|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24989443|NCT05224050|Cholinergic Agents|cholinergic agents|mesh-ancestor
24989444|NCT05224050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24989445|NCT05224050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989447|NCT05200143|Ipilimumab|ipilimumab|mesh-list
24989448|NCT05200143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25032769|NCT03578822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25032770|NCT03578822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032771|NCT03578822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25032772|NCT03578822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25032773|NCT03578822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25032774|NCT03578822|Antipyretics|antipyretics|mesh-ancestor
25032775|NCT03578679|Ivermectin|ivermectin|mesh-list
25032776|NCT03578679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25032777|NCT03578679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24462646|NCT00357149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462647|NCT00357149|Antimetabolites|antimetabolites|mesh-ancestor
24462648|NCT00357149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24462649|NCT00357149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24462650|NCT00357149|Immunologic Factors|immunologic factors|mesh-ancestor
24462651|NCT00357149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462652|NCT00357188|Ritonavir|ritonavir|mesh-list
24462686|NCT00357240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24462687|NCT00357240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24462688|NCT00357240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24462689|NCT00357240|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24438498|NCT00276068|Lidocaine|lidocaine|mesh-list
24438772|NCT00276757|Leucovorin|leucovorin|mesh-list
24446799|NCT00306020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24438848|NCT00276809|Antiemetics|antiemetics|mesh-ancestor
24438912|NCT00276874|Dopamine Agonists|dopamine agonists|mesh-ancestor
24462803|NCT00357604|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24462804|NCT00357604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24462805|NCT00357604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24462806|NCT00357617|Celecoxib|celecoxib|mesh-list
24462807|NCT00357617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24628833|NCT01101620|Protective Agents|protective agents|mesh-ancestor
24628834|NCT01101620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628862|NCT01101685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032780|NCT03578640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25032781|NCT03578497|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25032782|NCT03578497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25032783|NCT03578432|Everolimus|everolimus|mesh-list
25032784|NCT03578432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032785|NCT03578432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25032786|NCT03578432|Immunologic Factors|immunologic factors|mesh-ancestor
25032787|NCT03578432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032788|NCT03578354|Atenolol|atenolol|mesh-list
25032789|NCT03578354|4-Aminopyridine|4-aminopyridine|mesh-list
25032790|NCT03578354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25032791|NCT03578354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25032792|NCT03578354|Sympatholytics|sympatholytics|mesh-ancestor
24628863|NCT01101685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24628877|NCT01101698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628879|NCT01101698|Coagulants|coagulants|mesh-ancestor
24628880|NCT01101776|Interferons|interferons|mesh-list
24628881|NCT01101776|Interferon-beta|interferon-beta|mesh-list
24628882|NCT01101776|Interferon beta-1a|interferon beta-1a|mesh-list
24628883|NCT01101776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24628884|NCT01101776|Antiviral Agents|antiviral agents|mesh-ancestor
24628885|NCT01101776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24628886|NCT01101776|Immunologic Factors|immunologic factors|mesh-ancestor
24628887|NCT01101776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628888|NCT01101776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24629599|NCT01106547|Autonomic Agents|autonomic agents|mesh-ancestor
24628891|NCT01101789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24628892|NCT01101789|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24628893|NCT01101789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24628894|NCT01101789|Antimetabolites|antimetabolites|mesh-ancestor
24628895|NCT01101789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628896|NCT01101789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24628897|NCT01101802|Mycophenolic Acid|mycophenolic acid|mesh-list
24629047|NCT01102699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629051|NCT01102946|Growth Substances|growth substances|mesh-ancestor
24629138|NCT01103388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629139|NCT01103388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25404719|NCT03652974|Amisulpride|amisulpride|mesh-list
24629141|NCT01103401|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
24629142|NCT01103401|Dexamethasone|dexamethasone|mesh-list
24629143|NCT01103401|Dexamethasone acetate|dexamethasone acetate|mesh-list
24629144|NCT01103401|Ketorolac|ketorolac|mesh-list
24629145|NCT01103401|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24629146|NCT01103401|BB 1101|bb 1101|mesh-list
24629147|NCT01103401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24629148|NCT01103401|Antiemetics|antiemetics|mesh-ancestor
24629149|NCT01103401|Autonomic Agents|autonomic agents|mesh-ancestor
24629150|NCT01103401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24629151|NCT01103401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629152|NCT01103401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24629153|NCT01103401|Glucocorticoids|glucocorticoids|mesh-ancestor
24629155|NCT01103401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24629156|NCT01103401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24629157|NCT01103401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629415|NCT01105234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629416|NCT01105234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24629417|NCT01105234|Dermatologic Agents|dermatologic agents|mesh-ancestor
24629418|NCT01105273|Cyclophosphamide|cyclophosphamide|mesh-list
24629419|NCT01105273|Fludarabine|fludarabine|mesh-list
24629420|NCT01105273|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25032793|NCT03578354|Autonomic Agents|autonomic agents|mesh-ancestor
25032794|NCT03578354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25032795|NCT03578354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032796|NCT03578354|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25032797|NCT03578354|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25032798|NCT03578354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25032799|NCT03578354|Adrenergic Agents|adrenergic agents|mesh-ancestor
25032800|NCT03578354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25032801|NCT03578354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032802|NCT03578354|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24599459|NCT04562129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25032815|NCT03578042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25032816|NCT03578042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032817|NCT03578042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25032818|NCT03578042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032819|NCT03578042|Vasodilator Agents|vasodilator agents|mesh-ancestor
25032820|NCT03578042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25032821|NCT03578042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25032822|NCT03578042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25032824|NCT03578042|Natriuretic Agents|natriuretic agents|mesh-ancestor
25032825|NCT03578042|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25032826|NCT03577977|Interferons|interferons|mesh-list
25032827|NCT03577977|Interferon-beta|interferon-beta|mesh-list
25032828|NCT03577977|Interferon beta-1b|interferon beta-1b|mesh-list
25032829|NCT03577977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032830|NCT03577977|Antiviral Agents|antiviral agents|mesh-ancestor
25032831|NCT03577977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25032832|NCT03577977|Immunologic Factors|immunologic factors|mesh-ancestor
25032833|NCT03577977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634100|NCT01132040|Primidone|primidone|mesh-list
24407378|NCT00174395|Eletriptan|eletriptan|mesh-list
25032834|NCT03577977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25032835|NCT03577912|Anesthetics|anesthetics|mesh-list
25032836|NCT03577912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25032837|NCT03577912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629499|NCT01105611|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24629500|NCT01105611|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25032838|NCT03577899|Aflibercept|aflibercept|mesh-list
25032839|NCT03577899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25032845|NCT03577860|Bupivacaine|bupivacaine|mesh-list
25032846|NCT03577860|Anesthetics, Local|anesthetics, local|mesh-ancestor
25032847|NCT03577860|Anesthetics|anesthetics|mesh-ancestor
25032848|NCT03577860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25032849|NCT03577860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032850|NCT03577860|Sensory System Agents|sensory system agents|mesh-ancestor
25032851|NCT03577860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25032852|NCT03577834|Acetic Acid|acetic acid|mesh-list
25032853|NCT03577834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25032854|NCT03577834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25032855|NCT03577782|Vedolizumab|vedolizumab|mesh-list
25032856|NCT03577782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25032857|NCT03577743|Bevacizumab|bevacizumab|mesh-list
25032858|NCT03577743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25076177|NCT03375424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25076179|NCT03375398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25076180|NCT03375398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076186|NCT03375138|Abatacept|abatacept|mesh-list
25076187|NCT03375138|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25076189|NCT03375138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25076242|NCT03374540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076243|NCT03374540|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25032859|NCT03577743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032860|NCT03577743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25032861|NCT03577743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25032862|NCT03577743|Growth Substances|growth substances|mesh-ancestor
25032863|NCT03577743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032864|NCT03577743|Growth Inhibitors|growth inhibitors|mesh-ancestor
25113696|NCT02352948|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25113697|NCT02352948|Durvalumab|durvalumab|mesh-list
25113698|NCT02352948|Vinorelbine|vinorelbine|mesh-list
25113699|NCT02352948|Tremelimumab|tremelimumab|mesh-list
25113700|NCT02352948|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25113701|NCT02352948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25113702|NCT02352948|Antimetabolites|antimetabolites|mesh-ancestor
25113705|NCT02352948|Antiviral Agents|antiviral agents|mesh-ancestor
25113707|NCT02352948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25113708|NCT02352948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25113709|NCT02352948|Immunologic Factors|immunologic factors|mesh-ancestor
25113710|NCT02352948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25113711|NCT02352948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25113712|NCT02352948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25113713|NCT02352948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25113714|NCT02352948|Tubulin Modulators|tubulin modulators|mesh-ancestor
25113715|NCT02352948|Antimitotic Agents|antimitotic agents|mesh-ancestor
25113716|NCT02352948|Mitosis Modulators|mitosis modulators|mesh-ancestor
25113717|NCT02325349|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
25113718|NCT02325349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113719|NCT02314559|Propofol|propofol|mesh-list
25113720|NCT02314559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25113721|NCT02314559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25113722|NCT02314559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25113723|NCT02314559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25113724|NCT02314559|Anesthetics, General|anesthetics, general|mesh-ancestor
25113725|NCT02314559|Anesthetics|anesthetics|mesh-ancestor
24990935|NCT03555578|Leuprolide|leuprolide|mesh-list
24629501|NCT01105611|Protease Inhibitors|protease inhibitors|mesh-ancestor
24629507|NCT01105611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24629508|NCT01105611|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24629509|NCT01105611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24629511|NCT01105611|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24629513|NCT01105793|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24629514|NCT01105793|Hormone Antagonists|hormone antagonists|mesh-ancestor
24629516|NCT01105793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629582|NCT01106495|Simvastatin|simvastatin|mesh-list
24629583|NCT01106495|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24629584|NCT01106495|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24629585|NCT01106495|Antimetabolites|antimetabolites|mesh-ancestor
24629586|NCT01106495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629587|NCT01106495|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24629588|NCT01106495|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24629590|NCT01106547|Methylprednisolone|methylprednisolone|mesh-list
25032867|NCT03577652|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25032868|NCT03577652|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25032869|NCT03577652|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24629654|NCT01107054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24629655|NCT01107054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25691925|NCT01992523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691926|NCT01992523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691927|NCT01992874|Niacinamide|niacinamide|mesh-list
25691928|NCT01992874|Vitamin B Complex|vitamin b complex|mesh-ancestor
25691929|NCT01992874|Vitamins|vitamins|mesh-ancestor
25691930|NCT01992874|Micronutrients|micronutrients|mesh-ancestor
25691931|NCT01992874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691932|NCT01993017|Bupropion|bupropion|mesh-list
25691933|NCT01993017|Sertraline|sertraline|mesh-list
25691934|NCT01993017|Antidepressive Agents|antidepressive agents|mesh-list
24629659|NCT01107067|Testosterone|testosterone|mesh-list
24629879|NCT01108562|Sensory System Agents|sensory system agents|mesh-ancestor
24629880|NCT01108562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24629881|NCT01108562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24629882|NCT01108562|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24629883|NCT01108562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24629884|NCT01108562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24629885|NCT01108562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629911|NCT01108601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24629913|NCT01108601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24665153|NCT01310452|Coagulants|coagulants|mesh-ancestor
24629914|NCT01108601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629915|NCT01108601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629916|NCT01108601|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24629917|NCT01108601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24629918|NCT01108627|Formoterol Fumarate|formoterol fumarate|mesh-list
24629919|NCT01108627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24629920|NCT01108627|Autonomic Agents|autonomic agents|mesh-ancestor
24409241|NCT00181571|Dopamine Agents|dopamine agents|mesh-ancestor
24629921|NCT01108627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24629953|NCT01108874|Metaraminol|metaraminol|mesh-list
24629954|NCT01108874|Sympathomimetics|sympathomimetics|mesh-ancestor
24630061|NCT01109264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24551486|NCT00726726|GABA Modulators|gaba modulators|mesh-ancestor
24630062|NCT01109264|Alkylating Agents|alkylating agents|mesh-ancestor
25032881|NCT03577574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25032882|NCT03577574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032883|NCT03577496|Peppermint oil|peppermint oil|mesh-list
25032884|NCT03577496|Antiemetics|antiemetics|mesh-ancestor
25032885|NCT03577496|Autonomic Agents|autonomic agents|mesh-ancestor
25032886|NCT03577496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25032887|NCT03577496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032888|NCT03577496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25032889|NCT03577496|Parasympatholytics|parasympatholytics|mesh-ancestor
25032890|NCT03577457|Oxytocin|oxytocin|mesh-list
25032891|NCT03577457|Oxytocics|oxytocics|mesh-ancestor
25032892|NCT03577457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25032893|NCT03577457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032894|NCT03577392|Capecitabine|capecitabine|mesh-list
25032895|NCT03577392|Oxaliplatin|oxaliplatin|mesh-list
25032896|NCT03577392|Endostatins|endostatins|mesh-list
25032897|NCT03577392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25032898|NCT03577392|Antimetabolites|antimetabolites|mesh-ancestor
25032899|NCT03577392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032900|NCT03577392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032901|NCT03577392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25032902|NCT03577392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25032903|NCT03577392|Growth Substances|growth substances|mesh-ancestor
25032904|NCT03577392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032905|NCT03577392|Growth Inhibitors|growth inhibitors|mesh-ancestor
25032906|NCT03577249|Dialysis Solutions|dialysis solutions|mesh-list
25032907|NCT03577249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24630063|NCT01109264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630101|NCT01109498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24630103|NCT01109511|Naloxone|naloxone|mesh-list
24630104|NCT01109511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24630105|NCT01109511|Narcotics|narcotics|mesh-ancestor
24630106|NCT01109511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24630107|NCT01109511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630108|NCT01109511|Analgesics|analgesics|mesh-ancestor
24630109|NCT01109511|Sensory System Agents|sensory system agents|mesh-ancestor
24630110|NCT01109511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24630137|NCT01109693|Antidepressive Agents|antidepressive agents|mesh-ancestor
24630138|NCT01109693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24630139|NCT01109693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24630140|NCT01109693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24630141|NCT01109693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24630142|NCT01109693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630144|NCT01109693|Serotonin Agents|serotonin agents|mesh-ancestor
25032909|NCT03577184|Vildagliptin|vildagliptin|mesh-list
25032910|NCT03577184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25032911|NCT03577184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032912|NCT03577184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25032913|NCT03577184|Protease Inhibitors|protease inhibitors|mesh-ancestor
25032914|NCT03577184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691935|NCT01993017|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25076317|NCT03374007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076318|NCT03374007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25076319|NCT03373994|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25076320|NCT03373994|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25076321|NCT03373994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691936|NCT01993017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25032915|NCT03577184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032917|NCT03577158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25032918|NCT03577158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032919|NCT03577132|Atezolizumab|atezolizumab|mesh-list
25032920|NCT03577132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032921|NCT03576963|Nivolumab|nivolumab|mesh-list
25032922|NCT03576963|Guadecitabine|guadecitabine|mesh-list
25032923|NCT03576963|Azacitidine|azacitidine|mesh-list
25032924|NCT03576963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24552123|NCT04176419|Anticonvulsants|anticonvulsants|mesh-ancestor
25032925|NCT03576963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032926|NCT03576963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25032927|NCT03576963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797272|NCT01954992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630159|NCT01109758|Fenofibrate|fenofibrate|mesh-list
24630160|NCT01109758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24630161|NCT01109758|Antimetabolites|antimetabolites|mesh-ancestor
24630162|NCT01109758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630163|NCT01109758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24630173|NCT01109784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630175|NCT01109823|Ofloxacin|ofloxacin|mesh-list
24630189|NCT01109888|Fertility Agents|fertility agents|mesh-ancestor
24630190|NCT01109888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24630191|NCT01109888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630192|NCT01109888|Hormone Antagonists|hormone antagonists|mesh-ancestor
24630193|NCT01109888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24630194|NCT01109927|Insulin|insulin|mesh-list
24630195|NCT01109927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24630197|NCT01110031|Ofatumumab|ofatumumab|mesh-list
24630245|NCT01110486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24630246|NCT01110551|Vaccines|vaccines|mesh-list
24630247|NCT01110551|Immunologic Factors|immunologic factors|mesh-ancestor
24630248|NCT01110551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630249|NCT01110590|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24630250|NCT01110590|Vasodilator Agents|vasodilator agents|mesh-ancestor
24630251|NCT01110590|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24630252|NCT01110590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24630253|NCT01110590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25032929|NCT03576963|Antimetabolites|antimetabolites|mesh-ancestor
25032930|NCT03576963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25032932|NCT03576911|Coenzyme Q10|coenzyme q10|mesh-list
25032940|NCT03576820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25032941|NCT03576820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032943|NCT03576820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25032944|NCT03576820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25032945|NCT03576820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25032946|NCT03576820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25032947|NCT03576820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25032948|NCT03576820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032949|NCT03576794|Prednisolone|prednisolone|mesh-list
25032950|NCT03576794|Leflunomide|leflunomide|mesh-list
25032951|NCT03576794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25032952|NCT03576794|Glucocorticoids|glucocorticoids|mesh-ancestor
25032953|NCT03576794|Hormones|hormones|mesh-ancestor
25032954|NCT03576794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25032955|NCT03576794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032956|NCT03576794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25032957|NCT03576794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032958|NCT03576794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25032959|NCT03576794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691937|NCT01993017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25691938|NCT01993017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25691939|NCT01993017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25691940|NCT01993017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691941|NCT01993017|Dopamine Agents|dopamine agents|mesh-ancestor
25032960|NCT03576794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25032961|NCT03576794|Immunologic Factors|immunologic factors|mesh-ancestor
25032970|NCT03576677|Simendan|simendan|mesh-list
25032972|NCT03576677|Vasodilator Agents|vasodilator agents|mesh-ancestor
25032973|NCT03576677|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25032974|NCT03576677|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25032975|NCT03576677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25032976|NCT03576677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032977|NCT03576677|Protective Agents|protective agents|mesh-ancestor
25032978|NCT03576677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599737|NCT03913559|Promethazine|promethazine|mesh-list
24599769|NCT03913559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24599770|NCT03913559|Glucocorticoids|glucocorticoids|mesh-ancestor
24599771|NCT03913559|Hormones|hormones|mesh-ancestor
25032990|NCT03576664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25032991|NCT03576664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25032992|NCT03576664|Vasodilator Agents|vasodilator agents|mesh-ancestor
25032993|NCT03576664|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25032994|NCT03576664|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25032995|NCT03576651|Bevacizumab|bevacizumab|mesh-list
25032996|NCT03576651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24630326|NCT01110824|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24630329|NCT01110941|Leucovorin|leucovorin|mesh-list
24630372|NCT01111422|Acetylcysteine|acetylcysteine|mesh-list
24630373|NCT01111422|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24630374|NCT01111422|Antiviral Agents|antiviral agents|mesh-ancestor
24790278|NCT01941901|Bleomycin|bleomycin|mesh-list
24630375|NCT01111422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24630376|NCT01111422|Expectorants|expectorants|mesh-ancestor
24630377|NCT01111422|Respiratory System Agents|respiratory system agents|mesh-ancestor
24630378|NCT01111422|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24630379|NCT01111422|Antioxidants|antioxidants|mesh-ancestor
24630396|NCT01111513|Anesthetics|anesthetics|mesh-ancestor
24630397|NCT01111513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24630398|NCT01111513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630399|NCT01111513|Sensory System Agents|sensory system agents|mesh-ancestor
24630403|NCT01111591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24630404|NCT01111591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24630405|NCT01111591|Analgesics|analgesics|mesh-ancestor
24630406|NCT01111591|Sensory System Agents|sensory system agents|mesh-ancestor
24630407|NCT01111591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24630408|NCT01111591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630409|NCT01111591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24630410|NCT01111591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24630540|NCT01112215|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24630541|NCT01112215|Antitubercular Agents|antitubercular agents|mesh-ancestor
24630542|NCT01112215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24630543|NCT01112215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24630561|NCT01112462|Oxymetazoline|oxymetazoline|mesh-list
24630562|NCT01112462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24630563|NCT01112462|Analgesics|analgesics|mesh-ancestor
24630564|NCT01112462|Sensory System Agents|sensory system agents|mesh-ancestor
24630565|NCT01112462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25032997|NCT03576651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032998|NCT03576651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25032999|NCT03576651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25033000|NCT03576651|Growth Substances|growth substances|mesh-ancestor
25033001|NCT03576651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033002|NCT03576651|Growth Inhibitors|growth inhibitors|mesh-ancestor
25033003|NCT03576638|Levodopa|levodopa|mesh-list
25033004|NCT03576638|Carbidopa|carbidopa|mesh-list
25033005|NCT03576638|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25033006|NCT03576638|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25033007|NCT03576638|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25033008|NCT03576638|Dopamine Agents|dopamine agents|mesh-ancestor
25033009|NCT03576638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25033010|NCT03576638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989773|NCT04820205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24989774|NCT04820205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24989775|NCT04820205|Anesthetics, General|anesthetics, general|mesh-ancestor
24989776|NCT04820205|Anesthetics|anesthetics|mesh-ancestor
24989777|NCT04820205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24421534|NCT00219479|Phenytoin|phenytoin|mesh-list
24989783|NCT04776408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24989784|NCT04776408|Autonomic Agents|autonomic agents|mesh-ancestor
24989785|NCT04776408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24989786|NCT04776408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630566|NCT01112462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630567|NCT01112462|Antipyretics|antipyretics|mesh-ancestor
24630568|NCT01112462|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24630569|NCT01112462|Mydriatics|mydriatics|mesh-ancestor
24630570|NCT01112462|Autonomic Agents|autonomic agents|mesh-ancestor
24630571|NCT01112462|Sympathomimetics|sympathomimetics|mesh-ancestor
24630572|NCT01112462|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24630573|NCT01112462|Nasal Decongestants|nasal decongestants|mesh-ancestor
24630574|NCT01112462|Respiratory System Agents|respiratory system agents|mesh-ancestor
24630632|NCT01112826|Antimetabolites|antimetabolites|mesh-ancestor
24630633|NCT01112826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630634|NCT01112826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630635|NCT01112852|Terlipressin|terlipressin|mesh-list
24630649|NCT01112878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24630650|NCT01112878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630651|NCT01112878|Anticonvulsants|anticonvulsants|mesh-ancestor
24630652|NCT01112878|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24630653|NCT01112878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24989789|NCT04776408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24989790|NCT04776408|Antioxidants|antioxidants|mesh-ancestor
24989791|NCT04776408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989792|NCT04776408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24989793|NCT04776408|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24989794|NCT04776408|Vasodilator Agents|vasodilator agents|mesh-ancestor
24989795|NCT04776408|Gasotransmitters|gasotransmitters|mesh-ancestor
24630678|NCT01113047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24630679|NCT01113047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24630680|NCT01113047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630681|NCT01113047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24630682|NCT01113047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630683|NCT01113047|Vasodilator Agents|vasodilator agents|mesh-ancestor
24630684|NCT01113125|Fusidic Acid|fusidic acid|mesh-list
24630685|NCT01113125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24630686|NCT01113125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24630687|NCT01113125|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24630688|NCT01113125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25033014|NCT03576638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25691942|NCT01993017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25691943|NCT01993017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691944|NCT01993017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25691945|NCT01993017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25691946|NCT01993017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691947|NCT01993017|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25691948|NCT01993017|Serotonin Agents|serotonin agents|mesh-ancestor
25691949|NCT01993108|Naltrexone|naltrexone|mesh-list
25691950|NCT01993108|Methylphenidate|methylphenidate|mesh-list
25691951|NCT01993108|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25691952|NCT01993108|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25691953|NCT01993108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691954|NCT01993108|Sensory System Agents|sensory system agents|mesh-ancestor
25691955|NCT01993108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076434|NCT03373266|Isoflurane|isoflurane|mesh-list
25033015|NCT03576638|Immunologic Factors|immunologic factors|mesh-ancestor
25033016|NCT03576638|Dopamine Agonists|dopamine agonists|mesh-ancestor
25033017|NCT03576599|Zoledronic Acid|zoledronic acid|mesh-list
25033018|NCT03576599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25033019|NCT03576599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033047|NCT03576508|Lidocaine|lidocaine|mesh-list
25033048|NCT03576508|Epinephrine|epinephrine|mesh-list
25033049|NCT03576508|Capsaicin|capsaicin|mesh-list
25033050|NCT03576508|Anesthetics, Local|anesthetics, local|mesh-ancestor
25033051|NCT03576508|Anesthetics|anesthetics|mesh-ancestor
25033052|NCT03576508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24460082|NCT00347295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24630689|NCT01113125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630690|NCT01113138|Magnesium Sulfate|magnesium sulfate|mesh-list
24630691|NCT01113138|Analgesics|analgesics|mesh-ancestor
24630692|NCT01113138|Sensory System Agents|sensory system agents|mesh-ancestor
24630693|NCT01113138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24631361|NCT01117129|Abortifacient Agents|abortifacient agents|mesh-ancestor
24630694|NCT01113138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630695|NCT01113138|Anesthetics|anesthetics|mesh-ancestor
24630696|NCT01113138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25033054|NCT03576508|Sensory System Agents|sensory system agents|mesh-ancestor
25033055|NCT03576508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25033056|NCT03576508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25033057|NCT03576508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25033058|NCT03576508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25033059|NCT03576508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25033060|NCT03576508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033061|NCT03576508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25033062|NCT03576508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25033063|NCT03576508|Adrenergic Agents|adrenergic agents|mesh-ancestor
25033064|NCT03576508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25033065|NCT03576508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25033066|NCT03576508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25033067|NCT03576508|Autonomic Agents|autonomic agents|mesh-ancestor
25033068|NCT03576508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25033069|NCT03576508|Respiratory System Agents|respiratory system agents|mesh-ancestor
25033070|NCT03576508|Mydriatics|mydriatics|mesh-ancestor
25033071|NCT03576508|Sympathomimetics|sympathomimetics|mesh-ancestor
25033072|NCT03576508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25033073|NCT03576508|Antipruritics|antipruritics|mesh-ancestor
25033074|NCT03576508|Dermatologic Agents|dermatologic agents|mesh-ancestor
25033075|NCT03576469|Complement C1s|complement c1s|mesh-list
25033076|NCT03576469|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25033077|NCT03576469|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
25033078|NCT03576469|Immunologic Factors|immunologic factors|mesh-ancestor
25033079|NCT03576469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033080|NCT03576469|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25033081|NCT03576469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25033083|NCT03576456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25033084|NCT03576456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25033085|NCT03576456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033086|NCT03576456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25033087|NCT03576456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25033088|NCT03576456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24630789|NCT01113528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24630790|NCT01113528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25033089|NCT03576456|GABA Modulators|gaba modulators|mesh-ancestor
25033090|NCT03576456|GABA Agents|gaba agents|mesh-ancestor
25033091|NCT03576456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25033092|NCT03576456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033093|NCT03576378|Prednisone|prednisone|mesh-list
25033094|NCT03576378|Cyclophosphamide|cyclophosphamide|mesh-list
25033095|NCT03576378|Etoposide|etoposide|mesh-list
25033096|NCT03576378|Mitoxantrone|mitoxantrone|mesh-list
25033097|NCT03576378|Procarbazine|procarbazine|mesh-list
25033098|NCT03576378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25033099|NCT03576378|Immunologic Factors|immunologic factors|mesh-ancestor
25033100|NCT03576378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033101|NCT03576378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25033102|NCT03576378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25033103|NCT03576378|Alkylating Agents|alkylating agents|mesh-ancestor
25033104|NCT03576378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033105|NCT03576378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25033106|NCT03576378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25033107|NCT03576378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25033108|NCT03576378|Glucocorticoids|glucocorticoids|mesh-ancestor
25033109|NCT03576378|Hormones|hormones|mesh-ancestor
25033110|NCT03576378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25033111|NCT03576378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25033126|NCT03576287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24630791|NCT01113528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24630792|NCT01113528|Antipyretics|antipyretics|mesh-ancestor
24630793|NCT01113671|Vitamin E|vitamin e|mesh-list
24630794|NCT01113671|Tocopherols|tocopherols|mesh-list
24630795|NCT01113671|alpha-Tocopherol|alpha-tocopherol|mesh-list
24630796|NCT01113671|Vitamins|vitamins|mesh-ancestor
24630799|NCT01113671|Antioxidants|antioxidants|mesh-ancestor
24630807|NCT01113762|Histamine Agents|histamine agents|mesh-ancestor
24630808|NCT01113762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24630809|NCT01113762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630810|NCT01113762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630811|NCT01113762|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24630812|NCT01113762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24630813|NCT01113762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24630814|NCT01114048|Thalidomide|thalidomide|mesh-list
24630815|NCT01114048|Dexamethasone|dexamethasone|mesh-list
24630816|NCT01114048|Cyclophosphamide|cyclophosphamide|mesh-list
24630970|NCT01115322|Vitamins|vitamins|mesh-ancestor
24630971|NCT01115322|Micronutrients|micronutrients|mesh-ancestor
24630972|NCT01115322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630973|NCT01115426|Losartan|losartan|mesh-list
24630998|NCT01115439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033128|NCT03576287|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25033129|NCT03576287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24430632|NCT00248482|Cisplatin|cisplatin|mesh-list
25033130|NCT03576287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25033131|NCT03576287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033132|NCT03576105|Photosensitizing Agents|photosensitizing agents|mesh-list
25033133|NCT03576105|Methylene Blue|methylene blue|mesh-list
25033134|NCT03576105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553794|NCT00732914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25033135|NCT03576105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033136|NCT03576105|Dermatologic Agents|dermatologic agents|mesh-ancestor
25033137|NCT03576079|Salicylic Acid|salicylic acid|mesh-list
25033138|NCT03576079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25033139|NCT03576079|Antifungal Agents|antifungal agents|mesh-ancestor
25033140|NCT03576079|Keratolytic Agents|keratolytic agents|mesh-ancestor
25033141|NCT03576079|Dermatologic Agents|dermatologic agents|mesh-ancestor
25033142|NCT03576053|Lidocaine|lidocaine|mesh-list
25033143|NCT03576053|Serotonin|serotonin|mesh-list
25033144|NCT03576053|Histamine|histamine|mesh-list
25033145|NCT03576053|Anesthetics, Local|anesthetics, local|mesh-ancestor
24630999|NCT01115439|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24631001|NCT01115478|Vitamin A|vitamin a|mesh-list
24631002|NCT01115478|Vitamins|vitamins|mesh-ancestor
24631003|NCT01115478|Micronutrients|micronutrients|mesh-ancestor
24631004|NCT01115478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631005|NCT01115504|Thiamine|thiamine|mesh-list
24631006|NCT01115504|Vitamin B Complex|vitamin b complex|mesh-ancestor
24631007|NCT01115504|Vitamins|vitamins|mesh-ancestor
24631008|NCT01115504|Micronutrients|micronutrients|mesh-ancestor
24631009|NCT01115504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631010|NCT01115543|Calcitriol|calcitriol|mesh-list
24631011|NCT01115543|Alfacalcidol|alfacalcidol|mesh-list
24631012|NCT01115543|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
24631044|NCT01115946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631045|NCT01115946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24631130|NCT01116180|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24631131|NCT01116180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631132|NCT01116180|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24631133|NCT01116180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24631134|NCT01116180|Protease Inhibitors|protease inhibitors|mesh-ancestor
24631135|NCT01116180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631138|NCT01116193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24631139|NCT01116193|Antiemetics|antiemetics|mesh-ancestor
24631140|NCT01116193|Autonomic Agents|autonomic agents|mesh-ancestor
24631141|NCT01116193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24631142|NCT01116193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631143|NCT01116193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25076564|NCT03372200|Renal Agents|renal agents|mesh-ancestor
24631144|NCT01116193|Glucocorticoids|glucocorticoids|mesh-ancestor
24631145|NCT01116193|Hormones|hormones|mesh-ancestor
24631146|NCT01116193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24631203|NCT01116531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24631204|NCT01116531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631205|NCT01116531|Anticonvulsants|anticonvulsants|mesh-ancestor
25033146|NCT03576053|Anesthetics|anesthetics|mesh-ancestor
25033147|NCT03576053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25033148|NCT03576053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033149|NCT03576053|Sensory System Agents|sensory system agents|mesh-ancestor
25033150|NCT03576053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25033151|NCT03576053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25033152|NCT03576053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25033153|NCT03576053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25033154|NCT03576053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25033155|NCT03576053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033157|NCT03576053|Serotonin Agents|serotonin agents|mesh-ancestor
25033158|NCT03576053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25033159|NCT03576053|Histamine Agonists|histamine agonists|mesh-ancestor
25033160|NCT03576053|Histamine Agents|histamine agents|mesh-ancestor
25033161|NCT03576040|Edotreotide|edotreotide|mesh-list
25033162|NCT03576040|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25033163|NCT03576040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113748|NCT02278315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25113749|NCT02278315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25113750|NCT02278315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25113751|NCT02278315|Glucocorticoids|glucocorticoids|mesh-ancestor
25113753|NCT02278315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25113761|NCT02271919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631206|NCT01116531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24631207|NCT01116531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24631208|NCT01116531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631209|NCT01116531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24631210|NCT01116531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24631321|NCT01117038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24631322|NCT01117038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24631323|NCT01117038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631324|NCT01117038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24631325|NCT01117038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631326|NCT01117038|Vasodilator Agents|vasodilator agents|mesh-ancestor
24631327|NCT01117038|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24631328|NCT01117038|Protease Inhibitors|protease inhibitors|mesh-ancestor
24631329|NCT01117038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631330|NCT01117116|Fluticasone|fluticasone|mesh-list
24631332|NCT01117116|Budesonide|budesonide|mesh-list
24426035|NCT00234962|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24631333|NCT01117116|Formoterol Fumarate|formoterol fumarate|mesh-list
24631334|NCT01117116|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24631335|NCT01117116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24631336|NCT01117116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24631337|NCT01117116|Autonomic Agents|autonomic agents|mesh-ancestor
24631338|NCT01117116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24631359|NCT01117129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25113762|NCT02271919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25113763|NCT02271919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25113764|NCT02271919|Cholinergic Agents|cholinergic agents|mesh-ancestor
24600022|NCT02879409|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24600023|NCT02879409|Protease Inhibitors|protease inhibitors|mesh-ancestor
24600024|NCT02879409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600025|NCT02879409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113765|NCT02271919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25113766|NCT02271919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033164|NCT03575780|Tirbanibulin|tirbanibulin|mesh-list
25033165|NCT03575780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25033166|NCT03575780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033167|NCT03575637|Olanzapine|olanzapine|mesh-list
25033168|NCT03575637|Antiemetics|antiemetics|mesh-ancestor
25033169|NCT03575637|Autonomic Agents|autonomic agents|mesh-ancestor
25033170|NCT03575637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25404720|NCT03652974|Anticonvulsants|anticonvulsants|mesh-ancestor
25033171|NCT03575637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033172|NCT03575637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25033173|NCT03575637|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25033174|NCT03575637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25033175|NCT03575637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25033176|NCT03575637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25033177|NCT03575637|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25033178|NCT03575637|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25033179|NCT03575637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24631360|NCT01117129|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24631363|NCT01117129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24631365|NCT01117129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631367|NCT01117129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631368|NCT01117129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24631369|NCT01117129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24631516|NCT01118598|Micronutrients|micronutrients|mesh-ancestor
24631517|NCT01118598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631518|NCT01118598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24631745|NCT01119885|Narcotics|narcotics|mesh-ancestor
24631746|NCT01119885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24631747|NCT01119885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631748|NCT01119885|Analgesics|analgesics|mesh-ancestor
24631749|NCT01119885|Sensory System Agents|sensory system agents|mesh-ancestor
24631750|NCT01119885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24631754|NCT01119885|Anesthetics|anesthetics|mesh-ancestor
24631783|NCT01120158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631784|NCT01120158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24631786|NCT01120158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24632092|NCT01122004|Sensory System Agents|sensory system agents|mesh-ancestor
24632093|NCT01122004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24632207|NCT01122602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632209|NCT01122615|Sirolimus|sirolimus|mesh-list
24632210|NCT01122615|Sunitinib|sunitinib|mesh-list
24632211|NCT01122615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632212|NCT01122615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24632213|NCT01122615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24632214|NCT01122615|Growth Substances|growth substances|mesh-ancestor
24632215|NCT01122615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632216|NCT01122615|Growth Inhibitors|growth inhibitors|mesh-ancestor
24632217|NCT01122615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24632218|NCT01122615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632219|NCT01122615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033287|NCT03574649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25033187|NCT03575598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033188|NCT03575520|Cyclophosphamide|cyclophosphamide|mesh-list
25033189|NCT03575520|Doxorubicin|doxorubicin|mesh-list
25033190|NCT03575520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25033191|NCT03575520|Immunologic Factors|immunologic factors|mesh-ancestor
25033192|NCT03575520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033193|NCT03575520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25033194|NCT03575520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25033195|NCT03575520|Alkylating Agents|alkylating agents|mesh-ancestor
25033196|NCT03575520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033197|NCT03575520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25033198|NCT03575520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25033199|NCT03575520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24632221|NCT01122615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24632222|NCT01122615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24632223|NCT01122615|Antifungal Agents|antifungal agents|mesh-ancestor
24632224|NCT01122615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24632225|NCT01122615|Immunologic Factors|immunologic factors|mesh-ancestor
24632227|NCT01122641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24632439|NCT01123915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632441|NCT01123967|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24632442|NCT01123967|Autonomic Agents|autonomic agents|mesh-ancestor
24632443|NCT01123967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24632444|NCT01123967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632445|NCT01123967|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24632446|NCT01123967|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24632447|NCT01123967|Cholinergic Agents|cholinergic agents|mesh-ancestor
24632448|NCT01123967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24632458|NCT01124032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24632459|NCT01124058|Heparin|heparin|mesh-list
24632518|NCT01124383|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24632519|NCT01124383|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24632520|NCT01124383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24632521|NCT01124383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24632522|NCT01124383|Narcotics|narcotics|mesh-ancestor
24632523|NCT01124383|Analgesics|analgesics|mesh-ancestor
24632524|NCT01124383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24632525|NCT01124383|Sympathomimetics|sympathomimetics|mesh-ancestor
24632526|NCT01124383|Autonomic Agents|autonomic agents|mesh-ancestor
24632527|NCT01124383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24632528|NCT01124383|Adrenergic Agents|adrenergic agents|mesh-ancestor
24632529|NCT01124435|Celecoxib|celecoxib|mesh-list
24632530|NCT01124435|Carboplatin|carboplatin|mesh-list
24632583|NCT01124630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632584|NCT01124630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24632585|NCT01124630|Immunologic Factors|immunologic factors|mesh-ancestor
24632586|NCT01124630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632587|NCT01124630|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24632588|NCT01124630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24632589|NCT01124630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632591|NCT01124630|Protective Agents|protective agents|mesh-ancestor
24632592|NCT01124630|Vitamin B Complex|vitamin b complex|mesh-ancestor
24632593|NCT01124630|Vitamins|vitamins|mesh-ancestor
24632594|NCT01124630|Micronutrients|micronutrients|mesh-ancestor
24632595|NCT01124656|Pioglitazone|pioglitazone|mesh-list
24632596|NCT01124656|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25033200|NCT03575520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25033201|NCT03575520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25033202|NCT03575520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25033203|NCT03575312|Enrofloxacin|enrofloxacin|mesh-list
25033204|NCT03575312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25033205|NCT03575312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25033206|NCT03575247|Glucocorticoids|glucocorticoids|mesh-list
25033207|NCT03575247|Hormones|hormones|mesh-ancestor
25033208|NCT03575247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25033209|NCT03575247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033220|NCT03575234|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25033228|NCT03575130|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25033230|NCT03575078|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25033231|NCT03575078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632600|NCT01124656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24632637|NCT01124877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632638|NCT01124877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632639|NCT01124877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24632640|NCT01124877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24632641|NCT01124877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24632642|NCT01124877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24632838|NCT01125891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633013|NCT01126814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24633014|NCT01126814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633025|NCT01127009|Etoposide|etoposide|mesh-list
24633026|NCT01127009|Podophyllotoxin|podophyllotoxin|mesh-list
24633027|NCT01127009|Mitoxantrone|mitoxantrone|mesh-list
25033245|NCT03575000|Hormone Antagonists|hormone antagonists|mesh-ancestor
25033246|NCT03575000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25033247|NCT03575000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033248|NCT03575000|Dopamine Agonists|dopamine agonists|mesh-ancestor
25033249|NCT03575000|Dopamine Agents|dopamine agents|mesh-ancestor
25033250|NCT03575000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25033251|NCT03575000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033253|NCT03574909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25033254|NCT03574909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25033255|NCT03574909|Analgesics|analgesics|mesh-ancestor
25033256|NCT03574909|Sensory System Agents|sensory system agents|mesh-ancestor
25033257|NCT03574909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25033258|NCT03574909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033259|NCT03574909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25033261|NCT03574909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25033262|NCT03574909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25033263|NCT03574909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033264|NCT03574909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25033265|NCT03574909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25033266|NCT03574909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25033267|NCT03574909|Antipyretics|antipyretics|mesh-ancestor
25033269|NCT03574857|Chlorothiazide|chlorothiazide|mesh-list
25033270|NCT03574857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25033271|NCT03574857|Diuretics|diuretics|mesh-ancestor
25033277|NCT03574701|Vitamin A|vitamin a|mesh-list
25033283|NCT03574649|Cyclophosphamide|cyclophosphamide|mesh-list
25033284|NCT03574649|Carboplatin|carboplatin|mesh-list
25033285|NCT03574649|Fluorouracil|fluorouracil|mesh-list
25033288|NCT03574649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25033289|NCT03574649|Tubulin Modulators|tubulin modulators|mesh-ancestor
25033290|NCT03574649|Antimitotic Agents|antimitotic agents|mesh-ancestor
25033291|NCT03574649|Mitosis Modulators|mitosis modulators|mesh-ancestor
25033292|NCT03574649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033293|NCT03574649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25033294|NCT03574649|Immunologic Factors|immunologic factors|mesh-ancestor
24430480|NCT00247988|Tubulin Modulators|tubulin modulators|mesh-ancestor
25033295|NCT03574649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033296|NCT03574649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25033297|NCT03574649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25033298|NCT03574649|Alkylating Agents|alkylating agents|mesh-ancestor
25033311|NCT03574402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25033312|NCT03574402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25033313|NCT03574402|Antimetabolites|antimetabolites|mesh-ancestor
24990068|NCT04040946|Lipotropic Agents|lipotropic agents|mesh-ancestor
24990069|NCT04040946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24990070|NCT04040946|Antimetabolites|antimetabolites|mesh-ancestor
24990071|NCT04040946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990072|NCT04040946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24633059|NCT01127100|Fentanyl|fentanyl|mesh-list
24633129|NCT01127295|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24633130|NCT01127295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24633131|NCT01127308|Ertugliflozin|ertugliflozin|mesh-list
24633132|NCT01127308|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24633133|NCT01127308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633134|NCT01127308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24633135|NCT01127308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633136|NCT01127360|Bevacizumab|bevacizumab|mesh-list
24633208|NCT01127568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24633218|NCT01127620|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24990073|NCT04040946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24990074|NCT04040946|Nootropic Agents|nootropic agents|mesh-ancestor
24600144|NCT02465138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588251|NCT00901745|Giapreza|giapreza|mesh-list
24588252|NCT00901745|Norepinephrine|norepinephrine|mesh-list
24588253|NCT00901745|Angiotensinogen|angiotensinogen|mesh-list
24588254|NCT00901745|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24588255|NCT00901745|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24588256|NCT00901745|Protease Inhibitors|protease inhibitors|mesh-ancestor
24588257|NCT00901745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588258|NCT00901745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588259|NCT00901745|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24588260|NCT00901745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24588297|NCT00901875|Buprenorphine|buprenorphine|mesh-list
24588298|NCT00901875|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
24588299|NCT00901875|Naloxone|naloxone|mesh-list
24588300|NCT00901875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24588301|NCT00901875|Narcotics|narcotics|mesh-ancestor
24588317|NCT00902031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24588318|NCT00902031|Laxatives|laxatives|mesh-ancestor
24588319|NCT00902031|Cathartics|cathartics|mesh-ancestor
24588320|NCT00902057|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24588321|NCT00902057|Hemostatics|hemostatics|mesh-ancestor
25033314|NCT03574402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033315|NCT03574402|Antiviral Agents|antiviral agents|mesh-ancestor
24817647|NCT02084784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817648|NCT02084875|Tofacitinib|tofacitinib|mesh-list
24817649|NCT02084875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25033316|NCT03574402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25033317|NCT03574402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25033318|NCT03574402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24929030|NCT04115982|Vitamins|vitamins|mesh-ancestor
24633219|NCT01127620|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24633220|NCT01127620|Histamine Antagonists|histamine antagonists|mesh-ancestor
24633221|NCT01127620|Histamine Agents|histamine agents|mesh-ancestor
24431022|NCT00250042|Imatinib Mesylate|imatinib mesylate|mesh-list
24633222|NCT01127620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24633223|NCT01127620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633224|NCT01127620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633225|NCT01127672|Betamethasone|betamethasone|mesh-list
24633227|NCT01127672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24633229|NCT01127672|Hormones|hormones|mesh-ancestor
24633231|NCT01127672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633232|NCT01127672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24633233|NCT01127672|Respiratory System Agents|respiratory system agents|mesh-ancestor
24633251|NCT01127750|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24633252|NCT01127750|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24633253|NCT01127750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633254|NCT01127750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25033324|NCT03574402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25033325|NCT03574376|Bupivacaine|bupivacaine|mesh-list
25033326|NCT03574376|Anesthetics, Local|anesthetics, local|mesh-ancestor
25033327|NCT03574376|Anesthetics|anesthetics|mesh-ancestor
25033328|NCT03574376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25033329|NCT03574376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033330|NCT03574376|Sensory System Agents|sensory system agents|mesh-ancestor
25033331|NCT03574376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25033332|NCT03574285|Sarpogrelate|sarpogrelate|mesh-list
25033333|NCT03574285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25033334|NCT03574285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25033335|NCT03574285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033336|NCT03574285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25033337|NCT03574285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25033338|NCT03574285|Serotonin Agents|serotonin agents|mesh-ancestor
25033339|NCT03574285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24633255|NCT01127750|Immunologic Factors|immunologic factors|mesh-ancestor
24633256|NCT01127750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633258|NCT01127841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24633261|NCT01127841|Immunologic Factors|immunologic factors|mesh-ancestor
24633262|NCT01127841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633263|NCT01127841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24633264|NCT01127841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24633265|NCT01127841|Alkylating Agents|alkylating agents|mesh-ancestor
24633289|NCT01128075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443952|NCT00296348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24443953|NCT00296348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633292|NCT01128075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24633294|NCT01128101|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24633295|NCT01128101|Hormone Antagonists|hormone antagonists|mesh-ancestor
25033379|NCT03573986|Growth Substances|growth substances|mesh-ancestor
25033380|NCT03573986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033381|NCT03573986|Growth Inhibitors|growth inhibitors|mesh-ancestor
25033383|NCT03573934|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25033384|NCT03573934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25033385|NCT03573934|Hormones|hormones|mesh-ancestor
25033386|NCT03573934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25033387|NCT03573934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033388|NCT03573934|Incretins|incretins|mesh-ancestor
25033389|NCT03573687|Caseins|caseins|mesh-list
25033390|NCT03573687|Chelating Agents|chelating agents|mesh-ancestor
25033391|NCT03573687|Sequestering Agents|sequestering agents|mesh-ancestor
25033392|NCT03573687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691956|NCT01993108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25691957|NCT01993108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25691958|NCT01993108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25691959|NCT01993108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25691960|NCT01993108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691961|NCT01993108|Dopamine Agents|dopamine agents|mesh-ancestor
25691962|NCT01993108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24882674|NCT05148975|Sequestering Agents|sequestering agents|mesh-ancestor
24516665|NCT00602693|Antioxidants|antioxidants|mesh-ancestor
25033393|NCT03573622|Sarpogrelate|sarpogrelate|mesh-list
24633344|NCT01128712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633345|NCT01128712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24633347|NCT01128712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24633348|NCT01128712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24633349|NCT01128712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24633350|NCT01128985|Canagliflozin|canagliflozin|mesh-list
24633351|NCT01128985|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24633352|NCT01128985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633353|NCT01128985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25033435|NCT03573284|Protective Agents|protective agents|mesh-ancestor
24633471|NCT01129427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633473|NCT01129479|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24633474|NCT01129479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633475|NCT01129479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633476|NCT01129479|Cholinergic Agents|cholinergic agents|mesh-ancestor
24633477|NCT01129479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24633525|NCT01129856|Sodium Citrate|sodium citrate|mesh-list
24633526|NCT01129856|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25033399|NCT03573622|Serotonin Agents|serotonin agents|mesh-ancestor
25033400|NCT03573622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25033401|NCT03573622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033402|NCT03573596|Dasatinib|dasatinib|mesh-list
25033403|NCT03573596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25033404|NCT03573596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25033405|NCT03573596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25033406|NCT03573596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633527|NCT01129856|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24633528|NCT01129856|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24633529|NCT01129856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24633530|NCT01129856|Antiemetics|antiemetics|mesh-ancestor
24633531|NCT01129856|Autonomic Agents|autonomic agents|mesh-ancestor
24633578|NCT01130077|Immunologic Factors|immunologic factors|mesh-ancestor
24633579|NCT01130077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633580|NCT01130181|Cholecalciferol|cholecalciferol|mesh-list
24431945|NCT00253266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24633582|NCT01130181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24633583|NCT01130181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633584|NCT01130181|Vitamins|vitamins|mesh-ancestor
24633586|NCT01130181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25691963|NCT01993186|Glycerol|glycerol|mesh-list
25691964|NCT01993186|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25691965|NCT01993186|Protective Agents|protective agents|mesh-ancestor
25691966|NCT01993186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691967|NCT01993329|Mitomycin|mitomycin|mesh-list
25691968|NCT01993329|Cisplatin|cisplatin|mesh-list
25691969|NCT01993329|Ifosfamide|ifosfamide|mesh-list
25691970|NCT01993329|Mesna|mesna|mesh-list
25691971|NCT01993329|Protective Agents|protective agents|mesh-ancestor
25691972|NCT01993329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691973|NCT01993329|Alkylating Agents|alkylating agents|mesh-ancestor
25691974|NCT01993329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633591|NCT01130246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633592|NCT01130246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633593|NCT01130259|Iniparib|iniparib|mesh-list
24633594|NCT01130259|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24633595|NCT01130259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633596|NCT01130259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633597|NCT01130259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633598|NCT01130298|Testosterone|testosterone|mesh-list
24633599|NCT01130298|Androgens|androgens|mesh-ancestor
24633654|NCT01130506|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24633655|NCT01130636|Oseltamivir|oseltamivir|mesh-list
24633656|NCT01130636|Antiviral Agents|antiviral agents|mesh-ancestor
24633657|NCT01130636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25033423|NCT03573284|Autonomic Agents|autonomic agents|mesh-ancestor
25033424|NCT03573284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25033425|NCT03573284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033426|NCT03573284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25033427|NCT03573284|Respiratory System Agents|respiratory system agents|mesh-ancestor
25033428|NCT03573284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25033429|NCT03573284|Antioxidants|antioxidants|mesh-ancestor
25033430|NCT03573284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033431|NCT03573284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25033432|NCT03573284|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25033433|NCT03573284|Vasodilator Agents|vasodilator agents|mesh-ancestor
25033434|NCT03573284|Gasotransmitters|gasotransmitters|mesh-ancestor
25033437|NCT03573245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25033438|NCT03573245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25033439|NCT03573245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033440|NCT03573245|Hemostatics|hemostatics|mesh-ancestor
25033441|NCT03573245|Coagulants|coagulants|mesh-ancestor
24633658|NCT01130636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633659|NCT01130636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633660|NCT01130662|Decitabine|decitabine|mesh-list
24633661|NCT01130662|Midostaurin|midostaurin|mesh-list
24633662|NCT01130662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24633663|NCT01130662|Antimetabolites|antimetabolites|mesh-ancestor
24633664|NCT01130662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633665|NCT01130662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633666|NCT01130662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633676|NCT01130688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24633677|NCT01130688|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24394853|NCT00134420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394854|NCT00134420|Analgesics|analgesics|mesh-ancestor
24394855|NCT00134420|Sensory System Agents|sensory system agents|mesh-ancestor
24394856|NCT00134420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24394857|NCT00134420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24394858|NCT00134420|Sympatholytics|sympatholytics|mesh-ancestor
24394859|NCT00134420|Autonomic Agents|autonomic agents|mesh-ancestor
24394861|NCT00134420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24394873|NCT00134485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394874|NCT00134498|Atorvastatin|atorvastatin|mesh-list
24394875|NCT00134498|Torcetrapib|torcetrapib|mesh-list
24394876|NCT00134498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24394877|NCT00134498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24394878|NCT00134498|Antimetabolites|antimetabolites|mesh-ancestor
24455323|NCT01785459|Prochlorperazine|prochlorperazine|mesh-list
24394879|NCT00134498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395478|NCT00136110|Valproic Acid|valproic acid|mesh-list
24395479|NCT00136110|Anticonvulsants|anticonvulsants|mesh-ancestor
24395480|NCT00136110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395481|NCT00136110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033443|NCT03573102|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25033444|NCT03573102|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25033445|NCT03573102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25033447|NCT03573102|Analgesics|analgesics|mesh-ancestor
25033448|NCT03573102|Sensory System Agents|sensory system agents|mesh-ancestor
25033449|NCT03573102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25033450|NCT03573102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033451|NCT03573102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25033452|NCT03573102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25033453|NCT03573102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25033454|NCT03573102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25033553|NCT03572686|Anesthetics|anesthetics|mesh-ancestor
25033456|NCT03573102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25033457|NCT03573102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25033459|NCT03573102|Antipyretics|antipyretics|mesh-ancestor
25033460|NCT03573102|Protease Inhibitors|protease inhibitors|mesh-ancestor
25033461|NCT03573102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25033462|NCT03573063|Androgens|androgens|mesh-list
25033463|NCT03573063|Hormones|hormones|mesh-ancestor
25033464|NCT03573063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25033465|NCT03573063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033466|NCT03573050|Rivastigmine|rivastigmine|mesh-list
24395727|NCT00136747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395729|NCT00136747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24395730|NCT00136747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395731|NCT00136747|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24395732|NCT00136747|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24395733|NCT00136747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395734|NCT00136747|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24395735|NCT00136747|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24395879|NCT00137085|Sensory System Agents|sensory system agents|mesh-ancestor
24433823|NCT00260143|Androgens|androgens|mesh-ancestor
24435264|NCT00265811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24555514|NCT00741884|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24435265|NCT00265811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435267|NCT00265824|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24435268|NCT00265824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24395880|NCT00137085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24395881|NCT00137085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395882|NCT00137085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24395883|NCT00137085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24395884|NCT00137085|Anesthetics, General|anesthetics, general|mesh-ancestor
24395885|NCT00137085|Anesthetics|anesthetics|mesh-ancestor
24395886|NCT00137085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24395888|NCT00137085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24395892|NCT00137098|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24396076|NCT00137774|Temozolomide|temozolomide|mesh-list
24396077|NCT00137774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25033467|NCT03573050|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25033468|NCT03573050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25033469|NCT03573050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396078|NCT00137774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396079|NCT00137774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24396080|NCT00137774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24396081|NCT00137774|Growth Substances|growth substances|mesh-ancestor
24396082|NCT00137774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396083|NCT00137774|Growth Inhibitors|growth inhibitors|mesh-ancestor
24396084|NCT00137774|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24396085|NCT00137774|Alkylating Agents|alkylating agents|mesh-ancestor
24396086|NCT00137774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396087|NCT00137787|Ciprofloxacin|ciprofloxacin|mesh-list
24396115|NCT00137813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396116|NCT00137826|Bevacizumab|bevacizumab|mesh-list
24396177|NCT00137995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24396178|NCT00137995|Alkylating Agents|alkylating agents|mesh-ancestor
24396179|NCT00137995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24435269|NCT00265824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435270|NCT00265824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24435271|NCT00265824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24435272|NCT00265824|Growth Substances|growth substances|mesh-ancestor
24435273|NCT00265824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435274|NCT00265824|Growth Inhibitors|growth inhibitors|mesh-ancestor
24435275|NCT00265824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24435276|NCT00265824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435277|NCT00265824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435278|NCT00265863|Mitomycins|mitomycins|mesh-list
24435379|NCT00266136|Daunorubicin|daunorubicin|mesh-list
24396180|NCT00138060|Fluorouracil|fluorouracil|mesh-list
24396181|NCT00138060|Irinotecan|irinotecan|mesh-list
24396182|NCT00138060|Antimetabolites|antimetabolites|mesh-ancestor
25022937|NCT03658473|Naproxen|naproxen|mesh-list
24396187|NCT00138060|Immunologic Factors|immunologic factors|mesh-ancestor
24396188|NCT00138060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691975|NCT01993329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24396374|NCT00138866|Risedronic Acid|risedronic acid|mesh-list
24396375|NCT00138866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24396376|NCT00138866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24396377|NCT00138866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396520|NCT00139230|Docetaxel|docetaxel|mesh-list
24396572|NCT00139269|Tubulin Modulators|tubulin modulators|mesh-ancestor
24396573|NCT00139269|Antimitotic Agents|antimitotic agents|mesh-ancestor
24396574|NCT00139269|Mitosis Modulators|mitosis modulators|mesh-ancestor
24396576|NCT00139269|Antimetabolites|antimetabolites|mesh-ancestor
24396589|NCT00139282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24396734|NCT00139815|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24396735|NCT00139815|Antithrombins|antithrombins|mesh-ancestor
24396785|NCT00139893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396786|NCT00139932|Formoterol Fumarate|formoterol fumarate|mesh-list
24396787|NCT00139932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24396788|NCT00139932|Autonomic Agents|autonomic agents|mesh-ancestor
24396789|NCT00139932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24396790|NCT00139932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396792|NCT00139932|Respiratory System Agents|respiratory system agents|mesh-ancestor
24396793|NCT00139932|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24396794|NCT00139932|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24396796|NCT00139932|Adrenergic Agents|adrenergic agents|mesh-ancestor
24396797|NCT00139932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24396897|NCT00140309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24396898|NCT00140309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24396899|NCT00140309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396900|NCT00140309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396901|NCT00140309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396902|NCT00140309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24396904|NCT00140309|Leprostatic Agents|leprostatic agents|mesh-ancestor
24396974|NCT00140517|Pyrimethamine|pyrimethamine|mesh-list
24396975|NCT00140517|Sulfadoxine|sulfadoxine|mesh-list
24437323|NCT00273429|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25033484|NCT03572959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033485|NCT03572959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25033486|NCT03572959|Immunologic Factors|immunologic factors|mesh-ancestor
25033487|NCT03572959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25033488|NCT03572959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396976|NCT00140517|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24396977|NCT00140517|Amebicides|amebicides|mesh-ancestor
24396978|NCT00140517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24397137|NCT00140894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24397138|NCT00140894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24397139|NCT00140894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24397140|NCT00140894|Analgesics|analgesics|mesh-ancestor
24397141|NCT00140894|Sensory System Agents|sensory system agents|mesh-ancestor
24397144|NCT00140920|Diclofenac|diclofenac|mesh-list
24397164|NCT00140933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24397165|NCT00140933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397166|NCT00140933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24397167|NCT00140933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24397168|NCT00140933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24397169|NCT00140933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24397170|NCT00140933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397171|NCT00140933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24397172|NCT00140998|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24397173|NCT00140998|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24397174|NCT00140998|Estradiol|estradiol|mesh-list
24397224|NCT00141154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24397226|NCT00141154|Analgesics|analgesics|mesh-ancestor
24397341|NCT00141375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25691976|NCT01993329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25691977|NCT01993329|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25691978|NCT01993329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24397343|NCT00141375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24397345|NCT00141375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24397346|NCT00141375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24397470|NCT00141596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24397471|NCT00141596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397472|NCT00141596|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
25033508|NCT03572829|Glucocorticoids|glucocorticoids|mesh-ancestor
25033510|NCT03572829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24991412|NCT05193253|Liver Extracts|liver extracts|mesh-list
24397473|NCT00141596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24397474|NCT00141596|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24397475|NCT00141596|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24397477|NCT00141648|Cyclophosphamide|cyclophosphamide|mesh-list
24397478|NCT00141648|Doxorubicin|doxorubicin|mesh-list
24397610|NCT00142025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24397611|NCT00142025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397612|NCT00142025|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24397613|NCT00142025|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24397614|NCT00142038|Docetaxel|docetaxel|mesh-list
24397615|NCT00142038|Capecitabine|capecitabine|mesh-list
24397616|NCT00142038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24397617|NCT00142038|Tubulin Modulators|tubulin modulators|mesh-ancestor
24397618|NCT00142038|Antimitotic Agents|antimitotic agents|mesh-ancestor
24397619|NCT00142038|Mitosis Modulators|mitosis modulators|mesh-ancestor
24397620|NCT00142038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397621|NCT00142038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24397622|NCT00142038|Antimetabolites|antimetabolites|mesh-ancestor
24397694|NCT00142350|Irinotecan|irinotecan|mesh-list
24397695|NCT00142350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24397696|NCT00142350|Antimetabolites|antimetabolites|mesh-ancestor
24397697|NCT00142350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397705|NCT00142402|Modafinil|modafinil|mesh-list
24397709|NCT00142402|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24397710|NCT00142402|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24397711|NCT00142402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397712|NCT00142428|Cetuximab|cetuximab|mesh-list
24397713|NCT00142428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24397714|NCT00142428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24397840|NCT00142870|Bupropion|bupropion|mesh-list
25033511|NCT03572829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25033512|NCT03572829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25033513|NCT03572829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033515|NCT03572829|Dermatologic Agents|dermatologic agents|mesh-ancestor
25033516|NCT03572829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25033517|NCT03572829|Serotonin Agents|serotonin agents|mesh-ancestor
25033518|NCT03572829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25033519|NCT03572829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25033520|NCT03572829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25033521|NCT03572829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25033522|NCT03572829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25033523|NCT03572829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25033524|NCT03572829|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25033525|NCT03572790|Prucalopride|prucalopride|mesh-list
25033526|NCT03572790|Laxatives|laxatives|mesh-ancestor
25033527|NCT03572790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24600423|NCT00082706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033552|NCT03572686|Anesthetics, Local|anesthetics, local|mesh-ancestor
25033554|NCT03572686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25033555|NCT03572686|Sensory System Agents|sensory system agents|mesh-ancestor
25033557|NCT03572647|Hematinics|hematinics|mesh-ancestor
25033559|NCT03572595|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25033560|NCT03572595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033561|NCT03572582|Nivolumab|nivolumab|mesh-list
25033562|NCT03572582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25033563|NCT03572582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24991426|NCT05173597|Hormones|hormones|mesh-ancestor
25691979|NCT01993329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25691980|NCT01993667|Acetazolamide|acetazolamide|mesh-list
25076819|NCT03370562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25076820|NCT03370562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24882810|NCT04957368|Analgesics|analgesics|mesh-ancestor
24397841|NCT00142870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24397842|NCT00142870|Antidepressive Agents|antidepressive agents|mesh-ancestor
24397843|NCT00142870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24397844|NCT00142870|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24433985|NCT00261131|Botulinum Toxins|botulinum toxins|mesh-list
24397845|NCT00142870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24397846|NCT00142870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24397847|NCT00142870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397848|NCT00142870|Dopamine Agents|dopamine agents|mesh-ancestor
24397849|NCT00142870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24397850|NCT00142870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397851|NCT00142870|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25033564|NCT03572582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25033565|NCT03572582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033566|NCT03572517|Morphine|morphine|mesh-list
25033567|NCT03572517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25033568|NCT03572517|Narcotics|narcotics|mesh-ancestor
25033569|NCT03572517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25033570|NCT03572517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033571|NCT03572517|Analgesics|analgesics|mesh-ancestor
25033572|NCT03572517|Sensory System Agents|sensory system agents|mesh-ancestor
25033573|NCT03572517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25033574|NCT03572400|Gemcitabine|gemcitabine|mesh-list
25033575|NCT03572400|Durvalumab|durvalumab|mesh-list
24600515|NCT00959218|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24600516|NCT00959218|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24397852|NCT00142870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24397853|NCT00142870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24397891|NCT00142961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24397892|NCT00142961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397894|NCT00142974|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24397895|NCT00142974|Serotonin Agents|serotonin agents|mesh-ancestor
24556360|NCT00747331|Fenoldopam|fenoldopam|mesh-list
24397896|NCT00142974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24397897|NCT00142974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397898|NCT00142974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397899|NCT00142987|Tegaserod|tegaserod|mesh-list
24397900|NCT00142987|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24397901|NCT00142987|Serotonin Agents|serotonin agents|mesh-ancestor
24397905|NCT00143000|Ribavirin|ribavirin|mesh-list
24397938|NCT00143091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24397941|NCT00143104|Insulin|insulin|mesh-list
24397947|NCT00143130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24397948|NCT00143130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397949|NCT00143130|Anticonvulsants|anticonvulsants|mesh-ancestor
24397950|NCT00143130|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24397951|NCT00143130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24397952|NCT00143130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397953|NCT00143130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24397954|NCT00143130|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24398051|NCT00143325|Varenicline|varenicline|mesh-list
24398052|NCT00143325|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24398053|NCT00143325|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24398054|NCT00143325|Cholinergic Agents|cholinergic agents|mesh-ancestor
24398055|NCT00143325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24398056|NCT00143325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398057|NCT00143325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398271|NCT00144053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24398272|NCT00144053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24398273|NCT00144053|Tubulin Modulators|tubulin modulators|mesh-ancestor
24398274|NCT00144053|Antimitotic Agents|antimitotic agents|mesh-ancestor
25033592|NCT03572257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25691981|NCT01993667|Anticonvulsants|anticonvulsants|mesh-ancestor
25691982|NCT01993667|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25691983|NCT01993667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691984|NCT01993667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25691985|NCT01993667|Diuretics|diuretics|mesh-ancestor
25076834|NCT03370406|Antimetabolites|antimetabolites|mesh-ancestor
25076835|NCT03370406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076836|NCT03370406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25076849|NCT03370380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25076850|NCT03370367|Tretinoin|tretinoin|mesh-list
25076851|NCT03370367|Isotretinoin|isotretinoin|mesh-list
25076869|NCT03370159|Docetaxel|docetaxel|mesh-list
25033593|NCT03572257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033594|NCT03572231|Solifenacin Succinate|solifenacin succinate|mesh-list
25033595|NCT03572231|Mirabegron|mirabegron|mesh-list
25033596|NCT03572231|Fesoterodine|fesoterodine|mesh-list
25033597|NCT03572231|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25033598|NCT03572231|Oxybutynin|oxybutynin|mesh-list
25033599|NCT03572231|Darifenacin|darifenacin|mesh-list
25033600|NCT03572231|Propiverine|propiverine|mesh-list
25033601|NCT03572231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25033602|NCT03572231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25033603|NCT03572231|Cholinergic Agents|cholinergic agents|mesh-ancestor
25033604|NCT03572231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24398405|NCT00144326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24398406|NCT00144326|Autonomic Agents|autonomic agents|mesh-ancestor
24398407|NCT00144326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24398408|NCT00144326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398410|NCT00144326|Respiratory System Agents|respiratory system agents|mesh-ancestor
24398411|NCT00144326|Parasympatholytics|parasympatholytics|mesh-ancestor
24398412|NCT00144326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24398413|NCT00144326|Cholinergic Agents|cholinergic agents|mesh-ancestor
24398414|NCT00144326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24398415|NCT00144326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398416|NCT00144326|Anticonvulsants|anticonvulsants|mesh-ancestor
24398417|NCT00144352|Pyrimethamine|pyrimethamine|mesh-list
24398418|NCT00144352|Sulfadoxine|sulfadoxine|mesh-list
24398419|NCT00144352|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24398437|NCT00144378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24398438|NCT00144417|Moxifloxacin|moxifloxacin|mesh-list
24398439|NCT00144417|Rifampin|rifampin|mesh-list
24398440|NCT00144417|Isoniazid|isoniazid|mesh-list
24398441|NCT00144417|Pyrazinamide|pyrazinamide|mesh-list
24398442|NCT00144417|Ethambutol|ethambutol|mesh-list
24398443|NCT00144417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24398444|NCT00144417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24398464|NCT00144430|Pentostatin|pentostatin|mesh-list
24398538|NCT00144833|Lopinavir|lopinavir|mesh-list
24398539|NCT00144833|Fosamprenavir|fosamprenavir|mesh-list
24398540|NCT00144833|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24398541|NCT00144833|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24398542|NCT00144833|Protease Inhibitors|protease inhibitors|mesh-ancestor
24398791|NCT00145665|Antiviral Agents|antiviral agents|mesh-ancestor
24398792|NCT00145665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24398793|NCT00145665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24398794|NCT00145665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398795|NCT00145665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398796|NCT00145691|Oxcarbazepine|oxcarbazepine|mesh-list
24398797|NCT00145691|Anticonvulsants|anticonvulsants|mesh-ancestor
24398798|NCT00145691|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24398799|NCT00145691|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24398800|NCT00145691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24398839|NCT00145925|Diuretics|diuretics|mesh-ancestor
24398840|NCT00145925|Natriuretic Agents|natriuretic agents|mesh-ancestor
25033605|NCT03572231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033606|NCT03572231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033607|NCT03572231|Urological Agents|urological agents|mesh-ancestor
25033608|NCT03572231|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25033609|NCT03572231|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25033610|NCT03572231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25033611|NCT03572231|Adrenergic Agents|adrenergic agents|mesh-ancestor
25033612|NCT03572231|Parasympatholytics|parasympatholytics|mesh-ancestor
25033613|NCT03572231|Autonomic Agents|autonomic agents|mesh-ancestor
25033614|NCT03572231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25691986|NCT01993667|Natriuretic Agents|natriuretic agents|mesh-ancestor
25691987|NCT01993667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25691988|NCT01993823|Clotrimazole|clotrimazole|mesh-list
25691989|NCT01993823|Miconazole|miconazole|mesh-list
25691990|NCT01993823|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25691991|NCT01993823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25691992|NCT01993823|Antifungal Agents|antifungal agents|mesh-ancestor
25691993|NCT01993823|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25076880|NCT03370159|Micronutrients|micronutrients|mesh-ancestor
24954545|NCT03875911|Mitomycin|mitomycin|mesh-list
24954546|NCT03875911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24438714|NCT00276692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24399226|NCT00146926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24399227|NCT00146926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24399228|NCT00146926|Anesthetics, General|anesthetics, general|mesh-ancestor
24399229|NCT00146926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24399230|NCT00146926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24399231|NCT00146926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24399232|NCT00146926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24399233|NCT00146926|Sympathomimetics|sympathomimetics|mesh-ancestor
24399234|NCT00146926|Autonomic Agents|autonomic agents|mesh-ancestor
24399235|NCT00146926|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24399236|NCT00146926|Adrenergic Agents|adrenergic agents|mesh-ancestor
24399237|NCT00147004|Hydrocortisone|hydrocortisone|mesh-list
24399238|NCT00147004|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24399239|NCT00147004|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24399241|NCT00147004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24399253|NCT00147160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399255|NCT00147186|Viscosupplements|viscosupplements|mesh-ancestor
24399256|NCT00147186|Protective Agents|protective agents|mesh-ancestor
24399257|NCT00147186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399259|NCT00147264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24399260|NCT00147264|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25033618|NCT03572010|Fesoterodine|fesoterodine|mesh-list
25033619|NCT03572010|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25033620|NCT03572010|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25033621|NCT03572010|Cholinergic Agents|cholinergic agents|mesh-ancestor
25033622|NCT03572010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25033623|NCT03572010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033624|NCT03572010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033625|NCT03572010|Urological Agents|urological agents|mesh-ancestor
25033626|NCT03571919|Lidocaine|lidocaine|mesh-list
25033627|NCT03571919|Anesthetics, Local|anesthetics, local|mesh-ancestor
25033628|NCT03571919|Anesthetics|anesthetics|mesh-ancestor
25033629|NCT03571919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25033630|NCT03571919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033631|NCT03571919|Sensory System Agents|sensory system agents|mesh-ancestor
25033632|NCT03571919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25033633|NCT03571919|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25033634|NCT03571919|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25033635|NCT03571919|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25033636|NCT03571919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25033637|NCT03571919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033638|NCT03571815|Listerine|listerine|mesh-list
25033639|NCT03571815|Fluorides|fluorides|mesh-list
25033640|NCT03571815|Sodium Fluoride|sodium fluoride|mesh-list
25033641|NCT03571815|Fluorides, Topical|fluorides, topical|mesh-list
25033642|NCT03571815|Cariostatic Agents|cariostatic agents|mesh-ancestor
25033643|NCT03571815|Protective Agents|protective agents|mesh-ancestor
24399261|NCT00147264|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24399262|NCT00147264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399263|NCT00147303|Sarpogrelate|sarpogrelate|mesh-list
24399264|NCT00147303|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24399265|NCT00147303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24399266|NCT00147303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399378|NCT00147628|Sildenafil Citrate|sildenafil citrate|mesh-list
24399379|NCT00147628|Citric Acid|citric acid|mesh-list
24399380|NCT00147628|Sodium Citrate|sodium citrate|mesh-list
24399381|NCT00147628|Anticoagulants|anticoagulants|mesh-ancestor
24399382|NCT00147628|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24399383|NCT00147628|Chelating Agents|chelating agents|mesh-ancestor
24399384|NCT00147628|Sequestering Agents|sequestering agents|mesh-ancestor
24399385|NCT00147628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399386|NCT00147628|Vasodilator Agents|vasodilator agents|mesh-ancestor
24399437|NCT00147771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399439|NCT00147771|Interferon Inducers|interferon inducers|mesh-ancestor
24399440|NCT00147784|Interferons|interferons|mesh-list
24399441|NCT00147784|Ribavirin|ribavirin|mesh-list
24399442|NCT00147784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25691994|NCT01993823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25691995|NCT01993823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25691996|NCT01993823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399444|NCT00147784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24399445|NCT00147784|Antimetabolites|antimetabolites|mesh-ancestor
25033644|NCT03571815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033645|NCT03571815|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25033646|NCT03571815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25033647|NCT03571737|Ibuprofen|ibuprofen|mesh-list
25033648|NCT03571737|Lidocaine|lidocaine|mesh-list
25033649|NCT03571737|Anesthetics, Local|anesthetics, local|mesh-ancestor
25033650|NCT03571737|Anesthetics|anesthetics|mesh-ancestor
25033651|NCT03571737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25033685|NCT03571438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25033686|NCT03571438|Growth Substances|growth substances|mesh-ancestor
25033687|NCT03571438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033689|NCT03571438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25033690|NCT03571438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25033718|NCT03571321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25033720|NCT03571321|Autonomic Agents|autonomic agents|mesh-ancestor
25033721|NCT03571321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25033722|NCT03571321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25033723|NCT03571321|Glucocorticoids|glucocorticoids|mesh-ancestor
25033724|NCT03571321|Hormones|hormones|mesh-ancestor
25033725|NCT03571321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24399446|NCT00147784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399447|NCT00147836|Insulin|insulin|mesh-list
24399449|NCT00147836|Metformin|metformin|mesh-list
24399458|NCT00147862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24399459|NCT00147862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399460|NCT00147862|Hemostatics|hemostatics|mesh-ancestor
24399467|NCT00147875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24399479|NCT00147875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24399501|NCT00147901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24399503|NCT00147914|Clavulanic Acid|clavulanic acid|mesh-list
24399504|NCT00147914|Clavulanic Acids|clavulanic acids|mesh-list
24399505|NCT00147914|Cefdinir|cefdinir|mesh-list
24399506|NCT00147914|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24399507|NCT00147914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24399508|NCT00147914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24399516|NCT00147953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399517|NCT00147953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24399518|NCT00147979|Heparin|heparin|mesh-list
24399634|NCT00148278|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24399635|NCT00148278|Protective Agents|protective agents|mesh-ancestor
24399636|NCT00148291|Docetaxel|docetaxel|mesh-list
24399637|NCT00148291|Vinorelbine|vinorelbine|mesh-list
24399664|NCT00148395|Ifosfamide|ifosfamide|mesh-list
24399665|NCT00148395|Mitomycins|mitomycins|mesh-list
24399666|NCT00148395|Mitomycin|mitomycin|mesh-list
24399667|NCT00148395|Vinorelbine|vinorelbine|mesh-list
24399668|NCT00148395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399669|NCT00148395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24399670|NCT00148395|Antimetabolites|antimetabolites|mesh-ancestor
24399671|NCT00148395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399704|NCT00148447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25033726|NCT03571321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25033727|NCT03571321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25033728|NCT03571321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25033729|NCT03571321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25033730|NCT03571321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25033731|NCT03571321|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25033732|NCT03571321|Abortifacient Agents|abortifacient agents|mesh-ancestor
25033733|NCT03571321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25033734|NCT03571321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25033735|NCT03571321|Antimetabolites|antimetabolites|mesh-ancestor
25033736|NCT03571321|Dermatologic Agents|dermatologic agents|mesh-ancestor
25033737|NCT03571321|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24636391|NCT01145079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24636400|NCT01145170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24636401|NCT01145170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24636403|NCT01145326|Anesthetics, Local|anesthetics, local|mesh-ancestor
25033748|NCT03571308|Vincristine|vincristine|mesh-list
25033749|NCT03571308|Acalabrutinib|acalabrutinib|mesh-list
25033750|NCT03571308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25691997|NCT01993823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25691998|NCT01993823|Hormone Antagonists|hormone antagonists|mesh-ancestor
25076902|NCT03369847|Autonomic Agents|autonomic agents|mesh-ancestor
25076903|NCT03369847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816194|NCT02074891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25033751|NCT03571308|Immunologic Factors|immunologic factors|mesh-ancestor
25033752|NCT03571308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033753|NCT03571308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25033754|NCT03571308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25033755|NCT03571308|Alkylating Agents|alkylating agents|mesh-ancestor
25033756|NCT03571308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990416|NCT03117010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25033757|NCT03571308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25033758|NCT03571308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25033759|NCT03571308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25033760|NCT03571308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25033762|NCT03571308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25033763|NCT03571308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24399705|NCT00148447|Serotonin Agents|serotonin agents|mesh-ancestor
24399706|NCT00148447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033764|NCT03571308|Tubulin Modulators|tubulin modulators|mesh-ancestor
25033765|NCT03571308|Antimitotic Agents|antimitotic agents|mesh-ancestor
25033766|NCT03571308|Mitosis Modulators|mitosis modulators|mesh-ancestor
25033767|NCT03571308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25033770|NCT03571308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25033771|NCT03571308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25033772|NCT03571230|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25033773|NCT03571230|Amoxicillin|amoxicillin|mesh-list
25033774|NCT03571230|Metronidazole|metronidazole|mesh-list
25033775|NCT03571230|Clarithromycin|clarithromycin|mesh-list
25033776|NCT03571230|Levofloxacin|levofloxacin|mesh-list
25033777|NCT03571230|Tetracycline|tetracycline|mesh-list
25033778|NCT03571230|Tinidazole|tinidazole|mesh-list
25033779|NCT03571230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25033780|NCT03571230|Furazolidone|furazolidone|mesh-list
25033781|NCT03571230|Bismuth|bismuth|mesh-list
25033782|NCT03571230|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25033783|NCT03571230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25033784|NCT03571230|Antitubercular Agents|antitubercular agents|mesh-ancestor
25033785|NCT03571230|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25033786|NCT03571230|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25033787|NCT03571230|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25033788|NCT03571230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24806076|NCT02013492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25033806|NCT03571126|Autonomic Agents|autonomic agents|mesh-ancestor
25033807|NCT03571126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25033808|NCT03571126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033809|NCT03571126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25033810|NCT03571126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25033811|NCT03571126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25033812|NCT03571126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25033813|NCT03571126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25033814|NCT03571126|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25033815|NCT03571126|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25033816|NCT03571126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25039951|NCT03553498|Sensory System Agents|sensory system agents|mesh-ancestor
24399707|NCT00148447|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24399708|NCT00148447|Antidepressive Agents|antidepressive agents|mesh-ancestor
25033817|NCT03571126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033818|NCT03571126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25691999|NCT01993823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25692000|NCT01993823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692001|NCT01993823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25692002|NCT01993823|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25692003|NCT01993836|Anesthetics|anesthetics|mesh-list
25692004|NCT01993836|Propofol|propofol|mesh-list
25692005|NCT01993836|Isoflurane|isoflurane|mesh-list
25692006|NCT01993836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25692007|NCT01993836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076925|NCT03369795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076926|NCT03369795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25033819|NCT03571126|Serotonin Agents|serotonin agents|mesh-ancestor
25033820|NCT03571100|Chlorhexidine|chlorhexidine|mesh-list
25033821|NCT03571100|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25033822|NCT03571100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25033823|NCT03571100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25033824|NCT03571100|Disinfectants|disinfectants|mesh-ancestor
25033825|NCT03571100|Dermatologic Agents|dermatologic agents|mesh-ancestor
25033826|NCT03571087|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25033827|NCT03571087|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25033828|NCT03571087|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25033829|NCT03571087|Antimetabolites|antimetabolites|mesh-ancestor
25033830|NCT03571087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033831|NCT03571087|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25033832|NCT03571087|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25033833|NCT03571087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25033851|NCT03570645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25033852|NCT03570645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25033853|NCT03570645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25033854|NCT03570645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25033855|NCT03570645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25033856|NCT03570645|Analgesics|analgesics|mesh-ancestor
24399709|NCT00148447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24399710|NCT00148460|Tenecteplase|tenecteplase|mesh-list
24399711|NCT00148460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24399712|NCT00148460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24399723|NCT00148499|Ambroxol|ambroxol|mesh-list
24399777|NCT00148603|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24399778|NCT00148603|Hormone Antagonists|hormone antagonists|mesh-ancestor
24399787|NCT00148616|Dopamine Agents|dopamine agents|mesh-ancestor
24399845|NCT00148746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24399846|NCT00148746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399847|NCT00148746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24399848|NCT00148746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24399849|NCT00148746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24399851|NCT00148746|Sensory System Agents|sensory system agents|mesh-ancestor
24399852|NCT00148772|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24399853|NCT00148772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399854|NCT00148772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24399855|NCT00148772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400512|NCT00150722|Antimetabolites|antimetabolites|mesh-ancestor
24400513|NCT00150722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400514|NCT00150722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24400515|NCT00150722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24400516|NCT00150722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400517|NCT00150735|Levetiracetam|levetiracetam|mesh-list
24400518|NCT00150735|Anticonvulsants|anticonvulsants|mesh-ancestor
24400519|NCT00150735|Nootropic Agents|nootropic agents|mesh-ancestor
24400520|NCT00150748|Levetiracetam|levetiracetam|mesh-list
25033857|NCT03570645|Sensory System Agents|sensory system agents|mesh-ancestor
25033858|NCT03570645|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25033859|NCT03570645|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25033860|NCT03570645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25033861|NCT03570645|Adrenergic Agents|adrenergic agents|mesh-ancestor
25033862|NCT03570645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25033863|NCT03570645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033864|NCT03570541|Acetaminophen|acetaminophen|mesh-list
25033866|NCT03570541|Ropivacaine|ropivacaine|mesh-list
25033867|NCT03570541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25033868|NCT03570541|Narcotics|narcotics|mesh-ancestor
25033869|NCT03570541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25033870|NCT03570541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033871|NCT03570541|Analgesics|analgesics|mesh-ancestor
25033872|NCT03570541|Sensory System Agents|sensory system agents|mesh-ancestor
25033873|NCT03570541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25033874|NCT03570541|Anesthetics, Local|anesthetics, local|mesh-ancestor
24400521|NCT00150748|Anticonvulsants|anticonvulsants|mesh-ancestor
24400522|NCT00150748|Nootropic Agents|nootropic agents|mesh-ancestor
25692008|NCT01993836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25692009|NCT01993836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25692010|NCT01993836|Anesthetics, General|anesthetics, general|mesh-ancestor
24400526|NCT00150761|Histamine Antagonists|histamine antagonists|mesh-ancestor
24400527|NCT00150761|Histamine Agents|histamine agents|mesh-ancestor
24400528|NCT00150761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24400529|NCT00150761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400531|NCT00150774|Levetiracetam|levetiracetam|mesh-list
24400541|NCT00150826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400542|NCT00150826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24400543|NCT00150839|Mirtazapine|mirtazapine|mesh-list
24400544|NCT00150839|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24400545|NCT00150839|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24400546|NCT00150839|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24400547|NCT00150839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24401370|NCT00152815|Antioxidants|antioxidants|mesh-list
24401372|NCT00152815|Micronutrients|micronutrients|mesh-ancestor
24401373|NCT00152815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401374|NCT00152815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401375|NCT00152815|Protective Agents|protective agents|mesh-ancestor
24401376|NCT00152828|Celecoxib|celecoxib|mesh-list
24401460|NCT00152958|Dopamine Agonists|dopamine agonists|mesh-ancestor
24401461|NCT00152958|Dopamine Agents|dopamine agents|mesh-ancestor
24401462|NCT00152958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24401463|NCT00152984|Tiotropium Bromide|tiotropium bromide|mesh-list
24401464|NCT00152984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24401465|NCT00152984|Autonomic Agents|autonomic agents|mesh-ancestor
24401466|NCT00152984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24401467|NCT00152984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401468|NCT00152984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24401469|NCT00152984|Respiratory System Agents|respiratory system agents|mesh-ancestor
24401470|NCT00152984|Parasympatholytics|parasympatholytics|mesh-ancestor
24401471|NCT00152984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24401472|NCT00152984|Cholinergic Agents|cholinergic agents|mesh-ancestor
24401473|NCT00152984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24401474|NCT00152984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401475|NCT00152997|Pramipexole|pramipexole|mesh-list
25033888|NCT03570346|Dermatologic Agents|dermatologic agents|mesh-ancestor
25033912|NCT03570281|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25033913|NCT03570281|Antithrombins|antithrombins|mesh-ancestor
25033914|NCT03570281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25033915|NCT03570281|Protease Inhibitors|protease inhibitors|mesh-ancestor
25033916|NCT03570281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25033917|NCT03570164|Sevoflurane|sevoflurane|mesh-list
24401500|NCT00153049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401501|NCT00153049|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24401502|NCT00153049|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24401503|NCT00153075|Fenoterol|fenoterol|mesh-list
24401504|NCT00153075|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
24401505|NCT00153075|Ipratropium|ipratropium|mesh-list
24401507|NCT00153075|Autonomic Agents|autonomic agents|mesh-ancestor
24401523|NCT00153088|Telmisartan|telmisartan|mesh-list
24401581|NCT00153283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401593|NCT00153296|Anticonvulsants|anticonvulsants|mesh-ancestor
24401598|NCT00153296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24401599|NCT00153296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24401690|NCT00153673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24401691|NCT00153673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24401692|NCT00153673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401693|NCT00153699|Topiramate|topiramate|mesh-list
25033918|NCT03570164|Desflurane|desflurane|mesh-list
25033919|NCT03570164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25033920|NCT03570164|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25033921|NCT03570164|Anesthetics, General|anesthetics, general|mesh-ancestor
25033922|NCT03570164|Anesthetics|anesthetics|mesh-ancestor
25033923|NCT03570164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25033924|NCT03570164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401697|NCT00153725|Aspirin|aspirin|mesh-list
24401739|NCT00153933|Bortezomib|bortezomib|mesh-list
24401740|NCT00153933|Immunologic Factors|immunologic factors|mesh-ancestor
24401741|NCT00153933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401742|NCT00153933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24401743|NCT00153933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24401744|NCT00153933|Growth Substances|growth substances|mesh-ancestor
24401745|NCT00153933|Growth Inhibitors|growth inhibitors|mesh-ancestor
24401746|NCT00153933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402077|NCT00154739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24402082|NCT00154778|Protective Agents|protective agents|mesh-ancestor
24402083|NCT00154778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402085|NCT00154778|Vitamins|vitamins|mesh-ancestor
24402086|NCT00154778|Micronutrients|micronutrients|mesh-ancestor
24402133|NCT00155064|Losartan|losartan|mesh-list
24806077|NCT02013492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25113903|NCT02074436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402134|NCT00155064|Captopril|captopril|mesh-list
24402135|NCT00155064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24402136|NCT00155064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24402163|NCT00155259|Docetaxel|docetaxel|mesh-list
24402291|NCT00156325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24402292|NCT00156325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24557372|NCT00752427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24402293|NCT00156325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24402294|NCT00156325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402295|NCT00156325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24402296|NCT00156325|Serotonin Agents|serotonin agents|mesh-ancestor
24402297|NCT00156325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402299|NCT00156325|Antidepressive Agents|antidepressive agents|mesh-ancestor
24402480|NCT00157508|Sensory System Agents|sensory system agents|mesh-ancestor
24402481|NCT00157508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24402653|NCT00158132|Amantadine|amantadine|mesh-list
24402654|NCT00158132|Propranolol|propranolol|mesh-list
24402655|NCT00158132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24402656|NCT00158132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24402657|NCT00158132|Adrenergic Agents|adrenergic agents|mesh-ancestor
24402658|NCT00158132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24402659|NCT00158132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402660|NCT00158132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402661|NCT00158132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24402662|NCT00158132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24402663|NCT00158132|Vasodilator Agents|vasodilator agents|mesh-ancestor
24402664|NCT00158132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24402665|NCT00158132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24402666|NCT00158132|Antiviral Agents|antiviral agents|mesh-ancestor
24402667|NCT00158132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402668|NCT00158132|Dopamine Agents|dopamine agents|mesh-ancestor
24402757|NCT00158405|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24402761|NCT00158457|Antiviral Agents|antiviral agents|mesh-ancestor
24402762|NCT00158457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402763|NCT00158457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24402764|NCT00158457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24402765|NCT00158457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402766|NCT00158457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402767|NCT00158457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24402775|NCT00158470|Lamivudine|lamivudine|mesh-list
24402776|NCT00158470|Efavirenz|efavirenz|mesh-list
24402777|NCT00158470|Didanosine|didanosine|mesh-list
24402778|NCT00158470|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24402779|NCT00158470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24600892|NCT00961038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24600893|NCT00961038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24600894|NCT00961038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24402988|NCT00158873|Antiemetics|antiemetics|mesh-ancestor
24403172|NCT00159484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403173|NCT00159484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403174|NCT00159484|Tubulin Modulators|tubulin modulators|mesh-ancestor
24403175|NCT00159484|Antimitotic Agents|antimitotic agents|mesh-ancestor
24403176|NCT00159484|Mitosis Modulators|mitosis modulators|mesh-ancestor
24403177|NCT00159510|Nitric Oxide|nitric oxide|mesh-list
24403178|NCT00159510|Methylene Blue|methylene blue|mesh-list
24403179|NCT00159510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24403715|NCT00161304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24403716|NCT00161304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403717|NCT00161304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25113929|NCT01991977|Temozolomide|temozolomide|mesh-list
25113930|NCT01991977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25113931|NCT01991977|Alkylating Agents|alkylating agents|mesh-ancestor
25033928|NCT03570112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25033929|NCT03570099|Naloxone|naloxone|mesh-list
25033930|NCT03570099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25033931|NCT03570099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033932|NCT03570099|Sensory System Agents|sensory system agents|mesh-ancestor
25033933|NCT03570099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25033934|NCT03569995|Cytarabine|cytarabine|mesh-list
25033935|NCT03569995|Rituximab|rituximab|mesh-list
25033936|NCT03569995|Methotrexate|methotrexate|mesh-list
25033937|NCT03569995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25033938|NCT03569995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25033939|NCT03569995|Immunologic Factors|immunologic factors|mesh-ancestor
25033940|NCT03569995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033941|NCT03569995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25033942|NCT03569995|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25033943|NCT03569995|Abortifacient Agents|abortifacient agents|mesh-ancestor
24442590|NCT00291746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033944|NCT03569995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24403718|NCT00161304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403816|NCT00161655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403817|NCT00161655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403818|NCT00161655|Dermatologic Agents|dermatologic agents|mesh-ancestor
24403838|NCT00161681|Estrogens|estrogens|mesh-ancestor
24403841|NCT00161681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403842|NCT00161681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24403923|NCT00162188|Efavirenz|efavirenz|mesh-list
24403924|NCT00162188|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24403925|NCT00162188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24404084|NCT00162487|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24404085|NCT00162487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24404163|NCT00162669|Bevacizumab|bevacizumab|mesh-list
24404164|NCT00162669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24404165|NCT00162669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25033945|NCT03569995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25033946|NCT03569995|Antimetabolites|antimetabolites|mesh-ancestor
25033947|NCT03569995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033948|NCT03569995|Dermatologic Agents|dermatologic agents|mesh-ancestor
25033949|NCT03569995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25033950|NCT03569995|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25033951|NCT03569995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25033952|NCT03569995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24600895|NCT00961038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25033959|NCT03569696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033960|NCT03569683|Hyaluronic Acid|hyaluronic acid|mesh-list
25033961|NCT03569683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25033962|NCT03569683|Immunologic Factors|immunologic factors|mesh-ancestor
25033963|NCT03569683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033964|NCT03569683|Viscosupplements|viscosupplements|mesh-ancestor
25033965|NCT03569683|Protective Agents|protective agents|mesh-ancestor
25033966|NCT03569579|Memantine|memantine|mesh-list
25033967|NCT03569579|Donepezil|donepezil|mesh-list
25033968|NCT03569579|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25033969|NCT03569579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25033970|NCT03569579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033971|NCT03569579|Cholinergic Agents|cholinergic agents|mesh-ancestor
25033972|NCT03569579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25033973|NCT03569579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033974|NCT03569579|Nootropic Agents|nootropic agents|mesh-ancestor
25033975|NCT03569579|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25033976|NCT03569579|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25033977|NCT03569579|Dopamine Agents|dopamine agents|mesh-ancestor
25033978|NCT03569579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25033979|NCT03569579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25033980|NCT03569540|Glyburide|glyburide|mesh-list
25692011|NCT01993836|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25692012|NCT01993849|Acetylcysteine|acetylcysteine|mesh-list
25692013|NCT01993849|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24404492|NCT00163605|Thrombin|thrombin|mesh-list
25033982|NCT03569540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033984|NCT03569241|Hormones|hormones|mesh-ancestor
25033985|NCT03569241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25033986|NCT03569241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033987|NCT03569046|Antihypertensive Agents|antihypertensive agents|mesh-list
25033988|NCT03569046|Bupivacaine|bupivacaine|mesh-list
25033989|NCT03569046|Anesthetics, Local|anesthetics, local|mesh-list
25033990|NCT03569046|Anesthetics|anesthetics|mesh-list
25033991|NCT03569046|Anesthetics, General|anesthetics, general|mesh-list
25033992|NCT03569046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25033993|NCT03569046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033994|NCT03569046|Sensory System Agents|sensory system agents|mesh-ancestor
25033995|NCT03569046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25033996|NCT03568968|Niacinamide|niacinamide|mesh-list
25033997|NCT03568968|Niacin|niacin|mesh-list
25033998|NCT03568968|Nicotinic Acids|nicotinic acids|mesh-list
25033999|NCT03568968|Vitamin B Complex|vitamin b complex|mesh-ancestor
25034000|NCT03568968|Vitamins|vitamins|mesh-ancestor
25034001|NCT03568968|Micronutrients|micronutrients|mesh-ancestor
25034002|NCT03568968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600936|NCT00961324|Insulin|insulin|mesh-list
25034012|NCT03568916|Antithrombins|antithrombins|mesh-ancestor
25034013|NCT03568916|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24991667|NCT05064800|Dabigatran|dabigatran|mesh-list
24404493|NCT00163605|Calcium|calcium|mesh-list
24404494|NCT00163605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24404495|NCT00163605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404496|NCT00163605|Hemostatics|hemostatics|mesh-ancestor
24404538|NCT00163969|Sensory System Agents|sensory system agents|mesh-ancestor
24404539|NCT00163969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24404961|NCT00165191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404962|NCT00165204|Tibolone|tibolone|mesh-list
24405437|NCT00166842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24405438|NCT00166842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24405439|NCT00166842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405465|NCT00167154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405466|NCT00167154|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24405467|NCT00167154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24405468|NCT00167154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24405469|NCT00167154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24405470|NCT00167154|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24405471|NCT00167154|Dopamine Agents|dopamine agents|mesh-ancestor
24405473|NCT00167232|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24405474|NCT00167232|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25692014|NCT01993849|Antiviral Agents|antiviral agents|mesh-ancestor
25692015|NCT01993849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25692016|NCT01993849|Expectorants|expectorants|mesh-ancestor
25692017|NCT01993849|Respiratory System Agents|respiratory system agents|mesh-ancestor
25692018|NCT01993849|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25692019|NCT01993849|Antioxidants|antioxidants|mesh-ancestor
25692020|NCT01993849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692021|NCT01993849|Protective Agents|protective agents|mesh-ancestor
25692022|NCT01993849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692023|NCT01993849|Antidotes|antidotes|mesh-ancestor
24626527|NCT01087658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24626528|NCT01087658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626530|NCT01087710|Antioxidants|antioxidants|mesh-list
24626531|NCT01087710|Micronutrients|micronutrients|mesh-ancestor
24626535|NCT01087749|Losartan|losartan|mesh-list
24405797|NCT00168441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034014|NCT03568916|Protease Inhibitors|protease inhibitors|mesh-ancestor
25034015|NCT03568916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034016|NCT03568916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034017|NCT03568916|Anticoagulants|anticoagulants|mesh-ancestor
25034018|NCT03568838|Enoxaparin|enoxaparin|mesh-list
25034019|NCT03568838|Anticoagulants|anticoagulants|mesh-ancestor
25034020|NCT03568838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25034021|NCT03568838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25034022|NCT03568838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034023|NCT03568721|Acetaminophen|acetaminophen|mesh-list
25034024|NCT03568721|Ibuprofen|ibuprofen|mesh-list
25034025|NCT03568721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25034026|NCT03568721|Analgesics|analgesics|mesh-ancestor
25034027|NCT03568721|Sensory System Agents|sensory system agents|mesh-ancestor
25034028|NCT03568721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25034029|NCT03568721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034030|NCT03568721|Antipyretics|antipyretics|mesh-ancestor
25034031|NCT03568721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25034032|NCT03568721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24405798|NCT00168441|Cholinergic Agents|cholinergic agents|mesh-ancestor
24405799|NCT00168441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25034129|NCT03567629|Vitamin B Complex|vitamin b complex|mesh-ancestor
24405801|NCT00168441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24405802|NCT00168441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24405804|NCT00168467|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24405805|NCT00168467|Protease Inhibitors|protease inhibitors|mesh-ancestor
24405806|NCT00168467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405807|NCT00168467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405827|NCT00168493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405897|NCT00168740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405898|NCT00168740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24405899|NCT00168753|Alefacept|alefacept|mesh-list
24405900|NCT00168753|Dermatologic Agents|dermatologic agents|mesh-ancestor
24405901|NCT00168753|Immunologic Factors|immunologic factors|mesh-ancestor
24405902|NCT00168753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405903|NCT00168766|Interferons|interferons|mesh-list
24405904|NCT00168766|Interferon-beta|interferon-beta|mesh-list
24405905|NCT00168766|Interferon beta-1a|interferon beta-1a|mesh-list
24407530|NCT00174655|Tubulin Modulators|tubulin modulators|mesh-ancestor
24407531|NCT00174655|Antimitotic Agents|antimitotic agents|mesh-ancestor
24407532|NCT00174655|Mitosis Modulators|mitosis modulators|mesh-ancestor
24407533|NCT00174655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25034036|NCT03568721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034041|NCT03568578|Entecavir|entecavir|mesh-list
25034042|NCT03568578|Antiviral Agents|antiviral agents|mesh-ancestor
25034043|NCT03568578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25034044|NCT03568513|Curcumin|curcumin|mesh-list
25034045|NCT03568513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25034046|NCT03568513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25034047|NCT03568513|Analgesics|analgesics|mesh-ancestor
25034048|NCT03568513|Sensory System Agents|sensory system agents|mesh-ancestor
25034049|NCT03568513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25034050|NCT03568513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600986|NCT00961753|Ibuprofen|ibuprofen|mesh-list
24990825|NCT04005209|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25692024|NCT01993875|Lubiprostone|lubiprostone|mesh-list
25692025|NCT01993875|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25692026|NCT01993875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25692027|NCT01993875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692028|NCT01993888|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25692029|NCT01993888|Hemostatics|hemostatics|mesh-ancestor
24990832|NCT04005209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24990833|NCT04005209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990834|NCT03961789|Analgesics, Opioid|analgesics, opioid|mesh-list
24990835|NCT03961789|Narcotics|narcotics|mesh-ancestor
24408819|NCT00179712|Growth Substances|growth substances|mesh-ancestor
24408820|NCT00179712|Growth Inhibitors|growth inhibitors|mesh-ancestor
24990840|NCT03961789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24601014|NCT00961909|Metformin|metformin|mesh-list
24588329|NCT00902070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24588330|NCT00902070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588331|NCT00902070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588332|NCT00902135|Interferons|interferons|mesh-list
24588333|NCT00902135|Interferon-beta|interferon-beta|mesh-list
25034060|NCT03568136|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25034061|NCT03568136|Immunologic Factors|immunologic factors|mesh-ancestor
25034062|NCT03568136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408872|NCT00179816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408873|NCT00179816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24408874|NCT00179816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24408875|NCT00179816|Alkylating Agents|alkylating agents|mesh-ancestor
24409045|NCT00180791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24409046|NCT00180791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24409047|NCT00180791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409048|NCT00180791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409115|NCT00180908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24409116|NCT00180908|Alkylating Agents|alkylating agents|mesh-ancestor
24409316|NCT00181740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24409317|NCT00181740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24409410|NCT00181935|Autonomic Agents|autonomic agents|mesh-ancestor
24409411|NCT00181935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24409412|NCT00181935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24409413|NCT00181935|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24409414|NCT00181935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24409415|NCT00181935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24409496|NCT00182260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409498|NCT00182312|Caffeine citrate|caffeine citrate|mesh-list
24409500|NCT00182312|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24409697|NCT00182715|Vitamin B Complex|vitamin b complex|mesh-ancestor
24409699|NCT00182715|Micronutrients|micronutrients|mesh-ancestor
24409700|NCT00182715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24409770|NCT00183001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24409771|NCT00183001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409778|NCT00183040|Androgens|androgens|mesh-ancestor
24409779|NCT00183222|Naltrexone|naltrexone|mesh-list
24409780|NCT00183222|Ondansetron|ondansetron|mesh-list
24409781|NCT00183222|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24409782|NCT00183222|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24409783|NCT00183222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409784|NCT00183222|Sensory System Agents|sensory system agents|mesh-ancestor
24409785|NCT00183222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24409786|NCT00183222|Antiemetics|antiemetics|mesh-ancestor
24409787|NCT00183222|Autonomic Agents|autonomic agents|mesh-ancestor
24505696|NCT00542022|Sympathomimetics|sympathomimetics|mesh-ancestor
24409823|NCT00183404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25034063|NCT03567941|Acetaminophen|acetaminophen|mesh-list
25034064|NCT03567941|Hydrocodone|hydrocodone|mesh-list
25034065|NCT03567941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25034066|NCT03567941|Analgesics|analgesics|mesh-ancestor
25034067|NCT03567941|Sensory System Agents|sensory system agents|mesh-ancestor
25034068|NCT03567941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25034069|NCT03567941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034070|NCT03567941|Antipyretics|antipyretics|mesh-ancestor
25034079|NCT03567928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034080|NCT03567928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25034081|NCT03567928|Anesthetics, General|anesthetics, general|mesh-ancestor
24409825|NCT00183404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24409826|NCT00183404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24409827|NCT00183404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24409828|NCT00183404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24409829|NCT00183404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24409830|NCT00183404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24409832|NCT00183404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24409854|NCT00183742|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24409855|NCT00183742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409856|NCT00183742|Tubulin Modulators|tubulin modulators|mesh-ancestor
24409857|NCT00183742|Antimitotic Agents|antimitotic agents|mesh-ancestor
24409858|NCT00183742|Mitosis Modulators|mitosis modulators|mesh-ancestor
24409859|NCT00183742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409860|NCT00183742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24409861|NCT00183742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24409863|NCT00183742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409865|NCT00183807|Irinotecan|irinotecan|mesh-list
24409866|NCT00183807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409867|NCT00183807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24409868|NCT00183807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24409869|NCT00183807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409870|NCT00183807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409871|NCT00183807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24451846|NCT00324948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24451847|NCT00324948|Vasodilator Agents|vasodilator agents|mesh-ancestor
24451848|NCT00324948|Urological Agents|urological agents|mesh-ancestor
24409931|NCT00183898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409932|NCT00183911|Leucovorin|leucovorin|mesh-list
24409933|NCT00183911|Fluorouracil|fluorouracil|mesh-list
24409934|NCT00183911|Floxuridine|floxuridine|mesh-list
24409935|NCT00183911|Antimetabolites|antimetabolites|mesh-ancestor
24410035|NCT00184041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24410036|NCT00184041|Alkylating Agents|alkylating agents|mesh-ancestor
24410037|NCT00184041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25034088|NCT03567681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034113|NCT03567629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25034114|NCT03567629|Growth Substances|growth substances|mesh-ancestor
25034115|NCT03567629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034116|NCT03567629|Growth Inhibitors|growth inhibitors|mesh-ancestor
25034117|NCT03567629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25034118|NCT03567629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24410038|NCT00184041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24410039|NCT00184041|Tubulin Modulators|tubulin modulators|mesh-ancestor
24410040|NCT00184041|Antimitotic Agents|antimitotic agents|mesh-ancestor
24410041|NCT00184041|Mitosis Modulators|mitosis modulators|mesh-ancestor
25692030|NCT01993888|Coagulants|coagulants|mesh-ancestor
24410322|NCT00185094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410324|NCT00185094|Autonomic Agents|autonomic agents|mesh-ancestor
25034121|NCT03567629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25034122|NCT03567629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25034123|NCT03567629|Immunologic Factors|immunologic factors|mesh-ancestor
25034124|NCT03567629|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25034125|NCT03567629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25034126|NCT03567629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034127|NCT03567629|Antidotes|antidotes|mesh-ancestor
25034128|NCT03567629|Protective Agents|protective agents|mesh-ancestor
25034134|NCT03567447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25034135|NCT03567447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25034136|NCT03567434|Ethanol|ethanol|mesh-list
24411149|NCT00188045|Spironolactone|spironolactone|mesh-list
24506294|NCT00544596|Acetic Acid|acetic acid|mesh-list
24410468|NCT00185445|Fludarabine phosphate|fludarabine phosphate|mesh-list
25034231|NCT03566329|Anesthetics|anesthetics|mesh-ancestor
25034232|NCT03566329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25034233|NCT03566329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034234|NCT03566329|Sensory System Agents|sensory system agents|mesh-ancestor
25034235|NCT03566329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25034236|NCT03566329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25034237|NCT03566329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25034238|NCT03566329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25034239|NCT03566329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25034240|NCT03566329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034241|NCT03566329|Analgesics|analgesics|mesh-ancestor
25034242|NCT03566329|Anticonvulsants|anticonvulsants|mesh-ancestor
25034243|NCT03566329|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25034244|NCT03566329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25034245|NCT03566329|Tocolytic Agents|tocolytic agents|mesh-ancestor
25034246|NCT03566329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25039952|NCT03553498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24410487|NCT00185510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24410488|NCT00185510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25114001|NCT01552434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25114003|NCT01552434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25114004|NCT01552434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25114006|NCT01552434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25114008|NCT01552434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25114009|NCT01552434|Antimanic Agents|antimanic agents|mesh-ancestor
25114010|NCT01552434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25114011|NCT01552434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24990993|NCT03263559|Thiotepa|thiotepa|mesh-list
25034252|NCT03566316|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25034253|NCT03566316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25034254|NCT03566316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034255|NCT03566316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25034256|NCT03566316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034258|NCT03566316|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24601262|NCT00963703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25034294|NCT03566225|Fertility Agents|fertility agents|mesh-ancestor
25034295|NCT03566225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25034296|NCT03566225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25034297|NCT03566225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25034298|NCT03566134|Solifenacin Succinate|solifenacin succinate|mesh-list
24411128|NCT00187928|Anticonvulsants|anticonvulsants|mesh-ancestor
25034333|NCT03565406|Mocetinostat|mocetinostat|mesh-list
25034334|NCT03565406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25034335|NCT03565406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25034336|NCT03565406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25034337|NCT03565406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034338|NCT03565406|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24410563|NCT00185991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24410564|NCT00185991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24410565|NCT00185991|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24410566|NCT00185991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24410775|NCT00187057|Dexamethasone|dexamethasone|mesh-list
24410802|NCT00187057|Hormones|hormones|mesh-ancestor
24410853|NCT00187070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24410854|NCT00187070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24410855|NCT00187070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24410856|NCT00187070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24410857|NCT00187070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24410858|NCT00187070|Abortifacient Agents|abortifacient agents|mesh-ancestor
24410859|NCT00187070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24410860|NCT00187070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24410861|NCT00187070|Antimetabolites|antimetabolites|mesh-ancestor
24410862|NCT00187070|Dermatologic Agents|dermatologic agents|mesh-ancestor
24410863|NCT00187070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25034340|NCT03565354|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25034341|NCT03565354|Hematinics|hematinics|mesh-ancestor
25034342|NCT03565302|Terbutaline|terbutaline|mesh-list
25034343|NCT03565302|Formoterol Fumarate|formoterol fumarate|mesh-list
25034344|NCT03565302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25034345|NCT03565302|Autonomic Agents|autonomic agents|mesh-ancestor
25034359|NCT03565276|Tranexamic Acid|tranexamic acid|mesh-list
25034360|NCT03565276|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25034361|NCT03565276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25034362|NCT03565276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034363|NCT03565276|Hemostatics|hemostatics|mesh-ancestor
25034364|NCT03565276|Coagulants|coagulants|mesh-ancestor
24411030|NCT00187447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411031|NCT00187447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25692031|NCT01993927|Voglibose|voglibose|mesh-list
25692032|NCT01993927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24411089|NCT00187707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24411090|NCT00187707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24411091|NCT00187707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24411092|NCT00187707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411093|NCT00187707|Antimanic Agents|antimanic agents|mesh-ancestor
24411095|NCT00187746|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
24411098|NCT00187746|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24411099|NCT00187746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24411126|NCT00187915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24411127|NCT00187928|Topiramate|topiramate|mesh-list
24411143|NCT00188006|Heparin|heparin|mesh-list
25034372|NCT03565133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25034373|NCT03565133|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25034374|NCT03565133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034375|NCT03565133|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25034376|NCT03565133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25034377|NCT03565133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25034384|NCT03564964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034385|NCT03564964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034386|NCT03564912|Capecitabine|capecitabine|mesh-list
25034387|NCT03564912|Oxaliplatin|oxaliplatin|mesh-list
25034388|NCT03564912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25034389|NCT03564912|Antimetabolites|antimetabolites|mesh-ancestor
24411144|NCT00188006|Anticoagulants|anticoagulants|mesh-ancestor
24411145|NCT00188006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24411146|NCT00188006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24411147|NCT00188006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411148|NCT00188045|Propranolol|propranolol|mesh-list
24411150|NCT00188045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24411151|NCT00188045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24411152|NCT00188045|Adrenergic Agents|adrenergic agents|mesh-ancestor
24411153|NCT00188045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24411154|NCT00188045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411155|NCT00188045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411156|NCT00188045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24411268|NCT00188565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24411269|NCT00188565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411270|NCT00188565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24411271|NCT00188565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24411277|NCT00188604|Sodium Selenite|sodium selenite|mesh-list
24411278|NCT00188604|Trace Elements|trace elements|mesh-ancestor
24411279|NCT00188604|Micronutrients|micronutrients|mesh-ancestor
25034390|NCT03564912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034391|NCT03564912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25034392|NCT03564795|Sulfadiazine|sulfadiazine|mesh-list
25034393|NCT03564795|Silver Sulfadiazine|silver sulfadiazine|mesh-list
25034394|NCT03564795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25034395|NCT03564795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24991192|NCT01442194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24991193|NCT01442194|Immunologic Factors|immunologic factors|mesh-ancestor
24991194|NCT01442194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928954|NCT04117191|Tryptophan|tryptophan|mesh-list
24588334|NCT00902135|Interferon beta-1b|interferon beta-1b|mesh-list
24588335|NCT00902135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588336|NCT00902135|Antiviral Agents|antiviral agents|mesh-ancestor
24588337|NCT00902135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24588338|NCT00902135|Immunologic Factors|immunologic factors|mesh-ancestor
24588456|NCT00902772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24588457|NCT00902772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25077405|NCT03365115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24785533|NCT01914965|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24411280|NCT00188604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411281|NCT00188617|Gefitinib|gefitinib|mesh-list
24411282|NCT00188617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411285|NCT00188617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411286|NCT00188630|Acetylcysteine|acetylcysteine|mesh-list
24411289|NCT00188630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24411290|NCT00188630|Expectorants|expectorants|mesh-ancestor
24411291|NCT00188630|Respiratory System Agents|respiratory system agents|mesh-ancestor
24411292|NCT00188630|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24411650|NCT00189644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411651|NCT00189644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24411652|NCT00189644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24411653|NCT00189644|Alkylating Agents|alkylating agents|mesh-ancestor
24411654|NCT00189644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411655|NCT00189644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411656|NCT00189644|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24411724|NCT00189787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411725|NCT00189800|Solifenacin Succinate|solifenacin succinate|mesh-list
24411726|NCT00189800|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24411727|NCT00189800|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24411728|NCT00189800|Cholinergic Agents|cholinergic agents|mesh-ancestor
24411729|NCT00189800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24411730|NCT00189800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411731|NCT00189800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411732|NCT00189800|Urological Agents|urological agents|mesh-ancestor
24411734|NCT00189826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24411735|NCT00189826|Immunologic Factors|immunologic factors|mesh-ancestor
24411736|NCT00189826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411739|NCT00189826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411741|NCT00189839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24588458|NCT00902772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24588459|NCT00902772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24588460|NCT00902772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24588461|NCT00902772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24588463|NCT00902772|GABA Agents|gaba agents|mesh-ancestor
24588464|NCT00902772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25034407|NCT03564704|Cytarabine|cytarabine|mesh-list
25034408|NCT03564704|Dexamethasone|dexamethasone|mesh-list
25034409|NCT03564704|Cyclophosphamide|cyclophosphamide|mesh-list
25034410|NCT03564704|Methotrexate|methotrexate|mesh-list
25034411|NCT03564704|Etoposide|etoposide|mesh-list
25034412|NCT03564704|Vincristine|vincristine|mesh-list
24411742|NCT00189839|Immunologic Factors|immunologic factors|mesh-ancestor
24411743|NCT00189839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411851|NCT00190268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411852|NCT00190268|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24411853|NCT00190268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24411854|NCT00190268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411855|NCT00190294|Misoprostol|misoprostol|mesh-list
24411881|NCT00190307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24411882|NCT00190307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411883|NCT00190307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24411884|NCT00190307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24411885|NCT00190307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24411886|NCT00190307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24411887|NCT00190307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411888|NCT00190307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24411889|NCT00190307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24411890|NCT00190307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411891|NCT00190307|Antipyretics|antipyretics|mesh-ancestor
24411893|NCT00190333|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24411894|NCT00190333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24411895|NCT00190333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24411897|NCT00190333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24411957|NCT00190515|Micronutrients|micronutrients|mesh-ancestor
24411959|NCT00190554|Fluorouracil|fluorouracil|mesh-list
24412030|NCT00190632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24412031|NCT00190632|Dopamine Agents|dopamine agents|mesh-ancestor
25692033|NCT01993927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412032|NCT00190645|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24412033|NCT00190645|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24412034|NCT00190645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412035|NCT00190645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412045|NCT00190710|Gemcitabine|gemcitabine|mesh-list
24412046|NCT00190710|Carboplatin|carboplatin|mesh-list
24412047|NCT00190710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412048|NCT00190710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24412049|NCT00190710|Antimetabolites|antimetabolites|mesh-ancestor
24412050|NCT00190710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034413|NCT03564704|Doxorubicin|doxorubicin|mesh-list
25034414|NCT03564704|Mercaptopurine|mercaptopurine|mesh-list
25034416|NCT03564704|Pegaspargase|pegaspargase|mesh-list
25034417|NCT03564704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25034418|NCT03564704|Immunologic Factors|immunologic factors|mesh-ancestor
25034419|NCT03564704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034420|NCT03564704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25034455|NCT03564652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25034456|NCT03564574|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25034457|NCT03564574|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25034460|NCT03564548|Morphine|morphine|mesh-list
25034461|NCT03564548|Oxycodone|oxycodone|mesh-list
25034462|NCT03564548|Hydromorphone|hydromorphone|mesh-list
25034463|NCT03564548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25034464|NCT03564548|Narcotics|narcotics|mesh-ancestor
25034465|NCT03564548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24412082|NCT00190814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412083|NCT00190814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412084|NCT00190814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412085|NCT00190814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507922|NCT00553293|Hormones|hormones|mesh-list
24412203|NCT00190957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412204|NCT00190957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412205|NCT00190957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412235|NCT00191022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412236|NCT00191022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412237|NCT00191022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412329|NCT00191230|Antiviral Agents|antiviral agents|mesh-ancestor
24412330|NCT00191230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24412331|NCT00191230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412332|NCT00191230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24412333|NCT00191230|Immunologic Factors|immunologic factors|mesh-ancestor
24412334|NCT00191230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412335|NCT00191243|Gemcitabine|gemcitabine|mesh-list
24412336|NCT00191243|Docetaxel|docetaxel|mesh-list
24412337|NCT00191243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24412338|NCT00191243|Antimetabolites|antimetabolites|mesh-ancestor
24412395|NCT00191373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24412396|NCT00191373|Antimetabolites|antimetabolites|mesh-ancestor
24412397|NCT00191373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412398|NCT00191373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412399|NCT00191373|Antiviral Agents|antiviral agents|mesh-ancestor
24412457|NCT00191438|Tubulin Modulators|tubulin modulators|mesh-ancestor
25034467|NCT03564548|Analgesics|analgesics|mesh-ancestor
25034468|NCT03564548|Sensory System Agents|sensory system agents|mesh-ancestor
25034469|NCT03564548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25034471|NCT03564509|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25034472|NCT03564509|Hormones|hormones|mesh-ancestor
25023435|NCT03654612|Apatinib|apatinib|mesh-list
25034473|NCT03564509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25034474|NCT03564509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034475|NCT03564509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25034476|NCT03564379|JNJ-42165279|jnj-42165279|mesh-list
25034477|NCT03564379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034478|NCT03564379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034479|NCT03564301|Metronidazole|metronidazole|mesh-list
25034480|NCT03564301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25034481|NCT03564301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25034482|NCT03564301|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25034483|NCT03564301|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25034484|NCT03564158|Moxifloxacin|moxifloxacin|mesh-list
25034485|NCT03564158|Meropenem|meropenem|mesh-list
25692034|NCT01993927|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25034486|NCT03564158|Vaborbactam|vaborbactam|mesh-list
24412466|NCT00191464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412467|NCT00191490|Gemcitabine|gemcitabine|mesh-list
24412469|NCT00191490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412470|NCT00191490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24412503|NCT00191516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412504|NCT00191542|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24412506|NCT00191542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412507|NCT00191542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412508|NCT00191542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412509|NCT00191542|Adrenergic Agents|adrenergic agents|mesh-ancestor
24412510|NCT00191542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412511|NCT00191542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412512|NCT00191555|Haloperidol|haloperidol|mesh-list
24412513|NCT00191555|Olanzapine|olanzapine|mesh-list
24412514|NCT00191555|Haloperidol decanoate|haloperidol decanoate|mesh-list
24412515|NCT00191555|Antiemetics|antiemetics|mesh-ancestor
24412516|NCT00191555|Autonomic Agents|autonomic agents|mesh-ancestor
24412517|NCT00191555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24508927|NCT00557739|Adrenergic Agents|adrenergic agents|mesh-ancestor
24412668|NCT00191750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24412669|NCT00191750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24412670|NCT00191763|Gemcitabine|gemcitabine|mesh-list
24412671|NCT00191763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412672|NCT00191763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24412673|NCT00191763|Antimetabolites|antimetabolites|mesh-ancestor
24412674|NCT00191763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034487|NCT03564158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25034488|NCT03564158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25034489|NCT03564158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25034490|NCT03564158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25034491|NCT03564158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034492|NCT03564158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034493|NCT03564158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25034494|NCT03564158|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25034495|NCT03564106|Methylprednisolone|methylprednisolone|mesh-list
25034496|NCT03564106|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25034497|NCT03564106|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25034498|NCT03564106|Prednisolone|prednisolone|mesh-list
25034499|NCT03564106|Prednisolone acetate|prednisolone acetate|mesh-list
25034500|NCT03564106|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25034501|NCT03564106|Prednisolone phosphate|prednisolone phosphate|mesh-list
25034502|NCT03564106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25034503|NCT03564106|Antiemetics|antiemetics|mesh-ancestor
24991270|NCT05197088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991271|NCT05197088|Urological Agents|urological agents|mesh-ancestor
24991272|NCT05196347|Dapagliflozin|dapagliflozin|mesh-list
24991273|NCT05196347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24991274|NCT05196347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991275|NCT05196347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24991276|NCT05196347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991277|NCT05196256|Sufentanil|sufentanil|mesh-list
24412675|NCT00191763|Antiviral Agents|antiviral agents|mesh-ancestor
24412899|NCT00192634|Antiviral Agents|antiviral agents|mesh-ancestor
24412900|NCT00192634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24412970|NCT00192764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412971|NCT00192764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24412972|NCT00192764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24412973|NCT00192764|Alkylating Agents|alkylating agents|mesh-ancestor
24412974|NCT00192764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412975|NCT00192764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412976|NCT00192764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24412978|NCT00192777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24412979|NCT00192777|Antimetabolites|antimetabolites|mesh-ancestor
24412980|NCT00192777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412983|NCT00192803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24412984|NCT00192803|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24412985|NCT00192803|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24412986|NCT00192803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412988|NCT00192842|Curcumin|curcumin|mesh-list
24991279|NCT05196256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24991280|NCT05196256|Narcotics|narcotics|mesh-ancestor
24991281|NCT05196256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24991282|NCT05196256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991283|NCT05196256|Analgesics|analgesics|mesh-ancestor
24991288|NCT05196256|Anesthetics, General|anesthetics, general|mesh-ancestor
25034532|NCT03563950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25034533|NCT03563950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25034534|NCT03563950|Leprostatic Agents|leprostatic agents|mesh-ancestor
25034535|NCT03563950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25034536|NCT03563950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412989|NCT00192842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24412990|NCT00192842|Antimetabolites|antimetabolites|mesh-ancestor
24413068|NCT00193076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24413069|NCT00193089|Docetaxel|docetaxel|mesh-list
24413070|NCT00193089|Trastuzumab|trastuzumab|mesh-list
24413071|NCT00193089|Vinorelbine|vinorelbine|mesh-list
24413072|NCT00193089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413073|NCT00193089|Tubulin Modulators|tubulin modulators|mesh-ancestor
24413074|NCT00193089|Antimitotic Agents|antimitotic agents|mesh-ancestor
24413075|NCT00193089|Mitosis Modulators|mitosis modulators|mesh-ancestor
24413156|NCT00193193|Alkylating Agents|alkylating agents|mesh-ancestor
24413164|NCT00193232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413166|NCT00193245|Topotecan|topotecan|mesh-list
24413176|NCT00193271|Estramustine|estramustine|mesh-list
24413181|NCT00193271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413182|NCT00193271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24413183|NCT00193271|Alkylating Agents|alkylating agents|mesh-ancestor
24413184|NCT00193271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24413185|NCT00193284|Carboplatin|carboplatin|mesh-list
24413186|NCT00193284|Docetaxel|docetaxel|mesh-list
24413187|NCT00193284|Fluorouracil|fluorouracil|mesh-list
24413188|NCT00193284|Gefitinib|gefitinib|mesh-list
24413189|NCT00193284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413190|NCT00193284|Tubulin Modulators|tubulin modulators|mesh-ancestor
24413191|NCT00193284|Antimitotic Agents|antimitotic agents|mesh-ancestor
24413192|NCT00193284|Mitosis Modulators|mitosis modulators|mesh-ancestor
24413193|NCT00193284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413194|NCT00193284|Antimetabolites|antimetabolites|mesh-ancestor
24413195|NCT00193284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24413196|NCT00193284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24413197|NCT00193284|Immunologic Factors|immunologic factors|mesh-ancestor
24413198|NCT00193284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413199|NCT00193284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24413200|NCT00193284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413201|NCT00193297|Paclitaxel|paclitaxel|mesh-list
24413202|NCT00193297|Carboplatin|carboplatin|mesh-list
24413203|NCT00193297|Topotecan|topotecan|mesh-list
24413204|NCT00193297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25034539|NCT03563950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24634265|NCT01132638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034564|NCT03563794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034565|NCT03563794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991324|NCT05195086|Mycophenolic Acid|mycophenolic acid|mesh-list
24413205|NCT00193297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413329|NCT00193544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24413330|NCT00193544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24413331|NCT00193544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24413332|NCT00193544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24413333|NCT00193544|Growth Substances|growth substances|mesh-ancestor
24413334|NCT00193544|Growth Inhibitors|growth inhibitors|mesh-ancestor
24413335|NCT00193544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413370|NCT00193635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24413371|NCT00193635|Antitubercular Agents|antitubercular agents|mesh-ancestor
24413372|NCT00193635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24413471|NCT00193973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24413472|NCT00193973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413473|NCT00193973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24413474|NCT00193973|Antimetabolites|antimetabolites|mesh-ancestor
24413475|NCT00193973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413476|NCT00193973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413477|NCT00193973|Dermatologic Agents|dermatologic agents|mesh-ancestor
24413478|NCT00193973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413479|NCT00193973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25692035|NCT01993927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413480|NCT00193973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24413658|NCT00194766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24413659|NCT00194766|Alkylating Agents|alkylating agents|mesh-ancestor
24413660|NCT00194766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413661|NCT00194766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25034578|NCT03563664|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25034579|NCT03563664|Hormone Antagonists|hormone antagonists|mesh-ancestor
25034580|NCT03563664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25034581|NCT03563664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034582|NCT03563625|Bupivacaine|bupivacaine|mesh-list
25034583|NCT03563625|Anesthetics, Local|anesthetics, local|mesh-ancestor
25034584|NCT03563625|Anesthetics|anesthetics|mesh-ancestor
25034585|NCT03563625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25034586|NCT03563625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034587|NCT03563625|Sensory System Agents|sensory system agents|mesh-ancestor
25034588|NCT03563625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25034589|NCT03563586|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25034590|NCT03563586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25034591|NCT03563534|Fluorides|fluorides|mesh-list
25034592|NCT03563534|Cariostatic Agents|cariostatic agents|mesh-ancestor
25034593|NCT03563534|Protective Agents|protective agents|mesh-ancestor
25034594|NCT03563534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034595|NCT03563365|Adapalene|adapalene|mesh-list
25034596|NCT03563365|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25034597|NCT03563365|Resveratrol|resveratrol|mesh-list
25034598|NCT03563365|Antioxidants|antioxidants|mesh-ancestor
25034599|NCT03563365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034600|NCT03563365|Protective Agents|protective agents|mesh-ancestor
24413663|NCT00194818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24413664|NCT00194818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24413665|NCT00194818|Analgesics|analgesics|mesh-ancestor
24413666|NCT00194818|Sensory System Agents|sensory system agents|mesh-ancestor
24413667|NCT00194818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24413753|NCT00195104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413754|NCT00195104|Antiviral Agents|antiviral agents|mesh-ancestor
24413755|NCT00195104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24413756|NCT00195104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24413757|NCT00195104|Immunologic Factors|immunologic factors|mesh-ancestor
25034643|NCT03563170|Tubulin Modulators|tubulin modulators|mesh-ancestor
24797459|NCT01955655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24413864|NCT00195468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24413866|NCT00195481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24413867|NCT00195481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24413869|NCT00195481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413886|NCT00195559|Hormones|hormones|mesh-ancestor
24413887|NCT00195559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24413888|NCT00195559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413889|NCT00195559|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24413890|NCT00195559|Contraceptive Agents|contraceptive agents|mesh-ancestor
24413934|NCT00195637|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24413935|NCT00195637|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24413936|NCT00195637|Immunologic Factors|immunologic factors|mesh-ancestor
24413937|NCT00195637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413939|NCT00195689|Antibodies|antibodies|mesh-list
24413940|NCT00195689|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24413941|NCT00195689|Immunologic Factors|immunologic factors|mesh-ancestor
24413942|NCT00195689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413943|NCT00195689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24413979|NCT00195754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413980|NCT00195754|Antimanic Agents|antimanic agents|mesh-ancestor
24413981|NCT00195754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24413982|NCT00195754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24413983|NCT00195754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24413984|NCT00195767|Valproic Acid|valproic acid|mesh-list
24413985|NCT00195767|Anticonvulsants|anticonvulsants|mesh-ancestor
24414061|NCT00195871|Abortifacient Agents|abortifacient agents|mesh-ancestor
24414062|NCT00195871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24414063|NCT00195871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25034678|NCT03563144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034680|NCT03563144|Immunologic Factors|immunologic factors|mesh-ancestor
25034681|NCT03563144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034682|NCT03563144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25034683|NCT03563144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25034684|NCT03563144|Alkylating Agents|alkylating agents|mesh-ancestor
25034720|NCT03563001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25034721|NCT03563001|Adrenergic Agents|adrenergic agents|mesh-ancestor
25034722|NCT03563001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25034723|NCT03563001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588573|NCT00903188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24634263|NCT01132638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24634264|NCT01132638|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24588608|NCT00903227|Respiratory System Agents|respiratory system agents|mesh-ancestor
24588610|NCT00903227|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24588635|NCT00903747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24588636|NCT00903747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24588637|NCT00903747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24588638|NCT00903747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034760|NCT03562611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25034761|NCT03562611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25034762|NCT03562611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25034763|NCT03562611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25034764|NCT03562611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24797470|NCT01955759|Amiodarone|amiodarone|mesh-list
24414064|NCT00195871|Antimetabolites|antimetabolites|mesh-ancestor
24414078|NCT00195910|Morphine|morphine|mesh-list
24414093|NCT00195923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24414094|NCT00195923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24414095|NCT00195923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24414096|NCT00195923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414097|NCT00195923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414098|NCT00195936|Cinacalcet|cinacalcet|mesh-list
24414099|NCT00195936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24414100|NCT00195936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034765|NCT03562611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034766|NCT03562611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034768|NCT03562585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25034769|NCT03562585|Immunologic Factors|immunologic factors|mesh-ancestor
25034770|NCT03562585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034771|NCT03562533|Paclitaxel|paclitaxel|mesh-list
25034845|NCT03562143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034846|NCT03562130|Teduglutide|teduglutide|mesh-list
25034847|NCT03562130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25034848|NCT03562130|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25034849|NCT03562130|Protective Agents|protective agents|mesh-ancestor
24414101|NCT00195936|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24414104|NCT00195988|Mycophenolic Acid|mycophenolic acid|mesh-list
24414147|NCT00196378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24414149|NCT00196391|Progesterone|progesterone|mesh-list
24414150|NCT00196391|Progestins|progestins|mesh-ancestor
24414151|NCT00196391|Hormones|hormones|mesh-ancestor
24414319|NCT00196872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414320|NCT00196872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24414321|NCT00196872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24414322|NCT00196872|Alkylating Agents|alkylating agents|mesh-ancestor
24414323|NCT00196872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414324|NCT00196872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24414325|NCT00196872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24414326|NCT00196872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24414327|NCT00196872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24414328|NCT00196872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24414329|NCT00196872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414330|NCT00196885|Acetylcysteine|acetylcysteine|mesh-list
24414331|NCT00196885|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24414332|NCT00196885|Antiviral Agents|antiviral agents|mesh-ancestor
24414333|NCT00196885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24414334|NCT00196885|Expectorants|expectorants|mesh-ancestor
24414335|NCT00196885|Respiratory System Agents|respiratory system agents|mesh-ancestor
24414336|NCT00196885|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24414614|NCT00198198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24414615|NCT00198198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414616|NCT00198198|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24414617|NCT00198198|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24414618|NCT00198198|Serotonin Agents|serotonin agents|mesh-ancestor
24414619|NCT00198198|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24414620|NCT00198198|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24414691|NCT00198432|Vinorelbine|vinorelbine|mesh-list
24414692|NCT00198432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24414693|NCT00198432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24414694|NCT00198432|Tubulin Modulators|tubulin modulators|mesh-ancestor
24414695|NCT00198432|Antimitotic Agents|antimitotic agents|mesh-ancestor
24865854|NCT04750759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034866|NCT03561675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034867|NCT03561675|Diuretics|diuretics|mesh-ancestor
25034868|NCT03561675|Natriuretic Agents|natriuretic agents|mesh-ancestor
24461428|NCT00352313|Carboplatin|carboplatin|mesh-list
25034869|NCT03561675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034870|NCT03561649|Adalimumab|adalimumab|mesh-list
25034871|NCT03561649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25034872|NCT03561649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25034873|NCT03561558|Ibuprofen|ibuprofen|mesh-list
25034874|NCT03561558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25034875|NCT03561558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25034876|NCT03561558|Analgesics|analgesics|mesh-ancestor
25034877|NCT03561558|Sensory System Agents|sensory system agents|mesh-ancestor
25034878|NCT03561558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25034879|NCT03561558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034880|NCT03561558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25034881|NCT03561558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25034882|NCT03561558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25034883|NCT03561558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034884|NCT03561558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034885|NCT03561415|Posaconazole|posaconazole|mesh-list
25034886|NCT03561415|Antifungal Agents|antifungal agents|mesh-ancestor
25034887|NCT03561415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25034888|NCT03561415|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25034889|NCT03561415|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25034890|NCT03561415|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25034891|NCT03561415|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25034892|NCT03561415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25034893|NCT03561415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034894|NCT03561415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034895|NCT03561415|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25034896|NCT03561415|Hormone Antagonists|hormone antagonists|mesh-ancestor
24414744|NCT00198562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24414745|NCT00198562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24414746|NCT00198562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414747|NCT00198562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24992009|NCT04635254|Histamine|histamine|mesh-list
24992010|NCT04635254|Histamine Agonists|histamine agonists|mesh-ancestor
24992011|NCT04635254|Histamine Agents|histamine agents|mesh-ancestor
24992012|NCT04635254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24992013|NCT04635254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034897|NCT03561415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25034898|NCT03561415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034899|NCT03561402|Teriflunomide|teriflunomide|mesh-list
25034900|NCT03561402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25034901|NCT03561402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25034902|NCT03561402|Analgesics|analgesics|mesh-ancestor
25034903|NCT03561402|Sensory System Agents|sensory system agents|mesh-ancestor
25034904|NCT03561402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24602000|NCT00966966|Gemfibrozil|gemfibrozil|mesh-list
24414756|NCT00198588|Protease Inhibitors|protease inhibitors|mesh-ancestor
24414757|NCT00198588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414758|NCT00198588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414759|NCT00198588|Anticoagulants|anticoagulants|mesh-ancestor
24414760|NCT00198588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24414761|NCT00198601|Gentamicins|gentamicins|mesh-list
24414762|NCT00198601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24414763|NCT00198601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24414824|NCT00198978|Methotrexate|methotrexate|mesh-list
24414825|NCT00198978|Vincristine|vincristine|mesh-list
24414826|NCT00198978|Asparaginase|asparaginase|mesh-list
25114059|NCT01321073|Treprostinil|treprostinil|mesh-list
25114060|NCT01321073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24602056|NCT00967070|Nicotine|nicotine|mesh-list
25034924|NCT03561025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25034925|NCT03561025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25034926|NCT03561025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034934|NCT03560973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25034940|NCT03560908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25034941|NCT03560908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25034942|NCT03560908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034943|NCT03560908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034945|NCT03560856|Palbociclib|palbociclib|mesh-list
25034946|NCT03560856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25034947|NCT03560856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25034948|NCT03560856|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25034949|NCT03560856|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25034950|NCT03560856|Hormone Antagonists|hormone antagonists|mesh-ancestor
25034951|NCT03560856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25034952|NCT03560856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034953|NCT03560856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25034954|NCT03560856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414827|NCT00198978|Mercaptopurine|mercaptopurine|mesh-list
24414829|NCT00198978|Lenograstim|lenograstim|mesh-list
24415185|NCT00199095|Cytarabine|cytarabine|mesh-list
24415225|NCT00199095|Antimitotic Agents|antimitotic agents|mesh-ancestor
24415226|NCT00199095|Mitosis Modulators|mitosis modulators|mesh-ancestor
24415227|NCT00199095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24415264|NCT00199147|Etoposide|etoposide|mesh-list
24415265|NCT00199147|Idarubicin|idarubicin|mesh-list
24415266|NCT00199147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415267|NCT00199147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24415298|NCT00199186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24415299|NCT00199186|Alkylating Agents|alkylating agents|mesh-ancestor
24415304|NCT00199186|Antiemetics|antiemetics|mesh-ancestor
24415386|NCT00199355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24415387|NCT00199355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551124|NCT00724035|Narcotics|narcotics|mesh-ancestor
24415435|NCT00199446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415436|NCT00199446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415438|NCT00199472|Natriuretic Agents|natriuretic agents|mesh-ancestor
24415440|NCT00199511|Mannitol|mannitol|mesh-list
24415528|NCT00199784|Adrenergic Agents|adrenergic agents|mesh-ancestor
24415529|NCT00199784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24415530|NCT00199784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415531|NCT00199784|Protective Agents|protective agents|mesh-ancestor
24415532|NCT00199940|Ziprasidone|ziprasidone|mesh-list
25034955|NCT03560856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034956|NCT03560804|Olmesartan|olmesartan|mesh-list
25034957|NCT03560804|Chlorthalidone|chlorthalidone|mesh-list
25034958|NCT03560804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25034959|NCT03560804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25034960|NCT03560804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25034961|NCT03560804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034962|NCT03560804|Diuretics|diuretics|mesh-ancestor
25034963|NCT03560804|Natriuretic Agents|natriuretic agents|mesh-ancestor
25034964|NCT03560804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034965|NCT03560804|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25034966|NCT03560804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25034970|NCT03560583|Metoclopramide|metoclopramide|mesh-list
25034971|NCT03560583|Antiemetics|antiemetics|mesh-ancestor
25034972|NCT03560583|Autonomic Agents|autonomic agents|mesh-ancestor
25034973|NCT03560583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25034987|NCT03560427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25034988|NCT03560427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034990|NCT03560427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034991|NCT03560427|Analgesics|analgesics|mesh-ancestor
25034992|NCT03560427|Sensory System Agents|sensory system agents|mesh-ancestor
25034993|NCT03560427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24992085|NCT04457297|Trifluridine|trifluridine|mesh-list
24415533|NCT00199940|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24415534|NCT00199940|Serotonin Agents|serotonin agents|mesh-ancestor
24415535|NCT00199940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24415543|NCT00199940|Dopamine Agents|dopamine agents|mesh-ancestor
24415560|NCT00199966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24415562|NCT00199979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24415563|NCT00199979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24415564|NCT00199979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404721|NCT03652974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25077527|NCT03363984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25077528|NCT03363984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901056|NCT04389060|Grape Seed Extract|grape seed extract|mesh-list
25077529|NCT03363984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25077530|NCT03363984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25077531|NCT03363984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25077532|NCT03363984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25077533|NCT03363984|Anesthetics, General|anesthetics, general|mesh-ancestor
25077535|NCT03363984|GABA Modulators|gaba modulators|mesh-ancestor
25077536|NCT03363984|GABA Agents|gaba agents|mesh-ancestor
25077537|NCT03363984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24415565|NCT00199979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415569|NCT00199979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24415570|NCT00199979|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24415571|NCT00199979|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24415572|NCT00200174|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
24415573|NCT00200174|Exemestane|exemestane|mesh-list
24415574|NCT00200174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415575|NCT00200174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24415576|NCT00200174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24415577|NCT00200174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24415578|NCT00200174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415579|NCT00200174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25034995|NCT03560427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25034996|NCT03560427|Dopamine Agents|dopamine agents|mesh-ancestor
25034997|NCT03560375|Empagliflozin|empagliflozin|mesh-list
25034998|NCT03560375|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25034999|NCT03560375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035000|NCT03560375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25035001|NCT03560375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035002|NCT03560362|Epinephrine|epinephrine|mesh-list
25035003|NCT03560362|Bupivacaine|bupivacaine|mesh-list
25035004|NCT03560362|Anesthetics, Local|anesthetics, local|mesh-ancestor
25035005|NCT03560362|Anesthetics|anesthetics|mesh-ancestor
25035006|NCT03560362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25035007|NCT03560362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035008|NCT03560362|Sensory System Agents|sensory system agents|mesh-ancestor
25035009|NCT03560362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25035010|NCT03560362|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25035011|NCT03560362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25035012|NCT03560362|Adrenergic Agents|adrenergic agents|mesh-ancestor
25035013|NCT03560362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25035014|NCT03560362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035015|NCT03560362|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25035016|NCT03560362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24415580|NCT00200174|Hormone Antagonists|hormone antagonists|mesh-ancestor
24415614|NCT00200421|Atenolol|atenolol|mesh-list
24415622|NCT00200421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24415624|NCT00200421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24415658|NCT00200460|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24415659|NCT00200460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24415660|NCT00200460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24415661|NCT00200460|Adrenergic Agents|adrenergic agents|mesh-ancestor
24415662|NCT00200460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24415663|NCT00200460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415664|NCT00200460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415999|NCT00201708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24416000|NCT00201708|Alkylating Agents|alkylating agents|mesh-ancestor
24416001|NCT00201708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692036|NCT01993927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692037|NCT01994109|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
25692038|NCT01994109|Botulinum Toxins|botulinum toxins|mesh-list
25692039|NCT01994109|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25692040|NCT01994109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25692041|NCT01994109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692042|NCT01994109|Cholinergic Agents|cholinergic agents|mesh-ancestor
25692043|NCT01994109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25692044|NCT01994109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692045|NCT01994109|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25692046|NCT01994226|Naproxen|naproxen|mesh-list
25692047|NCT01994226|Colchicine|colchicine|mesh-list
24416002|NCT00201708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24416003|NCT00201708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24551253|NCT00724724|3-n-butylphthalide|3-n-butylphthalide|mesh-list
24416133|NCT00202020|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24416134|NCT00202059|Zoledronic Acid|zoledronic acid|mesh-list
24416135|NCT00202059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24416136|NCT00202059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416137|NCT00202124|Tryptophan|tryptophan|mesh-list
24416138|NCT00202124|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24416139|NCT00202124|Antidepressive Agents|antidepressive agents|mesh-ancestor
24416140|NCT00202124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24416141|NCT00202163|Testosterone|testosterone|mesh-list
25035017|NCT03560362|Autonomic Agents|autonomic agents|mesh-ancestor
25035018|NCT03560362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25035019|NCT03560362|Respiratory System Agents|respiratory system agents|mesh-ancestor
25035020|NCT03560362|Mydriatics|mydriatics|mesh-ancestor
25035021|NCT03560362|Sympathomimetics|sympathomimetics|mesh-ancestor
25035022|NCT03560362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25035023|NCT03560349|Lidocaine|lidocaine|mesh-list
25035024|NCT03560349|Anesthetics, Local|anesthetics, local|mesh-ancestor
25035025|NCT03560349|Anesthetics|anesthetics|mesh-ancestor
25035026|NCT03560349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25035027|NCT03560349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035028|NCT03560349|Sensory System Agents|sensory system agents|mesh-ancestor
25035031|NCT03560349|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25035057|NCT03560232|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25035059|NCT03560232|Sultamicillin|sultamicillin|mesh-list
25035060|NCT03560232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25035061|NCT03560232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25035062|NCT03560232|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25035063|NCT03560232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25035064|NCT03560232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035065|NCT03560232|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25035066|NCT03560024|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
25035067|NCT03560024|Growth Substances|growth substances|mesh-ancestor
25035068|NCT03560024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035069|NCT03560024|Vasodilator Agents|vasodilator agents|mesh-ancestor
25035070|NCT03560024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24416142|NCT00202163|Androgens|androgens|mesh-ancestor
24416228|NCT00202358|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24416229|NCT00202358|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24416230|NCT00202358|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24416231|NCT00202358|Adrenergic Agents|adrenergic agents|mesh-ancestor
24416232|NCT00202358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24416233|NCT00202358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416234|NCT00202397|Riluzole|riluzole|mesh-list
24416235|NCT00202397|Anticonvulsants|anticonvulsants|mesh-ancestor
24416236|NCT00202397|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24416260|NCT00202514|Antimanic Agents|antimanic agents|mesh-ancestor
24416261|NCT00202514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24416262|NCT00202514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24416263|NCT00202514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24416264|NCT00202553|Perindopril|perindopril|mesh-list
25035071|NCT03560024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035073|NCT03560011|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25035074|NCT03560011|Antibodies|antibodies|mesh-list
25035075|NCT03560011|Immunologic Factors|immunologic factors|mesh-ancestor
25035076|NCT03560011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035077|NCT03559985|Acetaminophen|acetaminophen|mesh-list
25035078|NCT03559985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25035079|NCT03559985|Analgesics|analgesics|mesh-ancestor
24602265|NCT00967837|Insulin|insulin|mesh-list
25035108|NCT03559751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25035109|NCT03559751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035110|NCT03559751|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25035111|NCT03559751|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25035112|NCT03559751|Cholinergic Agents|cholinergic agents|mesh-ancestor
25035113|NCT03559751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25035114|NCT03559751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035115|NCT03559725|Menthol|menthol|mesh-list
25035116|NCT03559725|Nicotine|nicotine|mesh-list
25035117|NCT03559725|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25035118|NCT03559725|Autonomic Agents|autonomic agents|mesh-ancestor
25035119|NCT03559725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25035120|NCT03559725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035121|NCT03559725|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25035122|NCT03559725|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25035123|NCT03559725|Cholinergic Agents|cholinergic agents|mesh-ancestor
25035124|NCT03559725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25035125|NCT03559725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035126|NCT03559725|Antipruritics|antipruritics|mesh-ancestor
24991861|NCT04860804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24991862|NCT04860804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991863|NCT04860804|Antipyretics|antipyretics|mesh-ancestor
25036366|NCT03547895|Ribavirin|ribavirin|mesh-list
24991866|NCT04860804|Anesthetics, General|anesthetics, general|mesh-ancestor
24991867|NCT04860804|Anesthetics|anesthetics|mesh-ancestor
24416293|NCT00202618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24416294|NCT00202618|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24416295|NCT00202618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24991868|NCT04860804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25035188|NCT03558971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25035189|NCT03558919|Solifenacin Succinate|solifenacin succinate|mesh-list
25035190|NCT03558919|Mirabegron|mirabegron|mesh-list
25035191|NCT03558919|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25035192|NCT03558919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25035193|NCT03558919|Cholinergic Agents|cholinergic agents|mesh-ancestor
25035194|NCT03558919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25035195|NCT03558919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416296|NCT00202618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416297|NCT00202618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24416298|NCT00202618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416299|NCT00202618|Vasodilator Agents|vasodilator agents|mesh-ancestor
24416300|NCT00202618|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24416301|NCT00202618|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24416302|NCT00202696|Nalmefene|nalmefene|mesh-list
24416303|NCT00202696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25035198|NCT03558919|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25035199|NCT03558919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25035201|NCT03558919|Adrenergic Agents|adrenergic agents|mesh-ancestor
25035202|NCT03558880|Anesthetics|anesthetics|mesh-list
25035203|NCT03558880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25035204|NCT03558880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035208|NCT03558750|Rituximab|rituximab|mesh-list
25035209|NCT03558750|Nivolumab|nivolumab|mesh-list
25035210|NCT03558750|Lenalidomide|lenalidomide|mesh-list
25035211|NCT03558750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25035212|NCT03558750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25035213|NCT03558750|Immunologic Factors|immunologic factors|mesh-ancestor
25035214|NCT03558750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035215|NCT03558750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25035216|NCT03558750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25035217|NCT03558750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416312|NCT00202774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24416313|NCT00202774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24416345|NCT00202800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416346|NCT00202800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24416515|NCT00203320|Analgesics|analgesics|mesh-ancestor
24416520|NCT00203320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24416550|NCT00203372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24416551|NCT00203372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24416552|NCT00203372|Growth Substances|growth substances|mesh-ancestor
24416553|NCT00203372|Growth Inhibitors|growth inhibitors|mesh-ancestor
24416554|NCT00203372|Tubulin Modulators|tubulin modulators|mesh-ancestor
25035248|NCT03557996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25692048|NCT01994226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25692049|NCT01994226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25692050|NCT01994226|Analgesics|analgesics|mesh-ancestor
25692051|NCT01994226|Sensory System Agents|sensory system agents|mesh-ancestor
25077596|NCT03363659|Temozolomide|temozolomide|mesh-list
25077597|NCT03363659|Disulfiram|disulfiram|mesh-list
25077598|NCT03363659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24859185|NCT02302456|Hemostatics|hemostatics|mesh-ancestor
25035249|NCT03557996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25035250|NCT03557983|Fenofibrate|fenofibrate|mesh-list
25035251|NCT03557983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25035252|NCT03557983|Antimetabolites|antimetabolites|mesh-ancestor
25035253|NCT03557983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035254|NCT03557983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25035256|NCT03557853|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25035257|NCT03557853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25035258|NCT03557853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25035259|NCT03557853|Immunologic Factors|immunologic factors|mesh-ancestor
25035260|NCT03557853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035261|NCT03557580|Isosorbide|isosorbide|mesh-list
25035262|NCT03557580|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24417037|NCT00204789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417050|NCT00204919|Micronutrients|micronutrients|mesh-ancestor
24417051|NCT00204919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417052|NCT00204919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24417190|NCT00205751|Leprostatic Agents|leprostatic agents|mesh-ancestor
24417191|NCT00205751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24417192|NCT00205751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24417193|NCT00205751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25035304|NCT03557229|Ascorbic Acid|ascorbic acid|mesh-list
25035305|NCT03557229|Vitamin E|vitamin e|mesh-list
25035306|NCT03557229|Acetylcysteine|acetylcysteine|mesh-list
25035307|NCT03557229|Melatonin|melatonin|mesh-list
25035308|NCT03557229|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25035309|NCT03557229|Micronutrients|micronutrients|mesh-ancestor
25035310|NCT03557229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035311|NCT03557229|Antioxidants|antioxidants|mesh-ancestor
25035312|NCT03557229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035313|NCT03557229|Protective Agents|protective agents|mesh-ancestor
24417206|NCT00205816|Tigecycline|tigecycline|mesh-list
24417397|NCT00206401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417399|NCT00206414|Fulvestrant|fulvestrant|mesh-list
24417400|NCT00206414|Anastrozole|anastrozole|mesh-list
25035327|NCT03556917|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25035328|NCT03556917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25035329|NCT03556917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035330|NCT03556917|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25035331|NCT03556917|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25035332|NCT03556917|Purinergic Agents|purinergic agents|mesh-ancestor
25035333|NCT03556917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25035334|NCT03556852|Misoprostol|misoprostol|mesh-list
25035335|NCT03556852|Carbetocin|carbetocin|mesh-list
24417445|NCT00206492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417460|NCT00206544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417461|NCT00206544|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24417462|NCT00206544|Hormone Antagonists|hormone antagonists|mesh-ancestor
24417463|NCT00206544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24417464|NCT00206544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417465|NCT00206544|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24417640|NCT00206986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417645|NCT00206986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24417762|NCT00207662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24417763|NCT00207662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24417764|NCT00207675|Infliximab|infliximab|mesh-list
24417765|NCT00207675|Dermatologic Agents|dermatologic agents|mesh-ancestor
25692052|NCT01994226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25692053|NCT01994226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692054|NCT01994226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25035346|NCT03556839|Atezolizumab|atezolizumab|mesh-list
25035347|NCT03556839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25692055|NCT01994226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25692056|NCT01994226|Gout Suppressants|gout suppressants|mesh-ancestor
25692057|NCT01994226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25692058|NCT01994226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25035348|NCT03556839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25035349|NCT03556839|Tubulin Modulators|tubulin modulators|mesh-ancestor
25035350|NCT03556839|Antimitotic Agents|antimitotic agents|mesh-ancestor
25035351|NCT03556839|Mitosis Modulators|mitosis modulators|mesh-ancestor
25035377|NCT03556592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035379|NCT03556592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25035380|NCT03556592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25035381|NCT03556592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25035382|NCT03556592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25035383|NCT03556592|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25035384|NCT03556592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25035415|NCT03556098|Hormones|hormones|mesh-list
25035416|NCT03556098|Incretins|incretins|mesh-list
25035417|NCT03556098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039953|NCT03553498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417804|NCT00207831|Antimetabolites|antimetabolites|mesh-ancestor
24417805|NCT00207831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417807|NCT00207844|Selenium|selenium|mesh-list
24417898|NCT00208156|Luteolytic Agents|luteolytic agents|mesh-ancestor
24417899|NCT00208156|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24417900|NCT00208156|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24417901|NCT00208169|Aripiprazole|aripiprazole|mesh-list
24417902|NCT00208169|Antidepressive Agents|antidepressive agents|mesh-ancestor
24418268|NCT00209144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035418|NCT03556098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25035420|NCT03556033|Dapagliflozin|dapagliflozin|mesh-list
25035421|NCT03556033|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25035422|NCT03556033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035423|NCT03556033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25035424|NCT03556033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035425|NCT03555994|Liraglutide|liraglutide|mesh-list
25035426|NCT03555994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25035427|NCT03555994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035464|NCT03555526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25035465|NCT03555526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25035466|NCT03555526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25035480|NCT03555526|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25035482|NCT03555487|Choline|choline|mesh-list
25035483|NCT03555487|Lipotropic Agents|lipotropic agents|mesh-ancestor
25035484|NCT03555487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25035485|NCT03555487|Antimetabolites|antimetabolites|mesh-ancestor
25035486|NCT03555487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035487|NCT03555487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24418270|NCT00209209|Interferon-alpha|interferon-alpha|mesh-list
24418271|NCT00209209|Interferon alpha-2|interferon alpha-2|mesh-list
24418362|NCT00209352|Acyclovir|acyclovir|mesh-list
24418379|NCT00209495|Glucocorticoids|glucocorticoids|mesh-ancestor
24418380|NCT00209495|Hormones|hormones|mesh-ancestor
24418381|NCT00209495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24418382|NCT00209495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24418442|NCT00209625|Immunologic Factors|immunologic factors|mesh-ancestor
24418644|NCT00209859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25035488|NCT03555487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25035489|NCT03555487|Nootropic Agents|nootropic agents|mesh-ancestor
25035490|NCT03555383|Hemostatics|hemostatics|mesh-list
25035491|NCT03555383|Coagulants|coagulants|mesh-ancestor
25035530|NCT03555032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25035531|NCT03555032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25035533|NCT03554980|Fluorides|fluorides|mesh-list
25035534|NCT03554980|Sodium Fluoride|sodium fluoride|mesh-list
25035535|NCT03554980|Fluorides, Topical|fluorides, topical|mesh-list
25035536|NCT03554980|Cariostatic Agents|cariostatic agents|mesh-ancestor
25035537|NCT03554980|Protective Agents|protective agents|mesh-ancestor
25035538|NCT03554980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035539|NCT03554980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25035540|NCT03554980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25035541|NCT03554915|Midazolam|midazolam|mesh-list
25035542|NCT03554915|Ketamine|ketamine|mesh-list
25035543|NCT03554915|Analgesics|analgesics|mesh-ancestor
25035544|NCT03554915|Sensory System Agents|sensory system agents|mesh-ancestor
25035545|NCT03554915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25035546|NCT03554915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035547|NCT03554915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25035548|NCT03554915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25035549|NCT03554915|Anesthetics, General|anesthetics, general|mesh-ancestor
25035550|NCT03554915|Anesthetics|anesthetics|mesh-ancestor
25035551|NCT03554915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25035552|NCT03554915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25035553|NCT03554915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24992262|NCT04032301|Ketamine|ketamine|mesh-list
24418645|NCT00209859|Glucocorticoids|glucocorticoids|mesh-ancestor
24418647|NCT00209859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24418677|NCT00209872|Antidepressive Agents|antidepressive agents|mesh-ancestor
24418858|NCT00210379|Immunologic Factors|immunologic factors|mesh-ancestor
24418860|NCT00210379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24418872|NCT00210392|Bortezomib|bortezomib|mesh-list
25035554|NCT03554915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24806079|NCT02013492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24992213|NCT04165122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24588694|NCT00903994|Analgesics|analgesics|mesh-ancestor
24588695|NCT00903994|Sensory System Agents|sensory system agents|mesh-ancestor
24588696|NCT00903994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588697|NCT00903994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588698|NCT00903994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24588718|NCT00904059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588720|NCT00904085|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24588721|NCT00904085|Narcotics|narcotics|mesh-ancestor
24553196|NCT00729898|Biphasic Insulins|biphasic insulins|mesh-list
25008070|NCT02097680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24588722|NCT00904085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24588731|NCT00904098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24634335|NCT01132794|Analgesics|analgesics|mesh-ancestor
24588732|NCT00904098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992280|NCT03984214|Dronabinol|dronabinol|mesh-list
24419019|NCT00210821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419020|NCT00210834|Epoetin Alfa|epoetin alfa|mesh-list
24419021|NCT00210834|Hematinics|hematinics|mesh-ancestor
24419180|NCT00211393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24419181|NCT00211393|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24419182|NCT00211393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24419183|NCT00211393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419184|NCT00211393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419185|NCT00211393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24419186|NCT00211393|Hormone Antagonists|hormone antagonists|mesh-ancestor
24419187|NCT00211393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24419190|NCT00211406|Anecortave|anecortave|mesh-list
24419232|NCT00211471|Growth Substances|growth substances|mesh-ancestor
24419233|NCT00211471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419234|NCT00211471|Growth Inhibitors|growth inhibitors|mesh-ancestor
24419235|NCT00211471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419236|NCT00211484|Anecortave|anecortave|mesh-list
24588733|NCT00904098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588735|NCT00904111|Anesthetics, Local|anesthetics, local|mesh-ancestor
24588736|NCT00904111|Anesthetics|anesthetics|mesh-ancestor
24588737|NCT00904111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24588738|NCT00904111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588739|NCT00904111|Sensory System Agents|sensory system agents|mesh-ancestor
24588740|NCT00904111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588741|NCT00904111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24588742|NCT00904111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24588743|NCT00904111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24588744|NCT00904111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24634362|NCT01133119|Anesthetics, Local|anesthetics, local|mesh-ancestor
24634363|NCT01133119|Anesthetics|anesthetics|mesh-ancestor
24634364|NCT01133119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24998400|NCT02960646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24588763|NCT00904202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588764|NCT00904202|Sensory System Agents|sensory system agents|mesh-ancestor
25035579|NCT03554447|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25035580|NCT03554447|Antidepressive Agents|antidepressive agents|mesh-ancestor
25035604|NCT03554408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25035605|NCT03554395|Antibodies|antibodies|mesh-list
25035606|NCT03554395|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25035607|NCT03554395|Immunologic Factors|immunologic factors|mesh-ancestor
25035608|NCT03554395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035609|NCT03554304|Moxifloxacin|moxifloxacin|mesh-list
25035610|NCT03554304|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24419237|NCT00211484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24419238|NCT00211484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25692059|NCT01994226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692060|NCT01994226|Tubulin Modulators|tubulin modulators|mesh-ancestor
24419239|NCT00211484|Growth Substances|growth substances|mesh-ancestor
24419290|NCT00211653|Expectorants|expectorants|mesh-ancestor
24419306|NCT00211679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419308|NCT00211679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24419309|NCT00211705|Pravastatin|pravastatin|mesh-list
24419325|NCT00211718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419326|NCT00211718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24419336|NCT00211796|GABA Agents|gaba agents|mesh-ancestor
24419337|NCT00211796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24419338|NCT00211796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035613|NCT03554304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25035615|NCT03554304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25035616|NCT03554304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035617|NCT03554304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25035618|NCT03554304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25035619|NCT03554304|Contraceptive Agents|contraceptive agents|mesh-ancestor
25035620|NCT03554304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25035621|NCT03554304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035622|NCT03554304|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25035623|NCT03554304|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25035624|NCT03554304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25035625|NCT03554291|Famotidine|famotidine|mesh-list
25035626|NCT03554291|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25035627|NCT03554291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25035628|NCT03554291|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25035629|NCT03554291|Histamine Antagonists|histamine antagonists|mesh-ancestor
25035630|NCT03554291|Histamine Agents|histamine agents|mesh-ancestor
25035631|NCT03554291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24602981|NCT00971815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25035656|NCT03554109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25035657|NCT03554109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24419339|NCT00211796|Antimanic Agents|antimanic agents|mesh-ancestor
24419340|NCT00211796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24419341|NCT00211796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24419342|NCT00211796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24419343|NCT00211848|Interferons|interferons|mesh-list
24419344|NCT00211848|Ribavirin|ribavirin|mesh-list
24419345|NCT00211848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419346|NCT00211848|Antiviral Agents|antiviral agents|mesh-ancestor
24419347|NCT00211848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24419403|NCT00212043|Carboplatin|carboplatin|mesh-list
24419404|NCT00212043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419406|NCT00212043|Antimetabolites|antimetabolites|mesh-ancestor
24419427|NCT00212082|Doxorubicin|doxorubicin|mesh-list
24419428|NCT00212082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419429|NCT00212082|Tubulin Modulators|tubulin modulators|mesh-ancestor
24419430|NCT00212082|Antimitotic Agents|antimitotic agents|mesh-ancestor
24419431|NCT00212082|Mitosis Modulators|mitosis modulators|mesh-ancestor
24419432|NCT00212082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419433|NCT00212082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24419455|NCT00212108|Gefitinib|gefitinib|mesh-list
24419586|NCT00212810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25035659|NCT03554109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25035660|NCT03554109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25035661|NCT03554109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25035662|NCT03554109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25035663|NCT03554109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25035664|NCT03554109|Antimetabolites|antimetabolites|mesh-ancestor
25035665|NCT03554109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25035666|NCT03554109|Antidotes|antidotes|mesh-ancestor
25035667|NCT03554109|Protective Agents|protective agents|mesh-ancestor
25035668|NCT03554109|Vitamin B Complex|vitamin b complex|mesh-ancestor
25035670|NCT03554109|Micronutrients|micronutrients|mesh-ancestor
25035671|NCT03554109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25692061|NCT01994226|Antimitotic Agents|antimitotic agents|mesh-ancestor
25692062|NCT01994226|Mitosis Modulators|mitosis modulators|mesh-ancestor
25692063|NCT01994226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25692064|NCT01994291|Ranibizumab|ranibizumab|mesh-list
25692065|NCT01994291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25035672|NCT03554031|Hormones|hormones|mesh-list
24561721|NCT00762567|Adrenergic Agents|adrenergic agents|mesh-ancestor
25035673|NCT03554031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25035674|NCT03554031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25114176|NCT01204684|Interferon Inducers|interferon inducers|mesh-ancestor
25114177|NCT01204684|Immunologic Factors|immunologic factors|mesh-ancestor
25114178|NCT01204684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25114179|NCT01191697|Bevacizumab|bevacizumab|mesh-list
25114180|NCT01191697|Trastuzumab|trastuzumab|mesh-list
24419587|NCT00212810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419588|NCT00212823|Almotriptan|almotriptan|mesh-list
24419589|NCT00212823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24419590|NCT00212823|Serotonin Agents|serotonin agents|mesh-ancestor
24419591|NCT00212823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24419592|NCT00212823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419955|NCT00214643|Clindamycin|clindamycin|mesh-list
24419956|NCT00214643|Clindamycin palmitate|clindamycin palmitate|mesh-list
24420124|NCT00215241|Sertraline|sertraline|mesh-list
24420125|NCT00215241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24420126|NCT00215241|Serotonin Agents|serotonin agents|mesh-ancestor
24420127|NCT00215241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24513104|NCT00578760|Analgesics|analgesics|mesh-ancestor
24420305|NCT00215501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420306|NCT00215514|Fluorouracil|fluorouracil|mesh-list
24420307|NCT00215514|Epirubicin|epirubicin|mesh-list
24420308|NCT00215514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420369|NCT00215774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24420823|NCT00216866|Warfarin|warfarin|mesh-list
24420824|NCT00216866|Anticoagulants|anticoagulants|mesh-ancestor
24420825|NCT00216866|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24420826|NCT00216866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25114183|NCT01191697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25114184|NCT01191697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992427|NCT03796156|Antipyretics|antipyretics|mesh-ancestor
24992428|NCT03794427|Anesthetics|anesthetics|mesh-list
24992429|NCT03794427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24992430|NCT03794427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992431|NCT03770676|Selenium|selenium|mesh-list
24992432|NCT03770676|Antioxidants|antioxidants|mesh-ancestor
24992433|NCT03770676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992434|NCT03770676|Protective Agents|protective agents|mesh-ancestor
24553865|NCT00733083|Analgesics|analgesics|mesh-ancestor
24553866|NCT00733083|Sensory System Agents|sensory system agents|mesh-ancestor
24553867|NCT00733148|Insulin|insulin|mesh-list
24553868|NCT00733148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24553995|NCT00733668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24553996|NCT00733668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24992435|NCT03770676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420827|NCT00216866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420828|NCT00216879|Betamethasone|betamethasone|mesh-list
24420829|NCT00216879|Betamethasone Valerate|betamethasone valerate|mesh-list
24420830|NCT00216879|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24420831|NCT00216879|Betamethasone benzoate|betamethasone benzoate|mesh-list
24420832|NCT00216879|Calcipotriene|calcipotriene|mesh-list
24420833|NCT00216879|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24420834|NCT00216879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24420835|NCT00216879|Glucocorticoids|glucocorticoids|mesh-ancestor
24420836|NCT00216879|Hormones|hormones|mesh-ancestor
24513350|NCT00580827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421022|NCT00217503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421023|NCT00217503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24421024|NCT00217503|Antimetabolites|antimetabolites|mesh-ancestor
24421025|NCT00217503|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24421032|NCT00217516|Antioxidants|antioxidants|mesh-ancestor
24421033|NCT00217516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421034|NCT00217516|Protective Agents|protective agents|mesh-ancestor
24421141|NCT00217815|Mitosis Modulators|mitosis modulators|mesh-ancestor
25035738|NCT03553329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25035740|NCT03553329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25035741|NCT03553329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035742|NCT03553303|Valsartan|valsartan|mesh-list
25035743|NCT03553303|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25035744|NCT03553303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25035745|NCT03553303|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25035746|NCT03553303|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25035747|NCT03553303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692066|NCT01994291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25692067|NCT01994291|Growth Substances|growth substances|mesh-ancestor
24883751|NCT04978272|Artenimol|artenimol|mesh-list
24883752|NCT04978272|Antimalarials|antimalarials|mesh-ancestor
24883759|NCT04874480|Decitabine|decitabine|mesh-list
25035748|NCT03553238|Cytarabine|cytarabine|mesh-list
25035749|NCT03553238|Dexamethasone|dexamethasone|mesh-list
25035750|NCT03553238|Cyclophosphamide|cyclophosphamide|mesh-list
25035751|NCT03553238|Methotrexate|methotrexate|mesh-list
24421142|NCT00217815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421143|NCT00217815|Antifungal Agents|antifungal agents|mesh-ancestor
24421293|NCT00218231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421294|NCT00218231|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24421295|NCT00218231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24421296|NCT00218231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421297|NCT00218244|Lobeline|lobeline|mesh-list
24421298|NCT00218244|Nicotine|nicotine|mesh-list
24421299|NCT00218244|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24421300|NCT00218244|Autonomic Agents|autonomic agents|mesh-ancestor
24421301|NCT00218244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24421302|NCT00218244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421411|NCT00218530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24421412|NCT00218530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554282|NCT00735241|Antidotes|antidotes|mesh-ancestor
24421598|NCT00219739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24421599|NCT00219739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24421600|NCT00219739|Antimetabolites|antimetabolites|mesh-ancestor
24437324|NCT00273429|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25035752|NCT03553238|Etoposide|etoposide|mesh-list
25035753|NCT03553238|Vincristine|vincristine|mesh-list
25035754|NCT03553238|Doxorubicin|doxorubicin|mesh-list
25035755|NCT03553238|Mercaptopurine|mercaptopurine|mesh-list
25035756|NCT03553238|Idarubicin|idarubicin|mesh-list
25035757|NCT03553238|Pegaspargase|pegaspargase|mesh-list
25035758|NCT03553238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25035759|NCT03553238|Immunologic Factors|immunologic factors|mesh-ancestor
25035760|NCT03553238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035761|NCT03553238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25035762|NCT03553238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25035763|NCT03553238|Alkylating Agents|alkylating agents|mesh-ancestor
25035764|NCT03553238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035765|NCT03553238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25035766|NCT03553238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25035788|NCT03553238|Antiviral Agents|antiviral agents|mesh-ancestor
25035789|NCT03553238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25035790|NCT03553238|Tubulin Modulators|tubulin modulators|mesh-ancestor
25035791|NCT03553238|Antimitotic Agents|antimitotic agents|mesh-ancestor
25035792|NCT03553238|Mitosis Modulators|mitosis modulators|mesh-ancestor
25035793|NCT03553238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25035800|NCT03553173|Bupropion|bupropion|mesh-list
25035801|NCT03553173|Varenicline|varenicline|mesh-list
25035802|NCT03553173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25107647|NCT03138785|Renal Agents|renal agents|mesh-ancestor
24421601|NCT00219739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421602|NCT00219739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24421603|NCT00219739|Immunologic Factors|immunologic factors|mesh-ancestor
24421604|NCT00219739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421605|NCT00219739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24421606|NCT00219739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421607|NCT00219752|Imatinib Mesylate|imatinib mesylate|mesh-list
24421608|NCT00219752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421609|NCT00219752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24421610|NCT00219752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421611|NCT00219752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421881|NCT00220454|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24421882|NCT00220454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25035809|NCT03553173|Dopamine Agents|dopamine agents|mesh-ancestor
25035810|NCT03553173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25035811|NCT03553173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036367|NCT03547895|Sofosbuvir|sofosbuvir|mesh-list
25035886|NCT03552354|Antithrombins|antithrombins|mesh-ancestor
25035887|NCT03552354|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25035888|NCT03552354|Protease Inhibitors|protease inhibitors|mesh-ancestor
25035889|NCT03552354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692068|NCT01994291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692069|NCT01994291|Growth Inhibitors|growth inhibitors|mesh-ancestor
25035890|NCT03552354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448366|NCT00311558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24448367|NCT00311558|Schistosomicides|schistosomicides|mesh-ancestor
24448368|NCT00311558|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24448369|NCT00311558|Anthelmintics|anthelmintics|mesh-ancestor
24448370|NCT00311636|Paclitaxel|paclitaxel|mesh-list
24448371|NCT00311636|Docetaxel|docetaxel|mesh-list
24448372|NCT00311636|Cyclophosphamide|cyclophosphamide|mesh-list
24448373|NCT00311636|Doxorubicin|doxorubicin|mesh-list
24448374|NCT00311636|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25035891|NCT03552354|Anticoagulants|anticoagulants|mesh-ancestor
25035892|NCT03552354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25035893|NCT03552315|Chromium|chromium|mesh-list
24423297|NCT00225342|Rosiglitazone|rosiglitazone|mesh-list
24422115|NCT00221429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422116|NCT00221429|Antimanic Agents|antimanic agents|mesh-ancestor
24422121|NCT00221429|GABA Agents|gaba agents|mesh-ancestor
24422122|NCT00221429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24422270|NCT00221871|Anesthetics|anesthetics|mesh-ancestor
24422271|NCT00221871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24422272|NCT00221871|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24422336|NCT00222144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24422337|NCT00222144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422339|NCT00222170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24422340|NCT00222170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24422341|NCT00222170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24422435|NCT00222495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035935|NCT03551964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422436|NCT00222495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422437|NCT00222495|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24422438|NCT00222495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24554721|NCT00737789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24554722|NCT00737789|Analgesics|analgesics|mesh-ancestor
24422439|NCT00222495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24422440|NCT00222495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24422772|NCT00223691|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24422773|NCT00223691|Histamine Antagonists|histamine antagonists|mesh-ancestor
24422774|NCT00223691|Histamine Agents|histamine agents|mesh-ancestor
24422775|NCT00223691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24422776|NCT00223691|Antipruritics|antipruritics|mesh-ancestor
24422777|NCT00223691|Dermatologic Agents|dermatologic agents|mesh-ancestor
24422778|NCT00223691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24422779|NCT00223691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24422949|NCT00224185|Chelating Agents|chelating agents|mesh-ancestor
24423113|NCT00224692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24423114|NCT00224692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423119|NCT00224692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24423120|NCT00224692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24423122|NCT00224692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24423243|NCT00225173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24423244|NCT00225173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24423245|NCT00225173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24423289|NCT00225290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24423290|NCT00225303|Etravirine|etravirine|mesh-list
24423291|NCT00225303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24423292|NCT00225303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24423293|NCT00225303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423294|NCT00225303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423295|NCT00225303|Antiviral Agents|antiviral agents|mesh-ancestor
24423296|NCT00225303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25035944|NCT03551847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25035945|NCT03551847|Antitubercular Agents|antitubercular agents|mesh-ancestor
25035947|NCT03551808|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25035948|NCT03551808|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25692070|NCT01994291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25692071|NCT01994486|Sofosbuvir|sofosbuvir|mesh-list
25692072|NCT01994486|Antiviral Agents|antiviral agents|mesh-ancestor
25692073|NCT01994486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25692074|NCT01994538|Oxymetazoline|oxymetazoline|mesh-list
25692075|NCT01994538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25692076|NCT01994538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25692077|NCT01994538|Adrenergic Agents|adrenergic agents|mesh-ancestor
25692078|NCT01994538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24454945|NCT03161353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24454946|NCT03161353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948383|NCT03920397|Vitamin D|vitamin d|mesh-list
24454947|NCT03161353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24454948|NCT03161353|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24454949|NCT03161353|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24454950|NCT03161353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25035949|NCT03551808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25035950|NCT03551808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25035951|NCT03551808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25035952|NCT03551808|Analgesics|analgesics|mesh-ancestor
25035953|NCT03551808|Sensory System Agents|sensory system agents|mesh-ancestor
25035954|NCT03551808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25035955|NCT03551808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035956|NCT03551808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25035957|NCT03551808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25035958|NCT03551808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25035959|NCT03551808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25035960|NCT03551808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437325|NCT00273429|Adrenergic Agents|adrenergic agents|mesh-ancestor
25035969|NCT03551561|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25036005|NCT03551197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25036006|NCT03551197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24992717|NCT03057431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797642|NCT01956981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24797643|NCT01956981|Anticonvulsants|anticonvulsants|mesh-ancestor
24797644|NCT01956981|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24797645|NCT01956981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24423710|NCT00226668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423712|NCT00226694|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24423713|NCT00226694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24423714|NCT00226694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24423715|NCT00226694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423717|NCT00226694|Serotonin Agents|serotonin agents|mesh-ancestor
24423747|NCT00226746|Antiviral Agents|antiviral agents|mesh-ancestor
24423748|NCT00226746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24423798|NCT00226902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24423799|NCT00226902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24423800|NCT00226902|Analgesics|analgesics|mesh-ancestor
24423801|NCT00226902|Sensory System Agents|sensory system agents|mesh-ancestor
24423802|NCT00226902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24423840|NCT00227032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24423841|NCT00227032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423842|NCT00227032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423844|NCT00227084|Coagulants|coagulants|mesh-ancestor
24423845|NCT00227097|Anticoagulants|anticoagulants|mesh-list
24423846|NCT00227110|Pioglitazone|pioglitazone|mesh-list
24423863|NCT00227136|Serotonin|serotonin|mesh-list
24424060|NCT00227773|Mitogens|mitogens|mesh-list
24424061|NCT00227773|Enzyme Inhibitors|enzyme inhibitors|mesh-list
24424062|NCT00227773|Vatalanib|vatalanib|mesh-list
25036368|NCT03547895|Furosemide|furosemide|mesh-list
24797648|NCT01956981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24591194|NCT00915512|Serotonin Agents|serotonin agents|mesh-ancestor
24797650|NCT01957007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797651|NCT01957007|Tubulin Modulators|tubulin modulators|mesh-ancestor
24797652|NCT01957007|Antimitotic Agents|antimitotic agents|mesh-ancestor
24797653|NCT01957007|Mitosis Modulators|mitosis modulators|mesh-ancestor
24797654|NCT01957007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797655|NCT01957046|Laxatives|laxatives|mesh-list
24992549|NCT03396692|Morphine|morphine|mesh-list
24424119|NCT00227981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24424120|NCT00227981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25692079|NCT01994538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692080|NCT01994538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692081|NCT01994538|Sympathomimetics|sympathomimetics|mesh-ancestor
25692082|NCT01994538|Autonomic Agents|autonomic agents|mesh-ancestor
25692083|NCT01994538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24948407|NCT03919786|Anesthetics|anesthetics|mesh-list
25692084|NCT01994538|Nasal Decongestants|nasal decongestants|mesh-ancestor
25692085|NCT01994538|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24424122|NCT00227981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24424251|NCT00228462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24424252|NCT00228462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24424253|NCT00228462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24424324|NCT00228852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24424325|NCT00228852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24424327|NCT00228865|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24424328|NCT00228865|Insulin, Isophane|insulin, isophane|mesh-list
24424459|NCT00229476|Serotonin Agents|serotonin agents|mesh-ancestor
24424460|NCT00229476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424461|NCT00229515|Sirolimus|sirolimus|mesh-list
24424462|NCT00229515|polysaccharide-K|polysaccharide-k|mesh-list
24424463|NCT00229515|Tirofiban|tirofiban|mesh-list
24424464|NCT00229515|Abciximab|abciximab|mesh-list
24424465|NCT00229515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24424466|NCT00229515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24424480|NCT00229515|Interferon Inducers|interferon inducers|mesh-ancestor
24424481|NCT00229515|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24424483|NCT00229528|Paroxetine|paroxetine|mesh-list
24424564|NCT00229775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24424565|NCT00229775|Antimalarials|antimalarials|mesh-ancestor
24424566|NCT00229775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24424567|NCT00229775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24424568|NCT00229775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24424569|NCT00229775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424570|NCT00229775|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24424571|NCT00229775|Renal Agents|renal agents|mesh-ancestor
24424572|NCT00229918|Triamcinolone|triamcinolone|mesh-list
24424573|NCT00229918|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24424574|NCT00229918|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24424575|NCT00229918|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24424578|NCT00229918|Hormones|hormones|mesh-ancestor
24424599|NCT00229996|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24424600|NCT00229996|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24424601|NCT00229996|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24424603|NCT00230035|Mycophenolic Acid|mycophenolic acid|mesh-list
24424629|NCT00230035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24424643|NCT00230035|Hormones|hormones|mesh-ancestor
24424732|NCT00230503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24424733|NCT00230503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424734|NCT00230503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24424735|NCT00230516|Lansoprazole|lansoprazole|mesh-list
24424736|NCT00230516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24424737|NCT00230516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24424738|NCT00230516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24424739|NCT00230516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24424740|NCT00230516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424741|NCT00230529|Infliximab|infliximab|mesh-list
24424742|NCT00230529|Dermatologic Agents|dermatologic agents|mesh-ancestor
24424743|NCT00230529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24424744|NCT00230529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24424745|NCT00230542|Carboplatin|carboplatin|mesh-list
24424777|NCT00230763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797656|NCT01957046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24797657|NCT01957189|Tamsulosin|tamsulosin|mesh-list
24797658|NCT01957189|Dutasteride|dutasteride|mesh-list
24797659|NCT01957189|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24555452|NCT00741585|Sympatholytics|sympatholytics|mesh-ancestor
24797660|NCT01957189|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24797661|NCT01957189|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24797662|NCT01957189|Adrenergic Agents|adrenergic agents|mesh-ancestor
24797663|NCT01957189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25036369|NCT03547895|Spironolactone|spironolactone|mesh-list
24797665|NCT01957189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036020|NCT03551067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25036021|NCT03551067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25036022|NCT03551067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036023|NCT03551067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25036024|NCT03551067|Analgesics|analgesics|mesh-ancestor
24603567|NCT00974441|Antimanic Agents|antimanic agents|mesh-ancestor
25036045|NCT03550859|Telmisartan|telmisartan|mesh-list
25036046|NCT03550859|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25036047|NCT03550859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25036048|NCT03550859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25036049|NCT03550859|Antimetabolites|antimetabolites|mesh-ancestor
24424778|NCT00230763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24424779|NCT00230763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24425160|NCT00232102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425166|NCT00232115|Sensory System Agents|sensory system agents|mesh-ancestor
24425167|NCT00232115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24425168|NCT00232115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425169|NCT00232115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24425170|NCT00232115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25036050|NCT03550859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036051|NCT03550859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25036052|NCT03550859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25036053|NCT03550859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036054|NCT03550859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25036055|NCT03550859|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25036056|NCT03550859|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25036062|NCT03550781|Prednisone|prednisone|mesh-list
25036063|NCT03550781|Cyclophosphamide|cyclophosphamide|mesh-list
25036064|NCT03550781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25036065|NCT03550781|Immunologic Factors|immunologic factors|mesh-ancestor
25036066|NCT03550781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036067|NCT03550781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25036068|NCT03550781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24555707|NCT00742846|Lidocaine|lidocaine|mesh-list
25036069|NCT03550781|Alkylating Agents|alkylating agents|mesh-ancestor
25036070|NCT03550781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036071|NCT03550781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25036072|NCT03550781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25036073|NCT03550781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25036074|NCT03550781|Glucocorticoids|glucocorticoids|mesh-ancestor
25036075|NCT03550781|Hormones|hormones|mesh-ancestor
25036076|NCT03550781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25036077|NCT03550781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25036097|NCT03550508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25114255|NCT01038778|Entinostat|entinostat|mesh-list
25114256|NCT01038778|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25114257|NCT01038778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25114258|NCT01038778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25114259|NCT01038778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25114260|NCT01038778|Analgesics|analgesics|mesh-ancestor
25114261|NCT01038778|Sensory System Agents|sensory system agents|mesh-ancestor
25114262|NCT01038778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25114263|NCT01038778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25114264|NCT01038778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25114265|NCT01038778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25114267|NCT01038778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25114268|NCT01038778|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25114269|NCT01038778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25114270|NCT01038778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24992718|NCT03048422|Tenofovir|tenofovir|mesh-list
25114271|NCT01038778|Antimetabolites|antimetabolites|mesh-ancestor
25036098|NCT03549975|Botulinum Toxins|botulinum toxins|mesh-list
25036119|NCT03549897|Autonomic Agents|autonomic agents|mesh-ancestor
25036120|NCT03549897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25036121|NCT03549897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036122|NCT03549897|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25036123|NCT03549897|Respiratory System Agents|respiratory system agents|mesh-ancestor
25036124|NCT03549897|Tocolytic Agents|tocolytic agents|mesh-ancestor
25036125|NCT03549897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25036126|NCT03549897|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25036127|NCT03549897|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25036128|NCT03549897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25036129|NCT03549897|Adrenergic Agents|adrenergic agents|mesh-ancestor
25036130|NCT03549897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25036132|NCT03549832|Ritonavir|ritonavir|mesh-list
24992605|NCT03382834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24992606|NCT03382834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992607|NCT03382834|Antiviral Agents|antiviral agents|mesh-ancestor
24992608|NCT03382834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24992609|NCT03353350|Efpeglenatide|efpeglenatide|mesh-list
24992610|NCT03353350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25036140|NCT03549832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692086|NCT01994538|Respiratory System Agents|respiratory system agents|mesh-ancestor
25692087|NCT01994590|Prednisone|prednisone|mesh-list
25036141|NCT03549832|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25036142|NCT03549832|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25036143|NCT03549832|Antiviral Agents|antiviral agents|mesh-ancestor
25036144|NCT03549832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25036145|NCT03549832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25036146|NCT03549832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25036147|NCT03549832|Antimetabolites|antimetabolites|mesh-ancestor
25036149|NCT03549819|Anticonvulsants|anticonvulsants|mesh-ancestor
25036150|NCT03549741|Cabergoline|cabergoline|mesh-list
25036181|NCT03549689|Dolutegravir|dolutegravir|mesh-list
25036182|NCT03549689|Antiviral Agents|antiviral agents|mesh-ancestor
25036183|NCT03549689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25036184|NCT03549689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25036185|NCT03549689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25036186|NCT03549689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036187|NCT03549689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036188|NCT03549689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25036189|NCT03549689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25036190|NCT03549689|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25036191|NCT03549689|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25036222|NCT03549611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866466|NCT04947631|Hormone Antagonists|hormone antagonists|mesh-ancestor
24992626|NCT03310905|Immunosuppressive Agents|immunosuppressive agents|mesh-list
24992627|NCT03310905|Immunologic Factors|immunologic factors|mesh-ancestor
24992628|NCT03310905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036223|NCT03549611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25036224|NCT03549611|Narcotics|narcotics|mesh-ancestor
25036225|NCT03549611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25036226|NCT03549611|Anticonvulsants|anticonvulsants|mesh-ancestor
25036227|NCT03549611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25036228|NCT03549611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25036229|NCT03549611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25036230|NCT03549611|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25036231|NCT03549611|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25036232|NCT03549611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25036233|NCT03549611|Antimanic Agents|antimanic agents|mesh-ancestor
25036234|NCT03549312|Tenofovir|tenofovir|mesh-list
25036235|NCT03549312|Emtricitabine|emtricitabine|mesh-list
25036236|NCT03549312|Sofosbuvir|sofosbuvir|mesh-list
25036237|NCT03549312|Cobicistat|cobicistat|mesh-list
25036238|NCT03549312|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25036239|NCT03549312|Velpatasvir|velpatasvir|mesh-list
25036242|NCT03549312|Elvitegravir|elvitegravir|mesh-list
25036331|NCT03548493|Anesthetics, General|anesthetics, general|mesh-ancestor
25036332|NCT03548493|Anesthetics|anesthetics|mesh-ancestor
25036333|NCT03548493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25036334|NCT03548493|Narcotics|narcotics|mesh-ancestor
25036336|NCT03548493|Sensory System Agents|sensory system agents|mesh-ancestor
25036337|NCT03548493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25036352|NCT03548233|BCG Vaccine|bcg vaccine|mesh-list
25036353|NCT03548233|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25036354|NCT03548233|Immunologic Factors|immunologic factors|mesh-ancestor
25036355|NCT03548233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036356|NCT03548155|Antipsychotic Agents|antipsychotic agents|mesh-list
25036357|NCT03548155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25036358|NCT03548155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25036359|NCT03548155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036360|NCT03548155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25036361|NCT03548129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25036362|NCT03548129|Fosfomycin|fosfomycin|mesh-list
25036363|NCT03548129|Anti-Infective Agents|anti-infective agents|mesh-list
25036364|NCT03547895|Vitamin K|vitamin k|mesh-list
25036365|NCT03547895|Vitamin K 1|vitamin k 1|mesh-list
25036371|NCT03547895|Vitamins|vitamins|mesh-ancestor
25036372|NCT03547895|Micronutrients|micronutrients|mesh-ancestor
25036373|NCT03547895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036374|NCT03547895|Antimetabolites|antimetabolites|mesh-ancestor
25036375|NCT03547895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036376|NCT03547895|Antiviral Agents|antiviral agents|mesh-ancestor
25036377|NCT03547895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25036378|NCT03547895|Diuretics|diuretics|mesh-ancestor
25036379|NCT03547895|Natriuretic Agents|natriuretic agents|mesh-ancestor
25036380|NCT03547895|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25036381|NCT03547895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25036383|NCT03547895|Hormone Antagonists|hormone antagonists|mesh-ancestor
25036384|NCT03547895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24904229|NCT04358016|Hormones|hormones|mesh-ancestor
25036385|NCT03547895|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25036386|NCT03547895|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25036387|NCT03547895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24603995|NCT00976755|Everolimus|everolimus|mesh-list
24604035|NCT00976976|Docetaxel|docetaxel|mesh-list
24604036|NCT00976976|Capecitabine|capecitabine|mesh-list
24604037|NCT00976976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604038|NCT00976976|Tubulin Modulators|tubulin modulators|mesh-ancestor
25036399|NCT03547804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25036400|NCT03547804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036401|NCT03547804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036402|NCT03547791|Betamethasone|betamethasone|mesh-list
25036403|NCT03547791|Betamethasone Valerate|betamethasone valerate|mesh-list
25036404|NCT03547791|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25036405|NCT03547791|Betamethasone benzoate|betamethasone benzoate|mesh-list
25036406|NCT03547791|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25036407|NCT03547791|Glucocorticoids|glucocorticoids|mesh-ancestor
25036408|NCT03547791|Hormones|hormones|mesh-ancestor
25036409|NCT03547791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25036410|NCT03547791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036411|NCT03547791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25036412|NCT03547791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25036413|NCT03547791|Respiratory System Agents|respiratory system agents|mesh-ancestor
25036414|NCT03547778|Misoprostol|misoprostol|mesh-list
25036415|NCT03547778|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25036416|NCT03547778|Abortifacient Agents|abortifacient agents|mesh-ancestor
25036417|NCT03547778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25036418|NCT03547778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036419|NCT03547778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25036420|NCT03547778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25036421|NCT03547778|Oxytocics|oxytocics|mesh-ancestor
25036422|NCT03547700|Ixazomib|ixazomib|mesh-list
25036423|NCT03547700|Romidepsin|romidepsin|mesh-list
25036424|NCT03547700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24425171|NCT00232115|Dermatologic Agents|dermatologic agents|mesh-ancestor
24425172|NCT00232115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24425173|NCT00232115|Immunologic Factors|immunologic factors|mesh-ancestor
24425174|NCT00232115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25036425|NCT03547700|Protease Inhibitors|protease inhibitors|mesh-ancestor
25036426|NCT03547700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036427|NCT03547700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036428|NCT03547700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25036473|NCT03547219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036475|NCT03547219|Serotonin Agents|serotonin agents|mesh-ancestor
25036476|NCT03547219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036477|NCT03547219|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25036478|NCT03547219|Antidepressive Agents|antidepressive agents|mesh-ancestor
25036479|NCT03547219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25036480|NCT03547024|Midazolam|midazolam|mesh-list
25036481|NCT03547024|Dextromethorphan|dextromethorphan|mesh-list
25036482|NCT03547024|Omeprazole|omeprazole|mesh-list
25036483|NCT03547024|Levonorgestrel|levonorgestrel|mesh-list
25036484|NCT03547024|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25036487|NCT03547024|Estradiol|estradiol|mesh-list
25036488|NCT03547024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25036506|NCT03547024|Contraceptive Agents|contraceptive agents|mesh-ancestor
25036507|NCT03547024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25036508|NCT03547024|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25036509|NCT03547024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25024436|NCT03646006|Bupivacaine|bupivacaine|mesh-list
25036510|NCT03547024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25036511|NCT03547024|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25036512|NCT03547024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036513|NCT03547024|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25036514|NCT03547024|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25036515|NCT03547024|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25036516|NCT03547024|Antitussive Agents|antitussive agents|mesh-ancestor
25036517|NCT03547024|Respiratory System Agents|respiratory system agents|mesh-ancestor
25036518|NCT03547024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25036519|NCT03547024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25036520|NCT03547024|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25036521|NCT03547024|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
25036522|NCT03547024|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25036523|NCT03547024|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25692088|NCT01994590|Abiraterone Acetate|abiraterone acetate|mesh-list
25036525|NCT03546959|Botulinum Toxins|botulinum toxins|mesh-list
24425175|NCT00232115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24425176|NCT00232115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425177|NCT00232154|Azithromycin|azithromycin|mesh-list
24425178|NCT00232154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24425261|NCT00232492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425262|NCT00232531|Niacin|niacin|mesh-list
24425263|NCT00232531|Nicotinic Acids|nicotinic acids|mesh-list
24425264|NCT00232531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24425265|NCT00232531|Antimetabolites|antimetabolites|mesh-ancestor
24425747|NCT00234195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425748|NCT00234195|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24425749|NCT00234195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24425750|NCT00234195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24425752|NCT00234234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24425753|NCT00234234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24425755|NCT00234299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24425756|NCT00234299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24425757|NCT00234299|Analgesics|analgesics|mesh-ancestor
24425758|NCT00234299|Sensory System Agents|sensory system agents|mesh-ancestor
24425759|NCT00234299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25036901|NCT03542357|Vasodilator Agents|vasodilator agents|mesh-ancestor
24425760|NCT00234299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425761|NCT00234299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24425779|NCT00234312|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24425780|NCT00234312|Antidepressive Agents|antidepressive agents|mesh-ancestor
24425781|NCT00234312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24425782|NCT00234377|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25036526|NCT03546959|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25036527|NCT03546959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25036528|NCT03546959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036529|NCT03546959|Cholinergic Agents|cholinergic agents|mesh-ancestor
25036530|NCT03546959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25036531|NCT03546959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036533|NCT03546855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25036534|NCT03546855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25036535|NCT03546855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036536|NCT03546855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036537|NCT03546803|Protective Agents|protective agents|mesh-list
25036538|NCT03546803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036540|NCT03546634|Immunologic Factors|immunologic factors|mesh-ancestor
25036541|NCT03546634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036561|NCT03546426|Sensory System Agents|sensory system agents|mesh-ancestor
25036562|NCT03546426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25036563|NCT03546426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036564|NCT03546400|Methylphenidate|methylphenidate|mesh-list
25036565|NCT03546400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25036566|NCT03546400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036567|NCT03546400|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25036568|NCT03546400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25036569|NCT03546400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25036570|NCT03546400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036571|NCT03546400|Dopamine Agents|dopamine agents|mesh-ancestor
25036572|NCT03546400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25036577|NCT03546283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25036590|NCT03546075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036591|NCT03546075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036592|NCT03546075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25036593|NCT03545997|Montelukast|montelukast|mesh-list
25036594|NCT03545997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25036595|NCT03545997|Respiratory System Agents|respiratory system agents|mesh-ancestor
25036596|NCT03545997|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25036597|NCT03545997|Hormone Antagonists|hormone antagonists|mesh-ancestor
25036616|NCT03545516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25036618|NCT03545516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25036619|NCT03545516|Analgesics|analgesics|mesh-ancestor
25036620|NCT03545516|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25036621|NCT03545516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25036622|NCT03545516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25692089|NCT01994590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24993243|NCT05198947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24993245|NCT05198947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993246|NCT05198856|Thalidomide|thalidomide|mesh-list
24993247|NCT05198856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24993248|NCT05198856|Immunologic Factors|immunologic factors|mesh-ancestor
24993249|NCT05198856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993250|NCT05198856|Leprostatic Agents|leprostatic agents|mesh-ancestor
24993251|NCT05198856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24993252|NCT05198856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24993253|NCT05198856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24993254|NCT05198856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24993255|NCT05198856|Growth Substances|growth substances|mesh-ancestor
25036623|NCT03545516|Adrenergic Agents|adrenergic agents|mesh-ancestor
25036624|NCT03545516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25036625|NCT03545516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036626|NCT03545373|Amoxicillin|amoxicillin|mesh-list
25036627|NCT03545373|Azithromycin|azithromycin|mesh-list
24425861|NCT00234507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425862|NCT00234507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24425863|NCT00234507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24425864|NCT00234546|Botulinum Toxins|botulinum toxins|mesh-list
24425865|NCT00234546|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24425866|NCT00234546|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24425867|NCT00234546|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25036629|NCT03545373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25036630|NCT03545347|Nandrolone Decanoate|nandrolone decanoate|mesh-list
25036631|NCT03545347|Nandrolone|nandrolone|mesh-list
25036632|NCT03545347|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
25036633|NCT03545347|Androgens|androgens|mesh-ancestor
25036634|NCT03545347|Hormones|hormones|mesh-ancestor
25036635|NCT03545347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25036636|NCT03545347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036660|NCT03544827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036661|NCT03544827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25036662|NCT03544827|Respiratory System Agents|respiratory system agents|mesh-ancestor
25036663|NCT03544827|Mydriatics|mydriatics|mesh-ancestor
25036664|NCT03544827|Parasympatholytics|parasympatholytics|mesh-ancestor
25036665|NCT03544827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25036666|NCT03544827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25036667|NCT03544827|Cholinergic Agents|cholinergic agents|mesh-ancestor
25036668|NCT03544827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25036669|NCT03544827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036670|NCT03544814|Cisplatin|cisplatin|mesh-list
25036671|NCT03544814|Pemetrexed|pemetrexed|mesh-list
25036672|NCT03544814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25036673|NCT03544814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036674|NCT03544814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036675|NCT03544814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25036676|NCT03544814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25036677|NCT03544775|Anesthetics|anesthetics|mesh-list
25036678|NCT03544775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25036679|NCT03544775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036680|NCT03544723|Pembrolizumab|pembrolizumab|mesh-list
25036681|NCT03544723|Nivolumab|nivolumab|mesh-list
25036682|NCT03544723|Durvalumab|durvalumab|mesh-list
25036683|NCT03544723|Atezolizumab|atezolizumab|mesh-list
25036684|NCT03544723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25036718|NCT03544229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036720|NCT03544125|Olaparib|olaparib|mesh-list
25036721|NCT03544125|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25036722|NCT03544125|Immunoglobulins|immunoglobulins|mesh-list
25036723|NCT03544125|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25036724|NCT03544125|Immunoglobulin G|immunoglobulin g|mesh-list
25036924|NCT03542149|Vitamin E|vitamin e|mesh-list
25036725|NCT03544125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25036726|NCT03544125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25036727|NCT03544125|Immunologic Factors|immunologic factors|mesh-ancestor
25036728|NCT03544125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036729|NCT03544125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036730|NCT03544125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036731|NCT03544073|Leuprolide|leuprolide|mesh-list
25024542|NCT03644667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25036732|NCT03544073|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25692090|NCT01994590|Glucocorticoids|glucocorticoids|mesh-ancestor
25036737|NCT03544073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25036738|NCT03544047|Paclitaxel|paclitaxel|mesh-list
25036739|NCT03544047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25036740|NCT03544047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25036741|NCT03544047|Tubulin Modulators|tubulin modulators|mesh-ancestor
25036742|NCT03544047|Antimitotic Agents|antimitotic agents|mesh-ancestor
25036743|NCT03544047|Mitosis Modulators|mitosis modulators|mesh-ancestor
25036744|NCT03544047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036760|NCT03543774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25036761|NCT03543774|Antimetabolites|antimetabolites|mesh-ancestor
25036762|NCT03543774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036763|NCT03543774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24993392|NCT05062135|Hormones|hormones|mesh-ancestor
25036764|NCT03543774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25036765|NCT03543774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036766|NCT03543683|Aspirin|aspirin|mesh-list
25036767|NCT03543683|Osimertinib|osimertinib|mesh-list
25036768|NCT03543683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25036769|NCT03543683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25036770|NCT03543683|Analgesics|analgesics|mesh-ancestor
25036771|NCT03543683|Sensory System Agents|sensory system agents|mesh-ancestor
25036772|NCT03543683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24604406|NCT00979160|Dasatinib|dasatinib|mesh-list
25036807|NCT03543254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25036808|NCT03543202|Anesthetics|anesthetics|mesh-list
25036809|NCT03543202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25036810|NCT03543202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036811|NCT03543072|Diphosphonates|diphosphonates|mesh-list
25036812|NCT03543072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24993462|NCT04707183|Anesthetics, Local|anesthetics, local|mesh-ancestor
24993463|NCT04707183|Anesthetics|anesthetics|mesh-ancestor
24993464|NCT04707183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24993465|NCT04707183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993466|NCT04707183|Sensory System Agents|sensory system agents|mesh-ancestor
24993467|NCT04707183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24993468|NCT04707183|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24993469|NCT04707183|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24993470|NCT04707183|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24993471|NCT04707183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24993472|NCT04707183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425869|NCT00234546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425870|NCT00234546|Cholinergic Agents|cholinergic agents|mesh-ancestor
24425871|NCT00234546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24425872|NCT00234546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588817|NCT00904397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24588818|NCT00904397|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24588819|NCT00904397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24604492|NCT00979706|Analgesics|analgesics|mesh-ancestor
24588861|NCT00904475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24588862|NCT00904475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24588863|NCT00904475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24588864|NCT00904475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588865|NCT00904540|Lidocaine|lidocaine|mesh-list
24588866|NCT00904540|Anesthetics, Local|anesthetics, local|mesh-ancestor
24588867|NCT00904540|Anesthetics|anesthetics|mesh-ancestor
24588868|NCT00904540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24588869|NCT00904540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588870|NCT00904540|Sensory System Agents|sensory system agents|mesh-ancestor
24588871|NCT00904540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25036863|NCT03542552|Sensory System Agents|sensory system agents|mesh-ancestor
25404879|NCT03646188|Doxorubicin|doxorubicin|mesh-list
25692091|NCT01994590|Hormones|hormones|mesh-ancestor
25692092|NCT01994590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25692093|NCT01994590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036866|NCT03542552|Anesthetics|anesthetics|mesh-ancestor
25036867|NCT03542552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25036873|NCT03542552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25036875|NCT03542552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25036876|NCT03542552|Vasodilator Agents|vasodilator agents|mesh-ancestor
25036877|NCT03542461|Nivolumab|nivolumab|mesh-list
25036878|NCT03542461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25036879|NCT03542461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25036880|NCT03542461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24557078|NCT00751205|Glucocorticoids|glucocorticoids|mesh-ancestor
25036881|NCT03542461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036882|NCT03542422|Apatinib|apatinib|mesh-list
25036890|NCT03542357|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
25036891|NCT03542357|Katacalcin|katacalcin|mesh-list
25036892|NCT03542357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25036893|NCT03542357|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25036894|NCT03542357|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25036895|NCT03542357|Serotonin Agents|serotonin agents|mesh-ancestor
25036896|NCT03542357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25036897|NCT03542357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036898|NCT03542357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036899|NCT03542357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25036900|NCT03542357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25036906|NCT03542279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25036907|NCT03542279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036908|NCT03542240|Curcumin|curcumin|mesh-list
25036909|NCT03542240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25036910|NCT03542240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25036911|NCT03542240|Analgesics|analgesics|mesh-ancestor
24992936|NCT02310867|Abatacept|abatacept|mesh-list
24425960|NCT00234871|Trandolapril|trandolapril|mesh-list
24425961|NCT00234871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24425962|NCT00234871|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24425982|NCT00234910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425983|NCT00234910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24425984|NCT00234910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24425985|NCT00234910|Antiviral Agents|antiviral agents|mesh-ancestor
24425986|NCT00234910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24425987|NCT00234910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24425988|NCT00234910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24426189|NCT00235235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24426190|NCT00235235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24426191|NCT00235235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24426192|NCT00235235|Tubulin Modulators|tubulin modulators|mesh-ancestor
24426193|NCT00235235|Antimitotic Agents|antimitotic agents|mesh-ancestor
24426194|NCT00235235|Mitosis Modulators|mitosis modulators|mesh-ancestor
24426195|NCT00235248|Aspirin|aspirin|mesh-list
24426490|NCT00236171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24426491|NCT00236223|Dexamethasone|dexamethasone|mesh-list
24426492|NCT00236223|Ketamine|ketamine|mesh-list
24426493|NCT00236223|Gabapentin|gabapentin|mesh-list
24426494|NCT00236223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24426495|NCT00236223|Antiemetics|antiemetics|mesh-ancestor
25036912|NCT03542240|Sensory System Agents|sensory system agents|mesh-ancestor
25036913|NCT03542240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25036914|NCT03542240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036915|NCT03542240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25036916|NCT03542240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25036917|NCT03542240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25036918|NCT03542240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036919|NCT03542240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036921|NCT03542214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25036922|NCT03542214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036923|NCT03542149|Tocopherols|tocopherols|mesh-list
25036925|NCT03542149|Tocotrienols|tocotrienols|mesh-list
25036926|NCT03542149|alpha-Tocopherol|alpha-tocopherol|mesh-list
25036927|NCT03542149|Piperaquine|piperaquine|mesh-list
25692094|NCT01994590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25692095|NCT01994590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25036928|NCT03542149|Antimalarials|antimalarials|mesh-ancestor
25036929|NCT03542149|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25036930|NCT03542149|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25036931|NCT03542149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25036932|NCT03542149|Antioxidants|antioxidants|mesh-ancestor
25036957|NCT03542006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036958|NCT03541993|Resveratrol|resveratrol|mesh-list
25036959|NCT03541993|Antioxidants|antioxidants|mesh-ancestor
25036960|NCT03541993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036961|NCT03541993|Protective Agents|protective agents|mesh-ancestor
25036962|NCT03541993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036963|NCT03541993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036964|NCT03541993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25036965|NCT03541928|Valacyclovir|valacyclovir|mesh-list
25036966|NCT03541928|Leuprolide|leuprolide|mesh-list
24588872|NCT00904540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24588873|NCT00904540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24588874|NCT00904540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24588875|NCT00904540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25037104|NCT03540472|Tacrolimus|tacrolimus|mesh-list
24588881|NCT00904605|Sensory System Agents|sensory system agents|mesh-ancestor
24588882|NCT00904605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25036989|NCT03541915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25036990|NCT03541915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036991|NCT03541915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25036992|NCT03541915|Tocolytic Agents|tocolytic agents|mesh-ancestor
25036993|NCT03541915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25036994|NCT03541837|Ropivacaine|ropivacaine|mesh-list
25036995|NCT03541837|Anesthetics, Local|anesthetics, local|mesh-ancestor
25036996|NCT03541837|Anesthetics|anesthetics|mesh-ancestor
25036997|NCT03541837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25036998|NCT03541837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036999|NCT03541837|Sensory System Agents|sensory system agents|mesh-ancestor
25037000|NCT03541837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25037001|NCT03541798|Anesthetics|anesthetics|mesh-list
25037002|NCT03541798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25037003|NCT03541798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037004|NCT03541759|Hydromorphone|hydromorphone|mesh-list
25037005|NCT03541759|Pirinitramide|pirinitramide|mesh-list
25037006|NCT03541759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25037007|NCT03541759|Narcotics|narcotics|mesh-ancestor
25037011|NCT03541759|Sensory System Agents|sensory system agents|mesh-ancestor
25037012|NCT03541759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25037013|NCT03541681|Anesthetics|anesthetics|mesh-list
25037014|NCT03541681|Glucocorticoids|glucocorticoids|mesh-list
25037015|NCT03541681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25037032|NCT03541564|Moxifloxacin|moxifloxacin|mesh-list
25037034|NCT03541564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25037035|NCT03541564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25037036|NCT03541564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25037037|NCT03541564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25037038|NCT03541564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037039|NCT03541564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037040|NCT03541564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25037041|NCT03541564|Dermatologic Agents|dermatologic agents|mesh-ancestor
25037042|NCT03541564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25037043|NCT03541265|Bupivacaine|bupivacaine|mesh-list
25037044|NCT03541265|Anesthetics, Local|anesthetics, local|mesh-ancestor
25037046|NCT03541265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25037047|NCT03541265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037048|NCT03541265|Sensory System Agents|sensory system agents|mesh-ancestor
25037049|NCT03541265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25037069|NCT03540953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25037070|NCT03540953|Alkylating Agents|alkylating agents|mesh-ancestor
25692096|NCT01994590|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25692097|NCT01994590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692098|NCT01994590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692099|NCT01994590|Hormone Antagonists|hormone antagonists|mesh-ancestor
25692100|NCT01994590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25078101|NCT03359161|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25078102|NCT03359161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25078103|NCT03359161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078104|NCT03359070|Miconazole|miconazole|mesh-list
25078105|NCT03359070|Clotrimazole|clotrimazole|mesh-list
25078106|NCT03359070|Antifungal Agents|antifungal agents|mesh-ancestor
24906229|NCT04341844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906230|NCT04341844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037071|NCT03540953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037072|NCT03540953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25037073|NCT03540953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037074|NCT03540914|Acetazolamide|acetazolamide|mesh-list
25037075|NCT03540914|Anticonvulsants|anticonvulsants|mesh-ancestor
25037076|NCT03540914|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25037077|NCT03540914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037078|NCT03540914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037079|NCT03540914|Diuretics|diuretics|mesh-ancestor
25037080|NCT03540914|Natriuretic Agents|natriuretic agents|mesh-ancestor
25037081|NCT03540914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037082|NCT03540849|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25037083|NCT03540849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25037084|NCT03540849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25037100|NCT03540628|Antioxidants|antioxidants|mesh-ancestor
25037101|NCT03540628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037102|NCT03540628|Protective Agents|protective agents|mesh-ancestor
25037103|NCT03540628|Vitamin B Complex|vitamin b complex|mesh-ancestor
25037105|NCT03540472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25037106|NCT03540472|Immunologic Factors|immunologic factors|mesh-ancestor
25037107|NCT03540472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037108|NCT03540472|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25037109|NCT03540472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037110|NCT03540472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037111|NCT03540368|Tranexamic Acid|tranexamic acid|mesh-list
25037112|NCT03540368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25037113|NCT03540368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25037128|NCT03540225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25037129|NCT03540225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037131|NCT03540212|Antiviral Agents|antiviral agents|mesh-ancestor
25037132|NCT03540212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25037133|NCT03540199|Antibodies|antibodies|mesh-list
25037134|NCT03540199|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25037135|NCT03540199|Immunologic Factors|immunologic factors|mesh-ancestor
25037136|NCT03540199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037137|NCT03540095|Bupivacaine|bupivacaine|mesh-list
25037138|NCT03540095|Anesthetics, Local|anesthetics, local|mesh-ancestor
25037139|NCT03540095|Anesthetics|anesthetics|mesh-ancestor
25037140|NCT03540095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25037141|NCT03540095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037142|NCT03540095|Sensory System Agents|sensory system agents|mesh-ancestor
25037143|NCT03540095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25037144|NCT03540017|Cisplatin|cisplatin|mesh-list
25037145|NCT03540017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25037146|NCT03539887|Ketamine|ketamine|mesh-list
25037147|NCT03539887|Analgesics|analgesics|mesh-ancestor
25037148|NCT03539887|Sensory System Agents|sensory system agents|mesh-ancestor
25037158|NCT03539887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25037159|NCT03539887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037161|NCT03539731|Antinematodal Agents|antinematodal agents|mesh-ancestor
25037162|NCT03539731|Anthelmintics|anthelmintics|mesh-ancestor
25037163|NCT03539731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25037164|NCT03539731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25037165|NCT03539718|Taurolidine|taurolidine|mesh-list
25037166|NCT03539718|Heparin|heparin|mesh-list
25692101|NCT01994720|Aspirin|aspirin|mesh-list
25692102|NCT01994720|Ticagrelor|ticagrelor|mesh-list
25692103|NCT01994720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25692104|NCT01994720|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25692105|NCT01994720|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25692106|NCT01994720|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25692107|NCT01994720|Purinergic Agents|purinergic agents|mesh-ancestor
25692108|NCT01994720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25692109|NCT01994720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037167|NCT03539718|Calcium heparin|calcium heparin|mesh-list
25037168|NCT03539718|Anticoagulants|anticoagulants|mesh-ancestor
25037169|NCT03539718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25037170|NCT03539718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25037171|NCT03539718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037172|NCT03539718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25037178|NCT03539627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037179|NCT03539562|Promethazine|promethazine|mesh-list
25037180|NCT03539562|Diphenhydramine|diphenhydramine|mesh-list
25037181|NCT03539562|Morphine|morphine|mesh-list
25037182|NCT03539562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25037183|NCT03539562|Narcotics|narcotics|mesh-ancestor
25037184|NCT03539562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25037185|NCT03539562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037186|NCT03539562|Analgesics|analgesics|mesh-ancestor
25037187|NCT03539562|Sensory System Agents|sensory system agents|mesh-ancestor
25037188|NCT03539562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25037189|NCT03539562|Antipruritics|antipruritics|mesh-ancestor
25037190|NCT03539562|Dermatologic Agents|dermatologic agents|mesh-ancestor
25037191|NCT03539562|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25037192|NCT03539562|Histamine Antagonists|histamine antagonists|mesh-ancestor
25037193|NCT03539562|Histamine Agents|histamine agents|mesh-ancestor
25037194|NCT03539562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25037195|NCT03539562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993783|NCT05405387|Hormones|hormones|mesh-ancestor
25037196|NCT03539562|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25037197|NCT03539562|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25037198|NCT03539562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25037199|NCT03539562|Anesthetics, Local|anesthetics, local|mesh-ancestor
25037200|NCT03539562|Anesthetics|anesthetics|mesh-ancestor
24993851|NCT05335655|Dexmedetomidine|dexmedetomidine|mesh-list
24993852|NCT05335655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24993853|NCT05335655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24993854|NCT05335655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993855|NCT05335655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24993857|NCT05335655|Sensory System Agents|sensory system agents|mesh-ancestor
24993858|NCT05335655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24993859|NCT05335655|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25037209|NCT03539367|Acetazolamide|acetazolamide|mesh-list
25037210|NCT03539367|Anticonvulsants|anticonvulsants|mesh-ancestor
25037211|NCT03539367|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25037212|NCT03539367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037213|NCT03539367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037214|NCT03539367|Diuretics|diuretics|mesh-ancestor
25037215|NCT03539367|Natriuretic Agents|natriuretic agents|mesh-ancestor
25037216|NCT03539367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037217|NCT03539328|Gemcitabine|gemcitabine|mesh-list
25037218|NCT03539328|Paclitaxel|paclitaxel|mesh-list
25037219|NCT03539328|Doxorubicin|doxorubicin|mesh-list
25037220|NCT03539328|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25037221|NCT03539328|Pembrolizumab|pembrolizumab|mesh-list
25037222|NCT03539328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24426497|NCT00236223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24426498|NCT00236223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426722|NCT00236535|Narcotics|narcotics|mesh-ancestor
24426723|NCT00236535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24426724|NCT00236535|Antitussive Agents|antitussive agents|mesh-ancestor
24426725|NCT00236535|Respiratory System Agents|respiratory system agents|mesh-ancestor
25037246|NCT03539224|Antiviral Agents|antiviral agents|mesh-ancestor
25037247|NCT03539224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25037248|NCT03539224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25037249|NCT03539224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25037250|NCT03539224|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25037251|NCT03539224|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24426919|NCT00236821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24426920|NCT00236821|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25037259|NCT03539172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25037260|NCT03539172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037261|NCT03539172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037262|NCT03539159|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25037263|NCT03539159|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25037264|NCT03539003|Remifentanil|remifentanil|mesh-list
25037265|NCT03539003|Propofol|propofol|mesh-list
25037266|NCT03539003|Sevoflurane|sevoflurane|mesh-list
25037267|NCT03539003|Desflurane|desflurane|mesh-list
25037268|NCT03539003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25037269|NCT03539003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25037270|NCT03539003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037271|NCT03539003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25037272|NCT03539003|Anesthetics, General|anesthetics, general|mesh-ancestor
25037273|NCT03539003|Anesthetics|anesthetics|mesh-ancestor
25037274|NCT03539003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25037275|NCT03539003|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24605123|NCT00983398|Melphalan|melphalan|mesh-list
25037298|NCT03538691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037299|NCT03538691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25037301|NCT03538691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25037302|NCT03538691|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24426945|NCT00236873|Anticonvulsants|anticonvulsants|mesh-ancestor
24426946|NCT00236873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24426947|NCT00236873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426949|NCT00236886|Anticonvulsants|anticonvulsants|mesh-ancestor
24426950|NCT00236886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24426951|NCT00236886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427228|NCT00237783|Dialysis Solutions|dialysis solutions|mesh-list
24427463|NCT00238225|Antiemetics|antiemetics|mesh-ancestor
24427464|NCT00238225|Autonomic Agents|autonomic agents|mesh-ancestor
24427465|NCT00238225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24427466|NCT00238225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427467|NCT00238225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24427468|NCT00238225|Glucocorticoids|glucocorticoids|mesh-ancestor
24427488|NCT00238225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24427489|NCT00238251|Temozolomide|temozolomide|mesh-list
25037306|NCT03538691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25037307|NCT03538691|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25037308|NCT03538691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25037310|NCT03538691|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25037311|NCT03538691|Analgesics|analgesics|mesh-ancestor
25037312|NCT03538691|Sensory System Agents|sensory system agents|mesh-ancestor
25037313|NCT03538691|Dopamine Agents|dopamine agents|mesh-ancestor
25037314|NCT03538691|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25037315|NCT03538691|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25037316|NCT03538691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037317|NCT03538691|Dopamine Agonists|dopamine agonists|mesh-ancestor
25037318|NCT03538496|Bupivacaine|bupivacaine|mesh-list
25037319|NCT03538496|Anesthetics, Local|anesthetics, local|mesh-ancestor
25037320|NCT03538496|Anesthetics|anesthetics|mesh-ancestor
25037321|NCT03538496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25037322|NCT03538496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037323|NCT03538496|Sensory System Agents|sensory system agents|mesh-ancestor
25037324|NCT03538496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25037325|NCT03538483|Bupivacaine|bupivacaine|mesh-list
25037326|NCT03538483|Anesthetics, Local|anesthetics, local|mesh-ancestor
25037327|NCT03538483|Anesthetics|anesthetics|mesh-ancestor
25037328|NCT03538483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25037348|NCT03538171|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24427627|NCT00238641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24427628|NCT00238641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24427629|NCT00238641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24427630|NCT00238641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24427631|NCT00238641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427632|NCT00238641|Cholinergic Agents|cholinergic agents|mesh-ancestor
24427633|NCT00238641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24427634|NCT00238641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427635|NCT00238641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24427636|NCT00238641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25037357|NCT03537950|Cannabidiol|cannabidiol|mesh-list
25037358|NCT03537950|Anticonvulsants|anticonvulsants|mesh-ancestor
25037359|NCT03537924|Acetazolamide|acetazolamide|mesh-list
25037360|NCT03537924|Anticonvulsants|anticonvulsants|mesh-ancestor
25037361|NCT03537924|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25037362|NCT03537924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037363|NCT03537924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037364|NCT03537924|Diuretics|diuretics|mesh-ancestor
25037365|NCT03537924|Natriuretic Agents|natriuretic agents|mesh-ancestor
25037366|NCT03537924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037367|NCT03537898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25037368|NCT03537898|Plasma-lyte 148|plasma-lyte 148|mesh-list
25692110|NCT01994720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037371|NCT03537807|Anticonvulsants|anticonvulsants|mesh-ancestor
25037372|NCT03537807|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25037373|NCT03537807|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25037374|NCT03537807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25037375|NCT03537807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037376|NCT03537807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037377|NCT03537807|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25037378|NCT03537807|Protective Agents|protective agents|mesh-ancestor
25037379|NCT03537768|Levonorgestrel|levonorgestrel|mesh-list
25037380|NCT03537768|Ulipristal acetate|ulipristal acetate|mesh-list
24605253|NCT00984152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25008547|NCT05166239|Lenvatinib|lenvatinib|mesh-list
25037392|NCT03537612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25037393|NCT03537612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427994|NCT00239408|Anticonvulsants|anticonvulsants|mesh-ancestor
24427995|NCT00239421|Fluticasone|fluticasone|mesh-list
24427997|NCT00239421|Formoterol Fumarate|formoterol fumarate|mesh-list
24427998|NCT00239421|Tiotropium Bromide|tiotropium bromide|mesh-list
24427999|NCT00239421|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24428000|NCT00239421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24428001|NCT00239421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25037395|NCT03537612|Sensory System Agents|sensory system agents|mesh-ancestor
25037404|NCT03537612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25037405|NCT03537612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037406|NCT03537573|Analgesics, Opioid|analgesics, opioid|mesh-list
25037407|NCT03537573|Narcotics|narcotics|mesh-ancestor
25037408|NCT03537573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25037409|NCT03537573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037410|NCT03537573|Analgesics|analgesics|mesh-ancestor
25037411|NCT03537573|Sensory System Agents|sensory system agents|mesh-ancestor
25037412|NCT03537573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25037413|NCT03537547|Antipsychotic Agents|antipsychotic agents|mesh-list
25037414|NCT03537547|Antidepressive Agents|antidepressive agents|mesh-list
25037415|NCT03537547|Psychotropic Drugs|psychotropic drugs|mesh-list
25037416|NCT03537547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25037417|NCT03537547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25037418|NCT03537547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037419|NCT03537534|Lidocaine|lidocaine|mesh-list
25037420|NCT03537534|Anesthetics, Local|anesthetics, local|mesh-ancestor
24428002|NCT00239421|Autonomic Agents|autonomic agents|mesh-ancestor
24428003|NCT00239421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24428004|NCT00239421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428005|NCT00239421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24428006|NCT00239421|Respiratory System Agents|respiratory system agents|mesh-ancestor
24428007|NCT00239421|Dermatologic Agents|dermatologic agents|mesh-ancestor
24428008|NCT00239421|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24428126|NCT00239538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428127|NCT00239538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24428128|NCT00239538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24428129|NCT00239551|Lansoprazole|lansoprazole|mesh-list
24428130|NCT00239551|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25037429|NCT03537534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25037430|NCT03537534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037437|NCT03537443|Vitamin D|vitamin d|mesh-list
24428136|NCT00239616|Hematinics|hematinics|mesh-ancestor
24428341|NCT00240266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24428342|NCT00240266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24428343|NCT00240266|Antimetabolites|antimetabolites|mesh-ancestor
24428344|NCT00240266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428345|NCT00240266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24428588|NCT00240773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24428589|NCT00240773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428590|NCT00240773|Antipyretics|antipyretics|mesh-ancestor
24428591|NCT00240773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24428592|NCT00240773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24428598|NCT00240786|Acetaminophen|acetaminophen|mesh-list
24563447|NCT00771563|Tubulin Modulators|tubulin modulators|mesh-ancestor
24428618|NCT00240812|Sensory System Agents|sensory system agents|mesh-ancestor
24428619|NCT00240812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24428620|NCT00240812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428621|NCT00240812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24428622|NCT00240812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25692707|NCT02004093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24428623|NCT00240812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24428624|NCT00240812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428649|NCT00240825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428803|NCT00241215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24428804|NCT00241215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428806|NCT00241241|Interferon-alpha|interferon-alpha|mesh-list
24428807|NCT00241241|Interferon alpha-2|interferon alpha-2|mesh-list
25037438|NCT03537443|Cholecalciferol|cholecalciferol|mesh-list
25037439|NCT03537443|Vitamins|vitamins|mesh-ancestor
25037440|NCT03537443|Micronutrients|micronutrients|mesh-ancestor
25037441|NCT03537443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037442|NCT03537443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25037446|NCT03537326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25037448|NCT03537326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25037449|NCT03537326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037450|NCT03537326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25037451|NCT03537326|Respiratory System Agents|respiratory system agents|mesh-ancestor
25037452|NCT03537326|Glucocorticoids|glucocorticoids|mesh-ancestor
25037453|NCT03537326|Hormones|hormones|mesh-ancestor
24560538|NCT02369458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037454|NCT03537326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25037550|NCT03536598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24588959|NCT00904904|Sensory System Agents|sensory system agents|mesh-ancestor
24588960|NCT00904904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588961|NCT00904904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588962|NCT00904904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24588963|NCT00904904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24588964|NCT00904904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24588965|NCT00904904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25025073|NCT03640156|Oxytocin|oxytocin|mesh-list
24588966|NCT00904904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588967|NCT00904904|Gout Suppressants|gout suppressants|mesh-ancestor
24588968|NCT00904904|Tocolytic Agents|tocolytic agents|mesh-ancestor
24588969|NCT00904904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24588985|NCT00905073|Cyclosporine|cyclosporine|mesh-list
24588986|NCT00905073|Methotrexate|methotrexate|mesh-list
24588987|NCT00905073|Cyclosporins|cyclosporins|mesh-list
24588988|NCT00905073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24588989|NCT00905073|Abortifacient Agents|abortifacient agents|mesh-ancestor
25037455|NCT03537287|Progesterone|progesterone|mesh-list
25037456|NCT03537287|Dydrogesterone|dydrogesterone|mesh-list
25037457|NCT03537287|Progestins|progestins|mesh-ancestor
25037481|NCT03537144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25037482|NCT03537144|Gout Suppressants|gout suppressants|mesh-ancestor
25037483|NCT03537144|Tocolytic Agents|tocolytic agents|mesh-ancestor
25037484|NCT03537144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25037485|NCT03537144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25037486|NCT03537144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037487|NCT03537144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037488|NCT03537027|Vitamin D|vitamin d|mesh-list
25037489|NCT03537027|Cholecalciferol|cholecalciferol|mesh-list
25037490|NCT03537027|Vitamins|vitamins|mesh-ancestor
25037491|NCT03537027|Micronutrients|micronutrients|mesh-ancestor
25037492|NCT03537027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037493|NCT03537027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25037494|NCT03537027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25037495|NCT03536910|Arginine Vasopressin|arginine vasopressin|mesh-list
25037497|NCT03536910|Coagulants|coagulants|mesh-ancestor
25037498|NCT03536910|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25037499|NCT03536910|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25037500|NCT03536910|Natriuretic Agents|natriuretic agents|mesh-ancestor
25037501|NCT03536910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037502|NCT03536845|Vitamin D|vitamin d|mesh-list
25037503|NCT03536845|Cholecalciferol|cholecalciferol|mesh-list
25037504|NCT03536845|Vitamins|vitamins|mesh-ancestor
25037505|NCT03536845|Micronutrients|micronutrients|mesh-ancestor
25037506|NCT03536845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037507|NCT03536845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24560790|NCT01451515|Antiemetics|antiemetics|mesh-ancestor
25692111|NCT01994720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25692112|NCT01994720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25692113|NCT01994720|Analgesics|analgesics|mesh-ancestor
24561268|NCT00759226|Cisplatin|cisplatin|mesh-list
25037508|NCT03536845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25037510|NCT03536806|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25037531|NCT03536741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
25037532|NCT03536741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25037533|NCT03536741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037534|NCT03536741|Anesthetics, General|anesthetics, general|mesh-ancestor
25037535|NCT03536637|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25037536|NCT03536637|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25037537|NCT03536637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25037539|NCT03536611|Dabigatran|dabigatran|mesh-list
25037540|NCT03536611|Anticoagulants|anticoagulants|mesh-ancestor
25037541|NCT03536611|Antithrombins|antithrombins|mesh-ancestor
25037542|NCT03536611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25037543|NCT03536611|Protease Inhibitors|protease inhibitors|mesh-ancestor
25037544|NCT03536611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037545|NCT03536611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037546|NCT03536598|Amlodipine|amlodipine|mesh-list
25037547|NCT03536598|Valsartan|valsartan|mesh-list
25037548|NCT03536598|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25037549|NCT03536598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25037564|NCT03536494|Mirabegron|mirabegron|mesh-list
24605498|NCT00985556|Tegafur|tegafur|mesh-list
25037579|NCT03536390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25037580|NCT03536390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037581|NCT03536390|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25037582|NCT03536390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25037583|NCT03536390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25037584|NCT03536390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561269|NCT00759226|Levoleucovorin|levoleucovorin|mesh-list
25037585|NCT03536390|Dopamine Agents|dopamine agents|mesh-ancestor
25037586|NCT03536390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25037587|NCT03536325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25037588|NCT03536325|Immunologic Factors|immunologic factors|mesh-ancestor
25037589|NCT03536325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037590|NCT03536234|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25037591|NCT03536234|Luteolytic Agents|luteolytic agents|mesh-ancestor
25037592|NCT03536234|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25037593|NCT03536234|Contraceptive Agents|contraceptive agents|mesh-ancestor
25037594|NCT03536234|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25037595|NCT03536234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037596|NCT03536234|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25037597|NCT03536234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25037598|NCT03536234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25037599|NCT03536208|Warfarin|warfarin|mesh-list
25037600|NCT03536208|Anticoagulants|anticoagulants|mesh-ancestor
24993414|NCT04937816|Empagliflozin|empagliflozin|mesh-list
24993415|NCT04937816|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24993416|NCT04937816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993417|NCT04937816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24993418|NCT04937816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993419|NCT04906902|Acalabrutinib|acalabrutinib|mesh-list
24993436|NCT04856293|Crizotinib|crizotinib|mesh-list
25037604|NCT03536065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037605|NCT03536065|Analgesics|analgesics|mesh-ancestor
25037606|NCT03536065|Sensory System Agents|sensory system agents|mesh-ancestor
25037607|NCT03536065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24605572|NCT00986115|Memantine|memantine|mesh-list
25037730|NCT03535519|Methotrexate|methotrexate|mesh-list
25037731|NCT03535519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25037732|NCT03535519|Abortifacient Agents|abortifacient agents|mesh-ancestor
25037733|NCT03535519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25037734|NCT03535519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037740|NCT03535519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037741|NCT03535519|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25037742|NCT03535519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25037743|NCT03535519|Immunologic Factors|immunologic factors|mesh-ancestor
25037744|NCT03535519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25037745|NCT03535519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24993444|NCT04783233|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
24428811|NCT00241241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24428812|NCT00241241|Immunologic Factors|immunologic factors|mesh-ancestor
24428813|NCT00241241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428814|NCT00241254|Methylprednisolone|methylprednisolone|mesh-list
24428815|NCT00241254|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24428816|NCT00241254|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24428818|NCT00241254|Prednisolone acetate|prednisolone acetate|mesh-list
24428819|NCT00241254|Cyclophosphamide|cyclophosphamide|mesh-list
24428820|NCT00241254|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24428821|NCT00241254|Prednisolone phosphate|prednisolone phosphate|mesh-list
24428822|NCT00241254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24515104|NCT00594555|Cytarabine|cytarabine|mesh-list
24428916|NCT00241514|Esomeprazole|esomeprazole|mesh-list
24428917|NCT00241514|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24428918|NCT00241514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24428919|NCT00241514|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24428920|NCT00241514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428921|NCT00241514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428922|NCT00241527|Esomeprazole|esomeprazole|mesh-list
24428940|NCT00241605|Metformin|metformin|mesh-list
24428941|NCT00241605|Rosiglitazone|rosiglitazone|mesh-list
24428942|NCT00241605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24429129|NCT00242775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429130|NCT00242775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24429131|NCT00242775|Respiratory System Agents|respiratory system agents|mesh-ancestor
24429176|NCT00242853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429177|NCT00242853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24429178|NCT00242853|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24429179|NCT00242853|Vasodilator Agents|vasodilator agents|mesh-ancestor
24429180|NCT00242853|Gasotransmitters|gasotransmitters|mesh-ancestor
24429181|NCT00242853|Protective Agents|protective agents|mesh-ancestor
24994446|NCT04138277|Miglustat|miglustat|mesh-list
24994447|NCT04138277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605724|NCT00987038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24589019|NCT00905190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24589020|NCT00905190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24589021|NCT00905190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24589022|NCT00905190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24589024|NCT00905216|Calcium heparin|calcium heparin|mesh-list
24589025|NCT00905216|Anticoagulants|anticoagulants|mesh-ancestor
24589026|NCT00905216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24589027|NCT00905216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24589028|NCT00905216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589029|NCT00905229|Vitamins|vitamins|mesh-list
24589030|NCT00905229|Vitamin K|vitamin k|mesh-list
24589031|NCT00905229|Vitamin K 1|vitamin k 1|mesh-list
24589032|NCT00905229|Micronutrients|micronutrients|mesh-ancestor
24589033|NCT00905229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589034|NCT00905229|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24589035|NCT00905229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24589036|NCT00905229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589037|NCT00905229|Hemostatics|hemostatics|mesh-ancestor
24429182|NCT00242879|Ritonavir|ritonavir|mesh-list
24429183|NCT00242879|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24429184|NCT00242879|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24429185|NCT00242879|Protease Inhibitors|protease inhibitors|mesh-ancestor
24515149|NCT00594867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24515151|NCT00594867|Antipyretics|antipyretics|mesh-ancestor
24429186|NCT00242879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429505|NCT00244179|Interferon-gamma|interferon-gamma|mesh-list
24429506|NCT00244179|Infliximab|infliximab|mesh-list
24429507|NCT00244179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429508|NCT00244179|Antiviral Agents|antiviral agents|mesh-ancestor
24429509|NCT00244179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24429510|NCT00244179|Dermatologic Agents|dermatologic agents|mesh-ancestor
24429511|NCT00244179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24429512|NCT00244179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24429513|NCT00244192|Infliximab|infliximab|mesh-list
24429771|NCT00245024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24429788|NCT00245089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24429789|NCT00245089|Tubulin Modulators|tubulin modulators|mesh-ancestor
24429790|NCT00245089|Antimitotic Agents|antimitotic agents|mesh-ancestor
24429791|NCT00245089|Mitosis Modulators|mitosis modulators|mesh-ancestor
24429792|NCT00245089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24429817|NCT00245141|Alkylating Agents|alkylating agents|mesh-ancestor
25692114|NCT01994720|Sensory System Agents|sensory system agents|mesh-ancestor
25692115|NCT01994720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24429823|NCT00245141|Antimitotic Agents|antimitotic agents|mesh-ancestor
24430198|NCT00246389|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25037750|NCT03535415|Hormones|hormones|mesh-list
24954763|NCT03873415|BMS-986165|bms-986165|mesh-list
24420542|NCT00216281|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25037751|NCT03535415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25037752|NCT03535415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037787|NCT03535259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25037788|NCT03535259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25037789|NCT03535259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037790|NCT03535259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037791|NCT03535233|Triamcinolone|triamcinolone|mesh-list
25037792|NCT03535233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25037793|NCT03535233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25037795|NCT03535233|Minoxidil|minoxidil|mesh-list
25037796|NCT03535233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25037797|NCT03535233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25037798|NCT03535233|Glucocorticoids|glucocorticoids|mesh-ancestor
25037799|NCT03535233|Hormones|hormones|mesh-ancestor
25037829|NCT03535168|GABA Modulators|gaba modulators|mesh-ancestor
25037830|NCT03535168|GABA Agents|gaba agents|mesh-ancestor
25037831|NCT03535168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25037832|NCT03535168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037833|NCT03535103|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25037835|NCT03535103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25037836|NCT03535103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037837|NCT03535090|Methylprednisolone|methylprednisolone|mesh-list
25037838|NCT03535090|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25037839|NCT03535090|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25037840|NCT03535090|Prednisolone|prednisolone|mesh-list
25037841|NCT03535090|Prednisolone acetate|prednisolone acetate|mesh-list
24605857|NCT00987766|Gemcitabine|gemcitabine|mesh-list
25037860|NCT03535051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797777|NCT01957956|Temozolomide|temozolomide|mesh-list
24430330|NCT00247130|Histamine Agents|histamine agents|mesh-ancestor
24430331|NCT00247130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430333|NCT00247169|Progesterone|progesterone|mesh-list
24430367|NCT00247481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430372|NCT00247494|Antitubercular Agents|antitubercular agents|mesh-ancestor
24561864|NCT00763347|Alogliptin|alogliptin|mesh-list
24562063|NCT00764413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24562064|NCT00764413|Glucocorticoids|glucocorticoids|mesh-ancestor
24430373|NCT00247494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24430374|NCT00247494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24430375|NCT00247494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430376|NCT00247494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430378|NCT00247507|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24430379|NCT00247507|Antiviral Agents|antiviral agents|mesh-ancestor
24430380|NCT00247507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25037861|NCT03535051|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25037862|NCT03535051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037863|NCT03535051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037864|NCT03534973|Caffeine|caffeine|mesh-list
25037865|NCT03534973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25037866|NCT03534973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037867|NCT03534973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25037868|NCT03534973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037869|NCT03534973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037870|NCT03534973|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25037872|NCT03534973|Purinergic Agents|purinergic agents|mesh-ancestor
25037873|NCT03534973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25037875|NCT03534895|Anesthetics|anesthetics|mesh-ancestor
25037876|NCT03534895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25037877|NCT03534895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037878|NCT03534895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25037879|NCT03534895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25037880|NCT03534895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25037881|NCT03534895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25037882|NCT03534895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25037883|NCT03534895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25037884|NCT03534895|Anesthetics, General|anesthetics, general|mesh-ancestor
25037885|NCT03534895|GABA Modulators|gaba modulators|mesh-ancestor
25037886|NCT03534895|GABA Agents|gaba agents|mesh-ancestor
25037887|NCT03534895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25037888|NCT03534895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430382|NCT00247507|Respiratory System Agents|respiratory system agents|mesh-ancestor
24430383|NCT00247507|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24430384|NCT00247507|Antioxidants|antioxidants|mesh-ancestor
25692708|NCT02004093|Antimetabolites|antimetabolites|mesh-ancestor
24430386|NCT00247507|Protective Agents|protective agents|mesh-ancestor
24430416|NCT00247650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24430426|NCT00247663|Letrozole|letrozole|mesh-list
24430465|NCT00247741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24430466|NCT00247741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24430467|NCT00247741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24430468|NCT00247741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430469|NCT00247910|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24430502|NCT00248092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430504|NCT00248092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430506|NCT00248118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24430507|NCT00248118|Antidepressive Agents|antidepressive agents|mesh-ancestor
24430660|NCT00248729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037890|NCT03534869|Sensory System Agents|sensory system agents|mesh-ancestor
25037891|NCT03534869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25037892|NCT03534869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037894|NCT03534713|Carboplatin|carboplatin|mesh-list
25037895|NCT03534713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24994532|NCT03930745|TOL-463|tol-463|mesh-list
25037918|NCT03534505|Anesthetics, Local|anesthetics, local|mesh-ancestor
25037919|NCT03534505|Anesthetics|anesthetics|mesh-ancestor
24562065|NCT00764413|Hormones|hormones|mesh-ancestor
25037920|NCT03534505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25037921|NCT03534505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037922|NCT03534505|Sensory System Agents|sensory system agents|mesh-ancestor
25037923|NCT03534505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25037924|NCT03534505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25037925|NCT03534505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25037926|NCT03534505|Analgesics|analgesics|mesh-ancestor
25037927|NCT03534505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25037928|NCT03534505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25037929|NCT03534505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25037930|NCT03534505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039957|NCT03553498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24430662|NCT00248963|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24431435|NCT00251706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24431436|NCT00251706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431437|NCT00251706|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24431824|NCT00253110|Serotonin Agents|serotonin agents|mesh-ancestor
24431825|NCT00253110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431826|NCT00253110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431827|NCT00253110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431828|NCT00253110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24431829|NCT00253110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24431830|NCT00253110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24431831|NCT00253110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24432496|NCT00254930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993515|NCT04512079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993516|NCT04512079|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24993517|NCT04512079|Antithrombins|antithrombins|mesh-ancestor
24993518|NCT04512079|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24993519|NCT04512079|Protease Inhibitors|protease inhibitors|mesh-ancestor
24993520|NCT04512079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24993539|NCT05416827|Dexamethasone|dexamethasone|mesh-list
24993540|NCT05416827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24867597|NCT03761277|Morphine|morphine|mesh-list
25037931|NCT03534505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037932|NCT03534492|Durvalumab|durvalumab|mesh-list
25037933|NCT03534492|Olaparib|olaparib|mesh-list
25037934|NCT03534492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25037935|NCT03534492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25037936|NCT03534492|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25037937|NCT03534492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037938|NCT03534492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037939|NCT03534479|Immunoglobulins|immunoglobulins|mesh-list
25037940|NCT03534479|Immunologic Factors|immunologic factors|mesh-ancestor
25037982|NCT03533803|Analgesics|analgesics|mesh-ancestor
25037983|NCT03533803|Sensory System Agents|sensory system agents|mesh-ancestor
25037984|NCT03533803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25037985|NCT03533803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037988|NCT03533803|Gout Suppressants|gout suppressants|mesh-ancestor
25037989|NCT03533803|Tocolytic Agents|tocolytic agents|mesh-ancestor
25037990|NCT03533803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25037991|NCT03533803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25037992|NCT03533803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037993|NCT03533803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037994|NCT03533699|Propranolol|propranolol|mesh-list
25037995|NCT03533699|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25037996|NCT03533699|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25037997|NCT03533699|Adrenergic Agents|adrenergic agents|mesh-ancestor
25037998|NCT03533699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24432676|NCT00255658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24432677|NCT00255658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24432964|NCT00257062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24432965|NCT00257062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038021|NCT03533387|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25038023|NCT03533387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038024|NCT03533387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25038025|NCT03533387|Vasodilator Agents|vasodilator agents|mesh-ancestor
25038026|NCT03533361|Lenvatinib|lenvatinib|mesh-list
25038027|NCT03533361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038028|NCT03533361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25038029|NCT03533361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038030|NCT03533361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038031|NCT03533335|Chlorhexidine|chlorhexidine|mesh-list
25038032|NCT03533335|Chlorine dioxide|chlorine dioxide|mesh-list
25038033|NCT03533335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25038034|NCT03533335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25038042|NCT03533231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25038043|NCT03533231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25038044|NCT03533231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25038045|NCT03533231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25038046|NCT03533231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038047|NCT03533231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038048|NCT03533231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038059|NCT03533179|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25038060|NCT03533179|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25038061|NCT03533179|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25038062|NCT03533179|Adrenergic Agents|adrenergic agents|mesh-ancestor
25038063|NCT03533179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25038064|NCT03533179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038065|NCT03533166|Chlorhexidine|chlorhexidine|mesh-list
25038066|NCT03533166|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25038067|NCT03533166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24433112|NCT00257595|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24433113|NCT00257595|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24433114|NCT00257595|Histamine Antagonists|histamine antagonists|mesh-ancestor
24433115|NCT00257595|Histamine Agents|histamine agents|mesh-ancestor
24433116|NCT00257595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24433117|NCT00257595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433118|NCT00257595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433120|NCT00257621|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24433121|NCT00257621|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24433165|NCT00257751|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24433166|NCT00257751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24433167|NCT00257751|Protease Inhibitors|protease inhibitors|mesh-ancestor
24433255|NCT00258050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24433256|NCT00258050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433271|NCT00258063|Norelgestromin|norelgestromin|mesh-list
24433272|NCT00258063|Contraceptive Agents|contraceptive agents|mesh-list
24563379|NCT00771368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25692116|NCT01994720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24433280|NCT00258063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24433447|NCT00258375|Mitosis Modulators|mitosis modulators|mesh-ancestor
24433448|NCT00258375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433449|NCT00258388|Prednisone|prednisone|mesh-list
24433450|NCT00258388|Docetaxel|docetaxel|mesh-list
24433451|NCT00258388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433452|NCT00258388|Tubulin Modulators|tubulin modulators|mesh-ancestor
24433453|NCT00258388|Antimitotic Agents|antimitotic agents|mesh-ancestor
24433454|NCT00258388|Mitosis Modulators|mitosis modulators|mesh-ancestor
25038072|NCT03533127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25038073|NCT03533127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25038074|NCT03533127|Growth Substances|growth substances|mesh-ancestor
25038075|NCT03533127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038076|NCT03533127|Growth Inhibitors|growth inhibitors|mesh-ancestor
25038077|NCT03533062|Botulinum Toxins|botulinum toxins|mesh-list
25038078|NCT03533062|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25038079|NCT03533062|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25038080|NCT03533062|Cholinergic Antagonists|cholinergic antagonists|mesh-list
25038081|NCT03533062|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25038082|NCT03533062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25038083|NCT03533062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038084|NCT03533062|Cholinergic Agents|cholinergic agents|mesh-ancestor
25038085|NCT03533062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24994689|NCT03413995|Rucaparib|rucaparib|mesh-list
25038086|NCT03533062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994756|NCT03175978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24994757|NCT03129100|Ixekizumab|ixekizumab|mesh-list
24994758|NCT03129100|Dermatologic Agents|dermatologic agents|mesh-ancestor
24433510|NCT00258622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433667|NCT00259675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433668|NCT00259675|Antiviral Agents|antiviral agents|mesh-ancestor
24433669|NCT00259675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24433670|NCT00259675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433671|NCT00259675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24433983|NCT00261118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433984|NCT00261118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24434098|NCT00261482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434099|NCT00261482|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24434407|NCT00262405|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24434411|NCT00262418|Ivermectin|ivermectin|mesh-list
24434414|NCT00262418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24434415|NCT00262418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434863|NCT00264173|Anticonvulsants|anticonvulsants|mesh-ancestor
24434864|NCT00264173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24994760|NCT03100006|Oregovomab|oregovomab|mesh-list
24994761|NCT03100006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24994762|NCT03100006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994763|NCT03100006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24994764|NCT03100006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622108|NCT01065662|Antifungal Agents|antifungal agents|mesh-ancestor
24622109|NCT01065662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24622110|NCT01065662|Immunologic Factors|immunologic factors|mesh-ancestor
24622111|NCT01065662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622112|NCT01065662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24622113|NCT01065662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622114|NCT01065662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622115|NCT01065701|Dexmedetomidine|dexmedetomidine|mesh-list
24622116|NCT01065701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24622117|NCT01065701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24932686|NCT04077905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24589038|NCT00905229|Coagulants|coagulants|mesh-ancestor
24589039|NCT00905333|Felodipine|felodipine|mesh-list
24589040|NCT00905333|Candesartan|candesartan|mesh-list
24589058|NCT00905528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589059|NCT00905528|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24589060|NCT00905528|Protease Inhibitors|protease inhibitors|mesh-ancestor
24589061|NCT00905528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589062|NCT00905541|Simvastatin|simvastatin|mesh-list
24589063|NCT00905541|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24589064|NCT00905541|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24589065|NCT00905541|Antimetabolites|antimetabolites|mesh-ancestor
24589072|NCT00905684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589073|NCT00905723|Estradiol|estradiol|mesh-list
24954856|NCT03871322|Ergocalciferols|ergocalciferols|mesh-list
24589074|NCT00905723|Estrogens|estrogens|mesh-ancestor
24589075|NCT00905723|Hormones|hormones|mesh-ancestor
24434865|NCT00264173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434866|NCT00264173|GABA Agents|gaba agents|mesh-ancestor
24434867|NCT00264173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25275734|NCT02369822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275735|NCT02369822|Protective Agents|protective agents|mesh-ancestor
25275737|NCT02369549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25275738|NCT02369549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25275739|NCT02369549|Analgesics|analgesics|mesh-ancestor
25275740|NCT02369549|Sensory System Agents|sensory system agents|mesh-ancestor
25275741|NCT02369549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275742|NCT02369549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275743|NCT02369549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25275744|NCT02369549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25275745|NCT02369549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25275746|NCT02369549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275747|NCT02369549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275748|NCT02369523|Bupivacaine|bupivacaine|mesh-list
25275749|NCT02369523|Ropivacaine|ropivacaine|mesh-list
25275750|NCT02369523|Anesthetics, Local|anesthetics, local|mesh-ancestor
25275751|NCT02369523|Anesthetics|anesthetics|mesh-ancestor
25275752|NCT02369523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25275753|NCT02369523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275754|NCT02369523|Sensory System Agents|sensory system agents|mesh-ancestor
25275755|NCT02369523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275756|NCT02369406|Lamivudine|lamivudine|mesh-list
25275757|NCT02369406|Zidovudine|zidovudine|mesh-list
25275758|NCT02369406|Nevirapine|nevirapine|mesh-list
25275759|NCT02369406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25275760|NCT02369406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25275761|NCT02369406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275762|NCT02369406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275763|NCT02369406|Antiviral Agents|antiviral agents|mesh-ancestor
25275764|NCT02369406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25275765|NCT02369406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25038087|NCT03533062|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24563552|NCT00772291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24563761|NCT00773201|Sympatholytics|sympatholytics|mesh-ancestor
24563762|NCT00773201|Autonomic Agents|autonomic agents|mesh-ancestor
25038088|NCT03533062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25038089|NCT03532919|Cystatins|cystatins|mesh-list
25038090|NCT03532919|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25038091|NCT03532919|Protease Inhibitors|protease inhibitors|mesh-ancestor
25038092|NCT03532919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038093|NCT03532919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038094|NCT03532906|Bupivacaine|bupivacaine|mesh-list
25038095|NCT03532906|Anesthetics, Local|anesthetics, local|mesh-ancestor
25038096|NCT03532906|Anesthetics|anesthetics|mesh-ancestor
25038136|NCT03532802|Adrenergic Agents|adrenergic agents|mesh-ancestor
25038097|NCT03532906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25038098|NCT03532906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038099|NCT03532906|Sensory System Agents|sensory system agents|mesh-ancestor
25038100|NCT03532906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25038101|NCT03532867|Tin Fluorides|tin fluorides|mesh-list
25038102|NCT03532867|Cariostatic Agents|cariostatic agents|mesh-ancestor
25038103|NCT03532867|Protective Agents|protective agents|mesh-ancestor
25038104|NCT03532867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038105|NCT03532854|Valsartan|valsartan|mesh-list
25038106|NCT03532854|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25038107|NCT03532854|Ezetimibe|ezetimibe|mesh-list
25038108|NCT03532854|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25038109|NCT03532854|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25038110|NCT03532854|Antimetabolites|antimetabolites|mesh-ancestor
24434902|NCT00264225|Narcotics|narcotics|mesh-ancestor
24435056|NCT00264953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24435057|NCT00264953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435058|NCT00264953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24435080|NCT00265018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24435185|NCT00265408|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24435186|NCT00265408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24435238|NCT00265694|Tubulin Modulators|tubulin modulators|mesh-ancestor
24435239|NCT00265694|Antimitotic Agents|antimitotic agents|mesh-ancestor
24435240|NCT00265694|Mitosis Modulators|mitosis modulators|mesh-ancestor
25692117|NCT01994720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24954905|NCT03870828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275766|NCT02369406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25275768|NCT02369406|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25275769|NCT02369406|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25275770|NCT02369380|Hyaluronic Acid|hyaluronic acid|mesh-list
25275771|NCT02369380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25275772|NCT02369380|Immunologic Factors|immunologic factors|mesh-ancestor
25275773|NCT02369380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275774|NCT02369380|Viscosupplements|viscosupplements|mesh-ancestor
25275775|NCT02369380|Protective Agents|protective agents|mesh-ancestor
25275776|NCT02369133|Acetaminophen|acetaminophen|mesh-list
25275777|NCT02369133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25275778|NCT02369133|Analgesics|analgesics|mesh-ancestor
25275779|NCT02369133|Sensory System Agents|sensory system agents|mesh-ancestor
25275780|NCT02369133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275781|NCT02369133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275782|NCT02369133|Antipyretics|antipyretics|mesh-ancestor
25275783|NCT02369250|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25275784|NCT02369250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25275785|NCT02369250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25275786|NCT02369250|Antimetabolites|antimetabolites|mesh-ancestor
25275787|NCT02369250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275788|NCT02369250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24563763|NCT00773201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275789|NCT02369250|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25275790|NCT02369250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275791|NCT02369146|UB-421|ub-421|mesh-list
24606219|NCT00989508|Vasodilator Agents|vasodilator agents|mesh-ancestor
25038124|NCT03532841|Sensory System Agents|sensory system agents|mesh-ancestor
25038125|NCT03532841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25038127|NCT03532802|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25038128|NCT03532802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25038129|NCT03532802|Sympatholytics|sympatholytics|mesh-ancestor
25038130|NCT03532802|Autonomic Agents|autonomic agents|mesh-ancestor
25038131|NCT03532802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25038132|NCT03532802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038133|NCT03532802|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25038134|NCT03532802|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25038135|NCT03532802|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25038137|NCT03532802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25038138|NCT03532802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038139|NCT03532763|Tocotrienols|tocotrienols|mesh-list
25038140|NCT03532763|Vitamin E|vitamin e|mesh-list
25038141|NCT03532763|Tocopherols|tocopherols|mesh-list
25038142|NCT03532763|Tocovid|tocovid|mesh-list
25038143|NCT03532763|Antioxidants|antioxidants|mesh-ancestor
25038144|NCT03532763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038145|NCT03532763|Protective Agents|protective agents|mesh-ancestor
24435331|NCT00266058|Artemether|artemether|mesh-list
24435418|NCT00266214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435476|NCT00266539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435477|NCT00266539|Analgesics|analgesics|mesh-ancestor
24435478|NCT00266539|Sensory System Agents|sensory system agents|mesh-ancestor
24435479|NCT00266539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24435480|NCT00266539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24435481|NCT00266539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24435482|NCT00266539|Anesthetics, General|anesthetics, general|mesh-ancestor
24435483|NCT00266539|Anesthetics|anesthetics|mesh-ancestor
24435484|NCT00266552|Risperidone|risperidone|mesh-list
24435485|NCT00266552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24435486|NCT00266552|Serotonin Agents|serotonin agents|mesh-ancestor
24435487|NCT00266552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24435488|NCT00266552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435489|NCT00266552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435490|NCT00266552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24435491|NCT00266552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24435523|NCT00266643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435525|NCT00266643|Sensory System Agents|sensory system agents|mesh-ancestor
24435526|NCT00266643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275792|NCT02369146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25275793|NCT02369146|Antiviral Agents|antiviral agents|mesh-ancestor
25275794|NCT02369146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25692118|NCT01994720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25275795|NCT02369081|Bisoprolol|bisoprolol|mesh-list
25275796|NCT02369081|Doxazosin|doxazosin|mesh-list
25275797|NCT02369081|Spironolactone|spironolactone|mesh-list
25275798|NCT02369081|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25275799|NCT02369081|Hormone Antagonists|hormone antagonists|mesh-ancestor
25275800|NCT02369081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25275801|NCT02369081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275802|NCT02369081|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25275803|NCT02369081|Diuretics|diuretics|mesh-ancestor
25275804|NCT02369081|Natriuretic Agents|natriuretic agents|mesh-ancestor
25275805|NCT02369081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25275806|NCT02369081|Sympatholytics|sympatholytics|mesh-ancestor
25275807|NCT02369081|Autonomic Agents|autonomic agents|mesh-ancestor
25275808|NCT02369081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275809|NCT02369081|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25275810|NCT02369081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25275811|NCT02369081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25275812|NCT02369081|Adrenergic Agents|adrenergic agents|mesh-ancestor
25275813|NCT02369081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24993695|NCT05415254|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24993696|NCT05415254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24993697|NCT05415254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993698|NCT05415254|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24993699|NCT05415254|Vitamins|vitamins|mesh-ancestor
25038146|NCT03532763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038147|NCT03532763|Vitamins|vitamins|mesh-ancestor
25038148|NCT03532763|Micronutrients|micronutrients|mesh-ancestor
25038149|NCT03532737|Pembrolizumab|pembrolizumab|mesh-list
25038150|NCT03532737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25038151|NCT03532737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038152|NCT03532711|Leucovorin|leucovorin|mesh-list
25038153|NCT03532711|Fluorouracil|fluorouracil|mesh-list
25038154|NCT03532711|Capecitabine|capecitabine|mesh-list
25038155|NCT03532711|Oxaliplatin|oxaliplatin|mesh-list
25275814|NCT02369081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275815|NCT02369081|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25275816|NCT02369081|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25038156|NCT03532711|Irinotecan|irinotecan|mesh-list
25038157|NCT03532711|Levoleucovorin|levoleucovorin|mesh-list
25038158|NCT03532711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038159|NCT03532711|Antimetabolites|antimetabolites|mesh-ancestor
25038160|NCT03532711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038161|NCT03532711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25038162|NCT03532711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038163|NCT03532711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25038164|NCT03532711|Immunologic Factors|immunologic factors|mesh-ancestor
25038165|NCT03532711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25038232|NCT05262465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038233|NCT05262452|Folfirinox|folfirinox|mesh-list
25038234|NCT05262452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038235|NCT05262413|Lenvatinib|lenvatinib|mesh-list
25038236|NCT05262413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038237|NCT05262413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25038238|NCT05262413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038239|NCT05262413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038240|NCT05262335|Paclitaxel|paclitaxel|mesh-list
25038241|NCT05262335|Docetaxel|docetaxel|mesh-list
25038242|NCT05262335|Capecitabine|capecitabine|mesh-list
25038243|NCT05262335|Oxaliplatin|oxaliplatin|mesh-list
25275862|NCT02368795|Diuretics|diuretics|mesh-ancestor
25038244|NCT05262335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25038245|NCT05262335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038246|NCT05262335|Tubulin Modulators|tubulin modulators|mesh-ancestor
25038247|NCT05262335|Antimitotic Agents|antimitotic agents|mesh-ancestor
25038248|NCT05262335|Mitosis Modulators|mitosis modulators|mesh-ancestor
25038249|NCT05262335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038250|NCT05262335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25038251|NCT05262335|Antimetabolites|antimetabolites|mesh-ancestor
25038252|NCT05262166|Dexmedetomidine|dexmedetomidine|mesh-list
25038253|NCT05262166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25038254|NCT05262166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25038255|NCT05262166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038256|NCT05262166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24994841|NCT02142738|Gemcitabine|gemcitabine|mesh-list
25038257|NCT05262166|Analgesics|analgesics|mesh-ancestor
24435527|NCT00266643|Antidepressive Agents|antidepressive agents|mesh-ancestor
24435528|NCT00266643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24435539|NCT00266747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24435584|NCT00267176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24435585|NCT00267176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435586|NCT00267176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24435820|NCT00268255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435821|NCT00268333|Leucovorin|leucovorin|mesh-list
24435822|NCT00268333|Fluorouracil|fluorouracil|mesh-list
24435823|NCT00268333|Oxaliplatin|oxaliplatin|mesh-list
25275817|NCT02368860|Capecitabine|capecitabine|mesh-list
25275818|NCT02368860|Oxaliplatin|oxaliplatin|mesh-list
25275819|NCT02368860|Irinotecan|irinotecan|mesh-list
25275820|NCT02368860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25275821|NCT02368860|Antimetabolites|antimetabolites|mesh-ancestor
25275822|NCT02368860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275823|NCT02368860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25275824|NCT02368860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25275825|NCT02368860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25275826|NCT02368860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275827|NCT02368730|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25275828|NCT02368730|Hemostatics|hemostatics|mesh-ancestor
25275829|NCT02368730|Coagulants|coagulants|mesh-ancestor
25275830|NCT02368730|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25275831|NCT02368730|Natriuretic Agents|natriuretic agents|mesh-ancestor
25275832|NCT02368730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275833|NCT02368964|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25275834|NCT02368964|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25275835|NCT02368964|Luteolytic Agents|luteolytic agents|mesh-ancestor
25275836|NCT02368964|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25275837|NCT02368964|Contraceptive Agents|contraceptive agents|mesh-ancestor
25275838|NCT02368964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25275839|NCT02368964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275840|NCT02368964|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25275841|NCT02368964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25275842|NCT02368964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25275843|NCT02368795|Indomethacin|indomethacin|mesh-list
25038271|NCT05261997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038272|NCT05261997|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24435824|NCT00268333|Calcium|calcium|mesh-list
24435825|NCT00268333|Levoleucovorin|levoleucovorin|mesh-list
24435826|NCT00268333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24435827|NCT00268333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435828|NCT00268333|Antimetabolites|antimetabolites|mesh-ancestor
25275847|NCT02368795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25275848|NCT02368795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25275849|NCT02368795|Analgesics|analgesics|mesh-ancestor
25275850|NCT02368795|Sensory System Agents|sensory system agents|mesh-ancestor
25275851|NCT02368795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275852|NCT02368795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275853|NCT02368795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25275854|NCT02368795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25275855|NCT02368795|Gout Suppressants|gout suppressants|mesh-ancestor
25275856|NCT02368795|Tocolytic Agents|tocolytic agents|mesh-ancestor
25275857|NCT02368795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25275858|NCT02368795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25275859|NCT02368795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275860|NCT02368795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275861|NCT02368795|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25275863|NCT02368795|Natriuretic Agents|natriuretic agents|mesh-ancestor
25275864|NCT02368795|Vasodilator Agents|vasodilator agents|mesh-ancestor
25275865|NCT02368795|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25275866|NCT02368717|Mesalamine|mesalamine|mesh-list
25275867|NCT02368717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25275868|NCT02368717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25275869|NCT02368717|Analgesics|analgesics|mesh-ancestor
25275870|NCT02368717|Sensory System Agents|sensory system agents|mesh-ancestor
25275871|NCT02368717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275872|NCT02368717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275873|NCT02368717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25275874|NCT02368717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25275875|NCT02368743|Mesalamine|mesalamine|mesh-list
25275876|NCT02368743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25275877|NCT02368743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25275881|NCT02368743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038273|NCT05261997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24954952|NCT03870256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24954953|NCT03870256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910239|NCT04301336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24910240|NCT04301336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910241|NCT04301336|Analgesics|analgesics|mesh-ancestor
24519767|NCT05177614|Micronutrients|micronutrients|mesh-list
25038300|NCT05241496|Anesthetics, Local|anesthetics, local|mesh-ancestor
25038301|NCT05241496|Anesthetics|anesthetics|mesh-ancestor
25038302|NCT05241496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25038303|NCT05241496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038304|NCT05241496|Sensory System Agents|sensory system agents|mesh-ancestor
25038305|NCT05241496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25038306|NCT05241496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25038307|NCT05241496|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25038308|NCT05241496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25038309|NCT05241496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25038310|NCT05241496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038311|NCT05229614|Pembrolizumab|pembrolizumab|mesh-list
25038312|NCT05229614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25038313|NCT05229614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038314|NCT05224401|Amoxicillin|amoxicillin|mesh-list
25038315|NCT05224401|Ciprofloxacin|ciprofloxacin|mesh-list
25038316|NCT05224401|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25038317|NCT05224401|Clavulanic Acids|clavulanic acids|mesh-list
25038318|NCT05224401|Clavulanic Acid|clavulanic acid|mesh-list
25038319|NCT05224401|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
25038320|NCT05224401|Trimethoprim|trimethoprim|mesh-list
25038321|NCT05224401|Sulfamethoxazole|sulfamethoxazole|mesh-list
25038322|NCT05224401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25038340|NCT05223101|Telmisartan|telmisartan|mesh-list
25275882|NCT02368743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25275883|NCT02368743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25275885|NCT02368665|Candesartan|candesartan|mesh-list
25275886|NCT02368665|Candesartan cilexetil|candesartan cilexetil|mesh-list
25275887|NCT02368665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25275888|NCT02368665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25275889|NCT02368665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25275890|NCT02368665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275891|NCT02368665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25275892|NCT02368665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275893|NCT02368665|Vasodilator Agents|vasodilator agents|mesh-ancestor
25275894|NCT02368665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25275895|NCT02368665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25275896|NCT02368652|Amlodipine|amlodipine|mesh-list
25275897|NCT02368652|Candesartan|candesartan|mesh-list
25275898|NCT02368652|Candesartan cilexetil|candesartan cilexetil|mesh-list
25275899|NCT02368652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25275900|NCT02368652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25275901|NCT02368652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25275902|NCT02368652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275903|NCT02368652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25275904|NCT02368652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275905|NCT02368652|Vasodilator Agents|vasodilator agents|mesh-ancestor
25275906|NCT02368652|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25275907|NCT02368652|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25275908|NCT02368470|Gemifloxacin|gemifloxacin|mesh-list
25275909|NCT02368470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25275910|NCT02368470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25275911|NCT02368470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275912|NCT02368470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275913|NCT02368470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25275914|NCT02368470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25692119|NCT01994720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25692120|NCT01994720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25692121|NCT01994720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692122|NCT01994720|Antipyretics|antipyretics|mesh-ancestor
25692123|NCT01994746|Glucagon|glucagon|mesh-list
25692124|NCT01994746|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25692125|NCT01994746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25692126|NCT01994746|Hormones|hormones|mesh-ancestor
25692127|NCT01994746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24954986|NCT03869931|Fenofibrate|fenofibrate|mesh-list
24954987|NCT03869931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24954988|NCT03869931|Antimetabolites|antimetabolites|mesh-ancestor
24954989|NCT03869931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954991|NCT03869762|Denosumab|denosumab|mesh-list
25275915|NCT02368470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25275916|NCT02368561|Hyaluronic Acid|hyaluronic acid|mesh-list
25275918|NCT02368561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25275919|NCT02368561|Immunologic Factors|immunologic factors|mesh-ancestor
25275920|NCT02368561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275921|NCT02368561|Viscosupplements|viscosupplements|mesh-ancestor
25275922|NCT02368561|Protective Agents|protective agents|mesh-ancestor
25275923|NCT02368288|Entecavir|entecavir|mesh-list
25038361|NCT05197439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25038362|NCT05197439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038363|NCT05197439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25038364|NCT05197439|Analgesics|analgesics|mesh-ancestor
25038365|NCT05197439|Sensory System Agents|sensory system agents|mesh-ancestor
25038366|NCT05197439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25038367|NCT05197439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25038368|NCT05197439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25038369|NCT05197439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25038370|NCT05197439|Adrenergic Agents|adrenergic agents|mesh-ancestor
25038371|NCT05197439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25038372|NCT05197439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038373|NCT05195775|Tadalafil|tadalafil|mesh-list
25038374|NCT05195775|Vasodilator Agents|vasodilator agents|mesh-ancestor
25038375|NCT05195775|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25038376|NCT05195775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25038377|NCT05195775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038378|NCT05195775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606575|NCT00990990|Linezolid|linezolid|mesh-list
25038412|NCT05175001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25038413|NCT05175001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038414|NCT05175001|Sensory System Agents|sensory system agents|mesh-ancestor
25038415|NCT05175001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25038416|NCT05175001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25038417|NCT05175001|Glucocorticoids|glucocorticoids|mesh-ancestor
24435829|NCT00268333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435830|NCT00268333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24435831|NCT00268333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435832|NCT00268333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24435833|NCT00268333|Immunologic Factors|immunologic factors|mesh-ancestor
24435834|NCT00268333|Antidotes|antidotes|mesh-ancestor
24435835|NCT00268333|Protective Agents|protective agents|mesh-ancestor
24435836|NCT00268333|Vitamin B Complex|vitamin b complex|mesh-ancestor
24435837|NCT00268333|Vitamins|vitamins|mesh-ancestor
24435838|NCT00268333|Micronutrients|micronutrients|mesh-ancestor
24435839|NCT00268359|Bevacizumab|bevacizumab|mesh-list
24435865|NCT00268398|Folic Acid|folic acid|mesh-list
24435866|NCT00268398|Fluorouracil|fluorouracil|mesh-list
24435867|NCT00268398|Oxaliplatin|oxaliplatin|mesh-list
24435889|NCT00268411|Antimetabolites|antimetabolites|mesh-ancestor
24435890|NCT00268411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275927|NCT02368171|Carbon Monoxide|carbon monoxide|mesh-list
25275928|NCT02368171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25275929|NCT02368171|Autonomic Agents|autonomic agents|mesh-ancestor
25275930|NCT02368171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275931|NCT02368171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275932|NCT02368171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25275933|NCT02368171|Respiratory System Agents|respiratory system agents|mesh-ancestor
25275934|NCT02368171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25275935|NCT02368171|Antioxidants|antioxidants|mesh-ancestor
25275936|NCT02368171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275937|NCT02368171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25275938|NCT02368171|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25275939|NCT02368171|Vasodilator Agents|vasodilator agents|mesh-ancestor
25275940|NCT02368171|Gasotransmitters|gasotransmitters|mesh-ancestor
25275941|NCT02368171|Protective Agents|protective agents|mesh-ancestor
25275942|NCT02368171|Antimetabolites|antimetabolites|mesh-ancestor
25275943|NCT02368054|Epinephrine|epinephrine|mesh-list
25692128|NCT01994746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692129|NCT01994746|Incretins|incretins|mesh-ancestor
25692130|NCT01994837|Venetoclax|venetoclax|mesh-list
25692131|NCT01994837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25692132|NCT01994850|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25275946|NCT02368054|Epinephryl borate|epinephryl borate|mesh-list
25275947|NCT02368054|Anesthetics, Local|anesthetics, local|mesh-ancestor
25275948|NCT02368054|Anesthetics|anesthetics|mesh-ancestor
25275949|NCT02368054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25275950|NCT02368054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275951|NCT02368054|Sensory System Agents|sensory system agents|mesh-ancestor
25275952|NCT02368054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25275953|NCT02368054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25275954|NCT02368054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25275955|NCT02368054|Adrenergic Agents|adrenergic agents|mesh-ancestor
25275958|NCT02368054|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25275959|NCT02368054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25275960|NCT02368054|Autonomic Agents|autonomic agents|mesh-ancestor
25275961|NCT02368054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25275962|NCT02368054|Respiratory System Agents|respiratory system agents|mesh-ancestor
25275963|NCT02368054|Mydriatics|mydriatics|mesh-ancestor
25275964|NCT02368054|Sympathomimetics|sympathomimetics|mesh-ancestor
25275965|NCT02368054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25275967|NCT02368379|Antimetabolites|antimetabolites|mesh-ancestor
25275968|NCT02368379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275969|NCT02368379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25275970|NCT02368015|Cefazolin|cefazolin|mesh-list
25275971|NCT02368015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25275972|NCT02368015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25275973|NCT02368197|Paclitaxel|paclitaxel|mesh-list
25275974|NCT02368197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25275975|NCT02368197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25275976|NCT02368197|Tubulin Modulators|tubulin modulators|mesh-ancestor
25275977|NCT02368197|Antimitotic Agents|antimitotic agents|mesh-ancestor
25275978|NCT02368197|Mitosis Modulators|mitosis modulators|mesh-ancestor
25275979|NCT02368197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25275980|NCT02368249|Terlipressin|terlipressin|mesh-list
25275981|NCT02368249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25275982|NCT02368249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25275983|NCT02367937|Flurbiprofen|flurbiprofen|mesh-list
25275984|NCT02367937|Midazolam|midazolam|mesh-list
25275985|NCT02367937|Omeprazole|omeprazole|mesh-list
25275986|NCT02367937|Simvastatin|simvastatin|mesh-list
25275987|NCT02367937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25275988|NCT02367937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25275989|NCT02367937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25275990|NCT02367937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275991|NCT02367937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25275992|NCT02367937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25275993|NCT02367937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25275994|NCT02367937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25275995|NCT02367937|Anesthetics, General|anesthetics, general|mesh-ancestor
25038478|NCT05092841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25038482|NCT05079217|Immunologic Factors|immunologic factors|mesh-ancestor
25038483|NCT05079217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038484|NCT05057130|Cisplatin|cisplatin|mesh-list
25038485|NCT05057130|Doxorubicin|doxorubicin|mesh-list
25038486|NCT05057130|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25038487|NCT05057130|Methotrexate|methotrexate|mesh-list
25038488|NCT05057130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038489|NCT05057130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25038490|NCT05057130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25038491|NCT05057130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25038492|NCT05057130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038493|NCT05057130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038494|NCT05057130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25038495|NCT05057130|Abortifacient Agents|abortifacient agents|mesh-ancestor
25038496|NCT05057130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24435891|NCT00268411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435892|NCT00268411|Antiviral Agents|antiviral agents|mesh-ancestor
24435893|NCT00268411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24435894|NCT00268411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435911|NCT00268515|Cyclosporine|cyclosporine|mesh-list
24435912|NCT00268515|Prednisone|prednisone|mesh-list
24435913|NCT00268515|Azathioprine|azathioprine|mesh-list
24435914|NCT00268515|Tacrolimus|tacrolimus|mesh-list
24435972|NCT00268567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435973|NCT00268567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435974|NCT00268567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404880|NCT03646188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24435999|NCT00268632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436000|NCT00268632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24436001|NCT00268632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436002|NCT00268632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24436003|NCT00268645|Insulin Glargine|insulin glargine|mesh-list
24436004|NCT00268645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24436005|NCT00268645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436292|NCT00269672|Immunologic Factors|immunologic factors|mesh-ancestor
24436293|NCT00269672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436294|NCT00269685|Vasopressins|vasopressins|mesh-list
24436295|NCT00269685|Arginine Vasopressin|arginine vasopressin|mesh-list
24436296|NCT00269685|Hemostatics|hemostatics|mesh-ancestor
24436297|NCT00269685|Coagulants|coagulants|mesh-ancestor
24436298|NCT00269685|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24436299|NCT00269685|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24436300|NCT00269685|Natriuretic Agents|natriuretic agents|mesh-ancestor
24436301|NCT00269685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436303|NCT00269724|Parasympatholytics|parasympatholytics|mesh-ancestor
24436304|NCT00269724|Autonomic Agents|autonomic agents|mesh-ancestor
24436305|NCT00269724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24436306|NCT00269724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25275996|NCT02367937|Anesthetics|anesthetics|mesh-ancestor
25275997|NCT02367937|GABA Modulators|gaba modulators|mesh-ancestor
25275998|NCT02367937|GABA Agents|gaba agents|mesh-ancestor
25275999|NCT02367937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25276000|NCT02367937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276001|NCT02367937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25276002|NCT02367937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25276003|NCT02367937|Antimetabolites|antimetabolites|mesh-ancestor
25276004|NCT02367937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25276005|NCT02367937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25276006|NCT02367937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25276007|NCT02367937|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25276008|NCT02367937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25276009|NCT02367937|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25276010|NCT02367937|Analgesics|analgesics|mesh-ancestor
25276011|NCT02367937|Sensory System Agents|sensory system agents|mesh-ancestor
25276012|NCT02367937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25276013|NCT02367937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25276014|NCT02367937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25276015|NCT02367937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25038497|NCT05057130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038498|NCT05057130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25038499|NCT05057130|Antimetabolites|antimetabolites|mesh-ancestor
25038500|NCT05057130|Dermatologic Agents|dermatologic agents|mesh-ancestor
25038501|NCT05057130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25038502|NCT05057130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25038503|NCT05057130|Immunologic Factors|immunologic factors|mesh-ancestor
24995262|NCT05416957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24995263|NCT05416957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24995264|NCT05416957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995265|NCT05416957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24995266|NCT05416957|Serotonin Agents|serotonin agents|mesh-ancestor
24995267|NCT05416957|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24589094|NCT00905814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589095|NCT00905853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
24589096|NCT00905853|Amiodarone|amiodarone|mesh-list
24589097|NCT00905853|Vasodilator Agents|vasodilator agents|mesh-ancestor
24589098|NCT00905853|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24589099|NCT00905853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24589100|NCT00905853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589101|NCT00905853|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24589102|NCT00905853|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24589103|NCT00905853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24436307|NCT00269724|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24436308|NCT00269724|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24436313|NCT00269737|Fentanyl|fentanyl|mesh-list
24436436|NCT00269906|Abciximab|abciximab|mesh-list
24436437|NCT00269906|Anticoagulants|anticoagulants|mesh-ancestor
24436438|NCT00269906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24436439|NCT00269932|Levofloxacin|levofloxacin|mesh-list
24436440|NCT00269932|Ofloxacin|ofloxacin|mesh-list
24436441|NCT00269932|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25692709|NCT02004093|Antiviral Agents|antiviral agents|mesh-ancestor
24819140|NCT02093598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24436442|NCT00269932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24436443|NCT00269932|Renal Agents|renal agents|mesh-ancestor
24436444|NCT00269932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24436495|NCT00270270|Hematinics|hematinics|mesh-ancestor
24436496|NCT00270283|Epoetin Alfa|epoetin alfa|mesh-list
24436497|NCT00270283|Hematinics|hematinics|mesh-ancestor
24436498|NCT00270322|Fentanyl|fentanyl|mesh-list
24436499|NCT00270322|Morphine|morphine|mesh-list
24436500|NCT00270322|Bupivacaine|bupivacaine|mesh-list
24436501|NCT00270322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24436513|NCT00270335|Propofol|propofol|mesh-list
24436522|NCT00270348|Hormones|hormones|mesh-ancestor
25276049|NCT02367755|GABA Modulators|gaba modulators|mesh-ancestor
24436523|NCT00270348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24436525|NCT00270348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24436526|NCT00270361|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24436527|NCT00270361|Natriuretic Agents|natriuretic agents|mesh-ancestor
24436528|NCT00270361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276016|NCT02367937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25276017|NCT02367937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25276018|NCT02367924|Trabectedin|trabectedin|mesh-list
25276019|NCT02367924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25276020|NCT02367924|Alkylating Agents|alkylating agents|mesh-ancestor
25276021|NCT02367924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276022|NCT02367924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25276023|NCT02367807|Tenofovir|tenofovir|mesh-list
25276024|NCT02367807|Emtricitabine|emtricitabine|mesh-list
25276025|NCT02367807|Antiviral Agents|antiviral agents|mesh-ancestor
25276026|NCT02367807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25276027|NCT02367807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25276028|NCT02367807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25276029|NCT02367807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25276030|NCT02367807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276031|NCT02367807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25276032|NCT02367807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25276033|NCT02367755|Lorazepam|lorazepam|mesh-list
25276034|NCT02367755|Propofol|propofol|mesh-list
25276035|NCT02367755|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25276036|NCT02367755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25276037|NCT02367755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276038|NCT02367755|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25276039|NCT02367755|Anesthetics, General|anesthetics, general|mesh-ancestor
25276040|NCT02367755|Anesthetics|anesthetics|mesh-ancestor
24589104|NCT00905853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589105|NCT00905853|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24589106|NCT00905853|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24589107|NCT00905853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24589109|NCT00905905|Ezetimibe|ezetimibe|mesh-list
24589114|NCT00905905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589115|NCT00905905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24606830|NCT05408000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038525|NCT05041062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038527|NCT05030519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25038528|NCT05030519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038534|NCT04983589|Pilocarpine|pilocarpine|mesh-list
25038536|NCT04983589|Autonomic Agents|autonomic agents|mesh-ancestor
25038537|NCT04983589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25038538|NCT04983589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038539|NCT04983589|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25038540|NCT04983589|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24564556|NCT00776724|Tubulin Modulators|tubulin modulators|mesh-ancestor
24436529|NCT00270374|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24436588|NCT00270543|Fluorouracil|fluorouracil|mesh-list
24436589|NCT00270543|Docetaxel|docetaxel|mesh-list
24436590|NCT00270543|Antimetabolites|antimetabolites|mesh-ancestor
24436591|NCT00270543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436592|NCT00270543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24436659|NCT00270777|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24436710|NCT00270907|Antiviral Agents|antiviral agents|mesh-ancestor
24436711|NCT00270907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24436712|NCT00270907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24436713|NCT00270907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24436719|NCT00271063|Annamycin|annamycin|mesh-list
25692133|NCT01994850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24436725|NCT00271206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24436726|NCT00271206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436760|NCT00271323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24436761|NCT00271323|Tubulin Modulators|tubulin modulators|mesh-ancestor
25276042|NCT02367755|Antiemetics|antiemetics|mesh-ancestor
25276043|NCT02367755|Autonomic Agents|autonomic agents|mesh-ancestor
25276044|NCT02367755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25276045|NCT02367755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25276046|NCT02367755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25276047|NCT02367755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25276048|NCT02367755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25276051|NCT02367755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25276052|NCT02367755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276054|NCT02367664|Immunologic Factors|immunologic factors|mesh-ancestor
25276055|NCT02367664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276056|NCT02367560|Methylprednisolone|methylprednisolone|mesh-list
25276057|NCT02367560|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25276058|NCT02367560|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25276059|NCT02367560|Prednisolone|prednisolone|mesh-list
25276060|NCT02367560|Prednisolone acetate|prednisolone acetate|mesh-list
25276061|NCT02367560|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25276062|NCT02367560|Prednisolone phosphate|prednisolone phosphate|mesh-list
25276063|NCT02367560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25276064|NCT02367560|Antiemetics|antiemetics|mesh-ancestor
25276065|NCT02367560|Autonomic Agents|autonomic agents|mesh-ancestor
25276066|NCT02367560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25276067|NCT02367560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276068|NCT02367560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25276069|NCT02367560|Glucocorticoids|glucocorticoids|mesh-ancestor
25276070|NCT02367560|Hormones|hormones|mesh-ancestor
25038541|NCT04983589|Cholinergic Agents|cholinergic agents|mesh-ancestor
25038542|NCT04983589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25038543|NCT04983589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038561|NCT04943445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25038563|NCT04943445|Tubulin Modulators|tubulin modulators|mesh-ancestor
25038564|NCT04943445|Antimitotic Agents|antimitotic agents|mesh-ancestor
25038589|NCT04907214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038590|NCT04907214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25038591|NCT04907214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038593|NCT04907071|Keratolytic Agents|keratolytic agents|mesh-ancestor
25038594|NCT04907071|Dermatologic Agents|dermatologic agents|mesh-ancestor
25038595|NCT04873583|Methylprednisolone|methylprednisolone|mesh-list
25038596|NCT04873583|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25038597|NCT04873583|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25038598|NCT04873583|Prednisolone|prednisolone|mesh-list
25038599|NCT04873583|Prednisolone acetate|prednisolone acetate|mesh-list
25038600|NCT04873583|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25038601|NCT04873583|Prednisolone phosphate|prednisolone phosphate|mesh-list
25038637|NCT04779554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25276071|NCT02367560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25276072|NCT02367560|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25276073|NCT02367560|Protective Agents|protective agents|mesh-ancestor
25276074|NCT02367560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25276075|NCT02367560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25276076|NCT02367547|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25276077|NCT02367547|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
25276078|NCT02367547|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25276079|NCT02367547|Dermatologic Agents|dermatologic agents|mesh-ancestor
25276080|NCT02367196|Rituximab|rituximab|mesh-list
25276081|NCT02367196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25276082|NCT02367196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25276083|NCT02367196|Immunologic Factors|immunologic factors|mesh-ancestor
25276084|NCT02367196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276085|NCT02367196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25038640|NCT04779554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25038641|NCT04779554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038642|NCT04772248|Adalimumab|adalimumab|mesh-list
25038643|NCT04772248|Etanercept|etanercept|mesh-list
25038644|NCT04772248|Golimumab|golimumab|mesh-list
25038645|NCT04772248|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
25038646|NCT04772248|Infliximab|infliximab|mesh-list
25038647|NCT04772248|Certolizumab Pegol|certolizumab pegol|mesh-list
25038648|NCT04772248|Tofacitinib|tofacitinib|mesh-list
25038649|NCT04772248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25038650|NCT04772248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25692134|NCT01994850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25692135|NCT01994993|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25692136|NCT01994993|Metronidazole|metronidazole|mesh-list
25692137|NCT01994993|Clindamycin|clindamycin|mesh-list
25692138|NCT01994993|Clindamycin palmitate|clindamycin palmitate|mesh-list
25692139|NCT01994993|Clindamycin phosphate|clindamycin phosphate|mesh-list
25692140|NCT01994993|Gentamicins|gentamicins|mesh-list
25692142|NCT01994993|Piperacillin|piperacillin|mesh-list
25038651|NCT04772248|Dermatologic Agents|dermatologic agents|mesh-ancestor
25038652|NCT04772248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25038653|NCT04772248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25038654|NCT04772248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25038655|NCT04772248|Analgesics|analgesics|mesh-ancestor
25038656|NCT04772248|Sensory System Agents|sensory system agents|mesh-ancestor
25038657|NCT04772248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24570115|NCT00803374|Ipilimumab|ipilimumab|mesh-list
25038658|NCT04772248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038659|NCT04772248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25038660|NCT04772248|Immunologic Factors|immunologic factors|mesh-ancestor
25038661|NCT04772248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25038662|NCT04772248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038663|NCT04772248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038691|NCT04676555|Immunologic Factors|immunologic factors|mesh-ancestor
25038692|NCT04676555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038694|NCT04634799|Plasminogen Inactivators|plasminogen inactivators|mesh-list
25038695|NCT04634799|Plasminogen Activator Inhibitor 1|plasminogen activator inhibitor 1|mesh-list
25276087|NCT02367404|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25276088|NCT02367404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25276089|NCT02367404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25276090|NCT02367404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276091|NCT02367404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25276092|NCT02367404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276093|NCT02367404|Analgesics|analgesics|mesh-ancestor
25276094|NCT02367404|Sensory System Agents|sensory system agents|mesh-ancestor
25276095|NCT02367404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25276096|NCT02367404|Antidepressive Agents|antidepressive agents|mesh-ancestor
25276097|NCT02367404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25276098|NCT02367404|Dopamine Agents|dopamine agents|mesh-ancestor
25276099|NCT02367248|Deferoxamine|deferoxamine|mesh-list
25276100|NCT02367248|Siderophores|siderophores|mesh-ancestor
25276101|NCT02367248|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25276102|NCT02367248|Chelating Agents|chelating agents|mesh-ancestor
25276103|NCT02367248|Sequestering Agents|sequestering agents|mesh-ancestor
25276104|NCT02367248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276105|NCT02367027|Rivaroxaban|rivaroxaban|mesh-list
25276106|NCT02367027|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25276107|NCT02367027|Antithrombins|antithrombins|mesh-ancestor
25276108|NCT02367027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25276109|NCT02367027|Protease Inhibitors|protease inhibitors|mesh-ancestor
25276110|NCT02367027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25276111|NCT02367027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276112|NCT02367027|Anticoagulants|anticoagulants|mesh-ancestor
25276113|NCT02367053|Glucagon|glucagon|mesh-list
25276114|NCT02367053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25276115|NCT02367053|Hormones|hormones|mesh-ancestor
25276116|NCT02367053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25276117|NCT02367053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276118|NCT02366884|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25276119|NCT02366884|Antifungal Agents|antifungal agents|mesh-list
25276120|NCT02366884|Clotrimazole|clotrimazole|mesh-list
25276121|NCT02366884|Miconazole|miconazole|mesh-list
25276122|NCT02366884|Antiprotozoal Agents|antiprotozoal agents|mesh-list
25276123|NCT02366884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25276124|NCT02366884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25276125|NCT02366884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25038707|NCT04624776|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25038708|NCT04624776|Prednisolone phosphate|prednisolone phosphate|mesh-list
25038709|NCT04624776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25038710|NCT04624776|Antiemetics|antiemetics|mesh-ancestor
25038711|NCT04624776|Autonomic Agents|autonomic agents|mesh-ancestor
25692143|NCT01994993|Ampicillin|ampicillin|mesh-list
25692144|NCT01994993|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25692145|NCT01994993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25692146|NCT01994993|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25038712|NCT04624776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25038713|NCT04624776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038714|NCT04624776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25038715|NCT04624776|Glucocorticoids|glucocorticoids|mesh-ancestor
24607106|NCT05213481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25038737|NCT04581473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25038738|NCT04581473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25038739|NCT04581473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038740|NCT04581473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25038741|NCT04554693|Metronidazole|metronidazole|mesh-list
25038742|NCT04554693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25038743|NCT04554693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25038744|NCT04554693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25038745|NCT04554693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25038752|NCT04544202|Trametinib|trametinib|mesh-list
25038753|NCT04544202|Dabrafenib|dabrafenib|mesh-list
25038754|NCT04544202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038755|NCT04544202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25038756|NCT04544202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038757|NCT04544202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038758|NCT04542408|Heparin|heparin|mesh-list
25038759|NCT04542408|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25038760|NCT04542408|Tinzaparin|tinzaparin|mesh-list
24436771|NCT00271336|Protective Agents|protective agents|mesh-ancestor
25276127|NCT02366884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25276128|NCT02366884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276129|NCT02366884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25276130|NCT02366884|Hormone Antagonists|hormone antagonists|mesh-ancestor
25276131|NCT02366884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25276132|NCT02366884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276133|NCT02366884|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25276134|NCT02366884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25276135|NCT02366884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25276136|NCT02366975|Testosterone|testosterone|mesh-list
25276137|NCT02366975|Androgens|androgens|mesh-ancestor
25276138|NCT02366975|Hormones|hormones|mesh-ancestor
25276139|NCT02366975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25276140|NCT02366975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276141|NCT02367118|Prednisone|prednisone|mesh-list
25276142|NCT02367118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25276143|NCT02367118|Glucocorticoids|glucocorticoids|mesh-ancestor
25276144|NCT02367118|Hormones|hormones|mesh-ancestor
25276145|NCT02367118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25276146|NCT02367118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276147|NCT02367118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25276148|NCT02367118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25276149|NCT02366949|Paclitaxel|paclitaxel|mesh-list
25276150|NCT02366949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25276151|NCT02366949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25276152|NCT02366949|Tubulin Modulators|tubulin modulators|mesh-ancestor
25276153|NCT02366949|Antimitotic Agents|antimitotic agents|mesh-ancestor
25276154|NCT02366949|Mitosis Modulators|mitosis modulators|mesh-ancestor
25276155|NCT02366949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276156|NCT02366546|Cyclophosphamide|cyclophosphamide|mesh-list
25276157|NCT02366546|Fludarabine|fludarabine|mesh-list
25276158|NCT02366546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25276159|NCT02366546|Immunologic Factors|immunologic factors|mesh-ancestor
25276160|NCT02366546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276161|NCT02366546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25276162|NCT02366546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25276163|NCT02366546|Alkylating Agents|alkylating agents|mesh-ancestor
25276164|NCT02366546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038769|NCT04542408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25038770|NCT04542408|Protease Inhibitors|protease inhibitors|mesh-ancestor
25038771|NCT04542408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038772|NCT04530383|Metformin|metformin|mesh-list
24995493|NCT05134363|Sensory System Agents|sensory system agents|mesh-ancestor
24995494|NCT05134363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24995495|NCT05134363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24995496|NCT05134363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24995497|NCT05134363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24995498|NCT05134363|Adrenergic Agents|adrenergic agents|mesh-ancestor
24995499|NCT05134363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24995500|NCT05134363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933442|NCT04070495|Clarithromycin|clarithromycin|mesh-list
24589121|NCT00905918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589122|NCT00905918|Antioxidants|antioxidants|mesh-ancestor
24589123|NCT00905918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589124|NCT00905918|Protective Agents|protective agents|mesh-ancestor
24589125|NCT00905931|Lycopene|lycopene|mesh-list
24589126|NCT00905931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24589127|NCT00905931|Antioxidants|antioxidants|mesh-ancestor
24589148|NCT00905983|Mitosis Modulators|mitosis modulators|mesh-ancestor
24589149|NCT00905996|Propranolol|propranolol|mesh-list
24589150|NCT00905996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24589151|NCT00905996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24589152|NCT00905996|Adrenergic Agents|adrenergic agents|mesh-ancestor
24436764|NCT00271323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436765|NCT00271336|Pentoxifylline|pentoxifylline|mesh-list
24436766|NCT00271336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24436767|NCT00271336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24436768|NCT00271336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436769|NCT00271336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24436770|NCT00271336|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24436774|NCT00271336|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24436775|NCT00271336|Antioxidants|antioxidants|mesh-ancestor
24436855|NCT00271583|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24436857|NCT00271583|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24436867|NCT00271713|Ergocalciferols|ergocalciferols|mesh-list
24436868|NCT00271713|Cholecalciferol|cholecalciferol|mesh-list
24436869|NCT00271713|Ibandronic Acid|ibandronic acid|mesh-list
25276165|NCT02366546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25276166|NCT02366546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25276167|NCT02366676|Hyaluronic Acid|hyaluronic acid|mesh-list
25276168|NCT02366676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25276169|NCT02366676|Immunologic Factors|immunologic factors|mesh-ancestor
25276170|NCT02366676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276171|NCT02366676|Viscosupplements|viscosupplements|mesh-ancestor
25276172|NCT02366676|Protective Agents|protective agents|mesh-ancestor
25276173|NCT02366585|Cyclosporine|cyclosporine|mesh-list
25276174|NCT02366585|Cyclosporins|cyclosporins|mesh-list
25276175|NCT02366585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25276176|NCT02366585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276177|NCT02366585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25276178|NCT02366585|Immunologic Factors|immunologic factors|mesh-ancestor
25276179|NCT02366585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276180|NCT02366585|Antifungal Agents|antifungal agents|mesh-ancestor
25276181|NCT02366585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25276182|NCT02366585|Dermatologic Agents|dermatologic agents|mesh-ancestor
25276183|NCT02366585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25276184|NCT02366585|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25276186|NCT02366481|Vitamin K|vitamin k|mesh-list
25276187|NCT02366481|Vitamin K 2|vitamin k 2|mesh-list
25276188|NCT02366481|Vitamin MK 7|vitamin mk 7|mesh-list
25276189|NCT02366481|Micronutrients|micronutrients|mesh-ancestor
25276190|NCT02366481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589153|NCT00905996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24589154|NCT00905996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589155|NCT00905996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589156|NCT00905996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24589157|NCT00905996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24589158|NCT00905996|Vasodilator Agents|vasodilator agents|mesh-ancestor
24589159|NCT00906048|Levofloxacin|levofloxacin|mesh-list
24589160|NCT00906048|Ofloxacin|ofloxacin|mesh-list
24589161|NCT00906048|Rifampin|rifampin|mesh-list
24589162|NCT00906048|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24589163|NCT00906048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24589164|NCT00906048|Renal Agents|renal agents|mesh-ancestor
24589165|NCT00906048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24589166|NCT00906048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24589167|NCT00906048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24589168|NCT00906048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038776|NCT04528563|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25038777|NCT04528563|Morphine|morphine|mesh-list
25038778|NCT04528563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25038779|NCT04528563|Narcotics|narcotics|mesh-ancestor
25692147|NCT01994993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25038796|NCT04521335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692148|NCT01994993|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25692149|NCT01994993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038797|NCT04521335|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25038798|NCT04521335|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25038799|NCT04521335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038800|NCT04521335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038801|NCT04516278|Bevacizumab|bevacizumab|mesh-list
25038802|NCT04516278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25038803|NCT04516278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038804|NCT04516278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25038805|NCT04516278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25038806|NCT04516278|Growth Substances|growth substances|mesh-ancestor
25038807|NCT04516278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276191|NCT02366481|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25276192|NCT02366481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25276193|NCT02366481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276194|NCT02366481|Hemostatics|hemostatics|mesh-ancestor
25276199|NCT02366247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25276200|NCT02366247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25276201|NCT02366247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25276202|NCT02366247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25276203|NCT02366247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276204|NCT02366247|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25276205|NCT02366247|Immunologic Factors|immunologic factors|mesh-ancestor
25276206|NCT02366247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276207|NCT02366377|Metformin|metformin|mesh-list
25276208|NCT02366377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25276209|NCT02366377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276210|NCT02366299|Dexmedetomidine|dexmedetomidine|mesh-list
25276211|NCT02366299|Propofol|propofol|mesh-list
25276212|NCT02366299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25276213|NCT02366299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25276214|NCT02366299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276215|NCT02366299|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25276216|NCT02366299|Anesthetics, General|anesthetics, general|mesh-ancestor
25276217|NCT02366299|Anesthetics|anesthetics|mesh-ancestor
25276218|NCT02366299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25276219|NCT02366299|Analgesics|analgesics|mesh-ancestor
25276220|NCT02366299|Sensory System Agents|sensory system agents|mesh-ancestor
25276221|NCT02366299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25276222|NCT02366299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25276223|NCT02366299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25276224|NCT02366299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25276225|NCT02366299|Adrenergic Agents|adrenergic agents|mesh-ancestor
25276226|NCT02366299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25276227|NCT02366299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276228|NCT02366065|Acetaminophen|acetaminophen|mesh-list
25008769|NCT04474223|Antiemetics|antiemetics|mesh-ancestor
25276229|NCT02366065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25276230|NCT02366065|Analgesics|analgesics|mesh-ancestor
25276231|NCT02366065|Sensory System Agents|sensory system agents|mesh-ancestor
25276232|NCT02366065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25038819|NCT04500899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038820|NCT04500899|Sympathomimetics|sympathomimetics|mesh-ancestor
25038821|NCT04500899|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25038822|NCT04500899|Nasal Decongestants|nasal decongestants|mesh-ancestor
25038823|NCT04500899|Respiratory System Agents|respiratory system agents|mesh-ancestor
25038824|NCT04500899|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25038825|NCT04500899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25038826|NCT04500899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25038827|NCT04500899|Adrenergic Agents|adrenergic agents|mesh-ancestor
25038828|NCT04500899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25039960|NCT03546907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24436941|NCT00272207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24436942|NCT00272207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436943|NCT00272207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24436944|NCT00272207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24436945|NCT00272207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24436946|NCT00272207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24436948|NCT00272285|Granisetron|granisetron|mesh-list
24436976|NCT00272415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24436977|NCT00272415|Alkylating Agents|alkylating agents|mesh-ancestor
24436978|NCT00272415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436981|NCT00272428|Vitamin E|vitamin e|mesh-list
24436982|NCT00272428|Beta Carotene|beta carotene|mesh-list
24436983|NCT00272428|Selenium|selenium|mesh-list
24455118|NCT02846545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24455119|NCT02846545|Immunologic Factors|immunologic factors|mesh-ancestor
24455120|NCT02846545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955108|NCT03868111|Anesthetics, General|anesthetics, general|mesh-ancestor
24955109|NCT03868111|Anesthetics|anesthetics|mesh-ancestor
24955110|NCT03868202|Estradiol|estradiol|mesh-list
24955111|NCT03868202|Progesterone|progesterone|mesh-list
24955112|NCT03868202|Estrogens|estrogens|mesh-ancestor
24955113|NCT03868202|Hormones|hormones|mesh-ancestor
24955114|NCT03868202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24955115|NCT03868202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436984|NCT00272428|Carotenoids|carotenoids|mesh-list
24436985|NCT00272428|Vitamins|vitamins|mesh-ancestor
24436986|NCT00272428|Micronutrients|micronutrients|mesh-ancestor
24436987|NCT00272428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436988|NCT00272428|Antioxidants|antioxidants|mesh-ancestor
24436989|NCT00272428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436990|NCT00272428|Protective Agents|protective agents|mesh-ancestor
24436991|NCT00272428|Trace Elements|trace elements|mesh-ancestor
24436992|NCT00272428|Provitamins|provitamins|mesh-ancestor
24436993|NCT00272454|Aspirin|aspirin|mesh-list
24436994|NCT00272454|Cilostazol|cilostazol|mesh-list
24436995|NCT00272454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24436996|NCT00272454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24436997|NCT00272454|Analgesics|analgesics|mesh-ancestor
24436998|NCT00272454|Sensory System Agents|sensory system agents|mesh-ancestor
24436999|NCT00272454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24437000|NCT00272454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437001|NCT00272454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24437002|NCT00272454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24437003|NCT00272454|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24437004|NCT00272454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24437016|NCT00272454|Protective Agents|protective agents|mesh-ancestor
24437017|NCT00272454|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24515866|NCT00599807|Vitamins|vitamins|mesh-ancestor
24437103|NCT00272688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437104|NCT00272688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437106|NCT00272701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24437107|NCT00272701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24437108|NCT00272701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24437208|NCT00272948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24437209|NCT00273013|Montelukast|montelukast|mesh-list
24437210|NCT00273013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24437211|NCT00273013|Respiratory System Agents|respiratory system agents|mesh-ancestor
24437212|NCT00273013|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24437213|NCT00273013|Hormone Antagonists|hormone antagonists|mesh-ancestor
24437214|NCT00273013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25276233|NCT02366065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276234|NCT02366065|Antipyretics|antipyretics|mesh-ancestor
25276235|NCT02366208|Adefovir|adefovir|mesh-list
25276236|NCT02366208|Thymalfasin|thymalfasin|mesh-list
25276237|NCT02366208|Antiviral Agents|antiviral agents|mesh-ancestor
25276238|NCT02366208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25276239|NCT02366208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25276240|NCT02366208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25276241|NCT02366208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25276242|NCT02366208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276243|NCT02366208|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25276244|NCT02366208|Immunologic Factors|immunologic factors|mesh-ancestor
25038829|NCT04500899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038830|NCT04500899|Protective Agents|protective agents|mesh-ancestor
25038831|NCT04486313|Nitazoxanide|nitazoxanide|mesh-list
25038832|NCT04486313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25038833|NCT04486313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25038834|NCT04465760|Antibodies|antibodies|mesh-list
25692150|NCT01994993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692151|NCT01994993|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25692152|NCT01995045|Triamcinolone|triamcinolone|mesh-list
25692153|NCT01995045|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25692154|NCT01995045|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25692155|NCT01995045|Bupivacaine|bupivacaine|mesh-list
25692156|NCT01995045|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25692157|NCT01995045|Anesthetics, Local|anesthetics, local|mesh-ancestor
25692158|NCT01995045|Anesthetics|anesthetics|mesh-ancestor
25692159|NCT01995045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25692160|NCT01995045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038838|NCT04459286|Ritonavir|ritonavir|mesh-list
25038852|NCT04459286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25038853|NCT04453852|Vaccines|vaccines|mesh-list
25038854|NCT04453852|Immunologic Factors|immunologic factors|mesh-ancestor
25038855|NCT04453852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038856|NCT04448834|Vincristine|vincristine|mesh-list
25038857|NCT04448834|Blinatumomab|blinatumomab|mesh-list
25038858|NCT04448834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25038859|NCT04448834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038860|NCT04448834|Tubulin Modulators|tubulin modulators|mesh-ancestor
25038861|NCT04448834|Antimitotic Agents|antimitotic agents|mesh-ancestor
25038862|NCT04448834|Mitosis Modulators|mitosis modulators|mesh-ancestor
25038863|NCT04448834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038864|NCT04445688|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25038865|NCT04445688|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25038866|NCT04445688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24571754|NCT00811486|Diuretics|diuretics|mesh-ancestor
25038867|NCT04445688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25038868|NCT04445688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276251|NCT02365909|Sensory System Agents|sensory system agents|mesh-ancestor
25276252|NCT02365909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25276253|NCT02365857|Dexmedetomidine|dexmedetomidine|mesh-list
25276255|NCT02365857|Anesthetics, Local|anesthetics, local|mesh-ancestor
25276256|NCT02365857|Anesthetics|anesthetics|mesh-ancestor
25276257|NCT02365857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25276258|NCT02365857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276259|NCT02365857|Sensory System Agents|sensory system agents|mesh-ancestor
25276260|NCT02365857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25276261|NCT02365857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25276262|NCT02365857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25276263|NCT02365857|Analgesics|analgesics|mesh-ancestor
25276264|NCT02365857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25276265|NCT02365857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25276266|NCT02365857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25276267|NCT02365857|Adrenergic Agents|adrenergic agents|mesh-ancestor
25276268|NCT02365857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25276269|NCT02365857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276270|NCT02365935|Paclitaxel|paclitaxel|mesh-list
25276271|NCT02365935|Cisplatin|cisplatin|mesh-list
25038875|NCT04424641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038883|NCT04379518|Interferons|interferons|mesh-list
25038884|NCT04379518|Interferon-alpha|interferon-alpha|mesh-list
25038885|NCT04379518|Interferon alpha-2|interferon alpha-2|mesh-list
25038886|NCT04379518|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
25038887|NCT04379518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038888|NCT04379518|Antiviral Agents|antiviral agents|mesh-ancestor
25038889|NCT04379518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25038890|NCT04379518|Immunologic Factors|immunologic factors|mesh-ancestor
25692161|NCT01995045|Sensory System Agents|sensory system agents|mesh-ancestor
25692162|NCT01995045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25692163|NCT01995045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25692164|NCT01995045|Glucocorticoids|glucocorticoids|mesh-ancestor
25692165|NCT01995045|Hormones|hormones|mesh-ancestor
25692166|NCT01995045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25692167|NCT01995045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24994206|NCT04771520|Piperazine|piperazine|mesh-list
24458028|NCT00336349|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24458029|NCT00336349|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24458030|NCT00336349|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24458031|NCT00336349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24449934|NCT00317408|Alkylating Agents|alkylating agents|mesh-ancestor
25276279|NCT02365675|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25276281|NCT02365675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25276282|NCT02365675|Emollients|emollients|mesh-ancestor
25276283|NCT02365675|Dermatologic Agents|dermatologic agents|mesh-ancestor
25276284|NCT02365571|Itraconazole|itraconazole|mesh-list
25276285|NCT02365571|Antifungal Agents|antifungal agents|mesh-ancestor
25276286|NCT02365571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25276287|NCT02365571|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25276288|NCT02365571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25276289|NCT02365571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25276290|NCT02365571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276291|NCT02365571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25276292|NCT02365571|Hormone Antagonists|hormone antagonists|mesh-ancestor
25276293|NCT02365571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25276294|NCT02365571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276295|NCT02365571|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25276296|NCT02365740|Insulin|insulin|mesh-list
25038895|NCT04378114|Sensory System Agents|sensory system agents|mesh-ancestor
25038896|NCT04378114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25038907|NCT04349124|Tocolytic Agents|tocolytic agents|mesh-ancestor
25038908|NCT04349124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25038909|NCT04333160|Hylan|hylan|mesh-list
25038910|NCT04333160|Viscosupplements|viscosupplements|mesh-ancestor
25038911|NCT04333160|Protective Agents|protective agents|mesh-ancestor
25038912|NCT04333160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038926|NCT04285671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25038927|NCT04285671|Trastuzumab|trastuzumab|mesh-list
25038928|NCT04285671|Necitumumab|necitumumab|mesh-list
25038929|NCT04285671|Osimertinib|osimertinib|mesh-list
25038930|NCT04285671|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
25038931|NCT04285671|Antibodies|antibodies|mesh-list
24994229|NCT04770740|Hemostatics|hemostatics|mesh-ancestor
24449933|NCT00317408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25276305|NCT02365948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276306|NCT02365948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25276307|NCT02365727|Clonidine|clonidine|mesh-list
25276308|NCT02365727|Epinephrine|epinephrine|mesh-list
25276309|NCT02365727|Bupivacaine|bupivacaine|mesh-list
25276310|NCT02365727|Ropivacaine|ropivacaine|mesh-list
25276311|NCT02365727|Anesthetics, Local|anesthetics, local|mesh-ancestor
25276312|NCT02365727|Anesthetics|anesthetics|mesh-ancestor
25276313|NCT02365727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25276314|NCT02365727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276315|NCT02365727|Sensory System Agents|sensory system agents|mesh-ancestor
25276316|NCT02365727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25276317|NCT02365727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25276318|NCT02365727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25276319|NCT02365727|Adrenergic Agents|adrenergic agents|mesh-ancestor
25276320|NCT02365727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25276321|NCT02365727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276322|NCT02365727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25276323|NCT02365727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25038933|NCT04285671|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25038934|NCT04285671|Immunologic Factors|immunologic factors|mesh-ancestor
25038935|NCT04285671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038936|NCT04285671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038937|NCT04285671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038938|NCT04285671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25038939|NCT04285671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038956|NCT04259086|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25038957|NCT04259086|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25038958|NCT04259086|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24671263|NCT01324583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458053|NCT00336401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24458054|NCT00336401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24458055|NCT00336401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458056|NCT00336401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25276324|NCT02365727|Autonomic Agents|autonomic agents|mesh-ancestor
25276325|NCT02365727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25276326|NCT02365727|Respiratory System Agents|respiratory system agents|mesh-ancestor
25276327|NCT02365727|Mydriatics|mydriatics|mesh-ancestor
25276328|NCT02365727|Sympathomimetics|sympathomimetics|mesh-ancestor
25276329|NCT02365727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25276339|NCT02365805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25276340|NCT02365805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25276341|NCT02365805|Tubulin Modulators|tubulin modulators|mesh-ancestor
25276342|NCT02365805|Antimitotic Agents|antimitotic agents|mesh-ancestor
25276343|NCT02365805|Mitosis Modulators|mitosis modulators|mesh-ancestor
25276344|NCT02365805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276345|NCT02365805|Antimetabolites|antimetabolites|mesh-ancestor
25276346|NCT02365805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25276347|NCT02365805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25276348|NCT02365805|Immunologic Factors|immunologic factors|mesh-ancestor
25276349|NCT02365805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276350|NCT02365805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25276351|NCT02365805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25276352|NCT02365805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25276353|NCT02365805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25276354|NCT02365805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25276355|NCT02365805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25038988|NCT04229368|Cholecalciferol|cholecalciferol|mesh-list
25038990|NCT04229368|Micronutrients|micronutrients|mesh-ancestor
25038991|NCT04229368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038992|NCT04229368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25038993|NCT04229368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25038994|NCT04225273|Lidocaine|lidocaine|mesh-list
25038995|NCT04225273|Anesthetics, Local|anesthetics, local|mesh-ancestor
25038996|NCT04225273|Anesthetics|anesthetics|mesh-ancestor
25038997|NCT04225273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25038998|NCT04225273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038999|NCT04225273|Sensory System Agents|sensory system agents|mesh-ancestor
25039000|NCT04225273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039001|NCT04225273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25039002|NCT04225273|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25039003|NCT04225273|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25039004|NCT04225273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25039005|NCT04225273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955206|NCT03866980|Pemetrexed|pemetrexed|mesh-list
25276356|NCT02365805|Alkylating Agents|alkylating agents|mesh-ancestor
25276357|NCT02365805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25276358|NCT02365623|Bedaquiline|bedaquiline|mesh-list
25276359|NCT02365623|Diarylquinolines|diarylquinolines|mesh-list
25276360|NCT02365623|Antitubercular Agents|antitubercular agents|mesh-ancestor
25276361|NCT02365623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25276362|NCT02365623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25039014|NCT04222712|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25039016|NCT04209296|Analgesics|analgesics|mesh-ancestor
24607439|NCT04626141|Abaloparatide|abaloparatide|mesh-list
25039037|NCT04174612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25039038|NCT04174612|Antimetabolites|antimetabolites|mesh-ancestor
25039039|NCT04174612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039040|NCT04174612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25039041|NCT04174612|Antiviral Agents|antiviral agents|mesh-ancestor
25039042|NCT04174612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25039043|NCT04174612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25039044|NCT04174612|Immunologic Factors|immunologic factors|mesh-ancestor
25039045|NCT04174612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039046|NCT04174612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25039047|NCT04174612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25039048|NCT04174612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25039049|NCT04174612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039050|NCT04174612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25039051|NCT04163432|Carboplatin|carboplatin|mesh-list
25039052|NCT04163432|Pemetrexed|pemetrexed|mesh-list
25039053|NCT04163432|Durvalumab|durvalumab|mesh-list
25039054|NCT04163432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25039055|NCT04163432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039057|NCT04163432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25039058|NCT04163432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25039059|NCT04163432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25039060|NCT04163185|Meloxicam|meloxicam|mesh-list
24458086|NCT00336518|Ribavirin|ribavirin|mesh-list
24458087|NCT00336518|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24458088|NCT00336518|Antimetabolites|antimetabolites|mesh-ancestor
24458089|NCT00336518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458090|NCT00336518|Antiviral Agents|antiviral agents|mesh-ancestor
24458091|NCT00336518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24458092|NCT00336531|Itraconazole|itraconazole|mesh-list
24458093|NCT00336531|Antifungal Agents|antifungal agents|mesh-ancestor
24458094|NCT00336531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24458095|NCT00336531|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25276389|NCT02365415|Sirolimus|sirolimus|mesh-list
25276390|NCT02365415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25276391|NCT02365415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25276392|NCT02365415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25276393|NCT02365415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25276394|NCT02365415|Antifungal Agents|antifungal agents|mesh-ancestor
25276395|NCT02365415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25276396|NCT02365415|Immunologic Factors|immunologic factors|mesh-ancestor
25039063|NCT04163185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25039064|NCT04163185|Analgesics|analgesics|mesh-ancestor
25039065|NCT04163185|Sensory System Agents|sensory system agents|mesh-ancestor
25039066|NCT04163185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039067|NCT04163185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039081|NCT04161456|Sensory System Agents|sensory system agents|mesh-ancestor
25039082|NCT04161456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039083|NCT04161456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039084|NCT04161456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25039085|NCT04161456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25039086|NCT04161456|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25039087|NCT04161456|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25039088|NCT04161456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039089|NCT04161456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995759|NCT04780581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24995760|NCT04780581|Prednisolone|prednisolone|mesh-list
24995761|NCT04780581|Prednisolone acetate|prednisolone acetate|mesh-list
24995762|NCT04780581|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24995763|NCT04780581|Prednisolone phosphate|prednisolone phosphate|mesh-list
24995764|NCT04780581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24995765|NCT04780581|Antiemetics|antiemetics|mesh-ancestor
24995766|NCT04780581|Autonomic Agents|autonomic agents|mesh-ancestor
24995767|NCT04780581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24995768|NCT04780581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995769|NCT04780581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24566212|NCT00784797|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24566213|NCT00784797|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24995771|NCT04780581|Hormones|hormones|mesh-ancestor
24995772|NCT04780581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24995773|NCT04780581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24995774|NCT04780581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24995775|NCT04780581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24995776|NCT04780581|Protective Agents|protective agents|mesh-ancestor
25276398|NCT02365493|Cefazolin|cefazolin|mesh-list
25276399|NCT02365493|Lactams|lactams|mesh-list
25276400|NCT02365493|beta-Lactams|beta-lactams|mesh-list
25276401|NCT02365493|Floxacillin|floxacillin|mesh-list
25276402|NCT02365493|Cloxacillin|cloxacillin|mesh-list
25276403|NCT02365493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25276404|NCT02365493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25276405|NCT02365402|Entecavir|entecavir|mesh-list
25276406|NCT02365402|Antiviral Agents|antiviral agents|mesh-ancestor
25276407|NCT02365402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25276408|NCT02365441|Imatinib Mesylate|imatinib mesylate|mesh-list
25276409|NCT02365441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25276410|NCT02365441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25276411|NCT02365441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25276412|NCT02365441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276414|NCT02365181|Anesthetics, Local|anesthetics, local|mesh-list
25276415|NCT02365181|Anesthetics|anesthetics|mesh-list
25276416|NCT02365181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25276417|NCT02365181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276418|NCT02365181|Sensory System Agents|sensory system agents|mesh-ancestor
25276419|NCT02365181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25276420|NCT02364986|Interferons|interferons|mesh-list
25276421|NCT02364986|Interferon-beta|interferon-beta|mesh-list
25276422|NCT02364986|Interferon beta-1a|interferon beta-1a|mesh-list
25276423|NCT02364986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25276424|NCT02364986|Antiviral Agents|antiviral agents|mesh-ancestor
25276425|NCT02364986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25276426|NCT02364986|Immunologic Factors|immunologic factors|mesh-ancestor
25276427|NCT02364986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276428|NCT02364986|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25276429|NCT02364934|Propofol|propofol|mesh-list
25276430|NCT02364934|Sevoflurane|sevoflurane|mesh-list
25276431|NCT02364934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25276432|NCT02364934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25276433|NCT02364934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276434|NCT02364934|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25276435|NCT02364934|Anesthetics, General|anesthetics, general|mesh-ancestor
24458110|NCT00336648|Growth Substances|growth substances|mesh-ancestor
24458111|NCT00336648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458112|NCT00336648|Growth Inhibitors|growth inhibitors|mesh-ancestor
24458113|NCT00336648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24458114|NCT00336648|Antimetabolites|antimetabolites|mesh-ancestor
24458131|NCT00336765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458132|NCT00336765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24458133|NCT00336765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402890|NCT00158717|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25276437|NCT02364934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25276439|NCT02364882|Sildenafil Citrate|sildenafil citrate|mesh-list
25276440|NCT02364882|Vasodilator Agents|vasodilator agents|mesh-ancestor
25276441|NCT02364882|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25276442|NCT02364882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25276443|NCT02364882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25276444|NCT02364882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276445|NCT02364882|Urological Agents|urological agents|mesh-ancestor
25276446|NCT02364804|Aprepitant|aprepitant|mesh-list
25276447|NCT02364804|Antiemetics|antiemetics|mesh-ancestor
25276448|NCT02364804|Autonomic Agents|autonomic agents|mesh-ancestor
25276449|NCT02364804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25276450|NCT02364804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276451|NCT02364804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25276452|NCT02364804|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25276453|NCT02364804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25276454|NCT02364804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039106|NCT04129086|Sensory System Agents|sensory system agents|mesh-ancestor
25039109|NCT04129086|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25039113|NCT04129086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25039114|NCT04129086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25039115|NCT04129086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25039116|NCT04129086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25039117|NCT04129086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039119|NCT04114136|Rosiglitazone|rosiglitazone|mesh-list
25039120|NCT04114136|Pembrolizumab|pembrolizumab|mesh-list
25039121|NCT04114136|Nivolumab|nivolumab|mesh-list
25039122|NCT04114136|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25039123|NCT04114136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039124|NCT04114136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25039125|NCT04114136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25039126|NCT04114136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24797900|NCT01959022|Adrenergic Agents|adrenergic agents|mesh-ancestor
25276455|NCT02365012|Midodrine|midodrine|mesh-list
25276456|NCT02365012|Sympathomimetics|sympathomimetics|mesh-ancestor
25276457|NCT02365012|Autonomic Agents|autonomic agents|mesh-ancestor
25276458|NCT02365012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24566416|NCT00785551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25276459|NCT02365012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276460|NCT02365012|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25276464|NCT02365012|Adrenergic Agents|adrenergic agents|mesh-ancestor
25276465|NCT02365012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25276466|NCT02365012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276467|NCT02364765|Remifentanil|remifentanil|mesh-list
25276468|NCT02364765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25276469|NCT02364765|Narcotics|narcotics|mesh-ancestor
25276470|NCT02364765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25276471|NCT02364765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276472|NCT02364765|Analgesics|analgesics|mesh-ancestor
25276473|NCT02364765|Sensory System Agents|sensory system agents|mesh-ancestor
25276474|NCT02364765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25276475|NCT02364531|Abiraterone Acetate|abiraterone acetate|mesh-list
25276476|NCT02364531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25276477|NCT02364531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25276478|NCT02364531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25276479|NCT02364531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276480|NCT02364531|Hormone Antagonists|hormone antagonists|mesh-ancestor
25276481|NCT02364531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25276482|NCT02364531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276483|NCT02364531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25276484|NCT02364479|Etanercept|etanercept|mesh-list
25276485|NCT02364479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25276486|NCT02364479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25276487|NCT02364479|Analgesics|analgesics|mesh-ancestor
25276488|NCT02364479|Sensory System Agents|sensory system agents|mesh-ancestor
25276489|NCT02364479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25114757|NCT00238420|Mitosis Modulators|mitosis modulators|mesh-ancestor
25114758|NCT00238420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25114759|NCT00238420|Immunologic Factors|immunologic factors|mesh-ancestor
25692168|NCT01995045|Immunologic Factors|immunologic factors|mesh-ancestor
25692169|NCT01995045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692170|NCT01995045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692171|NCT01995071|Ribavirin|ribavirin|mesh-list
25692172|NCT01995071|Antimetabolites|antimetabolites|mesh-ancestor
25692173|NCT01995071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692174|NCT01995071|Antiviral Agents|antiviral agents|mesh-ancestor
25692175|NCT01995071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25114760|NCT00238420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458229|NCT00337155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458230|NCT00337246|Cyclophosphamide|cyclophosphamide|mesh-list
24458232|NCT00337246|Fludarabine|fludarabine|mesh-list
24458233|NCT00337246|Fludarabine phosphate|fludarabine phosphate|mesh-list
24458234|NCT00337246|Mitoxantrone|mitoxantrone|mesh-list
24458235|NCT00337246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24458236|NCT00337246|Immunologic Factors|immunologic factors|mesh-ancestor
24458237|NCT00337246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458238|NCT00337246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25276490|NCT02364479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276491|NCT02364479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25276492|NCT02364479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25276493|NCT02364479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25276494|NCT02364479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25276495|NCT02364479|Immunologic Factors|immunologic factors|mesh-ancestor
25276497|NCT02364752|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
25276498|NCT02364752|Natriuretic Agents|natriuretic agents|mesh-ancestor
25276499|NCT02364752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276500|NCT02364752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25276501|NCT02364752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276503|NCT02364609|Afatinib|afatinib|mesh-list
25276504|NCT02364609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25276505|NCT02364609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25276506|NCT02364609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25276507|NCT02364609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25276508|NCT02364609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276509|NCT02364583|Primaquine|primaquine|mesh-list
25276510|NCT02364583|Antimalarials|antimalarials|mesh-ancestor
25276511|NCT02364583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25276512|NCT02364583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25039143|NCT04093765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25039144|NCT04093765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24458248|NCT00337246|Sensory System Agents|sensory system agents|mesh-ancestor
24458249|NCT00337246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25692176|NCT01995136|Travoprost|travoprost|mesh-list
25692177|NCT01995136|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25692178|NCT01995136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25692179|NCT01995136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24541072|NCT00670722|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24566679|NCT00787410|Gefitinib|gefitinib|mesh-list
25276513|NCT02364583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25276514|NCT02364453|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
25276515|NCT02364453|Growth Substances|growth substances|mesh-ancestor
25276516|NCT02364453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276517|NCT02364453|Vasodilator Agents|vasodilator agents|mesh-ancestor
25276518|NCT02364453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25276519|NCT02364453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276520|NCT02364206|Temozolomide|temozolomide|mesh-list
25276521|NCT02364206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25276523|NCT02364206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039155|NCT04049864|Lenalidomide|lenalidomide|mesh-list
25039156|NCT04049864|Vaccines|vaccines|mesh-list
25039157|NCT04049864|Immunologic Factors|immunologic factors|mesh-ancestor
25039158|NCT04049864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039159|NCT04049864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25039160|NCT04049864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25039161|NCT04049864|Growth Substances|growth substances|mesh-ancestor
25039162|NCT04049864|Growth Inhibitors|growth inhibitors|mesh-ancestor
25039163|NCT04049864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25039164|NCT04030962|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25039165|NCT04030962|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25039166|NCT04030143|Aripiprazole|aripiprazole|mesh-list
25039167|NCT04030143|Antidepressive Agents|antidepressive agents|mesh-ancestor
25039168|NCT04030143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25039169|NCT04030143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25039170|NCT04030143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25039171|NCT04030143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25039172|NCT04030143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039173|NCT04030143|Dopamine Agonists|dopamine agonists|mesh-ancestor
25039174|NCT04030143|Dopamine Agents|dopamine agents|mesh-ancestor
25039188|NCT04029610|Anesthetics, Local|anesthetics, local|mesh-ancestor
25692180|NCT01995201|Methotrexate|methotrexate|mesh-list
25692181|NCT01995201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25692182|NCT01995201|Abortifacient Agents|abortifacient agents|mesh-ancestor
25692183|NCT01995201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25692184|NCT01995201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276524|NCT02364206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25276525|NCT02364258|Atorvastatin|atorvastatin|mesh-list
25276526|NCT02364258|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25276527|NCT02364258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25276528|NCT02364258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25276529|NCT02364258|Antimetabolites|antimetabolites|mesh-ancestor
25276530|NCT02364258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276531|NCT02364258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25276532|NCT02364258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25276533|NCT02364258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25276534|NCT02364362|Docetaxel|docetaxel|mesh-list
25276535|NCT02364362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25276536|NCT02364362|Tubulin Modulators|tubulin modulators|mesh-ancestor
25276537|NCT02364362|Antimitotic Agents|antimitotic agents|mesh-ancestor
25276538|NCT02364362|Mitosis Modulators|mitosis modulators|mesh-ancestor
25276539|NCT02364362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276540|NCT02364089|Epinephrine|epinephrine|mesh-list
25276541|NCT02364089|Racepinephrine|racepinephrine|mesh-list
25276542|NCT02364089|Epinephryl borate|epinephryl borate|mesh-list
25276543|NCT02364089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25276544|NCT02364089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25276545|NCT02364089|Adrenergic Agents|adrenergic agents|mesh-ancestor
25276546|NCT02364089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25039190|NCT04029610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25039191|NCT04029610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039199|NCT04029610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25039201|NCT04029610|Adrenergic Agents|adrenergic agents|mesh-ancestor
25039202|NCT04029610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24566991|NCT00789165|Quinidine|quinidine|mesh-list
25692185|NCT01995201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24955341|NCT03865680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955342|NCT03865680|Cariostatic Agents|cariostatic agents|mesh-ancestor
24955343|NCT03865680|Protective Agents|protective agents|mesh-ancestor
25276547|NCT02364089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276548|NCT02364089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276549|NCT02364089|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25276550|NCT02364089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25276551|NCT02364089|Autonomic Agents|autonomic agents|mesh-ancestor
24791802|NCT03073694|Alkylating Agents|alkylating agents|mesh-ancestor
25276552|NCT02364089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25276553|NCT02364089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25276554|NCT02364089|Respiratory System Agents|respiratory system agents|mesh-ancestor
25276555|NCT02364089|Mydriatics|mydriatics|mesh-ancestor
25276556|NCT02364089|Sympathomimetics|sympathomimetics|mesh-ancestor
25276557|NCT02364089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25276558|NCT02363985|Vitamin A|vitamin a|mesh-list
25276559|NCT02363985|Vitamins|vitamins|mesh-ancestor
25276560|NCT02363985|Micronutrients|micronutrients|mesh-ancestor
25039203|NCT04029610|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25039204|NCT04029610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25039205|NCT04029610|Autonomic Agents|autonomic agents|mesh-ancestor
25039208|NCT04029610|Mydriatics|mydriatics|mesh-ancestor
25039209|NCT04029610|Sympathomimetics|sympathomimetics|mesh-ancestor
25039210|NCT04029610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25039212|NCT04021862|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25039213|NCT04021862|Immunologic Factors|immunologic factors|mesh-ancestor
25039214|NCT04021862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039217|NCT03957590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24994470|NCT04096170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24436920|NCT00272064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24436921|NCT00272064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458270|NCT00337298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24458271|NCT00337298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692186|NCT01995201|Antimetabolites|antimetabolites|mesh-ancestor
25692187|NCT01995201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692188|NCT01995201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25276561|NCT02363985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276562|NCT02363764|Dimercaprol|dimercaprol|mesh-list
25276563|NCT02363764|Chelating Agents|chelating agents|mesh-ancestor
25276564|NCT02363764|Sequestering Agents|sequestering agents|mesh-ancestor
25276565|NCT02363764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276566|NCT02363829|Nelfinavir|nelfinavir|mesh-list
25276567|NCT02363829|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25276568|NCT02363829|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25276569|NCT02363829|Protease Inhibitors|protease inhibitors|mesh-ancestor
25276570|NCT02363829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25276571|NCT02363829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276572|NCT02363829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25276573|NCT02363829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25276574|NCT02363829|Antiviral Agents|antiviral agents|mesh-ancestor
25276575|NCT02363829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25039218|NCT03957590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25039219|NCT03957590|Tubulin Modulators|tubulin modulators|mesh-ancestor
25039220|NCT03957590|Antimitotic Agents|antimitotic agents|mesh-ancestor
25039221|NCT03957590|Mitosis Modulators|mitosis modulators|mesh-ancestor
25039272|NCT03935958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25039226|NCT03949673|Diclofenac|diclofenac|mesh-list
25039227|NCT03949673|Naproxen|naproxen|mesh-list
25039228|NCT03949673|Fasinumab|fasinumab|mesh-list
25039229|NCT03949673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25039230|NCT03949673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25039233|NCT03949673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039234|NCT03949673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039235|NCT03949673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25039236|NCT03949673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25039260|NCT03936894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25039261|NCT03936894|Immunologic Factors|immunologic factors|mesh-ancestor
24994483|NCT04066491|Antiviral Agents|antiviral agents|mesh-ancestor
25276576|NCT02363699|Lidocaine|lidocaine|mesh-list
25276577|NCT02363699|Anesthetics, Local|anesthetics, local|mesh-ancestor
25276578|NCT02363699|Anesthetics|anesthetics|mesh-ancestor
25276579|NCT02363699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25276580|NCT02363699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276581|NCT02363699|Sensory System Agents|sensory system agents|mesh-ancestor
25276582|NCT02363699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25276583|NCT02363699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25276584|NCT02363699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25276585|NCT02363699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25276586|NCT02363699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25276587|NCT02363699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276588|NCT02363751|Bevacizumab|bevacizumab|mesh-list
25276589|NCT02363751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25276590|NCT02363751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25276591|NCT02363751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25276592|NCT02363751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24884686|NCT03727633|Ethiodized Oil|ethiodized oil|mesh-list
25276593|NCT02363751|Growth Substances|growth substances|mesh-ancestor
25276594|NCT02363751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276595|NCT02363751|Growth Inhibitors|growth inhibitors|mesh-ancestor
25276596|NCT02363556|Misoprostol|misoprostol|mesh-list
25276597|NCT02363556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25039262|NCT03936894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039263|NCT03935958|Curcumin|curcumin|mesh-list
25039264|NCT03935958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25039265|NCT03935958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25039266|NCT03935958|Analgesics|analgesics|mesh-ancestor
25039267|NCT03935958|Sensory System Agents|sensory system agents|mesh-ancestor
25039268|NCT03935958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039269|NCT03935958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039270|NCT03935958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25039271|NCT03935958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25039280|NCT03926026|Fluticasone|fluticasone|mesh-list
25039281|NCT03926026|Xhance|xhance|mesh-list
25039282|NCT03926026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25039283|NCT03926026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25039284|NCT03926026|Autonomic Agents|autonomic agents|mesh-ancestor
25039285|NCT03926026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039286|NCT03926026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039287|NCT03926026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25039288|NCT03926026|Respiratory System Agents|respiratory system agents|mesh-ancestor
25039289|NCT03926026|Dermatologic Agents|dermatologic agents|mesh-ancestor
25039290|NCT03926026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25039301|NCT03915067|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25039302|NCT03915067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25039303|NCT03915067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039304|NCT03915067|Cholinergic Agents|cholinergic agents|mesh-ancestor
25276598|NCT02363556|Abortifacient Agents|abortifacient agents|mesh-ancestor
25276599|NCT02363556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25276600|NCT02363556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276601|NCT02363556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25276602|NCT02363556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25276603|NCT02363556|Oxytocics|oxytocics|mesh-ancestor
25039310|NCT03911102|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25039312|NCT03911102|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25039313|NCT03911102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039314|NCT03911102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039315|NCT03911102|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25039316|NCT03911102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25039317|NCT03911102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039318|NCT03911102|Cholinergic Agents|cholinergic agents|mesh-ancestor
25039319|NCT03911102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25039320|NCT03896009|Meloxicam|meloxicam|mesh-list
25039321|NCT03896009|Rizatriptan|rizatriptan|mesh-list
25039322|NCT03896009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25039323|NCT03896009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25039324|NCT03896009|Analgesics|analgesics|mesh-ancestor
25039325|NCT03896009|Sensory System Agents|sensory system agents|mesh-ancestor
25039326|NCT03896009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039327|NCT03896009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039328|NCT03896009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25039329|NCT03896009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25039330|NCT03896009|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25039331|NCT03896009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25039332|NCT03896009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039333|NCT03896009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039334|NCT03896009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25039335|NCT03896009|Serotonin Agents|serotonin agents|mesh-ancestor
25039336|NCT03896009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25039337|NCT03888378|Minocycline|minocycline|mesh-list
25039338|NCT03888378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25276604|NCT02363452|Lamivudine|lamivudine|mesh-list
25276605|NCT02363452|Zidovudine|zidovudine|mesh-list
25276606|NCT02363452|Abacavir|abacavir|mesh-list
25276607|NCT02363452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
25276608|NCT02363452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25276609|NCT02363452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039346|NCT03881852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039347|NCT03881852|Adrenergic Agents|adrenergic agents|mesh-ancestor
25039348|NCT03881852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25039349|NCT03881852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533372|NCT00643409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24533373|NCT00643409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24533374|NCT00643409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533375|NCT00643409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437245|NCT00273039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24437246|NCT00273039|Antidepressive Agents|antidepressive agents|mesh-ancestor
24567574|NCT00791622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567575|NCT00791622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25276658|NCT02363361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25276638|NCT02363400|Tegafur|tegafur|mesh-list
25276639|NCT02363400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25276640|NCT02363400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25276641|NCT02363400|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25276642|NCT02363400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25276643|NCT02363400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25276644|NCT02363400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276645|NCT02363400|Alkylating Agents|alkylating agents|mesh-ancestor
25276646|NCT02363400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25276647|NCT02363400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25276648|NCT02363400|Antimetabolites|antimetabolites|mesh-ancestor
25276649|NCT02363530|Ethyl cellulose|ethyl cellulose|mesh-list
25039365|NCT03879408|Gout Suppressants|gout suppressants|mesh-ancestor
25692190|NCT01995201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692191|NCT01995201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25692192|NCT01995201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25692193|NCT01995201|Immunologic Factors|immunologic factors|mesh-ancestor
25692194|NCT01995201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25692195|NCT01995201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25692196|NCT01995266|Asunaprevir|asunaprevir|mesh-list
25692197|NCT01995266|Protease Inhibitors|protease inhibitors|mesh-ancestor
25692198|NCT01995266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692199|NCT01995266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692200|NCT01995513|Prednisone|prednisone|mesh-list
25692201|NCT01995513|Prednisolone|prednisolone|mesh-list
25692202|NCT01995513|Abiraterone Acetate|abiraterone acetate|mesh-list
25039366|NCT03879408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25039367|NCT03879408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039368|NCT03879408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039369|NCT03879408|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25039371|NCT03879408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25039372|NCT03879408|Antitussive Agents|antitussive agents|mesh-ancestor
25039373|NCT03879408|Respiratory System Agents|respiratory system agents|mesh-ancestor
25039374|NCT03877289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25039376|NCT03877289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25039377|NCT03877289|Parasympatholytics|parasympatholytics|mesh-ancestor
25039378|NCT03877289|Autonomic Agents|autonomic agents|mesh-ancestor
25039379|NCT03877289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039380|NCT03877289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039381|NCT03877289|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25039382|NCT03877289|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25039383|NCT03877289|Cholinergic Agents|cholinergic agents|mesh-ancestor
25039384|NCT03877289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25039385|NCT03877289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039386|NCT03877289|Urological Agents|urological agents|mesh-ancestor
25039387|NCT03866200|Resveratrol|resveratrol|mesh-list
25039388|NCT03866200|Antioxidants|antioxidants|mesh-ancestor
24996064|NCT04352205|Dermatologic Agents|dermatologic agents|mesh-ancestor
24996065|NCT04344873|Abatacept|abatacept|mesh-list
24996066|NCT04344873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24437265|NCT00273299|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24791818|NCT03049189|Everolimus|everolimus|mesh-list
24533376|NCT00643409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24533377|NCT00643409|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25276650|NCT02363530|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25276651|NCT02363530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25276652|NCT02363517|Sofosbuvir|sofosbuvir|mesh-list
25276653|NCT02363517|Antiviral Agents|antiviral agents|mesh-ancestor
25276654|NCT02363517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25276655|NCT02363361|Imatinib Mesylate|imatinib mesylate|mesh-list
25276656|NCT02363361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25276657|NCT02363361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25276665|NCT02363075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25276666|NCT02363075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276667|NCT02363075|Dopamine Agents|dopamine agents|mesh-ancestor
25276668|NCT02363075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25276669|NCT02362906|Azithromycin|azithromycin|mesh-list
25276670|NCT02362906|Erythromycin|erythromycin|mesh-list
25276671|NCT02362906|Erythromycin Estolate|erythromycin estolate|mesh-list
25276672|NCT02362906|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25276673|NCT02362906|Erythromycin stearate|erythromycin stearate|mesh-list
25276674|NCT02362906|Cephalosporins|cephalosporins|mesh-list
25276675|NCT02362906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25276676|NCT02362906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25276677|NCT02362906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24996067|NCT04344873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996068|NCT04344873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996069|NCT04344873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24996070|NCT04344873|Immunologic Factors|immunologic factors|mesh-ancestor
24996071|NCT04344873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039389|NCT03866200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039390|NCT03866200|Protective Agents|protective agents|mesh-ancestor
25039391|NCT03866200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039392|NCT03866200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039393|NCT03866200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25039411|NCT03844074|Bevacizumab|bevacizumab|mesh-list
25039412|NCT03844074|Ranibizumab|ranibizumab|mesh-list
25039413|NCT03844074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25039414|NCT03844074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25039415|NCT03844074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25039416|NCT03844074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25039417|NCT03844074|Growth Substances|growth substances|mesh-ancestor
25039418|NCT03844074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039419|NCT03844074|Growth Inhibitors|growth inhibitors|mesh-ancestor
25039420|NCT03840837|Rivastigmine|rivastigmine|mesh-list
25039421|NCT03840837|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25039422|NCT03840837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039424|NCT03840837|Cholinergic Agents|cholinergic agents|mesh-ancestor
25276678|NCT02362906|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25276679|NCT02362906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25276680|NCT02362906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276681|NCT02362958|Capecitabine|capecitabine|mesh-list
25276682|NCT02362958|Vinorelbine|vinorelbine|mesh-list
25276683|NCT02362958|Lapatinib|lapatinib|mesh-list
25276684|NCT02362958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25276685|NCT02362958|Antimetabolites|antimetabolites|mesh-ancestor
25276686|NCT02362958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276687|NCT02362958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25276688|NCT02362958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25276689|NCT02362958|Tubulin Modulators|tubulin modulators|mesh-ancestor
25276690|NCT02362958|Antimitotic Agents|antimitotic agents|mesh-ancestor
25276691|NCT02362958|Mitosis Modulators|mitosis modulators|mesh-ancestor
25276692|NCT02362958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25276693|NCT02362958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25276694|NCT02363127|Progesterone|progesterone|mesh-list
25276695|NCT02363127|Progestins|progestins|mesh-ancestor
25276696|NCT02363127|Hormones|hormones|mesh-ancestor
25276697|NCT02363127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25276698|NCT02363127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276699|NCT02362945|Oxytocin|oxytocin|mesh-list
25276700|NCT02362945|Oxytocics|oxytocics|mesh-ancestor
25276701|NCT02362945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25276702|NCT02362945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276705|NCT02362711|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25276706|NCT02362711|Contraceptive Agents|contraceptive agents|mesh-ancestor
25276707|NCT02362711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25276708|NCT02362711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276709|NCT02362711|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25276710|NCT02362711|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25276711|NCT02362711|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25276712|NCT02362711|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25276713|NCT02362711|Estrogens|estrogens|mesh-ancestor
25276714|NCT02362711|Hormones|hormones|mesh-ancestor
25276715|NCT02362711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25276716|NCT02362490|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25276717|NCT02362490|Antiviral Agents|antiviral agents|mesh-ancestor
25276718|NCT02362490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25276719|NCT02362516|BI 425809|bi 425809|mesh-list
25276720|NCT02362516|Nootropic Agents|nootropic agents|mesh-ancestor
25276721|NCT02362399|Sildenafil Citrate|sildenafil citrate|mesh-list
25039438|NCT03834753|Growth Substances|growth substances|mesh-ancestor
25039439|NCT03834753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567726|NCT00792324|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25039440|NCT03834753|Growth Inhibitors|growth inhibitors|mesh-ancestor
25039441|NCT03832569|Pembrolizumab|pembrolizumab|mesh-list
25039442|NCT03832569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25039443|NCT03832569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25039444|NCT03832179|Dexamethasone|dexamethasone|mesh-list
25039445|NCT03832179|Bevacizumab|bevacizumab|mesh-list
25039446|NCT03832179|Ranibizumab|ranibizumab|mesh-list
25039447|NCT03832179|Aflibercept|aflibercept|mesh-list
25039448|NCT03832179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25039449|NCT03832179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25039450|NCT03832179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25039451|NCT03832179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25039452|NCT03832179|Growth Substances|growth substances|mesh-ancestor
25039453|NCT03832179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039454|NCT03832179|Growth Inhibitors|growth inhibitors|mesh-ancestor
25039455|NCT03832179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25039456|NCT03832179|Antiemetics|antiemetics|mesh-ancestor
25039457|NCT03832179|Autonomic Agents|autonomic agents|mesh-ancestor
25039458|NCT03832179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039459|NCT03832179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25039460|NCT03832179|Glucocorticoids|glucocorticoids|mesh-ancestor
25276725|NCT02362399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25276726|NCT02362399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25276727|NCT02362399|Urological Agents|urological agents|mesh-ancestor
25276729|NCT02362529|Celecoxib|celecoxib|mesh-list
25276730|NCT02362529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25276731|NCT02362529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25276732|NCT02362529|Analgesics|analgesics|mesh-ancestor
25276733|NCT02362529|Sensory System Agents|sensory system agents|mesh-ancestor
25276734|NCT02362529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25276735|NCT02362529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276736|NCT02362529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25276737|NCT02362529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25276738|NCT02362529|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25276739|NCT02362529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25276740|NCT02362529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25276741|NCT02362529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276742|NCT02362529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25276743|NCT02362529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25276744|NCT02362581|Factor VIII|factor viii|mesh-list
25276745|NCT02362581|Coagulants|coagulants|mesh-ancestor
25276746|NCT02362308|Eplerenone|eplerenone|mesh-list
25039478|NCT03824587|Calcium acetate|calcium acetate|mesh-list
25039479|NCT03824587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25039480|NCT03824587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039491|NCT03818828|Trace Elements|trace elements|mesh-ancestor
25039492|NCT03818828|Micronutrients|micronutrients|mesh-ancestor
25039493|NCT03818828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039494|NCT03806933|Botulinum Toxins|botulinum toxins|mesh-list
25039495|NCT03806933|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25039496|NCT03806933|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25039497|NCT03806933|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25039498|NCT03806933|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25039499|NCT03806933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25039500|NCT03806933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039501|NCT03806933|Cholinergic Agents|cholinergic agents|mesh-ancestor
25039502|NCT03806933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25039503|NCT03806933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039504|NCT03806933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25039505|NCT03806933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039513|NCT03798743|Docetaxel|docetaxel|mesh-list
25276747|NCT02362308|Spironolactone|spironolactone|mesh-list
25276748|NCT02362308|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
25276749|NCT02362308|Mineralocorticoids|mineralocorticoids|mesh-list
25276750|NCT02362308|Hormone Antagonists|hormone antagonists|mesh-ancestor
25276751|NCT02362308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25276752|NCT02362308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276753|NCT02362308|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25276754|NCT02362308|Diuretics|diuretics|mesh-ancestor
25276755|NCT02362308|Natriuretic Agents|natriuretic agents|mesh-ancestor
25276756|NCT02362308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25276757|NCT02362308|Hormones|hormones|mesh-ancestor
25276758|NCT02362256|Clonidine|clonidine|mesh-list
25276759|NCT02362256|Naltrexone|naltrexone|mesh-list
25276760|NCT02362256|Lorazepam|lorazepam|mesh-list
25276761|NCT02362256|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25276762|NCT02362256|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25276763|NCT02362256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567787|NCT00792662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25276764|NCT02362256|Sensory System Agents|sensory system agents|mesh-ancestor
25276765|NCT02362256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25276766|NCT02362256|Analgesics|analgesics|mesh-ancestor
25276767|NCT02362256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25276768|NCT02362256|Sympatholytics|sympatholytics|mesh-ancestor
25276769|NCT02362256|Autonomic Agents|autonomic agents|mesh-ancestor
25276770|NCT02362256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25276771|NCT02362256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25276772|NCT02362256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25276773|NCT02362256|Adrenergic Agents|adrenergic agents|mesh-ancestor
25276774|NCT02362256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25276775|NCT02362256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276781|NCT02362256|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25276782|NCT02362256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25276783|NCT02362256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25276784|NCT02362256|GABA Modulators|gaba modulators|mesh-ancestor
25276786|NCT02362152|Diclofenac|diclofenac|mesh-list
25276787|NCT02362152|Fluorouracil|fluorouracil|mesh-list
25276788|NCT02362152|Imiquimod|imiquimod|mesh-list
25276789|NCT02362152|Antimetabolites|antimetabolites|mesh-ancestor
25276790|NCT02362152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276791|NCT02362152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25276792|NCT02362152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25276793|NCT02362152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25276794|NCT02362152|Immunologic Factors|immunologic factors|mesh-ancestor
25039555|NCT03778554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039556|NCT03778554|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25039557|NCT03778554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25039558|NCT03778554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25039559|NCT03778554|Adrenergic Agents|adrenergic agents|mesh-ancestor
25039560|NCT03778554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25039561|NCT03778554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039563|NCT03778554|Protective Agents|protective agents|mesh-ancestor
25039564|NCT03778554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25039565|NCT03778554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25039566|NCT03778554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25039567|NCT03778554|Vasodilator Agents|vasodilator agents|mesh-ancestor
25039568|NCT03778554|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25039569|NCT03778554|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24949418|NCT04813016|Narcotics|narcotics|mesh-ancestor
25039570|NCT03778554|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25039571|NCT03778554|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25039572|NCT03778554|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25039579|NCT03775421|Macitentan|macitentan|mesh-list
25039580|NCT03775421|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25039581|NCT03775421|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24608115|NCT02315326|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25039590|NCT03766295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039592|NCT03766295|Antiviral Agents|antiviral agents|mesh-ancestor
25039593|NCT03766295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25039594|NCT03766295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039595|NCT03766295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25276795|NCT02362152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276796|NCT02362152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25276797|NCT02362152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25276798|NCT02362152|Analgesics|analgesics|mesh-ancestor
25276799|NCT02362152|Sensory System Agents|sensory system agents|mesh-ancestor
25276800|NCT02362152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25276801|NCT02362152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25276802|NCT02362152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25276803|NCT02362152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25276804|NCT02362152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25276805|NCT02362152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25276806|NCT02362152|Interferon Inducers|interferon inducers|mesh-ancestor
25276807|NCT02362165|Dexamethasone|dexamethasone|mesh-list
25276808|NCT02362165|Cyclophosphamide|cyclophosphamide|mesh-list
25276809|NCT02362165|Doxorubicin|doxorubicin|mesh-list
25276810|NCT02362165|Bortezomib|bortezomib|mesh-list
25276811|NCT02362165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25276812|NCT02362165|Immunologic Factors|immunologic factors|mesh-ancestor
25276813|NCT02362165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276814|NCT02362165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25276815|NCT02362165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25276816|NCT02362165|Alkylating Agents|alkylating agents|mesh-ancestor
25276817|NCT02362165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276818|NCT02362165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25276820|NCT02362165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25276821|NCT02362165|Antiemetics|antiemetics|mesh-ancestor
25276822|NCT02362165|Autonomic Agents|autonomic agents|mesh-ancestor
25276823|NCT02362165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25276824|NCT02362165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25276825|NCT02362165|Glucocorticoids|glucocorticoids|mesh-ancestor
25276826|NCT02362165|Hormones|hormones|mesh-ancestor
25276827|NCT02362165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25276828|NCT02362165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25276829|NCT02362165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25276830|NCT02362165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25276831|NCT02362165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25276832|NCT02362165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25276833|NCT02362022|Morphine|morphine|mesh-list
25039605|NCT03761225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25039606|NCT03761225|Glucocorticoids|glucocorticoids|mesh-ancestor
25039607|NCT03761225|Hormones|hormones|mesh-ancestor
24567855|NCT00793195|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25039608|NCT03761225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25039609|NCT03761225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039610|NCT03761225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25039611|NCT03747575|Astegolimab|astegolimab|mesh-list
25039612|NCT03747575|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25039613|NCT03747575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25039614|NCT03747575|Antiviral Agents|antiviral agents|mesh-ancestor
25039615|NCT03747575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25039616|NCT03742518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25039617|NCT03740737|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25039618|NCT03740737|Hormones|hormones|mesh-ancestor
25039619|NCT03740737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25039620|NCT03740737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039621|NCT03738618|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25039622|NCT03738618|Hormones|hormones|mesh-ancestor
25039623|NCT03738618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25039624|NCT03738618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039625|NCT03737123|Gemcitabine|gemcitabine|mesh-list
25039626|NCT03737123|Carboplatin|carboplatin|mesh-list
25039627|NCT03737123|Docetaxel|docetaxel|mesh-list
25039628|NCT03737123|Atezolizumab|atezolizumab|mesh-list
25039629|NCT03737123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25039630|NCT03737123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25039631|NCT03737123|Antimetabolites|antimetabolites|mesh-ancestor
25276834|NCT02362022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25276835|NCT02362022|Narcotics|narcotics|mesh-ancestor
25276836|NCT02362022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25276837|NCT02362022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276838|NCT02362022|Analgesics|analgesics|mesh-ancestor
25276839|NCT02362022|Sensory System Agents|sensory system agents|mesh-ancestor
25276840|NCT02362022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25276841|NCT02361931|Epoetin Alfa|epoetin alfa|mesh-list
25276842|NCT02361931|Hematinics|hematinics|mesh-ancestor
25276843|NCT02361892|Ulipristal acetate|ulipristal acetate|mesh-list
25276844|NCT02361892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25276845|NCT02361892|Contraceptive Agents|contraceptive agents|mesh-ancestor
25276846|NCT02361892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25276847|NCT02361892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276848|NCT02361892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25039632|NCT03737123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039633|NCT03737123|Antiviral Agents|antiviral agents|mesh-ancestor
25039634|NCT03737123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25039635|NCT03737123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039636|NCT03737123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25039637|NCT03737123|Immunologic Factors|immunologic factors|mesh-ancestor
25039638|NCT03737123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393456|NCT00130091|Sensory System Agents|sensory system agents|mesh-ancestor
25039639|NCT03737123|Tubulin Modulators|tubulin modulators|mesh-ancestor
25039640|NCT03737123|Antimitotic Agents|antimitotic agents|mesh-ancestor
25039641|NCT03737123|Mitosis Modulators|mitosis modulators|mesh-ancestor
25039642|NCT03729362|Miglustat|miglustat|mesh-list
25039643|NCT03729362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039644|NCT03729362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039645|NCT03729362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25039665|NCT03721965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039666|NCT03721965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25039667|NCT03721965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25039676|NCT03720613|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25039677|NCT03720613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25039678|NCT03720613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039679|NCT03720613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25039680|NCT03720613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039681|NCT03720613|Sensory System Agents|sensory system agents|mesh-ancestor
25039682|NCT03720613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039683|NCT03712371|Chitosan|chitosan|mesh-list
25039684|NCT03712371|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25039685|NCT03712371|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25276849|NCT02361567|Acetaminophen|acetaminophen|mesh-list
25039686|NCT03712371|Antimetabolites|antimetabolites|mesh-ancestor
25039687|NCT03712371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039688|NCT03712371|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25039689|NCT03712371|Chelating Agents|chelating agents|mesh-ancestor
25039690|NCT03712371|Sequestering Agents|sequestering agents|mesh-ancestor
25039691|NCT03712371|Hemostatics|hemostatics|mesh-ancestor
25039692|NCT03712371|Coagulants|coagulants|mesh-ancestor
25039700|NCT03709121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25276850|NCT02361567|Oxycodone|oxycodone|mesh-list
25276851|NCT02361567|Tramadol|tramadol|mesh-list
25276852|NCT02361567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25276853|NCT02361567|Narcotics|narcotics|mesh-ancestor
25276854|NCT02361567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25276855|NCT02361567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276856|NCT02361567|Analgesics|analgesics|mesh-ancestor
25276857|NCT02361567|Sensory System Agents|sensory system agents|mesh-ancestor
25276858|NCT02361567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25276859|NCT02361567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25276860|NCT02361567|Antipyretics|antipyretics|mesh-ancestor
25276861|NCT02361879|Leuprolide|leuprolide|mesh-list
25276862|NCT02361879|Ulipristal acetate|ulipristal acetate|mesh-list
25276863|NCT02361879|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25276864|NCT02361879|Fertility Agents|fertility agents|mesh-ancestor
25276865|NCT02361879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25276866|NCT02361879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276867|NCT02361879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25276868|NCT02361879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25276869|NCT02361879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25276870|NCT02361879|Contraceptive Agents|contraceptive agents|mesh-ancestor
25276871|NCT02361879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25276872|NCT02361645|Ketorolac|ketorolac|mesh-list
25276873|NCT02361645|Indomethacin|indomethacin|mesh-list
25276874|NCT02361645|Nepafenac|nepafenac|mesh-list
25276875|NCT02361645|Bromfenac|bromfenac|mesh-list
25276876|NCT02361645|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25276877|NCT02361645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25276878|NCT02361645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25276879|NCT02361645|Analgesics|analgesics|mesh-ancestor
25276880|NCT02361645|Sensory System Agents|sensory system agents|mesh-ancestor
25276881|NCT02361645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25276882|NCT02361645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276883|NCT02361645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25276884|NCT02361645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25276885|NCT02361645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25276886|NCT02361645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25276887|NCT02361645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276888|NCT02361645|Gout Suppressants|gout suppressants|mesh-ancestor
25276889|NCT02361645|Tocolytic Agents|tocolytic agents|mesh-ancestor
25276890|NCT02361645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25276891|NCT02361645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25276892|NCT02361502|Mirabegron|mirabegron|mesh-list
25276893|NCT02361502|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25276894|NCT02361502|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25276895|NCT02361502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25692203|NCT01995513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25276896|NCT02361502|Adrenergic Agents|adrenergic agents|mesh-ancestor
25276897|NCT02361502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25276898|NCT02361502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994675|NCT03625323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24994676|NCT03625323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994678|NCT03534947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24994679|NCT03534947|Immunologic Factors|immunologic factors|mesh-ancestor
24994680|NCT03534947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994681|NCT03534947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994682|NCT03534947|Interferon Inducers|interferon inducers|mesh-ancestor
25039714|NCT03704584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25039715|NCT03704584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039716|NCT03704584|Sensory System Agents|sensory system agents|mesh-ancestor
25276899|NCT02361502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276900|NCT02361502|Urological Agents|urological agents|mesh-ancestor
25276902|NCT02361905|Ulipristal acetate|ulipristal acetate|mesh-list
25276903|NCT02361905|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25276904|NCT02361905|Fertility Agents|fertility agents|mesh-ancestor
25276905|NCT02361905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25276906|NCT02361905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276907|NCT02361905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25276908|NCT02361905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25276909|NCT02361905|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25276910|NCT02361905|Contraceptive Agents|contraceptive agents|mesh-ancestor
25276911|NCT02361905|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25276912|NCT02361775|Ropivacaine|ropivacaine|mesh-list
25276913|NCT02361775|Anesthetics, Local|anesthetics, local|mesh-ancestor
25276914|NCT02361775|Anesthetics|anesthetics|mesh-ancestor
25276915|NCT02361775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25276916|NCT02361775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276917|NCT02361775|Sensory System Agents|sensory system agents|mesh-ancestor
25276918|NCT02361775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25276919|NCT02361749|Botulinum Toxins|botulinum toxins|mesh-list
25276920|NCT02361749|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25276921|NCT02361749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25276922|NCT02361749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276923|NCT02361749|Cholinergic Agents|cholinergic agents|mesh-ancestor
25276924|NCT02361749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25276925|NCT02361749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276926|NCT02361619|Clarithromycin|clarithromycin|mesh-list
25276927|NCT02361619|Diclofenac|diclofenac|mesh-list
25276928|NCT02361619|Metoprolol|metoprolol|mesh-list
25276929|NCT02361619|Midazolam|midazolam|mesh-list
25276930|NCT02361619|Caffeine|caffeine|mesh-list
25276931|NCT02361619|Esomeprazole|esomeprazole|mesh-list
25276932|NCT02361619|Dabigatran|dabigatran|mesh-list
25276933|NCT02361619|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25276934|NCT02361619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25276935|NCT02361619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25276936|NCT02361619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276937|NCT02361619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25276938|NCT02361619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25276939|NCT02361619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25276940|NCT02361619|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25276941|NCT02361619|Anesthetics, General|anesthetics, general|mesh-ancestor
25276942|NCT02361619|Anesthetics|anesthetics|mesh-ancestor
25276943|NCT02361619|GABA Modulators|gaba modulators|mesh-ancestor
25276944|NCT02361619|GABA Agents|gaba agents|mesh-ancestor
25276945|NCT02361619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25276946|NCT02361619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25276947|NCT02361619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25276948|NCT02361619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25276949|NCT02361619|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25276950|NCT02361619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039768|NCT03662542|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25039769|NCT03662542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25039770|NCT03662542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25039771|NCT03662542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25039772|NCT03662542|Immunologic Factors|immunologic factors|mesh-ancestor
25039773|NCT03662542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039788|NCT03659929|Dopamine Agents|dopamine agents|mesh-ancestor
25039789|NCT03659929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25039790|NCT03659929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039791|NCT03659929|Adrenergic Agents|adrenergic agents|mesh-ancestor
25039792|NCT03659929|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25039793|NCT03659929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25039794|NCT03659929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25039795|NCT03659929|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25039796|NCT03657797|Latanoprost|latanoprost|mesh-list
25039797|NCT03657797|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25039798|NCT03657797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25039799|NCT03653026|Upadacitinib|upadacitinib|mesh-list
25039800|NCT03653026|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25039801|NCT03653026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25039802|NCT03653026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039803|NCT03653026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039804|NCT03653026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25039805|NCT03647592|Bevacizumab|bevacizumab|mesh-list
25039806|NCT03647592|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25039808|NCT03647592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25039809|NCT03647592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25039810|NCT03647592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25039811|NCT03647592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25039812|NCT03647592|Growth Substances|growth substances|mesh-ancestor
25039813|NCT03647592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039814|NCT03647592|Growth Inhibitors|growth inhibitors|mesh-ancestor
25039815|NCT03647592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25276951|NCT02361619|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25276952|NCT02361619|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25276953|NCT02361619|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25276954|NCT02361619|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25276955|NCT02361619|Purinergic Agents|purinergic agents|mesh-ancestor
25276956|NCT02361619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25276957|NCT02361619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25276958|NCT02361619|Analgesics|analgesics|mesh-ancestor
25276959|NCT02361619|Sensory System Agents|sensory system agents|mesh-ancestor
25276960|NCT02361619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25276961|NCT02361619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25276962|NCT02361619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25276963|NCT02361619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25276964|NCT02361619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25276965|NCT02361619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25276966|NCT02361619|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25276967|NCT02361619|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25276968|NCT02361619|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25276969|NCT02361619|Antithrombins|antithrombins|mesh-ancestor
25276970|NCT02361619|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25276971|NCT02361619|Protease Inhibitors|protease inhibitors|mesh-ancestor
25276972|NCT02361619|Anticoagulants|anticoagulants|mesh-ancestor
25276973|NCT02361619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25276974|NCT02361619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25276975|NCT02361619|Sympatholytics|sympatholytics|mesh-ancestor
25276976|NCT02361619|Autonomic Agents|autonomic agents|mesh-ancestor
25276977|NCT02361619|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25276978|NCT02361619|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25276979|NCT02361619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25276980|NCT02361619|Adrenergic Agents|adrenergic agents|mesh-ancestor
25276981|NCT02361528|Sargramostim|sargramostim|mesh-list
25276982|NCT02361528|Immunologic Factors|immunologic factors|mesh-ancestor
25276983|NCT02361528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276984|NCT02361190|Methyltestosterone|methyltestosterone|mesh-list
25276985|NCT02361190|Testosterone|testosterone|mesh-list
25276986|NCT02361190|Testosterone undecanoate|testosterone undecanoate|mesh-list
25276987|NCT02361190|Testosterone enanthate|testosterone enanthate|mesh-list
25276988|NCT02361190|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25276989|NCT02361190|Androgens|androgens|mesh-ancestor
25276990|NCT02361190|Hormones|hormones|mesh-ancestor
25039825|NCT03646994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25039826|NCT03646994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039827|NCT03646994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039828|NCT03646968|Docetaxel|docetaxel|mesh-list
25039829|NCT03646968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25039830|NCT03646968|Tubulin Modulators|tubulin modulators|mesh-ancestor
25039831|NCT03646968|Antimitotic Agents|antimitotic agents|mesh-ancestor
25039832|NCT03646968|Mitosis Modulators|mitosis modulators|mesh-ancestor
25039833|NCT03646968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039834|NCT03635996|Etripamil|etripamil|mesh-list
25039835|NCT03635996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25039836|NCT03635996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25026549|NCT03627039|Metformin|metformin|mesh-list
25026550|NCT03627039|Dapagliflozin|dapagliflozin|mesh-list
25026551|NCT03627039|Empagliflozin|empagliflozin|mesh-list
25276991|NCT02361190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25276992|NCT02361190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25276993|NCT02361190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25276994|NCT02361190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25276995|NCT02361190|Anabolic Agents|anabolic agents|mesh-ancestor
25276996|NCT02361112|Capecitabine|capecitabine|mesh-list
25276997|NCT02361112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25276998|NCT02361112|Antimetabolites|antimetabolites|mesh-ancestor
25276999|NCT02361112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277000|NCT02361112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25277001|NCT02361177|Oxytocin|oxytocin|mesh-list
25277002|NCT02361177|Oxytocics|oxytocics|mesh-ancestor
25277003|NCT02361177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25277004|NCT02361177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277005|NCT02360956|Olmesartan|olmesartan|mesh-list
25277006|NCT02360956|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25277007|NCT02360956|Antihypertensive Agents|antihypertensive agents|mesh-list
25026552|NCT03627039|Canagliflozin|canagliflozin|mesh-list
25026553|NCT03627039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25026554|NCT03627039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026555|NCT03627039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25026556|NCT03627039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026557|NCT03627013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25039837|NCT03635996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039838|NCT03635996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25039839|NCT03635996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039840|NCT03626545|Docetaxel|docetaxel|mesh-list
25039841|NCT03626545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25039842|NCT03626545|Tubulin Modulators|tubulin modulators|mesh-ancestor
25277011|NCT02360800|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25277012|NCT02360800|Hemostatics|hemostatics|mesh-list
25277013|NCT02360800|Coagulants|coagulants|mesh-ancestor
25277014|NCT02360826|Simvastatin|simvastatin|mesh-list
25277015|NCT02360826|Pravastatin|pravastatin|mesh-list
25277016|NCT02360826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25277017|NCT02360826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25277018|NCT02360826|Antimetabolites|antimetabolites|mesh-ancestor
25277019|NCT02360826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277020|NCT02360826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25039843|NCT03626545|Antimitotic Agents|antimitotic agents|mesh-ancestor
25039854|NCT03624127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25039855|NCT03624127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25039856|NCT03624127|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25039857|NCT03624127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25039858|NCT03624127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039859|NCT03624127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039860|NCT03624127|Dermatologic Agents|dermatologic agents|mesh-ancestor
25039861|NCT03624127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25039862|NCT03617367|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25039863|NCT03617367|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25039864|NCT03617367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25039865|NCT03617367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039866|NCT03617367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039867|NCT03617367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25039868|NCT03617367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25039869|NCT03617367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692204|NCT01995513|Glucocorticoids|glucocorticoids|mesh-ancestor
25692205|NCT01995513|Hormones|hormones|mesh-ancestor
25692206|NCT01995513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25277022|NCT02360826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277023|NCT02361060|Atropine|atropine|mesh-list
25277024|NCT02361060|Neostigmine|neostigmine|mesh-list
25277025|NCT02361060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25277026|NCT02361060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25277027|NCT02361060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25277028|NCT02361060|Autonomic Agents|autonomic agents|mesh-ancestor
25277029|NCT02361060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25277030|NCT02361060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277031|NCT02361060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25277032|NCT02361060|Respiratory System Agents|respiratory system agents|mesh-ancestor
25277033|NCT02361060|Mydriatics|mydriatics|mesh-ancestor
25277034|NCT02361060|Parasympatholytics|parasympatholytics|mesh-ancestor
25277035|NCT02361060|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25277036|NCT02361060|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25277037|NCT02361060|Cholinergic Agents|cholinergic agents|mesh-ancestor
25277038|NCT02361060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25039876|NCT03611881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039877|NCT03611881|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25039878|NCT03611881|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25039879|NCT03611881|Cholinergic Agents|cholinergic agents|mesh-ancestor
25039880|NCT03611881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25039881|NCT03611881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039882|NCT03611751|Apremilast|apremilast|mesh-list
25039883|NCT03611751|BMS-986165|bms-986165|mesh-list
25039884|NCT03611751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25039885|NCT03611751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25039886|NCT03611751|Analgesics|analgesics|mesh-ancestor
25039887|NCT03611751|Sensory System Agents|sensory system agents|mesh-ancestor
25039888|NCT03611751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039889|NCT03611751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039890|NCT03611751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25039891|NCT03611751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25039892|NCT03611751|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24994807|NCT02649673|Topotecan|topotecan|mesh-list
25692207|NCT01995513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692208|NCT01995513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25277039|NCT02361060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277040|NCT02361060|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25277041|NCT02361060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277042|NCT02361060|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25277043|NCT02360982|Fentanyl|fentanyl|mesh-list
25277044|NCT02360982|Propofol|propofol|mesh-list
25277045|NCT02360982|Bupivacaine|bupivacaine|mesh-list
25277046|NCT02360982|Rocuronium|rocuronium|mesh-list
25277047|NCT02360982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25277048|NCT02360982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25277049|NCT02360982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277050|NCT02360982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25277051|NCT02360982|Anesthetics, General|anesthetics, general|mesh-ancestor
25277052|NCT02360982|Anesthetics|anesthetics|mesh-ancestor
25277053|NCT02360982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25277054|NCT02360982|Narcotics|narcotics|mesh-ancestor
25277055|NCT02360982|Analgesics|analgesics|mesh-ancestor
25277056|NCT02360982|Sensory System Agents|sensory system agents|mesh-ancestor
25277057|NCT02360982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25277058|NCT02360982|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25277059|NCT02360982|Anesthetics, Local|anesthetics, local|mesh-ancestor
25277060|NCT02360982|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25277061|NCT02360982|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25277062|NCT02360982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25277063|NCT02360709|Sirolimus|sirolimus|mesh-list
25117016|NCT03105466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25117017|NCT05378061|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
25117018|NCT05378061|Growth Substances|growth substances|mesh-ancestor
25117019|NCT05378061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117020|NCT05378061|Vasodilator Agents|vasodilator agents|mesh-ancestor
25117021|NCT05378061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25117022|NCT05378061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529144|NCT00624754|Formoterol Fumarate|formoterol fumarate|mesh-list
24529145|NCT00624754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24529146|NCT00624754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24529147|NCT00624754|Autonomic Agents|autonomic agents|mesh-ancestor
24529148|NCT00624754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24529149|NCT00624754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529150|NCT00624754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24529151|NCT00624754|Respiratory System Agents|respiratory system agents|mesh-ancestor
24529152|NCT00624754|Glucocorticoids|glucocorticoids|mesh-ancestor
24568732|NCT00797264|Anesthetics|anesthetics|mesh-ancestor
24529154|NCT00624754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24529155|NCT00624754|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24529156|NCT00624754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24529157|NCT00624754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24529158|NCT00624754|Adrenergic Agents|adrenergic agents|mesh-ancestor
24529159|NCT00624754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24529160|NCT00624754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529161|NCT00624767|Insulin|insulin|mesh-list
24529162|NCT00624767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24529163|NCT00624767|Insulin Aspart|insulin aspart|mesh-list
24529164|NCT00624767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24529165|NCT00624767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277064|NCT02360709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25277065|NCT02360709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25277066|NCT02360709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25277067|NCT02360709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25277068|NCT02360709|Antifungal Agents|antifungal agents|mesh-ancestor
25277069|NCT02360709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25277070|NCT02360709|Immunologic Factors|immunologic factors|mesh-ancestor
25277071|NCT02360709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277072|NCT02360644|Vitamin D|vitamin d|mesh-list
25277073|NCT02360644|Cholecalciferol|cholecalciferol|mesh-list
25277085|NCT02360501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277086|NCT02360501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25277089|NCT02360618|Simvastatin|simvastatin|mesh-list
25277090|NCT02360618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25277091|NCT02360618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277092|NCT02360618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25277093|NCT02360618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25277095|NCT02360618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277096|NCT02360618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25277097|NCT02360618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25277098|NCT02360618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277100|NCT02360423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25277101|NCT02360423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25277102|NCT02360423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25277103|NCT02360423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25277104|NCT02360423|Antifungal Agents|antifungal agents|mesh-ancestor
25277105|NCT02360423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25277106|NCT02360423|Immunologic Factors|immunologic factors|mesh-ancestor
25158066|NCT04521621|Pembrolizumab|pembrolizumab|mesh-list
25158067|NCT04521621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25158068|NCT04521621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25158076|NCT04511247|Sirolimus|sirolimus|mesh-list
25158077|NCT04511247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25158078|NCT04511247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25158079|NCT04511247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25158080|NCT04511247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25158081|NCT04511247|Antifungal Agents|antifungal agents|mesh-ancestor
25158082|NCT04511247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25158083|NCT04511247|Immunologic Factors|immunologic factors|mesh-ancestor
25158084|NCT04511247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25158086|NCT04511234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25158087|NCT04511234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25158088|NCT04511234|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25158089|NCT04511234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25158090|NCT04511234|Antifungal Agents|antifungal agents|mesh-ancestor
25158091|NCT04511234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25158092|NCT04511234|Immunologic Factors|immunologic factors|mesh-ancestor
25158093|NCT04511234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277107|NCT02360423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277108|NCT02360592|Interferons|interferons|mesh-list
25277109|NCT02360592|Interferon-alpha|interferon-alpha|mesh-list
25277110|NCT02360592|Interferon alpha-2|interferon alpha-2|mesh-list
25277111|NCT02360592|Entecavir|entecavir|mesh-list
25277112|NCT02360592|Interleukin-2|interleukin-2|mesh-list
25277113|NCT02360592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25277114|NCT02360592|Antiviral Agents|antiviral agents|mesh-ancestor
25277125|NCT02360384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277126|NCT02360384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25158105|NCT04497142|Anticonvulsants|anticonvulsants|mesh-ancestor
25158106|NCT04497142|Nootropic Agents|nootropic agents|mesh-ancestor
25158107|NCT04493619|Carboplatin|carboplatin|mesh-list
25158108|NCT04493619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25158117|NCT04481555|Azithromycin|azithromycin|mesh-list
25158118|NCT04481555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25158119|NCT04481555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25158120|NCT04478838|Olanzapine|olanzapine|mesh-list
25158121|NCT04478838|Risperidone|risperidone|mesh-list
25158122|NCT04478838|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25158123|NCT04478838|Serotonin Agents|serotonin agents|mesh-ancestor
25158124|NCT04478838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25158125|NCT04478838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25158126|NCT04478838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25158127|NCT04478838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25158128|NCT04478838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25158129|NCT04478838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25158130|NCT04478838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25158131|NCT04478838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25158132|NCT04478838|Dopamine Agents|dopamine agents|mesh-ancestor
25158133|NCT04478838|Antiemetics|antiemetics|mesh-ancestor
25158134|NCT04478838|Autonomic Agents|autonomic agents|mesh-ancestor
24994910|NCT00883480|Antimetabolites|antimetabolites|mesh-ancestor
24626563|NCT01087840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626564|NCT01087840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25277127|NCT02360202|Clobetasol|clobetasol|mesh-list
25277128|NCT02360202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25277129|NCT02360202|Glucocorticoids|glucocorticoids|mesh-ancestor
25277130|NCT02360202|Hormones|hormones|mesh-ancestor
25277131|NCT02360202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25277132|NCT02360202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277133|NCT02360046|Hydrocortisone|hydrocortisone|mesh-list
25277134|NCT02360046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25277135|NCT02360254|Insulin|insulin|mesh-list
25277136|NCT02360254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25277137|NCT02360254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277138|NCT02360007|Buprenorphine|buprenorphine|mesh-list
25277139|NCT02360007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25277140|NCT02360007|Narcotics|narcotics|mesh-ancestor
25277141|NCT02360007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25277142|NCT02360007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277143|NCT02360007|Analgesics|analgesics|mesh-ancestor
25277144|NCT02360007|Sensory System Agents|sensory system agents|mesh-ancestor
25277145|NCT02360007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25277146|NCT02360007|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25277147|NCT02359942|Citric Acid|citric acid|mesh-list
25277148|NCT02359942|Sodium Citrate|sodium citrate|mesh-list
25277149|NCT02359942|Anticoagulants|anticoagulants|mesh-ancestor
25277150|NCT02359942|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25277151|NCT02359942|Chelating Agents|chelating agents|mesh-ancestor
25277152|NCT02359942|Sequestering Agents|sequestering agents|mesh-ancestor
25277153|NCT02359942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277154|NCT02359604|Esomeprazole|esomeprazole|mesh-list
25277155|NCT02359604|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25277156|NCT02359604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25277157|NCT02359604|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25277158|NCT02359604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277159|NCT02359604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277160|NCT02359695|Hormones|hormones|mesh-list
25158135|NCT04478838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25158136|NCT04478838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25158137|NCT04478838|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25158138|NCT04478838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25158139|NCT04478838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25117023|NCT05377619|Buspirone|buspirone|mesh-list
25117024|NCT05377619|Prucalopride|prucalopride|mesh-list
25117025|NCT05377619|Laxatives|laxatives|mesh-ancestor
24569133|NCT00799136|Mitosis Modulators|mitosis modulators|mesh-ancestor
25117026|NCT05377619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25117027|NCT05377619|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
25117028|NCT05377619|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25117029|NCT05377619|Serotonin Agents|serotonin agents|mesh-ancestor
25117030|NCT05377619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25117031|NCT05377619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117032|NCT05377619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117033|NCT05377619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25117034|NCT05377619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25117035|NCT05377619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25117036|NCT05377619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25117037|NCT05377606|Temazepam|temazepam|mesh-list
25117038|NCT05377606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25117041|NCT05377606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25117098|NCT05376722|Prednisone|prednisone|mesh-list
25117099|NCT05376722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25117100|NCT05376722|Glucocorticoids|glucocorticoids|mesh-ancestor
25117101|NCT05376722|Hormones|hormones|mesh-ancestor
25117102|NCT05376722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25117103|NCT05376722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107965|NCT03135795|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25692209|NCT01995513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25692210|NCT01995513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25692211|NCT01995513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24437573|NCT00274014|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24437574|NCT00274014|Respiratory System Agents|respiratory system agents|mesh-ancestor
24437575|NCT00274014|Parasympatholytics|parasympatholytics|mesh-ancestor
25277161|NCT02359695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25277162|NCT02359695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277164|NCT02359643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25277165|NCT02359643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25277166|NCT02359643|Analgesics|analgesics|mesh-ancestor
25277167|NCT02359643|Sensory System Agents|sensory system agents|mesh-ancestor
25277168|NCT02359643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25277169|NCT02359643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277170|NCT02359643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25277171|NCT02359643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25277172|NCT02359643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25277173|NCT02359643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25277174|NCT02359643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277175|NCT02359643|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25277176|NCT02359643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25277177|NCT02359643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277178|NCT02359643|Antipyretics|antipyretics|mesh-ancestor
25277179|NCT02359721|Clarithromycin|clarithromycin|mesh-list
25277187|NCT02359617|Insulin|insulin|mesh-list
25277188|NCT02359617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25117106|NCT05376670|Gentamicins|gentamicins|mesh-list
25117107|NCT05376670|Tobramycin|tobramycin|mesh-list
25117108|NCT05376670|Amikacin|amikacin|mesh-list
25117109|NCT05376670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25117110|NCT05376670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25117111|NCT05376670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25117112|NCT05376670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25117113|NCT05376670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458286|NCT00337376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458288|NCT00337376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25277189|NCT02359617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277190|NCT02359292|Charcoal|charcoal|mesh-list
25277191|NCT02359292|Antidotes|antidotes|mesh-ancestor
25277192|NCT02359292|Protective Agents|protective agents|mesh-ancestor
25277193|NCT02359292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277194|NCT02359214|Vitamin D|vitamin d|mesh-list
25277195|NCT02359214|Cholecalciferol|cholecalciferol|mesh-list
25277196|NCT02359214|Vitamins|vitamins|mesh-ancestor
25277197|NCT02359214|Micronutrients|micronutrients|mesh-ancestor
25277198|NCT02359214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277199|NCT02359214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25277200|NCT02359214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25277202|NCT02359370|Magnesium Sulfate|magnesium sulfate|mesh-list
25277203|NCT02359370|Anesthetics, Local|anesthetics, local|mesh-ancestor
25277204|NCT02359370|Anesthetics|anesthetics|mesh-ancestor
25117122|NCT05376202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25117123|NCT05376202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25117124|NCT05376189|Vitamin D|vitamin d|mesh-list
25117125|NCT05376189|Ergocalciferols|ergocalciferols|mesh-list
25117126|NCT05376189|Cholecalciferol|cholecalciferol|mesh-list
25117127|NCT05376189|Vitamins|vitamins|mesh-list
25117128|NCT05376189|Micronutrients|micronutrients|mesh-ancestor
25117129|NCT05376189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117130|NCT05376189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25117131|NCT05376189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24529272|NCT00625209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24529273|NCT00625209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24529274|NCT00625209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529275|NCT00625209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24569340|NCT00800280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533442|NCT00644020|Alkylating Agents|alkylating agents|mesh-ancestor
24437885|NCT00274612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437906|NCT00274677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277205|NCT02359370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25277206|NCT02359370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277207|NCT02359370|Sensory System Agents|sensory system agents|mesh-ancestor
25277208|NCT02359370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25277209|NCT02359370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25277210|NCT02359370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25277211|NCT02359370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25277212|NCT02359370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25277213|NCT02359370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277214|NCT02359370|Analgesics|analgesics|mesh-ancestor
25277215|NCT02359370|Anticonvulsants|anticonvulsants|mesh-ancestor
25277216|NCT02359370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25277218|NCT02359370|Tocolytic Agents|tocolytic agents|mesh-ancestor
24437907|NCT00274677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25008976|NCT03734029|Paclitaxel|paclitaxel|mesh-list
24533449|NCT00644033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533450|NCT00644033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533451|NCT00644085|Aspirin|aspirin|mesh-list
24533452|NCT00644085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24533453|NCT00644085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24437951|NCT00274820|Arsenic Trioxide|arsenic trioxide|mesh-list
24437952|NCT00274820|Vitamins|vitamins|mesh-ancestor
24437953|NCT00274820|Micronutrients|micronutrients|mesh-ancestor
25277221|NCT02359448|Antioxidants|antioxidants|mesh-ancestor
25277222|NCT02359448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277223|NCT02359448|Protective Agents|protective agents|mesh-ancestor
25277224|NCT02359448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277225|NCT02359448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25277226|NCT02359526|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
25277227|NCT02359526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25277228|NCT02359526|Glucocorticoids|glucocorticoids|mesh-ancestor
25277229|NCT02359526|Hormones|hormones|mesh-ancestor
25277230|NCT02359526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25277231|NCT02359526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25158151|NCT04453839|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25158153|NCT04453839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117213|NCT05374356|Bupivacaine|bupivacaine|mesh-list
25277232|NCT02359331|Amoxicillin|amoxicillin|mesh-list
25277233|NCT02359331|Moxifloxacin|moxifloxacin|mesh-list
25277234|NCT02359331|Metronidazole|metronidazole|mesh-list
25277235|NCT02359331|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25277236|NCT02359331|Tetracycline|tetracycline|mesh-list
25277237|NCT02359331|Anti-Infective Agents|anti-infective agents|mesh-list
25277238|NCT02359331|Bismuth|bismuth|mesh-list
25277239|NCT02359331|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25277240|NCT02359331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25277241|NCT02359331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25277242|NCT02359331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277311|NCT02358850|Antitussive Agents|antitussive agents|mesh-ancestor
25277244|NCT02359331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25277245|NCT02359331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25277246|NCT02359331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25277248|NCT02359331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25277249|NCT02359331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25277250|NCT02359266|Vitamin D|vitamin d|mesh-list
25277251|NCT02359266|Cholecalciferol|cholecalciferol|mesh-list
25277252|NCT02359266|Vitamins|vitamins|mesh-ancestor
25277253|NCT02359266|Micronutrients|micronutrients|mesh-ancestor
25277254|NCT02359266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277255|NCT02359266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25277256|NCT02359266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25277257|NCT02359149|Endothelial Growth Factors|endothelial growth factors|mesh-list
25277258|NCT02359149|Growth Substances|growth substances|mesh-ancestor
25277259|NCT02359149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277260|NCT02359500|Octreotide|octreotide|mesh-list
25277261|NCT02359500|Edotreotide|edotreotide|mesh-list
25277262|NCT02359500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25277263|NCT02359500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25277264|NCT02359500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25277265|NCT02359500|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25277266|NCT02359500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277267|NCT02359474|Trabectedin|trabectedin|mesh-list
25277268|NCT02359474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25277269|NCT02359474|Alkylating Agents|alkylating agents|mesh-ancestor
25277270|NCT02359474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277271|NCT02359474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25277272|NCT02358824|Amlodipine|amlodipine|mesh-list
25277273|NCT02358824|Telmisartan|telmisartan|mesh-list
25277274|NCT02358824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25277275|NCT02358824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25277276|NCT02358824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25277277|NCT02358824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277278|NCT02358824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25277279|NCT02358824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277280|NCT02358824|Vasodilator Agents|vasodilator agents|mesh-ancestor
25277281|NCT02358824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25277282|NCT02358824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25277283|NCT02358993|Ciprofloxacin|ciprofloxacin|mesh-list
25277284|NCT02358993|Methenamine hippurate|methenamine hippurate|mesh-list
25277285|NCT02358993|Methenamine mandelate|methenamine mandelate|mesh-list
25277286|NCT02358993|Methenamine|methenamine|mesh-list
25277287|NCT02358993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25277288|NCT02358993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25277289|NCT02358993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25277290|NCT02358993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25277291|NCT02358993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277292|NCT02358993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277293|NCT02358993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25277294|NCT02358993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25277295|NCT02358993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25277296|NCT02358993|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25277297|NCT02358993|Renal Agents|renal agents|mesh-ancestor
25277305|NCT02358850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25692212|NCT01995513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692213|NCT01995513|Hormone Antagonists|hormone antagonists|mesh-ancestor
25277306|NCT02358850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277307|NCT02358850|Antipyretics|antipyretics|mesh-ancestor
25277308|NCT02358850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25277309|NCT02358850|Narcotics|narcotics|mesh-ancestor
25277310|NCT02358850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25277313|NCT02359136|Epinephrine|epinephrine|mesh-list
25277314|NCT02359136|Analgesics|analgesics|mesh-list
25277315|NCT02359136|Anesthetics|anesthetics|mesh-list
25277316|NCT02359136|Ropivacaine|ropivacaine|mesh-list
25277317|NCT02359136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25277318|NCT02359136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277319|NCT02359136|Anesthetics, Local|anesthetics, local|mesh-ancestor
25277320|NCT02359136|Sensory System Agents|sensory system agents|mesh-ancestor
25277321|NCT02359136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25277322|NCT02359136|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25277323|NCT02359136|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25277324|NCT02359136|Adrenergic Agents|adrenergic agents|mesh-ancestor
25277325|NCT02359136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25277326|NCT02359136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277327|NCT02359136|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25277328|NCT02359136|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25117206|NCT05374499|Autonomic Agents|autonomic agents|mesh-ancestor
25117207|NCT05374499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25117208|NCT05374499|Respiratory System Agents|respiratory system agents|mesh-ancestor
25117209|NCT05374499|Mydriatics|mydriatics|mesh-ancestor
25117210|NCT05374499|Sympathomimetics|sympathomimetics|mesh-ancestor
25117211|NCT05374499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25117212|NCT05374356|Morphine|morphine|mesh-list
25117221|NCT05374356|Narcotics|narcotics|mesh-ancestor
25117222|NCT05374356|Analgesics|analgesics|mesh-ancestor
25117223|NCT05374291|Dapagliflozin|dapagliflozin|mesh-list
25117224|NCT05374291|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25117225|NCT05374291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117226|NCT05374291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25117227|NCT05374291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117228|NCT05374252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25117229|NCT05374252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117230|NCT05374252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24529285|NCT00625274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529286|NCT00625274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529287|NCT00625339|Lamivudine|lamivudine|mesh-list
24529288|NCT00625339|Entecavir|entecavir|mesh-list
24995027|NCT05418556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25277329|NCT02359136|Autonomic Agents|autonomic agents|mesh-ancestor
25277330|NCT02359136|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25277331|NCT02359136|Respiratory System Agents|respiratory system agents|mesh-ancestor
25277332|NCT02359136|Mydriatics|mydriatics|mesh-ancestor
25277333|NCT02359136|Sympathomimetics|sympathomimetics|mesh-ancestor
25277334|NCT02359136|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25277344|NCT02359162|Gemcitabine|gemcitabine|mesh-list
25277345|NCT02359162|Prednisone|prednisone|mesh-list
25277346|NCT02359162|Cyclophosphamide|cyclophosphamide|mesh-list
25277347|NCT02359162|Doxorubicin|doxorubicin|mesh-list
25277348|NCT02359162|Oxaliplatin|oxaliplatin|mesh-list
25277349|NCT02359162|Etoposide|etoposide|mesh-list
25277350|NCT02359162|Vincristine|vincristine|mesh-list
25277351|NCT02359162|Pegaspargase|pegaspargase|mesh-list
25277352|NCT02359162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25277353|NCT02359162|Immunologic Factors|immunologic factors|mesh-ancestor
25277354|NCT02359162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277355|NCT02359162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25277356|NCT02359162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25277357|NCT02359162|Alkylating Agents|alkylating agents|mesh-ancestor
25277358|NCT02359162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277359|NCT02359162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25277360|NCT02359162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25277361|NCT02359162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25277362|NCT02359162|Antimetabolites|antimetabolites|mesh-ancestor
25277363|NCT02359162|Antiviral Agents|antiviral agents|mesh-ancestor
25277364|NCT02359162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24529319|NCT00625430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529322|NCT00625430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529323|NCT00625430|Antiviral Agents|antiviral agents|mesh-ancestor
24529324|NCT00625430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24529325|NCT00625456|Molgramostim|molgramostim|mesh-list
24529361|NCT00625677|Vaccines|vaccines|mesh-list
24529362|NCT00625677|Immunologic Factors|immunologic factors|mesh-ancestor
24529392|NCT00625859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529393|NCT00625898|Cyclophosphamide|cyclophosphamide|mesh-list
25277365|NCT02359162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277366|NCT02359162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25277367|NCT02359162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25277368|NCT02359162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25277369|NCT02359162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25277370|NCT02359162|Glucocorticoids|glucocorticoids|mesh-ancestor
25277371|NCT02359162|Hormones|hormones|mesh-ancestor
25277372|NCT02359162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25277373|NCT02359162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25277374|NCT02359162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25277375|NCT02359162|Tubulin Modulators|tubulin modulators|mesh-ancestor
25277376|NCT02359162|Antimitotic Agents|antimitotic agents|mesh-ancestor
25277377|NCT02359162|Mitosis Modulators|mitosis modulators|mesh-ancestor
25277378|NCT02358707|Ibuprofen|ibuprofen|mesh-list
25277379|NCT02358707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25277380|NCT02358707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25277381|NCT02358707|Analgesics|analgesics|mesh-ancestor
25277382|NCT02358707|Sensory System Agents|sensory system agents|mesh-ancestor
25277383|NCT02358707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25277384|NCT02358707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277385|NCT02358707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25277386|NCT02358707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25277387|NCT02358707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25277388|NCT02358707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277389|NCT02358707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277390|NCT02358694|Immunoglobulins|immunoglobulins|mesh-list
25277391|NCT02358694|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25277392|NCT02358694|Antibodies|antibodies|mesh-list
25277393|NCT02358694|Immunologic Factors|immunologic factors|mesh-ancestor
25277394|NCT02358694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277395|NCT02358642|Lisinopril|lisinopril|mesh-list
25158284|NCT04378933|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25158285|NCT04378933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25158286|NCT04378933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25158287|NCT04378933|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25158288|NCT04372940|Tranexamic Acid|tranexamic acid|mesh-list
25158289|NCT04372940|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25158290|NCT04372940|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25158291|NCT04372940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25158293|NCT04372940|Coagulants|coagulants|mesh-ancestor
24701591|NCT01459627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24701592|NCT01459627|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25277396|NCT02358642|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25277397|NCT02358642|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25277398|NCT02358642|Protease Inhibitors|protease inhibitors|mesh-ancestor
25277399|NCT02358642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277400|NCT02358642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25277401|NCT02358642|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25277402|NCT02358642|Protective Agents|protective agents|mesh-ancestor
25277403|NCT02358642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277404|NCT02358499|Posaconazole|posaconazole|mesh-list
25277405|NCT02358499|Antifungal Agents|antifungal agents|mesh-ancestor
25277406|NCT02358499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25277407|NCT02358499|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25277408|NCT02358499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25277409|NCT02358499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25277410|NCT02358499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25277411|NCT02358499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25277412|NCT02358499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277413|NCT02358499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277414|NCT02358499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25277415|NCT02358499|Hormone Antagonists|hormone antagonists|mesh-ancestor
25277416|NCT02358499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25277473|NCT02358161|Immunologic Factors|immunologic factors|mesh-ancestor
25277425|NCT02358304|Vasodilator Agents|vasodilator agents|mesh-ancestor
24701593|NCT01459627|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24701594|NCT01459627|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24438021|NCT00274898|Antimitotic Agents|antimitotic agents|mesh-ancestor
24613333|NCT01018368|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24613334|NCT01018368|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24613335|NCT01018368|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24613336|NCT01018368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24613339|NCT01018381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24613340|NCT01018381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24701611|NCT01459809|Immunologic Factors|immunologic factors|mesh-ancestor
24701652|NCT01460134|Immunologic Factors|immunologic factors|mesh-ancestor
24701653|NCT01460134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701654|NCT01460212|Fluvoxamine|fluvoxamine|mesh-list
25277426|NCT02358265|Cyproheptadine|cyproheptadine|mesh-list
25277427|NCT02358265|Antipruritics|antipruritics|mesh-ancestor
25277428|NCT02358265|Dermatologic Agents|dermatologic agents|mesh-ancestor
25277429|NCT02358265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25277430|NCT02358265|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25277431|NCT02358265|Histamine Antagonists|histamine antagonists|mesh-ancestor
25277432|NCT02358265|Histamine Agents|histamine agents|mesh-ancestor
25277433|NCT02358265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25277434|NCT02358265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277435|NCT02358265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277436|NCT02358265|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25277437|NCT02358265|Serotonin Agents|serotonin agents|mesh-ancestor
25277438|NCT02358265|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25277439|NCT02358057|Dexmedetomidine|dexmedetomidine|mesh-list
25277440|NCT02358057|Alfentanil|alfentanil|mesh-list
25277441|NCT02358057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25277442|NCT02358057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25277443|NCT02358057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277444|NCT02358057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25158319|NCT04351737|Dexamethasone|dexamethasone|mesh-list
25158320|NCT04351737|Prednisolone|prednisolone|mesh-list
25158321|NCT04351737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25158322|NCT04351737|Methylprednisolone|methylprednisolone|mesh-list
25158323|NCT04351737|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25158324|NCT04351737|Prednisolone acetate|prednisolone acetate|mesh-list
25158325|NCT04351737|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25158326|NCT04351737|Prednisolone phosphate|prednisolone phosphate|mesh-list
25158327|NCT04351737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24995152|NCT05417893|Sirolimus|sirolimus|mesh-list
24701655|NCT01460212|Citalopram|citalopram|mesh-list
24701656|NCT01460212|Fluoxetine|fluoxetine|mesh-list
24701657|NCT01460212|Paroxetine|paroxetine|mesh-list
24701658|NCT01460212|Sertraline|sertraline|mesh-list
24701659|NCT01460212|Antidepressive Agents|antidepressive agents|mesh-list
24701660|NCT01460212|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24701661|NCT01460212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24701662|NCT01460212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24701663|NCT01460212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701664|NCT01460212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24701668|NCT01460212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24701669|NCT01460212|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24701670|NCT01460212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24701671|NCT01460212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701672|NCT01460212|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24701679|NCT01460355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24701680|NCT01460355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24701681|NCT01460355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24701682|NCT01460355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701689|NCT01460420|Bortezomib|bortezomib|mesh-list
24701690|NCT01460420|Immunologic Factors|immunologic factors|mesh-ancestor
24701691|NCT01460420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701692|NCT01460420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24701693|NCT01460420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25078246|NCT03357900|Remifentanil|remifentanil|mesh-list
24701694|NCT01460420|Growth Substances|growth substances|mesh-ancestor
24541908|NCT00675779|Atorvastatin|atorvastatin|mesh-list
24701727|NCT01460563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24701729|NCT01460563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24701731|NCT01460602|Bortezomib|bortezomib|mesh-list
24701732|NCT01460602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24701733|NCT01460602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701734|NCT01460602|Immunologic Factors|immunologic factors|mesh-ancestor
24701735|NCT01460602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701758|NCT01460667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277445|NCT02358057|Analgesics|analgesics|mesh-ancestor
25277446|NCT02358057|Sensory System Agents|sensory system agents|mesh-ancestor
25277447|NCT02358057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25277448|NCT02358057|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25277449|NCT02358057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25277450|NCT02358057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25277451|NCT02358057|Adrenergic Agents|adrenergic agents|mesh-ancestor
25277452|NCT02358057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25277453|NCT02358057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277454|NCT02358057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25277455|NCT02358057|Narcotics|narcotics|mesh-ancestor
25277456|NCT02358057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25277457|NCT02358057|Anesthetics, General|anesthetics, general|mesh-ancestor
25277458|NCT02358057|Anesthetics|anesthetics|mesh-ancestor
25158331|NCT04351737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25158332|NCT04351737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25158333|NCT04351737|Glucocorticoids|glucocorticoids|mesh-ancestor
25158334|NCT04351737|Hormones|hormones|mesh-ancestor
25158335|NCT04351737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25158336|NCT04351737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25158337|NCT04351737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25158338|NCT04351737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25158339|NCT04351737|Protective Agents|protective agents|mesh-ancestor
25158340|NCT04347915|Clevudine|clevudine|mesh-list
25158341|NCT04347915|Antiviral Agents|antiviral agents|mesh-ancestor
25158342|NCT04347915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25158343|NCT04347798|Hydroxychloroquine|hydroxychloroquine|mesh-list
25158344|NCT04347798|Chloroquine|chloroquine|mesh-list
25158345|NCT04347798|Antimalarials|antimalarials|mesh-ancestor
25158346|NCT04347798|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24570719|NCT00806169|Hormones|hormones|mesh-ancestor
25158347|NCT04347798|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25158348|NCT04347798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25158349|NCT04347798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25158350|NCT04347798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25158351|NCT04347798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25158352|NCT04347798|Amebicides|amebicides|mesh-ancestor
25158353|NCT04343976|Interferons|interferons|mesh-list
25158354|NCT04343976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701759|NCT01460667|Antipyretics|antipyretics|mesh-ancestor
24701760|NCT01460693|Imatinib Mesylate|imatinib mesylate|mesh-list
24701761|NCT01460693|Dasatinib|dasatinib|mesh-list
24701762|NCT01460693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25277464|NCT02358161|Antimitotic Agents|antimitotic agents|mesh-ancestor
25277465|NCT02358161|Mitosis Modulators|mitosis modulators|mesh-ancestor
25277466|NCT02358161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277467|NCT02358161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25277468|NCT02358161|Antimetabolites|antimetabolites|mesh-ancestor
25277469|NCT02358161|Antiviral Agents|antiviral agents|mesh-ancestor
25277470|NCT02358161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25277471|NCT02358161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277472|NCT02358161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25277476|NCT02357966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25277477|NCT02358187|Poly ICLC|poly iclc|mesh-list
25277478|NCT02358187|Interferon Inducers|interferon inducers|mesh-ancestor
25277479|NCT02358187|Immunologic Factors|immunologic factors|mesh-ancestor
25277480|NCT02358187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277481|NCT02358200|Paclitaxel|paclitaxel|mesh-list
25277482|NCT02358200|Carboplatin|carboplatin|mesh-list
25277483|NCT02358200|Talazoparib|talazoparib|mesh-list
25277484|NCT02358200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25277485|NCT02358200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25158355|NCT04343976|Antiviral Agents|antiviral agents|mesh-ancestor
25158356|NCT04343976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25158381|NCT04326673|Methyltestosterone|methyltestosterone|mesh-list
25692214|NCT01995513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25078265|NCT03357874|Purinergic Agents|purinergic agents|mesh-ancestor
24964409|NCT03783520|Eusol|eusol|mesh-list
25158382|NCT04326673|Testosterone|testosterone|mesh-list
25158383|NCT04326673|Testosterone undecanoate|testosterone undecanoate|mesh-list
25158384|NCT04326673|Testosterone enanthate|testosterone enanthate|mesh-list
25158385|NCT04326673|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25158386|NCT04326673|Androgens|androgens|mesh-ancestor
25158387|NCT04326673|Hormones|hormones|mesh-ancestor
24701763|NCT01460693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24701764|NCT01460693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701820|NCT01461174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25277489|NCT02358200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277490|NCT02358200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25277492|NCT02358018|Edotreotide|edotreotide|mesh-list
25277493|NCT02358018|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25277494|NCT02358018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277495|NCT02357797|Vortioxetine|vortioxetine|mesh-list
25277496|NCT02357797|Antidepressive Agents|antidepressive agents|mesh-ancestor
25277497|NCT02357797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25277498|NCT02357797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25277499|NCT02357797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25277500|NCT02357797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25277501|NCT02357797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277502|NCT02357797|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25277503|NCT02357797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25277504|NCT02357797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25277505|NCT02357797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277506|NCT02357797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25277507|NCT02357797|Serotonin Agents|serotonin agents|mesh-ancestor
25277508|NCT02357797|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25277509|NCT02357797|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25277510|NCT02357797|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25277511|NCT02357797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25277512|NCT02357849|Aripiprazole|aripiprazole|mesh-list
25277513|NCT02357849|Fluoxetine|fluoxetine|mesh-list
25277514|NCT02357849|Antidepressive Agents|antidepressive agents|mesh-ancestor
25277515|NCT02357849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25277516|NCT02357849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25158397|NCT04307953|Saracatinib|saracatinib|mesh-list
25158398|NCT04307953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25158399|NCT04307953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25158400|NCT04307953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701768|NCT01460706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701769|NCT01460797|Metformin|metformin|mesh-list
24701770|NCT01460797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24701779|NCT01460888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701780|NCT01460888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701782|NCT01460979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24701783|NCT01460979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24701784|NCT01460979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24701785|NCT01460979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701787|NCT01460979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24701789|NCT01460979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701790|NCT01461018|Immunoglobulins|immunoglobulins|mesh-list
24701791|NCT01461018|Antibodies|antibodies|mesh-list
24701798|NCT01461031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24701800|NCT01461031|Sensory System Agents|sensory system agents|mesh-ancestor
24701803|NCT01461174|Memantine|memantine|mesh-list
24701817|NCT01461174|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24701818|NCT01461174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24701819|NCT01461174|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25277521|NCT02357849|Dopamine Agents|dopamine agents|mesh-ancestor
25277522|NCT02357849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25277523|NCT02357849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277524|NCT02357849|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25277525|NCT02357849|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25277526|NCT02357849|Serotonin Agents|serotonin agents|mesh-ancestor
25692215|NCT01995526|Insulin|insulin|mesh-list
25692216|NCT01995526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25692217|NCT01995526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692218|NCT01995825|Lamotrigine|lamotrigine|mesh-list
25692219|NCT01995825|Anticonvulsants|anticonvulsants|mesh-list
25692220|NCT01995825|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25108038|NCT03134872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24701825|NCT01461460|Oxazolidinones|oxazolidinones|mesh-list
24701826|NCT01461460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24701827|NCT01461460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24701836|NCT01461577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701838|NCT01461616|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24701839|NCT01461616|Insulin Glargine|insulin glargine|mesh-list
24701840|NCT01461616|Insulin Detemir|insulin detemir|mesh-list
24701841|NCT01461616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24701974|NCT01463163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701975|NCT01463163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277533|NCT02357849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25277534|NCT02357849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25277535|NCT02357849|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25277536|NCT02357849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25277537|NCT02357849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277539|NCT02357693|Antiemetics|antiemetics|mesh-ancestor
25277540|NCT02357693|Autonomic Agents|autonomic agents|mesh-ancestor
25277541|NCT02357693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25277542|NCT02357693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277543|NCT02357693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25277544|NCT02357693|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24950932|NCT03909776|Cisplatin|cisplatin|mesh-list
25277545|NCT02357693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25277546|NCT02357693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277547|NCT02357732|Nivolumab|nivolumab|mesh-list
25277548|NCT02357732|Trametinib|trametinib|mesh-list
25277549|NCT02357732|Dabrafenib|dabrafenib|mesh-list
25277550|NCT02357732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25277551|NCT02357732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25277552|NCT02357732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25277553|NCT02357732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277554|NCT02357732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25277555|NCT02357732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277556|NCT02357524|Oritavancin|oritavancin|mesh-list
25277557|NCT02357524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25277558|NCT02357524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25277559|NCT02357537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25277560|NCT02357563|Leuprolide|leuprolide|mesh-list
25277561|NCT02357563|Ulipristal acetate|ulipristal acetate|mesh-list
25277562|NCT02357563|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25277563|NCT02357563|Fertility Agents|fertility agents|mesh-ancestor
25277564|NCT02357563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25277565|NCT02357563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277566|NCT02357563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25277567|NCT02357563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25277568|NCT02357563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25277569|NCT02357563|Contraceptive Agents|contraceptive agents|mesh-ancestor
25277570|NCT02357563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25277571|NCT02357615|Nifedipine|nifedipine|mesh-list
25277572|NCT02357615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25277573|NCT02357615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25277574|NCT02357615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277575|NCT02357615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25277576|NCT02357615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277577|NCT02357615|Vasodilator Agents|vasodilator agents|mesh-ancestor
25277578|NCT02357615|Tocolytic Agents|tocolytic agents|mesh-ancestor
25277579|NCT02357615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25277580|NCT02357602|Tenofovir|tenofovir|mesh-list
25277581|NCT02357602|Antiviral Agents|antiviral agents|mesh-ancestor
25277582|NCT02357602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25277583|NCT02357602|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25277584|NCT02357602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25277585|NCT02357602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277586|NCT02357602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277587|NCT02357602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25277588|NCT02357602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24701984|NCT01463228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701996|NCT01463280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701998|NCT01463332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24701999|NCT01463332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24702000|NCT01463332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702001|NCT01463332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24702002|NCT01463332|Analgesics|analgesics|mesh-ancestor
24702003|NCT01463332|Sensory System Agents|sensory system agents|mesh-ancestor
24702004|NCT01463332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24702005|NCT01463332|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25277589|NCT02357472|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25277590|NCT02357472|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25277591|NCT02357472|Immunologic Factors|immunologic factors|mesh-ancestor
25277592|NCT02357472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277593|NCT02357303|Acetylcysteine|acetylcysteine|mesh-list
25277594|NCT02357303|Simethicone|simethicone|mesh-list
25277595|NCT02357303|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25277596|NCT02357303|Antiviral Agents|antiviral agents|mesh-ancestor
25277597|NCT02357303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25277598|NCT02357303|Expectorants|expectorants|mesh-ancestor
24571434|NCT00809874|Caseins|caseins|mesh-list
25277599|NCT02357303|Respiratory System Agents|respiratory system agents|mesh-ancestor
25277600|NCT02357303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25277601|NCT02357303|Antioxidants|antioxidants|mesh-ancestor
25277602|NCT02357303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277603|NCT02357303|Protective Agents|protective agents|mesh-ancestor
25277604|NCT02357303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277605|NCT02357303|Antidotes|antidotes|mesh-ancestor
25277606|NCT02357303|Antifoaming Agents|antifoaming agents|mesh-ancestor
25277607|NCT02357303|Emollients|emollients|mesh-ancestor
25277608|NCT02357303|Dermatologic Agents|dermatologic agents|mesh-ancestor
25277609|NCT02357277|Budesonide|budesonide|mesh-list
25277610|NCT02357277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25277611|NCT02357277|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25277612|NCT02357277|Autonomic Agents|autonomic agents|mesh-ancestor
25277613|NCT02357277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25277614|NCT02357277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277615|NCT02357277|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25277616|NCT02357277|Respiratory System Agents|respiratory system agents|mesh-ancestor
25158450|NCT04297267|Antiviral Agents|antiviral agents|mesh-ancestor
25158451|NCT04297267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25158452|NCT04297267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25158453|NCT04297267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25158454|NCT04297267|Immunologic Factors|immunologic factors|mesh-ancestor
25158455|NCT04297267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25158469|NCT04283513|Ribavirin|ribavirin|mesh-list
25158470|NCT04283513|Antimetabolites|antimetabolites|mesh-ancestor
25158471|NCT04283513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613387|NCT01018823|Ertugliflozin|ertugliflozin|mesh-list
24702023|NCT01463592|Antimetabolites|antimetabolites|mesh-ancestor
24702024|NCT01463592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571668|NCT00811226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24571669|NCT00811226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24702025|NCT01463592|Immunologic Factors|immunologic factors|mesh-ancestor
24702057|NCT01463852|Tubulin Modulators|tubulin modulators|mesh-ancestor
24702058|NCT01463852|Antimitotic Agents|antimitotic agents|mesh-ancestor
24702059|NCT01463852|Mitosis Modulators|mitosis modulators|mesh-ancestor
24702060|NCT01463852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702061|NCT01463865|Ropivacaine|ropivacaine|mesh-list
24702062|NCT01463865|Anesthetics, Local|anesthetics, local|mesh-ancestor
25277617|NCT02357277|Glucocorticoids|glucocorticoids|mesh-ancestor
25277618|NCT02357277|Hormones|hormones|mesh-ancestor
25277619|NCT02357277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25277620|NCT02357407|Ciprofloxacin|ciprofloxacin|mesh-list
25277621|NCT02357407|Ofloxacin|ofloxacin|mesh-list
25692221|NCT01995825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25277622|NCT02357407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25277623|NCT02357407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25277624|NCT02357407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25277625|NCT02357407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25277626|NCT02357407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277627|NCT02357407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277628|NCT02357407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25277629|NCT02357407|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25277630|NCT02357407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25277631|NCT02357407|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25277632|NCT02357407|Renal Agents|renal agents|mesh-ancestor
25277633|NCT02357225|Bromides|bromides|mesh-list
25277634|NCT02357225|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
25277635|NCT02357225|Anticonvulsants|anticonvulsants|mesh-ancestor
25277636|NCT02357225|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25277637|NCT02357225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277638|NCT02357225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277639|NCT02357225|Cholinergic Agents|cholinergic agents|mesh-ancestor
25277640|NCT02357225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25277647|NCT02357212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25277648|NCT02357212|Vasodilator Agents|vasodilator agents|mesh-ancestor
25277649|NCT02357212|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25277650|NCT02357212|Purinergic Agonists|purinergic agonists|mesh-ancestor
25277651|NCT02357212|Purinergic Agents|purinergic agents|mesh-ancestor
25277652|NCT02357212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25277653|NCT02357212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277655|NCT02357004|Chlorthalidone|chlorthalidone|mesh-list
25277656|NCT02357004|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25277657|NCT02357004|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25277658|NCT02357004|Adrenergic Agents|adrenergic agents|mesh-ancestor
25277659|NCT02357004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25277660|NCT02357004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277661|NCT02357004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277662|NCT02357004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25277663|NCT02357004|Antioxidants|antioxidants|mesh-ancestor
25277664|NCT02357004|Protective Agents|protective agents|mesh-ancestor
25277665|NCT02357004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25277666|NCT02357004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25277667|NCT02357004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25277668|NCT02357004|Vasodilator Agents|vasodilator agents|mesh-ancestor
25277669|NCT02357004|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25277670|NCT02357004|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25277671|NCT02357004|Diuretics|diuretics|mesh-ancestor
25277672|NCT02357004|Natriuretic Agents|natriuretic agents|mesh-ancestor
25277673|NCT02357004|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25277674|NCT02357069|Etanercept|etanercept|mesh-list
25277675|NCT02357069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25277676|NCT02357069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25277677|NCT02357069|Analgesics|analgesics|mesh-ancestor
25158518|NCT04258488|Vitamin K|vitamin k|mesh-list
25158519|NCT04258488|Warfarin|warfarin|mesh-list
25158520|NCT04258488|Rivaroxaban|rivaroxaban|mesh-list
25158521|NCT04258488|Vitamins|vitamins|mesh-ancestor
25158522|NCT04258488|Micronutrients|micronutrients|mesh-ancestor
25158523|NCT04258488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25158524|NCT04258488|Anticoagulants|anticoagulants|mesh-ancestor
25158525|NCT04258488|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25158526|NCT04258488|Antithrombins|antithrombins|mesh-ancestor
25158527|NCT04258488|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25158528|NCT04258488|Protease Inhibitors|protease inhibitors|mesh-ancestor
25158529|NCT04258488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25158530|NCT04258488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25158531|NCT04258488|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25158532|NCT04258488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25158533|NCT04258488|Hemostatics|hemostatics|mesh-ancestor
25158534|NCT04258488|Coagulants|coagulants|mesh-ancestor
25158535|NCT04254692|Bupivacaine|bupivacaine|mesh-list
25117488|NCT05122598|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
25117489|NCT05122598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798002|NCT01959477|Busulfan|busulfan|mesh-list
24702063|NCT01463865|Anesthetics|anesthetics|mesh-ancestor
24702064|NCT01463865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24702065|NCT01463865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702066|NCT01463865|Sensory System Agents|sensory system agents|mesh-ancestor
24702067|NCT01463865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24702068|NCT01463956|Interferons|interferons|mesh-list
24702070|NCT01463956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24702071|NCT01463956|Antiviral Agents|antiviral agents|mesh-ancestor
24702072|NCT01463956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24702073|NCT01463956|Antimetabolites|antimetabolites|mesh-ancestor
24702125|NCT01464112|Bortezomib|bortezomib|mesh-list
24702126|NCT01464112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24702127|NCT01464112|Antiemetics|antiemetics|mesh-ancestor
24702128|NCT01464112|Autonomic Agents|autonomic agents|mesh-ancestor
24702132|NCT01464112|Glucocorticoids|glucocorticoids|mesh-ancestor
24702148|NCT01464138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702149|NCT01464138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702150|NCT01464242|Meglumine Antimoniate|meglumine antimoniate|mesh-list
24702152|NCT01464242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24702153|NCT01464242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702154|NCT01464242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702155|NCT01464242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24702156|NCT01464242|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24702157|NCT01464242|Protective Agents|protective agents|mesh-ancestor
24702158|NCT01464242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702159|NCT01464242|Vasodilator Agents|vasodilator agents|mesh-ancestor
25277678|NCT02357069|Sensory System Agents|sensory system agents|mesh-ancestor
25277679|NCT02357069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25277680|NCT02357069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277681|NCT02357069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25277682|NCT02357069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25277683|NCT02357069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25277684|NCT02357069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25277685|NCT02357069|Immunologic Factors|immunologic factors|mesh-ancestor
25277686|NCT02356913|Nicotine|nicotine|mesh-list
25277687|NCT02356913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25277688|NCT02356913|Autonomic Agents|autonomic agents|mesh-ancestor
25277689|NCT02356913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25277690|NCT02356913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277691|NCT02356913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25277692|NCT02356913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25277693|NCT02356913|Cholinergic Agents|cholinergic agents|mesh-ancestor
25277694|NCT02356913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25277695|NCT02356913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277696|NCT02356965|Ketamine|ketamine|mesh-list
25277697|NCT02356965|Analgesics|analgesics|mesh-ancestor
25277698|NCT02356965|Sensory System Agents|sensory system agents|mesh-ancestor
25277699|NCT02356965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25277700|NCT02356965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277701|NCT02356965|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25117490|NCT05115123|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25117491|NCT05115123|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25117492|NCT05115123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25117493|NCT05115123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25117494|NCT05115123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117495|NCT05115123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25117496|NCT05115123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117498|NCT05115123|Sensory System Agents|sensory system agents|mesh-ancestor
25117499|NCT05115123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25117500|NCT05115123|Antidepressive Agents|antidepressive agents|mesh-ancestor
25117501|NCT05115123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25117502|NCT05115123|Dopamine Agents|dopamine agents|mesh-ancestor
25117503|NCT05092451|Vidarabine|vidarabine|mesh-list
25117504|NCT05092451|Cyclophosphamide|cyclophosphamide|mesh-list
25117505|NCT05092451|Fludarabine|fludarabine|mesh-list
25117506|NCT05092451|Fludarabine phosphate|fludarabine phosphate|mesh-list
25117507|NCT05092451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25117508|NCT05092451|Immunologic Factors|immunologic factors|mesh-ancestor
25117509|NCT05092451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117510|NCT05092451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25117511|NCT05092451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25117512|NCT05092451|Alkylating Agents|alkylating agents|mesh-ancestor
25117513|NCT05092451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117514|NCT05092451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25117515|NCT05092451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25117516|NCT05092451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24798018|NCT01959828|Nitric Oxide|nitric oxide|mesh-list
24702160|NCT01464242|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24702161|NCT01464242|Antioxidants|antioxidants|mesh-ancestor
24702162|NCT01464242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24702163|NCT01464242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24702164|NCT01464242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24702165|NCT01464281|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24702166|NCT01464281|Antiviral Agents|antiviral agents|mesh-ancestor
24702167|NCT01464281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24702168|NCT01464450|Rivaroxaban|rivaroxaban|mesh-list
24702201|NCT01464528|Immunologic Factors|immunologic factors|mesh-ancestor
24702202|NCT01464528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702203|NCT01464528|Viscosupplements|viscosupplements|mesh-ancestor
24702204|NCT01464528|Protective Agents|protective agents|mesh-ancestor
24702205|NCT01464593|Doxorubicin|doxorubicin|mesh-list
24702206|NCT01464593|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24702207|NCT01464593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24702208|NCT01464593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25277702|NCT02356965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25277703|NCT02356965|Anesthetics, General|anesthetics, general|mesh-ancestor
25277704|NCT02356965|Anesthetics|anesthetics|mesh-ancestor
25277705|NCT02356965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25277706|NCT02356965|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25277707|NCT02356965|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25277708|NCT02356965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25277709|NCT02356965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277710|NCT02356835|Nitric Oxide|nitric oxide|mesh-list
25277711|NCT02356835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25277712|NCT02356835|Autonomic Agents|autonomic agents|mesh-ancestor
25277713|NCT02356835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25277714|NCT02356835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277715|NCT02356835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25277716|NCT02356835|Respiratory System Agents|respiratory system agents|mesh-ancestor
25277717|NCT02356835|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25277718|NCT02356835|Antioxidants|antioxidants|mesh-ancestor
25277719|NCT02356835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277720|NCT02356835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25277721|NCT02356835|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25277722|NCT02356835|Vasodilator Agents|vasodilator agents|mesh-ancestor
25277723|NCT02356835|Gasotransmitters|gasotransmitters|mesh-ancestor
25277724|NCT02356835|Protective Agents|protective agents|mesh-ancestor
25277725|NCT02356445|Methotrexate|methotrexate|mesh-list
25277726|NCT02356445|Azathioprine|azathioprine|mesh-list
25277728|NCT02356445|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25277729|NCT02356445|Abortifacient Agents|abortifacient agents|mesh-ancestor
25277730|NCT02356445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25158543|NCT04249596|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24702209|NCT01464593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24702210|NCT01464593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24702211|NCT01464593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702217|NCT01464606|Vincristine|vincristine|mesh-list
24702218|NCT01464606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24702219|NCT01464606|Immunologic Factors|immunologic factors|mesh-ancestor
24702220|NCT01464606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438879|NCT00276835|Protective Agents|protective agents|mesh-ancestor
24613389|NCT01018823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613390|NCT01018823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24613391|NCT01018823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702308|NCT01465009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24702309|NCT01465009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702310|NCT01465009|Antipyretics|antipyretics|mesh-ancestor
24702311|NCT01465074|Nicotine|nicotine|mesh-list
24702312|NCT01465074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24702313|NCT01465074|Autonomic Agents|autonomic agents|mesh-ancestor
24703027|NCT01469416|Clopidogrel|clopidogrel|mesh-list
25277739|NCT02356445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25277740|NCT02356445|Immunologic Factors|immunologic factors|mesh-ancestor
25277741|NCT02356445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25277742|NCT02356445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25277743|NCT02356445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25277744|NCT02356640|Levobupivacaine|levobupivacaine|mesh-list
25277745|NCT02356640|Anesthetics, Local|anesthetics, local|mesh-ancestor
25277746|NCT02356640|Anesthetics|anesthetics|mesh-ancestor
25277747|NCT02356640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25158545|NCT04249596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25158556|NCT04236609|Sirolimus|sirolimus|mesh-list
25158557|NCT04236609|Everolimus|everolimus|mesh-list
25158558|NCT04236609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25158559|NCT04236609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25158560|NCT04236609|Immunologic Factors|immunologic factors|mesh-ancestor
25158561|NCT04236609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25158562|NCT04236609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25158563|NCT04236609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25158564|NCT04236609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25158565|NCT04236609|Antifungal Agents|antifungal agents|mesh-ancestor
25158566|NCT04227275|Cyclophosphamide|cyclophosphamide|mesh-list
25158567|NCT04227275|Fludarabine|fludarabine|mesh-list
25158568|NCT04227275|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25158569|NCT04227275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25158570|NCT04227275|Immunologic Factors|immunologic factors|mesh-ancestor
25158571|NCT04227275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25158572|NCT04227275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25158573|NCT04227275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25158574|NCT04227275|Alkylating Agents|alkylating agents|mesh-ancestor
25158575|NCT04227275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277748|NCT02356640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277749|NCT02356640|Sensory System Agents|sensory system agents|mesh-ancestor
25277750|NCT02356640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24572214|NCT00813722|Natriuretic Agents|natriuretic agents|mesh-ancestor
24572215|NCT00813722|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24702346|NCT01465256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24702347|NCT01465256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702349|NCT01465256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24702350|NCT01465256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24702351|NCT01465256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24702358|NCT01465373|Progestins|progestins|mesh-ancestor
24702359|NCT01465373|Hormones|hormones|mesh-ancestor
24702360|NCT01465373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24702361|NCT01465373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277751|NCT02356679|Ethanol|ethanol|mesh-list
25277752|NCT02356679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25277753|NCT02356679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25277754|NCT02356679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25277755|NCT02356679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277756|NCT02356146|Tacrolimus|tacrolimus|mesh-list
25277757|NCT02356146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25277758|NCT02356146|Immunologic Factors|immunologic factors|mesh-ancestor
25277759|NCT02356146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277760|NCT02356146|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25277761|NCT02356146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277762|NCT02356146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277763|NCT02356328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25277764|NCT02356328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25277765|NCT02356419|Epoetin Alfa|epoetin alfa|mesh-list
25277766|NCT02356419|Hematinics|hematinics|mesh-ancestor
25277767|NCT02356341|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25277768|NCT02356341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25277769|NCT02355756|Maxadilan protein, insect|maxadilan protein, insect|mesh-list
25277770|NCT02355756|Vasodilator Agents|vasodilator agents|mesh-ancestor
25277771|NCT02355938|Vancomycin|vancomycin|mesh-list
25277772|NCT02355938|Fidaxomicin|fidaxomicin|mesh-list
25277773|NCT02355938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25277774|NCT02355938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24702362|NCT01465399|Mitogens|mitogens|mesh-list
24702363|NCT01465399|Mitosis Modulators|mitosis modulators|mesh-ancestor
24702387|NCT01465685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702388|NCT01465685|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24703097|NCT01469598|Tubulin Modulators|tubulin modulators|mesh-ancestor
24702418|NCT01465867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702419|NCT01465867|Trace Elements|trace elements|mesh-ancestor
24702420|NCT01465867|Micronutrients|micronutrients|mesh-ancestor
24702422|NCT01465893|Ergocalciferols|ergocalciferols|mesh-list
24702423|NCT01465893|Cholecalciferol|cholecalciferol|mesh-list
24702424|NCT01465893|Vitamins|vitamins|mesh-list
24702425|NCT01465893|Micronutrients|micronutrients|mesh-ancestor
24702426|NCT01465893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702427|NCT01465893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24702428|NCT01465893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24702429|NCT01465906|Bromides|bromides|mesh-list
24702430|NCT01465906|Tiotropium Bromide|tiotropium bromide|mesh-list
24702431|NCT01465906|Tulobuterol|tulobuterol|mesh-list
24702432|NCT01465906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24702433|NCT01465906|Autonomic Agents|autonomic agents|mesh-ancestor
24702434|NCT01465906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24885518|NCT05171530|Lenvatinib|lenvatinib|mesh-list
24702435|NCT01465906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702436|NCT01465906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24702437|NCT01465906|Respiratory System Agents|respiratory system agents|mesh-ancestor
24702438|NCT01465906|Parasympatholytics|parasympatholytics|mesh-ancestor
24702454|NCT01465919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702455|NCT01465919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702456|NCT01465919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24702457|NCT01465919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24702458|NCT01465919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24702459|NCT01465919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24702460|NCT01465919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24702461|NCT01465919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24702462|NCT01465919|Adrenergic Agents|adrenergic agents|mesh-ancestor
25277775|NCT02355704|Atorvastatin|atorvastatin|mesh-list
25277776|NCT02355704|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25277777|NCT02355704|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25277778|NCT02355704|Antimetabolites|antimetabolites|mesh-ancestor
25277779|NCT02355704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277780|NCT02355704|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25277781|NCT02355704|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25277782|NCT02355704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277783|NCT02355678|Acetaminophen|acetaminophen|mesh-list
25277784|NCT02355678|Dexamethasone|dexamethasone|mesh-list
25277785|NCT02355678|Propacetamol|propacetamol|mesh-list
25277786|NCT02355678|Tramadol|tramadol|mesh-list
25277787|NCT02355678|Anesthetics|anesthetics|mesh-list
25277788|NCT02355678|Anesthetics, Local|anesthetics, local|mesh-list
25277789|NCT02355678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25277790|NCT02355678|Antiemetics|antiemetics|mesh-ancestor
25277791|NCT02355678|Autonomic Agents|autonomic agents|mesh-ancestor
25277792|NCT02355678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24702463|NCT01465919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24702464|NCT01465919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24702465|NCT01465919|Serotonin Agents|serotonin agents|mesh-ancestor
24702466|NCT01465919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24702468|NCT01465984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24702469|NCT01465984|Analgesics|analgesics|mesh-ancestor
24702470|NCT01465984|Sensory System Agents|sensory system agents|mesh-ancestor
24702471|NCT01465984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24702472|NCT01465984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702473|NCT01465984|Antipyretics|antipyretics|mesh-ancestor
24702498|NCT01466114|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24702509|NCT01466231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24702510|NCT01466231|Immunologic Factors|immunologic factors|mesh-ancestor
24702540|NCT01466465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24702542|NCT01466478|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24702543|NCT01466478|Calcipotriene|calcipotriene|mesh-list
24702544|NCT01466478|Dermatologic Agents|dermatologic agents|mesh-ancestor
24702545|NCT01466478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24702641|NCT01467011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24702642|NCT01467011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25277793|NCT02355678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277794|NCT02355678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25277795|NCT02355678|Glucocorticoids|glucocorticoids|mesh-ancestor
25277796|NCT02355678|Hormones|hormones|mesh-ancestor
25277797|NCT02355678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25277798|NCT02355678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25277799|NCT02355678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25277800|NCT02355678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25277801|NCT02355678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25277802|NCT02355678|Analgesics|analgesics|mesh-ancestor
25277803|NCT02355678|Sensory System Agents|sensory system agents|mesh-ancestor
25277804|NCT02355678|Antipyretics|antipyretics|mesh-ancestor
25277805|NCT02355678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25277806|NCT02355678|Narcotics|narcotics|mesh-ancestor
25277807|NCT02355678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25277808|NCT02355678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25277809|NCT02355431|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25277810|NCT02355431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25158651|NCT04193774|Anesthetics|anesthetics|mesh-list
25158652|NCT04193774|Benoxinate|benoxinate|mesh-list
25692222|NCT01995825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25158653|NCT04193774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25158654|NCT04193774|Lubricant Eye Drops|lubricant eye drops|mesh-list
25158655|NCT04193774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25158656|NCT04193774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25158657|NCT04193774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25158658|NCT04193774|Anesthetics, Local|anesthetics, local|mesh-ancestor
24702643|NCT01467011|Antitubercular Agents|antitubercular agents|mesh-ancestor
24702644|NCT01467011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24702645|NCT01467011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24702646|NCT01467011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702647|NCT01467011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613393|NCT01018836|Anticonvulsants|anticonvulsants|mesh-ancestor
24613394|NCT01018836|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24613395|NCT01018836|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24613396|NCT01018836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24613397|NCT01018836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613399|NCT01018836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24613400|NCT01018836|Protective Agents|protective agents|mesh-ancestor
24613402|NCT01018849|Cholecalciferol|cholecalciferol|mesh-list
24613403|NCT01018849|Vitamins|vitamins|mesh-ancestor
24702677|NCT01467141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24702678|NCT01467141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702679|NCT01467219|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24702680|NCT01467219|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24702681|NCT01467219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702682|NCT01467232|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24702683|NCT01467258|Amantadine|amantadine|mesh-list
24702684|NCT01467258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24702685|NCT01467258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24702686|NCT01467258|Antiviral Agents|antiviral agents|mesh-ancestor
24702687|NCT01467258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24702689|NCT01467258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24702696|NCT01467297|Levofloxacin|levofloxacin|mesh-list
24702697|NCT01467297|Ofloxacin|ofloxacin|mesh-list
24702698|NCT01467297|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24702699|NCT01467297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24702700|NCT01467297|Renal Agents|renal agents|mesh-ancestor
24702701|NCT01467297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24702702|NCT01467297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24702703|NCT01467297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24702704|NCT01467297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277813|NCT02355431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277815|NCT02355522|Anesthetics, Local|anesthetics, local|mesh-ancestor
25277816|NCT02355522|Anesthetics|anesthetics|mesh-ancestor
25277817|NCT02355522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25277818|NCT02355522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277819|NCT02355522|Sensory System Agents|sensory system agents|mesh-ancestor
25277977|NCT02354547|Cyclophosphamide|cyclophosphamide|mesh-list
25277820|NCT02355522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25277821|NCT02355522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25277822|NCT02355522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25277823|NCT02355522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25158659|NCT04193774|Sensory System Agents|sensory system agents|mesh-ancestor
25158660|NCT04193774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25158673|NCT04186871|Abatacept|abatacept|mesh-list
25158674|NCT04186871|Branebrutinib|branebrutinib|mesh-list
25158675|NCT04186871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25158676|NCT04186871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25158677|NCT04186871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25158678|NCT04186871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25158679|NCT04186871|Immunologic Factors|immunologic factors|mesh-ancestor
25158680|NCT04186871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25158681|NCT04186871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25158682|NCT04186871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25158683|NCT04186871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702810|NCT01467986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702811|NCT01467986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24702812|NCT01467986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24702813|NCT01467986|Alkylating Agents|alkylating agents|mesh-ancestor
24702814|NCT01467986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24702815|NCT01467986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24702816|NCT01467986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24702817|NCT01467986|Antifungal Agents|antifungal agents|mesh-ancestor
24702818|NCT01467986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25692223|NCT01995825|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25692224|NCT01995825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462984|NCT00358293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24462985|NCT00358293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462986|NCT00358293|Anticonvulsants|anticonvulsants|mesh-ancestor
24956316|NCT03855332|Vasodilator Agents|vasodilator agents|mesh-ancestor
24956317|NCT03855332|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24956318|NCT03855332|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24956319|NCT03855332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24956320|NCT03855332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702819|NCT01467986|Immunologic Factors|immunologic factors|mesh-ancestor
24702820|NCT01467986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702914|NCT01468441|Fertility Agents|fertility agents|mesh-ancestor
24702936|NCT01468571|Natriuretic Agents|natriuretic agents|mesh-ancestor
24702937|NCT01468610|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24702938|NCT01468610|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24702939|NCT01468610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25277824|NCT02355522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25277825|NCT02355522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277826|NCT02355639|Betamethasone|betamethasone|mesh-list
25277827|NCT02355639|Betamethasone Valerate|betamethasone valerate|mesh-list
24703098|NCT01469598|Antimitotic Agents|antimitotic agents|mesh-ancestor
25277848|NCT02355184|Leronlimab|leronlimab|mesh-list
25277849|NCT02355184|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25277850|NCT02355184|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24572848|NCT00816894|Serotonin Agents|serotonin agents|mesh-ancestor
25039894|NCT03611751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702940|NCT01468610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24702941|NCT01468610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488589|NCT00469443|Growth Substances|growth substances|mesh-ancestor
24702942|NCT01468610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24702943|NCT01468610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702944|NCT01468610|Antidepressive Agents|antidepressive agents|mesh-ancestor
24702988|NCT01468740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24702989|NCT01468740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24702990|NCT01468740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24702991|NCT01468740|Tubulin Modulators|tubulin modulators|mesh-ancestor
24702992|NCT01468740|Antimitotic Agents|antimitotic agents|mesh-ancestor
24702993|NCT01468740|Mitosis Modulators|mitosis modulators|mesh-ancestor
24702994|NCT01469143|Insulin|insulin|mesh-list
24702995|NCT01469143|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24702996|NCT01469143|Insulin Aspart|insulin aspart|mesh-list
24702997|NCT01469143|Insulin, Long-Acting|insulin, long-acting|mesh-list
24702998|NCT01469143|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24702999|NCT01469143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24703000|NCT01469143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703001|NCT01469156|Ranibizumab|ranibizumab|mesh-list
24703009|NCT01469169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24703010|NCT01469169|Vasodilator Agents|vasodilator agents|mesh-ancestor
24703013|NCT01469338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24703014|NCT01469338|Glucocorticoids|glucocorticoids|mesh-ancestor
24703015|NCT01469338|Hormones|hormones|mesh-ancestor
24703016|NCT01469338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25277865|NCT02355236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25277866|NCT02355236|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25277867|NCT02355236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25277868|NCT02355236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277869|NCT02355236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277870|NCT02355236|Gout Suppressants|gout suppressants|mesh-ancestor
25277871|NCT02355197|Ascorbic Acid|ascorbic acid|mesh-list
25692225|NCT01995825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25692226|NCT01995825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25692227|NCT01995825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25692228|NCT01995825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25692229|NCT01995825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25692230|NCT01996332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25692231|NCT01996332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25692232|NCT01996332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25692234|NCT01996332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956431|NCT03854383|Vasodilator Agents|vasodilator agents|mesh-ancestor
24956432|NCT03854383|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24956433|NCT03854383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956434|NCT03854617|Vinorelbine|vinorelbine|mesh-list
24792350|NCT05303038|Growth Substances|growth substances|mesh-ancestor
25158715|NCT04185051|Aticaprant|aticaprant|mesh-list
25158716|NCT04185051|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25158717|NCT04185051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25158718|NCT04185051|Sensory System Agents|sensory system agents|mesh-ancestor
25158719|NCT04185051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25117668|NCT04917588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25117669|NCT04917588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25117670|NCT04917588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25117671|NCT04917588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25117672|NCT04917588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703028|NCT01469416|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24703029|NCT01469416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24703030|NCT01469416|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24703035|NCT01469416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703036|NCT01469416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703037|NCT01469416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24703038|NCT01469416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24703052|NCT01469481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703053|NCT01469481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703055|NCT01469507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25009438|NCT00799110|Imiquimod|imiquimod|mesh-list
24703056|NCT01469507|Immunologic Factors|immunologic factors|mesh-ancestor
25277873|NCT02355197|Micronutrients|micronutrients|mesh-ancestor
25277874|NCT02355197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277875|NCT02355197|Antioxidants|antioxidants|mesh-ancestor
25277876|NCT02355197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277877|NCT02355197|Protective Agents|protective agents|mesh-ancestor
25277878|NCT02355119|Gemcitabine|gemcitabine|mesh-list
25277879|NCT02355119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25277880|NCT02355119|Antimetabolites|antimetabolites|mesh-ancestor
24703099|NCT01469598|Mitosis Modulators|mitosis modulators|mesh-ancestor
25277888|NCT02355119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277889|NCT02355093|Ropivacaine|ropivacaine|mesh-list
25277890|NCT02355093|Anesthetics, Local|anesthetics, local|mesh-ancestor
25277891|NCT02355093|Anesthetics|anesthetics|mesh-ancestor
25277892|NCT02355093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25277893|NCT02355093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277894|NCT02355093|Sensory System Agents|sensory system agents|mesh-ancestor
25277895|NCT02355093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25277896|NCT02355054|Choline|choline|mesh-list
25277897|NCT02355054|Lipotropic Agents|lipotropic agents|mesh-ancestor
25277898|NCT02355054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25277899|NCT02355054|Antimetabolites|antimetabolites|mesh-ancestor
25277900|NCT02355054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277901|NCT02355054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25277902|NCT02355054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25277903|NCT02355054|Nootropic Agents|nootropic agents|mesh-ancestor
25117682|NCT04877457|Ocrelizumab|ocrelizumab|mesh-list
25117683|NCT04877457|Immunologic Factors|immunologic factors|mesh-ancestor
25117684|NCT04877457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117685|NCT04860518|Dexamethasone|dexamethasone|mesh-list
25117686|NCT04860518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25117687|NCT04860518|Antiemetics|antiemetics|mesh-ancestor
25117688|NCT04860518|Autonomic Agents|autonomic agents|mesh-ancestor
25117689|NCT04860518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25117690|NCT04860518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108129|NCT03134456|Pembrolizumab|pembrolizumab|mesh-list
24703057|NCT01469507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703058|NCT01469507|Viscosupplements|viscosupplements|mesh-ancestor
25692235|NCT01996657|Warfarin|warfarin|mesh-list
25692236|NCT01996657|Anticoagulants|anticoagulants|mesh-ancestor
25692237|NCT01996709|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25692238|NCT01996709|Contact Lens Solutions|contact lens solutions|mesh-list
25692239|NCT01996709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25692240|NCT01996709|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24956534|NCT03853525|Dermatologic Agents|dermatologic agents|mesh-ancestor
24956535|NCT03853642|Nitric Oxide|nitric oxide|mesh-list
24956536|NCT03853642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24922850|NCT04175990|Hormones|hormones|mesh-ancestor
24885840|NCT04409041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703059|NCT01469507|Protective Agents|protective agents|mesh-ancestor
24703060|NCT01469520|Lamivudine|lamivudine|mesh-list
24703061|NCT01469520|Zidovudine|zidovudine|mesh-list
24703062|NCT01469520|Nevirapine|nevirapine|mesh-list
24703063|NCT01469520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24703064|NCT01469520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24703065|NCT01469520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703066|NCT01469520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703067|NCT01469520|Antiviral Agents|antiviral agents|mesh-ancestor
24703068|NCT01469520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24703069|NCT01469520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24703070|NCT01469520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24703071|NCT01469520|Antimetabolites|antimetabolites|mesh-ancestor
24703072|NCT01469520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24703073|NCT01469520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24703074|NCT01469559|Insulin|insulin|mesh-list
24703075|NCT01469559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24703076|NCT01469559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703077|NCT01469572|Everolimus|everolimus|mesh-list
24703078|NCT01469572|Pasireotide|pasireotide|mesh-list
24613417|NCT01018914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703088|NCT01469598|Antimetabolites|antimetabolites|mesh-ancestor
24703089|NCT01469598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703090|NCT01469598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703091|NCT01469598|Antiviral Agents|antiviral agents|mesh-ancestor
24703092|NCT01469598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24703093|NCT01469598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703094|NCT01469598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24703095|NCT01469598|Immunologic Factors|immunologic factors|mesh-ancestor
24703096|NCT01469598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703102|NCT01469624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703103|NCT01469624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703104|NCT01469624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24703105|NCT01469624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24703106|NCT01469624|Protective Agents|protective agents|mesh-ancestor
24703107|NCT01469624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277904|NCT02354885|Tranexamic Acid|tranexamic acid|mesh-list
25277905|NCT02354885|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25277906|NCT02354885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25277907|NCT02354885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277908|NCT02354885|Hemostatics|hemostatics|mesh-ancestor
25277909|NCT02354885|Coagulants|coagulants|mesh-ancestor
25277910|NCT02354768|Lanreotide|lanreotide|mesh-list
25277911|NCT02354768|Loperamide|loperamide|mesh-list
25277912|NCT02354768|Antidiarrheals|antidiarrheals|mesh-list
25277913|NCT02354768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25277914|NCT02354768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25277915|NCT02354807|Mirabegron|mirabegron|mesh-list
25277916|NCT02354807|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25277917|NCT02354807|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25277918|NCT02354807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25277919|NCT02354807|Adrenergic Agents|adrenergic agents|mesh-ancestor
25277920|NCT02354807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25117693|NCT04860518|Hormones|hormones|mesh-ancestor
25117694|NCT04860518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25117695|NCT04860518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25117696|NCT04860518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25117697|NCT04859296|Dronabinol|dronabinol|mesh-list
25117698|NCT04859296|Hallucinogens|hallucinogens|mesh-ancestor
25158738|NCT04180436|Rivaroxaban|rivaroxaban|mesh-list
25158739|NCT04180436|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25692241|NCT01996709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25692242|NCT01996709|Disinfectants|disinfectants|mesh-ancestor
25692243|NCT01996826|Bevacizumab|bevacizumab|mesh-list
25692244|NCT01996826|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25692245|NCT01996826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25692246|NCT01996826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25692247|NCT01996826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25692248|NCT01996826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24956594|NCT03853200|Dental Disinfectants|dental disinfectants|mesh-ancestor
24956596|NCT03853096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24956597|NCT03853096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25277921|NCT02354807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277922|NCT02354807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25158740|NCT04180436|Antithrombins|antithrombins|mesh-ancestor
25158741|NCT04180436|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25158742|NCT04180436|Protease Inhibitors|protease inhibitors|mesh-ancestor
25158743|NCT04180436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24995450|NCT05166096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24703108|NCT01469624|Vasodilator Agents|vasodilator agents|mesh-ancestor
24703119|NCT01469702|Azithromycin|azithromycin|mesh-list
24703120|NCT01469702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24703121|NCT01469702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24703126|NCT01469884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24703127|NCT01469884|Immunologic Factors|immunologic factors|mesh-ancestor
24703128|NCT01469884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703129|NCT01469884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24703130|NCT01469884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703131|NCT01469884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703132|NCT01469884|Antifungal Agents|antifungal agents|mesh-ancestor
24703133|NCT01469884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24703134|NCT01469884|Dermatologic Agents|dermatologic agents|mesh-ancestor
24703135|NCT01469884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24703136|NCT01469884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703137|NCT01469975|Edetic Acid|edetic acid|mesh-list
24703138|NCT01469975|Pentetic Acid|pentetic acid|mesh-list
24703139|NCT01469975|Antidotes|antidotes|mesh-ancestor
24703140|NCT01469975|Protective Agents|protective agents|mesh-ancestor
24703141|NCT01469975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703142|NCT01469975|Chelating Agents|chelating agents|mesh-ancestor
24703143|NCT01469975|Sequestering Agents|sequestering agents|mesh-ancestor
25277923|NCT02354807|Urological Agents|urological agents|mesh-ancestor
25277924|NCT02354937|Cabotegravir|cabotegravir|mesh-list
25277925|NCT02354937|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25277926|NCT02354937|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25277927|NCT02354937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277928|NCT02354937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277929|NCT02354937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25277930|NCT02354937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25277931|NCT02354937|Antiviral Agents|antiviral agents|mesh-ancestor
25277932|NCT02354937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25277934|NCT02354950|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25277935|NCT02354950|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25277936|NCT02354950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573337|NCT00819468|Teduglutide|teduglutide|mesh-list
25277937|NCT02354950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798027|NCT01959828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798028|NCT01959828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24798029|NCT01959828|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24798030|NCT01959828|Vasodilator Agents|vasodilator agents|mesh-ancestor
24798031|NCT01959828|Gasotransmitters|gasotransmitters|mesh-ancestor
25158744|NCT04180436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25158745|NCT04180436|Anticoagulants|anticoagulants|mesh-ancestor
25158746|NCT04176393|Ivosidenib|ivosidenib|mesh-list
25158747|NCT04176393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25158748|NCT04176393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25158749|NCT04176393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25158750|NCT04175431|Prednisone|prednisone|mesh-list
25158751|NCT04175431|Abiraterone Acetate|abiraterone acetate|mesh-list
25158752|NCT04175431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25158753|NCT04175431|Glucocorticoids|glucocorticoids|mesh-ancestor
25158754|NCT04175431|Hormones|hormones|mesh-ancestor
25158755|NCT04175431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25158756|NCT04175431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25158757|NCT04175431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25692249|NCT01996826|Growth Substances|growth substances|mesh-ancestor
25692250|NCT01996826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692251|NCT01996826|Growth Inhibitors|growth inhibitors|mesh-ancestor
25692252|NCT01996826|Laxatives|laxatives|mesh-ancestor
24463014|NCT00358358|Autonomic Agents|autonomic agents|mesh-ancestor
24463015|NCT00358358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25158758|NCT04175431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25158759|NCT04175431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25158760|NCT04175431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25158761|NCT04175431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25158762|NCT04175431|Hormone Antagonists|hormone antagonists|mesh-ancestor
24703144|NCT01469975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703145|NCT01469975|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24703146|NCT01469975|Anticoagulants|anticoagulants|mesh-ancestor
24703147|NCT01469975|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24703148|NCT01469988|Testosterone|testosterone|mesh-list
24703181|NCT01470053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703182|NCT01470053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703183|NCT01470053|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24703184|NCT01470053|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24703185|NCT01470053|Histamine Antagonists|histamine antagonists|mesh-ancestor
24703186|NCT01470053|Histamine Agents|histamine agents|mesh-ancestor
24703187|NCT01470053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24703189|NCT01470092|Androgen Antagonists|androgen antagonists|mesh-ancestor
24703190|NCT01470092|Hormone Antagonists|hormone antagonists|mesh-ancestor
24703191|NCT01470092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24703192|NCT01470092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703193|NCT01470092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24703194|NCT01470092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24703195|NCT01470092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703196|NCT01470092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24703249|NCT01470352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24703250|NCT01470352|Dopamine Agents|dopamine agents|mesh-ancestor
24703251|NCT01470443|Oxaliplatin|oxaliplatin|mesh-list
25277938|NCT02354950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25277939|NCT02354950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25277940|NCT02354950|Antiviral Agents|antiviral agents|mesh-ancestor
25277941|NCT02354950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25277942|NCT02354872|Nicotine|nicotine|mesh-list
25277943|NCT02354872|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25277944|NCT02354872|Autonomic Agents|autonomic agents|mesh-ancestor
25277945|NCT02354872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25277946|NCT02354872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277947|NCT02354872|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25277948|NCT02354872|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25277949|NCT02354872|Cholinergic Agents|cholinergic agents|mesh-ancestor
25277954|NCT02354638|Autonomic Agents|autonomic agents|mesh-ancestor
25277955|NCT02354638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25277956|NCT02354638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277957|NCT02354638|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24798036|NCT01960023|Cetuximab|cetuximab|mesh-list
24798037|NCT01960023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24798038|NCT01960023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24798039|NCT01960049|Ropivacaine|ropivacaine|mesh-list
25158763|NCT04175431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24573520|NCT00820547|Fluorouracil|fluorouracil|mesh-list
25158768|NCT04171050|Anesthetics|anesthetics|mesh-list
25158769|NCT04171050|Anesthetics, Local|anesthetics, local|mesh-list
25158770|NCT04171050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25158771|NCT04171050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25158772|NCT04171050|Sensory System Agents|sensory system agents|mesh-ancestor
25158773|NCT04171050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25277958|NCT02354638|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25277959|NCT02354638|Cholinergic Agents|cholinergic agents|mesh-ancestor
25277960|NCT02354638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25277961|NCT02354638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25158774|NCT04170309|Ceftobiprole|ceftobiprole|mesh-list
25158775|NCT04170309|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
25158776|NCT04170309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25158777|NCT04170309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25158778|NCT04167176|Lidocaine|lidocaine|mesh-list
25158779|NCT04167176|Bupivacaine|bupivacaine|mesh-list
25158780|NCT04167176|Anesthetics, Local|anesthetics, local|mesh-ancestor
25158781|NCT04167176|Anesthetics|anesthetics|mesh-ancestor
25158782|NCT04167176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25158783|NCT04167176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25158784|NCT04167176|Sensory System Agents|sensory system agents|mesh-ancestor
25692253|NCT01996826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25692254|NCT01996839|Loteprednol Etabonate|loteprednol etabonate|mesh-list
24956662|NCT03852407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25158785|NCT04167176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25158786|NCT04167176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25158787|NCT04167176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25158788|NCT04167176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25158789|NCT04167176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25158790|NCT04167176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277962|NCT02354612|Bevacizumab|bevacizumab|mesh-list
25277963|NCT02354612|Capecitabine|capecitabine|mesh-list
25277964|NCT02354612|Axitinib|axitinib|mesh-list
25277965|NCT02354612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25277966|NCT02354612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25277967|NCT02354612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25277968|NCT02354612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25277969|NCT02354612|Growth Substances|growth substances|mesh-ancestor
25277970|NCT02354612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277971|NCT02354612|Growth Inhibitors|growth inhibitors|mesh-ancestor
25277972|NCT02354612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25277973|NCT02354612|Antimetabolites|antimetabolites|mesh-ancestor
25277974|NCT02354612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671082|NCT01323465|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24671083|NCT01323465|Antifungal Agents|antifungal agents|mesh-ancestor
25277975|NCT02354612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25277976|NCT02354612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25277979|NCT02354547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25277980|NCT02354547|Immunologic Factors|immunologic factors|mesh-ancestor
25277981|NCT02354547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25277982|NCT02354547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25277983|NCT02354547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25277984|NCT02354547|Alkylating Agents|alkylating agents|mesh-ancestor
25277985|NCT02354547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25277986|NCT02354547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25277987|NCT02354547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25277988|NCT02354547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24703320|NCT01471067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703321|NCT01471067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24703322|NCT01471067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24703323|NCT01471067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24703376|NCT01471470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24703378|NCT01471470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703379|NCT01471470|Growth Inhibitors|growth inhibitors|mesh-ancestor
24703380|NCT01471470|Tubulin Modulators|tubulin modulators|mesh-ancestor
24703381|NCT01471470|Antimitotic Agents|antimitotic agents|mesh-ancestor
24703415|NCT01471678|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24703416|NCT01471678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703417|NCT01471678|Hormone Antagonists|hormone antagonists|mesh-ancestor
24703418|NCT01471678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24703419|NCT01471704|Verapamil|verapamil|mesh-list
24703420|NCT01471704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24703421|NCT01471704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25277999|NCT02354560|Erythromycin|erythromycin|mesh-list
25278000|NCT02354560|Erythromycin Estolate|erythromycin estolate|mesh-list
25278001|NCT02354560|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25278002|NCT02354560|Erythromycin stearate|erythromycin stearate|mesh-list
25278003|NCT02354560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25278004|NCT02354560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25278005|NCT02354560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25278006|NCT02354560|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25278007|NCT02354560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25278008|NCT02354560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278009|NCT02354261|Itraconazole|itraconazole|mesh-list
25278010|NCT02354261|Antifungal Agents|antifungal agents|mesh-ancestor
25278011|NCT02354261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25278012|NCT02354261|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25278038|NCT02353949|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25278018|NCT02354261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25278019|NCT02354261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278020|NCT02354261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25278021|NCT02354170|Mifepristone|mifepristone|mesh-list
25278022|NCT02354170|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25692255|NCT01996839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25692256|NCT01996943|Ethanol|ethanol|mesh-list
24956758|NCT03851289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24956759|NCT03851289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956760|NCT03851341|Metformin|metformin|mesh-list
24956761|NCT03851341|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24703422|NCT01471704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24703423|NCT01471704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703424|NCT01471704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24703425|NCT01471704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703426|NCT01471704|Vasodilator Agents|vasodilator agents|mesh-ancestor
24703427|NCT01471730|Thrombin|thrombin|mesh-list
24703428|NCT01471730|Hemostatics|hemostatics|mesh-ancestor
24703429|NCT01471730|Coagulants|coagulants|mesh-ancestor
24703430|NCT01471808|Metformin|metformin|mesh-list
24703431|NCT01471808|Pioglitazone|pioglitazone|mesh-list
24703432|NCT01471808|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24703433|NCT01471808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24703434|NCT01471808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703435|NCT01471808|Incretins|incretins|mesh-ancestor
24562168|NCT00764907|Immunologic Factors|immunologic factors|mesh-ancestor
24573773|NCT00822055|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24573774|NCT00822055|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24573775|NCT00822055|Adrenergic Agents|adrenergic agents|mesh-ancestor
24573776|NCT00822055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24443937|NCT00296257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703436|NCT01471808|Hormones|hormones|mesh-ancestor
24703438|NCT01471808|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24703441|NCT01471808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703462|NCT01471886|Sensory System Agents|sensory system agents|mesh-ancestor
24703463|NCT01471886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24703464|NCT01471886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703465|NCT01471886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24703466|NCT01471886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24703467|NCT01471886|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24703468|NCT01471886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703469|NCT01471886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703470|NCT01471886|Gout Suppressants|gout suppressants|mesh-ancestor
24613433|NCT01019083|Anthelmintics|anthelmintics|mesh-ancestor
24703517|NCT01472016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703518|NCT01472029|Leucovorin|leucovorin|mesh-list
24703519|NCT01472029|Docetaxel|docetaxel|mesh-list
24703520|NCT01472029|Oxaliplatin|oxaliplatin|mesh-list
24703521|NCT01472029|Trastuzumab|trastuzumab|mesh-list
24703522|NCT01472029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703523|NCT01472029|Tubulin Modulators|tubulin modulators|mesh-ancestor
24703524|NCT01472029|Antimitotic Agents|antimitotic agents|mesh-ancestor
24703525|NCT01472029|Mitosis Modulators|mitosis modulators|mesh-ancestor
24703526|NCT01472029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703527|NCT01472029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24703528|NCT01472029|Antidotes|antidotes|mesh-ancestor
24703529|NCT01472029|Protective Agents|protective agents|mesh-ancestor
24703530|NCT01472029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703531|NCT01472029|Vitamin B Complex|vitamin b complex|mesh-ancestor
24703532|NCT01472029|Vitamins|vitamins|mesh-ancestor
24703533|NCT01472029|Micronutrients|micronutrients|mesh-ancestor
24703534|NCT01472055|Fludarabine|fludarabine|mesh-list
24703537|NCT01472146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703538|NCT01472146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24703539|NCT01472146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24703540|NCT01472146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24703541|NCT01472146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703542|NCT01472146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703543|NCT01472263|Pentoxifylline|pentoxifylline|mesh-list
25692257|NCT01996943|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25692258|NCT01996943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25692259|NCT01996943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25692260|NCT01996943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692261|NCT01997229|Eculizumab|eculizumab|mesh-list
25692262|NCT01997229|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25692263|NCT01997229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25692264|NCT01997229|Immunologic Factors|immunologic factors|mesh-ancestor
24703544|NCT01472263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24703545|NCT01472263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703547|NCT01472263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24703562|NCT01472315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24703655|NCT01473147|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24703657|NCT01473147|Hormones|hormones|mesh-ancestor
24703675|NCT01473277|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24703676|NCT01473277|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24703677|NCT01473277|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24703678|NCT01473277|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24703679|NCT01473277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24703680|NCT01473277|Glucocorticoids|glucocorticoids|mesh-ancestor
24703681|NCT01473277|Hormones|hormones|mesh-ancestor
24440505|NCT00283478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24440506|NCT00283478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703682|NCT01473277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24703683|NCT01473277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703684|NCT01473277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24703685|NCT01473277|Immunologic Factors|immunologic factors|mesh-ancestor
24703686|NCT01473277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703687|NCT01473277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703720|NCT01473316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703721|NCT01473316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24703722|NCT01473316|Hormone Antagonists|hormone antagonists|mesh-ancestor
24703745|NCT01473810|Endocine|endocine|mesh-list
24703746|NCT01473810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24703747|NCT01473810|Immunologic Factors|immunologic factors|mesh-ancestor
24613465|NCT01019265|Buprenorphine|buprenorphine|mesh-list
24613466|NCT01019265|Tramadol|tramadol|mesh-list
24613467|NCT01019265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24613468|NCT01019265|Narcotics|narcotics|mesh-ancestor
24613469|NCT01019265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24613470|NCT01019265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613471|NCT01019265|Analgesics|analgesics|mesh-ancestor
25158853|NCT04157153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25158854|NCT04157153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25158855|NCT04157153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25158856|NCT04157153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25158857|NCT04157153|Antifungal Agents|antifungal agents|mesh-ancestor
25158858|NCT04157153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25158859|NCT04157153|Immunologic Factors|immunologic factors|mesh-ancestor
25158860|NCT04157153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25158861|NCT04157075|Bupivacaine|bupivacaine|mesh-list
25158862|NCT04157075|Anesthetics, Local|anesthetics, local|mesh-ancestor
25158863|NCT04157075|Anesthetics|anesthetics|mesh-ancestor
25158864|NCT04157075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25158865|NCT04157075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25158866|NCT04157075|Sensory System Agents|sensory system agents|mesh-ancestor
24613478|NCT01019291|Disinfectants|disinfectants|mesh-ancestor
24613479|NCT01019291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24613480|NCT01019382|Gemcitabine|gemcitabine|mesh-list
24613481|NCT01019382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24613482|NCT01019382|Antimetabolites|antimetabolites|mesh-ancestor
24703748|NCT01473810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703749|NCT01473901|Temozolomide|temozolomide|mesh-list
24703750|NCT01473901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24703751|NCT01473901|Alkylating Agents|alkylating agents|mesh-ancestor
24703754|NCT01473914|Vitamins|vitamins|mesh-list
24703755|NCT01473914|Vitamin E|vitamin e|mesh-list
24703756|NCT01473914|Tocopherols|tocopherols|mesh-list
24703757|NCT01473914|Tocotrienols|tocotrienols|mesh-list
24703758|NCT01473914|alpha-Tocopherol|alpha-tocopherol|mesh-list
24703759|NCT01473914|Zinc|zinc|mesh-list
24703760|NCT01473914|Selenium|selenium|mesh-list
24703761|NCT01473914|Micronutrients|micronutrients|mesh-ancestor
24703762|NCT01473914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703763|NCT01473914|Trace Elements|trace elements|mesh-ancestor
24703764|NCT01473914|Antioxidants|antioxidants|mesh-ancestor
25278046|NCT02354001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25278047|NCT02354001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278048|NCT02354001|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25278049|NCT02354001|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25278050|NCT02354001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25278051|NCT02354053|Triumeq|triumeq|mesh-list
25278052|NCT02354053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25278053|NCT02354053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25278055|NCT02354053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25278056|NCT02353936|Afatinib|afatinib|mesh-list
25278057|NCT02353936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278058|NCT02353936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25278059|NCT02353936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25278060|NCT02353936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278061|NCT02353858|Fluorouracil|fluorouracil|mesh-list
25278062|NCT02353858|Antimetabolites|antimetabolites|mesh-ancestor
25278063|NCT02353858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278064|NCT02353858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25278065|NCT02353858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24573964|NCT00822744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703815|NCT01474460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24703816|NCT01474460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703863|NCT01475032|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24703864|NCT01475032|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24703865|NCT01475032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24703866|NCT01475032|Adrenergic Agents|adrenergic agents|mesh-ancestor
24703867|NCT01475032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24703868|NCT01475032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703869|NCT01475032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24703870|NCT01475032|Glucocorticoids|glucocorticoids|mesh-ancestor
24703872|NCT01475032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24703873|NCT01475227|Zinc|zinc|mesh-list
24703874|NCT01475227|Zinc Sulfate|zinc sulfate|mesh-list
24703875|NCT01475227|Trace Elements|trace elements|mesh-ancestor
24703876|NCT01475227|Micronutrients|micronutrients|mesh-ancestor
24703880|NCT01475266|Apaziquone|apaziquone|mesh-list
24703913|NCT01475552|Abciximab|abciximab|mesh-list
24703967|NCT01475708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24703969|NCT01475760|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24703970|NCT01475760|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24703971|NCT01475760|Antimetabolites|antimetabolites|mesh-ancestor
24703972|NCT01475760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703973|NCT01475760|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24703974|NCT01475760|Chelating Agents|chelating agents|mesh-ancestor
24703975|NCT01475760|Sequestering Agents|sequestering agents|mesh-ancestor
24703976|NCT01475760|Hemostatics|hemostatics|mesh-ancestor
24703977|NCT01475760|Coagulants|coagulants|mesh-ancestor
24703978|NCT01475877|Bromfenac|bromfenac|mesh-list
24574252|NCT00824317|Dopamine Agents|dopamine agents|mesh-ancestor
24574368|NCT00825071|Glucocorticoids|glucocorticoids|mesh-ancestor
24703979|NCT01475877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24703980|NCT01475877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24703981|NCT01475877|Analgesics|analgesics|mesh-ancestor
24703982|NCT01475877|Sensory System Agents|sensory system agents|mesh-ancestor
24703983|NCT01475877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24703984|NCT01475877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278066|NCT02353858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25278067|NCT02353858|Immunologic Factors|immunologic factors|mesh-ancestor
25278068|NCT02353858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278069|NCT02353988|Bicalutamide|bicalutamide|mesh-list
25278070|NCT02353988|Androgen Antagonists|androgen antagonists|mesh-ancestor
25278071|NCT02353988|Hormone Antagonists|hormone antagonists|mesh-ancestor
25278072|NCT02353988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25278073|NCT02353988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278074|NCT02353988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278075|NCT02353702|Ropivacaine|ropivacaine|mesh-list
25278076|NCT02353702|Anesthetics, Local|anesthetics, local|mesh-ancestor
25278077|NCT02353702|Anesthetics|anesthetics|mesh-ancestor
25158881|NCT04140721|Moxonidine|moxonidine|mesh-list
25158882|NCT04140721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25158896|NCT04109066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24703985|NCT01475877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24703986|NCT01475877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24703987|NCT01475890|Vitamin D|vitamin d|mesh-list
24703988|NCT01475890|Cholecalciferol|cholecalciferol|mesh-list
24703989|NCT01475890|Vitamins|vitamins|mesh-ancestor
24703990|NCT01475890|Micronutrients|micronutrients|mesh-ancestor
24703991|NCT01475890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703992|NCT01475890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24704017|NCT01476176|Sensory System Agents|sensory system agents|mesh-ancestor
24704018|NCT01476176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25692265|NCT01997229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692267|NCT01997333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25692268|NCT01997333|Antimetabolites|antimetabolites|mesh-ancestor
24704019|NCT01476176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704020|NCT01476176|Antipyretics|antipyretics|mesh-ancestor
24704021|NCT01476189|Acetaminophen|acetaminophen|mesh-list
24704022|NCT01476189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24704023|NCT01476189|Analgesics|analgesics|mesh-ancestor
24704024|NCT01476189|Sensory System Agents|sensory system agents|mesh-ancestor
24704040|NCT01476280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704041|NCT01476280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24704042|NCT01476280|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24704043|NCT01476280|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24704044|NCT01476280|Serotonin Agents|serotonin agents|mesh-ancestor
24704045|NCT01476280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24704046|NCT01476280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704047|NCT01476332|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24704065|NCT01476410|Immunoglobulins|immunoglobulins|mesh-list
24704066|NCT01476410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24704067|NCT01476410|Immunoconjugates|immunoconjugates|mesh-list
24704078|NCT01476410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24704079|NCT01476410|Alkylating Agents|alkylating agents|mesh-ancestor
24704080|NCT01476410|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24704081|NCT01476410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24704082|NCT01476410|Tubulin Modulators|tubulin modulators|mesh-ancestor
24704083|NCT01476410|Antimitotic Agents|antimitotic agents|mesh-ancestor
24704084|NCT01476410|Mitosis Modulators|mitosis modulators|mesh-ancestor
24704086|NCT01476488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24704087|NCT01476488|Immunologic Factors|immunologic factors|mesh-ancestor
25278078|NCT02353702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25278079|NCT02353702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278080|NCT02353702|Sensory System Agents|sensory system agents|mesh-ancestor
25278081|NCT02353702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25278082|NCT02353611|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25278083|NCT02353611|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25278084|NCT02353611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25278085|NCT02353715|Abiraterone Acetate|abiraterone acetate|mesh-list
25278086|NCT02353715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278087|NCT02353715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25278088|NCT02353715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25278089|NCT02353715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278090|NCT02353715|Hormone Antagonists|hormone antagonists|mesh-ancestor
24792515|NCT05085002|Fulvestrant|fulvestrant|mesh-list
25278091|NCT02353715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25278092|NCT02353715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278093|NCT02353715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25117793|NCT04762498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25117794|NCT04762498|Abortifacient Agents|abortifacient agents|mesh-ancestor
25117795|NCT04762498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25117796|NCT04762498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117797|NCT04762498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25158900|NCT04109066|Mitosis Modulators|mitosis modulators|mesh-ancestor
25158901|NCT04109066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25158902|NCT04109066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25158903|NCT04109066|Immunologic Factors|immunologic factors|mesh-ancestor
25158904|NCT04109066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704088|NCT01476488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704089|NCT01476488|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24704090|NCT01476488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574461|NCT00825253|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24574462|NCT00825253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24574463|NCT00825253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574464|NCT00825396|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24759021|NCT01749085|Ketoconazole|ketoconazole|mesh-list
25278094|NCT02353676|Bupivacaine|bupivacaine|mesh-list
25692269|NCT01997333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692270|NCT01997333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25692271|NCT01997411|Glucagon|glucagon|mesh-list
25692272|NCT01997411|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25692273|NCT01997411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25692274|NCT01997411|Hormones|hormones|mesh-ancestor
25278095|NCT02353676|Anesthetics, Local|anesthetics, local|mesh-ancestor
25278096|NCT02353676|Anesthetics|anesthetics|mesh-ancestor
25278097|NCT02353676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25278098|NCT02353676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278099|NCT02353676|Sensory System Agents|sensory system agents|mesh-ancestor
25278100|NCT02353676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25278101|NCT02353494|Piperaquine|piperaquine|mesh-list
25278102|NCT02353494|Artenimol|artenimol|mesh-list
25278103|NCT02353494|Antimalarials|antimalarials|mesh-ancestor
25278104|NCT02353494|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25278105|NCT02353494|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25278106|NCT02353494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25278107|NCT02353598|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25278108|NCT02353598|Immunologic Factors|immunologic factors|mesh-ancestor
25278109|NCT02353598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278110|NCT02353325|Ascorbic Acid|ascorbic acid|mesh-list
25278111|NCT02353325|Fesoterodine|fesoterodine|mesh-list
25278112|NCT02353325|Antioxidants|antioxidants|mesh-ancestor
25278113|NCT02353325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278114|NCT02353325|Protective Agents|protective agents|mesh-ancestor
25278115|NCT02353325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25158905|NCT04109066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25158906|NCT04109066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25158907|NCT04109066|Alkylating Agents|alkylating agents|mesh-ancestor
25158908|NCT04109066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25158909|NCT04109066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25158910|NCT04109066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24574484|NCT00825552|Dopamine Agents|dopamine agents|mesh-ancestor
25278140|NCT02353182|Anesthetics|anesthetics|mesh-ancestor
25278141|NCT02353182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25278142|NCT02353182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278143|NCT02353182|Sensory System Agents|sensory system agents|mesh-ancestor
25278144|NCT02353182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25278145|NCT02353182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25278146|NCT02353182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25278147|NCT02353182|Analgesics|analgesics|mesh-ancestor
25278148|NCT02353182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25278149|NCT02353182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25278150|NCT02353182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25278151|NCT02353182|Adrenergic Agents|adrenergic agents|mesh-ancestor
25278152|NCT02353182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25278153|NCT02353182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278155|NCT02353182|Narcotics|narcotics|mesh-ancestor
25278156|NCT02353507|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25278157|NCT02353507|Laxatives|laxatives|mesh-ancestor
25278158|NCT02353507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25278159|NCT02353429|Toremifene|toremifene|mesh-list
25278160|NCT02353429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25278161|NCT02353429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278162|NCT02353429|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25278163|NCT02353429|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25278164|NCT02353429|Hormone Antagonists|hormone antagonists|mesh-ancestor
25278165|NCT02353429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25278166|NCT02353429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278167|NCT02353429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25278168|NCT02353130|Memantine|memantine|mesh-list
25278169|NCT02353130|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25278170|NCT02353130|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25278171|NCT02353130|Dopamine Agents|dopamine agents|mesh-ancestor
25278172|NCT02353130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25278173|NCT02353130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278174|NCT02353130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278175|NCT02353130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25278176|NCT02353130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25278177|NCT02353078|Sucralfate|sucralfate|mesh-list
25278178|NCT02353078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25278179|NCT02353078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25278180|NCT02353026|Artesunate|artesunate|mesh-list
25278181|NCT02353026|Antimalarials|antimalarials|mesh-ancestor
24704186|NCT01477060|Lapatinib|lapatinib|mesh-list
25278182|NCT02353026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25278183|NCT02353026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25278184|NCT02353026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25278185|NCT02353026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278186|NCT02353026|Antiviral Agents|antiviral agents|mesh-ancestor
25278188|NCT02353026|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25278189|NCT02353026|Anthelmintics|anthelmintics|mesh-ancestor
25159018|NCT04054713|Acetic Acid|acetic acid|mesh-list
25159019|NCT04054713|Retinol acetate|retinol acetate|mesh-list
25159020|NCT04054713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25159021|NCT04054713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25159022|NCT04054713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24704187|NCT01477060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24704188|NCT01477060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704189|NCT01477060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24704190|NCT01477060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24704191|NCT01477060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704192|NCT01477060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704193|NCT01477073|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24704194|NCT01477073|Hormones|hormones|mesh-ancestor
24704264|NCT01477385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704265|NCT01477411|Digoxin|digoxin|mesh-list
24704266|NCT01477411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24704267|NCT01477411|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24704268|NCT01477411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704269|NCT01477411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704270|NCT01477411|Protective Agents|protective agents|mesh-ancestor
24704271|NCT01477411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704272|NCT01477424|Warfarin|warfarin|mesh-list
24704273|NCT01477424|Anticoagulants|anticoagulants|mesh-ancestor
24704274|NCT01477476|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24704275|NCT01477476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24704276|NCT01477489|Veliparib|veliparib|mesh-list
24704289|NCT01477606|Daunorubicin|daunorubicin|mesh-list
24704290|NCT01477606|Midostaurin|midostaurin|mesh-list
24704291|NCT01477606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24704292|NCT01477606|Antimetabolites|antimetabolites|mesh-ancestor
24704293|NCT01477606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704294|NCT01477606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24704295|NCT01477606|Antiviral Agents|antiviral agents|mesh-ancestor
24704296|NCT01477606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25278195|NCT02352987|Dermatologic Agents|dermatologic agents|mesh-ancestor
25278196|NCT02352987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25278197|NCT02352987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25278198|NCT02352987|Analgesics|analgesics|mesh-ancestor
25278199|NCT02352987|Sensory System Agents|sensory system agents|mesh-ancestor
25278200|NCT02352987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25278201|NCT02352987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278202|NCT02352987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25278203|NCT02352987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25278204|NCT02352987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25278205|NCT02352987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25278206|NCT02352987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278207|NCT02352714|Lidocaine|lidocaine|mesh-list
24798086|NCT01960426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25159023|NCT04054713|Immunologic Factors|immunologic factors|mesh-ancestor
25159024|NCT04054713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159025|NCT04054713|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25159026|NCT04054713|Protective Agents|protective agents|mesh-ancestor
25159027|NCT04054713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278208|NCT02352714|Anesthetics, Local|anesthetics, local|mesh-ancestor
25159039|NCT04042116|Nivolumab|nivolumab|mesh-list
25159040|NCT04042116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24704301|NCT01477606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24704302|NCT01477606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24704303|NCT01477606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704304|NCT01477606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24704305|NCT01477632|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24704341|NCT01477801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24704342|NCT01477801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704343|NCT01477801|Vitamins|vitamins|mesh-ancestor
24704344|NCT01477801|Micronutrients|micronutrients|mesh-ancestor
24704345|NCT01477801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24704346|NCT01477840|Misoprostol|misoprostol|mesh-list
24463154|NCT00359151|Celecoxib|celecoxib|mesh-list
24704347|NCT01477840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24704348|NCT01477840|Abortifacient Agents|abortifacient agents|mesh-ancestor
24704373|NCT01477983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704375|NCT01478022|Isosorbide|isosorbide|mesh-list
24704376|NCT01478022|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24704377|NCT01478022|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
24704378|NCT01478022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24704379|NCT01478022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24704380|NCT01478022|Analgesics|analgesics|mesh-ancestor
24704381|NCT01478022|Sensory System Agents|sensory system agents|mesh-ancestor
24704420|NCT01478165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24704421|NCT01478165|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24704422|NCT01478165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24704423|NCT01478165|Serotonin Agents|serotonin agents|mesh-ancestor
25278218|NCT02352714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278219|NCT02352545|Montelukast|montelukast|mesh-list
25278220|NCT02352545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25278221|NCT02352545|Respiratory System Agents|respiratory system agents|mesh-ancestor
25278222|NCT02352545|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25278223|NCT02352545|Hormone Antagonists|hormone antagonists|mesh-ancestor
25278224|NCT02352545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25159041|NCT04042116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25159042|NCT04042116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25159043|NCT04042116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704428|NCT01478230|Autonomic Agents|autonomic agents|mesh-ancestor
24704429|NCT01478230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24704430|NCT01478230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704431|NCT01478230|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24704432|NCT01478230|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24644391|NCT01190683|Antacids|antacids|mesh-ancestor
24704433|NCT01478230|Cholinergic Agents|cholinergic agents|mesh-ancestor
24704434|NCT01478230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24704435|NCT01478230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704437|NCT01478282|Dabigatran|dabigatran|mesh-list
24704438|NCT01478282|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24704439|NCT01478282|Antithrombins|antithrombins|mesh-ancestor
25278231|NCT02352597|Clomiphene|clomiphene|mesh-list
25278232|NCT02352597|Enclomiphene|enclomiphene|mesh-list
24575023|NCT00829023|Chlorhexidine|chlorhexidine|mesh-list
24575024|NCT00829023|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24575025|NCT00829023|Povidone-Iodine|povidone-iodine|mesh-list
25278233|NCT02352597|Zuclomiphene|zuclomiphene|mesh-list
25278234|NCT02352597|Estradiol|estradiol|mesh-list
25278235|NCT02352597|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25278236|NCT02352597|Phytoestrogens|phytoestrogens|mesh-list
25278237|NCT02352597|Estrogens|estrogens|mesh-ancestor
25278238|NCT02352597|Hormones|hormones|mesh-ancestor
25278239|NCT02352597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25278240|NCT02352597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278245|NCT02352597|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25278246|NCT02352597|Hormone Antagonists|hormone antagonists|mesh-ancestor
25278247|NCT02352597|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24704440|NCT01478282|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24704441|NCT01478282|Protease Inhibitors|protease inhibitors|mesh-ancestor
24704527|NCT01478633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704528|NCT01478633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704529|NCT01478633|Cholinergic Agents|cholinergic agents|mesh-ancestor
24704549|NCT01478685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704551|NCT01478724|Chelating Agents|chelating agents|mesh-ancestor
24704552|NCT01478724|Sequestering Agents|sequestering agents|mesh-ancestor
24704553|NCT01478724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704555|NCT01478737|Dexamethasone acetate|dexamethasone acetate|mesh-list
24704556|NCT01478737|BB 1101|bb 1101|mesh-list
24704557|NCT01478737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24704558|NCT01478737|Antiemetics|antiemetics|mesh-ancestor
24704559|NCT01478737|Autonomic Agents|autonomic agents|mesh-ancestor
24704560|NCT01478737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24704561|NCT01478737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704562|NCT01478737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24704563|NCT01478737|Glucocorticoids|glucocorticoids|mesh-ancestor
24704564|NCT01478737|Hormones|hormones|mesh-ancestor
24704622|NCT01479231|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24704623|NCT01479231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24704624|NCT01479231|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24704625|NCT01479231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704626|NCT01479231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704627|NCT01479244|Molgramostim|molgramostim|mesh-list
24704628|NCT01479244|Sargramostim|sargramostim|mesh-list
24704629|NCT01479244|Immunologic Factors|immunologic factors|mesh-ancestor
24704630|NCT01479244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704631|NCT01479244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24704632|NCT01479283|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24704633|NCT01479283|Cefazolin|cefazolin|mesh-list
24704634|NCT01479283|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24704635|NCT01479283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24704636|NCT01479283|Antitubercular Agents|antitubercular agents|mesh-ancestor
24704637|NCT01479296|Vaccines|vaccines|mesh-list
24704638|NCT01479296|Immunologic Factors|immunologic factors|mesh-ancestor
24704639|NCT01479296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704640|NCT01479361|Atovaquone|atovaquone|mesh-list
24704641|NCT01479361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25278248|NCT02352597|Fertility Agents|fertility agents|mesh-ancestor
25278249|NCT02352597|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25278250|NCT02352597|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25278251|NCT02352597|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25278252|NCT02352519|Anesthetics|anesthetics|mesh-list
25278253|NCT02352519|Anesthetics, Local|anesthetics, local|mesh-list
25278254|NCT02352519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25278255|NCT02352519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278256|NCT02352519|Sensory System Agents|sensory system agents|mesh-ancestor
25278257|NCT02352519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25278258|NCT02352701|Amoxicillin|amoxicillin|mesh-list
24704656|NCT01479556|Analgesics|analgesics|mesh-ancestor
24704657|NCT01479556|Sensory System Agents|sensory system agents|mesh-ancestor
24704658|NCT01479556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24704659|NCT01479556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704660|NCT01479556|Anticonvulsants|anticonvulsants|mesh-ancestor
24704707|NCT01479751|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24704708|NCT01479881|Cyclosporine|cyclosporine|mesh-list
24704723|NCT01479881|Protease Inhibitors|protease inhibitors|mesh-ancestor
24704725|NCT01479920|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24704726|NCT01479920|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25278259|NCT02352701|Levofloxacin|levofloxacin|mesh-list
25278260|NCT02352701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25278261|NCT02352701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25278262|NCT02352701|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25278263|NCT02352701|Renal Agents|renal agents|mesh-ancestor
25278264|NCT02352701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25278265|NCT02352701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24704729|NCT01479920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24704730|NCT01479920|Serotonin Agents|serotonin agents|mesh-ancestor
24704731|NCT01479920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704732|NCT01479920|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24704734|NCT01479920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24644408|NCT01190735|Caffeine|caffeine|mesh-list
24704748|NCT01480050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24544063|NCT00686868|Ofatumumab|ofatumumab|mesh-list
25278274|NCT02352402|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25278275|NCT02352402|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25278276|NCT02352402|Purinergic Agents|purinergic agents|mesh-ancestor
25278277|NCT02352402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25278278|NCT02352402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278279|NCT02352402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278281|NCT02352285|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25278282|NCT02352285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278283|NCT02352285|Natriuretic Agents|natriuretic agents|mesh-ancestor
25278284|NCT02352285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278285|NCT02352168|Budesonide|budesonide|mesh-list
25278286|NCT02352168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25278287|NCT02352168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25278288|NCT02352168|Autonomic Agents|autonomic agents|mesh-ancestor
25278289|NCT02352168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24575172|NCT00829894|Dopamine Agents|dopamine agents|mesh-ancestor
24575173|NCT00830050|Naproxen|naproxen|mesh-list
24575174|NCT00830050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24575175|NCT00830050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24575177|NCT00830050|Sensory System Agents|sensory system agents|mesh-ancestor
24575178|NCT00830050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24575179|NCT00830050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575180|NCT00830050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24575181|NCT00830050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24575182|NCT00830050|Gout Suppressants|gout suppressants|mesh-ancestor
25159114|NCT03996850|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
25159115|NCT03996850|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24704757|NCT01480050|Vasodilator Agents|vasodilator agents|mesh-ancestor
24704758|NCT01480050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24704759|NCT01480050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24704760|NCT01480050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704761|NCT01480063|4-Aminopyridine|4-aminopyridine|mesh-list
24442715|NCT00292266|Interferon beta-1a|interferon beta-1a|mesh-list
24704823|NCT01480713|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24704824|NCT01480713|Antiviral Agents|antiviral agents|mesh-ancestor
24704825|NCT01480713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24704826|NCT01480713|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24704827|NCT01480713|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24704828|NCT01480713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704829|NCT01480713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704831|NCT01480752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24704836|NCT01480752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704837|NCT01480752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24704838|NCT01480752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24704839|NCT01480765|Pregabalin|pregabalin|mesh-list
24704840|NCT01480765|Ketamine|ketamine|mesh-list
24704841|NCT01480765|Analgesics|analgesics|mesh-ancestor
24704842|NCT01480765|Sensory System Agents|sensory system agents|mesh-ancestor
25278290|NCT02352168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278291|NCT02352168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25278292|NCT02352168|Respiratory System Agents|respiratory system agents|mesh-ancestor
25278293|NCT02352168|Glucocorticoids|glucocorticoids|mesh-ancestor
25278294|NCT02352168|Hormones|hormones|mesh-ancestor
25278295|NCT02352168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25278296|NCT02352051|Methylphenidate|methylphenidate|mesh-list
25278297|NCT02352051|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25278298|NCT02352051|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25278299|NCT02352051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278300|NCT02352051|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25278301|NCT02352051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25278302|NCT02352051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25159116|NCT03996850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159117|NCT03994705|Cyclophosphamide|cyclophosphamide|mesh-list
25159118|NCT03994705|Fludarabine|fludarabine|mesh-list
25159119|NCT03994705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25159120|NCT03994705|Immunologic Factors|immunologic factors|mesh-ancestor
25159121|NCT03994705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159122|NCT03994705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25159123|NCT03994705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25159124|NCT03994705|Alkylating Agents|alkylating agents|mesh-ancestor
25159125|NCT03994705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159126|NCT03994705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25159127|NCT03994705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25159128|NCT03992456|Trifluridine|trifluridine|mesh-list
25159129|NCT03992456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25159130|NCT03992456|Panitumumab|panitumumab|mesh-list
25159131|NCT03992456|Antibodies|antibodies|mesh-list
24957292|NCT03845348|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24957293|NCT03845348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25159132|NCT03992456|Immunoglobulins|immunoglobulins|mesh-list
25159133|NCT03992456|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25159134|NCT03992456|Immunologic Factors|immunologic factors|mesh-ancestor
25159135|NCT03992456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159136|NCT03992456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25159137|NCT03992456|Antimetabolites|antimetabolites|mesh-ancestor
25159138|NCT03992456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159139|NCT03992456|Antiviral Agents|antiviral agents|mesh-ancestor
25159140|NCT03992456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24995818|NCT04638881|Anesthetics|anesthetics|mesh-ancestor
24704843|NCT01480765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24704844|NCT01480765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704845|NCT01480765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24704846|NCT01480765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24704847|NCT01480765|Anesthetics, General|anesthetics, general|mesh-ancestor
24704848|NCT01480765|Anesthetics|anesthetics|mesh-ancestor
24704849|NCT01480765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24704951|NCT01481311|Anticonvulsants|anticonvulsants|mesh-ancestor
24704952|NCT01481350|Sildenafil Citrate|sildenafil citrate|mesh-list
24704953|NCT01481350|Vasodilator Agents|vasodilator agents|mesh-ancestor
24704954|NCT01481350|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24704955|NCT01481350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24704956|NCT01481350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704957|NCT01481350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278303|NCT02352051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278304|NCT02352051|Dopamine Agents|dopamine agents|mesh-ancestor
25278305|NCT02352051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25278306|NCT02352051|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25278307|NCT02352051|Adrenergic Agents|adrenergic agents|mesh-ancestor
25278308|NCT02351973|Amiloride|amiloride|mesh-list
25278316|NCT02351973|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
25278317|NCT02351973|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25278319|NCT02352155|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25278320|NCT02352155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25278321|NCT02352155|Adrenergic Agents|adrenergic agents|mesh-ancestor
25278322|NCT02352155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25278323|NCT02352155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278324|NCT02352155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278325|NCT02352155|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25278326|NCT02352155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25278327|NCT02352155|Autonomic Agents|autonomic agents|mesh-ancestor
25278328|NCT02352155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25278329|NCT02352155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25278330|NCT02352155|Respiratory System Agents|respiratory system agents|mesh-ancestor
25159153|NCT03991936|Triamcinolone|triamcinolone|mesh-list
25159154|NCT03991936|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25159155|NCT03991936|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25159156|NCT03991936|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25159157|NCT03991936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25159158|NCT03991936|Glucocorticoids|glucocorticoids|mesh-ancestor
25159159|NCT03991936|Hormones|hormones|mesh-ancestor
25102793|NCT03166605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159160|NCT03991936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25159161|NCT03991936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159162|NCT03991936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25159163|NCT03991936|Immunologic Factors|immunologic factors|mesh-ancestor
25159164|NCT03991936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25159165|NCT03991936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159171|NCT03986424|Memantine|memantine|mesh-list
25159172|NCT03986424|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25159173|NCT03986424|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25159174|NCT03986424|Dopamine Agents|dopamine agents|mesh-ancestor
25159175|NCT03986424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25159176|NCT03986424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692275|NCT01997411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25692276|NCT01997411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692277|NCT01997411|Incretins|incretins|mesh-ancestor
25692278|NCT01997515|Ketamine|ketamine|mesh-list
25692279|NCT01997515|Analgesics|analgesics|mesh-ancestor
25278332|NCT02352155|Sympathomimetics|sympathomimetics|mesh-ancestor
25278333|NCT02352155|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25278334|NCT02351895|Copper|copper|mesh-list
25278335|NCT02351895|Trace Elements|trace elements|mesh-ancestor
25278336|NCT02351895|Micronutrients|micronutrients|mesh-ancestor
25278337|NCT02351895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278338|NCT02351882|Nabilone|nabilone|mesh-list
25278339|NCT02351882|Antiemetics|antiemetics|mesh-ancestor
25278340|NCT02351882|Autonomic Agents|autonomic agents|mesh-ancestor
25278341|NCT02351882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25278342|NCT02351882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278343|NCT02351882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25278344|NCT02351882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25278345|NCT02351882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25278346|NCT02351882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25278347|NCT02351882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25278348|NCT02352311|Tadalafil|tadalafil|mesh-list
25278349|NCT02352311|Dutasteride|dutasteride|mesh-list
25278355|NCT02352311|Urological Agents|urological agents|mesh-ancestor
25278356|NCT02352311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24575505|NCT00832221|Antidepressive Agents|antidepressive agents|mesh-ancestor
25278357|NCT02352311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25278358|NCT02352311|Hormone Antagonists|hormone antagonists|mesh-ancestor
25278359|NCT02352311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25278360|NCT02352311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278361|NCT02352025|Equol|equol|mesh-list
25278362|NCT02352025|Phytoestrogens|phytoestrogens|mesh-ancestor
25278363|NCT02352025|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25278364|NCT02352025|Estrogens|estrogens|mesh-ancestor
25278365|NCT02352025|Hormones|hormones|mesh-ancestor
25278366|NCT02352025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25278367|NCT02352025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278368|NCT02351908|Tenofovir|tenofovir|mesh-list
25278369|NCT02351908|Raltegravir Potassium|raltegravir potassium|mesh-list
25278370|NCT02351908|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25278371|NCT02351908|Dolutegravir|dolutegravir|mesh-list
25159182|NCT03978208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25159183|NCT03978208|Analgesics|analgesics|mesh-ancestor
25159184|NCT03978208|Sensory System Agents|sensory system agents|mesh-ancestor
25159185|NCT03978208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25159186|NCT03978208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159187|NCT03978208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25159188|NCT03978208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25159189|NCT03978208|Gout Suppressants|gout suppressants|mesh-ancestor
25159190|NCT03978208|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25159191|NCT03978208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25159192|NCT03978208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159194|NCT03969004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25118153|NCT04417517|Antimetabolites|antimetabolites|mesh-ancestor
25118154|NCT04417517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118155|NCT04417517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118156|NCT04417517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25118163|NCT04368364|Morphine|morphine|mesh-list
25118164|NCT04368364|Bupivacaine|bupivacaine|mesh-list
25118165|NCT04368364|Ropivacaine|ropivacaine|mesh-list
25118166|NCT04368364|Anesthetics, Local|anesthetics, local|mesh-ancestor
25118167|NCT04368364|Anesthetics|anesthetics|mesh-ancestor
25118168|NCT04368364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25118169|NCT04368364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118170|NCT04368364|Sensory System Agents|sensory system agents|mesh-ancestor
25118171|NCT04368364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25118172|NCT04368364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25118173|NCT04368364|Narcotics|narcotics|mesh-ancestor
25118174|NCT04368364|Analgesics|analgesics|mesh-ancestor
24627690|NCT01094457|Clopidogrel|clopidogrel|mesh-list
24432678|NCT00255658|Antifungal Agents|antifungal agents|mesh-ancestor
24529470|NCT00626158|Antimetabolites|antimetabolites|mesh-ancestor
24704958|NCT01481350|Urological Agents|urological agents|mesh-ancestor
24705005|NCT01481610|Analgesics|analgesics|mesh-ancestor
25278372|NCT02351908|Cobicistat|cobicistat|mesh-list
25278373|NCT02351908|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25278374|NCT02351908|Elvitegravir|elvitegravir|mesh-list
25278375|NCT02351908|Antiviral Agents|antiviral agents|mesh-ancestor
25278376|NCT02351908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25278377|NCT02351908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25278378|NCT02351908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25278379|NCT02351908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25278380|NCT02351908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278381|NCT02351908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25278382|NCT02351908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25278383|NCT02351908|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25278389|NCT02352064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278390|NCT02351869|Midazolam|midazolam|mesh-list
25278391|NCT02351869|Nitrous Oxide|nitrous oxide|mesh-list
25278392|NCT02351869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25278393|NCT02351869|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24575583|NCT00832442|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24575584|NCT00832442|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24792691|NCT04792385|Hormone Antagonists|hormone antagonists|mesh-ancestor
24792692|NCT04792385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24792693|NCT04792385|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24792694|NCT04792385|Diuretics|diuretics|mesh-ancestor
24792695|NCT04792385|Natriuretic Agents|natriuretic agents|mesh-ancestor
24792698|NCT04777006|Amitriptyline|amitriptyline|mesh-list
24792699|NCT04777006|Fluoxetine|fluoxetine|mesh-list
24792700|NCT04777006|Antidepressive Agents|antidepressive agents|mesh-list
24575585|NCT00832442|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24575586|NCT00832442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25278394|NCT02351869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25278395|NCT02351869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278396|NCT02351869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25278397|NCT02351869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25278398|NCT02351869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25278399|NCT02351869|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25278400|NCT02351869|Anesthetics, General|anesthetics, general|mesh-ancestor
25278401|NCT02351869|Anesthetics|anesthetics|mesh-ancestor
25278402|NCT02351869|GABA Modulators|gaba modulators|mesh-ancestor
25278403|NCT02351869|GABA Agents|gaba agents|mesh-ancestor
25278404|NCT02351869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25278405|NCT02351869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529474|NCT00626158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24529475|NCT00626158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529534|NCT00626613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529535|NCT00626613|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24529536|NCT00626613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24529537|NCT00626613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24529538|NCT00626613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24529539|NCT00626613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24529540|NCT00626613|Dopamine Agents|dopamine agents|mesh-ancestor
24529542|NCT00626613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529574|NCT00626717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529575|NCT00626717|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24457876|NCT00335543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24457877|NCT00335543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529576|NCT00626717|Dermatologic Agents|dermatologic agents|mesh-ancestor
24529578|NCT00626769|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24529579|NCT00626769|Protective Agents|protective agents|mesh-ancestor
24529580|NCT00626769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529581|NCT00626769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24529607|NCT00626977|Sympatholytics|sympatholytics|mesh-ancestor
24529608|NCT00626977|Autonomic Agents|autonomic agents|mesh-ancestor
24529609|NCT00626977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24529610|NCT00626977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24529611|NCT00626977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24529612|NCT00626977|Adrenergic Agents|adrenergic agents|mesh-ancestor
24529613|NCT00626977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25159195|NCT03969004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24995915|NCT04492072|Oxytocics|oxytocics|mesh-ancestor
25278406|NCT02351869|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25278407|NCT02351869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25278408|NCT02351869|Analgesics|analgesics|mesh-ancestor
25278409|NCT02351869|Sensory System Agents|sensory system agents|mesh-ancestor
25278410|NCT02351869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25278411|NCT02351765|Cisplatin|cisplatin|mesh-list
25278412|NCT02351765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278414|NCT02351687|Sulfadoxine|sulfadoxine|mesh-list
25278415|NCT02351687|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25278416|NCT02351687|Albendazole|albendazole|mesh-list
25278417|NCT02351687|Antimalarials|antimalarials|mesh-ancestor
25278418|NCT02351687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25278419|NCT02351687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25278425|NCT02351687|Renal Agents|renal agents|mesh-ancestor
25278426|NCT02351687|Anthelmintics|anthelmintics|mesh-ancestor
25278427|NCT02351687|Anticestodal Agents|anticestodal agents|mesh-ancestor
25278428|NCT02351687|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25278429|NCT02351687|Tubulin Modulators|tubulin modulators|mesh-ancestor
25278430|NCT02351687|Antimitotic Agents|antimitotic agents|mesh-ancestor
25278431|NCT02351687|Mitosis Modulators|mitosis modulators|mesh-ancestor
25278432|NCT02351687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278433|NCT02351752|Hydroxychloroquine|hydroxychloroquine|mesh-list
25278434|NCT02351752|Antimalarials|antimalarials|mesh-ancestor
25278435|NCT02351752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25278436|NCT02351752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25278437|NCT02351752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25278438|NCT02351752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25278439|NCT02351752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278440|NCT02351752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25278441|NCT02351622|Dexamethasone|dexamethasone|mesh-list
25278442|NCT02351622|Caffeic acid|caffeic acid|mesh-list
25159203|NCT03950570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25159204|NCT03945357|Gemcitabine|gemcitabine|mesh-list
25159205|NCT03945357|Clindamycin|clindamycin|mesh-list
25159206|NCT03945357|Clindamycin palmitate|clindamycin palmitate|mesh-list
25159207|NCT03945357|Clindamycin phosphate|clindamycin phosphate|mesh-list
25159208|NCT03945357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25159209|NCT03945357|Antimetabolites|antimetabolites|mesh-ancestor
25159210|NCT03945357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159211|NCT03945357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25159212|NCT03945357|Antiviral Agents|antiviral agents|mesh-ancestor
25159213|NCT03945357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25159214|NCT03945357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25159215|NCT03945357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25159216|NCT03945357|Immunologic Factors|immunologic factors|mesh-ancestor
25159217|NCT03945357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159218|NCT03945357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25159219|NCT03945357|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25159220|NCT03936829|Cyclophosphamide|cyclophosphamide|mesh-list
25159221|NCT03936829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24705009|NCT01481610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24705010|NCT01481610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24705011|NCT01481610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24705012|NCT01481610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692280|NCT01997515|Sensory System Agents|sensory system agents|mesh-ancestor
25692281|NCT01997515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25692282|NCT01997515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692283|NCT01997515|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25692284|NCT01997515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25692285|NCT01997515|Anesthetics, General|anesthetics, general|mesh-ancestor
25692286|NCT01997515|Anesthetics|anesthetics|mesh-ancestor
25692287|NCT01997515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25692288|NCT01997515|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25692289|NCT01997515|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25692290|NCT01997515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25692291|NCT01997515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692292|NCT01997905|Protein S|protein s|mesh-list
25692293|NCT01997905|Anticoagulants|anticoagulants|mesh-ancestor
24957537|NCT03844178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24957538|NCT03844178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957539|NCT03844178|Sensory System Agents|sensory system agents|mesh-ancestor
24957540|NCT03844178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24886661|NCT04523844|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24886662|NCT04523844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886663|NCT04523818|Fluorouracil|fluorouracil|mesh-list
24886664|NCT04523818|Capecitabine|capecitabine|mesh-list
24886665|NCT04523818|Antimetabolites|antimetabolites|mesh-ancestor
24705013|NCT01481610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705014|NCT01481610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24705056|NCT01481844|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24705057|NCT01481844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24705058|NCT01481844|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24705059|NCT01481844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24705060|NCT01481844|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24705062|NCT01481844|Alkylating Agents|alkylating agents|mesh-ancestor
24705113|NCT01482117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705115|NCT01482156|Dactolisib|dactolisib|mesh-list
24705128|NCT01482338|Hormone Antagonists|hormone antagonists|mesh-ancestor
24437222|NCT00273026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25278443|NCT02351622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25278444|NCT02351622|Antiemetics|antiemetics|mesh-ancestor
25278452|NCT02351622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25278453|NCT02351622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278455|NCT02351622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278456|NCT02351622|Protective Agents|protective agents|mesh-ancestor
25278457|NCT02351804|Dexamethasone|dexamethasone|mesh-list
25278458|NCT02351804|Ropivacaine|ropivacaine|mesh-list
25278459|NCT02351804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25278460|NCT02351804|Antiemetics|antiemetics|mesh-ancestor
25278461|NCT02351804|Autonomic Agents|autonomic agents|mesh-ancestor
25278462|NCT02351804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25278463|NCT02351804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278464|NCT02351804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25278465|NCT02351804|Glucocorticoids|glucocorticoids|mesh-ancestor
25159222|NCT03936829|Immunologic Factors|immunologic factors|mesh-ancestor
25159223|NCT03936829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159224|NCT03936829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25159225|NCT03936829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25159226|NCT03936829|Alkylating Agents|alkylating agents|mesh-ancestor
25159227|NCT03936829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159228|NCT03936829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25159229|NCT03936829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25159230|NCT03935893|Cyclophosphamide|cyclophosphamide|mesh-list
25159231|NCT03935893|Fludarabine|fludarabine|mesh-list
25159232|NCT03935893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25159233|NCT03935893|Immunologic Factors|immunologic factors|mesh-ancestor
25159234|NCT03935893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159235|NCT03935893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25159236|NCT03935893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25159237|NCT03935893|Alkylating Agents|alkylating agents|mesh-ancestor
25159238|NCT03935893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159239|NCT03935893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25159240|NCT03935893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24995958|NCT04464174|Gemcitabine|gemcitabine|mesh-list
24705129|NCT01482338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24705130|NCT01482338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705131|NCT01482338|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24705132|NCT01482338|Diuretics|diuretics|mesh-ancestor
24705133|NCT01482338|Natriuretic Agents|natriuretic agents|mesh-ancestor
24705134|NCT01482338|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24705135|NCT01482338|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24705136|NCT01482338|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24705137|NCT01482338|Contraceptive Agents|contraceptive agents|mesh-ancestor
25692294|NCT01998399|Ticagrelor|ticagrelor|mesh-list
25692295|NCT01998399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25692296|NCT01998399|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25692297|NCT01998399|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25692298|NCT01998399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25692299|NCT01998399|Purinergic Agents|purinergic agents|mesh-ancestor
25692300|NCT01998399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25692301|NCT01998399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783474|NCT01902186|Tenofovir|tenofovir|mesh-list
24705138|NCT01482338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24705139|NCT01482338|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24705140|NCT01482338|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24705141|NCT01482338|Progestins|progestins|mesh-ancestor
24705143|NCT01482377|Cetuximab|cetuximab|mesh-list
24705144|NCT01482377|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24705145|NCT01482377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25278466|NCT02351804|Hormones|hormones|mesh-ancestor
25278467|NCT02351804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25278468|NCT02351804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25278469|NCT02351804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278470|NCT02351804|Anesthetics, Local|anesthetics, local|mesh-ancestor
25278472|NCT02351804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25278473|NCT02351804|Sensory System Agents|sensory system agents|mesh-ancestor
25278474|NCT02351297|Caseins|caseins|mesh-list
24705152|NCT01482416|Hormones|hormones|mesh-ancestor
24705153|NCT01482416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24705154|NCT01482416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705155|NCT01482442|Sorafenib|sorafenib|mesh-list
24705156|NCT01482442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278495|NCT02351440|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25278496|NCT02351440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25278497|NCT02351440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25278498|NCT02351440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278499|NCT02351440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25278500|NCT02351440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278501|NCT02351440|Analgesics|analgesics|mesh-ancestor
25278502|NCT02351440|Sensory System Agents|sensory system agents|mesh-ancestor
25278503|NCT02351440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25278504|NCT02351440|Antidepressive Agents|antidepressive agents|mesh-ancestor
25278505|NCT02351440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25278506|NCT02351440|Dopamine Agents|dopamine agents|mesh-ancestor
25159277|NCT03918252|Nivolumab|nivolumab|mesh-list
25278513|NCT02350751|Antiviral Agents|antiviral agents|mesh-ancestor
25278514|NCT02350751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25278515|NCT02351024|Naproxen|naproxen|mesh-list
25278516|NCT02351024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25278517|NCT02351024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25278518|NCT02351024|Analgesics|analgesics|mesh-ancestor
25278519|NCT02351024|Sensory System Agents|sensory system agents|mesh-ancestor
25278520|NCT02351024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25278521|NCT02351024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278522|NCT02351024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25278523|NCT02351024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25278524|NCT02351024|Gout Suppressants|gout suppressants|mesh-ancestor
25278525|NCT02351024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25278526|NCT02351024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25278527|NCT02351024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278528|NCT02350725|Furosemide|furosemide|mesh-list
25278529|NCT02350725|Diuretics|diuretics|mesh-ancestor
25278530|NCT02350725|Natriuretic Agents|natriuretic agents|mesh-ancestor
25278531|NCT02350725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278532|NCT02350725|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25278533|NCT02350725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25278534|NCT02350725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278535|NCT02350959|Atorvastatin|atorvastatin|mesh-list
25278536|NCT02350959|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25278537|NCT02350959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25278538|NCT02350959|Antimetabolites|antimetabolites|mesh-ancestor
25278539|NCT02350959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278540|NCT02350959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25278541|NCT02350959|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25278542|NCT02350959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25278543|NCT02350985|Propranolol|propranolol|mesh-list
25278544|NCT02350985|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25278545|NCT02350985|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25278546|NCT02350985|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24705229|NCT01483014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692302|NCT01998399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705230|NCT01483014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705231|NCT01483053|S 20098|s 20098|mesh-list
24705232|NCT01483053|Citalopram|citalopram|mesh-list
24705234|NCT01483053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24705235|NCT01483053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24705236|NCT01483053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278547|NCT02350985|Adrenergic Agents|adrenergic agents|mesh-ancestor
25278548|NCT02350985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25278549|NCT02350985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278550|NCT02350985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278551|NCT02350985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25278552|NCT02350985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25278553|NCT02350985|Vasodilator Agents|vasodilator agents|mesh-ancestor
25278554|NCT02350985|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25278555|NCT02350985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25278556|NCT02350985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25278557|NCT02350985|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25278558|NCT02350985|Antidepressive Agents|antidepressive agents|mesh-ancestor
25278559|NCT02350985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25278560|NCT02350946|Oxytocin|oxytocin|mesh-list
25278561|NCT02350946|Oxytocics|oxytocics|mesh-ancestor
25278562|NCT02350946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25278563|NCT02350946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278564|NCT02350712|Carboplatin|carboplatin|mesh-list
25278565|NCT02350712|Cetuximab|cetuximab|mesh-list
25278566|NCT02350712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278567|NCT02350712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25278568|NCT02350439|Adenosine|adenosine|mesh-list
25278569|NCT02350439|Analgesics|analgesics|mesh-ancestor
25278570|NCT02350439|Sensory System Agents|sensory system agents|mesh-ancestor
25278571|NCT02350439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25278572|NCT02350439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159348|NCT03887377|Botulinum Toxins|botulinum toxins|mesh-list
25159349|NCT03887377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25159370|NCT03860987|Prednisone|prednisone|mesh-list
25159371|NCT03860987|Goserelin|goserelin|mesh-list
25159372|NCT03860987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25159373|NCT03860987|Glucocorticoids|glucocorticoids|mesh-ancestor
25159374|NCT03860987|Hormones|hormones|mesh-ancestor
24786147|NCT01918150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705237|NCT01483053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24705238|NCT01483053|Serotonin Agents|serotonin agents|mesh-ancestor
24705240|NCT01483053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24705241|NCT01483053|Antidepressive Agents|antidepressive agents|mesh-ancestor
25278573|NCT02350439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25278574|NCT02350439|Vasodilator Agents|vasodilator agents|mesh-ancestor
25278575|NCT02350439|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25278576|NCT02350439|Purinergic Agonists|purinergic agonists|mesh-ancestor
25278577|NCT02350439|Purinergic Agents|purinergic agents|mesh-ancestor
25278578|NCT02350439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25278579|NCT02350439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278580|NCT02350686|Capecitabine|capecitabine|mesh-list
25278581|NCT02350686|Oxaliplatin|oxaliplatin|mesh-list
25278582|NCT02350686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25278583|NCT02350686|Antimetabolites|antimetabolites|mesh-ancestor
24899595|NCT04402359|Ceftazidime|ceftazidime|mesh-list
25278584|NCT02350686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278585|NCT02350686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278586|NCT02350387|Oxymetazoline|oxymetazoline|mesh-list
25278587|NCT02350387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25278588|NCT02350387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25278589|NCT02350387|Adrenergic Agents|adrenergic agents|mesh-ancestor
25278590|NCT02350387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25278591|NCT02350387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278592|NCT02350387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278593|NCT02350387|Sympathomimetics|sympathomimetics|mesh-ancestor
25278594|NCT02350387|Autonomic Agents|autonomic agents|mesh-ancestor
25278595|NCT02350387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25278596|NCT02350387|Nasal Decongestants|nasal decongestants|mesh-ancestor
24957866|NCT03840057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24957867|NCT03840057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957868|NCT03840070|Hyaluronic Acid|hyaluronic acid|mesh-list
25278597|NCT02350387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25278598|NCT02350387|Respiratory System Agents|respiratory system agents|mesh-ancestor
25278599|NCT02350673|Atezolizumab|atezolizumab|mesh-list
25278600|NCT02350673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278601|NCT02350361|Endostatins|endostatins|mesh-list
25278602|NCT02350361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25278603|NCT02350361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25278604|NCT02350361|Growth Substances|growth substances|mesh-ancestor
25278708|NCT02350023|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25159375|NCT03860987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25159376|NCT03860987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159377|NCT03860987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25159378|NCT03860987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25159379|NCT03851588|Dolutegravir|dolutegravir|mesh-list
25159380|NCT03851588|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25159381|NCT03851588|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25159384|NCT03851588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25159385|NCT03851588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25159386|NCT03851588|Antiviral Agents|antiviral agents|mesh-ancestor
25159387|NCT03851588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25159390|NCT03850379|Ciprofloxacin|ciprofloxacin|mesh-list
25159391|NCT03850379|Levofloxacin|levofloxacin|mesh-list
25159393|NCT03850379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25159394|NCT03850379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25159395|NCT03850379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25159396|NCT03850379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25159397|NCT03850379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25159398|NCT03850379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159399|NCT03850379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25159400|NCT03850379|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25159401|NCT03850379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25159402|NCT03850379|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25159403|NCT03850379|Renal Agents|renal agents|mesh-ancestor
25278605|NCT02350361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278606|NCT02350361|Growth Inhibitors|growth inhibitors|mesh-ancestor
25278607|NCT02350361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278608|NCT02350335|Nicotine|nicotine|mesh-list
25278609|NCT02350335|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25278610|NCT02350335|Autonomic Agents|autonomic agents|mesh-ancestor
25278611|NCT02350335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25278612|NCT02350335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278613|NCT02350335|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25278614|NCT02350335|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25278615|NCT02350335|Cholinergic Agents|cholinergic agents|mesh-ancestor
25278616|NCT02350335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25102794|NCT03166605|Emollients|emollients|mesh-ancestor
25278617|NCT02350335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578089|NCT00846872|Secretagogues|secretagogues|mesh-list
24578090|NCT00846872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24578091|NCT00846872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278618|NCT02350426|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25278619|NCT02350426|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25278620|NCT02350426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278621|NCT02350530|Bevacizumab|bevacizumab|mesh-list
25278622|NCT02350530|Fluorouracil|fluorouracil|mesh-list
25278623|NCT02350530|Oxaliplatin|oxaliplatin|mesh-list
25278624|NCT02350530|Irinotecan|irinotecan|mesh-list
25278625|NCT02350530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25278626|NCT02350530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278627|NCT02350530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25278628|NCT02350530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25278629|NCT02350530|Growth Substances|growth substances|mesh-ancestor
25278630|NCT02350530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278631|NCT02350530|Growth Inhibitors|growth inhibitors|mesh-ancestor
25278632|NCT02350530|Antimetabolites|antimetabolites|mesh-ancestor
25278633|NCT02350530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278634|NCT02350530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25692303|NCT01998438|Tranexamic Acid|tranexamic acid|mesh-list
25692304|NCT01998438|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25692305|NCT01998438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25692710|NCT02004093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783827|NCT01904253|Amrubicin|amrubicin|mesh-list
24783828|NCT01904253|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25278635|NCT02350530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25278636|NCT02350530|Immunologic Factors|immunologic factors|mesh-ancestor
25278637|NCT02350530|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25278638|NCT02350530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25278639|NCT02350530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25278640|NCT02350543|Aspirin|aspirin|mesh-list
25278641|NCT02350543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25278642|NCT02350543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25278643|NCT02350543|Analgesics|analgesics|mesh-ancestor
25278644|NCT02350543|Sensory System Agents|sensory system agents|mesh-ancestor
25278645|NCT02350543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25278646|NCT02350543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278647|NCT02350543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25159417|NCT03828006|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25159419|NCT03828006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25159420|NCT03828006|Antimetabolites|antimetabolites|mesh-ancestor
25159421|NCT03828006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278648|NCT02350543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25278649|NCT02350543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25278650|NCT02350543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25278651|NCT02350543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278652|NCT02350543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25278653|NCT02350543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25278654|NCT02350543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25278655|NCT02350543|Antipyretics|antipyretics|mesh-ancestor
25278656|NCT02350517|Paclitaxel|paclitaxel|mesh-list
25278657|NCT02350517|Endostar protein|endostar protein|mesh-list
25278658|NCT02350517|Endostatins|endostatins|mesh-list
25278659|NCT02350517|Nedaplatin|nedaplatin|mesh-list
25278660|NCT02350517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25278661|NCT02350517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278662|NCT02350517|Tubulin Modulators|tubulin modulators|mesh-ancestor
25278663|NCT02350517|Antimitotic Agents|antimitotic agents|mesh-ancestor
25278664|NCT02350517|Mitosis Modulators|mitosis modulators|mesh-ancestor
25278665|NCT02350517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278666|NCT02350517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25278667|NCT02350517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25278668|NCT02350517|Growth Substances|growth substances|mesh-ancestor
25278669|NCT02350517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278670|NCT02350517|Growth Inhibitors|growth inhibitors|mesh-ancestor
25278671|NCT02350400|Irinotecan|irinotecan|mesh-list
25278672|NCT02350400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25278673|NCT02350400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25278674|NCT02350400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25278675|NCT02350400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278676|NCT02350400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278677|NCT02350179|Tranexamic Acid|tranexamic acid|mesh-list
25278678|NCT02350179|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25278679|NCT02350179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25159471|NCT03789916|Ticagrelor|ticagrelor|mesh-list
25159472|NCT03789916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25159473|NCT03789916|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25159474|NCT03789916|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25159475|NCT03789916|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25159476|NCT03789916|Purinergic Agents|purinergic agents|mesh-ancestor
25159477|NCT03789916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25159478|NCT03789916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159479|NCT03789916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159480|NCT03789916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25159481|NCT03789916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25159482|NCT03789916|Analgesics|analgesics|mesh-ancestor
25278680|NCT02350179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278681|NCT02350179|Hemostatics|hemostatics|mesh-ancestor
25278682|NCT02350179|Coagulants|coagulants|mesh-ancestor
25278683|NCT02350231|Progesterone|progesterone|mesh-list
25278684|NCT02350231|Progestins|progestins|mesh-ancestor
25278685|NCT02350231|Hormones|hormones|mesh-ancestor
25278686|NCT02350231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25692306|NCT01998438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692307|NCT01998438|Hemostatics|hemostatics|mesh-ancestor
25278687|NCT02350231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278689|NCT02350218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25278690|NCT02350218|Vasodilator Agents|vasodilator agents|mesh-ancestor
25278691|NCT02350218|Urological Agents|urological agents|mesh-ancestor
25278692|NCT02349919|Procaterol|procaterol|mesh-list
25278693|NCT02349919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25278694|NCT02349919|Autonomic Agents|autonomic agents|mesh-ancestor
25278695|NCT02349919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25278696|NCT02349919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278697|NCT02349919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25278698|NCT02349919|Respiratory System Agents|respiratory system agents|mesh-ancestor
25278699|NCT02349919|Sympathomimetics|sympathomimetics|mesh-ancestor
25278700|NCT02349919|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25278701|NCT02349919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25278702|NCT02349919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25278703|NCT02349919|Adrenergic Agents|adrenergic agents|mesh-ancestor
25278704|NCT02349919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25278705|NCT02349919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278706|NCT02350023|Betamethasone|betamethasone|mesh-list
25278707|NCT02350023|Latanoprost|latanoprost|mesh-list
25278709|NCT02350023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25278710|NCT02350023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25278711|NCT02350023|Glucocorticoids|glucocorticoids|mesh-ancestor
25278712|NCT02350023|Hormones|hormones|mesh-ancestor
25278713|NCT02350023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25278714|NCT02350023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278715|NCT02350023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25278716|NCT02350023|Respiratory System Agents|respiratory system agents|mesh-ancestor
25278717|NCT02349802|Exenatide|exenatide|mesh-list
25278718|NCT02349802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25278719|NCT02349802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159488|NCT03789916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25159489|NCT03789916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25159490|NCT03789916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25159491|NCT03789916|Antipyretics|antipyretics|mesh-ancestor
25159492|NCT03782103|Ethanol|ethanol|mesh-list
25159493|NCT03782103|Chlorhexidine|chlorhexidine|mesh-list
25159494|NCT03782103|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25159495|NCT03782103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25159496|NCT03782103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24529682|NCT00627575|Phenytoin|phenytoin|mesh-list
25159497|NCT03782103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25159498|NCT03782103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159499|NCT03782103|Disinfectants|disinfectants|mesh-ancestor
25159500|NCT03782103|Dermatologic Agents|dermatologic agents|mesh-ancestor
25159501|NCT03778931|Fulvestrant|fulvestrant|mesh-list
25159502|NCT03778931|Anastrozole|anastrozole|mesh-list
25102795|NCT03166605|Dermatologic Agents|dermatologic agents|mesh-ancestor
25159503|NCT03778931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25159504|NCT03778931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25159505|NCT03778931|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25159506|NCT03778931|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25159507|NCT03778931|Hormone Antagonists|hormone antagonists|mesh-ancestor
25159508|NCT03778931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25159509|NCT03778931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159510|NCT03778931|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25118398|NCT04189588|Antipruritics|antipruritics|mesh-ancestor
25118473|NCT04113018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25118474|NCT04113018|Glucocorticoids|glucocorticoids|mesh-ancestor
25118475|NCT04113018|Hormones|hormones|mesh-ancestor
25118476|NCT04113018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25118477|NCT04113018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25118478|NCT04113018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25692308|NCT01998438|Coagulants|coagulants|mesh-ancestor
25692309|NCT01998880|Rituximab|rituximab|mesh-list
25692310|NCT01998880|Obinutuzumab|obinutuzumab|mesh-list
25692311|NCT01998880|Chlorambucil|chlorambucil|mesh-list
25692312|NCT01998880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25118479|NCT04113018|Immunologic Factors|immunologic factors|mesh-ancestor
25692313|NCT01998880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24958140|NCT03836638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958182|NCT03836157|Growth Substances|growth substances|mesh-ancestor
24958183|NCT03836157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958184|NCT03836157|Growth Inhibitors|growth inhibitors|mesh-ancestor
24958185|NCT03836157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24958186|NCT03836157|Tubulin Modulators|tubulin modulators|mesh-ancestor
24958187|NCT03836157|Antimitotic Agents|antimitotic agents|mesh-ancestor
24958188|NCT03836157|Mitosis Modulators|mitosis modulators|mesh-ancestor
24958189|NCT03836157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958190|NCT03835676|Treprostinil|treprostinil|mesh-list
24958191|NCT03835676|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24958192|NCT03835715|Vortioxetine|vortioxetine|mesh-list
24958193|NCT03835715|Antidepressive Agents|antidepressive agents|mesh-ancestor
24958194|NCT03835715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25118480|NCT04113018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25118481|NCT04113018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25118482|NCT04113018|Growth Substances|growth substances|mesh-ancestor
25118483|NCT04113018|Growth Inhibitors|growth inhibitors|mesh-ancestor
24627720|NCT01094535|Secretin|secretin|mesh-list
25278720|NCT02349802|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25278721|NCT02349802|Incretins|incretins|mesh-ancestor
25278722|NCT02349802|Hormones|hormones|mesh-ancestor
25278723|NCT02349802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25278724|NCT02349958|Doxorubicin|doxorubicin|mesh-list
25278725|NCT02349958|Cisplatin|cisplatin|mesh-list
25278726|NCT02349958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25278727|NCT02349958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278728|NCT02349958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25278729|NCT02349958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25278730|NCT02349958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25278731|NCT02349958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278732|NCT02349763|Dexamethasone|dexamethasone|mesh-list
25278733|NCT02349763|Dexamethasone acetate|dexamethasone acetate|mesh-list
25278734|NCT02349763|BB 1101|bb 1101|mesh-list
25278735|NCT02349763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25278736|NCT02349763|Antiemetics|antiemetics|mesh-ancestor
25278737|NCT02349763|Autonomic Agents|autonomic agents|mesh-ancestor
25278738|NCT02349763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25278739|NCT02349763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278740|NCT02349763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25278741|NCT02349763|Glucocorticoids|glucocorticoids|mesh-ancestor
25278742|NCT02349763|Hormones|hormones|mesh-ancestor
25278743|NCT02349763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25159660|NCT03710564|Aflibercept|aflibercept|mesh-list
25278744|NCT02349763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25278745|NCT02349763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278746|NCT02349763|Protease Inhibitors|protease inhibitors|mesh-ancestor
25278747|NCT02349763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25278748|NCT02349763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278749|NCT02349945|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25278750|NCT02349945|Hormones|hormones|mesh-ancestor
25278751|NCT02349945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25278752|NCT02349945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278753|NCT02349841|Amoxicillin|amoxicillin|mesh-list
25278754|NCT02349841|Meropenem|meropenem|mesh-list
25278755|NCT02349841|Clavulanic Acids|clavulanic acids|mesh-list
24529614|NCT00626977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692314|NCT01998880|Immunologic Factors|immunologic factors|mesh-ancestor
25692315|NCT01998880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692316|NCT01998880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25692317|NCT01998880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25692318|NCT01998880|Alkylating Agents|alkylating agents|mesh-ancestor
25692319|NCT01998880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692320|NCT01998893|Rituximab|rituximab|mesh-list
25692321|NCT01998893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25692322|NCT01998893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25692323|NCT01998893|Immunologic Factors|immunologic factors|mesh-ancestor
25692324|NCT01998893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692325|NCT01998893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25692326|NCT01998906|Paclitaxel|paclitaxel|mesh-list
25692327|NCT01998906|Doxorubicin|doxorubicin|mesh-list
25692328|NCT01998906|Trastuzumab|trastuzumab|mesh-list
24529616|NCT00626990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24529617|NCT00626990|Alkylating Agents|alkylating agents|mesh-ancestor
24529677|NCT00627471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529679|NCT00627536|Mitosis Modulators|mitosis modulators|mesh-ancestor
24529680|NCT00627536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529681|NCT00627575|Lamotrigine|lamotrigine|mesh-list
24529693|NCT00627575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24529694|NCT00627575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24529695|NCT00627575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529696|NCT00627575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24529697|NCT00627575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24529698|NCT00627575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24529699|NCT00627575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24529700|NCT00627575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24529701|NCT00627575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24529744|NCT00627692|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24529745|NCT00627692|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24529746|NCT00627692|Serotonin Agents|serotonin agents|mesh-ancestor
24529747|NCT00627692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24529748|NCT00627692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529749|NCT00627692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529750|NCT00627731|Methylprednisolone|methylprednisolone|mesh-list
24529751|NCT00627731|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24529768|NCT00627731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24705274|NCT01483638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705275|NCT01483638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705277|NCT01483729|Lactams|lactams|mesh-list
24705278|NCT01483729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24705279|NCT01483729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24705280|NCT01483729|Protease Inhibitors|protease inhibitors|mesh-ancestor
24705281|NCT01483729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705282|NCT01483729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705283|NCT01483729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24705284|NCT01483729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24705285|NCT01483729|Antiviral Agents|antiviral agents|mesh-ancestor
24705286|NCT01483729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25278756|NCT02349841|Clavulanic Acid|clavulanic acid|mesh-list
25278757|NCT02349841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25278758|NCT02349841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25278759|NCT02349841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25278760|NCT02349841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278761|NCT02349841|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25278762|NCT02349828|Acyclovir|acyclovir|mesh-list
25278763|NCT02349828|Antiviral Agents|antiviral agents|mesh-ancestor
25278764|NCT02349828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25278765|NCT02349490|Hemostatics|hemostatics|mesh-list
25278766|NCT02349490|Coagulants|coagulants|mesh-ancestor
25278767|NCT02349516|Squalamine|squalamine|mesh-list
25278768|NCT02349516|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25278769|NCT02349516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25278770|NCT02349516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25278771|NCT02349516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25278772|NCT02349516|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25278773|NCT02349516|Protective Agents|protective agents|mesh-ancestor
25278774|NCT02349516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278775|NCT02349516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278776|NCT02349516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25278777|NCT02349516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25278778|NCT02349516|Growth Substances|growth substances|mesh-ancestor
24579474|NCT00855283|Glycopyrrolate|glycopyrrolate|mesh-list
25278779|NCT02349516|Growth Inhibitors|growth inhibitors|mesh-ancestor
25278780|NCT02349594|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25278781|NCT02349594|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25278782|NCT02349594|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25278783|NCT02349594|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25278784|NCT02349399|Cyproterone Acetate|cyproterone acetate|mesh-list
25278785|NCT02349399|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25278786|NCT02349399|Cyproterone|cyproterone|mesh-list
24705336|NCT01484184|Serotonin Agents|serotonin agents|mesh-ancestor
24705350|NCT01484327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24705351|NCT01484327|Antioxidants|antioxidants|mesh-ancestor
24705352|NCT01484327|Protective Agents|protective agents|mesh-ancestor
24705353|NCT01484327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24705354|NCT01484327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24613590|NCT01019798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24613591|NCT01019798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613592|NCT01019850|Vorinostat|vorinostat|mesh-list
24613593|NCT01019850|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24613626|NCT01020162|Sensory System Agents|sensory system agents|mesh-ancestor
24613627|NCT01020162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25278787|NCT02349399|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
25278788|NCT02349399|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25278789|NCT02349399|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25278790|NCT02349399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25278791|NCT02349399|Contraceptive Agents|contraceptive agents|mesh-ancestor
25278792|NCT02349399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25278793|NCT02349399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278794|NCT02349399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25278795|NCT02349399|Estrogens|estrogens|mesh-ancestor
25278796|NCT02349399|Hormones|hormones|mesh-ancestor
25278797|NCT02349399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25278798|NCT02349399|Androgen Antagonists|androgen antagonists|mesh-ancestor
25278799|NCT02349399|Hormone Antagonists|hormone antagonists|mesh-ancestor
25278800|NCT02349399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24529829|NCT00627952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529830|NCT00627952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25159511|NCT03778931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25159512|NCT03778931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25159513|NCT03778931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159522|NCT03776136|Pembrolizumab|pembrolizumab|mesh-list
25159523|NCT03776136|Lenvatinib|lenvatinib|mesh-list
25159524|NCT03776136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25159525|NCT03776136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25159526|NCT03776136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25159527|NCT03776136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25159528|NCT03776136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613633|NCT01020162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24613634|NCT01020162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24613635|NCT01020162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25278801|NCT02349399|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25159553|NCT03761056|Cyclophosphamide|cyclophosphamide|mesh-list
25159554|NCT03761056|Fludarabine|fludarabine|mesh-list
25159555|NCT03761056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25278807|NCT02349581|Sensory System Agents|sensory system agents|mesh-ancestor
25278808|NCT02349581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25278810|NCT02349607|Pregabalin|pregabalin|mesh-list
25278811|NCT02349607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25278812|NCT02349607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25278813|NCT02349607|Analgesics|analgesics|mesh-ancestor
25278814|NCT02349607|Sensory System Agents|sensory system agents|mesh-ancestor
25278815|NCT02349607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24580486|NCT00861939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25278816|NCT02349607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278817|NCT02349607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25278818|NCT02349607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25278819|NCT02349607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25278820|NCT02349607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25278821|NCT02349607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278822|NCT02349607|Anticonvulsants|anticonvulsants|mesh-ancestor
25278823|NCT02349607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25159556|NCT03761056|Immunologic Factors|immunologic factors|mesh-ancestor
25159557|NCT03761056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159558|NCT03761056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25159559|NCT03761056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25159560|NCT03761056|Alkylating Agents|alkylating agents|mesh-ancestor
25159561|NCT03761056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159562|NCT03761056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25159563|NCT03761056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24705401|NCT01484990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613639|NCT01020162|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24705427|NCT01485146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705428|NCT01485146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24705429|NCT01485146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705432|NCT01485185|Analgesics|analgesics|mesh-ancestor
24705433|NCT01485185|Sensory System Agents|sensory system agents|mesh-ancestor
24705434|NCT01485185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24705435|NCT01485185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705436|NCT01485185|Anticonvulsants|anticonvulsants|mesh-ancestor
24705437|NCT01485185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24705438|NCT01485185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24705439|NCT01485185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24705440|NCT01485185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24705441|NCT01485185|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24705442|NCT01485185|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24705443|NCT01485185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24705444|NCT01485185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705445|NCT01485185|Antimanic Agents|antimanic agents|mesh-ancestor
24705446|NCT01485185|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25278828|NCT02349607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25278829|NCT02349607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25278830|NCT02349282|Vitamin D|vitamin d|mesh-list
25278831|NCT02349282|Cholecalciferol|cholecalciferol|mesh-list
25278832|NCT02349282|Calcifediol|calcifediol|mesh-list
25278833|NCT02349282|Vitamins|vitamins|mesh-ancestor
25278834|NCT02349282|Micronutrients|micronutrients|mesh-ancestor
25278835|NCT02349282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278836|NCT02349282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25278837|NCT02349282|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25278838|NCT02349243|Entacapone|entacapone|mesh-list
25278839|NCT02349243|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25278840|NCT02349243|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25278841|NCT02349243|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25278842|NCT02349243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25278843|NCT02349243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278844|NCT02349204|Zaleplon|zaleplon|mesh-list
25278845|NCT02349204|Anticonvulsants|anticonvulsants|mesh-ancestor
25278846|NCT02349204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25278847|NCT02349204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25278848|NCT02349204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159582|NCT03736616|Cytarabine|cytarabine|mesh-list
25159583|NCT03736616|Rituximab|rituximab|mesh-list
25159584|NCT03736616|Carboplatin|carboplatin|mesh-list
25159585|NCT03736616|Etoposide|etoposide|mesh-list
25159586|NCT03736616|Melphalan|melphalan|mesh-list
25159587|NCT03736616|Ifosfamide|ifosfamide|mesh-list
25159588|NCT03736616|Carmustine|carmustine|mesh-list
25159589|NCT03736616|Acalabrutinib|acalabrutinib|mesh-list
25159590|NCT03736616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25159591|NCT03736616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25159592|NCT03736616|Immunologic Factors|immunologic factors|mesh-ancestor
25159593|NCT03736616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159594|NCT03736616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25159595|NCT03736616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25159596|NCT03736616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25159597|NCT03736616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25159598|NCT03736616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25159661|NCT03710564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25159599|NCT03736616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159600|NCT03736616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25159601|NCT03736616|Antimetabolites|antimetabolites|mesh-ancestor
25159602|NCT03736616|Antiviral Agents|antiviral agents|mesh-ancestor
25159603|NCT03736616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25159604|NCT03736616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25159605|NCT03736616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25159606|NCT03736616|Alkylating Agents|alkylating agents|mesh-ancestor
25159607|NCT03736616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24705450|NCT01485198|Acetaminophen|acetaminophen|mesh-list
25278849|NCT02349204|GABA Modulators|gaba modulators|mesh-ancestor
25278850|NCT02349204|GABA Agents|gaba agents|mesh-ancestor
25278851|NCT02349204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25278852|NCT02349204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278853|NCT02349165|Riboflavin|riboflavin|mesh-list
25278854|NCT02349165|Vitamin B Complex|vitamin b complex|mesh-ancestor
25278855|NCT02349165|Vitamins|vitamins|mesh-ancestor
25278856|NCT02349165|Micronutrients|micronutrients|mesh-ancestor
25278857|NCT02349165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278858|NCT02349165|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25278879|NCT02348788|Primaquine|primaquine|mesh-list
25278880|NCT02348788|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25278881|NCT02348788|Amebicides|amebicides|mesh-ancestor
25278882|NCT02348788|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25278883|NCT02348788|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25278884|NCT02348788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25278885|NCT02348788|Antimalarials|antimalarials|mesh-ancestor
25278886|NCT02348788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25159639|NCT03718403|Theophylline|theophylline|mesh-list
25159640|NCT03718403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25159641|NCT03718403|Autonomic Agents|autonomic agents|mesh-ancestor
25159642|NCT03718403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25159643|NCT03718403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159644|NCT03718403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25159645|NCT03718403|Respiratory System Agents|respiratory system agents|mesh-ancestor
25159646|NCT03718403|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25159647|NCT03718403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25159648|NCT03718403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159649|NCT03718403|Vasodilator Agents|vasodilator agents|mesh-ancestor
25159650|NCT03718403|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25159651|NCT03718403|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25159652|NCT03718403|Purinergic Agents|purinergic agents|mesh-ancestor
25159653|NCT03718403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24705451|NCT01485198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24705452|NCT01485198|Analgesics|analgesics|mesh-ancestor
25278887|NCT02348528|Dexamethasone|dexamethasone|mesh-list
25278888|NCT02348528|Lenalidomide|lenalidomide|mesh-list
25278889|NCT02348528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25278890|NCT02348528|Antiemetics|antiemetics|mesh-ancestor
25278891|NCT02348528|Autonomic Agents|autonomic agents|mesh-ancestor
24863568|NCT04355728|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25278892|NCT02348528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25278893|NCT02348528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278894|NCT02348528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25278895|NCT02348528|Glucocorticoids|glucocorticoids|mesh-ancestor
25278896|NCT02348528|Hormones|hormones|mesh-ancestor
25278897|NCT02348528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25278903|NCT02348528|Growth Substances|growth substances|mesh-ancestor
25278904|NCT02348528|Growth Inhibitors|growth inhibitors|mesh-ancestor
25278905|NCT02348463|Clindamycin|clindamycin|mesh-list
25278906|NCT02348463|Clindamycin palmitate|clindamycin palmitate|mesh-list
25278907|NCT02348463|Clindamycin phosphate|clindamycin phosphate|mesh-list
25278908|NCT02348463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25278909|NCT02348463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25278910|NCT02348463|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25278911|NCT02348463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25278912|NCT02348463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278913|NCT02348255|Bevacizumab|bevacizumab|mesh-list
25278914|NCT02348255|Carmustine|carmustine|mesh-list
25278915|NCT02348255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25278916|NCT02348255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278917|NCT02348255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25278918|NCT02348255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25278919|NCT02348255|Growth Substances|growth substances|mesh-ancestor
25278920|NCT02348255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278921|NCT02348255|Growth Inhibitors|growth inhibitors|mesh-ancestor
25278922|NCT02348255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25159662|NCT03710564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25159663|NCT03710564|Growth Substances|growth substances|mesh-ancestor
25159664|NCT03710564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159665|NCT03710564|Growth Inhibitors|growth inhibitors|mesh-ancestor
25159666|NCT03710564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25159667|NCT03697603|Brexpiprazole|brexpiprazole|mesh-list
25159668|NCT03697603|Serotonin Agents|serotonin agents|mesh-ancestor
25159669|NCT03697603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25159670|NCT03697603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159671|NCT03697603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159672|NCT03697603|Dopamine Agonists|dopamine agonists|mesh-ancestor
25159673|NCT03697603|Dopamine Agents|dopamine agents|mesh-ancestor
25159674|NCT03693404|Ketorolac|ketorolac|mesh-list
25159675|NCT03693404|Morphine|morphine|mesh-list
25159676|NCT03693404|Bupivacaine|bupivacaine|mesh-list
25159677|NCT03693404|Anesthetics|anesthetics|mesh-list
25159678|NCT03693404|Anesthetics, General|anesthetics, general|mesh-list
25159679|NCT03693404|Anesthetics, Local|anesthetics, local|mesh-ancestor
25159680|NCT03693404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25159681|NCT03693404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159682|NCT03693404|Sensory System Agents|sensory system agents|mesh-ancestor
25159683|NCT03693404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24996373|NCT03639558|Dermatologic Agents|dermatologic agents|mesh-ancestor
24705480|NCT01485315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705481|NCT01485367|Adapalene|adapalene|mesh-list
24705482|NCT01485367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24705489|NCT01485367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24705490|NCT01485367|Dermatologic Agents|dermatologic agents|mesh-ancestor
24705491|NCT01485406|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24705492|NCT01485406|Immunologic Factors|immunologic factors|mesh-ancestor
24705493|NCT01485406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705512|NCT01485562|Oxytocics|oxytocics|mesh-ancestor
24705513|NCT01485653|Mepivacaine|mepivacaine|mesh-list
24705514|NCT01485653|Anesthetics, Local|anesthetics, local|mesh-ancestor
24705515|NCT01485653|Anesthetics|anesthetics|mesh-ancestor
24705516|NCT01485653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24705517|NCT01485653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705553|NCT01485692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25278923|NCT02348255|Alkylating Agents|alkylating agents|mesh-ancestor
25278924|NCT02348255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278925|NCT02348268|Analgesics|analgesics|mesh-list
25278926|NCT02348268|Sensory System Agents|sensory system agents|mesh-ancestor
25278927|NCT02348268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25278928|NCT02348268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278929|NCT02348346|Titanium dioxide|titanium dioxide|mesh-list
25278930|NCT02348346|Sunscreening Agents|sunscreening agents|mesh-ancestor
25278931|NCT02348346|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25278932|NCT02348346|Protective Agents|protective agents|mesh-ancestor
25278933|NCT02348346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25278934|NCT02348346|Dermatologic Agents|dermatologic agents|mesh-ancestor
25278935|NCT02348346|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25278936|NCT02348333|Dotinurad|dotinurad|mesh-list
25278937|NCT02348333|Uricosuric Agents|uricosuric agents|mesh-ancestor
25278938|NCT02348333|Gout Suppressants|gout suppressants|mesh-ancestor
25278939|NCT02348333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25278940|NCT02348333|Renal Agents|renal agents|mesh-ancestor
25278941|NCT02348307|Dotinurad|dotinurad|mesh-list
25278942|NCT02348307|Uricosuric Agents|uricosuric agents|mesh-ancestor
25278943|NCT02348307|Gout Suppressants|gout suppressants|mesh-ancestor
25278944|NCT02348307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25278945|NCT02348307|Renal Agents|renal agents|mesh-ancestor
25278946|NCT02348424|Solithromycin|solithromycin|mesh-list
25278947|NCT02348424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25278948|NCT02348424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25278949|NCT02348450|Irinotecan|irinotecan|mesh-list
25278950|NCT02348450|Etoposide|etoposide|mesh-list
25278951|NCT02348450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278952|NCT02348450|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25278953|NCT02348450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25278954|NCT02348450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25159684|NCT03693404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25159685|NCT03693404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25159686|NCT03693404|Analgesics|analgesics|mesh-ancestor
25159687|NCT03693404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25159688|NCT03693404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25159689|NCT03693404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25159690|NCT03693404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705606|NCT01485822|Travoprost|travoprost|mesh-list
25159691|NCT03693404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159692|NCT03693404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25159693|NCT03693404|Narcotics|narcotics|mesh-ancestor
25159694|NCT03689946|Listerine|listerine|mesh-list
25159695|NCT03689946|Evolocumab|evolocumab|mesh-list
25159696|NCT03689946|Fluorides|fluorides|mesh-list
25159697|NCT03689946|Sodium Fluoride|sodium fluoride|mesh-list
25159698|NCT03689946|Cariostatic Agents|cariostatic agents|mesh-ancestor
25159699|NCT03689946|Protective Agents|protective agents|mesh-ancestor
25159700|NCT03689946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159701|NCT03689946|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25159702|NCT03689946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25159703|NCT03689946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25159704|NCT03689946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24958817|NCT03829566|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24958819|NCT03829566|Prednisolone acetate|prednisolone acetate|mesh-list
24958820|NCT03829566|Cyclophosphamide|cyclophosphamide|mesh-list
25159705|NCT03689946|Antimetabolites|antimetabolites|mesh-ancestor
25159706|NCT03689946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159707|NCT03689946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25159708|NCT03684590|Analgesics, Opioid|analgesics, opioid|mesh-list
24786172|NCT01918358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24705554|NCT01485692|Serotonin Agents|serotonin agents|mesh-ancestor
24705555|NCT01485692|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24705556|NCT01485692|Dopamine Agents|dopamine agents|mesh-ancestor
24705557|NCT01485692|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24705558|NCT01485692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24705559|NCT01485692|Antipruritics|antipruritics|mesh-ancestor
24705560|NCT01485692|Dermatologic Agents|dermatologic agents|mesh-ancestor
24705561|NCT01485692|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24705562|NCT01485692|Histamine Antagonists|histamine antagonists|mesh-ancestor
24705563|NCT01485692|Histamine Agents|histamine agents|mesh-ancestor
24705564|NCT01485692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24705565|NCT01485692|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24705566|NCT01485692|Anesthetics, Local|anesthetics, local|mesh-ancestor
24705567|NCT01485692|Sensory System Agents|sensory system agents|mesh-ancestor
24705568|NCT01485718|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
24705570|NCT01485718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24705571|NCT01485731|Nelfinavir|nelfinavir|mesh-list
24705572|NCT01485731|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24705573|NCT01485731|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24705574|NCT01485731|Protease Inhibitors|protease inhibitors|mesh-ancestor
24705575|NCT01485731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705576|NCT01485731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705577|NCT01485731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25278955|NCT02348450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278970|NCT02348398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25278971|NCT02348398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25278972|NCT02348398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25278973|NCT02348398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25278974|NCT02348398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278975|NCT02348242|Lubricant Eye Drops|lubricant eye drops|mesh-list
25278976|NCT02348242|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25278977|NCT02348242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25278978|NCT02348190|Heparin|heparin|mesh-list
25278979|NCT02348190|Anticoagulants|anticoagulants|mesh-ancestor
25159709|NCT03684590|Narcotics|narcotics|mesh-ancestor
25159710|NCT03684590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25159711|NCT03684590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159712|NCT03684590|Analgesics|analgesics|mesh-ancestor
25159713|NCT03684590|Sensory System Agents|sensory system agents|mesh-ancestor
25159714|NCT03684590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25159730|NCT03672292|Voriconazole|voriconazole|mesh-list
24705578|NCT01485731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24705579|NCT01485731|Antiviral Agents|antiviral agents|mesh-ancestor
24705580|NCT01485731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24705581|NCT01485744|Leucovorin|leucovorin|mesh-list
24705582|NCT01485744|Fluorouracil|fluorouracil|mesh-list
24705583|NCT01485744|Oxaliplatin|oxaliplatin|mesh-list
24705584|NCT01485744|Irinotecan|irinotecan|mesh-list
24705585|NCT01485744|Folfirinox|folfirinox|mesh-list
24705586|NCT01485744|Antimetabolites|antimetabolites|mesh-ancestor
24705597|NCT01485744|Protective Agents|protective agents|mesh-ancestor
24705598|NCT01485744|Vitamin B Complex|vitamin b complex|mesh-ancestor
24705599|NCT01485744|Vitamins|vitamins|mesh-ancestor
24705600|NCT01485744|Micronutrients|micronutrients|mesh-ancestor
24705601|NCT01485809|Gefitinib|gefitinib|mesh-list
24705602|NCT01485809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705603|NCT01485809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24705604|NCT01485809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705605|NCT01485809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705607|NCT01485822|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24705608|NCT01485822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24491453|NCT00482573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24705609|NCT01485822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24705610|NCT01485835|Dexamethasone|dexamethasone|mesh-list
24705611|NCT01485835|Bortezomib|bortezomib|mesh-list
25692329|NCT01998906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25692330|NCT01998906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705612|NCT01485835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24705613|NCT01485835|Antiemetics|antiemetics|mesh-ancestor
25692331|NCT01998906|Tubulin Modulators|tubulin modulators|mesh-ancestor
25692332|NCT01998906|Antimitotic Agents|antimitotic agents|mesh-ancestor
24958849|NCT03829592|Abortifacient Agents|abortifacient agents|mesh-ancestor
24958850|NCT03829592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24958851|NCT03829592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958852|NCT03829592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24958853|NCT03829592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24958854|NCT03829592|Oxytocics|oxytocics|mesh-ancestor
24958855|NCT03829345|Olaparib|olaparib|mesh-list
24958856|NCT03829345|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24958857|NCT03829345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24958859|NCT03829345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705614|NCT01485835|Autonomic Agents|autonomic agents|mesh-ancestor
24705615|NCT01485835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24705616|NCT01485835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705617|NCT01485835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24705618|NCT01485835|Glucocorticoids|glucocorticoids|mesh-ancestor
25278992|NCT02348177|Antiviral Agents|antiviral agents|mesh-ancestor
25278993|NCT02348177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25278994|NCT02348177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25278995|NCT02348177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25278996|NCT02347904|Oxaliplatin|oxaliplatin|mesh-list
25278997|NCT02347904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25278998|NCT02348125|Thioctic Acid|thioctic acid|mesh-list
25278999|NCT02348125|Antioxidants|antioxidants|mesh-ancestor
25279000|NCT02348125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279001|NCT02348125|Protective Agents|protective agents|mesh-ancestor
25159731|NCT03672292|Ibrexafungerp|ibrexafungerp|mesh-list
25159732|NCT03672292|Antifungal Agents|antifungal agents|mesh-ancestor
25159733|NCT03672292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25159734|NCT03672292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25159735|NCT03672292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25159736|NCT03672292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25159737|NCT03672292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159738|NCT03672292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25159739|NCT03672292|Hormone Antagonists|hormone antagonists|mesh-ancestor
25159740|NCT03672292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25159741|NCT03672292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159742|NCT03672292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24705636|NCT01485926|Antimitotic Agents|antimitotic agents|mesh-ancestor
25279002|NCT02348125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279003|NCT02348125|Vitamin B Complex|vitamin b complex|mesh-ancestor
25279004|NCT02348125|Vitamins|vitamins|mesh-ancestor
25279005|NCT02348125|Micronutrients|micronutrients|mesh-ancestor
25279006|NCT02347878|Aprepitant|aprepitant|mesh-list
25279007|NCT02347878|Antiemetics|antiemetics|mesh-ancestor
25279008|NCT02347878|Autonomic Agents|autonomic agents|mesh-ancestor
25279009|NCT02347878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25279010|NCT02347878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279011|NCT02347878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25279012|NCT02347878|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25279013|NCT02347878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25279014|NCT02347878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279015|NCT02347891|Belimumab|belimumab|mesh-list
25118730|NCT03905811|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25118731|NCT03905811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25118732|NCT03905811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25118733|NCT03905811|Adrenergic Agents|adrenergic agents|mesh-ancestor
25118734|NCT03905811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25118735|NCT03905811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118736|NCT03905811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118737|NCT03905811|Urological Agents|urological agents|mesh-ancestor
25279022|NCT02347501|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25279023|NCT02347501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25692333|NCT01998906|Mitosis Modulators|mitosis modulators|mesh-ancestor
25692334|NCT01998906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692335|NCT01998906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25692336|NCT01998906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25692337|NCT01998906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25692338|NCT01998906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692339|NCT01998906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25692711|NCT02004093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692712|NCT02004093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25279024|NCT02347501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279025|NCT02347501|Incretins|incretins|mesh-ancestor
25279026|NCT02347501|Hormones|hormones|mesh-ancestor
25279027|NCT02347501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25279028|NCT02347501|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25279029|NCT02347501|Protease Inhibitors|protease inhibitors|mesh-ancestor
25279030|NCT02347501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279031|NCT02347501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279032|NCT02347839|Gefitinib|gefitinib|mesh-list
25279033|NCT02347839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25279034|NCT02347839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25279035|NCT02347839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279036|NCT02347839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279037|NCT02347319|Silymarin|silymarin|mesh-list
25279038|NCT02347319|Antioxidants|antioxidants|mesh-ancestor
25279039|NCT02347319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279040|NCT02347319|Protective Agents|protective agents|mesh-ancestor
25279041|NCT02347319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279042|NCT02347358|Plasminogen|plasminogen|mesh-list
25279043|NCT02347358|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25279044|NCT02347358|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25279045|NCT02347358|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25279046|NCT02347358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279047|NCT02347163|Zoledronic Acid|zoledronic acid|mesh-list
25279048|NCT02347163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25279049|NCT02347163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279050|NCT02347046|Dotinurad|dotinurad|mesh-list
25279051|NCT02347046|Uricosuric Agents|uricosuric agents|mesh-ancestor
24581516|NCT00865410|Bupropion|bupropion|mesh-list
25279052|NCT02347046|Gout Suppressants|gout suppressants|mesh-ancestor
25279053|NCT02347046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25279054|NCT02347046|Renal Agents|renal agents|mesh-ancestor
25279055|NCT02347059|Dopamine|dopamine|mesh-list
25279056|NCT02347059|Levodopa|levodopa|mesh-list
25279057|NCT02347059|Pramipexole|pramipexole|mesh-list
25279058|NCT02347059|Dopamine Agonists|dopamine agonists|mesh-list
25159806|NCT03615326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25159807|NCT03615326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25159808|NCT03615326|Antimetabolites|antimetabolites|mesh-ancestor
25159809|NCT03615326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159810|NCT03610412|Magnesium Oxide|magnesium oxide|mesh-list
25159811|NCT03610412|Antacids|antacids|mesh-ancestor
24996441|NCT03480776|Antipyretics|antipyretics|mesh-ancestor
24705637|NCT01485926|Mitosis Modulators|mitosis modulators|mesh-ancestor
24705638|NCT01485926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705639|NCT01485926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24705640|NCT01485926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24705641|NCT01485926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705643|NCT01485939|Anesthetics, Local|anesthetics, local|mesh-ancestor
24705644|NCT01485939|Anesthetics|anesthetics|mesh-ancestor
25279063|NCT02347059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279064|NCT02347059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279065|NCT02347059|Antioxidants|antioxidants|mesh-ancestor
25279066|NCT02347059|Protective Agents|protective agents|mesh-ancestor
25279067|NCT02347059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25279068|NCT02347059|Sympathomimetics|sympathomimetics|mesh-ancestor
25279069|NCT02347059|Autonomic Agents|autonomic agents|mesh-ancestor
25279070|NCT02347059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25279071|NCT02347033|Sertraline|sertraline|mesh-list
25279072|NCT02347033|Antidepressive Agents|antidepressive agents|mesh-ancestor
25279073|NCT02347033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25279074|NCT02347033|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25279075|NCT02347033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25279076|NCT02347033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25279077|NCT02347033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279078|NCT02347033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25279079|NCT02347033|Serotonin Agents|serotonin agents|mesh-ancestor
25279080|NCT02347033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279081|NCT02346890|Sevelamer|sevelamer|mesh-list
25279082|NCT02346890|Chelating Agents|chelating agents|mesh-ancestor
25279083|NCT02346890|Sequestering Agents|sequestering agents|mesh-ancestor
25279084|NCT02346890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279085|NCT02346955|Pembrolizumab|pembrolizumab|mesh-list
25279086|NCT02346955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25279087|NCT02346955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25279089|NCT02346682|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25279090|NCT02346682|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25279091|NCT02346682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25279092|NCT02346682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25159836|NCT03599323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25159837|NCT03599323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159838|NCT03599323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25159839|NCT03599323|Hormone Antagonists|hormone antagonists|mesh-ancestor
25159840|NCT03599323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25159841|NCT03599323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159842|NCT03599323|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25159843|NCT03599323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25279095|NCT02346682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279096|NCT02346682|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25279097|NCT02346682|Antidepressive Agents|antidepressive agents|mesh-ancestor
25279098|NCT02346682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25279100|NCT02346682|GABA Modulators|gaba modulators|mesh-ancestor
25279101|NCT02346682|GABA Agents|gaba agents|mesh-ancestor
25279103|NCT02346539|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25279104|NCT02346539|Autonomic Agents|autonomic agents|mesh-ancestor
25279105|NCT02346539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25279106|NCT02346539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279107|NCT02346539|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25110072|NCT03120494|Tenofovir|tenofovir|mesh-list
25279108|NCT02346539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25279109|NCT02346539|Cholinergic Agents|cholinergic agents|mesh-ancestor
25279110|NCT02346539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25279111|NCT02346539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279112|NCT02346578|Flutamide|flutamide|mesh-list
25279113|NCT02346578|Androgen Antagonists|androgen antagonists|mesh-ancestor
25279114|NCT02346578|Hormone Antagonists|hormone antagonists|mesh-ancestor
25279115|NCT02346578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25279116|NCT02346578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279117|NCT02346578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25279118|NCT02346578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25279119|NCT02346201|Methylphenidate|methylphenidate|mesh-list
25279120|NCT02346201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25279121|NCT02346201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279122|NCT02346201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25279123|NCT02346201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25279124|NCT02346201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25279125|NCT02346201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279126|NCT02346201|Dopamine Agents|dopamine agents|mesh-ancestor
25279127|NCT02346201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25279128|NCT02346357|Ropivacaine|ropivacaine|mesh-list
25279129|NCT02346357|Anesthetics, Local|anesthetics, local|mesh-ancestor
25279130|NCT02346357|Anesthetics|anesthetics|mesh-ancestor
25279131|NCT02346357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25279132|NCT02346357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159874|NCT03575195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25159876|NCT03546361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25159877|NCT03546361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25159878|NCT03539744|Dexamethasone|dexamethasone|mesh-list
25159879|NCT03539744|Venetoclax|venetoclax|mesh-list
25159880|NCT03539744|Pomalidomide|pomalidomide|mesh-list
25159881|NCT03539744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25159882|NCT03539744|Antiemetics|antiemetics|mesh-ancestor
25159883|NCT03539744|Autonomic Agents|autonomic agents|mesh-ancestor
25159884|NCT03539744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25159885|NCT03539744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159886|NCT03539744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25159887|NCT03539744|Glucocorticoids|glucocorticoids|mesh-ancestor
25279134|NCT02346357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25279135|NCT02346331|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25279136|NCT02346331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25279137|NCT02346188|Ferrous fumarate|ferrous fumarate|mesh-list
25279138|NCT02346188|Zinc Oxide|zinc oxide|mesh-list
25279139|NCT02346188|Trace Elements|trace elements|mesh-ancestor
25279140|NCT02346188|Micronutrients|micronutrients|mesh-ancestor
25279141|NCT02346188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279176|NCT02346110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25279177|NCT02346110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25279178|NCT02346110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25279179|NCT02346110|Anesthetics, Local|anesthetics, local|mesh-ancestor
25279180|NCT02346110|Anesthetics|anesthetics|mesh-ancestor
25279181|NCT02346110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25279182|NCT02346110|Sensory System Agents|sensory system agents|mesh-ancestor
25279183|NCT02346110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25279184|NCT02346110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25279185|NCT02346110|Adrenergic Agents|adrenergic agents|mesh-ancestor
25279186|NCT02346110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25279187|NCT02346110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279188|NCT02346110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25279189|NCT02346110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25279190|NCT02346110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25279191|NCT02346110|Respiratory System Agents|respiratory system agents|mesh-ancestor
25279192|NCT02346110|Mydriatics|mydriatics|mesh-ancestor
25279193|NCT02346110|Sympathomimetics|sympathomimetics|mesh-ancestor
25279194|NCT02346110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25279195|NCT02346084|Maraviroc|maraviroc|mesh-list
25279196|NCT02346084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25279197|NCT02346084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25279198|NCT02346084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279199|NCT02346084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25279200|NCT02346084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25279201|NCT02346084|Antiviral Agents|antiviral agents|mesh-ancestor
25279202|NCT02346084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25279203|NCT02346084|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25279204|NCT02345902|Haloperidol|haloperidol|mesh-list
25279205|NCT02345902|Haloperidol decanoate|haloperidol decanoate|mesh-list
25279206|NCT02345902|Antiemetics|antiemetics|mesh-ancestor
25279207|NCT02345902|Autonomic Agents|autonomic agents|mesh-ancestor
25279208|NCT02345902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25279209|NCT02345902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279210|NCT02345902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25279211|NCT02345902|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25279212|NCT02345902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25279213|NCT02345902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25279214|NCT02345902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25279215|NCT02345902|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25279216|NCT02345902|Dopamine Agents|dopamine agents|mesh-ancestor
25159968|NCT03421639|Hormones|hormones|mesh-ancestor
25279217|NCT02345902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25279218|NCT02345902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279219|NCT02345902|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25279220|NCT02345837|Clomiphene|clomiphene|mesh-list
25279221|NCT02345837|Enclomiphene|enclomiphene|mesh-list
25279222|NCT02345837|Zuclomiphene|zuclomiphene|mesh-list
25279223|NCT02345837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25279224|NCT02345837|Hormone Antagonists|hormone antagonists|mesh-ancestor
25279225|NCT02345837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25279226|NCT02345837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279227|NCT02345837|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25279228|NCT02345837|Fertility Agents|fertility agents|mesh-ancestor
25279229|NCT02345837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25279230|NCT02345837|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25279231|NCT02345837|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25279232|NCT02345863|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25279233|NCT02345863|Obinutuzumab|obinutuzumab|mesh-list
25279234|NCT02345863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25279235|NCT02345863|Alkylating Agents|alkylating agents|mesh-ancestor
25279236|NCT02345863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279237|NCT02345863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25279238|NCT02345863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25279239|NCT02345993|Beclomethasone|beclomethasone|mesh-list
25279240|NCT02345993|Formoterol Fumarate|formoterol fumarate|mesh-list
24582744|NCT00871442|Fentanyl|fentanyl|mesh-list
25279241|NCT02345993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25279242|NCT02345993|Autonomic Agents|autonomic agents|mesh-ancestor
25279243|NCT02345993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25279244|NCT02345993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279245|NCT02345993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25279246|NCT02345993|Respiratory System Agents|respiratory system agents|mesh-ancestor
25279247|NCT02345993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25078522|NCT03355638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25078523|NCT03355638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25078524|NCT03355638|Analgesics|analgesics|mesh-ancestor
25078525|NCT03355638|Sensory System Agents|sensory system agents|mesh-ancestor
25078526|NCT03355638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078527|NCT03355638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25078528|NCT03355638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25078529|NCT03355638|Gout Suppressants|gout suppressants|mesh-ancestor
25078530|NCT03355612|Capecitabine|capecitabine|mesh-list
25078531|NCT03355612|Oxaliplatin|oxaliplatin|mesh-list
25078532|NCT03355612|Apatinib|apatinib|mesh-list
25078533|NCT03355612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25078534|NCT03355612|Antimetabolites|antimetabolites|mesh-ancestor
25078536|NCT03355612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609091|NCT00994981|Analgesics|analgesics|mesh-ancestor
24609092|NCT00994981|Sensory System Agents|sensory system agents|mesh-ancestor
24609095|NCT00994981|Anesthetics|anesthetics|mesh-ancestor
25279248|NCT02345993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25279249|NCT02345993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25279250|NCT02345993|Adrenergic Agents|adrenergic agents|mesh-ancestor
25279251|NCT02345993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25279252|NCT02345993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279253|NCT02345993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24996629|NCT03104413|Immunologic Factors|immunologic factors|mesh-ancestor
24996640|NCT03091491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25159971|NCT03421639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25159972|NCT03421639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25159973|NCT03421639|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25159974|NCT03421639|Hormone Antagonists|hormone antagonists|mesh-ancestor
25159975|NCT03413800|Dexamethasone|dexamethasone|mesh-list
25159976|NCT03413800|Lenalidomide|lenalidomide|mesh-list
25159977|NCT03413800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25159978|NCT03413800|Antiemetics|antiemetics|mesh-ancestor
25159979|NCT03413800|Autonomic Agents|autonomic agents|mesh-ancestor
25159980|NCT03413800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25159981|NCT03413800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25159982|NCT03413800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25159983|NCT03413800|Glucocorticoids|glucocorticoids|mesh-ancestor
25159984|NCT03413800|Hormones|hormones|mesh-ancestor
25159985|NCT03413800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25159986|NCT03413800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25159987|NCT03413800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25159988|NCT03413800|Immunologic Factors|immunologic factors|mesh-ancestor
25159989|NCT03413800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25279260|NCT02345980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25279261|NCT02345980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864458|NCT04143282|Metformin|metformin|mesh-list
25279262|NCT02345980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279263|NCT02345980|Urological Agents|urological agents|mesh-ancestor
25160014|NCT03401853|Rituximab|rituximab|mesh-list
25160015|NCT03401853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25160016|NCT03401853|Pembrolizumab|pembrolizumab|mesh-list
25160017|NCT03401853|Obinutuzumab|obinutuzumab|mesh-list
25160018|NCT03401853|Antibodies|antibodies|mesh-list
25160019|NCT03401853|Immunoglobulins|immunoglobulins|mesh-list
25160020|NCT03401853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25160021|NCT03401853|Immunologic Factors|immunologic factors|mesh-ancestor
25160022|NCT03401853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160023|NCT03401853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25160024|NCT03401853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25279264|NCT02345746|Leucovorin|leucovorin|mesh-list
25279265|NCT02345746|Folic Acid|folic acid|mesh-list
25692719|NCT02004132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25692720|NCT02004132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692721|NCT02004262|Cyclophosphamide|cyclophosphamide|mesh-list
25692722|NCT02004262|Pancrelipase|pancrelipase|mesh-list
25692723|NCT02004262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25692724|NCT02004262|Immunologic Factors|immunologic factors|mesh-ancestor
25692725|NCT02004262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692726|NCT02004262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25692727|NCT02004262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25692728|NCT02004262|Alkylating Agents|alkylating agents|mesh-ancestor
25692729|NCT02004262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692730|NCT02004262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25692731|NCT02004262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25692732|NCT02004262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25692733|NCT02004366|Insulin Glargine|insulin glargine|mesh-list
24785382|NCT01914042|Morphine|morphine|mesh-list
24959385|NCT03825367|Nivolumab|nivolumab|mesh-list
24785455|NCT01914432|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24785457|NCT01914432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24785458|NCT01914432|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24785459|NCT01914432|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24785460|NCT01914562|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
24785461|NCT01914562|Cathartics|cathartics|mesh-ancestor
24785462|NCT01914562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24785463|NCT01914627|Salicylic Acid|salicylic acid|mesh-list
24785464|NCT01914627|Salicylates|salicylates|mesh-list
24785465|NCT01914627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25279266|NCT02345746|Fluorouracil|fluorouracil|mesh-list
25279267|NCT02345746|Oxaliplatin|oxaliplatin|mesh-list
25279268|NCT02345746|Levoleucovorin|levoleucovorin|mesh-list
25279269|NCT02345746|Antimetabolites|antimetabolites|mesh-ancestor
25279286|NCT02345707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279287|NCT02345707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25279288|NCT02345707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25279289|NCT02345707|Antiviral Agents|antiviral agents|mesh-ancestor
25279290|NCT02345707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25279292|NCT02345616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25279293|NCT02345616|Autonomic Agents|autonomic agents|mesh-ancestor
25279294|NCT02345616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25279295|NCT02345616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279296|NCT02345616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25279297|NCT02345616|Respiratory System Agents|respiratory system agents|mesh-ancestor
25279298|NCT02345616|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25279299|NCT02345616|Antioxidants|antioxidants|mesh-ancestor
25279300|NCT02345616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279301|NCT02345616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25279302|NCT02345616|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24798169|NCT01961219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24798170|NCT01961219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798171|NCT01961336|Testosterone|testosterone|mesh-list
24798172|NCT01961336|Androgens|androgens|mesh-ancestor
25160065|NCT03354013|Calcium|calcium|mesh-list
25160066|NCT03354013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24864659|NCT02880540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25160067|NCT03354013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160068|NCT03338387|Acipimox|acipimox|mesh-list
25160069|NCT03338387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25160070|NCT03338387|Antimetabolites|antimetabolites|mesh-ancestor
25160071|NCT03338387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160072|NCT03338387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25160073|NCT03335839|Plasminogen|plasminogen|mesh-list
25160074|NCT03335839|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25160075|NCT03335839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25160076|NCT03335839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25279303|NCT02345616|Vasodilator Agents|vasodilator agents|mesh-ancestor
25279304|NCT02345616|Gasotransmitters|gasotransmitters|mesh-ancestor
25279305|NCT02345616|Protective Agents|protective agents|mesh-ancestor
25279306|NCT02345681|Furosemide|furosemide|mesh-list
25160077|NCT03335839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279307|NCT02345681|Diuretics|diuretics|mesh-ancestor
25279308|NCT02345681|Natriuretic Agents|natriuretic agents|mesh-ancestor
25279309|NCT02345681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279310|NCT02345681|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25279311|NCT02345681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25279312|NCT02345681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279314|NCT02345304|Midazolam|midazolam|mesh-list
25279315|NCT02345304|Omeprazole|omeprazole|mesh-list
25279316|NCT02345304|Warfarin|warfarin|mesh-list
25279317|NCT02345304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25279318|NCT02345304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25692734|NCT02004366|Linagliptin|linagliptin|mesh-list
25692735|NCT02004366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25692736|NCT02004366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692737|NCT02004366|Incretins|incretins|mesh-ancestor
25692738|NCT02004366|Hormones|hormones|mesh-ancestor
25692739|NCT02004366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25692740|NCT02004366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25692741|NCT02004366|Protease Inhibitors|protease inhibitors|mesh-ancestor
25692742|NCT02004366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692743|NCT02004366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692744|NCT02004613|Dexmedetomidine|dexmedetomidine|mesh-list
25279319|NCT02345304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25279320|NCT02345304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279321|NCT02345304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25279322|NCT02345304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25279323|NCT02345304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25279324|NCT02345304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25279325|NCT02345304|Anesthetics, General|anesthetics, general|mesh-ancestor
25279326|NCT02345304|Anesthetics|anesthetics|mesh-ancestor
25279327|NCT02345304|GABA Modulators|gaba modulators|mesh-ancestor
25279328|NCT02345304|GABA Agents|gaba agents|mesh-ancestor
25279329|NCT02345304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25279330|NCT02345304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279331|NCT02345304|Anticoagulants|anticoagulants|mesh-ancestor
25279332|NCT02345304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25279333|NCT02345304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25279334|NCT02345304|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25279335|NCT02345304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279336|NCT02345304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25279337|NCT02345304|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25279338|NCT02345304|Protective Agents|protective agents|mesh-ancestor
25279339|NCT02345343|Apixaban|apixaban|mesh-list
25279340|NCT02345343|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25279341|NCT02345343|Antithrombins|antithrombins|mesh-ancestor
25279342|NCT02345343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25279343|NCT02345343|Protease Inhibitors|protease inhibitors|mesh-ancestor
25279344|NCT02345343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279345|NCT02345343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279346|NCT02345343|Anticoagulants|anticoagulants|mesh-ancestor
25160089|NCT03326193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160090|NCT03321799|Anti-Infective Agents|anti-infective agents|mesh-list
25160091|NCT03321799|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25160092|NCT03314935|Leucovorin|leucovorin|mesh-list
25160093|NCT03314935|Gemcitabine|gemcitabine|mesh-list
25160094|NCT03314935|Paclitaxel|paclitaxel|mesh-list
25160095|NCT03314935|Fluorouracil|fluorouracil|mesh-list
25160096|NCT03314935|Oxaliplatin|oxaliplatin|mesh-list
24705685|NCT01486251|Axitinib|axitinib|mesh-list
25160097|NCT03314935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25160098|NCT03314935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25160099|NCT03314935|Tubulin Modulators|tubulin modulators|mesh-ancestor
25160100|NCT03314935|Antimitotic Agents|antimitotic agents|mesh-ancestor
25160101|NCT03314935|Mitosis Modulators|mitosis modulators|mesh-ancestor
25160102|NCT03314935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160103|NCT03314935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25160105|NCT03314935|Antiviral Agents|antiviral agents|mesh-ancestor
25160106|NCT03314935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25160107|NCT03314935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25160108|NCT03314935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25160109|NCT03314935|Immunologic Factors|immunologic factors|mesh-ancestor
25160110|NCT03314935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160111|NCT03314935|Antidotes|antidotes|mesh-ancestor
25160112|NCT03314935|Protective Agents|protective agents|mesh-ancestor
25279347|NCT02345590|Eplerenone|eplerenone|mesh-list
25279348|NCT02345590|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25279349|NCT02345590|Hormone Antagonists|hormone antagonists|mesh-ancestor
25279350|NCT02345590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25279351|NCT02345590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279352|NCT02345590|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25279353|NCT02345590|Diuretics|diuretics|mesh-ancestor
25279354|NCT02345590|Natriuretic Agents|natriuretic agents|mesh-ancestor
25279355|NCT02345590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25279356|NCT02345239|Pantoprazole|pantoprazole|mesh-list
25279357|NCT02345239|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25279358|NCT02345239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25279359|NCT02345239|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25279360|NCT02345239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279361|NCT02345239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279362|NCT02345148|Esketamine|esketamine|mesh-list
25279363|NCT02345148|Antidepressive Agents|antidepressive agents|mesh-ancestor
25279364|NCT02345148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25279372|NCT02345044|Natriuretic Agents|natriuretic agents|mesh-ancestor
25279373|NCT02345044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25279374|NCT02345213|Donepezil|donepezil|mesh-list
25279375|NCT02345213|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25279376|NCT02345213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279377|NCT02345213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279378|NCT02345213|Cholinergic Agents|cholinergic agents|mesh-ancestor
25279379|NCT02345213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25279380|NCT02345213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279381|NCT02345213|Nootropic Agents|nootropic agents|mesh-ancestor
25279382|NCT02344992|Insulin Lispro|insulin lispro|mesh-list
25279383|NCT02344992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25279384|NCT02344992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279385|NCT02345187|Micronutrients|micronutrients|mesh-list
25279386|NCT02345187|Trace Elements|trace elements|mesh-list
25279387|NCT02345187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279388|NCT02344940|Tamoxifen|tamoxifen|mesh-list
25279389|NCT02344940|Toremifene|toremifene|mesh-list
25279390|NCT02344940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25279391|NCT02344940|Hormone Antagonists|hormone antagonists|mesh-ancestor
25279392|NCT02344940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25279393|NCT02344940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279394|NCT02344940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25279395|NCT02344940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053079|NCT00108810|Ketoprofen|ketoprofen|mesh-list
25279396|NCT02344940|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25119059|NCT02951052|Rilpivirine|rilpivirine|mesh-list
25119060|NCT02951052|Cabotegravir|cabotegravir|mesh-list
25119061|NCT02951052|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25119062|NCT02951052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25119065|NCT02951052|Antiviral Agents|antiviral agents|mesh-ancestor
25160142|NCT03249012|Calcium, Dietary|calcium, dietary|mesh-list
25160143|NCT03249012|Calcitriol|calcitriol|mesh-list
25160144|NCT03249012|Calcium Carbonate|calcium carbonate|mesh-list
25160145|NCT03249012|Calcium|calcium|mesh-list
25160146|NCT03249012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25160147|NCT03249012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160148|NCT03249012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25160149|NCT03249012|Antacids|antacids|mesh-ancestor
25160150|NCT03249012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160151|NCT03249012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25160152|NCT03249012|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25160153|NCT03249012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25160154|NCT03249012|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25160156|NCT03249012|Micronutrients|micronutrients|mesh-ancestor
25160157|NCT03233828|Aldesleukin|aldesleukin|mesh-list
25160158|NCT03233828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705645|NCT01485939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24705646|NCT01485939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705647|NCT01485939|Sensory System Agents|sensory system agents|mesh-ancestor
24583928|NCT00877591|Analgesics|analgesics|mesh-ancestor
24705648|NCT01485939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24705649|NCT01485939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24705650|NCT01485939|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24705651|NCT01485939|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24705652|NCT01485939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24705653|NCT01485939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705654|NCT01485978|Ramipril|ramipril|mesh-list
24705655|NCT01485978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24705656|NCT01485978|Protease Inhibitors|protease inhibitors|mesh-ancestor
24705657|NCT01485978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279429|NCT02344862|Dotinurad|dotinurad|mesh-list
25279401|NCT02344888|Prednisolone|prednisolone|mesh-list
25279402|NCT02344888|Citric Acid|citric acid|mesh-list
25279403|NCT02344888|Sodium Citrate|sodium citrate|mesh-list
25279404|NCT02344888|Clomiphene|clomiphene|mesh-list
25279405|NCT02344888|Enclomiphene|enclomiphene|mesh-list
25279406|NCT02344888|Zuclomiphene|zuclomiphene|mesh-list
25279407|NCT02344888|Anticoagulants|anticoagulants|mesh-ancestor
25279408|NCT02344888|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25279409|NCT02344888|Chelating Agents|chelating agents|mesh-ancestor
25279410|NCT02344888|Sequestering Agents|sequestering agents|mesh-ancestor
25279411|NCT02344888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279412|NCT02344888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25279413|NCT02344888|Glucocorticoids|glucocorticoids|mesh-ancestor
25279414|NCT02344888|Hormones|hormones|mesh-ancestor
25279415|NCT02344888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25279416|NCT02344888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279417|NCT02344888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25279418|NCT02344888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25279419|NCT02344888|Hematinics|hematinics|mesh-ancestor
25279420|NCT02344888|Vitamins|vitamins|mesh-ancestor
25279421|NCT02344888|Micronutrients|micronutrients|mesh-ancestor
25279422|NCT02344888|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25279423|NCT02344888|Hormone Antagonists|hormone antagonists|mesh-ancestor
25279424|NCT02344888|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25279425|NCT02344888|Fertility Agents|fertility agents|mesh-ancestor
25279426|NCT02344888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25160159|NCT03233828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25160160|NCT03233828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25160161|NCT03233828|Antiviral Agents|antiviral agents|mesh-ancestor
25160162|NCT03233828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25160172|NCT03223103|Poly ICLC|poly iclc|mesh-list
24865058|NCT04690673|Analgesics|analgesics|mesh-ancestor
25160173|NCT03223103|Interferon Inducers|interferon inducers|mesh-ancestor
25160174|NCT03223103|Immunologic Factors|immunologic factors|mesh-ancestor
25160175|NCT03223103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160178|NCT03202628|Dexamethasone|dexamethasone|mesh-list
25160179|NCT03202628|Dexamethasone acetate|dexamethasone acetate|mesh-list
25160180|NCT03202628|Pomalidomide|pomalidomide|mesh-list
25160181|NCT03202628|Ixazomib|ixazomib|mesh-list
25160182|NCT03202628|Ichthammol|ichthammol|mesh-list
25160183|NCT03202628|BB 1101|bb 1101|mesh-list
25160184|NCT03202628|Glycine|glycine|mesh-list
25160185|NCT03202628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25160186|NCT03202628|Antiemetics|antiemetics|mesh-ancestor
25160187|NCT03202628|Autonomic Agents|autonomic agents|mesh-ancestor
25160188|NCT03202628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25160189|NCT03202628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160190|NCT03202628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25160191|NCT03202628|Glucocorticoids|glucocorticoids|mesh-ancestor
25160192|NCT03202628|Hormones|hormones|mesh-ancestor
25160193|NCT03202628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24705677|NCT01486082|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24705678|NCT01486082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24705679|NCT01486082|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24705680|NCT01486082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705681|NCT01486082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705682|NCT01486082|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24705683|NCT01486082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24705684|NCT01486082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25279427|NCT02344888|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25279428|NCT02344888|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25279435|NCT02344875|Uricosuric Agents|uricosuric agents|mesh-ancestor
25279436|NCT02344875|Gout Suppressants|gout suppressants|mesh-ancestor
25279437|NCT02344875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25279439|NCT02344823|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
25279440|NCT02344823|Vasodilator Agents|vasodilator agents|mesh-ancestor
25279441|NCT02344823|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25279442|NCT02344823|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25279443|NCT02344823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279444|NCT02344823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279445|NCT02344823|Urological Agents|urological agents|mesh-ancestor
25279446|NCT02344810|Leucovorin|leucovorin|mesh-list
25279447|NCT02344810|Fluorouracil|fluorouracil|mesh-list
25279448|NCT02344810|Oxaliplatin|oxaliplatin|mesh-list
25279449|NCT02344810|Calcium|calcium|mesh-list
25279450|NCT02344810|Levoleucovorin|levoleucovorin|mesh-list
25279451|NCT02344810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25279452|NCT02344810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279453|NCT02344810|Antimetabolites|antimetabolites|mesh-ancestor
25279454|NCT02344810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279455|NCT02344810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25279456|NCT02344810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25279457|NCT02344810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25279458|NCT02344810|Immunologic Factors|immunologic factors|mesh-ancestor
25279459|NCT02344810|Antidotes|antidotes|mesh-ancestor
25160194|NCT03202628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25160195|NCT03202628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25160196|NCT03202628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160197|NCT03202628|Protease Inhibitors|protease inhibitors|mesh-ancestor
25160198|NCT03202628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25160199|NCT03202628|Immunologic Factors|immunologic factors|mesh-ancestor
25160200|NCT03202628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25160201|NCT03202628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25160202|NCT03202628|Growth Substances|growth substances|mesh-ancestor
25160203|NCT03202628|Growth Inhibitors|growth inhibitors|mesh-ancestor
25160204|NCT03202628|Dermatologic Agents|dermatologic agents|mesh-ancestor
25053205|NCT00084344|Afimoxifene|afimoxifene|mesh-list
25160205|NCT03202628|Glycine Agents|glycine agents|mesh-ancestor
25160206|NCT03202628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25160207|NCT03199794|Factor VIII|factor viii|mesh-list
25160208|NCT03199794|Coagulants|coagulants|mesh-ancestor
25279460|NCT02344810|Protective Agents|protective agents|mesh-ancestor
25279461|NCT02344810|Vitamin B Complex|vitamin b complex|mesh-ancestor
25279462|NCT02344810|Vitamins|vitamins|mesh-ancestor
25279463|NCT02344810|Micronutrients|micronutrients|mesh-ancestor
25279464|NCT02344511|Vancomycin|vancomycin|mesh-list
25279465|NCT02344511|Cefazolin|cefazolin|mesh-list
25279466|NCT02344511|Dalbavancin|dalbavancin|mesh-list
25279467|NCT02344511|Oxacillin|oxacillin|mesh-list
25279468|NCT02344511|Nafcillin|nafcillin|mesh-list
25279469|NCT02344511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25279470|NCT02344511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25279471|NCT02344550|Everolimus|everolimus|mesh-list
25279472|NCT02344550|Letrozole|letrozole|mesh-list
25279473|NCT02344550|Leuprolide|leuprolide|mesh-list
25279474|NCT02344550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25279475|NCT02344550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25279476|NCT02344550|Immunologic Factors|immunologic factors|mesh-ancestor
25279477|NCT02344550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279478|NCT02344550|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25279479|NCT02344550|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25279480|NCT02344550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279481|NCT02344550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279482|NCT02344550|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25279483|NCT02344550|Hormone Antagonists|hormone antagonists|mesh-ancestor
25279484|NCT02344550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25279485|NCT02344550|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25279486|NCT02344550|Fertility Agents|fertility agents|mesh-ancestor
25279487|NCT02344550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25279488|NCT02344550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25279494|NCT02344784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25279495|NCT02344784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279496|NCT02344784|Dopamine Agents|dopamine agents|mesh-ancestor
25279497|NCT02344784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25279498|NCT02344602|Febuxostat|febuxostat|mesh-list
25279499|NCT02344602|Gout Suppressants|gout suppressants|mesh-ancestor
25279500|NCT02344602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25279501|NCT02344589|Lidocaine|lidocaine|mesh-list
25279505|NCT02344589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279506|NCT02344589|Sensory System Agents|sensory system agents|mesh-ancestor
25279507|NCT02344589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25279508|NCT02344589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25279509|NCT02344589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25279510|NCT02344589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25279511|NCT02344589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25279512|NCT02344589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279514|NCT02344641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25160250|NCT03097939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25160251|NCT03097939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25160252|NCT03097939|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25160253|NCT03097939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160255|NCT03096249|Oxytocics|oxytocics|mesh-ancestor
25160256|NCT03096249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25160257|NCT03096249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160258|NCT03086096|Irinotecan|irinotecan|mesh-list
25160259|NCT03086096|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25160260|NCT03086096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25160261|NCT03086096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25160262|NCT03086096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160263|NCT03086096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24798190|NCT01961453|Isosorbide|isosorbide|mesh-list
24705686|NCT01486251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705687|NCT01486251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24705688|NCT01486251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705689|NCT01486251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705690|NCT01486381|Insulin Aspart|insulin aspart|mesh-list
24705691|NCT01486381|Biphasic Insulins|biphasic insulins|mesh-list
24705692|NCT01486381|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24705694|NCT01486381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705695|NCT01486433|Aspirin|aspirin|mesh-list
24705696|NCT01486433|Simvastatin|simvastatin|mesh-list
24705697|NCT01486433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24705698|NCT01486433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24705771|NCT01486706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24705772|NCT01486706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24705773|NCT01486706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24610216|NCT01000623|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24610217|NCT01000623|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24610218|NCT01000623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24610219|NCT01000623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610220|NCT01000623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24610276|NCT01000896|Tubulin Modulators|tubulin modulators|mesh-ancestor
24610277|NCT01000896|Antimitotic Agents|antimitotic agents|mesh-ancestor
24610278|NCT01000896|Mitosis Modulators|mitosis modulators|mesh-ancestor
24610280|NCT01000896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610309|NCT01001247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24705774|NCT01486706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24584610|NCT00881140|Mifepristone|mifepristone|mesh-list
24705775|NCT01486706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24705776|NCT01486706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24705777|NCT01486706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279515|NCT02344641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279516|NCT02344641|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25279517|NCT02344641|Incretins|incretins|mesh-ancestor
25279518|NCT02344641|Hormones|hormones|mesh-ancestor
25279528|NCT02344732|Autonomic Agents|autonomic agents|mesh-ancestor
25279529|NCT02344732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25279530|NCT02344732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279531|NCT02344732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25279532|NCT02344732|Glucocorticoids|glucocorticoids|mesh-ancestor
25279534|NCT02344732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25279535|NCT02344732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25279536|NCT02344732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25279537|NCT02344732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25279538|NCT02344732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25279539|NCT02344732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25160272|NCT03069352|Cytarabine|cytarabine|mesh-list
25160273|NCT03069352|Venetoclax|venetoclax|mesh-list
25160274|NCT03069352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25160275|NCT03069352|Antimetabolites|antimetabolites|mesh-ancestor
25160276|NCT03069352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160277|NCT03069352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25160278|NCT03069352|Antiviral Agents|antiviral agents|mesh-ancestor
25160279|NCT03069352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25160280|NCT03069352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25160281|NCT03069352|Immunologic Factors|immunologic factors|mesh-ancestor
25160282|NCT03069352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160286|NCT03056040|Eculizumab|eculizumab|mesh-list
25160287|NCT03056040|Ravulizumab|ravulizumab|mesh-list
25160288|NCT03056040|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25160289|NCT03056040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25160290|NCT03056040|Immunologic Factors|immunologic factors|mesh-ancestor
25160291|NCT03056040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160292|NCT03047473|Avelumab|avelumab|mesh-list
25160293|NCT03047473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25160294|NCT03047473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25160299|NCT03026062|Durvalumab|durvalumab|mesh-list
25160300|NCT03026062|Ipilimumab|ipilimumab|mesh-list
25160301|NCT03026062|Tremelimumab|tremelimumab|mesh-list
25160302|NCT03026062|Immunoglobulins|immunoglobulins|mesh-list
25160303|NCT03026062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25160304|NCT03026062|Immunoglobulin G|immunoglobulin g|mesh-list
25119191|NCT02536794|Durvalumab|durvalumab|mesh-list
25160305|NCT03026062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25160306|NCT03026062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24798212|NCT01961739|Lidocaine|lidocaine|mesh-list
25692745|NCT02004613|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25692746|NCT02004613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25692747|NCT02004613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692748|NCT02004613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25692749|NCT02004613|Analgesics|analgesics|mesh-ancestor
25692750|NCT02004613|Sensory System Agents|sensory system agents|mesh-ancestor
25692751|NCT02004613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25692752|NCT02004613|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25692753|NCT02004613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25692754|NCT02004613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25692755|NCT02004613|Adrenergic Agents|adrenergic agents|mesh-ancestor
25692756|NCT02004613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25279541|NCT02344732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279542|NCT02344732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279543|NCT02344732|Parasympatholytics|parasympatholytics|mesh-ancestor
25160326|NCT03020199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25160327|NCT03020199|Respiratory System Agents|respiratory system agents|mesh-ancestor
25160328|NCT03020199|Immunologic Factors|immunologic factors|mesh-ancestor
25160329|NCT03020199|Dermatologic Agents|dermatologic agents|mesh-ancestor
25160330|NCT03014635|Botulinum Toxins|botulinum toxins|mesh-list
25160331|NCT03014635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25160332|NCT03014635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25160333|NCT03014635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25160334|NCT03014635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25160335|NCT03014635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160336|NCT03014635|Cholinergic Agents|cholinergic agents|mesh-ancestor
25160337|NCT03014635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25160338|NCT03014635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160339|NCT03014635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25160340|NCT03014635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24996923|NCT00602576|Sorafenib|sorafenib|mesh-list
25279578|NCT02344264|Ropivacaine|ropivacaine|mesh-list
25279579|NCT02344264|Anesthetics, Local|anesthetics, local|mesh-ancestor
25279580|NCT02344264|Anesthetics|anesthetics|mesh-ancestor
25279581|NCT02344264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25279582|NCT02344264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279583|NCT02344264|Sensory System Agents|sensory system agents|mesh-ancestor
25279584|NCT02344264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25279585|NCT02344303|Moxifloxacin|moxifloxacin|mesh-list
25279586|NCT02344303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25279587|NCT02344303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25279588|NCT02344303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25279589|NCT02344303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25279590|NCT02344303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279591|NCT02344303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279592|NCT02344303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25279616|NCT02344030|Keratolytic Agents|keratolytic agents|mesh-ancestor
25160345|NCT03014622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25160346|NCT03014622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160347|NCT03014622|Cholinergic Agents|cholinergic agents|mesh-ancestor
25160348|NCT03014622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25160349|NCT03014622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160350|NCT03014622|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25160351|NCT03014622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25160353|NCT03013218|Rituximab|rituximab|mesh-list
25160354|NCT03013218|Pembrolizumab|pembrolizumab|mesh-list
25160355|NCT03013218|Trastuzumab|trastuzumab|mesh-list
25160356|NCT03013218|Ramucirumab|ramucirumab|mesh-list
24865257|NCT04062708|Durvalumab|durvalumab|mesh-list
25160357|NCT03013218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25160358|NCT03013218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25160359|NCT03013218|Tubulin Modulators|tubulin modulators|mesh-ancestor
25160360|NCT03013218|Antimitotic Agents|antimitotic agents|mesh-ancestor
25160361|NCT03013218|Mitosis Modulators|mitosis modulators|mesh-ancestor
25279898|NCT02341872|Calcium|calcium|mesh-list
25160362|NCT03013218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160363|NCT03013218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25160364|NCT03013218|Immunologic Factors|immunologic factors|mesh-ancestor
25160365|NCT03013218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160366|NCT03013218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25160367|NCT03007979|Letrozole|letrozole|mesh-list
25160368|NCT03007979|Fulvestrant|fulvestrant|mesh-list
25160369|NCT03007979|Palbociclib|palbociclib|mesh-list
25160370|NCT03007979|Goserelin|goserelin|mesh-list
25160371|NCT03007979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25160372|NCT03007979|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25160373|NCT03007979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25279617|NCT02344030|Dermatologic Agents|dermatologic agents|mesh-ancestor
25160374|NCT03007979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279618|NCT02344017|Prednisone|prednisone|mesh-list
25692757|NCT02004613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692758|NCT02004886|Metformin|metformin|mesh-list
25279619|NCT02344017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25279620|NCT02344017|Glucocorticoids|glucocorticoids|mesh-ancestor
25279621|NCT02344017|Hormones|hormones|mesh-ancestor
24959932|NCT03820622|Paclitaxel|paclitaxel|mesh-list
25279622|NCT02344017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25279623|NCT02344017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279624|NCT02344017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25279625|NCT02344017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25279630|NCT02343718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25279631|NCT02343718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25279632|NCT02343718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25279633|NCT02343718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25279634|NCT02343718|Antifungal Agents|antifungal agents|mesh-ancestor
25279635|NCT02343718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25279636|NCT02343718|Immunologic Factors|immunologic factors|mesh-ancestor
25279637|NCT02343718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279638|NCT02343718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25279639|NCT02343718|Tubulin Modulators|tubulin modulators|mesh-ancestor
25279640|NCT02343718|Antimitotic Agents|antimitotic agents|mesh-ancestor
25279641|NCT02343718|Mitosis Modulators|mitosis modulators|mesh-ancestor
25279642|NCT02343718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279643|NCT02343692|Pancrelipase|pancrelipase|mesh-list
25279644|NCT02343692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25279645|NCT02343666|Plerixafor|plerixafor|mesh-list
25279646|NCT02343666|Carmustine|carmustine|mesh-list
25279647|NCT02343666|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
25279648|NCT02343666|Lenograstim|lenograstim|mesh-list
25279649|NCT02343666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25279650|NCT02343666|Immunologic Factors|immunologic factors|mesh-ancestor
25279651|NCT02343666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279652|NCT02343666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25279653|NCT02343666|Alkylating Agents|alkylating agents|mesh-ancestor
25279654|NCT02343666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279655|NCT02343666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25279656|NCT02343666|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25279657|NCT02343666|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25160431|NCT02958865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25160432|NCT02958865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053673|NCT00004897|Interferon-alpha|interferon-alpha|mesh-list
25160433|NCT02958865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160437|NCT02949700|Metformin|metformin|mesh-list
25160438|NCT02949700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25160439|NCT02949700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160440|NCT02942498|Vitamins|vitamins|mesh-list
24613656|NCT01020214|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24613657|NCT01020214|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24613658|NCT01020253|Alendronate|alendronate|mesh-list
24613659|NCT01020253|Alfacalcidol|alfacalcidol|mesh-list
24613660|NCT01020253|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
24705812|NCT01486940|Insulin Aspart|insulin aspart|mesh-list
24705813|NCT01486940|Insulin Detemir|insulin detemir|mesh-list
24705814|NCT01486940|Isophane Insulin, Human|isophane insulin, human|mesh-list
24705815|NCT01486940|Insulin, Isophane|insulin, isophane|mesh-list
24705816|NCT01486940|Isophane insulin, beef|isophane insulin, beef|mesh-list
24705817|NCT01486940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24705818|NCT01486940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705819|NCT01486953|Sevoflurane|sevoflurane|mesh-list
24705820|NCT01486953|Desflurane|desflurane|mesh-list
25279899|NCT02341872|Fluorides|fluorides|mesh-list
24705821|NCT01486953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24705822|NCT01486953|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24705823|NCT01486953|Anesthetics, General|anesthetics, general|mesh-ancestor
24705824|NCT01486953|Anesthetics|anesthetics|mesh-ancestor
25279671|NCT02343432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279672|NCT02343432|Sensory System Agents|sensory system agents|mesh-ancestor
25279673|NCT02343432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25279674|NCT02343432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25279675|NCT02343432|Glucocorticoids|glucocorticoids|mesh-ancestor
25279677|NCT02343432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25279678|NCT02343484|Ethanol|ethanol|mesh-list
24997056|NCT05419193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997057|NCT05419193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24997059|NCT05419193|Vasodilator Agents|vasodilator agents|mesh-ancestor
25160441|NCT02942498|Ascorbic Acid|ascorbic acid|mesh-list
25692759|NCT02004886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25160442|NCT02942498|Vitamin E|vitamin e|mesh-list
25160443|NCT02942498|Micronutrients|micronutrients|mesh-ancestor
25279679|NCT02343484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25279680|NCT02343484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25160444|NCT02942498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160445|NCT02942498|Antioxidants|antioxidants|mesh-ancestor
25160446|NCT02942498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160447|NCT02942498|Protective Agents|protective agents|mesh-ancestor
25279681|NCT02343484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25279682|NCT02343484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279683|NCT02343536|Prednisone|prednisone|mesh-list
25279684|NCT02343536|Cyclophosphamide|cyclophosphamide|mesh-list
25279685|NCT02343536|Rituximab|rituximab|mesh-list
25279686|NCT02343536|Vincristine|vincristine|mesh-list
25279687|NCT02343536|Azacitidine|azacitidine|mesh-list
25279688|NCT02343536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25279689|NCT02343536|Immunologic Factors|immunologic factors|mesh-ancestor
25279690|NCT02343536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279691|NCT02343536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25279692|NCT02343536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25279693|NCT02343536|Alkylating Agents|alkylating agents|mesh-ancestor
25279694|NCT02343536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279695|NCT02343536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25279696|NCT02343536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25279697|NCT02343536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25279698|NCT02343536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25279699|NCT02343536|Glucocorticoids|glucocorticoids|mesh-ancestor
25279700|NCT02343536|Hormones|hormones|mesh-ancestor
25279701|NCT02343536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25279702|NCT02343536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25160484|NCT02917083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545446|NCT00693433|Dexamethasone|dexamethasone|mesh-list
25160486|NCT02917083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25160511|NCT02911142|Prednisone|prednisone|mesh-list
25160512|NCT02911142|Cyclophosphamide|cyclophosphamide|mesh-list
25160513|NCT02911142|Rituximab|rituximab|mesh-list
25160514|NCT02911142|Doxorubicin|doxorubicin|mesh-list
25160515|NCT02911142|Vincristine|vincristine|mesh-list
25160516|NCT02911142|Lenalidomide|lenalidomide|mesh-list
24705826|NCT01486953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705827|NCT01486979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24705828|NCT01486979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24705840|NCT01486992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24705841|NCT01486992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705842|NCT01487096|Teriflunomide|teriflunomide|mesh-list
24705843|NCT01487096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24705844|NCT01487096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24705845|NCT01487096|Analgesics|analgesics|mesh-ancestor
24705846|NCT01487096|Sensory System Agents|sensory system agents|mesh-ancestor
25279723|NCT02343614|Celecoxib|celecoxib|mesh-list
25279724|NCT02343614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25279725|NCT02343614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25279726|NCT02343614|Analgesics|analgesics|mesh-ancestor
25279727|NCT02343614|Sensory System Agents|sensory system agents|mesh-ancestor
25279728|NCT02343614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25279729|NCT02343614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279730|NCT02343614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25279731|NCT02343614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25279732|NCT02343614|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25279733|NCT02343614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25279734|NCT02343614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279965|NCT02341703|Letrozole|letrozole|mesh-list
25279735|NCT02343614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279737|NCT02343393|Isosorbide|isosorbide|mesh-list
25279738|NCT02343393|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25279739|NCT02343393|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25279740|NCT02343393|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25279741|NCT02343393|Diuretics|diuretics|mesh-ancestor
25279742|NCT02343393|Natriuretic Agents|natriuretic agents|mesh-ancestor
25279743|NCT02343393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279744|NCT02343393|Vasodilator Agents|vasodilator agents|mesh-ancestor
25279745|NCT02343393|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25279746|NCT02343393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279747|NCT02343393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25279748|NCT02343211|Immunoglobulins|immunoglobulins|mesh-list
25279749|NCT02343211|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25279750|NCT02343211|Antibodies|antibodies|mesh-list
25692760|NCT02004886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692761|NCT02004990|Povidone-Iodine|povidone-iodine|mesh-list
24786051|NCT01917799|Heparin|heparin|mesh-list
24786052|NCT01917799|Enoxaparin|enoxaparin|mesh-list
24786053|NCT01917799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24786054|NCT01917799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24786055|NCT01917799|Analgesics|analgesics|mesh-ancestor
25279751|NCT02343211|Immunologic Factors|immunologic factors|mesh-ancestor
25279752|NCT02343211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279753|NCT02343289|Clarithromycin|clarithromycin|mesh-list
25279754|NCT02343289|Esketamine|esketamine|mesh-list
25160517|NCT02911142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25160518|NCT02911142|Immunologic Factors|immunologic factors|mesh-ancestor
25160519|NCT02911142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160520|NCT02911142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25160521|NCT02911142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25160522|NCT02911142|Alkylating Agents|alkylating agents|mesh-ancestor
25160523|NCT02911142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160524|NCT02911142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25160525|NCT02911142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25160526|NCT02911142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25160527|NCT02911142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25160528|NCT02911142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25160529|NCT02911142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25160530|NCT02911142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25160531|NCT02911142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25160532|NCT02911142|Glucocorticoids|glucocorticoids|mesh-ancestor
25160533|NCT02911142|Hormones|hormones|mesh-ancestor
25160534|NCT02911142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25160535|NCT02911142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25160536|NCT02911142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25160537|NCT02911142|Tubulin Modulators|tubulin modulators|mesh-ancestor
25160538|NCT02911142|Antimitotic Agents|antimitotic agents|mesh-ancestor
25160539|NCT02911142|Mitosis Modulators|mitosis modulators|mesh-ancestor
25160540|NCT02911142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25160541|NCT02911142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25160542|NCT02911142|Growth Substances|growth substances|mesh-ancestor
25160543|NCT02911142|Growth Inhibitors|growth inhibitors|mesh-ancestor
25160544|NCT02885272|Deoxyglucose|deoxyglucose|mesh-list
25160545|NCT02885272|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25160546|NCT02885272|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25160547|NCT02885272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160548|NCT02885272|Antimetabolites|antimetabolites|mesh-ancestor
25160549|NCT02885272|Antiviral Agents|antiviral agents|mesh-ancestor
25279755|NCT02343289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25279756|NCT02343289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25279757|NCT02343289|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25279758|NCT02343289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279759|NCT02343289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279760|NCT02343289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25279761|NCT02343289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25279762|NCT02343289|Antidepressive Agents|antidepressive agents|mesh-ancestor
25279763|NCT02343289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25279764|NCT02342977|Lacosamide|lacosamide|mesh-list
25279765|NCT02342977|Anticonvulsants|anticonvulsants|mesh-ancestor
25279766|NCT02342977|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25279767|NCT02342977|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25279768|NCT02342977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25692762|NCT02004990|Povidone|povidone|mesh-list
25692763|NCT02004990|Plasma Substitutes|plasma substitutes|mesh-ancestor
25692764|NCT02004990|Blood Substitutes|blood substitutes|mesh-ancestor
25692765|NCT02004990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25692766|NCT02004990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25692767|NCT02005029|Erythromycin|erythromycin|mesh-list
25692768|NCT02005029|Erythromycin Estolate|erythromycin estolate|mesh-list
25692769|NCT02005029|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25692770|NCT02005029|Erythromycin stearate|erythromycin stearate|mesh-list
25692771|NCT02005029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25279769|NCT02342977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279770|NCT02343250|Valsartan|valsartan|mesh-list
25279771|NCT02343250|Cilnidipine|cilnidipine|mesh-list
25279772|NCT02343250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25279773|NCT02343250|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25279774|NCT02343250|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25279775|NCT02343250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279776|NCT02343250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25279787|NCT02342769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279788|NCT02342769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279789|NCT02342769|Antiviral Agents|antiviral agents|mesh-ancestor
25279790|NCT02342769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25279791|NCT02342769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25279792|NCT02342769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25119485|NCT01595841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25119486|NCT01595841|Immunologic Factors|immunologic factors|mesh-ancestor
25119487|NCT01595841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119488|NCT05405049|Lidocaine|lidocaine|mesh-list
25160567|NCT02833844|Evolocumab|evolocumab|mesh-list
25160568|NCT02833844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25160569|NCT02833844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25160570|NCT02833844|Antimetabolites|antimetabolites|mesh-ancestor
25160571|NCT02833844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160572|NCT02833844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25160573|NCT02825940|Gemcitabine|gemcitabine|mesh-list
25160574|NCT02825940|Atezolizumab|atezolizumab|mesh-list
25160575|NCT02825940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24997177|NCT05337449|Fluorides|fluorides|mesh-list
24705847|NCT01487096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24705848|NCT01487096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705849|NCT01487096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24705850|NCT01487096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24705851|NCT01487096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24705852|NCT01487096|Immunologic Factors|immunologic factors|mesh-ancestor
24705853|NCT01487135|Moxifloxacin|moxifloxacin|mesh-list
24705854|NCT01487135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24705855|NCT01487135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24705856|NCT01487135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24705857|NCT01487135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24705858|NCT01487135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705919|NCT01487512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24705921|NCT01487564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24705922|NCT01487564|Narcotics|narcotics|mesh-ancestor
24705923|NCT01487564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24705924|NCT01487564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705925|NCT01487564|Analgesics|analgesics|mesh-ancestor
24705926|NCT01487564|Sensory System Agents|sensory system agents|mesh-ancestor
24586066|NCT00889057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705927|NCT01487564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24705928|NCT01487629|Bevacizumab|bevacizumab|mesh-list
24705929|NCT01487629|Ranibizumab|ranibizumab|mesh-list
24705930|NCT01487629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24705931|NCT01487629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705932|NCT01487629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24705933|NCT01487629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24705934|NCT01487629|Growth Substances|growth substances|mesh-ancestor
25279793|NCT02342769|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25279794|NCT02342769|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25279795|NCT02342717|Itraconazole|itraconazole|mesh-list
25279796|NCT02342717|BI 425809|bi 425809|mesh-list
25279797|NCT02342717|Antifungal Agents|antifungal agents|mesh-ancestor
25279798|NCT02342717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25279799|NCT02342717|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25279959|NCT02341729|Purinergic Agents|purinergic agents|mesh-ancestor
25279802|NCT02342717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279804|NCT02342717|Hormone Antagonists|hormone antagonists|mesh-ancestor
25279805|NCT02342717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25279806|NCT02342717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279807|NCT02342717|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25279808|NCT02342717|Nootropic Agents|nootropic agents|mesh-ancestor
25279809|NCT02342600|Trametinib|trametinib|mesh-list
25279810|NCT02342600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25279811|NCT02342600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25279812|NCT02342600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279813|NCT02342600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279815|NCT02342587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25160576|NCT02825940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25160577|NCT02825940|Antimetabolites|antimetabolites|mesh-ancestor
25160578|NCT02825940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160579|NCT02825940|Antiviral Agents|antiviral agents|mesh-ancestor
25160580|NCT02825940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25160581|NCT02825940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25160582|NCT02825940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25160583|NCT02825940|Immunologic Factors|immunologic factors|mesh-ancestor
25160584|NCT02825940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160585|NCT02793583|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25160586|NCT02793583|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25160587|NCT02793583|Alkylating Agents|alkylating agents|mesh-ancestor
25160588|NCT02793583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160589|NCT02793583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25160590|NCT02791334|Ramucirumab|ramucirumab|mesh-list
25160591|NCT02791334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25160596|NCT02781519|Hallucinogens|hallucinogens|mesh-ancestor
25160597|NCT02781519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160598|NCT02781519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25160599|NCT02781519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25160600|NCT02781519|Analgesics|analgesics|mesh-ancestor
25160601|NCT02781519|Sensory System Agents|sensory system agents|mesh-ancestor
25160602|NCT02781519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25160603|NCT02781519|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25160604|NCT02781519|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25160607|NCT02781519|Hormones|hormones|mesh-ancestor
25279816|NCT02342587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25279817|NCT02342587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279818|NCT02342587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279819|NCT02342509|Sevoflurane|sevoflurane|mesh-list
25279820|NCT02342509|Desflurane|desflurane|mesh-list
25279821|NCT02342509|Isoflurane|isoflurane|mesh-list
25279822|NCT02342509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25279823|NCT02342509|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25279824|NCT02342509|Anesthetics, General|anesthetics, general|mesh-ancestor
25279825|NCT02342509|Anesthetics|anesthetics|mesh-ancestor
25279826|NCT02342509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25279827|NCT02342509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279828|NCT02342574|Olorofim|olorofim|mesh-list
25279829|NCT02342574|Antifungal Agents|antifungal agents|mesh-ancestor
25279830|NCT02342574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25279831|NCT02342392|Ranibizumab|ranibizumab|mesh-list
25279832|NCT02342392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25279833|NCT02342392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25279834|NCT02342392|Growth Substances|growth substances|mesh-ancestor
25279835|NCT02342392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279836|NCT02342392|Growth Inhibitors|growth inhibitors|mesh-ancestor
25279837|NCT02342392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25279838|NCT02342353|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25279839|NCT02342353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25279840|NCT02342353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25279841|NCT02342353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279842|NCT02342353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279843|NCT02342366|Sodium Oxybate|sodium oxybate|mesh-list
25279858|NCT02342145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25279859|NCT02342145|Abortifacient Agents|abortifacient agents|mesh-ancestor
25279860|NCT02342145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25160618|NCT02773238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160619|NCT02773238|Antimetabolites|antimetabolites|mesh-ancestor
25160620|NCT02773238|Antiviral Agents|antiviral agents|mesh-ancestor
25160621|NCT02773238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25160622|NCT02758717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25160623|NCT02758717|Nivolumab|nivolumab|mesh-list
25160624|NCT02758717|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25160625|NCT02758717|Antibodies|antibodies|mesh-list
25160626|NCT02758717|Immunoglobulins|immunoglobulins|mesh-list
25160627|NCT02758717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25160628|NCT02758717|Immunoconjugates|immunoconjugates|mesh-list
25160629|NCT02758717|Immunologic Factors|immunologic factors|mesh-ancestor
25160630|NCT02758717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160631|NCT02758717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25692772|NCT02005029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25053883|NCT00004106|Temozolomide|temozolomide|mesh-list
24960186|NCT03818932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24960187|NCT03818932|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24960188|NCT03818932|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25160632|NCT02758717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25160633|NCT02758717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160634|NCT02711969|Apatinib|apatinib|mesh-list
25160635|NCT02711969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011283|NCT00477412|Glucocorticoids|glucocorticoids|mesh-ancestor
25160636|NCT02711969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25160637|NCT02711969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279897|NCT02342067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25160638|NCT02711969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279861|NCT02342145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279862|NCT02342145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25279863|NCT02342145|Antimetabolites|antimetabolites|mesh-ancestor
25279864|NCT02342145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279865|NCT02342145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25279866|NCT02342145|Dermatologic Agents|dermatologic agents|mesh-ancestor
25279867|NCT02342145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279868|NCT02342145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25279869|NCT02342145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25279870|NCT02342145|Immunologic Factors|immunologic factors|mesh-ancestor
25279871|NCT02342145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25279872|NCT02342145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25279873|NCT02342145|Antifungal Agents|antifungal agents|mesh-ancestor
25279874|NCT02342145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25279875|NCT02342145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25279876|NCT02342145|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25279877|NCT02342145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25279878|NCT02342145|Antitubercular Agents|antitubercular agents|mesh-ancestor
25279879|NCT02342145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25279880|NCT02342093|Drospirenone|drospirenone|mesh-list
25279881|NCT02342093|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25279882|NCT02342093|Hormone Antagonists|hormone antagonists|mesh-ancestor
25279883|NCT02342093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25279884|NCT02342093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279885|NCT02342093|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25279887|NCT02342093|Natriuretic Agents|natriuretic agents|mesh-ancestor
25160657|NCT02655562|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25160658|NCT02655562|Respiratory System Agents|respiratory system agents|mesh-ancestor
25160659|NCT02655562|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25160660|NCT02655562|Hormone Antagonists|hormone antagonists|mesh-ancestor
25160661|NCT02655562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25160662|NCT02655562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160663|NCT02655562|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25160664|NCT02655562|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25160665|NCT02655562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160666|NCT02633241|Dexmedetomidine|dexmedetomidine|mesh-list
25160667|NCT02633241|Propofol|propofol|mesh-list
25160668|NCT02633241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25160669|NCT02633241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25160670|NCT02633241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160671|NCT02633241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25160672|NCT02633241|Anesthetics, General|anesthetics, general|mesh-ancestor
25160673|NCT02633241|Anesthetics|anesthetics|mesh-ancestor
25160674|NCT02633241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25160675|NCT02633241|Analgesics|analgesics|mesh-ancestor
25160676|NCT02633241|Sensory System Agents|sensory system agents|mesh-ancestor
25011336|NCT05216419|Vitamin D|vitamin d|mesh-list
25160677|NCT02633241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25160678|NCT02633241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25160679|NCT02633241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25160680|NCT02633241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25160681|NCT02633241|Adrenergic Agents|adrenergic agents|mesh-ancestor
25160682|NCT02633241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25160683|NCT02633241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160684|NCT02623439|Cyclophosphamide|cyclophosphamide|mesh-list
25160685|NCT02623439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25160686|NCT02623439|Immunologic Factors|immunologic factors|mesh-ancestor
25692773|NCT02005029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25692774|NCT02005029|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25692775|NCT02005029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279888|NCT02342067|Pioglitazone|pioglitazone|mesh-list
25279889|NCT02342067|Cenicriviroc|cenicriviroc|mesh-list
25279890|NCT02342067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25279891|NCT02342067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279892|NCT02342067|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25279893|NCT02342067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279894|NCT02342067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25279895|NCT02342067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25279896|NCT02342067|Antiviral Agents|antiviral agents|mesh-ancestor
25279900|NCT02341872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25279901|NCT02341872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279902|NCT02341872|Cariostatic Agents|cariostatic agents|mesh-ancestor
25279903|NCT02341872|Protective Agents|protective agents|mesh-ancestor
25279904|NCT02342002|Misoprostol|misoprostol|mesh-list
25279905|NCT02342002|Mifepristone|mifepristone|mesh-list
25279906|NCT02342002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25279907|NCT02342002|Abortifacient Agents|abortifacient agents|mesh-ancestor
25279908|NCT02342002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25279909|NCT02342002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279910|NCT02342002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25279911|NCT02342002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25279912|NCT02342002|Oxytocics|oxytocics|mesh-ancestor
25279913|NCT02342002|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25279914|NCT02342002|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25279915|NCT02342002|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25279916|NCT02342002|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25279917|NCT02342002|Contraceptive Agents|contraceptive agents|mesh-ancestor
25279918|NCT02342002|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25279919|NCT02342002|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25279920|NCT02342002|Hormone Antagonists|hormone antagonists|mesh-ancestor
25119610|NCT05403125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119611|NCT05403125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25119612|NCT05403125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25119614|NCT05403099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25119615|NCT05403099|Immunologic Factors|immunologic factors|mesh-ancestor
25119616|NCT05403099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119617|NCT05403099|Viscosupplements|viscosupplements|mesh-ancestor
25119618|NCT05403099|Protective Agents|protective agents|mesh-ancestor
25119619|NCT05403086|Ketamine|ketamine|mesh-list
25119620|NCT05403086|Psilocybin|psilocybin|mesh-list
25119621|NCT05403086|Hallucinogens|hallucinogens|mesh-list
25119622|NCT05403086|Analgesics|analgesics|mesh-ancestor
25119636|NCT05403047|Tenofovir|tenofovir|mesh-list
25279926|NCT02341833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25279927|NCT02341833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25279928|NCT02341833|Anesthetics, General|anesthetics, general|mesh-ancestor
25279929|NCT02341833|Anesthetics|anesthetics|mesh-ancestor
25279930|NCT02341833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25279931|NCT02341833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279932|NCT02341963|Ketamine|ketamine|mesh-list
25279933|NCT02341963|Analgesics|analgesics|mesh-ancestor
25279934|NCT02341963|Sensory System Agents|sensory system agents|mesh-ancestor
25279935|NCT02341963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25279936|NCT02341963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279937|NCT02341963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25279938|NCT02341963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25279939|NCT02341963|Anesthetics, General|anesthetics, general|mesh-ancestor
25279940|NCT02341963|Anesthetics|anesthetics|mesh-ancestor
25279941|NCT02341963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25279942|NCT02341963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25279943|NCT02341963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25279944|NCT02341963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25692776|NCT02005029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692777|NCT02005354|Nitrous Oxide|nitrous oxide|mesh-list
25692778|NCT02005354|Anesthetics|anesthetics|mesh-list
25692779|NCT02005354|Anesthetics, Local|anesthetics, local|mesh-list
25692780|NCT02005354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25078620|NCT03355053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25279945|NCT02341963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279946|NCT02341794|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25279947|NCT02341794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25279948|NCT02341794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25279950|NCT02341794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279951|NCT02341794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25279952|NCT02341794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25279953|NCT02341794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279954|NCT02341729|Ticagrelor|ticagrelor|mesh-list
25279955|NCT02341729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25279956|NCT02341729|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25279957|NCT02341729|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25279958|NCT02341729|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24705936|NCT01487629|Growth Inhibitors|growth inhibitors|mesh-ancestor
24705977|NCT01488045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24705978|NCT01488045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24705979|NCT01488045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25279961|NCT02341729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279962|NCT02341729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279963|NCT02341703|Metformin|metformin|mesh-list
25279964|NCT02341703|Pioglitazone|pioglitazone|mesh-list
25279966|NCT02341703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25279967|NCT02341703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279968|NCT02341703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25279969|NCT02341703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25279970|NCT02341703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25279971|NCT02341703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25279972|NCT02341703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25279973|NCT02341703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25279974|NCT02341703|Hormone Antagonists|hormone antagonists|mesh-ancestor
25279975|NCT02341703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25279976|NCT02341404|Hydroxyflutamide|hydroxyflutamide|mesh-list
25279977|NCT02341404|Androgen Antagonists|androgen antagonists|mesh-ancestor
25279978|NCT02341404|Hormone Antagonists|hormone antagonists|mesh-ancestor
25279979|NCT02341404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25279980|NCT02341404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279981|NCT02341573|Leukotriene Antagonists|leukotriene antagonists|mesh-list
25279982|NCT02341573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25279983|NCT02341573|Respiratory System Agents|respiratory system agents|mesh-ancestor
25279984|NCT02341573|Hormone Antagonists|hormone antagonists|mesh-ancestor
25279985|NCT02341573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25279986|NCT02341573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279987|NCT02341586|Iron|iron|mesh-list
25279988|NCT02341586|Trace Elements|trace elements|mesh-ancestor
25279989|NCT02341586|Micronutrients|micronutrients|mesh-ancestor
25279990|NCT02341586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279991|NCT02341638|Aspirin|aspirin|mesh-list
25279992|NCT02341638|Itraconazole|itraconazole|mesh-list
25279993|NCT02341638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25160756|NCT02546583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160757|NCT02546583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25160758|NCT02546583|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25160763|NCT02511132|Gemcitabine|gemcitabine|mesh-list
25160764|NCT02511132|Docetaxel|docetaxel|mesh-list
25160765|NCT02511132|Irinotecan|irinotecan|mesh-list
25160766|NCT02511132|Temozolomide|temozolomide|mesh-list
25160767|NCT02511132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25160768|NCT02511132|Antimetabolites|antimetabolites|mesh-ancestor
25160769|NCT02511132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160770|NCT02511132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25160771|NCT02511132|Antiviral Agents|antiviral agents|mesh-ancestor
25160772|NCT02511132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25160773|NCT02511132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25160774|NCT02511132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25279994|NCT02341638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25279995|NCT02341638|Analgesics|analgesics|mesh-ancestor
25279996|NCT02341638|Sensory System Agents|sensory system agents|mesh-ancestor
25279997|NCT02341638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25279998|NCT02341638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692781|NCT02005354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25279999|NCT02341638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25280000|NCT02341638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25280001|NCT02341638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25280002|NCT02341638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25280003|NCT02341638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280004|NCT02341638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25280005|NCT02341638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25280006|NCT02341638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280007|NCT02341638|Antipyretics|antipyretics|mesh-ancestor
25280008|NCT02341638|Antifungal Agents|antifungal agents|mesh-ancestor
25280009|NCT02341638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25280010|NCT02341638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25280011|NCT02341638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25280012|NCT02341638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25280013|NCT02341638|Hormone Antagonists|hormone antagonists|mesh-ancestor
25280014|NCT02341638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25280015|NCT02341638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25280016|NCT02341547|Epoetin Alfa|epoetin alfa|mesh-list
25280017|NCT02341547|Hematinics|hematinics|mesh-ancestor
25280018|NCT02341352|Fluorides|fluorides|mesh-list
25280019|NCT02341352|Fluorides, Topical|fluorides, topical|mesh-list
25280020|NCT02341352|Immunoglobulins|immunoglobulins|mesh-list
25280021|NCT02341352|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25280022|NCT02341352|Antibodies|antibodies|mesh-list
25280023|NCT02341352|Cariostatic Agents|cariostatic agents|mesh-ancestor
25280024|NCT02341352|Protective Agents|protective agents|mesh-ancestor
25280025|NCT02341352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280026|NCT02341352|Immunologic Factors|immunologic factors|mesh-ancestor
25280028|NCT02341365|Vitamins|vitamins|mesh-ancestor
25280029|NCT02341365|Micronutrients|micronutrients|mesh-ancestor
25280030|NCT02341365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280031|NCT02341365|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25280032|NCT02341209|Doxycycline|doxycycline|mesh-list
25280033|NCT02341209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25280034|NCT02341209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25280035|NCT02341209|Antimalarials|antimalarials|mesh-ancestor
25280036|NCT02341209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25280037|NCT02341209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25280038|NCT02341300|Iron|iron|mesh-list
25280039|NCT02341300|Trace Elements|trace elements|mesh-ancestor
25280040|NCT02341300|Micronutrients|micronutrients|mesh-ancestor
25160813|NCT02499354|Trace Elements|trace elements|mesh-ancestor
25160814|NCT02499354|Micronutrients|micronutrients|mesh-ancestor
25160815|NCT02499354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160816|NCT02499354|Hematinics|hematinics|mesh-ancestor
25160817|NCT02499354|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25160818|NCT02499354|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25160819|NCT02492776|Omeprazole|omeprazole|mesh-list
25160820|NCT02492776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25160821|NCT02492776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25160822|NCT02492776|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25160823|NCT02492776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25160824|NCT02492776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160825|NCT02483585|Erenumab|erenumab|mesh-list
24705980|NCT01488045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24705981|NCT01488045|GABA Modulators|gaba modulators|mesh-ancestor
24706003|NCT01488253|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24706004|NCT01488253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706005|NCT01488253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706006|NCT01488253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24706055|NCT01488266|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24706056|NCT01488266|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24706057|NCT01488266|Adrenergic Agents|adrenergic agents|mesh-ancestor
25280041|NCT02341300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280042|NCT02341274|Tacrolimus|tacrolimus|mesh-list
25280043|NCT02341274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25280044|NCT02341274|Immunologic Factors|immunologic factors|mesh-ancestor
25280045|NCT02341274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280046|NCT02341274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25280047|NCT02341274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280048|NCT02341274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280049|NCT02341105|Amiodarone|amiodarone|mesh-list
25280050|NCT02341105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
25280051|NCT02341105|Vasodilator Agents|vasodilator agents|mesh-ancestor
25280052|NCT02341105|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25280053|NCT02341105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25280059|NCT02341105|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25280060|NCT02341105|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25280061|NCT02341105|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25280063|NCT02341079|Anesthetics, Local|anesthetics, local|mesh-ancestor
25280064|NCT02341079|Anesthetics|anesthetics|mesh-ancestor
25280065|NCT02341079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25280066|NCT02341079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280067|NCT02341079|Sensory System Agents|sensory system agents|mesh-ancestor
25280068|NCT02341079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25280069|NCT02340910|Oxymetazoline|oxymetazoline|mesh-list
25280070|NCT02340910|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25160826|NCT02483585|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25160827|NCT02483585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160828|NCT02483585|Analgesics|analgesics|mesh-ancestor
25280090|NCT02341027|Contraceptive Agents|contraceptive agents|mesh-list
25280091|NCT02341027|Levonorgestrel|levonorgestrel|mesh-list
25280092|NCT02341027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25280093|NCT02341027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280094|NCT02341027|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25280095|NCT02341027|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25280096|NCT02341027|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25280097|NCT02341027|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25280098|NCT02340988|Oritavancin|oritavancin|mesh-list
25280100|NCT02340988|Anticoagulants|anticoagulants|mesh-ancestor
25280101|NCT02340988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25280102|NCT02340988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25280103|NCT02340455|Pregabalin|pregabalin|mesh-list
25280104|NCT02340455|Analgesics|analgesics|mesh-ancestor
25280114|NCT02340455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25280115|NCT02340455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25280116|NCT02340455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25280117|NCT02340481|Simethicone|simethicone|mesh-list
25280118|NCT02340481|Loperamide|loperamide|mesh-list
25280119|NCT02340481|Antidiarrheals|antidiarrheals|mesh-list
25280120|NCT02340481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25280121|NCT02340481|Antifoaming Agents|antifoaming agents|mesh-ancestor
25280122|NCT02340481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280123|NCT02340481|Emollients|emollients|mesh-ancestor
25280124|NCT02340481|Dermatologic Agents|dermatologic agents|mesh-ancestor
25280125|NCT02340611|Olaparib|olaparib|mesh-list
25280126|NCT02340611|Cediranib|cediranib|mesh-list
25280127|NCT02340611|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25280128|NCT02340611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280129|NCT02340611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280130|NCT02340611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25280131|NCT02340611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25280132|NCT02340325|Kynurenic Acid|kynurenic acid|mesh-list
25280133|NCT02340325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25280134|NCT02340325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25280135|NCT02340325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25280136|NCT02340325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280137|NCT02340325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280139|NCT02340273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25280141|NCT02340273|Adrenergic Agents|adrenergic agents|mesh-ancestor
25280142|NCT02340273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25692782|NCT02005354|Sensory System Agents|sensory system agents|mesh-ancestor
25692783|NCT02005354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25692784|NCT02005354|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25692785|NCT02005354|Anesthetics, General|anesthetics, general|mesh-ancestor
25692786|NCT02005354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25692787|NCT02005354|Analgesics|analgesics|mesh-ancestor
24960664|NCT03814733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960665|NCT03814733|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24960666|NCT03814733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24960667|NCT03814733|Anesthetics, General|anesthetics, general|mesh-ancestor
24960668|NCT03814733|Anesthetics|anesthetics|mesh-ancestor
24889704|NCT04490694|Lenvatinib|lenvatinib|mesh-list
25280143|NCT02340273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280144|NCT02340273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280145|NCT02340273|Sympathomimetics|sympathomimetics|mesh-ancestor
25280146|NCT02340273|Autonomic Agents|autonomic agents|mesh-ancestor
25280147|NCT02340273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25280148|NCT02340273|Nasal Decongestants|nasal decongestants|mesh-ancestor
25280149|NCT02340273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25280150|NCT02340273|Respiratory System Agents|respiratory system agents|mesh-ancestor
25280151|NCT02340247|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25280152|NCT02340247|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
25280153|NCT02340247|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25280154|NCT02340247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25280155|NCT02340247|Cathartics|cathartics|mesh-ancestor
25280156|NCT02340117|Gemcitabine|gemcitabine|mesh-list
25280157|NCT02340117|Paclitaxel|paclitaxel|mesh-list
25280158|NCT02340117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25280159|NCT02340117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25280160|NCT02340117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25280161|NCT02340117|Tubulin Modulators|tubulin modulators|mesh-ancestor
25280162|NCT02340117|Antimitotic Agents|antimitotic agents|mesh-ancestor
25280163|NCT02340117|Mitosis Modulators|mitosis modulators|mesh-ancestor
25280164|NCT02340117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280165|NCT02340117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25280166|NCT02340117|Antimetabolites|antimetabolites|mesh-ancestor
25280167|NCT02340117|Antiviral Agents|antiviral agents|mesh-ancestor
25280168|NCT02340117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25280169|NCT02340117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280170|NCT02340117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25280171|NCT02340117|Immunologic Factors|immunologic factors|mesh-ancestor
25280172|NCT02340117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280173|NCT02340182|Metronidazole|metronidazole|mesh-list
25280174|NCT02340182|Vancomycin|vancomycin|mesh-list
25280175|NCT02340182|Ciprofloxacin|ciprofloxacin|mesh-list
25280176|NCT02340182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25280177|NCT02340182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25280178|NCT02340182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25280187|NCT02340169|Desoximetasone|desoximetasone|mesh-list
25280188|NCT02340169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25280189|NCT02340169|Glucocorticoids|glucocorticoids|mesh-ancestor
25280191|NCT02340169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25280192|NCT02340169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280193|NCT02340013|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25280194|NCT02340013|Medroxyprogesterone|medroxyprogesterone|mesh-list
25280195|NCT02340013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25280196|NCT02340013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25280197|NCT02340013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25280198|NCT02340013|Contraceptive Agents|contraceptive agents|mesh-ancestor
25280199|NCT02340013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25280200|NCT02340013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280201|NCT02340013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25280202|NCT02340013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25280203|NCT02340013|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25012502|NCT05052970|Dexamethasone acetate|dexamethasone acetate|mesh-list
25280204|NCT02340013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25280205|NCT02340013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25280206|NCT02339714|Loratadine|loratadine|mesh-list
25280207|NCT02339714|Antipruritics|antipruritics|mesh-ancestor
25280208|NCT02339714|Dermatologic Agents|dermatologic agents|mesh-ancestor
25280209|NCT02339714|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25280210|NCT02339714|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25692788|NCT02005484|Trastuzumab|trastuzumab|mesh-list
25692789|NCT02005484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25692790|NCT02005484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25692791|NCT02005549|Bevacizumab|bevacizumab|mesh-list
25692792|NCT02005549|Docetaxel|docetaxel|mesh-list
25692793|NCT02005549|Capecitabine|capecitabine|mesh-list
25280211|NCT02339714|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25280212|NCT02339714|Histamine Antagonists|histamine antagonists|mesh-ancestor
25692794|NCT02005549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25280213|NCT02339714|Histamine Agents|histamine agents|mesh-ancestor
25280214|NCT02339714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25280215|NCT02339714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280216|NCT02339714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280217|NCT02339805|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25280218|NCT02339805|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25160983|NCT02236013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25160984|NCT02236013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25160985|NCT02236013|Antiviral Agents|antiviral agents|mesh-ancestor
25160986|NCT02236013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25160987|NCT02236013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25160988|NCT02236013|Immunologic Factors|immunologic factors|mesh-ancestor
25160989|NCT02236013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25160990|NCT02236013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25160991|NCT02236013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25160992|NCT02236013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25160993|NCT02236013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25161014|NCT02202577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25161015|NCT02202577|Disinfectants|disinfectants|mesh-ancestor
25280219|NCT02339805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280221|NCT02339753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25280222|NCT02339662|Gabapentin|gabapentin|mesh-list
25280223|NCT02339662|Amitriptyline|amitriptyline|mesh-list
25280224|NCT02339662|Analgesics|analgesics|mesh-ancestor
25280225|NCT02339662|Sensory System Agents|sensory system agents|mesh-ancestor
25280226|NCT02339662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25280227|NCT02339662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280228|NCT02339662|Anticonvulsants|anticonvulsants|mesh-ancestor
25280229|NCT02339662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25280230|NCT02339662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25280231|NCT02339662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25280232|NCT02339662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25280233|NCT02339662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25280234|NCT02339662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25280235|NCT02339662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25280236|NCT02339662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280237|NCT02339662|Antimanic Agents|antimanic agents|mesh-ancestor
25280238|NCT02339662|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25280239|NCT02339662|Antidepressive Agents|antidepressive agents|mesh-ancestor
25280240|NCT02339662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25280241|NCT02339662|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25280242|NCT02339662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25280243|NCT02339662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25280244|NCT02339662|Adrenergic Agents|adrenergic agents|mesh-ancestor
25280245|NCT02339844|Aripiprazole|aripiprazole|mesh-list
25280246|NCT02339844|Antidepressive Agents|antidepressive agents|mesh-ancestor
25280247|NCT02339844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25280248|NCT02339844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25280249|NCT02339844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25280250|NCT02339844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25280251|NCT02339844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280252|NCT02339844|Dopamine Agonists|dopamine agonists|mesh-ancestor
25280253|NCT02339844|Dopamine Agents|dopamine agents|mesh-ancestor
25280254|NCT02339844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25280255|NCT02339844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280256|NCT02339844|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25280257|NCT02339844|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25280270|NCT02339350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280272|NCT02339350|Dermatologic Agents|dermatologic agents|mesh-ancestor
25280273|NCT02339350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280274|NCT02339350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25280275|NCT02339350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25280276|NCT02339350|Immunologic Factors|immunologic factors|mesh-ancestor
25280277|NCT02339350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25280278|NCT02339350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25280279|NCT02339441|Mycophenolic Acid|mycophenolic acid|mesh-list
25280280|NCT02339441|Cyclophosphamide|cyclophosphamide|mesh-list
25280281|NCT02339441|Methotrexate|methotrexate|mesh-list
25280282|NCT02339441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25280283|NCT02339441|Immunologic Factors|immunologic factors|mesh-ancestor
25280284|NCT02339441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280285|NCT02339441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25280286|NCT02339441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25280287|NCT02339441|Alkylating Agents|alkylating agents|mesh-ancestor
25280288|NCT02339441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280289|NCT02339441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25280290|NCT02339441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25280291|NCT02339441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25280292|NCT02339441|Abortifacient Agents|abortifacient agents|mesh-ancestor
25280293|NCT02339441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25161063|NCT02178410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161064|NCT02178410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25161065|NCT02178410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25161067|NCT02102113|Hallucinogens|hallucinogens|mesh-ancestor
25161068|NCT02102113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161069|NCT02102113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25161070|NCT02102113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25161071|NCT02102113|Analgesics|analgesics|mesh-ancestor
25161072|NCT02102113|Sensory System Agents|sensory system agents|mesh-ancestor
25161073|NCT02102113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25161074|NCT02102113|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25161075|NCT02102113|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25161076|NCT02102113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25161077|NCT02102113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161078|NCT02102113|Hormones|hormones|mesh-ancestor
25161079|NCT02102113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25161081|NCT02047513|Paclitaxel|paclitaxel|mesh-list
25161082|NCT02047513|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25161083|NCT02047513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25161084|NCT02047513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161085|NCT02047513|Tubulin Modulators|tubulin modulators|mesh-ancestor
25161086|NCT02047513|Antimitotic Agents|antimitotic agents|mesh-ancestor
25161087|NCT02047513|Mitosis Modulators|mitosis modulators|mesh-ancestor
25102797|NCT03166553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161088|NCT02047513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161089|NCT02047513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25161090|NCT02047513|Antimetabolites|antimetabolites|mesh-ancestor
25161091|NCT02047513|Antiviral Agents|antiviral agents|mesh-ancestor
25161092|NCT02047513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25161093|NCT02047513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25161094|NCT02047513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25161095|NCT02047513|Immunologic Factors|immunologic factors|mesh-ancestor
25161096|NCT02047513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161098|NCT01959698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24706061|NCT01488305|Trace Elements|trace elements|mesh-list
25280294|NCT02339441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25280295|NCT02339441|Antimetabolites|antimetabolites|mesh-ancestor
25280296|NCT02339441|Dermatologic Agents|dermatologic agents|mesh-ancestor
25280297|NCT02339441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280298|NCT02339441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25280299|NCT02339441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25280300|NCT02339441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25280301|NCT02339441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25280302|NCT02339441|Antitubercular Agents|antitubercular agents|mesh-ancestor
25280303|NCT02339441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25280304|NCT02339441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25280305|NCT02339324|Interferons|interferons|mesh-list
25280306|NCT02339324|Interferon-alpha|interferon-alpha|mesh-list
25280307|NCT02339324|Interferon alpha-2|interferon alpha-2|mesh-list
25280308|NCT02339324|Pembrolizumab|pembrolizumab|mesh-list
25280309|NCT02339324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25280310|NCT02339324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25280311|NCT02339324|Antiviral Agents|antiviral agents|mesh-ancestor
25280312|NCT02339324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25280313|NCT02339324|Immunologic Factors|immunologic factors|mesh-ancestor
25280314|NCT02339324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280315|NCT02339428|Diclofenac|diclofenac|mesh-list
25280316|NCT02339428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25280317|NCT02339428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25280318|NCT02339428|Analgesics|analgesics|mesh-ancestor
25280319|NCT02339428|Sensory System Agents|sensory system agents|mesh-ancestor
25280320|NCT02339428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25280321|NCT02339428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280322|NCT02339428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25280323|NCT02339428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25280324|NCT02339428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25280325|NCT02339428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280326|NCT02339428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280327|NCT02339207|Adafosbuvir|adafosbuvir|mesh-list
25280328|NCT02339207|Antiviral Agents|antiviral agents|mesh-ancestor
25280329|NCT02339207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25280330|NCT02339142|Methylprednisolone|methylprednisolone|mesh-list
25161099|NCT01959698|Carboplatin|carboplatin|mesh-list
25161100|NCT01959698|Etoposide|etoposide|mesh-list
25161101|NCT01959698|Etoposide phosphate|etoposide phosphate|mesh-list
25161102|NCT01959698|Ifosfamide|ifosfamide|mesh-list
25161103|NCT01959698|Isophosphamide mustard|isophosphamide mustard|mesh-list
25161104|NCT01959698|Podophyllotoxin|podophyllotoxin|mesh-list
25161105|NCT01959698|Antibodies|antibodies|mesh-list
25161106|NCT01959698|Immunoglobulins|immunoglobulins|mesh-list
25161107|NCT01959698|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25161108|NCT01959698|Immunologic Factors|immunologic factors|mesh-ancestor
25161109|NCT01959698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161110|NCT01959698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161111|NCT01959698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25102799|NCT03166280|Antiviral Agents|antiviral agents|mesh-ancestor
25161112|NCT01959698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25161113|NCT01959698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25161114|NCT01959698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25161115|NCT01959698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280333|NCT02339142|Prednisolone|prednisolone|mesh-list
25280334|NCT02339142|Prednisolone acetate|prednisolone acetate|mesh-list
25280335|NCT02339142|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25280336|NCT02339142|Prednisolone phosphate|prednisolone phosphate|mesh-list
25280337|NCT02339142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25280338|NCT02339142|Antiemetics|antiemetics|mesh-ancestor
25280339|NCT02339142|Autonomic Agents|autonomic agents|mesh-ancestor
25280340|NCT02339142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25280341|NCT02339142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280342|NCT02339142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25280343|NCT02339142|Glucocorticoids|glucocorticoids|mesh-ancestor
25280344|NCT02339142|Hormones|hormones|mesh-ancestor
25280345|NCT02339142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25280346|NCT02339142|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25280347|NCT02339142|Protective Agents|protective agents|mesh-ancestor
25280348|NCT02339142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25280349|NCT02339142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25280350|NCT02339090|Hormones|hormones|mesh-list
25280351|NCT02339090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25280352|NCT02339090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280353|NCT02339116|Bevacizumab|bevacizumab|mesh-list
25280354|NCT02339116|Oxaliplatin|oxaliplatin|mesh-list
25280355|NCT02339116|Irinotecan|irinotecan|mesh-list
25280356|NCT02339116|Fluorouracil|fluorouracil|mesh-list
25280357|NCT02339116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25280358|NCT02339116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25280359|NCT02339116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24529836|NCT00627965|Sildenafil Citrate|sildenafil citrate|mesh-list
25280360|NCT02339116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25280361|NCT02339116|Growth Substances|growth substances|mesh-ancestor
25280362|NCT02339116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280363|NCT02339116|Growth Inhibitors|growth inhibitors|mesh-ancestor
25280364|NCT02339116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25280365|NCT02339116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25280366|NCT02339116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280367|NCT02339116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280368|NCT02339116|Antimetabolites|antimetabolites|mesh-ancestor
25280369|NCT02339116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25280370|NCT02339116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25280371|NCT02339116|Immunologic Factors|immunologic factors|mesh-ancestor
25280372|NCT02338934|Vitamin D|vitamin d|mesh-list
25280373|NCT02338934|Cinacalcet|cinacalcet|mesh-list
25280374|NCT02338934|Vitamins|vitamins|mesh-ancestor
25280375|NCT02338934|Micronutrients|micronutrients|mesh-ancestor
25161146|NCT01834248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25161147|NCT01834248|Antimetabolites|antimetabolites|mesh-ancestor
25161148|NCT01834248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161149|NCT01834248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161150|NCT01834248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25161151|NCT01834248|Interferon Inducers|interferon inducers|mesh-ancestor
25161152|NCT01834248|Immunologic Factors|immunologic factors|mesh-ancestor
25161153|NCT01834248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161154|NCT01834248|Laxatives|laxatives|mesh-ancestor
25161155|NCT01834248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25161156|NCT01834248|Antiviral Agents|antiviral agents|mesh-ancestor
25161157|NCT01834248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25120104|NCT04695704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280376|NCT02338934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280377|NCT02338934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25280378|NCT02338934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25280380|NCT02338934|Hormone Antagonists|hormone antagonists|mesh-ancestor
25280381|NCT02338934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25280382|NCT02338856|Beta-lapachone|beta-lapachone|mesh-list
25280383|NCT02338856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25280384|NCT02338856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25280385|NCT02338856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25280386|NCT02338856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280387|NCT02338856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280388|NCT02338856|Antiviral Agents|antiviral agents|mesh-ancestor
25280389|NCT02338830|Progesterone|progesterone|mesh-list
25280390|NCT02338830|Progestins|progestins|mesh-ancestor
25280391|NCT02338830|Hormones|hormones|mesh-ancestor
25280392|NCT02338830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25280393|NCT02338830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280394|NCT02338687|Calcium|calcium|mesh-list
25280395|NCT02338687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25280396|NCT02338687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280397|NCT02338674|Tenofovir|tenofovir|mesh-list
25280398|NCT02338674|Telbivudine|telbivudine|mesh-list
25280399|NCT02338674|Antiviral Agents|antiviral agents|mesh-ancestor
25280400|NCT02338674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24546314|NCT00697671|Etoposide|etoposide|mesh-list
25280401|NCT02338674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25280402|NCT02338674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25280403|NCT02338674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280404|NCT02338674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280405|NCT02338674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25280406|NCT02338674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25280407|NCT02338518|Oxaliplatin|oxaliplatin|mesh-list
25280408|NCT02338518|Etoposide|etoposide|mesh-list
25280409|NCT02338518|Epirubicin|epirubicin|mesh-list
25280410|NCT02338518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25280411|NCT02338518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25280412|NCT02338518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25280413|NCT02338518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25280414|NCT02338518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25120109|NCT04670796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25120110|NCT04670796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24529831|NCT00627952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529832|NCT00627952|Vasodilator Agents|vasodilator agents|mesh-ancestor
24529833|NCT00627952|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24529834|NCT00627952|Protease Inhibitors|protease inhibitors|mesh-ancestor
24529835|NCT00627952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529837|NCT00627965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529849|NCT00628043|Hematinics|hematinics|mesh-ancestor
24529850|NCT00628056|Perhexiline|perhexiline|mesh-list
24529851|NCT00628056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25280430|NCT02338544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25280431|NCT02338570|Everolimus|everolimus|mesh-list
25280432|NCT02338570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25280433|NCT02338570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25280434|NCT02338570|Immunologic Factors|immunologic factors|mesh-ancestor
25280435|NCT02338570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280436|NCT02338622|Olaparib|olaparib|mesh-list
25280437|NCT02338622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25280438|NCT02338622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280439|NCT02338622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280440|NCT02338622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161196|NCT01715714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25161197|NCT01715714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25161220|NCT01682187|Lomustine|lomustine|mesh-list
25161221|NCT01682187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25161222|NCT01682187|Alkylating Agents|alkylating agents|mesh-ancestor
25161223|NCT01682187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161224|NCT01682187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25280441|NCT02338466|Tenecteplase|tenecteplase|mesh-list
25280442|NCT02338466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25280443|NCT02338466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25280444|NCT02338466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280445|NCT02338323|Febuxostat|febuxostat|mesh-list
25280446|NCT02338323|Benzbromarone|benzbromarone|mesh-list
25280447|NCT02338323|Gout Suppressants|gout suppressants|mesh-ancestor
25280448|NCT02338323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25280449|NCT02338323|Uricosuric Agents|uricosuric agents|mesh-ancestor
25280450|NCT02338323|Renal Agents|renal agents|mesh-ancestor
25280451|NCT02338310|Letrozole|letrozole|mesh-list
25280452|NCT02338310|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25280453|NCT02338310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25280454|NCT02338310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25280462|NCT02338024|Antiviral Agents|antiviral agents|mesh-ancestor
25280463|NCT02338024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25280464|NCT02338089|Oxytocin|oxytocin|mesh-list
25280465|NCT02338089|Oxytocics|oxytocics|mesh-ancestor
25280466|NCT02338089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25280467|NCT02338089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280473|NCT02338245|Capecitabine|capecitabine|mesh-list
25280474|NCT02338245|Lapatinib|lapatinib|mesh-list
25280475|NCT02338245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25280476|NCT02338245|Antimetabolites|antimetabolites|mesh-ancestor
25280477|NCT02338245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280478|NCT02338245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25280479|NCT02338245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25280480|NCT02338245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280481|NCT02338206|Hormones|hormones|mesh-list
25280482|NCT02338206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25161242|NCT01656343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
25161243|NCT01656343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25161244|NCT01656343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161245|NCT01656343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161246|NCT01656343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25161247|NCT01656343|Immunologic Factors|immunologic factors|mesh-ancestor
25161248|NCT01656343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161249|NCT01656343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25161250|NCT01656343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25161251|NCT01622868|Lapatinib|lapatinib|mesh-list
25161252|NCT01622868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161253|NCT01622868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25161254|NCT01622868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25161255|NCT01622868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161256|NCT01609790|Bevacizumab|bevacizumab|mesh-list
25161257|NCT01609790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25161258|NCT01609790|Trebananib|trebananib|mesh-list
25161259|NCT01609790|Endothelial Growth Factors|endothelial growth factors|mesh-list
25161260|NCT01609790|Antibodies|antibodies|mesh-list
25161261|NCT01609790|Immunoglobulins|immunoglobulins|mesh-list
25161262|NCT01609790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25161263|NCT01609790|Immunoglobulin G|immunoglobulin g|mesh-list
25161264|NCT01609790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161265|NCT01609790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25161266|NCT01609790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25161267|NCT01609790|Growth Substances|growth substances|mesh-ancestor
25161268|NCT01609790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161269|NCT01609790|Growth Inhibitors|growth inhibitors|mesh-ancestor
25161270|NCT01609790|Immunologic Factors|immunologic factors|mesh-ancestor
25161271|NCT01568177|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
25161272|NCT01568177|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25280483|NCT02338206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280485|NCT02338011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25280486|NCT02338011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25280487|NCT02338011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280488|NCT02338011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280489|NCT02338115|Paclitaxel|paclitaxel|mesh-list
25280490|NCT02338115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25280491|NCT02338115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25280492|NCT02338115|Tubulin Modulators|tubulin modulators|mesh-ancestor
25280493|NCT02338115|Antimitotic Agents|antimitotic agents|mesh-ancestor
25280498|NCT02337855|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25280499|NCT02337855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25280500|NCT02337855|Immunologic Factors|immunologic factors|mesh-ancestor
25280501|NCT02337855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280502|NCT02337855|Antacids|antacids|mesh-ancestor
24600628|NCT00959595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25280503|NCT02337855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280504|NCT02337855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25280505|NCT02337881|Sildenafil Citrate|sildenafil citrate|mesh-list
25280506|NCT02337881|Vasodilator Agents|vasodilator agents|mesh-ancestor
25280507|NCT02337881|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25280508|NCT02337881|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25280509|NCT02337881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280510|NCT02337881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280511|NCT02337881|Urological Agents|urological agents|mesh-ancestor
25280512|NCT02337972|Povidone-Iodine|povidone-iodine|mesh-list
25280513|NCT02337972|Povidone|povidone|mesh-list
25280514|NCT02337972|Plasma Substitutes|plasma substitutes|mesh-ancestor
25280515|NCT02337972|Blood Substitutes|blood substitutes|mesh-ancestor
25280516|NCT02337972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25280517|NCT02337972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25280518|NCT02337712|Etoposide|etoposide|mesh-list
25280519|NCT02337712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24621917|NCT01064726|Analgesics|analgesics|mesh-ancestor
25280520|NCT02337712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25280521|NCT02337712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25161283|NCT01540253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161284|NCT01540253|Tubulin Modulators|tubulin modulators|mesh-ancestor
25161285|NCT01540253|Antimitotic Agents|antimitotic agents|mesh-ancestor
25161286|NCT01540253|Mitosis Modulators|mitosis modulators|mesh-ancestor
25161287|NCT01540253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161288|NCT01539811|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25161289|NCT01539811|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25161290|NCT01539811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25161291|NCT01539811|Antitubercular Agents|antitubercular agents|mesh-ancestor
25161292|NCT01516879|Atorvastatin|atorvastatin|mesh-list
25161293|NCT01516879|Ezetimibe|ezetimibe|mesh-list
25161294|NCT01516879|Evolocumab|evolocumab|mesh-list
25161295|NCT01516879|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25161296|NCT01516879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25161297|NCT01516879|Antimetabolites|antimetabolites|mesh-ancestor
25161298|NCT01516879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161299|NCT01516879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25161300|NCT01516879|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25161301|NCT01516879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25161302|NCT01497392|Gemcitabine|gemcitabine|mesh-list
25161303|NCT01497392|Capecitabine|capecitabine|mesh-list
25161304|NCT01497392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25161305|NCT01497392|Antimetabolites|antimetabolites|mesh-ancestor
25161306|NCT01497392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161307|NCT01497392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161308|NCT01497392|Antiviral Agents|antiviral agents|mesh-ancestor
25161309|NCT01497392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25161310|NCT01497392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25161311|NCT01497392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25280522|NCT02337712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25280523|NCT02337712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280524|NCT02337712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280525|NCT02337426|Temozolomide|temozolomide|mesh-list
25280526|NCT02337426|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25280527|NCT02337426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25280528|NCT02337426|Alkylating Agents|alkylating agents|mesh-ancestor
25280529|NCT02337426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280530|NCT02337426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013669|NCT00472654|Vitamin D|vitamin d|mesh-list
25280531|NCT02337426|Dermatologic Agents|dermatologic agents|mesh-ancestor
25280532|NCT02337426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25280533|NCT02337426|Immunologic Factors|immunologic factors|mesh-ancestor
25280552|NCT02337322|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25280553|NCT02337322|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25280555|NCT02337322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280556|NCT02337322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280557|NCT02337322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25280558|NCT02337322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25280559|NCT02337322|Antiviral Agents|antiviral agents|mesh-ancestor
25280560|NCT02337322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25280561|NCT02337322|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25280562|NCT02337322|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25013791|NCT05222191|Diuretics|diuretics|mesh-ancestor
25280563|NCT02337322|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25280564|NCT02337322|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25280565|NCT02337192|Chlorhexidine|chlorhexidine|mesh-list
25280566|NCT02337192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25280567|NCT02337192|Curcumin|curcumin|mesh-list
25280568|NCT02337192|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25280569|NCT02337192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25280570|NCT02337192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25280571|NCT02337192|Disinfectants|disinfectants|mesh-ancestor
25280572|NCT02337192|Dermatologic Agents|dermatologic agents|mesh-ancestor
25280573|NCT02337192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25280574|NCT02337192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25280575|NCT02337192|Analgesics|analgesics|mesh-ancestor
25280576|NCT02337192|Sensory System Agents|sensory system agents|mesh-ancestor
25280586|NCT02337127|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25280587|NCT02337127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25280589|NCT02337127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280590|NCT02337127|Antiviral Agents|antiviral agents|mesh-ancestor
25280591|NCT02337127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25280592|NCT02337127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25280593|NCT02337127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25280594|NCT02337166|Hyaluronic Acid|hyaluronic acid|mesh-list
25280595|NCT02337166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25280596|NCT02337166|Immunologic Factors|immunologic factors|mesh-ancestor
25280597|NCT02337166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280598|NCT02337166|Viscosupplements|viscosupplements|mesh-ancestor
25280599|NCT02337166|Protective Agents|protective agents|mesh-ancestor
25280600|NCT02337205|Tirbanibulin|tirbanibulin|mesh-list
25280601|NCT02337205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280602|NCT02337205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102801|NCT03166397|Cyclophosphamide|cyclophosphamide|mesh-list
25161368|NCT01367002|Carboplatin|carboplatin|mesh-list
25161369|NCT01367002|Trastuzumab|trastuzumab|mesh-list
25161370|NCT01367002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25161371|NCT01367002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161372|NCT01367002|Tubulin Modulators|tubulin modulators|mesh-ancestor
25161373|NCT01367002|Antimitotic Agents|antimitotic agents|mesh-ancestor
25161374|NCT01367002|Mitosis Modulators|mitosis modulators|mesh-ancestor
25161375|NCT01367002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161376|NCT01367002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25161377|NCT01310192|Choline|choline|mesh-list
25161378|NCT01310192|Lipotropic Agents|lipotropic agents|mesh-ancestor
25161379|NCT01310192|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25161380|NCT01310192|Antimetabolites|antimetabolites|mesh-ancestor
25161381|NCT01310192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161382|NCT01310192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25161383|NCT01310192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25161384|NCT01310192|Nootropic Agents|nootropic agents|mesh-ancestor
25161385|NCT01261325|Brivaracetam|brivaracetam|mesh-list
25161386|NCT01261325|Anticonvulsants|anticonvulsants|mesh-list
25161387|NCT01120249|Everolimus|everolimus|mesh-list
25161388|NCT01120249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161389|NCT01120249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25161390|NCT01120249|Immunologic Factors|immunologic factors|mesh-ancestor
25161391|NCT01120249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280603|NCT02337023|Technetium Tc 99m bicisate|technetium tc 99m bicisate|mesh-list
25280604|NCT02337023|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25280605|NCT02337023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280606|NCT02337010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25280607|NCT02337036|Tacrolimus|tacrolimus|mesh-list
25280608|NCT02337036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25280609|NCT02337036|Immunologic Factors|immunologic factors|mesh-ancestor
25280610|NCT02337036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280611|NCT02337036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25280612|NCT02337036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280613|NCT02337036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280614|NCT02336984|Trastuzumab|trastuzumab|mesh-list
25280615|NCT02336984|Pertuzumab|pertuzumab|mesh-list
25280629|NCT02336659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25280630|NCT02336659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280631|NCT02336659|Incretins|incretins|mesh-ancestor
25280632|NCT02336659|Hormones|hormones|mesh-ancestor
25280633|NCT02336659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25280634|NCT02336659|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25280635|NCT02336659|Protease Inhibitors|protease inhibitors|mesh-ancestor
25280636|NCT02336659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280637|NCT02336659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280638|NCT02336633|Resveratrol|resveratrol|mesh-list
24463803|NCT00362271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24463804|NCT00362271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280640|NCT02336633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161402|NCT01063270|Rifampin|rifampin|mesh-list
25161403|NCT01063270|Clindamycin|clindamycin|mesh-list
25161404|NCT01063270|Clindamycin palmitate|clindamycin palmitate|mesh-list
25161405|NCT01063270|Clindamycin phosphate|clindamycin phosphate|mesh-list
25161406|NCT01063270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25161407|NCT01063270|Antitubercular Agents|antitubercular agents|mesh-ancestor
25161408|NCT01063270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25161409|NCT01063270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25161410|NCT01063270|Leprostatic Agents|leprostatic agents|mesh-ancestor
25161411|NCT01063270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25161412|NCT01063270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25161413|NCT01063270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161414|NCT01063270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25161415|NCT01063270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25161416|NCT01063270|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25161417|NCT01063270|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25161418|NCT01063270|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25161419|NCT01063270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25161420|NCT01063270|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25161421|NCT01014546|Vitamins|vitamins|mesh-list
25161422|NCT01014546|Ascorbic Acid|ascorbic acid|mesh-list
25161423|NCT01014546|Arsenic Trioxide|arsenic trioxide|mesh-list
25161424|NCT01014546|Micronutrients|micronutrients|mesh-ancestor
25161425|NCT01014546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161426|NCT01014546|Antioxidants|antioxidants|mesh-ancestor
25161427|NCT01014546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161428|NCT01014546|Protective Agents|protective agents|mesh-ancestor
25161429|NCT01014546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161430|NCT00945152|Vancomycin|vancomycin|mesh-list
25161431|NCT00945152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25161432|NCT00945152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25280641|NCT02336633|Protective Agents|protective agents|mesh-ancestor
25014157|NCT04963816|Bupivacaine|bupivacaine|mesh-list
25280642|NCT02336633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280643|NCT02336633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280644|NCT02336633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25120364|NCT03995004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25120365|NCT03995004|Glucocorticoids|glucocorticoids|mesh-ancestor
25120366|NCT03995004|Hormones|hormones|mesh-ancestor
25280645|NCT02336477|Mexiletine|mexiletine|mesh-list
25280646|NCT02336477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25280647|NCT02336477|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25280648|NCT02336477|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25280649|NCT02336477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25280650|NCT02336477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280651|NCT02336568|Oxytocin|oxytocin|mesh-list
25280652|NCT02336568|Oxytocics|oxytocics|mesh-ancestor
25280653|NCT02336568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25280654|NCT02336568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280655|NCT02336529|Bupivacaine|bupivacaine|mesh-list
25280656|NCT02336529|Anesthetics, Local|anesthetics, local|mesh-ancestor
25280657|NCT02336529|Anesthetics|anesthetics|mesh-ancestor
25280658|NCT02336529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25280659|NCT02336529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280660|NCT02336529|Sensory System Agents|sensory system agents|mesh-ancestor
25280661|NCT02336529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25280662|NCT02336516|Azithromycin|azithromycin|mesh-list
25280663|NCT02336516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25280664|NCT02336516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25280665|NCT02336308|Ketamine|ketamine|mesh-list
25280666|NCT02336308|Analgesics|analgesics|mesh-ancestor
25692795|NCT02005549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25692796|NCT02005549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25692797|NCT02005549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25692798|NCT02005549|Growth Substances|growth substances|mesh-ancestor
25692799|NCT02005549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692800|NCT02005549|Growth Inhibitors|growth inhibitors|mesh-ancestor
24961446|NCT03808142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961447|NCT03808259|Ketamine|ketamine|mesh-list
24961448|NCT03808259|Esketamine|esketamine|mesh-list
24961449|NCT03808259|Analgesics|analgesics|mesh-ancestor
24961450|NCT03808259|Sensory System Agents|sensory system agents|mesh-ancestor
24961451|NCT03808259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961452|NCT03808259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961453|NCT03808259|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25280667|NCT02336308|Sensory System Agents|sensory system agents|mesh-ancestor
25280668|NCT02336308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25280669|NCT02336308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280670|NCT02336308|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25280671|NCT02336308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25280672|NCT02336308|Anesthetics, General|anesthetics, general|mesh-ancestor
25280673|NCT02336308|Anesthetics|anesthetics|mesh-ancestor
25280674|NCT02336308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25280675|NCT02336308|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25280676|NCT02336308|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25280677|NCT02336308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25280678|NCT02336308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280679|NCT02336386|Dexamethasone|dexamethasone|mesh-list
25280680|NCT02336386|Cyclophosphamide|cyclophosphamide|mesh-list
25280681|NCT02336386|Doxorubicin|doxorubicin|mesh-list
25280682|NCT02336386|Bortezomib|bortezomib|mesh-list
25280683|NCT02336386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25120369|NCT03995004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25280698|NCT02336386|Hormones|hormones|mesh-ancestor
25280699|NCT02336386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25280700|NCT02336386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25280701|NCT02336386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280702|NCT02336386|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25280703|NCT02336386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25280704|NCT02336386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25280705|NCT02336048|Obinutuzumab|obinutuzumab|mesh-list
25280706|NCT02336048|Chlorambucil|chlorambucil|mesh-list
25280707|NCT02336048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25014355|NCT04671355|Autonomic Agents|autonomic agents|mesh-ancestor
25280708|NCT02336048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25280709|NCT02336048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25280710|NCT02336048|Alkylating Agents|alkylating agents|mesh-ancestor
25280711|NCT02336048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280712|NCT02336152|Anesthetics|anesthetics|mesh-list
25280713|NCT02336152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25280714|NCT02336152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280715|NCT02336347|Quinidine|quinidine|mesh-list
25280716|NCT02336347|Dextromethorphan|dextromethorphan|mesh-list
25280717|NCT02336347|Antitussive Agents|antitussive agents|mesh-ancestor
25280718|NCT02336347|Respiratory System Agents|respiratory system agents|mesh-ancestor
25280719|NCT02336347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25280720|NCT02336347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25280721|NCT02336347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25280722|NCT02336347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280723|NCT02336347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280724|NCT02336347|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25280725|NCT02336347|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25280726|NCT02336347|Adrenergic Agents|adrenergic agents|mesh-ancestor
25280727|NCT02336347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25280728|NCT02336347|Antimalarials|antimalarials|mesh-ancestor
25280729|NCT02336347|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25280730|NCT02336347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25280731|NCT02336347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25280732|NCT02336347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280733|NCT02336347|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25161537|NCT00334815|Podophyllotoxin|podophyllotoxin|mesh-list
25161538|NCT00334815|Endothelial Growth Factors|endothelial growth factors|mesh-list
25161539|NCT00334815|Antibodies|antibodies|mesh-list
25161540|NCT00334815|Immunoglobulins|immunoglobulins|mesh-list
25692801|NCT02005549|Tubulin Modulators|tubulin modulators|mesh-ancestor
25692802|NCT02005549|Antimitotic Agents|antimitotic agents|mesh-ancestor
25692803|NCT02005549|Mitosis Modulators|mitosis modulators|mesh-ancestor
25692804|NCT02005549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692805|NCT02005549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25692806|NCT02005549|Antimetabolites|antimetabolites|mesh-ancestor
25692807|NCT02005562|Cyclosporine|cyclosporine|mesh-list
25692808|NCT02005562|Mycophenolic Acid|mycophenolic acid|mesh-list
25078691|NCT03354312|Epinephryl borate|epinephryl borate|mesh-list
25078692|NCT03354312|Anesthetics, Local|anesthetics, local|mesh-ancestor
25078693|NCT03354312|Anesthetics|anesthetics|mesh-ancestor
24463913|NCT00362726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463914|NCT00362726|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25161541|NCT00334815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25161542|NCT00334815|Lenograstim|lenograstim|mesh-list
25161543|NCT00334815|Immunoglobulin G|immunoglobulin g|mesh-list
25161544|NCT00334815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706062|NCT01488305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706063|NCT01488344|Nintedanib|nintedanib|mesh-list
25280734|NCT02336347|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25280735|NCT02336347|Cholinergic Agents|cholinergic agents|mesh-ancestor
25280736|NCT02336347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25280737|NCT02336347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25280738|NCT02336347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25280739|NCT02336347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25280740|NCT02336347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25280741|NCT02336139|Sofosbuvir|sofosbuvir|mesh-list
25280742|NCT02336139|Velpatasvir|velpatasvir|mesh-list
25280743|NCT02336139|Antiviral Agents|antiviral agents|mesh-ancestor
25280744|NCT02336139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25280745|NCT02335736|Cetrorelix|cetrorelix|mesh-list
25280746|NCT02335736|Hormones|hormones|mesh-list
25280747|NCT02335736|Hormone Antagonists|hormone antagonists|mesh-list
25280748|NCT02335736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25280749|NCT02335736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280750|NCT02335736|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25280751|NCT02335736|Fertility Agents|fertility agents|mesh-ancestor
25280752|NCT02335736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25280753|NCT02335593|Zinc Sulfate|zinc sulfate|mesh-list
25280754|NCT02335593|Epoetin Alfa|epoetin alfa|mesh-list
25280755|NCT02335593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25280756|NCT02335593|Hematinics|hematinics|mesh-ancestor
25280757|NCT02335593|Astringents|astringents|mesh-ancestor
25280758|NCT02335593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280759|NCT02335593|Dermatologic Agents|dermatologic agents|mesh-ancestor
25280760|NCT02335684|Methamphetamine|methamphetamine|mesh-list
25280761|NCT02335684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25280762|NCT02335684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280763|NCT02335684|Sympathomimetics|sympathomimetics|mesh-ancestor
25280764|NCT02335684|Autonomic Agents|autonomic agents|mesh-ancestor
25280765|NCT02335684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25280766|NCT02335684|Dopamine Agents|dopamine agents|mesh-ancestor
25280767|NCT02335684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25280768|NCT02335684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280769|NCT02335684|Adrenergic Agents|adrenergic agents|mesh-ancestor
25161545|NCT00334815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25161546|NCT00334815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25161547|NCT00334815|Growth Substances|growth substances|mesh-ancestor
25161548|NCT00334815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161549|NCT00334815|Growth Inhibitors|growth inhibitors|mesh-ancestor
25161550|NCT00334815|Immunologic Factors|immunologic factors|mesh-ancestor
25161551|NCT00334815|Tubulin Modulators|tubulin modulators|mesh-ancestor
25161552|NCT00334815|Antimitotic Agents|antimitotic agents|mesh-ancestor
25161553|NCT00334815|Mitosis Modulators|mitosis modulators|mesh-ancestor
25161554|NCT00334815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692809|NCT02005562|Methylprednisolone|methylprednisolone|mesh-list
25692810|NCT02005562|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25692811|NCT02005562|Cyclosporins|cyclosporins|mesh-list
25692812|NCT02005562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692813|NCT02005562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692814|NCT02005562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25692815|NCT02005562|Immunologic Factors|immunologic factors|mesh-ancestor
25692816|NCT02005562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692817|NCT02005562|Antifungal Agents|antifungal agents|mesh-ancestor
25692818|NCT02005562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25161555|NCT00334815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25161556|NCT00334815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25161557|NCT00334815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25161616|NCT00042289|Emtricitabine|emtricitabine|mesh-list
25280809|NCT02335281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25280810|NCT02335281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25280811|NCT02335359|Tranexamic Acid|tranexamic acid|mesh-list
25280812|NCT02335359|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25280813|NCT02335359|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25280814|NCT02335359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280815|NCT02335359|Hemostatics|hemostatics|mesh-ancestor
25280816|NCT02335359|Coagulants|coagulants|mesh-ancestor
25280818|NCT02335398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25280819|NCT02335398|Narcotics|narcotics|mesh-ancestor
25280820|NCT02335398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25280821|NCT02335398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280822|NCT02335398|Analgesics|analgesics|mesh-ancestor
25280823|NCT02335398|Sensory System Agents|sensory system agents|mesh-ancestor
25280824|NCT02335398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25280825|NCT02335398|Antitussive Agents|antitussive agents|mesh-ancestor
25280826|NCT02335398|Respiratory System Agents|respiratory system agents|mesh-ancestor
25280827|NCT02335190|Lidocaine|lidocaine|mesh-list
25280828|NCT02335190|Anesthetics, Local|anesthetics, local|mesh-ancestor
25280829|NCT02335190|Anesthetics|anesthetics|mesh-ancestor
25280830|NCT02335190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25280831|NCT02335190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280832|NCT02335190|Sensory System Agents|sensory system agents|mesh-ancestor
25280833|NCT02335190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25280834|NCT02335190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25280835|NCT02335190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25280836|NCT02335190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25280837|NCT02335190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25280838|NCT02335190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280839|NCT02335164|Hemagglutinins|hemagglutinins|mesh-list
25280840|NCT02335164|Agglutinins|agglutinins|mesh-ancestor
25280841|NCT02335164|Immunologic Factors|immunologic factors|mesh-ancestor
25280842|NCT02335164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280843|NCT02335203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25280844|NCT02335203|Medroxyprogesterone|medroxyprogesterone|mesh-list
25280845|NCT02335203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25280846|NCT02335203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25280847|NCT02335203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25280848|NCT02335203|Contraceptive Agents|contraceptive agents|mesh-ancestor
25280849|NCT02335203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25280850|NCT02335203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280851|NCT02335203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25280852|NCT02335203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25161637|NCT00042289|Bedaquiline|bedaquiline|mesh-list
25161638|NCT00042289|Etravirine|etravirine|mesh-list
25161639|NCT00042289|Clofazimine|clofazimine|mesh-list
25161640|NCT00042289|Ofloxacin|ofloxacin|mesh-list
25161641|NCT00042289|Aminosalicylic Acid|aminosalicylic acid|mesh-list
25161642|NCT00042289|Kanamycin|kanamycin|mesh-list
25161643|NCT00042289|Ethionamide|ethionamide|mesh-list
25161644|NCT00042289|Prothionamide|prothionamide|mesh-list
25161645|NCT00042289|Capreomycin|capreomycin|mesh-list
25161647|NCT00042289|Etonogestrel|etonogestrel|mesh-list
25161648|NCT00042289|Estradiol|estradiol|mesh-list
25161649|NCT00042289|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25161650|NCT00042289|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25161651|NCT00042289|Protease Inhibitors|protease inhibitors|mesh-ancestor
25161652|NCT00042289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25161653|NCT00042289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25161654|NCT00042289|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25161655|NCT00042289|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25161656|NCT00042289|Antiviral Agents|antiviral agents|mesh-ancestor
25161657|NCT00042289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25161658|NCT00042289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25161659|NCT00042289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25161660|NCT00042289|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25161661|NCT00042289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25161662|NCT00042289|Estrogens|estrogens|mesh-ancestor
25161663|NCT00042289|Hormones|hormones|mesh-ancestor
25161664|NCT00042289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25161665|NCT00042289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25161666|NCT00042289|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25161667|NCT00042289|Contraceptive Agents|contraceptive agents|mesh-ancestor
24961741|NCT03806049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24961742|NCT03806049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24961743|NCT03806049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24961744|NCT03806049|Growth Substances|growth substances|mesh-ancestor
24961745|NCT03806049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961746|NCT03806049|Growth Inhibitors|growth inhibitors|mesh-ancestor
24961747|NCT03806049|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24961748|NCT03806049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24961770|NCT03805568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25692819|NCT02005562|Dermatologic Agents|dermatologic agents|mesh-ancestor
25692820|NCT02005562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25692821|NCT02005562|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25161668|NCT00042289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25161669|NCT00042289|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25161670|NCT00042289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25161671|NCT00042289|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25161672|NCT00042289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24706064|NCT01488344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706065|NCT01488344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24706066|NCT01488344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706067|NCT01488344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706068|NCT01488396|Cyclosporine|cyclosporine|mesh-list
25280853|NCT02335203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25280854|NCT02335203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25280855|NCT02335203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25280856|NCT02334904|Risperidone|risperidone|mesh-list
25280857|NCT02334904|Aripiprazole|aripiprazole|mesh-list
25280858|NCT02334904|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25280859|NCT02334904|Serotonin Agents|serotonin agents|mesh-ancestor
25280860|NCT02334904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25280861|NCT02334904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280862|NCT02334904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280863|NCT02334904|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25280864|NCT02334904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25280865|NCT02334904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25280866|NCT02334904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25280867|NCT02334904|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25280868|NCT02334904|Dopamine Agents|dopamine agents|mesh-ancestor
25280869|NCT02334904|Antidepressive Agents|antidepressive agents|mesh-ancestor
25280870|NCT02334904|Dopamine Agonists|dopamine agonists|mesh-ancestor
25280871|NCT02334904|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25280872|NCT02334904|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25280873|NCT02334904|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25280874|NCT02334904|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25161673|NCT00042289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25161674|NCT00042289|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25161675|NCT00042289|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25161676|NCT00042289|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25161677|NCT00042289|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25161678|NCT00042289|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25161679|NCT00042289|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25161680|NCT00042289|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25161681|NCT00042289|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25161682|NCT00042289|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25161683|NCT00042289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25161684|NCT00042289|Antitubercular Agents|antitubercular agents|mesh-ancestor
25161685|NCT00042289|Leprostatic Agents|leprostatic agents|mesh-ancestor
25692822|NCT02005562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25692823|NCT02005562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25692824|NCT02005562|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25692825|NCT02005562|Antitubercular Agents|antitubercular agents|mesh-ancestor
25692826|NCT02005562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25692827|NCT02005562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25692828|NCT02005562|Antiemetics|antiemetics|mesh-ancestor
25692829|NCT02005562|Autonomic Agents|autonomic agents|mesh-ancestor
25692830|NCT02005562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25692831|NCT02005562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25692832|NCT02005562|Glucocorticoids|glucocorticoids|mesh-ancestor
25692833|NCT02005562|Hormones|hormones|mesh-ancestor
25161686|NCT00042289|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25161687|NCT00042289|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25161688|NCT00042289|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25161689|NCT00042289|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25161690|NCT00042289|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25161691|NCT00042289|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25161692|NCT00042289|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25161693|NCT00042289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25161695|NCT00042289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25161696|NCT00042289|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25161697|NCT00042289|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25161699|NCT00042289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25161700|NCT00042289|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24706126|NCT01488734|Ergocalciferols|ergocalciferols|mesh-list
24706127|NCT01488734|Cholecalciferol|cholecalciferol|mesh-list
24706128|NCT01488734|Vitamins|vitamins|mesh-list
25280882|NCT02334501|Lansoprazole|lansoprazole|mesh-list
25280883|NCT02334501|Dexlansoprazole|dexlansoprazole|mesh-list
25280884|NCT02334501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25280885|NCT02334501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25280886|NCT02334501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25280887|NCT02334501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280888|NCT02334501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280889|NCT02334475|Methylprednisolone|methylprednisolone|mesh-list
25280890|NCT02334475|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25280891|NCT02334475|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25280892|NCT02334475|Prednisolone|prednisolone|mesh-list
25280893|NCT02334475|Prednisolone acetate|prednisolone acetate|mesh-list
25280894|NCT02334475|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25280895|NCT02334475|Prednisolone phosphate|prednisolone phosphate|mesh-list
25280896|NCT02334475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25280897|NCT02334475|Antiemetics|antiemetics|mesh-ancestor
25280898|NCT02334475|Autonomic Agents|autonomic agents|mesh-ancestor
25280899|NCT02334475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25280900|NCT02334475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280901|NCT02334475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25280902|NCT02334475|Glucocorticoids|glucocorticoids|mesh-ancestor
25280903|NCT02334475|Hormones|hormones|mesh-ancestor
25280904|NCT02334475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25280905|NCT02334475|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25280906|NCT02334475|Protective Agents|protective agents|mesh-ancestor
25120841|NCT02514031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25120842|NCT02467946|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25120843|NCT02467946|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25120844|NCT02467946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25120845|NCT02467946|Alkylating Agents|alkylating agents|mesh-ancestor
25120846|NCT02467946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120847|NCT02467946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120848|NCT02467946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25120849|NCT02449005|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25120850|NCT02449005|Hemostatics|hemostatics|mesh-ancestor
25120851|NCT02449005|Coagulants|coagulants|mesh-ancestor
25120853|NCT02332928|Antioxidants|antioxidants|mesh-ancestor
25120854|NCT02332928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120855|NCT02332928|Protective Agents|protective agents|mesh-ancestor
25120856|NCT02332928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120857|NCT02332928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25120862|NCT01990352|Doxorubicin|doxorubicin|mesh-list
25120863|NCT01990352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25120864|NCT01990352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25120865|NCT01990352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120866|NCT01990352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25120867|NCT01990352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25120868|NCT01990352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25120869|NCT01990352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529905|NCT00628238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24529906|NCT00628238|Immunologic Factors|immunologic factors|mesh-ancestor
24529907|NCT00628238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529908|NCT00628238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24529909|NCT00628238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24529910|NCT00628238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25280907|NCT02334475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25280908|NCT02334475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25280909|NCT02334605|Capsaicin|capsaicin|mesh-list
24961911|NCT03804723|Hormones|hormones|mesh-ancestor
25280910|NCT02334605|Antipruritics|antipruritics|mesh-ancestor
25280911|NCT02334605|Dermatologic Agents|dermatologic agents|mesh-ancestor
25280912|NCT02334605|Sensory System Agents|sensory system agents|mesh-ancestor
25280913|NCT02334605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25280914|NCT02334605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280915|NCT02334488|Mycophenolic Acid|mycophenolic acid|mesh-list
25280916|NCT02334488|Everolimus|everolimus|mesh-list
25280917|NCT02334488|Tacrolimus|tacrolimus|mesh-list
25280918|NCT02334488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25280919|NCT02334488|Immunologic Factors|immunologic factors|mesh-ancestor
25280920|NCT02334488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280921|NCT02334488|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25280922|NCT02334488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280923|NCT02334488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280924|NCT02334488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25280925|NCT02334488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25280926|NCT02334488|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25280927|NCT02334488|Antitubercular Agents|antitubercular agents|mesh-ancestor
25280928|NCT02334488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25280929|NCT02334488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25280930|NCT02334670|Fluconazole|fluconazole|mesh-list
25280931|NCT02334670|Antifungal Agents|antifungal agents|mesh-ancestor
25280932|NCT02334670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25280933|NCT02334670|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25280934|NCT02334670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25280935|NCT02334670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280936|NCT02334670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280937|NCT02334670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25280938|NCT02334670|Hormone Antagonists|hormone antagonists|mesh-ancestor
25280939|NCT02334670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25280940|NCT02334670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280941|NCT02334670|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25280942|NCT02334670|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24432856|NCT00256542|Anesthetics, Local|anesthetics, local|mesh-ancestor
24529996|NCT00628706|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24530010|NCT00628719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24530012|NCT00628719|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24530013|NCT00628719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24530014|NCT00628732|Cyclophosphamide|cyclophosphamide|mesh-list
24530015|NCT00628732|Topotecan|topotecan|mesh-list
24530016|NCT00628732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24530017|NCT00628732|Immunologic Factors|immunologic factors|mesh-ancestor
24530018|NCT00628732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530065|NCT00628914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24530066|NCT00628914|Antidepressive Agents|antidepressive agents|mesh-ancestor
24706172|NCT01489059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24449894|NCT00317408|Cyclosporins|cyclosporins|mesh-list
25280943|NCT02334631|Simethicone|simethicone|mesh-list
25280944|NCT02334631|Antifoaming Agents|antifoaming agents|mesh-ancestor
25280985|NCT02334176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280945|NCT02334631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280946|NCT02334631|Emollients|emollients|mesh-ancestor
25280947|NCT02334631|Dermatologic Agents|dermatologic agents|mesh-ancestor
25280948|NCT02334462|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25280949|NCT02334462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25280950|NCT02334462|Immunologic Factors|immunologic factors|mesh-ancestor
25280951|NCT02334462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280952|NCT02334462|Antacids|antacids|mesh-ancestor
25280953|NCT02334462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280954|NCT02334462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25280955|NCT02334254|Warfarin|warfarin|mesh-list
25280956|NCT02334254|Rivaroxaban|rivaroxaban|mesh-list
25280957|NCT02334254|Clopidogrel|clopidogrel|mesh-list
25280958|NCT02334254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25280959|NCT02334254|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25280960|NCT02334254|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25280961|NCT02334254|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25280962|NCT02334254|Purinergic Agents|purinergic agents|mesh-ancestor
25280963|NCT02334254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25280964|NCT02334254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280965|NCT02334254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25280966|NCT02334254|Anticoagulants|anticoagulants|mesh-ancestor
25280967|NCT02334254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25280968|NCT02334254|Antithrombins|antithrombins|mesh-ancestor
25280969|NCT02334254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25280970|NCT02334254|Protease Inhibitors|protease inhibitors|mesh-ancestor
24530068|NCT00628914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24530069|NCT00628914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24530070|NCT00628914|Parasympatholytics|parasympatholytics|mesh-ancestor
24530071|NCT00628914|Autonomic Agents|autonomic agents|mesh-ancestor
24530072|NCT00628914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24530073|NCT00628914|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24530074|NCT00628914|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24530104|NCT00629148|Capecitabine|capecitabine|mesh-list
24530105|NCT00629148|Vinorelbine|vinorelbine|mesh-list
24530121|NCT00629200|Interferon alpha-2|interferon alpha-2|mesh-list
24530122|NCT00629200|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
24530123|NCT00629200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530124|NCT00629200|Antiviral Agents|antiviral agents|mesh-ancestor
24457880|NCT00335543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457882|NCT00335582|Analgesics|analgesics|mesh-ancestor
24457883|NCT00335582|Sensory System Agents|sensory system agents|mesh-ancestor
24400568|NCT00150852|Vancomycin|vancomycin|mesh-list
24530125|NCT00629200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24530126|NCT00629200|Immunologic Factors|immunologic factors|mesh-ancestor
24530202|NCT00629317|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24530203|NCT00629317|Dermatologic Agents|dermatologic agents|mesh-ancestor
24530204|NCT00629343|Temozolomide|temozolomide|mesh-list
24530205|NCT00629343|Azacitidine|azacitidine|mesh-list
24530206|NCT00629343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24530207|NCT00629343|Alkylating Agents|alkylating agents|mesh-ancestor
24530208|NCT00629343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530209|NCT00629343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530210|NCT00629343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24530211|NCT00629343|Antimetabolites|antimetabolites|mesh-ancestor
24530212|NCT00629343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530213|NCT00629382|Polymyxins|polymyxins|mesh-list
24530214|NCT00629382|Polymyxin B|polymyxin b|mesh-list
25280971|NCT02334254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25280972|NCT02334163|Metronidazole|metronidazole|mesh-list
25280973|NCT02334163|Nitazoxanide|nitazoxanide|mesh-list
25280974|NCT02334163|Lactulose|lactulose|mesh-list
25280975|NCT02334163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25280976|NCT02334163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25280977|NCT02334163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25280978|NCT02334163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25280979|NCT02334163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25280980|NCT02334176|Lidocaine|lidocaine|mesh-list
25280981|NCT02334176|Epinephrine|epinephrine|mesh-list
25280982|NCT02334176|Anesthetics, Local|anesthetics, local|mesh-ancestor
25280983|NCT02334176|Anesthetics|anesthetics|mesh-ancestor
25280984|NCT02334176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25280988|NCT02334176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25280989|NCT02334176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25280990|NCT02334176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25280991|NCT02334176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25280992|NCT02334176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25280993|NCT02334176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25280994|NCT02334176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25280995|NCT02334176|Adrenergic Agents|adrenergic agents|mesh-ancestor
25280996|NCT02334176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25280997|NCT02334176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25280998|NCT02334176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25280999|NCT02334176|Autonomic Agents|autonomic agents|mesh-ancestor
25281000|NCT02334176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25281001|NCT02334176|Respiratory System Agents|respiratory system agents|mesh-ancestor
25281002|NCT02334176|Mydriatics|mydriatics|mesh-ancestor
25281003|NCT02334176|Sympathomimetics|sympathomimetics|mesh-ancestor
25281004|NCT02334176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25281005|NCT02334150|Sufentanil|sufentanil|mesh-list
25281006|NCT02334150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25281007|NCT02334150|Narcotics|narcotics|mesh-ancestor
24530245|NCT00629564|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24530246|NCT00629564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24530247|NCT00629564|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24530248|NCT00629564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530249|NCT00629564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530326|NCT00629889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24530327|NCT00629889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121392|NCT03103022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25121393|NCT03103022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121394|NCT03103022|Antipyretics|antipyretics|mesh-ancestor
25121395|NCT03103022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25121396|NCT03103022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25121397|NCT03103022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25121398|NCT03103022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25121399|NCT03103022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121400|NCT03103022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121401|NCT03102658|Micafungin|micafungin|mesh-list
24827953|NCT02142556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24613677|NCT01020279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613678|NCT01020279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613680|NCT01020292|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24613681|NCT01020292|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25281008|NCT02334150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25281009|NCT02334150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281010|NCT02334150|Analgesics|analgesics|mesh-ancestor
25281011|NCT02334150|Sensory System Agents|sensory system agents|mesh-ancestor
25281012|NCT02334150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25281013|NCT02334150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25281014|NCT02334150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25281015|NCT02334150|Anesthetics, General|anesthetics, general|mesh-ancestor
25281016|NCT02334150|Anesthetics|anesthetics|mesh-ancestor
25281017|NCT02334046|Remifentanil|remifentanil|mesh-list
25281018|NCT02334046|Sevoflurane|sevoflurane|mesh-list
25281019|NCT02334046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25281020|NCT02334046|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25281021|NCT02334046|Anesthetics, General|anesthetics, general|mesh-ancestor
25281022|NCT02334046|Anesthetics|anesthetics|mesh-ancestor
25281023|NCT02334046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25281024|NCT02334046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281025|NCT02334046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25281026|NCT02334046|Narcotics|narcotics|mesh-ancestor
25281027|NCT02334046|Analgesics|analgesics|mesh-ancestor
25281028|NCT02334046|Sensory System Agents|sensory system agents|mesh-ancestor
25281029|NCT02334046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25281030|NCT02334124|Ceftriaxone|ceftriaxone|mesh-list
25281031|NCT02334124|Floxacillin|floxacillin|mesh-list
25281032|NCT02334124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25281033|NCT02334124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25281034|NCT02333890|Chloroquine|chloroquine|mesh-list
25281035|NCT02333890|Amebicides|amebicides|mesh-ancestor
25281036|NCT02333890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25121402|NCT03102658|Antifungal Agents|antifungal agents|mesh-ancestor
25121403|NCT03102658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25121404|NCT03102801|Insulin|insulin|mesh-list
25121405|NCT03102801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25121406|NCT03102801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25121407|NCT03102801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121408|NCT03102476|Insulin Lispro|insulin lispro|mesh-list
25121409|NCT03102476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25121410|NCT03102476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121411|NCT03102359|Dexmedetomidine|dexmedetomidine|mesh-list
25121412|NCT03102359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25121413|NCT03102359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25121414|NCT03102359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121415|NCT03102359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25121416|NCT03102359|Analgesics|analgesics|mesh-ancestor
25121417|NCT03102359|Sensory System Agents|sensory system agents|mesh-ancestor
25121418|NCT03102359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25102802|NCT03166397|Fludarabine|fludarabine|mesh-list
25121419|NCT03102359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25121420|NCT03102359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25121421|NCT03102359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25121422|NCT03102359|Adrenergic Agents|adrenergic agents|mesh-ancestor
25121423|NCT03102359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25121659|NCT03100565|Sensory System Agents|sensory system agents|mesh-ancestor
25121660|NCT03100565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25121661|NCT03100565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25121662|NCT03100565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25121663|NCT03100565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25121664|NCT03100565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25121665|NCT03100565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121666|NCT03100435|Carbon Fiber|carbon fiber|mesh-list
25121667|NCT03100435|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25121668|NCT03100435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24530329|NCT00629889|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24530330|NCT00629889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25281037|NCT02333890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25281038|NCT02333890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25281039|NCT02333890|Antimalarials|antimalarials|mesh-ancestor
25281040|NCT02333890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25281041|NCT02333929|Rivaroxaban|rivaroxaban|mesh-list
25281042|NCT02333929|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25281043|NCT02333929|Antithrombins|antithrombins|mesh-ancestor
25281044|NCT02333929|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25281045|NCT02333929|Protease Inhibitors|protease inhibitors|mesh-ancestor
25281046|NCT02333929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25281047|NCT02333929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281048|NCT02333929|Anticoagulants|anticoagulants|mesh-ancestor
25281049|NCT02333851|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
25281050|NCT02333851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25281051|NCT02333851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281052|NCT02333838|Vidarabine|vidarabine|mesh-list
25281053|NCT02333838|Fludarabine|fludarabine|mesh-list
25281054|NCT02333838|Fludarabine phosphate|fludarabine phosphate|mesh-list
25281055|NCT02333838|Busulfan|busulfan|mesh-list
25281056|NCT02333838|Thiotepa|thiotepa|mesh-list
25281057|NCT02333838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281058|NCT02333838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25281059|NCT02333838|Antimetabolites|antimetabolites|mesh-ancestor
25281060|NCT02333838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281061|NCT02333838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25281062|NCT02333838|Immunologic Factors|immunologic factors|mesh-ancestor
25281063|NCT02333838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281064|NCT02333838|Antiviral Agents|antiviral agents|mesh-ancestor
25281065|NCT02333838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25281066|NCT02333838|Alkylating Agents|alkylating agents|mesh-ancestor
25281067|NCT02333838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25281068|NCT02333838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25281069|NCT02334007|Dalteparin|dalteparin|mesh-list
25281070|NCT02334007|Tinzaparin|tinzaparin|mesh-list
25281071|NCT02334007|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25281072|NCT02334007|Anticoagulants|anticoagulants|mesh-ancestor
25281073|NCT02334007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25281074|NCT02334007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25281075|NCT02334007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281076|NCT02333799|Linezolid|linezolid|mesh-list
24530334|NCT00629889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24530335|NCT00629889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24530336|NCT00629889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24530359|NCT00630019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24530360|NCT00630019|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24530361|NCT00630019|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24530362|NCT00630019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24530363|NCT00630019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24530374|NCT00630019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25015502|NCT02245230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24530375|NCT00630019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24530376|NCT00630019|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24530377|NCT00630019|Renal Agents|renal agents|mesh-ancestor
24530378|NCT00630019|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24530379|NCT00630019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24530408|NCT00630110|Antimitotic Agents|antimitotic agents|mesh-ancestor
24530409|NCT00630110|Mitosis Modulators|mitosis modulators|mesh-ancestor
24530410|NCT00630110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530411|NCT00630149|Pemetrexed|pemetrexed|mesh-list
24530412|NCT00630149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530413|NCT00630149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530414|NCT00630149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530415|NCT00630149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24530416|NCT00630149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24613682|NCT01020292|Protease Inhibitors|protease inhibitors|mesh-ancestor
24613683|NCT01020292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613684|NCT01020292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492051|NCT00485056|Pioglitazone|pioglitazone|mesh-list
24706257|NCT01489410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24706258|NCT01489410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24706259|NCT01489410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24706260|NCT01489410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706262|NCT01489488|Enzyme Activators|enzyme activators|mesh-ancestor
24706263|NCT01489488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706264|NCT01489566|Fluorouracil|fluorouracil|mesh-list
24706265|NCT01489566|Mitomycins|mitomycins|mesh-list
24706266|NCT01489566|Mitomycin|mitomycin|mesh-list
24706267|NCT01489566|Antimetabolites|antimetabolites|mesh-ancestor
24706268|NCT01489566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706269|NCT01489566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24706270|NCT01489566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706271|NCT01489566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24706272|NCT01489566|Immunologic Factors|immunologic factors|mesh-ancestor
24706304|NCT01489631|Narcotics|narcotics|mesh-ancestor
24706305|NCT01489631|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24706306|NCT01489631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24706307|NCT01489631|Anesthetics, General|anesthetics, general|mesh-ancestor
24706308|NCT01489644|Metformin|metformin|mesh-list
24706309|NCT01489644|Repaglinide|repaglinide|mesh-list
24706310|NCT01489644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25281077|NCT02333799|Bedaquiline|bedaquiline|mesh-list
25281078|NCT02333799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25281079|NCT02333799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25281080|NCT02333799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25281081|NCT02333799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25281082|NCT02333799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281083|NCT02333799|Antitubercular Agents|antitubercular agents|mesh-ancestor
25281084|NCT02333682|Vitamin D|vitamin d|mesh-list
25281085|NCT02333682|Cholecalciferol|cholecalciferol|mesh-list
25281086|NCT02333682|Calcifediol|calcifediol|mesh-list
25281087|NCT02333682|Vitamins|vitamins|mesh-ancestor
25281088|NCT02333682|Micronutrients|micronutrients|mesh-ancestor
25281089|NCT02333682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281090|NCT02333682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25281091|NCT02333682|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25281092|NCT02333565|Everolimus|everolimus|mesh-list
25281093|NCT02333565|Octreotide|octreotide|mesh-list
25281094|NCT02333565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281095|NCT02333565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25281096|NCT02333565|Immunologic Factors|immunologic factors|mesh-ancestor
25281097|NCT02333565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281098|NCT02333565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25281099|NCT02333565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25281101|NCT02333344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24530421|NCT00630175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530422|NCT00630175|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24530442|NCT00630357|Anticonvulsants|anticonvulsants|mesh-ancestor
24530443|NCT00630357|Nootropic Agents|nootropic agents|mesh-ancestor
24530445|NCT00630370|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24530446|NCT00630370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24530447|NCT00630370|Serotonin Agents|serotonin agents|mesh-ancestor
24530448|NCT00630370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24530449|NCT00630370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530490|NCT00630643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24530492|NCT00630682|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24530493|NCT00630682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530494|NCT00630682|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24530495|NCT00630682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24530496|NCT00630682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24530497|NCT00630682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121900|NCT03098407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25121901|NCT03098407|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25121902|NCT03098407|Antitussive Agents|antitussive agents|mesh-ancestor
25121903|NCT03098407|Respiratory System Agents|respiratory system agents|mesh-ancestor
25121905|NCT03098368|Dopamine Agonists|dopamine agonists|mesh-ancestor
25121906|NCT03098368|Dopamine Agents|dopamine agents|mesh-ancestor
25121907|NCT03098368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24706311|NCT01489644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706313|NCT01489683|Anesthetics, Local|anesthetics, local|mesh-ancestor
24706314|NCT01489683|Anesthetics|anesthetics|mesh-ancestor
24706315|NCT01489683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24706316|NCT01489683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706342|NCT01489709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706344|NCT01489709|Urological Agents|urological agents|mesh-ancestor
24706345|NCT01489852|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24706346|NCT01489852|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24706347|NCT01489852|Estradiol|estradiol|mesh-list
24706348|NCT01489852|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24706391|NCT01489943|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25281102|NCT02333344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281103|NCT02333513|Vincristine|vincristine|mesh-list
25281104|NCT02333513|Lomustine|lomustine|mesh-list
25281105|NCT02333513|Procarbazine|procarbazine|mesh-list
25281106|NCT02333513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25281107|NCT02333513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281108|NCT02333513|Tubulin Modulators|tubulin modulators|mesh-ancestor
25281109|NCT02333513|Antimitotic Agents|antimitotic agents|mesh-ancestor
25281110|NCT02333513|Mitosis Modulators|mitosis modulators|mesh-ancestor
25281111|NCT02333513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281112|NCT02333513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25281113|NCT02333513|Alkylating Agents|alkylating agents|mesh-ancestor
25281114|NCT02333253|Cetrorelix|cetrorelix|mesh-list
25281115|NCT02333253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25281116|NCT02333253|Fertility Agents|fertility agents|mesh-ancestor
25281117|NCT02333253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25281118|NCT02333253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281119|NCT02333253|Hormone Antagonists|hormone antagonists|mesh-ancestor
25281120|NCT02333253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25281121|NCT02333305|Coenzyme Q10|coenzyme q10|mesh-list
25281122|NCT02333305|Vitamins|vitamins|mesh-ancestor
25281123|NCT02333305|Micronutrients|micronutrients|mesh-ancestor
25281124|NCT02333305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281125|NCT02333188|Leucovorin|leucovorin|mesh-list
25281126|NCT02333188|Paclitaxel|paclitaxel|mesh-list
25281127|NCT02333188|Fluorouracil|fluorouracil|mesh-list
25281128|NCT02333188|Irinotecan|irinotecan|mesh-list
25281129|NCT02333188|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25281130|NCT02333188|Calcium|calcium|mesh-list
25281131|NCT02333188|Levoleucovorin|levoleucovorin|mesh-list
25121908|NCT03098368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121909|NCT03098368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530498|NCT00630682|Dopamine Agents|dopamine agents|mesh-ancestor
24530499|NCT00630682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24530560|NCT00630981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530561|NCT00630981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24530562|NCT00630981|Antidepressive Agents|antidepressive agents|mesh-ancestor
24530563|NCT00630981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24530564|NCT00630981|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24530565|NCT00630981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24530566|NCT00630981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24530567|NCT00631033|Metformin|metformin|mesh-list
24530568|NCT00631033|Diazoxide|diazoxide|mesh-list
24530569|NCT00631033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24530570|NCT00631033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530571|NCT00631033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24530572|NCT00631033|Vasodilator Agents|vasodilator agents|mesh-ancestor
24530573|NCT00631085|Tocopherols|tocopherols|mesh-list
24530574|NCT00631085|Vitamin E|vitamin e|mesh-list
24530575|NCT00631085|Tocotrienols|tocotrienols|mesh-list
24530576|NCT00631085|alpha-Tocopherol|alpha-tocopherol|mesh-list
24530577|NCT00631085|gamma-Tocopherol|gamma-tocopherol|mesh-list
24530578|NCT00631085|Antioxidants|antioxidants|mesh-ancestor
24530579|NCT00631085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457887|NCT00335582|Sympatholytics|sympatholytics|mesh-ancestor
24457888|NCT00335582|Autonomic Agents|autonomic agents|mesh-ancestor
24530663|NCT00631592|Antiviral Agents|antiviral agents|mesh-ancestor
24530664|NCT00631592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24530665|NCT00631618|Sunitinib|sunitinib|mesh-list
24530666|NCT00631618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530694|NCT00631722|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24530695|NCT00631813|Prucalopride|prucalopride|mesh-list
25281132|NCT02333188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25281133|NCT02333188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281134|NCT02333188|Tubulin Modulators|tubulin modulators|mesh-ancestor
25281135|NCT02333188|Antimitotic Agents|antimitotic agents|mesh-ancestor
25281136|NCT02333188|Mitosis Modulators|mitosis modulators|mesh-ancestor
25281137|NCT02333188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281138|NCT02333188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25015788|NCT00960141|Histamine Agents|histamine agents|mesh-ancestor
25281139|NCT02333188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281140|NCT02333188|Antimetabolites|antimetabolites|mesh-ancestor
24810041|NCT02037516|Neostigmine|neostigmine|mesh-list
25281141|NCT02333188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25281142|NCT02333188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25281143|NCT02333188|Immunologic Factors|immunologic factors|mesh-ancestor
25281144|NCT02333188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25281145|NCT02333188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25281146|NCT02333188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25281148|NCT02333188|Protective Agents|protective agents|mesh-ancestor
25281149|NCT02333188|Vitamin B Complex|vitamin b complex|mesh-ancestor
25281150|NCT02333188|Vitamins|vitamins|mesh-ancestor
25281151|NCT02333188|Micronutrients|micronutrients|mesh-ancestor
24530733|NCT00632086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24530734|NCT00632086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24530735|NCT00632086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530736|NCT00632086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24530737|NCT00632086|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24530738|NCT00632086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530739|NCT00632086|Antipyretics|antipyretics|mesh-ancestor
24530740|NCT00632216|Risedronic Acid|risedronic acid|mesh-list
24457893|NCT00335582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24457894|NCT00335582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530806|NCT00632580|Anesthetics|anesthetics|mesh-ancestor
24530807|NCT00632580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24530808|NCT00632580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530809|NCT00632580|Sensory System Agents|sensory system agents|mesh-ancestor
24530810|NCT00632580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25121985|NCT03097380|Tiotropium Bromide|tiotropium bromide|mesh-list
25122056|NCT03097198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122057|NCT03097198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25122058|NCT03097198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25122059|NCT03097198|Cholinergic Agents|cholinergic agents|mesh-ancestor
25122060|NCT03097198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25122061|NCT03097198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122062|NCT03097003|Apremilast|apremilast|mesh-list
25122063|NCT03097003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25122064|NCT03097003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25122065|NCT03097003|Analgesics|analgesics|mesh-ancestor
25122066|NCT03097003|Sensory System Agents|sensory system agents|mesh-ancestor
24833672|NCT02175017|Nivolumab|nivolumab|mesh-list
25122067|NCT03097003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25122068|NCT03097003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122069|NCT03097003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25122070|NCT03097003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25122071|NCT03097003|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25122075|NCT03096990|Apremilast|apremilast|mesh-list
25281152|NCT02333240|Antihypertensive Agents|antihypertensive agents|mesh-list
25281153|NCT02332941|Rituximab|rituximab|mesh-list
25281154|NCT02332941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25281155|NCT02332941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281156|NCT02332941|Immunologic Factors|immunologic factors|mesh-ancestor
25281157|NCT02332941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281158|NCT02332941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25281159|NCT02332967|Palmitic Acid|palmitic acid|mesh-list
25281160|NCT02332967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25281161|NCT02332967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281162|NCT02333123|Aspirin|aspirin|mesh-list
25281163|NCT02333123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25281164|NCT02333123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25281165|NCT02333123|Analgesics|analgesics|mesh-ancestor
25281166|NCT02333123|Sensory System Agents|sensory system agents|mesh-ancestor
25281167|NCT02333123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25281168|NCT02333123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281169|NCT02333123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25281170|NCT02333123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25281172|NCT02333123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25281173|NCT02333123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281174|NCT02333123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25281175|NCT02333123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25281176|NCT02333123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25281177|NCT02333123|Antipyretics|antipyretics|mesh-ancestor
25281178|NCT02333058|Treosulfan|treosulfan|mesh-list
25281179|NCT02333058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25281180|NCT02333058|Alkylating Agents|alkylating agents|mesh-ancestor
25281181|NCT02333058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281182|NCT02333058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281183|NCT02332954|Vortioxetine|vortioxetine|mesh-list
25281184|NCT02332954|Antidepressive Agents|antidepressive agents|mesh-ancestor
25281185|NCT02332954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25281186|NCT02332954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25281187|NCT02332954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25281188|NCT02332954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25281189|NCT02332954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281190|NCT02332954|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25122077|NCT03096990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25122078|NCT03096990|Analgesics|analgesics|mesh-ancestor
25122079|NCT03096990|Sensory System Agents|sensory system agents|mesh-ancestor
25122080|NCT03096990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25122081|NCT03096990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122082|NCT03096990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25122083|NCT03096990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25122174|NCT03095547|Olorofim|olorofim|mesh-list
25122321|NCT03095001|Antimitotic Agents|antimitotic agents|mesh-ancestor
25122322|NCT03095001|Mitosis Modulators|mitosis modulators|mesh-ancestor
25015925|NCT00702988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122323|NCT03095001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122324|NCT03095001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25122325|NCT03095001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25122326|NCT03095001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25122327|NCT03095001|Growth Substances|growth substances|mesh-ancestor
25122328|NCT03095001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122329|NCT03095001|Growth Inhibitors|growth inhibitors|mesh-ancestor
24798836|NCT01965405|Bupropion|bupropion|mesh-list
24530811|NCT00632606|Magnesium Sulfate|magnesium sulfate|mesh-list
24530812|NCT00632606|Metoclopramide|metoclopramide|mesh-list
24530813|NCT00632606|Analgesics|analgesics|mesh-ancestor
24530814|NCT00632606|Sensory System Agents|sensory system agents|mesh-ancestor
24530815|NCT00632606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24530816|NCT00632606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530817|NCT00632606|Anesthetics|anesthetics|mesh-ancestor
24530822|NCT00632606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24530823|NCT00632606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530824|NCT00632606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24530825|NCT00632606|Tocolytic Agents|tocolytic agents|mesh-ancestor
25281191|NCT02332954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25281192|NCT02332954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25281193|NCT02332954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281194|NCT02332954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25281195|NCT02332954|Serotonin Agents|serotonin agents|mesh-ancestor
25281196|NCT02332954|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25281197|NCT02332954|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25281198|NCT02332954|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25281199|NCT02332954|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25281200|NCT02332980|Pembrolizumab|pembrolizumab|mesh-list
25281201|NCT02332980|Idelalisib|idelalisib|mesh-list
25281202|NCT02332980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25281203|NCT02332980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281204|NCT02332980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25281205|NCT02332980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281206|NCT02332811|Sevelamer|sevelamer|mesh-list
25281207|NCT02332811|Chelating Agents|chelating agents|mesh-ancestor
25281208|NCT02332811|Sequestering Agents|sequestering agents|mesh-ancestor
25281209|NCT02332811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281210|NCT02332473|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24962617|NCT03796884|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
24962618|NCT03796884|Enzyme Activators|enzyme activators|mesh-ancestor
24962621|NCT03797222|Vitamin E|vitamin e|mesh-list
25281211|NCT02332473|Molgramostim|molgramostim|mesh-list
25281212|NCT02332473|Sargramostim|sargramostim|mesh-list
25281213|NCT02332473|Antiviral Agents|antiviral agents|mesh-ancestor
25281214|NCT02332473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25281215|NCT02332473|Immunologic Factors|immunologic factors|mesh-ancestor
25281216|NCT02332473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281217|NCT02332473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281218|NCT02332512|Apatinib|apatinib|mesh-list
25281219|NCT02332512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281220|NCT02332512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25281221|NCT02332512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25281222|NCT02332512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281223|NCT02332603|Methylprednisolone|methylprednisolone|mesh-list
25281224|NCT02332603|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25281225|NCT02332603|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25281226|NCT02332603|Prednisolone|prednisolone|mesh-list
25281227|NCT02332603|Prednisolone acetate|prednisolone acetate|mesh-list
25281228|NCT02332603|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25281229|NCT02332603|Prednisolone phosphate|prednisolone phosphate|mesh-list
25281230|NCT02332603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25281231|NCT02332603|Antiemetics|antiemetics|mesh-ancestor
24530961|NCT00633386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24530962|NCT00633386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530963|NCT00633386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531043|NCT00633672|Histamine Antagonists|histamine antagonists|mesh-ancestor
24531044|NCT00633672|Histamine Agents|histamine agents|mesh-ancestor
24531045|NCT00633672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24531046|NCT00633672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531047|NCT00633685|Fluoxetine|fluoxetine|mesh-list
24531063|NCT00633698|Niacinamide|niacinamide|mesh-list
24531064|NCT00633698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24531065|NCT00633698|Antimetabolites|antimetabolites|mesh-ancestor
24531066|NCT00633698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531067|NCT00633698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24531068|NCT00633698|Vasodilator Agents|vasodilator agents|mesh-ancestor
24531069|NCT00633698|Vitamin B Complex|vitamin b complex|mesh-ancestor
24531070|NCT00633698|Vitamins|vitamins|mesh-ancestor
24531071|NCT00633698|Micronutrients|micronutrients|mesh-ancestor
24531072|NCT00633698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531073|NCT00633763|Fallypride|fallypride|mesh-list
24531074|NCT00633763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24531075|NCT00633763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24706392|NCT01489943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24706393|NCT01489943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706460|NCT01490203|Antidotes|antidotes|mesh-ancestor
24706461|NCT01490203|Protective Agents|protective agents|mesh-ancestor
24706462|NCT01490203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706463|NCT01490203|Chelating Agents|chelating agents|mesh-ancestor
24706464|NCT01490203|Sequestering Agents|sequestering agents|mesh-ancestor
24706465|NCT01490203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706466|NCT01490203|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24706467|NCT01490203|Anticoagulants|anticoagulants|mesh-ancestor
24706478|NCT01490229|Ezetimibe|ezetimibe|mesh-list
24706503|NCT01490268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24706508|NCT01490333|Vitamin D|vitamin d|mesh-list
24706512|NCT01490333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706513|NCT01490333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24706514|NCT01490333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24706515|NCT01490346|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24706516|NCT01490346|Antiviral Agents|antiviral agents|mesh-ancestor
24706517|NCT01490346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24706518|NCT01490398|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24706519|NCT01490398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24706520|NCT01490398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24706521|NCT01490398|Antimetabolites|antimetabolites|mesh-ancestor
24706522|NCT01490398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706523|NCT01490398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24706524|NCT01490398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24706525|NCT01490398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706529|NCT01490437|Pemetrexed|pemetrexed|mesh-list
25692834|NCT02005562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25692835|NCT02005562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24706560|NCT01490567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706561|NCT01490567|Cholinergic Agents|cholinergic agents|mesh-ancestor
24706562|NCT01490567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25281232|NCT02332603|Autonomic Agents|autonomic agents|mesh-ancestor
25281233|NCT02332603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25281234|NCT02332603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281235|NCT02332603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25281236|NCT02332603|Glucocorticoids|glucocorticoids|mesh-ancestor
25281238|NCT02332603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25281239|NCT02332603|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25281240|NCT02332603|Protective Agents|protective agents|mesh-ancestor
25281241|NCT02332603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25281242|NCT02332603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281243|NCT02332447|Naloxone|naloxone|mesh-list
25281244|NCT02332447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25281245|NCT02332447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281246|NCT02332447|Sensory System Agents|sensory system agents|mesh-ancestor
25281247|NCT02332447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25281248|NCT02332629|Methylprednisolone|methylprednisolone|mesh-list
25281249|NCT02332629|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25281250|NCT02332629|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25281251|NCT02332629|Prednisolone|prednisolone|mesh-list
25281252|NCT02332629|Prednisolone acetate|prednisolone acetate|mesh-list
24531076|NCT00633763|Dopamine Agents|dopamine agents|mesh-ancestor
24531077|NCT00633763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24531078|NCT00633763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531079|NCT00633763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531080|NCT00633776|Formoterol Fumarate|formoterol fumarate|mesh-list
24531081|NCT00633776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24531082|NCT00633776|Autonomic Agents|autonomic agents|mesh-ancestor
24531083|NCT00633776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24531084|NCT00633776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531085|NCT00633776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25122405|NCT03094468|Antifungal Agents|antifungal agents|mesh-ancestor
25122406|NCT03094468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25122407|NCT03094468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25122479|NCT03093545|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25122480|NCT03093545|Antibodies|antibodies|mesh-list
25122481|NCT03093545|Immunologic Factors|immunologic factors|mesh-ancestor
25122482|NCT03093545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122483|NCT03093597|Petrolatum|petrolatum|mesh-list
25122484|NCT03093597|Emollients|emollients|mesh-ancestor
25122485|NCT03093597|Dermatologic Agents|dermatologic agents|mesh-ancestor
25122486|NCT03093402|Dronabinol|dronabinol|mesh-list
25122487|NCT03093402|Lenabasum|lenabasum|mesh-list
25122488|NCT03093402|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25122489|NCT03093402|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25122490|NCT03093402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25122491|NCT03093402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122492|NCT03093402|Hormones|hormones|mesh-ancestor
25122493|NCT03093402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25122494|NCT03093402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122495|NCT03093402|Hallucinogens|hallucinogens|mesh-ancestor
25122496|NCT03093402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24706563|NCT01490567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706564|NCT01490567|Nootropic Agents|nootropic agents|mesh-ancestor
24706566|NCT01490658|Repaglinide|repaglinide|mesh-list
24706567|NCT01490658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24706568|NCT01490658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706580|NCT01490749|Oxaliplatin|oxaliplatin|mesh-list
24706581|NCT01490749|Everolimus|everolimus|mesh-list
24706582|NCT01490749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706583|NCT01490749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24706584|NCT01490749|Antimetabolites|antimetabolites|mesh-ancestor
25281253|NCT02332629|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25281254|NCT02332629|Prednisolone phosphate|prednisolone phosphate|mesh-list
25281255|NCT02332629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25281256|NCT02332629|Antiemetics|antiemetics|mesh-ancestor
25281257|NCT02332629|Autonomic Agents|autonomic agents|mesh-ancestor
25281258|NCT02332629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25281259|NCT02332629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281260|NCT02332629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25281262|NCT02332629|Hormones|hormones|mesh-ancestor
25281263|NCT02332629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25281264|NCT02332629|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25016319|NCT00092066|Vitamins|vitamins|mesh-ancestor
25281265|NCT02332629|Protective Agents|protective agents|mesh-ancestor
25281266|NCT02332629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25281267|NCT02332629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281268|NCT02332616|Methylprednisolone|methylprednisolone|mesh-list
25281269|NCT02332616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25281270|NCT02332616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25281271|NCT02332616|Prednisolone|prednisolone|mesh-list
25281272|NCT02332616|Prednisolone acetate|prednisolone acetate|mesh-list
25281273|NCT02332616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25281274|NCT02332616|Prednisolone phosphate|prednisolone phosphate|mesh-list
25281275|NCT02332616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25281276|NCT02332616|Antiemetics|antiemetics|mesh-ancestor
25281277|NCT02332616|Autonomic Agents|autonomic agents|mesh-ancestor
25281278|NCT02332616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25281279|NCT02332616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281280|NCT02332616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25281281|NCT02332616|Glucocorticoids|glucocorticoids|mesh-ancestor
25281282|NCT02332616|Hormones|hormones|mesh-ancestor
25281283|NCT02332616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25281284|NCT02332616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25122613|NCT03091894|Dexmedetomidine|dexmedetomidine|mesh-list
25122680|NCT03091595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122681|NCT03091595|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25122682|NCT03091595|Estrogens|estrogens|mesh-ancestor
25122684|NCT03091595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25122685|NCT03091595|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25122686|NCT03091595|Hormone Antagonists|hormone antagonists|mesh-ancestor
25122687|NCT03091595|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25122688|NCT03091595|Diuretics|diuretics|mesh-ancestor
25122689|NCT03091595|Natriuretic Agents|natriuretic agents|mesh-ancestor
25122690|NCT03091426|Antimicrobial Cationic Peptides|antimicrobial cationic peptides|mesh-list
25122691|NCT03091426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25122692|NCT03091504|Albuterol|albuterol|mesh-list
25122693|NCT03091504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25122694|NCT03091504|Autonomic Agents|autonomic agents|mesh-ancestor
25122695|NCT03091504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25122696|NCT03091504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122697|NCT03091504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25122698|NCT03091504|Respiratory System Agents|respiratory system agents|mesh-ancestor
25122881|NCT03089645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25122898|NCT03089658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25122899|NCT03089658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531086|NCT00633776|Respiratory System Agents|respiratory system agents|mesh-ancestor
24531087|NCT00633776|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24531088|NCT00633776|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24531115|NCT00634062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24531116|NCT00634062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24531117|NCT00634062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24531118|NCT00634062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24531119|NCT00634062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24531120|NCT00634140|Ezetimibe|ezetimibe|mesh-list
24531122|NCT00634140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24531123|NCT00634140|Antimetabolites|antimetabolites|mesh-ancestor
24706593|NCT01490905|Ibuprofen|ibuprofen|mesh-list
24531124|NCT00634140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281286|NCT02332616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25281287|NCT02332616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281288|NCT02332174|Rufinamide|rufinamide|mesh-list
25281289|NCT02332174|Anticonvulsants|anticonvulsants|mesh-ancestor
25281290|NCT02332174|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25281291|NCT02332174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25281292|NCT02332174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25281293|NCT02332174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281294|NCT02332135|Vitamin D|vitamin d|mesh-list
25281295|NCT02332135|Vitamins|vitamins|mesh-ancestor
25281296|NCT02332135|Micronutrients|micronutrients|mesh-ancestor
25281297|NCT02332135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281298|NCT02332135|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25281299|NCT02332356|Adalimumab|adalimumab|mesh-list
25281300|NCT02332356|Azathioprine|azathioprine|mesh-list
25281301|NCT02332356|Infliximab|infliximab|mesh-list
25281302|NCT02332356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25281303|NCT02332356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25281304|NCT02332356|Dermatologic Agents|dermatologic agents|mesh-ancestor
25281305|NCT02332356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25281306|NCT02332356|Antimetabolites|antimetabolites|mesh-ancestor
25281307|NCT02332356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281308|NCT02332356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25281309|NCT02332356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281310|NCT02332356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25281311|NCT02332356|Immunologic Factors|immunologic factors|mesh-ancestor
25281312|NCT02332356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281313|NCT02332057|Diclofenac|diclofenac|mesh-list
25281314|NCT02332057|Lidocaine|lidocaine|mesh-list
25281315|NCT02332057|Anesthetics, Local|anesthetics, local|mesh-ancestor
25281316|NCT02332057|Anesthetics|anesthetics|mesh-ancestor
25281317|NCT02332057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25281318|NCT02332057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281319|NCT02332057|Sensory System Agents|sensory system agents|mesh-ancestor
25281320|NCT02332057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25281321|NCT02332057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25281322|NCT02332057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24531203|NCT00634439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24531204|NCT00634439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531236|NCT00634634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24531237|NCT00634634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531238|NCT00634634|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24531239|NCT00634634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24531353|NCT00635284|Immunologic Factors|immunologic factors|mesh-ancestor
24531354|NCT00635284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531356|NCT00635310|Hematinics|hematinics|mesh-ancestor
24531357|NCT00635323|Capecitabine|capecitabine|mesh-list
24445843|NCT00302705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24531358|NCT00635323|Irinotecan|irinotecan|mesh-list
24531359|NCT00635323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24531360|NCT00635323|Antimetabolites|antimetabolites|mesh-ancestor
24531396|NCT00635713|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24531425|NCT00635726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24531426|NCT00635726|Dermatologic Agents|dermatologic agents|mesh-ancestor
24531427|NCT00635726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24531428|NCT00635726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24531429|NCT00635726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24531430|NCT00635726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24531431|NCT00635726|Tubulin Modulators|tubulin modulators|mesh-ancestor
24531432|NCT00635726|Antimitotic Agents|antimitotic agents|mesh-ancestor
24531433|NCT00635726|Mitosis Modulators|mitosis modulators|mesh-ancestor
24531434|NCT00635791|Sorafenib|sorafenib|mesh-list
24531435|NCT00635791|Vorinostat|vorinostat|mesh-list
24531436|NCT00635791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706585|NCT01490749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706586|NCT01490749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24706587|NCT01490749|Immunologic Factors|immunologic factors|mesh-ancestor
24706588|NCT01490749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706589|NCT01490762|Insulin|insulin|mesh-list
24706590|NCT01490762|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24706591|NCT01490762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24706592|NCT01490762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706600|NCT01490905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24706601|NCT01490905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24706602|NCT01490905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24706603|NCT01490905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644536|NCT01191645|Naloxone|naloxone|mesh-list
24706604|NCT01490905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706605|NCT01490944|Iron|iron|mesh-list
24706606|NCT01490944|Folic Acid|folic acid|mesh-list
24706607|NCT01490944|Vitamin B 12|vitamin b 12|mesh-list
25281323|NCT02332057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25281324|NCT02332057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25281325|NCT02332057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281326|NCT02332057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25281327|NCT02332057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25281328|NCT02332057|Analgesics|analgesics|mesh-ancestor
25281329|NCT02332057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25281330|NCT02332057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25281331|NCT02332057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25281332|NCT02332057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25281333|NCT02332044|Bepotastine besilate|bepotastine besilate|mesh-list
25281334|NCT02332044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25281335|NCT02332031|Sorafenib|sorafenib|mesh-list
24963043|NCT03793114|Hormones|hormones|mesh-ancestor
24963044|NCT03793114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24611399|NCT01009437|Ritonavir|ritonavir|mesh-list
25078797|NCT03353857|Estrogens|estrogens|mesh-ancestor
25281336|NCT02332031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281337|NCT02332031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25281338|NCT02332031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25281339|NCT02332031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281340|NCT02331771|Donepezil|donepezil|mesh-list
25281341|NCT02331771|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25281342|NCT02331771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25281343|NCT02331771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281344|NCT02331771|Cholinergic Agents|cholinergic agents|mesh-ancestor
25281345|NCT02331771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25281346|NCT02331771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281347|NCT02331771|Nootropic Agents|nootropic agents|mesh-ancestor
25281348|NCT02331745|Lenograstim|lenograstim|mesh-list
25281349|NCT02331745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25281350|NCT02331745|Immunologic Factors|immunologic factors|mesh-ancestor
24531437|NCT00635791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24531438|NCT00635791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24531439|NCT00635791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531440|NCT00635791|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24531507|NCT00636142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24531508|NCT00636246|Sertraline|sertraline|mesh-list
24531509|NCT00636246|Reboxetine|reboxetine|mesh-list
24531510|NCT00636246|Antidepressive Agents|antidepressive agents|mesh-ancestor
24433170|NCT00257790|Tobramycin|tobramycin|mesh-list
24531869|NCT00637468|Sensory System Agents|sensory system agents|mesh-ancestor
24531870|NCT00637468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24531871|NCT00637468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531872|NCT00637468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24531874|NCT00637468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24531875|NCT00637468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24531904|NCT00637533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531905|NCT00637533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24531906|NCT00637533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24531908|NCT00637559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24634052|NCT01131936|Amlodipine|amlodipine|mesh-list
24531909|NCT00637559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24531910|NCT00637559|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24531911|NCT00637559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24531912|NCT00637559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531925|NCT00637611|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24531926|NCT00637611|Histamine Antagonists|histamine antagonists|mesh-ancestor
24531927|NCT00637611|Histamine Agents|histamine agents|mesh-ancestor
25122973|NCT03088254|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25122974|NCT03088254|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25122976|NCT03088371|Bupivacaine|bupivacaine|mesh-list
25122977|NCT03088371|Anesthetics, Local|anesthetics, local|mesh-ancestor
25122978|NCT03088371|Anesthetics|anesthetics|mesh-ancestor
25122979|NCT03088371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25122980|NCT03088371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122981|NCT03088371|Sensory System Agents|sensory system agents|mesh-ancestor
24613685|NCT01020292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24706608|NCT01490944|Hydroxocobalamin|hydroxocobalamin|mesh-list
24706609|NCT01490944|Vitamin B Complex|vitamin b complex|mesh-list
25281351|NCT02331745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281352|NCT02331823|Moxifloxacin|moxifloxacin|mesh-list
25281353|NCT02331823|Isoniazid|isoniazid|mesh-list
25281354|NCT02331823|Pyrazinamide|pyrazinamide|mesh-list
25281355|NCT02331823|Ethambutol|ethambutol|mesh-list
25281356|NCT02331823|Rifabutin|rifabutin|mesh-list
25281357|NCT02331823|Streptomycin|streptomycin|mesh-list
25281358|NCT02331823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25281359|NCT02331823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25281360|NCT02331823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25281361|NCT02331823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25281362|NCT02331823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692836|NCT02005562|Protective Agents|protective agents|mesh-ancestor
25692837|NCT02005562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25692838|NCT02005601|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25281407|NCT02331706|Interferons|interferons|mesh-list
25281363|NCT02331823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281364|NCT02331823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25692839|NCT02005601|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25281365|NCT02331823|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25281366|NCT02331823|Antitubercular Agents|antitubercular agents|mesh-ancestor
25281367|NCT02331823|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25281368|NCT02331823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25281369|NCT02331823|Antimetabolites|antimetabolites|mesh-ancestor
25281370|NCT02331823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25281371|NCT02331823|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25281372|NCT02331862|Methylprednisolone|methylprednisolone|mesh-list
25281373|NCT02331862|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25281374|NCT02331862|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25281375|NCT02331862|Prednisolone|prednisolone|mesh-list
25281376|NCT02331862|Prednisolone acetate|prednisolone acetate|mesh-list
25281377|NCT02331862|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25281378|NCT02331862|Prednisolone phosphate|prednisolone phosphate|mesh-list
25281379|NCT02331862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25281380|NCT02331862|Antiemetics|antiemetics|mesh-ancestor
25281381|NCT02331862|Autonomic Agents|autonomic agents|mesh-ancestor
25281382|NCT02331862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25281383|NCT02331862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281384|NCT02331862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25281385|NCT02331862|Glucocorticoids|glucocorticoids|mesh-ancestor
25281386|NCT02331862|Hormones|hormones|mesh-ancestor
25281387|NCT02331862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25122982|NCT03088371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25122983|NCT03088371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25122984|NCT03088371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25122985|NCT03088371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25123047|NCT03088306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25123048|NCT03088306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25123049|NCT03088306|Antipyretics|antipyretics|mesh-ancestor
25123050|NCT03088306|Anticonvulsants|anticonvulsants|mesh-ancestor
25123051|NCT03088306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25123052|NCT03088306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25123053|NCT03088306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25123054|NCT03088306|Antimanic Agents|antimanic agents|mesh-ancestor
25123068|NCT03087968|Prednisolone|prednisolone|mesh-list
25123069|NCT03087968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25123070|NCT03087968|Glucocorticoids|glucocorticoids|mesh-ancestor
25123071|NCT03087968|Hormones|hormones|mesh-ancestor
25123072|NCT03087968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25123075|NCT03087968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123122|NCT03088072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25123123|NCT03088072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25123124|NCT03088072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123125|NCT03088072|Antipyretics|antipyretics|mesh-ancestor
25123126|NCT03088072|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25123127|NCT03088072|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25123128|NCT03088072|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25123129|NCT03088072|Purinergic Agents|purinergic agents|mesh-ancestor
25123136|NCT03087890|Trimethoprim|trimethoprim|mesh-list
25123186|NCT03087539|Abciximab|abciximab|mesh-list
25123333|NCT03086070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25123334|NCT03086070|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25281388|NCT02331862|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25123335|NCT03086070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123337|NCT03085940|Hydroxychloroquine|hydroxychloroquine|mesh-list
25281389|NCT02331862|Protective Agents|protective agents|mesh-ancestor
25281390|NCT02331862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25281391|NCT02331862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281392|NCT02331927|Aflibercept|aflibercept|mesh-list
25281393|NCT02331927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25281394|NCT02331927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25281396|NCT02331927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281397|NCT02331927|Growth Inhibitors|growth inhibitors|mesh-ancestor
25281398|NCT02331927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281399|NCT02332005|Choline|choline|mesh-list
25281400|NCT02332005|Lipotropic Agents|lipotropic agents|mesh-ancestor
25281401|NCT02332005|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25281402|NCT02332005|Antimetabolites|antimetabolites|mesh-ancestor
25281403|NCT02332005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281404|NCT02332005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25281405|NCT02332005|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25281406|NCT02332005|Nootropic Agents|nootropic agents|mesh-ancestor
25281415|NCT02331602|Rivaroxaban|rivaroxaban|mesh-list
25281416|NCT02331602|Dabigatran|dabigatran|mesh-list
25281417|NCT02331602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25281418|NCT02331602|Antithrombins|antithrombins|mesh-ancestor
24963314|NCT03791827|Azathioprine|azathioprine|mesh-list
24963315|NCT03791827|Tacrolimus|tacrolimus|mesh-list
25078830|NCT03353363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078831|NCT03353363|Sensory System Agents|sensory system agents|mesh-ancestor
25078832|NCT03353363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078851|NCT03353103|Listerine|listerine|mesh-list
24789189|NCT01935830|Ritonavir|ritonavir|mesh-list
25281419|NCT02331602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25281420|NCT02331602|Protease Inhibitors|protease inhibitors|mesh-ancestor
25281421|NCT02331602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25281422|NCT02331602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281423|NCT02331602|Anticoagulants|anticoagulants|mesh-ancestor
24531930|NCT00637611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532022|NCT00637871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24532024|NCT00637871|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24532025|NCT00637871|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24532026|NCT00637871|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24532027|NCT00637871|Androgen Antagonists|androgen antagonists|mesh-ancestor
24532028|NCT00637884|Fexofenadine|fexofenadine|mesh-list
24532029|NCT00637884|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24532030|NCT00637884|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24532031|NCT00637884|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24532038|NCT00637897|Docetaxel|docetaxel|mesh-list
24457908|NCT00335647|Fluphenazine depot|fluphenazine depot|mesh-list
24457909|NCT00335647|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
24457910|NCT00335647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24457911|NCT00335647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24532054|NCT00637910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532055|NCT00637949|Rofecoxib|rofecoxib|mesh-list
24532056|NCT00637949|Lumiracoxib|lumiracoxib|mesh-list
24532057|NCT00637949|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24532058|NCT00637949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24532059|NCT00637949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532060|NCT00637949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532061|NCT00637949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24532062|NCT00637949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24706610|NCT01490944|Trace Elements|trace elements|mesh-ancestor
24706613|NCT01490944|Hematinics|hematinics|mesh-ancestor
24706652|NCT01491048|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24706653|NCT01491048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706654|NCT01491048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706655|NCT01491048|Cholinergic Agents|cholinergic agents|mesh-ancestor
24706656|NCT01491048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24706657|NCT01491048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706658|NCT01491048|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24706659|NCT01491048|Autonomic Agents|autonomic agents|mesh-ancestor
25281424|NCT02331576|Fentanyl|fentanyl|mesh-list
25281425|NCT02331576|Ropivacaine|ropivacaine|mesh-list
25281426|NCT02331576|Anesthetics, Local|anesthetics, local|mesh-ancestor
25281427|NCT02331576|Anesthetics|anesthetics|mesh-ancestor
25281428|NCT02331576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25281429|NCT02331576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281430|NCT02331576|Sensory System Agents|sensory system agents|mesh-ancestor
25281431|NCT02331576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25281432|NCT02331576|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25281433|NCT02331576|Narcotics|narcotics|mesh-ancestor
25281434|NCT02331576|Analgesics|analgesics|mesh-ancestor
25281435|NCT02331576|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25281436|NCT02331576|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25281437|NCT02331576|Anesthetics, General|anesthetics, general|mesh-ancestor
25281438|NCT02331511|Aspirin|aspirin|mesh-list
25281439|NCT02331511|Clopidogrel|clopidogrel|mesh-list
25281440|NCT02331511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25281441|NCT02331511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25281442|NCT02331511|Analgesics|analgesics|mesh-ancestor
25281443|NCT02331511|Sensory System Agents|sensory system agents|mesh-ancestor
25692840|NCT02005601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25692841|NCT02005601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25692842|NCT02005601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692843|NCT02005601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25692844|NCT02005601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692845|NCT02005601|Analgesics|analgesics|mesh-ancestor
25692846|NCT02005601|Sensory System Agents|sensory system agents|mesh-ancestor
25281444|NCT02331511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25281445|NCT02331511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281446|NCT02331511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25281447|NCT02331511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25281448|NCT02331511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25281449|NCT02331511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25281450|NCT02331511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281451|NCT02331511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25281452|NCT02331511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25281453|NCT02331511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25281454|NCT02331511|Antipyretics|antipyretics|mesh-ancestor
25281455|NCT02331511|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24532063|NCT00637949|Analgesics|analgesics|mesh-ancestor
24532414|NCT00639873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24532416|NCT00639873|Analgesics|analgesics|mesh-ancestor
24532417|NCT00639873|Sensory System Agents|sensory system agents|mesh-ancestor
24532418|NCT00639925|Gemcitabine|gemcitabine|mesh-list
24532419|NCT00639925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24532420|NCT00639925|Antimetabolites|antimetabolites|mesh-ancestor
24532421|NCT00639925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532422|NCT00639925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24532423|NCT00639925|Antiviral Agents|antiviral agents|mesh-ancestor
24532424|NCT00639925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24532425|NCT00639925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532426|NCT00639925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24532427|NCT00639925|Immunologic Factors|immunologic factors|mesh-ancestor
24394232|NCT00132613|Bleomycin|bleomycin|mesh-list
25123345|NCT03086148|Ketamine|ketamine|mesh-list
25123497|NCT03084250|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25123498|NCT03084250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25123499|NCT03084250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123500|NCT03084250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123501|NCT03084250|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25123502|NCT03084250|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25123503|NCT03084419|Abatacept|abatacept|mesh-list
25123504|NCT03084419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25123505|NCT03084419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123506|NCT03084419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123507|NCT03084419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25123508|NCT03084419|Immunologic Factors|immunologic factors|mesh-ancestor
25123509|NCT03084419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123510|NCT03084419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25123511|NCT03084328|Vitamin D|vitamin d|mesh-list
25123512|NCT03084328|Vitamins|vitamins|mesh-ancestor
25123513|NCT03084328|Micronutrients|micronutrients|mesh-ancestor
25123514|NCT03084328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123515|NCT03084328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25281456|NCT02331511|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25281457|NCT02331511|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25281458|NCT02331511|Purinergic Agents|purinergic agents|mesh-ancestor
25281459|NCT02331511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25281460|NCT02331563|Dexmedetomidine|dexmedetomidine|mesh-list
25281461|NCT02331563|Bupivacaine|bupivacaine|mesh-list
25281462|NCT02331563|Anesthetics, Local|anesthetics, local|mesh-ancestor
25281463|NCT02331563|Anesthetics|anesthetics|mesh-ancestor
25281464|NCT02331563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25281465|NCT02331563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281466|NCT02331563|Sensory System Agents|sensory system agents|mesh-ancestor
25281467|NCT02331563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25281468|NCT02331563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25281469|NCT02331563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25281470|NCT02331563|Analgesics|analgesics|mesh-ancestor
25281471|NCT02331563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25281472|NCT02331563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25281473|NCT02331563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25281474|NCT02331563|Adrenergic Agents|adrenergic agents|mesh-ancestor
25281475|NCT02331563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25281476|NCT02331563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017388|NCT01267812|Rituximab|rituximab|mesh-list
25281477|NCT02331303|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25281478|NCT02331303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281479|NCT02330952|Prednisone|prednisone|mesh-list
25281480|NCT02330952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25281481|NCT02330952|Glucocorticoids|glucocorticoids|mesh-ancestor
25281482|NCT02330952|Hormones|hormones|mesh-ancestor
25281484|NCT02330952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281485|NCT02330952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25281486|NCT02330952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281487|NCT02330991|Temozolomide|temozolomide|mesh-list
25281488|NCT02330991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25281489|NCT02330991|Alkylating Agents|alkylating agents|mesh-ancestor
25281490|NCT02330991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281491|NCT02330991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281492|NCT02331173|Dorzolamide|dorzolamide|mesh-list
25281493|NCT02331173|Brinzolamide|brinzolamide|mesh-list
25281494|NCT02331173|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25123521|NCT03084380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25123522|NCT03084380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25123523|NCT03084380|Alkylating Agents|alkylating agents|mesh-ancestor
25123524|NCT03084380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123525|NCT03084380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123526|NCT03084380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25123527|NCT03084601|Calcium|calcium|mesh-list
25123528|NCT03084601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25123529|NCT03084601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457923|NCT00335673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532643|NCT00640679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532644|NCT00640679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123530|NCT03084029|Oxytocin|oxytocin|mesh-list
25045720|NCT00924833|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25123680|NCT03082352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25123681|NCT03082352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25123682|NCT03082352|Sympatholytics|sympatholytics|mesh-ancestor
25123683|NCT03082352|Autonomic Agents|autonomic agents|mesh-ancestor
25123684|NCT03082352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25123685|NCT03082352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123686|NCT03082352|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25123687|NCT03082352|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25123688|NCT03082352|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25123689|NCT03082352|Adrenergic Agents|adrenergic agents|mesh-ancestor
25123690|NCT03082352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25123691|NCT03082352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532716|NCT00640887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24532718|NCT00640887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532781|NCT00641082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24532782|NCT00641082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24532783|NCT00641082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25108295|NCT03133299|Vitamin D|vitamin d|mesh-list
25281495|NCT02331173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25281496|NCT02331173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281497|NCT02331173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25281498|NCT02331030|Ropivacaine|ropivacaine|mesh-list
25281499|NCT02331030|Anesthetics, Local|anesthetics, local|mesh-ancestor
25281500|NCT02331030|Anesthetics|anesthetics|mesh-ancestor
25281501|NCT02331030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25281502|NCT02331030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017549|NCT00413764|Norethindrone|norethindrone|mesh-list
25281503|NCT02331030|Sensory System Agents|sensory system agents|mesh-ancestor
25281504|NCT02331030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25281505|NCT02331251|Gemcitabine|gemcitabine|mesh-list
25281506|NCT02331251|Paclitaxel|paclitaxel|mesh-list
25281507|NCT02331251|Vinorelbine|vinorelbine|mesh-list
25281508|NCT02331251|Docetaxel|docetaxel|mesh-list
25281509|NCT02331251|Doxorubicin|doxorubicin|mesh-list
25281510|NCT02331251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25281511|NCT02331251|Pembrolizumab|pembrolizumab|mesh-list
25281512|NCT02331251|Irinotecan|irinotecan|mesh-list
25281513|NCT02331251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25281514|NCT02331251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281515|NCT02331251|Tubulin Modulators|tubulin modulators|mesh-ancestor
25281516|NCT02331251|Antimitotic Agents|antimitotic agents|mesh-ancestor
25281517|NCT02331251|Mitosis Modulators|mitosis modulators|mesh-ancestor
25281518|NCT02331251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281519|NCT02331251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25281520|NCT02331251|Antimetabolites|antimetabolites|mesh-ancestor
25281521|NCT02331251|Antiviral Agents|antiviral agents|mesh-ancestor
25281525|NCT02331251|Immunologic Factors|immunologic factors|mesh-ancestor
25281526|NCT02331251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281527|NCT02331251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25281528|NCT02331251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25281529|NCT02331251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25281530|NCT02331251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25281531|NCT02331251|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25281532|NCT02330757|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24532991|NCT00641927|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24815059|NCT02068170|Immunologic Factors|immunologic factors|mesh-ancestor
24532992|NCT00641927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24532993|NCT00641927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24532994|NCT00641927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24532995|NCT00641927|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24532997|NCT00641979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24532998|NCT00641979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24533016|NCT00642096|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24533017|NCT00642096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24533018|NCT00642096|Diuretics|diuretics|mesh-ancestor
24533019|NCT00642096|Natriuretic Agents|natriuretic agents|mesh-ancestor
24533020|NCT00642096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533021|NCT00642096|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24533060|NCT00642135|Adrenergic Agents|adrenergic agents|mesh-ancestor
24533061|NCT00642135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24533123|NCT00642408|Micronutrients|micronutrients|mesh-list
24533124|NCT00642408|Trace Elements|trace elements|mesh-list
24533125|NCT00642408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533127|NCT00642421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24533128|NCT00642421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24533129|NCT00642421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24533130|NCT00642434|Metoprolol|metoprolol|mesh-list
24533131|NCT00642434|Carvedilol|carvedilol|mesh-list
24533132|NCT00642434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24533133|NCT00642434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24533134|NCT00642434|Sympatholytics|sympatholytics|mesh-ancestor
24533135|NCT00642434|Autonomic Agents|autonomic agents|mesh-ancestor
24533136|NCT00642434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24533137|NCT00642434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533138|NCT00642434|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24706660|NCT01491048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24706661|NCT01491048|Nootropic Agents|nootropic agents|mesh-ancestor
24706662|NCT01491061|Ranolazine|ranolazine|mesh-list
24706663|NCT01491061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24706664|NCT01491061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24706665|NCT01491061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706666|NCT01491100|Interferons|interferons|mesh-list
25281533|NCT02330757|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25281534|NCT02330757|Clomiphene|clomiphene|mesh-list
25281535|NCT02330757|Enclomiphene|enclomiphene|mesh-list
25281536|NCT02330757|Zuclomiphene|zuclomiphene|mesh-list
25281537|NCT02330757|Estradiol|estradiol|mesh-list
25281538|NCT02330757|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25281539|NCT02330757|Estrogens|estrogens|mesh-ancestor
25281540|NCT02330757|Hormones|hormones|mesh-ancestor
25281541|NCT02330757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25281542|NCT02330757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281543|NCT02330757|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25281544|NCT02330757|Contraceptive Agents|contraceptive agents|mesh-ancestor
25281545|NCT02330757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25281546|NCT02330757|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25281547|NCT02330757|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25281548|NCT02330757|Hormone Antagonists|hormone antagonists|mesh-ancestor
25281549|NCT02330757|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25281550|NCT02330757|Fertility Agents|fertility agents|mesh-ancestor
25281551|NCT02330757|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25281552|NCT02330757|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25281553|NCT02330796|Bucillamine|bucillamine|mesh-list
25281554|NCT02330796|Colchicine|colchicine|mesh-list
25281555|NCT02330796|Gout Suppressants|gout suppressants|mesh-ancestor
25281556|NCT02330796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25281557|NCT02330796|Tubulin Modulators|tubulin modulators|mesh-ancestor
25281558|NCT02330796|Antimitotic Agents|antimitotic agents|mesh-ancestor
25281559|NCT02330796|Mitosis Modulators|mitosis modulators|mesh-ancestor
25281560|NCT02330796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281561|NCT02330796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281562|NCT02330796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25281563|NCT02330796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25281564|NCT02330796|Analgesics|analgesics|mesh-ancestor
25281565|NCT02330796|Sensory System Agents|sensory system agents|mesh-ancestor
25281566|NCT02330796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25123765|NCT03081494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24963962|NCT03787147|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25123842|NCT03081416|Analgesics|analgesics|mesh-ancestor
24420543|NCT00216281|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25123914|NCT03080740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123916|NCT03080766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25123917|NCT03080766|Antimetabolites|antimetabolites|mesh-ancestor
25123918|NCT03080766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123919|NCT03080766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123920|NCT03080766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787848|NCT01927913|Deferasirox|deferasirox|mesh-list
24533143|NCT00642434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533144|NCT00642434|Antioxidants|antioxidants|mesh-ancestor
24533145|NCT00642434|Protective Agents|protective agents|mesh-ancestor
24533146|NCT00642434|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24533151|NCT00642434|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24533152|NCT00642499|Dronabinol|dronabinol|mesh-list
24533153|NCT00642499|Hallucinogens|hallucinogens|mesh-ancestor
24533154|NCT00642499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457926|NCT00335686|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24533207|NCT00642577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24533209|NCT00642577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24706667|NCT01491100|Interferon-beta|interferon-beta|mesh-list
24706668|NCT01491100|Interferon beta-1b|interferon beta-1b|mesh-list
24706669|NCT01491100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706670|NCT01491100|Antiviral Agents|antiviral agents|mesh-ancestor
24706671|NCT01491100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24706672|NCT01491100|Immunologic Factors|immunologic factors|mesh-ancestor
24706673|NCT01491100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706674|NCT01491100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24706675|NCT01491139|Olaparib|olaparib|mesh-list
24706676|NCT01491139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613691|NCT01020331|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24613698|NCT01020357|Caffeine|caffeine|mesh-list
24613736|NCT01020630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24613737|NCT01020630|Growth Substances|growth substances|mesh-ancestor
24613738|NCT01020630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613739|NCT01020630|Growth Inhibitors|growth inhibitors|mesh-ancestor
24613740|NCT01020630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24613741|NCT01020630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613745|NCT01020643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25281567|NCT02330796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281568|NCT02330796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25281569|NCT02330796|Antioxidants|antioxidants|mesh-ancestor
25281570|NCT02330796|Protective Agents|protective agents|mesh-ancestor
25281571|NCT02330705|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25281572|NCT02330705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25281573|NCT02330705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281574|NCT02330770|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25281575|NCT02330770|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25281576|NCT02330770|Luteolytic Agents|luteolytic agents|mesh-ancestor
25281577|NCT02330770|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25281578|NCT02330770|Contraceptive Agents|contraceptive agents|mesh-ancestor
25281579|NCT02330770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25281580|NCT02330770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281581|NCT02330770|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25281582|NCT02330770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25281583|NCT02330770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281584|NCT02330614|Carbamide Peroxide|carbamide peroxide|mesh-list
25281585|NCT02330614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25281586|NCT02330614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25281587|NCT02330640|Clopidogrel|clopidogrel|mesh-list
25281588|NCT02330640|Ticagrelor|ticagrelor|mesh-list
25281589|NCT02330640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25281590|NCT02330640|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25281591|NCT02330640|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24533210|NCT00642577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24533211|NCT00642577|Growth Substances|growth substances|mesh-ancestor
24533212|NCT00642577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533213|NCT00642577|Growth Inhibitors|growth inhibitors|mesh-ancestor
24533214|NCT00642577|Antimetabolites|antimetabolites|mesh-ancestor
24533215|NCT00642577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533216|NCT00642577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25692847|NCT02005601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24533217|NCT00642577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24533218|NCT00642577|Immunologic Factors|immunologic factors|mesh-ancestor
24533219|NCT00642577|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24533220|NCT00642577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24533221|NCT00642577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533222|NCT00642577|Antidotes|antidotes|mesh-ancestor
24533223|NCT00642577|Protective Agents|protective agents|mesh-ancestor
24533224|NCT00642577|Vitamin B Complex|vitamin b complex|mesh-ancestor
24533226|NCT00642577|Micronutrients|micronutrients|mesh-ancestor
24837664|NCT02192697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613746|NCT01020643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706698|NCT01491204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24706699|NCT01491204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706700|NCT01491204|Tubulin Modulators|tubulin modulators|mesh-ancestor
24706701|NCT01491204|Antimitotic Agents|antimitotic agents|mesh-ancestor
24706702|NCT01491204|Mitosis Modulators|mitosis modulators|mesh-ancestor
24706703|NCT01491204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706704|NCT01491217|Paclitaxel|paclitaxel|mesh-list
24706705|NCT01491217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24706706|NCT01491217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706707|NCT01491217|Tubulin Modulators|tubulin modulators|mesh-ancestor
24706708|NCT01491217|Antimitotic Agents|antimitotic agents|mesh-ancestor
24706709|NCT01491217|Mitosis Modulators|mitosis modulators|mesh-ancestor
24706711|NCT01491256|Atorvastatin|atorvastatin|mesh-list
24706727|NCT01491295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706728|NCT01491295|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24706729|NCT01491295|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24706730|NCT01491321|Loxoprofen|loxoprofen|mesh-list
24706731|NCT01491321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24706732|NCT01491321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24706733|NCT01491321|Analgesics|analgesics|mesh-ancestor
24706734|NCT01491321|Sensory System Agents|sensory system agents|mesh-ancestor
24706735|NCT01491321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24706750|NCT01491503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24706752|NCT01491503|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24706753|NCT01491503|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24706754|NCT01491503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706755|NCT01491503|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24706756|NCT01491503|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24706757|NCT01491503|Histamine Antagonists|histamine antagonists|mesh-ancestor
24706758|NCT01491503|Histamine Agents|histamine agents|mesh-ancestor
24706769|NCT01492114|Resveratrol|resveratrol|mesh-list
24706770|NCT01492114|Antioxidants|antioxidants|mesh-ancestor
24706771|NCT01492114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706772|NCT01492114|Protective Agents|protective agents|mesh-ancestor
24706773|NCT01492114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706774|NCT01492114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25281592|NCT02330640|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25281593|NCT02330640|Purinergic Agents|purinergic agents|mesh-ancestor
25281594|NCT02330640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25281595|NCT02330640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281596|NCT02330640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281597|NCT02330822|Hyaluronic Acid|hyaluronic acid|mesh-list
25281598|NCT02330822|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25281599|NCT02330822|Immunologic Factors|immunologic factors|mesh-ancestor
25281600|NCT02330822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281601|NCT02330822|Viscosupplements|viscosupplements|mesh-ancestor
25281602|NCT02330822|Protective Agents|protective agents|mesh-ancestor
25281603|NCT02330783|Bevacizumab|bevacizumab|mesh-list
25281604|NCT02330783|Sorafenib|sorafenib|mesh-list
25281605|NCT02330783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25281606|NCT02330783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281607|NCT02330783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25281608|NCT02330783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24533228|NCT00642655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25124164|NCT03079271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124144|NCT03079219|Antipruritics|antipruritics|mesh-ancestor
25281609|NCT02330783|Growth Substances|growth substances|mesh-ancestor
25281610|NCT02330783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281611|NCT02330783|Growth Inhibitors|growth inhibitors|mesh-ancestor
25281612|NCT02330783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25281613|NCT02330783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25281614|NCT02330783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281615|NCT02330367|Abivertinib|abivertinib|mesh-list
25281616|NCT02330367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25281617|NCT02330367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25281618|NCT02330367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281619|NCT02330679|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25281620|NCT02330679|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25281621|NCT02330679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25281622|NCT02330679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25281623|NCT02330679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281624|NCT02330679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25281625|NCT02330679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281626|NCT02330679|Antidepressive Agents|antidepressive agents|mesh-ancestor
25281627|NCT02330679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25281628|NCT02330380|Adalimumab|adalimumab|mesh-list
25281629|NCT02330380|Etanercept|etanercept|mesh-list
25281630|NCT02330380|Methotrexate|methotrexate|mesh-list
25281631|NCT02330380|Ustekinumab|ustekinumab|mesh-list
25281632|NCT02330380|Acitretin|acitretin|mesh-list
25281633|NCT02330380|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25281634|NCT02330380|Abortifacient Agents|abortifacient agents|mesh-ancestor
25281635|NCT02330380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25281636|NCT02330380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281637|NCT02330380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25281638|NCT02330380|Antimetabolites|antimetabolites|mesh-ancestor
25281639|NCT02330380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281640|NCT02330380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281641|NCT02330380|Dermatologic Agents|dermatologic agents|mesh-ancestor
25281642|NCT02330380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25281643|NCT02330380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25281644|NCT02330380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25281645|NCT02330380|Immunologic Factors|immunologic factors|mesh-ancestor
25281646|NCT02330380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25281647|NCT02330380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25281687|NCT02330120|Anesthetics|anesthetics|mesh-ancestor
25281648|NCT02330380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25281649|NCT02330380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25281650|NCT02330380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25281651|NCT02330380|Analgesics|analgesics|mesh-ancestor
25124159|NCT03079271|Anesthetics, Local|anesthetics, local|mesh-ancestor
25124160|NCT03079271|Anesthetics|anesthetics|mesh-ancestor
25124161|NCT03079271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25124162|NCT03079271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124163|NCT03079271|Sensory System Agents|sensory system agents|mesh-ancestor
25124165|NCT03078933|Nitric Oxide|nitric oxide|mesh-list
25124166|NCT03078933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25124167|NCT03078933|Autonomic Agents|autonomic agents|mesh-ancestor
25124168|NCT03078933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124169|NCT03078933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124170|NCT03078933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25124171|NCT03078933|Respiratory System Agents|respiratory system agents|mesh-ancestor
25124172|NCT03078933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25124173|NCT03078933|Antioxidants|antioxidants|mesh-ancestor
25124174|NCT03078933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124175|NCT03078933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25124176|NCT03078933|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25124331|NCT03077503|Dexmedetomidine|dexmedetomidine|mesh-list
25124332|NCT03077503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25124333|NCT03077503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25124334|NCT03077503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124335|NCT03077503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25124336|NCT03077503|Analgesics|analgesics|mesh-ancestor
25124337|NCT03077503|Sensory System Agents|sensory system agents|mesh-ancestor
25124338|NCT03077503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124339|NCT03077503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25124340|NCT03077503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25124341|NCT03077503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25124342|NCT03077503|Adrenergic Agents|adrenergic agents|mesh-ancestor
25124343|NCT03077503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25124344|NCT03077503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124345|NCT03077503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25124346|NCT03077503|Narcotics|narcotics|mesh-ancestor
24838211|NCT02196155|Cortisone|cortisone|mesh-list
25281652|NCT02330380|Sensory System Agents|sensory system agents|mesh-ancestor
25281653|NCT02330380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25281654|NCT02330380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25281655|NCT02330380|Keratolytic Agents|keratolytic agents|mesh-ancestor
25281656|NCT02330406|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25281657|NCT02330406|Anagliptin|anagliptin|mesh-list
25281658|NCT02330406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25281659|NCT02330406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281660|NCT02330406|Incretins|incretins|mesh-ancestor
25281661|NCT02330406|Hormones|hormones|mesh-ancestor
25281662|NCT02330406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25281663|NCT02330406|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25281664|NCT02330406|Protease Inhibitors|protease inhibitors|mesh-ancestor
25281665|NCT02330406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25281666|NCT02330406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281667|NCT02330302|Ropivacaine|ropivacaine|mesh-list
25281668|NCT02330302|Anesthetics, Local|anesthetics, local|mesh-ancestor
25281669|NCT02330302|Anesthetics|anesthetics|mesh-ancestor
25281670|NCT02330302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25281671|NCT02330302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281672|NCT02330302|Sensory System Agents|sensory system agents|mesh-ancestor
25281673|NCT02330302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25281674|NCT02330419|Naltrexone|naltrexone|mesh-list
25281675|NCT02330419|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25281676|NCT02330419|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25281677|NCT02330419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281678|NCT02330419|Sensory System Agents|sensory system agents|mesh-ancestor
25281679|NCT02330419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25281680|NCT02330120|Dexmedetomidine|dexmedetomidine|mesh-list
25281681|NCT02330120|Propofol|propofol|mesh-list
25281682|NCT02330120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25281683|NCT02330120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25281684|NCT02330120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281685|NCT02330120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25281686|NCT02330120|Anesthetics, General|anesthetics, general|mesh-ancestor
25281689|NCT02330120|Analgesics|analgesics|mesh-ancestor
25124349|NCT03077503|Anesthetics, General|anesthetics, general|mesh-ancestor
25124350|NCT03077503|Anesthetics|anesthetics|mesh-ancestor
25124456|NCT03076281|Doxycycline|doxycycline|mesh-list
25124676|NCT03073889|Anesthetics|anesthetics|mesh-ancestor
25124677|NCT03073889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25124678|NCT03073889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124679|NCT03073889|Sensory System Agents|sensory system agents|mesh-ancestor
25124680|NCT03073889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24531441|NCT00635856|Gefitinib|gefitinib|mesh-list
25281690|NCT02330120|Sensory System Agents|sensory system agents|mesh-ancestor
25281691|NCT02330120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25281692|NCT02330120|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25281693|NCT02330120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25281695|NCT02330120|Adrenergic Agents|adrenergic agents|mesh-ancestor
25281696|NCT02330120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25281697|NCT02330120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281698|NCT02330029|Pinaverium|pinaverium|mesh-list
25018465|NCT03698916|Celecoxib|celecoxib|mesh-list
25281699|NCT02330029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25281700|NCT02330029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25281701|NCT02330029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281702|NCT02330029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25281703|NCT02330029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281704|NCT02330029|Parasympatholytics|parasympatholytics|mesh-ancestor
25281705|NCT02330029|Autonomic Agents|autonomic agents|mesh-ancestor
25281706|NCT02330029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25281707|NCT02330068|Citalopram|citalopram|mesh-list
25281708|NCT02330068|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25281709|NCT02330068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25281710|NCT02330068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25281711|NCT02330068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281712|NCT02330068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25281713|NCT02330068|Serotonin Agents|serotonin agents|mesh-ancestor
25281714|NCT02330068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281715|NCT02330068|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25281716|NCT02330068|Antidepressive Agents|antidepressive agents|mesh-ancestor
25281717|NCT02330068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25281718|NCT02329860|Apatinib|apatinib|mesh-list
25281719|NCT02329860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281720|NCT02329860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25281721|NCT02329860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25281722|NCT02329860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281723|NCT02329795|Temozolomide|temozolomide|mesh-list
25281724|NCT02329795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25281725|NCT02329795|Alkylating Agents|alkylating agents|mesh-ancestor
25281790|NCT02329132|Ranibizumab|ranibizumab|mesh-list
24964535|NCT03782662|Antitubercular Agents|antitubercular agents|mesh-ancestor
24964536|NCT03782662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24964537|NCT03782662|Leprostatic Agents|leprostatic agents|mesh-ancestor
24964538|NCT03782662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24964539|NCT03782662|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24786283|NCT01918917|Morphine|morphine|mesh-list
25018601|NCT03698474|Anticonvulsants|anticonvulsants|mesh-ancestor
24706775|NCT01492114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24706776|NCT01492153|Insulin|insulin|mesh-list
24706777|NCT01492153|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24706778|NCT01492153|Isophane Insulin, Human|isophane insulin, human|mesh-list
24706779|NCT01492153|Insulin, Isophane|insulin, isophane|mesh-list
24706780|NCT01492153|Isophane insulin, beef|isophane insulin, beef|mesh-list
24706781|NCT01492153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24706782|NCT01492153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706783|NCT01492166|Insulin|insulin|mesh-list
24706784|NCT01492166|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24706785|NCT01492166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24706786|NCT01492166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706787|NCT01492179|Lidocaine|lidocaine|mesh-list
24706788|NCT01492179|Anesthetics, Local|anesthetics, local|mesh-ancestor
24706789|NCT01492179|Anesthetics|anesthetics|mesh-ancestor
24706790|NCT01492179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24706791|NCT01492179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706792|NCT01492179|Sensory System Agents|sensory system agents|mesh-ancestor
24706793|NCT01492179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25281726|NCT02329795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281727|NCT02329795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25124756|NCT03073018|Protease Inhibitors|protease inhibitors|mesh-ancestor
25124831|NCT03072264|Serotonin Agents|serotonin agents|mesh-ancestor
25124972|NCT03072121|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25124973|NCT03072121|Diuretics|diuretics|mesh-ancestor
25124974|NCT03072121|Natriuretic Agents|natriuretic agents|mesh-ancestor
25124975|NCT03072121|Vasodilator Agents|vasodilator agents|mesh-ancestor
25124976|NCT03072121|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25124977|NCT03072173|Xylometazoline|xylometazoline|mesh-list
25124978|NCT03072173|Nasal Decongestants|nasal decongestants|mesh-ancestor
25124979|NCT03072173|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25124980|NCT03072173|Respiratory System Agents|respiratory system agents|mesh-ancestor
25124982|NCT03072199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25124983|NCT03072199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25124984|NCT03072199|Immunologic Factors|immunologic factors|mesh-ancestor
24786301|NCT01918917|Anesthetics|anesthetics|mesh-ancestor
24706813|NCT01492543|Tegafur|tegafur|mesh-list
24706814|NCT01492543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24706815|NCT01492543|Antimetabolites|antimetabolites|mesh-ancestor
24706816|NCT01492543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706817|NCT01492543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706818|NCT01492556|Etoposide|etoposide|mesh-list
24706819|NCT01492556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24706820|NCT01492556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706821|NCT01492556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24706822|NCT01492556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24706823|NCT01492556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706857|NCT01492725|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25281830|NCT02328729|Sympathomimetics|sympathomimetics|mesh-ancestor
25692848|NCT02005601|Antidepressive Agents|antidepressive agents|mesh-ancestor
25692849|NCT02005601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25692850|NCT02005601|Dopamine Agents|dopamine agents|mesh-ancestor
25692851|NCT02005627|Immunologic Factors|immunologic factors|mesh-list
25692852|NCT02005627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692853|NCT02005666|Clindamycin|clindamycin|mesh-list
25692854|NCT02005666|Clindamycin palmitate|clindamycin palmitate|mesh-list
24964649|NCT03781544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24964650|NCT03781544|Analgesics|analgesics|mesh-ancestor
24964651|NCT03781544|Sensory System Agents|sensory system agents|mesh-ancestor
24964654|NCT03781544|Antipyretics|antipyretics|mesh-ancestor
24964682|NCT03781700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964684|NCT03781700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706858|NCT01492725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24706859|NCT01492725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24706860|NCT01492725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706861|NCT01492881|Doxorubicin|doxorubicin|mesh-list
24706862|NCT01492881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24706863|NCT01492881|Bortezomib|bortezomib|mesh-list
24706909|NCT01492972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706911|NCT01492972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24706912|NCT01492972|Luteolytic Agents|luteolytic agents|mesh-ancestor
24706913|NCT01492972|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24706914|NCT01492972|Contraceptive Agents|contraceptive agents|mesh-ancestor
24706915|NCT01492972|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24706916|NCT01492985|Vaccines|vaccines|mesh-list
24706917|NCT01492985|Immunologic Factors|immunologic factors|mesh-ancestor
25281728|NCT02329561|Tramadol|tramadol|mesh-list
25281729|NCT02329561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25281730|NCT02329561|Narcotics|narcotics|mesh-ancestor
25281731|NCT02329561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25281732|NCT02329561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281733|NCT02329561|Analgesics|analgesics|mesh-ancestor
25281734|NCT02329561|Sensory System Agents|sensory system agents|mesh-ancestor
25281735|NCT02329561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25281736|NCT02329626|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25281737|NCT02329626|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25281738|NCT02329626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281739|NCT02329756|Tranexamic Acid|tranexamic acid|mesh-list
25281740|NCT02329756|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25281741|NCT02329756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25281742|NCT02329756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281743|NCT02329756|Hemostatics|hemostatics|mesh-ancestor
25281744|NCT02329756|Coagulants|coagulants|mesh-ancestor
25281745|NCT02329535|Progesterone|progesterone|mesh-list
25281746|NCT02329535|Progestins|progestins|mesh-ancestor
25281747|NCT02329535|Hormones|hormones|mesh-ancestor
24706918|NCT01492985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706919|NCT01493050|Calcium Carbonate|calcium carbonate|mesh-list
24706920|NCT01493050|Calcium|calcium|mesh-list
24706921|NCT01493050|Sevelamer|sevelamer|mesh-list
25692855|NCT02005666|Clindamycin phosphate|clindamycin phosphate|mesh-list
25692856|NCT02005666|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25692857|NCT02005666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25692858|NCT02005666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25692859|NCT02005666|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25692860|NCT02005666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692861|NCT02005666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692862|NCT02005666|Dermatologic Agents|dermatologic agents|mesh-ancestor
25078953|NCT03352115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706922|NCT01493050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24706923|NCT01493050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706924|NCT01493050|Antacids|antacids|mesh-ancestor
25281748|NCT02329535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25281750|NCT02329405|Rifampin|rifampin|mesh-list
25281751|NCT02329405|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25281752|NCT02329405|Antitubercular Agents|antitubercular agents|mesh-ancestor
25281753|NCT02329405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25281754|NCT02329405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25281755|NCT02329405|Leprostatic Agents|leprostatic agents|mesh-ancestor
25281756|NCT02329405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25281757|NCT02329405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25281758|NCT02329405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281759|NCT02329405|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25281760|NCT02329405|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25281761|NCT02329405|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25281762|NCT02329405|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25281763|NCT02329405|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25281764|NCT02329405|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25281765|NCT02329288|Triamcinolone|triamcinolone|mesh-list
25281766|NCT02329288|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25281767|NCT02329288|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25281768|NCT02329288|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25281769|NCT02329288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25281770|NCT02329288|Glucocorticoids|glucocorticoids|mesh-ancestor
25281771|NCT02329288|Hormones|hormones|mesh-ancestor
25281772|NCT02329288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25281773|NCT02329288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281774|NCT02329288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25281775|NCT02329288|Immunologic Factors|immunologic factors|mesh-ancestor
24433807|NCT00260026|Docetaxel|docetaxel|mesh-list
25125137|NCT03070925|Anti-Infective Agents|anti-infective agents|mesh-list
25125209|NCT03070509|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25125210|NCT03070509|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25125211|NCT03070509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125212|NCT03070509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25125213|NCT03070509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25125214|NCT03070509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24586951|NCT00892892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25125215|NCT03070509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125216|NCT03070509|Dopamine Agents|dopamine agents|mesh-ancestor
25125217|NCT03070509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25125218|NCT03070379|Lidocaine|lidocaine|mesh-list
25281776|NCT02329288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25281777|NCT02329288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281778|NCT02329054|Favipiravir|favipiravir|mesh-list
25281779|NCT02329054|Antiviral Agents|antiviral agents|mesh-ancestor
25692863|NCT02005887|Letrozole|letrozole|mesh-list
25692864|NCT02005887|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24964882|NCT03779789|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24964887|NCT03779789|Serotonin Agents|serotonin agents|mesh-ancestor
25281780|NCT02329054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25281781|NCT02329197|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25281782|NCT02329197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25281783|NCT02329197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281784|NCT02329171|Imiquimod|imiquimod|mesh-list
25281785|NCT02329171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25281786|NCT02329171|Immunologic Factors|immunologic factors|mesh-ancestor
25281787|NCT02329171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281788|NCT02329171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281789|NCT02329171|Interferon Inducers|interferon inducers|mesh-ancestor
25281799|NCT02328950|Busulfan|busulfan|mesh-list
25281800|NCT02328950|Fludarabine|fludarabine|mesh-list
25281801|NCT02328950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25281802|NCT02328950|Immunologic Factors|immunologic factors|mesh-ancestor
25281803|NCT02328950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281804|NCT02328950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25281805|NCT02328950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25281806|NCT02328950|Alkylating Agents|alkylating agents|mesh-ancestor
25281807|NCT02328950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281808|NCT02328950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281809|NCT02328950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25281810|NCT02328950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25281811|NCT02328950|Antimetabolites|antimetabolites|mesh-ancestor
25281812|NCT02328950|Antiviral Agents|antiviral agents|mesh-ancestor
25281813|NCT02328950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25281814|NCT02328729|Epinephrine|epinephrine|mesh-list
25281815|NCT02328729|Racepinephrine|racepinephrine|mesh-list
25281816|NCT02328729|Epinephryl borate|epinephryl borate|mesh-list
25281817|NCT02328729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25281818|NCT02328729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25281819|NCT02328729|Adrenergic Agents|adrenergic agents|mesh-ancestor
25281820|NCT02328729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25125460|NCT03068533|Calcium Carbonate|calcium carbonate|mesh-list
25125461|NCT03068533|Calcium|calcium|mesh-list
25125462|NCT03068533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25125463|NCT03068533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125464|NCT03068533|Antacids|antacids|mesh-ancestor
25125465|NCT03068533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125466|NCT03068533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25125467|NCT03068442|Flutemetamol|flutemetamol|mesh-list
25125468|NCT03068442|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25125469|NCT03068442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125470|NCT03068429|Sertraline|sertraline|mesh-list
25125471|NCT03068429|Antidepressive Agents|antidepressive agents|mesh-ancestor
25125472|NCT03068429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25125473|NCT03068429|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25125474|NCT03068429|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25125475|NCT03068429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25125476|NCT03068429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125477|NCT03068429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25125478|NCT03068429|Serotonin Agents|serotonin agents|mesh-ancestor
25125480|NCT03068351|Daratumumab|daratumumab|mesh-list
25125589|NCT03067896|Tocolytic Agents|tocolytic agents|mesh-ancestor
25125734|NCT03066635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25125735|NCT03066635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125958|NCT03065569|Bupivacaine|bupivacaine|mesh-list
25125959|NCT03065569|Anesthetics, Local|anesthetics, local|mesh-ancestor
25125960|NCT03065569|Anesthetics|anesthetics|mesh-ancestor
25281872|NCT02328469|Antimalarials|antimalarials|mesh-ancestor
25125961|NCT03065569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25125962|NCT03065569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281821|NCT02328729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281822|NCT02328729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281823|NCT02328729|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25281824|NCT02328729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25281825|NCT02328729|Autonomic Agents|autonomic agents|mesh-ancestor
25281826|NCT02328729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25281827|NCT02328729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25281828|NCT02328729|Respiratory System Agents|respiratory system agents|mesh-ancestor
25281829|NCT02328729|Mydriatics|mydriatics|mesh-ancestor
25692865|NCT02005887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281831|NCT02328729|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25281832|NCT02328963|Mycophenolic Acid|mycophenolic acid|mesh-list
25692866|NCT02005887|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24964974|NCT03779672|Memantine|memantine|mesh-list
24964975|NCT03779672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24964976|NCT03779672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24964977|NCT03779672|Dopamine Agents|dopamine agents|mesh-ancestor
24964978|NCT03779672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24964979|NCT03779672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768478|NCT01808521|Acetylcysteine|acetylcysteine|mesh-list
24768553|NCT01809041|Remifentanil|remifentanil|mesh-list
24768697|NCT01810185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24964980|NCT03779672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281833|NCT02328963|Everolimus|everolimus|mesh-list
25281834|NCT02328963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281835|NCT02328963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25281836|NCT02328963|Immunologic Factors|immunologic factors|mesh-ancestor
25281837|NCT02328963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281838|NCT02328963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25281839|NCT02328963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25281840|NCT02328963|Antitubercular Agents|antitubercular agents|mesh-ancestor
25281841|NCT02328963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25281842|NCT02328963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25281843|NCT02328963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25281844|NCT02328963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281845|NCT02328794|Varenicline|varenicline|mesh-list
25281846|NCT02328794|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25281847|NCT02328794|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25281848|NCT02328794|Cholinergic Agents|cholinergic agents|mesh-ancestor
25281849|NCT02328794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25281850|NCT02328794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281851|NCT02328794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281852|NCT02328716|Cisplatin|cisplatin|mesh-list
25281853|NCT02328716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281854|NCT02328651|Ribavirin|ribavirin|mesh-list
25281855|NCT02328651|Antimetabolites|antimetabolites|mesh-ancestor
25281856|NCT02328651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281857|NCT02328651|Antiviral Agents|antiviral agents|mesh-ancestor
25281858|NCT02328651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25125974|NCT03065660|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25125975|NCT03065660|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25125976|NCT03065660|Hormone Antagonists|hormone antagonists|mesh-ancestor
25125977|NCT03065660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25125978|NCT03065660|Luteolytic Agents|luteolytic agents|mesh-ancestor
25125979|NCT03065660|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25126286|NCT03063489|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25126287|NCT03063489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25126289|NCT03063307|Cariostatic Agents|cariostatic agents|mesh-ancestor
25126290|NCT03063307|Protective Agents|protective agents|mesh-ancestor
25126291|NCT03063307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126292|NCT03063359|Fentanyl|fentanyl|mesh-list
25126293|NCT03063359|Morphine|morphine|mesh-list
25126294|NCT03063359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25126295|NCT03063359|Narcotics|narcotics|mesh-ancestor
25126296|NCT03063359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25126297|NCT03063359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126298|NCT03063359|Analgesics|analgesics|mesh-ancestor
25126299|NCT03063359|Sensory System Agents|sensory system agents|mesh-ancestor
25126300|NCT03063359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25126301|NCT03063359|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25126302|NCT03063359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24839469|NCT02204527|Micronutrients|micronutrients|mesh-ancestor
25281859|NCT02328521|Nicorandil|nicorandil|mesh-list
25281860|NCT02328521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25281861|NCT02328521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25281862|NCT02328521|Vasodilator Agents|vasodilator agents|mesh-ancestor
25692867|NCT02005887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25692868|NCT02005887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692869|NCT02005887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692870|NCT02005887|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25692871|NCT02005887|Hormone Antagonists|hormone antagonists|mesh-ancestor
25692872|NCT02005887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25692873|NCT02005887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692874|NCT02005887|Luteolytic Agents|luteolytic agents|mesh-ancestor
25692875|NCT02005887|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25281863|NCT02328521|Vitamin B Complex|vitamin b complex|mesh-ancestor
25281864|NCT02328521|Vitamins|vitamins|mesh-ancestor
25281865|NCT02328521|Micronutrients|micronutrients|mesh-ancestor
25281866|NCT02328521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281867|NCT02328469|Doxycycline|doxycycline|mesh-list
25281868|NCT02328469|Ceftriaxone|ceftriaxone|mesh-list
25281869|NCT02328469|Acyclovir|acyclovir|mesh-list
25281870|NCT02328469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25281871|NCT02328469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25281879|NCT02328495|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25281880|NCT02328495|Abortifacient Agents|abortifacient agents|mesh-ancestor
25281881|NCT02328495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25281882|NCT02328495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281883|NCT02328495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25281884|NCT02328495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25281885|NCT02328495|Oxytocics|oxytocics|mesh-ancestor
25281886|NCT02328183|Polymyxins|polymyxins|mesh-list
25281887|NCT02328183|Polymyxin B|polymyxin b|mesh-list
25281888|NCT02328183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25281889|NCT02328183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25281890|NCT02328053|Voriconazole|voriconazole|mesh-list
25281891|NCT02328053|Natamycin|natamycin|mesh-list
25281892|NCT02328053|Antifungal Agents|antifungal agents|mesh-list
25281893|NCT02328053|Clotrimazole|clotrimazole|mesh-list
25281894|NCT02328053|Miconazole|miconazole|mesh-list
25126304|NCT03063359|Anesthetics|anesthetics|mesh-ancestor
25126305|NCT03063190|Vitamin D|vitamin d|mesh-list
25126306|NCT03063190|Vitamins|vitamins|mesh-ancestor
25126307|NCT03063190|Micronutrients|micronutrients|mesh-ancestor
25126308|NCT03063190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126309|NCT03063190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25126310|NCT03063242|Sargramostim|sargramostim|mesh-list
25126311|NCT03063242|Immunologic Factors|immunologic factors|mesh-ancestor
25126312|NCT03063242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126318|NCT03062839|Melatonin|melatonin|mesh-list
25126319|NCT03062839|Antioxidants|antioxidants|mesh-ancestor
25126320|NCT03062839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25126321|NCT03062839|Protective Agents|protective agents|mesh-ancestor
25126322|NCT03062839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126323|NCT03062839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24792151|NCT05411887|Olmesartan|olmesartan|mesh-list
25126401|NCT03063112|Ethanol|ethanol|mesh-list
25126550|NCT03061604|Coagulants|coagulants|mesh-ancestor
25126551|NCT03061565|Epoetin Alfa|epoetin alfa|mesh-list
25126552|NCT03061565|Hematinics|hematinics|mesh-ancestor
24706930|NCT01493102|Arginine Vasopressin|arginine vasopressin|mesh-list
24706932|NCT01493102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24706933|NCT01493102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24706934|NCT01493102|Adrenergic Agents|adrenergic agents|mesh-ancestor
25281895|NCT02328053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25281896|NCT02328053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25281897|NCT02328053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25281898|NCT02328053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25281899|NCT02328053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281900|NCT02328053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25281901|NCT02328053|Hormone Antagonists|hormone antagonists|mesh-ancestor
25281902|NCT02328053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25281903|NCT02328053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281904|NCT02328053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25281905|NCT02328053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25281906|NCT02328053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25281907|NCT02328053|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25281908|NCT02328079|Acyclovir|acyclovir|mesh-list
25281909|NCT02328079|Antiviral Agents|antiviral agents|mesh-list
25281910|NCT02328079|Prednisolone|prednisolone|mesh-list
25281911|NCT02328079|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25281912|NCT02328079|Methylprednisolone|methylprednisolone|mesh-list
25281913|NCT02328079|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25281914|NCT02328079|Prednisolone acetate|prednisolone acetate|mesh-list
25281915|NCT02328079|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25281917|NCT02328079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25281918|NCT02328079|Glucocorticoids|glucocorticoids|mesh-ancestor
25281919|NCT02328079|Hormones|hormones|mesh-ancestor
25281920|NCT02328079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25281921|NCT02328079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281922|NCT02328079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25281923|NCT02328079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281924|NCT02328079|Antiemetics|antiemetics|mesh-ancestor
25281925|NCT02328079|Autonomic Agents|autonomic agents|mesh-ancestor
25281926|NCT02328079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25281927|NCT02328079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24457931|NCT00335686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24457932|NCT00335686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24457933|NCT00335686|Antiviral Agents|antiviral agents|mesh-ancestor
24457934|NCT00335686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24457935|NCT00335686|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24457936|NCT00335686|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24457937|NCT00335686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24457938|NCT00335686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24457939|NCT00335686|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25281928|NCT02328079|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25281929|NCT02328079|Protective Agents|protective agents|mesh-ancestor
25281930|NCT02328079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25126631|NCT03060798|Desflurane|desflurane|mesh-list
25126778|NCT03059719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25126779|NCT03059719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25126780|NCT03059719|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25126781|NCT03059719|Incretins|incretins|mesh-ancestor
25126783|NCT03059719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24803262|NCT01995331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25281931|NCT02328209|Ranibizumab|ranibizumab|mesh-list
25281932|NCT02328209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25281933|NCT02328209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25281934|NCT02328209|Growth Substances|growth substances|mesh-ancestor
25281935|NCT02328209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281936|NCT02328209|Growth Inhibitors|growth inhibitors|mesh-ancestor
25281937|NCT02328209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281939|NCT02328118|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25281940|NCT02328118|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25281941|NCT02328118|Ranibizumab|ranibizumab|mesh-list
25281942|NCT02328118|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25281943|NCT02328118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25281944|NCT02328118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25281945|NCT02328118|Growth Substances|growth substances|mesh-ancestor
24965209|NCT03778567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24965211|NCT03778567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24965212|NCT03778541|Temozolomide|temozolomide|mesh-list
24965213|NCT03778541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24965214|NCT03778541|Alkylating Agents|alkylating agents|mesh-ancestor
25281946|NCT02328118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25281947|NCT02328118|Growth Inhibitors|growth inhibitors|mesh-ancestor
25281948|NCT02328118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25281949|NCT02328118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25281950|NCT02328118|Glucocorticoids|glucocorticoids|mesh-ancestor
25281951|NCT02328118|Hormones|hormones|mesh-ancestor
25281952|NCT02328118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25281953|NCT02328118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25281954|NCT02328118|Immunologic Factors|immunologic factors|mesh-ancestor
25281955|NCT02328118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25281956|NCT02328118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281957|NCT02328443|Itraconazole|itraconazole|mesh-list
25281965|NCT02328443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25281966|NCT02328443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25281967|NCT02328443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25281968|NCT02328443|Anesthetics, General|anesthetics, general|mesh-ancestor
25281970|NCT02328443|GABA Modulators|gaba modulators|mesh-ancestor
25281971|NCT02328443|GABA Agents|gaba agents|mesh-ancestor
25281972|NCT02328443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25281973|NCT02328443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25281974|NCT02328443|Antifungal Agents|antifungal agents|mesh-ancestor
25281975|NCT02328443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25281976|NCT02328443|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25281977|NCT02328443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25281978|NCT02328443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25127083|NCT03058224|Analgesics|analgesics|mesh-ancestor
25127084|NCT03058224|Sensory System Agents|sensory system agents|mesh-ancestor
25281979|NCT02328443|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25281980|NCT02328443|Hormone Antagonists|hormone antagonists|mesh-ancestor
25281981|NCT02328443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25281982|NCT02328443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25281983|NCT02328443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25281984|NCT02328443|Antitubercular Agents|antitubercular agents|mesh-ancestor
25281985|NCT02328443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25281986|NCT02328443|Leprostatic Agents|leprostatic agents|mesh-ancestor
25281987|NCT02328443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25281988|NCT02328443|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25281989|NCT02328443|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25281990|NCT02328443|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25281991|NCT02328443|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25281992|NCT02328443|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25281993|NCT02328443|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25281994|NCT02328144|Metronidazole|metronidazole|mesh-list
25281995|NCT02328144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25281996|NCT02328144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25281997|NCT02328144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25281998|NCT02328144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25281999|NCT02327663|Emtricitabine|emtricitabine|mesh-list
25282000|NCT02327663|Antiviral Agents|antiviral agents|mesh-ancestor
25282001|NCT02327663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25282002|NCT02327663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25282003|NCT02327663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25282004|NCT02327663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282005|NCT02327663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282006|NCT02327663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25282007|NCT02327663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25692876|NCT02005887|Contraceptive Agents|contraceptive agents|mesh-ancestor
25692877|NCT02005887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25692878|NCT02005887|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25692879|NCT02005887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25692880|NCT02006056|Ondansetron|ondansetron|mesh-list
25692881|NCT02006056|Antiemetics|antiemetics|mesh-ancestor
25692882|NCT02006056|Autonomic Agents|autonomic agents|mesh-ancestor
25282008|NCT02327676|Emtricitabine|emtricitabine|mesh-list
25282009|NCT02327676|Antiviral Agents|antiviral agents|mesh-ancestor
25282010|NCT02327676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25282011|NCT02327676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25282012|NCT02327676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25282013|NCT02327676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282014|NCT02327676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282015|NCT02327676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25127093|NCT03058237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25127094|NCT03058237|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25127095|NCT03058237|GABA Agonists|gaba agonists|mesh-ancestor
25127096|NCT03058237|GABA Agents|gaba agents|mesh-ancestor
25282019|NCT02327728|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25282020|NCT02327728|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25282021|NCT02327728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25282022|NCT02327728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282023|NCT02327728|Cholinergic Agents|cholinergic agents|mesh-ancestor
25282024|NCT02327728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25282025|NCT02327728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282026|NCT02327728|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25282027|NCT02327728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25282028|NCT02327624|Clopidogrel|clopidogrel|mesh-list
25282029|NCT02327624|Ticagrelor|ticagrelor|mesh-list
25282030|NCT02327624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25282031|NCT02327624|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25282032|NCT02327624|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25282033|NCT02327624|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25282034|NCT02327624|Purinergic Agents|purinergic agents|mesh-ancestor
25282035|NCT02327624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25282036|NCT02327624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282037|NCT02327624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282038|NCT02327936|Fesoterodine|fesoterodine|mesh-list
25282039|NCT02327936|Oxybutynin|oxybutynin|mesh-list
25282040|NCT02327936|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25282041|NCT02327936|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25282042|NCT02327936|Cholinergic Agents|cholinergic agents|mesh-ancestor
25282043|NCT02327936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25282044|NCT02327936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282045|NCT02327936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282046|NCT02327936|Urological Agents|urological agents|mesh-ancestor
25282047|NCT02327936|Parasympatholytics|parasympatholytics|mesh-ancestor
25282048|NCT02327936|Autonomic Agents|autonomic agents|mesh-ancestor
25282049|NCT02327936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25282050|NCT02327793|Labetalol|labetalol|mesh-list
25282051|NCT02327793|Nitroglycerin|nitroglycerin|mesh-list
25282052|NCT02327793|Vasodilator Agents|vasodilator agents|mesh-ancestor
25282053|NCT02327793|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25282054|NCT02327793|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25282055|NCT02327793|Adrenergic Agents|adrenergic agents|mesh-ancestor
25282056|NCT02327793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25282057|NCT02327793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282058|NCT02327793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282059|NCT02327793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25127099|NCT03058094|Pemetrexed|pemetrexed|mesh-list
25127251|NCT03056495|Vorinostat|vorinostat|mesh-list
25127328|NCT03056599|Mitosis Modulators|mitosis modulators|mesh-ancestor
25127329|NCT03056599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25692883|NCT02006056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25692884|NCT02006056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692885|NCT02006056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25692886|NCT02006056|Antipruritics|antipruritics|mesh-ancestor
25692887|NCT02006056|Dermatologic Agents|dermatologic agents|mesh-ancestor
25692888|NCT02006056|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25692889|NCT02006056|Serotonin Agents|serotonin agents|mesh-ancestor
25692890|NCT02006056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24965347|NCT03777696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965348|NCT03777696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24965349|NCT03777696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24965350|NCT03777696|Oxytocics|oxytocics|mesh-ancestor
24965352|NCT03777423|Chromium|chromium|mesh-list
24965353|NCT03777423|Trace Elements|trace elements|mesh-ancestor
24965354|NCT03777423|Micronutrients|micronutrients|mesh-ancestor
24965355|NCT03777423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965356|NCT03777787|Denatonium|denatonium|mesh-list
24965357|NCT03777787|Aversive Agents|aversive agents|mesh-ancestor
24965359|NCT03777787|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
25127331|NCT03056599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25127332|NCT03056599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25127333|NCT03056599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25127335|NCT03056599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25020119|NCT03683277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25127336|NCT03056599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25127337|NCT03056599|Alkylating Agents|alkylating agents|mesh-ancestor
25127338|NCT03056599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25127339|NCT03056391|Acetaminophen|acetaminophen|mesh-list
25127340|NCT03056391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25127341|NCT03056391|Analgesics|analgesics|mesh-ancestor
25127342|NCT03056391|Sensory System Agents|sensory system agents|mesh-ancestor
25127343|NCT03056391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25127344|NCT03056391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127345|NCT03056391|Antipyretics|antipyretics|mesh-ancestor
24706935|NCT01493102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24706936|NCT01493102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706937|NCT01493102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706938|NCT01493102|Sympathomimetics|sympathomimetics|mesh-ancestor
24706939|NCT01493102|Autonomic Agents|autonomic agents|mesh-ancestor
24706951|NCT01493154|Cyclophosphamide|cyclophosphamide|mesh-list
24706952|NCT01493154|Vaccines|vaccines|mesh-list
24706953|NCT01493154|Immunologic Factors|immunologic factors|mesh-ancestor
24706954|NCT01493154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706955|NCT01493154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24706956|NCT01493154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24706957|NCT01493154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24706958|NCT01493154|Alkylating Agents|alkylating agents|mesh-ancestor
24706974|NCT01493310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706975|NCT01493310|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24706976|NCT01493310|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24706977|NCT01493310|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24706978|NCT01493310|Contraceptive Agents|contraceptive agents|mesh-ancestor
24706979|NCT01493310|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24706980|NCT01493310|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24706981|NCT01493310|Hormone Antagonists|hormone antagonists|mesh-ancestor
24706982|NCT01493310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24706983|NCT01493310|Luteolytic Agents|luteolytic agents|mesh-ancestor
24706984|NCT01493310|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25282060|NCT02327793|Sympathomimetics|sympathomimetics|mesh-ancestor
25282061|NCT02327793|Autonomic Agents|autonomic agents|mesh-ancestor
25282062|NCT02327793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25282063|NCT02327793|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25282064|NCT02327793|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25282065|NCT02327754|FYX-051|fyx-051|mesh-list
25282066|NCT02327754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282067|NCT02327754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282069|NCT02327689|Adefovir|adefovir|mesh-list
25282070|NCT02327689|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25282071|NCT02327689|Antiviral Agents|antiviral agents|mesh-ancestor
25282072|NCT02327689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25282073|NCT02327689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25692891|NCT02006056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692892|NCT02006056|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25692893|NCT02006056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25692894|NCT02006056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25692895|NCT02006056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25692896|NCT02006056|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25709245|NCT02263326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709246|NCT02263326|Antiviral Agents|antiviral agents|mesh-ancestor
25709247|NCT02263326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25709248|NCT02263326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24791481|NCT04294160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24965105|NCT03778723|Sensory System Agents|sensory system agents|mesh-ancestor
24791483|NCT04294160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791484|NCT04294160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24965601|NCT03775655|Sensory System Agents|sensory system agents|mesh-ancestor
24965602|NCT03775655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24965603|NCT03775655|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24965604|NCT03775655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24965605|NCT03775655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24965606|NCT03775655|Adrenergic Agents|adrenergic agents|mesh-ancestor
24965607|NCT03775655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24965608|NCT03775655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965609|NCT03775590|Acetic Acid|acetic acid|mesh-list
24965610|NCT03775590|Retinol acetate|retinol acetate|mesh-list
24965611|NCT03775590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24965612|NCT03775590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25282074|NCT02327689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25282075|NCT02327689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282076|NCT02327689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282077|NCT02327689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25282078|NCT02327689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25282079|NCT02327923|Ketorolac|ketorolac|mesh-list
25282080|NCT02327923|Lidocaine|lidocaine|mesh-list
25282081|NCT02327923|Atropine|atropine|mesh-list
25282082|NCT02327923|Ephedrine|ephedrine|mesh-list
25282083|NCT02327923|Fentanyl|fentanyl|mesh-list
25282084|NCT02327923|Glycopyrrolate|glycopyrrolate|mesh-list
25282085|NCT02327923|Morphine|morphine|mesh-list
25282086|NCT02327923|Tramadol|tramadol|mesh-list
24804627|NCT02004067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24457976|NCT00335933|Antimanic Agents|antimanic agents|mesh-ancestor
25020334|NCT03680976|CXA-10|cxa-10|mesh-list
24457978|NCT00335985|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24457979|NCT00335985|gamma-Globulins|gamma-globulins|mesh-list
24457980|NCT00335985|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24457981|NCT00335985|Immunologic Factors|immunologic factors|mesh-ancestor
24457982|NCT00335985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692897|NCT02006108|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25692898|NCT02006108|Hematinics|hematinics|mesh-ancestor
25692899|NCT02006108|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25692900|NCT02006108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25692901|NCT02006121|Apomorphine|apomorphine|mesh-list
25692902|NCT02006121|Emetics|emetics|mesh-ancestor
25692903|NCT02006121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692904|NCT02006121|Autonomic Agents|autonomic agents|mesh-ancestor
25692905|NCT02006121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25692906|NCT02006121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25692907|NCT02006121|Dopamine Agonists|dopamine agonists|mesh-ancestor
25692908|NCT02006121|Dopamine Agents|dopamine agents|mesh-ancestor
25692909|NCT02006121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25692910|NCT02006121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692911|NCT02006160|4-Aminopyridine|4-aminopyridine|mesh-list
25692912|NCT02006160|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25692913|NCT02006160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25709249|NCT02263326|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25282092|NCT02327923|Esmolol|esmolol|mesh-list
25282093|NCT02327923|Anesthetics, Local|anesthetics, local|mesh-ancestor
25282094|NCT02327923|Anesthetics|anesthetics|mesh-ancestor
25282095|NCT02327923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25282096|NCT02327923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282097|NCT02327923|Sensory System Agents|sensory system agents|mesh-ancestor
25282098|NCT02327923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25282099|NCT02327923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25282100|NCT02327923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25282101|NCT02327923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25282102|NCT02327923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25282103|NCT02327923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282104|NCT02327923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25282105|NCT02327923|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25282106|NCT02327923|Anesthetics, General|anesthetics, general|mesh-ancestor
25282107|NCT02327923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25282108|NCT02327923|Narcotics|narcotics|mesh-ancestor
25282109|NCT02327923|Analgesics|analgesics|mesh-ancestor
25282110|NCT02327923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25282111|NCT02327923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25282113|NCT02327923|Autonomic Agents|autonomic agents|mesh-ancestor
25282114|NCT02327923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25282115|NCT02327923|Antipruritics|antipruritics|mesh-ancestor
25282116|NCT02327923|Dermatologic Agents|dermatologic agents|mesh-ancestor
25282117|NCT02327923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25282118|NCT02327923|Serotonin Agents|serotonin agents|mesh-ancestor
25282119|NCT02327923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25282120|NCT02327923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25282121|NCT02327923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25282122|NCT02327923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25282123|NCT02327923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25282124|NCT02327923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25282125|NCT02327923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25282126|NCT02327923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25282127|NCT02327923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25127568|NCT03054610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25127569|NCT03054610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25127570|NCT03054610|Respiratory System Agents|respiratory system agents|mesh-ancestor
25127571|NCT03054610|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25127572|NCT03054610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25127573|NCT03054610|Autonomic Agents|autonomic agents|mesh-ancestor
25127574|NCT03054532|Durvalumab|durvalumab|mesh-list
25127575|NCT03054532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25127576|NCT03054532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25692915|NCT02006342|Insulin|insulin|mesh-list
25692916|NCT02006342|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25692917|NCT02006342|Insulin Glargine|insulin glargine|mesh-list
25692918|NCT02006342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25692919|NCT02006342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692920|NCT02006576|Ibuprofen|ibuprofen|mesh-list
25709250|NCT02263326|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24791723|NCT03333005|Antifungal Agents|antifungal agents|mesh-list
25282128|NCT02327923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282129|NCT02327923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25282130|NCT02327923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25282131|NCT02327923|Respiratory System Agents|respiratory system agents|mesh-ancestor
25282132|NCT02327923|Mydriatics|mydriatics|mesh-ancestor
25282133|NCT02327923|Parasympatholytics|parasympatholytics|mesh-ancestor
25282134|NCT02327923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25282135|NCT02327923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25282136|NCT02327923|Cholinergic Agents|cholinergic agents|mesh-ancestor
25282137|NCT02327923|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25282138|NCT02327923|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25282139|NCT02327923|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25282140|NCT02327923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25282141|NCT02327923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25282142|NCT02327923|Adrenergic Agents|adrenergic agents|mesh-ancestor
25282143|NCT02327923|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25282144|NCT02327923|Sympathomimetics|sympathomimetics|mesh-ancestor
25282145|NCT02327923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25282146|NCT02327923|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25282147|NCT02327923|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25282148|NCT02327923|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25282149|NCT02327923|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25282150|NCT02327715|Emtricitabine|emtricitabine|mesh-list
25282151|NCT02327715|Antiviral Agents|antiviral agents|mesh-ancestor
25282152|NCT02327715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25282153|NCT02327715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25020670|NCT03678532|Anesthetics|anesthetics|mesh-ancestor
25282154|NCT02327715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25282155|NCT02327715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282156|NCT02327715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282157|NCT02327715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25282158|NCT02327715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25282159|NCT02327702|Emtricitabine|emtricitabine|mesh-list
25282160|NCT02327702|Antiviral Agents|antiviral agents|mesh-ancestor
25282161|NCT02327702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25282162|NCT02327702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25282163|NCT02327702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25282164|NCT02327702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457984|NCT00335998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24457985|NCT00336141|Vorinostat|vorinostat|mesh-list
24457986|NCT00336141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24457987|NCT00336141|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24457988|NCT00336141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457989|NCT00336141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531988|NCT00637793|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25709251|NCT02263547|Teriflunomide|teriflunomide|mesh-list
25709252|NCT02263547|Colestipol|colestipol|mesh-list
25079059|NCT03350737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079060|NCT03350659|Midodrine|midodrine|mesh-list
25079061|NCT03350659|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25079062|NCT03350659|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25079063|NCT03350659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25079064|NCT03350659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25079065|NCT03350659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079066|NCT03350659|Adrenergic Agents|adrenergic agents|mesh-ancestor
24817233|NCT02082054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464438|NCT00364871|Antidepressive Agents|antidepressive agents|mesh-ancestor
24706985|NCT01493310|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24706987|NCT01493336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24706988|NCT01493336|Antimetabolites|antimetabolites|mesh-ancestor
24706989|NCT01493336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706990|NCT01493336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706994|NCT01493440|Atosiban|atosiban|mesh-list
24707002|NCT01493453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24707003|NCT01493453|Immunologic Factors|immunologic factors|mesh-ancestor
24707004|NCT01493453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707005|NCT01493453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24613749|NCT01020643|Anesthetics|anesthetics|mesh-ancestor
24613750|NCT01020708|Acetylcysteine|acetylcysteine|mesh-list
24613751|NCT01020708|Aminosalicylic Acid|aminosalicylic acid|mesh-list
24449936|NCT00317408|Analgesics|analgesics|mesh-ancestor
24613756|NCT01020708|Expectorants|expectorants|mesh-ancestor
24613757|NCT01020708|Respiratory System Agents|respiratory system agents|mesh-ancestor
24613758|NCT01020708|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24613759|NCT01020708|Antioxidants|antioxidants|mesh-ancestor
24613760|NCT01020708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613761|NCT01020708|Protective Agents|protective agents|mesh-ancestor
24613762|NCT01020708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613763|NCT01020708|Antidotes|antidotes|mesh-ancestor
24613784|NCT01020734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24613785|NCT01020734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24613786|NCT01020734|Alkylating Agents|alkylating agents|mesh-ancestor
24613787|NCT01020734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613788|NCT01020734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25282165|NCT02327702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584747|NCT00881556|Tacrolimus|tacrolimus|mesh-list
25282166|NCT02327702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25282167|NCT02327702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25282168|NCT02327338|Ibuprofen|ibuprofen|mesh-list
25282169|NCT02327338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25282170|NCT02327338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25282171|NCT02327338|Analgesics|analgesics|mesh-ancestor
25282172|NCT02327338|Sensory System Agents|sensory system agents|mesh-ancestor
25282173|NCT02327338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25282174|NCT02327338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282175|NCT02327338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25282176|NCT02327338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25282177|NCT02327338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25282178|NCT02327338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282179|NCT02327338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692921|NCT02006576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25692922|NCT02006576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25692923|NCT02006576|Analgesics|analgesics|mesh-ancestor
25692924|NCT02006576|Sensory System Agents|sensory system agents|mesh-ancestor
25692925|NCT02006576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25692926|NCT02006576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692927|NCT02006576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25692928|NCT02006576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25692929|NCT02006576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25692930|NCT02006576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25692931|NCT02006576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692932|NCT02006667|Gemcitabine|gemcitabine|mesh-list
25692933|NCT02006667|Cisplatin|cisplatin|mesh-list
25692934|NCT02006667|Trastuzumab|trastuzumab|mesh-list
25692935|NCT02006667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25692936|NCT02006667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25692937|NCT02006667|Antimetabolites|antimetabolites|mesh-ancestor
24464462|NCT00365001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24464463|NCT00365001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464464|NCT00365001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24464466|NCT00365001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282180|NCT02327299|Fesoterodine|fesoterodine|mesh-list
25282181|NCT02327299|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25282182|NCT02327299|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25282183|NCT02327299|Cholinergic Agents|cholinergic agents|mesh-ancestor
25282184|NCT02327299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25282185|NCT02327299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282186|NCT02327299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282187|NCT02327299|Urological Agents|urological agents|mesh-ancestor
25127784|NCT03053505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25127785|NCT03053284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25127788|NCT03053284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25127789|NCT03053284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25127790|NCT03053219|Abivertinib|abivertinib|mesh-list
25127791|NCT03053219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25127792|NCT03053219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25127793|NCT03053219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25127794|NCT03052998|Ivermectin|ivermectin|mesh-list
25127795|NCT03052998|Anticonvulsants|anticonvulsants|mesh-list
25127796|NCT03052998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25127797|NCT03052998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25128065|NCT03050905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128066|NCT03050905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128067|NCT03050905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25128068|NCT03050905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25128069|NCT03050905|Antiviral Agents|antiviral agents|mesh-ancestor
25128070|NCT03050905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25128071|NCT03050905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25128072|NCT03050905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25128073|NCT03050827|Oxybutynin|oxybutynin|mesh-list
25128074|NCT03050827|Parasympatholytics|parasympatholytics|mesh-ancestor
25128075|NCT03050827|Autonomic Agents|autonomic agents|mesh-ancestor
25128076|NCT03050827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25128084|NCT03050957|Menthol|menthol|mesh-list
25282188|NCT02327416|Entecavir|entecavir|mesh-list
25282189|NCT02327416|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25282190|NCT02327416|Interferon-alpha|interferon-alpha|mesh-list
25282191|NCT02327416|Adefovir|adefovir|mesh-list
25282192|NCT02327416|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
25282193|NCT02327416|Molgramostim|molgramostim|mesh-list
25282194|NCT02327416|Sargramostim|sargramostim|mesh-list
25282195|NCT02327416|Antiviral Agents|antiviral agents|mesh-ancestor
25282196|NCT02327416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25282197|NCT02327416|Immunologic Factors|immunologic factors|mesh-ancestor
25282198|NCT02327416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282199|NCT02327416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25282200|NCT02327416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25282201|NCT02327416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282202|NCT02327416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282203|NCT02327416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25282204|NCT02327234|Ibuprofen|ibuprofen|mesh-list
25282205|NCT02327234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25282206|NCT02327234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25282207|NCT02327234|Analgesics|analgesics|mesh-ancestor
25282208|NCT02327234|Sensory System Agents|sensory system agents|mesh-ancestor
25282209|NCT02327234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25282210|NCT02327234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282211|NCT02327234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25282212|NCT02327234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25282213|NCT02327234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25282214|NCT02327234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282215|NCT02327234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282216|NCT02327247|Felodipine|felodipine|mesh-list
25692938|NCT02006667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692939|NCT02006667|Antiviral Agents|antiviral agents|mesh-ancestor
25692940|NCT02006667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25692941|NCT02006667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282217|NCT02327247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25282218|NCT02327247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25282219|NCT02327247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25282220|NCT02327247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25282221|NCT02327247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282222|NCT02327247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25282223|NCT02327247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282224|NCT02327247|Vasodilator Agents|vasodilator agents|mesh-ancestor
25282225|NCT02327156|Dexmedetomidine|dexmedetomidine|mesh-list
25282226|NCT02327156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25282227|NCT02327156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25282228|NCT02327156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282229|NCT02327156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25282230|NCT02327156|Analgesics|analgesics|mesh-ancestor
25282231|NCT02327156|Sensory System Agents|sensory system agents|mesh-ancestor
25128263|NCT03049085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25128264|NCT03049085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25128265|NCT03049085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25128266|NCT03049085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25128267|NCT03049085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25128268|NCT03049085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128269|NCT03049085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25128270|NCT03049085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25128271|NCT03049085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128272|NCT03049085|Antipyretics|antipyretics|mesh-ancestor
25128273|NCT03049085|Antioxidants|antioxidants|mesh-ancestor
25128274|NCT03049085|Protective Agents|protective agents|mesh-ancestor
25128275|NCT03049345|Methylene Blue|methylene blue|mesh-list
25128276|NCT03049345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128277|NCT03049345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613789|NCT01020734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24613790|NCT01020734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24613791|NCT01020734|Abortifacient Agents|abortifacient agents|mesh-ancestor
24613792|NCT01020734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24613793|NCT01020734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24613794|NCT01020734|Antimetabolites|antimetabolites|mesh-ancestor
24613795|NCT01020734|Dermatologic Agents|dermatologic agents|mesh-ancestor
24613796|NCT01020734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707041|NCT01493791|Ulipristal acetate|ulipristal acetate|mesh-list
24707042|NCT01493791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24707043|NCT01493791|Contraceptive Agents|contraceptive agents|mesh-ancestor
24707061|NCT01493843|Growth Inhibitors|growth inhibitors|mesh-ancestor
24707063|NCT01493856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24707064|NCT01493856|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24707065|NCT01493856|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24707066|NCT01493856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707068|NCT01493973|Hematinics|hematinics|mesh-ancestor
24707069|NCT01493986|Ropivacaine|ropivacaine|mesh-list
24707070|NCT01493986|Anesthetics, Local|anesthetics, local|mesh-ancestor
24707071|NCT01493986|Anesthetics|anesthetics|mesh-ancestor
24707072|NCT01493986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24707089|NCT01494090|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24707103|NCT01494155|Antimalarials|antimalarials|mesh-ancestor
24707104|NCT01494155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24707105|NCT01494155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25282232|NCT02327156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25282233|NCT02327156|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25282234|NCT02327156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25282235|NCT02327156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25282236|NCT02327156|Adrenergic Agents|adrenergic agents|mesh-ancestor
25282237|NCT02327156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25282238|NCT02327156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282239|NCT02327000|Pregabalin|pregabalin|mesh-list
25282240|NCT02327000|Analgesics|analgesics|mesh-ancestor
25282241|NCT02327000|Sensory System Agents|sensory system agents|mesh-ancestor
25282242|NCT02327000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25282243|NCT02327000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282244|NCT02327000|Anticonvulsants|anticonvulsants|mesh-ancestor
25282245|NCT02327000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25282246|NCT02327000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25282247|NCT02327000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282248|NCT02327000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25282249|NCT02327000|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25282250|NCT02327000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25282251|NCT02327000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25282252|NCT02327000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25282253|NCT02327091|Alfacalcidol|alfacalcidol|mesh-list
25282254|NCT02327091|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
24707106|NCT01494155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24707107|NCT01494155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707108|NCT01494155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24707109|NCT01494259|Epinephrine|epinephrine|mesh-list
24707110|NCT01494259|Bupivacaine|bupivacaine|mesh-list
24707111|NCT01494259|Anesthetics, Local|anesthetics, local|mesh-ancestor
24707112|NCT01494259|Anesthetics|anesthetics|mesh-ancestor
24707113|NCT01494259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24707114|NCT01494259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707115|NCT01494259|Sensory System Agents|sensory system agents|mesh-ancestor
24707116|NCT01494259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24707117|NCT01494259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24707118|NCT01494259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24707119|NCT01494259|Adrenergic Agents|adrenergic agents|mesh-ancestor
24707120|NCT01494259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24707121|NCT01494259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707122|NCT01494259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24707123|NCT01494259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24707124|NCT01494259|Autonomic Agents|autonomic agents|mesh-ancestor
24707125|NCT01494259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24707126|NCT01494259|Respiratory System Agents|respiratory system agents|mesh-ancestor
24707127|NCT01494259|Mydriatics|mydriatics|mesh-ancestor
24707128|NCT01494259|Sympathomimetics|sympathomimetics|mesh-ancestor
24707129|NCT01494259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24707167|NCT01494402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707168|NCT01494402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282255|NCT02327091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25282256|NCT02327091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282257|NCT02327091|Vitamins|vitamins|mesh-ancestor
25282258|NCT02327091|Micronutrients|micronutrients|mesh-ancestor
25282259|NCT02326922|Levonorgestrel|levonorgestrel|mesh-list
25282260|NCT02326922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25282261|NCT02326922|Contraceptive Agents|contraceptive agents|mesh-ancestor
25282262|NCT02326922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25282263|NCT02326922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282264|NCT02326922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25282265|NCT02326922|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25282266|NCT02326922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25282267|NCT02326987|Pregabalin|pregabalin|mesh-list
25282268|NCT02326987|Analgesics|analgesics|mesh-ancestor
24966509|NCT03767322|Febuxostat|febuxostat|mesh-list
25282269|NCT02326987|Sensory System Agents|sensory system agents|mesh-ancestor
25282270|NCT02326987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25282271|NCT02326987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282272|NCT02326987|Anticonvulsants|anticonvulsants|mesh-ancestor
25282273|NCT02326987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25282274|NCT02326987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25282275|NCT02326987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282276|NCT02326987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25282277|NCT02326987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25128349|NCT03047837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25128427|NCT03047499|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25128428|NCT03047499|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25128429|NCT03047499|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25128430|NCT03047499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25128431|NCT03047499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128432|NCT03047499|Cholinergic Agents|cholinergic agents|mesh-ancestor
25128433|NCT03047499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25128434|NCT03047499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128435|NCT03047499|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25128436|NCT03047499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25128438|NCT03047733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25128439|NCT03047733|Immunologic Factors|immunologic factors|mesh-ancestor
25021789|NCT03668418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25128440|NCT03047733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128441|NCT03047733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25128442|NCT03047733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128443|NCT03047733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128567|NCT03046108|Hormones|hormones|mesh-ancestor
25128620|NCT03045770|Mitosis Modulators|mitosis modulators|mesh-ancestor
25128621|NCT03045770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128622|NCT03045770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25128623|NCT03045770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128624|NCT03045770|Antimetabolites|antimetabolites|mesh-ancestor
25128625|NCT03045770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25128626|NCT03045770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24841359|NCT02215460|Chlorhexidine|chlorhexidine|mesh-list
25282278|NCT02326987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25282279|NCT02326987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25282280|NCT02326987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25282281|NCT02327039|Dapagliflozin|dapagliflozin|mesh-list
25282282|NCT02327039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25282283|NCT02327039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282284|NCT02327039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25282285|NCT02327039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282286|NCT02327078|Nivolumab|nivolumab|mesh-list
25282287|NCT02327078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25282288|NCT02327078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25282289|NCT02327078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25282290|NCT02327078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282291|NCT02326779|Aspirin|aspirin|mesh-list
25282292|NCT02326779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25282293|NCT02326779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25282294|NCT02326779|Analgesics|analgesics|mesh-ancestor
25282295|NCT02326779|Sensory System Agents|sensory system agents|mesh-ancestor
25282296|NCT02326779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25282297|NCT02326779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282298|NCT02326779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25282299|NCT02326779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25282300|NCT02326779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25282301|NCT02326779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25282302|NCT02326779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282303|NCT02326779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25282304|NCT02326779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25692942|NCT02006667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25282305|NCT02326779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282306|NCT02326779|Antipyretics|antipyretics|mesh-ancestor
25282307|NCT02326727|Fentanyl|fentanyl|mesh-list
25282308|NCT02326727|Nitrous Oxide|nitrous oxide|mesh-list
25282309|NCT02326727|Propofol|propofol|mesh-list
25282310|NCT02326727|Ropivacaine|ropivacaine|mesh-list
25282311|NCT02326727|Isoflurane|isoflurane|mesh-list
25282312|NCT02326727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25282313|NCT02326727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25128627|NCT03045770|Immunologic Factors|immunologic factors|mesh-ancestor
25128628|NCT03045770|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25128629|NCT03045770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25128630|NCT03045770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25128632|NCT03045770|Protective Agents|protective agents|mesh-ancestor
25128633|NCT03045770|Vitamin B Complex|vitamin b complex|mesh-ancestor
25128634|NCT03045770|Vitamins|vitamins|mesh-ancestor
25128635|NCT03045770|Micronutrients|micronutrients|mesh-ancestor
25128636|NCT03045627|Cytarabine|cytarabine|mesh-list
25128637|NCT03045627|Aclarubicin|aclarubicin|mesh-list
25128638|NCT03045627|Lenograstim|lenograstim|mesh-list
25128639|NCT03045627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25128640|NCT03045627|Antimetabolites|antimetabolites|mesh-ancestor
25128641|NCT03045627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25128642|NCT03045627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25128643|NCT03045627|Antiviral Agents|antiviral agents|mesh-ancestor
25128644|NCT03045627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25128645|NCT03045627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25128646|NCT03045627|Immunologic Factors|immunologic factors|mesh-ancestor
25128647|NCT03045627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25128648|NCT03045627|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25128649|NCT03045627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25128650|NCT03045627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25128651|NCT03045627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25128652|NCT03045627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458005|NCT00336219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24458006|NCT00336219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24458007|NCT00336219|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24458008|NCT00336219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458009|NCT00336219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458010|NCT00336245|Copper|copper|mesh-list
24402258|NCT00156299|Choline|choline|mesh-list
25128735|NCT03045393|Maytansine|maytansine|mesh-list
25128876|NCT03044938|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25282314|NCT02326727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282315|NCT02326727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25282316|NCT02326727|Anesthetics, General|anesthetics, general|mesh-ancestor
25282317|NCT02326727|Anesthetics|anesthetics|mesh-ancestor
25282318|NCT02326727|Anesthetics, Local|anesthetics, local|mesh-ancestor
25282319|NCT02326727|Sensory System Agents|sensory system agents|mesh-ancestor
25282320|NCT02326727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25282321|NCT02326727|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25282322|NCT02326727|Narcotics|narcotics|mesh-ancestor
25282323|NCT02326727|Analgesics|analgesics|mesh-ancestor
25282324|NCT02326727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25282325|NCT02326727|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25282326|NCT02326727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25282327|NCT02326428|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25282328|NCT02326428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25282329|NCT02326428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25282330|NCT02326428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282331|NCT02326441|KX2-361|kx2-361|mesh-list
25282332|NCT02326441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25282333|NCT02326441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282334|NCT02326441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282335|NCT02326441|Tubulin Modulators|tubulin modulators|mesh-ancestor
25282336|NCT02326441|Antimitotic Agents|antimitotic agents|mesh-ancestor
25282337|NCT02326441|Mitosis Modulators|mitosis modulators|mesh-ancestor
25282338|NCT02326441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25282339|NCT02326584|Cytarabine|cytarabine|mesh-list
25282340|NCT02326584|Daunorubicin|daunorubicin|mesh-list
25692943|NCT02006667|Immunologic Factors|immunologic factors|mesh-ancestor
25692944|NCT02006667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692945|NCT02006667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25692946|NCT02006706|Methylprednisolone|methylprednisolone|mesh-list
25079158|NCT03349866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079182|NCT03349619|Resveratrol|resveratrol|mesh-list
25079183|NCT03349619|Antioxidants|antioxidants|mesh-ancestor
25079184|NCT03349619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079185|NCT03349619|Protective Agents|protective agents|mesh-ancestor
25079186|NCT03349619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079187|NCT03349619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25079188|NCT03349619|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25079189|NCT03349606|Amphetamine|amphetamine|mesh-list
25079190|NCT03349606|Dextroamphetamine|dextroamphetamine|mesh-list
25282341|NCT02326584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25282342|NCT02326584|Antimetabolites|antimetabolites|mesh-ancestor
25282343|NCT02326584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282344|NCT02326584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25282345|NCT02326584|Antiviral Agents|antiviral agents|mesh-ancestor
25282346|NCT02326584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25282347|NCT02326584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25282348|NCT02326584|Immunologic Factors|immunologic factors|mesh-ancestor
25282349|NCT02326584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282350|NCT02326584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25282351|NCT02326584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25128952|NCT03044080|Cholinergic Agents|cholinergic agents|mesh-ancestor
25128953|NCT03044080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24449728|NCT00316810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24449729|NCT00316810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449730|NCT00316810|Immunologic Factors|immunologic factors|mesh-ancestor
24449731|NCT00316810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449732|NCT00316810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25282352|NCT02326584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25282353|NCT02326584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458023|NCT00336336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458024|NCT00336336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24458025|NCT00336336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24402323|NCT00156611|Abciximab|abciximab|mesh-list
25692947|NCT02006706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25692948|NCT02006706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25692949|NCT02006706|Prednisolone|prednisolone|mesh-list
25692950|NCT02006706|Prednisolone acetate|prednisolone acetate|mesh-list
25692951|NCT02006706|Rituximab|rituximab|mesh-list
25692952|NCT02006706|Methotrexate|methotrexate|mesh-list
25692953|NCT02006706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25692954|NCT02006706|Prednisolone phosphate|prednisolone phosphate|mesh-list
25692955|NCT02006706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25692956|NCT02006706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25692957|NCT02006706|Immunologic Factors|immunologic factors|mesh-ancestor
24707203|NCT01494597|Antifungal Agents|antifungal agents|mesh-ancestor
24707205|NCT01494597|Dermatologic Agents|dermatologic agents|mesh-ancestor
24707206|NCT01494597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24707207|NCT01494597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24707209|NCT01494636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24707210|NCT01494636|Anesthetics, Local|anesthetics, local|mesh-ancestor
24707212|NCT01494636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24707213|NCT01494636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707214|NCT01494636|Sensory System Agents|sensory system agents|mesh-ancestor
24707215|NCT01494636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24707216|NCT01494636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24707217|NCT01494636|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24707218|NCT01494636|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24707221|NCT01494688|Paclitaxel|paclitaxel|mesh-list
24707260|NCT01495026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24707262|NCT01495026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24707263|NCT01495026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707264|NCT01495026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282354|NCT02326623|Anesthetics|anesthetics|mesh-list
25282355|NCT02326623|Anesthetics, Local|anesthetics, local|mesh-list
25282356|NCT02326623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25282357|NCT02326623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282358|NCT02326623|Sensory System Agents|sensory system agents|mesh-ancestor
25282359|NCT02326623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25282360|NCT02326610|Hormones|hormones|mesh-list
25282361|NCT02326610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25282362|NCT02326610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282363|NCT02326376|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25282364|NCT02326376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25282365|NCT02326350|Aspirin|aspirin|mesh-list
25282366|NCT02326350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25282367|NCT02326350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25282368|NCT02326350|Analgesics|analgesics|mesh-ancestor
25282369|NCT02326350|Sensory System Agents|sensory system agents|mesh-ancestor
25282370|NCT02326350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25282371|NCT02326350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282372|NCT02326350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25282373|NCT02326350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25282374|NCT02326350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25282375|NCT02326350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25282376|NCT02326350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129033|NCT03043248|Digoxin|digoxin|mesh-list
25129111|NCT03043196|Antimetabolites|antimetabolites|mesh-ancestor
25129180|NCT03042637|Tacrolimus|tacrolimus|mesh-list
25129331|NCT03041948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25129477|NCT03040817|Mosapride|mosapride|mesh-list
25129478|NCT03040817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25129479|NCT03040817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25129480|NCT03040817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25129481|NCT03040817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25129482|NCT03040817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25129483|NCT03040817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25129485|NCT03040817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25129545|NCT03040180|Bleomycin|bleomycin|mesh-list
25129692|NCT03039075|Metformin|metformin|mesh-list
25129693|NCT03039075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25129694|NCT03039075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129695|NCT03039049|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25129696|NCT03039049|Luteolytic Agents|luteolytic agents|mesh-ancestor
25129697|NCT03039049|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25129698|NCT03039049|Contraceptive Agents|contraceptive agents|mesh-ancestor
25129699|NCT03039049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25129700|NCT03039049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129701|NCT03039049|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25129702|NCT03039049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25129703|NCT03039049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25282377|NCT02326350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25022279|NCT03664414|Protective Agents|protective agents|mesh-ancestor
25282378|NCT02326350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24966711|NCT03765944|Sirolimus|sirolimus|mesh-list
25282379|NCT02326350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282380|NCT02326350|Antipyretics|antipyretics|mesh-ancestor
25282381|NCT02326285|Docetaxel|docetaxel|mesh-list
25282382|NCT02326285|Gefitinib|gefitinib|mesh-list
25282383|NCT02326285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25282384|NCT02326285|Tubulin Modulators|tubulin modulators|mesh-ancestor
25282385|NCT02326285|Antimitotic Agents|antimitotic agents|mesh-ancestor
25282386|NCT02326285|Mitosis Modulators|mitosis modulators|mesh-ancestor
25282387|NCT02326285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282388|NCT02326285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25282389|NCT02326285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282390|NCT02326090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25282391|NCT02326090|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25282392|NCT02326103|Ciprofloxacin|ciprofloxacin|mesh-list
25282393|NCT02326103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25282394|NCT02326103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25282395|NCT02326103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25282396|NCT02326103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25282397|NCT02326103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282398|NCT02326103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282399|NCT02326103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25282400|NCT02326103|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25282401|NCT02326103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25282402|NCT02326194|Vaccines|vaccines|mesh-list
24881814|NCT01239797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24881822|NCT01103349|Montelukast|montelukast|mesh-list
25282403|NCT02326194|Immunologic Factors|immunologic factors|mesh-ancestor
25282404|NCT02326194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282405|NCT02325986|Fluorouracil|fluorouracil|mesh-list
25282406|NCT02325986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25282407|NCT02325986|Antimetabolites|antimetabolites|mesh-ancestor
25282408|NCT02325986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282409|NCT02325986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25282410|NCT02325986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25129727|NCT03038516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25129793|NCT03038217|Antimetabolites|antimetabolites|mesh-ancestor
25130030|NCT03036748|Amiloride|amiloride|mesh-list
25130031|NCT03036748|Diuretics|diuretics|mesh-ancestor
25130032|NCT03036748|Natriuretic Agents|natriuretic agents|mesh-ancestor
25130033|NCT03036748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130034|NCT03036748|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
25130035|NCT03036748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25130036|NCT03036748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25130037|NCT03036748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130038|NCT03036748|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
25130039|NCT03036748|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24842302|NCT02220530|Analgesics|analgesics|mesh-ancestor
25282421|NCT02326038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25282422|NCT02326051|Enoxaparin|enoxaparin|mesh-list
25282423|NCT02326051|Enoxaparin sodium|enoxaparin sodium|mesh-list
25282424|NCT02326051|Anticoagulants|anticoagulants|mesh-ancestor
25282425|NCT02326051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25282426|NCT02326051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25282427|NCT02326051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282428|NCT02326168|BCG Vaccine|bcg vaccine|mesh-list
25282429|NCT02326168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25282433|NCT05076981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25282434|NCT05076981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282435|NCT05076955|Vancomycin|vancomycin|mesh-list
25282436|NCT05076955|Tobramycin|tobramycin|mesh-list
25282437|NCT05076955|Itraconazole|itraconazole|mesh-list
25282438|NCT05076955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25282439|NCT05076955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25282440|NCT05076955|Antifungal Agents|antifungal agents|mesh-ancestor
25282441|NCT05076955|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25282442|NCT05076955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25282443|NCT05076955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282444|NCT05076955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282445|NCT05076955|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25282446|NCT05076955|Hormone Antagonists|hormone antagonists|mesh-ancestor
25282447|NCT05076955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25282448|NCT05076955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465112|NCT00367913|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24966902|NCT03764267|Lidocaine|lidocaine|mesh-list
25282449|NCT05076955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25282450|NCT05076942|Cisplatin|cisplatin|mesh-list
25282451|NCT05076942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25282452|NCT05076799|Lactulose|lactulose|mesh-list
25282453|NCT05076799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25282454|NCT05076773|Morphine|morphine|mesh-list
25282455|NCT05076773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25282456|NCT05076773|Narcotics|narcotics|mesh-ancestor
25282457|NCT05076773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24458026|NCT00336336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458027|NCT00336349|Botulinum Toxins|botulinum toxins|mesh-list
25130269|NCT03034850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24873778|NCT05025423|Alkylating Agents|alkylating agents|mesh-ancestor
24707265|NCT01495026|Urological Agents|urological agents|mesh-ancestor
24707266|NCT01495026|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24707267|NCT01495026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24707268|NCT01495026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707269|NCT01495026|Hormone Antagonists|hormone antagonists|mesh-ancestor
24707271|NCT01495039|Nystatin|nystatin|mesh-list
24707278|NCT01495104|Valproic Acid|valproic acid|mesh-list
24707341|NCT01495260|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24707342|NCT01495260|Vitamins|vitamins|mesh-ancestor
24707343|NCT01495260|Micronutrients|micronutrients|mesh-ancestor
24707344|NCT01495260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707345|NCT01495260|Antiviral Agents|antiviral agents|mesh-ancestor
24707346|NCT01495260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24707347|NCT01495260|Expectorants|expectorants|mesh-ancestor
24707348|NCT01495260|Respiratory System Agents|respiratory system agents|mesh-ancestor
24707349|NCT01495260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24707350|NCT01495260|Antioxidants|antioxidants|mesh-ancestor
24644641|NCT01192230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24707352|NCT01495260|Protective Agents|protective agents|mesh-ancestor
24613847|NCT01021358|Antifungal Agents|antifungal agents|mesh-ancestor
24613848|NCT01021358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24613849|NCT01021358|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24613850|NCT01021358|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24613851|NCT01021358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613852|NCT01021358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707404|NCT01495624|Anesthetics|anesthetics|mesh-list
24707405|NCT01495624|BB 1101|bb 1101|mesh-list
24707406|NCT01495624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24707407|NCT01495624|Antiemetics|antiemetics|mesh-ancestor
24707408|NCT01495624|Autonomic Agents|autonomic agents|mesh-ancestor
24707409|NCT01495624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24707410|NCT01495624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707411|NCT01495624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24707412|NCT01495624|Glucocorticoids|glucocorticoids|mesh-ancestor
24707413|NCT01495624|Hormones|hormones|mesh-ancestor
25282458|NCT05076773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282459|NCT05076773|Analgesics|analgesics|mesh-ancestor
25282460|NCT05076773|Sensory System Agents|sensory system agents|mesh-ancestor
25282461|NCT05076773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25282462|NCT05076695|Trastuzumab|trastuzumab|mesh-list
25282463|NCT05076695|Fulvestrant|fulvestrant|mesh-list
25282464|NCT05076695|Palbociclib|palbociclib|mesh-list
25282465|NCT05076695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25282466|NCT05076695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25282467|NCT05076695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25282468|NCT05076695|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25692958|NCT02006706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692959|NCT02006706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25282469|NCT05076695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25282470|NCT05076695|Hormone Antagonists|hormone antagonists|mesh-ancestor
24600629|NCT00959595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282471|NCT05076695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25282472|NCT05076695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282473|NCT05076695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25282474|NCT05076695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25130275|NCT03034850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130276|NCT03034850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25130277|NCT03034850|Alkylating Agents|alkylating agents|mesh-ancestor
25130278|NCT03034759|Insulin|insulin|mesh-list
25130279|NCT03034759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25130280|NCT03034759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130281|NCT03035058|Vedolizumab|vedolizumab|mesh-list
24707414|NCT01495624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24707415|NCT01495624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24707416|NCT01495624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24707417|NCT01495624|Protease Inhibitors|protease inhibitors|mesh-ancestor
24493383|NCT00490789|Sirolimus|sirolimus|mesh-list
24707434|NCT01495845|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24707435|NCT01495845|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24707436|NCT01495845|Purinergic Agents|purinergic agents|mesh-ancestor
24707437|NCT01495845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24707438|NCT01495845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707439|NCT01495845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707440|NCT01495884|Lapatinib|lapatinib|mesh-list
24707441|NCT01495884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24707442|NCT01495884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24707459|NCT01495949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24707461|NCT01495949|Anesthetics|anesthetics|mesh-ancestor
24707462|NCT01495949|Anticonvulsants|anticonvulsants|mesh-ancestor
24707463|NCT01495949|GABA Modulators|gaba modulators|mesh-ancestor
24707464|NCT01495949|GABA Agents|gaba agents|mesh-ancestor
24707465|NCT01495949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24707466|NCT01495949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707467|NCT01495962|Botulinum Toxins|botulinum toxins|mesh-list
24707468|NCT01495962|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24707469|NCT01495962|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24707470|NCT01495962|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24707471|NCT01495962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24707472|NCT01495962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707473|NCT01495962|Cholinergic Agents|cholinergic agents|mesh-ancestor
24707474|NCT01495962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24707475|NCT01495962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707476|NCT01495962|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24707477|NCT01495962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24707478|NCT01496105|Lidocaine|lidocaine|mesh-list
24707479|NCT01496105|Anesthetics, Local|anesthetics, local|mesh-ancestor
24707480|NCT01496105|Anesthetics|anesthetics|mesh-ancestor
24707481|NCT01496105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24707482|NCT01496105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707483|NCT01496105|Sensory System Agents|sensory system agents|mesh-ancestor
24707484|NCT01496105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24707485|NCT01496105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25282478|NCT05076526|Hyaluronic Acid|hyaluronic acid|mesh-list
25282479|NCT05076526|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25282480|NCT05076526|Immunologic Factors|immunologic factors|mesh-ancestor
25282481|NCT05076526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282483|NCT05076526|Protective Agents|protective agents|mesh-ancestor
25282484|NCT05076474|Orlistat|orlistat|mesh-list
25282485|NCT05076474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282486|NCT05076474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282487|NCT05076474|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25282488|NCT05076474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25130283|NCT03035045|Acetaminophen|acetaminophen|mesh-list
25130284|NCT03035045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25130285|NCT03035045|Analgesics|analgesics|mesh-ancestor
25130286|NCT03035045|Sensory System Agents|sensory system agents|mesh-ancestor
25130287|NCT03035045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130288|NCT03035045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130289|NCT03035045|Antipyretics|antipyretics|mesh-ancestor
24806760|NCT02018094|Iodine|iodine|mesh-list
24707486|NCT01496105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24707488|NCT01496105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24707546|NCT01496521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24707547|NCT01496521|Analgesics|analgesics|mesh-ancestor
24707548|NCT01496521|Sensory System Agents|sensory system agents|mesh-ancestor
24707549|NCT01496521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24707550|NCT01496521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707551|NCT01496521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24707552|NCT01496521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24707553|NCT01496521|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24707554|NCT01496521|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24707555|NCT01496521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707556|NCT01496521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24707557|NCT01496521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24707558|NCT01496521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707559|NCT01496521|Antipyretics|antipyretics|mesh-ancestor
24707560|NCT01496534|Carboplatin|carboplatin|mesh-list
24707561|NCT01496534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24707562|NCT01496677|Tedizolid phosphate|tedizolid phosphate|mesh-list
24707563|NCT01496677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24707564|NCT01496677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24707565|NCT01496690|Pregabalin|pregabalin|mesh-list
24707566|NCT01496690|Analgesics|analgesics|mesh-ancestor
24707567|NCT01496690|Sensory System Agents|sensory system agents|mesh-ancestor
24707568|NCT01496690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24707699|NCT01497431|Protective Agents|protective agents|mesh-ancestor
24707700|NCT01497431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707701|NCT01497431|Trace Elements|trace elements|mesh-ancestor
24707702|NCT01497431|Micronutrients|micronutrients|mesh-ancestor
24707703|NCT01497431|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24707704|NCT01497431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24707705|NCT01497444|Sorafenib|sorafenib|mesh-list
25282489|NCT05076461|Ondansetron|ondansetron|mesh-list
25282490|NCT05076461|Antiemetics|antiemetics|mesh-ancestor
25282491|NCT05076461|Autonomic Agents|autonomic agents|mesh-ancestor
25282492|NCT05076461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25282493|NCT05076461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282494|NCT05076461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25282495|NCT05076461|Antipruritics|antipruritics|mesh-ancestor
25282496|NCT05076461|Dermatologic Agents|dermatologic agents|mesh-ancestor
25282497|NCT05076461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25282498|NCT05076461|Serotonin Agents|serotonin agents|mesh-ancestor
25282499|NCT05076461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25282500|NCT05076461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282501|NCT05076461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25282502|NCT05076461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25282503|NCT05076461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25282504|NCT05076461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25282505|NCT05076461|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25282506|NCT05076019|Atorvastatin|atorvastatin|mesh-list
25282507|NCT05076019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25282508|NCT05076019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25282509|NCT05076019|Antimetabolites|antimetabolites|mesh-ancestor
25102803|NCT03166397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24842725|NCT02223026|Incretins|incretins|mesh-ancestor
24707706|NCT01497444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24707707|NCT01497444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24707726|NCT01497483|Antifungal Agents|antifungal agents|mesh-ancestor
24707727|NCT01497483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24707728|NCT01497483|Dermatologic Agents|dermatologic agents|mesh-ancestor
24707729|NCT01497483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24707732|NCT01497483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24707738|NCT01497522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707739|NCT01497522|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24707740|NCT01497522|Protease Inhibitors|protease inhibitors|mesh-ancestor
24707741|NCT01497522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707742|NCT01497522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707744|NCT01497535|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24707745|NCT01497535|Insulin Glargine|insulin glargine|mesh-list
24707746|NCT01497535|Insulin Detemir|insulin detemir|mesh-list
24707747|NCT01497535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24707748|NCT01497535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707749|NCT01497548|Methylphenidate|methylphenidate|mesh-list
24707750|NCT01497548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24707751|NCT01497548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707752|NCT01497548|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24707753|NCT01497548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24707754|NCT01497548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24644768|NCT01193166|Olanzapine|olanzapine|mesh-list
24707755|NCT01497548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707756|NCT01497548|Dopamine Agents|dopamine agents|mesh-ancestor
24707758|NCT01497561|Insulin|insulin|mesh-list
24707778|NCT01497600|Isophane Insulin, Human|isophane insulin, human|mesh-list
24707779|NCT01497600|Insulin, Isophane|insulin, isophane|mesh-list
24707780|NCT01497600|Isophane insulin, beef|isophane insulin, beef|mesh-list
24707781|NCT01497600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24707782|NCT01497600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613882|NCT01021488|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24707783|NCT01497626|Bortezomib|bortezomib|mesh-list
24707784|NCT01497626|Lapatinib|lapatinib|mesh-list
24707785|NCT01497626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25282510|NCT05076019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282511|NCT05076019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25282512|NCT05076019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25282513|NCT05076019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282514|NCT05069857|Apatinib|apatinib|mesh-list
25282515|NCT05069857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25282516|NCT05069857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25282517|NCT05069857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25282518|NCT05069857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282519|NCT05069857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282520|NCT05063136|Capecitabine|capecitabine|mesh-list
25282521|NCT05063136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25282522|NCT05063136|Antimetabolites|antimetabolites|mesh-ancestor
25282523|NCT05063136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282524|NCT05063136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25282525|NCT05034809|Melatonin|melatonin|mesh-list
25282526|NCT05034809|Antioxidants|antioxidants|mesh-ancestor
25130290|NCT03034733|Dexamethasone|dexamethasone|mesh-list
24493822|NCT00492518|Acetylcysteine|acetylcysteine|mesh-list
25130440|NCT03033836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130442|NCT03033836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25130443|NCT03033836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25130444|NCT03033836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25130445|NCT03033836|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25130446|NCT03033836|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25130731|NCT03031184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25130732|NCT03031184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25130733|NCT03031184|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25130734|NCT03031184|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25130735|NCT03031184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25130736|NCT03031184|Adrenergic Agents|adrenergic agents|mesh-ancestor
25130737|NCT03031184|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25130738|NCT03031184|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25130739|NCT03031184|Serotonin Agents|serotonin agents|mesh-ancestor
25130740|NCT03031184|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25282527|NCT05034809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282528|NCT05034809|Protective Agents|protective agents|mesh-ancestor
25282529|NCT05034809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282530|NCT05034809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25282531|NCT04998032|Metformin|metformin|mesh-list
25282532|NCT04998032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25282533|NCT04998032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282534|NCT04993924|Cetrorelix|cetrorelix|mesh-list
25282535|NCT04993924|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25282536|NCT04993924|Fertility Agents|fertility agents|mesh-ancestor
25282537|NCT04993924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25282538|NCT04993924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282539|NCT04993924|Hormone Antagonists|hormone antagonists|mesh-ancestor
25282540|NCT04993924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25282541|NCT04893785|Temozolomide|temozolomide|mesh-list
25282542|NCT04893785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25282543|NCT04893785|Alkylating Agents|alkylating agents|mesh-ancestor
25282544|NCT04893785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282545|NCT04893785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25282546|NCT04873323|Moxifloxacin|moxifloxacin|mesh-list
25282547|NCT04873323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25282548|NCT04873323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25282549|NCT04873323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25282550|NCT04873323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25282551|NCT04873323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282552|NCT04873323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282553|NCT04873323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458032|NCT00336349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458033|NCT00336349|Cholinergic Agents|cholinergic agents|mesh-ancestor
24458034|NCT00336349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24621372|NCT01062048|Incretins|incretins|mesh-ancestor
24613886|NCT01021501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24613888|NCT01021501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24613889|NCT01021501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613891|NCT01021501|Tocolytic Agents|tocolytic agents|mesh-ancestor
24613892|NCT01021501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24613893|NCT01021540|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24613894|NCT01021540|Hormones|hormones|mesh-ancestor
24613895|NCT01021540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24707844|NCT01498081|Parasympatholytics|parasympatholytics|mesh-ancestor
24707845|NCT01498081|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24707847|NCT01498081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24707848|NCT01498081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707849|NCT01498380|Dexmedetomidine|dexmedetomidine|mesh-list
24707850|NCT01498380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24707851|NCT01498380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24707852|NCT01498380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707853|NCT01498380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24707854|NCT01498380|Analgesics|analgesics|mesh-ancestor
24707862|NCT01498380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707880|NCT01498718|Immunologic Factors|immunologic factors|mesh-ancestor
24707881|NCT01498718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707882|NCT01498783|Fluorouracil|fluorouracil|mesh-list
24707883|NCT01498783|Antimetabolites|antimetabolites|mesh-ancestor
24707884|NCT01498783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465727|NCT00370630|Hormones|hormones|mesh-ancestor
24707885|NCT01498783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24707886|NCT01498783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24707887|NCT01498783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24707888|NCT01498783|Immunologic Factors|immunologic factors|mesh-ancestor
24707889|NCT01498783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545588|NCT00693862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707993|NCT01499225|Doxycycline|doxycycline|mesh-list
24707994|NCT01499225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24707995|NCT01499225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24707996|NCT01499225|Antimalarials|antimalarials|mesh-ancestor
24707997|NCT01499225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24707998|NCT01499225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24707999|NCT01499251|Temozolomide|temozolomide|mesh-list
24708001|NCT01499251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24708002|NCT01499251|Alkylating Agents|alkylating agents|mesh-ancestor
24708003|NCT01499251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708004|NCT01499251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708005|NCT01499251|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
24708006|NCT01499251|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24708044|NCT01499602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24708045|NCT01499602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24708046|NCT01499602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24708047|NCT01499602|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24708048|NCT01499641|Methylprednisolone|methylprednisolone|mesh-list
24708049|NCT01499641|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25282554|NCT04803591|Tranexamic Acid|tranexamic acid|mesh-list
25282555|NCT04803591|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25282556|NCT04803591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25282557|NCT04803591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282558|NCT04803591|Hemostatics|hemostatics|mesh-ancestor
25282559|NCT04803591|Coagulants|coagulants|mesh-ancestor
25282560|NCT04696822|Epinephrine|epinephrine|mesh-list
25282561|NCT04696822|Racepinephrine|racepinephrine|mesh-list
25282562|NCT04696822|Epinephryl borate|epinephryl borate|mesh-list
24458035|NCT00336349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057330|NCT03506061|Ivacaftor|ivacaftor|mesh-list
24458036|NCT00336349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24458037|NCT00336349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24458038|NCT00336362|Hydroxyurea|hydroxyurea|mesh-list
24458039|NCT00336362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458040|NCT00336362|Antisickling Agents|antisickling agents|mesh-ancestor
24458041|NCT00336362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458042|NCT00336362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755435|NCT01726530|Sensory System Agents|sensory system agents|mesh-ancestor
24708050|NCT01499641|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24613935|NCT01021696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24613936|NCT01021696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24613937|NCT01021696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24613938|NCT01021696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24613939|NCT01021696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24613940|NCT01021696|Antipyretics|antipyretics|mesh-ancestor
24613941|NCT01021696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24613942|NCT01021735|Adalimumab|adalimumab|mesh-list
24613943|NCT01021735|Etanercept|etanercept|mesh-list
24613944|NCT01021735|Rituximab|rituximab|mesh-list
24708233|NCT01500837|Ofloxacin|ofloxacin|mesh-list
24708234|NCT01500837|Rifampin|rifampin|mesh-list
24708235|NCT01500837|Clindamycin|clindamycin|mesh-list
24708236|NCT01500837|Clindamycin palmitate|clindamycin palmitate|mesh-list
24708272|NCT01500863|Estradiol|estradiol|mesh-list
24708273|NCT01500863|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24708274|NCT01500863|Progesterone|progesterone|mesh-list
24708275|NCT01500863|Estrogens|estrogens|mesh-ancestor
24708276|NCT01500863|Hormones|hormones|mesh-ancestor
24708277|NCT01500863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24708278|NCT01500863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708279|NCT01500863|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24708281|NCT01500863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24708282|NCT01500863|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24708283|NCT01500863|Progestins|progestins|mesh-ancestor
24708284|NCT01500863|Luteolytic Agents|luteolytic agents|mesh-ancestor
24708285|NCT01500863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24708286|NCT01500863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708287|NCT01500915|Ranibizumab|ranibizumab|mesh-list
24708288|NCT01500915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24708289|NCT01500915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24708290|NCT01500915|Growth Substances|growth substances|mesh-ancestor
24708291|NCT01500915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708292|NCT01500915|Growth Inhibitors|growth inhibitors|mesh-ancestor
24708295|NCT01500928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24708296|NCT01500928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708297|NCT01500980|Chloroquine|chloroquine|mesh-list
24708298|NCT01500980|Primaquine|primaquine|mesh-list
24708299|NCT01500980|Amebicides|amebicides|mesh-ancestor
24708300|NCT01500980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24708301|NCT01500980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24644930|NCT01193881|R04929097|r04929097|mesh-list
24708342|NCT01501123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25282563|NCT04696822|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25282564|NCT04696822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25282565|NCT04696822|Adrenergic Agents|adrenergic agents|mesh-ancestor
25282566|NCT04696822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25282567|NCT04696822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282568|NCT04696822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282569|NCT04696822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25282570|NCT04696822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25282571|NCT04696822|Autonomic Agents|autonomic agents|mesh-ancestor
25130965|NCT03030157|Pirarubicin|pirarubicin|mesh-list
25130966|NCT03030157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25130967|NCT03029533|Leuprolide|leuprolide|mesh-list
25130968|NCT03029533|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25130969|NCT03029533|Fertility Agents|fertility agents|mesh-ancestor
25130970|NCT03029533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25130971|NCT03029533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708343|NCT01501123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24708344|NCT01501123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24708345|NCT01501123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24708346|NCT01501123|Dopamine Agents|dopamine agents|mesh-ancestor
24708347|NCT01501123|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24708348|NCT01501136|Gemcitabine|gemcitabine|mesh-list
24708349|NCT01501136|Dexamethasone|dexamethasone|mesh-list
24708350|NCT01501136|Dexamethasone acetate|dexamethasone acetate|mesh-list
24708351|NCT01501136|Cisplatin|cisplatin|mesh-list
24708352|NCT01501136|Etoposide|etoposide|mesh-list
24708353|NCT01501136|Etoposide phosphate|etoposide phosphate|mesh-list
24708354|NCT01501136|Ifosfamide|ifosfamide|mesh-list
24708355|NCT01501136|Isophosphamide mustard|isophosphamide mustard|mesh-list
24708356|NCT01501136|Pegaspargase|pegaspargase|mesh-list
24708357|NCT01501136|Asparaginase|asparaginase|mesh-list
24708358|NCT01501136|BB 1101|bb 1101|mesh-list
24708360|NCT01501136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708361|NCT01501136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24708425|NCT01501253|Vasodilator Agents|vasodilator agents|mesh-ancestor
24708426|NCT01501344|Calcium|calcium|mesh-list
24708427|NCT01501344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24708428|NCT01501344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708429|NCT01501370|Dexamethasone|dexamethasone|mesh-list
24708430|NCT01501370|Dexamethasone acetate|dexamethasone acetate|mesh-list
24708431|NCT01501370|Lenalidomide|lenalidomide|mesh-list
24708432|NCT01501370|Vorinostat|vorinostat|mesh-list
24708433|NCT01501370|BB 1101|bb 1101|mesh-list
24708475|NCT01501396|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24708476|NCT01501396|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24708477|NCT01501396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24708478|NCT01501396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24708479|NCT01501396|Contraceptive Agents|contraceptive agents|mesh-ancestor
24627592|NCT01093937|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24627593|NCT01093937|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24627594|NCT01093937|Cholinergic Agents|cholinergic agents|mesh-ancestor
24627595|NCT01093937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24796918|NCT01953120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24796920|NCT01953172|Tocotrienol, alpha|tocotrienol, alpha|mesh-list
24708480|NCT01501396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24708481|NCT01501396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24708482|NCT01501396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24708483|NCT01501396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24708484|NCT01501396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708485|NCT01501396|Appetite Stimulants|appetite stimulants|mesh-ancestor
24708486|NCT01501396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24708487|NCT01501422|Estrogens|estrogens|mesh-list
24708488|NCT01501422|Hormones|hormones|mesh-ancestor
25282572|NCT04696822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25282573|NCT04696822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25282574|NCT04696822|Respiratory System Agents|respiratory system agents|mesh-ancestor
25282575|NCT04696822|Mydriatics|mydriatics|mesh-ancestor
25282576|NCT04696822|Sympathomimetics|sympathomimetics|mesh-ancestor
25282577|NCT04696822|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25282578|NCT04608487|Cyclophosphamide|cyclophosphamide|mesh-list
25282579|NCT04608487|Fludarabine|fludarabine|mesh-list
25282580|NCT04608487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25282581|NCT04608487|Immunologic Factors|immunologic factors|mesh-ancestor
25282582|NCT04608487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282583|NCT04608487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25282584|NCT04608487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25282585|NCT04608487|Alkylating Agents|alkylating agents|mesh-ancestor
25282586|NCT04608487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282587|NCT04608487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25282588|NCT04608487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25282589|NCT04596917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25130973|NCT03029533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25130975|NCT03029676|Midazolam|midazolam|mesh-list
25130976|NCT03029676|Anesthetics|anesthetics|mesh-ancestor
25130977|NCT03029676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25130978|NCT03029676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25130979|NCT03029676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25130980|NCT03029676|Narcotics|narcotics|mesh-ancestor
25130981|NCT03029676|Analgesics|analgesics|mesh-ancestor
25130982|NCT03029676|Sensory System Agents|sensory system agents|mesh-ancestor
25130983|NCT03029676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25130984|NCT03029676|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25130985|NCT03029676|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25130986|NCT03029676|Anesthetics, General|anesthetics, general|mesh-ancestor
25130987|NCT03029676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25130988|NCT03029676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25130989|NCT03029676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25130990|NCT03029676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25130991|NCT03029676|GABA Modulators|gaba modulators|mesh-ancestor
25130992|NCT03029676|GABA Agents|gaba agents|mesh-ancestor
25130993|NCT03029676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25130994|NCT03029676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25130995|NCT03029689|Raltegravir Potassium|raltegravir potassium|mesh-list
25130996|NCT03029689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25130997|NCT03029689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25130998|NCT03029689|Antiviral Agents|antiviral agents|mesh-ancestor
25130999|NCT03029689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25131000|NCT03029689|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25131001|NCT03029689|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25131002|NCT03029689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131003|NCT03029689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131153|NCT03028532|Zuclomiphene|zuclomiphene|mesh-list
25131154|NCT03028532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25102804|NCT03166397|Immunologic Factors|immunologic factors|mesh-ancestor
25692960|NCT02006706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25692961|NCT02006706|Abortifacient Agents|abortifacient agents|mesh-ancestor
25692962|NCT02006706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25692963|NCT02006706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25692964|NCT02006706|Antimetabolites|antimetabolites|mesh-ancestor
25692965|NCT02006706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692966|NCT02006706|Dermatologic Agents|dermatologic agents|mesh-ancestor
24708489|NCT01501422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24708490|NCT01501422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282590|NCT04596917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25282591|NCT04596917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282592|NCT04501861|Vasopressins|vasopressins|mesh-list
25282593|NCT04501861|Arginine Vasopressin|arginine vasopressin|mesh-list
25282594|NCT04501861|Norepinephrine|norepinephrine|mesh-list
25282595|NCT04501861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25282596|NCT04501861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25282597|NCT04501861|Adrenergic Agents|adrenergic agents|mesh-ancestor
25282598|NCT04501861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25282599|NCT04501861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282600|NCT04501861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282601|NCT04501861|Sympathomimetics|sympathomimetics|mesh-ancestor
25282602|NCT04501861|Autonomic Agents|autonomic agents|mesh-ancestor
25282603|NCT04501861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25282604|NCT04501861|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25282605|NCT04501861|Hemostatics|hemostatics|mesh-ancestor
25282606|NCT04501861|Coagulants|coagulants|mesh-ancestor
25282607|NCT04501861|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25282608|NCT04501861|Natriuretic Agents|natriuretic agents|mesh-ancestor
25282610|NCT04498741|Dabigatran|dabigatran|mesh-list
25282611|NCT04498741|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25282612|NCT04498741|Tacrolimus|tacrolimus|mesh-list
25282613|NCT04498741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25282614|NCT04498741|Immunologic Factors|immunologic factors|mesh-ancestor
25282615|NCT04498741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282616|NCT04498741|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25282617|NCT04498741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282618|NCT04498741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282619|NCT04498741|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25282620|NCT04498741|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25282621|NCT04498741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25282622|NCT04498741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25282623|NCT04498741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25282624|NCT04498741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25131155|NCT03028532|Hormone Antagonists|hormone antagonists|mesh-ancestor
25131156|NCT03028532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25131157|NCT03028532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131158|NCT03028532|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25131159|NCT03028532|Fertility Agents|fertility agents|mesh-ancestor
25131160|NCT03028532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25131161|NCT03028532|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25131162|NCT03028532|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25131163|NCT03028155|Oxaliplatin|oxaliplatin|mesh-list
25131164|NCT03028155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131165|NCT03027960|Empagliflozin|empagliflozin|mesh-list
25131166|NCT03027960|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25131167|NCT03027960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131168|NCT03027960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25131169|NCT03027960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131170|NCT03027934|Ticagrelor|ticagrelor|mesh-list
25131171|NCT03027934|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25131172|NCT03027934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25131173|NCT03027934|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25131174|NCT03027934|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25131175|NCT03027934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25131272|NCT03026933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25131346|NCT03026725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131347|NCT03026478|Betamethasone|betamethasone|mesh-list
25131348|NCT03026478|Betamethasone Valerate|betamethasone valerate|mesh-list
25131349|NCT03026478|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25131350|NCT03026478|Betamethasone benzoate|betamethasone benzoate|mesh-list
25131351|NCT03026478|Clobetasol|clobetasol|mesh-list
25131352|NCT03026478|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25131353|NCT03026478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25131354|NCT03026478|Glucocorticoids|glucocorticoids|mesh-ancestor
25131355|NCT03026478|Hormones|hormones|mesh-ancestor
25282625|NCT04498741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25282626|NCT04498741|Anesthetics, General|anesthetics, general|mesh-ancestor
25282627|NCT04498741|Anesthetics|anesthetics|mesh-ancestor
25282628|NCT04498741|GABA Modulators|gaba modulators|mesh-ancestor
25282629|NCT04498741|GABA Agents|gaba agents|mesh-ancestor
25282630|NCT04498741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25282631|NCT04498741|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25282632|NCT04498741|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25282633|NCT04498741|Antimetabolites|antimetabolites|mesh-ancestor
24798135|NCT01960764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25282634|NCT04498741|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25282635|NCT04498741|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25282636|NCT04498741|Antithrombins|antithrombins|mesh-ancestor
25282637|NCT04498741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25282638|NCT04498741|Protease Inhibitors|protease inhibitors|mesh-ancestor
25282639|NCT04498741|Anticoagulants|anticoagulants|mesh-ancestor
25282640|NCT04407988|Letrozole|letrozole|mesh-list
25282641|NCT04407988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25282642|NCT04407988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25282643|NCT04407988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25282644|NCT04407988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282645|NCT04407988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282646|NCT04407988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25282647|NCT04407988|Hormone Antagonists|hormone antagonists|mesh-ancestor
25282648|NCT04407988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25282649|NCT04407988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282650|NCT04342078|Vitamin D|vitamin d|mesh-list
25282651|NCT04342078|Vitamins|vitamins|mesh-ancestor
25282652|NCT04342078|Micronutrients|micronutrients|mesh-ancestor
25282653|NCT04342078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282654|NCT04342078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25282655|NCT04218266|Apixaban|apixaban|mesh-list
25282656|NCT04218266|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25282657|NCT04218266|Antithrombins|antithrombins|mesh-ancestor
25282658|NCT04218266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25282659|NCT04218266|Protease Inhibitors|protease inhibitors|mesh-ancestor
25282660|NCT04218266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282661|NCT04218266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282662|NCT04218266|Anticoagulants|anticoagulants|mesh-ancestor
25282663|NCT04102241|Hemay005|hemay005|mesh-list
25282664|NCT04102241|Dermatologic Agents|dermatologic agents|mesh-ancestor
25282665|NCT04102241|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25282666|NCT04102241|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25131363|NCT03026244|Vitamin D|vitamin d|mesh-list
25131364|NCT03026244|Caseins|caseins|mesh-list
25131365|NCT03026244|Vitamins|vitamins|mesh-ancestor
25131366|NCT03026244|Micronutrients|micronutrients|mesh-ancestor
25131367|NCT03026244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131368|NCT03026244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25131369|NCT03026244|Chelating Agents|chelating agents|mesh-ancestor
25131370|NCT03026244|Sequestering Agents|sequestering agents|mesh-ancestor
25131371|NCT03026244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25131372|NCT03026140|Celecoxib|celecoxib|mesh-list
25131373|NCT03026140|Nivolumab|nivolumab|mesh-list
25131374|NCT03026140|Ipilimumab|ipilimumab|mesh-list
25131375|NCT03026140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25131392|NCT03026036|Raclopride|raclopride|mesh-list
25131687|NCT03024515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25131688|NCT03024515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131689|NCT03024515|Analgesics|analgesics|mesh-ancestor
25131690|NCT03024515|Sensory System Agents|sensory system agents|mesh-ancestor
25131691|NCT03024515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25131692|NCT03024450|Trastuzumab|trastuzumab|mesh-list
25131693|NCT03024450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25131694|NCT03024450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25131695|NCT03024697|Anesthetics|anesthetics|mesh-list
25131696|NCT03024697|Anesthetics, Local|anesthetics, local|mesh-list
25131697|NCT03024697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25131698|NCT03024697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25131699|NCT03024697|Sensory System Agents|sensory system agents|mesh-ancestor
25131700|NCT03024697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25282667|NCT04102241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282668|NCT04102241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282669|NCT04083014|Bortezomib|bortezomib|mesh-list
25282670|NCT04083014|Antibodies|antibodies|mesh-list
25282671|NCT04083014|Immunologic Factors|immunologic factors|mesh-ancestor
25282672|NCT04083014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282673|NCT04083014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25282692|NCT04026945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692967|NCT02006706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282701|NCT03980561|Varenicline|varenicline|mesh-list
25282702|NCT03980561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25282703|NCT03980561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25282704|NCT03980561|Cholinergic Agents|cholinergic agents|mesh-ancestor
25282705|NCT03980561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25282706|NCT03980561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282707|NCT03980561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282708|NCT03978767|Acetaminophen|acetaminophen|mesh-list
25282710|NCT03978767|Ketorolac|ketorolac|mesh-list
25282711|NCT03978767|Oxycodone|oxycodone|mesh-list
25282712|NCT03978767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25282718|NCT03978767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25282720|NCT03978767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25282721|NCT03978767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25282722|NCT03978767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282723|NCT03978767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282724|NCT03978767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25282725|NCT03978767|Narcotics|narcotics|mesh-ancestor
25282726|NCT03978767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25282727|NCT03971669|Vaccines|vaccines|mesh-list
25282728|NCT03971669|Immunologic Factors|immunologic factors|mesh-ancestor
25282729|NCT03971669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282730|NCT03838692|Ponatinib|ponatinib|mesh-list
25282731|NCT03838692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25282732|NCT03838692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25282733|NCT03838692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282734|NCT03838692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282735|NCT03774186|Pancrelipase|pancrelipase|mesh-list
25282736|NCT03774186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25282740|NCT03739268|Sevelamer|sevelamer|mesh-list
25282741|NCT03739268|Chelating Agents|chelating agents|mesh-ancestor
25282742|NCT03739268|Sequestering Agents|sequestering agents|mesh-ancestor
25282743|NCT03739268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282744|NCT03734263|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25282745|NCT03734263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25282746|NCT03671525|Nimodipine|nimodipine|mesh-list
25282747|NCT03671525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25282748|NCT03671525|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25132144|NCT03020940|Cefuroxime|cefuroxime|mesh-list
25132145|NCT03020940|Cefuroxime axetil|cefuroxime axetil|mesh-list
25132146|NCT03020940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25132147|NCT03020940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25132148|NCT03020901|Teicoplanin|teicoplanin|mesh-list
25132149|NCT03020901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25132164|NCT03020706|Analgesics|analgesics|mesh-ancestor
25132165|NCT03020706|Sensory System Agents|sensory system agents|mesh-ancestor
25132166|NCT03020706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25132167|NCT03020706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132168|NCT03020706|Anesthetics|anesthetics|mesh-ancestor
25132169|NCT03020706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25132170|NCT03020706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25132171|NCT03020706|Anticonvulsants|anticonvulsants|mesh-ancestor
24844383|NCT02232542|Dopamine Agents|dopamine agents|mesh-ancestor
25282749|NCT03671525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25282750|NCT03671525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282751|NCT03671525|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25282752|NCT03671525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282753|NCT03671525|Vasodilator Agents|vasodilator agents|mesh-ancestor
25282761|NCT03576443|Idelalisib|idelalisib|mesh-list
25282762|NCT03576443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25282763|NCT03576443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282764|NCT03576443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282765|NCT03505944|Venetoclax|venetoclax|mesh-list
25282774|NCT03353259|Tranexamic Acid|tranexamic acid|mesh-list
25282775|NCT03353259|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25282776|NCT03353259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25282777|NCT03353259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282778|NCT03353259|Hemostatics|hemostatics|mesh-ancestor
25282779|NCT03353259|Coagulants|coagulants|mesh-ancestor
25282780|NCT03128905|Prednisone|prednisone|mesh-list
25282781|NCT03128905|Colchicine|colchicine|mesh-list
25282782|NCT03128905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24466801|NCT00375050|Anticonvulsants|anticonvulsants|mesh-ancestor
25282783|NCT03128905|Glucocorticoids|glucocorticoids|mesh-ancestor
25132173|NCT03020706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25132406|NCT03018665|Metformin|metformin|mesh-list
25132407|NCT03018665|Exenatide|exenatide|mesh-list
25132408|NCT03018665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25132409|NCT03018665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25132410|NCT03018665|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25132411|NCT03018665|Incretins|incretins|mesh-ancestor
25132412|NCT03018665|Hormones|hormones|mesh-ancestor
25132413|NCT03018665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24808906|NCT02029794|Acetic Acid|acetic acid|mesh-list
24434862|NCT00264173|Valproic Acid|valproic acid|mesh-list
24458057|NCT00336401|Anesthetics, General|anesthetics, general|mesh-ancestor
24458058|NCT00336401|Anesthetics|anesthetics|mesh-ancestor
24458059|NCT00336401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25282784|NCT03128905|Hormones|hormones|mesh-ancestor
25282785|NCT03128905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25282786|NCT03128905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282787|NCT03128905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25282788|NCT03128905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25282789|NCT03128905|Gout Suppressants|gout suppressants|mesh-ancestor
25282790|NCT03128905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25282791|NCT03128905|Tubulin Modulators|tubulin modulators|mesh-ancestor
25282792|NCT03128905|Antimitotic Agents|antimitotic agents|mesh-ancestor
25282793|NCT03128905|Mitosis Modulators|mitosis modulators|mesh-ancestor
25282794|NCT03128905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132646|NCT03017495|Midazolam|midazolam|mesh-list
25132793|NCT03016988|Bortezomib|bortezomib|mesh-list
25132794|NCT03016988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25132795|NCT03016988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25132796|NCT03016988|Antimetabolites|antimetabolites|mesh-ancestor
25132797|NCT03016988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25132802|NCT03016988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24458075|NCT00336414|Hormones|hormones|mesh-ancestor
24458076|NCT00336414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24458077|NCT00336414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24458078|NCT00336414|Antimetabolites|antimetabolites|mesh-ancestor
24458079|NCT00336414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24458080|NCT00336453|Hemagglutinins|hemagglutinins|mesh-list
24458081|NCT00336453|Agglutinins|agglutinins|mesh-ancestor
24458082|NCT00336453|Immunologic Factors|immunologic factors|mesh-ancestor
24458083|NCT00336453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458084|NCT00336466|Epoetin Alfa|epoetin alfa|mesh-list
24458085|NCT00336466|Hematinics|hematinics|mesh-ancestor
24532503|NCT00640159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282824|NCT02913495|Progesterone|progesterone|mesh-list
25282825|NCT02913495|Progestins|progestins|mesh-ancestor
25282826|NCT02913495|Hormones|hormones|mesh-ancestor
25282827|NCT02913495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25282828|NCT02913495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282829|NCT02823990|Nivolumab|nivolumab|mesh-list
25282830|NCT02823990|Interleukin-2|interleukin-2|mesh-list
25282831|NCT02823990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282832|NCT02823990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25282833|NCT02823990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25282834|NCT02823990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25282835|NCT02823990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282836|NCT02823990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25282837|NCT02823990|Analgesics|analgesics|mesh-ancestor
25282838|NCT02823990|Sensory System Agents|sensory system agents|mesh-ancestor
25282839|NCT02823990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25282840|NCT02633098|Artesunate|artesunate|mesh-list
25282841|NCT02633098|Antimalarials|antimalarials|mesh-ancestor
25282842|NCT02633098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25282843|NCT02633098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25282844|NCT02633098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25282845|NCT02633098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25282846|NCT02633098|Antiviral Agents|antiviral agents|mesh-ancestor
25282847|NCT02633098|Schistosomicides|schistosomicides|mesh-ancestor
25282848|NCT02633098|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25282849|NCT02633098|Anthelmintics|anthelmintics|mesh-ancestor
25282850|NCT02624128|Cetuximab|cetuximab|mesh-list
25282851|NCT02624128|Valproic Acid|valproic acid|mesh-list
25282852|NCT02624128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25282853|NCT02624128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25282854|NCT02624128|Anticonvulsants|anticonvulsants|mesh-ancestor
25282855|NCT02624128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282856|NCT02624128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282857|NCT02624128|GABA Agents|gaba agents|mesh-ancestor
25282858|NCT02624128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25282859|NCT02624128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282860|NCT02624128|Antimanic Agents|antimanic agents|mesh-ancestor
25282861|NCT02624128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25132803|NCT03017066|Anesthetics|anesthetics|mesh-list
25132878|NCT03016650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25133029|NCT03015831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25133030|NCT03015701|Mifepristone|mifepristone|mesh-list
25133031|NCT03015701|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24467159|NCT00376467|Imatinib Mesylate|imatinib mesylate|mesh-list
25133032|NCT03015701|Abortifacient Agents|abortifacient agents|mesh-ancestor
25133033|NCT03015701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25133034|NCT03015701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133035|NCT03015701|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25133036|NCT03015701|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25133037|NCT03015701|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25133038|NCT03015701|Contraceptive Agents|contraceptive agents|mesh-ancestor
25133039|NCT03015701|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25133040|NCT03015701|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25133041|NCT03015701|Hormone Antagonists|hormone antagonists|mesh-ancestor
25133042|NCT03015701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25133043|NCT03015701|Luteolytic Agents|luteolytic agents|mesh-ancestor
25133044|NCT03015701|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25133045|NCT03015701|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24844744|NCT02234193|Lidocaine|lidocaine|mesh-list
24708491|NCT01501435|Fenofibric acid|fenofibric acid|mesh-list
24708492|NCT01501435|Fenofibrate|fenofibrate|mesh-list
24708493|NCT01501435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24708494|NCT01501435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24708495|NCT01501435|Antimetabolites|antimetabolites|mesh-ancestor
24708496|NCT01501435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708497|NCT01501435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24708498|NCT01501448|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24708499|NCT01501448|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24708505|NCT01501448|Estrogens|estrogens|mesh-ancestor
24708506|NCT01501448|Hormones|hormones|mesh-ancestor
24708507|NCT01501448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24644956|NCT01194232|Urological Agents|urological agents|mesh-ancestor
25282862|NCT02624128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25282863|NCT02624128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25282864|NCT02578069|Sirolimus|sirolimus|mesh-list
25282865|NCT02578069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25282866|NCT02578069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25282867|NCT02578069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25282868|NCT02578069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25282869|NCT02578069|Antifungal Agents|antifungal agents|mesh-ancestor
25282870|NCT02578069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25282871|NCT02578069|Immunologic Factors|immunologic factors|mesh-ancestor
25282872|NCT02578069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282873|NCT02427126|Aspirin|aspirin|mesh-list
25282874|NCT02427126|Apixaban|apixaban|mesh-list
25282875|NCT02427126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25282876|NCT02427126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25282877|NCT02427126|Analgesics|analgesics|mesh-ancestor
25282878|NCT02427126|Sensory System Agents|sensory system agents|mesh-ancestor
25024129|NCT03648658|Acetaminophen|acetaminophen|mesh-list
25282879|NCT02427126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25282880|NCT02427126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282884|NCT02427126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25282885|NCT02427126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282886|NCT02427126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25282887|NCT02427126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25282888|NCT02427126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282889|NCT02427126|Antipyretics|antipyretics|mesh-ancestor
25282890|NCT02427126|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25282891|NCT02427126|Antithrombins|antithrombins|mesh-ancestor
25282892|NCT02427126|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25133047|NCT03015675|Vitamins|vitamins|mesh-ancestor
25133048|NCT03015675|Micronutrients|micronutrients|mesh-ancestor
25133049|NCT03015675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133050|NCT03015675|Antioxidants|antioxidants|mesh-ancestor
25133051|NCT03015675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133052|NCT03015675|Protective Agents|protective agents|mesh-ancestor
25133053|NCT03015519|rGLP-1 protein|rglp-1 protein|mesh-list
25133055|NCT03015519|Hormones|hormones|mesh-ancestor
25133056|NCT03015519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25133057|NCT03015519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809593|NCT02034968|Nimotuzumab|nimotuzumab|mesh-list
24972800|NCT03715296|Growth Inhibitors|growth inhibitors|mesh-ancestor
24972801|NCT03715296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25692968|NCT02006706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24896088|NCT02382445|Propofol|propofol|mesh-list
25133212|NCT03013751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25133213|NCT03013751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25133214|NCT03013751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25133215|NCT03013751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133216|NCT03013647|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25133217|NCT03013647|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
25133218|NCT03013647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25133219|NCT03013647|Dermatologic Agents|dermatologic agents|mesh-ancestor
24708508|NCT01501448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708509|NCT01501448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24708510|NCT01501448|Contraceptive Agents|contraceptive agents|mesh-ancestor
24708511|NCT01501448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24708512|NCT01501448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24708513|NCT01501448|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24708514|NCT01501448|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24708515|NCT01501448|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24708516|NCT01501448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24708517|NCT01501487|Paclitaxel|paclitaxel|mesh-list
24494557|NCT00495846|Octreotide|octreotide|mesh-list
24708530|NCT01501500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24708531|NCT01501500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282893|NCT02427126|Protease Inhibitors|protease inhibitors|mesh-ancestor
25282894|NCT02427126|Anticoagulants|anticoagulants|mesh-ancestor
25282895|NCT05080569|Progesterone|progesterone|mesh-list
25282896|NCT05080569|Progestins|progestins|mesh-ancestor
25282897|NCT05080569|Hormones|hormones|mesh-ancestor
25282898|NCT05080569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25282899|NCT05080569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282900|NCT05080543|Terlipressin|terlipressin|mesh-list
25282901|NCT05080543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25282902|NCT05080543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25282903|NCT05080478|Clopidogrel|clopidogrel|mesh-list
25282904|NCT05080478|Ticagrelor|ticagrelor|mesh-list
25282905|NCT05080478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25282906|NCT05080478|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25282907|NCT05080478|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25282908|NCT05080478|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25282909|NCT05080478|Purinergic Agents|purinergic agents|mesh-ancestor
25282910|NCT05080478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25282911|NCT05080478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282912|NCT05080478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282913|NCT05080348|Ropivacaine|ropivacaine|mesh-list
25282914|NCT05080348|Anesthetics, Local|anesthetics, local|mesh-ancestor
25282915|NCT05080348|Anesthetics|anesthetics|mesh-ancestor
25282916|NCT05080348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25282917|NCT05080348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282918|NCT05080348|Sensory System Agents|sensory system agents|mesh-ancestor
25282919|NCT05080348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25282920|NCT05080192|Fenofibrate|fenofibrate|mesh-list
25282921|NCT05080192|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25282922|NCT05080192|Antimetabolites|antimetabolites|mesh-ancestor
25692969|NCT02006706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25692970|NCT02006706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25692971|NCT02006706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25692972|NCT02006706|Antiemetics|antiemetics|mesh-ancestor
25692973|NCT02006706|Autonomic Agents|autonomic agents|mesh-ancestor
25692974|NCT02006706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25692975|NCT02006706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25692976|NCT02006706|Glucocorticoids|glucocorticoids|mesh-ancestor
25692977|NCT02006706|Hormones|hormones|mesh-ancestor
25709253|NCT02263547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25079314|NCT03348735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24708532|NCT01501500|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24708533|NCT01501500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24708534|NCT01501500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708535|NCT01501500|Cholinergic Agents|cholinergic agents|mesh-ancestor
24708536|NCT01501500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24708537|NCT01501591|Hydroxyzine|hydroxyzine|mesh-list
24708538|NCT01501591|Antipruritics|antipruritics|mesh-ancestor
24708541|NCT01501591|Histamine Antagonists|histamine antagonists|mesh-ancestor
24708542|NCT01501591|Histamine Agents|histamine agents|mesh-ancestor
24708543|NCT01501591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24708544|NCT01501591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708545|NCT01501591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708546|NCT01501669|Capecitabine|capecitabine|mesh-list
24708547|NCT01501669|Irinotecan|irinotecan|mesh-list
24708548|NCT01501669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24708549|NCT01501669|Antimetabolites|antimetabolites|mesh-ancestor
25024417|NCT03646292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708550|NCT01501669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708551|NCT01501669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708552|NCT01501669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24708553|NCT01501669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24708554|NCT01501669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708555|NCT01501695|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
24708556|NCT01501695|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24708557|NCT01501695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25282923|NCT05080192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282924|NCT05080192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25282925|NCT05080140|Ezetimibe|ezetimibe|mesh-list
25282926|NCT05080140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25282927|NCT05080140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25282928|NCT05080140|Antimetabolites|antimetabolites|mesh-ancestor
25282929|NCT05080140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282930|NCT05080140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25282931|NCT05080049|Epoetin Alfa|epoetin alfa|mesh-list
25282932|NCT05080049|Hematinics|hematinics|mesh-ancestor
25282933|NCT05080010|Carboplatin|carboplatin|mesh-list
25282934|NCT05080010|Etoposide|etoposide|mesh-list
25282935|NCT05080010|Vincristine|vincristine|mesh-list
25282936|NCT05080010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25282937|NCT05080010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25282938|NCT05080010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25282939|NCT05080010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25282940|NCT05080010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282942|NCT05080010|Tubulin Modulators|tubulin modulators|mesh-ancestor
25282943|NCT05080010|Antimitotic Agents|antimitotic agents|mesh-ancestor
25282944|NCT05080010|Mitosis Modulators|mitosis modulators|mesh-ancestor
25282945|NCT05079880|Caffeine|caffeine|mesh-list
25282946|NCT05079880|Caffeine citrate|caffeine citrate|mesh-list
25282947|NCT05079880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692978|NCT02006706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25108440|NCT03132181|Empagliflozin|empagliflozin|mesh-list
24708558|NCT01501695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24708559|NCT01501695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708560|NCT01501695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24708561|NCT01501695|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24708562|NCT01501695|Dopamine Agents|dopamine agents|mesh-ancestor
24708563|NCT01501695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24708564|NCT01501695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708570|NCT01501708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24708571|NCT01501708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24708572|NCT01501708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708573|NCT01501708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708574|NCT01501708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24708575|NCT01501708|Hormone Antagonists|hormone antagonists|mesh-ancestor
24708576|NCT01501708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24708577|NCT01501708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708578|NCT01501708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24708579|NCT01501708|Amebicides|amebicides|mesh-ancestor
24708580|NCT01501708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24708581|NCT01501708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24708582|NCT01501708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24708583|NCT01501747|Acetaminophen|acetaminophen|mesh-list
24708593|NCT01501747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24708595|NCT01501747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24613957|NCT01021735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24613958|NCT01021787|Titanium dioxide|titanium dioxide|mesh-list
24613959|NCT01021787|Sunscreening Agents|sunscreening agents|mesh-ancestor
24613960|NCT01021787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24613961|NCT01021787|Protective Agents|protective agents|mesh-ancestor
24613962|NCT01021787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613963|NCT01021787|Dermatologic Agents|dermatologic agents|mesh-ancestor
24613964|NCT01021787|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24613965|NCT01021865|Glucagon|glucagon|mesh-list
25282948|NCT05079880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25282949|NCT05079880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282950|NCT05079880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25282951|NCT05079880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25282952|NCT05079880|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25282953|NCT05079880|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25282954|NCT05079880|Purinergic Agents|purinergic agents|mesh-ancestor
25282955|NCT05079880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25282956|NCT05079789|Amiloride|amiloride|mesh-list
25282957|NCT05079789|Furosemide|furosemide|mesh-list
25282958|NCT05079789|Diuretics|diuretics|mesh-ancestor
25282959|NCT05079789|Natriuretic Agents|natriuretic agents|mesh-ancestor
25282960|NCT05079789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282961|NCT05079789|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25282962|NCT05079789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25282963|NCT05079789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282964|NCT05079789|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24458120|NCT00336648|Immunologic Factors|immunologic factors|mesh-ancestor
24458122|NCT00336674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24458123|NCT00336674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458124|NCT00336739|Cinacalcet|cinacalcet|mesh-list
24458125|NCT00336739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24458126|NCT00336739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133369|NCT03013010|Oxaliplatin|oxaliplatin|mesh-list
25133448|NCT03012763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25133518|NCT03011970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25133519|NCT03011970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973333|NCT03710252|Antimetabolites|antimetabolites|mesh-ancestor
24458127|NCT00336739|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24458128|NCT00336739|Hormone Antagonists|hormone antagonists|mesh-ancestor
24458129|NCT00336739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24613966|NCT01021865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24613967|NCT01021865|Regadenoson|regadenoson|mesh-list
24613968|NCT01021865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24613969|NCT01021865|Hormones|hormones|mesh-ancestor
24613970|NCT01021865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24613971|NCT01021865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613975|NCT01021865|Purinergic Agonists|purinergic agonists|mesh-ancestor
24613976|NCT01021865|Purinergic Agents|purinergic agents|mesh-ancestor
24613977|NCT01021865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24613978|NCT01021865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282965|NCT05079789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25282966|NCT05079789|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
25282967|NCT05079789|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25282972|NCT05079087|Midazolam|midazolam|mesh-list
25282973|NCT05079087|Ketamine|ketamine|mesh-list
25282974|NCT05079087|Analgesics|analgesics|mesh-ancestor
25282975|NCT05079087|Sensory System Agents|sensory system agents|mesh-ancestor
25282976|NCT05079087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25282977|NCT05079087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25282978|NCT05079087|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25282979|NCT05079087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25282980|NCT05079087|Anesthetics, General|anesthetics, general|mesh-ancestor
25282981|NCT05079087|Anesthetics|anesthetics|mesh-ancestor
25282982|NCT05079087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25282983|NCT05079087|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25282984|NCT05079087|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25282985|NCT05079087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25282986|NCT05079087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25282987|NCT05079087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25282988|NCT05079087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25282989|NCT05079087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25282990|NCT05079087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25282991|NCT05079087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25282992|NCT05079087|GABA Modulators|gaba modulators|mesh-ancestor
25282993|NCT05079087|GABA Agents|gaba agents|mesh-ancestor
25282994|NCT05079022|Aflutinib|aflutinib|mesh-list
25282995|NCT05079022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25282996|NCT05079022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458134|NCT00336765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458135|NCT00336791|Paclitaxel|paclitaxel|mesh-list
24458136|NCT00336791|Cyclophosphamide|cyclophosphamide|mesh-list
25692979|NCT02006706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25282997|NCT05079022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283006|NCT05078788|Triamcinolone|triamcinolone|mesh-list
25283007|NCT05078788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25283008|NCT05078788|Glucocorticoids|glucocorticoids|mesh-ancestor
25283009|NCT05078788|Hormones|hormones|mesh-ancestor
25283010|NCT05078788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25283011|NCT05078788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283012|NCT05078710|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25283013|NCT05078710|Immunologic Factors|immunologic factors|mesh-ancestor
25283014|NCT05078710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283015|NCT05078372|Midazolam|midazolam|mesh-list
25283016|NCT05078372|Ropivacaine|ropivacaine|mesh-list
25283017|NCT05078372|Anesthetics, Local|anesthetics, local|mesh-ancestor
25283018|NCT05078372|Anesthetics|anesthetics|mesh-ancestor
25283019|NCT05078372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25283020|NCT05078372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283021|NCT05078372|Sensory System Agents|sensory system agents|mesh-ancestor
25283022|NCT05078372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25283023|NCT05078372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25283024|NCT05078372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25283025|NCT05078372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25283026|NCT05078372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25283027|NCT05078372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25283028|NCT05078372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25283029|NCT05078372|Anesthetics, General|anesthetics, general|mesh-ancestor
25283030|NCT05078372|GABA Modulators|gaba modulators|mesh-ancestor
25283031|NCT05078372|GABA Agents|gaba agents|mesh-ancestor
25283032|NCT05078372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25283033|NCT05078372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283034|NCT05078255|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
25283035|NCT05078255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25283036|NCT05078255|Incretins|incretins|mesh-ancestor
25283037|NCT05078255|Hormones|hormones|mesh-ancestor
25283038|NCT05078255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25283039|NCT05078255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133671|NCT03011567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133743|NCT03010761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25133744|NCT03010761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25133745|NCT03010761|Serotonin Agents|serotonin agents|mesh-ancestor
25133746|NCT03010761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133747|NCT03010761|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25133748|NCT03010761|Antidepressive Agents|antidepressive agents|mesh-ancestor
25133749|NCT03010761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25133750|NCT03010761|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25133751|NCT03010761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25133752|NCT03011021|Liraglutide|liraglutide|mesh-list
25133753|NCT03011021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25133754|NCT03011021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25133755|NCT03011021|Incretins|incretins|mesh-ancestor
25133757|NCT03011021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25133758|NCT03010540|Fentanyl|fentanyl|mesh-list
25133759|NCT03010540|Morphine|morphine|mesh-list
25133760|NCT03010540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25133761|NCT03010540|Narcotics|narcotics|mesh-ancestor
25133762|NCT03010540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25133763|NCT03010540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283040|NCT05078177|Rituximab|rituximab|mesh-list
25283041|NCT05078177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25283042|NCT05078177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283043|NCT05078177|Immunologic Factors|immunologic factors|mesh-ancestor
25283044|NCT05078177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468040|NCT00379509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24468171|NCT00380263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468172|NCT00380289|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25283045|NCT05078177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25283046|NCT05078138|Epoetin Alfa|epoetin alfa|mesh-list
25283047|NCT05078138|Hematinics|hematinics|mesh-ancestor
25133768|NCT03010540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25133791|NCT03010228|Aluminum sulfate|aluminum sulfate|mesh-list
25133867|NCT03009643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25134018|NCT03009058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25134019|NCT03009058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25134020|NCT03009058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25134021|NCT03009058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25025170|NCT03639480|Amlodipine|amlodipine|mesh-list
25134022|NCT03009058|Antidotes|antidotes|mesh-ancestor
25134023|NCT03009058|Protective Agents|protective agents|mesh-ancestor
25134024|NCT03009058|Vitamin B Complex|vitamin b complex|mesh-ancestor
25134025|NCT03009058|Vitamins|vitamins|mesh-ancestor
25134026|NCT03009058|Micronutrients|micronutrients|mesh-ancestor
25134027|NCT03009058|Hematinics|hematinics|mesh-ancestor
25134028|NCT03009409|Ketamine|ketamine|mesh-list
25134029|NCT03009409|Analgesics|analgesics|mesh-ancestor
25134030|NCT03009409|Sensory System Agents|sensory system agents|mesh-ancestor
25134031|NCT03009409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25134032|NCT03009409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134033|NCT03009409|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25134034|NCT03009409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25134035|NCT03009409|Anesthetics, General|anesthetics, general|mesh-ancestor
25134036|NCT03009409|Anesthetics|anesthetics|mesh-ancestor
25134037|NCT03009409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25134038|NCT03009409|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25134039|NCT03009409|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25134040|NCT03009409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25134041|NCT03009409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134042|NCT03009006|Calcium, Dietary|calcium, dietary|mesh-list
25134043|NCT03009006|Chlorhexidine|chlorhexidine|mesh-list
25134044|NCT03009006|Calcium|calcium|mesh-list
25134045|NCT03009006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25283048|NCT05077813|Vitamin D|vitamin d|mesh-list
25283049|NCT05077813|Ergocalciferols|ergocalciferols|mesh-list
25283050|NCT05077813|Cholecalciferol|cholecalciferol|mesh-list
25283051|NCT05077813|Vitamins|vitamins|mesh-list
25283052|NCT05077813|Minocycline|minocycline|mesh-list
25283053|NCT05077813|Tretinoin|tretinoin|mesh-list
25283054|NCT05077813|Alitretinoin|alitretinoin|mesh-list
25283055|NCT05077813|Isotretinoin|isotretinoin|mesh-list
25283056|NCT05077813|Micronutrients|micronutrients|mesh-ancestor
25283057|NCT05077813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283058|NCT05077813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25283059|NCT05077813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25283060|NCT05077813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25283061|NCT05077813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25283062|NCT05077813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283063|NCT05077813|Keratolytic Agents|keratolytic agents|mesh-ancestor
25283064|NCT05077813|Dermatologic Agents|dermatologic agents|mesh-ancestor
25283065|NCT05077592|Povidone-Iodine|povidone-iodine|mesh-list
25283067|NCT05077592|Plasma Substitutes|plasma substitutes|mesh-ancestor
25283068|NCT05077592|Blood Substitutes|blood substitutes|mesh-ancestor
25283069|NCT05077592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25283070|NCT05077592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25283071|NCT05077527|Cyclophosphamide|cyclophosphamide|mesh-list
25283072|NCT05077527|Fludarabine|fludarabine|mesh-list
25283073|NCT05077527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25283074|NCT05077527|Immunologic Factors|immunologic factors|mesh-ancestor
25283075|NCT05077527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283076|NCT05077527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25283077|NCT05077527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25283078|NCT05077527|Alkylating Agents|alkylating agents|mesh-ancestor
25283079|NCT05077527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692980|NCT02006706|Protective Agents|protective agents|mesh-ancestor
25692981|NCT02006706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25692982|NCT02006732|Tiotropium Bromide|tiotropium bromide|mesh-list
25283080|NCT05077527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283081|NCT05077527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25283082|NCT05077475|Cryptophycin 52|cryptophycin 52|mesh-list
25283083|NCT05077475|Antimitotic Agents|antimitotic agents|mesh-ancestor
25283084|NCT05077475|Mitosis Modulators|mitosis modulators|mesh-ancestor
25692983|NCT02006732|Olodaterol|olodaterol|mesh-list
24468922|NCT00383916|Pantoprazole|pantoprazole|mesh-list
25283085|NCT05077475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283086|NCT05077475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283087|NCT05077462|Cryptophycin 52|cryptophycin 52|mesh-list
25283088|NCT05077462|Antimitotic Agents|antimitotic agents|mesh-ancestor
25283089|NCT05077462|Mitosis Modulators|mitosis modulators|mesh-ancestor
25283090|NCT05077462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283091|NCT05077462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283092|NCT05077215|Pembrolizumab|pembrolizumab|mesh-list
25134271|NCT03007654|Chitosan|chitosan|mesh-list
25134272|NCT03007654|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25134273|NCT03007654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25134274|NCT03007654|Antimetabolites|antimetabolites|mesh-ancestor
25134275|NCT03007654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134276|NCT03007654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25134277|NCT03007654|Chelating Agents|chelating agents|mesh-ancestor
25134278|NCT03007654|Sequestering Agents|sequestering agents|mesh-ancestor
25134279|NCT03007654|Hemostatics|hemostatics|mesh-ancestor
25134280|NCT03007654|Coagulants|coagulants|mesh-ancestor
25134281|NCT03007160|Potassium Citrate|potassium citrate|mesh-list
25134283|NCT03007160|Natriuretic Agents|natriuretic agents|mesh-ancestor
25134284|NCT03007160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134285|NCT03007160|Expectorants|expectorants|mesh-ancestor
25134286|NCT03007160|Respiratory System Agents|respiratory system agents|mesh-ancestor
25134287|NCT03006874|Esomeprazole|esomeprazole|mesh-list
25134288|NCT03006874|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25134289|NCT03006874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25134290|NCT03006874|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25134291|NCT03006874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25134292|NCT03006874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134293|NCT03006965|Factor VIII|factor viii|mesh-list
25134294|NCT03006965|BAX 855|bax 855|mesh-list
25134295|NCT03006965|Coagulants|coagulants|mesh-ancestor
25134296|NCT03007004|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
25134297|NCT03007004|Botulinum Toxins|botulinum toxins|mesh-list
25134298|NCT03007004|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25134299|NCT03007004|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24587658|NCT00896285|Opiate Alkaloids|opiate alkaloids|mesh-list
25057890|NCT03500874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25134300|NCT03007004|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25134301|NCT03007004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24613979|NCT01021891|Insulin|insulin|mesh-list
24613980|NCT01021891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24613981|NCT01021891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613982|NCT01021930|Sirolimus|sirolimus|mesh-list
24613983|NCT01021930|Paclitaxel|paclitaxel|mesh-list
24613984|NCT01021930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24613985|NCT01021930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613986|NCT01021930|Tubulin Modulators|tubulin modulators|mesh-ancestor
24613987|NCT01021930|Antimitotic Agents|antimitotic agents|mesh-ancestor
24613988|NCT01021930|Mitosis Modulators|mitosis modulators|mesh-ancestor
24613989|NCT01021930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613990|NCT01021930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25283094|NCT05077215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25283095|NCT05077215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283096|NCT05077215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25283097|NCT05077215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25283098|NCT05077215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283099|NCT05077111|Anesthetics|anesthetics|mesh-list
25283100|NCT05077111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25283101|NCT05077111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283102|NCT05075863|Letrozole|letrozole|mesh-list
25283103|NCT05075863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283104|NCT05075863|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25283105|NCT05075863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25283106|NCT05075863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25283107|NCT05075863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283108|NCT05075863|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25283109|NCT05075863|Hormone Antagonists|hormone antagonists|mesh-ancestor
25283110|NCT05075863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25283111|NCT05075863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283112|NCT05068141|Paclitaxel|paclitaxel|mesh-list
25283113|NCT05068141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25283114|NCT05068141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469360|NCT00385502|Econazole|econazole|mesh-list
25283115|NCT05068141|Tubulin Modulators|tubulin modulators|mesh-ancestor
25283116|NCT05068141|Antimitotic Agents|antimitotic agents|mesh-ancestor
25283117|NCT05068141|Mitosis Modulators|mitosis modulators|mesh-ancestor
25283118|NCT05068141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283119|NCT05068037|Antiemetics|antiemetics|mesh-list
25283120|NCT05068037|Autonomic Agents|autonomic agents|mesh-ancestor
25283121|NCT05068037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25283122|NCT05068037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134302|NCT03007004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134303|NCT03007004|Cholinergic Agents|cholinergic agents|mesh-ancestor
25134304|NCT03007004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25134305|NCT03007004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134306|NCT03007004|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25134307|NCT03007004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25134308|NCT03007004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25134464|NCT03006003|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25134613|NCT03005704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25134614|NCT03005704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25025371|NCT03638037|Micronutrients|micronutrients|mesh-ancestor
25134615|NCT03005704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25134616|NCT03005704|Purinergic Agents|purinergic agents|mesh-ancestor
25134617|NCT03005704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25134618|NCT03005704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25134619|NCT03005704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25134620|NCT03005704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25134621|NCT03005704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25134623|NCT03005704|Sensory System Agents|sensory system agents|mesh-ancestor
25134624|NCT03005704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25134625|NCT03005704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25134631|NCT03005704|Antipyretics|antipyretics|mesh-ancestor
25134817|NCT03004625|Antiviral Agents|antiviral agents|mesh-ancestor
25134886|NCT03004339|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25134961|NCT03003728|Melphalan|melphalan|mesh-list
25135109|NCT03002636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25135110|NCT03002636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135111|NCT03002259|Dexamethasone|dexamethasone|mesh-list
25135112|NCT03002259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25135113|NCT03002259|Antiemetics|antiemetics|mesh-ancestor
25135114|NCT03002259|Autonomic Agents|autonomic agents|mesh-ancestor
25135115|NCT03002259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25135116|NCT03002259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135117|NCT03002259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25283124|NCT05053425|Cytarabine|cytarabine|mesh-list
25283125|NCT05053425|Azacitidine|azacitidine|mesh-list
25283126|NCT05053425|Venetoclax|venetoclax|mesh-list
25283127|NCT05053425|Idarubicin|idarubicin|mesh-list
25283128|NCT05053425|Cladribine|cladribine|mesh-list
25283129|NCT05053425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25283130|NCT05053425|Antimetabolites|antimetabolites|mesh-ancestor
25283131|NCT05053425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283132|NCT05053425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283133|NCT05053425|Antiviral Agents|antiviral agents|mesh-ancestor
25283134|NCT05053425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25283135|NCT05053425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25283136|NCT05053425|Immunologic Factors|immunologic factors|mesh-ancestor
25283137|NCT05053425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283138|NCT05053425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25283139|NCT05053425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25283140|NCT05053425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25283141|NCT05053425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25283142|NCT05044871|Paclitaxel|paclitaxel|mesh-list
25283143|NCT05044871|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25283144|NCT05044871|Bevacizumab|bevacizumab|mesh-list
25283145|NCT05044871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25283146|NCT05044871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283147|NCT05044871|Tubulin Modulators|tubulin modulators|mesh-ancestor
25283148|NCT05044871|Antimitotic Agents|antimitotic agents|mesh-ancestor
25283149|NCT05044871|Mitosis Modulators|mitosis modulators|mesh-ancestor
25283150|NCT05044871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283151|NCT05044871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25283152|NCT05044871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25283153|NCT05044871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25692984|NCT02006732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24469752|NCT00386997|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25025568|NCT03636048|Sensory System Agents|sensory system agents|mesh-ancestor
24982379|NCT02889133|Iron|iron|mesh-list
25283154|NCT05044871|Growth Substances|growth substances|mesh-ancestor
25283155|NCT05044871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283156|NCT05044871|Growth Inhibitors|growth inhibitors|mesh-ancestor
25283157|NCT05021562|Niraparib|niraparib|mesh-list
25283158|NCT05021562|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25283159|NCT05021562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25135120|NCT03002259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25135121|NCT03002259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25135122|NCT03002259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135123|NCT03002376|Cemiplimab|cemiplimab|mesh-list
25135124|NCT03002376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25135125|NCT03002376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135126|NCT03002064|Docetaxel|docetaxel|mesh-list
25135127|NCT03002064|Fluorouracil|fluorouracil|mesh-list
25135128|NCT03002064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25135129|NCT03002064|Tubulin Modulators|tubulin modulators|mesh-ancestor
25135130|NCT03002064|Antimitotic Agents|antimitotic agents|mesh-ancestor
25135131|NCT03002064|Mitosis Modulators|mitosis modulators|mesh-ancestor
25135132|NCT03002064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135133|NCT03002064|Antimetabolites|antimetabolites|mesh-ancestor
25283197|NCT04996199|Hormone Antagonists|hormone antagonists|mesh-ancestor
25135134|NCT03002064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25135135|NCT03002064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25135136|NCT03002064|Immunologic Factors|immunologic factors|mesh-ancestor
25135137|NCT03002064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135138|NCT03002090|Iron|iron|mesh-list
25135139|NCT03002090|Trace Elements|trace elements|mesh-ancestor
25135140|NCT03002090|Micronutrients|micronutrients|mesh-ancestor
25135141|NCT03002090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135219|NCT03000946|Hormones|hormones|mesh-ancestor
25283160|NCT05021562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283161|NCT05021562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283162|NCT05015686|Vaccines|vaccines|mesh-list
25283163|NCT05015686|Immunologic Factors|immunologic factors|mesh-ancestor
25283164|NCT05015686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283165|NCT05005260|Bupivacaine|bupivacaine|mesh-list
25283166|NCT05005260|Anesthetics, Local|anesthetics, local|mesh-ancestor
25283167|NCT05005260|Anesthetics|anesthetics|mesh-ancestor
25283168|NCT05005260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25283169|NCT05005260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283170|NCT05005260|Sensory System Agents|sensory system agents|mesh-ancestor
25283171|NCT05005260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25283172|NCT04996199|Zileuton|zileuton|mesh-list
25283173|NCT04996199|Carbamazepine|carbamazepine|mesh-list
25283174|NCT04996199|Oxcarbazepine|oxcarbazepine|mesh-list
25283175|NCT04996199|Anticonvulsants|anticonvulsants|mesh-ancestor
25283176|NCT04996199|Antimanic Agents|antimanic agents|mesh-ancestor
25283177|NCT04996199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25283178|NCT04996199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25283179|NCT04996199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283180|NCT04996199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25283181|NCT04996199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25283182|NCT04996199|Analgesics|analgesics|mesh-ancestor
25283183|NCT04996199|Sensory System Agents|sensory system agents|mesh-ancestor
25283184|NCT04996199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25283185|NCT04996199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25283186|NCT04996199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25283187|NCT04996199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283188|NCT04996199|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25283189|NCT04996199|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25283190|NCT04996199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25692985|NCT02006732|Autonomic Agents|autonomic agents|mesh-ancestor
24470582|NCT00390793|Dexamethasone acetate|dexamethasone acetate|mesh-list
25283191|NCT04996199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25283192|NCT04996199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25283193|NCT04996199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25283194|NCT04996199|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25283195|NCT04996199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25283196|NCT04996199|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25135301|NCT03000127|Androgens|androgens|mesh-ancestor
25135302|NCT03000127|Hormones|hormones|mesh-ancestor
25135303|NCT03000127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25135304|NCT03000127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458142|NCT00336791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458143|NCT00336791|Tubulin Modulators|tubulin modulators|mesh-ancestor
24458144|NCT00336791|Antimitotic Agents|antimitotic agents|mesh-ancestor
24458145|NCT00336791|Mitosis Modulators|mitosis modulators|mesh-ancestor
24458146|NCT00336791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458147|NCT00336791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24458148|NCT00336791|Immunologic Factors|immunologic factors|mesh-ancestor
24458149|NCT00336791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458150|NCT00336791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24403045|NCT00159133|Lorazepam|lorazepam|mesh-list
25283198|NCT04996199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25283200|NCT04990284|Opicapone|opicapone|mesh-list
25283201|NCT04990284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25283202|NCT04990284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25283203|NCT04990284|Dopamine Agents|dopamine agents|mesh-ancestor
25283204|NCT04990284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25283205|NCT04990284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283206|NCT04990284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283207|NCT04990284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25283208|NCT04990284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25283209|NCT04988971|Corticosterone|corticosterone|mesh-list
25283210|NCT04988971|Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether|fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether|mesh-list
25283211|NCT04988971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25283212|NCT04988971|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25283213|NCT04988971|Anesthetics, General|anesthetics, general|mesh-ancestor
25283214|NCT04988971|Anesthetics|anesthetics|mesh-ancestor
25283215|NCT04988971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25283216|NCT04988971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283217|NCT04984733|Nivolumab|nivolumab|mesh-list
25283218|NCT04984733|Temozolomide|temozolomide|mesh-list
25283219|NCT04984733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25283220|NCT04984733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25025880|NCT03632915|Lacosamide|lacosamide|mesh-list
25283221|NCT04984733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25283222|NCT04984733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283223|NCT04984733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25283224|NCT04984733|Alkylating Agents|alkylating agents|mesh-ancestor
25283225|NCT04973826|Aztreonam|aztreonam|mesh-list
25283226|NCT04973826|Avibactam|avibactam|mesh-list
25283227|NCT04973826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25283228|NCT04973826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25283229|NCT04973826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25283230|NCT04973826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25283231|NCT04973826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283232|NCT04940637|Niraparib|niraparib|mesh-list
25283233|NCT04940637|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25283234|NCT04940637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25283235|NCT04940637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283236|NCT04940637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283237|NCT04926454|Dexmedetomidine|dexmedetomidine|mesh-list
25283238|NCT04926454|Bupivacaine|bupivacaine|mesh-list
25283239|NCT04926454|Anesthetics, Local|anesthetics, local|mesh-ancestor
25283240|NCT04926454|Anesthetics|anesthetics|mesh-ancestor
25283241|NCT04926454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25283242|NCT04926454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692986|NCT02006732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25692987|NCT02006732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25692988|NCT02006732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25692989|NCT02006732|Respiratory System Agents|respiratory system agents|mesh-ancestor
25692990|NCT02006732|Parasympatholytics|parasympatholytics|mesh-ancestor
25692991|NCT02006732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24810525|NCT02040649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24470990|NCT00392886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24470991|NCT00392886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24470992|NCT00392886|Alkylating Agents|alkylating agents|mesh-ancestor
24470993|NCT00392886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470994|NCT00392886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495960|NCT00502684|Sensory System Agents|sensory system agents|mesh-ancestor
24965383|NCT03777761|Tucatinib|tucatinib|mesh-list
24471073|NCT00393263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24471074|NCT00393263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471075|NCT00393263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24471076|NCT00393263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24471077|NCT00393263|Analgesics|analgesics|mesh-ancestor
24471127|NCT00393393|Hylan|hylan|mesh-list
25283243|NCT04926454|Sensory System Agents|sensory system agents|mesh-ancestor
25283244|NCT04926454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25283245|NCT04926454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25283246|NCT04926454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25283247|NCT04926454|Analgesics|analgesics|mesh-ancestor
25135488|NCT02998905|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25135489|NCT02998905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135490|NCT02998905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25135491|NCT02998905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25135492|NCT02998905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25135493|NCT02998905|Antipyretics|antipyretics|mesh-ancestor
25135494|NCT02998736|Tadalafil|tadalafil|mesh-list
25135495|NCT02998736|Vasodilator Agents|vasodilator agents|mesh-ancestor
25135496|NCT02998736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25135497|NCT02998736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25135498|NCT02998736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25135499|NCT02998736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135500|NCT02998736|Urological Agents|urological agents|mesh-ancestor
25135501|NCT02998606|Naloxegol|naloxegol|mesh-list
25135502|NCT02998606|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25135503|NCT02998606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135504|NCT02998606|Sensory System Agents|sensory system agents|mesh-ancestor
25135505|NCT02998606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25135507|NCT02998437|Clarithromycin|clarithromycin|mesh-list
25135508|NCT02998437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25135509|NCT02998437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25135510|NCT02998437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25135511|NCT02998437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25135512|NCT02998437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25135513|NCT02998437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25135514|NCT02998437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25058037|NCT03499743|Celecoxib|celecoxib|mesh-list
25283248|NCT04926454|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25283249|NCT04926454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25283250|NCT04926454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25692992|NCT02006732|Cholinergic Agents|cholinergic agents|mesh-ancestor
25692993|NCT02006732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25692994|NCT02006732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25692995|NCT02006836|Insulin|insulin|mesh-list
25692996|NCT02006836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25692997|NCT02006836|Metformin|metformin|mesh-list
25692998|NCT02006836|Insulin Aspart|insulin aspart|mesh-list
25692999|NCT02006836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25693000|NCT02006836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693001|NCT02007070|Pembrolizumab|pembrolizumab|mesh-list
25693002|NCT02007070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25693003|NCT02007070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693004|NCT02007096|Bupivacaine|bupivacaine|mesh-list
25693005|NCT02007096|Anesthetics, Local|anesthetics, local|mesh-ancestor
25693006|NCT02007096|Anesthetics|anesthetics|mesh-ancestor
25283251|NCT04926454|Adrenergic Agents|adrenergic agents|mesh-ancestor
25283252|NCT04926454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25283253|NCT04926454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283286|NCT04824131|Antiviral Agents|antiviral agents|mesh-ancestor
25283287|NCT04824131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25135556|NCT02997800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25135629|NCT02997059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25135630|NCT02997059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25135631|NCT02997059|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25135632|NCT02997059|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25135633|NCT02996734|Denosumab|denosumab|mesh-list
25135634|NCT02996734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25135635|NCT02996734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458155|NCT00336791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24458156|NCT00336791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24458158|NCT00336791|Antimetabolites|antimetabolites|mesh-ancestor
24458159|NCT00336791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24458160|NCT00336882|Midazolam|midazolam|mesh-list
24458161|NCT00336882|Propofol|propofol|mesh-list
24590981|NCT00914563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24458166|NCT00336882|Anesthetics, General|anesthetics, general|mesh-ancestor
24458168|NCT00336882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24458169|NCT00336882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24458170|NCT00336882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24458171|NCT00336882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25283288|NCT04824131|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25283289|NCT04824131|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25283290|NCT04824131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25283291|NCT04824131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283292|NCT04824131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25283293|NCT04824131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25135643|NCT02996695|Artesunate|artesunate|mesh-list
25135723|NCT02995954|Protease Inhibitors|protease inhibitors|mesh-ancestor
25135795|NCT02995707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25135833|NCT02995291|Phentolamine|phentolamine|mesh-list
25135912|NCT02994953|Avelumab|avelumab|mesh-list
25283296|NCT04822376|Ansuvimab|ansuvimab|mesh-list
25283297|NCT04822376|Antiviral Agents|antiviral agents|mesh-ancestor
25283298|NCT04822376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25026162|NCT03631615|Antibodies|antibodies|mesh-list
25283299|NCT04807920|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25283300|NCT04807920|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25283301|NCT04807920|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25283302|NCT04807920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25283303|NCT04807920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283304|NCT04807920|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25283305|NCT04807920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25283306|NCT04807920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283308|NCT04807920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25283323|NCT04797312|Sufentanil|sufentanil|mesh-list
25283324|NCT04797312|Remifentanil|remifentanil|mesh-list
25283325|NCT04797312|Analgesics, Opioid|analgesics, opioid|mesh-list
25283326|NCT04797312|Anesthetics|anesthetics|mesh-ancestor
25283327|NCT04797312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25283328|NCT04797312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283329|NCT04797312|Narcotics|narcotics|mesh-ancestor
25283330|NCT04797312|Analgesics|analgesics|mesh-ancestor
25283331|NCT04797312|Sensory System Agents|sensory system agents|mesh-ancestor
25283332|NCT04797312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25136147|NCT02993367|Protective Agents|protective agents|mesh-ancestor
25136148|NCT02993367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136342|NCT02991768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25136343|NCT02991768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25136344|NCT02991768|Autonomic Agents|autonomic agents|mesh-ancestor
25136345|NCT02991768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25136346|NCT02991768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25136347|NCT02991768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25136348|NCT02991768|Respiratory System Agents|respiratory system agents|mesh-ancestor
25136349|NCT02991768|Glucocorticoids|glucocorticoids|mesh-ancestor
25136351|NCT02991768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25136352|NCT02991612|Rifaximin|rifaximin|mesh-list
25136353|NCT02991612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25136354|NCT02991612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25136379|NCT02991196|Nivolumab|nivolumab|mesh-list
25136579|NCT02990286|Rituximab|rituximab|mesh-list
25136644|NCT02990013|Disinfectants|disinfectants|mesh-ancestor
25136645|NCT02990013|Plasma Substitutes|plasma substitutes|mesh-ancestor
25136646|NCT02990013|Blood Substitutes|blood substitutes|mesh-ancestor
25136647|NCT02989701|Plerixafor|plerixafor|mesh-list
25136648|NCT02989701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25136649|NCT02989701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25136650|NCT02989701|Antiviral Agents|antiviral agents|mesh-ancestor
25136651|NCT02989701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24635557|NCT01140126|UB-421|ub-421|mesh-list
24613991|NCT01021930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24613992|NCT01021930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24613993|NCT01021930|Antifungal Agents|antifungal agents|mesh-ancestor
24613994|NCT01021930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24613995|NCT01021930|Immunologic Factors|immunologic factors|mesh-ancestor
24613996|NCT01021930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026352|NCT03629418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25026353|NCT03629418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026354|NCT03629418|Sympathomimetics|sympathomimetics|mesh-ancestor
24613997|NCT01021943|Spironolactone|spironolactone|mesh-list
24613999|NCT01021943|Hormone Antagonists|hormone antagonists|mesh-ancestor
25283334|NCT04797312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25283335|NCT04797312|Anesthetics, General|anesthetics, general|mesh-ancestor
25283336|NCT04735263|Atorvastatin|atorvastatin|mesh-list
25283337|NCT04735263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25283338|NCT04735263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25283339|NCT04735263|Antimetabolites|antimetabolites|mesh-ancestor
25283340|NCT04735263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283341|NCT04735263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25283342|NCT04735263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25283343|NCT04735263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25283344|NCT04734886|Vitamin D|vitamin d|mesh-list
25283345|NCT04734886|Ergocalciferols|ergocalciferols|mesh-list
25283346|NCT04734886|Cholecalciferol|cholecalciferol|mesh-list
25283347|NCT04734886|Vitamins|vitamins|mesh-list
25283348|NCT04734886|Micronutrients|micronutrients|mesh-ancestor
25283349|NCT04734886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283350|NCT04734886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25283351|NCT04734886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25283352|NCT04705259|Anti-Infective Agents|anti-infective agents|mesh-list
25283353|NCT04705259|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25283357|NCT04662723|Dapagliflozin|dapagliflozin|mesh-list
25283358|NCT04662723|Empagliflozin|empagliflozin|mesh-list
25283359|NCT04662723|Canagliflozin|canagliflozin|mesh-list
25283360|NCT04662723|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25283361|NCT04662723|Methylprednisolone|methylprednisolone|mesh-list
25283362|NCT04662723|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25283363|NCT04662723|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25137003|NCT02987699|Immunologic Factors|immunologic factors|mesh-ancestor
25137005|NCT02987738|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25137006|NCT02987738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137007|NCT02987738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25137008|NCT02987738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046080|NCT00880217|Methylphenidate|methylphenidate|mesh-list
25046081|NCT00880217|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25046082|NCT00880217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25046083|NCT00880217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046084|NCT00880217|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25046085|NCT00880217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25046086|NCT00880217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25406343|NCT03565835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046087|NCT00880217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283369|NCT04662723|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25283370|NCT04662723|Prednisolone phosphate|prednisolone phosphate|mesh-list
25283371|NCT04662723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25283372|NCT04662723|Antiemetics|antiemetics|mesh-ancestor
25283373|NCT04662723|Autonomic Agents|autonomic agents|mesh-ancestor
25283374|NCT04662723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25283375|NCT04662723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283376|NCT04662723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25283377|NCT04662723|Glucocorticoids|glucocorticoids|mesh-ancestor
25283378|NCT04662723|Hormones|hormones|mesh-ancestor
25283379|NCT04662723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25283380|NCT04662723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25283381|NCT04662723|Protective Agents|protective agents|mesh-ancestor
25283382|NCT04662723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25283383|NCT04662723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283384|NCT04662723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283385|NCT04662723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25283386|NCT04662723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25283387|NCT04662723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25283388|NCT04662723|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25283389|NCT04662723|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25283390|NCT04662723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25283391|NCT04662723|Protease Inhibitors|protease inhibitors|mesh-ancestor
25283392|NCT04662723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25283393|NCT04662723|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25283394|NCT04654429|Ondansetron|ondansetron|mesh-list
25283395|NCT04654429|Antiemetics|antiemetics|mesh-ancestor
25283396|NCT04654429|Autonomic Agents|autonomic agents|mesh-ancestor
25283397|NCT04654429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25283398|NCT04654429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283399|NCT04654429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25283400|NCT04654429|Antipruritics|antipruritics|mesh-ancestor
25283401|NCT04654429|Dermatologic Agents|dermatologic agents|mesh-ancestor
25283402|NCT04654429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25283403|NCT04654429|Serotonin Agents|serotonin agents|mesh-ancestor
25283404|NCT04654429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25283405|NCT04654429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283406|NCT04654429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25283407|NCT04654429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24458181|NCT00336921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24458182|NCT00336921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458183|NCT00336921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458184|NCT00336921|Urological Agents|urological agents|mesh-ancestor
24458185|NCT00336947|Tegafur|tegafur|mesh-list
24458186|NCT00336947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25283420|NCT04593563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25283421|NCT04554836|Cetuximab|cetuximab|mesh-list
25283422|NCT04554836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25283423|NCT04554836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283424|NCT04551911|Calcifediol|calcifediol|mesh-list
25283425|NCT04551911|Vitamins|vitamins|mesh-ancestor
25283426|NCT04551911|Micronutrients|micronutrients|mesh-ancestor
25283427|NCT04551911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283428|NCT04551911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25283429|NCT04536272|Heparin|heparin|mesh-list
25283430|NCT04536272|Calcium heparin|calcium heparin|mesh-list
25283431|NCT04536272|Enoxaparin|enoxaparin|mesh-list
25283432|NCT04536272|Nadroparin|nadroparin|mesh-list
25283433|NCT04536272|Anticoagulants|anticoagulants|mesh-ancestor
25283434|NCT04536272|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25283435|NCT04536272|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25693007|NCT02007096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25283436|NCT04536272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283440|NCT04529460|Antibodies|antibodies|mesh-list
25283441|NCT04529460|Immunologic Factors|immunologic factors|mesh-ancestor
25283442|NCT04529460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283443|NCT04478721|Meropenem|meropenem|mesh-list
25283444|NCT04478721|Temocillin|temocillin|mesh-list
25283445|NCT04478721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25283446|NCT04478721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25137541|NCT02984865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137542|NCT02984852|Tenofovir|tenofovir|mesh-list
25137543|NCT02984852|Emtricitabine|emtricitabine|mesh-list
25137544|NCT02984852|Darunavir|darunavir|mesh-list
25137545|NCT02984852|Cobicistat|cobicistat|mesh-list
25137546|NCT02984852|Antiviral Agents|antiviral agents|mesh-ancestor
25137547|NCT02984852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25137548|NCT02984852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25137549|NCT02984852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25137550|NCT02984852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25137551|NCT02984852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137552|NCT02984852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25137556|NCT02984852|Protease Inhibitors|protease inhibitors|mesh-ancestor
25137667|NCT02983214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25137759|NCT02982798|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25137760|NCT02982798|Antimetabolites|antimetabolites|mesh-ancestor
25137761|NCT02982798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25137762|NCT02982798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25283450|NCT04427956|Vitamin B Complex|vitamin b complex|mesh-ancestor
25283451|NCT04427956|Vitamins|vitamins|mesh-ancestor
25283452|NCT04427956|Micronutrients|micronutrients|mesh-ancestor
25283453|NCT04427956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283454|NCT04427956|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25283455|NCT04427956|Dermatologic Agents|dermatologic agents|mesh-ancestor
25283456|NCT04417062|Olaparib|olaparib|mesh-list
25283457|NCT04417062|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25283458|NCT04417062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25283459|NCT04417062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283460|NCT04417062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283494|NCT04380142|Levodopa|levodopa|mesh-list
25283495|NCT04380142|Carbidopa|carbidopa|mesh-list
25283502|NCT04380142|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25283503|NCT04380142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25283505|NCT04278573|Cholecalciferol|cholecalciferol|mesh-list
25283506|NCT04278573|Vitamins|vitamins|mesh-ancestor
25283507|NCT04278573|Micronutrients|micronutrients|mesh-ancestor
25283508|NCT04278573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283509|NCT04278573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25283510|NCT04278573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25283516|NCT04217278|Cytarabine|cytarabine|mesh-list
25283517|NCT04217278|Fludarabine|fludarabine|mesh-list
25283518|NCT04217278|Busulfan|busulfan|mesh-list
25283519|NCT04217278|Thiotepa|thiotepa|mesh-list
25283520|NCT04217278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283521|NCT04217278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25283522|NCT04217278|Antimetabolites|antimetabolites|mesh-ancestor
25283523|NCT04217278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283524|NCT04217278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25283525|NCT04217278|Immunologic Factors|immunologic factors|mesh-ancestor
25283526|NCT04217278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283527|NCT04217278|Antiviral Agents|antiviral agents|mesh-ancestor
25283528|NCT04217278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25283529|NCT04217278|Alkylating Agents|alkylating agents|mesh-ancestor
25283530|NCT04217278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25283531|NCT04217278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25283532|NCT04205266|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25283533|NCT04205266|Hematinics|hematinics|mesh-ancestor
25283534|NCT04205266|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25283535|NCT04205266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25283536|NCT04202263|Minocycline|minocycline|mesh-list
25283537|NCT04202263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25283538|NCT04202263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25283539|NCT04192955|Salicylates|salicylates|mesh-list
25283540|NCT04192955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25283541|NCT04192955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25283543|NCT04192955|Sensory System Agents|sensory system agents|mesh-ancestor
25283544|NCT04192955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25283545|NCT04192955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283546|NCT04192955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25283547|NCT04192955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25283548|NCT04192955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25138304|NCT02979223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25138305|NCT02979093|Oxytocin|oxytocin|mesh-list
25138306|NCT02979093|Oxytocics|oxytocics|mesh-ancestor
25138307|NCT02979093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25138308|NCT02979093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046278|NCT00860288|Metformin|metformin|mesh-list
25046279|NCT00860288|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25046280|NCT00860288|Vildagliptin|vildagliptin|mesh-list
25046281|NCT00860288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25046282|NCT00860288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046283|NCT00860288|Incretins|incretins|mesh-ancestor
25046284|NCT00860288|Hormones|hormones|mesh-ancestor
25046285|NCT00860288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25046286|NCT00860288|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25046287|NCT00860288|Protease Inhibitors|protease inhibitors|mesh-ancestor
25046288|NCT00860288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25046289|NCT00860288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25138309|NCT02978976|Betamethasone|betamethasone|mesh-list
25138384|NCT02977949|Hormone Antagonists|hormone antagonists|mesh-ancestor
25138385|NCT02977949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25138386|NCT02977949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283563|NCT04162756|Alkylating Agents|alkylating agents|mesh-ancestor
25283564|NCT04162756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283565|NCT04162756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283566|NCT04162756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25138683|NCT02976012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25138684|NCT02976012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25138685|NCT02976012|Growth Substances|growth substances|mesh-ancestor
25138686|NCT02976012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25138687|NCT02976012|Growth Inhibitors|growth inhibitors|mesh-ancestor
25138688|NCT02976012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458204|NCT00336960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24458205|NCT00336960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24458206|NCT00336960|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24458207|NCT00336960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24458208|NCT00336960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458210|NCT00337051|Sevoflurane|sevoflurane|mesh-list
24458211|NCT00337051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24458213|NCT00337051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458214|NCT00337051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24458215|NCT00337051|Anesthetics, General|anesthetics, general|mesh-ancestor
24458216|NCT00337051|Anesthetics|anesthetics|mesh-ancestor
24458217|NCT00337051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24458218|NCT00337051|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24458220|NCT00337090|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24458221|NCT00337090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24458222|NCT00337090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24458223|NCT00337090|Adrenergic Agents|adrenergic agents|mesh-ancestor
24458224|NCT00337090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25283590|NCT04149990|Valsartan|valsartan|mesh-list
25283591|NCT04149990|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25283592|NCT04149990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25283593|NCT04149990|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25283594|NCT04149990|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25283595|NCT04149990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283597|NCT04149964|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25283598|NCT04149964|Oxycodone|oxycodone|mesh-list
25283599|NCT04149964|Hydrocodone|hydrocodone|mesh-list
25283600|NCT04149964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25283601|NCT04149964|Analgesics|analgesics|mesh-ancestor
25283602|NCT04149964|Sensory System Agents|sensory system agents|mesh-ancestor
25283603|NCT04149964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25283604|NCT04149964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283605|NCT04149964|Antipyretics|antipyretics|mesh-ancestor
25283606|NCT04149964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25283607|NCT04149964|Narcotics|narcotics|mesh-ancestor
25283608|NCT04149964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25283609|NCT04149964|Antitussive Agents|antitussive agents|mesh-ancestor
25283610|NCT04149964|Respiratory System Agents|respiratory system agents|mesh-ancestor
25283611|NCT04149964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25283612|NCT04149964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25283613|NCT04149964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25283614|NCT04123379|Nivolumab|nivolumab|mesh-list
25283615|NCT04123379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25283616|NCT04123379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283617|NCT04123379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25283618|NCT04123379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283619|NCT04037605|Ketoconazole|ketoconazole|mesh-list
25283620|NCT04037605|Dexamethasone|dexamethasone|mesh-list
25283621|NCT04037605|Dexamethasone acetate|dexamethasone acetate|mesh-list
25283622|NCT04037605|Hydrocortisone|hydrocortisone|mesh-list
25283623|NCT04037605|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25283624|NCT04037605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25283625|NCT04037605|Hormones|hormones|mesh-list
24458226|NCT00337090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458227|NCT00337090|Urological Agents|urological agents|mesh-ancestor
24458228|NCT00337155|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
24403370|NCT00160030|Cisplatin|cisplatin|mesh-list
25138864|NCT02974920|Aspirin|aspirin|mesh-list
25138996|NCT02974348|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25138997|NCT02974348|Anthelmintics|anthelmintics|mesh-ancestor
25138998|NCT02974348|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25138999|NCT02974348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25139000|NCT02974166|Ibuprofen|ibuprofen|mesh-list
25139001|NCT02974166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25139002|NCT02974166|Cyclobenzaprine|cyclobenzaprine|mesh-list
25139003|NCT02974166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25027100|NCT03622541|Sorafenib|sorafenib|mesh-list
25139004|NCT02974166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25139005|NCT02974166|Analgesics|analgesics|mesh-ancestor
25139006|NCT02974166|Sensory System Agents|sensory system agents|mesh-ancestor
25139007|NCT02974166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25139008|NCT02974166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139009|NCT02974166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25139010|NCT02974166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25139011|NCT02974166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25139012|NCT02974166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139013|NCT02974166|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25139014|NCT02974166|Antidepressive Agents|antidepressive agents|mesh-ancestor
25139015|NCT02974166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25139016|NCT02974166|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25139017|NCT02974166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25139018|NCT02974166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25139019|NCT02974166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25139020|NCT02974270|Leuprolide|leuprolide|mesh-list
25139021|NCT02974270|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25139022|NCT02974270|Fertility Agents|fertility agents|mesh-ancestor
25139023|NCT02974270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24614008|NCT01022021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614009|NCT01022021|Immunologic Factors|immunologic factors|mesh-ancestor
24614012|NCT01022021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24614013|NCT01022021|Alkylating Agents|alkylating agents|mesh-ancestor
24614014|NCT01022021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614015|NCT01022047|Budesonide|budesonide|mesh-list
24614016|NCT01022047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24614017|NCT01022047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24614018|NCT01022047|Autonomic Agents|autonomic agents|mesh-ancestor
25283626|NCT04037605|Cosyntropin|cosyntropin|mesh-list
25283627|NCT04037605|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25283628|NCT04037605|BB 1101|bb 1101|mesh-list
25283629|NCT04037605|Ganirelix|ganirelix|mesh-list
25283630|NCT04037605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25283631|NCT04037605|Antiemetics|antiemetics|mesh-ancestor
25283632|NCT04037605|Autonomic Agents|autonomic agents|mesh-ancestor
25283633|NCT04037605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25283634|NCT04037605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283635|NCT04037605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25283636|NCT04037605|Glucocorticoids|glucocorticoids|mesh-ancestor
25283637|NCT04037605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25283638|NCT04037605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25283639|NCT04037605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283640|NCT04037605|Protease Inhibitors|protease inhibitors|mesh-ancestor
25283641|NCT04037605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25283642|NCT04037605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283643|NCT04037605|Antifungal Agents|antifungal agents|mesh-ancestor
25283644|NCT04037605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25283645|NCT04037605|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25283646|NCT04037605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25283647|NCT04037605|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25283648|NCT04037605|Hormone Antagonists|hormone antagonists|mesh-ancestor
25283649|NCT04037605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25283650|NCT04022967|Ritonavir|ritonavir|mesh-list
25283651|NCT04022967|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25283652|NCT04022967|Tenofovir|tenofovir|mesh-list
25283653|NCT04022967|Lamivudine|lamivudine|mesh-list
25283654|NCT04022967|Dolutegravir|dolutegravir|mesh-list
25283655|NCT04022967|Efavirenz|efavirenz|mesh-list
25283656|NCT04022967|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25283657|NCT04022967|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25283658|NCT04022967|Protease Inhibitors|protease inhibitors|mesh-ancestor
25139024|NCT02974270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139025|NCT02974270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25139026|NCT02974270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25139027|NCT02973880|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25139028|NCT02973880|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25087508|NCT03278938|Bupropion|bupropion|mesh-list
25139254|NCT02972476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25139255|NCT02972476|Adrenergic Agents|adrenergic agents|mesh-ancestor
25139256|NCT02972476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25139257|NCT02972476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139258|NCT02972476|Anticonvulsants|anticonvulsants|mesh-ancestor
25139259|NCT02972476|Sympathomimetics|sympathomimetics|mesh-ancestor
25139260|NCT02972320|Temozolomide|temozolomide|mesh-list
25139261|NCT02972320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25139262|NCT02972320|Alkylating Agents|alkylating agents|mesh-ancestor
25139263|NCT02972320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139264|NCT02972320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25139325|NCT02971930|Factor VIII|factor viii|mesh-list
25139403|NCT02971410|Simvastatin|simvastatin|mesh-list
25139482|NCT02970773|Rivaroxaban|rivaroxaban|mesh-list
25139509|NCT02970630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25139510|NCT02970630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139511|NCT02970630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25139512|NCT02970643|Olanzapine|olanzapine|mesh-list
25139513|NCT02970643|Palonosetron|palonosetron|mesh-list
25139514|NCT02970643|Antiemetics|antiemetics|mesh-ancestor
25139515|NCT02970643|Autonomic Agents|autonomic agents|mesh-ancestor
25139516|NCT02970643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25139517|NCT02970643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139518|NCT02970643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25283659|NCT04022967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25283660|NCT04022967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283661|NCT04022967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25283662|NCT04022967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25283663|NCT04022967|Antiviral Agents|antiviral agents|mesh-ancestor
25283664|NCT04022967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25283665|NCT04022967|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25283666|NCT04022967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25283667|NCT04022967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25283668|NCT04022967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25283669|NCT04022967|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25283670|NCT04022967|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25283671|NCT04022967|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25283672|NCT04022967|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25283673|NCT04022967|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25283674|NCT04022967|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25283675|NCT04022967|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25283676|NCT03971474|Gemcitabine|gemcitabine|mesh-list
25283677|NCT03971474|Docetaxel|docetaxel|mesh-list
25283678|NCT03971474|Pembrolizumab|pembrolizumab|mesh-list
25283679|NCT03971474|Pemetrexed|pemetrexed|mesh-list
25283680|NCT03971474|Ramucirumab|ramucirumab|mesh-list
25283681|NCT03971474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25283682|NCT03971474|Antibodies|antibodies|mesh-list
25283683|NCT03971474|Immunoglobulins|immunoglobulins|mesh-list
25283684|NCT03971474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25283685|NCT03971474|Lexatumumab|lexatumumab|mesh-list
25283686|NCT03971474|Immunologic Factors|immunologic factors|mesh-ancestor
25283687|NCT03971474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283688|NCT03971474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25283689|NCT03971474|Antimetabolites|antimetabolites|mesh-ancestor
25283690|NCT03971474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283691|NCT03971474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283692|NCT03971474|Antiviral Agents|antiviral agents|mesh-ancestor
25283693|NCT03971474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25283694|NCT03971474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25283695|NCT03971474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25139520|NCT02970643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25139521|NCT02970643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25139522|NCT02970643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25139523|NCT02970643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25139524|NCT02970643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25139525|NCT02970643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25139526|NCT02970643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139527|NCT02970643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25139528|NCT02970643|Serotonin Agents|serotonin agents|mesh-ancestor
25139529|NCT02970643|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25139530|NCT02970643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25139531|NCT02970539|Paclitaxel|paclitaxel|mesh-list
25139532|NCT02970539|Ramucirumab|ramucirumab|mesh-list
25139533|NCT02970539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25139534|NCT02970539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25139535|NCT02970539|Tubulin Modulators|tubulin modulators|mesh-ancestor
25139555|NCT02970682|Tamoxifen|tamoxifen|mesh-list
25139783|NCT02968927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25139784|NCT02968927|Antitubercular Agents|antitubercular agents|mesh-ancestor
25139785|NCT02968927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25139786|NCT02968927|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25139787|NCT02968927|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25139788|NCT02968927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25139789|NCT02968927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139790|NCT02968693|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25139791|NCT02968693|Vancomycin|vancomycin|mesh-list
25139802|NCT02968719|Donepezil|donepezil|mesh-list
25283696|NCT03971474|Tubulin Modulators|tubulin modulators|mesh-ancestor
25283697|NCT03971474|Antimitotic Agents|antimitotic agents|mesh-ancestor
25283698|NCT03971474|Mitosis Modulators|mitosis modulators|mesh-ancestor
25283699|NCT03971474|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25283700|NCT03971474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25283701|NCT03968562|Doxycycline|doxycycline|mesh-list
25283702|NCT03968562|Petrolatum|petrolatum|mesh-list
25283703|NCT03968562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25283704|NCT03968562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25283705|NCT03968562|Antimalarials|antimalarials|mesh-ancestor
25283706|NCT03968562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25283707|NCT03968562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25283708|NCT03968562|Emollients|emollients|mesh-ancestor
25283709|NCT03968562|Dermatologic Agents|dermatologic agents|mesh-ancestor
25283710|NCT03939026|Cyclophosphamide|cyclophosphamide|mesh-list
25283711|NCT03939026|Fludarabine|fludarabine|mesh-list
25283712|NCT03939026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25283713|NCT03939026|Immunologic Factors|immunologic factors|mesh-ancestor
25283714|NCT03939026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283715|NCT03939026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25283716|NCT03939026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25283717|NCT03939026|Alkylating Agents|alkylating agents|mesh-ancestor
25693008|NCT02007096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283718|NCT03939026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283719|NCT03939026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283720|NCT03939026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25283721|NCT03915613|Insulin|insulin|mesh-list
25283722|NCT03915613|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25283723|NCT03915613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25283724|NCT03915613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139808|NCT02968719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25139809|NCT02968719|Nootropic Agents|nootropic agents|mesh-ancestor
25139810|NCT02968641|Ritonavir|ritonavir|mesh-list
25139811|NCT02968641|Lonafarnib|lonafarnib|mesh-list
25139812|NCT02968641|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25139813|NCT02968641|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25139814|NCT02968641|Protease Inhibitors|protease inhibitors|mesh-ancestor
25139815|NCT02968641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25139816|NCT02968641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25139823|NCT02968498|Methamphetamine|methamphetamine|mesh-list
25139998|NCT02967432|Mupirocin|mupirocin|mesh-list
25140075|NCT02966847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25140076|NCT02966847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25046665|NCT00838279|Anticonvulsants|anticonvulsants|mesh-ancestor
25046666|NCT00838279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25140165|NCT02966743|Midazolam|midazolam|mesh-list
25140338|NCT02965248|Leucovorin|leucovorin|mesh-list
25140339|NCT02965248|Capecitabine|capecitabine|mesh-list
25140340|NCT02965248|Raltitrexed|raltitrexed|mesh-list
25140341|NCT02965248|Oxaliplatin|oxaliplatin|mesh-list
25140342|NCT02965248|Calcium|calcium|mesh-list
25140343|NCT02965248|Levoleucovorin|levoleucovorin|mesh-list
25140344|NCT02965248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25140345|NCT02965248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140346|NCT02965248|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25140347|NCT02965248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25140348|NCT02965248|Antimetabolites|antimetabolites|mesh-ancestor
25140349|NCT02965248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140350|NCT02965248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25140351|NCT02965248|Antidotes|antidotes|mesh-ancestor
25140352|NCT02965248|Protective Agents|protective agents|mesh-ancestor
25140353|NCT02965248|Vitamin B Complex|vitamin b complex|mesh-ancestor
25283725|NCT03868150|Amiodarone|amiodarone|mesh-list
25283726|NCT03868150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25283728|NCT03868150|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25283729|NCT03868150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25283730|NCT03868150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283731|NCT03868150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25283732|NCT03868150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25283733|NCT03868150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25283734|NCT03868150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25283735|NCT03868150|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25283736|NCT03868150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25283737|NCT03868150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25283738|NCT03864276|Propofol|propofol|mesh-list
25283739|NCT03864276|Desflurane|desflurane|mesh-list
25283740|NCT03864276|Anesthetics|anesthetics|mesh-ancestor
25283741|NCT03864276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25283742|NCT03864276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283743|NCT03864276|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25283744|NCT03864276|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25283745|NCT03864276|Anesthetics, General|anesthetics, general|mesh-ancestor
25283746|NCT03864276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25283747|NCT03856788|Bupivacaine|bupivacaine|mesh-list
25283748|NCT03856788|Anesthetics, Local|anesthetics, local|mesh-ancestor
25283749|NCT03856788|Anesthetics|anesthetics|mesh-ancestor
25283750|NCT03856788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25283751|NCT03856788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283752|NCT03856788|Sensory System Agents|sensory system agents|mesh-ancestor
25283753|NCT03856788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25283754|NCT03840902|Paclitaxel|paclitaxel|mesh-list
25283755|NCT03840902|Etoposide|etoposide|mesh-list
25283756|NCT03840902|Carboplatin|carboplatin|mesh-list
25283757|NCT03840902|Pemetrexed|pemetrexed|mesh-list
25283758|NCT03840902|Durvalumab|durvalumab|mesh-list
25283759|NCT03840902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25283760|NCT03840902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283761|NCT03840902|Tubulin Modulators|tubulin modulators|mesh-ancestor
25283762|NCT03840902|Antimitotic Agents|antimitotic agents|mesh-ancestor
24473034|NCT00401609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25283763|NCT03840902|Mitosis Modulators|mitosis modulators|mesh-ancestor
25283764|NCT03840902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283765|NCT03840902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25140581|NCT02963116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25140622|NCT02963324|Ivermectin|ivermectin|mesh-list
25140754|NCT02961855|Diclofenac|diclofenac|mesh-list
25140892|NCT02961660|Odalasvir|odalasvir|mesh-list
25027596|NCT03618589|Pregabalin|pregabalin|mesh-list
25140893|NCT02961660|Antiviral Agents|antiviral agents|mesh-ancestor
25140894|NCT02961660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25140895|NCT02961608|Tacrolimus|tacrolimus|mesh-list
25140896|NCT02961608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25140897|NCT02961608|Immunologic Factors|immunologic factors|mesh-ancestor
25140898|NCT02961608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140899|NCT02961608|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25140900|NCT02961608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25140901|NCT02961608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140902|NCT02961634|Ciclopirox|ciclopirox|mesh-list
25140903|NCT02961634|Antifungal Agents|antifungal agents|mesh-ancestor
25140904|NCT02961634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25140905|NCT02961491|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
25140906|NCT02961491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25140907|NCT02961491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506595|NCT00546130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25140908|NCT02961491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25140909|NCT02961491|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25140910|NCT02961166|Immunoglobulins|immunoglobulins|mesh-list
25140911|NCT02961166|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25140912|NCT02961166|Antibodies|antibodies|mesh-list
25140913|NCT02961166|Immunologic Factors|immunologic factors|mesh-ancestor
25140914|NCT02961166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25140915|NCT02961426|Sofosbuvir|sofosbuvir|mesh-list
25140916|NCT02961426|Antiviral Agents|antiviral agents|mesh-ancestor
25140917|NCT02961426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25140918|NCT02961361|Dexmedetomidine|dexmedetomidine|mesh-list
25140919|NCT02961361|Ropivacaine|ropivacaine|mesh-list
25140920|NCT02961361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25283766|NCT03840902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25283767|NCT03840902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25283768|NCT03840902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25283769|NCT03840902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25283774|NCT03821610|Alemtuzumab|alemtuzumab|mesh-list
25283775|NCT03821610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25283776|NCT03821610|Immunologic Factors|immunologic factors|mesh-ancestor
25283777|NCT03821610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283778|NCT03821610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25283779|NCT03821610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25283780|NCT03821610|Alkylating Agents|alkylating agents|mesh-ancestor
25283781|NCT03821610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283782|NCT03821610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283783|NCT03821610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25283784|NCT03821610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25283785|NCT03815929|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25283786|NCT03815929|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25283788|NCT03815929|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25283789|NCT03815929|Estrogens|estrogens|mesh-ancestor
25283790|NCT03815929|Hormones|hormones|mesh-ancestor
25283791|NCT03815929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25283792|NCT03815929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283793|NCT03815929|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25283794|NCT03815929|Contraceptive Agents|contraceptive agents|mesh-ancestor
25283795|NCT03815929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25283796|NCT03815929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25283797|NCT03811756|Coenzyme Q10|coenzyme q10|mesh-list
25283798|NCT03811756|Vitamins|vitamins|mesh-ancestor
25283799|NCT03811756|Micronutrients|micronutrients|mesh-ancestor
25283800|NCT03811756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283801|NCT03792516|Artesunate|artesunate|mesh-list
25283802|NCT03792516|Antimalarials|antimalarials|mesh-ancestor
25283803|NCT03792516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25283804|NCT03792516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25283805|NCT03792516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25693009|NCT02007096|Sensory System Agents|sensory system agents|mesh-ancestor
25693010|NCT02007096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25283806|NCT03792516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283807|NCT03792516|Antiviral Agents|antiviral agents|mesh-ancestor
25283808|NCT03792516|Schistosomicides|schistosomicides|mesh-ancestor
25283809|NCT03792516|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25141114|NCT02959554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25141115|NCT02959554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25141116|NCT02959554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25141117|NCT02959554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141118|NCT02959554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25141119|NCT02959554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25141120|NCT02959554|Growth Substances|growth substances|mesh-ancestor
25141121|NCT02959554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141122|NCT02959554|Growth Inhibitors|growth inhibitors|mesh-ancestor
25141123|NCT02959554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25141124|NCT02959554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25141126|NCT02959606|Clopidogrel|clopidogrel|mesh-list
25141138|NCT02959606|Serotonin Agents|serotonin agents|mesh-ancestor
25141312|NCT02958566|Narcotics|narcotics|mesh-ancestor
25141387|NCT02958111|Antimetabolites|antimetabolites|mesh-ancestor
25141408|NCT02958215|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25141409|NCT02958215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24459741|NCT00346294|Etanercept|etanercept|mesh-list
24708603|NCT01501747|Purinergic Agents|purinergic agents|mesh-ancestor
24708604|NCT01501747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24708605|NCT01501747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24708606|NCT01501747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24708607|NCT01501760|Bevacizumab|bevacizumab|mesh-list
24708608|NCT01501760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25027757|NCT03617289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24708609|NCT01501760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283813|NCT03768414|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25283814|NCT03768414|Cisplatin|cisplatin|mesh-list
25283815|NCT03768414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25283816|NCT03768414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283817|NCT03768414|Tubulin Modulators|tubulin modulators|mesh-ancestor
25283818|NCT03768414|Antimitotic Agents|antimitotic agents|mesh-ancestor
25283819|NCT03768414|Mitosis Modulators|mitosis modulators|mesh-ancestor
25283820|NCT03768414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283821|NCT03768414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25283822|NCT03768414|Antimetabolites|antimetabolites|mesh-ancestor
25283823|NCT03768414|Antiviral Agents|antiviral agents|mesh-ancestor
25283824|NCT03768414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25283825|NCT03768414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25283826|NCT03768414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25283827|NCT03768414|Immunologic Factors|immunologic factors|mesh-ancestor
25283828|NCT03768414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283829|NCT03764137|Panitumumab|panitumumab|mesh-list
25141410|NCT02958215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25141411|NCT02958215|Adrenergic Agents|adrenergic agents|mesh-ancestor
25141412|NCT02958215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25141413|NCT02958215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593265|NCT00927732|Quinidine|quinidine|mesh-list
25141414|NCT02958215|Protective Agents|protective agents|mesh-ancestor
25141465|NCT02957643|Iron|iron|mesh-list
25141548|NCT02957097|Gabapentin|gabapentin|mesh-list
25141604|NCT02956252|Anesthetics|anesthetics|mesh-list
25141605|NCT02956252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25141606|NCT02956252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141813|NCT02954393|Amoxicillin|amoxicillin|mesh-list
25141814|NCT02954393|Metronidazole|metronidazole|mesh-list
25141815|NCT02954393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25141816|NCT02954393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25141817|NCT02954393|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25141818|NCT02954393|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25141819|NCT02954276|Sumatriptan|sumatriptan|mesh-list
25141820|NCT02954276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25141821|NCT02954276|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25141822|NCT02954276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25141823|NCT02954276|Serotonin Agents|serotonin agents|mesh-ancestor
25141824|NCT02954276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25141825|NCT02954276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473681|NCT00403780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24628817|NCT01101568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628818|NCT01101581|Epratuzumab|epratuzumab|mesh-list
24628820|NCT01101581|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
24628822|NCT01101581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25141826|NCT02954276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141827|NCT02954484|Acetaminophen|acetaminophen|mesh-list
25141828|NCT02954484|Etoricoxib|etoricoxib|mesh-list
25141829|NCT02954484|Pregabalin|pregabalin|mesh-list
25141830|NCT02954484|Morphine|morphine|mesh-list
25141831|NCT02954484|Ropivacaine|ropivacaine|mesh-list
25141832|NCT02954484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24708674|NCT01501968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708675|NCT01501968|Antioxidants|antioxidants|mesh-ancestor
24708676|NCT01501968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283830|NCT03764137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25283831|NCT03764137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283832|NCT03757130|Liraglutide|liraglutide|mesh-list
25283833|NCT03757130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25283834|NCT03757130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283835|NCT03757130|Incretins|incretins|mesh-ancestor
25283836|NCT03757130|Hormones|hormones|mesh-ancestor
25283844|NCT03733418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25283845|NCT03732664|Pembrolizumab|pembrolizumab|mesh-list
25283846|NCT03732664|Nivolumab|nivolumab|mesh-list
25283847|NCT03732664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25283848|NCT03732664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283849|NCT03732664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25283850|NCT03732664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283859|NCT03618225|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25283860|NCT03618225|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25283861|NCT03618225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25283862|NCT03618225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25283863|NCT03618225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25141834|NCT02954484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25141835|NCT02954484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25141836|NCT02954484|Analgesics|analgesics|mesh-ancestor
25141837|NCT02954484|Sensory System Agents|sensory system agents|mesh-ancestor
25141838|NCT02954484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25141839|NCT02954484|Anesthetics, Local|anesthetics, local|mesh-ancestor
25141840|NCT02954484|Anesthetics|anesthetics|mesh-ancestor
25141841|NCT02954484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25141842|NCT02954484|Antipyretics|antipyretics|mesh-ancestor
25141843|NCT02954484|Anticonvulsants|anticonvulsants|mesh-ancestor
25141844|NCT02954484|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25141845|NCT02954484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25142000|NCT02953210|Analgesics|analgesics|mesh-ancestor
25142069|NCT02953015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25142099|NCT02953184|Antimitotic Agents|antimitotic agents|mesh-ancestor
25142100|NCT02953184|Mitosis Modulators|mitosis modulators|mesh-ancestor
25142101|NCT02953184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25142102|NCT02953184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25142103|NCT02953184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25142104|NCT02953184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25142105|NCT02953184|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25142106|NCT02953184|Protective Agents|protective agents|mesh-ancestor
25142107|NCT02952963|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
25142108|NCT02952963|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
25142109|NCT02952963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25142110|NCT02952963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25142111|NCT02952963|Antimetabolites|antimetabolites|mesh-ancestor
25142112|NCT02952963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859267|NCT02302586|Anesthetics|anesthetics|mesh-ancestor
24708677|NCT01501968|Protective Agents|protective agents|mesh-ancestor
24708678|NCT01501968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24708679|NCT01501968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24708680|NCT01502020|Imiquimod|imiquimod|mesh-list
24708681|NCT01502020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24708685|NCT01502020|Interferon Inducers|interferon inducers|mesh-ancestor
24708687|NCT01502046|Cannabidiol|cannabidiol|mesh-list
25693011|NCT02007278|Metformin|metformin|mesh-list
25693012|NCT02007278|Glimepiride|glimepiride|mesh-list
25693013|NCT02007278|Vildagliptin|vildagliptin|mesh-list
25693014|NCT02007278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25693015|NCT02007278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693016|NCT02007278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25693017|NCT02007278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24445966|NCT00303290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708694|NCT01502046|Sensory System Agents|sensory system agents|mesh-ancestor
24708695|NCT01502046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24708696|NCT01502046|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24708697|NCT01502046|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24708698|NCT01502046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24708699|NCT01502046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708701|NCT01502046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24708702|NCT01502202|Pemetrexed|pemetrexed|mesh-list
25283864|NCT03618225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25283942|NCT03351439|Analgesics|analgesics|mesh-ancestor
25283867|NCT03618225|Sensory System Agents|sensory system agents|mesh-ancestor
25283868|NCT03618225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25283869|NCT03618225|Antidepressive Agents|antidepressive agents|mesh-ancestor
25283870|NCT03618225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25283871|NCT03618225|Dopamine Agents|dopamine agents|mesh-ancestor
25283872|NCT03566199|Panobinostat|panobinostat|mesh-list
25283873|NCT03566199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283874|NCT03566199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25283875|NCT03566199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25283876|NCT03566199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283877|NCT03561831|Propofol|propofol|mesh-list
25283878|NCT03561831|Sevoflurane|sevoflurane|mesh-list
25283879|NCT03561831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25283880|NCT03561831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25283881|NCT03561831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283882|NCT03561831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25283883|NCT03561831|Anesthetics, General|anesthetics, general|mesh-ancestor
25283884|NCT03561831|Anesthetics|anesthetics|mesh-ancestor
25283885|NCT03561831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25283886|NCT03561831|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25283887|NCT03551626|Trametinib|trametinib|mesh-list
25283888|NCT03551626|Dabrafenib|dabrafenib|mesh-list
25283889|NCT03551626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283890|NCT03551626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25283891|NCT03551626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25283892|NCT03551626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142113|NCT02952963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25142114|NCT02952963|Cathartics|cathartics|mesh-ancestor
25142116|NCT02952573|Dexamethasone|dexamethasone|mesh-list
25142254|NCT02951793|Psychotropic Drugs|psychotropic drugs|mesh-list
25142327|NCT02951117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25142329|NCT02951117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142330|NCT02950935|Progesterone|progesterone|mesh-list
25142331|NCT02950935|Progestins|progestins|mesh-ancestor
25142332|NCT02950935|Hormones|hormones|mesh-ancestor
25142333|NCT02950935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25142334|NCT02950935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142335|NCT02950870|Ritonavir|ritonavir|mesh-list
25142336|NCT02950870|Ribavirin|ribavirin|mesh-list
25142337|NCT02950870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25142338|NCT02950870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25142339|NCT02950870|Protease Inhibitors|protease inhibitors|mesh-ancestor
25142340|NCT02950870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25142341|NCT02950870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142342|NCT02950870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25142343|NCT02950870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25142344|NCT02950870|Antiviral Agents|antiviral agents|mesh-ancestor
25142345|NCT02950870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25142346|NCT02950870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25142347|NCT02950870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25142348|NCT02950870|Antimetabolites|antimetabolites|mesh-ancestor
25142349|NCT02950623|Titanium dioxide|titanium dioxide|mesh-list
25142350|NCT02950623|Sunscreening Agents|sunscreening agents|mesh-ancestor
25142351|NCT02950623|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25142352|NCT02950623|Protective Agents|protective agents|mesh-ancestor
25142353|NCT02950623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142577|NCT02948881|Ibandronic Acid|ibandronic acid|mesh-list
25142578|NCT02948881|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25142579|NCT02948881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693018|NCT02007278|Immunologic Factors|immunologic factors|mesh-ancestor
24813238|NCT02057107|Tubulin Modulators|tubulin modulators|mesh-ancestor
25283894|NCT03544736|Carboplatin|carboplatin|mesh-list
25283895|NCT03544736|Nivolumab|nivolumab|mesh-list
25283896|NCT03544736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25283897|NCT03544736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283898|NCT03544736|Tubulin Modulators|tubulin modulators|mesh-ancestor
25283899|NCT03544736|Antimitotic Agents|antimitotic agents|mesh-ancestor
25283900|NCT03544736|Mitosis Modulators|mitosis modulators|mesh-ancestor
25283901|NCT03544736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283902|NCT03544736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25028632|NCT03609294|Linagliptin|linagliptin|mesh-list
25283908|NCT03508232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25283909|NCT03508232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25283910|NCT03501979|Capecitabine|capecitabine|mesh-list
25283911|NCT03501979|Trastuzumab|trastuzumab|mesh-list
25283912|NCT03501979|Tucatinib|tucatinib|mesh-list
25283913|NCT03501979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25283914|NCT03501979|Antimetabolites|antimetabolites|mesh-ancestor
25283915|NCT03501979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283916|NCT03501979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283917|NCT03501979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25283918|NCT03501979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25283919|NCT03501979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25283920|NCT03473574|Gemcitabine|gemcitabine|mesh-list
25283921|NCT03473574|Durvalumab|durvalumab|mesh-list
25283922|NCT03473574|Tremelimumab|tremelimumab|mesh-list
25283923|NCT03473574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283924|NCT03473574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25283925|NCT03473574|Antimetabolites|antimetabolites|mesh-ancestor
25283926|NCT03473574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283927|NCT03473574|Antiviral Agents|antiviral agents|mesh-ancestor
25283928|NCT03473574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25283929|NCT03473574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25283930|NCT03473574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24458239|NCT00337246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25028205|NCT03612947|Tocolytic Agents|tocolytic agents|mesh-ancestor
24533233|NCT00642681|Insulin|insulin|mesh-list
24708703|NCT01502202|Gefitinib|gefitinib|mesh-list
24708704|NCT01502202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708705|NCT01502202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24437223|NCT00273026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25283931|NCT03473574|Immunologic Factors|immunologic factors|mesh-ancestor
25283932|NCT03473574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283933|NCT03473574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25283934|NCT03370263|Belimumab|belimumab|mesh-list
25283935|NCT03370263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25283936|NCT03370263|Immunologic Factors|immunologic factors|mesh-ancestor
25283937|NCT03370263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25283938|NCT03351439|Celecoxib|celecoxib|mesh-list
25283939|NCT03351439|Naproxen|naproxen|mesh-list
24817998|NCT02086409|Calcium, Dietary|calcium, dietary|mesh-list
24897351|NCT04425993|Tocolytic Agents|tocolytic agents|mesh-ancestor
25283940|NCT03351439|Gabapentin|gabapentin|mesh-list
25283941|NCT03351439|Zopiclone|zopiclone|mesh-list
25283946|NCT03351439|Anticonvulsants|anticonvulsants|mesh-ancestor
25283947|NCT03351439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25283948|NCT03351439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25283949|NCT03351439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25283950|NCT03351439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25283951|NCT03351439|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25283952|NCT03351439|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25283953|NCT03351439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25283954|NCT03351439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283955|NCT03351439|Antimanic Agents|antimanic agents|mesh-ancestor
25283956|NCT03351439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25283957|NCT03351439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25283958|NCT03351439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25283959|NCT03351439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25283960|NCT03351439|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25283961|NCT03351439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25283962|NCT03351439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25283963|NCT03351439|Gout Suppressants|gout suppressants|mesh-ancestor
25283964|NCT03351439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25283965|NCT03316274|Nivolumab|nivolumab|mesh-list
25142669|NCT02947620|Metformin|metformin|mesh-list
25142719|NCT02947529|Tranexamic Acid|tranexamic acid|mesh-list
25142795|NCT02946944|Sildenafil Citrate|sildenafil citrate|mesh-list
25142797|NCT02946944|Vasodilator Agents|vasodilator agents|mesh-ancestor
25142798|NCT02946944|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25142799|NCT02946944|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25142800|NCT02946944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25142801|NCT02946944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25142802|NCT02946944|Urological Agents|urological agents|mesh-ancestor
25142803|NCT02946944|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25142804|NCT02946944|Antithrombins|antithrombins|mesh-ancestor
25142805|NCT02946944|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25142806|NCT02946944|Protease Inhibitors|protease inhibitors|mesh-ancestor
25142807|NCT02946944|Anticoagulants|anticoagulants|mesh-ancestor
25142808|NCT02946970|Quinine|quinine|mesh-list
25142809|NCT02946970|Antimalarials|antimalarials|mesh-ancestor
25283966|NCT03316274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25283967|NCT03316274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25283968|NCT03316274|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25283969|NCT03316274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25283970|NCT03252626|Alprostadil|alprostadil|mesh-list
25283971|NCT03252626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25283972|NCT03252626|Vasodilator Agents|vasodilator agents|mesh-ancestor
25028617|NCT03609307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25028618|NCT03609307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028619|NCT03609307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25028620|NCT03609307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25028621|NCT03609307|Growth Substances|growth substances|mesh-ancestor
25028622|NCT03609307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028623|NCT03609307|Growth Inhibitors|growth inhibitors|mesh-ancestor
25028624|NCT03609307|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25028625|NCT03609307|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25283997|NCT03236545|Estrogens|estrogens|mesh-list
25283998|NCT03236545|Hormones|hormones|mesh-ancestor
25693019|NCT02007278|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25693020|NCT02007278|Protease Inhibitors|protease inhibitors|mesh-ancestor
25693021|NCT02007278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550615|NCT00721448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550616|NCT00721487|Fluconazole|fluconazole|mesh-list
24550617|NCT00721487|Antifungal Agents|antifungal agents|mesh-ancestor
25283999|NCT03236545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25284000|NCT03236545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284001|NCT03199755|Lumefantrine|lumefantrine|mesh-list
25284002|NCT03199755|Artemether|artemether|mesh-list
25284003|NCT03199755|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25284004|NCT03199755|Antimalarials|antimalarials|mesh-ancestor
25142813|NCT02946970|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25142814|NCT02946970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25142815|NCT02946970|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25142816|NCT02946970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25142817|NCT02946970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25142818|NCT02946970|Analgesics|analgesics|mesh-ancestor
25142819|NCT02946970|Sensory System Agents|sensory system agents|mesh-ancestor
25142820|NCT02947061|Docetaxel|docetaxel|mesh-list
25142821|NCT02947061|Capecitabine|capecitabine|mesh-list
25142822|NCT02947061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25142823|NCT02947061|Tubulin Modulators|tubulin modulators|mesh-ancestor
25143017|NCT02945280|Apixaban|apixaban|mesh-list
25143018|NCT02945280|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25143019|NCT02945280|Antithrombins|antithrombins|mesh-ancestor
25143020|NCT02945280|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25143021|NCT02945280|Protease Inhibitors|protease inhibitors|mesh-ancestor
25143022|NCT02945280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25143023|NCT02945280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143024|NCT02945280|Anticoagulants|anticoagulants|mesh-ancestor
25143025|NCT02945267|Tegafur|tegafur|mesh-list
25143026|NCT02945267|Nimotuzumab|nimotuzumab|mesh-list
25143027|NCT02945267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25143028|NCT02945267|Antimetabolites|antimetabolites|mesh-ancestor
25143029|NCT02945267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25143030|NCT02945267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143031|NCT02945267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25143032|NCT02945241|Vancomycin|vancomycin|mesh-list
25284005|NCT03199755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25284006|NCT03199755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25284007|NCT03199755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25284008|NCT03184571|Pembrolizumab|pembrolizumab|mesh-list
25284009|NCT03184571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25284010|NCT03184571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25143342|NCT02943369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047340|NCT00821977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047341|NCT00821977|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25047343|NCT00821977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25047344|NCT00821977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047345|NCT00821249|Dexamethasone|dexamethasone|mesh-list
25047346|NCT00821249|Filanesib|filanesib|mesh-list
25047347|NCT00821249|Lenograstim|lenograstim|mesh-list
25047348|NCT00821249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25047349|NCT00821249|Antiemetics|antiemetics|mesh-ancestor
25047350|NCT00821249|Autonomic Agents|autonomic agents|mesh-ancestor
25047351|NCT00821249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25047352|NCT00821249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047353|NCT00821249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25047355|NCT00821249|Hormones|hormones|mesh-ancestor
25047356|NCT00821249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25047357|NCT00821249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25047358|NCT00821249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25047359|NCT00821249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25047360|NCT00821249|Immunologic Factors|immunologic factors|mesh-ancestor
25047361|NCT00821249|Antimitotic Agents|antimitotic agents|mesh-ancestor
25047362|NCT00821249|Mitosis Modulators|mitosis modulators|mesh-ancestor
25047363|NCT00821249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047364|NCT00821002|Latanoprost|latanoprost|mesh-list
25047365|NCT00821002|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25693022|NCT02007278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693023|NCT02007434|Loratadine|loratadine|mesh-list
25693024|NCT02007434|Ibuprofen|ibuprofen|mesh-list
25693025|NCT02007434|Lidocaine|lidocaine|mesh-list
25143343|NCT02943317|Avelumab|avelumab|mesh-list
25284017|NCT03139747|Everolimus|everolimus|mesh-list
25284018|NCT03139747|Lenvatinib|lenvatinib|mesh-list
25284019|NCT03139747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25284020|NCT03139747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25284021|NCT03139747|Immunologic Factors|immunologic factors|mesh-ancestor
25284022|NCT03139747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284023|NCT03139747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25284024|NCT03139747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25284025|NCT03139747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284026|NCT03059498|Bupivacaine|bupivacaine|mesh-list
25284027|NCT03059498|Anesthetics, Local|anesthetics, local|mesh-ancestor
25284028|NCT03059498|Anesthetics|anesthetics|mesh-ancestor
25284029|NCT03059498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25284030|NCT03059498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284031|NCT03059498|Sensory System Agents|sensory system agents|mesh-ancestor
25284032|NCT03059498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25284033|NCT02951013|Chrysarobin|chrysarobin|mesh-list
25284034|NCT02951013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25284035|NCT02951013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25284036|NCT02951013|Analgesics|analgesics|mesh-ancestor
25284037|NCT02951013|Sensory System Agents|sensory system agents|mesh-ancestor
25284038|NCT02951013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25284039|NCT02951013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284040|NCT02951013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25284041|NCT02951013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25284042|NCT02943590|Atorvastatin|atorvastatin|mesh-list
25284043|NCT02943590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25284044|NCT02943590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25284045|NCT02943590|Antimetabolites|antimetabolites|mesh-ancestor
25284046|NCT02943590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284047|NCT02943590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25284048|NCT02943590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25284049|NCT02943590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25284050|NCT02902120|Grazoprevir|grazoprevir|mesh-list
25284051|NCT02902120|Antiviral Agents|antiviral agents|mesh-ancestor
25284052|NCT02902120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25284053|NCT02896712|Modafinil|modafinil|mesh-list
25284054|NCT02896712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25047530|NCT00799292|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25028980|NCT03606577|Hormones|hormones|mesh-ancestor
24458246|NCT00337246|Antimetabolites|antimetabolites|mesh-ancestor
25284055|NCT02896712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284056|NCT02896712|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25284057|NCT02896712|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25284058|NCT02896712|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25284059|NCT02896712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284060|NCT02858869|Pembrolizumab|pembrolizumab|mesh-list
25284061|NCT02858869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25284062|NCT02858869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698162|NCT01439230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24698164|NCT01439230|Nootropic Agents|nootropic agents|mesh-ancestor
24550636|NCT00721526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24550637|NCT00721526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24550639|NCT00721526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25284063|NCT02654080|Vaccines|vaccines|mesh-list
25284064|NCT02654080|Immunologic Factors|immunologic factors|mesh-ancestor
25284065|NCT02654080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284066|NCT02639026|Durvalumab|durvalumab|mesh-list
25284067|NCT02639026|Tremelimumab|tremelimumab|mesh-list
25284068|NCT02639026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25284069|NCT02639026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25284070|NCT02618148|Estrogens|estrogens|mesh-list
25284071|NCT02618148|Hormones|hormones|mesh-ancestor
25284072|NCT02618148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25284073|NCT02618148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284081|NCT02486666|Enoxaparin|enoxaparin|mesh-list
25284082|NCT02486666|Enoxaparin sodium|enoxaparin sodium|mesh-list
25284083|NCT02486666|Anticoagulants|anticoagulants|mesh-ancestor
25284084|NCT02486666|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25284085|NCT02486666|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25284086|NCT02486666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284087|NCT02431767|Interleukin-12|interleukin-12|mesh-list
25284088|NCT02431767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25284089|NCT02431767|Immunologic Factors|immunologic factors|mesh-ancestor
25284090|NCT02431767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284091|NCT02431767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25284092|NCT02431767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25284093|NCT02431767|Growth Substances|growth substances|mesh-ancestor
25284094|NCT02431767|Growth Inhibitors|growth inhibitors|mesh-ancestor
25284095|NCT02431767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25284096|NCT02390284|Timolol|timolol|mesh-list
25284097|NCT02390284|Bimatoprost|bimatoprost|mesh-list
24458250|NCT00337246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24458251|NCT00337246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25144116|NCT02938572|Insulin Aspart|insulin aspart|mesh-list
25144191|NCT02937662|Cytarabine|cytarabine|mesh-list
25144261|NCT02937519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25144262|NCT02937402|Dimercaprol|dimercaprol|mesh-list
25144263|NCT02937402|Chelating Agents|chelating agents|mesh-ancestor
25144264|NCT02937402|Sequestering Agents|sequestering agents|mesh-ancestor
25144265|NCT02937402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047510|NCT00805350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24861469|NCT02318043|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24708706|NCT01502202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708707|NCT01502202|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24708708|NCT01502202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24708709|NCT01502202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24708710|NCT01502241|Temozolomide|temozolomide|mesh-list
24708711|NCT01502241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24708712|NCT01502241|Alkylating Agents|alkylating agents|mesh-ancestor
24708713|NCT01502241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708714|NCT01502241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708715|NCT01502267|Rituximab|rituximab|mesh-list
25693026|NCT02007434|Epinephrine|epinephrine|mesh-list
25693027|NCT02007434|Deoxycholic Acid|deoxycholic acid|mesh-list
25693028|NCT02007434|Anesthetics, Local|anesthetics, local|mesh-ancestor
25693029|NCT02007434|Anesthetics|anesthetics|mesh-ancestor
25693030|NCT02007434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25693031|NCT02007434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693032|NCT02007434|Sensory System Agents|sensory system agents|mesh-ancestor
25693033|NCT02007434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25693034|NCT02007434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25693035|NCT02007434|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25693036|NCT02007434|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24819070|NCT02092974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24819072|NCT02092974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819073|NCT02092974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24708716|NCT01502267|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24437224|NCT00273026|Autonomic Agents|autonomic agents|mesh-ancestor
25284098|NCT02390284|Travoprost|travoprost|mesh-list
25284099|NCT02390284|Dorzolamide|dorzolamide|mesh-list
25284100|NCT02390284|Acetazolamide|acetazolamide|mesh-list
25284101|NCT02390284|Methazolamide|methazolamide|mesh-list
25284102|NCT02390284|Latanoprost|latanoprost|mesh-list
25284103|NCT02390284|Brinzolamide|brinzolamide|mesh-list
25284104|NCT02390284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25284105|NCT02390284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25284106|NCT02390284|Adrenergic Agents|adrenergic agents|mesh-ancestor
25284107|NCT02390284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25284108|NCT02390284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284109|NCT02390284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284110|NCT02390284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25284111|NCT02390284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25284112|NCT02390284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25284113|NCT02390284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25284114|NCT02390284|Anticonvulsants|anticonvulsants|mesh-ancestor
25284115|NCT02390284|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25284116|NCT02390284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25284117|NCT02390284|Diuretics|diuretics|mesh-ancestor
25284118|NCT02390284|Natriuretic Agents|natriuretic agents|mesh-ancestor
25284119|NCT02389517|Dexamethasone|dexamethasone|mesh-list
25284120|NCT02389517|Lenalidomide|lenalidomide|mesh-list
25284121|NCT02389517|Ixazomib|ixazomib|mesh-list
25284122|NCT02389517|Glycine|glycine|mesh-list
25284123|NCT02389517|Proteasome Inhibitors|proteasome inhibitors|mesh-list
25284124|NCT02389517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25284125|NCT02389517|Antiemetics|antiemetics|mesh-ancestor
25284126|NCT02389517|Autonomic Agents|autonomic agents|mesh-ancestor
25284127|NCT02389517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25284128|NCT02389517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284129|NCT02389517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25284130|NCT02389517|Glucocorticoids|glucocorticoids|mesh-ancestor
25047511|NCT00805350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047512|NCT00805350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25047513|NCT00805350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25047514|NCT00805350|Serotonin Agents|serotonin agents|mesh-ancestor
25047515|NCT00805350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25047516|NCT00805350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047517|NCT00803114|Morphine|morphine|mesh-list
25047518|NCT00803114|Narcotics|narcotics|mesh-list
25047519|NCT00803114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25047520|NCT00803114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25047521|NCT00803114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047522|NCT00803114|Analgesics|analgesics|mesh-ancestor
25047523|NCT00803114|Sensory System Agents|sensory system agents|mesh-ancestor
25047524|NCT00803114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25047525|NCT00799292|Vasopressins|vasopressins|mesh-list
25047526|NCT00799292|Arginine Vasopressin|arginine vasopressin|mesh-list
25047527|NCT00799292|Hemostatics|hemostatics|mesh-ancestor
25047528|NCT00799292|Coagulants|coagulants|mesh-ancestor
25047529|NCT00799292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25047531|NCT00799292|Natriuretic Agents|natriuretic agents|mesh-ancestor
25047532|NCT00799292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047533|NCT00796289|Citric Acid|citric acid|mesh-list
25047534|NCT00796289|Sodium Citrate|sodium citrate|mesh-list
25047535|NCT00796289|Clomiphene|clomiphene|mesh-list
25047536|NCT00796289|Enclomiphene|enclomiphene|mesh-list
25047537|NCT00796289|Zuclomiphene|zuclomiphene|mesh-list
25047538|NCT00796289|Hormones|hormones|mesh-list
25047539|NCT00796289|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25093214|NCT03236987|Rifampin|rifampin|mesh-list
25693037|NCT02007434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25693038|NCT02007434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693039|NCT02007434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25144563|NCT02935855|Anticoagulants|anticoagulants|mesh-ancestor
25144564|NCT02935855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24819626|NCT02096289|Thioridazine|thioridazine|mesh-list
24587913|NCT00898573|Lapatinib|lapatinib|mesh-list
24708717|NCT01502267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25284131|NCT02389517|Hormones|hormones|mesh-ancestor
25284132|NCT02389517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25284133|NCT02389517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25284134|NCT02389517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25284135|NCT02389517|Immunologic Factors|immunologic factors|mesh-ancestor
25284136|NCT02389517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25284137|NCT02389517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25284138|NCT02389517|Growth Substances|growth substances|mesh-ancestor
25284139|NCT02389517|Growth Inhibitors|growth inhibitors|mesh-ancestor
25284140|NCT02389517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284141|NCT02389517|Protease Inhibitors|protease inhibitors|mesh-ancestor
25284142|NCT02389517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25284143|NCT02389517|Glycine Agents|glycine agents|mesh-ancestor
25284144|NCT02389517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25284145|NCT05082142|Tranexamic Acid|tranexamic acid|mesh-list
25284146|NCT05082142|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25284147|NCT05082142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25284148|NCT05082142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284149|NCT05082142|Hemostatics|hemostatics|mesh-ancestor
25284150|NCT05082142|Coagulants|coagulants|mesh-ancestor
25284151|NCT05081986|Cycloserine|cycloserine|mesh-list
25284152|NCT05081986|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25284153|NCT05081986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25284154|NCT05081986|Renal Agents|renal agents|mesh-ancestor
25284155|NCT05081986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25284156|NCT05081986|Antitubercular Agents|antitubercular agents|mesh-ancestor
25284157|NCT05081986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25284158|NCT05081986|Antimetabolites|antimetabolites|mesh-ancestor
25284159|NCT05081986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284160|NCT05081765|Olaparib|olaparib|mesh-list
25284161|NCT05081765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25284162|NCT05081765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25284163|NCT05081765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284164|NCT05081765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25284165|NCT05081687|Oxaliplatin|oxaliplatin|mesh-list
25284166|NCT05081687|Irinotecan|irinotecan|mesh-list
25144565|NCT02935855|Antithrombins|antithrombins|mesh-ancestor
25144566|NCT02935855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25144567|NCT02935855|Protease Inhibitors|protease inhibitors|mesh-ancestor
25144568|NCT02935855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25144569|NCT02935855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144570|NCT02935985|Fibrin fragment D|fibrin fragment d|mesh-list
25144571|NCT02935985|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25144572|NCT02935985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25144573|NCT02935985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25144574|NCT02935985|Hemostatics|hemostatics|mesh-ancestor
25144575|NCT02935985|Coagulants|coagulants|mesh-ancestor
25144576|NCT02935647|Propofol|propofol|mesh-list
25144577|NCT02935647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25144578|NCT02935647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25144579|NCT02935647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25144580|NCT02935647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25144581|NCT02935647|Anesthetics, General|anesthetics, general|mesh-ancestor
25144582|NCT02935647|Anesthetics|anesthetics|mesh-ancestor
24770103|NCT01817972|Azathioprine|azathioprine|mesh-list
25284167|NCT05081687|Folfirinox|folfirinox|mesh-list
25284168|NCT05081687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25284169|NCT05081687|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25284170|NCT05081687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25284171|NCT05081687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25284172|NCT05081687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284173|NCT05081674|Pembrolizumab|pembrolizumab|mesh-list
25284174|NCT05081674|Nivolumab|nivolumab|mesh-list
25284175|NCT05081674|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25284176|NCT05081674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25284177|NCT05081674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759720|NCT01754116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24759721|NCT01754116|Antiviral Agents|antiviral agents|mesh-ancestor
24759722|NCT01754116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24759726|NCT01754220|Montelukast|montelukast|mesh-list
25284178|NCT05081674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25284179|NCT05081674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284180|NCT05081674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25284181|NCT05081674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25284189|NCT05081102|Ibuprofen|ibuprofen|mesh-list
25284190|NCT05081102|Oxycodone|oxycodone|mesh-list
25284191|NCT05081102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25284192|NCT05081102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25284193|NCT05081102|Analgesics|analgesics|mesh-ancestor
25284194|NCT05081102|Sensory System Agents|sensory system agents|mesh-ancestor
25284195|NCT05081102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25284196|NCT05081102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284197|NCT05081102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25284198|NCT05081102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25284199|NCT05081102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25284200|NCT05081102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25284201|NCT05081102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284202|NCT05081102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25284203|NCT05081102|Narcotics|narcotics|mesh-ancestor
25284204|NCT05081102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25284205|NCT05080985|Bupivacaine|bupivacaine|mesh-list
25284206|NCT05080985|Anesthetics, Local|anesthetics, local|mesh-ancestor
25284207|NCT05080985|Anesthetics|anesthetics|mesh-ancestor
25144723|NCT02934906|gamma-Globulins|gamma-globulins|mesh-list
25144835|NCT02934022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25144836|NCT02934022|Antiviral Agents|antiviral agents|mesh-ancestor
25144837|NCT02934022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25144838|NCT02934022|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25284208|NCT05080985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25284209|NCT05080985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284210|NCT05080985|Sensory System Agents|sensory system agents|mesh-ancestor
25284211|NCT05080985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25284215|NCT05080803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25284216|NCT05080803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25284217|NCT05080803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25284218|NCT05080803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25284219|NCT05080803|Growth Substances|growth substances|mesh-ancestor
25284220|NCT05080803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284221|NCT05080803|Growth Inhibitors|growth inhibitors|mesh-ancestor
25693040|NCT02007434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25693041|NCT02007434|Analgesics|analgesics|mesh-ancestor
25693042|NCT02007434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25693043|NCT02007434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25079512|NCT03347461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24533272|NCT00642837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24708718|NCT01502267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708719|NCT01502267|Immunologic Factors|immunologic factors|mesh-ancestor
24708720|NCT01502267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284222|NCT05062278|Hydroxyurea|hydroxyurea|mesh-list
25284223|NCT05062278|Vinblastine|vinblastine|mesh-list
25284224|NCT05062278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25284225|NCT05062278|Antisickling Agents|antisickling agents|mesh-ancestor
25284226|NCT05062278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25284227|NCT05062278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284228|NCT05062278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25284229|NCT05062278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25284230|NCT05062278|Tubulin Modulators|tubulin modulators|mesh-ancestor
25284231|NCT05062278|Antimitotic Agents|antimitotic agents|mesh-ancestor
25284232|NCT05062278|Mitosis Modulators|mitosis modulators|mesh-ancestor
25284233|NCT05055830|Acetaminophen|acetaminophen|mesh-list
25284234|NCT05055830|Methadone|methadone|mesh-list
25284235|NCT05055830|Caffeine|caffeine|mesh-list
25284236|NCT05055830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25284237|NCT05055830|Analgesics|analgesics|mesh-ancestor
25284238|NCT05055830|Sensory System Agents|sensory system agents|mesh-ancestor
25284242|NCT05055830|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25284243|NCT05055830|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25284244|NCT05055830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25284245|NCT05055830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284246|NCT05055830|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25284247|NCT05055830|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25284248|NCT05055830|Purinergic Agents|purinergic agents|mesh-ancestor
25284249|NCT05055830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25284250|NCT05055830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25284251|NCT05055830|Narcotics|narcotics|mesh-ancestor
25284252|NCT05055830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25284253|NCT05055830|Antitussive Agents|antitussive agents|mesh-ancestor
25284254|NCT05055830|Respiratory System Agents|respiratory system agents|mesh-ancestor
25284255|NCT05010629|Carboplatin|carboplatin|mesh-list
25284256|NCT05010629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145329|NCT02930551|Anesthetics, Local|anesthetics, local|mesh-ancestor
25144988|NCT02933853|Insulin|insulin|mesh-list
25145121|NCT02932007|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
25145122|NCT02932007|Amebicides|amebicides|mesh-ancestor
25693044|NCT02007434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25693045|NCT02007434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25145123|NCT02932007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25145124|NCT02932007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25693046|NCT02007434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25693047|NCT02007434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25693048|NCT02007434|Adrenergic Agents|adrenergic agents|mesh-ancestor
25693049|NCT02007434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25693050|NCT02007434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25693051|NCT02007434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25693052|NCT02007434|Autonomic Agents|autonomic agents|mesh-ancestor
24759830|NCT01754974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24759831|NCT01755078|Calcium, Dietary|calcium, dietary|mesh-list
24759832|NCT01755078|Calcium Carbonate|calcium carbonate|mesh-list
25145125|NCT02932007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25145126|NCT02932007|Antimalarials|antimalarials|mesh-ancestor
25145127|NCT02932007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25145128|NCT02932007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25145129|NCT02932007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25145130|NCT02932007|Analgesics|analgesics|mesh-ancestor
25145131|NCT02932007|Sensory System Agents|sensory system agents|mesh-ancestor
25145132|NCT02932007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25145133|NCT02932007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145134|NCT02932007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25145135|NCT02932007|Filaricides|filaricides|mesh-ancestor
25145136|NCT02932007|Antinematodal Agents|antinematodal agents|mesh-ancestor
25145137|NCT02932007|Anthelmintics|anthelmintics|mesh-ancestor
25145138|NCT02932020|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25145139|NCT02932020|Methylprednisolone|methylprednisolone|mesh-list
25145140|NCT02932020|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25145141|NCT02932020|Prednisolone|prednisolone|mesh-list
25145142|NCT02932020|Prednisolone acetate|prednisolone acetate|mesh-list
25145143|NCT02932020|Bupivacaine|bupivacaine|mesh-list
25145144|NCT02932020|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25145145|NCT02932020|Prednisolone phosphate|prednisolone phosphate|mesh-list
25145146|NCT02932020|Anesthetics, Local|anesthetics, local|mesh-ancestor
25145147|NCT02932020|Anesthetics|anesthetics|mesh-ancestor
25145148|NCT02932020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25145149|NCT02932020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284260|NCT04997174|Celecoxib|celecoxib|mesh-list
25284261|NCT04997174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25284262|NCT04997174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25284263|NCT04997174|Analgesics|analgesics|mesh-ancestor
25284264|NCT04997174|Sensory System Agents|sensory system agents|mesh-ancestor
25284265|NCT04997174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25284266|NCT04997174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284267|NCT04997174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25284268|NCT04997174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25284269|NCT04997174|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25284270|NCT04997174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25284271|NCT04997174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25284272|NCT04997174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284273|NCT04976387|Acetaminophen|acetaminophen|mesh-list
25284274|NCT04976387|Ibuprofen|ibuprofen|mesh-list
25284275|NCT04976387|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25284276|NCT04976387|Hydrocodone|hydrocodone|mesh-list
25284277|NCT04976387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25284278|NCT04976387|Analgesics|analgesics|mesh-ancestor
25284284|NCT04976387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25284285|NCT04976387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25284286|NCT04976387|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25284287|NCT04976387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25284288|NCT04976387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284289|NCT04976387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25284290|NCT04976387|Narcotics|narcotics|mesh-ancestor
25284291|NCT04976387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25284292|NCT04976387|Antitussive Agents|antitussive agents|mesh-ancestor
25284293|NCT04976387|Respiratory System Agents|respiratory system agents|mesh-ancestor
25284294|NCT04895488|Vortioxetine|vortioxetine|mesh-list
25284295|NCT04895488|Antipsychotic Agents|antipsychotic agents|mesh-list
25284296|NCT04895488|Antidepressive Agents|antidepressive agents|mesh-ancestor
25145175|NCT02932254|Anesthetics|anesthetics|mesh-ancestor
25145249|NCT02931357|Immunologic Factors|immunologic factors|mesh-ancestor
25145322|NCT02930954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25145323|NCT02930954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25145324|NCT02930954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25145325|NCT02931201|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25145326|NCT02931201|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25145327|NCT02931201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145328|NCT02930551|Lidocaine|lidocaine|mesh-list
25145331|NCT02930551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25145332|NCT02930551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145333|NCT02930551|Sensory System Agents|sensory system agents|mesh-ancestor
25145334|NCT02930551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25693053|NCT02007434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25693054|NCT02007434|Respiratory System Agents|respiratory system agents|mesh-ancestor
25693055|NCT02007434|Mydriatics|mydriatics|mesh-ancestor
25693056|NCT02007434|Sympathomimetics|sympathomimetics|mesh-ancestor
25693057|NCT02007434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25693058|NCT02007434|Antipruritics|antipruritics|mesh-ancestor
25693059|NCT02007434|Dermatologic Agents|dermatologic agents|mesh-ancestor
24759980|NCT01755663|Autonomic Agents|autonomic agents|mesh-ancestor
24759981|NCT01755663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24759982|NCT01755663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550670|NCT00721552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24759983|NCT01755663|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25145335|NCT02930551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25145336|NCT02930551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25145337|NCT02930551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25145338|NCT02930551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25145339|NCT02930551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25047678|NCT00771134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25047679|NCT00770848|Prednisone|prednisone|mesh-list
25047680|NCT00770848|Mitoxantrone|mitoxantrone|mesh-list
25047681|NCT00770848|Rilotumumab|rilotumumab|mesh-list
25047682|NCT00770848|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25047683|NCT00770848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25047684|NCT00770848|Glucocorticoids|glucocorticoids|mesh-ancestor
25047685|NCT00770848|Hormones|hormones|mesh-ancestor
25047686|NCT00770848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25047687|NCT00770848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094419|NCT03226522|Dopamine Agents|dopamine agents|mesh-ancestor
25284297|NCT04895488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25284298|NCT04895488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25284299|NCT04895488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25284300|NCT04895488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25284301|NCT04895488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284302|NCT04895488|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25284303|NCT04895488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25284304|NCT04895488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25284305|NCT04895488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284306|NCT04895488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25284307|NCT04895488|Serotonin Agents|serotonin agents|mesh-ancestor
25284308|NCT04895488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25284309|NCT04895488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25284310|NCT04895488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25284311|NCT04895488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25284317|NCT04800692|Verapamil|verapamil|mesh-list
25284318|NCT04800692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25284319|NCT04800692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25284332|NCT04571697|Abortifacient Agents|abortifacient agents|mesh-ancestor
25284333|NCT04571697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25284334|NCT04571697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145340|NCT02930707|Magnesium Sulfate|magnesium sulfate|mesh-list
25145490|NCT02929459|Vitamins|vitamins|mesh-list
25145563|NCT02929095|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25145564|NCT02929095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25145565|NCT02929095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25145566|NCT02929095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25145567|NCT02929095|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25145568|NCT02929095|Anesthetics, General|anesthetics, general|mesh-ancestor
25145569|NCT02929095|Anesthetics|anesthetics|mesh-ancestor
25145570|NCT02929095|GABA Modulators|gaba modulators|mesh-ancestor
25145571|NCT02929095|GABA Agents|gaba agents|mesh-ancestor
25145572|NCT02929095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25145573|NCT02929095|Narcotics|narcotics|mesh-ancestor
25145574|NCT02928861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25145575|NCT02928861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25145576|NCT02928861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693060|NCT02007434|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25693061|NCT02007434|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25693062|NCT02007434|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25693063|NCT02007434|Histamine Antagonists|histamine antagonists|mesh-ancestor
25693064|NCT02007434|Histamine Agents|histamine agents|mesh-ancestor
24449965|NCT00317499|Analgesics|analgesics|mesh-ancestor
24449966|NCT00317499|Sensory System Agents|sensory system agents|mesh-ancestor
24449967|NCT00317499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24449968|NCT00317499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449969|NCT00317499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24449970|NCT00317499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24449971|NCT00317499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25284335|NCT04571697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25284337|NCT04571697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284338|NCT04571697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25284339|NCT04571697|Dermatologic Agents|dermatologic agents|mesh-ancestor
25284340|NCT04571697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25284341|NCT04571697|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25284342|NCT04571697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25284343|NCT04571697|Immunologic Factors|immunologic factors|mesh-ancestor
25284344|NCT04571697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25284345|NCT04571697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25284359|NCT04455100|Itraconazole|itraconazole|mesh-list
25284360|NCT04455100|Antifungal Agents|antifungal agents|mesh-ancestor
25284361|NCT04455100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25284364|NCT04455100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25284365|NCT04455100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284366|NCT04455100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25284367|NCT04455100|Hormone Antagonists|hormone antagonists|mesh-ancestor
25284368|NCT04455100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25284369|NCT04455100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284370|NCT04455100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25284371|NCT04439578|Rifampin|rifampin|mesh-list
25284372|NCT04439578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25284373|NCT04439578|Antitubercular Agents|antitubercular agents|mesh-ancestor
25284374|NCT04439578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25145577|NCT02928965|Minocycline|minocycline|mesh-list
25145770|NCT02927496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25145771|NCT02927496|Antimalarials|antimalarials|mesh-ancestor
25145772|NCT02927496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25145773|NCT02927496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25145774|NCT02927535|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
25145775|NCT02927535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25145776|NCT02927353|Adalimumab|adalimumab|mesh-list
25145777|NCT02927353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25284375|NCT04439578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25284376|NCT04439578|Leprostatic Agents|leprostatic agents|mesh-ancestor
25284377|NCT04439578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25284378|NCT04439578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25284379|NCT04439578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284380|NCT04439578|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25284381|NCT04439578|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25284382|NCT04439578|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25284383|NCT04439578|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25284384|NCT04439578|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25284385|NCT04439578|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25284386|NCT04423601|Itraconazole|itraconazole|mesh-list
25284387|NCT04423601|Antifungal Agents|antifungal agents|mesh-ancestor
25284388|NCT04423601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25284389|NCT04423601|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25284390|NCT04423601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25284392|NCT04423601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284393|NCT04423601|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25284394|NCT04423601|Hormone Antagonists|hormone antagonists|mesh-ancestor
25284395|NCT04423601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25284396|NCT04423601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284397|NCT04423601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25145791|NCT02927522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25145792|NCT02927522|Cholinergic Agents|cholinergic agents|mesh-ancestor
25145793|NCT02927522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25145794|NCT02927522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145795|NCT02927522|Nootropic Agents|nootropic agents|mesh-ancestor
25094968|NCT03221504|Oxymetazoline|oxymetazoline|mesh-list
25145850|NCT02926326|Azithromycin|azithromycin|mesh-list
25284412|NCT04315701|Cemiplimab|cemiplimab|mesh-list
25284413|NCT04315701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25284414|NCT04315701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25284415|NCT04249076|Clobetasol|clobetasol|mesh-list
25284416|NCT04249076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25284417|NCT04249076|Glucocorticoids|glucocorticoids|mesh-ancestor
25284418|NCT04249076|Hormones|hormones|mesh-ancestor
25284419|NCT04249076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25284420|NCT04249076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284421|NCT04246801|Clobetasol|clobetasol|mesh-list
25284422|NCT04246801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25284423|NCT04246801|Glucocorticoids|glucocorticoids|mesh-ancestor
25284424|NCT04246801|Hormones|hormones|mesh-ancestor
25284425|NCT04246801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25284426|NCT04246801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284427|NCT04167033|Hormones|hormones|mesh-list
25284428|NCT04167033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25284429|NCT04167033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145919|NCT02925975|Vasodilator Agents|vasodilator agents|mesh-ancestor
25145920|NCT02925975|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25145921|NCT02925975|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25145922|NCT02925702|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25145923|NCT02925702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25145924|NCT02925351|Clofarabine|clofarabine|mesh-list
25145925|NCT02925351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25145926|NCT02925351|Antimetabolites|antimetabolites|mesh-ancestor
24533286|NCT00642863|Protective Agents|protective agents|mesh-ancestor
25145931|NCT02925299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145933|NCT02925559|Gliclazide|gliclazide|mesh-list
25145934|NCT02925559|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25145935|NCT02925559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760160|NCT01756508|Eculizumab|eculizumab|mesh-list
25145936|NCT02925559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25145937|NCT02925559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145938|NCT02925247|Anticoagulants|anticoagulants|mesh-list
24708721|NCT01502267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24708725|NCT01502280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708726|NCT01502280|Protective Agents|protective agents|mesh-ancestor
24708727|NCT01502280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708728|NCT01502280|Vitamins|vitamins|mesh-ancestor
24708729|NCT01502280|Micronutrients|micronutrients|mesh-ancestor
24708730|NCT01502280|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24708731|NCT01502280|Dermatologic Agents|dermatologic agents|mesh-ancestor
24708732|NCT01502358|Vaccines|vaccines|mesh-list
25284432|NCT03971929|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25284433|NCT03971929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25284434|NCT03971929|Diuretics|diuretics|mesh-ancestor
25284435|NCT03971929|Natriuretic Agents|natriuretic agents|mesh-ancestor
25284436|NCT03971929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284437|NCT03971929|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25284438|NCT03971929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25284439|NCT03971929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284440|NCT03971084|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
25284441|NCT03971084|Caseins|caseins|mesh-list
25284442|NCT03971084|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25284443|NCT03971084|Serotonin Agents|serotonin agents|mesh-ancestor
25284444|NCT03971084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25284445|NCT03971084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284446|NCT03971084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284447|NCT03971084|Chelating Agents|chelating agents|mesh-ancestor
25284448|NCT03971084|Sequestering Agents|sequestering agents|mesh-ancestor
25284449|NCT03832647|Salicylic Acid|salicylic acid|mesh-list
25284450|NCT03832647|Salicylates|salicylates|mesh-list
25284451|NCT03832647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25284452|NCT03832647|Antifungal Agents|antifungal agents|mesh-ancestor
25284453|NCT03832647|Keratolytic Agents|keratolytic agents|mesh-ancestor
25284454|NCT03832647|Dermatologic Agents|dermatologic agents|mesh-ancestor
25284455|NCT03832647|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25284456|NCT03832647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25284457|NCT03832647|Analgesics|analgesics|mesh-ancestor
25284458|NCT03832647|Sensory System Agents|sensory system agents|mesh-ancestor
25284459|NCT03832647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25284460|NCT03832647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25145939|NCT02925416|Oritavancin|oritavancin|mesh-list
25146178|NCT02923869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146180|NCT02923869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25693065|NCT02007434|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25146181|NCT02923791|Lenograstim|lenograstim|mesh-list
25146182|NCT02923791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25146183|NCT02923791|Immunologic Factors|immunologic factors|mesh-ancestor
25146184|NCT02923791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146186|NCT02923687|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25146187|NCT02923687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25146188|NCT02923687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25146189|NCT02923687|Analgesics|analgesics|mesh-ancestor
25146200|NCT02923583|Abatacept|abatacept|mesh-list
25284461|NCT03832647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25284462|NCT03832647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25284463|NCT03832647|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25284464|NCT03832647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25284465|NCT03832647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284466|NCT03778671|Fentanyl|fentanyl|mesh-list
25284467|NCT03778671|Dexmedetomidine|dexmedetomidine|mesh-list
25284468|NCT03778671|Levobupivacaine|levobupivacaine|mesh-list
25284469|NCT03778671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25284470|NCT03778671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25284471|NCT03778671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284472|NCT03778671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25284473|NCT03778671|Analgesics|analgesics|mesh-ancestor
25284474|NCT03778671|Sensory System Agents|sensory system agents|mesh-ancestor
25284475|NCT03778671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25284476|NCT03778671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25284477|NCT03778671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25284478|NCT03778671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25284479|NCT03778671|Adrenergic Agents|adrenergic agents|mesh-ancestor
25284480|NCT03778671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24508998|NCT00557960|Autonomic Agents|autonomic agents|mesh-ancestor
25284481|NCT03778671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284482|NCT03778671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25284483|NCT03778671|Narcotics|narcotics|mesh-ancestor
25284484|NCT03778671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25284485|NCT03778671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25284486|NCT03778671|Anesthetics, General|anesthetics, general|mesh-ancestor
25284487|NCT03778671|Anesthetics|anesthetics|mesh-ancestor
25284488|NCT03778671|Anesthetics, Local|anesthetics, local|mesh-ancestor
25284489|NCT03698162|Bevacizumab|bevacizumab|mesh-list
25284490|NCT03698162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25284491|NCT03698162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25284492|NCT03698162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25284493|NCT03698162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25284494|NCT03698162|Growth Substances|growth substances|mesh-ancestor
25031712|NCT03586154|Anesthetics, General|anesthetics, general|mesh-ancestor
25284495|NCT03698162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284496|NCT03698162|Growth Inhibitors|growth inhibitors|mesh-ancestor
25284497|NCT03692715|Ciprofloxacin|ciprofloxacin|mesh-list
25284498|NCT03692715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25284499|NCT03692715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25284500|NCT03692715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25284501|NCT03692715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25284502|NCT03692715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146202|NCT02923583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25146203|NCT02923583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25146204|NCT02923583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25146205|NCT02923583|Immunologic Factors|immunologic factors|mesh-ancestor
25146206|NCT02923583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146207|NCT02923583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25146208|NCT02923388|Vitamins|vitamins|mesh-list
25146209|NCT02923388|Vitamin B 12|vitamin b 12|mesh-list
25146210|NCT02923388|Pyridoxine|pyridoxine|mesh-list
25146211|NCT02923388|Vitamin B 6|vitamin b 6|mesh-list
25146212|NCT02923388|Vitamin B Complex|vitamin b complex|mesh-list
25146213|NCT02923388|Micronutrients|micronutrients|mesh-ancestor
25146214|NCT02923388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146439|NCT02921659|Micronutrients|micronutrients|mesh-ancestor
25146440|NCT02921659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284503|NCT03692715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284504|NCT03692715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25284505|NCT03692715|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25284506|NCT03692715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25284528|NCT03563066|Benralizumab|benralizumab|mesh-list
25284529|NCT03563066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25284530|NCT03563066|Respiratory System Agents|respiratory system agents|mesh-ancestor
25284531|NCT03558789|Lactoferrin|lactoferrin|mesh-list
24760350|NCT01757587|Vildagliptin|vildagliptin|mesh-list
24760351|NCT01757587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25284532|NCT03558789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25284533|NCT03495921|Irinotecan|irinotecan|mesh-list
25284534|NCT03495921|Camptothecin|camptothecin|mesh-list
25284535|NCT03495921|Temozolomide|temozolomide|mesh-list
25284536|NCT03495921|Immunologic Factors|immunologic factors|mesh-list
25284537|NCT03495921|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25284538|NCT03495921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25284539|NCT03495921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25146446|NCT02921269|Bevacizumab|bevacizumab|mesh-list
25146447|NCT02921269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25146451|NCT02921269|Immunoglobulins|immunoglobulins|mesh-list
25146452|NCT02921269|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25146453|NCT02921269|Immunoglobulin G|immunoglobulin g|mesh-list
25146454|NCT02921269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25146455|NCT02921269|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25095744|NCT03216707|Capsaicin|capsaicin|mesh-list
25146538|NCT02920801|Protease Inhibitors|protease inhibitors|mesh-ancestor
25146597|NCT02920658|Glucocorticoids|glucocorticoids|mesh-ancestor
25146682|NCT02919605|Antifungal Agents|antifungal agents|mesh-ancestor
25146683|NCT02919605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25146684|NCT02919605|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25146685|NCT02919605|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25146686|NCT02919605|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25284540|NCT03495921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284541|NCT03495921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25284542|NCT03495921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25284543|NCT03495921|Alkylating Agents|alkylating agents|mesh-ancestor
25284544|NCT03495921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284545|NCT03495921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25284562|NCT03317223|Amoxicillin|amoxicillin|mesh-list
25284563|NCT03317223|Clarithromycin|clarithromycin|mesh-list
25284564|NCT03317223|Lansoprazole|lansoprazole|mesh-list
25284565|NCT03317223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25284566|NCT03317223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25284567|NCT03317223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25284568|NCT03317223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25284569|NCT03317223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284570|NCT03317223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25284571|NCT03317223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25284572|NCT03317223|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25284573|NCT03317223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25284574|NCT03317223|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25284575|NCT03304821|Sargramostim|sargramostim|mesh-list
25284576|NCT03304821|Immunologic Factors|immunologic factors|mesh-ancestor
25113615|NCT02474173|Antimitotic Agents|antimitotic agents|mesh-ancestor
25284599|NCT03136731|Immunologic Factors|immunologic factors|mesh-ancestor
25284600|NCT03136731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284601|NCT02983006|Nivolumab|nivolumab|mesh-list
25284602|NCT02983006|DS-8273a|ds-8273a|mesh-list
25284603|NCT02983006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25284604|NCT02983006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25284605|NCT02983006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25284606|NCT02983006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284607|NCT02936687|Ambrisentan|ambrisentan|mesh-list
25693066|NCT02007434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25693067|NCT02007577|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
25284608|NCT02936687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25284609|NCT02787590|Simvastatin|simvastatin|mesh-list
25284610|NCT02787590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25284611|NCT02787590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25284612|NCT02787590|Antimetabolites|antimetabolites|mesh-ancestor
25284613|NCT02787590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284614|NCT02787590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25284615|NCT02787590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25284616|NCT02787590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25032556|NCT03579927|Lenograstim|lenograstim|mesh-list
24864631|NCT03072628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864632|NCT03072628|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24864633|NCT03072628|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24864634|NCT03072628|Cholinergic Agents|cholinergic agents|mesh-ancestor
24864635|NCT03072628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25146906|NCT02918591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25146907|NCT02918409|Tobramycin|tobramycin|mesh-list
25146908|NCT02918409|Colistin|colistin|mesh-list
25146909|NCT02918409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25146910|NCT02918409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25146911|NCT02918331|Dexamethasone|dexamethasone|mesh-list
25146912|NCT02918331|Lenalidomide|lenalidomide|mesh-list
25146913|NCT02918331|Daratumumab|daratumumab|mesh-list
25146914|NCT02918331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25146915|NCT02918331|Antiemetics|antiemetics|mesh-ancestor
25146916|NCT02918331|Autonomic Agents|autonomic agents|mesh-ancestor
25146917|NCT02918331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25146918|NCT02918331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148079|NCT05312541|Bupivacaine|bupivacaine|mesh-list
25284634|NCT02659813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284636|NCT02566863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25284637|NCT02566863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25284638|NCT02566863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284639|NCT02566863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25284640|NCT02566863|Analgesics|analgesics|mesh-ancestor
25284641|NCT02566863|Sensory System Agents|sensory system agents|mesh-ancestor
25284642|NCT02566863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25284643|NCT02566863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25284644|NCT02566863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25284645|NCT02566863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25284646|NCT02566863|Adrenergic Agents|adrenergic agents|mesh-ancestor
25284647|NCT02566863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25284648|NCT02566863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284654|NCT05084456|Docetaxel|docetaxel|mesh-list
25284655|NCT05084456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25284656|NCT05084456|Tubulin Modulators|tubulin modulators|mesh-ancestor
25147135|NCT02916160|Valsartan|valsartan|mesh-list
25147250|NCT02915042|Sensory System Agents|sensory system agents|mesh-ancestor
25147251|NCT02915042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25147252|NCT02915042|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25147253|NCT02915042|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25147254|NCT02915042|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25147255|NCT02915042|Adrenergic Agents|adrenergic agents|mesh-ancestor
25147528|NCT02912910|Labetalol|labetalol|mesh-list
25147529|NCT02912910|Nifedipine|nifedipine|mesh-list
25147530|NCT02912910|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25147531|NCT02912910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25147532|NCT02912910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25147533|NCT02912910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25147534|NCT02912910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147535|NCT02912910|Vasodilator Agents|vasodilator agents|mesh-ancestor
25147536|NCT02912910|Tocolytic Agents|tocolytic agents|mesh-ancestor
25147537|NCT02912910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25147538|NCT02912910|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25147539|NCT02912910|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25147540|NCT02912910|Adrenergic Agents|adrenergic agents|mesh-ancestor
25147541|NCT02912910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25147542|NCT02912910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25147543|NCT02912910|Sympathomimetics|sympathomimetics|mesh-ancestor
25147544|NCT02912910|Autonomic Agents|autonomic agents|mesh-ancestor
25147545|NCT02912910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25693068|NCT02007577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25693069|NCT02007577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25693070|NCT02007577|Analgesics|analgesics|mesh-ancestor
25147649|NCT02912234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25147724|NCT02911350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25147725|NCT02911350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284658|NCT05084456|Mitosis Modulators|mitosis modulators|mesh-ancestor
25284659|NCT05084456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284660|NCT05084365|Sulforaphane|sulforaphane|mesh-list
25284661|NCT05084365|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25284662|NCT05084365|Protective Agents|protective agents|mesh-ancestor
25284663|NCT05084365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284664|NCT05084365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25284665|NCT05084235|Empagliflozin|empagliflozin|mesh-list
25284666|NCT05084235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25040841|NCT02810444|gamma-Globulins|gamma-globulins|mesh-list
25284667|NCT05084235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284668|NCT05084235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25284669|NCT05084235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284671|NCT05084196|Antioxidants|antioxidants|mesh-ancestor
25102805|NCT03166397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284672|NCT05084196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284673|NCT05084196|Protective Agents|protective agents|mesh-ancestor
25284674|NCT05084196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284675|NCT05084196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25284676|NCT05084079|Insulin|insulin|mesh-list
25284677|NCT05084079|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25284678|NCT05084079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25284679|NCT05084079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284680|NCT05084001|Listerine|listerine|mesh-list
25284681|NCT05084001|Fluorides|fluorides|mesh-list
25284682|NCT05084001|Sodium Fluoride|sodium fluoride|mesh-list
25284683|NCT05084001|Fluorides, Topical|fluorides, topical|mesh-list
25284684|NCT05084001|Cariostatic Agents|cariostatic agents|mesh-ancestor
25284685|NCT05084001|Protective Agents|protective agents|mesh-ancestor
25284686|NCT05084001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284687|NCT05084001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25284688|NCT05084001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25284689|NCT05083793|Pregabalin|pregabalin|mesh-list
25284690|NCT05083793|Analgesics|analgesics|mesh-ancestor
25284691|NCT05083793|Sensory System Agents|sensory system agents|mesh-ancestor
25284692|NCT05083793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25284693|NCT05083793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284694|NCT05083793|Anticonvulsants|anticonvulsants|mesh-ancestor
25147728|NCT02911480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25147729|NCT02911480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147730|NCT02911272|Oxytocin|oxytocin|mesh-list
25147731|NCT02911272|Oxytocics|oxytocics|mesh-ancestor
25147732|NCT02911272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25147733|NCT02911272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25147734|NCT02910778|Ticagrelor|ticagrelor|mesh-list
25147735|NCT02910778|Atorvastatin|atorvastatin|mesh-list
25147737|NCT02910778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25147990|NCT02909257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148068|NCT05312645|Analgesics|analgesics|mesh-ancestor
25148069|NCT05312645|Sensory System Agents|sensory system agents|mesh-ancestor
25148070|NCT05312645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25148071|NCT05312645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148072|NCT05312645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25148073|NCT05312645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25148074|NCT05312645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25148075|NCT05312645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25148076|NCT05312645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148077|NCT05312645|Emollients|emollients|mesh-ancestor
25148078|NCT05312645|Dermatologic Agents|dermatologic agents|mesh-ancestor
25148080|NCT05312541|Anesthetics, Local|anesthetics, local|mesh-list
25148081|NCT05312541|Anesthetics|anesthetics|mesh-list
25148082|NCT05312541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25148083|NCT05312541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148084|NCT05312541|Sensory System Agents|sensory system agents|mesh-ancestor
25148085|NCT05312541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25097498|NCT03203356|Hormones|hormones|mesh-list
24708733|NCT01502358|Immunologic Factors|immunologic factors|mesh-ancestor
24708734|NCT01502358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494790|NCT00497029|Fluorides|fluorides|mesh-list
24708735|NCT01502592|Ipilimumab|ipilimumab|mesh-list
24708736|NCT01502592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24708737|NCT01502592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708738|NCT01502592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24708739|NCT01502592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708740|NCT01502605|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24708741|NCT01502605|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24708742|NCT01502605|Dermatologic Agents|dermatologic agents|mesh-ancestor
24708743|NCT01502696|Interferon alpha-2|interferon alpha-2|mesh-list
24708744|NCT01502696|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24708745|NCT01502696|Antiviral Agents|antiviral agents|mesh-ancestor
24708746|NCT01502696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24708747|NCT01502696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25284695|NCT05083793|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25284696|NCT05083793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25284698|NCT05083793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25284699|NCT05083793|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25284700|NCT05083793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25284701|NCT05083793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25284702|NCT05083793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25284703|NCT05083689|Bevacizumab|bevacizumab|mesh-list
25284704|NCT05083689|Timolol|timolol|mesh-list
25284705|NCT05083689|Dorzolamide|dorzolamide|mesh-list
25284706|NCT05083689|Lubricant Eye Drops|lubricant eye drops|mesh-list
25284707|NCT05083689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25284708|NCT05083689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25284709|NCT05083689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25284710|NCT05083689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25284711|NCT05083689|Growth Substances|growth substances|mesh-ancestor
25284712|NCT05083689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284713|NCT05083689|Growth Inhibitors|growth inhibitors|mesh-ancestor
25284714|NCT05083689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25284715|NCT05083689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25284716|NCT05083689|Adrenergic Agents|adrenergic agents|mesh-ancestor
25284717|NCT05083689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25284718|NCT05083689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284719|NCT05083689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25284720|NCT05083689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25284721|NCT05083689|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25284722|NCT05083689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25113798|NCT02167945|Ribavirin|ribavirin|mesh-list
25284723|NCT05083689|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25284724|NCT05083689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25148224|NCT05311085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24795427|NCT02758847|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25148225|NCT05311085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148227|NCT05310929|Nitroglycerin|nitroglycerin|mesh-list
25148228|NCT05310929|Vasodilator Agents|vasodilator agents|mesh-ancestor
25148229|NCT05310929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25148230|NCT05310929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25148231|NCT05310929|Adrenergic Agents|adrenergic agents|mesh-ancestor
25148232|NCT05310929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25148233|NCT05310929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148234|NCT05310929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25148235|NCT05310929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25148236|NCT05310929|Sympathomimetics|sympathomimetics|mesh-ancestor
25148237|NCT05310929|Autonomic Agents|autonomic agents|mesh-ancestor
25148238|NCT05310929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25148239|NCT05310929|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25148240|NCT05310929|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25148241|NCT05310591|Nivolumab|nivolumab|mesh-list
25148242|NCT05310591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25148243|NCT05310591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25148244|NCT05310591|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25148245|NCT05310591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533289|NCT00642863|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24533290|NCT00642915|Insulin Glargine|insulin glargine|mesh-list
24533291|NCT00642915|Glimepiride|glimepiride|mesh-list
24533292|NCT00642915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25284725|NCT05083455|Enoxaparin|enoxaparin|mesh-list
25284726|NCT05083455|Rivaroxaban|rivaroxaban|mesh-list
25284727|NCT05083455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25284728|NCT05083455|Antithrombins|antithrombins|mesh-ancestor
25284729|NCT05083455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25284730|NCT05083455|Protease Inhibitors|protease inhibitors|mesh-ancestor
25284731|NCT05083455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25284732|NCT05083455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284733|NCT05083455|Anticoagulants|anticoagulants|mesh-ancestor
25284734|NCT05083455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25284735|NCT05083455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25284736|NCT05083429|Tiotropium Bromide|tiotropium bromide|mesh-list
25284737|NCT05083429|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25284738|NCT05083429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25284739|NCT05083429|Autonomic Agents|autonomic agents|mesh-ancestor
25284740|NCT05083429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25284741|NCT05083429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284742|NCT05083429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25284743|NCT05083429|Respiratory System Agents|respiratory system agents|mesh-ancestor
25284744|NCT05083429|Parasympatholytics|parasympatholytics|mesh-ancestor
25284745|NCT05083429|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25284746|NCT05083429|Cholinergic Agents|cholinergic agents|mesh-ancestor
25284747|NCT05083429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25284748|NCT05083429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284749|NCT05083429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25284750|NCT05083429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25284751|NCT05083429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25284752|NCT05083429|Adrenergic Agents|adrenergic agents|mesh-ancestor
25284753|NCT05083299|Sarpogrelate|sarpogrelate|mesh-list
25284754|NCT05083299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25284755|NCT05083299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25284756|NCT05083299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284757|NCT05083299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25284758|NCT05083299|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25284759|NCT05083299|Serotonin Agents|serotonin agents|mesh-ancestor
25284760|NCT05083299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25284761|NCT05083299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284762|NCT05083247|Gemcitabine|gemcitabine|mesh-list
25284763|NCT05083247|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25284764|NCT05083247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25284765|NCT05083247|Antimetabolites|antimetabolites|mesh-ancestor
25148402|NCT05124067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25148404|NCT05124067|Protease Inhibitors|protease inhibitors|mesh-ancestor
25148405|NCT05124067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25148406|NCT05124067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25148407|NCT05124067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25148408|NCT05124067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25148409|NCT05124067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25148410|NCT05124067|Analgesics|analgesics|mesh-ancestor
25148411|NCT05124067|Sensory System Agents|sensory system agents|mesh-ancestor
25148412|NCT05124067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25148413|NCT05124067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25148414|NCT05124067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25148415|NCT05124067|Adrenergic Agents|adrenergic agents|mesh-ancestor
25148416|NCT05124067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25148417|NCT05124067|Antipruritics|antipruritics|mesh-ancestor
25148418|NCT05124067|Dermatologic Agents|dermatologic agents|mesh-ancestor
25033670|NCT03571594|Octreotide|octreotide|mesh-list
25148419|NCT05124067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25148420|NCT05124067|Serotonin Agents|serotonin agents|mesh-ancestor
25148421|NCT05124067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25148422|NCT05124067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25148423|NCT05124067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25148424|NCT05124067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25148425|NCT05123040|Prednisone|prednisone|mesh-list
25148426|NCT05123040|Methylprednisolone|methylprednisolone|mesh-list
25148427|NCT05123040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25148428|NCT05123040|Glucocorticoids|glucocorticoids|mesh-ancestor
25148429|NCT05123040|Hormones|hormones|mesh-ancestor
25148430|NCT05123040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25148431|NCT05123040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284766|NCT05083247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284767|NCT05083247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25284768|NCT05083247|Antiviral Agents|antiviral agents|mesh-ancestor
25284769|NCT05083247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25284770|NCT05083247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25284771|NCT05083247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25284772|NCT05083247|Immunologic Factors|immunologic factors|mesh-ancestor
25284773|NCT05083247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284774|NCT05083026|Antibodies|antibodies|mesh-list
25284775|NCT05083026|Antibodies, Blocking|antibodies, blocking|mesh-list
25284776|NCT05083026|Immunologic Factors|immunologic factors|mesh-ancestor
25284777|NCT05083026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284778|NCT05083013|Chrysarobin|chrysarobin|mesh-list
25284779|NCT05083013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25284780|NCT05083013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25284781|NCT05083013|Analgesics|analgesics|mesh-ancestor
25284782|NCT05083013|Sensory System Agents|sensory system agents|mesh-ancestor
25284783|NCT05083013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25284784|NCT05083013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284785|NCT05083013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25284786|NCT05083013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25284787|NCT05082974|Varenicline|varenicline|mesh-list
25284788|NCT05082974|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25284789|NCT05082974|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25284790|NCT05082974|Cholinergic Agents|cholinergic agents|mesh-ancestor
25284791|NCT05082974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25284792|NCT05082974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284793|NCT05082974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284798|NCT05082753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25284799|NCT05082753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25284801|NCT05082662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25284802|NCT05082662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25284803|NCT05082662|Analgesics|analgesics|mesh-ancestor
25284804|NCT05082662|Sensory System Agents|sensory system agents|mesh-ancestor
25284805|NCT05082662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25148605|NCT04863339|Tranexamic Acid|tranexamic acid|mesh-list
25148606|NCT04863339|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25148607|NCT04863339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25148609|NCT04863339|Hemostatics|hemostatics|mesh-ancestor
25148738|NCT04660760|Immunologic Factors|immunologic factors|mesh-ancestor
25148815|NCT04567160|Propofol|propofol|mesh-list
25149023|NCT04243616|Carboplatin|carboplatin|mesh-list
25149098|NCT04105335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25149099|NCT04105335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25149101|NCT04105270|Pemetrexed|pemetrexed|mesh-list
25149102|NCT04105270|Durvalumab|durvalumab|mesh-list
25149103|NCT04105270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25149104|NCT04105270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25149105|NCT04105270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25149106|NCT04105270|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25149107|NCT04105270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25149108|NCT04105270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25149109|NCT04087096|Zoledronic Acid|zoledronic acid|mesh-list
25149110|NCT04087096|Denosumab|denosumab|mesh-list
25149111|NCT04087096|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24420567|NCT00216346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25149112|NCT04087096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098668|NCT03196479|Anesthetics|anesthetics|mesh-ancestor
24708748|NCT01502774|Cyclosporine|cyclosporine|mesh-list
25284806|NCT05082662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284807|NCT05082662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25284808|NCT05082662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25284809|NCT05082662|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25284810|NCT05082662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25284811|NCT05082662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284812|NCT05082441|Bupivacaine|bupivacaine|mesh-list
25284813|NCT05082441|Anesthetics, Local|anesthetics, local|mesh-ancestor
25284814|NCT05082441|Anesthetics|anesthetics|mesh-ancestor
25284815|NCT05082441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25284816|NCT05082441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284817|NCT05082441|Sensory System Agents|sensory system agents|mesh-ancestor
25284818|NCT05082441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25284819|NCT05073653|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25284820|NCT05073653|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25284821|NCT05073653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284822|NCT05072054|Atorvastatin|atorvastatin|mesh-list
25284823|NCT05072054|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24600891|NCT00961038|Ciprofloxacin|ciprofloxacin|mesh-list
25284824|NCT05072054|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25284825|NCT05072054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25284826|NCT05072054|Antimetabolites|antimetabolites|mesh-ancestor
25284827|NCT05072054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284828|NCT05072054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25284829|NCT05072054|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25284830|NCT05072054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25284843|NCT05049902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25284844|NCT05049902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25284845|NCT05049902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25284846|NCT05049902|Antacids|antacids|mesh-ancestor
25284847|NCT05049902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25284848|NCT05049902|Diuretics|diuretics|mesh-ancestor
25284849|NCT05049902|Natriuretic Agents|natriuretic agents|mesh-ancestor
25284850|NCT05049902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284851|NCT05049902|Expectorants|expectorants|mesh-ancestor
25284852|NCT05049902|Respiratory System Agents|respiratory system agents|mesh-ancestor
25284853|NCT05048069|Rebamipide|rebamipide|mesh-list
25284854|NCT05048069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25284855|NCT05048069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25284856|NCT05048069|Antioxidants|antioxidants|mesh-ancestor
25284857|NCT05048069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284858|NCT05048069|Protective Agents|protective agents|mesh-ancestor
25284859|NCT05048069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284860|NCT05048069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25284890|NCT05025735|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25284891|NCT05025735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284892|NCT05025735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25284893|NCT05025735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284894|NCT04962230|Ritonavir|ritonavir|mesh-list
25284895|NCT04962230|Carbamazepine|carbamazepine|mesh-list
25039896|NCT03611751|Dermatologic Agents|dermatologic agents|mesh-ancestor
25284896|NCT04962230|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25284897|NCT04962230|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25284898|NCT04962230|Protease Inhibitors|protease inhibitors|mesh-ancestor
25284899|NCT04962230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25284900|NCT04962230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284901|NCT04962230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25284902|NCT04962230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25284903|NCT04962230|Antiviral Agents|antiviral agents|mesh-ancestor
25284904|NCT04962230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25284905|NCT04962230|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25284906|NCT04962230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25284907|NCT04962230|Anticonvulsants|anticonvulsants|mesh-ancestor
25284908|NCT04962230|Antimanic Agents|antimanic agents|mesh-ancestor
25284909|NCT04962230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25284910|NCT04962230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25284911|NCT04962230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284912|NCT04962230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25284913|NCT04962230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25284914|NCT04962230|Analgesics|analgesics|mesh-ancestor
25284915|NCT04962230|Sensory System Agents|sensory system agents|mesh-ancestor
24420568|NCT00216346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25284916|NCT04962230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25284917|NCT04962230|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25284918|NCT04962230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25284919|NCT04962230|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25284920|NCT04962230|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25284921|NCT04941040|Analgesics, Opioid|analgesics, opioid|mesh-list
25284922|NCT04941040|Anesthetics|anesthetics|mesh-list
25284923|NCT04941040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25284924|NCT04941040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284925|NCT04941040|Narcotics|narcotics|mesh-ancestor
25284926|NCT04941040|Analgesics|analgesics|mesh-ancestor
25284927|NCT04941040|Sensory System Agents|sensory system agents|mesh-ancestor
25284928|NCT04941040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25284929|NCT04934410|Midazolam|midazolam|mesh-list
25284930|NCT04934410|Etomidate|etomidate|mesh-list
25284931|NCT04934410|Sevoflurane|sevoflurane|mesh-list
25284932|NCT04934410|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25284933|NCT04934410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25284934|NCT04934410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25284935|NCT04934410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284936|NCT04934410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25284937|NCT04934410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25284938|NCT04934410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25284939|NCT04934410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25284940|NCT04934410|Anesthetics, General|anesthetics, general|mesh-ancestor
25284941|NCT04934410|Anesthetics|anesthetics|mesh-ancestor
25284942|NCT04934410|GABA Modulators|gaba modulators|mesh-ancestor
24760837|NCT01760161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760838|NCT01760161|Sensory System Agents|sensory system agents|mesh-ancestor
24760839|NCT01760161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24760841|NCT01760174|Ropivacaine|ropivacaine|mesh-list
24760842|NCT01760174|Anesthetics, Local|anesthetics, local|mesh-ancestor
24760843|NCT01760174|Anesthetics|anesthetics|mesh-ancestor
24760844|NCT01760174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24760845|NCT01760174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760846|NCT01760174|Sensory System Agents|sensory system agents|mesh-ancestor
24760847|NCT01760174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24760848|NCT01760226|Prednisone|prednisone|mesh-list
24760849|NCT01760226|Cyclophosphamide|cyclophosphamide|mesh-list
24760850|NCT01760226|Rituximab|rituximab|mesh-list
24760871|NCT01760226|Hormones|hormones|mesh-ancestor
25284943|NCT04934410|GABA Agents|gaba agents|mesh-ancestor
25284944|NCT04934410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25284945|NCT04934410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284946|NCT04934410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25284947|NCT04934410|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24868705|NCT03393741|Vinorelbine|vinorelbine|mesh-list
24868706|NCT03393741|Docetaxel|docetaxel|mesh-list
24868707|NCT03393741|Epothilones|epothilones|mesh-list
24868708|NCT03393741|Vinca Alkaloids|vinca alkaloids|mesh-list
24868709|NCT03393741|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25040630|NCT02989597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25040631|NCT02989597|Analgesics|analgesics|mesh-ancestor
25040632|NCT02989597|Sensory System Agents|sensory system agents|mesh-ancestor
25040633|NCT02989597|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25040634|NCT02989597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25040635|NCT02989597|Anesthetics, General|anesthetics, general|mesh-ancestor
25040636|NCT02989597|Anesthetics|anesthetics|mesh-ancestor
25040637|NCT02989597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25040638|NCT02989597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25040639|NCT02989597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25040640|NCT02989597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25040641|NCT02989597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040642|NCT02989597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25040643|NCT02989597|Narcotics|narcotics|mesh-ancestor
25040644|NCT02989597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25040645|NCT02989597|Antitussive Agents|antitussive agents|mesh-ancestor
25040646|NCT02989597|Respiratory System Agents|respiratory system agents|mesh-ancestor
25040647|NCT02986659|Metformin|metformin|mesh-list
25284948|NCT04918927|Nitazoxanide|nitazoxanide|mesh-list
25284949|NCT04918927|Favipiravir|favipiravir|mesh-list
25284950|NCT04918927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25040648|NCT02986659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25284951|NCT04918927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25284952|NCT04918927|Antiviral Agents|antiviral agents|mesh-ancestor
25284953|NCT04880928|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25040649|NCT02986659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040650|NCT02978456|Sirolimus|sirolimus|mesh-list
25040651|NCT02978456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25040652|NCT02978456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25040653|NCT02978456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25040654|NCT02978456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25040655|NCT02978456|Antifungal Agents|antifungal agents|mesh-ancestor
25040656|NCT02978456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24868710|NCT03393741|Taxane|taxane|mesh-list
25284954|NCT04880928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25284955|NCT04873297|Metoclopramide|metoclopramide|mesh-list
25693071|NCT02007577|Sensory System Agents|sensory system agents|mesh-ancestor
25693072|NCT02007577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25693073|NCT02007577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693074|NCT02007577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25693075|NCT02007577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25693076|NCT02007863|Fludarabine|fludarabine|mesh-list
25693077|NCT02007863|Melphalan|melphalan|mesh-list
25693078|NCT02007863|Busulfan|busulfan|mesh-list
25693079|NCT02007863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693080|NCT02007863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693081|NCT02007863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25693082|NCT02007863|Immunologic Factors|immunologic factors|mesh-ancestor
25693083|NCT02007863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693084|NCT02007863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25284956|NCT04873297|Antiemetics|antiemetics|mesh-ancestor
25284957|NCT04873297|Autonomic Agents|autonomic agents|mesh-ancestor
25284958|NCT04873297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24898609|NCT04411693|Dexamethasone|dexamethasone|mesh-list
24446843|NCT00306254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24446844|NCT00306254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446845|NCT00306254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25693085|NCT02007863|Alkylating Agents|alkylating agents|mesh-ancestor
24475636|NCT00410982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24475701|NCT00411190|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24551856|NCT04892277|Cyclophosphamide|cyclophosphamide|mesh-list
25284959|NCT04873297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284960|NCT04873297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25284961|NCT04873297|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25284962|NCT04873297|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25284963|NCT04873297|Dopamine Agents|dopamine agents|mesh-ancestor
25284964|NCT04873297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25284965|NCT04873297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284966|NCT04858711|Lidocaine|lidocaine|mesh-list
25284967|NCT04858711|Fentanyl|fentanyl|mesh-list
25284968|NCT04858711|Dexmedetomidine|dexmedetomidine|mesh-list
25284969|NCT04858711|Ketamine|ketamine|mesh-list
25284970|NCT04858711|Anesthetics, Local|anesthetics, local|mesh-ancestor
25284971|NCT04858711|Anesthetics|anesthetics|mesh-ancestor
25284972|NCT04858711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25284973|NCT04858711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25284974|NCT04858711|Sensory System Agents|sensory system agents|mesh-ancestor
25284975|NCT04858711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25284976|NCT04858711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25284977|NCT04858711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25284978|NCT04858711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25284979|NCT04858711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25284980|NCT04858711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25284981|NCT04858711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25284982|NCT04858711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25284983|NCT04858711|Analgesics|analgesics|mesh-ancestor
25284984|NCT04858711|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25284985|NCT04858711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25040671|NCT02971891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040672|NCT02971891|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25040673|NCT02971891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25040674|NCT02971891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040675|NCT02964273|Tolvaptan|tolvaptan|mesh-list
25040676|NCT02964273|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25040677|NCT02964273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040678|NCT02964273|Natriuretic Agents|natriuretic agents|mesh-ancestor
25040679|NCT02964273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997437|NCT04899193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997438|NCT04877379|Ceftibuten|ceftibuten|mesh-list
24997439|NCT04877379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24997440|NCT04877379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25284990|NCT04858711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25284991|NCT04858711|Anesthetics, General|anesthetics, general|mesh-ancestor
25284992|NCT04858711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25284993|NCT04858711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25284994|NCT04858711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25284995|NCT04858711|Narcotics|narcotics|mesh-ancestor
25284996|NCT04858711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25284997|NCT04826484|Bupivacaine|bupivacaine|mesh-list
25284998|NCT04826484|Anesthetics, Local|anesthetics, local|mesh-ancestor
25284999|NCT04826484|Anesthetics|anesthetics|mesh-ancestor
25285000|NCT04826484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25285001|NCT04826484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285002|NCT04826484|Sensory System Agents|sensory system agents|mesh-ancestor
25285003|NCT04826484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25285004|NCT04810793|Amoxicillin|amoxicillin|mesh-list
25285005|NCT04810793|Levofloxacin|levofloxacin|mesh-list
25285006|NCT04810793|Ofloxacin|ofloxacin|mesh-list
25285007|NCT04810793|Tetracycline|tetracycline|mesh-list
25693086|NCT02007863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25693087|NCT02008227|Docetaxel|docetaxel|mesh-list
25693088|NCT02008227|Atezolizumab|atezolizumab|mesh-list
25693089|NCT02008227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693090|NCT02008227|Tubulin Modulators|tubulin modulators|mesh-ancestor
25693091|NCT02008227|Antimitotic Agents|antimitotic agents|mesh-ancestor
25693092|NCT02008227|Mitosis Modulators|mitosis modulators|mesh-ancestor
25693093|NCT02008227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760973|NCT01760642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24760974|NCT01760642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760975|NCT01760642|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24760976|NCT01760642|Antitubercular Agents|antitubercular agents|mesh-ancestor
24760977|NCT01760642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24760978|NCT01760642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25285008|NCT04810793|Furazolidone|furazolidone|mesh-list
25285009|NCT04810793|Esomeprazole|esomeprazole|mesh-list
25285010|NCT04810793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25285011|NCT04810793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25285012|NCT04810793|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25285013|NCT04810793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25285014|NCT04810793|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25285015|NCT04810793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25285016|NCT04810793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285017|NCT04810793|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25285018|NCT04810793|Renal Agents|renal agents|mesh-ancestor
25285019|NCT04810793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25285020|NCT04810793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25285021|NCT04810793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25285022|NCT04810793|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25285023|NCT04810793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25285024|NCT04810793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25285025|NCT04810793|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25285026|NCT04810793|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25285027|NCT04810793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25040748|NCT02907359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25040749|NCT02905188|Cyclophosphamide|cyclophosphamide|mesh-list
25040750|NCT02905188|Fludarabine|fludarabine|mesh-list
25040751|NCT02905188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25040752|NCT02905188|Immunologic Factors|immunologic factors|mesh-ancestor
25040753|NCT02905188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040754|NCT02905188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25040755|NCT02905188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25040756|NCT02905188|Alkylating Agents|alkylating agents|mesh-ancestor
25040757|NCT02905188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040758|NCT02905188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25040759|NCT02905188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25040760|NCT02884544|Dextroamphetamine|dextroamphetamine|mesh-list
25040761|NCT02884544|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25040762|NCT02884544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040763|NCT02884544|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25040764|NCT02884544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25060058|NCT03483181|Protease Inhibitors|protease inhibitors|mesh-ancestor
25040765|NCT02884544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25040766|NCT02884544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040767|NCT02884544|Dopamine Agents|dopamine agents|mesh-ancestor
25040768|NCT02884544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25040772|NCT02866227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25285031|NCT04756687|Dermatologic Agents|dermatologic agents|mesh-ancestor
25285032|NCT04756687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25285033|NCT04756687|Immunologic Factors|immunologic factors|mesh-ancestor
25285034|NCT04756687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040775|NCT02858895|Interleukin-4|interleukin-4|mesh-list
25040776|NCT02858895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25040777|NCT02858895|Immunologic Factors|immunologic factors|mesh-ancestor
25040778|NCT02858895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040780|NCT02858895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25040781|NCT02843633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25040782|NCT02829814|Cyclobenzaprine|cyclobenzaprine|mesh-list
25040783|NCT02829814|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25040784|NCT02829814|Antidepressive Agents|antidepressive agents|mesh-ancestor
25040785|NCT02829814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25040786|NCT02829814|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25040795|NCT02820714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25040811|NCT02814019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040813|NCT02814019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693094|NCT02008565|Loperamide|loperamide|mesh-list
25693095|NCT02008565|Antidiarrheals|antidiarrheals|mesh-list
25693096|NCT02008565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25693097|NCT02008617|Bupivacaine|bupivacaine|mesh-list
25693098|NCT02008617|Anesthetics, Local|anesthetics, local|mesh-ancestor
25693099|NCT02008617|Anesthetics|anesthetics|mesh-ancestor
25693100|NCT02008617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24708754|NCT01502774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708755|NCT01502774|Antifungal Agents|antifungal agents|mesh-ancestor
24708756|NCT01502774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24708757|NCT01502774|Dermatologic Agents|dermatologic agents|mesh-ancestor
24708758|NCT01502774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24708772|NCT01502904|Pravastatin|pravastatin|mesh-list
24708774|NCT01502904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24708775|NCT01502904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25285035|NCT04728633|Carmustine|carmustine|mesh-list
25285036|NCT04728633|Ethiodized Oil|ethiodized oil|mesh-list
25285037|NCT04728633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25285038|NCT04728633|Alkylating Agents|alkylating agents|mesh-ancestor
25285039|NCT04728633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285040|NCT04728633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25285052|NCT05393791|Abiraterone Acetate|abiraterone acetate|mesh-list
25285053|NCT05393791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25285054|NCT05393791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25285055|NCT05393791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25285056|NCT05393791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285057|NCT05393791|Hormone Antagonists|hormone antagonists|mesh-ancestor
25285058|NCT05393791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25285059|NCT05393791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285060|NCT05393791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25285061|NCT05393414|Acetaminophen|acetaminophen|mesh-list
25285062|NCT05393414|Ketorolac|ketorolac|mesh-list
25285063|NCT05393414|Morphine|morphine|mesh-list
25040816|NCT02813447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25040817|NCT02813447|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25040818|NCT02813447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25040819|NCT02813447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25040820|NCT02813447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040821|NCT02813447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25040822|NCT02813447|Serotonin Agents|serotonin agents|mesh-ancestor
25040823|NCT02813447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040824|NCT02811939|Dronabinol|dronabinol|mesh-list
25040825|NCT02811939|Hallucinogens|hallucinogens|mesh-ancestor
25040826|NCT02811939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040827|NCT02811939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25040828|NCT02811939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25040829|NCT02811939|Analgesics|analgesics|mesh-ancestor
25040830|NCT02811939|Sensory System Agents|sensory system agents|mesh-ancestor
25040831|NCT02811939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060147|NCT03482180|Atorvastatin|atorvastatin|mesh-list
25040832|NCT02811939|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25040833|NCT02811939|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25040834|NCT02811939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25693101|NCT02008617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693102|NCT02008617|Sensory System Agents|sensory system agents|mesh-ancestor
25693103|NCT02008617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25693104|NCT02008682|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25693105|NCT02008682|Liraglutide|liraglutide|mesh-list
25040835|NCT02811939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040836|NCT02811939|Hormones|hormones|mesh-ancestor
25040837|NCT02811939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25040838|NCT02811679|Blinatumomab|blinatumomab|mesh-list
25040839|NCT02811679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25040840|NCT02810444|Immunoglobulins|immunoglobulins|mesh-list
24708777|NCT01502904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708778|NCT01502904|Antifungal Agents|antifungal agents|mesh-ancestor
24708779|NCT01502904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24708780|NCT01502904|Immunologic Factors|immunologic factors|mesh-ancestor
25285158|NCT05392257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708789|NCT01502943|Aspirin|aspirin|mesh-list
24708833|NCT01503216|Cholecalciferol|cholecalciferol|mesh-list
25285064|NCT05393414|Analgesics, Opioid|analgesics, opioid|mesh-list
25285065|NCT05393414|Narcotics|narcotics|mesh-ancestor
25285066|NCT05393414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25285067|NCT05393414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285068|NCT05393414|Analgesics|analgesics|mesh-ancestor
25285069|NCT05393414|Sensory System Agents|sensory system agents|mesh-ancestor
25285070|NCT05393414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25285071|NCT05393414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25285072|NCT05393414|Antipyretics|antipyretics|mesh-ancestor
25285073|NCT05393414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25285074|NCT05393414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25285075|NCT05393414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25285076|NCT05393414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25285077|NCT05393414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25285078|NCT05393414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285079|NCT05393011|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25285080|NCT05393011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25285081|NCT05393011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040842|NCT02810444|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25040843|NCT02810444|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25040844|NCT02810444|Immunologic Factors|immunologic factors|mesh-ancestor
25040845|NCT02810444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040846|NCT02804282|Furosemide|furosemide|mesh-list
25040847|NCT02804282|Diuretics|diuretics|mesh-ancestor
25040848|NCT02804282|Natriuretic Agents|natriuretic agents|mesh-ancestor
25040849|NCT02804282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040850|NCT02804282|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25040851|NCT02804282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25040882|NCT02784002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25040883|NCT02784002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25040888|NCT02771626|Nivolumab|nivolumab|mesh-list
25040889|NCT02771626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25040890|NCT02771626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25040891|NCT02771626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25040892|NCT02771626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040896|NCT02762929|Bupivacaine|bupivacaine|mesh-list
25041019|NCT02683239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25041020|NCT02683239|Analgesics|analgesics|mesh-ancestor
25041021|NCT02683239|Sensory System Agents|sensory system agents|mesh-ancestor
25041022|NCT02683239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25041023|NCT02683239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041024|NCT02677298|Botulinum Toxins|botulinum toxins|mesh-list
25041025|NCT02677298|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25041026|NCT02677298|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25041027|NCT02677298|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25041028|NCT02677298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25041029|NCT02677298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041030|NCT02677298|Cholinergic Agents|cholinergic agents|mesh-ancestor
25041031|NCT02677298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25285122|NCT05392790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041050|NCT02665234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25041051|NCT02665234|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25041052|NCT02664558|Ubenimex|ubenimex|mesh-list
25041053|NCT02664558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25041054|NCT02664558|Immunologic Factors|immunologic factors|mesh-ancestor
25041055|NCT02664558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034809|NCT03562390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24601918|NCT00966576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25041056|NCT02664558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25041057|NCT02664558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25041094|NCT02654990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25041095|NCT02654990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041178|NCT02608697|Atorvastatin|atorvastatin|mesh-list
25041099|NCT02650804|Coenzyme Q10|coenzyme q10|mesh-list
25041100|NCT02650804|Gemcitabine|gemcitabine|mesh-list
25041101|NCT02650804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25041102|NCT02650804|Antimetabolites|antimetabolites|mesh-ancestor
24708859|NCT01503242|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24708860|NCT01503242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24708861|NCT01503242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24708871|NCT01503372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708872|NCT01503372|Antidotes|antidotes|mesh-ancestor
25285128|NCT05392686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25285129|NCT05392686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25285130|NCT05392686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285131|NCT05392686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25285132|NCT05392686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25285134|NCT05392673|Antioxidants|antioxidants|mesh-ancestor
25285135|NCT05392673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285136|NCT05392673|Protective Agents|protective agents|mesh-ancestor
25285137|NCT05392673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285139|NCT05392452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25285140|NCT05392452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285141|NCT05392387|Antiviral Agents|antiviral agents|mesh-list
25285142|NCT05392387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25285143|NCT05392374|TIC10 compound|tic10 compound|mesh-list
25285144|NCT05392374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25285145|NCT05392257|Rituximab|rituximab|mesh-list
25285146|NCT05392257|Lenalidomide|lenalidomide|mesh-list
25285147|NCT05392257|Zanubrutinib|zanubrutinib|mesh-list
25285148|NCT05392257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25285149|NCT05392257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25285150|NCT05392257|Immunologic Factors|immunologic factors|mesh-ancestor
25285151|NCT05392257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285152|NCT05392257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25285153|NCT05392257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25285154|NCT05392257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25285155|NCT05392257|Growth Substances|growth substances|mesh-ancestor
25285156|NCT05392257|Growth Inhibitors|growth inhibitors|mesh-ancestor
25285157|NCT05392257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25041103|NCT02650804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041104|NCT02650804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041105|NCT02650804|Antiviral Agents|antiviral agents|mesh-ancestor
25041106|NCT02650804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25041107|NCT02650804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041108|NCT02650804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25041109|NCT02650804|Immunologic Factors|immunologic factors|mesh-ancestor
25041110|NCT02650804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041111|NCT02650804|Vitamins|vitamins|mesh-ancestor
24997765|NCT04429685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24997766|NCT04429685|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24997767|NCT04429685|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24997768|NCT04429685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24997769|NCT04429685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997770|NCT04401709|Gemcitabine|gemcitabine|mesh-list
24997771|NCT04401709|Capecitabine|capecitabine|mesh-list
24997772|NCT04401709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24997773|NCT04401709|Antimetabolites|antimetabolites|mesh-ancestor
24997774|NCT04401709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997775|NCT04401709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24997776|NCT04401709|Antiviral Agents|antiviral agents|mesh-ancestor
24997777|NCT04401709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24997778|NCT04401709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24997779|NCT04401709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24997781|NCT04401709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041118|NCT02638805|Metformin|metformin|mesh-list
25041119|NCT02638805|Liraglutide|liraglutide|mesh-list
25041175|NCT02609048|Antimetabolites|antimetabolites|mesh-ancestor
25041176|NCT02609048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041177|NCT02609048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25041201|NCT02606305|Maytansine|maytansine|mesh-list
25041202|NCT02606305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25041203|NCT02606305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761297|NCT01762163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24761298|NCT01762163|Analgesics|analgesics|mesh-ancestor
24476543|NCT00415701|Anesthetics|anesthetics|mesh-ancestor
25041204|NCT02606305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25041205|NCT02606305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25041206|NCT02606305|Growth Substances|growth substances|mesh-ancestor
25041207|NCT02606305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041208|NCT02606305|Growth Inhibitors|growth inhibitors|mesh-ancestor
25041209|NCT02606305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25041210|NCT02606305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25041211|NCT02606305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25041212|NCT02606305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041215|NCT02606305|Tubulin Modulators|tubulin modulators|mesh-ancestor
25285168|NCT05392075|Vaccines|vaccines|mesh-list
25285169|NCT05392075|Immunologic Factors|immunologic factors|mesh-ancestor
25285170|NCT05392075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285171|NCT05391893|Diltiazem|diltiazem|mesh-list
25285172|NCT05391893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25285173|NCT05391893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25285174|NCT05391893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25285175|NCT05391893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285176|NCT05391893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25285177|NCT05391893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285178|NCT05391893|Vasodilator Agents|vasodilator agents|mesh-ancestor
25285179|NCT05391867|Sorafenib|sorafenib|mesh-list
25285180|NCT05391867|Lenvatinib|lenvatinib|mesh-list
25285181|NCT05391867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25285182|NCT05391867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25285183|NCT05391867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25285184|NCT05391867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285197|NCT05391789|Urinastatin|urinastatin|mesh-list
25285198|NCT05391789|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25285199|NCT05391789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25285200|NCT05391789|Protease Inhibitors|protease inhibitors|mesh-ancestor
25285201|NCT05391789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25285202|NCT05391789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041230|NCT02598960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25041231|NCT02598960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041265|NCT02591199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25041266|NCT02591199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25041267|NCT02591199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25041268|NCT02591199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041269|NCT02591199|Anticoagulants|anticoagulants|mesh-ancestor
25041270|NCT02591199|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25041436|NCT02527707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25041437|NCT02527707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25041438|NCT02527707|Protease Inhibitors|protease inhibitors|mesh-ancestor
24998002|NCT04038255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25041439|NCT02527707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041440|NCT02527707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041441|NCT02527707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25041442|NCT02527707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25041443|NCT02527707|Antiviral Agents|antiviral agents|mesh-ancestor
25041444|NCT02527707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25041445|NCT02527707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25041446|NCT02527707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25041448|NCT02521285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25041449|NCT02521285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25041450|NCT02521285|Analgesics|analgesics|mesh-ancestor
25041451|NCT02521285|Sensory System Agents|sensory system agents|mesh-ancestor
25041452|NCT02521285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25041453|NCT02521285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041454|NCT02521285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25041455|NCT02521285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25041456|NCT02521285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25041457|NCT02521285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25041458|NCT02521285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285212|NCT05391555|Remifentanil|remifentanil|mesh-list
25285213|NCT05391555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25285214|NCT05391555|Narcotics|narcotics|mesh-ancestor
25693106|NCT02008682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25693107|NCT02008682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693108|NCT02008682|Incretins|incretins|mesh-ancestor
24761349|NCT01762319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24761350|NCT01762319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25285215|NCT05391555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25285216|NCT05391555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285217|NCT05391555|Analgesics|analgesics|mesh-ancestor
25285218|NCT05391555|Sensory System Agents|sensory system agents|mesh-ancestor
25285219|NCT05391555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25285221|NCT05391451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25285222|NCT05391451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285223|NCT05386784|Cholecalciferol|cholecalciferol|mesh-list
25285224|NCT05386784|Vitamin D|vitamin d|mesh-list
25285225|NCT05386784|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25285226|NCT05386784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25285227|NCT05386784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285228|NCT05386784|Vitamins|vitamins|mesh-ancestor
25285229|NCT05386784|Micronutrients|micronutrients|mesh-ancestor
25285230|NCT05386784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25285231|NCT05386784|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25285232|NCT05386784|Hormone Antagonists|hormone antagonists|mesh-ancestor
25285233|NCT05386784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25285234|NCT05386784|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25285235|NCT05386784|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25285236|NCT05386524|Bevacizumab|bevacizumab|mesh-list
25285237|NCT05386524|Doxorubicin|doxorubicin|mesh-list
25285238|NCT05386524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25285239|NCT05386524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25285240|NCT05386524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25285241|NCT05386524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25042530|NCT01422148|Amiodarone|amiodarone|mesh-list
25041460|NCT02521285|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25041462|NCT02521285|Antipyretics|antipyretics|mesh-ancestor
25041463|NCT02519439|Ganaxolone|ganaxolone|mesh-list
25041464|NCT02519439|Neurosteroids|neurosteroids|mesh-ancestor
25041465|NCT02519439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25041466|NCT02519439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041467|NCT02519439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041468|NCT02519439|GABA Modulators|gaba modulators|mesh-ancestor
25041469|NCT02519439|GABA Agents|gaba agents|mesh-ancestor
25041470|NCT02515175|Vaccines|vaccines|mesh-list
25041471|NCT02515175|Immunologic Factors|immunologic factors|mesh-ancestor
25041472|NCT02515175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589245|NCT00906295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24589247|NCT00906295|Analgesics|analgesics|mesh-ancestor
24589248|NCT00906295|Sensory System Agents|sensory system agents|mesh-ancestor
24589249|NCT00906295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24589250|NCT00906295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041499|NCT02511886|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25041500|NCT02511886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041501|NCT02511886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25041502|NCT02511886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25041503|NCT02511886|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25285249|NCT05386524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25285250|NCT05386524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285251|NCT05385562|Triamcinolone|triamcinolone|mesh-list
25285252|NCT05385562|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25285253|NCT05385562|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25285254|NCT05385562|Hyaluronic Acid|hyaluronic acid|mesh-list
25285255|NCT05385562|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25285256|NCT05385562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25285257|NCT05385562|Glucocorticoids|glucocorticoids|mesh-ancestor
25285258|NCT05385562|Hormones|hormones|mesh-ancestor
25285259|NCT05385562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25285260|NCT05385562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285261|NCT05385562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25285262|NCT05385562|Immunologic Factors|immunologic factors|mesh-ancestor
25285263|NCT05385562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25285264|NCT05385562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285265|NCT05385562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25285266|NCT05385562|Viscosupplements|viscosupplements|mesh-ancestor
25285267|NCT05385562|Protective Agents|protective agents|mesh-ancestor
25285268|NCT05385549|Imatinib Mesylate|imatinib mesylate|mesh-list
25285269|NCT05385549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693109|NCT02008682|Hormones|hormones|mesh-ancestor
25693110|NCT02008682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25285270|NCT05385549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25285271|NCT05385549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25285272|NCT05385549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285273|NCT05385263|Nivolumab|nivolumab|mesh-list
25035233|NCT03558412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25285274|NCT05385263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25285275|NCT05385263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25285276|NCT05385263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25285277|NCT05385263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041619|NCT01616303|Oregovomab|oregovomab|mesh-list
25041620|NCT01616303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25041621|NCT01616303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041622|NCT01616303|Tubulin Modulators|tubulin modulators|mesh-ancestor
25041623|NCT01616303|Antimitotic Agents|antimitotic agents|mesh-ancestor
25041624|NCT01616303|Mitosis Modulators|mitosis modulators|mesh-ancestor
25041625|NCT01616303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041626|NCT01616303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25041627|NCT01616199|Vemurafenib|vemurafenib|mesh-list
25041628|NCT01616199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041629|NCT01616199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25041630|NCT01616199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041631|NCT01616199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041632|NCT01610245|Oseltamivir|oseltamivir|mesh-list
25041633|NCT01610245|Nitazoxanide|nitazoxanide|mesh-list
25041634|NCT01610245|Antiviral Agents|antiviral agents|mesh-ancestor
25041635|NCT01610245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25041636|NCT01610245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041637|NCT01610245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041638|NCT01610245|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25041639|NCT01607294|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
25041640|NCT01607294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25041641|NCT01607294|Antimetabolites|antimetabolites|mesh-ancestor
25285299|NCT05354128|Fibrinolytic Agents|fibrinolytic agents|mesh-list
25285300|NCT05354128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25285301|NCT05354128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285302|NCT05346874|Oxaliplatin|oxaliplatin|mesh-list
25285303|NCT05346874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24991977|NCT04690023|Anesthetics|anesthetics|mesh-ancestor
25285310|NCT05338931|Gossypol acetic acid|gossypol acetic acid|mesh-list
25285311|NCT05338931|Gossypol|gossypol|mesh-list
25285312|NCT05338931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25285313|NCT05338931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25285314|NCT05338931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25285315|NCT05338931|Contraceptive Agents|contraceptive agents|mesh-ancestor
25285316|NCT05338931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25285317|NCT05338931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285318|NCT05338931|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
25285319|NCT05338931|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
25285320|NCT05338931|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25285321|NCT05325502|Mannitol|mannitol|mesh-list
25285322|NCT05325502|Caffeine|caffeine|mesh-list
25285323|NCT05325502|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25285324|NCT05325502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285325|NCT05325502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25285326|NCT05325502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041652|NCT01605162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041653|NCT01605162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041654|NCT01605162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041656|NCT01604889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25041756|NCT01588535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25041757|NCT01588535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041758|NCT01588535|Sensory System Agents|sensory system agents|mesh-ancestor
25041759|NCT01588535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25041761|NCT01587144|Temozolomide|temozolomide|mesh-list
25041762|NCT01587144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25041763|NCT01587144|Alkylating Agents|alkylating agents|mesh-ancestor
25041764|NCT01587144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041765|NCT01587144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041766|NCT01587144|Schistosomicides|schistosomicides|mesh-ancestor
25041767|NCT01587144|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25041768|NCT01587144|Anthelmintics|anthelmintics|mesh-ancestor
25041769|NCT01587144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25041770|NCT01587144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25041771|NCT01584531|ON 01910|on 01910|mesh-list
25041772|NCT01584531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041773|NCT01584531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25041774|NCT01584531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041775|NCT01584531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041776|NCT01582347|Buprenorphine|buprenorphine|mesh-list
25041777|NCT01582347|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25285332|NCT05325502|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25285333|NCT05325502|Diuretics|diuretics|mesh-ancestor
25285334|NCT05325502|Natriuretic Agents|natriuretic agents|mesh-ancestor
25285335|NCT05318157|Emedastine|emedastine|mesh-list
25285336|NCT05318157|Budesonide|budesonide|mesh-list
25285337|NCT05318157|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25285338|NCT05318157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25285339|NCT05318157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25285340|NCT05318157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25285341|NCT05318157|Autonomic Agents|autonomic agents|mesh-ancestor
25285342|NCT05318157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25285343|NCT05318157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285344|NCT05318157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25285345|NCT05318157|Respiratory System Agents|respiratory system agents|mesh-ancestor
25285346|NCT05318157|Glucocorticoids|glucocorticoids|mesh-ancestor
25285347|NCT05318157|Hormones|hormones|mesh-ancestor
25285348|NCT05318157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25285349|NCT05318157|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25285350|NCT05318157|Histamine Antagonists|histamine antagonists|mesh-ancestor
25285351|NCT05318157|Histamine Agents|histamine agents|mesh-ancestor
25285352|NCT05318157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25285353|NCT05318157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285354|NCT05318157|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25041793|NCT01581203|Ribavirin|ribavirin|mesh-list
25041794|NCT01581203|Interferon-alpha|interferon-alpha|mesh-list
25041795|NCT01581203|Interferon alpha-2|interferon alpha-2|mesh-list
25041801|NCT01581203|Antimetabolites|antimetabolites|mesh-ancestor
25041802|NCT01581203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041803|NCT01581203|Immunologic Factors|immunologic factors|mesh-ancestor
25041804|NCT01581203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041805|NCT01581203|Protease Inhibitors|protease inhibitors|mesh-ancestor
25041806|NCT01581203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041807|NCT01581177|Albuterol|albuterol|mesh-list
25035526|NCT03555071|Vaccines|vaccines|mesh-list
25041808|NCT01581177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25041809|NCT01581177|Autonomic Agents|autonomic agents|mesh-ancestor
25041810|NCT01581177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25041811|NCT01581177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041812|NCT01581177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25041813|NCT01581177|Respiratory System Agents|respiratory system agents|mesh-ancestor
25041814|NCT01581177|Tocolytic Agents|tocolytic agents|mesh-ancestor
25041815|NCT01581177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25041816|NCT01581177|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25041817|NCT01581177|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25041818|NCT01581177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25041831|NCT01580696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041832|NCT01580696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041833|NCT01578655|Prednisone|prednisone|mesh-list
25041834|NCT01578655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25041835|NCT01578655|Glucocorticoids|glucocorticoids|mesh-ancestor
25041836|NCT01578655|Hormones|hormones|mesh-ancestor
25041837|NCT01578655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25041838|NCT01578655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041839|NCT01578655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25041840|NCT01578655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041841|NCT01577654|Folic Acid|folic acid|mesh-list
25041842|NCT01577654|Docetaxel|docetaxel|mesh-list
25041843|NCT01577654|Vinca Alkaloids|vinca alkaloids|mesh-list
25041844|NCT01577654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041845|NCT01577654|Tubulin Modulators|tubulin modulators|mesh-ancestor
25041846|NCT01577654|Antimitotic Agents|antimitotic agents|mesh-ancestor
25041847|NCT01577654|Mitosis Modulators|mitosis modulators|mesh-ancestor
25041848|NCT01577654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041849|NCT01577654|Hematinics|hematinics|mesh-ancestor
25041850|NCT01577654|Vitamin B Complex|vitamin b complex|mesh-ancestor
25041851|NCT01577654|Vitamins|vitamins|mesh-ancestor
25041852|NCT01577654|Micronutrients|micronutrients|mesh-ancestor
25041853|NCT01577654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041854|NCT01577173|Cetuximab|cetuximab|mesh-list
25041855|NCT01577173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24761533|NCT01763021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24761534|NCT01763021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24761536|NCT01763021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24761537|NCT01763021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761538|NCT01763021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761539|NCT01763021|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24761546|NCT01763281|Hormones|hormones|mesh-ancestor
25041856|NCT01577173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041857|NCT01573351|Interferons|interferons|mesh-list
25041858|NCT01573351|Ribavirin|ribavirin|mesh-list
25041859|NCT01573351|Interferon-alpha|interferon-alpha|mesh-list
25041860|NCT01573351|Interferon alpha-2|interferon alpha-2|mesh-list
25041861|NCT01573351|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25041862|NCT01573351|Asunaprevir|asunaprevir|mesh-list
25041863|NCT01573351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041864|NCT01573351|Antiviral Agents|antiviral agents|mesh-ancestor
25041865|NCT01573351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25041866|NCT01573351|Antimetabolites|antimetabolites|mesh-ancestor
25041890|NCT01567059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041891|NCT01567059|Glycine Agents|glycine agents|mesh-ancestor
25041892|NCT01567059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25041894|NCT01565655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041895|NCT01565655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25041896|NCT01565655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25041897|NCT01565655|Immunologic Factors|immunologic factors|mesh-ancestor
25041898|NCT01565655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041899|NCT01561768|Vaccines|vaccines|mesh-list
25041900|NCT01561768|Immunologic Factors|immunologic factors|mesh-ancestor
25041901|NCT01561768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041902|NCT01560104|Paclitaxel|paclitaxel|mesh-list
25041903|NCT01560104|Carboplatin|carboplatin|mesh-list
25041904|NCT01560104|Veliparib|veliparib|mesh-list
25041905|NCT01560104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25041906|NCT01560104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041907|NCT01560104|Tubulin Modulators|tubulin modulators|mesh-ancestor
25041908|NCT01560104|Antimitotic Agents|antimitotic agents|mesh-ancestor
25041909|NCT01560104|Mitosis Modulators|mitosis modulators|mesh-ancestor
25041910|NCT01560104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035694|NCT03553537|Prednisone|prednisone|mesh-list
25041911|NCT01560104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25041912|NCT01560104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25041914|NCT01557777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25041915|NCT01555554|Propranolol|propranolol|mesh-list
25041916|NCT01555554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25285421|NCT05204836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285422|NCT05199753|Antibodies|antibodies|mesh-list
25285423|NCT05199753|Immunologic Factors|immunologic factors|mesh-ancestor
25285426|NCT05199597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25285427|NCT05199597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25285428|NCT05199597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25285430|NCT05199597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25285431|NCT05199597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285432|NCT05199597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25285433|NCT05199597|Respiratory System Agents|respiratory system agents|mesh-ancestor
25285434|NCT05199597|Mydriatics|mydriatics|mesh-ancestor
25285435|NCT05199597|Parasympatholytics|parasympatholytics|mesh-ancestor
25285436|NCT05199597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25285437|NCT05199597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25285438|NCT05199597|Cholinergic Agents|cholinergic agents|mesh-ancestor
25285439|NCT05199597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25285440|NCT05199597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285441|NCT05174052|Dapagliflozin|dapagliflozin|mesh-list
25285442|NCT05174052|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25285443|NCT05174052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693111|NCT02008682|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25693112|NCT02008682|Protease Inhibitors|protease inhibitors|mesh-ancestor
25693113|NCT02008682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693114|NCT02008682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693115|NCT02008773|Valacyclovir|valacyclovir|mesh-list
25693116|NCT02008773|Antiviral Agents|antiviral agents|mesh-ancestor
25693117|NCT02008773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25285444|NCT05174052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25285445|NCT05174052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285446|NCT05155579|Vaccines|vaccines|mesh-list
25285447|NCT05155579|Immunologic Factors|immunologic factors|mesh-ancestor
25693118|NCT02008877|Sirolimus|sirolimus|mesh-list
24761647|NCT01763658|Dexamethasone|dexamethasone|mesh-list
24761648|NCT01763658|Prednisolone|prednisolone|mesh-list
24761649|NCT01763658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25285448|NCT05155579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285449|NCT05138575|Empagliflozin|empagliflozin|mesh-list
25285450|NCT05138575|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25285451|NCT05138575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285452|NCT05138575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25285453|NCT05138575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285457|NCT05057494|Venetoclax|venetoclax|mesh-list
25285458|NCT05057494|Obinutuzumab|obinutuzumab|mesh-list
25285459|NCT05057494|Acalabrutinib|acalabrutinib|mesh-list
25285460|NCT05057494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25285461|NCT05057494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25285462|NCT05046184|Midazolam|midazolam|mesh-list
25041927|NCT01554696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25041928|NCT01554696|Abortifacient Agents|abortifacient agents|mesh-ancestor
25041929|NCT01554696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25041930|NCT01554696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25041931|NCT01554696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25041932|NCT01554696|Antimetabolites|antimetabolites|mesh-ancestor
25042014|NCT01516541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042016|NCT01516476|Liraglutide|liraglutide|mesh-list
25042017|NCT01516476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25042018|NCT01516476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042019|NCT01516476|Incretins|incretins|mesh-ancestor
25042020|NCT01516476|Hormones|hormones|mesh-ancestor
25042021|NCT01516476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25042022|NCT01516307|Cyclophosphamide|cyclophosphamide|mesh-list
25042023|NCT01516307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25042024|NCT01516307|Immunologic Factors|immunologic factors|mesh-ancestor
25042025|NCT01516307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042026|NCT01516307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25042027|NCT01516307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25042028|NCT01516307|Alkylating Agents|alkylating agents|mesh-ancestor
24998652|NCT02232087|Xhance|xhance|mesh-list
24998669|NCT02232087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998670|NCT02232087|Glucocorticoids|glucocorticoids|mesh-ancestor
24998671|NCT02232087|Hormones|hormones|mesh-ancestor
25285463|NCT05046184|Ketamine|ketamine|mesh-list
25285464|NCT05046184|Analgesics|analgesics|mesh-ancestor
25285465|NCT05046184|Sensory System Agents|sensory system agents|mesh-ancestor
25285466|NCT05046184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25285467|NCT05046184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285468|NCT05046184|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25285469|NCT05046184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25285470|NCT05046184|Anesthetics, General|anesthetics, general|mesh-ancestor
25285471|NCT05046184|Anesthetics|anesthetics|mesh-ancestor
25285472|NCT05046184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25285473|NCT05046184|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25285474|NCT05046184|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25285484|NCT05032794|Bisacodyl|bisacodyl|mesh-list
25285485|NCT05032794|Cathartics|cathartics|mesh-ancestor
25285486|NCT05032794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25285487|NCT05032794|Laxatives|laxatives|mesh-ancestor
25285496|NCT05022563|Warfarin|warfarin|mesh-list
25285497|NCT05022563|Rivaroxaban|rivaroxaban|mesh-list
25285498|NCT05022563|Dabigatran|dabigatran|mesh-list
25285499|NCT05022563|Apixaban|apixaban|mesh-list
25285500|NCT05022563|Edoxaban|edoxaban|mesh-list
25285501|NCT05022563|Anticoagulants|anticoagulants|mesh-list
25285502|NCT05022563|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25285503|NCT05022563|Antithrombins|antithrombins|mesh-ancestor
25285504|NCT05022563|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25285505|NCT05022563|Protease Inhibitors|protease inhibitors|mesh-ancestor
25285506|NCT05022563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25285507|NCT05022563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042037|NCT01516203|Antitubercular Agents|antitubercular agents|mesh-ancestor
25042038|NCT01516203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25042039|NCT01516203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042040|NCT01516203|Leprostatic Agents|leprostatic agents|mesh-ancestor
25042041|NCT01516203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25042042|NCT01516203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693119|NCT02008877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25693120|NCT02008877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25693121|NCT02008877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25042043|NCT01516203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042044|NCT01516203|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25042045|NCT01516203|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25042070|NCT01516073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25042071|NCT01516073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042073|NCT01516073|Respiratory System Agents|respiratory system agents|mesh-ancestor
25042074|NCT01516073|Dermatologic Agents|dermatologic agents|mesh-ancestor
25042075|NCT01516073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25042077|NCT01515007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25042078|NCT01515007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042079|NCT01515007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25042080|NCT01515007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25042081|NCT01515007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25042082|NCT01515007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042083|NCT01515007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042084|NCT01515007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25042085|NCT01515007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25042086|NCT01510119|Hydroxychloroquine|hydroxychloroquine|mesh-list
25285522|NCT05005728|Carboplatin|carboplatin|mesh-list
25285523|NCT05005728|Olaparib|olaparib|mesh-list
25285524|NCT05005728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25285542|NCT04985266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285543|NCT04985266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25285544|NCT04985266|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25285545|NCT04985266|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25285546|NCT04985266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25285547|NCT04985266|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25285548|NCT04985266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25285549|NCT04983095|Hormones|hormones|mesh-list
25285550|NCT04983095|Androgens|androgens|mesh-list
25285551|NCT04983095|Hormone Antagonists|hormone antagonists|mesh-list
25285552|NCT04983095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25285553|NCT04983095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285554|NCT04950621|Propofol|propofol|mesh-list
25285555|NCT04950621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25285556|NCT04950621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25285557|NCT04950621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285558|NCT04950621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25285559|NCT04950621|Anesthetics, General|anesthetics, general|mesh-ancestor
24873331|NCT05274789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24873332|NCT05274789|Adrenergic Agents|adrenergic agents|mesh-ancestor
24873333|NCT05274789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24873334|NCT05274789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24873335|NCT05263895|Ritonavir|ritonavir|mesh-list
24873336|NCT05263895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24873337|NCT05263895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24873338|NCT05263895|Protease Inhibitors|protease inhibitors|mesh-ancestor
24873339|NCT05263895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24873340|NCT05263895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24873341|NCT05263895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24873342|NCT05263895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24873343|NCT05263895|Antiviral Agents|antiviral agents|mesh-ancestor
24873344|NCT05263895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042134|NCT01498328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285560|NCT04950621|Anesthetics|anesthetics|mesh-ancestor
25042135|NCT01498328|Growth Inhibitors|growth inhibitors|mesh-ancestor
25042137|NCT01497834|Protease Inhibitors|protease inhibitors|mesh-ancestor
25042138|NCT01497834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25042139|NCT01497834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042140|NCT01497704|Apatinib|apatinib|mesh-list
25042297|NCT01472198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042299|NCT01472198|Antiviral Agents|antiviral agents|mesh-ancestor
25042300|NCT01472198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042301|NCT01472198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25042302|NCT01472198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25042303|NCT01472198|Immunologic Factors|immunologic factors|mesh-ancestor
25042304|NCT01472198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042305|NCT01470131|Dexamethasone|dexamethasone|mesh-list
25042306|NCT01470131|Bortezomib|bortezomib|mesh-list
25042307|NCT01470131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25042308|NCT01470131|Antiemetics|antiemetics|mesh-ancestor
25042309|NCT01470131|Autonomic Agents|autonomic agents|mesh-ancestor
25042310|NCT01470131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25042314|NCT01470131|Hormones|hormones|mesh-ancestor
25285592|NCT04762316|Pyridoxal|pyridoxal|mesh-list
25285593|NCT04762316|Pyridoxine|pyridoxine|mesh-list
25285594|NCT04762316|Vitamin B 6|vitamin b 6|mesh-list
25285595|NCT04762316|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
25285596|NCT04762316|Vitamin B Complex|vitamin b complex|mesh-ancestor
25285597|NCT04762316|Vitamins|vitamins|mesh-ancestor
25285598|NCT04762316|Micronutrients|micronutrients|mesh-ancestor
25285599|NCT04762316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285600|NCT04753957|Progesterone|progesterone|mesh-list
25285601|NCT04753957|Progestins|progestins|mesh-ancestor
25285602|NCT04753957|Hormones|hormones|mesh-ancestor
25285603|NCT04753957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25285604|NCT04753957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285605|NCT04751994|Sorbitol|sorbitol|mesh-list
25285606|NCT04751994|Cathartics|cathartics|mesh-ancestor
25285607|NCT04751994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25285608|NCT04738422|Glycine|glycine|mesh-list
25285609|NCT04738422|Glycine Agents|glycine agents|mesh-ancestor
25285610|NCT04738422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25285611|NCT04738422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285612|NCT04738422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285627|NCT04722809|Botulinum Toxins|botulinum toxins|mesh-list
25285628|NCT04722809|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25285629|NCT04722809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25285630|NCT04722809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285631|NCT04722809|Cholinergic Agents|cholinergic agents|mesh-ancestor
25042342|NCT01460511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25042343|NCT01460511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285637|NCT04655586|Anticoagulants|anticoagulants|mesh-list
25285638|NCT04655586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25285639|NCT04655586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25285640|NCT04655586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042344|NCT01460511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042345|NCT01460511|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25042346|NCT01460511|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25042347|NCT01460511|Autonomic Agents|autonomic agents|mesh-ancestor
25285641|NCT04651166|Tranexamic Acid|tranexamic acid|mesh-list
25285642|NCT04651166|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25285643|NCT04651166|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25042348|NCT01460511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25042349|NCT01460511|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25042355|NCT01459679|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25042356|NCT01459679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25042357|NCT01459679|Vitamin B Complex|vitamin b complex|mesh-ancestor
25042359|NCT01459679|Micronutrients|micronutrients|mesh-ancestor
25042360|NCT01459679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042361|NCT01459679|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25042362|NCT01459679|Dermatologic Agents|dermatologic agents|mesh-ancestor
25042363|NCT01455896|Exenatide|exenatide|mesh-list
25042364|NCT01455896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25042365|NCT01455896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042366|NCT01455896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25042367|NCT01455896|Incretins|incretins|mesh-ancestor
25042368|NCT01455896|Hormones|hormones|mesh-ancestor
25042369|NCT01455896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25042370|NCT01455870|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25042371|NCT01455870|Exenatide|exenatide|mesh-list
24998935|NCT05421897|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24998936|NCT05421897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25285644|NCT04651166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285645|NCT04651166|Hemostatics|hemostatics|mesh-ancestor
25285646|NCT04651166|Coagulants|coagulants|mesh-ancestor
25285647|NCT04605081|Naltrexone|naltrexone|mesh-list
25285648|NCT04605081|Bupropion|bupropion|mesh-list
25285649|NCT04605081|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25285650|NCT04605081|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25285651|NCT04605081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285652|NCT04605081|Sensory System Agents|sensory system agents|mesh-ancestor
25285653|NCT04605081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25285654|NCT04605081|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25285655|NCT04605081|Antidepressive Agents|antidepressive agents|mesh-ancestor
25285656|NCT04605081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25285657|NCT04605081|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25285658|NCT04605081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25285659|NCT04605081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25285660|NCT04605081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285661|NCT04605081|Dopamine Agents|dopamine agents|mesh-ancestor
25285662|NCT04605081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25285663|NCT04605081|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25285664|NCT04605081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25285665|NCT04605081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25285666|NCT04572217|Topiramate|topiramate|mesh-list
25285667|NCT04572217|Phentermine|phentermine|mesh-list
25285668|NCT04572217|Anticonvulsants|anticonvulsants|mesh-ancestor
25285669|NCT04572217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25285670|NCT04572217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998944|NCT05421858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998945|NCT05421858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998946|NCT05421858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24998947|NCT05421858|Hormone Antagonists|hormone antagonists|mesh-ancestor
24998948|NCT05421858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24998949|NCT05421858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036307|NCT03548818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24998950|NCT05421858|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24998951|NCT05421858|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25042372|NCT01455870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25042373|NCT01455870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042375|NCT01455870|Hormones|hormones|mesh-ancestor
25042376|NCT01455870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25042377|NCT01455870|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25042378|NCT01455870|Protease Inhibitors|protease inhibitors|mesh-ancestor
25042379|NCT01455870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25042380|NCT01455870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042381|NCT01455870|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25042382|NCT01455857|Exenatide|exenatide|mesh-list
25285675|NCT04572217|Autonomic Agents|autonomic agents|mesh-ancestor
25285676|NCT04572217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25285677|NCT04572217|Adrenergic Agents|adrenergic agents|mesh-ancestor
25285678|NCT04572217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25285679|NCT04572217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285684|NCT04551261|Ritonavir|ritonavir|mesh-list
25285685|NCT04551261|Tenofovir|tenofovir|mesh-list
25285686|NCT04551261|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25285687|NCT04551261|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25285688|NCT04551261|Protease Inhibitors|protease inhibitors|mesh-ancestor
25285689|NCT04551261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25285690|NCT04551261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285691|NCT04551261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25285692|NCT04551261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25285693|NCT04551261|Antiviral Agents|antiviral agents|mesh-ancestor
25285694|NCT04551261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24512258|NCT00573885|Antioxidants|antioxidants|mesh-ancestor
25285695|NCT04551261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25285696|NCT04551261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25285697|NCT04551261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25285698|NCT04551261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25285699|NCT04534257|Sirolimus|sirolimus|mesh-list
25285700|NCT04534257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25285701|NCT04534257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25285702|NCT04534257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25285703|NCT04534257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25285704|NCT04534257|Antifungal Agents|antifungal agents|mesh-ancestor
25285705|NCT04534257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25285706|NCT04534257|Immunologic Factors|immunologic factors|mesh-ancestor
25285707|NCT04534257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285708|NCT04508634|Metformin|metformin|mesh-list
25285709|NCT04508634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25042680|NCT01393639|Hormones|hormones|mesh-ancestor
25042427|NCT01445899|Growth Substances|growth substances|mesh-ancestor
25042428|NCT01445899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042429|NCT01445899|Growth Inhibitors|growth inhibitors|mesh-ancestor
25042430|NCT01445899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042432|NCT01445795|Antimetabolites|antimetabolites|mesh-ancestor
25042433|NCT01445795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042434|NCT01445795|Antiviral Agents|antiviral agents|mesh-ancestor
25042435|NCT01445795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042436|NCT01444365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25059876|NCT03484416|Vitamin D|vitamin d|mesh-list
25060516|NCT03479320|Anesthetics|anesthetics|mesh-ancestor
25042512|NCT01425970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24761902|NCT01765231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24761903|NCT01765257|Rasagiline|rasagiline|mesh-list
24761932|NCT01765374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25285729|NCT04481243|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25285730|NCT04481243|Immunologic Factors|immunologic factors|mesh-ancestor
25285731|NCT04481243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285732|NCT04470128|Fentanyl|fentanyl|mesh-list
25285733|NCT04470128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25285734|NCT04470128|Narcotics|narcotics|mesh-ancestor
25285735|NCT04470128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25285736|NCT04470128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285737|NCT04470128|Analgesics|analgesics|mesh-ancestor
25285738|NCT04470128|Sensory System Agents|sensory system agents|mesh-ancestor
25285739|NCT04470128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25285740|NCT04470128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25285741|NCT04470128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25285742|NCT04470128|Anesthetics, General|anesthetics, general|mesh-ancestor
25285743|NCT04470128|Anesthetics|anesthetics|mesh-ancestor
25285744|NCT04429516|Morphine|morphine|mesh-list
25285745|NCT04429516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25285746|NCT04429516|Narcotics|narcotics|mesh-ancestor
25285747|NCT04429516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25285748|NCT04429516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285749|NCT04429516|Analgesics|analgesics|mesh-ancestor
25285750|NCT04429516|Sensory System Agents|sensory system agents|mesh-ancestor
25285751|NCT04429516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25042525|NCT01423058|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
25042526|NCT01423058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25042528|NCT01423058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042529|NCT01422148|Minocycline|minocycline|mesh-list
25042531|NCT01422148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25042532|NCT01422148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042533|NCT01422148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25042534|NCT01422148|Vasodilator Agents|vasodilator agents|mesh-ancestor
25042535|NCT01422148|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25042536|NCT01422148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25042537|NCT01422148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042538|NCT01422148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25042539|NCT01422148|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25042540|NCT01422148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25042541|NCT01422148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25042542|NCT01422148|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25042543|NCT01422148|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25042544|NCT01422148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25042546|NCT01421056|Analgesics|analgesics|mesh-ancestor
25042547|NCT01421056|Sensory System Agents|sensory system agents|mesh-ancestor
25042548|NCT01421056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25042549|NCT01421056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042550|NCT01421056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25042551|NCT01421056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25042615|NCT01408082|Azithromycin|azithromycin|mesh-list
25042616|NCT01408082|Dexamethasone|dexamethasone|mesh-list
25042617|NCT01408082|Dexamethasone acetate|dexamethasone acetate|mesh-list
25042619|NCT01408082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25042620|NCT01408082|Antiemetics|antiemetics|mesh-ancestor
25042621|NCT01408082|Autonomic Agents|autonomic agents|mesh-ancestor
25285752|NCT04410341|Vildagliptin|vildagliptin|mesh-list
25285753|NCT04410341|Citalopram|citalopram|mesh-list
25285754|NCT04410341|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25285755|NCT04410341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25285756|NCT04410341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25285757|NCT04410341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285758|NCT04410341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25285759|NCT04410341|Serotonin Agents|serotonin agents|mesh-ancestor
25285760|NCT04410341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285761|NCT04410341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25285762|NCT04410341|Antidepressive Agents|antidepressive agents|mesh-ancestor
25285763|NCT04410341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25285764|NCT04410341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25285765|NCT04410341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25693122|NCT02008877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693123|NCT02008877|Antifungal Agents|antifungal agents|mesh-ancestor
25693124|NCT02008877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25285766|NCT04410341|Protease Inhibitors|protease inhibitors|mesh-ancestor
25285767|NCT04410341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25285768|NCT04369950|Lidocaine|lidocaine|mesh-list
25285769|NCT04369950|Epinephrine|epinephrine|mesh-list
25285770|NCT04369950|Morphine|morphine|mesh-list
25285771|NCT04369950|Chloroprocaine|chloroprocaine|mesh-list
25285772|NCT04369950|Anesthetics, Local|anesthetics, local|mesh-ancestor
25285773|NCT04369950|Anesthetics|anesthetics|mesh-ancestor
25285774|NCT04369950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25285775|NCT04369950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285776|NCT04369950|Sensory System Agents|sensory system agents|mesh-ancestor
25285777|NCT04369950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25285778|NCT04369950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25285779|NCT04369950|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25285780|NCT04369950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25285781|NCT04369950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25285782|NCT04369950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285783|NCT04369950|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25285784|NCT04369950|Narcotics|narcotics|mesh-ancestor
25285785|NCT04369950|Analgesics|analgesics|mesh-ancestor
25285786|NCT04369950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25285787|NCT04369950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25285788|NCT04369950|Adrenergic Agents|adrenergic agents|mesh-ancestor
25285789|NCT04369950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25285790|NCT04369950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25042628|NCT01408082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25042629|NCT01408082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042630|NCT01408082|Protease Inhibitors|protease inhibitors|mesh-ancestor
25042631|NCT01408082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25042632|NCT01408082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042633|NCT01408082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25042634|NCT01408082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042635|NCT01407003|Licogliflozin|licogliflozin|mesh-list
24999269|NCT04795869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042637|NCT01407003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042639|NCT01407003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042640|NCT01402401|Trastuzumab|trastuzumab|mesh-list
25042641|NCT01402401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25042642|NCT01402401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042643|NCT01399684|Leucovorin|leucovorin|mesh-list
25042644|NCT01399684|Folic Acid|folic acid|mesh-list
25042645|NCT01399684|Bevacizumab|bevacizumab|mesh-list
25042646|NCT01399684|Fluorouracil|fluorouracil|mesh-list
25042647|NCT01399684|Oxaliplatin|oxaliplatin|mesh-list
25042648|NCT01399684|Levoleucovorin|levoleucovorin|mesh-list
25042649|NCT01399684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25042650|NCT01399684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25042651|NCT01399684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25042652|NCT01399684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25042653|NCT01399684|Growth Substances|growth substances|mesh-ancestor
25042654|NCT01399684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042655|NCT01399684|Growth Inhibitors|growth inhibitors|mesh-ancestor
25042656|NCT01399684|Antimetabolites|antimetabolites|mesh-ancestor
25042657|NCT01399684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042658|NCT01399684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25285791|NCT04369950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25042659|NCT01399684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25285792|NCT04369950|Autonomic Agents|autonomic agents|mesh-ancestor
25285793|NCT04369950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25285794|NCT04369950|Respiratory System Agents|respiratory system agents|mesh-ancestor
25285795|NCT04369950|Mydriatics|mydriatics|mesh-ancestor
25285796|NCT04369950|Sympathomimetics|sympathomimetics|mesh-ancestor
25285797|NCT04369950|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25285798|NCT04362488|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25285799|NCT04362488|Dermatologic Agents|dermatologic agents|mesh-ancestor
25285800|NCT04351230|Trastuzumab|trastuzumab|mesh-list
25285801|NCT04351230|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25285802|NCT04351230|Maytansine|maytansine|mesh-list
25285803|NCT04351230|Immunoconjugates|immunoconjugates|mesh-list
25285804|NCT04351230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25285805|NCT04351230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25285806|NCT04351230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25285807|NCT04351230|Tubulin Modulators|tubulin modulators|mesh-ancestor
25285808|NCT04351230|Antimitotic Agents|antimitotic agents|mesh-ancestor
25285809|NCT04351230|Mitosis Modulators|mitosis modulators|mesh-ancestor
25285810|NCT04351230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762069|NCT01765881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24762072|NCT01765881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285811|NCT04351230|Immunologic Factors|immunologic factors|mesh-ancestor
25285812|NCT04351230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285813|NCT04278092|Paclitaxel|paclitaxel|mesh-list
25285814|NCT04278092|Cetuximab|cetuximab|mesh-list
25285815|NCT04278092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25285816|NCT04278092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25285817|NCT04278092|Tubulin Modulators|tubulin modulators|mesh-ancestor
25285818|NCT04278092|Antimitotic Agents|antimitotic agents|mesh-ancestor
25285819|NCT04278092|Mitosis Modulators|mitosis modulators|mesh-ancestor
25285820|NCT04278092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285821|NCT04278092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25285822|NCT04262479|Vitamin D|vitamin d|mesh-list
25285823|NCT04262479|Vitamins|vitamins|mesh-ancestor
25285824|NCT04262479|Micronutrients|micronutrients|mesh-ancestor
25285825|NCT04262479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285826|NCT04262479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25285827|NCT04262024|Cabergoline|cabergoline|mesh-list
25285828|NCT04262024|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25285829|NCT04262024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25285830|NCT04262024|Dopamine Agonists|dopamine agonists|mesh-ancestor
25285831|NCT04262024|Dopamine Agents|dopamine agents|mesh-ancestor
25285832|NCT04262024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25285833|NCT04262024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042671|NCT01399580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042672|NCT01397968|Cenobamate|cenobamate|mesh-list
25042673|NCT01397968|Anticonvulsants|anticonvulsants|mesh-ancestor
25042674|NCT01397578|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25042675|NCT01397578|Immunologic Factors|immunologic factors|mesh-ancestor
25042676|NCT01397578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042677|NCT01393639|Prednisone|prednisone|mesh-list
25042678|NCT01393639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25042679|NCT01393639|Glucocorticoids|glucocorticoids|mesh-ancestor
24589361|NCT00907036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24589363|NCT00907036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24589364|NCT00907036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24589365|NCT00907036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24589366|NCT00907036|Alkylating Agents|alkylating agents|mesh-ancestor
24589367|NCT00907036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24589370|NCT00907114|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25285834|NCT04262024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285840|NCT04211259|Loratadine|loratadine|mesh-list
25285841|NCT04211259|Antipruritics|antipruritics|mesh-ancestor
25285842|NCT04211259|Dermatologic Agents|dermatologic agents|mesh-ancestor
25285843|NCT04211259|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25285844|NCT04211259|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25285845|NCT04211259|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25285846|NCT04211259|Histamine Antagonists|histamine antagonists|mesh-ancestor
25285847|NCT04211259|Histamine Agents|histamine agents|mesh-ancestor
25285848|NCT04211259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25285849|NCT04211259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285850|NCT04211259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285851|NCT04187053|Methylene Blue|methylene blue|mesh-list
25285852|NCT04187053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25285853|NCT04187053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285854|NCT04182334|TEMPO|tempo|mesh-list
25285855|NCT04182334|Antioxidants|antioxidants|mesh-ancestor
25285856|NCT04182334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285857|NCT04182334|Protective Agents|protective agents|mesh-ancestor
25285858|NCT04182334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285859|NCT04167111|Vitamin D|vitamin d|mesh-list
25285860|NCT04167111|Cholecalciferol|cholecalciferol|mesh-list
25285861|NCT04167111|Vitamins|vitamins|mesh-ancestor
25285862|NCT04167111|Micronutrients|micronutrients|mesh-ancestor
25285863|NCT04167111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285864|NCT04167111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25285865|NCT04167111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25285866|NCT04133311|Latanoprost|latanoprost|mesh-list
25285867|NCT04133311|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25285868|NCT04133311|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25285869|NCT04128956|Aspirin|aspirin|mesh-list
25693125|NCT02008877|Immunologic Factors|immunologic factors|mesh-ancestor
25693126|NCT02008877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693127|NCT02008890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25285870|NCT04128956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25285871|NCT04128956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25285872|NCT04128956|Analgesics|analgesics|mesh-ancestor
25285873|NCT04128956|Sensory System Agents|sensory system agents|mesh-ancestor
25285874|NCT04128956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24875789|NCT03839823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589378|NCT00907114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25042700|NCT01382654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042701|NCT01382654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25042702|NCT01382654|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25042703|NCT01382654|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25042704|NCT01382654|Histamine Antagonists|histamine antagonists|mesh-ancestor
25042705|NCT01382654|Histamine Agents|histamine agents|mesh-ancestor
25042706|NCT01382654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25042707|NCT01381731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25042708|NCT01381731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25042718|NCT01379209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25042719|NCT01379209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25042721|NCT01379209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285876|NCT04128956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25285877|NCT04128956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25285878|NCT04128956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25285879|NCT04128956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25285880|NCT04128956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285881|NCT04128956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25285882|NCT04128956|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25285883|NCT04128956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25285884|NCT04128956|Antipyretics|antipyretics|mesh-ancestor
25285922|NCT04065113|Ethanol|ethanol|mesh-list
25285923|NCT04065113|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25042770|NCT01371578|Ribavirin|ribavirin|mesh-list
25042771|NCT01371578|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25042772|NCT01371578|Ledipasvir|ledipasvir|mesh-list
25042773|NCT01371578|Antimetabolites|antimetabolites|mesh-ancestor
25042774|NCT01371578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042775|NCT01371578|Antiviral Agents|antiviral agents|mesh-ancestor
25042776|NCT01371578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25042777|NCT01369095|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25042778|NCT01369095|Citalopram|citalopram|mesh-list
25042779|NCT01369095|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25042802|NCT01366131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042803|NCT01366131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25042804|NCT01366131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24887178|NCT04519281|Ascorbic Acid|ascorbic acid|mesh-list
25042805|NCT01366131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25042806|NCT01366131|Growth Substances|growth substances|mesh-ancestor
25285925|NCT04065113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25285926|NCT04065113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285928|NCT04052776|Carbidopa|carbidopa|mesh-list
25285929|NCT04052776|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25285930|NCT04052776|Buspirone|buspirone|mesh-list
25285931|NCT04052776|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25285932|NCT04052776|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25285933|NCT04052776|Dopamine Agents|dopamine agents|mesh-ancestor
25285934|NCT04052776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25285935|NCT04052776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285936|NCT04052776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285937|NCT04052776|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25285938|NCT04052776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25285939|NCT04052776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25285940|NCT04052776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25285941|NCT04052776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25285942|NCT04052776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25285943|NCT04052776|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25285944|NCT04052776|Serotonin Agents|serotonin agents|mesh-ancestor
25285945|NCT04052776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25285946|NCT04052776|Immunologic Factors|immunologic factors|mesh-ancestor
25285947|NCT04052776|Dopamine Agonists|dopamine agonists|mesh-ancestor
25285948|NCT04035187|Itraconazole|itraconazole|mesh-list
25285949|NCT04035187|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
25285950|NCT04035187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25285951|NCT04035187|Antifungal Agents|antifungal agents|mesh-ancestor
25285952|NCT04035187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25285953|NCT04035187|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24762356|NCT01767896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285954|NCT04035187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25285955|NCT04035187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25285956|NCT04035187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037053|NCT03540979|Letrozole|letrozole|mesh-list
25285957|NCT04035187|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25285958|NCT04035187|Hormone Antagonists|hormone antagonists|mesh-ancestor
25285959|NCT04035187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25285960|NCT04035187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285961|NCT04035187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24876590|NCT03355118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24876591|NCT03345784|Cisplatin|cisplatin|mesh-list
24876592|NCT03345784|Adavosertib|adavosertib|mesh-list
24876593|NCT03345784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24876596|NCT03344965|Olaparib|olaparib|mesh-list
25042851|NCT01359566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25042852|NCT01359566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25042853|NCT01359566|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25042854|NCT01359566|GABA Agonists|gaba agonists|mesh-ancestor
25042855|NCT01359566|GABA Agents|gaba agents|mesh-ancestor
25042856|NCT01359566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25042857|NCT01359566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25042858|NCT01358695|Botulinum Toxins|botulinum toxins|mesh-list
25042859|NCT01358695|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25042868|NCT01358695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25042869|NCT01357642|Epinephrine|epinephrine|mesh-list
25285979|NCT04003610|Gemcitabine|gemcitabine|mesh-list
25285980|NCT04003610|Carboplatin|carboplatin|mesh-list
25285981|NCT04003610|Pembrolizumab|pembrolizumab|mesh-list
25285982|NCT04003610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25285983|NCT04003610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25285984|NCT04003610|Antimetabolites|antimetabolites|mesh-ancestor
25285985|NCT04003610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25285986|NCT04003610|Antiviral Agents|antiviral agents|mesh-ancestor
25285987|NCT04003610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25285988|NCT04003610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25285989|NCT04003610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25285990|NCT04003610|Immunologic Factors|immunologic factors|mesh-ancestor
25285991|NCT04003610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285992|NCT04003610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25285993|NCT03920293|Ravulizumab|ravulizumab|mesh-list
25285994|NCT03920293|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25285995|NCT03920293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25285996|NCT03920293|Immunologic Factors|immunologic factors|mesh-ancestor
25285997|NCT03920293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25285999|NCT03909074|Immunologic Factors|immunologic factors|mesh-ancestor
25286000|NCT03909074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286001|NCT03907540|Belumosudil|belumosudil|mesh-list
25286002|NCT03907540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25286003|NCT03907540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25286004|NCT03907540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286005|NCT03906877|Hyaluronic Acid|hyaluronic acid|mesh-list
25286006|NCT03906877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25286007|NCT03906877|Immunologic Factors|immunologic factors|mesh-ancestor
25286008|NCT03906877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286009|NCT03906877|Viscosupplements|viscosupplements|mesh-ancestor
25286010|NCT03906877|Protective Agents|protective agents|mesh-ancestor
25286011|NCT03904108|Ramucirumab|ramucirumab|mesh-list
25286012|NCT03904108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286013|NCT03899961|Oxytocin|oxytocin|mesh-list
25286014|NCT03899961|Carbetocin|carbetocin|mesh-list
25286015|NCT03899961|Oxytocics|oxytocics|mesh-ancestor
25286016|NCT03899961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25286017|NCT03899961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286018|NCT03880539|Vancomycin|vancomycin|mesh-list
25286019|NCT03880539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25042964|NCT01345045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25042965|NCT01345045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25042966|NCT01345045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25042967|NCT01345045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25042968|NCT01345045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25042969|NCT01344187|Riboflavin|riboflavin|mesh-list
25042970|NCT01344187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25063530|NCT03468231|Antidotes|antidotes|mesh-ancestor
25043011|NCT01337752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25693128|NCT02008890|Immunologic Factors|immunologic factors|mesh-ancestor
24641978|NCT01176903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24762399|NCT01768247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762400|NCT01768260|Aspirin|aspirin|mesh-list
24762401|NCT01768260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24762402|NCT01768260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24762403|NCT01768260|Analgesics|analgesics|mesh-ancestor
24762404|NCT01768260|Sensory System Agents|sensory system agents|mesh-ancestor
24965916|NCT03773094|Dermatologic Agents|dermatologic agents|mesh-ancestor
25043012|NCT01337752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043013|NCT01337752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25043014|NCT01337752|Glucocorticoids|glucocorticoids|mesh-ancestor
25043015|NCT01337752|Hormones|hormones|mesh-ancestor
25043016|NCT01337752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25043017|NCT01337752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25286051|NCT03782818|Olaparib|olaparib|mesh-list
25286023|NCT03869892|Capecitabine|capecitabine|mesh-list
25286024|NCT03869892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25286025|NCT03869892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286026|NCT03869892|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25286027|NCT03869892|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25286028|NCT03869892|Growth Substances|growth substances|mesh-ancestor
25286029|NCT03869892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286030|NCT03869892|Growth Inhibitors|growth inhibitors|mesh-ancestor
25286031|NCT03869892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25286032|NCT03869892|Antimetabolites|antimetabolites|mesh-ancestor
25037370|NCT03537807|Riluzole|riluzole|mesh-list
25286033|NCT03869892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286034|NCT03869892|Antiviral Agents|antiviral agents|mesh-ancestor
25286035|NCT03869892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25043018|NCT01337752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043019|NCT01337752|Immunologic Factors|immunologic factors|mesh-ancestor
25043031|NCT01336686|Colchicine|colchicine|mesh-list
25043032|NCT01336686|Gout Suppressants|gout suppressants|mesh-ancestor
25043033|NCT01336686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25043034|NCT01336686|Tubulin Modulators|tubulin modulators|mesh-ancestor
25043035|NCT01336686|Antimitotic Agents|antimitotic agents|mesh-ancestor
25043036|NCT01336686|Mitosis Modulators|mitosis modulators|mesh-ancestor
25043037|NCT01336686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043038|NCT01336686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043039|NCT01336465|Etrolizumab|etrolizumab|mesh-list
25043040|NCT01336465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25043041|NCT01336465|Immunologic Factors|immunologic factors|mesh-ancestor
25043042|NCT01336465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043043|NCT01332812|Dexamethasone|dexamethasone|mesh-list
25043044|NCT01332812|Dexamethasone acetate|dexamethasone acetate|mesh-list
25043045|NCT01332812|BB 1101|bb 1101|mesh-list
25043046|NCT01332812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25043047|NCT01332812|Antiemetics|antiemetics|mesh-ancestor
25043048|NCT01332812|Autonomic Agents|autonomic agents|mesh-ancestor
25043049|NCT01332812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25043050|NCT01332812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043051|NCT01332812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25286036|NCT03867799|Nivolumab|nivolumab|mesh-list
25286037|NCT03867799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25286038|NCT03867799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286039|NCT03867799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25286040|NCT03867799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286045|NCT03853187|Durvalumab|durvalumab|mesh-list
25286046|NCT03853187|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25286047|NCT03853187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25286048|NCT03853187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286049|NCT03853187|Immunologic Factors|immunologic factors|mesh-ancestor
25286050|NCT03853187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286073|NCT03712345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064503|NCT03459417|Antidepressive Agents|antidepressive agents|mesh-ancestor
25043171|NCT01311713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693129|NCT02008890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693130|NCT02008916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25693131|NCT02008916|Immunologic Factors|immunologic factors|mesh-ancestor
25693132|NCT02008916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693133|NCT02008942|Aspirin|aspirin|mesh-list
25693134|NCT02008942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25693135|NCT02008942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25043172|NCT01311713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693136|NCT02008942|Analgesics|analgesics|mesh-ancestor
25043173|NCT01309945|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25043174|NCT01309945|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25065030|NCT03454620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043176|NCT01309945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25043177|NCT01309945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043178|NCT01309945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25043179|NCT01309945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043181|NCT01309945|Sensory System Agents|sensory system agents|mesh-ancestor
25043182|NCT01309945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25043183|NCT01309945|Antidepressive Agents|antidepressive agents|mesh-ancestor
25043184|NCT01309945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25043185|NCT01309945|Dopamine Agents|dopamine agents|mesh-ancestor
25043187|NCT01309932|Ribavirin|ribavirin|mesh-list
25043188|NCT01309932|Interferon-alpha|interferon-alpha|mesh-list
25043189|NCT01309932|Interferon alpha-2|interferon alpha-2|mesh-list
25043190|NCT01309932|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24937582|NCT04027959|Vitamin B Complex|vitamin b complex|mesh-ancestor
25043191|NCT01309932|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
25043192|NCT01309932|Protease Inhibitors|protease inhibitors|mesh-list
25043193|NCT01309932|Asunaprevir|asunaprevir|mesh-list
25043194|NCT01309932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043195|NCT01309932|Antiviral Agents|antiviral agents|mesh-ancestor
25043196|NCT01309932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25043197|NCT01309932|Antimetabolites|antimetabolites|mesh-ancestor
25043198|NCT01309932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043199|NCT01309932|Immunologic Factors|immunologic factors|mesh-ancestor
25286092|NCT03575949|Deoxyglucose|deoxyglucose|mesh-list
25286093|NCT03575949|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25286094|NCT03575949|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25286095|NCT03575949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286096|NCT03575949|Antimetabolites|antimetabolites|mesh-ancestor
25286097|NCT03575949|Antiviral Agents|antiviral agents|mesh-ancestor
25286098|NCT03575949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25286099|NCT03525379|Resveratrol|resveratrol|mesh-list
25286100|NCT03525379|Antioxidants|antioxidants|mesh-ancestor
25286101|NCT03525379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286102|NCT03525379|Protective Agents|protective agents|mesh-ancestor
25286103|NCT03525379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286104|NCT03525379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25286105|NCT03525379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25286106|NCT03519906|Metoprolol|metoprolol|mesh-list
25286107|NCT03519906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25286108|NCT03519906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25286109|NCT03519906|Sympatholytics|sympatholytics|mesh-ancestor
25286110|NCT03519906|Autonomic Agents|autonomic agents|mesh-ancestor
25286111|NCT03519906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25286112|NCT03519906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286113|NCT03519906|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25286114|NCT03519906|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25286115|NCT03519906|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25286116|NCT03519906|Adrenergic Agents|adrenergic agents|mesh-ancestor
25286117|NCT03519906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25043209|NCT01303783|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25043210|NCT01303783|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25043211|NCT01303783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043212|NCT01303783|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25043213|NCT01303783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25043214|NCT01303783|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25043215|NCT01303783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043216|NCT01303783|Vasodilator Agents|vasodilator agents|mesh-ancestor
25043217|NCT01303783|Tocolytic Agents|tocolytic agents|mesh-ancestor
25043218|NCT01303783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25043220|NCT01302249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25043221|NCT01302249|Latanoprost|latanoprost|mesh-list
25043222|NCT01302249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25043223|NCT01302249|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25043224|NCT01302249|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25043225|NCT01302249|Adrenergic Agents|adrenergic agents|mesh-ancestor
25043226|NCT01302249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25043227|NCT01302249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043228|NCT01302249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043229|NCT01302249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25043230|NCT01302249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25043231|NCT01301157|Calcipotriene|calcipotriene|mesh-list
25043232|NCT01301157|Dermatologic Agents|dermatologic agents|mesh-ancestor
25043233|NCT01300208|CC-11050|cc-11050|mesh-list
25043234|NCT01300208|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25043235|NCT01300208|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25043236|NCT01300208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043238|NCT01298687|Travoprost|travoprost|mesh-list
25286118|NCT03519906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286119|NCT03519893|Losartan|losartan|mesh-list
25286120|NCT03519893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25286121|NCT03519893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25286122|NCT03519893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25286123|NCT03519893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25286124|NCT03519893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286125|NCT03476811|Analgesics|analgesics|mesh-list
25286126|NCT03476811|Bupivacaine|bupivacaine|mesh-list
25286127|NCT03476811|Anesthetics, Local|anesthetics, local|mesh-ancestor
25286128|NCT03476811|Anesthetics|anesthetics|mesh-ancestor
25286129|NCT03476811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25286130|NCT03476811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286131|NCT03476811|Sensory System Agents|sensory system agents|mesh-ancestor
25286132|NCT03476811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25286133|NCT03464942|Atezolizumab|atezolizumab|mesh-list
25286134|NCT03464942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286135|NCT03418922|Nivolumab|nivolumab|mesh-list
25286136|NCT03418922|Lenvatinib|lenvatinib|mesh-list
25286137|NCT03418922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25286138|NCT03418922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286139|NCT03418922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25043277|NCT01281254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043278|NCT01280565|Dacarbazine|dacarbazine|mesh-list
25043279|NCT01280565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25043280|NCT01280565|Alkylating Agents|alkylating agents|mesh-ancestor
25043281|NCT01280565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043282|NCT01280565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043283|NCT01280331|Morphine|morphine|mesh-list
25043284|NCT01280331|Oxycodone|oxycodone|mesh-list
25043285|NCT01280331|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25043286|NCT01280331|Narcotics|narcotics|mesh-ancestor
25043287|NCT01280331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25043288|NCT01280331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043289|NCT01280331|Analgesics|analgesics|mesh-ancestor
25043290|NCT01280331|Sensory System Agents|sensory system agents|mesh-ancestor
25043291|NCT01280331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25043292|NCT01279590|Atorvastatin|atorvastatin|mesh-list
25043293|NCT01279590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25043294|NCT01279590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25043295|NCT01279590|Antimetabolites|antimetabolites|mesh-ancestor
24950259|NCT01864109|Dexrazoxane|dexrazoxane|mesh-list
25043333|NCT01275105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043335|NCT01275105|Autonomic Agents|autonomic agents|mesh-ancestor
25043336|NCT01275105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25043337|NCT01275105|Nasal Decongestants|nasal decongestants|mesh-ancestor
24999711|NCT03501368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043338|NCT01275105|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25043339|NCT01275105|Respiratory System Agents|respiratory system agents|mesh-ancestor
25043340|NCT01275105|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25043341|NCT01275105|Mydriatics|mydriatics|mesh-ancestor
25043342|NCT01275105|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25043343|NCT01275105|Protective Agents|protective agents|mesh-ancestor
25043344|NCT01272791|Gemcitabine|gemcitabine|mesh-list
25286164|NCT03356756|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25286165|NCT03356756|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25286166|NCT03356756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286167|NCT03355534|Dexmedetomidine|dexmedetomidine|mesh-list
25286168|NCT03355534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25286169|NCT03355534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25286170|NCT03355534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286171|NCT03355534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25286172|NCT03355534|Analgesics|analgesics|mesh-ancestor
25286173|NCT03355534|Sensory System Agents|sensory system agents|mesh-ancestor
25286174|NCT03355534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25286175|NCT03355534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25286176|NCT03355534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25286177|NCT03355534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25286178|NCT03355534|Adrenergic Agents|adrenergic agents|mesh-ancestor
25286182|NCT03334461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25286183|NCT03285763|Atezolizumab|atezolizumab|mesh-list
25286184|NCT03285763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286185|NCT03252093|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
25286186|NCT03252093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25286187|NCT03252093|Vasodilator Agents|vasodilator agents|mesh-ancestor
25286188|NCT03196427|Vedolizumab|vedolizumab|mesh-list
25286189|NCT03196427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25286190|NCT03193853|Paclitaxel|paclitaxel|mesh-list
25286191|NCT03193853|Serabelisib|serabelisib|mesh-list
25286192|NCT03193853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25286193|NCT03193853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286194|NCT03193853|Tubulin Modulators|tubulin modulators|mesh-ancestor
25286195|NCT03193853|Antimitotic Agents|antimitotic agents|mesh-ancestor
25286196|NCT03193853|Mitosis Modulators|mitosis modulators|mesh-ancestor
25286197|NCT03193853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286198|NCT03193853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24877119|NCT02935205|Gout Suppressants|gout suppressants|mesh-ancestor
24877120|NCT02935205|Tocolytic Agents|tocolytic agents|mesh-ancestor
24877121|NCT02935205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25043351|NCT01272791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25043352|NCT01272791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043353|NCT01272791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25043354|NCT01272791|Immunologic Factors|immunologic factors|mesh-ancestor
25043355|NCT01272791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043356|NCT01272791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25043357|NCT01271920|Trastuzumab|trastuzumab|mesh-list
25043358|NCT01271920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25043359|NCT01271920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043360|NCT01271790|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25043361|NCT01271790|Interferon-alpha|interferon-alpha|mesh-list
25043362|NCT01271790|Ribavirin|ribavirin|mesh-list
25043363|NCT01271790|Antiviral Agents|antiviral agents|mesh-ancestor
25043364|NCT01271790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25043365|NCT01271790|Immunologic Factors|immunologic factors|mesh-ancestor
25043366|NCT01271790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043367|NCT01271790|Antimetabolites|antimetabolites|mesh-ancestor
25043368|NCT01271790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043369|NCT01270347|Levofloxacin|levofloxacin|mesh-list
25043370|NCT01270347|Ofloxacin|ofloxacin|mesh-list
25043371|NCT01270347|Tobramycin|tobramycin|mesh-list
25043372|NCT01270347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25043375|NCT01270347|Renal Agents|renal agents|mesh-ancestor
25286203|NCT03137966|Deferoxamine|deferoxamine|mesh-list
25286204|NCT03137966|Siderophores|siderophores|mesh-ancestor
25286205|NCT03137966|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25286206|NCT03137966|Chelating Agents|chelating agents|mesh-ancestor
25286207|NCT03137966|Sequestering Agents|sequestering agents|mesh-ancestor
25286208|NCT03137966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286209|NCT03114865|Dexamethasone|dexamethasone|mesh-list
25286210|NCT03114865|Blinatumomab|blinatumomab|mesh-list
25286211|NCT03114865|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25286212|NCT03114865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25286213|NCT03114865|Antiemetics|antiemetics|mesh-ancestor
25286214|NCT03114865|Autonomic Agents|autonomic agents|mesh-ancestor
25286215|NCT03114865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25286216|NCT03114865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286217|NCT03114865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25286218|NCT03114865|Glucocorticoids|glucocorticoids|mesh-ancestor
25286219|NCT03114865|Hormones|hormones|mesh-ancestor
25286220|NCT03114865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25286221|NCT03114865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25286222|NCT03114865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286223|NCT03114865|Immunologic Factors|immunologic factors|mesh-ancestor
25286224|NCT03085771|Deferoxamine|deferoxamine|mesh-list
25286225|NCT03085771|Siderophores|siderophores|mesh-ancestor
25286226|NCT03085771|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25286227|NCT03085771|Chelating Agents|chelating agents|mesh-ancestor
25286228|NCT03085771|Sequestering Agents|sequestering agents|mesh-ancestor
25286229|NCT03085771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286230|NCT03073980|Acetaminophen|acetaminophen|mesh-list
25286238|NCT03033446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25286239|NCT03033446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286240|NCT03033446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25286241|NCT03033446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286242|NCT03025035|Pembrolizumab|pembrolizumab|mesh-list
25286243|NCT03025035|Olaparib|olaparib|mesh-list
25286244|NCT03025035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25286245|NCT03025035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286246|NCT03025035|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25286247|NCT03025035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25286248|NCT03025035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043433|NCT01261312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043434|NCT01261312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043435|NCT01260870|Paclitaxel|paclitaxel|mesh-list
25043436|NCT01260870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25043437|NCT01260870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043438|NCT01260870|Tubulin Modulators|tubulin modulators|mesh-ancestor
25043439|NCT01260870|Antimitotic Agents|antimitotic agents|mesh-ancestor
25043440|NCT01260870|Mitosis Modulators|mitosis modulators|mesh-ancestor
25043441|NCT01260870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043442|NCT01258907|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25043443|NCT01258907|Immunologic Factors|immunologic factors|mesh-ancestor
25043444|NCT01258907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043445|NCT01257607|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25043446|NCT01257607|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25043447|NCT01256762|Paclitaxel|paclitaxel|mesh-list
25043448|NCT01256762|Bevacizumab|bevacizumab|mesh-list
25043449|NCT01256762|Imetelstat|imetelstat|mesh-list
25043450|NCT01256762|Motesanib diphosphate|motesanib diphosphate|mesh-list
25043451|NCT01256762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25043452|NCT01256762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043453|NCT01256762|Tubulin Modulators|tubulin modulators|mesh-ancestor
25286249|NCT02998567|Pembrolizumab|pembrolizumab|mesh-list
25286250|NCT02998567|Guadecitabine|guadecitabine|mesh-list
25286251|NCT02998567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25286252|NCT02998567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286253|NCT02985619|Triamcinolone|triamcinolone|mesh-list
25286254|NCT02985619|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25286255|NCT02985619|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25286256|NCT02985619|Bevacizumab|bevacizumab|mesh-list
25286257|NCT02985619|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25286258|NCT02985619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25286259|NCT02985619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286260|NCT02985619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25286261|NCT02985619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25286262|NCT02985619|Growth Substances|growth substances|mesh-ancestor
25286263|NCT02985619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286264|NCT02985619|Growth Inhibitors|growth inhibitors|mesh-ancestor
25286265|NCT02985619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25286266|NCT02985619|Glucocorticoids|glucocorticoids|mesh-ancestor
25286267|NCT02985619|Hormones|hormones|mesh-ancestor
24420569|NCT00216346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25286268|NCT02985619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25286269|NCT02985619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25286270|NCT02985619|Immunologic Factors|immunologic factors|mesh-ancestor
25286271|NCT02985619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25286272|NCT02985619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24877017|NCT03023631|Vaccines|vaccines|mesh-list
24815542|NCT02071004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815543|NCT02071004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25043483|NCT01254370|Travoprost|travoprost|mesh-list
25043484|NCT01254370|Latanoprost|latanoprost|mesh-list
25043485|NCT01254370|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25286308|NCT02624596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25286309|NCT02624596|Anesthetics, General|anesthetics, general|mesh-ancestor
25286310|NCT02624596|Anesthetics|anesthetics|mesh-ancestor
25043870|NCT01192035|Efavirenz|efavirenz|mesh-list
25286311|NCT02624596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25286312|NCT02624596|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25286313|NCT02624596|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25286314|NCT02624596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25286315|NCT02624596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286316|NCT02624596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25286317|NCT02624596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25286318|NCT02624596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25286319|NCT02624596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25286320|NCT02624596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25286321|NCT02624596|GABA Modulators|gaba modulators|mesh-ancestor
25286322|NCT02624596|GABA Agents|gaba agents|mesh-ancestor
25286327|NCT02322099|Alendronate|alendronate|mesh-list
25286328|NCT02322099|Cholecalciferol|cholecalciferol|mesh-list
25286329|NCT02322099|Vitamin D|vitamin d|mesh-list
25043544|NCT01242930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043545|NCT01242930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043546|NCT01242930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043547|NCT01242930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25043548|NCT01242930|Vitamin B Complex|vitamin b complex|mesh-ancestor
25043550|NCT01242930|Micronutrients|micronutrients|mesh-ancestor
25043551|NCT01241214|Cetirizine|cetirizine|mesh-list
25043552|NCT01241214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25043553|NCT01241214|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25043554|NCT01241214|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25043555|NCT01241214|Histamine Antagonists|histamine antagonists|mesh-ancestor
25043556|NCT01241214|Histamine Agents|histamine agents|mesh-ancestor
25043557|NCT01241214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25043558|NCT01241214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066904|NCT03449654|Incretins|incretins|mesh-ancestor
25043596|NCT01234779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25043597|NCT01234779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25043598|NCT01234779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25043599|NCT01234779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25043600|NCT01234779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25043601|NCT01234779|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25043602|NCT01234779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25043603|NCT01234779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25286330|NCT02322099|Tenofovir|tenofovir|mesh-list
25286331|NCT02322099|Calcium Carbonate|calcium carbonate|mesh-list
25286332|NCT02322099|Calcium|calcium|mesh-list
25286333|NCT02322099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25286334|NCT02322099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286335|NCT02322099|Antiviral Agents|antiviral agents|mesh-ancestor
25286336|NCT02322099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25286337|NCT02322099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25286338|NCT02322099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25286339|NCT02322099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25286340|NCT02322099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286341|NCT02322099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25286342|NCT02322099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25286343|NCT02322099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25286344|NCT02322099|Antacids|antacids|mesh-ancestor
25286345|NCT02322099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25286346|NCT02322099|Vitamins|vitamins|mesh-ancestor
25286347|NCT02322099|Micronutrients|micronutrients|mesh-ancestor
25286348|NCT02317627|Belumosudil|belumosudil|mesh-list
25286349|NCT02317627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25286350|NCT02317627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25286351|NCT02317627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286352|NCT02316236|Dexmedetomidine|dexmedetomidine|mesh-list
25286353|NCT02316236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25286354|NCT02316236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25286355|NCT02316236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286356|NCT02316236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25286357|NCT02316236|Analgesics|analgesics|mesh-ancestor
25286358|NCT02316236|Sensory System Agents|sensory system agents|mesh-ancestor
25286359|NCT02316236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25286360|NCT02316236|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25038410|NCT05175001|Anesthetics, Local|anesthetics, local|mesh-ancestor
25286361|NCT02316236|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25286362|NCT02316236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25286363|NCT02316236|Adrenergic Agents|adrenergic agents|mesh-ancestor
25286364|NCT02316236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25286365|NCT02316236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286366|NCT02267252|Antibodies|antibodies|mesh-list
25286367|NCT02267252|Immunologic Factors|immunologic factors|mesh-ancestor
25286368|NCT02267252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286369|NCT02246270|Heparin|heparin|mesh-list
25286370|NCT02246270|Calcium heparin|calcium heparin|mesh-list
25286371|NCT02246270|Anticoagulants|anticoagulants|mesh-ancestor
25286372|NCT02246270|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25286373|NCT02246270|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25286374|NCT02246270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286375|NCT02229968|Aminocaproic Acid|aminocaproic acid|mesh-list
25286376|NCT02229968|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25286377|NCT02229968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25286378|NCT02229968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043631|NCT01234025|Hormones|hormones|mesh-ancestor
25043632|NCT01234025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25043633|NCT01234025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762996|NCT01770600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762997|NCT01770600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25043634|NCT01234025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25043635|NCT01233960|Remestemcel-l|remestemcel-l|mesh-list
25043636|NCT01233960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25043637|NCT01233960|Antiviral Agents|antiviral agents|mesh-ancestor
25043638|NCT01233960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25043639|NCT01232595|Vancomycin|vancomycin|mesh-list
25043640|NCT01232595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25043641|NCT01232595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25043642|NCT01231347|Gemcitabine|gemcitabine|mesh-list
25043643|NCT01231347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25043644|NCT01231347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25043645|NCT01231347|Antimetabolites|antimetabolites|mesh-ancestor
25043677|NCT01225640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043678|NCT01225640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043679|NCT01225393|Adalimumab|adalimumab|mesh-list
25043680|NCT01225393|Methotrexate|methotrexate|mesh-list
25043681|NCT01225393|Leflunomide|leflunomide|mesh-list
25043682|NCT01225393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25043683|NCT01225393|Abortifacient Agents|abortifacient agents|mesh-ancestor
25286379|NCT02229968|Hemostatics|hemostatics|mesh-ancestor
25286380|NCT02229968|Coagulants|coagulants|mesh-ancestor
25286381|NCT02037529|Paclitaxel|paclitaxel|mesh-list
25286382|NCT02037529|Halichondrin B|halichondrin b|mesh-list
25286383|NCT02037529|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25286384|NCT02037529|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25286385|NCT02037529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286386|NCT02037529|Tubulin Modulators|tubulin modulators|mesh-ancestor
25286387|NCT02037529|Antimitotic Agents|antimitotic agents|mesh-ancestor
25286388|NCT02037529|Mitosis Modulators|mitosis modulators|mesh-ancestor
25286389|NCT02037529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286390|NCT02003742|Tamsulosin|tamsulosin|mesh-list
24589090|NCT00905814|Axitinib|axitinib|mesh-list
25286391|NCT02003742|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25286392|NCT02003742|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25286393|NCT02003742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25286394|NCT02003742|Adrenergic Agents|adrenergic agents|mesh-ancestor
25286395|NCT02003742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25286396|NCT02003742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286397|NCT02003742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286398|NCT02003742|Urological Agents|urological agents|mesh-ancestor
25286399|NCT01935128|Everolimus|everolimus|mesh-list
25286400|NCT01935128|Tacrolimus|tacrolimus|mesh-list
25286401|NCT01935128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25286402|NCT01935128|Immunologic Factors|immunologic factors|mesh-ancestor
25286403|NCT01935128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286404|NCT01935128|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25286405|NCT01935128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25286406|NCT01935128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286407|NCT01935128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286408|NCT01909934|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25286409|NCT01909934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25286410|NCT01909934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286411|NCT01884259|Docetaxel|docetaxel|mesh-list
25286412|NCT01884259|Fluorouracil|fluorouracil|mesh-list
25286413|NCT01884259|Cetuximab|cetuximab|mesh-list
25286414|NCT01884259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286415|NCT01884259|Tubulin Modulators|tubulin modulators|mesh-ancestor
25286416|NCT01884259|Antimitotic Agents|antimitotic agents|mesh-ancestor
25286417|NCT01884259|Mitosis Modulators|mitosis modulators|mesh-ancestor
25043766|NCT01205061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25286418|NCT01884259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286419|NCT01884259|Antimetabolites|antimetabolites|mesh-ancestor
25286420|NCT01884259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25286421|NCT01884259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25286422|NCT01884259|Immunologic Factors|immunologic factors|mesh-ancestor
25286423|NCT01884259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286424|NCT01884259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25286425|NCT01841359|Pramlintide|pramlintide|mesh-list
25043703|NCT01225380|Immunologic Factors|immunologic factors|mesh-ancestor
25043704|NCT01225380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043705|NCT01225380|Antimetabolites|antimetabolites|mesh-ancestor
25693137|NCT02008942|Sensory System Agents|sensory system agents|mesh-ancestor
25043706|NCT01225380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043707|NCT01224795|Peramivir|peramivir|mesh-list
24763103|NCT01771458|Tamoxifen|tamoxifen|mesh-list
24763118|NCT01771458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763119|NCT01771458|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25043708|NCT01224795|Antiviral Agents|antiviral agents|mesh-ancestor
25043709|NCT01224795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25043710|NCT01224795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043711|NCT01224795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043712|NCT01224262|Vaccines|vaccines|mesh-list
25043713|NCT01224262|Immunologic Factors|immunologic factors|mesh-ancestor
25043714|NCT01224262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043715|NCT01222702|Vancomycin|vancomycin|mesh-list
25043716|NCT01222702|Oxazolidinones|oxazolidinones|mesh-list
25043717|NCT01222702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25043718|NCT01222702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25043736|NCT01220947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25043737|NCT01220947|Antiviral Agents|antiviral agents|mesh-ancestor
25043738|NCT01220947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25043739|NCT01220947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25043740|NCT01220947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25043741|NCT01220947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25286426|NCT01841359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25286427|NCT01841359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286428|NCT01828697|Enoxaparin|enoxaparin|mesh-list
25286429|NCT01828697|Dalteparin|dalteparin|mesh-list
25286430|NCT01828697|Tinzaparin|tinzaparin|mesh-list
25286431|NCT01828697|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25286432|NCT01828697|Nadroparin|nadroparin|mesh-list
25286433|NCT01828697|Enoxaparin sodium|enoxaparin sodium|mesh-list
25286434|NCT01828697|Anticoagulants|anticoagulants|mesh-ancestor
25286435|NCT01828697|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25286436|NCT01828697|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25286437|NCT01828697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286438|NCT01794793|Cabergoline|cabergoline|mesh-list
25286439|NCT01794793|Pasireotide|pasireotide|mesh-list
25286440|NCT01794793|Somatostatin|somatostatin|mesh-list
25286441|NCT01794793|Hormones|hormones|mesh-ancestor
25286442|NCT01794793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25286443|NCT01794793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286444|NCT01794793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25286445|NCT01794793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25286446|NCT01794793|Dopamine Agonists|dopamine agonists|mesh-ancestor
25286447|NCT01794793|Dopamine Agents|dopamine agents|mesh-ancestor
25286448|NCT01794793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25286449|NCT01794793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286455|NCT01594580|Anti-Infective Agents|anti-infective agents|mesh-list
25286456|NCT01594580|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25286457|NCT01459666|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25286458|NCT01459666|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25286459|NCT01459666|Hemagglutinins|hemagglutinins|mesh-list
25286460|NCT01459666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25286461|NCT01459666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25286462|NCT01459666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286463|NCT01459666|Cholinergic Agents|cholinergic agents|mesh-ancestor
25286464|NCT01459666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25286465|NCT01459666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286466|NCT01459666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25286467|NCT01459666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25286468|NCT01459666|Agglutinins|agglutinins|mesh-ancestor
25286469|NCT01459666|Immunologic Factors|immunologic factors|mesh-ancestor
25286470|NCT01398319|Ethanol|ethanol|mesh-list
25286471|NCT01398319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25286472|NCT01398319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25043762|NCT01205061|Anesthetics|anesthetics|mesh-ancestor
25043763|NCT01205061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25043764|NCT01205061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043765|NCT01205061|Sensory System Agents|sensory system agents|mesh-ancestor
25043767|NCT01205061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25043768|NCT01205061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25043769|NCT01205061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25693138|NCT02008942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25693139|NCT02008942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693140|NCT02008942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25693141|NCT02008942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25043770|NCT01205061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25693142|NCT02008942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25043771|NCT01205061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043772|NCT01205048|Lidocaine|lidocaine|mesh-list
25043773|NCT01205048|Anesthetics, Local|anesthetics, local|mesh-ancestor
25043774|NCT01205048|Anesthetics|anesthetics|mesh-ancestor
25043775|NCT01205048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25043776|NCT01205048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043777|NCT01205048|Sensory System Agents|sensory system agents|mesh-ancestor
25067742|NCT03440268|Protective Agents|protective agents|mesh-ancestor
25043839|NCT01194960|Antimitotic Agents|antimitotic agents|mesh-ancestor
25043840|NCT01194960|Mitosis Modulators|mitosis modulators|mesh-ancestor
25043841|NCT01194960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043842|NCT01193361|Interferons|interferons|mesh-list
25043843|NCT01193361|Ribavirin|ribavirin|mesh-list
25043844|NCT01193361|Interferon-alpha|interferon-alpha|mesh-list
25043845|NCT01193361|Interferon alpha-2|interferon alpha-2|mesh-list
25043846|NCT01193361|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25043847|NCT01193361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043848|NCT01193361|Antiviral Agents|antiviral agents|mesh-ancestor
25043849|NCT01193361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25043850|NCT01193361|Antimetabolites|antimetabolites|mesh-ancestor
25043851|NCT01193361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043852|NCT01193361|Immunologic Factors|immunologic factors|mesh-ancestor
25043854|NCT01193140|Temozolomide|temozolomide|mesh-list
25286473|NCT01398319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25286474|NCT01398319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286475|NCT01369199|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25286476|NCT01369199|Entecavir|entecavir|mesh-list
25286477|NCT01369199|Antiviral Agents|antiviral agents|mesh-ancestor
25286478|NCT01369199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25286479|NCT01368497|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25286480|NCT01368497|Entecavir|entecavir|mesh-list
25286481|NCT01368497|Antiviral Agents|antiviral agents|mesh-ancestor
25286482|NCT01368497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25286483|NCT01305889|Sertraline|sertraline|mesh-list
25286484|NCT01305889|Antidepressive Agents|antidepressive agents|mesh-ancestor
25286485|NCT01305889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25286486|NCT01305889|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25286487|NCT01305889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25286488|NCT01305889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25286489|NCT01305889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286490|NCT01305889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25286491|NCT01305889|Serotonin Agents|serotonin agents|mesh-ancestor
25286492|NCT01305889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286493|NCT00666237|Mitomycins|mitomycins|mesh-list
25286494|NCT00666237|Mitomycin|mitomycin|mesh-list
25286495|NCT00666237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25286496|NCT00666237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286497|NCT00666237|Alkylating Agents|alkylating agents|mesh-ancestor
25286498|NCT00666237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286499|NCT00666237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25286500|NCT00666237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25286501|NCT00223171|Androgens|androgens|mesh-list
25286502|NCT00223171|Hormones|hormones|mesh-ancestor
25286503|NCT00223171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25286504|NCT00223171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286505|NCT04631393|Alfentanil|alfentanil|mesh-list
25286506|NCT04631393|Propofol|propofol|mesh-list
25286507|NCT04631393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25286508|NCT04631393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25286509|NCT04631393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286510|NCT04631393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25286511|NCT04631393|Anesthetics, General|anesthetics, general|mesh-ancestor
25286512|NCT04631393|Anesthetics|anesthetics|mesh-ancestor
25286513|NCT04631393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25286514|NCT04631393|Narcotics|narcotics|mesh-ancestor
25286515|NCT04631393|Analgesics|analgesics|mesh-ancestor
25043863|NCT01192880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25043864|NCT01192880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25043865|NCT01192880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043866|NCT01192880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25043867|NCT01192035|Ritonavir|ritonavir|mesh-list
25043868|NCT01192035|Lopinavir|lopinavir|mesh-list
25043869|NCT01192035|Nevirapine|nevirapine|mesh-list
25043871|NCT01192035|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25043872|NCT01192035|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25043873|NCT01192035|Protease Inhibitors|protease inhibitors|mesh-ancestor
25043875|NCT01192035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286516|NCT04631393|Sensory System Agents|sensory system agents|mesh-ancestor
25286517|NCT04631393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25286518|NCT04562324|Antipsychotic Agents|antipsychotic agents|mesh-list
25286519|NCT04562324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25286520|NCT04562324|Antidepressive Agents|antidepressive agents|mesh-list
25043876|NCT01192035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25043877|NCT01192035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25286525|NCT04562324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286527|NCT04537923|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25286528|NCT04537923|Insulin Glargine|insulin glargine|mesh-list
25286530|NCT04537923|Tirzepatide|tirzepatide|mesh-list
25286531|NCT04537923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25286532|NCT04537923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286533|NCT04537923|Incretins|incretins|mesh-ancestor
25286534|NCT04537923|Hormones|hormones|mesh-ancestor
25286535|NCT04537923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25286536|NCT04513314|Valproic Acid|valproic acid|mesh-list
25286537|NCT04513314|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25286538|NCT04513314|Antidepressive Agents|antidepressive agents|mesh-ancestor
25286539|NCT04513314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25286540|NCT04513314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25286541|NCT04513314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25286542|NCT04513314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25286543|NCT04513314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286544|NCT04513314|Anticonvulsants|anticonvulsants|mesh-ancestor
25286545|NCT04513314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25286546|NCT04513314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286547|NCT04513314|GABA Agents|gaba agents|mesh-ancestor
25286548|NCT04513314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25286549|NCT04513314|Antimanic Agents|antimanic agents|mesh-ancestor
25286550|NCT04447118|Docetaxel|docetaxel|mesh-list
25286551|NCT04447118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286552|NCT04447118|Tubulin Modulators|tubulin modulators|mesh-ancestor
25286553|NCT04447118|Antimitotic Agents|antimitotic agents|mesh-ancestor
25286554|NCT04447118|Mitosis Modulators|mitosis modulators|mesh-ancestor
25286555|NCT04447118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286556|NCT04443062|177Lu-PSMA-617|177lu-psma-617|mesh-list
25286557|NCT04443062|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25286558|NCT04443062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286564|NCT04406415|Nafamostat|nafamostat|mesh-list
25286565|NCT04406415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25286566|NCT04406415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25286567|NCT04406415|Analgesics|analgesics|mesh-ancestor
25286568|NCT04406415|Sensory System Agents|sensory system agents|mesh-ancestor
25286569|NCT04406415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25286570|NCT04406415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286571|NCT04406415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25286572|NCT04406415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25286573|NCT04406415|Anticoagulants|anticoagulants|mesh-ancestor
25286574|NCT04406415|Protease Inhibitors|protease inhibitors|mesh-ancestor
25043927|NCT01186991|Tubulin Modulators|tubulin modulators|mesh-ancestor
25043928|NCT01186991|Antimitotic Agents|antimitotic agents|mesh-ancestor
25043929|NCT01186991|Mitosis Modulators|mitosis modulators|mesh-ancestor
25043930|NCT01186991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043931|NCT01186991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25043932|NCT01186991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25043933|NCT01186991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24938213|NCT04021173|Fibrinolysin|fibrinolysin|mesh-list
25043934|NCT01186991|Growth Substances|growth substances|mesh-ancestor
25043935|NCT01186991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25043936|NCT01186991|Growth Inhibitors|growth inhibitors|mesh-ancestor
25043937|NCT01186991|Immunologic Factors|immunologic factors|mesh-ancestor
25043938|NCT01186861|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25043939|NCT01186861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25043940|NCT01186861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25043941|NCT01186861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25043942|NCT01186861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043943|NCT01183949|Bortezomib|bortezomib|mesh-list
25043944|NCT01183949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044059|NCT01168310|Adrenergic Agents|adrenergic agents|mesh-ancestor
25286576|NCT04406415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286578|NCT04406415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25286579|NCT04406415|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25286580|NCT04406415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25286581|NCT04406415|Immunologic Factors|immunologic factors|mesh-ancestor
25286600|NCT04200534|Nicotine|nicotine|mesh-list
25286601|NCT04200534|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25286602|NCT04200534|Autonomic Agents|autonomic agents|mesh-ancestor
25286603|NCT04200534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25286604|NCT04200534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286605|NCT04200534|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25286606|NCT04200534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25286607|NCT04200534|Cholinergic Agents|cholinergic agents|mesh-ancestor
25286608|NCT04200534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25286609|NCT04200534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25043964|NCT01175785|Cyclosporins|cyclosporins|mesh-list
25043965|NCT01175785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25043966|NCT01175785|Immunologic Factors|immunologic factors|mesh-ancestor
25043967|NCT01175785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044039|NCT01168713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044040|NCT01168713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044041|NCT01168713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044042|NCT01168713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25044043|NCT01168713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25044044|NCT01168310|Fluticasone|fluticasone|mesh-list
25044046|NCT01168310|Formoterol Fumarate|formoterol fumarate|mesh-list
25044047|NCT01168310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25044048|NCT01168310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25044049|NCT01168310|Autonomic Agents|autonomic agents|mesh-ancestor
25044050|NCT01168310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25044051|NCT01168310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044052|NCT01168310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25044053|NCT01168310|Respiratory System Agents|respiratory system agents|mesh-ancestor
25044054|NCT01168310|Dermatologic Agents|dermatologic agents|mesh-ancestor
25044055|NCT01168310|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25044056|NCT01168310|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25044057|NCT01168310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25044058|NCT01168310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25044060|NCT01168310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25069848|NCT03423810|Hydralazine|hydralazine|mesh-list
25286610|NCT04028388|Docetaxel|docetaxel|mesh-list
25286611|NCT04028388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286612|NCT04028388|Tubulin Modulators|tubulin modulators|mesh-ancestor
25286613|NCT04028388|Antimitotic Agents|antimitotic agents|mesh-ancestor
25286614|NCT04028388|Mitosis Modulators|mitosis modulators|mesh-ancestor
25286615|NCT04028388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286616|NCT04003506|Bupivacaine|bupivacaine|mesh-list
25286617|NCT04003506|Anesthetics, Local|anesthetics, local|mesh-ancestor
25286618|NCT04003506|Anesthetics|anesthetics|mesh-ancestor
24420579|NCT00216359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25286619|NCT04003506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25286620|NCT04003506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286621|NCT04003506|Sensory System Agents|sensory system agents|mesh-ancestor
25286622|NCT04003506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25286623|NCT03973593|Contraceptive Agents|contraceptive agents|mesh-list
25286624|NCT03973593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25286625|NCT03973593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286626|NCT03955640|Olaparib|olaparib|mesh-list
25286627|NCT03955640|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25286628|NCT03955640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25286629|NCT03955640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286630|NCT03955640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286631|NCT03910738|Methyltestosterone|methyltestosterone|mesh-list
25286632|NCT03910738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25286633|NCT03910738|Testosterone|testosterone|mesh-list
25286634|NCT03910738|Testosterone undecanoate|testosterone undecanoate|mesh-list
25286635|NCT03910738|Testosterone enanthate|testosterone enanthate|mesh-list
25286636|NCT03910738|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25286637|NCT03910738|Androgens|androgens|mesh-ancestor
25286638|NCT03910738|Hormones|hormones|mesh-ancestor
25286639|NCT03910738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25286640|NCT03910738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286641|NCT03910738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25286642|NCT03910738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286643|NCT03910738|Anabolic Agents|anabolic agents|mesh-ancestor
25286645|NCT03890744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286646|NCT03890744|Tubulin Modulators|tubulin modulators|mesh-ancestor
25286647|NCT03890744|Antimitotic Agents|antimitotic agents|mesh-ancestor
24763367|NCT01773096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25286648|NCT03890744|Mitosis Modulators|mitosis modulators|mesh-ancestor
25286649|NCT03890744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286650|NCT03885037|Infliximab|infliximab|mesh-list
25286651|NCT03885037|Dermatologic Agents|dermatologic agents|mesh-ancestor
25286652|NCT03885037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25286653|NCT03885037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25286654|NCT03820817|Rifaximin|rifaximin|mesh-list
25286655|NCT03820817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25286656|NCT03820817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25286657|NCT03820817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25044140|NCT01137968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25044142|NCT01137526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25044143|NCT01137526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044144|NCT01137526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044145|NCT01137526|Cholinergic Agents|cholinergic agents|mesh-ancestor
25044146|NCT01137526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25044147|NCT01137526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000487|NCT04374019|Artesunate|artesunate|mesh-list
25044148|NCT01137526|Nootropic Agents|nootropic agents|mesh-ancestor
25044149|NCT01133990|Leucovorin|leucovorin|mesh-list
25044151|NCT01133990|Fluorouracil|fluorouracil|mesh-list
25044152|NCT01133990|Irinotecan|irinotecan|mesh-list
25044153|NCT01133990|Calcium|calcium|mesh-list
25044154|NCT01133990|Levoleucovorin|levoleucovorin|mesh-list
25044155|NCT01133990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25044156|NCT01133990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044157|NCT01133990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25044158|NCT01133990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25044160|NCT01133990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044161|NCT01133990|Growth Inhibitors|growth inhibitors|mesh-ancestor
25044162|NCT01133990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25044163|NCT01133990|Antimetabolites|antimetabolites|mesh-ancestor
25044164|NCT01133990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044165|NCT01133990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25044166|NCT01133990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25286658|NCT03789097|Pembrolizumab|pembrolizumab|mesh-list
25286679|NCT03718793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286680|NCT03718793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25286681|NCT03718793|Respiratory System Agents|respiratory system agents|mesh-ancestor
25286682|NCT03718793|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25286683|NCT03718793|Antioxidants|antioxidants|mesh-ancestor
25286684|NCT03718793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286685|NCT03718793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25286686|NCT03718793|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25286687|NCT03718793|Vasodilator Agents|vasodilator agents|mesh-ancestor
25286688|NCT03718793|Gasotransmitters|gasotransmitters|mesh-ancestor
25286689|NCT03718793|Protective Agents|protective agents|mesh-ancestor
25286699|NCT03524326|Cetuximab|cetuximab|mesh-list
25286700|NCT03524326|Lenvatinib|lenvatinib|mesh-list
25286701|NCT03524326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25286702|NCT03524326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286703|NCT03524326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25286704|NCT03524326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25286705|NCT03524326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286706|NCT03512223|Dexamethasone|dexamethasone|mesh-list
25044232|NCT01128335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25044233|NCT01128335|Immunologic Factors|immunologic factors|mesh-ancestor
25044234|NCT01128335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044235|NCT01128335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25044236|NCT01128335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044237|NCT01128335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044238|NCT01126970|Orlistat|orlistat|mesh-list
25044239|NCT01126970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044240|NCT01126970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044241|NCT01126970|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25044242|NCT01126970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25044243|NCT01126190|Docetaxel|docetaxel|mesh-list
25044244|NCT01126190|Doxorubicin|doxorubicin|mesh-list
25044245|NCT01126190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044246|NCT01126190|Tubulin Modulators|tubulin modulators|mesh-ancestor
25044247|NCT01126190|Antimitotic Agents|antimitotic agents|mesh-ancestor
25044248|NCT01126190|Mitosis Modulators|mitosis modulators|mesh-ancestor
25044249|NCT01126190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693143|NCT02008942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25044250|NCT01126190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25044251|NCT01126190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25044252|NCT01126190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25044253|NCT01126190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044377|NCT01107496|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25044378|NCT01107496|Antidepressive Agents|antidepressive agents|mesh-ancestor
25286707|NCT03512223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25286708|NCT03512223|Antiemetics|antiemetics|mesh-ancestor
25286709|NCT03512223|Autonomic Agents|autonomic agents|mesh-ancestor
25286727|NCT03359460|Lenalidomide|lenalidomide|mesh-list
25286728|NCT03359460|Immunologic Factors|immunologic factors|mesh-ancestor
25286729|NCT03359460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286730|NCT03359460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25286731|NCT03359460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25286732|NCT03359460|Growth Substances|growth substances|mesh-ancestor
25286733|NCT03359460|Growth Inhibitors|growth inhibitors|mesh-ancestor
25286734|NCT03359460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286735|NCT03227263|Bevacizumab|bevacizumab|mesh-list
25286736|NCT03227263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25286737|NCT03227263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286738|NCT03227263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25286739|NCT03227263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25286740|NCT03227263|Growth Substances|growth substances|mesh-ancestor
25286741|NCT03227263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286742|NCT03227263|Growth Inhibitors|growth inhibitors|mesh-ancestor
25286751|NCT03150368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286752|NCT03150368|Tubulin Modulators|tubulin modulators|mesh-ancestor
25286753|NCT03150368|Antimitotic Agents|antimitotic agents|mesh-ancestor
25286754|NCT03150368|Mitosis Modulators|mitosis modulators|mesh-ancestor
25044401|NCT01106807|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
25044402|NCT01106807|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25044403|NCT01106807|Dermatologic Agents|dermatologic agents|mesh-ancestor
25044404|NCT01106807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25044405|NCT01106807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25044406|NCT01106807|Analgesics|analgesics|mesh-ancestor
25072349|NCT03401957|Cetuximab|cetuximab|mesh-list
25000810|NCT03081858|Paclitaxel|paclitaxel|mesh-list
25072942|NCT03398785|Mydriatics|mydriatics|mesh-ancestor
25044469|NCT01092065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25044470|NCT01092065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25044471|NCT01092065|Dopamine Agents|dopamine agents|mesh-ancestor
25044472|NCT01092065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25044473|NCT01092065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044474|NCT01092065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044475|NCT01089790|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25044476|NCT01089790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25044477|NCT01089790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044478|NCT01089790|Incretins|incretins|mesh-ancestor
25044479|NCT01089790|Hormones|hormones|mesh-ancestor
25044480|NCT01089790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25286758|NCT03147378|Tubulin Modulators|tubulin modulators|mesh-ancestor
25286759|NCT03147378|Antimitotic Agents|antimitotic agents|mesh-ancestor
25286760|NCT03147378|Mitosis Modulators|mitosis modulators|mesh-ancestor
25286761|NCT03147378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286763|NCT03136640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286764|NCT03136640|Tubulin Modulators|tubulin modulators|mesh-ancestor
25286765|NCT03136640|Antimitotic Agents|antimitotic agents|mesh-ancestor
25286766|NCT03136640|Mitosis Modulators|mitosis modulators|mesh-ancestor
25286767|NCT03136640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286780|NCT02914470|Atezolizumab|atezolizumab|mesh-list
25286781|NCT02914470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286782|NCT02660710|Rituximab|rituximab|mesh-list
25286783|NCT02660710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25286784|NCT02660710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286785|NCT02660710|Immunologic Factors|immunologic factors|mesh-ancestor
25286786|NCT02660710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286787|NCT02660710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25286788|NCT02492711|Gemcitabine|gemcitabine|mesh-list
25286789|NCT02492711|Capecitabine|capecitabine|mesh-list
25693144|NCT02008942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693145|NCT02008942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25286790|NCT02492711|Trastuzumab|trastuzumab|mesh-list
25286791|NCT02492711|Vinorelbine|vinorelbine|mesh-list
25286792|NCT02492711|Margetuximab|margetuximab|mesh-list
25286793|NCT02492711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25044489|NCT01087151|Immunologic Factors|immunologic factors|mesh-ancestor
25044490|NCT01087151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044491|NCT01087151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25044492|NCT01086748|Risperidone|risperidone|mesh-list
25044493|NCT01086748|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25044494|NCT01086748|Serotonin Agents|serotonin agents|mesh-ancestor
25044495|NCT01086748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25044496|NCT01086748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044497|NCT01086748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044498|NCT01086748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25044499|NCT01086748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25044568|NCT01080222|Ribavirin|ribavirin|mesh-list
25044569|NCT01080222|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25044570|NCT01080222|Antimetabolites|antimetabolites|mesh-ancestor
25044571|NCT01080222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044572|NCT01080222|Antiviral Agents|antiviral agents|mesh-ancestor
25044573|NCT01080222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25044574|NCT01077297|Tezosentan|tezosentan|mesh-list
25044575|NCT01077297|Vasodilator Agents|vasodilator agents|mesh-ancestor
25044576|NCT01076764|Heparin|heparin|mesh-list
25044577|NCT01076764|Calcium heparin|calcium heparin|mesh-list
25044578|NCT01076764|Otamixaban|otamixaban|mesh-list
25044579|NCT01076764|Eptifibatide|eptifibatide|mesh-list
25044580|NCT01076764|Anticoagulants|anticoagulants|mesh-ancestor
25044581|NCT01076764|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25044582|NCT01076764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25044583|NCT01076764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044584|NCT01076764|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25044585|NCT01076764|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25044628|NCT01071239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25044629|NCT01071239|Alkylating Agents|alkylating agents|mesh-ancestor
25286878|NCT05087706|Hormone Antagonists|hormone antagonists|mesh-ancestor
25044630|NCT01071239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044631|NCT01071239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044632|NCT01071239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25044633|NCT01069692|Ferric Compounds|ferric compounds|mesh-list
25286794|NCT02492711|Antimetabolites|antimetabolites|mesh-ancestor
25286795|NCT02492711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286796|NCT02492711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286797|NCT02492711|Antiviral Agents|antiviral agents|mesh-ancestor
25286798|NCT02492711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25286799|NCT02492711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25286800|NCT02492711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25286801|NCT02492711|Immunologic Factors|immunologic factors|mesh-ancestor
25286802|NCT02492711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286803|NCT02492711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25286804|NCT02492711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25286805|NCT02492711|Tubulin Modulators|tubulin modulators|mesh-ancestor
25286806|NCT02492711|Antimitotic Agents|antimitotic agents|mesh-ancestor
25286807|NCT02492711|Mitosis Modulators|mitosis modulators|mesh-ancestor
25286809|NCT02484716|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25286810|NCT02484716|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25286811|NCT02484716|Adrenergic Agents|adrenergic agents|mesh-ancestor
25286812|NCT02484716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25286813|NCT02484716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286814|NCT02484716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286815|NCT02484716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25286816|NCT02484716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25286817|NCT05088343|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25286818|NCT05088343|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25286819|NCT05088343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25286820|NCT05088343|Antimetabolites|antimetabolites|mesh-ancestor
25286821|NCT05088343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286822|NCT05088343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25286823|NCT05088343|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25286824|NCT05088343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25286825|NCT05088330|Daratumumab|daratumumab|mesh-list
25286826|NCT05088330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286827|NCT05088239|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25286828|NCT05088239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25286829|NCT05088174|Cyclosporine|cyclosporine|mesh-list
25286830|NCT05088174|Cyclosporins|cyclosporins|mesh-list
25286831|NCT05088174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044640|NCT01068704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044641|NCT01068704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044642|NCT01068704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25044643|NCT01068704|Hormone Antagonists|hormone antagonists|mesh-ancestor
25044644|NCT01068704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25044645|NCT01068704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044646|NCT01068704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25044647|NCT01068613|Tiotropium Bromide|tiotropium bromide|mesh-list
25044648|NCT01068613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25044649|NCT01068613|Autonomic Agents|autonomic agents|mesh-ancestor
25044650|NCT01068613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25044651|NCT01068613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044652|NCT01068613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25044653|NCT01068613|Respiratory System Agents|respiratory system agents|mesh-ancestor
25044654|NCT01068613|Parasympatholytics|parasympatholytics|mesh-ancestor
25044655|NCT01068613|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25044656|NCT01068613|Cholinergic Agents|cholinergic agents|mesh-ancestor
25044657|NCT01068613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25044658|NCT01068613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044660|NCT01065012|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25044661|NCT01065012|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25044662|NCT01065012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044663|NCT01065012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044664|NCT01064791|Mycophenolic Acid|mycophenolic acid|mesh-list
25044665|NCT01064791|Tacrolimus|tacrolimus|mesh-list
25044666|NCT01064791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25044667|NCT01064791|Immunologic Factors|immunologic factors|mesh-ancestor
25044668|NCT01064791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044669|NCT01064791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25044670|NCT01064791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044671|NCT01064791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286832|NCT05088174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286833|NCT05088174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25286834|NCT05088174|Immunologic Factors|immunologic factors|mesh-ancestor
25286835|NCT05088174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286836|NCT05088174|Antifungal Agents|antifungal agents|mesh-ancestor
25286837|NCT05088174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25286838|NCT05088174|Dermatologic Agents|dermatologic agents|mesh-ancestor
25286839|NCT05088174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25286840|NCT05088174|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25286841|NCT05088083|Paclitaxel|paclitaxel|mesh-list
25286842|NCT05088083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25286843|NCT05088083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286844|NCT05088083|Tubulin Modulators|tubulin modulators|mesh-ancestor
25286845|NCT05088083|Antimitotic Agents|antimitotic agents|mesh-ancestor
25286846|NCT05088083|Mitosis Modulators|mitosis modulators|mesh-ancestor
25286847|NCT05088083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286848|NCT05088057|Cyclophosphamide|cyclophosphamide|mesh-list
25286849|NCT05088057|Docetaxel|docetaxel|mesh-list
25286850|NCT05088057|Doxorubicin|doxorubicin|mesh-list
25286851|NCT05088057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25286852|NCT05088057|Immunologic Factors|immunologic factors|mesh-ancestor
25286853|NCT05088057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286854|NCT05088057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25286855|NCT05088057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25286856|NCT05088057|Alkylating Agents|alkylating agents|mesh-ancestor
25286857|NCT05088057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286858|NCT05088057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286859|NCT05088057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25286860|NCT05088057|Tubulin Modulators|tubulin modulators|mesh-ancestor
25286861|NCT05088057|Antimitotic Agents|antimitotic agents|mesh-ancestor
25286862|NCT05088057|Mitosis Modulators|mitosis modulators|mesh-ancestor
25286863|NCT05088057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25286864|NCT05088057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25286865|NCT05088057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25286866|NCT05088057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044675|NCT01064791|Antitubercular Agents|antitubercular agents|mesh-ancestor
25044676|NCT01064791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25044677|NCT01064791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25044678|NCT01064518|Botulinum Toxins|botulinum toxins|mesh-list
25044679|NCT01064518|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25044680|NCT01064518|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25040564|NCT03009019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25044681|NCT01064518|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25044682|NCT01064518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25044683|NCT01064518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044684|NCT01064518|Cholinergic Agents|cholinergic agents|mesh-ancestor
25044753|NCT01043029|Pioglitazone|pioglitazone|mesh-list
25044754|NCT01043029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25044755|NCT01043029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044757|NCT01042925|Trastuzumab|trastuzumab|mesh-list
25044758|NCT01042925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25044759|NCT01042925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044760|NCT01042925|Tubulin Modulators|tubulin modulators|mesh-ancestor
25044761|NCT01042925|Antimitotic Agents|antimitotic agents|mesh-ancestor
25044762|NCT01042925|Mitosis Modulators|mitosis modulators|mesh-ancestor
25044763|NCT01042925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044764|NCT01042925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25044765|NCT01038804|Docetaxel|docetaxel|mesh-list
25044766|NCT01038804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044767|NCT01038804|Tubulin Modulators|tubulin modulators|mesh-ancestor
24975611|NCT03440112|GABA Agents|gaba agents|mesh-ancestor
25044768|NCT01038804|Antimitotic Agents|antimitotic agents|mesh-ancestor
25044769|NCT01038804|Mitosis Modulators|mitosis modulators|mesh-ancestor
25044774|NCT01038739|Analgesics|analgesics|mesh-ancestor
25286867|NCT05087797|Nicorandil|nicorandil|mesh-list
25286868|NCT05087797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25286869|NCT05087797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25286870|NCT05087797|Vasodilator Agents|vasodilator agents|mesh-ancestor
25286871|NCT05087797|Vitamin B Complex|vitamin b complex|mesh-ancestor
25286872|NCT05087797|Vitamins|vitamins|mesh-ancestor
25286873|NCT05087797|Micronutrients|micronutrients|mesh-ancestor
25286874|NCT05087797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286875|NCT05087706|Bicalutamide|bicalutamide|mesh-list
25286876|NCT05087706|Leuprolide|leuprolide|mesh-list
25286877|NCT05087706|Androgen Antagonists|androgen antagonists|mesh-ancestor
25286879|NCT05087706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25286880|NCT05087706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286881|NCT05087706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286882|NCT05087706|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25286883|NCT05087706|Fertility Agents|fertility agents|mesh-ancestor
25286884|NCT05087706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25286885|NCT05087706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25286887|NCT05087693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25286888|NCT05087693|Autonomic Agents|autonomic agents|mesh-ancestor
25286889|NCT05087693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25286890|NCT05087693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286891|NCT05087693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25286892|NCT05087693|Respiratory System Agents|respiratory system agents|mesh-ancestor
25286893|NCT05087693|Tocolytic Agents|tocolytic agents|mesh-ancestor
25286894|NCT05087693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25286895|NCT05087693|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25286896|NCT05087693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25286897|NCT05087693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25286898|NCT05087693|Adrenergic Agents|adrenergic agents|mesh-ancestor
25286899|NCT05087693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25286900|NCT05087693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286901|NCT05087368|Vaccines|vaccines|mesh-list
25286902|NCT05087368|Immunologic Factors|immunologic factors|mesh-ancestor
25286903|NCT05087368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286904|NCT05087134|Choline|choline|mesh-list
24607330|NCT04764942|Dexamethasone|dexamethasone|mesh-list
24671291|NCT01324596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24671292|NCT01324596|Tubulin Modulators|tubulin modulators|mesh-ancestor
24671293|NCT01324596|Antimitotic Agents|antimitotic agents|mesh-ancestor
25286905|NCT05087134|Lipotropic Agents|lipotropic agents|mesh-ancestor
25286906|NCT05087134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25286907|NCT05087134|Antimetabolites|antimetabolites|mesh-ancestor
25286908|NCT05087134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286909|NCT05087134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25286910|NCT05087134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25286911|NCT05087134|Nootropic Agents|nootropic agents|mesh-ancestor
25286912|NCT05086848|Leucovorin|leucovorin|mesh-list
25044788|NCT01037179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044789|NCT01037179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25044790|NCT01037179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25044791|NCT01037179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25044792|NCT01037179|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25044793|NCT01037179|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25044794|NCT01037179|Histamine Antagonists|histamine antagonists|mesh-ancestor
25044795|NCT01037179|Histamine Agents|histamine agents|mesh-ancestor
25044796|NCT01037179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25044797|NCT01037179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044799|NCT01037166|Antiviral Agents|antiviral agents|mesh-ancestor
25044800|NCT01037166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25044801|NCT01037062|Entecavir|entecavir|mesh-list
25044802|NCT01037062|Antiviral Agents|antiviral agents|mesh-ancestor
25044803|NCT01037062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25044804|NCT01037036|Latanoprost|latanoprost|mesh-list
25044805|NCT01037036|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25044806|NCT01037036|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25044807|NCT01035879|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25044808|NCT01035879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25044809|NCT01035879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044810|NCT01035879|Incretins|incretins|mesh-ancestor
25044811|NCT01035879|Hormones|hormones|mesh-ancestor
25044812|NCT01035879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25044813|NCT01035879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25044814|NCT01035879|Protease Inhibitors|protease inhibitors|mesh-ancestor
25044815|NCT01035879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044816|NCT01035879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044817|NCT01035502|Idarubicin|idarubicin|mesh-list
25044818|NCT01035502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25044819|NCT01035502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044870|NCT01025648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25044871|NCT01025648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25044872|NCT01025648|Respiratory System Agents|respiratory system agents|mesh-ancestor
25286913|NCT05086848|Fluorouracil|fluorouracil|mesh-list
25286914|NCT05086848|Irinotecan|irinotecan|mesh-list
25286915|NCT05086848|Antimetabolites|antimetabolites|mesh-ancestor
25286921|NCT05086848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286922|NCT05086848|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25286923|NCT05086848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25286924|NCT05086848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25286925|NCT05086848|Antidotes|antidotes|mesh-ancestor
25286926|NCT05086848|Protective Agents|protective agents|mesh-ancestor
25286927|NCT05086848|Vitamin B Complex|vitamin b complex|mesh-ancestor
25286928|NCT05086848|Vitamins|vitamins|mesh-ancestor
25286929|NCT05086848|Micronutrients|micronutrients|mesh-ancestor
25286930|NCT05086822|Irinotecan|irinotecan|mesh-list
25286931|NCT05086822|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25286932|NCT05086822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25286933|NCT05086822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671297|NCT01324596|Hormones|hormones|mesh-ancestor
25286934|NCT05086822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286935|NCT05086822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25286942|NCT05086614|Thymalfasin|thymalfasin|mesh-list
25286943|NCT05086614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25286944|NCT05086614|Immunologic Factors|immunologic factors|mesh-ancestor
25286945|NCT05086614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286946|NCT05086081|Ticagrelor|ticagrelor|mesh-list
25286947|NCT05086081|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25286948|NCT05086081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25286949|NCT05086081|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25286950|NCT05086081|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25286951|NCT05086081|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25044878|NCT01024101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044879|NCT01024101|Tubulin Modulators|tubulin modulators|mesh-ancestor
25044880|NCT01024101|Antimitotic Agents|antimitotic agents|mesh-ancestor
25044881|NCT01024101|Mitosis Modulators|mitosis modulators|mesh-ancestor
25044882|NCT01024101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044883|NCT01024062|Paclitaxel|paclitaxel|mesh-list
25044884|NCT01024062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25044885|NCT01024062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044886|NCT01024062|Tubulin Modulators|tubulin modulators|mesh-ancestor
25044887|NCT01024062|Antimitotic Agents|antimitotic agents|mesh-ancestor
25044888|NCT01024062|Mitosis Modulators|mitosis modulators|mesh-ancestor
25044889|NCT01024062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044890|NCT01023880|Delanzomib|delanzomib|mesh-list
25044891|NCT01023880|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
25044892|NCT01023880|Protease Inhibitors|protease inhibitors|mesh-ancestor
25044894|NCT01023880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044895|NCT01023295|Fosbretabulin|fosbretabulin|mesh-list
25044896|NCT01023295|Combretastatin|combretastatin|mesh-list
25044897|NCT01023295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25044898|NCT01023295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044899|NCT01023295|Tubulin Modulators|tubulin modulators|mesh-ancestor
25044902|NCT01023295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044903|NCT01023204|Paclitaxel|paclitaxel|mesh-list
25044904|NCT01023204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25044905|NCT01023204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044906|NCT01023204|Tubulin Modulators|tubulin modulators|mesh-ancestor
25044907|NCT01023204|Antimitotic Agents|antimitotic agents|mesh-ancestor
25044908|NCT01023204|Mitosis Modulators|mitosis modulators|mesh-ancestor
25044909|NCT01023204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044910|NCT01022801|Entecavir|entecavir|mesh-list
25044911|NCT01022801|Antiviral Agents|antiviral agents|mesh-ancestor
25044913|NCT01020565|Entecavir|entecavir|mesh-list
25286952|NCT05086081|Purinergic Agents|purinergic agents|mesh-ancestor
25286953|NCT05086081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25286954|NCT05086081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286955|NCT05086081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286959|NCT05085912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25286960|NCT05085912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286964|NCT05085652|Anesthetics|anesthetics|mesh-list
25286965|NCT05085652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25286966|NCT05085652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286967|NCT05085587|Fluticasone|fluticasone|mesh-list
25286969|NCT05085587|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25286970|NCT05085587|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25286971|NCT05085587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25286972|NCT05085587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25286973|NCT05085587|Autonomic Agents|autonomic agents|mesh-ancestor
25286974|NCT05085587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25286975|NCT05085587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286976|NCT05085587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25286977|NCT05085587|Respiratory System Agents|respiratory system agents|mesh-ancestor
25286978|NCT05085587|Dermatologic Agents|dermatologic agents|mesh-ancestor
25286979|NCT05085587|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25286980|NCT05085587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25286981|NCT05085587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25286982|NCT05085587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25286983|NCT05085587|Adrenergic Agents|adrenergic agents|mesh-ancestor
25286984|NCT05085587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25286985|NCT05085587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25286986|NCT05085587|Glucocorticoids|glucocorticoids|mesh-ancestor
25286987|NCT05085587|Hormones|hormones|mesh-ancestor
25286988|NCT05085587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25286989|NCT05085587|Sympathomimetics|sympathomimetics|mesh-ancestor
25286990|NCT05085106|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
25044919|NCT01020097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044920|NCT01019187|Modafinil|modafinil|mesh-list
25044921|NCT01019187|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25044922|NCT01019187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044923|NCT01019187|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25044924|NCT01019187|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25044925|NCT01019187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24998408|NCT02960646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25044929|NCT01018875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044930|NCT01018875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044931|NCT01018875|Cholinergic Agents|cholinergic agents|mesh-ancestor
25044932|NCT01018875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25044933|NCT01018875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044934|NCT01018875|Nootropic Agents|nootropic agents|mesh-ancestor
25044935|NCT01016808|Morphine|morphine|mesh-list
25044936|NCT01016808|Oxycodone|oxycodone|mesh-list
25044937|NCT01016808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25044938|NCT01016808|Narcotics|narcotics|mesh-ancestor
25044939|NCT01016808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25044940|NCT01016808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044941|NCT01016808|Analgesics|analgesics|mesh-ancestor
25044942|NCT01016808|Sensory System Agents|sensory system agents|mesh-ancestor
25044943|NCT01016808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25044944|NCT01014078|Azithromycin|azithromycin|mesh-list
25044945|NCT01014078|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25044946|NCT01014078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25044947|NCT01014078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25286991|NCT05085106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25286992|NCT05085106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25286993|NCT05085106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25286994|NCT05085106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25286995|NCT05085106|Analgesics|analgesics|mesh-ancestor
25286996|NCT05085106|Sensory System Agents|sensory system agents|mesh-ancestor
25286997|NCT05085106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25286998|NCT05085106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25286999|NCT05085106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25287000|NCT05085106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25287006|NCT05084872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25287007|NCT05084872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25287008|NCT05084872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25287009|NCT05084872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25287010|NCT05084872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287011|NCT05084872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25287012|NCT05084573|Bupivacaine|bupivacaine|mesh-list
25287013|NCT05084573|Anesthetics, Local|anesthetics, local|mesh-ancestor
25287014|NCT05084573|Anesthetics|anesthetics|mesh-ancestor
25287015|NCT05084573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25287016|NCT05084573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287017|NCT05084573|Sensory System Agents|sensory system agents|mesh-ancestor
25287018|NCT05084573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25044969|NCT01009775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044970|NCT01009242|Methotrexate|methotrexate|mesh-list
25044971|NCT01009242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25044972|NCT01009242|Abortifacient Agents|abortifacient agents|mesh-ancestor
25044973|NCT01009242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25044974|NCT01009242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044975|NCT01009242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25044976|NCT01009242|Antimetabolites|antimetabolites|mesh-ancestor
25044977|NCT01009242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25044978|NCT01009242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25044979|NCT01009242|Dermatologic Agents|dermatologic agents|mesh-ancestor
25044980|NCT01009242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25044981|NCT01009242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25044982|NCT01009242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25044983|NCT01009242|Immunologic Factors|immunologic factors|mesh-ancestor
25044984|NCT01009242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25044985|NCT01009242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25044986|NCT01007721|Fluticasone|fluticasone|mesh-list
25044988|NCT01007721|Montelukast|montelukast|mesh-list
25044989|NCT01007721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25044990|NCT01007721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25044991|NCT01007721|Autonomic Agents|autonomic agents|mesh-ancestor
25044992|NCT01007721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25044993|NCT01007721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25044994|NCT01007721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25044995|NCT01007721|Respiratory System Agents|respiratory system agents|mesh-ancestor
25044996|NCT01007721|Dermatologic Agents|dermatologic agents|mesh-ancestor
25287019|NCT05079672|Dexmedetomidine|dexmedetomidine|mesh-list
25287020|NCT05079672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25287021|NCT05079672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25287022|NCT05079672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287023|NCT05079672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25287024|NCT05079672|Analgesics|analgesics|mesh-ancestor
25287025|NCT05079672|Sensory System Agents|sensory system agents|mesh-ancestor
25287026|NCT05079672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25287027|NCT05079672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25287028|NCT05079672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25287029|NCT05079672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25287030|NCT05079672|Adrenergic Agents|adrenergic agents|mesh-ancestor
25287031|NCT05079672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25287032|NCT05079672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287033|NCT05073939|Oxytocin|oxytocin|mesh-list
25287034|NCT05073939|Oxytocics|oxytocics|mesh-ancestor
25287035|NCT05073939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25287036|NCT05073939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287037|NCT05068206|Bevacizumab|bevacizumab|mesh-list
25287038|NCT05068206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24480737|NCT00431990|Hormones|hormones|mesh-ancestor
25287039|NCT05068206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25287040|NCT05068206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25287041|NCT05068206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25287042|NCT05068206|Growth Substances|growth substances|mesh-ancestor
25287043|NCT05068206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287044|NCT05068206|Growth Inhibitors|growth inhibitors|mesh-ancestor
25287045|NCT05063370|Simendan|simendan|mesh-list
25287046|NCT05063370|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25287047|NCT05063370|Vasodilator Agents|vasodilator agents|mesh-ancestor
25287048|NCT05063370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25287049|NCT05063370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25287050|NCT05063370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25287051|NCT05063370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287052|NCT05063370|Protective Agents|protective agents|mesh-ancestor
25287053|NCT05063370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287054|NCT05063006|Methamphetamine|methamphetamine|mesh-list
25287055|NCT05063006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25287056|NCT05063006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287057|NCT05063006|Sympathomimetics|sympathomimetics|mesh-ancestor
25287058|NCT05063006|Autonomic Agents|autonomic agents|mesh-ancestor
25287059|NCT05063006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25287060|NCT05063006|Dopamine Agents|dopamine agents|mesh-ancestor
25287061|NCT05063006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25287062|NCT05063006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045052|NCT01002248|Autonomic Agents|autonomic agents|mesh-ancestor
25045053|NCT01002248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045054|NCT01002248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045055|NCT01002248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25045056|NCT01002248|Glucocorticoids|glucocorticoids|mesh-ancestor
25045057|NCT01002248|Hormones|hormones|mesh-ancestor
25045058|NCT01002248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25045059|NCT01002248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25045060|NCT01002248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045061|NCT01001923|Fasinumab|fasinumab|mesh-list
25045062|NCT01001923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25045063|NCT01001923|Analgesics|analgesics|mesh-ancestor
25045064|NCT01001923|Sensory System Agents|sensory system agents|mesh-ancestor
25045065|NCT01001923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045066|NCT01001923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045068|NCT01001715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25045069|NCT01001715|Analgesics|analgesics|mesh-ancestor
25045070|NCT01001715|Sensory System Agents|sensory system agents|mesh-ancestor
25045071|NCT01001715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045072|NCT01001715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045073|NCT01001338|Allopurinol|allopurinol|mesh-list
25045074|NCT01001338|Lesinurad|lesinurad|mesh-list
25045075|NCT01001338|Antimetabolites|antimetabolites|mesh-ancestor
25045076|NCT01001338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045077|NCT01001338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045078|NCT01001338|Gout Suppressants|gout suppressants|mesh-ancestor
25045079|NCT01001338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25045080|NCT01001338|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25045199|NCT00986882|Ibuprofen|ibuprofen|mesh-list
25287063|NCT05063006|Adrenergic Agents|adrenergic agents|mesh-ancestor
25287064|NCT05063006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25287065|NCT05063006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25287066|NCT05063006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25287067|NCT05063006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25287068|NCT05028257|Vaccines|vaccines|mesh-list
25287069|NCT05028257|Immunologic Factors|immunologic factors|mesh-ancestor
25287070|NCT05028257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287071|NCT05020392|Vidarabine|vidarabine|mesh-list
25287072|NCT05020392|Cyclophosphamide|cyclophosphamide|mesh-list
25287073|NCT05020392|Fludarabine|fludarabine|mesh-list
25287074|NCT05020392|Fludarabine phosphate|fludarabine phosphate|mesh-list
25287075|NCT05020392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25287076|NCT05020392|Immunologic Factors|immunologic factors|mesh-ancestor
25287077|NCT05020392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287078|NCT05020392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25287079|NCT05020392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25287080|NCT05020392|Alkylating Agents|alkylating agents|mesh-ancestor
25287081|NCT05020392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287082|NCT05020392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693146|NCT02008942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25287083|NCT05020392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25287084|NCT05020392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25287085|NCT05020392|Antimetabolites|antimetabolites|mesh-ancestor
25287086|NCT05020392|Antiviral Agents|antiviral agents|mesh-ancestor
25287087|NCT05020392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25287088|NCT05018221|Vitamins|vitamins|mesh-list
25287089|NCT05018221|Vitamin K|vitamin k|mesh-list
25287091|NCT05018221|Sodium thiosulfate|sodium thiosulfate|mesh-list
25287092|NCT05018221|Magnesium citrate|magnesium citrate|mesh-list
25287093|NCT05018221|Citric Acid|citric acid|mesh-list
25287094|NCT05018221|Sodium Citrate|sodium citrate|mesh-list
25287095|NCT05018221|Micronutrients|micronutrients|mesh-ancestor
25287096|NCT05018221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287097|NCT05018221|Anticoagulants|anticoagulants|mesh-ancestor
25287098|NCT05018221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25287099|NCT05018221|Chelating Agents|chelating agents|mesh-ancestor
25287100|NCT05018221|Sequestering Agents|sequestering agents|mesh-ancestor
25287101|NCT05018221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287102|NCT05018221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25287103|NCT05018221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25287104|NCT05018221|Hemostatics|hemostatics|mesh-ancestor
25287105|NCT05018221|Coagulants|coagulants|mesh-ancestor
25287106|NCT05018221|Antidotes|antidotes|mesh-ancestor
25287107|NCT05018221|Protective Agents|protective agents|mesh-ancestor
25287108|NCT05018221|Antioxidants|antioxidants|mesh-ancestor
25287109|NCT05018221|Antitubercular Agents|antitubercular agents|mesh-ancestor
25287110|NCT05018221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25045201|NCT00986882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25045202|NCT00986882|Analgesics|analgesics|mesh-ancestor
25045203|NCT00986882|Sensory System Agents|sensory system agents|mesh-ancestor
25045204|NCT00986882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045205|NCT00986882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045206|NCT00986882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25045207|NCT00986882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25045208|NCT00986882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25045209|NCT00986882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045210|NCT00986882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045211|NCT00983814|Carbidopa|carbidopa|mesh-list
25045212|NCT00983814|Droxidopa|droxidopa|mesh-list
25045213|NCT00983814|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25045214|NCT00983814|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25045215|NCT00983814|Dopamine Agents|dopamine agents|mesh-ancestor
25045216|NCT00983814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25045217|NCT00983814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045218|NCT00983814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045219|NCT00983814|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25045220|NCT00983814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045221|NCT00982696|Analgesics, Opioid|analgesics, opioid|mesh-list
25045222|NCT00982696|Mitogens|mitogens|mesh-list
25045223|NCT00982696|Enkephalins|enkephalins|mesh-list
25045224|NCT00982696|Opioid Peptides|opioid peptides|mesh-list
25045225|NCT00982696|Narcotics|narcotics|mesh-ancestor
25045226|NCT00982696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25045227|NCT00982696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045304|NCT00969722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045306|NCT00968942|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25045307|NCT00968942|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25045308|NCT00968942|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25045309|NCT00968942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25045310|NCT00968942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045311|NCT00968942|Cholinergic Agents|cholinergic agents|mesh-ancestor
25045312|NCT00968942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25287111|NCT05018221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25287112|NCT05018221|Cathartics|cathartics|mesh-ancestor
25287113|NCT05018221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25287114|NCT05016947|Dexamethasone|dexamethasone|mesh-list
25287115|NCT05016947|Venetoclax|venetoclax|mesh-list
25287116|NCT05016947|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25287117|NCT05016947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25287118|NCT05016947|Antiemetics|antiemetics|mesh-ancestor
25287119|NCT05016947|Autonomic Agents|autonomic agents|mesh-ancestor
25287120|NCT05016947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25287121|NCT05016947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287122|NCT05016947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25287123|NCT05016947|Glucocorticoids|glucocorticoids|mesh-ancestor
25287124|NCT05016947|Hormones|hormones|mesh-ancestor
25287125|NCT05016947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25287126|NCT05016947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25287127|NCT05016947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25287128|NCT05016947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25287129|NCT05016947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25287131|NCT05013242|Dienogest|dienogest|mesh-list
25287132|NCT05013242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25287133|NCT05013242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25287134|NCT05013242|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25287135|NCT05013242|Contraceptive Agents|contraceptive agents|mesh-ancestor
25287136|NCT05013242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25287137|NCT05013242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287138|NCT05013242|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25045315|NCT00968942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045316|NCT00968825|Botulinum Toxins|botulinum toxins|mesh-list
25045317|NCT00968825|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25045318|NCT00968825|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25045319|NCT00968825|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25045320|NCT00968825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25045321|NCT00968825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045322|NCT00968825|Cholinergic Agents|cholinergic agents|mesh-ancestor
25045323|NCT00968825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25045324|NCT00968825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045325|NCT00968825|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25045326|NCT00968825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045327|NCT00966953|Honokiol|honokiol|mesh-list
25045328|NCT00966953|Triclosan|triclosan|mesh-list
25045329|NCT00966953|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25045330|NCT00966953|Fluorides|fluorides|mesh-list
25045331|NCT00966953|Cariostatic Agents|cariostatic agents|mesh-ancestor
25045332|NCT00966953|Protective Agents|protective agents|mesh-ancestor
25045333|NCT00966953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045334|NCT00966953|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25045335|NCT00966953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25045336|NCT00966953|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25045338|NCT00966953|Antimetabolites|antimetabolites|mesh-ancestor
25045339|NCT00966953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287149|NCT05008510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25287150|NCT05008510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25287151|NCT05008510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287152|NCT05008510|Immunologic Factors|immunologic factors|mesh-ancestor
25287153|NCT05008510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287165|NCT04951050|Sirolimus|sirolimus|mesh-list
25287166|NCT04951050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25287167|NCT04951050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25287168|NCT04951050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25287169|NCT04951050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25287170|NCT04951050|Antifungal Agents|antifungal agents|mesh-ancestor
25287171|NCT04951050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25287172|NCT04951050|Immunologic Factors|immunologic factors|mesh-ancestor
25287173|NCT04951050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287177|NCT04930549|Dapagliflozin|dapagliflozin|mesh-list
25287178|NCT04930549|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25287179|NCT04930549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287180|NCT04930549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25287181|NCT04930549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045489|NCT00945802|Antiemetics|antiemetics|mesh-ancestor
25045490|NCT00945802|Autonomic Agents|autonomic agents|mesh-ancestor
25045491|NCT00945802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045492|NCT00945802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045493|NCT00945802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25114840|NCT03120221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25114841|NCT03120221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25114842|NCT03120221|Trace Elements|trace elements|mesh-ancestor
25114843|NCT03120221|Micronutrients|micronutrients|mesh-ancestor
25114844|NCT03120221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25114845|NCT03120234|Fentanyl|fentanyl|mesh-list
25114846|NCT03120234|Dexmedetomidine|dexmedetomidine|mesh-list
25114847|NCT03120234|Ketamine|ketamine|mesh-list
25114848|NCT03120234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25114852|NCT03120234|Analgesics|analgesics|mesh-ancestor
25287210|NCT04861558|Fluorouracil|fluorouracil|mesh-list
25287211|NCT04861558|Oxaliplatin|oxaliplatin|mesh-list
25287212|NCT04861558|Irinotecan|irinotecan|mesh-list
25287213|NCT04861558|Antimetabolites|antimetabolites|mesh-ancestor
25287214|NCT04861558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287215|NCT04861558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25287216|NCT04861558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25287217|NCT04861558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25287218|NCT04861558|Immunologic Factors|immunologic factors|mesh-ancestor
25287219|NCT04861558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287220|NCT04861558|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25287221|NCT04861558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25287222|NCT04861558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25287224|NCT04837235|Dermatologic Agents|dermatologic agents|mesh-ancestor
25287225|NCT04837235|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25287226|NCT04837235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25287227|NCT04837235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25287228|NCT04837235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287229|NCT04775550|Dexamethasone|dexamethasone|mesh-list
25287230|NCT04775550|Lenalidomide|lenalidomide|mesh-list
25287231|NCT04775550|Bortezomib|bortezomib|mesh-list
25287232|NCT04775550|Daratumumab|daratumumab|mesh-list
25287233|NCT04775550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25287234|NCT04775550|Antiemetics|antiemetics|mesh-ancestor
25287235|NCT04775550|Autonomic Agents|autonomic agents|mesh-ancestor
25287236|NCT04775550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25114853|NCT03120234|Sensory System Agents|sensory system agents|mesh-ancestor
25114854|NCT03120234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25114855|NCT03120234|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25114856|NCT03120234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25114857|NCT03120234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25114858|NCT03120234|Adrenergic Agents|adrenergic agents|mesh-ancestor
25114859|NCT03120234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24820913|NCT02102633|Dabigatran|dabigatran|mesh-list
25114860|NCT03120234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25114861|NCT03120234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25114862|NCT03120234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25114863|NCT03120234|Anesthetics, General|anesthetics, general|mesh-ancestor
25114864|NCT03120234|Anesthetics|anesthetics|mesh-ancestor
25114865|NCT03120234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25114866|NCT03120234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25114867|NCT03120234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25114868|NCT03120234|Narcotics|narcotics|mesh-ancestor
25114869|NCT03120234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25114871|NCT03119857|Androgen Antagonists|androgen antagonists|mesh-list
25114872|NCT03119857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25114873|NCT03119857|Tubulin Modulators|tubulin modulators|mesh-ancestor
25114874|NCT03119857|Antimitotic Agents|antimitotic agents|mesh-ancestor
25114875|NCT03119857|Mitosis Modulators|mitosis modulators|mesh-ancestor
25114876|NCT03119857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893140|NCT04453371|Plasminogen|plasminogen|mesh-list
25114877|NCT03119857|Hormone Antagonists|hormone antagonists|mesh-ancestor
25114878|NCT03119857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25114879|NCT03119857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25114880|NCT03120182|Aspirin|aspirin|mesh-list
25114881|NCT03120182|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25114882|NCT03120182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25114883|NCT03120182|Analgesics|analgesics|mesh-ancestor
25114884|NCT03120182|Sensory System Agents|sensory system agents|mesh-ancestor
25114885|NCT03120182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25114886|NCT03120182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25114887|NCT03120182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24708873|NCT01503372|Protective Agents|protective agents|mesh-ancestor
25287237|NCT04775550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287238|NCT04775550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25287239|NCT04775550|Glucocorticoids|glucocorticoids|mesh-ancestor
25287240|NCT04775550|Hormones|hormones|mesh-ancestor
25287241|NCT04775550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25287242|NCT04775550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25287243|NCT04775550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25287244|NCT04775550|Immunologic Factors|immunologic factors|mesh-ancestor
25287245|NCT04775550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25287246|NCT04775550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25287247|NCT04775550|Growth Substances|growth substances|mesh-ancestor
25287248|NCT04775550|Growth Inhibitors|growth inhibitors|mesh-ancestor
25287249|NCT04771962|Sevoflurane|sevoflurane|mesh-list
25287250|NCT04771962|Desflurane|desflurane|mesh-list
25287251|NCT04771962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25287252|NCT04771962|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24609551|NCT00997191|Glucocorticoids|glucocorticoids|mesh-ancestor
25287253|NCT04771962|Anesthetics, General|anesthetics, general|mesh-ancestor
25287254|NCT04771962|Anesthetics|anesthetics|mesh-ancestor
25287255|NCT04771962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25287256|NCT04771962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287257|NCT04764097|Dapagliflozin|dapagliflozin|mesh-list
25287258|NCT04764097|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25287259|NCT04764097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287260|NCT04764097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25287261|NCT04764097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25114888|NCT03120182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25114889|NCT03120182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25114890|NCT03120182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25114891|NCT03120182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25114936|NCT03119714|Histamine Agents|histamine agents|mesh-ancestor
25114892|NCT03120182|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25114893|NCT03120182|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25114894|NCT03120182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25114895|NCT03120182|Antipyretics|antipyretics|mesh-ancestor
25114896|NCT03119948|Botulinum Toxins|botulinum toxins|mesh-list
25114897|NCT03119948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25114898|NCT03119948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25114899|NCT03119948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25114900|NCT03119948|Cholinergic Agents|cholinergic agents|mesh-ancestor
25114901|NCT03119948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25114902|NCT03119948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25114903|NCT03119532|Metronidazole|metronidazole|mesh-list
25114904|NCT03119532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25114905|NCT03119532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25114906|NCT03119532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25114907|NCT03119532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25114908|NCT03119623|Valsartan|valsartan|mesh-list
25114909|NCT03119623|Enalapril|enalapril|mesh-list
25114910|NCT03119623|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25114911|NCT03119623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25114912|NCT03119623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25114913|NCT03119623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25114914|NCT03119623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287262|NCT04726098|Dexamethasone|dexamethasone|mesh-list
25287263|NCT04726098|Dexamethasone acetate|dexamethasone acetate|mesh-list
25287264|NCT04726098|BB 1101|bb 1101|mesh-list
25287265|NCT04726098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25287266|NCT04726098|Antiemetics|antiemetics|mesh-ancestor
25287267|NCT04726098|Autonomic Agents|autonomic agents|mesh-ancestor
25287268|NCT04726098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25287269|NCT04726098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287270|NCT04726098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25287271|NCT04726098|Glucocorticoids|glucocorticoids|mesh-ancestor
25287272|NCT04726098|Hormones|hormones|mesh-ancestor
25287273|NCT04726098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25287274|NCT04726098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25287275|NCT04726098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25287276|NCT04726098|Protease Inhibitors|protease inhibitors|mesh-ancestor
25287277|NCT04726098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25287278|NCT04726098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287279|NCT04699071|Pembrolizumab|pembrolizumab|mesh-list
25287280|NCT04699071|Lenvatinib|lenvatinib|mesh-list
25287281|NCT04699071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25287282|NCT04699071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25287283|NCT04699071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25287284|NCT04699071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25287285|NCT04699071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287286|NCT04648189|Cetuximab|cetuximab|mesh-list
25287287|NCT04648189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25287288|NCT04648189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25287289|NCT04643249|Repaglinide|repaglinide|mesh-list
25287290|NCT04643249|Flurbiprofen|flurbiprofen|mesh-list
25287291|NCT04643249|Midazolam|midazolam|mesh-list
25287292|NCT04643249|Dextromethorphan|dextromethorphan|mesh-list
25287293|NCT04643249|Caffeine|caffeine|mesh-list
25287294|NCT04643249|Bupropion|bupropion|mesh-list
25287295|NCT04643249|Omeprazole|omeprazole|mesh-list
25287296|NCT04643249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25287297|NCT04643249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25287298|NCT04643249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25287299|NCT04643249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287300|NCT04643249|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24764226|NCT01780233|Fentanyl|fentanyl|mesh-list
25287301|NCT04643249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25287302|NCT04643249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25287303|NCT04643249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25287304|NCT04643249|Anesthetics, General|anesthetics, general|mesh-ancestor
25287305|NCT04643249|Anesthetics|anesthetics|mesh-ancestor
25287306|NCT04643249|GABA Modulators|gaba modulators|mesh-ancestor
25287307|NCT04643249|GABA Agents|gaba agents|mesh-ancestor
25287308|NCT04643249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25114930|NCT03119636|Dopamine Agents|dopamine agents|mesh-ancestor
25114931|NCT03119636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25114932|NCT03119636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25114933|NCT03119636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25114935|NCT03119714|Histamine Antagonists|histamine antagonists|mesh-ancestor
25114937|NCT03119714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25114938|NCT03119714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25114939|NCT03119714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25114940|NCT03119428|Nivolumab|nivolumab|mesh-list
25114941|NCT03119428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25114942|NCT03119428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25114943|NCT03119428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25114944|NCT03119428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25114945|NCT03119116|Rivaroxaban|rivaroxaban|mesh-list
25114946|NCT03119116|Apixaban|apixaban|mesh-list
25114947|NCT03119116|Dabigatran|dabigatran|mesh-list
25114948|NCT03119116|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25114949|NCT03119116|Antithrombins|antithrombins|mesh-ancestor
25114950|NCT03119116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25114951|NCT03119116|Protease Inhibitors|protease inhibitors|mesh-ancestor
25114952|NCT03119116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609939|NCT00999206|Vaccines|vaccines|mesh-list
24610060|NCT00999700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610061|NCT00999700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24610062|NCT00999739|Vaccines|vaccines|mesh-list
25114953|NCT03119116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708874|NCT01503372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708875|NCT01503372|Vitamin B Complex|vitamin b complex|mesh-ancestor
24708876|NCT01503372|Vitamins|vitamins|mesh-ancestor
24708877|NCT01503372|Micronutrients|micronutrients|mesh-ancestor
24708878|NCT01503385|Celecoxib|celecoxib|mesh-list
24708879|NCT01503385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24708880|NCT01503385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24708913|NCT01503424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24708914|NCT01503424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24708915|NCT01503424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24708916|NCT01503424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24708917|NCT01503424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24708918|NCT01503424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24708919|NCT01503424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24708940|NCT01503450|Antiemetics|antiemetics|mesh-ancestor
24708941|NCT01503450|Autonomic Agents|autonomic agents|mesh-ancestor
24708942|NCT01503450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24708943|NCT01503450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708944|NCT01503450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24708945|NCT01503450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24708946|NCT01503450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24708947|NCT01503450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24708948|NCT01503450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24708949|NCT01503450|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24645030|NCT01194882|Insulin|insulin|mesh-list
25287309|NCT04643249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287310|NCT04643249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25287311|NCT04643249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25287312|NCT04643249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25287313|NCT04643249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25287314|NCT04643249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25287315|NCT04643249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25287316|NCT04643249|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25287317|NCT04643249|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25287318|NCT04643249|Purinergic Agents|purinergic agents|mesh-ancestor
25287319|NCT04643249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25287320|NCT04643249|Antidepressive Agents|antidepressive agents|mesh-ancestor
25287321|NCT04643249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25693147|NCT02008942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25287322|NCT04643249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25287323|NCT04643249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25287324|NCT04643249|Dopamine Agents|dopamine agents|mesh-ancestor
25287325|NCT04643249|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25287326|NCT04643249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25287327|NCT04643249|Antitussive Agents|antitussive agents|mesh-ancestor
25287328|NCT04643249|Respiratory System Agents|respiratory system agents|mesh-ancestor
25287329|NCT04643249|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25287330|NCT04643249|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25045580|NCT00944294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045581|NCT00939276|Nepafenac|nepafenac|mesh-list
25045582|NCT00939276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25045583|NCT00939276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25045594|NCT00938652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25045595|NCT00938652|Antimetabolites|antimetabolites|mesh-ancestor
25045596|NCT00938652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045597|NCT00938652|Antiviral Agents|antiviral agents|mesh-ancestor
25045598|NCT00938652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25045599|NCT00938652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045600|NCT00938652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25045601|NCT00938652|Immunologic Factors|immunologic factors|mesh-ancestor
25045602|NCT00938652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045603|NCT00938652|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25045604|NCT00938587|Prednisone|prednisone|mesh-list
25045605|NCT00938587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25287331|NCT04643249|Analgesics|analgesics|mesh-ancestor
25287332|NCT04643249|Sensory System Agents|sensory system agents|mesh-ancestor
25287333|NCT04643249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25287334|NCT04643249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25287335|NCT04643249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25287336|NCT04643249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25287337|NCT04643249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25287338|NCT04643249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25287339|NCT04643249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25287340|NCT04558294|Ketanserin|ketanserin|mesh-list
25287341|NCT04558294|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
25287342|NCT04558294|Hallucinogens|hallucinogens|mesh-ancestor
25287343|NCT04558294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287344|NCT04558294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25287345|NCT04558294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25287346|NCT04558294|Serotonin Agents|serotonin agents|mesh-ancestor
25287347|NCT04558294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25287348|NCT04558294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287349|NCT04558294|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25287350|NCT04558294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25287351|NCT04558294|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25287357|NCT04537897|Midazolam|midazolam|mesh-list
25287358|NCT04537897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25287359|NCT04537897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25287360|NCT04537897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25287361|NCT04537897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287362|NCT04537897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25287363|NCT04537897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25287364|NCT04537897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25287365|NCT04537897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25287366|NCT04537897|Anesthetics, General|anesthetics, general|mesh-ancestor
25287367|NCT04537897|Anesthetics|anesthetics|mesh-ancestor
25287368|NCT04537897|GABA Modulators|gaba modulators|mesh-ancestor
25287369|NCT04537897|GABA Agents|gaba agents|mesh-ancestor
25287370|NCT04537897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25287371|NCT04537897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287378|NCT04507581|Anesthetics|anesthetics|mesh-list
25287379|NCT04507581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24888450|NCT04505228|Cholinergic Agents|cholinergic agents|mesh-ancestor
24888451|NCT04505228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25114970|NCT03119194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25114971|NCT03119194|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25114972|NCT03119194|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25114973|NCT03119038|Ketorolac|ketorolac|mesh-list
25114987|NCT03119038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25114988|NCT03119038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25114989|NCT03119038|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25114990|NCT03119038|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24764382|NCT01780948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24764383|NCT01780948|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24764384|NCT01780948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764385|NCT01780948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24764386|NCT01780948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24764387|NCT01780948|Immunologic Factors|immunologic factors|mesh-ancestor
25114991|NCT03119038|Autonomic Agents|autonomic agents|mesh-ancestor
25114992|NCT03119038|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25114993|NCT03119038|Respiratory System Agents|respiratory system agents|mesh-ancestor
25114994|NCT03119038|Mydriatics|mydriatics|mesh-ancestor
25114995|NCT03119038|Sympathomimetics|sympathomimetics|mesh-ancestor
25287380|NCT04507581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287381|NCT04507438|Donepezil|donepezil|mesh-list
25114996|NCT03119038|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25114997|NCT03119038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25114998|NCT03119038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25114999|NCT03119038|Analgesics|analgesics|mesh-ancestor
25115000|NCT03119038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25115001|NCT03119038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25287382|NCT04507438|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25287383|NCT04507438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25287384|NCT04507438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287385|NCT04507438|Cholinergic Agents|cholinergic agents|mesh-ancestor
25287386|NCT04507438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25287387|NCT04507438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287388|NCT04507438|Nootropic Agents|nootropic agents|mesh-ancestor
25287389|NCT04505670|Donepezil|donepezil|mesh-list
25287390|NCT04505670|Zinc Oxide|zinc oxide|mesh-list
25287391|NCT04505670|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25287392|NCT04505670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25287393|NCT04505670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287394|NCT04505670|Cholinergic Agents|cholinergic agents|mesh-ancestor
25287395|NCT04505670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25287396|NCT04505670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287397|NCT04505670|Nootropic Agents|nootropic agents|mesh-ancestor
25287398|NCT04505670|Dermatologic Agents|dermatologic agents|mesh-ancestor
25287399|NCT04505670|Sunscreening Agents|sunscreening agents|mesh-ancestor
25287400|NCT04505670|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25287401|NCT04505670|Protective Agents|protective agents|mesh-ancestor
25287414|NCT04405063|Paclitaxel|paclitaxel|mesh-list
25287415|NCT04405063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25287416|NCT04405063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25287417|NCT04405063|Tubulin Modulators|tubulin modulators|mesh-ancestor
25287418|NCT04405063|Antimitotic Agents|antimitotic agents|mesh-ancestor
25287419|NCT04405063|Mitosis Modulators|mitosis modulators|mesh-ancestor
25115009|NCT03119324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25115010|NCT03119324|Analgesics|analgesics|mesh-ancestor
25115011|NCT03119324|Sensory System Agents|sensory system agents|mesh-ancestor
25115012|NCT03119324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25115013|NCT03119324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115014|NCT03119324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25115015|NCT03119324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25115016|NCT03119324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25115062|NCT03118713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115063|NCT03118713|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25115064|NCT03118713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25115065|NCT03118713|Immunologic Factors|immunologic factors|mesh-ancestor
25115066|NCT03118713|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25115067|NCT03118713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115069|NCT03118479|Testosterone|testosterone|mesh-list
25287420|NCT04405063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287421|NCT04362566|Bupivacaine|bupivacaine|mesh-list
25287422|NCT04362566|Anesthetics, Local|anesthetics, local|mesh-ancestor
25287423|NCT04362566|Anesthetics|anesthetics|mesh-ancestor
25287424|NCT04362566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25287425|NCT04362566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287426|NCT04362566|Sensory System Agents|sensory system agents|mesh-ancestor
25287427|NCT04362566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25693148|NCT02008942|Antipyretics|antipyretics|mesh-ancestor
25693149|NCT02009163|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25693150|NCT02009163|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25693151|NCT02009163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693152|NCT02009163|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25693153|NCT02009163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25287428|NCT04354649|Hydroxychloroquine|hydroxychloroquine|mesh-list
25287429|NCT04354649|Antimalarials|antimalarials|mesh-ancestor
25287430|NCT04354649|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25287431|NCT04354649|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25287432|NCT04354649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25287433|NCT04354649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25287434|NCT04354649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287435|NCT04354649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25287436|NCT04335084|Vitamin D|vitamin d|mesh-list
25287437|NCT04335084|Vitamins|vitamins|mesh-list
25287438|NCT04335084|Ascorbic Acid|ascorbic acid|mesh-list
25287439|NCT04335084|Hydroxychloroquine|hydroxychloroquine|mesh-list
25287440|NCT04335084|Micronutrients|micronutrients|mesh-ancestor
25287441|NCT04335084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287442|NCT04335084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25287443|NCT04335084|Antimalarials|antimalarials|mesh-ancestor
25287444|NCT04335084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25287445|NCT04335084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25287446|NCT04335084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25287447|NCT04335084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25287448|NCT04335084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287449|NCT04335084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25287450|NCT04335084|Antioxidants|antioxidants|mesh-ancestor
25287451|NCT04335084|Protective Agents|protective agents|mesh-ancestor
25115085|NCT03118336|Empagliflozin|empagliflozin|mesh-list
25115086|NCT03118336|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25115087|NCT03118336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115088|NCT03118336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25115089|NCT03118336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115090|NCT03118167|Antioxidants|antioxidants|mesh-list
25115091|NCT03118167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115092|NCT03118167|Protective Agents|protective agents|mesh-ancestor
25115093|NCT03118167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115094|NCT03118037|Zaleplon|zaleplon|mesh-list
25115100|NCT03118037|GABA Agents|gaba agents|mesh-ancestor
25115101|NCT03118037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25115102|NCT03118037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115103|NCT03118076|Dexmedetomidine|dexmedetomidine|mesh-list
25115104|NCT03118076|Ropivacaine|ropivacaine|mesh-list
25115105|NCT03118076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25115106|NCT03118076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25115107|NCT03118076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115108|NCT03118076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25115109|NCT03118076|Analgesics|analgesics|mesh-ancestor
25115110|NCT03118076|Sensory System Agents|sensory system agents|mesh-ancestor
25115111|NCT03118076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25115112|NCT03118076|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25115113|NCT03118076|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25115114|NCT03118076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25115115|NCT03118076|Adrenergic Agents|adrenergic agents|mesh-ancestor
25115116|NCT03118076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25115117|NCT03118076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115120|NCT03118128|Metformin|metformin|mesh-list
25115123|NCT03117790|Dexmedetomidine|dexmedetomidine|mesh-list
25115124|NCT03117790|Morphine|morphine|mesh-list
25115125|NCT03117790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25115126|NCT03117790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25115127|NCT03117790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115128|NCT03117790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25115129|NCT03117790|Analgesics|analgesics|mesh-ancestor
25115130|NCT03117790|Sensory System Agents|sensory system agents|mesh-ancestor
24853867|NCT02270788|Sorafenib|sorafenib|mesh-list
25115131|NCT03117790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25115132|NCT03117790|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24998066|NCT03841565|Glucocorticoids|glucocorticoids|mesh-ancestor
25115133|NCT03117790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25115134|NCT03117790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25115135|NCT03117790|Adrenergic Agents|adrenergic agents|mesh-ancestor
25115136|NCT03117790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25115137|NCT03117790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115138|NCT03117790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25115139|NCT03117790|Narcotics|narcotics|mesh-ancestor
25115140|NCT03117894|Acetaminophen|acetaminophen|mesh-list
25115142|NCT03117894|Morphine|morphine|mesh-list
25115143|NCT03117894|Remifentanil|remifentanil|mesh-list
25115144|NCT03117894|Ondansetron|ondansetron|mesh-list
25115145|NCT03117894|Propofol|propofol|mesh-list
25115146|NCT03117894|Ropivacaine|ropivacaine|mesh-list
25115147|NCT03117894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25115148|NCT03117894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25115149|NCT03117894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115150|NCT03117894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25115151|NCT03117894|Anesthetics, General|anesthetics, general|mesh-ancestor
25115152|NCT03117894|Anesthetics|anesthetics|mesh-ancestor
25115153|NCT03117894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25115154|NCT03117894|Narcotics|narcotics|mesh-ancestor
25115155|NCT03117894|Analgesics|analgesics|mesh-ancestor
25115156|NCT03117894|Sensory System Agents|sensory system agents|mesh-ancestor
25115157|NCT03117894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25287469|NCT04240288|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25287470|NCT04240288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25287471|NCT04240288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25287472|NCT04240288|Antitubercular Agents|antitubercular agents|mesh-ancestor
25287473|NCT04122196|Pregabalin|pregabalin|mesh-list
25287474|NCT04122196|Analgesics|analgesics|mesh-ancestor
25287475|NCT04122196|Sensory System Agents|sensory system agents|mesh-ancestor
25287476|NCT04122196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25287477|NCT04122196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287478|NCT04122196|Anticonvulsants|anticonvulsants|mesh-ancestor
25287479|NCT04122196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25287480|NCT04122196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25287487|NCT04094012|Isoniazid|isoniazid|mesh-list
25287488|NCT04094012|Rifapentine|rifapentine|mesh-list
25287489|NCT04094012|Antitubercular Agents|antitubercular agents|mesh-ancestor
25287490|NCT04094012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25287491|NCT04094012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24420580|NCT00216372|Lanreotide|lanreotide|mesh-list
25287492|NCT04094012|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25287493|NCT04094012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25287494|NCT04094012|Antimetabolites|antimetabolites|mesh-ancestor
25287495|NCT04094012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287496|NCT04094012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25287497|NCT04094012|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25287498|NCT04094012|Leprostatic Agents|leprostatic agents|mesh-ancestor
25287499|NCT04076761|Trifluridine|trifluridine|mesh-list
25287500|NCT04076761|Antimetabolites|antimetabolites|mesh-ancestor
25287501|NCT04076761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287502|NCT04076761|Antiviral Agents|antiviral agents|mesh-ancestor
25287503|NCT04076761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25115166|NCT03117894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25115167|NCT03117894|Serotonin Agents|serotonin agents|mesh-ancestor
25115168|NCT03117894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25115169|NCT03117894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115170|NCT03117894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25115171|NCT03117894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25115172|NCT03117894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25115173|NCT03117894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25115174|NCT03117894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25115175|NCT03117894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25115176|NCT03117894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25115177|NCT03117894|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25115178|NCT03117894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25115179|NCT03117894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25115180|NCT03117660|Vitamin A|vitamin a|mesh-list
25115181|NCT03117660|Vitamins|vitamins|mesh-ancestor
25115182|NCT03117660|Micronutrients|micronutrients|mesh-ancestor
25115183|NCT03117660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115184|NCT03117972|Leucovorin|leucovorin|mesh-list
25115185|NCT03117972|Bevacizumab|bevacizumab|mesh-list
25115186|NCT03117972|Fluorouracil|fluorouracil|mesh-list
25115187|NCT03117972|Capecitabine|capecitabine|mesh-list
25115188|NCT03117972|Oxaliplatin|oxaliplatin|mesh-list
25115189|NCT03117972|Irinotecan|irinotecan|mesh-list
25115190|NCT03117972|Levoleucovorin|levoleucovorin|mesh-list
25115191|NCT03117972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25115192|NCT03117972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25115193|NCT03117972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25115194|NCT03117972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25287511|NCT04021381|Magnesium citrate|magnesium citrate|mesh-list
25287512|NCT04021381|Cathartics|cathartics|mesh-ancestor
25287513|NCT04021381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25287514|NCT03970304|Vaccines|vaccines|mesh-list
25287515|NCT03970304|Immunologic Factors|immunologic factors|mesh-ancestor
25287516|NCT03970304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287517|NCT03966053|Trifluoperazine|trifluoperazine|mesh-list
25287518|NCT03966053|Antiemetics|antiemetics|mesh-ancestor
25287519|NCT03966053|Autonomic Agents|autonomic agents|mesh-ancestor
25287520|NCT03966053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25287521|NCT03966053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287522|NCT03966053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25287523|NCT03966053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25287524|NCT03966053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25287525|NCT03966053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25287526|NCT03966053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24456653|NCT00331890|Choline|choline|mesh-list
25287527|NCT03966053|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25287528|NCT03966053|Dopamine Agents|dopamine agents|mesh-ancestor
25287543|NCT03898154|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25287544|NCT03898154|Prednisolone|prednisolone|mesh-list
25287545|NCT03898154|Prednisolone acetate|prednisolone acetate|mesh-list
25287546|NCT03898154|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25287547|NCT03898154|Prednisolone phosphate|prednisolone phosphate|mesh-list
25287548|NCT03898154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25287549|NCT03898154|Antiemetics|antiemetics|mesh-ancestor
25287550|NCT03898154|Autonomic Agents|autonomic agents|mesh-ancestor
25115478|NCT03116295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25287551|NCT03898154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25287552|NCT03898154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287553|NCT03898154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25287554|NCT03898154|Glucocorticoids|glucocorticoids|mesh-ancestor
25287555|NCT03898154|Hormones|hormones|mesh-ancestor
25287556|NCT03898154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25115214|NCT03117920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115215|NCT03117920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25115216|NCT03117855|Capecitabine|capecitabine|mesh-list
25115217|NCT03117855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25115218|NCT03117855|Antimetabolites|antimetabolites|mesh-ancestor
25115219|NCT03117855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115220|NCT03117855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25115221|NCT03117998|Volagidemab|volagidemab|mesh-list
25115222|NCT03117998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25115223|NCT03117998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115224|NCT03117595|Fentanyl|fentanyl|mesh-list
25115225|NCT03117595|Morphine|morphine|mesh-list
25115226|NCT03117595|Bupivacaine|bupivacaine|mesh-list
25115227|NCT03117595|Anesthetics, Local|anesthetics, local|mesh-ancestor
25115228|NCT03117595|Anesthetics|anesthetics|mesh-ancestor
25115229|NCT03117595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25115230|NCT03117595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115231|NCT03117595|Sensory System Agents|sensory system agents|mesh-ancestor
25115232|NCT03117595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25115233|NCT03117595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25115234|NCT03117595|Narcotics|narcotics|mesh-ancestor
25115235|NCT03117595|Analgesics|analgesics|mesh-ancestor
25115236|NCT03117595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25115237|NCT03117595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25115238|NCT03117595|Anesthetics, General|anesthetics, general|mesh-ancestor
25115239|NCT03117335|Endostatins|endostatins|mesh-list
25115240|NCT03117335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25115241|NCT03117335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25115242|NCT03117335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25115243|NCT03117335|Growth Substances|growth substances|mesh-ancestor
25115244|NCT03117335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115245|NCT03117335|Growth Inhibitors|growth inhibitors|mesh-ancestor
25115246|NCT03117439|Antifungal Agents|antifungal agents|mesh-list
25115247|NCT03117439|Clotrimazole|clotrimazole|mesh-list
25115248|NCT03117439|Miconazole|miconazole|mesh-list
25115249|NCT03117439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25115250|NCT03117439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24889325|NCT04494321|Hormones|hormones|mesh-ancestor
24708950|NCT01503450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25287557|NCT03898154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25287558|NCT03898154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25287559|NCT03898154|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25287560|NCT03898154|Protective Agents|protective agents|mesh-ancestor
25287561|NCT03857087|Edetic Acid|edetic acid|mesh-list
25287562|NCT03857087|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25287563|NCT03857087|Chelating Agents|chelating agents|mesh-ancestor
25287564|NCT03857087|Sequestering Agents|sequestering agents|mesh-ancestor
25287565|NCT03857087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287566|NCT03857087|Anticoagulants|anticoagulants|mesh-ancestor
25287567|NCT03857087|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25287568|NCT03857087|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25287569|NCT03845140|Praziquantel|praziquantel|mesh-list
25287570|NCT03845140|Anthelmintics|anthelmintics|mesh-ancestor
25287571|NCT03845140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25287572|NCT03845140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25287574|NCT03827447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25287575|NCT03827447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25287576|NCT03823521|Cardioplegic Solutions|cardioplegic solutions|mesh-list
25287577|NCT03823521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25287578|NCT03727724|Cetuximab|cetuximab|mesh-list
25287579|NCT03727724|Afatinib|afatinib|mesh-list
25287580|NCT03727724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25287581|NCT03727724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25287582|NCT03727724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25287583|NCT03727724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25287584|NCT03727724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287585|NCT03697031|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25287586|NCT03697031|Hormones|hormones|mesh-ancestor
25287587|NCT03697031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25287588|NCT03697031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287589|NCT03672487|Benzonidazole|benzonidazole|mesh-list
25287590|NCT03672487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25287591|NCT03672487|Immunologic Factors|immunologic factors|mesh-ancestor
25287592|NCT03672487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287593|NCT03672487|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25115251|NCT03117439|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25115252|NCT03117439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25115253|NCT03117439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25115254|NCT03117439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115255|NCT03117439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25115256|NCT03117439|Hormone Antagonists|hormone antagonists|mesh-ancestor
25115257|NCT03117439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25115258|NCT03117439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115259|NCT03117439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25115260|NCT03117439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25115262|NCT03117530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25115263|NCT03117530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25115264|NCT03117725|Melatonin|melatonin|mesh-list
25115265|NCT03117725|Antioxidants|antioxidants|mesh-ancestor
25115266|NCT03117725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115267|NCT03117725|Protective Agents|protective agents|mesh-ancestor
25115268|NCT03117725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115269|NCT03117725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25115270|NCT03117257|Cisplatin|cisplatin|mesh-list
25115271|NCT03117257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25115272|NCT03117192|Zinc Sulfate|zinc sulfate|mesh-list
25115273|NCT03117192|Astringents|astringents|mesh-ancestor
25115274|NCT03117192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115275|NCT03117192|Dermatologic Agents|dermatologic agents|mesh-ancestor
25115276|NCT03117166|Lidocaine|lidocaine|mesh-list
25115277|NCT03117166|Anesthetics, Local|anesthetics, local|mesh-ancestor
25115278|NCT03117166|Anesthetics|anesthetics|mesh-ancestor
25115279|NCT03117166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25115280|NCT03117166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115281|NCT03117166|Sensory System Agents|sensory system agents|mesh-ancestor
25115282|NCT03117166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25115283|NCT03117166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25115284|NCT03117166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25115285|NCT03117166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24708951|NCT01503450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25287594|NCT03672487|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25287595|NCT03672487|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25287596|NCT03672487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25287597|NCT03644953|Hydroxyurea|hydroxyurea|mesh-list
25287598|NCT03644953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25287599|NCT03644953|Antisickling Agents|antisickling agents|mesh-ancestor
25287600|NCT03644953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25287601|NCT03644953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287602|NCT03644953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25287603|NCT03630835|Annexin A5|annexin a5|mesh-list
25287604|NCT03630835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25287605|NCT03630835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287606|NCT03541850|Ascorbic Acid|ascorbic acid|mesh-list
25287607|NCT03541850|Methyltestosterone|methyltestosterone|mesh-list
25287608|NCT03541850|Hormones|hormones|mesh-list
25287609|NCT03541850|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25287610|NCT03541850|Androgens|androgens|mesh-list
25287611|NCT03541850|Androgen Antagonists|androgen antagonists|mesh-list
25287612|NCT03541850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25287613|NCT03541850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287615|NCT03541850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287616|NCT03541850|Protective Agents|protective agents|mesh-ancestor
25287617|NCT03541850|Vitamins|vitamins|mesh-ancestor
25287618|NCT03541850|Micronutrients|micronutrients|mesh-ancestor
25287619|NCT03541850|Estrogens|estrogens|mesh-ancestor
25287620|NCT03541850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25287621|NCT03541850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25287622|NCT03541850|Anabolic Agents|anabolic agents|mesh-ancestor
25287623|NCT03541850|Hormone Antagonists|hormone antagonists|mesh-ancestor
25287624|NCT03474497|Pembrolizumab|pembrolizumab|mesh-list
25287625|NCT03474497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25287626|NCT03474497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25287627|NCT03469050|Rifaximin|rifaximin|mesh-list
25287628|NCT03469050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25287629|NCT03469050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25287630|NCT03469050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25062351|NCT04923659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25115286|NCT03117166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25115287|NCT03117166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115290|NCT03116971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25115291|NCT03116971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25115292|NCT03116971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25115312|NCT03117023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25115313|NCT03117023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115314|NCT03117062|Salicylic Acid|salicylic acid|mesh-list
25115315|NCT03117062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25115316|NCT03117062|Antifungal Agents|antifungal agents|mesh-ancestor
25115317|NCT03117062|Keratolytic Agents|keratolytic agents|mesh-ancestor
25115318|NCT03117062|Dermatologic Agents|dermatologic agents|mesh-ancestor
25115319|NCT03116893|Itraconazole|itraconazole|mesh-list
25115321|NCT03116893|Antifungal Agents|antifungal agents|mesh-ancestor
25115322|NCT03116893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25115323|NCT03116893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25115324|NCT03116893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25115325|NCT03116893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25115326|NCT03116893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115327|NCT03116893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25115328|NCT03116893|Hormone Antagonists|hormone antagonists|mesh-ancestor
25115329|NCT03116893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25287631|NCT03415061|Insulin|insulin|mesh-list
25287632|NCT03415061|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25287633|NCT03415061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25287634|NCT03415061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287635|NCT03403621|Pentamidine|pentamidine|mesh-list
25287636|NCT03403621|Antifungal Agents|antifungal agents|mesh-ancestor
25287637|NCT03403621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25287638|NCT03403621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25287639|NCT03403621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25287640|NCT03403621|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25287641|NCT03327844|Calcium, Dietary|calcium, dietary|mesh-list
25287642|NCT03327844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25287643|NCT03327844|Metronidazole|metronidazole|mesh-list
25287644|NCT03327844|Ciprofloxacin|ciprofloxacin|mesh-list
25287645|NCT03327844|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25287646|NCT03327844|Calcium|calcium|mesh-list
25287647|NCT03327844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25287648|NCT03327844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287649|NCT03327844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25287650|NCT03327844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25287651|NCT03327844|Antitubercular Agents|antitubercular agents|mesh-ancestor
25287652|NCT03327844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25287653|NCT03327844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25287654|NCT03327844|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25287655|NCT03327844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25287656|NCT03327844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25287657|NCT03327844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287658|NCT03327844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25287659|NCT03327844|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25287660|NCT03327844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25287661|NCT03189706|Irinotecan|irinotecan|mesh-list
25287662|NCT03189706|Temozolomide|temozolomide|mesh-list
25287663|NCT03189706|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25287664|NCT03189706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25287665|NCT03189706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25287666|NCT03189706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287667|NCT03189706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25287668|NCT03189706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25287669|NCT03189706|Alkylating Agents|alkylating agents|mesh-ancestor
25287670|NCT03158883|Avelumab|avelumab|mesh-list
25287671|NCT03158883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25287672|NCT03158883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25287673|NCT03113994|Calcium, Dietary|calcium, dietary|mesh-list
25287674|NCT03113994|Vitamin D|vitamin d|mesh-list
25287675|NCT03113994|Coenzyme Q10|coenzyme q10|mesh-list
25287676|NCT03113994|Ubiquinone|ubiquinone|mesh-list
25287677|NCT03113994|Calcium Carbonate|calcium carbonate|mesh-list
25287678|NCT03113994|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25287679|NCT03113994|Calcium|calcium|mesh-list
25287680|NCT03113994|Vitamins|vitamins|mesh-ancestor
25287681|NCT03113994|Micronutrients|micronutrients|mesh-ancestor
25115352|NCT03116737|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25115353|NCT03116737|Anesthetics, Local|anesthetics, local|mesh-ancestor
25115354|NCT03116737|Anesthetics|anesthetics|mesh-ancestor
25115355|NCT03116737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25115356|NCT03116737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115357|NCT03116737|Sensory System Agents|sensory system agents|mesh-ancestor
25115358|NCT03116737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25115359|NCT03116659|Doxycycline|doxycycline|mesh-list
25115360|NCT03116659|Imiquimod|imiquimod|mesh-list
25115361|NCT03116659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25115362|NCT03116659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25115363|NCT03116659|Antimalarials|antimalarials|mesh-ancestor
25115364|NCT03116659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25115365|NCT03116659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25115366|NCT03116659|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25115367|NCT03116659|Immunologic Factors|immunologic factors|mesh-ancestor
25115368|NCT03116659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115369|NCT03116659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25115370|NCT03116659|Interferon Inducers|interferon inducers|mesh-ancestor
25115371|NCT03116672|Diclofenac|diclofenac|mesh-list
25115372|NCT03116672|Ketorolac|ketorolac|mesh-list
25115373|NCT03116672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25115374|NCT03116672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25115375|NCT03116672|Analgesics|analgesics|mesh-ancestor
25115376|NCT03116672|Sensory System Agents|sensory system agents|mesh-ancestor
25115377|NCT03116672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24783430|NCT01902017|Histamine Agents|histamine agents|mesh-ancestor
25115378|NCT03116672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115380|NCT03116672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25115381|NCT03116672|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25287682|NCT03113994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287683|NCT03113994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25287684|NCT03113994|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25287685|NCT03113994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25287686|NCT03113994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25287687|NCT03113994|Antimetabolites|antimetabolites|mesh-ancestor
25287688|NCT03113994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287689|NCT03113994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25287690|NCT03113994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25287691|NCT03113994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25287692|NCT03113994|Antacids|antacids|mesh-ancestor
25287693|NCT03113994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25287694|NCT02960568|Primaquine|primaquine|mesh-list
25287695|NCT02960568|Antimalarials|antimalarials|mesh-ancestor
25287696|NCT02960568|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25287697|NCT02960568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25287698|NCT02960568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25287699|NCT02953665|Liraglutide|liraglutide|mesh-list
25287700|NCT02953665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25287701|NCT02953665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287702|NCT02953665|Incretins|incretins|mesh-ancestor
25287703|NCT02953665|Hormones|hormones|mesh-ancestor
25287704|NCT02953665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25287705|NCT02864004|Apomorphine|apomorphine|mesh-list
25287706|NCT02864004|Emetics|emetics|mesh-ancestor
25287707|NCT02864004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287708|NCT02864004|Autonomic Agents|autonomic agents|mesh-ancestor
25287709|NCT02864004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25287710|NCT02864004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25287712|NCT02864004|Dopamine Agents|dopamine agents|mesh-ancestor
25287713|NCT02864004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25287714|NCT02864004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287715|NCT02834403|Aspirin|aspirin|mesh-list
25287716|NCT02834403|Docetaxel|docetaxel|mesh-list
25287717|NCT02834403|Amlodipine|amlodipine|mesh-list
25287718|NCT02834403|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
25287719|NCT02834403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25287720|NCT02834403|Tubulin Modulators|tubulin modulators|mesh-ancestor
25287721|NCT02834403|Antimitotic Agents|antimitotic agents|mesh-ancestor
25287722|NCT02834403|Mitosis Modulators|mitosis modulators|mesh-ancestor
25287723|NCT02834403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287724|NCT02834403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25287725|NCT02834403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25287726|NCT02834403|Analgesics|analgesics|mesh-ancestor
25115399|NCT03116555|Apatinib|apatinib|mesh-list
25115400|NCT03116555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25115401|NCT03116555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25115402|NCT03116555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25115403|NCT03116555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115404|NCT03116555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25115405|NCT03116555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25115406|NCT03116516|Amlodipine|amlodipine|mesh-list
25115407|NCT03116516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25115408|NCT03116516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25115409|NCT03116516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25115410|NCT03116516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25115411|NCT03116516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115412|NCT03116516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25115413|NCT03116516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115414|NCT03116516|Vasodilator Agents|vasodilator agents|mesh-ancestor
25115415|NCT03116516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25115416|NCT03116516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24620838|NCT01059396|Propranolol|propranolol|mesh-list
25115417|NCT03116516|Antimetabolites|antimetabolites|mesh-ancestor
25115418|NCT03116516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25115419|NCT03116516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25115420|NCT03116516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25115421|NCT03116269|Aspirin|aspirin|mesh-list
25115422|NCT03116269|Cilostazol|cilostazol|mesh-list
25115423|NCT03116269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25115424|NCT03116269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25115425|NCT03116269|Analgesics|analgesics|mesh-ancestor
25115426|NCT03116269|Sensory System Agents|sensory system agents|mesh-ancestor
25115427|NCT03116269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25115428|NCT03116269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115429|NCT03116269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25115430|NCT03116269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25115431|NCT03116269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25287727|NCT02834403|Sensory System Agents|sensory system agents|mesh-ancestor
25287728|NCT02834403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25287729|NCT02834403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287730|NCT02834403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25287731|NCT02834403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25287732|NCT02834403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25287733|NCT02834403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25287734|NCT02834403|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25287735|NCT02834403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25287736|NCT02834403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25287737|NCT02834403|Antipyretics|antipyretics|mesh-ancestor
25287738|NCT02834403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25287739|NCT02834403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25287740|NCT02834403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25287741|NCT02834403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25287742|NCT02834403|Vasodilator Agents|vasodilator agents|mesh-ancestor
25287743|NCT02770040|Infliximab|infliximab|mesh-list
25287744|NCT02770040|Dermatologic Agents|dermatologic agents|mesh-ancestor
25287745|NCT02770040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25287746|NCT02770040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25287747|NCT02721654|Plasma-lyte 148|plasma-lyte 148|mesh-list
25287748|NCT02721654|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25287749|NCT02721654|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25287750|NCT02712112|Imatinib Mesylate|imatinib mesylate|mesh-list
25287751|NCT02712112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25287752|NCT02712112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25287753|NCT02712112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25287754|NCT02712112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287755|NCT02701088|Mitomycins|mitomycins|mesh-list
25287756|NCT02701088|Mitomycin|mitomycin|mesh-list
25287757|NCT02701088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25287758|NCT02701088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25287759|NCT02701088|Alkylating Agents|alkylating agents|mesh-ancestor
25287760|NCT02701088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287761|NCT02701088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25287762|NCT02701088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25287763|NCT02634411|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25287764|NCT02634411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25115435|NCT03116269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25115436|NCT03116269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25115437|NCT03116269|Antipyretics|antipyretics|mesh-ancestor
25115438|NCT03116269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25115439|NCT03116269|Autonomic Agents|autonomic agents|mesh-ancestor
25115440|NCT03116269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25115441|NCT03116269|Respiratory System Agents|respiratory system agents|mesh-ancestor
25115442|NCT03116269|Vasodilator Agents|vasodilator agents|mesh-ancestor
25115443|NCT03116269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25115444|NCT03116269|Protective Agents|protective agents|mesh-ancestor
25115445|NCT03116269|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25115446|NCT03116269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25115447|NCT03116321|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25115448|NCT03116321|Anticonvulsants|anticonvulsants|mesh-ancestor
25115449|NCT03116321|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25115450|NCT03116321|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25115451|NCT03116321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25115452|NCT03116321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115453|NCT03116087|Methyltestosterone|methyltestosterone|mesh-list
25115455|NCT03116087|Testosterone undecanoate|testosterone undecanoate|mesh-list
25115456|NCT03116087|Testosterone enanthate|testosterone enanthate|mesh-list
25115457|NCT03116087|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25115458|NCT03116087|Androgens|androgens|mesh-ancestor
25115459|NCT03116087|Hormones|hormones|mesh-ancestor
25115460|NCT03116087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25115461|NCT03116087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115462|NCT03116087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25115463|NCT03116087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25115464|NCT03116087|Anabolic Agents|anabolic agents|mesh-ancestor
25115465|NCT03116308|Opicapone|opicapone|mesh-list
25115466|NCT03116308|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25115467|NCT03116308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25115469|NCT03116308|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25287765|NCT02634411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25287766|NCT02634411|Antitubercular Agents|antitubercular agents|mesh-ancestor
25287767|NCT02624765|Digoxin|digoxin|mesh-list
25287768|NCT02624765|Sotalol|sotalol|mesh-list
25287769|NCT02624765|Flecainide|flecainide|mesh-list
25287770|NCT02624765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25287771|NCT02624765|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25287772|NCT02624765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25287773|NCT02624765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287774|NCT02624765|Protective Agents|protective agents|mesh-ancestor
25287775|NCT02624765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287776|NCT02624765|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25287777|NCT02624765|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25287778|NCT02624765|Adrenergic Agents|adrenergic agents|mesh-ancestor
25287779|NCT02624765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25287780|NCT02624765|Sympatholytics|sympatholytics|mesh-ancestor
25287781|NCT02624765|Autonomic Agents|autonomic agents|mesh-ancestor
25287782|NCT02624765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25287783|NCT02624765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25287784|NCT02624765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25287785|NCT02624765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25287786|NCT05090449|Losartan|losartan|mesh-list
25287787|NCT05090449|Chlorthalidone|chlorthalidone|mesh-list
25287788|NCT05090449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25115634|NCT03114280|Carboplatin|carboplatin|mesh-list
25287789|NCT05090449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24673711|NCT01339741|Vitamin D|vitamin d|mesh-list
25287790|NCT05090449|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24895940|NCT02816424|Protective Agents|protective agents|mesh-ancestor
25287791|NCT05090449|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25287792|NCT05090449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287793|NCT05090449|Diuretics|diuretics|mesh-ancestor
25287794|NCT05090449|Natriuretic Agents|natriuretic agents|mesh-ancestor
25287795|NCT05090449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287796|NCT05090449|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25287797|NCT05090449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25287798|NCT05090176|Povidone|povidone|mesh-list
25287799|NCT05090176|Plasma Substitutes|plasma substitutes|mesh-ancestor
25287800|NCT05090176|Blood Substitutes|blood substitutes|mesh-ancestor
25287801|NCT05090137|Diuretics|diuretics|mesh-list
25287802|NCT05090137|Natriuretic Agents|natriuretic agents|mesh-ancestor
25287803|NCT05090137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287804|NCT05090124|Adalimumab|adalimumab|mesh-list
25115474|NCT03116282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25115475|NCT03116282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115476|NCT03116295|Opicapone|opicapone|mesh-list
25115477|NCT03116295|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25115479|NCT03116295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115480|NCT03116295|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25115481|NCT03116295|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25115482|NCT03115892|Chlorhexidine|chlorhexidine|mesh-list
25115483|NCT03115892|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25115484|NCT03115892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25115485|NCT03115892|Disinfectants|disinfectants|mesh-ancestor
25115486|NCT03115697|Rifaximin|rifaximin|mesh-list
25115487|NCT03115697|Lactulose|lactulose|mesh-list
25115488|NCT03115697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25115489|NCT03115697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25115490|NCT03115697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25115491|NCT03115736|Tenofovir|tenofovir|mesh-list
25115492|NCT03115736|Antiviral Agents|antiviral agents|mesh-ancestor
25115493|NCT03115736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25115500|NCT03115775|Vitamin D|vitamin d|mesh-list
25115501|NCT03115775|Ergocalciferols|ergocalciferols|mesh-list
25115502|NCT03115775|Cholecalciferol|cholecalciferol|mesh-list
25115503|NCT03115775|Vitamins|vitamins|mesh-list
25115504|NCT03115775|Micronutrients|micronutrients|mesh-ancestor
25115505|NCT03115775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115506|NCT03115775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25115507|NCT03115775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25115508|NCT03115489|Ketamine|ketamine|mesh-list
25115509|NCT03115489|Propofol|propofol|mesh-list
25115510|NCT03115489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25115511|NCT03115489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25287805|NCT05090124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25287806|NCT05090124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25287807|NCT05089981|Acetylcysteine|acetylcysteine|mesh-list
25287808|NCT05089981|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25287809|NCT05089981|Antiviral Agents|antiviral agents|mesh-ancestor
25287810|NCT05089981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25287811|NCT05089981|Expectorants|expectorants|mesh-ancestor
25287812|NCT05089981|Respiratory System Agents|respiratory system agents|mesh-ancestor
25287813|NCT05089981|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25287814|NCT05089981|Antioxidants|antioxidants|mesh-ancestor
25287815|NCT05089981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287816|NCT05089981|Protective Agents|protective agents|mesh-ancestor
25287817|NCT05089981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287818|NCT05089981|Antidotes|antidotes|mesh-ancestor
25115524|NCT03115762|Bevacizumab|bevacizumab|mesh-list
25115525|NCT03115762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25115526|NCT03115762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25115527|NCT03115762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25115528|NCT03115762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25115529|NCT03115762|Growth Substances|growth substances|mesh-ancestor
25115530|NCT03115762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115531|NCT03115762|Growth Inhibitors|growth inhibitors|mesh-ancestor
25115532|NCT03115307|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25115533|NCT03115307|Luteolytic Agents|luteolytic agents|mesh-ancestor
25115534|NCT03115307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25115535|NCT03115307|Contraceptive Agents|contraceptive agents|mesh-ancestor
25115536|NCT03115307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25115537|NCT03115307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115548|NCT03115619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115549|NCT03115619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25115550|NCT03115619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25115551|NCT03115619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25115552|NCT03115619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25115553|NCT03115619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25115555|NCT03115255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25115556|NCT03115255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25287819|NCT05089604|Tacrolimus|tacrolimus|mesh-list
25287820|NCT05089604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25287821|NCT05089604|Immunologic Factors|immunologic factors|mesh-ancestor
25287822|NCT05089604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287823|NCT05089604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25287824|NCT05089604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25287825|NCT05089604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287826|NCT05089539|Valsartan|valsartan|mesh-list
25287827|NCT05089539|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25287828|NCT05089539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25287829|NCT05089539|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25287830|NCT05089539|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25287831|NCT05089539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287842|NCT05089448|Amlodipine|amlodipine|mesh-list
25287843|NCT05089448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25287844|NCT05089448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25287845|NCT05089448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25287846|NCT05089448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287847|NCT05089448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25287848|NCT05089448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287849|NCT05089448|Vasodilator Agents|vasodilator agents|mesh-ancestor
25287850|NCT05089383|Progesterone|progesterone|mesh-list
25287851|NCT05089383|Progestins|progestins|mesh-ancestor
25287852|NCT05089383|Hormones|hormones|mesh-ancestor
25287853|NCT05089383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25287854|NCT05089383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287855|NCT05089344|Clomiphene|clomiphene|mesh-list
25287856|NCT05089344|Enclomiphene|enclomiphene|mesh-list
25115564|NCT03115034|Melatonin|melatonin|mesh-list
25115565|NCT03115034|Antioxidants|antioxidants|mesh-ancestor
25115566|NCT03115034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115567|NCT03115034|Protective Agents|protective agents|mesh-ancestor
25115568|NCT03115034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115569|NCT03115034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25115570|NCT03114904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25115571|NCT03114904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25115572|NCT03114904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115573|NCT03115073|Clotrimazole|clotrimazole|mesh-list
25115574|NCT03115073|Miconazole|miconazole|mesh-list
25115575|NCT03115073|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25115576|NCT03115073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25115577|NCT03115073|Antifungal Agents|antifungal agents|mesh-ancestor
25115578|NCT03115073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25115680|NCT03113773|Aldesleukin|aldesleukin|mesh-list
25115579|NCT03115073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25115580|NCT03115073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25115581|NCT03115073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115582|NCT03115073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25287857|NCT05089344|Zuclomiphene|zuclomiphene|mesh-list
25287859|NCT05089344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25287860|NCT05089344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287861|NCT05089344|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25287862|NCT05089344|Hormone Antagonists|hormone antagonists|mesh-ancestor
25287863|NCT05089344|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25287864|NCT05089344|Fertility Agents|fertility agents|mesh-ancestor
25287865|NCT05089344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25287866|NCT05089344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25287867|NCT05089344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25287868|NCT05088889|Nivolumab|nivolumab|mesh-list
25287869|NCT05088889|Ipilimumab|ipilimumab|mesh-list
25287870|NCT05088889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25287871|NCT05088889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25287872|NCT05088889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25287873|NCT05088889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287874|NCT05088798|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
25287875|NCT05088798|Dopamine Agents|dopamine agents|mesh-ancestor
25287876|NCT05088798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25287877|NCT05088798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287878|NCT05088798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287879|NCT05088720|Misoprostol|misoprostol|mesh-list
25287880|NCT05088720|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25287881|NCT05088720|Abortifacient Agents|abortifacient agents|mesh-ancestor
25287882|NCT05088720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25287883|NCT05088720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287884|NCT05088720|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25287885|NCT05088720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25287886|NCT05088720|Oxytocics|oxytocics|mesh-ancestor
25287887|NCT05088707|Misoprostol|misoprostol|mesh-list
25287888|NCT05088707|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25287889|NCT05088707|Abortifacient Agents|abortifacient agents|mesh-ancestor
25287890|NCT05088707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25287891|NCT05088707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287892|NCT05088707|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25287893|NCT05088707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25287894|NCT05088707|Oxytocics|oxytocics|mesh-ancestor
25287895|NCT05084118|Landiolol|landiolol|mesh-list
25287896|NCT05084118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25287897|NCT05084118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25287898|NCT05084118|Adrenergic Agents|adrenergic agents|mesh-ancestor
25287899|NCT05084118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25287900|NCT05084118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287901|NCT05084118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287902|NCT05084118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25287903|NCT05081349|Hydroxyurea|hydroxyurea|mesh-list
25287904|NCT05081349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25287905|NCT05081349|Antisickling Agents|antisickling agents|mesh-ancestor
25287906|NCT05081349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25287907|NCT05081349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115616|NCT03114813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25115617|NCT03114813|Adrenergic Agents|adrenergic agents|mesh-ancestor
25115618|NCT03114813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25115619|NCT03114813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115620|NCT03114813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115621|NCT03114813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25115622|NCT03114813|Antioxidants|antioxidants|mesh-ancestor
25115623|NCT03114813|Protective Agents|protective agents|mesh-ancestor
25115624|NCT03114813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25115625|NCT03114813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25115626|NCT03114813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25115627|NCT03114813|Vasodilator Agents|vasodilator agents|mesh-ancestor
25115628|NCT03114813|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25115629|NCT03114813|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25115630|NCT03114371|Oxytocin|oxytocin|mesh-list
25115631|NCT03114371|Oxytocics|oxytocics|mesh-ancestor
25115632|NCT03114371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25115635|NCT03114280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25115636|NCT03114228|Midostaurin|midostaurin|mesh-list
25115637|NCT03114228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25115638|NCT03114228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25115639|NCT03114228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25115640|NCT03114228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115641|NCT03114111|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25115642|NCT03114111|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25115643|NCT03114111|Dermatologic Agents|dermatologic agents|mesh-ancestor
25115644|NCT03114085|Capecitabine|capecitabine|mesh-list
25115645|NCT03114085|Apatinib|apatinib|mesh-list
25115646|NCT03114085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25287908|NCT05081349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25287909|NCT05077540|Misoprostol|misoprostol|mesh-list
25287910|NCT05077540|Oxytocin|oxytocin|mesh-list
25287911|NCT05077540|Oxytocics|oxytocics|mesh-ancestor
25287912|NCT05077540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25287913|NCT05077540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287914|NCT05077540|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25287915|NCT05077540|Abortifacient Agents|abortifacient agents|mesh-ancestor
25287916|NCT05077540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25287917|NCT05077540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25287918|NCT05073549|Anti-Infective Agents|anti-infective agents|mesh-list
25287919|NCT05073549|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25287920|NCT05057468|Cyclosporine|cyclosporine|mesh-list
25287921|NCT05057468|Rituximab|rituximab|mesh-list
25287922|NCT05057468|Cyclosporins|cyclosporins|mesh-list
25287923|NCT05057468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25287924|NCT05057468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25287925|NCT05057468|Immunologic Factors|immunologic factors|mesh-ancestor
25287926|NCT05057468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287927|NCT05057468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25287928|NCT05057468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25287929|NCT05057468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287930|NCT05057468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25287931|NCT05057468|Antifungal Agents|antifungal agents|mesh-ancestor
25287932|NCT05057468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25287933|NCT05057468|Dermatologic Agents|dermatologic agents|mesh-ancestor
25287934|NCT05057468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25287935|NCT05043077|Phenylephrine|phenylephrine|mesh-list
25287936|NCT05043077|Oxymetazoline|oxymetazoline|mesh-list
25287937|NCT05043077|Tropicamide|tropicamide|mesh-list
25287938|NCT05043077|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25287939|NCT05043077|Mydriatics|mydriatics|mesh-ancestor
25287940|NCT05043077|Autonomic Agents|autonomic agents|mesh-ancestor
25288018|NCT04850651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25287941|NCT05043077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25287942|NCT05043077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287943|NCT05043077|Sympathomimetics|sympathomimetics|mesh-ancestor
25287944|NCT05043077|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25287945|NCT05043077|Nasal Decongestants|nasal decongestants|mesh-ancestor
25287946|NCT05043077|Respiratory System Agents|respiratory system agents|mesh-ancestor
25287947|NCT05043077|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25287948|NCT05043077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25287949|NCT05043077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25287950|NCT05043077|Adrenergic Agents|adrenergic agents|mesh-ancestor
25287951|NCT05043077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25287952|NCT05043077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115660|NCT03114072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115662|NCT03114072|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24674683|NCT04832087|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25115663|NCT03114072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25115664|NCT03114072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25115665|NCT03114072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25115666|NCT03114215|Biotin|biotin|mesh-list
25115667|NCT03114215|Vitamin B Complex|vitamin b complex|mesh-ancestor
25115668|NCT03114215|Vitamins|vitamins|mesh-ancestor
25115669|NCT03114215|Micronutrients|micronutrients|mesh-ancestor
25115670|NCT03114215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115671|NCT03114020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25115672|NCT03114020|Hyaluronic Acid|hyaluronic acid|mesh-list
25115673|NCT03114020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25115674|NCT03114020|Immunologic Factors|immunologic factors|mesh-ancestor
25115675|NCT03114020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115676|NCT03114020|Viscosupplements|viscosupplements|mesh-ancestor
25115677|NCT03114020|Protective Agents|protective agents|mesh-ancestor
25115678|NCT03113851|Molgramostim|molgramostim|mesh-list
25115679|NCT03113851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25115681|NCT03113773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25115682|NCT03113773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25115683|NCT03113773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25115684|NCT03113773|Antiviral Agents|antiviral agents|mesh-ancestor
25115685|NCT03113773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25115686|NCT03113448|Capsaicin|capsaicin|mesh-list
25115687|NCT03113448|Antipruritics|antipruritics|mesh-ancestor
25115688|NCT03113448|Dermatologic Agents|dermatologic agents|mesh-ancestor
25115689|NCT03113448|Sensory System Agents|sensory system agents|mesh-ancestor
25115690|NCT03113448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24515681|NCT00598715|Tubulin Modulators|tubulin modulators|mesh-ancestor
25115691|NCT03113448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115692|NCT03113396|Baclofen|baclofen|mesh-list
25115693|NCT03113396|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25115694|NCT03113396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115698|NCT03113396|GABA Agonists|gaba agonists|mesh-ancestor
25287953|NCT05043077|Protective Agents|protective agents|mesh-ancestor
25287954|NCT05043077|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25287955|NCT05043077|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25287956|NCT05043077|Cholinergic Agents|cholinergic agents|mesh-ancestor
25287957|NCT04991103|Dexamethasone|dexamethasone|mesh-list
25287958|NCT04991103|Lenalidomide|lenalidomide|mesh-list
25287959|NCT04991103|Bortezomib|bortezomib|mesh-list
25287960|NCT04991103|Daratumumab|daratumumab|mesh-list
25287961|NCT04991103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25287962|NCT04991103|Antiemetics|antiemetics|mesh-ancestor
25287963|NCT04991103|Autonomic Agents|autonomic agents|mesh-ancestor
25287964|NCT04991103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25287965|NCT04991103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287966|NCT04991103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25287967|NCT04991103|Glucocorticoids|glucocorticoids|mesh-ancestor
25287968|NCT04991103|Hormones|hormones|mesh-ancestor
25287969|NCT04991103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25287970|NCT04991103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25287971|NCT04991103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25287972|NCT04991103|Immunologic Factors|immunologic factors|mesh-ancestor
25287973|NCT04991103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25287974|NCT04991103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25287975|NCT04991103|Growth Substances|growth substances|mesh-ancestor
25287976|NCT04991103|Growth Inhibitors|growth inhibitors|mesh-ancestor
25287977|NCT04945213|Biperiden|biperiden|mesh-list
25287978|NCT04945213|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25287979|NCT04945213|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25287980|NCT04945213|Parasympatholytics|parasympatholytics|mesh-ancestor
25287981|NCT04945213|Autonomic Agents|autonomic agents|mesh-ancestor
25287982|NCT04945213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25287983|NCT04945213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287984|NCT04945213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25287985|NCT04945213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25287986|NCT04945213|Cholinergic Agents|cholinergic agents|mesh-ancestor
25287987|NCT04945213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25287988|NCT04945213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25287989|NCT04908592|Dexamethasone|dexamethasone|mesh-list
25287990|NCT04908592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25287991|NCT04908592|Antiemetics|antiemetics|mesh-ancestor
25287992|NCT04908592|Autonomic Agents|autonomic agents|mesh-ancestor
25115701|NCT03113396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115702|NCT03113708|Heparin|heparin|mesh-list
25115703|NCT03113708|Calcium heparin|calcium heparin|mesh-list
25115704|NCT03113708|Anticoagulants|anticoagulants|mesh-ancestor
25115705|NCT03113708|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25115706|NCT03113708|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25115707|NCT03113708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115709|NCT03113344|Azithromycin|azithromycin|mesh-list
25115710|NCT03113344|Meropenem|meropenem|mesh-list
25115711|NCT03113344|Ceftriaxone|ceftriaxone|mesh-list
25115712|NCT03113344|Imipenem|imipenem|mesh-list
25115713|NCT03113344|Penicillins|penicillins|mesh-list
25115714|NCT03113344|Erythromycin|erythromycin|mesh-list
25115715|NCT03113344|Ceftazidime|ceftazidime|mesh-list
25115716|NCT03113344|Ampicillin|ampicillin|mesh-list
25115717|NCT03113344|Cephalosporins|cephalosporins|mesh-list
25115718|NCT03113344|Acyclovir|acyclovir|mesh-list
25115719|NCT03113344|Ganciclovir|ganciclovir|mesh-list
25115720|NCT03113344|Antiviral Agents|antiviral agents|mesh-list
25115721|NCT03113344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25115722|NCT03113344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25115723|NCT03113344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25115724|NCT03113344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115725|NCT03113344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25115726|NCT03113344|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25115727|NCT03113084|Heparin|heparin|mesh-list
25115728|NCT03113084|Calcium heparin|calcium heparin|mesh-list
25115729|NCT03113084|Anticoagulants|anticoagulants|mesh-ancestor
25115730|NCT03113084|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25115731|NCT03113084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25115732|NCT03113084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115733|NCT03113266|Antibodies|antibodies|mesh-list
25115734|NCT03113266|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25115735|NCT03113266|Immunologic Factors|immunologic factors|mesh-ancestor
25115736|NCT03113266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115737|NCT03113019|Vaccines|vaccines|mesh-list
25115738|NCT03113019|Immunologic Factors|immunologic factors|mesh-ancestor
24708952|NCT01503450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708953|NCT01503450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24708954|NCT01503450|Serotonin Agents|serotonin agents|mesh-ancestor
24708955|NCT01503502|Imatinib Mesylate|imatinib mesylate|mesh-list
24708957|NCT01503502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708958|NCT01503502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25287993|NCT04908592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25287994|NCT04908592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25287995|NCT04908592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25287996|NCT04908592|Glucocorticoids|glucocorticoids|mesh-ancestor
25287997|NCT04908592|Hormones|hormones|mesh-ancestor
25287998|NCT04908592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25080321|NCT03340493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780398|NCT01884298|Lidocaine|lidocaine|mesh-list
24765889|NCT01791192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765913|NCT01791309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24765914|NCT01791309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24765915|NCT01791309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765916|NCT01791374|Rilotumumab|rilotumumab|mesh-list
24765917|NCT01791374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24765926|NCT01791400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24765931|NCT01791400|Dopamine Agents|dopamine agents|mesh-ancestor
25287999|NCT04908592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25288000|NCT04908592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25288001|NCT04895930|Aflutinib|aflutinib|mesh-list
25288002|NCT04895930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25288003|NCT04895930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25288004|NCT04895930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288005|NCT04870424|Colchicine|colchicine|mesh-list
25288006|NCT04870424|Gout Suppressants|gout suppressants|mesh-ancestor
25288007|NCT04870424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25288008|NCT04870424|Tubulin Modulators|tubulin modulators|mesh-ancestor
25288009|NCT04870424|Antimitotic Agents|antimitotic agents|mesh-ancestor
25288010|NCT04870424|Mitosis Modulators|mitosis modulators|mesh-ancestor
25288011|NCT04870424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288012|NCT04870424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25288013|NCT04850651|Fluconazole|fluconazole|mesh-list
25288014|NCT04850651|Antifungal Agents|antifungal agents|mesh-ancestor
25288015|NCT04850651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25288016|NCT04850651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25288017|NCT04850651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25288019|NCT04850651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288020|NCT04850651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25288021|NCT04850651|Hormone Antagonists|hormone antagonists|mesh-ancestor
25288022|NCT04850651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25288023|NCT04850651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288024|NCT04850651|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25115739|NCT03113019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115741|NCT03113110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25115742|NCT03113110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115743|NCT03113110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25115744|NCT03113110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115745|NCT03113162|Cytarabine|cytarabine|mesh-list
25115746|NCT03113162|Etoposide|etoposide|mesh-list
25115747|NCT03113162|Melphalan|melphalan|mesh-list
25115748|NCT03113162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25115749|NCT03113162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25115750|NCT03113162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25115751|NCT03113162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25115752|NCT03113162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25115753|NCT03113162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115754|NCT03113162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25115755|NCT03113162|Antimetabolites|antimetabolites|mesh-ancestor
25115756|NCT03113162|Antiviral Agents|antiviral agents|mesh-ancestor
25115757|NCT03113162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25115758|NCT03113162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25115759|NCT03113162|Immunologic Factors|immunologic factors|mesh-ancestor
25115760|NCT03113162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115761|NCT03113162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25115762|NCT03113162|Alkylating Agents|alkylating agents|mesh-ancestor
25115763|NCT03113162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25115764|NCT03112889|Valproic Acid|valproic acid|mesh-list
25115765|NCT03112889|Anticonvulsants|anticonvulsants|mesh-ancestor
25115766|NCT03112889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693154|NCT02009163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25693155|NCT02009163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693156|NCT02009163|Dopamine Agents|dopamine agents|mesh-ancestor
25693157|NCT02009163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25693158|NCT02009332|Gemcitabine|gemcitabine|mesh-list
25693159|NCT02009332|Sirolimus|sirolimus|mesh-list
25693160|NCT02009332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25693161|NCT02009332|Antimetabolites|antimetabolites|mesh-ancestor
25693162|NCT02009332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693163|NCT02009332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24766070|NCT01792375|Oxytocics|oxytocics|mesh-ancestor
25115767|NCT03112889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115768|NCT03112889|GABA Agents|gaba agents|mesh-ancestor
25115769|NCT03112889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25288025|NCT04850651|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25288026|NCT04828005|Naloxone|naloxone|mesh-list
25288027|NCT04828005|Nalmefene|nalmefene|mesh-list
25288028|NCT04828005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25288029|NCT04828005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288030|NCT04828005|Sensory System Agents|sensory system agents|mesh-ancestor
25288031|NCT04828005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25288032|NCT04788550|Listerine|listerine|mesh-list
25288033|NCT04788550|Fluorides|fluorides|mesh-list
25288034|NCT04788550|Sodium Fluoride|sodium fluoride|mesh-list
25288035|NCT04788550|Fluorides, Topical|fluorides, topical|mesh-list
25288036|NCT04788550|Cariostatic Agents|cariostatic agents|mesh-ancestor
25288037|NCT04788550|Protective Agents|protective agents|mesh-ancestor
25288038|NCT04788550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288039|NCT04788550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25288040|NCT04788550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25288041|NCT04759768|Naltrexone|naltrexone|mesh-list
25288042|NCT04759768|Nalmefene|nalmefene|mesh-list
25288043|NCT04759768|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25288044|NCT04759768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288045|NCT04759768|Sensory System Agents|sensory system agents|mesh-ancestor
25288046|NCT04759768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25288047|NCT04759768|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25288048|NCT04757493|Prucalopride|prucalopride|mesh-list
25288049|NCT04757493|Laxatives|laxatives|mesh-ancestor
25288050|NCT04757493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25288051|NCT04757493|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
25288052|NCT04757493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25288053|NCT04757493|Serotonin Agents|serotonin agents|mesh-ancestor
25288054|NCT04757493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25288055|NCT04757493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288056|NCT04757493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115780|NCT03112707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25115781|NCT03112707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115782|NCT03112707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25115783|NCT03112707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25115784|NCT03112707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25115785|NCT03112707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25115786|NCT03112707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115787|NCT03112707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25115788|NCT03112707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25115789|NCT03112707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25115790|NCT03112707|Antipyretics|antipyretics|mesh-ancestor
25115791|NCT03112642|Anesthetics|anesthetics|mesh-list
25115792|NCT03112642|Bupivacaine|bupivacaine|mesh-list
25115793|NCT03112642|Anesthetics, Local|anesthetics, local|mesh-list
25115794|NCT03112642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25115795|NCT03112642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115796|NCT03112642|Sensory System Agents|sensory system agents|mesh-ancestor
25115797|NCT03112642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25115798|NCT03112577|Fluticasone|fluticasone|mesh-list
25115800|NCT03112577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25115801|NCT03112577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25115802|NCT03112577|Autonomic Agents|autonomic agents|mesh-ancestor
25115803|NCT03112577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25115804|NCT03112577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115805|NCT03112577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25115806|NCT03112577|Respiratory System Agents|respiratory system agents|mesh-ancestor
25115807|NCT03112577|Dermatologic Agents|dermatologic agents|mesh-ancestor
25115808|NCT03112577|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25115809|NCT03112538|Insulin|insulin|mesh-list
25115810|NCT03112538|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25115811|NCT03112538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25115812|NCT03112538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115813|NCT03112785|Cimetidine|cimetidine|mesh-list
25115814|NCT03112785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25288057|NCT04750291|Botulinum Toxins|botulinum toxins|mesh-list
25288058|NCT04750291|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25288059|NCT04750291|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25288060|NCT04750291|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25288082|NCT04713319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288083|NCT04691986|Niacinamide|niacinamide|mesh-list
25693164|NCT02009332|Antiviral Agents|antiviral agents|mesh-ancestor
25288086|NCT04691986|Vitamin B Complex|vitamin b complex|mesh-ancestor
25288087|NCT04691986|Vitamins|vitamins|mesh-ancestor
25288088|NCT04691986|Micronutrients|micronutrients|mesh-ancestor
25288089|NCT04691986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288090|NCT04691986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25288091|NCT04691986|Antimetabolites|antimetabolites|mesh-ancestor
25288092|NCT04691986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288093|NCT04691986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25288094|NCT04691986|Vasodilator Agents|vasodilator agents|mesh-ancestor
25288095|NCT04595786|Tranexamic Acid|tranexamic acid|mesh-list
25288096|NCT04595786|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25288097|NCT04595786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25288098|NCT04595786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115820|NCT03112785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115821|NCT03112785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115822|NCT03112785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25115823|NCT03112785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25115824|NCT03112785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25115825|NCT03112551|Magnesium Sulfate|magnesium sulfate|mesh-list
25115826|NCT03112551|Analgesics|analgesics|mesh-ancestor
25115827|NCT03112551|Sensory System Agents|sensory system agents|mesh-ancestor
25115828|NCT03112551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25115829|NCT03112551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115830|NCT03112551|Anesthetics|anesthetics|mesh-ancestor
25115831|NCT03112551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25115832|NCT03112551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25115833|NCT03112551|Anticonvulsants|anticonvulsants|mesh-ancestor
25115834|NCT03112551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25115835|NCT03112551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24675663|NCT01344395|Ketorolac|ketorolac|mesh-list
25115836|NCT03112551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115837|NCT03112551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25115838|NCT03112551|Tocolytic Agents|tocolytic agents|mesh-ancestor
25115839|NCT03112551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25115840|NCT03112564|Fentanyl|fentanyl|mesh-list
25115841|NCT03112564|Sevoflurane|sevoflurane|mesh-list
25115842|NCT03112564|Rocuronium|rocuronium|mesh-list
25115843|NCT03112564|Cisatracurium|cisatracurium|mesh-list
25115844|NCT03112564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25115845|NCT03112564|Narcotics|narcotics|mesh-ancestor
25115846|NCT03112564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25115847|NCT03112564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115848|NCT03112564|Analgesics|analgesics|mesh-ancestor
25115849|NCT03112564|Sensory System Agents|sensory system agents|mesh-ancestor
25115850|NCT03112564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25115851|NCT03112564|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25115852|NCT03112564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24708959|NCT01503502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708960|NCT01503502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288111|NCT04536194|Dopamine|dopamine|mesh-list
25288112|NCT04536194|Norepinephrine|norepinephrine|mesh-list
25288113|NCT04536194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25288114|NCT04536194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25288115|NCT04536194|Adrenergic Agents|adrenergic agents|mesh-ancestor
25288116|NCT04536194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25288117|NCT04536194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288118|NCT04536194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288119|NCT04536194|Sympathomimetics|sympathomimetics|mesh-ancestor
25288120|NCT04536194|Autonomic Agents|autonomic agents|mesh-ancestor
25288121|NCT04536194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25288122|NCT04536194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25288123|NCT04536194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25288124|NCT04536194|Dopamine Agents|dopamine agents|mesh-ancestor
25288125|NCT04536194|Protective Agents|protective agents|mesh-ancestor
25288126|NCT04449042|Anesthetics|anesthetics|mesh-list
25288127|NCT04449042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25288128|NCT04449042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288129|NCT04341090|Apatinib|apatinib|mesh-list
25288130|NCT04341090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25288131|NCT04341090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25288132|NCT04341090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25115853|NCT03112564|Anesthetics, General|anesthetics, general|mesh-ancestor
25115854|NCT03112564|Anesthetics|anesthetics|mesh-ancestor
25115855|NCT03112564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25115856|NCT03112564|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24675921|NCT01346670|Lovastatin|lovastatin|mesh-list
25115857|NCT03112564|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25115858|NCT03112564|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25115859|NCT03112564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25115860|NCT03112655|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
25115861|NCT03112655|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25115862|NCT03112655|Antidepressive Agents|antidepressive agents|mesh-ancestor
25115863|NCT03112655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25115865|NCT03112148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25115866|NCT03112148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25115867|NCT03112148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115869|NCT03112187|Trace Elements|trace elements|mesh-ancestor
25115870|NCT03112187|Micronutrients|micronutrients|mesh-ancestor
25115871|NCT03112187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115872|NCT03112135|Epinephrine|epinephrine|mesh-list
25115873|NCT03112135|Tranexamic Acid|tranexamic acid|mesh-list
25115874|NCT03112135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25115875|NCT03112135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25115876|NCT03112135|Adrenergic Agents|adrenergic agents|mesh-ancestor
25115877|NCT03112135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25115878|NCT03112135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115879|NCT03112135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115880|NCT03112135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25115881|NCT03112135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25115882|NCT03112135|Autonomic Agents|autonomic agents|mesh-ancestor
25115883|NCT03112135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25115884|NCT03112135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25115885|NCT03112135|Respiratory System Agents|respiratory system agents|mesh-ancestor
25115886|NCT03112135|Mydriatics|mydriatics|mesh-ancestor
25115887|NCT03112135|Sympathomimetics|sympathomimetics|mesh-ancestor
25115888|NCT03112135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24891580|NCT04469413|Analgesics|analgesics|mesh-ancestor
25288133|NCT04341090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288137|NCT04254731|Methadone|methadone|mesh-list
25288138|NCT04254731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25288139|NCT04254731|Narcotics|narcotics|mesh-ancestor
25288140|NCT04254731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25288141|NCT04254731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288142|NCT04254731|Analgesics|analgesics|mesh-ancestor
25288143|NCT04254731|Sensory System Agents|sensory system agents|mesh-ancestor
25288144|NCT04254731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25288145|NCT04254731|Antitussive Agents|antitussive agents|mesh-ancestor
25288146|NCT04254731|Respiratory System Agents|respiratory system agents|mesh-ancestor
25288147|NCT04207918|Nimotuzumab|nimotuzumab|mesh-list
25288148|NCT04207918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25288149|NCT04207918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25288154|NCT04089150|Gemcitabine|gemcitabine|mesh-list
25288155|NCT04089150|Paclitaxel|paclitaxel|mesh-list
25288156|NCT04089150|Fluorouracil|fluorouracil|mesh-list
25288157|NCT04089150|Capecitabine|capecitabine|mesh-list
25288158|NCT04089150|Oxaliplatin|oxaliplatin|mesh-list
25288159|NCT04089150|Irinotecan|irinotecan|mesh-list
25288160|NCT04089150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25288161|NCT04089150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25288162|NCT04089150|Tubulin Modulators|tubulin modulators|mesh-ancestor
25288163|NCT04089150|Antimitotic Agents|antimitotic agents|mesh-ancestor
25288164|NCT04089150|Mitosis Modulators|mitosis modulators|mesh-ancestor
25288165|NCT04089150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288166|NCT04089150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25288167|NCT04089150|Antimetabolites|antimetabolites|mesh-ancestor
25288168|NCT04089150|Antiviral Agents|antiviral agents|mesh-ancestor
25288169|NCT04089150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25115889|NCT03112135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25115890|NCT03112135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25115891|NCT03112135|Hemostatics|hemostatics|mesh-ancestor
25115892|NCT03112135|Coagulants|coagulants|mesh-ancestor
25115893|NCT03112278|Salicylic Acid|salicylic acid|mesh-list
25115894|NCT03112278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25115895|NCT03112278|Antifungal Agents|antifungal agents|mesh-ancestor
25115896|NCT03112278|Keratolytic Agents|keratolytic agents|mesh-ancestor
25115897|NCT03112278|Dermatologic Agents|dermatologic agents|mesh-ancestor
25115898|NCT03112382|Vitamins|vitamins|mesh-list
25115899|NCT03112382|Vitamin A|vitamin a|mesh-list
25115900|NCT03112382|Retinol palmitate|retinol palmitate|mesh-list
25115901|NCT03112382|Micronutrients|micronutrients|mesh-ancestor
25115902|NCT03112382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115904|NCT03112382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25115905|NCT03112382|Protective Agents|protective agents|mesh-ancestor
25115906|NCT03112382|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25115907|NCT03112382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25115908|NCT03112226|Estradiol|estradiol|mesh-list
24821850|NCT02108366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25115909|NCT03112226|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
25115910|NCT03112226|Estrogens|estrogens|mesh-ancestor
25115911|NCT03112226|Hormones|hormones|mesh-ancestor
25115912|NCT03112226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25115913|NCT03112226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115914|NCT03112226|Hormone Antagonists|hormone antagonists|mesh-ancestor
25115915|NCT03112005|Mydriatics|mydriatics|mesh-list
25115916|NCT03112005|Autonomic Agents|autonomic agents|mesh-ancestor
25115917|NCT03112005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25115918|NCT03112005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115919|NCT03111966|Grazoprevir|grazoprevir|mesh-list
25115920|NCT03111966|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25288170|NCT04089150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25288171|NCT04089150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25288172|NCT04089150|Immunologic Factors|immunologic factors|mesh-ancestor
25288173|NCT04089150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288174|NCT04089150|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25288175|NCT04089150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25288176|NCT04089150|Antidotes|antidotes|mesh-ancestor
25288177|NCT04089150|Protective Agents|protective agents|mesh-ancestor
25288178|NCT04089150|Vitamin B Complex|vitamin b complex|mesh-ancestor
25288185|NCT04082780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25288186|NCT03925727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25288187|NCT03925727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25288188|NCT03925350|Niraparib|niraparib|mesh-list
25288189|NCT03925350|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25288190|NCT03925350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25288191|NCT03925350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288192|NCT03925350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25288193|NCT03906526|Nivolumab|nivolumab|mesh-list
25288194|NCT03906526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25288197|NCT03906526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288199|NCT03789604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25288200|NCT03789604|Immunologic Factors|immunologic factors|mesh-ancestor
25288201|NCT03789604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288202|NCT03522064|Carboplatin|carboplatin|mesh-list
25288203|NCT03522064|Methyltestosterone|methyltestosterone|mesh-list
25288204|NCT03522064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25288205|NCT03522064|Testosterone|testosterone|mesh-list
25288206|NCT03522064|Testosterone undecanoate|testosterone undecanoate|mesh-list
25288207|NCT03522064|Testosterone enanthate|testosterone enanthate|mesh-list
25288208|NCT03522064|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25288209|NCT03522064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25288210|NCT03522064|Androgens|androgens|mesh-ancestor
25288211|NCT03522064|Hormones|hormones|mesh-ancestor
25288212|NCT03522064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25115930|NCT03112031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115931|NCT03112031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25115932|NCT03112031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25115933|NCT03112031|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25045610|NCT00938587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25115955|NCT03111901|Sensory System Agents|sensory system agents|mesh-ancestor
25115956|NCT03111901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25115957|NCT03111901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115960|NCT03111797|Narcotics|narcotics|mesh-ancestor
25115961|NCT03111797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25115962|NCT03111797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115963|NCT03111797|Analgesics|analgesics|mesh-ancestor
25115964|NCT03111797|Sensory System Agents|sensory system agents|mesh-ancestor
25115965|NCT03111797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25115966|NCT03111810|Prednisolone|prednisolone|mesh-list
25115967|NCT03111810|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25115968|NCT03111810|Methylprednisolone|methylprednisolone|mesh-list
25115969|NCT03111810|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25115970|NCT03111810|Prednisolone acetate|prednisolone acetate|mesh-list
25115971|NCT03111810|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25115972|NCT03111810|Prednisolone phosphate|prednisolone phosphate|mesh-list
25115973|NCT03111810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25115974|NCT03111810|Glucocorticoids|glucocorticoids|mesh-ancestor
25115976|NCT03111810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25115977|NCT03111810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25115978|NCT03111810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25115979|NCT03111810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25115980|NCT03111810|Antiemetics|antiemetics|mesh-ancestor
25115981|NCT03111810|Autonomic Agents|autonomic agents|mesh-ancestor
25115982|NCT03111810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25115983|NCT03111810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25115984|NCT03111810|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25288213|NCT03522064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288214|NCT03522064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25288215|NCT03522064|Anabolic Agents|anabolic agents|mesh-ancestor
25116007|NCT03111511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25116008|NCT03111511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25116009|NCT03111511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25116010|NCT03111511|Anesthetics, General|anesthetics, general|mesh-ancestor
25116013|NCT03111511|GABA Agents|gaba agents|mesh-ancestor
25116014|NCT03111511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25116015|NCT03111511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288219|NCT03408652|Zoledronic Acid|zoledronic acid|mesh-list
25288220|NCT03408652|Denosumab|denosumab|mesh-list
25288221|NCT03408652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25288222|NCT03408652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288223|NCT03372941|Dalbavancin|dalbavancin|mesh-list
25288224|NCT03372941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25288225|NCT03372941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25288226|NCT03292861|Mycophenolic Acid|mycophenolic acid|mesh-list
25288227|NCT03292861|Sirolimus|sirolimus|mesh-list
25288228|NCT03292861|Tacrolimus|tacrolimus|mesh-list
25288229|NCT03292861|Thymoglobulin|thymoglobulin|mesh-list
25288230|NCT03292861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25288231|NCT03292861|Immunologic Factors|immunologic factors|mesh-ancestor
25288232|NCT03292861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288233|NCT03292861|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25288234|NCT03292861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25288235|NCT03292861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288236|NCT03292861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25288237|NCT03292861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25288238|NCT03292861|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25288239|NCT03292861|Antitubercular Agents|antitubercular agents|mesh-ancestor
25288240|NCT03292861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25288241|NCT03292861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25288242|NCT03292861|Antifungal Agents|antifungal agents|mesh-ancestor
25288243|NCT03263117|Anesthetics|anesthetics|mesh-list
25288244|NCT03263117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25288245|NCT03263117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288246|NCT03181035|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
25288247|NCT03181035|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25288248|NCT03181035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288249|NCT03030261|Dexamethasone|dexamethasone|mesh-list
25288250|NCT03030261|Pomalidomide|pomalidomide|mesh-list
25288251|NCT03030261|Elotuzumab|elotuzumab|mesh-list
25288252|NCT03030261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25288253|NCT03030261|Antiemetics|antiemetics|mesh-ancestor
25288254|NCT03030261|Autonomic Agents|autonomic agents|mesh-ancestor
25288255|NCT03030261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25288256|NCT03030261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288257|NCT03030261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25288258|NCT03030261|Glucocorticoids|glucocorticoids|mesh-ancestor
25288259|NCT03030261|Hormones|hormones|mesh-ancestor
25288260|NCT03030261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25288261|NCT03030261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25288262|NCT03030261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25288263|NCT03030261|Immunologic Factors|immunologic factors|mesh-ancestor
25116060|NCT03111420|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25116061|NCT03111420|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25116062|NCT03111420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25116063|NCT03111420|Purinergic Agents|purinergic agents|mesh-ancestor
25116064|NCT03111420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25288264|NCT03030261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25288265|NCT03030261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25288266|NCT03030261|Growth Substances|growth substances|mesh-ancestor
25288267|NCT03030261|Growth Inhibitors|growth inhibitors|mesh-ancestor
25288268|NCT02969850|Vitamin D|vitamin d|mesh-list
25288269|NCT02969850|Calcium|calcium|mesh-list
25288270|NCT02969850|Vitamins|vitamins|mesh-ancestor
25288271|NCT02969850|Micronutrients|micronutrients|mesh-ancestor
25288272|NCT02969850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288273|NCT02969850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25288274|NCT02969850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25288275|NCT02837432|Hydrocortisone|hydrocortisone|mesh-list
25288276|NCT02837432|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25288277|NCT02837432|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25288278|NCT02837432|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25288279|NCT02837432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25288295|NCT02339766|Morphine|morphine|mesh-list
25288296|NCT02339766|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25288297|NCT02339766|Narcotics|narcotics|mesh-ancestor
25288298|NCT02339766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25288299|NCT02339766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288300|NCT02339766|Analgesics|analgesics|mesh-ancestor
25288301|NCT02339766|Sensory System Agents|sensory system agents|mesh-ancestor
25288302|NCT02339766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25288306|NCT05091775|Mesalamine|mesalamine|mesh-list
25288307|NCT05091775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25288308|NCT05091775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25116078|NCT03111615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25116079|NCT03111615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116080|NCT03111446|Anesthetics|anesthetics|mesh-list
25116081|NCT03111446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25116082|NCT03111446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116083|NCT03111186|Acetaminophen|acetaminophen|mesh-list
25116086|NCT03111186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25116087|NCT03111186|Analgesics|analgesics|mesh-ancestor
25116088|NCT03111186|Sensory System Agents|sensory system agents|mesh-ancestor
25116157|NCT03110848|Autonomic Agents|autonomic agents|mesh-ancestor
25116089|NCT03111186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116090|NCT03111186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116091|NCT03111186|Antipyretics|antipyretics|mesh-ancestor
25116092|NCT03111186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25116093|NCT03111186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25116094|NCT03111186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25116095|NCT03111186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25116096|NCT03111186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25116097|NCT03111186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116098|NCT03111186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25116099|NCT03111186|Narcotics|narcotics|mesh-ancestor
25116100|NCT03111186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25116101|NCT03111121|Glycopyrrolate|glycopyrrolate|mesh-list
25116102|NCT03111121|Neostigmine|neostigmine|mesh-list
24677052|NCT01353937|Becaplermin|becaplermin|mesh-list
25116103|NCT03111121|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25116104|NCT03111121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25116105|NCT03111121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116106|NCT03111121|Cholinergic Agents|cholinergic agents|mesh-ancestor
25116107|NCT03111121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25116108|NCT03111121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116109|NCT03111121|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25116110|NCT03111121|Autonomic Agents|autonomic agents|mesh-ancestor
25116111|NCT03111121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116115|NCT03110952|alpha-Tocopherol|alpha-tocopherol|mesh-list
25288309|NCT05091775|Analgesics|analgesics|mesh-ancestor
25288310|NCT05091775|Sensory System Agents|sensory system agents|mesh-ancestor
25288311|NCT05091775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25288312|NCT05091775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288313|NCT05091775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25288314|NCT05091775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25288315|NCT05091606|Anesthetics|anesthetics|mesh-list
25288316|NCT05091606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25288317|NCT05091606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288318|NCT05091463|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
25288319|NCT05091463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25288320|NCT05091463|Immunologic Factors|immunologic factors|mesh-ancestor
24766762|NCT01796613|Desogestrel|desogestrel|mesh-list
25288321|NCT05091463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288322|NCT05091359|Calcium|calcium|mesh-list
25288323|NCT05091359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25288324|NCT05091359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288325|NCT05091203|Vitamin D|vitamin d|mesh-list
25288326|NCT05091203|Vitamins|vitamins|mesh-ancestor
25288327|NCT05091203|Micronutrients|micronutrients|mesh-ancestor
25288328|NCT05091203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288329|NCT05091203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25288330|NCT05091177|Acetylcholine|acetylcholine|mesh-list
25288331|NCT05091177|Antibodies|antibodies|mesh-list
25288332|NCT05091177|Neostigmine|neostigmine|mesh-list
25288333|NCT05091177|Immunologic Factors|immunologic factors|mesh-ancestor
25288334|NCT05091177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288335|NCT05091177|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25288336|NCT05091177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25288337|NCT05091177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288338|NCT05091177|Cholinergic Agents|cholinergic agents|mesh-ancestor
25288339|NCT05091177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25288340|NCT05091177|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25288341|NCT05091177|Autonomic Agents|autonomic agents|mesh-ancestor
25288342|NCT05091177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25288343|NCT05091177|Vasodilator Agents|vasodilator agents|mesh-ancestor
25288344|NCT05091177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25288345|NCT05091151|Dexmedetomidine|dexmedetomidine|mesh-list
25288346|NCT05091151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25288347|NCT05091151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25116118|NCT03110952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116119|NCT03110952|Antioxidants|antioxidants|mesh-ancestor
25116120|NCT03110952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116121|NCT03110952|Protective Agents|protective agents|mesh-ancestor
25116122|NCT03110952|Vitamins|vitamins|mesh-ancestor
25116123|NCT03110952|Micronutrients|micronutrients|mesh-ancestor
25116124|NCT03111069|Doxorubicin|doxorubicin|mesh-list
25116125|NCT03111069|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24473824|NCT00404261|Glucocorticoids|glucocorticoids|mesh-ancestor
25116126|NCT03111069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25116127|NCT03111069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25116154|NCT03110848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25116128|NCT03111069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25116129|NCT03111069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25116130|NCT03111069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25116131|NCT03111069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116132|NCT03110757|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25116133|NCT03110757|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25116134|NCT03110757|Immunologic Factors|immunologic factors|mesh-ancestor
25116135|NCT03110757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116136|NCT03110757|Antacids|antacids|mesh-ancestor
25116137|NCT03110757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116138|NCT03110757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25116139|NCT03110848|Methylprednisolone|methylprednisolone|mesh-list
25116140|NCT03110848|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25116141|NCT03110848|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25116142|NCT03110848|Prednisolone|prednisolone|mesh-list
24892257|NCT04464629|Hormones|hormones|mesh-ancestor
24546106|NCT00696748|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24708961|NCT01503580|Solifenacin Succinate|solifenacin succinate|mesh-list
24708962|NCT01503580|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24708963|NCT01503580|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24708964|NCT01503580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24708965|NCT01503580|Cholinergic Agents|cholinergic agents|mesh-ancestor
24708966|NCT01503580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24708967|NCT01503580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708969|NCT01503580|Urological Agents|urological agents|mesh-ancestor
24708983|NCT01503658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24708984|NCT01503658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24708985|NCT01503658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708986|NCT01503658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24708987|NCT01503658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24708988|NCT01503658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708989|NCT01503658|Antipyretics|antipyretics|mesh-ancestor
24708990|NCT01503658|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24708991|NCT01503658|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24708992|NCT01503658|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25288348|NCT05091151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288349|NCT05091151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25288350|NCT05091151|Analgesics|analgesics|mesh-ancestor
25288351|NCT05091151|Sensory System Agents|sensory system agents|mesh-ancestor
25288352|NCT05091151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25288353|NCT05091151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25288354|NCT05091151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25288355|NCT05091151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25288356|NCT05091151|Adrenergic Agents|adrenergic agents|mesh-ancestor
25288357|NCT05091151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25288358|NCT05091151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288359|NCT05091138|Buprenorphine|buprenorphine|mesh-list
25288360|NCT05091138|Bupivacaine|bupivacaine|mesh-list
25288361|NCT05091138|Anesthetics, Local|anesthetics, local|mesh-ancestor
25288362|NCT05091138|Anesthetics|anesthetics|mesh-ancestor
25288363|NCT05091138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25288364|NCT05091138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288365|NCT05091138|Sensory System Agents|sensory system agents|mesh-ancestor
25288366|NCT05091138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25288367|NCT05091138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25288368|NCT05091138|Narcotics|narcotics|mesh-ancestor
25288369|NCT05091138|Analgesics|analgesics|mesh-ancestor
25288370|NCT05091138|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25288371|NCT05091099|Zoledronic Acid|zoledronic acid|mesh-list
25288372|NCT05091099|Alendronate|alendronate|mesh-list
25288373|NCT05091099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25116143|NCT03110848|Prednisolone acetate|prednisolone acetate|mesh-list
25116144|NCT03110848|Atorvastatin|atorvastatin|mesh-list
25116145|NCT03110848|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25116146|NCT03110848|Prednisolone phosphate|prednisolone phosphate|mesh-list
25116147|NCT03110848|Glucocorticoids|glucocorticoids|mesh-list
25116148|NCT03110848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25116149|NCT03110848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25116150|NCT03110848|Antimetabolites|antimetabolites|mesh-ancestor
25116151|NCT03110848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116152|NCT03110848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25116153|NCT03110848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25116155|NCT03110848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25116158|NCT03110848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116159|NCT03110848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116160|NCT03110848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25116161|NCT03110848|Hormones|hormones|mesh-ancestor
25116162|NCT03110848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25116163|NCT03110848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25116164|NCT03110848|Protective Agents|protective agents|mesh-ancestor
25116165|NCT03110848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25116166|NCT03110848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25116167|NCT03110653|Remifentanil|remifentanil|mesh-list
25116168|NCT03110653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25116169|NCT03110653|Narcotics|narcotics|mesh-ancestor
25116170|NCT03110653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25116171|NCT03110653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116172|NCT03110653|Analgesics|analgesics|mesh-ancestor
25116173|NCT03110653|Sensory System Agents|sensory system agents|mesh-ancestor
25116174|NCT03110653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116175|NCT03110640|Cyclophosphamide|cyclophosphamide|mesh-list
25116176|NCT03110640|Fludarabine|fludarabine|mesh-list
25288374|NCT05091099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288375|NCT05091086|Zoledronic Acid|zoledronic acid|mesh-list
25288376|NCT05091086|Denosumab|denosumab|mesh-list
25288377|NCT05091086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25288378|NCT05091086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288379|NCT05091008|Sofosbuvir|sofosbuvir|mesh-list
25288380|NCT05091008|Ledipasvir|ledipasvir|mesh-list
25288381|NCT05091008|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25288382|NCT05091008|Antiviral Agents|antiviral agents|mesh-ancestor
25288383|NCT05091008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25288384|NCT05090761|Magnesium Sulfate|magnesium sulfate|mesh-list
25288385|NCT05090761|Buprenorphine|buprenorphine|mesh-list
25288386|NCT05090761|Bupivacaine|bupivacaine|mesh-list
25288387|NCT05090761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25288388|NCT05090761|Anesthetics, Local|anesthetics, local|mesh-ancestor
25288389|NCT05090761|Anesthetics|anesthetics|mesh-ancestor
25288390|NCT05090761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25080383|NCT03339700|Antimetabolites|antimetabolites|mesh-ancestor
25080384|NCT03339700|Antiviral Agents|antiviral agents|mesh-ancestor
25288391|NCT05090761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288392|NCT05090761|Sensory System Agents|sensory system agents|mesh-ancestor
25288393|NCT05090761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25288394|NCT05090761|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25288395|NCT05090761|Narcotics|narcotics|mesh-ancestor
25288396|NCT05090761|Analgesics|analgesics|mesh-ancestor
25288397|NCT05090761|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25288398|NCT05090761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25288399|NCT05090761|Anticonvulsants|anticonvulsants|mesh-ancestor
25288400|NCT05090761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25288401|NCT05090761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25288402|NCT05090761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288403|NCT05090761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25288404|NCT05090761|Tocolytic Agents|tocolytic agents|mesh-ancestor
25288405|NCT05090761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25288407|NCT05090592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25288408|NCT05090592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25288409|NCT05090592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25288410|NCT05090592|Autonomic Agents|autonomic agents|mesh-ancestor
25288411|NCT05090592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25288412|NCT05090592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288413|NCT05090592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25288414|NCT05090592|Respiratory System Agents|respiratory system agents|mesh-ancestor
25288415|NCT05090592|Mydriatics|mydriatics|mesh-ancestor
25116184|NCT03110640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25116185|NCT03110640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25116186|NCT03110341|Epoetin Alfa|epoetin alfa|mesh-list
25116187|NCT03110341|Hematinics|hematinics|mesh-ancestor
25116188|NCT03110679|Hyaluronic Acid|hyaluronic acid|mesh-list
25116189|NCT03110679|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25116190|NCT03110679|Immunologic Factors|immunologic factors|mesh-ancestor
25116191|NCT03110679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116192|NCT03110679|Viscosupplements|viscosupplements|mesh-ancestor
25116193|NCT03110679|Protective Agents|protective agents|mesh-ancestor
25116194|NCT03110094|Adalimumab|adalimumab|mesh-list
25116195|NCT03110094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25116196|NCT03110094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25116197|NCT03110120|Levobupivacaine|levobupivacaine|mesh-list
25116198|NCT03110120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25116199|NCT03110120|Anesthetics, Local|anesthetics, local|mesh-ancestor
25116200|NCT03110120|Anesthetics|anesthetics|mesh-ancestor
25116201|NCT03110120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25116202|NCT03110120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116203|NCT03110120|Sensory System Agents|sensory system agents|mesh-ancestor
25116204|NCT03110120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116205|NCT03110172|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25116206|NCT03110172|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25116207|NCT03110172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25116208|NCT03110172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25116233|NCT03110198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25116234|NCT03110159|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25116235|NCT03110159|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25116236|NCT03110159|Dermatologic Agents|dermatologic agents|mesh-ancestor
25288416|NCT05090592|Parasympatholytics|parasympatholytics|mesh-ancestor
25288417|NCT05090592|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25288418|NCT05090592|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25288419|NCT05090592|Cholinergic Agents|cholinergic agents|mesh-ancestor
25288420|NCT05090592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25288421|NCT05090592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288422|NCT05081583|Midazolam|midazolam|mesh-list
25288423|NCT05081583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25288424|NCT05081583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25288425|NCT05081583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25288426|NCT05081583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288427|NCT05081583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25288428|NCT05081583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25288429|NCT05081583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25288430|NCT05081583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25288431|NCT05081583|Anesthetics, General|anesthetics, general|mesh-ancestor
25693165|NCT02009332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25288432|NCT05081583|Anesthetics|anesthetics|mesh-ancestor
25288433|NCT05081583|GABA Modulators|gaba modulators|mesh-ancestor
25288434|NCT05081583|GABA Agents|gaba agents|mesh-ancestor
25288435|NCT05081583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25288436|NCT05081583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116252|NCT03109990|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25116253|NCT03109990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25116254|NCT03109990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25116255|NCT03109990|Adrenergic Agents|adrenergic agents|mesh-ancestor
25116256|NCT03109990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25116257|NCT03109990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116258|NCT03109847|Metformin|metformin|mesh-list
25116259|NCT03109847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25116260|NCT03109847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116261|NCT03109691|Dexamethasone|dexamethasone|mesh-list
25116262|NCT03109691|Bupivacaine|bupivacaine|mesh-list
25116263|NCT03109691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25116264|NCT03109691|Antiemetics|antiemetics|mesh-ancestor
25116265|NCT03109691|Autonomic Agents|autonomic agents|mesh-ancestor
25116266|NCT03109691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116267|NCT03109691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116268|NCT03109691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25116269|NCT03109691|Glucocorticoids|glucocorticoids|mesh-ancestor
25116270|NCT03109691|Hormones|hormones|mesh-ancestor
25116271|NCT03109691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25116272|NCT03109691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25116273|NCT03109691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25116274|NCT03109691|Anesthetics, Local|anesthetics, local|mesh-ancestor
25116275|NCT03109691|Anesthetics|anesthetics|mesh-ancestor
25116276|NCT03109691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25116277|NCT03109691|Sensory System Agents|sensory system agents|mesh-ancestor
25116278|NCT03109730|Tenofovir|tenofovir|mesh-list
25116279|NCT03109730|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25116280|NCT03109730|Entecavir|entecavir|mesh-list
25116281|NCT03109730|Antiviral Agents|antiviral agents|mesh-ancestor
25116287|NCT03109730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25288437|NCT05081336|Ezetimibe|ezetimibe|mesh-list
25288438|NCT05081336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25288439|NCT05081336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25288440|NCT05081336|Antimetabolites|antimetabolites|mesh-ancestor
25288441|NCT05081336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288442|NCT05081336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25288443|NCT05077839|Trifluridine|trifluridine|mesh-list
25288444|NCT05077839|Antimetabolites|antimetabolites|mesh-ancestor
25288445|NCT05077839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288453|NCT05077683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25288454|NCT05077683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288456|NCT05077085|Vancomycin|vancomycin|mesh-list
25288457|NCT05077085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25288458|NCT05077085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25288459|NCT05069129|Vaccines|vaccines|mesh-list
25288460|NCT05069129|Immunologic Factors|immunologic factors|mesh-ancestor
25288461|NCT05069129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288462|NCT05067985|Anesthetics|anesthetics|mesh-list
25288463|NCT05067985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25288464|NCT05067985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288465|NCT05056259|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25288466|NCT05056259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25288467|NCT05056259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288474|NCT04952350|Atorvastatin|atorvastatin|mesh-list
25288475|NCT04952350|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25288476|NCT04952350|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25288477|NCT04952350|Antimetabolites|antimetabolites|mesh-ancestor
25288478|NCT04952350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288479|NCT04952350|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25288480|NCT04952350|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25116298|NCT03109756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116299|NCT03109717|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-list
25116300|NCT03109717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25116301|NCT03109717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116302|NCT03109600|Vaccines|vaccines|mesh-list
25116303|NCT03109600|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25116304|NCT03109600|Immunologic Factors|immunologic factors|mesh-ancestor
25116305|NCT03109600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116306|NCT03109652|Tranexamic Acid|tranexamic acid|mesh-list
25116307|NCT03109652|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25116308|NCT03109652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25116309|NCT03109652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116310|NCT03109652|Hemostatics|hemostatics|mesh-ancestor
25116311|NCT03109652|Coagulants|coagulants|mesh-ancestor
25116312|NCT03109392|Lidocaine|lidocaine|mesh-list
25116313|NCT03109392|Anesthetics, Local|anesthetics, local|mesh-ancestor
25116314|NCT03109392|Anesthetics|anesthetics|mesh-ancestor
25116315|NCT03109392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25116316|NCT03109392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116317|NCT03109392|Sensory System Agents|sensory system agents|mesh-ancestor
25116318|NCT03109392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116319|NCT03109392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24678536|NCT01363037|Maraviroc|maraviroc|mesh-list
25116320|NCT03109392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25116321|NCT03109392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25116322|NCT03109392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25116323|NCT03109392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116324|NCT03109379|Trospium chloride|trospium chloride|mesh-list
25116325|NCT03109379|Parasympatholytics|parasympatholytics|mesh-ancestor
25116326|NCT03109379|Autonomic Agents|autonomic agents|mesh-ancestor
25116327|NCT03109379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24708994|NCT01503658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24708995|NCT01503671|Atorvastatin|atorvastatin|mesh-list
24708996|NCT01503671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24708997|NCT01503671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24708998|NCT01503671|Antimetabolites|antimetabolites|mesh-ancestor
24708999|NCT01503671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709000|NCT01503671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25288500|NCT04850144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25288501|NCT04850144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288502|NCT04850144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25288503|NCT04850144|Respiratory System Agents|respiratory system agents|mesh-ancestor
25288505|NCT04850144|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25288506|NCT04850144|Cholinergic Agents|cholinergic agents|mesh-ancestor
25288507|NCT04850144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25288508|NCT04850144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288509|NCT04850144|Anticonvulsants|anticonvulsants|mesh-ancestor
25288510|NCT04850144|Antidotes|antidotes|mesh-ancestor
25288511|NCT04850144|Protective Agents|protective agents|mesh-ancestor
25288512|NCT04812808|Bazedoxifene|bazedoxifene|mesh-list
25288513|NCT04812808|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25116328|NCT03109379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116329|NCT03109379|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25116330|NCT03109379|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25116331|NCT03109379|Cholinergic Agents|cholinergic agents|mesh-ancestor
25116332|NCT03109379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25116333|NCT03109379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116334|NCT03109379|Urological Agents|urological agents|mesh-ancestor
25116336|NCT03109080|Adenosine|adenosine|mesh-list
24678675|NCT01363375|Carbon Fiber|carbon fiber|mesh-list
25116337|NCT03109080|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25116338|NCT03109080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25116339|NCT03109080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116340|NCT03109080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25116341|NCT03109080|Analgesics|analgesics|mesh-ancestor
25116342|NCT03109080|Sensory System Agents|sensory system agents|mesh-ancestor
25116343|NCT03109080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116344|NCT03109080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116345|NCT03109080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25116346|NCT03109080|Vasodilator Agents|vasodilator agents|mesh-ancestor
25116347|NCT03109080|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25116348|NCT03109080|Purinergic Agonists|purinergic agonists|mesh-ancestor
25116349|NCT03109080|Purinergic Agents|purinergic agents|mesh-ancestor
25116350|NCT03109080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25116351|NCT03109158|Cetuximab|cetuximab|mesh-list
25116352|NCT03109158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25116353|NCT03109158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25116354|NCT03109119|Propofol|propofol|mesh-list
25116355|NCT03109119|Sevoflurane|sevoflurane|mesh-list
25116356|NCT03109119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25116357|NCT03109119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25116358|NCT03109119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116359|NCT03109119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25116360|NCT03109119|Anesthetics, General|anesthetics, general|mesh-ancestor
24767353|NCT01800357|Analgesics|analgesics|mesh-ancestor
25116361|NCT03109119|Anesthetics|anesthetics|mesh-ancestor
25116362|NCT03109119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25116363|NCT03109119|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25116364|NCT03109314|Donepezil|donepezil|mesh-list
24892833|NCT04458324|Buspirone|buspirone|mesh-list
25288514|NCT04812808|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25288515|NCT04812808|Hormone Antagonists|hormone antagonists|mesh-ancestor
25288516|NCT04812808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25288521|NCT04710199|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25288522|NCT04710199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288523|NCT04710199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25288524|NCT04710199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25288525|NCT04710199|Antiviral Agents|antiviral agents|mesh-ancestor
25288526|NCT04710199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25288527|NCT04710199|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25288528|NCT04648696|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25288529|NCT04648696|Vancomycin|vancomycin|mesh-list
25288530|NCT04648696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25288531|NCT04648696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25288532|NCT04648696|Antitubercular Agents|antitubercular agents|mesh-ancestor
25288537|NCT04590794|Plasminogen|plasminogen|mesh-list
25288538|NCT04590794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25288539|NCT04590794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25288540|NCT04590794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288541|NCT04543643|Carvedilol|carvedilol|mesh-list
25288542|NCT04543643|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25288543|NCT04543643|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25288544|NCT04543643|Adrenergic Agents|adrenergic agents|mesh-ancestor
25288545|NCT04543643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25288546|NCT04543643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288547|NCT04543643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288548|NCT04543643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25288549|NCT04543643|Antioxidants|antioxidants|mesh-ancestor
25116365|NCT03109314|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25116366|NCT03109314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25116367|NCT03109314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116368|NCT03109314|Cholinergic Agents|cholinergic agents|mesh-ancestor
25116369|NCT03109314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25116370|NCT03109314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116371|NCT03109314|Nootropic Agents|nootropic agents|mesh-ancestor
25116373|NCT03108846|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25116374|NCT03108846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25116375|NCT03108846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25116376|NCT03108846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116377|NCT03108846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25116378|NCT03108846|Serotonin Agents|serotonin agents|mesh-ancestor
25116379|NCT03108846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116380|NCT03108846|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25116381|NCT03108846|Antidepressive Agents|antidepressive agents|mesh-ancestor
25116382|NCT03108846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25116383|NCT03108937|Dexmedetomidine|dexmedetomidine|mesh-list
25116384|NCT03108937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25116385|NCT03108937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25116386|NCT03108937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116387|NCT03108937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25116388|NCT03108937|Analgesics|analgesics|mesh-ancestor
25116389|NCT03108937|Sensory System Agents|sensory system agents|mesh-ancestor
25116390|NCT03108937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116391|NCT03108937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25116392|NCT03108937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25116393|NCT03108937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25116394|NCT03108937|Adrenergic Agents|adrenergic agents|mesh-ancestor
25116395|NCT03108937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25116396|NCT03108937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116397|NCT03108833|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25116398|NCT03108833|Saruplase|saruplase|mesh-list
25288550|NCT04543643|Protective Agents|protective agents|mesh-ancestor
25288551|NCT04543643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25288552|NCT04543643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25288553|NCT04543643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25288554|NCT04543643|Vasodilator Agents|vasodilator agents|mesh-ancestor
25693166|NCT02009332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767398|NCT01800526|Protective Agents|protective agents|mesh-ancestor
24767399|NCT01800526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767400|NCT01800526|Antidotes|antidotes|mesh-ancestor
24767402|NCT01800630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24767403|NCT01800630|Antimetabolites|antimetabolites|mesh-ancestor
25080443|NCT03338426|Atorvastatin|atorvastatin|mesh-list
24781865|NCT01892644|Chelating Agents|chelating agents|mesh-ancestor
25288555|NCT04543643|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25288556|NCT04543643|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25288557|NCT04526652|Dexmedetomidine|dexmedetomidine|mesh-list
25288558|NCT04526652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25288559|NCT04526652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25288560|NCT04526652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288561|NCT04526652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25288562|NCT04526652|Analgesics|analgesics|mesh-ancestor
25288563|NCT04526652|Sensory System Agents|sensory system agents|mesh-ancestor
25288564|NCT04526652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25288565|NCT04526652|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25288566|NCT04526652|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25288567|NCT04526652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25288568|NCT04526652|Adrenergic Agents|adrenergic agents|mesh-ancestor
25288569|NCT04526652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25288570|NCT04526652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288571|NCT04401800|Lenvatinib|lenvatinib|mesh-list
25288572|NCT04401800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25288573|NCT04401800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25288574|NCT04401800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25288575|NCT04401800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116401|NCT03108833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116402|NCT03108963|Metformin|metformin|mesh-list
25116403|NCT03108963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25116404|NCT03108963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116405|NCT03108989|Neostigmine|neostigmine|mesh-list
24572825|NCT00816868|Capecitabine|capecitabine|mesh-list
25116406|NCT03108989|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25116407|NCT03108989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25116408|NCT03108989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116409|NCT03108989|Cholinergic Agents|cholinergic agents|mesh-ancestor
25116410|NCT03108989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25116411|NCT03108989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116412|NCT03108989|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25116413|NCT03108989|Autonomic Agents|autonomic agents|mesh-ancestor
25116414|NCT03108989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116415|NCT03108872|Anticoagulants|anticoagulants|mesh-list
25116416|NCT03108690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25116417|NCT03108690|Meropenem|meropenem|mesh-list
25116418|NCT03108690|Tazobactam|tazobactam|mesh-list
25116419|NCT03108690|Piperacillin|piperacillin|mesh-list
25116420|NCT03108690|Ampicillin|ampicillin|mesh-list
25116421|NCT03108690|Cefuroxime|cefuroxime|mesh-list
25116422|NCT03108690|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25116423|NCT03108690|Lactams|lactams|mesh-list
25116424|NCT03108690|beta-Lactams|beta-lactams|mesh-list
25116425|NCT03108690|Penicillin G|penicillin g|mesh-list
25116426|NCT03108690|Dicloxacillin|dicloxacillin|mesh-list
25116427|NCT03108690|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25116428|NCT03108690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25116429|NCT03108690|Antitubercular Agents|antitubercular agents|mesh-ancestor
25116430|NCT03108690|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25116431|NCT03108690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25116437|NCT03108807|Hemostatics|hemostatics|mesh-ancestor
25288576|NCT04341467|Olanzapine|olanzapine|mesh-list
25288577|NCT04341467|Amisulpride|amisulpride|mesh-list
25288578|NCT04341467|Antiemetics|antiemetics|mesh-ancestor
25288579|NCT04341467|Autonomic Agents|autonomic agents|mesh-ancestor
25288580|NCT04341467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25288581|NCT04341467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288582|NCT04341467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25288583|NCT04341467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25693167|NCT02009332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25693168|NCT02009332|Immunologic Factors|immunologic factors|mesh-ancestor
25693169|NCT02009332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693170|NCT02009332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25693171|NCT02009332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25693172|NCT02009332|Antifungal Agents|antifungal agents|mesh-ancestor
25693173|NCT02009397|Ipilimumab|ipilimumab|mesh-list
25288584|NCT04341467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25288585|NCT04341467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25080449|NCT03338426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25080456|NCT03338348|Azacitidine|azacitidine|mesh-list
25080457|NCT03338348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24767480|NCT01801046|Analgesics|analgesics|mesh-ancestor
24767481|NCT01801046|Sensory System Agents|sensory system agents|mesh-ancestor
24398014|NCT00143234|Amlodipine|amlodipine|mesh-list
25288586|NCT04341467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25288587|NCT04341467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25288588|NCT04341467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25288589|NCT04341467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25288590|NCT04341467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288591|NCT04341467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25288592|NCT04341467|Serotonin Agents|serotonin agents|mesh-ancestor
25288593|NCT04341467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25288594|NCT04341467|Dopamine Agents|dopamine agents|mesh-ancestor
25288595|NCT04341467|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25288596|NCT04341467|Antidepressive Agents|antidepressive agents|mesh-ancestor
25288597|NCT04287660|Clarithromycin|clarithromycin|mesh-list
25288598|NCT04287660|Dexamethasone|dexamethasone|mesh-list
25288599|NCT04287660|Lenalidomide|lenalidomide|mesh-list
25288600|NCT04287660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25288601|NCT04287660|Antiemetics|antiemetics|mesh-ancestor
25288602|NCT04287660|Autonomic Agents|autonomic agents|mesh-ancestor
25288603|NCT04287660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25288604|NCT04287660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288605|NCT04287660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25288606|NCT04287660|Glucocorticoids|glucocorticoids|mesh-ancestor
25288607|NCT04287660|Hormones|hormones|mesh-ancestor
25288608|NCT04287660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25288609|NCT04287660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25288610|NCT04287660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25288611|NCT04287660|Immunologic Factors|immunologic factors|mesh-ancestor
25288612|NCT04287660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25288613|NCT04287660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25288614|NCT04287660|Growth Substances|growth substances|mesh-ancestor
25288615|NCT04287660|Growth Inhibitors|growth inhibitors|mesh-ancestor
25288616|NCT04287660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25288617|NCT04287660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25288618|NCT04287660|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25288619|NCT04287660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25116446|NCT03108664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25116447|NCT03108313|Fluorides|fluorides|mesh-list
25116448|NCT03108313|Cariostatic Agents|cariostatic agents|mesh-ancestor
25116449|NCT03108313|Protective Agents|protective agents|mesh-ancestor
25116450|NCT03108313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116451|NCT03108625|Vortioxetine|vortioxetine|mesh-list
25116452|NCT03108625|Antidepressive Agents|antidepressive agents|mesh-ancestor
25116453|NCT03108625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25116454|NCT03108625|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25116455|NCT03108625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25116456|NCT03108625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25116457|NCT03108625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116458|NCT03108625|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25116459|NCT03108625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25116460|NCT03108625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25116461|NCT03108625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116462|NCT03108625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25116463|NCT03108625|Serotonin Agents|serotonin agents|mesh-ancestor
25116464|NCT03108625|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25693174|NCT02009397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25693175|NCT02009397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693176|NCT02009397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25693177|NCT02009397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693178|NCT02009722|Morphine|morphine|mesh-list
25693179|NCT02009722|Hydromorphone|hydromorphone|mesh-list
25693180|NCT02009722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25693181|NCT02009722|Narcotics|narcotics|mesh-ancestor
25693182|NCT02009722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25693183|NCT02009722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767536|NCT01801774|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24767537|NCT01801774|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24767538|NCT01801774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24767572|NCT01802268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767573|NCT01802268|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25116465|NCT03108625|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25116466|NCT03108625|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25116467|NCT03108625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25116469|NCT03108300|Propranolol|propranolol|mesh-list
25288814|NCT03121001|Immunologic Factors|immunologic factors|mesh-ancestor
25116470|NCT03108300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25116471|NCT03108300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25116472|NCT03108300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25116473|NCT03108300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25116474|NCT03108300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25116475|NCT03108300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116476|NCT03108300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24893345|NCT04451174|Prednisone|prednisone|mesh-list
24709002|NCT01503671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709003|NCT01503736|Citric Acid|citric acid|mesh-list
25288620|NCT04287660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288621|NCT04287660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25288622|NCT04287660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25288623|NCT04255277|Moxifloxacin|moxifloxacin|mesh-list
25288624|NCT04255277|Levonorgestrel|levonorgestrel|mesh-list
25288625|NCT04255277|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25288626|NCT04255277|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25288627|NCT04255277|Contraceptive Agents|contraceptive agents|mesh-list
25288628|NCT04255277|Contraceptives, Oral|contraceptives, oral|mesh-list
25288629|NCT04255277|Charcoal|charcoal|mesh-list
25288630|NCT04255277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25288631|NCT04255277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25288632|NCT04255277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25288633|NCT04255277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25288634|NCT04255277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25288641|NCT04255277|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24897192|NCT04427709|Oxytocin|oxytocin|mesh-list
25288642|NCT04255277|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25288643|NCT04255277|Estrogens|estrogens|mesh-ancestor
25288644|NCT04255277|Hormones|hormones|mesh-ancestor
25288645|NCT04255277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25288646|NCT04255277|Antidotes|antidotes|mesh-ancestor
25288647|NCT04255277|Protective Agents|protective agents|mesh-ancestor
25288652|NCT04058158|Eculizumab|eculizumab|mesh-list
25116503|NCT03108248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25116504|NCT03108248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25116505|NCT03108248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25116506|NCT03108248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25116507|NCT03108248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25116508|NCT03108248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116509|NCT03108248|Hemostatics|hemostatics|mesh-ancestor
25116510|NCT03108248|Coagulants|coagulants|mesh-ancestor
25116511|NCT03108287|Amoxicillin|amoxicillin|mesh-list
25116512|NCT03108287|Clarithromycin|clarithromycin|mesh-list
25116513|NCT03108287|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
25116514|NCT03108287|Rabeprazole|rabeprazole|mesh-list
25116516|NCT03108287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25116517|NCT03108287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25116518|NCT03108287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25116519|NCT03108287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25116520|NCT03108287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116521|NCT03108287|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25116522|NCT03108287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25693184|NCT02009722|Analgesics|analgesics|mesh-ancestor
25693185|NCT02009722|Sensory System Agents|sensory system agents|mesh-ancestor
25693186|NCT02009722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25693187|NCT02009878|Tolvaptan|tolvaptan|mesh-list
25693188|NCT02009878|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25693189|NCT02009878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693190|NCT02009878|Natriuretic Agents|natriuretic agents|mesh-ancestor
25693191|NCT02009878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693192|NCT02010021|Letrozole|letrozole|mesh-list
24620400|NCT01056874|Antiviral Agents|antiviral agents|mesh-ancestor
24620401|NCT01056874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24620402|NCT01056874|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24482454|NCT00439049|Sympathomimetics|sympathomimetics|mesh-ancestor
25693193|NCT02010021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25116523|NCT03108287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25116524|NCT03108287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25116525|NCT03108287|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25116531|NCT03108274|Mycophenolic Acid|mycophenolic acid|mesh-list
25116532|NCT03108274|Midazolam|midazolam|mesh-list
25116533|NCT03108274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25116534|NCT03108274|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25116535|NCT03108274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25116536|NCT03108274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116537|NCT03108274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25116538|NCT03108274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25116539|NCT03108274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25116540|NCT03108274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25288653|NCT04058158|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25288654|NCT04058158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25288655|NCT04058158|Immunologic Factors|immunologic factors|mesh-ancestor
25288816|NCT03121001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25288656|NCT04058158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288657|NCT03966807|Nicotine|nicotine|mesh-list
25288658|NCT03966807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25288659|NCT03966807|Autonomic Agents|autonomic agents|mesh-ancestor
25288660|NCT03966807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25288661|NCT03966807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288662|NCT03966807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25288663|NCT03966807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25288664|NCT03966807|Cholinergic Agents|cholinergic agents|mesh-ancestor
25288665|NCT03966807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25288666|NCT03966807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288667|NCT03922620|Bupivacaine|bupivacaine|mesh-list
25288668|NCT03922620|Anesthetics, Local|anesthetics, local|mesh-ancestor
25288669|NCT03922620|Anesthetics|anesthetics|mesh-ancestor
25288670|NCT03922620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25288671|NCT03922620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288672|NCT03922620|Sensory System Agents|sensory system agents|mesh-ancestor
25288673|NCT03922620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116565|NCT03107858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116566|NCT03107858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116568|NCT03107858|Autonomic Agents|autonomic agents|mesh-ancestor
25116569|NCT03107858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116570|NCT03107858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25116571|NCT03107858|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25116572|NCT03107858|Dopamine Agents|dopamine agents|mesh-ancestor
25116573|NCT03107858|Protective Agents|protective agents|mesh-ancestor
25116574|NCT03107962|Pembrolizumab|pembrolizumab|mesh-list
25116575|NCT03107962|Antibodies|antibodies|mesh-list
25116576|NCT03107962|Antibodies, Blocking|antibodies, blocking|mesh-list
25116577|NCT03107962|Immunologic Factors|immunologic factors|mesh-ancestor
25116578|NCT03107962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709025|NCT01503788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25116588|NCT03107923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116589|NCT03107923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116590|NCT03107923|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25116591|NCT03107923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25116592|NCT03107923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25693194|NCT02010021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25693195|NCT02010021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25693196|NCT02010021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693197|NCT02010021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693198|NCT02010021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25693199|NCT02010021|Hormone Antagonists|hormone antagonists|mesh-ancestor
24767737|NCT01802931|Ketoconazole|ketoconazole|mesh-list
25116593|NCT03107923|Adrenergic Agents|adrenergic agents|mesh-ancestor
25116594|NCT03107923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25116595|NCT03107923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116596|NCT03107923|Protective Agents|protective agents|mesh-ancestor
25116597|NCT03107689|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
25116598|NCT03107689|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25116599|NCT03107689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25116600|NCT03107702|Melatonin|melatonin|mesh-list
25116601|NCT03107702|Antioxidants|antioxidants|mesh-ancestor
25116602|NCT03107702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116603|NCT03107702|Protective Agents|protective agents|mesh-ancestor
25116604|NCT03107702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116605|NCT03107702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24709026|NCT01503788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709027|NCT01503801|Nitric Oxide|nitric oxide|mesh-list
24709028|NCT01503801|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-list
24709029|NCT01503801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24709030|NCT01503801|Autonomic Agents|autonomic agents|mesh-ancestor
24709031|NCT01503801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24709032|NCT01503801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709075|NCT01503918|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
24709076|NCT01503918|Antiviral Agents|antiviral agents|mesh-ancestor
24709077|NCT01503918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24709078|NCT01503918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24709079|NCT01503918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24645034|NCT01194934|Lenograstim|lenograstim|mesh-list
24709080|NCT01503918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709083|NCT01503983|Trastuzumab|trastuzumab|mesh-list
24709084|NCT01503983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24709085|NCT01503983|Antimetabolites|antimetabolites|mesh-ancestor
25288815|NCT03121001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288728|NCT03593915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288729|NCT03593915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25288730|NCT03593915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25288731|NCT03593915|Growth Inhibitors|growth inhibitors|mesh-ancestor
25288732|NCT03593915|Growth Substances|growth substances|mesh-ancestor
25288733|NCT03593915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288734|NCT03593915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25288741|NCT03425565|Pembrolizumab|pembrolizumab|mesh-list
25288751|NCT03423680|Dopamine Agonists|dopamine agonists|mesh-ancestor
25288752|NCT03423680|Dopamine Agents|dopamine agents|mesh-ancestor
25288753|NCT03423680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25288754|NCT03423680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116607|NCT03107481|Hydromorphone|hydromorphone|mesh-list
25116608|NCT03107481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25116609|NCT03107481|Analgesics|analgesics|mesh-ancestor
25116610|NCT03107481|Sensory System Agents|sensory system agents|mesh-ancestor
25116611|NCT03107481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116612|NCT03107481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116613|NCT03107481|Antipyretics|antipyretics|mesh-ancestor
25116614|NCT03107481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25116615|NCT03107481|Narcotics|narcotics|mesh-ancestor
25116616|NCT03107481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25116617|NCT03107429|Acetazolamide|acetazolamide|mesh-list
25116618|NCT03107429|Anticonvulsants|anticonvulsants|mesh-ancestor
25116619|NCT03107429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25116620|NCT03107429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25116621|NCT03107429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116622|NCT03107429|Diuretics|diuretics|mesh-ancestor
25116623|NCT03107429|Natriuretic Agents|natriuretic agents|mesh-ancestor
25116624|NCT03107429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116625|NCT03107325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25116626|NCT03107325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25116627|NCT03107325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116628|NCT03107208|Insulin Glargine|insulin glargine|mesh-list
25116629|NCT03107208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25116630|NCT03107208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116631|NCT03107247|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
25116632|NCT03107247|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25116633|NCT03107247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116634|NCT03107338|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
25709254|NCT02263547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24767907|NCT01804244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24767909|NCT01804335|Dermatologic Agents|dermatologic agents|mesh-ancestor
24767910|NCT01804361|Cyclosporine|cyclosporine|mesh-list
24767911|NCT01804361|Cyclosporins|cyclosporins|mesh-list
24767912|NCT01804361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25116635|NCT03107338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25116636|NCT03107338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25116637|NCT03107338|Analgesics|analgesics|mesh-ancestor
25108825|NCT03130153|Antipyretics|antipyretics|mesh-ancestor
24709086|NCT01503983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709087|NCT01503983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24709173|NCT01504282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24709174|NCT01504282|Alkylating Agents|alkylating agents|mesh-ancestor
24709175|NCT01504282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709176|NCT01504282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24709177|NCT01504282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25288755|NCT03423680|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25288756|NCT03423680|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25288757|NCT03423680|Serotonin Agents|serotonin agents|mesh-ancestor
25288758|NCT03423680|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25288759|NCT03423680|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25288760|NCT03423680|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25288761|NCT03423680|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25288762|NCT03393468|Dapivirine|dapivirine|mesh-list
24680525|NCT01375322|Valsartan|valsartan|mesh-list
25288763|NCT03393468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25288764|NCT03393468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25288765|NCT03393468|Antiviral Agents|antiviral agents|mesh-ancestor
25288766|NCT03393468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25116665|NCT03107078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116666|NCT03107078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25288805|NCT03295981|Zoledronic Acid|zoledronic acid|mesh-list
25288806|NCT03295981|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25288807|NCT03295981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288808|NCT03121001|Mycophenolic Acid|mycophenolic acid|mesh-list
25288809|NCT03121001|Sirolimus|sirolimus|mesh-list
25288810|NCT03121001|Cyclophosphamide|cyclophosphamide|mesh-list
25288811|NCT03121001|Fludarabine|fludarabine|mesh-list
25288812|NCT03121001|Thymoglobulin|thymoglobulin|mesh-list
25288813|NCT03121001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25288817|NCT03121001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25288818|NCT03121001|Alkylating Agents|alkylating agents|mesh-ancestor
25288819|NCT03121001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288820|NCT03121001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25288821|NCT03121001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25116695|NCT03106831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116696|NCT03106831|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25116697|NCT03106740|Minocycline|minocycline|mesh-list
25116698|NCT03106740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25116699|NCT03106740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25116700|NCT03106597|Amlodipine|amlodipine|mesh-list
25116701|NCT03106597|Manidipine|manidipine|mesh-list
25116702|NCT03106597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25116703|NCT03106597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25116704|NCT03106597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25116705|NCT03106597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116706|NCT03106597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25116707|NCT03106597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116708|NCT03106597|Vasodilator Agents|vasodilator agents|mesh-ancestor
25116709|NCT03106818|Ketorolac|ketorolac|mesh-list
25116710|NCT03106818|Magnesium Sulfate|magnesium sulfate|mesh-list
25116711|NCT03106818|Bupivacaine|bupivacaine|mesh-list
25116712|NCT03106818|Anesthetics, Local|anesthetics, local|mesh-list
25116713|NCT03106818|Anesthetics|anesthetics|mesh-list
25116714|NCT03106818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25116715|NCT03106818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116716|NCT03106818|Sensory System Agents|sensory system agents|mesh-ancestor
25116717|NCT03106818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25693200|NCT02010021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25693201|NCT02010021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693202|NCT02010203|BCG Vaccine|bcg vaccine|mesh-list
25693203|NCT02010203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25116718|NCT03106818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25288833|NCT02965898|Cholecalciferol|cholecalciferol|mesh-list
24768003|NCT01805115|Oxytocics|oxytocics|mesh-ancestor
25288834|NCT02965898|Vitamins|vitamins|mesh-list
25288835|NCT02965898|Micronutrients|micronutrients|mesh-ancestor
25288836|NCT02965898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288837|NCT02965898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25288838|NCT02965898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25116729|NCT03106818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25116730|NCT03106818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25116731|NCT03106818|Tocolytic Agents|tocolytic agents|mesh-ancestor
25116732|NCT03106818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25116733|NCT03106662|Cyclophosphamide|cyclophosphamide|mesh-list
25116734|NCT03106662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25116735|NCT03106662|Immunologic Factors|immunologic factors|mesh-ancestor
25116736|NCT03106662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116737|NCT03106662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25116738|NCT03106662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25116739|NCT03106662|Alkylating Agents|alkylating agents|mesh-ancestor
25116740|NCT03106662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116741|NCT03106662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25116742|NCT03106662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25116743|NCT03106623|Solifenacin Succinate|solifenacin succinate|mesh-list
25116744|NCT03106623|Mirabegron|mirabegron|mesh-list
25116745|NCT03106623|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25116746|NCT03106623|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25116747|NCT03106623|Cholinergic Agents|cholinergic agents|mesh-ancestor
25116748|NCT03106623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25116749|NCT03106623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116750|NCT03106623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116751|NCT03106623|Urological Agents|urological agents|mesh-ancestor
24709179|NCT01504295|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24709180|NCT01504321|Moxonidine|moxonidine|mesh-list
24709181|NCT01504321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24709182|NCT01504334|Pirfenidone|pirfenidone|mesh-list
24709183|NCT01504334|Analgesics|analgesics|mesh-ancestor
24709184|NCT01504334|Sensory System Agents|sensory system agents|mesh-ancestor
24709185|NCT01504334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24709186|NCT01504334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288873|NCT02660645|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25288874|NCT02660645|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25288875|NCT02660645|Dermatologic Agents|dermatologic agents|mesh-ancestor
25288876|NCT02563015|Vitamin D|vitamin d|mesh-list
25288877|NCT02563015|Cholecalciferol|cholecalciferol|mesh-list
25288878|NCT02563015|Vitamins|vitamins|mesh-ancestor
25288879|NCT02563015|Micronutrients|micronutrients|mesh-ancestor
25288880|NCT02563015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288881|NCT02563015|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25288882|NCT02563015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25288883|NCT02531932|Carboplatin|carboplatin|mesh-list
25288884|NCT02531932|Everolimus|everolimus|mesh-list
25288885|NCT02531932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25288886|NCT02531932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25288887|NCT02531932|Immunologic Factors|immunologic factors|mesh-ancestor
24681204|NCT01378884|Antiemetics|antiemetics|mesh-ancestor
25288888|NCT02531932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288897|NCT05094947|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
25288898|NCT05094947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25288899|NCT05094947|Adrenergic Agents|adrenergic agents|mesh-ancestor
25288900|NCT05094947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25288901|NCT05094947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288902|NCT05094947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288903|NCT05094804|Pembrolizumab|pembrolizumab|mesh-list
25116752|NCT03106623|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25116776|NCT03106532|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25116777|NCT03106545|Bupivacaine|bupivacaine|mesh-list
25116778|NCT03106545|Anesthetics, Local|anesthetics, local|mesh-ancestor
25116779|NCT03106545|Anesthetics|anesthetics|mesh-ancestor
25116780|NCT03106545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25116781|NCT03106545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116782|NCT03106545|Sensory System Agents|sensory system agents|mesh-ancestor
25116783|NCT03106545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116784|NCT03106454|Ferrous fumarate|ferrous fumarate|mesh-list
25116785|NCT03106454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25116786|NCT03106454|Norethindrone|norethindrone|mesh-list
25116787|NCT03106454|Norethindrone Acetate|norethindrone acetate|mesh-list
25116788|NCT03106454|Estradiol|estradiol|mesh-list
25116789|NCT03106454|Estrogens|estrogens|mesh-ancestor
25693204|NCT02010203|Immunologic Factors|immunologic factors|mesh-ancestor
25693205|NCT02010203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116790|NCT03106454|Hormones|hormones|mesh-ancestor
25116791|NCT03106454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25116792|NCT03106454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116793|NCT03106454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25116794|NCT03106454|Contraceptive Agents|contraceptive agents|mesh-ancestor
25116795|NCT03106454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25116796|NCT03106454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25116797|NCT03106454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25116798|NCT03106454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25116799|NCT03106454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25116800|NCT03106454|Trace Elements|trace elements|mesh-ancestor
25116801|NCT03106454|Micronutrients|micronutrients|mesh-ancestor
24793303|NCT03542695|Copper|copper|mesh-list
25116802|NCT03106363|Ethanol|ethanol|mesh-list
25116803|NCT03106363|Dronabinol|dronabinol|mesh-list
25116804|NCT03106363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25116805|NCT03106363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25116806|NCT03106363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25116807|NCT03106363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116808|NCT03106363|Hallucinogens|hallucinogens|mesh-ancestor
25116809|NCT03106363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25116810|NCT03106363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25288904|NCT05094804|Nivolumab|nivolumab|mesh-list
25288905|NCT05094804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25288906|NCT05094804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25288907|NCT05094804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25288908|NCT05094804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116811|NCT03106363|Analgesics|analgesics|mesh-ancestor
25116812|NCT03106363|Sensory System Agents|sensory system agents|mesh-ancestor
25116813|NCT03106363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116814|NCT03106363|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25116815|NCT03106363|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25116816|NCT03106363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25116817|NCT03106363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116818|NCT03106363|Hormones|hormones|mesh-ancestor
25116819|NCT03106363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25116820|NCT03106519|Bupivacaine|bupivacaine|mesh-list
25116821|NCT03106519|Anesthetics, Local|anesthetics, local|mesh-ancestor
25116822|NCT03106519|Anesthetics|anesthetics|mesh-ancestor
25116823|NCT03106519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25116824|NCT03106519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116825|NCT03106519|Sensory System Agents|sensory system agents|mesh-ancestor
25116826|NCT03106519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116827|NCT03106389|Misoprostol|misoprostol|mesh-list
25116828|NCT03106389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25116829|NCT03106389|Abortifacient Agents|abortifacient agents|mesh-ancestor
25116830|NCT03106389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25116831|NCT03106389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116832|NCT03106389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25116833|NCT03106389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25116835|NCT03106311|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25116836|NCT03106311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25116837|NCT03106311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116838|NCT03106402|Bromfenac|bromfenac|mesh-list
25116839|NCT03106402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25116840|NCT03106402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25116841|NCT03106402|Analgesics|analgesics|mesh-ancestor
25116842|NCT03106402|Sensory System Agents|sensory system agents|mesh-ancestor
25116843|NCT03106402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116844|NCT03106402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116845|NCT03106402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25116846|NCT03106402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25288909|NCT05094596|Montelukast|montelukast|mesh-list
25288910|NCT05094596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25288911|NCT05094596|Respiratory System Agents|respiratory system agents|mesh-ancestor
25288912|NCT05094596|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25288913|NCT05094596|Hormone Antagonists|hormone antagonists|mesh-ancestor
25288914|NCT05094596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25693206|NCT02010255|Sofosbuvir|sofosbuvir|mesh-list
25693207|NCT02010255|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25288915|NCT05094596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288916|NCT05094596|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25288917|NCT05094596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25288918|NCT05094596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288919|NCT05094492|Fluorides|fluorides|mesh-list
25288920|NCT05094492|Fluorides, Topical|fluorides, topical|mesh-list
25288921|NCT05094492|Cariostatic Agents|cariostatic agents|mesh-ancestor
25288922|NCT05094492|Protective Agents|protective agents|mesh-ancestor
25288923|NCT05094492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288924|NCT05094414|Valacyclovir|valacyclovir|mesh-list
25288925|NCT05094414|Antiviral Agents|antiviral agents|mesh-ancestor
25288926|NCT05094414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25288927|NCT05094375|Misoprostol|misoprostol|mesh-list
25288928|NCT05094375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25288929|NCT05094375|Abortifacient Agents|abortifacient agents|mesh-ancestor
25288930|NCT05094375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25288931|NCT05094375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288932|NCT05094375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25288933|NCT05094375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25288934|NCT05094375|Oxytocics|oxytocics|mesh-ancestor
25288935|NCT05093907|Capecitabine|capecitabine|mesh-list
25288936|NCT05093907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25288937|NCT05093907|Antimetabolites|antimetabolites|mesh-ancestor
25288938|NCT05093907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288939|NCT05093907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25288940|NCT05093478|Lidocaine|lidocaine|mesh-list
25288941|NCT05093478|Capsaicin|capsaicin|mesh-list
25288942|NCT05093478|Anesthetics, Local|anesthetics, local|mesh-ancestor
25288943|NCT05093478|Anesthetics|anesthetics|mesh-ancestor
25288944|NCT05093478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25288945|NCT05093478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893962|NCT04445779|Micronutrients|micronutrients|mesh-ancestor
24893963|NCT04445779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893964|NCT04445779|Vitamins|vitamins|mesh-ancestor
24893965|NCT04445467|Favipiravir|favipiravir|mesh-list
24893966|NCT04445467|Antiviral Agents|antiviral agents|mesh-ancestor
25116847|NCT03106298|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25116848|NCT03106298|Hematinics|hematinics|mesh-ancestor
25116849|NCT03105830|Acetaminophen|acetaminophen|mesh-list
25116850|NCT03105830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25116851|NCT03105830|Analgesics|analgesics|mesh-ancestor
25116852|NCT03105830|Sensory System Agents|sensory system agents|mesh-ancestor
25116853|NCT03105830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25288946|NCT05093478|Sensory System Agents|sensory system agents|mesh-ancestor
25288947|NCT05093478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25288948|NCT05093478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25288949|NCT05093478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25288950|NCT05093478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25116854|NCT03105830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116855|NCT03105830|Antipyretics|antipyretics|mesh-ancestor
25116856|NCT03105986|Probenecid|probenecid|mesh-list
25116857|NCT03105986|Uricosuric Agents|uricosuric agents|mesh-ancestor
25116858|NCT03105986|Gout Suppressants|gout suppressants|mesh-ancestor
25116859|NCT03105986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25116860|NCT03105986|Renal Agents|renal agents|mesh-ancestor
25116861|NCT03105960|Chlorhexidine|chlorhexidine|mesh-list
25116862|NCT03105960|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25116863|NCT03105960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25116864|NCT03105960|Disinfectants|disinfectants|mesh-ancestor
25116865|NCT03105661|Atenolol|atenolol|mesh-list
25116866|NCT03105661|Labetalol|labetalol|mesh-list
25116867|NCT03105661|Nifedipine|nifedipine|mesh-list
24709187|NCT01504334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24709188|NCT01504334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24709189|NCT01504334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24614080|NCT01022463|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24614081|NCT01022463|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24614083|NCT01022463|Adrenergic Agents|adrenergic agents|mesh-ancestor
24614084|NCT01022463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24614085|NCT01022463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614114|NCT01022541|Oxaliplatin|oxaliplatin|mesh-list
24614115|NCT01022541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24614116|NCT01022541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614117|NCT01022541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25288951|NCT05093478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25288952|NCT05093478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288953|NCT05093478|Antipruritics|antipruritics|mesh-ancestor
24768272|NCT01806948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25288954|NCT05093478|Dermatologic Agents|dermatologic agents|mesh-ancestor
25288955|NCT05093387|Carboplatin|carboplatin|mesh-list
24681669|NCT01381523|Naproxen|naproxen|mesh-list
25288956|NCT05093387|Pembrolizumab|pembrolizumab|mesh-list
25288957|NCT05093387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25288958|NCT05093387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25288959|NCT05093231|Pembrolizumab|pembrolizumab|mesh-list
25288960|NCT05093231|Olaparib|olaparib|mesh-list
25288961|NCT05093231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25288962|NCT05093231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25288963|NCT05093231|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25288964|NCT05093231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25288965|NCT05093231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288974|NCT05092945|Niacin|niacin|mesh-list
25116874|NCT03105661|Tocolytic Agents|tocolytic agents|mesh-ancestor
25116875|NCT03105661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25116876|NCT03105661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25116877|NCT03105661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25116878|NCT03105661|Sympatholytics|sympatholytics|mesh-ancestor
25116879|NCT03105661|Autonomic Agents|autonomic agents|mesh-ancestor
25116880|NCT03105661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116881|NCT03105661|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25116882|NCT03105661|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25116883|NCT03105661|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25116884|NCT03105661|Adrenergic Agents|adrenergic agents|mesh-ancestor
25116885|NCT03105661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25116886|NCT03105661|Sympathomimetics|sympathomimetics|mesh-ancestor
25116887|NCT03105661|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25116888|NCT03105661|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25116889|NCT03105791|Analgesics, Opioid|analgesics, opioid|mesh-list
25116890|NCT03105791|Narcotics|narcotics|mesh-ancestor
25116891|NCT03105791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25116892|NCT03105791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116893|NCT03105791|Analgesics|analgesics|mesh-ancestor
25116894|NCT03105791|Sensory System Agents|sensory system agents|mesh-ancestor
25116895|NCT03105791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116896|NCT03105674|Anesthetics|anesthetics|mesh-list
25116897|NCT03105674|Anesthetics, Local|anesthetics, local|mesh-list
25116898|NCT03105674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25116899|NCT03105674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116900|NCT03105674|Sensory System Agents|sensory system agents|mesh-ancestor
25116901|NCT03105674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116902|NCT03105765|Ketamine|ketamine|mesh-list
25116903|NCT03105765|Analgesics|analgesics|mesh-ancestor
25116904|NCT03105765|Sensory System Agents|sensory system agents|mesh-ancestor
25116905|NCT03105765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116906|NCT03105765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116907|NCT03105765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25116908|NCT03105765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25116910|NCT03105765|Anesthetics|anesthetics|mesh-ancestor
25288975|NCT05092945|Nicotinic Acids|nicotinic acids|mesh-list
25288976|NCT05092945|Niacinamide|niacinamide|mesh-list
25288977|NCT05092945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25288978|NCT05092945|Antimetabolites|antimetabolites|mesh-ancestor
25288979|NCT05092945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25288980|NCT05092945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25288981|NCT05092945|Vasodilator Agents|vasodilator agents|mesh-ancestor
25288982|NCT05092945|Vitamin B Complex|vitamin b complex|mesh-ancestor
25288984|NCT05092945|Micronutrients|micronutrients|mesh-ancestor
25288985|NCT05092945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288986|NCT05089526|Lidocaine|lidocaine|mesh-list
25288987|NCT05089526|Fentanyl|fentanyl|mesh-list
25288988|NCT05089526|Dexmedetomidine|dexmedetomidine|mesh-list
25288989|NCT05089526|Ketamine|ketamine|mesh-list
25288990|NCT05089526|Anesthetics, Local|anesthetics, local|mesh-ancestor
25288991|NCT05089526|Anesthetics|anesthetics|mesh-ancestor
25288992|NCT05089526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25288993|NCT05089526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25288994|NCT05089526|Sensory System Agents|sensory system agents|mesh-ancestor
25288995|NCT05089526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25288996|NCT05089526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25693208|NCT02010255|Ledipasvir|ledipasvir|mesh-list
25288997|NCT05089526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25288998|NCT05089526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25693209|NCT02010255|Antiviral Agents|antiviral agents|mesh-ancestor
24768345|NCT01807429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24768346|NCT01807429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24768347|NCT01807429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24768348|NCT01807429|GABA Modulators|gaba modulators|mesh-ancestor
24768349|NCT01807429|GABA Agents|gaba agents|mesh-ancestor
24768350|NCT01807494|Cimetidine|cimetidine|mesh-list
24768361|NCT01807494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24768363|NCT01807611|Cyclophosphamide|cyclophosphamide|mesh-list
24768364|NCT01807611|Melphalan|melphalan|mesh-list
24768365|NCT01807611|Mechlorethamine|mechlorethamine|mesh-list
24768366|NCT01807611|Thiotepa|thiotepa|mesh-list
25288999|NCT05089526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25289000|NCT05089526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289001|NCT05089526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25289002|NCT05089526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25289003|NCT05089526|Analgesics|analgesics|mesh-ancestor
25289004|NCT05089526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25289005|NCT05089526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25289006|NCT05089526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25289007|NCT05089526|Adrenergic Agents|adrenergic agents|mesh-ancestor
25289008|NCT05089526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25289009|NCT05089526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25289010|NCT05089526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25289011|NCT05089526|Anesthetics, General|anesthetics, general|mesh-ancestor
25289012|NCT05089526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25116912|NCT03105765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25116914|NCT03105765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25116915|NCT03105765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116916|NCT03105505|Fusidic Acid|fusidic acid|mesh-list
25116917|NCT03105505|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25116918|NCT03105505|Permethrin|permethrin|mesh-list
25116919|NCT03105505|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25116920|NCT03105505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25116921|NCT03105505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116922|NCT03105505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25116923|NCT03105505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25116924|NCT03105505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25116925|NCT03105193|Lidocaine|lidocaine|mesh-list
25116926|NCT03105193|Anesthetics, Local|anesthetics, local|mesh-ancestor
25116927|NCT03105193|Anesthetics|anesthetics|mesh-ancestor
25045611|NCT00938587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045612|NCT00936871|Moxifloxacin|moxifloxacin|mesh-list
25045613|NCT00936871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25045614|NCT00936871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25045615|NCT00936871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25045616|NCT00936871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25045617|NCT00936871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045618|NCT00936871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045619|NCT00936871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045620|NCT00935987|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
25045621|NCT00935987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25045622|NCT00935987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045623|NCT00935987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045624|NCT00934921|Ondansetron|ondansetron|mesh-list
25289015|NCT05089526|Narcotics|narcotics|mesh-ancestor
25289016|NCT05089526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25289041|NCT05049616|Nifedipine|nifedipine|mesh-list
25289042|NCT05049616|Diuretics|diuretics|mesh-list
25289043|NCT05049616|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25289044|NCT05049616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25045626|NCT00934921|Autonomic Agents|autonomic agents|mesh-ancestor
25045627|NCT00934921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045628|NCT00934921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045629|NCT00934921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25045630|NCT00934921|Antipruritics|antipruritics|mesh-ancestor
25045631|NCT00934921|Dermatologic Agents|dermatologic agents|mesh-ancestor
25693210|NCT02010255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25693211|NCT02010567|Capecitabine|capecitabine|mesh-list
25693212|NCT02010567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25693213|NCT02010567|Antimetabolites|antimetabolites|mesh-ancestor
25693214|NCT02010567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693215|NCT02010567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693216|NCT02010632|Clopidogrel|clopidogrel|mesh-list
25693217|NCT02010632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25693218|NCT02010632|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24559408|NCT04908579|Anesthetics, General|anesthetics, general|mesh-ancestor
25045632|NCT00934921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25116928|NCT03105193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25116929|NCT03105193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116930|NCT03105193|Sensory System Agents|sensory system agents|mesh-ancestor
25116931|NCT03105193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116932|NCT03105193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25116933|NCT03105193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25116934|NCT03105193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25116935|NCT03105193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25116936|NCT03105193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116937|NCT03105310|Interferons|interferons|mesh-list
25116938|NCT03105310|Interferon-alpha|interferon-alpha|mesh-list
25116939|NCT03105310|Ezetimibe|ezetimibe|mesh-list
25116940|NCT03105310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25116941|NCT03105310|Antiviral Agents|antiviral agents|mesh-ancestor
25116942|NCT03105310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25116943|NCT03105310|Immunologic Factors|immunologic factors|mesh-ancestor
25116944|NCT03105310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289158|NCT04582981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709245|NCT01504659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24709246|NCT01504659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24709247|NCT01504659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24709248|NCT01504659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709249|NCT01504724|Bevacizumab|bevacizumab|mesh-list
24709250|NCT01504724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24709251|NCT01504724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24709252|NCT01504724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24709253|NCT01504724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24709254|NCT01504724|Growth Substances|growth substances|mesh-ancestor
24709255|NCT01504724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709256|NCT01504724|Growth Inhibitors|growth inhibitors|mesh-ancestor
24709257|NCT01504776|Bortezomib|bortezomib|mesh-list
25289045|NCT05049616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25289046|NCT05049616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289047|NCT05049616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24516842|NCT00604032|Dermatologic Agents|dermatologic agents|mesh-ancestor
25289048|NCT05049616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289049|NCT05049616|Vasodilator Agents|vasodilator agents|mesh-ancestor
25289050|NCT05049616|Tocolytic Agents|tocolytic agents|mesh-ancestor
25289051|NCT05049616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25289052|NCT05049616|Natriuretic Agents|natriuretic agents|mesh-ancestor
25289053|NCT05049616|Protease Inhibitors|protease inhibitors|mesh-ancestor
25289054|NCT05049616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25289055|NCT05036876|Insulin Glargine|insulin glargine|mesh-list
25289056|NCT05036876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25289057|NCT05036876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289058|NCT05022810|Acetaminophen|acetaminophen|mesh-list
25289059|NCT05022810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25289060|NCT05022810|Analgesics|analgesics|mesh-ancestor
25289061|NCT05022810|Sensory System Agents|sensory system agents|mesh-ancestor
25289062|NCT05022810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25289063|NCT05022810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289064|NCT05022810|Antipyretics|antipyretics|mesh-ancestor
25289065|NCT05003349|Salicylic Acid|salicylic acid|mesh-list
25289066|NCT05003349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25289067|NCT05003349|Antifungal Agents|antifungal agents|mesh-ancestor
25289068|NCT05003349|Keratolytic Agents|keratolytic agents|mesh-ancestor
25289069|NCT05003349|Dermatologic Agents|dermatologic agents|mesh-ancestor
25289070|NCT04993560|Vaccines|vaccines|mesh-list
25116946|NCT03105310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25116947|NCT03105310|Antimetabolites|antimetabolites|mesh-ancestor
25116948|NCT03105310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25116949|NCT03105310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25116950|NCT03105583|Vitamins|vitamins|mesh-list
25116951|NCT03105583|Micronutrients|micronutrients|mesh-ancestor
24812659|NCT02053935|Dopamine Agents|dopamine agents|mesh-ancestor
25116952|NCT03105583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116953|NCT03105180|Mannitol|mannitol|mesh-list
25116955|NCT03105180|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25709255|NCT02263547|Analgesics|analgesics|mesh-ancestor
25116956|NCT03105180|Diuretics|diuretics|mesh-ancestor
25116957|NCT03105180|Natriuretic Agents|natriuretic agents|mesh-ancestor
25116958|NCT03105180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116959|NCT03105180|Cathartics|cathartics|mesh-ancestor
25116960|NCT03105180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25116961|NCT03105115|Fentanyl|fentanyl|mesh-list
25116962|NCT03105115|Bupivacaine|bupivacaine|mesh-list
25116963|NCT03105115|Anesthetics, Local|anesthetics, local|mesh-ancestor
25116964|NCT03105115|Anesthetics|anesthetics|mesh-ancestor
25116965|NCT03105115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25116966|NCT03105115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25116967|NCT03105115|Sensory System Agents|sensory system agents|mesh-ancestor
25116968|NCT03105115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25116969|NCT03105115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25116970|NCT03105115|Narcotics|narcotics|mesh-ancestor
25116971|NCT03105115|Analgesics|analgesics|mesh-ancestor
25116972|NCT03105115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25116973|NCT03105115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25116974|NCT03105115|Anesthetics, General|anesthetics, general|mesh-ancestor
25289071|NCT04993560|Immunologic Factors|immunologic factors|mesh-ancestor
25289072|NCT04993560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289073|NCT04947085|Ketamine|ketamine|mesh-list
25289074|NCT04947085|Analgesics|analgesics|mesh-ancestor
25289075|NCT04947085|Sensory System Agents|sensory system agents|mesh-ancestor
25289076|NCT04947085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25289077|NCT04947085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289577|NCT05095571|Niacin|niacin|mesh-list
25116998|NCT03105375|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25116999|NCT03105375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25117000|NCT03105375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117001|NCT03105466|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
25117002|NCT03105466|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25117003|NCT03105466|Tacrolimus|tacrolimus|mesh-list
25117039|NCT05377606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24611364|NCT01008982|Belimumab|belimumab|mesh-list
25117040|NCT05377606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117042|NCT05377606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25117043|NCT05377606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25117044|NCT05377606|GABA Modulators|gaba modulators|mesh-ancestor
25117045|NCT05377606|GABA Agents|gaba agents|mesh-ancestor
25117046|NCT05377606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25117047|NCT05377606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117078|NCT05376943|Antiviral Agents|antiviral agents|mesh-list
25117079|NCT05376943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25117080|NCT05376904|Ropivacaine|ropivacaine|mesh-list
24709258|NCT01504776|Panobinostat|panobinostat|mesh-list
24709259|NCT01504776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289087|NCT04885816|Sirolimus|sirolimus|mesh-list
25289088|NCT04885816|Everolimus|everolimus|mesh-list
25289089|NCT04885816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289090|NCT04885816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25289091|NCT04885816|Immunologic Factors|immunologic factors|mesh-ancestor
25289092|NCT04885816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289093|NCT04885816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25289094|NCT04885816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25289095|NCT04885816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25289096|NCT04885816|Antifungal Agents|antifungal agents|mesh-ancestor
25289097|NCT04865614|Sevoflurane|sevoflurane|mesh-list
25289098|NCT04865614|Etomidate|etomidate|mesh-list
25289099|NCT04865614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24682562|NCT01386736|Vitamin D|vitamin d|mesh-list
25289100|NCT04865614|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25289101|NCT04865614|Anesthetics, General|anesthetics, general|mesh-ancestor
25289102|NCT04865614|Anesthetics|anesthetics|mesh-ancestor
25289103|NCT04865614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25289104|NCT04865614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289105|NCT04865614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25289106|NCT04865614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25289107|NCT04854811|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
25289108|NCT04854811|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25289109|NCT04854811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25289110|NCT04854811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289111|NCT04770454|Buspirone|buspirone|mesh-list
25289112|NCT04770454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25289113|NCT04770454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25289114|NCT04770454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25289115|NCT04770454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289116|NCT04770454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25693219|NCT02010632|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25693220|NCT02010632|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25693221|NCT02010632|Purinergic Agents|purinergic agents|mesh-ancestor
25693222|NCT02010632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24451790|NCT00324818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24451791|NCT00324818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24451792|NCT00324831|Prednisone|prednisone|mesh-list
24768576|NCT01809171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768579|NCT01809184|Insulin|insulin|mesh-list
25289117|NCT04770454|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25289118|NCT04770454|Serotonin Agents|serotonin agents|mesh-ancestor
25289119|NCT04770454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25289120|NCT04770454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289121|NCT04691128|Anesthetics|anesthetics|mesh-list
25289122|NCT04691128|Propofol|propofol|mesh-list
25289123|NCT04691128|Desflurane|desflurane|mesh-list
25117081|NCT05376904|Anesthetics, Local|anesthetics, local|mesh-ancestor
25117082|NCT05376904|Anesthetics|anesthetics|mesh-ancestor
25117083|NCT05376904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25117084|NCT05376904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117085|NCT05376904|Sensory System Agents|sensory system agents|mesh-ancestor
25117086|NCT05376904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25117087|NCT05376865|Vitamin D|vitamin d|mesh-list
25117088|NCT05376865|Vitamins|vitamins|mesh-ancestor
25117089|NCT05376865|Micronutrients|micronutrients|mesh-ancestor
25117090|NCT05376865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117091|NCT05376865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25117092|NCT05376852|Decitabine|decitabine|mesh-list
25117093|NCT05376852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25117094|NCT05376852|Antimetabolites|antimetabolites|mesh-ancestor
25117095|NCT05376852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117096|NCT05376852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045633|NCT00934921|Serotonin Agents|serotonin agents|mesh-ancestor
25117132|NCT05375916|Hydromorphone|hydromorphone|mesh-list
25117133|NCT05375916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25117134|NCT05375916|Narcotics|narcotics|mesh-ancestor
25117135|NCT05375916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25117136|NCT05375916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117137|NCT05375916|Analgesics|analgesics|mesh-ancestor
25117138|NCT05375916|Sensory System Agents|sensory system agents|mesh-ancestor
25117139|NCT05375916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25117140|NCT05375630|Vitamin K|vitamin k|mesh-list
25117141|NCT05375630|Vitamin K 2|vitamin k 2|mesh-list
25117142|NCT05375630|Vitamins|vitamins|mesh-ancestor
25117143|NCT05375630|Micronutrients|micronutrients|mesh-ancestor
25117144|NCT05375630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117145|NCT05375630|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25117146|NCT05375630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25117148|NCT05375630|Hemostatics|hemostatics|mesh-ancestor
25289124|NCT04691128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25289125|NCT04691128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289126|NCT04691128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25289127|NCT04691128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25289128|NCT04691128|Anesthetics, General|anesthetics, general|mesh-ancestor
25289129|NCT04691128|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25289130|NCT04682522|Metronidazole|metronidazole|mesh-list
25289131|NCT04682522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25289132|NCT04682522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25289133|NCT04682522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25289134|NCT04682522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25289135|NCT04657809|Insulin|insulin|mesh-list
25289136|NCT04657809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25289137|NCT04657809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289138|NCT04601584|Antibodies|antibodies|mesh-list
25289139|NCT04601584|Immunoglobulins|immunoglobulins|mesh-list
25289140|NCT04601584|Immunologic Factors|immunologic factors|mesh-ancestor
25289141|NCT04601584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289142|NCT04585854|Caffeine|caffeine|mesh-list
25289143|NCT04585854|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25289144|NCT04585854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289145|NCT04585854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25289146|NCT04585854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25289147|NCT04585854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693223|NCT02010632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693224|NCT02010632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693225|NCT02010645|Decitabine|decitabine|mesh-list
25693226|NCT02010645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25289148|NCT04585854|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25289149|NCT04585854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25289150|NCT04585854|Purinergic Agents|purinergic agents|mesh-ancestor
25289151|NCT04585854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25289152|NCT04582981|Raltitrexed|raltitrexed|mesh-list
25289153|NCT04582981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25289154|NCT04582981|Antimetabolites|antimetabolites|mesh-ancestor
25289155|NCT04582981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289156|NCT04582981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289157|NCT04582981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25117169|NCT05375240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25117170|NCT05375240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25117172|NCT05375188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25117173|NCT05375188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25117174|NCT05375188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117175|NCT05375188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25117176|NCT05375188|Analgesics|analgesics|mesh-ancestor
25117177|NCT05375188|Sensory System Agents|sensory system agents|mesh-ancestor
25117178|NCT05375188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25117182|NCT05375188|Adrenergic Agents|adrenergic agents|mesh-ancestor
25117183|NCT05375188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25117184|NCT05375188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117186|NCT05374603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25117187|NCT05374603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25117191|NCT05374499|Epinephrine|epinephrine|mesh-list
25117192|NCT05374499|Bupivacaine|bupivacaine|mesh-list
25117193|NCT05374499|Anesthetics, Local|anesthetics, local|mesh-ancestor
25117194|NCT05374499|Anesthetics|anesthetics|mesh-ancestor
25117195|NCT05374499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25289167|NCT04504240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25117196|NCT05374499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709260|NCT01504776|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24709261|NCT01504776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709262|NCT01504776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709273|NCT01504906|Cyclosporins|cyclosporins|mesh-list
24709274|NCT01504906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709285|NCT01504906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25289168|NCT04504240|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25289169|NCT04504240|Histamine Antagonists|histamine antagonists|mesh-ancestor
25289170|NCT04504240|Histamine Agents|histamine agents|mesh-ancestor
25289171|NCT04504240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25289172|NCT04504240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289173|NCT04504240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289174|NCT04492306|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
25289175|NCT04492306|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25289176|NCT04492306|Protective Agents|protective agents|mesh-ancestor
25289177|NCT04492306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289178|NCT04492306|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25289179|NCT04492306|Antioxidants|antioxidants|mesh-ancestor
25289180|NCT04492306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683338|NCT01391377|Vitamins|vitamins|mesh-ancestor
25289181|NCT04469179|Immunoglobulins|immunoglobulins|mesh-list
25289182|NCT04469179|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25289183|NCT04469179|Immunologic Factors|immunologic factors|mesh-ancestor
25289184|NCT04469179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117197|NCT05374499|Sensory System Agents|sensory system agents|mesh-ancestor
25117198|NCT05374499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25117199|NCT05374499|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25117200|NCT05374499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25117201|NCT05374499|Adrenergic Agents|adrenergic agents|mesh-ancestor
25117202|NCT05374499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25117203|NCT05374499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117204|NCT05374499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25117205|NCT05374499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24797887|NCT01958944|Protective Agents|protective agents|mesh-ancestor
25117231|NCT05372991|Atropine|atropine|mesh-list
25117232|NCT05372991|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25117233|NCT05372991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25117234|NCT05372991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25117235|NCT05372991|Autonomic Agents|autonomic agents|mesh-ancestor
25117236|NCT05372991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25117237|NCT05372991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117238|NCT05372991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24768816|NCT01810731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768817|NCT01810770|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
24768819|NCT01810796|Ranolazine|ranolazine|mesh-list
25117239|NCT05372991|Respiratory System Agents|respiratory system agents|mesh-ancestor
25117240|NCT05372991|Mydriatics|mydriatics|mesh-ancestor
25117241|NCT05372991|Parasympatholytics|parasympatholytics|mesh-ancestor
25117242|NCT05372991|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25117243|NCT05372991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25117244|NCT05372991|Cholinergic Agents|cholinergic agents|mesh-ancestor
25117245|NCT05372991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25117246|NCT05372991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117247|NCT05371600|Midazolam|midazolam|mesh-list
24709286|NCT01504906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24709287|NCT01504906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24709289|NCT01504906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24709290|NCT01504984|Imatinib Mesylate|imatinib mesylate|mesh-list
24709291|NCT01504984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24709292|NCT01504984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24709293|NCT01504984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709294|NCT01504984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709295|NCT01505049|Vaccines|vaccines|mesh-list
24709296|NCT01505049|Immunologic Factors|immunologic factors|mesh-ancestor
24709297|NCT01505049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709298|NCT01505088|Benzalkonium Compounds|benzalkonium compounds|mesh-list
24709361|NCT01505231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709362|NCT01505231|Sympathomimetics|sympathomimetics|mesh-ancestor
24683987|NCT01394913|Etanercept|etanercept|mesh-list
24709455|NCT01505855|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24709456|NCT01505855|Immunologic Factors|immunologic factors|mesh-ancestor
24709505|NCT01506024|Cholinergic Agents|cholinergic agents|mesh-ancestor
24709533|NCT01506063|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25289200|NCT04429802|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
25289201|NCT04429802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25289202|NCT04429802|Serotonin Agents|serotonin agents|mesh-ancestor
25289203|NCT04429802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24420581|NCT00216372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289204|NCT04429802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289205|NCT04429802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289206|NCT04387760|Hydroxychloroquine|hydroxychloroquine|mesh-list
25289207|NCT04387760|Favipiravir|favipiravir|mesh-list
25289208|NCT04387760|Antimalarials|antimalarials|mesh-ancestor
25289209|NCT04387760|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25289210|NCT04387760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25289211|NCT04387760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25289212|NCT04387760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25289213|NCT04387760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289214|NCT04387760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25289215|NCT04387760|Antiviral Agents|antiviral agents|mesh-ancestor
25289216|NCT04356534|Antibodies|antibodies|mesh-list
25289217|NCT04356534|Immunologic Factors|immunologic factors|mesh-ancestor
25289218|NCT04356534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289219|NCT04331756|Anesthetics|anesthetics|mesh-list
25289220|NCT04331756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25289221|NCT04331756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289222|NCT04300244|Nivolumab|nivolumab|mesh-list
25117251|NCT05371600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117252|NCT05371600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25117253|NCT05371600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25117254|NCT05371600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25117255|NCT05371600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25117256|NCT05371600|Anesthetics, General|anesthetics, general|mesh-ancestor
25117257|NCT05371600|Anesthetics|anesthetics|mesh-ancestor
25117258|NCT05371600|GABA Modulators|gaba modulators|mesh-ancestor
25117259|NCT05371600|GABA Agents|gaba agents|mesh-ancestor
25117260|NCT05371600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25117261|NCT05371600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117262|NCT05369676|Ritonavir|ritonavir|mesh-list
25117263|NCT05369676|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25117264|NCT05369676|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25117265|NCT05369676|Protease Inhibitors|protease inhibitors|mesh-ancestor
25117266|NCT05369676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25117267|NCT05369676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117268|NCT05369676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25693227|NCT02010645|Antimetabolites|antimetabolites|mesh-ancestor
25693228|NCT02010645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117269|NCT05369676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25117270|NCT05369676|Antiviral Agents|antiviral agents|mesh-ancestor
25117271|NCT05369676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25117272|NCT05369676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25117273|NCT05369676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24977632|NCT02560298|Carboplatin|carboplatin|mesh-list
25289228|NCT04300244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289229|NCT04300244|Immunologic Factors|immunologic factors|mesh-ancestor
25289230|NCT04300244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289231|NCT04298203|Topiramate|topiramate|mesh-list
25289232|NCT04298203|Phentermine|phentermine|mesh-list
25289233|NCT04298203|Anticonvulsants|anticonvulsants|mesh-ancestor
25289234|NCT04298203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25289235|NCT04298203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289236|NCT04298203|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25289237|NCT04298203|Appetite Depressants|appetite depressants|mesh-ancestor
25289238|NCT04298203|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25289239|NCT04298203|Sympathomimetics|sympathomimetics|mesh-ancestor
25289240|NCT04298203|Autonomic Agents|autonomic agents|mesh-ancestor
25289241|NCT04298203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25289242|NCT04298203|Adrenergic Agents|adrenergic agents|mesh-ancestor
25289243|NCT04298203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25289244|NCT04298203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289245|NCT04214418|Hydroxychloroquine|hydroxychloroquine|mesh-list
25289246|NCT04214418|Atezolizumab|atezolizumab|mesh-list
25289247|NCT04214418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289248|NCT04214418|Antimalarials|antimalarials|mesh-ancestor
25289249|NCT04214418|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25289250|NCT04214418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25289251|NCT04214418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25289252|NCT04214418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25289253|NCT04214418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289254|NCT04214418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25117297|NCT05361330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117298|NCT05361330|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25117299|NCT05361330|Antidepressive Agents|antidepressive agents|mesh-ancestor
25117300|NCT05361330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25117301|NCT05361330|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25117302|NCT05361330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24778939|NCT01872988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25117306|NCT05350917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117308|NCT05338866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25117309|NCT05338866|Antimetabolites|antimetabolites|mesh-ancestor
25117310|NCT05338866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117311|NCT05338866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289269|NCT04182672|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25289270|NCT04182672|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25289271|NCT04182672|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25289272|NCT04182672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25289273|NCT04182672|Glucocorticoids|glucocorticoids|mesh-ancestor
25289274|NCT04182672|Hormones|hormones|mesh-ancestor
25289275|NCT04182672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25289276|NCT04182672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289277|NCT04182672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25289278|NCT04182672|Immunologic Factors|immunologic factors|mesh-ancestor
25289279|NCT04182672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25289280|NCT04182672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289287|NCT04085445|Paclitaxel|paclitaxel|mesh-list
25289288|NCT04085445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25289289|NCT04085445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289290|NCT04085445|Tubulin Modulators|tubulin modulators|mesh-ancestor
25289291|NCT04085445|Antimitotic Agents|antimitotic agents|mesh-ancestor
25289292|NCT04085445|Mitosis Modulators|mitosis modulators|mesh-ancestor
25289293|NCT04085445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117329|NCT05331807|Vitamin D|vitamin d|mesh-list
25117330|NCT05331807|Ergocalciferols|ergocalciferols|mesh-list
25117331|NCT05331807|Cholecalciferol|cholecalciferol|mesh-list
25117332|NCT05331807|Vitamins|vitamins|mesh-list
25117333|NCT05331807|Micronutrients|micronutrients|mesh-ancestor
25117334|NCT05331807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117335|NCT05331807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25117345|NCT05314127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117346|NCT05314127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25117351|NCT05314127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25117352|NCT05314127|Interferon Inducers|interferon inducers|mesh-ancestor
25117353|NCT05314127|Dermatologic Agents|dermatologic agents|mesh-ancestor
25117354|NCT05314127|Keratolytic Agents|keratolytic agents|mesh-ancestor
25117355|NCT05314127|Emollients|emollients|mesh-ancestor
25289299|NCT03854032|Linrodostat|linrodostat|mesh-list
25289300|NCT03854032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25289301|NCT03854032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289302|NCT03854032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25289303|NCT03854032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289304|NCT03854032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25289305|NCT03818763|Factor VIII|factor viii|mesh-list
25289306|NCT03818763|Coagulants|coagulants|mesh-ancestor
25289307|NCT03710876|Gemcitabine|gemcitabine|mesh-list
25289308|NCT03710876|Celecoxib|celecoxib|mesh-list
25289309|NCT03710876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25289310|NCT03710876|Antimetabolites|antimetabolites|mesh-ancestor
25289311|NCT03710876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289312|NCT03710876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289313|NCT03710876|Antiviral Agents|antiviral agents|mesh-ancestor
25289314|NCT03710876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25289315|NCT03710876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25289316|NCT03710876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25289317|NCT03710876|Immunologic Factors|immunologic factors|mesh-ancestor
25289318|NCT03710876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289319|NCT03710876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25289320|NCT03710876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25289321|NCT03710876|Analgesics|analgesics|mesh-ancestor
25289322|NCT03710876|Sensory System Agents|sensory system agents|mesh-ancestor
25289323|NCT03710876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25289324|NCT03710876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25289325|NCT03710876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25289326|NCT03710876|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25289327|NCT03710876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25289328|NCT03688828|Amoxicillin|amoxicillin|mesh-list
25289329|NCT03688828|Clarithromycin|clarithromycin|mesh-list
25289330|NCT03688828|Potassium Citrate|potassium citrate|mesh-list
25289331|NCT03688828|Esomeprazole|esomeprazole|mesh-list
25289332|NCT03688828|Bismuth|bismuth|mesh-list
25289333|NCT03688828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289334|NCT03688828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25289335|NCT03688828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25289336|NCT03688828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25289337|NCT03688828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25289338|NCT03688828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25289339|NCT03688828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25117414|NCT05283382|Cannabidiol|cannabidiol|mesh-list
25117415|NCT05283382|Anticonvulsants|anticonvulsants|mesh-ancestor
25289340|NCT03688828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25289341|NCT03688828|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25289342|NCT03688828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25289343|NCT03688828|Antacids|antacids|mesh-ancestor
25289344|NCT03688828|Diuretics|diuretics|mesh-ancestor
25117417|NCT05268744|Trace Elements|trace elements|mesh-list
25117418|NCT05268744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117419|NCT05261464|Metoprolol|metoprolol|mesh-list
25117420|NCT05261464|Diltiazem|diltiazem|mesh-list
25117421|NCT05261464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25117422|NCT05261464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25117423|NCT05261464|Sympatholytics|sympatholytics|mesh-ancestor
25117424|NCT05261464|Autonomic Agents|autonomic agents|mesh-ancestor
25117425|NCT05261464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25117426|NCT05261464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117427|NCT05261464|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25117428|NCT05261464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25117429|NCT05261464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25117430|NCT05261464|Adrenergic Agents|adrenergic agents|mesh-ancestor
25289345|NCT03688828|Natriuretic Agents|natriuretic agents|mesh-ancestor
25289346|NCT03688828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289347|NCT03688828|Expectorants|expectorants|mesh-ancestor
24769114|NCT01812603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769115|NCT01812616|Nabiximols|nabiximols|mesh-list
24769116|NCT01812616|Analgesics|analgesics|mesh-ancestor
24769128|NCT01812720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24769131|NCT01812720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24769154|NCT01812954|Adalimumab|adalimumab|mesh-list
25289348|NCT03688828|Respiratory System Agents|respiratory system agents|mesh-ancestor
25289349|NCT03643822|Dexamethasone|dexamethasone|mesh-list
25289350|NCT03643822|Dexamethasone acetate|dexamethasone acetate|mesh-list
25289351|NCT03643822|Dexmedetomidine|dexmedetomidine|mesh-list
25289352|NCT03643822|BB 1101|bb 1101|mesh-list
25289353|NCT03643822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25289354|NCT03643822|Antiemetics|antiemetics|mesh-ancestor
25289355|NCT03643822|Autonomic Agents|autonomic agents|mesh-ancestor
25289356|NCT03643822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25289357|NCT03643822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289358|NCT03643822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25289359|NCT03643822|Glucocorticoids|glucocorticoids|mesh-ancestor
25289360|NCT03643822|Hormones|hormones|mesh-ancestor
25289361|NCT03643822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25289362|NCT03643822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25289363|NCT03643822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289364|NCT03643822|Protease Inhibitors|protease inhibitors|mesh-ancestor
25289365|NCT03643822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25289513|NCT02395640|Epirubicin|epirubicin|mesh-list
25289366|NCT03643822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289367|NCT03643822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25289368|NCT03643822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25289369|NCT03643822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25289370|NCT03643822|Analgesics|analgesics|mesh-ancestor
25289371|NCT03643822|Sensory System Agents|sensory system agents|mesh-ancestor
25289372|NCT03643822|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25289373|NCT03643822|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25289374|NCT03643822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25289375|NCT03643822|Adrenergic Agents|adrenergic agents|mesh-ancestor
25289376|NCT03643822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25289377|NCT03634150|Doxorubicin|doxorubicin|mesh-list
25289378|NCT03634150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25289379|NCT03634150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289380|NCT03634150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25289381|NCT03634150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25289382|NCT03634150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25289383|NCT03634150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289384|NCT03593759|Prednisone|prednisone|mesh-list
25289385|NCT03593759|Prednisolone|prednisolone|mesh-list
25289386|NCT03593759|Methotrexate|methotrexate|mesh-list
25289387|NCT03593759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25117452|NCT05164367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25117453|NCT05164367|Cholinergic Agents|cholinergic agents|mesh-ancestor
25117454|NCT05164367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25117455|NCT05164367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117456|NCT05164081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25117458|NCT05164081|Clindamycin palmitate|clindamycin palmitate|mesh-list
25117459|NCT05164081|Clindamycin phosphate|clindamycin phosphate|mesh-list
25117460|NCT05164081|Gentamicins|gentamicins|mesh-list
25117461|NCT05164081|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25117462|NCT05164081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25117463|NCT05164081|Antitubercular Agents|antitubercular agents|mesh-ancestor
25117464|NCT05164081|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25117465|NCT05164081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25117471|NCT05135845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25117472|NCT05135845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117474|NCT05133804|Methylphenidate|methylphenidate|mesh-list
25117475|NCT05133804|Reboxetine|reboxetine|mesh-list
25117476|NCT05133804|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25117477|NCT05133804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117478|NCT05133804|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25117523|NCT05044611|Amiloride|amiloride|mesh-list
25289388|NCT03593759|Glucocorticoids|glucocorticoids|mesh-ancestor
25289389|NCT03593759|Hormones|hormones|mesh-ancestor
25406344|NCT03565835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25693229|NCT02010645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693230|NCT02010645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693231|NCT02010775|Botulinum Toxins|botulinum toxins|mesh-list
25693232|NCT02010775|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25693233|NCT02010775|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24769249|NCT01813552|Ritonavir|ritonavir|mesh-list
24769250|NCT01813552|Omeprazole|omeprazole|mesh-list
24769251|NCT01813552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24769252|NCT01813552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24769253|NCT01813552|Protease Inhibitors|protease inhibitors|mesh-ancestor
24661421|NCT01289327|Narcotics|narcotics|mesh-ancestor
25289390|NCT03593759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25289391|NCT03593759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289392|NCT03593759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25289393|NCT03593759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289394|NCT03593759|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25289395|NCT03593759|Abortifacient Agents|abortifacient agents|mesh-ancestor
25289396|NCT03593759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25289397|NCT03593759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25289398|NCT03593759|Antimetabolites|antimetabolites|mesh-ancestor
25289399|NCT03593759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289400|NCT03593759|Dermatologic Agents|dermatologic agents|mesh-ancestor
25289401|NCT03593759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25289402|NCT03593759|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25289403|NCT03593759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25289404|NCT03593759|Immunologic Factors|immunologic factors|mesh-ancestor
25289405|NCT03593759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25289406|NCT03593759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25289407|NCT03564821|Ivosidenib|ivosidenib|mesh-list
25289408|NCT03564821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289409|NCT03564821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25289410|NCT03564821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289411|NCT03329378|Paclitaxel|paclitaxel|mesh-list
25289412|NCT03329378|Docetaxel|docetaxel|mesh-list
25289413|NCT03329378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25289414|NCT03329378|Cyclophosphamide|cyclophosphamide|mesh-list
25289415|NCT03329378|Carboplatin|carboplatin|mesh-list
25289416|NCT03329378|Doxorubicin|doxorubicin|mesh-list
25289417|NCT03329378|Trastuzumab|trastuzumab|mesh-list
25289418|NCT03329378|Pertuzumab|pertuzumab|mesh-list
25289419|NCT03329378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25289422|NCT03329378|Antimitotic Agents|antimitotic agents|mesh-ancestor
25289423|NCT03329378|Mitosis Modulators|mitosis modulators|mesh-ancestor
25289424|NCT03329378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289425|NCT03329378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25289426|NCT03329378|Immunologic Factors|immunologic factors|mesh-ancestor
25289427|NCT03329378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289428|NCT03329378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25289429|NCT03329378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25289430|NCT03329378|Alkylating Agents|alkylating agents|mesh-ancestor
25289431|NCT03329378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25289432|NCT03329378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25117530|NCT05044611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117531|NCT05044611|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
25117532|NCT05044611|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25117538|NCT05027516|Ceftriaxone|ceftriaxone|mesh-list
25117539|NCT05027516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25117540|NCT05027516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25117541|NCT05024734|Gemcitabine|gemcitabine|mesh-list
25117542|NCT05024734|Docetaxel|docetaxel|mesh-list
25117543|NCT05024734|Epirubicin|epirubicin|mesh-list
25117544|NCT05024734|Mitomycins|mitomycins|mesh-list
25117545|NCT05024734|Mitomycin|mitomycin|mesh-list
25117546|NCT05024734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25117547|NCT05024734|Antimetabolites|antimetabolites|mesh-ancestor
25117548|NCT05024734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117549|NCT05024734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25117550|NCT05024734|Antiviral Agents|antiviral agents|mesh-ancestor
25117551|NCT05024734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25117552|NCT05024734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25117553|NCT05024734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25693234|NCT02010775|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25693235|NCT02010775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25693236|NCT02010775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693237|NCT02010775|Cholinergic Agents|cholinergic agents|mesh-ancestor
25693238|NCT02010775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25693239|NCT02010775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769339|NCT01813773|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24769340|NCT01813773|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25117554|NCT05024734|Immunologic Factors|immunologic factors|mesh-ancestor
25117555|NCT05024734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117556|NCT05024734|Tubulin Modulators|tubulin modulators|mesh-ancestor
25117557|NCT05024734|Antimitotic Agents|antimitotic agents|mesh-ancestor
25117558|NCT05024734|Mitosis Modulators|mitosis modulators|mesh-ancestor
25117559|NCT05024734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24685652|NCT05250141|Carbidopa|carbidopa|mesh-list
25117560|NCT05024734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25117561|NCT05024734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25117562|NCT05024734|Alkylating Agents|alkylating agents|mesh-ancestor
25289433|NCT03329378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25289434|NCT03329378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25289435|NCT03329378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25289436|NCT03329378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25289437|NCT03268083|Vaccines|vaccines|mesh-list
25289438|NCT03268083|Immunologic Factors|immunologic factors|mesh-ancestor
25289439|NCT03268083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289440|NCT03170817|Regadenoson|regadenoson|mesh-list
25289441|NCT03170817|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25289442|NCT03170817|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25289443|NCT03170817|Purinergic Agonists|purinergic agonists|mesh-ancestor
25289444|NCT03170817|Purinergic Agents|purinergic agents|mesh-ancestor
25289445|NCT03170817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25289446|NCT03170817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289447|NCT03170817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289448|NCT02979860|Oxymetazoline|oxymetazoline|mesh-list
25289449|NCT02979860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25289450|NCT02979860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25289451|NCT02979860|Adrenergic Agents|adrenergic agents|mesh-ancestor
25289452|NCT02979860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25289453|NCT02979860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289454|NCT02979860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289455|NCT02979860|Sympathomimetics|sympathomimetics|mesh-ancestor
25289456|NCT02979860|Autonomic Agents|autonomic agents|mesh-ancestor
25289457|NCT02979860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25289458|NCT02979860|Nasal Decongestants|nasal decongestants|mesh-ancestor
25289459|NCT02979860|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25289460|NCT02979860|Respiratory System Agents|respiratory system agents|mesh-ancestor
25289461|NCT02926651|Tranexamic Acid|tranexamic acid|mesh-list
25289462|NCT02926651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25289463|NCT02926651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25289464|NCT02926651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289465|NCT02926651|Hemostatics|hemostatics|mesh-ancestor
25289466|NCT02926651|Coagulants|coagulants|mesh-ancestor
25289467|NCT02896335|Palbociclib|palbociclib|mesh-list
25289468|NCT02896335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289469|NCT02896335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25289470|NCT02896335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25289471|NCT02896335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289472|NCT02843074|Dexamethasone|dexamethasone|mesh-list
25289473|NCT02843074|Lenalidomide|lenalidomide|mesh-list
25289474|NCT02843074|Elotuzumab|elotuzumab|mesh-list
25117580|NCT05020860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25117581|NCT05020860|Alkylating Agents|alkylating agents|mesh-ancestor
25117582|NCT05020860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25117583|NCT05020860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25117584|NCT05020860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25117585|NCT05020860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25117586|NCT05020860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25117587|NCT05020860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25117589|NCT05012566|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25117590|NCT05012566|Hyaluronic Acid|hyaluronic acid|mesh-list
25117591|NCT05012566|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25117592|NCT05012566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25117593|NCT05012566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117594|NCT05012566|Cholinergic Agents|cholinergic agents|mesh-ancestor
25117595|NCT05012566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25117596|NCT05012566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117604|NCT04994535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25117605|NCT04994535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25693240|NCT02010775|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25693241|NCT02010775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25693242|NCT02011113|Dexamethasone|dexamethasone|mesh-list
24620445|NCT01057160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24620446|NCT01057160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620447|NCT01057160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620448|NCT01057186|Alfacalcidol|alfacalcidol|mesh-list
24620449|NCT01057186|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
24620450|NCT01057186|Sevelamer|sevelamer|mesh-list
24620451|NCT01057186|Chelating Agents|chelating agents|mesh-ancestor
24620452|NCT01057186|Sequestering Agents|sequestering agents|mesh-ancestor
24620453|NCT01057186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117606|NCT04994535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25117607|NCT04994535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117608|NCT04994535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25117609|NCT04994535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25117610|NCT04994535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117611|NCT04994535|Cholinergic Agents|cholinergic agents|mesh-ancestor
25117612|NCT04994535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25289475|NCT02843074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25289476|NCT02843074|Antiemetics|antiemetics|mesh-ancestor
25289477|NCT02843074|Autonomic Agents|autonomic agents|mesh-ancestor
25289478|NCT02843074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25289479|NCT02843074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289480|NCT02843074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25289481|NCT02843074|Glucocorticoids|glucocorticoids|mesh-ancestor
25289483|NCT02843074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25289484|NCT02843074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25289485|NCT02843074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289486|NCT02843074|Immunologic Factors|immunologic factors|mesh-ancestor
25289487|NCT02843074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25289488|NCT02843074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25289489|NCT02843074|Growth Substances|growth substances|mesh-ancestor
24633257|NCT01127841|Rituximab|rituximab|mesh-list
25289490|NCT02843074|Growth Inhibitors|growth inhibitors|mesh-ancestor
25289491|NCT02805504|Bupivacaine|bupivacaine|mesh-list
25289492|NCT02805504|Anesthetics, Local|anesthetics, local|mesh-ancestor
25289493|NCT02805504|Anesthetics|anesthetics|mesh-ancestor
25289494|NCT02805504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25289495|NCT02805504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289496|NCT02805504|Sensory System Agents|sensory system agents|mesh-ancestor
25289497|NCT02805504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25289498|NCT02605148|Vitamin D|vitamin d|mesh-list
25289499|NCT02605148|Vitamins|vitamins|mesh-ancestor
25289500|NCT02605148|Micronutrients|micronutrients|mesh-ancestor
25289501|NCT02605148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289502|NCT02605148|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25289503|NCT02505750|Capecitabine|capecitabine|mesh-list
25289504|NCT02505750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25289505|NCT02505750|Antimetabolites|antimetabolites|mesh-ancestor
25289506|NCT02505750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289507|NCT02505750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289508|NCT02419378|Alemtuzumab|alemtuzumab|mesh-list
25289509|NCT02419378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25289510|NCT02419378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289511|NCT02395640|Capecitabine|capecitabine|mesh-list
25289512|NCT02395640|Oxaliplatin|oxaliplatin|mesh-list
25289514|NCT02395640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25289515|NCT02395640|Antimetabolites|antimetabolites|mesh-ancestor
25117620|NCT04966676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998069|NCT03841565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25117640|NCT04930458|Protective Agents|protective agents|mesh-ancestor
25117641|NCT04930458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25117642|NCT04930458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25117643|NCT04930458|Chelating Agents|chelating agents|mesh-ancestor
25117644|NCT04930458|Sequestering Agents|sequestering agents|mesh-ancestor
25117645|NCT04930458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117661|NCT04917588|Lidocaine|lidocaine|mesh-list
25693243|NCT02011113|Pomalidomide|pomalidomide|mesh-list
25693244|NCT02011113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25693245|NCT02011113|Antiemetics|antiemetics|mesh-ancestor
25693246|NCT02011113|Autonomic Agents|autonomic agents|mesh-ancestor
25693247|NCT02011113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25693248|NCT02011113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693249|NCT02011113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25693250|NCT02011113|Glucocorticoids|glucocorticoids|mesh-ancestor
25693251|NCT02011113|Hormones|hormones|mesh-ancestor
25709256|NCT02263547|Sensory System Agents|sensory system agents|mesh-ancestor
24620460|NCT01057212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24620461|NCT01057212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24620478|NCT01057264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24620479|NCT01057264|Growth Substances|growth substances|mesh-ancestor
24620480|NCT01057264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117662|NCT04917588|Anesthetics, Local|anesthetics, local|mesh-ancestor
25117663|NCT04917588|Anesthetics|anesthetics|mesh-ancestor
25117709|NCT04859296|Hormones|hormones|mesh-ancestor
25289516|NCT02395640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289517|NCT02395640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289518|NCT02395640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25289519|NCT02395640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25289520|NCT02395640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25289521|NCT02395640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25289522|NCT05096715|Bevacizumab|bevacizumab|mesh-list
25289523|NCT05096715|Atezolizumab|atezolizumab|mesh-list
25289524|NCT05096715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25289525|NCT05096715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289526|NCT05096715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25289527|NCT05096715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25289528|NCT05096715|Growth Substances|growth substances|mesh-ancestor
25289529|NCT05096715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289530|NCT05096715|Growth Inhibitors|growth inhibitors|mesh-ancestor
25289531|NCT05096676|Oxytocin|oxytocin|mesh-list
25289532|NCT05096676|Oxytocics|oxytocics|mesh-ancestor
25289533|NCT05096676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25289534|NCT05096676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289535|NCT05096520|Lidocaine|lidocaine|mesh-list
25289536|NCT05096520|Anesthetics, Local|anesthetics, local|mesh-ancestor
25289537|NCT05096520|Anesthetics|anesthetics|mesh-ancestor
25289538|NCT05096520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24420582|NCT00216385|Gatifloxacin|gatifloxacin|mesh-list
25289539|NCT05096520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289540|NCT05096520|Sensory System Agents|sensory system agents|mesh-ancestor
25289541|NCT05096520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25289542|NCT05096520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25289556|NCT05096312|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
25289558|NCT05096312|Trace Elements|trace elements|mesh-ancestor
25289559|NCT05096312|Micronutrients|micronutrients|mesh-ancestor
25289560|NCT05096312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117759|NCT04832009|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25117760|NCT04832009|Antioxidants|antioxidants|mesh-ancestor
25117761|NCT04832009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117762|NCT04832009|Protective Agents|protective agents|mesh-ancestor
25117763|NCT04832009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117764|NCT04832009|Vitamins|vitamins|mesh-ancestor
25117765|NCT04832009|Micronutrients|micronutrients|mesh-ancestor
25117766|NCT04832009|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25117767|NCT04832009|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25117768|NCT04832009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25117769|NCT04823468|Cisplatin|cisplatin|mesh-list
25117770|NCT04823468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25117771|NCT04823442|Bisoprolol|bisoprolol|mesh-list
25117772|NCT04823442|Mirabegron|mirabegron|mesh-list
25117773|NCT04823442|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25117774|NCT04823442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25117775|NCT04823442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25117776|NCT04823442|Adrenergic Agents|adrenergic agents|mesh-ancestor
25117777|NCT04823442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25117778|NCT04823442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117779|NCT04823442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117780|NCT04823442|Urological Agents|urological agents|mesh-ancestor
25117781|NCT04823442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25117782|NCT04823442|Sympatholytics|sympatholytics|mesh-ancestor
25117783|NCT04823442|Autonomic Agents|autonomic agents|mesh-ancestor
24779364|NCT01875757|Vitamin D|vitamin d|mesh-list
25117784|NCT04823442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25117785|NCT04823442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25117799|NCT04762498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117800|NCT04762498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25117801|NCT04762498|Dermatologic Agents|dermatologic agents|mesh-ancestor
25693252|NCT02011113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25693253|NCT02011113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25693254|NCT02011113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693255|NCT02011113|Immunologic Factors|immunologic factors|mesh-ancestor
25117802|NCT04762498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25117803|NCT04762498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24709534|NCT01506063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24709535|NCT01506063|Histamine Antagonists|histamine antagonists|mesh-ancestor
24709536|NCT01506063|Histamine Agents|histamine agents|mesh-ancestor
24709537|NCT01506063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24709538|NCT01506063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709550|NCT01506115|Trioxsalen|trioxsalen|mesh-list
24709563|NCT01506167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24709564|NCT01506167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25289561|NCT05096312|Dermatologic Agents|dermatologic agents|mesh-ancestor
25289562|NCT05096312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25289563|NCT05096312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25289564|NCT05096312|Analgesics|analgesics|mesh-ancestor
25289565|NCT05096312|Sensory System Agents|sensory system agents|mesh-ancestor
25289566|NCT05096312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25289567|NCT05096312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25289568|NCT05096312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25289569|NCT05095714|Liver Extracts|liver extracts|mesh-list
25289570|NCT05095714|Hematinics|hematinics|mesh-ancestor
25289571|NCT05095636|Apatinib|apatinib|mesh-list
25289572|NCT05095636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289573|NCT05095636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25289574|NCT05095636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25289575|NCT05095636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289576|NCT05095571|Niacinamide|niacinamide|mesh-list
25289578|NCT05095571|Nicotinic Acids|nicotinic acids|mesh-list
25289579|NCT05095571|Vitamin B Complex|vitamin b complex|mesh-ancestor
25289580|NCT05095571|Vitamins|vitamins|mesh-ancestor
25289581|NCT05095571|Micronutrients|micronutrients|mesh-ancestor
25289582|NCT05095571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289583|NCT05095571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25289584|NCT05095571|Antimetabolites|antimetabolites|mesh-ancestor
24855117|NCT02277587|Cortisone|cortisone|mesh-list
25289585|NCT05095571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289586|NCT05095571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25289587|NCT05095571|Vasodilator Agents|vasodilator agents|mesh-ancestor
25289588|NCT05095480|Red yeast rice|red yeast rice|mesh-list
25289589|NCT05095480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25289590|NCT05095480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25289591|NCT05095480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25289592|NCT05095480|Antimetabolites|antimetabolites|mesh-ancestor
25289593|NCT05095480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289594|NCT05095480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25117804|NCT04762498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25117805|NCT04762498|Immunologic Factors|immunologic factors|mesh-ancestor
25117806|NCT04762498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25117807|NCT04762498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25117820|NCT04727138|Midazolam|midazolam|mesh-list
25117821|NCT04727138|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25117822|NCT04727138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25117823|NCT04727138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25117824|NCT04727138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117825|NCT04727138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25117826|NCT04727138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25117827|NCT04727138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25117828|NCT04727138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25117829|NCT04727138|Anesthetics, General|anesthetics, general|mesh-ancestor
25117830|NCT04727138|Anesthetics|anesthetics|mesh-ancestor
25117831|NCT04727138|GABA Modulators|gaba modulators|mesh-ancestor
25117832|NCT04727138|GABA Agents|gaba agents|mesh-ancestor
25117833|NCT04727138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25117834|NCT04727138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117835|NCT04720326|Tacrolimus|tacrolimus|mesh-list
25117836|NCT04720326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25117837|NCT04720326|Immunologic Factors|immunologic factors|mesh-ancestor
25117838|NCT04720326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117839|NCT04720326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25117840|NCT04720326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25117841|NCT04720326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117842|NCT04718727|Olanzapine|olanzapine|mesh-list
25117843|NCT04718727|Antiemetics|antiemetics|mesh-ancestor
25117844|NCT04718727|Autonomic Agents|autonomic agents|mesh-ancestor
25117845|NCT04718727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25117846|NCT04718727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117847|NCT04718727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25117848|NCT04718727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25693256|NCT02011113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25117849|NCT04718727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25117850|NCT04718727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25117851|NCT04718727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24709574|NCT01506167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24614124|NCT01022541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614125|NCT01022632|Curcumin|curcumin|mesh-list
25289595|NCT05095480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25289596|NCT05095467|Paclitaxel|paclitaxel|mesh-list
25289597|NCT05095467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25289598|NCT05095467|Tegafur|tegafur|mesh-list
25289599|NCT05095467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25289600|NCT05095467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289601|NCT05095467|Tubulin Modulators|tubulin modulators|mesh-ancestor
25289602|NCT05095467|Antimitotic Agents|antimitotic agents|mesh-ancestor
25289603|NCT05095467|Mitosis Modulators|mitosis modulators|mesh-ancestor
25289604|NCT05095467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289605|NCT05095467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25289606|NCT05095467|Antimetabolites|antimetabolites|mesh-ancestor
25289607|NCT05095259|Insulin|insulin|mesh-list
25289608|NCT05095259|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25289609|NCT05095259|Epinephrine|epinephrine|mesh-list
25289610|NCT05095259|Glucagon|glucagon|mesh-list
25289611|NCT05095259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25289612|NCT05095259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289613|NCT05095259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25289614|NCT05095259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25289625|NCT05095259|Sympathomimetics|sympathomimetics|mesh-ancestor
25289626|NCT05095259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25289627|NCT05095259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25289628|NCT05095259|Hormones|hormones|mesh-ancestor
25289629|NCT05095259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25289630|NCT05095207|Bicalutamide|bicalutamide|mesh-list
25117852|NCT04718727|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25117853|NCT04718727|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25117854|NCT04718727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25117855|NCT04718727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117856|NCT04718727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25117857|NCT04718727|Serotonin Agents|serotonin agents|mesh-ancestor
25117871|NCT04674254|Bevacizumab|bevacizumab|mesh-list
25117872|NCT04674254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25117873|NCT04674254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25117874|NCT04674254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25117875|NCT04674254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25117876|NCT04674254|Growth Substances|growth substances|mesh-ancestor
25117877|NCT04674254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117878|NCT04674254|Growth Inhibitors|growth inhibitors|mesh-ancestor
25117879|NCT04670471|Remifentanil|remifentanil|mesh-list
25117880|NCT04670471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25117881|NCT04670471|Narcotics|narcotics|mesh-ancestor
25117882|NCT04670471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25117884|NCT04670471|Analgesics|analgesics|mesh-ancestor
25289631|NCT05095207|Androgen Antagonists|androgen antagonists|mesh-ancestor
25289632|NCT05095207|Hormone Antagonists|hormone antagonists|mesh-ancestor
25289633|NCT05095207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25289634|NCT05095207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289635|NCT05095207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289636|NCT05095077|Tadalafil|tadalafil|mesh-list
25289637|NCT05095077|Vasodilator Agents|vasodilator agents|mesh-ancestor
25289638|NCT05095077|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25289639|NCT05095077|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25289640|NCT05095077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25289641|NCT05095077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289642|NCT05095077|Urological Agents|urological agents|mesh-ancestor
25289643|NCT05095025|Bupivacaine|bupivacaine|mesh-list
25289644|NCT05095025|Anesthetics, Local|anesthetics, local|mesh-ancestor
25289645|NCT05095025|Anesthetics|anesthetics|mesh-ancestor
25289646|NCT05095025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25693257|NCT02011113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25693258|NCT02011113|Growth Substances|growth substances|mesh-ancestor
25289647|NCT05095025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289648|NCT05095025|Sensory System Agents|sensory system agents|mesh-ancestor
25289649|NCT05095025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25289650|NCT05091619|Vaccines|vaccines|mesh-list
25289651|NCT05091619|Immunologic Factors|immunologic factors|mesh-ancestor
25289652|NCT05091619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289653|NCT05084027|Fludarabine|fludarabine|mesh-list
25289654|NCT05084027|Melphalan|melphalan|mesh-list
25289658|NCT05084027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25289659|NCT05084027|Immunologic Factors|immunologic factors|mesh-ancestor
25289667|NCT05083286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25289668|NCT05083286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289669|NCT05083286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25289670|NCT05083286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25289671|NCT05083286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117897|NCT04669197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25117898|NCT04669197|Antimetabolites|antimetabolites|mesh-ancestor
25117899|NCT04669197|Antiviral Agents|antiviral agents|mesh-ancestor
25117900|NCT04669197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25117901|NCT04669197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25117902|NCT04669197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25117903|NCT04669197|Immunologic Factors|immunologic factors|mesh-ancestor
25117904|NCT04669197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117905|NCT04669197|Antimalarials|antimalarials|mesh-ancestor
25117906|NCT04669197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25117907|NCT04669197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25117908|NCT04669197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25117917|NCT04659174|Xanomeline|xanomeline|mesh-list
25117918|NCT04659174|Trospium chloride|trospium chloride|mesh-list
25117919|NCT04659174|Parasympatholytics|parasympatholytics|mesh-ancestor
25117920|NCT04659174|Autonomic Agents|autonomic agents|mesh-ancestor
25117921|NCT04659174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25117922|NCT04659174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117923|NCT04659174|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25117924|NCT04659174|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25117925|NCT04659174|Cholinergic Agents|cholinergic agents|mesh-ancestor
25117926|NCT04659174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25117927|NCT04659174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900530|NCT04393025|Clopidogrel|clopidogrel|mesh-list
24614126|NCT01022632|Fluoxetine|fluoxetine|mesh-list
24614127|NCT01022632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24614128|NCT01022632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24614129|NCT01022632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24614130|NCT01022632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709576|NCT01506167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709668|NCT01506622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25289673|NCT05083286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25289674|NCT05057481|Mycophenolic Acid|mycophenolic acid|mesh-list
25289675|NCT05057481|Rituximab|rituximab|mesh-list
25289676|NCT05057481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25289677|NCT05057481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289678|NCT05057481|Immunologic Factors|immunologic factors|mesh-ancestor
25289679|NCT05057481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289680|NCT05057481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25289681|NCT05057481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25289682|NCT05057481|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25289683|NCT05057481|Antitubercular Agents|antitubercular agents|mesh-ancestor
25289684|NCT05057481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25289685|NCT05057481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25289686|NCT05057481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25289687|NCT05057481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289688|NCT05001360|Nivolumab|nivolumab|mesh-list
25289689|NCT05001360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25289691|NCT05001360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289692|NCT05001360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289694|NCT04986839|Ibuprofen|ibuprofen|mesh-list
25289695|NCT04986839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25289696|NCT04986839|Analgesics|analgesics|mesh-ancestor
25289697|NCT04986839|Sensory System Agents|sensory system agents|mesh-ancestor
25289698|NCT04986839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25289699|NCT04986839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289700|NCT04986839|Antipyretics|antipyretics|mesh-ancestor
25289701|NCT04986839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25289702|NCT04986839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25117928|NCT04659174|Urological Agents|urological agents|mesh-ancestor
25117929|NCT04659174|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25117930|NCT04659174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24769728|NCT01815437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769729|NCT01815437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24769730|NCT01815437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24769731|NCT01815528|Catumaxomab|catumaxomab|mesh-list
24769732|NCT01815528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24769733|NCT01815541|Teicoplanin|teicoplanin|mesh-list
24769734|NCT01815541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25117931|NCT04659174|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25117932|NCT04659174|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25117933|NCT04648631|Pulmonary Surfactants|pulmonary surfactants|mesh-list
24779509|NCT01876563|Vitamin D|vitamin d|mesh-list
25117934|NCT04648631|Respiratory System Agents|respiratory system agents|mesh-ancestor
25117935|NCT04644016|Cyclosporine|cyclosporine|mesh-list
25117936|NCT04644016|Mycophenolic Acid|mycophenolic acid|mesh-list
25117937|NCT04644016|Fludarabine|fludarabine|mesh-list
25117938|NCT04644016|Busulfan|busulfan|mesh-list
25117939|NCT04644016|Clofarabine|clofarabine|mesh-list
25117940|NCT04644016|Cyclosporins|cyclosporins|mesh-list
25117941|NCT04644016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25117942|NCT04644016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25117943|NCT04644016|Antimetabolites|antimetabolites|mesh-ancestor
25117944|NCT04644016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117945|NCT04644016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25117946|NCT04644016|Immunologic Factors|immunologic factors|mesh-ancestor
25117947|NCT04644016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117948|NCT04644016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25117949|NCT04644016|Antifungal Agents|antifungal agents|mesh-ancestor
25117950|NCT04644016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25117951|NCT04644016|Dermatologic Agents|dermatologic agents|mesh-ancestor
25117952|NCT04644016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25117953|NCT04644016|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25117954|NCT04644016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25117955|NCT04644016|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25117956|NCT04644016|Antitubercular Agents|antitubercular agents|mesh-ancestor
25117957|NCT04644016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25117958|NCT04644016|Alkylating Agents|alkylating agents|mesh-ancestor
25117959|NCT04644016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25117960|NCT04644016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24709669|NCT01506622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24709671|NCT01506635|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24709672|NCT01506635|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24709673|NCT01506635|Adrenergic Agents|adrenergic agents|mesh-ancestor
24709674|NCT01506635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24709675|NCT01506635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709676|NCT01506635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447440|NCT00308477|Hormones|hormones|mesh-ancestor
25289703|NCT04986839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25289704|NCT04986839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25289705|NCT04986839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25289706|NCT04986839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289708|NCT04901299|Fulvestrant|fulvestrant|mesh-list
25289709|NCT04901299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25289710|NCT04901299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289711|NCT04901299|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25289712|NCT04901299|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25289713|NCT04901299|Hormone Antagonists|hormone antagonists|mesh-ancestor
25289714|NCT04901299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25289715|NCT04901299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289716|NCT04895761|Cyclophosphamide|cyclophosphamide|mesh-list
25289717|NCT04895761|Letrozole|letrozole|mesh-list
25289718|NCT04895761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25289719|NCT04895761|Immunologic Factors|immunologic factors|mesh-ancestor
25289720|NCT04895761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289721|NCT04895761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25693259|NCT02011113|Growth Inhibitors|growth inhibitors|mesh-ancestor
25693260|NCT02011386|Golimumab|golimumab|mesh-list
25693261|NCT02011386|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25693262|NCT02011386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25693263|NCT02011386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25693264|NCT02011386|Immunologic Factors|immunologic factors|mesh-ancestor
25693265|NCT02011386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118022|NCT04542837|Lenvatinib|lenvatinib|mesh-list
25289726|NCT04895761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25289727|NCT04895761|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25289728|NCT04895761|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25693266|NCT02011464|Bupivacaine|bupivacaine|mesh-list
25080780|NCT03335527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25080781|NCT03335527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25080793|NCT03335501|Pancrelipase|pancrelipase|mesh-list
25289729|NCT04895761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25289730|NCT04895761|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25289731|NCT04895761|Hormone Antagonists|hormone antagonists|mesh-ancestor
25289732|NCT04895761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25289733|NCT04877678|Bepotastine besilate|bepotastine besilate|mesh-list
25117961|NCT04636671|Dexamethasone|dexamethasone|mesh-list
25117962|NCT04636671|Methylprednisolone|methylprednisolone|mesh-list
25117963|NCT04636671|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25117964|NCT04636671|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25117965|NCT04636671|Prednisolone|prednisolone|mesh-list
25117966|NCT04636671|Prednisolone acetate|prednisolone acetate|mesh-list
25117967|NCT04636671|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25117968|NCT04636671|Prednisolone phosphate|prednisolone phosphate|mesh-list
25117969|NCT04636671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25117971|NCT04636671|Autonomic Agents|autonomic agents|mesh-ancestor
25117972|NCT04636671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25117973|NCT04636671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117974|NCT04636671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25117975|NCT04636671|Glucocorticoids|glucocorticoids|mesh-ancestor
25117976|NCT04636671|Hormones|hormones|mesh-ancestor
25117977|NCT04636671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25117978|NCT04636671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25117979|NCT04636671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25117980|NCT04636671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25117981|NCT04636671|Protective Agents|protective agents|mesh-ancestor
25117982|NCT04632589|Losartan|losartan|mesh-list
25117983|NCT04632589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25117984|NCT04632589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25117985|NCT04632589|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25117986|NCT04632589|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25117987|NCT04632589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25117988|NCT04591626|Insulin Glargine|insulin glargine|mesh-list
25117989|NCT04591626|Dulaglutide|dulaglutide|mesh-list
25117990|NCT04591626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25117991|NCT04591626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25117998|NCT04581447|Metformin|metformin|mesh-list
25289734|NCT04877678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25289735|NCT04793100|Aflibercept|aflibercept|mesh-list
25289736|NCT04793100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25289737|NCT04793100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25289738|NCT04793100|Growth Substances|growth substances|mesh-ancestor
25289739|NCT04793100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289740|NCT04793100|Growth Inhibitors|growth inhibitors|mesh-ancestor
25289741|NCT04793100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289742|NCT04760028|Anesthetics|anesthetics|mesh-list
25289743|NCT04760028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25289744|NCT04760028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118005|NCT04574479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118007|NCT04574479|Sensory System Agents|sensory system agents|mesh-ancestor
25045634|NCT00934921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25118008|NCT04574479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25118009|NCT04551040|Terazosin|terazosin|mesh-list
24482275|NCT00438321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25118010|NCT04551040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25118011|NCT04551040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25118012|NCT04551040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25118013|NCT04551040|Adrenergic Agents|adrenergic agents|mesh-ancestor
25118014|NCT04551040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25118015|NCT04551040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118016|NCT04551040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118017|NCT04551040|Urological Agents|urological agents|mesh-ancestor
25118032|NCT04520048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118033|NCT04520048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118034|NCT04512430|Bevacizumab|bevacizumab|mesh-list
25118035|NCT04512430|Carboplatin|carboplatin|mesh-list
25118036|NCT04512430|Pemetrexed|pemetrexed|mesh-list
25693267|NCT02011464|Anesthetics, Local|anesthetics, local|mesh-ancestor
25693268|NCT02011464|Anesthetics|anesthetics|mesh-ancestor
25693269|NCT02011464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24769927|NCT01816997|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24769929|NCT01816997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24483160|NCT00442052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24769930|NCT01816997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24769931|NCT01816997|Antimetabolites|antimetabolites|mesh-ancestor
24769932|NCT01816997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769933|NCT01816997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24769934|NCT01816997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24709696|NCT01506752|Donepezil|donepezil|mesh-list
24709742|NCT01506804|Prednisolone acetate|prednisolone acetate|mesh-list
24709743|NCT01506804|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24709744|NCT01506804|Prednisolone phosphate|prednisolone phosphate|mesh-list
25289755|NCT04603365|Temozolomide|temozolomide|mesh-list
25289756|NCT04603365|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25289757|NCT04603365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25289758|NCT04603365|Alkylating Agents|alkylating agents|mesh-ancestor
25289759|NCT04603365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289760|NCT04603365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289761|NCT04603365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25289767|NCT04492891|Cyclosporine|cyclosporine|mesh-list
25289768|NCT04492891|Cyclosporins|cyclosporins|mesh-list
25289769|NCT04492891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25289770|NCT04492891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289771|NCT04492891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25289772|NCT04492891|Immunologic Factors|immunologic factors|mesh-ancestor
24420592|NCT00216398|Lanreotide|lanreotide|mesh-list
25289773|NCT04492891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289774|NCT04492891|Antifungal Agents|antifungal agents|mesh-ancestor
25289775|NCT04492891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25289776|NCT04492891|Dermatologic Agents|dermatologic agents|mesh-ancestor
25289777|NCT04492891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25118037|NCT04512430|Atezolizumab|atezolizumab|mesh-list
25118038|NCT04512430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25118039|NCT04512430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118040|NCT04512430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25118041|NCT04512430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25118042|NCT04512430|Growth Substances|growth substances|mesh-ancestor
25118043|NCT04512430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118044|NCT04512430|Growth Inhibitors|growth inhibitors|mesh-ancestor
25118045|NCT04512430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25118046|NCT04512430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118047|NCT04512430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25118048|NCT04512430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25118056|NCT04495868|Lidocaine|lidocaine|mesh-list
25118057|NCT04495868|Anesthetics, Local|anesthetics, local|mesh-ancestor
25118060|NCT04495868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118061|NCT04495868|Sensory System Agents|sensory system agents|mesh-ancestor
25118062|NCT04495868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25118063|NCT04495868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25118064|NCT04495868|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25118065|NCT04495868|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25118066|NCT04495868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25118067|NCT04495868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289778|NCT04492891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25289779|NCT04430985|Leucovorin|leucovorin|mesh-list
25289780|NCT04430985|Fluorouracil|fluorouracil|mesh-list
25289781|NCT04430985|Oxaliplatin|oxaliplatin|mesh-list
25289782|NCT04430985|Nivolumab|nivolumab|mesh-list
25289783|NCT04430985|Ipilimumab|ipilimumab|mesh-list
25289784|NCT04430985|Antimetabolites|antimetabolites|mesh-ancestor
25693270|NCT02011464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693271|NCT02011464|Sensory System Agents|sensory system agents|mesh-ancestor
25693272|NCT02011464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25693273|NCT02011516|Baclofen|baclofen|mesh-list
25693274|NCT02011516|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25693275|NCT02011516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693276|NCT02011516|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25693277|NCT02011516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25693278|NCT02011516|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25693279|NCT02011516|GABA Agonists|gaba agonists|mesh-ancestor
25693280|NCT02011516|GABA Agents|gaba agents|mesh-ancestor
24770002|NCT01817348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289785|NCT04430985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289786|NCT04430985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25289787|NCT04430985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289788|NCT04430985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25289789|NCT04430985|Immunologic Factors|immunologic factors|mesh-ancestor
25289790|NCT04430985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289791|NCT04430985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25289792|NCT04430985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25289793|NCT04430985|Antidotes|antidotes|mesh-ancestor
25289794|NCT04430985|Protective Agents|protective agents|mesh-ancestor
25289795|NCT04430985|Vitamin B Complex|vitamin b complex|mesh-ancestor
25289796|NCT04430985|Vitamins|vitamins|mesh-ancestor
25289797|NCT04430985|Micronutrients|micronutrients|mesh-ancestor
25289798|NCT04262869|Paclitaxel|paclitaxel|mesh-list
25289799|NCT04262869|Carboplatin|carboplatin|mesh-list
25289800|NCT04262869|Pemetrexed|pemetrexed|mesh-list
25289801|NCT04262869|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25289802|NCT04262869|Durvalumab|durvalumab|mesh-list
25289803|NCT04262869|Immunoglobulins|immunoglobulins|mesh-list
25289804|NCT04262869|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25289805|NCT04262869|Immunoglobulin G|immunoglobulin g|mesh-list
25289806|NCT04262869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25289807|NCT04262869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289808|NCT04262869|Tubulin Modulators|tubulin modulators|mesh-ancestor
25289809|NCT04262869|Antimitotic Agents|antimitotic agents|mesh-ancestor
25289810|NCT04262869|Mitosis Modulators|mitosis modulators|mesh-ancestor
25289811|NCT04262869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289812|NCT04262869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25289813|NCT04262869|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25289814|NCT04262869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25289815|NCT04262869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25289816|NCT04262869|Immunologic Factors|immunologic factors|mesh-ancestor
25289817|NCT04262869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289818|NCT04230109|Pembrolizumab|pembrolizumab|mesh-list
25289819|NCT04230109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25289820|NCT04230109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118074|NCT04474366|Anesthetics, Local|anesthetics, local|mesh-ancestor
25118075|NCT04474366|Anesthetics|anesthetics|mesh-ancestor
25118076|NCT04474366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25118077|NCT04474366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118078|NCT04474366|Sensory System Agents|sensory system agents|mesh-ancestor
25289949|NCT03821272|Vaccines|vaccines|mesh-list
25118079|NCT04474366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25118080|NCT04472611|Colchicine|colchicine|mesh-list
24794620|NCT04868565|Caffeine|caffeine|mesh-list
25118081|NCT04472611|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25118082|NCT04472611|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25118083|NCT04472611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25118084|NCT04472611|Antimetabolites|antimetabolites|mesh-ancestor
25118085|NCT04472611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118086|NCT04472611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25118087|NCT04472611|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25118088|NCT04472611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25118089|NCT04472611|Gout Suppressants|gout suppressants|mesh-ancestor
25118090|NCT04472611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25118091|NCT04472611|Tubulin Modulators|tubulin modulators|mesh-ancestor
25118092|NCT04472611|Antimitotic Agents|antimitotic agents|mesh-ancestor
25118093|NCT04472611|Mitosis Modulators|mitosis modulators|mesh-ancestor
25289842|NCT04064814|Thioctic Acid|thioctic acid|mesh-list
25289843|NCT04064814|Flunarizine|flunarizine|mesh-list
25289844|NCT04064814|Antioxidants|antioxidants|mesh-ancestor
25289845|NCT04064814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289846|NCT04064814|Protective Agents|protective agents|mesh-ancestor
25289847|NCT04064814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289848|NCT04064814|Vitamin B Complex|vitamin b complex|mesh-ancestor
25289849|NCT04064814|Vitamins|vitamins|mesh-ancestor
25289850|NCT04064814|Micronutrients|micronutrients|mesh-ancestor
25289851|NCT04064814|Anticonvulsants|anticonvulsants|mesh-ancestor
25289852|NCT04064814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25289853|NCT04064814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25693281|NCT02011516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25289854|NCT04064814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24817881|NCT02085967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25118106|NCT04438213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25406345|NCT03565835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118107|NCT04438213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118108|NCT04438213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25118109|NCT04438213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118110|NCT04438213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25118111|NCT04438213|Diuretics|diuretics|mesh-ancestor
25118112|NCT04438213|Natriuretic Agents|natriuretic agents|mesh-ancestor
25118113|NCT04438213|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25118114|NCT04438213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25289859|NCT04064814|Vasodilator Agents|vasodilator agents|mesh-ancestor
25289860|NCT04039230|Talazoparib|talazoparib|mesh-list
25289861|NCT04039230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25289862|NCT04039230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25289863|NCT04039230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289864|NCT04039230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25289866|NCT03998735|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25289867|NCT03998735|Autonomic Agents|autonomic agents|mesh-ancestor
25289868|NCT03998735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25289869|NCT03998735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289870|NCT03998735|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25289871|NCT03998735|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25289872|NCT03998735|Cholinergic Agents|cholinergic agents|mesh-ancestor
25289873|NCT03998735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25289874|NCT03998735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289875|NCT03998735|Respiratory System Agents|respiratory system agents|mesh-ancestor
25289876|NCT03981952|Vaccines|vaccines|mesh-list
25289877|NCT03981952|Immunologic Factors|immunologic factors|mesh-ancestor
25289878|NCT03981952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289879|NCT03968939|Diphenhydramine|diphenhydramine|mesh-list
25289880|NCT03968939|Promethazine|promethazine|mesh-list
25289881|NCT03968939|Melatonin|melatonin|mesh-list
25289882|NCT03968939|Antioxidants|antioxidants|mesh-ancestor
25289883|NCT03968939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855218|NCT02278172|Vitamins|vitamins|mesh-list
24689898|NCT01398046|Dasatinib|dasatinib|mesh-list
25289884|NCT03968939|Protective Agents|protective agents|mesh-ancestor
25289885|NCT03968939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289886|NCT03968939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25289887|NCT03968939|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25289888|NCT03968939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25289889|NCT03968939|Anesthetics, Local|anesthetics, local|mesh-ancestor
25289890|NCT03968939|Anesthetics|anesthetics|mesh-ancestor
25118138|NCT04433494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25118139|NCT04433494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118140|NCT04433494|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25118141|NCT04433494|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25118142|NCT04433494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25118144|NCT04423211|Goserelin|goserelin|mesh-list
25118145|NCT04423211|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25118146|NCT04423211|Fertility Agents|fertility agents|mesh-ancestor
25118147|NCT04423211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25118148|NCT04423211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118149|NCT04423211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25118150|NCT04423211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118151|NCT04417517|Azacitidine|azacitidine|mesh-list
25118152|NCT04417517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24794671|NCT04776850|BB 1101|bb 1101|mesh-list
25289894|NCT03968939|Autonomic Agents|autonomic agents|mesh-ancestor
25289895|NCT03968939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25289896|NCT03968939|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25289897|NCT03968939|Histamine Antagonists|histamine antagonists|mesh-ancestor
25289898|NCT03968939|Histamine Agents|histamine agents|mesh-ancestor
25289899|NCT03968939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25289900|NCT03968939|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25289901|NCT03968939|Antipruritics|antipruritics|mesh-ancestor
25289902|NCT03968939|Dermatologic Agents|dermatologic agents|mesh-ancestor
25289903|NCT03959891|Letrozole|letrozole|mesh-list
25289904|NCT03959891|Fulvestrant|fulvestrant|mesh-list
25289905|NCT03959891|Palbociclib|palbociclib|mesh-list
25289906|NCT03959891|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25289907|NCT03959891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25709257|NCT02263547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25289908|NCT03959891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25289909|NCT03959891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25289910|NCT03959891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289911|NCT03959891|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25289912|NCT03959891|Hormone Antagonists|hormone antagonists|mesh-ancestor
25289913|NCT03959891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25289914|NCT03959891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289915|NCT03959891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25289916|NCT03959891|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25289917|NCT03959891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25118198|NCT04319328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25118199|NCT04319328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25118200|NCT04319328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25118201|NCT04319328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25118202|NCT04319328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25118203|NCT04319328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118204|NCT04319328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118205|NCT04319328|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25118206|NCT04319328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25118207|NCT04318678|Cyclophosphamide|cyclophosphamide|mesh-list
25118208|NCT04318678|Rituximab|rituximab|mesh-list
25118209|NCT04318678|Fludarabine|fludarabine|mesh-list
25118210|NCT04318678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25118211|NCT04318678|Immunologic Factors|immunologic factors|mesh-ancestor
25118212|NCT04318678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118213|NCT04318678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25118214|NCT04318678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25118215|NCT04318678|Alkylating Agents|alkylating agents|mesh-ancestor
25118216|NCT04318678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118217|NCT04318678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118218|NCT04318678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25118219|NCT04318678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25118220|NCT04303000|Analgesics, Opioid|analgesics, opioid|mesh-list
25118221|NCT04303000|Naloxone|naloxone|mesh-list
25118222|NCT04303000|Narcotics|narcotics|mesh-ancestor
24709757|NCT01506804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24709809|NCT01507194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24709811|NCT01507194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25289938|NCT03856619|Teriflunomide|teriflunomide|mesh-list
25289939|NCT03856619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25289940|NCT03856619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25289941|NCT03856619|Analgesics|analgesics|mesh-ancestor
25289942|NCT03856619|Sensory System Agents|sensory system agents|mesh-ancestor
25289943|NCT03856619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25289944|NCT03856619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289945|NCT03856619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25289946|NCT03856619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25289947|NCT03856619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25289948|NCT03856619|Immunologic Factors|immunologic factors|mesh-ancestor
25289950|NCT03821272|Immunologic Factors|immunologic factors|mesh-ancestor
25289951|NCT03821272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289952|NCT03806309|Leucovorin|leucovorin|mesh-list
25289953|NCT03806309|Fluorouracil|fluorouracil|mesh-list
25289954|NCT03806309|Irinotecan|irinotecan|mesh-list
25289955|NCT03806309|Antimetabolites|antimetabolites|mesh-ancestor
25289956|NCT03806309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289957|NCT03806309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25289958|NCT03806309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118228|NCT04303000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25118229|NCT04302870|Memantine|memantine|mesh-list
25118230|NCT04302870|Trazodone|trazodone|mesh-list
25118231|NCT04302870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25118232|NCT04302870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25118233|NCT04302870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25118234|NCT04302870|Dopamine Agents|dopamine agents|mesh-ancestor
25118235|NCT04302870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25118236|NCT04302870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118237|NCT04302870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118238|NCT04302870|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25118239|NCT04302870|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25118240|NCT04302870|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25118241|NCT04302870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25118242|NCT04302870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25118243|NCT04302870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25118244|NCT04302870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25118245|NCT04302870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24900633|NCT04392375|Vasodilator Agents|vasodilator agents|mesh-ancestor
25118246|NCT04302870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25118247|NCT04302870|Serotonin Agents|serotonin agents|mesh-ancestor
25118248|NCT04302870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25118249|NCT04302870|Antidepressive Agents|antidepressive agents|mesh-ancestor
25118251|NCT04299113|Mocetinostat|mocetinostat|mesh-list
25118331|NCT04221880|Lidocaine|lidocaine|mesh-list
25118252|NCT04299113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25118253|NCT04299113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118254|NCT04299113|Tubulin Modulators|tubulin modulators|mesh-ancestor
25118255|NCT04299113|Antimitotic Agents|antimitotic agents|mesh-ancestor
25118256|NCT04299113|Mitosis Modulators|mitosis modulators|mesh-ancestor
24899867|NCT04399343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24709812|NCT01507194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709813|NCT01507194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24709814|NCT01507194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24709815|NCT01507194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24709816|NCT01507194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24709817|NCT01507194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24709818|NCT01507194|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24709819|NCT01507272|Liraglutide|liraglutide|mesh-list
24709820|NCT01507272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24709821|NCT01507272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709838|NCT01507337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24709839|NCT01507337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709840|NCT01507337|Incretins|incretins|mesh-ancestor
25289959|NCT03806309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25289960|NCT03806309|Immunologic Factors|immunologic factors|mesh-ancestor
25289961|NCT03806309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289962|NCT03806309|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25289963|NCT03806309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25289964|NCT03806309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25289965|NCT03806309|Antidotes|antidotes|mesh-ancestor
25289966|NCT03806309|Protective Agents|protective agents|mesh-ancestor
25289967|NCT03806309|Vitamin B Complex|vitamin b complex|mesh-ancestor
25289968|NCT03806309|Vitamins|vitamins|mesh-ancestor
25289969|NCT03806309|Micronutrients|micronutrients|mesh-ancestor
25289970|NCT03714815|Macitentan|macitentan|mesh-list
25289971|NCT03714815|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25289972|NCT03714815|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25289973|NCT03714815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289974|NCT03714815|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25289975|NCT03636165|Methylprednisolone|methylprednisolone|mesh-list
25289976|NCT03636165|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25289977|NCT03636165|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25289978|NCT03636165|Prednisolone|prednisolone|mesh-list
25289979|NCT03636165|Prednisolone acetate|prednisolone acetate|mesh-list
25289980|NCT03636165|Ropivacaine|ropivacaine|mesh-list
25289981|NCT03636165|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25289982|NCT03636165|Prednisolone phosphate|prednisolone phosphate|mesh-list
25289983|NCT03636165|Anesthetics, Local|anesthetics, local|mesh-ancestor
25289984|NCT03636165|Anesthetics|anesthetics|mesh-ancestor
25289985|NCT03636165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25289986|NCT03636165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25289987|NCT03636165|Sensory System Agents|sensory system agents|mesh-ancestor
25289988|NCT03636165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25289989|NCT03636165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25118257|NCT04299113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118258|NCT04299113|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25118259|NCT04299113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25118260|NCT04277247|Botulinum Toxins|botulinum toxins|mesh-list
25118261|NCT04277247|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25118262|NCT04277247|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25118263|NCT04277247|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25118264|NCT04277247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25118265|NCT04277247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118266|NCT04277247|Cholinergic Agents|cholinergic agents|mesh-ancestor
25118267|NCT04277247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25118268|NCT04277247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118269|NCT04277247|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25118270|NCT04277247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25118271|NCT04274426|Gemcitabine|gemcitabine|mesh-list
25118273|NCT04274426|Maytansine|maytansine|mesh-list
25118274|NCT04274426|Carboplatin|carboplatin|mesh-list
25118275|NCT04274426|Doxorubicin|doxorubicin|mesh-list
25118276|NCT04274426|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25118277|NCT04274426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25118278|NCT04274426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118279|NCT04274426|Tubulin Modulators|tubulin modulators|mesh-ancestor
25118280|NCT04274426|Antimitotic Agents|antimitotic agents|mesh-ancestor
25118281|NCT04274426|Mitosis Modulators|mitosis modulators|mesh-ancestor
25118282|NCT04274426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25289996|NCT03636165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25289997|NCT03636165|Protective Agents|protective agents|mesh-ancestor
25289998|NCT03636165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25289999|NCT03636165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290000|NCT03564873|Azacitidine|azacitidine|mesh-list
25290001|NCT03564873|Homoharringtonine|homoharringtonine|mesh-list
25290002|NCT03564873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25290003|NCT03564873|Antimetabolites|antimetabolites|mesh-ancestor
25290004|NCT03564873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290005|NCT03564873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290006|NCT03564873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25290007|NCT03564873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25290008|NCT03564873|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25290015|NCT03521037|Rucaparib|rucaparib|mesh-list
25290016|NCT03521037|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25290017|NCT03521037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25290018|NCT03521037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290019|NCT03521037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290020|NCT03422094|Nivolumab|nivolumab|mesh-list
25290021|NCT03422094|Ipilimumab|ipilimumab|mesh-list
25290022|NCT03422094|Poly ICLC|poly iclc|mesh-list
25290023|NCT03422094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25290024|NCT03422094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290025|NCT03422094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24420593|NCT00216398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290026|NCT03422094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290027|NCT03422094|Interferon Inducers|interferon inducers|mesh-ancestor
25290028|NCT03422094|Immunologic Factors|immunologic factors|mesh-ancestor
25290029|NCT03422094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118304|NCT04245865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118305|NCT04245865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25118306|NCT04245865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25118307|NCT04245865|Growth Substances|growth substances|mesh-ancestor
25118308|NCT04245865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691710|NCT01408836|Prednisolone|prednisolone|mesh-list
25118309|NCT04245865|Growth Inhibitors|growth inhibitors|mesh-ancestor
25118310|NCT04245865|Antimetabolites|antimetabolites|mesh-ancestor
25118311|NCT04245865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118312|NCT04245865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25118313|NCT04245865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25118314|NCT04245865|Immunologic Factors|immunologic factors|mesh-ancestor
25118316|NCT04245865|Protective Agents|protective agents|mesh-ancestor
25118317|NCT04245865|Vitamin B Complex|vitamin b complex|mesh-ancestor
24779882|NCT01879488|Sequestering Agents|sequestering agents|mesh-ancestor
25118319|NCT04245865|Micronutrients|micronutrients|mesh-ancestor
25118320|NCT04245865|Antioxidants|antioxidants|mesh-ancestor
25290047|NCT03311555|Antimitotic Agents|antimitotic agents|mesh-ancestor
25290048|NCT03311555|Mitosis Modulators|mitosis modulators|mesh-ancestor
25290049|NCT03311555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290050|NCT03311555|Hormones|hormones|mesh-ancestor
25290051|NCT03311555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25290052|NCT03311555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118337|NCT04221880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118338|NCT04221880|Sensory System Agents|sensory system agents|mesh-ancestor
25118339|NCT04221880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25118340|NCT04221880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25118341|NCT04221880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25118342|NCT04221880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25118343|NCT04221880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25118344|NCT04221880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118345|NCT04219449|Protein C|protein c|mesh-list
25118346|NCT04219449|Anticoagulants|anticoagulants|mesh-ancestor
25118347|NCT04219449|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25118348|NCT04219449|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25118349|NCT04219449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709889|NCT01507454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709890|NCT01507467|Nimorazole|nimorazole|mesh-list
24709891|NCT01507467|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
24709892|NCT01507467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24709893|NCT01507467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24561725|NCT00762632|Everolimus|everolimus|mesh-list
24709894|NCT01507467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24709895|NCT01507480|Bevacizumab|bevacizumab|mesh-list
24709896|NCT01507480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24709897|NCT01507480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24709898|NCT01507480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24709899|NCT01507480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25290053|NCT03264404|Pembrolizumab|pembrolizumab|mesh-list
25290054|NCT03264404|Azacitidine|azacitidine|mesh-list
25290055|NCT03264404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25290056|NCT03264404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290057|NCT03264404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25290058|NCT03264404|Antimetabolites|antimetabolites|mesh-ancestor
25290059|NCT03264404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290060|NCT03264404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25290061|NCT03223298|Botulinum Toxins|botulinum toxins|mesh-list
25290062|NCT03223298|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25290063|NCT03223298|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25290064|NCT03223298|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25290065|NCT03223298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25290066|NCT03223298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290067|NCT03223298|Cholinergic Agents|cholinergic agents|mesh-ancestor
25290068|NCT03223298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25290069|NCT03223298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290070|NCT03223298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25290071|NCT03223298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25290072|NCT03046862|Gemcitabine|gemcitabine|mesh-list
25290073|NCT03046862|Durvalumab|durvalumab|mesh-list
25290074|NCT03046862|Tremelimumab|tremelimumab|mesh-list
25290075|NCT03046862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290076|NCT03046862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25290077|NCT03046862|Antimetabolites|antimetabolites|mesh-ancestor
25290078|NCT03046862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290079|NCT03046862|Antiviral Agents|antiviral agents|mesh-ancestor
25290080|NCT03046862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25290081|NCT03046862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25290082|NCT03046862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25290083|NCT03046862|Immunologic Factors|immunologic factors|mesh-ancestor
25118368|NCT04189588|Diphenhydramine|diphenhydramine|mesh-list
25118369|NCT04189588|Promethazine|promethazine|mesh-list
25118370|NCT04189588|Cetirizine|cetirizine|mesh-list
25118371|NCT04189588|Paclitaxel|paclitaxel|mesh-list
25118372|NCT04189588|Rituximab|rituximab|mesh-list
25118373|NCT04189588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24900634|NCT04392375|Tocolytic Agents|tocolytic agents|mesh-ancestor
25118374|NCT04189588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118375|NCT04189588|Tubulin Modulators|tubulin modulators|mesh-ancestor
25118376|NCT04189588|Antimitotic Agents|antimitotic agents|mesh-ancestor
25118377|NCT04189588|Mitosis Modulators|mitosis modulators|mesh-ancestor
25118378|NCT04189588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118379|NCT04189588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25118380|NCT04189588|Immunologic Factors|immunologic factors|mesh-ancestor
25118381|NCT04189588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118382|NCT04189588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25118383|NCT04189588|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25118384|NCT04189588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25118385|NCT04189588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25118386|NCT04189588|Anesthetics, Local|anesthetics, local|mesh-ancestor
25118388|NCT04189588|Sensory System Agents|sensory system agents|mesh-ancestor
25118389|NCT04189588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25118390|NCT04189588|Antiemetics|antiemetics|mesh-ancestor
25118391|NCT04189588|Autonomic Agents|autonomic agents|mesh-ancestor
25118392|NCT04189588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25118393|NCT04189588|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25118394|NCT04189588|Histamine Antagonists|histamine antagonists|mesh-ancestor
24709939|NCT01507701|Sensory System Agents|sensory system agents|mesh-ancestor
24709940|NCT01507701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24709943|NCT01507701|Sympatholytics|sympatholytics|mesh-ancestor
24709965|NCT01507740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24709966|NCT01507740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709967|NCT01507740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709968|NCT01507792|Loratadine|loratadine|mesh-list
24709969|NCT01507792|Omeprazole|omeprazole|mesh-list
24709970|NCT01507792|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24709971|NCT01507792|Histamine|histamine|mesh-list
24709972|NCT01507792|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24709973|NCT01507792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24709974|NCT01507792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709975|NCT01507792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709976|NCT01507792|Antipruritics|antipruritics|mesh-ancestor
24709977|NCT01507792|Dermatologic Agents|dermatologic agents|mesh-ancestor
25118411|NCT04181008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118413|NCT04181008|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25118414|NCT04180397|Furosemide|furosemide|mesh-list
25118415|NCT04180397|Diuretics|diuretics|mesh-ancestor
25118416|NCT04180397|Natriuretic Agents|natriuretic agents|mesh-ancestor
25118417|NCT04180397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118418|NCT04180397|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25118419|NCT04180397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25118420|NCT04180397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118421|NCT04175470|Tocotrienols|tocotrienols|mesh-list
25118422|NCT04175470|Vitamin E|vitamin e|mesh-list
25118423|NCT04175470|Tocopherols|tocopherols|mesh-list
25118424|NCT04175470|Bevacizumab|bevacizumab|mesh-list
25118425|NCT04175470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25118426|NCT04175470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118427|NCT04175470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25118428|NCT04175470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25118429|NCT04175470|Growth Substances|growth substances|mesh-ancestor
25118430|NCT04175470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118431|NCT04175470|Growth Inhibitors|growth inhibitors|mesh-ancestor
25290140|NCT02758431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290141|NCT02758431|Anabolic Agents|anabolic agents|mesh-ancestor
25290142|NCT02758431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25290143|NCT02758431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25290144|NCT02758431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290145|NCT02758431|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25290146|NCT02698293|Vitamin D|vitamin d|mesh-list
25290147|NCT02698293|Ergocalciferols|ergocalciferols|mesh-list
25290148|NCT02698293|Cholecalciferol|cholecalciferol|mesh-list
25290149|NCT02698293|Vitamins|vitamins|mesh-list
25290150|NCT02698293|Micronutrients|micronutrients|mesh-ancestor
25290151|NCT02698293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290152|NCT02698293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25118433|NCT04175470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118434|NCT04175470|Protective Agents|protective agents|mesh-ancestor
25118436|NCT04175470|Micronutrients|micronutrients|mesh-ancestor
25118437|NCT04168931|Trastuzumab|trastuzumab|mesh-list
25118438|NCT04168931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25118439|NCT04168931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118440|NCT04150562|Avelumab|avelumab|mesh-list
25118441|NCT04150562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25118442|NCT04150562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118443|NCT04146038|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
25118444|NCT04146038|Sodium Salicylate|sodium salicylate|mesh-list
25118445|NCT04146038|Azacitidine|azacitidine|mesh-list
25118446|NCT04146038|Decitabine|decitabine|mesh-list
25118447|NCT04146038|Venetoclax|venetoclax|mesh-list
25118448|NCT04146038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25118449|NCT04146038|Antimetabolites|antimetabolites|mesh-ancestor
25118450|NCT04146038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118451|NCT04146038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24693620|NCT01421368|Antiviral Agents|antiviral agents|mesh-ancestor
25118452|NCT04146038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25118453|NCT04146038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25118454|NCT04146038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25118455|NCT04146038|Analgesics|analgesics|mesh-ancestor
25118456|NCT04146038|Sensory System Agents|sensory system agents|mesh-ancestor
25290153|NCT02698293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25290154|NCT02643056|Panitumumab|panitumumab|mesh-list
25290155|NCT02643056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25290156|NCT02643056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290157|NCT02471118|Adalimumab|adalimumab|mesh-list
25290158|NCT02471118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25290159|NCT02471118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25290160|NCT02417285|Obinutuzumab|obinutuzumab|mesh-list
25290161|NCT02417285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25290162|NCT02417285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290163|NCT02398396|Lactitol|lactitol|mesh-list
25290164|NCT02398396|Cathartics|cathartics|mesh-ancestor
25290165|NCT02398396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25290191|NCT05098574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24620601|NCT01057849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25290193|NCT05098574|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25290194|NCT05098574|Hormone Antagonists|hormone antagonists|mesh-ancestor
25290195|NCT05098574|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25290196|NCT05098574|Diuretics|diuretics|mesh-ancestor
25290197|NCT05098574|Natriuretic Agents|natriuretic agents|mesh-ancestor
25118497|NCT04082520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118498|NCT04082520|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25118500|NCT04059172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25118501|NCT04059172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25118502|NCT04059172|Analgesics|analgesics|mesh-ancestor
25118503|NCT04059172|Sensory System Agents|sensory system agents|mesh-ancestor
25118504|NCT04059172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25118505|NCT04059172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118506|NCT04059172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25118507|NCT04059172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25118508|NCT04059172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25118509|NCT04059172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25118510|NCT04059172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118515|NCT04025775|Insulin|insulin|mesh-list
25118516|NCT04025775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25118517|NCT04025775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118518|NCT04025372|Bicalutamide|bicalutamide|mesh-list
25118519|NCT04025372|Androgen Antagonists|androgen antagonists|mesh-ancestor
25118520|NCT04025372|Hormone Antagonists|hormone antagonists|mesh-ancestor
25118521|NCT04025372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25118522|NCT04025372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118523|NCT04025372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118524|NCT04021550|Thioctic Acid|thioctic acid|mesh-list
25118525|NCT04021550|Telmisartan|telmisartan|mesh-list
25118526|NCT04021550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25118527|NCT04021550|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25118528|NCT04021550|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25118529|NCT04021550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118531|NCT04021550|Protective Agents|protective agents|mesh-ancestor
25290205|NCT05098353|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25290206|NCT05098353|Antidepressive Agents|antidepressive agents|mesh-ancestor
25290207|NCT05098353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25290208|NCT05098353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25290209|NCT05098353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25290210|NCT05098353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25290211|NCT05098353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290212|NCT05098327|Pioglitazone|pioglitazone|mesh-list
25290213|NCT05098327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25290214|NCT05098327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290215|NCT05098119|Paclitaxel|paclitaxel|mesh-list
25290216|NCT05098119|Carboplatin|carboplatin|mesh-list
25290217|NCT05098119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25290218|NCT05098119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290219|NCT05098119|Tubulin Modulators|tubulin modulators|mesh-ancestor
25290220|NCT05098119|Antimitotic Agents|antimitotic agents|mesh-ancestor
25290221|NCT05098119|Mitosis Modulators|mitosis modulators|mesh-ancestor
25290222|NCT05098119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290223|NCT05098067|Ondansetron|ondansetron|mesh-list
25290224|NCT05098067|Metoclopramide|metoclopramide|mesh-list
25290225|NCT05098067|Capsaicin|capsaicin|mesh-list
25290226|NCT05098067|Antiemetics|antiemetics|mesh-ancestor
25290227|NCT05098067|Autonomic Agents|autonomic agents|mesh-ancestor
25290228|NCT05098067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25290229|NCT05098067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290230|NCT05098067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25290231|NCT05098067|Antipruritics|antipruritics|mesh-ancestor
25290232|NCT05098067|Dermatologic Agents|dermatologic agents|mesh-ancestor
25290233|NCT05098067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25290234|NCT05098067|Serotonin Agents|serotonin agents|mesh-ancestor
25290235|NCT05098067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25290236|NCT05098067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290237|NCT05098067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25290238|NCT05098067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25290239|NCT05098067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25290240|NCT05098067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25290241|NCT05098067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25118533|NCT04021550|Vitamin B Complex|vitamin b complex|mesh-ancestor
25693282|NCT02011516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770828|NCT01822639|Enalapril|enalapril|mesh-list
25118534|NCT04021550|Vitamins|vitamins|mesh-ancestor
25118535|NCT04021550|Micronutrients|micronutrients|mesh-ancestor
25118536|NCT04014790|KRN 7000|krn 7000|mesh-list
25118537|NCT04014790|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25118538|NCT04014790|Immunologic Factors|immunologic factors|mesh-ancestor
25118539|NCT04014790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118540|NCT04014790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118541|NCT04009343|Lumefantrine|lumefantrine|mesh-list
25118542|NCT04009343|Artemether|artemether|mesh-list
25118543|NCT04009343|Piperaquine|piperaquine|mesh-list
25118544|NCT04009343|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25118545|NCT04009343|Artenimol|artenimol|mesh-list
25118546|NCT04009343|Antimalarials|antimalarials|mesh-ancestor
25118547|NCT04009343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25118548|NCT04009343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25118549|NCT04009343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25118550|NCT03994731|Acetaminophen|acetaminophen|mesh-list
25118551|NCT03994731|Folic Acid|folic acid|mesh-list
25118552|NCT03994731|Fexofenadine|fexofenadine|mesh-list
25118553|NCT03994731|Methylprednisolone|methylprednisolone|mesh-list
25118554|NCT03994731|Methotrexate|methotrexate|mesh-list
25118555|NCT03994731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25118556|NCT03994731|Abortifacient Agents|abortifacient agents|mesh-ancestor
25118557|NCT03994731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24780090|NCT01881347|Resveratrol|resveratrol|mesh-list
25118558|NCT03994731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118559|NCT03994731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25118560|NCT03994731|Antimetabolites|antimetabolites|mesh-ancestor
25118561|NCT03994731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118562|NCT03994731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118563|NCT03994731|Dermatologic Agents|dermatologic agents|mesh-ancestor
25118564|NCT03994731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25118565|NCT03994731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25118566|NCT03994731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25290242|NCT05098067|Sensory System Agents|sensory system agents|mesh-ancestor
25290243|NCT05098067|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25290244|NCT05098067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25290245|NCT05098067|Dopamine Agents|dopamine agents|mesh-ancestor
25290246|NCT05097950|Acetaminophen|acetaminophen|mesh-list
25290247|NCT05097950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25290248|NCT05097950|Analgesics|analgesics|mesh-ancestor
25290249|NCT05097950|Sensory System Agents|sensory system agents|mesh-ancestor
25290250|NCT05097950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25290251|NCT05097950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290252|NCT05097950|Antipyretics|antipyretics|mesh-ancestor
25290253|NCT05097911|Bevacizumab|bevacizumab|mesh-list
25290254|NCT05097911|Atezolizumab|atezolizumab|mesh-list
25290255|NCT05097911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25290256|NCT05097911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290257|NCT05097911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25290258|NCT05097911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25290269|NCT05097508|Anticonvulsants|anticonvulsants|mesh-ancestor
25290270|NCT05097508|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25290271|NCT05097508|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25290272|NCT05097508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25290273|NCT05097508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25290274|NCT05097508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290275|NCT05097508|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25290276|NCT05097508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25290277|NCT05097508|Cholinergic Agents|cholinergic agents|mesh-ancestor
25290278|NCT05097508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25290279|NCT05097508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290280|NCT05097365|Folic Acid|folic acid|mesh-list
25290281|NCT05097365|Vitamin B 12|vitamin b 12|mesh-list
25290282|NCT05097365|Hydroxocobalamin|hydroxocobalamin|mesh-list
25290283|NCT05097365|Vitamins|vitamins|mesh-ancestor
25290284|NCT05097365|Micronutrients|micronutrients|mesh-ancestor
25118575|NCT03994731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25118576|NCT03994731|Antiemetics|antiemetics|mesh-ancestor
25118577|NCT03994731|Autonomic Agents|autonomic agents|mesh-ancestor
25118578|NCT03994731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25118579|NCT03994731|Glucocorticoids|glucocorticoids|mesh-ancestor
25118580|NCT03994731|Hormones|hormones|mesh-ancestor
25118581|NCT03994731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25118582|NCT03994731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25118583|NCT03994731|Protective Agents|protective agents|mesh-ancestor
25118584|NCT03994731|Hematinics|hematinics|mesh-ancestor
24770931|NCT01823159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693283|NCT02011945|Nivolumab|nivolumab|mesh-list
25693284|NCT02011945|Dasatinib|dasatinib|mesh-list
24770933|NCT01823172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770934|NCT01823172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118585|NCT03994731|Vitamin B Complex|vitamin b complex|mesh-ancestor
25118586|NCT03994731|Vitamins|vitamins|mesh-ancestor
25118587|NCT03994731|Micronutrients|micronutrients|mesh-ancestor
25118588|NCT03994731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25118589|NCT03994731|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25118590|NCT03994731|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25118591|NCT03994731|Histamine Antagonists|histamine antagonists|mesh-ancestor
25118592|NCT03994731|Histamine Agents|histamine agents|mesh-ancestor
25118593|NCT03994731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25118594|NCT03991013|Dolutegravir|dolutegravir|mesh-list
25118595|NCT03991013|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25118596|NCT03991013|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25118597|NCT03991013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25118598|NCT03991013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118599|NCT03991013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25118600|NCT03991013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25118601|NCT03991013|Antiviral Agents|antiviral agents|mesh-ancestor
25118602|NCT03991013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24817983|NCT02086279|Hormones|hormones|mesh-list
24614144|NCT01022632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24614145|NCT01022632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24614146|NCT01022632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25290285|NCT05097365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290286|NCT05097365|Hematinics|hematinics|mesh-ancestor
25290287|NCT05097365|Vitamin B Complex|vitamin b complex|mesh-ancestor
25290314|NCT05097248|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25290315|NCT05097209|Gemcitabine|gemcitabine|mesh-list
25290316|NCT05097209|Cisplatin|cisplatin|mesh-list
25290317|NCT05097209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290318|NCT05097209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25290319|NCT05097209|Antimetabolites|antimetabolites|mesh-ancestor
25118620|NCT03971708|Lidocaine|lidocaine|mesh-list
25118621|NCT03971708|Ropivacaine|ropivacaine|mesh-list
25118622|NCT03971708|Anesthetics, Local|anesthetics, local|mesh-ancestor
25118623|NCT03971708|Anesthetics|anesthetics|mesh-ancestor
25118624|NCT03971708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25118625|NCT03971708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118626|NCT03971708|Sensory System Agents|sensory system agents|mesh-ancestor
25118627|NCT03971708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25118628|NCT03971708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25118629|NCT03971708|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25118630|NCT03971708|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25118631|NCT03971708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25118632|NCT03971708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118633|NCT03966014|Amoxicillin|amoxicillin|mesh-list
25118634|NCT03966014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25118635|NCT03966014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25118636|NCT03965728|Methotrexate|methotrexate|mesh-list
25118637|NCT03965728|Midazolam|midazolam|mesh-list
25118638|NCT03965728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25118639|NCT03965728|Abortifacient Agents|abortifacient agents|mesh-ancestor
25118640|NCT03965728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25118641|NCT03965728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118642|NCT03965728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25118643|NCT03965728|Antimetabolites|antimetabolites|mesh-ancestor
25118644|NCT03965728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693285|NCT02011945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25693286|NCT02011945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693287|NCT02011945|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25693288|NCT02011945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693289|NCT02011945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25693290|NCT02011945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693291|NCT02012192|Paclitaxel|paclitaxel|mesh-list
25693292|NCT02012192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24770996|NCT01824043|Growth Substances|growth substances|mesh-ancestor
25118645|NCT03965728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118646|NCT03965728|Dermatologic Agents|dermatologic agents|mesh-ancestor
25290320|NCT05097209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290321|NCT05097209|Antiviral Agents|antiviral agents|mesh-ancestor
25290322|NCT05097209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25290323|NCT05097209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25290324|NCT05097209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25290325|NCT05097209|Immunologic Factors|immunologic factors|mesh-ancestor
25290326|NCT05097209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290327|NCT05089851|Sunscreening Agents|sunscreening agents|mesh-list
25290328|NCT05089851|Botulinum Toxins|botulinum toxins|mesh-list
25290329|NCT05089851|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25290330|NCT05089851|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25290331|NCT05089851|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25290332|NCT05089851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25290333|NCT05089851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290334|NCT05089851|Cholinergic Agents|cholinergic agents|mesh-ancestor
25290335|NCT05089851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25290336|NCT05089851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290337|NCT05089851|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25290338|NCT05089851|Protective Agents|protective agents|mesh-ancestor
25290339|NCT05089851|Dermatologic Agents|dermatologic agents|mesh-ancestor
25290340|NCT05089851|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25290341|NCT05089851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25290342|NCT05087940|Diuretics|diuretics|mesh-list
25290343|NCT05087940|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
25290344|NCT05087940|Natriuretic Agents|natriuretic agents|mesh-ancestor
25290345|NCT05087940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290346|NCT05087940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25290347|NCT05087940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290348|NCT05083325|Oseltamivir|oseltamivir|mesh-list
25290349|NCT05083325|Antiviral Agents|antiviral agents|mesh-ancestor
25290350|NCT05083325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25290351|NCT05083325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25290352|NCT05083325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290353|NCT05060484|Vaccines|vaccines|mesh-list
25290354|NCT05060484|Immunologic Factors|immunologic factors|mesh-ancestor
25290355|NCT05060484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290356|NCT05057572|Carvedilol|carvedilol|mesh-list
25118648|NCT03965728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25118649|NCT03965728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25118650|NCT03965728|Immunologic Factors|immunologic factors|mesh-ancestor
25118651|NCT03965728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25118652|NCT03965728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25118653|NCT03965728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25118654|NCT03965728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25118655|NCT03965728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25118656|NCT03965728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25118657|NCT03965728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25118658|NCT03965728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25118659|NCT03965728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25118660|NCT03965728|Anesthetics, General|anesthetics, general|mesh-ancestor
25118661|NCT03965728|Anesthetics|anesthetics|mesh-ancestor
25118662|NCT03965728|GABA Modulators|gaba modulators|mesh-ancestor
25118663|NCT03965728|GABA Agents|gaba agents|mesh-ancestor
25118664|NCT03965728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25118665|NCT03963895|Thrombin|thrombin|mesh-list
25118666|NCT03963895|Hemostatics|hemostatics|mesh-ancestor
25118667|NCT03963895|Coagulants|coagulants|mesh-ancestor
25118668|NCT03956446|Doxycycline|doxycycline|mesh-list
25118669|NCT03956446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25118670|NCT03956446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25118671|NCT03956446|Antimalarials|antimalarials|mesh-ancestor
25118672|NCT03956446|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25118673|NCT03956446|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25118674|NCT03955172|Everolimus|everolimus|mesh-list
25118675|NCT03955172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118676|NCT03955172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25118677|NCT03955172|Immunologic Factors|immunologic factors|mesh-ancestor
25118678|NCT03955172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118679|NCT03954613|Memantine|memantine|mesh-list
25118680|NCT03954613|Donepezil|donepezil|mesh-list
25118681|NCT03954613|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25290357|NCT05057572|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25290358|NCT05057572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25693293|NCT02012192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771068|NCT01824433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771077|NCT01824459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290359|NCT05057572|Adrenergic Agents|adrenergic agents|mesh-ancestor
25290360|NCT05057572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25290361|NCT05057572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290362|NCT05057572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290363|NCT05057572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25290364|NCT05057572|Antioxidants|antioxidants|mesh-ancestor
25290365|NCT05057572|Protective Agents|protective agents|mesh-ancestor
25290366|NCT05057572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25290367|NCT05057572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25290368|NCT05057572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25290369|NCT05057572|Vasodilator Agents|vasodilator agents|mesh-ancestor
25290370|NCT05057572|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25290371|NCT05057572|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25290372|NCT05026801|Azithromycin|azithromycin|mesh-list
25290373|NCT05026801|Hydroxychloroquine|hydroxychloroquine|mesh-list
25290374|NCT05026801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25290375|NCT05026801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25290376|NCT05026801|Antimalarials|antimalarials|mesh-ancestor
25290377|NCT05026801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25290378|NCT05026801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25118748|NCT03870399|Hormone Antagonists|hormone antagonists|mesh-ancestor
25118749|NCT03870399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25118750|NCT03870399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118751|NCT03870399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25118752|NCT03870399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118753|NCT03870399|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25118754|NCT03870399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24627742|NCT01094626|Hormones|hormones|mesh-ancestor
25290396|NCT04999631|Ethanol|ethanol|mesh-list
25290397|NCT04999631|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
25290398|NCT04999631|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25290399|NCT04999631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25290400|NCT04999631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25290401|NCT04999631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290402|NCT04999631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25290403|NCT04999631|Immunologic Factors|immunologic factors|mesh-ancestor
25290404|NCT04985955|Tofacitinib|tofacitinib|mesh-list
25290405|NCT04985955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25290406|NCT04985955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25290407|NCT04985955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290426|NCT04908293|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25290427|NCT04908293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25290428|NCT04858854|Sulforaphane|sulforaphane|mesh-list
25290429|NCT04858854|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25290430|NCT04858854|Protective Agents|protective agents|mesh-ancestor
25290431|NCT04858854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290432|NCT04858854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290433|NCT04853004|Antibodies|antibodies|mesh-list
25290434|NCT04853004|Immunologic Factors|immunologic factors|mesh-ancestor
25118762|NCT03818061|Bevacizumab|bevacizumab|mesh-list
25118763|NCT03818061|Atezolizumab|atezolizumab|mesh-list
25118764|NCT03818061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25118765|NCT03818061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118766|NCT03818061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25118767|NCT03818061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25118768|NCT03818061|Growth Substances|growth substances|mesh-ancestor
25118769|NCT03818061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118770|NCT03818061|Growth Inhibitors|growth inhibitors|mesh-ancestor
25118774|NCT03783026|Apremilast|apremilast|mesh-list
25118775|NCT03783026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25118776|NCT03783026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25118777|NCT03783026|Analgesics|analgesics|mesh-ancestor
25118778|NCT03783026|Sensory System Agents|sensory system agents|mesh-ancestor
25118779|NCT03783026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25118780|NCT03783026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118781|NCT03783026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25118782|NCT03783026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25118783|NCT03783026|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25118784|NCT03783026|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25118785|NCT03783026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693294|NCT02012192|Tubulin Modulators|tubulin modulators|mesh-ancestor
25693295|NCT02012192|Antimitotic Agents|antimitotic agents|mesh-ancestor
24771171|NCT01825031|Antimitotic Agents|antimitotic agents|mesh-ancestor
24771172|NCT01825031|Mitosis Modulators|mitosis modulators|mesh-ancestor
24771173|NCT01825031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771178|NCT01825044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25693296|NCT02012192|Mitosis Modulators|mitosis modulators|mesh-ancestor
25118787|NCT03760523|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
25118789|NCT03760523|Alkylating Agents|alkylating agents|mesh-ancestor
25118790|NCT03760523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118791|NCT03760523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290435|NCT04853004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290442|NCT04806100|Carbon Fiber|carbon fiber|mesh-list
25290443|NCT04806100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25290444|NCT04806100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25290445|NCT04796636|Ascorbic Acid|ascorbic acid|mesh-list
25290446|NCT04796636|Antioxidants|antioxidants|mesh-ancestor
25290447|NCT04796636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290448|NCT04796636|Protective Agents|protective agents|mesh-ancestor
25290449|NCT04796636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290450|NCT04796636|Vitamins|vitamins|mesh-ancestor
25290451|NCT04796636|Micronutrients|micronutrients|mesh-ancestor
25290455|NCT04718636|Moxifloxacin|moxifloxacin|mesh-list
25290456|NCT04718636|Contraceptive Agents|contraceptive agents|mesh-list
25290457|NCT04718636|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25290458|NCT04718636|Contraceptives, Oral|contraceptives, oral|mesh-list
25290741|NCT03945721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25290468|NCT04718636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25290469|NCT04718636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290470|NCT04718636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290471|NCT04707261|Dapagliflozin|dapagliflozin|mesh-list
25290472|NCT04707261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25118810|NCT03734744|Vitamin D|vitamin d|mesh-list
25118811|NCT03734744|Cholecalciferol|cholecalciferol|mesh-list
25118812|NCT03734744|Vitamins|vitamins|mesh-ancestor
25118813|NCT03734744|Micronutrients|micronutrients|mesh-ancestor
25118814|NCT03734744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118815|NCT03734744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25118816|NCT03734744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25118817|NCT03711448|Prednisone|prednisone|mesh-list
25118818|NCT03711448|Ustekinumab|ustekinumab|mesh-list
25118819|NCT03711448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25118820|NCT03711448|Glucocorticoids|glucocorticoids|mesh-ancestor
25118821|NCT03711448|Hormones|hormones|mesh-ancestor
25118822|NCT03711448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25118823|NCT03711448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118824|NCT03711448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25118825|NCT03711448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118826|NCT03711448|Dermatologic Agents|dermatologic agents|mesh-ancestor
25290473|NCT04707261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290474|NCT04707261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25290475|NCT04707261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290476|NCT04689945|Morphine|morphine|mesh-list
25290477|NCT04689945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25290478|NCT04689945|Narcotics|narcotics|mesh-ancestor
25290479|NCT04689945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25290480|NCT04689945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290481|NCT04689945|Analgesics|analgesics|mesh-ancestor
25290482|NCT04689945|Sensory System Agents|sensory system agents|mesh-ancestor
25290483|NCT04689945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25290484|NCT04644796|Bupivacaine|bupivacaine|mesh-list
25290485|NCT04644796|Anesthetics, Local|anesthetics, local|mesh-ancestor
25290486|NCT04644796|Anesthetics|anesthetics|mesh-ancestor
25290487|NCT04644796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25290488|NCT04644796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290489|NCT04644796|Sensory System Agents|sensory system agents|mesh-ancestor
25290490|NCT04644796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25119213|NCT02489903|Irinotecan|irinotecan|mesh-list
25290514|NCT04546620|Prednisone|prednisone|mesh-list
25290515|NCT04546620|Cyclophosphamide|cyclophosphamide|mesh-list
25290516|NCT04546620|Rituximab|rituximab|mesh-list
25118855|NCT03576716|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
25693297|NCT02012192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693298|NCT02012218|Brexpiprazole|brexpiprazole|mesh-list
25693299|NCT02012218|Serotonin Agents|serotonin agents|mesh-ancestor
25693300|NCT02012218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25118857|NCT03576716|Vitamins|vitamins|mesh-ancestor
25118858|NCT03576716|Micronutrients|micronutrients|mesh-ancestor
25118859|NCT03576716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118860|NCT03576716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25118861|NCT03572049|Itraconazole|itraconazole|mesh-list
25118862|NCT03572049|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
25118863|NCT03572049|Antifungal Agents|antifungal agents|mesh-ancestor
25118864|NCT03572049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25118865|NCT03572049|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25118866|NCT03572049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25118867|NCT03572049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25118868|NCT03572049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118869|NCT03572049|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25118870|NCT03572049|Hormone Antagonists|hormone antagonists|mesh-ancestor
25118871|NCT03572049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25118872|NCT03572049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25118873|NCT03572049|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25290517|NCT04546620|Doxorubicin|doxorubicin|mesh-list
25290518|NCT04546620|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25290519|NCT04546620|Vincristine|vincristine|mesh-list
25290520|NCT04546620|Acalabrutinib|acalabrutinib|mesh-list
25290521|NCT04546620|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25290522|NCT04546620|Prednisolone phosphate|prednisolone phosphate|mesh-list
25290523|NCT04546620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25290524|NCT04546620|Immunologic Factors|immunologic factors|mesh-ancestor
25290525|NCT04546620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290526|NCT04546620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25290527|NCT04546620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25290528|NCT04546620|Alkylating Agents|alkylating agents|mesh-ancestor
25290529|NCT04546620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290530|NCT04546620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290531|NCT04546620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25290532|NCT04546620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25290533|NCT04546620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25290534|NCT04546620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25290535|NCT04546620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25290536|NCT04546620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25290537|NCT04546620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25290538|NCT04546620|Tubulin Modulators|tubulin modulators|mesh-ancestor
25290539|NCT04546620|Antimitotic Agents|antimitotic agents|mesh-ancestor
25290540|NCT04546620|Mitosis Modulators|mitosis modulators|mesh-ancestor
25290541|NCT04546620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25290542|NCT04546620|Glucocorticoids|glucocorticoids|mesh-ancestor
25119214|NCT02489903|Pemetrexed|pemetrexed|mesh-list
25290566|NCT04523935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25290567|NCT04523935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25290568|NCT04523935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25290569|NCT04523935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25290570|NCT04523935|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25290571|NCT04523935|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25290572|NCT04523935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25290573|NCT04523935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290574|NCT04523935|Antimanic Agents|antimanic agents|mesh-ancestor
25290575|NCT04523935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25290576|NCT04523935|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25290577|NCT04523935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25290578|NCT04523935|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25290579|NCT04523935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25290580|NCT04523935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25290581|NCT04523935|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25290582|NCT04523935|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25290583|NCT04523935|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25290584|NCT04523935|GABA Agonists|gaba agonists|mesh-ancestor
25290585|NCT04523935|GABA Agents|gaba agents|mesh-ancestor
25290586|NCT04523935|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25290587|NCT04523935|Antidepressive Agents|antidepressive agents|mesh-ancestor
25290588|NCT04523935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25290589|NCT04523935|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25290590|NCT04523935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25290591|NCT04523935|Adrenergic Agents|adrenergic agents|mesh-ancestor
25118947|NCT03406715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118948|NCT03406715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25118949|NCT03406715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118950|NCT03367819|Cemiplimab|cemiplimab|mesh-list
25118951|NCT03367819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25118952|NCT03367819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118953|NCT03343197|Ivosidenib|ivosidenib|mesh-list
25118954|NCT03343197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25118955|NCT03343197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25118956|NCT03343197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780492|NCT01884623|Cetuximab|cetuximab|mesh-list
25290605|NCT04523935|Cholinergic Agents|cholinergic agents|mesh-ancestor
25290606|NCT04515186|Miltefosine|miltefosine|mesh-list
25290607|NCT04515186|Meglumine Antimoniate|meglumine antimoniate|mesh-list
25290608|NCT04515186|Antifungal Agents|antifungal agents|mesh-ancestor
25290609|NCT04515186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25290610|NCT04515186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290611|NCT04515186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25290612|NCT04515186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25290613|NCT04507841|Niraparib|niraparib|mesh-list
25290614|NCT04507841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25290615|NCT04507841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25290616|NCT04507841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290617|NCT04507841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290618|NCT04414241|Hydroxychloroquine|hydroxychloroquine|mesh-list
25290619|NCT04414241|Antimalarials|antimalarials|mesh-ancestor
25290620|NCT04414241|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25290621|NCT04414241|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25290622|NCT04414241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25290623|NCT04414241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25290624|NCT04414241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290625|NCT04414241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25118986|NCT03177746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25118987|NCT03177746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25118988|NCT03177746|Urological Agents|urological agents|mesh-ancestor
25290643|NCT04389775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290644|NCT04389775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25290645|NCT04345887|Spironolactone|spironolactone|mesh-list
25290646|NCT04345887|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25290647|NCT04345887|Hormone Antagonists|hormone antagonists|mesh-ancestor
25290648|NCT04345887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25290649|NCT04345887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290650|NCT04345887|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25290651|NCT04345887|Diuretics|diuretics|mesh-ancestor
25290652|NCT04345887|Natriuretic Agents|natriuretic agents|mesh-ancestor
25290653|NCT04316169|Hydroxychloroquine|hydroxychloroquine|mesh-list
25290654|NCT04316169|Letrozole|letrozole|mesh-list
25290655|NCT04316169|Fulvestrant|fulvestrant|mesh-list
25290656|NCT04316169|Anastrozole|anastrozole|mesh-list
25290657|NCT04316169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290658|NCT04316169|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25290659|NCT04316169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25290660|NCT04316169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25290661|NCT04316169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290662|NCT04316169|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25290663|NCT04316169|Hormone Antagonists|hormone antagonists|mesh-ancestor
25290664|NCT04316169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25290665|NCT04316169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290666|NCT04316169|Antimalarials|antimalarials|mesh-ancestor
25290667|NCT04316169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25290668|NCT04316169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25119063|NCT02951052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25119064|NCT02951052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119066|NCT02951052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25119067|NCT02951052|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24901642|NCT04382443|Colchicine|colchicine|mesh-list
24614147|NCT01022632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614149|NCT01022645|Levonorgestrel|levonorgestrel|mesh-list
24614150|NCT01022645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24614151|NCT01022645|Contraceptive Agents|contraceptive agents|mesh-ancestor
24614152|NCT01022645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24614153|NCT01022645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614154|NCT01022645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24614155|NCT01022645|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24614156|NCT01022645|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24614157|NCT01022645|Trace Elements|trace elements|mesh-ancestor
25290680|NCT04305145|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24771515|NCT01827618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771520|NCT01827722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24771521|NCT01827722|Antiemetics|antiemetics|mesh-ancestor
24771522|NCT01827722|Autonomic Agents|autonomic agents|mesh-ancestor
24771523|NCT01827722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25080923|NCT03334877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24966997|NCT03763669|Hematinics|hematinics|mesh-ancestor
24966999|NCT03763669|Micronutrients|micronutrients|mesh-ancestor
24967001|NCT03763409|Losartan|losartan|mesh-list
24967014|NCT03763396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290681|NCT04305145|Prednisolone phosphate|prednisolone phosphate|mesh-list
25290682|NCT04305145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25290683|NCT04305145|Glucocorticoids|glucocorticoids|mesh-ancestor
25290684|NCT04305145|Hormones|hormones|mesh-ancestor
25290685|NCT04305145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25290686|NCT04305145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290687|NCT04305145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25290688|NCT04305145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290689|NCT04305145|Antiemetics|antiemetics|mesh-ancestor
25290690|NCT04305145|Autonomic Agents|autonomic agents|mesh-ancestor
25290691|NCT04305145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25290692|NCT04305145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25290693|NCT04305145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25290694|NCT04305145|Protective Agents|protective agents|mesh-ancestor
25290695|NCT04305145|Dermatologic Agents|dermatologic agents|mesh-ancestor
25290696|NCT04305145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25290697|NCT04188145|Bevacizumab|bevacizumab|mesh-list
25290698|NCT04188145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25290699|NCT04188145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290700|NCT04188145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25290701|NCT04188145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25290702|NCT04188145|Growth Substances|growth substances|mesh-ancestor
25290708|NCT04181606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25290709|NCT04181606|Adrenergic Agents|adrenergic agents|mesh-ancestor
25290710|NCT04181606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25119068|NCT02951052|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25119069|NCT02951052|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25119070|NCT02951052|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25119072|NCT02871843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25119073|NCT02871843|Alkylating Agents|alkylating agents|mesh-ancestor
25119074|NCT02871843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119075|NCT02871843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119076|NCT02848131|Dasatinib|dasatinib|mesh-list
25119077|NCT02848131|Quercetin|quercetin|mesh-list
25119078|NCT02848131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119079|NCT02848131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25119080|NCT02848131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25119081|NCT02848131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119082|NCT02848131|Antioxidants|antioxidants|mesh-ancestor
25119083|NCT02848131|Protective Agents|protective agents|mesh-ancestor
25119084|NCT02848131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119107|NCT02801097|Irinotecan|irinotecan|mesh-list
25119108|NCT02801097|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25119109|NCT02801097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25119110|NCT02801097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25119111|NCT02801097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119112|NCT02801097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119114|NCT02759380|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25119115|NCT02759380|Estrogens|estrogens|mesh-ancestor
25119116|NCT02759380|Hormones|hormones|mesh-ancestor
25119117|NCT02759380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25119118|NCT02759380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693301|NCT02012218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693302|NCT02012218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693303|NCT02012218|Dopamine Agonists|dopamine agonists|mesh-ancestor
25693304|NCT02012218|Dopamine Agents|dopamine agents|mesh-ancestor
25693305|NCT02012348|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25693306|NCT02012348|Benzalkonium Compounds|benzalkonium compounds|mesh-list
25693307|NCT02012348|Triclocarban|triclocarban|mesh-list
25693308|NCT02012348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25693309|NCT02012348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25693310|NCT02012491|Misoprostol|misoprostol|mesh-list
25119119|NCT02724410|Amoxicillin|amoxicillin|mesh-list
25119120|NCT02724410|Clavulanic Acid|clavulanic acid|mesh-list
25290711|NCT04181606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290712|NCT04181606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290713|NCT04128774|Dexamethasone|dexamethasone|mesh-list
25290714|NCT04128774|Dexamethasone acetate|dexamethasone acetate|mesh-list
25290715|NCT04128774|BB 1101|bb 1101|mesh-list
25290716|NCT04128774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25290717|NCT04128774|Antiemetics|antiemetics|mesh-ancestor
25290718|NCT04128774|Autonomic Agents|autonomic agents|mesh-ancestor
25290719|NCT04128774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25290720|NCT04128774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290721|NCT04128774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25290722|NCT04128774|Glucocorticoids|glucocorticoids|mesh-ancestor
25290723|NCT04128774|Hormones|hormones|mesh-ancestor
25290724|NCT04128774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25290725|NCT04128774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25290726|NCT04128774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290727|NCT04128774|Protease Inhibitors|protease inhibitors|mesh-ancestor
25290728|NCT04128774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25290729|NCT04128774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290730|NCT04088123|Ticagrelor|ticagrelor|mesh-list
25290731|NCT04088123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25290732|NCT04088123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25290733|NCT04088123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25290734|NCT04088123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25290735|NCT04088123|Purinergic Agents|purinergic agents|mesh-ancestor
25290736|NCT04088123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25290737|NCT04088123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290738|NCT04088123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290739|NCT03945721|Niraparib|niraparib|mesh-list
25290740|NCT03945721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25119151|NCT02708680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420594|NCT00216411|Botulinum Toxins|botulinum toxins|mesh-list
25119152|NCT02708680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119153|NCT02672475|Paclitaxel|paclitaxel|mesh-list
25119154|NCT02672475|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25119155|NCT02672475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25119156|NCT02672475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119157|NCT02672475|Tubulin Modulators|tubulin modulators|mesh-ancestor
25119158|NCT02672475|Antimitotic Agents|antimitotic agents|mesh-ancestor
25119159|NCT02672475|Mitosis Modulators|mitosis modulators|mesh-ancestor
24614172|NCT01022736|Sensory System Agents|sensory system agents|mesh-ancestor
24614173|NCT01022736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24614174|NCT01022736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614175|NCT01022736|Anticonvulsants|anticonvulsants|mesh-ancestor
25290751|NCT03847181|Vitamin K|vitamin k|mesh-list
25290752|NCT03847181|Warfarin|warfarin|mesh-list
25290753|NCT03847181|Rivaroxaban|rivaroxaban|mesh-list
25290754|NCT03847181|Apixaban|apixaban|mesh-list
25290755|NCT03847181|Anticoagulants|anticoagulants|mesh-list
25290756|NCT03847181|Vitamins|vitamins|mesh-ancestor
25290757|NCT03847181|Micronutrients|micronutrients|mesh-ancestor
25290758|NCT03847181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290759|NCT03847181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25290760|NCT03847181|Antithrombins|antithrombins|mesh-ancestor
25290761|NCT03847181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25290762|NCT03847181|Protease Inhibitors|protease inhibitors|mesh-ancestor
25290763|NCT03847181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25290764|NCT03847181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290765|NCT03847181|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25290766|NCT03847181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25290767|NCT03847181|Hemostatics|hemostatics|mesh-ancestor
25290768|NCT03847181|Coagulants|coagulants|mesh-ancestor
25290804|NCT03608436|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25290805|NCT03608436|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25290806|NCT03608436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25290807|NCT03608436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25290808|NCT03608436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290809|NCT03556904|Docetaxel|docetaxel|mesh-list
25290810|NCT03556904|Hormones|hormones|mesh-list
25290811|NCT03556904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290812|NCT03556904|Tubulin Modulators|tubulin modulators|mesh-ancestor
25290813|NCT03556904|Antimitotic Agents|antimitotic agents|mesh-ancestor
25290814|NCT03556904|Mitosis Modulators|mitosis modulators|mesh-ancestor
25290815|NCT03556904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290816|NCT03556904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25693311|NCT02012491|Mifepristone|mifepristone|mesh-list
25290817|NCT03556904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290818|NCT03477851|Tramadol|tramadol|mesh-list
25290819|NCT03477851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25290820|NCT03477851|Narcotics|narcotics|mesh-ancestor
25290821|NCT03477851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25290822|NCT03477851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290823|NCT03477851|Analgesics|analgesics|mesh-ancestor
25290824|NCT03477851|Sensory System Agents|sensory system agents|mesh-ancestor
25290825|NCT03477851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25290826|NCT03412188|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25290827|NCT03412188|gamma-Globulins|gamma-globulins|mesh-list
25119211|NCT02489903|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25119212|NCT02489903|Carboplatin|carboplatin|mesh-list
25119219|NCT02489903|Antimitotic Agents|antimitotic agents|mesh-ancestor
25119220|NCT02489903|Mitosis Modulators|mitosis modulators|mesh-ancestor
25119221|NCT02489903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119222|NCT02489903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25119223|NCT02489903|Antimetabolites|antimetabolites|mesh-ancestor
25119224|NCT02489903|Antiviral Agents|antiviral agents|mesh-ancestor
25119225|NCT02489903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25119226|NCT02489903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25119227|NCT02489903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25119228|NCT02489903|Immunologic Factors|immunologic factors|mesh-ancestor
25119229|NCT02489903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119230|NCT02489903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25119231|NCT02489903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25119232|NCT02489903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25119233|NCT02489903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25119234|NCT02489903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25119235|NCT02489006|Olaparib|olaparib|mesh-list
25119236|NCT02489006|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25119237|NCT02489006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25119238|NCT02489006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119239|NCT02489006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119240|NCT02428270|Trametinib|trametinib|mesh-list
25119241|NCT02428270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119242|NCT02428270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25290828|NCT03412188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290829|NCT03412188|Immunologic Factors|immunologic factors|mesh-ancestor
25290830|NCT03412188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290831|NCT03412188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25290832|NCT03412188|Glucocorticoids|glucocorticoids|mesh-ancestor
25290833|NCT03412188|Hormones|hormones|mesh-ancestor
25290834|NCT03412188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25290835|NCT03412188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25290836|NCT03412188|Protective Agents|protective agents|mesh-ancestor
25290837|NCT03412188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25290841|NCT03250975|Azithromycin|azithromycin|mesh-list
25290842|NCT03250975|Budesonide|budesonide|mesh-list
25290843|NCT03250975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25290844|NCT03250975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25290845|NCT03250975|Autonomic Agents|autonomic agents|mesh-ancestor
25290846|NCT03250975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25290847|NCT03250975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290848|NCT03250975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25290849|NCT03250975|Respiratory System Agents|respiratory system agents|mesh-ancestor
25290850|NCT03250975|Glucocorticoids|glucocorticoids|mesh-ancestor
25290851|NCT03250975|Hormones|hormones|mesh-ancestor
25290852|NCT03250975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25290853|NCT03250975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25290854|NCT03250975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25290855|NCT03218137|Adenosine|adenosine|mesh-list
25290856|NCT03218137|Verapamil|verapamil|mesh-list
25290857|NCT03218137|Analgesics|analgesics|mesh-ancestor
25290858|NCT03218137|Sensory System Agents|sensory system agents|mesh-ancestor
25290859|NCT03218137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25290860|NCT03218137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290861|NCT03218137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25290862|NCT03218137|Vasodilator Agents|vasodilator agents|mesh-ancestor
25290863|NCT03218137|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25290864|NCT03218137|Purinergic Agonists|purinergic agonists|mesh-ancestor
25290865|NCT03218137|Purinergic Agents|purinergic agents|mesh-ancestor
25290866|NCT03218137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25406346|NCT03565835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24771805|NCT01829893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24771806|NCT01829893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771807|NCT01829893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771808|NCT01829893|Urological Agents|urological agents|mesh-ancestor
24771809|NCT01829893|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24771810|NCT01829893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25290867|NCT03218137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290868|NCT03218137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25290869|NCT03218137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25119252|NCT02428205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25119253|NCT02428205|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25119254|NCT02428205|Vasodilator Agents|vasodilator agents|mesh-ancestor
25119255|NCT02402842|Docetaxel|docetaxel|mesh-list
25119256|NCT02402842|Fluorouracil|fluorouracil|mesh-list
25119257|NCT02402842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119258|NCT02402842|Tubulin Modulators|tubulin modulators|mesh-ancestor
25119259|NCT02402842|Antimitotic Agents|antimitotic agents|mesh-ancestor
25119260|NCT02402842|Mitosis Modulators|mitosis modulators|mesh-ancestor
25119261|NCT02402842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119262|NCT02402842|Antimetabolites|antimetabolites|mesh-ancestor
25119263|NCT02402842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25119264|NCT02402842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25119265|NCT02402842|Immunologic Factors|immunologic factors|mesh-ancestor
25119266|NCT02402842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119267|NCT02399943|Panitumumab|panitumumab|mesh-list
25119268|NCT02399943|Trametinib|trametinib|mesh-list
25119269|NCT02399943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25119270|NCT02399943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119271|NCT02399943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25119272|NCT02399943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25119273|NCT02399943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119274|NCT02398656|Tenecteplase|tenecteplase|mesh-list
25119275|NCT02398656|Clopidogrel|clopidogrel|mesh-list
25119276|NCT02398656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25119277|NCT02398656|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25119278|NCT02398656|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25119279|NCT02398656|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25119280|NCT02398656|Purinergic Agents|purinergic agents|mesh-ancestor
25119281|NCT02398656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25119282|NCT02398656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290870|NCT03218137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25290871|NCT03079999|Aspirin|aspirin|mesh-list
25290872|NCT03079999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25290873|NCT03079999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25290874|NCT03079999|Analgesics|analgesics|mesh-ancestor
25290875|NCT03079999|Sensory System Agents|sensory system agents|mesh-ancestor
25290876|NCT03079999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25290877|NCT03079999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290878|NCT03079999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25290879|NCT03079999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25290880|NCT03079999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25290881|NCT03079999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25290882|NCT03079999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290883|NCT03079999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25290884|NCT03079999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25290885|NCT03079999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25290886|NCT03079999|Antipyretics|antipyretics|mesh-ancestor
25290887|NCT02958709|Rifampin|rifampin|mesh-list
25290888|NCT02958709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25290889|NCT02958709|Antitubercular Agents|antitubercular agents|mesh-ancestor
25290890|NCT02958709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25290891|NCT02958709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25290892|NCT02958709|Leprostatic Agents|leprostatic agents|mesh-ancestor
25290893|NCT02958709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25290894|NCT02958709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25290895|NCT02958709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693312|NCT02012491|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25693313|NCT02012491|Abortifacient Agents|abortifacient agents|mesh-ancestor
25693314|NCT02012491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25693315|NCT02012491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693316|NCT02012491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25693317|NCT02012491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25290896|NCT02958709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25290897|NCT02958709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25290898|NCT02958709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25290899|NCT02958709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25290900|NCT02958709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25290901|NCT02958709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25290902|NCT02957292|Levonorgestrel|levonorgestrel|mesh-list
25290903|NCT02957292|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25290904|NCT02957292|Contraceptive Agents|contraceptive agents|mesh-ancestor
25290905|NCT02957292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25290906|NCT02957292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290907|NCT02957292|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25290908|NCT02957292|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25290909|NCT02957292|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25119294|NCT02375295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25119295|NCT02375295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119296|NCT02375295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119297|NCT02375295|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24900716|NCT04391582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25119298|NCT02375295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25119325|NCT02124187|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25119327|NCT02124187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25119328|NCT02124187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290910|NCT02947581|Albendazole|albendazole|mesh-list
25290911|NCT02947581|Praziquantel|praziquantel|mesh-list
25290912|NCT02947581|Anthelmintics|anthelmintics|mesh-ancestor
25290913|NCT02947581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25290914|NCT02947581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25064033|NCT03463642|Emollients|emollients|mesh-ancestor
25290915|NCT02947581|Anticestodal Agents|anticestodal agents|mesh-ancestor
25290916|NCT02947581|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25290917|NCT02947581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25290918|NCT02947581|Tubulin Modulators|tubulin modulators|mesh-ancestor
25290919|NCT02947581|Antimitotic Agents|antimitotic agents|mesh-ancestor
25290920|NCT02947581|Mitosis Modulators|mitosis modulators|mesh-ancestor
25290921|NCT02947581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290922|NCT02947581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290923|NCT02861898|Cetuximab|cetuximab|mesh-list
25290924|NCT02861898|Mannitol|mannitol|mesh-list
25290925|NCT02861898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25290926|NCT02861898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290927|NCT02861898|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25290928|NCT02861898|Diuretics|diuretics|mesh-ancestor
25290929|NCT02861898|Natriuretic Agents|natriuretic agents|mesh-ancestor
25290930|NCT02861898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290931|NCT02806687|Gemcitabine|gemcitabine|mesh-list
25290932|NCT02806687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25290933|NCT02806687|Antimetabolites|antimetabolites|mesh-ancestor
25290934|NCT02806687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290935|NCT02806687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290936|NCT02806687|Antiviral Agents|antiviral agents|mesh-ancestor
25290937|NCT02806687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25290938|NCT02806687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25290939|NCT02806687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25290940|NCT02806687|Immunologic Factors|immunologic factors|mesh-ancestor
25290941|NCT02806687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290943|NCT02632396|Ixazomib|ixazomib|mesh-list
25290944|NCT02632396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25290945|NCT02632396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290946|NCT02632396|Immunologic Factors|immunologic factors|mesh-ancestor
25290947|NCT02632396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290948|NCT02632396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25119331|NCT02124187|Cholinergic Agents|cholinergic agents|mesh-ancestor
25119332|NCT02124187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25119333|NCT02124187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119334|NCT02096354|Irinotecan|irinotecan|mesh-list
25119335|NCT02096354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119336|NCT02096354|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25119337|NCT02096354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25119338|NCT02096354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902557|NCT04372407|Hormone Antagonists|hormone antagonists|mesh-ancestor
25290972|NCT05101005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25290973|NCT05101005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25290974|NCT05101005|Antifungal Agents|antifungal agents|mesh-ancestor
25290975|NCT05101005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25290976|NCT05101005|Immunologic Factors|immunologic factors|mesh-ancestor
25290977|NCT05101005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290979|NCT05100719|Simethicone|simethicone|mesh-list
25290980|NCT05100719|Citric Acid|citric acid|mesh-list
25290981|NCT05100719|Sodium Citrate|sodium citrate|mesh-list
25290982|NCT05100719|Alverine|alverine|mesh-list
25290983|NCT05100719|Anticoagulants|anticoagulants|mesh-ancestor
25290984|NCT05100719|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25290985|NCT05100719|Chelating Agents|chelating agents|mesh-ancestor
25290986|NCT05100719|Sequestering Agents|sequestering agents|mesh-ancestor
25290987|NCT05100719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25290988|NCT05100719|Antifoaming Agents|antifoaming agents|mesh-ancestor
25290989|NCT05100719|Emollients|emollients|mesh-ancestor
25119369|NCT01979796|Nicotine|nicotine|mesh-list
25119370|NCT01979796|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25119371|NCT01979796|Autonomic Agents|autonomic agents|mesh-ancestor
25119372|NCT01979796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25119373|NCT01979796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119374|NCT01979796|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25119375|NCT01979796|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25119376|NCT01979796|Cholinergic Agents|cholinergic agents|mesh-ancestor
25119377|NCT01979796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24710147|NCT01508611|Protective Agents|protective agents|mesh-ancestor
25119378|NCT01979796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119379|NCT01936857|Buprenorphine|buprenorphine|mesh-list
25119380|NCT01936857|Methadone|methadone|mesh-list
25119381|NCT01936857|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25119382|NCT01936857|Naloxone|naloxone|mesh-list
25119383|NCT01936857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25119384|NCT01936857|Narcotics|narcotics|mesh-ancestor
25119385|NCT01936857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25119386|NCT01936857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119387|NCT01936857|Analgesics|analgesics|mesh-ancestor
25119388|NCT01936857|Sensory System Agents|sensory system agents|mesh-ancestor
25119389|NCT01936857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25119390|NCT01936857|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25119391|NCT01936857|Antitussive Agents|antitussive agents|mesh-ancestor
25119392|NCT01936857|Respiratory System Agents|respiratory system agents|mesh-ancestor
24636330|NCT01144832|Ebastine|ebastine|mesh-list
25119393|NCT01903330|Cyclophosphamide|cyclophosphamide|mesh-list
25119394|NCT01903330|Bevacizumab|bevacizumab|mesh-list
25119395|NCT01903330|Sargramostim|sargramostim|mesh-list
25119398|NCT01903330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119399|NCT01903330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25119400|NCT01903330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25119401|NCT01903330|Alkylating Agents|alkylating agents|mesh-ancestor
25119402|NCT01903330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119403|NCT01903330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119404|NCT01903330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24614176|NCT01022736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25290990|NCT05100719|Dermatologic Agents|dermatologic agents|mesh-ancestor
25290991|NCT05100719|Parasympatholytics|parasympatholytics|mesh-ancestor
25290992|NCT05100719|Autonomic Agents|autonomic agents|mesh-ancestor
25290993|NCT05100719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25290994|NCT05100719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25290995|NCT05100719|Anticonvulsants|anticonvulsants|mesh-ancestor
25290996|NCT05100563|Naltrexone|naltrexone|mesh-list
25290997|NCT05100563|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25290998|NCT05100563|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25290999|NCT05100563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291000|NCT05100563|Sensory System Agents|sensory system agents|mesh-ancestor
25291001|NCT05100563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25119405|NCT01903330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25119406|NCT01903330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25119407|NCT01903330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25119408|NCT01903330|Growth Substances|growth substances|mesh-ancestor
25119409|NCT01903330|Growth Inhibitors|growth inhibitors|mesh-ancestor
25119410|NCT01878617|Gemcitabine|gemcitabine|mesh-list
25119411|NCT01878617|Cyclophosphamide|cyclophosphamide|mesh-list
25119412|NCT01878617|Vincristine|vincristine|mesh-list
25119413|NCT01878617|Pemetrexed|pemetrexed|mesh-list
25119414|NCT01878617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25119415|NCT01878617|Immunologic Factors|immunologic factors|mesh-ancestor
25119416|NCT01878617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119417|NCT01878617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25119418|NCT01878617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25119419|NCT01878617|Alkylating Agents|alkylating agents|mesh-ancestor
25119420|NCT01878617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119421|NCT01878617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119422|NCT01878617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25119423|NCT01878617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25119424|NCT01878617|Antimetabolites|antimetabolites|mesh-ancestor
25119425|NCT01878617|Antiviral Agents|antiviral agents|mesh-ancestor
25119426|NCT01878617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25119427|NCT01878617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25119428|NCT01878617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25119429|NCT01878617|Tubulin Modulators|tubulin modulators|mesh-ancestor
25119430|NCT01878617|Antimitotic Agents|antimitotic agents|mesh-ancestor
25119431|NCT01878617|Mitosis Modulators|mitosis modulators|mesh-ancestor
25119432|NCT01878617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25119433|NCT01878617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25119434|NCT01735461|Calcium Carbonate|calcium carbonate|mesh-list
25119435|NCT01735461|Calcium|calcium|mesh-list
25119436|NCT01735461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25119437|NCT01735461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119438|NCT01735461|Antacids|antacids|mesh-ancestor
24710040|NCT01507610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710041|NCT01508143|Misoprostol|misoprostol|mesh-list
24710139|NCT01508572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24710140|NCT01508572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25291002|NCT05100446|Amoxicillin|amoxicillin|mesh-list
25291003|NCT05100446|Esomeprazole|esomeprazole|mesh-list
25291004|NCT05100446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25291005|NCT05100446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25291006|NCT05100446|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25291007|NCT05100446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25291008|NCT05100446|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25291009|NCT05100446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291010|NCT05100446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291011|NCT05100329|Mitoxantrone|mitoxantrone|mesh-list
25291012|NCT05100329|Analgesics|analgesics|mesh-ancestor
25291013|NCT05100329|Sensory System Agents|sensory system agents|mesh-ancestor
25291014|NCT05100329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25291015|NCT05100329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291016|NCT05100329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291017|NCT05100329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25291018|NCT05100329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25291019|NCT05100329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291020|NCT05100329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291021|NCT05100303|Cytarabine|cytarabine|mesh-list
25291022|NCT05100303|Mitoxantrone|mitoxantrone|mesh-list
25291023|NCT05100303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25291024|NCT05100303|Antimetabolites|antimetabolites|mesh-ancestor
25291025|NCT05100303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291026|NCT05100303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291027|NCT05100303|Antiviral Agents|antiviral agents|mesh-ancestor
25291028|NCT05100303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25291029|NCT05100303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25291030|NCT05100303|Immunologic Factors|immunologic factors|mesh-ancestor
25291031|NCT05100303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291032|NCT05100303|Analgesics|analgesics|mesh-ancestor
25291033|NCT05100303|Sensory System Agents|sensory system agents|mesh-ancestor
25291034|NCT05100303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25291035|NCT05100303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25291036|NCT05100303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25119439|NCT01735461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119440|NCT01735461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25119442|NCT01731444|Oxymetazoline|oxymetazoline|mesh-list
25119443|NCT01731444|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25119444|NCT01731444|Mydriatics|mydriatics|mesh-ancestor
25119445|NCT01731444|Autonomic Agents|autonomic agents|mesh-ancestor
25119446|NCT01731444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25119447|NCT01731444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119448|NCT01731444|Sympathomimetics|sympathomimetics|mesh-ancestor
25119449|NCT01731444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25119450|NCT01731444|Nasal Decongestants|nasal decongestants|mesh-ancestor
25119451|NCT01731444|Respiratory System Agents|respiratory system agents|mesh-ancestor
25119452|NCT01731444|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25119453|NCT01731444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25119454|NCT01731444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25119455|NCT01731444|Adrenergic Agents|adrenergic agents|mesh-ancestor
25119456|NCT01731444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24620617|NCT01057849|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24620618|NCT01057875|Caffeine|caffeine|mesh-list
25119457|NCT01731444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119458|NCT01731444|Protective Agents|protective agents|mesh-ancestor
25119459|NCT01715285|Prednisone|prednisone|mesh-list
25119460|NCT01715285|Abiraterone Acetate|abiraterone acetate|mesh-list
25119461|NCT01715285|Androgens|androgens|mesh-list
25119462|NCT01715285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25119463|NCT01715285|Glucocorticoids|glucocorticoids|mesh-ancestor
25119464|NCT01715285|Hormones|hormones|mesh-ancestor
25119465|NCT01715285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25119466|NCT01715285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119467|NCT01715285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25119468|NCT01715285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119469|NCT01715285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25119470|NCT01715285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25119471|NCT01715285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119472|NCT01715285|Hormone Antagonists|hormone antagonists|mesh-ancestor
25291037|NCT05100303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291038|NCT05100186|Dexamethasone|dexamethasone|mesh-list
25291047|NCT05100186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25291048|NCT05100186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25291050|NCT05100017|Methocarbamol|methocarbamol|mesh-list
25291051|NCT05100017|Oxybutynin|oxybutynin|mesh-list
25291052|NCT05100017|Parasympatholytics|parasympatholytics|mesh-ancestor
25291053|NCT05100017|Autonomic Agents|autonomic agents|mesh-ancestor
25291054|NCT05100017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25291055|NCT05100017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291056|NCT05100017|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25291057|NCT05100017|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25291058|NCT05100017|Cholinergic Agents|cholinergic agents|mesh-ancestor
25291059|NCT05100017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25291060|NCT05100017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291061|NCT05100017|Urological Agents|urological agents|mesh-ancestor
25291062|NCT05100017|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25291063|NCT05100017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25291064|NCT05099848|Leucovorin|leucovorin|mesh-list
25291065|NCT05099848|Fluorouracil|fluorouracil|mesh-list
25291066|NCT05099848|Oxaliplatin|oxaliplatin|mesh-list
25291067|NCT05099848|Apatinib|apatinib|mesh-list
25291068|NCT05099848|Antimetabolites|antimetabolites|mesh-ancestor
25291069|NCT05099848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291070|NCT05099848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25291071|NCT05099848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291072|NCT05099848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25291073|NCT05099848|Immunologic Factors|immunologic factors|mesh-ancestor
25291074|NCT05099848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291075|NCT05099848|Antidotes|antidotes|mesh-ancestor
25291076|NCT05099848|Protective Agents|protective agents|mesh-ancestor
25119479|NCT01595841|Sirolimus|sirolimus|mesh-list
25119480|NCT01595841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25119481|NCT01595841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25119482|NCT01595841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25119483|NCT01595841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119484|NCT01595841|Antifungal Agents|antifungal agents|mesh-ancestor
25119489|NCT05405049|Fentanyl|fentanyl|mesh-list
25119490|NCT05405049|Morphine|morphine|mesh-list
25119491|NCT05405049|Bupivacaine|bupivacaine|mesh-list
25119492|NCT05405049|Anesthetics, Local|anesthetics, local|mesh-ancestor
25119493|NCT05405049|Anesthetics|anesthetics|mesh-ancestor
25119494|NCT05405049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25119495|NCT05405049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119496|NCT05405049|Sensory System Agents|sensory system agents|mesh-ancestor
25119497|NCT05405049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25119498|NCT05405049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25119499|NCT05405049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25119500|NCT05405049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25119501|NCT05405049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25119502|NCT05405049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119503|NCT05405049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25119504|NCT05405049|Narcotics|narcotics|mesh-ancestor
25119505|NCT05405049|Analgesics|analgesics|mesh-ancestor
25119506|NCT05405049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25693318|NCT02012491|Oxytocics|oxytocics|mesh-ancestor
25693319|NCT02012491|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25119507|NCT05405049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25119508|NCT05405049|Anesthetics, General|anesthetics, general|mesh-ancestor
24710141|NCT01508572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24710143|NCT01508572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710144|NCT01508572|Growth Inhibitors|growth inhibitors|mesh-ancestor
24710146|NCT01508611|Cariostatic Agents|cariostatic agents|mesh-ancestor
25291087|NCT05099718|Protective Agents|protective agents|mesh-ancestor
25291089|NCT05099614|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25291090|NCT05099614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291091|NCT05099614|Sensory System Agents|sensory system agents|mesh-ancestor
25291092|NCT05099614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25291093|NCT05099601|Silymarin|silymarin|mesh-list
25291094|NCT05099601|Antioxidants|antioxidants|mesh-ancestor
25291095|NCT05099601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291096|NCT05099601|Protective Agents|protective agents|mesh-ancestor
25291097|NCT05099601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291098|NCT05099575|Oxytocin|oxytocin|mesh-list
25291099|NCT05099575|Oxytocics|oxytocics|mesh-ancestor
25291100|NCT05099575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25291101|NCT05099575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291102|NCT05099198|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25291103|NCT05099198|Glimepiride|glimepiride|mesh-list
25291104|NCT05099198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25291105|NCT05099198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291106|NCT05099198|Incretins|incretins|mesh-ancestor
25291107|NCT05099198|Hormones|hormones|mesh-ancestor
25291108|NCT05099198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25291109|NCT05099198|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25291110|NCT05099198|Protease Inhibitors|protease inhibitors|mesh-ancestor
25291111|NCT05099198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045635|NCT00934921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045636|NCT00934921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25045637|NCT00934921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25045638|NCT00934921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25045639|NCT00934921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25045640|NCT00934921|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25045641|NCT00934180|Ondansetron|ondansetron|mesh-list
25045642|NCT00934180|Antiemetics|antiemetics|mesh-ancestor
25045643|NCT00934180|Autonomic Agents|autonomic agents|mesh-ancestor
25045644|NCT00934180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25119785|NCT05256056|Anesthetics|anesthetics|mesh-ancestor
25045645|NCT00934180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045646|NCT00934180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25045647|NCT00934180|Antipruritics|antipruritics|mesh-ancestor
25045648|NCT00934180|Dermatologic Agents|dermatologic agents|mesh-ancestor
25045649|NCT00934180|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25045650|NCT00934180|Serotonin Agents|serotonin agents|mesh-ancestor
25045651|NCT00934180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25045652|NCT00934180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824718|NCT02125084|Everolimus|everolimus|mesh-list
25045654|NCT00934180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25045655|NCT00934180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25045656|NCT00934180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25045657|NCT00934180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25045658|NCT00929968|Fluticasone|fluticasone|mesh-list
25045659|NCT00929968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24902693|NCT04371575|Analgesics|analgesics|mesh-ancestor
25291112|NCT05099198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291113|NCT05099198|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25291114|NCT05099198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25291117|NCT05099081|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25291118|NCT05099081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25291119|NCT05092165|Methylene Blue|methylene blue|mesh-list
25291120|NCT05092165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291121|NCT05092165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291122|NCT05092152|Propofol|propofol|mesh-list
25291123|NCT05092152|Esketamine|esketamine|mesh-list
25291124|NCT05092152|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25291125|NCT05092152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25291126|NCT05092152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291127|NCT05092152|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25291128|NCT05092152|Anesthetics, General|anesthetics, general|mesh-ancestor
25291129|NCT05092152|Anesthetics|anesthetics|mesh-ancestor
25291130|NCT05092152|Antidepressive Agents|antidepressive agents|mesh-ancestor
25291131|NCT05092152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25291132|NCT05088356|Vidarabine|vidarabine|mesh-list
25291133|NCT05088356|Plerixafor|plerixafor|mesh-list
25291134|NCT05088356|Cyclophosphamide|cyclophosphamide|mesh-list
25291135|NCT05088356|Melphalan|melphalan|mesh-list
25291136|NCT05088356|Fludarabine|fludarabine|mesh-list
25291137|NCT05088356|Fludarabine phosphate|fludarabine phosphate|mesh-list
25291138|NCT05088356|Tacrolimus|tacrolimus|mesh-list
25291139|NCT05088356|Alkylating Agents|alkylating agents|mesh-list
25291140|NCT05088356|Lenograstim|lenograstim|mesh-list
25291141|NCT05088356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25291142|NCT05088356|Immunologic Factors|immunologic factors|mesh-ancestor
25291143|NCT05088356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291144|NCT05088356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25291145|NCT05088356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25291146|NCT05088356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291147|NCT05088356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291148|NCT05088356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25291149|NCT05088356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25291150|NCT05088356|Antimetabolites|antimetabolites|mesh-ancestor
25045662|NCT00929968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045663|NCT00929968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119528|NCT05404516|Sorafenib|sorafenib|mesh-list
25119529|NCT05404516|Idarubicin|idarubicin|mesh-list
25119530|NCT05404516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25119531|NCT05404516|Antimetabolites|antimetabolites|mesh-ancestor
25119532|NCT05404516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119533|NCT05404516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119534|NCT05404516|Antiviral Agents|antiviral agents|mesh-ancestor
25119535|NCT05404516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25119536|NCT05404516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25119537|NCT05404516|Immunologic Factors|immunologic factors|mesh-ancestor
25119538|NCT05404516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119539|NCT05404516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25119540|NCT05404516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25119541|NCT05404516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25119542|NCT05404516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25119543|NCT05404516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25119544|NCT05404061|Hormones|hormones|mesh-list
25119545|NCT05404061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25119546|NCT05404061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119549|NCT05403749|Aflibercept|aflibercept|mesh-list
25119550|NCT05403749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24614205|NCT01022918|Bevacizumab|bevacizumab|mesh-list
25119551|NCT05403749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25119552|NCT05403749|Growth Substances|growth substances|mesh-ancestor
25119553|NCT05403749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119554|NCT05403749|Growth Inhibitors|growth inhibitors|mesh-ancestor
25119555|NCT05403749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119556|NCT05403723|Carboplatin|carboplatin|mesh-list
25119557|NCT05403723|Etoposide|etoposide|mesh-list
25119558|NCT05403723|Durvalumab|durvalumab|mesh-list
25291151|NCT05088356|Antiviral Agents|antiviral agents|mesh-ancestor
25291152|NCT05088356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24900717|NCT04391582|Coccidiostats|coccidiostats|mesh-ancestor
25291153|NCT05088356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25291154|NCT05088356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291155|NCT05088356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25291156|NCT05088356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25291157|NCT05088356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25291158|NCT05087615|Ondansetron|ondansetron|mesh-list
25291167|NCT05087615|Dermatologic Agents|dermatologic agents|mesh-ancestor
25291168|NCT05087615|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25291169|NCT05087615|Serotonin Agents|serotonin agents|mesh-ancestor
25291170|NCT05087615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25291171|NCT05087615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291172|NCT05087615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25291173|NCT05087615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25291174|NCT05087615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25291175|NCT05087615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25291176|NCT05087615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25291177|NCT05087615|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25291178|NCT05087615|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25291179|NCT05087615|Dopamine Agents|dopamine agents|mesh-ancestor
25291180|NCT05081700|Ocrelizumab|ocrelizumab|mesh-list
25291181|NCT05081700|Immunologic Factors|immunologic factors|mesh-ancestor
25291182|NCT05081700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291183|NCT05033041|Metoclopramide|metoclopramide|mesh-list
24772154|NCT01832051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291184|NCT05033041|Antiemetics|antiemetics|mesh-ancestor
25291185|NCT05033041|Autonomic Agents|autonomic agents|mesh-ancestor
25291186|NCT05033041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25291187|NCT05033041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291188|NCT05033041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25291189|NCT05033041|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25291190|NCT05033041|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25291191|NCT05033041|Dopamine Agents|dopamine agents|mesh-ancestor
25291192|NCT05033041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25119569|NCT05403489|Dimercaprol|dimercaprol|mesh-list
25119570|NCT05403489|Chelating Agents|chelating agents|mesh-ancestor
25119571|NCT05403489|Sequestering Agents|sequestering agents|mesh-ancestor
25119572|NCT05403489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119584|NCT05403307|Vaccines|vaccines|mesh-list
25119585|NCT05403307|Immunologic Factors|immunologic factors|mesh-ancestor
25119586|NCT05403307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119587|NCT05403281|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25119588|NCT05403281|Dapagliflozin|dapagliflozin|mesh-list
25119589|NCT05403281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25119590|NCT05403281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119591|NCT05403281|Incretins|incretins|mesh-ancestor
25119592|NCT05403281|Hormones|hormones|mesh-ancestor
25119593|NCT05403281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25119594|NCT05403281|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25119595|NCT05403281|Protease Inhibitors|protease inhibitors|mesh-ancestor
25119596|NCT05403281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25119597|NCT05403281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119598|NCT05403281|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25119599|NCT05403229|Topiramate|topiramate|mesh-list
24710149|NCT01508637|Terazosin|terazosin|mesh-list
24710150|NCT01508637|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24710151|NCT01508637|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24710152|NCT01508637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25291193|NCT05033041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291194|NCT04956809|Dapagliflozin|dapagliflozin|mesh-list
25291195|NCT04956809|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25291199|NCT04911660|Empagliflozin|empagliflozin|mesh-list
25291200|NCT04911660|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25291201|NCT04911660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291202|NCT04911660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25291203|NCT04911660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614206|NCT01022918|Temozolomide|temozolomide|mesh-list
25291204|NCT04863261|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
25291205|NCT04863261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25291206|NCT04863261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25291207|NCT04863261|Antiviral Agents|antiviral agents|mesh-ancestor
25291208|NCT04863261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25291209|NCT04856566|Ethanol|ethanol|mesh-list
25291210|NCT04856566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25291211|NCT04856566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25291212|NCT04856566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25291213|NCT04856566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291214|NCT04825704|Bupivacaine|bupivacaine|mesh-list
25291215|NCT04825704|Anesthetics, Local|anesthetics, local|mesh-ancestor
25291216|NCT04825704|Anesthetics|anesthetics|mesh-ancestor
25291217|NCT04825704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25291218|NCT04825704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291219|NCT04825704|Sensory System Agents|sensory system agents|mesh-ancestor
25291220|NCT04825704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25291221|NCT04730232|Paclitaxel|paclitaxel|mesh-list
25291222|NCT04730232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25291223|NCT04730232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291224|NCT04730232|Tubulin Modulators|tubulin modulators|mesh-ancestor
25291225|NCT04730232|Antimitotic Agents|antimitotic agents|mesh-ancestor
25119600|NCT05403229|Anticonvulsants|anticonvulsants|mesh-ancestor
25119623|NCT05403086|Sensory System Agents|sensory system agents|mesh-ancestor
25119624|NCT05403086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25119625|NCT05403086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119626|NCT05403086|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25119627|NCT05403086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25119628|NCT05403086|Anesthetics, General|anesthetics, general|mesh-ancestor
25119629|NCT05403086|Anesthetics|anesthetics|mesh-ancestor
25693320|NCT02012491|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24772227|NCT01832415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25119630|NCT05403086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25119631|NCT05403086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25119632|NCT05403086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25119633|NCT05403086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25119634|NCT05403086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119635|NCT05403086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25119637|NCT05403047|Antiviral Agents|antiviral agents|mesh-ancestor
25119638|NCT05403047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25119639|NCT05403047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25119640|NCT05403047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25119641|NCT05403047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25119642|NCT05403047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119643|NCT05403047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25119644|NCT05403047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25119649|NCT05399290|Doxycycline|doxycycline|mesh-list
25119650|NCT05399290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25119651|NCT05399290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25119652|NCT05399290|Antimalarials|antimalarials|mesh-ancestor
25119653|NCT05399290|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25291226|NCT04730232|Mitosis Modulators|mitosis modulators|mesh-ancestor
25291227|NCT04730232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291228|NCT04701918|Pembrolizumab|pembrolizumab|mesh-list
25291229|NCT04701918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25291230|NCT04701918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291231|NCT04658277|Clarithromycin|clarithromycin|mesh-list
25291232|NCT04658277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25291233|NCT04658277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25291234|NCT04658277|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25291235|NCT04658277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291236|NCT04658277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291237|NCT04658277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25291250|NCT04540848|Anesthetics, Local|anesthetics, local|mesh-ancestor
25291251|NCT04540848|Anesthetics|anesthetics|mesh-ancestor
25291252|NCT04540848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25291253|NCT04540848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291254|NCT04540848|Sensory System Agents|sensory system agents|mesh-ancestor
25291255|NCT04540848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25291256|NCT04531592|Valproic Acid|valproic acid|mesh-list
25291257|NCT04531592|Anticonvulsants|anticonvulsants|mesh-ancestor
25291258|NCT04531592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291259|NCT04531592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291260|NCT04531592|GABA Agents|gaba agents|mesh-ancestor
25291261|NCT04531592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25120398|NCT03955575|Hormones|hormones|mesh-ancestor
25291262|NCT04531592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291263|NCT04531592|Antimanic Agents|antimanic agents|mesh-ancestor
25291264|NCT04531592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25291265|NCT04531592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25119663|NCT05398913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119664|NCT05387148|Cannabidiol|cannabidiol|mesh-list
25119665|NCT05387148|Anticonvulsants|anticonvulsants|mesh-ancestor
25119678|NCT05357898|Pembrolizumab|pembrolizumab|mesh-list
25119679|NCT05357898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25119680|NCT05357898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119681|NCT05344365|Iloperidone|iloperidone|mesh-list
25119682|NCT05344365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25119683|NCT05344365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25119684|NCT05344365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25119685|NCT05344365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119686|NCT05344365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25119695|NCT05328440|Fulvestrant|fulvestrant|mesh-list
25119703|NCT05323175|Ropivacaine|ropivacaine|mesh-list
25291266|NCT04531592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25291267|NCT04531579|Valproic Acid|valproic acid|mesh-list
25291268|NCT04531579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25291269|NCT04531579|Anticonvulsants|anticonvulsants|mesh-ancestor
25291270|NCT04531579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291271|NCT04531579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291272|NCT04531579|GABA Agents|gaba agents|mesh-ancestor
25291273|NCT04531579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24638403|NCT01156389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25693321|NCT02012491|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25291274|NCT04531579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291275|NCT04531579|Antimanic Agents|antimanic agents|mesh-ancestor
25291276|NCT04531579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25291277|NCT04531579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25291278|NCT04531579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25291279|NCT04517357|Apatinib|apatinib|mesh-list
25291292|NCT04510584|Growth Inhibitors|growth inhibitors|mesh-ancestor
25291293|NCT04469764|Letrozole|letrozole|mesh-list
25291294|NCT04469764|Anastrozole|anastrozole|mesh-list
25291295|NCT04469764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291296|NCT04469764|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25291297|NCT04469764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25291298|NCT04469764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291299|NCT04469764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291300|NCT04469764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25291301|NCT04469764|Hormone Antagonists|hormone antagonists|mesh-ancestor
25291302|NCT04469764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25291303|NCT04469764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291304|NCT04469764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25291305|NCT04379024|Bazedoxifene|bazedoxifene|mesh-list
25291306|NCT04379024|Estrogens|estrogens|mesh-list
25291307|NCT04379024|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25291308|NCT04379024|Hormones|hormones|mesh-ancestor
25291309|NCT04379024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25291310|NCT04379024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291311|NCT04379024|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25291312|NCT04379024|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25291313|NCT04379024|Hormone Antagonists|hormone antagonists|mesh-ancestor
25291314|NCT04379024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25291315|NCT04272008|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25291316|NCT04272008|Estradiol|estradiol|mesh-list
25291317|NCT04272008|Estrogens|estrogens|mesh-ancestor
25291318|NCT04272008|Hormones|hormones|mesh-ancestor
25291319|NCT04272008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25291320|NCT04272008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291321|NCT04272008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25291322|NCT04272008|Contraceptive Agents|contraceptive agents|mesh-ancestor
25291323|NCT04272008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25291324|NCT04272008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25119775|NCT05258110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25119776|NCT05258110|Anesthetics, General|anesthetics, general|mesh-ancestor
25119777|NCT05258110|Anesthetics|anesthetics|mesh-ancestor
25119778|NCT05258110|GABA Modulators|gaba modulators|mesh-ancestor
25119779|NCT05258110|GABA Agents|gaba agents|mesh-ancestor
25119780|NCT05258110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25119781|NCT05258110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119782|NCT05258110|Nootropic Agents|nootropic agents|mesh-ancestor
25119783|NCT05256056|Bupivacaine|bupivacaine|mesh-list
25119784|NCT05256056|Anesthetics, Local|anesthetics, local|mesh-ancestor
25119786|NCT05256056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25119787|NCT05256056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119788|NCT05256056|Sensory System Agents|sensory system agents|mesh-ancestor
25119789|NCT05256056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25119790|NCT05220514|PK 11195|pk 11195|mesh-list
25119791|NCT05220514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291328|NCT04176718|Daratumumab|daratumumab|mesh-list
25291329|NCT04176718|Pomalidomide|pomalidomide|mesh-list
25291330|NCT04176718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25291331|NCT04176718|Antiemetics|antiemetics|mesh-ancestor
25291332|NCT04176718|Autonomic Agents|autonomic agents|mesh-ancestor
25291333|NCT04176718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25291334|NCT04176718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291335|NCT04176718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25291336|NCT04176718|Glucocorticoids|glucocorticoids|mesh-ancestor
25291337|NCT04176718|Hormones|hormones|mesh-ancestor
25291338|NCT04176718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25291339|NCT04176718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25291340|NCT04176718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291341|NCT04176718|Immunologic Factors|immunologic factors|mesh-ancestor
25291342|NCT04176718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25291343|NCT04176718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25291344|NCT04176718|Growth Substances|growth substances|mesh-ancestor
25291345|NCT04176718|Growth Inhibitors|growth inhibitors|mesh-ancestor
25291351|NCT03825289|Hydroxychloroquine|hydroxychloroquine|mesh-list
25291352|NCT03825289|Trametinib|trametinib|mesh-list
25291353|NCT03825289|Antimalarials|antimalarials|mesh-ancestor
25291354|NCT03825289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25291355|NCT03825289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24483803|NCT00445055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25291356|NCT03825289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25291357|NCT03825289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291358|NCT03825289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291359|NCT03825289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25291360|NCT03825289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291361|NCT03825289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25291362|NCT03809533|Sofosbuvir|sofosbuvir|mesh-list
25291363|NCT03809533|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25291364|NCT03809533|Velpatasvir|velpatasvir|mesh-list
25291365|NCT03809533|Antiviral Agents|antiviral agents|mesh-ancestor
25291366|NCT03809533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25119823|NCT05137262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25119824|NCT05137262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25119825|NCT05137262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25119826|NCT05137262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119827|NCT05137262|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25119828|NCT05137262|Abortifacient Agents|abortifacient agents|mesh-ancestor
25119829|NCT05137262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25119830|NCT05137262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119831|NCT05137262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25119832|NCT05137262|Antimetabolites|antimetabolites|mesh-ancestor
25119833|NCT05137262|Dermatologic Agents|dermatologic agents|mesh-ancestor
25119834|NCT05137262|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25119835|NCT05137262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25119836|NCT05137262|Immunologic Factors|immunologic factors|mesh-ancestor
25119837|NCT05137262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25119858|NCT05110001|Moxifloxacin|moxifloxacin|mesh-list
25119859|NCT05110001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25119860|NCT05110001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25119861|NCT05110001|Disinfectants|disinfectants|mesh-ancestor
25119862|NCT05110001|Dermatologic Agents|dermatologic agents|mesh-ancestor
25119863|NCT05110001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25119864|NCT05110001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25119865|NCT05110001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25119866|NCT05110001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25119867|NCT05110001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119868|NCT05110001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119869|NCT05110001|Antifungal Agents|antifungal agents|mesh-ancestor
25119870|NCT05080790|Zoledronic Acid|zoledronic acid|mesh-list
25119871|NCT05080790|Interleukin-2|interleukin-2|mesh-list
25291379|NCT03481842|Axitinib|axitinib|mesh-list
25291380|NCT03481842|Afatinib|afatinib|mesh-list
25291381|NCT03481842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291382|NCT03481842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25291383|NCT03481842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291384|NCT03481842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291385|NCT03466346|Fluoxetine|fluoxetine|mesh-list
25291386|NCT03466346|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25291387|NCT03466346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25291388|NCT03466346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25291389|NCT03466346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291390|NCT03466346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25291391|NCT03466346|Serotonin Agents|serotonin agents|mesh-ancestor
25291392|NCT03466346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291393|NCT03466346|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25291394|NCT03466346|Antidepressive Agents|antidepressive agents|mesh-ancestor
25291395|NCT03466346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25291396|NCT03466346|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25291397|NCT03466346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25291398|NCT03466346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291399|NCT03449706|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25291400|NCT03449706|Antiviral Agents|antiviral agents|mesh-ancestor
25291401|NCT03449706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25291402|NCT03237819|Magnesium Sulfate|magnesium sulfate|mesh-list
25291403|NCT03237819|Analgesics|analgesics|mesh-ancestor
25291404|NCT03237819|Sensory System Agents|sensory system agents|mesh-ancestor
25291405|NCT03237819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25291406|NCT03237819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291407|NCT03237819|Anesthetics|anesthetics|mesh-ancestor
25291408|NCT03237819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25291409|NCT03237819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25291410|NCT03237819|Anticonvulsants|anticonvulsants|mesh-ancestor
25693322|NCT02012491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25119875|NCT05080790|Analgesics|analgesics|mesh-ancestor
25119905|NCT05059587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25119906|NCT05059587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119907|NCT05059587|Cholinergic Agents|cholinergic agents|mesh-ancestor
25119908|NCT05059587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25119911|NCT05041127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25119912|NCT05041127|Cetuximab|cetuximab|mesh-list
25119913|NCT05041127|Antibodies|antibodies|mesh-list
25119914|NCT05041127|Immunoglobulins|immunoglobulins|mesh-list
25119915|NCT05041127|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25119916|NCT05041127|Immunologic Factors|immunologic factors|mesh-ancestor
25119917|NCT05041127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25119918|NCT05041127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119919|NCT05012254|Paclitaxel|paclitaxel|mesh-list
25119920|NCT05012254|Cisplatin|cisplatin|mesh-list
25119921|NCT05012254|Carboplatin|carboplatin|mesh-list
25119922|NCT05012254|Nivolumab|nivolumab|mesh-list
25119923|NCT05012254|Pemetrexed|pemetrexed|mesh-list
25119924|NCT05012254|Ipilimumab|ipilimumab|mesh-list
25119925|NCT05012254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25119926|NCT05012254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25119927|NCT05012254|Tubulin Modulators|tubulin modulators|mesh-ancestor
25119928|NCT05012254|Antimitotic Agents|antimitotic agents|mesh-ancestor
25119929|NCT05012254|Mitosis Modulators|mitosis modulators|mesh-ancestor
24903003|NCT04368351|Azithromycin|azithromycin|mesh-list
24710171|NCT01508806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24710172|NCT01508806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710173|NCT01508806|Incretins|incretins|mesh-ancestor
24710174|NCT01508806|Hormones|hormones|mesh-ancestor
24710175|NCT01508806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25291411|NCT03237819|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25291412|NCT03237819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25291413|NCT03237819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291414|NCT03237819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25291415|NCT03237819|Tocolytic Agents|tocolytic agents|mesh-ancestor
25291416|NCT03237819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25291417|NCT03205956|Levodopa|levodopa|mesh-list
25291418|NCT03205956|Carbidopa|carbidopa|mesh-list
25291419|NCT03205956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25291420|NCT03205956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25291421|NCT03205956|Dopamine Agents|dopamine agents|mesh-ancestor
25291422|NCT03205956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25291423|NCT03205956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291424|NCT03205956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291425|NCT03205956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25291426|NCT03205956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291435|NCT03139916|Temozolomide|temozolomide|mesh-list
25291436|NCT03139916|Bavituximab|bavituximab|mesh-list
25291437|NCT03139916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25291438|NCT03139916|Alkylating Agents|alkylating agents|mesh-ancestor
25120410|NCT03919435|Renal Agents|renal agents|mesh-ancestor
25291439|NCT03139916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291441|NCT03139916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25291442|NCT03019003|Durvalumab|durvalumab|mesh-list
25291443|NCT03019003|Decitabine|decitabine|mesh-list
25291444|NCT03019003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25119930|NCT05012254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119951|NCT05011812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25119952|NCT05011812|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25119953|NCT05011812|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25119954|NCT05011812|Protease Inhibitors|protease inhibitors|mesh-ancestor
25119955|NCT05011812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25119957|NCT05011812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25119958|NCT05011812|Antiviral Agents|antiviral agents|mesh-ancestor
25119959|NCT05011812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25119960|NCT05011812|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25119961|NCT05011812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25119962|NCT05005689|Fluorides|fluorides|mesh-list
25119963|NCT05005689|Sodium Fluoride|sodium fluoride|mesh-list
25291445|NCT03019003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291446|NCT03019003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25291447|NCT03019003|Antimetabolites|antimetabolites|mesh-ancestor
25291448|NCT03019003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291449|NCT03019003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291450|NCT02951130|Milrinone|milrinone|mesh-list
25291451|NCT02951130|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25291452|NCT02951130|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25291453|NCT02951130|Vasodilator Agents|vasodilator agents|mesh-ancestor
25291454|NCT02951130|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25291455|NCT02951130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25291456|NCT02951130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25291457|NCT02951130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25291458|NCT02951130|Protective Agents|protective agents|mesh-ancestor
25291459|NCT02951130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291483|NCT02813655|Cosyntropin|cosyntropin|mesh-list
25119979|NCT04966507|Listerine|listerine|mesh-list
25119980|NCT04966507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
25119981|NCT04966507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24710274|NCT01509300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710275|NCT01509300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24710276|NCT01509300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24710277|NCT01509300|Alkylating Agents|alkylating agents|mesh-ancestor
24710278|NCT01509300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710279|NCT01509300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24710280|NCT01509300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24710281|NCT01509300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25291484|NCT02813655|Hormones|hormones|mesh-ancestor
25291485|NCT02813655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25291486|NCT02813655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291487|NCT02747407|Vaccines|vaccines|mesh-list
25291488|NCT02747407|Immunologic Factors|immunologic factors|mesh-ancestor
25291489|NCT02747407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291490|NCT02718833|Dexamethasone|dexamethasone|mesh-list
25291491|NCT02718833|Bortezomib|bortezomib|mesh-list
25291492|NCT02718833|Pomalidomide|pomalidomide|mesh-list
25291493|NCT02718833|Elotuzumab|elotuzumab|mesh-list
25291494|NCT02718833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25291495|NCT02718833|Antiemetics|antiemetics|mesh-ancestor
25291496|NCT02718833|Autonomic Agents|autonomic agents|mesh-ancestor
25291497|NCT02718833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25291498|NCT02718833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25291499|NCT02718833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25291500|NCT02718833|Glucocorticoids|glucocorticoids|mesh-ancestor
25291501|NCT02718833|Hormones|hormones|mesh-ancestor
25291502|NCT02718833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25291503|NCT02718833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25291504|NCT02718833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25291505|NCT02718833|Immunologic Factors|immunologic factors|mesh-ancestor
25291506|NCT02718833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25291507|NCT02718833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25291508|NCT02718833|Growth Substances|growth substances|mesh-ancestor
25291509|NCT02718833|Growth Inhibitors|growth inhibitors|mesh-ancestor
25120032|NCT04913610|Mitosis Modulators|mitosis modulators|mesh-ancestor
25291527|NCT02467452|Parasympatholytics|parasympatholytics|mesh-ancestor
25291528|NCT02467452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25291529|NCT02467452|Cholinergic Agents|cholinergic agents|mesh-ancestor
25291530|NCT02467452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25291531|NCT02467452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120044|NCT04843904|Rituximab|rituximab|mesh-list
25120045|NCT04843904|Obinutuzumab|obinutuzumab|mesh-list
25120046|NCT04843904|Venetoclax|venetoclax|mesh-list
25120047|NCT04843904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25120048|NCT04843904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120049|NCT04843904|Immunologic Factors|immunologic factors|mesh-ancestor
25120050|NCT04843904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120051|NCT04843904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25120052|NCT04812002|Bevacizumab|bevacizumab|mesh-list
25120053|NCT04812002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25120054|NCT04812002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25120055|NCT04812002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120056|NCT04812002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25120057|NCT04812002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25120058|NCT04812002|Growth Substances|growth substances|mesh-ancestor
25120059|NCT04812002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120060|NCT04812002|Growth Inhibitors|growth inhibitors|mesh-ancestor
25120137|NCT04585776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25120138|NCT04585776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120139|NCT04582383|Doxycycline|doxycycline|mesh-list
25120140|NCT04582383|Spironolactone|spironolactone|mesh-list
25120141|NCT04582383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25120142|NCT04582383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24967147|NCT03762382|Tenofovir|tenofovir|mesh-list
25120143|NCT04582383|Antimalarials|antimalarials|mesh-ancestor
25120144|NCT04582383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25120145|NCT04582383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25120147|NCT04582383|Hormone Antagonists|hormone antagonists|mesh-ancestor
25120158|NCT04577326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25120159|NCT04577326|Alkylating Agents|alkylating agents|mesh-ancestor
25120160|NCT04577326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120161|NCT04577326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120162|NCT04577326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25120163|NCT04564521|Nitroglycerin|nitroglycerin|mesh-list
25120164|NCT04564521|Vasodilator Agents|vasodilator agents|mesh-ancestor
25120168|NCT04530136|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25120169|NCT04530136|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25120170|NCT04530136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25120171|NCT04530136|Immunologic Factors|immunologic factors|mesh-ancestor
25120172|NCT04530136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120173|NCT04520711|Pembrolizumab|pembrolizumab|mesh-list
25120174|NCT04520711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25120175|NCT04520711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120176|NCT04494412|Zanamivir|zanamivir|mesh-list
25120177|NCT04494412|Antiviral Agents|antiviral agents|mesh-ancestor
25120178|NCT04494412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25120179|NCT04494412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25120180|NCT04494412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120181|NCT04475991|Maraviroc|maraviroc|mesh-list
25120182|NCT04475991|Favipiravir|favipiravir|mesh-list
25120183|NCT04475991|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25120184|NCT04475991|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25120411|NCT03919435|Antimalarials|antimalarials|mesh-ancestor
25120185|NCT04475991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120186|NCT04475991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25120187|NCT04475991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25120200|NCT04419389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25120201|NCT04419389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120202|NCT04419389|Immunologic Factors|immunologic factors|mesh-ancestor
25120203|NCT04419389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120204|NCT04419389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25120205|NCT04387071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25120206|NCT04387071|Antibodies|antibodies|mesh-list
25120207|NCT04387071|Immunoglobulins|immunoglobulins|mesh-list
25120208|NCT04387071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25120209|NCT04387071|Immunologic Factors|immunologic factors|mesh-ancestor
25120210|NCT04387071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120211|NCT04387071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120212|NCT04383938|Pembrolizumab|pembrolizumab|mesh-list
25120213|NCT04383938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25120214|NCT04383938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120215|NCT04328441|BCG Vaccine|bcg vaccine|mesh-list
25120216|NCT04328441|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25120217|NCT04328441|Immunologic Factors|immunologic factors|mesh-ancestor
25120218|NCT04328441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120219|NCT04323956|Prednisone|prednisone|mesh-list
25120220|NCT04323956|Cortisone|cortisone|mesh-list
25120221|NCT04323956|Cyclophosphamide|cyclophosphamide|mesh-list
25120222|NCT04323956|Rituximab|rituximab|mesh-list
25120223|NCT04323956|Doxorubicin|doxorubicin|mesh-list
25120224|NCT04323956|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25120225|NCT04323956|Vincristine|vincristine|mesh-list
25120226|NCT04323956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25120227|NCT04323956|Antibodies|antibodies|mesh-list
25120228|NCT04323956|Immunoglobulins|immunoglobulins|mesh-list
25120229|NCT04323956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25120230|NCT04323956|Lenograstim|lenograstim|mesh-list
25120231|NCT04323956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25120232|NCT04323956|Immunologic Factors|immunologic factors|mesh-ancestor
25120233|NCT04323956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120234|NCT04323956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25120235|NCT04323956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25120236|NCT04323956|Alkylating Agents|alkylating agents|mesh-ancestor
24710282|NCT01509300|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24710283|NCT01509300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24710284|NCT01509300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24710285|NCT01509300|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25120237|NCT04323956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120238|NCT04323956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693323|NCT02012491|Contraceptive Agents|contraceptive agents|mesh-ancestor
25120239|NCT04323956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25120240|NCT04323956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25120241|NCT04323956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25120242|NCT04323956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25120243|NCT04323956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25120244|NCT04323956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25120246|NCT04323956|Hormones|hormones|mesh-ancestor
25120247|NCT04323956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25120248|NCT04323956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25120249|NCT04323956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25120250|NCT04323956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25120251|NCT04323956|Tubulin Modulators|tubulin modulators|mesh-ancestor
25120252|NCT04323956|Antimitotic Agents|antimitotic agents|mesh-ancestor
25120253|NCT04323956|Mitosis Modulators|mitosis modulators|mesh-ancestor
24710286|NCT01509300|Antitubercular Agents|antitubercular agents|mesh-ancestor
24710287|NCT01509300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24710398|NCT01510171|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24710399|NCT01510171|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24710400|NCT01510171|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24710401|NCT01510171|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24710402|NCT01510171|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24710403|NCT01510171|Purinergic Agents|purinergic agents|mesh-ancestor
24710404|NCT01510171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24614200|NCT01022840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24614201|NCT01022840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24614202|NCT01022840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614203|NCT01022840|Antidepressive Agents|antidepressive agents|mesh-ancestor
24614204|NCT01022840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24614207|NCT01022918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24614208|NCT01022918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24710410|NCT01510288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24710411|NCT01510288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710485|NCT01510795|Natriuretic Agents|natriuretic agents|mesh-ancestor
24710486|NCT01510847|Testosterone undecanoate|testosterone undecanoate|mesh-list
24710487|NCT01510847|Androgens|androgens|mesh-ancestor
24710489|NCT01510847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25120254|NCT04314713|Scopolamine|scopolamine|mesh-list
25120255|NCT04314713|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25120256|NCT04314713|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25120257|NCT04314713|Antiemetics|antiemetics|mesh-ancestor
25120258|NCT04314713|Autonomic Agents|autonomic agents|mesh-ancestor
25120259|NCT04314713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25120260|NCT04314713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120261|NCT04314713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25120262|NCT04314713|Mydriatics|mydriatics|mesh-ancestor
25120263|NCT04314713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25120264|NCT04314713|Cholinergic Agents|cholinergic agents|mesh-ancestor
25120265|NCT04314713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25120266|NCT04314713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120267|NCT04314713|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25120268|NCT04314713|Parasympatholytics|parasympatholytics|mesh-ancestor
25120269|NCT04276233|Prednisone|prednisone|mesh-list
25120270|NCT04276233|Prednisolone|prednisolone|mesh-list
24622102|NCT01065662|Sirolimus|sirolimus|mesh-list
25120271|NCT04276233|Albuterol|albuterol|mesh-list
25120272|NCT04276233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25120273|NCT04276233|Glucocorticoids|glucocorticoids|mesh-ancestor
25120274|NCT04276233|Hormones|hormones|mesh-ancestor
25120275|NCT04276233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25120276|NCT04276233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120277|NCT04276233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25120278|NCT04276233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120279|NCT04276233|Autonomic Agents|autonomic agents|mesh-ancestor
25120280|NCT04276233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25120281|NCT04276233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25120282|NCT04276233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25120283|NCT04276233|Respiratory System Agents|respiratory system agents|mesh-ancestor
25120284|NCT04276233|Tocolytic Agents|tocolytic agents|mesh-ancestor
25120285|NCT04276233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25120286|NCT04276233|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25406347|NCT03565835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25120287|NCT04276233|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25120288|NCT04276233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25120291|NCT04276233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120304|NCT04113109|Icatibant|icatibant|mesh-list
25120305|NCT04113109|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25120306|NCT04113109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24903569|NCT04362241|Hormones|hormones|mesh-ancestor
24710490|NCT01510847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710491|NCT01510860|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24710494|NCT01510977|Bisacodyl|bisacodyl|mesh-list
24710516|NCT01511029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24710517|NCT01511029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710518|NCT01511029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24710519|NCT01511029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710520|NCT01511029|Antioxidants|antioxidants|mesh-ancestor
24710522|NCT01511029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24710627|NCT01511263|Natriuretic Agents|natriuretic agents|mesh-ancestor
24710628|NCT01511263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710629|NCT01511263|Vasodilator Agents|vasodilator agents|mesh-ancestor
24710630|NCT01511263|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24710631|NCT01511263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24710632|NCT01511263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710633|NCT01511263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24710634|NCT01511263|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24710635|NCT01511263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24496814|NCT00506961|Simvastatin|simvastatin|mesh-list
24710636|NCT01511263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24710637|NCT01511263|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25120412|NCT03919435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24710638|NCT01511263|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24710639|NCT01511263|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24710640|NCT01511289|Imatinib Mesylate|imatinib mesylate|mesh-list
24710641|NCT01511289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24710642|NCT01511289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24710643|NCT01511289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24710659|NCT01511302|Analgesics|analgesics|mesh-ancestor
24710660|NCT01511302|Sensory System Agents|sensory system agents|mesh-ancestor
24710661|NCT01511302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24710662|NCT01511302|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24710663|NCT01511367|Fluticasone|fluticasone|mesh-list
24710664|NCT01511367|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24710665|NCT01511367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24710666|NCT01511367|Autonomic Agents|autonomic agents|mesh-ancestor
24710667|NCT01511367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24710668|NCT01511367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710669|NCT01511367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25120307|NCT04113109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120308|NCT04113109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25120309|NCT04113109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25120310|NCT04113109|Analgesics|analgesics|mesh-ancestor
25120311|NCT04113109|Sensory System Agents|sensory system agents|mesh-ancestor
25120312|NCT04113109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25120313|NCT04113109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120314|NCT04113109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25120315|NCT04113109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25120316|NCT04113109|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
25120317|NCT04113109|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
25120318|NCT04113109|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25120319|NCT04113109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25120320|NCT04113109|Immunologic Factors|immunologic factors|mesh-ancestor
25120321|NCT04090697|Oxandrolone|oxandrolone|mesh-list
25120322|NCT04090697|Androgens|androgens|mesh-ancestor
25120323|NCT04090697|Hormones|hormones|mesh-ancestor
24864058|NCT01388491|Estradiol|estradiol|mesh-list
25120324|NCT04090697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25120325|NCT04090697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120326|NCT04090697|Anabolic Agents|anabolic agents|mesh-ancestor
24710670|NCT01511367|Respiratory System Agents|respiratory system agents|mesh-ancestor
24710671|NCT01511367|Glucocorticoids|glucocorticoids|mesh-ancestor
24710672|NCT01511367|Hormones|hormones|mesh-ancestor
24710673|NCT01511367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24710674|NCT01511367|Sympathomimetics|sympathomimetics|mesh-ancestor
24710675|NCT01511367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24710676|NCT01511367|Dermatologic Agents|dermatologic agents|mesh-ancestor
24710677|NCT01511367|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24710678|NCT01511471|Ticagrelor|ticagrelor|mesh-list
24710679|NCT01511471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24710680|NCT01511471|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24614250|NCT01023243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24614252|NCT01023243|Sensory System Agents|sensory system agents|mesh-ancestor
24710931|NCT01512355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25120370|NCT03995004|Antioxidants|antioxidants|mesh-ancestor
25120371|NCT03995004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120372|NCT03995004|Protective Agents|protective agents|mesh-ancestor
25120373|NCT03995004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25120374|NCT03995004|Cathartics|cathartics|mesh-ancestor
25120375|NCT03958500|Methylene Blue|methylene blue|mesh-list
25120376|NCT03958500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25120377|NCT03958500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120379|NCT03957876|Daunorubicin|daunorubicin|mesh-list
25120380|NCT03957876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25120381|NCT03957876|Antimetabolites|antimetabolites|mesh-ancestor
25120382|NCT03957876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120383|NCT03957876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120384|NCT03957876|Antiviral Agents|antiviral agents|mesh-ancestor
25120385|NCT03957876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25120386|NCT03957876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25120387|NCT03957876|Immunologic Factors|immunologic factors|mesh-ancestor
25120395|NCT03955575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25120396|NCT03955575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120397|NCT03955575|Incretins|incretins|mesh-ancestor
25120399|NCT03955575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24710718|NCT01511692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24710719|NCT01511692|Immunologic Factors|immunologic factors|mesh-ancestor
24710848|NCT01511991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24710849|NCT01511991|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24710850|NCT01511991|Anesthetics, General|anesthetics, general|mesh-ancestor
24710851|NCT01511991|Anesthetics|anesthetics|mesh-ancestor
24710852|NCT01511991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24710853|NCT01511991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710854|NCT01512004|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24710855|NCT01512004|Propiverine|propiverine|mesh-list
24710856|NCT01512004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24710857|NCT01512004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24710858|NCT01512004|Cholinergic Agents|cholinergic agents|mesh-ancestor
24710894|NCT01512173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710895|NCT01512173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710896|NCT01512173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24710897|NCT01512173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24710898|NCT01512173|Vasodilator Agents|vasodilator agents|mesh-ancestor
24710899|NCT01512199|Paclitaxel|paclitaxel|mesh-list
24710900|NCT01512199|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24710901|NCT01512199|Trastuzumab|trastuzumab|mesh-list
24710902|NCT01512199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24710903|NCT01512199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24710904|NCT01512199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24710905|NCT01512199|Tubulin Modulators|tubulin modulators|mesh-ancestor
24710932|NCT01512355|Adrenergic Agents|adrenergic agents|mesh-ancestor
24710933|NCT01512355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24710934|NCT01512355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710935|NCT01512459|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24710936|NCT01512459|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24710940|NCT01512459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24710943|NCT01512459|Antidepressive Agents|antidepressive agents|mesh-ancestor
25064218|NCT03462173|Yimitasvir|yimitasvir|mesh-list
24710944|NCT01512459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24710945|NCT01512485|Clopidogrel|clopidogrel|mesh-list
24710946|NCT01512485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24710947|NCT01512485|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24710948|NCT01512485|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24710949|NCT01512485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24773133|NCT01837667|Docetaxel|docetaxel|mesh-list
24710950|NCT01512485|Purinergic Agents|purinergic agents|mesh-ancestor
24710951|NCT01512485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24710952|NCT01512485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710953|NCT01512485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710954|NCT01512511|Nitrous Oxide|nitrous oxide|mesh-list
24710955|NCT01512511|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24710956|NCT01512511|Anesthetics, General|anesthetics, general|mesh-ancestor
24710957|NCT01512511|Anesthetics|anesthetics|mesh-ancestor
24710958|NCT01512511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24710959|NCT01512511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710961|NCT01512511|Analgesics|analgesics|mesh-ancestor
24710989|NCT01512862|Micronutrients|micronutrients|mesh-ancestor
24710990|NCT01512862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24710991|NCT01512901|Betamethasone|betamethasone|mesh-list
24710992|NCT01512901|Betamethasone Valerate|betamethasone valerate|mesh-list
24710993|NCT01512901|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24710994|NCT01512901|Betamethasone benzoate|betamethasone benzoate|mesh-list
24710995|NCT01512901|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24710996|NCT01512901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24710997|NCT01512901|Glucocorticoids|glucocorticoids|mesh-ancestor
24710999|NCT01512901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25120400|NCT03955575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25120401|NCT03955575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25120402|NCT03955575|Antimetabolites|antimetabolites|mesh-ancestor
25120403|NCT03955575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120404|NCT03955575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25120405|NCT03919435|Trimethoprim|trimethoprim|mesh-list
25120406|NCT03919435|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25120407|NCT03919435|Sulfamethoxazole|sulfamethoxazole|mesh-list
25120408|NCT03919435|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25120409|NCT03919435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25120413|NCT03919435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25120414|NCT03919435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25120415|NCT03919435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25120416|NCT03919435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120417|NCT03919435|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25120418|NCT03919435|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24479906|NCT00428883|Acetylcysteine|acetylcysteine|mesh-list
24711000|NCT01512901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711001|NCT01512901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24711002|NCT01512901|Respiratory System Agents|respiratory system agents|mesh-ancestor
24711003|NCT01512914|Ropivacaine|ropivacaine|mesh-list
24711004|NCT01512914|Anesthetics, Local|anesthetics, local|mesh-ancestor
24711005|NCT01512914|Anesthetics|anesthetics|mesh-ancestor
24711006|NCT01512914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24711007|NCT01512914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711008|NCT01512914|Sensory System Agents|sensory system agents|mesh-ancestor
24711009|NCT01512914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24711010|NCT01512953|Lansoprazole|lansoprazole|mesh-list
24614295|NCT01023360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711074|NCT01513083|Mitosis Modulators|mitosis modulators|mesh-ancestor
24711075|NCT01513083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711076|NCT01513174|Olaparib|olaparib|mesh-list
24711077|NCT01513174|Gefitinib|gefitinib|mesh-list
24711078|NCT01513174|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24711079|NCT01513174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25120427|NCT03882060|Hematinics|hematinics|mesh-ancestor
25120437|NCT03844997|Palbociclib|palbociclib|mesh-list
24519348|NCT01898793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25120438|NCT03844997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120439|NCT03844997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25120440|NCT03844997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25120441|NCT03844997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711164|NCT01513772|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24711236|NCT01514175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24711237|NCT01514175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711297|NCT01514695|Narcotics|narcotics|mesh-ancestor
24711298|NCT01514695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24711299|NCT01514695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711300|NCT01514695|Analgesics|analgesics|mesh-ancestor
24711301|NCT01514695|Sensory System Agents|sensory system agents|mesh-ancestor
24711393|NCT01514968|Immunologic Factors|immunologic factors|mesh-ancestor
24497607|NCT00510666|Tramadol|tramadol|mesh-list
24711394|NCT01514968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711395|NCT01514968|Antifungal Agents|antifungal agents|mesh-ancestor
24711396|NCT01514968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24711397|NCT01514968|Dermatologic Agents|dermatologic agents|mesh-ancestor
24711398|NCT01514968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24711399|NCT01514968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24711400|NCT01514968|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24711401|NCT01514968|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24711402|NCT01514968|Protease Inhibitors|protease inhibitors|mesh-ancestor
24711403|NCT01514968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24614340|NCT01023607|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24614342|NCT01023633|Oxaliplatin|oxaliplatin|mesh-list
24614343|NCT01023633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614344|NCT01023750|Fenofibrate|fenofibrate|mesh-list
24614345|NCT01023750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24614346|NCT01023750|Antimetabolites|antimetabolites|mesh-ancestor
24614347|NCT01023750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120443|NCT03836066|Atezolizumab|atezolizumab|mesh-list
25120444|NCT03836066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25120445|NCT03836066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120446|NCT03836066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25120447|NCT03836066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25120448|NCT03836066|Growth Substances|growth substances|mesh-ancestor
25120449|NCT03836066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120450|NCT03836066|Growth Inhibitors|growth inhibitors|mesh-ancestor
25120451|NCT03790397|Osimertinib|osimertinib|mesh-list
25120452|NCT03790397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120453|NCT03790397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25120454|NCT03790397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25120455|NCT03790397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120456|NCT03777215|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
25120457|NCT03777215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25120458|NCT03777215|Vasodilator Agents|vasodilator agents|mesh-ancestor
25120459|NCT03738878|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25120460|NCT03738878|Valsartan|valsartan|mesh-list
25120461|NCT03738878|Bradykinin|bradykinin|mesh-list
25120462|NCT03738878|Kininogens|kininogens|mesh-list
25120463|NCT03738878|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25120464|NCT03738878|Substance P|substance p|mesh-list
24614348|NCT01023750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24614349|NCT01023867|Donepezil|donepezil|mesh-list
24614350|NCT01023867|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24614351|NCT01023867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24614352|NCT01023867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614353|NCT01023867|Cholinergic Agents|cholinergic agents|mesh-ancestor
24614354|NCT01023867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24614355|NCT01023867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614357|NCT01023919|Sirolimus|sirolimus|mesh-list
24614363|NCT01023919|Mitosis Modulators|mitosis modulators|mesh-ancestor
24614364|NCT01023919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614365|NCT01023919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24614366|NCT01023919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24711444|NCT01515228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24711445|NCT01515228|Respiratory System Agents|respiratory system agents|mesh-ancestor
24711446|NCT01515228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24711447|NCT01515228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24711448|NCT01515228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24711449|NCT01515228|Vasodilator Agents|vasodilator agents|mesh-ancestor
24711450|NCT01515228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24856172|NCT02283060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711451|NCT01515228|Protective Agents|protective agents|mesh-ancestor
24711452|NCT01515228|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24711453|NCT01515228|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24711454|NCT01515228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711455|NCT01515371|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24711456|NCT01515371|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24711457|NCT01515371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24711458|NCT01515371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711459|NCT01515371|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25120466|NCT03738878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25120467|NCT03738878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120468|NCT03738878|Incretins|incretins|mesh-ancestor
25120469|NCT03738878|Hormones|hormones|mesh-ancestor
24711460|NCT01515371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24711461|NCT01515371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711496|NCT01515774|Dopamine Agents|dopamine agents|mesh-ancestor
24711497|NCT01515774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24711498|NCT01515813|Tenofovir|tenofovir|mesh-list
24711499|NCT01515813|Emtricitabine|emtricitabine|mesh-list
24711500|NCT01515813|Efavirenz|efavirenz|mesh-list
24711501|NCT01515813|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24711502|NCT01515813|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24711503|NCT01515813|Pravastatin|pravastatin|mesh-list
24711504|NCT01515813|Antiviral Agents|antiviral agents|mesh-ancestor
24711523|NCT01515826|Moxifloxacin|moxifloxacin|mesh-list
24711524|NCT01515826|Dexamethasone|dexamethasone|mesh-list
24711525|NCT01515826|Dexamethasone acetate|dexamethasone acetate|mesh-list
24711526|NCT01515826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24711527|NCT01515826|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24711563|NCT01515839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711564|NCT01515839|Vitamin B Complex|vitamin b complex|mesh-ancestor
24711566|NCT01515839|Micronutrients|micronutrients|mesh-ancestor
24711567|NCT01515839|Nootropic Agents|nootropic agents|mesh-ancestor
24711568|NCT01515839|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24711569|NCT01515839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711570|NCT01515839|Cholinergic Agents|cholinergic agents|mesh-ancestor
24711571|NCT01515839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24711572|NCT01515839|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24711573|NCT01515839|Antiviral Agents|antiviral agents|mesh-ancestor
24711615|NCT01516255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711633|NCT01516372|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24711634|NCT01516372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24711635|NCT01516372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24711637|NCT01516450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24711639|NCT01516450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711640|NCT01516463|Bacitracin|bacitracin|mesh-list
24711641|NCT01516463|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24711642|NCT01516463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24711643|NCT01516463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24711644|NCT01516554|Methyltestosterone|methyltestosterone|mesh-list
24711645|NCT01516554|Testosterone|testosterone|mesh-list
24711646|NCT01516554|Testosterone undecanoate|testosterone undecanoate|mesh-list
24711647|NCT01516554|Testosterone enanthate|testosterone enanthate|mesh-list
24711649|NCT01516554|Androgens|androgens|mesh-ancestor
24711667|NCT01516567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711668|NCT01516567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24711669|NCT01516567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24711670|NCT01516567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24711671|NCT01516567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24711682|NCT01516580|Doxorubicin|doxorubicin|mesh-list
24711683|NCT01516580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24711684|NCT01516580|Methotrexate|methotrexate|mesh-list
24711685|NCT01516580|Vincristine|vincristine|mesh-list
24711686|NCT01516580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24614381|NCT01024075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25120472|NCT03738878|Protease Inhibitors|protease inhibitors|mesh-ancestor
25120473|NCT03738878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25120474|NCT03738878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120475|NCT03738878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25120476|NCT03738878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25120477|NCT03738878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25120478|NCT03738878|Vasodilator Agents|vasodilator agents|mesh-ancestor
25120479|NCT03738878|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25120480|NCT03738878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24614382|NCT01024075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614383|NCT01024075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24614384|NCT01024075|Glucocorticoids|glucocorticoids|mesh-ancestor
24614385|NCT01024075|Hormones|hormones|mesh-ancestor
24614386|NCT01024075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24614387|NCT01024075|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24614388|NCT01024075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614389|NCT01024140|Citalopram|citalopram|mesh-list
24614390|NCT01024140|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24614391|NCT01024140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24614392|NCT01024140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24614393|NCT01024140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614394|NCT01024140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24614395|NCT01024140|Serotonin Agents|serotonin agents|mesh-ancestor
24614396|NCT01024140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614397|NCT01024140|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24614398|NCT01024140|Antidepressive Agents|antidepressive agents|mesh-ancestor
24614399|NCT01024140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24614400|NCT01024179|Sirolimus|sirolimus|mesh-list
24614401|NCT01024179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24614402|NCT01024179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24614403|NCT01024179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24614404|NCT01024179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614405|NCT01024179|Antifungal Agents|antifungal agents|mesh-ancestor
24614431|NCT01024270|Abortifacient Agents|abortifacient agents|mesh-ancestor
24498005|NCT00512980|Hormones|hormones|mesh-ancestor
24711698|NCT01516580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25120483|NCT03710460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25120484|NCT03710460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120485|NCT03710460|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25120486|NCT03710460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120490|NCT03604289|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
25120491|NCT03604289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25120492|NCT03604289|Vasodilator Agents|vasodilator agents|mesh-ancestor
25120503|NCT03575793|Nivolumab|nivolumab|mesh-list
25120504|NCT03575793|Ipilimumab|ipilimumab|mesh-list
25120505|NCT03575793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25120506|NCT03575793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120507|NCT03575793|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25120508|NCT03575793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120509|NCT03530267|Aflibercept|aflibercept|mesh-list
25120510|NCT03530267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24711699|NCT01516580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711700|NCT01516580|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24711701|NCT01516580|Abortifacient Agents|abortifacient agents|mesh-ancestor
24711702|NCT01516580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24711703|NCT01516580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24711705|NCT01516580|Dermatologic Agents|dermatologic agents|mesh-ancestor
24711706|NCT01516580|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24711707|NCT01516580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24711708|NCT01516580|Antiviral Agents|antiviral agents|mesh-ancestor
24711709|NCT01516580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24711710|NCT01516580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24711711|NCT01516580|Tubulin Modulators|tubulin modulators|mesh-ancestor
24711712|NCT01516580|Antimitotic Agents|antimitotic agents|mesh-ancestor
24711713|NCT01516580|Mitosis Modulators|mitosis modulators|mesh-ancestor
25120511|NCT03530267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25120513|NCT03530267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120514|NCT03530267|Growth Inhibitors|growth inhibitors|mesh-ancestor
25120515|NCT03530267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120516|NCT03492125|Rituximab|rituximab|mesh-list
25120517|NCT03492125|Obinutuzumab|obinutuzumab|mesh-list
25120518|NCT03492125|Venetoclax|venetoclax|mesh-list
25120519|NCT03492125|Acalabrutinib|acalabrutinib|mesh-list
25120520|NCT03492125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25120521|NCT03492125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120522|NCT03492125|Immunologic Factors|immunologic factors|mesh-ancestor
25120523|NCT03492125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120524|NCT03492125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25120525|NCT03472573|Dexamethasone|dexamethasone|mesh-list
25120526|NCT03472573|Palbociclib|palbociclib|mesh-list
25120527|NCT03472573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25120528|NCT03472573|Antiemetics|antiemetics|mesh-ancestor
25120529|NCT03472573|Autonomic Agents|autonomic agents|mesh-ancestor
25120542|NCT03384784|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24711732|NCT01516710|Liver Extracts|liver extracts|mesh-list
24711733|NCT01516710|Hematinics|hematinics|mesh-ancestor
24711735|NCT01516723|Everolimus|everolimus|mesh-list
24711736|NCT01516723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24711737|NCT01516723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25120543|NCT03384784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25120544|NCT03384784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120545|NCT03384784|Cholinergic Agents|cholinergic agents|mesh-ancestor
25120546|NCT03384784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25120547|NCT03384784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120548|NCT03384784|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25120550|NCT03384784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25120551|NCT03384784|Nootropic Agents|nootropic agents|mesh-ancestor
25120556|NCT03337087|Calcium, Dietary|calcium, dietary|mesh-list
25120557|NCT03337087|Leucovorin|leucovorin|mesh-list
25120559|NCT03337087|Fluorouracil|fluorouracil|mesh-list
25120560|NCT03337087|Irinotecan|irinotecan|mesh-list
25120561|NCT03337087|Rucaparib|rucaparib|mesh-list
25120562|NCT03337087|Calcium|calcium|mesh-list
25120563|NCT03337087|Levoleucovorin|levoleucovorin|mesh-list
25120564|NCT03337087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25120565|NCT03337087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120566|NCT03337087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24855801|NCT02281045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855802|NCT02281058|Abatacept|abatacept|mesh-list
25120567|NCT03337087|Antimetabolites|antimetabolites|mesh-ancestor
25120568|NCT03337087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120569|NCT03337087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25120570|NCT03337087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120571|NCT03337087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25120572|NCT03337087|Immunologic Factors|immunologic factors|mesh-ancestor
25120573|NCT03337087|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25120574|NCT03337087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25120589|NCT03299088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120590|NCT03299088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25120591|NCT03299088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25120592|NCT03299088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120594|NCT03290079|Lenvatinib|lenvatinib|mesh-list
25120595|NCT03290079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25120596|NCT03290079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120597|NCT03290079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25120598|NCT03290079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25120599|NCT03290079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711738|NCT01516723|Immunologic Factors|immunologic factors|mesh-ancestor
24711739|NCT01516723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711740|NCT01516723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24711741|NCT01516723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24711786|NCT01516944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24711787|NCT01516996|Docetaxel|docetaxel|mesh-list
24711788|NCT01516996|Nimotuzumab|nimotuzumab|mesh-list
24711789|NCT01516996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24711790|NCT01516996|Tubulin Modulators|tubulin modulators|mesh-ancestor
24711791|NCT01516996|Antimitotic Agents|antimitotic agents|mesh-ancestor
24711839|NCT01517334|Minocycline|minocycline|mesh-list
24711840|NCT01517334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24711841|NCT01517334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24711842|NCT01517347|Interleukin-2|interleukin-2|mesh-list
24711843|NCT01517347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24711844|NCT01517347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24711846|NCT01517347|Sensory System Agents|sensory system agents|mesh-ancestor
24711847|NCT01517347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24711848|NCT01517347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711849|NCT01517360|Oxytocin|oxytocin|mesh-list
24711850|NCT01517360|Oxytocics|oxytocics|mesh-ancestor
24498092|NCT00513188|Abortifacient Agents|abortifacient agents|mesh-ancestor
24711851|NCT01517360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24711852|NCT01517360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711854|NCT01517399|Digoxin|digoxin|mesh-list
24711884|NCT01517399|Purinergic Agents|purinergic agents|mesh-ancestor
24711885|NCT01517399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24711886|NCT01517399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24711887|NCT01517399|Protective Agents|protective agents|mesh-ancestor
24711888|NCT01517399|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24711889|NCT01517399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24711890|NCT01517399|Hemostatics|hemostatics|mesh-ancestor
24711891|NCT01517399|Coagulants|coagulants|mesh-ancestor
24711892|NCT01517490|Insulin|insulin|mesh-list
24711893|NCT01517490|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24711894|NCT01517490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24711895|NCT01517490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711896|NCT01517555|Acetaminophen|acetaminophen|mesh-list
24711897|NCT01517555|Liraglutide|liraglutide|mesh-list
24711898|NCT01517555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24711899|NCT01517555|Analgesics|analgesics|mesh-ancestor
25120606|NCT03240068|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
25120607|NCT03240068|Angiotensin II|angiotensin ii|mesh-list
25120608|NCT03240068|Angiotensinogen|angiotensinogen|mesh-list
25120609|NCT03240068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25120610|NCT03240068|Vasodilator Agents|vasodilator agents|mesh-ancestor
25120611|NCT03240068|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25120612|NCT03240068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25120614|NCT03240068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25120615|NCT03240068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120623|NCT03092154|Hypolipidemic Agents|hypolipidemic agents|mesh-list
25120624|NCT03092154|Antimetabolites|antimetabolites|mesh-ancestor
24711900|NCT01517555|Sensory System Agents|sensory system agents|mesh-ancestor
24711901|NCT01517555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24711902|NCT01517555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711903|NCT01517555|Antipyretics|antipyretics|mesh-ancestor
24711904|NCT01517555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24711905|NCT01517555|Incretins|incretins|mesh-ancestor
24711906|NCT01517555|Hormones|hormones|mesh-ancestor
24711908|NCT01517568|Liraglutide|liraglutide|mesh-list
24711914|NCT01517607|Mesalamine|mesalamine|mesh-list
24711945|NCT01517828|Sensory System Agents|sensory system agents|mesh-ancestor
24711946|NCT01517828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24711947|NCT01517828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711949|NCT01517828|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24711951|NCT01517828|Anesthetics|anesthetics|mesh-ancestor
24711952|NCT01517828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24711963|NCT01517828|GABA Agents|gaba agents|mesh-ancestor
24711964|NCT01517854|Sildenafil Citrate|sildenafil citrate|mesh-list
24711965|NCT01517854|Vasodilator Agents|vasodilator agents|mesh-ancestor
24711966|NCT01517854|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24711967|NCT01517854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24711968|NCT01517854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25120625|NCT03092154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120626|NCT03092154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25120627|NCT03029390|Metformin|metformin|mesh-list
25120628|NCT03029390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25120629|NCT03029390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120630|NCT03020030|Leucovorin|leucovorin|mesh-list
25120631|NCT03020030|Cytarabine|cytarabine|mesh-list
25120632|NCT03020030|Dexamethasone|dexamethasone|mesh-list
25120633|NCT03020030|Hydrocortisone|hydrocortisone|mesh-list
25120634|NCT03020030|Cyclophosphamide|cyclophosphamide|mesh-list
25120635|NCT03020030|Doxorubicin|doxorubicin|mesh-list
25120636|NCT03020030|Methotrexate|methotrexate|mesh-list
25120637|NCT03020030|Etoposide|etoposide|mesh-list
25120638|NCT03020030|Vincristine|vincristine|mesh-list
25120639|NCT03020030|Dasatinib|dasatinib|mesh-list
25120640|NCT03020030|Asparaginase|asparaginase|mesh-list
25120641|NCT03020030|Mercaptopurine|mercaptopurine|mesh-list
24711969|NCT01517854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711970|NCT01517854|Urological Agents|urological agents|mesh-ancestor
24711971|NCT01517932|Dexmedetomidine|dexmedetomidine|mesh-list
24711972|NCT01517932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24711973|NCT01517932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24711974|NCT01517932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711975|NCT01517932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24711976|NCT01517932|Analgesics|analgesics|mesh-ancestor
24711977|NCT01517932|Sensory System Agents|sensory system agents|mesh-ancestor
24711978|NCT01517932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24711979|NCT01517932|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24711980|NCT01517932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24711981|NCT01517932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24711982|NCT01517932|Adrenergic Agents|adrenergic agents|mesh-ancestor
24711985|NCT01517997|Paclitaxel|paclitaxel|mesh-list
24711986|NCT01517997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24711987|NCT01517997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24711988|NCT01517997|Tubulin Modulators|tubulin modulators|mesh-ancestor
24711989|NCT01517997|Antimitotic Agents|antimitotic agents|mesh-ancestor
24711990|NCT01517997|Mitosis Modulators|mitosis modulators|mesh-ancestor
24711991|NCT01517997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711993|NCT01518062|Hormones|hormones|mesh-ancestor
24711994|NCT01518062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24711995|NCT01518062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711996|NCT01518101|Metformin|metformin|mesh-list
24712004|NCT01518101|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24712005|NCT01518101|Protease Inhibitors|protease inhibitors|mesh-ancestor
24712006|NCT01518101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24712008|NCT01518166|Liraglutide|liraglutide|mesh-list
24712009|NCT01518166|Griseofulvin|griseofulvin|mesh-list
24712010|NCT01518166|Digoxin|digoxin|mesh-list
25120642|NCT03020030|Pegaspargase|pegaspargase|mesh-list
25120643|NCT03020030|Dexrazoxane|dexrazoxane|mesh-list
25120644|NCT03020030|Razoxane|razoxane|mesh-list
25120645|NCT03020030|Levoleucovorin|levoleucovorin|mesh-list
25120646|NCT03020030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25120647|NCT03020030|Immunologic Factors|immunologic factors|mesh-ancestor
25121011|NCT01228331|Antiviral Agents|antiviral agents|mesh-ancestor
25120648|NCT03020030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120649|NCT03020030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24712059|NCT01518231|Antioxidants|antioxidants|mesh-ancestor
24712060|NCT01518231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24712074|NCT01518465|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24712075|NCT01518465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24712077|NCT01518465|Autonomic Agents|autonomic agents|mesh-ancestor
24712078|NCT01518465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24712079|NCT01518465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712080|NCT01518465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24712081|NCT01518465|Glucocorticoids|glucocorticoids|mesh-ancestor
24712082|NCT01518465|Hormones|hormones|mesh-ancestor
24712083|NCT01518465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24712084|NCT01518465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24712085|NCT01518465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24712086|NCT01518465|Immunologic Factors|immunologic factors|mesh-ancestor
24712087|NCT01518465|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24712088|NCT01518465|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24712089|NCT01518465|Growth Substances|growth substances|mesh-ancestor
24712090|NCT01518465|Growth Inhibitors|growth inhibitors|mesh-ancestor
24712091|NCT01518465|Anticoagulants|anticoagulants|mesh-ancestor
24712092|NCT01518465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24614449|NCT01024322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24614450|NCT01024322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614451|NCT01024322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24614452|NCT01024322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24614453|NCT01024322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24614454|NCT01024322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24614455|NCT01024322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614456|NCT01024322|Antiemetics|antiemetics|mesh-ancestor
24614457|NCT01024322|Autonomic Agents|autonomic agents|mesh-ancestor
24614458|NCT01024322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24614459|NCT01024322|Glucocorticoids|glucocorticoids|mesh-ancestor
24614460|NCT01024322|Hormones|hormones|mesh-ancestor
24547506|NCT00704314|Simvastatin|simvastatin|mesh-list
24712179|NCT01518998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24712180|NCT01518998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712181|NCT01518998|Vasodilator Agents|vasodilator agents|mesh-ancestor
24712182|NCT01519011|Azacitidine|azacitidine|mesh-list
24712183|NCT01519011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24712184|NCT01519011|Antimetabolites|antimetabolites|mesh-ancestor
24712185|NCT01519011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712186|NCT01519011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24712188|NCT01519037|Cinacalcet|cinacalcet|mesh-list
24773762|NCT01841827|Autonomic Agents|autonomic agents|mesh-ancestor
24773763|NCT01841827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24712189|NCT01519037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24712190|NCT01519037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712191|NCT01519037|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24712232|NCT01519297|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24712251|NCT01519336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25120652|NCT03020030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120653|NCT03020030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120654|NCT03020030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25120655|NCT03020030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25120659|NCT03020030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25120660|NCT03020030|Glucocorticoids|glucocorticoids|mesh-ancestor
25120661|NCT03020030|Hormones|hormones|mesh-ancestor
24712252|NCT01519336|Protease Inhibitors|protease inhibitors|mesh-ancestor
24712253|NCT01519336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24712254|NCT01519336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712255|NCT01519336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24712256|NCT01519336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24712257|NCT01519336|Antiviral Agents|antiviral agents|mesh-ancestor
24712258|NCT01519336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24712259|NCT01519336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24712260|NCT01519336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24712262|NCT01519401|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24712263|NCT01519401|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24712264|NCT01519401|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24712266|NCT01519401|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24712267|NCT01519401|Estrogens|estrogens|mesh-ancestor
24712276|NCT01519401|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24712277|NCT01519401|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24712278|NCT01519401|Hormone Antagonists|hormone antagonists|mesh-ancestor
24712279|NCT01519401|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24712280|NCT01519401|Diuretics|diuretics|mesh-ancestor
24712281|NCT01519401|Natriuretic Agents|natriuretic agents|mesh-ancestor
24712282|NCT01519544|Acetazolamide|acetazolamide|mesh-list
24712283|NCT01519544|Temazepam|temazepam|mesh-list
24712284|NCT01519544|Anticonvulsants|anticonvulsants|mesh-ancestor
24712285|NCT01519544|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24712286|NCT01519544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24712287|NCT01519544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712288|NCT01519544|Diuretics|diuretics|mesh-ancestor
24712289|NCT01519544|Natriuretic Agents|natriuretic agents|mesh-ancestor
24712290|NCT01519544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712291|NCT01519544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24712292|NCT01519544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24712293|NCT01519544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24712294|NCT01519544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24712295|NCT01519544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24712296|NCT01519544|GABA Modulators|gaba modulators|mesh-ancestor
24712297|NCT01519544|GABA Agents|gaba agents|mesh-ancestor
24712298|NCT01519544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24712305|NCT01519726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24712306|NCT01519726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712308|NCT01519726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24712309|NCT01519726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24712310|NCT01519726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24712311|NCT01519726|Anesthetics, General|anesthetics, general|mesh-ancestor
24712312|NCT01519726|Anesthetics|anesthetics|mesh-ancestor
25120665|NCT03020030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25120666|NCT03020030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25120667|NCT03020030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25120668|NCT03020030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25120669|NCT03020030|Abortifacient Agents|abortifacient agents|mesh-ancestor
25120670|NCT03020030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25120671|NCT03020030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25120673|NCT03020030|Dermatologic Agents|dermatologic agents|mesh-ancestor
25120674|NCT03020030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24712313|NCT01519726|GABA Modulators|gaba modulators|mesh-ancestor
24712314|NCT01519726|GABA Agents|gaba agents|mesh-ancestor
24712315|NCT01519726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25693324|NCT02012491|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25693325|NCT02012491|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24712317|NCT01519752|Oxiconazole|oxiconazole|mesh-list
24712318|NCT01519752|Antifungal Agents|antifungal agents|mesh-ancestor
24712319|NCT01519752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24712320|NCT01519856|Piribedil|piribedil|mesh-list
24712327|NCT01519856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614515|NCT01024543|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24712328|NCT01519986|Vitamin D|vitamin d|mesh-list
24712329|NCT01519986|Cholecalciferol|cholecalciferol|mesh-list
24712330|NCT01519986|Vitamins|vitamins|mesh-ancestor
24712331|NCT01519986|Micronutrients|micronutrients|mesh-ancestor
24712332|NCT01519986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712333|NCT01519986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24712334|NCT01519986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24712335|NCT01520012|Esomeprazole|esomeprazole|mesh-list
24712336|NCT01520012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24712337|NCT01520012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24712338|NCT01520012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24712347|NCT01520077|Antimetabolites|antimetabolites|mesh-ancestor
24712349|NCT01520077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24712377|NCT01520285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24712378|NCT01520285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24712379|NCT01520285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712380|NCT01520285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24712381|NCT01520285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712382|NCT01520285|Vasodilator Agents|vasodilator agents|mesh-ancestor
24712383|NCT01520298|Acetaminophen|acetaminophen|mesh-list
24712384|NCT01520298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24712385|NCT01520298|Analgesics|analgesics|mesh-ancestor
24712386|NCT01520298|Sensory System Agents|sensory system agents|mesh-ancestor
24712387|NCT01520298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24712388|NCT01520298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712389|NCT01520298|Antipyretics|antipyretics|mesh-ancestor
25120675|NCT03020030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25120676|NCT03020030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25120678|NCT03020030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25120679|NCT03020030|Antidotes|antidotes|mesh-ancestor
25120680|NCT03020030|Protective Agents|protective agents|mesh-ancestor
25120681|NCT03020030|Vitamin B Complex|vitamin b complex|mesh-ancestor
25120682|NCT03020030|Vitamins|vitamins|mesh-ancestor
25120683|NCT03020030|Micronutrients|micronutrients|mesh-ancestor
25120684|NCT03020030|Tubulin Modulators|tubulin modulators|mesh-ancestor
25120685|NCT03020030|Antimitotic Agents|antimitotic agents|mesh-ancestor
25120686|NCT03020030|Mitosis Modulators|mitosis modulators|mesh-ancestor
25120687|NCT03020030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25120688|NCT03020030|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25120689|NCT02970318|Rituximab|rituximab|mesh-list
25120690|NCT02970318|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25120691|NCT02970318|Acalabrutinib|acalabrutinib|mesh-list
25120692|NCT02970318|Idelalisib|idelalisib|mesh-list
25120693|NCT02970318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25120694|NCT02970318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120695|NCT02970318|Immunologic Factors|immunologic factors|mesh-ancestor
25120696|NCT02970318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904218|NCT04358055|Viscosupplements|viscosupplements|mesh-ancestor
24712390|NCT01520350|Aripiprazole|aripiprazole|mesh-list
24712391|NCT01520350|Antidepressive Agents|antidepressive agents|mesh-ancestor
24712392|NCT01520350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24712393|NCT01520350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24712394|NCT01520350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24712395|NCT01520350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24712396|NCT01520350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712397|NCT01520350|Dopamine Agonists|dopamine agonists|mesh-ancestor
24712398|NCT01520350|Dopamine Agents|dopamine agents|mesh-ancestor
24712399|NCT01520350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24614516|NCT01024543|Mydriatics|mydriatics|mesh-ancestor
24773938|NCT01843010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773939|NCT01843010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24773940|NCT01843010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24773941|NCT01843075|Liraglutide|liraglutide|mesh-list
24773942|NCT01843075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24712400|NCT01520350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712401|NCT01520350|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24712402|NCT01520350|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24712404|NCT01520350|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24712405|NCT01520350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24712406|NCT01520350|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24712407|NCT01520350|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24712409|NCT01520389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24712410|NCT01520389|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24712412|NCT01520389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24712414|NCT01520389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24712415|NCT01520389|Immunologic Factors|immunologic factors|mesh-ancestor
24712416|NCT01520389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712417|NCT01520415|Lidocaine|lidocaine|mesh-list
24712418|NCT01520415|Bupivacaine|bupivacaine|mesh-list
24712419|NCT01520415|Anesthetics, Local|anesthetics, local|mesh-ancestor
25120697|NCT02970318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25120698|NCT02970318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25120699|NCT02970318|Alkylating Agents|alkylating agents|mesh-ancestor
25120700|NCT02970318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120701|NCT02970318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25120702|NCT02936843|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
25120703|NCT02936843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25120704|NCT02936843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25120705|NCT02936843|Analgesics|analgesics|mesh-ancestor
25120706|NCT02936843|Sensory System Agents|sensory system agents|mesh-ancestor
25120707|NCT02936843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25120708|NCT02936843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120709|NCT02936843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25120710|NCT02936843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25120711|NCT02900976|Rituximab|rituximab|mesh-list
25120712|NCT02900976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25120713|NCT02900976|Antibodies|antibodies|mesh-list
25120714|NCT02900976|Immunoglobulins|immunoglobulins|mesh-list
25120715|NCT02900976|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25120716|NCT02900976|Immunologic Factors|immunologic factors|mesh-ancestor
25120717|NCT02900976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120718|NCT02900976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120719|NCT02900976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25120720|NCT02735057|Paclitaxel|paclitaxel|mesh-list
25120721|NCT02735057|Carboplatin|carboplatin|mesh-list
25120722|NCT02735057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25120723|NCT02735057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120724|NCT02735057|Tubulin Modulators|tubulin modulators|mesh-ancestor
25120725|NCT02735057|Antimitotic Agents|antimitotic agents|mesh-ancestor
25120726|NCT02735057|Mitosis Modulators|mitosis modulators|mesh-ancestor
25120727|NCT02735057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712420|NCT01520415|Anesthetics|anesthetics|mesh-ancestor
24712421|NCT01520415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24712422|NCT01520415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712423|NCT01520415|Sensory System Agents|sensory system agents|mesh-ancestor
24712424|NCT01520415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24712425|NCT01520415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24712426|NCT01520415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24712427|NCT01520415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24712428|NCT01520415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25120728|NCT02720185|Dasatinib|dasatinib|mesh-list
25120729|NCT02720185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120730|NCT02720185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25120731|NCT02720185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25120732|NCT02720185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693326|NCT02012491|Hormone Antagonists|hormone antagonists|mesh-ancestor
25693327|NCT02012491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25693328|NCT02012491|Luteolytic Agents|luteolytic agents|mesh-ancestor
25693329|NCT02012491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24774014|NCT01843296|Anesthetics, General|anesthetics, general|mesh-ancestor
24774015|NCT01843296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24774016|NCT01843296|Anticonvulsants|anticonvulsants|mesh-ancestor
25120733|NCT02714894|Clozapine|clozapine|mesh-list
25120734|NCT02714894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25120735|NCT02714894|Serotonin Agents|serotonin agents|mesh-ancestor
25120736|NCT02714894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25120737|NCT02714894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120738|NCT02714894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120739|NCT02714894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25120740|NCT02714894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25120741|NCT02714894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25120742|NCT02714894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25120743|NCT02714894|GABA Antagonists|gaba antagonists|mesh-ancestor
25120744|NCT02714894|GABA Agents|gaba agents|mesh-ancestor
25120745|NCT02710669|Propafenone|propafenone|mesh-list
25120746|NCT02710669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25120747|NCT02710669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25120748|NCT02710669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25120749|NCT02710669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25120750|NCT02710669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712440|NCT01520467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24712441|NCT01520467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24712442|NCT01520467|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24712443|NCT01520467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24712444|NCT01520467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24712445|NCT01520467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712450|NCT01520584|Vitamins|vitamins|mesh-list
24712453|NCT01520753|Insulin|insulin|mesh-list
24712454|NCT01520753|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24712455|NCT01520753|Insulin Aspart|insulin aspart|mesh-list
24712456|NCT01520753|Insulin, Long-Acting|insulin, long-acting|mesh-list
25120766|NCT02684461|Paclitaxel|paclitaxel|mesh-list
25120767|NCT02684461|Pembrolizumab|pembrolizumab|mesh-list
25120768|NCT02684461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25120769|NCT02684461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120770|NCT02684461|Tubulin Modulators|tubulin modulators|mesh-ancestor
25120771|NCT02684461|Antimitotic Agents|antimitotic agents|mesh-ancestor
25120772|NCT02684461|Mitosis Modulators|mitosis modulators|mesh-ancestor
25120773|NCT02684461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120774|NCT02684461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25120785|NCT02639650|Dactinomycin|dactinomycin|mesh-list
25120787|NCT02639650|Etoposide|etoposide|mesh-list
24712457|NCT01520753|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24712458|NCT01520753|Biphasic Insulins|biphasic insulins|mesh-list
25120790|NCT02639650|Carboplatin|carboplatin|mesh-list
25120791|NCT02639650|Methotrexate|methotrexate|mesh-list
25120792|NCT02639650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25120793|NCT02639650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120794|NCT02639650|Tubulin Modulators|tubulin modulators|mesh-ancestor
25120795|NCT02639650|Antimitotic Agents|antimitotic agents|mesh-ancestor
25120796|NCT02639650|Mitosis Modulators|mitosis modulators|mesh-ancestor
25120797|NCT02639650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120798|NCT02639650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25120799|NCT02639650|Immunologic Factors|immunologic factors|mesh-ancestor
25120800|NCT02639650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712459|NCT01520753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25693330|NCT02012491|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25693331|NCT02012959|Tolvaptan|tolvaptan|mesh-list
25693332|NCT02012959|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25693333|NCT02012959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693334|NCT02012959|Natriuretic Agents|natriuretic agents|mesh-ancestor
25693335|NCT02012959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693336|NCT02013037|Eculizumab|eculizumab|mesh-list
24712462|NCT01520766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24712473|NCT01520766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24712474|NCT01520766|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24712475|NCT01520792|Acetaminophen|acetaminophen|mesh-list
24712476|NCT01520792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24712477|NCT01520792|Analgesics|analgesics|mesh-ancestor
24712478|NCT01520792|Sensory System Agents|sensory system agents|mesh-ancestor
24712479|NCT01520792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24712480|NCT01520792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712481|NCT01520792|Antipyretics|antipyretics|mesh-ancestor
24712483|NCT01520818|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24712484|NCT01520818|Insulin Aspart|insulin aspart|mesh-list
24712496|NCT01520831|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24642793|NCT01181414|Amiodarone|amiodarone|mesh-list
24712520|NCT01521299|Antisickling Agents|antisickling agents|mesh-ancestor
24712521|NCT01521299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24712522|NCT01521299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712526|NCT01521312|Hormones|hormones|mesh-ancestor
24712538|NCT01521377|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24712539|NCT01521377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24712540|NCT01521377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24712541|NCT01521377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25120801|NCT02639650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25120802|NCT02639650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25120803|NCT02639650|Alkylating Agents|alkylating agents|mesh-ancestor
25120804|NCT02639650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25120805|NCT02639650|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25120806|NCT02639650|Abortifacient Agents|abortifacient agents|mesh-ancestor
25120807|NCT02639650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25120808|NCT02639650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25120809|NCT02639650|Antimetabolites|antimetabolites|mesh-ancestor
25120810|NCT02639650|Dermatologic Agents|dermatologic agents|mesh-ancestor
25120811|NCT02639650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25120812|NCT02639650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25120813|NCT02639650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25120814|NCT02639650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25120815|NCT02639650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25120816|NCT02639650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25120817|NCT02639650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25120818|NCT02639650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25120819|NCT02639650|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25120820|NCT02581748|Trastuzumab|trastuzumab|mesh-list
25120821|NCT02581748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25120822|NCT02581748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120823|NCT02514031|Gemcitabine|gemcitabine|mesh-list
25120824|NCT02514031|Beta-lapachone|beta-lapachone|mesh-list
25120825|NCT02514031|Paclitaxel|paclitaxel|mesh-list
25120826|NCT02514031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25120827|NCT02514031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120828|NCT02514031|Tubulin Modulators|tubulin modulators|mesh-ancestor
25120829|NCT02514031|Antimitotic Agents|antimitotic agents|mesh-ancestor
25120830|NCT02514031|Mitosis Modulators|mitosis modulators|mesh-ancestor
25120874|NCT01868451|Vinblastine|vinblastine|mesh-list
25120875|NCT01868451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25120876|NCT01868451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120877|NCT01868451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25120878|NCT01868451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25120879|NCT01868451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25120880|NCT01868451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120881|NCT01868451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25120882|NCT01868451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25120883|NCT01868451|Alkylating Agents|alkylating agents|mesh-ancestor
25120884|NCT01868451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25120885|NCT01868451|Tubulin Modulators|tubulin modulators|mesh-ancestor
25120886|NCT01868451|Antimitotic Agents|antimitotic agents|mesh-ancestor
25120887|NCT01868451|Mitosis Modulators|mitosis modulators|mesh-ancestor
24712542|NCT01521377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24614517|NCT01024543|Autonomic Agents|autonomic agents|mesh-ancestor
24712543|NCT01521377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693337|NCT02013037|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24484308|NCT00447577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484309|NCT00447577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24774166|NCT01844024|Misoprostol|misoprostol|mesh-list
24774167|NCT01844024|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24774168|NCT01844024|Abortifacient Agents|abortifacient agents|mesh-ancestor
24911598|NCT04285775|Analgesics|analgesics|mesh-ancestor
24712544|NCT01521377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712545|NCT01521377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24712546|NCT01521377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24712547|NCT01521377|Contraceptive Agents|contraceptive agents|mesh-ancestor
24712548|NCT01521377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24712549|NCT01521377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712550|NCT01521377|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24712551|NCT01521377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25120905|NCT00495508|Lumefantrine|lumefantrine|mesh-list
25120906|NCT00495508|Artemether|artemether|mesh-list
25120907|NCT00495508|Quinine|quinine|mesh-list
25120908|NCT00495508|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25120909|NCT00495508|Antimalarials|antimalarials|mesh-ancestor
25120910|NCT00495508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25120911|NCT00495508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25120912|NCT00495508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25120913|NCT00495508|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25120914|NCT00495508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120915|NCT00495508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25120916|NCT00495508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25120917|NCT00495508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25120918|NCT00495508|Analgesics|analgesics|mesh-ancestor
25120919|NCT00495508|Sensory System Agents|sensory system agents|mesh-ancestor
25120920|NCT01554046|Methylphenidate|methylphenidate|mesh-list
25120921|NCT01554046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25120922|NCT01554046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120923|NCT01554046|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25120924|NCT01554046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25120926|NCT01554046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120927|NCT01554046|Dopamine Agents|dopamine agents|mesh-ancestor
25120928|NCT01554046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25120929|NCT01506986|Metronidazole|metronidazole|mesh-list
25120930|NCT01506986|Clarithromycin|clarithromycin|mesh-list
25120931|NCT01506986|Lansoprazole|lansoprazole|mesh-list
25120932|NCT01506986|Dexlansoprazole|dexlansoprazole|mesh-list
25120933|NCT01506986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24614570|NCT01024868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614571|NCT01024868|Sensory System Agents|sensory system agents|mesh-ancestor
24614572|NCT01024868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24614573|NCT01025102|Sufentanil|sufentanil|mesh-list
24614574|NCT01025102|Ropivacaine|ropivacaine|mesh-list
25120939|NCT01506986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120940|NCT01506986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25120941|NCT01506986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25120942|NCT01506986|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25120943|NCT01506986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25120944|NCT01506986|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25120946|NCT01295944|Carboplatin|carboplatin|mesh-list
25120947|NCT01295944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25120948|NCT01295944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120949|NCT01295944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25120950|NCT01295944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25120951|NCT01295944|Growth Substances|growth substances|mesh-ancestor
24614575|NCT01025102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24614576|NCT01025102|Narcotics|narcotics|mesh-ancestor
24614577|NCT01025102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24614578|NCT01025102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712558|NCT01521455|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24712581|NCT01521572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24712582|NCT01521572|Respiratory System Agents|respiratory system agents|mesh-ancestor
25693338|NCT02013037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25693339|NCT02013037|Immunologic Factors|immunologic factors|mesh-ancestor
25693340|NCT02013037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693341|NCT02013206|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25693342|NCT02013206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693343|NCT02013206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24774195|NCT01844401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774196|NCT01844401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24712584|NCT01521572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24712585|NCT01521572|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24712586|NCT01521572|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24712587|NCT01521572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24712588|NCT01521572|Adrenergic Agents|adrenergic agents|mesh-ancestor
24712589|NCT01521572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24712590|NCT01521572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712592|NCT01521624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24712593|NCT01521624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712594|NCT01521689|Rituximab|rituximab|mesh-list
24712595|NCT01521689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24712596|NCT01521689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24712597|NCT01521689|Immunologic Factors|immunologic factors|mesh-ancestor
24712598|NCT01521689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712599|NCT01521689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24712600|NCT01521767|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24712601|NCT01521767|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24712602|NCT01521767|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24712603|NCT01521767|Cholinergic Agents|cholinergic agents|mesh-ancestor
25120957|NCT01285557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120958|NCT01285557|Antimetabolites|antimetabolites|mesh-ancestor
25120959|NCT01285557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120960|NCT01285557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25120961|NCT01285557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25120962|NCT01285557|Immunologic Factors|immunologic factors|mesh-ancestor
25120963|NCT01285557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25120964|NCT01228331|Cytarabine|cytarabine|mesh-list
25120965|NCT01228331|Dexamethasone|dexamethasone|mesh-list
25120966|NCT01228331|Methylprednisolone|methylprednisolone|mesh-list
25120967|NCT01228331|Cyclophosphamide|cyclophosphamide|mesh-list
25120968|NCT01228331|Doxorubicin|doxorubicin|mesh-list
25120969|NCT01228331|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25120970|NCT01228331|Methotrexate|methotrexate|mesh-list
25120971|NCT01228331|Etoposide|etoposide|mesh-list
25120972|NCT01228331|Vincristine|vincristine|mesh-list
25120973|NCT01228331|Daunorubicin|daunorubicin|mesh-list
25120974|NCT01228331|Mercaptopurine|mercaptopurine|mesh-list
25120975|NCT01228331|Clofarabine|clofarabine|mesh-list
25120976|NCT01228331|Pegaspargase|pegaspargase|mesh-list
25120977|NCT01228331|Thioguanine|thioguanine|mesh-list
25120978|NCT01228331|Etoposide phosphate|etoposide phosphate|mesh-list
24712604|NCT01521767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24712605|NCT01521767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712606|NCT01521767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712607|NCT01521767|Urological Agents|urological agents|mesh-ancestor
24712608|NCT01521793|Retinol acetate|retinol acetate|mesh-list
24712609|NCT01521793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24712610|NCT01521793|Immunologic Factors|immunologic factors|mesh-ancestor
24712611|NCT01521793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712612|NCT01521793|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24712614|NCT01521793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24712615|NCT01521819|Ranibizumab|ranibizumab|mesh-list
24712616|NCT01521819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24712617|NCT01521819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25120984|NCT01228331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25120985|NCT01228331|Alkylating Agents|alkylating agents|mesh-ancestor
25120986|NCT01228331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25120987|NCT01228331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25120988|NCT01228331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25120989|NCT01228331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25120991|NCT01228331|Autonomic Agents|autonomic agents|mesh-ancestor
25120992|NCT01228331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25693344|NCT02013206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693345|NCT02013206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774288|NCT01844947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24712618|NCT01521819|Growth Substances|growth substances|mesh-ancestor
24712619|NCT01521819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712620|NCT01521819|Growth Inhibitors|growth inhibitors|mesh-ancestor
24712621|NCT01521819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24712622|NCT01521936|Vitamin D|vitamin d|mesh-list
24712623|NCT01521936|Ergocalciferols|ergocalciferols|mesh-list
24712624|NCT01521936|Cholecalciferol|cholecalciferol|mesh-list
24712625|NCT01521936|Vitamins|vitamins|mesh-list
24712626|NCT01521936|Micronutrients|micronutrients|mesh-ancestor
24712627|NCT01521936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712628|NCT01521936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24712629|NCT01521936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24712630|NCT01521962|Alogliptin|alogliptin|mesh-list
24712631|NCT01521962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24712634|NCT01521962|Hormones|hormones|mesh-ancestor
24712648|NCT01521975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712649|NCT01522040|Magnesium Sulfate|magnesium sulfate|mesh-list
24712651|NCT01522040|Sensory System Agents|sensory system agents|mesh-ancestor
24712652|NCT01522040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24712653|NCT01522040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712654|NCT01522040|Anesthetics|anesthetics|mesh-ancestor
24712655|NCT01522040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24712656|NCT01522040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24712657|NCT01522040|Anticonvulsants|anticonvulsants|mesh-ancestor
24712658|NCT01522040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24712659|NCT01522040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24712660|NCT01522040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712661|NCT01522040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24712662|NCT01522040|Tocolytic Agents|tocolytic agents|mesh-ancestor
25120993|NCT01228331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25120994|NCT01228331|Glucocorticoids|glucocorticoids|mesh-ancestor
25120995|NCT01228331|Hormones|hormones|mesh-ancestor
25120996|NCT01228331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25120997|NCT01228331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25120998|NCT01228331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25120999|NCT01228331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25121000|NCT01228331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25121001|NCT01228331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121002|NCT01228331|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25121003|NCT01228331|Abortifacient Agents|abortifacient agents|mesh-ancestor
25121004|NCT01228331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25121005|NCT01228331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25121006|NCT01228331|Antimetabolites|antimetabolites|mesh-ancestor
25121007|NCT01228331|Dermatologic Agents|dermatologic agents|mesh-ancestor
25121008|NCT01228331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25121009|NCT01228331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25121010|NCT01228331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25121012|NCT01228331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25121013|NCT01228331|Tubulin Modulators|tubulin modulators|mesh-ancestor
25121014|NCT01228331|Antimitotic Agents|antimitotic agents|mesh-ancestor
25121015|NCT01228331|Mitosis Modulators|mitosis modulators|mesh-ancestor
25121016|NCT01228331|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25121017|NCT01228331|Protective Agents|protective agents|mesh-ancestor
25121018|NCT01171937|Risperidone|risperidone|mesh-list
25121019|NCT01171937|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25121020|NCT01171937|Serotonin Agents|serotonin agents|mesh-ancestor
25121021|NCT01171937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24712663|NCT01522040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24712664|NCT01522092|Citalopram|citalopram|mesh-list
24712665|NCT01522092|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25693346|NCT02013245|Vaccines|vaccines|mesh-list
25693347|NCT02013245|Immunologic Factors|immunologic factors|mesh-ancestor
25693348|NCT02013245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693349|NCT02013375|Sirolimus|sirolimus|mesh-list
25693350|NCT02013375|Cyclophosphamide|cyclophosphamide|mesh-list
25693351|NCT02013375|Alemtuzumab|alemtuzumab|mesh-list
25693352|NCT02013375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25693353|NCT02013375|Immunologic Factors|immunologic factors|mesh-ancestor
25693354|NCT02013375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693355|NCT02013375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25693356|NCT02013375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25693357|NCT02013375|Alkylating Agents|alkylating agents|mesh-ancestor
24498997|NCT00517257|Atorvastatin|atorvastatin|mesh-list
24712666|NCT01522092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24712678|NCT01522326|Ibuprofen|ibuprofen|mesh-list
24712679|NCT01522326|Metoclopramide|metoclopramide|mesh-list
24712680|NCT01522326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24712681|NCT01522326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24712682|NCT01522326|Analgesics|analgesics|mesh-ancestor
24712683|NCT01522326|Sensory System Agents|sensory system agents|mesh-ancestor
24712684|NCT01522326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24712685|NCT01522326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712686|NCT01522326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24712687|NCT01522326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24712688|NCT01522326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25121022|NCT01171937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121023|NCT01171937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121024|NCT01171937|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25121025|NCT01171937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25121026|NCT01171937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25121027|NCT01171937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25121028|NCT01171937|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25121029|NCT01171937|Dopamine Agents|dopamine agents|mesh-ancestor
25121030|NCT00977691|Sirolimus|sirolimus|mesh-list
25121031|NCT00977691|Cyclophosphamide|cyclophosphamide|mesh-list
25121032|NCT00977691|Alemtuzumab|alemtuzumab|mesh-list
25121033|NCT00977691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25121034|NCT00977691|Immunologic Factors|immunologic factors|mesh-ancestor
25121035|NCT00977691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121036|NCT00977691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25121037|NCT00977691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25121038|NCT00977691|Alkylating Agents|alkylating agents|mesh-ancestor
25121039|NCT00977691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121040|NCT00977691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121041|NCT00977691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25121042|NCT00977691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25121043|NCT00977691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25121044|NCT00977691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25121045|NCT00977691|Antifungal Agents|antifungal agents|mesh-ancestor
25121046|NCT00977691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25121047|NCT00964002|Efavirenz|efavirenz|mesh-list
25121048|NCT00964002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25121049|NCT00964002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25121050|NCT00964002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121087|NCT00583778|Cholinergic Agents|cholinergic agents|mesh-ancestor
25121051|NCT00964002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904784|NCT04353180|Tretinoin|tretinoin|mesh-list
24712689|NCT01522326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24712690|NCT01522326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712691|NCT01522326|Antiemetics|antiemetics|mesh-ancestor
24712692|NCT01522326|Autonomic Agents|autonomic agents|mesh-ancestor
24712693|NCT01522326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24712694|NCT01522326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24712695|NCT01522326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24712696|NCT01522326|Dopamine Agents|dopamine agents|mesh-ancestor
24712697|NCT01522326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24712698|NCT01522378|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24712699|NCT01522378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121052|NCT00964002|Antiviral Agents|antiviral agents|mesh-ancestor
25121053|NCT00964002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25121054|NCT00964002|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25121055|NCT00964002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25121056|NCT00964002|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25121057|NCT00964002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25121058|NCT00964002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25121059|NCT00964002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25121060|NCT00887783|Vinorelbine|vinorelbine|mesh-list
25121061|NCT00887783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25121062|NCT00887783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121063|NCT00887783|Tubulin Modulators|tubulin modulators|mesh-ancestor
25121064|NCT00887783|Antimitotic Agents|antimitotic agents|mesh-ancestor
25121065|NCT00887783|Mitosis Modulators|mitosis modulators|mesh-ancestor
25121066|NCT00887783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121067|NCT00790218|Adenosine|adenosine|mesh-list
25121068|NCT00790218|Analgesics|analgesics|mesh-ancestor
25121069|NCT00790218|Sensory System Agents|sensory system agents|mesh-ancestor
24774438|NCT01845532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24774439|NCT01845532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774440|NCT01845532|Sensory System Agents|sensory system agents|mesh-ancestor
24774441|NCT01845532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25081282|NCT03331523|Betamethasone Valerate|betamethasone valerate|mesh-list
25121070|NCT00790218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25121071|NCT00790218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121072|NCT00790218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25121073|NCT00790218|Vasodilator Agents|vasodilator agents|mesh-ancestor
24904795|NCT04353024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24712700|NCT01522378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24712701|NCT01522378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712726|NCT01522612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712727|NCT01522612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24712728|NCT01522612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24712729|NCT01522612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24712730|NCT01522612|Immunologic Factors|immunologic factors|mesh-ancestor
24712731|NCT01522612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712732|NCT01522612|Antidotes|antidotes|mesh-ancestor
24712733|NCT01522612|Protective Agents|protective agents|mesh-ancestor
24712734|NCT01522612|Vitamin B Complex|vitamin b complex|mesh-ancestor
24712735|NCT01522612|Vitamins|vitamins|mesh-ancestor
24712736|NCT01522612|Micronutrients|micronutrients|mesh-ancestor
24712737|NCT01522612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24712738|NCT01522625|Tenofovir|tenofovir|mesh-list
24712739|NCT01522625|Antiviral Agents|antiviral agents|mesh-ancestor
24712740|NCT01522625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24712741|NCT01522625|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24712742|NCT01522625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24712743|NCT01522625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920688|NCT04199143|Anesthetics|anesthetics|mesh-ancestor
24712744|NCT01522625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712745|NCT01522625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24712746|NCT01522625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24712747|NCT01522677|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24712748|NCT01522677|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25121074|NCT00790218|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25121075|NCT00790218|Purinergic Agonists|purinergic agonists|mesh-ancestor
25121076|NCT00790218|Purinergic Agents|purinergic agents|mesh-ancestor
25121077|NCT00790218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25121078|NCT00790218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121080|NCT00583778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25121081|NCT00583778|Autonomic Agents|autonomic agents|mesh-ancestor
25121082|NCT00583778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25121083|NCT00583778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121084|NCT00583778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25121085|NCT00583778|Respiratory System Agents|respiratory system agents|mesh-ancestor
25121086|NCT00583778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25121090|NCT00432094|Paclitaxel|paclitaxel|mesh-list
25121091|NCT00432094|Etoposide|etoposide|mesh-list
24782375|NCT01895764|Methotrexate|methotrexate|mesh-list
25121092|NCT00432094|Carboplatin|carboplatin|mesh-list
25121093|NCT00432094|Ifosfamide|ifosfamide|mesh-list
25121094|NCT00432094|Thiotepa|thiotepa|mesh-list
25121095|NCT00432094|Mesna|mesna|mesh-list
25121096|NCT00432094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25121097|NCT00432094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121098|NCT00432094|Tubulin Modulators|tubulin modulators|mesh-ancestor
25121099|NCT00432094|Antimitotic Agents|antimitotic agents|mesh-ancestor
25121100|NCT00432094|Mitosis Modulators|mitosis modulators|mesh-ancestor
25121101|NCT00432094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121102|NCT00432094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24712749|NCT01522677|Dermatologic Agents|dermatologic agents|mesh-ancestor
24712750|NCT01522729|Fentanyl|fentanyl|mesh-list
24712762|NCT01522768|Paclitaxel|paclitaxel|mesh-list
24712794|NCT01522872|Autonomic Agents|autonomic agents|mesh-ancestor
24712795|NCT01522872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24712796|NCT01522872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712797|NCT01522872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24712798|NCT01522872|Glucocorticoids|glucocorticoids|mesh-ancestor
24712799|NCT01522872|Hormones|hormones|mesh-ancestor
25693358|NCT02013375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693359|NCT02013375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693360|NCT02013375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25693361|NCT02013375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25693362|NCT02013375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24774520|NCT01846026|Vitamins|vitamins|mesh-ancestor
24712800|NCT01522872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24712801|NCT01522872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24712802|NCT01522872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24712803|NCT01522872|Protease Inhibitors|protease inhibitors|mesh-ancestor
24712804|NCT01522872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24712805|NCT01522872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712806|NCT01522872|Immunologic Factors|immunologic factors|mesh-ancestor
24904986|NCT04351867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904987|NCT04351867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24904988|NCT04351867|Antimetabolites|antimetabolites|mesh-ancestor
24881635|NCT01918644|Capecitabine|capecitabine|mesh-list
25121103|NCT00432094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25121104|NCT00432094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121105|NCT00432094|Immunologic Factors|immunologic factors|mesh-ancestor
25121106|NCT00432094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121107|NCT00432094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25121108|NCT00432094|Alkylating Agents|alkylating agents|mesh-ancestor
25121109|NCT00432094|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25121110|NCT00432094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25121111|NCT00432094|Protective Agents|protective agents|mesh-ancestor
25121112|NCT00416351|Clofarabine|clofarabine|mesh-list
25121113|NCT00416351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25121114|NCT00416351|Antimetabolites|antimetabolites|mesh-ancestor
25121115|NCT00416351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121116|NCT00416351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121117|NCT00072358|Carbamide Peroxide|carbamide peroxide|mesh-list
25121118|NCT00072358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25121119|NCT00072358|Irinotecan|irinotecan|mesh-list
25121120|NCT00072358|Temozolomide|temozolomide|mesh-list
24712807|NCT01522872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24712808|NCT01522872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24712809|NCT01522872|Growth Substances|growth substances|mesh-ancestor
24712810|NCT01522872|Growth Inhibitors|growth inhibitors|mesh-ancestor
24712811|NCT01522872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24712812|NCT01522872|Alkylating Agents|alkylating agents|mesh-ancestor
24712900|NCT01523093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24905028|NCT04351347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905029|NCT04351308|Apatinib|apatinib|mesh-list
25121122|NCT00072358|Isotretinoin|isotretinoin|mesh-list
25121123|NCT00072358|Antibodies|antibodies|mesh-list
25121124|NCT00072358|Immunoglobulins|immunoglobulins|mesh-list
25121125|NCT00072358|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25121126|NCT00072358|Sargramostim|sargramostim|mesh-list
25121127|NCT00072358|Immunoglobulin G|immunoglobulin g|mesh-list
25121128|NCT00072358|Immunologic Factors|immunologic factors|mesh-ancestor
25121129|NCT00072358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121130|NCT00072358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121131|NCT00072358|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25121132|NCT00072358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25121133|NCT00072358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121134|NCT00072358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121135|NCT00072358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25121136|NCT00072358|Alkylating Agents|alkylating agents|mesh-ancestor
25121137|NCT00072358|Dermatologic Agents|dermatologic agents|mesh-ancestor
25121138|NCT00072358|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25121139|NCT00072358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25121140|NCT03104959|Acetylcysteine|acetylcysteine|mesh-list
25121141|NCT03104959|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25121142|NCT03104959|Antiviral Agents|antiviral agents|mesh-ancestor
25121143|NCT03104959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25121144|NCT03104959|Expectorants|expectorants|mesh-ancestor
24774600|NCT01846806|Rifaximin|rifaximin|mesh-list
25121145|NCT03104959|Respiratory System Agents|respiratory system agents|mesh-ancestor
25121146|NCT03104959|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25121147|NCT03104959|Antioxidants|antioxidants|mesh-ancestor
25121148|NCT03104959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121149|NCT03104959|Protective Agents|protective agents|mesh-ancestor
25121150|NCT03104959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121151|NCT03104959|Antidotes|antidotes|mesh-ancestor
25121153|NCT03104998|Coenzyme Q10|coenzyme q10|mesh-list
25121154|NCT03104998|Micronutrients|micronutrients|mesh-ancestor
25121155|NCT03104998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121156|NCT03104998|Vitamins|vitamins|mesh-ancestor
25121157|NCT03104855|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
25121159|NCT03104855|Vitamins|vitamins|mesh-ancestor
25121160|NCT03104855|Micronutrients|micronutrients|mesh-ancestor
25121161|NCT03104855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121162|NCT03104855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25121163|NCT03104621|Benzalkonium Compounds|benzalkonium compounds|mesh-list
25121169|NCT03104634|Autonomic Agents|autonomic agents|mesh-ancestor
25121170|NCT03104634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25121171|NCT03104634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121172|NCT03104634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25121173|NCT03104634|Respiratory System Agents|respiratory system agents|mesh-ancestor
25121174|NCT03104634|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25121175|NCT03104634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25121176|NCT03104634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25121177|NCT03104634|Adrenergic Agents|adrenergic agents|mesh-ancestor
25121178|NCT03104634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24614621|NCT01025466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24614622|NCT01025466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24614623|NCT01025466|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24712958|NCT01523379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24712959|NCT01523379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712960|NCT01523379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24712961|NCT01523379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24712962|NCT01523379|Analgesics|analgesics|mesh-ancestor
24712963|NCT01523379|Sensory System Agents|sensory system agents|mesh-ancestor
24712964|NCT01523379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24712965|NCT01523379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712982|NCT01523431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24712983|NCT01523431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24712984|NCT01523431|Immunologic Factors|immunologic factors|mesh-ancestor
24712985|NCT01523431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712986|NCT01523431|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24712988|NCT01523431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24713000|NCT01523548|Antimetabolites|antimetabolites|mesh-ancestor
24713005|NCT01523574|Calcium, Dietary|calcium, dietary|mesh-list
24713006|NCT01523574|Vitamin E|vitamin e|mesh-list
24713007|NCT01523574|Oxaliplatin|oxaliplatin|mesh-list
24713008|NCT01523574|Magnesium Sulfate|magnesium sulfate|mesh-list
24713009|NCT01523574|Calcium|calcium|mesh-list
24713010|NCT01523574|Vitamins|vitamins|mesh-ancestor
24713011|NCT01523574|Micronutrients|micronutrients|mesh-ancestor
24713012|NCT01523574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713013|NCT01523574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24713014|NCT01523574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24713015|NCT01523574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24713016|NCT01523574|Analgesics|analgesics|mesh-ancestor
25121180|NCT03104634|Anticonvulsants|anticonvulsants|mesh-ancestor
25121185|NCT03104426|Darbepoetin alfa|darbepoetin alfa|mesh-list
25121186|NCT03104426|Hematinics|hematinics|mesh-ancestor
25121193|NCT03104335|Apatinib|apatinib|mesh-list
25121194|NCT03104335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121195|NCT03104335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25121196|NCT03104335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24713017|NCT01523574|Sensory System Agents|sensory system agents|mesh-ancestor
24713018|NCT01523574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24713019|NCT01523574|Anesthetics|anesthetics|mesh-ancestor
24713020|NCT01523574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24713035|NCT01523678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25693363|NCT02013375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24713036|NCT01523678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24713078|NCT01524081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24713079|NCT01524081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24713080|NCT01524081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24713081|NCT01524081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24713082|NCT01524081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24713083|NCT01524081|Antifungal Agents|antifungal agents|mesh-ancestor
24713084|NCT01524081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24713085|NCT01524081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24713086|NCT01524081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24713087|NCT01524081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713088|NCT01524081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24713089|NCT01524081|Hormone Antagonists|hormone antagonists|mesh-ancestor
24713131|NCT01524354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24713132|NCT01524354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713133|NCT01524367|Dexmedetomidine|dexmedetomidine|mesh-list
24713134|NCT01524367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24713135|NCT01524367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24713136|NCT01524367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713137|NCT01524367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24713139|NCT01524367|Sensory System Agents|sensory system agents|mesh-ancestor
24713140|NCT01524367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24713141|NCT01524367|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24713142|NCT01524367|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24713143|NCT01524367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24713144|NCT01524367|Adrenergic Agents|adrenergic agents|mesh-ancestor
24713145|NCT01524367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24713146|NCT01524367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713147|NCT01524432|Clotrimazole|clotrimazole|mesh-list
24713148|NCT01524432|Miconazole|miconazole|mesh-list
24713149|NCT01524432|Antifungal Agents|antifungal agents|mesh-list
24713150|NCT01524432|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24900718|NCT04391582|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24713155|NCT01524432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713156|NCT01524432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24713162|NCT01524445|Bortezomib|bortezomib|mesh-list
24713177|NCT01524497|Antidepressive Agents|antidepressive agents|mesh-ancestor
24713178|NCT01524575|Gemcitabine|gemcitabine|mesh-list
24713179|NCT01524575|Oxaliplatin|oxaliplatin|mesh-list
24713180|NCT01524575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24713487|NCT01526174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25121197|NCT03104335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121199|NCT03104309|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25121200|NCT03104309|Contraceptive Agents|contraceptive agents|mesh-ancestor
25121201|NCT03104309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25121202|NCT03104309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121203|NCT03104309|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25121204|NCT03104309|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25121205|NCT03104309|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25121206|NCT03104140|Ketamine|ketamine|mesh-list
25121207|NCT03104140|Thiopental|thiopental|mesh-list
25121208|NCT03104140|Analgesics|analgesics|mesh-ancestor
25121209|NCT03104140|Sensory System Agents|sensory system agents|mesh-ancestor
25121210|NCT03104140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25121211|NCT03104140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121212|NCT03104140|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25121213|NCT03104140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25121214|NCT03104140|Anesthetics, General|anesthetics, general|mesh-ancestor
25121215|NCT03104140|Anesthetics|anesthetics|mesh-ancestor
25121216|NCT03104140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25121217|NCT03104140|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25121218|NCT03104140|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25121219|NCT03104140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25121220|NCT03104140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121221|NCT03104140|Anticonvulsants|anticonvulsants|mesh-ancestor
25121222|NCT03104140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25121223|NCT03104140|GABA Modulators|gaba modulators|mesh-ancestor
25121224|NCT03104140|GABA Agents|gaba agents|mesh-ancestor
24713181|NCT01524575|Antimetabolites|antimetabolites|mesh-ancestor
24713196|NCT01524601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25067459|NCT03443765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25067460|NCT03443765|Immunologic Factors|immunologic factors|mesh-ancestor
25067461|NCT03443726|Epinephrine|epinephrine|mesh-list
25067462|NCT03443726|Carticaine|carticaine|mesh-list
24713197|NCT01524601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24713198|NCT01524653|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24713199|NCT01524653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24713200|NCT01524653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24713201|NCT01524653|Antimetabolites|antimetabolites|mesh-ancestor
24713202|NCT01524653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713203|NCT01524653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24713204|NCT01524653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24713205|NCT01524653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24713206|NCT01524705|Insulin|insulin|mesh-list
24713207|NCT01524705|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24713208|NCT01524705|Metformin|metformin|mesh-list
25121226|NCT03104010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25121227|NCT03104010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121228|NCT03103893|Sirolimus|sirolimus|mesh-list
25121229|NCT03103893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25121230|NCT03103893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25121231|NCT03103893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25121232|NCT03103893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121233|NCT03103893|Antifungal Agents|antifungal agents|mesh-ancestor
25121234|NCT03103893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25121235|NCT03103893|Immunologic Factors|immunologic factors|mesh-ancestor
25121236|NCT03103893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121237|NCT03104036|Mesalamine|mesalamine|mesh-list
25121238|NCT03104036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25121239|NCT03104036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25121240|NCT03104036|Analgesics|analgesics|mesh-ancestor
24713384|NCT01525914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24713385|NCT01525914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713386|NCT01525914|Hormone Antagonists|hormone antagonists|mesh-ancestor
24713387|NCT01525914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24713388|NCT01525914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713390|NCT01525966|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24713391|NCT01525966|Carboplatin|carboplatin|mesh-list
24713392|NCT01525966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24713393|NCT01525966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24713394|NCT01525966|Tubulin Modulators|tubulin modulators|mesh-ancestor
24713400|NCT01526005|Autonomic Agents|autonomic agents|mesh-ancestor
24443314|NCT00294463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24443315|NCT00294463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24713475|NCT01526161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24713555|NCT01526525|Acetaminophen|acetaminophen|mesh-list
24713556|NCT01526525|Parecoxib|parecoxib|mesh-list
24713557|NCT01526525|Ketamine|ketamine|mesh-list
24713558|NCT01526525|Morphine|morphine|mesh-list
24713559|NCT01526525|Tramadol|tramadol|mesh-list
24713560|NCT01526525|Analgesics|analgesics|mesh-ancestor
24713561|NCT01526525|Sensory System Agents|sensory system agents|mesh-ancestor
24713562|NCT01526525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24713563|NCT01526525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713564|NCT01526525|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24713565|NCT01526525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24713566|NCT01526525|Anesthetics, General|anesthetics, general|mesh-ancestor
24713567|NCT01526525|Anesthetics|anesthetics|mesh-ancestor
24713568|NCT01526525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24713569|NCT01526525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24713570|NCT01526525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24713571|NCT01526525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24713572|NCT01526525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713573|NCT01526525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24713574|NCT01526525|Narcotics|narcotics|mesh-ancestor
24713575|NCT01526525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24713576|NCT01526525|Antipyretics|antipyretics|mesh-ancestor
25121241|NCT03104036|Sensory System Agents|sensory system agents|mesh-ancestor
25121242|NCT03104036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25121247|NCT03103867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25121248|NCT03103867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121249|NCT03103685|Clopidogrel|clopidogrel|mesh-list
25693364|NCT02013375|Antifungal Agents|antifungal agents|mesh-ancestor
25693365|NCT02013375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25693366|NCT02013531|Brexpiprazole|brexpiprazole|mesh-list
25693367|NCT02013531|Serotonin Agents|serotonin agents|mesh-ancestor
25693368|NCT02013531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24920871|NCT04197115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920872|NCT04197115|Protective Agents|protective agents|mesh-ancestor
24920874|NCT04196998|Entecavir|entecavir|mesh-list
24920875|NCT04196998|Antiviral Agents|antiviral agents|mesh-ancestor
24920876|NCT04196998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24920877|NCT04196998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24920890|NCT04196452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920891|NCT04196400|Betamethasone|betamethasone|mesh-list
24920892|NCT04196400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24920893|NCT04196400|Glucocorticoids|glucocorticoids|mesh-ancestor
24920894|NCT04196400|Hormones|hormones|mesh-ancestor
24952616|NCT03892928|Anesthetics, General|anesthetics, general|mesh-ancestor
25121250|NCT03103685|Ticagrelor|ticagrelor|mesh-list
25121251|NCT03103685|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24713577|NCT01526525|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24713578|NCT01526525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24713579|NCT01526525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24713580|NCT01526525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24713587|NCT01526564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443345|NCT00294580|Antimalarials|antimalarials|mesh-ancestor
24443346|NCT00294580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24443347|NCT00294580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24906794|NCT04337268|Hormones|hormones|mesh-ancestor
24443348|NCT00294580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24443349|NCT00294593|Leucovorin|leucovorin|mesh-list
24443350|NCT00294593|Folic Acid|folic acid|mesh-list
24443351|NCT00294593|Levoleucovorin|levoleucovorin|mesh-list
24443352|NCT00294593|Antidotes|antidotes|mesh-ancestor
24713588|NCT01526564|Nootropic Agents|nootropic agents|mesh-ancestor
24713589|NCT01526616|Metformin|metformin|mesh-list
24713590|NCT01526616|Spironolactone|spironolactone|mesh-list
24713591|NCT01526616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24713592|NCT01526616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713593|NCT01526616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24713594|NCT01526616|Hormone Antagonists|hormone antagonists|mesh-ancestor
24713595|NCT01526616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24713608|NCT01526694|Glucocorticoids|glucocorticoids|mesh-ancestor
24713609|NCT01526694|Hormones|hormones|mesh-ancestor
24713610|NCT01526694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24713611|NCT01526694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24713612|NCT01526694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24713613|NCT01526694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24713614|NCT01526694|Alkylating Agents|alkylating agents|mesh-ancestor
24614678|NCT01025778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24614679|NCT01025778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24614680|NCT01025778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24614681|NCT01025778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24614682|NCT01025778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24614683|NCT01025778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24614684|NCT01025778|Antimetabolites|antimetabolites|mesh-ancestor
24614685|NCT01025882|Gemcitabine|gemcitabine|mesh-list
24614688|NCT01025882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614689|NCT01025882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614690|NCT01025882|Antiviral Agents|antiviral agents|mesh-ancestor
24614691|NCT01025882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24614692|NCT01025882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24614693|NCT01025882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25693369|NCT02013531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693370|NCT02013531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693371|NCT02013531|Dopamine Agonists|dopamine agonists|mesh-ancestor
25693372|NCT02013531|Dopamine Agents|dopamine agents|mesh-ancestor
25693373|NCT02013544|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25693374|NCT02013544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25693375|NCT02013544|Immunologic Factors|immunologic factors|mesh-ancestor
25693376|NCT02013544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693377|NCT02013609|Brexpiprazole|brexpiprazole|mesh-list
25693378|NCT02013609|Serotonin Agents|serotonin agents|mesh-ancestor
25693379|NCT02013609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25693380|NCT02013609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693381|NCT02013609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614694|NCT01025882|Immunologic Factors|immunologic factors|mesh-ancestor
25067537|NCT03443141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067538|NCT03443141|Antioxidants|antioxidants|mesh-ancestor
25693382|NCT02013609|Dopamine Agonists|dopamine agonists|mesh-ancestor
25693383|NCT02013609|Dopamine Agents|dopamine agents|mesh-ancestor
25693384|NCT02013622|Brexpiprazole|brexpiprazole|mesh-list
25693385|NCT02013622|Serotonin Agents|serotonin agents|mesh-ancestor
25693386|NCT02013622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25693387|NCT02013622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693388|NCT02013622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693389|NCT02013622|Dopamine Agonists|dopamine agonists|mesh-ancestor
25693390|NCT02013622|Dopamine Agents|dopamine agents|mesh-ancestor
25693391|NCT02013765|Trastuzumab|trastuzumab|mesh-list
25693392|NCT02013765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24614695|NCT01025882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614697|NCT01025921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24713618|NCT01526694|Leprostatic Agents|leprostatic agents|mesh-ancestor
24713619|NCT01526694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24713620|NCT01526694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24713621|NCT01526694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24713622|NCT01526694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25121252|NCT03103685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25121253|NCT03103685|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25121254|NCT03103685|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25121256|NCT03103685|Purinergic Agents|purinergic agents|mesh-ancestor
25121257|NCT03103685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25121258|NCT03103685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121259|NCT03103685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121260|NCT03103555|Cyclophosphamide|cyclophosphamide|mesh-list
25121261|NCT03103555|Bortezomib|bortezomib|mesh-list
25121262|NCT03103555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25121263|NCT03103555|Immunologic Factors|immunologic factors|mesh-ancestor
25121264|NCT03103555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121265|NCT03103555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25121266|NCT03103555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25121267|NCT03103555|Alkylating Agents|alkylating agents|mesh-ancestor
24812825|NCT02054806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812826|NCT02054884|Paclitaxel|paclitaxel|mesh-list
25121268|NCT03103555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905270|NCT04349410|Hormones|hormones|mesh-ancestor
24713623|NCT01526694|Growth Substances|growth substances|mesh-ancestor
24812827|NCT02054884|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24713624|NCT01526694|Growth Inhibitors|growth inhibitors|mesh-ancestor
24713625|NCT01526837|Bevacizumab|bevacizumab|mesh-list
24713626|NCT01526837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24713627|NCT01526837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24713628|NCT01526837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24713629|NCT01526837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24713633|NCT01526850|Cyclosporine|cyclosporine|mesh-list
24713638|NCT01526850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24713639|NCT01526850|Immunologic Factors|immunologic factors|mesh-ancestor
24713640|NCT01526850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713641|NCT01526850|Antifungal Agents|antifungal agents|mesh-ancestor
24713642|NCT01526850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24713643|NCT01526850|Dermatologic Agents|dermatologic agents|mesh-ancestor
24713644|NCT01526850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24713645|NCT01526850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24713681|NCT01527019|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24713682|NCT01527019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24713683|NCT01527032|Thalidomide|thalidomide|mesh-list
24713684|NCT01527032|Dexamethasone|dexamethasone|mesh-list
24713686|NCT01527032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24713687|NCT01527032|Antiemetics|antiemetics|mesh-ancestor
24713688|NCT01527032|Autonomic Agents|autonomic agents|mesh-ancestor
24713689|NCT01527032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24713690|NCT01527032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713691|NCT01527032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24713692|NCT01527032|Glucocorticoids|glucocorticoids|mesh-ancestor
24713693|NCT01527032|Hormones|hormones|mesh-ancestor
24713694|NCT01527032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24713695|NCT01527032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24713696|NCT01527032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693393|NCT02013765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693394|NCT02013791|Cyclosporine|cyclosporine|mesh-list
25693395|NCT02013791|Cyclosporins|cyclosporins|mesh-list
25693396|NCT02013791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25067562|NCT03442673|Gemcitabine|gemcitabine|mesh-list
25067563|NCT03442673|Vinorelbine|vinorelbine|mesh-list
25067564|NCT03442673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25067565|NCT03442673|Antimetabolites|antimetabolites|mesh-ancestor
25067566|NCT03442673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952624|NCT03892928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25067567|NCT03442673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25067568|NCT03442673|Antiviral Agents|antiviral agents|mesh-ancestor
25067569|NCT03442673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25067570|NCT03442673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25067571|NCT03442673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25067572|NCT03442673|Immunologic Factors|immunologic factors|mesh-ancestor
25067587|NCT03442283|Vitamins|vitamins|mesh-list
24713697|NCT01527032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24713698|NCT01527032|Alkylating Agents|alkylating agents|mesh-ancestor
25121272|NCT03103412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25121273|NCT03103412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121274|NCT03103412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121275|NCT03103568|Tolbutamide|tolbutamide|mesh-list
25121276|NCT03103568|Metoprolol|metoprolol|mesh-list
25121277|NCT03103568|Furosemide|furosemide|mesh-list
25121278|NCT03103568|Chlorzoxazone|chlorzoxazone|mesh-list
25121279|NCT03103568|Nitisinone|nitisinone|mesh-list
25121280|NCT03103568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25121281|NCT03103568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24713699|NCT01527032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713700|NCT01527032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24713701|NCT01527032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24713702|NCT01527032|Immunologic Factors|immunologic factors|mesh-ancestor
24713703|NCT01527032|Leprostatic Agents|leprostatic agents|mesh-ancestor
24713704|NCT01527032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24713705|NCT01527032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24713706|NCT01527032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24713707|NCT01527032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24713720|NCT01527279|Histamine Antagonists|histamine antagonists|mesh-ancestor
24713721|NCT01527279|Histamine Agents|histamine agents|mesh-ancestor
24713722|NCT01527279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24713723|NCT01527279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713724|NCT01527279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713816|NCT01527656|Insulin Aspart|insulin aspart|mesh-list
24713817|NCT01527656|Biphasic Insulins|biphasic insulins|mesh-list
24713818|NCT01527656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24713819|NCT01527656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713820|NCT01527669|Lovastatin|lovastatin|mesh-list
24713821|NCT01527669|L 647318|l 647318|mesh-list
24713822|NCT01527669|Dihydromevinolin|dihydromevinolin|mesh-list
24713823|NCT01527669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24713824|NCT01527669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24713825|NCT01527669|Antimetabolites|antimetabolites|mesh-ancestor
24713826|NCT01527669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713827|NCT01527669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24713828|NCT01527669|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24713829|NCT01527669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24713830|NCT01527734|Tetrodotoxin|tetrodotoxin|mesh-list
24713831|NCT01527734|Anesthetics, Local|anesthetics, local|mesh-ancestor
24713860|NCT01527864|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24713861|NCT01527864|Carboplatin|carboplatin|mesh-list
24713862|NCT01527864|Endostatins|endostatins|mesh-list
25693397|NCT02013791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693398|NCT02013791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25693399|NCT02013791|Immunologic Factors|immunologic factors|mesh-ancestor
25693400|NCT02013791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693401|NCT02013791|Antifungal Agents|antifungal agents|mesh-ancestor
25693402|NCT02013791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25693403|NCT02013791|Dermatologic Agents|dermatologic agents|mesh-ancestor
25693404|NCT02013791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25693405|NCT02013791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25709258|NCT02263547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709259|NCT02263547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25709260|NCT02263547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24713863|NCT01527864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24713864|NCT01527864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24713865|NCT01527864|Tubulin Modulators|tubulin modulators|mesh-ancestor
24713866|NCT01527864|Antimitotic Agents|antimitotic agents|mesh-ancestor
24713867|NCT01527864|Mitosis Modulators|mitosis modulators|mesh-ancestor
24713868|NCT01527864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713869|NCT01527864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24713870|NCT01527864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24713871|NCT01527864|Growth Substances|growth substances|mesh-ancestor
24713872|NCT01527864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121285|NCT03103568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121286|NCT03103568|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25121287|NCT03103568|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25121288|NCT03103568|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25121290|NCT03103568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24905375|NCT04348006|Growth Substances|growth substances|mesh-ancestor
24713873|NCT01527864|Growth Inhibitors|growth inhibitors|mesh-ancestor
24614732|NCT01026116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24614733|NCT01026116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24614734|NCT01026116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24614736|NCT01026129|Remifentanil|remifentanil|mesh-list
24614737|NCT01026129|Anesthetics, Local|anesthetics, local|mesh-ancestor
24614738|NCT01026129|Anesthetics|anesthetics|mesh-ancestor
24645606|NCT01198860|Protective Agents|protective agents|mesh-ancestor
24713906|NCT01527968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713908|NCT01527968|Coagulants|coagulants|mesh-ancestor
24713909|NCT01527994|Aprepitant|aprepitant|mesh-list
24713910|NCT01527994|Antiemetics|antiemetics|mesh-ancestor
24713911|NCT01527994|Autonomic Agents|autonomic agents|mesh-ancestor
24713912|NCT01527994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24713913|NCT01527994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713914|NCT01527994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24713915|NCT01527994|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24713916|NCT01527994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24713917|NCT01527994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713968|NCT01528501|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24713969|NCT01528501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24713970|NCT01528501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714042|NCT01528852|Disinfectants|disinfectants|mesh-ancestor
24714043|NCT01528852|Dermatologic Agents|dermatologic agents|mesh-ancestor
24714044|NCT01528865|Tenofovir|tenofovir|mesh-list
24714045|NCT01528865|Lamivudine|lamivudine|mesh-list
24714046|NCT01528865|Antiviral Agents|antiviral agents|mesh-ancestor
24714047|NCT01528865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714048|NCT01528865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24714049|NCT01528865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24714050|NCT01528865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24714051|NCT01528865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714052|NCT01528865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24714053|NCT01528865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24714054|NCT01528930|Amikacin|amikacin|mesh-list
24714055|NCT01528930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24714056|NCT01528930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714057|NCT01528943|Epoprostenol|epoprostenol|mesh-list
24714058|NCT01528943|Tezosentan|tezosentan|mesh-list
24714059|NCT01528943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24714061|NCT01528943|Vasodilator Agents|vasodilator agents|mesh-ancestor
24714097|NCT01529164|Antimetabolites|antimetabolites|mesh-ancestor
24714098|NCT01529164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714099|NCT01529164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24714100|NCT01529164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24714101|NCT01529164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24714102|NCT01529164|Immunologic Factors|immunologic factors|mesh-ancestor
24905385|NCT04347733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905387|NCT04347733|Immunologic Factors|immunologic factors|mesh-ancestor
24905388|NCT04347733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121291|NCT03103568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121292|NCT03103568|Diuretics|diuretics|mesh-ancestor
25121293|NCT03103568|Natriuretic Agents|natriuretic agents|mesh-ancestor
25121294|NCT03103568|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25121295|NCT03103568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25693406|NCT02013817|Cyclophosphamide|cyclophosphamide|mesh-list
25693407|NCT02013817|Rituximab|rituximab|mesh-list
24621572|NCT01063101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24621573|NCT01063101|Anticoagulants|anticoagulants|mesh-ancestor
24621574|NCT01063101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24621575|NCT01063127|Insulin|insulin|mesh-list
24537796|NCT00656214|Protective Agents|protective agents|mesh-ancestor
24621576|NCT01063127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24621577|NCT01063127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496474|NCT00504946|Vitamins|vitamins|mesh-ancestor
24496475|NCT00504946|Micronutrients|micronutrients|mesh-ancestor
25121296|NCT03103568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25121297|NCT03103568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121298|NCT03103568|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25121299|NCT03103568|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25121300|NCT03103451|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25121301|NCT03103451|Immunologic Factors|immunologic factors|mesh-ancestor
25121302|NCT03103451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121303|NCT03103646|Itraconazole|itraconazole|mesh-list
25121304|NCT03103646|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
25121305|NCT03103646|Antifungal Agents|antifungal agents|mesh-ancestor
25121306|NCT03103646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25121307|NCT03103646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25121308|NCT03103646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25121309|NCT03103646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121310|NCT03103646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121311|NCT03103646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25121312|NCT03103646|Hormone Antagonists|hormone antagonists|mesh-ancestor
25121313|NCT03103646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25121314|NCT03103646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714103|NCT01529164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714104|NCT01529164|Antidotes|antidotes|mesh-ancestor
24714253|NCT01529541|Protease Inhibitors|protease inhibitors|mesh-ancestor
24714254|NCT01529541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24714255|NCT01529541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500655|NCT00525408|Docetaxel|docetaxel|mesh-list
24714256|NCT01529554|Everolimus|everolimus|mesh-list
24714345|NCT01530217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24714346|NCT01530217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714347|NCT01530217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24714348|NCT01530217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24714349|NCT01530217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24714350|NCT01530217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121317|NCT03103204|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25121318|NCT03103204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25121319|NCT03103204|Disinfectants|disinfectants|mesh-ancestor
25121321|NCT03103399|Carbidopa|carbidopa|mesh-list
25121322|NCT03103399|Entacapone|entacapone|mesh-list
25121323|NCT03103399|Benserazide|benserazide|mesh-list
25121324|NCT03103399|Dopa Decarboxylase|dopa decarboxylase|mesh-list
24905445|NCT04347720|Ibuprofen|ibuprofen|mesh-list
24714351|NCT01530217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714353|NCT01530230|Oxytocics|oxytocics|mesh-ancestor
24714354|NCT01530230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24714355|NCT01530230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714356|NCT01530295|Docetaxel|docetaxel|mesh-list
24714357|NCT01530295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24714358|NCT01530295|Tubulin Modulators|tubulin modulators|mesh-ancestor
24714433|NCT01530594|Immunologic Factors|immunologic factors|mesh-ancestor
24714434|NCT01530594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714435|NCT01530594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24714436|NCT01530594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24714437|NCT01530594|Growth Substances|growth substances|mesh-ancestor
24714438|NCT01530594|Growth Inhibitors|growth inhibitors|mesh-ancestor
24714439|NCT01530594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693408|NCT02013817|Fludarabine|fludarabine|mesh-list
25693409|NCT02013817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25693410|NCT02013817|Immunologic Factors|immunologic factors|mesh-ancestor
25693411|NCT02013817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693412|NCT02013817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25693413|NCT02013817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25693414|NCT02013817|Alkylating Agents|alkylating agents|mesh-ancestor
25693415|NCT02013817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693416|NCT02013817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693417|NCT02013817|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25693418|NCT02013817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24522656|NCT03491059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24522657|NCT03491059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522658|NCT03491059|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24522659|NCT03491059|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24522661|NCT03491059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24522662|NCT03491059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714440|NCT01530607|Cyclophosphamide|cyclophosphamide|mesh-list
24714442|NCT01530607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24714444|NCT01530607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714445|NCT01530607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24500857|NCT00525993|Etoricoxib|etoricoxib|mesh-list
24714482|NCT01530763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24714483|NCT01530763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714487|NCT01530815|Bupivacaine|bupivacaine|mesh-list
24714488|NCT01530815|Anesthetics, Local|anesthetics, local|mesh-ancestor
24714489|NCT01530815|Anesthetics|anesthetics|mesh-ancestor
24714490|NCT01530815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24714491|NCT01530815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714492|NCT01530815|Sensory System Agents|sensory system agents|mesh-ancestor
24714493|NCT01530815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24714494|NCT01530984|Ipilimumab|ipilimumab|mesh-list
24714495|NCT01530984|Sargramostim|sargramostim|mesh-list
24714496|NCT01530984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24714497|NCT01530984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24714498|NCT01530984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24714499|NCT01530984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714567|NCT01531309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24714568|NCT01531309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714569|NCT01531322|Vaccines|vaccines|mesh-list
24714570|NCT01531322|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24714571|NCT01531322|Immunologic Factors|immunologic factors|mesh-ancestor
24443410|NCT00294892|Antiviral Agents|antiviral agents|mesh-ancestor
24443413|NCT00294892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24443414|NCT00294892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24443415|NCT00294892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24443416|NCT00294892|Anticonvulsants|anticonvulsants|mesh-ancestor
24443417|NCT00294892|Antimanic Agents|antimanic agents|mesh-ancestor
24443418|NCT00294892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24443419|NCT00294892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24443420|NCT00294892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443421|NCT00294892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24714648|NCT01531764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24714649|NCT01531764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24714650|NCT01531764|Tubulin Modulators|tubulin modulators|mesh-ancestor
25121327|NCT03103399|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25121328|NCT03103399|Dopamine Agents|dopamine agents|mesh-ancestor
25121329|NCT03103399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25121330|NCT03103399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121331|NCT03103399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121332|NCT03103399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121333|NCT03103399|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25121334|NCT03103334|Methotrexate|methotrexate|mesh-list
25121335|NCT03103334|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25121336|NCT03103334|Abortifacient Agents|abortifacient agents|mesh-ancestor
25121337|NCT03103334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25121338|NCT03103334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121339|NCT03103334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25121340|NCT03103334|Antimetabolites|antimetabolites|mesh-ancestor
24714699|NCT01532011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24714700|NCT01532011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24714701|NCT01532011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693419|NCT02013830|Bevacizumab|bevacizumab|mesh-list
25693420|NCT02013830|Capecitabine|capecitabine|mesh-list
25693421|NCT02013830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25693422|NCT02013830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693423|NCT02013830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25693424|NCT02013830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25693425|NCT02013830|Growth Substances|growth substances|mesh-ancestor
24921312|NCT04192643|Tranexamic Acid|tranexamic acid|mesh-list
24921313|NCT04192643|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24921314|NCT04192643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24714702|NCT01532076|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24714755|NCT01532544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24714756|NCT01532674|Anti-Infective Agents|anti-infective agents|mesh-list
24714757|NCT01532674|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24714758|NCT01532726|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
24714759|NCT01532726|Anticonvulsants|anticonvulsants|mesh-ancestor
24714760|NCT01532726|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24714761|NCT01532726|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24714762|NCT01532726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24714804|NCT01532856|Hormones|hormones|mesh-ancestor
24714816|NCT01532895|Hydromorphone|hydromorphone|mesh-list
24714817|NCT01532895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24714818|NCT01532895|Narcotics|narcotics|mesh-ancestor
24856138|NCT02282956|Ropivacaine|ropivacaine|mesh-list
24856194|NCT02283177|Idarubicin|idarubicin|mesh-list
24856195|NCT02283177|Crenolanib|crenolanib|mesh-list
24612305|NCT01013454|Varenicline|varenicline|mesh-list
24714819|NCT01532895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24714820|NCT01532895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714821|NCT01532895|Analgesics|analgesics|mesh-ancestor
24714822|NCT01532895|Sensory System Agents|sensory system agents|mesh-ancestor
24714903|NCT01533324|Leucovorin|leucovorin|mesh-list
24714922|NCT01533376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24714924|NCT01533389|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24714925|NCT01533389|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24714926|NCT01533389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24714927|NCT01533389|Adrenergic Agents|adrenergic agents|mesh-ancestor
24714928|NCT01533389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24714929|NCT01533389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714930|NCT01533389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714931|NCT01533389|Urological Agents|urological agents|mesh-ancestor
24714932|NCT01533441|Vitamin K|vitamin k|mesh-list
24714933|NCT01533441|Vitamin K 2|vitamin k 2|mesh-list
24714934|NCT01533441|Vitamins|vitamins|mesh-ancestor
24714935|NCT01533441|Micronutrients|micronutrients|mesh-ancestor
24714936|NCT01533441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714937|NCT01533441|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24714938|NCT01533441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25121341|NCT03103334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121342|NCT03103334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121343|NCT03103334|Dermatologic Agents|dermatologic agents|mesh-ancestor
25121344|NCT03103334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121345|NCT03103334|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25121346|NCT03103334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25121347|NCT03103334|Immunologic Factors|immunologic factors|mesh-ancestor
25121348|NCT03103334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25121349|NCT03103334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25121351|NCT03103152|Vitamin D|vitamin d|mesh-list
25121352|NCT03103152|Ergocalciferols|ergocalciferols|mesh-list
25121353|NCT03103152|Cholecalciferol|cholecalciferol|mesh-list
25121354|NCT03103152|Vitamins|vitamins|mesh-list
25121355|NCT03103152|Micronutrients|micronutrients|mesh-ancestor
25121356|NCT03103152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121357|NCT03103152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25121358|NCT03103152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24714939|NCT01533441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714940|NCT01533441|Hemostatics|hemostatics|mesh-ancestor
24501375|NCT00528359|Olanzapine|olanzapine|mesh-list
24714941|NCT01533441|Coagulants|coagulants|mesh-ancestor
24714942|NCT01533506|Stiripentol|stiripentol|mesh-list
24714943|NCT01533506|Anticonvulsants|anticonvulsants|mesh-ancestor
24714945|NCT01533545|Mepivacaine|mepivacaine|mesh-list
24714988|NCT01533675|Hydrogen Peroxide|hydrogen peroxide|mesh-list
24714989|NCT01533675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24714990|NCT01533675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714991|NCT01533740|Leucovorin|leucovorin|mesh-list
25693426|NCT02013830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693427|NCT02013830|Growth Inhibitors|growth inhibitors|mesh-ancestor
25693428|NCT02013830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24714992|NCT01533740|Folic Acid|folic acid|mesh-list
24714993|NCT01533740|Bevacizumab|bevacizumab|mesh-list
24714994|NCT01533740|Fluorouracil|fluorouracil|mesh-list
24714995|NCT01533740|Irinotecan|irinotecan|mesh-list
24714996|NCT01533740|Levoleucovorin|levoleucovorin|mesh-list
24714997|NCT01533740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25693429|NCT02013830|Antimetabolites|antimetabolites|mesh-ancestor
24921387|NCT04192331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24522667|NCT03421756|Sirolimus|sirolimus|mesh-list
24522668|NCT03421756|Alemtuzumab|alemtuzumab|mesh-list
24522669|NCT03421756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24496756|NCT00506571|Oxaliplatin|oxaliplatin|mesh-list
24496757|NCT00506571|Irinotecan|irinotecan|mesh-list
24714998|NCT01533740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24714999|NCT01533740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24715000|NCT01533740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24614796|NCT01026363|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24614798|NCT01026376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24614799|NCT01026376|Antimetabolites|antimetabolites|mesh-ancestor
24614800|NCT01026376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614801|NCT01026376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614803|NCT01026415|Rifampin|rifampin|mesh-list
24715138|NCT01534754|Mesalamine|mesalamine|mesh-list
24715139|NCT01534754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24715140|NCT01534754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24715141|NCT01534754|Analgesics|analgesics|mesh-ancestor
24715142|NCT01534754|Sensory System Agents|sensory system agents|mesh-ancestor
24715143|NCT01534754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24715144|NCT01534754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715219|NCT01535157|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24715220|NCT01535157|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24715221|NCT01535157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715222|NCT01535157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715223|NCT01535157|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25121359|NCT03103152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25121360|NCT03103152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25121361|NCT03103152|Analgesics|analgesics|mesh-ancestor
25121362|NCT03103152|Sensory System Agents|sensory system agents|mesh-ancestor
25121363|NCT03103152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25121364|NCT03103152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24715224|NCT01535157|Hormone Antagonists|hormone antagonists|mesh-ancestor
24715226|NCT01535157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715236|NCT01535183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715237|NCT01535183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715238|NCT01535183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715239|NCT01535417|Celecoxib|celecoxib|mesh-list
24715240|NCT01535417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24715241|NCT01535417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24715242|NCT01535417|Analgesics|analgesics|mesh-ancestor
24715243|NCT01535417|Sensory System Agents|sensory system agents|mesh-ancestor
24715244|NCT01535417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24715245|NCT01535417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715246|NCT01535417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24715286|NCT01535612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24715287|NCT01535612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715288|NCT01535677|Metformin|metformin|mesh-list
24715289|NCT01535677|Dapagliflozin|dapagliflozin|mesh-list
24715290|NCT01535677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24715291|NCT01535677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715292|NCT01535677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24715293|NCT01535677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715379|NCT01536158|Ibuprofen|ibuprofen|mesh-list
24715380|NCT01536158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24715381|NCT01536158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25693430|NCT02013830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693431|NCT02014363|Amitriptyline|amitriptyline|mesh-list
25693432|NCT02014363|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25693433|NCT02014363|Antidepressive Agents|antidepressive agents|mesh-ancestor
25693434|NCT02014363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25693435|NCT02014363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25693436|NCT02014363|Analgesics|analgesics|mesh-ancestor
25693437|NCT02014363|Sensory System Agents|sensory system agents|mesh-ancestor
25693438|NCT02014363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25693439|NCT02014363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693440|NCT02014363|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25693441|NCT02014363|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24622369|NCT01066728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24622370|NCT01066754|Fexofenadine|fexofenadine|mesh-list
24622371|NCT01066754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24715382|NCT01536158|Analgesics|analgesics|mesh-ancestor
24715391|NCT01536158|Antipyretics|antipyretics|mesh-ancestor
24715436|NCT01536314|Dopamine Agents|dopamine agents|mesh-ancestor
24614835|NCT01026415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24614836|NCT01026415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614837|NCT01026415|Immunologic Factors|immunologic factors|mesh-ancestor
24614838|NCT01026415|Antifungal Agents|antifungal agents|mesh-ancestor
24614839|NCT01026415|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24614840|NCT01026415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24614841|NCT01026415|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24614842|NCT01026415|Hormone Antagonists|hormone antagonists|mesh-ancestor
24715484|NCT01536665|Liraglutide|liraglutide|mesh-list
24715485|NCT01536665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24715486|NCT01536665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715487|NCT01536665|Incretins|incretins|mesh-ancestor
24715489|NCT01536665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24715490|NCT01536691|Ondansetron|ondansetron|mesh-list
24715491|NCT01536691|Aprepitant|aprepitant|mesh-list
24715492|NCT01536691|Fosaprepitant|fosaprepitant|mesh-list
24715493|NCT01536691|Ramosetron|ramosetron|mesh-list
24715494|NCT01536691|Antiemetics|antiemetics|mesh-ancestor
24715495|NCT01536691|Autonomic Agents|autonomic agents|mesh-ancestor
25121365|NCT03103152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25121366|NCT03103152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25121367|NCT03103152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25121368|NCT03103152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121369|NCT03103152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25121370|NCT03103152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25121371|NCT03103152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121372|NCT03103152|Antipyretics|antipyretics|mesh-ancestor
25121373|NCT03103074|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
25121374|NCT03103074|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25121375|NCT03103074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25121376|NCT03103074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25121377|NCT03103074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121378|NCT03103074|Cholinergic Agents|cholinergic agents|mesh-ancestor
25121379|NCT03103074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25121380|NCT03103074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121381|NCT03102892|Anti-Infective Agents|anti-infective agents|mesh-list
25121382|NCT03102892|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25121383|NCT03103009|Pasireotide|pasireotide|mesh-list
25121384|NCT03103009|Hormones|hormones|mesh-ancestor
25121385|NCT03103009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24622048|NCT01065285|Vaccines|vaccines|mesh-list
25121386|NCT03103009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121388|NCT03103022|Ibuprofen|ibuprofen|mesh-list
25121389|NCT03103022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25121390|NCT03103022|Analgesics|analgesics|mesh-ancestor
25121391|NCT03103022|Sensory System Agents|sensory system agents|mesh-ancestor
25121424|NCT03102359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121425|NCT03102398|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
25121426|NCT03102398|Vasodilator Agents|vasodilator agents|mesh-ancestor
25121427|NCT03102398|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24715496|NCT01536691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24900719|NCT04391621|Triamcinolone|triamcinolone|mesh-list
24856278|NCT02283476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24856279|NCT02283476|Growth Substances|growth substances|mesh-ancestor
24856280|NCT02283476|Growth Inhibitors|growth inhibitors|mesh-ancestor
24856281|NCT02283489|Paclitaxel|paclitaxel|mesh-list
24856282|NCT02283489|Endostatins|endostatins|mesh-list
24715497|NCT01536691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715498|NCT01536691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24715508|NCT01536691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24715509|NCT01536691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24715510|NCT01536691|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24715511|NCT01536717|Carticaine|carticaine|mesh-list
24715512|NCT01536717|Anesthetics, Local|anesthetics, local|mesh-ancestor
25693442|NCT02014363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25693443|NCT02014363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715513|NCT01536717|Anesthetics|anesthetics|mesh-ancestor
24715514|NCT01536717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25121428|NCT03102398|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24921524|NCT04190004|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24921525|NCT04190004|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25067801|NCT03438955|Telmisartan|telmisartan|mesh-list
25121429|NCT03102398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121430|NCT03102398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121431|NCT03102398|Urological Agents|urological agents|mesh-ancestor
24627858|NCT01095172|Hormones|hormones|mesh-ancestor
25121432|NCT03101995|Gemcitabine|gemcitabine|mesh-list
25121433|NCT03101995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25121434|NCT03101995|Antimetabolites|antimetabolites|mesh-ancestor
25121435|NCT03101995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121436|NCT03101995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121437|NCT03101995|Antiviral Agents|antiviral agents|mesh-ancestor
25121438|NCT03101995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25121439|NCT03101995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121440|NCT03101995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24715516|NCT01536717|Sensory System Agents|sensory system agents|mesh-ancestor
24715517|NCT01536717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25121463|NCT03101800|Antimetabolites|antimetabolites|mesh-ancestor
25121464|NCT03101800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121465|NCT03101800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907357|NCT04330872|Aspirin|aspirin|mesh-list
25121466|NCT03101800|Gout Suppressants|gout suppressants|mesh-ancestor
25121467|NCT03101800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25121468|NCT03101800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25121469|NCT03101800|Antioxidants|antioxidants|mesh-ancestor
25121470|NCT03101800|Protective Agents|protective agents|mesh-ancestor
25121471|NCT03101800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856283|NCT02283489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24812885|NCT02055079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24812886|NCT02055079|Immunologic Factors|immunologic factors|mesh-ancestor
24812887|NCT02055079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121472|NCT03101800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25121473|NCT03101800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121474|NCT03101800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25121475|NCT03101800|Immunologic Factors|immunologic factors|mesh-ancestor
25121476|NCT03101735|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25121477|NCT03101735|Dermatologic Agents|dermatologic agents|mesh-ancestor
25121478|NCT03101735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25121479|NCT03101735|Immunologic Factors|immunologic factors|mesh-ancestor
25121519|NCT03101709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121520|NCT03101709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121521|NCT03101709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25121530|NCT03101319|Vitamin D|vitamin d|mesh-list
25121531|NCT03101319|Cholecalciferol|cholecalciferol|mesh-list
25121532|NCT03101319|Vitamins|vitamins|mesh-ancestor
25121533|NCT03101319|Micronutrients|micronutrients|mesh-ancestor
25121534|NCT03101319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121535|NCT03101319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25121536|NCT03101319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25121537|NCT03101280|Atezolizumab|atezolizumab|mesh-list
25121538|NCT03101280|Rucaparib|rucaparib|mesh-list
25121539|NCT03101280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121540|NCT03101280|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25121541|NCT03101280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121542|NCT03101280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121543|NCT03101644|Darunavir|darunavir|mesh-list
25121544|NCT03101644|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25121545|NCT03101644|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25121546|NCT03101644|Protease Inhibitors|protease inhibitors|mesh-ancestor
25121547|NCT03101644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121548|NCT03101644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121549|NCT03101644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25121550|NCT03101644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25121551|NCT03101644|Antiviral Agents|antiviral agents|mesh-ancestor
25121552|NCT03101644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25121553|NCT03101072|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25121554|NCT03101072|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25121557|NCT03100955|Cisplatin|cisplatin|mesh-list
25121558|NCT03100955|Etoposide|etoposide|mesh-list
25121559|NCT03100955|Etoposide phosphate|etoposide phosphate|mesh-list
25121560|NCT03100955|Apatinib|apatinib|mesh-list
25121561|NCT03100955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626491|NCT01087580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25693444|NCT02014363|Adrenergic Agents|adrenergic agents|mesh-ancestor
25693445|NCT02014363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25693446|NCT02014402|Thrombin|thrombin|mesh-list
25693447|NCT02014402|Hemostatics|hemostatics|mesh-ancestor
24715519|NCT01536743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715520|NCT01536743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24715521|NCT01536743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715523|NCT01536873|Dolutegravir|dolutegravir|mesh-list
24715563|NCT01537107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715564|NCT01537107|Antifungal Agents|antifungal agents|mesh-ancestor
24715565|NCT01537107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24715566|NCT01537107|Immunologic Factors|immunologic factors|mesh-ancestor
24715567|NCT01537107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715568|NCT01537107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24715569|NCT01537107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715570|NCT01537146|Ropivacaine|ropivacaine|mesh-list
24715571|NCT01537146|Anesthetics, Local|anesthetics, local|mesh-ancestor
24715572|NCT01537146|Anesthetics|anesthetics|mesh-ancestor
24715573|NCT01537146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24715652|NCT01537861|Cyclophosphamide|cyclophosphamide|mesh-list
24715653|NCT01537861|Lenalidomide|lenalidomide|mesh-list
24715655|NCT01537861|Pomalidomide|pomalidomide|mesh-list
24715656|NCT01537861|Lenograstim|lenograstim|mesh-list
24715662|NCT01537861|Alkylating Agents|alkylating agents|mesh-ancestor
24420595|NCT00216411|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24715663|NCT01537861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715664|NCT01537861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715665|NCT01537861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24715666|NCT01537861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24715668|NCT01537861|Autonomic Agents|autonomic agents|mesh-ancestor
24715669|NCT01537861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24715670|NCT01537861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24715671|NCT01537861|Glucocorticoids|glucocorticoids|mesh-ancestor
24715672|NCT01537861|Hormones|hormones|mesh-ancestor
24614914|NCT01026714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24614915|NCT01026714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24614916|NCT01026714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24614917|NCT01026714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24614918|NCT01026714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24614919|NCT01026714|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24715678|NCT01537861|Growth Substances|growth substances|mesh-ancestor
24715679|NCT01537861|Growth Inhibitors|growth inhibitors|mesh-ancestor
24715680|NCT01537861|Leprostatic Agents|leprostatic agents|mesh-ancestor
24715754|NCT01538446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715755|NCT01538446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715756|NCT01538459|Dexamethasone|dexamethasone|mesh-list
24715757|NCT01538459|Bupivacaine|bupivacaine|mesh-list
24715758|NCT01538459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24715759|NCT01538459|Antiemetics|antiemetics|mesh-ancestor
24715760|NCT01538459|Autonomic Agents|autonomic agents|mesh-ancestor
24715761|NCT01538459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24715762|NCT01538459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715763|NCT01538459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24715764|NCT01538459|Glucocorticoids|glucocorticoids|mesh-ancestor
24715766|NCT01538459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24715767|NCT01538459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24715768|NCT01538459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715769|NCT01538459|Anesthetics, Local|anesthetics, local|mesh-ancestor
24715770|NCT01538459|Anesthetics|anesthetics|mesh-ancestor
24715771|NCT01538459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24715774|NCT01538485|Vitamin D|vitamin d|mesh-list
24614949|NCT01026961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24614950|NCT01026961|Protective Agents|protective agents|mesh-ancestor
24715817|NCT01538641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24715818|NCT01538641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443574|NCT00295425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24715819|NCT01538641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24715821|NCT01538667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24715822|NCT01538667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24715823|NCT01538667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25121562|NCT03100955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25121563|NCT03100955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25121564|NCT03100955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25121565|NCT03100955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121566|NCT03100955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121567|NCT03100955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24856333|NCT02283775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24856334|NCT02283775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24622780|NCT01068405|Methotrexate|methotrexate|mesh-list
24622781|NCT01068405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24856335|NCT02283775|Growth Substances|growth substances|mesh-ancestor
24856336|NCT02283775|Growth Inhibitors|growth inhibitors|mesh-ancestor
24856337|NCT02283801|Lamotrigine|lamotrigine|mesh-list
24856338|NCT02283801|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
24856339|NCT02283801|Anticonvulsants|anticonvulsants|mesh-ancestor
25121569|NCT03101137|Bupivacaine|bupivacaine|mesh-list
25121570|NCT03101137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25121571|NCT03101137|Antiemetics|antiemetics|mesh-ancestor
25121572|NCT03101137|Autonomic Agents|autonomic agents|mesh-ancestor
25121573|NCT03101137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25121574|NCT03101137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121575|NCT03101137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25121576|NCT03101137|Glucocorticoids|glucocorticoids|mesh-ancestor
25121577|NCT03101137|Hormones|hormones|mesh-ancestor
25121578|NCT03101137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25121579|NCT03101137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25121580|NCT03101137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715824|NCT01538667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24715825|NCT01538667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715826|NCT01538667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715827|NCT01538667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715828|NCT01538667|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24715829|NCT01538667|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24715830|NCT01538693|Cyproheptadine|cyproheptadine|mesh-list
24715889|NCT01538875|Sympathomimetics|sympathomimetics|mesh-ancestor
24715890|NCT01538875|Autonomic Agents|autonomic agents|mesh-ancestor
24715891|NCT01538875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24715892|NCT01538875|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24715893|NCT01538875|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24715894|NCT01538875|Vasodilator Agents|vasodilator agents|mesh-ancestor
24715896|NCT01538901|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24715897|NCT01538901|Immunologic Factors|immunologic factors|mesh-ancestor
24548457|NCT00709553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24715956|NCT01539174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24715957|NCT01539174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24715958|NCT01539174|Alkylating Agents|alkylating agents|mesh-ancestor
24715971|NCT01539174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24715972|NCT01539174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24715973|NCT01539174|Tubulin Modulators|tubulin modulators|mesh-ancestor
24715974|NCT01539174|Antimitotic Agents|antimitotic agents|mesh-ancestor
24715975|NCT01539174|Mitosis Modulators|mitosis modulators|mesh-ancestor
24715977|NCT01539265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24715978|NCT01539265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24715979|NCT01539265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24715980|NCT01539265|Adrenergic Agents|adrenergic agents|mesh-ancestor
24715981|NCT01539265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24715982|NCT01539265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715983|NCT01539265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715984|NCT01539265|Urological Agents|urological agents|mesh-ancestor
24715985|NCT01539330|Voriconazole|voriconazole|mesh-list
24715986|NCT01539330|Antifungal Agents|antifungal agents|mesh-ancestor
25121581|NCT03101137|Anesthetics, Local|anesthetics, local|mesh-ancestor
25121583|NCT03101137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25121584|NCT03101137|Sensory System Agents|sensory system agents|mesh-ancestor
25121585|NCT03101085|Equol|equol|mesh-list
25121586|NCT03101085|Phytoestrogens|phytoestrogens|mesh-ancestor
25121587|NCT03101085|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25121588|NCT03101085|Estrogens|estrogens|mesh-ancestor
25121589|NCT03101085|Hormones|hormones|mesh-ancestor
25121590|NCT03101085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25121591|NCT03101085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121592|NCT03101124|Tranexamic Acid|tranexamic acid|mesh-list
24626504|NCT01087593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715987|NCT01539330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24715988|NCT01539330|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24715989|NCT01539330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24715990|NCT01539330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716238|NCT01540747|Protective Agents|protective agents|mesh-ancestor
24715991|NCT01539330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693448|NCT02014402|Coagulants|coagulants|mesh-ancestor
25693449|NCT02014441|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
24715992|NCT01539330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24715993|NCT01539330|Hormone Antagonists|hormone antagonists|mesh-ancestor
24716018|NCT01539473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24716019|NCT01539473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716020|NCT01539473|Adrenergic Agents|adrenergic agents|mesh-ancestor
24716021|NCT01539473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24716022|NCT01539564|Minocycline|minocycline|mesh-list
24716023|NCT01539564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24716024|NCT01539564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24716025|NCT01539577|Dexamethasone|dexamethasone|mesh-list
24716026|NCT01539577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24716027|NCT01539577|Antiemetics|antiemetics|mesh-ancestor
24716028|NCT01539577|Autonomic Agents|autonomic agents|mesh-ancestor
24716029|NCT01539577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24716030|NCT01539577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716031|NCT01539577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24716032|NCT01539577|Glucocorticoids|glucocorticoids|mesh-ancestor
24716034|NCT01539577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24716035|NCT01539577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24716036|NCT01539577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24716037|NCT01539603|Sirolimus|sirolimus|mesh-list
24716038|NCT01539603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24716039|NCT01539603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24716040|NCT01539603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24716041|NCT01539603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121604|NCT03100994|Anesthetics, Local|anesthetics, local|mesh-ancestor
25121605|NCT03100994|Anesthetics|anesthetics|mesh-ancestor
25121606|NCT03100994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25121607|NCT03100994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121608|NCT03100994|Sensory System Agents|sensory system agents|mesh-ancestor
25121609|NCT03100994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25121610|NCT03100877|Cyclophosphamide|cyclophosphamide|mesh-list
25121611|NCT03100877|Melphalan|melphalan|mesh-list
25121612|NCT03100877|Mechlorethamine|mechlorethamine|mesh-list
25121613|NCT03100877|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25121614|NCT03100877|Lenalidomide|lenalidomide|mesh-list
25121615|NCT03100877|Lenograstim|lenograstim|mesh-list
25121616|NCT03100877|Mitogens|mitogens|mesh-list
25121617|NCT03100877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25121618|NCT03100877|Immunologic Factors|immunologic factors|mesh-ancestor
25121619|NCT03100877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121620|NCT03100877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25121621|NCT03100877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25121622|NCT03100877|Alkylating Agents|alkylating agents|mesh-ancestor
25121623|NCT03100877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121624|NCT03100877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121625|NCT03100877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25121626|NCT03100877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25121627|NCT03100877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24716042|NCT01539603|Antifungal Agents|antifungal agents|mesh-ancestor
24716043|NCT01539603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24614952|NCT01026961|Dermatologic Agents|dermatologic agents|mesh-ancestor
24614953|NCT01026961|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24614954|NCT01026961|Histamine Antagonists|histamine antagonists|mesh-ancestor
24614955|NCT01026961|Histamine Agents|histamine agents|mesh-ancestor
24614973|NCT01027117|Vasodilator Agents|vasodilator agents|mesh-ancestor
24614974|NCT01027117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24614975|NCT01027117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24614996|NCT01027429|Procaine|procaine|mesh-list
24615007|NCT01027429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24615008|NCT01027481|Ranibizumab|ranibizumab|mesh-list
25121628|NCT03100877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25121629|NCT03100877|Growth Substances|growth substances|mesh-ancestor
25121630|NCT03100877|Growth Inhibitors|growth inhibitors|mesh-ancestor
25121631|NCT03100877|Mitosis Modulators|mitosis modulators|mesh-ancestor
25121632|NCT03100604|Sevoflurane|sevoflurane|mesh-list
25121633|NCT03100604|Desflurane|desflurane|mesh-list
25121634|NCT03100604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25121635|NCT03100604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25121636|NCT03100604|Anesthetics, General|anesthetics, general|mesh-ancestor
25121637|NCT03100604|Anesthetics|anesthetics|mesh-ancestor
25121638|NCT03100604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25121639|NCT03100604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121640|NCT03100513|Lactulose|lactulose|mesh-list
25121641|NCT03100513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25121642|NCT03100734|Etanercept|etanercept|mesh-list
24522810|NCT03110822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522811|NCT03110822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24921920|NCT04185233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24921921|NCT04185233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921922|NCT04185233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24921924|NCT04185233|Sensory System Agents|sensory system agents|mesh-ancestor
24921925|NCT04185233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24921931|NCT04184947|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
24921932|NCT04184947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921933|NCT04184947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25067892|NCT03437902|Micronutrients|micronutrients|mesh-ancestor
25067893|NCT03437902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067894|NCT03437902|Antioxidants|antioxidants|mesh-ancestor
25067895|NCT03437902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067896|NCT03437902|Protective Agents|protective agents|mesh-ancestor
25067897|NCT03437824|Vitamin B 12|vitamin b 12|mesh-list
25067898|NCT03437824|Hydroxocobalamin|hydroxocobalamin|mesh-list
25121643|NCT03100734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25121644|NCT03100734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25121645|NCT03100734|Analgesics|analgesics|mesh-ancestor
25121646|NCT03100734|Sensory System Agents|sensory system agents|mesh-ancestor
25121647|NCT03100734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25121648|NCT03100734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121649|NCT03100734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25121650|NCT03100734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25121651|NCT03100734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25121652|NCT03100734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25121653|NCT03100734|Immunologic Factors|immunologic factors|mesh-ancestor
24716046|NCT01539616|Fenofibrate|fenofibrate|mesh-list
24716047|NCT01539616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24716048|NCT01539616|Antimetabolites|antimetabolites|mesh-ancestor
24716049|NCT01539616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716050|NCT01539616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24716053|NCT01539655|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
24716054|NCT01539655|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24716055|NCT01539655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24716056|NCT01539655|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24716061|NCT01539655|Histamine Agents|histamine agents|mesh-ancestor
24716073|NCT01539707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24716074|NCT01539707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716075|NCT01539707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716076|NCT01539707|Urological Agents|urological agents|mesh-ancestor
24716077|NCT01539720|Levonorgestrel|levonorgestrel|mesh-list
24716078|NCT01539720|Ulipristal acetate|ulipristal acetate|mesh-list
24716079|NCT01539720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24716086|NCT01539733|Haloperidol|haloperidol|mesh-list
24716134|NCT01540084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25121655|NCT03100565|Anesthetics, Local|anesthetics, local|mesh-ancestor
25121656|NCT03100565|Anesthetics|anesthetics|mesh-ancestor
25121657|NCT03100565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25121658|NCT03100565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716135|NCT01540084|Anesthetics, General|anesthetics, general|mesh-ancestor
24716136|NCT01540084|Anesthetics|anesthetics|mesh-ancestor
25693450|NCT02014441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25693451|NCT02014441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693452|NCT02014467|Vitamin D|vitamin d|mesh-list
25693453|NCT02014467|Denosumab|denosumab|mesh-list
25693454|NCT02014467|Calcium|calcium|mesh-list
25693455|NCT02014467|Vitamins|vitamins|mesh-ancestor
25693456|NCT02014467|Micronutrients|micronutrients|mesh-ancestor
25693457|NCT02014467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693458|NCT02014467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25693459|NCT02014467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25693460|NCT02014584|Dutasteride|dutasteride|mesh-list
25693461|NCT02014584|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25693462|NCT02014584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25693463|NCT02014584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693464|NCT02014584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693465|NCT02014584|Hormone Antagonists|hormone antagonists|mesh-ancestor
25693466|NCT02014584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24716137|NCT01540110|Cyclophosphamide|cyclophosphamide|mesh-list
24716138|NCT01540110|Docetaxel|docetaxel|mesh-list
24716139|NCT01540110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24716140|NCT01540110|Immunologic Factors|immunologic factors|mesh-ancestor
24716141|NCT01540110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716142|NCT01540110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24716143|NCT01540110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24716154|NCT01540240|Antimetabolites|antimetabolites|mesh-ancestor
24716155|NCT01540240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716156|NCT01540240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24716157|NCT01540240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24716158|NCT01540240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716159|NCT01540240|Antiviral Agents|antiviral agents|mesh-ancestor
24548593|NCT00710359|Hematinics|hematinics|mesh-ancestor
24615016|NCT01027494|Dexamethasone|dexamethasone|mesh-list
24615017|NCT01027494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24615018|NCT01027494|Antiemetics|antiemetics|mesh-ancestor
24615019|NCT01027494|Autonomic Agents|autonomic agents|mesh-ancestor
24615020|NCT01027494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24615021|NCT01027494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615022|NCT01027494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24615023|NCT01027494|Glucocorticoids|glucocorticoids|mesh-ancestor
24615025|NCT01027494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24615030|NCT01027494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24615031|NCT01027494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24615032|NCT01027494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615033|NCT01027494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716229|NCT01540734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24716230|NCT01540734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716232|NCT01540747|Folic Acid|folic acid|mesh-list
24716233|NCT01540747|Vitamin B Complex|vitamin b complex|mesh-list
24716234|NCT01540747|Inositol|inositol|mesh-list
24716235|NCT01540747|Melatonin|melatonin|mesh-list
24716236|NCT01540747|Antioxidants|antioxidants|mesh-ancestor
24716237|NCT01540747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121687|NCT03100318|Dotinurad|dotinurad|mesh-list
25121688|NCT03100318|Benzbromarone|benzbromarone|mesh-list
25121689|NCT03100318|Uricosuric Agents|uricosuric agents|mesh-ancestor
25121690|NCT03100318|Gout Suppressants|gout suppressants|mesh-ancestor
25121691|NCT03100318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25121692|NCT03100318|Renal Agents|renal agents|mesh-ancestor
25121693|NCT03100422|Armin|armin|mesh-list
25121694|NCT03100422|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25121695|NCT03100422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121696|NCT03100422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121697|NCT03100422|Cholinergic Agents|cholinergic agents|mesh-ancestor
25121698|NCT03100422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25121699|NCT03100422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121700|NCT03100019|Resveratrol|resveratrol|mesh-list
25121701|NCT03100019|Antioxidants|antioxidants|mesh-ancestor
25121702|NCT03100019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121703|NCT03100019|Protective Agents|protective agents|mesh-ancestor
25121704|NCT03100019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121705|NCT03100019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121706|NCT03100019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25121707|NCT03100071|Apixaban|apixaban|mesh-list
25121708|NCT03100071|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25121709|NCT03100071|Antithrombins|antithrombins|mesh-ancestor
25121710|NCT03100071|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25121711|NCT03100071|Protease Inhibitors|protease inhibitors|mesh-ancestor
25121712|NCT03100071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121713|NCT03100071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716326|NCT01541085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24716327|NCT01541085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24716328|NCT01541085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24716329|NCT01541085|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24716330|NCT01541085|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24716334|NCT01541124|Morphine|morphine|mesh-list
24716406|NCT01541332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24716407|NCT01541332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24716408|NCT01541332|Growth Substances|growth substances|mesh-ancestor
24716409|NCT01541332|Growth Inhibitors|growth inhibitors|mesh-ancestor
24716411|NCT01541436|Antipruritics|antipruritics|mesh-ancestor
24716412|NCT01541436|Dermatologic Agents|dermatologic agents|mesh-ancestor
24922066|NCT04183634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922067|NCT04183634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953215|NCT03887858|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24716413|NCT01541436|Sensory System Agents|sensory system agents|mesh-ancestor
24716414|NCT01541436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25121714|NCT03100071|Anticoagulants|anticoagulants|mesh-ancestor
25121715|NCT03099720|Ropivacaine|ropivacaine|mesh-list
25121716|NCT03099720|Anesthetics, Local|anesthetics, local|mesh-ancestor
25121717|NCT03099720|Anesthetics|anesthetics|mesh-ancestor
25121718|NCT03099720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25121719|NCT03099720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121720|NCT03099720|Sensory System Agents|sensory system agents|mesh-ancestor
25121721|NCT03099720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25121722|NCT03099759|Vitamin D|vitamin d|mesh-list
25121723|NCT03099759|Cholecalciferol|cholecalciferol|mesh-list
25121724|NCT03099759|Ergocalciferols|ergocalciferols|mesh-list
25121725|NCT03099759|Vitamins|vitamins|mesh-ancestor
25121726|NCT03099759|Micronutrients|micronutrients|mesh-ancestor
25121727|NCT03099759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121728|NCT03099759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25121729|NCT03099759|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25121730|NCT03099824|Avasopasem manganese|avasopasem manganese|mesh-list
25121731|NCT03099824|Antioxidants|antioxidants|mesh-ancestor
25121732|NCT03099824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121733|NCT03099824|Protective Agents|protective agents|mesh-ancestor
25121734|NCT03099824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121735|NCT03099785|Rifamycins|rifamycins|mesh-list
25121736|NCT03099785|Rifamycin SV|rifamycin sv|mesh-list
25121737|NCT03099785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25121738|NCT03099785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25121739|NCT03099785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25121740|NCT03099590|Puerarin|puerarin|mesh-list
25121741|NCT03099590|Vasodilator Agents|vasodilator agents|mesh-ancestor
25121742|NCT03099616|Propofol|propofol|mesh-list
25121743|NCT03099616|Desflurane|desflurane|mesh-list
25121744|NCT03099616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25121745|NCT03099616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25121746|NCT03099616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615055|NCT01027611|Lidocaine|lidocaine|mesh-list
24615056|NCT01027611|Proxymetacaine|proxymetacaine|mesh-list
24615057|NCT01027611|Propoxycaine|propoxycaine|mesh-list
24716466|NCT01541670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646691|NCT01204801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24646692|NCT01204801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24646693|NCT01204801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24716468|NCT01541709|Imatinib Mesylate|imatinib mesylate|mesh-list
24716469|NCT01541709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24716470|NCT01541709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24716471|NCT01541709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716472|NCT01541709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716473|NCT01541904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25121747|NCT03099616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25121748|NCT03099616|Anesthetics, General|anesthetics, general|mesh-ancestor
25121749|NCT03099616|Anesthetics|anesthetics|mesh-ancestor
25121750|NCT03099616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25121751|NCT03099382|Docetaxel|docetaxel|mesh-list
25121752|NCT03099382|Irinotecan|irinotecan|mesh-list
25121753|NCT03099382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121754|NCT03099382|Tubulin Modulators|tubulin modulators|mesh-ancestor
25121755|NCT03099382|Antimitotic Agents|antimitotic agents|mesh-ancestor
25121756|NCT03099382|Mitosis Modulators|mitosis modulators|mesh-ancestor
25121757|NCT03099382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121758|NCT03099382|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25121759|NCT03099382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25121760|NCT03099382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121761|NCT03099278|Ezetimibe|ezetimibe|mesh-list
25121762|NCT03099278|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25121763|NCT03099278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24716474|NCT01541904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25693467|NCT02014584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693468|NCT02014740|Metformin|metformin|mesh-list
25693469|NCT02014740|Liraglutide|liraglutide|mesh-list
24716475|NCT01541943|Losartan|losartan|mesh-list
24716567|NCT01542437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24716569|NCT01542437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693470|NCT02014740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24953217|NCT03887858|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25068008|NCT03437200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25068009|NCT03437200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623556|NCT01072175|Dabrafenib|dabrafenib|mesh-list
24623642|NCT01072955|Heparin|heparin|mesh-list
24623789|NCT01073670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24623936|NCT01074060|Plerixafor|plerixafor|mesh-list
24716570|NCT01542450|Insulin|insulin|mesh-list
24716571|NCT01542450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24716572|NCT01542450|Insulin Detemir|insulin detemir|mesh-list
24716573|NCT01542450|Isophane Insulin, Human|isophane insulin, human|mesh-list
24548653|NCT00711204|Donepezil|donepezil|mesh-list
24716599|NCT01542697|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24716600|NCT01542697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24420596|NCT00216411|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24716601|NCT01542697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716628|NCT01542801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24716629|NCT01542801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24716630|NCT01542801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24716631|NCT01542801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24716632|NCT01542801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716633|NCT01542801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716634|NCT01542801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24716693|NCT01543321|Tetrabenazine|tetrabenazine|mesh-list
24716694|NCT01543321|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24716695|NCT01543321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24716696|NCT01543321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24716698|NCT01543321|Adrenergic Agents|adrenergic agents|mesh-ancestor
24716777|NCT01543932|Purinergic Agents|purinergic agents|mesh-ancestor
24716778|NCT01543932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24716779|NCT01543932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716780|NCT01543932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716781|NCT01543945|Dexamethasone|dexamethasone|mesh-list
24716782|NCT01543945|Dexamethasone acetate|dexamethasone acetate|mesh-list
24716783|NCT01543945|Ondansetron|ondansetron|mesh-list
24716784|NCT01543945|Antiemetics|antiemetics|mesh-list
24716785|NCT01543945|Dimenhydrinate|dimenhydrinate|mesh-list
24716786|NCT01543945|BB 1101|bb 1101|mesh-list
24716787|NCT01543945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24716788|NCT01543945|Autonomic Agents|autonomic agents|mesh-ancestor
24716789|NCT01543945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24716790|NCT01543945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716791|NCT01543945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24716792|NCT01543945|Glucocorticoids|glucocorticoids|mesh-ancestor
25121764|NCT03099278|Antimetabolites|antimetabolites|mesh-ancestor
25121765|NCT03099278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121766|NCT03099278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25121767|NCT03099122|Mycophenolic Acid|mycophenolic acid|mesh-list
25121768|NCT03099122|Prednisone|prednisone|mesh-list
25121769|NCT03099122|Methylprednisolone|methylprednisolone|mesh-list
25121770|NCT03099122|Tacrolimus|tacrolimus|mesh-list
25121771|NCT03099122|Thymoglobulin|thymoglobulin|mesh-list
25121772|NCT03099122|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25121773|NCT03099122|Immunoglobulins|immunoglobulins|mesh-list
25121774|NCT03099122|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25121775|NCT03099122|Antibodies|antibodies|mesh-list
25121776|NCT03099122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25121777|NCT03099122|Glucocorticoids|glucocorticoids|mesh-ancestor
25121778|NCT03099122|Hormones|hormones|mesh-ancestor
25121779|NCT03099122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25121780|NCT03099122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121781|NCT03099122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25121782|NCT03099122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121783|NCT03099122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25121784|NCT03099122|Immunologic Factors|immunologic factors|mesh-ancestor
25121785|NCT03099122|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25121786|NCT03099122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121787|NCT03099122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693471|NCT02014740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693472|NCT02014740|Incretins|incretins|mesh-ancestor
25693473|NCT02014740|Hormones|hormones|mesh-ancestor
25693474|NCT02014740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25693475|NCT02015104|BCG Vaccine|bcg vaccine|mesh-list
25693476|NCT02015104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25693477|NCT02015104|Immunologic Factors|immunologic factors|mesh-ancestor
25121788|NCT03099122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25121789|NCT03099122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25121790|NCT03099122|Antitubercular Agents|antitubercular agents|mesh-ancestor
25121791|NCT03099122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25121792|NCT03099122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25121793|NCT03099122|Antiemetics|antiemetics|mesh-ancestor
25121794|NCT03099122|Autonomic Agents|autonomic agents|mesh-ancestor
25121796|NCT03099122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25121808|NCT03099213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121809|NCT03099213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25121810|NCT03098875|Remifentanil|remifentanil|mesh-list
25121811|NCT03098875|Propofol|propofol|mesh-list
25121812|NCT03098875|Sevoflurane|sevoflurane|mesh-list
25121813|NCT03098875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25121814|NCT03098875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25121815|NCT03098875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121816|NCT03098875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25121817|NCT03098875|Anesthetics, General|anesthetics, general|mesh-ancestor
25121818|NCT03098875|Anesthetics|anesthetics|mesh-ancestor
25121819|NCT03098875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25121820|NCT03098875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25121821|NCT03098875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25121822|NCT03098875|Narcotics|narcotics|mesh-ancestor
25121823|NCT03098875|Analgesics|analgesics|mesh-ancestor
25121824|NCT03098875|Sensory System Agents|sensory system agents|mesh-ancestor
25121825|NCT03098875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25121826|NCT03099031|Tinzaparin|tinzaparin|mesh-list
25121827|NCT03099031|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25121828|NCT03099031|Dalteparin|dalteparin|mesh-list
25121829|NCT03099031|Anticoagulants|anticoagulants|mesh-ancestor
25121830|NCT03099031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25121831|NCT03099031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25121832|NCT03099031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121833|NCT03098888|Dimercaprol|dimercaprol|mesh-list
25121834|NCT03098888|Chelating Agents|chelating agents|mesh-ancestor
25121835|NCT03098888|Sequestering Agents|sequestering agents|mesh-ancestor
25121836|NCT03098888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121837|NCT03098953|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25121838|NCT03098953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25121839|NCT03098823|Prednisone|prednisone|mesh-list
25121840|NCT03098823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25076238|NCT03374540|Vitamin K|vitamin k|mesh-list
24716793|NCT01543945|Hormones|hormones|mesh-ancestor
24716794|NCT01543945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24716795|NCT01543945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24716796|NCT01543945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24716800|NCT01543945|Antipruritics|antipruritics|mesh-ancestor
24716801|NCT01543945|Dermatologic Agents|dermatologic agents|mesh-ancestor
24716802|NCT01543945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24716803|NCT01543945|Serotonin Agents|serotonin agents|mesh-ancestor
25121842|NCT03098823|Hormones|hormones|mesh-ancestor
25121843|NCT03098823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25121844|NCT03098823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121845|NCT03098823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25121846|NCT03098823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121847|NCT03098810|Zinc Sulfate|zinc sulfate|mesh-list
25121848|NCT03098810|Astringents|astringents|mesh-ancestor
25121849|NCT03098810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121850|NCT03098810|Dermatologic Agents|dermatologic agents|mesh-ancestor
25121851|NCT03098680|Verapamil|verapamil|mesh-list
25121852|NCT03098680|Nicardipine|nicardipine|mesh-list
25121853|NCT03098680|Phentolamine|phentolamine|mesh-list
25121854|NCT03098680|Phenylephrine|phenylephrine|mesh-list
25121855|NCT03098680|Dobutamine|dobutamine|mesh-list
25121856|NCT03098680|Oxymetazoline|oxymetazoline|mesh-list
25121857|NCT03098680|Albuterol|albuterol|mesh-list
25121858|NCT03098680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25121859|NCT03098680|Autonomic Agents|autonomic agents|mesh-ancestor
25121860|NCT03098680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25121861|NCT03098680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121862|NCT03098680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25121863|NCT03098680|Respiratory System Agents|respiratory system agents|mesh-ancestor
25121864|NCT03098680|Tocolytic Agents|tocolytic agents|mesh-ancestor
25121865|NCT03098680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25121866|NCT03098680|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25121867|NCT03098680|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25121868|NCT03098680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25121869|NCT03098680|Adrenergic Agents|adrenergic agents|mesh-ancestor
24716804|NCT01543945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24716805|NCT01543945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24716806|NCT01543945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24716807|NCT01543945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24716808|NCT01543945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24716809|NCT01543945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24716823|NCT01544140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24716824|NCT01544140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716825|NCT01544140|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24716849|NCT01544283|Tetracaine|tetracaine|mesh-list
24716850|NCT01544283|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24716851|NCT01544283|Anesthetics, Local|anesthetics, local|mesh-ancestor
24716852|NCT01544283|Anesthetics|anesthetics|mesh-ancestor
24646790|NCT01205139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24716853|NCT01544283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24716854|NCT01544283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716855|NCT01544283|Sensory System Agents|sensory system agents|mesh-ancestor
24716856|NCT01544283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25121870|NCT03098680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25121871|NCT03098680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121872|NCT03098680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25121874|NCT03098680|Sympathomimetics|sympathomimetics|mesh-ancestor
25121875|NCT03098680|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25121876|NCT03098680|Nasal Decongestants|nasal decongestants|mesh-ancestor
25121877|NCT03098680|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25121878|NCT03098680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25121879|NCT03098680|Protective Agents|protective agents|mesh-ancestor
25121880|NCT03098680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25121881|NCT03098680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25121882|NCT03098680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25121883|NCT03098680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25121884|NCT03098680|Vasodilator Agents|vasodilator agents|mesh-ancestor
25121885|NCT03098680|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25121886|NCT03098680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25076271|NCT03374345|Mitogens|mitogens|mesh-ancestor
24716919|NCT01544634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24716989|NCT01544894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716990|NCT01544894|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24716991|NCT01544894|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24716992|NCT01544894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24716994|NCT01544907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24716995|NCT01544907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24716996|NCT01544907|Tubulin Modulators|tubulin modulators|mesh-ancestor
24716997|NCT01544907|Antimitotic Agents|antimitotic agents|mesh-ancestor
24716998|NCT01544907|Mitosis Modulators|mitosis modulators|mesh-ancestor
24716999|NCT01544907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717011|NCT01544959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24717012|NCT01544959|Anesthetics, General|anesthetics, general|mesh-ancestor
24717013|NCT01544959|Anesthetics|anesthetics|mesh-ancestor
24717014|NCT01544959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24717019|NCT01544972|Acetaminophen|acetaminophen|mesh-list
24503804|NCT00532961|Tobramycin|tobramycin|mesh-list
24717063|NCT01545297|Sensory System Agents|sensory system agents|mesh-ancestor
24717064|NCT01545297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24717144|NCT01545856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24717145|NCT01545856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717146|NCT01545856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717147|NCT01545947|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24717149|NCT01545947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24717150|NCT01545947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24717237|NCT01546935|Antiviral Agents|antiviral agents|mesh-ancestor
24717238|NCT01546935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24717239|NCT01546935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717240|NCT01546935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717241|NCT01546961|Chloroquine|chloroquine|mesh-list
24717242|NCT01546961|Amebicides|amebicides|mesh-ancestor
24717243|NCT01546961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24717244|NCT01546961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24717245|NCT01546961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24922508|NCT04179617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922510|NCT04179071|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24922513|NCT04179071|Histamine Antagonists|histamine antagonists|mesh-ancestor
24922514|NCT04179071|Histamine Agents|histamine agents|mesh-ancestor
24922515|NCT04179071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24922518|NCT04178863|Timolol|timolol|mesh-list
24922561|NCT04178876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25121887|NCT03098680|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25121888|NCT03098680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25121889|NCT03098537|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25121890|NCT03098537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121891|NCT03098537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121893|NCT03098407|Methadone|methadone|mesh-list
25121894|NCT03098407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25121895|NCT03098407|Narcotics|narcotics|mesh-ancestor
24717764|NCT01549743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121897|NCT03098407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121898|NCT03098407|Analgesics|analgesics|mesh-ancestor
25121899|NCT03098407|Sensory System Agents|sensory system agents|mesh-ancestor
25121910|NCT03098355|Interleukin-2|interleukin-2|mesh-list
25121911|NCT03098355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121912|NCT03098355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25121913|NCT03098355|Analgesics|analgesics|mesh-ancestor
25076293|NCT03374293|Antibodies|antibodies|mesh-list
24717356|NCT01547325|Doxycycline|doxycycline|mesh-list
24717357|NCT01547325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24717358|NCT01547325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24717359|NCT01547325|Antimalarials|antimalarials|mesh-ancestor
24717360|NCT01547325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24717361|NCT01547325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24717363|NCT01547377|Selenium|selenium|mesh-list
24717441|NCT01548066|Anticonvulsants|anticonvulsants|mesh-ancestor
24717442|NCT01548066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717443|NCT01548066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717524|NCT01548274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24645967|NCT01201005|Vitamins|vitamins|mesh-ancestor
24717525|NCT01548274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717527|NCT01548326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24717528|NCT01548326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24717529|NCT01548326|Antimetabolites|antimetabolites|mesh-ancestor
24717534|NCT01548482|Sirolimus|sirolimus|mesh-list
24717604|NCT01548859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717605|NCT01548859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24717606|NCT01548859|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24717607|NCT01548872|Cardioplegic Solutions|cardioplegic solutions|mesh-list
24717608|NCT01548872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24717609|NCT01548911|Gemtuzumab|gemtuzumab|mesh-list
24717610|NCT01548911|Calicheamicins|calicheamicins|mesh-list
24717611|NCT01548911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24717614|NCT01548924|Paclitaxel|paclitaxel|mesh-list
24615134|NCT01028092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615135|NCT01028092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24615136|NCT01028092|Immunologic Factors|immunologic factors|mesh-ancestor
24615137|NCT01028092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615138|NCT01028092|Antifungal Agents|antifungal agents|mesh-ancestor
24615139|NCT01028092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24615140|NCT01028092|Dermatologic Agents|dermatologic agents|mesh-ancestor
24615141|NCT01028092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24615142|NCT01028092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24615143|NCT01028092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24615144|NCT01028092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24615146|NCT01028092|Sensory System Agents|sensory system agents|mesh-ancestor
24717726|NCT01549574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24717727|NCT01549600|Psyllium|psyllium|mesh-list
25121914|NCT03098355|Sensory System Agents|sensory system agents|mesh-ancestor
25121915|NCT03098355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25121916|NCT03098355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693478|NCT02015104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693479|NCT02015195|Ethanol|ethanol|mesh-list
25693480|NCT02015195|Acetic Acid|acetic acid|mesh-list
25693481|NCT02015195|Retinol acetate|retinol acetate|mesh-list
25693482|NCT02015195|Lidocaine|lidocaine|mesh-list
25693483|NCT02015195|Anesthetics, Local|anesthetics, local|mesh-ancestor
25693484|NCT02015195|Anesthetics|anesthetics|mesh-ancestor
25121917|NCT03098342|Amorolfine|amorolfine|mesh-list
25121918|NCT03098342|Methylene Blue|methylene blue|mesh-list
25693485|NCT02015195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25121919|NCT03098342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121920|NCT03098342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121921|NCT03098342|Antifungal Agents|antifungal agents|mesh-ancestor
25121922|NCT03098342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25121923|NCT03098225|Methylprednisolone|methylprednisolone|mesh-list
25121924|NCT03098225|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25121925|NCT03098225|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25121926|NCT03098225|Prednisolone|prednisolone|mesh-list
25121927|NCT03098225|Prednisolone acetate|prednisolone acetate|mesh-list
25121928|NCT03098225|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25121929|NCT03098225|Prednisolone phosphate|prednisolone phosphate|mesh-list
25121930|NCT03098225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25121931|NCT03098225|Antiemetics|antiemetics|mesh-ancestor
25121932|NCT03098225|Autonomic Agents|autonomic agents|mesh-ancestor
25076305|NCT03374228|Linrodostat|linrodostat|mesh-list
24717728|NCT01549600|Cathartics|cathartics|mesh-ancestor
24717729|NCT01549600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24717730|NCT01549691|Alprazolam|alprazolam|mesh-list
24717731|NCT01549691|Zopiclone|zopiclone|mesh-list
24717732|NCT01549691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24717808|NCT01550107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24717809|NCT01550107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24717810|NCT01550107|Antioxidants|antioxidants|mesh-ancestor
24717811|NCT01550107|Protective Agents|protective agents|mesh-ancestor
24717812|NCT01550107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717813|NCT01550146|Dexamethasone|dexamethasone|mesh-list
24717814|NCT01550146|Dexamethasone acetate|dexamethasone acetate|mesh-list
24717816|NCT01550146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24717817|NCT01550146|Antiemetics|antiemetics|mesh-ancestor
24717921|NCT01550848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24717922|NCT01550848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717923|NCT01550848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24717924|NCT01550848|Immunologic Factors|immunologic factors|mesh-ancestor
24717925|NCT01550848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717926|NCT01550900|Metformin|metformin|mesh-list
24717927|NCT01550900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24717928|NCT01550900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717929|NCT01550926|Orlistat|orlistat|mesh-list
24717930|NCT01550926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717931|NCT01550926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717932|NCT01550926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24717933|NCT01550926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24718014|NCT01551485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24718015|NCT01551485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24718016|NCT01551485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718017|NCT01551485|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24718018|NCT01551485|GABA Agonists|gaba agonists|mesh-ancestor
24718019|NCT01551485|GABA Agents|gaba agents|mesh-ancestor
24718020|NCT01551485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24718035|NCT01551511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24718036|NCT01551589|Docetaxel|docetaxel|mesh-list
25121933|NCT03098225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25121934|NCT03098225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121935|NCT03098225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25121936|NCT03098225|Glucocorticoids|glucocorticoids|mesh-ancestor
25121937|NCT03098225|Hormones|hormones|mesh-ancestor
25121938|NCT03098225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25121939|NCT03098225|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25121940|NCT03098225|Protective Agents|protective agents|mesh-ancestor
25121941|NCT03098225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25121942|NCT03098225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121943|NCT03098160|Ipilimumab|ipilimumab|mesh-list
25121944|NCT03098160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25121945|NCT03098160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718042|NCT01551615|Metformin|metformin|mesh-list
24718095|NCT01551836|Sensory System Agents|sensory system agents|mesh-ancestor
24718098|NCT01551836|Antipyretics|antipyretics|mesh-ancestor
24718182|NCT01552668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24718184|NCT01552798|Acetaminophen|acetaminophen|mesh-list
24718185|NCT01552798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24718186|NCT01552798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24718187|NCT01552798|Analgesics|analgesics|mesh-ancestor
24908637|NCT04318158|Bupivacaine|bupivacaine|mesh-list
24718188|NCT01552798|Sensory System Agents|sensory system agents|mesh-ancestor
24718202|NCT01552837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24624072|NCT01074632|Dopamine Agents|dopamine agents|mesh-ancestor
24718203|NCT01552837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24718204|NCT01552837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24718205|NCT01552837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24718206|NCT01552837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718207|NCT01552850|Oxycodone|oxycodone|mesh-list
24718208|NCT01552850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24718209|NCT01552850|Narcotics|narcotics|mesh-ancestor
24718299|NCT01553773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718300|NCT01553786|Lenalidomide|lenalidomide|mesh-list
24718301|NCT01553786|Immunologic Factors|immunologic factors|mesh-ancestor
24718302|NCT01553786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718303|NCT01553786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24718304|NCT01553786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24718305|NCT01553786|Growth Substances|growth substances|mesh-ancestor
24718306|NCT01553786|Growth Inhibitors|growth inhibitors|mesh-ancestor
24718307|NCT01553786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718308|NCT01553903|Tamoxifen|tamoxifen|mesh-list
24718309|NCT01553903|Letrozole|letrozole|mesh-list
24718363|NCT01554345|Antioxidants|antioxidants|mesh-ancestor
25122103|NCT03096301|Antifungal Agents|antifungal agents|mesh-ancestor
24718364|NCT01554345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615175|NCT01028287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24615176|NCT01028287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615177|NCT01028313|Methylprednisolone|methylprednisolone|mesh-list
24615178|NCT01028313|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24615179|NCT01028313|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24615180|NCT01028313|Prednisolone|prednisolone|mesh-list
24718427|NCT01554852|Leprostatic Agents|leprostatic agents|mesh-ancestor
24718428|NCT01554852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24718429|NCT01554852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24718430|NCT01554852|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24718431|NCT01554930|Methylprednisolone|methylprednisolone|mesh-list
24718432|NCT01554930|Mannitol|mannitol|mesh-list
24718433|NCT01554930|Immunoglobulins|immunoglobulins|mesh-list
24718434|NCT01554930|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24718496|NCT01555112|Antiviral Agents|antiviral agents|mesh-ancestor
25121947|NCT03098160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121949|NCT03098199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121950|NCT03098199|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25121951|NCT03098199|Fertility Agents|fertility agents|mesh-ancestor
25121952|NCT03098199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25121953|NCT03098121|Grazoprevir|grazoprevir|mesh-list
25121954|NCT03098121|Antiviral Agents|antiviral agents|mesh-ancestor
25121955|NCT03098121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25121956|NCT03097848|Sorafenib|sorafenib|mesh-list
25121957|NCT03097848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121958|NCT03097848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25076331|NCT03373877|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
25076332|NCT03373877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25076333|NCT03373864|Anesthetics|anesthetics|mesh-list
25076334|NCT03373864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25076335|NCT03373864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718497|NCT01555112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24718498|NCT01555190|Folic Acid|folic acid|mesh-list
24718499|NCT01555190|Inositol|inositol|mesh-list
24718500|NCT01555190|Hematinics|hematinics|mesh-ancestor
24718501|NCT01555190|Vitamin B Complex|vitamin b complex|mesh-ancestor
24718547|NCT01555580|Immunologic Factors|immunologic factors|mesh-ancestor
24718548|NCT01555580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718549|NCT01555580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718550|NCT01555632|Atorvastatin|atorvastatin|mesh-list
24718551|NCT01555632|Calcium|calcium|mesh-list
24718552|NCT01555632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24718553|NCT01555632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718554|NCT01555632|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24718652|NCT01556321|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25693486|NCT02015195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718661|NCT01556334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25693487|NCT02015195|Sensory System Agents|sensory system agents|mesh-ancestor
24624109|NCT01074801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24624110|NCT01074801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24922668|NCT04178109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24922669|NCT04178109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24922670|NCT04178109|Analgesics|analgesics|mesh-ancestor
24922671|NCT04178109|Antipyretics|antipyretics|mesh-ancestor
24922672|NCT04178109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24922673|NCT04178109|Narcotics|narcotics|mesh-ancestor
24718662|NCT01556334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24856574|NCT02285699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24856575|NCT02285699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718727|NCT01556737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718738|NCT01556815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718739|NCT01556815|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25121960|NCT03097848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121962|NCT03097900|Caffeine citrate|caffeine citrate|mesh-list
25121963|NCT03097900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121964|NCT03097900|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25121965|NCT03097900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121966|NCT03097900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25121967|NCT03097900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121968|NCT03097900|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25121969|NCT03097900|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25121971|NCT03097900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25121972|NCT03097835|Anesthetics|anesthetics|mesh-list
25121973|NCT03097835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25121974|NCT03097835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121975|NCT03097601|Sunitinib|sunitinib|mesh-list
25121976|NCT03097601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25121977|NCT03097601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25121978|NCT03097601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25121979|NCT03097601|Growth Substances|growth substances|mesh-ancestor
25121980|NCT03097601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121981|NCT03097601|Growth Inhibitors|growth inhibitors|mesh-ancestor
25121982|NCT03097601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25121983|NCT03097601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25121984|NCT03097601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121986|NCT03097380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25121987|NCT03097380|Autonomic Agents|autonomic agents|mesh-ancestor
25121988|NCT03097380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25121989|NCT03097380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25121990|NCT03097380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25121991|NCT03097380|Respiratory System Agents|respiratory system agents|mesh-ancestor
25121992|NCT03097380|Parasympatholytics|parasympatholytics|mesh-ancestor
25121993|NCT03097380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25121994|NCT03097380|Cholinergic Agents|cholinergic agents|mesh-ancestor
24718740|NCT01556815|Estrogens|estrogens|mesh-ancestor
24718741|NCT01556815|Hormones|hormones|mesh-ancestor
24718742|NCT01556815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25121995|NCT03097380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25121996|NCT03097380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25121997|NCT03097445|Nicotine|nicotine|mesh-list
25121998|NCT03097445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25121999|NCT03097445|Autonomic Agents|autonomic agents|mesh-ancestor
25122000|NCT03097445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25122001|NCT03097445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122002|NCT03097445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25122003|NCT03097445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25122004|NCT03097445|Cholinergic Agents|cholinergic agents|mesh-ancestor
25693488|NCT02015195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25693489|NCT02015195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25693490|NCT02015195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25693491|NCT02015195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25693492|NCT02015195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25693493|NCT02015195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693494|NCT02015195|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25693495|NCT02015195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24600433|NCT00082706|Vitamins|vitamins|mesh-ancestor
25122005|NCT03097445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25122006|NCT03097445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122007|NCT03097406|Imidacloprid|imidacloprid|mesh-list
25122008|NCT03097406|Cholinergic Agents|cholinergic agents|mesh-ancestor
25122009|NCT03097406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25122010|NCT03097406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122011|NCT03097406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122012|NCT03097120|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25122013|NCT03097120|Medroxyprogesterone|medroxyprogesterone|mesh-list
25122014|NCT03097120|Estrogens|estrogens|mesh-list
25122015|NCT03097120|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25122016|NCT03097120|Hormones|hormones|mesh-ancestor
25122017|NCT03097120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25122018|NCT03097120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122019|NCT03097120|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25122020|NCT03097120|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25122021|NCT03097120|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25122022|NCT03097120|Contraceptive Agents|contraceptive agents|mesh-ancestor
25122023|NCT03097120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25122024|NCT03097120|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25122025|NCT03097120|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25122026|NCT03097120|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25122027|NCT03097120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25122028|NCT03097120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25122029|NCT03097068|Ranibizumab|ranibizumab|mesh-list
25122031|NCT03097068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25122032|NCT03097068|Growth Substances|growth substances|mesh-ancestor
25122035|NCT03097068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25122036|NCT03097211|Levodopa|levodopa|mesh-list
25122037|NCT03097211|Benserazide|benserazide|mesh-list
25122038|NCT03097211|Resveratrol|resveratrol|mesh-list
25122039|NCT03097211|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
25122040|NCT03097211|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25122041|NCT03097211|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25122042|NCT03097211|Dopamine Agents|dopamine agents|mesh-ancestor
25122043|NCT03097211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25122044|NCT03097211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122045|NCT03097211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122046|NCT03097211|Antioxidants|antioxidants|mesh-ancestor
25122047|NCT03097211|Protective Agents|protective agents|mesh-ancestor
25122048|NCT03097211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25122049|NCT03097211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25122050|NCT03097198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25122051|NCT03097198|Tropicamide|tropicamide|mesh-list
25122052|NCT03097198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25122053|NCT03097198|Mydriatics|mydriatics|mesh-ancestor
25122054|NCT03097198|Autonomic Agents|autonomic agents|mesh-ancestor
24718743|NCT01556815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718744|NCT01556815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24718745|NCT01556867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
24718797|NCT01557257|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24718798|NCT01557257|Narcotics|narcotics|mesh-ancestor
24718799|NCT01557257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24718800|NCT01557257|Analgesics|analgesics|mesh-ancestor
24718801|NCT01557270|Dexmedetomidine|dexmedetomidine|mesh-list
24718844|NCT01557374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718845|NCT01557374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24718846|NCT01557374|Immunologic Factors|immunologic factors|mesh-ancestor
24718847|NCT01557374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647056|NCT01206036|Antifungal Agents|antifungal agents|mesh-ancestor
24647057|NCT01206036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24718848|NCT01557374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24718849|NCT01557439|Levocetirizine|levocetirizine|mesh-list
24718850|NCT01557439|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24718851|NCT01557439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24718852|NCT01557439|Histamine Antagonists|histamine antagonists|mesh-ancestor
24718853|NCT01557439|Histamine Agents|histamine agents|mesh-ancestor
24718854|NCT01557439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24718855|NCT01557439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718856|NCT01557439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718857|NCT01557478|Melatonin|melatonin|mesh-list
24718858|NCT01557478|Antioxidants|antioxidants|mesh-ancestor
24601030|NCT00962286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601031|NCT00962286|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24601032|NCT00962286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24601034|NCT00962299|Beclomethasone|beclomethasone|mesh-list
24718937|NCT01558011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718938|NCT01558011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24718939|NCT01558011|Antimetabolites|antimetabolites|mesh-ancestor
24718940|NCT01558115|Denosumab|denosumab|mesh-list
25122055|NCT03097198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25122084|NCT03096990|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25122085|NCT03096990|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25122086|NCT03096990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25122087|NCT03096990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122088|NCT03096756|Avasopasem manganese|avasopasem manganese|mesh-list
25122089|NCT03096756|Antioxidants|antioxidants|mesh-ancestor
25122090|NCT03096756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122091|NCT03096756|Protective Agents|protective agents|mesh-ancestor
25122092|NCT03096756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122093|NCT03096704|Vitamin D|vitamin d|mesh-list
25122094|NCT03096704|Vitamins|vitamins|mesh-ancestor
25122095|NCT03096704|Micronutrients|micronutrients|mesh-ancestor
25122096|NCT03096704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122097|NCT03096704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24783755|NCT01903785|Respiratory System Agents|respiratory system agents|mesh-ancestor
25122098|NCT03096470|Anesthetics|anesthetics|mesh-list
25122099|NCT03096470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25122100|NCT03096470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122101|NCT03096301|Salicylic Acid|salicylic acid|mesh-list
25122102|NCT03096301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25122104|NCT03096301|Keratolytic Agents|keratolytic agents|mesh-ancestor
25122105|NCT03096301|Dermatologic Agents|dermatologic agents|mesh-ancestor
25122106|NCT03096327|Montelukast|montelukast|mesh-list
25122107|NCT03096327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25122108|NCT03096327|Respiratory System Agents|respiratory system agents|mesh-ancestor
25122109|NCT03096327|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25122110|NCT03096327|Hormone Antagonists|hormone antagonists|mesh-ancestor
25122111|NCT03096327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25122112|NCT03096327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122113|NCT03096327|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25122114|NCT03096327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25122115|NCT03096327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122118|NCT03096340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25122119|NCT03096340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25122120|NCT03096340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25122121|NCT03096340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25122122|NCT03096340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25122123|NCT03096340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122124|NCT03096392|Insulin|insulin|mesh-list
25122125|NCT03096392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25122126|NCT03096392|Insulin Lispro|insulin lispro|mesh-list
25122127|NCT03096392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25122128|NCT03096392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122129|NCT03096522|Phenytoin|phenytoin|mesh-list
25122130|NCT03096522|Anticonvulsants|anticonvulsants|mesh-ancestor
25122134|NCT03096522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122135|NCT03096522|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25122136|NCT03096522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25122138|NCT03096457|Pentamidine|pentamidine|mesh-list
24718941|NCT01558115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24718942|NCT01558115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718943|NCT01558167|Rituximab|rituximab|mesh-list
24718944|NCT01558167|Lenalidomide|lenalidomide|mesh-list
24718945|NCT01558167|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24718946|NCT01558167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25693496|NCT02015195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25693497|NCT02015195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25693498|NCT02015195|Immunologic Factors|immunologic factors|mesh-ancestor
25693499|NCT02015195|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25693500|NCT02015195|Protective Agents|protective agents|mesh-ancestor
24601993|NCT00966901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24718947|NCT01558167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718949|NCT01558167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718950|NCT01558167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24718953|NCT01558167|Growth Substances|growth substances|mesh-ancestor
24718971|NCT01558193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718972|NCT01558193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24718973|NCT01558193|Dermatologic Agents|dermatologic agents|mesh-ancestor
24718974|NCT01558245|Kallikreins|kallikreins|mesh-list
24718975|NCT01558245|Coagulants|coagulants|mesh-ancestor
24718976|NCT01558245|Fertility Agents, Male|fertility agents, male|mesh-ancestor
24718977|NCT01558245|Fertility Agents|fertility agents|mesh-ancestor
24718978|NCT01558245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24718979|NCT01558245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718980|NCT01558310|Ustekinumab|ustekinumab|mesh-list
24718981|NCT01558310|Dermatologic Agents|dermatologic agents|mesh-ancestor
24718982|NCT01558336|Praziquantel|praziquantel|mesh-list
24718983|NCT01558336|Anthelmintics|anthelmintics|mesh-ancestor
24718984|NCT01558336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24718985|NCT01558336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24718986|NCT01558375|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24718987|NCT01558375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24718988|NCT01558453|Oxaliplatin|oxaliplatin|mesh-list
24718989|NCT01558453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718990|NCT01558466|Sildenafil Citrate|sildenafil citrate|mesh-list
24718996|NCT01558466|Urological Agents|urological agents|mesh-ancestor
24718997|NCT01558622|Ascorbic Acid|ascorbic acid|mesh-list
24718998|NCT01558622|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
24718999|NCT01558622|Ketoprofen|ketoprofen|mesh-list
24719000|NCT01558622|Meperidine|meperidine|mesh-list
24719017|NCT01558622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24719018|NCT01558622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24719026|NCT01558713|Bupivacaine|bupivacaine|mesh-list
24719027|NCT01558713|Ropivacaine|ropivacaine|mesh-list
25122139|NCT03096457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25122140|NCT03096457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25122141|NCT03096457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25122142|NCT03096457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25122143|NCT03096457|Antifungal Agents|antifungal agents|mesh-ancestor
25122144|NCT03096457|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25122145|NCT03096405|Methicillin|methicillin|mesh-list
25122146|NCT03096405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25122147|NCT03096405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25122152|NCT03096223|KHK4083|khk4083|mesh-list
24719028|NCT01558713|Levobupivacaine|levobupivacaine|mesh-list
24719029|NCT01558713|Anesthetics, Local|anesthetics, local|mesh-ancestor
24719030|NCT01558713|Anesthetics|anesthetics|mesh-ancestor
24719031|NCT01558713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24856602|NCT02285738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856603|NCT02285738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24856604|NCT02285738|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24856605|NCT02285738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24719032|NCT01558713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719033|NCT01558713|Sensory System Agents|sensory system agents|mesh-ancestor
24719034|NCT01558713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24719035|NCT01558713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24719036|NCT01558713|Narcotics|narcotics|mesh-ancestor
24719037|NCT01558713|Analgesics|analgesics|mesh-ancestor
24719038|NCT01558713|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24719039|NCT01558713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24719040|NCT01558713|Anesthetics, General|anesthetics, general|mesh-ancestor
24719041|NCT01558830|Ranolazine|ranolazine|mesh-list
24719042|NCT01558830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24719043|NCT01558830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24719044|NCT01558830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719045|NCT01558869|Capecitabine|capecitabine|mesh-list
25693501|NCT02015195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719046|NCT01558869|Oxaliplatin|oxaliplatin|mesh-list
24719047|NCT01558869|Irinotecan|irinotecan|mesh-list
25693502|NCT02015234|Cyclobenzaprine|cyclobenzaprine|mesh-list
25693503|NCT02015234|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25693504|NCT02015234|Antidepressive Agents|antidepressive agents|mesh-ancestor
24603038|NCT00972101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603089|NCT00972387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603308|NCT00973219|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24719048|NCT01558869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24719049|NCT01558869|Antimetabolites|antimetabolites|mesh-ancestor
24719050|NCT01558869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719051|NCT01558869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719052|NCT01558869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24719058|NCT01558934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719059|NCT01558934|Sensory System Agents|sensory system agents|mesh-ancestor
24719060|NCT01558934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24719061|NCT01558934|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24719062|NCT01558934|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24719063|NCT01558934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24719064|NCT01558934|Adrenergic Agents|adrenergic agents|mesh-ancestor
24719065|NCT01558934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24719066|NCT01558934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719162|NCT01559584|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24719163|NCT01559584|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24719164|NCT01559584|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24719165|NCT01559584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24719166|NCT01559584|Glucocorticoids|glucocorticoids|mesh-ancestor
24719168|NCT01559584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24719169|NCT01559584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719221|NCT01560052|Prednisolone acetate|prednisolone acetate|mesh-list
24719222|NCT01560052|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24719223|NCT01560052|Prednisolone phosphate|prednisolone phosphate|mesh-list
24719224|NCT01560052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24719225|NCT01560052|Antiemetics|antiemetics|mesh-ancestor
24719226|NCT01560052|Autonomic Agents|autonomic agents|mesh-ancestor
24719227|NCT01560052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24719228|NCT01560052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122153|NCT03096223|Dermatologic Agents|dermatologic agents|mesh-ancestor
25122154|NCT03095872|Petrolatum|petrolatum|mesh-list
25122155|NCT03095872|Emollients|emollients|mesh-ancestor
25122156|NCT03095872|Dermatologic Agents|dermatologic agents|mesh-ancestor
25122157|NCT03096184|Apatinib|apatinib|mesh-list
25122158|NCT03096184|Tegafur|tegafur|mesh-list
24856620|NCT02285751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25122159|NCT03096184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25122160|NCT03096184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25122161|NCT03096184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25122162|NCT03096184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122163|NCT03096184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25122164|NCT03096184|Antimetabolites|antimetabolites|mesh-ancestor
25122165|NCT03096028|Vitamin B 12|vitamin b 12|mesh-list
25122166|NCT03096028|Hydroxocobalamin|hydroxocobalamin|mesh-list
25122167|NCT03096028|Vitamins|vitamins|mesh-ancestor
25122168|NCT03096028|Micronutrients|micronutrients|mesh-ancestor
25122169|NCT03096028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122170|NCT03096028|Vitamin B Complex|vitamin b complex|mesh-ancestor
25122171|NCT03096028|Hematinics|hematinics|mesh-ancestor
25122172|NCT03095547|Cyclosporine|cyclosporine|mesh-list
25122173|NCT03095547|Posaconazole|posaconazole|mesh-list
25122175|NCT03095547|Pantoprazole|pantoprazole|mesh-list
24719229|NCT01560052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24719230|NCT01560052|Glucocorticoids|glucocorticoids|mesh-ancestor
24719231|NCT01560052|Hormones|hormones|mesh-ancestor
24549133|NCT00713622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24719287|NCT01560390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24719288|NCT01560390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24719289|NCT01560390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24719290|NCT01560390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719291|NCT01560442|Buprenorphine|buprenorphine|mesh-list
24719292|NCT01560442|Methadone|methadone|mesh-list
24719293|NCT01560442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24719294|NCT01560442|Narcotics|narcotics|mesh-ancestor
24719297|NCT01560442|Analgesics|analgesics|mesh-ancestor
24719299|NCT01560442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24719300|NCT01560442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24719301|NCT01560442|Antitussive Agents|antitussive agents|mesh-ancestor
24719302|NCT01560442|Respiratory System Agents|respiratory system agents|mesh-ancestor
25693505|NCT02015234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25693506|NCT02015234|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24719341|NCT01560702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693507|NCT02015234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719342|NCT01560702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719343|NCT01560702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24719344|NCT01560702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24719345|NCT01560702|Autonomic Agents|autonomic agents|mesh-ancestor
24719346|NCT01560702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24719347|NCT01560702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24719348|NCT01560702|Respiratory System Agents|respiratory system agents|mesh-ancestor
24719393|NCT01561066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24719394|NCT01561066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24719395|NCT01561066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719396|NCT01561066|Hemostatics|hemostatics|mesh-ancestor
24719397|NCT01561066|Coagulants|coagulants|mesh-ancestor
24719398|NCT01561092|Citalopram|citalopram|mesh-list
24719399|NCT01561092|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24719474|NCT01561508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24719510|NCT01561950|Purinergic Agents|purinergic agents|mesh-ancestor
24719511|NCT01561950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25122176|NCT03095547|Tacrolimus|tacrolimus|mesh-list
25122177|NCT03095547|Cyclosporins|cyclosporins|mesh-list
25122178|NCT03095547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25122179|NCT03095547|Immunologic Factors|immunologic factors|mesh-ancestor
25122180|NCT03095547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856622|NCT02285751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25122181|NCT03095547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25122182|NCT03095547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25122183|NCT03095547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122184|NCT03095547|Antifungal Agents|antifungal agents|mesh-ancestor
25122188|NCT03095547|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25122189|NCT03095547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25122190|NCT03095547|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25122191|NCT03095547|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25122192|NCT03095547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25122193|NCT03095547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25122194|NCT03095547|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25122195|NCT03095547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25122196|NCT03095547|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25122197|NCT03095547|Hormone Antagonists|hormone antagonists|mesh-ancestor
25122198|NCT03095547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25122199|NCT03095703|Sirolimus|sirolimus|mesh-list
25122200|NCT03095703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25122207|NCT03095703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122208|NCT03095469|Dexmedetomidine|dexmedetomidine|mesh-list
25122209|NCT03095469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25122210|NCT03095469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25122214|NCT03095469|Sensory System Agents|sensory system agents|mesh-ancestor
25122215|NCT03095469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25122216|NCT03095469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25122217|NCT03095469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25122218|NCT03095469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25122219|NCT03095469|Adrenergic Agents|adrenergic agents|mesh-ancestor
25122220|NCT03095469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25122221|NCT03095469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122222|NCT03095404|Lidocaine|lidocaine|mesh-list
25122223|NCT03095404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25122224|NCT03095404|Anesthetics, Local|anesthetics, local|mesh-ancestor
25122225|NCT03095404|Anesthetics|anesthetics|mesh-ancestor
25122226|NCT03095404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25122227|NCT03095404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122228|NCT03095404|Sensory System Agents|sensory system agents|mesh-ancestor
25122229|NCT03095404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25122230|NCT03095404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25122231|NCT03095404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25122232|NCT03095404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25122233|NCT03095404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25122234|NCT03095404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122239|NCT03095144|Anesthetics|anesthetics|mesh-list
25122240|NCT03095144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25122241|NCT03095144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122242|NCT03095209|Paclitaxel|paclitaxel|mesh-list
25122243|NCT03095209|Carboplatin|carboplatin|mesh-list
24719512|NCT01561950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693508|NCT02015234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24719513|NCT01561950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856643|NCT02285829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24856644|NCT02285829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856645|NCT02285972|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
24856647|NCT02285972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24856648|NCT02285972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24856649|NCT02285972|Analgesics|analgesics|mesh-ancestor
24856650|NCT02285972|Sensory System Agents|sensory system agents|mesh-ancestor
24719515|NCT01562197|Lomustine|lomustine|mesh-list
24719516|NCT01562197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719517|NCT01562197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24719518|NCT01562197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24719519|NCT01562197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719520|NCT01562197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24719521|NCT01562197|Alkylating Agents|alkylating agents|mesh-ancestor
25122244|NCT03095209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25122245|NCT03095209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25122246|NCT03095209|Tubulin Modulators|tubulin modulators|mesh-ancestor
25122247|NCT03095209|Antimitotic Agents|antimitotic agents|mesh-ancestor
25122248|NCT03095209|Mitosis Modulators|mitosis modulators|mesh-ancestor
25122249|NCT03095209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122251|NCT03095222|Analgesics|analgesics|mesh-ancestor
25122252|NCT03095222|Sensory System Agents|sensory system agents|mesh-ancestor
25122253|NCT03095222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25122254|NCT03095222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122255|NCT03095222|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25122256|NCT03095222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25122257|NCT03095222|Anesthetics, General|anesthetics, general|mesh-ancestor
25122258|NCT03095222|Anesthetics|anesthetics|mesh-ancestor
25122259|NCT03095222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25122260|NCT03095222|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25122261|NCT03095222|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25122262|NCT03095222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25122263|NCT03095222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122264|NCT03095378|Anti-Infective Agents|anti-infective agents|mesh-list
24615279|NCT01028573|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24615280|NCT01028573|Laxatives|laxatives|mesh-ancestor
24615281|NCT01028573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24615282|NCT01028638|Bevacizumab|bevacizumab|mesh-list
24615283|NCT01028638|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
24615284|NCT01028638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24719592|NCT01562717|Ibuprofen|ibuprofen|mesh-list
24719652|NCT01562990|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
24719653|NCT01562990|Oxaliplatin|oxaliplatin|mesh-list
24719654|NCT01562990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24856651|NCT02285972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24856660|NCT02285985|Hormones|hormones|mesh-ancestor
24719655|NCT01562990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719656|NCT01562990|Immunologic Factors|immunologic factors|mesh-ancestor
24719657|NCT01562990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719671|NCT01563120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24719672|NCT01563120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719673|NCT01563224|Baclofen|baclofen|mesh-list
24719674|NCT01563224|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24719675|NCT01563224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719676|NCT01563224|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24719677|NCT01563224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24719678|NCT01563224|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24719679|NCT01563224|GABA Agonists|gaba agonists|mesh-ancestor
24719680|NCT01563224|GABA Agents|gaba agents|mesh-ancestor
24719681|NCT01563224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24719682|NCT01563224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719685|NCT01563289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24719737|NCT01563718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24719738|NCT01563835|Fentanyl|fentanyl|mesh-list
24719739|NCT01563835|Bupivacaine|bupivacaine|mesh-list
25122266|NCT03095378|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25122268|NCT03095378|Sodium Citrate|sodium citrate|mesh-list
25122269|NCT03095378|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25068268|NCT03434704|Thiotepa|thiotepa|mesh-list
25068269|NCT03434704|Treosulfan|treosulfan|mesh-list
25068270|NCT03434704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25068271|NCT03434704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068272|NCT03434704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25068273|NCT03434704|Immunologic Factors|immunologic factors|mesh-ancestor
25068274|NCT03434704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068275|NCT03434704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25068276|NCT03434704|Alkylating Agents|alkylating agents|mesh-ancestor
25068277|NCT03434704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25068278|NCT03434704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25068279|NCT03434704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25068280|NCT03434704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25122270|NCT03095378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25122271|NCT03095378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122272|NCT03095378|Anticoagulants|anticoagulants|mesh-ancestor
25122273|NCT03095378|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25122274|NCT03095378|Chelating Agents|chelating agents|mesh-ancestor
25122275|NCT03095378|Sequestering Agents|sequestering agents|mesh-ancestor
25122277|NCT03095326|Zinc Sulfate|zinc sulfate|mesh-list
25122278|NCT03095326|Vaccines|vaccines|mesh-list
25122279|NCT03095326|Immunologic Factors|immunologic factors|mesh-ancestor
25122280|NCT03095326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122281|NCT03095326|Trace Elements|trace elements|mesh-ancestor
25122282|NCT03095326|Micronutrients|micronutrients|mesh-ancestor
25122283|NCT03095326|Astringents|astringents|mesh-ancestor
25122284|NCT03095326|Dermatologic Agents|dermatologic agents|mesh-ancestor
25122285|NCT03095235|Riboflavin|riboflavin|mesh-list
25122286|NCT03095235|Vitamins|vitamins|mesh-ancestor
25122287|NCT03095235|Micronutrients|micronutrients|mesh-ancestor
25122288|NCT03095235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122289|NCT03095235|Vitamin B Complex|vitamin b complex|mesh-ancestor
25122290|NCT03095235|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25122291|NCT03095235|Dermatologic Agents|dermatologic agents|mesh-ancestor
25122292|NCT03095105|Resveratrol|resveratrol|mesh-list
25122293|NCT03095105|Antioxidants|antioxidants|mesh-ancestor
25122294|NCT03095105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122295|NCT03095105|Protective Agents|protective agents|mesh-ancestor
25122296|NCT03095105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122297|NCT03095105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25122298|NCT03095105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24719740|NCT01563835|Citric Acid|citric acid|mesh-list
24719741|NCT01563835|Sodium Citrate|sodium citrate|mesh-list
24719742|NCT01563835|Anesthetics, Local|anesthetics, local|mesh-ancestor
24719743|NCT01563835|Anesthetics|anesthetics|mesh-ancestor
24719744|NCT01563835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24719745|NCT01563835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719748|NCT01563835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24719826|NCT01564251|Antiviral Agents|antiviral agents|mesh-ancestor
24719827|NCT01564251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24719828|NCT01564251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24719829|NCT01564251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25122301|NCT03095079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25122303|NCT03095079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122304|NCT03095079|Growth Inhibitors|growth inhibitors|mesh-ancestor
25122305|NCT03095079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24856678|NCT02286206|GABA Antagonists|gaba antagonists|mesh-ancestor
24856679|NCT02286206|GABA Agents|gaba agents|mesh-ancestor
24856680|NCT02286219|Immunoglobulins|immunoglobulins|mesh-list
24856681|NCT02286219|Immunoglobulin G|immunoglobulin g|mesh-list
24856682|NCT02286219|Immunologic Factors|immunologic factors|mesh-ancestor
25122306|NCT03095040|Everolimus|everolimus|mesh-list
25693509|NCT02015234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25693510|NCT02015234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25693511|NCT02015234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25693512|NCT02015546|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
25693513|NCT02015546|Antidepressive Agents|antidepressive agents|mesh-ancestor
25693514|NCT02015546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25693515|NCT02015546|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25693516|NCT02015546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25693517|NCT02015546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25693518|NCT02015546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693519|NCT02015546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25693520|NCT02015546|Serotonin Agents|serotonin agents|mesh-ancestor
25122307|NCT03095040|Vorolanib|vorolanib|mesh-list
25122308|NCT03095040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24606010|NCT00988520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24606012|NCT00988663|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25122309|NCT03095040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25122310|NCT03095040|Immunologic Factors|immunologic factors|mesh-ancestor
25122311|NCT03095040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122312|NCT03095040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25122313|NCT03095040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25122314|NCT03095040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122315|NCT03095001|Paclitaxel|paclitaxel|mesh-list
25122316|NCT03095001|Bevacizumab|bevacizumab|mesh-list
25122317|NCT03095001|Carboplatin|carboplatin|mesh-list
25122318|NCT03095001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25122319|NCT03095001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719917|NCT01564979|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24719918|NCT01564979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24719919|NCT01564979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24814679|NCT02065947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24719920|NCT01564979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615325|NCT01028781|Growth Inhibitors|growth inhibitors|mesh-ancestor
24615326|NCT01028781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24615328|NCT01028846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24615329|NCT01028846|Vasodilator Agents|vasodilator agents|mesh-ancestor
24615330|NCT01028924|Teduglutide|teduglutide|mesh-list
24615331|NCT01028924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24615332|NCT01028924|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24615333|NCT01028924|Protective Agents|protective agents|mesh-ancestor
24615334|NCT01028924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615336|NCT01028950|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24615337|NCT01028950|Antithrombins|antithrombins|mesh-ancestor
24615338|NCT01028950|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24719985|NCT01565590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24719986|NCT01565590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719987|NCT01565590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24719988|NCT01565590|Anesthetics, General|anesthetics, general|mesh-ancestor
24719989|NCT01565590|Anesthetics|anesthetics|mesh-ancestor
24719990|NCT01565590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24719991|NCT01565590|Analgesics|analgesics|mesh-ancestor
24719992|NCT01565590|Sensory System Agents|sensory system agents|mesh-ancestor
24719993|NCT01565590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24720000|NCT01565720|Moxifloxacin|moxifloxacin|mesh-list
24720063|NCT01566253|Sensory System Agents|sensory system agents|mesh-ancestor
24720064|NCT01566253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24720065|NCT01566253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24720066|NCT01566253|Antipyretics|antipyretics|mesh-ancestor
25122320|NCT03095001|Tubulin Modulators|tubulin modulators|mesh-ancestor
24627902|NCT01095575|Narcotics|narcotics|mesh-ancestor
25122331|NCT03094663|Dexamethasone|dexamethasone|mesh-list
25122332|NCT03094663|Dexamethasone acetate|dexamethasone acetate|mesh-list
25122333|NCT03094663|Methylprednisolone|methylprednisolone|mesh-list
25122334|NCT03094663|Epinephrine|epinephrine|mesh-list
25122335|NCT03094663|Bupivacaine|bupivacaine|mesh-list
25122336|NCT03094663|BB 1101|bb 1101|mesh-list
25122429|NCT03094442|Antiemetics|antiemetics|mesh-ancestor
25122337|NCT03094663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25122338|NCT03094663|Antiemetics|antiemetics|mesh-ancestor
25122339|NCT03094663|Autonomic Agents|autonomic agents|mesh-ancestor
25122340|NCT03094663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24856683|NCT02286219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856684|NCT02286258|Calcium, Dietary|calcium, dietary|mesh-list
25122341|NCT03094663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122342|NCT03094663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25122343|NCT03094663|Glucocorticoids|glucocorticoids|mesh-ancestor
25122344|NCT03094663|Hormones|hormones|mesh-ancestor
25122345|NCT03094663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25122346|NCT03094663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25122347|NCT03094663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25122348|NCT03094663|Protease Inhibitors|protease inhibitors|mesh-ancestor
25693521|NCT02015546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693522|NCT02015546|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25693523|NCT02015546|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25693524|NCT02015637|Ceftriaxone|ceftriaxone|mesh-list
25122349|NCT03094663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25122350|NCT03094663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122351|NCT03094663|Anesthetics, Local|anesthetics, local|mesh-ancestor
25122352|NCT03094663|Anesthetics|anesthetics|mesh-ancestor
24607174|NCT05072093|Emtricitabine|emtricitabine|mesh-list
24607175|NCT05072093|Cabotegravir|cabotegravir|mesh-list
25068331|NCT03434340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25068332|NCT03434340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068333|NCT03434340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25068334|NCT03434340|Glucocorticoids|glucocorticoids|mesh-ancestor
25068335|NCT03434340|Hormones|hormones|mesh-ancestor
24607176|NCT05072093|Doxycycline|doxycycline|mesh-list
25122353|NCT03094663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25122354|NCT03094663|Sensory System Agents|sensory system agents|mesh-ancestor
25122355|NCT03094663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25122356|NCT03094663|Protective Agents|protective agents|mesh-ancestor
25122357|NCT03094663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25122358|NCT03094663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25122359|NCT03094663|Adrenergic Agents|adrenergic agents|mesh-ancestor
25076587|NCT03371953|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25076588|NCT03371953|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25076589|NCT03371953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25076590|NCT03371953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076591|NCT03371953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720067|NCT01566253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24720068|NCT01566253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24720069|NCT01566253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25122361|NCT03094663|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25122362|NCT03094663|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25122363|NCT03094663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25122364|NCT03094663|Respiratory System Agents|respiratory system agents|mesh-ancestor
25122365|NCT03094663|Mydriatics|mydriatics|mesh-ancestor
25122366|NCT03094663|Sympathomimetics|sympathomimetics|mesh-ancestor
25122367|NCT03094663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25122368|NCT03094663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24954513|NCT03876574|Antiviral Agents|antiviral agents|mesh-ancestor
24720070|NCT01566253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24720071|NCT01566253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720072|NCT01566253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720073|NCT01566266|Amoxicillin|amoxicillin|mesh-list
24720074|NCT01566266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24720075|NCT01566266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24720076|NCT01566279|Everolimus|everolimus|mesh-list
24720077|NCT01566279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720078|NCT01566279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24720079|NCT01566279|Immunologic Factors|immunologic factors|mesh-ancestor
24720080|NCT01566279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720081|NCT01566292|Botulinum Toxins|botulinum toxins|mesh-list
24720082|NCT01566292|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24720083|NCT01566292|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24720084|NCT01566292|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24720085|NCT01566292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24720086|NCT01566292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720092|NCT01566422|Vancomycin|vancomycin|mesh-list
24720103|NCT01566474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24720108|NCT01566487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24720109|NCT01566487|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24720190|NCT01566825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24720191|NCT01566825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720192|NCT01566825|Adrenergic Agents|adrenergic agents|mesh-ancestor
24720193|NCT01566825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24720195|NCT01566890|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
24720196|NCT01566890|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24720197|NCT01566890|Purinergic Agonists|purinergic agonists|mesh-ancestor
24720198|NCT01566890|Purinergic Agents|purinergic agents|mesh-ancestor
24720199|NCT01566890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24900720|NCT04391621|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25122430|NCT03094442|Autonomic Agents|autonomic agents|mesh-ancestor
24615379|NCT01029223|Adrenergic Agents|adrenergic agents|mesh-ancestor
24615380|NCT01029223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25693525|NCT02015637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25693526|NCT02015637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25693527|NCT02015676|Paclitaxel|paclitaxel|mesh-list
25693528|NCT02015676|Trastuzumab|trastuzumab|mesh-list
25693529|NCT02015676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25693530|NCT02015676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693531|NCT02015676|Tubulin Modulators|tubulin modulators|mesh-ancestor
25693532|NCT02015676|Antimitotic Agents|antimitotic agents|mesh-ancestor
24720250|NCT01567475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24720251|NCT01567475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720252|NCT01567475|Immunologic Factors|immunologic factors|mesh-ancestor
24720253|NCT01567475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720254|NCT01567475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24720255|NCT01567475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24720257|NCT01567488|Octreotide|octreotide|mesh-list
24720258|NCT01567488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720259|NCT01567488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24720260|NCT01567488|Immunologic Factors|immunologic factors|mesh-ancestor
24720261|NCT01567488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720262|NCT01567488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24720263|NCT01567488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24720264|NCT01567501|Cetirizine|cetirizine|mesh-list
24720265|NCT01567501|Levocetirizine|levocetirizine|mesh-list
24720266|NCT01567501|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24720267|NCT01567501|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25064692|NCT03457597|Midazolam|midazolam|mesh-list
24720268|NCT01567501|Histamine Antagonists|histamine antagonists|mesh-ancestor
24720307|NCT01567618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720308|NCT01567657|Midazolam|midazolam|mesh-list
25122369|NCT03094663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25122370|NCT03094481|Epinephrine|epinephrine|mesh-list
25122371|NCT03094481|Bupivacaine|bupivacaine|mesh-list
25122372|NCT03094481|Anesthetics, Local|anesthetics, local|mesh-ancestor
25122373|NCT03094481|Anesthetics|anesthetics|mesh-ancestor
25122374|NCT03094481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25122375|NCT03094481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122376|NCT03094481|Sensory System Agents|sensory system agents|mesh-ancestor
25122377|NCT03094481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25122378|NCT03094481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25122379|NCT03094481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25122380|NCT03094481|Adrenergic Agents|adrenergic agents|mesh-ancestor
25122381|NCT03094481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25122382|NCT03094481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122383|NCT03094481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25122384|NCT03094481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25122385|NCT03094481|Autonomic Agents|autonomic agents|mesh-ancestor
25122386|NCT03094481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25122387|NCT03094481|Respiratory System Agents|respiratory system agents|mesh-ancestor
25122388|NCT03094481|Mydriatics|mydriatics|mesh-ancestor
25122389|NCT03094481|Sympathomimetics|sympathomimetics|mesh-ancestor
25122390|NCT03094481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25122391|NCT03094533|Propofol|propofol|mesh-list
25122392|NCT03094533|Sevoflurane|sevoflurane|mesh-list
25122393|NCT03094533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25122394|NCT03094533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25122395|NCT03094533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122396|NCT03094533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25122397|NCT03094533|Anesthetics, General|anesthetics, general|mesh-ancestor
25122398|NCT03094533|Anesthetics|anesthetics|mesh-ancestor
25122399|NCT03094533|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25122400|NCT03094533|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25122401|NCT03094403|Azelaic acid|azelaic acid|mesh-list
24647364|NCT01208454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25122402|NCT03094403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24627908|NCT01095640|Adapalene|adapalene|mesh-list
24784355|NCT01907594|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25122414|NCT03094507|Protease Inhibitors|protease inhibitors|mesh-ancestor
25122415|NCT03094507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25122416|NCT03094507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122417|NCT03094507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25122418|NCT03094507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25122419|NCT03094507|Antiviral Agents|antiviral agents|mesh-ancestor
25122420|NCT03094507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25122421|NCT03094507|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25122422|NCT03094507|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25122423|NCT03094507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25122424|NCT03094507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25122425|NCT03094182|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25122426|NCT03094182|Hematinics|hematinics|mesh-ancestor
25122427|NCT03094442|Dexamethasone|dexamethasone|mesh-list
25122428|NCT03094442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25122431|NCT03094442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25122432|NCT03094442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720310|NCT01567657|Propofol|propofol|mesh-list
24720329|NCT01567657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24720331|NCT01567670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24720332|NCT01567670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720381|NCT01568125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720383|NCT01568125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24720387|NCT01568268|Palonosetron|palonosetron|mesh-list
24720388|NCT01568268|Antiemetics|antiemetics|mesh-ancestor
24720389|NCT01568268|Autonomic Agents|autonomic agents|mesh-ancestor
24720411|NCT01568294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720412|NCT01568294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24720413|NCT01568294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24720414|NCT01568294|Growth Substances|growth substances|mesh-ancestor
24720415|NCT01568294|Growth Inhibitors|growth inhibitors|mesh-ancestor
24720450|NCT01568450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720451|NCT01568450|Analgesics|analgesics|mesh-ancestor
24720452|NCT01568450|Sensory System Agents|sensory system agents|mesh-ancestor
24720453|NCT01568450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24720454|NCT01568632|Imetelstat|imetelstat|mesh-list
24720455|NCT01568632|Motesanib diphosphate|motesanib diphosphate|mesh-list
24720533|NCT01569048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24720534|NCT01569048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24720535|NCT01569048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25122433|NCT03094442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25122434|NCT03094442|Glucocorticoids|glucocorticoids|mesh-ancestor
25122435|NCT03094442|Hormones|hormones|mesh-ancestor
25122436|NCT03094442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25122437|NCT03094442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25122438|NCT03094442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25122439|NCT03094156|Resveratrol|resveratrol|mesh-list
25122440|NCT03094156|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
25122441|NCT03094156|Antioxidants|antioxidants|mesh-ancestor
25122442|NCT03094156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122443|NCT03094156|Protective Agents|protective agents|mesh-ancestor
25122444|NCT03094156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122445|NCT03094156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25122446|NCT03094156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25122447|NCT03094156|Dopamine Agents|dopamine agents|mesh-ancestor
25122448|NCT03094156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25122449|NCT03093805|Calcipotriene|calcipotriene|mesh-list
25122450|NCT03093805|Dermatologic Agents|dermatologic agents|mesh-ancestor
25122451|NCT03093883|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25122452|NCT03093883|Hematinics|hematinics|mesh-ancestor
25122453|NCT03093909|Gemcitabine|gemcitabine|mesh-list
25122454|NCT03093909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25122455|NCT03093909|Antimetabolites|antimetabolites|mesh-ancestor
24720536|NCT01569048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24720537|NCT01569048|Adrenergic Agents|adrenergic agents|mesh-ancestor
24720538|NCT01569048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24720539|NCT01569048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720540|NCT01569048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24720541|NCT01569048|Narcotics|narcotics|mesh-ancestor
24720542|NCT01569113|Levonorgestrel|levonorgestrel|mesh-list
24720543|NCT01569113|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24720544|NCT01569113|Ulipristal acetate|ulipristal acetate|mesh-list
24720545|NCT01569113|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
24720546|NCT01569113|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
24720547|NCT01569113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24720548|NCT01569113|Contraceptive Agents|contraceptive agents|mesh-ancestor
24646175|NCT01202422|Pregabalin|pregabalin|mesh-list
24720549|NCT01569113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24615383|NCT01029275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24615384|NCT01029275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24615400|NCT01029522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615401|NCT01029522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24615402|NCT01029522|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24615403|NCT01029522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615404|NCT01029613|Adalimumab|adalimumab|mesh-list
25122459|NCT03093909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25122461|NCT03093909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25122462|NCT03093909|Immunologic Factors|immunologic factors|mesh-ancestor
25122463|NCT03093909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122464|NCT03093467|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
25122465|NCT03093467|Antipsychotic Agents|antipsychotic agents|mesh-list
24539631|NCT00664781|Rucaparib|rucaparib|mesh-list
24720682|NCT01569945|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24720683|NCT01569945|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24720684|NCT01569945|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24720685|NCT01569945|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24720698|NCT01569984|Growth Inhibitors|growth inhibitors|mesh-ancestor
24720699|NCT01570049|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24856762|NCT02286687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856763|NCT02286687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24856764|NCT02286700|Desonide|desonide|mesh-list
24856765|NCT02286700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24647391|NCT01208701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24647392|NCT01208701|Antimetabolites|antimetabolites|mesh-ancestor
24647393|NCT01208701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720700|NCT01570049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24720701|NCT01570049|Alkylating Agents|alkylating agents|mesh-ancestor
24720702|NCT01570049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720703|NCT01570049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720750|NCT01570569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24720751|NCT01570569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24615435|NCT01029743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24615436|NCT01029743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720752|NCT01570569|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24720753|NCT01570569|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24720754|NCT01570569|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24720755|NCT01570569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24720756|NCT01570569|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24720768|NCT01570582|Paclitaxel|paclitaxel|mesh-list
24720824|NCT01570907|Antidepressive Agents|antidepressive agents|mesh-ancestor
24720825|NCT01570907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24720826|NCT01570907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24720827|NCT01570907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24720828|NCT01570907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24720829|NCT01570907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720830|NCT01570959|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24720842|NCT01570985|Glucocorticoids|glucocorticoids|mesh-ancestor
24720911|NCT01571414|Lopinavir|lopinavir|mesh-list
24720912|NCT01571414|Efavirenz|efavirenz|mesh-list
24720913|NCT01571414|Rifampin|rifampin|mesh-list
24720914|NCT01571414|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24720915|NCT01571414|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24720916|NCT01571414|Protease Inhibitors|protease inhibitors|mesh-ancestor
24720917|NCT01571414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720918|NCT01571414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615437|NCT01029743|Antipyretics|antipyretics|mesh-ancestor
24720979|NCT01571791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24720980|NCT01571791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24720981|NCT01571791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24721085|NCT01572116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24721086|NCT01572116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25122466|NCT03093467|Antidepressive Agents|antidepressive agents|mesh-list
25122467|NCT03093467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25122468|NCT03093467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25122469|NCT03093467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25122470|NCT03093467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122471|NCT03093740|Sofosbuvir|sofosbuvir|mesh-list
25122472|NCT03093740|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25122473|NCT03093740|Antiviral Agents|antiviral agents|mesh-ancestor
25122474|NCT03093740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25122478|NCT03093545|Immunoglobulins|immunoglobulins|mesh-list
25122497|NCT03093402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25122498|NCT03093402|Analgesics|analgesics|mesh-ancestor
25122499|NCT03093402|Sensory System Agents|sensory system agents|mesh-ancestor
25122500|NCT03093402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25122501|NCT03093129|Artesunate|artesunate|mesh-list
24721144|NCT01572324|Protective Agents|protective agents|mesh-ancestor
24721145|NCT01572324|Vitamin B Complex|vitamin b complex|mesh-ancestor
24721146|NCT01572324|Vitamins|vitamins|mesh-ancestor
24721147|NCT01572324|Micronutrients|micronutrients|mesh-ancestor
24721148|NCT01572350|Triamcinolone|triamcinolone|mesh-list
24721163|NCT01572350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24721164|NCT01572350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24721165|NCT01572350|Immunologic Factors|immunologic factors|mesh-ancestor
24721166|NCT01572350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693533|NCT02015676|Mitosis Modulators|mitosis modulators|mesh-ancestor
24721167|NCT01572350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721225|NCT01572597|Respiratory System Agents|respiratory system agents|mesh-ancestor
24721227|NCT01572597|Antioxidants|antioxidants|mesh-ancestor
24721228|NCT01572597|Protective Agents|protective agents|mesh-ancestor
24721229|NCT01572597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721230|NCT01572623|Clopidogrel|clopidogrel|mesh-list
24721231|NCT01572623|Atorvastatin|atorvastatin|mesh-list
24721232|NCT01572623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24721233|NCT01572623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24721234|NCT01572623|Antimetabolites|antimetabolites|mesh-ancestor
24721240|NCT01572623|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24721241|NCT01572623|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24721242|NCT01572623|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24721243|NCT01572623|Purinergic Agents|purinergic agents|mesh-ancestor
24721244|NCT01572623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24721245|NCT01572623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721247|NCT01572649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24721248|NCT01572649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909975|NCT04303312|Benzydamine|benzydamine|mesh-list
24721250|NCT01572688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24721251|NCT01572688|Alkylating Agents|alkylating agents|mesh-ancestor
24721252|NCT01572688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721253|NCT01572688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24721254|NCT01572688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24721255|NCT01572688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24721256|NCT01572688|Immunologic Factors|immunologic factors|mesh-ancestor
24721257|NCT01572688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721258|NCT01572805|Melatonin|melatonin|mesh-list
24721259|NCT01572805|Antioxidants|antioxidants|mesh-ancestor
24721260|NCT01572805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721365|NCT01573715|Cisatracurium|cisatracurium|mesh-list
24721366|NCT01573715|Atracurium|atracurium|mesh-list
24721367|NCT01573715|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24721368|NCT01573715|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24721369|NCT01573715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25122502|NCT03093129|Antimalarials|antimalarials|mesh-ancestor
25122503|NCT03093129|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25122504|NCT03093129|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25122505|NCT03093129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25122506|NCT03093129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25122507|NCT03093129|Antiviral Agents|antiviral agents|mesh-ancestor
25122508|NCT03093129|Schistosomicides|schistosomicides|mesh-ancestor
25122509|NCT03093129|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25122510|NCT03093129|Anthelmintics|anthelmintics|mesh-ancestor
25122512|NCT03093389|Antioxidants|antioxidants|mesh-ancestor
25122513|NCT03093389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122514|NCT03093389|Protective Agents|protective agents|mesh-ancestor
24647460|NCT01208935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122515|NCT03093389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122516|NCT03093389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25122517|NCT03093389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25122519|NCT03093090|Diuretics|diuretics|mesh-ancestor
24721370|NCT01573715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721371|NCT01573715|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24721372|NCT01573715|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24721373|NCT01573715|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24721374|NCT01573715|Cholinergic Agents|cholinergic agents|mesh-ancestor
24721375|NCT01573715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24721376|NCT01573715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721378|NCT01573741|Analgesics|analgesics|mesh-ancestor
24721379|NCT01573741|Sensory System Agents|sensory system agents|mesh-ancestor
24721380|NCT01573741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24721381|NCT01573741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721382|NCT01573741|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24721383|NCT01573741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24721384|NCT01573741|Anesthetics, General|anesthetics, general|mesh-ancestor
24721385|NCT01573741|Anesthetics|anesthetics|mesh-ancestor
24721392|NCT01573754|Antimalarials|antimalarials|mesh-ancestor
24615500|NCT01030042|Vitamin B Complex|vitamin b complex|mesh-ancestor
24615501|NCT01030042|Vitamins|vitamins|mesh-ancestor
24615502|NCT01030042|Micronutrients|micronutrients|mesh-ancestor
24615503|NCT01030042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24615504|NCT01030081|Amlodipine|amlodipine|mesh-list
24615505|NCT01030081|Nifedipine|nifedipine|mesh-list
24615506|NCT01030081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25068413|NCT03433534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25068414|NCT03433534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24615507|NCT01030081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24615508|NCT01030081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24615509|NCT01030081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615510|NCT01030081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24615511|NCT01030081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721430|NCT01574014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24721431|NCT01574027|Vitamin D|vitamin d|mesh-list
24721432|NCT01574027|Cholecalciferol|cholecalciferol|mesh-list
24721433|NCT01574027|Vitamins|vitamins|mesh-ancestor
24721434|NCT01574027|Micronutrients|micronutrients|mesh-ancestor
24721435|NCT01574027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721463|NCT01574313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721465|NCT01574313|Micronutrients|micronutrients|mesh-ancestor
25122520|NCT03093090|Natriuretic Agents|natriuretic agents|mesh-ancestor
25122521|NCT03093090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122522|NCT03093090|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25122523|NCT03093090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25122524|NCT03093090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122525|NCT03093168|Cyclophosphamide|cyclophosphamide|mesh-list
25122526|NCT03093168|Fludarabine|fludarabine|mesh-list
25122527|NCT03093168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25122528|NCT03093168|Immunologic Factors|immunologic factors|mesh-ancestor
25122529|NCT03093168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122530|NCT03093168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25122531|NCT03093168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25122532|NCT03093168|Alkylating Agents|alkylating agents|mesh-ancestor
25122533|NCT03093168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122534|NCT03093168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25122535|NCT03093168|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25122537|NCT03093103|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25122538|NCT03093103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122539|NCT03093103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25122540|NCT03093103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122541|NCT03092986|Paclitaxel|paclitaxel|mesh-list
25122542|NCT03092986|Vinblastine|vinblastine|mesh-list
25122543|NCT03092986|Carboplatin|carboplatin|mesh-list
25122544|NCT03092986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25122545|NCT03092986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25122546|NCT03092986|Tubulin Modulators|tubulin modulators|mesh-ancestor
25122547|NCT03092986|Antimitotic Agents|antimitotic agents|mesh-ancestor
25122548|NCT03092986|Mitosis Modulators|mitosis modulators|mesh-ancestor
25076676|NCT03371342|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24721532|NCT01575418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24437225|NCT00273026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25122550|NCT03092908|Acetic Acid|acetic acid|mesh-list
25122551|NCT03092908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25122552|NCT03092908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25122561|NCT03092765|Quetmolimab|quetmolimab|mesh-list
25122562|NCT03092765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25122563|NCT03092544|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25122564|NCT03092544|Dermatologic Agents|dermatologic agents|mesh-ancestor
25122565|NCT03092544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25122566|NCT03092544|Immunologic Factors|immunologic factors|mesh-ancestor
25122567|NCT03092544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122568|NCT03092310|Pancrelipase|pancrelipase|mesh-list
25122569|NCT03092310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25122570|NCT03092193|Naproxen|naproxen|mesh-list
25122571|NCT03092193|Esomeprazole|esomeprazole|mesh-list
25122572|NCT03092193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25122573|NCT03092193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25076687|NCT03371095|Infliximab|infliximab|mesh-list
24721545|NCT01575483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24721546|NCT01575483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721547|NCT01575483|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25693534|NCT02015676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721548|NCT01575483|Protease Inhibitors|protease inhibitors|mesh-ancestor
25693535|NCT02015676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25693536|NCT02015793|Adalimumab|adalimumab|mesh-list
24953596|NCT03883698|Sofosbuvir|sofosbuvir|mesh-list
24721549|NCT01575483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646711|NCT01204996|Mitosis Modulators|mitosis modulators|mesh-ancestor
24721550|NCT01575483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721552|NCT01575509|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24721595|NCT01575717|Micronutrients|micronutrients|mesh-ancestor
24721596|NCT01575717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721597|NCT01575717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24721598|NCT01575717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24721599|NCT01575782|Chloroquine|chloroquine|mesh-list
24721600|NCT01575782|Amebicides|amebicides|mesh-ancestor
24856807|NCT02286973|Coagulants|coagulants|mesh-ancestor
24856808|NCT02286986|Cannabidiol|cannabidiol|mesh-list
24721601|NCT01575782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24721602|NCT01575782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24721603|NCT01575782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24721604|NCT01575782|Antimalarials|antimalarials|mesh-ancestor
24721605|NCT01575782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24721606|NCT01575795|Ticagrelor|ticagrelor|mesh-list
24721607|NCT01575795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24721608|NCT01575795|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25122574|NCT03092193|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25122575|NCT03092193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25122576|NCT03092193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122577|NCT03092193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25122578|NCT03092193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25122579|NCT03092193|Analgesics|analgesics|mesh-ancestor
25122580|NCT03092193|Sensory System Agents|sensory system agents|mesh-ancestor
25122581|NCT03092193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25122582|NCT03092193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122583|NCT03092193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25122584|NCT03092193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25122587|NCT03092206|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25122588|NCT03092206|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25122589|NCT03092206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25122590|NCT03092206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25122591|NCT03092206|Antiviral Agents|antiviral agents|mesh-ancestor
24721609|NCT01575795|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24721671|NCT01576263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24721674|NCT01576315|Antifungal Agents|antifungal agents|mesh-ancestor
24721740|NCT01576692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24721750|NCT01576731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24721751|NCT01576731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24721752|NCT01576731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721753|NCT01576731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24721754|NCT01576731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24721755|NCT01576731|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24721756|NCT01576731|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24721757|NCT01576731|Protease Inhibitors|protease inhibitors|mesh-ancestor
24721758|NCT01576731|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24646889|NCT01205360|Sensory System Agents|sensory system agents|mesh-ancestor
24721759|NCT01576731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24721760|NCT01576731|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24721761|NCT01576731|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24721763|NCT01576770|Tetracaine|tetracaine|mesh-list
24721764|NCT01576770|Ethyl Chloride|ethyl chloride|mesh-list
24721765|NCT01576770|Anesthetics, Local|anesthetics, local|mesh-ancestor
24721783|NCT01577017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24721785|NCT01577017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721786|NCT01577017|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24721813|NCT01577121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721814|NCT01577199|Clomiphene|clomiphene|mesh-list
24721815|NCT01577199|Enclomiphene|enclomiphene|mesh-list
24721816|NCT01577199|Zuclomiphene|zuclomiphene|mesh-list
24721817|NCT01577199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24721818|NCT01577199|Hormone Antagonists|hormone antagonists|mesh-ancestor
24721819|NCT01577199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24721820|NCT01577199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693537|NCT02015793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25122592|NCT03092206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25122593|NCT03092206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25122594|NCT03092206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25122595|NCT03092206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25122596|NCT03092206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122597|NCT03092466|Ropivacaine|ropivacaine|mesh-list
25122598|NCT03092466|Anesthetics, Local|anesthetics, local|mesh-ancestor
25122599|NCT03092466|Anesthetics|anesthetics|mesh-ancestor
25122600|NCT03092466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25122601|NCT03092466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721821|NCT01577199|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24721822|NCT01577199|Fertility Agents|fertility agents|mesh-ancestor
24721823|NCT01577199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24721824|NCT01577199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24721825|NCT01577199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24721826|NCT01577342|Moxifloxacin|moxifloxacin|mesh-list
24721827|NCT01577342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24721861|NCT01577589|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
24721862|NCT01577589|Cephalosporins|cephalosporins|mesh-list
24721863|NCT01577589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24721864|NCT01577589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24721865|NCT01577693|Dutasteride|dutasteride|mesh-list
24721866|NCT01577693|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24721867|NCT01577693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24721868|NCT01577693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24721869|NCT01577693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721870|NCT01577693|Hormone Antagonists|hormone antagonists|mesh-ancestor
24721871|NCT01577693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24444118|NCT00296751|Sensory System Agents|sensory system agents|mesh-ancestor
24721916|NCT01577940|Anesthetics, Local|anesthetics, local|mesh-ancestor
24721917|NCT01577940|Anesthetics|anesthetics|mesh-ancestor
24721918|NCT01577940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24721919|NCT01577940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721920|NCT01577940|Sensory System Agents|sensory system agents|mesh-ancestor
24721921|NCT01577940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24721923|NCT01577992|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24721924|NCT01577992|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24721925|NCT01577992|Dopamine Agents|dopamine agents|mesh-ancestor
24722001|NCT01578265|Ondansetron|ondansetron|mesh-list
24722002|NCT01578265|Antiemetics|antiemetics|mesh-ancestor
24722003|NCT01578265|Autonomic Agents|autonomic agents|mesh-ancestor
24722004|NCT01578265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24722005|NCT01578265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722006|NCT01578265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24722007|NCT01578265|Antipruritics|antipruritics|mesh-ancestor
24722026|NCT01578343|Vidarabine|vidarabine|mesh-list
24647637|NCT01209845|Analgesics|analgesics|mesh-ancestor
24647638|NCT01209845|Sensory System Agents|sensory system agents|mesh-ancestor
24647639|NCT01209845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24722108|NCT01578564|SOR-C13|sor-c13|mesh-list
24722109|NCT01578564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24722110|NCT01578564|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24549725|NCT00717379|Hormones|hormones|mesh-ancestor
24615633|NCT01030796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24615635|NCT01030900|Alemtuzumab|alemtuzumab|mesh-list
24615636|NCT01030900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24722170|NCT01578824|Cholinergic Agents|cholinergic agents|mesh-ancestor
24722171|NCT01578824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24722172|NCT01578824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722174|NCT01578889|Immunologic Factors|immunologic factors|mesh-ancestor
24981663|NCT02220985|Antimetabolites|antimetabolites|mesh-ancestor
25122605|NCT03092076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25122606|NCT03092076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25122607|NCT03092076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25122608|NCT03092076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25122609|NCT03092076|Purinergic Agents|purinergic agents|mesh-ancestor
25122610|NCT03092076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25122611|NCT03092076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122612|NCT03092076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122614|NCT03091894|Propofol|propofol|mesh-list
25122615|NCT03091894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25122616|NCT03091894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25122617|NCT03091894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122618|NCT03091894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25122619|NCT03091894|Anesthetics, General|anesthetics, general|mesh-ancestor
25076731|NCT03370835|Metoprolol|metoprolol|mesh-list
24722175|NCT01578889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722176|NCT01578928|Pasireotide|pasireotide|mesh-list
24722177|NCT01578928|Hormones|hormones|mesh-ancestor
24722178|NCT01578928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24722179|NCT01578928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722180|NCT01579019|Ritonavir|ritonavir|mesh-list
24722181|NCT01579019|Ribavirin|ribavirin|mesh-list
24722182|NCT01579019|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24722183|NCT01579019|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24722184|NCT01579019|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24722185|NCT01579019|Protease Inhibitors|protease inhibitors|mesh-ancestor
24722240|NCT01579227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24722241|NCT01579227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24722242|NCT01579227|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24722243|NCT01579227|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24910289|NCT04301375|Tubulin Modulators|tubulin modulators|mesh-ancestor
24722244|NCT01579227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24722245|NCT01579227|Antioxidants|antioxidants|mesh-ancestor
24722246|NCT01579227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722247|NCT01579227|Protective Agents|protective agents|mesh-ancestor
24722291|NCT01579500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722292|NCT01579500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24722293|NCT01579500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24722294|NCT01579539|Methylprednisolone|methylprednisolone|mesh-list
24647671|NCT01209988|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24647672|NCT01209988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24647673|NCT01209988|Adrenergic Agents|adrenergic agents|mesh-ancestor
24647674|NCT01209988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25122625|NCT03091894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25122626|NCT03091894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25076745|NCT03370835|Antioxidants|antioxidants|mesh-ancestor
24722335|NCT01579734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24722336|NCT01579734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24722337|NCT01579734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24722338|NCT01579734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24722339|NCT01579734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24722340|NCT01579760|Aflibercept|aflibercept|mesh-list
24615692|NCT01031355|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24615694|NCT01031355|Calcium|calcium|mesh-list
24722559|NCT01581411|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24722560|NCT01581411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24722561|NCT01581411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24722562|NCT01581411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722563|NCT01581450|Nitrous Oxide|nitrous oxide|mesh-list
24722564|NCT01581450|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24722565|NCT01581450|Anesthetics, General|anesthetics, general|mesh-ancestor
24722566|NCT01581450|Anesthetics|anesthetics|mesh-ancestor
24722567|NCT01581450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24722568|NCT01581450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722569|NCT01581450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24722570|NCT01581450|Analgesics|analgesics|mesh-ancestor
24722571|NCT01581450|Sensory System Agents|sensory system agents|mesh-ancestor
24722572|NCT01581450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24722573|NCT01581476|Quinapril|quinapril|mesh-list
24722574|NCT01581476|Atorvastatin|atorvastatin|mesh-list
24722575|NCT01581476|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24722576|NCT01581476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24722577|NCT01581476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24722578|NCT01581476|Antimetabolites|antimetabolites|mesh-ancestor
24722579|NCT01581476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722580|NCT01581476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24722581|NCT01581476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24722582|NCT01581476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722583|NCT01581476|Protease Inhibitors|protease inhibitors|mesh-ancestor
24722584|NCT01581476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24722585|NCT01581515|Everolimus|everolimus|mesh-list
24722600|NCT01581775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722601|NCT01581775|Antimanic Agents|antimanic agents|mesh-ancestor
24722602|NCT01581775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24722603|NCT01581775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24722604|NCT01581775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24722605|NCT01581788|Valproic Acid|valproic acid|mesh-list
24722606|NCT01581788|Anticonvulsants|anticonvulsants|mesh-ancestor
24722607|NCT01581788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722608|NCT01581788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722609|NCT01581788|GABA Agents|gaba agents|mesh-ancestor
24722610|NCT01581788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24722611|NCT01581788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722612|NCT01581788|Antimanic Agents|antimanic agents|mesh-ancestor
25122628|NCT03091894|Adrenergic Agents|adrenergic agents|mesh-ancestor
25122629|NCT03091894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25122630|NCT03091894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122631|NCT03091868|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25122632|NCT03091868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25122633|NCT03091868|Immunologic Factors|immunologic factors|mesh-ancestor
25122634|NCT03091868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122635|NCT03091868|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25122636|NCT03091868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25122637|NCT03091868|Dopamine Agonists|dopamine agonists|mesh-ancestor
25122638|NCT03091868|Dopamine Agents|dopamine agents|mesh-ancestor
25122639|NCT03091868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25122640|NCT03091868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122641|NCT03091803|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
25122642|NCT03091803|Chelating Agents|chelating agents|mesh-ancestor
25122643|NCT03091803|Sequestering Agents|sequestering agents|mesh-ancestor
25122644|NCT03091803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722649|NCT01581866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24722650|NCT01581866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24722651|NCT01581866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24722652|NCT01581866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24722653|NCT01581866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24722655|NCT01581879|Ziprasidone|ziprasidone|mesh-list
25122673|NCT03091595|Drospirenone|drospirenone|mesh-list
24722656|NCT01581879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24722657|NCT01581879|Serotonin Agents|serotonin agents|mesh-ancestor
24722658|NCT01581879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24722659|NCT01581879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722660|NCT01581879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722661|NCT01581879|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24722662|NCT01581879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24722664|NCT01581879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24722666|NCT01581879|Dopamine Agents|dopamine agents|mesh-ancestor
24722667|NCT01581918|Carbamazepine|carbamazepine|mesh-list
24722699|NCT01582165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24722700|NCT01582165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24722701|NCT01582165|Antimetabolites|antimetabolites|mesh-ancestor
24722702|NCT01582165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722703|NCT01582165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24722704|NCT01582165|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24722713|NCT01582321|Cantharidin|cantharidin|mesh-list
24722799|NCT01582646|Tocolytic Agents|tocolytic agents|mesh-ancestor
24722800|NCT01582646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24722801|NCT01582646|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24722802|NCT01582646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24722803|NCT01582646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24722804|NCT01582646|Adrenergic Agents|adrenergic agents|mesh-ancestor
24680557|NCT01375348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24680558|NCT01375348|Narcotics|narcotics|mesh-ancestor
24680559|NCT01375348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24680560|NCT01375348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680561|NCT01375348|Analgesics|analgesics|mesh-ancestor
24680562|NCT01375348|Sensory System Agents|sensory system agents|mesh-ancestor
25068510|NCT03432884|Moxifloxacin|moxifloxacin|mesh-list
24722805|NCT01582646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24722806|NCT01582646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122646|NCT03091712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25122647|NCT03091712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122648|NCT03091699|Nicotine|nicotine|mesh-list
25122649|NCT03091699|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25122650|NCT03091699|Autonomic Agents|autonomic agents|mesh-ancestor
25122651|NCT03091699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25122652|NCT03091699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122653|NCT03091699|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25122654|NCT03091699|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25122655|NCT03091699|Cholinergic Agents|cholinergic agents|mesh-ancestor
25122656|NCT03091699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25122657|NCT03091699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122658|NCT03091543|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
25122659|NCT03091543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25122660|NCT03091543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122661|NCT03091543|Dopamine Agents|dopamine agents|mesh-ancestor
25122662|NCT03091543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25122663|NCT03091543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122664|NCT03091569|Vitamin K|vitamin k|mesh-list
25122665|NCT03091569|Vitamins|vitamins|mesh-ancestor
25122666|NCT03091569|Micronutrients|micronutrients|mesh-ancestor
25122667|NCT03091569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122668|NCT03091569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25122669|NCT03091569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24722808|NCT01582672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24722809|NCT01582672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24722811|NCT01582672|Growth Substances|growth substances|mesh-ancestor
24722812|NCT01582672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722813|NCT01582672|Growth Inhibitors|growth inhibitors|mesh-ancestor
24722814|NCT01582672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24722815|NCT01582672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722818|NCT01582711|Rifapentine|rifapentine|mesh-list
24615764|NCT01031667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24615765|NCT01031667|Antioxidants|antioxidants|mesh-ancestor
24615766|NCT01031719|Vaccines|vaccines|mesh-list
24722835|NCT01582737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615767|NCT01031719|Immunologic Factors|immunologic factors|mesh-ancestor
24722836|NCT01582737|Anticoagulants|anticoagulants|mesh-ancestor
24722837|NCT01582932|Calcipotriene|calcipotriene|mesh-list
24722838|NCT01582932|Dermatologic Agents|dermatologic agents|mesh-ancestor
24722839|NCT01582997|Dabrafenib|dabrafenib|mesh-list
24722840|NCT01582997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25122670|NCT03091569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122672|NCT03091569|Coagulants|coagulants|mesh-ancestor
25122674|NCT03091595|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25122675|NCT03091595|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25122676|NCT03091595|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25122677|NCT03091595|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25122678|NCT03091595|Contraceptive Agents|contraceptive agents|mesh-ancestor
25122679|NCT03091595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25122699|NCT03091504|Tocolytic Agents|tocolytic agents|mesh-ancestor
24722889|NCT01583244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24722890|NCT01583361|Oxaliplatin|oxaliplatin|mesh-list
25693538|NCT02015793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25693539|NCT02015819|Leucovorin|leucovorin|mesh-list
25693540|NCT02015819|Flucytosine|flucytosine|mesh-list
25693541|NCT02015819|Calcium|calcium|mesh-list
25693542|NCT02015819|Levoleucovorin|levoleucovorin|mesh-list
25693543|NCT02015819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24722891|NCT01583361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693544|NCT02015819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693545|NCT02015819|Antidotes|antidotes|mesh-ancestor
24722893|NCT01583426|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24722894|NCT01583426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24722895|NCT01583426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24722896|NCT01583426|Tubulin Modulators|tubulin modulators|mesh-ancestor
24722920|NCT01583439|Antimetabolites|antimetabolites|mesh-ancestor
24722921|NCT01583439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24722973|NCT01583842|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24722974|NCT01583842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24722975|NCT01583842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722976|NCT01583842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647809|NCT01210911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647810|NCT01210911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647811|NCT01210911|Antiviral Agents|antiviral agents|mesh-ancestor
24722977|NCT01583842|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24722978|NCT01583959|Folic Acid|folic acid|mesh-list
24722979|NCT01583959|Hematinics|hematinics|mesh-ancestor
24722980|NCT01583959|Vitamin B Complex|vitamin b complex|mesh-ancestor
24722981|NCT01583959|Vitamins|vitamins|mesh-ancestor
24722982|NCT01583959|Micronutrients|micronutrients|mesh-ancestor
24722983|NCT01583959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722984|NCT01583972|Vitamin A|vitamin a|mesh-list
24722985|NCT01583972|Retinol palmitate|retinol palmitate|mesh-list
24722986|NCT01583972|Vitamins|vitamins|mesh-ancestor
24722987|NCT01583972|Micronutrients|micronutrients|mesh-ancestor
24722988|NCT01583972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722994|NCT01584050|Folic Acid|folic acid|mesh-list
24723006|NCT01584076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723007|NCT01584076|Nootropic Agents|nootropic agents|mesh-ancestor
24723008|NCT01584115|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
24723009|NCT01584115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24723010|NCT01584115|Immunologic Factors|immunologic factors|mesh-ancestor
24723011|NCT01584115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723012|NCT01584206|Ezetimibe|ezetimibe|mesh-list
24723013|NCT01584206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24723014|NCT01584206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24723015|NCT01584206|Antimetabolites|antimetabolites|mesh-ancestor
24723016|NCT01584206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723018|NCT01584271|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24723019|NCT01584271|Carbamide Peroxide|carbamide peroxide|mesh-list
24723022|NCT01584297|Ketoconazole|ketoconazole|mesh-list
24723032|NCT01584297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723033|NCT01584297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24723034|NCT01584362|Oxfendazole|oxfendazole|mesh-list
24723035|NCT01584362|Anthelmintics|anthelmintics|mesh-ancestor
24723049|NCT01584492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24723050|NCT01584492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24723051|NCT01584492|Adrenergic Agents|adrenergic agents|mesh-ancestor
24549822|NCT00717652|Keratolytic Agents|keratolytic agents|mesh-ancestor
24723142|NCT01585415|Aldesleukin|aldesleukin|mesh-list
24723143|NCT01585415|Cyclophosphamide|cyclophosphamide|mesh-list
24723144|NCT01585415|Fludarabine|fludarabine|mesh-list
24723145|NCT01585415|Vemurafenib|vemurafenib|mesh-list
25122700|NCT03091504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25122701|NCT03091504|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25122702|NCT03091504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25122703|NCT03091504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25122704|NCT03091504|Adrenergic Agents|adrenergic agents|mesh-ancestor
25122705|NCT03091504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25122706|NCT03091504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122707|NCT03091166|Dexmedetomidine|dexmedetomidine|mesh-list
25122708|NCT03091166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25122709|NCT03091166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25122710|NCT03091166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122711|NCT03091166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25122712|NCT03091166|Analgesics|analgesics|mesh-ancestor
25122713|NCT03091166|Sensory System Agents|sensory system agents|mesh-ancestor
25122714|NCT03091166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25122715|NCT03091166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25122716|NCT03091166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25122717|NCT03091166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25122718|NCT03091166|Adrenergic Agents|adrenergic agents|mesh-ancestor
25122719|NCT03091166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25693546|NCT02015819|Protective Agents|protective agents|mesh-ancestor
25693547|NCT02015819|Vitamin B Complex|vitamin b complex|mesh-ancestor
25693548|NCT02015819|Vitamins|vitamins|mesh-ancestor
24683689|NCT01393548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25122720|NCT03091166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122721|NCT03091075|Oxandrolone|oxandrolone|mesh-list
25122722|NCT03091075|Androgens|androgens|mesh-ancestor
25122723|NCT03091075|Hormones|hormones|mesh-ancestor
25122724|NCT03091075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25122725|NCT03091075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122726|NCT03091075|Anabolic Agents|anabolic agents|mesh-ancestor
25122727|NCT03091257|Trametinib|trametinib|mesh-list
25122728|NCT03091257|Dabrafenib|dabrafenib|mesh-list
25122729|NCT03091257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25122730|NCT03091257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25122731|NCT03091257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24723146|NCT01585415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24723147|NCT01585415|Immunologic Factors|immunologic factors|mesh-ancestor
24723148|NCT01585415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723149|NCT01585415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24723150|NCT01585415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24723151|NCT01585415|Alkylating Agents|alkylating agents|mesh-ancestor
25122732|NCT03091257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122734|NCT03090971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25122735|NCT03090971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25122737|NCT03090971|Sensory System Agents|sensory system agents|mesh-ancestor
24723152|NCT01585415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723153|NCT01585415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24723154|NCT01585415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24723155|NCT01585415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24723156|NCT01585415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24723157|NCT01585415|Antiviral Agents|antiviral agents|mesh-ancestor
24723205|NCT01585870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723206|NCT01585935|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24723207|NCT01585935|SMOFlipid|smoflipid|mesh-list
24723208|NCT01585935|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24647573|NCT01209455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24723209|NCT01585935|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24723210|NCT01585935|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24723285|NCT01586299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723287|NCT01586442|Spironolactone|spironolactone|mesh-list
24723288|NCT01586442|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24723383|NCT01587222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24723384|NCT01587222|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24723385|NCT01587222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24723386|NCT01587222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24723387|NCT01587222|Adrenergic Agents|adrenergic agents|mesh-ancestor
24723388|NCT01587222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24723389|NCT01587222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723400|NCT01587313|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
24723403|NCT01587313|Natriuretic Agents|natriuretic agents|mesh-ancestor
24723404|NCT01587313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723405|NCT01587313|Vasodilator Agents|vasodilator agents|mesh-ancestor
24723406|NCT01587313|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24723407|NCT01587313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723408|NCT01587313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24723409|NCT01587326|Citalopram|citalopram|mesh-list
24723410|NCT01587326|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24723411|NCT01587326|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24723412|NCT01587326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24723413|NCT01587326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723428|NCT01587339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723429|NCT01587339|Anticonvulsants|anticonvulsants|mesh-ancestor
24723440|NCT01587378|Metformin|metformin|mesh-list
24723443|NCT01587430|Cytarabine|cytarabine|mesh-list
25045669|NCT00928590|Travoprost|travoprost|mesh-list
24723573|NCT01588093|Mecasermin|mecasermin|mesh-list
24723574|NCT01588093|Growth Substances|growth substances|mesh-ancestor
24723575|NCT01588093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723576|NCT01588171|Enoxaparin|enoxaparin|mesh-list
24723577|NCT01588171|Bemiparin|bemiparin|mesh-list
24723578|NCT01588171|Anticoagulants|anticoagulants|mesh-ancestor
24723579|NCT01588171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25693549|NCT02015819|Micronutrients|micronutrients|mesh-ancestor
25693550|NCT02015819|Antifungal Agents|antifungal agents|mesh-ancestor
25068673|NCT03432312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068674|NCT03432312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25068675|NCT03432312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24723580|NCT01588171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24723678|NCT01588782|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24723679|NCT01588795|Vitamin D|vitamin d|mesh-list
24723680|NCT01588795|Cholecalciferol|cholecalciferol|mesh-list
24723681|NCT01588795|Diuretics|diuretics|mesh-list
25122738|NCT03090971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25122739|NCT03090971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122741|NCT03090971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25122742|NCT03090971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25122743|NCT03090971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25122744|NCT03090971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122745|NCT03090698|Triamcinolone|triamcinolone|mesh-list
25122746|NCT03090698|Hylan|hylan|mesh-list
25122747|NCT03090698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25122748|NCT03090698|Glucocorticoids|glucocorticoids|mesh-ancestor
25122749|NCT03090698|Hormones|hormones|mesh-ancestor
25076821|NCT03370562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723734|NCT01588912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723736|NCT01588912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24723738|NCT01588925|Dexamethasone acetate|dexamethasone acetate|mesh-list
24723739|NCT01588925|BB 1101|bb 1101|mesh-list
24723740|NCT01588925|Hyaluronic Acid|hyaluronic acid|mesh-list
24812979|NCT02055690|Fosbretabulin|fosbretabulin|mesh-list
24723741|NCT01588925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24723742|NCT01588925|Antiemetics|antiemetics|mesh-ancestor
24723743|NCT01588925|Autonomic Agents|autonomic agents|mesh-ancestor
24723744|NCT01588925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24723745|NCT01588925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723746|NCT01588925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24723747|NCT01588925|Glucocorticoids|glucocorticoids|mesh-ancestor
24723748|NCT01588925|Hormones|hormones|mesh-ancestor
24723793|NCT01589081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723794|NCT01589081|Progestins|progestins|mesh-ancestor
24723795|NCT01589081|Hormones|hormones|mesh-ancestor
24723796|NCT01589081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24723797|NCT01589146|Heparin|heparin|mesh-list
24723798|NCT01589146|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24723919|NCT01589809|Antimetabolites|antimetabolites|mesh-ancestor
24723920|NCT01589809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550133|NCT00719173|Antiemetics|antiemetics|mesh-ancestor
24615818|NCT01032057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24615819|NCT01032057|Antimetabolites|antimetabolites|mesh-ancestor
24615820|NCT01032057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615821|NCT01032057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24615822|NCT01032057|Antiviral Agents|antiviral agents|mesh-ancestor
24615823|NCT01032057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24615824|NCT01032057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615825|NCT01032057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25122750|NCT03090698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25122751|NCT03090698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122752|NCT03090698|Viscosupplements|viscosupplements|mesh-ancestor
25122753|NCT03090698|Protective Agents|protective agents|mesh-ancestor
25122768|NCT03090880|Tinzaparin|tinzaparin|mesh-list
25122769|NCT03090880|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25122771|NCT03090880|Anticoagulants|anticoagulants|mesh-ancestor
25122772|NCT03090880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25122773|NCT03090880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25122774|NCT03090880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122775|NCT03090503|Risperidone|risperidone|mesh-list
25122776|NCT03090503|Aripiprazole|aripiprazole|mesh-list
25122777|NCT03090503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25122778|NCT03090503|Serotonin Agents|serotonin agents|mesh-ancestor
25122779|NCT03090503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24724112|NCT01591122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122783|NCT03090503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25122784|NCT03090503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25693551|NCT02015819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25693552|NCT02015819|Antimetabolites|antimetabolites|mesh-ancestor
25709261|NCT02263547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25122785|NCT03090503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25122786|NCT03090503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25122787|NCT03090503|Dopamine Agents|dopamine agents|mesh-ancestor
25122788|NCT03090503|Antidepressive Agents|antidepressive agents|mesh-ancestor
25122789|NCT03090503|Dopamine Agonists|dopamine agonists|mesh-ancestor
25122790|NCT03090503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25122791|NCT03090503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25122792|NCT03090503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25122793|NCT03090503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25122794|NCT03090490|Antipsychotic Agents|antipsychotic agents|mesh-list
25122795|NCT03090490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24724113|NCT01591122|Hormone Antagonists|hormone antagonists|mesh-ancestor
24724114|NCT01591122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24724116|NCT01591135|Fluorouracil|fluorouracil|mesh-list
24724117|NCT01591135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24724118|NCT01591135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24724119|NCT01591135|Tubulin Modulators|tubulin modulators|mesh-ancestor
24724120|NCT01591135|Antimitotic Agents|antimitotic agents|mesh-ancestor
24724121|NCT01591135|Mitosis Modulators|mitosis modulators|mesh-ancestor
24724122|NCT01591135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724137|NCT01591226|Citric Acid|citric acid|mesh-list
24724138|NCT01591226|Sodium Citrate|sodium citrate|mesh-list
24724139|NCT01591226|Anticoagulants|anticoagulants|mesh-ancestor
24724140|NCT01591226|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24724141|NCT01591226|Chelating Agents|chelating agents|mesh-ancestor
24724142|NCT01591226|Sequestering Agents|sequestering agents|mesh-ancestor
24724143|NCT01591226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724186|NCT01591850|Ritonavir|ritonavir|mesh-list
24724187|NCT01591850|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24724188|NCT01591850|Rifampin|rifampin|mesh-list
24724189|NCT01591850|Ketoconazole|ketoconazole|mesh-list
24724190|NCT01591850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24724191|NCT01591850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24724192|NCT01591850|Protease Inhibitors|protease inhibitors|mesh-ancestor
24724193|NCT01591850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724194|NCT01591850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724288|NCT01592136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724386|NCT01592318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24724389|NCT01592526|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24724390|NCT01592526|Autonomic Agents|autonomic agents|mesh-ancestor
24724391|NCT01592526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24724392|NCT01592526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724393|NCT01592526|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24724414|NCT01592981|Alkylating Agents|alkylating agents|mesh-ancestor
24724415|NCT01592981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724416|NCT01592981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24724474|NCT01593163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24724475|NCT01593163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724476|NCT01593163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724477|NCT01593280|Morphine|morphine|mesh-list
24724478|NCT01593280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24724479|NCT01593280|Narcotics|narcotics|mesh-ancestor
24724483|NCT01593280|Sensory System Agents|sensory system agents|mesh-ancestor
25122796|NCT03090490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25122797|NCT03090490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122798|NCT03090490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25122799|NCT03090516|Donepezil|donepezil|mesh-list
25122800|NCT03090516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25122801|NCT03090516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25122802|NCT03090516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122803|NCT03090516|Cholinergic Agents|cholinergic agents|mesh-ancestor
25122804|NCT03090516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25122805|NCT03090516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122806|NCT03090516|Nootropic Agents|nootropic agents|mesh-ancestor
25122807|NCT03090269|Methylphenidate|methylphenidate|mesh-list
25122808|NCT03090269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25122809|NCT03090269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122810|NCT03090269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25122876|NCT03089671|Dermatologic Agents|dermatologic agents|mesh-ancestor
25122815|NCT03090269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25122817|NCT03090087|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25122818|NCT03090087|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25122819|NCT03090087|Purinergic Agonists|purinergic agonists|mesh-ancestor
25122820|NCT03090087|Purinergic Agents|purinergic agents|mesh-ancestor
25122821|NCT03090087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25693553|NCT02015819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685165|NCT01798004|Antimitotic Agents|antimitotic agents|mesh-ancestor
24685166|NCT01798004|Mitosis Modulators|mitosis modulators|mesh-ancestor
24685167|NCT01798004|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24685168|NCT01798004|Protective Agents|protective agents|mesh-ancestor
24685170|NCT01724606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24685171|NCT01724606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24685172|NCT01724606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24685173|NCT01724606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685174|NCT01460810|Silicon|silicon|mesh-list
24685175|NCT01460810|Trace Elements|trace elements|mesh-ancestor
24685176|NCT01460810|Micronutrients|micronutrients|mesh-ancestor
24685177|NCT01460810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685293|NCT05274113|Dexamethasone|dexamethasone|mesh-list
24685294|NCT05274113|Ropivacaine|ropivacaine|mesh-list
24685295|NCT05274113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24724484|NCT01593280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24724485|NCT01593293|Pemetrexed|pemetrexed|mesh-list
24724486|NCT01593293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24724487|NCT01593293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724488|NCT01593293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724489|NCT01593293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24724500|NCT01593319|Anesthetics, Local|anesthetics, local|mesh-ancestor
24724506|NCT01593332|Rituximab|rituximab|mesh-list
24724554|NCT01593488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24724555|NCT01593488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24724556|NCT01593488|Immunologic Factors|immunologic factors|mesh-ancestor
24724557|NCT01593488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724558|NCT01593501|Vitamin D|vitamin d|mesh-list
24724559|NCT01593501|Cholecalciferol|cholecalciferol|mesh-list
24724560|NCT01593501|Vitamins|vitamins|mesh-ancestor
24724561|NCT01593501|Micronutrients|micronutrients|mesh-ancestor
24724562|NCT01593501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724563|NCT01593501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24724564|NCT01593501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24724633|NCT01593930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25122822|NCT03090087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122823|NCT03090087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122831|NCT03089957|Urinastatin|urinastatin|mesh-list
25122832|NCT03089957|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25122833|NCT03089957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25122834|NCT03089957|Protease Inhibitors|protease inhibitors|mesh-ancestor
24724634|NCT01593930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724635|NCT01593930|Sensory System Agents|sensory system agents|mesh-ancestor
24724636|NCT01593930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24724637|NCT01593930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24647882|NCT01211275|Pemetrexed|pemetrexed|mesh-list
24724638|NCT01593930|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24724639|NCT01593930|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24724640|NCT01593930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24724642|NCT01593995|Mitogens|mitogens|mesh-list
24724739|NCT01594489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24724740|NCT01594489|Autonomic Agents|autonomic agents|mesh-ancestor
24724741|NCT01594489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24724742|NCT01594489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724743|NCT01594489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24724751|NCT01594489|Purinergic Agents|purinergic agents|mesh-ancestor
24724752|NCT01594489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24724842|NCT01595009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24724843|NCT01595009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25693554|NCT02016105|Adalimumab|adalimumab|mesh-list
25693555|NCT02016105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25693556|NCT02016105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25693557|NCT02016170|Ticagrelor|ticagrelor|mesh-list
25693558|NCT02016170|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25693559|NCT02016170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25693560|NCT02016170|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25693561|NCT02016170|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25693562|NCT02016170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25693563|NCT02016170|Purinergic Agents|purinergic agents|mesh-ancestor
25693564|NCT02016170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25693565|NCT02016170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693566|NCT02016170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693567|NCT02016183|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24611623|NCT01010139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611625|NCT01010139|Sensory System Agents|sensory system agents|mesh-ancestor
24611626|NCT01010139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24724844|NCT01595009|Immunologic Factors|immunologic factors|mesh-ancestor
24724845|NCT01595009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724846|NCT01595022|Contraceptive Agents|contraceptive agents|mesh-list
24724902|NCT01595633|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24724903|NCT01595633|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24724904|NCT01595633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25122875|NCT03089671|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24724905|NCT01595633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725167|NCT01596647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24725168|NCT01596647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24725169|NCT01596647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24725170|NCT01596647|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24725171|NCT01596660|Bupivacaine|bupivacaine|mesh-list
24725172|NCT01596660|Anesthetics, Local|anesthetics, local|mesh-ancestor
24725173|NCT01596660|Anesthetics|anesthetics|mesh-ancestor
24725174|NCT01596660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24725175|NCT01596660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725176|NCT01596660|Sensory System Agents|sensory system agents|mesh-ancestor
24725177|NCT01596660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24725178|NCT01596673|Hydrocodone|hydrocodone|mesh-list
24725198|NCT01596764|Naloxone|naloxone|mesh-list
24725245|NCT01596868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24725246|NCT01596868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24725247|NCT01596868|Antimetabolites|antimetabolites|mesh-ancestor
24910544|NCT04296695|Tenofovir|tenofovir|mesh-list
24725248|NCT01596868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725249|NCT01596868|Antiviral Agents|antiviral agents|mesh-ancestor
24725250|NCT01596868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24725387|NCT01597531|Incretins|incretins|mesh-ancestor
24725388|NCT01597531|Hormones|hormones|mesh-ancestor
24437226|NCT00273026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122837|NCT03090048|Vitamin A|vitamin a|mesh-list
25122838|NCT03090048|Azithromycin|azithromycin|mesh-list
25122839|NCT03090048|Retinol palmitate|retinol palmitate|mesh-list
25122840|NCT03090048|Vitamins|vitamins|mesh-ancestor
25122841|NCT03090048|Micronutrients|micronutrients|mesh-ancestor
25122842|NCT03090048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122843|NCT03090048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25122844|NCT03090048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25122845|NCT03090048|Antioxidants|antioxidants|mesh-ancestor
25122846|NCT03090048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122847|NCT03090048|Protective Agents|protective agents|mesh-ancestor
25122848|NCT03090048|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25122849|NCT03090048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25122850|NCT03090035|Interferons|interferons|mesh-list
25122851|NCT03090035|Ribavirin|ribavirin|mesh-list
25122852|NCT03090035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25122853|NCT03090035|Antiviral Agents|antiviral agents|mesh-ancestor
25122854|NCT03090035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25122855|NCT03090035|Antimetabolites|antimetabolites|mesh-ancestor
25122856|NCT03090035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122857|NCT03090009|Flurbiprofen|flurbiprofen|mesh-list
25122858|NCT03090009|Analgesics|analgesics|mesh-ancestor
25122859|NCT03090009|Sensory System Agents|sensory system agents|mesh-ancestor
25122860|NCT03090009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25122861|NCT03090009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122862|NCT03090009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25122863|NCT03090009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24725389|NCT01597531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24647996|NCT01211808|Diltiazem|diltiazem|mesh-list
24450582|NCT00319709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24450583|NCT00319709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24450584|NCT00319709|Adrenergic Agents|adrenergic agents|mesh-ancestor
24450585|NCT00319709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24725405|NCT01597648|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24725406|NCT01597648|Antiviral Agents|antiviral agents|mesh-ancestor
24725407|NCT01597648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24725412|NCT01597661|Bupropion|bupropion|mesh-list
25693568|NCT02016183|Candesartan|candesartan|mesh-list
25693569|NCT02016183|Candesartan cilexetil|candesartan cilexetil|mesh-list
25693570|NCT02016183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25693571|NCT02016183|Diuretics|diuretics|mesh-ancestor
25693572|NCT02016183|Natriuretic Agents|natriuretic agents|mesh-ancestor
24686618|NCT04679818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686619|NCT04679818|Analgesics|analgesics|mesh-ancestor
24686620|NCT04679818|Sensory System Agents|sensory system agents|mesh-ancestor
24686621|NCT04679818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24686622|NCT04679818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24686623|NCT04679818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24686624|NCT04679818|Anesthetics, General|anesthetics, general|mesh-ancestor
24686625|NCT04679818|Anesthetics|anesthetics|mesh-ancestor
24686626|NCT04674514|Dexamethasone|dexamethasone|mesh-list
24686627|NCT04674514|Lenalidomide|lenalidomide|mesh-list
24686629|NCT04674514|Antiemetics|antiemetics|mesh-ancestor
24686659|NCT04641702|Atropine|atropine|mesh-list
24686660|NCT04641702|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24686661|NCT04641702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25068769|NCT03431831|Bupropion|bupropion|mesh-list
25122864|NCT03090009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25122865|NCT03090009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25122866|NCT03090009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25122867|NCT03090009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25122868|NCT03090009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122869|NCT03089723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25122870|NCT03089671|Vitamins|vitamins|mesh-list
25122871|NCT03089671|Riboflavin|riboflavin|mesh-list
25122872|NCT03089671|Vitamin B Complex|vitamin b complex|mesh-list
25122873|NCT03089671|Micronutrients|micronutrients|mesh-ancestor
25122874|NCT03089671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122877|NCT03089645|Docetaxel|docetaxel|mesh-list
25122878|NCT03089645|Durvalumab|durvalumab|mesh-list
25122879|NCT03089645|Tremelimumab|tremelimumab|mesh-list
25122880|NCT03089645|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24725473|NCT01597817|Hemostatics|hemostatics|mesh-ancestor
24725474|NCT01597817|Coagulants|coagulants|mesh-ancestor
24725618|NCT01598584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725706|NCT01599013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24725707|NCT01599013|Tubulin Modulators|tubulin modulators|mesh-ancestor
24725708|NCT01599013|Antimitotic Agents|antimitotic agents|mesh-ancestor
24616127|NCT01034124|Anesthetics, General|anesthetics, general|mesh-ancestor
24616128|NCT01034124|Anesthetics|anesthetics|mesh-ancestor
24616129|NCT01034124|GABA Modulators|gaba modulators|mesh-ancestor
24616130|NCT01034124|GABA Agents|gaba agents|mesh-ancestor
24616131|NCT01034124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24616133|NCT01034124|Anticoagulants|anticoagulants|mesh-ancestor
24550416|NCT00720512|Vitamins|vitamins|mesh-ancestor
24725766|NCT01599468|Hemostatics|hemostatics|mesh-ancestor
24725767|NCT01599468|Coagulants|coagulants|mesh-ancestor
24725769|NCT01599572|Trace Elements|trace elements|mesh-ancestor
24725809|NCT01599884|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24725810|NCT01599884|Antiviral Agents|antiviral agents|mesh-ancestor
24725811|NCT01599884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25693573|NCT02016183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693574|NCT02016183|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25693575|NCT02016183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25693576|NCT02016183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693577|NCT02016183|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25693578|NCT02016183|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25693579|NCT02016482|Adalimumab|adalimumab|mesh-list
25693580|NCT02016482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25693581|NCT02016482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25693582|NCT02016625|Cyclosporine|cyclosporine|mesh-list
25693583|NCT02016625|Tacrolimus|tacrolimus|mesh-list
25693584|NCT02016625|Cyclosporins|cyclosporins|mesh-list
25693585|NCT02016625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25693586|NCT02016625|Immunologic Factors|immunologic factors|mesh-ancestor
25693587|NCT02016625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709262|NCT02263547|Immunologic Factors|immunologic factors|mesh-ancestor
25709263|NCT02263547|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25709264|NCT02263547|Antimetabolites|antimetabolites|mesh-ancestor
25709265|NCT02263547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709266|NCT02263547|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25709267|NCT02263547|Sequestering Agents|sequestering agents|mesh-ancestor
25709268|NCT02264353|Donepezil|donepezil|mesh-list
25709269|NCT02264353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24611755|NCT01010581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24611756|NCT01010581|Immunologic Factors|immunologic factors|mesh-ancestor
24611757|NCT01010581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24611758|NCT01010581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24611759|NCT01010581|Hematinics|hematinics|mesh-ancestor
24725812|NCT01599884|Expectorants|expectorants|mesh-ancestor
24725813|NCT01599884|Respiratory System Agents|respiratory system agents|mesh-ancestor
24725814|NCT01599884|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24725815|NCT01599884|Antioxidants|antioxidants|mesh-ancestor
24725816|NCT01599884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725817|NCT01599884|Protective Agents|protective agents|mesh-ancestor
24616166|NCT01034410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24616167|NCT01034410|Immunologic Factors|immunologic factors|mesh-ancestor
24616168|NCT01034410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616169|NCT01034514|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
24616170|NCT01034514|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24616171|NCT01034514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616172|NCT01034683|Leucovorin|leucovorin|mesh-list
24616173|NCT01034683|Antidotes|antidotes|mesh-ancestor
24616174|NCT01034683|Protective Agents|protective agents|mesh-ancestor
25122882|NCT03089645|Tubulin Modulators|tubulin modulators|mesh-ancestor
25122883|NCT03089645|Antimitotic Agents|antimitotic agents|mesh-ancestor
25122884|NCT03089645|Mitosis Modulators|mitosis modulators|mesh-ancestor
25122885|NCT03089645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122886|NCT03089645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25122887|NCT03089645|Immunologic Factors|immunologic factors|mesh-ancestor
24856929|NCT02287870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24648383|NCT01213979|Ferric Compounds|ferric compounds|mesh-list
25122888|NCT03089645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122889|NCT03089567|Listerine|listerine|mesh-list
25122890|NCT03089567|Fluorides|fluorides|mesh-list
25122891|NCT03089567|Sodium Fluoride|sodium fluoride|mesh-list
25122892|NCT03089567|Cariostatic Agents|cariostatic agents|mesh-ancestor
25122893|NCT03089567|Protective Agents|protective agents|mesh-ancestor
25122894|NCT03089567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122895|NCT03089567|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25122896|NCT03089567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25122897|NCT03089658|Avelumab|avelumab|mesh-list
25045664|NCT00929968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25045665|NCT00929968|Respiratory System Agents|respiratory system agents|mesh-ancestor
25045666|NCT00929968|Dermatologic Agents|dermatologic agents|mesh-ancestor
25045667|NCT00929968|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25045668|NCT00928590|Timolol|timolol|mesh-list
25045670|NCT00928590|Cloprostenol|cloprostenol|mesh-list
25045671|NCT00928590|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25045672|NCT00928590|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25045673|NCT00928590|Adrenergic Agents|adrenergic agents|mesh-ancestor
25045674|NCT00928590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25045675|NCT00928590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045676|NCT00928590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045677|NCT00928590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25045678|NCT00928590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25045679|NCT00928590|Luteolytic Agents|luteolytic agents|mesh-ancestor
25045680|NCT00928590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25045681|NCT00928590|Contraceptive Agents|contraceptive agents|mesh-ancestor
24725958|NCT01600807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24725959|NCT01600807|Immunologic Factors|immunologic factors|mesh-ancestor
24725960|NCT01600807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725983|NCT01601002|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24725984|NCT01601002|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24725985|NCT01601002|Serotonin Agents|serotonin agents|mesh-ancestor
25045682|NCT00928590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25045683|NCT00928590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25045685|NCT00927914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693588|NCT02016625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25693589|NCT02016625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693590|NCT02016625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693591|NCT02016625|Antifungal Agents|antifungal agents|mesh-ancestor
25693592|NCT02016625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25693593|NCT02016625|Dermatologic Agents|dermatologic agents|mesh-ancestor
25693594|NCT02016625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24687637|NCT03858621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24687708|NCT03777462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687709|NCT03777462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24687711|NCT03777462|Antiviral Agents|antiviral agents|mesh-ancestor
24687712|NCT03777462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24687713|NCT03777462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24687714|NCT03777462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24687715|NCT03777462|Immunologic Factors|immunologic factors|mesh-ancestor
24687716|NCT03777462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953588|NCT03883347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24953589|NCT03883347|Adrenergic Agents|adrenergic agents|mesh-ancestor
24953590|NCT03883347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24953591|NCT03883347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687833|NCT03659799|Insulin Aspart|insulin aspart|mesh-list
25045686|NCT00927914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045687|NCT00927641|Ketoprofen|ketoprofen|mesh-list
25045688|NCT00927641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25045689|NCT00927641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25045690|NCT00927641|Analgesics|analgesics|mesh-ancestor
25045691|NCT00927641|Sensory System Agents|sensory system agents|mesh-ancestor
25045692|NCT00927641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25045693|NCT00927641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045694|NCT00927641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25045695|NCT00927641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25045696|NCT00927641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25045697|NCT00927641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25045698|NCT00927641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045699|NCT00925535|Rifabutin|rifabutin|mesh-list
25045700|NCT00925535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25045701|NCT00925535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25045702|NCT00925535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25045703|NCT00925535|Antitubercular Agents|antitubercular agents|mesh-ancestor
25045704|NCT00924833|Carvedilol|carvedilol|mesh-list
25045705|NCT00924833|Nebivolol|nebivolol|mesh-list
25045706|NCT00924833|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25045707|NCT00924833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25045708|NCT00924833|Adrenergic Agents|adrenergic agents|mesh-ancestor
25045709|NCT00924833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25045710|NCT00924833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725986|NCT01601002|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24726052|NCT01601366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24726053|NCT01601509|Tramazoline|tramazoline|mesh-list
24726054|NCT01601509|Sympathomimetics|sympathomimetics|mesh-ancestor
24726055|NCT01601509|Autonomic Agents|autonomic agents|mesh-ancestor
24726056|NCT01601509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24726061|NCT01601561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726062|NCT01601730|Dexetimide|dexetimide|mesh-list
24726063|NCT01601730|Modafinil|modafinil|mesh-list
25045712|NCT00924833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25045713|NCT00924833|Antioxidants|antioxidants|mesh-ancestor
25693595|NCT02016716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25693596|NCT02016716|Immunologic Factors|immunologic factors|mesh-ancestor
25693597|NCT02016716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693598|NCT02016885|Glycopyrrolate|glycopyrrolate|mesh-list
25693599|NCT02016885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25693600|NCT02016885|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25693601|NCT02016885|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25693602|NCT02016885|Cholinergic Agents|cholinergic agents|mesh-ancestor
25693603|NCT02016885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25693604|NCT02016885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693605|NCT02016885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693606|NCT02016898|Mitomycins|mitomycins|mesh-list
25693607|NCT02016898|Mitomycin|mitomycin|mesh-list
25693608|NCT02016898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25693609|NCT02016898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693610|NCT02016898|Alkylating Agents|alkylating agents|mesh-ancestor
25709270|NCT02264353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709271|NCT02264353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709272|NCT02264353|Cholinergic Agents|cholinergic agents|mesh-ancestor
25709273|NCT02264353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25709274|NCT02264353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045714|NCT00924833|Protective Agents|protective agents|mesh-ancestor
25045715|NCT00924833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25045716|NCT00924833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25045717|NCT00924833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25045718|NCT00924833|Vasodilator Agents|vasodilator agents|mesh-ancestor
25045719|NCT00924833|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25122900|NCT03089333|Dapagliflozin|dapagliflozin|mesh-list
25122901|NCT03089333|Glyburide|glyburide|mesh-list
25122902|NCT03089333|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25122970|NCT03088254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25122906|NCT03089073|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25122908|NCT03089073|Coagulants|coagulants|mesh-ancestor
25122909|NCT03089073|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25122910|NCT03089073|Natriuretic Agents|natriuretic agents|mesh-ancestor
25122911|NCT03089073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122912|NCT03088891|Antioxidants|antioxidants|mesh-list
25122913|NCT03088891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122914|NCT03088891|Protective Agents|protective agents|mesh-ancestor
25122915|NCT03088891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122916|NCT03088722|Contraceptive Agents|contraceptive agents|mesh-list
25122917|NCT03088722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25122918|NCT03088722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122919|NCT03088631|Metformin|metformin|mesh-list
25122920|NCT03088631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25122921|NCT03088631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122922|NCT03088670|Metformin|metformin|mesh-list
25122923|NCT03088670|Vildagliptin|vildagliptin|mesh-list
25122924|NCT03088670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25122925|NCT03088670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122929|NCT03088670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122931|NCT03088709|Cyclophosphamide|cyclophosphamide|mesh-list
25122932|NCT03088709|Tacrolimus|tacrolimus|mesh-list
25122933|NCT03088709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25122934|NCT03088709|Immunologic Factors|immunologic factors|mesh-ancestor
25122935|NCT03088709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122936|NCT03088709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25122937|NCT03088709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25122938|NCT03088709|Alkylating Agents|alkylating agents|mesh-ancestor
25122939|NCT03088709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122940|NCT03088709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25122941|NCT03088709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25122942|NCT03088709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25122943|NCT03088709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25122944|NCT03088709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25122945|NCT03088709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24648437|NCT01214408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648438|NCT01214486|Raltegravir Potassium|raltegravir potassium|mesh-list
24648439|NCT01214486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24648440|NCT01214486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25122946|NCT03088709|Antitubercular Agents|antitubercular agents|mesh-ancestor
25122947|NCT03088709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25122948|NCT03088709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25122949|NCT03088644|(18)F-JNJ-64413739|(18)f-jnj-64413739|mesh-list
25122950|NCT03088644|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25122951|NCT03088644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122952|NCT03088358|Enoxaparin|enoxaparin|mesh-list
25122953|NCT03088358|Anticoagulants|anticoagulants|mesh-ancestor
25122954|NCT03088358|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25122955|NCT03088358|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25122956|NCT03088358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122957|NCT03088254|Amlodipine|amlodipine|mesh-list
25122958|NCT03088254|Telmisartan|telmisartan|mesh-list
25122959|NCT03088254|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25122960|NCT03088254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25122961|NCT03088254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25122962|NCT03088254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25122963|NCT03088254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25122964|NCT03088254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25122965|NCT03088254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25122966|NCT03088254|Vasodilator Agents|vasodilator agents|mesh-ancestor
25122967|NCT03088254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25069084|NCT03429179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25069086|NCT03429127|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25069087|NCT03429127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25069126|NCT03428802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069127|NCT03428685|Dydrogesterone|dydrogesterone|mesh-list
25069128|NCT03428685|Progestins|progestins|mesh-ancestor
25069129|NCT03428685|Hormones|hormones|mesh-ancestor
25069130|NCT03428685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25122968|NCT03088254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25122969|NCT03088254|Antimetabolites|antimetabolites|mesh-ancestor
25122971|NCT03088254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25122972|NCT03088254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24799555|NCT01969656|Vitamins|vitamins|mesh-ancestor
25122986|NCT03088371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24727082|NCT01607970|Oxytocics|oxytocics|mesh-ancestor
24726193|NCT01602250|Ropivacaine|ropivacaine|mesh-list
24726194|NCT01602250|Levobupivacaine|levobupivacaine|mesh-list
24726195|NCT01602250|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24726215|NCT01602302|Infliximab|infliximab|mesh-list
24726216|NCT01602302|Certolizumab Pegol|certolizumab pegol|mesh-list
24726217|NCT01602302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24726218|NCT01602302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24513978|NCT00586911|Betaine|betaine|mesh-list
24726233|NCT01602406|Trastuzumab|trastuzumab|mesh-list
25123023|NCT03088280|Thymoglobulin|thymoglobulin|mesh-list
25123024|NCT03088280|Immunologic Factors|immunologic factors|mesh-ancestor
25123025|NCT03088280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123026|NCT03088280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25123027|NCT03088306|Acetaminophen|acetaminophen|mesh-list
25123028|NCT03088306|Fentanyl|fentanyl|mesh-list
25123029|NCT03088306|Ketamine|ketamine|mesh-list
24726292|NCT01602757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24726293|NCT01602757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24726298|NCT01602822|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24726357|NCT01602913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24726358|NCT01602913|Antidepressive Agents|antidepressive agents|mesh-ancestor
24726443|NCT01603212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24726444|NCT01603212|Immunologic Factors|immunologic factors|mesh-ancestor
24726520|NCT01603693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726521|NCT01603745|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
24726522|NCT01603745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24726523|NCT01603745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726618|NCT01604811|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24726619|NCT01604811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24726620|NCT01604811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24726621|NCT01604811|Adrenergic Agents|adrenergic agents|mesh-ancestor
25693611|NCT02016898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693612|NCT02016898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25693613|NCT02016898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693614|NCT02017015|Gemcitabine|gemcitabine|mesh-list
25693615|NCT02017015|Paclitaxel|paclitaxel|mesh-list
25693616|NCT02017015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25693617|NCT02017015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693618|NCT02017015|Tubulin Modulators|tubulin modulators|mesh-ancestor
24953676|NCT03882788|Fentanyl|fentanyl|mesh-list
24726622|NCT01604811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24726626|NCT01604863|Paclitaxel|paclitaxel|mesh-list
24726644|NCT01604928|Adrenergic Agents|adrenergic agents|mesh-ancestor
24726645|NCT01604928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24726646|NCT01604928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726647|NCT01604928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726648|NCT01604928|Urological Agents|urological agents|mesh-ancestor
24726649|NCT01604928|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24726650|NCT01604928|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24726651|NCT01604928|Cholinergic Agents|cholinergic agents|mesh-ancestor
25123030|NCT03088306|Gabapentin|gabapentin|mesh-list
25123031|NCT03088306|Hydromorphone|hydromorphone|mesh-list
25123032|NCT03088306|Anesthetics|anesthetics|mesh-ancestor
25123033|NCT03088306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25123034|NCT03088306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123035|NCT03088306|Analgesics|analgesics|mesh-ancestor
25123036|NCT03088306|Sensory System Agents|sensory system agents|mesh-ancestor
25123037|NCT03088306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25123038|NCT03088306|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25123040|NCT03088306|Anesthetics, General|anesthetics, general|mesh-ancestor
25123041|NCT03088306|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25123042|NCT03088306|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25123043|NCT03088306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25123044|NCT03088306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123045|NCT03088306|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25123046|NCT03088306|Narcotics|narcotics|mesh-ancestor
25123073|NCT03087968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123074|NCT03087968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25123076|NCT03087942|Indoleacetic Acids|indoleacetic acids|mesh-list
25077049|NCT03368391|Sympathomimetics|sympathomimetics|mesh-ancestor
24726728|NCT01605344|Antidotes|antidotes|mesh-ancestor
24726729|NCT01605344|Protective Agents|protective agents|mesh-ancestor
24726806|NCT01606046|Anesthetics, Local|anesthetics, local|mesh-list
24726807|NCT01606046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24726889|NCT01606540|Sensory System Agents|sensory system agents|mesh-ancestor
24726890|NCT01606540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24726891|NCT01606540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726892|NCT01606540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24726949|NCT01607034|Antioxidants|antioxidants|mesh-ancestor
24726950|NCT01607034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726951|NCT01607034|Protective Agents|protective agents|mesh-ancestor
24726952|NCT01607034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726953|NCT01607034|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24648282|NCT01213394|Mycophenolic Acid|mycophenolic acid|mesh-list
24726954|NCT01607034|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24726955|NCT01607034|Dopamine Agonists|dopamine agonists|mesh-ancestor
24726956|NCT01607034|Dopamine Agents|dopamine agents|mesh-ancestor
24727050|NCT01607762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24727078|NCT01607918|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24727079|NCT01607918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24727080|NCT01607918|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25123077|NCT03087942|Plant Growth Regulators|plant growth regulators|mesh-ancestor
25123078|NCT03087942|Growth Substances|growth substances|mesh-ancestor
25123079|NCT03087942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123080|NCT03088046|Progesterone|progesterone|mesh-list
25123081|NCT03088046|Progestins|progestins|mesh-ancestor
25123082|NCT03088046|Hormones|hormones|mesh-ancestor
25123083|NCT03088046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25123084|NCT03088046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123085|NCT03088384|Ketamine|ketamine|mesh-list
25123086|NCT03088384|Analgesics|analgesics|mesh-ancestor
25123087|NCT03088384|Sensory System Agents|sensory system agents|mesh-ancestor
25123088|NCT03088384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25123089|NCT03088384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123090|NCT03088384|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25693619|NCT02017015|Antimitotic Agents|antimitotic agents|mesh-ancestor
25123091|NCT03088384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25123092|NCT03088384|Anesthetics, General|anesthetics, general|mesh-ancestor
25123093|NCT03088384|Anesthetics|anesthetics|mesh-ancestor
25123094|NCT03088384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25123095|NCT03088384|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25123096|NCT03088384|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25123097|NCT03088384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25123098|NCT03088384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123100|NCT03088176|Dabrafenib|dabrafenib|mesh-list
25123101|NCT03088176|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25123102|NCT03088176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123103|NCT03088176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25123104|NCT03088176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123105|NCT03088176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123106|NCT03088176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25123107|NCT03088072|Aspirin|aspirin|mesh-list
25123108|NCT03088072|Warfarin|warfarin|mesh-list
24648652|NCT01216111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24648653|NCT01216111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24648654|NCT01216111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123110|NCT03088072|Clopidogrel|clopidogrel|mesh-list
25123111|NCT03088072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25123112|NCT03088072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25123113|NCT03088072|Analgesics|analgesics|mesh-ancestor
25123114|NCT03088072|Sensory System Agents|sensory system agents|mesh-ancestor
25123115|NCT03088072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25123116|NCT03088072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123117|NCT03088072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25123118|NCT03088072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25123119|NCT03088072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25123120|NCT03088072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25123121|NCT03088072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123130|NCT03088072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25123131|NCT03088072|Anticoagulants|anticoagulants|mesh-ancestor
25123132|NCT03088072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25123133|NCT03088072|Antithrombins|antithrombins|mesh-ancestor
25123134|NCT03088072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25123135|NCT03088072|Protease Inhibitors|protease inhibitors|mesh-ancestor
25048497|NCT00694135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123137|NCT03087890|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25123138|NCT03087890|Sulfamethoxazole|sulfamethoxazole|mesh-list
25123139|NCT03087890|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25123140|NCT03087890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25123141|NCT03087890|Renal Agents|renal agents|mesh-ancestor
25123142|NCT03087890|Antimalarials|antimalarials|mesh-ancestor
25123143|NCT03087890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25123144|NCT03087890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25123145|NCT03087890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25123146|NCT03087890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123147|NCT03087890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123148|NCT03087890|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24727083|NCT01607970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24727084|NCT01607970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727085|NCT01607983|Nitric Oxide|nitric oxide|mesh-list
24727086|NCT01607983|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24727087|NCT01607983|Autonomic Agents|autonomic agents|mesh-ancestor
24727088|NCT01607983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24727089|NCT01607983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727090|NCT01607983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24727141|NCT01608217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24727142|NCT01608269|Lamivudine|lamivudine|mesh-list
24727143|NCT01608269|Abacavir|abacavir|mesh-list
24727144|NCT01608269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24727145|NCT01608269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24727146|NCT01608269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123149|NCT03087890|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25123150|NCT03087890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25123151|NCT03087890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24727148|NCT01608269|Antiviral Agents|antiviral agents|mesh-ancestor
24727160|NCT01608334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24727161|NCT01608334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24727162|NCT01608334|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24727163|NCT01608334|Anesthetics, General|anesthetics, general|mesh-ancestor
24727232|NCT01608698|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24727233|NCT01608698|Chlormadinone Acetate|chlormadinone acetate|mesh-list
24727234|NCT01608698|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24727235|NCT01608698|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24727236|NCT01608698|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24727237|NCT01608698|Contraceptive Agents|contraceptive agents|mesh-ancestor
24727323|NCT01609153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24727354|NCT01609205|Adalimumab|adalimumab|mesh-list
24727407|NCT01609647|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24727408|NCT01609647|Purinergic Agents|purinergic agents|mesh-ancestor
24727409|NCT01609647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24727410|NCT01609647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727411|NCT01609647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727413|NCT01609673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727415|NCT01609673|Immunologic Factors|immunologic factors|mesh-ancestor
24727416|NCT01609673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727417|NCT01609816|Dasatinib|dasatinib|mesh-list
24727418|NCT01609816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727419|NCT01609816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24727420|NCT01609816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616399|NCT01036893|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24616401|NCT01036893|Serotonin Agents|serotonin agents|mesh-ancestor
24616402|NCT01036893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24727500|NCT01610765|Antiviral Agents|antiviral agents|mesh-list
24727501|NCT01610765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24727505|NCT01610869|Nintedanib|nintedanib|mesh-list
24727604|NCT01611363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24727605|NCT01611363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727606|NCT01611415|Ipragliflozin|ipragliflozin|mesh-list
24727608|NCT01611415|Diuretics|diuretics|mesh-ancestor
24727609|NCT01611415|Natriuretic Agents|natriuretic agents|mesh-ancestor
24727610|NCT01611415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727615|NCT01611415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24727682|NCT01612247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727684|NCT01612247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24727709|NCT01612273|Aspirin|aspirin|mesh-list
24616446|NCT01037348|Growth Inhibitors|growth inhibitors|mesh-ancestor
24616447|NCT01037348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616448|NCT01037387|Bronchodilator Agents|bronchodilator agents|mesh-list
24857019|NCT02288741|Protease Inhibitors|protease inhibitors|mesh-ancestor
24857020|NCT02288741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616449|NCT01037387|Autonomic Agents|autonomic agents|mesh-ancestor
24727903|NCT01613209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728035|NCT01613963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24728115|NCT01614223|Respiratory System Agents|respiratory system agents|mesh-ancestor
25123159|NCT03087877|Acetaminophen|acetaminophen|mesh-list
25123160|NCT03087877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25123161|NCT03087877|Analgesics|analgesics|mesh-ancestor
25123162|NCT03087877|Sensory System Agents|sensory system agents|mesh-ancestor
25123163|NCT03087877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25123164|NCT03087877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123165|NCT03087877|Antipyretics|antipyretics|mesh-ancestor
25123167|NCT03087864|Carboplatin|carboplatin|mesh-list
25123168|NCT03087864|Atezolizumab|atezolizumab|mesh-list
25123169|NCT03087864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25123170|NCT03087864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123171|NCT03087864|Tubulin Modulators|tubulin modulators|mesh-ancestor
25123172|NCT03087864|Antimitotic Agents|antimitotic agents|mesh-ancestor
25123173|NCT03087864|Mitosis Modulators|mitosis modulators|mesh-ancestor
25123174|NCT03087864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123175|NCT03087669|Norepinephrine|norepinephrine|mesh-list
25123176|NCT03087669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25069374|NCT03426969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25069375|NCT03426969|Immunologic Factors|immunologic factors|mesh-ancestor
25069376|NCT03426969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069377|NCT03426969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25069384|NCT03426969|Antimetabolites|antimetabolites|mesh-ancestor
25069388|NCT03426969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25069389|NCT03426969|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25069390|NCT03426969|Antitubercular Agents|antitubercular agents|mesh-ancestor
25069391|NCT03426969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25069392|NCT03426969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24728117|NCT01614236|Analgesics|analgesics|mesh-ancestor
24728118|NCT01614236|Sensory System Agents|sensory system agents|mesh-ancestor
24728119|NCT01614236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24728120|NCT01614236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728182|NCT01614405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24728273|NCT01615211|Hormone Antagonists|hormone antagonists|mesh-ancestor
24728274|NCT01615211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24728275|NCT01615211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728276|NCT01615211|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24728277|NCT01615211|Abortifacient Agents|abortifacient agents|mesh-ancestor
24728278|NCT01615211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24728279|NCT01615224|Misoprostol|misoprostol|mesh-list
24728280|NCT01615224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24728281|NCT01615224|Abortifacient Agents|abortifacient agents|mesh-ancestor
24728282|NCT01615224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24648811|NCT01216956|Nicotinic Acids|nicotinic acids|mesh-list
24728283|NCT01615224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857027|NCT02288923|Acetaminophen|acetaminophen|mesh-list
24728284|NCT01615224|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24728553|NCT01616966|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24728554|NCT01616966|Narcotics|narcotics|mesh-ancestor
24728555|NCT01616966|Analgesics|analgesics|mesh-ancestor
24728556|NCT01616966|Sensory System Agents|sensory system agents|mesh-ancestor
24728557|NCT01616966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24728558|NCT01616992|Bupivacaine|bupivacaine|mesh-list
24728605|NCT01617213|Growth Substances|growth substances|mesh-ancestor
24728606|NCT01617213|Growth Inhibitors|growth inhibitors|mesh-ancestor
25123178|NCT03087669|Adrenergic Agents|adrenergic agents|mesh-ancestor
25123179|NCT03087669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25123180|NCT03087669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123181|NCT03087669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123182|NCT03087669|Sympathomimetics|sympathomimetics|mesh-ancestor
25123183|NCT03087669|Autonomic Agents|autonomic agents|mesh-ancestor
25123184|NCT03087669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25123185|NCT03087669|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24800781|NCT01978431|Dopamine Agents|dopamine agents|mesh-ancestor
25123187|NCT03087539|Anticoagulants|anticoagulants|mesh-ancestor
24728694|NCT01617707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24728695|NCT01617707|Anesthetics, General|anesthetics, general|mesh-ancestor
24728696|NCT01617707|Anesthetics|anesthetics|mesh-ancestor
24728697|NCT01617707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24728698|NCT01617707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24728801|NCT01618396|Anesthetics|anesthetics|mesh-ancestor
24728802|NCT01618396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24728803|NCT01618396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24728804|NCT01618396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24728805|NCT01618396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24728806|NCT01618396|GABA Modulators|gaba modulators|mesh-ancestor
25693620|NCT02017015|Mitosis Modulators|mitosis modulators|mesh-ancestor
25693621|NCT02017015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693622|NCT02017015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25693623|NCT02017015|Antimetabolites|antimetabolites|mesh-ancestor
25693624|NCT02017015|Antiviral Agents|antiviral agents|mesh-ancestor
25693625|NCT02017015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25693626|NCT02017015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693627|NCT02017015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25693628|NCT02017015|Immunologic Factors|immunologic factors|mesh-ancestor
25693629|NCT02017015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693630|NCT02017171|Allopurinol|allopurinol|mesh-list
24728808|NCT01618396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24857067|NCT02289248|Analgesics|analgesics|mesh-ancestor
24616603|NCT01038349|Methotrexate|methotrexate|mesh-list
24728921|NCT01618890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24728922|NCT01618890|Vasodilator Agents|vasodilator agents|mesh-ancestor
24728923|NCT01618903|Levetiracetam|levetiracetam|mesh-list
24728924|NCT01618903|Anticonvulsants|anticonvulsants|mesh-ancestor
24728925|NCT01618903|Nootropic Agents|nootropic agents|mesh-ancestor
24728926|NCT01618929|Montelukast|montelukast|mesh-list
24728927|NCT01618929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24728928|NCT01618929|Respiratory System Agents|respiratory system agents|mesh-ancestor
24728929|NCT01618929|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24728930|NCT01618929|Hormone Antagonists|hormone antagonists|mesh-ancestor
24728931|NCT01618929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24728932|NCT01618929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123194|NCT03087201|Nabiximols|nabiximols|mesh-list
25123195|NCT03087201|Analgesics|analgesics|mesh-ancestor
25123196|NCT03087201|Sensory System Agents|sensory system agents|mesh-ancestor
25123197|NCT03087201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25123198|NCT03087201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123199|NCT03087032|Insulin Glargine|insulin glargine|mesh-list
25123200|NCT03087032|Liraglutide|liraglutide|mesh-list
25123201|NCT03087032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25123202|NCT03087032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123203|NCT03087032|Incretins|incretins|mesh-ancestor
25123204|NCT03087032|Hormones|hormones|mesh-ancestor
25123205|NCT03087032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25123206|NCT03087162|Dexlansoprazole|dexlansoprazole|mesh-list
25123208|NCT03087162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25123209|NCT03087162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25123210|NCT03087162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25123211|NCT03087162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123212|NCT03087162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123213|NCT03087149|Vitamin D|vitamin d|mesh-list
25123214|NCT03087149|Vitamins|vitamins|mesh-ancestor
25123215|NCT03087149|Micronutrients|micronutrients|mesh-ancestor
25123216|NCT03087149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123217|NCT03087149|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25123218|NCT03087136|polysaccharide-K|polysaccharide-k|mesh-list
25123219|NCT03087136|Antibodies|antibodies|mesh-list
25123220|NCT03087136|Immunologic Factors|immunologic factors|mesh-ancestor
25123221|NCT03087136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123222|NCT03087136|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25123223|NCT03087136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25123224|NCT03087136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123225|NCT03087136|Antiviral Agents|antiviral agents|mesh-ancestor
24729001|NCT01619176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24729002|NCT01619176|Immunologic Factors|immunologic factors|mesh-ancestor
24857068|NCT02289248|Sensory System Agents|sensory system agents|mesh-ancestor
24612539|NCT01014416|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24612540|NCT01014416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612541|NCT01014416|Natriuretic Agents|natriuretic agents|mesh-ancestor
24612543|NCT01014468|Bevacizumab|bevacizumab|mesh-list
24729003|NCT01619176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24729004|NCT01619176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25123226|NCT03087136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25123227|NCT03087136|Interferon Inducers|interferon inducers|mesh-ancestor
25123228|NCT03087136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25123229|NCT03087136|Protective Agents|protective agents|mesh-ancestor
25123230|NCT03086720|Sodium Hypochlorite|sodium hypochlorite|mesh-list
25123232|NCT03086720|Disinfectants|disinfectants|mesh-ancestor
25123233|NCT03086720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24690669|NCT01403363|Anesthetics, General|anesthetics, general|mesh-ancestor
25123234|NCT03086681|Cisplatin|cisplatin|mesh-list
25123235|NCT03086681|Endostar protein|endostar protein|mesh-list
25123236|NCT03086681|Endostatins|endostatins|mesh-list
25123237|NCT03086681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123238|NCT03086681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25123239|NCT03086681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25123240|NCT03086681|Growth Substances|growth substances|mesh-ancestor
25123241|NCT03086681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123242|NCT03086681|Growth Inhibitors|growth inhibitors|mesh-ancestor
25123243|NCT03086759|Triamcinolone|triamcinolone|mesh-list
25123244|NCT03086759|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25123245|NCT03086759|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25123246|NCT03086759|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25123247|NCT03086759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25123248|NCT03086759|Glucocorticoids|glucocorticoids|mesh-ancestor
25123249|NCT03086759|Hormones|hormones|mesh-ancestor
24626529|NCT01087710|Vitamins|vitamins|mesh-list
24729005|NCT01619176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24729006|NCT01619176|Analgesics|analgesics|mesh-ancestor
24729007|NCT01619176|Sensory System Agents|sensory system agents|mesh-ancestor
24729008|NCT01619176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24729009|NCT01619280|Nitroprusside|nitroprusside|mesh-list
24729010|NCT01619280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24729011|NCT01619280|Vasodilator Agents|vasodilator agents|mesh-ancestor
24729014|NCT01619436|Clonidine|clonidine|mesh-list
24729062|NCT01619644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24729063|NCT01619644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729064|NCT01619644|Antimanic Agents|antimanic agents|mesh-ancestor
24729065|NCT01619644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24729066|NCT01619644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24729082|NCT01619761|Melphalan|melphalan|mesh-list
24729083|NCT01619761|Mechlorethamine|mechlorethamine|mesh-list
24616626|NCT01038388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24616627|NCT01038388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616628|NCT01038388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24616629|NCT01038388|Glucocorticoids|glucocorticoids|mesh-ancestor
24616630|NCT01038388|Hormones|hormones|mesh-ancestor
24616631|NCT01038388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24616632|NCT01038388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24616633|NCT01038388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616634|NCT01038388|Immunologic Factors|immunologic factors|mesh-ancestor
25123250|NCT03086759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25123251|NCT03086759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123252|NCT03086759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25123253|NCT03086759|Immunologic Factors|immunologic factors|mesh-ancestor
25123254|NCT03086759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123255|NCT03086759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123256|NCT03086733|Metformin|metformin|mesh-list
25123257|NCT03086733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25123258|NCT03086733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123259|NCT03086785|Apatinib|apatinib|mesh-list
25123260|NCT03086785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123261|NCT03086785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25123262|NCT03086785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123263|NCT03086785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123264|NCT03086382|Lacosamide|lacosamide|mesh-list
24616635|NCT01038388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24616636|NCT01038388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24616637|NCT01038388|Growth Substances|growth substances|mesh-ancestor
24616638|NCT01038388|Growth Inhibitors|growth inhibitors|mesh-ancestor
24729197|NCT01620333|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24729198|NCT01620333|Biphasic Insulins|biphasic insulins|mesh-list
24729199|NCT01620333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24729200|NCT01620333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729201|NCT01620424|Insulin|insulin|mesh-list
24729202|NCT01620424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24729203|NCT01620424|Insulin Aspart|insulin aspart|mesh-list
24729204|NCT01620424|Insulin, Long-Acting|insulin, long-acting|mesh-list
24729205|NCT01620424|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24857101|NCT02289274|Analgesics|analgesics|mesh-ancestor
25406428|NCT03560531|Palbociclib|palbociclib|mesh-list
25693631|NCT02017171|Antimetabolites|antimetabolites|mesh-ancestor
25709275|NCT02264353|Nootropic Agents|nootropic agents|mesh-ancestor
24540376|NCT00667758|Cetrorelix|cetrorelix|mesh-list
24729288|NCT01620944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24729289|NCT01621022|Bupropion|bupropion|mesh-list
24729290|NCT01621022|Nicotine|nicotine|mesh-list
24729291|NCT01621022|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24729292|NCT01621022|Autonomic Agents|autonomic agents|mesh-ancestor
24729293|NCT01621022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24729361|NCT01621269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24729362|NCT01621269|Immunologic Factors|immunologic factors|mesh-ancestor
24616667|NCT01038570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24616681|NCT01038583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24616682|NCT01038583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24616684|NCT01038583|Antipyretics|antipyretics|mesh-ancestor
24616685|NCT01038648|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24616686|NCT01038648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24616687|NCT01038648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616688|NCT01038648|Incretins|incretins|mesh-ancestor
24616689|NCT01038648|Hormones|hormones|mesh-ancestor
24616690|NCT01038648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24729532|NCT01622322|Sensory System Agents|sensory system agents|mesh-ancestor
24729533|NCT01622322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24729534|NCT01622361|Tamoxifen|tamoxifen|mesh-list
25123265|NCT03086382|Anticonvulsants|anticonvulsants|mesh-ancestor
25123266|NCT03086382|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25123267|NCT03086382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25123268|NCT03086382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25123269|NCT03086382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123270|NCT03086226|Itraconazole|itraconazole|mesh-list
25123271|NCT03086226|Antifungal Agents|antifungal agents|mesh-ancestor
25123272|NCT03086226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25123273|NCT03086226|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25123274|NCT03086226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25123275|NCT03086226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123276|NCT03086226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123277|NCT03086226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25123278|NCT03086226|Hormone Antagonists|hormone antagonists|mesh-ancestor
25123279|NCT03086226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25123280|NCT03086226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123281|NCT03086226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25123282|NCT03086291|Simvastatin|simvastatin|mesh-list
25123283|NCT03086291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25123284|NCT03086291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25123285|NCT03086291|Antimetabolites|antimetabolites|mesh-ancestor
25123286|NCT03086291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729535|NCT01622361|Cyclophosphamide|cyclophosphamide|mesh-list
24729536|NCT01622361|Docetaxel|docetaxel|mesh-list
24729537|NCT01622361|Doxorubicin|doxorubicin|mesh-list
24729538|NCT01622361|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24729539|NCT01622361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24729584|NCT01622439|Hormones|hormones|mesh-ancestor
24729618|NCT01622777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729619|NCT01622777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24729620|NCT01622777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24729621|NCT01622777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729623|NCT01622790|Abacavir|abacavir|mesh-list
24729624|NCT01622790|Dideoxynucleosides|dideoxynucleosides|mesh-list
24729625|NCT01622790|Dolutegravir|dolutegravir|mesh-list
24729626|NCT01622790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24729627|NCT01622790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24729628|NCT01622790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729629|NCT01622790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729630|NCT01622790|Antiviral Agents|antiviral agents|mesh-ancestor
24729729|NCT01623505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729730|NCT01623505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24729731|NCT01623505|Autonomic Agents|autonomic agents|mesh-ancestor
24729732|NCT01623505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24729733|NCT01623570|Menotropins|menotropins|mesh-list
24729734|NCT01623570|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25123291|NCT03086564|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25123293|NCT03086564|Hormones|hormones|mesh-ancestor
25123294|NCT03086564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25123295|NCT03086564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123296|NCT03086564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25123297|NCT03086564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123298|NCT03086395|Obinutuzumab|obinutuzumab|mesh-list
25123299|NCT03086395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25123300|NCT03086395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123301|NCT03086473|Caffeine|caffeine|mesh-list
25123302|NCT03086473|Caffeine citrate|caffeine citrate|mesh-list
25123303|NCT03086473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123304|NCT03086473|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25123305|NCT03086473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729735|NCT01623570|Fertility Agents|fertility agents|mesh-ancestor
24729762|NCT01623713|Dopamine Agents|dopamine agents|mesh-ancestor
24729763|NCT01623778|Interferons|interferons|mesh-list
24729764|NCT01623778|Interferon-alpha|interferon-alpha|mesh-list
24729765|NCT01623778|Interferon alpha-2|interferon alpha-2|mesh-list
24729767|NCT01623778|Antiviral Agents|antiviral agents|mesh-ancestor
24729781|NCT01623921|Antimetabolites|antimetabolites|mesh-ancestor
24729782|NCT01623921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729783|NCT01623921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24729784|NCT01623921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24729785|NCT01623921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729786|NCT01623921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24729787|NCT01623921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24616719|NCT01038882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616721|NCT01038895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24616722|NCT01038895|Protease Inhibitors|protease inhibitors|mesh-ancestor
24616723|NCT01038895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616727|NCT01039025|Melphalan|melphalan|mesh-list
24616728|NCT01039025|Topotecan|topotecan|mesh-list
24616729|NCT01039025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24729892|NCT01624428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857197|NCT02289703|Antithrombins|antithrombins|mesh-ancestor
24857198|NCT02289703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24857199|NCT02289703|Protease Inhibitors|protease inhibitors|mesh-ancestor
24857200|NCT02289703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857201|NCT02289703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857202|NCT02289703|Anticoagulants|anticoagulants|mesh-ancestor
24857203|NCT02289768|Salicylic Acid|salicylic acid|mesh-list
24857204|NCT02289768|Salicylates|salicylates|mesh-list
24729894|NCT01624441|Epirubicin|epirubicin|mesh-list
24729895|NCT01624441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24729896|NCT01624441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24729897|NCT01624441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25123306|NCT03086473|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25123307|NCT03086473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123308|NCT03086473|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25123309|NCT03086473|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25123310|NCT03086473|Purinergic Agents|purinergic agents|mesh-ancestor
25123311|NCT03086473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25123312|NCT03086915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
25123313|NCT03086915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25123314|NCT03086915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25123315|NCT03086915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123316|NCT03086174|Antibodies|antibodies|mesh-list
25123317|NCT03086174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25123318|NCT03086174|Immunologic Factors|immunologic factors|mesh-ancestor
25123319|NCT03086174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123320|NCT03085992|Bevacizumab|bevacizumab|mesh-list
25123321|NCT03085992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25123322|NCT03085992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123323|NCT03085992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25123324|NCT03085992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25123325|NCT03085992|Growth Substances|growth substances|mesh-ancestor
25123326|NCT03085992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729898|NCT01624441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24729899|NCT01624441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729900|NCT01624441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729901|NCT01624493|Gemcitabine|gemcitabine|mesh-list
24729902|NCT01624493|Carboplatin|carboplatin|mesh-list
24729903|NCT01624493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24729904|NCT01624493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24729905|NCT01624493|Antimetabolites|antimetabolites|mesh-ancestor
24729906|NCT01624493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729976|NCT01624805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24729977|NCT01624805|Glucocorticoids|glucocorticoids|mesh-ancestor
24729979|NCT01624805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24729980|NCT01624805|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24857205|NCT02289768|Fluorouracil|fluorouracil|mesh-list
24857206|NCT02289768|Antimetabolites|antimetabolites|mesh-ancestor
24729981|NCT01624805|Protective Agents|protective agents|mesh-ancestor
24729982|NCT01624805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24729983|NCT01624805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24729984|NCT01624857|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24729996|NCT01625156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24730004|NCT01625260|Gemcitabine|gemcitabine|mesh-list
24616739|NCT01039025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24616740|NCT01039025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616741|NCT01039090|Dopamine|dopamine|mesh-list
24616742|NCT01039090|Apomorphine|apomorphine|mesh-list
24616743|NCT01039090|Dopamine Agonists|dopamine agonists|mesh-list
24616744|NCT01039090|Emetics|emetics|mesh-ancestor
24616745|NCT01039090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616746|NCT01039090|Autonomic Agents|autonomic agents|mesh-ancestor
24730120|NCT01626222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123327|NCT03085992|Growth Inhibitors|growth inhibitors|mesh-ancestor
25123328|NCT03086005|Metformin|metformin|mesh-list
25123329|NCT03086005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25123330|NCT03086005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123331|NCT03086070|Omeprazole|omeprazole|mesh-list
25123332|NCT03086070|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25123346|NCT03086148|Analgesics|analgesics|mesh-ancestor
25123347|NCT03086148|Sensory System Agents|sensory system agents|mesh-ancestor
24730734|NCT01630070|Paclitaxel|paclitaxel|mesh-list
25123348|NCT03086148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25123349|NCT03086148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123350|NCT03086148|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25123351|NCT03086148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25123352|NCT03086148|Anesthetics, General|anesthetics, general|mesh-ancestor
25123353|NCT03086148|Anesthetics|anesthetics|mesh-ancestor
25123354|NCT03086148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25123355|NCT03086148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25123356|NCT03086148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25123357|NCT03086148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25123358|NCT03086148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123359|NCT03085654|Oxytocin|oxytocin|mesh-list
25123360|NCT03085654|Oxytocics|oxytocics|mesh-ancestor
25123361|NCT03085654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25123362|NCT03085654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123363|NCT03085628|Oxytocin|oxytocin|mesh-list
25123364|NCT03085628|Oxytocics|oxytocics|mesh-ancestor
25123365|NCT03085628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25123366|NCT03085628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123368|NCT03085784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25123369|NCT03085784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25123370|NCT03085784|Growth Substances|growth substances|mesh-ancestor
25123371|NCT03085784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123372|NCT03085784|Growth Inhibitors|growth inhibitors|mesh-ancestor
25077269|NCT03366246|Anesthetics|anesthetics|mesh-ancestor
24730121|NCT01626222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24730122|NCT01626222|Immunologic Factors|immunologic factors|mesh-ancestor
24730123|NCT01626222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730124|NCT01626222|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24730125|NCT01626222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24730144|NCT01626443|Vitamins|vitamins|mesh-ancestor
25123373|NCT03085784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691413|NCT01406470|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25123374|NCT03085849|Durvalumab|durvalumab|mesh-list
25123375|NCT03085849|Tremelimumab|tremelimumab|mesh-list
25123376|NCT03085849|Guadecitabine|guadecitabine|mesh-list
25123377|NCT03085849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25123378|NCT03085849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123379|NCT03085823|Sirolimus|sirolimus|mesh-list
25123380|NCT03085823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25123381|NCT03085823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25123382|NCT03085823|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25123383|NCT03085823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123384|NCT03085823|Antifungal Agents|antifungal agents|mesh-ancestor
25123385|NCT03085823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24730163|NCT01626560|Daptomycin|daptomycin|mesh-list
24616786|NCT01039181|Calcitriol|calcitriol|mesh-list
24616787|NCT01039181|Vitamins|vitamins|mesh-ancestor
24616788|NCT01039181|Micronutrients|micronutrients|mesh-ancestor
24616789|NCT01039181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616790|NCT01039181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24616791|NCT01039181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24616792|NCT01039181|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24616793|NCT01039181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24616794|NCT01039181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616795|NCT01039181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24730218|NCT01627132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730219|NCT01627132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24730220|NCT01627132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24730221|NCT01627132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730222|NCT01627145|Solifenacin Succinate|solifenacin succinate|mesh-list
24730223|NCT01627145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24730224|NCT01627145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24730225|NCT01627145|Cholinergic Agents|cholinergic agents|mesh-ancestor
24730226|NCT01627145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24730227|NCT01627145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077355|NCT03365466|Calcium heparin|calcium heparin|mesh-list
24730228|NCT01627145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730284|NCT01627236|Protective Agents|protective agents|mesh-ancestor
24730294|NCT01627262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24730295|NCT01627262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24730297|NCT01627353|Lidocaine|lidocaine|mesh-list
24730298|NCT01627353|Magnesium Sulfate|magnesium sulfate|mesh-list
24730299|NCT01627353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24730300|NCT01627353|Antiemetics|antiemetics|mesh-ancestor
24730301|NCT01627353|Autonomic Agents|autonomic agents|mesh-ancestor
24730346|NCT01627431|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24730347|NCT01627431|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24730348|NCT01627431|Purinergic Agents|purinergic agents|mesh-ancestor
24730349|NCT01627431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24730350|NCT01627587|Ketoconazole|ketoconazole|mesh-list
24730351|NCT01627587|Antifungal Agents|antifungal agents|mesh-ancestor
24730352|NCT01627587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24730353|NCT01627587|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24730354|NCT01627587|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24730355|NCT01627587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24730356|NCT01627587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730357|NCT01627587|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24730358|NCT01627587|Hormone Antagonists|hormone antagonists|mesh-ancestor
24730419|NCT01627873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24730420|NCT01627873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649147|NCT01218711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24730421|NCT01627873|Analgesics|analgesics|mesh-ancestor
25123386|NCT03085823|Immunologic Factors|immunologic factors|mesh-ancestor
25123387|NCT03085823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123388|NCT03085563|Midazolam|midazolam|mesh-list
25123389|NCT03085563|Nitrous Oxide|nitrous oxide|mesh-list
25123390|NCT03085563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25123391|NCT03085563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25123392|NCT03085563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25123393|NCT03085563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123394|NCT03085563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25123395|NCT03085563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25123396|NCT03085563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25709276|NCT02264574|Obinutuzumab|obinutuzumab|mesh-list
25709277|NCT02264574|Chlorambucil|chlorambucil|mesh-list
24692000|NCT01410214|Mitosis Modulators|mitosis modulators|mesh-ancestor
25123397|NCT03085563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25123398|NCT03085563|Anesthetics, General|anesthetics, general|mesh-ancestor
25123399|NCT03085563|Anesthetics|anesthetics|mesh-ancestor
25123400|NCT03085563|GABA Modulators|gaba modulators|mesh-ancestor
25123401|NCT03085563|GABA Agents|gaba agents|mesh-ancestor
25123402|NCT03085563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25123403|NCT03085563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730422|NCT01627873|Sensory System Agents|sensory system agents|mesh-ancestor
24730423|NCT01627873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24730424|NCT01627873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24730425|NCT01627873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24730426|NCT01627873|Anesthetics, General|anesthetics, general|mesh-ancestor
24730427|NCT01627873|Anesthetics|anesthetics|mesh-ancestor
24730428|NCT01627886|Ibandronic Acid|ibandronic acid|mesh-list
24730429|NCT01627886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24730430|NCT01627886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730431|NCT01627938|Mitoxantrone|mitoxantrone|mesh-list
24730432|NCT01627938|Dexrazoxane|dexrazoxane|mesh-list
24730644|NCT01629446|Sensory System Agents|sensory system agents|mesh-ancestor
24730645|NCT01629446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24730646|NCT01629446|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24730647|NCT01629446|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24730648|NCT01629446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24730649|NCT01629446|Adrenergic Agents|adrenergic agents|mesh-ancestor
24730650|NCT01629446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24730651|NCT01629446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730652|NCT01629511|Gemcitabine|gemcitabine|mesh-list
24730653|NCT01629511|Methotrexate|methotrexate|mesh-list
24730654|NCT01629511|Clofarabine|clofarabine|mesh-list
24730655|NCT01629511|Busulfan|busulfan|mesh-list
24730656|NCT01629511|Tacrolimus|tacrolimus|mesh-list
24730657|NCT01629511|Thymoglobulin|thymoglobulin|mesh-list
24730659|NCT01629511|Lenograstim|lenograstim|mesh-list
24730731|NCT01630057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730732|NCT01630057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24730733|NCT01630057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730735|NCT01630070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24730736|NCT01630070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730737|NCT01630070|Tubulin Modulators|tubulin modulators|mesh-ancestor
24730738|NCT01630070|Antimitotic Agents|antimitotic agents|mesh-ancestor
24730739|NCT01630070|Mitosis Modulators|mitosis modulators|mesh-ancestor
24730741|NCT01630083|Capecitabine|capecitabine|mesh-list
24730827|NCT01630655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123405|NCT03085563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25123406|NCT03085563|Analgesics|analgesics|mesh-ancestor
25123407|NCT03085563|Sensory System Agents|sensory system agents|mesh-ancestor
25123408|NCT03085563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25123410|NCT03085225|Trabectedin|trabectedin|mesh-list
25123411|NCT03085225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25123412|NCT03085225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123413|NCT03085225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25123414|NCT03085225|Alkylating Agents|alkylating agents|mesh-ancestor
25123415|NCT03085225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123416|NCT03085368|Trastuzumab|trastuzumab|mesh-list
25123417|NCT03085368|Lapatinib|lapatinib|mesh-list
25123418|NCT03085368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25123419|NCT03085368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123420|NCT03085368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25123421|NCT03085368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123422|NCT03085368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123423|NCT03085290|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25123424|NCT03085290|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25123425|NCT03085394|Tranexamic Acid|tranexamic acid|mesh-list
25123426|NCT03085394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25123427|NCT03085394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25123428|NCT03085394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123429|NCT03085394|Hemostatics|hemostatics|mesh-ancestor
24730828|NCT01630655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25693632|NCT02017171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730829|NCT01630655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730930|NCT01631383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24730946|NCT01631396|Cholinergic Agents|cholinergic agents|mesh-ancestor
24730947|NCT01631396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24730948|NCT01631396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730949|NCT01631396|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24730950|NCT01631396|Autonomic Agents|autonomic agents|mesh-ancestor
24730951|NCT01631396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24730953|NCT01631409|Atenolol|atenolol|mesh-list
24731060|NCT01631877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731061|NCT01631968|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24731063|NCT01631968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24731064|NCT01631994|Metoclopramide|metoclopramide|mesh-list
24731065|NCT01631994|Antiemetics|antiemetics|mesh-ancestor
24731066|NCT01631994|Autonomic Agents|autonomic agents|mesh-ancestor
24731067|NCT01631994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24731145|NCT01632657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731146|NCT01632722|Bevacizumab|bevacizumab|mesh-list
24731147|NCT01632722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24731148|NCT01632722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123435|NCT03085186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123437|NCT03084952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25123438|NCT03084952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24649574|NCT01220375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25123439|NCT03084952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25123440|NCT03084861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25123441|NCT03084861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25123442|NCT03084978|Anesthetics|anesthetics|mesh-list
25123443|NCT03084978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24732197|NCT01638273|Analgesics|analgesics|mesh-ancestor
25123444|NCT03084978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123445|NCT03085030|Antioxidants|antioxidants|mesh-list
25123446|NCT03085030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123447|NCT03085030|Protective Agents|protective agents|mesh-ancestor
25123448|NCT03085030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123449|NCT03084809|Leucovorin|leucovorin|mesh-list
25123450|NCT03084809|Oxaliplatin|oxaliplatin|mesh-list
25123451|NCT03084809|Fluorouracil|fluorouracil|mesh-list
25123452|NCT03084809|Levoleucovorin|levoleucovorin|mesh-list
25123453|NCT03084809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123454|NCT03084809|Antidotes|antidotes|mesh-ancestor
25123455|NCT03084809|Protective Agents|protective agents|mesh-ancestor
24731150|NCT01632722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24731151|NCT01632722|Growth Substances|growth substances|mesh-ancestor
24731152|NCT01632722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731153|NCT01632722|Growth Inhibitors|growth inhibitors|mesh-ancestor
24731154|NCT01632761|Vitamin D|vitamin d|mesh-list
24731157|NCT01632761|Vitamins|vitamins|mesh-list
24731214|NCT01633294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731215|NCT01633294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731217|NCT01633359|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
24731218|NCT01633359|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24731219|NCT01633359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24731220|NCT01633359|Antimetabolites|antimetabolites|mesh-ancestor
24731221|NCT01633359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731223|NCT01633359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123458|NCT03084809|Vitamins|vitamins|mesh-ancestor
25123459|NCT03084809|Micronutrients|micronutrients|mesh-ancestor
25123460|NCT03084809|Antimetabolites|antimetabolites|mesh-ancestor
25123461|NCT03084809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123462|NCT03084809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25123463|NCT03084809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25123464|NCT03084809|Immunologic Factors|immunologic factors|mesh-ancestor
25123465|NCT03084588|Methadone|methadone|mesh-list
25123466|NCT03084588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25123467|NCT03084588|Narcotics|narcotics|mesh-ancestor
25123468|NCT03084588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25123469|NCT03084588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123470|NCT03084588|Analgesics|analgesics|mesh-ancestor
25123471|NCT03084588|Sensory System Agents|sensory system agents|mesh-ancestor
25123472|NCT03084588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25693633|NCT02017171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123473|NCT03084588|Antitussive Agents|antitussive agents|mesh-ancestor
25693634|NCT02017171|Gout Suppressants|gout suppressants|mesh-ancestor
25123474|NCT03084588|Respiratory System Agents|respiratory system agents|mesh-ancestor
25123475|NCT03084575|Glycerol|glycerol|mesh-list
25123476|NCT03084575|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25123477|NCT03084575|Protective Agents|protective agents|mesh-ancestor
24649575|NCT01220440|Methylphenidate|methylphenidate|mesh-list
25123478|NCT03084575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123479|NCT03084783|Dexamethasone|dexamethasone|mesh-list
25123480|NCT03084783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24731273|NCT01633970|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24731274|NCT01633970|Bevacizumab|bevacizumab|mesh-list
24731275|NCT01633970|Carboplatin|carboplatin|mesh-list
24731357|NCT01634373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24731358|NCT01634373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24731359|NCT01634373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24731360|NCT01634373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731361|NCT01634386|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24731362|NCT01634386|Antidepressive Agents|antidepressive agents|mesh-ancestor
24731363|NCT01634386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24731364|NCT01634386|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24731365|NCT01634386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24731366|NCT01634386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24731367|NCT01634386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731368|NCT01634399|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24731369|NCT01634399|Antidepressive Agents|antidepressive agents|mesh-ancestor
24731370|NCT01634399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24731371|NCT01634399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24731372|NCT01634399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24616957|NCT01040091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616958|NCT01040091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24616959|NCT01040091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25123481|NCT03084783|Antiemetics|antiemetics|mesh-ancestor
25123482|NCT03084783|Autonomic Agents|autonomic agents|mesh-ancestor
25123483|NCT03084783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25123484|NCT03084783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123485|NCT03084783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25123486|NCT03084783|Glucocorticoids|glucocorticoids|mesh-ancestor
25123487|NCT03084783|Hormones|hormones|mesh-ancestor
25123488|NCT03084783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25123489|NCT03084783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25123490|NCT03084783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123491|NCT03084250|Tenofovir|tenofovir|mesh-list
24786801|NCT01921816|Dialysis Solutions|dialysis solutions|mesh-list
25123494|NCT03084250|Adefovir|adefovir|mesh-list
25123495|NCT03084250|Antiviral Agents|antiviral agents|mesh-ancestor
25123531|NCT03084029|Oxytocics|oxytocics|mesh-ancestor
25123532|NCT03084029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25123533|NCT03084029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123534|NCT03083821|Entecavir|entecavir|mesh-list
25123535|NCT03083821|Antiviral Agents|antiviral agents|mesh-ancestor
25123536|NCT03083821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25123537|NCT03083782|Cyclosporine|cyclosporine|mesh-list
25123538|NCT03083782|Apixaban|apixaban|mesh-list
25123539|NCT03083782|Tacrolimus|tacrolimus|mesh-list
24616960|NCT01040091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24616961|NCT01040091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24616962|NCT01040091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24731395|NCT01634438|Heparin|heparin|mesh-list
24731471|NCT01634893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24731578|NCT01635686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24731579|NCT01635686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24731580|NCT01635686|Analgesics|analgesics|mesh-ancestor
24731669|NCT01635972|Dopamine Agents|dopamine agents|mesh-ancestor
24731670|NCT01635972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24731671|NCT01635972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731672|NCT01635972|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24731673|NCT01635972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24731674|NCT01635972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731675|NCT01635972|Antifungal Agents|antifungal agents|mesh-ancestor
24731676|NCT01635972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24731678|NCT01636037|Carbidopa|carbidopa|mesh-list
24731735|NCT01636310|Cholinergic Agents|cholinergic agents|mesh-ancestor
24731736|NCT01636310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24731737|NCT01636310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123540|NCT03083782|Cyclosporins|cyclosporins|mesh-list
25123541|NCT03083782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25123542|NCT03083782|Immunologic Factors|immunologic factors|mesh-ancestor
25123543|NCT03083782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123544|NCT03083782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25123545|NCT03083782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123546|NCT03083782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123547|NCT03083782|Antifungal Agents|antifungal agents|mesh-ancestor
25123548|NCT03083782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25123549|NCT03083782|Dermatologic Agents|dermatologic agents|mesh-ancestor
25123550|NCT03083782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25123551|NCT03083782|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24731748|NCT01636336|Nicotine|nicotine|mesh-list
24731839|NCT01636622|Vemurafenib|vemurafenib|mesh-list
24731840|NCT01636622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24731841|NCT01636622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731843|NCT01636622|Antimitotic Agents|antimitotic agents|mesh-ancestor
24731844|NCT01636622|Mitosis Modulators|mitosis modulators|mesh-ancestor
24731845|NCT01636622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731846|NCT01636622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24731847|NCT01636622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731848|NCT01636700|Tramadol|tramadol|mesh-list
24731849|NCT01636700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24731850|NCT01636700|Narcotics|narcotics|mesh-ancestor
24733187|NCT01643889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731853|NCT01636700|Analgesics|analgesics|mesh-ancestor
24649773|NCT01221883|Autonomic Agents|autonomic agents|mesh-ancestor
24731854|NCT01636700|Sensory System Agents|sensory system agents|mesh-ancestor
24731855|NCT01636700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24731856|NCT01636869|Bupivacaine|bupivacaine|mesh-list
24731861|NCT01636869|Sensory System Agents|sensory system agents|mesh-ancestor
24731862|NCT01636869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24731895|NCT01636999|Anesthetics, General|anesthetics, general|mesh-ancestor
24520239|NCT03486314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24731899|NCT01636999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24731900|NCT01636999|Analgesics|analgesics|mesh-ancestor
24731901|NCT01636999|Sensory System Agents|sensory system agents|mesh-ancestor
24731902|NCT01636999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24731903|NCT01637025|Cellulose, Oxidized|cellulose, oxidized|mesh-list
24731905|NCT01637025|Coagulants|coagulants|mesh-ancestor
24731906|NCT01637155|Vitamin D|vitamin d|mesh-list
24731907|NCT01637155|Cholecalciferol|cholecalciferol|mesh-list
24731908|NCT01637155|Vitamins|vitamins|mesh-ancestor
24731914|NCT01637194|Cetuximab|cetuximab|mesh-list
24731994|NCT01637454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731995|NCT01637454|Sympathomimetics|sympathomimetics|mesh-ancestor
24731996|NCT01637454|Autonomic Agents|autonomic agents|mesh-ancestor
24732038|NCT01637558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24732039|NCT01637558|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24732040|NCT01637558|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24732041|NCT01637571|Dexlansoprazole|dexlansoprazole|mesh-list
24732042|NCT01637571|Lansoprazole|lansoprazole|mesh-list
24732043|NCT01637571|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24732044|NCT01637571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24732045|NCT01637571|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24732046|NCT01637571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732047|NCT01637571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732049|NCT01637636|Ketoconazole|ketoconazole|mesh-list
24827486|NCT02139657|Immunoglobulins|immunoglobulins|mesh-list
24732050|NCT01637636|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25123552|NCT03083782|Antithrombins|antithrombins|mesh-ancestor
25123553|NCT03083782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25123554|NCT03083782|Protease Inhibitors|protease inhibitors|mesh-ancestor
25123555|NCT03083782|Anticoagulants|anticoagulants|mesh-ancestor
25123556|NCT03083834|Cosyntropin|cosyntropin|mesh-list
25123557|NCT03083834|Hormones|hormones|mesh-ancestor
25123558|NCT03083834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25123559|NCT03083834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123560|NCT03083613|Paclitaxel|paclitaxel|mesh-list
24693442|NCT01420471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693443|NCT01420523|Raltegravir Potassium|raltegravir potassium|mesh-list
24732051|NCT01637636|Antitubercular Agents|antitubercular agents|mesh-ancestor
24732072|NCT01637675|Tanshinone|tanshinone|mesh-list
24732110|NCT01637766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24732111|NCT01637766|Immunologic Factors|immunologic factors|mesh-ancestor
24732112|NCT01637766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732113|NCT01637818|Acetaminophen|acetaminophen|mesh-list
24732114|NCT01637818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24732115|NCT01637818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
24732116|NCT01637818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24732117|NCT01637818|Analgesics|analgesics|mesh-ancestor
24732118|NCT01637818|Sensory System Agents|sensory system agents|mesh-ancestor
24732119|NCT01637818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24732120|NCT01637818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732183|NCT01638247|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24732184|NCT01638247|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24732185|NCT01638247|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24732186|NCT01638247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24732187|NCT01638247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732188|NCT01638247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732190|NCT01638260|Liraglutide|liraglutide|mesh-list
24732191|NCT01638260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24732192|NCT01638260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732193|NCT01638260|Incretins|incretins|mesh-ancestor
24732194|NCT01638260|Hormones|hormones|mesh-ancestor
24732195|NCT01638260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24732196|NCT01638273|Pregabalin|pregabalin|mesh-list
24732198|NCT01638273|Sensory System Agents|sensory system agents|mesh-ancestor
24732199|NCT01638273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24732215|NCT01638325|Insulin Lispro|insulin lispro|mesh-list
24732216|NCT01638325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24732217|NCT01638325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732218|NCT01638364|Ethanol|ethanol|mesh-list
24732219|NCT01638364|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24732220|NCT01638364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24732221|NCT01638364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24732222|NCT01638364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617060|NCT01040559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617061|NCT01040559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617062|NCT01040585|Linezolid|linezolid|mesh-list
24732315|NCT01638780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24732316|NCT01638858|Ranibizumab|ranibizumab|mesh-list
24732317|NCT01638858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24732318|NCT01638858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24732319|NCT01638858|Growth Substances|growth substances|mesh-ancestor
24732320|NCT01638858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732321|NCT01638858|Growth Inhibitors|growth inhibitors|mesh-ancestor
24732322|NCT01638858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732323|NCT01638936|Maytansine|maytansine|mesh-list
24732324|NCT01638936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24732325|NCT01638936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732326|NCT01638936|Tubulin Modulators|tubulin modulators|mesh-ancestor
24732428|NCT01639326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24732429|NCT01639326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123561|NCT03083613|Raltitrexed|raltitrexed|mesh-list
25123562|NCT03083613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25123563|NCT03083613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123564|NCT03083613|Tubulin Modulators|tubulin modulators|mesh-ancestor
25123565|NCT03083613|Antimitotic Agents|antimitotic agents|mesh-ancestor
25123566|NCT03083613|Mitosis Modulators|mitosis modulators|mesh-ancestor
25123567|NCT03083613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123568|NCT03083613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25123569|NCT03083613|Antimetabolites|antimetabolites|mesh-ancestor
24649949|NCT01222897|Valacyclovir|valacyclovir|mesh-list
25123570|NCT03083613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25123571|NCT03083613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732430|NCT01639326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732431|NCT01639326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693635|NCT02017171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25693636|NCT02017171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25693637|NCT02017171|Antioxidants|antioxidants|mesh-ancestor
25693638|NCT02017171|Protective Agents|protective agents|mesh-ancestor
25069877|NCT03423342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069878|NCT03423342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25069879|NCT03423342|Antimetabolites|antimetabolites|mesh-ancestor
24832526|NCT02171598|Anticoagulants|anticoagulants|mesh-ancestor
24693746|NCT01422096|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24693747|NCT01422096|Fertility Agents|fertility agents|mesh-ancestor
24693748|NCT01422096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24693749|NCT01422096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693841|NCT01422616|Hydralazine|hydralazine|mesh-list
24732433|NCT01639456|Cyclophosphamide|cyclophosphamide|mesh-list
24732434|NCT01639456|Fludarabine|fludarabine|mesh-list
24732435|NCT01639456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24732436|NCT01639456|Immunologic Factors|immunologic factors|mesh-ancestor
24732437|NCT01639456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732438|NCT01639456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24732439|NCT01639456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24732440|NCT01639456|Alkylating Agents|alkylating agents|mesh-ancestor
24732441|NCT01639456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732447|NCT01639456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24732448|NCT01639521|Gemcitabine|gemcitabine|mesh-list
24732449|NCT01639521|Doxorubicin|doxorubicin|mesh-list
24732450|NCT01639521|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24732451|NCT01639521|Methotrexate|methotrexate|mesh-list
24732452|NCT01639521|Vinblastine|vinblastine|mesh-list
24732453|NCT01639521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732454|NCT01639521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24732455|NCT01639521|Antimetabolites|antimetabolites|mesh-ancestor
24732456|NCT01639521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732457|NCT01639521|Antiviral Agents|antiviral agents|mesh-ancestor
24649480|NCT01220102|Analgesics|analgesics|mesh-ancestor
24732458|NCT01639521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24732459|NCT01639521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732460|NCT01639521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24617103|NCT01041066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24617104|NCT01041066|Adrenergic Agents|adrenergic agents|mesh-ancestor
24617105|NCT01041066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24617106|NCT01041066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617107|NCT01041066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617115|NCT01041066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24617116|NCT01041066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24617117|NCT01041066|Vasodilator Agents|vasodilator agents|mesh-ancestor
24732542|NCT01640093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734046|NCT01650428|Growth Substances|growth substances|mesh-ancestor
24732543|NCT01640093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732544|NCT01640093|Hormone Antagonists|hormone antagonists|mesh-ancestor
24732545|NCT01640093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24732546|NCT01640093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732547|NCT01640093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24732637|NCT01640639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25123573|NCT03083691|Ipilimumab|ipilimumab|mesh-list
25123574|NCT03083691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25123575|NCT03083691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650062|NCT01223690|Clarithromycin|clarithromycin|mesh-list
25123576|NCT03083691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25123577|NCT03083691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123578|NCT03083704|Enoxaparin|enoxaparin|mesh-list
25123579|NCT03083704|Rivaroxaban|rivaroxaban|mesh-list
25123580|NCT03083704|Apixaban|apixaban|mesh-list
25123581|NCT03083704|Edoxaban|edoxaban|mesh-list
25123582|NCT03083704|Enoxaparin sodium|enoxaparin sodium|mesh-list
25123583|NCT03083704|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25123584|NCT03083704|Antithrombins|antithrombins|mesh-ancestor
25123585|NCT03083704|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25123586|NCT03083704|Protease Inhibitors|protease inhibitors|mesh-ancestor
25123587|NCT03083704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123588|NCT03083704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693639|NCT02017171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693640|NCT02017327|Bimatoprost|bimatoprost|mesh-list
25693641|NCT02017327|Latanoprost|latanoprost|mesh-list
25693642|NCT02017327|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25693643|NCT02017327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25693644|NCT02017327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25693645|NCT02017535|Fluoxetine|fluoxetine|mesh-list
25693646|NCT02017535|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25693647|NCT02017535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25123590|NCT03083704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25123591|NCT03083704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25123592|NCT03083457|Anesthetics|anesthetics|mesh-list
25123593|NCT03083457|Anesthetics, General|anesthetics, general|mesh-list
25123594|NCT03083457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25123595|NCT03083457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954584|NCT03874832|Dopamine Agents|dopamine agents|mesh-ancestor
24732638|NCT01640639|Immunologic Factors|immunologic factors|mesh-ancestor
24732639|NCT01640639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732640|NCT01640639|Leprostatic Agents|leprostatic agents|mesh-ancestor
24732641|NCT01640639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24732642|NCT01640639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24732643|NCT01640639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24732644|NCT01640639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24732648|NCT01640665|Capecitabine|capecitabine|mesh-list
24732718|NCT01641016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24732719|NCT01641016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24732720|NCT01641016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732721|NCT01641016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732722|NCT01641016|Antiviral Agents|antiviral agents|mesh-ancestor
24732723|NCT01641016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25123607|NCT03083210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123608|NCT03083184|Ethanol|ethanol|mesh-list
25123609|NCT03083184|Enoxaparin|enoxaparin|mesh-list
25123610|NCT03083184|Anticoagulants|anticoagulants|mesh-ancestor
25123611|NCT03083184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25123612|NCT03083184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25123613|NCT03083184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954613|NCT03874585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24732724|NCT01641016|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24732725|NCT01641016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24732726|NCT01641016|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24732727|NCT01641016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24732728|NCT01641016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24732730|NCT01641224|Pinaverium|pinaverium|mesh-list
24617198|NCT01041508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24650258|NCT01224847|Cocaine|cocaine|mesh-list
24650348|NCT01225302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617199|NCT01041508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24617200|NCT01041508|Antimetabolites|antimetabolites|mesh-ancestor
24617202|NCT01041625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24617203|NCT01041625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24617204|NCT01041625|Analgesics|analgesics|mesh-ancestor
24617205|NCT01041625|Sensory System Agents|sensory system agents|mesh-ancestor
24617215|NCT01041690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24732794|NCT01641406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732795|NCT01641406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24732796|NCT01641419|Dexamethasone|dexamethasone|mesh-list
24732797|NCT01641419|Dexamethasone acetate|dexamethasone acetate|mesh-list
24732799|NCT01641419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24732800|NCT01641419|Antiemetics|antiemetics|mesh-ancestor
24732801|NCT01641419|Autonomic Agents|autonomic agents|mesh-ancestor
24732802|NCT01641419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24732803|NCT01641419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732804|NCT01641419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24732805|NCT01641419|Glucocorticoids|glucocorticoids|mesh-ancestor
24732806|NCT01641419|Hormones|hormones|mesh-ancestor
24732807|NCT01641419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24732817|NCT01641458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732818|NCT01641458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732819|NCT01641458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24732820|NCT01641458|Immunologic Factors|immunologic factors|mesh-ancestor
24732821|NCT01641458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732835|NCT01641523|Protective Agents|protective agents|mesh-ancestor
24732836|NCT01641523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732838|NCT01641536|Antiviral Agents|antiviral agents|mesh-ancestor
24732839|NCT01641536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24732840|NCT01641549|Fibrinolytic Agents|fibrinolytic agents|mesh-list
24732841|NCT01641549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24732842|NCT01641549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732843|NCT01641575|Gemcitabine|gemcitabine|mesh-list
24732844|NCT01641575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732845|NCT01641575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24732846|NCT01641575|Antimetabolites|antimetabolites|mesh-ancestor
24732847|NCT01641575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732848|NCT01641575|Antiviral Agents|antiviral agents|mesh-ancestor
24732849|NCT01641575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24732850|NCT01641575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732851|NCT01641575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25077450|NCT03364569|Coagulants|coagulants|mesh-ancestor
25077451|NCT03364530|Gemcitabine|gemcitabine|mesh-list
25077452|NCT03364530|Oxaliplatin|oxaliplatin|mesh-list
25077453|NCT03364530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25123614|NCT03083184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25123615|NCT03083184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25123616|NCT03083184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25123617|NCT03083184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123618|NCT03083041|Apatinib|apatinib|mesh-list
25123619|NCT03083041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123620|NCT03083041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25123621|NCT03083041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123622|NCT03083041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123623|NCT03083080|Epinephrine|epinephrine|mesh-list
25123624|NCT03083080|Ropivacaine|ropivacaine|mesh-list
25123625|NCT03083080|Anesthetics, Local|anesthetics, local|mesh-ancestor
25123626|NCT03083080|Anesthetics|anesthetics|mesh-ancestor
25123627|NCT03083080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25123628|NCT03083080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123629|NCT03083080|Sensory System Agents|sensory system agents|mesh-ancestor
25123630|NCT03083080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25123631|NCT03083080|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25123632|NCT03083080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25123633|NCT03083080|Adrenergic Agents|adrenergic agents|mesh-ancestor
25123634|NCT03083080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25077454|NCT03364530|Antimetabolites|antimetabolites|mesh-ancestor
25077457|NCT03364530|Antiviral Agents|antiviral agents|mesh-ancestor
24732852|NCT01641575|Immunologic Factors|immunologic factors|mesh-ancestor
24732894|NCT01642108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24732895|NCT01642108|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24732896|NCT01642108|Protease Inhibitors|protease inhibitors|mesh-ancestor
24732902|NCT01642134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24732903|NCT01642134|Analgesics|analgesics|mesh-ancestor
24732904|NCT01642134|Sensory System Agents|sensory system agents|mesh-ancestor
24732905|NCT01642134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24732906|NCT01642134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732907|NCT01642134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24732908|NCT01642134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24732921|NCT01642186|Everolimus|everolimus|mesh-list
24732987|NCT01642771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732988|NCT01642771|Antimetabolites|antimetabolites|mesh-ancestor
24732989|NCT01642771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25123635|NCT03083080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123636|NCT03083080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25123637|NCT03083080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25123639|NCT03083080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25123640|NCT03083080|Respiratory System Agents|respiratory system agents|mesh-ancestor
25123641|NCT03083080|Mydriatics|mydriatics|mesh-ancestor
25123642|NCT03083080|Sympathomimetics|sympathomimetics|mesh-ancestor
25123643|NCT03083080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25123644|NCT03082846|Temozolomide|temozolomide|mesh-list
25123645|NCT03082846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25123646|NCT03082846|Alkylating Agents|alkylating agents|mesh-ancestor
24650655|NCT01227200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123647|NCT03082846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123648|NCT03082846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123649|NCT03082885|Thymalfasin|thymalfasin|mesh-list
25123650|NCT03082885|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25123651|NCT03082885|Immunologic Factors|immunologic factors|mesh-ancestor
25123652|NCT03082885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732990|NCT01642771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24732991|NCT01642771|Immunologic Factors|immunologic factors|mesh-ancestor
24732992|NCT01642771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733013|NCT01642940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733014|NCT01642940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733015|NCT01642966|Ticagrelor|ticagrelor|mesh-list
24733016|NCT01642966|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24694463|NCT01425619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694464|NCT01425658|Clonidine|clonidine|mesh-list
24694465|NCT01425658|Fentanyl|fentanyl|mesh-list
24694466|NCT01425658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24694507|NCT01425775|Vitamin D|vitamin d|mesh-list
24694508|NCT01425775|Vitamins|vitamins|mesh-ancestor
24733017|NCT01642966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24733018|NCT01642966|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24733020|NCT01642966|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24617258|NCT01041963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24617259|NCT01041963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617260|NCT01041963|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24617261|NCT01041963|Protease Inhibitors|protease inhibitors|mesh-ancestor
24617262|NCT01041963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617264|NCT01042028|Irinotecan|irinotecan|mesh-list
24617265|NCT01042028|Cetuximab|cetuximab|mesh-list
24617266|NCT01042028|Everolimus|everolimus|mesh-list
24617267|NCT01042028|Oxaliplatin|oxaliplatin|mesh-list
24733098|NCT01643278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24733099|NCT01643278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733100|NCT01643278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24733101|NCT01643278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733102|NCT01643278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24733103|NCT01643278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733104|NCT01643434|Clonidine|clonidine|mesh-list
24733105|NCT01643434|Spironolactone|spironolactone|mesh-list
24733106|NCT01643434|Analgesics|analgesics|mesh-ancestor
24733107|NCT01643434|Sensory System Agents|sensory system agents|mesh-ancestor
24733108|NCT01643434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24733109|NCT01643434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733110|NCT01643434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24733111|NCT01643434|Sympatholytics|sympatholytics|mesh-ancestor
24733112|NCT01643434|Autonomic Agents|autonomic agents|mesh-ancestor
25123658|NCT03082742|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25123659|NCT03082742|Furosemide|furosemide|mesh-list
25123660|NCT03082742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25123661|NCT03082742|Diuretics|diuretics|mesh-ancestor
25123662|NCT03082742|Natriuretic Agents|natriuretic agents|mesh-ancestor
25123663|NCT03082742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123664|NCT03082742|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25123665|NCT03082742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25123666|NCT03082742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123667|NCT03082742|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25123668|NCT03082339|Cortisone|cortisone|mesh-list
25123669|NCT03082339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25123670|NCT03082300|Naquotinib|naquotinib|mesh-list
25123671|NCT03082300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123672|NCT03082300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24733113|NCT01643434|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24733114|NCT01643434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24733115|NCT01643434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24733116|NCT01643434|Adrenergic Agents|adrenergic agents|mesh-ancestor
24733183|NCT01643889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24733184|NCT01643889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24733185|NCT01643889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24733186|NCT01643889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24733188|NCT01643889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733189|NCT01643889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733190|NCT01643889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733191|NCT01643889|Antiemetics|antiemetics|mesh-ancestor
24733192|NCT01643889|Autonomic Agents|autonomic agents|mesh-ancestor
24733193|NCT01643889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24733194|NCT01643889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24733245|NCT01644253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733247|NCT01644253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24733248|NCT01644253|Alkylating Agents|alkylating agents|mesh-ancestor
24733250|NCT01644253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617287|NCT01042041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24617288|NCT01042041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693648|NCT02017535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25693649|NCT02017535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693650|NCT02017535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25693651|NCT02017535|Serotonin Agents|serotonin agents|mesh-ancestor
25693652|NCT02017535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693653|NCT02017535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24617289|NCT01042041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733259|NCT01644799|Immunologic Factors|immunologic factors|mesh-ancestor
24733260|NCT01644799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733261|NCT01644799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24733262|NCT01644799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24733263|NCT01644799|Growth Substances|growth substances|mesh-ancestor
24733264|NCT01644799|Growth Inhibitors|growth inhibitors|mesh-ancestor
24733265|NCT01644799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733266|NCT01644799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733267|NCT01644799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733269|NCT01644825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24733270|NCT01644825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733271|NCT01644825|Tubulin Modulators|tubulin modulators|mesh-ancestor
25123673|NCT03082300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123674|NCT03082300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123675|NCT03082573|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25123676|NCT03082573|Hormones|hormones|mesh-ancestor
25123677|NCT03082573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25123678|NCT03082573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733272|NCT01644825|Antimitotic Agents|antimitotic agents|mesh-ancestor
24733273|NCT01644825|Mitosis Modulators|mitosis modulators|mesh-ancestor
24733343|NCT01645384|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24733344|NCT01645384|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24733346|NCT01645410|Atorvastatin|atorvastatin|mesh-list
24733347|NCT01645410|Calcium|calcium|mesh-list
24733348|NCT01645410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24733349|NCT01645410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733350|NCT01645410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24733351|NCT01645410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24733352|NCT01645410|Antimetabolites|antimetabolites|mesh-ancestor
24733353|NCT01645410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733354|NCT01645410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24733355|NCT01645410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24733356|NCT01645410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733358|NCT01645423|Calcium|calcium|mesh-list
24733380|NCT01645475|Hemostatics|hemostatics|mesh-ancestor
24733381|NCT01645475|Coagulants|coagulants|mesh-ancestor
24733382|NCT01645475|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24733384|NCT01645475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733385|NCT01645748|Cisplatin|cisplatin|mesh-list
24733386|NCT01645748|Docetaxel|docetaxel|mesh-list
24733387|NCT01645748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733388|NCT01645748|Tubulin Modulators|tubulin modulators|mesh-ancestor
24733389|NCT01645748|Antimitotic Agents|antimitotic agents|mesh-ancestor
24733390|NCT01645748|Mitosis Modulators|mitosis modulators|mesh-ancestor
24733392|NCT01645774|Oxymetazoline|oxymetazoline|mesh-list
24733394|NCT01645774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24733395|NCT01645774|Adrenergic Agents|adrenergic agents|mesh-ancestor
24733396|NCT01645774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24733397|NCT01645774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733398|NCT01645774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733399|NCT01645774|Sympathomimetics|sympathomimetics|mesh-ancestor
24733400|NCT01645774|Autonomic Agents|autonomic agents|mesh-ancestor
24733401|NCT01645774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24733454|NCT01646307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24733455|NCT01646307|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24733456|NCT01646307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733458|NCT01646437|Vitamin D|vitamin d|mesh-list
24733459|NCT01646437|Cholecalciferol|cholecalciferol|mesh-list
24733460|NCT01646437|Vitamins|vitamins|mesh-ancestor
24733461|NCT01646437|Micronutrients|micronutrients|mesh-ancestor
24733462|NCT01646437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733463|NCT01646437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24733464|NCT01646437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24733542|NCT01646775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733543|NCT01646775|Analgesics|analgesics|mesh-ancestor
25693654|NCT02017535|Antidepressive Agents|antidepressive agents|mesh-ancestor
25693656|NCT02017535|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24612432|NCT01013987|Maraviroc|maraviroc|mesh-list
24694866|NCT05113615|Respiratory System Agents|respiratory system agents|mesh-ancestor
24694867|NCT05113615|Parasympatholytics|parasympatholytics|mesh-ancestor
24694868|NCT05113615|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24694869|NCT05113615|Cholinergic Agents|cholinergic agents|mesh-ancestor
24694870|NCT05113615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24541199|NCT00671424|Diuretics|diuretics|mesh-ancestor
24733544|NCT01646775|Sensory System Agents|sensory system agents|mesh-ancestor
24733545|NCT01646775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24733546|NCT01646775|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24733547|NCT01646775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24617386|NCT01042730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24617387|NCT01042782|Everolimus|everolimus|mesh-list
24617388|NCT01042782|Mitomycin|mitomycin|mesh-list
24617389|NCT01042782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733580|NCT01647165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733581|NCT01647165|Immunologic Factors|immunologic factors|mesh-ancestor
24733582|NCT01647165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24733583|NCT01647165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25123679|NCT03082352|Metoprolol|metoprolol|mesh-list
25123692|NCT03082092|Methylprednisolone|methylprednisolone|mesh-list
25123693|NCT03082092|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25123694|NCT03082092|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25123695|NCT03082092|Prednisolone|prednisolone|mesh-list
25123696|NCT03082092|Prednisolone acetate|prednisolone acetate|mesh-list
25123697|NCT03082092|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25123698|NCT03082092|Prednisolone phosphate|prednisolone phosphate|mesh-list
25123699|NCT03082092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25123700|NCT03082092|Antiemetics|antiemetics|mesh-ancestor
25123701|NCT03082092|Autonomic Agents|autonomic agents|mesh-ancestor
25123702|NCT03082092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25123703|NCT03082092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123704|NCT03082092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25123705|NCT03082092|Glucocorticoids|glucocorticoids|mesh-ancestor
25123706|NCT03082092|Hormones|hormones|mesh-ancestor
24733584|NCT01647165|Growth Substances|growth substances|mesh-ancestor
24733585|NCT01647165|Growth Inhibitors|growth inhibitors|mesh-ancestor
24733586|NCT01647256|Nikkomycin|nikkomycin|mesh-list
24733587|NCT01647256|Antifungal Agents|antifungal agents|mesh-ancestor
24733591|NCT01647347|Povidone-Iodine|povidone-iodine|mesh-list
24733645|NCT01647685|Prednisolone phosphate|prednisolone phosphate|mesh-list
24733646|NCT01647685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24733647|NCT01647685|Antiemetics|antiemetics|mesh-ancestor
24733648|NCT01647685|Autonomic Agents|autonomic agents|mesh-ancestor
24733649|NCT01647685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24733650|NCT01647685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733903|NCT01649479|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
24733904|NCT01649479|Immunologic Factors|immunologic factors|mesh-ancestor
24733905|NCT01649479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733907|NCT01649544|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24733908|NCT01649544|Vasodilator Agents|vasodilator agents|mesh-ancestor
24733909|NCT01649544|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24733910|NCT01649544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24617445|NCT01043211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24733974|NCT01649921|Interferon-gamma|interferon-gamma|mesh-list
24733975|NCT01649921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733976|NCT01649921|Antiviral Agents|antiviral agents|mesh-ancestor
24733977|NCT01649921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24733978|NCT01649960|Sirolimus|sirolimus|mesh-list
24733979|NCT01649960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24733980|NCT01649960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24733981|NCT01649960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24733982|NCT01649960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733983|NCT01649960|Antifungal Agents|antifungal agents|mesh-ancestor
25693657|NCT02017535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25693658|NCT02017535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693659|NCT02017860|Everolimus|everolimus|mesh-list
25693660|NCT02017860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693661|NCT02017860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25693662|NCT02017860|Immunologic Factors|immunologic factors|mesh-ancestor
25693663|NCT02017860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693664|NCT02017899|Vaccines|vaccines|mesh-list
24733984|NCT01649960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24733985|NCT01649960|Immunologic Factors|immunologic factors|mesh-ancestor
24522499|NCT03673956|Vancomycin|vancomycin|mesh-list
24733986|NCT01649960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541253|NCT00671645|Growth Inhibitors|growth inhibitors|mesh-ancestor
24733987|NCT01650012|Eplerenone|eplerenone|mesh-list
24733988|NCT01650012|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24733989|NCT01650012|Hormone Antagonists|hormone antagonists|mesh-ancestor
24734044|NCT01650428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24734045|NCT01650428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24734047|NCT01650428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734048|NCT01650428|Growth Inhibitors|growth inhibitors|mesh-ancestor
24734049|NCT01650428|Antimetabolites|antimetabolites|mesh-ancestor
24734050|NCT01650428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734054|NCT01650428|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24734055|NCT01650428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25123707|NCT03082092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25123708|NCT03082092|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25123709|NCT03082092|Protective Agents|protective agents|mesh-ancestor
25123710|NCT03082092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25123711|NCT03082092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123713|NCT03082183|BI 425809|bi 425809|mesh-list
25123714|NCT03082183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25123715|NCT03082183|Antitubercular Agents|antitubercular agents|mesh-ancestor
25123716|NCT03082183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25123717|NCT03082183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25123718|NCT03082183|Leprostatic Agents|leprostatic agents|mesh-ancestor
25123719|NCT03082183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24734056|NCT01650428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734057|NCT01650441|Beclomethasone|beclomethasone|mesh-list
24734058|NCT01650441|Formoterol Fumarate|formoterol fumarate|mesh-list
24734059|NCT01650441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24734150|NCT01650740|Sensory System Agents|sensory system agents|mesh-ancestor
24734151|NCT01650740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24734152|NCT01650740|Antidepressive Agents|antidepressive agents|mesh-ancestor
24734153|NCT01650740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24734154|NCT01650740|Dopamine Agents|dopamine agents|mesh-ancestor
24617458|NCT01043341|Vaccines|vaccines|mesh-list
24617459|NCT01043341|Immunologic Factors|immunologic factors|mesh-ancestor
24734187|NCT01650961|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24734188|NCT01650961|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24734190|NCT01650961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24734191|NCT01650961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734192|NCT01651130|Carbetocin|carbetocin|mesh-list
24734193|NCT01651130|Oxytocics|oxytocics|mesh-ancestor
24734194|NCT01651130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24734195|NCT01651130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734196|NCT01651156|Tolvaptan|tolvaptan|mesh-list
24734274|NCT01651416|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24734275|NCT01651416|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24734276|NCT01651416|Amodiaquine|amodiaquine|mesh-list
24734277|NCT01651416|Artenimol|artenimol|mesh-list
24734278|NCT01651416|Antimalarials|antimalarials|mesh-ancestor
24734279|NCT01651416|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24734280|NCT01651416|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24734281|NCT01651416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24734369|NCT01651988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734370|NCT01651988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24734371|NCT01651988|Anesthetics, General|anesthetics, general|mesh-ancestor
24734373|NCT01652014|Mycophenolic Acid|mycophenolic acid|mesh-list
24912775|NCT04272255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24734476|NCT01652339|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24734477|NCT01652339|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24734479|NCT01652378|Ondansetron|ondansetron|mesh-list
24734480|NCT01652378|Anesthetics, Local|anesthetics, local|mesh-ancestor
24734481|NCT01652378|Anesthetics|anesthetics|mesh-ancestor
24734482|NCT01652378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24734483|NCT01652378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734484|NCT01652378|Sensory System Agents|sensory system agents|mesh-ancestor
24734488|NCT01652378|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24734515|NCT01652417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24734517|NCT01652417|Hormones|hormones|mesh-ancestor
24734518|NCT01652417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24734519|NCT01652417|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24734520|NCT01652417|Protective Agents|protective agents|mesh-ancestor
24734521|NCT01652417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25693666|NCT02017899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734523|NCT01652534|Amantadine|amantadine|mesh-list
25693667|NCT02018042|Abatacept|abatacept|mesh-list
25693668|NCT02018042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25693669|NCT02018042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123720|NCT03082183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123721|NCT03082183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123722|NCT03082183|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25123723|NCT03082183|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25123724|NCT03082183|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25123725|NCT03082183|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25123726|NCT03082183|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25123727|NCT03082183|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25123728|NCT03082183|Nootropic Agents|nootropic agents|mesh-ancestor
25123729|NCT03082053|Capecitabine|capecitabine|mesh-list
25123730|NCT03082053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25123731|NCT03082053|Antimetabolites|antimetabolites|mesh-ancestor
24734598|NCT01652781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24734599|NCT01652781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734602|NCT01652794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24734603|NCT01652794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24734604|NCT01652794|Antimetabolites|antimetabolites|mesh-ancestor
24734605|NCT01652794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734606|NCT01652794|Antiviral Agents|antiviral agents|mesh-ancestor
24734714|NCT01653314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24734715|NCT01653314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24734716|NCT01653314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734717|NCT01653314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734719|NCT01653457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24734720|NCT01653457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24734721|NCT01653457|Dopamine Agents|dopamine agents|mesh-ancestor
24734722|NCT01653457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24734723|NCT01653457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734724|NCT01653457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734727|NCT01653470|Leucovorin|leucovorin|mesh-list
24734781|NCT01653717|Immunologic Factors|immunologic factors|mesh-ancestor
24650124|NCT01224093|Rituximab|rituximab|mesh-list
24734793|NCT01653977|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
24734794|NCT01653990|Moxifloxacin|moxifloxacin|mesh-list
24734795|NCT01653990|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24734796|NCT01653990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24734878|NCT01654497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24734879|NCT01654497|Protective Agents|protective agents|mesh-ancestor
24734880|NCT01654562|Simvastatin|simvastatin|mesh-list
24734881|NCT01654562|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24734882|NCT01654562|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24734924|NCT01654718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734925|NCT01654731|Bezafibrate|bezafibrate|mesh-list
24734926|NCT01654731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24734927|NCT01654731|Antimetabolites|antimetabolites|mesh-ancestor
24734987|NCT01655095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24819242|NCT02094287|Histamine Agents|histamine agents|mesh-ancestor
24734988|NCT01655095|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24734989|NCT01655095|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24734990|NCT01655095|Serotonin Agents|serotonin agents|mesh-ancestor
24734991|NCT01655095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24735003|NCT01655147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735004|NCT01655147|Hormone Antagonists|hormone antagonists|mesh-ancestor
24735005|NCT01655147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24735006|NCT01655147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123732|NCT03082053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123733|NCT03082053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123735|NCT03081923|Tremelimumab|tremelimumab|mesh-list
25123736|NCT03081923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25123737|NCT03081923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123738|NCT03082001|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25123739|NCT03081949|Selenium|selenium|mesh-list
25123740|NCT03081949|Selenious Acid|selenious acid|mesh-list
25123741|NCT03081949|Sodium Selenite|sodium selenite|mesh-list
25693670|NCT02018042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693671|NCT02018042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25693672|NCT02018042|Immunologic Factors|immunologic factors|mesh-ancestor
25693673|NCT02018042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693674|NCT02018042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25693675|NCT02018107|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25693676|NCT02018107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25693677|NCT02018107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123742|NCT03081949|Antioxidants|antioxidants|mesh-ancestor
25123743|NCT03081949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077552|NCT03363815|Metformin|metformin|mesh-list
24735007|NCT01655147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24735008|NCT01655147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24735009|NCT01655147|Antitubercular Agents|antitubercular agents|mesh-ancestor
24735010|NCT01655147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24735011|NCT01655147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24735012|NCT01655147|Leprostatic Agents|leprostatic agents|mesh-ancestor
24735013|NCT01655147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24735014|NCT01655147|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24735015|NCT01655147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24735016|NCT01655147|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24735017|NCT01655147|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24735018|NCT01655147|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24735020|NCT01655199|Albuterol|albuterol|mesh-list
24735055|NCT01655303|Autonomic Agents|autonomic agents|mesh-ancestor
24735056|NCT01655303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24735057|NCT01655303|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24735058|NCT01655303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24735059|NCT01655303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24735060|NCT01655303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24735061|NCT01655316|Verapamil|verapamil|mesh-list
24735062|NCT01655316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24735069|NCT01655368|Psychotropic Drugs|psychotropic drugs|mesh-list
24617580|NCT01044004|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24617581|NCT01044004|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24617582|NCT01044004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617583|NCT01044095|Vaccines|vaccines|mesh-list
24617584|NCT01044095|Immunologic Factors|immunologic factors|mesh-ancestor
24617585|NCT01044095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617586|NCT01044186|Deferasirox|deferasirox|mesh-list
24617587|NCT01044186|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24617588|NCT01044186|Chelating Agents|chelating agents|mesh-ancestor
24617589|NCT01044186|Sequestering Agents|sequestering agents|mesh-ancestor
24617590|NCT01044186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617591|NCT01044199|Vaccines|vaccines|mesh-list
24617592|NCT01044199|Immunologic Factors|immunologic factors|mesh-ancestor
24420597|NCT00216411|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24735188|NCT01655927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735189|NCT01655927|Hemostatics|hemostatics|mesh-ancestor
24735190|NCT01655927|Coagulants|coagulants|mesh-ancestor
24735191|NCT01655966|Vitamin D|vitamin d|mesh-list
24735240|NCT01656005|Sympatholytics|sympatholytics|mesh-ancestor
24735241|NCT01656005|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24735242|NCT01656005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24735243|NCT01656005|Glucocorticoids|glucocorticoids|mesh-ancestor
24735244|NCT01656005|Hormones|hormones|mesh-ancestor
25123744|NCT03081949|Protective Agents|protective agents|mesh-ancestor
25123745|NCT03081949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123746|NCT03081949|Trace Elements|trace elements|mesh-ancestor
25123747|NCT03081949|Micronutrients|micronutrients|mesh-ancestor
25123748|NCT03081832|Oxytocin|oxytocin|mesh-list
25123749|NCT03081832|Oxytocics|oxytocics|mesh-ancestor
25123750|NCT03081832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25077566|NCT03363815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24735245|NCT01656005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24735246|NCT01656018|Rilpivirine|rilpivirine|mesh-list
24735247|NCT01656018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24735248|NCT01656018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24735249|NCT01656018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735250|NCT01656018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693678|NCT02018458|Paclitaxel|paclitaxel|mesh-list
25693679|NCT02018458|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24695748|NCT01596621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695749|NCT01596621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24695780|NCT01231906|Cyclophosphamide|cyclophosphamide|mesh-list
24695781|NCT01231906|Ifosfamide|ifosfamide|mesh-list
24735251|NCT01656018|Antiviral Agents|antiviral agents|mesh-ancestor
24617603|NCT01044238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617605|NCT01044238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24617606|NCT01044251|Frovatriptan|frovatriptan|mesh-list
24735398|NCT01656798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735399|NCT01656798|Urological Agents|urological agents|mesh-ancestor
24735401|NCT01656811|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24735408|NCT01656811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24735409|NCT01656811|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24735410|NCT01656811|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24735411|NCT01656811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24735412|NCT01656811|Adrenergic Agents|adrenergic agents|mesh-ancestor
24735413|NCT01656811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24735468|NCT01657201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735469|NCT01657201|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24735470|NCT01657201|Hormone Antagonists|hormone antagonists|mesh-ancestor
24735471|NCT01657201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24735472|NCT01657201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617775|NCT01045681|BB 1101|bb 1101|mesh-list
24735473|NCT01657201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24735474|NCT01657240|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
24735475|NCT01657240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24735476|NCT01657240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24735556|NCT01657656|Vitamin D|vitamin d|mesh-list
24735557|NCT01657656|Vitamins|vitamins|mesh-ancestor
24735558|NCT01657656|Micronutrients|micronutrients|mesh-ancestor
24735559|NCT01657656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735560|NCT01657656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24617640|NCT01044394|Bisacodyl|bisacodyl|mesh-list
24617641|NCT01044394|Cathartics|cathartics|mesh-ancestor
24617642|NCT01044394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24617643|NCT01044394|Laxatives|laxatives|mesh-ancestor
24617644|NCT01044446|Dialysis Solutions|dialysis solutions|mesh-list
24617645|NCT01044446|Icodextrin|icodextrin|mesh-list
24617646|NCT01044446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24617647|NCT01044485|Docetaxel|docetaxel|mesh-list
24617648|NCT01044485|Lapatinib|lapatinib|mesh-list
24617649|NCT01044485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617650|NCT01044485|Tubulin Modulators|tubulin modulators|mesh-ancestor
24735627|NCT01657864|Lamotrigine|lamotrigine|mesh-list
24735720|NCT01658202|Autonomic Agents|autonomic agents|mesh-ancestor
24735721|NCT01658202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24735722|NCT01658202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735723|NCT01658202|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24735724|NCT01658202|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24735812|NCT01658878|Sorafenib|sorafenib|mesh-list
24735813|NCT01658878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24735814|NCT01658878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24735815|NCT01658878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24735819|NCT01658891|Beclomethasone|beclomethasone|mesh-list
24735877|NCT01659099|Antimitotic Agents|antimitotic agents|mesh-ancestor
24735878|NCT01659099|Mitosis Modulators|mitosis modulators|mesh-ancestor
24735879|NCT01659190|Calcium Carbonate|calcium carbonate|mesh-list
24735880|NCT01659190|Antacids|antacids|mesh-ancestor
25123751|NCT03081832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123752|NCT03082482|Nicotine|nicotine|mesh-list
25123753|NCT03082482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25123754|NCT03082482|Autonomic Agents|autonomic agents|mesh-ancestor
25123755|NCT03082482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25123756|NCT03082482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123757|NCT03082482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25123758|NCT03082482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25123759|NCT03082482|Cholinergic Agents|cholinergic agents|mesh-ancestor
25693680|NCT02018458|Cyclophosphamide|cyclophosphamide|mesh-list
25693681|NCT02018458|Carboplatin|carboplatin|mesh-list
25693682|NCT02018458|Doxorubicin|doxorubicin|mesh-list
25693683|NCT02018458|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25693684|NCT02018458|Vaccines|vaccines|mesh-list
25123760|NCT03082482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25123761|NCT03082482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123762|NCT03081494|Spartalizumab|spartalizumab|mesh-list
25123763|NCT03081494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25123764|NCT03081494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124108|NCT03079505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735881|NCT01659190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735882|NCT01659190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24735883|NCT01659242|Sulfasalazine|sulfasalazine|mesh-list
24735884|NCT01659242|Methotrexate|methotrexate|mesh-list
24735885|NCT01659242|Leflunomide|leflunomide|mesh-list
24735886|NCT01659242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24735887|NCT01659242|Abortifacient Agents|abortifacient agents|mesh-ancestor
24735888|NCT01659242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24735889|NCT01659242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735890|NCT01659242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24735891|NCT01659242|Antimetabolites|antimetabolites|mesh-ancestor
24735893|NCT01659242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24735971|NCT01659372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24735972|NCT01659372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24735973|NCT01659372|Gout Suppressants|gout suppressants|mesh-ancestor
24735974|NCT01659372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24735975|NCT01659372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735976|NCT01659372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735977|NCT01659437|Clarithromycin|clarithromycin|mesh-list
24735978|NCT01659437|Streptomycin|streptomycin|mesh-list
24735979|NCT01659437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24735980|NCT01659437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24735981|NCT01659437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24735982|NCT01659437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735983|NCT01659437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735987|NCT01659476|Miotics|miotics|mesh-ancestor
24736066|NCT01659905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736067|NCT01659918|Montelukast|montelukast|mesh-list
24736068|NCT01659918|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24736069|NCT01659918|Respiratory System Agents|respiratory system agents|mesh-ancestor
24736157|NCT01660477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24736158|NCT01660477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736159|NCT01660477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24736258|NCT01661101|Dabigatran|dabigatran|mesh-list
24736259|NCT01661101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24736260|NCT01661101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25123766|NCT03081702|Hydroxychloroquine|hydroxychloroquine|mesh-list
25123768|NCT03081702|Antimalarials|antimalarials|mesh-ancestor
25123769|NCT03081702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25123770|NCT03081702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25123771|NCT03081702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25123772|NCT03081702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123773|NCT03081702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123774|NCT03081702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25123775|NCT03081702|Antifungal Agents|antifungal agents|mesh-ancestor
24696861|NCT01431430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25123776|NCT03081702|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25123777|NCT03081702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25123778|NCT03081702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25123779|NCT03081702|Hormone Antagonists|hormone antagonists|mesh-ancestor
25123780|NCT03081702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25123781|NCT03081702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123782|NCT03081702|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25123783|NCT03081728|Acetaminophen|acetaminophen|mesh-list
25123784|NCT03081728|Diclofenac|diclofenac|mesh-list
24736261|NCT01661101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24736262|NCT01661101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24736331|NCT01661335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24736332|NCT01661335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736333|NCT01661335|Antipruritics|antipruritics|mesh-ancestor
24736334|NCT01661335|Dermatologic Agents|dermatologic agents|mesh-ancestor
24736335|NCT01661335|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24736336|NCT01661335|Serotonin Agents|serotonin agents|mesh-ancestor
24736339|NCT01661335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24736344|NCT01661439|Heparin|heparin|mesh-list
24736407|NCT01661985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24696143|NCT01427582|Alkylating Agents|alkylating agents|mesh-ancestor
24696146|NCT01427686|Dobutamine|dobutamine|mesh-list
24696152|NCT01427686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696153|NCT01427686|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24696154|NCT01427686|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24696155|NCT01427686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24696156|NCT01427686|Adrenergic Agents|adrenergic agents|mesh-ancestor
24696157|NCT01427686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24736408|NCT01661985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24736409|NCT01661985|Antimalarials|antimalarials|mesh-ancestor
24736410|NCT01661985|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24736435|NCT01662089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736436|NCT01662128|Capecitabine|capecitabine|mesh-list
24736437|NCT01662128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24736438|NCT01662128|Antimetabolites|antimetabolites|mesh-ancestor
24736439|NCT01662128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736440|NCT01662128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24736441|NCT01662180|Hormones|hormones|mesh-list
24736442|NCT01662180|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24736443|NCT01662180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24736444|NCT01662180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736508|NCT01662687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24447957|NCT00309920|Doxorubicin|doxorubicin|mesh-list
24525348|NCT03633058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24525349|NCT03633058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24525350|NCT03633058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24525351|NCT03633058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24525352|NCT03633058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123786|NCT03081728|Anesthetics, Local|anesthetics, local|mesh-ancestor
25123787|NCT03081728|Anesthetics|anesthetics|mesh-ancestor
25123788|NCT03081728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25123789|NCT03081728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123790|NCT03081728|Sensory System Agents|sensory system agents|mesh-ancestor
25123791|NCT03081728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25123792|NCT03081728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25123793|NCT03081728|Analgesics|analgesics|mesh-ancestor
25123794|NCT03081728|Antipyretics|antipyretics|mesh-ancestor
24696881|NCT01431456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25123795|NCT03081728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25123796|NCT03081728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25123797|NCT03081728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25123798|NCT03081728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25123799|NCT03081728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123800|NCT03081728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525375|NCT03593655|Tenofovir|tenofovir|mesh-list
24525376|NCT03593655|Emtricitabine|emtricitabine|mesh-list
24525377|NCT03593655|Dapivirine|dapivirine|mesh-list
24736649|NCT01664013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736650|NCT01664013|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24736651|NCT01664013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24736652|NCT01664065|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
24736653|NCT01664065|Cephalosporins|cephalosporins|mesh-list
24736654|NCT01664065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24736655|NCT01664065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24736656|NCT01664195|Epoetin Alfa|epoetin alfa|mesh-list
24736657|NCT01664195|Hematinics|hematinics|mesh-ancestor
24736658|NCT01664221|Epoetin Alfa|epoetin alfa|mesh-list
24736659|NCT01664221|Hematinics|hematinics|mesh-ancestor
24736660|NCT01664260|Acetylcysteine|acetylcysteine|mesh-list
24736661|NCT01664260|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24736718|NCT01664754|Exemestane|exemestane|mesh-list
24736719|NCT01664754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24736720|NCT01664754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24736721|NCT01664754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736722|NCT01664754|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24736723|NCT01664754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24736724|NCT01664754|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25693685|NCT02018458|Immunologic Factors|immunologic factors|mesh-ancestor
25693686|NCT02018458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693687|NCT02018458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25693688|NCT02018458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693689|NCT02018458|Tubulin Modulators|tubulin modulators|mesh-ancestor
25693690|NCT02018458|Antimitotic Agents|antimitotic agents|mesh-ancestor
25693691|NCT02018458|Mitosis Modulators|mitosis modulators|mesh-ancestor
24736725|NCT01664754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24736726|NCT01664754|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24736727|NCT01664754|Hormone Antagonists|hormone antagonists|mesh-ancestor
24736728|NCT01664754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24736729|NCT01664754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736730|NCT01664819|Antioxidants|antioxidants|mesh-list
24736732|NCT01664819|Protective Agents|protective agents|mesh-ancestor
24617842|NCT01045902|Moxifloxacin|moxifloxacin|mesh-list
24617844|NCT01045902|Sulbactam|sulbactam|mesh-list
25123815|NCT03081676|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
25123816|NCT03081676|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25123817|NCT03081676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25123818|NCT03081676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25123819|NCT03081676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123820|NCT03081676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25123821|NCT03081676|Immunologic Factors|immunologic factors|mesh-ancestor
25123822|NCT03081676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25123823|NCT03081676|Hormones|hormones|mesh-ancestor
25077626|NCT03363425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24617852|NCT01045902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24736783|NCT01665222|Narcotics|narcotics|mesh-ancestor
24736835|NCT01665274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736901|NCT01665586|Sensory System Agents|sensory system agents|mesh-ancestor
24736912|NCT01665638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736913|NCT01665638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24736914|NCT01665638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736916|NCT01665638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24736917|NCT01665677|Atorvastatin|atorvastatin|mesh-list
24736918|NCT01665677|Calcium|calcium|mesh-list
24736919|NCT01665677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24736920|NCT01665677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736932|NCT01665742|Vitamin E|vitamin e|mesh-list
24736976|NCT01666080|Anticonvulsants|anticonvulsants|mesh-ancestor
24736977|NCT01666080|Nootropic Agents|nootropic agents|mesh-ancestor
24736978|NCT01666171|Metformin|metformin|mesh-list
24736979|NCT01666171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24736980|NCT01666171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736981|NCT01666223|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
24737052|NCT01666587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24737053|NCT01666587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24737054|NCT01666587|Analgesics|analgesics|mesh-ancestor
24737055|NCT01666587|Sensory System Agents|sensory system agents|mesh-ancestor
24737058|NCT01666587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24737128|NCT01667094|Cefepime|cefepime|mesh-list
24737129|NCT01667094|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24737135|NCT01667094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123824|NCT03081676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25123825|NCT03081676|Incretins|incretins|mesh-ancestor
25123826|NCT03081416|Diphenhydramine|diphenhydramine|mesh-list
25123827|NCT03081416|Dexamethasone|dexamethasone|mesh-list
25123828|NCT03081416|Ketorolac|ketorolac|mesh-list
25123829|NCT03081416|Ketamine|ketamine|mesh-list
25123830|NCT03081416|Metoclopramide|metoclopramide|mesh-list
25123831|NCT03081416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25123832|NCT03081416|Antiemetics|antiemetics|mesh-ancestor
25123833|NCT03081416|Autonomic Agents|autonomic agents|mesh-ancestor
25123834|NCT03081416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25123835|NCT03081416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123836|NCT03081416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25123837|NCT03081416|Glucocorticoids|glucocorticoids|mesh-ancestor
25123838|NCT03081416|Hormones|hormones|mesh-ancestor
24627947|NCT01095809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25123839|NCT03081416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25077646|NCT03363204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24737136|NCT01667094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737138|NCT01667120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24737139|NCT01667120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24737140|NCT01667120|Analgesics|analgesics|mesh-ancestor
24737141|NCT01667120|Sensory System Agents|sensory system agents|mesh-ancestor
24737142|NCT01667120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737143|NCT01667120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737144|NCT01667120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24737145|NCT01667120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24737146|NCT01667120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24737147|NCT01667120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737148|NCT01667120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737149|NCT01667211|Paclitaxel|paclitaxel|mesh-list
24737150|NCT01667211|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24737151|NCT01667211|Nedaplatin|nedaplatin|mesh-list
24737158|NCT01667263|Tretinoin|tretinoin|mesh-list
24737195|NCT01667523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737196|NCT01667523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24737197|NCT01667523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737198|NCT01667523|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24737199|NCT01667523|Protective Agents|protective agents|mesh-ancestor
24737200|NCT01667575|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25123849|NCT03081416|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25123850|NCT03081416|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25123851|NCT03081416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25123852|NCT03081416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123853|NCT03081416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25123854|NCT03081416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25123855|NCT03081416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25123856|NCT03081416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25123857|NCT03081416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123858|NCT03081416|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25123859|NCT03081416|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25123860|NCT03081416|Dopamine Agents|dopamine agents|mesh-ancestor
25123861|NCT03081416|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24737201|NCT01667575|Amoxicillin|amoxicillin|mesh-list
24737268|NCT01667744|Antidepressive Agents|antidepressive agents|mesh-ancestor
24737269|NCT01667744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24737270|NCT01667874|Gentamicins|gentamicins|mesh-list
24737357|NCT01668498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737359|NCT01668550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24737385|NCT01668680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24737386|NCT01668680|Analgesics|analgesics|mesh-ancestor
24737387|NCT01668680|Sensory System Agents|sensory system agents|mesh-ancestor
24737388|NCT01668680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737389|NCT01668680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24737390|NCT01668680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24737391|NCT01668680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24653049|NCT01241682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737409|NCT01668901|Aspirin|aspirin|mesh-list
24737410|NCT01668901|Warfarin|warfarin|mesh-list
24737411|NCT01668901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24737412|NCT01668901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24737413|NCT01668901|Analgesics|analgesics|mesh-ancestor
24737414|NCT01668901|Sensory System Agents|sensory system agents|mesh-ancestor
24737415|NCT01668901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737416|NCT01668901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737417|NCT01668901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24737418|NCT01668901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24737419|NCT01668901|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24737420|NCT01668901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24737421|NCT01668901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617892|NCT01045980|Ergocalciferols|ergocalciferols|mesh-list
24617893|NCT01045980|Cholecalciferol|cholecalciferol|mesh-list
24617894|NCT01045980|Vitamins|vitamins|mesh-list
24737498|NCT01669226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737499|NCT01669239|Doxorubicin|doxorubicin|mesh-list
24737500|NCT01669239|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24737501|NCT01669239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24737502|NCT01669239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123862|NCT03081416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25123863|NCT03081416|Anesthetics, Local|anesthetics, local|mesh-ancestor
25123864|NCT03081416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25123865|NCT03081416|Histamine Antagonists|histamine antagonists|mesh-ancestor
25123866|NCT03081416|Histamine Agents|histamine agents|mesh-ancestor
25123867|NCT03081416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25123868|NCT03081039|Gemcitabine|gemcitabine|mesh-list
25693692|NCT02018458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696870|NCT01431456|Nadroparin|nadroparin|mesh-list
25123869|NCT03081039|Carboplatin|carboplatin|mesh-list
25123870|NCT03081039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123871|NCT03081039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25123872|NCT03081039|Antimetabolites|antimetabolites|mesh-ancestor
25123873|NCT03081039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123874|NCT03081039|Antiviral Agents|antiviral agents|mesh-ancestor
25123875|NCT03081039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25123876|NCT03081039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123877|NCT03081039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25123878|NCT03081039|Immunologic Factors|immunologic factors|mesh-ancestor
24737506|NCT01669239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737507|NCT01669291|Leuprolide|leuprolide|mesh-list
24737508|NCT01669291|Cetrorelix|cetrorelix|mesh-list
24737509|NCT01669291|Menotropins|menotropins|mesh-list
24737510|NCT01669291|Ganirelix|ganirelix|mesh-list
24737511|NCT01669291|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24737512|NCT01669291|Fertility Agents|fertility agents|mesh-ancestor
24737513|NCT01669291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24737514|NCT01669291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737515|NCT01669291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24737516|NCT01669291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737517|NCT01669291|Hormone Antagonists|hormone antagonists|mesh-ancestor
24737519|NCT01669304|Verapamil|verapamil|mesh-list
24737520|NCT01669304|Sertraline|sertraline|mesh-list
24737558|NCT01669499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24737559|NCT01669499|Glucocorticoids|glucocorticoids|mesh-ancestor
24737560|NCT01669499|Hormones|hormones|mesh-ancestor
24737561|NCT01669499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24737562|NCT01669499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24737563|NCT01669499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737564|NCT01669499|Protease Inhibitors|protease inhibitors|mesh-ancestor
24737565|NCT01669499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737566|NCT01669499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737653|NCT01670084|Alkylating Agents|alkylating agents|mesh-ancestor
24653155|NCT01242228|Saxagliptin|saxagliptin|mesh-list
24737654|NCT01670084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737655|NCT01670084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737656|NCT01670084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24737657|NCT01670084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24737658|NCT01670084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24737660|NCT01670084|Autonomic Agents|autonomic agents|mesh-ancestor
24737661|NCT01670084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737662|NCT01670084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24737663|NCT01670084|Glucocorticoids|glucocorticoids|mesh-ancestor
24737664|NCT01670084|Hormones|hormones|mesh-ancestor
25123907|NCT03080740|Clindamycin phosphate|clindamycin phosphate|mesh-list
24737665|NCT01670084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24737684|NCT01670084|Vitamins|vitamins|mesh-ancestor
24737718|NCT01670175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737719|NCT01670175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24737720|NCT01670175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24737721|NCT01670175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24737722|NCT01670175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24737723|NCT01670175|Antifungal Agents|antifungal agents|mesh-ancestor
25123879|NCT03081039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123880|NCT03081169|Heparin|heparin|mesh-list
25123881|NCT03081169|Enoxaparin|enoxaparin|mesh-list
25123882|NCT03081169|Enoxaparin sodium|enoxaparin sodium|mesh-list
25123883|NCT03081169|Anticoagulants|anticoagulants|mesh-ancestor
25123884|NCT03081169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25123885|NCT03081169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25077697|NCT03362814|Ritonavir|ritonavir|mesh-list
24737724|NCT01670175|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24737726|NCT01670175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737805|NCT01670669|Laxatives|laxatives|mesh-ancestor
24737806|NCT01670669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24737807|NCT01670669|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24737808|NCT01670669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24737809|NCT01670669|Serotonin Agents|serotonin agents|mesh-ancestor
24737810|NCT01670669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24737878|NCT01671384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24737879|NCT01671384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24737880|NCT01671410|Morphine|morphine|mesh-list
24737881|NCT01671410|Buprenorphine|buprenorphine|mesh-list
24737897|NCT01671709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25693693|NCT02018458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24737898|NCT01671709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737899|NCT01671709|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24737900|NCT01671709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24737901|NCT01671709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737903|NCT01671722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24737904|NCT01671722|Respiratory System Agents|respiratory system agents|mesh-ancestor
24737905|NCT01671722|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24737906|NCT01671722|Hormone Antagonists|hormone antagonists|mesh-ancestor
24737907|NCT01671722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24737908|NCT01671722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737923|NCT01671787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24737924|NCT01671787|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24737925|NCT01671787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24737935|NCT01671800|Cholinergic Agents|cholinergic agents|mesh-ancestor
24737936|NCT01671800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24737937|NCT01671800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737938|NCT01671813|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24737939|NCT01671813|Immunoconjugates|immunoconjugates|mesh-list
24737940|NCT01671813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24738009|NCT01672307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24738010|NCT01672307|Vasodilator Agents|vasodilator agents|mesh-ancestor
24738011|NCT01672346|Adenosine|adenosine|mesh-list
24738012|NCT01672346|Analgesics|analgesics|mesh-ancestor
24738013|NCT01672346|Sensory System Agents|sensory system agents|mesh-ancestor
24738017|NCT01672346|Vasodilator Agents|vasodilator agents|mesh-ancestor
24738018|NCT01672346|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24738019|NCT01672346|Purinergic Agonists|purinergic agonists|mesh-ancestor
24738020|NCT01672346|Purinergic Agents|purinergic agents|mesh-ancestor
24738021|NCT01672346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24738022|NCT01672346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738024|NCT01672359|Lipotropic Agents|lipotropic agents|mesh-ancestor
24738031|NCT01672450|Ipilimumab|ipilimumab|mesh-list
24738058|NCT01672593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24738059|NCT01672606|Rocuronium|rocuronium|mesh-list
24738060|NCT01672606|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24738061|NCT01672606|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24738062|NCT01672606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24738063|NCT01672606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24738064|NCT01672606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738065|NCT01672671|Paclitaxel|paclitaxel|mesh-list
24738066|NCT01672671|Doxorubicin|doxorubicin|mesh-list
24738067|NCT01672671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24738068|NCT01672671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738069|NCT01672671|Tubulin Modulators|tubulin modulators|mesh-ancestor
24738077|NCT01672814|Riboflavin|riboflavin|mesh-list
24738182|NCT01673997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25123886|NCT03081169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123887|NCT03081442|Misoprostol|misoprostol|mesh-list
25123888|NCT03081442|Contraceptive Agents|contraceptive agents|mesh-list
25123889|NCT03081442|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25123890|NCT03081442|Abortifacient Agents|abortifacient agents|mesh-ancestor
25123891|NCT03081442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25123892|NCT03081442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123893|NCT03081442|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24913835|NCT04260516|Antidotes|antidotes|mesh-ancestor
25123894|NCT03081442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24738183|NCT01673997|Sympatholytics|sympatholytics|mesh-ancestor
24738227|NCT01674218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24738228|NCT01674218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24738229|NCT01674218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24738230|NCT01674218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24738231|NCT01674218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24738232|NCT01674218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738233|NCT01674218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738234|NCT01674257|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24738235|NCT01674257|Fluorides|fluorides|mesh-list
24738236|NCT01674257|Cariostatic Agents|cariostatic agents|mesh-ancestor
24738237|NCT01674257|Protective Agents|protective agents|mesh-ancestor
24738238|NCT01674257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738239|NCT01674257|Hematinics|hematinics|mesh-ancestor
24738248|NCT01674283|Glucagon|glucagon|mesh-list
24738249|NCT01674283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24738250|NCT01674283|Hormones|hormones|mesh-ancestor
24738251|NCT01674283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24738252|NCT01674283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527260|NCT00615745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24738256|NCT01674504|Montelukast|montelukast|mesh-list
24738301|NCT01674686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24738302|NCT01674686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24738303|NCT01674686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24738304|NCT01674686|Serotonin Agents|serotonin agents|mesh-ancestor
24738305|NCT01674686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24738306|NCT01674686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738307|NCT01674738|Bevacizumab|bevacizumab|mesh-list
24738308|NCT01674738|Pemetrexed|pemetrexed|mesh-list
24738309|NCT01674738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24738310|NCT01674738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738311|NCT01674738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24738320|NCT01674777|Ipragliflozin|ipragliflozin|mesh-list
24738372|NCT01675076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24738373|NCT01675076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738375|NCT01675089|Zoledronic Acid|zoledronic acid|mesh-list
24738376|NCT01675089|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24738377|NCT01675089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738378|NCT01675115|Aspirin|aspirin|mesh-list
24738379|NCT01675115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24738380|NCT01675115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24738381|NCT01675115|Analgesics|analgesics|mesh-ancestor
24738382|NCT01675115|Sensory System Agents|sensory system agents|mesh-ancestor
24738383|NCT01675115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24738410|NCT01675219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24738411|NCT01675219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24738412|NCT01675310|Metformin|metformin|mesh-list
24738413|NCT01675310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24738414|NCT01675310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738415|NCT01675362|Selenium|selenium|mesh-list
24738416|NCT01675362|Losartan|losartan|mesh-list
24738417|NCT01675362|Verapamil|verapamil|mesh-list
24738418|NCT01675362|Calcium Channel Blockers|calcium channel blockers|mesh-list
24738419|NCT01675362|Calcium|calcium|mesh-list
24738420|NCT01675362|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24738421|NCT01675362|Antioxidants|antioxidants|mesh-list
24738422|NCT01675362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25123896|NCT03080974|Nivolumab|nivolumab|mesh-list
25123897|NCT03080974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25123898|NCT03080974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123899|NCT03080974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25123900|NCT03080974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123901|NCT03080675|Vitamins|vitamins|mesh-list
25123902|NCT03080675|Micronutrients|micronutrients|mesh-ancestor
25123903|NCT03080675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123905|NCT03080740|Clindamycin|clindamycin|mesh-list
25123906|NCT03080740|Clindamycin palmitate|clindamycin palmitate|mesh-list
25123908|NCT03080740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25123909|NCT03080740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25123910|NCT03080740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25123911|NCT03080740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25123912|NCT03080740|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25123921|NCT03080441|Midodrine|midodrine|mesh-list
25123922|NCT03080441|Sympathomimetics|sympathomimetics|mesh-ancestor
25123923|NCT03080441|Autonomic Agents|autonomic agents|mesh-ancestor
25123924|NCT03080441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25123925|NCT03080441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123926|NCT03080441|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25123927|NCT03080441|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25123928|NCT03080441|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25123929|NCT03080441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25123930|NCT03080441|Adrenergic Agents|adrenergic agents|mesh-ancestor
25123931|NCT03080441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25123932|NCT03080441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123933|NCT03080805|Capecitabine|capecitabine|mesh-list
25123934|NCT03080805|Lapatinib|lapatinib|mesh-list
25123935|NCT03080805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25123936|NCT03080805|Antimetabolites|antimetabolites|mesh-ancestor
25123937|NCT03080805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123938|NCT03080805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25123939|NCT03080805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25123940|NCT03080805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25123942|NCT03080415|Antiviral Agents|antiviral agents|mesh-ancestor
25123943|NCT03080415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25123944|NCT03080363|Lidocaine|lidocaine|mesh-list
25123945|NCT03080363|Bupivacaine|bupivacaine|mesh-list
25123946|NCT03080363|Anesthetics, Local|anesthetics, local|mesh-ancestor
25123947|NCT03080363|Anesthetics|anesthetics|mesh-ancestor
25123948|NCT03080363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25123949|NCT03080363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123950|NCT03080363|Sensory System Agents|sensory system agents|mesh-ancestor
25123951|NCT03080363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25123952|NCT03080363|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25123953|NCT03080363|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25123954|NCT03080363|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25123955|NCT03080363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25123956|NCT03080363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123957|NCT03080324|Fentanyl|fentanyl|mesh-list
25123958|NCT03080324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25123959|NCT03080324|Narcotics|narcotics|mesh-ancestor
25123960|NCT03080324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25123961|NCT03080324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123962|NCT03080324|Analgesics|analgesics|mesh-ancestor
25123963|NCT03080324|Sensory System Agents|sensory system agents|mesh-ancestor
25123964|NCT03080324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25077754|NCT03362281|Omeprazole|omeprazole|mesh-list
24738423|NCT01675362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738441|NCT01675557|Vitamin D|vitamin d|mesh-list
24738471|NCT01675648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24738472|NCT01675648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738473|NCT01675648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24738474|NCT01675648|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24738475|NCT01675648|Sensory System Agents|sensory system agents|mesh-ancestor
24738476|NCT01675648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24738477|NCT01675648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24738478|NCT01675648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24738479|NCT01675648|Adrenergic Agents|adrenergic agents|mesh-ancestor
24738480|NCT01675648|Analgesics|analgesics|mesh-ancestor
24738481|NCT01675648|Sympatholytics|sympatholytics|mesh-ancestor
24738482|NCT01675700|Nitroglycerin|nitroglycerin|mesh-list
24738483|NCT01675700|Vasodilator Agents|vasodilator agents|mesh-ancestor
24738484|NCT01675804|Methylphenidate|methylphenidate|mesh-list
24738485|NCT01675804|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24738486|NCT01675804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738525|NCT01675947|Immunologic Factors|immunologic factors|mesh-ancestor
24738526|NCT01675973|Ranolazine|ranolazine|mesh-list
24403138|NCT00159458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24403139|NCT00159458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403140|NCT00159458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24403141|NCT00159458|Immunologic Factors|immunologic factors|mesh-ancestor
24403142|NCT00159458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738530|NCT01675986|Pregabalin|pregabalin|mesh-list
25123967|NCT03080324|Anesthetics, General|anesthetics, general|mesh-ancestor
25123968|NCT03080324|Anesthetics|anesthetics|mesh-ancestor
25123969|NCT03080545|Calcitriol|calcitriol|mesh-list
25123970|NCT03080545|Betamethasone|betamethasone|mesh-list
25123971|NCT03080545|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25123972|NCT03080545|Calcipotriene|calcipotriene|mesh-list
25123976|NCT03080545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25123977|NCT03080545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123978|NCT03080545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25123979|NCT03080545|Respiratory System Agents|respiratory system agents|mesh-ancestor
24738531|NCT01675986|Hydroxyzine|hydroxyzine|mesh-list
24738532|NCT01675986|Analgesics|analgesics|mesh-ancestor
24738533|NCT01675986|Sensory System Agents|sensory system agents|mesh-ancestor
24738534|NCT01675986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24738535|NCT01675986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738536|NCT01675986|Anticonvulsants|anticonvulsants|mesh-ancestor
24738619|NCT01676363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738623|NCT01676493|Codeine|codeine|mesh-list
24738624|NCT01676493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24738625|NCT01676493|Narcotics|narcotics|mesh-ancestor
24738626|NCT01676493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24738627|NCT01676493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738628|NCT01676493|Analgesics|analgesics|mesh-ancestor
24738629|NCT01676493|Sensory System Agents|sensory system agents|mesh-ancestor
24738672|NCT01676597|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24738673|NCT01676597|Protective Agents|protective agents|mesh-ancestor
24738674|NCT01676597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693694|NCT02018458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24697761|NCT01437046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697763|NCT01437189|Antidepressive Agents|antidepressive agents|mesh-ancestor
24697764|NCT01437189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24697765|NCT01437189|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24697766|NCT01437189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24697767|NCT01437189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24697773|NCT01437228|Povidone|povidone|mesh-list
24738675|NCT01676597|Vasodilator Agents|vasodilator agents|mesh-ancestor
24738676|NCT01676597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24738677|NCT01676597|Antioxidants|antioxidants|mesh-ancestor
24738678|NCT01676649|Paclitaxel|paclitaxel|mesh-list
24738679|NCT01676649|Carboplatin|carboplatin|mesh-list
24738680|NCT01676649|Ipilimumab|ipilimumab|mesh-list
24738681|NCT01676649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24738682|NCT01676649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738683|NCT01676649|Tubulin Modulators|tubulin modulators|mesh-ancestor
24738684|NCT01676649|Antimitotic Agents|antimitotic agents|mesh-ancestor
24738720|NCT01677039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24403304|NCT00159757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738722|NCT01677039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738724|NCT01677065|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24738725|NCT01677065|Narcotics|narcotics|mesh-ancestor
24738726|NCT01677065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24738727|NCT01677065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738728|NCT01677065|Analgesics|analgesics|mesh-ancestor
24738729|NCT01677065|Sensory System Agents|sensory system agents|mesh-ancestor
24738730|NCT01677065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24738731|NCT01677104|Liraglutide|liraglutide|mesh-list
24738732|NCT01677104|Exenatide|exenatide|mesh-list
24738733|NCT01677104|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24738734|NCT01677104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25123980|NCT03080545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25123981|NCT03080545|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25123982|NCT03080545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25123983|NCT03080545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25123984|NCT03080545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25123985|NCT03080545|Vitamins|vitamins|mesh-ancestor
25123986|NCT03080545|Micronutrients|micronutrients|mesh-ancestor
25123987|NCT03080545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25123988|NCT03080545|Dermatologic Agents|dermatologic agents|mesh-ancestor
25123989|NCT03080480|Pioglitazone|pioglitazone|mesh-list
25123990|NCT03080480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25123991|NCT03080480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800630|NCT01977209|Gossypol|gossypol|mesh-list
25123992|NCT03080350|Fentanyl|fentanyl|mesh-list
25123993|NCT03080350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25123994|NCT03080350|Narcotics|narcotics|mesh-ancestor
25123995|NCT03080350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25123996|NCT03080350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25123997|NCT03080350|Analgesics|analgesics|mesh-ancestor
25123998|NCT03080350|Sensory System Agents|sensory system agents|mesh-ancestor
25123999|NCT03080350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124000|NCT03080350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25124001|NCT03080350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25124002|NCT03080350|Anesthetics, General|anesthetics, general|mesh-ancestor
25124003|NCT03080350|Anesthetics|anesthetics|mesh-ancestor
25124004|NCT03080181|Pasireotide|pasireotide|mesh-list
25124005|NCT03080181|Hormones|hormones|mesh-ancestor
25124111|NCT03079427|Cisplatin|cisplatin|mesh-list
25124006|NCT03080181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25124007|NCT03080181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124008|NCT03080194|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25124009|NCT03080194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25124010|NCT03080194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25693695|NCT02018458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25693696|NCT02018458|Alkylating Agents|alkylating agents|mesh-ancestor
25693697|NCT02018458|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25693698|NCT02018458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25693699|NCT02018458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25693700|NCT02018458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25693701|NCT02018458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124011|NCT03080194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24954627|NCT03874273|Crizotinib|crizotinib|mesh-list
24738735|NCT01677104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738737|NCT01677104|Hormones|hormones|mesh-ancestor
25693702|NCT02018627|Glucagon|glucagon|mesh-list
24738789|NCT01677442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24738790|NCT01677442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738791|NCT01677468|Doxorubicin|doxorubicin|mesh-list
24527819|NCT00618397|Anesthetics|anesthetics|mesh-ancestor
24738792|NCT01677468|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25124012|NCT03080194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124013|NCT03080194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25124014|NCT03080194|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25124015|NCT03080194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25124016|NCT03080194|Serotonin Agents|serotonin agents|mesh-ancestor
25124017|NCT03080194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25124018|NCT03080194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124019|NCT03080194|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25124020|NCT03080194|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25124021|NCT03080194|Dopamine Agents|dopamine agents|mesh-ancestor
25124022|NCT03079973|Calcipotriene|calcipotriene|mesh-list
25124023|NCT03079973|Dermatologic Agents|dermatologic agents|mesh-ancestor
25124024|NCT03079830|Pirinitramide|pirinitramide|mesh-list
25124025|NCT03079830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25124026|NCT03079830|Narcotics|narcotics|mesh-ancestor
25124027|NCT03079830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25124028|NCT03079830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124029|NCT03079830|Analgesics|analgesics|mesh-ancestor
25124030|NCT03079830|Sensory System Agents|sensory system agents|mesh-ancestor
25124031|NCT03079830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124032|NCT03080103|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25124033|NCT03080103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25124034|NCT03079895|Nicotine|nicotine|mesh-list
25124035|NCT03079895|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25124036|NCT03079895|Autonomic Agents|autonomic agents|mesh-ancestor
25124037|NCT03079895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124038|NCT03079895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738793|NCT01677468|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
24738794|NCT01677468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24738795|NCT01677468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738804|NCT01677546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24738813|NCT01677572|Immunoglobulin G|immunoglobulin g|mesh-list
24738855|NCT01677897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738884|NCT01678001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738885|NCT01678001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24738886|NCT01678001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24738887|NCT01678001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738888|NCT01678001|Cholinergic Agents|cholinergic agents|mesh-ancestor
24738889|NCT01678001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24738890|NCT01678053|Omeprazole|omeprazole|mesh-list
24738891|NCT01678053|Botulinum Toxins|botulinum toxins|mesh-list
24738892|NCT01678053|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24738952|NCT01678417|Immunologic Factors|immunologic factors|mesh-ancestor
24738953|NCT01678417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738954|NCT01678417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24738955|NCT01678430|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25124040|NCT03079895|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25124041|NCT03079895|Cholinergic Agents|cholinergic agents|mesh-ancestor
25124042|NCT03079895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25124043|NCT03079895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124044|NCT03079687|Olaparib|olaparib|mesh-list
25077824|NCT03361774|Protective Agents|protective agents|mesh-ancestor
24738956|NCT01678430|Chlorambucil|chlorambucil|mesh-list
24738957|NCT01678430|Ofatumumab|ofatumumab|mesh-list
24739027|NCT01678716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739028|NCT01678937|Cyclosporine|cyclosporine|mesh-list
24739029|NCT01678937|Sirolimus|sirolimus|mesh-list
24739030|NCT01678937|Mycophenolic Acid|mycophenolic acid|mesh-list
24739031|NCT01678937|Tacrolimus|tacrolimus|mesh-list
24739032|NCT01678937|Cyclosporins|cyclosporins|mesh-list
24739033|NCT01678937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24739034|NCT01678937|Immunologic Factors|immunologic factors|mesh-ancestor
24739035|NCT01678937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739036|NCT01678937|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24739131|NCT01679327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24739133|NCT01679327|Antidotes|antidotes|mesh-ancestor
24739134|NCT01679327|Protective Agents|protective agents|mesh-ancestor
24739135|NCT01679327|Vitamin B Complex|vitamin b complex|mesh-ancestor
24739136|NCT01679327|Vitamins|vitamins|mesh-ancestor
24739137|NCT01679327|Micronutrients|micronutrients|mesh-ancestor
24739138|NCT01679340|Oxaliplatin|oxaliplatin|mesh-list
24739139|NCT01679340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739140|NCT01679392|Ropivacaine|ropivacaine|mesh-list
24739141|NCT01679392|Anesthetics, Local|anesthetics, local|mesh-ancestor
24739142|NCT01679392|Anesthetics|anesthetics|mesh-ancestor
24739143|NCT01679392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24739144|NCT01679392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528240|NCT00620477|Anesthetics|anesthetics|mesh-ancestor
24739202|NCT01679795|Hormone Antagonists|hormone antagonists|mesh-ancestor
24739203|NCT01679795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24739204|NCT01679795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739205|NCT01679795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24739206|NCT01679795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24739207|NCT01679795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739302|NCT01680263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24739328|NCT01680471|GABA Agents|gaba agents|mesh-ancestor
24739329|NCT01680471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24739330|NCT01680471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739331|NCT01680536|Maraviroc|maraviroc|mesh-list
24739332|NCT01680536|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24739412|NCT01681446|Antiviral Agents|antiviral agents|mesh-ancestor
24739413|NCT01681446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24739414|NCT01681446|Immunologic Factors|immunologic factors|mesh-ancestor
24739415|NCT01681446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739416|NCT01681537|Cytarabine|cytarabine|mesh-list
24739417|NCT01681537|Etoposide|etoposide|mesh-list
24739418|NCT01681537|Mitoxantrone|mitoxantrone|mesh-list
24739419|NCT01681537|Lenalidomide|lenalidomide|mesh-list
24739420|NCT01681537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24739421|NCT01681537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739422|NCT01681537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24739423|NCT01681537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24739424|NCT01681537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124046|NCT03079687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124047|NCT03079687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124048|NCT03079687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25124050|NCT03079440|Temozolomide|temozolomide|mesh-list
25124051|NCT03079440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25124052|NCT03079440|Antimetabolites|antimetabolites|mesh-ancestor
25124053|NCT03079440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124054|NCT03079440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25124055|NCT03079440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25124056|NCT03079440|Alkylating Agents|alkylating agents|mesh-ancestor
25124057|NCT03079557|Botulinum Toxins|botulinum toxins|mesh-list
25124058|NCT03079557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25124059|NCT03079557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25124060|NCT03079557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25124061|NCT03079557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25124062|NCT03079557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124063|NCT03079557|Cholinergic Agents|cholinergic agents|mesh-ancestor
25124064|NCT03079557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25124065|NCT03079557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124066|NCT03079557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25124067|NCT03079557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24739425|NCT01681537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739426|NCT01681537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24739427|NCT01681537|Antimetabolites|antimetabolites|mesh-ancestor
24739428|NCT01681537|Antiviral Agents|antiviral agents|mesh-ancestor
24739429|NCT01681537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24739430|NCT01681537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24739431|NCT01681537|Immunologic Factors|immunologic factors|mesh-ancestor
24739432|NCT01681537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698197|NCT01439542|Hormones|hormones|mesh-list
24739467|NCT01681667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24739469|NCT01681667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739470|NCT01681680|Metformin|metformin|mesh-list
24739471|NCT01681680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24739472|NCT01681680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739473|NCT01681693|Metformin|metformin|mesh-list
24739474|NCT01681693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24739475|NCT01681693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739476|NCT01681875|Nicotine|nicotine|mesh-list
24739477|NCT01681875|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24739478|NCT01681875|Autonomic Agents|autonomic agents|mesh-ancestor
24739479|NCT01681875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24739480|NCT01681875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739481|NCT01681875|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24739482|NCT01681875|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25124068|NCT03079453|Dexamethasone|dexamethasone|mesh-list
25124069|NCT03079453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25124070|NCT03079453|Antiemetics|antiemetics|mesh-ancestor
25124071|NCT03079453|Autonomic Agents|autonomic agents|mesh-ancestor
25124072|NCT03079453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124073|NCT03079453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124074|NCT03079453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25124075|NCT03079453|Glucocorticoids|glucocorticoids|mesh-ancestor
25124076|NCT03079453|Hormones|hormones|mesh-ancestor
24656035|NCT01259362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24656036|NCT01259414|Ethiodized Oil|ethiodized oil|mesh-list
24656037|NCT01259414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656038|NCT01259479|Satraplatin|satraplatin|mesh-list
24697488|NCT01435200|Hematinics|hematinics|mesh-ancestor
25124077|NCT03079453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25124078|NCT03079453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25124079|NCT03079453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25124080|NCT03079388|Azithromycin|azithromycin|mesh-list
25124081|NCT03079388|Pyrimethamine|pyrimethamine|mesh-list
25124082|NCT03079388|Sulfadoxine|sulfadoxine|mesh-list
25124083|NCT03079388|Albendazole|albendazole|mesh-list
25124084|NCT03079388|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25124085|NCT03079388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25124086|NCT03079388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24739483|NCT01681875|Cholinergic Agents|cholinergic agents|mesh-ancestor
24739540|NCT01682408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24739541|NCT01682408|Diuretics|diuretics|mesh-ancestor
24739542|NCT01682408|Natriuretic Agents|natriuretic agents|mesh-ancestor
24739543|NCT01682408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739544|NCT01682408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24739545|NCT01682408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24739546|NCT01682408|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24739547|NCT01682408|Histamine Antagonists|histamine antagonists|mesh-ancestor
24739549|NCT01682408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24739564|NCT01682421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24739565|NCT01682421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739566|NCT01682421|Protease Inhibitors|protease inhibitors|mesh-ancestor
24739567|NCT01682421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24739568|NCT01682499|Calcium, Dietary|calcium, dietary|mesh-list
24739569|NCT01682499|Magnesium Sulfate|magnesium sulfate|mesh-list
24739570|NCT01682499|Calcium|calcium|mesh-list
24739571|NCT01682499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24739572|NCT01682499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739573|NCT01682499|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24739574|NCT01682499|Analgesics|analgesics|mesh-ancestor
24739575|NCT01682499|Sensory System Agents|sensory system agents|mesh-ancestor
24739595|NCT01682577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693703|NCT02018627|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25693704|NCT02018627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25693705|NCT02018627|Hormones|hormones|mesh-ancestor
25693706|NCT02018627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25693707|NCT02018627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693708|NCT02018627|Incretins|incretins|mesh-ancestor
25693709|NCT02018653|Calcium, Dietary|calcium, dietary|mesh-list
25693710|NCT02018653|Antidiarrheals|antidiarrheals|mesh-list
25693711|NCT02018653|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
25693712|NCT02018653|Calcium|calcium|mesh-list
24739596|NCT01682577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25124089|NCT03079388|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25124090|NCT03079388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25124091|NCT03079388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124092|NCT03079388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124093|NCT03079388|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25124094|NCT03079388|Renal Agents|renal agents|mesh-ancestor
25124095|NCT03079388|Anthelmintics|anthelmintics|mesh-ancestor
24656094|NCT01259830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24656095|NCT01259830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124096|NCT03079388|Anticestodal Agents|anticestodal agents|mesh-ancestor
25124097|NCT03079388|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25124098|NCT03079388|Tubulin Modulators|tubulin modulators|mesh-ancestor
25124099|NCT03079388|Antimitotic Agents|antimitotic agents|mesh-ancestor
25124100|NCT03079388|Mitosis Modulators|mitosis modulators|mesh-ancestor
24739601|NCT01682733|Cholinergic Agents|cholinergic agents|mesh-ancestor
24739602|NCT01682733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24739623|NCT01683006|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24739624|NCT01683006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24739625|NCT01683006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24739626|NCT01683006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739627|NCT01683032|Methylphenidate|methylphenidate|mesh-list
24739628|NCT01683032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24739629|NCT01683032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739631|NCT01683032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24739632|NCT01683032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24739633|NCT01683032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739634|NCT01683032|Dopamine Agents|dopamine agents|mesh-ancestor
24618057|NCT01046630|Anesthetics|anesthetics|mesh-ancestor
24618058|NCT01046630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24618059|NCT01046630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24618060|NCT01046630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24618061|NCT01046630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24618062|NCT01046630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618063|NCT01046708|Progesterone|progesterone|mesh-list
24618064|NCT01046708|Progestins|progestins|mesh-ancestor
24618065|NCT01046708|Hormones|hormones|mesh-ancestor
24618066|NCT01046708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24618067|NCT01046708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618068|NCT01046721|Exenatide|exenatide|mesh-list
24618069|NCT01046721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24739652|NCT01683175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24739653|NCT01683175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24739662|NCT01683188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24739663|NCT01683188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739664|NCT01683253|Dopamine|dopamine|mesh-list
24739665|NCT01683253|Levodopa|levodopa|mesh-list
24739666|NCT01683253|Carbidopa|carbidopa|mesh-list
24739667|NCT01683253|Dopamine Agonists|dopamine agonists|mesh-list
24739668|NCT01683253|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24739669|NCT01683253|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24739670|NCT01683253|Dopamine Agents|dopamine agents|mesh-ancestor
24739671|NCT01683253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24739672|NCT01683253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739673|NCT01683253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739674|NCT01683253|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24739675|NCT01683253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24739676|NCT01683253|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24739677|NCT01683253|Sympathomimetics|sympathomimetics|mesh-ancestor
24739678|NCT01683253|Autonomic Agents|autonomic agents|mesh-ancestor
25124107|NCT03079505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25124109|NCT03079505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124116|NCT03079427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124117|NCT03079427|Antiviral Agents|antiviral agents|mesh-ancestor
25124118|NCT03079427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25124119|NCT03079427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124120|NCT03079427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25124121|NCT03079427|Immunologic Factors|immunologic factors|mesh-ancestor
25124122|NCT03079427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739679|NCT01683253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24739680|NCT01683253|Protective Agents|protective agents|mesh-ancestor
24739681|NCT01683292|Apomorphine|apomorphine|mesh-list
24698589|NCT01441986|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24698590|NCT01441986|Antiviral Agents|antiviral agents|mesh-ancestor
24739683|NCT01683292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739684|NCT01683292|Autonomic Agents|autonomic agents|mesh-ancestor
24739685|NCT01683292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24739686|NCT01683292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24739687|NCT01683292|Dopamine Agonists|dopamine agonists|mesh-ancestor
24739688|NCT01683292|Dopamine Agents|dopamine agents|mesh-ancestor
24739689|NCT01683292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24739690|NCT01683292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739691|NCT01683552|Fexofenadine|fexofenadine|mesh-list
24739693|NCT01683552|Aprepitant|aprepitant|mesh-list
24739694|NCT01683552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24739695|NCT01683552|Glucocorticoids|glucocorticoids|mesh-ancestor
24739696|NCT01683552|Hormones|hormones|mesh-ancestor
24739697|NCT01683552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24739698|NCT01683552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739699|NCT01683552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24739700|NCT01683552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739701|NCT01683552|Antiemetics|antiemetics|mesh-ancestor
25124123|NCT03079219|Dexamethasone|dexamethasone|mesh-list
25124124|NCT03079219|Dexamethasone acetate|dexamethasone acetate|mesh-list
25124125|NCT03079219|Ondansetron|ondansetron|mesh-list
25124126|NCT03079219|Olanzapine|olanzapine|mesh-list
25124127|NCT03079219|Aprepitant|aprepitant|mesh-list
25124128|NCT03079219|Fosaprepitant|fosaprepitant|mesh-list
25124129|NCT03079219|BB 1101|bb 1101|mesh-list
25124130|NCT03079219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25124131|NCT03079219|Antiemetics|antiemetics|mesh-ancestor
25124132|NCT03079219|Autonomic Agents|autonomic agents|mesh-ancestor
25124133|NCT03079219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124134|NCT03079219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124135|NCT03079219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25124136|NCT03079219|Glucocorticoids|glucocorticoids|mesh-ancestor
25124137|NCT03079219|Hormones|hormones|mesh-ancestor
24739702|NCT01683552|Autonomic Agents|autonomic agents|mesh-ancestor
24739703|NCT01683552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24739704|NCT01683552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24739727|NCT01683682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24739728|NCT01683682|Tubulin Modulators|tubulin modulators|mesh-ancestor
24739729|NCT01683682|Antimitotic Agents|antimitotic agents|mesh-ancestor
24739730|NCT01683682|Mitosis Modulators|mitosis modulators|mesh-ancestor
24651270|NCT01230983|Prednisone|prednisone|mesh-list
24739731|NCT01683682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739732|NCT01683682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24739733|NCT01683682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24739746|NCT01683760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739747|NCT01683760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24739749|NCT01683760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24739750|NCT01683760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739751|NCT01683760|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24739755|NCT01683786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24739756|NCT01683955|Tranexamic Acid|tranexamic acid|mesh-list
24739757|NCT01683955|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24739758|NCT01683955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24739760|NCT01683955|Hemostatics|hemostatics|mesh-ancestor
24739761|NCT01683955|Coagulants|coagulants|mesh-ancestor
24739762|NCT01684059|Zinc Sulfate|zinc sulfate|mesh-list
24739767|NCT01684072|Immunologic Factors|immunologic factors|mesh-ancestor
24739768|NCT01684072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739769|NCT01684085|Lorazepam|lorazepam|mesh-list
24739770|NCT01684085|Anticonvulsants|anticonvulsants|mesh-ancestor
24739771|NCT01684085|Antiemetics|antiemetics|mesh-ancestor
24739772|NCT01684085|Autonomic Agents|autonomic agents|mesh-ancestor
24739773|NCT01684085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24739774|NCT01684085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739775|NCT01684085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24914624|NCT04253561|Pertuzumab|pertuzumab|mesh-list
24739776|NCT01684085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24739777|NCT01684085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24739778|NCT01684085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24739779|NCT01684085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24739780|NCT01684085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24739781|NCT01684085|GABA Modulators|gaba modulators|mesh-ancestor
24739782|NCT01684085|GABA Agents|gaba agents|mesh-ancestor
24739783|NCT01684085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25693713|NCT02018653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24698788|NCT01442974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24698789|NCT01442974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698790|NCT01442974|Tubulin Modulators|tubulin modulators|mesh-ancestor
24698791|NCT01442974|Antimitotic Agents|antimitotic agents|mesh-ancestor
24698792|NCT01442974|Mitosis Modulators|mitosis modulators|mesh-ancestor
24698795|NCT01442974|Antimetabolites|antimetabolites|mesh-ancestor
24528966|NCT00624026|Memantine|memantine|mesh-list
24739784|NCT01684085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739785|NCT01684098|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
24739786|NCT01684098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24739787|NCT01684098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739788|NCT01684111|Vinorelbine|vinorelbine|mesh-list
25124138|NCT03079219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25124140|NCT03079219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25124141|NCT03079219|Protease Inhibitors|protease inhibitors|mesh-ancestor
25124142|NCT03079219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124177|NCT03078933|Vasodilator Agents|vasodilator agents|mesh-ancestor
25124178|NCT03078933|Gasotransmitters|gasotransmitters|mesh-ancestor
25124179|NCT03078933|Protective Agents|protective agents|mesh-ancestor
25124182|NCT03078829|Leuprolide|leuprolide|mesh-list
25124183|NCT03078829|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25124184|NCT03078829|Fertility Agents|fertility agents|mesh-ancestor
25124185|NCT03078829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25077902|NCT03361098|Incretins|incretins|mesh-ancestor
24739795|NCT01684111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739796|NCT01684111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24739797|NCT01684111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24739798|NCT01684241|Vaccines|vaccines|mesh-list
24739799|NCT01684241|Immunologic Factors|immunologic factors|mesh-ancestor
24739800|NCT01684241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739801|NCT01684306|Modafinil|modafinil|mesh-list
24739802|NCT01684306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24739803|NCT01684306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739804|NCT01684306|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24739805|NCT01684306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24739806|NCT01684306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24739821|NCT01684449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739822|NCT01684449|Antiviral Agents|antiviral agents|mesh-ancestor
24739823|NCT01684449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24739824|NCT01684449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24739825|NCT01684449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24739826|NCT01684449|Immunologic Factors|immunologic factors|mesh-ancestor
24739827|NCT01684449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739828|NCT01684449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24739833|NCT01684657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24739834|NCT01684657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24739835|NCT01684657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739836|NCT01684657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24739837|NCT01684683|Theophylline|theophylline|mesh-list
24739838|NCT01684683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24739839|NCT01684683|Autonomic Agents|autonomic agents|mesh-ancestor
24739840|NCT01684683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24739841|NCT01684683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739842|NCT01684683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24618086|NCT01046786|Prednisolone acetate|prednisolone acetate|mesh-list
24739843|NCT01684683|Respiratory System Agents|respiratory system agents|mesh-ancestor
24739853|NCT01684774|Anesthetics, Local|anesthetics, local|mesh-ancestor
24739855|NCT01684774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24739856|NCT01684774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739857|NCT01684774|Sensory System Agents|sensory system agents|mesh-ancestor
24740520|NCT01688934|Naproxen|naproxen|mesh-list
24739858|NCT01684774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24529054|NCT00624312|Epoetin Alfa|epoetin alfa|mesh-list
24739859|NCT01684787|Ribavirin|ribavirin|mesh-list
25693714|NCT02018653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693715|NCT02018653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25693716|NCT02018653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25693717|NCT02018822|Urethane|urethane|mesh-list
25693718|NCT02018822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693719|NCT02018822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25693720|NCT02018822|Anesthetics, General|anesthetics, general|mesh-ancestor
25693721|NCT02018822|Anesthetics|anesthetics|mesh-ancestor
25693722|NCT02018822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24739860|NCT01684787|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24739861|NCT01684787|Interferon-alpha|interferon-alpha|mesh-list
24739862|NCT01684787|Antimetabolites|antimetabolites|mesh-ancestor
24739863|NCT01684787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739865|NCT01684787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24739866|NCT01684787|Immunologic Factors|immunologic factors|mesh-ancestor
25124191|NCT03079050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25124192|NCT03079050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25124193|NCT03079050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25124194|NCT03079050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124195|NCT03079050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124196|NCT03079076|Bupivacaine|bupivacaine|mesh-list
25124197|NCT03079076|Anesthetics, Local|anesthetics, local|mesh-ancestor
25124198|NCT03079076|Anesthetics|anesthetics|mesh-ancestor
25124199|NCT03079076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25124200|NCT03079076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124201|NCT03079076|Sensory System Agents|sensory system agents|mesh-ancestor
25124202|NCT03079076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124203|NCT03079141|Eplerenone|eplerenone|mesh-list
25124204|NCT03079141|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25124205|NCT03079141|Hormone Antagonists|hormone antagonists|mesh-ancestor
25124206|NCT03079141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25124207|NCT03079141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124208|NCT03079141|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24739867|NCT01684787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739868|NCT01684800|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24739869|NCT01684800|Hemostatics|hemostatics|mesh-ancestor
24739870|NCT01684800|Coagulants|coagulants|mesh-ancestor
24739871|NCT01684800|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24739872|NCT01684800|Natriuretic Agents|natriuretic agents|mesh-ancestor
24739873|NCT01684800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739874|NCT01684813|Clopidogrel|clopidogrel|mesh-list
24739875|NCT01684813|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24739900|NCT01684969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24739901|NCT01684969|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24739902|NCT01684969|Dopamine Agents|dopamine agents|mesh-ancestor
24739903|NCT01684969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24739946|NCT01685359|Epoetin Alfa|epoetin alfa|mesh-list
24739947|NCT01685359|Hematinics|hematinics|mesh-ancestor
24739948|NCT01685398|Timolol|timolol|mesh-list
24739949|NCT01685398|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24739950|NCT01685398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24739951|NCT01685398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24739952|NCT01685398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25124219|NCT03079115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124220|NCT03078842|Zinc|zinc|mesh-list
25124221|NCT03078842|Trace Elements|trace elements|mesh-ancestor
25124222|NCT03078842|Micronutrients|micronutrients|mesh-ancestor
25124223|NCT03078842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124224|NCT03078725|Metformin|metformin|mesh-list
24739953|NCT01685398|Adrenergic Agents|adrenergic agents|mesh-ancestor
24739954|NCT01685398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24739955|NCT01685398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739956|NCT01685398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739957|NCT01685398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24739958|NCT01685398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24739959|NCT01685489|polysaccharide-K|polysaccharide-k|mesh-list
24739960|NCT01685489|Docetaxel|docetaxel|mesh-list
24739961|NCT01685489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618080|NCT01046773|Micronutrients|micronutrients|mesh-ancestor
24618081|NCT01046773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24618082|NCT01046786|Methylprednisolone|methylprednisolone|mesh-list
24618083|NCT01046786|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24618084|NCT01046786|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24618085|NCT01046786|Prednisolone|prednisolone|mesh-list
24618087|NCT01046786|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24618088|NCT01046786|Prednisolone phosphate|prednisolone phosphate|mesh-list
24618089|NCT01046786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24618091|NCT01046786|Autonomic Agents|autonomic agents|mesh-ancestor
24618101|NCT01046786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618102|NCT01046799|Entecavir|entecavir|mesh-list
24618103|NCT01046799|Antiviral Agents|antiviral agents|mesh-ancestor
24699009|NCT01444248|Glimepiride|glimepiride|mesh-list
24699010|NCT01444248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24618130|NCT01046942|Aspirin|aspirin|mesh-list
24618131|NCT01046942|Clopidogrel|clopidogrel|mesh-list
24618132|NCT01046942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24618133|NCT01046942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25124228|NCT03078465|Clopidogrel|clopidogrel|mesh-list
25124229|NCT03078465|Ticagrelor|ticagrelor|mesh-list
25124230|NCT03078465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25124231|NCT03078465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25124232|NCT03078465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25124233|NCT03078465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25124234|NCT03078465|Purinergic Agents|purinergic agents|mesh-ancestor
25124235|NCT03078465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25124236|NCT03078465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124237|NCT03078465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124238|NCT03078777|Fexofenadine|fexofenadine|mesh-list
25124239|NCT03078777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25124240|NCT03078777|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24618148|NCT01046942|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24618149|NCT01046942|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24618150|NCT01046942|Purinergic Agents|purinergic agents|mesh-ancestor
24618151|NCT01046942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24618152|NCT01046955|Alemtuzumab|alemtuzumab|mesh-list
24618153|NCT01046955|Thymoglobulin|thymoglobulin|mesh-list
24618154|NCT01046955|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24618155|NCT01046955|Daclizumab|daclizumab|mesh-list
24618156|NCT01046955|Immunologic Factors|immunologic factors|mesh-ancestor
24618157|NCT01046955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618158|NCT01046955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24618159|NCT01046955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24618160|NCT01046955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618161|NCT01046981|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24618162|NCT01046981|Metronidazole|metronidazole|mesh-list
24618163|NCT01046981|Cefazolin|cefazolin|mesh-list
24618164|NCT01046981|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24618165|NCT01046981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24618166|NCT01046981|Antitubercular Agents|antitubercular agents|mesh-ancestor
24618167|NCT01046981|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24618168|NCT01046981|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24739962|NCT01685489|Tubulin Modulators|tubulin modulators|mesh-ancestor
24739963|NCT01685489|Antimitotic Agents|antimitotic agents|mesh-ancestor
24739964|NCT01685489|Mitosis Modulators|mitosis modulators|mesh-ancestor
24739965|NCT01685489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739966|NCT01685489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24739967|NCT01685489|Immunologic Factors|immunologic factors|mesh-ancestor
24739979|NCT01685502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24740000|NCT01685658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24740001|NCT01685658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740002|NCT01685762|Metformin|metformin|mesh-list
24740003|NCT01685762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24740004|NCT01685762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740005|NCT01685827|Eflornithine|eflornithine|mesh-list
24740006|NCT01685827|Nifurtimox|nifurtimox|mesh-list
24740007|NCT01685827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24740008|NCT01685827|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24740015|NCT01685853|Bisacodyl|bisacodyl|mesh-list
24740026|NCT01685931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25124241|NCT03078777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24834337|NCT02177825|Imatinib Mesylate|imatinib mesylate|mesh-list
25124242|NCT03078777|Histamine Antagonists|histamine antagonists|mesh-ancestor
25124243|NCT03078777|Histamine Agents|histamine agents|mesh-ancestor
25124245|NCT03078777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124246|NCT03078777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077971|NCT03360266|Protective Agents|protective agents|mesh-ancestor
25077972|NCT03360266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740100|NCT01686386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740101|NCT01686386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740102|NCT01686386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24740111|NCT01686386|Growth Substances|growth substances|mesh-ancestor
24740113|NCT01686386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24740117|NCT01686464|Prednisone|prednisone|mesh-list
25693723|NCT02018822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693724|NCT02019069|Cytarabine|cytarabine|mesh-list
24740118|NCT01686464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24740174|NCT01686659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24740175|NCT01686659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24740176|NCT01686711|Pioglitazone|pioglitazone|mesh-list
24740177|NCT01686711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24740178|NCT01686711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740180|NCT01686789|Interferon-alpha|interferon-alpha|mesh-list
24740181|NCT01686789|Interferon alpha-2|interferon alpha-2|mesh-list
24740182|NCT01686789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24740183|NCT01686789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24740184|NCT01686789|Antiviral Agents|antiviral agents|mesh-ancestor
24740185|NCT01686789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24740186|NCT01686789|Immunologic Factors|immunologic factors|mesh-ancestor
24740187|NCT01686789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740188|NCT01686802|Ibuprofen|ibuprofen|mesh-list
24740189|NCT01686802|Morphine|morphine|mesh-list
24740190|NCT01686802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24740191|NCT01686802|Narcotics|narcotics|mesh-ancestor
24740192|NCT01686802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24740193|NCT01686802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740194|NCT01686802|Analgesics|analgesics|mesh-ancestor
24740195|NCT01686802|Sensory System Agents|sensory system agents|mesh-ancestor
24740196|NCT01686802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740197|NCT01686802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24740198|NCT01686802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24740201|NCT01686802|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24740204|NCT01687049|Red yeast rice|red yeast rice|mesh-list
24740229|NCT01687140|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24740230|NCT01687140|Antitubercular Agents|antitubercular agents|mesh-ancestor
24740231|NCT01687140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24740232|NCT01687140|Antimetabolites|antimetabolites|mesh-ancestor
24740233|NCT01687140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740242|NCT01687205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24740244|NCT01687348|Anesthetics, Local|anesthetics, local|mesh-ancestor
24740269|NCT01687439|Vinorelbine|vinorelbine|mesh-list
24740276|NCT01687439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740277|NCT01687439|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24740278|NCT01687439|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24740279|NCT01687439|Growth Substances|growth substances|mesh-ancestor
24740280|NCT01687439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740281|NCT01687439|Growth Inhibitors|growth inhibitors|mesh-ancestor
24740282|NCT01687491|Enoxaparin|enoxaparin|mesh-list
24740292|NCT01687582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24740293|NCT01687582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740294|NCT01687582|Incretins|incretins|mesh-ancestor
24740339|NCT01687868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24740340|NCT01687868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24740341|NCT01687868|Adrenergic Agents|adrenergic agents|mesh-ancestor
24740342|NCT01687868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24448182|NCT00310596|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24448183|NCT00310596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25124264|NCT03078257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124265|NCT03078257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124266|NCT03078257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25124267|NCT03078257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25124268|NCT03078257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24740368|NCT01688024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24740370|NCT01688089|Carbidopa|carbidopa|mesh-list
24740371|NCT01688089|Entacapone|entacapone|mesh-list
24740389|NCT01688154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24740390|NCT01688206|Atezolizumab|atezolizumab|mesh-list
24740391|NCT01688206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24740392|NCT01688349|Glucocorticoids|glucocorticoids|mesh-list
24740393|NCT01688349|Hormones|hormones|mesh-ancestor
24740394|NCT01688349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24740395|NCT01688349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740396|NCT01688362|Dexamethasone|dexamethasone|mesh-list
24740397|NCT01688362|Bupivacaine|bupivacaine|mesh-list
24740398|NCT01688362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24740399|NCT01688362|Antiemetics|antiemetics|mesh-ancestor
24740400|NCT01688362|Autonomic Agents|autonomic agents|mesh-ancestor
24740401|NCT01688362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740402|NCT01688362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740403|NCT01688362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24740404|NCT01688362|Glucocorticoids|glucocorticoids|mesh-ancestor
24740405|NCT01688362|Hormones|hormones|mesh-ancestor
24740406|NCT01688362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24740407|NCT01688362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24740408|NCT01688362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24740409|NCT01688362|Anesthetics, Local|anesthetics, local|mesh-ancestor
24740410|NCT01688362|Anesthetics|anesthetics|mesh-ancestor
24657548|NCT01268176|Micronutrients|micronutrients|mesh-ancestor
24657549|NCT01268176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657550|NCT01268176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24657551|NCT01268176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24657552|NCT01268202|Pravastatin|pravastatin|mesh-list
24740411|NCT01688362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24740412|NCT01688362|Sensory System Agents|sensory system agents|mesh-ancestor
24740413|NCT01688375|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24740414|NCT01688375|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24740415|NCT01688375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24740416|NCT01688401|Melphalan|melphalan|mesh-list
24740417|NCT01688401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24740434|NCT01688518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24740435|NCT01688518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740440|NCT01688518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24740441|NCT01688518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24740442|NCT01688518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740443|NCT01688544|Benzimidazole|benzimidazole|mesh-list
24740444|NCT01688544|Anthelmintics|anthelmintics|mesh-ancestor
24740445|NCT01688544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24740446|NCT01688544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24740447|NCT01688570|Cyproheptadine|cyproheptadine|mesh-list
24740448|NCT01688570|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24740449|NCT01688570|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24740511|NCT01688700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24740512|NCT01688791|Paclitaxel|paclitaxel|mesh-list
24740513|NCT01688791|Carboplatin|carboplatin|mesh-list
24740514|NCT01688791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24740515|NCT01688791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25124271|NCT03078257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25124272|NCT03078257|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25124273|NCT03078257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124274|NCT03078257|Antipyretics|antipyretics|mesh-ancestor
25124275|NCT03078257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24740607|NCT01689259|Cyclobenzaprine|cyclobenzaprine|mesh-list
25124276|NCT03078257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25124277|NCT03078257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25124278|NCT03078257|Purinergic Agents|purinergic agents|mesh-ancestor
25124279|NCT03078257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25124281|NCT03078231|Autonomic Agents|autonomic agents|mesh-ancestor
25124282|NCT03078231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124283|NCT03078231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740516|NCT01688791|Tubulin Modulators|tubulin modulators|mesh-ancestor
24740517|NCT01688791|Antimitotic Agents|antimitotic agents|mesh-ancestor
24740518|NCT01688791|Mitosis Modulators|mitosis modulators|mesh-ancestor
24740519|NCT01688791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618183|NCT01047072|Mycophenolic Acid|mycophenolic acid|mesh-list
24740521|NCT01688934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24740523|NCT01688934|Analgesics|analgesics|mesh-ancestor
24740524|NCT01688934|Sensory System Agents|sensory system agents|mesh-ancestor
24740525|NCT01688934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740526|NCT01688934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740527|NCT01688934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24740528|NCT01688934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24740529|NCT01688934|Gout Suppressants|gout suppressants|mesh-ancestor
24657553|NCT01268202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24740549|NCT01688960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24740550|NCT01688960|Growth Substances|growth substances|mesh-ancestor
24740551|NCT01688960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740552|NCT01688960|Growth Inhibitors|growth inhibitors|mesh-ancestor
24740554|NCT01689051|Glucagon|glucagon|mesh-list
24740555|NCT01689051|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24740556|NCT01689051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24740557|NCT01689051|Hormones|hormones|mesh-ancestor
24740558|NCT01689051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24740559|NCT01689051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613019|NCT01016509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24613020|NCT01016509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613021|NCT01016626|Mycophenolic Acid|mycophenolic acid|mesh-list
24613030|NCT01016639|Capecitabine|capecitabine|mesh-list
24740561|NCT01689090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
24740562|NCT01689090|Citric Acid|citric acid|mesh-list
24740563|NCT01689090|Sodium Citrate|sodium citrate|mesh-list
24740564|NCT01689090|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
24740565|NCT01689090|Anticoagulants|anticoagulants|mesh-ancestor
24740566|NCT01689090|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24740567|NCT01689090|Chelating Agents|chelating agents|mesh-ancestor
24740568|NCT01689090|Sequestering Agents|sequestering agents|mesh-ancestor
24740569|NCT01689090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740570|NCT01689090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24740571|NCT01689090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24740572|NCT01689090|Analgesics|analgesics|mesh-ancestor
24740573|NCT01689090|Sensory System Agents|sensory system agents|mesh-ancestor
24740574|NCT01689090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740575|NCT01689090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740576|NCT01689090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24740594|NCT01689116|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24740595|NCT01689129|Insulin|insulin|mesh-list
24740596|NCT01689129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25124285|NCT03078062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25124286|NCT03078062|Antiemetics|antiemetics|mesh-ancestor
25124287|NCT03078062|Autonomic Agents|autonomic agents|mesh-ancestor
25124288|NCT03078062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124289|NCT03078062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124290|NCT03078062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25124291|NCT03078062|Glucocorticoids|glucocorticoids|mesh-ancestor
25124292|NCT03078062|Hormones|hormones|mesh-ancestor
25124293|NCT03078062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25124294|NCT03078062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25124295|NCT03078062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25124296|NCT03078101|Empagliflozin|empagliflozin|mesh-list
24740597|NCT01689129|Insulin Glargine|insulin glargine|mesh-list
24740598|NCT01689129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24740599|NCT01689129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740600|NCT01689142|Insulin|insulin|mesh-list
24740601|NCT01689142|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24740602|NCT01689142|Insulin Glargine|insulin glargine|mesh-list
24740603|NCT01689142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24740604|NCT01689142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740605|NCT01689194|Cisplatin|cisplatin|mesh-list
24740606|NCT01689194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24740608|NCT01689259|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24740609|NCT01689259|Antidepressive Agents|antidepressive agents|mesh-ancestor
24740610|NCT01689259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24740613|NCT01689259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24740667|NCT01689623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24740668|NCT01689623|Protease Inhibitors|protease inhibitors|mesh-ancestor
24740669|NCT01689636|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
24740670|NCT01689636|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24740671|NCT01689636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740672|NCT01689662|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
24740673|NCT01689662|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24740674|NCT01689662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740676|NCT01689714|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24740677|NCT01689714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740678|NCT01689727|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
24740679|NCT01689727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24740680|NCT01689727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740682|NCT01689753|Sodium Citrate|sodium citrate|mesh-list
24740683|NCT01689753|Anticoagulants|anticoagulants|mesh-ancestor
24740684|NCT01689753|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25693725|NCT02019069|Daunorubicin|daunorubicin|mesh-list
25693726|NCT02019069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25693727|NCT02019069|Antimetabolites|antimetabolites|mesh-ancestor
25693728|NCT02019069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693729|NCT02019069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693730|NCT02019069|Antiviral Agents|antiviral agents|mesh-ancestor
24699973|NCT01449877|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24699974|NCT01449877|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24699975|NCT01449877|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24699976|NCT01449877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699977|NCT01449877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699978|NCT01449877|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24699979|NCT01449877|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24699980|NCT01449877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24699981|NCT01449877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24699982|NCT01450046|Vitamin E|vitamin e|mesh-list
24699983|NCT01450046|Tocopherols|tocopherols|mesh-list
24699984|NCT01450046|Tocotrienols|tocotrienols|mesh-list
24700042|NCT01450215|Immunologic Factors|immunologic factors|mesh-ancestor
24700043|NCT01450215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700044|NCT01450215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24700045|NCT01450215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24740685|NCT01689753|Chelating Agents|chelating agents|mesh-ancestor
24618211|NCT01047098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618213|NCT01047202|Immunologic Factors|immunologic factors|mesh-ancestor
24618214|NCT01047202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618216|NCT01047215|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24618217|NCT01047215|Antidepressive Agents|antidepressive agents|mesh-ancestor
24618218|NCT01047215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24618219|NCT01047215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24618220|NCT01047215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24618221|NCT01047215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24618222|NCT01047215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618223|NCT01047215|Dopamine Agonists|dopamine agonists|mesh-ancestor
24618224|NCT01047215|Dopamine Agents|dopamine agents|mesh-ancestor
24651349|NCT01231139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740717|NCT01689987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405409|NCT00166829|Tacrolimus|tacrolimus|mesh-list
24740718|NCT01689987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24740740|NCT01690039|Furosemide|furosemide|mesh-list
24740741|NCT01690039|Diuretics|diuretics|mesh-ancestor
24740742|NCT01690039|Natriuretic Agents|natriuretic agents|mesh-ancestor
24740743|NCT01690039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740744|NCT01690039|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24740772|NCT01690221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740775|NCT01690247|Immunologic Factors|immunologic factors|mesh-ancestor
24740776|NCT01690247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740778|NCT01690286|Antifungal Agents|antifungal agents|mesh-ancestor
24740779|NCT01690286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25078047|NCT03359681|Metformin|metformin|mesh-list
24740837|NCT01690364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740838|NCT01690364|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24740839|NCT01690364|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24740840|NCT01690364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24740841|NCT01690364|Cholinergic Agents|cholinergic agents|mesh-ancestor
24740842|NCT01690364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24740843|NCT01690364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740844|NCT01690403|Rifapentine|rifapentine|mesh-list
25693731|NCT02019069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25693732|NCT02019069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25693733|NCT02019069|Immunologic Factors|immunologic factors|mesh-ancestor
25693734|NCT02019069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693735|NCT02019069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25693736|NCT02019069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25693737|NCT02019069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25693738|NCT02019069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693739|NCT02019277|Paclitaxel|paclitaxel|mesh-list
25693740|NCT02019277|Docetaxel|docetaxel|mesh-list
25693741|NCT02019277|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25693742|NCT02019277|Trastuzumab|trastuzumab|mesh-list
25693743|NCT02019277|Pertuzumab|pertuzumab|mesh-list
25693744|NCT02019277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25693745|NCT02019277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693746|NCT02019277|Tubulin Modulators|tubulin modulators|mesh-ancestor
25693747|NCT02019277|Antimitotic Agents|antimitotic agents|mesh-ancestor
25693748|NCT02019277|Mitosis Modulators|mitosis modulators|mesh-ancestor
25070830|NCT03415763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070831|NCT03415763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25070833|NCT03415763|Protective Agents|protective agents|mesh-ancestor
25070834|NCT03415763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070835|NCT03415763|Vitamin B Complex|vitamin b complex|mesh-ancestor
25070836|NCT03415763|Vitamins|vitamins|mesh-ancestor
25070837|NCT03415763|Micronutrients|micronutrients|mesh-ancestor
24740845|NCT01690403|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24740892|NCT01690559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24740893|NCT01690559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24740895|NCT01690572|Hyaluronic Acid|hyaluronic acid|mesh-list
24740896|NCT01690572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24740901|NCT01690572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740902|NCT01690572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24740903|NCT01690572|Immunologic Factors|immunologic factors|mesh-ancestor
24740904|NCT01690572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740905|NCT01690572|Viscosupplements|viscosupplements|mesh-ancestor
24740906|NCT01690572|Protective Agents|protective agents|mesh-ancestor
24740908|NCT01690598|Veliparib|veliparib|mesh-list
24740911|NCT01690598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24740932|NCT01690702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124357|NCT03077516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124358|NCT03077516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25124359|NCT03077516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24741328|NCT01693419|Gemcitabine|gemcitabine|mesh-list
25124360|NCT03077516|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25124361|NCT03077516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25124362|NCT03077516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124363|NCT03077516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124364|NCT03077555|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25124365|NCT03077555|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25124366|NCT03077555|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25124367|NCT03077555|Estradiol|estradiol|mesh-list
25124368|NCT03077555|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25078051|NCT03359655|Bromides|bromides|mesh-list
24740933|NCT01690702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24740934|NCT01690702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24740935|NCT01690702|Alkylating Agents|alkylating agents|mesh-ancestor
24740936|NCT01690702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24740937|NCT01690702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24740938|NCT01690702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24740939|NCT01690702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24740940|NCT01690702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24740942|NCT01690767|Anesthetics, Local|anesthetics, local|mesh-ancestor
24740943|NCT01690767|Anesthetics|anesthetics|mesh-ancestor
24740944|NCT01690767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24740945|NCT01690767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740946|NCT01690767|Sensory System Agents|sensory system agents|mesh-ancestor
24740947|NCT01690767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740948|NCT01690767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24740949|NCT01690767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24740950|NCT01690767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24448069|NCT00310128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25124373|NCT03077555|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25124374|NCT03077555|Contraceptive Agents|contraceptive agents|mesh-ancestor
25124375|NCT03077555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25124376|NCT03077555|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25124377|NCT03077555|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25693749|NCT02019277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693750|NCT02019277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25693751|NCT02019420|Linezolid|linezolid|mesh-list
25693752|NCT02019420|Tedizolid|tedizolid|mesh-list
25693753|NCT02019420|Tedizolid phosphate|tedizolid phosphate|mesh-list
25693754|NCT02019420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25693755|NCT02019420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25693756|NCT02019420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25693757|NCT02019420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709278|NCT02264574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24700120|NCT01450774|Autonomic Agents|autonomic agents|mesh-ancestor
25124378|NCT03077555|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25124380|NCT03077217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25124381|NCT03077217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25124382|NCT03077217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25124383|NCT03077009|Hyaluronic Acid|hyaluronic acid|mesh-list
25124384|NCT03077009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25124385|NCT03077009|Immunologic Factors|immunologic factors|mesh-ancestor
25124386|NCT03077009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124387|NCT03077009|Viscosupplements|viscosupplements|mesh-ancestor
25124388|NCT03077009|Protective Agents|protective agents|mesh-ancestor
25124389|NCT03076905|Olorofim|olorofim|mesh-list
25124390|NCT03076905|Antifungal Agents|antifungal agents|mesh-ancestor
25124391|NCT03076905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25124392|NCT03076710|Bupivacaine|bupivacaine|mesh-list
25124393|NCT03076710|Anesthetics, Local|anesthetics, local|mesh-ancestor
24740989|NCT01690884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24740990|NCT01690884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740991|NCT01690962|Vitamins|vitamins|mesh-list
24740992|NCT01690962|Hydroxocobalamin|hydroxocobalamin|mesh-list
24740993|NCT01690962|Vitamin B 12|vitamin b 12|mesh-list
24740994|NCT01690962|Vitamin B Complex|vitamin b complex|mesh-list
24740995|NCT01690962|Micronutrients|micronutrients|mesh-ancestor
24740996|NCT01690962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740997|NCT01690962|Hematinics|hematinics|mesh-ancestor
24740998|NCT01690975|Benzonatate|benzonatate|mesh-list
24740999|NCT01690975|Antitussive Agents|antitussive agents|mesh-ancestor
24741000|NCT01690975|Respiratory System Agents|respiratory system agents|mesh-ancestor
24741007|NCT01691001|Sensory System Agents|sensory system agents|mesh-ancestor
24741028|NCT01691365|Antioxidants|antioxidants|mesh-list
24741029|NCT01691365|Micronutrients|micronutrients|mesh-ancestor
24741030|NCT01691365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437227|NCT00273026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24741031|NCT01691365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741032|NCT01691365|Protective Agents|protective agents|mesh-ancestor
24741033|NCT01691404|Quercetin|quercetin|mesh-list
24741034|NCT01691404|Antioxidants|antioxidants|mesh-ancestor
24741035|NCT01691404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741036|NCT01691404|Protective Agents|protective agents|mesh-ancestor
24741037|NCT01691404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741038|NCT01691456|Montelukast|montelukast|mesh-list
24405757|NCT00168350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741095|NCT01691807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741101|NCT01691937|Sufentanil|sufentanil|mesh-list
24741102|NCT01691937|Ropivacaine|ropivacaine|mesh-list
24741103|NCT01691937|Anesthetics, Local|anesthetics, local|mesh-ancestor
24741104|NCT01691937|Anesthetics|anesthetics|mesh-ancestor
24741105|NCT01691937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24741107|NCT01691937|Sensory System Agents|sensory system agents|mesh-ancestor
24741108|NCT01691937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24741109|NCT01691937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24697986|NCT01438190|Metformin|metformin|mesh-list
24741111|NCT01691937|Analgesics|analgesics|mesh-ancestor
24741112|NCT01691937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24741113|NCT01691937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24741114|NCT01691937|Anesthetics, General|anesthetics, general|mesh-ancestor
24741115|NCT01691976|Estrogens|estrogens|mesh-list
24741116|NCT01691976|Hormones|hormones|mesh-ancestor
24741117|NCT01691976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24741120|NCT01692132|Laxatives|laxatives|mesh-ancestor
24741142|NCT01692171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24741143|NCT01692171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741145|NCT01692210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24741146|NCT01692210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24741147|NCT01692210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741148|NCT01692210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24741149|NCT01692210|Analgesics|analgesics|mesh-ancestor
24741150|NCT01692210|Sensory System Agents|sensory system agents|mesh-ancestor
25693758|NCT02019420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741246|NCT01693003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24741247|NCT01693003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741248|NCT01693003|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24741249|NCT01693003|Respiratory System Agents|respiratory system agents|mesh-ancestor
24741250|NCT01693003|Parasympatholytics|parasympatholytics|mesh-ancestor
24741251|NCT01693003|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24741252|NCT01693003|Cholinergic Agents|cholinergic agents|mesh-ancestor
24741253|NCT01693003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24741254|NCT01693003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741257|NCT01693081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741273|NCT01693276|Tubulin Modulators|tubulin modulators|mesh-ancestor
24741274|NCT01693276|Antimitotic Agents|antimitotic agents|mesh-ancestor
24741291|NCT01693289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24741292|NCT01693289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24741293|NCT01693289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741294|NCT01693289|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24741295|NCT01693289|Hormone Antagonists|hormone antagonists|mesh-ancestor
24741296|NCT01693289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24741298|NCT01693302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24741299|NCT01693302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25124445|NCT03076320|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25124446|NCT03076320|Dermatologic Agents|dermatologic agents|mesh-ancestor
25124447|NCT03076320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25124448|NCT03076320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25124449|NCT03076320|Analgesics|analgesics|mesh-ancestor
25124450|NCT03076320|Sensory System Agents|sensory system agents|mesh-ancestor
25124451|NCT03076320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124452|NCT03076320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124453|NCT03076320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24741323|NCT01693393|Antifungal Agents|antifungal agents|mesh-ancestor
24741324|NCT01693393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24741325|NCT01693393|Dermatologic Agents|dermatologic agents|mesh-ancestor
24741326|NCT01693393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24741327|NCT01693393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24741329|NCT01693419|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24741330|NCT01693419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24741331|NCT01693419|Antimetabolites|antimetabolites|mesh-ancestor
24741404|NCT01693822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530771|NCT00632385|Eletriptan|eletriptan|mesh-list
24530772|NCT00632385|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24530773|NCT00632385|Serotonin Agents|serotonin agents|mesh-ancestor
24530774|NCT00632385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24530778|NCT00632476|Vitamins|vitamins|mesh-ancestor
24741405|NCT01694017|Tenofovir|tenofovir|mesh-list
24741406|NCT01694017|Zidovudine|zidovudine|mesh-list
24741407|NCT01694017|Antiviral Agents|antiviral agents|mesh-ancestor
24741408|NCT01694017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24741409|NCT01694017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24741410|NCT01694017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24741411|NCT01694017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24741412|NCT01694017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741413|NCT01694017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24741414|NCT01694017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24741415|NCT01694017|Antimetabolites|antimetabolites|mesh-ancestor
24741416|NCT05289648|Niraparib|niraparib|mesh-list
24741417|NCT05289648|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24741418|NCT05289648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24741419|NCT05289648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741420|NCT05289648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24741421|NCT05289063|Atorvastatin|atorvastatin|mesh-list
24741422|NCT05289063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25124454|NCT03076320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25124455|NCT03076281|Metformin|metformin|mesh-list
25124457|NCT03076281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25124458|NCT03076281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124459|NCT03076281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25124460|NCT03076281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25124461|NCT03076281|Antimalarials|antimalarials|mesh-ancestor
25124462|NCT03076281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25124463|NCT03076281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25124464|NCT03076021|Dextromethorphan|dextromethorphan|mesh-list
25124465|NCT03076021|Isotretinoin|isotretinoin|mesh-list
25124466|NCT03076021|Antitussive Agents|antitussive agents|mesh-ancestor
25124467|NCT03076021|Respiratory System Agents|respiratory system agents|mesh-ancestor
25124468|NCT03076021|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25071191|NCT03412500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25124469|NCT03076021|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25124470|NCT03076021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25124471|NCT03076021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741453|NCT05288738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24741603|NCT05291130|Protective Agents|protective agents|mesh-ancestor
24741462|NCT05288738|Adrenergic Agents|adrenergic agents|mesh-ancestor
24741463|NCT05288738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24741475|NCT05288673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24741476|NCT05288673|Immunologic Factors|immunologic factors|mesh-ancestor
24618237|NCT01047423|Antimetabolites|antimetabolites|mesh-ancestor
24741477|NCT05288673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741478|NCT05288660|Ravulizumab|ravulizumab|mesh-list
24741479|NCT05288660|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24741480|NCT05288660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24741484|NCT05288465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24741485|NCT05288465|Protective Agents|protective agents|mesh-ancestor
24741486|NCT05288465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741487|NCT05288465|Nootropic Agents|nootropic agents|mesh-ancestor
24741527|NCT05288335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24741528|NCT05288335|Dopamine Agents|dopamine agents|mesh-ancestor
24741529|NCT05288335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24741530|NCT05288335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741531|NCT05288335|Adrenergic Agents|adrenergic agents|mesh-ancestor
24741532|NCT05288335|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24741533|NCT05288335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24741534|NCT05288335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24741535|NCT05288335|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25124474|NCT03076099|Dexmedetomidine|dexmedetomidine|mesh-list
25124475|NCT03076099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25124476|NCT03076099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25124477|NCT03076099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124478|NCT03076099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25124482|NCT03076099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24954667|NCT03873974|Immunoglobulin M|immunoglobulin m|mesh-list
24741537|NCT05288192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24741538|NCT05288192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24741539|NCT05288192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24741540|NCT05288192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24741541|NCT05288192|Glucocorticoids|glucocorticoids|mesh-ancestor
24741587|NCT05291338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24741588|NCT05291338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24741589|NCT05291338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24741590|NCT05291338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24741591|NCT05291338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24741592|NCT05291338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741593|NCT05291195|Sodium Hypochlorite|sodium hypochlorite|mesh-list
24741595|NCT05291195|Disinfectants|disinfectants|mesh-ancestor
24741596|NCT05291195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24530974|NCT00633412|Histamine Agents|histamine agents|mesh-ancestor
24741598|NCT05291130|Vitamins|vitamins|mesh-ancestor
24741599|NCT05291130|Micronutrients|micronutrients|mesh-ancestor
24741600|NCT05291130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741601|NCT05291130|Antioxidants|antioxidants|mesh-ancestor
24741602|NCT05291130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741614|NCT05291104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741651|NCT05290935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24741652|NCT05290935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24741653|NCT05290935|Tubulin Modulators|tubulin modulators|mesh-ancestor
24741654|NCT05290935|Antimitotic Agents|antimitotic agents|mesh-ancestor
24741655|NCT05290935|Mitosis Modulators|mitosis modulators|mesh-ancestor
24741656|NCT05290935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124490|NCT03075657|Haloperidol decanoate|haloperidol decanoate|mesh-list
25124491|NCT03075657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25124492|NCT03075657|Serotonin Agents|serotonin agents|mesh-ancestor
25124493|NCT03075657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24741657|NCT05290935|Immunologic Factors|immunologic factors|mesh-ancestor
24741658|NCT05290935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693759|NCT02019472|Adalimumab|adalimumab|mesh-list
25693760|NCT02019472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24741660|NCT05290857|Coagulants|coagulants|mesh-ancestor
24741667|NCT05290506|Linagliptin|linagliptin|mesh-list
24741668|NCT05290506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24531040|NCT00633672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24741669|NCT05290506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24741690|NCT05290324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741691|NCT05290324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24741692|NCT05290324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24741739|NCT05292742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24741740|NCT05292742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24741752|NCT05292677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24741753|NCT05292677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448573|NCT00312260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437228|NCT00273026|Respiratory System Agents|respiratory system agents|mesh-ancestor
25124505|NCT03075657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25124506|NCT03075657|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25124507|NCT03075579|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24741855|NCT05291910|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24741856|NCT05291910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24741857|NCT05291910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24741858|NCT05291910|Tubulin Modulators|tubulin modulators|mesh-ancestor
25124521|NCT03075358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124522|NCT03075358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25124523|NCT03075358|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25124524|NCT03075358|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25124525|NCT03075358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25124526|NCT03075358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628001|NCT01096082|Lithium Carbonate|lithium carbonate|mesh-list
24954708|NCT03872830|Analgesics|analgesics|mesh-ancestor
24741883|NCT05291793|Protective Agents|protective agents|mesh-ancestor
24741921|NCT05294744|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24741922|NCT05294744|Antiviral Agents|antiviral agents|mesh-ancestor
24741923|NCT05294744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24741924|NCT05294744|Expectorants|expectorants|mesh-ancestor
24741925|NCT05294744|Respiratory System Agents|respiratory system agents|mesh-ancestor
24741926|NCT05294744|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24741927|NCT05294744|Antioxidants|antioxidants|mesh-ancestor
24531355|NCT00635310|Liver Extracts|liver extracts|mesh-list
24741928|NCT05294744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741929|NCT05294744|Protective Agents|protective agents|mesh-ancestor
24741930|NCT05294744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741931|NCT05294744|Antidotes|antidotes|mesh-ancestor
24741933|NCT05294679|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24741934|NCT05294679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24741935|NCT05294679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741936|NCT05294679|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24741937|NCT05294679|Anesthetics, General|anesthetics, general|mesh-ancestor
24741938|NCT05294679|Anesthetics|anesthetics|mesh-ancestor
24741939|NCT05294666|Cyclosporine|cyclosporine|mesh-list
25124527|NCT03074942|Reslizumab|reslizumab|mesh-list
25124528|NCT03074942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25124529|NCT03074942|Respiratory System Agents|respiratory system agents|mesh-ancestor
25124530|NCT03074968|Benzydamine|benzydamine|mesh-list
25124531|NCT03074968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25124532|NCT03075020|Carbon Monoxide|carbon monoxide|mesh-list
25124533|NCT03075020|Antimetabolites|antimetabolites|mesh-ancestor
25124534|NCT03075020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124535|NCT03075020|Gasotransmitters|gasotransmitters|mesh-ancestor
24954715|NCT03872596|Antidepressive Agents|antidepressive agents|mesh-ancestor
24954716|NCT03872596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24741941|NCT05294666|Cyclosporins|cyclosporins|mesh-list
24659077|NCT01275547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24741942|NCT05294666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24741943|NCT05294666|Immunologic Factors|immunologic factors|mesh-ancestor
24741944|NCT05294666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741987|NCT05294523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24741988|NCT05294523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741990|NCT05294484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24741991|NCT05294484|Diuretics|diuretics|mesh-ancestor
24741992|NCT05294484|Natriuretic Agents|natriuretic agents|mesh-ancestor
24741993|NCT05294484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547259|NCT00703235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25071374|NCT03410836|Sensory System Agents|sensory system agents|mesh-ancestor
24741994|NCT05294484|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24741995|NCT05294484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24741996|NCT05294484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741997|NCT05294406|Piperaquine|piperaquine|mesh-list
24741998|NCT05294406|Artenimol|artenimol|mesh-list
24741999|NCT05294406|Antimalarials|antimalarials|mesh-ancestor
24742000|NCT05294406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24742001|NCT05294406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24406682|NCT00171002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406683|NCT00171002|Vasodilator Agents|vasodilator agents|mesh-ancestor
24406685|NCT00171002|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24742004|NCT05294393|Ropivacaine|ropivacaine|mesh-list
24742005|NCT05294393|Anesthetics, Local|anesthetics, local|mesh-ancestor
24742006|NCT05294393|Anesthetics|anesthetics|mesh-ancestor
24742110|NCT05293574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24742111|NCT05293574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24742112|NCT05293574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24742113|NCT05293574|Contraceptive Agents|contraceptive agents|mesh-ancestor
24742114|NCT05293574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24742142|NCT05293132|Ubiquinone|ubiquinone|mesh-list
24742143|NCT05293132|Montelukast|montelukast|mesh-list
24742144|NCT05293132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24742145|NCT05293132|Respiratory System Agents|respiratory system agents|mesh-ancestor
24742146|NCT05293132|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24742147|NCT05293132|Hormone Antagonists|hormone antagonists|mesh-ancestor
24742148|NCT05293132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24742149|NCT05293132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618287|NCT01047579|Protective Agents|protective agents|mesh-ancestor
24618288|NCT01047657|Orlistat|orlistat|mesh-list
24618289|NCT01047657|Sibutramine|sibutramine|mesh-list
24618290|NCT01047657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618291|NCT01047657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618292|NCT01047657|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24618293|NCT01047657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24618294|NCT01047657|Antidepressive Agents|antidepressive agents|mesh-ancestor
24618295|NCT01047657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24618296|NCT01047657|Appetite Depressants|appetite depressants|mesh-ancestor
24618297|NCT01047670|Hydrocortisone|hydrocortisone|mesh-list
24618338|NCT01047956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24618339|NCT01047956|Antitussive Agents|antitussive agents|mesh-ancestor
24742161|NCT05293119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24742162|NCT05293119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124536|NCT03075020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25124537|NCT03075020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124538|NCT03074994|Anesthetics|anesthetics|mesh-list
25124539|NCT03074994|Anesthetics, Local|anesthetics, local|mesh-list
25124540|NCT03074994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24742163|NCT05293080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
24742164|NCT05296863|Minoxidil|minoxidil|mesh-list
24742165|NCT05296863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24742166|NCT05296863|Vasodilator Agents|vasodilator agents|mesh-ancestor
24742167|NCT05296772|Pembrolizumab|pembrolizumab|mesh-list
24742168|NCT05296772|Antibodies|antibodies|mesh-list
24742169|NCT05296772|Immunoglobulins|immunoglobulins|mesh-list
24742170|NCT05296772|Immunologic Factors|immunologic factors|mesh-ancestor
24742171|NCT05296772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742172|NCT05296772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25693761|NCT02019472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25693762|NCT02019472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25693763|NCT02019472|Immunologic Factors|immunologic factors|mesh-ancestor
25693764|NCT02019472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693765|NCT02019602|Certolizumab Pegol|certolizumab pegol|mesh-list
25693766|NCT02019602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25693767|NCT02019602|Immunologic Factors|immunologic factors|mesh-ancestor
25693768|NCT02019602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742173|NCT05296772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693769|NCT02019602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24742191|NCT05296564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24406906|NCT00171535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406907|NCT00171535|Vasodilator Agents|vasodilator agents|mesh-ancestor
24742202|NCT05296317|Lenograstim|lenograstim|mesh-list
24742203|NCT05296317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24742206|NCT05296317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24742207|NCT05296317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24742208|NCT05296317|Alkylating Agents|alkylating agents|mesh-ancestor
24742209|NCT05296317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742210|NCT05296317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24742211|NCT05296317|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24742212|NCT05296317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24742255|NCT05295355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742256|NCT05295355|Anticonvulsants|anticonvulsants|mesh-ancestor
24742257|NCT05295173|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24742259|NCT05295173|Reteplase|reteplase|mesh-list
24742260|NCT05295173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24742261|NCT05295173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24742262|NCT05295173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742263|NCT05294900|Paclitaxel|paclitaxel|mesh-list
24742264|NCT05294900|Carboplatin|carboplatin|mesh-list
24742292|NCT05288062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24406980|NCT00171665|Diclofenac|diclofenac|mesh-list
24742293|NCT05288062|Glucocorticoids|glucocorticoids|mesh-ancestor
24742294|NCT05288062|Hormones|hormones|mesh-ancestor
24742295|NCT05288062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24742296|NCT05288062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24742297|NCT05288062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24742298|NCT05288062|Protease Inhibitors|protease inhibitors|mesh-ancestor
24651649|NCT01232777|Bevacizumab|bevacizumab|mesh-list
24742299|NCT05288062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24742300|NCT05288062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742301|NCT05288062|Immunologic Factors|immunologic factors|mesh-ancestor
24742302|NCT05288062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24742303|NCT05288062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24742304|NCT05288062|Growth Substances|growth substances|mesh-ancestor
24742305|NCT05288062|Growth Inhibitors|growth inhibitors|mesh-ancestor
24742306|NCT05288062|Dermatologic Agents|dermatologic agents|mesh-ancestor
24742307|NCT05280405|Infliximab|infliximab|mesh-list
24742308|NCT05280405|Dermatologic Agents|dermatologic agents|mesh-ancestor
24742309|NCT05280405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24742310|NCT05280405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24742311|NCT05275647|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24742312|NCT05275647|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25124542|NCT03074994|Sensory System Agents|sensory system agents|mesh-ancestor
25124543|NCT03074994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124544|NCT03074864|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25124545|NCT03074864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24844635|NCT02233582|Ibuprofen|ibuprofen|mesh-list
25124546|NCT03074864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25124547|NCT03074864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124548|NCT03074864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124550|NCT03075241|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25124551|NCT03075241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25124552|NCT03075241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25124553|NCT03075241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124554|NCT03075241|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25124555|NCT03075241|GABA Agonists|gaba agonists|mesh-ancestor
25124556|NCT03075241|GABA Agents|gaba agents|mesh-ancestor
25124557|NCT03075241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25124558|NCT03075241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124560|NCT03074825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24742340|NCT05273996|Bupropion|bupropion|mesh-list
24742341|NCT05273996|Sertraline|sertraline|mesh-list
24742342|NCT05273996|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25071510|NCT03408587|Ipilimumab|ipilimumab|mesh-list
24742343|NCT05273996|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24742344|NCT05273996|Antidepressive Agents|antidepressive agents|mesh-ancestor
24742345|NCT05273996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24742346|NCT05273996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24742353|NCT05273996|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24742367|NCT05273242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24742368|NCT05273242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24742369|NCT05273242|Antiviral Agents|antiviral agents|mesh-ancestor
24742370|NCT05273242|Schistosomicides|schistosomicides|mesh-ancestor
24742371|NCT05273242|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24742372|NCT05273242|Anthelmintics|anthelmintics|mesh-ancestor
24742415|NCT05267938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24742416|NCT05267938|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24742417|NCT05267938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24742418|NCT05267938|Autonomic Agents|autonomic agents|mesh-ancestor
24742419|NCT05267938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25124563|NCT03074825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124565|NCT03074773|Bupivacaine|bupivacaine|mesh-list
25124566|NCT03074773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25124567|NCT03074773|Antiemetics|antiemetics|mesh-ancestor
25124568|NCT03074773|Autonomic Agents|autonomic agents|mesh-ancestor
25124569|NCT03074773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124570|NCT03074773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124571|NCT03074773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25124572|NCT03074773|Glucocorticoids|glucocorticoids|mesh-ancestor
24742420|NCT05267938|Respiratory System Agents|respiratory system agents|mesh-ancestor
24742422|NCT05267938|Sympathomimetics|sympathomimetics|mesh-ancestor
24742423|NCT05267938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24742424|NCT05267431|Methotrexate|methotrexate|mesh-list
24742425|NCT05267431|Hydroquinone|hydroquinone|mesh-list
24742537|NCT05238506|Anesthetics, Local|anesthetics, local|mesh-ancestor
24742538|NCT05238506|Anesthetics|anesthetics|mesh-ancestor
24742539|NCT05238506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24742540|NCT05238506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742541|NCT05238506|Sensory System Agents|sensory system agents|mesh-ancestor
24742542|NCT05238506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24742543|NCT05238506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24742544|NCT05238506|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24742545|NCT05238506|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24742546|NCT05238506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24742547|NCT05238506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742549|NCT05236608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24742550|NCT05236608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24742551|NCT05236608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24407166|NCT00172172|Calcium|calcium|mesh-list
24742564|NCT05225116|Lenvatinib|lenvatinib|mesh-list
24742565|NCT05225116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24742566|NCT05225116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24742567|NCT05225116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24742568|NCT05225116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742576|NCT05220826|Ethylene|ethylene|mesh-list
24742577|NCT05220826|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24742578|NCT05220826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24742599|NCT05219799|Sympathomimetics|sympathomimetics|mesh-ancestor
24742650|NCT05215327|Vaccines|vaccines|mesh-list
24742651|NCT05215327|Immunologic Factors|immunologic factors|mesh-ancestor
24742652|NCT05215327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742653|NCT05210413|Spartalizumab|spartalizumab|mesh-list
24742654|NCT05210413|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24742655|NCT05210413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742656|NCT05210413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24742657|NCT05203705|Enoxaparin|enoxaparin|mesh-list
24618347|NCT01047982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618349|NCT01047995|Darunavir|darunavir|mesh-list
25124576|NCT03074773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25124577|NCT03074773|Anesthetics, Local|anesthetics, local|mesh-ancestor
25124578|NCT03074773|Anesthetics|anesthetics|mesh-ancestor
25124579|NCT03074773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25124580|NCT03074773|Sensory System Agents|sensory system agents|mesh-ancestor
25124581|NCT03074786|Tenofovir|tenofovir|mesh-list
25124582|NCT03074786|Emtricitabine|emtricitabine|mesh-list
25124583|NCT03074786|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25124584|NCT03074786|Dapivirine|dapivirine|mesh-list
25124585|NCT03074786|Antiviral Agents|antiviral agents|mesh-ancestor
25709279|NCT02264574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071633|NCT03407027|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24618351|NCT01047995|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24618352|NCT01047995|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24618353|NCT01047995|Protease Inhibitors|protease inhibitors|mesh-ancestor
24618354|NCT01047995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618355|NCT01047995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618357|NCT01047995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24618358|NCT01047995|Antiviral Agents|antiviral agents|mesh-ancestor
24618359|NCT01047995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24618360|NCT01047995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24618361|NCT01047995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24742726|NCT05189444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742833|NCT05150756|Anesthetics|anesthetics|mesh-ancestor
24742834|NCT05150756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24742835|NCT05150756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742836|NCT05150756|Sensory System Agents|sensory system agents|mesh-ancestor
24742837|NCT05150756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24742838|NCT05150756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24742839|NCT05150756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24742840|NCT05150756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24742841|NCT05150756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24742842|NCT05150756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742848|NCT05146778|Dexmedetomidine|dexmedetomidine|mesh-list
24742849|NCT05146778|Analgesics, Opioid|analgesics, opioid|mesh-list
24742850|NCT05146778|Anesthetics|anesthetics|mesh-list
24742851|NCT05146778|Anesthetics, Local|anesthetics, local|mesh-ancestor
24742852|NCT05146778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24742853|NCT05146778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742854|NCT05146778|Sensory System Agents|sensory system agents|mesh-ancestor
24742855|NCT05146778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24742863|NCT05146778|Analgesics|analgesics|mesh-ancestor
24742899|NCT05111314|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
24742900|NCT05111314|Chelating Agents|chelating agents|mesh-ancestor
24742901|NCT05111314|Sequestering Agents|sequestering agents|mesh-ancestor
24742902|NCT05111314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742903|NCT05111314|Anticoagulants|anticoagulants|mesh-ancestor
24742904|NCT05111314|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24742905|NCT05111314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24742906|NCT05110898|Olmesartan|olmesartan|mesh-list
24742907|NCT05110898|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24742908|NCT05110898|Indapamide|indapamide|mesh-list
24742909|NCT05110898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24742927|NCT05103696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742928|NCT05103696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25124586|NCT03074786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25124587|NCT03074786|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25124588|NCT03074786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25124589|NCT03074786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124590|NCT03074786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124591|NCT03074786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25124592|NCT03074786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25124593|NCT03074591|Ferric Compounds|ferric compounds|mesh-list
25124594|NCT03074591|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25124595|NCT03074591|Hematinics|hematinics|mesh-ancestor
25124596|NCT03074578|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25124597|NCT03074578|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
24742939|NCT05098041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742940|NCT05098041|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24742941|NCT05098041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24651786|NCT01233843|Carboplatin|carboplatin|mesh-list
24742942|NCT05098041|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24742943|NCT05098041|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24742944|NCT05098041|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24742947|NCT05096325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24743008|NCT05057273|Adalimumab|adalimumab|mesh-list
24743009|NCT05057273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24743010|NCT05057273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24743011|NCT05039476|Vitamin A|vitamin a|mesh-list
24743012|NCT05039476|Vitamins|vitamins|mesh-ancestor
24743088|NCT05013229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743089|NCT05008926|Naloxegol|naloxegol|mesh-list
24743090|NCT05008926|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24743091|NCT05008926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071679|NCT03406858|Immunologic Factors|immunologic factors|mesh-ancestor
24743092|NCT05008926|Sensory System Agents|sensory system agents|mesh-ancestor
24743093|NCT05008926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24532605|NCT00640588|Adefovir|adefovir|mesh-list
24743131|NCT04984044|Vitamin D|vitamin d|mesh-list
25124598|NCT03074578|beta-Endorphin|beta-endorphin|mesh-list
25124600|NCT03074578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25124601|NCT03074578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124602|NCT03074578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25124603|NCT03074578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124604|NCT03074448|Picosulfate sodium|picosulfate sodium|mesh-list
25124605|NCT03074448|Cathartics|cathartics|mesh-ancestor
25124606|NCT03074448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24659960|NCT01281150|Carboplatin|carboplatin|mesh-list
25124607|NCT03074435|Ivermectin|ivermectin|mesh-list
25124608|NCT03074435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25124609|NCT03074435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25124610|NCT03074344|Hyaluronic Acid|hyaluronic acid|mesh-list
25124611|NCT03074344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24743132|NCT04984044|Cholecalciferol|cholecalciferol|mesh-list
24743133|NCT04984044|Vitamins|vitamins|mesh-ancestor
24743134|NCT04984044|Micronutrients|micronutrients|mesh-ancestor
24743135|NCT04984044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743136|NCT04984044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24743137|NCT04984044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24743179|NCT04973930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24743181|NCT04973930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24743182|NCT04973930|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24743242|NCT04936854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24743243|NCT04936854|Antifungal Agents|antifungal agents|mesh-ancestor
24743361|NCT04869605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24743362|NCT04869605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124613|NCT03074344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124614|NCT03074344|Viscosupplements|viscosupplements|mesh-ancestor
25124615|NCT03074344|Protective Agents|protective agents|mesh-ancestor
25124616|NCT03074097|Bupivacaine|bupivacaine|mesh-list
25124617|NCT03074097|Anesthetics, Local|anesthetics, local|mesh-ancestor
25124618|NCT03074097|Anesthetics|anesthetics|mesh-ancestor
25124619|NCT03074097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25124620|NCT03074097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124621|NCT03074097|Sensory System Agents|sensory system agents|mesh-ancestor
25124622|NCT03074097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124623|NCT03074123|Cosyntropin|cosyntropin|mesh-list
25124624|NCT03074123|Hormones|hormones|mesh-ancestor
25124625|NCT03074123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24659962|NCT01281150|Veliparib|veliparib|mesh-list
24660398|NCT01283217|Docetaxel|docetaxel|mesh-list
25124626|NCT03074123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618448|NCT01048320|Gemcitabine|gemcitabine|mesh-list
24743460|NCT04781647|Interferons|interferons|mesh-list
24743493|NCT04762888|Edetic Acid|edetic acid|mesh-list
24743494|NCT04762888|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
24743495|NCT04762888|Chelating Agents|chelating agents|mesh-ancestor
24743496|NCT04762888|Sequestering Agents|sequestering agents|mesh-ancestor
24743497|NCT04762888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743498|NCT04762888|Anticoagulants|anticoagulants|mesh-ancestor
24743499|NCT04762888|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24743500|NCT04762888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24743501|NCT04762199|Osimertinib|osimertinib|mesh-list
24743502|NCT04762199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24743503|NCT04762199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24743504|NCT04762199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24743505|NCT04762199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743507|NCT04761159|Analgesics|analgesics|mesh-ancestor
24743508|NCT04761159|Sensory System Agents|sensory system agents|mesh-ancestor
24743509|NCT04761159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24743510|NCT04761159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743669|NCT04671082|Tolperisone|tolperisone|mesh-list
24743709|NCT04657016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24743712|NCT04655144|Antiemetics|antiemetics|mesh-ancestor
25693770|NCT02019667|(3-aminopropyl)(n-butyl)phosphinic acid|(3-aminopropyl)(n-butyl)phosphinic acid|mesh-list
25693771|NCT02019667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24743714|NCT04655144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24743715|NCT04655144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618460|NCT01048320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124628|NCT03073928|Anesthetics, Local|anesthetics, local|mesh-ancestor
25124629|NCT03073928|Anesthetics|anesthetics|mesh-ancestor
24450000|NCT00317577|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25124630|NCT03073928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25124631|NCT03073928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124632|NCT03073928|Sensory System Agents|sensory system agents|mesh-ancestor
25124633|NCT03073928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124634|NCT03074136|Sodium Hypochlorite|sodium hypochlorite|mesh-list
25124636|NCT03074136|Disinfectants|disinfectants|mesh-ancestor
25124637|NCT03074136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25124639|NCT03073850|Edoxaban|edoxaban|mesh-list
25124640|NCT03073850|Anticoagulants|anticoagulants|mesh-list
25124641|NCT03073850|Clopidogrel|clopidogrel|mesh-list
25124642|NCT03073850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25124643|NCT03073850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25124644|NCT03073850|Analgesics|analgesics|mesh-ancestor
25124645|NCT03073850|Sensory System Agents|sensory system agents|mesh-ancestor
25124646|NCT03073850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124647|NCT03073850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660399|NCT01283217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25124648|NCT03073850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25124649|NCT03073850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25124650|NCT03073850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24618461|NCT01048320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24618462|NCT01048385|Ubiquinone|ubiquinone|mesh-list
24618463|NCT01048385|Coenzyme Q10|coenzyme q10|mesh-list
24618472|NCT01048398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24618473|NCT01048398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618474|NCT01048398|Antipyretics|antipyretics|mesh-ancestor
24618475|NCT01048398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24618476|NCT01048398|Narcotics|narcotics|mesh-ancestor
24618477|NCT01048398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24618478|NCT01048515|Caffeine|caffeine|mesh-list
24743763|NCT04635098|Adrenergic Agents|adrenergic agents|mesh-ancestor
24743764|NCT04635098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24743765|NCT04635098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124654|NCT03073850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25124655|NCT03073850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124656|NCT03073850|Antipyretics|antipyretics|mesh-ancestor
24743938|NCT04564885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743939|NCT04564443|Calcium|calcium|mesh-list
24743940|NCT04564443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24743941|NCT04564443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743943|NCT04562831|Niacin|niacin|mesh-list
24743944|NCT04562831|Nicotinic Acids|nicotinic acids|mesh-list
24743945|NCT04562831|Vitamin B Complex|vitamin b complex|mesh-ancestor
24743946|NCT04562831|Vitamins|vitamins|mesh-ancestor
24743947|NCT04562831|Micronutrients|micronutrients|mesh-ancestor
24652681|NCT01239719|Clemastine|clemastine|mesh-list
24408594|NCT00178802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24408595|NCT00178802|Immunologic Factors|immunologic factors|mesh-ancestor
24408596|NCT00178802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408597|NCT00178802|Antiviral Agents|antiviral agents|mesh-ancestor
24743948|NCT04562831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743949|NCT04562831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24743975|NCT04560972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24743976|NCT04560972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24660797|NCT01285817|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24743977|NCT04560972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24408598|NCT00178802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24743982|NCT04560972|Keratolytic Agents|keratolytic agents|mesh-ancestor
24743983|NCT04560972|Dermatologic Agents|dermatologic agents|mesh-ancestor
24743984|NCT04560972|Tubulin Modulators|tubulin modulators|mesh-ancestor
24743985|NCT04560972|Antimitotic Agents|antimitotic agents|mesh-ancestor
24743986|NCT04560972|Mitosis Modulators|mitosis modulators|mesh-ancestor
24743987|NCT04548648|Isavuconazole|isavuconazole|mesh-list
24743988|NCT04548648|Acalabrutinib|acalabrutinib|mesh-list
24743989|NCT04548648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24743990|NCT04548648|Antifungal Agents|antifungal agents|mesh-ancestor
24744035|NCT04529499|Favipiravir|favipiravir|mesh-list
24744036|NCT04529499|Antiviral Agents|antiviral agents|mesh-ancestor
24744037|NCT04529499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24744038|NCT04526132|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
24744039|NCT04526132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24744040|NCT04526132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24744041|NCT04526132|Analgesics|analgesics|mesh-ancestor
24744042|NCT04526132|Sensory System Agents|sensory system agents|mesh-ancestor
24744043|NCT04526132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24744044|NCT04526132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124669|NCT03073863|Antimetabolites|antimetabolites|mesh-ancestor
25124670|NCT03073863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124671|NCT03073863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25124672|NCT03073863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25124673|NCT03073863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24789292|NCT01936129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25124674|NCT03073889|Ropivacaine|ropivacaine|mesh-list
25124675|NCT03073889|Anesthetics, Local|anesthetics, local|mesh-ancestor
25124682|NCT03073408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25124683|NCT03073408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25124684|NCT03073408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744045|NCT04526132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24744046|NCT04526132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24744068|NCT04520776|Meloxicam|meloxicam|mesh-list
24744069|NCT04520776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24744070|NCT04520776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24744071|NCT04520776|Analgesics|analgesics|mesh-ancestor
24744072|NCT04520776|Sensory System Agents|sensory system agents|mesh-ancestor
24744073|NCT04520776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24744074|NCT04520776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744100|NCT04515147|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24744101|NCT04515147|Immunologic Factors|immunologic factors|mesh-ancestor
24744102|NCT04515147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744103|NCT04508504|Ropivacaine|ropivacaine|mesh-list
24744104|NCT04508504|Anesthetics, Local|anesthetics, local|mesh-ancestor
24744105|NCT04508504|Anesthetics|anesthetics|mesh-ancestor
24408680|NCT00179062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24408715|NCT00179231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24408716|NCT00179231|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24408717|NCT00179231|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24744106|NCT04508504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24744107|NCT04508504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744108|NCT04508504|Sensory System Agents|sensory system agents|mesh-ancestor
24744109|NCT04508504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24744111|NCT04505280|Anesthetics, Local|anesthetics, local|mesh-ancestor
24408745|NCT00179257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24408746|NCT00179257|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25124692|NCT03073343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25124693|NCT03073343|Lipotropic Agents|lipotropic agents|mesh-ancestor
25124694|NCT03073343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25124695|NCT03073343|Antimetabolites|antimetabolites|mesh-ancestor
24539603|NCT00664690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25124696|NCT03073343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124697|NCT03073343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25124698|NCT03072992|Curcumin|curcumin|mesh-list
25124699|NCT03072992|Paclitaxel|paclitaxel|mesh-list
25124700|NCT03072992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25124701|NCT03072992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25124702|NCT03072992|Tubulin Modulators|tubulin modulators|mesh-ancestor
25124703|NCT03072992|Antimitotic Agents|antimitotic agents|mesh-ancestor
25124704|NCT03072992|Mitosis Modulators|mitosis modulators|mesh-ancestor
25124705|NCT03072992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124706|NCT03072992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25124707|NCT03072992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25124708|NCT03072992|Analgesics|analgesics|mesh-ancestor
25124709|NCT03072992|Sensory System Agents|sensory system agents|mesh-ancestor
25124710|NCT03072992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124711|NCT03072992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124712|NCT03072992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25124713|NCT03072992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25124714|NCT03072992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124716|NCT03073265|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25124717|NCT03073265|Antithrombins|antithrombins|mesh-ancestor
25124735|NCT03073057|Glucocorticoids|glucocorticoids|mesh-ancestor
25124736|NCT03073057|Hormones|hormones|mesh-ancestor
25124737|NCT03073057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25124738|NCT03073057|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25124739|NCT03073057|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25124740|NCT03073057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25124741|NCT03073057|Adrenergic Agents|adrenergic agents|mesh-ancestor
25124742|NCT03073057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25124743|NCT03073057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124744|NCT03073057|Antidotes|antidotes|mesh-ancestor
24744212|NCT04460924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124746|NCT03073018|Fosinopril|fosinopril|mesh-list
25124747|NCT03073018|Pravastatin|pravastatin|mesh-list
25124748|NCT03073018|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24660825|NCT01286090|Cisapride|cisapride|mesh-list
25124749|NCT03073018|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25124750|NCT03073018|Antimetabolites|antimetabolites|mesh-ancestor
25124751|NCT03073018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124752|NCT03073018|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25124753|NCT03073018|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25124754|NCT03073018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124755|NCT03073018|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25124757|NCT03073018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24744537|NCT04233801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24744538|NCT04233801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653229|NCT01242579|Maraviroc|maraviroc|mesh-list
24744596|NCT04224558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24744597|NCT04224558|Analgesics|analgesics|mesh-ancestor
24744598|NCT04224558|Sensory System Agents|sensory system agents|mesh-ancestor
24744599|NCT04224558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24744600|NCT04224558|Antipyretics|antipyretics|mesh-ancestor
24744601|NCT04224558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24744602|NCT04224558|Antiemetics|antiemetics|mesh-ancestor
25124765|NCT03072849|Fluticasone|fluticasone|mesh-list
25124766|NCT03072849|Azithromycin|azithromycin|mesh-list
25124767|NCT03072849|Montelukast|montelukast|mesh-list
25124768|NCT03072849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24660962|NCT01287351|Xhance|xhance|mesh-list
24661032|NCT01287624|Tubulin Modulators|tubulin modulators|mesh-ancestor
24661034|NCT01287624|Mitosis Modulators|mitosis modulators|mesh-ancestor
24661035|NCT01287624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661037|NCT01287624|Antimetabolites|antimetabolites|mesh-ancestor
25124769|NCT03072849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24744727|NCT04169451|Hormone Antagonists|hormone antagonists|mesh-ancestor
24744728|NCT04169451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24744729|NCT04169451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409246|NCT00181597|Hydrocortisone|hydrocortisone|mesh-list
24409248|NCT00181597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24744792|NCT04136262|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24744793|NCT04136262|Abortifacient Agents|abortifacient agents|mesh-ancestor
24744794|NCT04136262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24744795|NCT04136262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744796|NCT04136262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24744797|NCT04136262|Antimetabolites|antimetabolites|mesh-ancestor
24745047|NCT04012177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24745048|NCT04012177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24745050|NCT04012177|Vitamin B Complex|vitamin b complex|mesh-ancestor
24745051|NCT04012177|Vitamins|vitamins|mesh-ancestor
24745052|NCT04012177|Micronutrients|micronutrients|mesh-ancestor
24745053|NCT04012177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745054|NCT04012177|Vasodilator Agents|vasodilator agents|mesh-ancestor
24745055|NCT04007289|Apixaban|apixaban|mesh-list
24745056|NCT04007289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24745057|NCT04007289|Antithrombins|antithrombins|mesh-ancestor
24745058|NCT04007289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24745059|NCT04007289|Protease Inhibitors|protease inhibitors|mesh-ancestor
24745080|NCT04002934|Bazedoxifene|bazedoxifene|mesh-list
24745151|NCT03930615|Antiviral Agents|antiviral agents|mesh-ancestor
24745167|NCT03928600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745168|NCT03928600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25124771|NCT03072849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124772|NCT03072849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124774|NCT03072849|Respiratory System Agents|respiratory system agents|mesh-ancestor
25072120|NCT03403101|Irinotecan|irinotecan|mesh-list
25124775|NCT03072849|Dermatologic Agents|dermatologic agents|mesh-ancestor
25124776|NCT03072849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25124777|NCT03072849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24745169|NCT03928600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24745170|NCT03928600|Oxytocics|oxytocics|mesh-ancestor
24900721|NCT04391621|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24745178|NCT03926091|Cyclophosphamide|cyclophosphamide|mesh-list
24745179|NCT03926091|Docetaxel|docetaxel|mesh-list
24745180|NCT03926091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24745181|NCT03926091|Immunologic Factors|immunologic factors|mesh-ancestor
24745182|NCT03926091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745183|NCT03926091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24745184|NCT03926091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24745185|NCT03926091|Alkylating Agents|alkylating agents|mesh-ancestor
24745188|NCT03926091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24745189|NCT03926091|Tubulin Modulators|tubulin modulators|mesh-ancestor
24618520|NCT01048684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618521|NCT01048827|Busulfan|busulfan|mesh-list
24618522|NCT01048827|Alkylating Agents|alkylating agents|mesh-ancestor
24618523|NCT01048827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618524|NCT01048827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24618525|NCT01048827|Immunologic Factors|immunologic factors|mesh-ancestor
24618528|NCT01048827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409947|NCT00183924|Carboplatin|carboplatin|mesh-list
24409948|NCT00183924|Docetaxel|docetaxel|mesh-list
24409949|NCT00183924|Estramustine|estramustine|mesh-list
24409950|NCT00183924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409951|NCT00183924|Tubulin Modulators|tubulin modulators|mesh-ancestor
24409952|NCT00183924|Antimitotic Agents|antimitotic agents|mesh-ancestor
24409953|NCT00183924|Mitosis Modulators|mitosis modulators|mesh-ancestor
24409954|NCT00183924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745613|NCT03677934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745614|NCT03677934|Growth Inhibitors|growth inhibitors|mesh-ancestor
24745615|NCT03677934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25124779|NCT03072849|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25124780|NCT03072849|Hormone Antagonists|hormone antagonists|mesh-ancestor
25124781|NCT03072849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25124782|NCT03072849|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25124783|NCT03072849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25124784|NCT03072849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124787|NCT03072485|Diclofenac|diclofenac|mesh-list
25124788|NCT03072485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25124789|NCT03072485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124790|NCT03072485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25124791|NCT03072485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25124792|NCT03072485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25124793|NCT03072485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25124794|NCT03072485|Antifungal Agents|antifungal agents|mesh-ancestor
25124795|NCT03072485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25124796|NCT03072485|Immunologic Factors|immunologic factors|mesh-ancestor
25124797|NCT03072485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24745771|NCT03596385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24745772|NCT03596385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24745773|NCT03596385|Vasodilator Agents|vasodilator agents|mesh-ancestor
24745774|NCT03596385|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24745775|NCT03596385|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24745776|NCT03591731|Nivolumab|nivolumab|mesh-list
24745777|NCT03591731|Ipilimumab|ipilimumab|mesh-list
24745778|NCT03591731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24745779|NCT03591731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745780|NCT03591731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24745781|NCT03591731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745813|NCT03582475|Etoposide phosphate|etoposide phosphate|mesh-list
24745814|NCT03582475|Podophyllotoxin|podophyllotoxin|mesh-list
24745815|NCT03582475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745816|NCT03582475|Tubulin Modulators|tubulin modulators|mesh-ancestor
24745817|NCT03582475|Antimitotic Agents|antimitotic agents|mesh-ancestor
24745818|NCT03582475|Mitosis Modulators|mitosis modulators|mesh-ancestor
24745819|NCT03582475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745820|NCT03582475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24745821|NCT03582475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25693772|NCT02019667|Protective Agents|protective agents|mesh-ancestor
24953953|NCT03880357|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24953954|NCT03880357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25072155|NCT03402984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072156|NCT03402984|Cholinergic Agents|cholinergic agents|mesh-ancestor
25072157|NCT03402984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25072158|NCT03402984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072159|NCT03402984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25072160|NCT03402880|Pembrolizumab|pembrolizumab|mesh-list
25072161|NCT03402880|Immunoglobulins|immunoglobulins|mesh-list
24745822|NCT03582475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24745823|NCT03582475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24745824|NCT03582475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24745825|NCT03582475|Keratolytic Agents|keratolytic agents|mesh-ancestor
24745826|NCT03582475|Dermatologic Agents|dermatologic agents|mesh-ancestor
24745827|NCT03576417|Nivolumab|nivolumab|mesh-list
24745856|NCT03569475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24745857|NCT03569475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24745859|NCT03569475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24745860|NCT03569475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24745861|NCT03569475|Analgesics|analgesics|mesh-ancestor
25124801|NCT03072485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124802|NCT03072485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24745862|NCT03569475|Sensory System Agents|sensory system agents|mesh-ancestor
24745863|NCT03569475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24745864|NCT03546556|Alovudine|alovudine|mesh-list
24745865|NCT03546556|Dideoxynucleosides|dideoxynucleosides|mesh-list
24745866|NCT03546556|Antiviral Agents|antiviral agents|mesh-ancestor
24745891|NCT03529396|Antimalarials|antimalarials|mesh-ancestor
24745945|NCT03498001|Liraglutide|liraglutide|mesh-list
24745946|NCT03498001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24745947|NCT03498001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745948|NCT03498001|Incretins|incretins|mesh-ancestor
24745949|NCT03498001|Hormones|hormones|mesh-ancestor
24745950|NCT03498001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24661658|NCT01290276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24661659|NCT01290276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24661660|NCT01290276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661661|NCT01290276|Dopamine Agents|dopamine agents|mesh-ancestor
24618585|NCT01049022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24618586|NCT01049022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24618587|NCT01049048|Vitamin D|vitamin d|mesh-list
24618588|NCT01049048|Cholecalciferol|cholecalciferol|mesh-list
24618589|NCT01049048|Vitamins|vitamins|mesh-ancestor
24618590|NCT01049048|Micronutrients|micronutrients|mesh-ancestor
24746170|NCT03260504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24746173|NCT03251924|Antibodies|antibodies|mesh-list
24746174|NCT03251924|Immunoglobulins|immunoglobulins|mesh-list
24746175|NCT03251924|Antibodies, Blocking|antibodies, blocking|mesh-list
24746176|NCT03251924|Immunologic Factors|immunologic factors|mesh-ancestor
24746177|NCT03251924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746178|NCT03251924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24746179|NCT03251924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746180|NCT03251924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24746232|NCT03216343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746355|NCT05437497|Anesthetics|anesthetics|mesh-ancestor
24746356|NCT05437471|Letrozole|letrozole|mesh-list
24746357|NCT05437471|Dydrogesterone|dydrogesterone|mesh-list
24746358|NCT05437471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746359|NCT05437471|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25693773|NCT02019667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693774|NCT02019667|GABA Antagonists|gaba antagonists|mesh-ancestor
25693775|NCT02019667|GABA Agents|gaba agents|mesh-ancestor
25693776|NCT02019667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25693777|NCT02019667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693778|NCT02019758|Fluticasone|fluticasone|mesh-list
25693779|NCT02019758|Budesonide|budesonide|mesh-list
25693780|NCT02019758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25693781|NCT02019758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25693782|NCT02019758|Autonomic Agents|autonomic agents|mesh-ancestor
24746360|NCT05437471|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24746361|NCT05437471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124803|NCT03072485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25693783|NCT02019758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124804|NCT03072485|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25124805|NCT03072485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124806|NCT03072485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124807|NCT03072589|Regadenoson|regadenoson|mesh-list
25124808|NCT03072589|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25124809|NCT03072589|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25124810|NCT03072589|Purinergic Agonists|purinergic agonists|mesh-ancestor
25124811|NCT03072589|Purinergic Agents|purinergic agents|mesh-ancestor
25124812|NCT03072589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25124813|NCT03072589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124814|NCT03072589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124815|NCT03072511|Nicotine|nicotine|mesh-list
25124816|NCT03072511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25124817|NCT03072511|Autonomic Agents|autonomic agents|mesh-ancestor
24746459|NCT05432518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24746460|NCT05432518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24746461|NCT05432518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746462|NCT05432518|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24746463|NCT05427513|Tranexamic Acid|tranexamic acid|mesh-list
24746464|NCT05427513|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24746465|NCT05427513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24746466|NCT05427513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746467|NCT05427513|Hemostatics|hemostatics|mesh-ancestor
24746468|NCT05427513|Coagulants|coagulants|mesh-ancestor
24746575|NCT05006079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24746576|NCT05006079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24746577|NCT05006079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24746578|NCT05006079|GABA Modulators|gaba modulators|mesh-ancestor
24746579|NCT05006079|GABA Agents|gaba agents|mesh-ancestor
24746691|NCT04427293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746693|NCT04312009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24746694|NCT04312009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24746695|NCT04312009|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24746696|NCT04312009|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24746697|NCT04312009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124818|NCT03072511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124819|NCT03072511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124821|NCT03072511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25124822|NCT03072511|Cholinergic Agents|cholinergic agents|mesh-ancestor
25124823|NCT03072511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25124824|NCT03072511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124825|NCT03072264|Fluoxetine|fluoxetine|mesh-list
25124826|NCT03072264|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24621635|NCT01063205|Antidotes|antidotes|mesh-ancestor
24867331|NCT01126749|Antimetabolites|antimetabolites|mesh-ancestor
25124827|NCT03072264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25124828|NCT03072264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25124829|NCT03072264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124830|NCT03072264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25124832|NCT03072264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124833|NCT03072264|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25124834|NCT03072264|Antidepressive Agents|antidepressive agents|mesh-ancestor
25124835|NCT03072264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25124836|NCT03072264|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24954997|NCT03869736|Anesthetics|anesthetics|mesh-ancestor
24746723|NCT04100096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746724|NCT04100096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746725|NCT04100096|Dopamine Agonists|dopamine agonists|mesh-ancestor
24746726|NCT04100096|Dopamine Agents|dopamine agents|mesh-ancestor
24746761|NCT03819296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24746791|NCT03537014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24746792|NCT03537014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746793|NCT03537014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24746794|NCT03537014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24746795|NCT03537014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24746796|NCT03537014|Adrenergic Agents|adrenergic agents|mesh-ancestor
24746808|NCT03473925|Pembrolizumab|pembrolizumab|mesh-list
24618648|NCT01049425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24618649|NCT01049425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24618650|NCT01049425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618651|NCT01049438|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24618652|NCT01049438|Doxycycline|doxycycline|mesh-list
24618653|NCT01049438|Minocycline|minocycline|mesh-list
24618654|NCT01049438|Mupirocin|mupirocin|mesh-list
24618655|NCT01049438|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24618656|NCT01049438|Trimethoprim|trimethoprim|mesh-list
24618657|NCT01049438|Sulfamethoxazole|sulfamethoxazole|mesh-list
24618658|NCT01049438|Hexachlorophene|hexachlorophene|mesh-list
24618659|NCT01049438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24618660|NCT01049438|Antimalarials|antimalarials|mesh-ancestor
24618661|NCT01049438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24747572|NCT00496795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25124867|NCT03072082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25124868|NCT03072082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124869|NCT03072082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25124870|NCT03072082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25124871|NCT03072082|Analgesics|analgesics|mesh-ancestor
25124872|NCT03072082|Sensory System Agents|sensory system agents|mesh-ancestor
25124873|NCT03072082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124874|NCT03072082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25124875|NCT03072082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25124876|NCT03072082|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25124877|NCT03072082|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25124878|NCT03072082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124879|NCT03072082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25124880|NCT03072082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25124881|NCT03072082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124882|NCT03072082|Antipyretics|antipyretics|mesh-ancestor
25124883|NCT03072082|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25124884|NCT03072082|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25124885|NCT03072082|Antimetabolites|antimetabolites|mesh-ancestor
25124886|NCT03072082|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25124887|NCT03072082|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24747573|NCT00496795|Tubulin Modulators|tubulin modulators|mesh-ancestor
24747574|NCT00496795|Antimitotic Agents|antimitotic agents|mesh-ancestor
24747575|NCT00496795|Mitosis Modulators|mitosis modulators|mesh-ancestor
24747576|NCT00496795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412026|NCT00190632|Analgesics|analgesics|mesh-ancestor
24412027|NCT00190632|Sensory System Agents|sensory system agents|mesh-ancestor
24618699|NCT01049464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24618701|NCT01049464|Anticonvulsants|anticonvulsants|mesh-ancestor
24747761|NCT03110432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24747762|NCT03110432|Vitamin B Complex|vitamin b complex|mesh-ancestor
24747763|NCT03110432|Vitamins|vitamins|mesh-ancestor
24747764|NCT03110432|Micronutrients|micronutrients|mesh-ancestor
24747765|NCT03110432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24747766|NCT03110432|Vasodilator Agents|vasodilator agents|mesh-ancestor
25124888|NCT03072082|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25124889|NCT03072082|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25124891|NCT03072082|Purinergic Agents|purinergic agents|mesh-ancestor
25124892|NCT03072082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25124893|NCT03072082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25124894|NCT03072082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24747770|NCT03096834|Erenumab|erenumab|mesh-list
24747771|NCT03096834|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
24747772|NCT03096834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24747773|NCT03096834|Analgesics|analgesics|mesh-ancestor
24747778|NCT03089203|Fludarabine|fludarabine|mesh-list
24747786|NCT03089203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24747919|NCT03015792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24747920|NCT03015792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24747921|NCT03015792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24747922|NCT03015792|Glucocorticoids|glucocorticoids|mesh-ancestor
24748009|NCT02999633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24748010|NCT02999633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748011|NCT02999633|Protease Inhibitors|protease inhibitors|mesh-ancestor
24748012|NCT02999633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24748147|NCT02886286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24748148|NCT02886286|Anesthetics, General|anesthetics, general|mesh-ancestor
24412617|NCT00191672|Antimetabolites|antimetabolites|mesh-ancestor
24748271|NCT02750319|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24748272|NCT02750319|Antiviral Agents|antiviral agents|mesh-ancestor
24748273|NCT02750319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24748274|NCT02750319|Expectorants|expectorants|mesh-ancestor
24748275|NCT02750319|Respiratory System Agents|respiratory system agents|mesh-ancestor
24701050|NCT01456507|Sensory System Agents|sensory system agents|mesh-ancestor
24748276|NCT02750319|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25124897|NCT03072082|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25124898|NCT03072082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25124899|NCT03072082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25124900|NCT03072082|Adrenergic Agents|adrenergic agents|mesh-ancestor
25124901|NCT03072082|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25124902|NCT03072082|Diuretics|diuretics|mesh-ancestor
25124903|NCT03072082|Natriuretic Agents|natriuretic agents|mesh-ancestor
25124904|NCT03072082|Vasodilator Agents|vasodilator agents|mesh-ancestor
25124905|NCT03072082|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24748375|NCT02656706|Nivolumab|nivolumab|mesh-list
24748428|NCT02599324|Antimitotic Agents|antimitotic agents|mesh-ancestor
24748429|NCT02599324|Mitosis Modulators|mitosis modulators|mesh-ancestor
24538472|NCT00659451|Losartan|losartan|mesh-list
24748430|NCT02599324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748431|NCT02599324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24748432|NCT02599324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24748433|NCT02599324|Immunologic Factors|immunologic factors|mesh-ancestor
24748434|NCT02599324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618783|NCT01049646|Angiotensinogen|angiotensinogen|mesh-list
24618784|NCT01049646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24618785|NCT01049646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24618786|NCT01049646|Protease Inhibitors|protease inhibitors|mesh-ancestor
24618787|NCT01049646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618788|NCT01049646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618789|NCT01049672|Alfentanil|alfentanil|mesh-list
24748748|NCT02185820|Growth Substances|growth substances|mesh-ancestor
24748749|NCT02185820|Growth Inhibitors|growth inhibitors|mesh-ancestor
24748750|NCT02168829|Aspirin|aspirin|mesh-list
24748751|NCT02168829|Rivaroxaban|rivaroxaban|mesh-list
24748757|NCT02168829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748758|NCT02168829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24748759|NCT02168829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24748840|NCT02075177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24748841|NCT02075177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24748842|NCT02075177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748843|NCT02075177|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24748844|NCT02075177|Hormone Antagonists|hormone antagonists|mesh-ancestor
24748845|NCT02075177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24748846|NCT02075177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748847|NCT02075177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24748848|NCT02075177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748924|NCT01976754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24748926|NCT01976754|Sensory System Agents|sensory system agents|mesh-ancestor
24748927|NCT01976754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24748928|NCT01976754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24748929|NCT01976754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24748930|NCT01976754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24748931|NCT01976754|Adrenergic Agents|adrenergic agents|mesh-ancestor
24618798|NCT01049672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24618799|NCT01049672|Anesthetics, General|anesthetics, general|mesh-ancestor
24749081|NCT01817751|Urological Agents|urological agents|mesh-ancestor
24749082|NCT01817751|Anticonvulsants|anticonvulsants|mesh-ancestor
24749083|NCT01817751|GABA Agents|gaba agents|mesh-ancestor
24749084|NCT01817751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24749156|NCT01606098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24749157|NCT01606098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24749158|NCT01606098|Growth Substances|growth substances|mesh-ancestor
25124907|NCT03072290|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25124908|NCT03072290|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25124910|NCT03072290|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25124911|NCT03072290|Anesthetics, Local|anesthetics, local|mesh-ancestor
25124912|NCT03072290|Anesthetics|anesthetics|mesh-ancestor
25124913|NCT03072290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25124914|NCT03072290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124915|NCT03072290|Sensory System Agents|sensory system agents|mesh-ancestor
25124916|NCT03072290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124917|NCT03072290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25124918|NCT03072290|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25124919|NCT03072290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24955056|NCT03868969|Fosfomycin|fosfomycin|mesh-list
25693784|NCT02019758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749159|NCT01606098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749160|NCT01606098|Growth Inhibitors|growth inhibitors|mesh-ancestor
24749161|NCT01499095|Insulin|insulin|mesh-list
24749162|NCT01499095|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24749163|NCT01499095|Insulin Glargine|insulin glargine|mesh-list
24749164|NCT01499095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24749251|NCT01396408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749252|NCT01396408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24749253|NCT01396408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24749254|NCT01396408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24749255|NCT01396408|Antifungal Agents|antifungal agents|mesh-ancestor
24749256|NCT01396408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24749257|NCT01396408|Immunologic Factors|immunologic factors|mesh-ancestor
24749258|NCT01380938|Ribavirin|ribavirin|mesh-list
24749259|NCT01380938|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24749260|NCT01380938|Interferon-alpha|interferon-alpha|mesh-list
24749261|NCT01380938|Antimetabolites|antimetabolites|mesh-ancestor
24749263|NCT01380938|Antiviral Agents|antiviral agents|mesh-ancestor
24618826|NCT01049841|Antifungal Agents|antifungal agents|mesh-ancestor
24618827|NCT01049841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24618828|NCT01049841|Immunologic Factors|immunologic factors|mesh-ancestor
24618829|NCT01049841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618830|NCT01049854|Vidarabine|vidarabine|mesh-list
24618831|NCT01049854|Cyclophosphamide|cyclophosphamide|mesh-list
24618832|NCT01049854|Thiotepa|thiotepa|mesh-list
24618833|NCT01049854|Busulfan|busulfan|mesh-list
24618834|NCT01049854|Fludarabine phosphate|fludarabine phosphate|mesh-list
24618835|NCT01049854|Fludarabine|fludarabine|mesh-list
24618836|NCT01049854|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24618837|NCT01049854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24618838|NCT01049854|Immunologic Factors|immunologic factors|mesh-ancestor
24618839|NCT01049854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618840|NCT01049854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24618841|NCT01049854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24749309|NCT01204242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24749310|NCT01204242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24749311|NCT01204242|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24749312|NCT01204242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24749319|NCT01190787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24749320|NCT01190787|Immunologic Factors|immunologic factors|mesh-ancestor
24749321|NCT01190787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749372|NCT01150045|Leucovorin|leucovorin|mesh-list
24749373|NCT01150045|Celecoxib|celecoxib|mesh-list
24749374|NCT01150045|Fluorouracil|fluorouracil|mesh-list
24749375|NCT01150045|Oxaliplatin|oxaliplatin|mesh-list
24749376|NCT01150045|Antimetabolites|antimetabolites|mesh-ancestor
24749377|NCT01150045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124932|NCT03072121|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25124933|NCT03072121|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25124935|NCT03072121|Clopidogrel|clopidogrel|mesh-list
25124936|NCT03072121|Atorvastatin|atorvastatin|mesh-list
25124937|NCT03072121|Calcium|calcium|mesh-list
25124938|NCT03072121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25124939|NCT03072121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749386|NCT01150045|Vitamins|vitamins|mesh-ancestor
24749426|NCT01096368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24749427|NCT01096368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24749428|NCT01096368|Tubulin Modulators|tubulin modulators|mesh-ancestor
24749429|NCT01096368|Antimitotic Agents|antimitotic agents|mesh-ancestor
24749518|NCT00942877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24749519|NCT00942877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749520|NCT00896389|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24749521|NCT00896389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24749522|NCT00896389|Diuretics|diuretics|mesh-ancestor
24749523|NCT00896389|Natriuretic Agents|natriuretic agents|mesh-ancestor
24749524|NCT00896389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749525|NCT00896389|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24749587|NCT00579527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24749588|NCT00579527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749589|NCT00579527|Antifungal Agents|antifungal agents|mesh-ancestor
24749590|NCT00579527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24749591|NCT00579527|Dermatologic Agents|dermatologic agents|mesh-ancestor
24749592|NCT00579527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24749593|NCT00579527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24749778|NCT00304070|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24749839|NCT01694134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25124940|NCT03072121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25124941|NCT03072121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25072489|NCT03401372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25072490|NCT03401372|Glucocorticoids|glucocorticoids|mesh-ancestor
25072492|NCT03401372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24701419|NCT01458847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24701420|NCT01458964|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25072493|NCT03401372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25072494|NCT03401372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25124942|NCT03072121|Analgesics|analgesics|mesh-ancestor
25124943|NCT03072121|Sensory System Agents|sensory system agents|mesh-ancestor
25124944|NCT03072121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25124945|NCT03072121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25124946|NCT03072121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25124947|NCT03072121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25124948|NCT03072121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25124949|NCT03072121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25124950|NCT03072121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25124951|NCT03072121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25124952|NCT03072121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25124953|NCT03072121|Antipyretics|antipyretics|mesh-ancestor
25124954|NCT03072121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25124955|NCT03072121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24749840|NCT01694134|Glucocorticoids|glucocorticoids|mesh-ancestor
24749841|NCT01694134|Hormones|hormones|mesh-ancestor
24749842|NCT01694134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24749843|NCT01694134|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24749844|NCT01694134|Protective Agents|protective agents|mesh-ancestor
24749845|NCT01694134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24618960|NCT01050374|Piperazine|piperazine|mesh-list
24618987|NCT01050426|Vitamin B Complex|vitamin b complex|mesh-ancestor
24618988|NCT01050426|Vitamins|vitamins|mesh-ancestor
24618989|NCT01050426|Micronutrients|micronutrients|mesh-ancestor
24618990|NCT01050426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24618991|NCT01050426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618992|NCT01050452|Ivermectin|ivermectin|mesh-list
24618993|NCT01050452|Albendazole|albendazole|mesh-list
24618994|NCT01050452|Mebendazole|mebendazole|mesh-list
24618995|NCT01050452|Piperazine|piperazine|mesh-list
24618996|NCT01050452|Piperazine citrate|piperazine citrate|mesh-list
24618997|NCT01050452|DMP 777|dmp 777|mesh-list
24618998|NCT01050452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24618999|NCT01050452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24619000|NCT01050452|Anthelmintics|anthelmintics|mesh-ancestor
24619001|NCT01050452|Anticestodal Agents|anticestodal agents|mesh-ancestor
24619002|NCT01050452|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24750206|NCT01697098|Dexamethasone acetate|dexamethasone acetate|mesh-list
24619003|NCT01050452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24619004|NCT01050452|Tubulin Modulators|tubulin modulators|mesh-ancestor
24750208|NCT01697098|BB 1101|bb 1101|mesh-list
24750241|NCT01697228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24750242|NCT01697293|Paclitaxel|paclitaxel|mesh-list
24750243|NCT01697293|Cyclophosphamide|cyclophosphamide|mesh-list
24750244|NCT01697293|Doxorubicin|doxorubicin|mesh-list
24750245|NCT01697293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24750246|NCT01697293|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24750591|NCT01699490|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24750592|NCT01699490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24750593|NCT01699490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750594|NCT01699594|Mannitol|mannitol|mesh-list
24750595|NCT01699594|Methacholine Chloride|methacholine chloride|mesh-list
24750596|NCT01699594|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24750597|NCT01699594|Diuretics|diuretics|mesh-ancestor
24750598|NCT01699594|Natriuretic Agents|natriuretic agents|mesh-ancestor
24663932|NCT01304212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663933|NCT01304212|Anesthetics, Local|anesthetics, local|mesh-ancestor
24663934|NCT01304212|Anesthetics|anesthetics|mesh-ancestor
24857320|NCT02290717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663935|NCT01304212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24663972|NCT01304316|Autonomic Agents|autonomic agents|mesh-ancestor
25693785|NCT02019758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25693786|NCT02019758|Respiratory System Agents|respiratory system agents|mesh-ancestor
25693787|NCT02019758|Dermatologic Agents|dermatologic agents|mesh-ancestor
25693788|NCT02019758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25693789|NCT02019758|Glucocorticoids|glucocorticoids|mesh-ancestor
25693790|NCT02019758|Hormones|hormones|mesh-ancestor
25693791|NCT02019758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24750599|NCT01699594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701465|NCT01459198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701466|NCT01459211|Dexamethasone|dexamethasone|mesh-list
24701467|NCT01459211|Lenalidomide|lenalidomide|mesh-list
25124960|NCT03072121|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25124962|NCT03072121|Purinergic Agents|purinergic agents|mesh-ancestor
25124963|NCT03072121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25124964|NCT03072121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25124965|NCT03072121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25124966|NCT03072121|Sympatholytics|sympatholytics|mesh-ancestor
25124967|NCT03072121|Autonomic Agents|autonomic agents|mesh-ancestor
25124968|NCT03072121|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25124969|NCT03072121|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25124970|NCT03072121|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25124971|NCT03072121|Adrenergic Agents|adrenergic agents|mesh-ancestor
25124987|NCT03071679|Antimicrobial Cationic Peptides|antimicrobial cationic peptides|mesh-list
25124988|NCT03071679|Imiquimod|imiquimod|mesh-list
24750602|NCT01699594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24750700|NCT01700270|Serotonin Agents|serotonin agents|mesh-ancestor
24750730|NCT01700400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750731|NCT01700400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24750742|NCT01700426|Vitamins|vitamins|mesh-list
24750774|NCT01700491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24750775|NCT01700504|Gentamicins|gentamicins|mesh-list
24750776|NCT01700504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24750777|NCT01700504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24750778|NCT01700504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24750779|NCT01700504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750780|NCT01700504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750781|NCT01700569|Leucovorin|leucovorin|mesh-list
24750782|NCT01700569|Folic Acid|folic acid|mesh-list
24750783|NCT01700569|Temozolomide|temozolomide|mesh-list
24750784|NCT01700569|Levoleucovorin|levoleucovorin|mesh-list
24540886|NCT00669812|Hormones|hormones|mesh-ancestor
24663973|NCT01304316|Nasal Decongestants|nasal decongestants|mesh-ancestor
24664010|NCT01304563|Vaccines|vaccines|mesh-list
24750831|NCT01700881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750833|NCT01700881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750834|NCT01700881|Protective Agents|protective agents|mesh-ancestor
24751006|NCT01701518|Antiemetics|antiemetics|mesh-ancestor
24751007|NCT01701518|Autonomic Agents|autonomic agents|mesh-ancestor
24751008|NCT01701518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24751009|NCT01701518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751010|NCT01701518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24751038|NCT01701778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24751039|NCT01701778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24751040|NCT01701778|Adrenergic Agents|adrenergic agents|mesh-ancestor
24751041|NCT01701778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24751042|NCT01701778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751043|NCT01701778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25124989|NCT03071679|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25124990|NCT03071679|Immunologic Factors|immunologic factors|mesh-ancestor
25124991|NCT03071679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25124992|NCT03071679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25124993|NCT03071679|Interferon Inducers|interferon inducers|mesh-ancestor
25124994|NCT03071679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25124995|NCT03071822|Gemcitabine|gemcitabine|mesh-list
25124996|NCT03071822|Dexamethasone|dexamethasone|mesh-list
25124997|NCT03071822|Etoposide|etoposide|mesh-list
25124998|NCT03071822|Ifosfamide|ifosfamide|mesh-list
25124999|NCT03071822|Asparaginase|asparaginase|mesh-list
25125000|NCT03071822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125001|NCT03071822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25125002|NCT03071822|Antiemetics|antiemetics|mesh-ancestor
25125003|NCT03071822|Autonomic Agents|autonomic agents|mesh-ancestor
25078171|NCT03358719|Nivolumab|nivolumab|mesh-list
24751044|NCT01701778|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24751046|NCT01701778|Anesthetics|anesthetics|mesh-ancestor
24751108|NCT01702103|Mometasone Furoate|mometasone furoate|mesh-list
24751110|NCT01702103|Dermatologic Agents|dermatologic agents|mesh-ancestor
24751111|NCT01702103|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24751112|NCT01702129|Doxorubicin|doxorubicin|mesh-list
24751113|NCT01702129|Cetuximab|cetuximab|mesh-list
24751114|NCT01702129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24751413|NCT01703910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25693792|NCT02019940|Riluzole|riluzole|mesh-list
25693793|NCT02019940|Anticonvulsants|anticonvulsants|mesh-ancestor
24751415|NCT01703910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24751416|NCT01703910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25072681|NCT03399903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25072682|NCT03399903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24835522|NCT02183051|Analgesics|analgesics|mesh-ancestor
24751417|NCT01703910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24751418|NCT01703910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24751419|NCT01703910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24751420|NCT01703910|Alkylating Agents|alkylating agents|mesh-ancestor
24619303|NCT01051934|Growth Substances|growth substances|mesh-ancestor
24751488|NCT01704612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24751489|NCT01704612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751490|NCT01704612|Sensory System Agents|sensory system agents|mesh-ancestor
24751491|NCT01704612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24751492|NCT01704638|Digoxin|digoxin|mesh-list
24751493|NCT01704638|Fluvoxamine|fluvoxamine|mesh-list
24751508|NCT01704638|Serotonin Agents|serotonin agents|mesh-ancestor
24415992|NCT00201708|Cyclophosphamide|cyclophosphamide|mesh-list
24751512|NCT01704638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24656977|NCT01264874|Vitamin D|vitamin d|mesh-list
24751513|NCT01704638|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24751514|NCT01704690|Paclitaxel|paclitaxel|mesh-list
24751515|NCT01704690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24751516|NCT01704690|Cisplatin|cisplatin|mesh-list
24751517|NCT01704690|Fluorouracil|fluorouracil|mesh-list
24751518|NCT01704690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24751519|NCT01704690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751520|NCT01704690|Tubulin Modulators|tubulin modulators|mesh-ancestor
24751568|NCT01704794|Vitamin B Complex|vitamin b complex|mesh-list
24751570|NCT01704794|Hematinics|hematinics|mesh-ancestor
24751571|NCT01704794|Vitamins|vitamins|mesh-ancestor
24751572|NCT01704794|Micronutrients|micronutrients|mesh-ancestor
24619159|NCT01051115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619160|NCT01051167|Cetuximab|cetuximab|mesh-list
24619161|NCT01051167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24752022|NCT01707823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24752023|NCT01707823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24752038|NCT01707940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24752039|NCT01707940|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24752040|NCT01707940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24752042|NCT01707940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125004|NCT03071822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125005|NCT03071822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125006|NCT03071822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25125007|NCT03071822|Glucocorticoids|glucocorticoids|mesh-ancestor
25125008|NCT03071822|Hormones|hormones|mesh-ancestor
25125009|NCT03071822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25125010|NCT03071822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25125011|NCT03071822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25125012|NCT03071822|Antimetabolites|antimetabolites|mesh-ancestor
25125013|NCT03071822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125014|NCT03071822|Antiviral Agents|antiviral agents|mesh-ancestor
25125015|NCT03071822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25125016|NCT03071822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125017|NCT03071822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25125018|NCT03071822|Immunologic Factors|immunologic factors|mesh-ancestor
25125019|NCT03071822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24752043|NCT01707940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24752044|NCT01707940|Hormone Antagonists|hormone antagonists|mesh-ancestor
24752229|NCT01709071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752231|NCT01709292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24752232|NCT01709292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24752233|NCT01709292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752234|NCT01709292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752314|NCT01709760|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24752315|NCT01709760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24752316|NCT01709760|Immunologic Factors|immunologic factors|mesh-ancestor
24752317|NCT01709760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24752318|NCT01709760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24752319|NCT01709825|Sulfalene|sulfalene|mesh-list
25693794|NCT02019940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25693795|NCT02019940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25693796|NCT02019940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25709280|NCT02264574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24752320|NCT01709825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24752353|NCT01709994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752355|NCT01710007|Atorvastatin|atorvastatin|mesh-list
24752356|NCT01710007|Pitavastatin|pitavastatin|mesh-list
24752357|NCT01710007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24752358|NCT01710007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24752359|NCT01710007|Antimetabolites|antimetabolites|mesh-ancestor
24657948|NCT01269606|Insulin|insulin|mesh-list
24752361|NCT01710007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24752420|NCT01710228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24752421|NCT01710228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24752422|NCT01710228|Protective Agents|protective agents|mesh-ancestor
24664971|NCT01309607|Carboplatin|carboplatin|mesh-list
24752423|NCT01710228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24752424|NCT01710228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24752425|NCT01710384|Betamethasone|betamethasone|mesh-list
24752426|NCT01710384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24752427|NCT01710384|Glucocorticoids|glucocorticoids|mesh-ancestor
24752462|NCT01710540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24752463|NCT01710540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752464|NCT01710553|Metformin|metformin|mesh-list
24752465|NCT01710553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24752466|NCT01710553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752467|NCT01710566|Misoprostol|misoprostol|mesh-list
24752468|NCT01710566|Oxytocin|oxytocin|mesh-list
24752469|NCT01710566|Oxytocics|oxytocics|mesh-ancestor
24752470|NCT01710566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24752471|NCT01710566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983289|NCT01444092|Budesonide|budesonide|mesh-list
25125020|NCT03071822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25125021|NCT03071822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25125022|NCT03071822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25125024|NCT03071731|Bromides|bromides|mesh-list
25125025|NCT03071731|Ipratropium|ipratropium|mesh-list
25125026|NCT03071731|Bronchodilator Agents|bronchodilator agents|mesh-list
25125027|NCT03071731|Anticonvulsants|anticonvulsants|mesh-ancestor
25125028|NCT03071731|Autonomic Agents|autonomic agents|mesh-ancestor
24752472|NCT01710566|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24752560|NCT01710995|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
24752561|NCT01710995|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24752562|NCT01710995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752563|NCT01710995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752565|NCT01711060|Oxytocics|oxytocics|mesh-ancestor
24752566|NCT01711060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24752567|NCT01711060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752568|NCT01711073|Plerixafor|plerixafor|mesh-list
24752569|NCT01711073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24752570|NCT01711073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24752571|NCT01711073|Antiviral Agents|antiviral agents|mesh-ancestor
24752700|NCT01711567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752701|NCT01711567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24619182|NCT01051271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24619183|NCT01051271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24619184|NCT01051271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24619185|NCT01051271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24619186|NCT01051271|Anesthetics, General|anesthetics, general|mesh-ancestor
24619187|NCT01051271|Anesthetics|anesthetics|mesh-ancestor
24619188|NCT01051271|GABA Modulators|gaba modulators|mesh-ancestor
24619189|NCT01051271|GABA Agents|gaba agents|mesh-ancestor
24619190|NCT01051271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24619191|NCT01051271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619193|NCT01051284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24619195|NCT01051284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619196|NCT01051284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24619197|NCT01051284|Antiviral Agents|antiviral agents|mesh-ancestor
24665194|NCT01310738|Amphotericin B|amphotericin b|mesh-list
24619198|NCT01051284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24619199|NCT01051284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24619200|NCT01051284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24619201|NCT01051284|Immunologic Factors|immunologic factors|mesh-ancestor
24619202|NCT01051284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619203|NCT01051362|Carboplatin|carboplatin|mesh-list
24619204|NCT01051362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24619207|NCT01051388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25072905|NCT03398824|Metformin|metformin|mesh-list
25072909|NCT03398811|Etonogestrel|etonogestrel|mesh-list
25125045|NCT03071575|Immunologic Factors|immunologic factors|mesh-ancestor
24619211|NCT01051388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619212|NCT01051401|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25125036|NCT03071731|Cholinergic Agents|cholinergic agents|mesh-ancestor
24752880|NCT01712568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24752881|NCT01712568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752882|NCT01712568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752883|NCT01712646|Oxytocin|oxytocin|mesh-list
24752884|NCT01712646|Oxytocics|oxytocics|mesh-ancestor
24752885|NCT01712646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24752886|NCT01712646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752890|NCT01712828|Diphenhydramine|diphenhydramine|mesh-list
24752891|NCT01712828|Promethazine|promethazine|mesh-list
24752892|NCT01712828|Sirolimus|sirolimus|mesh-list
24752893|NCT01712828|Quinidine|quinidine|mesh-list
24752894|NCT01712828|Lenalidomide|lenalidomide|mesh-list
24752895|NCT01712828|Immunologic Factors|immunologic factors|mesh-ancestor
24752896|NCT01712828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752897|NCT01712828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24752898|NCT01712828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24752899|NCT01712828|Growth Substances|growth substances|mesh-ancestor
24752900|NCT01712828|Growth Inhibitors|growth inhibitors|mesh-ancestor
24752901|NCT01712828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543134|NCT00681993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543135|NCT00681993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543136|NCT00681993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24752919|NCT01712828|Histamine Agents|histamine agents|mesh-ancestor
24752920|NCT01712828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24752921|NCT01712828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752922|NCT01712828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24752923|NCT01712828|Antipruritics|antipruritics|mesh-ancestor
24752924|NCT01712828|Dermatologic Agents|dermatologic agents|mesh-ancestor
24619287|NCT01051765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619288|NCT01051804|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24619289|NCT01051804|Lubricant Eye Drops|lubricant eye drops|mesh-list
24619290|NCT01051804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24619292|NCT01051934|Bevacizumab|bevacizumab|mesh-list
24619293|NCT01051934|Carboplatin|carboplatin|mesh-list
24619294|NCT01051934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24753090|NCT01713777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753091|NCT01713777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24753092|NCT01713777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753093|NCT01713777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24753094|NCT01713777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24753095|NCT01713777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25125041|NCT03071536|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25125042|NCT03071536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25125043|NCT03071536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125044|NCT03071575|Vaccines|vaccines|mesh-list
25693797|NCT02019940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693798|NCT02019940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693799|NCT02019940|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25693800|NCT02019940|Protective Agents|protective agents|mesh-ancestor
25693801|NCT02019979|Metformin|metformin|mesh-list
25693802|NCT02019979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25693803|NCT02019979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693804|NCT02020031|Vancomycin|vancomycin|mesh-list
25693805|NCT02020031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25693806|NCT02020031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24634395|NCT01133353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634398|NCT01133366|Anticoagulants|anticoagulants|mesh-ancestor
24634400|NCT01133366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25072961|NCT03398473|Epoetin Alfa|epoetin alfa|mesh-list
25072962|NCT03398473|Hematinics|hematinics|mesh-ancestor
25072963|NCT03398434|Apixaban|apixaban|mesh-list
25072964|NCT03398434|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25072965|NCT03398434|Antithrombins|antithrombins|mesh-ancestor
25072966|NCT03398434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25125046|NCT03071575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753096|NCT01713777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24753098|NCT01713803|Buprenorphine|buprenorphine|mesh-list
24753152|NCT01714037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753154|NCT01714037|Antimitotic Agents|antimitotic agents|mesh-ancestor
24418014|NCT00208312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24753376|NCT01715077|Ipilimumab|ipilimumab|mesh-list
24753400|NCT01715142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753402|NCT01715168|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24753403|NCT01715168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24753404|NCT01715168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24753405|NCT01715168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24753440|NCT01715363|Vitamin B Complex|vitamin b complex|mesh-ancestor
24753441|NCT01715363|Vitamins|vitamins|mesh-ancestor
24753442|NCT01715363|Micronutrients|micronutrients|mesh-ancestor
24753443|NCT01715363|Hematinics|hematinics|mesh-ancestor
24753444|NCT01715441|Irinotecan|irinotecan|mesh-list
24619300|NCT01051934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24619301|NCT01051934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24619302|NCT01051934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24753463|NCT01715519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753591|NCT01716377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753592|NCT01716377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665817|NCT01314898|Diuretics|diuretics|mesh-ancestor
24666102|NCT01317368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666103|NCT01317368|Sensory System Agents|sensory system agents|mesh-ancestor
24666104|NCT01317368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24753760|NCT01717599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24753761|NCT01717599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24753762|NCT01717599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24753763|NCT01717599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753764|NCT01717599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753781|NCT01717690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24619344|NCT01052051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24619345|NCT01052051|Antacids|antacids|mesh-ancestor
24619346|NCT01052051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619347|NCT01052051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24619348|NCT01052129|Naproxen|naproxen|mesh-list
24619350|NCT01052129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25125052|NCT03071549|Dermatologic Agents|dermatologic agents|mesh-ancestor
24888252|NCT04508231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125053|NCT03071549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25125054|NCT03071549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25125055|NCT03071549|Analgesics|analgesics|mesh-ancestor
25125056|NCT03071549|Sensory System Agents|sensory system agents|mesh-ancestor
25125057|NCT03071549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125058|NCT03071549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619351|NCT01052129|Analgesics|analgesics|mesh-ancestor
24619352|NCT01052129|Sensory System Agents|sensory system agents|mesh-ancestor
24753824|NCT01717963|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
24753826|NCT01717963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24753827|NCT01717963|Narcotics|narcotics|mesh-ancestor
24753830|NCT01717963|Analgesics|analgesics|mesh-ancestor
25693807|NCT02020278|Tolvaptan|tolvaptan|mesh-list
25693808|NCT02020278|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25693809|NCT02020278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693810|NCT02020278|Natriuretic Agents|natriuretic agents|mesh-ancestor
25693811|NCT02020278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693812|NCT02020408|Raclopride|raclopride|mesh-list
25693813|NCT02020408|Amphetamine|amphetamine|mesh-list
25693814|NCT02020408|Dextroamphetamine|dextroamphetamine|mesh-list
25709281|NCT02264574|Alkylating Agents|alkylating agents|mesh-ancestor
24753948|NCT01718379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24753949|NCT01718379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24754005|NCT01718652|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24754006|NCT01718652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24634689|NCT01134536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24634690|NCT01134536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24634691|NCT01134536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24634692|NCT01134536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24634693|NCT01134536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634694|NCT01134536|Adrenergic Agents|adrenergic agents|mesh-ancestor
24754012|NCT01718678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754013|NCT01718678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24754081|NCT01718951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754082|NCT01718951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24754083|NCT01718964|Hydrocortisone|hydrocortisone|mesh-list
24754085|NCT01718964|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24754086|NCT01718964|Diuretics|diuretics|mesh-ancestor
24754087|NCT01718964|Natriuretic Agents|natriuretic agents|mesh-ancestor
24754088|NCT01718964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754089|NCT01718964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24754090|NCT01719042|Ondansetron|ondansetron|mesh-list
24754091|NCT01719042|Antiemetics|antiemetics|mesh-ancestor
24754092|NCT01719042|Autonomic Agents|autonomic agents|mesh-ancestor
24754093|NCT01719042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24754094|NCT01719042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754095|NCT01719042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24754096|NCT01719042|Antipruritics|antipruritics|mesh-ancestor
24754097|NCT01719042|Dermatologic Agents|dermatologic agents|mesh-ancestor
24754098|NCT01719042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24754099|NCT01719042|Serotonin Agents|serotonin agents|mesh-ancestor
25125129|NCT03071042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24754131|NCT01719185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754132|NCT01719185|Vitamin B Complex|vitamin b complex|mesh-ancestor
24754134|NCT01719185|Micronutrients|micronutrients|mesh-ancestor
24418855|NCT00210379|Methotrexate|methotrexate|mesh-list
24754169|NCT01719588|Sensory System Agents|sensory system agents|mesh-ancestor
25125062|NCT03071549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125063|NCT03071549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125064|NCT03071770|Ivosidenib|ivosidenib|mesh-list
25125065|NCT03071770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125066|NCT03071770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125067|NCT03071770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125068|NCT03071497|Protoporphyrin IX|protoporphyrin ix|mesh-list
25125069|NCT03071497|Zinc protoporphyrin|zinc protoporphyrin|mesh-list
25125070|NCT03071497|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25125071|NCT03071497|Dermatologic Agents|dermatologic agents|mesh-ancestor
25125072|NCT03071497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125073|NCT03071497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125074|NCT03071705|Metformin|metformin|mesh-list
25125075|NCT03071705|Gefitinib|gefitinib|mesh-list
25125076|NCT03071705|Afatinib|afatinib|mesh-list
25125077|NCT03071705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24754233|NCT01719705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24754234|NCT01719705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24754235|NCT01719770|Rocuronium|rocuronium|mesh-list
24754236|NCT01719770|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24754237|NCT01719770|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24754238|NCT01719770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24754239|NCT01719770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24754240|NCT01719770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754241|NCT01719835|Gemcitabine|gemcitabine|mesh-list
24754242|NCT01719835|Methylprednisolone|methylprednisolone|mesh-list
24754243|NCT01719835|Prednisolone|prednisolone|mesh-list
24754244|NCT01719835|Cyclophosphamide|cyclophosphamide|mesh-list
24754245|NCT01719835|Doxorubicin|doxorubicin|mesh-list
24754247|NCT01719835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24754268|NCT01719835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24754269|NCT01719835|Antiemetics|antiemetics|mesh-ancestor
24619389|NCT01052298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24619415|NCT01052337|Anesthetics|anesthetics|mesh-list
24619416|NCT01052337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24619417|NCT01052337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619418|NCT01052363|Bevacizumab|bevacizumab|mesh-list
25693815|NCT02020408|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25693816|NCT02020408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693817|NCT02020408|Sympathomimetics|sympathomimetics|mesh-ancestor
25693818|NCT02020408|Autonomic Agents|autonomic agents|mesh-ancestor
25693819|NCT02020408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25693820|NCT02020408|Dopamine Agents|dopamine agents|mesh-ancestor
25693821|NCT02020408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24619419|NCT01052363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24619420|NCT01052363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24754290|NCT01719926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24754291|NCT01719926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24754292|NCT01719926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24754293|NCT01719926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754358|NCT01720108|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24754359|NCT01720108|Antithrombins|antithrombins|mesh-ancestor
24754360|NCT01720108|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24754361|NCT01720108|Protease Inhibitors|protease inhibitors|mesh-ancestor
24754362|NCT01720108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24754363|NCT01720108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754364|NCT01720108|Anticoagulants|anticoagulants|mesh-ancestor
25125079|NCT03071705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125080|NCT03071705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25125081|NCT03071705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125082|NCT03071705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125083|NCT03071289|Cisplatin|cisplatin|mesh-list
25125084|NCT03071289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125085|NCT03071302|Tissue Inhibitor of Metalloproteinase-3|tissue inhibitor of metalloproteinase-3|mesh-list
25125086|NCT03071302|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
25125087|NCT03071302|Protease Inhibitors|protease inhibitors|mesh-ancestor
25125088|NCT03071302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125089|NCT03071302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125090|NCT03071380|Rivaroxaban|rivaroxaban|mesh-list
25125091|NCT03071380|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25125092|NCT03071380|Antithrombins|antithrombins|mesh-ancestor
25125093|NCT03071380|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25125094|NCT03071380|Protease Inhibitors|protease inhibitors|mesh-ancestor
25125095|NCT03071380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125096|NCT03071380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955184|NCT03867214|Coagulants|coagulants|mesh-ancestor
24544602|NCT00689624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754399|NCT01720394|Oxytocics|oxytocics|mesh-ancestor
24754443|NCT01720498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24754444|NCT01720537|Bococizumab|bococizumab|mesh-list
24754445|NCT01720537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24754446|NCT01720537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24754447|NCT01720537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24754448|NCT01720537|Antimetabolites|antimetabolites|mesh-ancestor
24754449|NCT01720537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754450|NCT01720537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24754451|NCT01720537|Immunologic Factors|immunologic factors|mesh-ancestor
24754452|NCT01720537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754453|NCT01720615|Remifentanil|remifentanil|mesh-list
24754454|NCT01720615|Propofol|propofol|mesh-list
24754494|NCT01720875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24754496|NCT01720875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24754497|NCT01720875|Glucocorticoids|glucocorticoids|mesh-ancestor
24754498|NCT01720875|Hormones|hormones|mesh-ancestor
24754499|NCT01720875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24754500|NCT01720875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24754501|NCT01720875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24754502|NCT01720875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24754503|NCT01720875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24754504|NCT01720875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754523|NCT01721135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754524|NCT01721135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125097|NCT03071380|Anticoagulants|anticoagulants|mesh-ancestor
25125098|NCT03071055|Ranibizumab|ranibizumab|mesh-list
25125099|NCT03071055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25125100|NCT03071055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25125101|NCT03071055|Growth Substances|growth substances|mesh-ancestor
25125102|NCT03071055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125103|NCT03071055|Growth Inhibitors|growth inhibitors|mesh-ancestor
25125104|NCT03071055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125105|NCT03071172|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25125106|NCT03071172|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25125107|NCT03071172|Progesterone|progesterone|mesh-list
25125108|NCT03071172|Hormones|hormones|mesh-ancestor
25125109|NCT03071172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25125110|NCT03071172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073133|NCT03397069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25073134|NCT03397069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25073135|NCT03397069|Anesthetics, General|anesthetics, general|mesh-ancestor
25073136|NCT03397069|Anesthetics|anesthetics|mesh-ancestor
25073137|NCT03397069|GABA Modulators|gaba modulators|mesh-ancestor
25073138|NCT03397069|GABA Agents|gaba agents|mesh-ancestor
25073139|NCT03397069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25073140|NCT03397069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073141|NCT03396861|Aflibercept|aflibercept|mesh-list
25073142|NCT03396861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25073143|NCT03396861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25073144|NCT03396861|Growth Substances|growth substances|mesh-ancestor
25073145|NCT03396861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073146|NCT03396861|Growth Inhibitors|growth inhibitors|mesh-ancestor
24634738|NCT01134848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24634739|NCT01134848|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25125111|NCT03071172|Progestins|progestins|mesh-ancestor
25125112|NCT03071172|Luteolytic Agents|luteolytic agents|mesh-ancestor
25125113|NCT03071172|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25125114|NCT03071172|Contraceptive Agents|contraceptive agents|mesh-ancestor
24754550|NCT01721382|Incretins|incretins|mesh-ancestor
24754600|NCT01721707|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24754601|NCT01721707|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24754602|NCT01721707|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24754603|NCT01721707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24754604|NCT01721707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754606|NCT01721798|Levonorgestrel|levonorgestrel|mesh-list
24754607|NCT01721798|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24754608|NCT01721798|Contraceptive Agents|contraceptive agents|mesh-ancestor
24754609|NCT01721798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24754610|NCT01721798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754611|NCT01721798|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24754612|NCT01721798|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24754613|NCT01721798|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24754614|NCT01721798|Trace Elements|trace elements|mesh-ancestor
24754615|NCT01721798|Micronutrients|micronutrients|mesh-ancestor
24544806|NCT00690313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544807|NCT00690313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544808|NCT00690313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24754616|NCT01721915|Vitamin D|vitamin d|mesh-list
24754649|NCT01722201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24754650|NCT01722201|Dopamine Agents|dopamine agents|mesh-ancestor
24754651|NCT01722214|Adalimumab|adalimumab|mesh-list
24754652|NCT01722214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24754653|NCT01722214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24754654|NCT01722227|Liraglutide|liraglutide|mesh-list
24754655|NCT01722227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24754656|NCT01722227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754657|NCT01722227|Incretins|incretins|mesh-ancestor
24754658|NCT01722227|Hormones|hormones|mesh-ancestor
24754661|NCT01722240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24754662|NCT01722240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754664|NCT01722240|Hormones|hormones|mesh-ancestor
24754724|NCT01722513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24754725|NCT01722513|Vasodilator Agents|vasodilator agents|mesh-ancestor
24754726|NCT01722513|Urological Agents|urological agents|mesh-ancestor
24754727|NCT01722539|Pyrimethamine|pyrimethamine|mesh-list
24754728|NCT01722539|Piperaquine|piperaquine|mesh-list
25693822|NCT02020408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693823|NCT02020408|Adrenergic Agents|adrenergic agents|mesh-ancestor
25693824|NCT02020408|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25693825|NCT02020408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25693826|NCT02020408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25693827|NCT02020408|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25693828|NCT02020408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25693829|NCT02020408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25693830|NCT02020408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25693831|NCT02020408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25693832|NCT02020408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25693833|NCT02020512|Bimatoprost|bimatoprost|mesh-list
25693834|NCT02020512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25693835|NCT02020577|Cetuximab|cetuximab|mesh-list
25693836|NCT02020577|Afatinib|afatinib|mesh-list
25693837|NCT02020577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24754729|NCT01722539|Sulfadoxine|sulfadoxine|mesh-list
24754730|NCT01722539|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25125115|NCT03071172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25073193|NCT03396484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125116|NCT03071172|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25125117|NCT03071172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25125118|NCT03071172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125120|NCT03070938|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25125121|NCT03071042|Docetaxel|docetaxel|mesh-list
25125122|NCT03071042|Apatinib|apatinib|mesh-list
24955212|NCT03866993|Paclitaxel|paclitaxel|mesh-list
24955213|NCT03866993|Carboplatin|carboplatin|mesh-list
24754731|NCT01722539|Albendazole|albendazole|mesh-list
24754732|NCT01722539|Praziquantel|praziquantel|mesh-list
24754733|NCT01722539|Antimalarials|antimalarials|mesh-ancestor
24754734|NCT01722539|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24754789|NCT01722799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754791|NCT01722942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24754792|NCT01722942|Vasodilator Agents|vasodilator agents|mesh-ancestor
24754793|NCT01722942|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24754794|NCT01722942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24754795|NCT01722942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660762|NCT01285661|Vitamin K|vitamin k|mesh-list
24754813|NCT01722968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24754814|NCT01722968|Growth Substances|growth substances|mesh-ancestor
24754815|NCT01722968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754816|NCT01722968|Growth Inhibitors|growth inhibitors|mesh-ancestor
24754817|NCT01723059|Amoxicillin|amoxicillin|mesh-list
24754818|NCT01723059|Metronidazole|metronidazole|mesh-list
24754819|NCT01723059|Clarithromycin|clarithromycin|mesh-list
24754820|NCT01723059|Omeprazole|omeprazole|mesh-list
24545040|NCT00691470|Warfarin|warfarin|mesh-list
24545041|NCT00691470|Anticoagulants|anticoagulants|mesh-ancestor
24754821|NCT01723059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24754822|NCT01723059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24754865|NCT01723371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24754866|NCT01723371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24754867|NCT01723371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24619537|NCT01052896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619539|NCT01052909|Glimepiride|glimepiride|mesh-list
24619540|NCT01052909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24619541|NCT01052909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24755011|NCT01724268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24755013|NCT01724268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24755019|NCT01724372|Aripiprazole|aripiprazole|mesh-list
24755020|NCT01724372|Antipsychotic Agents|antipsychotic agents|mesh-list
24545278|NCT00692900|Docetaxel|docetaxel|mesh-list
24755149|NCT01724983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24755150|NCT01724983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755152|NCT01724983|Narcotics|narcotics|mesh-ancestor
24755153|NCT01724983|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24755154|NCT01725009|Levetiracetam|levetiracetam|mesh-list
24755155|NCT01725009|Anticonvulsants|anticonvulsants|mesh-ancestor
24755221|NCT01725204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755223|NCT01725230|Simvastatin|simvastatin|mesh-list
24755227|NCT01725230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755228|NCT01725230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24755229|NCT01725230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24755230|NCT01725230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24755231|NCT01725243|Carbetocin|carbetocin|mesh-list
24755232|NCT01725243|Oxytocics|oxytocics|mesh-ancestor
24755261|NCT01725542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755262|NCT01725542|Antiviral Agents|antiviral agents|mesh-ancestor
24755263|NCT01725542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25125127|NCT03071042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755269|NCT01725555|Keratolytic Agents|keratolytic agents|mesh-ancestor
24755270|NCT01725555|Dermatologic Agents|dermatologic agents|mesh-ancestor
24755271|NCT01725555|Tubulin Modulators|tubulin modulators|mesh-ancestor
24755272|NCT01725555|Antimitotic Agents|antimitotic agents|mesh-ancestor
24755313|NCT01725776|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24755314|NCT01725776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24755315|NCT01725776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693838|NCT02020577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755316|NCT01725776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635106|NCT01136941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24635107|NCT01136967|Lenvatinib|lenvatinib|mesh-list
24635108|NCT01136967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24635109|NCT01136967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24635110|NCT01136967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635111|NCT01136967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635112|NCT01137019|Everolimus|everolimus|mesh-list
24635184|NCT01137656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635185|NCT01137656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755317|NCT01725776|Protective Agents|protective agents|mesh-ancestor
24755318|NCT01725776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755320|NCT01725802|Carbidopa|carbidopa|mesh-list
24755321|NCT01725802|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24755322|NCT01725802|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24755323|NCT01725802|Dopamine Agents|dopamine agents|mesh-ancestor
24755324|NCT01725802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24755325|NCT01725802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755326|NCT01725802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755327|NCT01725802|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24755328|NCT01725802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24755391|NCT01726400|Antimetabolites|antimetabolites|mesh-ancestor
24755471|NCT01726686|Ropivacaine|ropivacaine|mesh-list
24755472|NCT01726686|Anesthetics, Local|anesthetics, local|mesh-ancestor
24755473|NCT01726686|Anesthetics|anesthetics|mesh-ancestor
24755474|NCT01726686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24755475|NCT01726686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755478|NCT01726725|Desflurane|desflurane|mesh-list
24755566|NCT01727427|Tinzaparin|tinzaparin|mesh-list
24755567|NCT01727427|PENTA|penta|mesh-list
24755568|NCT01727427|Nadroparin|nadroparin|mesh-list
24755569|NCT01727427|Warfarin|warfarin|mesh-list
24755574|NCT01727427|Phenprocoumon|phenprocoumon|mesh-list
24755575|NCT01727427|Acenocoumarol|acenocoumarol|mesh-list
24755576|NCT01727427|Bemiparin|bemiparin|mesh-list
24755577|NCT01727427|Vitamins|vitamins|mesh-ancestor
24619615|NCT01053208|Analgesics|analgesics|mesh-ancestor
24619616|NCT01053208|Sensory System Agents|sensory system agents|mesh-ancestor
24619617|NCT01053208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24619618|NCT01053208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619619|NCT01053208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24755621|NCT01727531|Anthelmintics|anthelmintics|mesh-ancestor
25125130|NCT03071068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25125131|NCT03071068|Antibodies|antibodies|mesh-list
25125132|NCT03071068|Immunoglobulins|immunoglobulins|mesh-list
25125133|NCT03071068|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25125134|NCT03071068|Immunologic Factors|immunologic factors|mesh-ancestor
25125135|NCT03071068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125136|NCT03071068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125138|NCT03070925|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25125139|NCT03070860|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25125140|NCT03070860|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24955228|NCT03866746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24955229|NCT03866681|Sirolimus|sirolimus|mesh-list
24955230|NCT03866681|Warfarin|warfarin|mesh-list
24755622|NCT01727557|Anesthetics|anesthetics|mesh-list
24449494|NCT00315848|Sensory System Agents|sensory system agents|mesh-ancestor
24755623|NCT01727557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24755689|NCT01728363|Clavulanic Acid|clavulanic acid|mesh-list
24755690|NCT01728363|Ticarcillin|ticarcillin|mesh-list
24755691|NCT01728363|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
24755692|NCT01728363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24755693|NCT01728363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24755694|NCT01728363|Antitubercular Agents|antitubercular agents|mesh-ancestor
24755695|NCT01728363|Leprostatic Agents|leprostatic agents|mesh-ancestor
24755696|NCT01728363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24755697|NCT01728363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693839|NCT02020577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25693840|NCT02020577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693841|NCT02020577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693842|NCT02020616|Metformin|metformin|mesh-list
25693843|NCT02020616|Exenatide|exenatide|mesh-list
25693844|NCT02020616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25693845|NCT02020616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693846|NCT02020616|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25693847|NCT02020616|Incretins|incretins|mesh-ancestor
24755698|NCT01728363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693848|NCT02020616|Hormones|hormones|mesh-ancestor
25693849|NCT02020616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25709282|NCT02264574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755751|NCT01728922|Cholecalciferol|cholecalciferol|mesh-list
24755752|NCT01728922|Vitamins|vitamins|mesh-list
24755753|NCT01728922|Micronutrients|micronutrients|mesh-ancestor
24755754|NCT01728922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755755|NCT01728922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24755756|NCT01728922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24755757|NCT01728935|Tenofovir|tenofovir|mesh-list
24420603|NCT00216411|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24420604|NCT00216411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24420606|NCT00216424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24755792|NCT01729104|Immunologic Factors|immunologic factors|mesh-ancestor
24420607|NCT00216424|Antimetabolites|antimetabolites|mesh-ancestor
24420608|NCT00216424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755793|NCT01729104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755794|NCT01729104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24755795|NCT01729104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24755797|NCT01729104|Growth Substances|growth substances|mesh-ancestor
24755888|NCT01729806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24755889|NCT01729806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755891|NCT01729897|Propofol|propofol|mesh-list
24755892|NCT01729897|Etomidate|etomidate|mesh-list
24755893|NCT01729897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24755894|NCT01729897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24755895|NCT01729897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755896|NCT01729897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24700594|NCT01453504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24755897|NCT01729897|Anesthetics, General|anesthetics, general|mesh-ancestor
24755898|NCT01729897|Anesthetics|anesthetics|mesh-ancestor
24755969|NCT01730495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24755970|NCT01730495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24755971|NCT01730495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24755972|NCT01730495|Immunologic Factors|immunologic factors|mesh-ancestor
24755973|NCT01730508|Interferons|interferons|mesh-list
24755974|NCT01730508|Interferon-alpha|interferon-alpha|mesh-list
24755975|NCT01730508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755976|NCT01730508|Antiviral Agents|antiviral agents|mesh-ancestor
24755977|NCT01730508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25125145|NCT03070847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125146|NCT03070847|Hemostatics|hemostatics|mesh-ancestor
25125147|NCT03070847|Coagulants|coagulants|mesh-ancestor
25125148|NCT03070665|Norepinephrine|norepinephrine|mesh-list
25125149|NCT03070665|Ephedrine|ephedrine|mesh-list
25125150|NCT03070665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25125151|NCT03070665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25125152|NCT03070665|Adrenergic Agents|adrenergic agents|mesh-ancestor
25125153|NCT03070665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25125154|NCT03070665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125155|NCT03070665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125156|NCT03070665|Sympathomimetics|sympathomimetics|mesh-ancestor
25125157|NCT03070665|Autonomic Agents|autonomic agents|mesh-ancestor
24756021|NCT01731067|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24756022|NCT01731067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24756023|NCT01731067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24756024|NCT01731067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756025|NCT01731067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24756026|NCT01731067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24756027|NCT01731067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24756090|NCT01731158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756091|NCT01731158|Growth Inhibitors|growth inhibitors|mesh-ancestor
24756092|NCT01731158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24756093|NCT01731158|Immunologic Factors|immunologic factors|mesh-ancestor
24756094|NCT01731158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24756095|NCT01731158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756097|NCT01731158|Antiviral Agents|antiviral agents|mesh-ancestor
24756175|NCT01731457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24756176|NCT01731457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756177|NCT01731457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25709283|NCT02264821|Morphine|morphine|mesh-list
25709284|NCT02264821|Ropivacaine|ropivacaine|mesh-list
24756178|NCT01731457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24756179|NCT01731457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24756180|NCT01731457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24756181|NCT01731457|Immunologic Factors|immunologic factors|mesh-ancestor
24756267|NCT01731899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756268|NCT01731925|Sunitinib|sunitinib|mesh-list
24756269|NCT01731925|Lanreotide|lanreotide|mesh-list
24756271|NCT01731925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24756272|NCT01731925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24756273|NCT01731925|Growth Substances|growth substances|mesh-ancestor
24756274|NCT01731925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756275|NCT01731925|Growth Inhibitors|growth inhibitors|mesh-ancestor
24756276|NCT01731925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24662103|NCT01292525|Tacrolimus|tacrolimus|mesh-list
24421072|NCT00217555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421073|NCT00217555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24756331|NCT01732367|Lamivudine|lamivudine|mesh-list
24756332|NCT01732367|Adefovir|adefovir|mesh-list
24756333|NCT01732367|Antiviral Agents|antiviral agents|mesh-ancestor
24756334|NCT01732367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24756335|NCT01732367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24756336|NCT01732367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24756337|NCT01732367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756339|NCT01732367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24662164|NCT01293097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756405|NCT01733043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24756406|NCT01733043|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24756407|NCT01733043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24756408|NCT01733043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24756486|NCT01733589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756487|NCT01733589|Growth Inhibitors|growth inhibitors|mesh-ancestor
24756490|NCT01733706|Autonomic Agents|autonomic agents|mesh-ancestor
24756491|NCT01733706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24756492|NCT01733706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756493|NCT01733706|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24756509|NCT01733966|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24756510|NCT01733966|Ciprofloxacin|ciprofloxacin|mesh-list
24756511|NCT01733966|Secnidazole|secnidazole|mesh-list
24756512|NCT01733966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24421210|NCT00218127|Analgesics|analgesics|mesh-ancestor
24756574|NCT01734252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756575|NCT01734252|Anticoagulants|anticoagulants|mesh-ancestor
24756576|NCT01734252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24756578|NCT01734330|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24756579|NCT01734330|Autonomic Agents|autonomic agents|mesh-ancestor
24756580|NCT01734330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24756581|NCT01734330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756582|NCT01734330|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24756583|NCT01734330|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24756584|NCT01734330|Cholinergic Agents|cholinergic agents|mesh-ancestor
24756585|NCT01734330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24756586|NCT01734330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756587|NCT01734408|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25125166|NCT03070574|Sensory System Agents|sensory system agents|mesh-ancestor
25125167|NCT03070574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125168|NCT03070574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125169|NCT03070574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25125170|NCT03070574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25125171|NCT03070574|Antitubercular Agents|antitubercular agents|mesh-ancestor
25125172|NCT03070574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25125173|NCT03070574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25125174|NCT03070704|Liraglutide|liraglutide|mesh-list
25125175|NCT03070704|Xultophy|xultophy|mesh-list
24756637|NCT01734954|Midazolam|midazolam|mesh-list
24756638|NCT01734954|Analgesics|analgesics|mesh-list
24756639|NCT01734954|Anesthetics|anesthetics|mesh-list
24756640|NCT01734954|Levobupivacaine|levobupivacaine|mesh-list
24756641|NCT01734954|Anesthetics, Local|anesthetics, local|mesh-list
24756642|NCT01734954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24756643|NCT01734954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756644|NCT01734954|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24756645|NCT01734954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24756646|NCT01734954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24756647|NCT01734954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25073455|NCT03394989|Xhance|xhance|mesh-list
24756772|NCT01735487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24756830|NCT01736020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24756831|NCT01736020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756832|NCT01736020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24756833|NCT01736020|Anesthetics, General|anesthetics, general|mesh-ancestor
24756951|NCT01736761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25125177|NCT03070704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125180|NCT03070704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25125181|NCT03070678|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25125182|NCT03070678|Mefenamic Acid|mefenamic acid|mesh-list
25125183|NCT03070678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25125184|NCT03070678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125185|NCT03070678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25125186|NCT03070678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125187|NCT03070678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25125188|NCT03070678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24756952|NCT01736761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24756953|NCT01736761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24619745|NCT01053611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24619746|NCT01053611|Anesthetics, General|anesthetics, general|mesh-ancestor
24619747|NCT01053611|Anesthetics|anesthetics|mesh-ancestor
24619748|NCT01053611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24619749|NCT01053611|Narcotics|narcotics|mesh-ancestor
24619750|NCT01053611|Analgesics|analgesics|mesh-ancestor
24619751|NCT01053611|Sensory System Agents|sensory system agents|mesh-ancestor
24619752|NCT01053611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24619753|NCT01053637|Acetaminophen|acetaminophen|mesh-list
24619754|NCT01053637|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
24757049|NCT01737359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24757084|NCT01737671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24757131|NCT01738087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24757132|NCT01738087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24757133|NCT01738087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24757136|NCT01738087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125193|NCT03070678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25125194|NCT03070678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25125195|NCT03070678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125196|NCT03070522|Prednisone|prednisone|mesh-list
25125197|NCT03070522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25125198|NCT03070522|Glucocorticoids|glucocorticoids|mesh-ancestor
25125199|NCT03070522|Hormones|hormones|mesh-ancestor
25125200|NCT03070522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25125201|NCT03070522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125202|NCT03070522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25125203|NCT03070522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125204|NCT03070613|Lectins|lectins|mesh-list
25125205|NCT03070613|Agglutinins|agglutinins|mesh-ancestor
25125206|NCT03070613|Immunologic Factors|immunologic factors|mesh-ancestor
25125207|NCT03070613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125208|NCT03070613|Coagulants|coagulants|mesh-ancestor
25125233|NCT03070405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25125234|NCT03070405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25125235|NCT03070405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24757137|NCT01738100|Morphine|morphine|mesh-list
24757138|NCT01738100|Clopidogrel|clopidogrel|mesh-list
24757139|NCT01738100|Ticagrelor|ticagrelor|mesh-list
24757206|NCT01738425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757207|NCT01738425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757209|NCT01738451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24757210|NCT01738451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24757211|NCT01738451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693850|NCT02020941|Dexamethasone|dexamethasone|mesh-list
25693851|NCT02020941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24757332|NCT01739218|Bevacizumab|bevacizumab|mesh-list
24757333|NCT01739218|Carboplatin|carboplatin|mesh-list
24757334|NCT01739218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25125236|NCT03070405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125237|NCT03070405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125238|NCT03070405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25125239|NCT03070405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25125240|NCT03070405|Antitubercular Agents|antitubercular agents|mesh-ancestor
25125241|NCT03070405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25125242|NCT03070353|Dextrans|dextrans|mesh-list
25125243|NCT03070353|Anticoagulants|anticoagulants|mesh-ancestor
25125244|NCT03070353|Plasma Substitutes|plasma substitutes|mesh-ancestor
25125245|NCT03070353|Blood Substitutes|blood substitutes|mesh-ancestor
25125246|NCT03070275|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25125247|NCT03070275|Hemostatics|hemostatics|mesh-ancestor
25125256|NCT03070223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24533521|NCT00644306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24533522|NCT00644306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125258|NCT03070028|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25125259|NCT03070028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25125260|NCT03070028|Disinfectants|disinfectants|mesh-ancestor
25125261|NCT03070028|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
24955311|NCT03865550|Ketamine|ketamine|mesh-list
24619775|NCT01053650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619777|NCT01053689|Glimepiride|glimepiride|mesh-list
24619778|NCT01053689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24619779|NCT01053689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24619780|NCT01053689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619795|NCT01053806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24619797|NCT01053806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757436|NCT01739985|Dexamethasone|dexamethasone|mesh-list
24757437|NCT01739985|Dexamethasone acetate|dexamethasone acetate|mesh-list
24757438|NCT01739985|Droperidol|droperidol|mesh-list
24757439|NCT01739985|Ondansetron|ondansetron|mesh-list
24757440|NCT01739985|BB 1101|bb 1101|mesh-list
24757441|NCT01739985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24757442|NCT01739985|Antiemetics|antiemetics|mesh-ancestor
24757443|NCT01739985|Autonomic Agents|autonomic agents|mesh-ancestor
24757444|NCT01739985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24757445|NCT01739985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125262|NCT03070028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25125264|NCT03070054|Bupivacaine|bupivacaine|mesh-list
25125265|NCT03070054|Anesthetics, Local|anesthetics, local|mesh-ancestor
25125266|NCT03070054|Anesthetics|anesthetics|mesh-ancestor
25125267|NCT03070054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25125268|NCT03070054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125269|NCT03070054|Sensory System Agents|sensory system agents|mesh-ancestor
25125270|NCT03070054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125271|NCT03070054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25125273|NCT03070054|Adrenergic Agents|adrenergic agents|mesh-ancestor
25125274|NCT03070054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25125275|NCT03070054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125276|NCT03070054|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25125277|NCT03070054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24422321|NCT00222053|Growth Inhibitors|growth inhibitors|mesh-ancestor
24757632|NCT01741506|Dalteparin|dalteparin|mesh-list
24757633|NCT01741506|Tinzaparin|tinzaparin|mesh-list
24422322|NCT00222053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24422323|NCT00222079|Esomeprazole|esomeprazole|mesh-list
24757634|NCT01741506|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24757635|NCT01741506|Anticoagulants|anticoagulants|mesh-ancestor
24757636|NCT01741506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24757637|NCT01741506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24757638|NCT01741506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757639|NCT01741519|Landiolol|landiolol|mesh-list
24757640|NCT01741519|Esmolol|esmolol|mesh-list
24757641|NCT01741519|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24757642|NCT01741519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24757643|NCT01741519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24757717|NCT01742247|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24757718|NCT01742247|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24757719|NCT01742247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24757720|NCT01742247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757722|NCT01742247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24757723|NCT01742273|Vitamin K|vitamin k|mesh-list
24757724|NCT01742273|Vitamin K 1|vitamin k 1|mesh-list
24757725|NCT01742273|Vitamins|vitamins|mesh-ancestor
24757726|NCT01742273|Micronutrients|micronutrients|mesh-ancestor
24757727|NCT01742273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757764|NCT01742390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24757766|NCT01742390|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24757767|NCT01742390|Dopamine Agents|dopamine agents|mesh-ancestor
24757768|NCT01742390|Antidepressive Agents|antidepressive agents|mesh-ancestor
24757769|NCT01742390|Dopamine Agonists|dopamine agonists|mesh-ancestor
24757770|NCT01742390|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24757771|NCT01742390|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24758029|NCT01743365|Afatinib|afatinib|mesh-list
24758052|NCT01743690|Nystatin|nystatin|mesh-list
25125278|NCT03070054|Autonomic Agents|autonomic agents|mesh-ancestor
24758381|NCT01745601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25125290|NCT03069950|Dexamethasone|dexamethasone|mesh-list
25125291|NCT03069950|Fluorouracil|fluorouracil|mesh-list
25125292|NCT03069950|Irinotecan|irinotecan|mesh-list
25125293|NCT03069950|Panitumumab|panitumumab|mesh-list
25125294|NCT03069950|Floxuridine|floxuridine|mesh-list
25125295|NCT03069950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25125296|NCT03069950|Antiemetics|antiemetics|mesh-ancestor
25125297|NCT03069950|Autonomic Agents|autonomic agents|mesh-ancestor
25125298|NCT03069950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125299|NCT03069950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125300|NCT03069950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25125301|NCT03069950|Glucocorticoids|glucocorticoids|mesh-ancestor
25125302|NCT03069950|Hormones|hormones|mesh-ancestor
25125303|NCT03069950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24955354|NCT03865511|Osimertinib|osimertinib|mesh-list
24758105|NCT01743885|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24758107|NCT01743898|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24758108|NCT01743898|Antithrombins|antithrombins|mesh-ancestor
24758110|NCT01743898|Protease Inhibitors|protease inhibitors|mesh-ancestor
24758111|NCT01743898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758112|NCT01743898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758113|NCT01743898|Anticoagulants|anticoagulants|mesh-ancestor
24758114|NCT01743911|Tadalafil|tadalafil|mesh-list
24758115|NCT01743911|Vasodilator Agents|vasodilator agents|mesh-ancestor
24758116|NCT01743911|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24758117|NCT01743911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24758118|NCT01743911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758198|NCT01744288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24758199|NCT01744288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758200|NCT01744288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758290|NCT01744886|Anesthetics, Local|anesthetics, local|mesh-ancestor
24758291|NCT01744886|Anesthetics|anesthetics|mesh-ancestor
24758292|NCT01744886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24758309|NCT01745081|Natriuretic Agents|natriuretic agents|mesh-ancestor
24758310|NCT01745081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758311|NCT01745159|Tacrolimus|tacrolimus|mesh-list
24758312|NCT01745159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24758313|NCT01745159|Immunologic Factors|immunologic factors|mesh-ancestor
25125305|NCT03069950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125306|NCT03069950|Antimetabolites|antimetabolites|mesh-ancestor
25125307|NCT03069950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125308|NCT03069950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25125310|NCT03069950|Immunologic Factors|immunologic factors|mesh-ancestor
25125311|NCT03069950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25125312|NCT03069950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25125313|NCT03069950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125314|NCT03069950|Antidotes|antidotes|mesh-ancestor
25125315|NCT03069950|Protective Agents|protective agents|mesh-ancestor
25125316|NCT03069950|Vitamin B Complex|vitamin b complex|mesh-ancestor
25125317|NCT03069950|Vitamins|vitamins|mesh-ancestor
25125318|NCT03069950|Micronutrients|micronutrients|mesh-ancestor
25125319|NCT03069950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24758315|NCT01745159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24619950|NCT01054651|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24619951|NCT01054651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24619952|NCT01054651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619975|NCT01055041|Respiratory System Agents|respiratory system agents|mesh-ancestor
24619976|NCT01055041|Glucocorticoids|glucocorticoids|mesh-ancestor
24619977|NCT01055041|Hormones|hormones|mesh-ancestor
24619978|NCT01055041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24619979|NCT01055041|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24549005|NCT00712855|Sorafenib|sorafenib|mesh-list
24758380|NCT01745601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24758452|NCT01745809|Chelating Agents|chelating agents|mesh-ancestor
24758453|NCT01745809|Sequestering Agents|sequestering agents|mesh-ancestor
24758454|NCT01745809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758455|NCT01745835|Bisacodyl|bisacodyl|mesh-list
24758456|NCT01745835|Cathartics|cathartics|mesh-ancestor
24758457|NCT01745835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24758458|NCT01745835|Laxatives|laxatives|mesh-ancestor
24758459|NCT01745965|Trastuzumab|trastuzumab|mesh-list
24758460|NCT01745965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24758461|NCT01745965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758462|NCT01746199|Pyrimethamine|pyrimethamine|mesh-list
24758463|NCT01746199|Sulfadoxine|sulfadoxine|mesh-list
24758464|NCT01746199|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24758465|NCT01746199|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24758466|NCT01746199|Sulfamethoxazole|sulfamethoxazole|mesh-list
24758467|NCT01746199|Antimalarials|antimalarials|mesh-ancestor
24758468|NCT01746199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24758469|NCT01746199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24758470|NCT01746199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24758471|NCT01746199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24758509|NCT01746602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758510|NCT01746602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24758511|NCT01746602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24758512|NCT01746641|Remifentanil|remifentanil|mesh-list
24758513|NCT01746641|Propofol|propofol|mesh-list
24758514|NCT01746641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24758515|NCT01746641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25125320|NCT03069781|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25125321|NCT03069781|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25125322|NCT03069781|Estradiol|estradiol|mesh-list
25125323|NCT03069781|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25125324|NCT03069781|Estrogens|estrogens|mesh-ancestor
25125325|NCT03069781|Hormones|hormones|mesh-ancestor
25125326|NCT03069781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25125327|NCT03069781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125328|NCT03069781|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25125329|NCT03069781|Contraceptive Agents|contraceptive agents|mesh-ancestor
25125330|NCT03069781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25125331|NCT03069781|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24758516|NCT01746641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758517|NCT01746641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24758518|NCT01746641|Anesthetics, General|anesthetics, general|mesh-ancestor
24758572|NCT01746823|Antifungal Agents|antifungal agents|mesh-ancestor
24758573|NCT01746823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24758574|NCT01746823|Dermatologic Agents|dermatologic agents|mesh-ancestor
24758575|NCT01746823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24758576|NCT01746823|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24758577|NCT01746875|Aflibercept|aflibercept|mesh-list
24758611|NCT01746992|Hormones|hormones|mesh-ancestor
24758638|NCT01747044|Antidepressive Agents|antidepressive agents|mesh-ancestor
24758639|NCT01747044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24758644|NCT01747135|Sequestering Agents|sequestering agents|mesh-ancestor
24758645|NCT01747135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758647|NCT01747148|Antiviral Agents|antiviral agents|mesh-ancestor
24758656|NCT01747174|Adenosine|adenosine|mesh-list
24620027|NCT01055301|Dexamethasone|dexamethasone|mesh-list
24620028|NCT01055301|Cyclophosphamide|cyclophosphamide|mesh-list
24620029|NCT01055301|Melphalan|melphalan|mesh-list
24620030|NCT01055301|Doxorubicin|doxorubicin|mesh-list
24620031|NCT01055301|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24620032|NCT01055301|Etoposide|etoposide|mesh-list
24758674|NCT01747226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758675|NCT01747252|Resveratrol|resveratrol|mesh-list
24758676|NCT01747252|Antioxidants|antioxidants|mesh-ancestor
24758678|NCT01747252|Protective Agents|protective agents|mesh-ancestor
24758695|NCT01747278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24758696|NCT01747564|Mirabegron|mirabegron|mesh-list
24758697|NCT01747564|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24758698|NCT01747564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24758699|NCT01747564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24758700|NCT01747564|Adrenergic Agents|adrenergic agents|mesh-ancestor
24758701|NCT01747564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24758887|NCT01748396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758889|NCT01748396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758950|NCT01748630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25125336|NCT03069820|Mitosis Modulators|mitosis modulators|mesh-ancestor
25125337|NCT03069820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125339|NCT03069768|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25125340|NCT03069768|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25125341|NCT03069768|Cholinergic Agents|cholinergic agents|mesh-ancestor
25125342|NCT03069768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24758952|NCT01748630|Adrenergic Agents|adrenergic agents|mesh-ancestor
24758954|NCT01748630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758955|NCT01748630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24758956|NCT01748630|Narcotics|narcotics|mesh-ancestor
24758957|NCT01748630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24758958|NCT01748630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24620047|NCT01055301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24424005|NCT00227682|Arsenic Trioxide|arsenic trioxide|mesh-list
24403819|NCT00161655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459775|NCT00346359|Alkylating Agents|alkylating agents|mesh-ancestor
24459776|NCT00346359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24459777|NCT00346359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24459778|NCT00346385|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
24459779|NCT00346385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24459780|NCT00346385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125349|NCT03069911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25125350|NCT03069911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125351|NCT03069911|Cholinergic Agents|cholinergic agents|mesh-ancestor
25125352|NCT03069911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25125353|NCT03069911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125354|NCT03069911|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25125355|NCT03069911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125356|NCT03069339|Carvedilol|carvedilol|mesh-list
25125357|NCT03069339|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25125358|NCT03069339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25125359|NCT03069339|Adrenergic Agents|adrenergic agents|mesh-ancestor
25125360|NCT03069339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25125361|NCT03069339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125362|NCT03069339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955370|NCT03865160|Mydriatics|mydriatics|mesh-ancestor
25125370|NCT03069339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25125371|NCT03069339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25125373|NCT03069001|Sofosbuvir|sofosbuvir|mesh-list
25125374|NCT03069001|Simeprevir|simeprevir|mesh-list
24955394|NCT03864913|Hormones|hormones|mesh-ancestor
24424406|NCT00229216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24394408|NCT00133237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24394409|NCT00133237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24394410|NCT00133237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24394411|NCT00133237|Antifungal Agents|antifungal agents|mesh-ancestor
24455308|NCT01820910|Antimalarials|antimalarials|mesh-ancestor
24455309|NCT01820910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24455310|NCT01820910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24455311|NCT01808599|Rituximab|rituximab|mesh-list
24455312|NCT01808599|Chlorambucil|chlorambucil|mesh-list
24394598|NCT00133692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24394599|NCT00133692|Vasodilator Agents|vasodilator agents|mesh-ancestor
24394600|NCT00133692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24394601|NCT00133692|Protease Inhibitors|protease inhibitors|mesh-ancestor
24394602|NCT00133692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394603|NCT00133731|Heparin|heparin|mesh-list
24394825|NCT00134368|Sensory System Agents|sensory system agents|mesh-ancestor
25125378|NCT03069001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25125379|NCT03069001|Protease Inhibitors|protease inhibitors|mesh-ancestor
25125380|NCT03069001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125381|NCT03069027|Lidocaine|lidocaine|mesh-list
25125382|NCT03069027|Epinephrine|epinephrine|mesh-list
25045721|NCT00924833|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25045722|NCT00924833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25045723|NCT00924833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25045724|NCT00920985|Contraceptive Agents|contraceptive agents|mesh-list
25045725|NCT00920985|Gestodene|gestodene|mesh-list
24955399|NCT03865147|Ibuprofen|ibuprofen|mesh-list
24394826|NCT00134368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24394827|NCT00134368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394828|NCT00134368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24394829|NCT00134368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24394830|NCT00134368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24394860|NCT00134420|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24394862|NCT00134420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24394863|NCT00134420|Adrenergic Agents|adrenergic agents|mesh-ancestor
24394864|NCT00134420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24394865|NCT00134485|Atorvastatin|atorvastatin|mesh-list
24394866|NCT00134485|Torcetrapib|torcetrapib|mesh-list
24394867|NCT00134485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24394868|NCT00134485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24394950|NCT00134693|Antiemetics|antiemetics|mesh-ancestor
24394951|NCT00134693|Autonomic Agents|autonomic agents|mesh-ancestor
24394952|NCT00134693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24395082|NCT00135018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24395083|NCT00135018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395084|NCT00135018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395085|NCT00135057|Insulin|insulin|mesh-list
24395086|NCT00135057|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24395090|NCT00135057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395455|NCT00135967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24395489|NCT00136175|Gemcitabine|gemcitabine|mesh-list
24395490|NCT00136175|Paclitaxel|paclitaxel|mesh-list
24395491|NCT00136175|Carboplatin|carboplatin|mesh-list
24395492|NCT00136175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24459796|NCT00346489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459797|NCT00346489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24533718|NCT00644956|Tadalafil|tadalafil|mesh-list
24413977|NCT00195754|GABA Agents|gaba agents|mesh-ancestor
24424847|NCT00230997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24396540|NCT00139230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396541|NCT00139230|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24396542|NCT00139230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24396626|NCT00139555|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24396627|NCT00139555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24396628|NCT00139555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396629|NCT00139555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24396630|NCT00139555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396635|NCT00139568|Tegaserod|tegaserod|mesh-list
24396815|NCT00140062|Latanoprost|latanoprost|mesh-list
24396816|NCT00140062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24396858|NCT00140166|Vitamin B Complex|vitamin b complex|mesh-ancestor
24396859|NCT00140166|Vitamins|vitamins|mesh-ancestor
25045726|NCT00920985|Contraceptives, Oral|contraceptives, oral|mesh-list
25045727|NCT00920985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25045728|NCT00920985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25045729|NCT00920985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25045730|NCT00920985|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25045731|NCT00920985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25045732|NCT00920985|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25045733|NCT00920985|Progestins|progestins|mesh-ancestor
25045734|NCT00920985|Hormones|hormones|mesh-ancestor
25045736|NCT00920764|Atrasentan|atrasentan|mesh-list
25045737|NCT00920764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25045738|NCT00920764|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25045739|NCT00920764|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25045740|NCT00920764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25045741|NCT00917826|Valganciclovir|valganciclovir|mesh-list
25045742|NCT00917826|Ganciclovir|ganciclovir|mesh-list
25045743|NCT00917826|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25045744|NCT00917826|Arginine butyrate|arginine butyrate|mesh-list
25045745|NCT00917826|Antiviral Agents|antiviral agents|mesh-ancestor
25125383|NCT03069027|Racepinephrine|racepinephrine|mesh-list
25125384|NCT03069027|Epinephryl borate|epinephryl borate|mesh-list
25125385|NCT03069027|Anesthetics, Local|anesthetics, local|mesh-ancestor
24396860|NCT00140166|Micronutrients|micronutrients|mesh-ancestor
24396861|NCT00140166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396862|NCT00140166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24396863|NCT00140166|Antimetabolites|antimetabolites|mesh-ancestor
24396864|NCT00140166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396865|NCT00140166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24396866|NCT00140166|Vasodilator Agents|vasodilator agents|mesh-ancestor
24397029|NCT00140595|Rituximab|rituximab|mesh-list
24397309|NCT00141336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24397310|NCT00141336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397311|NCT00141336|Anticonvulsants|anticonvulsants|mesh-ancestor
24397312|NCT00141336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24397313|NCT00141336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24397314|NCT00141336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397315|NCT00141336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24397316|NCT00141336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24397909|NCT00143000|Antiviral Agents|antiviral agents|mesh-ancestor
24397910|NCT00143000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24397911|NCT00143026|Levodopa|levodopa|mesh-list
24397912|NCT00143026|Carbidopa|carbidopa|mesh-list
24397913|NCT00143026|Entacapone|entacapone|mesh-list
24397914|NCT00143026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24533726|NCT00644982|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24533727|NCT00644982|Antidepressive Agents|antidepressive agents|mesh-ancestor
24533728|NCT00644982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24533729|NCT00644982|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24533730|NCT00644982|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24533731|NCT00644982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24533732|NCT00644982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533733|NCT00644982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24533734|NCT00644982|Serotonin Agents|serotonin agents|mesh-ancestor
24398375|NCT00144248|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24398376|NCT00144261|Nevirapine|nevirapine|mesh-list
24398377|NCT00144261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24398378|NCT00144261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24398379|NCT00144261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398380|NCT00144261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125388|NCT03069027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125389|NCT03069027|Sensory System Agents|sensory system agents|mesh-ancestor
25125390|NCT03069027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125391|NCT03069027|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25125392|NCT03069027|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25125393|NCT03069027|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25125394|NCT03069027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25125395|NCT03069027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125396|NCT03069027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25125397|NCT03069027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25125398|NCT03069027|Adrenergic Agents|adrenergic agents|mesh-ancestor
25125399|NCT03069027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25125400|NCT03069027|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25125401|NCT03069027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25125403|NCT03069027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25125404|NCT03069027|Respiratory System Agents|respiratory system agents|mesh-ancestor
25125405|NCT03069027|Mydriatics|mydriatics|mesh-ancestor
25125406|NCT03069027|Sympathomimetics|sympathomimetics|mesh-ancestor
25125407|NCT03069027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24398381|NCT00144261|Antiviral Agents|antiviral agents|mesh-ancestor
24398382|NCT00144261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24398383|NCT00144261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24398384|NCT00144261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24398385|NCT00144261|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24399099|NCT00146588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24399101|NCT00146588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24399102|NCT00146588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24399103|NCT00146588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24399104|NCT00146588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24399132|NCT00146614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24399905|NCT00148863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24399907|NCT00148863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399908|NCT00148863|Immunologic Factors|immunologic factors|mesh-ancestor
24399909|NCT00148863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399910|NCT00148876|Capecitabine|capecitabine|mesh-list
24399911|NCT00148876|Trastuzumab|trastuzumab|mesh-list
24399912|NCT00148876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24399913|NCT00148876|Antimetabolites|antimetabolites|mesh-ancestor
24399914|NCT00148876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399915|NCT00148876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399947|NCT00149084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24399948|NCT00149084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24399949|NCT00149110|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25125409|NCT03069183|Anesthetics, Local|anesthetics, local|mesh-ancestor
25125410|NCT03069183|Anesthetics|anesthetics|mesh-ancestor
25125411|NCT03069183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25125412|NCT03069183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125413|NCT03069183|Sensory System Agents|sensory system agents|mesh-ancestor
25125414|NCT03069183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125415|NCT03069248|Interferons|interferons|mesh-list
25125416|NCT03069248|Interferon-alpha|interferon-alpha|mesh-list
25125417|NCT03069248|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
25125418|NCT03069248|Rituximab|rituximab|mesh-list
25125419|NCT03069248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25125420|NCT03069248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125421|NCT03069248|Immunologic Factors|immunologic factors|mesh-ancestor
25125422|NCT03069248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125423|NCT03069248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24399950|NCT00149110|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24399951|NCT00149110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24399952|NCT00149110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24400085|NCT00149617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400334|NCT00150358|Urological Agents|urological agents|mesh-ancestor
24400335|NCT00150371|Atorvastatin|atorvastatin|mesh-list
24400336|NCT00150371|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24400338|NCT00150371|Antimetabolites|antimetabolites|mesh-ancestor
24400339|NCT00150371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400340|NCT00150371|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24400571|NCT00150865|Ropivacaine|ropivacaine|mesh-list
24400572|NCT00150865|Anesthetics, Local|anesthetics, local|mesh-ancestor
24400573|NCT00150865|Anesthetics|anesthetics|mesh-ancestor
24400574|NCT00150865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24400575|NCT00150865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400576|NCT00150865|Sensory System Agents|sensory system agents|mesh-ancestor
24400577|NCT00150865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24400578|NCT00150891|Cyclosporine|cyclosporine|mesh-list
25693852|NCT02020941|Antiemetics|antiemetics|mesh-ancestor
24400580|NCT00150891|Azathioprine|azathioprine|mesh-list
24400581|NCT00150891|Tacrolimus|tacrolimus|mesh-list
24400582|NCT00150891|Cyclosporins|cyclosporins|mesh-list
24400583|NCT00150891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24400584|NCT00150891|Immunologic Factors|immunologic factors|mesh-ancestor
24400615|NCT00151008|Bexarotene|bexarotene|mesh-list
24401280|NCT00152620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24401559|NCT00153244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24401594|NCT00153296|Antimanic Agents|antimanic agents|mesh-ancestor
24401595|NCT00153296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24401596|NCT00153296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24459881|NCT00346749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24401597|NCT00153296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401666|NCT00153660|Naproxen|naproxen|mesh-list
24401667|NCT00153660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24401668|NCT00153660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24401670|NCT00153660|Sensory System Agents|sensory system agents|mesh-ancestor
24401671|NCT00153660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24401672|NCT00153660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401673|NCT00153660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24401674|NCT00153660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24401675|NCT00153660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25125425|NCT03069248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25125426|NCT03068975|Alvimopan|alvimopan|mesh-list
25125427|NCT03068975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25125428|NCT03068962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
25125429|NCT03068962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25125430|NCT03068936|Cisplatin|cisplatin|mesh-list
25125431|NCT03068936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125432|NCT03068832|Poly I-C|poly i-c|mesh-list
25125433|NCT03068832|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25125434|NCT03068832|Poly ICLC|poly iclc|mesh-list
25125435|NCT03068832|Interferon Inducers|interferon inducers|mesh-ancestor
25125436|NCT03068832|Immunologic Factors|immunologic factors|mesh-ancestor
24955471|NCT03864666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24402147|NCT00155233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24402554|NCT00157729|Vitamins|vitamins|mesh-ancestor
24402555|NCT00157729|Micronutrients|micronutrients|mesh-ancestor
24402556|NCT00157729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402720|NCT00158301|Fluoxetine|fluoxetine|mesh-list
24402721|NCT00158301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24402722|NCT00158301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24402723|NCT00158301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24402724|NCT00158301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402725|NCT00158301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24402726|NCT00158301|Serotonin Agents|serotonin agents|mesh-ancestor
24402727|NCT00158301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402728|NCT00158301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24402729|NCT00158301|Antidepressive Agents|antidepressive agents|mesh-ancestor
24402730|NCT00158301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24402731|NCT00158301|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24402732|NCT00158301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24402733|NCT00158301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402867|NCT00158574|Leprostatic Agents|leprostatic agents|mesh-ancestor
24402868|NCT00158574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24402869|NCT00158574|Antimetabolites|antimetabolites|mesh-ancestor
24402870|NCT00158587|Primaquine|primaquine|mesh-list
24402871|NCT00158587|Antimalarials|antimalarials|mesh-ancestor
24402872|NCT00158587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24402873|NCT00158587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24402874|NCT00158587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24403621|NCT00161070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24403622|NCT00161070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24403750|NCT00161421|Hormone Antagonists|hormone antagonists|mesh-ancestor
24403752|NCT00161434|Antiviral Agents|antiviral agents|mesh-ancestor
24403753|NCT00161434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24403754|NCT00161447|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24403755|NCT00161447|Medroxyprogesterone|medroxyprogesterone|mesh-list
24403791|NCT00161564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403792|NCT00161564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24403794|NCT00161577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24403820|NCT00161655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25693853|NCT02020941|Autonomic Agents|autonomic agents|mesh-ancestor
24403821|NCT00161655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24403822|NCT00161655|Immunologic Factors|immunologic factors|mesh-ancestor
24403823|NCT00161655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24403824|NCT00161655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24403825|NCT00161655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24403826|NCT00161655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24403827|NCT00161655|Analgesics|analgesics|mesh-ancestor
24403828|NCT00161655|Sensory System Agents|sensory system agents|mesh-ancestor
24403829|NCT00161655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125443|NCT03068741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25125444|NCT03068741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25125445|NCT03069144|Calcitriol|calcitriol|mesh-list
25125446|NCT03069144|Calcipotriene|calcipotriene|mesh-list
25125447|NCT03069144|Dermatologic Agents|dermatologic agents|mesh-ancestor
24900722|NCT04391621|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25125448|NCT03069144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25125449|NCT03069144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125450|NCT03069144|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25125451|NCT03069144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25125452|NCT03069144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125453|NCT03069144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25125454|NCT03069144|Vitamins|vitamins|mesh-ancestor
25125455|NCT03069144|Micronutrients|micronutrients|mesh-ancestor
25125456|NCT03069144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25125457|NCT03068650|Rindopepimut|rindopepimut|mesh-list
24955481|NCT03864666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24403830|NCT00161655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24403831|NCT00161655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24403833|NCT00161668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24403917|NCT00162149|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24403918|NCT00162149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24403919|NCT00162149|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24403920|NCT00162149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24403921|NCT00162149|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24403922|NCT00162149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24403956|NCT00162214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24403957|NCT00162214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403958|NCT00162214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24404152|NCT00162643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24404154|NCT00162656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24404155|NCT00162656|Immunologic Factors|immunologic factors|mesh-ancestor
24404195|NCT00162721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24404196|NCT00162721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24404197|NCT00162721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404316|NCT00163111|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24404412|NCT00163384|Glucocorticoids|glucocorticoids|mesh-ancestor
25125483|NCT03068247|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25125484|NCT03068247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25125485|NCT03068247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25125486|NCT03068247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125487|NCT03068247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24404583|NCT00164112|Levofloxacin|levofloxacin|mesh-list
24404584|NCT00164112|Ofloxacin|ofloxacin|mesh-list
24404585|NCT00164112|Telithromycin|telithromycin|mesh-list
24404586|NCT00164112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25125525|NCT03068260|Anesthetics|anesthetics|mesh-ancestor
25709285|NCT02264821|Anesthetics, Local|anesthetics, local|mesh-list
25709286|NCT02264821|Anesthetics|anesthetics|mesh-list
25709287|NCT02264821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25709288|NCT02264821|Narcotics|narcotics|mesh-ancestor
25709289|NCT02264821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25709290|NCT02264821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709291|NCT02264821|Analgesics|analgesics|mesh-ancestor
25709292|NCT02264821|Sensory System Agents|sensory system agents|mesh-ancestor
25709293|NCT02264821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25709294|NCT02264990|Paclitaxel|paclitaxel|mesh-list
24640280|NCT01167231|Acarbose|acarbose|mesh-list
24404684|NCT00164450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404685|NCT00164450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24404686|NCT00164450|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24404687|NCT00164450|Leprostatic Agents|leprostatic agents|mesh-ancestor
24404688|NCT00164463|Moxifloxacin|moxifloxacin|mesh-list
24404689|NCT00164463|Isoniazid|isoniazid|mesh-list
24404722|NCT00164710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404723|NCT00164710|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24404724|NCT00164710|Renal Agents|renal agents|mesh-ancestor
24459895|NCT00346801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125562|NCT03067883|Antiviral Agents|antiviral agents|mesh-ancestor
24459896|NCT00346801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24404725|NCT00164710|Leprostatic Agents|leprostatic agents|mesh-ancestor
24404726|NCT00164710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24404728|NCT00164736|Lopinavir|lopinavir|mesh-list
24404729|NCT00164736|Lamivudine|lamivudine|mesh-list
24404730|NCT00164736|Zidovudine|zidovudine|mesh-list
24404731|NCT00164736|Nevirapine|nevirapine|mesh-list
24404767|NCT00164775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404769|NCT00164775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24404770|NCT00164775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404771|NCT00164788|Esomeprazole|esomeprazole|mesh-list
24405075|NCT00165451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25125490|NCT03068247|Sensory System Agents|sensory system agents|mesh-ancestor
25125491|NCT03068247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125492|NCT03068247|Antidepressive Agents|antidepressive agents|mesh-ancestor
25125493|NCT03068247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25125494|NCT03068247|Dopamine Agents|dopamine agents|mesh-ancestor
25125495|NCT03068065|Metformin|metformin|mesh-list
25125496|NCT03068065|Liraglutide|liraglutide|mesh-list
25125497|NCT03068065|Gliclazide|gliclazide|mesh-list
25125498|NCT03068065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25125499|NCT03068065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125500|NCT03068065|Incretins|incretins|mesh-ancestor
25125501|NCT03068065|Hormones|hormones|mesh-ancestor
25125502|NCT03068065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25125503|NCT03068234|Pirfenidone|pirfenidone|mesh-list
25125504|NCT03068234|Analgesics|analgesics|mesh-ancestor
24405244|NCT00166127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405245|NCT00166153|Mycophenolic Acid|mycophenolic acid|mesh-list
24405347|NCT00166595|Risperidone|risperidone|mesh-list
24405348|NCT00166595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24405349|NCT00166595|Serotonin Agents|serotonin agents|mesh-ancestor
24405350|NCT00166595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24405351|NCT00166595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405352|NCT00166595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405353|NCT00166595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24405354|NCT00166595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24406039|NCT00169039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406040|NCT00169039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406041|NCT00169039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24406212|NCT00169247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25709295|NCT02264990|Cisplatin|cisplatin|mesh-list
24406213|NCT00169299|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25709296|NCT02264990|Carboplatin|carboplatin|mesh-list
25709297|NCT02264990|Pemetrexed|pemetrexed|mesh-list
25709298|NCT02264990|Veliparib|veliparib|mesh-list
25709299|NCT02264990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25709300|NCT02264990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25709301|NCT02264990|Tubulin Modulators|tubulin modulators|mesh-ancestor
25709302|NCT02264990|Antimitotic Agents|antimitotic agents|mesh-ancestor
25709303|NCT02264990|Mitosis Modulators|mitosis modulators|mesh-ancestor
25709304|NCT02264990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709305|NCT02264990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709306|NCT02264990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25709307|NCT02264990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25709308|NCT02264990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25709309|NCT02265224|Acetylcysteine|acetylcysteine|mesh-list
25709310|NCT02265224|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25709311|NCT02265224|Antiviral Agents|antiviral agents|mesh-ancestor
25709312|NCT02265224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24406214|NCT00169299|Medroxyprogesterone|medroxyprogesterone|mesh-list
24406215|NCT00169299|Estrogens|estrogens|mesh-list
24406216|NCT00169299|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24406217|NCT00169299|Hormones|hormones|mesh-ancestor
24406218|NCT00169299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24406219|NCT00169299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406374|NCT00169988|Serotonin Agents|serotonin agents|mesh-ancestor
24406713|NCT00171067|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24406714|NCT00171067|Protease Inhibitors|protease inhibitors|mesh-ancestor
24406715|NCT00171067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24406716|NCT00171067|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24406736|NCT00171093|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24406737|NCT00171106|Valsartan|valsartan|mesh-list
24406738|NCT00171106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25125506|NCT03068234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125507|NCT03068234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125508|NCT03068234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25125509|NCT03068234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25125510|NCT03068234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25125511|NCT03068234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25125512|NCT03068234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125513|NCT03068260|Acetaminophen|acetaminophen|mesh-list
25125514|NCT03068260|Ibuprofen|ibuprofen|mesh-list
25125515|NCT03068260|Morphine|morphine|mesh-list
25125516|NCT03068260|Ropivacaine|ropivacaine|mesh-list
25125517|NCT03068260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25125518|NCT03068260|Narcotics|narcotics|mesh-ancestor
24955528|NCT03864575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24406739|NCT00171106|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24406860|NCT00171483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24406861|NCT00171483|Serotonin Agents|serotonin agents|mesh-ancestor
24406862|NCT00171483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24406863|NCT00171483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406900|NCT00171535|Valsartan|valsartan|mesh-list
24406901|NCT00171535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24406922|NCT00171574|Lisinopril|lisinopril|mesh-list
24407063|NCT00171782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407064|NCT00171782|Diuretics|diuretics|mesh-ancestor
24407065|NCT00171782|Natriuretic Agents|natriuretic agents|mesh-ancestor
24407066|NCT00171782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407067|NCT00171782|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24407068|NCT00171782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24407069|NCT00171795|Rivastigmine|rivastigmine|mesh-list
24407070|NCT00171795|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24407071|NCT00171795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407072|NCT00171795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407073|NCT00171795|Cholinergic Agents|cholinergic agents|mesh-ancestor
24407074|NCT00171795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24407075|NCT00171795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407076|NCT00171795|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24407077|NCT00171795|Protective Agents|protective agents|mesh-ancestor
24407078|NCT00171808|Letrozole|letrozole|mesh-list
24407079|NCT00171808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407080|NCT00171808|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24407081|NCT00171808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24407082|NCT00171808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407083|NCT00171808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407265|NCT00173888|Mitosis Modulators|mitosis modulators|mesh-ancestor
24407266|NCT00173901|Ceftazidime|ceftazidime|mesh-list
24407267|NCT00173901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24407268|NCT00173901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24407289|NCT00174226|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24407290|NCT00174226|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24407291|NCT00174226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24407292|NCT00174226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24407293|NCT00174226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407294|NCT00174226|Adrenergic Agents|adrenergic agents|mesh-ancestor
24407449|NCT00174551|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24407450|NCT00174551|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24407451|NCT00174551|Adrenergic Agents|adrenergic agents|mesh-ancestor
25125519|NCT03068260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25125520|NCT03068260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125522|NCT03068260|Sensory System Agents|sensory system agents|mesh-ancestor
25125523|NCT03068260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125524|NCT03068260|Anesthetics, Local|anesthetics, local|mesh-ancestor
25125533|NCT03068260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125534|NCT03068208|Methylene Blue|methylene blue|mesh-list
25125535|NCT03068208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125536|NCT03068208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125537|NCT03067974|Ketamine|ketamine|mesh-list
25125538|NCT03067974|Analgesics|analgesics|mesh-ancestor
24955546|NCT03863925|Propofol|propofol|mesh-list
24408111|NCT00176553|Respiratory System Agents|respiratory system agents|mesh-ancestor
24407452|NCT00174551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24407453|NCT00174551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407454|NCT00174551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407456|NCT00174564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407457|NCT00174577|Risperidone|risperidone|mesh-list
24407458|NCT00174577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24407459|NCT00174577|Serotonin Agents|serotonin agents|mesh-ancestor
24407731|NCT00175253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407732|NCT00175266|Alemtuzumab|alemtuzumab|mesh-list
24407733|NCT00175266|Infliximab|infliximab|mesh-list
24407734|NCT00175266|Dermatologic Agents|dermatologic agents|mesh-ancestor
24407768|NCT00175396|Androgens|androgens|mesh-list
24407769|NCT00175396|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24407770|NCT00175396|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24407771|NCT00175396|Fertility Agents|fertility agents|mesh-ancestor
24407772|NCT00175396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24407773|NCT00175396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407774|NCT00175396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24407775|NCT00175396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407776|NCT00175396|Androgen Antagonists|androgen antagonists|mesh-ancestor
24407804|NCT00175591|Anesthetics, Local|anesthetics, local|mesh-ancestor
24407805|NCT00175591|Anesthetics|anesthetics|mesh-ancestor
25125543|NCT03067974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25125544|NCT03067974|Anesthetics, General|anesthetics, general|mesh-ancestor
25125545|NCT03067974|Anesthetics|anesthetics|mesh-ancestor
25125546|NCT03067974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25125547|NCT03067974|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25125548|NCT03067974|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25125549|NCT03067974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24955563|NCT03863977|Glucocorticoids|glucocorticoids|mesh-ancestor
24407806|NCT00175591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24407807|NCT00175591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407808|NCT00175591|Sensory System Agents|sensory system agents|mesh-ancestor
24407809|NCT00175591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24407822|NCT00175630|Anesthetics, Local|anesthetics, local|mesh-ancestor
24407823|NCT00175630|Anesthetics|anesthetics|mesh-ancestor
24407824|NCT00175630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24407825|NCT00175630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407827|NCT00175630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24408081|NCT00176514|Antineoplastic Agents|antineoplastic agents|mesh-list
24408083|NCT00176527|Interferon-alpha|interferon-alpha|mesh-list
24408084|NCT00176527|Interferon alpha-2|interferon alpha-2|mesh-list
24408085|NCT00176527|Docetaxel|docetaxel|mesh-list
24408108|NCT00176540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408109|NCT00176553|Dextromethorphan|dextromethorphan|mesh-list
24408110|NCT00176553|Antitussive Agents|antitussive agents|mesh-ancestor
24408112|NCT00176553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24408113|NCT00176553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24408114|NCT00176553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24759004|NCT01748929|Antimitotic Agents|antimitotic agents|mesh-ancestor
24427568|NCT00238368|Hormones|hormones|mesh-ancestor
25709313|NCT02265224|Expectorants|expectorants|mesh-ancestor
25709314|NCT02265224|Respiratory System Agents|respiratory system agents|mesh-ancestor
25709315|NCT02265224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25709316|NCT02265224|Antioxidants|antioxidants|mesh-ancestor
25709317|NCT02265224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709318|NCT02265224|Protective Agents|protective agents|mesh-ancestor
25709319|NCT02265224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125550|NCT03067974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125551|NCT03067935|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
25125552|NCT03067935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25125553|NCT03067935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25125555|NCT03067883|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24408168|NCT00176774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408169|NCT00176774|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24408170|NCT00176774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24408171|NCT00176774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408172|NCT00176774|Antidotes|antidotes|mesh-ancestor
24408173|NCT00176774|Protective Agents|protective agents|mesh-ancestor
24408174|NCT00176774|Vitamin B Complex|vitamin b complex|mesh-ancestor
24408176|NCT00176774|Micronutrients|micronutrients|mesh-ancestor
24408515|NCT00178100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24408516|NCT00178100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24408517|NCT00178100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408518|NCT00178100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24408519|NCT00178100|Serotonin Agents|serotonin agents|mesh-ancestor
24408520|NCT00178100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408521|NCT00178100|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24408522|NCT00178100|Antidepressive Agents|antidepressive agents|mesh-ancestor
24408523|NCT00178100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24408631|NCT00178945|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24408632|NCT00178945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24408633|NCT00178945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408635|NCT00178945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24408636|NCT00178945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408637|NCT00178945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24408638|NCT00178945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24408640|NCT00178971|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24408662|NCT00179023|Sympathomimetics|sympathomimetics|mesh-ancestor
24408934|NCT00180089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24408978|NCT00180128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408979|NCT00180128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408980|NCT00180128|Antiviral Agents|antiviral agents|mesh-ancestor
24409296|NCT00181688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409297|NCT00181688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409298|NCT00181688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24409299|NCT00181688|Hormone Antagonists|hormone antagonists|mesh-ancestor
24409300|NCT00181688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24409301|NCT00181688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409431|NCT00181987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24409432|NCT00181987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24409433|NCT00181987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409439|NCT00182013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24409440|NCT00182013|Serotonin Agents|serotonin agents|mesh-ancestor
24409467|NCT00182039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24409468|NCT00182039|Adrenergic Agents|adrenergic agents|mesh-ancestor
24409469|NCT00182039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24409470|NCT00182039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409471|NCT00182052|Rosiglitazone|rosiglitazone|mesh-list
24409472|NCT00182052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25125557|NCT03067883|Protease Inhibitors|protease inhibitors|mesh-ancestor
25125558|NCT03067883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125559|NCT03067883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125560|NCT03067883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25125561|NCT03067883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25125567|NCT03067896|Dexmedetomidine|dexmedetomidine|mesh-list
25125568|NCT03067896|Bupivacaine|bupivacaine|mesh-list
25125569|NCT03067896|Anesthetics, Local|anesthetics, local|mesh-ancestor
25125570|NCT03067896|Anesthetics|anesthetics|mesh-ancestor
25125571|NCT03067896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25125572|NCT03067896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125573|NCT03067896|Sensory System Agents|sensory system agents|mesh-ancestor
24409727|NCT00182806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24409728|NCT00182806|Antimetabolites|antimetabolites|mesh-ancestor
24641154|NCT01172223|Paclitaxel|paclitaxel|mesh-list
24409730|NCT00182806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409731|NCT00182806|Antiviral Agents|antiviral agents|mesh-ancestor
24409732|NCT00182806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24409733|NCT00182806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409734|NCT00182806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24409735|NCT00182806|Immunologic Factors|immunologic factors|mesh-ancestor
24409736|NCT00182806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409737|NCT00182806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24409772|NCT00183001|Hemostatics|hemostatics|mesh-ancestor
24409773|NCT00183001|Coagulants|coagulants|mesh-ancestor
24409774|NCT00183040|Hormones|hormones|mesh-list
24409997|NCT00184015|Bortezomib|bortezomib|mesh-list
24410000|NCT00184015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24410001|NCT00184015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24410002|NCT00184015|Growth Substances|growth substances|mesh-ancestor
24410003|NCT00184015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410004|NCT00184015|Growth Inhibitors|growth inhibitors|mesh-ancestor
24410006|NCT00184041|Prednisone|prednisone|mesh-list
24410007|NCT00184041|Methotrexate|methotrexate|mesh-list
24410008|NCT00184041|Cyclophosphamide|cyclophosphamide|mesh-list
24410951|NCT00187122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24410952|NCT00187122|Antimetabolites|antimetabolites|mesh-ancestor
24410953|NCT00187122|Dermatologic Agents|dermatologic agents|mesh-ancestor
24410954|NCT00187122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24410955|NCT00187122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25125576|NCT03067896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25125578|NCT03067896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25125579|NCT03067896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25125580|NCT03067896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25125581|NCT03067896|Adrenergic Agents|adrenergic agents|mesh-ancestor
25125582|NCT03067896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25125583|NCT03067896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802130|NCT01987739|Zolpidem|zolpidem|mesh-list
25125584|NCT03067896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25125585|NCT03067896|Anticonvulsants|anticonvulsants|mesh-ancestor
25125586|NCT03067896|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25125587|NCT03067896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24955611|NCT03863626|Furosemide|furosemide|mesh-list
24410956|NCT00187122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24410957|NCT00187122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24410958|NCT00187122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24410959|NCT00187122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24410960|NCT00187122|Antiviral Agents|antiviral agents|mesh-ancestor
24410961|NCT00187122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24410962|NCT00187122|Tubulin Modulators|tubulin modulators|mesh-ancestor
24410963|NCT00187122|Antimitotic Agents|antimitotic agents|mesh-ancestor
24410964|NCT00187122|Mitosis Modulators|mitosis modulators|mesh-ancestor
24410965|NCT00187122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24410966|NCT00187161|Cytarabine|cytarabine|mesh-list
24410967|NCT00187161|Cyclophosphamide|cyclophosphamide|mesh-list
24410968|NCT00187161|Doxorubicin|doxorubicin|mesh-list
24410969|NCT00187161|Methotrexate|methotrexate|mesh-list
24459940|NCT00346879|Antithrombins|antithrombins|mesh-ancestor
24459941|NCT00346879|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24459942|NCT00346879|Protease Inhibitors|protease inhibitors|mesh-ancestor
24459943|NCT00346879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24410970|NCT00187161|Etoposide|etoposide|mesh-list
24411287|NCT00188630|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24411288|NCT00188630|Antiviral Agents|antiviral agents|mesh-ancestor
24411314|NCT00188643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24411315|NCT00188643|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24411318|NCT00188669|Tocotrienols|tocotrienols|mesh-list
24411319|NCT00188669|alpha-Tocopherol|alpha-tocopherol|mesh-list
24411320|NCT00188669|Pentoxifylline|pentoxifylline|mesh-list
24411321|NCT00188669|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24411322|NCT00188669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411323|NCT00188669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411326|NCT00188669|Protective Agents|protective agents|mesh-ancestor
24411327|NCT00188669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411328|NCT00188669|Vasodilator Agents|vasodilator agents|mesh-ancestor
24411329|NCT00188669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25693854|NCT02020941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24420598|NCT00216411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24641827|NCT01175577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641828|NCT01175577|Protective Agents|protective agents|mesh-ancestor
24641829|NCT01175577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641830|NCT01175733|Panitumumab|panitumumab|mesh-list
24641831|NCT01175733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24411330|NCT00188669|Antioxidants|antioxidants|mesh-ancestor
24411331|NCT00188669|Vitamins|vitamins|mesh-ancestor
24411332|NCT00188669|Micronutrients|micronutrients|mesh-ancestor
24412246|NCT00191022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412247|NCT00191035|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24459959|NCT00346957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24459960|NCT00346957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24459961|NCT00346957|Growth Substances|growth substances|mesh-ancestor
24459962|NCT00346957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125588|NCT03067896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24922814|NCT04176978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24922815|NCT04176978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24922816|NCT04176978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125590|NCT03067896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25125591|NCT03067740|Dexmedetomidine|dexmedetomidine|mesh-list
25125592|NCT03067740|Bupivacaine|bupivacaine|mesh-list
25125593|NCT03067740|Anesthetics, Local|anesthetics, local|mesh-ancestor
25125594|NCT03067740|Anesthetics|anesthetics|mesh-ancestor
25125595|NCT03067740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25125596|NCT03067740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125597|NCT03067740|Sensory System Agents|sensory system agents|mesh-ancestor
25125598|NCT03067740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125599|NCT03067740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25125600|NCT03067740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25125601|NCT03067740|Analgesics|analgesics|mesh-ancestor
25125602|NCT03067740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25125603|NCT03067740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25125604|NCT03067740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25125605|NCT03067740|Adrenergic Agents|adrenergic agents|mesh-ancestor
25125606|NCT03067740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25125607|NCT03067740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125608|NCT03067701|Carbon Monoxide|carbon monoxide|mesh-list
25125609|NCT03067701|Antimetabolites|antimetabolites|mesh-ancestor
25125610|NCT03067701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125611|NCT03067701|Gasotransmitters|gasotransmitters|mesh-ancestor
25125612|NCT03067701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25125613|NCT03067701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125614|NCT03067753|Methylprednisolone|methylprednisolone|mesh-list
25125615|NCT03067753|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25125616|NCT03067753|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25125617|NCT03067753|Prednisolone|prednisolone|mesh-list
25125618|NCT03067753|Prednisolone acetate|prednisolone acetate|mesh-list
25125620|NCT03067753|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25125621|NCT03067753|Prednisolone phosphate|prednisolone phosphate|mesh-list
25125622|NCT03067753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25125623|NCT03067753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125627|NCT03067753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25125628|NCT03067753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25125629|NCT03067753|Glucocorticoids|glucocorticoids|mesh-ancestor
24412363|NCT00191256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412364|NCT00191256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24428370|NCT00240305|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24428371|NCT00240305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412365|NCT00191256|Immunologic Factors|immunologic factors|mesh-ancestor
24412366|NCT00191256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412367|NCT00191295|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24412368|NCT00191295|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24412369|NCT00191295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412406|NCT00191399|Olanzapine|olanzapine|mesh-list
25693855|NCT02020941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693856|NCT02020941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25693857|NCT02020941|Glucocorticoids|glucocorticoids|mesh-ancestor
25693858|NCT02020941|Hormones|hormones|mesh-ancestor
25693859|NCT02020941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25693860|NCT02020941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25693861|NCT02020941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693862|NCT02021292|Macitentan|macitentan|mesh-list
24642939|NCT01182246|Genistein|genistein|mesh-list
24412561|NCT00191594|Antidepressive Agents|antidepressive agents|mesh-ancestor
24459964|NCT00346957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459965|NCT00346957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24412586|NCT00191620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24412587|NCT00191620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412588|NCT00191620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24412835|NCT00192569|Ribavirin|ribavirin|mesh-list
24412836|NCT00192569|Interferon-alpha|interferon-alpha|mesh-list
24412872|NCT00192608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24412873|NCT00192608|Antiviral Agents|antiviral agents|mesh-ancestor
24412888|NCT00192621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24412889|NCT00192621|Antimetabolites|antimetabolites|mesh-ancestor
24412890|NCT00192621|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24412891|NCT00192621|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24412961|NCT00192712|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24412993|NCT00192842|Antiviral Agents|antiviral agents|mesh-ancestor
24412994|NCT00192842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24412995|NCT00192842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412996|NCT00192842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24412997|NCT00192842|Immunologic Factors|immunologic factors|mesh-ancestor
24412998|NCT00192842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412999|NCT00192842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25125639|NCT03067792|Tubulin Modulators|tubulin modulators|mesh-ancestor
25125640|NCT03067792|Antimitotic Agents|antimitotic agents|mesh-ancestor
25125641|NCT03067792|Mitosis Modulators|mitosis modulators|mesh-ancestor
24533922|NCT00645437|Renal Agents|renal agents|mesh-ancestor
25125642|NCT03067792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25125643|NCT03067792|Antimetabolites|antimetabolites|mesh-ancestor
25125644|NCT03067792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25125645|NCT03067792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25125646|NCT03067792|Immunologic Factors|immunologic factors|mesh-ancestor
25125647|NCT03067792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25125648|NCT03067792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25125649|NCT03067792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25125650|NCT03067792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25125651|NCT03067792|Antidotes|antidotes|mesh-ancestor
25125652|NCT03067792|Protective Agents|protective agents|mesh-ancestor
25125653|NCT03067792|Vitamin B Complex|vitamin b complex|mesh-ancestor
25125654|NCT03067792|Vitamins|vitamins|mesh-ancestor
25125655|NCT03067792|Micronutrients|micronutrients|mesh-ancestor
25125656|NCT03067597|Dinoprostone|dinoprostone|mesh-list
25125657|NCT03067597|Oxytocics|oxytocics|mesh-ancestor
24413313|NCT00193531|Carboplatin|carboplatin|mesh-list
24413314|NCT00193531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24413315|NCT00193531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413316|NCT00193531|Tubulin Modulators|tubulin modulators|mesh-ancestor
24413317|NCT00193531|Antimitotic Agents|antimitotic agents|mesh-ancestor
24413323|NCT00193544|Thalidomide|thalidomide|mesh-list
24414375|NCT00197340|Anesthetics, Local|anesthetics, local|mesh-ancestor
24414376|NCT00197340|Anesthetics|anesthetics|mesh-ancestor
24414377|NCT00197340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24414799|NCT00198679|Chlorhexidine|chlorhexidine|mesh-list
24414800|NCT00198679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24414801|NCT00198679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24414802|NCT00198679|Disinfectants|disinfectants|mesh-ancestor
24414803|NCT00198718|Vitamin A|vitamin a|mesh-list
24414804|NCT00198718|Retinol palmitate|retinol palmitate|mesh-list
24697846|NCT01437618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24697847|NCT01437618|Growth Substances|growth substances|mesh-ancestor
25693863|NCT02021292|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25693864|NCT02021292|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25693865|NCT02021292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693866|NCT02021292|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25693867|NCT02021318|Darbepoetin alfa|darbepoetin alfa|mesh-list
25693868|NCT02021318|Hematinics|hematinics|mesh-ancestor
25693869|NCT02021331|Cimetidine|cimetidine|mesh-list
25693870|NCT02021331|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25693871|NCT02021331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25693872|NCT02021331|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25693873|NCT02021331|Histamine Antagonists|histamine antagonists|mesh-ancestor
25074299|NCT03389256|Apatinib|apatinib|mesh-list
24697848|NCT01437618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697849|NCT01437618|Growth Inhibitors|growth inhibitors|mesh-ancestor
24697880|NCT01437709|Immunologic Factors|immunologic factors|mesh-ancestor
24697881|NCT01437709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697883|NCT01437748|Tiotropium Bromide|tiotropium bromide|mesh-list
24697884|NCT01437748|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24697885|NCT01437748|Autonomic Agents|autonomic agents|mesh-ancestor
24697886|NCT01437748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24697997|NCT01438359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697998|NCT01438359|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24697999|NCT01438359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24698000|NCT01438359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698001|NCT01438372|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24698002|NCT01438372|Hematinics|hematinics|mesh-ancestor
25010653|NCT03428958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24698003|NCT01438515|Chlorhexidine|chlorhexidine|mesh-list
24698101|NCT01438749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24698102|NCT01438749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698104|NCT01438866|Sodium Fluoride|sodium fluoride|mesh-list
24698108|NCT01438866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698109|NCT01438944|Nicotine|nicotine|mesh-list
24698110|NCT01438944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24698111|NCT01438944|Autonomic Agents|autonomic agents|mesh-ancestor
24698112|NCT01438944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24698113|NCT01438944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698119|NCT01439100|Oxycodone|oxycodone|mesh-list
24698204|NCT01439750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24698205|NCT01439750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698206|NCT01439750|Immunologic Factors|immunologic factors|mesh-ancestor
24698207|NCT01439750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698208|NCT01439750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24698209|NCT01439750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24698210|NCT01439802|Copper|copper|mesh-list
24698211|NCT01439802|Trace Elements|trace elements|mesh-ancestor
24698212|NCT01439802|Micronutrients|micronutrients|mesh-ancestor
24698215|NCT01439984|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24698216|NCT01439984|Antidepressive Agents|antidepressive agents|mesh-ancestor
24698217|NCT01439984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24698218|NCT01439984|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24698219|NCT01439984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24698220|NCT01439984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24698226|NCT01439997|Hemostatics|hemostatics|mesh-ancestor
24698238|NCT01440062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24698239|NCT01440088|Doxorubicin|doxorubicin|mesh-list
24698240|NCT01440088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24698241|NCT01440088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24698242|NCT01440088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698243|NCT01440088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24698244|NCT01440088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24698245|NCT01440088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698246|NCT01440088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698247|NCT01440114|Fentanyl|fentanyl|mesh-list
24698248|NCT01440114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24698249|NCT01440114|Narcotics|narcotics|mesh-ancestor
24612821|NCT01015482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24612822|NCT01015482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24612823|NCT01015482|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24612824|NCT01015482|Anesthetics, General|anesthetics, general|mesh-ancestor
24612825|NCT01015482|Anesthetics|anesthetics|mesh-ancestor
24612826|NCT01015482|GABA Modulators|gaba modulators|mesh-ancestor
24612827|NCT01015482|GABA Agents|gaba agents|mesh-ancestor
24892572|NCT04461665|Vitamin D|vitamin d|mesh-list
24612828|NCT01015482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24612829|NCT01015482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612830|NCT01015482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24698349|NCT01440673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24698350|NCT01440673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698351|NCT01440673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25010686|NCT03393611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25010687|NCT03393611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25010689|NCT03382301|Cyclosporins|cyclosporins|mesh-list
25693874|NCT02021331|Histamine Agents|histamine agents|mesh-ancestor
25010690|NCT03382301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25010691|NCT03382301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967463|NCT03759782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25010692|NCT03382301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25010694|NCT03382301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010695|NCT03382301|Antifungal Agents|antifungal agents|mesh-ancestor
25010696|NCT03382301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25010697|NCT03382301|Dermatologic Agents|dermatologic agents|mesh-ancestor
25010698|NCT03382301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25010699|NCT03382301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25010700|NCT03296553|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25010702|NCT03296553|Antiviral Agents|antiviral agents|mesh-ancestor
25010703|NCT03296553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24429098|NCT00242697|Anesthetics|anesthetics|mesh-list
25010705|NCT03291028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010706|NCT03291028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010707|NCT03205423|Gabapentin|gabapentin|mesh-list
25010708|NCT03205423|Analgesics|analgesics|mesh-ancestor
25010709|NCT03205423|Sensory System Agents|sensory system agents|mesh-ancestor
24698352|NCT01440673|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24698355|NCT01440725|Mitogens|mitogens|mesh-list
24698399|NCT01440985|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24698400|NCT01440985|Autonomic Agents|autonomic agents|mesh-ancestor
24698401|NCT01440985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24698402|NCT01440985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698403|NCT01440985|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24698404|NCT01440985|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24698419|NCT01440998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698421|NCT01441128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698422|NCT01441128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24698423|NCT01441128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698424|NCT01441128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698425|NCT01441193|Vaccines|vaccines|mesh-list
24698426|NCT01441193|Immunologic Factors|immunologic factors|mesh-ancestor
24698427|NCT01441193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698429|NCT01441206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24698430|NCT01441206|Antitubercular Agents|antitubercular agents|mesh-ancestor
24698431|NCT01441206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24698432|NCT01441206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24698433|NCT01441206|Leprostatic Agents|leprostatic agents|mesh-ancestor
24698434|NCT01441206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24698435|NCT01441206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698455|NCT01441284|Pramipexole|pramipexole|mesh-list
24698456|NCT01441284|Antioxidants|antioxidants|mesh-ancestor
24698457|NCT01441284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698458|NCT01441284|Protective Agents|protective agents|mesh-ancestor
25010714|NCT03205423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25010715|NCT03205423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25010716|NCT03205423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25010717|NCT03205423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25010718|NCT03205423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24698459|NCT01441284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698460|NCT01441284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24698538|NCT01441804|Interferon-alpha|interferon-alpha|mesh-list
24698539|NCT01441804|Antimetabolites|antimetabolites|mesh-ancestor
24698558|NCT01441908|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24698559|NCT01441908|Antimetabolites|antimetabolites|mesh-ancestor
24698560|NCT01441908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698561|NCT01441908|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24429275|NCT00243178|Clopidogrel|clopidogrel|mesh-list
24698562|NCT01441908|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24698563|NCT01441908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698565|NCT01441934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698566|NCT01441934|Vasodilator Agents|vasodilator agents|mesh-ancestor
24698567|NCT01441934|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24698568|NCT01441934|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24698569|NCT01441934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698570|NCT01441934|Urological Agents|urological agents|mesh-ancestor
24698572|NCT01441947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24698573|NCT01441947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698574|NCT01441947|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24698575|NCT01441947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24954209|NCT03878264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24954214|NCT03878082|Acetaminophen|acetaminophen|mesh-list
24954215|NCT03878082|Propacetamol|propacetamol|mesh-list
24954216|NCT03878082|Analgesics|analgesics|mesh-ancestor
24954217|NCT03878082|Sensory System Agents|sensory system agents|mesh-ancestor
24954218|NCT03878082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24698576|NCT01441947|Hormone Antagonists|hormone antagonists|mesh-ancestor
24698577|NCT01441947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24399258|NCT00147264|Telmisartan|telmisartan|mesh-list
24698610|NCT01442272|Micronutrients|micronutrients|mesh-ancestor
24698611|NCT01442272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698612|NCT01442272|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24698636|NCT01442428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24698637|NCT01442428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24698638|NCT01442428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698639|NCT01442428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24698640|NCT01442428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24698643|NCT01442428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24698658|NCT01442519|Alkylating Agents|alkylating agents|mesh-ancestor
24698659|NCT01442519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698660|NCT01442519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24698661|NCT01442519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698662|NCT01442519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24698664|NCT01442519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698666|NCT01442532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24612846|NCT01015547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24612847|NCT01015547|Abortifacient Agents|abortifacient agents|mesh-ancestor
25010720|NCT03205423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010721|NCT03205423|Antimanic Agents|antimanic agents|mesh-ancestor
25010743|NCT03098485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25010744|NCT03098485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25010745|NCT03098485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25010746|NCT03098485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010747|NCT03098485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010748|NCT03098485|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25010749|NCT03098485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25010750|NCT03086486|Linezolid|linezolid|mesh-list
25010751|NCT03086486|Bedaquiline|bedaquiline|mesh-list
24429552|NCT00244348|Fluorouracil|fluorouracil|mesh-list
25010752|NCT03086486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25010753|NCT03086486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25010754|NCT03086486|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25010755|NCT03086486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698712|NCT01442701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24698713|NCT01442701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24698714|NCT01442701|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24698715|NCT01442701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24698716|NCT01442701|Antimetabolites|antimetabolites|mesh-ancestor
24698717|NCT01442701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698718|NCT01442701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24698719|NCT01442727|Selenium|selenium|mesh-list
24698720|NCT01442727|Selenious Acid|selenious acid|mesh-list
24698737|NCT01442818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24698738|NCT01442818|Narcotics|narcotics|mesh-ancestor
24698739|NCT01442818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24399438|NCT00147771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698751|NCT01442909|Antimitotic Agents|antimitotic agents|mesh-ancestor
24698752|NCT01442909|Mitosis Modulators|mitosis modulators|mesh-ancestor
24698753|NCT01442909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698754|NCT01442909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698755|NCT01442909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24698756|NCT01442909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24698757|NCT01442935|Leucovorin|leucovorin|mesh-list
24698758|NCT01442935|Folic Acid|folic acid|mesh-list
24698759|NCT01442935|Bevacizumab|bevacizumab|mesh-list
24698760|NCT01442935|Cetuximab|cetuximab|mesh-list
24698761|NCT01442935|Oxaliplatin|oxaliplatin|mesh-list
24698762|NCT01442935|Irinotecan|irinotecan|mesh-list
24698763|NCT01442935|Fluorouracil|fluorouracil|mesh-list
25693875|NCT02021331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25693876|NCT02021331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693877|NCT02021331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693878|NCT02021331|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25693879|NCT02021331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25074536|NCT03387631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24698764|NCT01442935|Levoleucovorin|levoleucovorin|mesh-list
24698765|NCT01442935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24698766|NCT01442935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698767|NCT01442935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24698768|NCT01442935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24698769|NCT01442935|Growth Substances|growth substances|mesh-ancestor
24698770|NCT01442935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698771|NCT01442935|Growth Inhibitors|growth inhibitors|mesh-ancestor
24698772|NCT01442935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24698773|NCT01442935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24698774|NCT01442935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698777|NCT01442935|Protective Agents|protective agents|mesh-ancestor
24698778|NCT01442935|Vitamin B Complex|vitamin b complex|mesh-ancestor
24698780|NCT01442935|Micronutrients|micronutrients|mesh-ancestor
24698781|NCT01442935|Hematinics|hematinics|mesh-ancestor
24698833|NCT01443065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25010757|NCT03086486|Antitubercular Agents|antitubercular agents|mesh-ancestor
25010759|NCT03077243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010760|NCT03049449|Cyclophosphamide|cyclophosphamide|mesh-list
25010761|NCT03049449|Fludarabine|fludarabine|mesh-list
24429664|NCT00244608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24429665|NCT00244608|Adrenergic Agents|adrenergic agents|mesh-ancestor
25010763|NCT03049449|Immunologic Factors|immunologic factors|mesh-ancestor
24698834|NCT01443065|Immunologic Factors|immunologic factors|mesh-ancestor
24698836|NCT01443104|Everolimus|everolimus|mesh-list
24698837|NCT01443104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698838|NCT01443104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24698912|NCT01443520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24698913|NCT01443520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24698914|NCT01443520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698915|NCT01443520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24698916|NCT01443520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698917|NCT01443520|Analgesics|analgesics|mesh-ancestor
24698918|NCT01443520|Sensory System Agents|sensory system agents|mesh-ancestor
24698919|NCT01443520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24698920|NCT01443520|Antidepressive Agents|antidepressive agents|mesh-ancestor
24698921|NCT01443520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24698922|NCT01443520|Dopamine Agents|dopamine agents|mesh-ancestor
24698923|NCT01443520|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24698924|NCT01443572|Anesthetics|anesthetics|mesh-list
24698925|NCT01443572|Sevoflurane|sevoflurane|mesh-list
24698942|NCT01443741|Insulin|insulin|mesh-list
24612905|NCT01015729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612907|NCT01015729|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24612908|NCT01015729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24612909|NCT01015729|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24612910|NCT01015794|Ephedrine|ephedrine|mesh-list
24612911|NCT01015794|Pseudoephedrine|pseudoephedrine|mesh-list
24612912|NCT01015794|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24612913|NCT01015794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484605|NCT00449423|Acipimox|acipimox|mesh-list
24698992|NCT01444131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698993|NCT01444131|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24699044|NCT01444586|Protease Inhibitors|protease inhibitors|mesh-ancestor
24699045|NCT01444586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699046|NCT01444586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699047|NCT01444586|Anticoagulants|anticoagulants|mesh-ancestor
24699048|NCT01444612|Heparin|heparin|mesh-list
24699049|NCT01444612|Calcium heparin|calcium heparin|mesh-list
24699050|NCT01444612|Enoxaparin|enoxaparin|mesh-list
24699051|NCT01444612|Dalteparin|dalteparin|mesh-list
24699052|NCT01444612|Tinzaparin|tinzaparin|mesh-list
24699053|NCT01444612|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24699055|NCT01444612|Fondaparinux|fondaparinux|mesh-list
24699056|NCT01444612|Anticoagulants|anticoagulants|mesh-ancestor
24699057|NCT01444612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24699058|NCT01444612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24699130|NCT01445106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24699131|NCT01445106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24699132|NCT01445106|Antiviral Agents|antiviral agents|mesh-ancestor
24699133|NCT01445106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24699134|NCT01445119|Carboplatin|carboplatin|mesh-list
24699135|NCT01445119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24699136|NCT01445210|Ropivacaine|ropivacaine|mesh-list
24699137|NCT01445210|Anesthetics, Local|anesthetics, local|mesh-ancestor
25693880|NCT02021331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693881|NCT02021461|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25074671|NCT03386838|Carboplatin|carboplatin|mesh-list
25074672|NCT03386838|Fluorouracil|fluorouracil|mesh-list
24699208|NCT01445418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24699209|NCT01445431|Mineral Oil|mineral oil|mesh-list
24699210|NCT01445431|Emollients|emollients|mesh-ancestor
24699211|NCT01445431|Dermatologic Agents|dermatologic agents|mesh-ancestor
25010764|NCT03049449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010766|NCT03049449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25010767|NCT03049449|Alkylating Agents|alkylating agents|mesh-ancestor
24967557|NCT03758677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24967558|NCT03758677|Antimetabolites|antimetabolites|mesh-ancestor
24967559|NCT03758677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967560|NCT03758677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967561|NCT03758677|Antiviral Agents|antiviral agents|mesh-ancestor
24967562|NCT03758677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24967563|NCT03758677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24967564|NCT03758677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24699212|NCT01445522|Cyclophosphamide|cyclophosphamide|mesh-list
24699214|NCT01445522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24699216|NCT01445522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699217|NCT01445522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24699218|NCT01445522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24699219|NCT01445522|Alkylating Agents|alkylating agents|mesh-ancestor
24699221|NCT01445522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24699249|NCT01445639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24699250|NCT01445639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699251|NCT01445691|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24699252|NCT01445691|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24699253|NCT01445691|Dermatologic Agents|dermatologic agents|mesh-ancestor
24699254|NCT01445743|Vaccines|vaccines|mesh-list
24699255|NCT01445743|Immunologic Factors|immunologic factors|mesh-ancestor
24699256|NCT01445743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699257|NCT01445756|Lidocaine|lidocaine|mesh-list
24699258|NCT01445756|Anesthetics, Local|anesthetics, local|mesh-ancestor
24699275|NCT01445860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24699276|NCT01445860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699277|NCT01445938|Lumefantrine|lumefantrine|mesh-list
24699278|NCT01445938|Antimalarials|antimalarials|mesh-ancestor
24699279|NCT01445938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24699280|NCT01445938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24699281|NCT01445938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24699334|NCT01446211|Dermatologic Agents|dermatologic agents|mesh-ancestor
24699335|NCT01446211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699336|NCT01446211|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24429799|NCT00245115|Busulfan|busulfan|mesh-list
24699337|NCT01446211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24699338|NCT01446211|Hormones|hormones|mesh-ancestor
24699339|NCT01446211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24699340|NCT01446211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24699344|NCT01446276|Resveratrol|resveratrol|mesh-list
24699410|NCT01446484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24699413|NCT01446497|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24699465|NCT01446952|Antioxidants|antioxidants|mesh-ancestor
24699466|NCT01446952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699467|NCT01446952|Protective Agents|protective agents|mesh-ancestor
24699468|NCT01446978|Vaccines|vaccines|mesh-list
24699469|NCT01446978|Immunologic Factors|immunologic factors|mesh-ancestor
24699470|NCT01446978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699471|NCT01447043|Ranibizumab|ranibizumab|mesh-list
24699472|NCT01447043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24699473|NCT01447043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24699474|NCT01447043|Growth Substances|growth substances|mesh-ancestor
24699475|NCT01447043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699476|NCT01447043|Growth Inhibitors|growth inhibitors|mesh-ancestor
24699477|NCT01447043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24699563|NCT01447589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24585920|NCT00888108|Navitoclax|navitoclax|mesh-list
24585921|NCT00888108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585922|NCT00888108|Tubulin Modulators|tubulin modulators|mesh-ancestor
24585923|NCT00888108|Antimitotic Agents|antimitotic agents|mesh-ancestor
24585924|NCT00888108|Mitosis Modulators|mitosis modulators|mesh-ancestor
24585956|NCT00888394|Cholinergic Agents|cholinergic agents|mesh-ancestor
24585977|NCT00888758|Immunologic Factors|immunologic factors|mesh-ancestor
24585978|NCT00888758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693882|NCT02021461|Anticonvulsants|anticonvulsants|mesh-ancestor
25693883|NCT02021461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24699564|NCT01447589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24699565|NCT01447589|Antiviral Agents|antiviral agents|mesh-ancestor
24699566|NCT01447589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24699568|NCT01447654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24699569|NCT01447654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24699570|NCT01447654|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24699571|NCT01447654|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24699572|NCT01447654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699573|NCT01447797|Irbesartan|irbesartan|mesh-list
24699574|NCT01447797|Atorvastatin|atorvastatin|mesh-list
24699599|NCT01448018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24699601|NCT01448018|Growth Substances|growth substances|mesh-ancestor
24699664|NCT01448330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24699665|NCT01448330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699666|NCT01448330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24699667|NCT01448330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24699775|NCT01448837|Luteolytic Agents|luteolytic agents|mesh-ancestor
24699776|NCT01448837|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24699777|NCT01448837|Contraceptive Agents|contraceptive agents|mesh-ancestor
24699778|NCT01448837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24699779|NCT01448837|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24699781|NCT01448993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24699782|NCT01448993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24699783|NCT01449045|Lumefantrine|lumefantrine|mesh-list
24699784|NCT01449045|Artemether|artemether|mesh-list
24699785|NCT01449045|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24699786|NCT01449045|Antimalarials|antimalarials|mesh-ancestor
24699787|NCT01449045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24699788|NCT01449045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24699789|NCT01449045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24699790|NCT01449110|Resveratrol|resveratrol|mesh-list
24699791|NCT01449110|Antioxidants|antioxidants|mesh-ancestor
24699792|NCT01449110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699793|NCT01449110|Protective Agents|protective agents|mesh-ancestor
24699794|NCT01449110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700027|NCT01450176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24700028|NCT01450176|Analgesics|analgesics|mesh-ancestor
24700029|NCT01450176|Sensory System Agents|sensory system agents|mesh-ancestor
24700030|NCT01450176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24700031|NCT01450176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700032|NCT01450176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24700033|NCT01450176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24613076|NCT01016886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24613077|NCT01016886|Sympatholytics|sympatholytics|mesh-ancestor
24613078|NCT01016886|Autonomic Agents|autonomic agents|mesh-ancestor
24613079|NCT01016886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24613080|NCT01016886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613081|NCT01016886|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24430038|NCT00245934|Analgesics|analgesics|mesh-ancestor
24585987|NCT00888784|Adrenergic Agents|adrenergic agents|mesh-ancestor
24585988|NCT00888784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24585989|NCT00888784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613082|NCT01016886|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24613083|NCT01016886|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24613084|NCT01016886|Adrenergic Agents|adrenergic agents|mesh-ancestor
24613085|NCT01016886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24613086|NCT01016886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613087|NCT01016886|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24700082|NCT01450410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700165|NCT01451060|Autonomic Agents|autonomic agents|mesh-ancestor
24700166|NCT01451060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24700167|NCT01451060|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24700260|NCT01451593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700261|NCT01451593|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24700262|NCT01451593|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24700263|NCT01451658|Propranolol|propranolol|mesh-list
24700264|NCT01451658|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24700265|NCT01451658|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24700266|NCT01451658|Adrenergic Agents|adrenergic agents|mesh-ancestor
24700267|NCT01451658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24700268|NCT01451658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700269|NCT01451658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700270|NCT01451658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24700271|NCT01451658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24700280|NCT01451710|Prednisolone phosphate|prednisolone phosphate|mesh-list
24700281|NCT01451710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24700282|NCT01451710|Glucocorticoids|glucocorticoids|mesh-ancestor
24700284|NCT01451710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24700285|NCT01451710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700338|NCT01451879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700340|NCT01451879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24700341|NCT01451879|Antiviral Agents|antiviral agents|mesh-ancestor
24430172|NCT00246272|Dopamine Agents|dopamine agents|mesh-ancestor
24700342|NCT01451879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24700343|NCT01451879|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24700344|NCT01451879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24700345|NCT01451905|Liraglutide|liraglutide|mesh-list
24700346|NCT01451905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24700347|NCT01451905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700348|NCT01451905|Incretins|incretins|mesh-ancestor
24700349|NCT01451905|Hormones|hormones|mesh-ancestor
24700350|NCT01451905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25010776|NCT03000569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010777|NCT03000569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010779|NCT02964507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25010780|NCT02964507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010781|NCT02964507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25010782|NCT02964507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25010783|NCT02964507|Hormone Antagonists|hormone antagonists|mesh-ancestor
25010784|NCT02964507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25010785|NCT02964507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010787|NCT02955394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25010788|NCT02955394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010789|NCT02955394|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25010790|NCT02955394|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25010791|NCT02955394|Hormone Antagonists|hormone antagonists|mesh-ancestor
25010792|NCT02955394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25010793|NCT02955394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010794|NCT02942277|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25010795|NCT02942277|Antimalarials|antimalarials|mesh-ancestor
25010796|NCT02942277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25010797|NCT02942277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25010798|NCT02942277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24700393|NCT01452256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24486014|NCT00455845|Levonorgestrel|levonorgestrel|mesh-list
24700394|NCT01452256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24700395|NCT01452256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700396|NCT01452256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24700397|NCT01452256|Anesthetics, General|anesthetics, general|mesh-ancestor
24700398|NCT01452256|Anesthetics|anesthetics|mesh-ancestor
24700399|NCT01452256|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24700400|NCT01452334|BMS-936559|bms-936559|mesh-list
24700401|NCT01452334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24700402|NCT01452334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24700403|NCT01452373|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24700404|NCT01452373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24700405|NCT01452373|Immunologic Factors|immunologic factors|mesh-ancestor
24700406|NCT01452373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700407|NCT01452477|Tanshinone|tanshinone|mesh-list
24700408|NCT01452477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24700409|NCT01452477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24700410|NCT01452477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25010800|NCT02942017|Neurosteroids|neurosteroids|mesh-ancestor
25010801|NCT02942017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25010802|NCT02942017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010803|NCT02942017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010804|NCT02942017|GABA Modulators|gaba modulators|mesh-ancestor
25010805|NCT02942017|GABA Agents|gaba agents|mesh-ancestor
25010806|NCT02942004|Pregnanolone|pregnanolone|mesh-list
25010807|NCT02942004|Brexanolone|brexanolone|mesh-list
25010808|NCT02942004|Neurosteroids|neurosteroids|mesh-ancestor
25010809|NCT02942004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25010810|NCT02942004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010811|NCT02942004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010812|NCT02942004|GABA Modulators|gaba modulators|mesh-ancestor
25010813|NCT02942004|GABA Agents|gaba agents|mesh-ancestor
25010814|NCT02942004|Anesthetics|anesthetics|mesh-ancestor
25010815|NCT02942004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25010817|NCT02939573|Colchicine|colchicine|mesh-list
24700436|NCT01452568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24700437|NCT01452568|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24700438|NCT01452568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24700439|NCT01452568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700440|NCT01452568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24700441|NCT01452568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24430237|NCT00246610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825037|NCT02127034|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24700456|NCT01452607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24700457|NCT01452607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24700502|NCT01452711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613088|NCT01016886|Protease Inhibitors|protease inhibitors|mesh-ancestor
24613089|NCT01016886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613093|NCT01016990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613094|NCT01016990|GABA Agents|gaba agents|mesh-ancestor
24613095|NCT01016990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24613096|NCT01016990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613097|NCT01016990|Antimanic Agents|antimanic agents|mesh-ancestor
24613098|NCT01016990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24613099|NCT01016990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24613100|NCT01016990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24613101|NCT01017094|Silver Sulfadiazine|silver sulfadiazine|mesh-list
24613102|NCT01017094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24613103|NCT01017094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24613104|NCT01017107|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
24700516|NCT01452750|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24700517|NCT01452750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24700518|NCT01452750|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24700519|NCT01452750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25010824|NCT02939573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010825|NCT02939573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010827|NCT02939573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25010828|NCT02939573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25010829|NCT02939573|Immunologic Factors|immunologic factors|mesh-ancestor
25010830|NCT02939573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010848|NCT02929589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25010849|NCT02929589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25010850|NCT02929589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25010851|NCT02929589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010852|NCT02929589|Narcotics|narcotics|mesh-ancestor
25010853|NCT02929589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25010854|NCT02910635|Moxifloxacin|moxifloxacin|mesh-list
25010855|NCT02910635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25010856|NCT02910635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24700520|NCT01452750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700521|NCT01452763|Lansoprazole|lansoprazole|mesh-list
24700522|NCT01452763|Dexlansoprazole|dexlansoprazole|mesh-list
24700523|NCT01452763|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24700524|NCT01452763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24700525|NCT01452763|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24700526|NCT01452763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700527|NCT01452763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700606|NCT01453530|Autonomic Agents|autonomic agents|mesh-ancestor
24700607|NCT01453530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24700608|NCT01453530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24700609|NCT01453530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24700610|NCT01453530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24700612|NCT01453582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24700613|NCT01453660|Cisplatin|cisplatin|mesh-list
24700614|NCT01453660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24700615|NCT01453686|Hydrocortisone|hydrocortisone|mesh-list
24700616|NCT01453686|Clobetasol|clobetasol|mesh-list
24700617|NCT01453686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24700618|NCT01453686|Glucocorticoids|glucocorticoids|mesh-ancestor
24700619|NCT01453686|Hormones|hormones|mesh-ancestor
24700620|NCT01453686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24700621|NCT01453686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700622|NCT01453738|Plasma-lyte 148|plasma-lyte 148|mesh-list
25010867|NCT02861014|Ocrelizumab|ocrelizumab|mesh-list
25010868|NCT02861014|Immunologic Factors|immunologic factors|mesh-ancestor
25010869|NCT02861014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010870|NCT02840227|Anesthetics|anesthetics|mesh-list
25010871|NCT02840227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25010872|NCT02840227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010875|NCT02820857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010876|NCT02820857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24700646|NCT01453920|Growth Substances|growth substances|mesh-ancestor
24700647|NCT01453920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700648|NCT01453920|Growth Inhibitors|growth inhibitors|mesh-ancestor
24700662|NCT01454011|Testosterone|testosterone|mesh-list
24700663|NCT01454011|Testosterone undecanoate|testosterone undecanoate|mesh-list
24700664|NCT01454011|Testosterone enanthate|testosterone enanthate|mesh-list
24700665|NCT01454011|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24700666|NCT01454011|Androgens|androgens|mesh-ancestor
24700667|NCT01454011|Hormones|hormones|mesh-ancestor
24700668|NCT01454011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24700669|NCT01454011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700670|NCT01454011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24700671|NCT01454011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24700672|NCT01454011|Anabolic Agents|anabolic agents|mesh-ancestor
24700673|NCT01454154|Glyburide|glyburide|mesh-list
24700674|NCT01454154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24700675|NCT01454154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700690|NCT01454180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24700691|NCT01454180|Immunologic Factors|immunologic factors|mesh-ancestor
24700692|NCT01454180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700693|NCT01454180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24700694|NCT01454180|Antidotes|antidotes|mesh-ancestor
24700697|NCT01454180|Vitamins|vitamins|mesh-ancestor
25010878|NCT02820857|Growth Substances|growth substances|mesh-ancestor
25010879|NCT02820857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010880|NCT02820857|Growth Inhibitors|growth inhibitors|mesh-ancestor
24978128|NCT05178745|Irinotecan|irinotecan|mesh-list
24700749|NCT01454700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700750|NCT01454804|Trastuzumab|trastuzumab|mesh-list
24700751|NCT01454804|Lapatinib|lapatinib|mesh-list
24700752|NCT01454804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24700753|NCT01454804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24700754|NCT01454804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24700755|NCT01454804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700756|NCT01454804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700757|NCT01454869|Heparin|heparin|mesh-list
24700758|NCT01454869|Anticoagulants|anticoagulants|mesh-ancestor
24700759|NCT01454869|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24700760|NCT01454869|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24700761|NCT01454869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700778|NCT01455129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24825056|NCT02127060|Vitamins|vitamins|mesh-ancestor
24700779|NCT01455129|Autonomic Agents|autonomic agents|mesh-ancestor
24700780|NCT01455129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24700846|NCT01455350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700848|NCT01455441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24700849|NCT01455441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700850|NCT01455441|Incretins|incretins|mesh-ancestor
24700851|NCT01455441|Hormones|hormones|mesh-ancestor
24700852|NCT01455441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24700853|NCT01455506|Fludarabine|fludarabine|mesh-list
24700854|NCT01455506|Busulfan|busulfan|mesh-list
24700917|NCT01455883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24700918|NCT01455883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24700919|NCT01455883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700920|NCT01455883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24700921|NCT01455883|Immunologic Factors|immunologic factors|mesh-ancestor
24700922|NCT01455883|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24700923|NCT01455883|Incretins|incretins|mesh-ancestor
24700924|NCT01455883|Hormones|hormones|mesh-ancestor
24613129|NCT01017198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24613130|NCT01017224|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
24613131|NCT01017224|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24613132|NCT01017224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613133|NCT01017354|Calcifediol|calcifediol|mesh-list
24613134|NCT01017354|Vitamins|vitamins|mesh-ancestor
24449555|NCT00315965|Carbon Monoxide|carbon monoxide|mesh-list
24613138|NCT01017367|Antibodies|antibodies|mesh-list
24613139|NCT01017367|Immunologic Factors|immunologic factors|mesh-ancestor
24613140|NCT01017367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613141|NCT01017380|Celecoxib|celecoxib|mesh-list
24613142|NCT01017380|Etoricoxib|etoricoxib|mesh-list
24613177|NCT01017458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613178|NCT01017458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24613179|NCT01017458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613180|NCT01017458|Anabolic Agents|anabolic agents|mesh-ancestor
24613181|NCT01017640|Mitomycins|mitomycins|mesh-list
24613182|NCT01017640|Mitomycin|mitomycin|mesh-list
24613183|NCT01017640|Veliparib|veliparib|mesh-list
24613194|NCT01017666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24613196|NCT01017666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24613197|NCT01017666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613198|NCT01017666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613199|NCT01017679|Gefitinib|gefitinib|mesh-list
24613200|NCT01017679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010903|NCT02737306|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25010904|NCT02737306|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25010905|NCT02737306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613201|NCT01017679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24643954|NCT01188057|Alprazolam|alprazolam|mesh-list
24613202|NCT01017679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700954|NCT01455974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24700955|NCT01456078|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
24700956|NCT01456078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24700957|NCT01456078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700958|NCT01456117|Pioglitazone|pioglitazone|mesh-list
24700959|NCT01456117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24700960|NCT01456117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700961|NCT01456208|Norepinephrine|norepinephrine|mesh-list
24700962|NCT01456208|Angiotensin II|angiotensin ii|mesh-list
24700964|NCT01456208|Angiotensinogen|angiotensinogen|mesh-list
24700965|NCT01456208|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24700966|NCT01456208|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24700967|NCT01456208|Adrenergic Agents|adrenergic agents|mesh-ancestor
24700968|NCT01456208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24700969|NCT01456208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700970|NCT01456208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700971|NCT01456208|Sympathomimetics|sympathomimetics|mesh-ancestor
24700972|NCT01456208|Autonomic Agents|autonomic agents|mesh-ancestor
24700973|NCT01456208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24700974|NCT01456208|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24700975|NCT01456208|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24700976|NCT01456208|Protease Inhibitors|protease inhibitors|mesh-ancestor
24700977|NCT01456208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700979|NCT01456234|Antiviral Agents|antiviral agents|mesh-ancestor
24700980|NCT01456234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24700981|NCT01456234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700982|NCT01456234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700983|NCT01456247|Lansoprazole|lansoprazole|mesh-list
24700984|NCT01456247|Dexlansoprazole|dexlansoprazole|mesh-list
24700990|NCT01456260|Lansoprazole|lansoprazole|mesh-list
24700993|NCT01456260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24700994|NCT01456260|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24700995|NCT01456260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700996|NCT01456260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700997|NCT01456312|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24701004|NCT01456325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701005|NCT01456325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701006|NCT01456351|Rituximab|rituximab|mesh-list
24701007|NCT01456351|Fludarabine|fludarabine|mesh-list
24701008|NCT01456351|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24701009|NCT01456351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24701010|NCT01456351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701011|NCT01456351|Immunologic Factors|immunologic factors|mesh-ancestor
24701012|NCT01456351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701013|NCT01456351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24701020|NCT01456364|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24701021|NCT01456364|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24701023|NCT01456364|Purinergic Agents|purinergic agents|mesh-ancestor
25010914|NCT02728648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010922|NCT02614547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010923|NCT02614547|GABA Modulators|gaba modulators|mesh-ancestor
25709320|NCT02265224|Antidotes|antidotes|mesh-ancestor
24701070|NCT01456585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24701071|NCT01456585|Antimetabolites|antimetabolites|mesh-ancestor
24701072|NCT01456585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701073|NCT01456585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701074|NCT01456585|Antiviral Agents|antiviral agents|mesh-ancestor
24701079|NCT01456585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701083|NCT01456611|Analgesics|analgesics|mesh-ancestor
24701089|NCT01456611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24701090|NCT01456611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701091|NCT01456611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701093|NCT01456624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24701094|NCT01456624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701095|NCT01456624|Appetite Stimulants|appetite stimulants|mesh-ancestor
24431259|NCT00250991|Eptifibatide|eptifibatide|mesh-list
24701096|NCT01456624|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24701097|NCT01456624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701098|NCT01456650|Glyburide|glyburide|mesh-list
24701099|NCT01456650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24701100|NCT01456650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701101|NCT01456689|Midazolam|midazolam|mesh-list
24701102|NCT01456689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24701103|NCT01456689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24701104|NCT01456689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24701108|NCT01456689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24701109|NCT01456689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24701110|NCT01456689|Anesthetics, General|anesthetics, general|mesh-ancestor
24701111|NCT01456689|Anesthetics|anesthetics|mesh-ancestor
24701112|NCT01456689|GABA Modulators|gaba modulators|mesh-ancestor
24701113|NCT01456689|GABA Agents|gaba agents|mesh-ancestor
24701114|NCT01456689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24701115|NCT01456689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701116|NCT01456715|Vaccines|vaccines|mesh-list
24701117|NCT01456715|Immunologic Factors|immunologic factors|mesh-ancestor
24701118|NCT01456715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010924|NCT02614547|GABA Agents|gaba agents|mesh-ancestor
25010931|NCT02589691|Rocuronium|rocuronium|mesh-list
25010932|NCT02589691|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25010946|NCT02583048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25010947|NCT02583048|Antitubercular Agents|antitubercular agents|mesh-ancestor
25010948|NCT02583048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24795321|NCT03052933|Gemcitabine|gemcitabine|mesh-list
24701121|NCT01457001|Micronutrients|micronutrients|mesh-ancestor
24701122|NCT01457001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701123|NCT01457001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24701124|NCT01457040|Etoposide|etoposide|mesh-list
24701132|NCT01457131|Cyclophosphamide|cyclophosphamide|mesh-list
24701133|NCT01457131|Fludarabine|fludarabine|mesh-list
24701226|NCT01457716|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24701227|NCT01457716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24701228|NCT01457716|Adrenergic Agents|adrenergic agents|mesh-ancestor
24701229|NCT01457716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24701230|NCT01457716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701231|NCT01457820|Allopurinol|allopurinol|mesh-list
24701232|NCT01457820|Antimetabolites|antimetabolites|mesh-ancestor
24701233|NCT01457820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701234|NCT01457820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701235|NCT01457820|Gout Suppressants|gout suppressants|mesh-ancestor
24701236|NCT01457820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24701244|NCT01457859|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24701245|NCT01457859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24701246|NCT01457859|Antimetabolites|antimetabolites|mesh-ancestor
24701247|NCT01457859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701248|NCT01457859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24701249|NCT01457911|Metformin|metformin|mesh-list
24701250|NCT01457911|Glimepiride|glimepiride|mesh-list
24701251|NCT01457911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24701252|NCT01457911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701253|NCT01457911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24701254|NCT01457911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24701255|NCT01457911|Immunologic Factors|immunologic factors|mesh-ancestor
24701261|NCT01457937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24701262|NCT01457937|Antimetabolites|antimetabolites|mesh-ancestor
24701263|NCT01457937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701264|NCT01457989|Ezogabine|ezogabine|mesh-list
24701265|NCT01457989|Anticonvulsants|anticonvulsants|mesh-ancestor
24701266|NCT01457989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25075778|NCT03378297|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25075779|NCT03378297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075780|NCT03378297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075786|NCT03378297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25075787|NCT03378297|Analgesics|analgesics|mesh-ancestor
25075796|NCT03378297|Antipyretics|antipyretics|mesh-ancestor
24431526|NCT00252044|Dopamine Agents|dopamine agents|mesh-ancestor
25010959|NCT02539160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25010960|NCT02539160|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25010961|NCT02539160|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25010962|NCT02539160|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25010963|NCT02539160|Purinergic Agents|purinergic agents|mesh-ancestor
25010964|NCT02539160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25010965|NCT02539160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787016|NCT01923077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25010966|NCT02539160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701267|NCT01457989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701268|NCT01458015|Oxycodone|oxycodone|mesh-list
24701284|NCT01458041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24701286|NCT01458054|Ritonavir|ritonavir|mesh-list
24701287|NCT01458054|Omeprazole|omeprazole|mesh-list
24701288|NCT01458054|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24701289|NCT01458054|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24701290|NCT01458054|Protease Inhibitors|protease inhibitors|mesh-ancestor
24701291|NCT01458054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701292|NCT01458054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701298|NCT01458054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24701299|NCT01458054|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24701300|NCT01458054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24701301|NCT01458054|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24701303|NCT01458067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613219|NCT01017770|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24613220|NCT01017770|Anthelmintics|anthelmintics|mesh-ancestor
24613221|NCT01017796|Ascorbic Acid|ascorbic acid|mesh-list
24613222|NCT01017796|Acetylcysteine|acetylcysteine|mesh-list
24613223|NCT01017796|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24613224|NCT01017796|Antiviral Agents|antiviral agents|mesh-ancestor
24613225|NCT01017796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24613226|NCT01017796|Expectorants|expectorants|mesh-ancestor
24613227|NCT01017796|Respiratory System Agents|respiratory system agents|mesh-ancestor
24613228|NCT01017796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24613229|NCT01017796|Antioxidants|antioxidants|mesh-ancestor
24613230|NCT01017796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613239|NCT01017809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24613240|NCT01017809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613241|NCT01017809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24613242|NCT01017809|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24613243|NCT01017809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24613244|NCT01017809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701324|NCT01458301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24701325|NCT01458431|Anesthetics|anesthetics|mesh-list
24701326|NCT01458431|Levobupivacaine|levobupivacaine|mesh-list
24701327|NCT01458431|Anesthetics, Local|anesthetics, local|mesh-list
24402651|NCT00158093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24701350|NCT01458600|Methimazole|methimazole|mesh-list
24701351|NCT01458600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24701358|NCT01458600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24701359|NCT01458600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24402759|NCT00158457|Emtricitabine|emtricitabine|mesh-list
24701360|NCT01458600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701361|NCT01458600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701362|NCT01458600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24701363|NCT01458600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24701364|NCT01458600|Adrenergic Agents|adrenergic agents|mesh-ancestor
25693884|NCT02021461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25693885|NCT02021461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25693886|NCT02021461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693887|NCT02021643|Sofosbuvir|sofosbuvir|mesh-list
25693888|NCT02021643|Ribavirin|ribavirin|mesh-list
25693889|NCT02021643|Antiviral Agents|antiviral agents|mesh-ancestor
25709321|NCT02265237|Ritonavir|ritonavir|mesh-list
24998447|NCT02761694|Hormone Antagonists|hormone antagonists|mesh-ancestor
24998448|NCT02761694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24998449|NCT02761694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998456|NCT02717156|Pembrolizumab|pembrolizumab|mesh-list
24998457|NCT02717156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24998458|NCT02717156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998460|NCT02691793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998510|NCT02574455|Capecitabine|capecitabine|mesh-list
24701365|NCT01458600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24701366|NCT01458600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24701367|NCT01458600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24701368|NCT01458600|Vasodilator Agents|vasodilator agents|mesh-ancestor
25109085|NCT03127319|Apatinib|apatinib|mesh-list
24701369|NCT01458600|Sympatholytics|sympatholytics|mesh-ancestor
24701370|NCT01458600|Autonomic Agents|autonomic agents|mesh-ancestor
24431638|NCT00252603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24701371|NCT01458600|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24701372|NCT01458600|Antithyroid Agents|antithyroid agents|mesh-ancestor
24644031|NCT01188408|Docetaxel|docetaxel|mesh-list
24701384|NCT01458626|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24701386|NCT01458626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24701387|NCT01458626|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24701388|NCT01458626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24701389|NCT01458626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701390|NCT01458626|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24701391|NCT01458626|Histamine Antagonists|histamine antagonists|mesh-ancestor
24701392|NCT01458626|Histamine Agents|histamine agents|mesh-ancestor
24701444|NCT01459133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24701445|NCT01459133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701446|NCT01459146|Lumefantrine|lumefantrine|mesh-list
24701447|NCT01459146|Artemether|artemether|mesh-list
24701448|NCT01459146|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24701449|NCT01459146|Albendazole|albendazole|mesh-list
24701473|NCT01459211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24701474|NCT01459211|Glucocorticoids|glucocorticoids|mesh-ancestor
24701485|NCT01459250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24701486|NCT01459250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24701487|NCT01459250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701488|NCT01459315|Dolutegravir|dolutegravir|mesh-list
24701489|NCT01459315|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24701493|NCT01459315|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24701494|NCT01459315|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24701495|NCT01459315|Antiviral Agents|antiviral agents|mesh-ancestor
24701535|NCT01459445|Drospirenone|drospirenone|mesh-list
24701536|NCT01459445|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24701537|NCT01459445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24701538|NCT01459445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701539|NCT01459445|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24701540|NCT01459445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24701541|NCT01459445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24701542|NCT01459445|Contraceptive Agents|contraceptive agents|mesh-ancestor
24701543|NCT01459445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24701544|NCT01459445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24967794|NCT03756727|Micronutrients|micronutrients|mesh-ancestor
24701547|NCT01459445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24701548|NCT01459445|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24701549|NCT01459445|Hormone Antagonists|hormone antagonists|mesh-ancestor
24701550|NCT01459445|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24701551|NCT01459445|Diuretics|diuretics|mesh-ancestor
24701552|NCT01459445|Natriuretic Agents|natriuretic agents|mesh-ancestor
24701590|NCT01459627|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24633737|NCT01131000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24633738|NCT01131000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25693890|NCT02021643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25693891|NCT02021643|Antimetabolites|antimetabolites|mesh-ancestor
25693892|NCT02021643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693893|NCT02021656|Sofosbuvir|sofosbuvir|mesh-list
25693894|NCT02021656|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25693895|NCT02021656|Ledipasvir|ledipasvir|mesh-list
25693896|NCT02021656|Antiviral Agents|antiviral agents|mesh-ancestor
25693897|NCT02021656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25693898|NCT02021929|Sorafenib|sorafenib|mesh-list
25693899|NCT02021929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048640|NCT00679731|Antimetabolites|antimetabolites|mesh-ancestor
24998718|NCT01376427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24998719|NCT01376427|Antiemetics|antiemetics|mesh-ancestor
24998720|NCT01376427|Autonomic Agents|autonomic agents|mesh-ancestor
24998728|NCT01376427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998729|NCT01376427|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24998730|NCT01376427|Abortifacient Agents|abortifacient agents|mesh-ancestor
24904777|NCT04353336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24998731|NCT01376427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24998732|NCT01376427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24998734|NCT01376427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633740|NCT01131000|Sensory System Agents|sensory system agents|mesh-ancestor
24633741|NCT01131000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24633742|NCT01131000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633743|NCT01131000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24633744|NCT01131000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24633749|NCT01131026|Levofloxacin|levofloxacin|mesh-list
24633750|NCT01131026|Ofloxacin|ofloxacin|mesh-list
24633751|NCT01131026|Lansoprazole|lansoprazole|mesh-list
24633752|NCT01131026|Dexlansoprazole|dexlansoprazole|mesh-list
24633753|NCT01131026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24633754|NCT01131026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24633755|NCT01131026|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24633756|NCT01131026|Renal Agents|renal agents|mesh-ancestor
24633757|NCT01131026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24633802|NCT01131195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24443988|NCT00296465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633806|NCT01131195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24633807|NCT01131195|Antimetabolites|antimetabolites|mesh-ancestor
24633808|NCT01131234|Cediranib|cediranib|mesh-list
24633809|NCT01131234|R04929097|r04929097|mesh-list
24633810|NCT01131234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24586024|NCT00888836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586026|NCT00888862|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24586027|NCT00888862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24586028|NCT00888862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24586029|NCT00888862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586030|NCT00888862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24586031|NCT00888862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586032|NCT00888862|Antidepressive Agents|antidepressive agents|mesh-ancestor
24633811|NCT01131234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633812|NCT01131234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633813|NCT01131234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24633814|NCT01131247|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24633815|NCT01131247|Ofatumumab|ofatumumab|mesh-list
24633816|NCT01131247|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24633817|NCT01131247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24633824|NCT01131273|Methadone|methadone|mesh-list
24633863|NCT01131468|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24633866|NCT01131468|Expectorants|expectorants|mesh-ancestor
24633871|NCT01131468|Protective Agents|protective agents|mesh-ancestor
24633872|NCT01131468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633873|NCT01131468|Antidotes|antidotes|mesh-ancestor
24633874|NCT01131546|Amlodipine|amlodipine|mesh-list
24633875|NCT01131546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24633927|NCT01131728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24634048|NCT01131923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634049|NCT01131923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24634053|NCT01131936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24634054|NCT01131936|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24634055|NCT01131936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24634056|NCT01131936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634057|NCT01131936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25693900|NCT02021929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25693901|NCT02021929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693902|NCT02021929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693903|NCT02021942|Pasireotide|pasireotide|mesh-list
25693904|NCT02021942|Hormones|hormones|mesh-ancestor
25693905|NCT02021942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25693906|NCT02021942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693907|NCT02022007|Metformin|metformin|mesh-list
25693908|NCT02022007|Saxagliptin|saxagliptin|mesh-list
25693909|NCT02022007|Biguanides|biguanides|mesh-list
25693910|NCT02022007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25693911|NCT02022007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25048666|NCT00678119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998907|NCT05422001|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24998908|NCT05422001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24998909|NCT05422001|Anesthetics, General|anesthetics, general|mesh-ancestor
24998910|NCT05422001|Anesthetics|anesthetics|mesh-ancestor
24998911|NCT05422001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24936783|NCT04036201|Bupivacaine|bupivacaine|mesh-list
24936784|NCT04036201|Hyaluronic Acid|hyaluronic acid|mesh-list
24999000|NCT05393713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24634058|NCT01131936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634059|NCT01131936|Vasodilator Agents|vasodilator agents|mesh-ancestor
24634061|NCT01131949|Anticonvulsants|anticonvulsants|mesh-ancestor
24634067|NCT01131949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24634068|NCT01131949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24634069|NCT01131949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24634070|NCT01131949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24634072|NCT01131962|Sclerosing Solutions|sclerosing solutions|mesh-list
24634106|NCT01132040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634108|NCT01132157|Desflurane|desflurane|mesh-list
24634109|NCT01132157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24444027|NCT00296530|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24444028|NCT00296530|Glucocorticoids|glucocorticoids|mesh-ancestor
24634110|NCT01132157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24444029|NCT00296530|Hormones|hormones|mesh-ancestor
24634111|NCT01132157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634112|NCT01132157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24634174|NCT01132235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24819609|NCT02096224|Anesthetics|anesthetics|mesh-ancestor
24634183|NCT01132235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24634184|NCT01132235|Immunologic Factors|immunologic factors|mesh-ancestor
24634185|NCT01132248|Mefloquine|mefloquine|mesh-list
24634186|NCT01132248|Antimalarials|antimalarials|mesh-ancestor
24634187|NCT01132248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24634188|NCT01132248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24634189|NCT01132248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24634190|NCT01132352|Levetiracetam|levetiracetam|mesh-list
24634191|NCT01132352|Anticonvulsants|anticonvulsants|mesh-ancestor
24586049|NCT00888901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24586051|NCT00888901|Protective Agents|protective agents|mesh-ancestor
24586052|NCT00888901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24586053|NCT00888901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586054|NCT00889018|Carboplatin|carboplatin|mesh-list
24634308|NCT01132768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24634309|NCT01132768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634310|NCT01132768|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24634311|NCT01132768|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24634313|NCT01132768|Adrenergic Agents|adrenergic agents|mesh-ancestor
24634314|NCT01132768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24634316|NCT01132781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24634317|NCT01132781|Autonomic Agents|autonomic agents|mesh-ancestor
24634318|NCT01132781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24634319|NCT01132781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634320|NCT01132781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24432489|NCT00254917|Vaccines|vaccines|mesh-list
24634321|NCT01132781|Respiratory System Agents|respiratory system agents|mesh-ancestor
24634377|NCT01133223|Plasminogen|plasminogen|mesh-list
24634378|NCT01133223|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24634379|NCT01133223|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24634380|NCT01133223|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24665722|NCT01314339|Desloratadine|desloratadine|mesh-list
25693912|NCT02022007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693913|NCT02022007|Incretins|incretins|mesh-ancestor
25693914|NCT02022007|Hormones|hormones|mesh-ancestor
25693915|NCT02022007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25693916|NCT02022007|Protease Inhibitors|protease inhibitors|mesh-ancestor
25693917|NCT02022007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693918|NCT02022007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693919|NCT02022657|Tenofovir|tenofovir|mesh-list
25693920|NCT02022657|Emtricitabine|emtricitabine|mesh-list
24634381|NCT01133223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634382|NCT01133301|Naltrexone|naltrexone|mesh-list
25048735|NCT00673062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25048736|NCT00673062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048737|NCT00673062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25048738|NCT00673062|Respiratory System Agents|respiratory system agents|mesh-ancestor
25048739|NCT00673062|Nasal Decongestants|nasal decongestants|mesh-ancestor
25048740|NCT00673062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25048741|NCT00673062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25048742|NCT00673062|Sympathomimetics|sympathomimetics|mesh-ancestor
24634383|NCT01133301|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24634384|NCT01133301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24634385|NCT01133301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634386|NCT01133301|Sensory System Agents|sensory system agents|mesh-ancestor
24634387|NCT01133301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24586065|NCT00889057|Sorafenib|sorafenib|mesh-list
24586074|NCT00889096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24586075|NCT00889096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586076|NCT00889096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586077|NCT00889096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25105742|NCT05017610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24634403|NCT01133366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24634404|NCT01133431|Glimepiride|glimepiride|mesh-list
24634405|NCT01133431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24634406|NCT01133431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24634407|NCT01133431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634408|NCT01133431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24634409|NCT01133431|Immunologic Factors|immunologic factors|mesh-ancestor
24634466|NCT01133483|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24634468|NCT01133483|Histamine Antagonists|histamine antagonists|mesh-ancestor
24634469|NCT01133483|Histamine Agents|histamine agents|mesh-ancestor
24634470|NCT01133496|Alendronate|alendronate|mesh-list
24634471|NCT01133496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24634472|NCT01133496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634532|NCT01133873|Analgesics|analgesics|mesh-ancestor
24634533|NCT01133873|Sensory System Agents|sensory system agents|mesh-ancestor
24819533|NCT02095847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24819534|NCT02095886|BMS-955176|bms-955176|mesh-list
24819535|NCT02095886|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24819536|NCT02095886|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24819537|NCT02095886|Antiviral Agents|antiviral agents|mesh-ancestor
24819542|NCT02095899|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24489462|NCT00473486|Carboplatin|carboplatin|mesh-list
24520451|NCT01657500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24914914|NCT05253066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914915|NCT05253066|Tubulin Modulators|tubulin modulators|mesh-ancestor
24914916|NCT05253066|Antimitotic Agents|antimitotic agents|mesh-ancestor
24914917|NCT05253066|Mitosis Modulators|mitosis modulators|mesh-ancestor
24914918|NCT05253066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914919|NCT05253066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24914920|NCT05253066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24914921|NCT05253066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24914922|NCT05253066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24914923|NCT05253066|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24914924|NCT05253066|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24914925|NCT05253066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24914926|NCT05253066|Hormone Antagonists|hormone antagonists|mesh-ancestor
24819551|NCT02095938|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24819552|NCT02095938|Dopamine Agents|dopamine agents|mesh-ancestor
24819553|NCT02095938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24819554|NCT02095938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819555|NCT02095938|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24819556|NCT02095938|Antidepressive Agents|antidepressive agents|mesh-ancestor
24819558|NCT02095990|Antioxidants|antioxidants|mesh-ancestor
25065388|NCT03451110|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25065389|NCT03451110|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
25693921|NCT02022657|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25693922|NCT02022657|Antiviral Agents|antiviral agents|mesh-ancestor
25693923|NCT02022657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25693924|NCT02022657|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25693925|NCT02022657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25693926|NCT02022657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693927|NCT02022657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999152|NCT05095116|Fluticasone|fluticasone|mesh-list
24999153|NCT05095116|Xhance|xhance|mesh-list
24999154|NCT05095116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24999155|NCT05095116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24999156|NCT05095116|Autonomic Agents|autonomic agents|mesh-ancestor
24999157|NCT05095116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24999158|NCT05095116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999159|NCT05095116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24999160|NCT05095116|Respiratory System Agents|respiratory system agents|mesh-ancestor
25065390|NCT03451110|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24819559|NCT02095990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819560|NCT02095990|Protective Agents|protective agents|mesh-ancestor
24819561|NCT02095990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819562|NCT02095990|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24819564|NCT02096055|Cladribine|cladribine|mesh-list
24819565|NCT02096055|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
24819566|NCT02096055|Guadecitabine|guadecitabine|mesh-list
24819567|NCT02096055|Azacitidine|azacitidine|mesh-list
24819568|NCT02096055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24819569|NCT02096055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24819570|NCT02096055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24819571|NCT02096055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24819572|NCT02096055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819573|NCT02096055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819574|NCT02096055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24819575|NCT02096055|Immunologic Factors|immunologic factors|mesh-ancestor
24819576|NCT02096055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819577|NCT02096055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24819578|NCT02096055|Antimetabolites|antimetabolites|mesh-ancestor
24819579|NCT02096068|Dexmedetomidine|dexmedetomidine|mesh-list
24819580|NCT02096068|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24520456|NCT01497509|Epinephrine|epinephrine|mesh-list
24819583|NCT02096068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24819584|NCT02096068|Analgesics|analgesics|mesh-ancestor
24819585|NCT02096068|Sensory System Agents|sensory system agents|mesh-ancestor
24819586|NCT02096068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24819599|NCT02096133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24819600|NCT02096133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819601|NCT02096133|Vitamins|vitamins|mesh-ancestor
24819606|NCT02096224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24819607|NCT02096224|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24819608|NCT02096224|Anesthetics, General|anesthetics, general|mesh-ancestor
24819610|NCT02096224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24819611|NCT02096224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819612|NCT02096250|Ferrous fumarate|ferrous fumarate|mesh-list
24819613|NCT02096250|Edetic Acid|edetic acid|mesh-list
24914975|NCT05252325|Anesthetics|anesthetics|mesh-ancestor
24914977|NCT05252325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914978|NCT05252325|Sensory System Agents|sensory system agents|mesh-ancestor
24914979|NCT05252325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24914980|NCT05252325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24914981|NCT05252325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24914982|NCT05252325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24914983|NCT05252325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24914984|NCT05252325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914985|NCT05252325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24914986|NCT05252325|Immunologic Factors|immunologic factors|mesh-ancestor
24914987|NCT05252325|Viscosupplements|viscosupplements|mesh-ancestor
25693928|NCT02022657|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25693929|NCT02022657|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25693930|NCT02022748|Ticagrelor|ticagrelor|mesh-list
25693931|NCT02022748|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25693932|NCT02022748|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25693933|NCT02022748|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25693934|NCT02022748|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25693935|NCT02022748|Purinergic Agents|purinergic agents|mesh-ancestor
24798354|NCT01963039|Protective Agents|protective agents|mesh-ancestor
24798355|NCT01963039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914988|NCT05252325|Protective Agents|protective agents|mesh-ancestor
24914991|NCT05252117|Anesthetics, Local|anesthetics, local|mesh-ancestor
24914992|NCT05252117|Anesthetics|anesthetics|mesh-ancestor
24914993|NCT05252117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24914994|NCT05252117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914995|NCT05252117|Sensory System Agents|sensory system agents|mesh-ancestor
24914996|NCT05252117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24914998|NCT05251766|Docetaxel|docetaxel|mesh-list
24914999|NCT05251766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24915000|NCT05251766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065392|NCT03451045|Lenabasum|lenabasum|mesh-list
25065393|NCT03451045|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25065394|NCT03451045|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25065395|NCT03451045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25065396|NCT03451045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065397|NCT03451045|Hormones|hormones|mesh-ancestor
24775473|NCT01852539|Anesthetics, General|anesthetics, general|mesh-ancestor
25065398|NCT03451045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25065399|NCT03451045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065400|NCT03451045|Hallucinogens|hallucinogens|mesh-ancestor
24440770|NCT00284752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489777|NCT00475358|Dopamine Agents|dopamine agents|mesh-ancestor
24489778|NCT00475397|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24915026|NCT05251610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24915027|NCT05251610|Adrenergic Agents|adrenergic agents|mesh-ancestor
24915058|NCT04938882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24915059|NCT04938882|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24915060|NCT04938882|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24915061|NCT04938882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24915062|NCT04938882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915063|NCT04933903|Nivolumab|nivolumab|mesh-list
24915064|NCT04933903|Ipilimumab|ipilimumab|mesh-list
24915065|NCT04933903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24915066|NCT04933903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915067|NCT04933903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24915068|NCT04933903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915069|NCT04911517|Capecitabine|capecitabine|mesh-list
24915070|NCT04911517|Antibodies|antibodies|mesh-list
24915071|NCT04911517|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24738325|NCT01674842|Cisplatin|cisplatin|mesh-list
24915072|NCT04911517|Immunologic Factors|immunologic factors|mesh-ancestor
24915073|NCT04911517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915074|NCT04911517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24915075|NCT04911517|Antimetabolites|antimetabolites|mesh-ancestor
24915076|NCT04911517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693936|NCT02022748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25693937|NCT02022748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693938|NCT02022748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693939|NCT02023099|Ritonavir|ritonavir|mesh-list
25693940|NCT02023099|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25693941|NCT02023099|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25693942|NCT02023099|Protease Inhibitors|protease inhibitors|mesh-ancestor
25693943|NCT02023099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693944|NCT02023099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693945|NCT02023099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24937585|NCT04027517|Hematinics|hematinics|mesh-ancestor
24937586|NCT04027530|Ertugliflozin|ertugliflozin|mesh-list
24999660|NCT03602066|Chlorine dioxide|chlorine dioxide|mesh-list
24999661|NCT03602066|Dental Disinfectants|dental disinfectants|mesh-ancestor
24999662|NCT03602066|Disinfectants|disinfectants|mesh-ancestor
24840806|NCT02212639|Digoxin|digoxin|mesh-list
24999710|NCT03501368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24999712|NCT03501368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999713|NCT03493685|Irbesartan|irbesartan|mesh-list
24999714|NCT03493685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24999715|NCT03493685|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24999716|NCT03493685|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24999717|NCT03493685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999718|NCT03492671|Gemcitabine|gemcitabine|mesh-list
24999719|NCT03492671|Paclitaxel|paclitaxel|mesh-list
24915079|NCT04865978|Apixaban|apixaban|mesh-list
24915080|NCT04865978|Anticoagulants|anticoagulants|mesh-ancestor
24915081|NCT04865978|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24915082|NCT04865978|Antithrombins|antithrombins|mesh-ancestor
24915083|NCT04865978|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24915084|NCT04865978|Protease Inhibitors|protease inhibitors|mesh-ancestor
24915085|NCT04865978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24915086|NCT04865978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915087|NCT04816513|Ustekinumab|ustekinumab|mesh-list
24915088|NCT04816513|Dermatologic Agents|dermatologic agents|mesh-ancestor
24489785|NCT00475397|Analgesics|analgesics|mesh-ancestor
24915110|NCT04674670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25065401|NCT03451045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25065402|NCT03451045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25065403|NCT03451045|Analgesics|analgesics|mesh-ancestor
25065404|NCT03451045|Sensory System Agents|sensory system agents|mesh-ancestor
25065405|NCT03451045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25065406|NCT03451019|Sevelamer|sevelamer|mesh-list
25065407|NCT03451019|Chelating Agents|chelating agents|mesh-ancestor
25065408|NCT03451019|Sequestering Agents|sequestering agents|mesh-ancestor
25065409|NCT03451019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065410|NCT03450967|Durvalumab|durvalumab|mesh-list
25065411|NCT03450967|Tremelimumab|tremelimumab|mesh-list
25065412|NCT03450967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25065413|NCT03450967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065414|NCT03450863|Insulin Aspart|insulin aspart|mesh-list
25065415|NCT03450863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25065416|NCT03450863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915111|NCT04674670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915112|NCT04674670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24915113|NCT04674670|Antidepressive Agents|antidepressive agents|mesh-ancestor
24915114|NCT04674670|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24915132|NCT04669132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915133|NCT04669132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24915135|NCT04648319|Nivolumab|nivolumab|mesh-list
24915136|NCT04648319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25693946|NCT02023099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25693947|NCT02023099|Antiviral Agents|antiviral agents|mesh-ancestor
25693948|NCT02023099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25693949|NCT02023099|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25693950|NCT02023099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25693951|NCT02023112|Ritonavir|ritonavir|mesh-list
25693952|NCT02023112|Ribavirin|ribavirin|mesh-list
25693953|NCT02023112|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25693954|NCT02023112|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25693955|NCT02023112|Protease Inhibitors|protease inhibitors|mesh-ancestor
25693956|NCT02023112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693957|NCT02023112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693958|NCT02023112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25693959|NCT02023112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25693960|NCT02023112|Antiviral Agents|antiviral agents|mesh-ancestor
25709322|NCT02265237|Ribavirin|ribavirin|mesh-list
24915137|NCT04648319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999794|NCT03188796|Vitamins|vitamins|mesh-ancestor
24533878|NCT00645320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25065418|NCT03450798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25065419|NCT03450798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065420|NCT05322499|Paclitaxel|paclitaxel|mesh-list
24915157|NCT04538092|Analgesics|analgesics|mesh-list
24915167|NCT04173312|Anesthetics, Local|anesthetics, local|mesh-ancestor
24915169|NCT04173312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24915170|NCT04173312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915171|NCT04173312|Sensory System Agents|sensory system agents|mesh-ancestor
24915182|NCT04126083|Lofexidine|lofexidine|mesh-list
24915188|NCT04126083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24915189|NCT04126083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24915190|NCT04126083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24915191|NCT04126083|Adrenergic Agents|adrenergic agents|mesh-ancestor
24915192|NCT04126083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24915193|NCT04126083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915205|NCT04004845|Misoprostol|misoprostol|mesh-list
24915206|NCT04004845|Oxytocin|oxytocin|mesh-list
24915207|NCT04004845|Oxytocics|oxytocics|mesh-ancestor
24915208|NCT04004845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24915209|NCT04004845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915210|NCT04004845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24915211|NCT04004845|Abortifacient Agents|abortifacient agents|mesh-ancestor
24819614|NCT02096250|Ferric Compounds|ferric compounds|mesh-list
24915212|NCT04004845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24915213|NCT04004845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24915215|NCT03899857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24915216|NCT03899857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915217|NCT03854019|Quinidine|quinidine|mesh-list
24915218|NCT03854019|Dextromethorphan|dextromethorphan|mesh-list
24915253|NCT03737370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693961|NCT02023112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25693962|NCT02023112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25693963|NCT02023112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25693964|NCT02023112|Antimetabolites|antimetabolites|mesh-ancestor
25693965|NCT02023125|Esomeprazole|esomeprazole|mesh-list
25693966|NCT02023125|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25693967|NCT02023125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24915254|NCT03737370|Tubulin Modulators|tubulin modulators|mesh-ancestor
24915255|NCT03737370|Antimitotic Agents|antimitotic agents|mesh-ancestor
24915256|NCT03737370|Mitosis Modulators|mitosis modulators|mesh-ancestor
24915303|NCT03538899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915305|NCT03538899|Immunologic Factors|immunologic factors|mesh-ancestor
24915306|NCT03538899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915307|NCT03538899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24915308|NCT03538899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915309|NCT03538899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24915311|NCT03432897|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24915312|NCT03432897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24915313|NCT03432897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915314|NCT03432897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915315|NCT03355157|Tamoxifen|tamoxifen|mesh-list
24915316|NCT03355157|Paclitaxel|paclitaxel|mesh-list
24915317|NCT03355157|Vinorelbine|vinorelbine|mesh-list
24915318|NCT03355157|Capecitabine|capecitabine|mesh-list
24915319|NCT03355157|Letrozole|letrozole|mesh-list
24915320|NCT03355157|Epirubicin|epirubicin|mesh-list
24915321|NCT03355157|Fulvestrant|fulvestrant|mesh-list
24915322|NCT03355157|Palbociclib|palbociclib|mesh-list
24915323|NCT03355157|Exemestane|exemestane|mesh-list
24915324|NCT03355157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24915325|NCT03355157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915326|NCT03355157|Tubulin Modulators|tubulin modulators|mesh-ancestor
24915327|NCT03355157|Antimitotic Agents|antimitotic agents|mesh-ancestor
24915328|NCT03355157|Mitosis Modulators|mitosis modulators|mesh-ancestor
24915329|NCT03355157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915330|NCT03355157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24915331|NCT03355157|Antimetabolites|antimetabolites|mesh-ancestor
24915332|NCT03355157|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24915333|NCT03355157|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24915334|NCT03355157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24915335|NCT03355157|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24915336|NCT03355157|Hormone Antagonists|hormone antagonists|mesh-ancestor
24915343|NCT03355157|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24915344|NCT03355157|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24915345|NCT03355157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24915346|NCT03355157|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24915347|NCT03355157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24915348|NCT03324035|Tramadol|tramadol|mesh-list
24915349|NCT03324035|Amitriptyline|amitriptyline|mesh-list
24915370|NCT03196180|Fluorouracil|fluorouracil|mesh-list
24446924|NCT00306644|Rosiglitazone|rosiglitazone|mesh-list
24915393|NCT02819141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24915394|NCT02819141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24915395|NCT02819141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915396|NCT02819141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24915397|NCT02819141|Analgesics|analgesics|mesh-ancestor
24915398|NCT02819141|Sensory System Agents|sensory system agents|mesh-ancestor
24915399|NCT02819141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25065451|NCT05322265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065452|NCT05322265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065453|NCT05322265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25065454|NCT05322265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25065455|NCT05322265|Autonomic Agents|autonomic agents|mesh-ancestor
25065456|NCT05322265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25065457|NCT05322265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24827744|NCT02141139|Sensory System Agents|sensory system agents|mesh-ancestor
24827745|NCT02141139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24827746|NCT02141139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693968|NCT02023125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25693969|NCT02023125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25693970|NCT02023125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693971|NCT02023151|Omalizumab|omalizumab|mesh-list
25693972|NCT02023151|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25693973|NCT02023151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25000083|NCT01827553|Gemcitabine|gemcitabine|mesh-list
24938048|NCT04022811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24938049|NCT04022811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24915400|NCT02819141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24915401|NCT02819141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24915402|NCT02819141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24915403|NCT02819141|Adrenergic Agents|adrenergic agents|mesh-ancestor
24915404|NCT02819141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24915405|NCT02819141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915406|NCT02725593|Dapagliflozin|dapagliflozin|mesh-list
24915407|NCT02725593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24915408|NCT02725593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915409|NCT02725593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24915410|NCT02725593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915411|NCT02636946|Bimatoprost|bimatoprost|mesh-list
24915412|NCT02636946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24915414|NCT02631941|Formoterol Fumarate|formoterol fumarate|mesh-list
24915426|NCT02631941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24915427|NCT02631941|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24915429|NCT02631941|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24915430|NCT02631941|Adrenergic Agents|adrenergic agents|mesh-ancestor
24915431|NCT02631941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24915432|NCT02631941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915433|NCT02631941|Antidotes|antidotes|mesh-ancestor
24915434|NCT02631941|Protective Agents|protective agents|mesh-ancestor
24915435|NCT02562378|Doxorubicin|doxorubicin|mesh-list
24915436|NCT02562378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24915437|NCT02562378|Trastuzumab|trastuzumab|mesh-list
24915438|NCT02562378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24915439|NCT02562378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915440|NCT02562378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24915441|NCT02562378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24915442|NCT02562378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24915443|NCT02562378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915444|NCT02562378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24915446|NCT02387099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915447|NCT02387099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24915448|NCT02387099|Immunologic Factors|immunologic factors|mesh-ancestor
24915449|NCT02387099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915460|NCT02237508|Budesonide|budesonide|mesh-list
24915461|NCT02237508|Formoterol Fumarate|formoterol fumarate|mesh-list
24915462|NCT02237508|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24915463|NCT02237508|Charcoal|charcoal|mesh-list
25065458|NCT05322265|Respiratory System Agents|respiratory system agents|mesh-ancestor
24950181|NCT02243813|Psilocybin|psilocybin|mesh-list
24950186|NCT02024230|Rivaroxaban|rivaroxaban|mesh-list
24915464|NCT02237508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24915465|NCT02237508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24915466|NCT02237508|Autonomic Agents|autonomic agents|mesh-ancestor
24915467|NCT02237508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24915468|NCT02237508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915469|NCT02237508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24915470|NCT02237508|Respiratory System Agents|respiratory system agents|mesh-ancestor
24915471|NCT02237508|Glucocorticoids|glucocorticoids|mesh-ancestor
24915472|NCT02237508|Hormones|hormones|mesh-ancestor
24915473|NCT02237508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24915474|NCT02237508|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24915475|NCT02237508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25693974|NCT02023151|Respiratory System Agents|respiratory system agents|mesh-ancestor
25693975|NCT02023411|Teriparatide|teriparatide|mesh-list
25693976|NCT02023411|Hormones|hormones|mesh-list
25693977|NCT02023411|Parathyroid Hormone|parathyroid hormone|mesh-list
25693978|NCT02023411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25693979|NCT02023411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693980|NCT02023411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25693981|NCT02023411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25048843|NCT00662597|Carboplatin|carboplatin|mesh-list
25048844|NCT00662597|Vadimezan|vadimezan|mesh-list
25048845|NCT00662597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25048846|NCT00662597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048867|NCT00660881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25048868|NCT00660881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048870|NCT00659191|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25048871|NCT00659191|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24915476|NCT02237508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24915477|NCT02237508|Adrenergic Agents|adrenergic agents|mesh-ancestor
24616073|NCT01033877|Immunologic Factors|immunologic factors|mesh-ancestor
24616074|NCT01033877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616076|NCT01033903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24616077|NCT01033903|Abortifacient Agents|abortifacient agents|mesh-ancestor
24616078|NCT01033903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24616079|NCT01033903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616080|NCT01033903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24616081|NCT01033903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24616082|NCT01033903|Oxytocics|oxytocics|mesh-ancestor
24616083|NCT01033955|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24490264|NCT00477373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915513|NCT01583283|Ricolinostat|ricolinostat|mesh-list
24915514|NCT01583283|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
24915515|NCT01583283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24915516|NCT01583283|Antiemetics|antiemetics|mesh-ancestor
24915526|NCT01583283|Immunologic Factors|immunologic factors|mesh-ancestor
24915527|NCT01583283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24915528|NCT01583283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24915532|NCT01583283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915533|NCT01341600|Omeprazole|omeprazole|mesh-list
24915534|NCT01341600|Clopidogrel|clopidogrel|mesh-list
24915535|NCT01341600|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24915536|NCT01341600|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24915537|NCT01341600|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24915538|NCT01341600|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24915539|NCT01341600|Purinergic Agents|purinergic agents|mesh-ancestor
24915540|NCT01341600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24915541|NCT01341600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520460|NCT01497509|Epinephryl borate|epinephryl borate|mesh-list
24520461|NCT01497509|Anesthetics, Local|anesthetics, local|mesh-ancestor
24520462|NCT01497509|Anesthetics|anesthetics|mesh-ancestor
24520463|NCT01497509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24520464|NCT01497509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520470|NCT01497509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24520471|NCT01497509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24520472|NCT01497509|Anesthetics, General|anesthetics, general|mesh-ancestor
24520473|NCT01497509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24520474|NCT01497509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24520475|NCT01497509|Adrenergic Agents|adrenergic agents|mesh-ancestor
24950187|NCT02024230|Anticoagulants|anticoagulants|mesh-ancestor
24950188|NCT02024230|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24950189|NCT02024230|Antithrombins|antithrombins|mesh-ancestor
24950190|NCT02024230|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24950191|NCT02024230|Protease Inhibitors|protease inhibitors|mesh-ancestor
24950192|NCT02024230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950194|NCT01967238|Vaccines|vaccines|mesh-list
25065460|NCT05322265|Sympathomimetics|sympathomimetics|mesh-ancestor
25065461|NCT05322265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25065462|NCT05322252|Misoprostol|misoprostol|mesh-list
25065463|NCT05322252|Mifepristone|mifepristone|mesh-list
25065464|NCT05322252|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25065465|NCT05322252|Abortifacient Agents|abortifacient agents|mesh-ancestor
25065466|NCT05322252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24534110|NCT00646061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25693982|NCT02023697|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25693983|NCT02023697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25693984|NCT02023866|Cysteamine|cysteamine|mesh-list
25693985|NCT02023866|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
25693986|NCT02023866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25693987|NCT02023879|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25693988|NCT02023879|Immunologic Factors|immunologic factors|mesh-ancestor
25693989|NCT02023879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644029|NCT01188317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24938228|NCT04020653|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24938229|NCT04020653|Citric Acid|citric acid|mesh-list
24938230|NCT04020653|Sodium Citrate|sodium citrate|mesh-list
24938231|NCT04020653|Anticoagulants|anticoagulants|mesh-ancestor
24938232|NCT04020653|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24938233|NCT04020653|Chelating Agents|chelating agents|mesh-ancestor
24938234|NCT04020653|Sequestering Agents|sequestering agents|mesh-ancestor
24938235|NCT04020653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938236|NCT04020653|Antimalarials|antimalarials|mesh-ancestor
24938237|NCT04020653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24938238|NCT04020653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24938242|NCT04020653|Trace Elements|trace elements|mesh-ancestor
25065467|NCT05322252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065468|NCT05322252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25065469|NCT05322252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25065470|NCT05322252|Oxytocics|oxytocics|mesh-ancestor
25065471|NCT05322252|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25065472|NCT05322252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25065473|NCT05322252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25065474|NCT05322252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25065475|NCT05322252|Contraceptive Agents|contraceptive agents|mesh-ancestor
25065476|NCT05322252|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25065477|NCT05322252|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25065478|NCT05322252|Hormone Antagonists|hormone antagonists|mesh-ancestor
25065479|NCT05322252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25065480|NCT05322252|Luteolytic Agents|luteolytic agents|mesh-ancestor
25065481|NCT05322252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25065482|NCT05322252|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24915543|NCT01341600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24915544|NCT01341600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24915545|NCT01341600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24915546|NCT01341600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24915547|NCT01328626|Venetoclax|venetoclax|mesh-list
24825397|NCT02128308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24915548|NCT01328626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915549|NCT00529113|Gemcitabine|gemcitabine|mesh-list
24915556|NCT00529113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24915557|NCT00529113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24915558|NCT00529113|Immunologic Factors|immunologic factors|mesh-ancestor
24915559|NCT00529113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915560|NCT04250792|Naltrexone|naltrexone|mesh-list
24915561|NCT04250792|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24915562|NCT04250792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24915563|NCT04250792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915564|NCT04250792|Sensory System Agents|sensory system agents|mesh-ancestor
24915565|NCT04250792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25693990|NCT02024204|Fluticasone|fluticasone|mesh-list
25693991|NCT02024204|Xhance|xhance|mesh-list
25693992|NCT02024204|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25693993|NCT02024204|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25693994|NCT02024204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25693995|NCT02024204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25693996|NCT02024204|Autonomic Agents|autonomic agents|mesh-ancestor
25693997|NCT02024204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25693998|NCT02024204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25693999|NCT02024204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25694000|NCT02024204|Respiratory System Agents|respiratory system agents|mesh-ancestor
25694001|NCT02024204|Dermatologic Agents|dermatologic agents|mesh-ancestor
25694002|NCT02024204|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25694003|NCT02024204|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25694004|NCT02024204|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25694005|NCT02024204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25694006|NCT02024204|Adrenergic Agents|adrenergic agents|mesh-ancestor
25694007|NCT02024204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25694008|NCT02024204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694009|NCT02024204|Glucocorticoids|glucocorticoids|mesh-ancestor
25000448|NCT04437485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25000449|NCT04437485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25000450|NCT04437485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24841760|NCT02217852|Captopril|captopril|mesh-list
24644059|NCT01188759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644060|NCT01188759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25694010|NCT02024204|Hormones|hormones|mesh-ancestor
24644062|NCT01188824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24644063|NCT01188824|Autonomic Agents|autonomic agents|mesh-ancestor
24644064|NCT01188824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24644065|NCT01188824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644066|NCT01188824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24644067|NCT01188824|Respiratory System Agents|respiratory system agents|mesh-ancestor
24915594|NCT04250246|Antimetabolites|antimetabolites|mesh-ancestor
24915595|NCT04250246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24915596|NCT04250142|Methamphetamine|methamphetamine|mesh-list
24915597|NCT04250142|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24915598|NCT04250142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915617|NCT04250116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24915618|NCT04250116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915619|NCT04250116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915620|NCT04250116|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24915621|NCT04250116|Antithrombins|antithrombins|mesh-ancestor
24915622|NCT04250116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24915626|NCT04250051|Vidarabine|vidarabine|mesh-list
24915637|NCT04250051|Immunologic Factors|immunologic factors|mesh-ancestor
24915638|NCT04250051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915639|NCT04250051|Antiviral Agents|antiviral agents|mesh-ancestor
24915640|NCT04250051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24915641|NCT04250051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24915642|NCT04250051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24915662|NCT04249570|Plasma Substitutes|plasma substitutes|mesh-ancestor
24915663|NCT04249570|Blood Substitutes|blood substitutes|mesh-ancestor
24915664|NCT04249570|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24950344|NCT00632853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24950345|NCT00632853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950346|NCT00632853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950347|NCT00610051|Alprostadil|alprostadil|mesh-list
24950348|NCT00610051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24950349|NCT00610051|Vasodilator Agents|vasodilator agents|mesh-ancestor
24950350|NCT00610051|Urological Agents|urological agents|mesh-ancestor
24950351|NCT00458003|Phenylephrine|phenylephrine|mesh-list
24950352|NCT00458003|Oxymetazoline|oxymetazoline|mesh-list
24950353|NCT00458003|Ephedrine|ephedrine|mesh-list
25694011|NCT02024204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25694012|NCT02024204|Sympathomimetics|sympathomimetics|mesh-ancestor
25694013|NCT02024386|Riociguat|riociguat|mesh-list
25694014|NCT02024386|Enzyme Activators|enzyme activators|mesh-ancestor
25694015|NCT02024386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694016|NCT02024477|Saxagliptin|saxagliptin|mesh-list
25694017|NCT02024477|Incretins|incretins|mesh-ancestor
25694018|NCT02024477|Hormones|hormones|mesh-ancestor
25694019|NCT02024477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25694020|NCT02024477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694021|NCT02024477|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25694022|NCT02024477|Protease Inhibitors|protease inhibitors|mesh-ancestor
25694023|NCT02024477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25694024|NCT02024477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694025|NCT02024477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25694026|NCT02024646|Brodalumab|brodalumab|mesh-list
25694027|NCT02024646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25694028|NCT02024646|Dermatologic Agents|dermatologic agents|mesh-ancestor
25694029|NCT02024646|Immunologic Factors|immunologic factors|mesh-ancestor
25694030|NCT02024646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694031|NCT02024711|Hyaluronic Acid|hyaluronic acid|mesh-list
25694032|NCT02024711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25694033|NCT02024711|Immunologic Factors|immunologic factors|mesh-ancestor
24644086|NCT01188889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24644087|NCT01188889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644088|NCT01188889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000484|NCT04433988|Vasodilator Agents|vasodilator agents|mesh-ancestor
25000485|NCT04433988|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25000486|NCT04433988|Antioxidants|antioxidants|mesh-ancestor
24950354|NCT00458003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24950355|NCT00458003|Mydriatics|mydriatics|mesh-ancestor
24950356|NCT00458003|Autonomic Agents|autonomic agents|mesh-ancestor
24950357|NCT00458003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24807123|NCT02019875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24953430|NCT03885297|Liraglutide|liraglutide|mesh-list
24953431|NCT03885297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24953432|NCT03885297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953433|NCT03885297|Incretins|incretins|mesh-ancestor
24915694|NCT04249154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738949|NCT01678417|Rituximab|rituximab|mesh-list
24915695|NCT04249284|BMS-986165|bms-986165|mesh-list
24915696|NCT04249284|Dermatologic Agents|dermatologic agents|mesh-ancestor
24915697|NCT04249284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24915698|NCT04249284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25065483|NCT05322187|Pembrolizumab|pembrolizumab|mesh-list
25065484|NCT05322187|Lenvatinib|lenvatinib|mesh-list
25065485|NCT05322187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24434888|NCT00264186|Cholinergic Agents|cholinergic agents|mesh-ancestor
24434889|NCT00264212|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24434890|NCT00264212|Irbesartan|irbesartan|mesh-list
24434891|NCT00264212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25065486|NCT05322187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25065487|NCT05322187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065488|NCT05322187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25065489|NCT05322187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25065490|NCT05322187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915699|NCT04249284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915700|NCT04248998|Metformin|metformin|mesh-list
24915711|NCT04248998|Immunologic Factors|immunologic factors|mesh-ancestor
24915712|NCT04248998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915713|NCT04248998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24915714|NCT04248998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24915715|NCT04248998|Alkylating Agents|alkylating agents|mesh-ancestor
24915716|NCT04248998|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24915717|NCT04248998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24827846|NCT02141958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915718|NCT04248998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24915719|NCT04248998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24915720|NCT04248998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25065507|NCT05321524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25694034|NCT02024711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694035|NCT02024711|Viscosupplements|viscosupplements|mesh-ancestor
25694036|NCT02024711|Protective Agents|protective agents|mesh-ancestor
25694037|NCT02024724|Dexamethasone|dexamethasone|mesh-list
25694038|NCT02024724|Triamcinolone|triamcinolone|mesh-list
25694039|NCT02024724|Bupivacaine|bupivacaine|mesh-list
25694040|NCT02024724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25694041|NCT02024724|Antiemetics|antiemetics|mesh-ancestor
25000687|NCT03787849|Anesthetics|anesthetics|mesh-list
25000688|NCT03787849|Propofol|propofol|mesh-list
25000689|NCT03787849|Sevoflurane|sevoflurane|mesh-list
25065508|NCT05321511|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25065509|NCT05321511|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24819675|NCT02096601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819676|NCT02096614|Cyclophosphamide|cyclophosphamide|mesh-list
24819677|NCT02096614|Fludarabine|fludarabine|mesh-list
24819678|NCT02096614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24819679|NCT02096614|Immunologic Factors|immunologic factors|mesh-ancestor
24819680|NCT02096614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819681|NCT02096614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24819682|NCT02096614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24915821|NCT04248101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24915824|NCT04248179|Anesthetics, Local|anesthetics, local|mesh-ancestor
24915825|NCT04248179|Anesthetics|anesthetics|mesh-ancestor
24435262|NCT00265772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915826|NCT04248179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24915827|NCT04248179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915851|NCT04247815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915852|NCT04247815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24915853|NCT04247815|Antimetabolites|antimetabolites|mesh-ancestor
24915854|NCT04247815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915865|NCT04247373|Anesthetics|anesthetics|mesh-ancestor
24915866|NCT04247373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24915867|NCT04247373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915868|NCT04247373|Sensory System Agents|sensory system agents|mesh-ancestor
24915869|NCT04247373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24915870|NCT04247230|Tetracaine|tetracaine|mesh-list
24915871|NCT04247230|Anesthetics, Local|anesthetics, local|mesh-ancestor
24915872|NCT04247230|Anesthetics|anesthetics|mesh-ancestor
24915873|NCT04247230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24915874|NCT04247230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915875|NCT04247230|Sensory System Agents|sensory system agents|mesh-ancestor
24915876|NCT04247230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24915877|NCT04247087|Vitamin K|vitamin k|mesh-list
24915878|NCT04247087|Vitamin K 1|vitamin k 1|mesh-list
24915908|NCT04246905|Sulforaphane|sulforaphane|mesh-list
25065519|NCT05321511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25065520|NCT05321511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065541|NCT05321121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25065542|NCT05321121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065543|NCT05321121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25065549|NCT05321121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25065550|NCT05321121|Adrenergic Agents|adrenergic agents|mesh-ancestor
25065551|NCT05321121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25065552|NCT05321121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065554|NCT05320926|Clopidogrel|clopidogrel|mesh-list
25065555|NCT05320926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25065556|NCT05320926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25065557|NCT05320926|Analgesics|analgesics|mesh-ancestor
25065558|NCT05320926|Sensory System Agents|sensory system agents|mesh-ancestor
25065559|NCT05320926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24915911|NCT04246905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915912|NCT04246905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694042|NCT02024724|Autonomic Agents|autonomic agents|mesh-ancestor
25694043|NCT02024724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25694044|NCT02024724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694045|NCT02024724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25694046|NCT02024724|Glucocorticoids|glucocorticoids|mesh-ancestor
25694047|NCT02024724|Hormones|hormones|mesh-ancestor
25694048|NCT02024724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25694049|NCT02024724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25694050|NCT02024724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694051|NCT02024724|Anesthetics, Local|anesthetics, local|mesh-ancestor
25694052|NCT02024724|Anesthetics|anesthetics|mesh-ancestor
24915914|NCT04246723|Sofosbuvir|sofosbuvir|mesh-list
24915915|NCT04246723|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24915916|NCT04246723|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24915917|NCT04246723|Protease Inhibitors|protease inhibitors|mesh-ancestor
24915918|NCT04246723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24915919|NCT04246723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915920|NCT04246723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24915921|NCT04246723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24915946|NCT04246567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24915947|NCT04246567|Narcotics|narcotics|mesh-ancestor
24915948|NCT04246567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24915949|NCT04246567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915950|NCT04246567|Analgesics|analgesics|mesh-ancestor
24915951|NCT04246567|Sensory System Agents|sensory system agents|mesh-ancestor
24915952|NCT04246567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24915953|NCT04246567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24915954|NCT04246567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24915955|NCT04246567|Anesthetics, General|anesthetics, general|mesh-ancestor
24915956|NCT04246567|Anesthetics|anesthetics|mesh-ancestor
24915957|NCT04246697|Acetaminophen|acetaminophen|mesh-list
24915958|NCT04246697|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24915959|NCT04246697|Morphine|morphine|mesh-list
24915960|NCT04246697|Oxycodone|oxycodone|mesh-list
24915961|NCT04246697|Gabapentin|gabapentin|mesh-list
24915962|NCT04246697|Bupivacaine|bupivacaine|mesh-list
24915983|NCT04246697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24520486|NCT00630565|Dexamethasone|dexamethasone|mesh-list
24520487|NCT00630565|Cyclophosphamide|cyclophosphamide|mesh-list
24915984|NCT04246697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24915985|NCT04246697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24915986|NCT04246697|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24915987|NCT04246697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24915988|NCT04246502|Capecitabine|capecitabine|mesh-list
24915992|NCT04246502|Antimetabolites|antimetabolites|mesh-ancestor
24915994|NCT04246502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915995|NCT04246502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24915996|NCT04246255|Lidocaine|lidocaine|mesh-list
24915997|NCT04246255|Anesthetics, Local|anesthetics, local|mesh-ancestor
24915998|NCT04246255|Anesthetics|anesthetics|mesh-ancestor
24915999|NCT04246255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24916000|NCT04246255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819683|NCT02096614|Alkylating Agents|alkylating agents|mesh-ancestor
24916001|NCT04246255|Sensory System Agents|sensory system agents|mesh-ancestor
24916002|NCT04246255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24916003|NCT04246255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24916004|NCT04246255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24916005|NCT04246255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25065560|NCT05320926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065561|NCT05320926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25065562|NCT05320926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25065563|NCT05320926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25065564|NCT05320926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25065565|NCT05320926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065566|NCT05320926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25065567|NCT05320926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25065568|NCT05320926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25065569|NCT05320926|Antipyretics|antipyretics|mesh-ancestor
25065570|NCT05320926|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25065571|NCT05320926|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25065572|NCT05320926|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25065573|NCT05320926|Purinergic Agents|purinergic agents|mesh-ancestor
25065575|NCT05320874|Antibodies|antibodies|mesh-list
25065576|NCT05320874|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25065577|NCT05320874|Immunologic Factors|immunologic factors|mesh-ancestor
25065578|NCT05320874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065579|NCT05320757|Olaparib|olaparib|mesh-list
25065580|NCT05320757|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25048963|NCT00656357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25048964|NCT00654992|Epoetin Alfa|epoetin alfa|mesh-list
25048965|NCT00654992|Hematinics|hematinics|mesh-ancestor
25048966|NCT00654706|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25048967|NCT00654706|Sertindole|sertindole|mesh-list
25048968|NCT00654706|Antidepressive Agents|antidepressive agents|mesh-ancestor
25048969|NCT00654706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25048970|NCT00654706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25048971|NCT00654706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24950359|NCT00458003|Sympathomimetics|sympathomimetics|mesh-ancestor
25065581|NCT05320757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25065582|NCT05320757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065583|NCT05320757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065585|NCT05320692|Chlorotrianisene|chlorotrianisene|mesh-list
25065586|NCT05320692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065587|NCT05320692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25065588|NCT05320692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25065589|NCT05320692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065590|NCT05320692|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25065601|NCT05320640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25065602|NCT05320640|Antimetabolites|antimetabolites|mesh-ancestor
25065603|NCT05320640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065604|NCT05320640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065605|NCT05320640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25065606|NCT05320588|Pembrolizumab|pembrolizumab|mesh-list
25065607|NCT05320588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25065608|NCT05320588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065609|NCT05320575|Zanubrutinib|zanubrutinib|mesh-list
25065610|NCT05320575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065611|NCT05320575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25065614|NCT05320094|Sorbitol|sorbitol|mesh-list
25065615|NCT05320094|Charcoal|charcoal|mesh-list
24916007|NCT04246255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916008|NCT04246229|Bilirubin|bilirubin|mesh-list
24916009|NCT04246229|Antioxidants|antioxidants|mesh-ancestor
24916010|NCT04246229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916011|NCT04246229|Protective Agents|protective agents|mesh-ancestor
24916012|NCT04246229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916013|NCT04245787|Fluorides|fluorides|mesh-list
24916027|NCT04245371|Anesthetics|anesthetics|mesh-ancestor
24916037|NCT04245618|Gemcitabine|gemcitabine|mesh-list
24916038|NCT04245618|Cisplatin|cisplatin|mesh-list
24549958|NCT00718354|Immunologic Factors|immunologic factors|mesh-ancestor
24549959|NCT00718354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435876|NCT00268398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916039|NCT04245618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24916040|NCT04245618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24916041|NCT04245618|Antimetabolites|antimetabolites|mesh-ancestor
24916042|NCT04245618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916043|NCT04245618|Antiviral Agents|antiviral agents|mesh-ancestor
24916044|NCT04245618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24916045|NCT04245618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916046|NCT04245618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24916047|NCT04245618|Immunologic Factors|immunologic factors|mesh-ancestor
24916048|NCT04245618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065626|NCT05311813|Antimalarials|antimalarials|mesh-ancestor
25065627|NCT05311813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25065628|NCT05311813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25694053|NCT02024724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25694054|NCT02024724|Sensory System Agents|sensory system agents|mesh-ancestor
25694055|NCT02024867|Trimethoprim|trimethoprim|mesh-list
25694056|NCT02024867|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25694057|NCT02024867|Sulfamethoxazole|sulfamethoxazole|mesh-list
25694058|NCT02024867|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25694059|NCT02024867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25065629|NCT05311813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25065630|NCT05311813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644383|NCT01190683|Cholecalciferol|cholecalciferol|mesh-list
24644384|NCT01190683|Vitamins|vitamins|mesh-list
24644385|NCT01190683|Calcium Carbonate|calcium carbonate|mesh-list
24644386|NCT01190683|Calcium|calcium|mesh-list
24644387|NCT01190683|Micronutrients|micronutrients|mesh-ancestor
25048990|NCT00649025|Xhance|xhance|mesh-list
25065631|NCT05311813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065632|NCT05311813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25065633|NCT05311813|Anticoagulants|anticoagulants|mesh-ancestor
25065634|NCT05311813|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25065635|NCT05311813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25065658|NCT05306704|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
25065659|NCT05306704|Calcifediol|calcifediol|mesh-list
25065660|NCT05306704|Vitamins|vitamins|mesh-ancestor
25065661|NCT05306704|Micronutrients|micronutrients|mesh-ancestor
25065662|NCT05306704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065663|NCT05306704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24435877|NCT00268398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24550086|NCT00719056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24916068|NCT04245046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24916069|NCT04245046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24916072|NCT04245046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25065682|NCT05303311|Dexamethasone|dexamethasone|mesh-list
25065683|NCT05303311|Meperidine|meperidine|mesh-list
25065684|NCT05303311|Bupivacaine|bupivacaine|mesh-list
24916086|NCT04244981|Thrombin|thrombin|mesh-list
24916087|NCT04244981|Hemostatics|hemostatics|mesh-ancestor
24916088|NCT04244981|Coagulants|coagulants|mesh-ancestor
24916089|NCT04245033|Piperaquine|piperaquine|mesh-list
24916090|NCT04245033|Artenimol|artenimol|mesh-list
24916091|NCT04245033|Antimalarials|antimalarials|mesh-ancestor
24916092|NCT04245033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24916093|NCT04245033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24916094|NCT04245033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24916095|NCT04244695|Dexamethasone|dexamethasone|mesh-list
24916096|NCT04244695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24819695|NCT02096913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24819696|NCT02096913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25065737|NCT05283161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065738|NCT05283161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25065739|NCT05283161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25065740|NCT05283161|Analgesics|analgesics|mesh-ancestor
25065741|NCT05283161|Sensory System Agents|sensory system agents|mesh-ancestor
25065742|NCT05283161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25065743|NCT05283161|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25065744|NCT05283161|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25065745|NCT05283161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25065746|NCT05283161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065747|NCT05283161|Hormones|hormones|mesh-ancestor
25065748|NCT05283161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25065749|NCT05278858|Triamcinolone|triamcinolone|mesh-list
25065750|NCT05278858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25065751|NCT05278858|Glucocorticoids|glucocorticoids|mesh-ancestor
25065752|NCT05278858|Hormones|hormones|mesh-ancestor
25065753|NCT05278858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25065754|NCT05278858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065755|NCT05269381|Cyclophosphamide|cyclophosphamide|mesh-list
25065764|NCT05269381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065765|NCT05269381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065766|NCT05269381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25065767|NCT05269381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24819718|NCT02097004|Entecavir|entecavir|mesh-list
24819719|NCT02097004|Antiviral Agents|antiviral agents|mesh-ancestor
24916109|NCT04244591|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24916110|NCT04244591|Prednisolone|prednisolone|mesh-list
24916111|NCT04244591|Prednisolone acetate|prednisolone acetate|mesh-list
24916112|NCT04244591|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24916113|NCT04244591|Prednisolone phosphate|prednisolone phosphate|mesh-list
24916114|NCT04244591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24916115|NCT04244591|Antiemetics|antiemetics|mesh-ancestor
24916116|NCT04244591|Autonomic Agents|autonomic agents|mesh-ancestor
25065771|NCT05260528|Cytarabine|cytarabine|mesh-list
24950570|NCT03914092|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25694060|NCT02024867|Renal Agents|renal agents|mesh-ancestor
25694061|NCT02024867|Antimalarials|antimalarials|mesh-ancestor
25694062|NCT02024867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25694063|NCT02024867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25694064|NCT02024867|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25065772|NCT05260528|Idarubicin|idarubicin|mesh-list
25694065|NCT02024867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25001117|NCT05457647|Riboflavin|riboflavin|mesh-list
25001155|NCT05443971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25001156|NCT05443971|Immunologic Factors|immunologic factors|mesh-ancestor
25001157|NCT05443971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393465|NCT00130091|Adrenergic Agents|adrenergic agents|mesh-ancestor
24393466|NCT00130091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24393468|NCT00130143|Amifostine|amifostine|mesh-list
25065773|NCT05260528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24451033|NCT00321490|Dopamine Agents|dopamine agents|mesh-ancestor
24776243|NCT01857284|Antiviral Agents|antiviral agents|mesh-ancestor
24807403|NCT02021851|Ondansetron|ondansetron|mesh-list
24953460|NCT03884491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24953461|NCT03884491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24953462|NCT03884491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953463|NCT03884491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24953464|NCT03884491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24953465|NCT03884491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24953466|NCT03884491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953467|NCT03884491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24953468|NCT03884491|Serotonin Agents|serotonin agents|mesh-ancestor
24953469|NCT03884491|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24953470|NCT03884491|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25065775|NCT05260528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065776|NCT05260528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065777|NCT05260528|Antiviral Agents|antiviral agents|mesh-ancestor
25065778|NCT05260528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25065779|NCT05260528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25065780|NCT05260528|Immunologic Factors|immunologic factors|mesh-ancestor
25065782|NCT05260528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25065859|NCT05045378|Ketamine|ketamine|mesh-list
25065860|NCT05045378|Analgesics|analgesics|mesh-ancestor
25065861|NCT05045378|Sensory System Agents|sensory system agents|mesh-ancestor
25065862|NCT05045378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25065863|NCT05045378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065864|NCT05045378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25065865|NCT05045378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25065866|NCT05045378|Anesthetics, General|anesthetics, general|mesh-ancestor
25694066|NCT02024867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694067|NCT02024867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25694068|NCT02024867|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25694069|NCT02024867|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25694070|NCT02024867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25694071|NCT02024971|Metformin|metformin|mesh-list
25694072|NCT02024971|Pioglitazone|pioglitazone|mesh-list
25694073|NCT02024971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25694074|NCT02024971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694075|NCT02025075|Rocuronium|rocuronium|mesh-list
25065867|NCT05045378|Anesthetics|anesthetics|mesh-ancestor
25065871|NCT05045378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25065872|NCT05045378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065873|NCT05045378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25065874|NCT05045378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25065875|NCT05045378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24916119|NCT04244591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25065876|NCT05045378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25065877|NCT05045378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25065878|NCT05045378|GABA Modulators|gaba modulators|mesh-ancestor
25065879|NCT05045378|GABA Agents|gaba agents|mesh-ancestor
25065881|NCT04984889|Anticoagulants|anticoagulants|mesh-ancestor
25065882|NCT04984889|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25065883|NCT04984889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25065884|NCT04984889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950721|NCT03912740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24950793|NCT03911817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065885|NCT04977830|Xenon|xenon|mesh-list
25065886|NCT04977830|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25065887|NCT04977830|Anesthetics, General|anesthetics, general|mesh-ancestor
25065888|NCT04977830|Anesthetics|anesthetics|mesh-ancestor
25065889|NCT04977830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25065890|NCT04977830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065891|NCT04966481|Cetuximab|cetuximab|mesh-list
25065892|NCT04966481|Palbociclib|palbociclib|mesh-list
25065893|NCT04966481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25065894|NCT04966481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065895|NCT04966481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24916120|NCT04244591|Glucocorticoids|glucocorticoids|mesh-ancestor
24916121|NCT04244591|Hormones|hormones|mesh-ancestor
24916122|NCT04244591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24916123|NCT04244591|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24916124|NCT04244591|Protective Agents|protective agents|mesh-ancestor
24916125|NCT04244591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24916126|NCT04244591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739409|NCT01681446|Interferons|interferons|mesh-list
24916127|NCT04244708|Temozolomide|temozolomide|mesh-list
24916128|NCT04244708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24916129|NCT04244708|Alkylating Agents|alkylating agents|mesh-ancestor
24916131|NCT04244708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24916149|NCT04243954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25694076|NCT02025075|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25694077|NCT02025075|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25694078|NCT02025075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25694079|NCT02025075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25694080|NCT02025075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694081|NCT02025179|Teriparatide|teriparatide|mesh-list
25694082|NCT02025179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25694083|NCT02025179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694084|NCT02025179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25694085|NCT02025426|Phenylephrine|phenylephrine|mesh-list
25694086|NCT02025426|Oxymetazoline|oxymetazoline|mesh-list
25694087|NCT02025426|Ephedrine|ephedrine|mesh-list
25694088|NCT02025426|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24644663|NCT01192308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24644664|NCT01192308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065897|NCT04966481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065898|NCT04946630|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25065899|NCT04946630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25065900|NCT04946630|Autonomic Agents|autonomic agents|mesh-ancestor
25065901|NCT04946630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25065902|NCT04946630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065903|NCT04946630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25065904|NCT04946630|Respiratory System Agents|respiratory system agents|mesh-ancestor
25065905|NCT04946630|Glucocorticoids|glucocorticoids|mesh-ancestor
25065907|NCT04946630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25065908|NCT04946630|Sympathomimetics|sympathomimetics|mesh-ancestor
25065909|NCT04908228|Obinutuzumab|obinutuzumab|mesh-list
25065910|NCT04908228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25065911|NCT04908228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065913|NCT04905121|Hallucinogens|hallucinogens|mesh-ancestor
25065914|NCT04905121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065915|NCT04905121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25065916|NCT04796363|Anesthetics|anesthetics|mesh-list
25065917|NCT04796363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25065918|NCT04796363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065919|NCT04768166|Miglustat|miglustat|mesh-list
25065920|NCT04768166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25065941|NCT04760041|GABA Agents|gaba agents|mesh-ancestor
25065942|NCT04760041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25065943|NCT04760041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065944|NCT04754035|Venetoclax|venetoclax|mesh-list
25065945|NCT04754035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065953|NCT04650984|Doxorubicin|doxorubicin|mesh-list
25065954|NCT04650984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25065955|NCT04650984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065956|NCT04650984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25065957|NCT04650984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25065958|NCT04650984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25065959|NCT04650984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065960|NCT04642404|Cannabidiol|cannabidiol|mesh-list
25065961|NCT04642404|Anticonvulsants|anticonvulsants|mesh-ancestor
25065966|NCT04628429|Erenumab|erenumab|mesh-list
25065992|NCT04614714|Vasodilator Agents|vasodilator agents|mesh-ancestor
25065993|NCT04609579|Pembrolizumab|pembrolizumab|mesh-list
25065994|NCT04609579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25065995|NCT04609579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065996|NCT04557527|Hyaluronic Acid|hyaluronic acid|mesh-list
25065997|NCT04557527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25065998|NCT04557527|Immunologic Factors|immunologic factors|mesh-ancestor
25065999|NCT04557527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066000|NCT04557527|Viscosupplements|viscosupplements|mesh-ancestor
25066001|NCT04557527|Protective Agents|protective agents|mesh-ancestor
25066002|NCT04546178|Antipsychotic Agents|antipsychotic agents|mesh-list
25066003|NCT04546178|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25066004|NCT04546178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25066005|NCT04546178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066013|NCT04450173|Venetoclax|venetoclax|mesh-list
25066014|NCT04450173|Obinutuzumab|obinutuzumab|mesh-list
25066015|NCT04450173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066016|NCT04450173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25066017|NCT04430699|Cisplatin|cisplatin|mesh-list
25066018|NCT04430699|Pembrolizumab|pembrolizumab|mesh-list
25066019|NCT04430699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066020|NCT04430699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25066021|NCT04383002|Nitric Oxide|nitric oxide|mesh-list
25066022|NCT04383002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25066023|NCT04383002|Autonomic Agents|autonomic agents|mesh-ancestor
25066024|NCT04383002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25066025|NCT04383002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694089|NCT02025426|Mydriatics|mydriatics|mesh-ancestor
25694090|NCT02025426|Autonomic Agents|autonomic agents|mesh-ancestor
25694091|NCT02025426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25694092|NCT02025426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694093|NCT02025426|Sympathomimetics|sympathomimetics|mesh-ancestor
25694094|NCT02025426|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25049078|NCT00637052|Mitosis Modulators|mitosis modulators|mesh-ancestor
24393785|NCT00131027|Etoposide|etoposide|mesh-list
25049079|NCT00637052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049080|NCT00637052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25049081|NCT00636480|Chlorhexidine|chlorhexidine|mesh-list
25049082|NCT00636480|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25049083|NCT00636480|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25049084|NCT00636480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25049087|NCT00635505|Albuterol|albuterol|mesh-list
25066026|NCT04383002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25066027|NCT04383002|Respiratory System Agents|respiratory system agents|mesh-ancestor
25066028|NCT04383002|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25066029|NCT04383002|Antioxidants|antioxidants|mesh-ancestor
25066030|NCT04383002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066031|NCT04383002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25066032|NCT04383002|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25066033|NCT04383002|Vasodilator Agents|vasodilator agents|mesh-ancestor
25066034|NCT04383002|Gasotransmitters|gasotransmitters|mesh-ancestor
24916164|NCT04244097|Neostigmine|neostigmine|mesh-list
24916165|NCT04244097|Anesthetics, Local|anesthetics, local|mesh-ancestor
24916166|NCT04244097|Anesthetics|anesthetics|mesh-ancestor
24916167|NCT04244097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24916168|NCT04244097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916169|NCT04244097|Sensory System Agents|sensory system agents|mesh-ancestor
24916170|NCT04244097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24916171|NCT04244097|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24916172|NCT04244097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916173|NCT04244097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916174|NCT04244097|Cholinergic Agents|cholinergic agents|mesh-ancestor
24916175|NCT04244097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24916178|NCT04243993|Calcium|calcium|mesh-list
24916189|NCT04243850|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24916190|NCT04243850|Purinergic Agents|purinergic agents|mesh-ancestor
24916191|NCT04243850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24916192|NCT04243850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24916193|NCT04243850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24916195|NCT04243733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24916196|NCT04243733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916197|NCT04243733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916198|NCT04243733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25066035|NCT04383002|Protective Agents|protective agents|mesh-ancestor
25066037|NCT04375228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25066038|NCT04375228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24916201|NCT04243811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24916202|NCT04243811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916203|NCT04243434|Prednisone|prednisone|mesh-list
24916204|NCT04243434|Cyclophosphamide|cyclophosphamide|mesh-list
24916205|NCT04243434|Doxorubicin|doxorubicin|mesh-list
24916206|NCT04243434|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24916207|NCT04243434|Vincristine|vincristine|mesh-list
24916208|NCT04243434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24916209|NCT04243434|Immunologic Factors|immunologic factors|mesh-ancestor
24916210|NCT04243434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694095|NCT02025426|Nasal Decongestants|nasal decongestants|mesh-ancestor
25694096|NCT02025426|Respiratory System Agents|respiratory system agents|mesh-ancestor
25694097|NCT02025426|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25694098|NCT02025426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25694099|NCT02025426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25694100|NCT02025426|Adrenergic Agents|adrenergic agents|mesh-ancestor
25694101|NCT02025426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25694102|NCT02025426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694103|NCT02025426|Protective Agents|protective agents|mesh-ancestor
25694104|NCT02025426|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25694105|NCT02025439|Amantadine|amantadine|mesh-list
25694106|NCT02025439|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25694107|NCT02025439|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25001747|NCT05132660|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25001782|NCT05084508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25001804|NCT05045144|Vaccines|vaccines|mesh-list
25001805|NCT05045144|Immunologic Factors|immunologic factors|mesh-ancestor
25001806|NCT05045144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939491|NCT04008979|Sensory System Agents|sensory system agents|mesh-ancestor
24644714|NCT01192724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24644715|NCT01192724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24644716|NCT01192724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916211|NCT04243434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24916212|NCT04243434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24490983|NCT00480675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24490984|NCT00480675|Methylprednisolone|methylprednisolone|mesh-list
24916228|NCT04243434|Antimitotic Agents|antimitotic agents|mesh-ancestor
24916229|NCT04243434|Mitosis Modulators|mitosis modulators|mesh-ancestor
24916230|NCT04243109|Dexamethasone|dexamethasone|mesh-list
24916231|NCT04243109|Cyclophosphamide|cyclophosphamide|mesh-list
24916232|NCT04243109|Pomalidomide|pomalidomide|mesh-list
24916233|NCT04243109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24916234|NCT04243109|Immunologic Factors|immunologic factors|mesh-ancestor
24916235|NCT04243109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916236|NCT04243109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24916237|NCT04243109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24916249|NCT04243109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24916251|NCT04243109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24916252|NCT04243109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24916253|NCT04243109|Growth Substances|growth substances|mesh-ancestor
24916254|NCT04243109|Growth Inhibitors|growth inhibitors|mesh-ancestor
24916255|NCT04242914|Midazolam|midazolam|mesh-list
24916256|NCT04242914|Ketamine|ketamine|mesh-list
24819734|NCT02097043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24819735|NCT02097043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24819736|NCT02097069|Folic Acid|folic acid|mesh-list
24819737|NCT02097069|Inositol|inositol|mesh-list
24819738|NCT02097069|Hematinics|hematinics|mesh-ancestor
24825623|NCT02129257|Micronutrients|micronutrients|mesh-ancestor
24825624|NCT02129257|Hematinics|hematinics|mesh-ancestor
24819739|NCT02097069|Vitamin B Complex|vitamin b complex|mesh-ancestor
24819740|NCT02097069|Vitamins|vitamins|mesh-ancestor
24819741|NCT02097069|Micronutrients|micronutrients|mesh-ancestor
24819742|NCT02097069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819743|NCT02097082|Paclitaxel|paclitaxel|mesh-list
25066043|NCT04370145|Tinidazole|tinidazole|mesh-list
25066044|NCT04370145|Teicoplanin|teicoplanin|mesh-list
25066045|NCT04370145|Sulperazone|sulperazone|mesh-list
25066046|NCT04370145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25066047|NCT04370145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25066048|NCT04370145|Alkylating Agents|alkylating agents|mesh-ancestor
25066049|NCT04370145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066050|NCT04370145|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25066051|NCT04370145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25066052|NCT04370145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25066053|NCT04370145|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25066054|NCT04370145|Renal Agents|renal agents|mesh-ancestor
25066055|NCT04368429|Vaccines|vaccines|mesh-list
25066062|NCT04366908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25066063|NCT04358003|Coal Tar|coal tar|mesh-list
25066064|NCT04358003|Keratolytic Agents|keratolytic agents|mesh-ancestor
25066065|NCT04358003|Dermatologic Agents|dermatologic agents|mesh-ancestor
25694108|NCT02025439|Antiviral Agents|antiviral agents|mesh-ancestor
25694109|NCT02025439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25694110|NCT02025439|Dopamine Agents|dopamine agents|mesh-ancestor
25694111|NCT02025439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25694112|NCT02025439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694113|NCT02025439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694114|NCT02025439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25694115|NCT02025439|Analgesics|analgesics|mesh-ancestor
25694116|NCT02025439|Sensory System Agents|sensory system agents|mesh-ancestor
25694117|NCT02025439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25694118|NCT02025621|Simendan|simendan|mesh-list
25694119|NCT02025621|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25694120|NCT02025621|Vasodilator Agents|vasodilator agents|mesh-ancestor
25066066|NCT04331067|Paclitaxel|paclitaxel|mesh-list
25066067|NCT04331067|Carboplatin|carboplatin|mesh-list
24393915|NCT00131261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066070|NCT04331067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066071|NCT04331067|Tubulin Modulators|tubulin modulators|mesh-ancestor
25066072|NCT04331067|Antimitotic Agents|antimitotic agents|mesh-ancestor
25066074|NCT04331067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066075|NCT04331067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25066076|NCT04331067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25066078|NCT04311073|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25066079|NCT04311073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25066080|NCT04311073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066081|NCT04311073|Hemostatics|hemostatics|mesh-ancestor
25066082|NCT04311073|Coagulants|coagulants|mesh-ancestor
24950966|NCT03909737|Azithromycin|azithromycin|mesh-list
24819744|NCT02097082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24819745|NCT02097082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24819746|NCT02097082|Tubulin Modulators|tubulin modulators|mesh-ancestor
24819747|NCT02097082|Antimitotic Agents|antimitotic agents|mesh-ancestor
24825625|NCT02129270|Lidocaine|lidocaine|mesh-list
24825626|NCT02129270|Anesthetics, Local|anesthetics, local|mesh-ancestor
24819766|NCT02097147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24819767|NCT02097160|Vitamin D|vitamin d|mesh-list
24819768|NCT02097160|Vitamins|vitamins|mesh-ancestor
24819769|NCT02097160|Micronutrients|micronutrients|mesh-ancestor
24819770|NCT02097160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819771|NCT02097160|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24819772|NCT02097173|Methotrexate|methotrexate|mesh-list
24739630|NCT01683032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24916281|NCT04242927|Vitamins|vitamins|mesh-ancestor
24916282|NCT04242927|Micronutrients|micronutrients|mesh-ancestor
24916283|NCT04242927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916284|NCT04242927|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24916285|NCT04242927|Antimetabolites|antimetabolites|mesh-ancestor
24916286|NCT04242927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916287|NCT04242927|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24916288|NCT04242927|Vasodilator Agents|vasodilator agents|mesh-ancestor
24916317|NCT04242368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24916318|NCT04242368|Respiratory System Agents|respiratory system agents|mesh-ancestor
24916319|NCT04242368|Dermatologic Agents|dermatologic agents|mesh-ancestor
24916320|NCT04242368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24916321|NCT04242017|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24916322|NCT04242017|Luteolytic Agents|luteolytic agents|mesh-ancestor
24916323|NCT04242017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24916324|NCT04242017|Contraceptive Agents|contraceptive agents|mesh-ancestor
24916325|NCT04242017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24916326|NCT04242017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916327|NCT04242017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24916328|NCT04242017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24438305|NCT00275457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438306|NCT00275457|Protective Agents|protective agents|mesh-ancestor
24438307|NCT00275457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438308|NCT00275457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24438309|NCT00275457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24438310|NCT00275457|Dopamine Agonists|dopamine agonists|mesh-ancestor
24916335|NCT04241705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25694121|NCT02025621|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25694122|NCT02025621|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25694123|NCT02025621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25694124|NCT02025621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694125|NCT02025621|Protective Agents|protective agents|mesh-ancestor
25694126|NCT02025621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694127|NCT02025634|Acetaminophen|acetaminophen|mesh-list
25694128|NCT02025634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25694129|NCT02025634|Analgesics|analgesics|mesh-ancestor
24644894|NCT01193595|Growth Inhibitors|growth inhibitors|mesh-ancestor
24644895|NCT01193621|Haloperidol|haloperidol|mesh-list
24644896|NCT01193621|Haloperidol decanoate|haloperidol decanoate|mesh-list
24644898|NCT01193621|Autonomic Agents|autonomic agents|mesh-ancestor
24644899|NCT01193621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24644900|NCT01193621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644901|NCT01193621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24644902|NCT01193621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24916336|NCT04241705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24916337|NCT04241705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24916338|NCT04241653|Sevoflurane|sevoflurane|mesh-list
24916339|NCT04241653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24916340|NCT04241653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24916341|NCT04241653|Anesthetics, General|anesthetics, general|mesh-ancestor
24916342|NCT04241653|Anesthetics|anesthetics|mesh-ancestor
24916343|NCT04241653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24916344|NCT04241653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916369|NCT04241601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24916370|NCT04241601|Antiviral Agents|antiviral agents|mesh-ancestor
24916371|NCT04241601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24916375|NCT04241523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25066094|NCT04298606|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
25066095|NCT04298606|Mitogens|mitogens|mesh-list
25066096|NCT04298606|Immunologic Factors|immunologic factors|mesh-ancestor
25066097|NCT04298606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951038|NCT03908944|Respiratory System Agents|respiratory system agents|mesh-ancestor
24951039|NCT03908619|Esomeprazole|esomeprazole|mesh-list
24951040|NCT03908619|Omeprazole|omeprazole|mesh-list
24951041|NCT03908619|Rabeprazole|rabeprazole|mesh-list
25066098|NCT04298606|Mitosis Modulators|mitosis modulators|mesh-ancestor
25066099|NCT04298606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066100|NCT04298606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25066101|NCT04283890|Nivolumab|nivolumab|mesh-list
25066102|NCT04283890|Ipilimumab|ipilimumab|mesh-list
25066103|NCT04283890|Melphalan|melphalan|mesh-list
25066104|NCT04283890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25066105|NCT04283890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066106|NCT04283890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25066107|NCT04283890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066108|NCT04283890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25066109|NCT04283890|Alkylating Agents|alkylating agents|mesh-ancestor
25066110|NCT04283890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25066111|NCT04283890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25066112|NCT04283890|Immunologic Factors|immunologic factors|mesh-ancestor
25066113|NCT04283890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916409|NCT04241276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916410|NCT04241276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24916411|NCT04241276|Antimetabolites|antimetabolites|mesh-ancestor
24916412|NCT04241276|Antiviral Agents|antiviral agents|mesh-ancestor
24916413|NCT04241276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24916414|NCT04241276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916415|NCT04241276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24916416|NCT04241276|Immunologic Factors|immunologic factors|mesh-ancestor
24916417|NCT04241276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066121|NCT04255407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25066122|NCT04238143|Complement Factor H|complement factor h|mesh-list
25066123|NCT04238143|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25066124|NCT04238143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25694130|NCT02025634|Sensory System Agents|sensory system agents|mesh-ancestor
25694131|NCT02025634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25694132|NCT02025634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694133|NCT02025634|Antipyretics|antipyretics|mesh-ancestor
25694134|NCT02025725|Metoclopramide|metoclopramide|mesh-list
25694135|NCT02025725|Antiemetics|antiemetics|mesh-ancestor
25694136|NCT02025725|Autonomic Agents|autonomic agents|mesh-ancestor
25694137|NCT02025725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25694138|NCT02025725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694139|NCT02025725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25694140|NCT02025725|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25694141|NCT02025725|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24449411|NCT00315536|Glycopyrrolate|glycopyrrolate|mesh-list
24798593|NCT01964287|Gemcitabine|gemcitabine|mesh-list
24645090|NCT01195649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24645117|NCT01195805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645118|NCT01195805|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24645119|NCT01195974|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
24645120|NCT01195974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25066125|NCT04238143|Immunologic Factors|immunologic factors|mesh-ancestor
25066126|NCT04238143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066127|NCT04221087|Dexamethasone|dexamethasone|mesh-list
25066128|NCT04221087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25066129|NCT04221087|Antiemetics|antiemetics|mesh-ancestor
25066130|NCT04221087|Autonomic Agents|autonomic agents|mesh-ancestor
25066131|NCT04221087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25066132|NCT04221087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066133|NCT04221087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25066134|NCT04221087|Glucocorticoids|glucocorticoids|mesh-ancestor
25066135|NCT04221087|Hormones|hormones|mesh-ancestor
24951042|NCT03908619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25066157|NCT04169100|Prednisone|prednisone|mesh-list
25066158|NCT04169100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25066159|NCT04169100|Glucocorticoids|glucocorticoids|mesh-ancestor
25066160|NCT04169100|Hormones|hormones|mesh-ancestor
24951121|NCT03908333|Antioxidants|antioxidants|mesh-ancestor
25066161|NCT04169100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25066162|NCT04169100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066163|NCT04169100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25066164|NCT04169100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066165|NCT04155840|Rituximab|rituximab|mesh-list
25066166|NCT04155840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25066167|NCT04155840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25066168|NCT04155840|Antibodies|antibodies|mesh-list
25066169|NCT04155840|Immunoglobulins|immunoglobulins|mesh-list
25066170|NCT04155840|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25066171|NCT04155840|Immunologic Factors|immunologic factors|mesh-ancestor
25066172|NCT04155840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066173|NCT04155840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066174|NCT04155840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25066175|NCT04155840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25066176|NCT04155840|Alkylating Agents|alkylating agents|mesh-ancestor
25066177|NCT04155840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916435|NCT04240756|Amphetamine|amphetamine|mesh-list
24916436|NCT04240756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24520489|NCT00630565|Etoposide|etoposide|mesh-list
24916447|NCT04240756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24916448|NCT04240756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24916449|NCT04240834|Aspirin|aspirin|mesh-list
24916450|NCT04240834|Ticagrelor|ticagrelor|mesh-list
24916521|NCT04239859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916466|NCT04240834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24916467|NCT04240834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24916469|NCT04240834|Purinergic Agents|purinergic agents|mesh-ancestor
24916470|NCT04240834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24916472|NCT04240496|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24916473|NCT04240496|Serotonin Agents|serotonin agents|mesh-ancestor
24916474|NCT04240496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24916475|NCT04240496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916476|NCT04240496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916477|NCT04240496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24916478|NCT04240496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24916479|NCT04240496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24916480|NCT04240496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24819775|NCT02097173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24819776|NCT02097173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694142|NCT02025725|Dopamine Agents|dopamine agents|mesh-ancestor
25694143|NCT02025725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25694144|NCT02025725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694145|NCT02025751|Metoclopramide|metoclopramide|mesh-list
25694146|NCT02025751|Antiemetics|antiemetics|mesh-ancestor
25694147|NCT02025751|Autonomic Agents|autonomic agents|mesh-ancestor
25694148|NCT02025751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25694149|NCT02025751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694150|NCT02025751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24819777|NCT02097173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24819785|NCT02097173|Immunologic Factors|immunologic factors|mesh-ancestor
24819786|NCT02097173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24819787|NCT02097173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24819788|NCT02097264|Adalimumab|adalimumab|mesh-list
24819789|NCT02097264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24819790|NCT02097264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24819791|NCT02097316|Insulin|insulin|mesh-list
24819792|NCT02097316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24819793|NCT02097316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819794|NCT02097329|Palbociclib|palbociclib|mesh-list
24819795|NCT02097329|Rabeprazole|rabeprazole|mesh-list
24819796|NCT02097329|Famotidine|famotidine|mesh-list
24819797|NCT02097329|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
24819798|NCT02097329|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
24819799|NCT02097329|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24819800|NCT02097329|Magnesium Hydroxide|magnesium hydroxide|mesh-list
24819801|NCT02097329|Antacids|antacids|mesh-list
25066201|NCT04119453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066202|NCT04119453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25066203|NCT04119453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25066204|NCT04119453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819820|NCT02097342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24819821|NCT02097342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819828|NCT02097342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819829|NCT02097342|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24819830|NCT02097381|Ritonavir|ritonavir|mesh-list
24819831|NCT02097381|Lopinavir|lopinavir|mesh-list
24819832|NCT02097381|Darunavir|darunavir|mesh-list
24819833|NCT02097381|Tenofovir|tenofovir|mesh-list
24819834|NCT02097381|Emtricitabine|emtricitabine|mesh-list
24819835|NCT02097381|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24916485|NCT04240535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24916486|NCT04240535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24916487|NCT04240535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916488|NCT04240535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24916489|NCT04240535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24916490|NCT04240535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916491|NCT04240535|Cholinergic Agents|cholinergic agents|mesh-ancestor
24916492|NCT04240535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24916494|NCT04239794|Sevoflurane|sevoflurane|mesh-list
24916495|NCT04239794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24916505|NCT04239833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24916506|NCT04239833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916507|NCT04239833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916508|NCT04239859|Cyclosporine|cyclosporine|mesh-list
24916509|NCT04239859|Methotrexate|methotrexate|mesh-list
24916510|NCT04239859|Acitretin|acitretin|mesh-list
24916511|NCT04239859|Cyclosporins|cyclosporins|mesh-list
24916512|NCT04239859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24916513|NCT04239859|Abortifacient Agents|abortifacient agents|mesh-ancestor
24916514|NCT04239859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24916515|NCT04239859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916516|NCT04239859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24916517|NCT04239859|Antimetabolites|antimetabolites|mesh-ancestor
24916518|NCT04239859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916519|NCT04239859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24916520|NCT04239859|Dermatologic Agents|dermatologic agents|mesh-ancestor
24916548|NCT04239625|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24916549|NCT04239625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24916550|NCT04239625|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24916551|NCT04239625|Immunologic Factors|immunologic factors|mesh-ancestor
24916552|NCT04239586|Glyburide|glyburide|mesh-list
24916553|NCT04239586|Glipizide|glipizide|mesh-list
24916554|NCT04239586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24916555|NCT04239586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916556|NCT04239755|Doxycycline|doxycycline|mesh-list
24916557|NCT04239755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24916558|NCT04239755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24916559|NCT04239755|Antimalarials|antimalarials|mesh-ancestor
24916560|NCT04239755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24916561|NCT04239755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24645316|NCT01197261|Naloxone|naloxone|mesh-list
24645317|NCT01197261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24645318|NCT01197261|Narcotics|narcotics|mesh-ancestor
24645319|NCT01197261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24645321|NCT01197261|Analgesics|analgesics|mesh-ancestor
24394073|NCT00131989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394102|NCT00132106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394103|NCT00132106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24916611|NCT04238767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24916612|NCT04238767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916613|NCT04238767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916615|NCT04238767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24916625|NCT04238832|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24916626|NCT04238832|Autonomic Agents|autonomic agents|mesh-ancestor
24916627|NCT04238832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25066210|NCT04092673|Fulvestrant|fulvestrant|mesh-list
25066211|NCT04092673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25066212|NCT04092673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066213|NCT04092673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25066214|NCT04092673|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25066215|NCT04092673|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25066216|NCT04092673|Hormone Antagonists|hormone antagonists|mesh-ancestor
24916628|NCT04238832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916629|NCT04238832|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24916630|NCT04238832|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24916631|NCT04238832|Cholinergic Agents|cholinergic agents|mesh-ancestor
24916632|NCT04238832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24916633|NCT04238832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916638|NCT04238884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24916640|NCT04238884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916660|NCT04238208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24916661|NCT04238208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916662|NCT04238208|Sensory System Agents|sensory system agents|mesh-ancestor
24916663|NCT04238208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24916664|NCT04238208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24916665|NCT04238208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24916666|NCT04238208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24916667|NCT04238208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24916668|NCT04238208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916670|NCT04238208|Dermatologic Agents|dermatologic agents|mesh-ancestor
24916671|NCT04238221|Doxofylline|doxofylline|mesh-list
24916672|NCT04238221|Antitussive Agents|antitussive agents|mesh-ancestor
24916673|NCT04238221|Respiratory System Agents|respiratory system agents|mesh-ancestor
24916674|NCT04238221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24916675|NCT04238221|Autonomic Agents|autonomic agents|mesh-ancestor
24916676|NCT04238221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24916677|NCT04238221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916678|NCT04238221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24916726|NCT04237922|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24916727|NCT04237922|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24916728|NCT04237922|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24916729|NCT04237922|Purinergic Agents|purinergic agents|mesh-ancestor
24916730|NCT04237922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24916731|NCT04237922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694151|NCT02025751|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25694152|NCT02025751|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25694153|NCT02025751|Dopamine Agents|dopamine agents|mesh-ancestor
25694154|NCT02025751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25694155|NCT02025751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694156|NCT02025907|Canagliflozin|canagliflozin|mesh-list
25694157|NCT02025907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25002520|NCT04573946|Ergocalciferols|ergocalciferols|mesh-list
25002521|NCT04573946|Cholecalciferol|cholecalciferol|mesh-list
25002522|NCT04573946|Vitamins|vitamins|mesh-list
25002523|NCT04573946|Micronutrients|micronutrients|mesh-ancestor
24645622|NCT01198938|Protective Agents|protective agents|mesh-ancestor
25002587|NCT04490057|Nicotine|nicotine|mesh-list
25002588|NCT04490057|Varenicline|varenicline|mesh-list
24916732|NCT04237922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916733|NCT04237935|Clopidogrel|clopidogrel|mesh-list
24916734|NCT04237935|Ticagrelor|ticagrelor|mesh-list
24916735|NCT04237935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25066217|NCT04092673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25066218|NCT04092673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066222|NCT04060628|Docetaxel|docetaxel|mesh-list
25066223|NCT04060628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066224|NCT04060628|Tubulin Modulators|tubulin modulators|mesh-ancestor
25066225|NCT04060628|Antimitotic Agents|antimitotic agents|mesh-ancestor
25066226|NCT04060628|Mitosis Modulators|mitosis modulators|mesh-ancestor
25066227|NCT04060628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066228|NCT04044534|Insulin|insulin|mesh-list
25066229|NCT04044534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25066230|NCT04044534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066231|NCT04037072|Mitomycins|mitomycins|mesh-list
25066232|NCT04037072|Mitomycin|mitomycin|mesh-list
25066233|NCT04037072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25066234|NCT04037072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066235|NCT04037072|Alkylating Agents|alkylating agents|mesh-ancestor
24520492|NCT00630565|Immunologic Factors|immunologic factors|mesh-ancestor
24520493|NCT00630565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916766|NCT04237246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24916767|NCT04237246|Immunologic Factors|immunologic factors|mesh-ancestor
24916768|NCT04237246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916769|NCT04237246|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24916771|NCT04237246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916772|NCT04237376|Tenofovir|tenofovir|mesh-list
24916773|NCT04237376|Antiviral Agents|antiviral agents|mesh-ancestor
24916774|NCT04237376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24916775|NCT04237376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24916776|NCT04237376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24916777|NCT04237376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916778|NCT04237376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916779|NCT04237376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25066242|NCT04033237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25066243|NCT04033237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066244|NCT04033237|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25066245|NCT04033237|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25066246|NCT04033237|Cholinergic Agents|cholinergic agents|mesh-ancestor
25066251|NCT04019873|Dolutegravir|dolutegravir|mesh-list
25066252|NCT04019873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25066253|NCT04019873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24916781|NCT04237493|Insulin|insulin|mesh-list
24916806|NCT04237129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916807|NCT04237090|Diphenhydramine|diphenhydramine|mesh-list
24916808|NCT04237090|Promethazine|promethazine|mesh-list
24916809|NCT04237090|Cetirizine|cetirizine|mesh-list
24916810|NCT04237090|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24916811|NCT04237090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24916812|NCT04237090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24916813|NCT04237090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916814|NCT04237090|Anesthetics, Local|anesthetics, local|mesh-ancestor
24916815|NCT04237090|Anesthetics|anesthetics|mesh-ancestor
24916816|NCT04237090|Sensory System Agents|sensory system agents|mesh-ancestor
24916818|NCT04237090|Antiemetics|antiemetics|mesh-ancestor
24916819|NCT04237090|Autonomic Agents|autonomic agents|mesh-ancestor
24916820|NCT04237090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24916821|NCT04237090|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25694158|NCT02025907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694159|NCT02025907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25694160|NCT02025907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694161|NCT02026011|Naltrexone|naltrexone|mesh-list
25694162|NCT02026011|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25694163|NCT02026011|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25694164|NCT02026011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916822|NCT04237090|Histamine Antagonists|histamine antagonists|mesh-ancestor
24916823|NCT04237090|Histamine Agents|histamine agents|mesh-ancestor
24645801|NCT01200004|Growth Substances|growth substances|mesh-ancestor
24645802|NCT01200004|Growth Inhibitors|growth inhibitors|mesh-ancestor
24645803|NCT01200004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24645804|NCT01200004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24645805|NCT01200004|Antimetabolites|antimetabolites|mesh-ancestor
24645807|NCT01200004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916824|NCT04237090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24491606|NCT00483145|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24491607|NCT00483145|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24491608|NCT00483145|Dermatologic Agents|dermatologic agents|mesh-ancestor
24520535|NCT05337657|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24520536|NCT05337657|Hormone Antagonists|hormone antagonists|mesh-ancestor
25066260|NCT04019873|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25066261|NCT04019873|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25066262|NCT03961256|Exenatide|exenatide|mesh-list
25066263|NCT03961256|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25066264|NCT03961256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066265|NCT03961256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25066266|NCT03961256|Incretins|incretins|mesh-ancestor
25066267|NCT03961256|Hormones|hormones|mesh-ancestor
25066268|NCT03961256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25066270|NCT03819088|Zinc Sulfate|zinc sulfate|mesh-list
24440794|NCT00284791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066271|NCT03819088|Trace Elements|trace elements|mesh-ancestor
25066272|NCT03819088|Micronutrients|micronutrients|mesh-ancestor
25066273|NCT03819088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066274|NCT03819088|Astringents|astringents|mesh-ancestor
25066275|NCT03819088|Dermatologic Agents|dermatologic agents|mesh-ancestor
24520537|NCT05337657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24520538|NCT05337657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520540|NCT05337332|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24916825|NCT04237090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916826|NCT04237090|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24916827|NCT04237090|Antipruritics|antipruritics|mesh-ancestor
24916828|NCT04237090|Dermatologic Agents|dermatologic agents|mesh-ancestor
24916829|NCT04237090|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24916830|NCT04236895|Insulin Glargine|insulin glargine|mesh-list
24916831|NCT04236895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24916832|NCT04236895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916833|NCT04236778|Vancomycin|vancomycin|mesh-list
24819836|NCT02097381|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24819837|NCT02097381|Protease Inhibitors|protease inhibitors|mesh-ancestor
24819838|NCT02097381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819839|NCT02097381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819840|NCT02097381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24819841|NCT02097381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24819842|NCT02097381|Antiviral Agents|antiviral agents|mesh-ancestor
24819843|NCT02097381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24740112|NCT01686386|Growth Inhibitors|growth inhibitors|mesh-ancestor
24916834|NCT04236778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24916835|NCT04236778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24780295|NCT01883323|Fludarabine|fludarabine|mesh-list
24916837|NCT04236453|Emtricitabine|emtricitabine|mesh-list
24916838|NCT04236453|Darunavir|darunavir|mesh-list
24920693|NCT04199143|Sensory System Agents|sensory system agents|mesh-ancestor
25066291|NCT03756311|Paclitaxel|paclitaxel|mesh-list
25066292|NCT03756311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25066293|NCT03756311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25066294|NCT03756311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694165|NCT02026011|Sensory System Agents|sensory system agents|mesh-ancestor
25694166|NCT02026011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25694167|NCT02026141|Dexmedetomidine|dexmedetomidine|mesh-list
25694168|NCT02026141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25694169|NCT02026141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25066295|NCT03756311|Tubulin Modulators|tubulin modulators|mesh-ancestor
25066296|NCT03756311|Antimitotic Agents|antimitotic agents|mesh-ancestor
25066297|NCT03756311|Mitosis Modulators|mitosis modulators|mesh-ancestor
24452147|NCT00326157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24452148|NCT00326157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24452149|NCT00326157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24452150|NCT00326235|Buspirone|buspirone|mesh-list
24452151|NCT00326235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25694170|NCT02026141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694171|NCT02026141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24645947|NCT01200784|Antimetabolites|antimetabolites|mesh-ancestor
24645948|NCT01200784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645949|NCT01200784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24916848|NCT04236453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916849|NCT04236453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24916850|NCT04236453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24916851|NCT04236453|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24916855|NCT04236453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24916856|NCT04236323|Remifentanil|remifentanil|mesh-list
24916879|NCT04236219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24916880|NCT04236115|Felypressin|felypressin|mesh-list
24916882|NCT04236115|Anesthetics, Local|anesthetics, local|mesh-ancestor
24916883|NCT04236115|Anesthetics|anesthetics|mesh-ancestor
24916884|NCT04236115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24916885|NCT04236115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740179|NCT01686789|Interferons|interferons|mesh-list
24916889|NCT04235985|Chlorhexidine|chlorhexidine|mesh-list
24916890|NCT04235985|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24916891|NCT04235985|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24916892|NCT04235985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24916893|NCT04235985|Disinfectants|disinfectants|mesh-ancestor
24916894|NCT04235985|Dermatologic Agents|dermatologic agents|mesh-ancestor
24916895|NCT04235816|Azithromycin|azithromycin|mesh-list
24916896|NCT04235816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24916897|NCT04235816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24916899|NCT04236258|Nifedipine|nifedipine|mesh-list
24916900|NCT04236258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24916901|NCT04236258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24916902|NCT04236258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916903|NCT04236258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24916904|NCT04236258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916905|NCT04236258|Vasodilator Agents|vasodilator agents|mesh-ancestor
24916906|NCT04236258|Tocolytic Agents|tocolytic agents|mesh-ancestor
24916907|NCT04236258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24916908|NCT04236258|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24916909|NCT04236258|Protease Inhibitors|protease inhibitors|mesh-ancestor
24916910|NCT04236258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916911|NCT04236258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25066313|NCT03707028|Paclitaxel|paclitaxel|mesh-list
25066314|NCT03707028|Apatinib|apatinib|mesh-list
25066315|NCT03707028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25066316|NCT03707028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066317|NCT03707028|Tubulin Modulators|tubulin modulators|mesh-ancestor
24534749|NCT00647946|Tenofovir|tenofovir|mesh-list
25066320|NCT03707028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066322|NCT03707028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828689|NCT02146976|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25076884|NCT03369990|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24828690|NCT02147015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24916931|NCT04235426|Hydroxocobalamin|hydroxocobalamin|mesh-list
24916932|NCT04235426|Diclofenac|diclofenac|mesh-list
24916933|NCT04235426|Vitamins|vitamins|mesh-ancestor
24916934|NCT04235426|Micronutrients|micronutrients|mesh-ancestor
24916935|NCT04235426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694172|NCT02026141|Analgesics|analgesics|mesh-ancestor
25694173|NCT02026141|Sensory System Agents|sensory system agents|mesh-ancestor
25694174|NCT02026141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25694175|NCT02026141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25694176|NCT02026141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25694177|NCT02026141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25694178|NCT02026141|Adrenergic Agents|adrenergic agents|mesh-ancestor
25694179|NCT02026141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25694180|NCT02026141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694181|NCT02026297|Tranexamic Acid|tranexamic acid|mesh-list
24916937|NCT04235426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24916939|NCT04235426|Sensory System Agents|sensory system agents|mesh-ancestor
24916940|NCT04235426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24916941|NCT04235426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24916942|NCT04235426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24916943|NCT04235426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24916944|NCT04235426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916945|NCT04235426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916946|NCT04235426|Vitamin B Complex|vitamin b complex|mesh-ancestor
24916947|NCT04235426|Hematinics|hematinics|mesh-ancestor
25066323|NCT03634228|Cytarabine|cytarabine|mesh-list
25066324|NCT03634228|Venetoclax|venetoclax|mesh-list
25066325|NCT03634228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25066326|NCT03634228|Antimetabolites|antimetabolites|mesh-ancestor
25066327|NCT03634228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066328|NCT03634228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066329|NCT03634228|Antiviral Agents|antiviral agents|mesh-ancestor
25066330|NCT03634228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25066331|NCT03634228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25066332|NCT03634228|Immunologic Factors|immunologic factors|mesh-ancestor
24441693|NCT00288041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441697|NCT00288041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441700|NCT00288158|Antimetabolites|antimetabolites|mesh-ancestor
25066333|NCT03634228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066337|NCT03593213|Cariprazine|cariprazine|mesh-list
25066338|NCT03593213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25066339|NCT03593213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25066340|NCT03593213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25066341|NCT03593213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066342|NCT03593213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25066343|NCT03557619|Venetoclax|venetoclax|mesh-list
25066344|NCT03557619|Levonorgestrel|levonorgestrel|mesh-list
25066345|NCT03557619|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25066346|NCT03557619|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25066347|NCT03557619|Estradiol|estradiol|mesh-list
25066348|NCT03557619|Estrogens|estrogens|mesh-ancestor
25066349|NCT03557619|Hormones|hormones|mesh-ancestor
25066350|NCT03557619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25066351|NCT03557619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066352|NCT03557619|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25066353|NCT03557619|Contraceptive Agents|contraceptive agents|mesh-ancestor
24916949|NCT04235569|Warfarin|warfarin|mesh-list
24916950|NCT04235569|Enoxaparin sodium|enoxaparin sodium|mesh-list
24916951|NCT04235569|Anticoagulants|anticoagulants|mesh-ancestor
24916952|NCT04235569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24916953|NCT04235569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24916954|NCT04235569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916955|NCT04235673|Melatonin|melatonin|mesh-list
25066358|NCT03557619|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25066359|NCT03557619|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25066360|NCT03557619|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25066362|NCT03507452|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25066363|NCT03507452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066364|NCT03499704|Metformin|metformin|mesh-list
25694182|NCT02026297|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25694183|NCT02026297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25694184|NCT02026297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694185|NCT02026297|Hemostatics|hemostatics|mesh-ancestor
25694186|NCT02026297|Coagulants|coagulants|mesh-ancestor
25694187|NCT02027311|Midazolam|midazolam|mesh-list
25694188|NCT02027311|Meperidine|meperidine|mesh-list
25066365|NCT03499704|Pioglitazone|pioglitazone|mesh-list
25694189|NCT02027311|Etomidate|etomidate|mesh-list
25694190|NCT02027311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25694191|NCT02027311|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24646057|NCT01201642|Glucocorticoids|glucocorticoids|mesh-ancestor
24646058|NCT01201642|Hormones|hormones|mesh-ancestor
24646059|NCT01201642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24646060|NCT01201642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066366|NCT03499704|Dapagliflozin|dapagliflozin|mesh-list
25066367|NCT03499704|Alogliptin|alogliptin|mesh-list
25066368|NCT03499704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25066369|NCT03499704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825839|NCT02130804|Salicylates|salicylates|mesh-list
25066370|NCT03499704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25066371|NCT03499704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066372|NCT03499704|Incretins|incretins|mesh-ancestor
25066373|NCT03499704|Hormones|hormones|mesh-ancestor
25066374|NCT03499704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25066375|NCT03499704|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25066376|NCT03499704|Protease Inhibitors|protease inhibitors|mesh-ancestor
25066377|NCT03499704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25066378|NCT03443869|Acyclovir|acyclovir|mesh-list
25066379|NCT03443869|Valganciclovir|valganciclovir|mesh-list
25066380|NCT03443869|Letermovir|letermovir|mesh-list
25066381|NCT03443869|Antiviral Agents|antiviral agents|mesh-ancestor
25066382|NCT03443869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25066383|NCT03443869|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25066412|NCT03399539|Protease Inhibitors|protease inhibitors|mesh-ancestor
25066413|NCT03399539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25066414|NCT03399539|Dermatologic Agents|dermatologic agents|mesh-ancestor
25066415|NCT03399539|Glycine Agents|glycine agents|mesh-ancestor
25066416|NCT03399539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25066417|NCT03248531|Adalimumab|adalimumab|mesh-list
25066418|NCT03248531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25066419|NCT03248531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25066420|NCT03247036|Fibrinolytic Agents|fibrinolytic agents|mesh-list
25066421|NCT03247036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25066422|NCT03247036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066423|NCT03245918|Aprepitant|aprepitant|mesh-list
25066424|NCT03245918|Fosaprepitant|fosaprepitant|mesh-list
25066425|NCT03245918|Antiemetics|antiemetics|mesh-ancestor
25066435|NCT03205605|Parasympatholytics|parasympatholytics|mesh-ancestor
25066436|NCT03205605|Autonomic Agents|autonomic agents|mesh-ancestor
25066438|NCT03205605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066439|NCT03205605|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25066440|NCT03205605|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24916961|NCT04235270|Tadalafil|tadalafil|mesh-list
24520570|NCT05337085|Sensory System Agents|sensory system agents|mesh-ancestor
24520571|NCT05337085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24520572|NCT05337085|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24520573|NCT05337085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24520574|NCT05337085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24520575|NCT05337085|Adrenergic Agents|adrenergic agents|mesh-ancestor
24916983|NCT04236050|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24916984|NCT04236050|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24916985|NCT04236050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24916986|NCT04236050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24916987|NCT04236050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916988|NCT04235439|Insulin Lispro|insulin lispro|mesh-list
24916989|NCT04235439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24916990|NCT04235439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916991|NCT04234776|Ketamine|ketamine|mesh-list
24916992|NCT04234776|Aripiprazole|aripiprazole|mesh-list
24916993|NCT04234776|Citalopram|citalopram|mesh-list
24916994|NCT04234776|Analgesics|analgesics|mesh-ancestor
24916995|NCT04234776|Sensory System Agents|sensory system agents|mesh-ancestor
24916996|NCT04234776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24916997|NCT04234776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916998|NCT04234776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24916999|NCT04234776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25066443|NCT03205605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776988|NCT01860833|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25694192|NCT02027311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25694193|NCT02027311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694194|NCT02027311|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25694195|NCT02027311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25066444|NCT03205605|Urological Agents|urological agents|mesh-ancestor
25694196|NCT02027311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24462901|NCT00357851|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24462902|NCT00357851|Protease Inhibitors|protease inhibitors|mesh-ancestor
24462903|NCT00357851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462905|NCT00357864|Carbachol|carbachol|mesh-list
24646390|NCT01203384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24646391|NCT01203384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24951367|NCT03905564|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
24951378|NCT03905564|Antiemetics|antiemetics|mesh-ancestor
24917000|NCT04234776|Anesthetics, General|anesthetics, general|mesh-ancestor
24917001|NCT04234776|Anesthetics|anesthetics|mesh-ancestor
24917002|NCT04234776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24917003|NCT04234776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24917004|NCT04234776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24917005|NCT04234776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24917006|NCT04234776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917007|NCT04234776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24917008|NCT04234776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24917009|NCT04234776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24917010|NCT04234776|Serotonin Agents|serotonin agents|mesh-ancestor
24917011|NCT04234776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24520588|NCT05336825|Anesthetics, Local|anesthetics, local|mesh-ancestor
24520589|NCT05336825|Anesthetics|anesthetics|mesh-ancestor
24520590|NCT05336825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24917014|NCT04234776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24917015|NCT04234776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24917016|NCT04234776|Dopamine Agonists|dopamine agonists|mesh-ancestor
24917017|NCT04234776|Dopamine Agents|dopamine agents|mesh-ancestor
24917018|NCT04234776|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24917019|NCT04234776|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24917020|NCT04234776|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24917022|NCT04234776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24917023|NCT04234776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24917025|NCT04234997|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24917026|NCT04234997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24917027|NCT04234997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24917028|NCT04234997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917029|NCT04234997|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
24917030|NCT04234997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24917031|NCT04234997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917032|NCT04234932|Latanoprost|latanoprost|mesh-list
24917033|NCT04234932|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24951389|NCT03905018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951390|NCT03905018|Urological Agents|urological agents|mesh-ancestor
24951392|NCT03904836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24951393|NCT03904836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24951394|NCT03904888|Anesthetics|anesthetics|mesh-list
24951395|NCT03904888|Anesthetics, Local|anesthetics, local|mesh-list
24917037|NCT04234321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917039|NCT04234594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24917040|NCT04234594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917041|NCT04234607|Carboplatin|carboplatin|mesh-list
24917042|NCT04234607|Etoposide|etoposide|mesh-list
24917043|NCT04234607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917044|NCT04234607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24917045|NCT04234607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24917046|NCT04234607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24917047|NCT04234607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917051|NCT04234516|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
24917052|NCT04234516|Naloxone|naloxone|mesh-list
24917053|NCT04234516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24917054|NCT04234516|Narcotics|narcotics|mesh-ancestor
24917055|NCT04234516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24917056|NCT04234516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694197|NCT02027311|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25694198|NCT02027311|Anesthetics, General|anesthetics, general|mesh-ancestor
25694199|NCT02027311|Anesthetics|anesthetics|mesh-ancestor
25694200|NCT02027311|GABA Modulators|gaba modulators|mesh-ancestor
25694201|NCT02027311|GABA Agents|gaba agents|mesh-ancestor
25694202|NCT02027311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24844336|NCT02232360|Fenofibrate|fenofibrate|mesh-list
24844337|NCT02232360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24646658|NCT01204476|Everolimus|everolimus|mesh-list
25002957|NCT04145674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25002958|NCT04145674|Analgesics|analgesics|mesh-ancestor
25002959|NCT04145674|Sensory System Agents|sensory system agents|mesh-ancestor
25002960|NCT04145674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25002961|NCT04145674|Antitussive Agents|antitussive agents|mesh-ancestor
25002962|NCT04145674|Respiratory System Agents|respiratory system agents|mesh-ancestor
25002963|NCT04145674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25049295|NCT00624858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049297|NCT00624351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25049298|NCT00624351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25049299|NCT00622063|Beta-lapachone|beta-lapachone|mesh-list
25049300|NCT00622063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25049301|NCT00622063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25049302|NCT00622063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25049303|NCT00622063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917057|NCT04234516|Analgesics|analgesics|mesh-ancestor
24917060|NCT04234516|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24917062|NCT04234191|Hydromorphone|hydromorphone|mesh-list
24917063|NCT04234191|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
24917064|NCT04234191|Naloxone|naloxone|mesh-list
24917065|NCT04234191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24917066|NCT04234191|Narcotics|narcotics|mesh-ancestor
24520608|NCT05336721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520610|NCT05336721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24520611|NCT05336721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24520612|NCT05336513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24520613|NCT05336175|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
24520614|NCT05336175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24520615|NCT05336175|Vasodilator Agents|vasodilator agents|mesh-ancestor
24951396|NCT03904888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24951397|NCT03904888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951398|NCT03904888|Sensory System Agents|sensory system agents|mesh-ancestor
24951399|NCT03904888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24442964|NCT00293358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951400|NCT03904680|Vitamin D|vitamin d|mesh-list
24819845|NCT02097381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24819846|NCT02097381|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24819847|NCT02097381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24819849|NCT02097394|Pancrelipase|pancrelipase|mesh-list
24819850|NCT02097394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24819851|NCT02097407|Dexmedetomidine|dexmedetomidine|mesh-list
24819852|NCT02097407|Propofol|propofol|mesh-list
24819853|NCT02097407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24819854|NCT02097407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24819857|NCT02097407|Anesthetics, General|anesthetics, general|mesh-ancestor
24616255|NCT01035320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25694203|NCT02027311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694204|NCT02027311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25694205|NCT02027311|Narcotics|narcotics|mesh-ancestor
25694206|NCT02027311|Analgesics|analgesics|mesh-ancestor
25694207|NCT02027311|Sensory System Agents|sensory system agents|mesh-ancestor
25694208|NCT02027311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25694209|NCT02027376|Docetaxel|docetaxel|mesh-list
25694210|NCT02027376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694211|NCT02027376|Tubulin Modulators|tubulin modulators|mesh-ancestor
25694212|NCT02027376|Antimitotic Agents|antimitotic agents|mesh-ancestor
25694213|NCT02027376|Mitosis Modulators|mitosis modulators|mesh-ancestor
25694214|NCT02027376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694215|NCT02027428|Paclitaxel|paclitaxel|mesh-list
25694216|NCT02027428|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25694217|NCT02027428|Carboplatin|carboplatin|mesh-list
25694218|NCT02027428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25694219|NCT02027428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694220|NCT02027428|Tubulin Modulators|tubulin modulators|mesh-ancestor
25694221|NCT02027428|Antimitotic Agents|antimitotic agents|mesh-ancestor
24462955|NCT00358176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24646673|NCT01204580|Immunologic Factors|immunologic factors|mesh-ancestor
24616261|NCT01035450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25077134|NCT03367182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616262|NCT01035450|Immunologic Factors|immunologic factors|mesh-ancestor
24616263|NCT01035450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917082|NCT04233996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917084|NCT04234048|Retinamide|retinamide|mesh-list
24917085|NCT04234048|Tretinoin|tretinoin|mesh-list
24917086|NCT04234048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917087|NCT04234048|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24917088|NCT04234048|Protective Agents|protective agents|mesh-ancestor
24917089|NCT04234048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917090|NCT04234048|Keratolytic Agents|keratolytic agents|mesh-ancestor
24917091|NCT04234048|Dermatologic Agents|dermatologic agents|mesh-ancestor
24917092|NCT04233697|Romidepsin|romidepsin|mesh-list
24917093|NCT04233697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24917094|NCT04233697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24819865|NCT02097407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24819866|NCT02097407|Adrenergic Agents|adrenergic agents|mesh-ancestor
24819867|NCT02097407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24819868|NCT02097407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819869|NCT02097459|Tamoxifen|tamoxifen|mesh-list
24819870|NCT02097459|Toremifene|toremifene|mesh-list
24819871|NCT02097459|Anastrozole|anastrozole|mesh-list
24819872|NCT02097459|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24819873|NCT02097459|Hormone Antagonists|hormone antagonists|mesh-ancestor
24657187|NCT01266057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819874|NCT02097459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24953471|NCT03884491|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24953472|NCT03884491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25066445|NCT03205605|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24819900|NCT02097511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24819901|NCT02097511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24819902|NCT02097511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24819903|NCT02097511|Serotonin Agents|serotonin agents|mesh-ancestor
24819905|NCT02097589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24819906|NCT02097589|Immunologic Factors|immunologic factors|mesh-ancestor
24819907|NCT02097589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819908|NCT02097589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24819909|NCT02097589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24819910|NCT02097589|Antimetabolites|antimetabolites|mesh-ancestor
24819911|NCT02097589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819912|NCT02097589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24819913|NCT02097589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24819914|NCT02097589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819915|NCT02097615|Chlorhexidine|chlorhexidine|mesh-list
24819916|NCT02097615|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24819917|NCT02097615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24917112|NCT04233463|Respiratory System Agents|respiratory system agents|mesh-ancestor
24917113|NCT04233463|Glucocorticoids|glucocorticoids|mesh-ancestor
24917114|NCT04233463|Hormones|hormones|mesh-ancestor
24657188|NCT01266057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24917115|NCT04233463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24917116|NCT04233346|Ponatinib|ponatinib|mesh-list
24917117|NCT04233346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917118|NCT04233346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24917119|NCT04233346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25694222|NCT02027428|Mitosis Modulators|mitosis modulators|mesh-ancestor
25694223|NCT02027428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694224|NCT02028676|Lamivudine|lamivudine|mesh-list
25694225|NCT02028676|Zidovudine|zidovudine|mesh-list
25694226|NCT02028676|Efavirenz|efavirenz|mesh-list
25694227|NCT02028676|Nevirapine|nevirapine|mesh-list
25694228|NCT02028676|Abacavir|abacavir|mesh-list
25694229|NCT02028676|Dideoxynucleosides|dideoxynucleosides|mesh-list
25694230|NCT02028676|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
24646981|NCT01205932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24646982|NCT01205958|Pyranoprofen|pyranoprofen|mesh-list
24646983|NCT01205958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24646984|NCT01205958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24646985|NCT01205958|Analgesics|analgesics|mesh-ancestor
24646986|NCT01205958|Sensory System Agents|sensory system agents|mesh-ancestor
24646987|NCT01205958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24646988|NCT01205958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646989|NCT01205958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24520677|NCT05334316|Glucocorticoids|glucocorticoids|mesh-ancestor
24520678|NCT05334316|Hormones|hormones|mesh-ancestor
24520679|NCT05334316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24520680|NCT05334316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24520681|NCT05334316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917154|NCT04232813|Estradiol|estradiol|mesh-list
24917155|NCT04232813|Estrogens|estrogens|mesh-ancestor
24917156|NCT04232813|Hormones|hormones|mesh-ancestor
24917157|NCT04232813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24917158|NCT04232813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917159|NCT04233021|Osimertinib|osimertinib|mesh-list
24917160|NCT04233021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066481|NCT03119584|Linaclotide|linaclotide|mesh-list
25066482|NCT03119584|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25066483|NCT03119584|Enzyme Activators|enzyme activators|mesh-ancestor
25066484|NCT03119584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066485|NCT03119584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25066486|NCT03118986|Olanzapine|olanzapine|mesh-list
25066487|NCT03118986|Antiemetics|antiemetics|mesh-ancestor
24443032|NCT00293475|Dermatologic Agents|dermatologic agents|mesh-ancestor
24443038|NCT00293475|Diuretics|diuretics|mesh-ancestor
25066488|NCT03118986|Autonomic Agents|autonomic agents|mesh-ancestor
25066489|NCT03118986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25066490|NCT03118986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066491|NCT03118986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25066492|NCT03118986|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25066493|NCT03118986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24917167|NCT04232644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917168|NCT04232644|Sympathomimetics|sympathomimetics|mesh-ancestor
24917169|NCT04232644|Autonomic Agents|autonomic agents|mesh-ancestor
24917170|NCT04232644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24917171|NCT04232644|Dopamine Agents|dopamine agents|mesh-ancestor
24917172|NCT04232644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24917173|NCT04232644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917174|NCT04232644|Adrenergic Agents|adrenergic agents|mesh-ancestor
24917175|NCT04232644|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24917176|NCT04232644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24917177|NCT04232644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24917178|NCT04232644|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24917179|NCT04232722|Sorafenib|sorafenib|mesh-list
24492043|NCT00485030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24492044|NCT00485030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24492045|NCT00485030|Immunologic Factors|immunologic factors|mesh-ancestor
24492046|NCT00485030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492047|NCT00485030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24492048|NCT00485030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24520719|NCT05334004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520720|NCT05334004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24520721|NCT05334004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24917180|NCT04232722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917182|NCT04232722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25694231|NCT02028676|Trimethoprim|trimethoprim|mesh-list
25694232|NCT02028676|Sulfamethoxazole|sulfamethoxazole|mesh-list
25694233|NCT02028676|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25694234|NCT02028676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25694235|NCT02028676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25694236|NCT02028676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25694237|NCT02028676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694238|NCT02028676|Antiviral Agents|antiviral agents|mesh-ancestor
24917183|NCT04232722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917196|NCT04232150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24917197|NCT04232150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24917198|NCT04232150|Anesthetics, General|anesthetics, general|mesh-ancestor
24917199|NCT04232150|GABA Modulators|gaba modulators|mesh-ancestor
24917200|NCT04232150|GABA Agents|gaba agents|mesh-ancestor
24917201|NCT04232150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24917202|NCT04232150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917205|NCT04231864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24917206|NCT04231864|Immunoglobulin G|immunoglobulin g|mesh-list
25066494|NCT03118986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25066495|NCT03118986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25066496|NCT03118986|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25066497|NCT03118986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25066498|NCT03118986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25066499|NCT03118986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066500|NCT03118986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25066501|NCT03118986|Serotonin Agents|serotonin agents|mesh-ancestor
25066502|NCT03047330|Leuprolide|leuprolide|mesh-list
25066503|NCT03047330|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24917211|NCT04232033|Mitogens|mitogens|mesh-list
24917227|NCT04232085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917228|NCT04232085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24917229|NCT04232085|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24917230|NCT04232085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917231|NCT04232085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24917232|NCT04232085|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24917233|NCT04232085|Antitubercular Agents|antitubercular agents|mesh-ancestor
24917234|NCT04232085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24917235|NCT04232085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24917236|NCT04232085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24917237|NCT04231851|Cytarabine|cytarabine|mesh-list
24917238|NCT04231851|Daunorubicin|daunorubicin|mesh-list
24917239|NCT04231851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24917240|NCT04231851|Antimetabolites|antimetabolites|mesh-ancestor
24917241|NCT04231851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917242|NCT04231851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917243|NCT04231851|Antiviral Agents|antiviral agents|mesh-ancestor
24492108|NCT00485342|Interferon alpha-2|interferon alpha-2|mesh-list
24492109|NCT00485342|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25066513|NCT03019588|Pembrolizumab|pembrolizumab|mesh-list
25066514|NCT03019588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25066515|NCT03019588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066516|NCT03019588|Tubulin Modulators|tubulin modulators|mesh-ancestor
25066517|NCT03019588|Antimitotic Agents|antimitotic agents|mesh-ancestor
25066518|NCT03019588|Mitosis Modulators|mitosis modulators|mesh-ancestor
25066519|NCT03019588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066520|NCT03019588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25066521|NCT02951377|Dexamethasone|dexamethasone|mesh-list
25066522|NCT02951377|Lidocaine|lidocaine|mesh-list
25066523|NCT02951377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25066524|NCT02951377|Antiemetics|antiemetics|mesh-ancestor
25066525|NCT02951377|Autonomic Agents|autonomic agents|mesh-ancestor
25066526|NCT02951377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25066527|NCT02951377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066528|NCT02951377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25066529|NCT02951377|Glucocorticoids|glucocorticoids|mesh-ancestor
25066535|NCT02951377|Anesthetics|anesthetics|mesh-ancestor
25066536|NCT02951377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25066537|NCT02951377|Sensory System Agents|sensory system agents|mesh-ancestor
25066538|NCT02951377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25066539|NCT02951377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24828939|NCT02148432|Dexmedetomidine|dexmedetomidine|mesh-list
24492110|NCT00485342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24492111|NCT00485342|Antiviral Agents|antiviral agents|mesh-ancestor
24948074|NCT03923075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25003463|NCT03657264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25003464|NCT03657264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25003490|NCT03601806|Thalidomide|thalidomide|mesh-list
25003491|NCT03601806|Pomalidomide|pomalidomide|mesh-list
25003492|NCT03601806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25003493|NCT03601806|Immunologic Factors|immunologic factors|mesh-ancestor
25003494|NCT03601806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25003495|NCT03601806|Leprostatic Agents|leprostatic agents|mesh-ancestor
25003496|NCT03601806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25003497|NCT03601806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25003498|NCT03601806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25003499|NCT03601806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24492112|NCT00485342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24917259|NCT04231435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917260|NCT04231435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24917261|NCT04231435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25077228|NCT03366584|Autonomic Agents|autonomic agents|mesh-ancestor
24917262|NCT04231435|Antimetabolites|antimetabolites|mesh-ancestor
24917263|NCT04231435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066542|NCT02951377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066545|NCT02844907|Antiemetics|antiemetics|mesh-ancestor
25066546|NCT02844907|Autonomic Agents|autonomic agents|mesh-ancestor
25066547|NCT02844907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25066548|NCT02844907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066549|NCT02844907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25066550|NCT02844907|Glucocorticoids|glucocorticoids|mesh-ancestor
25066551|NCT02844907|Hormones|hormones|mesh-ancestor
25066552|NCT02844907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24951403|NCT03904680|Micronutrients|micronutrients|mesh-ancestor
25066553|NCT02844907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25066554|NCT02844907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066555|NCT02811523|Doxorubicin|doxorubicin|mesh-list
25066556|NCT02811523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25066557|NCT02811523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066558|NCT02811523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25066559|NCT02811523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25066560|NCT02811523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25066561|NCT02811523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066562|NCT02743741|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25066563|NCT02743741|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25066564|NCT02743741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066581|NCT02700451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25066598|NCT02366494|Docetaxel|docetaxel|mesh-list
25066599|NCT02366494|Leuprolide|leuprolide|mesh-list
25066600|NCT02366494|Goserelin|goserelin|mesh-list
25066601|NCT02366494|Bicalutamide|bicalutamide|mesh-list
25066602|NCT02366494|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25066603|NCT02366494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066604|NCT02366494|Tubulin Modulators|tubulin modulators|mesh-ancestor
25066605|NCT02366494|Antimitotic Agents|antimitotic agents|mesh-ancestor
25066606|NCT02366494|Mitosis Modulators|mitosis modulators|mesh-ancestor
24829007|NCT02149095|Treprostinil|treprostinil|mesh-list
24917269|NCT04231435|Protective Agents|protective agents|mesh-ancestor
25694239|NCT02028676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25694240|NCT02028676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25694241|NCT02028676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25694242|NCT02028676|Antimetabolites|antimetabolites|mesh-ancestor
25694243|NCT02028676|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25694244|NCT02028676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25694245|NCT02028676|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25694246|NCT02028676|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25694247|NCT02028676|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25694248|NCT02028676|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25694249|NCT02028676|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25694250|NCT02028676|Renal Agents|renal agents|mesh-ancestor
25694251|NCT02028676|Antimalarials|antimalarials|mesh-ancestor
25694252|NCT02028676|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25694253|NCT02028676|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25694254|NCT02028676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25003593|NCT03295396|TIC10 compound|tic10 compound|mesh-list
25003594|NCT03295396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25003595|NCT03288324|Tofacitinib|tofacitinib|mesh-list
25003596|NCT03288324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25003597|NCT03288324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24941053|NCT03995147|Prednisone|prednisone|mesh-list
25003598|NCT03288324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25003599|NCT03284866|Vaccines|vaccines|mesh-list
25003600|NCT03284866|Immunologic Factors|immunologic factors|mesh-ancestor
24845049|NCT02235948|Folic Acid|folic acid|mesh-list
24917270|NCT04231617|Glyburide|glyburide|mesh-list
24917272|NCT04231617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917273|NCT04231682|Denosumab|denosumab|mesh-list
24917274|NCT04231682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24917276|NCT04231448|Prednisone|prednisone|mesh-list
25066627|NCT02262923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25066628|NCT02262923|Dopamine Agents|dopamine agents|mesh-ancestor
25066629|NCT02262923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25066630|NCT02262923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066631|NCT02234323|Factor VIII|factor viii|mesh-list
25066632|NCT02234323|Coagulants|coagulants|mesh-ancestor
25066633|NCT02206984|Tamoxifen|tamoxifen|mesh-list
25066634|NCT02206984|Fulvestrant|fulvestrant|mesh-list
25066635|NCT02206984|Anastrozole|anastrozole|mesh-list
25066636|NCT02206984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25066637|NCT02206984|Hormone Antagonists|hormone antagonists|mesh-ancestor
24917306|NCT04231370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917307|NCT04231370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24917308|NCT04231370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24917309|NCT04231370|Growth Substances|growth substances|mesh-ancestor
24917310|NCT04231370|Growth Inhibitors|growth inhibitors|mesh-ancestor
24917311|NCT04231370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24819921|NCT02097810|Entrectinib|entrectinib|mesh-list
24917312|NCT04231214|Tiotropium Bromide|tiotropium bromide|mesh-list
24917313|NCT04231214|Olodaterol|olodaterol|mesh-list
24917314|NCT04231214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24917315|NCT04231214|Autonomic Agents|autonomic agents|mesh-ancestor
24520769|NCT05326425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066638|NCT02206984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25066639|NCT02206984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066640|NCT02206984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25066641|NCT02206984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066642|NCT02206984|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25066643|NCT02206984|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25066644|NCT02206984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25066645|NCT02206984|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25066646|NCT02206984|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25066647|NCT02206984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25066648|NCT02206984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25066649|NCT02206984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066650|NCT02194595|Insulin|insulin|mesh-list
25066651|NCT02194595|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25066652|NCT02194595|Insulin Glargine|insulin glargine|mesh-list
25066653|NCT02194595|Exenatide|exenatide|mesh-list
25066654|NCT02194595|Insulin Lispro|insulin lispro|mesh-list
25066655|NCT02194595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25066656|NCT02194595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694255|NCT02028676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25694256|NCT02028676|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25694257|NCT02028676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25694258|NCT02028715|Acetaminophen|acetaminophen|mesh-list
25694259|NCT02028715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25694260|NCT02028715|Analgesics|analgesics|mesh-ancestor
25694261|NCT02028715|Sensory System Agents|sensory system agents|mesh-ancestor
25694262|NCT02028715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25694263|NCT02028715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694264|NCT02028715|Antipyretics|antipyretics|mesh-ancestor
25694265|NCT02028754|Levofloxacin|levofloxacin|mesh-list
25694266|NCT02028754|Ofloxacin|ofloxacin|mesh-list
25694267|NCT02028754|Prednisolone|prednisolone|mesh-list
25694268|NCT02028754|Prednisolone acetate|prednisolone acetate|mesh-list
25049389|NCT00612170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049390|NCT00612170|Adrenergic Agents|adrenergic agents|mesh-ancestor
25049391|NCT00612170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25049392|NCT00612170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049393|NCT00612118|Azelastine|azelastine|mesh-list
25049394|NCT00612118|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
25049395|NCT00612118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25049396|NCT00612118|Autonomic Agents|autonomic agents|mesh-ancestor
25049397|NCT00612118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25049398|NCT00612118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049399|NCT00612118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25049400|NCT00612118|Respiratory System Agents|respiratory system agents|mesh-ancestor
25049401|NCT00612118|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24647574|NCT01209455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24647575|NCT01209455|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24647576|NCT01209455|Histamine Antagonists|histamine antagonists|mesh-ancestor
24647577|NCT01209455|Histamine Agents|histamine agents|mesh-ancestor
25066657|NCT02194595|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25066658|NCT02194595|Incretins|incretins|mesh-ancestor
25066659|NCT02194595|Hormones|hormones|mesh-ancestor
24917316|NCT04231214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24917317|NCT04231214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917318|NCT04231214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24917319|NCT04231214|Respiratory System Agents|respiratory system agents|mesh-ancestor
24917320|NCT04231214|Parasympatholytics|parasympatholytics|mesh-ancestor
24917321|NCT04231214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24917322|NCT04231214|Cholinergic Agents|cholinergic agents|mesh-ancestor
24917323|NCT04231214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24917324|NCT04231214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917325|NCT04231123|Anesthetics|anesthetics|mesh-list
24917326|NCT04231123|Anesthetics, Local|anesthetics, local|mesh-list
24917327|NCT04231123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25066664|NCT02168140|Alkylating Agents|alkylating agents|mesh-ancestor
25066665|NCT02168140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066666|NCT02168140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066667|NCT02168140|Antioxidants|antioxidants|mesh-ancestor
25066668|NCT02168140|Protective Agents|protective agents|mesh-ancestor
25066669|NCT02168140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917376|NCT04230460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24917377|NCT04230460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24917413|NCT04230083|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24917414|NCT04230083|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24917415|NCT04230083|Hormone Antagonists|hormone antagonists|mesh-ancestor
24917416|NCT04230083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24917417|NCT04230083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24917442|NCT04229979|Azacitidine|azacitidine|mesh-list
25694269|NCT02028754|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25694270|NCT02028754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25694271|NCT02028754|Glucocorticoids|glucocorticoids|mesh-ancestor
25694272|NCT02028754|Hormones|hormones|mesh-ancestor
25694273|NCT02028754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25694274|NCT02028754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694275|NCT02028754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25694276|NCT02028754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694277|NCT02028754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25694278|NCT02028754|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25694279|NCT02028754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25694280|NCT02028754|Renal Agents|renal agents|mesh-ancestor
25694281|NCT02028754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25694282|NCT02028754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25694283|NCT02028754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25694284|NCT02028754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25694285|NCT02028754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694286|NCT02028754|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25694287|NCT02028754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25694288|NCT02028754|Laxatives|laxatives|mesh-ancestor
25694289|NCT02028767|Metformin|metformin|mesh-list
24845233|NCT02237079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647615|NCT01209728|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24647616|NCT01209728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24647617|NCT01209728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24647618|NCT01209728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647619|NCT01209806|Simethicone|simethicone|mesh-list
24647620|NCT01209806|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
24647621|NCT01209806|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24941240|NCT03993236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24941241|NCT03993236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24941242|NCT03993236|Antimetabolites|antimetabolites|mesh-ancestor
24941243|NCT03993236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941244|NCT03993236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24941245|NCT03993236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24941246|NCT03993236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24647722|NCT01210339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24647723|NCT01210339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24647724|NCT01210378|Nitroglycerin|nitroglycerin|mesh-list
24647725|NCT01210378|Vasodilator Agents|vasodilator agents|mesh-ancestor
24647726|NCT01210391|Caseins|caseins|mesh-list
24647727|NCT01210391|Chelating Agents|chelating agents|mesh-ancestor
24647728|NCT01210391|Sequestering Agents|sequestering agents|mesh-ancestor
24917443|NCT04229979|Decitabine|decitabine|mesh-list
24917444|NCT04229979|Venetoclax|venetoclax|mesh-list
24917445|NCT04229979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24917446|NCT04229979|Antimetabolites|antimetabolites|mesh-ancestor
24917447|NCT04229979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917448|NCT04229979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825953|NCT02131220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24825954|NCT02131220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24582591|NCT00870558|Ethiodized Oil|ethiodized oil|mesh-list
24825955|NCT02131220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825956|NCT02131220|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24825958|NCT02131246|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24917449|NCT04229979|Antiviral Agents|antiviral agents|mesh-ancestor
24917450|NCT04229979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24917451|NCT04229979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24917452|NCT04229979|Immunologic Factors|immunologic factors|mesh-ancestor
24917453|NCT04229979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917454|NCT04229979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917458|NCT04229758|Anticoagulants|anticoagulants|mesh-list
24917459|NCT04229719|Melatonin|melatonin|mesh-list
24917460|NCT04229719|Antioxidants|antioxidants|mesh-ancestor
24917461|NCT04229719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917462|NCT04229719|Protective Agents|protective agents|mesh-ancestor
24917463|NCT04229719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917466|NCT04229459|Cetuximab|cetuximab|mesh-list
25066686|NCT02099188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25066687|NCT02099188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25694290|NCT02028767|Empagliflozin|empagliflozin|mesh-list
25694291|NCT02028767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25694292|NCT02028767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694293|NCT02028767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25694294|NCT02028767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694295|NCT02028780|Dabigatran|dabigatran|mesh-list
25694296|NCT02028780|Antithrombins|antithrombins|mesh-ancestor
25694297|NCT02028780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25694298|NCT02028780|Protease Inhibitors|protease inhibitors|mesh-ancestor
25694299|NCT02028780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25694300|NCT02028780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694301|NCT02028780|Anticoagulants|anticoagulants|mesh-ancestor
25694302|NCT02028871|Insulin|insulin|mesh-list
25694303|NCT02028871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25694304|NCT02028871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694305|NCT02029235|Acetaminophen|acetaminophen|mesh-list
25694306|NCT02029235|Ibuprofen|ibuprofen|mesh-list
25694307|NCT02029235|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25694308|NCT02029235|Hydrocodone|hydrocodone|mesh-list
25694309|NCT02029235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25694310|NCT02029235|Analgesics|analgesics|mesh-ancestor
25694311|NCT02029235|Sensory System Agents|sensory system agents|mesh-ancestor
25694312|NCT02029235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24647797|NCT01210755|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24647798|NCT01210755|Antithrombins|antithrombins|mesh-ancestor
25694313|NCT02029235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694314|NCT02029235|Antipyretics|antipyretics|mesh-ancestor
25694315|NCT02029235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25066688|NCT02099188|Immunologic Factors|immunologic factors|mesh-ancestor
25066689|NCT02099188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066690|NCT02099188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25066691|NCT02099188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25066696|NCT02099188|Vitamin B Complex|vitamin b complex|mesh-ancestor
25066697|NCT02099188|Vitamins|vitamins|mesh-ancestor
25066698|NCT02099188|Micronutrients|micronutrients|mesh-ancestor
25066699|NCT02099188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25066701|NCT02099188|Alkylating Agents|alkylating agents|mesh-ancestor
24951704|NCT03901716|GABA Modulators|gaba modulators|mesh-ancestor
24951705|NCT03901716|GABA Agents|gaba agents|mesh-ancestor
24951706|NCT03901716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24951707|NCT03901716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951708|NCT03901612|Ropivacaine|ropivacaine|mesh-list
24951709|NCT03901612|Anesthetics, Local|anesthetics, local|mesh-ancestor
24951710|NCT03901612|Anesthetics|anesthetics|mesh-ancestor
24951711|NCT03901612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24951712|NCT03901612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951713|NCT03901612|Sensory System Agents|sensory system agents|mesh-ancestor
24951714|NCT03901612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24951715|NCT03901768|Dexamethasone|dexamethasone|mesh-list
24951716|NCT03901768|Triamcinolone|triamcinolone|mesh-list
24951717|NCT03901768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24951718|NCT03901768|Antiemetics|antiemetics|mesh-ancestor
24917515|NCT04229602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24917524|NCT04229498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24917525|NCT04229407|Vitamins|vitamins|mesh-list
24917526|NCT04229407|Vitamin B Complex|vitamin b complex|mesh-list
24917527|NCT04229407|Micronutrients|micronutrients|mesh-ancestor
24917528|NCT04229407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917529|NCT04228926|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24917530|NCT04228926|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24917531|NCT04228757|Phytoestrogens|phytoestrogens|mesh-list
24917532|NCT04228757|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24917533|NCT04228757|Estrogens|estrogens|mesh-ancestor
24917534|NCT04228757|Hormones|hormones|mesh-ancestor
24917535|NCT04228757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24917536|NCT04228757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917537|NCT04228315|Primaquine|primaquine|mesh-list
25694316|NCT02029235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25694317|NCT02029235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25694318|NCT02029235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25694319|NCT02029235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25694320|NCT02029235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694321|NCT02029235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25694322|NCT02029235|Narcotics|narcotics|mesh-ancestor
25694323|NCT02029235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25694324|NCT02029235|Antitussive Agents|antitussive agents|mesh-ancestor
25694325|NCT02029235|Respiratory System Agents|respiratory system agents|mesh-ancestor
25694326|NCT02029274|Siponimod|siponimod|mesh-list
25694327|NCT02029274|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24917538|NCT04228315|Antimalarials|antimalarials|mesh-ancestor
24917539|NCT04228315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24917540|NCT04228315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24917541|NCT04228315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24917542|NCT04228263|Aspirin|aspirin|mesh-list
24917543|NCT04228263|Folic Acid|folic acid|mesh-list
24917544|NCT04228263|Hydroxychloroquine|hydroxychloroquine|mesh-list
24917545|NCT04228263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24917546|NCT04228263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24917547|NCT04228263|Analgesics|analgesics|mesh-ancestor
24917548|NCT04228263|Sensory System Agents|sensory system agents|mesh-ancestor
24917549|NCT04228263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24917550|NCT04228263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917551|NCT04228263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24917587|NCT04227990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917589|NCT04227990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24917590|NCT04227990|Tubulin Modulators|tubulin modulators|mesh-ancestor
24917591|NCT04227990|Antimitotic Agents|antimitotic agents|mesh-ancestor
24917630|NCT04227912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24917632|NCT04227912|Sensory System Agents|sensory system agents|mesh-ancestor
24492476|NCT00486421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24492477|NCT00486460|Gemcitabine|gemcitabine|mesh-list
24492478|NCT00486460|Curcumin|curcumin|mesh-list
24917633|NCT04227912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24917651|NCT04227210|Vaccines|vaccines|mesh-list
24917652|NCT04227210|Immunologic Factors|immunologic factors|mesh-ancestor
24917653|NCT04227210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917666|NCT04227483|Prednisolone|prednisolone|mesh-list
24917667|NCT04227483|Deflazacort|deflazacort|mesh-list
24917668|NCT04227483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24917671|NCT04227483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24917672|NCT04227483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917673|NCT04227483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24917674|NCT04227483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917675|NCT04227483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24917676|NCT04227483|Immunologic Factors|immunologic factors|mesh-ancestor
24917678|NCT04227522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24917679|NCT04227522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917680|NCT04227522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917681|NCT04227522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917682|NCT04227509|Pembrolizumab|pembrolizumab|mesh-list
24917683|NCT04227509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24917684|NCT04227509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917685|NCT04227431|Insulin|insulin|mesh-list
24917686|NCT04227431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24917687|NCT04227431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917688|NCT04227093|Acetazolamide|acetazolamide|mesh-list
24917689|NCT04227093|Anticonvulsants|anticonvulsants|mesh-ancestor
24917690|NCT04227093|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25066722|NCT02099175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25066723|NCT02099175|Antidotes|antidotes|mesh-ancestor
25066724|NCT02099175|Protective Agents|protective agents|mesh-ancestor
25066725|NCT02099175|Vitamin B Complex|vitamin b complex|mesh-ancestor
25066727|NCT02099175|Micronutrients|micronutrients|mesh-ancestor
25066728|NCT02099175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25066729|NCT02099175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25066730|NCT02099175|Alkylating Agents|alkylating agents|mesh-ancestor
25066731|NCT02087826|Metformin|metformin|mesh-list
25066732|NCT02087826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25066733|NCT02087826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066734|NCT01451736|Risperidone|risperidone|mesh-list
25066735|NCT01451736|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25066736|NCT01451736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25066737|NCT01451736|Serotonin Agents|serotonin agents|mesh-ancestor
25066738|NCT01451736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25066739|NCT01451736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066740|NCT01451736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066741|NCT01451736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25066742|NCT01451736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24647909|NCT01211327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24647910|NCT01211327|Glucocorticoids|glucocorticoids|mesh-ancestor
24647911|NCT01211327|Hormones|hormones|mesh-ancestor
24647913|NCT01211327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25049492|NCT00602329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25049494|NCT00602329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647918|NCT01211327|Immunologic Factors|immunologic factors|mesh-ancestor
24825984|NCT02131350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443171|NCT00293839|Parasympatholytics|parasympatholytics|mesh-ancestor
25066743|NCT01451736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25066745|NCT01451736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25066746|NCT01451736|Dopamine Agents|dopamine agents|mesh-ancestor
25066747|NCT01451736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25066748|NCT01451736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25066749|NCT01333046|Azacitidine|azacitidine|mesh-list
24917691|NCT04227093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917710|NCT04226963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24917711|NCT04226963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24917712|NCT04226963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24917714|NCT04226963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917716|NCT04226885|Midazolam|midazolam|mesh-list
24917717|NCT04226885|Dexmedetomidine|dexmedetomidine|mesh-list
24917718|NCT04226885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24917719|NCT04226885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24917720|NCT04226885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066750|NCT01333046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25066751|NCT01333046|Antimetabolites|antimetabolites|mesh-ancestor
25066752|NCT01333046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694328|NCT02029274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694329|NCT02029274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25694330|NCT02029274|Immunologic Factors|immunologic factors|mesh-ancestor
25694331|NCT02029274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694332|NCT02029417|Cytarabine|cytarabine|mesh-list
25694333|NCT02029417|Decitabine|decitabine|mesh-list
25694334|NCT02029417|Azacitidine|azacitidine|mesh-list
25694335|NCT02029417|Homoharringtonine|homoharringtonine|mesh-list
25694336|NCT02029417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24798767|NCT01964911|Sensory System Agents|sensory system agents|mesh-ancestor
25066753|NCT01333046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066754|NCT01333046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25066756|NCT01166633|Pitavastatin|pitavastatin|mesh-list
25066757|NCT01166633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25066758|NCT01166633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25066759|NCT01166633|Antimetabolites|antimetabolites|mesh-ancestor
25066760|NCT01166633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066761|NCT01166633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25066762|NCT01166633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25066763|NCT01166633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25077441|NCT03364764|Antifungal Agents|antifungal agents|mesh-ancestor
25077442|NCT03364764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25066764|NCT00872950|Amifampridine|amifampridine|mesh-list
25066765|NCT00872950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25066766|NCT00872950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24917721|NCT04226885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24917722|NCT04226885|Analgesics|analgesics|mesh-ancestor
24917723|NCT04226885|Sensory System Agents|sensory system agents|mesh-ancestor
24917724|NCT04226885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24917725|NCT04226885|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24917726|NCT04226885|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24917727|NCT04226885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24917728|NCT04226885|Adrenergic Agents|adrenergic agents|mesh-ancestor
24917729|NCT04226885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24917730|NCT04226885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917731|NCT04226885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24917733|NCT04226885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24917734|NCT04226885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24917735|NCT04226885|Anesthetics, General|anesthetics, general|mesh-ancestor
24520773|NCT05326360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24520774|NCT05326360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520775|NCT05326360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24520776|NCT05326360|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24520777|NCT05326360|Serotonin Agents|serotonin agents|mesh-ancestor
24520778|NCT05326360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24520779|NCT05326360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520780|NCT05325164|Morphine|morphine|mesh-list
24520781|NCT05325164|Methadone|methadone|mesh-list
24520782|NCT05325164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24520783|NCT05325164|Narcotics|narcotics|mesh-ancestor
24520784|NCT05325164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24520785|NCT05325164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520786|NCT05325164|Analgesics|analgesics|mesh-ancestor
24520787|NCT05325164|Sensory System Agents|sensory system agents|mesh-ancestor
24520788|NCT05325164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24520789|NCT05325164|Antitussive Agents|antitussive agents|mesh-ancestor
24520795|NCT05324059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24917736|NCT04226885|Anesthetics|anesthetics|mesh-ancestor
24917737|NCT04226885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24917738|NCT04226885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24917739|NCT04226885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24819922|NCT02097810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25694338|NCT02029417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694339|NCT02029417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694340|NCT02029417|Antiviral Agents|antiviral agents|mesh-ancestor
25694341|NCT02029417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24648250|NCT01213355|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24648251|NCT01213355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774676|NCT01847326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24648252|NCT01213355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648254|NCT01213355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24648255|NCT01213355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648257|NCT01213355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24648258|NCT01213355|Antiemetics|antiemetics|mesh-ancestor
24648259|NCT01213355|Autonomic Agents|autonomic agents|mesh-ancestor
24648260|NCT01213355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24648261|NCT01213355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24648279|NCT01213381|Immunologic Factors|immunologic factors|mesh-ancestor
24648280|NCT01213381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648281|NCT01213381|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24648283|NCT01213394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25066767|NCT00872950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066768|NCT00872950|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25066769|NCT00872950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25066770|NCT00872950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066773|NCT00493896|Fondaparinux|fondaparinux|mesh-list
25066774|NCT00493896|Anticoagulants|anticoagulants|mesh-ancestor
25066775|NCT00493896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25066776|NCT00493896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25066786|NCT03450499|Ketamine|ketamine|mesh-list
25066787|NCT03450499|Analgesics|analgesics|mesh-ancestor
25066788|NCT03450499|Sensory System Agents|sensory system agents|mesh-ancestor
25066789|NCT03450499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25066790|NCT03450499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066791|NCT03450499|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25066792|NCT03450499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25066793|NCT03450499|Anesthetics, General|anesthetics, general|mesh-ancestor
25066794|NCT03450499|Anesthetics|anesthetics|mesh-ancestor
25066795|NCT03450499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25066796|NCT03450499|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25066797|NCT03450499|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25694342|NCT02029417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25694343|NCT02029417|Immunologic Factors|immunologic factors|mesh-ancestor
25694344|NCT02029417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694345|NCT02029417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25694346|NCT02029417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25694347|NCT02029417|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25709323|NCT02265237|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25709324|NCT02265237|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25709325|NCT02265237|Protease Inhibitors|protease inhibitors|mesh-ancestor
25709326|NCT02265237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709327|NCT02265237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709328|NCT02265237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25709329|NCT02265237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25709330|NCT02265237|Antiviral Agents|antiviral agents|mesh-ancestor
25709331|NCT02265237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25709332|NCT02265237|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25709333|NCT02265237|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25049531|NCT00594984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25004169|NCT02591953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25004171|NCT02569489|Trastuzumab|trastuzumab|mesh-list
25004172|NCT02569489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25004193|NCT02503722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25004194|NCT02503722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24648508|NCT01215084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24648509|NCT01215084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004227|NCT02201381|Metformin|metformin|mesh-list
25004228|NCT02201381|Doxycycline|doxycycline|mesh-list
25004229|NCT02201381|Mebendazole|mebendazole|mesh-list
25004230|NCT02201381|Atorvastatin|atorvastatin|mesh-list
24941613|NCT03989557|Aspirin|aspirin|mesh-list
25066798|NCT03450499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25066799|NCT03450499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066800|NCT03450434|Histamine|histamine|mesh-list
25066801|NCT03450434|Glutarimide|glutarimide|mesh-list
25066802|NCT03450434|Histamine Agonists|histamine agonists|mesh-ancestor
24819923|NCT02097810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819924|NCT02097810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066803|NCT03450434|Histamine Agents|histamine agents|mesh-ancestor
25066804|NCT03450434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25066805|NCT03450434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066806|NCT03450434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066807|NCT03450434|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25066808|NCT03450434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25066810|NCT03450317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25066811|NCT03450317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25066812|NCT03450317|Analgesics|analgesics|mesh-ancestor
25066813|NCT03450317|Sensory System Agents|sensory system agents|mesh-ancestor
25066814|NCT03450317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25066815|NCT03450317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066816|NCT03450317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25066817|NCT03450317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25066818|NCT03450317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25066819|NCT03450317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24819925|NCT02097953|Rifampin|rifampin|mesh-list
24819926|NCT02097953|Daptomycin|daptomycin|mesh-list
25406429|NCT03560531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694348|NCT02029495|Brodalumab|brodalumab|mesh-list
25694349|NCT02029495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25694350|NCT02029495|Dermatologic Agents|dermatologic agents|mesh-ancestor
25694351|NCT02029495|Immunologic Factors|immunologic factors|mesh-ancestor
25694352|NCT02029495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694353|NCT02029638|Acetaminophen|acetaminophen|mesh-list
25694354|NCT02029638|Diphenhydramine|diphenhydramine|mesh-list
25694355|NCT02029638|Promethazine|promethazine|mesh-list
25694356|NCT02029638|Mycophenolic Acid|mycophenolic acid|mesh-list
25694357|NCT02029638|Prednisone|prednisone|mesh-list
25694358|NCT02029638|Methylprednisolone|methylprednisolone|mesh-list
25694359|NCT02029638|Cyclophosphamide|cyclophosphamide|mesh-list
25694360|NCT02029638|Fludarabine|fludarabine|mesh-list
25694361|NCT02029638|Thymoglobulin|thymoglobulin|mesh-list
25694362|NCT02029638|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25694363|NCT02029638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25694364|NCT02029638|Immunologic Factors|immunologic factors|mesh-ancestor
25694365|NCT02029638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694366|NCT02029638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25694367|NCT02029638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25694368|NCT02029638|Alkylating Agents|alkylating agents|mesh-ancestor
25694369|NCT02029638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694370|NCT02029638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694371|NCT02029638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24941638|NCT03989271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648512|NCT01215136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24648514|NCT01215136|Tubulin Modulators|tubulin modulators|mesh-ancestor
24648515|NCT01215136|Antimitotic Agents|antimitotic agents|mesh-ancestor
24648516|NCT01215136|Mitosis Modulators|mitosis modulators|mesh-ancestor
24648518|NCT01215136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24648548|NCT01215331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24648549|NCT01215331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648550|NCT01215409|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24648551|NCT01215409|Vasodilator Agents|vasodilator agents|mesh-ancestor
24648552|NCT01215409|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24648553|NCT01215409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24917789|NCT04226105|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24917790|NCT04226105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24826024|NCT02131818|Amoxicillin|amoxicillin|mesh-list
24826059|NCT02132104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24826060|NCT02132104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826061|NCT02132234|Adalimumab|adalimumab|mesh-list
24826062|NCT02132234|Etanercept|etanercept|mesh-list
24917832|NCT04225728|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24917833|NCT04225728|Teferrol|teferrol|mesh-list
24917834|NCT04225728|Trace Elements|trace elements|mesh-ancestor
24917835|NCT04225728|Micronutrients|micronutrients|mesh-ancestor
24917836|NCT04225728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917837|NCT04225728|Hematinics|hematinics|mesh-ancestor
24917838|NCT04225468|Analgesics, Opioid|analgesics, opioid|mesh-list
24917839|NCT04225468|Narcotics|narcotics|mesh-ancestor
24917840|NCT04225468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24917841|NCT04225468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917842|NCT04225468|Analgesics|analgesics|mesh-ancestor
25066820|NCT03450317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066821|NCT03450317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25066822|NCT03450317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25066823|NCT03450317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25066824|NCT03450317|Antipyretics|antipyretics|mesh-ancestor
25066825|NCT03450226|Bupivacaine|bupivacaine|mesh-list
25066826|NCT03450226|Anesthetics, Local|anesthetics, local|mesh-ancestor
25066827|NCT03450226|Anesthetics|anesthetics|mesh-ancestor
25066828|NCT03450226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24951745|NCT03901378|Pembrolizumab|pembrolizumab|mesh-list
25066829|NCT03450226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066830|NCT03450226|Sensory System Agents|sensory system agents|mesh-ancestor
25066831|NCT03450226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25066832|NCT03450161|Fentanyl|fentanyl|mesh-list
25066833|NCT03450161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25066834|NCT03450161|Narcotics|narcotics|mesh-ancestor
24918247|NCT04221672|Terlipressin|terlipressin|mesh-list
24917843|NCT04225468|Sensory System Agents|sensory system agents|mesh-ancestor
24917844|NCT04225468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24917846|NCT04225364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24917847|NCT04225364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24520796|NCT05324059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520797|NCT05324059|Anticonvulsants|anticonvulsants|mesh-ancestor
24520798|NCT05324059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24917863|NCT04225325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24917864|NCT04225325|Antiviral Agents|antiviral agents|mesh-ancestor
25694372|NCT02029638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25694373|NCT02029638|Glucocorticoids|glucocorticoids|mesh-ancestor
25694374|NCT02029638|Hormones|hormones|mesh-ancestor
25694375|NCT02029638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25694376|NCT02029638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25694377|NCT02029638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25694378|NCT02029638|Analgesics|analgesics|mesh-ancestor
25694379|NCT02029638|Sensory System Agents|sensory system agents|mesh-ancestor
25694380|NCT02029638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25694381|NCT02029638|Antipyretics|antipyretics|mesh-ancestor
25694382|NCT02029638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25694383|NCT02029638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25694384|NCT02029638|Antitubercular Agents|antitubercular agents|mesh-ancestor
25694385|NCT02029638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24917865|NCT04225325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24917866|NCT04225325|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25709334|NCT02265237|Antimetabolites|antimetabolites|mesh-ancestor
24648679|NCT01216345|Cetuximab|cetuximab|mesh-list
24917867|NCT04225325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24917868|NCT04225325|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24917869|NCT04225325|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24917870|NCT04225325|Protease Inhibitors|protease inhibitors|mesh-ancestor
24917871|NCT04225325|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24917872|NCT04225325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24917873|NCT04225312|Natalizumab|natalizumab|mesh-list
24917874|NCT04225312|Immunologic Factors|immunologic factors|mesh-ancestor
24917875|NCT04225312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917876|NCT04224922|Paclitaxel|paclitaxel|mesh-list
24917877|NCT04224922|Cyclophosphamide|cyclophosphamide|mesh-list
24917878|NCT04224922|Epirubicin|epirubicin|mesh-list
24917879|NCT04224922|Carboplatin|carboplatin|mesh-list
24917880|NCT04224922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24917881|NCT04224922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917882|NCT04224922|Tubulin Modulators|tubulin modulators|mesh-ancestor
24520799|NCT05324059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24520800|NCT05324059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520801|NCT05324059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25066840|NCT03450161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25066841|NCT03450161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25066842|NCT03450161|Anesthetics, General|anesthetics, general|mesh-ancestor
25066844|NCT03450109|Goserelin|goserelin|mesh-list
25066845|NCT03450109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25066847|NCT03450057|Daratumumab|daratumumab|mesh-list
25066848|NCT03450057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066849|NCT03449940|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25066850|NCT03449940|Ceftriaxone|ceftriaxone|mesh-list
25066851|NCT03449940|Diclofenac|diclofenac|mesh-list
25066852|NCT03449940|Lidocaine|lidocaine|mesh-list
25066853|NCT03449940|Analgesics|analgesics|mesh-list
25066854|NCT03449940|Anesthetics, Local|anesthetics, local|mesh-ancestor
25066855|NCT03449940|Anesthetics|anesthetics|mesh-ancestor
25066856|NCT03449940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25066857|NCT03449940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066858|NCT03449940|Sensory System Agents|sensory system agents|mesh-ancestor
25066859|NCT03449940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25066860|NCT03449940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25066861|NCT03449940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25066862|NCT03449940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25066863|NCT03449940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24657189|NCT01266057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25066864|NCT03449940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066865|NCT03449940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25066866|NCT03449940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25066867|NCT03449940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25066868|NCT03449940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25066869|NCT03449940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25066870|NCT03449940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25066871|NCT03449940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24520802|NCT05324059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24917883|NCT04224922|Antimitotic Agents|antimitotic agents|mesh-ancestor
24917884|NCT04224922|Mitosis Modulators|mitosis modulators|mesh-ancestor
24917901|NCT04225195|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24917902|NCT04225195|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24917932|NCT04224818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24917933|NCT04224818|Contraceptive Agents|contraceptive agents|mesh-ancestor
24917942|NCT04224649|Anesthetics|anesthetics|mesh-ancestor
24917943|NCT04224649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24917944|NCT04224649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917946|NCT04224649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24917953|NCT04224649|Immunologic Factors|immunologic factors|mesh-ancestor
24917954|NCT04224649|Viscosupplements|viscosupplements|mesh-ancestor
24917955|NCT04224649|Protective Agents|protective agents|mesh-ancestor
24917956|NCT04224636|Bevacizumab|bevacizumab|mesh-list
24917957|NCT04224636|Atezolizumab|atezolizumab|mesh-list
24917958|NCT04224636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24917959|NCT04224636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917960|NCT04224636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24917961|NCT04224636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24917962|NCT04224636|Growth Substances|growth substances|mesh-ancestor
24917963|NCT04224636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917964|NCT04224636|Growth Inhibitors|growth inhibitors|mesh-ancestor
24917972|NCT04224675|Atenolol|atenolol|mesh-list
25709335|NCT02265341|Ponatinib|ponatinib|mesh-list
24622153|NCT01065857|Sequestering Agents|sequestering agents|mesh-ancestor
24622154|NCT01065857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622155|NCT01065857|Cathartics|cathartics|mesh-ancestor
24622156|NCT01065857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24622157|NCT01065857|Antacids|antacids|mesh-ancestor
24622158|NCT01065870|Gemcitabine|gemcitabine|mesh-list
24622159|NCT01065870|Capecitabine|capecitabine|mesh-list
24622160|NCT01065870|Docetaxel|docetaxel|mesh-list
24622161|NCT01065870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24622162|NCT01065870|Antimetabolites|antimetabolites|mesh-ancestor
24622165|NCT01065870|Antiviral Agents|antiviral agents|mesh-ancestor
24917973|NCT04224675|Captopril|captopril|mesh-list
24917974|NCT04224675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24917975|NCT04224675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24520844|NCT05306379|Simvastatin|simvastatin|mesh-list
24520845|NCT05306379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24520846|NCT05306379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24520847|NCT05306379|Antimetabolites|antimetabolites|mesh-ancestor
24520848|NCT05306379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520849|NCT05306379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25066874|NCT03449836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24520850|NCT05306379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24520851|NCT05306379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917976|NCT04224675|Sympatholytics|sympatholytics|mesh-ancestor
24917977|NCT04224675|Autonomic Agents|autonomic agents|mesh-ancestor
24917978|NCT04224675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24917979|NCT04224675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917980|NCT04224675|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24917981|NCT04224675|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24917982|NCT04224675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24918003|NCT04224441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24918004|NCT04224441|Alkylating Agents|alkylating agents|mesh-ancestor
24918005|NCT04224441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918006|NCT04224441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24918007|NCT04224441|Antiemetics|antiemetics|mesh-ancestor
24918008|NCT04224441|Autonomic Agents|autonomic agents|mesh-ancestor
24918017|NCT04224441|Dopamine Agents|dopamine agents|mesh-ancestor
24918018|NCT04224441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24918019|NCT04224415|Irinotecan|irinotecan|mesh-list
24918020|NCT04224415|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24918021|NCT04224415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24918022|NCT04224415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918023|NCT04224415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918024|NCT04224415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24918025|NCT04224051|Metformin|metformin|mesh-list
24918026|NCT04224051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24918027|NCT04224051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819929|NCT02097953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24819930|NCT02097953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24819931|NCT02097953|Leprostatic Agents|leprostatic agents|mesh-ancestor
24819932|NCT02097953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24819933|NCT02097953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819934|NCT02097953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694386|NCT02029638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25694387|NCT02029638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25694388|NCT02029638|Antiemetics|antiemetics|mesh-ancestor
25694389|NCT02029638|Autonomic Agents|autonomic agents|mesh-ancestor
25694390|NCT02029638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25694391|NCT02029638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25694392|NCT02029638|Protective Agents|protective agents|mesh-ancestor
25694393|NCT02029638|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25694394|NCT02029638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25694395|NCT02029638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24819936|NCT02097953|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24819937|NCT02097953|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24819938|NCT02097953|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24918050|NCT04224350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24918051|NCT04224350|Immunologic Factors|immunologic factors|mesh-ancestor
24918052|NCT04224350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918101|NCT04223739|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24918102|NCT04223739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24918103|NCT04223739|Adrenergic Agents|adrenergic agents|mesh-ancestor
24918104|NCT04223739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24918105|NCT04223739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918106|NCT04223219|Magnesium Sulfate|magnesium sulfate|mesh-list
24918107|NCT04223219|Fentanyl|fentanyl|mesh-list
24918108|NCT04223219|Dexmedetomidine|dexmedetomidine|mesh-list
24918109|NCT04223219|Ketamine|ketamine|mesh-list
24918110|NCT04223219|Propofol|propofol|mesh-list
24918111|NCT04223219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24918112|NCT04223219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24918113|NCT04223219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918114|NCT04223219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24918115|NCT04223219|Anesthetics, General|anesthetics, general|mesh-ancestor
24918116|NCT04223219|Anesthetics|anesthetics|mesh-ancestor
25066875|NCT03449836|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25066876|NCT03449836|Autonomic Agents|autonomic agents|mesh-ancestor
25066877|NCT03449836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25066878|NCT03449836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066879|NCT03449836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24918117|NCT04223219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24918118|NCT04223219|Analgesics|analgesics|mesh-ancestor
24918119|NCT04223219|Sensory System Agents|sensory system agents|mesh-ancestor
24918120|NCT04223219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24918121|NCT04223219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24918122|NCT04223219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24918123|NCT04223219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24918124|NCT04223219|Adrenergic Agents|adrenergic agents|mesh-ancestor
24918125|NCT04223219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24918126|NCT04223219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918127|NCT04223219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24918152|NCT04222855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24918153|NCT04222855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24918155|NCT04222855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24918177|NCT04222062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24918178|NCT04222348|Metformin|metformin|mesh-list
24918179|NCT04222348|Insulin Detemir|insulin detemir|mesh-list
24918180|NCT04222348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24918181|NCT04222348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918182|NCT04222114|Catumaxomab|catumaxomab|mesh-list
24918183|NCT04222114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24819975|NCT02098330|Protective Agents|protective agents|mesh-ancestor
24819976|NCT02098330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24819977|NCT02098330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616554|NCT01038024|Antioxidants|antioxidants|mesh-list
24741549|NCT05288179|Pirfenidone|pirfenidone|mesh-list
24918184|NCT04222088|Chloroquine|chloroquine|mesh-list
24918185|NCT04222088|Lumefantrine|lumefantrine|mesh-list
24918186|NCT04222088|Amebicides|amebicides|mesh-ancestor
24918187|NCT04222088|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24918188|NCT04222088|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24918189|NCT04222088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24918215|NCT04221919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066880|NCT03449836|Respiratory System Agents|respiratory system agents|mesh-ancestor
25066881|NCT03449836|Dermatologic Agents|dermatologic agents|mesh-ancestor
25066882|NCT03449836|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24918216|NCT04221971|Cyclophosphamide|cyclophosphamide|mesh-list
24918217|NCT04221971|Fludarabine|fludarabine|mesh-list
24918233|NCT04222010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24918235|NCT04221555|Oxaliplatin|oxaliplatin|mesh-list
24918236|NCT04221555|Durvalumab|durvalumab|mesh-list
24918237|NCT04221555|Tremelimumab|tremelimumab|mesh-list
24918238|NCT04221555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24918239|NCT04221555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24918240|NCT04221555|Tubulin Modulators|tubulin modulators|mesh-ancestor
24918241|NCT04221555|Antimitotic Agents|antimitotic agents|mesh-ancestor
24918242|NCT04221555|Mitosis Modulators|mitosis modulators|mesh-ancestor
24918243|NCT04221555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918244|NCT04221555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24918246|NCT04221555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918268|NCT04221256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918270|NCT04221256|Serotonin Agents|serotonin agents|mesh-ancestor
24918271|NCT04221256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918272|NCT04221256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24918296|NCT04221152|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24918297|NCT04221152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918298|NCT04221152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24918299|NCT04221152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918300|NCT04220931|Botulinum Toxins|botulinum toxins|mesh-list
24918301|NCT04220931|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24918302|NCT04220931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24918303|NCT04220931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918304|NCT04220931|Cholinergic Agents|cholinergic agents|mesh-ancestor
24918305|NCT04220931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24918313|NCT04220996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918314|NCT04220996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24918336|NCT04220528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24493228|NCT00489996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493229|NCT00489996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24493230|NCT00489996|Immunologic Factors|immunologic factors|mesh-ancestor
24493231|NCT00489996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493232|NCT00490087|Levonorgestrel|levonorgestrel|mesh-list
24493233|NCT00490087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24493234|NCT00490087|Contraceptive Agents|contraceptive agents|mesh-ancestor
24493235|NCT00490087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24493236|NCT00490087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493237|NCT00490087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24918337|NCT04220528|Antimetabolites|antimetabolites|mesh-ancestor
24918338|NCT04220528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918339|NCT04220528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24918341|NCT04220398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24918342|NCT04220398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918343|NCT04220606|Nitroglycerin|nitroglycerin|mesh-list
24918344|NCT04220606|Vasodilator Agents|vasodilator agents|mesh-ancestor
24918345|NCT04220632|Prednisone|prednisone|mesh-list
24918346|NCT04220632|Methylprednisolone|methylprednisolone|mesh-list
24918347|NCT04220632|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24918348|NCT04220632|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24918349|NCT04220632|Prednisolone|prednisolone|mesh-list
24918350|NCT04220632|Prednisolone acetate|prednisolone acetate|mesh-list
24918351|NCT04220632|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24918354|NCT04220632|Glucocorticoids|glucocorticoids|mesh-ancestor
24918355|NCT04220632|Hormones|hormones|mesh-ancestor
24918356|NCT04220632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24918357|NCT04220632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918358|NCT04220632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24918359|NCT04220632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24918360|NCT04220632|Antiemetics|antiemetics|mesh-ancestor
24918361|NCT04220632|Autonomic Agents|autonomic agents|mesh-ancestor
24918362|NCT04220632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24918363|NCT04220632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24649281|NCT01219153|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24918398|NCT04220073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24918399|NCT04220073|Immunologic Factors|immunologic factors|mesh-ancestor
25066885|NCT03449797|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25066886|NCT03449797|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25066887|NCT03449797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24918400|NCT04220073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918401|NCT04219995|Methylprednisolone|methylprednisolone|mesh-list
24918402|NCT04219995|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24918403|NCT04219995|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24918404|NCT04219995|Prednisolone|prednisolone|mesh-list
24918405|NCT04219995|Prednisolone acetate|prednisolone acetate|mesh-list
24918406|NCT04219995|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24918407|NCT04219995|Prednisolone phosphate|prednisolone phosphate|mesh-list
24918408|NCT04219995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24918409|NCT04219995|Antiemetics|antiemetics|mesh-ancestor
24918410|NCT04219995|Autonomic Agents|autonomic agents|mesh-ancestor
24918411|NCT04219995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24918415|NCT04219995|Hormones|hormones|mesh-ancestor
24918422|NCT04219865|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24918423|NCT04219865|Antioxidants|antioxidants|mesh-ancestor
24918424|NCT04219865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918425|NCT04219865|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24918426|NCT04219865|Protective Agents|protective agents|mesh-ancestor
24451466|NCT00323830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451467|NCT00323830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24451468|NCT00323830|Antimetabolites|antimetabolites|mesh-ancestor
24918431|NCT04219982|Antiemetics|antiemetics|mesh-ancestor
24918432|NCT04219982|Autonomic Agents|autonomic agents|mesh-ancestor
24918433|NCT04219982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24918434|NCT04219982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918435|NCT04219982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24918436|NCT04219982|Mydriatics|mydriatics|mesh-ancestor
24918437|NCT04219982|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25694396|NCT02029638|Anesthetics, Local|anesthetics, local|mesh-ancestor
25694397|NCT02029638|Anesthetics|anesthetics|mesh-ancestor
25694398|NCT02029638|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25694399|NCT02029638|Histamine Antagonists|histamine antagonists|mesh-ancestor
25694400|NCT02029638|Histamine Agents|histamine agents|mesh-ancestor
25694401|NCT02029638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24918438|NCT04219982|Cholinergic Agents|cholinergic agents|mesh-ancestor
24918439|NCT04219982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24493392|NCT00490828|Hydrocortisone|hydrocortisone|mesh-list
24520894|NCT05246007|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24520895|NCT05246007|Adrenergic Agents|adrenergic agents|mesh-ancestor
24520896|NCT05246007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24520897|NCT05246007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520899|NCT05243940|Dexmedetomidine|dexmedetomidine|mesh-list
24520900|NCT05243940|Ketamine|ketamine|mesh-list
24520901|NCT05243940|Remifentanil|remifentanil|mesh-list
24520902|NCT05243940|Anesthetics, Local|anesthetics, local|mesh-ancestor
24616917|NCT01039766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616918|NCT01039844|Paclitaxel|paclitaxel|mesh-list
24616919|NCT01039844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24616920|NCT01039844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616921|NCT01039844|Tubulin Modulators|tubulin modulators|mesh-ancestor
24616922|NCT01039844|Antimitotic Agents|antimitotic agents|mesh-ancestor
25066888|NCT03449719|Abiraterone Acetate|abiraterone acetate|mesh-list
25066889|NCT03449719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616923|NCT01039844|Mitosis Modulators|mitosis modulators|mesh-ancestor
24616924|NCT01039844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616925|NCT01039883|Albaconazole|albaconazole|mesh-list
24616926|NCT01039883|Antifungal Agents|antifungal agents|mesh-ancestor
24616927|NCT01039883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24623763|NCT01073527|Purinergic Agents|purinergic agents|mesh-ancestor
24623764|NCT01073540|Cephalexin|cephalexin|mesh-list
24623765|NCT01073540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24623766|NCT01073540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24623767|NCT01073553|Cephalexin|cephalexin|mesh-list
24623768|NCT01073553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24623769|NCT01073553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24623770|NCT01073579|Vigabatrin|vigabatrin|mesh-list
24623771|NCT01073579|Anticonvulsants|anticonvulsants|mesh-ancestor
24623772|NCT01073579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493394|NCT00490828|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24520921|NCT05243940|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24520922|NCT05243940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24520923|NCT05243940|Anesthetics, General|anesthetics, general|mesh-ancestor
24520924|NCT05243940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24520925|NCT05243940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24520926|NCT05243940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24520927|NCT05243940|Narcotics|narcotics|mesh-ancestor
24520928|NCT05237141|Etonogestrel|etonogestrel|mesh-list
24520929|NCT05237141|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24520943|NCT05225610|Sensory System Agents|sensory system agents|mesh-ancestor
24826362|NCT02134093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24826363|NCT02134093|Narcotics|narcotics|mesh-ancestor
24520944|NCT05225610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24520946|NCT05225610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24623773|NCT01073579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617148|NCT01041235|Antimitotic Agents|antimitotic agents|mesh-ancestor
24617149|NCT01041235|Mitosis Modulators|mitosis modulators|mesh-ancestor
24617150|NCT01041235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617152|NCT01041313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24617153|NCT01041313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24617154|NCT01041313|Dopamine Agents|dopamine agents|mesh-ancestor
24617155|NCT01041313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24617156|NCT01041313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617157|NCT01041313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617158|NCT01041313|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24918471|NCT04219358|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24617159|NCT01041313|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24918473|NCT04219358|Dermatologic Agents|dermatologic agents|mesh-ancestor
24918474|NCT04219280|Methylphenidate|methylphenidate|mesh-list
24493422|NCT00490880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493423|NCT00490880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493424|NCT00490880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24520948|NCT05225610|Adrenergic Agents|adrenergic agents|mesh-ancestor
24520949|NCT05225610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24520950|NCT05225610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918477|NCT04219280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24918478|NCT04219280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24918479|NCT04219280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24918480|NCT04219280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918481|NCT04219280|Dopamine Agents|dopamine agents|mesh-ancestor
24918482|NCT04219280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24918484|NCT04219046|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24918485|NCT04219046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826379|NCT02134249|Dopamine Agents|dopamine agents|mesh-ancestor
24443338|NCT00294567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24443339|NCT00294567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443340|NCT00294567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24918486|NCT04219046|Sensory System Agents|sensory system agents|mesh-ancestor
24493454|NCT00490997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24493455|NCT00490997|Anesthetics, General|anesthetics, general|mesh-ancestor
24493456|NCT00490997|Anesthetics|anesthetics|mesh-ancestor
24493458|NCT00490997|Sensory System Agents|sensory system agents|mesh-ancestor
24520959|NCT05217589|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24520960|NCT05217589|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
24520981|NCT05210764|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25694402|NCT02029638|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25694403|NCT02029638|Antipruritics|antipruritics|mesh-ancestor
25694404|NCT02029638|Dermatologic Agents|dermatologic agents|mesh-ancestor
25694405|NCT02029703|Hylan|hylan|mesh-list
25694406|NCT02029703|Viscosupplements|viscosupplements|mesh-ancestor
25694407|NCT02029703|Protective Agents|protective agents|mesh-ancestor
25694408|NCT02029703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520982|NCT05210764|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24520984|NCT05210764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520985|NCT05210764|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24520986|NCT05210764|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24520987|NCT05210764|Antidepressive Agents|antidepressive agents|mesh-ancestor
24520988|NCT05210764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24520989|NCT05210725|Rivaroxaban|rivaroxaban|mesh-list
24520990|NCT05210725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24520991|NCT05210725|Antithrombins|antithrombins|mesh-ancestor
24520992|NCT05210725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24918489|NCT04218890|Thromboplastin|thromboplastin|mesh-list
24918490|NCT04218890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24918491|NCT04218890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24918492|NCT04218890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918493|NCT04218890|Hemostatics|hemostatics|mesh-ancestor
24918494|NCT04218890|Coagulants|coagulants|mesh-ancestor
24918495|NCT04218890|Anticoagulants|anticoagulants|mesh-ancestor
24918496|NCT04218890|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24918497|NCT04218890|Protease Inhibitors|protease inhibitors|mesh-ancestor
24918498|NCT04218890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918499|NCT04218890|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24918500|NCT04218890|Antithrombins|antithrombins|mesh-ancestor
24918501|NCT04218981|Antipsychotic Agents|antipsychotic agents|mesh-list
24918502|NCT04218981|Paroxetine|paroxetine|mesh-list
24918503|NCT04218981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24918504|NCT04218981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24918505|NCT04218981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24918506|NCT04218981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826429|NCT02134366|Clobazam|clobazam|mesh-list
24826430|NCT02134366|Anticonvulsants|anticonvulsants|mesh-ancestor
24826431|NCT02134366|Antiemetics|antiemetics|mesh-ancestor
24826432|NCT02134366|Autonomic Agents|autonomic agents|mesh-ancestor
24826433|NCT02134366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24826434|NCT02134366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493467|NCT00491049|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24493468|NCT00491049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24493469|NCT00491049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24520999|NCT05210374|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24521001|NCT05210374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24521047|NCT05174507|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24521052|NCT05174507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24521055|NCT05133895|Prednisone|prednisone|mesh-list
24521056|NCT05133895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24521057|NCT05133895|Glucocorticoids|glucocorticoids|mesh-ancestor
24521058|NCT05133895|Hormones|hormones|mesh-ancestor
24918509|NCT04218981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918510|NCT04218981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24918511|NCT04218981|Antidepressive Agents|antidepressive agents|mesh-ancestor
24918512|NCT04218981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25066894|NCT03449719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25066895|NCT03449719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066896|NCT03449719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25066900|NCT03449693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25066902|NCT03449654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25066903|NCT03449654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066905|NCT03449654|Hormones|hormones|mesh-ancestor
25066906|NCT03449654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25066907|NCT03449537|Caseins|caseins|mesh-list
25066908|NCT03449537|Chelating Agents|chelating agents|mesh-ancestor
25066909|NCT03449537|Sequestering Agents|sequestering agents|mesh-ancestor
25066910|NCT03449537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066911|NCT03449524|CXA-10|cxa-10|mesh-list
25066912|NCT03449524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24951877|NCT03899675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066913|NCT03449251|Verapamil|verapamil|mesh-list
24918513|NCT04218981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24918514|NCT04218981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24918515|NCT04218981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918516|NCT04218981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24918517|NCT04218981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24918534|NCT04218513|Edaravone|edaravone|mesh-list
24918536|NCT04218513|Antioxidants|antioxidants|mesh-ancestor
24918537|NCT04218513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918538|NCT04218513|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24493487|NCT00491114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493488|NCT00491114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24521059|NCT05133895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25066914|NCT03449251|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
24826465|NCT02134405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24826466|NCT02134405|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24826467|NCT02134405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826468|NCT02134405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066915|NCT03449251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25066916|NCT03449251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25066917|NCT03449251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25066918|NCT03449251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066919|NCT03449251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25066920|NCT03449251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066921|NCT03449251|Vasodilator Agents|vasodilator agents|mesh-ancestor
24829369|NCT02151812|Tubulin Modulators|tubulin modulators|mesh-ancestor
24829370|NCT02151812|Antimitotic Agents|antimitotic agents|mesh-ancestor
24829371|NCT02151812|Mitosis Modulators|mitosis modulators|mesh-ancestor
24521060|NCT05133895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521061|NCT05133895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24521077|NCT05113368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24521078|NCT05113368|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24521079|NCT05113368|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24918539|NCT04218513|Protective Agents|protective agents|mesh-ancestor
24918540|NCT04218513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918541|NCT04218500|Niacinamide|niacinamide|mesh-list
24918542|NCT04218500|Niacin|niacin|mesh-list
24918569|NCT04218552|Amlodipine|amlodipine|mesh-list
24918587|NCT04218149|Anesthetics, Local|anesthetics, local|mesh-ancestor
24918588|NCT04218149|Anesthetics|anesthetics|mesh-ancestor
24918589|NCT04218149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24918590|NCT04218149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918591|NCT04218149|Sensory System Agents|sensory system agents|mesh-ancestor
24918592|NCT04218149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24918593|NCT04218162|Lasmiditan|lasmiditan|mesh-list
24918594|NCT04218162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24918595|NCT04218162|Serotonin Agents|serotonin agents|mesh-ancestor
24918596|NCT04218162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24918597|NCT04218162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918598|NCT04218162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918599|NCT04217733|Ethosuximide|ethosuximide|mesh-list
24918600|NCT04217733|Mebeverine|mebeverine|mesh-list
24918601|NCT04217733|Alverine|alverine|mesh-list
24918602|NCT04217733|Anticonvulsants|anticonvulsants|mesh-ancestor
24918603|NCT04217733|Parasympatholytics|parasympatholytics|mesh-ancestor
24918604|NCT04217733|Autonomic Agents|autonomic agents|mesh-ancestor
24918605|NCT04217733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24826480|NCT02134470|Androgens|androgens|mesh-ancestor
24918606|NCT04217733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918607|NCT04217798|Etoposide|etoposide|mesh-list
25066922|NCT03449251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25066924|NCT03449173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25066925|NCT03449173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25066926|NCT03449173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25066927|NCT03449173|Growth Substances|growth substances|mesh-ancestor
25066928|NCT03449173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066929|NCT03449173|Growth Inhibitors|growth inhibitors|mesh-ancestor
24829378|NCT02151929|Everolimus|everolimus|mesh-list
24918608|NCT04217798|Niraparib|niraparib|mesh-list
24918609|NCT04217798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24918632|NCT04217265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24918633|NCT04217265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918634|NCT04217265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918635|NCT04217265|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24918636|NCT04217265|Hormone Antagonists|hormone antagonists|mesh-ancestor
24918637|NCT04217265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24918649|NCT04217447|Sensory System Agents|sensory system agents|mesh-ancestor
24918650|NCT04217447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24918651|NCT04217447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918652|NCT04217447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24918653|NCT04217447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24918654|NCT04217447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24918655|NCT04217447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24918656|NCT04217447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918657|NCT04217447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24918658|NCT04217447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24918659|NCT04217447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918660|NCT04217447|Antipyretics|antipyretics|mesh-ancestor
24918661|NCT04217421|Allopurinol|allopurinol|mesh-list
24918662|NCT04217421|Mannitol|mannitol|mesh-list
24918663|NCT04217421|Antimetabolites|antimetabolites|mesh-ancestor
24918664|NCT04217421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918665|NCT04217421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918666|NCT04217421|Gout Suppressants|gout suppressants|mesh-ancestor
24521080|NCT05113368|Hormone Antagonists|hormone antagonists|mesh-ancestor
24918667|NCT04217421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24918668|NCT04217421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24918669|NCT04217421|Antioxidants|antioxidants|mesh-ancestor
24742003|NCT05294393|Magnesium Sulfate|magnesium sulfate|mesh-list
24918670|NCT04217421|Protective Agents|protective agents|mesh-ancestor
24918671|NCT04217421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918672|NCT04217421|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24918673|NCT04217421|Diuretics|diuretics|mesh-ancestor
24918674|NCT04217421|Natriuretic Agents|natriuretic agents|mesh-ancestor
24918675|NCT04217512|Pantoprazole|pantoprazole|mesh-list
24918676|NCT04217512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24918677|NCT04217512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24918678|NCT04217512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24918679|NCT04217512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918680|NCT04217512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918681|NCT04217356|Hydroxyurea|hydroxyurea|mesh-list
24918682|NCT04217356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24918683|NCT04217356|Antisickling Agents|antisickling agents|mesh-ancestor
24918685|NCT04217356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918686|NCT04217356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24918688|NCT04217148|Dexamethasone acetate|dexamethasone acetate|mesh-list
24918689|NCT04217148|Tretinoin|tretinoin|mesh-list
24826501|NCT02134717|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24650824|NCT01228214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650825|NCT01228214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24708648|NCT01501890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918690|NCT04217148|BB 1101|bb 1101|mesh-list
24918691|NCT04217148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24918692|NCT04217148|Antiemetics|antiemetics|mesh-ancestor
24918693|NCT04217148|Autonomic Agents|autonomic agents|mesh-ancestor
24918694|NCT04217148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24918695|NCT04217148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918696|NCT04217148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25066930|NCT03449173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25066931|NCT03449173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25066932|NCT03449173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066933|NCT03449082|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25066934|NCT03449082|Hemostatics|hemostatics|mesh-ancestor
25066935|NCT03449082|Coagulants|coagulants|mesh-ancestor
25066936|NCT03449056|Albuterol|albuterol|mesh-list
25066937|NCT03449056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24918697|NCT04217148|Glucocorticoids|glucocorticoids|mesh-ancestor
24918698|NCT04217148|Hormones|hormones|mesh-ancestor
24918699|NCT04217148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24918700|NCT04217148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24918710|NCT04216836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24918711|NCT04217096|Paclitaxel|paclitaxel|mesh-list
24918712|NCT04217096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24918713|NCT04217096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24918714|NCT04217096|Tubulin Modulators|tubulin modulators|mesh-ancestor
24918715|NCT04217096|Antimitotic Agents|antimitotic agents|mesh-ancestor
24918716|NCT04217096|Mitosis Modulators|mitosis modulators|mesh-ancestor
24918717|NCT04217096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918718|NCT04216758|Gemcitabine|gemcitabine|mesh-list
24918719|NCT04216758|Paclitaxel|paclitaxel|mesh-list
24918720|NCT04216758|Tegafur|tegafur|mesh-list
24918722|NCT04216758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24918723|NCT04216758|Tubulin Modulators|tubulin modulators|mesh-ancestor
24918724|NCT04216758|Antimitotic Agents|antimitotic agents|mesh-ancestor
24918725|NCT04216758|Mitosis Modulators|mitosis modulators|mesh-ancestor
24918726|NCT04216758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918727|NCT04216758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24918728|NCT04216758|Antimetabolites|antimetabolites|mesh-ancestor
24918729|NCT04216758|Antiviral Agents|antiviral agents|mesh-ancestor
24617430|NCT01043211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617431|NCT01043211|Sensory System Agents|sensory system agents|mesh-ancestor
24918732|NCT04216758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24918733|NCT04216758|Immunologic Factors|immunologic factors|mesh-ancestor
24918734|NCT04216758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918736|NCT04216784|Diuretics|diuretics|mesh-ancestor
24918737|NCT04216784|Natriuretic Agents|natriuretic agents|mesh-ancestor
24918738|NCT04216784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918739|NCT04216784|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24918740|NCT04216784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24918741|NCT04216784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918742|NCT04216706|Calcium Channel Blockers|calcium channel blockers|mesh-list
24918743|NCT04216706|Sympatholytics|sympatholytics|mesh-list
24918744|NCT04216706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24918745|NCT04216706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918746|NCT04216706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24522306|NCT04001621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24918747|NCT04216706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918748|NCT04216706|Autonomic Agents|autonomic agents|mesh-ancestor
24918763|NCT04216888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918764|NCT04216628|Oxytocin|oxytocin|mesh-list
24918765|NCT04216628|Oxytocics|oxytocics|mesh-ancestor
25694409|NCT02029755|Anesthetics|anesthetics|mesh-list
25694410|NCT02029755|Anesthetics, Local|anesthetics, local|mesh-list
25694411|NCT02029755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25694412|NCT02029755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694413|NCT02029755|Sensory System Agents|sensory system agents|mesh-ancestor
25694414|NCT02029755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25066944|NCT03449056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24829389|NCT02152059|Nintedanib|nintedanib|mesh-list
24918775|NCT04216511|Autoantibodies|autoantibodies|mesh-list
24918776|NCT04216511|Immunologic Factors|immunologic factors|mesh-ancestor
24918777|NCT04216511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918778|NCT04216459|Cholecalciferol|cholecalciferol|mesh-list
24918779|NCT04216459|Thiamine|thiamine|mesh-list
24918780|NCT04216459|Vitamins|vitamins|mesh-ancestor
24918781|NCT04216459|Micronutrients|micronutrients|mesh-ancestor
24918782|NCT04216459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918783|NCT04216459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24918784|NCT04216459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24918785|NCT04216459|Vitamin B Complex|vitamin b complex|mesh-ancestor
24918786|NCT04216355|Azacitidine|azacitidine|mesh-list
24918787|NCT04216355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24918788|NCT04216355|Antimetabolites|antimetabolites|mesh-ancestor
24918790|NCT04216355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24918806|NCT04216771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24918807|NCT04216771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24918808|NCT04216771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24918809|NCT04216771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918810|NCT04216550|Apatinib|apatinib|mesh-list
24918811|NCT04216550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24918812|NCT04216550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24918813|NCT04216550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918814|NCT04216550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918815|NCT04216472|Paclitaxel|paclitaxel|mesh-list
24918816|NCT04216472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24918987|NCT04214990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24918820|NCT04216472|Tubulin Modulators|tubulin modulators|mesh-ancestor
24918821|NCT04216472|Antimitotic Agents|antimitotic agents|mesh-ancestor
24918847|NCT04215731|Fluorouracil|fluorouracil|mesh-list
24918848|NCT04215731|Oxaliplatin|oxaliplatin|mesh-list
24918849|NCT04215731|Irinotecan|irinotecan|mesh-list
24918850|NCT04215731|Levoleucovorin|levoleucovorin|mesh-list
24918851|NCT04215731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24918852|NCT04215731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24918853|NCT04215731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24918854|NCT04215731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24535773|NCT00649688|Metoprolol|metoprolol|mesh-list
24918855|NCT04215731|Growth Substances|growth substances|mesh-ancestor
24918856|NCT04215731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918857|NCT04215731|Growth Inhibitors|growth inhibitors|mesh-ancestor
24918858|NCT04215731|Antimetabolites|antimetabolites|mesh-ancestor
24918859|NCT04215731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918860|NCT04215731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24918862|NCT04215731|Immunologic Factors|immunologic factors|mesh-ancestor
24918863|NCT04215731|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24918864|NCT04215731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24918865|NCT04215731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918866|NCT04215731|Antidotes|antidotes|mesh-ancestor
25066945|NCT03449056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25066946|NCT03449056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25066947|NCT03449056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25066948|NCT03449056|Adrenergic Agents|adrenergic agents|mesh-ancestor
25066949|NCT03449056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25066950|NCT03449056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066951|NCT03448835|Docetaxel|docetaxel|mesh-list
25066952|NCT03448835|Capecitabine|capecitabine|mesh-list
25066953|NCT03448835|Oxaliplatin|oxaliplatin|mesh-list
25066954|NCT03448835|Atezolizumab|atezolizumab|mesh-list
24918867|NCT04215731|Protective Agents|protective agents|mesh-ancestor
24918868|NCT04215731|Vitamin B Complex|vitamin b complex|mesh-ancestor
24918869|NCT04215731|Vitamins|vitamins|mesh-ancestor
24918870|NCT04215731|Micronutrients|micronutrients|mesh-ancestor
24918871|NCT04215614|Lidocaine|lidocaine|mesh-list
24918872|NCT04215614|Bupivacaine|bupivacaine|mesh-list
24918873|NCT04215614|Anesthetics, Local|anesthetics, local|mesh-ancestor
24918874|NCT04215614|Anesthetics|anesthetics|mesh-ancestor
24918875|NCT04215614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24437346|NCT00273442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918876|NCT04215614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918877|NCT04215614|Sensory System Agents|sensory system agents|mesh-ancestor
24918878|NCT04215614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24918879|NCT04215614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24918898|NCT04215835|Abortifacient Agents|abortifacient agents|mesh-ancestor
24918899|NCT04215835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24918900|NCT04215835|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24918901|NCT04215835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24918902|NCT04215835|Oxytocics|oxytocics|mesh-ancestor
24918903|NCT04215770|Penicillins|penicillins|mesh-list
24918904|NCT04215770|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24918905|NCT04215770|Penicillin G|penicillin g|mesh-list
24918906|NCT04215770|Penicillin G Benzathine|penicillin g benzathine|mesh-list
24918907|NCT04215770|Penicillin G Procaine|penicillin g procaine|mesh-list
24918908|NCT04215770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24918909|NCT04215770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24918910|NCT04215770|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24918911|NCT04215770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918912|NCT04215770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918913|NCT04215536|Empagliflozin|empagliflozin|mesh-list
24493875|NCT00492700|Rosiglitazone|rosiglitazone|mesh-list
24918917|NCT04215536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24918918|NCT04215536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918919|NCT04215536|Protease Inhibitors|protease inhibitors|mesh-ancestor
24918920|NCT04215536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918921|NCT04215393|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24918922|NCT04215393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24918923|NCT04215159|Gemcitabine|gemcitabine|mesh-list
24918924|NCT04215159|Trastuzumab|trastuzumab|mesh-list
24918925|NCT04215159|Irinotecan|irinotecan|mesh-list
24918926|NCT04215159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24918927|NCT04215159|Antimetabolites|antimetabolites|mesh-ancestor
24918928|NCT04215159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918929|NCT04215159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24918930|NCT04215159|Antiviral Agents|antiviral agents|mesh-ancestor
24918931|NCT04215159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24918966|NCT04214938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24617432|NCT01043211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24617433|NCT01043211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24522307|NCT04001621|Antimetabolites|antimetabolites|mesh-ancestor
25066957|NCT03448835|Antimitotic Agents|antimitotic agents|mesh-ancestor
24617699|NCT01045083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24617700|NCT01045083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617701|NCT01045083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24617702|NCT01045083|Serotonin Agents|serotonin agents|mesh-ancestor
24617703|NCT01045083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617704|NCT01045083|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24857716|NCT02293681|Infliximab|infliximab|mesh-list
24437340|NCT00273442|Adrenergic Agents|adrenergic agents|mesh-ancestor
24437341|NCT00273442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24437342|NCT00273442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437343|NCT00273442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437344|NCT00273442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24437345|NCT00273442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24918985|NCT04214990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24918986|NCT04214990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24437478|NCT00273741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437479|NCT00273741|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24437480|NCT00273741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24437481|NCT00273741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24826542|NCT02135029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24437482|NCT00273741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437483|NCT00273741|Dopamine Agents|dopamine agents|mesh-ancestor
24437484|NCT00273741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24437485|NCT00273767|Epoetin Alfa|epoetin alfa|mesh-list
24437486|NCT00273767|Hematinics|hematinics|mesh-ancestor
24437487|NCT00273871|Cyclosporine|cyclosporine|mesh-list
24437489|NCT00273871|Cyclosporins|cyclosporins|mesh-list
24437490|NCT00273871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24437491|NCT00273871|Immunologic Factors|immunologic factors|mesh-ancestor
24437494|NCT00273871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24437495|NCT00273871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437496|NCT00273871|Antifungal Agents|antifungal agents|mesh-ancestor
24437497|NCT00273871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24437565|NCT00274001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24437566|NCT00274001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24918991|NCT04214990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24918992|NCT04214990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918993|NCT04214990|Antipyretics|antipyretics|mesh-ancestor
24919005|NCT04214977|Anesthetics|anesthetics|mesh-list
24919006|NCT04214977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24919007|NCT04214977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919008|NCT04214821|Moxifloxacin|moxifloxacin|mesh-list
24919009|NCT04214821|Levofloxacin|levofloxacin|mesh-list
24919010|NCT04214821|Ofloxacin|ofloxacin|mesh-list
24919011|NCT04214821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24919012|NCT04214821|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24919013|NCT04214821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24919014|NCT04214821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24919016|NCT04214821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24437568|NCT00274014|Tiotropium Bromide|tiotropium bromide|mesh-list
24437569|NCT00274014|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24437572|NCT00274014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919022|NCT04214821|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24919023|NCT04214821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24919024|NCT04214808|Dutasteride|dutasteride|mesh-list
25694415|NCT02029872|Chlorhexidine|chlorhexidine|mesh-list
25694416|NCT02029872|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25694417|NCT02029872|Mupirocin|mupirocin|mesh-list
25694418|NCT02029872|Calcium|calcium|mesh-list
25694419|NCT02029872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25694420|NCT02029872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694421|NCT02029872|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25694422|NCT02029872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25694423|NCT02029872|Disinfectants|disinfectants|mesh-ancestor
24919025|NCT04214808|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24919026|NCT04214808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24919028|NCT04214808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919029|NCT04214808|Hormone Antagonists|hormone antagonists|mesh-ancestor
24919030|NCT04214808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24919031|NCT04214808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919032|NCT04214665|Thioctic Acid|thioctic acid|mesh-list
24919033|NCT04214665|Antioxidants|antioxidants|mesh-ancestor
25066958|NCT03448835|Mitosis Modulators|mitosis modulators|mesh-ancestor
24521301|NCT04898894|Antimetabolites|antimetabolites|mesh-ancestor
25066959|NCT03448835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066960|NCT03448835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25066961|NCT03448835|Antimetabolites|antimetabolites|mesh-ancestor
25066962|NCT03448770|Lactulose|lactulose|mesh-list
25066963|NCT03448770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25066964|NCT03448744|Entecavir|entecavir|mesh-list
25066965|NCT03448744|Thymalfasin|thymalfasin|mesh-list
25066966|NCT03448744|Antiviral Agents|antiviral agents|mesh-ancestor
25066967|NCT03448744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24829407|NCT02152228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24829408|NCT02152228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24586866|NCT00892450|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24829409|NCT02152306|Amlodipine|amlodipine|mesh-list
24829410|NCT02152306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24829411|NCT02152306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24919034|NCT04214665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919035|NCT04214665|Protective Agents|protective agents|mesh-ancestor
24919036|NCT04214665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919037|NCT04214665|Vitamin B Complex|vitamin b complex|mesh-ancestor
24919038|NCT04214665|Vitamins|vitamins|mesh-ancestor
24919039|NCT04214665|Micronutrients|micronutrients|mesh-ancestor
24919040|NCT04214626|Prednisone|prednisone|mesh-list
24919041|NCT04214626|Cyclophosphamide|cyclophosphamide|mesh-list
24919062|NCT04214626|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24919071|NCT04214626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24919073|NCT04214626|Antimitotic Agents|antimitotic agents|mesh-ancestor
24919074|NCT04214626|Mitosis Modulators|mitosis modulators|mesh-ancestor
24919075|NCT04214626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24919076|NCT04214626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24919077|NCT04214626|Growth Substances|growth substances|mesh-ancestor
24919078|NCT04214626|Growth Inhibitors|growth inhibitors|mesh-ancestor
24919079|NCT04214626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24919080|NCT04214626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24919081|NCT04214626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24494232|NCT00494468|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24919105|NCT04214145|Nasal Decongestants|nasal decongestants|mesh-ancestor
24919106|NCT04214145|Respiratory System Agents|respiratory system agents|mesh-ancestor
24919116|NCT04214145|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24919117|NCT04214145|Natriuretic Agents|natriuretic agents|mesh-ancestor
24919118|NCT04214106|Thiamine|thiamine|mesh-list
24919119|NCT04214106|Vitamin B Complex|vitamin b complex|mesh-ancestor
24919120|NCT04214106|Vitamins|vitamins|mesh-ancestor
24919121|NCT04214106|Micronutrients|micronutrients|mesh-ancestor
24919122|NCT04214106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919123|NCT04213924|Ibuprofen|ibuprofen|mesh-list
24919124|NCT04213924|Lidocaine|lidocaine|mesh-list
24919125|NCT04213924|Bupivacaine|bupivacaine|mesh-list
24919126|NCT04213924|Anesthetics, Local|anesthetics, local|mesh-ancestor
24919127|NCT04213924|Anesthetics|anesthetics|mesh-ancestor
24919128|NCT04213924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24919129|NCT04213924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919130|NCT04213924|Sensory System Agents|sensory system agents|mesh-ancestor
24919131|NCT04213924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24919132|NCT04213924|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24919133|NCT04213924|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24919134|NCT04213924|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24919135|NCT04213924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24919138|NCT04213924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24919146|NCT04213937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24919147|NCT04213937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919148|NCT04213937|Tubulin Modulators|tubulin modulators|mesh-ancestor
24919149|NCT04213937|Antimitotic Agents|antimitotic agents|mesh-ancestor
24617712|NCT01045109|Cholecalciferol|cholecalciferol|mesh-list
24617713|NCT01045109|Vitamins|vitamins|mesh-list
24617714|NCT01045109|Micronutrients|micronutrients|mesh-ancestor
24944114|NCT03963336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617715|NCT01045109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617716|NCT01045109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24617717|NCT01045109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24617718|NCT01045278|Interferons|interferons|mesh-list
24617719|NCT01045278|Ribavirin|ribavirin|mesh-list
24617720|NCT01045278|Interferon-alpha|interferon-alpha|mesh-list
24617721|NCT01045278|Interferon alpha-2|interferon alpha-2|mesh-list
24617722|NCT01045278|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24919156|NCT04214054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24919157|NCT04214054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919161|NCT04213898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25066983|NCT03448640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25066984|NCT03448640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066985|NCT03448640|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25066986|NCT03448640|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25066987|NCT03448640|Cholinergic Agents|cholinergic agents|mesh-ancestor
24951963|NCT03899597|Oxytocin|oxytocin|mesh-list
25066988|NCT03448640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24952010|NCT03899038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24952011|NCT03899038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952012|NCT03898752|Coenzyme Q10|coenzyme q10|mesh-list
24952013|NCT03898752|Vitamins|vitamins|mesh-ancestor
24919162|NCT04213898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919163|NCT04213898|Tubulin Modulators|tubulin modulators|mesh-ancestor
24919164|NCT04213898|Antimitotic Agents|antimitotic agents|mesh-ancestor
24919165|NCT04213898|Mitosis Modulators|mitosis modulators|mesh-ancestor
24919166|NCT04213898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919167|NCT04213898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24919168|NCT04213898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24919169|NCT04213898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24919220|NCT04213378|Tubulin Modulators|tubulin modulators|mesh-ancestor
24919221|NCT04213378|Antimitotic Agents|antimitotic agents|mesh-ancestor
24919222|NCT04213378|Mitosis Modulators|mitosis modulators|mesh-ancestor
24494228|NCT00494468|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24494229|NCT00494468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24494230|NCT00494468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24494231|NCT00494468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521102|NCT05112081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521103|NCT05112081|Cholinergic Agents|cholinergic agents|mesh-ancestor
24521104|NCT05112081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24919223|NCT04213378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919224|NCT04213716|Calcium, Dietary|calcium, dietary|mesh-list
24919225|NCT04213716|Calcium|calcium|mesh-list
24919226|NCT04213716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24919227|NCT04213716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919228|NCT04213716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24919229|NCT04213612|Cyclophosphamide|cyclophosphamide|mesh-list
24919230|NCT04213612|Doxorubicin|doxorubicin|mesh-list
24919231|NCT04213612|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24919232|NCT04213612|Vincristine|vincristine|mesh-list
24919233|NCT04213612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24919234|NCT04213612|Immunologic Factors|immunologic factors|mesh-ancestor
24919235|NCT04213612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521138|NCT05104554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521139|NCT05100199|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24521140|NCT05100199|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24521141|NCT05100199|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24521142|NCT05100199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24521143|NCT05100199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521144|NCT05100199|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24521145|NCT05100199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24521146|NCT05100199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437586|NCT00274027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24437587|NCT00274027|Respiratory System Agents|respiratory system agents|mesh-ancestor
24437588|NCT00274027|Parasympatholytics|parasympatholytics|mesh-ancestor
24437589|NCT00274027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24521147|NCT05100199|Cholinergic Agents|cholinergic agents|mesh-ancestor
24521148|NCT05100199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25694424|NCT02029872|Dermatologic Agents|dermatologic agents|mesh-ancestor
25694425|NCT02029872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24521150|NCT05074355|Venetoclax|venetoclax|mesh-list
24521151|NCT05074355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24521152|NCT05074355|Antimetabolites|antimetabolites|mesh-ancestor
24521156|NCT05053334|Omalizumab|omalizumab|mesh-list
24521162|NCT05037045|Hormones|hormones|mesh-ancestor
24521163|NCT05037045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24521164|NCT05037045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521165|NCT05018520|Prednisone|prednisone|mesh-list
24521166|NCT05018520|Rituximab|rituximab|mesh-list
24521167|NCT05018520|Cyclophosphamide|cyclophosphamide|mesh-list
24521168|NCT05018520|Vincristine|vincristine|mesh-list
24521169|NCT05018520|Doxorubicin|doxorubicin|mesh-list
24521170|NCT05018520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24521171|NCT05018520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24521172|NCT05018520|Immunologic Factors|immunologic factors|mesh-ancestor
24919240|NCT04213612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919241|NCT04213612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24919242|NCT04213612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24919243|NCT04213612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24952022|NCT03899285|Serotonin Agents|serotonin agents|mesh-ancestor
24952023|NCT03899285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952024|NCT03899285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24952025|NCT03899285|Antidepressive Agents|antidepressive agents|mesh-ancestor
24952026|NCT03899285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24952027|NCT03898882|Oxytocin|oxytocin|mesh-list
24494262|NCT00494598|Anesthetics, General|anesthetics, general|mesh-ancestor
24494264|NCT00494611|Cetuximab|cetuximab|mesh-list
24919271|NCT04213287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24919272|NCT04213287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24919273|NCT04213287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24919274|NCT04213209|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24919275|NCT04213209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24919276|NCT04213209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919277|NCT04213391|Sulforaphane|sulforaphane|mesh-list
24919278|NCT04213391|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24919279|NCT04213391|Protective Agents|protective agents|mesh-ancestor
24919280|NCT04213391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919281|NCT04213391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919282|NCT04213222|Bevacizumab|bevacizumab|mesh-list
24919283|NCT04213222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24919284|NCT04213222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919285|NCT04213222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24919286|NCT04213222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24919287|NCT04213222|Growth Substances|growth substances|mesh-ancestor
24919288|NCT04213222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919289|NCT04213222|Growth Inhibitors|growth inhibitors|mesh-ancestor
24919290|NCT04213105|Denosumab|denosumab|mesh-list
24919291|NCT04213105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24919292|NCT04213105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919293|NCT04212793|Bevacizumab|bevacizumab|mesh-list
24919294|NCT04212793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24919295|NCT04212793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919296|NCT04212793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24919298|NCT04212793|Growth Substances|growth substances|mesh-ancestor
24919299|NCT04212793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919300|NCT04212793|Growth Inhibitors|growth inhibitors|mesh-ancestor
24742646|NCT05215548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24952033|NCT03898635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24952034|NCT03898635|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24952035|NCT03898635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952036|NCT03898635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952037|NCT03898583|Calcitriol|calcitriol|mesh-list
24952038|NCT03898583|Betamethasone|betamethasone|mesh-list
24952039|NCT03898583|Betamethasone Valerate|betamethasone valerate|mesh-list
24953473|NCT03884348|Amoxicillin|amoxicillin|mesh-list
24953474|NCT03884348|Metronidazole|metronidazole|mesh-list
24953475|NCT03884348|Clarithromycin|clarithromycin|mesh-list
24919301|NCT04212832|Bupivacaine|bupivacaine|mesh-list
24919302|NCT04212832|Anesthetics, Local|anesthetics, local|mesh-ancestor
24919303|NCT04212832|Anesthetics|anesthetics|mesh-ancestor
24919304|NCT04212832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24919305|NCT04212832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919307|NCT04212832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24919308|NCT04212845|Dexamethasone|dexamethasone|mesh-list
24919309|NCT04212845|Bupivacaine|bupivacaine|mesh-list
24919310|NCT04212845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24919311|NCT04212845|Antiemetics|antiemetics|mesh-ancestor
24919312|NCT04212845|Autonomic Agents|autonomic agents|mesh-ancestor
24919313|NCT04212845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24437637|NCT00274066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24437846|NCT00274560|Parasympatholytics|parasympatholytics|mesh-ancestor
24437847|NCT00274560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24437848|NCT00274560|Cholinergic Agents|cholinergic agents|mesh-ancestor
24919328|NCT04212702|Immunologic Factors|immunologic factors|mesh-ancestor
24919329|NCT04212702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919330|NCT04212429|Moxifloxacin|moxifloxacin|mesh-list
24919331|NCT04212429|Levofloxacin|levofloxacin|mesh-list
24919333|NCT04212429|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24919334|NCT04212429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24919335|NCT04212429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24919336|NCT04212429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24919337|NCT04212429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24919338|NCT04212429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24919339|NCT04212429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24919340|NCT04212429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494326|NCT00494884|Vildagliptin|vildagliptin|mesh-list
24494327|NCT00494884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24494330|NCT00494884|Protease Inhibitors|protease inhibitors|mesh-ancestor
24919341|NCT04212429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919342|NCT04212429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24919343|NCT04212429|Renal Agents|renal agents|mesh-ancestor
24919344|NCT04212429|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24919345|NCT04212429|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24437927|NCT00274794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437928|NCT00274794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24437930|NCT00274807|Etoposide|etoposide|mesh-list
24437931|NCT00274807|Mitoxantrone|mitoxantrone|mesh-list
24438023|NCT00274898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438024|NCT00274898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24919352|NCT04212650|Losartan|losartan|mesh-list
24919353|NCT04212650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24919354|NCT04212650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24919355|NCT04212650|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24919356|NCT04212650|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24919357|NCT04212650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919358|NCT04212403|Levofloxacin|levofloxacin|mesh-list
24494359|NCT00494897|Antimetabolites|antimetabolites|mesh-ancestor
24953479|NCT03884348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24953480|NCT03884348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24829463|NCT02152475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494364|NCT00494897|Antiviral Agents|antiviral agents|mesh-ancestor
24494365|NCT00494897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24494366|NCT00494897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24521173|NCT05018520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521174|NCT05018520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24521175|NCT05018520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24521176|NCT05018520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24521177|NCT05018520|Alkylating Agents|alkylating agents|mesh-ancestor
24438025|NCT00274898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24438027|NCT00274898|Sensory System Agents|sensory system agents|mesh-ancestor
24438028|NCT00274898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24438029|NCT00274898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438030|NCT00274898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24438031|NCT00274898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24438032|NCT00274898|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24438199|NCT00275106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24521178|NCT05018520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521179|NCT05018520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24652844|NCT01240538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652845|NCT01240538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24652868|NCT01240824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24652869|NCT01240824|Respiratory System Agents|respiratory system agents|mesh-ancestor
24652871|NCT01240824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24652872|NCT01240824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24521180|NCT05018520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24521181|NCT05018520|Glucocorticoids|glucocorticoids|mesh-ancestor
24521182|NCT05018520|Hormones|hormones|mesh-ancestor
24919367|NCT04212403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919368|NCT04212403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919369|NCT04212403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24919370|NCT04212403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24919371|NCT04212533|Vitamin D|vitamin d|mesh-list
24919372|NCT04212533|Vitamins|vitamins|mesh-ancestor
24919373|NCT04212533|Micronutrients|micronutrients|mesh-ancestor
24919374|NCT04212533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919375|NCT04212533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24919377|NCT04211896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24919378|NCT04211896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919379|NCT04211896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24919380|NCT04211896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919381|NCT04212026|Nivolumab|nivolumab|mesh-list
24919382|NCT04212026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24919383|NCT04212026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919384|NCT04212026|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24919385|NCT04212026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919393|NCT04212078|Levofloxacin|levofloxacin|mesh-list
24919394|NCT04212078|Ofloxacin|ofloxacin|mesh-list
24494379|NCT00494988|Isophane insulin, beef|isophane insulin, beef|mesh-list
24919396|NCT04212078|Cefuroxime axetil|cefuroxime axetil|mesh-list
24536480|NCT00651352|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24919397|NCT04212078|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24919398|NCT04212078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24919399|NCT04212078|Renal Agents|renal agents|mesh-ancestor
24919400|NCT04212078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24919401|NCT04212078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24919402|NCT04212078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24919403|NCT04212078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24919404|NCT04212078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919405|NCT04212078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919406|NCT04212078|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24919407|NCT04212078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24521222|NCT04958538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24521223|NCT04958538|Antimetabolites|antimetabolites|mesh-ancestor
24521224|NCT04958538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953481|NCT03884348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24779206|NCT01874639|Hemostatics|hemostatics|mesh-list
24953482|NCT03884348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24953483|NCT03884348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953484|NCT03884348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24953485|NCT03884348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24953486|NCT03884465|Treprostinil|treprostinil|mesh-list
25066989|NCT03448640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066991|NCT03448588|Antioxidants|antioxidants|mesh-ancestor
24829468|NCT02152514|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24521225|NCT04958538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24521226|NCT04958538|Dermatologic Agents|dermatologic agents|mesh-ancestor
24438200|NCT00275106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24438202|NCT00275106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438203|NCT00275106|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24438204|NCT00275106|Abortifacient Agents|abortifacient agents|mesh-ancestor
24438205|NCT00275106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25694426|NCT02029872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25694427|NCT02029872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25694428|NCT02029872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694429|NCT02029989|Chrysarobin|chrysarobin|mesh-list
25694430|NCT02029989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25694431|NCT02029989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25694432|NCT02029989|Analgesics|analgesics|mesh-ancestor
25694433|NCT02029989|Sensory System Agents|sensory system agents|mesh-ancestor
24653173|NCT01242267|Alkylating Agents|alkylating agents|mesh-ancestor
24653174|NCT01242267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653175|NCT01242267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24653176|NCT01242267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24653214|NCT01242410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653215|NCT01242449|Trastuzumab|trastuzumab|mesh-list
24653216|NCT01242449|Vinorelbine|vinorelbine|mesh-list
24653217|NCT01242449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24653218|NCT01242449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653219|NCT01242449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24653230|NCT01242579|Dapivirine|dapivirine|mesh-list
24438209|NCT00275106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24438210|NCT00275106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24438211|NCT00275106|Antiviral Agents|antiviral agents|mesh-ancestor
24438212|NCT00275106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24521228|NCT04958538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24521229|NCT04958538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24521230|NCT04958538|Immunologic Factors|immunologic factors|mesh-ancestor
24521231|NCT04958538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24521232|NCT04958538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24521233|NCT04951388|Somatomedin B|somatomedin b|mesh-list
24521234|NCT04951388|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24521250|NCT04931602|Micronutrients|micronutrients|mesh-ancestor
24919420|NCT04211961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919422|NCT04211961|Parasympatholytics|parasympatholytics|mesh-ancestor
24919423|NCT04211987|Cytarabine|cytarabine|mesh-list
24919424|NCT04211987|Methotrexate|methotrexate|mesh-list
24919425|NCT04211987|Etoposide|etoposide|mesh-list
24919426|NCT04211987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24919427|NCT04211987|Antimetabolites|antimetabolites|mesh-ancestor
24919428|NCT04211987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919429|NCT04211987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919430|NCT04211987|Antiviral Agents|antiviral agents|mesh-ancestor
24919431|NCT04211987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24919432|NCT04211987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24919433|NCT04211987|Immunologic Factors|immunologic factors|mesh-ancestor
24919434|NCT04211987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919435|NCT04211987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24919436|NCT04211987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24919437|NCT04211987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24919438|NCT04211987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24919439|NCT04211987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24919440|NCT04211987|Abortifacient Agents|abortifacient agents|mesh-ancestor
24617723|NCT01045278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617724|NCT01045278|Antiviral Agents|antiviral agents|mesh-ancestor
24494438|NCT00495287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24494439|NCT00495287|Antimetabolites|antimetabolites|mesh-ancestor
24521251|NCT04931602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438213|NCT00275106|Antidotes|antidotes|mesh-ancestor
24438214|NCT00275106|Protective Agents|protective agents|mesh-ancestor
24438252|NCT00275197|Antidepressive Agents|antidepressive agents|mesh-ancestor
24521252|NCT04931602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24617727|NCT01045278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617728|NCT01045278|Immunologic Factors|immunologic factors|mesh-ancestor
24617729|NCT01045278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623783|NCT01073644|Growth Inhibitors|growth inhibitors|mesh-ancestor
25066992|NCT03448588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25066993|NCT03448588|Protective Agents|protective agents|mesh-ancestor
25694434|NCT02029989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25694435|NCT02029989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694436|NCT02029989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25694437|NCT02029989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25694438|NCT02030041|Vitamin D|vitamin d|mesh-list
25694439|NCT02030041|Cholecalciferol|cholecalciferol|mesh-list
25694440|NCT02030041|Simvastatin|simvastatin|mesh-list
25694441|NCT02030041|Vitamins|vitamins|mesh-ancestor
25694442|NCT02030041|Micronutrients|micronutrients|mesh-ancestor
25694443|NCT02030041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694444|NCT02030041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25694445|NCT02030041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25066994|NCT03448588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25066995|NCT03448588|Trace Elements|trace elements|mesh-ancestor
24623784|NCT01073644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24919441|NCT04211987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24919442|NCT04211987|Dermatologic Agents|dermatologic agents|mesh-ancestor
24919443|NCT04211987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24919444|NCT04211987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24919445|NCT04211987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24919446|NCT04212065|Buprenorphine|buprenorphine|mesh-list
24919447|NCT04212065|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24919448|NCT04212065|Narcotics|narcotics|mesh-ancestor
24919449|NCT04212065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24919450|NCT04212065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919451|NCT04212065|Analgesics|analgesics|mesh-ancestor
25078006|NCT03359876|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25078007|NCT03359876|Protease Inhibitors|protease inhibitors|mesh-ancestor
24438253|NCT00275197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24438254|NCT00275197|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24438255|NCT00275197|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24438256|NCT00275197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24657193|NCT01266174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24438257|NCT00275197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521260|NCT04919096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24521261|NCT04919096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24521262|NCT04919096|Growth Substances|growth substances|mesh-ancestor
24521263|NCT04919096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521264|NCT04919096|Growth Inhibitors|growth inhibitors|mesh-ancestor
24521265|NCT04919096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24521267|NCT04909697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24521268|NCT04909697|Protease Inhibitors|protease inhibitors|mesh-ancestor
24521269|NCT04909697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24521270|NCT04909697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521271|NCT04907279|Aripiprazole|aripiprazole|mesh-list
24919462|NCT04212000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24919463|NCT04212000|Hormone Antagonists|hormone antagonists|mesh-ancestor
24919464|NCT04212000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24919465|NCT04212000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438262|NCT00275210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438289|NCT00275418|Beta Carotene|beta carotene|mesh-list
24438290|NCT00275418|Carotenoids|carotenoids|mesh-list
24438291|NCT00275418|Antioxidants|antioxidants|mesh-ancestor
24438292|NCT00275418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438374|NCT00275652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24438375|NCT00275652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438376|NCT00275652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919466|NCT04212000|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24919469|NCT04211805|Immunologic Factors|immunologic factors|mesh-ancestor
24919470|NCT04211805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919480|NCT04211558|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24919481|NCT04211558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919483|NCT04211558|Immunologic Factors|immunologic factors|mesh-ancestor
24919484|NCT04211558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919485|NCT04211844|Sofosbuvir|sofosbuvir|mesh-list
24919486|NCT04211844|Ledipasvir|ledipasvir|mesh-list
24919487|NCT04211844|Antiviral Agents|antiviral agents|mesh-ancestor
24919488|NCT04211844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24919489|NCT04211545|Rabeprazole|rabeprazole|mesh-list
24919490|NCT04211545|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24494489|NCT00495339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24494490|NCT00495339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24494491|NCT00495339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24494492|NCT00495339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24521272|NCT04907279|Antidepressive Agents|antidepressive agents|mesh-ancestor
24521284|NCT04907279|Serotonin Agents|serotonin agents|mesh-ancestor
24521286|NCT04907279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24521287|NCT04907279|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24521288|NCT04907279|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24521290|NCT04898894|Cytarabine|cytarabine|mesh-list
24521291|NCT04898894|Hydrocortisone|hydrocortisone|mesh-list
25066996|NCT03448588|Micronutrients|micronutrients|mesh-ancestor
25066997|NCT03448549|Capecitabine|capecitabine|mesh-list
25066998|NCT03448549|Tegafur|tegafur|mesh-list
25066999|NCT03448549|Oxaliplatin|oxaliplatin|mesh-list
25067000|NCT03448549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25067001|NCT03448549|Antimetabolites|antimetabolites|mesh-ancestor
24919491|NCT04211545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24919492|NCT04211545|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24919493|NCT04211545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24919494|NCT04211545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919495|NCT04211298|Dexmedetomidine|dexmedetomidine|mesh-list
24919496|NCT04211298|Propofol|propofol|mesh-list
24919497|NCT04211298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24919498|NCT04211298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24919499|NCT04211298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919500|NCT04211298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24919501|NCT04211298|Anesthetics, General|anesthetics, general|mesh-ancestor
24905109|NCT04350528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24919502|NCT04211298|Anesthetics|anesthetics|mesh-ancestor
24919503|NCT04211298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24919504|NCT04211298|Analgesics|analgesics|mesh-ancestor
24919505|NCT04211298|Sensory System Agents|sensory system agents|mesh-ancestor
24919506|NCT04211298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24919507|NCT04211298|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24919508|NCT04211298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24919509|NCT04211298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24919510|NCT04211298|Adrenergic Agents|adrenergic agents|mesh-ancestor
24919511|NCT04211298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24919512|NCT04211298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919513|NCT04211012|Paclitaxel|paclitaxel|mesh-list
24919514|NCT04211012|Cisplatin|cisplatin|mesh-list
24742830|NCT05150756|Lidocaine|lidocaine|mesh-list
24919515|NCT04211012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24919516|NCT04211012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919517|NCT04211012|Tubulin Modulators|tubulin modulators|mesh-ancestor
24919518|NCT04211012|Antimitotic Agents|antimitotic agents|mesh-ancestor
24919519|NCT04211012|Mitosis Modulators|mitosis modulators|mesh-ancestor
24494516|NCT00495547|Epoetin Alfa|epoetin alfa|mesh-list
24494517|NCT00495547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24494518|NCT00495547|Antimetabolites|antimetabolites|mesh-ancestor
24494519|NCT00495547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438378|NCT00275652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24438379|NCT00275652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24919537|NCT04210713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24919538|NCT04210713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24919539|NCT04210739|Betamethasone|betamethasone|mesh-list
24919540|NCT04210739|Betamethasone Valerate|betamethasone valerate|mesh-list
24919541|NCT04210739|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24919542|NCT04210739|Betamethasone benzoate|betamethasone benzoate|mesh-list
24919543|NCT04210739|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24919544|NCT04210739|Glucocorticoids|glucocorticoids|mesh-ancestor
24919545|NCT04210739|Hormones|hormones|mesh-ancestor
24919546|NCT04210739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24919547|NCT04210739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919548|NCT04210739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25067009|NCT03448094|Resveratrol|resveratrol|mesh-list
25067010|NCT03448094|Antioxidants|antioxidants|mesh-ancestor
25067011|NCT03448094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067012|NCT03448094|Protective Agents|protective agents|mesh-ancestor
25067013|NCT03448094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067014|NCT03448094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25067015|NCT03448094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25067016|NCT03447925|Salicylic Acid|salicylic acid|mesh-list
24829497|NCT02152787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24829501|NCT02152787|Anesthetics|anesthetics|mesh-ancestor
24919549|NCT04210739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24919550|NCT04210739|Respiratory System Agents|respiratory system agents|mesh-ancestor
24919552|NCT04210453|Vitamins|vitamins|mesh-ancestor
24919553|NCT04210453|Micronutrients|micronutrients|mesh-ancestor
24919554|NCT04210453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919555|NCT04210453|Antioxidants|antioxidants|mesh-ancestor
24919557|NCT04210453|Protective Agents|protective agents|mesh-ancestor
24919558|NCT04210765|Clomiphene|clomiphene|mesh-list
24919559|NCT04210765|Enclomiphene|enclomiphene|mesh-list
24919565|NCT04210765|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24919567|NCT04210765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24919568|NCT04210765|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24919569|NCT04210765|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24919570|NCT04210544|Caseins|caseins|mesh-list
24919571|NCT04210544|Chelating Agents|chelating agents|mesh-ancestor
24919572|NCT04210544|Sequestering Agents|sequestering agents|mesh-ancestor
24919573|NCT04210544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919588|NCT04209920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443777|NCT00295971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919589|NCT04209699|BMS-986165|bms-986165|mesh-list
24919590|NCT04209699|Famotidine|famotidine|mesh-list
24919591|NCT04209699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24919592|NCT04209699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24919593|NCT04209699|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24919594|NCT04209699|Histamine Antagonists|histamine antagonists|mesh-ancestor
24521294|NCT04898894|Fludarabine|fludarabine|mesh-list
24521295|NCT04898894|Venetoclax|venetoclax|mesh-list
24919595|NCT04209699|Histamine Agents|histamine agents|mesh-ancestor
24919596|NCT04209699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24919597|NCT04209699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919598|NCT04209699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919599|NCT04209699|Dermatologic Agents|dermatologic agents|mesh-ancestor
24919601|NCT04209699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24919602|NCT04209777|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24919603|NCT04209777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24623785|NCT01073644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623786|NCT01073644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623787|NCT01073670|Acetaminophen|acetaminophen|mesh-list
24623788|NCT01073670|Indomethacin|indomethacin|mesh-list
24623790|NCT01073670|Analgesics|analgesics|mesh-ancestor
24623791|NCT01073670|Sensory System Agents|sensory system agents|mesh-ancestor
24623794|NCT01073670|Antipyretics|antipyretics|mesh-ancestor
24618107|NCT01046838|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25067017|NCT03447925|Salicylates|salicylates|mesh-list
25067018|NCT03447925|Petrolatum|petrolatum|mesh-list
25067019|NCT03447925|Emollients|emollients|mesh-ancestor
25067020|NCT03447925|Dermatologic Agents|dermatologic agents|mesh-ancestor
25067021|NCT03447925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25067022|NCT03447925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25067023|NCT03447925|Analgesics|analgesics|mesh-ancestor
25067024|NCT03447925|Sensory System Agents|sensory system agents|mesh-ancestor
25067025|NCT03447925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25067026|NCT03447925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067027|NCT03447925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25067028|NCT03447925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25067029|NCT03447925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24829506|NCT02152865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24829507|NCT02152917|Tranexamic Acid|tranexamic acid|mesh-list
24829511|NCT02152917|Hemostatics|hemostatics|mesh-ancestor
24618108|NCT01046838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24494620|NCT00496158|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24494621|NCT00496158|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24494622|NCT00496158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24494624|NCT00496184|Nifedipine|nifedipine|mesh-list
24521296|NCT04898894|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24521297|NCT04898894|Abortifacient Agents|abortifacient agents|mesh-ancestor
24521298|NCT04898894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24521299|NCT04898894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521300|NCT04898894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24521302|NCT04898894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521303|NCT04898894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24521304|NCT04898894|Dermatologic Agents|dermatologic agents|mesh-ancestor
24521305|NCT04898894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24521306|NCT04898894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24438380|NCT00275652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24438381|NCT00275665|Valganciclovir|valganciclovir|mesh-list
24438382|NCT00275665|Antiviral Agents|antiviral agents|mesh-ancestor
24438383|NCT00275665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24438384|NCT00275730|Indomethacin|indomethacin|mesh-list
24438385|NCT00275730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24438386|NCT00275730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24438387|NCT00275730|Analgesics|analgesics|mesh-ancestor
24521307|NCT04898894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24521308|NCT04898894|Immunologic Factors|immunologic factors|mesh-ancestor
24521309|NCT04898894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24618116|NCT01046864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618117|NCT01046864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24618118|NCT01046864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618119|NCT01046864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24618120|NCT01046864|Immunologic Factors|immunologic factors|mesh-ancestor
24618121|NCT01046864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618122|NCT01046864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24618123|NCT01046864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24618124|NCT01046864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618126|NCT01046864|Protective Agents|protective agents|mesh-ancestor
24618127|NCT01046864|Vitamin B Complex|vitamin b complex|mesh-ancestor
24618129|NCT01046864|Micronutrients|micronutrients|mesh-ancestor
24623795|NCT01073670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24623796|NCT01073670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24623797|NCT01073670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24623798|NCT01073670|Gout Suppressants|gout suppressants|mesh-ancestor
24623799|NCT01073670|Tocolytic Agents|tocolytic agents|mesh-ancestor
24623800|NCT01073670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25067037|NCT03447873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25067038|NCT03447873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24829513|NCT02152943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24494644|NCT00496223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24494645|NCT00496223|Alkylating Agents|alkylating agents|mesh-ancestor
24521312|NCT04898894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24521313|NCT04898894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24521317|NCT04876937|Dexmedetomidine|dexmedetomidine|mesh-list
24521330|NCT04876937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919609|NCT04209439|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
24919610|NCT04209439|Bupivacaine|bupivacaine|mesh-list
24919611|NCT04209439|Anesthetics, Local|anesthetics, local|mesh-ancestor
24919612|NCT04209439|Anesthetics|anesthetics|mesh-ancestor
24919613|NCT04209439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24919614|NCT04209439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919615|NCT04209439|Sensory System Agents|sensory system agents|mesh-ancestor
24919616|NCT04209439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24919617|NCT04209439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24919618|NCT04209439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24919619|NCT04209439|Analgesics|analgesics|mesh-ancestor
24919620|NCT04209439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24919621|NCT04209439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24919622|NCT04209478|Morphine|morphine|mesh-list
24919623|NCT04209478|Tramadol|tramadol|mesh-list
24919624|NCT04209478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24919625|NCT04209478|Narcotics|narcotics|mesh-ancestor
24919626|NCT04209478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24919627|NCT04209478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919628|NCT04209478|Analgesics|analgesics|mesh-ancestor
24919629|NCT04209478|Sensory System Agents|sensory system agents|mesh-ancestor
24919630|NCT04209478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24919631|NCT04209426|Tacrine|tacrine|mesh-list
24919632|NCT04209426|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24919633|NCT04209426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438388|NCT00275730|Sensory System Agents|sensory system agents|mesh-ancestor
24919654|NCT04209166|Norepinephrine|norepinephrine|mesh-list
24919655|NCT04209166|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24919656|NCT04209166|Serotonin|serotonin|mesh-list
24919657|NCT04209166|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
24919658|NCT04209166|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
24919660|NCT04209166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24919661|NCT04209166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24919662|NCT04209166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24919663|NCT04209166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24919664|NCT04209166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919665|NCT04209166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24919666|NCT04209166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25067039|NCT03447873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25067040|NCT03447873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919667|NCT04209166|Adrenergic Agents|adrenergic agents|mesh-ancestor
24919668|NCT04209166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24919669|NCT04209166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494716|NCT00496600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494717|NCT00496600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24494718|NCT00496600|Immunologic Factors|immunologic factors|mesh-ancestor
24521336|NCT04861181|Niraparib|niraparib|mesh-list
24521337|NCT04861181|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24521338|NCT04861181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24521339|NCT04861181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521340|NCT04861181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24521341|NCT04856631|Cetuximab|cetuximab|mesh-list
24521342|NCT04856631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24521343|NCT04856631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919670|NCT04209166|Sympathomimetics|sympathomimetics|mesh-ancestor
24919671|NCT04209166|Autonomic Agents|autonomic agents|mesh-ancestor
24919672|NCT04209166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24919673|NCT04209166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24919674|NCT04209166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24919675|NCT04209166|Serotonin Agents|serotonin agents|mesh-ancestor
24919676|NCT04209166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24919677|NCT04209166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24919690|NCT04208854|Tubulin Modulators|tubulin modulators|mesh-ancestor
24919691|NCT04208854|Antimitotic Agents|antimitotic agents|mesh-ancestor
24884010|NCT03613506|Captopril|captopril|mesh-list
24919692|NCT04208854|Mitosis Modulators|mitosis modulators|mesh-ancestor
24919693|NCT04208854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919694|NCT04208776|Propranolol|propranolol|mesh-list
24919695|NCT04208776|Midodrine|midodrine|mesh-list
24919696|NCT04208776|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24919697|NCT04208776|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24919698|NCT04208776|Adrenergic Agents|adrenergic agents|mesh-ancestor
24494737|NCT00496665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24521344|NCT04848597|Paclitaxel|paclitaxel|mesh-list
24521345|NCT04848597|Antibodies|antibodies|mesh-list
24521346|NCT04848597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24521347|NCT04848597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24521348|NCT04848597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826772|NCT02135913|Vitamins|vitamins|mesh-ancestor
24826773|NCT02135913|Micronutrients|micronutrients|mesh-ancestor
24826774|NCT02135913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536979|NCT00653055|Cabergoline|cabergoline|mesh-list
24536991|NCT00653120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24521349|NCT04848597|Tubulin Modulators|tubulin modulators|mesh-ancestor
24521350|NCT04848597|Antimitotic Agents|antimitotic agents|mesh-ancestor
24521404|NCT04791059|Analgesics|analgesics|mesh-ancestor
24521405|NCT04791059|Sensory System Agents|sensory system agents|mesh-ancestor
24521406|NCT04791059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24521407|NCT04791059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24521408|NCT04791059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24521409|NCT04791059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24521410|NCT04791059|Adrenergic Agents|adrenergic agents|mesh-ancestor
24521418|NCT04791059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24919699|NCT04208776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24919705|NCT04208776|Sympathomimetics|sympathomimetics|mesh-ancestor
24919706|NCT04208776|Autonomic Agents|autonomic agents|mesh-ancestor
24919707|NCT04208776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24919708|NCT04208776|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24946282|NCT03941795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24946283|NCT03941795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799009|NCT01966575|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24799010|NCT01966575|Contraceptive Agents|contraceptive agents|mesh-ancestor
24799027|NCT01966653|Renal Agents|renal agents|mesh-ancestor
24919709|NCT04208776|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25067042|NCT03447873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25067044|NCT03447873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25067045|NCT03447873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25067046|NCT03447873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25067047|NCT03447691|Remifentanil|remifentanil|mesh-list
25067048|NCT03447691|Anesthetics|anesthetics|mesh-list
25067049|NCT03447691|Propofol|propofol|mesh-list
25067050|NCT03447691|Desflurane|desflurane|mesh-list
25067056|NCT03447691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24829526|NCT02152943|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24829532|NCT02152969|Amlodipine|amlodipine|mesh-list
24919710|NCT04208776|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24919711|NCT04208776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24919712|NCT04208945|Colistin|colistin|mesh-list
24919713|NCT04208945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24919714|NCT04208945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24919715|NCT04208958|Vancomycin|vancomycin|mesh-list
24919716|NCT04208958|Nivolumab|nivolumab|mesh-list
24919717|NCT04208958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24919718|NCT04208958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919719|NCT04208958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24919720|NCT04208958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919721|NCT04208958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24919722|NCT04208958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24919723|NCT04208594|Propranolol|propranolol|mesh-list
24919724|NCT04208594|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24919725|NCT04208594|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24919728|NCT04208594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919730|NCT04208594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24906299|NCT04341727|Chloroquine|chloroquine|mesh-list
24954663|NCT03874156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24919731|NCT04208594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24919733|NCT04208555|Terconazole|terconazole|mesh-list
24919734|NCT04208555|Antifungal Agents|antifungal agents|mesh-ancestor
24919735|NCT04208555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24919736|NCT04208763|Imipenem|imipenem|mesh-list
24919737|NCT04208763|Colistin|colistin|mesh-list
24919738|NCT04208763|Tigecycline|tigecycline|mesh-list
24919739|NCT04208763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24919740|NCT04208763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24919741|NCT04208763|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24919742|NCT04208763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24919743|NCT04208763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919744|NCT04208373|Itraconazole|itraconazole|mesh-list
24919745|NCT04208373|Etravirine|etravirine|mesh-list
24919746|NCT04208373|Antifungal Agents|antifungal agents|mesh-ancestor
24919747|NCT04208373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24537017|NCT00653302|Metformin|metformin|mesh-list
24919748|NCT04208373|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24919749|NCT04208373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24919750|NCT04208373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24919751|NCT04208373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919752|NCT04208373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24919753|NCT04208373|Hormone Antagonists|hormone antagonists|mesh-ancestor
24919754|NCT04208373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25067058|NCT03447691|Analgesics|analgesics|mesh-ancestor
25067059|NCT03447691|Sensory System Agents|sensory system agents|mesh-ancestor
24826801|NCT02136030|Deoxycholic Acid|deoxycholic acid|mesh-list
24826802|NCT02136030|Amebicides|amebicides|mesh-ancestor
24826803|NCT02136030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24829539|NCT02152969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24829540|NCT02152969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694446|NCT02030041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25694447|NCT02030041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25694448|NCT02030041|Antimetabolites|antimetabolites|mesh-ancestor
25694449|NCT02030041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694450|NCT02030041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24829541|NCT02152969|Vasodilator Agents|vasodilator agents|mesh-ancestor
24829543|NCT02152969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24654864|NCT01251835|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24654866|NCT01251848|Sitaxsentan|sitaxsentan|mesh-list
24743034|NCT05030025|Antiviral Agents|antiviral agents|mesh-ancestor
24919755|NCT04208373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919756|NCT04208373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24919757|NCT04208373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24521419|NCT04791059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24521420|NCT04791059|Narcotics|narcotics|mesh-ancestor
24521421|NCT04791059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24521422|NCT04791059|Antidepressive Agents|antidepressive agents|mesh-ancestor
24521423|NCT04791059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24521425|NCT04769050|Capecitabine|capecitabine|mesh-list
24521426|NCT04769050|Trastuzumab|trastuzumab|mesh-list
24521427|NCT04769050|Pertuzumab|pertuzumab|mesh-list
24919758|NCT04208373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24919759|NCT04208373|Antiviral Agents|antiviral agents|mesh-ancestor
24919762|NCT04208581|Budesonide|budesonide|mesh-list
24919763|NCT04208581|Bromides|bromides|mesh-list
24919764|NCT04208581|Formoterol Fumarate|formoterol fumarate|mesh-list
24919765|NCT04208581|Tiotropium Bromide|tiotropium bromide|mesh-list
24919766|NCT04208581|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24919767|NCT04208581|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24919768|NCT04208581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24919769|NCT04208581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24919770|NCT04208581|Autonomic Agents|autonomic agents|mesh-ancestor
24919771|NCT04208581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24919772|NCT04208581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919773|NCT04208581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24919774|NCT04208581|Respiratory System Agents|respiratory system agents|mesh-ancestor
24919780|NCT04208581|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24826804|NCT02136030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24826834|NCT02136329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919781|NCT04208581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24919782|NCT04208581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24919783|NCT04208581|Adrenergic Agents|adrenergic agents|mesh-ancestor
24919784|NCT04208581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24919785|NCT04208581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919786|NCT04208581|Parasympatholytics|parasympatholytics|mesh-ancestor
24919787|NCT04208581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25067071|NCT03447184|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25067073|NCT03447184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25067074|NCT03447184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067075|NCT03447184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25067076|NCT03447184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25067077|NCT03447184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067078|NCT03447184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24494830|NCT00497237|Beclomethasone|beclomethasone|mesh-list
24494831|NCT00497237|Formoterol Fumarate|formoterol fumarate|mesh-list
24521428|NCT04769050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24521429|NCT04769050|Tubulin Modulators|tubulin modulators|mesh-ancestor
24521430|NCT04769050|Antimitotic Agents|antimitotic agents|mesh-ancestor
24919791|NCT04208399|Antiviral Agents|antiviral agents|mesh-ancestor
24919792|NCT04208399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24919793|NCT04208334|Curcumin|curcumin|mesh-list
24919794|NCT04208334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24919795|NCT04208334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24919796|NCT04208334|Analgesics|analgesics|mesh-ancestor
24919797|NCT04208334|Sensory System Agents|sensory system agents|mesh-ancestor
24919798|NCT04208334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24919799|NCT04208334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919800|NCT04208334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24919801|NCT04208334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25694451|NCT02030041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25694452|NCT02030041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25694453|NCT02030405|Ixazomib|ixazomib|mesh-list
25694454|NCT02030405|Proteasome Inhibitors|proteasome inhibitors|mesh-list
25694455|NCT02030405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694456|NCT02030405|Protease Inhibitors|protease inhibitors|mesh-ancestor
25694457|NCT02030405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24919802|NCT04208334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919803|NCT04208334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25067097|NCT03447093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24919807|NCT04208516|Dexmedetomidine|dexmedetomidine|mesh-list
24919809|NCT04208516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24919810|NCT04208516|Antiemetics|antiemetics|mesh-ancestor
24494858|NCT00497315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24494859|NCT00497315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494860|NCT00497315|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24494861|NCT00497315|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24494862|NCT00497328|Acetylcysteine|acetylcysteine|mesh-list
24494863|NCT00497328|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24494864|NCT00497328|Antiviral Agents|antiviral agents|mesh-ancestor
24494866|NCT00497328|Expectorants|expectorants|mesh-ancestor
24521431|NCT04769050|Mitosis Modulators|mitosis modulators|mesh-ancestor
24521432|NCT04769050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521433|NCT04769050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24521434|NCT04769050|Antimetabolites|antimetabolites|mesh-ancestor
24521435|NCT04769050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24521436|NCT04763135|Mirtazapine|mirtazapine|mesh-list
24443949|NCT00296348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24521440|NCT04763135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24521458|NCT04763135|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24521459|NCT04763135|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24521460|NCT04763135|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24919812|NCT04208516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24919817|NCT04208516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24919819|NCT04208516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919820|NCT04208516|Anesthetics, Local|anesthetics, local|mesh-ancestor
24919821|NCT04208516|Anesthetics|anesthetics|mesh-ancestor
24919829|NCT04208516|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24919830|NCT04208516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24919831|NCT04208516|Analgesics|analgesics|mesh-ancestor
24919832|NCT04208516|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24919833|NCT04208516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24919834|NCT04208516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24919835|NCT04208516|Adrenergic Agents|adrenergic agents|mesh-ancestor
24919836|NCT04208516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24919837|NCT04208061|Ritonavir|ritonavir|mesh-list
24919838|NCT04208061|Darunavir|darunavir|mesh-list
24494878|NCT00497354|Anesthetics|anesthetics|mesh-list
24521466|NCT04758416|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24521467|NCT04758416|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24521468|NCT04758416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443951|NCT00296348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438610|NCT00276523|Interferon-alpha|interferon-alpha|mesh-list
24438611|NCT00276523|Interferon alpha-2|interferon alpha-2|mesh-list
24438612|NCT00276523|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24438613|NCT00276523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438614|NCT00276523|Antiviral Agents|antiviral agents|mesh-ancestor
24521469|NCT04756726|Dexamethasone|dexamethasone|mesh-list
24521470|NCT04756726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24521471|NCT04756726|Antiemetics|antiemetics|mesh-ancestor
24521472|NCT04756726|Autonomic Agents|autonomic agents|mesh-ancestor
24521473|NCT04756726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24521474|NCT04756726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521475|NCT04756726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24521476|NCT04756726|Glucocorticoids|glucocorticoids|mesh-ancestor
25067098|NCT03447093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067099|NCT03447093|Antimetabolites|antimetabolites|mesh-ancestor
25694458|NCT02030405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694459|NCT02030535|Tiotropium Bromide|tiotropium bromide|mesh-list
25694460|NCT02030535|Olodaterol|olodaterol|mesh-list
25694461|NCT02030535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25067101|NCT03446976|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25067102|NCT03446976|Immunologic Factors|immunologic factors|mesh-ancestor
25067103|NCT03446976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067104|NCT03446937|Dexamethasone|dexamethasone|mesh-list
25067105|NCT03446937|Betamethasone|betamethasone|mesh-list
24521477|NCT04756726|Hormones|hormones|mesh-ancestor
24623803|NCT01073670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623804|NCT01073683|Docetaxel|docetaxel|mesh-list
24623805|NCT01073683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623806|NCT01073683|Tubulin Modulators|tubulin modulators|mesh-ancestor
24623807|NCT01073683|Antimitotic Agents|antimitotic agents|mesh-ancestor
24623808|NCT01073683|Mitosis Modulators|mitosis modulators|mesh-ancestor
24623809|NCT01073683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623810|NCT01073696|Granisetron|granisetron|mesh-list
24623811|NCT01073696|Antiemetics|antiemetics|mesh-ancestor
24623812|NCT01073696|Autonomic Agents|autonomic agents|mesh-ancestor
24623813|NCT01073696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24623814|NCT01073696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623815|NCT01073696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24623816|NCT01073696|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24623817|NCT01073696|Serotonin Agents|serotonin agents|mesh-ancestor
24521481|NCT04745975|Gemcitabine|gemcitabine|mesh-list
24521485|NCT04745975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24443963|NCT00296361|Immunologic Factors|immunologic factors|mesh-ancestor
24521490|NCT04745975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521491|NCT04745975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24521558|NCT04657003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521559|NCT04657003|Incretins|incretins|mesh-ancestor
24521560|NCT04657003|Hormones|hormones|mesh-ancestor
24521561|NCT04657003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24521562|NCT04655976|Docetaxel|docetaxel|mesh-list
24521563|NCT04655976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618503|NCT01048580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618504|NCT01048580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618506|NCT01048619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618507|NCT01048619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24618508|NCT01048619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618509|NCT01048619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618510|NCT01048632|Oxandrolone|oxandrolone|mesh-list
24618511|NCT01048632|Androgens|androgens|mesh-ancestor
24618512|NCT01048632|Hormones|hormones|mesh-ancestor
24438615|NCT00276523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24438616|NCT00276523|Immunologic Factors|immunologic factors|mesh-ancestor
24438617|NCT00276523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438618|NCT00276536|Interferons|interferons|mesh-list
24438619|NCT00276536|Interferon-alpha|interferon-alpha|mesh-list
24438620|NCT00276536|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
24438621|NCT00276536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438622|NCT00276536|Antiviral Agents|antiviral agents|mesh-ancestor
24438623|NCT00276536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24438624|NCT00276536|Immunologic Factors|immunologic factors|mesh-ancestor
24439007|NCT00277082|Camptothecin|camptothecin|mesh-list
24439008|NCT00277082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24439009|NCT00277082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439010|NCT00277082|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24439011|NCT00277082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24439049|NCT00277264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24439050|NCT00277264|Respiratory System Agents|respiratory system agents|mesh-ancestor
24439053|NCT00277264|Cholinergic Agents|cholinergic agents|mesh-ancestor
24439054|NCT00277264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24618513|NCT01048632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24618514|NCT01048632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618515|NCT01048632|Anabolic Agents|anabolic agents|mesh-ancestor
24623818|NCT01073696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24623819|NCT01073696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623820|NCT01073709|Acetaminophen|acetaminophen|mesh-list
24623821|NCT01073709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24623822|NCT01073709|Analgesics|analgesics|mesh-ancestor
25067106|NCT03446937|Betamethasone Valerate|betamethasone valerate|mesh-list
25067107|NCT03446937|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25067108|NCT03446937|Betamethasone benzoate|betamethasone benzoate|mesh-list
24623823|NCT01073709|Sensory System Agents|sensory system agents|mesh-ancestor
24623824|NCT01073709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24623825|NCT01073709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623826|NCT01073709|Antipyretics|antipyretics|mesh-ancestor
24623827|NCT01073748|Acetaminophen|acetaminophen|mesh-list
24623828|NCT01073748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24623829|NCT01073748|Analgesics|analgesics|mesh-ancestor
24623838|NCT01073761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24623839|NCT01073761|Protease Inhibitors|protease inhibitors|mesh-ancestor
24623840|NCT01073761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623841|NCT01073761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623842|NCT01073761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24623843|NCT01073761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24623844|NCT01073761|Antiviral Agents|antiviral agents|mesh-ancestor
24623845|NCT01073761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24623846|NCT01073761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24623847|NCT01073761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24623848|NCT01073800|Atorvastatin|atorvastatin|mesh-list
24623849|NCT01073800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24439055|NCT00277264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439056|NCT00277342|Insulin|insulin|mesh-list
24439057|NCT00277342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24623850|NCT01073800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24623851|NCT01073800|Antimetabolites|antimetabolites|mesh-ancestor
24623852|NCT01073800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623853|NCT01073800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24743180|NCT04973930|Antidepressive Agents|antidepressive agents|mesh-ancestor
24919840|NCT04208061|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24919841|NCT04208061|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24919842|NCT04208061|Protease Inhibitors|protease inhibitors|mesh-ancestor
24826873|NCT02136641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24826874|NCT02136641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826875|NCT02136641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24826876|NCT02136641|Narcotics|narcotics|mesh-ancestor
24711845|NCT01517347|Analgesics|analgesics|mesh-ancestor
24826877|NCT02136641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24826878|NCT02136641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24826879|NCT02136641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24919843|NCT04208061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24919844|NCT04208061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919845|NCT04208061|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24919846|NCT04208061|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24919847|NCT04208061|Antiviral Agents|antiviral agents|mesh-ancestor
24919848|NCT04208061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24521655|NCT04622904|Anesthetics, General|anesthetics, general|mesh-ancestor
24448662|NCT00312546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448663|NCT00312546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448664|NCT00312546|GABA Agents|gaba agents|mesh-ancestor
25078138|NCT03359018|Apatinib|apatinib|mesh-list
24919850|NCT04208061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24919852|NCT04208061|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24919853|NCT04208061|Anticoagulants|anticoagulants|mesh-ancestor
24919855|NCT04207957|Antifungal Agents|antifungal agents|mesh-ancestor
24919856|NCT04207957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24494969|NCT00497601|Amphotericin B|amphotericin b|mesh-list
24919858|NCT04207632|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24919859|NCT04207632|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24919860|NCT04207632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24919861|NCT04207632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24919862|NCT04207632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919863|NCT04207632|Cholinergic Agents|cholinergic agents|mesh-ancestor
24919864|NCT04207632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24919866|NCT04207632|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24521589|NCT04642651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24521590|NCT04642651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25067110|NCT03446937|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24655878|NCT01258530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067111|NCT03446937|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25067112|NCT03446937|BB 1101|bb 1101|mesh-list
25067113|NCT03446937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25067114|NCT03446937|Antiemetics|antiemetics|mesh-ancestor
25067115|NCT03446937|Autonomic Agents|autonomic agents|mesh-ancestor
25067116|NCT03446937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24521591|NCT04642651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521592|NCT04642651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24919884|NCT04207411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24919885|NCT04207411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919886|NCT04207385|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24919887|NCT04207385|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24919888|NCT04207385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24919889|NCT04207385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24919890|NCT04207385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919891|NCT04207385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24919892|NCT04207385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919897|NCT04207515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24919898|NCT04207515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919901|NCT04207450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24919902|NCT04207398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24919903|NCT04207398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24919904|NCT04207398|Adrenergic Agents|adrenergic agents|mesh-ancestor
24919905|NCT04207398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24919906|NCT04207398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919907|NCT04207398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919928|NCT04207112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24919929|NCT04207112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24919930|NCT04207112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24919931|NCT04207112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24521656|NCT04622904|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24919932|NCT04207112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919934|NCT04207112|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24919935|NCT04207112|Antitubercular Agents|antitubercular agents|mesh-ancestor
24495049|NCT00498225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24521602|NCT04637594|Pembrolizumab|pembrolizumab|mesh-list
24521604|NCT04637594|Durvalumab|durvalumab|mesh-list
24521605|NCT04637594|Avelumab|avelumab|mesh-list
24521606|NCT04637594|Atezolizumab|atezolizumab|mesh-list
24521607|NCT04637594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24521608|NCT04637594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24521609|NCT04637594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24521610|NCT04637594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067118|NCT03446937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25067119|NCT03446937|Glucocorticoids|glucocorticoids|mesh-ancestor
24521617|NCT04637529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521618|NCT04637529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24521619|NCT04637529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24521620|NCT04637529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24521621|NCT04637529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24919941|NCT04207021|Analgesics|analgesics|mesh-ancestor
24919942|NCT04207021|Sensory System Agents|sensory system agents|mesh-ancestor
24919943|NCT04207021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24919944|NCT04207021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919945|NCT04207021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24919948|NCT04207021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24919949|NCT04207021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919952|NCT04206865|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24919953|NCT04206865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24919954|NCT04206865|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24919955|NCT04206865|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24919956|NCT04206865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919957|NCT04206618|Denosumab|denosumab|mesh-list
24919958|NCT04206618|Teriparatide|teriparatide|mesh-list
24919959|NCT04206618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25694462|NCT02030535|Autonomic Agents|autonomic agents|mesh-ancestor
25694463|NCT02030535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24919960|NCT04206618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919962|NCT04206631|Doxycycline|doxycycline|mesh-list
24919978|NCT04206176|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24919979|NCT04206176|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24919980|NCT04206176|Purinergic Agents|purinergic agents|mesh-ancestor
24919981|NCT04206176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24919982|NCT04206176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919983|NCT04206176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919984|NCT04205916|Moxifloxacin|moxifloxacin|mesh-list
24919985|NCT04205916|Dexamethasone|dexamethasone|mesh-list
24919987|NCT04205916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24919988|NCT04205916|Antiemetics|antiemetics|mesh-ancestor
24919989|NCT04205916|Autonomic Agents|autonomic agents|mesh-ancestor
24919990|NCT04205916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24521650|NCT04622904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24521651|NCT04622904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521652|NCT04622904|Analgesics|analgesics|mesh-ancestor
24521653|NCT04622904|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25067121|NCT03446937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25067122|NCT03446937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25067123|NCT03446937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25067124|NCT03446937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25067125|NCT03446937|Respiratory System Agents|respiratory system agents|mesh-ancestor
25067126|NCT03446937|Protease Inhibitors|protease inhibitors|mesh-ancestor
24521654|NCT04622904|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24919997|NCT04205916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919998|NCT04205916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24919999|NCT04205916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24920000|NCT04205916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24920001|NCT04205916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24920002|NCT04205916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920003|NCT04205916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920004|NCT04205916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24920005|NCT04205916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24920006|NCT04205916|Analgesics|analgesics|mesh-ancestor
24920007|NCT04205916|Sensory System Agents|sensory system agents|mesh-ancestor
24920008|NCT04205916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24920009|NCT04205916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24920010|NCT04205903|Paclitaxel|paclitaxel|mesh-list
24920011|NCT04205903|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24920012|NCT04205903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24920013|NCT04205903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24920014|NCT04205903|Tubulin Modulators|tubulin modulators|mesh-ancestor
24920015|NCT04205903|Antimitotic Agents|antimitotic agents|mesh-ancestor
24920016|NCT04205903|Mitosis Modulators|mitosis modulators|mesh-ancestor
24920017|NCT04205903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495172|NCT00498901|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24495173|NCT00498901|Fertility Agents|fertility agents|mesh-ancestor
24495174|NCT00498901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24521691|NCT04597333|Oxytocics|oxytocics|mesh-ancestor
24521692|NCT04597333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24920050|NCT04205851|Antiviral Agents|antiviral agents|mesh-ancestor
24920051|NCT04205851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24920052|NCT04205682|Cannabidiol|cannabidiol|mesh-list
24920053|NCT04205682|Anticonvulsants|anticonvulsants|mesh-ancestor
24920054|NCT04205578|3-n-butylphthalide|3-n-butylphthalide|mesh-list
24920055|NCT04205578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24920056|NCT04205578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24920057|NCT04205578|Protective Agents|protective agents|mesh-ancestor
24920058|NCT04205578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920059|NCT04205565|Oxiracetam|oxiracetam|mesh-list
24623855|NCT01073800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623856|NCT01073813|Minocycline|minocycline|mesh-list
24623857|NCT01073813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24623858|NCT01073813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24623859|NCT01073826|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24439058|NCT00277342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439059|NCT00277472|Valsartan|valsartan|mesh-list
24439060|NCT00277472|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24439061|NCT00277472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25694464|NCT02030535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656167|NCT01260246|Hormones|hormones|mesh-ancestor
24439062|NCT00277472|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24439065|NCT00277472|Diuretics|diuretics|mesh-ancestor
24439102|NCT00277550|Serotonin Agents|serotonin agents|mesh-ancestor
24439103|NCT00277550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24623861|NCT01073826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623862|NCT01073826|Incretins|incretins|mesh-ancestor
24623863|NCT01073826|Hormones|hormones|mesh-ancestor
24618967|NCT01050374|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24618968|NCT01050374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24618969|NCT01050374|Tubulin Modulators|tubulin modulators|mesh-ancestor
24618970|NCT01050374|Antimitotic Agents|antimitotic agents|mesh-ancestor
24618971|NCT01050374|Mitosis Modulators|mitosis modulators|mesh-ancestor
24618972|NCT01050374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444032|NCT00296608|Fluorouracil|fluorouracil|mesh-list
24618973|NCT01050374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24521708|NCT04575038|Brequinar|brequinar|mesh-list
24521709|NCT04575038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24521710|NCT04575038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24521711|NCT04575038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521712|NCT04575038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24521713|NCT04575038|Immunologic Factors|immunologic factors|mesh-ancestor
24623867|NCT01073826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623868|NCT01073826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623869|NCT01073839|Gemcitabine|gemcitabine|mesh-list
24623870|NCT01073839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623871|NCT01073839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24623872|NCT01073839|Antimetabolites|antimetabolites|mesh-ancestor
24623873|NCT01073839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623874|NCT01073839|Antiviral Agents|antiviral agents|mesh-ancestor
24623875|NCT01073839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24623876|NCT01073839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623877|NCT01073839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25067131|NCT03446911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25067134|NCT03446872|Antimetabolites|antimetabolites|mesh-ancestor
25067136|NCT03446872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24495211|NCT00498979|Mitosis Modulators|mitosis modulators|mesh-ancestor
24495212|NCT00498979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24495213|NCT00498979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24495214|NCT00498979|Schistosomicides|schistosomicides|mesh-ancestor
24495215|NCT00498979|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24521714|NCT04575038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521717|NCT04553536|Sufentanil|sufentanil|mesh-list
24521718|NCT04553536|Remifentanil|remifentanil|mesh-list
24521719|NCT04553536|Dsuvia|dsuvia|mesh-list
24521720|NCT04553536|Bromides|bromides|mesh-list
24521721|NCT04553536|Propofol|propofol|mesh-list
24521722|NCT04553536|Esketamine|esketamine|mesh-list
24521723|NCT04553536|Rocuronium|rocuronium|mesh-list
24826911|NCT02136823|Memantine|memantine|mesh-list
24521724|NCT04553536|Cisatracurium|cisatracurium|mesh-list
24521725|NCT04553536|Atracurium|atracurium|mesh-list
24521726|NCT04553536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24521727|NCT04553536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24521728|NCT04553536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521729|NCT04553536|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24521730|NCT04553536|Anesthetics, General|anesthetics, general|mesh-ancestor
24521731|NCT04553536|Anesthetics|anesthetics|mesh-ancestor
24521732|NCT04553536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24521733|NCT04553536|Narcotics|narcotics|mesh-ancestor
24521734|NCT04553536|Analgesics|analgesics|mesh-ancestor
24521735|NCT04553536|Sensory System Agents|sensory system agents|mesh-ancestor
24521750|NCT04551547|Immunologic Factors|immunologic factors|mesh-ancestor
24623879|NCT01073839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623880|NCT01073852|Hydroxychloroquine|hydroxychloroquine|mesh-list
24623881|NCT01073852|Antimalarials|antimalarials|mesh-ancestor
24623882|NCT01073852|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24623883|NCT01073852|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24623884|NCT01073852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25694465|NCT02030535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25694466|NCT02030535|Respiratory System Agents|respiratory system agents|mesh-ancestor
25694467|NCT02030535|Parasympatholytics|parasympatholytics|mesh-ancestor
25694468|NCT02030535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24623885|NCT01073852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623886|NCT01073852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623887|NCT01073852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24623888|NCT01073891|Moxifloxacin|moxifloxacin|mesh-list
24623889|NCT01073891|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24623890|NCT01073891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24623891|NCT01073891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24623892|NCT01073891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24623893|NCT01073891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24623894|NCT01073891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623895|NCT01073891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623896|NCT01073891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623897|NCT01073891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24623904|NCT01073904|Levonorgestrel|levonorgestrel|mesh-list
24623916|NCT01073995|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24623917|NCT01073995|Bupivacaine|bupivacaine|mesh-list
24920060|NCT04205565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24920061|NCT04205565|Nootropic Agents|nootropic agents|mesh-ancestor
24521752|NCT04549792|Ustekinumab|ustekinumab|mesh-list
24521753|NCT04549792|Dermatologic Agents|dermatologic agents|mesh-ancestor
24521754|NCT04547140|Protease Inhibitors|protease inhibitors|mesh-list
24521755|NCT04547140|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
24826970|NCT02136979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826979|NCT02136992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24826980|NCT02136992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826981|NCT02136992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24826982|NCT02136992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24826983|NCT02136992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24826984|NCT02136992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24521756|NCT04547140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920090|NCT04205240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920092|NCT04205240|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24920093|NCT04205240|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24920094|NCT04205240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920095|NCT04205240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24920096|NCT04205240|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25067140|NCT03446872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067141|NCT03446872|Antidotes|antidotes|mesh-ancestor
25067142|NCT03446872|Protective Agents|protective agents|mesh-ancestor
25067143|NCT03446872|Vitamin B Complex|vitamin b complex|mesh-ancestor
25067144|NCT03446872|Vitamins|vitamins|mesh-ancestor
25067145|NCT03446872|Micronutrients|micronutrients|mesh-ancestor
25067146|NCT03446638|Cytarabine|cytarabine|mesh-list
25067147|NCT03446638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24439529|NCT00279240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439530|NCT00279253|Clonidine|clonidine|mesh-list
24439531|NCT00279253|Analgesics|analgesics|mesh-ancestor
24439532|NCT00279253|Sensory System Agents|sensory system agents|mesh-ancestor
24439533|NCT00279253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24439534|NCT00279253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439535|NCT00279253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24439536|NCT00279253|Sympatholytics|sympatholytics|mesh-ancestor
24439537|NCT00279253|Autonomic Agents|autonomic agents|mesh-ancestor
24439538|NCT00279253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24439539|NCT00279253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24439540|NCT00279253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25067148|NCT03446638|Antimetabolites|antimetabolites|mesh-ancestor
25067149|NCT03446638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067150|NCT03446638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24920097|NCT04205240|Antitubercular Agents|antitubercular agents|mesh-ancestor
24920098|NCT04205240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24920099|NCT04205240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24920100|NCT04205201|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24920101|NCT04205201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24495286|NCT00499135|Growth Inhibitors|growth inhibitors|mesh-ancestor
24495287|NCT00499135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24495288|NCT00499135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495289|NCT00499135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495290|NCT00499135|Antiviral Agents|antiviral agents|mesh-ancestor
24439541|NCT00279253|Adrenergic Agents|adrenergic agents|mesh-ancestor
24439542|NCT00279253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24439543|NCT00279253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439544|NCT00279266|Thiamine|thiamine|mesh-list
24439582|NCT00279448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24439583|NCT00279448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24439584|NCT00279448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439586|NCT00279461|Ergocalciferols|ergocalciferols|mesh-list
24439587|NCT00279461|Cholecalciferol|cholecalciferol|mesh-list
24439588|NCT00279461|Vitamins|vitamins|mesh-list
24439623|NCT00279565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24439624|NCT00279565|Antimetabolites|antimetabolites|mesh-ancestor
24439625|NCT00279565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439626|NCT00279565|Immunologic Factors|immunologic factors|mesh-ancestor
24439627|NCT00279565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439628|NCT00279565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24439677|NCT00279760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920110|NCT04205227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24920111|NCT04205227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24920113|NCT04205305|Nicardipine|nicardipine|mesh-list
24920114|NCT04205305|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24920115|NCT04205305|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24920116|NCT04205305|Adrenergic Agents|adrenergic agents|mesh-ancestor
24495304|NCT00499265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495305|NCT00499291|Paclitaxel|paclitaxel|mesh-list
24495306|NCT00499291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24495307|NCT00499291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24521770|NCT04533451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24521771|NCT04533451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24521772|NCT04533451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24521773|NCT04533451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521774|NCT04533451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24521775|NCT04533451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24521776|NCT04519476|Methylprednisolone|methylprednisolone|mesh-list
24521777|NCT04519476|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24521778|NCT04519476|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24521779|NCT04519476|Prednisolone|prednisolone|mesh-list
24521780|NCT04519476|Prednisolone acetate|prednisolone acetate|mesh-list
24521781|NCT04519476|Lenalidomide|lenalidomide|mesh-list
24521782|NCT04519476|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25067151|NCT03446638|Antiviral Agents|antiviral agents|mesh-ancestor
25067152|NCT03446638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25067153|NCT03446638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25067154|NCT03446638|Immunologic Factors|immunologic factors|mesh-ancestor
25067155|NCT03446638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067157|NCT03446625|Antioxidants|antioxidants|mesh-ancestor
24521829|NCT04480190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24521830|NCT04480190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24521831|NCT04480190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24521832|NCT04480190|Immunologic Factors|immunologic factors|mesh-ancestor
24521833|NCT04480190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521834|NCT04480125|Azacitidine|azacitidine|mesh-list
24521835|NCT04480125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24521836|NCT04480125|Antimetabolites|antimetabolites|mesh-ancestor
24521837|NCT04480125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521839|NCT04480125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24954842|NCT03871361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24521844|NCT04472143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521845|NCT04472143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24521846|NCT04472143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24521847|NCT04472143|Serotonin Agents|serotonin agents|mesh-ancestor
24920119|NCT04205305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521848|NCT04472143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24521849|NCT04472143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521851|NCT04460248|Lenalidomide|lenalidomide|mesh-list
24521852|NCT04460248|Zanubrutinib|zanubrutinib|mesh-list
24439679|NCT00279825|Levodopa|levodopa|mesh-list
24439680|NCT00279825|Carbidopa|carbidopa|mesh-list
24439681|NCT00279825|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24439682|NCT00279825|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24439683|NCT00279825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24439684|NCT00279825|Dopamine Agents|dopamine agents|mesh-ancestor
24439685|NCT00279825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24439686|NCT00279825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439687|NCT00279825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439688|NCT00279825|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24439689|NCT00279825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24439690|NCT00279825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24439691|NCT00279825|Immunologic Factors|immunologic factors|mesh-ancestor
24439692|NCT00279825|Dopamine Agonists|dopamine agonists|mesh-ancestor
24439693|NCT00279903|Cortisone|cortisone|mesh-list
24439694|NCT00279903|Botulinum Toxins|botulinum toxins|mesh-list
24439695|NCT00279903|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24439696|NCT00279903|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24439697|NCT00279903|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24439698|NCT00279903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24439699|NCT00279903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521856|NCT04460248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521857|NCT04460248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24521858|NCT04460248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24521859|NCT04460248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24521860|NCT04460248|Growth Substances|growth substances|mesh-ancestor
24521861|NCT04460248|Growth Inhibitors|growth inhibitors|mesh-ancestor
24521862|NCT04460248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24920132|NCT04205344|Anesthetics|anesthetics|mesh-ancestor
24920133|NCT04205344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24495325|NCT00499577|Immunologic Factors|immunologic factors|mesh-ancestor
24495326|NCT00499577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495327|NCT00499642|Moxifloxacin|moxifloxacin|mesh-list
24495328|NCT00499642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24495329|NCT00499642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24495330|NCT00499642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24495331|NCT00499642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24495332|NCT00499642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24521863|NCT04460248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24521864|NCT04460248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521865|NCT04456439|Diphenhydramine|diphenhydramine|mesh-list
24521866|NCT04456439|Promethazine|promethazine|mesh-list
24521867|NCT04456439|Remestemcel-l|remestemcel-l|mesh-list
24521868|NCT04456439|Hydrocortisone|hydrocortisone|mesh-list
24521869|NCT04456439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24521870|NCT04456439|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24521871|NCT04456439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24439700|NCT00279903|Cholinergic Agents|cholinergic agents|mesh-ancestor
24439701|NCT00279903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24439702|NCT00279903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439703|NCT00279903|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25694469|NCT02030535|Cholinergic Agents|cholinergic agents|mesh-ancestor
25694470|NCT02030535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25694471|NCT02030535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694472|NCT02030574|Gemcitabine|gemcitabine|mesh-list
25694473|NCT02030574|Cisplatin|cisplatin|mesh-list
24439704|NCT00279903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24439705|NCT00279903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25067160|NCT03446625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521872|NCT04456439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24920137|NCT04205357|Sulfasalazine|sulfasalazine|mesh-list
24920138|NCT04205357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24920139|NCT04205357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24920140|NCT04205357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24920141|NCT04205357|Analgesics|analgesics|mesh-ancestor
24920142|NCT04205357|Sensory System Agents|sensory system agents|mesh-ancestor
24920143|NCT04205357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24920144|NCT04205357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920145|NCT04205357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24920146|NCT04205357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24920147|NCT04205357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24920148|NCT04205097|Neostigmine|neostigmine|mesh-list
24920149|NCT04205097|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24920150|NCT04205097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920167|NCT04204980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920169|NCT04204954|Tea Tree Oil|tea tree oil|mesh-list
24920170|NCT04204954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24920171|NCT04204954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24920172|NCT04204954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24920173|NCT04204954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24920174|NCT04204954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920175|NCT04204954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920176|NCT04204954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24920177|NCT04204954|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24920178|NCT04204954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24920179|NCT04204954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24920180|NCT04205058|Caffeine|caffeine|mesh-list
24920181|NCT04205058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24920182|NCT04205058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920183|NCT04205058|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24920184|NCT04205058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920185|NCT04205058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920186|NCT04205058|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24920187|NCT04205058|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24920188|NCT04205058|Purinergic Agents|purinergic agents|mesh-ancestor
24920189|NCT04205058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24920199|NCT04204798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24920200|NCT04204798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24920201|NCT04204798|Adrenergic Agents|adrenergic agents|mesh-ancestor
24920202|NCT04204798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24920203|NCT04204798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920204|NCT04204772|Charcoal|charcoal|mesh-list
25067161|NCT03446625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25067162|NCT03446625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25067170|NCT03446599|Vitamins|vitamins|mesh-ancestor
25067171|NCT03446599|Micronutrients|micronutrients|mesh-ancestor
25067172|NCT03446599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829616|NCT02153437|Adrenergic Agents|adrenergic agents|mesh-ancestor
24743537|NCT04753216|Growth Inhibitors|growth inhibitors|mesh-ancestor
24920205|NCT04204772|Antidotes|antidotes|mesh-ancestor
24920206|NCT04204772|Protective Agents|protective agents|mesh-ancestor
24920207|NCT04204772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920208|NCT04204577|Apatinib|apatinib|mesh-list
24920209|NCT04204577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24920210|NCT04204577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24920211|NCT04204577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920212|NCT04204577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920213|NCT04204902|Tepotinib|tepotinib|mesh-list
24920214|NCT04204902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24920215|NCT04204278|Hyaluronic Acid|hyaluronic acid|mesh-list
24920216|NCT04204278|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24920217|NCT04204278|Immunologic Factors|immunologic factors|mesh-ancestor
24920218|NCT04204278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920219|NCT04204278|Viscosupplements|viscosupplements|mesh-ancestor
24920241|NCT04204083|Hyaluronic Acid|hyaluronic acid|mesh-list
24920242|NCT04204083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24920243|NCT04204083|Immunologic Factors|immunologic factors|mesh-ancestor
24920244|NCT04204083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656927|NCT01264640|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24656931|NCT01264653|Epinephrine|epinephrine|mesh-list
24920245|NCT04204083|Viscosupplements|viscosupplements|mesh-ancestor
24920246|NCT04204083|Protective Agents|protective agents|mesh-ancestor
24920248|NCT04204096|Immunologic Factors|immunologic factors|mesh-ancestor
24920249|NCT04204096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920250|NCT04204304|Isotretinoin|isotretinoin|mesh-list
24920251|NCT04204304|Dermatologic Agents|dermatologic agents|mesh-ancestor
24619358|NCT01052129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24619359|NCT01052129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24619360|NCT01052129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619361|NCT01052181|Cholecalciferol|cholecalciferol|mesh-list
24619362|NCT01052181|Vitamin D|vitamin d|mesh-list
24619363|NCT01052181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24619365|NCT01052181|Vitamins|vitamins|mesh-ancestor
24920259|NCT04204044|Vitamins|vitamins|mesh-ancestor
24920260|NCT04204044|Micronutrients|micronutrients|mesh-ancestor
24920261|NCT04204265|Hyaluronic Acid|hyaluronic acid|mesh-list
24920262|NCT04204265|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24920263|NCT04204265|Immunologic Factors|immunologic factors|mesh-ancestor
25067174|NCT03446547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25067175|NCT03446547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25067176|NCT03446534|Amoxicillin|amoxicillin|mesh-list
25067177|NCT03446534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25067178|NCT03446534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25067179|NCT03446495|Trabectedin|trabectedin|mesh-list
25067180|NCT03446495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24829627|NCT02153541|Antipyrine|antipyrine|mesh-list
24920264|NCT04204265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920265|NCT04204265|Viscosupplements|viscosupplements|mesh-ancestor
24920266|NCT04204265|Protective Agents|protective agents|mesh-ancestor
24920267|NCT04203732|Anesthetics|anesthetics|mesh-list
24920268|NCT04203732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24920269|NCT04203732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920270|NCT04203771|Ibuprofen|ibuprofen|mesh-list
24920271|NCT04203771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24920272|NCT04203771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24920273|NCT04203771|Analgesics|analgesics|mesh-ancestor
24920274|NCT04203771|Sensory System Agents|sensory system agents|mesh-ancestor
24920275|NCT04203771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24920276|NCT04203771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920277|NCT04203771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24920287|NCT04203680|Cardioplegic Solutions|cardioplegic solutions|mesh-list
24920288|NCT04203680|Tryptophan|tryptophan|mesh-list
24920291|NCT04203680|Antidepressive Agents|antidepressive agents|mesh-ancestor
24920292|NCT04203680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24619782|NCT01053689|Immunologic Factors|immunologic factors|mesh-ancestor
24920293|NCT04203186|Lumefantrine|lumefantrine|mesh-list
24920294|NCT04203186|Artemether|artemether|mesh-list
24920295|NCT04203186|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24920296|NCT04203186|Atovaquone|atovaquone|mesh-list
24920297|NCT04203186|Proguanil|proguanil|mesh-list
24920298|NCT04203186|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
24920299|NCT04203186|Antimalarials|antimalarials|mesh-ancestor
24920300|NCT04203186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24920301|NCT04203186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24920302|NCT04203186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24920303|NCT04203186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920304|NCT04203186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920305|NCT04203186|Antimetabolites|antimetabolites|mesh-ancestor
24920306|NCT04203342|Ketoconazole|ketoconazole|mesh-list
24920307|NCT04203342|Antifungal Agents|antifungal agents|mesh-ancestor
24920308|NCT04203342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24920309|NCT04203342|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24920310|NCT04203342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24920311|NCT04203342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920312|NCT04203342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920313|NCT04203342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24920314|NCT04203342|Hormone Antagonists|hormone antagonists|mesh-ancestor
24495516|NCT00500604|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24495517|NCT00500604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24495518|NCT00500669|Povidone-Iodine|povidone-iodine|mesh-list
24495519|NCT00500669|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24495520|NCT00500669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24521972|NCT04388683|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25694474|NCT02030574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694475|NCT02030574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25694476|NCT02030574|Antimetabolites|antimetabolites|mesh-ancestor
24521973|NCT04388683|Antioxidants|antioxidants|mesh-ancestor
24920332|NCT04203368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24920333|NCT04203368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24920335|NCT04203212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24920336|NCT04203212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24920337|NCT04203056|Aripiprazole|aripiprazole|mesh-list
24920338|NCT04203056|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
24920339|NCT04203056|Antidepressive Agents|antidepressive agents|mesh-ancestor
24920340|NCT04203056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24920341|NCT04203056|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24920342|NCT04203056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24920359|NCT04203043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920360|NCT04203043|Antioxidants|antioxidants|mesh-ancestor
24920361|NCT04203043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920362|NCT04203043|Protective Agents|protective agents|mesh-ancestor
24920363|NCT04203043|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24920365|NCT04202809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24920368|NCT04202978|Oxaliplatin|oxaliplatin|mesh-list
24920369|NCT04202978|Apatinib|apatinib|mesh-list
24920370|NCT04202978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24920371|NCT04202978|Antimetabolites|antimetabolites|mesh-ancestor
24920372|NCT04202978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920373|NCT04202978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24920374|NCT04202978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24920375|NCT04202978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920376|NCT04203511|Paclitaxel|paclitaxel|mesh-list
24920377|NCT04203511|Etoposide|etoposide|mesh-list
24495576|NCT00501150|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24495577|NCT00501150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495578|NCT00501150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495579|NCT00501215|Parathyroid Hormone|parathyroid hormone|mesh-list
24495580|NCT00501215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24495582|NCT00501241|ATI 7505|ati 7505|mesh-list
24920381|NCT04203511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24920382|NCT04203511|Tubulin Modulators|tubulin modulators|mesh-ancestor
24920383|NCT04203511|Antimitotic Agents|antimitotic agents|mesh-ancestor
25067184|NCT03446443|Metronidazole|metronidazole|mesh-list
25067185|NCT03446443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25067186|NCT03446443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25067187|NCT03446443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25067188|NCT03446443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24920384|NCT04203511|Mitosis Modulators|mitosis modulators|mesh-ancestor
24920385|NCT04203511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920386|NCT04203511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24920387|NCT04203511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24920388|NCT04203511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920389|NCT04203511|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24920390|NCT04203511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24920399|NCT04202835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920400|NCT04202835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24495602|NCT00501254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24522015|NCT04377932|Alkylating Agents|alkylating agents|mesh-ancestor
24522016|NCT04377932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522017|NCT04377932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522018|NCT04377932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24522019|NCT04377932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24522020|NCT04377932|Antimetabolites|antimetabolites|mesh-ancestor
24522024|NCT04371952|Doxycycline|doxycycline|mesh-list
24522025|NCT04371952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24522026|NCT04371952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24522027|NCT04371952|Antimalarials|antimalarials|mesh-ancestor
24522028|NCT04371952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24522029|NCT04371952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24522030|NCT04365257|Prazosin|prazosin|mesh-list
24522037|NCT04365257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522038|NCT04365257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694477|NCT02030574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694478|NCT02030574|Antiviral Agents|antiviral agents|mesh-ancestor
24920401|NCT04202835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24920414|NCT04203485|Mitosis Modulators|mitosis modulators|mesh-ancestor
24920415|NCT04203485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920416|NCT04203485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920417|NCT04203485|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24920418|NCT04203485|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24484835|NCT00450164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25067196|NCT03445897|Pentamidine|pentamidine|mesh-list
25067197|NCT03445897|Antifungal Agents|antifungal agents|mesh-ancestor
25067198|NCT03445897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25067199|NCT03445897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25067200|NCT03445897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25067201|NCT03445897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25067202|NCT03445897|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25067203|NCT03445845|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
25067204|NCT03445845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24920419|NCT04203485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24920421|NCT04202887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24920422|NCT04202887|Narcotics|narcotics|mesh-ancestor
24920423|NCT04202887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24920424|NCT04202887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495621|NCT00501267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495622|NCT00501267|Urological Agents|urological agents|mesh-ancestor
24495623|NCT00501267|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24495624|NCT00501267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24495625|NCT00501267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24522084|NCT04321395|Vigabatrin|vigabatrin|mesh-list
24522085|NCT04321395|Anticonvulsants|anticonvulsants|mesh-ancestor
24522086|NCT04321395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24522087|NCT04321395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522088|NCT04321395|GABA Agents|gaba agents|mesh-ancestor
24522089|NCT04321395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24522090|NCT04321395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067295|NCT03444649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24522111|NCT04275661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24920425|NCT04202887|Analgesics|analgesics|mesh-ancestor
24920426|NCT04202887|Sensory System Agents|sensory system agents|mesh-ancestor
24920427|NCT04202887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24920428|NCT04202887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24920429|NCT04202887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24920430|NCT04202887|Anesthetics, General|anesthetics, general|mesh-ancestor
24920431|NCT04202887|Anesthetics|anesthetics|mesh-ancestor
24920432|NCT04202861|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24920433|NCT04202861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24920434|NCT04202536|Tenofovir|tenofovir|mesh-list
24920435|NCT04202536|Antiviral Agents|antiviral agents|mesh-ancestor
24920436|NCT04202536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24920437|NCT04202536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24920438|NCT04202536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24920439|NCT04202536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920440|NCT04202536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920441|NCT04202536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24495643|NCT00501397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24495644|NCT00501410|Leucovorin|leucovorin|mesh-list
24495645|NCT00501410|Fluorouracil|fluorouracil|mesh-list
24495646|NCT00501410|Oxaliplatin|oxaliplatin|mesh-list
24495647|NCT00501410|Cetuximab|cetuximab|mesh-list
24495648|NCT00501410|Dasatinib|dasatinib|mesh-list
24495649|NCT00501410|Antimetabolites|antimetabolites|mesh-ancestor
24619783|NCT01053728|Insulin Glargine|insulin glargine|mesh-list
24619784|NCT01053728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24619785|NCT01053728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619786|NCT01053806|Lenalidomide|lenalidomide|mesh-list
24619788|NCT01053806|Immunologic Factors|immunologic factors|mesh-ancestor
24619789|NCT01053806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067205|NCT03445780|Ethyl Chloride|ethyl chloride|mesh-list
25067206|NCT03445780|Anesthetics, Local|anesthetics, local|mesh-ancestor
25067207|NCT03445780|Anesthetics|anesthetics|mesh-ancestor
25067208|NCT03445780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25067209|NCT03445780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067210|NCT03445780|Sensory System Agents|sensory system agents|mesh-ancestor
25067211|NCT03445780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25067212|NCT03445702|Metformin|metformin|mesh-list
25067213|NCT03445702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24799172|NCT01967524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799174|NCT01967524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24799175|NCT01967524|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24657101|NCT01265680|Epoetin Alfa|epoetin alfa|mesh-list
24657102|NCT01265680|Hematinics|hematinics|mesh-ancestor
24657103|NCT01265810|Calcium|calcium|mesh-list
24657104|NCT01265810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24657105|NCT01265810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067214|NCT03445702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067215|NCT03445624|Infliximab|infliximab|mesh-list
25067216|NCT03445624|Dermatologic Agents|dermatologic agents|mesh-ancestor
24829655|NCT02153593|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24829656|NCT02153593|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24829657|NCT02153593|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24829661|NCT02153606|Glycerol|glycerol|mesh-list
24619790|NCT01053806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24619791|NCT01053806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24619792|NCT01053806|Growth Substances|growth substances|mesh-ancestor
24619793|NCT01053806|Growth Inhibitors|growth inhibitors|mesh-ancestor
24619794|NCT01053806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24619796|NCT01053806|Antimetabolites|antimetabolites|mesh-ancestor
24619843|NCT01054001|Sildenafil Citrate|sildenafil citrate|mesh-list
24619994|NCT01055145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620215|NCT01055925|Laxatives|laxatives|mesh-ancestor
24620216|NCT01055925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24620217|NCT01055938|Valproic Acid|valproic acid|mesh-list
24620218|NCT01055938|Anticonvulsants|anticonvulsants|mesh-ancestor
24620222|NCT01055938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24620223|NCT01055938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620224|NCT01055938|Antimanic Agents|antimanic agents|mesh-ancestor
24623922|NCT01073995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623927|NCT01073995|Hormones|hormones|mesh-ancestor
24623928|NCT01073995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24623929|NCT01073995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24454856|NCT03474029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24623930|NCT01073995|Immunologic Factors|immunologic factors|mesh-ancestor
24623931|NCT01073995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623932|NCT01073995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623933|NCT01074021|Nimotuzumab|nimotuzumab|mesh-list
24623934|NCT01074021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24623967|NCT01074073|Serotonin Agents|serotonin agents|mesh-ancestor
24623975|NCT01074086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623977|NCT01074138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623978|NCT01074138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495696|NCT00501605|Cediranib|cediranib|mesh-list
25067217|NCT03445624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25067218|NCT03445624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25694479|NCT02030574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25694480|NCT02030574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25694481|NCT02030574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25694482|NCT02030574|Immunologic Factors|immunologic factors|mesh-ancestor
25694483|NCT02030574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694484|NCT02030600|Insulin|insulin|mesh-list
25694485|NCT02030600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25694486|NCT02030600|Insulin Glargine|insulin glargine|mesh-list
25694487|NCT02030600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25694488|NCT02030600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694489|NCT02030821|Tranexamic Acid|tranexamic acid|mesh-list
25694490|NCT02030821|Aminocaproic Acid|aminocaproic acid|mesh-list
25694491|NCT02030821|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25694492|NCT02030821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25694493|NCT02030821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694494|NCT02030821|Hemostatics|hemostatics|mesh-ancestor
25694495|NCT02030821|Coagulants|coagulants|mesh-ancestor
25694496|NCT02031276|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25694497|NCT02031276|Immunologic Factors|immunologic factors|mesh-ancestor
25067219|NCT03445611|Lidocaine|lidocaine|mesh-list
25067220|NCT03445611|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25067221|NCT03445611|Anesthetics, Local|anesthetics, local|mesh-ancestor
25067222|NCT03445611|Anesthetics|anesthetics|mesh-ancestor
24829669|NCT02153762|Hydrocortisone|hydrocortisone|mesh-list
24522169|NCT04158440|Docetaxel|docetaxel|mesh-list
24522170|NCT04158440|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24522171|NCT04158440|Cisplatin|cisplatin|mesh-list
24522172|NCT04158440|Carboplatin|carboplatin|mesh-list
24522173|NCT04158440|Pemetrexed|pemetrexed|mesh-list
24522174|NCT04158440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24522175|NCT04158440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522176|NCT04158440|Tubulin Modulators|tubulin modulators|mesh-ancestor
24620466|NCT01057264|Gemcitabine|gemcitabine|mesh-list
24620534|NCT01057355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24620535|NCT01057355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920446|NCT04202484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24920447|NCT04202484|Antimetabolites|antimetabolites|mesh-ancestor
24920448|NCT04202484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920449|NCT04202380|Azithromycin|azithromycin|mesh-list
24920450|NCT04202380|Ampicillin|ampicillin|mesh-list
24920451|NCT04202380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24522180|NCT04158440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24522181|NCT04158440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24522182|NCT04158440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24522183|NCT04123262|Tamoxifen|tamoxifen|mesh-list
24522184|NCT04123262|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24522185|NCT04123262|Hormone Antagonists|hormone antagonists|mesh-ancestor
24522186|NCT04123262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24522187|NCT04123262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522188|NCT04123262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24522192|NCT04123262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24952314|NCT03895411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24952320|NCT03894904|Heparin|heparin|mesh-list
24952321|NCT03894904|Papaverine|papaverine|mesh-list
25067232|NCT03445533|Ipilimumab|ipilimumab|mesh-list
24522194|NCT04112303|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
24522195|NCT04112303|Antiviral Agents|antiviral agents|mesh-ancestor
24522196|NCT04112303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24522197|NCT04111926|Dexmedetomidine|dexmedetomidine|mesh-list
24522198|NCT04111926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24522199|NCT04111926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24522200|NCT04111926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522203|NCT04111926|Sensory System Agents|sensory system agents|mesh-ancestor
24522204|NCT04111926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24522205|NCT04111926|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24522206|NCT04111926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24522207|NCT04111926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24522208|NCT04111926|Adrenergic Agents|adrenergic agents|mesh-ancestor
24920457|NCT04202367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920458|NCT04202367|Sensory System Agents|sensory system agents|mesh-ancestor
24920459|NCT04202367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24920460|NCT04202471|Chlorhexidine|chlorhexidine|mesh-list
24920461|NCT04202471|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24920462|NCT04202471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24920463|NCT04202471|Disinfectants|disinfectants|mesh-ancestor
24920464|NCT04202289|Sulfadiazine|sulfadiazine|mesh-list
24920465|NCT04202289|Silver Sulfadiazine|silver sulfadiazine|mesh-list
24920466|NCT04202289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24920467|NCT04202289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24920468|NCT04202289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24920469|NCT04202289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24920470|NCT04202289|Coccidiostats|coccidiostats|mesh-ancestor
24920471|NCT04202289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24920472|NCT04202406|Acetaminophen|acetaminophen|mesh-list
24920502|NCT04202224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24920503|NCT04202224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24920504|NCT04202224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24920505|NCT04202224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24920506|NCT04202224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920507|NCT04202224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518716|NCT04472637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518717|NCT04472637|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24518718|NCT04472637|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24518719|NCT04472637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24518721|NCT04450329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24901048|NCT04389320|Hydroxychloroquine|hydroxychloroquine|mesh-list
24901049|NCT04389320|Antimalarials|antimalarials|mesh-ancestor
24901050|NCT04389320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24482411|NCT00438945|Eprosartan|eprosartan|mesh-list
24920509|NCT04201951|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24920510|NCT04201951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24920511|NCT04201951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920512|NCT04201951|Hemostatics|hemostatics|mesh-ancestor
24920513|NCT04201951|Coagulants|coagulants|mesh-ancestor
24920514|NCT04202068|Ceftriaxone|ceftriaxone|mesh-list
24920515|NCT04202068|Sulbactam|sulbactam|mesh-list
24920516|NCT04202068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24920517|NCT04202068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24920518|NCT04202068|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25067233|NCT03445533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25067234|NCT03445533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25067235|NCT03445533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25067236|NCT03445533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067237|NCT03445468|Vaccines|vaccines|mesh-list
25067238|NCT03445468|Immunologic Factors|immunologic factors|mesh-ancestor
25067239|NCT03445468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067240|NCT03445286|Fluorides|fluorides|mesh-list
25067241|NCT03445286|Cariostatic Agents|cariostatic agents|mesh-ancestor
25067242|NCT03445286|Protective Agents|protective agents|mesh-ancestor
25067243|NCT03445286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067244|NCT03445182|Anesthetics|anesthetics|mesh-list
25067245|NCT03445182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25067246|NCT03445182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067247|NCT03445104|Huperzine A|huperzine a|mesh-list
25067248|NCT03445104|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25067249|NCT03445104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24439715|NCT00280033|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24439716|NCT00280033|Immunologic Factors|immunologic factors|mesh-ancestor
24439717|NCT00280033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067250|NCT03445104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067251|NCT03445104|Cholinergic Agents|cholinergic agents|mesh-ancestor
25067252|NCT03445104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25067253|NCT03445104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067254|NCT03445104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25067255|NCT03445104|Protective Agents|protective agents|mesh-ancestor
25067285|NCT03444649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067286|NCT03444649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25067287|NCT03444649|Antiviral Agents|antiviral agents|mesh-ancestor
25067288|NCT03444649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25067289|NCT03444649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25067290|NCT03444649|Immunologic Factors|immunologic factors|mesh-ancestor
25067291|NCT03444649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067292|NCT03444649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25067293|NCT03444649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25067294|NCT03444649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25067297|NCT03444636|Bupivacaine|bupivacaine|mesh-list
25067298|NCT03444636|Ropivacaine|ropivacaine|mesh-list
25067299|NCT03444636|Anesthetics, Local|anesthetics, local|mesh-ancestor
24920519|NCT04202068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920520|NCT04202068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920521|NCT04201808|Tenofovir|tenofovir|mesh-list
25694498|NCT02031276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694499|NCT02031458|Atezolizumab|atezolizumab|mesh-list
25694500|NCT02031458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694501|NCT02031536|Everolimus|everolimus|mesh-list
25694502|NCT02031536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694503|NCT02031536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25694504|NCT02031536|Immunologic Factors|immunologic factors|mesh-ancestor
25694505|NCT02031536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694506|NCT02031640|Beclomethasone|beclomethasone|mesh-list
25694507|NCT02031640|Albuterol|albuterol|mesh-list
25694508|NCT02031640|Bronchodilator Agents|bronchodilator agents|mesh-list
24920522|NCT04201808|Antiviral Agents|antiviral agents|mesh-ancestor
24920523|NCT04201808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24920524|NCT04201808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24920525|NCT04201808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24920526|NCT04201808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920527|NCT04201808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920528|NCT04201808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24920529|NCT04201808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24920530|NCT04201860|Hemostatics|hemostatics|mesh-list
24920531|NCT04201860|Coagulants|coagulants|mesh-ancestor
24439874|NCT00280605|Urological Agents|urological agents|mesh-ancestor
24439875|NCT00280618|Oxaliplatin|oxaliplatin|mesh-list
24439876|NCT00280618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439877|NCT00280644|Leflunomide|leflunomide|mesh-list
24920532|NCT04201990|Apatinib|apatinib|mesh-list
24920533|NCT04201990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24920538|NCT04201678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24920539|NCT04201678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920541|NCT04201769|Palonosetron|palonosetron|mesh-list
24920542|NCT04201769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24920543|NCT04201769|Antiemetics|antiemetics|mesh-ancestor
24920544|NCT04201769|Autonomic Agents|autonomic agents|mesh-ancestor
24920545|NCT04201769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24920546|NCT04201769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920547|NCT04201769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24920548|NCT04201769|Glucocorticoids|glucocorticoids|mesh-ancestor
24920549|NCT04201769|Hormones|hormones|mesh-ancestor
24450655|NCT00319878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24920560|NCT04201561|Paclitaxel|paclitaxel|mesh-list
24920561|NCT04201561|Carboplatin|carboplatin|mesh-list
24920562|NCT04201561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24920563|NCT04201561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24920564|NCT04201561|Tubulin Modulators|tubulin modulators|mesh-ancestor
24920565|NCT04201561|Antimitotic Agents|antimitotic agents|mesh-ancestor
24920566|NCT04201561|Mitosis Modulators|mitosis modulators|mesh-ancestor
24920567|NCT04201561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920568|NCT04201561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920569|NCT04201561|Trace Elements|trace elements|mesh-ancestor
24920570|NCT04201561|Micronutrients|micronutrients|mesh-ancestor
24920571|NCT04201652|Anesthetics|anesthetics|mesh-list
24920572|NCT04201652|Anesthetics, Local|anesthetics, local|mesh-list
24920573|NCT04201652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24920574|NCT04201652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920575|NCT04201652|Sensory System Agents|sensory system agents|mesh-ancestor
24920576|NCT04201652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24920577|NCT04201054|Fluconazole|fluconazole|mesh-list
25067301|NCT03444636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25067302|NCT03444636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067303|NCT03444636|Sensory System Agents|sensory system agents|mesh-ancestor
25067304|NCT03444636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25067305|NCT03444636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24439966|NCT00280969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25067306|NCT03444636|Narcotics|narcotics|mesh-ancestor
25067307|NCT03444636|Analgesics|analgesics|mesh-ancestor
25067308|NCT03444636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24829761|NCT02154334|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24829762|NCT02154334|Respiratory System Agents|respiratory system agents|mesh-ancestor
24829763|NCT02154334|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24829764|NCT02154334|Mydriatics|mydriatics|mesh-ancestor
24829765|NCT02154334|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24920578|NCT04201054|Antifungal Agents|antifungal agents|mesh-ancestor
24920579|NCT04201054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24920580|NCT04201054|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24920581|NCT04201054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24920582|NCT04201054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920583|NCT04201054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920584|NCT04201054|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24920585|NCT04201054|Hormone Antagonists|hormone antagonists|mesh-ancestor
24920586|NCT04201054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24920587|NCT04201054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694509|NCT02031640|Autonomic Agents|autonomic agents|mesh-ancestor
25694510|NCT02031640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25694511|NCT02031640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920588|NCT04201054|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24495840|NCT00502138|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24495841|NCT00502138|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
24495842|NCT00502138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495844|NCT00502164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495845|NCT00502164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24522209|NCT04111926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24522210|NCT04111926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522279|NCT04020913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522281|NCT04017247|Oxytocics|oxytocics|mesh-ancestor
24522282|NCT04017247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24522283|NCT04017247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522288|NCT04004819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522289|NCT04004819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24522300|NCT04004078|Hormone Antagonists|hormone antagonists|mesh-ancestor
24955042|NCT03869047|Adrenergic Agents|adrenergic agents|mesh-ancestor
24522301|NCT04004078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24522302|NCT04004078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920589|NCT04201054|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24495852|NCT00502229|Metformin|metformin|mesh-list
24495853|NCT00502229|Clomiphene|clomiphene|mesh-list
24495854|NCT00502229|Enclomiphene|enclomiphene|mesh-list
24495855|NCT00502229|Zuclomiphene|zuclomiphene|mesh-list
24495856|NCT00502229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24920590|NCT04201145|Pembrolizumab|pembrolizumab|mesh-list
25067311|NCT03444519|Mannitol|mannitol|mesh-list
25067332|NCT03444467|Glucagon|glucagon|mesh-list
25067333|NCT03444467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25067334|NCT03444467|Hormones|hormones|mesh-ancestor
25067335|NCT03444467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25067336|NCT03444467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067337|NCT03444402|Esomeprazole|esomeprazole|mesh-list
25067338|NCT03444402|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25067339|NCT03444402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25067340|NCT03444402|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25067341|NCT03444402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25067342|NCT03444402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067343|NCT03444272|Sofosbuvir|sofosbuvir|mesh-list
25067344|NCT03444272|Antiviral Agents|antiviral agents|mesh-ancestor
25067345|NCT03444272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24920610|NCT04201249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24920611|NCT04201249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24920612|NCT04201249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920613|NCT04200885|Dexamethasone|dexamethasone|mesh-list
24920614|NCT04200885|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
24920617|NCT04200885|Antiemetics|antiemetics|mesh-ancestor
24920626|NCT04200885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24920627|NCT04200885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24920628|NCT04200885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24920629|NCT04200885|Analgesics|analgesics|mesh-ancestor
24920630|NCT04200885|Sensory System Agents|sensory system agents|mesh-ancestor
24920632|NCT04200599|Oxytocin|oxytocin|mesh-list
24920633|NCT04200599|Oxytocics|oxytocics|mesh-ancestor
24920634|NCT04200599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24920635|NCT04200599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920636|NCT04200586|Dapagliflozin|dapagliflozin|mesh-list
24920637|NCT04200586|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24920638|NCT04200586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920639|NCT04200586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24920640|NCT04200586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920641|NCT04200235|Dexmedetomidine|dexmedetomidine|mesh-list
24920662|NCT04200092|Serotonin Agents|serotonin agents|mesh-ancestor
24920663|NCT04200092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24920664|NCT04200092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920665|NCT04200222|Vanadium|vanadium|mesh-list
24920666|NCT04200222|Trace Elements|trace elements|mesh-ancestor
24920667|NCT04200222|Micronutrients|micronutrients|mesh-ancestor
24920668|NCT04200222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920669|NCT04200040|Dacarbazine|dacarbazine|mesh-list
24920670|NCT04200040|Molgramostim|molgramostim|mesh-list
24920671|NCT04200040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24920673|NCT04200040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920675|NCT04199494|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24920676|NCT04199494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25067347|NCT03444246|Cadexomer iodine|cadexomer iodine|mesh-list
25067348|NCT03444246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24901939|NCT04379739|Apatinib|apatinib|mesh-list
25067349|NCT03444246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25067350|NCT03444246|Trace Elements|trace elements|mesh-ancestor
25067351|NCT03444246|Micronutrients|micronutrients|mesh-ancestor
25067352|NCT03444246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067353|NCT03444142|Exenatide|exenatide|mesh-list
25067354|NCT03444142|Dulaglutide|dulaglutide|mesh-list
25067355|NCT03444142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25067356|NCT03444142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067357|NCT03444142|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25067358|NCT03444142|Incretins|incretins|mesh-ancestor
25067359|NCT03444142|Hormones|hormones|mesh-ancestor
25067360|NCT03444142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25067388|NCT03443960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067390|NCT03443960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25067391|NCT03443960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25067392|NCT03443960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25067393|NCT03443960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25067394|NCT03443960|Analgesics|analgesics|mesh-ancestor
25067395|NCT03443960|Sensory System Agents|sensory system agents|mesh-ancestor
25067396|NCT03443960|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25067397|NCT03443960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25067398|NCT03443960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25067399|NCT03443960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067400|NCT03443960|Adrenergic Agents|adrenergic agents|mesh-ancestor
25067401|NCT03443960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25067402|NCT03443921|Paclitaxel|paclitaxel|mesh-list
25067403|NCT03443921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25067404|NCT03443921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25067405|NCT03443921|Tubulin Modulators|tubulin modulators|mesh-ancestor
25067406|NCT03443921|Antimitotic Agents|antimitotic agents|mesh-ancestor
25067407|NCT03443921|Mitosis Modulators|mitosis modulators|mesh-ancestor
25067408|NCT03443921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067409|NCT03443843|Fluticasone|fluticasone|mesh-list
24439967|NCT00280969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24439968|NCT00280995|Mipomersen|mipomersen|mesh-list
24439969|NCT00280995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24439970|NCT00280995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24439971|NCT00280995|Antimetabolites|antimetabolites|mesh-ancestor
24439972|NCT00280995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439973|NCT00280995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24439974|NCT00281008|Mipomersen|mipomersen|mesh-list
24439975|NCT00281008|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24439976|NCT00281008|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25039961|NCT03546907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039962|NCT03546907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039964|NCT03542669|Doxorubicin|doxorubicin|mesh-list
25039965|NCT03542669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25039966|NCT03542669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25039992|NCT03521934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039993|NCT03515044|Rifaximin|rifaximin|mesh-list
25039994|NCT03515044|Lactulose|lactulose|mesh-list
25039995|NCT03515044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25039996|NCT03515044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25039997|NCT03515044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25039998|NCT03512964|Dolutegravir|dolutegravir|mesh-list
25039999|NCT03512964|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25040000|NCT03512964|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25040001|NCT03512964|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25040002|NCT03512964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25040003|NCT03512964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040004|NCT03512964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25040005|NCT03512964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25040006|NCT03512964|Antiviral Agents|antiviral agents|mesh-ancestor
25040007|NCT03512964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25040008|NCT03512964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25040058|NCT03471767|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25040059|NCT03471767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25040060|NCT03471767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25040061|NCT03471767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040062|NCT03471767|Dopamine Agents|dopamine agents|mesh-ancestor
25040063|NCT03471767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25040064|NCT03471767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103269|NCT03163576|Niacin|niacin|mesh-list
25040065|NCT03471767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25040066|NCT03471767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25040067|NCT03471767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25040068|NCT03471767|Antitussive Agents|antitussive agents|mesh-ancestor
25040069|NCT03471767|Respiratory System Agents|respiratory system agents|mesh-ancestor
25040070|NCT03471767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24439977|NCT00281008|Antimetabolites|antimetabolites|mesh-ancestor
24439979|NCT00281008|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25040071|NCT03471767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25040072|NCT03460756|Ganaxolone|ganaxolone|mesh-list
25040073|NCT03460756|Neurosteroids|neurosteroids|mesh-ancestor
25040074|NCT03460756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25040075|NCT03460756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040076|NCT03460756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040077|NCT03460756|GABA Modulators|gaba modulators|mesh-ancestor
25040078|NCT03460756|GABA Agents|gaba agents|mesh-ancestor
25040079|NCT03455504|Venetoclax|venetoclax|mesh-list
25040080|NCT03455504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25040081|NCT03448081|Calcipotriene|calcipotriene|mesh-list
25040082|NCT03448081|Dermatologic Agents|dermatologic agents|mesh-ancestor
25040083|NCT03446807|Droxidopa|droxidopa|mesh-list
25040084|NCT03446807|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25040085|NCT03446807|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25040086|NCT03430843|Paclitaxel|paclitaxel|mesh-list
25040087|NCT03430843|Docetaxel|docetaxel|mesh-list
25040088|NCT03430843|Irinotecan|irinotecan|mesh-list
25040089|NCT03430843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25040090|NCT03430843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25040091|NCT03430843|Tubulin Modulators|tubulin modulators|mesh-ancestor
25040092|NCT03430843|Antimitotic Agents|antimitotic agents|mesh-ancestor
25040093|NCT03430843|Mitosis Modulators|mitosis modulators|mesh-ancestor
25040094|NCT03430843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983630|NCT05183334|Analgesics|analgesics|mesh-ancestor
24996703|NCT02718066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996704|NCT02717624|Acalabrutinib|acalabrutinib|mesh-list
24996705|NCT02717624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996706|NCT02666599|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24996707|NCT02666599|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24996709|NCT02666547|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25040095|NCT03430843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25040096|NCT03430843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25040097|NCT03430843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25040128|NCT03404115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25040129|NCT03371082|Insulin Glargine|insulin glargine|mesh-list
25040130|NCT03371082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25040131|NCT03371082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040132|NCT03361956|JNJ-56136379|jnj-56136379|mesh-list
25040133|NCT03361956|Antiviral Agents|antiviral agents|mesh-ancestor
25040134|NCT03361956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25040135|NCT03352427|Everolimus|everolimus|mesh-list
25040136|NCT03352427|Dasatinib|dasatinib|mesh-list
25040137|NCT03352427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25040138|NCT03352427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25040139|NCT03352427|Immunologic Factors|immunologic factors|mesh-ancestor
25040140|NCT03352427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040141|NCT03352427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25040142|NCT03352427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25040143|NCT03352427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040144|NCT03350035|Ganaxolone|ganaxolone|mesh-list
25040145|NCT03350035|Neurosteroids|neurosteroids|mesh-ancestor
25040146|NCT03350035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25040147|NCT03350035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040148|NCT03350035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040162|NCT03340974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040194|NCT03320434|Antiemetics|antiemetics|mesh-ancestor
25040195|NCT03320434|Autonomic Agents|autonomic agents|mesh-ancestor
25040196|NCT03320434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25040197|NCT03320434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040198|NCT03320434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25040199|NCT03320434|Glucocorticoids|glucocorticoids|mesh-ancestor
25040201|NCT03320434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25103308|NCT03162653|Protective Agents|protective agents|mesh-ancestor
25103309|NCT03162653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103310|NCT03162653|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25103311|NCT03162653|Diuretics|diuretics|mesh-ancestor
25103312|NCT03162653|Natriuretic Agents|natriuretic agents|mesh-ancestor
24572959|NCT00817375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25103319|NCT03162588|Epoetin Alfa|epoetin alfa|mesh-list
25103320|NCT03162588|Hematinics|hematinics|mesh-ancestor
25103321|NCT03162406|Vitamin D|vitamin d|mesh-list
25103322|NCT03162406|Cholecalciferol|cholecalciferol|mesh-list
24902280|NCT04374981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24902281|NCT04374981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24902282|NCT04374981|Analgesics|analgesics|mesh-ancestor
25040202|NCT03320434|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25040203|NCT03320434|Protective Agents|protective agents|mesh-ancestor
25040204|NCT03320434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25040205|NCT03320434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25040207|NCT03318393|Calcium heparin|calcium heparin|mesh-list
25040208|NCT03318393|Bivalirudin|bivalirudin|mesh-list
25040209|NCT03318393|Anticoagulants|anticoagulants|mesh-ancestor
25040210|NCT03318393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25040211|NCT03318393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25040212|NCT03318393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040213|NCT03318393|Antithrombins|antithrombins|mesh-ancestor
25040214|NCT03318393|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25040215|NCT03318393|Protease Inhibitors|protease inhibitors|mesh-ancestor
25040253|NCT03250117|Dopamine Agonists|dopamine agonists|mesh-ancestor
25040254|NCT03250117|Dopamine Agents|dopamine agents|mesh-ancestor
25040255|NCT03250117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25040256|NCT03250117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040257|NCT03250117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040266|NCT03228394|Ganaxolone|ganaxolone|mesh-list
25040267|NCT03228394|Neurosteroids|neurosteroids|mesh-ancestor
25040268|NCT03228394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25040269|NCT03228394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040306|NCT03191864|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25040307|NCT03187834|Amoxicillin|amoxicillin|mesh-list
24608875|NCT00994149|Diazoxide|diazoxide|mesh-list
25040319|NCT03180684|Immunologic Factors|immunologic factors|mesh-ancestor
25040320|NCT03180684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040321|NCT03180684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25040322|NCT03180684|Interferon Inducers|interferon inducers|mesh-ancestor
25040323|NCT03172910|Rivaroxaban|rivaroxaban|mesh-list
25040324|NCT03172910|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25040325|NCT03172910|Antithrombins|antithrombins|mesh-ancestor
25040326|NCT03172910|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25040327|NCT03172910|Protease Inhibitors|protease inhibitors|mesh-ancestor
25040328|NCT03172910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25040329|NCT03172910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040330|NCT03172910|Anticoagulants|anticoagulants|mesh-ancestor
25040336|NCT03162783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25040337|NCT03162783|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25040338|NCT03161093|Naproxen|naproxen|mesh-list
25040339|NCT03161093|Fasinumab|fasinumab|mesh-list
25040340|NCT03161093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25040341|NCT03161093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25040342|NCT03161093|Analgesics|analgesics|mesh-ancestor
25040343|NCT03161093|Sensory System Agents|sensory system agents|mesh-ancestor
25040344|NCT03161093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25040345|NCT03161093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040346|NCT03161093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25040351|NCT03161093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040352|NCT03150797|Melatonin|melatonin|mesh-list
25040353|NCT03150797|Antioxidants|antioxidants|mesh-ancestor
25694512|NCT02031640|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25694513|NCT02031640|Respiratory System Agents|respiratory system agents|mesh-ancestor
25694514|NCT02031640|Tocolytic Agents|tocolytic agents|mesh-ancestor
25694515|NCT02031640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25694516|NCT02031640|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25694517|NCT02031640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25694518|NCT02031640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25694519|NCT02031640|Adrenergic Agents|adrenergic agents|mesh-ancestor
25694520|NCT02031640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25694521|NCT02031640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694522|NCT02031640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25040354|NCT03150797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103398|NCT03161652|Dopamine|dopamine|mesh-list
25103399|NCT03161652|Sulpiride|sulpiride|mesh-list
25103400|NCT03161652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25103401|NCT03161652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25103402|NCT03161652|Growth Substances|growth substances|mesh-ancestor
25103403|NCT03161652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103404|NCT03161652|Growth Inhibitors|growth inhibitors|mesh-ancestor
25103405|NCT03161652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25040355|NCT03150797|Protective Agents|protective agents|mesh-ancestor
25040356|NCT03150797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040357|NCT03150797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25040358|NCT03148860|Methotrexate|methotrexate|mesh-list
24798213|NCT01961739|Anesthetics, Local|anesthetics, local|mesh-ancestor
24798214|NCT01961739|Anesthetics|anesthetics|mesh-ancestor
24955106|NCT03868111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24911768|NCT04284150|Midazolam|midazolam|mesh-list
24798215|NCT01961739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24798216|NCT01961739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798217|NCT01961739|Sensory System Agents|sensory system agents|mesh-ancestor
24798218|NCT01961739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24798219|NCT01961739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24798220|NCT01961739|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24798221|NCT01961739|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24798222|NCT01961739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24798223|NCT01961739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591955|NCT00919815|Cyclosporine|cyclosporine|mesh-list
24589188|NCT00906061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589190|NCT00906061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24589192|NCT00906061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24589193|NCT00906061|Immunologic Factors|immunologic factors|mesh-ancestor
24607098|NCT05213481|Tepotinib|tepotinib|mesh-list
25040374|NCT03148860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25040375|NCT03137407|Botulinum Toxins|botulinum toxins|mesh-list
25040376|NCT03137407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25040408|NCT03110575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25040409|NCT03110575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25040410|NCT03110575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25040413|NCT03094416|Rabeprazole|rabeprazole|mesh-list
25040414|NCT03094416|Pantoprazole|pantoprazole|mesh-list
25040415|NCT03094416|Lansoprazole|lansoprazole|mesh-list
25040416|NCT03094416|Dexlansoprazole|dexlansoprazole|mesh-list
25040417|NCT03094416|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25040418|NCT03094416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25040419|NCT03094416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25040454|NCT03062540|Cyclobenzaprine|cyclobenzaprine|mesh-list
24609120|NCT00995033|Varenicline|varenicline|mesh-list
24609121|NCT00995033|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25026970|NCT03623789|Coagulants|coagulants|mesh-ancestor
24637223|NCT01149330|Analgesics|analgesics|mesh-ancestor
25040568|NCT03009019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040569|NCT03006276|Celecoxib|celecoxib|mesh-list
25040570|NCT03006276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25040571|NCT03006276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25040572|NCT03006276|Analgesics|analgesics|mesh-ancestor
25040573|NCT03006276|Sensory System Agents|sensory system agents|mesh-ancestor
25040574|NCT03006276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25040575|NCT03006276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040576|NCT03006276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25040577|NCT03006276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25040578|NCT03006276|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25040579|NCT03006276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25040580|NCT03006276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25040581|NCT03006276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040582|NCT03001817|Fenofibrate|fenofibrate|mesh-list
25040583|NCT03001817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25040584|NCT03001817|Antimetabolites|antimetabolites|mesh-ancestor
25040585|NCT03001817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040586|NCT03001817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24609232|NCT00995618|Analgesics|analgesics|mesh-ancestor
24607213|NCT04994561|Dasatinib|dasatinib|mesh-list
25694523|NCT02031640|Glucocorticoids|glucocorticoids|mesh-ancestor
25694524|NCT02031640|Hormones|hormones|mesh-ancestor
25694525|NCT02031640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25694526|NCT02032173|Ranibizumab|ranibizumab|mesh-list
25694527|NCT02032173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25694528|NCT02032173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25694529|NCT02032173|Growth Substances|growth substances|mesh-ancestor
25694530|NCT02032173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103465|NCT03161340|Sirolimus|sirolimus|mesh-list
25103466|NCT03161340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25103467|NCT03161340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24969553|NCT03742258|Hormones|hormones|mesh-ancestor
24903221|NCT04365309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24903222|NCT04365309|Analgesics|analgesics|mesh-ancestor
24903223|NCT04365309|Sensory System Agents|sensory system agents|mesh-ancestor
24903224|NCT04365309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24903225|NCT04365309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903226|NCT04365309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24903250|NCT04364893|Enzyme Inhibitors|enzyme inhibitors|mesh-list
24607214|NCT04994561|Resveratrol|resveratrol|mesh-list
24607215|NCT04994561|Quercetin|quercetin|mesh-list
24607216|NCT04994561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24607217|NCT04994561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607218|NCT04994561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607219|NCT04994561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24607220|NCT04994561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24607221|NCT04994561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607222|NCT04994561|Antioxidants|antioxidants|mesh-ancestor
24607223|NCT04994561|Protective Agents|protective agents|mesh-ancestor
24607254|NCT04941443|Narcotics|narcotics|mesh-ancestor
24607256|NCT04941443|Antitussive Agents|antitussive agents|mesh-ancestor
24607257|NCT04941443|Respiratory System Agents|respiratory system agents|mesh-ancestor
24607258|NCT04893291|Sirolimus|sirolimus|mesh-list
24607259|NCT04893291|Everolimus|everolimus|mesh-list
24607260|NCT04893291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607261|NCT04893291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24607262|NCT04893291|Immunologic Factors|immunologic factors|mesh-ancestor
24607263|NCT04893291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607264|NCT04893291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24607265|NCT04893291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24607266|NCT04893291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24607267|NCT04893291|Antifungal Agents|antifungal agents|mesh-ancestor
24607268|NCT04870125|Carbon Monoxide|carbon monoxide|mesh-list
24607269|NCT04870125|Antimetabolites|antimetabolites|mesh-ancestor
24607270|NCT04870125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607271|NCT04870125|Gasotransmitters|gasotransmitters|mesh-ancestor
24607272|NCT04870125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24607273|NCT04870125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607274|NCT04867707|Zanamivir|zanamivir|mesh-list
24607275|NCT04867707|Antiviral Agents|antiviral agents|mesh-ancestor
24607276|NCT04867707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24607277|NCT04867707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24607278|NCT04867707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607279|NCT04857398|Insulin|insulin|mesh-list
24607280|NCT04857398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24607281|NCT04857398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607282|NCT04850846|Metformin|metformin|mesh-list
24607283|NCT04850846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24607284|NCT04850846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607302|NCT04836832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25067412|NCT03443843|Pseudoephedrine|pseudoephedrine|mesh-list
24607360|NCT04756232|Mecamylamine|mecamylamine|mesh-list
24607361|NCT04756232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24607362|NCT04756232|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
24607363|NCT04756232|Autonomic Agents|autonomic agents|mesh-ancestor
24607364|NCT04756232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24607365|NCT04756232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607366|NCT04756232|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24607367|NCT04756232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24607368|NCT04756232|Cholinergic Agents|cholinergic agents|mesh-ancestor
24607369|NCT04756232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24607370|NCT04756232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694531|NCT02032173|Growth Inhibitors|growth inhibitors|mesh-ancestor
25694532|NCT02032173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694533|NCT02032212|Nicotine|nicotine|mesh-list
25694534|NCT02032212|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25694535|NCT02032212|Autonomic Agents|autonomic agents|mesh-ancestor
25694536|NCT02032212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25694537|NCT02032212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694538|NCT02032212|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25694539|NCT02032212|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25694540|NCT02032212|Cholinergic Agents|cholinergic agents|mesh-ancestor
25694541|NCT02032212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24984001|NCT04931667|Lorecivivint|lorecivivint|mesh-list
24607443|NCT04597697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24607444|NCT04597697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853505|NCT02268565|Antipyretics|antipyretics|mesh-ancestor
24440035|NCT00281489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440036|NCT00281502|Rifaximin|rifaximin|mesh-list
24607478|NCT04477512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24955169|NCT03867097|Iloprost|iloprost|mesh-list
24520030|NCT04029116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24912458|NCT04275284|Immunologic Factors|immunologic factors|mesh-ancestor
24607479|NCT04477512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607480|NCT04477512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24607481|NCT04477512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607482|NCT04477512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24607483|NCT04477512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24607484|NCT04477512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607485|NCT04477512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24607486|NCT04477512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24607487|NCT04477512|Hormone Antagonists|hormone antagonists|mesh-ancestor
24607520|NCT04433780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24607521|NCT04433780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24607522|NCT04433780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24607523|NCT04433780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607524|NCT04433780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24607525|NCT04433780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24607526|NCT04429152|Tenofovir|tenofovir|mesh-list
24607527|NCT04429152|Lamivudine|lamivudine|mesh-list
24607531|NCT04429152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24607532|NCT04429152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24607533|NCT04429152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607534|NCT04429152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24607535|NCT04429152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24607536|NCT04424264|Tenofovir|tenofovir|mesh-list
24607540|NCT04424264|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24607542|NCT04424264|Isoniazid|isoniazid|mesh-list
24607543|NCT04424264|Antiviral Agents|antiviral agents|mesh-ancestor
24607544|NCT04424264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24607545|NCT04424264|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24607558|NCT04424264|Antitubercular Agents|antitubercular agents|mesh-ancestor
24607559|NCT04424264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24607560|NCT04424264|Leprostatic Agents|leprostatic agents|mesh-ancestor
24607561|NCT04424264|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24607562|NCT04424264|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24607563|NCT04424264|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24607564|NCT04424264|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24607565|NCT04424264|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24607566|NCT04424264|Antimetabolites|antimetabolites|mesh-ancestor
24607567|NCT04424264|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24607568|NCT04420299|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24607570|NCT04420299|Anticoagulants|anticoagulants|mesh-ancestor
24607571|NCT04420299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24607572|NCT04420299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24607573|NCT04420299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607574|NCT04406272|Bevacizumab|bevacizumab|mesh-list
24607575|NCT04406272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24607576|NCT04406272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607577|NCT04406272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24607578|NCT04406272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24607579|NCT04406272|Growth Substances|growth substances|mesh-ancestor
24607580|NCT04406272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607581|NCT04406272|Growth Inhibitors|growth inhibitors|mesh-ancestor
24607582|NCT04364360|Sulforaphane|sulforaphane|mesh-list
24607583|NCT04364360|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24607584|NCT04364360|Protective Agents|protective agents|mesh-ancestor
24607585|NCT04364360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607586|NCT04364360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607587|NCT04285866|Durvalumab|durvalumab|mesh-list
24607588|NCT04285866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24607589|NCT04285866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607590|NCT04273061|Atezolizumab|atezolizumab|mesh-list
24607591|NCT04273061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25709336|NCT02265341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25709337|NCT02265341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24609663|NCT00997711|Antifungal Agents|antifungal agents|mesh-ancestor
24607642|NCT04191135|Antiviral Agents|antiviral agents|mesh-ancestor
24607643|NCT04191135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24607644|NCT04191135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24607645|NCT04191135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24607646|NCT04191135|Immunologic Factors|immunologic factors|mesh-ancestor
24607647|NCT04191135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607648|NCT04191135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24607649|NCT04191135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24607650|NCT04139525|Heparin|heparin|mesh-list
24607651|NCT04139525|Calcium heparin|calcium heparin|mesh-list
24607652|NCT04139525|Citric Acid|citric acid|mesh-list
24607653|NCT04139525|Sodium Citrate|sodium citrate|mesh-list
24607654|NCT04139525|Anticoagulants|anticoagulants|mesh-ancestor
24607655|NCT04139525|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24607656|NCT04139525|Chelating Agents|chelating agents|mesh-ancestor
24607657|NCT04139525|Sequestering Agents|sequestering agents|mesh-ancestor
24607658|NCT04139525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607659|NCT04139525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24607660|NCT04139525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24607710|NCT03971409|Immunoconjugates|immunoconjugates|mesh-list
24853537|NCT02268773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24607753|NCT03742505|Cholecalciferol|cholecalciferol|mesh-list
24607754|NCT03742505|Vitamin D|vitamin d|mesh-list
24607755|NCT03742505|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24607756|NCT03742505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607757|NCT03742505|Vitamins|vitamins|mesh-ancestor
24607758|NCT03742505|Micronutrients|micronutrients|mesh-ancestor
24607759|NCT03742505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24607760|NCT03735979|Argatroban|argatroban|mesh-list
24607761|NCT03735979|Eptifibatide|eptifibatide|mesh-list
24607763|NCT03735979|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24607764|NCT03735979|Protease Inhibitors|protease inhibitors|mesh-ancestor
24607765|NCT03735979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637070|NCT01148472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24607766|NCT03735979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607768|NCT03735979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24607769|NCT03709446|Leflunomide|leflunomide|mesh-list
24607770|NCT03709446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24607771|NCT03709446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607772|NCT03709446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24853552|NCT02268903|Natriuretic Agents|natriuretic agents|mesh-ancestor
24853553|NCT02268903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607802|NCT03612466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607803|NCT03612466|Antacids|antacids|mesh-ancestor
24607804|NCT03612466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607805|NCT03612466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24827614|NCT02140450|Timolol|timolol|mesh-list
24607806|NCT03612466|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24607807|NCT03612466|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24607808|NCT03612466|Antiviral Agents|antiviral agents|mesh-ancestor
24607809|NCT03612466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24607810|NCT03606785|Tranexamic Acid|tranexamic acid|mesh-list
24607822|NCT03467789|Vitamin D|vitamin d|mesh-list
24607823|NCT03467789|Ergocalciferols|ergocalciferols|mesh-list
24607824|NCT03467789|Cholecalciferol|cholecalciferol|mesh-list
24607825|NCT03467789|Vitamins|vitamins|mesh-list
24607826|NCT03467789|Micronutrients|micronutrients|mesh-ancestor
24607827|NCT03467789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607828|NCT03467789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24607829|NCT03467789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24607879|NCT03274804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607880|NCT03274804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24607881|NCT03274804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24607882|NCT03274804|Antiviral Agents|antiviral agents|mesh-ancestor
24607883|NCT03274804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24607884|NCT03274804|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24607885|NCT03270059|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24607886|NCT03270059|Hematinics|hematinics|mesh-ancestor
24637083|NCT01148576|Essential 303 forte|essential 303 forte|mesh-list
24607887|NCT03270059|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24607888|NCT03270059|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24607924|NCT03185208|Antimanic Agents|antimanic agents|mesh-ancestor
24607931|NCT03179449|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24903858|NCT04360785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903859|NCT04360785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24903860|NCT04360785|Antimetabolites|antimetabolites|mesh-ancestor
24903861|NCT04360785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903862|NCT04360785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24903863|NCT04360785|Dermatologic Agents|dermatologic agents|mesh-ancestor
24903864|NCT04360785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903865|NCT04360785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24903866|NCT04360785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24903867|NCT04360785|Immunologic Factors|immunologic factors|mesh-ancestor
24903868|NCT04360785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24903870|NCT04360655|Antibodies|antibodies|mesh-list
25103787|NCT03158376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24607964|NCT03077698|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24607966|NCT03077698|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24607967|NCT03077698|Contraceptive Agents|contraceptive agents|mesh-ancestor
24607968|NCT03077698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24607969|NCT03077698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853583|NCT02269072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24853584|NCT02269072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853585|NCT02269072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24853586|NCT02269072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24853587|NCT02269072|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24853588|NCT02269072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24853589|NCT02269072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24607988|NCT02999022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607989|NCT02911935|Azithromycin|azithromycin|mesh-list
24607990|NCT02911935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24607991|NCT02911935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24607992|NCT02874742|Dexamethasone|dexamethasone|mesh-list
24607993|NCT02874742|Lenalidomide|lenalidomide|mesh-list
24607995|NCT02874742|Daratumumab|daratumumab|mesh-list
24607996|NCT02874742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24607997|NCT02874742|Antiemetics|antiemetics|mesh-ancestor
24607998|NCT02874742|Autonomic Agents|autonomic agents|mesh-ancestor
24607999|NCT02874742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24608000|NCT02874742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608001|NCT02874742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24608002|NCT02874742|Glucocorticoids|glucocorticoids|mesh-ancestor
24608003|NCT02874742|Hormones|hormones|mesh-ancestor
24657194|NCT01266174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608004|NCT02874742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24608005|NCT02874742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24608006|NCT02874742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608007|NCT02874742|Immunologic Factors|immunologic factors|mesh-ancestor
24671310|NCT01324635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671311|NCT01324739|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24671312|NCT01324739|Natriuretic Agents|natriuretic agents|mesh-ancestor
24671313|NCT01324739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671314|NCT01324752|Losartan|losartan|mesh-list
24671315|NCT01324752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24671320|NCT01324843|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24671321|NCT01324843|Anesthetics, Local|anesthetics, local|mesh-ancestor
24671322|NCT01324843|Anesthetics|anesthetics|mesh-ancestor
24671323|NCT01324843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24671324|NCT01324843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671325|NCT01324843|Sensory System Agents|sensory system agents|mesh-ancestor
24671326|NCT01324843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25694542|NCT02032212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694543|NCT02032407|Dapsone|dapsone|mesh-list
25694544|NCT02032407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25694545|NCT02032407|Antimalarials|antimalarials|mesh-ancestor
25694546|NCT02032407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25694547|NCT02032407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25694548|NCT02032407|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25694549|NCT02032407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25694550|NCT02032407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694551|NCT02032407|Leprostatic Agents|leprostatic agents|mesh-ancestor
25694552|NCT02032407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25694553|NCT02032433|Naltrexone|naltrexone|mesh-list
25694554|NCT02032433|Buprenorphine|buprenorphine|mesh-list
24781527|NCT01890200|Ribavirin|ribavirin|mesh-list
25103842|NCT03158025|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24969708|NCT03740516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24955215|NCT03866993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610030|NCT00999505|Amantadine|amantadine|mesh-list
24608016|NCT02644525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608017|NCT02644525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24608018|NCT02644525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608019|NCT02644525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608020|NCT02618577|Edoxaban|edoxaban|mesh-list
24853590|NCT02269072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853591|NCT02269072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24853592|NCT02269072|Hormone Antagonists|hormone antagonists|mesh-ancestor
24853593|NCT02269072|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24853594|NCT02269072|Fertility Agents|fertility agents|mesh-ancestor
24853595|NCT02269072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24853596|NCT02269072|Natriuretic Agents|natriuretic agents|mesh-ancestor
24853597|NCT02269176|Losartan|losartan|mesh-list
24853598|NCT02269176|Telmisartan|telmisartan|mesh-list
24675283|NCT00871351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24853599|NCT02269176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24608021|NCT02618577|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24543843|NCT00685646|Hormone Antagonists|hormone antagonists|mesh-ancestor
24543844|NCT00685646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24543845|NCT00685672|Epinephrine|epinephrine|mesh-list
24543846|NCT00685672|Racepinephrine|racepinephrine|mesh-list
24543847|NCT00685672|Epinephryl borate|epinephryl borate|mesh-list
24608073|NCT02379247|Tubulin Modulators|tubulin modulators|mesh-ancestor
24608074|NCT02379247|Antimitotic Agents|antimitotic agents|mesh-ancestor
24608075|NCT02379247|Mitosis Modulators|mitosis modulators|mesh-ancestor
24608076|NCT02379247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608078|NCT02360280|Ketamine|ketamine|mesh-list
24608079|NCT02360280|Analgesics|analgesics|mesh-ancestor
24608080|NCT02360280|Sensory System Agents|sensory system agents|mesh-ancestor
24608081|NCT02360280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24608082|NCT02360280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637123|NCT01148901|Infliximab|infliximab|mesh-list
24608083|NCT02360280|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24608084|NCT02360280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24608085|NCT02360280|Anesthetics, General|anesthetics, general|mesh-ancestor
24608086|NCT02360280|Anesthetics|anesthetics|mesh-ancestor
24608087|NCT02360280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24608088|NCT02360280|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24608144|NCT02096588|Simvastatin|simvastatin|mesh-list
24853613|NCT02269202|Anesthetics, General|anesthetics, general|mesh-ancestor
24853615|NCT02269202|GABA Modulators|gaba modulators|mesh-ancestor
24853616|NCT02269202|GABA Agents|gaba agents|mesh-ancestor
24853617|NCT02269202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24853618|NCT02269202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853619|NCT02269228|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
24608170|NCT02044497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24608171|NCT02007655|Apixaban|apixaban|mesh-list
24608172|NCT02007655|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24608173|NCT02007655|Antithrombins|antithrombins|mesh-ancestor
24608174|NCT02007655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24608175|NCT02007655|Protease Inhibitors|protease inhibitors|mesh-ancestor
24608176|NCT02007655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608190|NCT01965704|Ondansetron|ondansetron|mesh-list
24608191|NCT01965704|Antiemetics|antiemetics|mesh-ancestor
24608212|NCT01664182|Endothelial Growth Factors|endothelial growth factors|mesh-list
24608213|NCT01664182|Antibodies|antibodies|mesh-list
24608214|NCT01664182|Immunoglobulins|immunoglobulins|mesh-list
24608215|NCT01664182|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24608216|NCT01664182|Immunoglobulin G|immunoglobulin g|mesh-list
24608217|NCT01664182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608218|NCT01664182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24608219|NCT01664182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24608220|NCT01664182|Growth Substances|growth substances|mesh-ancestor
24608221|NCT01664182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608235|NCT01661881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24853626|NCT02269280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24853627|NCT02269280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25694555|NCT02032433|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25694556|NCT02032433|Naloxone|naloxone|mesh-list
25694557|NCT02032433|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24905018|NCT04351412|Fluorides|fluorides|mesh-list
24853628|NCT02269293|Paclitaxel|paclitaxel|mesh-list
24853629|NCT02269293|Carboplatin|carboplatin|mesh-list
24853630|NCT02269293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24608236|NCT01661881|Antimetabolites|antimetabolites|mesh-ancestor
24608237|NCT01661881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608238|NCT01661881|Antiviral Agents|antiviral agents|mesh-ancestor
24608239|NCT01661881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24608240|NCT01661881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24608258|NCT01646814|Antipyretics|antipyretics|mesh-ancestor
24608259|NCT01621568|Sunitinib|sunitinib|mesh-list
24608282|NCT00775684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608283|NCT00775684|Incretins|incretins|mesh-ancestor
24608536|NCT00992472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24608285|NCT00775684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24608286|NCT00775684|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24608287|NCT00775684|Protease Inhibitors|protease inhibitors|mesh-ancestor
24608288|NCT00775684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608289|NCT00775684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608290|NCT00775684|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24608291|NCT00775684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24608292|NCT00775684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24608293|NCT00775684|Immunologic Factors|immunologic factors|mesh-ancestor
24608325|NCT00991848|Lidocaine|lidocaine|mesh-list
24608326|NCT00991848|Anesthetics, Local|anesthetics, local|mesh-ancestor
24608327|NCT00991848|Anesthetics|anesthetics|mesh-ancestor
24608328|NCT00991848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24853631|NCT02269293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24853632|NCT02269293|Tubulin Modulators|tubulin modulators|mesh-ancestor
24853633|NCT02269293|Antimitotic Agents|antimitotic agents|mesh-ancestor
24608334|NCT00991848|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24608335|NCT00991848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24608375|NCT00992030|Alkylating Agents|alkylating agents|mesh-ancestor
24608376|NCT00992030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24608377|NCT00992030|Tubulin Modulators|tubulin modulators|mesh-ancestor
24608378|NCT00992030|Antimitotic Agents|antimitotic agents|mesh-ancestor
24608379|NCT00992030|Mitosis Modulators|mitosis modulators|mesh-ancestor
24608381|NCT00992069|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24608382|NCT00992069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24608383|NCT00992069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608384|NCT00992069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608385|NCT00992069|Antiviral Agents|antiviral agents|mesh-ancestor
24608386|NCT00992069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24608387|NCT00992069|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24608388|NCT00992069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24608389|NCT00992069|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24608390|NCT00992069|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24608391|NCT00992069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24608392|NCT00992069|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24608393|NCT00992082|Ketorolac|ketorolac|mesh-list
24671331|NCT01324960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24671333|NCT01324960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671334|NCT01324960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608471|NCT00992199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608472|NCT00992199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24608473|NCT00992199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24608474|NCT00992199|Immunologic Factors|immunologic factors|mesh-ancestor
24608475|NCT00992199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608477|NCT00992238|Parasympatholytics|parasympatholytics|mesh-ancestor
24608478|NCT00992238|Autonomic Agents|autonomic agents|mesh-ancestor
24608479|NCT00992238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24853643|NCT02269358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24853644|NCT02269358|Abortifacient Agents|abortifacient agents|mesh-ancestor
24853645|NCT02269358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24853646|NCT02269358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853647|NCT02269358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24853648|NCT02269358|Antimetabolites|antimetabolites|mesh-ancestor
24853649|NCT02269358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694558|NCT02032433|Narcotics|narcotics|mesh-ancestor
25103961|NCT03156439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103962|NCT03156439|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25103963|NCT03156439|Protective Agents|protective agents|mesh-ancestor
25103964|NCT03156452|Mycophenolic Acid|mycophenolic acid|mesh-list
24468715|NCT00382954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24468716|NCT00382954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25103965|NCT03156452|Prednisolone|prednisolone|mesh-list
24853650|NCT02269358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24853651|NCT02269358|Dermatologic Agents|dermatologic agents|mesh-ancestor
24853652|NCT02269358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24853653|NCT02269358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24853654|NCT02269358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24853655|NCT02269358|Immunologic Factors|immunologic factors|mesh-ancestor
24608480|NCT00992238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608481|NCT00992238|Urological Agents|urological agents|mesh-ancestor
24608482|NCT00992329|Ciprofloxacin|ciprofloxacin|mesh-list
24608483|NCT00992329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24608484|NCT00992329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24608485|NCT00992329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24608486|NCT00992329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24608534|NCT00992472|Antiemetics|antiemetics|mesh-ancestor
24608535|NCT00992472|Autonomic Agents|autonomic agents|mesh-ancestor
24609646|NCT00997659|Micronutrients|micronutrients|mesh-ancestor
24853660|NCT02269462|Efavirenz|efavirenz|mesh-list
24853661|NCT02269462|Nevirapine|nevirapine|mesh-list
24853662|NCT02269462|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24853663|NCT02269462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24853664|NCT02269462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24853665|NCT02269462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853666|NCT02269462|Antiviral Agents|antiviral agents|mesh-ancestor
24608538|NCT00992472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24608539|NCT00992472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24608540|NCT00992472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24608541|NCT00992472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24608542|NCT00992472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24608543|NCT00992472|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24608544|NCT00992472|Dopamine Agents|dopamine agents|mesh-ancestor
24455566|NCT00327808|Budesonide|budesonide|mesh-list
24608553|NCT00992524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24608554|NCT00992524|Oxytocics|oxytocics|mesh-ancestor
24608555|NCT00992537|Insulin|insulin|mesh-list
24608556|NCT00992537|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24608557|NCT00992537|Insulin Aspart|insulin aspart|mesh-list
24608561|NCT00992537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608562|NCT00992576|Hydromorphone|hydromorphone|mesh-list
24608563|NCT00992576|Naloxone|naloxone|mesh-list
24608564|NCT00992576|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24608565|NCT00992576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608566|NCT00992576|Sensory System Agents|sensory system agents|mesh-ancestor
24608567|NCT00992576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24608572|NCT00992654|Maraviroc|maraviroc|mesh-list
24608575|NCT00992654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608576|NCT00992654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24608577|NCT00992654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24608578|NCT00992654|Antiviral Agents|antiviral agents|mesh-ancestor
24608579|NCT00992654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446792|NCT00305903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608581|NCT00992667|Acetovanillone|acetovanillone|mesh-list
24608582|NCT00992667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24608583|NCT00992667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24608584|NCT00992667|Analgesics|analgesics|mesh-ancestor
24608585|NCT00992667|Sensory System Agents|sensory system agents|mesh-ancestor
24608586|NCT00992667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25694559|NCT02032433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25694560|NCT02032433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694561|NCT02032433|Analgesics|analgesics|mesh-ancestor
25694562|NCT02032433|Sensory System Agents|sensory system agents|mesh-ancestor
25694563|NCT02032433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25694564|NCT02032433|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25694565|NCT02032433|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24608587|NCT00992667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608588|NCT00992667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24608589|NCT00992667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24608590|NCT00992667|Antioxidants|antioxidants|mesh-ancestor
24608591|NCT00992667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694566|NCT02032758|Propranolol|propranolol|mesh-list
24608592|NCT00992667|Protective Agents|protective agents|mesh-ancestor
25027651|NCT03618173|Dexamethasone|dexamethasone|mesh-list
24853667|NCT02269462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24853668|NCT02269462|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24853669|NCT02269462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24853670|NCT02269462|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24853671|NCT02269462|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24853672|NCT02269462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24608593|NCT00992667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608664|NCT00992914|Lidocaine|lidocaine|mesh-list
24608665|NCT00992914|Anesthetics, Local|anesthetics, local|mesh-ancestor
24608666|NCT00992914|Anesthetics|anesthetics|mesh-ancestor
24608667|NCT00992914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24608668|NCT00992914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608669|NCT00992914|Sensory System Agents|sensory system agents|mesh-ancestor
24608670|NCT00992914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24608671|NCT00992914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24608672|NCT00992914|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24608673|NCT00992914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24608674|NCT00992914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24608675|NCT00992914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608676|NCT00993057|Insulin|insulin|mesh-list
24608677|NCT00993057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24608678|NCT00993057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608679|NCT00993070|Capsaicin|capsaicin|mesh-list
24608680|NCT00993070|Antipruritics|antipruritics|mesh-ancestor
24853673|NCT02269462|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24853674|NCT02269462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24853675|NCT02269462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24608704|NCT00993109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608706|NCT00993109|Tocolytic Agents|tocolytic agents|mesh-ancestor
24608707|NCT00993109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24608708|NCT00993122|Ribavirin|ribavirin|mesh-list
24608709|NCT00993122|Antimetabolites|antimetabolites|mesh-ancestor
24608736|NCT00993343|Sirolimus|sirolimus|mesh-list
24608756|NCT00993343|Antifungal Agents|antifungal agents|mesh-ancestor
24853679|NCT02269514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24853680|NCT02269514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853681|NCT02269514|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24853682|NCT02269514|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24608757|NCT00993343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24608758|NCT00993343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24608759|NCT00993343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24608760|NCT00993356|Lanreotide|lanreotide|mesh-list
24608761|NCT00993356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608762|NCT00993408|Selexipag|selexipag|mesh-list
24608763|NCT00993408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24608764|NCT00993512|Bleomycin|bleomycin|mesh-list
24608765|NCT00993512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24608766|NCT00993512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608767|NCT00993525|Ranibizumab|ranibizumab|mesh-list
24608768|NCT00993525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24608769|NCT00993525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24608770|NCT00993525|Growth Substances|growth substances|mesh-ancestor
24608771|NCT00993525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608772|NCT00993525|Growth Inhibitors|growth inhibitors|mesh-ancestor
24608773|NCT00993525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608774|NCT00993642|Panobinostat|panobinostat|mesh-list
24608775|NCT00993642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608776|NCT00993642|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24608777|NCT00993642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608803|NCT00993720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24608804|NCT00993733|Dialysis Solutions|dialysis solutions|mesh-list
24853684|NCT02269514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24853685|NCT02269514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853686|NCT02269540|Acetylcysteine|acetylcysteine|mesh-list
24608862|NCT00994097|Pemetrexed|pemetrexed|mesh-list
24608863|NCT00994097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608864|NCT00994097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24608865|NCT00994097|Antimetabolites|antimetabolites|mesh-ancestor
25694567|NCT02032758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25694568|NCT02032758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24608866|NCT00994097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608868|NCT00994097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24608869|NCT00994097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608870|NCT00994097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24608923|NCT00994396|Micronutrients|micronutrients|mesh-ancestor
24608924|NCT00994396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608925|NCT00994396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24608926|NCT00994396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24608927|NCT00994500|Bortezomib|bortezomib|mesh-list
24608928|NCT00994500|Vorinostat|vorinostat|mesh-list
24608939|NCT00994513|Vitamins|vitamins|mesh-ancestor
24608940|NCT00994513|Micronutrients|micronutrients|mesh-ancestor
24608941|NCT00994526|Vitamin E|vitamin e|mesh-list
24608942|NCT00994526|Calcium|calcium|mesh-list
24608943|NCT00994526|Vitamins|vitamins|mesh-ancestor
24608944|NCT00994526|Micronutrients|micronutrients|mesh-ancestor
24608945|NCT00994526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608946|NCT00994526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24608947|NCT00994526|Antioxidants|antioxidants|mesh-ancestor
24608948|NCT00994526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853690|NCT02269540|Antiviral Agents|antiviral agents|mesh-ancestor
24853691|NCT02269540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24608961|NCT00994617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24672268|NCT01331135|Antifungal Agents|antifungal agents|mesh-ancestor
24608962|NCT00994617|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24608963|NCT00994617|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24608996|NCT00994773|Entecavir|entecavir|mesh-list
24608997|NCT00994773|Simvastatin|simvastatin|mesh-list
24608998|NCT00994773|Antiviral Agents|antiviral agents|mesh-ancestor
24609002|NCT00994773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609003|NCT00994773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609004|NCT00994773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24609005|NCT00994773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24609006|NCT00994773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24609007|NCT00994773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24609008|NCT00994773|Antimetabolites|antimetabolites|mesh-ancestor
24609009|NCT00994773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24609010|NCT00994773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24609012|NCT00994786|Analgesics|analgesics|mesh-ancestor
24609013|NCT00994786|Sensory System Agents|sensory system agents|mesh-ancestor
24609014|NCT00994786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24609015|NCT00994786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609016|NCT00994786|Anticonvulsants|anticonvulsants|mesh-ancestor
24609017|NCT00994786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24609018|NCT00994786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24609019|NCT00994786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609020|NCT00994786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24609021|NCT00994786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24609022|NCT00994786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24609042|NCT00994825|Protective Agents|protective agents|mesh-ancestor
24609043|NCT00994825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609044|NCT00994903|Simvastatin|simvastatin|mesh-list
24609045|NCT00994903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24609046|NCT00994903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24609047|NCT00994903|Antimetabolites|antimetabolites|mesh-ancestor
24609048|NCT00994903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609049|NCT00994903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24609050|NCT00994903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24609051|NCT00994903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609052|NCT00994916|Amifampridine|amifampridine|mesh-list
24609072|NCT00994968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24609073|NCT00994968|Immunologic Factors|immunologic factors|mesh-ancestor
24609074|NCT00994968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609075|NCT00994968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24609076|NCT00994968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24853692|NCT02269540|Expectorants|expectorants|mesh-ancestor
24853693|NCT02269540|Respiratory System Agents|respiratory system agents|mesh-ancestor
24853694|NCT02269540|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24853695|NCT02269540|Antioxidants|antioxidants|mesh-ancestor
24853696|NCT02269540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853697|NCT02269540|Protective Agents|protective agents|mesh-ancestor
24853698|NCT02269540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853700|NCT02269540|Antidepressive Agents|antidepressive agents|mesh-ancestor
24853701|NCT02269540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24456497|NCT00331487|Pioglitazone|pioglitazone|mesh-list
24609077|NCT00994968|Alkylating Agents|alkylating agents|mesh-ancestor
24609078|NCT00994968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609109|NCT00994994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609111|NCT00994994|Coagulants|coagulants|mesh-ancestor
24609112|NCT00994994|Antidepressive Agents|antidepressive agents|mesh-ancestor
24609113|NCT00994994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24609114|NCT00994994|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24609115|NCT00994994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609228|NCT00995618|Gout Suppressants|gout suppressants|mesh-ancestor
24609229|NCT00995618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24853702|NCT02269540|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24853703|NCT02269540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24853704|NCT02269540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24853705|NCT02269540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24853706|NCT02269540|Serotonin Agents|serotonin agents|mesh-ancestor
24853707|NCT02269540|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24853708|NCT02269605|Bryostatin 1|bryostatin 1|mesh-list
24853709|NCT02269605|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24853710|NCT02269605|Immunologic Factors|immunologic factors|mesh-ancestor
24853711|NCT02269605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853712|NCT02269605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24853713|NCT02269644|Azithromycin|azithromycin|mesh-list
24853714|NCT02269644|Linezolid|linezolid|mesh-list
24609230|NCT00995618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24609231|NCT00995618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24609251|NCT00995657|Autonomic Agents|autonomic agents|mesh-ancestor
24609252|NCT00995657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24609253|NCT00995657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609254|NCT00995657|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24609255|NCT00995657|Respiratory System Agents|respiratory system agents|mesh-ancestor
24609256|NCT00995657|Dermatologic Agents|dermatologic agents|mesh-ancestor
24609257|NCT00995657|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24609258|NCT00995800|Fluticasone|fluticasone|mesh-list
24609259|NCT00995800|Xhance|xhance|mesh-list
24609260|NCT00995800|Formoterol Fumarate|formoterol fumarate|mesh-list
24609261|NCT00995800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24609262|NCT00995800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24609263|NCT00995800|Autonomic Agents|autonomic agents|mesh-ancestor
24609264|NCT00995800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24609265|NCT00995800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853715|NCT02269644|Dalbavancin|dalbavancin|mesh-list
24853716|NCT02269644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24853717|NCT02269644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24853718|NCT02269644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24853719|NCT02269644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24853720|NCT02269644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609319|NCT00996021|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24609320|NCT00996021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25027872|NCT03616236|Naloxone|naloxone|mesh-list
24609344|NCT00996151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24609345|NCT00996151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609348|NCT00996177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24609349|NCT00996177|Narcotics|narcotics|mesh-ancestor
24609350|NCT00996177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24609351|NCT00996177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609352|NCT00996177|Analgesics|analgesics|mesh-ancestor
24609353|NCT00996177|Sensory System Agents|sensory system agents|mesh-ancestor
24609354|NCT00996177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24609355|NCT00996177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24609356|NCT00996177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24609427|NCT00996697|Tiotropium Bromide|tiotropium bromide|mesh-list
24609428|NCT00996697|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24609429|NCT00996697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24609430|NCT00996697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24609431|NCT00996697|Autonomic Agents|autonomic agents|mesh-ancestor
24609506|NCT00997009|Antimitotic Agents|antimitotic agents|mesh-ancestor
24609507|NCT00997009|Mitosis Modulators|mitosis modulators|mesh-ancestor
24609508|NCT00997009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609509|NCT00997009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24609510|NCT00997022|Sorafenib|sorafenib|mesh-list
24609511|NCT00997022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609543|NCT00997191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24609544|NCT00997191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609545|NCT00997191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24609587|NCT00997412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609588|NCT00997412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24609589|NCT00997412|Antitubercular Agents|antitubercular agents|mesh-ancestor
24609590|NCT00997412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24609591|NCT00997412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24609592|NCT00997412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609593|NCT00997412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853722|NCT02269696|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24853723|NCT02269696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24853725|NCT02269696|Autonomic Agents|autonomic agents|mesh-ancestor
24853726|NCT02269696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24853727|NCT02269696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853728|NCT02269696|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24853729|NCT02269696|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24853730|NCT02269696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24853734|NCT02269735|Insulin|insulin|mesh-list
24609645|NCT00997659|Trace Elements|trace elements|mesh-ancestor
24609647|NCT00997659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609648|NCT00997659|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24609649|NCT00997659|Chelating Agents|chelating agents|mesh-ancestor
24609650|NCT00997659|Sequestering Agents|sequestering agents|mesh-ancestor
24609651|NCT00997659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609652|NCT00997685|Capecitabine|capecitabine|mesh-list
24609653|NCT00997685|Oxaliplatin|oxaliplatin|mesh-list
24610054|NCT00999700|Mitosis Modulators|mitosis modulators|mesh-ancestor
24609654|NCT00997685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24609655|NCT00997685|Antimetabolites|antimetabolites|mesh-ancestor
24609656|NCT00997685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609657|NCT00997685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609658|NCT00997711|Sirolimus|sirolimus|mesh-list
24853738|NCT02269735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24853739|NCT02269735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609659|NCT00997711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24609660|NCT00997711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24609661|NCT00997711|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24671378|NCT01325259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24671379|NCT01325259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609672|NCT00997750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24609673|NCT00997750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609674|NCT00997750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24609675|NCT00997750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24609736|NCT00997997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24609737|NCT00997997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24609738|NCT00997997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24609739|NCT00997997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24609741|NCT00997997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609755|NCT00998036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609756|NCT00998036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609757|NCT00998036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24609758|NCT00998036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24609759|NCT00998036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24609760|NCT00998036|Antifungal Agents|antifungal agents|mesh-ancestor
24609761|NCT00998036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24609762|NCT00998036|Immunologic Factors|immunologic factors|mesh-ancestor
24609763|NCT00998036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609764|NCT00998075|Aspirin|aspirin|mesh-list
24609765|NCT00998075|Esomeprazole|esomeprazole|mesh-list
24609766|NCT00998075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24609767|NCT00998075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24609768|NCT00998075|Analgesics|analgesics|mesh-ancestor
24609769|NCT00998075|Sensory System Agents|sensory system agents|mesh-ancestor
24609770|NCT00998075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955359|NCT03865160|Atropine|atropine|mesh-list
24609771|NCT00998075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609772|NCT00998075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24609773|NCT00998075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24609774|NCT00998075|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24609775|NCT00998075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24609776|NCT00998075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609777|NCT00998075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24609778|NCT00998075|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24609779|NCT00998075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609780|NCT00998075|Antipyretics|antipyretics|mesh-ancestor
24609801|NCT00998166|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24609802|NCT00998166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24609803|NCT00998192|Paclitaxel|paclitaxel|mesh-list
24609806|NCT00998192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609807|NCT00998192|Tubulin Modulators|tubulin modulators|mesh-ancestor
24609808|NCT00998192|Antimitotic Agents|antimitotic agents|mesh-ancestor
24609809|NCT00998192|Mitosis Modulators|mitosis modulators|mesh-ancestor
24609810|NCT00998192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609811|NCT00998218|Ranolazine|ranolazine|mesh-list
24609812|NCT00998218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24609813|NCT00998218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24609814|NCT00998218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609815|NCT00998283|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
24609816|NCT00998283|Immunologic Factors|immunologic factors|mesh-ancestor
24609817|NCT00998283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609818|NCT00998322|Gemcitabine|gemcitabine|mesh-list
24610443|NCT01002092|Endostar protein|endostar protein|mesh-list
24609837|NCT00998504|Antioxidants|antioxidants|mesh-ancestor
24853910|NCT02270827|Protective Agents|protective agents|mesh-ancestor
24609838|NCT00998504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609839|NCT00998504|Protective Agents|protective agents|mesh-ancestor
24609840|NCT00998504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609841|NCT00998504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609842|NCT00998504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24609844|NCT00998556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24609845|NCT00998556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24609846|NCT00998556|Hormone Antagonists|hormone antagonists|mesh-ancestor
24609847|NCT00998556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24609871|NCT00998634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24609872|NCT00998634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24609873|NCT00998634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609874|NCT00998686|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24609913|NCT00998972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24609914|NCT00998972|Expectorants|expectorants|mesh-ancestor
24609915|NCT00998972|Respiratory System Agents|respiratory system agents|mesh-ancestor
24609916|NCT00998972|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24609917|NCT00998972|Antioxidants|antioxidants|mesh-ancestor
24609918|NCT00998972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609920|NCT00998972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609921|NCT00998972|Antidotes|antidotes|mesh-ancestor
24609922|NCT00999128|Rabeprazole|rabeprazole|mesh-list
24609923|NCT00999128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24609924|NCT00999128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24609925|NCT00999128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24853748|NCT02269904|Antimetabolites|antimetabolites|mesh-ancestor
24853749|NCT02269904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853750|NCT02269904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24853751|NCT02269904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24853752|NCT02269904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24853753|NCT02269904|Immunologic Factors|immunologic factors|mesh-ancestor
24609926|NCT00999128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609927|NCT00999128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609928|NCT00999180|Botulinum Toxins|botulinum toxins|mesh-list
24609929|NCT00999180|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24609930|NCT00999180|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24609931|NCT00999180|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24393178|NCT00129038|Analgesics|analgesics|mesh-ancestor
24637304|NCT01149798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24609932|NCT00999180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24609933|NCT00999180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609947|NCT00999219|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24609948|NCT00999219|GABA Agonists|gaba agonists|mesh-ancestor
24609963|NCT00999258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24609982|NCT00999297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609983|NCT00999336|Betrixaban|betrixaban|mesh-list
24609984|NCT00999336|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24609985|NCT00999336|Antithrombins|antithrombins|mesh-ancestor
25104533|NCT03152474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24907809|NCT04327427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24908108|NCT04324476|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24908255|NCT04322175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24908256|NCT04322175|Analgesics|analgesics|mesh-ancestor
24908257|NCT04322175|Sensory System Agents|sensory system agents|mesh-ancestor
24609986|NCT00999336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24609987|NCT00999336|Protease Inhibitors|protease inhibitors|mesh-ancestor
24609988|NCT00999336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609989|NCT00999336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609990|NCT00999336|Anticoagulants|anticoagulants|mesh-ancestor
24609991|NCT00999349|Silymarin|silymarin|mesh-list
24609992|NCT00999349|Antioxidants|antioxidants|mesh-ancestor
24609993|NCT00999349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609994|NCT00999349|Protective Agents|protective agents|mesh-ancestor
24609995|NCT00999349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609996|NCT00999427|Povidone-Iodine|povidone-iodine|mesh-list
24609997|NCT00999427|Povidone|povidone|mesh-list
24609998|NCT00999427|Plasma Substitutes|plasma substitutes|mesh-ancestor
24609999|NCT00999427|Blood Substitutes|blood substitutes|mesh-ancestor
24610000|NCT00999427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24610001|NCT00999427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24610002|NCT00999440|Methadone|methadone|mesh-list
24610003|NCT00999440|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24610004|NCT00999440|Narcotics|narcotics|mesh-ancestor
24853754|NCT02269904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675376|NCT00442897|Ezetimibe|ezetimibe|mesh-list
24853755|NCT02269969|Tobramycin|tobramycin|mesh-list
24853756|NCT02269969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24853757|NCT02269969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24853758|NCT02270281|Dexmedetomidine|dexmedetomidine|mesh-list
24853759|NCT02270281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24853760|NCT02270281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24853761|NCT02270281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610042|NCT00999505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24610043|NCT00999557|Bimatoprost|bimatoprost|mesh-list
24610044|NCT00999557|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24610051|NCT00999700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610052|NCT00999700|Tubulin Modulators|tubulin modulators|mesh-ancestor
24610053|NCT00999700|Antimitotic Agents|antimitotic agents|mesh-ancestor
24456560|NCT00331708|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24853765|NCT02270281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24853766|NCT02270281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24853767|NCT02270281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24853768|NCT02270281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24853769|NCT02270281|Adrenergic Agents|adrenergic agents|mesh-ancestor
24853770|NCT02270281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24853771|NCT02270281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853772|NCT02270307|Cyclophosphamide|cyclophosphamide|mesh-list
24853773|NCT02270307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24853774|NCT02270307|Immunologic Factors|immunologic factors|mesh-ancestor
24853775|NCT02270307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853776|NCT02270307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24853777|NCT02270307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24853778|NCT02270307|Alkylating Agents|alkylating agents|mesh-ancestor
24670452|NCT02567825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610065|NCT00999739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610066|NCT00999752|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24610068|NCT00999752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24610069|NCT00999752|Diuretics|diuretics|mesh-ancestor
24610070|NCT00999752|Natriuretic Agents|natriuretic agents|mesh-ancestor
24610071|NCT00999752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610072|NCT00999752|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24610073|NCT00999752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24610074|NCT00999752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610075|NCT00999752|Vasodilator Agents|vasodilator agents|mesh-ancestor
24610076|NCT00999752|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25694569|NCT02032758|Adrenergic Agents|adrenergic agents|mesh-ancestor
25694570|NCT02032758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25694571|NCT02032758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694572|NCT02032758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694573|NCT02032758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24610077|NCT00999752|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24610083|NCT00999791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24909213|NCT04312061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909214|NCT04312061|Analgesics|analgesics|mesh-ancestor
24909215|NCT04312061|Sensory System Agents|sensory system agents|mesh-ancestor
24909216|NCT04312061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25104649|NCT03151681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104652|NCT03151681|Vasodilator Agents|vasodilator agents|mesh-ancestor
24610084|NCT00999791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610085|NCT00999791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24672478|NCT01332370|Rosiglitazone|rosiglitazone|mesh-list
24853779|NCT02270307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853781|NCT02270307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24853782|NCT02270424|Fluticasone|fluticasone|mesh-list
24853783|NCT02270424|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24853784|NCT02270424|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24853785|NCT02270424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24853786|NCT02270424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24853787|NCT02270424|Autonomic Agents|autonomic agents|mesh-ancestor
24853788|NCT02270424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24853789|NCT02270424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853790|NCT02270424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24853791|NCT02270424|Respiratory System Agents|respiratory system agents|mesh-ancestor
24853792|NCT02270424|Dermatologic Agents|dermatologic agents|mesh-ancestor
24853793|NCT02270424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24853794|NCT02270424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24853795|NCT02270424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24853796|NCT02270424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24853797|NCT02270424|Adrenergic Agents|adrenergic agents|mesh-ancestor
24853798|NCT02270424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24853815|NCT02270437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24853816|NCT02270437|Narcotics|narcotics|mesh-ancestor
24610111|NCT00999843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610112|NCT00999843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610113|NCT00999869|Triamcinolone|triamcinolone|mesh-list
24610114|NCT00999869|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24610115|NCT00999869|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24610116|NCT00999869|Botulinum Toxins|botulinum toxins|mesh-list
24610117|NCT00999869|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24610118|NCT00999869|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24671393|NCT01325415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24853916|NCT02270918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671394|NCT01325415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671395|NCT01325415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24671396|NCT01325415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671397|NCT01325415|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24637315|NCT01149824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24671398|NCT01325415|Sensory System Agents|sensory system agents|mesh-ancestor
24671399|NCT01325415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24671400|NCT01325558|Gemcitabine|gemcitabine|mesh-list
24671401|NCT01325558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24393256|NCT00129298|Tiagabine|tiagabine|mesh-list
24671402|NCT01325558|Antimetabolites|antimetabolites|mesh-ancestor
24671403|NCT01325558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671404|NCT01325558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24671432|NCT01325818|Pravastatin|pravastatin|mesh-list
24610198|NCT01000545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610200|NCT01000545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24610201|NCT01000545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24610202|NCT01000545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24610203|NCT01000545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610204|NCT01000597|Fluticasone|fluticasone|mesh-list
24610223|NCT01000623|Antidepressive Agents|antidepressive agents|mesh-ancestor
24610224|NCT01000623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24610225|NCT01000688|Vildagliptin|vildagliptin|mesh-list
24610226|NCT01000688|Acarbose|acarbose|mesh-list
24610227|NCT01000688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25694574|NCT02032758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25694575|NCT02032758|Vasodilator Agents|vasodilator agents|mesh-ancestor
25694576|NCT02032875|Ribavirin|ribavirin|mesh-list
25694577|NCT02032875|Sofosbuvir|sofosbuvir|mesh-list
25694578|NCT02032875|Antimetabolites|antimetabolites|mesh-ancestor
25694579|NCT02032875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694580|NCT02032875|Antiviral Agents|antiviral agents|mesh-ancestor
25104734|NCT03151369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25104735|NCT03151213|Pregabalin|pregabalin|mesh-list
25104736|NCT03151213|Analgesics|analgesics|mesh-ancestor
24610228|NCT01000688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610229|NCT01000688|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24610230|NCT01000688|Protease Inhibitors|protease inhibitors|mesh-ancestor
24610231|NCT01000688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610232|NCT01000688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610233|NCT01000688|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24610234|NCT01000779|Propranolol|propranolol|mesh-list
24610235|NCT01000779|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24610236|NCT01000779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24610237|NCT01000779|Adrenergic Agents|adrenergic agents|mesh-ancestor
24610238|NCT01000779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24610239|NCT01000779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610240|NCT01000779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610241|NCT01000779|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24610242|NCT01000779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24610243|NCT01000779|Vasodilator Agents|vasodilator agents|mesh-ancestor
24610245|NCT01000792|Levocetirizine|levocetirizine|mesh-list
24610246|NCT01000792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24610293|NCT01001130|Dermatologic Agents|dermatologic agents|mesh-ancestor
24610294|NCT01001130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24610295|NCT01001143|Decitabine|decitabine|mesh-list
24610296|NCT01001143|Bexarotene|bexarotene|mesh-list
24610297|NCT01001143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24610298|NCT01001143|Antimetabolites|antimetabolites|mesh-ancestor
24610299|NCT01001143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610300|NCT01001143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610301|NCT01001143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610302|NCT01001247|Rilpivirine|rilpivirine|mesh-list
24610303|NCT01001247|Omeprazole|omeprazole|mesh-list
24610304|NCT01001247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24610305|NCT01001247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24610306|NCT01001247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24610307|NCT01001247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610308|NCT01001247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610330|NCT01001260|Antipyretics|antipyretics|mesh-ancestor
24610331|NCT01001364|Budesonide|budesonide|mesh-list
24610332|NCT01001364|Formoterol Fumarate|formoterol fumarate|mesh-list
24610333|NCT01001364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24610334|NCT01001364|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24610335|NCT01001364|Autonomic Agents|autonomic agents|mesh-ancestor
24610336|NCT01001364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24610337|NCT01001364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610338|NCT01001364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24393304|NCT00129519|Imiquimod|imiquimod|mesh-list
24955437|NCT03865147|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24610339|NCT01001364|Respiratory System Agents|respiratory system agents|mesh-ancestor
24610340|NCT01001364|Glucocorticoids|glucocorticoids|mesh-ancestor
24610341|NCT01001364|Hormones|hormones|mesh-ancestor
24671474|NCT01326078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24671475|NCT01326078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24671486|NCT01326117|Urological Agents|urological agents|mesh-ancestor
24671489|NCT01326221|Antiviral Agents|antiviral agents|mesh-ancestor
24671490|NCT01326221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24671491|NCT01326221|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24671492|NCT01326221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24671493|NCT01326221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671494|NCT01326221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671495|NCT01326221|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24671496|NCT01326221|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24671497|NCT01326312|Leuprolide|leuprolide|mesh-list
24671498|NCT01326312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24671499|NCT01326312|Fertility Agents|fertility agents|mesh-ancestor
24671500|NCT01326312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24671501|NCT01326312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671502|NCT01326312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24671503|NCT01326312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694581|NCT02032875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25694582|NCT02032888|Sofosbuvir|sofosbuvir|mesh-list
25694583|NCT02032888|Antiviral Agents|antiviral agents|mesh-ancestor
24671504|NCT01326325|Ketamine|ketamine|mesh-list
24671505|NCT01326325|Analgesics|analgesics|mesh-ancestor
24671506|NCT01326325|Sensory System Agents|sensory system agents|mesh-ancestor
24671507|NCT01326325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24671508|NCT01326325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853824|NCT02270437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24853825|NCT02270437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853826|NCT02270437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24853827|NCT02270437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24671575|NCT01326585|Protease Inhibitors|protease inhibitors|mesh-ancestor
24671576|NCT01326585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671577|NCT01326585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637376|NCT01149980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24672798|NCT01333852|Metformin|metformin|mesh-list
24671619|NCT01326767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671620|NCT01326858|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
24671621|NCT01326858|Ketotifen|ketotifen|mesh-list
24671622|NCT01326858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24853834|NCT02270606|Calcium, Dietary|calcium, dietary|mesh-list
24853835|NCT02270606|Leucovorin|leucovorin|mesh-list
25028290|NCT03612219|Apatinib|apatinib|mesh-list
24853836|NCT02270606|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
24671639|NCT01326858|Antipruritics|antipruritics|mesh-ancestor
24671640|NCT01326858|Dermatologic Agents|dermatologic agents|mesh-ancestor
24671641|NCT01326871|Gemcitabine|gemcitabine|mesh-list
24671642|NCT01326871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24671665|NCT01327066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24671666|NCT01327066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24671667|NCT01327066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24671668|NCT01327066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24671669|NCT01327066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671670|NCT01327066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671671|NCT01327066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24671674|NCT01327079|Methadone|methadone|mesh-list
24671740|NCT01327469|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24671742|NCT01327469|Tubulin Modulators|tubulin modulators|mesh-ancestor
24671743|NCT01327469|Antimitotic Agents|antimitotic agents|mesh-ancestor
24671744|NCT01327469|Mitosis Modulators|mitosis modulators|mesh-ancestor
24671745|NCT01327469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455786|NCT00328965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455787|NCT00328965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24671758|NCT01327521|Epirubicin|epirubicin|mesh-list
24853837|NCT02270606|Tetrahydrofolates|tetrahydrofolates|mesh-list
24853838|NCT02270606|Fluorouracil|fluorouracil|mesh-list
24853839|NCT02270606|Oxaliplatin|oxaliplatin|mesh-list
24853840|NCT02270606|Calcium|calcium|mesh-list
24853841|NCT02270606|Levoleucovorin|levoleucovorin|mesh-list
24853842|NCT02270606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24955463|NCT03864783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24853843|NCT02270606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853844|NCT02270606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24853845|NCT02270606|Antimetabolites|antimetabolites|mesh-ancestor
24853846|NCT02270606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853847|NCT02270606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24671760|NCT01327521|Mitomycin|mitomycin|mesh-list
24671761|NCT01327521|Maleic acid|maleic acid|mesh-list
24671762|NCT01327521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24671763|NCT01327521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24671764|NCT01327521|Antimetabolites|antimetabolites|mesh-ancestor
24671765|NCT01327521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671766|NCT01327521|Antiviral Agents|antiviral agents|mesh-ancestor
24671767|NCT01327521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24610395|NCT01001780|Alkylating Agents|alkylating agents|mesh-ancestor
24671844|NCT01328145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671845|NCT01328145|Antipyretics|antipyretics|mesh-ancestor
24671846|NCT01328171|Folic Acid|folic acid|mesh-list
24671847|NCT01328171|Vitamin B Complex|vitamin b complex|mesh-list
24671848|NCT01328171|Oxaliplatin|oxaliplatin|mesh-list
24671849|NCT01328171|Irinotecan|irinotecan|mesh-list
24671850|NCT01328171|Panitumumab|panitumumab|mesh-list
24671851|NCT01328171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24671852|NCT01328171|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24671862|NCT01328223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24671863|NCT01328223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24671864|NCT01328223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671865|NCT01328223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671867|NCT01328236|Doxorubicin|doxorubicin|mesh-list
24671868|NCT01328236|Bortezomib|bortezomib|mesh-list
24671869|NCT01328236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24671870|NCT01328236|Antiemetics|antiemetics|mesh-ancestor
24671871|NCT01328236|Autonomic Agents|autonomic agents|mesh-ancestor
24671872|NCT01328236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24671873|NCT01328236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671874|NCT01328236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24671875|NCT01328236|Glucocorticoids|glucocorticoids|mesh-ancestor
24671876|NCT01328236|Hormones|hormones|mesh-ancestor
24671877|NCT01328236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24671878|NCT01328236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24671879|NCT01328236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24671882|NCT01328236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24671922|NCT01328457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24671923|NCT01328457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24671924|NCT01328457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24671925|NCT01328457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24671926|NCT01328457|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24671927|NCT01328457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673081|NCT01335321|Hylan|hylan|mesh-list
24671947|NCT01328470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24671948|NCT01328470|Protective Agents|protective agents|mesh-ancestor
24671949|NCT01328470|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24671950|NCT01328470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24671951|NCT01328470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24455999|NCT00329511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456000|NCT00329511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24671952|NCT01328652|Dexlansoprazole|dexlansoprazole|mesh-list
24671953|NCT01328652|Lansoprazole|lansoprazole|mesh-list
24671954|NCT01328652|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24671955|NCT01328652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671956|NCT01328652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671957|NCT01328652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24671958|NCT01328652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24671959|NCT01328821|Pentoxifylline|pentoxifylline|mesh-list
24671960|NCT01328821|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24955482|NCT03864666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24955483|NCT03864705|Metformin|metformin|mesh-list
24955484|NCT03864705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24955485|NCT03864705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955486|NCT03864250|Prednisone|prednisone|mesh-list
24853882|NCT02270788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24853883|NCT02270788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24672022|NCT01329289|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24672023|NCT01329289|Pasireotide|pasireotide|mesh-list
24672024|NCT01329289|BB 1101|bb 1101|mesh-list
24672081|NCT01329627|Immunologic Factors|immunologic factors|mesh-ancestor
24672082|NCT01329627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672083|NCT01329627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24672084|NCT01329627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24672085|NCT01329627|Alkylating Agents|alkylating agents|mesh-ancestor
24672086|NCT01329627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24672087|NCT01329627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24672088|NCT01329627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24672089|NCT01329627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24672090|NCT01329627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672091|NCT01329640|Paclitaxel|paclitaxel|mesh-list
24672116|NCT01329731|Cariostatic Agents|cariostatic agents|mesh-ancestor
24672117|NCT01329731|Protective Agents|protective agents|mesh-ancestor
24672118|NCT01329731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672119|NCT01329744|Mecasermin|mecasermin|mesh-list
24672120|NCT01329744|Growth Substances|growth substances|mesh-ancestor
24672121|NCT01329744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672122|NCT01329770|Vitamins|vitamins|mesh-list
24672123|NCT01329770|Ascorbic Acid|ascorbic acid|mesh-list
24672124|NCT01329770|Vitamin E|vitamin e|mesh-list
24672141|NCT01329796|Lidocaine|lidocaine|mesh-list
24672162|NCT01329887|Serotonin Agents|serotonin agents|mesh-ancestor
24672163|NCT01329887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24672216|NCT01330615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24853894|NCT02270827|Aminophylline|aminophylline|mesh-list
24853895|NCT02270827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24853896|NCT02270827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24853897|NCT02270827|Autonomic Agents|autonomic agents|mesh-ancestor
24853898|NCT02270827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24853899|NCT02270827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853900|NCT02270827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24456654|NCT00331890|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
24456655|NCT00331890|Lipotropic Agents|lipotropic agents|mesh-ancestor
24456656|NCT00331890|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24456657|NCT00331890|Antimetabolites|antimetabolites|mesh-ancestor
24456658|NCT00331890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456659|NCT00331890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24672217|NCT01330615|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24910060|NCT04302584|Norepinephrine|norepinephrine|mesh-list
24672218|NCT01330615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24672219|NCT01330615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24672220|NCT01330615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672221|NCT01330615|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24672223|NCT01330654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24672224|NCT01330654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24672225|NCT01330654|Sympatholytics|sympatholytics|mesh-ancestor
24672226|NCT01330654|Autonomic Agents|autonomic agents|mesh-ancestor
24672227|NCT01330654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24672228|NCT01330654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672229|NCT01330654|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24672230|NCT01330654|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24672231|NCT01330654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24672232|NCT01330654|Adrenergic Agents|adrenergic agents|mesh-ancestor
24672233|NCT01330654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24672234|NCT01330654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853905|NCT02270827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440037|NCT00281502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24440038|NCT00281502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24853906|NCT02270827|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24853909|NCT02270827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24456660|NCT00331890|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24456661|NCT00331890|Nootropic Agents|nootropic agents|mesh-ancestor
24456662|NCT00331955|Doxorubicin|doxorubicin|mesh-list
24401810|NCT00154050|Candesartan|candesartan|mesh-list
24610438|NCT01002079|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24393442|NCT00130065|Vitamins|vitamins|mesh-ancestor
24610474|NCT01002534|Urological Agents|urological agents|mesh-ancestor
24610476|NCT01002690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24610477|NCT01002690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24672250|NCT01330810|Sensory System Agents|sensory system agents|mesh-ancestor
24456376|NCT00331045|Alvimopan|alvimopan|mesh-list
24672251|NCT01330810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24672252|NCT01330810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672253|NCT01330810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24672255|NCT01330810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672256|NCT01330810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672257|NCT01330810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672258|NCT01330901|Ustekinumab|ustekinumab|mesh-list
24672259|NCT01330901|Dermatologic Agents|dermatologic agents|mesh-ancestor
24672260|NCT01331122|Droxidopa|droxidopa|mesh-list
24672261|NCT01331122|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24672262|NCT01331122|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24672263|NCT01331135|Sirolimus|sirolimus|mesh-list
24672264|NCT01331135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24672265|NCT01331135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24672266|NCT01331135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24672267|NCT01331135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24456666|NCT00331955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24456667|NCT00331955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24456668|NCT00331955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24456669|NCT00331955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672270|NCT01331135|Immunologic Factors|immunologic factors|mesh-ancestor
24672271|NCT01331135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672302|NCT01331434|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24672303|NCT01331434|Hormone Antagonists|hormone antagonists|mesh-ancestor
24672970|NCT01334619|Anesthetics, Local|anesthetics, local|mesh-ancestor
24672304|NCT01331434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24672305|NCT01331434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853920|NCT02270970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24853922|NCT02270970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853923|NCT02270996|Anti-Infective Agents|anti-infective agents|mesh-list
24672349|NCT01331655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24672350|NCT01331655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672351|NCT01331655|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24672352|NCT01331655|Diuretics|diuretics|mesh-ancestor
24672353|NCT01331655|Natriuretic Agents|natriuretic agents|mesh-ancestor
25709338|NCT02265341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709339|NCT02265341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709340|NCT02265510|Gemcitabine|gemcitabine|mesh-list
25709341|NCT02265510|Dexamethasone|dexamethasone|mesh-list
24485017|NCT00451113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24910452|NCT04297215|Hemostatics|hemostatics|mesh-ancestor
24910453|NCT04297215|Coagulants|coagulants|mesh-ancestor
24910454|NCT04297202|Apatinib|apatinib|mesh-list
24910455|NCT04297202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910456|NCT04297202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24910457|NCT04297202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672354|NCT01331655|Vitamin B Complex|vitamin b complex|mesh-ancestor
24672355|NCT01331655|Vitamins|vitamins|mesh-ancestor
24672356|NCT01331655|Micronutrients|micronutrients|mesh-ancestor
24672357|NCT01331707|Everolimus|everolimus|mesh-list
24456452|NCT00331149|Ropinirole|ropinirole|mesh-list
24672399|NCT01331928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24672401|NCT01331941|Paclitaxel|paclitaxel|mesh-list
24672402|NCT01331941|Trebananib|trebananib|mesh-list
24672403|NCT01331941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24672404|NCT01331941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672405|NCT01331941|Tubulin Modulators|tubulin modulators|mesh-ancestor
24672406|NCT01331941|Antimitotic Agents|antimitotic agents|mesh-ancestor
24672407|NCT01331941|Mitosis Modulators|mitosis modulators|mesh-ancestor
24672408|NCT01331941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853925|NCT02271035|Hyaluronic Acid|hyaluronic acid|mesh-list
24853926|NCT02271035|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24853927|NCT02271035|Immunologic Factors|immunologic factors|mesh-ancestor
24853928|NCT02271035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853929|NCT02271035|Viscosupplements|viscosupplements|mesh-ancestor
24853930|NCT02271035|Protective Agents|protective agents|mesh-ancestor
24853931|NCT02271113|Enoxaparin|enoxaparin|mesh-list
24853932|NCT02271113|Enoxaparin sodium|enoxaparin sodium|mesh-list
24853933|NCT02271113|Anticoagulants|anticoagulants|mesh-ancestor
24853934|NCT02271113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24455575|NCT00327808|Hormones|hormones|mesh-ancestor
25028593|NCT03609489|Capecitabine|capecitabine|mesh-list
24672409|NCT01331941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24672410|NCT01331941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24672431|NCT01331993|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24672432|NCT01331993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24672433|NCT01331993|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24672435|NCT01332097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24672439|NCT01332097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672440|NCT01332097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24672465|NCT01332344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672466|NCT01332344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24672467|NCT01332344|Respiratory System Agents|respiratory system agents|mesh-ancestor
24672468|NCT01332344|Dermatologic Agents|dermatologic agents|mesh-ancestor
24672469|NCT01332344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24672470|NCT01332344|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24672471|NCT01332344|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24672472|NCT01332344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24672473|NCT01332344|Adrenergic Agents|adrenergic agents|mesh-ancestor
24672474|NCT01332344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24672475|NCT01332344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672476|NCT01332370|Metformin|metformin|mesh-list
24672477|NCT01332370|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24673883|NCT01340950|Efavirenz|efavirenz|mesh-list
24672495|NCT01332383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672496|NCT01332396|Lapatinib|lapatinib|mesh-list
24672497|NCT01332396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672498|NCT01332396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24672499|NCT01332396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672500|NCT01332396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672501|NCT01332409|Fluticasone|fluticasone|mesh-list
24672502|NCT01332409|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24853935|NCT02271113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24853936|NCT02271113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672518|NCT01332409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672520|NCT01332409|Hormones|hormones|mesh-ancestor
24672521|NCT01332409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25694584|NCT02032888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25694585|NCT02032901|Sofosbuvir|sofosbuvir|mesh-list
25694586|NCT02032901|Antiviral Agents|antiviral agents|mesh-ancestor
25694587|NCT02032901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25694588|NCT02033369|Pramipexole|pramipexole|mesh-list
25694589|NCT02033369|Antioxidants|antioxidants|mesh-ancestor
25694590|NCT02033369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672522|NCT01332409|Sympathomimetics|sympathomimetics|mesh-ancestor
24672523|NCT01332422|Fluticasone|fluticasone|mesh-list
24672524|NCT01332422|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24672525|NCT01332422|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24672526|NCT01332422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24672540|NCT01332422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672541|NCT01332422|Glucocorticoids|glucocorticoids|mesh-ancestor
24672543|NCT01332422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24672544|NCT01332422|Sympathomimetics|sympathomimetics|mesh-ancestor
24672545|NCT01332448|Orlistat|orlistat|mesh-list
24672546|NCT01332448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672547|NCT01332448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672548|NCT01332448|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24672549|NCT01332448|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24672550|NCT01332552|Ritonavir|ritonavir|mesh-list
24672551|NCT01332552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24672552|NCT01332552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24672553|NCT01332552|Protease Inhibitors|protease inhibitors|mesh-ancestor
24672554|NCT01332552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672555|NCT01332552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672556|NCT01332552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24672557|NCT01332552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24393523|NCT00130195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24672558|NCT01332552|Antiviral Agents|antiviral agents|mesh-ancestor
24672559|NCT01332552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24672560|NCT01332552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24672561|NCT01332552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24672562|NCT01332565|Dolutegravir|dolutegravir|mesh-list
24672563|NCT01332565|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24672564|NCT01332565|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24672674|NCT01333085|Mitosis Modulators|mitosis modulators|mesh-ancestor
24672675|NCT01333085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672676|NCT01333085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24672677|NCT01333085|Immunologic Factors|immunologic factors|mesh-ancestor
24672678|NCT01333085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672679|NCT01333124|Gemcitabine|gemcitabine|mesh-list
24853942|NCT02271126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853944|NCT02271126|Coagulants|coagulants|mesh-ancestor
24853945|NCT02271165|Immunoglobulins|immunoglobulins|mesh-list
24672680|NCT01333124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24672681|NCT01333124|Antimetabolites|antimetabolites|mesh-ancestor
24672682|NCT01333124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672683|NCT01333124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672684|NCT01333124|Antiviral Agents|antiviral agents|mesh-ancestor
24672685|NCT01333124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24672686|NCT01333124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672687|NCT01333124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24672727|NCT01333358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672728|NCT01333410|Mometasone Furoate|mometasone furoate|mesh-list
24672730|NCT01333410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24672731|NCT01333410|Immunologic Factors|immunologic factors|mesh-ancestor
24672732|NCT01333410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672733|NCT01333410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24672734|NCT01333410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672735|NCT01333410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672736|NCT01333410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24672737|NCT01333410|Dermatologic Agents|dermatologic agents|mesh-ancestor
24853955|NCT02271191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24456693|NCT00332020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24456694|NCT00332020|Protease Inhibitors|protease inhibitors|mesh-ancestor
24456695|NCT00332020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456696|NCT00332020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672960|NCT01334580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24672961|NCT01334580|Narcotics|narcotics|mesh-ancestor
24672962|NCT01334580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24672963|NCT01334580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672964|NCT01334580|Analgesics|analgesics|mesh-ancestor
24672965|NCT01334580|Sensory System Agents|sensory system agents|mesh-ancestor
24672966|NCT01334580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24819129|NCT02093585|Antiviral Agents|antiviral agents|mesh-ancestor
24819130|NCT02093585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24819131|NCT02093585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24819132|NCT02093585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24819133|NCT02093585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819134|NCT02093585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819135|NCT02093585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24819136|NCT02093585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24910920|NCT04292418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24910921|NCT04292418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672967|NCT01334580|Antitussive Agents|antitussive agents|mesh-ancestor
24672968|NCT01334580|Respiratory System Agents|respiratory system agents|mesh-ancestor
24672969|NCT01334619|Ropivacaine|ropivacaine|mesh-list
24672973|NCT01334619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672974|NCT01334619|Sensory System Agents|sensory system agents|mesh-ancestor
24672975|NCT01334619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24672976|NCT01334632|Morphine|morphine|mesh-list
24672977|NCT01334632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24451997|NCT00325689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853967|NCT02271282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24853968|NCT02271282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853969|NCT02271282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24853970|NCT02271295|Enoxaparin|enoxaparin|mesh-list
24673047|NCT01335048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24673048|NCT01335048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24673049|NCT01335048|Antimetabolites|antimetabolites|mesh-ancestor
24673050|NCT01335048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673051|NCT01335048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24673052|NCT01335048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24673053|NCT01335048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673054|NCT01335048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24673055|NCT01335048|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24440039|NCT00281502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24440040|NCT00281515|Lonafarnib|lonafarnib|mesh-list
24440041|NCT00281515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24440042|NCT00281515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673056|NCT01335048|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24673058|NCT01335048|Purinergic Agents|purinergic agents|mesh-ancestor
24673059|NCT01335048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24673060|NCT01335048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673062|NCT01335074|Sorafenib|sorafenib|mesh-list
24673063|NCT01335074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673064|NCT01335074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24673065|NCT01335074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673066|NCT01335074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673067|NCT01335074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24673068|NCT01335074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673069|NCT01335074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24853974|NCT02271295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853975|NCT02271347|Brincidofovir|brincidofovir|mesh-list
24853976|NCT02271347|Antiviral Agents|antiviral agents|mesh-ancestor
24853977|NCT02271347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24853978|NCT02271360|Cabergoline|cabergoline|mesh-list
24853979|NCT02271360|Calcium Dobesilate|calcium dobesilate|mesh-list
24853981|NCT02271360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24853982|NCT02271360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853983|NCT02271360|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24673111|NCT01335360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673112|NCT01335360|Antiviral Agents|antiviral agents|mesh-ancestor
25694591|NCT02033369|Protective Agents|protective agents|mesh-ancestor
25694592|NCT02033369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694593|NCT02033369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25694594|NCT02033369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25694595|NCT02033369|Dopamine Agonists|dopamine agonists|mesh-ancestor
25694596|NCT02033369|Dopamine Agents|dopamine agents|mesh-ancestor
25694597|NCT02033369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25694598|NCT02033876|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25694599|NCT02033876|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25694600|NCT02033876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25694601|NCT02033889|Insulin|insulin|mesh-list
25694602|NCT02033889|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25694603|NCT02033889|Metformin|metformin|mesh-list
24911192|NCT04290390|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24673113|NCT01335360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673114|NCT01335360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24673115|NCT01335360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24673116|NCT01335360|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24673884|NCT01340950|Nevirapine|nevirapine|mesh-list
24673117|NCT01335360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24673118|NCT01335373|Metronidazole|metronidazole|mesh-list
24440043|NCT00281567|Tiotropium Bromide|tiotropium bromide|mesh-list
24440044|NCT00281567|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24440045|NCT00281567|Autonomic Agents|autonomic agents|mesh-ancestor
24440055|NCT00281593|Telmisartan|telmisartan|mesh-list
24440056|NCT00281593|Ramipril|ramipril|mesh-list
24440057|NCT00281593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24440062|NCT00281593|Protease Inhibitors|protease inhibitors|mesh-ancestor
24673119|NCT01335373|Miconazole|miconazole|mesh-list
24673120|NCT01335373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673121|NCT01335373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24955610|NCT03863392|Oxytocics|oxytocics|mesh-ancestor
24673122|NCT01335373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24673149|NCT01335529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673150|NCT01335529|Antimetabolites|antimetabolites|mesh-ancestor
24673151|NCT01335529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673152|NCT01335529|Immunologic Factors|immunologic factors|mesh-ancestor
24673153|NCT01335529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673154|NCT01335646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24673156|NCT01335646|Sensory System Agents|sensory system agents|mesh-ancestor
24673157|NCT01335646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24673158|NCT01335646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457237|NCT00333567|Analgesics|analgesics|mesh-ancestor
24673159|NCT01335685|Prednisone|prednisone|mesh-list
24673160|NCT01335685|Melphalan|melphalan|mesh-list
24673161|NCT01335685|Ixazomib|ixazomib|mesh-list
24673162|NCT01335685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24673163|NCT01335685|Glucocorticoids|glucocorticoids|mesh-ancestor
24673164|NCT01335685|Hormones|hormones|mesh-ancestor
24673165|NCT01335685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24673166|NCT01335685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673167|NCT01335685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24673237|NCT01336348|Tirofiban|tirofiban|mesh-list
24673238|NCT01336348|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24673239|NCT01336348|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24673240|NCT01336348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24673241|NCT01336348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24673242|NCT01336348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673243|NCT01336439|Botulinum Toxins|botulinum toxins|mesh-list
24673244|NCT01336439|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24673245|NCT01336439|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24673246|NCT01336439|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24457455|NCT00334425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673356|NCT01337375|Antiviral Agents|antiviral agents|mesh-ancestor
24673357|NCT01337375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673358|NCT01337375|Immunologic Factors|immunologic factors|mesh-ancestor
24673359|NCT01337375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673360|NCT01337401|Cediranib|cediranib|mesh-list
24673361|NCT01337401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24674113|NCT01342016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24457505|NCT00334646|Cyclophosphamide|cyclophosphamide|mesh-list
24457506|NCT00334646|Casopitant|casopitant|mesh-list
24457507|NCT00334646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24457508|NCT00334646|Immunologic Factors|immunologic factors|mesh-ancestor
24457509|NCT00334646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673467|NCT01338311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24673468|NCT01338311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673469|NCT01338311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24673470|NCT01338311|Respiratory System Agents|respiratory system agents|mesh-ancestor
24854001|NCT02271399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24673505|NCT01338454|Tranexamic Acid|tranexamic acid|mesh-list
24673506|NCT01338454|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25694604|NCT02033889|Insulin Glargine|insulin glargine|mesh-list
24673507|NCT01338454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24673508|NCT01338454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673509|NCT01338454|Hemostatics|hemostatics|mesh-ancestor
24975089|NCT04753749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24975090|NCT04753749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24975091|NCT04753749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24975092|NCT04753749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975093|NCT04753749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24975094|NCT04753749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24975095|NCT04753749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673510|NCT01338454|Coagulants|coagulants|mesh-ancestor
24673511|NCT01338558|Bevacizumab|bevacizumab|mesh-list
24673512|NCT01338558|Cetuximab|cetuximab|mesh-list
24673513|NCT01338558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24673514|NCT01338558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673515|NCT01338558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24610654|NCT01004380|Farletuzumab|farletuzumab|mesh-list
24673516|NCT01338558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24673517|NCT01338558|Growth Substances|growth substances|mesh-ancestor
24673518|NCT01338558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673519|NCT01338558|Growth Inhibitors|growth inhibitors|mesh-ancestor
24673541|NCT01338753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24673542|NCT01338753|Growth Substances|growth substances|mesh-ancestor
24673543|NCT01338753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673544|NCT01338753|Growth Inhibitors|growth inhibitors|mesh-ancestor
24673545|NCT01338753|Tubulin Modulators|tubulin modulators|mesh-ancestor
24673546|NCT01338753|Antimitotic Agents|antimitotic agents|mesh-ancestor
24673547|NCT01338753|Mitosis Modulators|mitosis modulators|mesh-ancestor
24673548|NCT01338753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673549|NCT01338753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24673550|NCT01338753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24673551|NCT01338753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24673552|NCT01338753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673554|NCT01338844|Vitamin B Complex|vitamin b complex|mesh-ancestor
24673556|NCT01338844|Micronutrients|micronutrients|mesh-ancestor
24673563|NCT01338896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673565|NCT01338909|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24673566|NCT01338909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24673567|NCT01338909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24673568|NCT01338909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24673569|NCT01338909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24673570|NCT01338909|Purinergic Agents|purinergic agents|mesh-ancestor
24673571|NCT01338909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24673572|NCT01338909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673573|NCT01338909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673574|NCT01338922|Insulin|insulin|mesh-list
24673592|NCT01339039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24673593|NCT01339039|Growth Substances|growth substances|mesh-ancestor
24673594|NCT01339039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673595|NCT01339039|Growth Inhibitors|growth inhibitors|mesh-ancestor
24673596|NCT01339039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24673597|NCT01339039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24854006|NCT02271399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854007|NCT02271399|Antipyretics|antipyretics|mesh-ancestor
24854008|NCT02271399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24854009|NCT02271399|Antithrombins|antithrombins|mesh-ancestor
24854010|NCT02271399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24854011|NCT02271399|Protease Inhibitors|protease inhibitors|mesh-ancestor
24854012|NCT02271399|Anticoagulants|anticoagulants|mesh-ancestor
24854013|NCT02271412|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24673607|NCT01339065|Anesthetics, General|anesthetics, general|mesh-ancestor
24673608|NCT01339065|Anesthetics|anesthetics|mesh-ancestor
24673609|NCT01339065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24673610|NCT01339065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24447516|NCT00308763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694605|NCT02033889|Glimepiride|glimepiride|mesh-list
25694606|NCT02033889|Insulin Detemir|insulin detemir|mesh-list
25694607|NCT02033889|Ertugliflozin|ertugliflozin|mesh-list
25694608|NCT02033889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25694609|NCT02033889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694610|NCT02033889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25694611|NCT02033889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25694612|NCT02033889|Immunologic Factors|immunologic factors|mesh-ancestor
25694613|NCT02033889|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25694614|NCT02033889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694615|NCT02033993|Paclitaxel|paclitaxel|mesh-list
24911953|NCT04282941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911954|NCT04283110|Midazolam|midazolam|mesh-list
24975178|NCT04689347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24975179|NCT04689347|Alkylating Agents|alkylating agents|mesh-ancestor
24975180|NCT04678479|Ganaxolone|ganaxolone|mesh-list
24673611|NCT01339065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24673612|NCT01339065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24673613|NCT01339065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673614|NCT01339143|Pioglitazone|pioglitazone|mesh-list
24673615|NCT01339143|Vildagliptin|vildagliptin|mesh-list
24673616|NCT01339143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24673617|NCT01339143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673618|NCT01339143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24673619|NCT01339143|Protease Inhibitors|protease inhibitors|mesh-ancestor
24673620|NCT01339143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673621|NCT01339143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673622|NCT01339286|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24673623|NCT01339286|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24637630|NCT01151865|Analgesics|analgesics|mesh-ancestor
24673624|NCT01339286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24673625|NCT01339286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24673626|NCT01339286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673627|NCT01339286|Adrenergic Agents|adrenergic agents|mesh-ancestor
24673660|NCT01339572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673661|NCT01339624|Ketorolac|ketorolac|mesh-list
24673662|NCT01339624|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24673663|NCT01339624|Fentanyl|fentanyl|mesh-list
24673664|NCT01339624|Morphine|morphine|mesh-list
24673665|NCT01339624|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24673666|NCT01339624|Narcotics|narcotics|mesh-ancestor
24673667|NCT01339624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24673668|NCT01339624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673669|NCT01339624|Analgesics|analgesics|mesh-ancestor
24673691|NCT01339663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24673692|NCT01339663|Alkylating Agents|alkylating agents|mesh-ancestor
24673943|NCT01341262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24673693|NCT01339663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673694|NCT01339663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673695|NCT01339663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24457812|NCT00335270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24457813|NCT00335270|Antiviral Agents|antiviral agents|mesh-ancestor
24457814|NCT00335270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24457815|NCT00335270|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24457816|NCT00335270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24673717|NCT01339741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24673749|NCT01339988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24673751|NCT01339988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673752|NCT01339988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673753|NCT01339988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24673754|NCT01340118|Budesonide|budesonide|mesh-list
24673755|NCT01340118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24673756|NCT01340118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24673757|NCT01340118|Autonomic Agents|autonomic agents|mesh-ancestor
24673758|NCT01340118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24673759|NCT01340118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673784|NCT01340248|Protective Agents|protective agents|mesh-ancestor
24673785|NCT01340248|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24673786|NCT01340248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24673787|NCT01340248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24673788|NCT01340248|Vasodilator Agents|vasodilator agents|mesh-ancestor
24673789|NCT01340248|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24673790|NCT01340248|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24673791|NCT01340326|Valsartan|valsartan|mesh-list
24673792|NCT01340326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24673793|NCT01340326|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24673794|NCT01340326|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24673795|NCT01340326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694616|NCT02033993|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25694617|NCT02033993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25694618|NCT02033993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694619|NCT02033993|Tubulin Modulators|tubulin modulators|mesh-ancestor
25694620|NCT02033993|Antimitotic Agents|antimitotic agents|mesh-ancestor
24912761|NCT04272372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24912762|NCT04272372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24912763|NCT04272372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487276|NCT00462553|Gemcitabine|gemcitabine|mesh-list
24487277|NCT00462553|Sunitinib|sunitinib|mesh-list
24487278|NCT00462553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24487279|NCT00462553|Antimetabolites|antimetabolites|mesh-ancestor
24520044|NCT04019964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912797|NCT04271839|Autonomic Agents|autonomic agents|mesh-ancestor
24912798|NCT04271839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24912803|NCT04271839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24912804|NCT04271839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24673796|NCT01340417|Melatonin|melatonin|mesh-list
24673797|NCT01340417|Antioxidants|antioxidants|mesh-ancestor
24673798|NCT01340417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673840|NCT01340599|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24673846|NCT01340677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673847|NCT01340677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24673870|NCT01340846|Hormone Antagonists|hormone antagonists|mesh-ancestor
24673871|NCT01340846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24673872|NCT01340846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854017|NCT02271412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854018|NCT02271412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24673873|NCT01340846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24673874|NCT01340846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673875|NCT01340846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24673876|NCT01340846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24673877|NCT01340846|Antimetabolites|antimetabolites|mesh-ancestor
24673878|NCT01340846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24673879|NCT01340846|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24673880|NCT01340950|Tenofovir|tenofovir|mesh-list
24673881|NCT01340950|Lamivudine|lamivudine|mesh-list
24673882|NCT01340950|Zidovudine|zidovudine|mesh-list
24673885|NCT01340950|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
24673886|NCT01340950|Antiviral Agents|antiviral agents|mesh-ancestor
24673887|NCT01340950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673888|NCT01340950|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24673889|NCT01340950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24673890|NCT01340950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673891|NCT01340950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673892|NCT01340950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24673893|NCT01340950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24673894|NCT01340950|Antimetabolites|antimetabolites|mesh-ancestor
24673895|NCT01340950|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24637652|NCT01152203|Bevacizumab|bevacizumab|mesh-list
24673896|NCT01340950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24673897|NCT01340950|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24673923|NCT01341184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24673924|NCT01341184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673926|NCT01341184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24673944|NCT01341262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24673945|NCT01341262|Alkylating Agents|alkylating agents|mesh-ancestor
24673946|NCT01341262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673947|NCT01341262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673948|NCT01341262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24673975|NCT01341353|Calcium Channel Blockers|calcium channel blockers|mesh-list
24673976|NCT01341353|Calcium|calcium|mesh-list
25694621|NCT02033993|Mitosis Modulators|mitosis modulators|mesh-ancestor
25694622|NCT02033993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694623|NCT02034006|Ranibizumab|ranibizumab|mesh-list
25694624|NCT02034006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25694625|NCT02034006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25694626|NCT02034006|Growth Substances|growth substances|mesh-ancestor
25694627|NCT02034006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694628|NCT02034006|Growth Inhibitors|growth inhibitors|mesh-ancestor
25694629|NCT02034006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694630|NCT02034019|Dexamethasone|dexamethasone|mesh-list
25694631|NCT02034019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25694632|NCT02034019|Antiemetics|antiemetics|mesh-ancestor
25694633|NCT02034019|Autonomic Agents|autonomic agents|mesh-ancestor
24912924|NCT04270344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24912925|NCT04270344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24912971|NCT04269928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912972|NCT04269928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912973|NCT04269928|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24912974|NCT04269928|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24912975|NCT04269928|Autonomic Agents|autonomic agents|mesh-ancestor
24795007|NCT03962998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24673977|NCT01341353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24673978|NCT01341353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673979|NCT01341353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24673980|NCT01341353|Vasodilator Agents|vasodilator agents|mesh-ancestor
24673981|NCT01341353|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24673982|NCT01341353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24854022|NCT02271438|Moxifloxacin|moxifloxacin|mesh-list
24674046|NCT01341717|Immunologic Factors|immunologic factors|mesh-ancestor
24674047|NCT01341743|Entecavir|entecavir|mesh-list
24674048|NCT01341743|Adefovir|adefovir|mesh-list
24674049|NCT01341743|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
24674050|NCT01341743|Antiviral Agents|antiviral agents|mesh-ancestor
24674051|NCT01341743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24674052|NCT01341743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24674501|NCT05157698|Antidepressive Agents|antidepressive agents|mesh-ancestor
24674092|NCT01341964|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24674093|NCT01341964|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24674094|NCT01341964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674095|NCT01341964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24674096|NCT01341964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24674097|NCT01341964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674098|NCT01341964|Antipyretics|antipyretics|mesh-ancestor
24674099|NCT01341964|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24674100|NCT01341964|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24674101|NCT01341964|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24674102|NCT01341964|Purinergic Agents|purinergic agents|mesh-ancestor
24674103|NCT01341964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24674104|NCT01342016|Prednisone|prednisone|mesh-list
24674130|NCT01342198|Sensory System Agents|sensory system agents|mesh-ancestor
24674131|NCT01342198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24674132|NCT01342198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674133|NCT01342198|Anticonvulsants|anticonvulsants|mesh-ancestor
24674154|NCT01342224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674155|NCT01342224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24674156|NCT01342224|Antiviral Agents|antiviral agents|mesh-ancestor
24674157|NCT01342224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24674158|NCT01342224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674159|NCT01342224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24674160|NCT01342224|Vasodilator Agents|vasodilator agents|mesh-ancestor
24674161|NCT01342224|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24674162|NCT01342224|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24674163|NCT01342224|Urological Agents|urological agents|mesh-ancestor
24674165|NCT01342237|Etoposide|etoposide|mesh-list
24674166|NCT01342237|Melphalan|melphalan|mesh-list
24674167|NCT01342237|Topotecan|topotecan|mesh-list
24674168|NCT01342237|Thiotepa|thiotepa|mesh-list
24674169|NCT01342237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24674295|NCT01342939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24674297|NCT01342939|Protease Inhibitors|protease inhibitors|mesh-ancestor
24674298|NCT01342939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674299|NCT01342939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674300|NCT05251584|Gentamicins|gentamicins|mesh-list
24674301|NCT05251584|Mupirocin|mupirocin|mesh-list
24674302|NCT05251584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24674303|NCT05251584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25694634|NCT02034019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25694635|NCT02034019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694636|NCT02034019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25694637|NCT02034019|Glucocorticoids|glucocorticoids|mesh-ancestor
25694638|NCT02034019|Hormones|hormones|mesh-ancestor
25694639|NCT02034019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25694640|NCT02034019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25694641|NCT02034019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694642|NCT02034162|Mebendazole|mebendazole|mesh-list
24674304|NCT05251584|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24674305|NCT05251584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674306|NCT05251584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458427|NCT00337792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458429|NCT00337792|Antiemetics|antiemetics|mesh-ancestor
24458430|NCT00337792|Autonomic Agents|autonomic agents|mesh-ancestor
24458431|NCT00337792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24458432|NCT00337805|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24458433|NCT00337805|Plasma Substitutes|plasma substitutes|mesh-ancestor
24458434|NCT00337805|Blood Substitutes|blood substitutes|mesh-ancestor
24458440|NCT00337922|Lamivudine|lamivudine|mesh-list
24854040|NCT02271464|Capecitabine|capecitabine|mesh-list
24854041|NCT02271464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24854042|NCT02271464|Immunologic Factors|immunologic factors|mesh-ancestor
24854043|NCT02271464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854044|NCT02271464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24854045|NCT02271464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24674353|NCT05250752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24674354|NCT05250752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674355|NCT05250661|Propolis|propolis|mesh-list
24674356|NCT05250661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24674357|NCT05250245|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24674358|NCT05250245|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24674359|NCT05250245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24674360|NCT05250245|Cholinergic Agents|cholinergic agents|mesh-ancestor
24674361|NCT05250245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24674362|NCT05250245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674363|NCT05250245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458492|NCT00338130|Alkylating Agents|alkylating agents|mesh-ancestor
24610510|NCT01002729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610520|NCT01002807|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24610521|NCT01002807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610523|NCT01002898|Lopinavir|lopinavir|mesh-list
24610524|NCT01002898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24610525|NCT01002898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24610526|NCT01002898|Protease Inhibitors|protease inhibitors|mesh-ancestor
24610527|NCT01002898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610528|NCT01002898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610529|NCT01002898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24610530|NCT01002898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24610531|NCT01002898|Antiviral Agents|antiviral agents|mesh-ancestor
24610532|NCT01002898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24610533|NCT01002898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24610534|NCT01002898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24610535|NCT01002911|Cefazolin|cefazolin|mesh-list
24610536|NCT01002911|Cephalexin|cephalexin|mesh-list
24610537|NCT01002911|Bacitracin|bacitracin|mesh-list
24610538|NCT01002911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24610539|NCT01002911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24610554|NCT01003054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24610555|NCT01003054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24610556|NCT01003054|Alkylating Agents|alkylating agents|mesh-ancestor
24610557|NCT01003054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610558|NCT01003054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610559|NCT01003054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24610560|NCT01003054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24674424|NCT05226442|Heparin|heparin|mesh-list
24674425|NCT05226442|Calcium heparin|calcium heparin|mesh-list
24674426|NCT05226442|Argatroban|argatroban|mesh-list
24674438|NCT05220319|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24674439|NCT05220319|Prednisolone|prednisolone|mesh-list
24674457|NCT05214066|Immunologic Factors|immunologic factors|mesh-ancestor
24674458|NCT05214066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674459|NCT05214066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24674460|NCT05211024|Penicillins|penicillins|mesh-list
24674461|NCT05211024|Penicillin G|penicillin g|mesh-list
24674462|NCT05211024|Penicillin G Benzathine|penicillin g benzathine|mesh-list
24674791|NCT04409964|Lidocaine|lidocaine|mesh-list
24674482|NCT05164549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674483|NCT05164549|Analgesics|analgesics|mesh-ancestor
24674484|NCT05164549|Sensory System Agents|sensory system agents|mesh-ancestor
24674485|NCT05164549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24674486|NCT05164549|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24674487|NCT05164549|Antitussive Agents|antitussive agents|mesh-ancestor
24520057|NCT03980769|Thymoglobulin|thymoglobulin|mesh-list
24913322|NCT04266509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24913323|NCT04266509|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24674488|NCT05164549|Respiratory System Agents|respiratory system agents|mesh-ancestor
24674489|NCT05162274|Lazertinib|lazertinib|mesh-list
24674490|NCT05162274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24674491|NCT05162274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674492|NCT05162274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674493|NCT05157698|Naltrexone|naltrexone|mesh-list
24674494|NCT05157698|Bupropion|bupropion|mesh-list
24674495|NCT05157698|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24674496|NCT05157698|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24674497|NCT05157698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674498|NCT05157698|Sensory System Agents|sensory system agents|mesh-ancestor
24674528|NCT05124691|Anticestodal Agents|anticestodal agents|mesh-ancestor
24674529|NCT05124691|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24854056|NCT02271464|Antimetabolites|antimetabolites|mesh-ancestor
24854058|NCT02271542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24674534|NCT05124691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674535|NCT05124691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24674536|NCT05119101|Magnesium Sulfate|magnesium sulfate|mesh-list
24674831|NCT04346394|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24610575|NCT01003483|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24610576|NCT01003483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24610577|NCT01003522|Anesthetics|anesthetics|mesh-list
24610578|NCT01003522|Anesthetics, General|anesthetics, general|mesh-list
24610579|NCT01003522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24610580|NCT01003522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610581|NCT01003561|Anesthetics|anesthetics|mesh-list
24610588|NCT01003613|Analgesics|analgesics|mesh-ancestor
24610589|NCT01003613|Sensory System Agents|sensory system agents|mesh-ancestor
24610590|NCT01003613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24610591|NCT01003613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610592|NCT01003613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24610593|NCT01003613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24674591|NCT05063149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24674592|NCT05063149|Immunologic Factors|immunologic factors|mesh-ancestor
24674593|NCT05063149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854065|NCT02271555|Sevoflurane|sevoflurane|mesh-list
24854066|NCT02271555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24674608|NCT05027919|Lofexidine|lofexidine|mesh-list
24674609|NCT05027919|Clonidine|clonidine|mesh-list
24674610|NCT05027919|Morphine|morphine|mesh-list
24674611|NCT05027919|Naloxone|naloxone|mesh-list
24610606|NCT01003678|Clofarabine|clofarabine|mesh-list
24610607|NCT01003678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24610608|NCT01003678|Antimetabolites|antimetabolites|mesh-ancestor
24610609|NCT01003678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610610|NCT01003678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610611|NCT01003847|Fenofibrate|fenofibrate|mesh-list
24610612|NCT01003847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24674650|NCT04983407|Mitosis Modulators|mitosis modulators|mesh-ancestor
24674651|NCT04983407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674652|NCT04983407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24674653|NCT04983407|Antimetabolites|antimetabolites|mesh-ancestor
24674654|NCT04983407|Antiviral Agents|antiviral agents|mesh-ancestor
24674655|NCT04983407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24674656|NCT04983407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674657|NCT04983407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24674658|NCT04983407|Immunologic Factors|immunologic factors|mesh-ancestor
24674659|NCT04983407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674744|NCT04693689|Immunologic Factors|immunologic factors|mesh-ancestor
24674745|NCT04693689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610649|NCT01004315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24854080|NCT02271646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24854081|NCT02271646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854082|NCT02271646|Sensory System Agents|sensory system agents|mesh-ancestor
24854083|NCT02271646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24675684|NCT01344512|Ciprofloxacin|ciprofloxacin|mesh-list
24854084|NCT02271802|Butyric Acid|butyric acid|mesh-list
25694643|NCT02034162|Piperazine|piperazine|mesh-list
25694644|NCT02034162|Piperazine citrate|piperazine citrate|mesh-list
25694645|NCT02034162|DMP 777|dmp 777|mesh-list
24854085|NCT02271802|Histamine Antagonists|histamine antagonists|mesh-ancestor
25694646|NCT02034162|Antinematodal Agents|antinematodal agents|mesh-ancestor
24975696|NCT03239145|Growth Substances|growth substances|mesh-ancestor
24393924|NCT00131300|Hylan|hylan|mesh-list
24975697|NCT03239145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975698|NCT03239145|Growth Inhibitors|growth inhibitors|mesh-ancestor
24975706|NCT03233217|Vaccines|vaccines|mesh-list
24975707|NCT03233217|Immunologic Factors|immunologic factors|mesh-ancestor
24975708|NCT03233217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975709|NCT03205358|Vaccines|vaccines|mesh-list
24975710|NCT03205358|Immunologic Factors|immunologic factors|mesh-ancestor
24975711|NCT03205358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854086|NCT02271802|Histamine Agents|histamine agents|mesh-ancestor
24854087|NCT02271802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24854088|NCT02271802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854089|NCT02271802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674768|NCT04541108|Mitosis Modulators|mitosis modulators|mesh-ancestor
24674769|NCT04541108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674770|NCT04541108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24674771|NCT04541108|Antimetabolites|antimetabolites|mesh-ancestor
24674772|NCT04541108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24674773|NCT04541108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24674774|NCT04541108|Immunologic Factors|immunologic factors|mesh-ancestor
24674775|NCT04541108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674776|NCT04490993|Epirubicin|epirubicin|mesh-list
24674777|NCT04490993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24674778|NCT04490993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24674779|NCT04490993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24674780|NCT04490993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24674781|NCT04490993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674825|NCT04346394|Yohimbine|yohimbine|mesh-list
24674826|NCT04346394|Mydriatics|mydriatics|mesh-ancestor
24674870|NCT04213677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24674871|NCT04213677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674872|NCT04179110|Pembrolizumab|pembrolizumab|mesh-list
24674873|NCT04179110|Ramucirumab|ramucirumab|mesh-list
24674874|NCT04179110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24674875|NCT04179110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24674926|NCT03875690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24674928|NCT03875690|Protective Agents|protective agents|mesh-ancestor
24674929|NCT03875690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24674930|NCT03875690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24674931|NCT03845296|Rucaparib|rucaparib|mesh-list
24854093|NCT02271893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24854094|NCT02271893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24674932|NCT03845296|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24674933|NCT03845296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674934|NCT03845296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674935|NCT03845296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24674936|NCT03809013|Trastuzumab|trastuzumab|mesh-list
24674937|NCT03809013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24674956|NCT03749057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674957|NCT03749057|Anticoagulants|anticoagulants|mesh-ancestor
24674958|NCT03740958|Argatroban|argatroban|mesh-list
24674980|NCT03685188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24674987|NCT03685188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24674988|NCT03685188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24674989|NCT03685188|Anesthetics, General|anesthetics, general|mesh-ancestor
24674990|NCT03685188|Anesthetics|anesthetics|mesh-ancestor
24674991|NCT03649880|Misonidazole|misonidazole|mesh-list
24674992|NCT03649880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24674993|NCT03649880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24674994|NCT03649880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24674995|NCT03649880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24674996|NCT03635749|Aspirin|aspirin|mesh-list
24674997|NCT03635749|Atorvastatin|atorvastatin|mesh-list
24675021|NCT03599791|Fluticasone|fluticasone|mesh-list
24675022|NCT03599791|Xhance|xhance|mesh-list
25694647|NCT02034162|Anthelmintics|anthelmintics|mesh-ancestor
25694648|NCT02034162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25694649|NCT02034162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25694650|NCT02034162|Tubulin Modulators|tubulin modulators|mesh-ancestor
25694651|NCT02034162|Antimitotic Agents|antimitotic agents|mesh-ancestor
25694652|NCT02034162|Mitosis Modulators|mitosis modulators|mesh-ancestor
25694653|NCT02034162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694654|NCT02034162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24675023|NCT03599791|Azelastine|azelastine|mesh-list
25105493|NCT03146104|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25105494|NCT03145623|Grazoprevir|grazoprevir|mesh-list
25105495|NCT03145623|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25105496|NCT03145623|Antiviral Agents|antiviral agents|mesh-ancestor
25105497|NCT03145623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25105498|NCT03145961|Pembrolizumab|pembrolizumab|mesh-list
25105499|NCT03145961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25105500|NCT03145961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105501|NCT03145896|Vitamin D|vitamin d|mesh-list
25105502|NCT03145896|Vitamins|vitamins|mesh-ancestor
24675024|NCT03599791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24675025|NCT03599791|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24675026|NCT03599791|Autonomic Agents|autonomic agents|mesh-ancestor
24675027|NCT03599791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24675028|NCT03599791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675029|NCT03599791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24675030|NCT03599791|Respiratory System Agents|respiratory system agents|mesh-ancestor
24675031|NCT03599791|Dermatologic Agents|dermatologic agents|mesh-ancestor
24675032|NCT03599791|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24675033|NCT03599791|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24675034|NCT03599791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675035|NCT03599791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675043|NCT03526432|Bevacizumab|bevacizumab|mesh-list
24675082|NCT03246958|Nivolumab|nivolumab|mesh-list
24675083|NCT03246958|Ipilimumab|ipilimumab|mesh-list
24675084|NCT03246958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24675085|NCT03246958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24675086|NCT03246958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24675087|NCT03246958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675088|NCT03160521|Risperidone|risperidone|mesh-list
24675090|NCT03160521|Serotonin Agents|serotonin agents|mesh-ancestor
24675091|NCT03160521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24675092|NCT03160521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675093|NCT03160521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675094|NCT03160521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24675095|NCT03160521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24675096|NCT03160521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24675097|NCT03160521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24675098|NCT03160521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24675099|NCT03160521|Dopamine Agents|dopamine agents|mesh-ancestor
24675100|NCT03143816|Insulin|insulin|mesh-list
24675101|NCT03143816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24675123|NCT03122847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24675124|NCT03122847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24675126|NCT03078192|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24675127|NCT03078192|Anesthetics, General|anesthetics, general|mesh-ancestor
24675128|NCT03078192|Anesthetics|anesthetics|mesh-ancestor
24675129|NCT03078192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24675130|NCT03078192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675131|NCT03004131|Fluticasone|fluticasone|mesh-list
24675132|NCT03004131|Xhance|xhance|mesh-list
24675133|NCT03004131|Loratadine|loratadine|mesh-list
24675135|NCT03004131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24675156|NCT02959944|Hormones|hormones|mesh-ancestor
24675183|NCT02869009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675185|NCT02869009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24675186|NCT02869009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675187|NCT02869009|Antipyretics|antipyretics|mesh-ancestor
24675188|NCT02869009|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24675189|NCT02869009|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24675190|NCT02869009|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24675191|NCT02869009|Purinergic Agents|purinergic agents|mesh-ancestor
24675192|NCT02869009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24675193|NCT02855697|Olaparib|olaparib|mesh-list
25694655|NCT02034162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25694656|NCT02034435|Amlodipine|amlodipine|mesh-list
25694657|NCT02034435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25694658|NCT02034435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25694659|NCT02034435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25694660|NCT02034435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694661|NCT02034435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25694662|NCT02034435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675194|NCT02855697|Cediranib|cediranib|mesh-list
24675195|NCT02855697|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24675196|NCT02855697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675239|NCT02562599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24675240|NCT02562599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675242|NCT02489448|Tremelimumab|tremelimumab|mesh-list
24675243|NCT02489448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24812574|NCT02053597|Antimitotic Agents|antimitotic agents|mesh-ancestor
24812575|NCT02053597|Mitosis Modulators|mitosis modulators|mesh-ancestor
24675244|NCT02489448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24675245|NCT02456012|Esomeprazole|esomeprazole|mesh-list
24675246|NCT02456012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24675247|NCT02456012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24675248|NCT02456012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24610661|NCT01004419|Hormone Antagonists|hormone antagonists|mesh-ancestor
24610662|NCT01004419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24610663|NCT01004419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610664|NCT01004445|Amikacin|amikacin|mesh-list
24610665|NCT01004445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24610666|NCT01004445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24610667|NCT01004497|Cytarabine|cytarabine|mesh-list
24610668|NCT01004497|Dexamethasone|dexamethasone|mesh-list
24610669|NCT01004497|Dexamethasone acetate|dexamethasone acetate|mesh-list
24610670|NCT01004497|Cyclophosphamide|cyclophosphamide|mesh-list
24610671|NCT01004497|Vincristine|vincristine|mesh-list
24610672|NCT01004497|Daunorubicin|daunorubicin|mesh-list
24610673|NCT01004497|Dasatinib|dasatinib|mesh-list
24610674|NCT01004497|Mitoxantrone|mitoxantrone|mesh-list
24610675|NCT01004497|BB 1101|bb 1101|mesh-list
24610676|NCT01004497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24610677|NCT01004497|Immunologic Factors|immunologic factors|mesh-ancestor
24610678|NCT01004497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610679|NCT01004497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24610680|NCT01004497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24610681|NCT01004497|Alkylating Agents|alkylating agents|mesh-ancestor
24610682|NCT01004497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610683|NCT01004497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610715|NCT01004601|Docetaxel|docetaxel|mesh-list
24610716|NCT01004601|Pemetrexed|pemetrexed|mesh-list
24610717|NCT01004601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610718|NCT01004601|Tubulin Modulators|tubulin modulators|mesh-ancestor
24812576|NCT02053597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812577|NCT02053597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24812578|NCT02053597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24675334|NCT00536380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24675335|NCT00536380|Cholinergic Agents|cholinergic agents|mesh-ancestor
24675336|NCT00536380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24675340|NCT00536380|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24675346|NCT00521599|Mometasone Furoate|mometasone furoate|mesh-list
24675347|NCT00521599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24675348|NCT00521599|Dermatologic Agents|dermatologic agents|mesh-ancestor
24675349|NCT00521599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24675350|NCT00496834|Losartan|losartan|mesh-list
24675351|NCT00496834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24675372|NCT00496834|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24675373|NCT00496834|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24675374|NCT00442897|Atorvastatin|atorvastatin|mesh-list
24675375|NCT00442897|Simvastatin|simvastatin|mesh-list
24675377|NCT00442897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24675378|NCT00442897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24675379|NCT00442897|Antimetabolites|antimetabolites|mesh-ancestor
24675380|NCT00442897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675381|NCT00442897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24675400|NCT00394355|Autonomic Agents|autonomic agents|mesh-ancestor
24675401|NCT00394355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24675402|NCT00394355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675403|NCT00394355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24675404|NCT00394355|Respiratory System Agents|respiratory system agents|mesh-ancestor
24675405|NCT00394355|Dermatologic Agents|dermatologic agents|mesh-ancestor
24675429|NCT00166504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675431|NCT00166504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24675432|NCT00166504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675433|NCT00101972|Antibodies|antibodies|mesh-list
24675434|NCT00101972|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24675495|NCT01343329|Vasodilator Agents|vasodilator agents|mesh-ancestor
24675496|NCT01343329|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24675497|NCT01343381|Heparin|heparin|mesh-list
24675498|NCT01343381|Calcium heparin|calcium heparin|mesh-list
24976073|NCT01702571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976074|NCT01581840|Panitumumab|panitumumab|mesh-list
24976075|NCT01581840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24976076|NCT01581840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976078|NCT01578239|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
24520185|NCT03576885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675499|NCT01343381|Anticoagulants|anticoagulants|mesh-ancestor
24675500|NCT01343381|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24675501|NCT01343381|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24812591|NCT02053727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812592|NCT02053727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812593|NCT02053727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24812594|NCT02053727|Immunologic Factors|immunologic factors|mesh-ancestor
24812595|NCT02053727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675517|NCT01343680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675518|NCT01343706|BI 409306|bi 409306|mesh-list
24675519|NCT01343706|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24675520|NCT01343706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675521|NCT01343706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675522|NCT01343745|Formoterol Fumarate|formoterol fumarate|mesh-list
24675523|NCT01343745|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24675524|NCT01343745|Autonomic Agents|autonomic agents|mesh-ancestor
24675525|NCT01343745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24675526|NCT01343745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675527|NCT01343745|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24675528|NCT01343745|Respiratory System Agents|respiratory system agents|mesh-ancestor
24675529|NCT01343745|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24675530|NCT01343745|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24675531|NCT01343745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24675532|NCT01343745|Adrenergic Agents|adrenergic agents|mesh-ancestor
24675533|NCT01343745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24675534|NCT01343745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675535|NCT01343862|Cycloserine|cycloserine|mesh-list
24675556|NCT01344031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440076|NCT00281606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24440077|NCT00281619|Mycophenolic Acid|mycophenolic acid|mesh-list
24675577|NCT01344174|Autonomic Agents|autonomic agents|mesh-ancestor
24675779|NCT01345240|Immunologic Factors|immunologic factors|mesh-ancestor
24675584|NCT01344174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24675585|NCT01344174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24675586|NCT01344174|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24675587|NCT01344174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24675588|NCT01344174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675589|NCT01344174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675590|NCT01344174|Antiviral Agents|antiviral agents|mesh-ancestor
24675591|NCT01344174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24675592|NCT01344174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24675593|NCT01344174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24812597|NCT02053766|Dexmedetomidine|dexmedetomidine|mesh-list
24812599|NCT02053766|Sevoflurane|sevoflurane|mesh-list
24812600|NCT02053766|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24812601|NCT02053766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24812602|NCT02053766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812603|NCT02053766|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24812604|NCT02053766|Anesthetics, General|anesthetics, general|mesh-ancestor
24812606|NCT02053766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24675613|NCT01344213|Anticonvulsants|anticonvulsants|mesh-ancestor
24675614|NCT01344213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24675615|NCT01344213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24675616|NCT01344213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694663|NCT02034435|Vasodilator Agents|vasodilator agents|mesh-ancestor
25694664|NCT02034513|Insulin|insulin|mesh-list
25694665|NCT02034513|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25694666|NCT02034513|Insulin Glargine|insulin glargine|mesh-list
25694667|NCT02034513|Insulin Aspart|insulin aspart|mesh-list
25694668|NCT02034513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25694669|NCT02034513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694670|NCT02034552|Prednisone|prednisone|mesh-list
25694671|NCT02034552|Abiraterone Acetate|abiraterone acetate|mesh-list
25694672|NCT02034552|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25694673|NCT02034552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24520223|NCT03561376|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24520224|NCT03561376|Protective Agents|protective agents|mesh-ancestor
24520225|NCT03561376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520226|NCT03486314|Rifampin|rifampin|mesh-list
24795111|NCT03626922|Glucocorticoids|glucocorticoids|mesh-ancestor
24795113|NCT03626922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24675617|NCT01344213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24675618|NCT01344213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24675619|NCT01344213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24675620|NCT01344213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24675621|NCT01344213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24675622|NCT01344213|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24675623|NCT01344213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24675624|NCT01344213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24675625|NCT01344213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24675626|NCT01344213|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24675627|NCT01344213|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24675628|NCT01344213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675630|NCT01344252|Anesthetics, Local|anesthetics, local|mesh-ancestor
24675631|NCT01344252|Anesthetics|anesthetics|mesh-ancestor
24675632|NCT01344252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24675633|NCT01344252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675634|NCT01344252|Sensory System Agents|sensory system agents|mesh-ancestor
24675635|NCT01344252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24675636|NCT01344252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24812615|NCT02053766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675637|NCT01344252|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24675638|NCT01344252|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24675639|NCT01344252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24675640|NCT01344252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545397|NCT00693251|Immunologic Factors|immunologic factors|mesh-ancestor
24440078|NCT00281619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24440133|NCT00281892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24440134|NCT00281892|Immunologic Factors|immunologic factors|mesh-ancestor
24440135|NCT00281892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440136|NCT00281892|Antiviral Agents|antiviral agents|mesh-ancestor
24675642|NCT01344291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24675643|NCT01344291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24675644|NCT01344291|Analgesics|analgesics|mesh-ancestor
24610856|NCT01005537|Aldesleukin|aldesleukin|mesh-list
24675645|NCT01344291|Sensory System Agents|sensory system agents|mesh-ancestor
24675646|NCT01344291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24675647|NCT01344291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675648|NCT01344291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24675649|NCT01344291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24675650|NCT01344291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24675651|NCT01344291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675652|NCT01344291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675681|NCT01344473|Chelating Agents|chelating agents|mesh-ancestor
24675682|NCT01344473|Sequestering Agents|sequestering agents|mesh-ancestor
24675683|NCT01344473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675685|NCT01344512|Ceftazidime|ceftazidime|mesh-list
24675686|NCT01344512|Voriconazole|voriconazole|mesh-list
24675687|NCT01344512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24675688|NCT01344512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24675689|NCT01344512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24675690|NCT01344512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24675691|NCT01344512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675692|NCT01344512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694674|NCT02034552|Glucocorticoids|glucocorticoids|mesh-ancestor
25694675|NCT02034552|Hormones|hormones|mesh-ancestor
25694676|NCT02034552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25694677|NCT02034552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694678|NCT02034552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25694679|NCT02034552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694680|NCT02034552|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25694681|NCT02034552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25694682|NCT02034552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533227|NCT00642655|Rituximab|rituximab|mesh-list
24976352|NCT04051268|Immunologic Factors|immunologic factors|mesh-ancestor
24976354|NCT04031508|SMOFlipid|smoflipid|mesh-list
24675693|NCT01344512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24675694|NCT01344512|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24675695|NCT01344512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24675696|NCT01344512|Antifungal Agents|antifungal agents|mesh-ancestor
24675697|NCT01344512|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24675708|NCT01344564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24675710|NCT01344590|Ethanol|ethanol|mesh-list
24675711|NCT01344590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24675712|NCT01344590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24675713|NCT01344590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24440137|NCT00281892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24440138|NCT00281905|Cyclophosphamide|cyclophosphamide|mesh-list
24440139|NCT00281905|Carboplatin|carboplatin|mesh-list
24440140|NCT00281905|Methotrexate|methotrexate|mesh-list
24440141|NCT00281905|Vincristine|vincristine|mesh-list
24440142|NCT00281905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24440143|NCT00281905|Immunologic Factors|immunologic factors|mesh-ancestor
24675714|NCT01344590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675715|NCT01344655|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24675716|NCT01344655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24675717|NCT01344655|Autonomic Agents|autonomic agents|mesh-ancestor
24675718|NCT01344655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24675719|NCT01344655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675720|NCT01344655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24675721|NCT01344655|Respiratory System Agents|respiratory system agents|mesh-ancestor
24675722|NCT01344655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24675723|NCT01344655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24675724|NCT01344655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24675725|NCT01344655|Adrenergic Agents|adrenergic agents|mesh-ancestor
24675726|NCT01344655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24675727|NCT01344655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675729|NCT01344681|Micafungin|micafungin|mesh-list
24675730|NCT01344681|Antifungal Agents|antifungal agents|mesh-ancestor
24675731|NCT01344681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24675732|NCT01344681|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24675754|NCT01344720|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24675755|NCT01344720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24675757|NCT01344720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675758|NCT01344863|Trastuzumab|trastuzumab|mesh-list
24675759|NCT01344863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24675760|NCT01344863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24675761|NCT01344954|Rivaroxaban|rivaroxaban|mesh-list
24675762|NCT01344954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24675763|NCT01344954|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24675764|NCT01344954|Antithrombins|antithrombins|mesh-ancestor
24675765|NCT01344954|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24675766|NCT01344954|Protease Inhibitors|protease inhibitors|mesh-ancestor
24675767|NCT01344954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675768|NCT01344954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675769|NCT01344954|Anticoagulants|anticoagulants|mesh-ancestor
24675770|NCT01344954|Immunologic Factors|immunologic factors|mesh-ancestor
24675776|NCT01345084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24675777|NCT01345084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24460012|NCT00347113|Albendazole|albendazole|mesh-list
24675778|NCT01345240|Vaccines|vaccines|mesh-list
24675780|NCT01345240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675781|NCT01345279|Paclitaxel|paclitaxel|mesh-list
24675858|NCT01345851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675859|NCT01345864|Scopolamine|scopolamine|mesh-list
24675860|NCT01345864|Donepezil|donepezil|mesh-list
24675861|NCT01345864|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24675862|NCT01345864|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24675863|NCT01345864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675864|NCT01345864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675865|NCT01345864|Cholinergic Agents|cholinergic agents|mesh-ancestor
24675866|NCT01345864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24675867|NCT01345864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675868|NCT01345864|Nootropic Agents|nootropic agents|mesh-ancestor
25694683|NCT02034552|Hormone Antagonists|hormone antagonists|mesh-ancestor
25694684|NCT02034552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25694685|NCT02034565|Apixaban|apixaban|mesh-list
24976676|NCT05275777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675869|NCT01345864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24675870|NCT01345864|Antiemetics|antiemetics|mesh-ancestor
24675871|NCT01345864|Autonomic Agents|autonomic agents|mesh-ancestor
24675872|NCT01345864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24675892|NCT01346007|Immunologic Factors|immunologic factors|mesh-ancestor
24675893|NCT01346007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675895|NCT01346137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24675896|NCT01346137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24675897|NCT01346137|Analgesics|analgesics|mesh-ancestor
24675898|NCT01346137|Sensory System Agents|sensory system agents|mesh-ancestor
24675899|NCT01346137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24675900|NCT01346137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675901|NCT01346137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24675902|NCT01346137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24675903|NCT01346137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24675904|NCT01346137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24675954|NCT01346865|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24675955|NCT01346865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24675956|NCT01346865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675957|NCT01346865|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24675958|NCT01346865|Vasodilator Agents|vasodilator agents|mesh-ancestor
24675977|NCT01346930|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
24675979|NCT01346930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675980|NCT01346930|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
24676002|NCT01347424|Growth Inhibitors|growth inhibitors|mesh-ancestor
24676003|NCT01347593|Ceftizoxime|ceftizoxime|mesh-list
24676004|NCT01347593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24676005|NCT01347593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24676006|NCT01347684|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
24676007|NCT01347684|Antidepressive Agents|antidepressive agents|mesh-ancestor
24676008|NCT01347684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24676009|NCT01347814|Domperidone|domperidone|mesh-list
24676010|NCT01347814|Antiemetics|antiemetics|mesh-ancestor
24676011|NCT01347814|Autonomic Agents|autonomic agents|mesh-ancestor
24676012|NCT01347814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24676013|NCT01347814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676014|NCT01347814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24676015|NCT01347814|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24676016|NCT01347814|Dopamine Agents|dopamine agents|mesh-ancestor
24676017|NCT01347814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24676018|NCT01347814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676019|NCT01347853|Ketorolac|ketorolac|mesh-list
24676020|NCT01347853|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24676021|NCT01347853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24394182|NCT00132535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24394183|NCT00132535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24955923|NCT03859583|Dermatologic Agents|dermatologic agents|mesh-ancestor
24676022|NCT01347853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24676023|NCT01347853|Analgesics|analgesics|mesh-ancestor
24676024|NCT01347853|Sensory System Agents|sensory system agents|mesh-ancestor
24676025|NCT01347853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24676026|NCT01347853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676057|NCT01347983|Abortifacient Agents|abortifacient agents|mesh-ancestor
24854110|NCT02271958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24854111|NCT02271958|Luteolytic Agents|luteolytic agents|mesh-ancestor
24854112|NCT02271958|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24854113|NCT02271958|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24854115|NCT02271971|Cholecalciferol|cholecalciferol|mesh-list
24854117|NCT02271971|Micronutrients|micronutrients|mesh-ancestor
24854118|NCT02271971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676058|NCT01347983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24676059|NCT01347983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676060|NCT01347983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24676061|NCT01347983|Antimetabolites|antimetabolites|mesh-ancestor
24676062|NCT01347983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694686|NCT02034565|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25694687|NCT02034565|Antithrombins|antithrombins|mesh-ancestor
25694688|NCT02034565|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24976714|NCT05274672|Ciprofloxacin|ciprofloxacin|mesh-list
24676063|NCT01347983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24676064|NCT01347983|Dermatologic Agents|dermatologic agents|mesh-ancestor
24676065|NCT01347983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676066|NCT01347983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24676067|NCT01347983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24676068|NCT01347983|Immunologic Factors|immunologic factors|mesh-ancestor
24676069|NCT01347983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24676070|NCT01347983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24676071|NCT01347996|Interleukin-2|interleukin-2|mesh-list
24676072|NCT01347996|Histamine|histamine|mesh-list
24676073|NCT01347996|Histamine phosphate|histamine phosphate|mesh-list
24676074|NCT01347996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24676075|NCT01347996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24676076|NCT01347996|Analgesics|analgesics|mesh-ancestor
24676077|NCT01347996|Sensory System Agents|sensory system agents|mesh-ancestor
24676078|NCT01347996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24676079|NCT01347996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676080|NCT01347996|Histamine Agonists|histamine agonists|mesh-ancestor
24676081|NCT01347996|Histamine Agents|histamine agents|mesh-ancestor
24676082|NCT01347996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24610785|NCT01005147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610786|NCT01005147|Hemostatics|hemostatics|mesh-ancestor
24610787|NCT01005147|Coagulants|coagulants|mesh-ancestor
24610789|NCT01005160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24610790|NCT01005160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610791|NCT01005199|Everolimus|everolimus|mesh-list
24676090|NCT01348126|Docetaxel|docetaxel|mesh-list
24676091|NCT01348126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24676092|NCT01348126|Tubulin Modulators|tubulin modulators|mesh-ancestor
24676093|NCT01348126|Antimitotic Agents|antimitotic agents|mesh-ancestor
24676094|NCT01348126|Mitosis Modulators|mitosis modulators|mesh-ancestor
24610792|NCT01005199|Sorafenib|sorafenib|mesh-list
24610793|NCT01005199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610794|NCT01005199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24676095|NCT01348126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676097|NCT01348204|Antioxidants|antioxidants|mesh-ancestor
24854119|NCT02271971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24854120|NCT02271971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24676098|NCT01348204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676099|NCT01348204|Protective Agents|protective agents|mesh-ancestor
24676100|NCT01348204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676102|NCT01348243|Lidocaine|lidocaine|mesh-list
24676103|NCT01348243|Anesthetics, Local|anesthetics, local|mesh-ancestor
24676104|NCT01348243|Anesthetics|anesthetics|mesh-ancestor
24676105|NCT01348243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24781783|NCT01891812|Sensory System Agents|sensory system agents|mesh-ancestor
24781784|NCT01891812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24626573|NCT01087879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24676106|NCT01348243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676107|NCT01348243|Sensory System Agents|sensory system agents|mesh-ancestor
24676108|NCT01348243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24676109|NCT01348243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24676110|NCT01348243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24676111|NCT01348243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24676112|NCT01348243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24676113|NCT01348243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676129|NCT01348308|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24676131|NCT01348308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24676132|NCT01348308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24676133|NCT01348308|Antiviral Agents|antiviral agents|mesh-ancestor
24676134|NCT01348308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24676135|NCT01348308|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24676136|NCT01348321|Levamisole|levamisole|mesh-list
24676158|NCT01348503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24676159|NCT01348503|Growth Substances|growth substances|mesh-ancestor
24676160|NCT01348503|Growth Inhibitors|growth inhibitors|mesh-ancestor
24676161|NCT01348503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24676162|NCT01348503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24676163|NCT01348503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676164|NCT01348503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676165|NCT01348724|Naloxegol|naloxegol|mesh-list
24676166|NCT01348724|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24676167|NCT01348724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694689|NCT02034565|Protease Inhibitors|protease inhibitors|mesh-ancestor
25694690|NCT02034565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819413|NCT02095405|Caffeine|caffeine|mesh-list
24676168|NCT01348724|Sensory System Agents|sensory system agents|mesh-ancestor
24676169|NCT01348724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24676170|NCT01348880|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24676171|NCT01348880|Vasodilator Agents|vasodilator agents|mesh-ancestor
24676172|NCT01348880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24676189|NCT01349010|Probucol|probucol|mesh-list
24676190|NCT01349010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24676191|NCT01349010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24676192|NCT01349010|Antimetabolites|antimetabolites|mesh-ancestor
24676193|NCT01349010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676194|NCT01349010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24676195|NCT01349010|Antioxidants|antioxidants|mesh-ancestor
24676196|NCT01349010|Protective Agents|protective agents|mesh-ancestor
24676197|NCT01349010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676198|NCT01349088|Niacinamide|niacinamide|mesh-list
24854121|NCT02271997|Ferrous fumarate|ferrous fumarate|mesh-list
24854122|NCT02271997|Ferrous gluconate|ferrous gluconate|mesh-list
24854123|NCT02271997|Trace Elements|trace elements|mesh-ancestor
24854124|NCT02271997|Micronutrients|micronutrients|mesh-ancestor
24676219|NCT01349127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676220|NCT01349127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24676221|NCT01349127|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24676222|NCT01349205|Sodium Benzoate|sodium benzoate|mesh-list
24676223|NCT01349205|Caffeine, sodium benzoate drug combination|caffeine, sodium benzoate drug combination|mesh-list
24676224|NCT01349205|Caffeine|caffeine|mesh-list
24676225|NCT01349205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24828347|NCT02145104|Valsartan|valsartan|mesh-list
24676226|NCT01349205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676227|NCT01349205|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24676228|NCT01349205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676229|NCT01349205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676230|NCT01349205|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24676231|NCT01349205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24676265|NCT01349270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24676266|NCT01349270|Immunologic Factors|immunologic factors|mesh-ancestor
24676267|NCT01349296|Everolimus|everolimus|mesh-list
24676268|NCT01349296|Nintedanib|nintedanib|mesh-list
24676269|NCT01349296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24676270|NCT01349296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24676271|NCT01349296|Immunologic Factors|immunologic factors|mesh-ancestor
24676289|NCT01349413|Esomeprazole|esomeprazole|mesh-list
24676290|NCT01349413|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24676291|NCT01349413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24676292|NCT01349413|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24676293|NCT01349413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676294|NCT01349413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676295|NCT01349439|Propranolol|propranolol|mesh-list
24676296|NCT01349439|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24676297|NCT01349439|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24676298|NCT01349439|Adrenergic Agents|adrenergic agents|mesh-ancestor
24676299|NCT01349439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24676300|NCT01349439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676301|NCT01349439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676302|NCT01349439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24676303|NCT01349439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24676304|NCT01349439|Vasodilator Agents|vasodilator agents|mesh-ancestor
24676305|NCT01349452|Ganciclovir|ganciclovir|mesh-list
24676306|NCT01349452|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
24676307|NCT01349452|Lubricant Eye Drops|lubricant eye drops|mesh-list
24676308|NCT01349452|Antiviral Agents|antiviral agents|mesh-ancestor
24676309|NCT01349452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24676310|NCT01349452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24676311|NCT01349452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676341|NCT01349738|Sulfamethoxazole|sulfamethoxazole|mesh-list
24676342|NCT01349738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24676343|NCT01349738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24676344|NCT01349738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24676345|NCT01349738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676346|NCT01349738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676347|NCT01349738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24676348|NCT01349738|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24676349|NCT01349738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25694691|NCT02034565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105631|NCT05254574|Analgesics|analgesics|mesh-ancestor
24783541|NCT01902511|Immunologic Factors|immunologic factors|mesh-ancestor
24977061|NCT04196283|Tubulin Modulators|tubulin modulators|mesh-ancestor
24977062|NCT04196283|Antimitotic Agents|antimitotic agents|mesh-ancestor
24977063|NCT04196283|Mitosis Modulators|mitosis modulators|mesh-ancestor
24676350|NCT01349738|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24676351|NCT01349738|Renal Agents|renal agents|mesh-ancestor
24676352|NCT01349738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24676353|NCT01349738|Antimalarials|antimalarials|mesh-ancestor
24676354|NCT01349738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24676355|NCT01349738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24676356|NCT01349738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24676357|NCT01349738|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24676358|NCT01349738|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24676359|NCT01349738|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24676360|NCT01349751|Levobupivacaine|levobupivacaine|mesh-list
24676361|NCT01349751|Anesthetics, Local|anesthetics, local|mesh-ancestor
24676362|NCT01349751|Anesthetics|anesthetics|mesh-ancestor
24676363|NCT01349751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24676364|NCT01349751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676365|NCT01349751|Sensory System Agents|sensory system agents|mesh-ancestor
24676366|NCT01349751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24676367|NCT01349764|Vitamin D|vitamin d|mesh-list
24676319|NCT01349647|Vaccines|vaccines|mesh-list
24676371|NCT01349764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676372|NCT01349764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24676373|NCT01349764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24676375|NCT01349777|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24676376|NCT01349777|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24676377|NCT01349777|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24676378|NCT01349777|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24676379|NCT01349777|Purinergic Agents|purinergic agents|mesh-ancestor
24676423|NCT01350037|Anesthetics, General|anesthetics, general|mesh-ancestor
24676424|NCT01350037|Anesthetics|anesthetics|mesh-ancestor
24854130|NCT02272049|Anesthetics|anesthetics|mesh-ancestor
24462888|NCT00357825|Antidepressive Agents|antidepressive agents|mesh-ancestor
24462889|NCT00357825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24854131|NCT02272049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24854132|NCT02272049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854133|NCT02272101|Vitamin D|vitamin d|mesh-list
24854134|NCT02272101|Vitamins|vitamins|mesh-ancestor
24676425|NCT01350050|Carticaine|carticaine|mesh-list
24676426|NCT01350050|Anesthetics, Local|anesthetics, local|mesh-ancestor
24676427|NCT01350050|Anesthetics|anesthetics|mesh-ancestor
24676428|NCT01350050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24676457|NCT01350154|Urological Agents|urological agents|mesh-ancestor
24676458|NCT01350323|Bevacizumab|bevacizumab|mesh-list
24676459|NCT01350323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24676460|NCT01350323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24676461|NCT01350323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24676462|NCT01350323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24460725|NCT00349362|Testosterone|testosterone|mesh-list
24676463|NCT01350323|Growth Substances|growth substances|mesh-ancestor
24676464|NCT01350323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676498|NCT01350622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24676499|NCT01350622|Analgesics|analgesics|mesh-ancestor
24676500|NCT01350622|Sensory System Agents|sensory system agents|mesh-ancestor
24676501|NCT01350622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24676502|NCT01350622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676503|NCT01350622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24676504|NCT01350622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24676505|NCT01350622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24610798|NCT01005199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610799|NCT01005199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610800|NCT01005238|Lamivudine|lamivudine|mesh-list
24610801|NCT01005238|Telbivudine|telbivudine|mesh-list
24610802|NCT01005238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24447583|NCT00309101|Tacrolimus|tacrolimus|mesh-list
25694692|NCT02034565|Anticoagulants|anticoagulants|mesh-ancestor
25694693|NCT02034578|Apixaban|apixaban|mesh-list
25694694|NCT02034578|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25694695|NCT02034578|Antithrombins|antithrombins|mesh-ancestor
25694696|NCT02034578|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25694697|NCT02034578|Protease Inhibitors|protease inhibitors|mesh-ancestor
25694698|NCT02034578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610824|NCT01005381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25709342|NCT02265510|Paclitaxel|paclitaxel|mesh-list
24610825|NCT01005381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24610826|NCT01005381|Antacids|antacids|mesh-ancestor
24610827|NCT01005381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610828|NCT01005381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24610829|NCT01005433|Dexmedetomidine|dexmedetomidine|mesh-list
24610830|NCT01005433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24610831|NCT01005433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24610832|NCT01005433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610833|NCT01005433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24610834|NCT01005433|Analgesics|analgesics|mesh-ancestor
24610835|NCT01005433|Sensory System Agents|sensory system agents|mesh-ancestor
25030077|NCT03598634|Riboflavin|riboflavin|mesh-list
24610836|NCT01005433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24610837|NCT01005433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24610850|NCT01005472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24676517|NCT01350817|Tubulin Modulators|tubulin modulators|mesh-ancestor
24676518|NCT01350817|Antimitotic Agents|antimitotic agents|mesh-ancestor
24676519|NCT01350817|Mitosis Modulators|mitosis modulators|mesh-ancestor
24676520|NCT01350817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676539|NCT01350882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676541|NCT01350882|Anticoagulants|anticoagulants|mesh-ancestor
24676575|NCT01351168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676576|NCT01351168|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24676577|NCT01351168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24676578|NCT01351168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24676579|NCT01351168|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24676608|NCT01351298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24676609|NCT01351298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24676610|NCT01351298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24676613|NCT01351298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24676614|NCT01351298|Respiratory System Agents|respiratory system agents|mesh-ancestor
24676616|NCT01351428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24676617|NCT01351428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24676618|NCT01351428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676619|NCT01351428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24676620|NCT01351428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676621|NCT01351428|Vasodilator Agents|vasodilator agents|mesh-ancestor
24676622|NCT01351428|Tocolytic Agents|tocolytic agents|mesh-ancestor
24676623|NCT01351428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24676624|NCT01351493|Nitric Oxide|nitric oxide|mesh-list
24676625|NCT01351493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24676633|NCT01351493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676634|NCT01351493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24676668|NCT01351948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676669|NCT01351948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24676670|NCT01352026|Metformin|metformin|mesh-list
24676671|NCT01352026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24676672|NCT01352026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676673|NCT01352039|Heparin|heparin|mesh-list
24676674|NCT01352039|Calcium heparin|calcium heparin|mesh-list
24676675|NCT01352039|Anticoagulants|anticoagulants|mesh-ancestor
24676676|NCT01352039|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24854145|NCT02272166|Anesthetics|anesthetics|mesh-ancestor
24854146|NCT02272166|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24676677|NCT01352039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24676678|NCT01352039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676679|NCT01352065|Bosentan|bosentan|mesh-list
24676680|NCT01352065|Ambrisentan|ambrisentan|mesh-list
24676681|NCT01352065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24676682|NCT01352065|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24687967|NCT03563690|Celecoxib|celecoxib|mesh-list
24676683|NCT01352065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676684|NCT01352091|Goserelin|goserelin|mesh-list
24676685|NCT01352091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24676686|NCT01352091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24676687|NCT01352130|Ondansetron|ondansetron|mesh-list
24676688|NCT01352130|Granisetron|granisetron|mesh-list
24676720|NCT01352234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676721|NCT01352234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24676722|NCT01352234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24637891|NCT01153802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24676723|NCT01352234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676724|NCT01352234|Antipyretics|antipyretics|mesh-ancestor
24676725|NCT01352299|Pyrithione zinc|pyrithione zinc|mesh-list
24440224|NCT00281983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24676726|NCT01352299|Keratolytic Agents|keratolytic agents|mesh-ancestor
24676727|NCT01352299|Dermatologic Agents|dermatologic agents|mesh-ancestor
24676728|NCT01352312|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24676730|NCT01352312|Pentostatin|pentostatin|mesh-list
24676731|NCT01352312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24676732|NCT01352312|Alkylating Agents|alkylating agents|mesh-ancestor
24676753|NCT01352338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24676754|NCT01352338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24676755|NCT01352338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24676756|NCT01352338|Growth Substances|growth substances|mesh-ancestor
24676757|NCT01352338|Growth Inhibitors|growth inhibitors|mesh-ancestor
24676758|NCT01352494|Gemcitabine|gemcitabine|mesh-list
24676759|NCT01352494|Docetaxel|docetaxel|mesh-list
24676760|NCT01352494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24676761|NCT01352494|Antimetabolites|antimetabolites|mesh-ancestor
24676762|NCT01352494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676763|NCT01352494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24676764|NCT01352494|Antiviral Agents|antiviral agents|mesh-ancestor
24956140|NCT03856970|Glyburide|glyburide|mesh-list
24676765|NCT01352494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24676766|NCT01352494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676804|NCT01352559|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24854147|NCT02272166|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24854150|NCT02272270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24854151|NCT02272270|Alkylating Agents|alkylating agents|mesh-ancestor
24854152|NCT02272270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854153|NCT02272270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24854154|NCT02272270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24854155|NCT02272270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24854156|NCT02272387|Vitamin D|vitamin d|mesh-list
24854157|NCT02272387|Cholecalciferol|cholecalciferol|mesh-list
24854158|NCT02272387|Vitamins|vitamins|mesh-ancestor
24854159|NCT02272387|Micronutrients|micronutrients|mesh-ancestor
24440225|NCT00281983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24440226|NCT00281983|Abortifacient Agents|abortifacient agents|mesh-ancestor
24440227|NCT00281983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24440228|NCT00281983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24440229|NCT00281983|Antimetabolites|antimetabolites|mesh-ancestor
24440230|NCT00281983|Dermatologic Agents|dermatologic agents|mesh-ancestor
24854160|NCT02272387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854161|NCT02272387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24854162|NCT02272387|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24854164|NCT02272478|Gemtuzumab|gemtuzumab|mesh-list
24854165|NCT02272478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24676819|NCT01352572|Antidepressive Agents|antidepressive agents|mesh-list
24676820|NCT01352572|Levomilnacipran|levomilnacipran|mesh-list
24676821|NCT01352572|Nortriptyline|nortriptyline|mesh-list
24676822|NCT01352572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24676823|NCT01352572|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24676824|NCT01352572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24676825|NCT01352572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24676826|NCT01352572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676827|NCT01352572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24676828|NCT01352572|Serotonin Agents|serotonin agents|mesh-ancestor
24676829|NCT01352572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461191|NCT00351195|Etoposide|etoposide|mesh-list
24676830|NCT01352572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24676831|NCT01352572|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24676832|NCT01352572|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24676833|NCT01352572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610855|NCT01005472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610857|NCT01005537|Cyclophosphamide|cyclophosphamide|mesh-list
24610858|NCT01005537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24610859|NCT01005537|Immunologic Factors|immunologic factors|mesh-ancestor
24610860|NCT01005537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610861|NCT01005537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25709343|NCT02265510|Lenalidomide|lenalidomide|mesh-list
25709344|NCT02265510|Bortezomib|bortezomib|mesh-list
25709345|NCT02265510|Azacitidine|azacitidine|mesh-list
25709346|NCT02265510|Pomalidomide|pomalidomide|mesh-list
24676868|NCT01352650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676869|NCT01352650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24676870|NCT01352650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676871|NCT01352650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24676872|NCT01352650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24676873|NCT01352650|Antiviral Agents|antiviral agents|mesh-ancestor
24676878|NCT01352663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676879|NCT01352702|Dabigatran|dabigatran|mesh-list
24676880|NCT01352702|Phenprocoumon|phenprocoumon|mesh-list
24676881|NCT01352702|Antithrombins|antithrombins|mesh-ancestor
24676882|NCT01352702|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24828514|NCT02145832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24828515|NCT02145832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828516|NCT02145832|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24828517|NCT02145832|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24676883|NCT01352702|Protease Inhibitors|protease inhibitors|mesh-ancestor
24676884|NCT01352702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24956242|NCT03855865|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24676885|NCT01352702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676886|NCT01352702|Anticoagulants|anticoagulants|mesh-ancestor
24676887|NCT01352728|Axitinib|axitinib|mesh-list
24676888|NCT01352728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24676889|NCT01352728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24676890|NCT01352728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676904|NCT01353209|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24676905|NCT01353209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24676906|NCT01353209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854179|NCT02272517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854180|NCT02272517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24854181|NCT02272517|Antidepressive Agents|antidepressive agents|mesh-ancestor
24676907|NCT01353209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676926|NCT01353339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24676927|NCT01353339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24676929|NCT01353339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676930|NCT01353339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24676931|NCT01353339|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24676932|NCT01353339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24676933|NCT01353378|Dexmedetomidine|dexmedetomidine|mesh-list
24676934|NCT01353378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24676935|NCT01353378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24676936|NCT01353378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676937|NCT01353378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24676939|NCT01353378|Sensory System Agents|sensory system agents|mesh-ancestor
24676941|NCT01353378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24676942|NCT01353378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24676960|NCT01353456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24676961|NCT01353456|Adrenergic Agents|adrenergic agents|mesh-ancestor
24676962|NCT01353456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24676963|NCT01353456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676965|NCT01353469|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24676966|NCT01353469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24676967|NCT01353469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676968|NCT01353482|Pemetrexed|pemetrexed|mesh-list
24676969|NCT01353482|Vorinostat|vorinostat|mesh-list
24676970|NCT01353482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24676971|NCT01353482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676972|NCT01353482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676973|NCT01353482|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24676974|NCT01353482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24676975|NCT01353482|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24676976|NCT01353599|Mometasone Furoate|mometasone furoate|mesh-list
24677112|NCT01354418|Protective Agents|protective agents|mesh-ancestor
24676994|NCT01353729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24828571|NCT02146261|Quetmolimab|quetmolimab|mesh-list
24676995|NCT01353729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25694699|NCT02034578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694700|NCT02034578|Anticoagulants|anticoagulants|mesh-ancestor
25694701|NCT02034591|Apixaban|apixaban|mesh-list
25694702|NCT02034591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25694703|NCT02034591|Antithrombins|antithrombins|mesh-ancestor
24676996|NCT01353729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676997|NCT01353729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676998|NCT01353729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24677008|NCT01353742|Adefovir|adefovir|mesh-list
24677010|NCT01353742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24677011|NCT01353742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24677012|NCT01353742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24677013|NCT01353742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677014|NCT01353742|Antiviral Agents|antiviral agents|mesh-ancestor
24677015|NCT01353742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24677016|NCT01353742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24677017|NCT01353742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24677018|NCT01353794|Sorafenib|sorafenib|mesh-list
24677019|NCT01353794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24677020|NCT01353794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24677022|NCT01353794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677023|NCT01353833|Aldesleukin|aldesleukin|mesh-list
24677024|NCT01353833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24677025|NCT01353833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24677026|NCT01353833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24677027|NCT01353833|Antiviral Agents|antiviral agents|mesh-ancestor
24677028|NCT01353833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24677029|NCT01353846|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24677030|NCT01353846|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24677031|NCT01353846|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24677032|NCT01353846|Estradiol|estradiol|mesh-list
24677033|NCT01353846|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24677034|NCT01353846|Progesterone|progesterone|mesh-list
24677035|NCT01353846|Estrogens|estrogens|mesh-ancestor
24677036|NCT01353846|Hormones|hormones|mesh-ancestor
24677037|NCT01353846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24677038|NCT01353846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677039|NCT01353846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24677040|NCT01353846|Contraceptive Agents|contraceptive agents|mesh-ancestor
24677041|NCT01353846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24677042|NCT01353846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24677043|NCT01353846|Progestins|progestins|mesh-ancestor
24677058|NCT01353937|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
24677059|NCT01353937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24677061|NCT01353937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677062|NCT01354158|Droxidopa|droxidopa|mesh-list
24677063|NCT01354158|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24677064|NCT01354158|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24677065|NCT01354262|Vitamin D|vitamin d|mesh-list
24677084|NCT01354301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24677085|NCT01354301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24677086|NCT01354301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677087|NCT01354301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24677088|NCT01354301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24677089|NCT01354301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24677092|NCT01354301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24677093|NCT01354405|Lanreotide|lanreotide|mesh-list
24677094|NCT01354405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24677095|NCT01354418|Phenylephrine|phenylephrine|mesh-list
24637947|NCT01154361|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
24677096|NCT01354418|Oxymetazoline|oxymetazoline|mesh-list
24677097|NCT01354418|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24677098|NCT01354418|Mydriatics|mydriatics|mesh-ancestor
24677099|NCT01354418|Autonomic Agents|autonomic agents|mesh-ancestor
24637953|NCT01154387|Tacrolimus|tacrolimus|mesh-list
24677100|NCT01354418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24677101|NCT01354418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677102|NCT01354418|Sympathomimetics|sympathomimetics|mesh-ancestor
24677103|NCT01354418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24677104|NCT01354418|Nasal Decongestants|nasal decongestants|mesh-ancestor
24677105|NCT01354418|Respiratory System Agents|respiratory system agents|mesh-ancestor
24677106|NCT01354418|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24677107|NCT01354418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24677108|NCT01354418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24677109|NCT01354418|Adrenergic Agents|adrenergic agents|mesh-ancestor
24677110|NCT01354418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24677111|NCT01354418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694704|NCT02034591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25030254|NCT03597477|Analgesics|analgesics|mesh-ancestor
24677113|NCT01354457|Epratuzumab|epratuzumab|mesh-list
24677114|NCT01354457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24677115|NCT01354457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24677116|NCT01354470|Modafinil|modafinil|mesh-list
24677117|NCT01354470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24676580|NCT01351168|GABA Agonists|gaba agonists|mesh-ancestor
24677147|NCT01354483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677148|NCT01354483|Antimanic Agents|antimanic agents|mesh-ancestor
24677149|NCT01354483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24677150|NCT01354483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24677151|NCT01354522|Cyclophosphamide|cyclophosphamide|mesh-list
24677152|NCT01354522|Docetaxel|docetaxel|mesh-list
24440231|NCT00281983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24440232|NCT00281983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24677153|NCT01354522|Doxorubicin|doxorubicin|mesh-list
24677154|NCT01354522|Capecitabine|capecitabine|mesh-list
24677155|NCT01354522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24677156|NCT01354522|Immunologic Factors|immunologic factors|mesh-ancestor
24677157|NCT01354522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677158|NCT01354522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24677159|NCT01354522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24677160|NCT01354522|Alkylating Agents|alkylating agents|mesh-ancestor
24677161|NCT01354522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677162|NCT01354522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24677163|NCT01354522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24677164|NCT01354522|Tubulin Modulators|tubulin modulators|mesh-ancestor
24677165|NCT01354522|Antimitotic Agents|antimitotic agents|mesh-ancestor
24677166|NCT01354522|Mitosis Modulators|mitosis modulators|mesh-ancestor
24854185|NCT02272517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24854186|NCT02272517|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24854187|NCT02272517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24677167|NCT01354522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24677168|NCT01354522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24677169|NCT01354522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24677170|NCT01354522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24677171|NCT01354522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24677174|NCT01354613|Dobutamine|dobutamine|mesh-list
24676642|NCT01351597|Docetaxel|docetaxel|mesh-list
24677220|NCT01354860|Cholinergic Agents|cholinergic agents|mesh-ancestor
24677221|NCT01354860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24677222|NCT01354860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677223|NCT01354860|Respiratory System Agents|respiratory system agents|mesh-ancestor
24677224|NCT01354886|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24677225|NCT01354886|Hormones|hormones|mesh-ancestor
24677226|NCT01354886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24677228|NCT01354925|Insulin|insulin|mesh-list
24677266|NCT01355276|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24677268|NCT01355354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24677269|NCT01355354|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24677270|NCT01355354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24677271|NCT01355354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677272|NCT01355354|Protective Agents|protective agents|mesh-ancestor
24677273|NCT01355354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677274|NCT01355367|Nifedipine|nifedipine|mesh-list
24677275|NCT01355367|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24677276|NCT01355367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24677277|NCT01355367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677278|NCT01355367|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24677279|NCT01355367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677280|NCT01355367|Vasodilator Agents|vasodilator agents|mesh-ancestor
24677281|NCT01355367|Tocolytic Agents|tocolytic agents|mesh-ancestor
24677282|NCT01355367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24677283|NCT01355380|Iloprost|iloprost|mesh-list
24677284|NCT01355380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24677285|NCT01355380|Vasodilator Agents|vasodilator agents|mesh-ancestor
24677286|NCT01355445|Irinotecan|irinotecan|mesh-list
24677332|NCT01355952|Vitamins|vitamins|mesh-ancestor
24854188|NCT02272517|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24854189|NCT02272517|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24854190|NCT02272582|Heparin|heparin|mesh-list
24854191|NCT02272582|Anticoagulants|anticoagulants|mesh-ancestor
24854192|NCT02272582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24854193|NCT02272582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24409437|NCT00182013|Risperidone|risperidone|mesh-list
24702151|NCT01464242|Pentoxifylline|pentoxifylline|mesh-list
24854194|NCT02272582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854195|NCT02272647|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24854196|NCT02272647|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24854197|NCT02272647|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24854198|NCT02272647|Medroxyprogesterone|medroxyprogesterone|mesh-list
24854200|NCT02272647|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24854201|NCT02272647|Progesterone|progesterone|mesh-list
24854202|NCT02272647|Estrogens|estrogens|mesh-ancestor
24854203|NCT02272647|Hormones|hormones|mesh-ancestor
24854204|NCT02272647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24854205|NCT02272647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854206|NCT02272647|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24854207|NCT02272647|Contraceptive Agents|contraceptive agents|mesh-ancestor
24854208|NCT02272647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24854209|NCT02272647|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24456890|NCT00332553|Hormones|hormones|mesh-ancestor
24677342|NCT01355991|Parasympatholytics|parasympatholytics|mesh-ancestor
24677343|NCT01355991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24677344|NCT01355991|Cholinergic Agents|cholinergic agents|mesh-ancestor
24677345|NCT01355991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24677346|NCT01355991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677347|NCT01355991|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24677348|NCT01355991|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24677349|NCT01355991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24610891|NCT01005641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610892|NCT01005758|Cytarabine|cytarabine|mesh-list
24854210|NCT02272647|Progestins|progestins|mesh-ancestor
24854211|NCT02272647|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24545729|NCT00694694|Lumefantrine|lumefantrine|mesh-list
24854215|NCT02272647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24854216|NCT02272647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24854217|NCT02272660|Parecoxib|parecoxib|mesh-list
24610893|NCT01005758|Dexamethasone|dexamethasone|mesh-list
24610894|NCT01005758|Prednisone|prednisone|mesh-list
24610895|NCT01005758|Methylprednisolone|methylprednisolone|mesh-list
24610896|NCT01005758|Prednisolone|prednisolone|mesh-list
24677357|NCT01356017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24677358|NCT01356017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677359|NCT01356017|Vasodilator Agents|vasodilator agents|mesh-ancestor
24677360|NCT01356017|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24677361|NCT01356017|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24677362|NCT01356043|Niacin|niacin|mesh-list
24677363|NCT01356043|Amlodipine|amlodipine|mesh-list
24677364|NCT01356043|Telmisartan|telmisartan|mesh-list
24677365|NCT01356043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24677366|NCT01356043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24677367|NCT01356043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24677368|NCT01356043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677369|NCT01356043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24677370|NCT01356043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677371|NCT01356043|Vasodilator Agents|vasodilator agents|mesh-ancestor
24677372|NCT01356043|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24677373|NCT01356043|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24677374|NCT01356043|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24677375|NCT01356043|Antimetabolites|antimetabolites|mesh-ancestor
24677376|NCT01356043|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24677377|NCT01356043|Vitamin B Complex|vitamin b complex|mesh-ancestor
24677378|NCT01356043|Vitamins|vitamins|mesh-ancestor
24677415|NCT01356225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24677416|NCT01356225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677427|NCT01356303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694705|NCT02034591|Protease Inhibitors|protease inhibitors|mesh-ancestor
25694706|NCT02034591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25694707|NCT02034591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694708|NCT02034591|Anticoagulants|anticoagulants|mesh-ancestor
25694709|NCT02034799|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25694710|NCT02034799|Hemostatics|hemostatics|mesh-ancestor
24472855|NCT00400777|Diuretics|diuretics|mesh-ancestor
24472856|NCT00400777|Natriuretic Agents|natriuretic agents|mesh-ancestor
24472857|NCT00400777|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24472858|NCT00400790|Propofol|propofol|mesh-list
24677429|NCT01356329|Enoxaparin|enoxaparin|mesh-list
24677430|NCT01356329|Anticoagulants|anticoagulants|mesh-ancestor
24677431|NCT01356329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24854218|NCT02272660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24854219|NCT02272660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24854220|NCT02272660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854221|NCT02272660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854222|NCT02272660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24854223|NCT02272660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24677432|NCT01356329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24677433|NCT01356329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677434|NCT01356355|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24677435|NCT01356355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24677436|NCT01356355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24677437|NCT01356355|Cholinergic Agents|cholinergic agents|mesh-ancestor
24677438|NCT01356355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24677439|NCT01356355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677440|NCT01356355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677441|NCT01356355|Urological Agents|urological agents|mesh-ancestor
24677442|NCT01356368|Docetaxel|docetaxel|mesh-list
24677458|NCT01356433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677460|NCT01356433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677461|NCT01356433|Protective Agents|protective agents|mesh-ancestor
24677462|NCT01356472|Imipenem|imipenem|mesh-list
24677463|NCT01356472|Cilastatin|cilastatin|mesh-list
24677464|NCT01356472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24677465|NCT01356472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24677485|NCT01356524|Hormones|hormones|mesh-ancestor
24677497|NCT01356615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24677498|NCT01356615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677499|NCT01356641|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24677500|NCT01356641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24677523|NCT01356680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24677524|NCT01356680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24677525|NCT01356680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24677527|NCT01356680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24677528|NCT01356680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24677529|NCT01356680|Tubulin Modulators|tubulin modulators|mesh-ancestor
24677530|NCT01356680|Antimitotic Agents|antimitotic agents|mesh-ancestor
24854224|NCT02272660|Analgesics|analgesics|mesh-ancestor
24854225|NCT02272660|Sensory System Agents|sensory system agents|mesh-ancestor
24854226|NCT02272660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24854227|NCT02272660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854228|NCT02272660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24854229|NCT02272660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24677531|NCT01356680|Mitosis Modulators|mitosis modulators|mesh-ancestor
24677532|NCT01356680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24677534|NCT01356732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24677535|NCT01356732|Narcotics|narcotics|mesh-ancestor
24677536|NCT01356732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24677537|NCT01356732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677538|NCT01356732|Analgesics|analgesics|mesh-ancestor
24677539|NCT01356732|Sensory System Agents|sensory system agents|mesh-ancestor
24677550|NCT01356745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677551|NCT01356745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24677552|NCT01356745|Analgesics|analgesics|mesh-ancestor
24677593|NCT01356927|Contraceptive Agents|contraceptive agents|mesh-ancestor
25694711|NCT02034799|Coagulants|coagulants|mesh-ancestor
25694712|NCT02034877|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25694713|NCT02034877|Immunologic Factors|immunologic factors|mesh-ancestor
25694714|NCT02034877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694715|NCT02034916|Talazoparib|talazoparib|mesh-list
25694716|NCT02034916|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25694717|NCT02034916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709347|NCT02265510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24472874|NCT00400855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24915096|NCT04674670|Naltrexone|naltrexone|mesh-list
24915097|NCT04674670|Bromocriptine|bromocriptine|mesh-list
24915098|NCT04674670|Amisulpride|amisulpride|mesh-list
24677594|NCT01356927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24677595|NCT01356927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677596|NCT01356927|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24677597|NCT01356927|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24677598|NCT01356927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24677599|NCT01356927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24677600|NCT01356992|Enoxaparin|enoxaparin|mesh-list
24677601|NCT01356992|Anticoagulants|anticoagulants|mesh-ancestor
24677602|NCT01356992|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24677603|NCT01356992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24677604|NCT01356992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677605|NCT01357031|Amitriptyline|amitriptyline|mesh-list
24677606|NCT01357031|Melatonin|melatonin|mesh-list
24677607|NCT01357031|Antioxidants|antioxidants|mesh-ancestor
24677608|NCT01357031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677609|NCT01357031|Protective Agents|protective agents|mesh-ancestor
24677634|NCT01357252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677635|NCT01357317|Calcium, Dietary|calcium, dietary|mesh-list
24677636|NCT01357317|Calcium|calcium|mesh-list
24677637|NCT01357317|Calcium acetate|calcium acetate|mesh-list
24854230|NCT02272699|Paclitaxel|paclitaxel|mesh-list
24610898|NCT01005758|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24610899|NCT01005758|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24677691|NCT01357876|Metformin|metformin|mesh-list
24677692|NCT01357876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24677693|NCT01357876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677694|NCT01357902|Lamotrigine|lamotrigine|mesh-list
24677695|NCT01357902|Anticonvulsants|anticonvulsants|mesh-ancestor
24637990|NCT01154439|Everolimus|everolimus|mesh-list
24677696|NCT01357902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24677697|NCT01357902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24677698|NCT01357902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677713|NCT01358045|Calcitriol|calcitriol|mesh-list
24677714|NCT01358045|Diclofenac|diclofenac|mesh-list
24677715|NCT01358045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24854238|NCT02272699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24854240|NCT02272738|Paclitaxel|paclitaxel|mesh-list
24854241|NCT02272738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24854242|NCT02272738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24854243|NCT02272738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24854244|NCT02272738|Tubulin Modulators|tubulin modulators|mesh-ancestor
24456916|NCT00332631|Expectorants|expectorants|mesh-ancestor
24677716|NCT01358045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24677068|NCT01354262|Vitamins|vitamins|mesh-list
24677725|NCT01358045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677726|NCT01358045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24677727|NCT01358045|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24677728|NCT01358045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24677729|NCT01358045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24677731|NCT01358045|Micronutrients|micronutrients|mesh-ancestor
24677732|NCT01358045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24677733|NCT01358071|Doxorubicin|doxorubicin|mesh-list
24677734|NCT01358071|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24858550|NCT02298218|Meloxicam|meloxicam|mesh-list
24440233|NCT00281983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24440234|NCT00281983|Antifungal Agents|antifungal agents|mesh-ancestor
24440235|NCT00281983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24440236|NCT00281983|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25694718|NCT02034916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694719|NCT02034916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694720|NCT02035267|Deoxycholic Acid|deoxycholic acid|mesh-list
25694721|NCT02035267|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25694722|NCT02035267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25694723|NCT02035345|Carboplatin|carboplatin|mesh-list
25694724|NCT02035345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694725|NCT02035553|Pimavanserin|pimavanserin|mesh-list
24440237|NCT00281983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24677735|NCT01358071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24677736|NCT01358071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24677737|NCT01358071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24677738|NCT01358071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24677739|NCT01358071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24677740|NCT01358071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677742|NCT01358240|Antifungal Agents|antifungal agents|mesh-ancestor
24677743|NCT01358240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24677744|NCT01358240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24677745|NCT01358240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24677746|NCT01358240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24677747|NCT01358240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677748|NCT01358240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24677749|NCT01358240|Hormone Antagonists|hormone antagonists|mesh-ancestor
24677750|NCT01358240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24677751|NCT01358240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677752|NCT01358253|Cytarabine|cytarabine|mesh-list
24677753|NCT01358253|Dexamethasone|dexamethasone|mesh-list
24677754|NCT01358253|Prednisone|prednisone|mesh-list
24677755|NCT01358253|Cyclophosphamide|cyclophosphamide|mesh-list
24677756|NCT01358253|Rituximab|rituximab|mesh-list
24677781|NCT01358253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24677782|NCT01358253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24677783|NCT01358253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24677784|NCT01358253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24677785|NCT01358253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24677786|NCT01358253|Abortifacient Agents|abortifacient agents|mesh-ancestor
24677787|NCT01358253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24677788|NCT01358253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24677789|NCT01358253|Antimetabolites|antimetabolites|mesh-ancestor
24677790|NCT01358253|Dermatologic Agents|dermatologic agents|mesh-ancestor
24677791|NCT01358253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24677793|NCT01358253|Antiviral Agents|antiviral agents|mesh-ancestor
24677797|NCT01358253|Antimitotic Agents|antimitotic agents|mesh-ancestor
24854245|NCT02272738|Antimitotic Agents|antimitotic agents|mesh-ancestor
24854246|NCT02272738|Mitosis Modulators|mitosis modulators|mesh-ancestor
24854247|NCT02272738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854248|NCT02272738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24677798|NCT01358253|Mitosis Modulators|mitosis modulators|mesh-ancestor
24677800|NCT01358344|Vorapaxar|vorapaxar|mesh-list
24677801|NCT01358344|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24677841|NCT01358409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677842|NCT01358409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677844|NCT01358435|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24677845|NCT01358435|Insulin, Isophane|insulin, isophane|mesh-list
24677846|NCT01358435|Isophane Insulin, Human|isophane insulin, human|mesh-list
24677847|NCT01358435|Isophane insulin, beef|isophane insulin, beef|mesh-list
24677848|NCT01358435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24677849|NCT01358435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677851|NCT01358500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24677852|NCT01358500|Narcotics|narcotics|mesh-ancestor
24677853|NCT01358500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24677854|NCT01358500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677855|NCT01358500|Analgesics|analgesics|mesh-ancestor
24677856|NCT01358500|Sensory System Agents|sensory system agents|mesh-ancestor
24677881|NCT01359020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677882|NCT01359020|Antipyretics|antipyretics|mesh-ancestor
24677883|NCT01359020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24677884|NCT01359020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24677885|NCT01359020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24677886|NCT01359020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24677887|NCT01359020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24638013|NCT01154465|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24677888|NCT01359020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677889|NCT01359059|Pregabalin|pregabalin|mesh-list
24677890|NCT01359059|Analgesics|analgesics|mesh-ancestor
24677891|NCT01359059|Sensory System Agents|sensory system agents|mesh-ancestor
24677892|NCT01359059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24677894|NCT01359059|Anticonvulsants|anticonvulsants|mesh-ancestor
24677895|NCT01359059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24677896|NCT01359059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25694726|NCT02035553|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24678230|NCT01360424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677897|NCT01359059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677898|NCT01359059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24677900|NCT01359059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24677901|NCT01359059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24677902|NCT01359059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24677904|NCT01359085|Analgesics|analgesics|mesh-ancestor
24677905|NCT01359085|Sensory System Agents|sensory system agents|mesh-ancestor
24677918|NCT01359098|Dexamethasone|dexamethasone|mesh-list
24677919|NCT01359098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24677920|NCT01359098|Antiemetics|antiemetics|mesh-ancestor
24854260|NCT02272764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24456922|NCT00332631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677924|NCT01359098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24677925|NCT01359098|Glucocorticoids|glucocorticoids|mesh-ancestor
24677926|NCT01359098|Hormones|hormones|mesh-ancestor
24677927|NCT01359098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24677928|NCT01359098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24677929|NCT01359098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24677930|NCT01359098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24677931|NCT01359098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677932|NCT01359098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24677933|NCT01359098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24677934|NCT01359098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24677935|NCT01359098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24677936|NCT01359098|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24677937|NCT01359098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24677938|NCT01359163|Ethynodiol Diacetate|ethynodiol diacetate|mesh-list
24677939|NCT01359163|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24677940|NCT01359163|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24677941|NCT01359163|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24677943|NCT01359163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24677944|NCT01359163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677945|NCT01359163|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24677946|NCT01359163|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24677947|NCT01359202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24677949|NCT01359228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24677950|NCT01359228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24677951|NCT01359228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24677952|NCT01359241|Insulin|insulin|mesh-list
24677953|NCT01359241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24677954|NCT01359241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677955|NCT01359397|Bevacizumab|bevacizumab|mesh-list
24677956|NCT01359397|Trastuzumab|trastuzumab|mesh-list
24677957|NCT01359397|Docetaxel|docetaxel|mesh-list
24677958|NCT01359397|Oxaliplatin|oxaliplatin|mesh-list
24677959|NCT01359397|Capecitabine|capecitabine|mesh-list
24677960|NCT01359397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24677961|NCT01359397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24677962|NCT01359397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24677963|NCT01359397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24677964|NCT01359397|Growth Substances|growth substances|mesh-ancestor
24677965|NCT01359397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677985|NCT01359423|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24677999|NCT01359488|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
24678000|NCT01359488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24678001|NCT01359488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678003|NCT01359514|Calcium Channel Blockers|calcium channel blockers|mesh-list
24678004|NCT01359514|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24678005|NCT01359514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24828771|NCT02147548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24828772|NCT02147548|GABA Modulators|gaba modulators|mesh-ancestor
24828773|NCT02147548|GABA Agents|gaba agents|mesh-ancestor
24828774|NCT02147548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24678006|NCT01359514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678007|NCT01359514|Analgesics|analgesics|mesh-ancestor
24678008|NCT01359514|Sensory System Agents|sensory system agents|mesh-ancestor
24678010|NCT01359514|Anticonvulsants|anticonvulsants|mesh-ancestor
24678015|NCT01359514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24678016|NCT01359514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24678029|NCT01359605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915228|NCT03854019|Adrenergic Agents|adrenergic agents|mesh-ancestor
24915229|NCT03854019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24915230|NCT03854019|Antimalarials|antimalarials|mesh-ancestor
24678031|NCT01359618|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24678032|NCT01359618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24678033|NCT01359618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24678034|NCT01359618|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24678035|NCT01359618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24678036|NCT01359618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678037|NCT01359618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678038|NCT01359618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24782657|NCT01897116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678039|NCT01359618|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24678040|NCT01359618|Contraceptive Agents|contraceptive agents|mesh-ancestor
24678041|NCT01359618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24678042|NCT01359618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678043|NCT01359618|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24678044|NCT01359618|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24678045|NCT01359618|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24678047|NCT01359657|Dexamethasone acetate|dexamethasone acetate|mesh-list
24678048|NCT01359657|Lenalidomide|lenalidomide|mesh-list
24678049|NCT01359657|Bortezomib|bortezomib|mesh-list
24678050|NCT01359657|BB 1101|bb 1101|mesh-list
24678051|NCT01359657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24678052|NCT01359657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24678068|NCT01359657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24678069|NCT01359657|Growth Substances|growth substances|mesh-ancestor
24854263|NCT02272764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854264|NCT02272764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24854265|NCT02272764|Hormone Antagonists|hormone antagonists|mesh-ancestor
24678070|NCT01359657|Growth Inhibitors|growth inhibitors|mesh-ancestor
24678071|NCT01359670|Sildenafil Citrate|sildenafil citrate|mesh-list
24678072|NCT01359670|Tadalafil|tadalafil|mesh-list
24678073|NCT01359670|Vasodilator Agents|vasodilator agents|mesh-ancestor
24678074|NCT01359670|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24678104|NCT01359722|Expectorants|expectorants|mesh-ancestor
24678105|NCT01359722|Respiratory System Agents|respiratory system agents|mesh-ancestor
24678106|NCT01359722|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24678107|NCT01359722|Antioxidants|antioxidants|mesh-ancestor
24678108|NCT01359722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678109|NCT01359722|Protective Agents|protective agents|mesh-ancestor
24678110|NCT01359722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678111|NCT01359722|Antidotes|antidotes|mesh-ancestor
24678112|NCT01359826|Milnacipran|milnacipran|mesh-list
24678113|NCT01359826|Levomilnacipran|levomilnacipran|mesh-list
24678114|NCT01359826|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24678115|NCT01359826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24679162|NCT01367210|Protease Inhibitors|protease inhibitors|mesh-ancestor
24678116|NCT01359826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24447677|NCT00309374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24678138|NCT01359930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24678139|NCT01359930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678140|NCT01359930|Dopamine Agents|dopamine agents|mesh-ancestor
24678141|NCT01359930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24678142|NCT01359930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24678143|NCT01359930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24678144|NCT01359930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678146|NCT01360034|Nifedipine|nifedipine|mesh-list
24678152|NCT01360034|Vasodilator Agents|vasodilator agents|mesh-ancestor
24854271|NCT02272829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24854272|NCT02272829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678199|NCT01360151|Ranibizumab|ranibizumab|mesh-list
24678200|NCT01360151|Verteporfin|verteporfin|mesh-list
24678201|NCT01360151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24678202|NCT01360151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25694727|NCT02035553|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25694728|NCT02035553|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25694729|NCT02035553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25694730|NCT02035553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25694731|NCT02035553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694732|NCT02035553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24678204|NCT01360151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678205|NCT01360151|Growth Inhibitors|growth inhibitors|mesh-ancestor
24678206|NCT01360151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24678207|NCT01360151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24678208|NCT01360151|Dermatologic Agents|dermatologic agents|mesh-ancestor
24678209|NCT01360190|Fluoxetine|fluoxetine|mesh-list
24678210|NCT01360190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24678211|NCT01360190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24678212|NCT01360190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24677390|NCT01356121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24678229|NCT01360424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24678238|NCT01360437|Purinergic Agents|purinergic agents|mesh-ancestor
24678239|NCT01360437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24678240|NCT01360437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678241|NCT01360437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678243|NCT01360463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24678244|NCT01360463|Narcotics|narcotics|mesh-ancestor
24678245|NCT01360463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24678246|NCT01360463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678247|NCT01360463|Analgesics|analgesics|mesh-ancestor
24678248|NCT01360463|Sensory System Agents|sensory system agents|mesh-ancestor
24678249|NCT01360463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24678250|NCT01360463|Antitussive Agents|antitussive agents|mesh-ancestor
24678251|NCT01360463|Respiratory System Agents|respiratory system agents|mesh-ancestor
24678252|NCT01360476|Vitamin D|vitamin d|mesh-list
24610901|NCT01005758|Cyclophosphamide|cyclophosphamide|mesh-list
24610905|NCT01005758|Etoposide|etoposide|mesh-list
24610906|NCT01005758|Vincristine|vincristine|mesh-list
24610907|NCT01005758|Imatinib Mesylate|imatinib mesylate|mesh-list
24610908|NCT01005758|Mercaptopurine|mercaptopurine|mesh-list
24610909|NCT01005758|Pegaspargase|pegaspargase|mesh-list
24610910|NCT01005758|Etoposide phosphate|etoposide phosphate|mesh-list
24610911|NCT01005758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24610912|NCT01005758|Immunologic Factors|immunologic factors|mesh-ancestor
24610913|NCT01005758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854273|NCT02272829|Analgesics|analgesics|mesh-ancestor
24854274|NCT02272829|Sensory System Agents|sensory system agents|mesh-ancestor
24610914|NCT01005758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24610915|NCT01005758|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24610916|NCT01005758|Alkylating Agents|alkylating agents|mesh-ancestor
24610917|NCT01005758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610918|NCT01005758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610921|NCT01005758|Antiemetics|antiemetics|mesh-ancestor
24678328|NCT01361269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24678329|NCT01361269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24678330|NCT01361269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24678331|NCT01361269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678332|NCT01361269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678333|NCT01361373|Levodopa|levodopa|mesh-list
24678334|NCT01361373|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24678335|NCT01361373|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24678336|NCT01361373|Dopamine Agents|dopamine agents|mesh-ancestor
24678337|NCT01361373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24678339|NCT01361373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678340|NCT01361399|Aspirin|aspirin|mesh-list
24678341|NCT01361399|Lidocaine|lidocaine|mesh-list
24678342|NCT01361399|Anesthetics, Local|anesthetics, local|mesh-ancestor
24678343|NCT01361399|Anesthetics|anesthetics|mesh-ancestor
24678344|NCT01361399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24678361|NCT01361399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24678362|NCT01361399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678363|NCT01361399|Antipyretics|antipyretics|mesh-ancestor
24678364|NCT01361425|Methyldopa|methyldopa|mesh-list
24678365|NCT01361425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24678366|NCT01361425|Sympatholytics|sympatholytics|mesh-ancestor
24678392|NCT01361542|Immunologic Factors|immunologic factors|mesh-ancestor
24678393|NCT01361763|Dabigatran|dabigatran|mesh-list
24678394|NCT01361763|Antithrombins|antithrombins|mesh-ancestor
24678395|NCT01361763|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24678396|NCT01361763|Protease Inhibitors|protease inhibitors|mesh-ancestor
24678397|NCT01361763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462819|NCT00357630|Gemcitabine|gemcitabine|mesh-list
24678479|NCT01362218|Analgesics|analgesics|mesh-ancestor
24677616|NCT01357031|Analgesics|analgesics|mesh-ancestor
25694733|NCT02035553|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24678514|NCT01362426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24678515|NCT01362426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24957033|NCT03847792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24957034|NCT03847792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24957035|NCT03847792|Anesthetics, General|anesthetics, general|mesh-ancestor
24678516|NCT01362426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24678517|NCT01362426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678518|NCT01362426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24678519|NCT01362426|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24678520|NCT01362426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24678521|NCT01362426|Serotonin Agents|serotonin agents|mesh-ancestor
24678522|NCT01362426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24678523|NCT01362426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678524|NCT01362426|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24678525|NCT01362426|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24678526|NCT01362426|Dopamine Agents|dopamine agents|mesh-ancestor
24678527|NCT01362764|Abiraterone Acetate|abiraterone acetate|mesh-list
24678528|NCT01362764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24678529|NCT01362764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24678530|NCT01362764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678531|NCT01362764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678532|NCT01362764|Hormone Antagonists|hormone antagonists|mesh-ancestor
24657195|NCT01266174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678533|NCT01362764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24678534|NCT01362764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678535|NCT01362764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24678577|NCT01363089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24678578|NCT01363089|Sympathomimetics|sympathomimetics|mesh-ancestor
24678624|NCT01363284|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24678625|NCT01363284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24678626|NCT01363284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24678627|NCT01363284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678628|NCT01363284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24678629|NCT01363284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678631|NCT01363284|Sensory System Agents|sensory system agents|mesh-ancestor
24678632|NCT01363284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24678633|NCT01363284|Antidepressive Agents|antidepressive agents|mesh-ancestor
24678634|NCT01363284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24678635|NCT01363284|Dopamine Agents|dopamine agents|mesh-ancestor
24678636|NCT01363310|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24610967|NCT01005979|Cyclophosphamide|cyclophosphamide|mesh-list
24610969|NCT01005979|Lenalidomide|lenalidomide|mesh-list
24610970|NCT01005979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24610971|NCT01005979|Immunologic Factors|immunologic factors|mesh-ancestor
24610972|NCT01005979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610973|NCT01005979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24610974|NCT01005979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24610975|NCT01005979|Alkylating Agents|alkylating agents|mesh-ancestor
24610976|NCT01005979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610994|NCT01006031|Immunologic Factors|immunologic factors|mesh-ancestor
24611018|NCT01006395|Zoledronic Acid|zoledronic acid|mesh-list
24611019|NCT01006395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24678639|NCT01363310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24678640|NCT01363310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24678657|NCT01363323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24678658|NCT01363323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678659|NCT01363323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678660|NCT01363323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24678661|NCT01363323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678662|NCT01363323|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25694734|NCT02035553|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25694735|NCT02035553|Serotonin Agents|serotonin agents|mesh-ancestor
24473647|NCT00403663|Sensory System Agents|sensory system agents|mesh-ancestor
24473648|NCT00403663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24473650|NCT00403663|Narcotics|narcotics|mesh-ancestor
24473651|NCT00403663|Analgesics|analgesics|mesh-ancestor
24678663|NCT01363323|Sensory System Agents|sensory system agents|mesh-ancestor
24677757|NCT01358253|Doxorubicin|doxorubicin|mesh-list
24678689|NCT01363544|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24678690|NCT01363544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24678691|NCT01363544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24678692|NCT01363544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678693|NCT01363544|Dopamine Agents|dopamine agents|mesh-ancestor
24854289|NCT02272868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24854290|NCT02272868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24854292|NCT02272998|Ponatinib|ponatinib|mesh-list
24678694|NCT01363544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24678695|NCT01363557|Gefitinib|gefitinib|mesh-list
24678696|NCT01363557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24678706|NCT01363570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24678707|NCT01363583|Epoprostenol|epoprostenol|mesh-list
24678708|NCT01363583|Tezosentan|tezosentan|mesh-list
24678709|NCT01363583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24678710|NCT01363583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24678711|NCT01363583|Vasodilator Agents|vasodilator agents|mesh-ancestor
24678712|NCT01363609|Insulin Glargine|insulin glargine|mesh-list
24678713|NCT01363609|Liraglutide|liraglutide|mesh-list
24678714|NCT01363609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24678715|NCT01363609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678716|NCT01363609|Incretins|incretins|mesh-ancestor
24678718|NCT01363609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24678719|NCT01363648|Choline|choline|mesh-list
24678743|NCT01363817|Dexamethasone|dexamethasone|mesh-list
24678745|NCT01363817|Antiemetics|antiemetics|mesh-ancestor
24678746|NCT01363817|Autonomic Agents|autonomic agents|mesh-ancestor
24678747|NCT01363817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24678748|NCT01363817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678749|NCT01363817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24678750|NCT01363817|Glucocorticoids|glucocorticoids|mesh-ancestor
24678751|NCT01363817|Hormones|hormones|mesh-ancestor
24678752|NCT01363817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24678753|NCT01363817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24678754|NCT01363817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24678755|NCT01363934|Darbepoetin alfa|darbepoetin alfa|mesh-list
24678756|NCT01363934|Hematinics|hematinics|mesh-ancestor
24678757|NCT01364012|Paclitaxel|paclitaxel|mesh-list
24678758|NCT01364012|Bevacizumab|bevacizumab|mesh-list
24678759|NCT01364012|Carboplatin|carboplatin|mesh-list
24678760|NCT01364012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24678761|NCT01364012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24678762|NCT01364012|Tubulin Modulators|tubulin modulators|mesh-ancestor
24463277|NCT00359814|Cyclosporins|cyclosporins|mesh-list
24463278|NCT00359814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24463279|NCT00359814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828894|NCT02148094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828895|NCT02148094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828896|NCT02148094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24828897|NCT02148094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24828898|NCT02148120|Beclomethasone|beclomethasone|mesh-list
24828899|NCT02148120|Formoterol Fumarate|formoterol fumarate|mesh-list
24828900|NCT02148120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24828901|NCT02148120|Autonomic Agents|autonomic agents|mesh-ancestor
24828902|NCT02148120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24828903|NCT02148120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694736|NCT02035553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25694737|NCT02035553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694738|NCT02035696|Vaccines|vaccines|mesh-list
25694739|NCT02035696|Immunologic Factors|immunologic factors|mesh-ancestor
24463280|NCT00359814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24678780|NCT01364194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24678781|NCT01364194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678782|NCT01364194|Sensory System Agents|sensory system agents|mesh-ancestor
24677863|NCT01358591|Calcium|calcium|mesh-list
24854304|NCT02273102|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24854305|NCT02273102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854306|NCT02273102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678785|NCT01364220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24678786|NCT01364220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24678800|NCT01364376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678801|NCT01364376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463092|NCT00358618|Anesthetics, General|anesthetics, general|mesh-ancestor
24678803|NCT01364376|Protective Agents|protective agents|mesh-ancestor
24678804|NCT01364376|Vitamin B Complex|vitamin b complex|mesh-ancestor
24678805|NCT01364376|Vitamins|vitamins|mesh-ancestor
24678806|NCT01364376|Micronutrients|micronutrients|mesh-ancestor
24678807|NCT01364402|Epoetin Alfa|epoetin alfa|mesh-list
24678808|NCT01364402|Hematinics|hematinics|mesh-ancestor
24678809|NCT01364415|Pasireotide|pasireotide|mesh-list
24678810|NCT01364415|Hormones|hormones|mesh-ancestor
24678811|NCT01364415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24678812|NCT01364415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678813|NCT01364493|Capecitabine|capecitabine|mesh-list
24678814|NCT01364493|Oxaliplatin|oxaliplatin|mesh-list
24678815|NCT01364493|Trastuzumab|trastuzumab|mesh-list
24678816|NCT01364493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24678825|NCT01364519|Autonomic Agents|autonomic agents|mesh-ancestor
24679417|NCT01368341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24678826|NCT01364519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24678827|NCT01364519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678828|NCT01364519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24678829|NCT01364519|Respiratory System Agents|respiratory system agents|mesh-ancestor
24678830|NCT01364519|Dermatologic Agents|dermatologic agents|mesh-ancestor
24678831|NCT01364519|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24678833|NCT01364571|Immunologic Factors|immunologic factors|mesh-ancestor
24678834|NCT01364571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678835|NCT01364675|Metformin|metformin|mesh-list
24678836|NCT01364675|Enalapril|enalapril|mesh-list
24678837|NCT01364675|Simvastatin|simvastatin|mesh-list
24678838|NCT01364675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24854307|NCT02273102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24854308|NCT02273102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24678856|NCT01364701|Sildenafil Citrate|sildenafil citrate|mesh-list
24678858|NCT01364701|Vasodilator Agents|vasodilator agents|mesh-ancestor
24678870|NCT01364805|Micronutrients|micronutrients|mesh-ancestor
24678871|NCT01364805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678872|NCT01364805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24678873|NCT01364805|Antimetabolites|antimetabolites|mesh-ancestor
24678874|NCT01364805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678875|NCT01364805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24678876|NCT01364805|Antiviral Agents|antiviral agents|mesh-ancestor
24678877|NCT01364805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24678878|NCT01364805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678879|NCT01364805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24678880|NCT01364805|Immunologic Factors|immunologic factors|mesh-ancestor
24678881|NCT01364805|Antioxidants|antioxidants|mesh-ancestor
24678882|NCT01364805|Protective Agents|protective agents|mesh-ancestor
24678901|NCT01364987|Peficitinib|peficitinib|mesh-list
24678902|NCT01364987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24678903|NCT01364987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638250|NCT01155635|Antioxidants|antioxidants|mesh-ancestor
24678904|NCT01364987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24678905|NCT01364987|Antitubercular Agents|antitubercular agents|mesh-ancestor
24678906|NCT01364987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24678907|NCT01364987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24678908|NCT01364987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678922|NCT01365065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854309|NCT02273102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24679163|NCT01367210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854310|NCT02273102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854312|NCT02273128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24812621|NCT02053779|Contraceptive Agents|contraceptive agents|mesh-ancestor
24473442|NCT00402792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24678925|NCT01365104|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24678926|NCT01365104|Chelating Agents|chelating agents|mesh-ancestor
24678927|NCT01365104|Sequestering Agents|sequestering agents|mesh-ancestor
25694740|NCT02035696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678928|NCT01365104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678935|NCT01365260|Hyaluronic Acid|hyaluronic acid|mesh-list
24678936|NCT01365260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24678937|NCT01365260|Immunologic Factors|immunologic factors|mesh-ancestor
24678944|NCT01365312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25078342|NCT03357575|Hyaluronic Acid|hyaluronic acid|mesh-list
24463151|NCT00359125|Luteolytic Agents|luteolytic agents|mesh-ancestor
24678945|NCT01365312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678946|NCT01365351|Hormones|hormones|mesh-list
24678947|NCT01365351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24678948|NCT01365351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678949|NCT01365403|Carbamazepine|carbamazepine|mesh-list
24678950|NCT01365403|Anticonvulsants|anticonvulsants|mesh-ancestor
24678951|NCT01365403|Antimanic Agents|antimanic agents|mesh-ancestor
24678952|NCT01365403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24678953|NCT01365403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24678954|NCT01365403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678955|NCT01365403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24678956|NCT01365403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24678957|NCT01365403|Analgesics|analgesics|mesh-ancestor
24678958|NCT01365403|Sensory System Agents|sensory system agents|mesh-ancestor
24678959|NCT01365403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24678960|NCT01365403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24678961|NCT01365403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24678962|NCT01365403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678963|NCT01365403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24678964|NCT01365403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24678965|NCT01365598|Primaquine|primaquine|mesh-list
24462502|NCT00356486|Ribavirin|ribavirin|mesh-list
24679038|NCT01366183|Immunologic Factors|immunologic factors|mesh-ancestor
24679039|NCT01366183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679040|NCT01366235|Chloroquine|chloroquine|mesh-list
24679041|NCT01366235|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24679043|NCT01366235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24679046|NCT01366235|Antimalarials|antimalarials|mesh-ancestor
24679051|NCT01366235|Sensory System Agents|sensory system agents|mesh-ancestor
24679052|NCT01366235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679053|NCT01366235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679093|NCT01366339|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24679094|NCT01366339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679095|NCT01366339|Sensory System Agents|sensory system agents|mesh-ancestor
24679096|NCT01366339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679097|NCT01366352|Methylnaltrexone|methylnaltrexone|mesh-list
24679098|NCT01366352|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24679099|NCT01366352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679100|NCT01366352|Sensory System Agents|sensory system agents|mesh-ancestor
24679101|NCT01366352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679102|NCT01366365|Methylnaltrexone|methylnaltrexone|mesh-list
24679103|NCT01366365|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24679104|NCT01366365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679105|NCT01366365|Sensory System Agents|sensory system agents|mesh-ancestor
24679106|NCT01366365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679107|NCT01366378|Methylnaltrexone|methylnaltrexone|mesh-list
24679108|NCT01366378|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24679109|NCT01366378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679110|NCT01366378|Sensory System Agents|sensory system agents|mesh-ancestor
24679111|NCT01366378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679112|NCT01366391|Metformin|metformin|mesh-list
24679113|NCT01366391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24679114|NCT01366391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679115|NCT01366547|Lamivudine|lamivudine|mesh-list
24679116|NCT01366547|Abacavir|abacavir|mesh-list
24679117|NCT01366547|Dideoxynucleosides|dideoxynucleosides|mesh-list
24679118|NCT01366547|Dolutegravir|dolutegravir|mesh-list
24679123|NCT01366547|Antiviral Agents|antiviral agents|mesh-ancestor
24679160|NCT01367210|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24679161|NCT01367210|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24957116|NCT03847155|Cholinergic Agents|cholinergic agents|mesh-ancestor
24957117|NCT03847155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24957119|NCT03847272|Prednisone|prednisone|mesh-list
24957124|NCT03847272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24957125|NCT03847272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957126|NCT03847272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24957129|NCT03847441|Vitamin D|vitamin d|mesh-list
24679164|NCT01367223|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
24679165|NCT01367223|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24679166|NCT01367223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24679167|NCT01367288|Zoledronic Acid|zoledronic acid|mesh-list
24679168|NCT01367288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24679169|NCT01367288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679170|NCT01367301|Paclitaxel|paclitaxel|mesh-list
24679171|NCT01367301|Carboplatin|carboplatin|mesh-list
24679172|NCT01367301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24679173|NCT01367301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24679174|NCT01367301|Tubulin Modulators|tubulin modulators|mesh-ancestor
24679175|NCT01367301|Antimitotic Agents|antimitotic agents|mesh-ancestor
24679176|NCT01367301|Mitosis Modulators|mitosis modulators|mesh-ancestor
24679177|NCT01367301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679178|NCT01367418|Sufentanil|sufentanil|mesh-list
24679179|NCT01367418|Morphine|morphine|mesh-list
24679180|NCT01367418|Bupivacaine|bupivacaine|mesh-list
24679181|NCT01367418|Ropivacaine|ropivacaine|mesh-list
24679182|NCT01367418|Anesthetics, Local|anesthetics, local|mesh-ancestor
24679183|NCT01367418|Anesthetics|anesthetics|mesh-ancestor
24679184|NCT01367418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24679185|NCT01367418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679186|NCT01367418|Sensory System Agents|sensory system agents|mesh-ancestor
24679187|NCT01367418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679220|NCT01367522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679221|NCT01367522|Sensory System Agents|sensory system agents|mesh-ancestor
24679224|NCT01367535|Methylnaltrexone|methylnaltrexone|mesh-list
24679263|NCT01367587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812625|NCT02053779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24812626|NCT02053779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812627|NCT02053818|Sufentanil|sufentanil|mesh-list
24679265|NCT01367600|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24679266|NCT01367600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679267|NCT01367600|Sensory System Agents|sensory system agents|mesh-ancestor
24638392|NCT01156389|Ritonavir|ritonavir|mesh-list
24679268|NCT01367600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679270|NCT01367613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24679271|NCT01367613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679272|NCT01367613|Sensory System Agents|sensory system agents|mesh-ancestor
24679273|NCT01367613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679274|NCT01367626|Letrozole|letrozole|mesh-list
24679275|NCT01367626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24679276|NCT01367626|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24679277|NCT01367626|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24679278|NCT01367626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24679279|NCT01367626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679280|NCT01367626|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24679281|NCT01367626|Hormone Antagonists|hormone antagonists|mesh-ancestor
24463820|NCT00362310|Indinavir|indinavir|mesh-list
24679282|NCT01367626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24679283|NCT01367626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679284|NCT01367652|Letrozole|letrozole|mesh-list
24679285|NCT01367652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24679286|NCT01367652|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24679309|NCT01367743|Autonomic Agents|autonomic agents|mesh-ancestor
24679310|NCT01367743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679311|NCT01367743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24679312|NCT01367743|Respiratory System Agents|respiratory system agents|mesh-ancestor
24679313|NCT01367743|Mydriatics|mydriatics|mesh-ancestor
24679314|NCT01367743|Sympathomimetics|sympathomimetics|mesh-ancestor
24679322|NCT01367756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679323|NCT01367756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24679324|NCT01367756|Antidepressive Agents|antidepressive agents|mesh-ancestor
24679325|NCT01367756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24679326|NCT01367912|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24679327|NCT01367912|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24679328|NCT01367912|Estradiol|estradiol|mesh-list
24679329|NCT01367912|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24679355|NCT01367990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679356|NCT01367990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24957237|NCT03846284|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
24679358|NCT01368003|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24679359|NCT01368003|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24679360|NCT01368003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24679361|NCT01368003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679362|NCT01368003|Hormone Antagonists|hormone antagonists|mesh-ancestor
24679363|NCT01368003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24812629|NCT02053818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24812630|NCT02053818|Narcotics|narcotics|mesh-ancestor
24679364|NCT01368003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679365|NCT01368016|Nicotine|nicotine|mesh-list
24679366|NCT01368016|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24679367|NCT01368016|Autonomic Agents|autonomic agents|mesh-ancestor
24679368|NCT01368016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24539024|NCT00661856|Genistein|genistein|mesh-list
24679369|NCT01368016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679370|NCT01368016|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24679371|NCT01368016|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24679372|NCT01368016|Cholinergic Agents|cholinergic agents|mesh-ancestor
24679373|NCT01368016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24657196|NCT01266187|Leucovorin|leucovorin|mesh-list
24679374|NCT01368016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679375|NCT01368068|Tibolone|tibolone|mesh-list
24679376|NCT01368068|Citalopram|citalopram|mesh-list
24679377|NCT01368068|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24679378|NCT01368068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24679398|NCT01368198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24679400|NCT01368328|Niacin|niacin|mesh-list
24679402|NCT01368328|Micronutrients|micronutrients|mesh-ancestor
24679403|NCT01368328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679404|NCT01368328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24679405|NCT01368328|Antimetabolites|antimetabolites|mesh-ancestor
24679406|NCT01368328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679407|NCT01368328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24679408|NCT01368328|Vasodilator Agents|vasodilator agents|mesh-ancestor
24679409|NCT01368328|Vitamin B Complex|vitamin b complex|mesh-ancestor
24679410|NCT01368328|Vitamins|vitamins|mesh-ancestor
24679411|NCT01368341|Amoxicillin|amoxicillin|mesh-list
24679412|NCT01368341|Doxycycline|doxycycline|mesh-list
24679413|NCT01368341|Penicillin V|penicillin v|mesh-list
24679414|NCT01368341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24679415|NCT01368341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24679416|NCT01368341|Antimalarials|antimalarials|mesh-ancestor
24611043|NCT01006551|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24611044|NCT01006551|Serotonin Agents|serotonin agents|mesh-ancestor
24611045|NCT01006551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24611046|NCT01006551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611047|NCT01006551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611048|NCT01006551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24611049|NCT01006551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24611050|NCT01006551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24611051|NCT01006551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24611052|NCT01006551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24611053|NCT01006551|Dopamine Agents|dopamine agents|mesh-ancestor
24611055|NCT01006668|Sevoflurane|sevoflurane|mesh-list
24611056|NCT01006668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24611057|NCT01006668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24611058|NCT01006668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611059|NCT01006668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24611060|NCT01006668|Anesthetics, General|anesthetics, general|mesh-ancestor
24611061|NCT01006668|Anesthetics|anesthetics|mesh-ancestor
24812632|NCT02053818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854315|NCT02273154|Buspirone|buspirone|mesh-list
24854316|NCT02273154|Paroxetine|paroxetine|mesh-list
24854317|NCT02273154|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24854318|NCT02273154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24854319|NCT02273154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24854320|NCT02273154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854321|NCT02273154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24854322|NCT02273154|Serotonin Agents|serotonin agents|mesh-ancestor
24854323|NCT02273154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854324|NCT02273154|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24611069|NCT01006694|Antidepressive Agents|antidepressive agents|mesh-list
24611070|NCT01006694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24611071|NCT01006720|Neostigmine|neostigmine|mesh-list
24611072|NCT01006720|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24611073|NCT01006720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611074|NCT01006720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611075|NCT01006720|Cholinergic Agents|cholinergic agents|mesh-ancestor
24679473|NCT01368783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24679474|NCT01368783|Antiviral Agents|antiviral agents|mesh-ancestor
24854337|NCT02273258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24854338|NCT02273258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854340|NCT02273271|Antiviral Agents|antiviral agents|mesh-ancestor
24854341|NCT02273271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24854342|NCT02273440|Theophylline|theophylline|mesh-list
24854343|NCT02273440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24854344|NCT02273440|Autonomic Agents|autonomic agents|mesh-ancestor
24854345|NCT02273440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25694741|NCT02036424|Dexamethasone|dexamethasone|mesh-list
24854346|NCT02273440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854347|NCT02273440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24854348|NCT02273440|Respiratory System Agents|respiratory system agents|mesh-ancestor
24679477|NCT01368783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24679478|NCT01368783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24679479|NCT01368783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24679480|NCT01368848|Bevacizumab|bevacizumab|mesh-list
24679481|NCT01368848|Docetaxel|docetaxel|mesh-list
24679482|NCT01368848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24679483|NCT01368848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24854365|NCT02273453|GABA Agents|gaba agents|mesh-ancestor
24854366|NCT02273453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24854367|NCT02273453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854368|NCT02273466|Desipramine|desipramine|mesh-list
24854369|NCT02273466|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24854370|NCT02273466|Antidepressive Agents|antidepressive agents|mesh-ancestor
24854371|NCT02273466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24456967|NCT00332787|Serotonin Agents|serotonin agents|mesh-ancestor
24679521|NCT01369082|Cyclosporins|cyclosporins|mesh-list
24679522|NCT01369082|Immunosuppressive Agents|immunosuppressive agents|mesh-list
24679523|NCT01369082|Immunologic Factors|immunologic factors|mesh-ancestor
24679524|NCT01369082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679525|NCT01369082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24679526|NCT01369082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24679571|NCT01369277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24679572|NCT01369277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679573|NCT01369277|Vitamin B Complex|vitamin b complex|mesh-ancestor
24854372|NCT02273466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678447|NCT01361997|Ethanol|ethanol|mesh-list
24679581|NCT01369290|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24679582|NCT01369290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24679583|NCT01369290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24679584|NCT01369290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679585|NCT01369290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24679597|NCT01369290|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24679598|NCT01369290|Analgesics|analgesics|mesh-ancestor
24679599|NCT01369290|Sensory System Agents|sensory system agents|mesh-ancestor
24679600|NCT01369303|Tenofovir|tenofovir|mesh-list
24679601|NCT01369303|Antiviral Agents|antiviral agents|mesh-ancestor
24679602|NCT01369303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24679603|NCT01369303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24679604|NCT01369303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24679605|NCT01369303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24679606|NCT01369303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679607|NCT01369303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24679608|NCT01369303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24657197|NCT01266187|Cetuximab|cetuximab|mesh-list
24679629|NCT01369472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679630|NCT01369472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679631|NCT01369472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24679633|NCT01369472|Protective Agents|protective agents|mesh-ancestor
24679634|NCT01369472|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24679635|NCT01369472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24679636|NCT01369472|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24679637|NCT01369472|Vasodilator Agents|vasodilator agents|mesh-ancestor
24679638|NCT01369472|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24679639|NCT01369472|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24679640|NCT01369576|Zopiclone|zopiclone|mesh-list
24679641|NCT01369576|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24679649|NCT01369602|Vitamins|vitamins|mesh-ancestor
24858842|NCT02299765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24679703|NCT01370135|Growth Substances|growth substances|mesh-ancestor
24679704|NCT01370135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678546|NCT01363063|Ketorolac|ketorolac|mesh-list
24854394|NCT02273505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24854396|NCT02273505|Sensory System Agents|sensory system agents|mesh-ancestor
24854397|NCT02273505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24854398|NCT02273505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854399|NCT02273505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24854400|NCT02273505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24854401|NCT02273505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24854402|NCT02273505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854403|NCT02273505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854404|NCT02273505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24854405|NCT02273505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24854406|NCT02273505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24854407|NCT02273505|Antipyretics|antipyretics|mesh-ancestor
24854408|NCT02273505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24478440|NCT00422864|Leucovorin|leucovorin|mesh-list
24679735|NCT01370291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24679736|NCT01370291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24854412|NCT02273531|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
24854413|NCT02273531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24854414|NCT02273544|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
24854415|NCT02273544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24854416|NCT02273557|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
24854417|NCT02273557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24854418|NCT02273570|Vitamin D|vitamin d|mesh-list
24854419|NCT02273570|Calcium|calcium|mesh-list
24854421|NCT02273570|Micronutrients|micronutrients|mesh-ancestor
24854422|NCT02273570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854423|NCT02273570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24854424|NCT02273570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24854425|NCT02273583|Cyclophosphamide|cyclophosphamide|mesh-list
24854426|NCT02273583|Methotrexate|methotrexate|mesh-list
24679765|NCT01370343|Vitamins|vitamins|mesh-ancestor
24679766|NCT01370343|Micronutrients|micronutrients|mesh-ancestor
24679767|NCT01370434|Dexamethasone|dexamethasone|mesh-list
24679768|NCT01370434|Doxorubicin|doxorubicin|mesh-list
24679788|NCT01370434|Antimitotic Agents|antimitotic agents|mesh-ancestor
24679789|NCT01370434|Mitosis Modulators|mitosis modulators|mesh-ancestor
24679791|NCT01370707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24679792|NCT01370707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679793|NCT01370772|Cyclophosphamide|cyclophosphamide|mesh-list
24679794|NCT01370772|Rituximab|rituximab|mesh-list
24679795|NCT01370772|Fludarabine|fludarabine|mesh-list
24679796|NCT01370772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24854436|NCT02273583|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24854437|NCT02273583|Abortifacient Agents|abortifacient agents|mesh-ancestor
24854438|NCT02273583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24854439|NCT02273583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24854441|NCT02273583|Dermatologic Agents|dermatologic agents|mesh-ancestor
24854442|NCT02273583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854443|NCT02273583|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24854444|NCT02273583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24854445|NCT02273609|Vitamin K|vitamin k|mesh-list
24886590|NCT04525326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854446|NCT02273609|Warfarin|warfarin|mesh-list
24854447|NCT02273609|Acenocoumarol|acenocoumarol|mesh-list
24854448|NCT02273609|Vitamins|vitamins|mesh-ancestor
24854449|NCT02273609|Micronutrients|micronutrients|mesh-ancestor
24679833|NCT01371058|Policosanol|policosanol|mesh-list
24679834|NCT01371058|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24679835|NCT01371058|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25694742|NCT02036424|Bevacizumab|bevacizumab|mesh-list
25694743|NCT02036424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25694744|NCT02036424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694745|NCT02036424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25694746|NCT02036424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25694747|NCT02036424|Growth Substances|growth substances|mesh-ancestor
25694748|NCT02036424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694749|NCT02036424|Growth Inhibitors|growth inhibitors|mesh-ancestor
25694750|NCT02036424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25694751|NCT02036424|Antiemetics|antiemetics|mesh-ancestor
24679836|NCT01371058|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24679837|NCT01371058|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24679838|NCT01371058|Purinergic Agents|purinergic agents|mesh-ancestor
24679839|NCT01371058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24679840|NCT01371058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679841|NCT01371058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679842|NCT01371058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24679843|NCT01371058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24679844|NCT01371058|Antimetabolites|antimetabolites|mesh-ancestor
24679845|NCT01371058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24678652|NCT01363323|Naltrexone|naltrexone|mesh-list
24679856|NCT01371331|Tacrolimus|tacrolimus|mesh-list
24679857|NCT01371331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24611082|NCT01006798|Immunologic Factors|immunologic factors|mesh-ancestor
24854450|NCT02273609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854451|NCT02273609|Anticoagulants|anticoagulants|mesh-ancestor
24854452|NCT02273609|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24854455|NCT02273609|Hemostatics|hemostatics|mesh-ancestor
24854457|NCT02273622|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
24457056|NCT00333021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611083|NCT01006798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611085|NCT01006863|Oxymetazoline|oxymetazoline|mesh-list
24611086|NCT01006863|Ephedrine|ephedrine|mesh-list
24611087|NCT01006863|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24611088|NCT01006863|Mydriatics|mydriatics|mesh-ancestor
24611089|NCT01006863|Autonomic Agents|autonomic agents|mesh-ancestor
24611090|NCT01006863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24611091|NCT01006863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679858|NCT01371331|Immunologic Factors|immunologic factors|mesh-ancestor
24679859|NCT01371331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679860|NCT01371331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24679861|NCT01371331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24679862|NCT01371331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679863|NCT01371344|Tacrolimus|tacrolimus|mesh-list
24679864|NCT01371344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24679865|NCT01371344|Immunologic Factors|immunologic factors|mesh-ancestor
24679866|NCT01371344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679867|NCT01371344|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24679868|NCT01371344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24679869|NCT01371344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679870|NCT01371435|Paroxetine|paroxetine|mesh-list
24679871|NCT01371435|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24679872|NCT01371435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24657198|NCT01266187|Fluorouracil|fluorouracil|mesh-list
24679892|NCT01371448|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24679893|NCT01371448|Antidepressive Agents|antidepressive agents|mesh-ancestor
24679894|NCT01371448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24679895|NCT01371448|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24679896|NCT01371448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24679897|NCT01371448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24679899|NCT01371461|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24679900|NCT01371461|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24679903|NCT01371461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24679904|NCT01371461|Serotonin Agents|serotonin agents|mesh-ancestor
24679905|NCT01371461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463242|NCT00359658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24679906|NCT01371461|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24679907|NCT01371461|Antidepressive Agents|antidepressive agents|mesh-ancestor
24679908|NCT01371461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24679909|NCT01371461|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24854462|NCT02273622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854463|NCT02273622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24854465|NCT02273635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24679936|NCT01371604|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24679937|NCT01371604|Antimetabolites|antimetabolites|mesh-ancestor
24679938|NCT01371604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679939|NCT01371604|Antiviral Agents|antiviral agents|mesh-ancestor
24679940|NCT01371604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24679941|NCT01371682|Ropinirole|ropinirole|mesh-list
24679942|NCT01371682|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24679943|NCT01371682|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24679944|NCT01371682|Dopamine Agonists|dopamine agonists|mesh-ancestor
24679945|NCT01371682|Dopamine Agents|dopamine agents|mesh-ancestor
24679946|NCT01371682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24679947|NCT01371682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679948|NCT01371682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679950|NCT01371968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24679951|NCT01371968|Narcotics|narcotics|mesh-ancestor
24679952|NCT01371968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24679953|NCT01371968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679954|NCT01371968|Analgesics|analgesics|mesh-ancestor
24679955|NCT01371968|Sensory System Agents|sensory system agents|mesh-ancestor
24679956|NCT01371968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679957|NCT01371968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24679958|NCT01371968|Anesthetics, General|anesthetics, general|mesh-ancestor
24679959|NCT01371968|Anesthetics|anesthetics|mesh-ancestor
25031497|NCT03587220|Lidocaine|lidocaine|mesh-list
24679960|NCT01372007|Lanreotide|lanreotide|mesh-list
24679962|NCT01372111|Cisplatin|cisplatin|mesh-list
24679965|NCT01372280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24679967|NCT01372280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679968|NCT01372280|Cholinergic Agents|cholinergic agents|mesh-ancestor
24679969|NCT01372280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24679970|NCT01372280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679971|NCT01372280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24679972|NCT01372280|Autonomic Agents|autonomic agents|mesh-ancestor
24679980|NCT01372293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24680009|NCT01372449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24680010|NCT01372449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680011|NCT01372449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680012|NCT01372449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24680013|NCT01372449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24680014|NCT01372540|Filanesib|filanesib|mesh-list
24680015|NCT01372540|Antimitotic Agents|antimitotic agents|mesh-ancestor
24680016|NCT01372540|Mitosis Modulators|mitosis modulators|mesh-ancestor
24680017|NCT01372540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680018|NCT01372540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680019|NCT01372579|Carboplatin|carboplatin|mesh-list
24680020|NCT01372579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680021|NCT01372644|Pasireotide|pasireotide|mesh-list
24680022|NCT01372644|Hormones|hormones|mesh-ancestor
24854466|NCT02273635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24854467|NCT02273635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24854468|NCT02273635|Analgesics|analgesics|mesh-ancestor
24854469|NCT02273635|Sensory System Agents|sensory system agents|mesh-ancestor
24854470|NCT02273635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24854471|NCT02273635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854472|NCT02273635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24680023|NCT01372644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24680062|NCT01372904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24680063|NCT01372904|Antiemetics|antiemetics|mesh-ancestor
24680064|NCT01372904|Autonomic Agents|autonomic agents|mesh-ancestor
24680065|NCT01372904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24680066|NCT01372904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680067|NCT01372904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24680068|NCT01372904|Glucocorticoids|glucocorticoids|mesh-ancestor
24680070|NCT01372904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24680071|NCT01372904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24680072|NCT01372904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680086|NCT01372930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24680087|NCT01372930|Immunologic Factors|immunologic factors|mesh-ancestor
24680088|NCT01372982|Letrozole|letrozole|mesh-list
24680089|NCT01372982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680090|NCT01372982|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24680091|NCT01372982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24680092|NCT01372982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680093|NCT01372982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680094|NCT01372982|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24680095|NCT01372982|Hormone Antagonists|hormone antagonists|mesh-ancestor
24680096|NCT01372982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24680097|NCT01372982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680098|NCT01373008|Beclomethasone|beclomethasone|mesh-list
24680099|NCT01373008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24680117|NCT01373021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24680118|NCT01373021|Adrenergic Agents|adrenergic agents|mesh-ancestor
24680119|NCT01373021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24680120|NCT01373021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680121|NCT01373021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24680122|NCT01373021|Narcotics|narcotics|mesh-ancestor
24546529|NCT00699023|Ezetimibe|ezetimibe|mesh-list
24680124|NCT01373021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24447022|NCT00307203|Autonomic Agents|autonomic agents|mesh-ancestor
24447023|NCT00307203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24709159|NCT01504256|Antimetabolites|antimetabolites|mesh-ancestor
24543950|NCT00686114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24543951|NCT00686114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543952|NCT00686140|Celecoxib|celecoxib|mesh-list
24680125|NCT01373021|Anesthetics, General|anesthetics, general|mesh-ancestor
24680126|NCT01373021|Anesthetics|anesthetics|mesh-ancestor
24680127|NCT01373060|Ipragliflozin|ipragliflozin|mesh-list
24680128|NCT01373060|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24680129|NCT01373060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680130|NCT01373060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24680131|NCT01373060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680141|NCT01373138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24680142|NCT01373138|Histamine Antagonists|histamine antagonists|mesh-ancestor
24680143|NCT01373138|Histamine Agents|histamine agents|mesh-ancestor
24680144|NCT01373138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24680145|NCT01373138|Autonomic Agents|autonomic agents|mesh-ancestor
24680146|NCT01373138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24680147|NCT01373138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24680148|NCT01373138|Respiratory System Agents|respiratory system agents|mesh-ancestor
24680149|NCT01373138|Nasal Decongestants|nasal decongestants|mesh-ancestor
24680150|NCT01373138|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24680151|NCT01373138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24680152|NCT01373138|Sympathomimetics|sympathomimetics|mesh-ancestor
24680153|NCT01373138|Adrenergic Agents|adrenergic agents|mesh-ancestor
24680154|NCT01373216|Exenatide|exenatide|mesh-list
24680155|NCT01373216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24678885|NCT01364857|Enzyme Activators|enzyme activators|mesh-ancestor
24611098|NCT01006863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24611099|NCT01006863|Adrenergic Agents|adrenergic agents|mesh-ancestor
24611100|NCT01006863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24611101|NCT01006863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611102|NCT01006863|Protective Agents|protective agents|mesh-ancestor
24611103|NCT01006863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24854489|NCT02273700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24854490|NCT02273700|Protease Inhibitors|protease inhibitors|mesh-ancestor
24854491|NCT02273700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854492|NCT02273700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854493|NCT02273700|Anticoagulants|anticoagulants|mesh-ancestor
24457084|NCT00333086|Letrozole|letrozole|mesh-list
24680175|NCT01373359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24680176|NCT01373359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24680177|NCT01373372|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
24680178|NCT01373372|Hormones|hormones|mesh-ancestor
24680260|NCT01373684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680261|NCT01373684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680262|NCT01373684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24680263|NCT01373684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24680264|NCT01373697|Ibuprofen|ibuprofen|mesh-list
24680265|NCT01373697|Ketoprofen|ketoprofen|mesh-list
24680266|NCT01373697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24680267|NCT01373697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24680268|NCT01373697|Analgesics|analgesics|mesh-ancestor
24680288|NCT01373749|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24680289|NCT01373749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680290|NCT01373749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680291|NCT01373749|Urological Agents|urological agents|mesh-ancestor
24680292|NCT01373970|Pantoprazole|pantoprazole|mesh-list
24680293|NCT01373970|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24680294|NCT01373970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24680295|NCT01373970|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24680296|NCT01373970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680313|NCT01374126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24680314|NCT01374126|Antimalarials|antimalarials|mesh-ancestor
24680315|NCT01374126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24680316|NCT01374126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24680317|NCT01374126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680318|NCT01374126|Antiviral Agents|antiviral agents|mesh-ancestor
24680319|NCT01374126|Schistosomicides|schistosomicides|mesh-ancestor
25694752|NCT02036424|Autonomic Agents|autonomic agents|mesh-ancestor
25694753|NCT02036424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25694754|NCT02036424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25694755|NCT02036424|Glucocorticoids|glucocorticoids|mesh-ancestor
25694756|NCT02036424|Hormones|hormones|mesh-ancestor
25709348|NCT02265510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680320|NCT01374126|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24680322|NCT01374191|Botulinum Toxins|botulinum toxins|mesh-list
24680323|NCT01374191|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24680324|NCT01374191|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24680325|NCT01374191|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24680326|NCT01374191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24680327|NCT01374191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680328|NCT01374191|Cholinergic Agents|cholinergic agents|mesh-ancestor
24680329|NCT01374191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24680330|NCT01374191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680331|NCT01374191|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24680332|NCT01374191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24680333|NCT01374282|Penicillamine|penicillamine|mesh-list
24854498|NCT02273713|Antimitotic Agents|antimitotic agents|mesh-ancestor
24854499|NCT02273713|Mitosis Modulators|mitosis modulators|mesh-ancestor
24812636|NCT02053818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24812637|NCT02053818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24812638|NCT02053818|Anesthetics, General|anesthetics, general|mesh-ancestor
24854500|NCT02273713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680373|NCT01374581|Antiviral Agents|antiviral agents|mesh-ancestor
24680374|NCT01374581|Schistosomicides|schistosomicides|mesh-ancestor
24680413|NCT01374698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24680414|NCT01374698|Analgesics|analgesics|mesh-ancestor
24680415|NCT01374698|Sensory System Agents|sensory system agents|mesh-ancestor
24680416|NCT01374698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24680417|NCT01374698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680418|NCT01374698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24680419|NCT01374698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24680420|NCT01374698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24680421|NCT01374698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24680422|NCT01374698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680423|NCT01374698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24680424|NCT01374698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24680425|NCT01374698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680426|NCT01374698|Antipyretics|antipyretics|mesh-ancestor
24679075|NCT01366313|Morphine|morphine|mesh-list
24680463|NCT01374763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680465|NCT01374763|Sensory System Agents|sensory system agents|mesh-ancestor
24680466|NCT01374763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24680467|NCT01374763|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24680468|NCT01374789|Panitumumab|panitumumab|mesh-list
24680469|NCT01374789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24680470|NCT01374789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680471|NCT01374828|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24680472|NCT01374828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24680473|NCT01374828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24854502|NCT02273765|Lamivudine|lamivudine|mesh-list
24854503|NCT02273765|Efavirenz|efavirenz|mesh-list
24854504|NCT02273765|Raltegravir Potassium|raltegravir potassium|mesh-list
24854505|NCT02273765|Antiviral Agents|antiviral agents|mesh-ancestor
24854506|NCT02273765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24854507|NCT02273765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24854508|NCT02273765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24680474|NCT01374828|Analgesics|analgesics|mesh-ancestor
24680475|NCT01374828|Sensory System Agents|sensory system agents|mesh-ancestor
24680476|NCT01374828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24680477|NCT01374828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680478|NCT01374828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24680479|NCT01374828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24680480|NCT01374828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24680481|NCT01374828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680482|NCT01374828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680483|NCT01374841|Cyclophosphamide|cyclophosphamide|mesh-list
24680484|NCT01374841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24680485|NCT01374841|Immunologic Factors|immunologic factors|mesh-ancestor
24680486|NCT01374841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463648|NCT00361790|Citalopram|citalopram|mesh-list
24854513|NCT02273765|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24854514|NCT02273765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24854515|NCT02273765|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24854516|NCT02273765|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24854517|NCT02273765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24854518|NCT02273765|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24854519|NCT02273765|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24457101|NCT00333112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457103|NCT00333112|Urological Agents|urological agents|mesh-ancestor
24680530|NCT01375322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24680546|NCT01375335|Autonomic Agents|autonomic agents|mesh-ancestor
24680581|NCT01375387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24680582|NCT01375387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24680583|NCT01375387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24680584|NCT01375387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680585|NCT01375400|Aspirin|aspirin|mesh-list
24680586|NCT01375400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24680587|NCT01375400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24680588|NCT01375400|Analgesics|analgesics|mesh-ancestor
24854520|NCT02273765|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24854521|NCT02273791|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24854522|NCT02273791|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24854523|NCT02273791|Clomiphene|clomiphene|mesh-list
24854524|NCT02273791|Enclomiphene|enclomiphene|mesh-list
24854525|NCT02273791|Zuclomiphene|zuclomiphene|mesh-list
24854526|NCT02273791|Estradiol|estradiol|mesh-list
24854527|NCT02273791|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24854528|NCT02273791|Estrogens|estrogens|mesh-ancestor
24854529|NCT02273791|Hormones|hormones|mesh-ancestor
24457112|NCT00333125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24457113|NCT00333125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24457114|NCT00333125|Adrenergic Agents|adrenergic agents|mesh-ancestor
24680589|NCT01375400|Sensory System Agents|sensory system agents|mesh-ancestor
24680636|NCT01375634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465189|NCT00368238|Epoetin Alfa|epoetin alfa|mesh-list
24680638|NCT01375699|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24680639|NCT01375699|Sildenafil Citrate|sildenafil citrate|mesh-list
24680640|NCT01375699|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24680641|NCT01375699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680642|NCT01375699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24611134|NCT01007500|Autonomic Agents|autonomic agents|mesh-ancestor
24611135|NCT01007500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24611136|NCT01007500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611149|NCT01007500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24611150|NCT01007500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24611151|NCT01007500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24611152|NCT01007500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24611153|NCT01007500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24611154|NCT01007539|Choline|choline|mesh-list
24611155|NCT01007539|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
24611156|NCT01007539|Lipotropic Agents|lipotropic agents|mesh-ancestor
24611157|NCT01007539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24611158|NCT01007539|Antimetabolites|antimetabolites|mesh-ancestor
24611159|NCT01007539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680656|NCT01375816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24680657|NCT01375816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680713|NCT01376011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680714|NCT01376011|Protective Agents|protective agents|mesh-ancestor
24680715|NCT01376011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680717|NCT01376076|Risperidone|risperidone|mesh-list
24680718|NCT01376076|Cariprazine|cariprazine|mesh-list
24657199|NCT01266187|Oxaliplatin|oxaliplatin|mesh-list
24680719|NCT01376076|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24680720|NCT01376076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24680721|NCT01376076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24680722|NCT01376076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24680723|NCT01376076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24465282|NCT00368706|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24465283|NCT00368706|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24465284|NCT00368706|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25694757|NCT02036424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25694758|NCT02036424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24819806|NCT02097329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819808|NCT02097329|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24819809|NCT02097329|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24491288|NCT00481923|Hormones|hormones|mesh-ancestor
24465285|NCT00368706|Cholinergic Agents|cholinergic agents|mesh-ancestor
24465286|NCT00368706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24465287|NCT00368706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465288|NCT00368706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680759|NCT01376128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680761|NCT01376141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24680762|NCT01376141|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24680763|NCT01376141|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24680764|NCT01376141|Serotonin Agents|serotonin agents|mesh-ancestor
24680765|NCT01376141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24680766|NCT01376141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680767|NCT01376141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680768|NCT01376154|Lamivudine|lamivudine|mesh-list
24680769|NCT01376154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24680770|NCT01376154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24680771|NCT01376154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680772|NCT01376154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680773|NCT01376154|Antiviral Agents|antiviral agents|mesh-ancestor
24680774|NCT01376154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24680775|NCT01376154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24680776|NCT01376154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24680777|NCT01376180|Lamotrigine|lamotrigine|mesh-list
24680778|NCT01376180|Anticonvulsants|anticonvulsants|mesh-ancestor
24680779|NCT01376180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24680780|NCT01376180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24680781|NCT01376180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680782|NCT01376180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24680783|NCT01376180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680784|NCT01376180|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24680785|NCT01376180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24680786|NCT01376180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24679395|NCT01368068|Hormones|hormones|mesh-ancestor
24680846|NCT01376284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680847|NCT01376284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680848|NCT01376284|Hormone Antagonists|hormone antagonists|mesh-ancestor
24680849|NCT01376284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24854549|NCT02273817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24854550|NCT02273817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854551|NCT02273817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24854552|NCT02273843|Vitamin D|vitamin d|mesh-list
24854553|NCT02273843|Ergocalciferols|ergocalciferols|mesh-list
24854554|NCT02273843|Cholecalciferol|cholecalciferol|mesh-list
24457137|NCT00333164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24680851|NCT01376323|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24680852|NCT01376323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24680853|NCT01376323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680854|NCT01376323|Incretins|incretins|mesh-ancestor
24680855|NCT01376323|Hormones|hormones|mesh-ancestor
24680856|NCT01376323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24680857|NCT01376323|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24680858|NCT01376323|Protease Inhibitors|protease inhibitors|mesh-ancestor
24680859|NCT01376323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24958006|NCT03838497|Immunologic Factors|immunologic factors|mesh-ancestor
24680860|NCT01376323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680861|NCT01376401|Prednisone|prednisone|mesh-list
24680862|NCT01376401|Bortezomib|bortezomib|mesh-list
24680863|NCT01376401|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24680864|NCT01376401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24680865|NCT01376401|Glucocorticoids|glucocorticoids|mesh-ancestor
24680866|NCT01376401|Hormones|hormones|mesh-ancestor
24680867|NCT01376401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24680868|NCT01376401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694759|NCT02036502|Dexamethasone|dexamethasone|mesh-list
25694760|NCT02036502|Pembrolizumab|pembrolizumab|mesh-list
25694761|NCT02036502|Lenalidomide|lenalidomide|mesh-list
25694762|NCT02036502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25694763|NCT02036502|Antiemetics|antiemetics|mesh-ancestor
25694764|NCT02036502|Autonomic Agents|autonomic agents|mesh-ancestor
24709712|NCT01506765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447144|NCT00307606|Hormones|hormones|mesh-ancestor
24916523|NCT04239859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24916524|NCT04239859|Immunologic Factors|immunologic factors|mesh-ancestor
24916525|NCT04239859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24916526|NCT04239859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24680869|NCT01376401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24680960|NCT01377259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24680961|NCT01377259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680962|NCT01377285|Pentoxifylline|pentoxifylline|mesh-list
24854555|NCT02273843|Vitamins|vitamins|mesh-list
24854564|NCT02273895|Autonomic Agents|autonomic agents|mesh-ancestor
24854565|NCT02273895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24680975|NCT01377324|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24680994|NCT01377415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24680995|NCT01377415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680996|NCT01377415|Sensory System Agents|sensory system agents|mesh-ancestor
24680997|NCT01377415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24680998|NCT01377428|Formoterol Fumarate|formoterol fumarate|mesh-list
24680999|NCT01377428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24681000|NCT01377428|Autonomic Agents|autonomic agents|mesh-ancestor
24681001|NCT01377428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24681002|NCT01377428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681003|NCT01377428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24681004|NCT01377428|Respiratory System Agents|respiratory system agents|mesh-ancestor
24681005|NCT01377428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24681006|NCT01377428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24681007|NCT01377428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24681008|NCT01377428|Adrenergic Agents|adrenergic agents|mesh-ancestor
24681009|NCT01377428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24681010|NCT01377428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681011|NCT01377532|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24681012|NCT01377532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681013|NCT01377532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681014|NCT01377532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681015|NCT01377532|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24681016|NCT01377545|Anesthetics|anesthetics|mesh-list
24681017|NCT01377545|Anesthetics, Local|anesthetics, local|mesh-list
24681018|NCT01377545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24681019|NCT01377545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681020|NCT01377545|Sensory System Agents|sensory system agents|mesh-ancestor
24681021|NCT01377545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24681022|NCT01377597|Ranibizumab|ranibizumab|mesh-list
24681023|NCT01377597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24681024|NCT01377597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24681025|NCT01377597|Growth Substances|growth substances|mesh-ancestor
24440238|NCT00281983|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24681026|NCT01377597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681027|NCT01377597|Growth Inhibitors|growth inhibitors|mesh-ancestor
24681036|NCT01377610|Sensory System Agents|sensory system agents|mesh-ancestor
24681037|NCT01377610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24681038|NCT01377610|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24854566|NCT02273895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854567|NCT02273895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24854568|NCT02273895|Mydriatics|mydriatics|mesh-ancestor
24854569|NCT02273895|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24854570|NCT02273895|Cholinergic Agents|cholinergic agents|mesh-ancestor
24854571|NCT02273895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24854572|NCT02273895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457153|NCT00333242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694765|NCT02036502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25694766|NCT02036502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694767|NCT02036502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25694768|NCT02036502|Glucocorticoids|glucocorticoids|mesh-ancestor
25694769|NCT02036502|Hormones|hormones|mesh-ancestor
25694770|NCT02036502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25694771|NCT02036502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25694772|NCT02036502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25709349|NCT02265510|Tubulin Modulators|tubulin modulators|mesh-ancestor
24916714|NCT04237987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24916715|NCT04237987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24916716|NCT04237987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24446536|NCT00305292|Modafinil|modafinil|mesh-list
24457154|NCT00333242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681039|NCT01377610|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24681055|NCT01377974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24681056|NCT01378039|Budesonide|budesonide|mesh-list
24681057|NCT01378039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24681058|NCT01378039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24681059|NCT01378039|Autonomic Agents|autonomic agents|mesh-ancestor
24465606|NCT00370253|Sympathomimetics|sympathomimetics|mesh-ancestor
24681060|NCT01378039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24681061|NCT01378039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681062|NCT01378039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24681063|NCT01378039|Respiratory System Agents|respiratory system agents|mesh-ancestor
24681064|NCT01378039|Glucocorticoids|glucocorticoids|mesh-ancestor
24681066|NCT01378039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24681067|NCT01378091|Prednisone|prednisone|mesh-list
24681068|NCT01378091|Docetaxel|docetaxel|mesh-list
24681069|NCT01378091|Lenalidomide|lenalidomide|mesh-list
24681070|NCT01378091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681071|NCT01378091|Tubulin Modulators|tubulin modulators|mesh-ancestor
24681073|NCT01378091|Mitosis Modulators|mitosis modulators|mesh-ancestor
24681074|NCT01378091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681075|NCT01378091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24681077|NCT01378091|Hormones|hormones|mesh-ancestor
24611161|NCT01007539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24611162|NCT01007539|Nootropic Agents|nootropic agents|mesh-ancestor
24611163|NCT01007565|Anesthetics|anesthetics|mesh-list
24611164|NCT01007565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24611165|NCT01007565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611166|NCT01007578|Paclitaxel|paclitaxel|mesh-list
24611167|NCT01007578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24611168|NCT01007578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611169|NCT01007578|Tubulin Modulators|tubulin modulators|mesh-ancestor
24611170|NCT01007578|Antimitotic Agents|antimitotic agents|mesh-ancestor
24611171|NCT01007578|Mitosis Modulators|mitosis modulators|mesh-ancestor
24611172|NCT01007578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611173|NCT01007630|Rasagiline|rasagiline|mesh-list
24611174|NCT01007630|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24448029|NCT00310089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611175|NCT01007630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611176|NCT01007630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611177|NCT01007630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24611178|NCT01007630|Protective Agents|protective agents|mesh-ancestor
24854574|NCT02273895|Parasympatholytics|parasympatholytics|mesh-ancestor
24854575|NCT02273947|BMS-955176|bms-955176|mesh-list
24854576|NCT02273947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24854577|NCT02273947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24854578|NCT02273947|Antiviral Agents|antiviral agents|mesh-ancestor
24854579|NCT02273947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24854580|NCT02273986|Digoxin|digoxin|mesh-list
24611208|NCT01007773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24611216|NCT01007799|Vitamins|vitamins|mesh-list
24681090|NCT01378143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24681091|NCT01378143|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24681092|NCT01378156|Vaccines|vaccines|mesh-list
24681093|NCT01378156|Immunologic Factors|immunologic factors|mesh-ancestor
24681094|NCT01378156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681095|NCT01378286|Artesunate|artesunate|mesh-list
24681096|NCT01378286|Chloroquine|chloroquine|mesh-list
24681097|NCT01378286|Amodiaquine|amodiaquine|mesh-list
24681098|NCT01378286|Antimalarials|antimalarials|mesh-ancestor
24681099|NCT01378286|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24681100|NCT01378286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25694773|NCT02036502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25694774|NCT02036502|Immunologic Factors|immunologic factors|mesh-ancestor
25694775|NCT02036502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25694776|NCT02036502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24681101|NCT01378286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24681102|NCT01378286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681103|NCT01378286|Antiviral Agents|antiviral agents|mesh-ancestor
24681120|NCT01378533|Tubulin Modulators|tubulin modulators|mesh-ancestor
24681131|NCT01378533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24681132|NCT01378533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25694777|NCT02036502|Growth Substances|growth substances|mesh-ancestor
24681133|NCT01378533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24681134|NCT01378533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681135|NCT01378546|Amifampridine|amifampridine|mesh-list
24681136|NCT01378546|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24681137|NCT01378546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24854610|NCT02274090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854611|NCT02274142|Methamphetamine|methamphetamine|mesh-list
24457177|NCT00333294|Mitosis Modulators|mitosis modulators|mesh-ancestor
24457178|NCT00333294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457179|NCT00333294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24457180|NCT00333294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457181|NCT00333307|Methocarbamol|methocarbamol|mesh-list
24681180|NCT01378741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24681181|NCT01378741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24681182|NCT01378741|Adrenergic Agents|adrenergic agents|mesh-ancestor
24681183|NCT01378741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24681184|NCT01378741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681185|NCT01378754|Fospropofol|fospropofol|mesh-list
24681186|NCT01378754|Propofol|propofol|mesh-list
24681187|NCT01378754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24681192|NCT01378754|Anesthetics|anesthetics|mesh-ancestor
24681263|NCT01379079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681264|NCT01379079|Antipyretics|antipyretics|mesh-ancestor
24681265|NCT01379144|Latanoprost|latanoprost|mesh-list
24681266|NCT01379144|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24681267|NCT01379144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24681280|NCT01379300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681281|NCT01379300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681282|NCT01379300|Anticoagulants|anticoagulants|mesh-ancestor
24681284|NCT01379326|Piperazine|piperazine|mesh-list
24681295|NCT01379326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681296|NCT01379326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681297|NCT01379482|Paclitaxel|paclitaxel|mesh-list
24681298|NCT01379482|Docetaxel|docetaxel|mesh-list
24681299|NCT01379482|Cisplatin|cisplatin|mesh-list
24681300|NCT01379482|Doxorubicin|doxorubicin|mesh-list
24681301|NCT01379482|Oxaliplatin|oxaliplatin|mesh-list
24681302|NCT01379482|Irinotecan|irinotecan|mesh-list
24681303|NCT01379482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24681304|NCT01379482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681305|NCT01379482|Tubulin Modulators|tubulin modulators|mesh-ancestor
24681306|NCT01379482|Antimitotic Agents|antimitotic agents|mesh-ancestor
24854617|NCT02274142|Dopamine Agents|dopamine agents|mesh-ancestor
24681325|NCT01379677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24681326|NCT01379677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681327|NCT01379807|Docetaxel|docetaxel|mesh-list
24681328|NCT01379807|Panitumumab|panitumumab|mesh-list
24681329|NCT01379807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681330|NCT01379807|Tubulin Modulators|tubulin modulators|mesh-ancestor
24681331|NCT01379807|Antimitotic Agents|antimitotic agents|mesh-ancestor
24681332|NCT01379807|Mitosis Modulators|mitosis modulators|mesh-ancestor
24681333|NCT01379807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681368|NCT01380015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24681369|NCT01380015|Protease Inhibitors|protease inhibitors|mesh-ancestor
24681370|NCT01380015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681371|NCT01380249|Bromides|bromides|mesh-list
24681372|NCT01380249|Anticonvulsants|anticonvulsants|mesh-ancestor
24681373|NCT01380275|Docetaxel|docetaxel|mesh-list
24681374|NCT01380275|Irinotecan|irinotecan|mesh-list
24681375|NCT01380275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24854624|NCT02274142|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24854625|NCT02274181|Enclomiphene|enclomiphene|mesh-list
24854626|NCT02274181|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24854627|NCT02274181|Hormone Antagonists|hormone antagonists|mesh-ancestor
24854631|NCT02274181|Fertility Agents|fertility agents|mesh-ancestor
24854632|NCT02274181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24854633|NCT02274181|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24854634|NCT02274181|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24854635|NCT02274259|Ranibizumab|ranibizumab|mesh-list
25694778|NCT02036502|Growth Inhibitors|growth inhibitors|mesh-ancestor
25694779|NCT02036515|Metformin|metformin|mesh-list
25694780|NCT02036515|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24854636|NCT02274259|Aflibercept|aflibercept|mesh-list
25694781|NCT02036515|Glimepiride|glimepiride|mesh-list
24858034|NCT02294656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24858035|NCT02294656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24858036|NCT02294656|Immunologic Factors|immunologic factors|mesh-ancestor
24858037|NCT02294656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854637|NCT02274259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24854639|NCT02274259|Growth Substances|growth substances|mesh-ancestor
24681400|NCT01380314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24681401|NCT01380314|Immunologic Factors|immunologic factors|mesh-ancestor
24448140|NCT00310505|Deoxycholic Acid|deoxycholic acid|mesh-list
24681402|NCT01380314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681403|NCT01380314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681404|NCT01380314|Interferon Inducers|interferon inducers|mesh-ancestor
24638889|NCT01158937|Meropenem|meropenem|mesh-list
24681406|NCT01380314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24681407|NCT01380314|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24681408|NCT01380314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24681409|NCT01380353|Diclofenac|diclofenac|mesh-list
24681410|NCT01380353|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
24681411|NCT01380353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24681412|NCT01380353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24681413|NCT01380353|Analgesics|analgesics|mesh-ancestor
24681426|NCT01380431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681427|NCT01380431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24854641|NCT02274259|Growth Inhibitors|growth inhibitors|mesh-ancestor
24854642|NCT02274259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24854644|NCT02274337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24854645|NCT02274337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854646|NCT02274337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681428|NCT01380431|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24681429|NCT01380431|Protective Agents|protective agents|mesh-ancestor
24681430|NCT01380431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681431|NCT01380457|Dronabinol|dronabinol|mesh-list
24681432|NCT01380457|Hallucinogens|hallucinogens|mesh-ancestor
24681433|NCT01380457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681434|NCT01380457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24681435|NCT01380457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24681488|NCT01380678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681489|NCT01380678|Growth Inhibitors|growth inhibitors|mesh-ancestor
24681490|NCT01380678|Histamine Agents|histamine agents|mesh-ancestor
24681491|NCT01380678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24681492|NCT01380678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681493|NCT01380717|Calcium Channel Blockers|calcium channel blockers|mesh-list
24681495|NCT01380717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24681496|NCT01380717|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24681497|NCT01380717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24854652|NCT02274454|Calcium|calcium|mesh-list
24854653|NCT02274454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24854654|NCT02274454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854655|NCT02274454|Oxytocics|oxytocics|mesh-ancestor
24854656|NCT02274454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24679992|NCT01372371|Vancomycin|vancomycin|mesh-list
24611226|NCT01007851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611227|NCT01007851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24611228|NCT01007851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24611229|NCT01007851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611230|NCT01007864|Pramipexole|pramipexole|mesh-list
24611232|NCT01007864|Piribedil|piribedil|mesh-list
24611233|NCT01007864|Antioxidants|antioxidants|mesh-ancestor
24611235|NCT01007864|Protective Agents|protective agents|mesh-ancestor
24611278|NCT01008098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24611279|NCT01008098|Antidepressive Agents|antidepressive agents|mesh-ancestor
25694782|NCT02036515|Ertugliflozin|ertugliflozin|mesh-list
25694783|NCT02036515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25694784|NCT02036515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694785|NCT02036515|Incretins|incretins|mesh-ancestor
25694786|NCT02036515|Hormones|hormones|mesh-ancestor
25694787|NCT02036515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25694788|NCT02036515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25694789|NCT02036515|Protease Inhibitors|protease inhibitors|mesh-ancestor
25694790|NCT02036515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916863|NCT04236323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24916865|NCT04236310|Anastrozole|anastrozole|mesh-list
24916866|NCT04236310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24544755|NCT00690105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24611280|NCT01008098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24611281|NCT01008111|Hydrogen Peroxide|hydrogen peroxide|mesh-list
24611282|NCT01008111|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24611283|NCT01008111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24611284|NCT01008137|Vaccines|vaccines|mesh-list
24611285|NCT01008137|Immunologic Factors|immunologic factors|mesh-ancestor
24638934|NCT01159236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611286|NCT01008137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611288|NCT01008293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24611289|NCT01008345|Ezetimibe|ezetimibe|mesh-list
24611290|NCT01008345|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24611291|NCT01008345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24611292|NCT01008345|Antimetabolites|antimetabolites|mesh-ancestor
24611293|NCT01008345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611294|NCT01008345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24611295|NCT01008358|Tremelimumab|tremelimumab|mesh-list
24681522|NCT01380912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681523|NCT01380912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24681524|NCT01380912|Glucocorticoids|glucocorticoids|mesh-ancestor
24681525|NCT01380912|Hormones|hormones|mesh-ancestor
24681526|NCT01380912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24681540|NCT01381055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681541|NCT01381055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24681542|NCT01381055|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24681543|NCT01381055|Protective Agents|protective agents|mesh-ancestor
24681544|NCT01381055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681545|NCT01381055|Vasodilator Agents|vasodilator agents|mesh-ancestor
24681546|NCT01381055|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24681547|NCT01381055|Antioxidants|antioxidants|mesh-ancestor
24681548|NCT01381185|Aspirin|aspirin|mesh-list
24681549|NCT01381185|Clopidogrel|clopidogrel|mesh-list
24681550|NCT01381185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24681562|NCT01381185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24681564|NCT01381185|Antipyretics|antipyretics|mesh-ancestor
24681565|NCT01381185|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24681566|NCT01381185|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24681567|NCT01381185|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24681568|NCT01381185|Purinergic Agents|purinergic agents|mesh-ancestor
24681569|NCT01381185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24681570|NCT01381276|Beta Carotene|beta carotene|mesh-list
24681571|NCT01381276|Vitamin A|vitamin a|mesh-list
24681572|NCT01381276|Retinol palmitate|retinol palmitate|mesh-list
24681573|NCT01381276|Carotenoids|carotenoids|mesh-list
24854663|NCT02274506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854664|NCT02274506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24854665|NCT02274506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24854666|NCT02274506|Alkylating Agents|alkylating agents|mesh-ancestor
24854667|NCT02274506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681719|NCT01381627|Remifentanil|remifentanil|mesh-list
24681574|NCT01381276|Antioxidants|antioxidants|mesh-ancestor
24681575|NCT01381276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681576|NCT01381276|Protective Agents|protective agents|mesh-ancestor
24681577|NCT01381276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681578|NCT01381276|Provitamins|provitamins|mesh-ancestor
24681579|NCT01381276|Vitamins|vitamins|mesh-ancestor
24681580|NCT01381276|Micronutrients|micronutrients|mesh-ancestor
24681581|NCT01381276|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24681582|NCT01381276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681583|NCT01381289|Ivacaftor|ivacaftor|mesh-list
24681584|NCT01381289|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25694791|NCT02036515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694792|NCT02036515|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25694793|NCT02036515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25694794|NCT02036515|Immunologic Factors|immunologic factors|mesh-ancestor
25694795|NCT02036515|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24681585|NCT01381289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24544844|NCT00690560|Doxorubicin|doxorubicin|mesh-list
24544846|NCT00690560|Vincristine|vincristine|mesh-list
24681586|NCT01381289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681587|NCT01381354|Thioctic Acid|thioctic acid|mesh-list
24681598|NCT01381354|Vitamins|vitamins|mesh-ancestor
24681599|NCT01381354|Micronutrients|micronutrients|mesh-ancestor
24681600|NCT01381354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681601|NCT01381354|Antiviral Agents|antiviral agents|mesh-ancestor
24681602|NCT01381354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24681607|NCT01381354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681608|NCT01381354|Protective Agents|protective agents|mesh-ancestor
24681609|NCT01381354|Antidotes|antidotes|mesh-ancestor
24681610|NCT01381354|Vitamin B Complex|vitamin b complex|mesh-ancestor
24681611|NCT01381354|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24681612|NCT01381354|Dermatologic Agents|dermatologic agents|mesh-ancestor
24681613|NCT01381354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24681614|NCT01381354|Antimetabolites|antimetabolites|mesh-ancestor
24681615|NCT01381354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24681616|NCT01381354|Vasodilator Agents|vasodilator agents|mesh-ancestor
24681759|NCT01381835|Antiviral Agents|antiviral agents|mesh-ancestor
24681617|NCT01381354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24681618|NCT01381354|Nootropic Agents|nootropic agents|mesh-ancestor
24681619|NCT01381367|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24681620|NCT01381367|Immunologic Factors|immunologic factors|mesh-ancestor
24681621|NCT01381367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681652|NCT01381497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681653|NCT01381497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681657|NCT01381497|Serotonin Agents|serotonin agents|mesh-ancestor
24681658|NCT01381497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24681660|NCT01381510|Dutasteride|dutasteride|mesh-list
24681661|NCT01381510|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
24681662|NCT01381510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24681663|NCT01381510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680181|NCT01373398|Apaziquone|apaziquone|mesh-list
24681681|NCT01381523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681682|NCT01381523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681704|NCT01381601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681705|NCT01381614|Bevacizumab|bevacizumab|mesh-list
24681706|NCT01381614|Sunitinib|sunitinib|mesh-list
24681707|NCT01381614|Sorafenib|sorafenib|mesh-list
24681708|NCT01381614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24681709|NCT01381614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681710|NCT01381614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24681711|NCT01381614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24681712|NCT01381614|Growth Substances|growth substances|mesh-ancestor
24681713|NCT01381614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681714|NCT01381614|Growth Inhibitors|growth inhibitors|mesh-ancestor
24681715|NCT01381614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24681716|NCT01381614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681717|NCT01381614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854679|NCT02274610|Tubulin Modulators|tubulin modulators|mesh-ancestor
24854680|NCT02274610|Antimitotic Agents|antimitotic agents|mesh-ancestor
24854681|NCT02274610|Mitosis Modulators|mitosis modulators|mesh-ancestor
24854682|NCT02274610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854683|NCT02274623|Calcifediol|calcifediol|mesh-list
24854684|NCT02274623|Vitamins|vitamins|mesh-ancestor
24854685|NCT02274623|Micronutrients|micronutrients|mesh-ancestor
24854686|NCT02274623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854687|NCT02274623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24854688|NCT02274740|Metformin|metformin|mesh-list
24854689|NCT02274740|Lixisenatide|lixisenatide|mesh-list
24854690|NCT02274740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24854691|NCT02274740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854692|NCT02274961|Pantoprazole|pantoprazole|mesh-list
24854693|NCT02274961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24681721|NCT01381627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24681722|NCT01381627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681732|NCT01381627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681733|NCT01381627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24681734|NCT01381627|Narcotics|narcotics|mesh-ancestor
24440239|NCT00281983|Antitubercular Agents|antitubercular agents|mesh-ancestor
24440240|NCT00281983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24681736|NCT01381640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24681737|NCT01381640|Analgesics|analgesics|mesh-ancestor
25694796|NCT02036580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25694797|NCT02036580|Immunologic Factors|immunologic factors|mesh-ancestor
24681738|NCT01381640|Sensory System Agents|sensory system agents|mesh-ancestor
24681739|NCT01381640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24681740|NCT01381640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681741|NCT01381640|Antipyretics|antipyretics|mesh-ancestor
24681742|NCT01381705|Rituximab|rituximab|mesh-list
24681743|NCT01381705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24681744|NCT01381705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681745|NCT01381705|Immunologic Factors|immunologic factors|mesh-ancestor
24681746|NCT01381705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681747|NCT01381705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24681749|NCT01381796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24681750|NCT01381796|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24681751|NCT01381796|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24681752|NCT01381796|Serotonin Agents|serotonin agents|mesh-ancestor
24681753|NCT01381796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24681754|NCT01381796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681755|NCT01381796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681756|NCT01381809|Epoetin Alfa|epoetin alfa|mesh-list
24681757|NCT01381809|Hematinics|hematinics|mesh-ancestor
24681760|NCT01381835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24681761|NCT01381835|Protease Inhibitors|protease inhibitors|mesh-ancestor
24854694|NCT02274961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24854695|NCT02274961|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24854696|NCT02274961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854698|NCT02274974|Lidocaine|lidocaine|mesh-list
24681809|NCT01382134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681810|NCT01382134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24681811|NCT01382134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24681813|NCT01382134|Antipyretics|antipyretics|mesh-ancestor
24681814|NCT01382134|Hemostatics|hemostatics|mesh-ancestor
24681815|NCT01382134|Coagulants|coagulants|mesh-ancestor
24681816|NCT01382134|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24681817|NCT01382134|Natriuretic Agents|natriuretic agents|mesh-ancestor
24681818|NCT01382147|Daunorubicin|daunorubicin|mesh-list
24681819|NCT01382147|Mitoxantrone|mitoxantrone|mesh-list
24457269|NCT00333632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24482252|NCT00438269|Cefazolin|cefazolin|mesh-list
24482253|NCT00438269|Tazobactam|tazobactam|mesh-list
24482254|NCT00438269|Piperacillin|piperacillin|mesh-list
24681825|NCT01382147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681827|NCT01382147|Sensory System Agents|sensory system agents|mesh-ancestor
24681828|NCT01382147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24681829|NCT01382147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681830|NCT01382160|Adalimumab|adalimumab|mesh-list
24681831|NCT01382160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24681832|NCT01382160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24681833|NCT01382199|Lactoferrin|lactoferrin|mesh-list
24681834|NCT01382199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24681835|NCT01382238|Dolutegravir|dolutegravir|mesh-list
24681836|NCT01382238|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24681837|NCT01382238|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24681838|NCT01382238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681839|NCT01382238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681840|NCT01382238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24681841|NCT01382238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24681842|NCT01382238|Antiviral Agents|antiviral agents|mesh-ancestor
24681843|NCT01382238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24681844|NCT01382277|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24440241|NCT00281996|Gemcitabine|gemcitabine|mesh-list
24440242|NCT00281996|Imatinib Mesylate|imatinib mesylate|mesh-list
24440244|NCT00281996|Antimetabolites|antimetabolites|mesh-ancestor
24681845|NCT01382277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24681846|NCT01382277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24681847|NCT01382277|Antimetabolites|antimetabolites|mesh-ancestor
24681848|NCT01382277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681849|NCT01382277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24681850|NCT01382277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24681851|NCT01382277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681852|NCT01382342|Rasagiline|rasagiline|mesh-list
24681853|NCT01382342|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24854725|NCT02275013|Vasodilator Agents|vasodilator agents|mesh-ancestor
24854726|NCT02275013|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24854727|NCT02275013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24457270|NCT00333632|GABA Modulators|gaba modulators|mesh-ancestor
24457271|NCT00333632|GABA Agents|gaba agents|mesh-ancestor
24457272|NCT00333632|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24746951|NCT02500797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24681880|NCT01382498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24681881|NCT01382498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681882|NCT01382498|Hemostatics|hemostatics|mesh-ancestor
24681883|NCT01382498|Coagulants|coagulants|mesh-ancestor
24681884|NCT01382511|Simvastatin|simvastatin|mesh-list
24681885|NCT01382511|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24681886|NCT01382511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24829479|NCT02152553|Hydrocortisone|hydrocortisone|mesh-list
24681887|NCT01382511|Antimetabolites|antimetabolites|mesh-ancestor
24681888|NCT01382511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681889|NCT01382511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24681890|NCT01382511|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24854738|NCT02275039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457274|NCT00333645|Antifungal Agents|antifungal agents|mesh-ancestor
24681922|NCT01383044|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24681923|NCT01383044|Adrenergic Agents|adrenergic agents|mesh-ancestor
24681924|NCT01383044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24854794|NCT02275598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681925|NCT01383044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681926|NCT01383044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681927|NCT01383044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24681928|NCT01383044|Antioxidants|antioxidants|mesh-ancestor
24681929|NCT01383044|Protective Agents|protective agents|mesh-ancestor
24681930|NCT01383044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24681931|NCT01383044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24681932|NCT01383044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24681933|NCT01383044|Vasodilator Agents|vasodilator agents|mesh-ancestor
24681934|NCT01383044|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24681959|NCT01383330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681960|NCT01383330|Appetite Stimulants|appetite stimulants|mesh-ancestor
24681961|NCT01383330|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24681974|NCT01383343|Immunoglobulins|immunoglobulins|mesh-list
24681975|NCT01383343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24681976|NCT01383343|Immunoglobulin G|immunoglobulin g|mesh-list
24681978|NCT01383343|Levoleucovorin|levoleucovorin|mesh-list
24681979|NCT01383343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681980|NCT01383343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24681981|NCT01383343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24681982|NCT01383343|Growth Substances|growth substances|mesh-ancestor
24681983|NCT01383343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681984|NCT01383343|Growth Inhibitors|growth inhibitors|mesh-ancestor
24681985|NCT01383343|Immunologic Factors|immunologic factors|mesh-ancestor
24681986|NCT01383343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24682068|NCT01383668|Antifungal Agents|antifungal agents|mesh-ancestor
24682069|NCT01383668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24682070|NCT01383668|Immunologic Factors|immunologic factors|mesh-ancestor
24680614|NCT01375556|Ethanol|ethanol|mesh-list
24682115|NCT01384331|Desogestrel|desogestrel|mesh-list
24682116|NCT01384331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24682117|NCT01384331|Contraceptive Agents|contraceptive agents|mesh-ancestor
24854761|NCT02275182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24854762|NCT02275182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854763|NCT02275247|Ropivacaine|ropivacaine|mesh-list
24854764|NCT02275247|Anesthetics, Local|anesthetics, local|mesh-ancestor
24854765|NCT02275247|Anesthetics|anesthetics|mesh-ancestor
24854766|NCT02275247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24854767|NCT02275247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854768|NCT02275247|Sensory System Agents|sensory system agents|mesh-ancestor
24457299|NCT00333931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25694798|NCT02036580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694799|NCT02036775|Ambroxol|ambroxol|mesh-list
25694800|NCT02036775|Expectorants|expectorants|mesh-ancestor
25694801|NCT02036775|Respiratory System Agents|respiratory system agents|mesh-ancestor
25694802|NCT02036840|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25694803|NCT02036840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25694804|NCT02037061|Bupivacaine|bupivacaine|mesh-list
24447258|NCT00307723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447259|NCT00307723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24457300|NCT00333931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24457301|NCT00333931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694805|NCT02037061|Anesthetics, Local|anesthetics, local|mesh-ancestor
25694806|NCT02037061|Anesthetics|anesthetics|mesh-ancestor
24682714|NCT01388075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457303|NCT00333931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24482921|NCT00440960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24482948|NCT00441051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24482949|NCT00441051|Analgesics|analgesics|mesh-ancestor
24682118|NCT01384331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24682119|NCT01384331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682120|NCT01384331|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24682121|NCT01384331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24682122|NCT01384331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24682220|NCT01384812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682221|NCT01384864|Proflavine|proflavine|mesh-list
24682222|NCT01384864|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24682223|NCT01384864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24682224|NCT01384903|Antithrombins|antithrombins|mesh-list
24682225|NCT01384903|Antithrombin III|antithrombin iii|mesh-list
24682226|NCT01384903|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24682227|NCT01384903|Protease Inhibitors|protease inhibitors|mesh-ancestor
24682228|NCT01384903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682229|NCT01384903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682230|NCT01384903|Anticoagulants|anticoagulants|mesh-ancestor
24682231|NCT01384994|Folic Acid|folic acid|mesh-list
24682232|NCT01384994|Vitamin B Complex|vitamin b complex|mesh-list
24682233|NCT01384994|Oxaliplatin|oxaliplatin|mesh-list
24854791|NCT02275416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854793|NCT02275598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24854796|NCT02275663|Fludarabine|fludarabine|mesh-list
24854797|NCT02275663|Azacitidine|azacitidine|mesh-list
24854798|NCT02275663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24854799|NCT02275663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24854800|NCT02275663|Antimetabolites|antimetabolites|mesh-ancestor
24854801|NCT02275663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854802|NCT02275663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24854803|NCT02275663|Immunologic Factors|immunologic factors|mesh-ancestor
24854804|NCT02275663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854805|NCT02275663|Antiviral Agents|antiviral agents|mesh-ancestor
24854806|NCT02275663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24682238|NCT01384994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682269|NCT01385228|Antimitotic Agents|antimitotic agents|mesh-ancestor
24682270|NCT01385228|Mitosis Modulators|mitosis modulators|mesh-ancestor
24682271|NCT01385228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682272|NCT01385228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24682273|NCT01385228|Glucocorticoids|glucocorticoids|mesh-ancestor
24682274|NCT01385228|Hormones|hormones|mesh-ancestor
24682275|NCT01385228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24682276|NCT01385228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682277|NCT01385228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24682278|NCT01385345|Vitamin D|vitamin d|mesh-list
24682279|NCT01385345|Cholecalciferol|cholecalciferol|mesh-list
24682280|NCT01385345|Vitamins|vitamins|mesh-ancestor
24682281|NCT01385345|Micronutrients|micronutrients|mesh-ancestor
24682282|NCT01385345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682283|NCT01385345|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24682284|NCT01385345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24682285|NCT01385527|Triamcinolone|triamcinolone|mesh-list
24682286|NCT01385527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24682287|NCT01385527|Glucocorticoids|glucocorticoids|mesh-ancestor
24682288|NCT01385527|Hormones|hormones|mesh-ancestor
24682289|NCT01385527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24682325|NCT01385891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24682326|NCT01385891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24682327|NCT01385891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682328|NCT01385891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694807|NCT02037061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25694808|NCT02037061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694809|NCT02037061|Sensory System Agents|sensory system agents|mesh-ancestor
25694810|NCT02037061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25709351|NCT02265510|Mitosis Modulators|mitosis modulators|mesh-ancestor
25709352|NCT02265510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682329|NCT01385891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24682330|NCT01385891|Antimetabolites|antimetabolites|mesh-ancestor
24682349|NCT01386086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24682350|NCT01386086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24682351|NCT01386086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682352|NCT01386086|Dopamine Agonists|dopamine agonists|mesh-ancestor
24682353|NCT01386086|Dopamine Agents|dopamine agents|mesh-ancestor
24682354|NCT01386086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24682355|NCT01386086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682365|NCT01386151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682367|NCT01386164|Immunologic Factors|immunologic factors|mesh-ancestor
24682368|NCT01386164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682369|NCT01386177|Doxazosin|doxazosin|mesh-list
24682370|NCT01386177|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
24682371|NCT01386177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24682372|NCT01386177|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24682373|NCT01386177|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24682374|NCT01386177|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24682375|NCT01386177|Adrenergic Agents|adrenergic agents|mesh-ancestor
24682376|NCT01386177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24682377|NCT01386177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682378|NCT01386177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682379|NCT01386177|Hallucinogens|hallucinogens|mesh-ancestor
24682380|NCT01386177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24682381|NCT01386177|Serotonin Agents|serotonin agents|mesh-ancestor
24682382|NCT01386177|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24682383|NCT01386177|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24682384|NCT01386177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24682385|NCT01386229|Ketamine|ketamine|mesh-list
24854810|NCT02275702|Antiemetics|antiemetics|mesh-ancestor
24854811|NCT02275702|Autonomic Agents|autonomic agents|mesh-ancestor
24854812|NCT02275702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24854813|NCT02275702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854814|NCT02275702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24854815|NCT02275702|Glucocorticoids|glucocorticoids|mesh-ancestor
24854817|NCT02275702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24854818|NCT02275702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24854819|NCT02275702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24854822|NCT02275806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24854823|NCT02275806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24854824|NCT02275806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24854825|NCT02275806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457364|NCT00334139|Zoledronic Acid|zoledronic acid|mesh-list
24680931|NCT01377051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682452|NCT01386398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682453|NCT01386502|Pidilizumab|pidilizumab|mesh-list
24682454|NCT01386502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24682455|NCT01386502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24682456|NCT01386567|Methyltestosterone|methyltestosterone|mesh-list
24682457|NCT01386567|Citric Acid|citric acid|mesh-list
24682458|NCT01386567|Sodium Citrate|sodium citrate|mesh-list
24682459|NCT01386567|Enclomiphene|enclomiphene|mesh-list
24682460|NCT01386567|Clomiphene|clomiphene|mesh-list
24682461|NCT01386567|Zuclomiphene|zuclomiphene|mesh-list
24682462|NCT01386567|Testosterone|testosterone|mesh-list
24682463|NCT01386567|Testosterone undecanoate|testosterone undecanoate|mesh-list
24682464|NCT01386567|Testosterone enanthate|testosterone enanthate|mesh-list
24682480|NCT01386567|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24682481|NCT01386567|Fertility Agents|fertility agents|mesh-ancestor
24682482|NCT01386567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24682483|NCT01386567|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24854835|NCT02275897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24854836|NCT02275897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709353|NCT02265510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25709354|NCT02265510|Antiemetics|antiemetics|mesh-ancestor
25709355|NCT02265510|Autonomic Agents|autonomic agents|mesh-ancestor
25709356|NCT02265510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25709357|NCT02265510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794528|NCT05067387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24794530|NCT05067387|Hormones|hormones|mesh-ancestor
24854837|NCT02275897|Sympathomimetics|sympathomimetics|mesh-ancestor
24854838|NCT02275897|Autonomic Agents|autonomic agents|mesh-ancestor
24854839|NCT02275897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24854840|NCT02275897|Dopamine Agents|dopamine agents|mesh-ancestor
24854841|NCT02275897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24682484|NCT01386567|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24682486|NCT01386580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24682487|NCT01386580|Trastuzumab|trastuzumab|mesh-list
24680976|NCT01377324|Estradiol|estradiol|mesh-list
24682496|NCT01386593|Rifampin|rifampin|mesh-list
24682497|NCT01386593|Fluconazole|fluconazole|mesh-list
24682498|NCT01386593|Paroxetine|paroxetine|mesh-list
24682499|NCT01386593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24682500|NCT01386593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24682501|NCT01386593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24682502|NCT01386593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24682503|NCT01386593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682504|NCT01386593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682505|NCT01386593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24682506|NCT01386593|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24682507|NCT01386593|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24682508|NCT01386593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24682509|NCT01386593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24682510|NCT01386593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24682511|NCT01386593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24682512|NCT01386593|Serotonin Agents|serotonin agents|mesh-ancestor
24854844|NCT02275897|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24854845|NCT02275897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24854846|NCT02275897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24854847|NCT02275897|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24854849|NCT02275962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24854850|NCT02275962|Antitubercular Agents|antitubercular agents|mesh-ancestor
24854851|NCT02275962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24854852|NCT02275962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24854853|NCT02275962|Leprostatic Agents|leprostatic agents|mesh-ancestor
24854854|NCT02275962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24854855|NCT02275962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682544|NCT01386658|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
24682545|NCT01386658|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
24682546|NCT01386658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682547|NCT01386658|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24682548|NCT01386658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24682549|NCT01386658|Immunologic Factors|immunologic factors|mesh-ancestor
24682551|NCT01386671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24682552|NCT01386671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682555|NCT01386710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24682605|NCT01387048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24682606|NCT01387048|Analgesics|analgesics|mesh-ancestor
24682607|NCT01387048|Sensory System Agents|sensory system agents|mesh-ancestor
24682608|NCT01387048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24682609|NCT01387048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682610|NCT01387048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24682611|NCT01387048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24682612|NCT01387048|Dermatologic Agents|dermatologic agents|mesh-ancestor
24682613|NCT01387048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24682614|NCT01387087|Peficitinib|peficitinib|mesh-list
24682615|NCT01387087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682616|NCT01387087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682617|NCT01387087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24682618|NCT01387087|Immunologic Factors|immunologic factors|mesh-ancestor
24682619|NCT01387087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682620|NCT01387191|Epoprostenol|epoprostenol|mesh-list
24682621|NCT01387191|Tezosentan|tezosentan|mesh-list
24682622|NCT01387191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24682623|NCT01387191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24682624|NCT01387191|Vasodilator Agents|vasodilator agents|mesh-ancestor
24682625|NCT01387204|Trametinib|trametinib|mesh-list
24829565|NCT02153125|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24682626|NCT01387204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24682627|NCT01387204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25694811|NCT02037165|Celecoxib|celecoxib|mesh-list
25694812|NCT02037165|Pregabalin|pregabalin|mesh-list
24682648|NCT01387373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682699|NCT01388036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682700|NCT01388036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682703|NCT01388049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682704|NCT01388062|Antibodies|antibodies|mesh-list
24483904|NCT00445861|Antimitotic Agents|antimitotic agents|mesh-ancestor
24483905|NCT00445861|Mitosis Modulators|mitosis modulators|mesh-ancestor
24483908|NCT00445874|Ketotifen|ketotifen|mesh-list
24682705|NCT01388062|Immunologic Factors|immunologic factors|mesh-ancestor
24682706|NCT01388062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682707|NCT01388075|Rifampin|rifampin|mesh-list
24682708|NCT01388075|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24682709|NCT01388075|Antitubercular Agents|antitubercular agents|mesh-ancestor
24682710|NCT01388075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24682711|NCT01388075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24682712|NCT01388075|Leprostatic Agents|leprostatic agents|mesh-ancestor
24682713|NCT01388075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24682715|NCT01388075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682716|NCT01388075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24682717|NCT01388075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24682727|NCT01388088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682728|NCT01388088|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24682730|NCT01388088|Natriuretic Agents|natriuretic agents|mesh-ancestor
24682731|NCT01388088|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24682732|NCT01388088|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24682733|NCT01388088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24682734|NCT01388088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682735|NCT01388088|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24682758|NCT01388322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682760|NCT01388387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24682761|NCT01388387|Immunologic Factors|immunologic factors|mesh-ancestor
24682762|NCT01388387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682763|NCT01388387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24682764|NCT01388387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682765|NCT01388387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682766|NCT01388413|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24682767|NCT01388413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24682768|NCT01388439|Oseltamivir|oseltamivir|mesh-list
24682769|NCT01388439|Antiviral Agents|antiviral agents|mesh-ancestor
24682770|NCT01388439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24682771|NCT01388439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682772|NCT01388439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682773|NCT01388517|Vitamin D|vitamin d|mesh-list
24682774|NCT01388517|Calcitriol|calcitriol|mesh-list
24682775|NCT01388517|Petrolatum|petrolatum|mesh-list
24682776|NCT01388517|Tacrolimus|tacrolimus|mesh-list
24682777|NCT01388517|Vitamins|vitamins|mesh-ancestor
24682778|NCT01388517|Micronutrients|micronutrients|mesh-ancestor
24682779|NCT01388517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682780|NCT01388517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24854858|NCT02275962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24854859|NCT02275962|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24854860|NCT02275962|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24854861|NCT02275962|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24854862|NCT02275962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24854864|NCT02275975|Antifungal Agents|antifungal agents|mesh-ancestor
24854865|NCT02275975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24854866|NCT02275975|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24457413|NCT00334360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682799|NCT01388582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682800|NCT01388582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24682821|NCT01388595|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24682822|NCT01388595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24682823|NCT01388595|Adrenergic Agents|adrenergic agents|mesh-ancestor
24682824|NCT01388595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24682825|NCT01388595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682826|NCT01388621|Gemcitabine|gemcitabine|mesh-list
24682827|NCT01388621|Carboplatin|carboplatin|mesh-list
24682828|NCT01388621|Doxorubicin|doxorubicin|mesh-list
24858356|NCT02296567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24858357|NCT02296567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24858358|NCT02296567|Growth Substances|growth substances|mesh-ancestor
24682829|NCT01388621|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24682830|NCT01388621|Panitumumab|panitumumab|mesh-list
24682831|NCT01388621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24682832|NCT01388621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24682833|NCT01388621|Antimetabolites|antimetabolites|mesh-ancestor
24682834|NCT01388621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682835|NCT01388621|Antiviral Agents|antiviral agents|mesh-ancestor
24682836|NCT01388621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24682837|NCT01388621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682838|NCT01388621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24682839|NCT01388621|Immunologic Factors|immunologic factors|mesh-ancestor
24682840|NCT01388621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682841|NCT01388621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24682842|NCT01388621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24682843|NCT01388621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24682844|NCT01388621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24682845|NCT01388660|Clopidogrel|clopidogrel|mesh-list
24682846|NCT01388660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24682848|NCT01388660|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24854867|NCT02275975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24854868|NCT02275975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854884|NCT02276001|Cyclosporine|cyclosporine|mesh-list
24854888|NCT02276001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24854889|NCT02276001|Immunologic Factors|immunologic factors|mesh-ancestor
24854890|NCT02276001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854891|NCT02276001|Antifungal Agents|antifungal agents|mesh-ancestor
24854892|NCT02276001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24854893|NCT02276001|Dermatologic Agents|dermatologic agents|mesh-ancestor
24854894|NCT02276001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24854895|NCT02276001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24854896|NCT02276014|Beta Carotene|beta carotene|mesh-list
24682849|NCT01388660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24682850|NCT01388660|Purinergic Agents|purinergic agents|mesh-ancestor
24682851|NCT01388660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24611405|NCT01009437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24611406|NCT01009437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24611407|NCT01009437|Antiviral Agents|antiviral agents|mesh-ancestor
24611408|NCT01009437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24611409|NCT01009437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24611410|NCT01009437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24854898|NCT02276014|Antioxidants|antioxidants|mesh-ancestor
24854899|NCT02276014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854900|NCT02276014|Protective Agents|protective agents|mesh-ancestor
24854901|NCT02276014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611411|NCT01009476|Nicergoline|nicergoline|mesh-list
24611413|NCT01009476|Galantamine|galantamine|mesh-list
24611414|NCT01009476|Nootropic Agents|nootropic agents|mesh-list
24611415|NCT01009476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24611416|NCT01009476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611417|NCT01009476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682857|NCT01388738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24682881|NCT01388855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24682882|NCT01388959|Rituximab|rituximab|mesh-list
24682883|NCT01388959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24682885|NCT01388959|Immunologic Factors|immunologic factors|mesh-ancestor
24682891|NCT01389024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682892|NCT01389024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682893|NCT01389024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24682894|NCT01389063|Maraviroc|maraviroc|mesh-list
24682906|NCT01389167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682908|NCT01389167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24682942|NCT01389388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682944|NCT01389401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24682945|NCT01389401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24682946|NCT01389401|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24682947|NCT01389401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25694813|NCT02037165|Analgesics|analgesics|mesh-ancestor
25694814|NCT02037165|Sensory System Agents|sensory system agents|mesh-ancestor
25694815|NCT02037165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25694816|NCT02037165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858506|NCT02298088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24858507|NCT02298088|Purinergic Agents|purinergic agents|mesh-ancestor
24858508|NCT02298088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24858509|NCT02298088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682948|NCT01389401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682949|NCT01389414|Gemcitabine|gemcitabine|mesh-list
24682950|NCT01389414|Oxaliplatin|oxaliplatin|mesh-list
24682951|NCT01389414|Panitumumab|panitumumab|mesh-list
24682967|NCT01389427|Vincristine|vincristine|mesh-list
24682968|NCT01389427|Rituximab|rituximab|mesh-list
24682969|NCT01389427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24682970|NCT01389427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24682971|NCT01389427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24682972|NCT01389427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24682973|NCT01389427|Antifungal Agents|antifungal agents|mesh-ancestor
24682974|NCT01389427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24682975|NCT01389427|Immunologic Factors|immunologic factors|mesh-ancestor
24682977|NCT01389427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24854919|NCT02276300|Alkylating Agents|alkylating agents|mesh-ancestor
24854920|NCT02276300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448562|NCT00312260|Sensory System Agents|sensory system agents|mesh-ancestor
24448572|NCT00312260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24854921|NCT02276300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24854922|NCT02276300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24854923|NCT02276300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24682988|NCT01389427|Tubulin Modulators|tubulin modulators|mesh-ancestor
24682989|NCT01389427|Antimitotic Agents|antimitotic agents|mesh-ancestor
24682990|NCT01389427|Mitosis Modulators|mitosis modulators|mesh-ancestor
24682991|NCT01389427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24682992|NCT01389427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24682993|NCT01389427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24682994|NCT01389427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682995|NCT01389440|Gemcitabine|gemcitabine|mesh-list
24682996|NCT01389440|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24682997|NCT01389440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24682998|NCT01389440|Antimetabolites|antimetabolites|mesh-ancestor
24682999|NCT01389440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683000|NCT01389440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24683001|NCT01389440|Antiviral Agents|antiviral agents|mesh-ancestor
24683002|NCT01389440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24683003|NCT01389440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683004|NCT01389440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24683005|NCT01389440|Immunologic Factors|immunologic factors|mesh-ancestor
24683006|NCT01389440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683007|NCT01389440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24683008|NCT01389505|Bevacizumab|bevacizumab|mesh-list
24683009|NCT01389505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24683033|NCT01389544|Analgesics|analgesics|mesh-ancestor
24683046|NCT01389609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24683047|NCT01389609|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24683048|NCT01389609|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24683049|NCT01389609|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24683050|NCT01389609|Adrenergic Agents|adrenergic agents|mesh-ancestor
24683091|NCT01389791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24854955|NCT02276495|Sensory System Agents|sensory system agents|mesh-ancestor
24854956|NCT02276495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24854957|NCT02276495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24854958|NCT02276495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24854959|NCT02276495|Adrenergic Agents|adrenergic agents|mesh-ancestor
24854960|NCT02276495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24854961|NCT02276495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854962|NCT02276495|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24854963|NCT02276495|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24683092|NCT01389791|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24683093|NCT01389791|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24683094|NCT01389791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24683096|NCT01389908|Antiemetics|antiemetics|mesh-ancestor
24683097|NCT01389908|Autonomic Agents|autonomic agents|mesh-ancestor
25694817|NCT02037165|Anticonvulsants|anticonvulsants|mesh-ancestor
25694818|NCT02037165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25694819|NCT02037165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25694820|NCT02037165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424893|NCT00231218|Propolis|propolis|mesh-list
24683098|NCT01389908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24683099|NCT01389908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683100|NCT01389908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24683101|NCT01389908|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24683102|NCT01389908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24683103|NCT01389908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24683104|NCT01389908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24683105|NCT01389908|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24683106|NCT01389908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24683107|NCT01389908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24683109|NCT01389908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24683113|NCT01390012|BB 1101|bb 1101|mesh-list
24683114|NCT01390012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24683115|NCT01390012|Antiemetics|antiemetics|mesh-ancestor
24683133|NCT01390051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24683134|NCT01390051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683135|NCT01390311|Azacitidine|azacitidine|mesh-list
24683136|NCT01390311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24683137|NCT01390311|Antimetabolites|antimetabolites|mesh-ancestor
24683138|NCT01390311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683139|NCT01390311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24683147|NCT01390324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24683148|NCT01390324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683149|NCT01390324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24683151|NCT01390324|Gout Suppressants|gout suppressants|mesh-ancestor
24683152|NCT01390324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24683153|NCT01390324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683154|NCT01390324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683155|NCT01390324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24683156|NCT01390324|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24683157|NCT01390324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24683159|NCT01390324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24683160|NCT01390337|Cytarabine|cytarabine|mesh-list
24683161|NCT01390337|Daunorubicin|daunorubicin|mesh-list
24854964|NCT02276495|Autonomic Agents|autonomic agents|mesh-ancestor
24486441|NCT00457964|Everolimus|everolimus|mesh-list
24683162|NCT01390337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24683163|NCT01390337|Antimetabolites|antimetabolites|mesh-ancestor
24683164|NCT01390337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683165|NCT01390337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24683166|NCT01390337|Antiviral Agents|antiviral agents|mesh-ancestor
24683167|NCT01390337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24683229|NCT01390883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24683230|NCT01390883|Antithrombins|antithrombins|mesh-ancestor
24683231|NCT01390883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24683232|NCT01390883|Protease Inhibitors|protease inhibitors|mesh-ancestor
24683233|NCT01390883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683234|NCT01390883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683235|NCT01390883|Anticoagulants|anticoagulants|mesh-ancestor
24683236|NCT01390883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24683237|NCT01390883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24683238|NCT01390896|PENTA|penta|mesh-list
24683239|NCT01390896|Fondaparinux|fondaparinux|mesh-list
24683240|NCT01390896|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24683241|NCT01390896|Antithrombins|antithrombins|mesh-ancestor
24683242|NCT01390896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24639625|NCT01163396|Irinotecan|irinotecan|mesh-list
24683244|NCT01390896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683245|NCT01390896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829597|NCT02153177|Antitussive Agents|antitussive agents|mesh-ancestor
24683247|NCT01390896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24683248|NCT01390896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24683249|NCT01390922|Botulinum Toxins|botulinum toxins|mesh-list
24683250|NCT01390922|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24683251|NCT01390922|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24683252|NCT01390922|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24683253|NCT01390922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24683254|NCT01390922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683255|NCT01390922|Cholinergic Agents|cholinergic agents|mesh-ancestor
25709358|NCT02265510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24917186|NCT04232332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683256|NCT01390922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24683282|NCT01390961|Dermatologic Agents|dermatologic agents|mesh-ancestor
24683283|NCT01390961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24683285|NCT01391052|Norethindrone Acetate|norethindrone acetate|mesh-list
24683286|NCT01391052|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24683287|NCT01391052|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24683288|NCT01391052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24683290|NCT01391052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24683296|NCT01391104|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24683297|NCT01391104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24854966|NCT02276495|Respiratory System Agents|respiratory system agents|mesh-ancestor
24854967|NCT02276495|Mydriatics|mydriatics|mesh-ancestor
24854968|NCT02276495|Sympathomimetics|sympathomimetics|mesh-ancestor
24854969|NCT02276495|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24683298|NCT01391104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683299|NCT01391104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683300|NCT01391104|Urological Agents|urological agents|mesh-ancestor
24611418|NCT01009476|Cholinergic Agents|cholinergic agents|mesh-ancestor
24611419|NCT01009476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24611420|NCT01009476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611421|NCT01009476|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24683302|NCT01391156|Finasteride|finasteride|mesh-list
24683303|NCT01391156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24683304|NCT01391156|Vasodilator Agents|vasodilator agents|mesh-ancestor
24683305|NCT01391156|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24683306|NCT01391156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24683307|NCT01391156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683308|NCT01391156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683309|NCT01391156|Hormone Antagonists|hormone antagonists|mesh-ancestor
24683310|NCT01391156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24683311|NCT01391156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683312|NCT01391156|Urological Agents|urological agents|mesh-ancestor
24683313|NCT01391221|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24683314|NCT01391221|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24683315|NCT01391221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24683316|NCT01391221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24683349|NCT01391403|Antimalarials|antimalarials|mesh-ancestor
24683350|NCT01391403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24683351|NCT01391403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24683352|NCT01391403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24683353|NCT01391520|Deferiprone|deferiprone|mesh-list
24683354|NCT01391520|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24683355|NCT01391520|Chelating Agents|chelating agents|mesh-ancestor
24683356|NCT01391520|Sequestering Agents|sequestering agents|mesh-ancestor
24683357|NCT01391520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683358|NCT01391572|Fluorouracil|fluorouracil|mesh-list
24683359|NCT01391572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24683360|NCT01391572|Antimetabolites|antimetabolites|mesh-ancestor
24683361|NCT01391572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683362|NCT01391572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24683363|NCT01391572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24683364|NCT01391572|Immunologic Factors|immunologic factors|mesh-ancestor
24683365|NCT01391572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683366|NCT01391598|Lidocaine|lidocaine|mesh-list
24683367|NCT01391598|Anesthetics, Local|anesthetics, local|mesh-ancestor
24683368|NCT01391598|Anesthetics|anesthetics|mesh-ancestor
24639972|NCT01165255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683369|NCT01391598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24854970|NCT02276495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24854971|NCT02276495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24854972|NCT02276495|Analgesics|analgesics|mesh-ancestor
24854973|NCT02276495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24681588|NCT01381354|Riboflavin|riboflavin|mesh-list
24683407|NCT01392079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24683408|NCT01392079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24683409|NCT01392144|Nitric Oxide|nitric oxide|mesh-list
24683410|NCT01392144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24683411|NCT01392144|Autonomic Agents|autonomic agents|mesh-ancestor
24683412|NCT01392144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24683413|NCT01392144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694821|NCT02037165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24683415|NCT01392144|Respiratory System Agents|respiratory system agents|mesh-ancestor
24683416|NCT01392144|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24683417|NCT01392144|Antioxidants|antioxidants|mesh-ancestor
24683418|NCT01392144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683419|NCT01392144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24683420|NCT01392144|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24683421|NCT01392144|Vasodilator Agents|vasodilator agents|mesh-ancestor
24683422|NCT01392144|Gasotransmitters|gasotransmitters|mesh-ancestor
24683423|NCT01392144|Protective Agents|protective agents|mesh-ancestor
24683424|NCT01392157|Copper|copper|mesh-list
24683425|NCT01392157|Levonorgestrel|levonorgestrel|mesh-list
24683426|NCT01392157|Trace Elements|trace elements|mesh-ancestor
24683427|NCT01392157|Micronutrients|micronutrients|mesh-ancestor
24683428|NCT01392157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683429|NCT01392157|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24683430|NCT01392157|Contraceptive Agents|contraceptive agents|mesh-ancestor
24683431|NCT01392157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24683432|NCT01392157|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24683433|NCT01392157|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24683434|NCT01392157|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24683435|NCT01392209|Bevacizumab|bevacizumab|mesh-list
24683436|NCT01392209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24683437|NCT01392209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24683438|NCT01392209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24854985|NCT02276690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24854986|NCT02276755|Vitamin D|vitamin d|mesh-list
24854987|NCT02276755|Cholecalciferol|cholecalciferol|mesh-list
24854988|NCT02276755|Vitamins|vitamins|mesh-ancestor
24854989|NCT02276755|Micronutrients|micronutrients|mesh-ancestor
24854990|NCT02276755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683440|NCT01392209|Growth Substances|growth substances|mesh-ancestor
24683441|NCT01392209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683442|NCT01392209|Growth Inhibitors|growth inhibitors|mesh-ancestor
24683443|NCT01392287|Memantine|memantine|mesh-list
24683444|NCT01392287|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24683445|NCT01392287|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24683446|NCT01392287|Dopamine Agents|dopamine agents|mesh-ancestor
24683447|NCT01392287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24683476|NCT01392430|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24683477|NCT01392430|Renal Agents|renal agents|mesh-ancestor
24683478|NCT01392534|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24683479|NCT01392534|Telmisartan|telmisartan|mesh-list
24683480|NCT01392534|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
24683481|NCT01392534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24683482|NCT01392534|Diuretics|diuretics|mesh-ancestor
24683483|NCT01392534|Natriuretic Agents|natriuretic agents|mesh-ancestor
24683484|NCT01392534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683485|NCT01392534|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24683486|NCT01392534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24683487|NCT01392534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683488|NCT01392534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24681659|NCT01381510|Finasteride|finasteride|mesh-list
24683520|NCT01392755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24683539|NCT01392794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24683540|NCT01392794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683542|NCT01392807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24488010|NCT00466180|Antiviral Agents|antiviral agents|mesh-ancestor
24488011|NCT00466180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24488012|NCT00466180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24488013|NCT00466180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24488172|NCT00466895|Growth Inhibitors|growth inhibitors|mesh-ancestor
24854991|NCT02276755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24854992|NCT02276755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24854993|NCT02276768|Trimebutine|trimebutine|mesh-list
24854994|NCT02276768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24854995|NCT02276768|Parasympatholytics|parasympatholytics|mesh-ancestor
24854996|NCT02276768|Autonomic Agents|autonomic agents|mesh-ancestor
24854997|NCT02276768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24854998|NCT02276768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854999|NCT02276846|Paclitaxel|paclitaxel|mesh-list
24855000|NCT02276846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24855001|NCT02276846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855002|NCT02276846|Tubulin Modulators|tubulin modulators|mesh-ancestor
24858750|NCT02299271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858751|NCT02299310|Valsartan|valsartan|mesh-list
24858757|NCT02299310|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24858758|NCT02299310|Protease Inhibitors|protease inhibitors|mesh-ancestor
24858759|NCT02299310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24858760|NCT02299401|Misoprostol|misoprostol|mesh-list
24858761|NCT02299401|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24713234|NCT01524731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713235|NCT01524744|Pimecrolimus|pimecrolimus|mesh-list
24713236|NCT01524744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24713237|NCT01524744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24855003|NCT02276846|Antimitotic Agents|antimitotic agents|mesh-ancestor
24855004|NCT02276846|Mitosis Modulators|mitosis modulators|mesh-ancestor
24855005|NCT02276846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488307|NCT00467662|Acyclovir|acyclovir|mesh-list
24488308|NCT00467662|Docosanol|docosanol|mesh-list
24488309|NCT00467662|Antiviral Agents|antiviral agents|mesh-ancestor
24683574|NCT01392898|Liraglutide|liraglutide|mesh-list
24683575|NCT01392898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24683576|NCT01392898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468181|NCT00380354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683577|NCT01392898|Incretins|incretins|mesh-ancestor
24683578|NCT01392898|Hormones|hormones|mesh-ancestor
24683579|NCT01392898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24683580|NCT01392911|Rifampin|rifampin|mesh-list
24683581|NCT01392911|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24683582|NCT01392911|Antitubercular Agents|antitubercular agents|mesh-ancestor
24683583|NCT01392911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24683584|NCT01392911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24683585|NCT01392911|Leprostatic Agents|leprostatic agents|mesh-ancestor
24683586|NCT01392911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24683587|NCT01392911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683588|NCT01392911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683589|NCT01392911|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24683590|NCT01392911|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24683591|NCT01392911|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24683592|NCT01392911|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24683593|NCT01392911|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24683594|NCT01392911|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24683595|NCT01393080|Nimotuzumab|nimotuzumab|mesh-list
24683596|NCT01393080|Cisplatin|cisplatin|mesh-list
24683597|NCT01393080|Paclitaxel|paclitaxel|mesh-list
24683598|NCT01393080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24683599|NCT01393080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24683600|NCT01393080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24611460|NCT01009593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639805|NCT01164215|Antidotes|antidotes|mesh-ancestor
24611461|NCT01009593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24611462|NCT01009593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611463|NCT01009593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611464|NCT01009697|Codeine|codeine|mesh-list
24611465|NCT01009697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24611478|NCT01009788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468313|NCT00381030|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24683707|NCT01393574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683708|NCT01393574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24683709|NCT01393574|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24683710|NCT01393574|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24683711|NCT01393574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24683712|NCT01393574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24683713|NCT01393574|Dopamine Agents|dopamine agents|mesh-ancestor
25694822|NCT02037165|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25694823|NCT02037165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25694824|NCT02037165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25694825|NCT02037165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25694826|NCT02037165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25694827|NCT02037165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25694828|NCT02037165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25694829|NCT02037165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25694830|NCT02037165|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25694831|NCT02037165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25694832|NCT02037165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25694833|NCT02037230|Gemcitabine|gemcitabine|mesh-list
24683714|NCT01393574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24683747|NCT01393912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24683748|NCT01393925|Parecoxib|parecoxib|mesh-list
24683749|NCT01393925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24683750|NCT01393925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24683752|NCT01393925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683753|NCT01393925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24683754|NCT01393925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24683755|NCT01393925|Analgesics|analgesics|mesh-ancestor
24683756|NCT01393925|Sensory System Agents|sensory system agents|mesh-ancestor
24683761|NCT01394016|Fulvestrant|fulvestrant|mesh-list
24683794|NCT01394224|Levetiracetam|levetiracetam|mesh-list
24683795|NCT01394224|Anticonvulsants|anticonvulsants|mesh-ancestor
24683826|NCT01394354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683827|NCT01394354|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24683830|NCT01394406|Sensory System Agents|sensory system agents|mesh-ancestor
24683831|NCT01394406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24683832|NCT01394406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683833|NCT01394406|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24683834|NCT01394406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24683835|NCT01394406|Anesthetics, General|anesthetics, general|mesh-ancestor
24683836|NCT01394406|Anesthetics|anesthetics|mesh-ancestor
24683837|NCT01394406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24683838|NCT01394406|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24683839|NCT01394406|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24683840|NCT01394406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24683841|NCT01394406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683842|NCT01394419|Acetylcysteine|acetylcysteine|mesh-list
24683843|NCT01394419|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24855017|NCT02276911|Sensory System Agents|sensory system agents|mesh-ancestor
24855018|NCT02276911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24855019|NCT02276911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683844|NCT01394419|Antiviral Agents|antiviral agents|mesh-ancestor
24683845|NCT01394419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24683846|NCT01394419|Expectorants|expectorants|mesh-ancestor
24683847|NCT01394419|Respiratory System Agents|respiratory system agents|mesh-ancestor
24683848|NCT01394419|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24683849|NCT01394419|Antioxidants|antioxidants|mesh-ancestor
24683851|NCT01394419|Protective Agents|protective agents|mesh-ancestor
24683887|NCT01394497|Respiratory System Agents|respiratory system agents|mesh-ancestor
24683888|NCT01394497|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24683889|NCT01394497|Antioxidants|antioxidants|mesh-ancestor
24657200|NCT01266187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24683890|NCT01394497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683891|NCT01394497|Protective Agents|protective agents|mesh-ancestor
24683892|NCT01394497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683894|NCT01394640|Immunologic Factors|immunologic factors|mesh-ancestor
24683895|NCT01394640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683898|NCT01394653|Autonomic Agents|autonomic agents|mesh-ancestor
24683899|NCT01394653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24683900|NCT01394653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683901|NCT01394653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24683902|NCT01394653|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24683903|NCT01394653|Serotonin Agents|serotonin agents|mesh-ancestor
24683904|NCT01394653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24684231|NCT01395953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24683905|NCT01394653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683906|NCT01394679|Deoxyglucose|deoxyglucose|mesh-list
25033436|NCT03573245|Tranexamic Acid|tranexamic acid|mesh-list
24683934|NCT01394757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24683935|NCT01394757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24683936|NCT01394757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24683937|NCT01394757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683938|NCT01394757|Antidepressive Agents|antidepressive agents|mesh-ancestor
24683939|NCT01394757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24683941|NCT01394770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24683942|NCT01394770|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24855025|NCT02276989|Riboflavin|riboflavin|mesh-list
24855026|NCT02276989|Quinine|quinine|mesh-list
24855027|NCT02276989|Acetazolamide|acetazolamide|mesh-list
24855028|NCT02276989|Vitamins|vitamins|mesh-ancestor
24489613|NCT00474435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24858981|NCT02300740|Vasodilator Agents|vasodilator agents|mesh-ancestor
24546398|NCT00697944|Antifungal Agents|antifungal agents|mesh-ancestor
24683952|NCT01394796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683954|NCT01394796|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24683955|NCT01394796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24683956|NCT01394796|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24683957|NCT01394835|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
24683958|NCT01394835|Protein C Inhibitor|protein c inhibitor|mesh-list
24683959|NCT01394835|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24683960|NCT01394835|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24683961|NCT01394835|Protease Inhibitors|protease inhibitors|mesh-ancestor
24468618|NCT00382421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24468619|NCT00382421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24468620|NCT00382421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24468621|NCT00382421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24468622|NCT00382421|Antipyretics|antipyretics|mesh-ancestor
24468623|NCT00382421|Sympatholytics|sympatholytics|mesh-ancestor
24683975|NCT01394848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24683976|NCT01394848|Immunologic Factors|immunologic factors|mesh-ancestor
24683977|NCT01394848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683978|NCT01394848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24683979|NCT01394848|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24683980|NCT01394848|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24681963|NCT01383343|Calcium, Dietary|calcium, dietary|mesh-list
24684015|NCT01395147|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24684016|NCT01395147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24684036|NCT01395199|Vasodilator Agents|vasodilator agents|mesh-ancestor
24684038|NCT01395251|Glucocorticoids|glucocorticoids|mesh-list
24684039|NCT01395251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24684040|NCT01395251|Hormones|hormones|mesh-ancestor
24684041|NCT01395251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24684042|NCT01395251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684043|NCT01395251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24684044|NCT01395251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684045|NCT01395290|Cholecalciferol|cholecalciferol|mesh-list
24684046|NCT01395290|Vitamin D|vitamin d|mesh-list
24684047|NCT01395290|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24682029|NCT01383460|Immunologic Factors|immunologic factors|mesh-ancestor
24611510|NCT01009879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24611511|NCT01009879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24611512|NCT01009879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24611513|NCT01009879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24611514|NCT01009879|Immunologic Factors|immunologic factors|mesh-ancestor
24611515|NCT01009892|Codeine|codeine|mesh-list
24684080|NCT01395433|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24684081|NCT01395433|Antidepressive Agents|antidepressive agents|mesh-ancestor
24684083|NCT01395433|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24684207|NCT01395875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24684222|NCT01395927|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24684223|NCT01395927|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24684224|NCT01395927|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24684225|NCT01395927|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24684226|NCT01395927|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24684228|NCT01395927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855037|NCT02276989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855038|NCT02276989|Diuretics|diuretics|mesh-ancestor
24855039|NCT02276989|Natriuretic Agents|natriuretic agents|mesh-ancestor
24855040|NCT02276989|Antimalarials|antimalarials|mesh-ancestor
24855041|NCT02276989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24684230|NCT01395953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24684232|NCT01395953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24684233|NCT01395953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684261|NCT01396291|Asenapine|asenapine|mesh-list
24684262|NCT01396291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24684263|NCT01396291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24684264|NCT01396291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24684265|NCT01396291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694834|NCT02037230|Adavosertib|adavosertib|mesh-list
25694835|NCT02037230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25694836|NCT02037230|Antimetabolites|antimetabolites|mesh-ancestor
24684266|NCT01396291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24684267|NCT01396304|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24684269|NCT01396304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24684270|NCT01396304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684271|NCT01396304|Laxatives|laxatives|mesh-ancestor
24684272|NCT01396304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24684273|NCT01396564|Metformin|metformin|mesh-list
24684274|NCT01396564|Pioglitazone|pioglitazone|mesh-list
24684275|NCT01396564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24684276|NCT01396564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684277|NCT01396642|Emollients|emollients|mesh-list
24684312|NCT01396681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684315|NCT01396707|Trastuzumab|trastuzumab|mesh-list
24684316|NCT01396707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24684317|NCT01396707|Antimetabolites|antimetabolites|mesh-ancestor
24682183|NCT01384643|Propofol|propofol|mesh-list
24960050|NCT03819790|Lixisenatide|lixisenatide|mesh-list
24684356|NCT01397006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24684358|NCT01397006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24640103|NCT01166048|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24684359|NCT01397006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24684360|NCT01397006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24684361|NCT01397019|Leucovorin|leucovorin|mesh-list
24468974|NCT00384124|Imiquimod|imiquimod|mesh-list
24684362|NCT01397019|Oxaliplatin|oxaliplatin|mesh-list
24684363|NCT01397019|Irinotecan|irinotecan|mesh-list
24684364|NCT01397019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684365|NCT01397019|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24684366|NCT01397019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24684367|NCT01397019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24684368|NCT01397019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684369|NCT01397019|Antidotes|antidotes|mesh-ancestor
24684370|NCT01397019|Protective Agents|protective agents|mesh-ancestor
24855042|NCT02276989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24855043|NCT02276989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24855044|NCT02276989|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24855045|NCT02276989|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24855046|NCT02276989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24855047|NCT02276989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24855049|NCT02276989|Sensory System Agents|sensory system agents|mesh-ancestor
24684371|NCT01397019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684372|NCT01397019|Vitamin B Complex|vitamin b complex|mesh-ancestor
24684373|NCT01397019|Vitamins|vitamins|mesh-ancestor
24684374|NCT01397019|Micronutrients|micronutrients|mesh-ancestor
24684375|NCT01397097|Etonogestrel|etonogestrel|mesh-list
24684393|NCT01397214|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24684394|NCT01397214|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24684395|NCT01397214|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24684407|NCT01397331|Isoflurane|isoflurane|mesh-list
24684408|NCT01397331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24684409|NCT01397331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24640122|NCT01166087|Serotonin Agents|serotonin agents|mesh-ancestor
24684410|NCT01397331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684411|NCT01397331|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24684412|NCT01397331|Anesthetics, General|anesthetics, general|mesh-ancestor
24684413|NCT01397331|Anesthetics|anesthetics|mesh-ancestor
24684414|NCT01397331|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24684415|NCT05269290|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
24684416|NCT05269290|Antiviral Agents|antiviral agents|mesh-ancestor
24684417|NCT05269290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24684418|NCT05268835|Clindamycin|clindamycin|mesh-list
24684419|NCT05268835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24684420|NCT05268835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24684421|NCT05268835|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24684422|NCT05268835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24684423|NCT05268835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684424|NCT05268718|Voriconazole|voriconazole|mesh-list
24684425|NCT05268718|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24684426|NCT05268718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24684427|NCT05268718|Antifungal Agents|antifungal agents|mesh-ancestor
24684457|NCT05268562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24684458|NCT05268562|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24684459|NCT05268562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24855053|NCT02277041|Abortifacient Agents|abortifacient agents|mesh-ancestor
24855054|NCT02277041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24855055|NCT02277041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855056|NCT02277041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24855057|NCT02277041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24855058|NCT02277041|Oxytocics|oxytocics|mesh-ancestor
24800476|NCT01975805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24546998|NCT00701831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24684471|NCT05268185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684516|NCT05243251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24684517|NCT05243251|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24684518|NCT05243251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24684519|NCT05243251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24684520|NCT05243251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24684521|NCT05243251|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24684522|NCT05243251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24684523|NCT05243251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24684524|NCT05243251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684550|NCT05186558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24611544|NCT01009957|Everolimus|everolimus|mesh-list
24684551|NCT05186558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24684552|NCT05186558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24684553|NCT05186558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24684554|NCT05186558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24684555|NCT05186558|Growth Substances|growth substances|mesh-ancestor
24684556|NCT05186558|Growth Inhibitors|growth inhibitors|mesh-ancestor
24684557|NCT05092698|Vitamin D|vitamin d|mesh-list
24684558|NCT05092698|Cholecalciferol|cholecalciferol|mesh-list
24684559|NCT05092698|Vitamins|vitamins|mesh-ancestor
24684560|NCT05092698|Micronutrients|micronutrients|mesh-ancestor
24684561|NCT05092698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684562|NCT05092698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24684563|NCT05092698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24855059|NCT02277067|Misoprostol|misoprostol|mesh-list
24855060|NCT02277067|Carbetocin|carbetocin|mesh-list
24855061|NCT02277067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24855062|NCT02277067|Abortifacient Agents|abortifacient agents|mesh-ancestor
24855063|NCT02277067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24684598|NCT05009355|Antioxidants|antioxidants|mesh-ancestor
24684599|NCT05009355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684600|NCT05009355|Protective Agents|protective agents|mesh-ancestor
24684601|NCT04975269|Acetazolamide|acetazolamide|mesh-list
24684618|NCT04965870|Antiviral Agents|antiviral agents|mesh-ancestor
24684619|NCT04965870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24684621|NCT04941937|Dexamethasone|dexamethasone|mesh-list
24684622|NCT04941937|Lenalidomide|lenalidomide|mesh-list
24684623|NCT04941937|Pomalidomide|pomalidomide|mesh-list
24684624|NCT04941937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24684625|NCT04941937|Antiemetics|antiemetics|mesh-ancestor
24684626|NCT04941937|Autonomic Agents|autonomic agents|mesh-ancestor
24684627|NCT04941937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24684628|NCT04941937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684629|NCT04941937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24684630|NCT04941937|Glucocorticoids|glucocorticoids|mesh-ancestor
24684632|NCT04941937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24684641|NCT04941937|Leprostatic Agents|leprostatic agents|mesh-ancestor
24684642|NCT04941937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24684643|NCT04941937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24684644|NCT04925986|Pembrolizumab|pembrolizumab|mesh-list
24684645|NCT04925986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24684646|NCT04925986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684647|NCT04893096|Felzartamab|felzartamab|mesh-list
24684648|NCT04893096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684697|NCT04695054|Anesthetics|anesthetics|mesh-ancestor
24684698|NCT04695054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24684699|NCT04695054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684701|NCT04695054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24684702|NCT04695054|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24469381|NCT00385606|Antiviral Agents|antiviral agents|mesh-ancestor
24684703|NCT04604353|Calcium|calcium|mesh-list
24684704|NCT04604353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25033768|NCT03571308|Glucocorticoids|glucocorticoids|mesh-ancestor
24684705|NCT04604353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684706|NCT04598815|Sirolimus|sirolimus|mesh-list
24684707|NCT04598815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24684708|NCT04598815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25694837|NCT02037230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694838|NCT02037230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684740|NCT04500756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684741|NCT04472416|Analgesics|analgesics|mesh-list
24684742|NCT04472416|Sensory System Agents|sensory system agents|mesh-ancestor
24684743|NCT04472416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24547536|NCT00704548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24547537|NCT00704548|Antimetabolites|antimetabolites|mesh-ancestor
24684744|NCT04472416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684745|NCT04466540|Hydroxychloroquine|hydroxychloroquine|mesh-list
24684746|NCT04466540|Antimalarials|antimalarials|mesh-ancestor
24684747|NCT04466540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24684748|NCT04466540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24684783|NCT04182373|Protease Inhibitors|protease inhibitors|mesh-ancestor
24855068|NCT02277132|Sildenafil Citrate|sildenafil citrate|mesh-list
24855069|NCT02277132|Vasodilator Agents|vasodilator agents|mesh-ancestor
24855070|NCT02277132|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24457538|NCT00334672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24684784|NCT04182373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24684802|NCT04093596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684803|NCT04093596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24684804|NCT04093596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24684845|NCT03580473|Moxifloxacin|moxifloxacin|mesh-list
24684846|NCT03580473|Dexamethasone|dexamethasone|mesh-list
24684847|NCT03580473|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24684869|NCT03580473|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24684870|NCT03580473|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24684871|NCT03524170|Atezolizumab|atezolizumab|mesh-list
24684872|NCT03524170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684894|NCT03481556|Immunologic Factors|immunologic factors|mesh-ancestor
24684908|NCT03308578|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24855072|NCT02277132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855073|NCT02277132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855074|NCT02277132|Urological Agents|urological agents|mesh-ancestor
24855075|NCT02277171|Nitric Oxide|nitric oxide|mesh-list
24855076|NCT02277171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24855082|NCT02277171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24457542|NCT00334672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684911|NCT03308578|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24684912|NCT03308578|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24469616|NCT00386555|Docetaxel|docetaxel|mesh-list
24684913|NCT03308578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24684914|NCT03283813|Inositol|inositol|mesh-list
24684915|NCT03283813|Vitamin B Complex|vitamin b complex|mesh-ancestor
24684916|NCT03283813|Vitamins|vitamins|mesh-ancestor
24684917|NCT03283813|Micronutrients|micronutrients|mesh-ancestor
24684918|NCT03283813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684919|NCT03283384|Letrozole|letrozole|mesh-list
24684939|NCT03245827|Clomiphene|clomiphene|mesh-list
24684940|NCT03245827|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24684941|NCT03245827|Hormone Antagonists|hormone antagonists|mesh-ancestor
24684942|NCT03245827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24684943|NCT03245827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684944|NCT03245827|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24684945|NCT03245827|Fertility Agents|fertility agents|mesh-ancestor
24684946|NCT03245827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24684947|NCT03245827|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24684948|NCT03245827|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24684949|NCT03129321|Econazole|econazole|mesh-list
24684950|NCT03129321|Antifungal Agents|antifungal agents|mesh-ancestor
24684951|NCT03129321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24684952|NCT03129321|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24684953|NCT03129321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24684954|NCT03129321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24684957|NCT03129321|Hormone Antagonists|hormone antagonists|mesh-ancestor
24611556|NCT01009970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611557|NCT01009970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24685753|NCT05226325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24611558|NCT01009970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24611559|NCT01009970|Alkylating Agents|alkylating agents|mesh-ancestor
24611560|NCT01009970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611561|NCT01009970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611562|NCT01009970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24611563|NCT01009970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24611564|NCT01009970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24611565|NCT01009970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24611567|NCT01009970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24684963|NCT03121534|Antiemetics|antiemetics|mesh-ancestor
25694839|NCT02037230|Antiviral Agents|antiviral agents|mesh-ancestor
25694840|NCT02037230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24684985|NCT03116997|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24684986|NCT03116997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24684987|NCT03107611|Pimecrolimus|pimecrolimus|mesh-list
24684989|NCT03107611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24684990|NCT03107611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24684991|NCT03107611|Analgesics|analgesics|mesh-ancestor
24684992|NCT03107611|Sensory System Agents|sensory system agents|mesh-ancestor
24684993|NCT03107611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24684994|NCT03107611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684995|NCT03107611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24684996|NCT03107611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24684997|NCT03107611|Dermatologic Agents|dermatologic agents|mesh-ancestor
24684998|NCT03107611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24960365|NCT03817567|Antibodies|antibodies|mesh-list
24684999|NCT03107611|Immunologic Factors|immunologic factors|mesh-ancestor
24685000|NCT03107611|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24685001|NCT03107611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998401|NCT02960646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24469730|NCT00386867|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24685035|NCT02871219|Growth Substances|growth substances|mesh-ancestor
24685036|NCT02871219|Growth Inhibitors|growth inhibitors|mesh-ancestor
24685037|NCT02871219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24685112|NCT02215122|Sympathomimetics|sympathomimetics|mesh-ancestor
24685114|NCT02112734|Ergocalciferols|ergocalciferols|mesh-list
24685115|NCT02112734|Cholecalciferol|cholecalciferol|mesh-list
24685116|NCT02112734|Vitamins|vitamins|mesh-list
24685117|NCT02112734|Micronutrients|micronutrients|mesh-ancestor
24685118|NCT02112734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685119|NCT02112734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24685120|NCT02112734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24685121|NCT02094716|Permethrin|permethrin|mesh-list
24685122|NCT02094716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24685123|NCT02094716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685199|NCT01175356|Cyclophosphamide|cyclophosphamide|mesh-list
24685200|NCT01175356|Melphalan|melphalan|mesh-list
24685201|NCT01175356|Busulfan|busulfan|mesh-list
24685202|NCT01175356|Doxorubicin|doxorubicin|mesh-list
24685203|NCT01175356|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24685204|NCT01175356|Etoposide|etoposide|mesh-list
24685205|NCT01175356|Vincristine|vincristine|mesh-list
24685206|NCT01175356|Topotecan|topotecan|mesh-list
24685207|NCT01175356|Etoposide phosphate|etoposide phosphate|mesh-list
24685208|NCT01175356|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24685209|NCT01175356|Isotretinoin|isotretinoin|mesh-list
24685210|NCT01175356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24685211|NCT01175356|Immunologic Factors|immunologic factors|mesh-ancestor
24685212|NCT01175356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685213|NCT01175356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24682683|NCT01387906|Bimatoprost|bimatoprost|mesh-list
24685218|NCT01175356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24685219|NCT01175356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24685220|NCT01175356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24685221|NCT01175356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24685222|NCT01175356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24685223|NCT01175356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24685224|NCT01175356|Tubulin Modulators|tubulin modulators|mesh-ancestor
24685225|NCT01175356|Antimitotic Agents|antimitotic agents|mesh-ancestor
24685226|NCT01175356|Mitosis Modulators|mitosis modulators|mesh-ancestor
24685227|NCT01175356|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24685228|NCT01175356|Dermatologic Agents|dermatologic agents|mesh-ancestor
24685229|NCT01175356|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24685242|NCT00667329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685243|NCT00667329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24685244|NCT00667329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24685245|NCT00667329|Alkylating Agents|alkylating agents|mesh-ancestor
24685246|NCT00667329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685247|NCT00667329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24685248|NCT00667329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25694841|NCT02037230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25694842|NCT02037230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25694843|NCT02037230|Immunologic Factors|immunologic factors|mesh-ancestor
25694844|NCT02037230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694845|NCT02037256|Bortezomib|bortezomib|mesh-list
25694846|NCT02037256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694848|NCT02037295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25694849|NCT02037295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24685249|NCT00667329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24469883|NCT00387699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24685253|NCT00492167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685254|NCT00409435|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
24685255|NCT00409435|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24685256|NCT00409435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24685257|NCT00409435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685258|NCT00409435|Cholinergic Agents|cholinergic agents|mesh-ancestor
24685259|NCT00409435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24640523|NCT01168739|Protective Agents|protective agents|mesh-ancestor
24685260|NCT00409435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685262|NCT05274438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24685263|NCT05274438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24685264|NCT05274438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24685265|NCT05274438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685266|NCT05274191|Maleic acid|maleic acid|mesh-list
24685267|NCT05274191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24685268|NCT05274191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611568|NCT01009970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24611569|NCT01009970|Glucocorticoids|glucocorticoids|mesh-ancestor
24611570|NCT01009970|Hormones|hormones|mesh-ancestor
24611571|NCT01009970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24611572|NCT01009970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24611573|NCT01009970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24611574|NCT01009970|Tubulin Modulators|tubulin modulators|mesh-ancestor
24611575|NCT01009970|Antimitotic Agents|antimitotic agents|mesh-ancestor
24611576|NCT01009970|Mitosis Modulators|mitosis modulators|mesh-ancestor
24611577|NCT01010022|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24611578|NCT01010022|Plasma Substitutes|plasma substitutes|mesh-ancestor
24611580|NCT01010048|Nifedipine|nifedipine|mesh-list
24611581|NCT01010048|Bromides|bromides|mesh-list
24611582|NCT01010048|Propantheline|propantheline|mesh-list
24611583|NCT01010048|Tamsulosin|tamsulosin|mesh-list
24611584|NCT01010048|Progesterone|progesterone|mesh-list
24611585|NCT01010048|Progestins|progestins|mesh-ancestor
24611586|NCT01010048|Hormones|hormones|mesh-ancestor
24611587|NCT01010048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24611588|NCT01010048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685328|NCT05273775|Vitamins|vitamins|mesh-ancestor
24685329|NCT05273775|Micronutrients|micronutrients|mesh-ancestor
24685330|NCT05273775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685331|NCT05273775|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24685341|NCT05273775|GABA Agents|gaba agents|mesh-ancestor
24685342|NCT05273775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24685343|NCT05273775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685344|NCT05273775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24685345|NCT05273775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24685346|NCT05273775|Antimetabolites|antimetabolites|mesh-ancestor
24685347|NCT05273775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24685349|NCT05273775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24685385|NCT05273398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24685386|NCT05273398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24812688|NCT02054078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24812689|NCT02054078|Growth Substances|growth substances|mesh-ancestor
24812690|NCT02054078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685387|NCT05273398|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24685388|NCT05273398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24685389|NCT05273398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24685390|NCT05273398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24685391|NCT05273398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24685392|NCT05273398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24685393|NCT05273398|Anesthetics, General|anesthetics, general|mesh-ancestor
24685394|NCT05273398|Anesthetics|anesthetics|mesh-ancestor
24685395|NCT05273398|GABA Modulators|gaba modulators|mesh-ancestor
24685396|NCT05273398|GABA Agents|gaba agents|mesh-ancestor
24685397|NCT05273398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24685398|NCT05273398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685399|NCT05273346|Analgesics|analgesics|mesh-list
24685428|NCT05272865|Dronabinol|dronabinol|mesh-list
24685479|NCT05271539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24685481|NCT05271539|Hormones|hormones|mesh-ancestor
24685482|NCT05271539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24685483|NCT05271539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24685484|NCT05271539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812696|NCT02054143|Anesthetics|anesthetics|mesh-ancestor
24685517|NCT05271253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24829747|NCT02154334|Dermatologic Agents|dermatologic agents|mesh-ancestor
24685518|NCT05271253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685519|NCT05271253|Sensory System Agents|sensory system agents|mesh-ancestor
24685522|NCT05271253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24685523|NCT05271253|Analgesics|analgesics|mesh-ancestor
24685524|NCT05271253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24685525|NCT05271253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24685526|NCT05271253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24685527|NCT05271253|Adrenergic Agents|adrenergic agents|mesh-ancestor
24685528|NCT05271253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24998402|NCT02960646|Alkylating Agents|alkylating agents|mesh-ancestor
24685529|NCT05271253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685530|NCT05271188|Anesthetics|anesthetics|mesh-list
24685531|NCT05271188|Anesthetics, Local|anesthetics, local|mesh-list
24685532|NCT05271188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24685533|NCT05271188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685534|NCT05271188|Sensory System Agents|sensory system agents|mesh-ancestor
24685535|NCT05271188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24685536|NCT05271162|Empagliflozin|empagliflozin|mesh-list
24685537|NCT05271162|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24685538|NCT05271162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685539|NCT05271162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24685540|NCT05271162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685541|NCT05271136|Sunscreening Agents|sunscreening agents|mesh-list
24685542|NCT05271136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24685543|NCT05271136|Protective Agents|protective agents|mesh-ancestor
24685544|NCT05271136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685545|NCT05271136|Dermatologic Agents|dermatologic agents|mesh-ancestor
24685546|NCT05271058|Dexamethasone|dexamethasone|mesh-list
24685547|NCT05271058|Dexamethasone acetate|dexamethasone acetate|mesh-list
24685548|NCT05271058|Triamcinolone|triamcinolone|mesh-list
24685549|NCT05271058|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24685554|NCT05271058|Antiemetics|antiemetics|mesh-ancestor
24685599|NCT05270421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685600|NCT05270421|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24685601|NCT05270421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24685602|NCT05270421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685603|NCT05270382|Cetylpyridinium|cetylpyridinium|mesh-list
24685604|NCT05270382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24685605|NCT05270382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24685606|NCT05270343|Cholecalciferol|cholecalciferol|mesh-list
24685607|NCT05270343|Vitamin D|vitamin d|mesh-list
24685608|NCT05270343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24685609|NCT05270343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685610|NCT05270343|Vitamins|vitamins|mesh-ancestor
24685611|NCT05270343|Micronutrients|micronutrients|mesh-ancestor
24685612|NCT05270343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24685636|NCT05253846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24685637|NCT05253846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24685638|NCT05253846|Immunologic Factors|immunologic factors|mesh-ancestor
24685639|NCT05253846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685640|NCT05253846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24685641|NCT05253846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24685642|NCT05253846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812705|NCT02054182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24812707|NCT02054299|Proguanil|proguanil|mesh-list
24812708|NCT02054299|Sumatriptan|sumatriptan|mesh-list
24812709|NCT02054299|Amitriptyline|amitriptyline|mesh-list
24685735|NCT05232006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24685743|NCT05226325|Dexmedetomidine|dexmedetomidine|mesh-list
24685744|NCT05226325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24685745|NCT05226325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24685746|NCT05226325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685747|NCT05226325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24685748|NCT05226325|Analgesics|analgesics|mesh-ancestor
24685749|NCT05226325|Sensory System Agents|sensory system agents|mesh-ancestor
24685750|NCT05226325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24685751|NCT05226325|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24685752|NCT05226325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24685754|NCT05226325|Adrenergic Agents|adrenergic agents|mesh-ancestor
24685755|NCT05226325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24611591|NCT01010048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24611592|NCT01010048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24611595|NCT01010048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611596|NCT01010048|Urological Agents|urological agents|mesh-ancestor
24611597|NCT01010048|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24611598|NCT01010048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24611599|NCT01010048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24611600|NCT01010048|Vasodilator Agents|vasodilator agents|mesh-ancestor
24611601|NCT01010048|Tocolytic Agents|tocolytic agents|mesh-ancestor
24611602|NCT01010048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24611603|NCT01010048|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24812710|NCT02054299|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24812711|NCT02054299|Fenoterol|fenoterol|mesh-list
24685802|NCT05207280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24685805|NCT05173142|Gemcitabine|gemcitabine|mesh-list
24685806|NCT05173142|Docetaxel|docetaxel|mesh-list
24685841|NCT05166746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685842|NCT05165875|Hydrocortisone|hydrocortisone|mesh-list
24685843|NCT05165875|Lidocaine|lidocaine|mesh-list
24685844|NCT05165875|Anesthetics, Local|anesthetics, local|mesh-ancestor
24685845|NCT05165875|Anesthetics|anesthetics|mesh-ancestor
24685846|NCT05165875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24829784|NCT02154438|Anesthetics|anesthetics|mesh-ancestor
24685847|NCT05165875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685848|NCT05165875|Sensory System Agents|sensory system agents|mesh-ancestor
24470658|NCT00390923|Selegiline|selegiline|mesh-list
24685849|NCT05165875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24685904|NCT05155917|Insulin Glargine|insulin glargine|mesh-list
24685919|NCT05142072|Vitamins|vitamins|mesh-ancestor
24685920|NCT05142072|Micronutrients|micronutrients|mesh-ancestor
24685921|NCT05142072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685922|NCT05142072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24685923|NCT05142072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24685924|NCT05138029|Dexamethasone|dexamethasone|mesh-list
24685925|NCT05138029|Dexamethasone acetate|dexamethasone acetate|mesh-list
24685960|NCT05135039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685961|NCT05135039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24812722|NCT02054299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24686004|NCT05088928|Apixaban|apixaban|mesh-list
24686005|NCT05088928|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24686006|NCT05088928|Antithrombins|antithrombins|mesh-ancestor
24686007|NCT05088928|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24686008|NCT05088928|Protease Inhibitors|protease inhibitors|mesh-ancestor
24686009|NCT05088928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24686010|NCT05088928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686011|NCT05088928|Anticoagulants|anticoagulants|mesh-ancestor
24611630|NCT01010152|Analgesics|analgesics|mesh-ancestor
24611631|NCT01010152|Sensory System Agents|sensory system agents|mesh-ancestor
24611632|NCT01010152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24611633|NCT01010152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611634|NCT01010152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24611635|NCT01010152|Narcotics|narcotics|mesh-ancestor
24611636|NCT01010152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24611637|NCT01010152|Antitussive Agents|antitussive agents|mesh-ancestor
24611638|NCT01010152|Respiratory System Agents|respiratory system agents|mesh-ancestor
24686033|NCT05075122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686034|NCT05074056|Ketorolac|ketorolac|mesh-list
24686035|NCT05074056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24686036|NCT05074056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24686037|NCT05074056|Analgesics|analgesics|mesh-ancestor
24686038|NCT05074056|Sensory System Agents|sensory system agents|mesh-ancestor
24812724|NCT02054299|Sensory System Agents|sensory system agents|mesh-ancestor
24812725|NCT02054299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812726|NCT02054299|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24686079|NCT05064137|Fluorides, Topical|fluorides, topical|mesh-list
24686080|NCT05064137|Cariostatic Agents|cariostatic agents|mesh-ancestor
24686081|NCT05064137|Protective Agents|protective agents|mesh-ancestor
24686082|NCT05064137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686083|NCT05064137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24686084|NCT05064137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24686085|NCT05063097|Carbon Monoxide|carbon monoxide|mesh-list
24686086|NCT05063097|Antimetabolites|antimetabolites|mesh-ancestor
24686087|NCT05063097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686119|NCT05051150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686121|NCT05051150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24686122|NCT05051150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24686123|NCT05051150|Autonomic Agents|autonomic agents|mesh-ancestor
24686124|NCT05051150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24686125|NCT05051150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24686126|NCT05051150|Respiratory System Agents|respiratory system agents|mesh-ancestor
24686127|NCT05051150|Mydriatics|mydriatics|mesh-ancestor
24686128|NCT05051150|Sympathomimetics|sympathomimetics|mesh-ancestor
24686129|NCT05051150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24686131|NCT05045313|Digoxin|digoxin|mesh-list
24686132|NCT05045313|Warfarin|warfarin|mesh-list
24686133|NCT05045313|Anticoagulants|anticoagulants|mesh-ancestor
24686134|NCT05045313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24686135|NCT05045313|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24440267|NCT00282126|Natriuretic Agents|natriuretic agents|mesh-ancestor
24440269|NCT00282126|Expectorants|expectorants|mesh-ancestor
24440274|NCT00282139|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24440344|NCT00282451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24440365|NCT00282503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24440366|NCT00282503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440385|NCT00282724|Dermatologic Agents|dermatologic agents|mesh-ancestor
24440386|NCT00282724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24440387|NCT00282724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440388|NCT00282724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24440389|NCT00282724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440398|NCT00282945|Metformin|metformin|mesh-list
24686136|NCT05045313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24686137|NCT05045313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686138|NCT05045313|Protective Agents|protective agents|mesh-ancestor
24686139|NCT05045313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686140|NCT05045313|Uricosuric Agents|uricosuric agents|mesh-ancestor
24686141|NCT05045313|Gout Suppressants|gout suppressants|mesh-ancestor
24686142|NCT05045313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24686143|NCT05045313|Renal Agents|renal agents|mesh-ancestor
24686145|NCT05032508|Anesthetics, Local|anesthetics, local|mesh-ancestor
24686146|NCT05032508|Anesthetics|anesthetics|mesh-ancestor
24448806|NCT00313157|Metoprolol|metoprolol|mesh-list
24686147|NCT05032508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24686148|NCT05032508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686149|NCT05032508|Sensory System Agents|sensory system agents|mesh-ancestor
24686150|NCT05032508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24686151|NCT05032508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24686152|NCT05032508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24686153|NCT05032508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24686154|NCT05032508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24686155|NCT05032508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686156|NCT05020574|Cephalexin|cephalexin|mesh-list
24686157|NCT05020574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24686158|NCT05020574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24686180|NCT05007561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812727|NCT02054299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24812731|NCT02054299|Vitamin B Complex|vitamin b complex|mesh-ancestor
24855098|NCT02277223|Analgesics|analgesics|mesh-ancestor
24686266|NCT04949633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24686267|NCT04949633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686287|NCT04918823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24686288|NCT04918823|Immunologic Factors|immunologic factors|mesh-ancestor
24686289|NCT04918823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686290|NCT04918823|Antifungal Agents|antifungal agents|mesh-ancestor
24686291|NCT04918823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24686292|NCT04918823|Dermatologic Agents|dermatologic agents|mesh-ancestor
24686293|NCT04918823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24686294|NCT04918823|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24686295|NCT04918823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24611649|NCT01010178|Vasodilator Agents|vasodilator agents|mesh-ancestor
24611650|NCT01010178|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24611651|NCT01010178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24611652|NCT01010178|Purinergic Agents|purinergic agents|mesh-ancestor
24611653|NCT01010178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25694850|NCT02037425|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24492567|NCT00486785|Alfuzosin|alfuzosin|mesh-list
24611654|NCT01010243|Pioglitazone|pioglitazone|mesh-list
24611655|NCT01010243|Dexamethasone|dexamethasone|mesh-list
24611656|NCT01010243|Lenalidomide|lenalidomide|mesh-list
24611657|NCT01010243|Treosulfan|treosulfan|mesh-list
24611658|NCT01010243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24611659|NCT01010243|Antiemetics|antiemetics|mesh-ancestor
24611660|NCT01010243|Autonomic Agents|autonomic agents|mesh-ancestor
24611661|NCT01010243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24611662|NCT01010243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855099|NCT02277223|Sensory System Agents|sensory system agents|mesh-ancestor
24855100|NCT02277223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24855108|NCT02277457|Crizotinib|crizotinib|mesh-list
24686403|NCT04870333|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24686404|NCT04870333|Anticestodal Agents|anticestodal agents|mesh-ancestor
24686405|NCT04870333|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24686406|NCT04870333|Anthelmintics|anthelmintics|mesh-ancestor
24686407|NCT04870333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24686408|NCT04870333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24683605|NCT01393145|Fluticasone|fluticasone|mesh-list
24686527|NCT04760691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24686560|NCT04706767|Analgesics|analgesics|mesh-ancestor
24686561|NCT04706767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24686571|NCT04699383|Gout Suppressants|gout suppressants|mesh-ancestor
24686572|NCT04699383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24686573|NCT04699383|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24686574|NCT04699383|Antioxidants|antioxidants|mesh-ancestor
24686575|NCT04699383|Protective Agents|protective agents|mesh-ancestor
24686576|NCT04699383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686577|NCT04699383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24686578|NCT04699383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24686579|NCT04699383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24686580|NCT04699383|Schistosomicides|schistosomicides|mesh-ancestor
24686581|NCT04699383|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24686582|NCT04699383|Anthelmintics|anthelmintics|mesh-ancestor
24686584|NCT04697719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24686585|NCT04697719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24686586|NCT04697719|Analgesics|analgesics|mesh-ancestor
24686587|NCT04697719|Sensory System Agents|sensory system agents|mesh-ancestor
24686588|NCT04697719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24686687|NCT04640636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24686688|NCT04640636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24686689|NCT04640636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686690|NCT04640636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24686744|NCT04604691|Blinatumomab|blinatumomab|mesh-list
24686745|NCT04604691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24686779|NCT04579848|Methotrexate|methotrexate|mesh-list
24686780|NCT04579848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24686901|NCT04525755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24686902|NCT04525755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686903|NCT04525755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24683803|NCT01394341|Incretins|incretins|mesh-ancestor
24686948|NCT04496245|Immunologic Factors|immunologic factors|mesh-ancestor
24686966|NCT04476745|Vitamin D|vitamin d|mesh-list
24686967|NCT04476745|Cholecalciferol|cholecalciferol|mesh-list
24686968|NCT04476745|Vitamins|vitamins|mesh-ancestor
24686969|NCT04476745|Micronutrients|micronutrients|mesh-ancestor
24855122|NCT02277587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855123|NCT02277600|Darunavir|darunavir|mesh-list
24855124|NCT02277600|Cobicistat|cobicistat|mesh-list
24855125|NCT02277600|Fostemsavir|fostemsavir|mesh-list
24855126|NCT02277600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24686970|NCT04476745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686971|NCT04476745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24686972|NCT04476745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24687078|NCT04394130|Anesthetics|anesthetics|mesh-ancestor
24687079|NCT04394130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24687080|NCT04394130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687081|NCT04394130|Sensory System Agents|sensory system agents|mesh-ancestor
24687082|NCT04394130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24855133|NCT02277600|Antiviral Agents|antiviral agents|mesh-ancestor
24687087|NCT04391608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24687088|NCT04391608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24687089|NCT04391608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687090|NCT04391608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24687091|NCT04391608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24715712|NCT01538316|Phytoestrogens|phytoestrogens|mesh-ancestor
24687092|NCT04389177|Paclitaxel|paclitaxel|mesh-list
24687093|NCT04389177|Cisplatin|cisplatin|mesh-list
24687094|NCT04389177|Pembrolizumab|pembrolizumab|mesh-list
24687095|NCT04389177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24687260|NCT04164199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687261|NCT04164199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24687262|NCT04164199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24687263|NCT04164199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24855134|NCT02277600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24855135|NCT02277600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24855136|NCT02277600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24855137|NCT02277600|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24855138|NCT02277600|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24855140|NCT02277678|Oxycodone|oxycodone|mesh-list
24855141|NCT02277678|Analgesics, Opioid|analgesics, opioid|mesh-list
24472302|NCT00398814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24472303|NCT00398814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24472304|NCT00398814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472305|NCT00398827|Dexmedetomidine|dexmedetomidine|mesh-list
24472306|NCT00398827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24472307|NCT00398827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24472308|NCT00398827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472310|NCT00398827|Analgesics|analgesics|mesh-ancestor
24687317|NCT04057131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24687318|NCT04057131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24687319|NCT04057131|Analgesics|analgesics|mesh-ancestor
24687320|NCT04057131|Sensory System Agents|sensory system agents|mesh-ancestor
24687321|NCT04057131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24687322|NCT04057131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687323|NCT04057131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24611704|NCT01010373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448814|NCT00313157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24855161|NCT02277730|Nasal Decongestants|nasal decongestants|mesh-ancestor
24687482|NCT03967925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24687483|NCT03967925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24687484|NCT03967925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24687524|NCT03932318|Lintuzumab|lintuzumab|mesh-list
24687525|NCT03932318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24687526|NCT03932318|Antimetabolites|antimetabolites|mesh-ancestor
24687527|NCT03932318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687528|NCT03932318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855162|NCT02277730|Respiratory System Agents|respiratory system agents|mesh-ancestor
24855163|NCT02277730|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24472654|NCT00400075|Antimetabolites|antimetabolites|mesh-ancestor
24472655|NCT00400075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24687695|NCT03778944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24687697|NCT03778944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24687698|NCT03778944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687699|NCT03778944|Protective Agents|protective agents|mesh-ancestor
24687700|NCT03777462|Gemcitabine|gemcitabine|mesh-list
24687701|NCT03777462|Paclitaxel|paclitaxel|mesh-list
24687702|NCT03777462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24687703|NCT03777462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24687759|NCT03705338|Anesthetics|anesthetics|mesh-list
24687760|NCT03705338|Anesthetics, General|anesthetics, general|mesh-list
24687761|NCT03705338|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24687762|NCT03705338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24687763|NCT03705338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684191|NCT01395875|Xhance|xhance|mesh-list
24687814|NCT03661996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24687815|NCT03661996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24687816|NCT03661996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687817|NCT03661996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24687848|NCT03638999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687851|NCT03635021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24687852|NCT03635021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694851|NCT02037425|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25694852|NCT02037425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25709359|NCT02265510|Glucocorticoids|glucocorticoids|mesh-ancestor
24687853|NCT03635021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24687854|NCT03635021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24687855|NCT03635021|Growth Substances|growth substances|mesh-ancestor
24687856|NCT03635021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687857|NCT03635021|Growth Inhibitors|growth inhibitors|mesh-ancestor
24687858|NCT03620942|Phenylephrine|phenylephrine|mesh-list
24687859|NCT03620942|Oxymetazoline|oxymetazoline|mesh-list
24687862|NCT03620942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24684234|NCT01395953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24688087|NCT03399617|Micronutrients|micronutrients|mesh-list
24688088|NCT03399617|Trace Elements|trace elements|mesh-list
24688089|NCT03399617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688090|NCT03399552|Avelumab|avelumab|mesh-list
24688091|NCT03399552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24688092|NCT03399552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688143|NCT03317405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24688144|NCT03317405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688145|NCT03317405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24688146|NCT03317405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688147|NCT03317405|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24688200|NCT03276533|Lidocaine|lidocaine|mesh-list
24688201|NCT03276533|Dexmedetomidine|dexmedetomidine|mesh-list
24688202|NCT03276533|Anesthetics, Local|anesthetics, local|mesh-ancestor
24688203|NCT03276533|Anesthetics|anesthetics|mesh-ancestor
24473247|NCT00402454|Leprostatic Agents|leprostatic agents|mesh-ancestor
24688204|NCT03276533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24688205|NCT03276533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688206|NCT03276533|Sensory System Agents|sensory system agents|mesh-ancestor
24688207|NCT03276533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24688208|NCT03276533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24688209|NCT03276533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24855176|NCT02277847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24855177|NCT02277847|Antimetabolites|antimetabolites|mesh-ancestor
24855178|NCT02277847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855179|NCT02277847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855180|NCT02277847|Antiviral Agents|antiviral agents|mesh-ancestor
24855181|NCT02277847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24688210|NCT03276533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24688211|NCT03276533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24688279|NCT03191240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24688280|NCT03191240|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24688281|NCT03191240|Natriuretic Agents|natriuretic agents|mesh-ancestor
24688282|NCT03191240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688284|NCT03180294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24688285|NCT03180294|Antidepressive Agents|antidepressive agents|mesh-ancestor
24688286|NCT03180294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24688287|NCT03180294|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24688288|NCT03180294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24688289|NCT03180294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24688290|NCT03180294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688291|NCT03180294|Dopamine Agents|dopamine agents|mesh-ancestor
24688292|NCT03180294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24688293|NCT03180294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688294|NCT03180294|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24688295|NCT03180294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24688296|NCT03180294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24688339|NCT03092011|Narcotics|narcotics|mesh-ancestor
24688340|NCT03092011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24688341|NCT03092011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688342|NCT03092011|Analgesics|analgesics|mesh-ancestor
24688343|NCT03092011|Sensory System Agents|sensory system agents|mesh-ancestor
24688344|NCT03092011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24688345|NCT03092011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24688346|NCT03092011|Sympatholytics|sympatholytics|mesh-ancestor
24688347|NCT03092011|Autonomic Agents|autonomic agents|mesh-ancestor
24688476|NCT03055390|Autonomic Agents|autonomic agents|mesh-ancestor
24688477|NCT03055390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24688478|NCT03055390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688479|NCT03055390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24688481|NCT03055390|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24688482|NCT03055390|Cholinergic Agents|cholinergic agents|mesh-ancestor
24794687|NCT04776850|Hormones|hormones|mesh-ancestor
24688483|NCT03055390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24688484|NCT03055390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688485|NCT03055390|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24688486|NCT03055390|Parasympatholytics|parasympatholytics|mesh-ancestor
24688488|NCT03038802|Immunologic Factors|immunologic factors|mesh-ancestor
24688489|NCT03038802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688491|NCT03028740|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24688492|NCT03028740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688493|NCT03028740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24688494|NCT03028740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24688495|NCT03028740|Antiviral Agents|antiviral agents|mesh-ancestor
24688496|NCT03028740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24611828|NCT01010958|Valproic Acid|valproic acid|mesh-list
24688692|NCT02740699|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24688693|NCT02740699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24688694|NCT02729701|Bazedoxifene|bazedoxifene|mesh-list
24688695|NCT02729701|Estrogens|estrogens|mesh-list
24688696|NCT02729701|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24688697|NCT02729701|Hormones|hormones|mesh-ancestor
24688698|NCT02729701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24688699|NCT02729701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688700|NCT02729701|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24688701|NCT02729701|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24688702|NCT02729701|Hormone Antagonists|hormone antagonists|mesh-ancestor
24688703|NCT02729701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24688723|NCT02719314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24688725|NCT02719314|Autonomic Agents|autonomic agents|mesh-ancestor
24688726|NCT02719314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24688727|NCT02719314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688728|NCT02719314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24688729|NCT02719314|Hormones|hormones|mesh-ancestor
24688730|NCT02719314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24688731|NCT02719314|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24688732|NCT02719314|Protective Agents|protective agents|mesh-ancestor
24688733|NCT02711826|Acetaminophen|acetaminophen|mesh-list
24688734|NCT02711826|Diphenhydramine|diphenhydramine|mesh-list
24688735|NCT02711826|Promethazine|promethazine|mesh-list
24688736|NCT02711826|Mycophenolic Acid|mycophenolic acid|mesh-list
24688737|NCT02711826|Everolimus|everolimus|mesh-list
24688738|NCT02711826|Tacrolimus|tacrolimus|mesh-list
24688739|NCT02711826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24688740|NCT02711826|Immunologic Factors|immunologic factors|mesh-ancestor
24688741|NCT02711826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688742|NCT02711826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24688743|NCT02711826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24688744|NCT02711826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688751|NCT02711826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24688752|NCT02711826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24855191|NCT02277886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24855192|NCT02277886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24855193|NCT02277886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855194|NCT02277886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688810|NCT02636569|Sensory System Agents|sensory system agents|mesh-ancestor
24688839|NCT02636322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688841|NCT02636322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24688842|NCT02636322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24688843|NCT02636322|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24688844|NCT02636322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24688845|NCT02636322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24688892|NCT02578368|Docetaxel|docetaxel|mesh-list
24688893|NCT02578368|Fluorouracil|fluorouracil|mesh-list
24688894|NCT02578368|Oxaliplatin|oxaliplatin|mesh-list
24688895|NCT02578368|Trastuzumab|trastuzumab|mesh-list
24688896|NCT02578368|Levoleucovorin|levoleucovorin|mesh-list
24688946|NCT02551991|Protective Agents|protective agents|mesh-ancestor
24688947|NCT02551991|Vitamin B Complex|vitamin b complex|mesh-ancestor
24688948|NCT02551991|Vitamins|vitamins|mesh-ancestor
24688949|NCT02551991|Micronutrients|micronutrients|mesh-ancestor
24688950|NCT02539225|Paclitaxel|paclitaxel|mesh-list
24855195|NCT02277938|Amantadine|amantadine|mesh-list
24855196|NCT02277938|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24688951|NCT02539225|Oxaliplatin|oxaliplatin|mesh-list
24688952|NCT02539225|Ramucirumab|ramucirumab|mesh-list
25694853|NCT02037425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24476802|NCT00416533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476803|NCT00416533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24476804|NCT00416533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24476805|NCT00416533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24918151|NCT04222855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24493068|NCT00489385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493069|NCT00489385|Antiviral Agents|antiviral agents|mesh-ancestor
24688953|NCT02539225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24688954|NCT02539225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688955|NCT02539225|Tubulin Modulators|tubulin modulators|mesh-ancestor
24688956|NCT02539225|Antimitotic Agents|antimitotic agents|mesh-ancestor
24688957|NCT02539225|Mitosis Modulators|mitosis modulators|mesh-ancestor
24688990|NCT02482233|Nicotine|nicotine|mesh-list
24688991|NCT02482233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24688992|NCT02482233|Autonomic Agents|autonomic agents|mesh-ancestor
24688993|NCT02482233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961111|NCT03810872|Tubulin Modulators|tubulin modulators|mesh-ancestor
24688994|NCT02482233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688995|NCT02482233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24688996|NCT02482233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24688997|NCT02482233|Cholinergic Agents|cholinergic agents|mesh-ancestor
24689082|NCT02314988|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24689083|NCT02314988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24689084|NCT02314988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689085|NCT02314988|Hemostatics|hemostatics|mesh-ancestor
24689086|NCT02314988|Coagulants|coagulants|mesh-ancestor
24689087|NCT02299999|Gemcitabine|gemcitabine|mesh-list
24689089|NCT02299999|Vincristine|vincristine|mesh-list
24689090|NCT02299999|Vinorelbine|vinorelbine|mesh-list
24689107|NCT02299999|Bicalutamide|bicalutamide|mesh-list
24689109|NCT02299999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24689110|NCT02299999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689111|NCT02299999|Tubulin Modulators|tubulin modulators|mesh-ancestor
24689144|NCT02299999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24689146|NCT02293109|Cytarabine|cytarabine|mesh-list
24689147|NCT02293109|Dexamethasone|dexamethasone|mesh-list
24689148|NCT02293109|Methylprednisolone|methylprednisolone|mesh-list
24689149|NCT02293109|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24689181|NCT02293109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24689182|NCT02293109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24689402|NCT01564537|Autonomic Agents|autonomic agents|mesh-ancestor
24689403|NCT01564537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24689415|NCT01564537|Growth Inhibitors|growth inhibitors|mesh-ancestor
24689416|NCT01564537|Protease Inhibitors|protease inhibitors|mesh-ancestor
24689417|NCT01564537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689418|NCT01564537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611893|NCT01011166|Ribavirin|ribavirin|mesh-list
24689458|NCT01513187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689459|NCT01513187|Antiviral Agents|antiviral agents|mesh-ancestor
24689460|NCT01513187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24689461|NCT01513187|Immunologic Factors|immunologic factors|mesh-ancestor
24689462|NCT01513187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689464|NCT01464268|Dextrans|dextrans|mesh-list
24689465|NCT01464268|Vitamin B Complex|vitamin b complex|mesh-ancestor
24689466|NCT01464268|Vitamins|vitamins|mesh-ancestor
24689467|NCT01464268|Micronutrients|micronutrients|mesh-ancestor
24689498|NCT01354977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689499|NCT01354977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689500|NCT01354977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24689502|NCT01334606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24689503|NCT01334606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689504|NCT01233297|Azithromycin|azithromycin|mesh-list
24689505|NCT01233297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24689506|NCT01233297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24689507|NCT01226732|Capecitabine|capecitabine|mesh-list
24689508|NCT01226732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25694854|NCT02037425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694855|NCT02037425|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25694856|NCT02037425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25694857|NCT02037425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694858|NCT02037425|Cholinergic Agents|cholinergic agents|mesh-ancestor
25694859|NCT02037425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25694860|NCT02037477|Esomeprazole|esomeprazole|mesh-list
25694861|NCT02037477|Rabeprazole|rabeprazole|mesh-list
24689510|NCT01226732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689511|NCT01226732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689512|NCT01216683|Rituximab|rituximab|mesh-list
24689535|NCT01152541|Vitamin B Complex|vitamin b complex|mesh-ancestor
24689537|NCT01152541|Micronutrients|micronutrients|mesh-ancestor
24689538|NCT01152541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689539|NCT01152541|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24689540|NCT01152541|Dermatologic Agents|dermatologic agents|mesh-ancestor
24689594|NCT01085097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689595|NCT01085097|Antiemetics|antiemetics|mesh-ancestor
24689596|NCT01085097|Autonomic Agents|autonomic agents|mesh-ancestor
24689597|NCT01085097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24689598|NCT01085097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24689599|NCT01085097|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24689600|NCT01085097|Protective Agents|protective agents|mesh-ancestor
24689601|NCT00962988|Bupropion|bupropion|mesh-list
24689602|NCT00962988|Nicotine|nicotine|mesh-list
24689603|NCT00962988|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24689604|NCT00962988|Autonomic Agents|autonomic agents|mesh-ancestor
24689605|NCT00962988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24689606|NCT00962988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689607|NCT00962988|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24689608|NCT00962988|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24689609|NCT00962988|Cholinergic Agents|cholinergic agents|mesh-ancestor
24689610|NCT00962988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24689611|NCT00962988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689612|NCT00962988|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24689625|NCT00920621|Vitamins|vitamins|mesh-list
24689626|NCT00920621|Micronutrients|micronutrients|mesh-ancestor
24689627|NCT00920621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689628|NCT00920621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24689629|NCT00920621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24689630|NCT00916747|Zoledronic Acid|zoledronic acid|mesh-list
24689631|NCT00916747|Pravastatin|pravastatin|mesh-list
24689632|NCT00916747|Lonafarnib|lonafarnib|mesh-list
24689633|NCT00916747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24689634|NCT00916747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689635|NCT00916747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24689636|NCT00916747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24689637|NCT00916747|Antimetabolites|antimetabolites|mesh-ancestor
24689638|NCT00916747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689639|NCT00916747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24689640|NCT00916747|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24689641|NCT00916747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689642|NCT00856947|Vitamin D|vitamin d|mesh-list
24689643|NCT00856947|Cholecalciferol|cholecalciferol|mesh-list
24689644|NCT00856947|Vitamins|vitamins|mesh-ancestor
24689645|NCT00856947|Micronutrients|micronutrients|mesh-ancestor
24689646|NCT00856947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689647|NCT00856947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24689648|NCT00856947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24611894|NCT01011166|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24689649|NCT00785525|Lenograstim|lenograstim|mesh-list
24689650|NCT00785525|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24684960|NCT03121534|Dexamethasone|dexamethasone|mesh-list
24611908|NCT01011205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611909|NCT01011205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24611910|NCT01011205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611911|NCT01011205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24611912|NCT01011205|Antitubercular Agents|antitubercular agents|mesh-ancestor
24611913|NCT01011205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24611914|NCT01011205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24611915|NCT01011205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24611917|NCT01011205|Autonomic Agents|autonomic agents|mesh-ancestor
24611918|NCT01011205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24611919|NCT01011205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25694862|NCT02037477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25694863|NCT02037477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24611920|NCT01011205|Glucocorticoids|glucocorticoids|mesh-ancestor
24611921|NCT01011205|Hormones|hormones|mesh-ancestor
24801319|NCT01982799|Antipyretics|antipyretics|mesh-ancestor
24611922|NCT01011205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24611923|NCT01011205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24474855|NCT00407771|Tirofiban|tirofiban|mesh-list
24689693|NCT00600015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24685003|NCT03089866|Midazolam|midazolam|mesh-list
24689857|NCT01397513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24689858|NCT01397513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24689859|NCT01397513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689860|NCT01397513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24689861|NCT01397513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24689862|NCT01397513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689863|NCT01397513|Antipyretics|antipyretics|mesh-ancestor
24689864|NCT01397630|Oxytocin|oxytocin|mesh-list
24689865|NCT01397630|Oxytocics|oxytocics|mesh-ancestor
24689866|NCT01397630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24689867|NCT01397630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689868|NCT01397734|Arsenic Trioxide|arsenic trioxide|mesh-list
24689869|NCT01397734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689870|NCT01397799|Tirbanibulin|tirbanibulin|mesh-list
24689871|NCT01397799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689872|NCT01397799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689873|NCT01397994|Nicorandil|nicorandil|mesh-list
24689874|NCT01397994|Atenolol|atenolol|mesh-list
24689875|NCT01397994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24689876|NCT01397994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24689877|NCT01397994|Sympatholytics|sympatholytics|mesh-ancestor
24689878|NCT01397994|Autonomic Agents|autonomic agents|mesh-ancestor
24689984|NCT01398293|Antiviral Agents|antiviral agents|mesh-ancestor
24689985|NCT01398293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24689986|NCT01398293|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24689987|NCT01398293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24689988|NCT01398293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24611924|NCT01011205|Protective Agents|protective agents|mesh-ancestor
24689989|NCT01398293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24689990|NCT01398293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24855227|NCT02278302|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24855228|NCT02278302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24690030|NCT01398592|Incretins|incretins|mesh-ancestor
24690031|NCT01398592|Hormones|hormones|mesh-ancestor
24690032|NCT01398592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24690033|NCT01398592|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24690034|NCT01398592|Protease Inhibitors|protease inhibitors|mesh-ancestor
24690035|NCT01398592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690066|NCT01398722|Insulin|insulin|mesh-list
24690067|NCT01398722|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24690068|NCT01398722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24690069|NCT01398722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690070|NCT01398995|Insulin|insulin|mesh-list
24690071|NCT01398995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24690072|NCT01398995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690073|NCT01399086|Fulvestrant|fulvestrant|mesh-list
24690074|NCT01399086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24690075|NCT01399086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24690076|NCT01399086|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24690077|NCT01399086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24690091|NCT01399216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24690092|NCT01399216|Anticoagulants|anticoagulants|mesh-ancestor
24690093|NCT01399216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24690094|NCT01399242|Everolimus|everolimus|mesh-list
24690095|NCT01399242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24690096|NCT01399242|Immunologic Factors|immunologic factors|mesh-ancestor
24690097|NCT01399242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690098|NCT01399242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24690102|NCT01399346|Insulin|insulin|mesh-list
24690147|NCT01399645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690149|NCT01399645|Hormones|hormones|mesh-ancestor
24690150|NCT01399645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24690151|NCT01399840|Talazoparib|talazoparib|mesh-list
24690152|NCT01399840|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24690153|NCT01399840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690154|NCT01399840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690190|NCT01400165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25694864|NCT02037477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25694865|NCT02037477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690191|NCT01400165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690192|NCT01400165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24690261|NCT01400646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690262|NCT01400646|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24690263|NCT01400646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24690264|NCT01400646|Hemostatics|hemostatics|mesh-ancestor
24690265|NCT01400646|Coagulants|coagulants|mesh-ancestor
24690266|NCT01400672|Imiquimod|imiquimod|mesh-list
24690267|NCT01400672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24690268|NCT01400672|Immunologic Factors|immunologic factors|mesh-ancestor
24690269|NCT01400672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690270|NCT01400672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24690271|NCT01400672|Interferon Inducers|interferon inducers|mesh-ancestor
24690272|NCT01400685|Rituximab|rituximab|mesh-list
24690273|NCT01400685|Lenalidomide|lenalidomide|mesh-list
24690274|NCT01400685|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24690275|NCT01400685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24690276|NCT01400685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24690277|NCT01400685|Immunologic Factors|immunologic factors|mesh-ancestor
24690278|NCT01400685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690279|NCT01400685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24690280|NCT01400685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24961390|NCT03809156|Riociguat|riociguat|mesh-list
24855248|NCT02278419|Protease Inhibitors|protease inhibitors|mesh-ancestor
24855249|NCT02278419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855250|NCT02278419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855254|NCT02278458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690320|NCT01400828|Cholinergic Agents|cholinergic agents|mesh-ancestor
24690321|NCT01400828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24690322|NCT01400828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690323|NCT01400828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690324|NCT01400828|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24690325|NCT01400828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24690326|NCT01400828|Histamine Antagonists|histamine antagonists|mesh-ancestor
24690363|NCT01401075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24690364|NCT01401075|Immunologic Factors|immunologic factors|mesh-ancestor
24690365|NCT01401075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690366|NCT01401075|Appetite Stimulants|appetite stimulants|mesh-ancestor
24690367|NCT01401075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24690369|NCT01401179|Cefazolin|cefazolin|mesh-list
24690370|NCT01401179|Erythromycin|erythromycin|mesh-list
24690396|NCT01401192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24690398|NCT01401387|Pancrelipase|pancrelipase|mesh-list
24690399|NCT01401387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24690400|NCT01401491|Clozapine|clozapine|mesh-list
24690401|NCT01401491|Fluvoxamine|fluvoxamine|mesh-list
24690402|NCT01401491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24690403|NCT01401491|Serotonin Agents|serotonin agents|mesh-ancestor
24690404|NCT01401491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24690405|NCT01401491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855255|NCT02278458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855256|NCT02278458|Antiviral Agents|antiviral agents|mesh-ancestor
24855257|NCT02278458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24855258|NCT02278458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855259|NCT02278458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24855260|NCT02278458|Immunologic Factors|immunologic factors|mesh-ancestor
24855261|NCT02278458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855263|NCT02278510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24690449|NCT01402024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690450|NCT01402024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24690451|NCT01402024|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24690452|NCT01402024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24690453|NCT01402024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690454|NCT01402076|Rosiglitazone|rosiglitazone|mesh-list
24475638|NCT00410982|Antimetabolites|antimetabolites|mesh-ancestor
24690456|NCT01402076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24690457|NCT01402076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24690458|NCT01402076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24690459|NCT01402076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690460|NCT01402076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24690461|NCT01402076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24690462|NCT01402076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24690463|NCT01402076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24690464|NCT01402076|Anesthetics, General|anesthetics, general|mesh-ancestor
24690465|NCT01402076|Anesthetics|anesthetics|mesh-ancestor
24690466|NCT01402076|GABA Modulators|gaba modulators|mesh-ancestor
24690467|NCT01402076|GABA Agents|gaba agents|mesh-ancestor
24690468|NCT01402076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24690469|NCT01402076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690509|NCT01402193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690510|NCT01402193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690589|NCT01402622|Anesthetics, General|anesthetics, general|mesh-ancestor
24690591|NCT01402674|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24690592|NCT01402674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690593|NCT01402674|Appetite Depressants|appetite depressants|mesh-ancestor
24690594|NCT01402674|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24611980|NCT01011621|Betamethasone|betamethasone|mesh-list
24611981|NCT01011621|Betamethasone Valerate|betamethasone valerate|mesh-list
24611982|NCT01011621|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24611983|NCT01011621|Betamethasone benzoate|betamethasone benzoate|mesh-list
24611984|NCT01011621|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24611985|NCT01011621|Prednisolone phosphate|prednisolone phosphate|mesh-list
24611986|NCT01011621|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24611988|NCT01011621|Glucocorticoids|glucocorticoids|mesh-ancestor
24611990|NCT01011621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24611991|NCT01011621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611992|NCT01011621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24611993|NCT01011621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24690609|NCT01402843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24690610|NCT01402843|Antimetabolites|antimetabolites|mesh-ancestor
24690611|NCT01402843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690612|NCT01402843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24690613|NCT01402882|Tranexamic Acid|tranexamic acid|mesh-list
24690665|NCT01403363|Sensory System Agents|sensory system agents|mesh-ancestor
24855266|NCT02278510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855267|NCT02278510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855268|NCT02278575|Antithrombins|antithrombins|mesh-list
24855269|NCT02278575|Antithrombin III|antithrombin iii|mesh-list
24855270|NCT02278575|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24855271|NCT02278575|Protease Inhibitors|protease inhibitors|mesh-ancestor
24855272|NCT02278575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855273|NCT02278575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690708|NCT01403415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24690709|NCT01403415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24690748|NCT01403662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24690782|NCT01403896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24690784|NCT01403896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24690785|NCT01403948|BI 836826|bi 836826|mesh-list
24690786|NCT01403948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24690787|NCT01403948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24690788|NCT01404000|Charcoal|charcoal|mesh-list
24690789|NCT01404000|Antidotes|antidotes|mesh-ancestor
24690790|NCT01404000|Protective Agents|protective agents|mesh-ancestor
24690822|NCT01404117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24690823|NCT01404117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24690934|NCT01404468|Anesthetics, Local|anesthetics, local|mesh-ancestor
24690935|NCT01404468|Anesthetics|anesthetics|mesh-ancestor
24855274|NCT02278575|Anticoagulants|anticoagulants|mesh-ancestor
24855276|NCT02278588|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24855277|NCT02278588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24685502|NCT05271370|Leronlimab|leronlimab|mesh-list
24690947|NCT01404507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24690948|NCT01404598|Naproxen|naproxen|mesh-list
24690949|NCT01404598|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
24690950|NCT01404598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24690951|NCT01404598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24690959|NCT01404598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24690960|NCT01404598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690961|NCT01404598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690962|NCT01404598|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24690964|NCT01404637|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24690965|NCT01404637|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24690966|NCT01404637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24690967|NCT01404637|Adrenergic Agents|adrenergic agents|mesh-ancestor
24690968|NCT01404637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24690991|NCT01404689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24690992|NCT01404689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24690993|NCT01404689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24690994|NCT01404689|Adrenergic Agents|adrenergic agents|mesh-ancestor
24690995|NCT01404689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24690996|NCT01404689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690997|NCT01404702|Zoledronic Acid|zoledronic acid|mesh-list
24690998|NCT01404702|Aldesleukin|aldesleukin|mesh-list
24690999|NCT01404702|Interleukin-2|interleukin-2|mesh-list
24691000|NCT01404702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691001|NCT01404702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24691012|NCT01404715|Imatinib Mesylate|imatinib mesylate|mesh-list
24691013|NCT01404715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24691014|NCT01404715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470299|NCT00389558|Amikacin|amikacin|mesh-list
24691033|NCT01404767|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24691034|NCT01404767|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24691035|NCT01404767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24691036|NCT01404767|Adrenergic Agents|adrenergic agents|mesh-ancestor
24691037|NCT01404767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24691038|NCT01404767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691040|NCT01404793|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24691041|NCT01404793|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24691042|NCT01404793|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24691043|NCT01404793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24691044|NCT01404793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691045|NCT01404806|Dolutegravir|dolutegravir|mesh-list
24691046|NCT01404806|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24691047|NCT01404806|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24691048|NCT01404806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691545|NCT01407822|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24691049|NCT01404806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855296|NCT02278692|Vitamin K|vitamin k|mesh-list
24855297|NCT02278692|Vitamins|vitamins|mesh-ancestor
24855298|NCT02278692|Micronutrients|micronutrients|mesh-ancestor
24855299|NCT02278692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855300|NCT02278692|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24855301|NCT02278692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24855302|NCT02278692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855303|NCT02278692|Hemostatics|hemostatics|mesh-ancestor
24855304|NCT02278692|Coagulants|coagulants|mesh-ancestor
24691122|NCT01405157|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24691123|NCT01405157|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24691124|NCT01405157|Prednisolone|prednisolone|mesh-list
24691125|NCT01405157|Prednisolone acetate|prednisolone acetate|mesh-list
24691126|NCT01405157|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24691127|NCT01405157|Prednisolone phosphate|prednisolone phosphate|mesh-list
24691128|NCT01405157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24691225|NCT01405586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691226|NCT01405586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24691227|NCT01405586|Antimetabolites|antimetabolites|mesh-ancestor
24691228|NCT01405586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691229|NCT01405586|Antiviral Agents|antiviral agents|mesh-ancestor
24612058|NCT01011751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24612078|NCT01011920|Cytarabine|cytarabine|mesh-list
24612079|NCT01011920|Rituximab|rituximab|mesh-list
24612080|NCT01011920|Methotrexate|methotrexate|mesh-list
24612081|NCT01011920|Thiotepa|thiotepa|mesh-list
24612082|NCT01011920|Carmustine|carmustine|mesh-list
24612083|NCT01011920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24691302|NCT01406002|Protease Inhibitors|protease inhibitors|mesh-ancestor
24691303|NCT01406002|Anticoagulants|anticoagulants|mesh-ancestor
24691305|NCT01406080|Tretinoin|tretinoin|mesh-list
24691306|NCT01406080|Emollients|emollients|mesh-list
24691337|NCT01406171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691338|NCT01406171|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24691339|NCT01406171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24691340|NCT01406171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24691341|NCT01406171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24691342|NCT01406171|Anesthetics, General|anesthetics, general|mesh-ancestor
24691343|NCT01406171|Anesthetics|anesthetics|mesh-ancestor
24691344|NCT01406171|GABA Modulators|gaba modulators|mesh-ancestor
24691345|NCT01406171|GABA Agents|gaba agents|mesh-ancestor
24691346|NCT01406171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24691347|NCT01406171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691348|NCT01406171|Antifungal Agents|antifungal agents|mesh-ancestor
24691349|NCT01406171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24691375|NCT01406275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691377|NCT01406301|Fondaparinux|fondaparinux|mesh-list
24691378|NCT01406301|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24691379|NCT01406301|Antithrombins|antithrombins|mesh-ancestor
24691380|NCT01406301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24691381|NCT01406301|Protease Inhibitors|protease inhibitors|mesh-ancestor
24691382|NCT01406301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691383|NCT01406301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691384|NCT01406301|Anticoagulants|anticoagulants|mesh-ancestor
24691385|NCT01406301|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24691386|NCT01406301|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24691387|NCT01406327|Ambrisentan|ambrisentan|mesh-list
24691388|NCT01406327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24691389|NCT01406392|Misoprostol|misoprostol|mesh-list
24961772|NCT03805568|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24691390|NCT01406392|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24691482|NCT01406782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24855307|NCT02278861|Sunscreening Agents|sunscreening agents|mesh-list
24691483|NCT01407016|Metronidazole|metronidazole|mesh-list
24691484|NCT01407016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24691485|NCT01407016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24691486|NCT01407016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24691487|NCT01407016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24691489|NCT01407211|Vitamins|vitamins|mesh-ancestor
24691513|NCT01407471|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24691514|NCT01407471|Hormone Antagonists|hormone antagonists|mesh-ancestor
24691515|NCT01407471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24691516|NCT01407471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691517|NCT01407471|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24691518|NCT01407471|Diuretics|diuretics|mesh-ancestor
24691519|NCT01407471|Natriuretic Agents|natriuretic agents|mesh-ancestor
24691522|NCT01407471|Hormones|hormones|mesh-ancestor
24691543|NCT01407822|Gemcitabine|gemcitabine|mesh-list
24691544|NCT01407822|Cisplatin|cisplatin|mesh-list
24691571|NCT01407887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691572|NCT01407887|Antiviral Agents|antiviral agents|mesh-ancestor
24691573|NCT01407887|Schistosomicides|schistosomicides|mesh-ancestor
24691574|NCT01407887|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24691575|NCT01407887|Anthelmintics|anthelmintics|mesh-ancestor
24691576|NCT01407887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691577|NCT01407887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691624|NCT01408173|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24691625|NCT01408173|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24691626|NCT01408173|Purinergic Agents|purinergic agents|mesh-ancestor
24691627|NCT01408173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24691628|NCT01408186|Rabeprazole|rabeprazole|mesh-list
24691629|NCT01408186|Famotidine|famotidine|mesh-list
24691630|NCT01408186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24691631|NCT01408186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24691755|NCT01408953|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24691756|NCT01408953|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24691757|NCT01408953|Growth Substances|growth substances|mesh-ancestor
24691781|NCT01409005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24691782|NCT01409005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691783|NCT01409005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24691784|NCT01409005|Immunologic Factors|immunologic factors|mesh-ancestor
24691785|NCT01409005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691786|NCT01409018|Itraconazole|itraconazole|mesh-list
24691787|NCT01409018|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
24691788|NCT01409018|Antifungal Agents|antifungal agents|mesh-ancestor
24691789|NCT01409018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24691790|NCT01409018|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24691791|NCT01409018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24691792|NCT01409018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691793|NCT01409018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691794|NCT01409018|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24691795|NCT01409018|Hormone Antagonists|hormone antagonists|mesh-ancestor
24691797|NCT01409018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691965|NCT01409772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691966|NCT01410162|Tacrolimus|tacrolimus|mesh-list
24691967|NCT01410162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24691968|NCT01410162|Immunologic Factors|immunologic factors|mesh-ancestor
24691969|NCT01410162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691970|NCT01410162|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24691971|NCT01410162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691972|NCT01410162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691973|NCT01410201|Dexamethasone|dexamethasone|mesh-list
24550066|NCT00718913|Tubulin Modulators|tubulin modulators|mesh-ancestor
24691974|NCT01410201|Dexamethasone acetate|dexamethasone acetate|mesh-list
24691976|NCT01410201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24692011|NCT01410630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24692012|NCT01410630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24692013|NCT01410630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692014|NCT01410682|Chlorhexidine|chlorhexidine|mesh-list
24692015|NCT01410682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24692044|NCT01411072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692045|NCT01411072|Antiviral Agents|antiviral agents|mesh-ancestor
24692155|NCT01411670|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
24692156|NCT01411670|Protein C|protein c|mesh-list
24612124|NCT01012063|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24612125|NCT01012063|Hematinics|hematinics|mesh-ancestor
24612126|NCT01012102|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
24612127|NCT01012102|Freund's Adjuvant|freund's adjuvant|mesh-list
24612128|NCT01012102|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24612129|NCT01012102|Immunologic Factors|immunologic factors|mesh-ancestor
24612130|NCT01012102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035492|NCT03555188|Ondansetron|ondansetron|mesh-list
24612131|NCT01012141|Docetaxel|docetaxel|mesh-list
24612132|NCT01012141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612133|NCT01012141|Tubulin Modulators|tubulin modulators|mesh-ancestor
24612134|NCT01012141|Antimitotic Agents|antimitotic agents|mesh-ancestor
24692294|NCT01412645|Antioxidants|antioxidants|mesh-ancestor
24692295|NCT01412645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692296|NCT01412645|Protective Agents|protective agents|mesh-ancestor
24692297|NCT01412645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692298|NCT01412645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24692299|NCT01412645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24692301|NCT01412658|Glycerol|glycerol|mesh-list
24692302|NCT01412658|Chelating Agents|chelating agents|mesh-ancestor
24692303|NCT01412658|Sequestering Agents|sequestering agents|mesh-ancestor
24692304|NCT01412658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692305|NCT01412658|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24692306|NCT01412658|Protective Agents|protective agents|mesh-ancestor
24692307|NCT01412658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692308|NCT01412671|Sorafenib|sorafenib|mesh-list
24692309|NCT01412671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692310|NCT01412671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24692363|NCT01413048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24692364|NCT01413048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24692365|NCT01413230|Cholecalciferol|cholecalciferol|mesh-list
24692382|NCT01413477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24692383|NCT01413477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692384|NCT01413477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24692385|NCT01413477|Respiratory System Agents|respiratory system agents|mesh-ancestor
24477754|NCT00419835|Protease Inhibitors|protease inhibitors|mesh-ancestor
24692386|NCT01413477|Dermatologic Agents|dermatologic agents|mesh-ancestor
24692387|NCT01413477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24692388|NCT01413477|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24692389|NCT01413477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24692390|NCT01413477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692391|NCT01413477|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24692393|NCT01413477|Micronutrients|micronutrients|mesh-ancestor
24692394|NCT01413477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24692395|NCT01413490|Rimantadine|rimantadine|mesh-list
24692396|NCT01413490|Antiviral Agents|antiviral agents|mesh-ancestor
24692397|NCT01413490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24692398|NCT01413490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24692399|NCT01413490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855316|NCT02278913|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24692400|NCT01413490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692401|NCT01413581|Bile Acids and Salts|bile acids and salts|mesh-list
24692402|NCT01413581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24692403|NCT01413620|Vitamins|vitamins|mesh-list
24692404|NCT01413620|Vitamin E|vitamin e|mesh-list
24692405|NCT01413620|Tocopherols|tocopherols|mesh-list
24692406|NCT01413620|Tocotrienols|tocotrienols|mesh-list
24692407|NCT01413620|alpha-Tocopherol|alpha-tocopherol|mesh-list
24692408|NCT01413620|Micronutrients|micronutrients|mesh-ancestor
24692423|NCT01413763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692424|NCT01413763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694866|NCT02037477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692425|NCT01413763|Interferon Inducers|interferon inducers|mesh-ancestor
24692426|NCT01413854|Diclofenac|diclofenac|mesh-list
24692437|NCT01413854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692438|NCT01414140|Levonorgestrel|levonorgestrel|mesh-list
24692439|NCT01414140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24692440|NCT01414140|Contraceptive Agents|contraceptive agents|mesh-ancestor
24692441|NCT01414140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24692442|NCT01414140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692443|NCT01414140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24692444|NCT01414140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24692445|NCT01414140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24692446|NCT01414231|Cytarabine|cytarabine|mesh-list
24692447|NCT01414231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24692448|NCT01414231|Antimetabolites|antimetabolites|mesh-ancestor
24692449|NCT01414231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692450|NCT01414231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692451|NCT01414231|Antiviral Agents|antiviral agents|mesh-ancestor
24692452|NCT01414231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24692453|NCT01414231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24692454|NCT01414231|Immunologic Factors|immunologic factors|mesh-ancestor
24692455|NCT01414231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692456|NCT01414465|Orlistat|orlistat|mesh-list
24692457|NCT01414465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24692458|NCT01414465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692459|NCT01414465|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24692460|NCT01414465|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24692462|NCT01414504|Immunologic Factors|immunologic factors|mesh-ancestor
24692476|NCT01414569|Dexamethasone acetate|dexamethasone acetate|mesh-list
24692477|NCT01414569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24692478|NCT01414569|Antiemetics|antiemetics|mesh-ancestor
24692479|NCT01414569|Autonomic Agents|autonomic agents|mesh-ancestor
24692603|NCT01415505|Natriuretic Agents|natriuretic agents|mesh-ancestor
24692604|NCT01415505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692605|NCT01415505|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24692606|NCT01415505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24692607|NCT01415505|Vasodilator Agents|vasodilator agents|mesh-ancestor
24692608|NCT01415505|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24692609|NCT01415505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24692610|NCT01415505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24692611|NCT01415505|Adrenergic Agents|adrenergic agents|mesh-ancestor
24692612|NCT01415505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24692613|NCT01415557|Micronutrients|micronutrients|mesh-list
24692641|NCT01415687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24692642|NCT01415687|Laxatives|laxatives|mesh-ancestor
24692643|NCT01415713|Leucovorin|leucovorin|mesh-list
24692644|NCT01415713|Gemcitabine|gemcitabine|mesh-list
24692645|NCT01415713|Oxaliplatin|oxaliplatin|mesh-list
24692646|NCT01415713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24692647|NCT01415713|Antimetabolites|antimetabolites|mesh-ancestor
24692648|NCT01415713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692649|NCT01415713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692650|NCT01415713|Antiviral Agents|antiviral agents|mesh-ancestor
24692651|NCT01415713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24642341|NCT01179009|Anesthetics|anesthetics|mesh-ancestor
24478147|NCT00421642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24692780|NCT01416337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24692781|NCT01416337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24692782|NCT01416337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692815|NCT01416662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692816|NCT01416662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692818|NCT01416662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24692819|NCT01416662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24692820|NCT01416662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24692821|NCT01416662|Immunologic Factors|immunologic factors|mesh-ancestor
24692822|NCT01416662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692823|NCT01416701|Vitamin D|vitamin d|mesh-list
24692824|NCT01416701|Cholecalciferol|cholecalciferol|mesh-list
24692887|NCT01417013|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24692888|NCT01417013|Lubricant Eye Drops|lubricant eye drops|mesh-list
24692889|NCT01417013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24692890|NCT01417065|Sirolimus|sirolimus|mesh-list
24692891|NCT01417065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24692892|NCT01417065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24692893|NCT01417065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24692894|NCT01417065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692895|NCT01417065|Antifungal Agents|antifungal agents|mesh-ancestor
24692896|NCT01417065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24692897|NCT01417065|Immunologic Factors|immunologic factors|mesh-ancestor
24692934|NCT01417390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693192|NCT01418625|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24693193|NCT01418625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24693194|NCT01418625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24693195|NCT01418625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693197|NCT01418625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693198|NCT01418625|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24693199|NCT01418625|Antidepressive Agents|antidepressive agents|mesh-ancestor
24693200|NCT01418625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24693201|NCT01418651|Milnacipran|milnacipran|mesh-list
24693202|NCT01418651|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24693203|NCT01418651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24693204|NCT01418651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24693205|NCT01418651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693233|NCT01418794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24693251|NCT01419132|Furosemide|furosemide|mesh-list
24693252|NCT01419132|Diuretics|diuretics|mesh-list
24693253|NCT01419132|Natriuretic Agents|natriuretic agents|mesh-ancestor
24693288|NCT01419366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693289|NCT01419366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693290|NCT01419366|Cholinergic Agents|cholinergic agents|mesh-ancestor
24693291|NCT01419366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24693292|NCT01419366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693319|NCT01419457|Antiviral Agents|antiviral agents|mesh-ancestor
24693320|NCT01419457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24693322|NCT01419548|Carboplatin|carboplatin|mesh-list
24693323|NCT01419548|Veliparib|veliparib|mesh-list
24693324|NCT01419548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24693325|NCT01419548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24693326|NCT01419548|Tubulin Modulators|tubulin modulators|mesh-ancestor
24693327|NCT01419548|Antimitotic Agents|antimitotic agents|mesh-ancestor
24693328|NCT01419548|Mitosis Modulators|mitosis modulators|mesh-ancestor
24693329|NCT01419548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693330|NCT01419548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24693331|NCT01419548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693332|NCT01419652|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24693333|NCT01419652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693335|NCT01419691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24693337|NCT01419730|Cholecalciferol|cholecalciferol|mesh-list
24693338|NCT01419730|Vitamins|vitamins|mesh-ancestor
24693339|NCT01419730|Micronutrients|micronutrients|mesh-ancestor
24693340|NCT01419730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693341|NCT01419730|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24693363|NCT01420055|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24693364|NCT01420055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693365|NCT01420055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24693366|NCT01420055|Immunologic Factors|immunologic factors|mesh-ancestor
24693367|NCT01420055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693368|NCT01420094|Aspirin|aspirin|mesh-list
24693369|NCT01420094|Acetaminophen|acetaminophen|mesh-list
24693370|NCT01420094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24693432|NCT01420471|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24693433|NCT01420471|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24693434|NCT01420471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24693435|NCT01420471|Glucocorticoids|glucocorticoids|mesh-ancestor
24693436|NCT01420471|Hormones|hormones|mesh-ancestor
24693437|NCT01420471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24693438|NCT01420471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693475|NCT01420666|Analgesics|analgesics|mesh-ancestor
24693476|NCT01420666|Sensory System Agents|sensory system agents|mesh-ancestor
24612256|NCT01012960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24693499|NCT01420822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24693501|NCT01420900|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24693534|NCT01421043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24693535|NCT01421043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693536|NCT01421069|Etanercept|etanercept|mesh-list
24693537|NCT01421069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24478999|NCT00425204|Panitumumab|panitumumab|mesh-list
24693538|NCT01421069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24693539|NCT01421069|Analgesics|analgesics|mesh-ancestor
24693540|NCT01421069|Sensory System Agents|sensory system agents|mesh-ancestor
24693630|NCT01421368|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24693631|NCT01421368|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24693632|NCT01421368|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24693633|NCT01421368|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24693634|NCT01421368|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24693635|NCT01421368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24693636|NCT01421368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24693638|NCT01421693|Gatifloxacin|gatifloxacin|mesh-list
24693639|NCT01421693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24693640|NCT01421693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24693642|NCT01421693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24693725|NCT01421979|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24686501|NCT04760691|Emtricitabine|emtricitabine|mesh-list
24693737|NCT01422018|Bevacizumab|bevacizumab|mesh-list
24693764|NCT01422109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693765|NCT01422109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24693766|NCT01422109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24693767|NCT01422109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693768|NCT01422109|Antipyretics|antipyretics|mesh-ancestor
24693786|NCT01422291|Narcotics|narcotics|mesh-ancestor
24693821|NCT01422499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693823|NCT01422590|Mitiglinide|mitiglinide|mesh-list
24693824|NCT01422590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24693825|NCT01422590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693826|NCT01422590|Incretins|incretins|mesh-ancestor
24693858|NCT01422616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24693859|NCT01422616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24693860|NCT01422616|Adrenergic Agents|adrenergic agents|mesh-ancestor
24855334|NCT02279121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24855335|NCT02279121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24693861|NCT01422616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24693862|NCT01422616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693863|NCT01422616|Analgesics|analgesics|mesh-ancestor
24693864|NCT01422616|Sensory System Agents|sensory system agents|mesh-ancestor
24693865|NCT01422616|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24693866|NCT01422616|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24693867|NCT01422616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24693868|NCT01422616|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24693869|NCT01422616|Protective Agents|protective agents|mesh-ancestor
24693870|NCT01422616|Sympathomimetics|sympathomimetics|mesh-ancestor
24694137|NCT01424111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24694138|NCT01424124|Montelukast|montelukast|mesh-list
24694139|NCT01424124|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24694140|NCT01424124|Respiratory System Agents|respiratory system agents|mesh-ancestor
24694141|NCT01424124|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24694142|NCT01424124|Hormone Antagonists|hormone antagonists|mesh-ancestor
24694310|NCT01424891|Antimetabolites|antimetabolites|mesh-ancestor
24694311|NCT01424891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694312|NCT01424891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24694313|NCT01424891|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24694314|NCT01424891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24694315|NCT01425060|Contraceptive Agents|contraceptive agents|mesh-list
24694316|NCT01425060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24694317|NCT01425060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694318|NCT01425073|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24694319|NCT01425073|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24694320|NCT01425073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24694321|NCT01425073|Renal Agents|renal agents|mesh-ancestor
24694322|NCT01425073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24694323|NCT01425073|Antimalarials|antimalarials|mesh-ancestor
24694324|NCT01425073|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24694325|NCT01425073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24694326|NCT01425099|Dolutegravir|dolutegravir|mesh-list
24694327|NCT01425099|Prednisone|prednisone|mesh-list
24855341|NCT02279134|Antimitotic Agents|antimitotic agents|mesh-ancestor
24855342|NCT02279134|Mitosis Modulators|mitosis modulators|mesh-ancestor
24855343|NCT02279134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855345|NCT02279147|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24524168|NCT05206110|Ketorolac|ketorolac|mesh-list
24694328|NCT01425099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24694329|NCT01425099|Glucocorticoids|glucocorticoids|mesh-ancestor
24694330|NCT01425099|Hormones|hormones|mesh-ancestor
24694518|NCT05386914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24695346|NCT03759028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24695347|NCT03759028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24695348|NCT03759028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24695349|NCT03759028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24695350|NCT03759028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24686691|NCT04640636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24696407|NCT01429402|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24696409|NCT01429402|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24696410|NCT01429402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24696411|NCT01429402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696412|NCT01429402|Cholinergic Agents|cholinergic agents|mesh-ancestor
24696413|NCT01429402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24696414|NCT01429402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696415|NCT01429402|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24696416|NCT01429402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24830471|NCT02159326|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
24830472|NCT02159326|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
24830473|NCT02159326|Riociguat|riociguat|mesh-list
24830474|NCT02159326|Enzyme Activators|enzyme activators|mesh-ancestor
24830475|NCT02159326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696417|NCT01429415|Magnesium Sulfate|magnesium sulfate|mesh-list
24696418|NCT01429415|Analgesics|analgesics|mesh-ancestor
24696419|NCT01429415|Sensory System Agents|sensory system agents|mesh-ancestor
24696420|NCT01429415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24696421|NCT01429415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696489|NCT01429701|Sensory System Agents|sensory system agents|mesh-ancestor
24696490|NCT01429714|Oxymetazoline|oxymetazoline|mesh-list
24696491|NCT01429714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24696492|NCT01429714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24697242|NCT01433952|Micronutrients|micronutrients|mesh-ancestor
24697243|NCT01433952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697244|NCT01434017|Dexamethasone|dexamethasone|mesh-list
24697245|NCT01434017|Dexamethasone acetate|dexamethasone acetate|mesh-list
24697246|NCT01434017|Droperidol|droperidol|mesh-list
24697247|NCT01434017|Ondansetron|ondansetron|mesh-list
24697248|NCT01434017|BB 1101|bb 1101|mesh-list
24697249|NCT01434017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24697250|NCT01434017|Antiemetics|antiemetics|mesh-ancestor
24697251|NCT01434017|Autonomic Agents|autonomic agents|mesh-ancestor
24697252|NCT01434017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24697323|NCT01434147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697324|NCT01434147|Growth Inhibitors|growth inhibitors|mesh-ancestor
24697325|NCT01434147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24697326|NCT01434147|Antimetabolites|antimetabolites|mesh-ancestor
24697327|NCT01434147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697402|NCT01434303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697403|NCT01434303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24697404|NCT01434303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24697405|NCT01434303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697407|NCT01434381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24697408|NCT01434381|Immunologic Factors|immunologic factors|mesh-ancestor
24697409|NCT01434381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694867|NCT02037555|Antithrombins|antithrombins|mesh-list
25694868|NCT02037555|Antithrombin III|antithrombin iii|mesh-list
25694869|NCT02037555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25694870|NCT02037555|Protease Inhibitors|protease inhibitors|mesh-ancestor
25694871|NCT02037555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24697410|NCT01434381|Antacids|antacids|mesh-ancestor
24521293|NCT04898894|Fludarabine phosphate|fludarabine phosphate|mesh-list
24612789|NCT01015417|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24612791|NCT01015417|Clavulanic Acid|clavulanic acid|mesh-list
24697599|NCT01435837|Purinergic Agents|purinergic agents|mesh-ancestor
24697600|NCT01435837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24697601|NCT01435902|Fluticasone|fluticasone|mesh-list
24697602|NCT01435902|Xhance|xhance|mesh-list
24697603|NCT01435902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24697604|NCT01435902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24697605|NCT01435902|Autonomic Agents|autonomic agents|mesh-ancestor
24697606|NCT01435902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24697607|NCT01435902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801484|NCT01983761|Tacrolimus|tacrolimus|mesh-list
24440417|NCT00282997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440418|NCT00282997|Anticonvulsants|anticonvulsants|mesh-ancestor
24697608|NCT01435902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24697609|NCT01435902|Respiratory System Agents|respiratory system agents|mesh-ancestor
24697610|NCT01435902|Dermatologic Agents|dermatologic agents|mesh-ancestor
24697611|NCT01435902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24697612|NCT01435915|Ropinirole|ropinirole|mesh-list
24697613|NCT01435915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24697614|NCT01435915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24697615|NCT01435915|Dopamine Agonists|dopamine agonists|mesh-ancestor
24697616|NCT01435915|Dopamine Agents|dopamine agents|mesh-ancestor
25035830|NCT03553082|Anesthetics|anesthetics|mesh-ancestor
24697617|NCT01435915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24697618|NCT01435915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697619|NCT01435915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697620|NCT01435941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24697621|NCT01435941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
24697622|NCT01435941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24697623|NCT01435941|Analgesics|analgesics|mesh-ancestor
24697624|NCT01435941|Sensory System Agents|sensory system agents|mesh-ancestor
24697922|NCT01437839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855351|NCT02279147|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24855352|NCT02279147|Autonomic Agents|autonomic agents|mesh-ancestor
24855353|NCT02279147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24855354|NCT02279186|Tranexamic Acid|tranexamic acid|mesh-list
24855355|NCT02279186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24855356|NCT02279186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24457821|NCT00335270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24697923|NCT01437839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697924|NCT01437839|Anticoagulants|anticoagulants|mesh-ancestor
24697925|NCT01437982|Loteprednol Etabonate|loteprednol etabonate|mesh-list
24697927|NCT01437982|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24697928|NCT01437982|Methylprednisolone|methylprednisolone|mesh-list
24697959|NCT01438021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24698322|NCT01440582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698324|NCT01440608|Anthelmintics|anthelmintics|mesh-ancestor
24698325|NCT01440608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24698326|NCT01440608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24698330|NCT01440608|Tubulin Modulators|tubulin modulators|mesh-ancestor
24698331|NCT01440608|Antimitotic Agents|antimitotic agents|mesh-ancestor
24698332|NCT01440608|Mitosis Modulators|mitosis modulators|mesh-ancestor
24698333|NCT01440608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698334|NCT01440608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698367|NCT01440790|Ascorbic Acid|ascorbic acid|mesh-list
24698368|NCT01440790|Micronutrients|micronutrients|mesh-ancestor
24698369|NCT01440790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698370|NCT01440790|Antioxidants|antioxidants|mesh-ancestor
24698371|NCT01440790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698372|NCT01440790|Protective Agents|protective agents|mesh-ancestor
24698373|NCT01440829|N-Methylaspartate|n-methylaspartate|mesh-list
24698374|NCT01440829|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
24698375|NCT01440829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24698405|NCT01440985|Cholinergic Agents|cholinergic agents|mesh-ancestor
24698406|NCT01440985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24855368|NCT02279342|Gout Suppressants|gout suppressants|mesh-ancestor
24855369|NCT02279342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25694872|NCT02037555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694873|NCT02037555|Anticoagulants|anticoagulants|mesh-ancestor
24855370|NCT02279381|Chlorhexidine|chlorhexidine|mesh-list
24855371|NCT02279381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24855372|NCT02279381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24524893|NCT04234217|Niacin|niacin|mesh-list
24698933|NCT01443624|Hematinics|hematinics|mesh-ancestor
24698934|NCT01443676|Bevacizumab|bevacizumab|mesh-list
24698935|NCT01443676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24612895|NCT01015729|Sensory System Agents|sensory system agents|mesh-ancestor
24612896|NCT01015729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24612956|NCT01016041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24612957|NCT01016041|Immunologic Factors|immunologic factors|mesh-ancestor
24612958|NCT01016041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612959|NCT01016054|Gemcitabine|gemcitabine|mesh-list
24612960|NCT01016054|Carboplatin|carboplatin|mesh-list
24698974|NCT01444118|Cyclophosphamide|cyclophosphamide|mesh-list
24698976|NCT01444118|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
24698977|NCT01444118|Immunologic Factors|immunologic factors|mesh-ancestor
24698978|NCT01444118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698979|NCT01444118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24698980|NCT01444118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24698981|NCT01444118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24855374|NCT02279394|Dexamethasone|dexamethasone|mesh-list
24855375|NCT02279394|Lenalidomide|lenalidomide|mesh-list
24699096|NCT01444846|Protective Agents|protective agents|mesh-ancestor
24699097|NCT01444846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24699098|NCT01444846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699161|NCT01445223|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24699162|NCT01445223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24699196|NCT01445392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24699197|NCT01445392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699198|NCT01445392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699199|NCT01445392|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24687144|NCT04302168|Choline|choline|mesh-list
24699309|NCT01446120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24855379|NCT02279394|Autonomic Agents|autonomic agents|mesh-ancestor
24855380|NCT02279394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24855381|NCT02279394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855382|NCT02279394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24855383|NCT02279394|Glucocorticoids|glucocorticoids|mesh-ancestor
24855385|NCT02279394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24855386|NCT02279394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24855387|NCT02279394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855388|NCT02279394|Immunologic Factors|immunologic factors|mesh-ancestor
24855389|NCT02279394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24855390|NCT02279394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24855391|NCT02279394|Growth Substances|growth substances|mesh-ancestor
24699310|NCT01446120|Insulin, Isophane|insulin, isophane|mesh-list
24699311|NCT01446120|Isophane Insulin, Human|isophane insulin, human|mesh-list
24699312|NCT01446120|Isophane insulin, beef|isophane insulin, beef|mesh-list
24699313|NCT01446120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24699314|NCT01446120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699315|NCT01446211|Gusperimus|gusperimus|mesh-list
24699316|NCT01446211|Cyclophosphamide|cyclophosphamide|mesh-list
24699445|NCT01446783|Growth Substances|growth substances|mesh-ancestor
24699446|NCT01446783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699447|NCT01446900|Rituximab|rituximab|mesh-list
24699448|NCT01446900|Cladribine|cladribine|mesh-list
24699449|NCT01446900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24699450|NCT01446900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24699451|NCT01446900|Immunologic Factors|immunologic factors|mesh-ancestor
24699452|NCT01446900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699453|NCT01446900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24699454|NCT01446900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24699455|NCT01446926|Vaccines|vaccines|mesh-list
24699456|NCT01446926|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24699457|NCT01446926|Immunologic Factors|immunologic factors|mesh-ancestor
24855393|NCT02279511|Adenosine|adenosine|mesh-list
24699488|NCT01447069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24699489|NCT01447069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24699490|NCT01447069|Adrenergic Agents|adrenergic agents|mesh-ancestor
24699491|NCT01447069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24699492|NCT01447069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699549|NCT01447563|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24699550|NCT01447563|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24830525|NCT02159690|Hormones|hormones|mesh-ancestor
24830563|NCT02160054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24449428|NCT00315549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24699575|NCT01447797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24699576|NCT01447797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24699578|NCT01447797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699580|NCT01447797|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24699581|NCT01447797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699582|NCT01447797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24699583|NCT01447797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24699584|NCT01447797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24699585|NCT01447862|Ibutilide|ibutilide|mesh-list
24699586|NCT01447862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24699587|NCT01447875|Propofol|propofol|mesh-list
24699588|NCT01447875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24699589|NCT01447875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24699590|NCT01447875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699591|NCT01447875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24699592|NCT01447875|Anesthetics, General|anesthetics, general|mesh-ancestor
24699593|NCT01447875|Anesthetics|anesthetics|mesh-ancestor
24699594|NCT01447979|Pancrelipase|pancrelipase|mesh-list
24699595|NCT01447979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24699596|NCT01447992|Pancrelipase|pancrelipase|mesh-list
24699756|NCT01448772|Hormones|hormones|mesh-ancestor
24699757|NCT01448772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24699758|NCT01448798|Thrombin|thrombin|mesh-list
24699759|NCT01448798|Hemostatics|hemostatics|mesh-list
24699760|NCT01448798|Coagulants|coagulants|mesh-ancestor
24699761|NCT01448837|Timolol|timolol|mesh-list
24699762|NCT01448837|Bimatoprost|bimatoprost|mesh-list
24699763|NCT01448837|Latanoprost|latanoprost|mesh-list
24699764|NCT01448837|Cloprostenol|cloprostenol|mesh-list
24699765|NCT01448837|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24699849|NCT01449344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24699851|NCT01449344|Autonomic Agents|autonomic agents|mesh-ancestor
24699852|NCT01449344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24699853|NCT01449344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24699854|NCT01449344|Glucocorticoids|glucocorticoids|mesh-ancestor
24699897|NCT01449448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24797649|NCT01957007|Docetaxel|docetaxel|mesh-list
24699898|NCT01449552|Tranexamic Acid|tranexamic acid|mesh-list
24699899|NCT01449552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24699900|NCT01449552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24699901|NCT01449552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699902|NCT01449552|Hemostatics|hemostatics|mesh-ancestor
24699903|NCT01449552|Coagulants|coagulants|mesh-ancestor
24855406|NCT02279537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24855407|NCT02279537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24855408|NCT02279537|Growth Substances|growth substances|mesh-ancestor
24855409|NCT02279537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855410|NCT02279537|Growth Inhibitors|growth inhibitors|mesh-ancestor
24855411|NCT02279537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24699904|NCT01449565|Naltrexone|naltrexone|mesh-list
24699905|NCT01449565|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24699906|NCT01449565|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24699907|NCT01449565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699908|NCT01449565|Sensory System Agents|sensory system agents|mesh-ancestor
24699909|NCT01449565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24699910|NCT01449578|Pramipexole|pramipexole|mesh-list
24699911|NCT01449578|Antioxidants|antioxidants|mesh-ancestor
24454254|NCT04266730|Pembrolizumab|pembrolizumab|mesh-list
24699912|NCT01449578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699913|NCT01449578|Protective Agents|protective agents|mesh-ancestor
24699914|NCT01449578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699915|NCT01449578|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24699916|NCT01449578|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24699937|NCT01449617|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24699938|NCT01449617|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24699939|NCT01449617|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24699940|NCT01449617|Purinergic Agents|purinergic agents|mesh-ancestor
24699941|NCT01449617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24699942|NCT01449799|Fluticasone|fluticasone|mesh-list
24699944|NCT01449799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24699945|NCT01449799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24687389|NCT04009967|Pembrolizumab|pembrolizumab|mesh-list
24699970|NCT01449877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24699971|NCT01449877|Renal Agents|renal agents|mesh-ancestor
24699972|NCT01449877|Antimalarials|antimalarials|mesh-ancestor
24700001|NCT01450124|Sensory System Agents|sensory system agents|mesh-ancestor
24700002|NCT01450124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24700003|NCT01450124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700004|NCT01450124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24700006|NCT01450163|Oxaliplatin|oxaliplatin|mesh-list
24700007|NCT01450163|Pregabalin|pregabalin|mesh-list
24700008|NCT01450163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24700009|NCT01450163|Analgesics|analgesics|mesh-ancestor
24700010|NCT01450163|Sensory System Agents|sensory system agents|mesh-ancestor
24700011|NCT01450163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24700012|NCT01450163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700013|NCT01450163|Anticonvulsants|anticonvulsants|mesh-ancestor
24855412|NCT02279563|Fluticasone|fluticasone|mesh-list
24855413|NCT02279563|Xhance|xhance|mesh-list
24855414|NCT02279563|Azelastine|azelastine|mesh-list
24855415|NCT02279563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24700016|NCT01450163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613040|NCT01016665|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24613041|NCT01016665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613042|NCT01016665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613043|NCT01016665|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24613044|NCT01016665|Hormone Antagonists|hormone antagonists|mesh-ancestor
24613045|NCT01016665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24613046|NCT01016665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613048|NCT01016717|Pantoprazole|pantoprazole|mesh-list
24613049|NCT01016717|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24613050|NCT01016717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24613051|NCT01016717|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24613052|NCT01016717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613053|NCT01016717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613054|NCT01016730|Bortezomib|bortezomib|mesh-list
24613055|NCT01016730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613056|NCT01016795|Lenograstim|lenograstim|mesh-list
24613057|NCT01016795|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24613058|NCT01016795|Immunologic Factors|immunologic factors|mesh-ancestor
24613059|NCT01016795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613060|NCT01016821|Oxycodone|oxycodone|mesh-list
24613061|NCT01016821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24613062|NCT01016821|Narcotics|narcotics|mesh-ancestor
24613063|NCT01016821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24613064|NCT01016821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687500|NCT03947671|Antipyretics|antipyretics|mesh-ancestor
24700132|NCT01450774|Glucocorticoids|glucocorticoids|mesh-ancestor
24700134|NCT01450774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24700135|NCT01450865|Flupirtine|flupirtine|mesh-list
24700136|NCT01450865|Analgesics|analgesics|mesh-ancestor
24700137|NCT01450865|Sensory System Agents|sensory system agents|mesh-ancestor
24440419|NCT00282997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24440420|NCT00282997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24440421|NCT00282997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440422|NCT00282997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24440423|NCT00282997|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24440424|NCT00282997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24440425|NCT00282997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24440426|NCT00282997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24700138|NCT01450865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24700139|NCT01450865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700140|NCT01450930|Hydrocortisone|hydrocortisone|mesh-list
24700141|NCT01450930|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24700142|NCT01450930|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24700143|NCT01450930|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24700144|NCT01450930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24700145|NCT01450956|Sevoflurane|sevoflurane|mesh-list
24700146|NCT01450956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24700147|NCT01450956|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24700148|NCT01450956|Anesthetics, General|anesthetics, general|mesh-ancestor
24700149|NCT01450956|Anesthetics|anesthetics|mesh-ancestor
24700227|NCT01451333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24700228|NCT01451333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24700229|NCT01451333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700230|NCT01451333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700231|NCT01451333|Antiviral Agents|antiviral agents|mesh-ancestor
24700232|NCT01451333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24700233|NCT01451333|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24700234|NCT01451333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25694874|NCT02037893|Antipyrine|antipyrine|mesh-list
25694875|NCT02037893|Benzocaine|benzocaine|mesh-list
24700235|NCT01451333|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24700236|NCT01451333|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24700237|NCT01451333|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24643750|NCT01187108|Antioxidants|antioxidants|mesh-ancestor
24700238|NCT01451333|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24700239|NCT01451489|Cyclophosphamide|cyclophosphamide|mesh-list
24700581|NCT01453400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24700582|NCT01453400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700583|NCT01453400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24700584|NCT01453400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24700585|NCT01453400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700586|NCT01453400|Antipyretics|antipyretics|mesh-ancestor
24700587|NCT01453426|Dimethyl Fumarate|dimethyl fumarate|mesh-list
24700588|NCT01453426|Dermatologic Agents|dermatologic agents|mesh-ancestor
24700728|NCT01454609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24700729|NCT01454609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700730|NCT01454622|Metformin|metformin|mesh-list
24700731|NCT01454622|Canagliflozin|canagliflozin|mesh-list
24700732|NCT01454622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24700733|NCT01454622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700762|NCT01455025|Plerixafor|plerixafor|mesh-list
24700763|NCT01455025|Lenograstim|lenograstim|mesh-list
24700764|NCT01455025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24700765|NCT01455025|Immunologic Factors|immunologic factors|mesh-ancestor
24700766|NCT01455025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700767|NCT01455025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24700768|NCT01455025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24700769|NCT01455025|Antiviral Agents|antiviral agents|mesh-ancestor
24687665|NCT03807921|Analgesics|analgesics|mesh-ancestor
24700861|NCT01455506|Immunologic Factors|immunologic factors|mesh-ancestor
24700862|NCT01455506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700863|NCT01455506|Alkylating Agents|alkylating agents|mesh-ancestor
24687710|NCT03777462|Antimetabolites|antimetabolites|mesh-ancestor
24613218|NCT01017770|Schistosomicides|schistosomicides|mesh-ancestor
24701044|NCT01456507|Oxycodone|oxycodone|mesh-list
24701045|NCT01456507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24701047|NCT01456507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24701048|NCT01456507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701081|NCT01456611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24701082|NCT01456611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24701084|NCT01456611|Sensory System Agents|sensory system agents|mesh-ancestor
24701085|NCT01456611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24701086|NCT01456611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701087|NCT01456611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24701088|NCT01456611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24701176|NCT01457495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24701178|NCT01457495|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24701179|NCT01457508|Edetic Acid|edetic acid|mesh-list
24701180|NCT01457508|Pentetic Acid|pentetic acid|mesh-list
24701181|NCT01457508|Antidotes|antidotes|mesh-ancestor
24701182|NCT01457508|Protective Agents|protective agents|mesh-ancestor
24613235|NCT01017796|Micronutrients|micronutrients|mesh-ancestor
24613236|NCT01017809|Aprepitant|aprepitant|mesh-list
24613237|NCT01017809|Antiemetics|antiemetics|mesh-ancestor
24613238|NCT01017809|Autonomic Agents|autonomic agents|mesh-ancestor
24613265|NCT01017926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24613266|NCT01017926|GABA Modulators|gaba modulators|mesh-ancestor
24613267|NCT01017926|GABA Agents|gaba agents|mesh-ancestor
24613268|NCT01017926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24613269|NCT01017926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701305|NCT01458067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633771|NCT01131039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24633844|NCT01131377|Acetazolamide|acetazolamide|mesh-list
25694876|NCT02037893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25694877|NCT02037893|Anesthetics, Local|anesthetics, local|mesh-ancestor
24633845|NCT01131377|Anticonvulsants|anticonvulsants|mesh-ancestor
24633846|NCT01131377|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24633847|NCT01131377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633848|NCT01131377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694878|NCT02037893|Anesthetics|anesthetics|mesh-ancestor
24633849|NCT01131377|Diuretics|diuretics|mesh-ancestor
24633850|NCT01131377|Natriuretic Agents|natriuretic agents|mesh-ancestor
24633851|NCT01131377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633852|NCT01131429|Cisplatin|cisplatin|mesh-list
24633853|NCT01131429|Docetaxel|docetaxel|mesh-list
24633854|NCT01131429|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24633855|NCT01131429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633905|NCT01131689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24812741|NCT02054299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24633906|NCT01131689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633907|NCT01131689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633908|NCT01131702|Ranitidine|ranitidine|mesh-list
24633909|NCT01131702|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
24633910|NCT01131702|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24633911|NCT01131702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24687943|NCT03584516|Protective Agents|protective agents|mesh-ancestor
24634088|NCT01131988|Immunologic Factors|immunologic factors|mesh-ancestor
24634089|NCT01131988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634090|NCT01131988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24634091|NCT01131988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634092|NCT01131988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634094|NCT01132027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24634095|NCT01132027|Immunologic Factors|immunologic factors|mesh-ancestor
24634097|NCT01132027|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24634157|NCT01132222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634159|NCT01132222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24634160|NCT01132222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24634162|NCT01132222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634164|NCT01132222|Autonomic Agents|autonomic agents|mesh-ancestor
24634165|NCT01132222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24634166|NCT01132222|Respiratory System Agents|respiratory system agents|mesh-ancestor
24634167|NCT01132222|Nasal Decongestants|nasal decongestants|mesh-ancestor
24634168|NCT01132222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24634169|NCT01132222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24688027|NCT03522584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24634227|NCT01132573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24634228|NCT01132573|Antimetabolites|antimetabolites|mesh-ancestor
24634229|NCT01132573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634230|NCT01132573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24634231|NCT01132573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634233|NCT01132586|Lenalidomide|lenalidomide|mesh-list
24634234|NCT01132586|Idarubicin|idarubicin|mesh-list
24634235|NCT01132586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24634236|NCT01132586|Antimetabolites|antimetabolites|mesh-ancestor
24634333|NCT01132794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634336|NCT01132794|Sensory System Agents|sensory system agents|mesh-ancestor
24634337|NCT01132794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24634338|NCT01132794|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24634339|NCT01132794|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24634340|NCT01132794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24634341|NCT01132794|Adrenergic Agents|adrenergic agents|mesh-ancestor
24634342|NCT01132794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24634343|NCT01132794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634345|NCT01132911|Vorinostat|vorinostat|mesh-list
24634365|NCT01133119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634368|NCT01133210|Maraviroc|maraviroc|mesh-list
24634371|NCT01133210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634373|NCT01133210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24634374|NCT01133210|Antiviral Agents|antiviral agents|mesh-ancestor
24634375|NCT01133210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24634376|NCT01133210|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24634435|NCT01133470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24634436|NCT01133470|Respiratory System Agents|respiratory system agents|mesh-ancestor
24634437|NCT01133470|Nasal Decongestants|nasal decongestants|mesh-ancestor
24634438|NCT01133470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24634453|NCT01133483|Autonomic Agents|autonomic agents|mesh-ancestor
24634454|NCT01133483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24634455|NCT01133483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812749|NCT02054429|Insulin|insulin|mesh-list
24812750|NCT02054429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24812751|NCT02054429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24812752|NCT02054429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634456|NCT01133483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24688148|NCT03317405|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24634565|NCT01133925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24634566|NCT01133925|Tubulin Modulators|tubulin modulators|mesh-ancestor
24634567|NCT01133925|Antimitotic Agents|antimitotic agents|mesh-ancestor
24634568|NCT01133925|Mitosis Modulators|mitosis modulators|mesh-ancestor
24634569|NCT01133925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634570|NCT01133925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24634571|NCT01133925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24634572|NCT01133925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24634605|NCT01134341|Folic Acid|folic acid|mesh-list
24634606|NCT01134341|Vitamin B 12|vitamin b 12|mesh-list
24634607|NCT01134341|Vitamin B Complex|vitamin b complex|mesh-list
24634608|NCT01134341|Bexarotene|bexarotene|mesh-list
24634609|NCT01134341|10-deazaaminopterin|10-deazaaminopterin|mesh-list
24634610|NCT01134341|Aminopterin|aminopterin|mesh-list
24634611|NCT01134341|Micronutrients|micronutrients|mesh-ancestor
24634612|NCT01134341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634613|NCT01134341|Hematinics|hematinics|mesh-ancestor
24634614|NCT01134341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24634615|NCT01134341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24634616|NCT01134341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634617|NCT01134341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634619|NCT01134406|Viscosupplements|viscosupplements|mesh-ancestor
25036325|NCT03548493|Fentanyl|fentanyl|mesh-list
24634620|NCT01134406|Protective Agents|protective agents|mesh-ancestor
24634621|NCT01134406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634622|NCT01134432|Prednisolone|prednisolone|mesh-list
24634623|NCT01134432|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24634890|NCT01135680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24634891|NCT01135680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24634892|NCT01135680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24634893|NCT01135680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24634894|NCT01135680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634910|NCT01135758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24855436|NCT02279576|Tubulin Modulators|tubulin modulators|mesh-ancestor
24855437|NCT02279576|Antimitotic Agents|antimitotic agents|mesh-ancestor
24528198|NCT00620347|Sunitinib|sunitinib|mesh-list
24634911|NCT01135758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24634912|NCT01135758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24634962|NCT01136252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24634963|NCT01136278|Clonidine|clonidine|mesh-list
24634964|NCT01136278|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
24634965|NCT01136278|Analgesics|analgesics|mesh-ancestor
24634966|NCT01136278|Sensory System Agents|sensory system agents|mesh-ancestor
24634967|NCT01136278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24634968|NCT01136278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634969|NCT01136278|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24634970|NCT01136278|Sympatholytics|sympatholytics|mesh-ancestor
24634971|NCT01136278|Autonomic Agents|autonomic agents|mesh-ancestor
24634972|NCT01136278|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24855438|NCT02279576|Mitosis Modulators|mitosis modulators|mesh-ancestor
24457859|NCT00335439|Sensory System Agents|sensory system agents|mesh-ancestor
24635229|NCT01137903|Renal Agents|renal agents|mesh-ancestor
24635230|NCT01137903|Antimalarials|antimalarials|mesh-ancestor
24635231|NCT01137903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24635232|NCT01137903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24635233|NCT01137903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24635234|NCT01137903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24635235|NCT01137903|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24635236|NCT01137903|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24635237|NCT01137916|Imatinib Mesylate|imatinib mesylate|mesh-list
24635238|NCT01137916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24635339|NCT01138553|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24855439|NCT02279576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855440|NCT02279589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24635340|NCT01138553|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24635342|NCT01138553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25694879|NCT02037893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25694880|NCT02037893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635343|NCT01138553|Luteolytic Agents|luteolytic agents|mesh-ancestor
24635344|NCT01138553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24635345|NCT01138553|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24635347|NCT01138605|Darunavir|darunavir|mesh-list
24635348|NCT01138605|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24635349|NCT01138605|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24440427|NCT00283036|Irbesartan|irbesartan|mesh-list
24440428|NCT00283036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24440450|NCT00283179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24440617|NCT00283985|Glucocorticoids|glucocorticoids|mesh-ancestor
24440618|NCT00283985|Hormones|hormones|mesh-ancestor
24440619|NCT00283985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24440620|NCT00283985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24440635|NCT00284024|Domperidone|domperidone|mesh-list
24440636|NCT00284024|Antiemetics|antiemetics|mesh-ancestor
24440637|NCT00284024|Autonomic Agents|autonomic agents|mesh-ancestor
24440638|NCT00284024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24440639|NCT00284024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440735|NCT00284505|Leprostatic Agents|leprostatic agents|mesh-ancestor
24440736|NCT00284505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24440737|NCT00284505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24440738|NCT00284505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24440739|NCT00284505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24440740|NCT00284505|Growth Substances|growth substances|mesh-ancestor
24635351|NCT01138605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635352|NCT01138605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635353|NCT01138605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24635354|NCT01138605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24635355|NCT01138605|Antiviral Agents|antiviral agents|mesh-ancestor
24635356|NCT01138605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24635357|NCT01138605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24635419|NCT01139138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24635420|NCT01139138|Immunologic Factors|immunologic factors|mesh-ancestor
24635421|NCT01139138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688499|NCT03012672|Mitoxantrone|mitoxantrone|mesh-list
24635482|NCT01139671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635483|NCT01139671|Analgesics|analgesics|mesh-ancestor
24635572|NCT01140399|Natriuretic Agents|natriuretic agents|mesh-ancestor
24635573|NCT01140399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635574|NCT01140399|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24635575|NCT01140399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24688538|NCT03011775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24635621|NCT01140438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635622|NCT01140438|Incretins|incretins|mesh-ancestor
24635624|NCT01140438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24635625|NCT01140438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24635626|NCT01140438|Protease Inhibitors|protease inhibitors|mesh-ancestor
24635627|NCT01140438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635628|NCT01140438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635633|NCT01140529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24635635|NCT01140529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24855442|NCT02279589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635735|NCT01140984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635736|NCT01140984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24635737|NCT01140984|Glucocorticoids|glucocorticoids|mesh-ancestor
24855445|NCT02279615|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24635820|NCT01141296|Antimetabolites|antimetabolites|mesh-ancestor
24855449|NCT02279615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24855450|NCT02279615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855451|NCT02279615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635821|NCT01141296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635822|NCT01141296|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24635823|NCT01141322|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24635824|NCT01141322|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24635825|NCT01141322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24635826|NCT01141439|Fluticasone|fluticasone|mesh-list
24635829|NCT01141439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24635896|NCT01141855|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24635897|NCT01141855|Cholinergic Agents|cholinergic agents|mesh-ancestor
24635898|NCT01141855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24635902|NCT01141881|Plasminogen|plasminogen|mesh-list
24635904|NCT01141881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24635906|NCT01141881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24635941|NCT01141972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635942|NCT01141972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24635943|NCT01141998|Cholecalciferol|cholecalciferol|mesh-list
24635944|NCT01141998|Vitamin D|vitamin d|mesh-list
24635945|NCT01141998|Calcium, Dietary|calcium, dietary|mesh-list
24635946|NCT01141998|Calcium|calcium|mesh-list
24635947|NCT01141998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24635948|NCT01141998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635963|NCT01142258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24635964|NCT01142258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24635965|NCT01142258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24635966|NCT01142258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635967|NCT01142258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24635969|NCT01142258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24636069|NCT01142622|Anesthetics, Local|anesthetics, local|mesh-ancestor
24636070|NCT01142622|Anesthetics|anesthetics|mesh-ancestor
24636071|NCT01142622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24636076|NCT01142635|Rocuronium|rocuronium|mesh-list
24636081|NCT01142635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24636082|NCT01142635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636083|NCT01142648|Glycopyrrolate|glycopyrrolate|mesh-list
24636128|NCT01143025|Ropivacaine|ropivacaine|mesh-list
24636129|NCT01143025|Anesthetics, Local|anesthetics, local|mesh-ancestor
24636131|NCT01143025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24636132|NCT01143025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636133|NCT01143025|Sensory System Agents|sensory system agents|mesh-ancestor
24636134|NCT01143025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24636135|NCT01143129|Dexamethasone|dexamethasone|mesh-list
24636139|NCT01143129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24636140|NCT01143129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636141|NCT01143129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24636201|NCT01143857|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24636202|NCT01143857|Cholinergic Agents|cholinergic agents|mesh-ancestor
24636203|NCT01143857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24636204|NCT01143857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636205|NCT01143857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636207|NCT01143948|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24636208|NCT01143948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24636209|NCT01143948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636210|NCT01143974|Pemetrexed|pemetrexed|mesh-list
24440741|NCT00284505|Growth Inhibitors|growth inhibitors|mesh-ancestor
24440742|NCT00284505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440743|NCT00284531|Daclizumab|daclizumab|mesh-list
24440744|NCT00284531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24440745|NCT00284531|Immunologic Factors|immunologic factors|mesh-ancestor
24440746|NCT00284531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440747|NCT00284583|Lidocaine|lidocaine|mesh-list
24440748|NCT00284583|Anesthetics, Local|anesthetics, local|mesh-ancestor
24440749|NCT00284583|Anesthetics|anesthetics|mesh-ancestor
24636212|NCT01143974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636213|NCT01143974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636214|NCT01143974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24636235|NCT01144091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636236|NCT01144091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24636241|NCT01144091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24636243|NCT01144117|Epoetin Alfa|epoetin alfa|mesh-list
24636311|NCT01144702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24636312|NCT01144702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24636314|NCT01144702|Schistosomicides|schistosomicides|mesh-ancestor
24688857|NCT02636322|Growth Substances|growth substances|mesh-ancestor
24636358|NCT01144923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24636363|NCT01144923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24636364|NCT01144923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636365|NCT01144923|Antimanic Agents|antimanic agents|mesh-ancestor
25036576|NCT03546283|Cardiac Glycosides|cardiac glycosides|mesh-list
24636366|NCT01144923|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24636367|NCT01144923|Antidepressive Agents|antidepressive agents|mesh-ancestor
24636368|NCT01144923|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24636369|NCT01144923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24636370|NCT01144923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24636371|NCT01144923|Adrenergic Agents|adrenergic agents|mesh-ancestor
24636372|NCT01144988|Bevacizumab|bevacizumab|mesh-list
24636524|NCT01145976|Thymoglobulin|thymoglobulin|mesh-list
24688959|NCT02535650|Tipifarnib|tipifarnib|mesh-list
24636550|NCT01146028|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24636551|NCT01146028|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24636552|NCT01146028|Parasympatholytics|parasympatholytics|mesh-ancestor
24636553|NCT01146028|Autonomic Agents|autonomic agents|mesh-ancestor
24636554|NCT01146028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24636555|NCT01146028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24636564|NCT01146041|Cholinergic Agents|cholinergic agents|mesh-ancestor
24636565|NCT01146041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24855460|NCT02279628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24855461|NCT02279628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636584|NCT01146093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24636585|NCT01146093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636629|NCT01146483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24636630|NCT01146483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24636631|NCT01146483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636632|NCT01146483|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24636633|NCT01146483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24636636|NCT01146509|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24636637|NCT01146509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406430|NCT03560531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25694881|NCT02037893|Sensory System Agents|sensory system agents|mesh-ancestor
25694882|NCT02037893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25694883|NCT02037893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24636638|NCT01146509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636639|NCT01146509|Cholinergic Agents|cholinergic agents|mesh-ancestor
24636640|NCT01146509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24636641|NCT01146509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636791|NCT01147354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636792|NCT01147354|Protective Agents|protective agents|mesh-ancestor
24636793|NCT01147354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636794|NCT01147354|Trace Elements|trace elements|mesh-ancestor
24636796|NCT01147419|Blood Substitutes|blood substitutes|mesh-list
24636833|NCT01147588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24636858|NCT01147705|Antimetabolites|antimetabolites|mesh-ancestor
24636859|NCT01147705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636860|NCT01147705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636869|NCT01147718|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24636870|NCT01147718|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24636871|NCT01147718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689152|NCT02293109|Prednisolone acetate|prednisolone acetate|mesh-list
24636993|NCT01148277|GABA Agents|gaba agents|mesh-ancestor
24636994|NCT01148277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24636995|NCT01148277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636996|NCT01148303|Etoricoxib|etoricoxib|mesh-list
24636997|NCT01148303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24636998|NCT01148303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24636999|NCT01148303|Analgesics|analgesics|mesh-ancestor
24637000|NCT01148303|Sensory System Agents|sensory system agents|mesh-ancestor
24637001|NCT01148303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24689236|NCT01982448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637044|NCT01148446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24637045|NCT01148446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24637046|NCT01148446|Alkylating Agents|alkylating agents|mesh-ancestor
24637047|NCT01148446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637048|NCT01148446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637049|NCT01148446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24637050|NCT01148446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24637052|NCT01148446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24637054|NCT01148446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637059|NCT01148446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24637060|NCT01148446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24637061|NCT01148446|Tubulin Modulators|tubulin modulators|mesh-ancestor
24830684|NCT02160353|Hormone Antagonists|hormone antagonists|mesh-ancestor
24830685|NCT02160353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24830687|NCT02160548|Albuterol|albuterol|mesh-list
24830688|NCT02160548|Pralidoxime|pralidoxime|mesh-list
24637062|NCT01148446|Antimitotic Agents|antimitotic agents|mesh-ancestor
24637120|NCT01148667|Chelating Agents|chelating agents|mesh-ancestor
24637121|NCT01148667|Sequestering Agents|sequestering agents|mesh-ancestor
24637122|NCT01148667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637124|NCT01148901|Dermatologic Agents|dermatologic agents|mesh-ancestor
24637125|NCT01148901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24637126|NCT01148901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24637127|NCT01148966|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24855479|NCT02279875|Leprostatic Agents|leprostatic agents|mesh-ancestor
24530451|NCT00630383|Histamine|histamine|mesh-list
24637128|NCT01148966|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24637129|NCT01148966|Dermatologic Agents|dermatologic agents|mesh-ancestor
24637130|NCT01148992|Lofexidine|lofexidine|mesh-list
24637131|NCT01148992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24637132|NCT01148992|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24637185|NCT01149174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24637186|NCT01149174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637188|NCT01149174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694884|NCT02037893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25694885|NCT02037893|Analgesics|analgesics|mesh-ancestor
25694886|NCT02037893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25694887|NCT02037893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24637189|NCT01149174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24637190|NCT01149174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637191|NCT01149226|Chloral Hydrate|chloral hydrate|mesh-list
24637192|NCT01149226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24637193|NCT01149226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24637194|NCT01149226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637237|NCT01149356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637238|NCT01149356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24637239|NCT01149356|Hormone Antagonists|hormone antagonists|mesh-ancestor
24637240|NCT01149356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24637241|NCT01149356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637242|NCT01149356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24637243|NCT01149395|Dexlansoprazole|dexlansoprazole|mesh-list
24637244|NCT01149395|Lansoprazole|lansoprazole|mesh-list
24637245|NCT01149395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24637246|NCT01149395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24637247|NCT01149395|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24637248|NCT01149395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637249|NCT01149395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637250|NCT01149408|Decitabine|decitabine|mesh-list
24637270|NCT01149564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637271|NCT01149577|Olanzapine|olanzapine|mesh-list
24637272|NCT01149577|Antiemetics|antiemetics|mesh-ancestor
24637273|NCT01149577|Autonomic Agents|autonomic agents|mesh-ancestor
24637274|NCT01149577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24637275|NCT01149577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637276|NCT01149577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24637305|NCT01149798|Paclitaxel|paclitaxel|mesh-list
24637392|NCT01149980|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24637393|NCT01149980|Cholinergic Agents|cholinergic agents|mesh-ancestor
24637409|NCT01150110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24637410|NCT01150110|Antifungal Agents|antifungal agents|mesh-ancestor
24637411|NCT01150110|Keratolytic Agents|keratolytic agents|mesh-ancestor
24637412|NCT01150110|Dermatologic Agents|dermatologic agents|mesh-ancestor
24689471|NCT01464268|Anticoagulants|anticoagulants|mesh-ancestor
24637438|NCT01150318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637439|NCT01150331|Levetiracetam|levetiracetam|mesh-list
24637440|NCT01150331|Clonazepam|clonazepam|mesh-list
24637441|NCT01150331|Anticonvulsants|anticonvulsants|mesh-list
24637442|NCT01150331|Nootropic Agents|nootropic agents|mesh-ancestor
24637443|NCT01150331|GABA Modulators|gaba modulators|mesh-ancestor
24637444|NCT01150331|GABA Agents|gaba agents|mesh-ancestor
24637491|NCT01150630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637492|NCT01150630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24637516|NCT01150955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637517|NCT01150955|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24637518|NCT01151072|Insulin|insulin|mesh-list
24637519|NCT01151072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24637520|NCT01151072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637521|NCT01151176|Insulin|insulin|mesh-list
24637523|NCT01151176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24637524|NCT01151176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637525|NCT01151241|Anesthetics|anesthetics|mesh-list
24637526|NCT01151241|Anesthetics, Local|anesthetics, local|mesh-list
24637527|NCT01151241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24637609|NCT01151787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24637611|NCT01151787|Sensory System Agents|sensory system agents|mesh-ancestor
24637612|NCT01151787|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24637613|NCT01151787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24637614|NCT01151787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24637615|NCT01151787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637616|NCT01151787|Adrenergic Agents|adrenergic agents|mesh-ancestor
24637617|NCT01151787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24637618|NCT01151800|Benzocaine|benzocaine|mesh-list
24637619|NCT01151800|Anesthetics, Local|anesthetics, local|mesh-ancestor
24637620|NCT01151800|Anesthetics|anesthetics|mesh-ancestor
24637621|NCT01151800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24637655|NCT01152203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637656|NCT01152203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24637657|NCT01152203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24637658|NCT01152203|Growth Substances|growth substances|mesh-ancestor
24637662|NCT01152203|Alkylating Agents|alkylating agents|mesh-ancestor
24637663|NCT01152203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637665|NCT01152242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24637666|NCT01152242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637667|NCT01152346|Azacitidine|azacitidine|mesh-list
24637668|NCT01152346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24637669|NCT01152346|Antimetabolites|antimetabolites|mesh-ancestor
24637708|NCT01152736|Nicotine|nicotine|mesh-list
24637709|NCT01152736|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24401043|NCT00152022|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24531512|NCT00636246|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24637710|NCT01152736|Autonomic Agents|autonomic agents|mesh-ancestor
24637711|NCT01152736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24637712|NCT01152736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637713|NCT01152736|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24637714|NCT01152736|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24637715|NCT01152736|Cholinergic Agents|cholinergic agents|mesh-ancestor
24637716|NCT01152736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24637717|NCT01152736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637718|NCT01152749|Nicotine|nicotine|mesh-list
24830709|NCT02160548|Cholinergic Agents|cholinergic agents|mesh-ancestor
24830710|NCT02160548|Antidotes|antidotes|mesh-ancestor
24830711|NCT02160548|Protective Agents|protective agents|mesh-ancestor
24637719|NCT01152749|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24637720|NCT01152749|Autonomic Agents|autonomic agents|mesh-ancestor
24637721|NCT01152749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24637722|NCT01152749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637760|NCT01152931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637762|NCT01152931|Antioxidants|antioxidants|mesh-ancestor
24637763|NCT01152931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637764|NCT01152931|Protective Agents|protective agents|mesh-ancestor
24637765|NCT01152931|Antimalarials|antimalarials|mesh-ancestor
24637766|NCT01152931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24637767|NCT01152931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24637768|NCT01152931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24637769|NCT01152931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637771|NCT01152931|Schistosomicides|schistosomicides|mesh-ancestor
24637787|NCT01153165|Antidepressive Agents|antidepressive agents|mesh-ancestor
24637788|NCT01153165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24689675|NCT00678730|Dronabinol|dronabinol|mesh-list
24637828|NCT01153256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24637829|NCT01153256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637830|NCT01153256|Anesthetics|anesthetics|mesh-ancestor
24637831|NCT01153256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24637832|NCT01153256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24637833|NCT01153256|Anticonvulsants|anticonvulsants|mesh-ancestor
24637834|NCT01153256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24637835|NCT01153256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24637836|NCT01153256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637837|NCT01153256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24637838|NCT01153256|Tocolytic Agents|tocolytic agents|mesh-ancestor
24637839|NCT01153256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24637840|NCT01153334|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25694888|NCT02037984|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25694889|NCT02037984|Immunologic Factors|immunologic factors|mesh-ancestor
25694890|NCT02037984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694891|NCT02038010|Trastuzumab|trastuzumab|mesh-list
25694892|NCT02038010|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25694893|NCT02038010|Maytansine|maytansine|mesh-list
25694894|NCT02038010|Immunoconjugates|immunoconjugates|mesh-list
25694895|NCT02038010|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
24521971|NCT04388683|Respiratory System Agents|respiratory system agents|mesh-ancestor
24920159|NCT04204837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24920220|NCT04204278|Protective Agents|protective agents|mesh-ancestor
24920221|NCT04204382|Levofloxacin|levofloxacin|mesh-list
24920222|NCT04204382|Ofloxacin|ofloxacin|mesh-list
24920223|NCT04204382|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24920224|NCT04204382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24920225|NCT04204382|Renal Agents|renal agents|mesh-ancestor
24637841|NCT01153334|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24637842|NCT01153334|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24637843|NCT01153334|Antimetabolites|antimetabolites|mesh-ancestor
24637844|NCT01153334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637845|NCT01153334|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24637846|NCT01153334|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24637874|NCT01153750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637875|NCT01153750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24637876|NCT01153750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637877|NCT01153750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637878|NCT01153802|Dopamine|dopamine|mesh-list
24855505|NCT02279953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24855506|NCT02279953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24855507|NCT02279953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24855508|NCT02279953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637977|NCT01154426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637978|NCT01154426|Antiviral Agents|antiviral agents|mesh-ancestor
24637979|NCT01154426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24637980|NCT01154426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637981|NCT01154426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24637982|NCT01154426|Immunologic Factors|immunologic factors|mesh-ancestor
24637983|NCT01154426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638014|NCT01154465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24638015|NCT01154491|Epoetin Alfa|epoetin alfa|mesh-list
24638016|NCT01154491|Hematinics|hematinics|mesh-ancestor
24638017|NCT01154504|Adrenomedullin|adrenomedullin|mesh-list
24830724|NCT02160587|Disinfectants|disinfectants|mesh-ancestor
24638060|NCT01154764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24638061|NCT01154764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24638062|NCT01154764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24638063|NCT01154764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24638064|NCT01154764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638065|NCT01154764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24638066|NCT01154764|Hormone Antagonists|hormone antagonists|mesh-ancestor
24638067|NCT01154764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24638068|NCT01154764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638069|NCT01154764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24638070|NCT01154790|Naproxen|naproxen|mesh-list
24638113|NCT01154933|Exenatide|exenatide|mesh-list
24638114|NCT01154933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24638115|NCT01154933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638116|NCT01154933|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24638117|NCT01154933|Incretins|incretins|mesh-ancestor
24638118|NCT01154933|Hormones|hormones|mesh-ancestor
24638119|NCT01154933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24447012|NCT00307099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24638120|NCT01154959|Moxifloxacin|moxifloxacin|mesh-list
24638121|NCT01154959|Rifampin|rifampin|mesh-list
24638122|NCT01154959|Isoniazid|isoniazid|mesh-list
24638123|NCT01154959|Pyrazinamide|pyrazinamide|mesh-list
25694896|NCT02038010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25694897|NCT02038010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694898|NCT02038010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25694899|NCT02038010|Tubulin Modulators|tubulin modulators|mesh-ancestor
25694900|NCT02038010|Antimitotic Agents|antimitotic agents|mesh-ancestor
25694901|NCT02038010|Mitosis Modulators|mitosis modulators|mesh-ancestor
25694902|NCT02038010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694903|NCT02038010|Immunologic Factors|immunologic factors|mesh-ancestor
24638124|NCT01154959|Ethambutol|ethambutol|mesh-list
24638125|NCT01154959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25406431|NCT03560531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24638126|NCT01154959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24638127|NCT01154959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24638128|NCT01154959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24638129|NCT01154959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24638130|NCT01154959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638131|NCT01154959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638132|NCT01154959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24638133|NCT01154959|Antitubercular Agents|antitubercular agents|mesh-ancestor
24638134|NCT01154959|Leprostatic Agents|leprostatic agents|mesh-ancestor
24638151|NCT01155089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638152|NCT01155089|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24638153|NCT01155089|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24638154|NCT01155089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24638155|NCT01155089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638156|NCT01155089|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24638157|NCT01155089|Hormone Antagonists|hormone antagonists|mesh-ancestor
24638201|NCT01155245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24638202|NCT01155258|Sirolimus|sirolimus|mesh-list
24638203|NCT01155258|Vinorelbine|vinorelbine|mesh-list
24638204|NCT01155258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24638205|NCT01155258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24830732|NCT02160704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830733|NCT02160704|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24830734|NCT02160704|Fertility Agents|fertility agents|mesh-ancestor
24830735|NCT02160704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24638206|NCT01155258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24638207|NCT01155258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638208|NCT01155258|Antifungal Agents|antifungal agents|mesh-ancestor
24638209|NCT01155258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24638210|NCT01155258|Immunologic Factors|immunologic factors|mesh-ancestor
24638211|NCT01155258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638263|NCT01155765|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24457924|NCT00335686|Lopinavir|lopinavir|mesh-list
24638264|NCT01155765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24638265|NCT01155765|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24638266|NCT01155765|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24638267|NCT01155765|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24638268|NCT01155765|Purinergic Agents|purinergic agents|mesh-ancestor
24638269|NCT01155765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24638270|NCT01155765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638271|NCT01155765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638272|NCT01155791|Prednisone|prednisone|mesh-list
24638273|NCT01155791|Docetaxel|docetaxel|mesh-list
24638274|NCT01155791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638275|NCT01155791|Tubulin Modulators|tubulin modulators|mesh-ancestor
24638276|NCT01155791|Antimitotic Agents|antimitotic agents|mesh-ancestor
24638332|NCT01155934|Dopamine Agents|dopamine agents|mesh-ancestor
24638442|NCT01156740|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24638443|NCT01156740|Amoxicillin|amoxicillin|mesh-list
24638444|NCT01156740|Penicillins|penicillins|mesh-list
24638445|NCT01156740|beta-Lactams|beta-lactams|mesh-list
24638446|NCT01156740|Penicillin G|penicillin g|mesh-list
24638447|NCT01156740|Penicillin G Benzathine|penicillin g benzathine|mesh-list
24638466|NCT01156883|Cytarabine|cytarabine|mesh-list
24638467|NCT01156883|Dexamethasone|dexamethasone|mesh-list
24638468|NCT01156883|Prednisone|prednisone|mesh-list
24638469|NCT01156883|Methylprednisolone|methylprednisolone|mesh-list
24638470|NCT01156883|Cyclophosphamide|cyclophosphamide|mesh-list
24638471|NCT01156883|Ifosfamide|ifosfamide|mesh-list
24638472|NCT01156883|Doxorubicin|doxorubicin|mesh-list
24638473|NCT01156883|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24638474|NCT01156883|Methotrexate|methotrexate|mesh-list
24638475|NCT01156883|Vincristine|vincristine|mesh-list
24638476|NCT01156883|Daunorubicin|daunorubicin|mesh-list
24638477|NCT01156883|Asparaginase|asparaginase|mesh-list
24638497|NCT01156883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25694904|NCT02038010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694905|NCT02038010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830737|NCT02160704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24462960|NCT00358202|Ceftriaxone|ceftriaxone|mesh-list
24462961|NCT00358202|Cefepime|cefepime|mesh-list
24638498|NCT01156883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25694906|NCT02038023|Iron|iron|mesh-list
25694907|NCT02038023|Dextrans|dextrans|mesh-list
24522125|NCT04256317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638499|NCT01156883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24638533|NCT01156948|Abortifacient Agents|abortifacient agents|mesh-ancestor
24638534|NCT01156948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24638535|NCT01156948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638536|NCT01156948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24638604|NCT01157312|Enclomiphene|enclomiphene|mesh-list
24638605|NCT01157312|Zuclomiphene|zuclomiphene|mesh-list
24638606|NCT01157312|Anticoagulants|anticoagulants|mesh-ancestor
24638607|NCT01157312|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24638608|NCT01157312|Chelating Agents|chelating agents|mesh-ancestor
24690037|NCT01398618|Rifampin|rifampin|mesh-list
24639397|NCT01161277|Autonomic Agents|autonomic agents|mesh-ancestor
24638747|NCT01157858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24855525|NCT02279966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24638748|NCT01157936|Allopurinol|allopurinol|mesh-list
24638749|NCT01157936|Antimetabolites|antimetabolites|mesh-ancestor
24638802|NCT01158183|Antiviral Agents|antiviral agents|mesh-ancestor
24638803|NCT01158183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24638804|NCT01158183|Immunologic Factors|immunologic factors|mesh-ancestor
24638805|NCT01158183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638806|NCT01158183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24638807|NCT01158248|Panitumumab|panitumumab|mesh-list
24638809|NCT01158248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24638810|NCT01158274|Capecitabine|capecitabine|mesh-list
24638811|NCT01158274|R04929097|r04929097|mesh-list
24638812|NCT01158274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24638813|NCT01158274|Antimetabolites|antimetabolites|mesh-ancestor
24998403|NCT02960646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638814|NCT01158274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638815|NCT01158274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638816|NCT01158274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24638817|NCT01158287|Sorafenib|sorafenib|mesh-list
24638818|NCT01158287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638819|NCT01158287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24638820|NCT01158287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24638864|NCT01158846|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24638865|NCT01158846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24638866|NCT01158846|Purinergic Agents|purinergic agents|mesh-ancestor
24638867|NCT01158846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24638868|NCT01158846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638869|NCT01158846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638870|NCT01158846|Antithrombins|antithrombins|mesh-ancestor
24638871|NCT01158846|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24638872|NCT01158846|Protease Inhibitors|protease inhibitors|mesh-ancestor
24638873|NCT01158846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24638874|NCT01158846|Anticoagulants|anticoagulants|mesh-ancestor
24638875|NCT01158859|Pregabalin|pregabalin|mesh-list
24638876|NCT01158859|Analgesics|analgesics|mesh-ancestor
24638928|NCT01159236|Cyclophosphamide|cyclophosphamide|mesh-list
24638932|NCT01159236|Epirubicin|epirubicin|mesh-list
24639029|NCT01159639|Purinergic Agents|purinergic agents|mesh-ancestor
24639030|NCT01159639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24639031|NCT01159639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639032|NCT01159639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639034|NCT01159652|Zolpidem|zolpidem|mesh-list
24639035|NCT01159652|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24639036|NCT01159652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24639037|NCT01159652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24639038|NCT01159652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639039|NCT01159652|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24639063|NCT01159847|Incretins|incretins|mesh-ancestor
24639064|NCT01159847|Hormones|hormones|mesh-ancestor
24639065|NCT01159847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24855529|NCT02279966|Antidepressive Agents|antidepressive agents|mesh-ancestor
24855530|NCT02279966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24690232|NCT01400568|Fluticasone|fluticasone|mesh-list
24639112|NCT01160302|Curcumin|curcumin|mesh-list
25694908|NCT02038023|Iron-Dextran Complex|iron-dextran complex|mesh-list
25694909|NCT02038023|Trace Elements|trace elements|mesh-ancestor
24454688|NCT03797014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24639113|NCT01160302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24639114|NCT01160302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24639115|NCT01160302|Analgesics|analgesics|mesh-ancestor
24639116|NCT01160302|Sensory System Agents|sensory system agents|mesh-ancestor
24639117|NCT01160302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24639118|NCT01160302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639119|NCT01160302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24639120|NCT01160302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24639121|NCT01160302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639122|NCT01160302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639400|NCT01161277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24639184|NCT01160432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24639185|NCT01160432|Narcotics|narcotics|mesh-ancestor
24639186|NCT01160432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24639187|NCT01160432|Analgesics|analgesics|mesh-ancestor
24639223|NCT01160718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24639224|NCT01160718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639247|NCT01160900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639248|NCT01160900|Anticoagulants|anticoagulants|mesh-ancestor
24639250|NCT01160926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639251|NCT01160926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24639252|NCT01160926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639253|NCT01160926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639254|NCT01160952|Itraconazole|itraconazole|mesh-list
24639255|NCT01160952|Antifungal Agents|antifungal agents|mesh-ancestor
24639256|NCT01160952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24639257|NCT01160952|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24639258|NCT01160952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24639259|NCT01160952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639260|NCT01160952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855544|NCT02279992|Vasodilator Agents|vasodilator agents|mesh-ancestor
24855545|NCT02279992|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24855546|NCT02279992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24855547|NCT02279992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639304|NCT01161017|Amitriptyline|amitriptyline|mesh-list
24639305|NCT01161017|Anticonvulsants|anticonvulsants|mesh-ancestor
24639306|NCT01161017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24639307|NCT01161017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639308|NCT01161017|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24639309|NCT01161017|Antidepressive Agents|antidepressive agents|mesh-ancestor
24639337|NCT01161134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24639338|NCT01161134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639339|NCT01161134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24639340|NCT01161134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24639341|NCT01161134|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24639342|NCT01161134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24639343|NCT01161134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639344|NCT01161134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462842|NCT00357682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24639346|NCT01161147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24639347|NCT01161147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24639349|NCT01161147|Sensory System Agents|sensory system agents|mesh-ancestor
24639350|NCT01161147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24639351|NCT01161147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639352|NCT01161147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24639353|NCT01161147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24639354|NCT01161147|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24639355|NCT01161147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24639383|NCT01161277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24639384|NCT01161277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639386|NCT01161277|Dopamine Agents|dopamine agents|mesh-ancestor
24639387|NCT01161277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25694910|NCT02038023|Micronutrients|micronutrients|mesh-ancestor
25694911|NCT02038023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694912|NCT02038023|Anticoagulants|anticoagulants|mesh-ancestor
25694913|NCT02038023|Plasma Substitutes|plasma substitutes|mesh-ancestor
24920553|NCT04201769|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24920554|NCT04201769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24920555|NCT04201769|Serotonin Agents|serotonin agents|mesh-ancestor
24522292|NCT04004078|Miconazole|miconazole|mesh-list
24639388|NCT01161277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639389|NCT01161277|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24639390|NCT01161277|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24639391|NCT01161277|Serotonin Agents|serotonin agents|mesh-ancestor
24639392|NCT01161277|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24639393|NCT01161277|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24639394|NCT01161277|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24639395|NCT01161277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24639396|NCT01161277|Antiemetics|antiemetics|mesh-ancestor
24639402|NCT01161316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24639403|NCT01161316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639404|NCT01161368|Vinorelbine|vinorelbine|mesh-list
24639405|NCT01161368|Lapatinib|lapatinib|mesh-list
24639406|NCT01161368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24855572|NCT02280070|Oxaliplatin|oxaliplatin|mesh-list
24855573|NCT02280070|Antibodies|antibodies|mesh-list
24457962|NCT00335933|Gabapentin|gabapentin|mesh-list
24639446|NCT01161550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639447|NCT01161654|Naratriptan|naratriptan|mesh-list
24639448|NCT01161654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24639449|NCT01161654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24639450|NCT01161654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24639451|NCT01161654|Serotonin Agents|serotonin agents|mesh-ancestor
24639452|NCT01161654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24639453|NCT01161654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639454|NCT01161654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667128|NCT01322438|Rifampin|rifampin|mesh-list
24639455|NCT01161667|Naratriptan|naratriptan|mesh-list
24639537|NCT01162746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24639538|NCT01162746|Glucocorticoids|glucocorticoids|mesh-ancestor
24639539|NCT01162746|Hormones|hormones|mesh-ancestor
24639540|NCT01162746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24639541|NCT01162746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24639542|NCT01162746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639543|NCT01162746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24639544|NCT01162746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24639545|NCT01162746|Growth Substances|growth substances|mesh-ancestor
24639546|NCT01162746|Growth Inhibitors|growth inhibitors|mesh-ancestor
24639548|NCT01162824|Acetylcholine|acetylcholine|mesh-list
24639549|NCT01162824|Analgesics|analgesics|mesh-ancestor
24639585|NCT01162941|Prednisolone|prednisolone|mesh-list
24440750|NCT00284583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24440751|NCT00284583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855575|NCT02280070|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
24855576|NCT02280070|Immunologic Factors|immunologic factors|mesh-ancestor
24855577|NCT02280070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855578|NCT02280070|Antimetabolites|antimetabolites|mesh-ancestor
24855579|NCT02280070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855580|NCT02280070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24639624|NCT01163396|Oxaliplatin|oxaliplatin|mesh-list
24639626|NCT01163396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24639627|NCT01163396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639628|NCT01163396|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24639629|NCT01163396|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24639630|NCT01163396|Growth Substances|growth substances|mesh-ancestor
25694914|NCT02038023|Blood Substitutes|blood substitutes|mesh-ancestor
25694915|NCT02038023|Hematinics|hematinics|mesh-ancestor
25694916|NCT02038179|Allopurinol|allopurinol|mesh-list
24639631|NCT01163396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639632|NCT01163396|Growth Inhibitors|growth inhibitors|mesh-ancestor
25694917|NCT02038179|Antimetabolites|antimetabolites|mesh-ancestor
25694918|NCT02038179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694919|NCT02038179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25694920|NCT02038179|Gout Suppressants|gout suppressants|mesh-ancestor
25694921|NCT02038179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25694922|NCT02038179|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24639633|NCT01163396|Antimetabolites|antimetabolites|mesh-ancestor
24639634|NCT01163396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639635|NCT01163396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24639636|NCT01163396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24639637|NCT01163396|Immunologic Factors|immunologic factors|mesh-ancestor
24639638|NCT01163396|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24639674|NCT01163734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24639675|NCT01163734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24639676|NCT01163734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993856|NCT05335655|Analgesics|analgesics|mesh-ancestor
24639677|NCT01163799|Alefacept|alefacept|mesh-list
24639678|NCT01163799|Dermatologic Agents|dermatologic agents|mesh-ancestor
24639679|NCT01163799|Immunologic Factors|immunologic factors|mesh-ancestor
24639711|NCT01164046|Heparin|heparin|mesh-list
24639712|NCT01164046|Enoxaparin|enoxaparin|mesh-list
24639713|NCT01164046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24639823|NCT01164306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24639824|NCT01164306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639832|NCT01164488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24639833|NCT01164488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24639834|NCT01164488|Protease Inhibitors|protease inhibitors|mesh-ancestor
24639835|NCT01164488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639836|NCT01164488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639838|NCT01164488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24639839|NCT01164488|Antiviral Agents|antiviral agents|mesh-ancestor
24639840|NCT01164488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24639841|NCT01164488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24639842|NCT01164488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24639843|NCT01164488|Antifungal Agents|antifungal agents|mesh-ancestor
24855602|NCT02280109|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24855603|NCT02280109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24855604|NCT02280109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855605|NCT02280109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855606|NCT02280109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24855607|NCT02280109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24855608|NCT02280148|Propofol|propofol|mesh-list
24855609|NCT02280148|Anesthetics|anesthetics|mesh-ancestor
24457990|NCT00336154|Tetracycline|tetracycline|mesh-list
24639885|NCT01164774|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24639886|NCT01164774|Protease Inhibitors|protease inhibitors|mesh-ancestor
24639887|NCT01164774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639888|NCT01164774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639939|NCT01165060|Bezafibrate|bezafibrate|mesh-list
24640110|NCT01166048|Analgesics|analgesics|mesh-ancestor
24640111|NCT01166048|Sensory System Agents|sensory system agents|mesh-ancestor
24640112|NCT01166048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24640113|NCT01166048|Antidepressive Agents|antidepressive agents|mesh-ancestor
24640114|NCT01166048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24640137|NCT01166100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640138|NCT01166100|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24640139|NCT01166100|Antidepressive Agents|antidepressive agents|mesh-ancestor
24640140|NCT01166100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24640141|NCT01166100|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24640142|NCT01166100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24640143|NCT01166100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640144|NCT01166165|Cholecalciferol|cholecalciferol|mesh-list
25694924|NCT02038179|Protective Agents|protective agents|mesh-ancestor
25694925|NCT02038179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694926|NCT02038647|Paclitaxel|paclitaxel|mesh-list
25694927|NCT02038647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25694928|NCT02038647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694929|NCT02038647|Tubulin Modulators|tubulin modulators|mesh-ancestor
25694930|NCT02038647|Antimitotic Agents|antimitotic agents|mesh-ancestor
25694931|NCT02038647|Mitosis Modulators|mitosis modulators|mesh-ancestor
24801774|NCT01985724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25694932|NCT02038647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801775|NCT01985724|Alkylating Agents|alkylating agents|mesh-ancestor
24801776|NCT01985724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801777|NCT01985724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24801778|NCT01985724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24801779|NCT01985724|Tubulin Modulators|tubulin modulators|mesh-ancestor
24801780|NCT01985724|Antimitotic Agents|antimitotic agents|mesh-ancestor
24801781|NCT01985724|Mitosis Modulators|mitosis modulators|mesh-ancestor
24801782|NCT01985724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24561347|NCT00759551|Olmesartan|olmesartan|mesh-list
24640146|NCT01166165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24640192|NCT01166594|Growth Inhibitors|growth inhibitors|mesh-ancestor
24640194|NCT01166685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640195|NCT01166685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24640196|NCT01166685|Immunologic Factors|immunologic factors|mesh-ancestor
24640197|NCT01166685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640198|NCT01166711|Chromium|chromium|mesh-list
24695218|NCT04203472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24695219|NCT04203472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24695221|NCT04203472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24640199|NCT01166711|Paclitaxel|paclitaxel|mesh-list
24640200|NCT01166711|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24640201|NCT01166711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24640202|NCT01166711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640203|NCT01166711|Tubulin Modulators|tubulin modulators|mesh-ancestor
24640204|NCT01166711|Antimitotic Agents|antimitotic agents|mesh-ancestor
24640205|NCT01166711|Mitosis Modulators|mitosis modulators|mesh-ancestor
24642924|NCT01182142|Antimetabolites|antimetabolites|mesh-ancestor
24695222|NCT04203472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695223|NCT04203472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24695224|NCT04203472|Respiratory System Agents|respiratory system agents|mesh-ancestor
24640206|NCT01166711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640207|NCT01166711|Trace Elements|trace elements|mesh-ancestor
24640208|NCT01166711|Micronutrients|micronutrients|mesh-ancestor
24855640|NCT02280486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24855641|NCT02280486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640258|NCT01167062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640259|NCT01167062|Urological Agents|urological agents|mesh-ancestor
24640260|NCT01167101|Pantoprazole|pantoprazole|mesh-list
24640262|NCT01167101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24640263|NCT01167101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24855660|NCT02280525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855661|NCT02280525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24855662|NCT02280525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24458043|NCT00336362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24640298|NCT01167478|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24640299|NCT01167478|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24640300|NCT01167478|Purinergic Agents|purinergic agents|mesh-ancestor
24640301|NCT01167478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24640303|NCT01167530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640304|NCT01167530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24640305|NCT01167530|Immunologic Factors|immunologic factors|mesh-ancestor
24640306|NCT01167530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640307|NCT01167699|Oxycodone|oxycodone|mesh-list
24640308|NCT01167699|Naloxone|naloxone|mesh-list
24640309|NCT01167699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24640310|NCT01167699|Narcotics|narcotics|mesh-ancestor
24640311|NCT01167699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25694933|NCT02038790|Buprenorphine|buprenorphine|mesh-list
25694934|NCT02038790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25694935|NCT02038790|Naloxone|naloxone|mesh-list
25694936|NCT02038790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25694937|NCT02038790|Narcotics|narcotics|mesh-ancestor
25694938|NCT02038790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25694939|NCT02038790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694940|NCT02038790|Analgesics|analgesics|mesh-ancestor
25694941|NCT02038790|Sensory System Agents|sensory system agents|mesh-ancestor
25694942|NCT02038790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25694943|NCT02038790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24640312|NCT01167699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640313|NCT01167699|Analgesics|analgesics|mesh-ancestor
24640314|NCT01167699|Sensory System Agents|sensory system agents|mesh-ancestor
24640315|NCT01167699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24640316|NCT01167699|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24640317|NCT01167725|Leucovorin|leucovorin|mesh-list
24640318|NCT01167725|Bevacizumab|bevacizumab|mesh-list
24640319|NCT01167725|Cetuximab|cetuximab|mesh-list
24640320|NCT01167725|Fluorouracil|fluorouracil|mesh-list
24640321|NCT01167725|Capecitabine|capecitabine|mesh-list
24640322|NCT01167725|Oxaliplatin|oxaliplatin|mesh-list
24640323|NCT01167725|Irinotecan|irinotecan|mesh-list
24640324|NCT01167725|Mitomycins|mitomycins|mesh-list
24640350|NCT01167738|Metformin|metformin|mesh-list
24462844|NCT00357682|Sensory System Agents|sensory system agents|mesh-ancestor
24640363|NCT01167738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640364|NCT01167738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24640365|NCT01167738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24640366|NCT01167738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24640367|NCT01167738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24640368|NCT01167764|Tranexamic Acid|tranexamic acid|mesh-list
24640369|NCT01167764|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24640370|NCT01167764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24640371|NCT01167764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640372|NCT01167764|Hemostatics|hemostatics|mesh-ancestor
24640373|NCT01167764|Coagulants|coagulants|mesh-ancestor
24640395|NCT01167920|Angiotensin II|angiotensin ii|mesh-list
24640396|NCT01167920|Diuretics|diuretics|mesh-list
24640397|NCT01167920|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24640398|NCT01167920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24855663|NCT02280525|Alkylating Agents|alkylating agents|mesh-ancestor
24855664|NCT02280525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855665|NCT02280525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855666|NCT02280525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24640999|NCT01171170|Growth Inhibitors|growth inhibitors|mesh-ancestor
24855667|NCT02280525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24855668|NCT02280525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24855670|NCT02280525|Antiviral Agents|antiviral agents|mesh-ancestor
24855671|NCT02280525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24855672|NCT02280525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24855673|NCT02280525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24855674|NCT02280525|Growth Substances|growth substances|mesh-ancestor
24855675|NCT02280525|Growth Inhibitors|growth inhibitors|mesh-ancestor
24855676|NCT02280538|Hyaluronic Acid|hyaluronic acid|mesh-list
24640399|NCT01167920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640400|NCT01167920|Natriuretic Agents|natriuretic agents|mesh-ancestor
24640407|NCT01167933|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24640408|NCT01167933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24640409|NCT01167933|Antimetabolites|antimetabolites|mesh-ancestor
24640410|NCT01167933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640411|NCT01167933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24640412|NCT01167933|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24640413|NCT01167933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640414|NCT01167946|Methylprednisolone|methylprednisolone|mesh-list
24640415|NCT01167946|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24667564|NCT05384496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640416|NCT01167946|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24640417|NCT01167946|Prednisolone|prednisolone|mesh-list
24640418|NCT01167946|Prednisolone acetate|prednisolone acetate|mesh-list
24640419|NCT01167946|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24640420|NCT01167946|Prednisolone phosphate|prednisolone phosphate|mesh-list
24640421|NCT01167946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24640422|NCT01167946|Antiemetics|antiemetics|mesh-ancestor
24855685|NCT02280590|Antimetabolites|antimetabolites|mesh-ancestor
24458066|NCT00336414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640470|NCT01168440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640511|NCT01168531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24640512|NCT01168544|Vitamin D|vitamin d|mesh-list
24640513|NCT01168544|Ergocalciferols|ergocalciferols|mesh-list
24640514|NCT01168544|Cholecalciferol|cholecalciferol|mesh-list
24640515|NCT01168544|Vitamins|vitamins|mesh-list
24640516|NCT01168544|Micronutrients|micronutrients|mesh-ancestor
24640517|NCT01168544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694944|NCT02038881|Vaccines|vaccines|mesh-list
24640518|NCT01168544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24640520|NCT01168739|Quercetin|quercetin|mesh-list
24640741|NCT01169805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24640742|NCT01169805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24640743|NCT01169805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24640744|NCT01169805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24640745|NCT01169805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24640746|NCT01169818|Insulin Glargine|insulin glargine|mesh-list
24640747|NCT01169818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24640748|NCT01169818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640749|NCT01169857|Bortezomib|bortezomib|mesh-list
24640750|NCT01169857|Proteasome Inhibitors|proteasome inhibitors|mesh-list
24640751|NCT01169857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640752|NCT01169857|Protease Inhibitors|protease inhibitors|mesh-ancestor
24640753|NCT01169857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640787|NCT01170052|Antifungal Agents|antifungal agents|mesh-ancestor
24640788|NCT01170052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24640789|NCT01170052|Immunologic Factors|immunologic factors|mesh-ancestor
24640790|NCT01170052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640791|NCT01170078|Epoetin Alfa|epoetin alfa|mesh-list
24691235|NCT01405612|Midazolam|midazolam|mesh-list
24812795|NCT02054663|Purinergic Agents|purinergic agents|mesh-ancestor
24812796|NCT02054663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24812797|NCT02054663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812798|NCT02054663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812799|NCT02054676|Ibuprofen|ibuprofen|mesh-list
24640978|NCT01170871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640979|NCT01170871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24640980|NCT01170871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24640981|NCT01171092|Bortezomib|bortezomib|mesh-list
24640997|NCT01171170|Growth Substances|growth substances|mesh-ancestor
24640998|NCT01171170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641000|NCT01171170|Vasodilator Agents|vasodilator agents|mesh-ancestor
24641001|NCT01171209|Interferons|interferons|mesh-list
24641003|NCT01171209|Interferon-alpha|interferon-alpha|mesh-list
24641024|NCT01171378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641025|NCT01171456|Metformin|metformin|mesh-list
24641026|NCT01171456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24641027|NCT01171456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641028|NCT01171469|Imiquimod|imiquimod|mesh-list
24641029|NCT01171469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24641030|NCT01171469|Immunologic Factors|immunologic factors|mesh-ancestor
24641031|NCT01171469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641032|NCT01171469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641033|NCT01171469|Interferon Inducers|interferon inducers|mesh-ancestor
24641034|NCT01171482|Fluorouracil|fluorouracil|mesh-list
24641035|NCT01171482|Sorafenib|sorafenib|mesh-list
24641036|NCT01171482|Mitomycins|mitomycins|mesh-list
24641037|NCT01171482|Mitomycin|mitomycin|mesh-list
24641038|NCT01171482|Antimetabolites|antimetabolites|mesh-ancestor
24641039|NCT01171482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641040|NCT01171482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24641061|NCT01171755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641063|NCT01171755|Antiviral Agents|antiviral agents|mesh-ancestor
24645769|NCT01199757|Xhance|xhance|mesh-list
24641064|NCT01171755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24641065|NCT01171755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641066|NCT01171755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24641067|NCT01171755|Immunologic Factors|immunologic factors|mesh-ancestor
24691350|NCT01406197|Progesterone|progesterone|mesh-list
24812814|NCT02054793|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24641197|NCT01172405|Purinergic Agents|purinergic agents|mesh-ancestor
24641198|NCT01172405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25694945|NCT02038881|Immunologic Factors|immunologic factors|mesh-ancestor
25694946|NCT02038881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641199|NCT01172431|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24641200|NCT01172431|Indapamide|indapamide|mesh-list
24641201|NCT01172431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24855717|NCT02280694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25694947|NCT02038894|Propofol|propofol|mesh-list
24855719|NCT02280694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855720|NCT02280694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24641236|NCT01172509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641237|NCT01172509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24641238|NCT01172509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24641239|NCT01172509|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24641240|NCT01172509|GABA Agonists|gaba agonists|mesh-ancestor
24641242|NCT01172509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24641243|NCT01172509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641244|NCT01172548|Imatinib Mesylate|imatinib mesylate|mesh-list
24641245|NCT01172548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641246|NCT01172548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24641247|NCT01172548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641248|NCT01172548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641249|NCT01172626|Valproic Acid|valproic acid|mesh-list
24641250|NCT01172626|Anticonvulsants|anticonvulsants|mesh-ancestor
24641251|NCT01172626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641252|NCT01172626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641253|NCT01172626|GABA Agents|gaba agents|mesh-ancestor
24641254|NCT01172626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24641255|NCT01172626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641256|NCT01172626|Antimanic Agents|antimanic agents|mesh-ancestor
24641257|NCT01172626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24641258|NCT01172626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24641285|NCT01172691|Gasotransmitters|gasotransmitters|mesh-ancestor
24641286|NCT01172691|Protective Agents|protective agents|mesh-ancestor
24641287|NCT01172717|Panitumumab|panitumumab|mesh-list
24641288|NCT01172717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24641289|NCT01172717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641290|NCT01172756|Riociguat|riociguat|mesh-list
24641291|NCT01172756|Enzyme Activators|enzyme activators|mesh-ancestor
24641292|NCT01172756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641293|NCT01172769|Sirolimus|sirolimus|mesh-list
24641294|NCT01172769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
24641613|NCT01174472|Mitosis Modulators|mitosis modulators|mesh-ancestor
24691490|NCT01407211|Micronutrients|micronutrients|mesh-ancestor
24641304|NCT01172769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641305|NCT01172782|Hydromorphone|hydromorphone|mesh-list
24641340|NCT01172925|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24641341|NCT01172925|Respiratory System Agents|respiratory system agents|mesh-ancestor
24641342|NCT01172925|Parasympatholytics|parasympatholytics|mesh-ancestor
24641343|NCT01172925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24641344|NCT01172925|Cholinergic Agents|cholinergic agents|mesh-ancestor
24641345|NCT01172925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24641369|NCT01173003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24641371|NCT01173003|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24641372|NCT01173003|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24641374|NCT01173068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24641375|NCT01173068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24641376|NCT01173081|Teriparatide|teriparatide|mesh-list
24641377|NCT01173081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24994162|NCT04829799|Analgesics|analgesics|mesh-ancestor
24641378|NCT01173081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641380|NCT01173107|Colchicine|colchicine|mesh-list
24641381|NCT01173107|Gout Suppressants|gout suppressants|mesh-ancestor
24641382|NCT01173107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24641383|NCT01173107|Tubulin Modulators|tubulin modulators|mesh-ancestor
24641384|NCT01173107|Antimitotic Agents|antimitotic agents|mesh-ancestor
24641385|NCT01173107|Mitosis Modulators|mitosis modulators|mesh-ancestor
24641428|NCT01173549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24641429|NCT01173549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641430|NCT01173562|Mebendazole|mebendazole|mesh-list
24641441|NCT01173562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641442|NCT01173562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641445|NCT01173627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24691606|NCT01408160|Cytarabine|cytarabine|mesh-list
24641493|NCT01173926|Insulin Aspart|insulin aspart|mesh-list
24641511|NCT01173978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24641512|NCT01173978|Glucocorticoids|glucocorticoids|mesh-ancestor
24641513|NCT01173978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24641514|NCT01173978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641527|NCT01174056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24641529|NCT01174056|Analgesics|analgesics|mesh-ancestor
24641530|NCT01174056|Sensory System Agents|sensory system agents|mesh-ancestor
24641531|NCT01174056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24641532|NCT01174056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24641533|NCT01174056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24641534|NCT01174056|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24641535|NCT01174056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641536|NCT01174056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641537|NCT01174056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24855766|NCT02280876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24855767|NCT02280876|Antiviral Agents|antiviral agents|mesh-ancestor
24855768|NCT02280876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24855769|NCT02280993|Dexamethasone|dexamethasone|mesh-list
24641574|NCT01174290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24641575|NCT01174290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641576|NCT01174290|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24641603|NCT01174420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641605|NCT01174420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641606|NCT01174420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24855780|NCT02280993|Hormones|hormones|mesh-ancestor
24641607|NCT01174420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641608|NCT01174472|Paclitaxel|paclitaxel|mesh-list
24641609|NCT01174472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24641610|NCT01174472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641611|NCT01174472|Tubulin Modulators|tubulin modulators|mesh-ancestor
24641612|NCT01174472|Antimitotic Agents|antimitotic agents|mesh-ancestor
24641614|NCT01174472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641615|NCT01174524|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24691761|NCT01408979|Analgesics|analgesics|mesh-ancestor
24641659|NCT01174849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641660|NCT01174888|Cytarabine|cytarabine|mesh-list
24641661|NCT01174888|Etoposide|etoposide|mesh-list
24641662|NCT01174888|Podophyllotoxin|podophyllotoxin|mesh-list
24641663|NCT01174888|Mitoxantrone|mitoxantrone|mesh-list
24641664|NCT01174888|Bortezomib|bortezomib|mesh-list
24641665|NCT01174888|Etoposide phosphate|etoposide phosphate|mesh-list
24641666|NCT01174888|Midostaurin|midostaurin|mesh-list
24641667|NCT01174888|Staurosporine|staurosporine|mesh-list
24641668|NCT01174888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24641669|NCT01174888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641670|NCT01174888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24641671|NCT01174888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24641672|NCT01174888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641673|NCT01174888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641674|NCT01174888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24641675|NCT01174888|Antimetabolites|antimetabolites|mesh-ancestor
24691807|NCT01409174|Aldesleukin|aldesleukin|mesh-list
24641719|NCT01174914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24641720|NCT01174914|Protease Inhibitors|protease inhibitors|mesh-ancestor
24641721|NCT01174914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24641722|NCT01174914|Antimetabolites|antimetabolites|mesh-ancestor
24641723|NCT01174927|Heroin|heroin|mesh-list
24641724|NCT01174927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24641725|NCT01174927|Narcotics|narcotics|mesh-ancestor
25694948|NCT02038894|Sevoflurane|sevoflurane|mesh-list
25694949|NCT02038894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25694950|NCT02038894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25694951|NCT02038894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641726|NCT01174927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25694952|NCT02038894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24641776|NCT01175291|Bevacizumab|bevacizumab|mesh-list
24641777|NCT01175291|Fluorouracil|fluorouracil|mesh-list
24641778|NCT01175291|Oxaliplatin|oxaliplatin|mesh-list
24641817|NCT01175525|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
24641818|NCT01175525|Immunologic Factors|immunologic factors|mesh-ancestor
24641819|NCT01175525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641840|NCT01175746|Sensory System Agents|sensory system agents|mesh-ancestor
24641841|NCT01175746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24641842|NCT01175746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24641843|NCT01175746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24641844|NCT01175746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24641845|NCT01175746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688501|NCT03012672|Lenograstim|lenograstim|mesh-list
24641846|NCT01175746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24641847|NCT01175746|Vasodilator Agents|vasodilator agents|mesh-ancestor
24641848|NCT01175772|Celecoxib|celecoxib|mesh-list
24641849|NCT01175772|Methotrexate|methotrexate|mesh-list
24641850|NCT01175772|Cyclophosphamide|cyclophosphamide|mesh-list
24641851|NCT01175772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24641852|NCT01175772|Abortifacient Agents|abortifacient agents|mesh-ancestor
24641853|NCT01175772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24641854|NCT01175772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641855|NCT01175772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24641856|NCT01175772|Antimetabolites|antimetabolites|mesh-ancestor
24641857|NCT01175772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641858|NCT01175772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855832|NCT02281279|Immunologic Factors|immunologic factors|mesh-ancestor
24855833|NCT02281279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855834|NCT02281279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24855835|NCT02281279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25037558|NCT03536598|Antimetabolites|antimetabolites|mesh-ancestor
24458265|NCT00337298|Lisinopril|lisinopril|mesh-list
24641990|NCT01177176|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24641991|NCT01177176|Cholinergic Agents|cholinergic agents|mesh-ancestor
24641992|NCT01177176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24641993|NCT01177176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641994|NCT01177176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24641995|NCT01177176|Antidepressive Agents|antidepressive agents|mesh-ancestor
24641996|NCT01177176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24641997|NCT01177176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24641998|NCT01177176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24642040|NCT01177371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24642041|NCT01177371|Alkylating Agents|alkylating agents|mesh-ancestor
24642042|NCT01177371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642120|NCT01177683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24642121|NCT01177683|Alkylating Agents|alkylating agents|mesh-ancestor
24642143|NCT01177852|Histamine Antagonists|histamine antagonists|mesh-ancestor
24642145|NCT01177852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24642223|NCT01178320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24642224|NCT01178320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24642225|NCT01178320|Antimetabolites|antimetabolites|mesh-ancestor
24642226|NCT01178320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642227|NCT01178320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24642228|NCT01178320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24642229|NCT01178320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642254|NCT01178645|Antimetabolites|antimetabolites|mesh-ancestor
24642255|NCT01178645|Antiviral Agents|antiviral agents|mesh-ancestor
24642257|NCT01178645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24642258|NCT01178645|Immunologic Factors|immunologic factors|mesh-ancestor
24642259|NCT01178645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642260|NCT01178645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25694953|NCT02038894|Anesthetics, General|anesthetics, general|mesh-ancestor
25694954|NCT02038894|Anesthetics|anesthetics|mesh-ancestor
25694955|NCT02038894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25694956|NCT02038894|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25694957|NCT02038907|Vaccines|vaccines|mesh-list
25694958|NCT02038907|Immunologic Factors|immunologic factors|mesh-ancestor
25694959|NCT02038907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694960|NCT02038920|Vedolizumab|vedolizumab|mesh-list
24642261|NCT01178645|Alkylating Agents|alkylating agents|mesh-ancestor
24642262|NCT01178645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24642266|NCT01178658|Busulfan|busulfan|mesh-list
24642267|NCT01178658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24642268|NCT01178658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642269|NCT01178658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24855852|NCT02281305|Tubulin Modulators|tubulin modulators|mesh-ancestor
24642389|NCT01179152|Respiratory System Agents|respiratory system agents|mesh-ancestor
24642391|NCT01179152|Hormones|hormones|mesh-ancestor
24642392|NCT01179152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24642393|NCT01179152|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24642394|NCT01179152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24642395|NCT01179152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24642396|NCT01179152|Adrenergic Agents|adrenergic agents|mesh-ancestor
24642397|NCT01179152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24965150|NCT03778645|Mydriatics|mydriatics|mesh-ancestor
24642398|NCT01179152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642399|NCT01179230|Dipyridamole|dipyridamole|mesh-list
24642400|NCT01179230|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24642416|NCT01179256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642417|NCT01179269|Paclitaxel|paclitaxel|mesh-list
24642418|NCT01179269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24642419|NCT01179269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642420|NCT01179269|Tubulin Modulators|tubulin modulators|mesh-ancestor
24642422|NCT01179269|Mitosis Modulators|mitosis modulators|mesh-ancestor
24855871|NCT02281396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855872|NCT02281643|Doxycycline|doxycycline|mesh-list
24642437|NCT01179412|Blood Substitutes|blood substitutes|mesh-ancestor
24642438|NCT01179438|Dexmedetomidine|dexmedetomidine|mesh-list
24642439|NCT01179438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24642440|NCT01179438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24642441|NCT01179438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642442|NCT01179438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24642443|NCT01179438|Analgesics|analgesics|mesh-ancestor
24644220|NCT01189773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642444|NCT01179438|Sensory System Agents|sensory system agents|mesh-ancestor
24642445|NCT01179438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24642458|NCT01179464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24642482|NCT01179646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24642483|NCT01179646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24642484|NCT01179646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24642485|NCT01179646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642486|NCT01179646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642487|NCT01179659|Pantoprazole|pantoprazole|mesh-list
24642488|NCT01179659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24642489|NCT01179659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24642490|NCT01179659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24642491|NCT01179659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642492|NCT01179659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642494|NCT01179724|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24642495|NCT01179724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24642496|NCT01179724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24642497|NCT01179724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642498|NCT01179724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642500|NCT01179776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24642501|NCT01179776|Vasodilator Agents|vasodilator agents|mesh-ancestor
24642503|NCT01179828|Clobazam|clobazam|mesh-list
24642504|NCT01179828|Imipramine|imipramine|mesh-list
24642505|NCT01179828|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24642506|NCT01179828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24642507|NCT01179828|Narcotics|narcotics|mesh-ancestor
24642508|NCT01179828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24642509|NCT01179828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642510|NCT01179828|Analgesics|analgesics|mesh-ancestor
24642511|NCT01179828|Sensory System Agents|sensory system agents|mesh-ancestor
25694961|NCT02038920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25694962|NCT02038933|Nivolumab|nivolumab|mesh-list
25694963|NCT02038933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25694964|NCT02038933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694965|NCT02038933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24642513|NCT01179828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24642514|NCT01179828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24642515|NCT01179828|Cholinergic Agents|cholinergic agents|mesh-ancestor
24642516|NCT01179828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24642542|NCT01179971|Antimetabolites|antimetabolites|mesh-ancestor
24642543|NCT01179971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855896|NCT02281682|Interferon Inducers|interferon inducers|mesh-ancestor
24855897|NCT02281682|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24855898|NCT02281682|Dermatologic Agents|dermatologic agents|mesh-ancestor
24855900|NCT02281708|Vinorelbine|vinorelbine|mesh-list
24855901|NCT02281708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642559|NCT01180075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24642560|NCT01180075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24642561|NCT01180075|Antiviral Agents|antiviral agents|mesh-ancestor
24668150|NCT05070039|Antibodies|antibodies|mesh-list
24642562|NCT01180075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24642563|NCT01180075|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24642564|NCT01180075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24642565|NCT01180075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24642575|NCT01180166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24642576|NCT01180166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642577|NCT01180179|Lansoprazole|lansoprazole|mesh-list
24642578|NCT01180179|Dexlansoprazole|dexlansoprazole|mesh-list
24642579|NCT01180179|Famotidine|famotidine|mesh-list
24642580|NCT01180179|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24642581|NCT01180179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24642582|NCT01180179|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24642583|NCT01180179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642584|NCT01180179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642585|NCT01180179|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24642586|NCT01180179|Histamine Antagonists|histamine antagonists|mesh-ancestor
24642587|NCT01180179|Histamine Agents|histamine agents|mesh-ancestor
24642588|NCT01180179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24642589|NCT01180179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642590|NCT01180205|Amlodipine|amlodipine|mesh-list
24642591|NCT01180205|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24642592|NCT01180205|Telmisartan|telmisartan|mesh-list
24642593|NCT01180205|Olmesartan|olmesartan|mesh-list
24642602|NCT01180205|Diuretics|diuretics|mesh-ancestor
24642603|NCT01180205|Natriuretic Agents|natriuretic agents|mesh-ancestor
24642604|NCT01180205|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24642605|NCT01180205|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24642606|NCT01180205|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24642607|NCT01180231|Moxonidine|moxonidine|mesh-list
24642608|NCT01180231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24642609|NCT01180322|Cytarabine|cytarabine|mesh-list
24642610|NCT01180322|Etoposide|etoposide|mesh-list
24642611|NCT01180322|Idarubicin|idarubicin|mesh-list
24642612|NCT01180322|Azacitidine|azacitidine|mesh-list
24642613|NCT01180322|Lenograstim|lenograstim|mesh-list
24642655|NCT01180413|Protease Inhibitors|protease inhibitors|mesh-ancestor
24642656|NCT01180413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25694966|NCT02038933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694967|NCT02039115|Prednisone|prednisone|mesh-list
25694968|NCT02039115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25694969|NCT02039115|Glucocorticoids|glucocorticoids|mesh-ancestor
25694970|NCT02039115|Hormones|hormones|mesh-ancestor
25694971|NCT02039115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25694972|NCT02039115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25694973|NCT02039115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24642658|NCT01180426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462847|NCT00357682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24642659|NCT01180426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642661|NCT01180569|Immunologic Factors|immunologic factors|mesh-ancestor
24642662|NCT01180569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642663|NCT01180569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24692488|NCT01414608|Paclitaxel|paclitaxel|mesh-list
24642768|NCT01181310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642769|NCT01181310|Nootropic Agents|nootropic agents|mesh-ancestor
24642770|NCT01181310|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24642771|NCT01181310|Antiemetics|antiemetics|mesh-ancestor
24642772|NCT01181310|Autonomic Agents|autonomic agents|mesh-ancestor
24642773|NCT01181310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24642774|NCT01181310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24642775|NCT01181310|Mydriatics|mydriatics|mesh-ancestor
24642776|NCT01181310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24642777|NCT01181310|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24642778|NCT01181310|Parasympatholytics|parasympatholytics|mesh-ancestor
24642801|NCT01181414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24642802|NCT01181414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24642803|NCT01181414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642804|NCT01181414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24642819|NCT01181505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642820|NCT01181505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642821|NCT01181505|Urological Agents|urological agents|mesh-ancestor
24642822|NCT01181544|Heparin|heparin|mesh-list
24642823|NCT01181544|Anticoagulants|anticoagulants|mesh-ancestor
24642824|NCT01181544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24642825|NCT01181544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24894481|NCT04440267|Antimetabolites|antimetabolites|mesh-ancestor
24642826|NCT01181544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642827|NCT01181570|Adalimumab|adalimumab|mesh-list
24642828|NCT01181570|Mannitol|mannitol|mesh-list
24642829|NCT01181570|Citric Acid|citric acid|mesh-list
24642943|NCT01182246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642944|NCT01182246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24642945|NCT01182246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642946|NCT01182246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642947|NCT01182246|Phytoestrogens|phytoestrogens|mesh-ancestor
24642948|NCT01182246|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24642949|NCT01182246|Estrogens|estrogens|mesh-ancestor
24642950|NCT01182246|Hormones|hormones|mesh-ancestor
24642951|NCT01182246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24642952|NCT01182272|Sorafenib|sorafenib|mesh-list
24642953|NCT01182272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642954|NCT01182272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24642955|NCT01182272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642956|NCT01182272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642957|NCT01182597|Pantoprazole|pantoprazole|mesh-list
24642975|NCT01182662|Cyclosporine|cyclosporine|mesh-list
24642977|NCT01182662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643010|NCT01183247|Sirolimus|sirolimus|mesh-list
24643206|NCT01184443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24643207|NCT01184443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643208|NCT01184443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24643209|NCT01184443|Serotonin Agents|serotonin agents|mesh-ancestor
24643211|NCT01184482|Lapatinib|lapatinib|mesh-list
24643212|NCT01184482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24643268|NCT01184833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24643269|NCT01184833|Immunologic Factors|immunologic factors|mesh-ancestor
24643270|NCT01184833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643271|NCT01184833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24643273|NCT01184911|Sulfadoxine|sulfadoxine|mesh-list
24855931|NCT02281929|Glucocorticoids|glucocorticoids|mesh-ancestor
24855933|NCT02281929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24855934|NCT02281929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855935|NCT02281929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24643419|NCT01185535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24643420|NCT01185535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643448|NCT01185743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24643449|NCT01185743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24643450|NCT01185743|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24830788|NCT02161367|Dermatologic Agents|dermatologic agents|mesh-ancestor
24830789|NCT02161614|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24830790|NCT02161614|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24830791|NCT02161614|Estradiol|estradiol|mesh-list
24830792|NCT02161614|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24830793|NCT02161614|Estrogens|estrogens|mesh-ancestor
24643457|NCT01185743|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24643458|NCT01185743|Dopamine Agents|dopamine agents|mesh-ancestor
24643459|NCT01185769|Tocotrienols|tocotrienols|mesh-list
24643461|NCT01185769|Tocopherols|tocopherols|mesh-list
24643462|NCT01185769|Antioxidants|antioxidants|mesh-ancestor
24643642|NCT01186471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643643|NCT01186471|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24643770|NCT01187212|Antimetabolites|antimetabolites|mesh-ancestor
24643771|NCT01187212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643772|NCT01187212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24643773|NCT01187212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643805|NCT01187485|Testosterone enanthate|testosterone enanthate|mesh-list
24643806|NCT01187485|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24643808|NCT01187485|Hormones|hormones|mesh-ancestor
24643809|NCT01187485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24643810|NCT01187485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643811|NCT01187485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24643812|NCT01187485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24643813|NCT01187485|Anabolic Agents|anabolic agents|mesh-ancestor
24643815|NCT01187537|Anesthetics, Local|anesthetics, local|mesh-ancestor
24965316|NCT03777930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24772180|NCT01832311|Ketorolac|ketorolac|mesh-list
24855949|NCT02281968|Gout Suppressants|gout suppressants|mesh-ancestor
24643886|NCT01187862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24693011|NCT01417806|Topotecan|topotecan|mesh-list
24644205|NCT01189721|Anesthetics, General|anesthetics, general|mesh-ancestor
24644207|NCT01189721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24644208|NCT01189721|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24644210|NCT01189773|Codeine|codeine|mesh-list
24644218|NCT01189773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24644219|NCT01189773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24830794|NCT02161614|Hormones|hormones|mesh-ancestor
25694974|NCT02039115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694975|NCT02039427|Dexamethasone|dexamethasone|mesh-list
25694976|NCT02039427|Ketorolac|ketorolac|mesh-list
25694977|NCT02039427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25694978|NCT02039427|Antiemetics|antiemetics|mesh-ancestor
25694979|NCT02039427|Autonomic Agents|autonomic agents|mesh-ancestor
25694980|NCT02039427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25694981|NCT02039427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730287|NCT01627262|Mesalamine|mesalamine|mesh-list
25694982|NCT02039427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25694983|NCT02039427|Glucocorticoids|glucocorticoids|mesh-ancestor
24921489|NCT04190745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921490|NCT04190745|Tubulin Modulators|tubulin modulators|mesh-ancestor
24921491|NCT04190745|Antimitotic Agents|antimitotic agents|mesh-ancestor
24921492|NCT04190745|Mitosis Modulators|mitosis modulators|mesh-ancestor
24644221|NCT01189773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644222|NCT01189773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24644223|NCT01189773|Narcotics|narcotics|mesh-ancestor
24644224|NCT01189773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24644225|NCT01189773|Antitussive Agents|antitussive agents|mesh-ancestor
24644226|NCT01189773|Respiratory System Agents|respiratory system agents|mesh-ancestor
24644227|NCT01189864|Diclofenac|diclofenac|mesh-list
24644228|NCT01189864|Prednisolone acetate|prednisolone acetate|mesh-list
24644229|NCT01189864|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24644230|NCT01189864|Methylprednisolone|methylprednisolone|mesh-list
24644231|NCT01189864|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24644232|NCT01189864|Prednisolone|prednisolone|mesh-list
24644233|NCT01189864|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24668450|NCT04918147|Analgesics|analgesics|mesh-ancestor
24644234|NCT01189864|Prednisolone phosphate|prednisolone phosphate|mesh-list
24644235|NCT01189864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24644236|NCT01189864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24644237|NCT01189864|Analgesics|analgesics|mesh-ancestor
24644238|NCT01189864|Sensory System Agents|sensory system agents|mesh-ancestor
24440968|NCT00285428|Immunologic Factors|immunologic factors|mesh-ancestor
24440969|NCT00285428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440970|NCT00285428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440971|NCT00285493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24440972|NCT00285493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24644239|NCT01189864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24644240|NCT01189864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644241|NCT01189864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24644357|NCT01190462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24644358|NCT01190462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644359|NCT01190553|Amantadine|amantadine|mesh-list
24644360|NCT01190553|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24644361|NCT01190553|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24644362|NCT01190553|Antiviral Agents|antiviral agents|mesh-ancestor
24644363|NCT01190553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24644364|NCT01190553|Dopamine Agents|dopamine agents|mesh-ancestor
24855968|NCT02282085|Antipsychotic Agents|antipsychotic agents|mesh-list
24855969|NCT02282085|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
24644365|NCT01190553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24644366|NCT01190553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644367|NCT01190553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644368|NCT01190553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24644370|NCT01190553|Sensory System Agents|sensory system agents|mesh-ancestor
24644371|NCT01190553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24644372|NCT01190670|Tacrolimus|tacrolimus|mesh-list
24644392|NCT01190683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644393|NCT01190683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24644395|NCT01190722|Etoricoxib|etoricoxib|mesh-list
24644428|NCT01190748|Nootropic Agents|nootropic agents|mesh-ancestor
24644429|NCT01190761|Galantamine|galantamine|mesh-list
24644430|NCT01190761|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24644443|NCT01190982|Tubulin Modulators|tubulin modulators|mesh-ancestor
25694984|NCT02039427|Hormones|hormones|mesh-ancestor
25694985|NCT02039427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25694986|NCT02039427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25694987|NCT02039427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25694988|NCT02039427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24644444|NCT01190982|Antimitotic Agents|antimitotic agents|mesh-ancestor
25694989|NCT02039427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25694990|NCT02039427|Analgesics|analgesics|mesh-ancestor
25694991|NCT02039427|Sensory System Agents|sensory system agents|mesh-ancestor
25694992|NCT02039427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24644477|NCT01191203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24644478|NCT01191203|Contraceptive Agents|contraceptive agents|mesh-ancestor
24644479|NCT01191203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24668491|NCT04892706|Analgesics|analgesics|mesh-ancestor
24644480|NCT01191203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24644481|NCT01191203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24644482|NCT01191203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24644483|NCT01191203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24644484|NCT01191203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644485|NCT01191216|Docetaxel|docetaxel|mesh-list
24644487|NCT01191216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644488|NCT01191216|Tubulin Modulators|tubulin modulators|mesh-ancestor
24644489|NCT01191216|Antimitotic Agents|antimitotic agents|mesh-ancestor
24644490|NCT01191216|Mitosis Modulators|mitosis modulators|mesh-ancestor
24693293|NCT01419366|Nootropic Agents|nootropic agents|mesh-ancestor
24644524|NCT01191554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644526|NCT01191554|Coagulants|coagulants|mesh-ancestor
24644527|NCT01191593|Ropivacaine|ropivacaine|mesh-list
24644528|NCT01191593|Anesthetics, Local|anesthetics, local|mesh-ancestor
24644529|NCT01191593|Anesthetics|anesthetics|mesh-ancestor
24644530|NCT01191593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24644531|NCT01191593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644532|NCT01191593|Sensory System Agents|sensory system agents|mesh-ancestor
24644533|NCT01191593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24830798|NCT02161614|Contraceptive Agents|contraceptive agents|mesh-ancestor
24644534|NCT01191645|Remifentanil|remifentanil|mesh-list
24644535|NCT01191645|Metoclopramide|metoclopramide|mesh-list
24644537|NCT01191645|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24644538|NCT01191645|Narcotics|narcotics|mesh-ancestor
24644539|NCT01191645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24644540|NCT01191645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644541|NCT01191645|Analgesics|analgesics|mesh-ancestor
24644542|NCT01191645|Sensory System Agents|sensory system agents|mesh-ancestor
24644544|NCT01191645|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24644546|NCT01191645|Autonomic Agents|autonomic agents|mesh-ancestor
24644547|NCT01191645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24644548|NCT01191645|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24440974|NCT00285519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24644549|NCT01191645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24644550|NCT01191645|Dopamine Agents|dopamine agents|mesh-ancestor
24644571|NCT01191710|Progestins|progestins|mesh-ancestor
24644572|NCT01191710|Hormones|hormones|mesh-ancestor
24855971|NCT02282085|Serotonin Agents|serotonin agents|mesh-ancestor
25694993|NCT02039427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25694994|NCT02039427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25694995|NCT02039427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25694996|NCT02039505|Vedolizumab|vedolizumab|mesh-list
25694997|NCT02039505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25694998|NCT02039674|Paclitaxel|paclitaxel|mesh-list
25694999|NCT02039674|Bevacizumab|bevacizumab|mesh-list
25695000|NCT02039674|Carboplatin|carboplatin|mesh-list
24855972|NCT02282085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25695001|NCT02039674|Pembrolizumab|pembrolizumab|mesh-list
24458392|NCT00337740|Adrenergic Agents|adrenergic agents|mesh-ancestor
24644573|NCT01191710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24644574|NCT01191710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644575|NCT01191892|Gemcitabine|gemcitabine|mesh-list
24644576|NCT01191892|Carboplatin|carboplatin|mesh-list
24644577|NCT01191892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644578|NCT01191892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24693343|NCT01419821|Vitamin D|vitamin d|mesh-list
24644735|NCT01192763|R04929097|r04929097|mesh-list
24644736|NCT01192763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966028|NCT03771846|Irinotecan|irinotecan|mesh-list
24644737|NCT01192763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644738|NCT01192789|Amoxicillin|amoxicillin|mesh-list
24644739|NCT01192789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24644740|NCT01192789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24644741|NCT01192802|Albendazole|albendazole|mesh-list
24644742|NCT01192802|Anthelmintics|anthelmintics|mesh-ancestor
24644743|NCT01192802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24644744|NCT01192802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24644745|NCT01192802|Anticestodal Agents|anticestodal agents|mesh-ancestor
24644746|NCT01192802|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24644747|NCT01192802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24645066|NCT01195324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645342|NCT01197781|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24645343|NCT01197781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24645370|NCT01198106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645371|NCT01198106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24830805|NCT02161653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24830806|NCT02161653|Glucocorticoids|glucocorticoids|mesh-ancestor
24830807|NCT02161653|Hormones|hormones|mesh-ancestor
24830808|NCT02161653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24830809|NCT02161653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645372|NCT01198106|Mydriatics|mydriatics|mesh-ancestor
24645373|NCT01198106|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24645375|NCT01198106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24645376|NCT01198106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645377|NCT01198106|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24645378|NCT01198106|Parasympatholytics|parasympatholytics|mesh-ancestor
24645379|NCT01198106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24645380|NCT01198106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24645381|NCT01198106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24645451|NCT01198249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24645452|NCT01198249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645454|NCT01198249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24645455|NCT01198249|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24645456|NCT01198249|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24645457|NCT01198249|Diuretics|diuretics|mesh-ancestor
24645767|NCT01199614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24645772|NCT01199757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24645773|NCT01199757|Autonomic Agents|autonomic agents|mesh-ancestor
24645774|NCT01199757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24645775|NCT01199757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645776|NCT01199757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24645777|NCT01199757|Respiratory System Agents|respiratory system agents|mesh-ancestor
24645778|NCT01199757|Dermatologic Agents|dermatologic agents|mesh-ancestor
24645779|NCT01199757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24645780|NCT01199783|Vancomycin|vancomycin|mesh-list
24645781|NCT01199783|Daptomycin|daptomycin|mesh-list
24693593|NCT01421212|Antibodies|antibodies|mesh-list
24645841|NCT01200212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24645842|NCT01200212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24645843|NCT01200212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24645844|NCT01200212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24645845|NCT01200212|Growth Substances|growth substances|mesh-ancestor
24830823|NCT02161653|Vitamins|vitamins|mesh-ancestor
24830824|NCT02161653|Micronutrients|micronutrients|mesh-ancestor
24830825|NCT02161679|Carboplatin|carboplatin|mesh-list
24830826|NCT02161679|Camptothecin|camptothecin|mesh-list
24645846|NCT01200212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695002|NCT02039674|Pemetrexed|pemetrexed|mesh-list
25695003|NCT02039674|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25695004|NCT02039674|Ipilimumab|ipilimumab|mesh-list
24623114|NCT01070277|Albendazole|albendazole|mesh-list
24623115|NCT01070277|Tinidazole|tinidazole|mesh-list
24623116|NCT01070277|Anthelmintics|anthelmintics|mesh-ancestor
25079067|NCT03350659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24623382|NCT01071161|Azithromycin|azithromycin|mesh-list
24921974|NCT04185103|Valsartan|valsartan|mesh-list
24645847|NCT01200212|Growth Inhibitors|growth inhibitors|mesh-ancestor
24645848|NCT01200251|Bimatoprost|bimatoprost|mesh-list
24645849|NCT01200251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24645850|NCT01200264|Apremilast|apremilast|mesh-list
24645851|NCT01200264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24645852|NCT01200264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24812858|NCT02054975|Vitamins|vitamins|mesh-list
24812859|NCT02054975|Micronutrients|micronutrients|mesh-ancestor
24812860|NCT02054975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812861|NCT02054975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24812862|NCT02054975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24812863|NCT02054988|Caffeine|caffeine|mesh-list
24812864|NCT02054988|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24812866|NCT02054988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24812869|NCT02054988|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24812870|NCT02054988|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24812871|NCT02054988|Purinergic Agents|purinergic agents|mesh-ancestor
24812872|NCT02054988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24812873|NCT02055014|Liraglutide|liraglutide|mesh-list
24677683|NCT01357811|Digoxin|digoxin|mesh-list
24856012|NCT02282150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24856013|NCT02282176|Azithromycin|azithromycin|mesh-list
24856014|NCT02282176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24856015|NCT02282176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24856032|NCT02282280|Sensory System Agents|sensory system agents|mesh-ancestor
24856033|NCT02282280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24693798|NCT01422317|Vitamin E|vitamin e|mesh-list
24645974|NCT01201044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645975|NCT01201044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24645976|NCT01201044|Antiviral Agents|antiviral agents|mesh-ancestor
24645977|NCT01201044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24645978|NCT01201044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24645979|NCT01201044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24645980|NCT01201044|Immunologic Factors|immunologic factors|mesh-ancestor
24645981|NCT01201044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645983|NCT01201070|Antithrombin III|antithrombin iii|mesh-list
24645984|NCT01201070|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24645985|NCT01201070|Protease Inhibitors|protease inhibitors|mesh-ancestor
24645986|NCT01201070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830827|NCT02161679|Immunoconjugates|immunoconjugates|mesh-list
24830828|NCT02161679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24645987|NCT01201070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645988|NCT01201070|Anticoagulants|anticoagulants|mesh-ancestor
24463138|NCT00359125|Mifepristone|mifepristone|mesh-list
24645989|NCT01201122|Mesalamine|mesalamine|mesh-list
24646128|NCT01202097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24646129|NCT01202097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24646130|NCT01202097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24646131|NCT01202097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24646132|NCT01202097|Adrenergic Agents|adrenergic agents|mesh-ancestor
24646133|NCT01202097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25695005|NCT02039674|Gefitinib|gefitinib|mesh-list
25695006|NCT02039674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25695007|NCT02039674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25695008|NCT02039674|Tubulin Modulators|tubulin modulators|mesh-ancestor
25695009|NCT02039674|Antimitotic Agents|antimitotic agents|mesh-ancestor
25695010|NCT02039674|Mitosis Modulators|mitosis modulators|mesh-ancestor
25695011|NCT02039674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695012|NCT02039674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24646134|NCT01202097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801960|NCT01986582|Oxymetazoline|oxymetazoline|mesh-list
24801961|NCT01986582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24646162|NCT01202240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646163|NCT01202240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24646164|NCT01202240|Hormone Antagonists|hormone antagonists|mesh-ancestor
24646165|NCT01202240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24646166|NCT01202240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646167|NCT01202240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24856205|NCT02283177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24856206|NCT02283177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24856207|NCT02283177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24856208|NCT02283177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856209|NCT02283190|Asparaginase|asparaginase|mesh-list
24856210|NCT02283190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24856211|NCT02283203|Acetaminophen|acetaminophen|mesh-list
24856212|NCT02283203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24856213|NCT02283203|Analgesics|analgesics|mesh-ancestor
24856214|NCT02283203|Sensory System Agents|sensory system agents|mesh-ancestor
24694008|NCT01423305|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24646272|NCT01202890|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24646273|NCT01202890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24646274|NCT01202890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24856215|NCT02283203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24856216|NCT02283203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856218|NCT02283242|Galantamine|galantamine|mesh-list
24856219|NCT02283242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24856220|NCT02283242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856222|NCT02283242|Cholinergic Agents|cholinergic agents|mesh-ancestor
24856224|NCT02283242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856225|NCT02283242|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24856226|NCT02283242|Autonomic Agents|autonomic agents|mesh-ancestor
24856227|NCT02283242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24646275|NCT01202890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24646288|NCT01203020|Fludarabine phosphate|fludarabine phosphate|mesh-list
24646289|NCT01203020|Busulfan|busulfan|mesh-list
24694022|NCT01423435|Vasodilator Agents|vasodilator agents|mesh-ancestor
24856228|NCT02283242|Nootropic Agents|nootropic agents|mesh-ancestor
24856229|NCT02283320|Docetaxel|docetaxel|mesh-list
24856230|NCT02283320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24856231|NCT02283320|Tubulin Modulators|tubulin modulators|mesh-ancestor
24856232|NCT02283320|Antimitotic Agents|antimitotic agents|mesh-ancestor
24856233|NCT02283320|Mitosis Modulators|mitosis modulators|mesh-ancestor
24856234|NCT02283320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856235|NCT02283359|Irinotecan|irinotecan|mesh-list
24856236|NCT02283359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24856237|NCT02283359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24856238|NCT02283359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856239|NCT02283359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856240|NCT02283359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24856241|NCT02283372|Gemcitabine|gemcitabine|mesh-list
24856242|NCT02283372|Paclitaxel|paclitaxel|mesh-list
24856243|NCT02283372|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24856244|NCT02283372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24856245|NCT02283372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24856246|NCT02283372|Tubulin Modulators|tubulin modulators|mesh-ancestor
24856247|NCT02283372|Antimitotic Agents|antimitotic agents|mesh-ancestor
25695013|NCT02039674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25695014|NCT02039674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25695015|NCT02039674|Growth Substances|growth substances|mesh-ancestor
25695016|NCT02039674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695017|NCT02039674|Growth Inhibitors|growth inhibitors|mesh-ancestor
25695018|NCT02039674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25695019|NCT02039674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25695020|NCT02039674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24856248|NCT02283372|Mitosis Modulators|mitosis modulators|mesh-ancestor
24856249|NCT02283372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856250|NCT02283372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24856251|NCT02283372|Antimetabolites|antimetabolites|mesh-ancestor
24856252|NCT02283372|Antiviral Agents|antiviral agents|mesh-ancestor
24856261|NCT02283424|Tubulin Modulators|tubulin modulators|mesh-ancestor
24646334|NCT01203254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24646335|NCT01203254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24646336|NCT01203254|Antimetabolites|antimetabolites|mesh-ancestor
24646393|NCT01203384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646394|NCT01203384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646395|NCT01203488|Vitamin A|vitamin a|mesh-list
24646396|NCT01203488|Vitamins|vitamins|mesh-ancestor
24856262|NCT02283424|Antimitotic Agents|antimitotic agents|mesh-ancestor
24856263|NCT02283424|Mitosis Modulators|mitosis modulators|mesh-ancestor
24646497|NCT01204125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24646499|NCT01204125|Antimitotic Agents|antimitotic agents|mesh-ancestor
24646500|NCT01204125|Mitosis Modulators|mitosis modulators|mesh-ancestor
24646518|NCT01204164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24856354|NCT02283866|Anesthetics|anesthetics|mesh-ancestor
24856355|NCT02283866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24856356|NCT02283866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856357|NCT02283905|Voriconazole|voriconazole|mesh-list
24856358|NCT02283905|Amphotericin B|amphotericin b|mesh-list
24856359|NCT02283905|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24856360|NCT02283905|Antifungal Agents|antifungal agents|mesh-ancestor
24856361|NCT02283905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24856362|NCT02283905|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24856363|NCT02283905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24856364|NCT02283905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856365|NCT02283905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856366|NCT02283905|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24856367|NCT02283905|Hormone Antagonists|hormone antagonists|mesh-ancestor
24856368|NCT02283905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24856369|NCT02283905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812959|NCT02055456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24812960|NCT02055456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812962|NCT02055456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24812963|NCT02055482|Darbepoetin alfa|darbepoetin alfa|mesh-list
24812964|NCT02055482|Hematinics|hematinics|mesh-ancestor
24812965|NCT02055586|Alovudine|alovudine|mesh-list
24812966|NCT02055586|Fluorides|fluorides|mesh-list
24812967|NCT02055586|Cariostatic Agents|cariostatic agents|mesh-ancestor
24612566|NCT01014481|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24648919|NCT01217398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24695877|NCT01426100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24695881|NCT01426165|Magnesium Sulfate|magnesium sulfate|mesh-list
24649432|NCT01219764|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24649433|NCT01219816|Epratuzumab|epratuzumab|mesh-list
24649434|NCT01219816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24649435|NCT01219816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649436|NCT01219907|Cyclophosphamide|cyclophosphamide|mesh-list
24696042|NCT01427114|Rituximab|rituximab|mesh-list
24612653|NCT01014832|Insulin|insulin|mesh-list
24649725|NCT01221740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650080|NCT01223742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650081|NCT01223742|Nootropic Agents|nootropic agents|mesh-ancestor
24650082|NCT01223755|Sirolimus|sirolimus|mesh-list
24650083|NCT01223755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24650967|NCT01228617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650968|NCT01228617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24650969|NCT01228617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24650970|NCT01228617|Cholinergic Agents|cholinergic agents|mesh-ancestor
24650971|NCT01228617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25709360|NCT02265510|Hormones|hormones|mesh-ancestor
24650972|NCT01228617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650973|NCT01228630|Loratadine|loratadine|mesh-list
24651125|NCT01229605|Tubulin Modulators|tubulin modulators|mesh-ancestor
24651332|NCT01231113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651333|NCT01231113|Antiviral Agents|antiviral agents|mesh-ancestor
24651334|NCT01231113|Schistosomicides|schistosomicides|mesh-ancestor
24651335|NCT01231113|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24651336|NCT01231113|Anthelmintics|anthelmintics|mesh-ancestor
24651338|NCT01231126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24812991|NCT02055703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812992|NCT02055703|Nootropic Agents|nootropic agents|mesh-ancestor
24651625|NCT01232439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651626|NCT01232439|Sensory System Agents|sensory system agents|mesh-ancestor
24651627|NCT01232439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24651628|NCT01232439|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24651688|NCT01233245|Interferon beta-1b|interferon beta-1b|mesh-list
24651689|NCT01233245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651690|NCT01233245|Antiviral Agents|antiviral agents|mesh-ancestor
24651691|NCT01233245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24651692|NCT01233245|Immunologic Factors|immunologic factors|mesh-ancestor
24651693|NCT01233245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651694|NCT01233245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24651696|NCT01233362|Immunologic Factors|immunologic factors|mesh-ancestor
24651735|NCT01233583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24651945|NCT01234792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651947|NCT01234818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24651948|NCT01234818|Contraceptive Agents|contraceptive agents|mesh-ancestor
24651949|NCT01234818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24651950|NCT01234818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651951|NCT01234818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24651952|NCT01234818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24651953|NCT01234818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24651954|NCT01234857|Sirolimus|sirolimus|mesh-list
24651955|NCT01234857|Exemestane|exemestane|mesh-list
24651956|NCT01234857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24652057|NCT01235455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652058|NCT01235455|Antiviral Agents|antiviral agents|mesh-ancestor
24652059|NCT01235455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24652060|NCT01235455|Immunologic Factors|immunologic factors|mesh-ancestor
24652061|NCT01235455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652062|NCT01235455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24652065|NCT01235637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24652066|NCT01235637|Narcotics|narcotics|mesh-ancestor
24652068|NCT01235637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652069|NCT01235637|Analgesics|analgesics|mesh-ancestor
24652070|NCT01235637|Sensory System Agents|sensory system agents|mesh-ancestor
24652071|NCT01235637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24652072|NCT01235637|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24652073|NCT01235637|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24652074|NCT01235637|Anesthetics, General|anesthetics, general|mesh-ancestor
24652075|NCT01235637|Anesthetics|anesthetics|mesh-ancestor
24652317|NCT01237769|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24830863|NCT02161822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830864|NCT02161822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24830865|NCT02161822|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24652457|NCT01238393|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24652458|NCT01238393|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24652459|NCT01238393|Growth Substances|growth substances|mesh-ancestor
24652780|NCT01240109|Remifentanil|remifentanil|mesh-list
24653920|NCT01246232|Antidepressive Agents|antidepressive agents|mesh-ancestor
24654119|NCT01247714|Adrenergic Agents|adrenergic agents|mesh-ancestor
24654120|NCT01247714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24654189|NCT01248195|Clozapine|clozapine|mesh-list
24654190|NCT01248195|Amisulpride|amisulpride|mesh-list
24654191|NCT01248195|Antiemetics|antiemetics|mesh-ancestor
24654192|NCT01248195|Autonomic Agents|autonomic agents|mesh-ancestor
24654193|NCT01248195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24654194|NCT01248195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654195|NCT01248195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24654196|NCT01248195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24654197|NCT01248195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24643439|NCT01185743|Olanzapine|olanzapine|mesh-list
24697255|NCT01434017|Glucocorticoids|glucocorticoids|mesh-ancestor
24654841|NCT01251822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24654842|NCT01251822|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24654843|NCT01251822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24654845|NCT01251822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24654846|NCT01251822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654901|NCT01252056|Cilostazol|cilostazol|mesh-list
24654902|NCT01252056|Probucol|probucol|mesh-list
24656565|NCT01262612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657201|NCT01266187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656566|NCT01262612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656567|NCT01262729|Xenon|xenon|mesh-list
24656568|NCT01262729|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24656601|NCT01263002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656602|NCT01263080|Folic Acid|folic acid|mesh-list
24656603|NCT01263080|Vitamin B Complex|vitamin b complex|mesh-list
24656604|NCT01263080|Mirtazapine|mirtazapine|mesh-list
24656605|NCT01263080|Vitamins|vitamins|mesh-ancestor
24656606|NCT01263080|Micronutrients|micronutrients|mesh-ancestor
24656607|NCT01263080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658090|NCT01270412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658091|NCT01270412|Viscosupplements|viscosupplements|mesh-ancestor
24658092|NCT01270412|Protective Agents|protective agents|mesh-ancestor
24658094|NCT01270438|Bevacizumab|bevacizumab|mesh-list
24658095|NCT01270438|Fluorouracil|fluorouracil|mesh-list
24658096|NCT01270438|Oxaliplatin|oxaliplatin|mesh-list
24658097|NCT01270438|Calcium|calcium|mesh-list
24658208|NCT01270932|Lenalidomide|lenalidomide|mesh-list
24658209|NCT01270932|BB 1101|bb 1101|mesh-list
24658210|NCT01270932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24658211|NCT01270932|Antiemetics|antiemetics|mesh-ancestor
24658212|NCT01270932|Autonomic Agents|autonomic agents|mesh-ancestor
24658213|NCT01270932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658214|NCT01270932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658215|NCT01270932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24658216|NCT01270932|Glucocorticoids|glucocorticoids|mesh-ancestor
24658217|NCT01270932|Hormones|hormones|mesh-ancestor
24658218|NCT01270932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24658219|NCT01270932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24658220|NCT01270932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697934|NCT01437982|Glucocorticoids|glucocorticoids|mesh-ancestor
24698158|NCT01439230|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24698159|NCT01439230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24659307|NCT01276730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24659308|NCT01276730|Keratolytic Agents|keratolytic agents|mesh-ancestor
24659339|NCT01276925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659340|NCT01276925|Sensory System Agents|sensory system agents|mesh-ancestor
24659341|NCT01276925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24659342|NCT01276977|Zolmitriptan|zolmitriptan|mesh-list
24659343|NCT01276977|Eletriptan|eletriptan|mesh-list
24659344|NCT01276977|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24659345|NCT01276977|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24659346|NCT01276977|Serotonin Agents|serotonin agents|mesh-ancestor
24659347|NCT01276977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24659348|NCT01276977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659349|NCT01276977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659350|NCT01277016|Melphalan|melphalan|mesh-list
24659430|NCT01277640|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24659431|NCT01277640|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24659436|NCT01277705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659437|NCT01277731|Methylprednisolone|methylprednisolone|mesh-list
24659438|NCT01277731|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24659558|NCT01278459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24659560|NCT01278498|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24659561|NCT01278498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24659562|NCT01278498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24659563|NCT01278498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659564|NCT01278498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24857255|NCT02290327|Pantoprazole|pantoprazole|mesh-list
24857256|NCT02290327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24659599|NCT01278784|Antioxidants|antioxidants|mesh-ancestor
24659600|NCT01278784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659601|NCT01278784|Protective Agents|protective agents|mesh-ancestor
24659770|NCT01279694|Prednisone|prednisone|mesh-list
24659771|NCT01279694|Melphalan|melphalan|mesh-list
24659829|NCT01279980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659830|NCT01279980|Sensory System Agents|sensory system agents|mesh-ancestor
24659831|NCT01279980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24659833|NCT01280006|Indomethacin|indomethacin|mesh-list
24659834|NCT01280006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24659835|NCT01280006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24660487|NCT01283841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24660550|NCT01284413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24660551|NCT01284413|Antimetabolites|antimetabolites|mesh-ancestor
24660552|NCT01284413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660553|NCT01284413|Antiviral Agents|antiviral agents|mesh-ancestor
24660554|NCT01284413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24660555|NCT01284413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660687|NCT01285245|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24660866|NCT01286701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24660868|NCT01286701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660870|NCT01286766|Docetaxel|docetaxel|mesh-list
24660871|NCT01286766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660872|NCT01286766|Tubulin Modulators|tubulin modulators|mesh-ancestor
24660873|NCT01286766|Antimitotic Agents|antimitotic agents|mesh-ancestor
24660874|NCT01286766|Mitosis Modulators|mitosis modulators|mesh-ancestor
24660875|NCT01286766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660876|NCT01286857|Silicon|silicon|mesh-list
25079146|NCT03349957|Idarubicin|idarubicin|mesh-list
24660893|NCT01286909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660894|NCT01286909|Protective Agents|protective agents|mesh-ancestor
24660895|NCT01286909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660896|NCT01286909|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24660897|NCT01286909|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24830870|NCT02161952|Pirfenidone|pirfenidone|mesh-list
24830871|NCT02161952|Analgesics|analgesics|mesh-ancestor
24830872|NCT02161952|Sensory System Agents|sensory system agents|mesh-ancestor
24830873|NCT02161952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24830874|NCT02161952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830875|NCT02161952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24830876|NCT02161952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24612888|NCT01015664|Immunologic Factors|immunologic factors|mesh-ancestor
24660949|NCT01287338|Sensory System Agents|sensory system agents|mesh-ancestor
24660950|NCT01287338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24660981|NCT01287455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24698779|NCT01442935|Vitamins|vitamins|mesh-ancestor
24661080|NCT01287741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24661081|NCT01287741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24661082|NCT01287741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24661083|NCT01287741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24661084|NCT01287741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661085|NCT01287741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24661086|NCT01287741|Glucocorticoids|glucocorticoids|mesh-ancestor
24661088|NCT01287741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24857278|NCT02290470|Dexamethasone|dexamethasone|mesh-list
24394449|NCT00133328|Valsartan|valsartan|mesh-list
24661217|NCT01288495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24661218|NCT01288508|Psyllium|psyllium|mesh-list
24661219|NCT01288508|Cathartics|cathartics|mesh-ancestor
24661220|NCT01288508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24661221|NCT01288547|Theobromine|theobromine|mesh-list
24661222|NCT01288547|Caffeine|caffeine|mesh-list
24661270|NCT01288742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24661271|NCT01288742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24661272|NCT01288742|Protective Agents|protective agents|mesh-ancestor
24661533|NCT01289769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24661534|NCT01289769|Adrenergic Agents|adrenergic agents|mesh-ancestor
24661535|NCT01289769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24661536|NCT01289769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661538|NCT01289925|Antioxidants|antioxidants|mesh-ancestor
24661539|NCT01289925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661540|NCT01289925|Protective Agents|protective agents|mesh-ancestor
24661541|NCT01289925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661542|NCT01289925|Trace Elements|trace elements|mesh-ancestor
24661571|NCT01289951|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24661573|NCT01289951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24661574|NCT01289951|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24661575|NCT01289951|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24661576|NCT01289951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661577|NCT01289951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661578|NCT01290003|Tazobactam|tazobactam|mesh-list
24661579|NCT01290003|Piperacillin|piperacillin|mesh-list
24661873|NCT01291433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24661875|NCT01291433|Protective Agents|protective agents|mesh-ancestor
24661876|NCT01291433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661877|NCT01291433|Vasodilator Agents|vasodilator agents|mesh-ancestor
24661878|NCT01291433|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24661880|NCT01291433|Vitamins|vitamins|mesh-ancestor
24661881|NCT01291433|Micronutrients|micronutrients|mesh-ancestor
24661973|NCT01291615|Antiviral Agents|antiviral agents|mesh-ancestor
24661974|NCT01291615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24661975|NCT01291615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661976|NCT01291615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24661977|NCT01291615|Immunologic Factors|immunologic factors|mesh-ancestor
24661978|NCT01291615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661980|NCT01291628|Trace Elements|trace elements|mesh-ancestor
24661981|NCT01291628|Micronutrients|micronutrients|mesh-ancestor
24661982|NCT01291628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661983|NCT01291641|Cilostazol|cilostazol|mesh-list
24661984|NCT01291641|Probucol|probucol|mesh-list
24661985|NCT01291641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
24661986|NCT01291641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24661987|NCT01291641|Autonomic Agents|autonomic agents|mesh-ancestor
24661988|NCT01291641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24661989|NCT01291641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661990|NCT01291641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24661991|NCT01291641|Respiratory System Agents|respiratory system agents|mesh-ancestor
24662010|NCT01291654|Sensory System Agents|sensory system agents|mesh-ancestor
25038428|NCT05162976|Nivolumab|nivolumab|mesh-list
24662011|NCT01291654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24662012|NCT01291654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662013|NCT01291654|Antipyretics|antipyretics|mesh-ancestor
24662041|NCT01292031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24662042|NCT01292031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24662044|NCT01292083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24662045|NCT01292083|Antimetabolites|antimetabolites|mesh-ancestor
24662074|NCT01292343|Protective Agents|protective agents|mesh-ancestor
24662075|NCT01292343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857285|NCT02290470|BB 1101|bb 1101|mesh-list
24857286|NCT02290470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24662076|NCT01292343|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24662077|NCT01292343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24662078|NCT01292343|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24662079|NCT01292343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24498205|NCT00513513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24498206|NCT00513539|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
24624111|NCT01074801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624113|NCT01074853|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24624114|NCT01074853|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24662080|NCT01292343|Antimetabolites|antimetabolites|mesh-ancestor
24662081|NCT01292343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662137|NCT01292785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24662138|NCT01292785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662139|NCT01292863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24662142|NCT01292993|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
24662143|NCT01292993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24662268|NCT01293734|Respiratory System Agents|respiratory system agents|mesh-ancestor
24662269|NCT01293734|Glucocorticoids|glucocorticoids|mesh-ancestor
24662270|NCT01293734|Hormones|hormones|mesh-ancestor
24662271|NCT01293734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24662272|NCT01293734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24662273|NCT01293734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24662274|NCT01293734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662275|NCT01293734|Vasodilator Agents|vasodilator agents|mesh-ancestor
24657202|NCT01266187|Antimetabolites|antimetabolites|mesh-ancestor
24662276|NCT01293734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24662277|NCT01293734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24662278|NCT01293734|Purinergic Agents|purinergic agents|mesh-ancestor
24662279|NCT01293734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24662280|NCT01293747|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24662281|NCT01293747|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24662282|NCT01293747|Estradiol|estradiol|mesh-list
24662443|NCT01294969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24662444|NCT01294969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662445|NCT01294969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24662446|NCT01294969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24662447|NCT01294969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24662448|NCT01294969|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24662536|NCT01295268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24699318|NCT01446211|Azathioprine|azathioprine|mesh-list
24662674|NCT01296178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662677|NCT01296204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662678|NCT01296230|Hormones|hormones|mesh-list
24451552|NCT00324142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24662679|NCT01296230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24662680|NCT01296230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857309|NCT02290470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24857310|NCT02290470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24857311|NCT02290470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24662801|NCT01296997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662802|NCT01297010|Dexamethasone|dexamethasone|mesh-list
25695021|NCT02039674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25695022|NCT02039674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25695023|NCT02039778|Temozolomide|temozolomide|mesh-list
25695024|NCT02039778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25695025|NCT02039778|Alkylating Agents|alkylating agents|mesh-ancestor
25695026|NCT02039778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662812|NCT01297010|Hormones|hormones|mesh-ancestor
24662813|NCT01297010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24662819|NCT01297023|Calcium, Dietary|calcium, dietary|mesh-list
24662907|NCT01297634|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24699412|NCT01446497|Timolol|timolol|mesh-list
24662953|NCT01297777|Imatinib Mesylate|imatinib mesylate|mesh-list
24662954|NCT01297777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662955|NCT01297777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24662956|NCT01297777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24662957|NCT01297777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662959|NCT01297803|Mitomycin|mitomycin|mesh-list
24662960|NCT01297803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24662961|NCT01297803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662962|NCT01297803|Alkylating Agents|alkylating agents|mesh-ancestor
24662963|NCT01297803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662964|NCT01297803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24662965|NCT01297803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24662966|NCT01297816|Minocycline|minocycline|mesh-list
24662967|NCT01297816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24662968|NCT01297816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24662969|NCT01297829|Ibuprofen|ibuprofen|mesh-list
24662970|NCT01297829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24663040|NCT01298011|Antimitotic Agents|antimitotic agents|mesh-ancestor
24663041|NCT01298011|Mitosis Modulators|mitosis modulators|mesh-ancestor
24663042|NCT01298011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663043|NCT01298011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24663044|NCT01298011|Antimetabolites|antimetabolites|mesh-ancestor
24663045|NCT01298011|Antiviral Agents|antiviral agents|mesh-ancestor
24699459|NCT01446952|Vitamin E|vitamin e|mesh-list
24663215|NCT01299298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24663216|NCT01299415|Vadimezan|vadimezan|mesh-list
24663217|NCT01299415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663220|NCT01299558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24663221|NCT01299558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24663222|NCT01299558|Autonomic Agents|autonomic agents|mesh-ancestor
24663223|NCT01299558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663224|NCT01299558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440975|NCT00285519|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24440976|NCT00285519|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24663225|NCT01299558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24857315|NCT02290717|Fluticasone|fluticasone|mesh-list
24663226|NCT01299558|Respiratory System Agents|respiratory system agents|mesh-ancestor
24663337|NCT01300611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24663338|NCT01300611|Vasodilator Agents|vasodilator agents|mesh-ancestor
24663339|NCT01300637|Metformin|metformin|mesh-list
25695027|NCT02039778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25695028|NCT02039908|Methylphenidate|methylphenidate|mesh-list
25695029|NCT02039908|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25695030|NCT02039908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695031|NCT02039908|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24663340|NCT01300637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25695032|NCT02039908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24663345|NCT01300676|Hormones|hormones|mesh-ancestor
24663346|NCT01300676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24663347|NCT01300676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663348|NCT01300676|Progestins|progestins|mesh-ancestor
24663349|NCT01300754|Lidocaine|lidocaine|mesh-list
24663350|NCT01300754|Anesthetics, Local|anesthetics, local|mesh-ancestor
24663351|NCT01300754|Anesthetics|anesthetics|mesh-ancestor
24663352|NCT01300754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24663353|NCT01300754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663354|NCT01300754|Sensory System Agents|sensory system agents|mesh-ancestor
24663355|NCT01300754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663356|NCT01300754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24663357|NCT01300754|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24663419|NCT01301040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24663501|NCT01301820|Growth Substances|growth substances|mesh-ancestor
24663502|NCT01301820|Growth Inhibitors|growth inhibitors|mesh-ancestor
24663503|NCT01301820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663728|NCT01303536|Autonomic Agents|autonomic agents|mesh-ancestor
24663750|NCT01303549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24663751|NCT01303549|Antifungal Agents|antifungal agents|mesh-ancestor
24663774|NCT01303614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663775|NCT01303614|Sensory System Agents|sensory system agents|mesh-ancestor
24663776|NCT01303614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663777|NCT01303614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24663778|NCT01303614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24663779|NCT01303614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24663780|NCT01303614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24663883|NCT01303926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663884|NCT01303926|Growth Inhibitors|growth inhibitors|mesh-ancestor
24663885|NCT01303926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663886|NCT01303926|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24663887|NCT01303926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24663889|NCT01303952|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24663890|NCT01303952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24663891|NCT01303952|Immunologic Factors|immunologic factors|mesh-ancestor
24663892|NCT01303952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663894|NCT01304069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24663895|NCT01304069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24663896|NCT01304069|Analgesics|analgesics|mesh-ancestor
24663897|NCT01304069|Sensory System Agents|sensory system agents|mesh-ancestor
24663898|NCT01304069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24699684|NCT01448499|Clozapine|clozapine|mesh-list
24664147|NCT01305395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24664148|NCT01305395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24664149|NCT01305395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24664150|NCT01305395|Antifungal Agents|antifungal agents|mesh-ancestor
24664191|NCT01305707|Clomipramine|clomipramine|mesh-list
24664192|NCT01305707|Mianserin|mianserin|mesh-list
24664253|NCT01305733|Racepinephrine|racepinephrine|mesh-list
24664257|NCT01305733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24664259|NCT01305733|Sensory System Agents|sensory system agents|mesh-ancestor
24664260|NCT01305733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24664261|NCT01305733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664262|NCT01305733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24664263|NCT01305733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24394202|NCT00132548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24664264|NCT01305733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24664265|NCT01305733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24664266|NCT01305733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664345|NCT01306318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664346|NCT01306318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24664347|NCT01306318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24664348|NCT01306318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24664349|NCT01306318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24664350|NCT01306318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664352|NCT01306318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24613017|NCT01016509|Insulin|insulin|mesh-list
24857327|NCT02291055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24857328|NCT02291055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24857329|NCT02291094|Lidocaine|lidocaine|mesh-list
24857330|NCT02291094|Remifentanil|remifentanil|mesh-list
24857331|NCT02291094|Anesthetics, Local|anesthetics, local|mesh-ancestor
24857332|NCT02291094|Anesthetics|anesthetics|mesh-ancestor
24857333|NCT02291094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24857334|NCT02291094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857335|NCT02291094|Sensory System Agents|sensory system agents|mesh-ancestor
24857336|NCT02291094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857337|NCT02291094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24664471|NCT01306981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24664472|NCT01307189|Tiotropium Bromide|tiotropium bromide|mesh-list
24664507|NCT01307332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24664508|NCT01307332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24664509|NCT01307475|Adenosine|adenosine|mesh-list
24664510|NCT01307475|Analgesics|analgesics|mesh-ancestor
24664645|NCT01308177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24664646|NCT01308177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24664647|NCT01308177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24664648|NCT01308177|Protease Inhibitors|protease inhibitors|mesh-ancestor
24664649|NCT01308177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24664650|NCT01308177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664651|NCT01308177|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24664652|NCT01308177|Protective Agents|protective agents|mesh-ancestor
24664653|NCT01308177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664654|NCT01308177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24664720|NCT01308268|Antimitotic Agents|antimitotic agents|mesh-ancestor
24664721|NCT01308268|Mitosis Modulators|mitosis modulators|mesh-ancestor
24857338|NCT02291094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24459842|NCT00346580|Nelfinavir|nelfinavir|mesh-list
24664722|NCT01308268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664723|NCT01308268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24664724|NCT01308320|Fentanyl|fentanyl|mesh-list
24664725|NCT01308320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24664726|NCT01308320|Narcotics|narcotics|mesh-ancestor
24664727|NCT01308320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24664728|NCT01308320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664729|NCT01308320|Analgesics|analgesics|mesh-ancestor
24664730|NCT01308320|Sensory System Agents|sensory system agents|mesh-ancestor
24664731|NCT01308320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24664732|NCT01308320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24830888|NCT02161965|Protease Inhibitors|protease inhibitors|mesh-ancestor
24664733|NCT01308320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24664734|NCT01308320|Anesthetics, General|anesthetics, general|mesh-ancestor
24664735|NCT01308320|Anesthetics|anesthetics|mesh-ancestor
24664736|NCT01308346|Everolimus|everolimus|mesh-list
24664737|NCT01308346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24664738|NCT01308346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24664739|NCT01308346|Immunologic Factors|immunologic factors|mesh-ancestor
24699814|NCT01449188|Antiemetics|antiemetics|mesh-ancestor
24664910|NCT01309178|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24664911|NCT01309178|Diuretics|diuretics|mesh-ancestor
24664912|NCT01309178|Natriuretic Agents|natriuretic agents|mesh-ancestor
24664913|NCT01309399|Teriparatide|teriparatide|mesh-list
24664914|NCT01309399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24664915|NCT01309399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664916|NCT01309399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24664952|NCT01309477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664953|NCT01309477|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24664956|NCT01309490|Ribavirin|ribavirin|mesh-list
24664957|NCT01309490|Antimetabolites|antimetabolites|mesh-ancestor
24664958|NCT01309490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664960|NCT01309490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24664961|NCT01309542|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24664962|NCT01309542|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24664963|NCT01309542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24664964|NCT01309542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24664965|NCT01309542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664966|NCT01309542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24664967|NCT01309542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664986|NCT01309633|Bevacizumab|bevacizumab|mesh-list
24664987|NCT01309633|Sunitinib|sunitinib|mesh-list
24664988|NCT01309633|Cisplatin|cisplatin|mesh-list
24664989|NCT01309633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24664990|NCT01309633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24664991|NCT01309633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24664992|NCT01309633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24664993|NCT01309633|Growth Substances|growth substances|mesh-ancestor
24664994|NCT01309633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664996|NCT01309633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24664997|NCT01309633|Antimetabolites|antimetabolites|mesh-ancestor
24664998|NCT01309633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664999|NCT01309633|Antiviral Agents|antiviral agents|mesh-ancestor
24665035|NCT01309776|Antidepressive Agents|antidepressive agents|mesh-ancestor
24665036|NCT01309776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24451810|NCT00324831|Alkylating Agents|alkylating agents|mesh-ancestor
24665037|NCT01309776|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24665038|NCT01309789|Prednisone|prednisone|mesh-list
24665039|NCT01309789|Cyclophosphamide|cyclophosphamide|mesh-list
24665040|NCT01309789|Doxorubicin|doxorubicin|mesh-list
24665041|NCT01309789|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24665042|NCT01309789|Vincristine|vincristine|mesh-list
24665043|NCT01309789|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24665044|NCT01309789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24665066|NCT01309789|Mitosis Modulators|mitosis modulators|mesh-ancestor
24665067|NCT01309789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24665068|NCT01309854|Pioglitazone|pioglitazone|mesh-list
24665069|NCT01309854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24665070|NCT01309854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665071|NCT01309984|Propofol|propofol|mesh-list
24665072|NCT01309984|Fospropofol|fospropofol|mesh-list
24699921|NCT01449617|Clopidogrel|clopidogrel|mesh-list
24665125|NCT01310296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24665126|NCT01310296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665127|NCT01310296|Sensory System Agents|sensory system agents|mesh-ancestor
24665128|NCT01310296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24665129|NCT01310296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24665130|NCT01310296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24665132|NCT01310296|Adrenergic Agents|adrenergic agents|mesh-ancestor
24665133|NCT01310296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665134|NCT01310296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665135|NCT01310296|Analgesics|analgesics|mesh-ancestor
24665136|NCT01310296|Sympatholytics|sympatholytics|mesh-ancestor
24665137|NCT01310296|Autonomic Agents|autonomic agents|mesh-ancestor
24665138|NCT01310361|Amoxicillin|amoxicillin|mesh-list
24665139|NCT01310361|Penicillins|penicillins|mesh-list
24665468|NCT01312376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665469|NCT01312376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665470|NCT01312376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24665471|NCT01312376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24665472|NCT01312376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24665497|NCT01312441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24665498|NCT01312493|Panitumumab|panitumumab|mesh-list
24665499|NCT01312493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24665500|NCT01312493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665502|NCT01312714|Cholecalciferol|cholecalciferol|mesh-list
24665504|NCT01312714|Micronutrients|micronutrients|mesh-ancestor
24665505|NCT01312714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665506|NCT01312714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24665507|NCT01312714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24665508|NCT01312792|Ampicillin|ampicillin|mesh-list
24665509|NCT01312792|Cephradine|cephradine|mesh-list
24665510|NCT01312792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24665511|NCT01312792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24665512|NCT01312831|Vitamin B 12|vitamin b 12|mesh-list
24665513|NCT01312831|Hydroxocobalamin|hydroxocobalamin|mesh-list
24665514|NCT01312831|Vitamins|vitamins|mesh-ancestor
24665515|NCT01312831|Micronutrients|micronutrients|mesh-ancestor
24665516|NCT01312831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665517|NCT01312831|Vitamin B Complex|vitamin b complex|mesh-ancestor
24665518|NCT01312831|Hematinics|hematinics|mesh-ancestor
24665519|NCT01313143|Esmolol|esmolol|mesh-list
24665662|NCT01314027|Oxaliplatin|oxaliplatin|mesh-list
24665663|NCT01314027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24665664|NCT01314027|Antimetabolites|antimetabolites|mesh-ancestor
24665665|NCT01314027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665666|NCT01314027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665667|NCT01314027|Antiviral Agents|antiviral agents|mesh-ancestor
24665668|NCT01314027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24665669|NCT01314027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24665670|NCT01314027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24665718|NCT01314300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24665726|NCT01314339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665727|NCT01314339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665728|NCT01314339|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24665729|NCT01314339|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24665730|NCT01314339|Histamine Antagonists|histamine antagonists|mesh-ancestor
24665731|NCT01314339|Histamine Agents|histamine agents|mesh-ancestor
24665732|NCT01314352|Desloratadine|desloratadine|mesh-list
24665761|NCT01314586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24665762|NCT01314586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665763|NCT01314599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24665764|NCT01314677|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24665765|NCT01314677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24665892|NCT01315704|Vitamin D|vitamin d|mesh-list
24665954|NCT01316081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665956|NCT01316094|Ipragliflozin|ipragliflozin|mesh-list
24665957|NCT01316094|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24665958|NCT01316094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665959|NCT01316094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24665960|NCT01316094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665983|NCT01316445|Anesthetics, General|anesthetics, general|mesh-ancestor
24665984|NCT01316445|Anesthetics|anesthetics|mesh-ancestor
24665985|NCT01316445|GABA Modulators|gaba modulators|mesh-ancestor
24665986|NCT01316445|GABA Agents|gaba agents|mesh-ancestor
24857348|NCT02291341|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24857349|NCT02291341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24399100|NCT00146588|Antimetabolites|antimetabolites|mesh-ancestor
24665987|NCT01316445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665988|NCT01316445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665989|NCT01316458|Imatinib Mesylate|imatinib mesylate|mesh-list
24665990|NCT01316458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665991|NCT01316458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24665992|NCT01316458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24665993|NCT01316458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665994|NCT01316549|Fludarabine|fludarabine|mesh-list
24665995|NCT01316549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24667709|NCT05323214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24667710|NCT05323214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24667711|NCT05323214|Narcotics|narcotics|mesh-ancestor
24667712|NCT05323214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24667713|NCT05323214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24667714|NCT05323214|Anesthetics, General|anesthetics, general|mesh-ancestor
24667718|NCT05320107|Ketamine|ketamine|mesh-list
24667719|NCT05320107|Analgesics|analgesics|mesh-ancestor
24667720|NCT05320107|Sensory System Agents|sensory system agents|mesh-ancestor
24667721|NCT05320107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24456222|NCT00330746|Gemcitabine|gemcitabine|mesh-list
24667859|NCT05266586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24667860|NCT05266586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24667861|NCT05266586|Antimetabolites|antimetabolites|mesh-ancestor
24667862|NCT05266586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449097|NCT00314210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830920|NCT02162121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830922|NCT02162134|Cefuroxime|cefuroxime|mesh-list
24667863|NCT05266586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24667864|NCT05261516|Magnesium Sulfate|magnesium sulfate|mesh-list
24667865|NCT05261516|Analgesics|analgesics|mesh-ancestor
24700777|NCT01455129|Tiotropium Bromide|tiotropium bromide|mesh-list
24830925|NCT02162134|Midazolam|midazolam|mesh-list
24830926|NCT02162134|Propofol|propofol|mesh-list
24830927|NCT02162134|Sevoflurane|sevoflurane|mesh-list
24588814|NCT00904397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24830928|NCT02162134|Atracurium|atracurium|mesh-list
24830929|NCT02162134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24830930|NCT02162134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24830931|NCT02162134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700963|NCT01456208|Giapreza|giapreza|mesh-list
25038987|NCT04229368|Vitamin D|vitamin d|mesh-list
25695033|NCT02039908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25695034|NCT02039908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695035|NCT02039908|Dopamine Agents|dopamine agents|mesh-ancestor
25695036|NCT02039908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25695037|NCT02039947|Trametinib|trametinib|mesh-list
25695038|NCT02039947|Dabrafenib|dabrafenib|mesh-list
25695039|NCT02039947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25695040|NCT02039947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25695041|NCT02039947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25695042|NCT02039947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695043|NCT02040116|Rituximab|rituximab|mesh-list
24601089|NCT00962637|Sequestering Agents|sequestering agents|mesh-ancestor
24601090|NCT00962637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601091|NCT00962637|Androgens|androgens|mesh-ancestor
24601093|NCT00962637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24601134|NCT00962936|Pidilizumab|pidilizumab|mesh-list
24601135|NCT00962936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24601140|NCT00963001|Treprostinil|treprostinil|mesh-list
24440977|NCT00285519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24441005|NCT00285662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24441006|NCT00285662|Renal Agents|renal agents|mesh-ancestor
24441007|NCT00285675|Calcitriol|calcitriol|mesh-list
24441008|NCT00285675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24441009|NCT00285675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441010|NCT00285675|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25695044|NCT02040116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25695045|NCT02040116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25695046|NCT02040116|Immunologic Factors|immunologic factors|mesh-ancestor
25695047|NCT02040116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695048|NCT02040116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25695049|NCT02040298|Clemastine|clemastine|mesh-list
25695050|NCT02040298|Antipruritics|antipruritics|mesh-ancestor
25695051|NCT02040298|Dermatologic Agents|dermatologic agents|mesh-ancestor
24533839|NCT00645268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533840|NCT00645268|Urological Agents|urological agents|mesh-ancestor
24830951|NCT02162134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24830952|NCT02162134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24463360|NCT00360295|Azithromycin|azithromycin|mesh-list
24441011|NCT00285675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24441012|NCT00285675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441060|NCT00285883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24441061|NCT00285883|Antiviral Agents|antiviral agents|mesh-ancestor
24441070|NCT00285896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441072|NCT00286013|Gemcitabine|gemcitabine|mesh-list
24441073|NCT00286013|Oxaliplatin|oxaliplatin|mesh-list
24441074|NCT00286013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24441075|NCT00286013|Antimetabolites|antimetabolites|mesh-ancestor
24696056|NCT01427114|Antimitotic Agents|antimitotic agents|mesh-ancestor
24696057|NCT01427114|Mitosis Modulators|mitosis modulators|mesh-ancestor
24696058|NCT01427114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24441091|NCT00286052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24441092|NCT00286104|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24441093|NCT00286104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24441095|NCT00286117|Anastrozole|anastrozole|mesh-list
24441096|NCT00286117|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24533872|NCT00645320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24533873|NCT00645320|Serotonin Agents|serotonin agents|mesh-ancestor
24533874|NCT00645320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24533875|NCT00645320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533876|NCT00645320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444575|NCT00298545|Calcitriol|calcitriol|mesh-list
24830957|NCT02162134|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24830958|NCT02162134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24830959|NCT02162134|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24830979|NCT02162303|Gout Suppressants|gout suppressants|mesh-ancestor
24731904|NCT01637025|Hemostatics|hemostatics|mesh-ancestor
24450243|NCT00318201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24450244|NCT00318201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450245|NCT00318201|Vasodilator Agents|vasodilator agents|mesh-ancestor
24450246|NCT00318201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24450247|NCT00318201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24450248|NCT00318201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24450249|NCT00318201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24450250|NCT00318201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450253|NCT00318318|Hormones|hormones|mesh-ancestor
24533929|NCT00645437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24533930|NCT00645437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24533931|NCT00645502|Risperidone|risperidone|mesh-list
24533934|NCT00645502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24533937|NCT00645502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24458367|NCT00337623|Hormones|hormones|mesh-ancestor
24458368|NCT00337623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24404677|NCT00164450|Rifapentine|rifapentine|mesh-list
24533975|NCT00645580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24533976|NCT00645580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533977|NCT00645580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24533978|NCT00645580|Serotonin Agents|serotonin agents|mesh-ancestor
24542845|NCT00680511|Dopamine Agents|dopamine agents|mesh-ancestor
24441109|NCT00286130|Leucovorin|leucovorin|mesh-list
24830980|NCT02162303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24534004|NCT00645632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534005|NCT00645632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24534007|NCT00645632|Dermatologic Agents|dermatologic agents|mesh-ancestor
24534008|NCT00645632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24534009|NCT00645632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24534010|NCT00645632|Immunologic Factors|immunologic factors|mesh-ancestor
24534011|NCT00645632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24534012|NCT00645632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24534013|NCT00645632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24534014|NCT00645632|Alkylating Agents|alkylating agents|mesh-ancestor
24534015|NCT00645658|Testosterone|testosterone|mesh-list
24458378|NCT00337649|Antimitotic Agents|antimitotic agents|mesh-ancestor
24458379|NCT00337649|Mitosis Modulators|mitosis modulators|mesh-ancestor
24458380|NCT00337649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458381|NCT00337701|Enfuvirtide|enfuvirtide|mesh-list
24534104|NCT00646061|Autonomic Agents|autonomic agents|mesh-ancestor
24534105|NCT00646061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24534106|NCT00646061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534107|NCT00646061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24534108|NCT00646061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24450316|NCT00318760|Analgesics|analgesics|mesh-ancestor
24449105|NCT00314379|Antioxidants|antioxidants|mesh-ancestor
24449106|NCT00314379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449107|NCT00314379|Protective Agents|protective agents|mesh-ancestor
24534281|NCT00646607|Vitamin B Complex|vitamin b complex|mesh-ancestor
24534176|NCT00646321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24534177|NCT00646321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695053|NCT02040298|Histamine Antagonists|histamine antagonists|mesh-ancestor
25695054|NCT02040298|Histamine Agents|histamine agents|mesh-ancestor
24534185|NCT00646321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24534186|NCT00646321|Adrenergic Agents|adrenergic agents|mesh-ancestor
24831027|NCT02162537|Pemetrexed|pemetrexed|mesh-list
25695055|NCT02040298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25695056|NCT02040298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695057|NCT02040298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450214|NCT00317993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450215|NCT00317993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24450216|NCT00317993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24458391|NCT00337740|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24534280|NCT00646607|Protective Agents|protective agents|mesh-ancestor
24450322|NCT00318760|Autonomic Agents|autonomic agents|mesh-ancestor
24450357|NCT00318838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450358|NCT00318838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24450359|NCT00318838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450360|NCT00318890|Docetaxel|docetaxel|mesh-list
24450361|NCT00318890|Amifostine|amifostine|mesh-list
24450362|NCT00318890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450363|NCT00318890|Tubulin Modulators|tubulin modulators|mesh-ancestor
24450364|NCT00318890|Antimitotic Agents|antimitotic agents|mesh-ancestor
24450365|NCT00318890|Mitosis Modulators|mitosis modulators|mesh-ancestor
24450367|NCT00318890|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25695058|NCT02040298|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25695059|NCT02040428|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24802350|NCT01989676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802351|NCT01989676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24534304|NCT00646620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24831042|NCT02162550|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24831043|NCT02162550|Incretins|incretins|mesh-ancestor
24831044|NCT02162550|Hormones|hormones|mesh-ancestor
24831045|NCT02162550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24831046|NCT02162693|Hyaluronic Acid|hyaluronic acid|mesh-list
24831047|NCT02162693|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24831048|NCT02162693|Immunologic Factors|immunologic factors|mesh-ancestor
25695060|NCT02040428|Hemostatics|hemostatics|mesh-ancestor
25695061|NCT02040428|Coagulants|coagulants|mesh-ancestor
25695062|NCT02040532|Gabapentin|gabapentin|mesh-list
25695063|NCT02040532|Analgesics|analgesics|mesh-ancestor
25695064|NCT02040532|Sensory System Agents|sensory system agents|mesh-ancestor
25695065|NCT02040532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25695066|NCT02040532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695067|NCT02040532|Anticonvulsants|anticonvulsants|mesh-ancestor
25695068|NCT02040532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25695069|NCT02040532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24636175|NCT01143584|Dopamine Agents|dopamine agents|mesh-ancestor
24636248|NCT01144169|Hydroxychloroquine|hydroxychloroquine|mesh-list
24636249|NCT01144169|Antimalarials|antimalarials|mesh-ancestor
24636352|NCT01144923|Analgesics|analgesics|mesh-ancestor
24450392|NCT00318955|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24450393|NCT00318955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24450394|NCT00318955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24450395|NCT00318955|Adrenergic Agents|adrenergic agents|mesh-ancestor
24450396|NCT00318955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24450397|NCT00318955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450401|NCT00318968|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24636535|NCT01146002|Guanfacine|guanfacine|mesh-list
24450404|NCT00318981|Methylphenidate|methylphenidate|mesh-list
24450428|NCT00319007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831063|NCT02162784|Glucocorticoids|glucocorticoids|mesh-ancestor
25040614|NCT02990806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25040615|NCT02989597|Dexamethasone|dexamethasone|mesh-list
25040616|NCT02989597|Sufentanil|sufentanil|mesh-list
25040617|NCT02989597|Ketamine|ketamine|mesh-list
25040618|NCT02989597|Remifentanil|remifentanil|mesh-list
25040619|NCT02989597|Methadone|methadone|mesh-list
25040620|NCT02989597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25040621|NCT02989597|Antiemetics|antiemetics|mesh-ancestor
25040622|NCT02989597|Autonomic Agents|autonomic agents|mesh-ancestor
25040623|NCT02989597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25040250|NCT03250117|Ropinirole|ropinirole|mesh-list
24451567|NCT00324298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450449|NCT00319163|Contraceptive Agents|contraceptive agents|mesh-ancestor
24602703|NCT00970580|Paclitaxel|paclitaxel|mesh-list
24534457|NCT00647049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24534458|NCT00647049|Alkylating Agents|alkylating agents|mesh-ancestor
24534459|NCT00647049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24534460|NCT00647101|Latanoprost|latanoprost|mesh-list
24458403|NCT00337766|Natriuretic Agents|natriuretic agents|mesh-ancestor
24458404|NCT00337766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458405|NCT00337792|Fentanyl|fentanyl|mesh-list
24458406|NCT00337792|Midazolam|midazolam|mesh-list
24458407|NCT00337792|Oxycodone|oxycodone|mesh-list
24458408|NCT00337792|Lorazepam|lorazepam|mesh-list
24458409|NCT00337792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24458410|NCT00337792|Narcotics|narcotics|mesh-ancestor
24458411|NCT00337792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24458412|NCT00337792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458413|NCT00337792|Analgesics|analgesics|mesh-ancestor
24405241|NCT00166127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534477|NCT00647140|Levodopa|levodopa|mesh-list
24831142|NCT02163655|Diuretics|diuretics|mesh-ancestor
24831143|NCT02163655|Natriuretic Agents|natriuretic agents|mesh-ancestor
24831144|NCT02163655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831145|NCT02163655|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24463655|NCT00361790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534537|NCT00647530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24637036|NCT01148446|Rituximab|rituximab|mesh-list
24450234|NCT00318201|Erythromycin|erythromycin|mesh-list
24450235|NCT00318201|Erythromycin Estolate|erythromycin estolate|mesh-list
24450236|NCT00318201|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24450237|NCT00318201|Erythromycin stearate|erythromycin stearate|mesh-list
24450238|NCT00318201|Diltiazem|diltiazem|mesh-list
24450440|NCT00319150|Hematinics|hematinics|mesh-ancestor
24450441|NCT00319163|Levonorgestrel|levonorgestrel|mesh-list
24450442|NCT00319163|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24450443|NCT00319163|Estradiol|estradiol|mesh-list
24450444|NCT00319163|Estrogens|estrogens|mesh-ancestor
24450445|NCT00319163|Hormones|hormones|mesh-ancestor
24450446|NCT00319163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24450447|NCT00319163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450448|NCT00319163|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24534586|NCT00647660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24534587|NCT00647660|Adrenergic Agents|adrenergic agents|mesh-ancestor
24534588|NCT00647660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25695070|NCT02040532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25695071|NCT02040532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25695072|NCT02040532|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25695073|NCT02040532|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25695074|NCT02040532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24603047|NCT00972140|Formoterol Fumarate|formoterol fumarate|mesh-list
24603082|NCT00972387|Prednisone|prednisone|mesh-list
24548885|NCT00712504|Docetaxel|docetaxel|mesh-list
24625680|NCT01082848|Serotonin Agents|serotonin agents|mesh-ancestor
24625681|NCT01082848|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24625682|NCT01082848|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24625683|NCT01082848|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24548704|NCT00711789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548706|NCT00711841|Dexamethasone acetate|dexamethasone acetate|mesh-list
24548707|NCT00711841|BB 1101|bb 1101|mesh-list
24548708|NCT00711841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24548709|NCT00711841|Antiemetics|antiemetics|mesh-ancestor
24548710|NCT00711841|Autonomic Agents|autonomic agents|mesh-ancestor
24548711|NCT00711841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24548712|NCT00711841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548713|NCT00711841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24548714|NCT00711841|Glucocorticoids|glucocorticoids|mesh-ancestor
24548715|NCT00711841|Hormones|hormones|mesh-ancestor
24548792|NCT00712062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548793|NCT00712062|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24548794|NCT00712062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24548795|NCT00712101|Abciximab|abciximab|mesh-list
24548796|NCT00712101|Anticoagulants|anticoagulants|mesh-ancestor
24548797|NCT00712101|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24548798|NCT00712114|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24548799|NCT00712114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24548800|NCT00712114|Immunologic Factors|immunologic factors|mesh-ancestor
24548802|NCT00712140|Trastuzumab|trastuzumab|mesh-list
24548806|NCT00712205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24548807|NCT00712205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548837|NCT00712439|Analgesics|analgesics|mesh-ancestor
24548872|NCT00712465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548873|NCT00712478|Insulin|insulin|mesh-list
24548875|NCT00712478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695075|NCT02040532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548879|NCT00712491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24548881|NCT00712491|Antifungal Agents|antifungal agents|mesh-ancestor
24548882|NCT00712491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24548883|NCT00712491|Immunologic Factors|immunologic factors|mesh-ancestor
24548884|NCT00712491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548887|NCT00712504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24625688|NCT01082926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24797723|NCT01957449|Sympatholytics|sympatholytics|mesh-ancestor
24625690|NCT01082926|Sensory System Agents|sensory system agents|mesh-ancestor
24548909|NCT00712556|Fluorides|fluorides|mesh-list
24548917|NCT00712595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548918|NCT00712595|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24548919|NCT00712595|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24548920|NCT00712595|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24548921|NCT00712595|Contraceptive Agents|contraceptive agents|mesh-ancestor
24548946|NCT00712686|Antiemetics|antiemetics|mesh-ancestor
24548947|NCT00712686|Autonomic Agents|autonomic agents|mesh-ancestor
24548948|NCT00712686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24548949|NCT00712686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548950|NCT00712686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24548951|NCT00712686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24548952|NCT00712686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24548953|NCT00712686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24548954|NCT00712686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24548955|NCT00712686|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24548956|NCT00712686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24548957|NCT00712686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24548958|NCT00712686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548959|NCT00712686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24548960|NCT00712686|Serotonin Agents|serotonin agents|mesh-ancestor
24548961|NCT00712686|Antidepressive Agents|antidepressive agents|mesh-ancestor
24548962|NCT00712686|Dopamine Agonists|dopamine agonists|mesh-ancestor
24548963|NCT00712686|Dopamine Agents|dopamine agents|mesh-ancestor
25406509|NCT03555149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25695076|NCT02040532|Antimanic Agents|antimanic agents|mesh-ancestor
25695077|NCT02040623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25695078|NCT02040623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24447658|NCT00309335|Adrenergic Agents|adrenergic agents|mesh-ancestor
24449136|NCT00314548|Epoprostenol|epoprostenol|mesh-list
24831214|NCT02164110|Immunologic Factors|immunologic factors|mesh-ancestor
24447659|NCT00309335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24447660|NCT00309335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625691|NCT01082926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24853504|NCT02268565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24447661|NCT00309335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447662|NCT00309335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24447663|NCT00309361|Phentolamine|phentolamine|mesh-list
24548989|NCT00712764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24548990|NCT00712764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548991|NCT00712777|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24549001|NCT00712790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549002|NCT00712790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24549003|NCT00712790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549004|NCT00712790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549006|NCT00712855|Mapatumumab|mapatumumab|mesh-list
24549007|NCT00712855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549008|NCT00712855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24549009|NCT00712855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549010|NCT00712855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549011|NCT00712894|Verapamil|verapamil|mesh-list
24549036|NCT00713011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549037|NCT00713011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24549038|NCT00713011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549039|NCT00713011|Vasodilator Agents|vasodilator agents|mesh-ancestor
24549041|NCT00713011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24549078|NCT00713336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24549079|NCT00713336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24549080|NCT00713336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24549081|NCT00713336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24549082|NCT00713336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625692|NCT01082926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625693|NCT01082926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24549086|NCT00713336|Contraceptive Agents|contraceptive agents|mesh-ancestor
24549087|NCT00713336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24549088|NCT00713336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549089|NCT00713336|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24549090|NCT00713336|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24549091|NCT00713336|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24549092|NCT00713440|Acetaminophen|acetaminophen|mesh-list
24549093|NCT00713440|Prednisolone|prednisolone|mesh-list
24549094|NCT00713440|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24549095|NCT00713440|Methylprednisolone|methylprednisolone|mesh-list
24549096|NCT00713440|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24549098|NCT00713440|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24549099|NCT00713440|Prednisolone phosphate|prednisolone phosphate|mesh-list
24549140|NCT00713674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24549141|NCT00713674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549142|NCT00713674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549144|NCT00713687|Oxaliplatin|oxaliplatin|mesh-list
24549145|NCT00713687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24549146|NCT00713687|Antimetabolites|antimetabolites|mesh-ancestor
24549147|NCT00713687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549148|NCT00713687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549149|NCT00713687|Antiviral Agents|antiviral agents|mesh-ancestor
24549150|NCT00713687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24549152|NCT00713687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24549153|NCT00713687|Immunologic Factors|immunologic factors|mesh-ancestor
24549154|NCT00713687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625696|NCT01082926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24638262|NCT01155765|Clopidogrel|clopidogrel|mesh-list
24625698|NCT01083017|Antihypertensive Agents|antihypertensive agents|mesh-list
24625699|NCT01083017|Diuretics|diuretics|mesh-ancestor
24625700|NCT01083017|Natriuretic Agents|natriuretic agents|mesh-ancestor
24625701|NCT01083017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625702|NCT01083017|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24625703|NCT01083017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25075945|NCT03377101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549167|NCT00713726|Anesthetics|anesthetics|mesh-ancestor
24549168|NCT00713739|Prazosin|prazosin|mesh-list
24549223|NCT00713999|Praziquantel|praziquantel|mesh-list
24940104|NCT04003688|Sensory System Agents|sensory system agents|mesh-ancestor
24940105|NCT04003688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24940106|NCT04003688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940107|NCT04003688|Anesthetics|anesthetics|mesh-ancestor
24940108|NCT04003688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24940109|NCT04003688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24940110|NCT04003688|Anticonvulsants|anticonvulsants|mesh-ancestor
24940111|NCT04003688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24940112|NCT04003688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24831265|NCT02164578|Rivaroxaban|rivaroxaban|mesh-list
24831266|NCT02164578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24940114|NCT04003688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24853525|NCT02268773|Aspirin|aspirin|mesh-list
24549235|NCT00714064|Antidotes|antidotes|mesh-ancestor
24549236|NCT00714064|Protective Agents|protective agents|mesh-ancestor
24549237|NCT00714064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549238|NCT00714064|Chelating Agents|chelating agents|mesh-ancestor
24549239|NCT00714064|Sequestering Agents|sequestering agents|mesh-ancestor
24549240|NCT00714064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549241|NCT00714064|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24549242|NCT00714064|Anticoagulants|anticoagulants|mesh-ancestor
24549255|NCT00714103|Adenosine|adenosine|mesh-list
25050617|NCT00482092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24782032|NCT01893450|Vasodilator Agents|vasodilator agents|mesh-ancestor
24940122|NCT04003376|Vitamins|vitamins|mesh-ancestor
24940123|NCT04003376|Micronutrients|micronutrients|mesh-ancestor
24940124|NCT04003376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940125|NCT04003376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24940126|NCT04003376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24940127|NCT04003376|Glucocorticoids|glucocorticoids|mesh-ancestor
24940128|NCT04003376|Hormones|hormones|mesh-ancestor
24549285|NCT00714246|Mitosis Modulators|mitosis modulators|mesh-ancestor
24549286|NCT00714246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549287|NCT00714376|Docetaxel|docetaxel|mesh-list
24549288|NCT00714376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549289|NCT00714376|Tubulin Modulators|tubulin modulators|mesh-ancestor
24549290|NCT00714376|Antimitotic Agents|antimitotic agents|mesh-ancestor
24549291|NCT00714376|Mitosis Modulators|mitosis modulators|mesh-ancestor
24549292|NCT00714376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549293|NCT00714480|Thymoglobulin|thymoglobulin|mesh-list
24549294|NCT00714480|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24549295|NCT00714480|Immunologic Factors|immunologic factors|mesh-ancestor
24549317|NCT00714584|Naltrexone|naltrexone|mesh-list
24549318|NCT00714584|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24549319|NCT00714584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24549320|NCT00714584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549321|NCT00714584|Sensory System Agents|sensory system agents|mesh-ancestor
24549323|NCT00714623|Sirolimus|sirolimus|mesh-list
24549347|NCT00714779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940129|NCT04003376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24940130|NCT04003376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24940131|NCT04003376|Immunologic Factors|immunologic factors|mesh-ancestor
24940132|NCT04003376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24940133|NCT04003376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940134|NCT04003467|Teriparatide|teriparatide|mesh-list
24940135|NCT04003467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24940136|NCT04003467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549390|NCT00715013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549391|NCT00715013|Tubulin Modulators|tubulin modulators|mesh-ancestor
24549591|NCT00716183|Clavulanic Acid|clavulanic acid|mesh-list
24447702|NCT00309478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24447703|NCT00309478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24447704|NCT00309478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24447705|NCT00309478|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24627791|NCT01094964|Alkylating Agents|alkylating agents|mesh-ancestor
24447709|NCT00309478|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24447710|NCT00309478|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24447711|NCT00309478|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24447713|NCT00309491|Aminoglutethimide|aminoglutethimide|mesh-list
24447714|NCT00309491|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24447715|NCT00309491|Hormone Antagonists|hormone antagonists|mesh-ancestor
24940137|NCT04003467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24940138|NCT04003402|Ethanol|ethanol|mesh-list
24940139|NCT04003402|ASP8062|asp8062|mesh-list
24940140|NCT04003402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24940141|NCT04003402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24940142|NCT04003402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24940143|NCT04003402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940144|NCT04003402|Analgesics|analgesics|mesh-ancestor
24549422|NCT00715091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24549423|NCT00715091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24549424|NCT00715091|Analgesics|analgesics|mesh-ancestor
24549425|NCT00715091|Sensory System Agents|sensory system agents|mesh-ancestor
24549426|NCT00715091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24549427|NCT00715091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549428|NCT00715091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24549429|NCT00715091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24549431|NCT00715091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549437|NCT00715273|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
24549438|NCT00715273|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24549439|NCT00715273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24549441|NCT00715273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549442|NCT00715273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24549444|NCT00715273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24940150|NCT04003402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940151|NCT04003350|Acetaminophen|acetaminophen|mesh-list
24940152|NCT04003350|Meloxicam|meloxicam|mesh-list
24940153|NCT04003350|Oxycodone|oxycodone|mesh-list
24940154|NCT04003350|Tramadol|tramadol|mesh-list
24940155|NCT04003350|Gabapentin|gabapentin|mesh-list
24940156|NCT04003350|Esomeprazole|esomeprazole|mesh-list
24940157|NCT04003350|Metaxalone|metaxalone|mesh-list
24853572|NCT02269046|Antimetabolites|antimetabolites|mesh-ancestor
24549592|NCT00716183|Lactams|lactams|mesh-list
24549499|NCT00715663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24549500|NCT00715663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549502|NCT00715689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24549503|NCT00715689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549504|NCT00715702|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
24549505|NCT00715702|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24549506|NCT00715702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549507|NCT00715702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24549508|NCT00715702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24940178|NCT04003350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24940180|NCT04003350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24549518|NCT00715715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549520|NCT00715780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24549521|NCT00715780|Insulin Aspart|insulin aspart|mesh-list
24549522|NCT00715780|Insulin, Long-Acting|insulin, long-acting|mesh-list
24549523|NCT00715780|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24549524|NCT00715780|Insulin Detemir|insulin detemir|mesh-list
24549530|NCT00715780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549531|NCT00715858|Doxycycline|doxycycline|mesh-list
24549532|NCT00715858|Rifampin|rifampin|mesh-list
24549533|NCT00715858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24940192|NCT04003207|Hormones|hormones|mesh-list
24940193|NCT04003207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24940194|NCT04003207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940195|NCT04003181|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24940197|NCT04003181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24940198|NCT04003181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24940199|NCT04003012|Lidocaine|lidocaine|mesh-list
24940200|NCT04003012|Anesthetics, Local|anesthetics, local|mesh-ancestor
24940201|NCT04003012|Anesthetics|anesthetics|mesh-ancestor
24940202|NCT04003012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24800436|NCT01975714|Bimatoprost|bimatoprost|mesh-list
24549555|NCT00715871|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24549556|NCT00715871|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24549557|NCT00715871|Cholinergic Agents|cholinergic agents|mesh-ancestor
24549558|NCT00715871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24549559|NCT00715871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549560|NCT00715975|Clobetasol|clobetasol|mesh-list
24549588|NCT00716183|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24549589|NCT00716183|Amoxicillin|amoxicillin|mesh-list
24549590|NCT00716183|Clavulanic Acids|clavulanic acids|mesh-list
24549594|NCT00716183|Cloxacillin|cloxacillin|mesh-list
24549595|NCT00716183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24549629|NCT00716469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549630|NCT00716469|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24549631|NCT00716469|Dermatologic Agents|dermatologic agents|mesh-ancestor
24549632|NCT00716521|Zolpidem|zolpidem|mesh-list
24549633|NCT00716521|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24549634|NCT00716521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24549635|NCT00716521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24549636|NCT00716521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549637|NCT00716521|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24549638|NCT00716521|GABA Agonists|gaba agonists|mesh-ancestor
24549639|NCT00716521|GABA Agents|gaba agents|mesh-ancestor
24549640|NCT00716521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24940203|NCT04003012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940204|NCT04003012|Sensory System Agents|sensory system agents|mesh-ancestor
24940205|NCT04003012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24940206|NCT04003012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25695079|NCT02040766|Beclomethasone|beclomethasone|mesh-list
24940207|NCT04003012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25695080|NCT02040766|Albuterol|albuterol|mesh-list
25695081|NCT02040766|Bronchodilator Agents|bronchodilator agents|mesh-list
24940208|NCT04003012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24940209|NCT04003012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25075946|NCT03377101|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24549641|NCT00716521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549642|NCT00716547|Celecoxib|celecoxib|mesh-list
24549643|NCT00716547|Ketoprofen|ketoprofen|mesh-list
24549644|NCT00716547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24734225|NCT01651325|Isavuconazole|isavuconazole|mesh-list
24549688|NCT00716924|Purinergic Agents|purinergic agents|mesh-ancestor
24549689|NCT00716924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24549691|NCT00716924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549713|NCT00717340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24940221|NCT04002635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24940222|NCT04002635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940223|NCT04002635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24940224|NCT04002635|Contraceptive Agents|contraceptive agents|mesh-ancestor
24940225|NCT04002635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24940226|NCT04002635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24940227|NCT04002635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24853620|NCT02269228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24853621|NCT02269280|Azacitidine|azacitidine|mesh-list
24853622|NCT02269280|Decitabine|decitabine|mesh-list
24853623|NCT02269280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24853624|NCT02269280|Antimetabolites|antimetabolites|mesh-ancestor
24853625|NCT02269280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549742|NCT00717379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24549743|NCT00717379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24549744|NCT00717379|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24549745|NCT00717379|Protective Agents|protective agents|mesh-ancestor
24549746|NCT00717470|Mycophenolic Acid|mycophenolic acid|mesh-list
24549747|NCT00717470|Prednisone|prednisone|mesh-list
24549748|NCT00717470|Methylprednisolone|methylprednisolone|mesh-list
24549749|NCT00717470|Tacrolimus|tacrolimus|mesh-list
24549751|NCT00717470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24549752|NCT00717470|Glucocorticoids|glucocorticoids|mesh-ancestor
24549761|NCT00717470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549762|NCT00717470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549763|NCT00717470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24549764|NCT00717470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24549765|NCT00717470|Antitubercular Agents|antitubercular agents|mesh-ancestor
24940229|NCT04002635|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24549803|NCT00717587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549804|NCT00717587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24549805|NCT00717587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24549806|NCT00717587|Growth Substances|growth substances|mesh-ancestor
24549807|NCT00717587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549808|NCT00717587|Growth Inhibitors|growth inhibitors|mesh-ancestor
24549809|NCT00717587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24549810|NCT00717587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24452681|NCT05457829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24549811|NCT00717587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549812|NCT00717587|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24549813|NCT00717587|Dermatologic Agents|dermatologic agents|mesh-ancestor
24940240|NCT04002323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940241|NCT04002323|Antiviral Agents|antiviral agents|mesh-ancestor
24940242|NCT04002323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24940243|NCT04002323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24940244|NCT04002323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24549834|NCT00717678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24549835|NCT00717678|Antitubercular Agents|antitubercular agents|mesh-ancestor
24549836|NCT00717678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24549837|NCT00717678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24549839|NCT00717704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24940255|NCT04002271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24940256|NCT04002271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24549870|NCT00717808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549923|NCT00717990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24549924|NCT00717990|Antimetabolites|antimetabolites|mesh-ancestor
24549925|NCT00717990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549960|NCT00718354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24549961|NCT00718354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24549962|NCT00718354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24549963|NCT00718354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549964|NCT00718354|Anticoagulants|anticoagulants|mesh-ancestor
25695082|NCT02040766|Autonomic Agents|autonomic agents|mesh-ancestor
25695083|NCT02040766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25695084|NCT02040766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695085|NCT02040766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25695086|NCT02040766|Respiratory System Agents|respiratory system agents|mesh-ancestor
25695087|NCT02040766|Tocolytic Agents|tocolytic agents|mesh-ancestor
25695088|NCT02040766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25695089|NCT02040766|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25695090|NCT02040766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24940266|NCT04002700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24940267|NCT04002700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24940268|NCT04002700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24940269|NCT04002700|Dopamine Agents|dopamine agents|mesh-ancestor
24940270|NCT04002700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24940271|NCT04002700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608626|NCT00992823|Iron|iron|mesh-list
24550054|NCT00718796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24550055|NCT00718796|Antimetabolites|antimetabolites|mesh-ancestor
24550097|NCT00719095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24550098|NCT00719095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550099|NCT00719095|Analgesics|analgesics|mesh-ancestor
24550100|NCT00719095|Sensory System Agents|sensory system agents|mesh-ancestor
24550121|NCT00719121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550122|NCT00719173|Cyclophosphamide|cyclophosphamide|mesh-list
24550124|NCT00719173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24550125|NCT00719173|Immunologic Factors|immunologic factors|mesh-ancestor
24550126|NCT00719173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550127|NCT00719173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24550128|NCT00719173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24550129|NCT00719173|Alkylating Agents|alkylating agents|mesh-ancestor
24550130|NCT00719173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550131|NCT00719173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550132|NCT00719173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24550222|NCT00719745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24550223|NCT00719745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550224|NCT00719745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550225|NCT00719758|Beraprost|beraprost|mesh-list
24447803|NCT00309621|Alitretinoin|alitretinoin|mesh-list
24550248|NCT00719797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24550249|NCT00719797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24550250|NCT00719797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550251|NCT00719797|Antidotes|antidotes|mesh-ancestor
24831590|NCT02167061|Metformin|metformin|mesh-list
24550252|NCT00719797|Protective Agents|protective agents|mesh-ancestor
24550253|NCT00719797|Vitamin B Complex|vitamin b complex|mesh-ancestor
24550254|NCT00719797|Vitamins|vitamins|mesh-ancestor
24550255|NCT00719797|Micronutrients|micronutrients|mesh-ancestor
24550256|NCT00719823|Maraviroc|maraviroc|mesh-list
24550294|NCT00720148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550295|NCT00720148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24550296|NCT00720148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24550297|NCT00720148|Growth Substances|growth substances|mesh-ancestor
24550299|NCT00720148|Growth Inhibitors|growth inhibitors|mesh-ancestor
24447817|NCT00309673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24447818|NCT00309673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550331|NCT00720304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550332|NCT00720304|Tubulin Modulators|tubulin modulators|mesh-ancestor
24550333|NCT00720304|Antimitotic Agents|antimitotic agents|mesh-ancestor
24550334|NCT00720304|Mitosis Modulators|mitosis modulators|mesh-ancestor
24940278|NCT04002440|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24940279|NCT04002440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940280|NCT04002349|Budesonide|budesonide|mesh-list
24940281|NCT04002349|Levocabastine|levocabastine|mesh-list
24550341|NCT00720408|Immunologic Factors|immunologic factors|mesh-ancestor
24550342|NCT00720408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550343|NCT00720408|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24550344|NCT00720408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550345|NCT00720408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940286|NCT04002349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940287|NCT04002349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25050619|NCT00482092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25695091|NCT02040766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25695092|NCT02040766|Adrenergic Agents|adrenergic agents|mesh-ancestor
25695093|NCT02040766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25695094|NCT02040766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695095|NCT02040766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25695096|NCT02040766|Glucocorticoids|glucocorticoids|mesh-ancestor
25695097|NCT02040766|Hormones|hormones|mesh-ancestor
24831961|NCT02169856|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24831962|NCT02169856|Cholinergic Agents|cholinergic agents|mesh-ancestor
24831964|NCT02169882|Dexamethasone|dexamethasone|mesh-list
24831965|NCT02169882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24940337|NCT04001959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940338|NCT04002089|Bupivacaine|bupivacaine|mesh-list
24940339|NCT04002089|Anesthetics, Local|anesthetics, local|mesh-ancestor
24940340|NCT04002089|Anesthetics|anesthetics|mesh-ancestor
24940341|NCT04002089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24940342|NCT04002089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533365|NCT00643409|Azithromycin|azithromycin|mesh-list
24533366|NCT00643409|Levofloxacin|levofloxacin|mesh-list
24533367|NCT00643409|Ofloxacin|ofloxacin|mesh-list
24533368|NCT00643409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24533369|NCT00643409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24533370|NCT00643409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24437336|NCT00273442|Dorzolamide|dorzolamide|mesh-list
24533419|NCT00643799|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25695101|NCT02040779|Bronchodilator Agents|bronchodilator agents|mesh-list
24458281|NCT00337376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24458282|NCT00337376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458283|NCT00337376|Tubulin Modulators|tubulin modulators|mesh-ancestor
24458284|NCT00337376|Antimitotic Agents|antimitotic agents|mesh-ancestor
24533430|NCT00643877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24533431|NCT00644020|Fluorouracil|fluorouracil|mesh-list
24533432|NCT00644020|Mitomycins|mitomycins|mesh-list
24450045|NCT00317681|Immunologic Factors|immunologic factors|mesh-ancestor
25079294|NCT03348917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24450046|NCT00317681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450047|NCT00317681|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24450049|NCT00317681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450051|NCT00317733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24450052|NCT00317733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24450053|NCT00317733|Analgesics|analgesics|mesh-ancestor
24450064|NCT00317746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24450065|NCT00317746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24450066|NCT00317746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450067|NCT00317746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24450068|NCT00317746|Serotonin Agents|serotonin agents|mesh-ancestor
24450069|NCT00317746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437636|NCT00274066|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24940343|NCT04002089|Sensory System Agents|sensory system agents|mesh-ancestor
24940344|NCT04002089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24940345|NCT04002245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
24940346|NCT04002245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24831990|NCT02169973|JNJ-42165279|jnj-42165279|mesh-list
24533448|NCT00644033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24394236|NCT00132639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050622|NCT00481325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25050624|NCT00481325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050625|NCT00481325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050626|NCT00481325|Serotonin Agents|serotonin agents|mesh-ancestor
25050627|NCT00481325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050628|NCT00481325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25050629|NCT00481325|Antidepressive Agents|antidepressive agents|mesh-ancestor
25050630|NCT00481325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25050631|NCT00480831|Paclitaxel|paclitaxel|mesh-list
25050632|NCT00480831|Bevacizumab|bevacizumab|mesh-list
25050633|NCT00480831|Carboplatin|carboplatin|mesh-list
25050634|NCT00480831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25050635|NCT00480831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050636|NCT00480831|Tubulin Modulators|tubulin modulators|mesh-ancestor
25050637|NCT00480831|Antimitotic Agents|antimitotic agents|mesh-ancestor
25050638|NCT00480831|Mitosis Modulators|mitosis modulators|mesh-ancestor
25050639|NCT00480831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050640|NCT00480831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25050641|NCT00480831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24701665|NCT01460212|Serotonin Agents|serotonin agents|mesh-ancestor
24701666|NCT01460212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701667|NCT01460212|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24701701|NCT01460498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701702|NCT01460498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701703|NCT01460498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050643|NCT00480831|Growth Substances|growth substances|mesh-ancestor
25050644|NCT00480831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050645|NCT00480831|Growth Inhibitors|growth inhibitors|mesh-ancestor
25050648|NCT00479817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25050649|NCT00479817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050650|NCT00479817|Tubulin Modulators|tubulin modulators|mesh-ancestor
25050651|NCT00479817|Antimitotic Agents|antimitotic agents|mesh-ancestor
25050652|NCT00479817|Mitosis Modulators|mitosis modulators|mesh-ancestor
25050653|NCT00479817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050654|NCT00479817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25050655|NCT00479817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25050656|NCT00479817|Growth Substances|growth substances|mesh-ancestor
25050657|NCT00479817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050658|NCT00479817|Growth Inhibitors|growth inhibitors|mesh-ancestor
25050659|NCT00479258|Insulin|insulin|mesh-list
25050660|NCT00479258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25050661|NCT00479258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25050662|NCT00479258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050663|NCT00478972|Rimonabant|rimonabant|mesh-list
25050664|NCT00478972|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25050665|NCT00478972|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24701828|NCT01461460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24701829|NCT01461460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24701830|NCT01461460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701831|NCT01461460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701832|NCT01461460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701833|NCT01461460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24701835|NCT01461577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24701852|NCT01461772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701853|NCT01461876|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24701910|NCT01462669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695102|NCT02040779|Autonomic Agents|autonomic agents|mesh-ancestor
24701929|NCT01462968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24701936|NCT01463046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701937|NCT01463046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701938|NCT01463046|Antiviral Agents|antiviral agents|mesh-ancestor
24701939|NCT01463046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24701940|NCT01463046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24701941|NCT01463046|Immunologic Factors|immunologic factors|mesh-ancestor
24701942|NCT01463046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701945|NCT01463046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24701946|NCT01463046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701947|NCT01463046|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24701986|NCT01463280|Anesthetics, Local|anesthetics, local|mesh-ancestor
24701987|NCT01463280|Anesthetics|anesthetics|mesh-ancestor
24701988|NCT01463280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24701989|NCT01463280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701990|NCT01463280|Sensory System Agents|sensory system agents|mesh-ancestor
24701991|NCT01463280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24701992|NCT01463280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24701993|NCT01463280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24701994|NCT01463280|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24701995|NCT01463280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24702022|NCT01463592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24613341|NCT01018381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24613342|NCT01018381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613343|NCT01018381|Antiviral Agents|antiviral agents|mesh-ancestor
24613344|NCT01018446|Busulfan|busulfan|mesh-list
24613345|NCT01018446|Alkylating Agents|alkylating agents|mesh-ancestor
24613346|NCT01018446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613347|NCT01018446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24613348|NCT01018446|Immunologic Factors|immunologic factors|mesh-ancestor
24613353|NCT01018485|Botulinum Toxins|botulinum toxins|mesh-list
25050681|NCT00478595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050682|NCT00478179|Bupivacaine|bupivacaine|mesh-list
25050683|NCT00478179|Anesthetics, Local|anesthetics, local|mesh-ancestor
25050684|NCT00478179|Anesthetics|anesthetics|mesh-ancestor
25050685|NCT00478179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25050686|NCT00478179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050687|NCT00478179|Sensory System Agents|sensory system agents|mesh-ancestor
24956413|NCT03854708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24613354|NCT01018485|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24613355|NCT01018485|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24613356|NCT01018485|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24613357|NCT01018485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24613358|NCT01018485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613359|NCT01018485|Cholinergic Agents|cholinergic agents|mesh-ancestor
24613360|NCT01018485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24613361|NCT01018485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613362|NCT01018485|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24613371|NCT01018615|Silymarin|silymarin|mesh-list
24702040|NCT01463774|Metformin|metformin|mesh-list
24702041|NCT01463774|Canagliflozin|canagliflozin|mesh-list
24702042|NCT01463774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24702043|NCT01463774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806807|NCT02018263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806808|NCT02018263|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24806809|NCT02018263|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24702044|NCT01463774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24702045|NCT01463774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702046|NCT01463813|Vitamin D|vitamin d|mesh-list
24702047|NCT01463813|Ergocalciferols|ergocalciferols|mesh-list
24702048|NCT01463813|Cholecalciferol|cholecalciferol|mesh-list
24702050|NCT01463813|Micronutrients|micronutrients|mesh-ancestor
24702051|NCT01463813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702052|NCT01463813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24702053|NCT01463813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24702055|NCT01463852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24702056|NCT01463852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24702074|NCT01463956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702075|NCT01464008|Interferons|interferons|mesh-list
24702076|NCT01464008|Ribavirin|ribavirin|mesh-list
24832098|NCT02170675|Ketoconazole|ketoconazole|mesh-list
24832130|NCT02170740|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832131|NCT02170740|Protease Inhibitors|protease inhibitors|mesh-ancestor
24702106|NCT01464060|Metronidazole|metronidazole|mesh-list
24702107|NCT01464060|Clarithromycin|clarithromycin|mesh-list
24702108|NCT01464060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24702109|NCT01464060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24702110|NCT01464060|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24702111|NCT01464060|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24702112|NCT01464060|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24702113|NCT01464060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702114|NCT01464060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487771|NCT00464958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24702115|NCT01464060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24702116|NCT01464060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24702118|NCT01464099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24702119|NCT01464099|Insulin Aspart|insulin aspart|mesh-list
24702120|NCT01464099|Insulin, Long-Acting|insulin, long-acting|mesh-list
24702121|NCT01464099|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24702122|NCT01464099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24702123|NCT01464099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702124|NCT01464112|Dexamethasone|dexamethasone|mesh-list
24702212|NCT01464593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702213|NCT01464606|Dactinomycin|dactinomycin|mesh-list
24702214|NCT01464606|Cyclophosphamide|cyclophosphamide|mesh-list
24702215|NCT01464606|Ifosfamide|ifosfamide|mesh-list
24438881|NCT00276835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24956416|NCT03854708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832133|NCT02170766|Pantoprazole|pantoprazole|mesh-list
24832134|NCT02170766|Dabigatran|dabigatran|mesh-list
24832207|NCT02170909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832209|NCT02170922|Dabigatran|dabigatran|mesh-list
24832214|NCT02170922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832216|NCT02170935|Dabigatran|dabigatran|mesh-list
24832217|NCT02170935|Antithrombins|antithrombins|mesh-ancestor
24940365|NCT04002024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24940367|NCT04002024|Analgesics|analgesics|mesh-ancestor
24940368|NCT04002024|Sensory System Agents|sensory system agents|mesh-ancestor
24940369|NCT04002024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24940370|NCT04002024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702248|NCT01464671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702249|NCT01464762|Bedaquiline|bedaquiline|mesh-list
24702250|NCT01464762|Antitubercular Agents|antitubercular agents|mesh-ancestor
24702251|NCT01464762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24702252|NCT01464762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24702253|NCT01464801|Resveratrol|resveratrol|mesh-list
24702254|NCT01464801|Antioxidants|antioxidants|mesh-ancestor
24702255|NCT01464801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702256|NCT01464801|Protective Agents|protective agents|mesh-ancestor
24702257|NCT01464801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702258|NCT01464801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702259|NCT01464801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24702267|NCT01464944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702276|NCT01464944|Antipyretics|antipyretics|mesh-ancestor
24702301|NCT01465009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702302|NCT01465009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24702303|NCT01465009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24702304|NCT01465009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24702305|NCT01465009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24940372|NCT04002024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24940373|NCT04002024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24940374|NCT04002024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24940375|NCT04002024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940377|NCT04001712|Caffeine citrate|caffeine citrate|mesh-list
24940378|NCT04001712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702406|NCT01465828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24702407|NCT01465828|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24702408|NCT01465828|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24702410|NCT01465828|Purinergic Agents|purinergic agents|mesh-ancestor
24702411|NCT01465828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24702412|NCT01465828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702413|NCT01465828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702415|NCT01465867|Antioxidants|antioxidants|mesh-ancestor
24702439|NCT01465906|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24702440|NCT01465906|Cholinergic Agents|cholinergic agents|mesh-ancestor
24702441|NCT01465906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24702442|NCT01465906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702443|NCT01465906|Anticonvulsants|anticonvulsants|mesh-ancestor
24702447|NCT01465919|Mirtazapine|mirtazapine|mesh-list
24702475|NCT01466101|Analgesics|analgesics|mesh-ancestor
24702476|NCT01466101|Sensory System Agents|sensory system agents|mesh-ancestor
24702477|NCT01466101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24702478|NCT01466101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702479|NCT01466101|Anticonvulsants|anticonvulsants|mesh-ancestor
24702480|NCT01466101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24702481|NCT01466101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24702482|NCT01466101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702483|NCT01466101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24702484|NCT01466101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24940379|NCT04001712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24940380|NCT04001712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940381|NCT04001712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24940382|NCT04001712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24940383|NCT04001712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24940384|NCT04001712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24940385|NCT04001712|Purinergic Agents|purinergic agents|mesh-ancestor
24940386|NCT04001712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24940388|NCT04001855|Retinol acetate|retinol acetate|mesh-list
24940389|NCT04001855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24702485|NCT01466101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24702486|NCT01466101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24702487|NCT01466101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24702496|NCT01466114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702497|NCT01466114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24703206|NCT01470157|Anesthetics, General|anesthetics, general|mesh-ancestor
24702511|NCT01466231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702512|NCT01466244|Cetuximab|cetuximab|mesh-list
24702513|NCT01466244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24702514|NCT01466244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24702515|NCT01466257|Cetuximab|cetuximab|mesh-list
24702516|NCT01466257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24702517|NCT01466257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24702518|NCT01466452|Aspirin|aspirin|mesh-list
24702519|NCT01466452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24702520|NCT01466452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24702521|NCT01466452|Analgesics|analgesics|mesh-ancestor
24702522|NCT01466452|Sensory System Agents|sensory system agents|mesh-ancestor
24702523|NCT01466452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24702524|NCT01466452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702525|NCT01466452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24702526|NCT01466452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24702527|NCT01466452|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24702528|NCT01466452|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24702529|NCT01466452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702530|NCT01466452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24702531|NCT01466452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24940392|NCT04001855|Immunologic Factors|immunologic factors|mesh-ancestor
24940393|NCT04001855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940394|NCT04001855|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24804222|NCT02001584|GABA Agents|gaba agents|mesh-ancestor
24804223|NCT02001740|Lidocaine|lidocaine|mesh-list
24804224|NCT02001740|Anesthetics, Local|anesthetics, local|mesh-ancestor
24804225|NCT02001740|Anesthetics|anesthetics|mesh-ancestor
24804226|NCT02001740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24940395|NCT04001855|Protective Agents|protective agents|mesh-ancestor
24940396|NCT04001855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24940397|NCT04001725|Metformin|metformin|mesh-list
24940398|NCT04001725|Dexamethasone|dexamethasone|mesh-list
24940399|NCT04001725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24940400|NCT04001725|Antiemetics|antiemetics|mesh-ancestor
24940401|NCT04001725|Autonomic Agents|autonomic agents|mesh-ancestor
24940402|NCT04001725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24702556|NCT01466517|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24702557|NCT01466517|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24702558|NCT01466517|Analgesics|analgesics|mesh-ancestor
24702559|NCT01466517|Sensory System Agents|sensory system agents|mesh-ancestor
24702560|NCT01466517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24702561|NCT01466517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702562|NCT01466517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24702563|NCT01466517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24702564|NCT01466517|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24702592|NCT01466712|Autonomic Agents|autonomic agents|mesh-ancestor
24702593|NCT01466712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24702594|NCT01466712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702595|NCT01466712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24702596|NCT01466712|Respiratory System Agents|respiratory system agents|mesh-ancestor
24702597|NCT01466712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24702598|NCT01466712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24702599|NCT01466712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24702600|NCT01466712|Adrenergic Agents|adrenergic agents|mesh-ancestor
24702601|NCT01466712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24702602|NCT01466712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702603|NCT01466712|Parasympatholytics|parasympatholytics|mesh-ancestor
24702604|NCT01466712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24702605|NCT01466712|Cholinergic Agents|cholinergic agents|mesh-ancestor
24702612|NCT01466829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24702613|NCT01466829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702639|NCT01467011|Mycophenolic Acid|mycophenolic acid|mesh-list
24702640|NCT01467011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24613404|NCT01018849|Micronutrients|micronutrients|mesh-ancestor
24613405|NCT01018849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613406|NCT01018849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24613407|NCT01018849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24613408|NCT01018914|Mycophenolic Acid|mycophenolic acid|mesh-list
24613409|NCT01018914|Tacrolimus|tacrolimus|mesh-list
24613410|NCT01018914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24613411|NCT01018914|Immunologic Factors|immunologic factors|mesh-ancestor
24613412|NCT01018914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613413|NCT01018914|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24613414|NCT01018914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613415|NCT01018914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613416|NCT01018914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24940403|NCT04001725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940404|NCT04001725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24940407|NCT04001725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24940408|NCT04001725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24940409|NCT04001725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24940410|NCT04001725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24940439|NCT04001465|Cholinergic Agents|cholinergic agents|mesh-ancestor
24940440|NCT04001465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24940441|NCT04001465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765190|NCT01786538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695103|NCT02040779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25695104|NCT02040779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695105|NCT02040779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25695106|NCT02040779|Respiratory System Agents|respiratory system agents|mesh-ancestor
25695107|NCT02040779|Tocolytic Agents|tocolytic agents|mesh-ancestor
24468913|NCT00383890|Analgesics|analgesics|mesh-ancestor
24495826|NCT00502112|Lintuzumab|lintuzumab|mesh-list
24804461|NCT02002663|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24804463|NCT02002663|Prednisolone acetate|prednisolone acetate|mesh-list
24765191|NCT01786538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24765202|NCT01786616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24765203|NCT01786616|Autonomic Agents|autonomic agents|mesh-ancestor
24853870|NCT02270788|Abortifacient Agents|abortifacient agents|mesh-ancestor
24702853|NCT01468051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24702855|NCT01468051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702856|NCT01468051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24702857|NCT01468155|Dabigatran|dabigatran|mesh-list
24702858|NCT01468155|Antithrombins|antithrombins|mesh-ancestor
24702859|NCT01468155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24702860|NCT01468155|Protease Inhibitors|protease inhibitors|mesh-ancestor
24702861|NCT01468155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702862|NCT01468155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702863|NCT01468155|Anticoagulants|anticoagulants|mesh-ancestor
24702864|NCT01468259|Droxidopa|droxidopa|mesh-list
24702865|NCT01468259|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24702866|NCT01468259|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24702867|NCT01468272|Beclomethasone|beclomethasone|mesh-list
24702868|NCT01468272|Formoterol Fumarate|formoterol fumarate|mesh-list
24702869|NCT01468272|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24702870|NCT01468272|Autonomic Agents|autonomic agents|mesh-ancestor
24702871|NCT01468272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24702872|NCT01468272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702887|NCT01468285|Histamine Agonists|histamine agonists|mesh-ancestor
24702888|NCT01468285|Histamine Agents|histamine agents|mesh-ancestor
24702889|NCT01468285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24702890|NCT01468285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702891|NCT01468285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702892|NCT01468389|Capecitabine|capecitabine|mesh-list
24702949|NCT01468688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702950|NCT01468688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702951|NCT01468714|Ketoconazole|ketoconazole|mesh-list
24702952|NCT01468714|Antifungal Agents|antifungal agents|mesh-ancestor
24702953|NCT01468714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24702954|NCT01468714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24832352|NCT02171338|Tazobactam|tazobactam|mesh-list
24832353|NCT02171338|Piperacillin|piperacillin|mesh-list
24735986|NCT01659476|Methacholine Chloride|methacholine chloride|mesh-list
24702955|NCT01468714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24702956|NCT01468714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702957|NCT01468714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702958|NCT01468714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24702959|NCT01468714|Hormone Antagonists|hormone antagonists|mesh-ancestor
24703207|NCT01470157|Anesthetics|anesthetics|mesh-ancestor
24702960|NCT01468714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24702961|NCT01468714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765204|NCT01786616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24765205|NCT01786616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765206|NCT01786616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24765207|NCT01786616|Respiratory System Agents|respiratory system agents|mesh-ancestor
24765208|NCT01786616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24765209|NCT01786616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24765210|NCT01786616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24765214|NCT01786655|Epinephrine|epinephrine|mesh-list
24940443|NCT04001231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24702962|NCT01468714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24702964|NCT01468740|Cyclophosphamide|cyclophosphamide|mesh-list
24702965|NCT01468740|Dacarbazine|dacarbazine|mesh-list
24702966|NCT01468740|Doxorubicin|doxorubicin|mesh-list
24702980|NCT01468740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24702981|NCT01468740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25695108|NCT02040779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25695109|NCT02040779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25695110|NCT02040779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24605817|NCT00987454|Hematinics|hematinics|mesh-ancestor
24702982|NCT01468740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24702983|NCT01468740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24702984|NCT01468740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702985|NCT01468740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24702986|NCT01468740|Glucocorticoids|glucocorticoids|mesh-ancestor
24702987|NCT01468740|Hormones|hormones|mesh-ancestor
24703031|NCT01469416|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24703032|NCT01469416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24703033|NCT01469416|Purinergic Agents|purinergic agents|mesh-ancestor
24703034|NCT01469416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24613418|NCT01018914|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24613419|NCT01018914|Antitubercular Agents|antitubercular agents|mesh-ancestor
24613420|NCT01018914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24613421|NCT01018914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24703079|NCT01469572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703080|NCT01469572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24703081|NCT01469572|Immunologic Factors|immunologic factors|mesh-ancestor
24703082|NCT01469572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703083|NCT01469572|Hormones|hormones|mesh-ancestor
24703086|NCT01469598|Docetaxel|docetaxel|mesh-list
24703087|NCT01469598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24703149|NCT01469988|Androgens|androgens|mesh-ancestor
24703151|NCT01469988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24703152|NCT01469988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703153|NCT01470040|Aspirin|aspirin|mesh-list
24488807|NCT00470197|Cytarabine|cytarabine|mesh-list
24703154|NCT01470040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24703155|NCT01470040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24703156|NCT01470040|Analgesics|analgesics|mesh-ancestor
24703166|NCT01470040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24703167|NCT01470040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703168|NCT01470040|Antipyretics|antipyretics|mesh-ancestor
24940447|NCT04001231|Hormones|hormones|mesh-ancestor
24940448|NCT04001231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24940452|NCT04001400|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24940453|NCT04001400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24940454|NCT04001400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853889|NCT02270788|Vitamins|vitamins|mesh-ancestor
24703176|NCT01470053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24703177|NCT01470053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703178|NCT01470053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24703179|NCT01470053|Respiratory System Agents|respiratory system agents|mesh-ancestor
24703180|NCT01470053|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24703197|NCT01470092|Anabolic Agents|anabolic agents|mesh-ancestor
24703198|NCT01470092|Hormones|hormones|mesh-ancestor
24703199|NCT01470157|Ketamine|ketamine|mesh-list
24703200|NCT01470157|Analgesics|analgesics|mesh-ancestor
24703201|NCT01470157|Sensory System Agents|sensory system agents|mesh-ancestor
24703202|NCT01470157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24703203|NCT01470157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703204|NCT01470157|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24703205|NCT01470157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24703208|NCT01470157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24703209|NCT01470157|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24703210|NCT01470157|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24703213|NCT01470209|Everolimus|everolimus|mesh-list
24703223|NCT01470326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703224|NCT01470326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24703225|NCT01470339|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24703226|NCT01470339|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24703227|NCT01470339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24703228|NCT01470339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24703244|NCT01470352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703245|NCT01470352|Analgesics|analgesics|mesh-ancestor
24703246|NCT01470352|Sensory System Agents|sensory system agents|mesh-ancestor
24703247|NCT01470352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25695111|NCT02040779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24804921|NCT02005783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24703248|NCT01470352|Antidepressive Agents|antidepressive agents|mesh-ancestor
24703288|NCT01470755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24703289|NCT01470755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703290|NCT01470794|Flucytosine|flucytosine|mesh-list
24703291|NCT01470794|Antifungal Agents|antifungal agents|mesh-ancestor
24703292|NCT01470794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24940455|NCT04001387|Anesthetics|anesthetics|mesh-list
24940456|NCT04001387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24940457|NCT04001387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940461|NCT04001530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24940462|NCT04001309|Anti-Infective Agents|anti-infective agents|mesh-list
24940463|NCT04001309|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24940464|NCT04001374|Ticagrelor|ticagrelor|mesh-list
24940465|NCT04001374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24940466|NCT04001374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24940467|NCT04001374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24940468|NCT04001374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24703305|NCT01471067|Fludarabine|fludarabine|mesh-list
24703306|NCT01471067|Fludarabine phosphate|fludarabine phosphate|mesh-list
24703307|NCT01471067|Melphalan|melphalan|mesh-list
24703308|NCT01471067|Busulfan|busulfan|mesh-list
24703326|NCT01471067|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24703327|NCT01471067|Antitubercular Agents|antitubercular agents|mesh-ancestor
24703328|NCT01471067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24703329|NCT01471067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24703330|NCT01471067|Alkylating Agents|alkylating agents|mesh-ancestor
24703331|NCT01471067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24703332|NCT01471132|Paclitaxel|paclitaxel|mesh-list
24703333|NCT01471132|Oxaliplatin|oxaliplatin|mesh-list
24703334|NCT01471132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24703335|NCT01471132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703336|NCT01471132|Tubulin Modulators|tubulin modulators|mesh-ancestor
24703337|NCT01471132|Antimitotic Agents|antimitotic agents|mesh-ancestor
24703338|NCT01471132|Mitosis Modulators|mitosis modulators|mesh-ancestor
24703339|NCT01471132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703340|NCT01471145|Naltrexone|naltrexone|mesh-list
24703341|NCT01471145|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24703342|NCT01471145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24703343|NCT01471145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703344|NCT01471145|Sensory System Agents|sensory system agents|mesh-ancestor
24703345|NCT01471145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24703346|NCT01471158|Timolol|timolol|mesh-list
24703347|NCT01471158|Dorzolamide|dorzolamide|mesh-list
24703348|NCT01471158|Maleic acid|maleic acid|mesh-list
24703349|NCT01471158|Brinzolamide|brinzolamide|mesh-list
24703350|NCT01471158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24703351|NCT01471158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24703352|NCT01471158|Adrenergic Agents|adrenergic agents|mesh-ancestor
24703353|NCT01471158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24703354|NCT01471158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940475|NCT04001569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24940476|NCT04001569|Tubulin Modulators|tubulin modulators|mesh-ancestor
24940477|NCT04001569|Antimitotic Agents|antimitotic agents|mesh-ancestor
24940478|NCT04001569|Mitosis Modulators|mitosis modulators|mesh-ancestor
24832365|NCT02171338|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24832366|NCT02171338|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24940479|NCT04001569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940480|NCT04001348|Diazepam|diazepam|mesh-list
24940493|NCT04001348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24940495|NCT04001348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24940496|NCT04001348|Anesthetics, General|anesthetics, general|mesh-ancestor
24940497|NCT04001348|Anesthetics|anesthetics|mesh-ancestor
24703358|NCT01471158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703367|NCT01471418|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24703368|NCT01471418|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24703369|NCT01471418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703370|NCT01471470|Bevacizumab|bevacizumab|mesh-list
24703371|NCT01471470|Docetaxel|docetaxel|mesh-list
24703372|NCT01471470|Capecitabine|capecitabine|mesh-list
24703373|NCT01471470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24703374|NCT01471470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25695112|NCT02040779|Adrenergic Agents|adrenergic agents|mesh-ancestor
24703375|NCT01471470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25406510|NCT03555149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24703406|NCT01471678|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24703407|NCT01471678|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24703409|NCT01471678|Adrenergic Agents|adrenergic agents|mesh-ancestor
24703410|NCT01471678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24470585|NCT00390793|Doxorubicin|doxorubicin|mesh-list
24703411|NCT01471678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703412|NCT01471678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703413|NCT01471678|Urological Agents|urological agents|mesh-ancestor
24703414|NCT01471678|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24703450|NCT01471847|Antimetabolites|antimetabolites|mesh-ancestor
24940507|NCT04000919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940508|NCT04000919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940509|NCT04000919|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24940510|NCT04000919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24940511|NCT04000789|Vitamins|vitamins|mesh-list
24940512|NCT04000789|Vitamin E|vitamin e|mesh-list
24940513|NCT04000789|Vitamin A|vitamin a|mesh-list
24940514|NCT04000789|Hyaluronic Acid|hyaluronic acid|mesh-list
24940515|NCT04000789|Micronutrients|micronutrients|mesh-ancestor
24765242|NCT01787123|Cerebrolysin|cerebrolysin|mesh-list
24940517|NCT04000789|Antioxidants|antioxidants|mesh-ancestor
24940518|NCT04000789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940519|NCT04000789|Protective Agents|protective agents|mesh-ancestor
24940520|NCT04000789|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24940521|NCT04000789|Immunologic Factors|immunologic factors|mesh-ancestor
24940522|NCT04000789|Viscosupplements|viscosupplements|mesh-ancestor
24940523|NCT04000906|Paclitaxel|paclitaxel|mesh-list
24940524|NCT04000906|Cisplatin|cisplatin|mesh-list
24940530|NCT04000906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940531|NCT04000932|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
24703498|NCT01471990|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
24703499|NCT01471990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24703500|NCT01471990|Vasodilator Agents|vasodilator agents|mesh-ancestor
24703501|NCT01471990|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24703502|NCT01471990|Protective Agents|protective agents|mesh-ancestor
24703503|NCT01471990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703504|NCT01471990|Growth Substances|growth substances|mesh-ancestor
24703505|NCT01471990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24613432|NCT01019083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703570|NCT01472497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24703571|NCT01472497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703573|NCT01472510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24703574|NCT01472510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24703575|NCT01472510|Growth Substances|growth substances|mesh-ancestor
24703576|NCT01472510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703577|NCT01472510|Growth Inhibitors|growth inhibitors|mesh-ancestor
24703578|NCT01472510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703579|NCT01472640|Liraglutide|liraglutide|mesh-list
24703580|NCT01472640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24703581|NCT01472640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703582|NCT01472640|Incretins|incretins|mesh-ancestor
24703583|NCT01472640|Hormones|hormones|mesh-ancestor
24703585|NCT01472653|Cetuximab|cetuximab|mesh-list
24703586|NCT01472653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703587|NCT01472653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24703588|NCT01472666|Caseins|caseins|mesh-list
24703618|NCT01472796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24489327|NCT00472368|Panobinostat|panobinostat|mesh-list
24703619|NCT01472900|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24703620|NCT01472900|Dermatologic Agents|dermatologic agents|mesh-ancestor
24703621|NCT01472913|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24703622|NCT01472913|Hemostatics|hemostatics|mesh-ancestor
24703623|NCT01472913|Coagulants|coagulants|mesh-ancestor
24703624|NCT01472926|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24703625|NCT01472926|Plasminogen|plasminogen|mesh-list
24703626|NCT01472926|Tenecteplase|tenecteplase|mesh-list
24703627|NCT01472926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24703628|NCT01472926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24703630|NCT01472978|Metronidazole|metronidazole|mesh-list
24940535|NCT04000932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24940536|NCT04000932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940538|NCT04000633|Anesthetics, Local|anesthetics, local|mesh-ancestor
24940539|NCT04000633|Anesthetics|anesthetics|mesh-ancestor
24940540|NCT04000633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24940541|NCT04000633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853924|NCT02270996|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24703656|NCT01473147|Incretins|incretins|mesh-ancestor
24703658|NCT01473147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24703659|NCT01473173|Esomeprazole|esomeprazole|mesh-list
24703660|NCT01473173|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24703661|NCT01473173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24703662|NCT01473173|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24703663|NCT01473173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703664|NCT01473173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703732|NCT01473472|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24703733|NCT01473472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703734|NCT01473472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703735|NCT01473472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24703736|NCT01473472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24703737|NCT01473537|Calcium|calcium|mesh-list
24703738|NCT01473537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24703739|NCT01473537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703740|NCT01473797|Cladribine|cladribine|mesh-list
24703741|NCT01473797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703742|NCT01473797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24703743|NCT01473797|Immunologic Factors|immunologic factors|mesh-ancestor
24703744|NCT01473797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703752|NCT01473901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703753|NCT01473901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703765|NCT01473914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703766|NCT01473914|Protective Agents|protective agents|mesh-ancestor
24703767|NCT01474174|Vaccines|vaccines|mesh-list
24703768|NCT01474174|Immunologic Factors|immunologic factors|mesh-ancestor
24703769|NCT01474174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703770|NCT01474187|Capecitabine|capecitabine|mesh-list
24703771|NCT01474187|Irinotecan|irinotecan|mesh-list
24703827|NCT01474499|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24703828|NCT01474499|Protective Agents|protective agents|mesh-ancestor
24703829|NCT01474499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703830|NCT01474499|Cathartics|cathartics|mesh-ancestor
24940545|NCT04000633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24940546|NCT04000633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24940547|NCT04000633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24853938|NCT02271126|Thromboplastin|thromboplastin|mesh-list
24703831|NCT01474499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24703832|NCT01474499|Antidiarrheals|antidiarrheals|mesh-ancestor
24703833|NCT01474642|Capecitabine|capecitabine|mesh-list
24703858|NCT01475032|Autonomic Agents|autonomic agents|mesh-ancestor
24703859|NCT01475032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24703862|NCT01475032|Respiratory System Agents|respiratory system agents|mesh-ancestor
24703914|NCT01475552|Clopidogrel|clopidogrel|mesh-list
24703915|NCT01475552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24703916|NCT01475552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24703917|NCT01475552|Analgesics|analgesics|mesh-ancestor
24703918|NCT01475552|Sensory System Agents|sensory system agents|mesh-ancestor
24703919|NCT01475552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24703920|NCT01475552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703921|NCT01475552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24703922|NCT01475552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24703923|NCT01475552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24703924|NCT01475552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24703925|NCT01475552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832408|NCT02171481|Anticoagulants|anticoagulants|mesh-ancestor
24698398|NCT01440985|Nicotine|nicotine|mesh-list
24703926|NCT01475552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24703942|NCT01475578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703956|NCT01475617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24703957|NCT01475617|Vitamin B Complex|vitamin b complex|mesh-ancestor
24703958|NCT01475617|Hematinics|hematinics|mesh-ancestor
24703959|NCT01475656|Levetiracetam|levetiracetam|mesh-list
24703960|NCT01475656|Anticonvulsants|anticonvulsants|mesh-ancestor
24703961|NCT01475656|Nootropic Agents|nootropic agents|mesh-ancestor
24703962|NCT01475708|Doxycycline|doxycycline|mesh-list
24703963|NCT01475708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24703964|NCT01475708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24703965|NCT01475708|Antimalarials|antimalarials|mesh-ancestor
24703966|NCT01475708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24703993|NCT01475890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24703996|NCT01476007|Vitamin B 12|vitamin b 12|mesh-list
24703997|NCT01476007|Vitamin B Complex|vitamin b complex|mesh-list
24703998|NCT01476007|Micronutrients|micronutrients|mesh-ancestor
24703999|NCT01476007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704000|NCT01476007|Hematinics|hematinics|mesh-ancestor
24704001|NCT01476124|Morphine|morphine|mesh-list
24704002|NCT01476124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24704003|NCT01476124|Narcotics|narcotics|mesh-ancestor
24704006|NCT01476124|Analgesics|analgesics|mesh-ancestor
24613485|NCT01019382|Antiviral Agents|antiviral agents|mesh-ancestor
24613486|NCT01019382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24613487|NCT01019382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613488|NCT01019382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24613489|NCT01019382|Immunologic Factors|immunologic factors|mesh-ancestor
24613490|NCT01019382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613491|NCT01019395|Daptomycin|daptomycin|mesh-list
24613492|NCT01019395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24613493|NCT01019395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24940552|NCT04000386|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24940557|NCT04000295|Paclitaxel|paclitaxel|mesh-list
24940558|NCT04000295|Etoposide|etoposide|mesh-list
24940559|NCT04000295|Apatinib|apatinib|mesh-list
24940560|NCT04000295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24940561|NCT04000295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24940562|NCT04000295|Tubulin Modulators|tubulin modulators|mesh-ancestor
24940563|NCT04000295|Antimitotic Agents|antimitotic agents|mesh-ancestor
24940564|NCT04000295|Mitosis Modulators|mitosis modulators|mesh-ancestor
24940565|NCT04000295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940566|NCT04000295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24940567|NCT04000295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24940568|NCT04000295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24940569|NCT04000295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24940570|NCT04000126|Lidocaine|lidocaine|mesh-list
24940571|NCT04000126|Anesthetics, Local|anesthetics, local|mesh-ancestor
24940572|NCT04000126|Anesthetics|anesthetics|mesh-ancestor
24940573|NCT04000126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24940586|NCT03999580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940587|NCT03999580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24765449|NCT01788605|Ramosetron|ramosetron|mesh-list
24613494|NCT01019408|Chloroquine|chloroquine|mesh-list
24765451|NCT01788605|Autonomic Agents|autonomic agents|mesh-ancestor
24765452|NCT01788605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24613495|NCT01019408|Amebicides|amebicides|mesh-ancestor
24613496|NCT01019408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24613497|NCT01019408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24613498|NCT01019408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24613499|NCT01019408|Antimalarials|antimalarials|mesh-ancestor
24613500|NCT01019408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24613502|NCT01019434|Temozolomide|temozolomide|mesh-list
24613503|NCT01019434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24613504|NCT01019434|Alkylating Agents|alkylating agents|mesh-ancestor
24613505|NCT01019434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613506|NCT01019434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613507|NCT01019434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24441195|NCT00286364|Androgens|androgens|mesh-list
24613521|NCT01019447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613522|NCT01019447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24613523|NCT01019590|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24613524|NCT01019590|Olmesartan|olmesartan|mesh-list
24613525|NCT01019590|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24613526|NCT01019590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24613527|NCT01019590|Diuretics|diuretics|mesh-ancestor
24613528|NCT01019590|Natriuretic Agents|natriuretic agents|mesh-ancestor
24613529|NCT01019590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613544|NCT01019642|Vitamin D|vitamin d|mesh-list
24613545|NCT01019642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24613546|NCT01019642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613548|NCT01019642|Micronutrients|micronutrients|mesh-ancestor
24613549|NCT01019642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24471781|NCT00396747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24471782|NCT00396747|Antiemetics|antiemetics|mesh-ancestor
24471783|NCT00396747|Autonomic Agents|autonomic agents|mesh-ancestor
24471784|NCT00396747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24471785|NCT00396747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24471850|NCT00397072|Sagopilone|sagopilone|mesh-list
24613550|NCT01019655|Nadroparin|nadroparin|mesh-list
24704107|NCT01476605|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
24704108|NCT01476605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24704109|NCT01476683|Racecadotril|racecadotril|mesh-list
24704110|NCT01476683|Thiorphan|thiorphan|mesh-list
24704111|NCT01476683|Antidiarrheals|antidiarrheals|mesh-ancestor
24704112|NCT01476683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24704113|NCT01476683|Protease Inhibitors|protease inhibitors|mesh-ancestor
24704114|NCT01476683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704115|NCT01476683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704116|NCT01476774|Buprenorphine|buprenorphine|mesh-list
24704117|NCT01476774|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24704118|NCT01476774|Narcotics|narcotics|mesh-ancestor
24704119|NCT01476774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24704120|NCT01476774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704121|NCT01476774|Analgesics|analgesics|mesh-ancestor
24704122|NCT01476774|Sensory System Agents|sensory system agents|mesh-ancestor
24704140|NCT01476800|Ketoconazole|ketoconazole|mesh-list
24704141|NCT01476800|Mirabegron|mirabegron|mesh-list
24704142|NCT01476800|Antifungal Agents|antifungal agents|mesh-ancestor
24704143|NCT01476800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24704144|NCT01476800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24704145|NCT01476800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24765453|NCT01788605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765454|NCT01788605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24765455|NCT01788605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24765456|NCT01788605|Serotonin Agents|serotonin agents|mesh-ancestor
24704148|NCT01476800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24704149|NCT01476800|Hormone Antagonists|hormone antagonists|mesh-ancestor
24704150|NCT01476800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24704151|NCT01476800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704152|NCT01476800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24704153|NCT01476800|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24704154|NCT01476800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24704155|NCT01476800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24704156|NCT01476800|Adrenergic Agents|adrenergic agents|mesh-ancestor
24704157|NCT01476800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24704158|NCT01476800|Urological Agents|urological agents|mesh-ancestor
24704160|NCT01476813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24704161|NCT01476813|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24704162|NCT01476813|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24704163|NCT01476813|Cholinergic Agents|cholinergic agents|mesh-ancestor
24704164|NCT01476813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24704166|NCT01476813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704174|NCT01477021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704175|NCT01477021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24704176|NCT01477021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24704177|NCT01477034|Vitamin D|vitamin d|mesh-list
24704178|NCT01477034|Ergocalciferols|ergocalciferols|mesh-list
24704179|NCT01477034|Cholecalciferol|cholecalciferol|mesh-list
24704195|NCT01477073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24704196|NCT01477073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704197|NCT01477112|Beta Carotene|beta carotene|mesh-list
24704198|NCT01477112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704199|NCT01477112|Provitamins|provitamins|mesh-ancestor
24704200|NCT01477112|Vitamins|vitamins|mesh-ancestor
24704214|NCT01477203|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24704215|NCT01477203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24704216|NCT01477203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24704217|NCT01477203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704218|NCT01477203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24704219|NCT01477203|Serotonin Agents|serotonin agents|mesh-ancestor
24704220|NCT01477203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704221|NCT01477203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24704222|NCT01477203|Antidepressive Agents|antidepressive agents|mesh-ancestor
24606788|NCT05408208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24606789|NCT05408208|Dermatologic Agents|dermatologic agents|mesh-ancestor
24606790|NCT05408208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606791|NCT05408208|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24606792|NCT05408208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24704223|NCT01477203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24704224|NCT01477242|Ondansetron|ondansetron|mesh-list
24704225|NCT01477242|Antiemetics|antiemetics|mesh-ancestor
24704226|NCT01477242|Autonomic Agents|autonomic agents|mesh-ancestor
24765461|NCT01788670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24765462|NCT01788670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24765463|NCT01788670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556296|NCT00746746|Antiviral Agents|antiviral agents|mesh-ancestor
24556297|NCT00746746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24556298|NCT00746746|Immunologic Factors|immunologic factors|mesh-ancestor
24940615|NCT03999437|Terbinafine|terbinafine|mesh-list
24704227|NCT01477242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24704228|NCT01477242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704229|NCT01477242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24704230|NCT01477242|Antipruritics|antipruritics|mesh-ancestor
24704231|NCT01477242|Dermatologic Agents|dermatologic agents|mesh-ancestor
24832430|NCT02171520|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832431|NCT02171520|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832432|NCT02171520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617831|NCT01045889|Glucocorticoids|glucocorticoids|mesh-ancestor
24704232|NCT01477242|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24704233|NCT01477242|Serotonin Agents|serotonin agents|mesh-ancestor
24704234|NCT01477242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24704235|NCT01477242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704259|NCT01477294|Purinergic Agents|purinergic agents|mesh-ancestor
24704260|NCT01477294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24704262|NCT01477385|Cariostatic Agents|cariostatic agents|mesh-ancestor
24704263|NCT01477385|Protective Agents|protective agents|mesh-ancestor
24704310|NCT01477632|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24704311|NCT01477632|Estrogens|estrogens|mesh-ancestor
24704312|NCT01477632|Hormones|hormones|mesh-ancestor
24704313|NCT01477632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24704314|NCT01477632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704315|NCT01477632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24704316|NCT01477632|Contraceptive Agents|contraceptive agents|mesh-ancestor
24704317|NCT01477632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24704318|NCT01477632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24704319|NCT01477632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24704320|NCT01477632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24704321|NCT01477632|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24704322|NCT01477736|Oxybutynin|oxybutynin|mesh-list
24704323|NCT01477736|Botulinum Toxins|botulinum toxins|mesh-list
24704324|NCT01477736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24704325|NCT01477736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24704326|NCT01477736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24704327|NCT01477736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24704328|NCT01477736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704329|NCT01477736|Cholinergic Agents|cholinergic agents|mesh-ancestor
24704330|NCT01477736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24704331|NCT01477736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704332|NCT01477736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24704335|NCT01477736|Autonomic Agents|autonomic agents|mesh-ancestor
24704336|NCT01477736|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24704337|NCT01477736|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24704338|NCT01477736|Urological Agents|urological agents|mesh-ancestor
24704339|NCT01477801|Cholecalciferol|cholecalciferol|mesh-list
24704382|NCT01478022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24704383|NCT01478022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695113|NCT02040779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25695114|NCT02040779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695115|NCT02040779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25695116|NCT02040779|Glucocorticoids|glucocorticoids|mesh-ancestor
25695117|NCT02040779|Hormones|hormones|mesh-ancestor
25695118|NCT02040779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25695119|NCT02040870|Ceritinib|ceritinib|mesh-list
25695120|NCT02040870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24704416|NCT01478165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704417|NCT01478165|Antiemetics|antiemetics|mesh-ancestor
24704418|NCT01478165|Autonomic Agents|autonomic agents|mesh-ancestor
24704419|NCT01478165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24940617|NCT03999437|Antifungal Agents|antifungal agents|mesh-ancestor
24940618|NCT03999437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24940619|NCT03999437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628631|NCT01100203|Eplerenone|eplerenone|mesh-list
24940620|NCT03999437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940622|NCT03999099|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24940623|NCT03999099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24940624|NCT03999099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24940625|NCT03999099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704452|NCT01478308|Antimitotic Agents|antimitotic agents|mesh-ancestor
24704453|NCT01478308|Mitosis Modulators|mitosis modulators|mesh-ancestor
24704454|NCT01478308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704455|NCT01478308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24704456|NCT01478308|Glucocorticoids|glucocorticoids|mesh-ancestor
24704458|NCT01478308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24704459|NCT01478308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24704460|NCT01478386|Hyaluronic Acid|hyaluronic acid|mesh-list
24704461|NCT01478386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24704462|NCT01478386|Immunologic Factors|immunologic factors|mesh-ancestor
24704463|NCT01478386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704464|NCT01478386|Viscosupplements|viscosupplements|mesh-ancestor
24704465|NCT01478386|Protective Agents|protective agents|mesh-ancestor
24704479|NCT01478490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704480|NCT01478490|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24704481|NCT01478490|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24704482|NCT01478490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24704483|NCT01478490|Urological Agents|urological agents|mesh-ancestor
24704484|NCT01478503|Mirabegron|mirabegron|mesh-list
24704485|NCT01478503|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24704486|NCT01478503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24704487|NCT01478503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24704488|NCT01478503|Adrenergic Agents|adrenergic agents|mesh-ancestor
24704489|NCT01478503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24704530|NCT01478633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24704531|NCT01478633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704532|NCT01478633|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24704533|NCT01478633|Autonomic Agents|autonomic agents|mesh-ancestor
24704534|NCT01478633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24704535|NCT01478633|Nootropic Agents|nootropic agents|mesh-ancestor
24704536|NCT01478685|Paclitaxel|paclitaxel|mesh-list
24704537|NCT01478685|Carboplatin|carboplatin|mesh-list
24704538|NCT01478685|Azacitidine|azacitidine|mesh-list
24704539|NCT01478685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24704541|NCT01478685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24704542|NCT01478685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613579|NCT01019798|Sunitinib|sunitinib|mesh-list
24613580|NCT01019798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24704547|NCT01478685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25695121|NCT02040870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25695122|NCT02040870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25695123|NCT02040870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695124|NCT02041091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25695125|NCT02041091|Immunologic Factors|immunologic factors|mesh-ancestor
25695126|NCT02041091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695127|NCT02041299|Deferiprone|deferiprone|mesh-list
25695128|NCT02041299|Deferoxamine|deferoxamine|mesh-list
25695129|NCT02041299|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25695130|NCT02041299|Chelating Agents|chelating agents|mesh-ancestor
24644398|NCT01190722|Analgesics|analgesics|mesh-ancestor
24704592|NCT01479036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25695131|NCT02041299|Sequestering Agents|sequestering agents|mesh-ancestor
24467823|NCT00378833|Micronutrients|micronutrients|mesh-ancestor
24467824|NCT00378833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467825|NCT00378872|Tranexamic Acid|tranexamic acid|mesh-list
24467826|NCT00378872|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24467827|NCT00378872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24467828|NCT00378872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467829|NCT00378872|Hemostatics|hemostatics|mesh-ancestor
24704593|NCT01479036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24704594|NCT01479036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24704595|NCT01479036|Growth Substances|growth substances|mesh-ancestor
24896913|NCT04432220|Anticoagulants|anticoagulants|mesh-ancestor
24704596|NCT01479036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704597|NCT01479036|Growth Inhibitors|growth inhibitors|mesh-ancestor
24704598|NCT01479075|Insulin|insulin|mesh-list
24704599|NCT01479075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24704600|NCT01479075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24704601|NCT01479075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704603|NCT01479088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24704604|NCT01479088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704605|NCT01479088|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24704606|NCT01479088|Hormone Antagonists|hormone antagonists|mesh-ancestor
24704607|NCT01479088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24704608|NCT01479114|Lenograstim|lenograstim|mesh-list
24704609|NCT01479114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24704610|NCT01479114|Immunologic Factors|immunologic factors|mesh-ancestor
24704611|NCT01479114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704612|NCT01479179|Trastuzumab|trastuzumab|mesh-list
24704613|NCT01479179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24704614|NCT01479179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24704615|NCT01479192|Fenretinide|fenretinide|mesh-list
24704662|NCT01479556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24704663|NCT01479556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704664|NCT01479556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24704665|NCT01479556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24704666|NCT01479556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24704674|NCT01479634|Antiviral Agents|antiviral agents|mesh-ancestor
24704675|NCT01479634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24704676|NCT01479634|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24853992|NCT02271399|Rivaroxaban|rivaroxaban|mesh-list
24456723|NCT00332059|Adrenergic Agents|adrenergic agents|mesh-ancestor
24442320|NCT00290680|Celecoxib|celecoxib|mesh-list
24704686|NCT01479751|Sensory System Agents|sensory system agents|mesh-ancestor
24704687|NCT01479751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24704688|NCT01479751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704689|NCT01479751|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24704690|NCT01479751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24704691|NCT01479751|Anesthetics, General|anesthetics, general|mesh-ancestor
24704692|NCT01479751|Anesthetics|anesthetics|mesh-ancestor
24704693|NCT01479751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24704694|NCT01479751|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24490466|NCT00478504|Enclomiphene|enclomiphene|mesh-list
24704695|NCT01479751|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24704697|NCT01479751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704698|NCT01479751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25695132|NCT02041299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695133|NCT02041299|Siderophores|siderophores|mesh-ancestor
25695134|NCT02041325|Lenalidomide|lenalidomide|mesh-list
25695135|NCT02041325|Immunologic Factors|immunologic factors|mesh-ancestor
25695136|NCT02041325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695137|NCT02041325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25695138|NCT02041325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25695139|NCT02041325|Growth Substances|growth substances|mesh-ancestor
25695140|NCT02041325|Growth Inhibitors|growth inhibitors|mesh-ancestor
25695141|NCT02041325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607440|NCT04626141|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24704716|NCT01479881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704717|NCT01479881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704718|NCT01479881|Antifungal Agents|antifungal agents|mesh-ancestor
24704719|NCT01479881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24704720|NCT01479881|Dermatologic Agents|dermatologic agents|mesh-ancestor
24704721|NCT01479881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24704722|NCT01479881|Antiviral Agents|antiviral agents|mesh-ancestor
24704733|NCT01479920|Antidepressive Agents|antidepressive agents|mesh-ancestor
24704735|NCT01479920|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24704736|NCT01479920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24704737|NCT01479920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704739|NCT01479933|Ergocalciferols|ergocalciferols|mesh-list
24704740|NCT01479933|Cholecalciferol|cholecalciferol|mesh-list
24704741|NCT01479933|Vitamins|vitamins|mesh-list
24704742|NCT01479933|Micronutrients|micronutrients|mesh-ancestor
24704743|NCT01479933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704744|NCT01479933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24704745|NCT01479933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24490541|NCT00478907|Ketamine|ketamine|mesh-list
24704746|NCT01480050|Temozolomide|temozolomide|mesh-list
24704747|NCT01480050|Mibefradil|mibefradil|mesh-list
24704762|NCT01480063|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24704763|NCT01480063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24704764|NCT01480063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704765|NCT01480141|Afatinib|afatinib|mesh-list
24704766|NCT01480141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24704782|NCT01480323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24704783|NCT01480323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24704784|NCT01480323|Antiviral Agents|antiviral agents|mesh-ancestor
24704785|NCT01480323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24704786|NCT01480336|Amiodarone|amiodarone|mesh-list
24704787|NCT01480336|Ranolazine|ranolazine|mesh-list
24704788|NCT01480336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24704789|NCT01480336|Vasodilator Agents|vasodilator agents|mesh-ancestor
24704790|NCT01480336|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24704791|NCT01480336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24704804|NCT01480492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704821|NCT01480713|Raltegravir Potassium|raltegravir potassium|mesh-list
24704822|NCT01480713|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24704851|NCT01480765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24704852|NCT01480765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24704853|NCT01480765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704855|NCT01480765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24704859|NCT01480765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24704860|NCT01480765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24704861|NCT01480778|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
24704862|NCT01480778|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24704863|NCT01480778|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24704864|NCT01480778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24704865|NCT01480778|Contraceptive Agents|contraceptive agents|mesh-ancestor
24704866|NCT01480778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24704867|NCT01480778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704868|NCT01480778|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24613581|NCT01019798|Tubulin Modulators|tubulin modulators|mesh-ancestor
24613582|NCT01019798|Antimitotic Agents|antimitotic agents|mesh-ancestor
24613583|NCT01019798|Mitosis Modulators|mitosis modulators|mesh-ancestor
24613584|NCT01019798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613585|NCT01019798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24613586|NCT01019798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24613587|NCT01019798|Growth Substances|growth substances|mesh-ancestor
24613588|NCT01019798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704879|NCT01480791|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24704880|NCT01480791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24704883|NCT01480817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24704899|NCT01480986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24704900|NCT01480986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24704901|NCT01480986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705031|NCT01481831|Autonomic Agents|autonomic agents|mesh-ancestor
24704903|NCT01480986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24704904|NCT01480986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25695142|NCT02041429|Paclitaxel|paclitaxel|mesh-list
24704905|NCT01481194|Dexamethasone|dexamethasone|mesh-list
24704906|NCT01481194|Cyclophosphamide|cyclophosphamide|mesh-list
24468207|NCT00380484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24468208|NCT00380484|Autonomic Agents|autonomic agents|mesh-ancestor
24468209|NCT00380484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24468210|NCT00380484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468211|NCT00380484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24468212|NCT00380484|Respiratory System Agents|respiratory system agents|mesh-ancestor
24468295|NCT00380965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24468296|NCT00380965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704907|NCT01481194|Doxorubicin|doxorubicin|mesh-list
24704908|NCT01481194|Lenalidomide|lenalidomide|mesh-list
24704909|NCT01481194|Bortezomib|bortezomib|mesh-list
24704910|NCT01481194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24704911|NCT01481194|Immunologic Factors|immunologic factors|mesh-ancestor
24704912|NCT01481194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704913|NCT01481194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24704914|NCT01481194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24704933|NCT01481194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24704934|NCT01481194|Growth Substances|growth substances|mesh-ancestor
24704935|NCT01481194|Growth Inhibitors|growth inhibitors|mesh-ancestor
24704936|NCT01481233|Colchicine|colchicine|mesh-list
24704937|NCT01481233|Gout Suppressants|gout suppressants|mesh-ancestor
24704938|NCT01481233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24704939|NCT01481233|Tubulin Modulators|tubulin modulators|mesh-ancestor
24704940|NCT01481233|Antimitotic Agents|antimitotic agents|mesh-ancestor
24704941|NCT01481233|Mitosis Modulators|mitosis modulators|mesh-ancestor
24442801|NCT00292747|Papaverine|papaverine|mesh-list
24704960|NCT01481389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24704961|NCT01481389|Autonomic Agents|autonomic agents|mesh-ancestor
24704962|NCT01481389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24704963|NCT01481389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704964|NCT01481389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24704965|NCT01481389|Respiratory System Agents|respiratory system agents|mesh-ancestor
24704966|NCT01481389|Vasodilator Agents|vasodilator agents|mesh-ancestor
24556307|NCT00746967|Sildenafil Citrate|sildenafil citrate|mesh-list
24556308|NCT00746967|Vasodilator Agents|vasodilator agents|mesh-ancestor
24556309|NCT00746967|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24556310|NCT00746967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24556311|NCT00746967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556312|NCT00746967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556313|NCT00746967|Urological Agents|urological agents|mesh-ancestor
24638639|NCT01157455|Antipyretics|antipyretics|mesh-ancestor
24638695|NCT01157572|Metoprolol|metoprolol|mesh-list
24638844|NCT01158729|Antithrombin III|antithrombin iii|mesh-list
24625709|NCT01083212|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24704982|NCT01481519|Glucocorticoids|glucocorticoids|mesh-ancestor
24704983|NCT01481519|Hormones|hormones|mesh-ancestor
24704984|NCT01481519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24704985|NCT01481519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24704986|NCT01481519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24704987|NCT01481519|Protease Inhibitors|protease inhibitors|mesh-ancestor
24704988|NCT01481519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704989|NCT01481519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704990|NCT01481519|Plasma Substitutes|plasma substitutes|mesh-ancestor
24704991|NCT01481519|Blood Substitutes|blood substitutes|mesh-ancestor
24704992|NCT01481519|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24704993|NCT01481519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24704994|NCT01481519|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24704995|NCT01481519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24704996|NCT01481532|Histamine Antagonists|histamine antagonists|mesh-list
24704997|NCT01481532|Histamine Agents|histamine agents|mesh-ancestor
25695143|NCT02041429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25695144|NCT02041429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25695145|NCT02041429|Tubulin Modulators|tubulin modulators|mesh-ancestor
25695146|NCT02041429|Antimitotic Agents|antimitotic agents|mesh-ancestor
25695147|NCT02041429|Mitosis Modulators|mitosis modulators|mesh-ancestor
25695148|NCT02041429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695149|NCT02042183|Lubiprostone|lubiprostone|mesh-list
25695150|NCT02042183|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24696559|NCT01430013|Endostar protein|endostar protein|mesh-list
25695151|NCT02042183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25695152|NCT02042183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695153|NCT02042443|Calcium, Dietary|calcium, dietary|mesh-list
25695155|NCT02042443|Folic Acid|folic acid|mesh-list
24607700|NCT03978091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24704998|NCT01481532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24704999|NCT01481532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705000|NCT01481532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705001|NCT01481610|Diclofenac|diclofenac|mesh-list
24705002|NCT01481610|Lumiracoxib|lumiracoxib|mesh-list
24705003|NCT01481610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24705004|NCT01481610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24705018|NCT01481714|Magnesium Oxide|magnesium oxide|mesh-list
24705021|NCT01481714|Anticoagulants|anticoagulants|mesh-ancestor
24705022|NCT01481714|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24705023|NCT01481714|Chelating Agents|chelating agents|mesh-ancestor
24705024|NCT01481714|Sequestering Agents|sequestering agents|mesh-ancestor
24705025|NCT01481714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705026|NCT01481714|Cathartics|cathartics|mesh-ancestor
24705027|NCT01481714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24705028|NCT01481714|Antacids|antacids|mesh-ancestor
24705029|NCT01481831|Palonosetron|palonosetron|mesh-list
24705030|NCT01481831|Antiemetics|antiemetics|mesh-ancestor
24705033|NCT01481831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705035|NCT01481831|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24705036|NCT01481831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24705037|NCT01481831|Serotonin Agents|serotonin agents|mesh-ancestor
24705038|NCT01481831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24705040|NCT01481844|Amoxicillin|amoxicillin|mesh-list
24705048|NCT01481844|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
24705049|NCT01481844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24705063|NCT01481844|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
24705064|NCT01481844|Antidiarrheals|antidiarrheals|mesh-ancestor
24705065|NCT01481870|Sorafenib|sorafenib|mesh-list
24705066|NCT01481870|Sunitinib|sunitinib|mesh-list
24705067|NCT01481870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705068|NCT01481870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24940636|NCT03999203|Nitric Oxide|nitric oxide|mesh-list
24940637|NCT03999203|Citric Acid|citric acid|mesh-list
24940638|NCT03999203|Sodium Citrate|sodium citrate|mesh-list
24705086|NCT01482052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705087|NCT01482104|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24705088|NCT01482104|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
24705089|NCT01482104|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24705090|NCT01482104|Dermatologic Agents|dermatologic agents|mesh-ancestor
24705091|NCT01482117|Cilostazol|cilostazol|mesh-list
24705093|NCT01482117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24705094|NCT01482117|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24705095|NCT01482117|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24705096|NCT01482117|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24705097|NCT01482117|Purinergic Agents|purinergic agents|mesh-ancestor
24705098|NCT01482117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24705099|NCT01482117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705100|NCT01482117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705101|NCT01482117|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24705102|NCT01482117|Autonomic Agents|autonomic agents|mesh-ancestor
24705103|NCT01482117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24705104|NCT01482117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24705105|NCT01482117|Respiratory System Agents|respiratory system agents|mesh-ancestor
24705106|NCT01482117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24705107|NCT01482117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24705108|NCT01482117|Vasodilator Agents|vasodilator agents|mesh-ancestor
24705109|NCT01482117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24705110|NCT01482117|Protective Agents|protective agents|mesh-ancestor
24705111|NCT01482117|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24705112|NCT01482117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24705224|NCT01482936|Sensory System Agents|sensory system agents|mesh-ancestor
24705225|NCT01482936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24705250|NCT01483248|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25695156|NCT02042443|Fluorouracil|fluorouracil|mesh-list
25695157|NCT02042443|Capecitabine|capecitabine|mesh-list
25695158|NCT02042443|Trametinib|trametinib|mesh-list
25695159|NCT02042443|Calcium|calcium|mesh-list
25695160|NCT02042443|Levoleucovorin|levoleucovorin|mesh-list
25695161|NCT02042443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25695162|NCT02042443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628755|NCT01101386|Voriconazole|voriconazole|mesh-list
25695163|NCT02042443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24705288|NCT01483729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24705289|NCT01483729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24705290|NCT01483781|Canagliflozin|canagliflozin|mesh-list
24705291|NCT01483781|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24705292|NCT01483781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705293|NCT01483781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24705335|NCT01484184|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24705337|NCT01484262|Liraglutide|liraglutide|mesh-list
24705338|NCT01484262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24705339|NCT01484262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705340|NCT01484262|Incretins|incretins|mesh-ancestor
24705341|NCT01484262|Hormones|hormones|mesh-ancestor
24705342|NCT01484262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24705343|NCT01484327|Carvedilol|carvedilol|mesh-list
24705344|NCT01484327|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24705345|NCT01484327|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24705346|NCT01484327|Adrenergic Agents|adrenergic agents|mesh-ancestor
24705347|NCT01484327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24705348|NCT01484327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705349|NCT01484327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613602|NCT01019876|Fludarabine|fludarabine|mesh-list
24613604|NCT01019876|Immunologic Factors|immunologic factors|mesh-ancestor
24613609|NCT01019876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613610|NCT01019876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613611|NCT01019876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24613613|NCT01019941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613614|NCT01019941|Tubulin Modulators|tubulin modulators|mesh-ancestor
24613615|NCT01019941|Antimitotic Agents|antimitotic agents|mesh-ancestor
24613636|NCT01020162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24613637|NCT01020162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705365|NCT01484613|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24705366|NCT01484613|Contraceptive Agents|contraceptive agents|mesh-ancestor
24705367|NCT01484613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24705368|NCT01484613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705369|NCT01484613|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24705370|NCT01484613|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24705371|NCT01484613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24705372|NCT01484717|Nicotine|nicotine|mesh-list
24705373|NCT01484717|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24705374|NCT01484717|Autonomic Agents|autonomic agents|mesh-ancestor
24705375|NCT01484717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24940648|NCT03999203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24940649|NCT03999203|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24940650|NCT03999203|Vasodilator Agents|vasodilator agents|mesh-ancestor
24940651|NCT03999203|Gasotransmitters|gasotransmitters|mesh-ancestor
24940652|NCT03999203|Protective Agents|protective agents|mesh-ancestor
24940653|NCT03999203|Anticoagulants|anticoagulants|mesh-ancestor
24940654|NCT03999203|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24940655|NCT03999203|Chelating Agents|chelating agents|mesh-ancestor
24940656|NCT03999203|Sequestering Agents|sequestering agents|mesh-ancestor
24705378|NCT01484717|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24705387|NCT01484964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705388|NCT01484964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24705389|NCT01484964|Immunologic Factors|immunologic factors|mesh-ancestor
25695164|NCT02042443|Antimetabolites|antimetabolites|mesh-ancestor
25695165|NCT02042443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695166|NCT02042443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25695167|NCT02042443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25695168|NCT02042443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25695169|NCT02042443|Immunologic Factors|immunologic factors|mesh-ancestor
25695170|NCT02042443|Antidotes|antidotes|mesh-ancestor
25695171|NCT02042443|Protective Agents|protective agents|mesh-ancestor
25695172|NCT02042443|Vitamin B Complex|vitamin b complex|mesh-ancestor
25695173|NCT02042443|Vitamins|vitamins|mesh-ancestor
25695174|NCT02042443|Micronutrients|micronutrients|mesh-ancestor
25695175|NCT02042443|Hematinics|hematinics|mesh-ancestor
25695176|NCT02042443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25695177|NCT02042443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25695178|NCT02042534|Warfarin|warfarin|mesh-list
24705390|NCT01484964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705391|NCT01484990|Levodopa|levodopa|mesh-list
24705392|NCT01484990|Carbidopa|carbidopa|mesh-list
24705393|NCT01484990|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24705394|NCT01484990|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24705395|NCT01484990|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24705396|NCT01484990|Dopamine Agents|dopamine agents|mesh-ancestor
24705397|NCT01484990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24705398|NCT01484990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705402|NCT01484990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24705403|NCT01484990|Immunologic Factors|immunologic factors|mesh-ancestor
24705404|NCT01484990|Dopamine Agonists|dopamine agonists|mesh-ancestor
24705406|NCT01485003|Immunologic Factors|immunologic factors|mesh-ancestor
24705407|NCT01485003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705409|NCT01485068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24705410|NCT01485068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705415|NCT01485081|Paclitaxel|paclitaxel|mesh-list
24705426|NCT01485146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24705453|NCT01485198|Sensory System Agents|sensory system agents|mesh-ancestor
24705454|NCT01485198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24705455|NCT01485198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705456|NCT01485198|Antipyretics|antipyretics|mesh-ancestor
24705458|NCT01485211|Vitamin B Complex|vitamin b complex|mesh-ancestor
24705459|NCT01485211|Vitamins|vitamins|mesh-ancestor
24705472|NCT01485224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24705473|NCT01485224|Growth Substances|growth substances|mesh-ancestor
24705474|NCT01485224|Growth Inhibitors|growth inhibitors|mesh-ancestor
24705475|NCT01485224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705476|NCT01485315|Mannitol|mannitol|mesh-list
24705477|NCT01485315|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24705478|NCT01485315|Diuretics|diuretics|mesh-ancestor
24705479|NCT01485315|Natriuretic Agents|natriuretic agents|mesh-ancestor
24705518|NCT01485653|Sensory System Agents|sensory system agents|mesh-ancestor
24705519|NCT01485653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24705520|NCT01485679|Deoxyglucose|deoxyglucose|mesh-list
24705521|NCT01485679|Antimetabolites|antimetabolites|mesh-ancestor
24705522|NCT01485679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705523|NCT01485679|Antiviral Agents|antiviral agents|mesh-ancestor
24705524|NCT01485679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24705525|NCT01485692|Promethazine|promethazine|mesh-list
24705526|NCT01485692|Diphenhydramine|diphenhydramine|mesh-list
24705527|NCT01485692|Midazolam|midazolam|mesh-list
24705528|NCT01485692|Haloperidol|haloperidol|mesh-list
24705529|NCT01485692|Olanzapine|olanzapine|mesh-list
24705530|NCT01485692|Haloperidol decanoate|haloperidol decanoate|mesh-list
24705531|NCT01485692|Ziprasidone|ziprasidone|mesh-list
24705536|NCT01485692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24705592|NCT01485744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705593|NCT01485744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24705594|NCT01485744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24705595|NCT01485744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705626|NCT01485848|Tubulin Modulators|tubulin modulators|mesh-ancestor
24705627|NCT01485848|Antimitotic Agents|antimitotic agents|mesh-ancestor
24705628|NCT01485848|Mitosis Modulators|mitosis modulators|mesh-ancestor
24705629|NCT01485848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832523|NCT02171598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24705630|NCT01485926|Carboplatin|carboplatin|mesh-list
24705631|NCT01485926|Docetaxel|docetaxel|mesh-list
24705632|NCT01485926|Trastuzumab|trastuzumab|mesh-list
24705633|NCT01485926|Lapatinib|lapatinib|mesh-list
24705634|NCT01485926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705658|NCT01485978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705659|NCT01485978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24705661|NCT01486004|Antiviral Agents|antiviral agents|mesh-ancestor
24705662|NCT01486004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24705663|NCT01486004|Protease Inhibitors|protease inhibitors|mesh-ancestor
24705664|NCT01486004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705665|NCT01486004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940663|NCT03999190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24940664|NCT03999190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940665|NCT03999190|Dopamine Agents|dopamine agents|mesh-ancestor
24608458|NCT00992160|Vestipitant|vestipitant|mesh-list
24608459|NCT00992160|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24608468|NCT00992199|Fluorouracil|fluorouracil|mesh-list
24608515|NCT00992355|Sensory System Agents|sensory system agents|mesh-ancestor
24608520|NCT00992381|Naproxen|naproxen|mesh-list
24940666|NCT03999190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24940667|NCT03999190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24940668|NCT03999190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24940669|NCT03999190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24940670|NCT03999190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24940671|NCT03999190|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24940672|NCT03999008|Budesonide|budesonide|mesh-list
24940673|NCT03999008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24940674|NCT03999008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24940675|NCT03999008|Autonomic Agents|autonomic agents|mesh-ancestor
24940676|NCT03999008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24940677|NCT03999008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940678|NCT03999008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24940679|NCT03999008|Respiratory System Agents|respiratory system agents|mesh-ancestor
24940680|NCT03999008|Glucocorticoids|glucocorticoids|mesh-ancestor
24940681|NCT03999008|Hormones|hormones|mesh-ancestor
24854039|NCT02271464|Bevacizumab|bevacizumab|mesh-list
24613648|NCT01020214|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24705721|NCT01486459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705722|NCT01486459|Antimanic Agents|antimanic agents|mesh-ancestor
24705723|NCT01486459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24705724|NCT01486459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24705730|NCT01486485|Sensory System Agents|sensory system agents|mesh-ancestor
24705731|NCT01486485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24705732|NCT01486485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705733|NCT01486485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24705734|NCT01486485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24705735|NCT01486485|Anticoagulants|anticoagulants|mesh-ancestor
24705736|NCT01486485|Protease Inhibitors|protease inhibitors|mesh-ancestor
24705737|NCT01486485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705738|NCT01486485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705739|NCT01486485|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24705740|NCT01486485|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24705741|NCT01486485|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24705742|NCT01486485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24705743|NCT01486485|Immunologic Factors|immunologic factors|mesh-ancestor
24940682|NCT03999008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24940683|NCT03999125|Dexamethasone|dexamethasone|mesh-list
24940684|NCT03999125|Dexamethasone acetate|dexamethasone acetate|mesh-list
24940685|NCT03999125|Ranibizumab|ranibizumab|mesh-list
24940686|NCT03999125|Aflibercept|aflibercept|mesh-list
24940687|NCT03999125|BB 1101|bb 1101|mesh-list
24940688|NCT03999125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24940689|NCT03999125|Antiemetics|antiemetics|mesh-ancestor
24940690|NCT03999125|Autonomic Agents|autonomic agents|mesh-ancestor
24940691|NCT03999125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24940692|NCT03999125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940693|NCT03999125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24705746|NCT01486550|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24705748|NCT01486550|Blood Substitutes|blood substitutes|mesh-ancestor
24705749|NCT01486563|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24705761|NCT01486602|Mitosis Modulators|mitosis modulators|mesh-ancestor
24705762|NCT01486602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705764|NCT01486706|Solifenacin Succinate|solifenacin succinate|mesh-list
24705778|NCT01486706|Antimanic Agents|antimanic agents|mesh-ancestor
24705779|NCT01486706|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24705780|NCT01486706|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24705781|NCT01486706|Cholinergic Agents|cholinergic agents|mesh-ancestor
24705782|NCT01486706|Urological Agents|urological agents|mesh-ancestor
25695179|NCT02042534|Rivaroxaban|rivaroxaban|mesh-list
25695180|NCT02042534|Anticoagulants|anticoagulants|mesh-ancestor
25695181|NCT02042534|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25695182|NCT02042534|Antithrombins|antithrombins|mesh-ancestor
25695183|NCT02042534|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24608843|NCT00993876|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24705783|NCT01486823|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24705784|NCT01486823|Immunologic Factors|immunologic factors|mesh-ancestor
24705785|NCT01486823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705786|NCT01486862|Insulin Aspart|insulin aspart|mesh-list
24705787|NCT01486862|Biphasic Insulins|biphasic insulins|mesh-list
24705788|NCT01486862|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24705789|NCT01486862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24705790|NCT01486862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613641|NCT01020162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24613642|NCT01020162|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24613643|NCT01020162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24613644|NCT01020162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24613645|NCT01020162|Adrenergic Agents|adrenergic agents|mesh-ancestor
24613646|NCT01020214|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24613647|NCT01020214|Olmesartan|olmesartan|mesh-list
24705807|NCT01486914|Insulin Aspart|insulin aspart|mesh-list
24705808|NCT01486914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24705809|NCT01486914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705810|NCT01486940|Insulin|insulin|mesh-list
24705811|NCT01486940|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24705829|NCT01486979|Estradiol|estradiol|mesh-list
24705830|NCT01486979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24705831|NCT01486979|Estrogens|estrogens|mesh-ancestor
24705832|NCT01486979|Hormones|hormones|mesh-ancestor
24705833|NCT01486979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24705834|NCT01486979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705835|NCT01486979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24705836|NCT01486979|Contraceptive Agents|contraceptive agents|mesh-ancestor
24705837|NCT01486979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24705838|NCT01486979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24705839|NCT01486992|Nimotuzumab|nimotuzumab|mesh-list
24705859|NCT01487135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705860|NCT01487135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705861|NCT01487226|Paclitaxel|paclitaxel|mesh-list
24705862|NCT01487226|Cisplatin|cisplatin|mesh-list
24940696|NCT03999125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24940697|NCT03999125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24940698|NCT03999125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24940699|NCT03999125|Protease Inhibitors|protease inhibitors|mesh-ancestor
24940700|NCT03999125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24940701|NCT03999125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705870|NCT01487278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24705872|NCT01487278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24705873|NCT01487278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705874|NCT01487278|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24705875|NCT01487278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24705876|NCT01487278|Oxytocics|oxytocics|mesh-ancestor
24705877|NCT01487304|Hormones|hormones|mesh-list
24705878|NCT01487304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24705879|NCT01487304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705880|NCT01487317|Rivastigmine|rivastigmine|mesh-list
24705881|NCT01487317|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24705882|NCT01487317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705883|NCT01487317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705884|NCT01487317|Cholinergic Agents|cholinergic agents|mesh-ancestor
24705885|NCT01487317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24705886|NCT01487317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705887|NCT01487317|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24705888|NCT01487317|Protective Agents|protective agents|mesh-ancestor
24705889|NCT01487369|Insulin Aspart|insulin aspart|mesh-list
24705916|NCT01487512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705917|NCT01487512|Analgesics|analgesics|mesh-ancestor
24705918|NCT01487512|Sensory System Agents|sensory system agents|mesh-ancestor
25695184|NCT02042534|Protease Inhibitors|protease inhibitors|mesh-ancestor
25695185|NCT02042534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705937|NCT01487785|Gemcitabine|gemcitabine|mesh-list
24705938|NCT01487785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24705939|NCT01487785|Antimetabolites|antimetabolites|mesh-ancestor
24705940|NCT01487785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705941|NCT01487785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705942|NCT01487785|Antiviral Agents|antiviral agents|mesh-ancestor
24705943|NCT01487785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24705955|NCT01487811|Insulin Aspart|insulin aspart|mesh-list
24705956|NCT01487811|Biphasic Insulins|biphasic insulins|mesh-list
24705957|NCT01487811|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24940724|NCT03998969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940726|NCT03998696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24940738|NCT03998670|Sympathomimetics|sympathomimetics|mesh-ancestor
24940739|NCT03998670|Autonomic Agents|autonomic agents|mesh-ancestor
24705958|NCT01487811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24705959|NCT01487811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705961|NCT01487993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24705962|NCT01487993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705963|NCT01488045|Fentanyl|fentanyl|mesh-list
24705964|NCT01488045|Midazolam|midazolam|mesh-list
24705965|NCT01488045|Propofol|propofol|mesh-list
24705966|NCT01488045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24705967|NCT01488045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24705968|NCT01488045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705969|NCT01488045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24705970|NCT01488045|Anesthetics, General|anesthetics, general|mesh-ancestor
24705971|NCT01488045|Anesthetics|anesthetics|mesh-ancestor
24705972|NCT01488045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24706023|NCT01488266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24706024|NCT01488266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24706025|NCT01488266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706026|NCT01488266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24706027|NCT01488266|Serotonin Agents|serotonin agents|mesh-ancestor
24706028|NCT01488266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706029|NCT01488266|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24706030|NCT01488266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24706031|NCT01488266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24706032|NCT01488266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24706033|NCT01488266|Dopamine Agents|dopamine agents|mesh-ancestor
24706034|NCT01488266|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24706035|NCT01488266|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24706036|NCT01488266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706037|NCT01488266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24706038|NCT01488266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24854067|NCT02271555|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24706039|NCT01488266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24706040|NCT01488266|Dopamine Agonists|dopamine agonists|mesh-ancestor
24706041|NCT01488266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24706042|NCT01488266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24706072|NCT01488396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706073|NCT01488396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24706074|NCT01488396|Immunologic Factors|immunologic factors|mesh-ancestor
24706075|NCT01488396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706076|NCT01488396|Antifungal Agents|antifungal agents|mesh-ancestor
24706077|NCT01488396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24706078|NCT01488396|Dermatologic Agents|dermatologic agents|mesh-ancestor
24706079|NCT01488396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24706080|NCT01488396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24706084|NCT01488526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24706085|NCT01488526|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24706086|NCT01488526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24706087|NCT01488526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706088|NCT01488526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706089|NCT01488526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24706090|NCT01488526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24706091|NCT01488552|Metformin|metformin|mesh-list
24706092|NCT01488552|Gemcitabine|gemcitabine|mesh-list
24706093|NCT01488552|Paclitaxel|paclitaxel|mesh-list
24706094|NCT01488552|Folfirinox|folfirinox|mesh-list
24706095|NCT01488552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24706096|NCT01488552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706129|NCT01488734|Micronutrients|micronutrients|mesh-ancestor
24609041|NCT00994825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609079|NCT00994968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609080|NCT00994968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24609081|NCT00994968|Tubulin Modulators|tubulin modulators|mesh-ancestor
24609082|NCT00994968|Antimitotic Agents|antimitotic agents|mesh-ancestor
24609083|NCT00994968|Mitosis Modulators|mitosis modulators|mesh-ancestor
24609084|NCT00994968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24609085|NCT00994968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24706130|NCT01488734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940748|NCT03998670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24940749|NCT03998761|Progesterone|progesterone|mesh-list
24940750|NCT03998761|Dydrogesterone|dydrogesterone|mesh-list
24940751|NCT03998761|Progestins|progestins|mesh-ancestor
24940752|NCT03998761|Hormones|hormones|mesh-ancestor
24940753|NCT03998761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24940754|NCT03998761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940755|NCT03998826|Piroxicam|piroxicam|mesh-list
24940756|NCT03998826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24956783|NCT03851172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24956784|NCT03851172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956785|NCT03851172|Mydriatics|mydriatics|mesh-ancestor
24956786|NCT03851172|Autonomic Agents|autonomic agents|mesh-ancestor
24956787|NCT03851172|Parasympatholytics|parasympatholytics|mesh-ancestor
24449865|NCT00317343|Anticoagulants|anticoagulants|mesh-list
24706149|NCT01488773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24706150|NCT01488773|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24706153|NCT01488838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706171|NCT01489059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24956788|NCT03851172|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24956789|NCT03851172|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24956790|NCT03851172|Cholinergic Agents|cholinergic agents|mesh-ancestor
24706173|NCT01489059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706175|NCT01489072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24706176|NCT01489072|Narcotics|narcotics|mesh-ancestor
24706177|NCT01489072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24706178|NCT01489072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706179|NCT01489072|Analgesics|analgesics|mesh-ancestor
24706180|NCT01489072|Sensory System Agents|sensory system agents|mesh-ancestor
24706181|NCT01489072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24706182|NCT01489124|Imipenem|imipenem|mesh-list
24706183|NCT01489124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24706184|NCT01489124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24706185|NCT01489137|Remifentanil|remifentanil|mesh-list
24706186|NCT01489137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24706187|NCT01489137|Narcotics|narcotics|mesh-ancestor
24706190|NCT01489137|Analgesics|analgesics|mesh-ancestor
24706202|NCT01489202|Chromium|chromium|mesh-list
24706203|NCT01489202|Everolimus|everolimus|mesh-list
24706204|NCT01489202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706205|NCT01489202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24706206|NCT01489202|Immunologic Factors|immunologic factors|mesh-ancestor
24706207|NCT01489202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706208|NCT01489202|Trace Elements|trace elements|mesh-ancestor
24706209|NCT01489202|Micronutrients|micronutrients|mesh-ancestor
24706210|NCT01489228|Benzonidazole|benzonidazole|mesh-list
24706211|NCT01489228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24706212|NCT01489228|Immunologic Factors|immunologic factors|mesh-ancestor
24706213|NCT01489228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706214|NCT01489228|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24706215|NCT01489228|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24706216|NCT01489228|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24706217|NCT01489228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24706218|NCT01489319|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
24706219|NCT01489319|Sodium Salicylate|sodium salicylate|mesh-list
24613666|NCT01020279|Ketoprofen|ketoprofen|mesh-list
25695186|NCT02042534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695187|NCT02042872|Zoledronic Acid|zoledronic acid|mesh-list
25695188|NCT02042872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25695189|NCT02042872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695190|NCT02043132|Tranexamic Acid|tranexamic acid|mesh-list
25695191|NCT02043132|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
25695192|NCT02043132|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25695193|NCT02043132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471994|NCT00397722|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24671915|NCT01328392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24613667|NCT01020279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24706228|NCT01489319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24706229|NCT01489319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706230|NCT01489319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706231|NCT01489371|Doxorubicin|doxorubicin|mesh-list
24706232|NCT01489371|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24706233|NCT01489371|Interleukin-12|interleukin-12|mesh-list
24706234|NCT01489371|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24706235|NCT01489371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706236|NCT01489371|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24706237|NCT01489371|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24706238|NCT01489371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706239|NCT01489371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706240|NCT01489371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24706241|NCT01489371|Immunologic Factors|immunologic factors|mesh-ancestor
24706242|NCT01489371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706243|NCT01489371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24706244|NCT01489371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24706245|NCT01489371|Growth Substances|growth substances|mesh-ancestor
24706246|NCT01489371|Growth Inhibitors|growth inhibitors|mesh-ancestor
24706247|NCT01489410|Ethanol|ethanol|mesh-list
24706248|NCT01489410|Doxorubicin|doxorubicin|mesh-list
24706249|NCT01489410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24706250|NCT01489410|Ethiodized Oil|ethiodized oil|mesh-list
24706251|NCT01489410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24706252|NCT01489410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706253|NCT01489410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24706254|NCT01489410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24706255|NCT01489410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706256|NCT01489410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956798|NCT03851393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854098|NCT02271958|Mifepristone|mifepristone|mesh-list
24706286|NCT01489631|Ropivacaine|ropivacaine|mesh-list
24706287|NCT01489631|Anesthetics, Local|anesthetics, local|mesh-ancestor
24706288|NCT01489631|Anesthetics|anesthetics|mesh-ancestor
24706289|NCT01489631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24706290|NCT01489631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706323|NCT01489683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706324|NCT01489696|Tamsulosin|tamsulosin|mesh-list
24706325|NCT01489696|Mirabegron|mirabegron|mesh-list
24706326|NCT01489696|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24706327|NCT01489696|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24706328|NCT01489696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24706329|NCT01489696|Adrenergic Agents|adrenergic agents|mesh-ancestor
24706330|NCT01489696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24706331|NCT01489696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706332|NCT01489696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706333|NCT01489696|Urological Agents|urological agents|mesh-ancestor
24706334|NCT01489696|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24706335|NCT01489696|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24706336|NCT01489696|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24706337|NCT01489709|Solifenacin Succinate|solifenacin succinate|mesh-list
24706338|NCT01489709|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24706339|NCT01489709|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24706340|NCT01489709|Cholinergic Agents|cholinergic agents|mesh-ancestor
24706349|NCT01489852|Estrogens|estrogens|mesh-ancestor
24706350|NCT01489852|Hormones|hormones|mesh-ancestor
25695194|NCT02043132|Hemostatics|hemostatics|mesh-ancestor
25695195|NCT02043132|Coagulants|coagulants|mesh-ancestor
25695196|NCT02043145|Botulinum Toxins|botulinum toxins|mesh-list
25695197|NCT02043145|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25695198|NCT02043145|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25695199|NCT02043145|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25695200|NCT02043145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24610416|NCT01001897|Abortifacient Agents|abortifacient agents|mesh-ancestor
24706351|NCT01489852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25050688|NCT00478179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25050689|NCT00477529|Docetaxel|docetaxel|mesh-list
25050690|NCT00477529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050691|NCT00477529|Tubulin Modulators|tubulin modulators|mesh-ancestor
25050692|NCT00477529|Antimitotic Agents|antimitotic agents|mesh-ancestor
25050693|NCT00477529|Mitosis Modulators|mitosis modulators|mesh-ancestor
25050694|NCT00477529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050695|NCT00474188|Dexamethasone|dexamethasone|mesh-list
25050696|NCT00474188|Lenalidomide|lenalidomide|mesh-list
25050697|NCT00474188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24706353|NCT01489852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24706354|NCT01489852|Contraceptive Agents|contraceptive agents|mesh-ancestor
24706355|NCT01489852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24492173|NCT00485550|Dopamine Agents|dopamine agents|mesh-ancestor
24706368|NCT01489904|Botulinum Toxins|botulinum toxins|mesh-list
24706369|NCT01489904|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24706370|NCT01489904|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24706371|NCT01489904|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24706372|NCT01489904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24706373|NCT01489904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706374|NCT01489904|Cholinergic Agents|cholinergic agents|mesh-ancestor
24706375|NCT01489904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24706376|NCT01489904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706377|NCT01489904|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24613731|NCT01020539|Dermatologic Agents|dermatologic agents|mesh-ancestor
24706378|NCT01489904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24706380|NCT01489917|Hemostatics|hemostatics|mesh-list
24706381|NCT01489917|Anticoagulants|anticoagulants|mesh-ancestor
24706382|NCT01489917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24706383|NCT01489917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25050701|NCT00474188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050702|NCT00474188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25050703|NCT00474188|Glucocorticoids|glucocorticoids|mesh-ancestor
24706384|NCT01489917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706385|NCT01489917|Coagulants|coagulants|mesh-ancestor
24706386|NCT01489943|Pioglitazone|pioglitazone|mesh-list
24706387|NCT01489943|Midazolam|midazolam|mesh-list
24706388|NCT01489943|Omeprazole|omeprazole|mesh-list
24706389|NCT01489943|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24706403|NCT01489943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706404|NCT01489943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24706405|NCT01489943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24706406|NCT01489943|Antimetabolites|antimetabolites|mesh-ancestor
24706407|NCT01489943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24706408|NCT01489943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24706409|NCT01489943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706411|NCT01489943|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24706412|NCT01489943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24706413|NCT01489943|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24706414|NCT01489982|Zopiclone|zopiclone|mesh-list
24706415|NCT01489982|Doxepin|doxepin|mesh-list
24706416|NCT01489982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24706417|NCT01489982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24706418|NCT01489982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706419|NCT01489982|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24706420|NCT01489982|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24706421|NCT01489982|Antidepressive Agents|antidepressive agents|mesh-ancestor
24706422|NCT01489982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24706423|NCT01489982|Histamine Antagonists|histamine antagonists|mesh-ancestor
24706424|NCT01489982|Histamine Agents|histamine agents|mesh-ancestor
24706425|NCT01489982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24706426|NCT01489982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706427|NCT01489995|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
24706428|NCT01489995|Antiviral Agents|antiviral agents|mesh-ancestor
24706429|NCT01489995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24706430|NCT01489995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706431|NCT01489995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706483|NCT01490229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25050704|NCT00474188|Hormones|hormones|mesh-ancestor
25050705|NCT00474188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25050706|NCT00474188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25695201|NCT02043145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050707|NCT00474188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050708|NCT00474188|Immunologic Factors|immunologic factors|mesh-ancestor
24812580|NCT02053597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706484|NCT01490255|Amlodipine|amlodipine|mesh-list
24706485|NCT01490255|Ranolazine|ranolazine|mesh-list
24706486|NCT01490255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24706493|NCT01490255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24706494|NCT01490268|Sufentanil|sufentanil|mesh-list
24706495|NCT01490268|Dsuvia|dsuvia|mesh-list
24706496|NCT01490268|Hydromorphone|hydromorphone|mesh-list
24706497|NCT01490268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24706498|NCT01490268|Narcotics|narcotics|mesh-ancestor
24706499|NCT01490268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24706500|NCT01490268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706501|NCT01490268|Analgesics|analgesics|mesh-ancestor
24706502|NCT01490268|Sensory System Agents|sensory system agents|mesh-ancestor
24706526|NCT01490411|Immunologic Factors|immunologic factors|mesh-list
24706527|NCT01490411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706528|NCT01490437|Dexamethasone|dexamethasone|mesh-list
24706530|NCT01490437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706544|NCT01490437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24706546|NCT01490476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706547|NCT01490476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24706549|NCT01490476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706557|NCT01490567|Donepezil|donepezil|mesh-list
24706558|NCT01490567|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24706559|NCT01490567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706595|NCT01490905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24706625|NCT01490996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24706626|NCT01490996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706627|NCT01490996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24706628|NCT01490996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24706629|NCT01490996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706631|NCT01491009|Remifentanil|remifentanil|mesh-list
24706632|NCT01491009|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24706633|NCT01491009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24706634|NCT01491009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24706635|NCT01491009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706636|NCT01491009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24706637|NCT01491009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24706638|NCT01491009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24706639|NCT01491009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24706640|NCT01491009|Anesthetics, General|anesthetics, general|mesh-ancestor
24706641|NCT01491009|Anesthetics|anesthetics|mesh-ancestor
24706642|NCT01491009|GABA Modulators|gaba modulators|mesh-ancestor
24706643|NCT01491009|GABA Agents|gaba agents|mesh-ancestor
24706644|NCT01491009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24706645|NCT01491009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706646|NCT01491009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24706647|NCT01491009|Narcotics|narcotics|mesh-ancestor
24706648|NCT01491009|Analgesics|analgesics|mesh-ancestor
24706649|NCT01491009|Sensory System Agents|sensory system agents|mesh-ancestor
24706650|NCT01491009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24706651|NCT01491048|Tacrine|tacrine|mesh-list
24956803|NCT03851263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706685|NCT01491191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24706686|NCT01491191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24706687|NCT01491191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24706688|NCT01491191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24613692|NCT01020331|Dopamine Agents|dopamine agents|mesh-ancestor
24613693|NCT01020331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24613694|NCT01020331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613695|NCT01020331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613696|NCT01020331|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24613697|NCT01020331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24613699|NCT01020357|Caffeine citrate|caffeine citrate|mesh-list
24644545|NCT01191645|Antiemetics|antiemetics|mesh-ancestor
24613700|NCT01020357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613701|NCT01020357|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24613702|NCT01020357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613703|NCT01020357|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24613704|NCT01020357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446419|NCT00304655|Serotonin Agents|serotonin agents|mesh-ancestor
24613732|NCT01020539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24613733|NCT01020630|Sunitinib|sunitinib|mesh-list
24600184|NCT02008292|Physostigmine|physostigmine|mesh-list
24613734|NCT01020630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613735|NCT01020630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24706710|NCT01491217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706712|NCT01491256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24706713|NCT01491256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24706714|NCT01491256|Antimetabolites|antimetabolites|mesh-ancestor
24706715|NCT01491256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706716|NCT01491256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24706717|NCT01491256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24706718|NCT01491256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706719|NCT01491295|Tenofovir|tenofovir|mesh-list
24706720|NCT01491295|Lamivudine|lamivudine|mesh-list
24706721|NCT01491295|Adefovir|adefovir|mesh-list
24706722|NCT01491295|Antiviral Agents|antiviral agents|mesh-ancestor
24956804|NCT03851263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24956805|NCT03850886|Niacinamide|niacinamide|mesh-list
24956807|NCT03850886|Nicotinic Acids|nicotinic acids|mesh-list
24956808|NCT03850886|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24956809|NCT03850886|Vitamins|vitamins|mesh-ancestor
24956810|NCT03850886|Micronutrients|micronutrients|mesh-ancestor
24956811|NCT03850886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956812|NCT03850886|Vitamin B Complex|vitamin b complex|mesh-ancestor
24956813|NCT03850886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24940757|NCT03998826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24940758|NCT03998826|Analgesics|analgesics|mesh-ancestor
24940759|NCT03998826|Sensory System Agents|sensory system agents|mesh-ancestor
24940760|NCT03998826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24706767|NCT01492062|Pancrelipase|pancrelipase|mesh-list
24706768|NCT01492062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24706794|NCT01492179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24706795|NCT01492179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24706796|NCT01492179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24706797|NCT01492179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24706798|NCT01492179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706799|NCT01492205|Insulin|insulin|mesh-list
24706800|NCT01492205|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24706801|NCT01492205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24706802|NCT01492205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706803|NCT01492218|Insulin|insulin|mesh-list
24706804|NCT01492218|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24706805|NCT01492218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24706806|NCT01492218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706807|NCT01492387|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24706808|NCT01492387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24940766|NCT03998826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940767|NCT03998592|Vaccines|vaccines|mesh-list
24706809|NCT01492504|Asunaprevir|asunaprevir|mesh-list
24706810|NCT01492504|Protease Inhibitors|protease inhibitors|mesh-ancestor
24706811|NCT01492504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706829|NCT01492608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706830|NCT01492608|Anesthetics|anesthetics|mesh-ancestor
24706831|NCT01492608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24706832|NCT01492608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24706833|NCT01492608|Anticonvulsants|anticonvulsants|mesh-ancestor
24706834|NCT01492608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24706835|NCT01492608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24706836|NCT01492608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706837|NCT01492608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24706838|NCT01492608|Tocolytic Agents|tocolytic agents|mesh-ancestor
24706839|NCT01492608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24706840|NCT01492621|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24706841|NCT01492621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24706842|NCT01492621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24706843|NCT01492621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24706844|NCT01492621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706845|NCT01492621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24706846|NCT01492621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695202|NCT02043145|Cholinergic Agents|cholinergic agents|mesh-ancestor
25695203|NCT02043145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25695204|NCT02043145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706847|NCT01492621|Antidepressive Agents|antidepressive agents|mesh-ancestor
24706884|NCT01492894|Dermatologic Agents|dermatologic agents|mesh-ancestor
24706885|NCT01492894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24706886|NCT01492894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24706887|NCT01492894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24706888|NCT01492894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706889|NCT01492920|Acetylcarnitine|acetylcarnitine|mesh-list
24706890|NCT01492920|Vitamin B Complex|vitamin b complex|mesh-ancestor
24706892|NCT01492920|Micronutrients|micronutrients|mesh-ancestor
24706893|NCT01492920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940768|NCT03998592|Immunologic Factors|immunologic factors|mesh-ancestor
24675709|NCT01344564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706894|NCT01492920|Nootropic Agents|nootropic agents|mesh-ancestor
24706897|NCT01492959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24706898|NCT01492959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706899|NCT01492972|Leuprolide|leuprolide|mesh-list
24706900|NCT01492972|Goserelin|goserelin|mesh-list
24706901|NCT01492972|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24706902|NCT01492972|Buserelin|buserelin|mesh-list
24706903|NCT01492972|Androgens|androgens|mesh-list
24706904|NCT01492972|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24706905|NCT01492972|Fertility Agents|fertility agents|mesh-ancestor
24706906|NCT01492972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24706907|NCT01492972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706908|NCT01492972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24706925|NCT01493050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706963|NCT01493310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24706964|NCT01493310|Mifepristone|mifepristone|mesh-list
24706965|NCT01493310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24706966|NCT01493310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706967|NCT01493310|Tubulin Modulators|tubulin modulators|mesh-ancestor
24706968|NCT01493310|Antimitotic Agents|antimitotic agents|mesh-ancestor
24706969|NCT01493310|Mitosis Modulators|mitosis modulators|mesh-ancestor
24706970|NCT01493310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706971|NCT01493310|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24706972|NCT01493310|Abortifacient Agents|abortifacient agents|mesh-ancestor
24706973|NCT01493310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24707006|NCT01493453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24707007|NCT01493453|Alkylating Agents|alkylating agents|mesh-ancestor
24707008|NCT01493453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707009|NCT01493453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24707010|NCT01493453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24707011|NCT01493479|Rituximab|rituximab|mesh-list
24707012|NCT01493479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24707013|NCT01493479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24707014|NCT01493479|Immunologic Factors|immunologic factors|mesh-ancestor
24707015|NCT01493479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707016|NCT01493479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24707017|NCT01493570|BI 409306|bi 409306|mesh-list
24707018|NCT01493570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24707019|NCT01493570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707020|NCT01493570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492916|NCT00488605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707021|NCT01493622|Minocycline|minocycline|mesh-list
24707022|NCT01493622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24940769|NCT03998592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940770|NCT03998436|Esmolol|esmolol|mesh-list
24613802|NCT01020825|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24613803|NCT01020825|Hemostatics|hemostatics|mesh-ancestor
24613804|NCT01020825|Coagulants|coagulants|mesh-ancestor
24613805|NCT01020864|Carboplatin|carboplatin|mesh-list
24613807|NCT01020864|Vinorelbine|vinorelbine|mesh-list
24613808|NCT01020864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613809|NCT01020864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24613814|NCT01020864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613815|NCT01020955|Mecasermin|mecasermin|mesh-list
24613816|NCT01020955|Growth Substances|growth substances|mesh-ancestor
24613817|NCT01020955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613818|NCT01020994|Octenidine|octenidine|mesh-list
24613819|NCT01020994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24613820|NCT01020994|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24613821|NCT01021150|Cisplatin|cisplatin|mesh-list
24613822|NCT01021150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613823|NCT01021163|Acetylcysteine|acetylcysteine|mesh-list
24613824|NCT01021163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25695205|NCT02043145|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24707073|NCT01493986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707074|NCT01493986|Sensory System Agents|sensory system agents|mesh-ancestor
24707075|NCT01493986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24707076|NCT01493999|Clopidogrel|clopidogrel|mesh-list
24707077|NCT01493999|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24707078|NCT01493999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24707079|NCT01493999|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24707080|NCT01493999|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24707081|NCT01493999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24707082|NCT01493999|Purinergic Agents|purinergic agents|mesh-ancestor
24707083|NCT01493999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24707084|NCT01493999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707158|NCT01494363|Protective Agents|protective agents|mesh-ancestor
24707159|NCT01494363|Vitamin B Complex|vitamin b complex|mesh-ancestor
24707161|NCT01494363|Micronutrients|micronutrients|mesh-ancestor
24707162|NCT01494402|Aspirin|aspirin|mesh-list
24707163|NCT01494402|Esomeprazole|esomeprazole|mesh-list
24707164|NCT01494402|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24707165|NCT01494402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24707166|NCT01494402|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24707179|NCT01494402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24707180|NCT01494402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24707181|NCT01494402|Antipyretics|antipyretics|mesh-ancestor
24707182|NCT01494415|Paclitaxel|paclitaxel|mesh-list
24707183|NCT01494415|Carboplatin|carboplatin|mesh-list
24707184|NCT01494415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24707185|NCT01494415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24707186|NCT01494415|Tubulin Modulators|tubulin modulators|mesh-ancestor
24707187|NCT01494415|Antimitotic Agents|antimitotic agents|mesh-ancestor
24707188|NCT01494415|Mitosis Modulators|mitosis modulators|mesh-ancestor
24707189|NCT01494415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707190|NCT01494441|Calcium, Dietary|calcium, dietary|mesh-list
24707191|NCT01494441|Calcium|calcium|mesh-list
24940771|NCT03998436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24940772|NCT03998436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24940773|NCT03998436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24707192|NCT01494441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24707193|NCT01494441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707194|NCT01494441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24707195|NCT01494597|Cyclosporine|cyclosporine|mesh-list
24707196|NCT01494597|Isavuconazole|isavuconazole|mesh-list
24707197|NCT01494597|Cyclosporins|cyclosporins|mesh-list
24707198|NCT01494597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707199|NCT01494597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707200|NCT01494597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24707201|NCT01494597|Immunologic Factors|immunologic factors|mesh-ancestor
24707202|NCT01494597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707219|NCT01494636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24707220|NCT01494636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707222|NCT01494688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24707223|NCT01494688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24707224|NCT01494688|Tubulin Modulators|tubulin modulators|mesh-ancestor
24707225|NCT01494688|Antimitotic Agents|antimitotic agents|mesh-ancestor
24707226|NCT01494688|Mitosis Modulators|mitosis modulators|mesh-ancestor
24707227|NCT01494688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707228|NCT01494714|Petrolatum|petrolatum|mesh-list
24707229|NCT01494714|Emollients|emollients|mesh-ancestor
24707230|NCT01494714|Dermatologic Agents|dermatologic agents|mesh-ancestor
24707231|NCT01494727|Amlodipine|amlodipine|mesh-list
24707232|NCT01494727|Valsartan|valsartan|mesh-list
24707233|NCT01494727|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
24707234|NCT01494727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24707235|NCT01494727|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24707236|NCT01494727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24707237|NCT01494727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707238|NCT01494727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24707239|NCT01494727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707240|NCT01494727|Vasodilator Agents|vasodilator agents|mesh-ancestor
24707243|NCT01494740|Vaccines|vaccines|mesh-list
24707249|NCT01494805|Growth Substances|growth substances|mesh-ancestor
24707250|NCT01494805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707251|NCT01494805|Growth Inhibitors|growth inhibitors|mesh-ancestor
24707252|NCT01494805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24707254|NCT01494857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24707255|NCT01494857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24707257|NCT01495026|Dutasteride|dutasteride|mesh-list
24707258|NCT01495026|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24707259|NCT01495026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24707270|NCT01495026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24707272|NCT01495039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24707273|NCT01495039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24707274|NCT01495039|Antifungal Agents|antifungal agents|mesh-ancestor
24707302|NCT01495117|Plasma Substitutes|plasma substitutes|mesh-ancestor
24707303|NCT01495117|Blood Substitutes|blood substitutes|mesh-ancestor
24707304|NCT01495156|Antipsychotic Agents|antipsychotic agents|mesh-list
24707305|NCT01495156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24707306|NCT01495156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24707307|NCT01495156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24707310|NCT01495169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24707333|NCT01495208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24707334|NCT01495208|Growth Substances|growth substances|mesh-ancestor
24707335|NCT01495208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707336|NCT01495208|Growth Inhibitors|growth inhibitors|mesh-ancestor
24707337|NCT01495208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24707339|NCT01495260|Thioctic Acid|thioctic acid|mesh-list
24707340|NCT01495260|Acetylcysteine|acetylcysteine|mesh-list
24707351|NCT01495260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707353|NCT01495260|Antidotes|antidotes|mesh-ancestor
24707354|NCT01495260|Vitamin B Complex|vitamin b complex|mesh-ancestor
24707355|NCT01495338|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
24613858|NCT01021358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613860|NCT01021436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24613861|NCT01021436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24613862|NCT01021475|Domperidone|domperidone|mesh-list
24613863|NCT01021475|Antiemetics|antiemetics|mesh-ancestor
24613864|NCT01021475|Autonomic Agents|autonomic agents|mesh-ancestor
24613865|NCT01021475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24613866|NCT01021475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613867|NCT01021475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24613868|NCT01021475|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24613869|NCT01021475|Dopamine Agents|dopamine agents|mesh-ancestor
24940785|NCT03997864|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24940786|NCT03997864|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24940787|NCT03997864|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24940788|NCT03997864|Adrenergic Agents|adrenergic agents|mesh-ancestor
24940789|NCT03997864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24613870|NCT01021475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24613872|NCT01021488|Enoxaparin|enoxaparin|mesh-list
24613874|NCT01021488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24613875|NCT01021488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24613876|NCT01021488|Antimetabolites|antimetabolites|mesh-ancestor
24613877|NCT01021488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613878|NCT01021488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24550802|NCT00722579|Cobalt|cobalt|mesh-list
24613879|NCT01021488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24613880|NCT01021488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613881|NCT01021488|Anticoagulants|anticoagulants|mesh-ancestor
24707359|NCT01495338|Analgesics|analgesics|mesh-ancestor
24707360|NCT01495338|Sensory System Agents|sensory system agents|mesh-ancestor
24707419|NCT01495624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707420|NCT01495624|Anesthetics, Local|anesthetics, local|mesh-ancestor
24707421|NCT01495624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24707422|NCT01495624|Sensory System Agents|sensory system agents|mesh-ancestor
24707423|NCT01495715|Idebenone|idebenone|mesh-list
24707424|NCT01495715|Antioxidants|antioxidants|mesh-ancestor
24707425|NCT01495715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707426|NCT01495715|Protective Agents|protective agents|mesh-ancestor
24707427|NCT01495715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707428|NCT01495806|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
24707429|NCT01495806|Cathartics|cathartics|mesh-ancestor
24707430|NCT01495806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24707431|NCT01495845|Clopidogrel|clopidogrel|mesh-list
24707432|NCT01495845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24707433|NCT01495845|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24674115|NCT01342016|Immunologic Factors|immunologic factors|mesh-ancestor
24674117|NCT01342016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707493|NCT01496196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707496|NCT01496261|Aspirin|aspirin|mesh-list
24707497|NCT01496261|Clopidogrel|clopidogrel|mesh-list
24707498|NCT01496261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24707500|NCT01496261|Analgesics|analgesics|mesh-ancestor
24707501|NCT01496261|Sensory System Agents|sensory system agents|mesh-ancestor
24707502|NCT01496261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24707503|NCT01496261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707517|NCT01496261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24707518|NCT01496326|Ibuprofen|ibuprofen|mesh-list
24707519|NCT01496326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24707520|NCT01496326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24707521|NCT01496326|Analgesics|analgesics|mesh-ancestor
24707522|NCT01496326|Sensory System Agents|sensory system agents|mesh-ancestor
24707523|NCT01496326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24707524|NCT01496326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707525|NCT01496326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24707534|NCT01496417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24707535|NCT01496417|Immunologic Factors|immunologic factors|mesh-ancestor
24707536|NCT01496417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707537|NCT01496417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24707539|NCT01496443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24707540|NCT01496443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24707541|NCT01496443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707542|NCT01496443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24707543|NCT01496443|Immunologic Factors|immunologic factors|mesh-ancestor
24707544|NCT01496521|Aspirin|aspirin|mesh-list
24707545|NCT01496521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24707573|NCT01496690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707574|NCT01496690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24707575|NCT01496690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24707576|NCT01496690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24707577|NCT01496690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24707578|NCT01496690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24940792|NCT03997539|Vinorelbine|vinorelbine|mesh-list
24940793|NCT03997539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24707591|NCT01496742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24707592|NCT01496742|Growth Substances|growth substances|mesh-ancestor
24707593|NCT01496742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707594|NCT01496742|Growth Inhibitors|growth inhibitors|mesh-ancestor
24707595|NCT01496742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707596|NCT01496742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24707611|NCT01496989|Immunologic Factors|immunologic factors|mesh-ancestor
24707612|NCT01496989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707613|NCT01496989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24707614|NCT01496989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24707615|NCT01496989|Growth Substances|growth substances|mesh-ancestor
24707616|NCT01496989|Growth Inhibitors|growth inhibitors|mesh-ancestor
24707617|NCT01496989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24707618|NCT01497002|Cytarabine|cytarabine|mesh-list
24707619|NCT01497002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24707620|NCT01497002|Antimetabolites|antimetabolites|mesh-ancestor
24707621|NCT01497002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707622|NCT01497002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24707623|NCT01497002|Antiviral Agents|antiviral agents|mesh-ancestor
24707624|NCT01497002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24707625|NCT01497002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24707626|NCT01497002|Immunologic Factors|immunologic factors|mesh-ancestor
24707627|NCT01497002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707628|NCT01497041|Docetaxel|docetaxel|mesh-list
24707629|NCT01497041|Oxaliplatin|oxaliplatin|mesh-list
24707630|NCT01497041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24707631|NCT01497041|Tubulin Modulators|tubulin modulators|mesh-ancestor
24707632|NCT01497041|Antimitotic Agents|antimitotic agents|mesh-ancestor
24707633|NCT01497041|Mitosis Modulators|mitosis modulators|mesh-ancestor
24707634|NCT01497041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707636|NCT01497093|Dexamethasone|dexamethasone|mesh-list
24707637|NCT01497093|Bortezomib|bortezomib|mesh-list
24707638|NCT01497093|Pomalidomide|pomalidomide|mesh-list
24707660|NCT01497132|Cholecalciferol|cholecalciferol|mesh-list
24707661|NCT01497132|Vitamins|vitamins|mesh-ancestor
24707662|NCT01497132|Micronutrients|micronutrients|mesh-ancestor
25695206|NCT02043145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25695207|NCT02043301|Bococizumab|bococizumab|mesh-list
25007820|NCT02642965|Cytarabine|cytarabine|mesh-list
24674453|NCT05220319|Protective Agents|protective agents|mesh-ancestor
24674512|NCT05148312|Budesonide|budesonide|mesh-list
24707663|NCT01497132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707664|NCT01497132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24707665|NCT01497132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24707666|NCT01497145|Darbepoetin alfa|darbepoetin alfa|mesh-list
24707667|NCT01497145|Hematinics|hematinics|mesh-ancestor
24707668|NCT01497288|Fentanyl|fentanyl|mesh-list
24707669|NCT01497288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24707670|NCT01497288|Narcotics|narcotics|mesh-ancestor
24707671|NCT01497288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24707672|NCT01497288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940812|NCT03997292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24854135|NCT02272101|Micronutrients|micronutrients|mesh-ancestor
24707673|NCT01497288|Analgesics|analgesics|mesh-ancestor
24707674|NCT01497288|Sensory System Agents|sensory system agents|mesh-ancestor
24707675|NCT01497288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24707676|NCT01497288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24707677|NCT01497288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24707678|NCT01497288|Anesthetics, General|anesthetics, general|mesh-ancestor
24707679|NCT01497288|Anesthetics|anesthetics|mesh-ancestor
24707680|NCT01497327|Sofosbuvir|sofosbuvir|mesh-list
24707681|NCT01497327|Antiviral Agents|antiviral agents|mesh-ancestor
24707708|NCT01497444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707709|NCT01497444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707710|NCT01497470|Paclitaxel|paclitaxel|mesh-list
24707711|NCT01497470|Carboplatin|carboplatin|mesh-list
24707718|NCT01497483|Cyclosporine|cyclosporine|mesh-list
24707763|NCT01497561|Isophane insulin, beef|isophane insulin, beef|mesh-list
24707764|NCT01497561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24707765|NCT01497561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707767|NCT01497574|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24707768|NCT01497574|Insulin Glargine|insulin glargine|mesh-list
24707769|NCT01497574|Insulin Detemir|insulin detemir|mesh-list
24707770|NCT01497574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24707771|NCT01497574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707772|NCT01497587|Insulin Detemir|insulin detemir|mesh-list
24707773|NCT01497587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24707775|NCT01497600|Insulin|insulin|mesh-list
24707776|NCT01497600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24707777|NCT01497600|Insulin Detemir|insulin detemir|mesh-list
24707793|NCT01497652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24707794|NCT01497652|Protective Agents|protective agents|mesh-ancestor
24707795|NCT01497652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707796|NCT01497717|Adalimumab|adalimumab|mesh-list
24707797|NCT01497717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24707798|NCT01497717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24707799|NCT01497873|Topotecan|topotecan|mesh-list
24707800|NCT01497873|Belotecan|belotecan|mesh-list
24707801|NCT01497873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24707802|NCT01497873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24707803|NCT01497873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707804|NCT01497873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707805|NCT01497873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24707806|NCT01497912|Atorvastatin|atorvastatin|mesh-list
24707807|NCT01497912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24707808|NCT01497912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24707809|NCT01497912|Antimetabolites|antimetabolites|mesh-ancestor
24707814|NCT01497977|Phytoestrogens|phytoestrogens|mesh-list
24940819|NCT03997279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24940821|NCT03997279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24707819|NCT01497977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707821|NCT01497990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24707822|NCT01497990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24707823|NCT01498003|Tirofiban|tirofiban|mesh-list
24707824|NCT01498003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24707825|NCT01498003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24707826|NCT01498003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707827|NCT01498003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24707828|NCT01498016|Busulfan|busulfan|mesh-list
25695208|NCT02043301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25695209|NCT02043301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25695210|NCT02043301|Antimetabolites|antimetabolites|mesh-ancestor
24707829|NCT01498016|Alkylating Agents|alkylating agents|mesh-ancestor
24707830|NCT01498016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707831|NCT01498016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24707832|NCT01498016|Immunologic Factors|immunologic factors|mesh-ancestor
24674725|NCT04721132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24674729|NCT04721132|Immunoglobulins|immunoglobulins|mesh-list
24707833|NCT01498016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707834|NCT01498016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24707855|NCT01498380|Sensory System Agents|sensory system agents|mesh-ancestor
24707856|NCT01498380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24707857|NCT01498380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24707858|NCT01498380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24707859|NCT01498380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24707860|NCT01498380|Adrenergic Agents|adrenergic agents|mesh-ancestor
24707861|NCT01498380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24707901|NCT01498796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707904|NCT01498809|Autonomic Agents|autonomic agents|mesh-ancestor
24707905|NCT01498809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24707906|NCT01498809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707907|NCT01498809|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24707921|NCT01498835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24707922|NCT01498835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707923|NCT01498835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707924|NCT01498861|Dolutegravir|dolutegravir|mesh-list
24707925|NCT01498861|Moxifloxacin|moxifloxacin|mesh-list
24707926|NCT01498861|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24707927|NCT01498861|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24707928|NCT01498861|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24707929|NCT01498861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707945|NCT01498861|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24493955|NCT00493194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707946|NCT01498900|Repaglinide|repaglinide|mesh-list
24707947|NCT01498900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24707948|NCT01498900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707949|NCT01498913|Repaglinide|repaglinide|mesh-list
24707959|NCT01498939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707961|NCT01499004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24707962|NCT01499004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707963|NCT01499004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707964|NCT01499069|Solifenacin Succinate|solifenacin succinate|mesh-list
24940822|NCT03997279|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24940823|NCT03997279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854144|NCT02272166|Anesthetics, General|anesthetics, general|mesh-ancestor
24707965|NCT01499069|Fesoterodine|fesoterodine|mesh-list
24707966|NCT01499069|Propiverine|propiverine|mesh-list
24707967|NCT01499069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24707968|NCT01499069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24707969|NCT01499069|Cholinergic Agents|cholinergic agents|mesh-ancestor
24707970|NCT01499069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24707971|NCT01499069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707975|NCT01499069|Autonomic Agents|autonomic agents|mesh-ancestor
24707988|NCT01499121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707989|NCT01499121|Growth Inhibitors|growth inhibitors|mesh-ancestor
24707990|NCT01499121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24707991|NCT01499121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707992|NCT01499121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708007|NCT01499251|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
24708008|NCT01499407|Abciximab|abciximab|mesh-list
24708009|NCT01499407|Anticoagulants|anticoagulants|mesh-ancestor
24708010|NCT01499407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24708011|NCT01499433|Caspofungin|caspofungin|mesh-list
24708012|NCT01499433|Antifungal Agents|antifungal agents|mesh-ancestor
24708013|NCT01499433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24708014|NCT01499433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708015|NCT01499433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708016|NCT01499446|Fluticasone|fluticasone|mesh-list
24708017|NCT01499446|Xhance|xhance|mesh-list
24708018|NCT01499446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24708019|NCT01499446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24708020|NCT01499446|Autonomic Agents|autonomic agents|mesh-ancestor
24708021|NCT01499446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25695211|NCT02043301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695212|NCT02043301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24708032|NCT01499485|Diuretics|diuretics|mesh-ancestor
24940825|NCT03997279|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24940826|NCT03997279|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24940828|NCT03997279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24940829|NCT03997279|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24940830|NCT03997019|Analgesics, Opioid|analgesics, opioid|mesh-list
24940831|NCT03997019|Narcotics|narcotics|mesh-ancestor
24940832|NCT03997019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24940833|NCT03997019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940834|NCT03997019|Analgesics|analgesics|mesh-ancestor
24940835|NCT03997019|Sensory System Agents|sensory system agents|mesh-ancestor
24940836|NCT03997019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24940837|NCT03997006|Atropine|atropine|mesh-list
24940838|NCT03997006|Aminophylline|aminophylline|mesh-list
24940841|NCT03997006|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24940842|NCT03997006|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24940843|NCT03997006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24940844|NCT03997006|Autonomic Agents|autonomic agents|mesh-ancestor
24940845|NCT03997006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24940846|NCT03997006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940847|NCT03997006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24940848|NCT03997006|Respiratory System Agents|respiratory system agents|mesh-ancestor
24940850|NCT03997006|Parasympatholytics|parasympatholytics|mesh-ancestor
24940851|NCT03997006|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24940852|NCT03997006|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24940853|NCT03997006|Cholinergic Agents|cholinergic agents|mesh-ancestor
24854148|NCT02272270|Minocycline|minocycline|mesh-list
24708038|NCT01499602|Norethindrone|norethindrone|mesh-list
24708039|NCT01499602|Norethindrone Acetate|norethindrone acetate|mesh-list
24708040|NCT01499602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24708041|NCT01499602|Contraceptive Agents|contraceptive agents|mesh-ancestor
24708042|NCT01499602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24708043|NCT01499602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708061|NCT01499641|Glucocorticoids|glucocorticoids|mesh-ancestor
24708062|NCT01499641|Hormones|hormones|mesh-ancestor
24708063|NCT01499641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24708064|NCT01499641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24708066|NCT01499641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24940854|NCT03997006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24940855|NCT03997006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940856|NCT03997006|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24940857|NCT03997006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708067|NCT01499641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708068|NCT01499693|Pantoprazole|pantoprazole|mesh-list
24708069|NCT01499693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24708070|NCT01499693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24708071|NCT01499693|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24708072|NCT01499693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760198|NCT01756651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24708073|NCT01499693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708074|NCT01499758|Atorvastatin|atorvastatin|mesh-list
24708075|NCT01499758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24708076|NCT01499758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24708077|NCT01499758|Antimetabolites|antimetabolites|mesh-ancestor
24708078|NCT01499758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708079|NCT01499758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24708081|NCT01499758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708095|NCT01499953|Fondaparinux|fondaparinux|mesh-list
24708104|NCT01499953|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24708105|NCT01500005|Vitamin D|vitamin d|mesh-list
24708106|NCT01500005|Vitamins|vitamins|mesh-ancestor
24708107|NCT01500005|Micronutrients|micronutrients|mesh-ancestor
24708174|NCT01500473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708175|NCT01500473|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24708176|NCT01500473|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24708178|NCT01500473|Hormones|hormones|mesh-ancestor
24708179|NCT01500473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24708180|NCT01500538|Vorinostat|vorinostat|mesh-list
24708181|NCT01500538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708182|NCT01500538|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24708183|NCT01500538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708184|NCT01500538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708185|NCT01500577|Nimesulide|nimesulide|mesh-list
24708186|NCT01500577|Simvastatin|simvastatin|mesh-list
25695213|NCT02043366|Flurbiprofen|flurbiprofen|mesh-list
24445797|NCT00302627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24473768|NCT00404183|Acetaminophen|acetaminophen|mesh-list
24613896|NCT01021540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613898|NCT01021566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24613899|NCT01021566|Narcotics|narcotics|mesh-ancestor
24613900|NCT01021566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24613901|NCT01021566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613902|NCT01021566|Analgesics|analgesics|mesh-ancestor
24613903|NCT01021566|Sensory System Agents|sensory system agents|mesh-ancestor
24708324|NCT01501123|Haloperidol|haloperidol|mesh-list
24613906|NCT01021566|Respiratory System Agents|respiratory system agents|mesh-ancestor
24613907|NCT01021579|Metformin|metformin|mesh-list
24708191|NCT01500577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24708192|NCT01500577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24708193|NCT01500577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708194|NCT01500577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24708195|NCT01500577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24708197|NCT01500577|Sensory System Agents|sensory system agents|mesh-ancestor
24708198|NCT01500577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24708199|NCT01500577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708200|NCT01500577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24708201|NCT01500577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24708202|NCT01500577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24708203|NCT01500590|Ramipril|ramipril|mesh-list
24708204|NCT01500590|Irbesartan|irbesartan|mesh-list
24708205|NCT01500590|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24708206|NCT01500590|Protease Inhibitors|protease inhibitors|mesh-ancestor
24708207|NCT01500590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708208|NCT01500590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708209|NCT01500590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24708210|NCT01500590|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24708211|NCT01500590|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24708212|NCT01500785|Vitamin B 12|vitamin b 12|mesh-list
24708213|NCT01500785|Hydroxocobalamin|hydroxocobalamin|mesh-list
24708214|NCT01500785|Simendan|simendan|mesh-list
24708215|NCT01500785|Vitamins|vitamins|mesh-ancestor
24708216|NCT01500785|Micronutrients|micronutrients|mesh-ancestor
24708217|NCT01500785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708237|NCT01500837|Clindamycin phosphate|clindamycin phosphate|mesh-list
24708238|NCT01500837|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24708239|NCT01500837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24708241|NCT01500837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24708242|NCT01500837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24708243|NCT01500837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24708244|NCT01500837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708245|NCT01500837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708246|NCT01500837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708247|NCT01500837|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24708262|NCT01500850|Insulin Glargine|insulin glargine|mesh-list
24708263|NCT01500850|Insulin glulisine|insulin glulisine|mesh-list
24708264|NCT01500850|Insulin, Isophane|insulin, isophane|mesh-list
24708265|NCT01500850|Isophane Insulin, Human|isophane insulin, human|mesh-list
24708266|NCT01500850|Isophane insulin, beef|isophane insulin, beef|mesh-list
24708267|NCT01500850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24644921|NCT01193855|Dutasteride|dutasteride|mesh-list
24708268|NCT01500850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708302|NCT01500980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24708303|NCT01500980|Antimalarials|antimalarials|mesh-ancestor
24708304|NCT01500980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24708305|NCT01500993|Fluorouracil|fluorouracil|mesh-list
24708306|NCT01500993|Capecitabine|capecitabine|mesh-list
24708307|NCT01500993|Antimetabolites|antimetabolites|mesh-ancestor
24940861|NCT03997006|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24854182|NCT02272517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24708308|NCT01500993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708309|NCT01500993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24708310|NCT01500993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708311|NCT01500993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25695214|NCT02043366|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
25695215|NCT02043366|Sufentanil|sufentanil|mesh-list
25695216|NCT02043366|Remifentanil|remifentanil|mesh-list
24676653|NCT01351636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24461522|NCT00352521|Growth Substances|growth substances|mesh-ancestor
24708312|NCT01500993|Immunologic Factors|immunologic factors|mesh-ancestor
24708313|NCT01500993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708314|NCT01501032|Pancrelipase|pancrelipase|mesh-list
24708315|NCT01501032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24708316|NCT01501084|Exenatide|exenatide|mesh-list
24708317|NCT01501084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24708319|NCT01501084|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24708320|NCT01501084|Incretins|incretins|mesh-ancestor
24708321|NCT01501084|Hormones|hormones|mesh-ancestor
24708322|NCT01501084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24708323|NCT01501123|Midazolam|midazolam|mesh-list
24708325|NCT01501123|Haloperidol decanoate|haloperidol decanoate|mesh-list
24708326|NCT01501123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24708327|NCT01501123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24708328|NCT01501123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24708329|NCT01501123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708330|NCT01501123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24708337|NCT01501123|GABA Agents|gaba agents|mesh-ancestor
24708338|NCT01501123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24708339|NCT01501123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708340|NCT01501123|Antiemetics|antiemetics|mesh-ancestor
24708341|NCT01501123|Autonomic Agents|autonomic agents|mesh-ancestor
24708391|NCT01501149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24708392|NCT01501149|Antiemetics|antiemetics|mesh-ancestor
24708393|NCT01501149|Autonomic Agents|autonomic agents|mesh-ancestor
24708394|NCT01501149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24708395|NCT01501149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708396|NCT01501149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24708438|NCT01501370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708439|NCT01501370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24708440|NCT01501370|Glucocorticoids|glucocorticoids|mesh-ancestor
24708441|NCT01501370|Hormones|hormones|mesh-ancestor
24708442|NCT01501370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24708443|NCT01501370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24708444|NCT01501370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708445|NCT01501370|Protease Inhibitors|protease inhibitors|mesh-ancestor
24708446|NCT01501370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708447|NCT01501370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708448|NCT01501370|Immunologic Factors|immunologic factors|mesh-ancestor
24708449|NCT01501370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24708450|NCT01501370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24708567|NCT01501708|Caspofungin|caspofungin|mesh-list
24708568|NCT01501708|Antifungal Agents|antifungal agents|mesh-ancestor
24708569|NCT01501708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24613998|NCT01021943|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24614000|NCT01021943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24614001|NCT01021943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614002|NCT01021943|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24614003|NCT01021943|Diuretics|diuretics|mesh-ancestor
24614004|NCT01021943|Natriuretic Agents|natriuretic agents|mesh-ancestor
24614005|NCT01022021|Rituximab|rituximab|mesh-list
24614006|NCT01022021|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24614007|NCT01022021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24708610|NCT01501760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24708611|NCT01501760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24940862|NCT03997006|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24940863|NCT03997006|Purinergic Agents|purinergic agents|mesh-ancestor
24708627|NCT01501786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24708628|NCT01501786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24708629|NCT01501786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24708630|NCT01501786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708632|NCT01501799|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24708633|NCT01501799|Dermatologic Agents|dermatologic agents|mesh-ancestor
24708634|NCT01501799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24708635|NCT01501799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25695217|NCT02043366|Butorphanol|butorphanol|mesh-list
24708636|NCT01501799|Analgesics|analgesics|mesh-ancestor
24708637|NCT01501799|Sensory System Agents|sensory system agents|mesh-ancestor
25695218|NCT02043366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25695219|NCT02043366|Narcotics|narcotics|mesh-ancestor
24708638|NCT01501799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24708639|NCT01501799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708640|NCT01501799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24708641|NCT01501799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24708643|NCT01501890|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
24708644|NCT01501890|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
24708645|NCT01501890|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24708646|NCT01501890|Hormone Antagonists|hormone antagonists|mesh-ancestor
24708653|NCT01501890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24708654|NCT01501890|Contraceptive Agents|contraceptive agents|mesh-ancestor
24708655|NCT01501890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24708656|NCT01501890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24708657|NCT01501890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24708659|NCT01501916|Cholecalciferol|cholecalciferol|mesh-list
24708660|NCT01501916|Vitamins|vitamins|mesh-ancestor
24708661|NCT01501916|Micronutrients|micronutrients|mesh-ancestor
24708809|NCT01502943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24940864|NCT03997006|Protective Agents|protective agents|mesh-ancestor
24940865|NCT03997058|Estazolam|estazolam|mesh-list
24940866|NCT03997058|Anticonvulsants|anticonvulsants|mesh-ancestor
24940867|NCT03997058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24708810|NCT01502943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24708812|NCT01503008|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
24708813|NCT01503008|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24708814|NCT01503008|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
24708815|NCT01503008|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24708816|NCT01503008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708817|NCT01503008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708818|NCT01503008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708819|NCT01503008|Protease Inhibitors|protease inhibitors|mesh-ancestor
24708820|NCT01503060|Lidocaine|lidocaine|mesh-list
24708821|NCT01503060|Anesthetics, Local|anesthetics, local|mesh-ancestor
24708822|NCT01503060|Anesthetics|anesthetics|mesh-ancestor
24708823|NCT01503060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24708824|NCT01503060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708825|NCT01503060|Sensory System Agents|sensory system agents|mesh-ancestor
24708826|NCT01503060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24708827|NCT01503060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24708828|NCT01503060|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24708829|NCT01503060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24708830|NCT01503060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24708832|NCT01503216|Vitamin D|vitamin d|mesh-list
24708900|NCT01503398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24708901|NCT01503398|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24708902|NCT01503398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24708903|NCT01503398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24708904|NCT01503398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708905|NCT01503398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24708906|NCT01503398|Serotonin Agents|serotonin agents|mesh-ancestor
24708907|NCT01503424|Olanzapine|olanzapine|mesh-list
24708908|NCT01503424|Antiemetics|antiemetics|mesh-ancestor
24708909|NCT01503424|Autonomic Agents|autonomic agents|mesh-ancestor
24708910|NCT01503424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24708911|NCT01503424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708912|NCT01503424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24614051|NCT01022151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24614052|NCT01022151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24614053|NCT01022151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614054|NCT01022151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24614055|NCT01022151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24614056|NCT01022151|Purinergic Agents|purinergic agents|mesh-ancestor
24614057|NCT01022151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24614058|NCT01022151|Protective Agents|protective agents|mesh-ancestor
24614059|NCT01022151|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24614060|NCT01022164|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24708921|NCT01503424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24708922|NCT01503424|Serotonin Agents|serotonin agents|mesh-ancestor
24708923|NCT01503437|Olanzapine|olanzapine|mesh-list
24708924|NCT01503437|Antiemetics|antiemetics|mesh-ancestor
24708925|NCT01503437|Autonomic Agents|autonomic agents|mesh-ancestor
24708926|NCT01503437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24708927|NCT01503437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708928|NCT01503437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24708929|NCT01503437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24709034|NCT01503801|Respiratory System Agents|respiratory system agents|mesh-ancestor
24709035|NCT01503801|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24709036|NCT01503801|Antioxidants|antioxidants|mesh-ancestor
24709037|NCT01503801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709038|NCT01503801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24709039|NCT01503801|Vasodilator Agents|vasodilator agents|mesh-ancestor
24709040|NCT01503801|Gasotransmitters|gasotransmitters|mesh-ancestor
24709041|NCT01503801|Protective Agents|protective agents|mesh-ancestor
24709042|NCT01503905|Tamoxifen|tamoxifen|mesh-list
24709043|NCT01503905|Cyclophosphamide|cyclophosphamide|mesh-list
24709044|NCT01503905|Docetaxel|docetaxel|mesh-list
24709046|NCT01503905|Epirubicin|epirubicin|mesh-list
24709047|NCT01503905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24709048|NCT01503905|Immunologic Factors|immunologic factors|mesh-ancestor
24709049|NCT01503905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709050|NCT01503905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24709051|NCT01503905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24709052|NCT01503905|Alkylating Agents|alkylating agents|mesh-ancestor
24709053|NCT01503905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709054|NCT01503905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495111|NCT00498342|Antidotes|antidotes|mesh-ancestor
24709067|NCT01503905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24709068|NCT01503905|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24709069|NCT01503905|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24709070|NCT01503905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24709071|NCT01503918|Valacyclovir|valacyclovir|mesh-list
24709072|NCT01503918|Acyclovir|acyclovir|mesh-list
24709073|NCT01503918|Valganciclovir|valganciclovir|mesh-list
24709074|NCT01503918|Ganciclovir|ganciclovir|mesh-list
24709122|NCT01504139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709123|NCT01504139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24709125|NCT01504178|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24709126|NCT01504178|Levodopa|levodopa|mesh-list
24709127|NCT01504178|Apomorphine|apomorphine|mesh-list
24709128|NCT01504178|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
24709129|NCT01504178|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24709130|NCT01504178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24709131|NCT01504178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24709132|NCT01504178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709133|NCT01504178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24765686|NCT01789892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24765687|NCT01789892|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24765688|NCT01789892|Protective Agents|protective agents|mesh-ancestor
24535886|NCT00649896|Estradiol|estradiol|mesh-list
24940872|NCT03997058|GABA Modulators|gaba modulators|mesh-ancestor
24940873|NCT03997058|GABA Agents|gaba agents|mesh-ancestor
24940874|NCT03997058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24940875|NCT03997058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940876|NCT03996772|Rivaroxaban|rivaroxaban|mesh-list
24940879|NCT03996772|Dabigatran|dabigatran|mesh-list
24940880|NCT03996772|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24940881|NCT03996772|Antithrombins|antithrombins|mesh-ancestor
24940882|NCT03996772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24940883|NCT03996772|Protease Inhibitors|protease inhibitors|mesh-ancestor
24940884|NCT03996772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24940885|NCT03996772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940886|NCT03996772|Anticoagulants|anticoagulants|mesh-ancestor
24940887|NCT03996993|Bicalutamide|bicalutamide|mesh-list
24940888|NCT03996993|Androgen Antagonists|androgen antagonists|mesh-ancestor
24940889|NCT03996993|Hormone Antagonists|hormone antagonists|mesh-ancestor
24940890|NCT03996993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24940891|NCT03996993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709135|NCT01504178|Analgesics|analgesics|mesh-ancestor
24709138|NCT01504178|Antidepressive Agents|antidepressive agents|mesh-ancestor
24709139|NCT01504178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24709140|NCT01504178|Dopamine Agents|dopamine agents|mesh-ancestor
24709141|NCT01504178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24709142|NCT01504178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24709158|NCT01504256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709160|NCT01504256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24709161|NCT01504256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24709162|NCT01504256|Immunologic Factors|immunologic factors|mesh-ancestor
24709163|NCT01504256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709164|NCT01504256|Antidotes|antidotes|mesh-ancestor
24709165|NCT01504256|Protective Agents|protective agents|mesh-ancestor
24709166|NCT01504256|Vitamin B Complex|vitamin b complex|mesh-ancestor
24709167|NCT01504256|Vitamins|vitamins|mesh-ancestor
24709168|NCT01504256|Micronutrients|micronutrients|mesh-ancestor
24709169|NCT01504256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24709170|NCT01504282|Mitomycins|mitomycins|mesh-list
24709171|NCT01504282|Mitomycin|mitomycin|mesh-list
24709172|NCT01504282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24709190|NCT01504334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24709191|NCT01504334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24709199|NCT01504386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709200|NCT01504386|Sensory System Agents|sensory system agents|mesh-ancestor
24709201|NCT01504386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24709202|NCT01504490|Bexarotene|bexarotene|mesh-list
24709203|NCT01504490|Efatutazone|efatutazone|mesh-list
24709205|NCT01504503|Donepezil|donepezil|mesh-list
24940892|NCT03996993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24940893|NCT03996538|Metformin|metformin|mesh-list
24940894|NCT03996538|Vaccines|vaccines|mesh-list
24940895|NCT03996538|Immunologic Factors|immunologic factors|mesh-ancestor
24940896|NCT03996538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940897|NCT03996538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24709215|NCT01504516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709216|NCT01504516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709217|NCT01504516|Cholinergic Agents|cholinergic agents|mesh-ancestor
24709218|NCT01504516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24709219|NCT01504516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709220|NCT01504516|Nootropic Agents|nootropic agents|mesh-ancestor
24709221|NCT01504542|Vaccines|vaccines|mesh-list
24709222|NCT01504542|Immunologic Factors|immunologic factors|mesh-ancestor
24709224|NCT01504581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24709225|NCT01504581|Antiviral Agents|antiviral agents|mesh-ancestor
24614067|NCT01022229|Vitamin B Complex|vitamin b complex|mesh-ancestor
24614068|NCT01022333|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
24614069|NCT01022333|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24614070|NCT01022333|Protective Agents|protective agents|mesh-ancestor
24614071|NCT01022333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614072|NCT01022333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614073|NCT01022463|Atenolol|atenolol|mesh-list
24614074|NCT01022463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24614075|NCT01022463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24614076|NCT01022463|Sympatholytics|sympatholytics|mesh-ancestor
24614077|NCT01022463|Autonomic Agents|autonomic agents|mesh-ancestor
24614078|NCT01022463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24614079|NCT01022463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709299|NCT01505088|Dexamethasone|dexamethasone|mesh-list
24709317|NCT01505088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24709318|NCT01505088|Glucocorticoids|glucocorticoids|mesh-ancestor
24614123|NCT01022541|Antimetabolites|antimetabolites|mesh-ancestor
24709320|NCT01505088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24709321|NCT01505088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24709322|NCT01505088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24709323|NCT01505088|Anticoagulants|anticoagulants|mesh-ancestor
24709324|NCT01505088|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24709325|NCT01505088|Chelating Agents|chelating agents|mesh-ancestor
24709326|NCT01505088|Sequestering Agents|sequestering agents|mesh-ancestor
24802489|NCT01990586|Rabeprazole|rabeprazole|mesh-list
24709327|NCT01505088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709328|NCT01505088|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24709329|NCT01505088|Protective Agents|protective agents|mesh-ancestor
24709330|NCT01505088|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24709331|NCT01505088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24709333|NCT01505127|Clarithromycin|clarithromycin|mesh-list
24709334|NCT01505127|Lansoprazole|lansoprazole|mesh-list
24709335|NCT01505127|Dexlansoprazole|dexlansoprazole|mesh-list
24709336|NCT01505127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24709337|NCT01505127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24709338|NCT01505127|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24709339|NCT01505127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709340|NCT01505127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709341|NCT01505127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24940901|NCT03996421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940902|NCT03996577|Lidocaine|lidocaine|mesh-list
24940903|NCT03996577|Anesthetics, Local|anesthetics, local|mesh-ancestor
24940904|NCT03996577|Anesthetics|anesthetics|mesh-ancestor
24940905|NCT03996577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24940906|NCT03996577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940907|NCT03996577|Sensory System Agents|sensory system agents|mesh-ancestor
24678026|NCT01359605|Varespladib methyl|varespladib methyl|mesh-list
24709343|NCT01505127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24709421|NCT01505504|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24709422|NCT01505504|Histamine Antagonists|histamine antagonists|mesh-ancestor
24709423|NCT01505504|Histamine Agents|histamine agents|mesh-ancestor
24709424|NCT01505504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24709425|NCT01505504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709426|NCT01505504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709427|NCT01505504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24709428|NCT01505504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24709429|NCT01505504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24709430|NCT01505504|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24709431|NCT01505504|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24709432|NCT01505504|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24709433|NCT01505504|Adrenergic Agents|adrenergic agents|mesh-ancestor
24709459|NCT01505894|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24709460|NCT01505894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709461|NCT01505894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709462|NCT01505920|Lidocaine|lidocaine|mesh-list
24709463|NCT01505920|Anesthetics, Local|anesthetics, local|mesh-ancestor
24709464|NCT01505920|Anesthetics|anesthetics|mesh-ancestor
24709465|NCT01505920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24709466|NCT01505920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709467|NCT01505920|Sensory System Agents|sensory system agents|mesh-ancestor
24709468|NCT01505920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24709469|NCT01505920|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24709470|NCT01505920|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24709471|NCT01505920|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24709472|NCT01505920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24709473|NCT01505920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709474|NCT01505946|Thrombin|thrombin|mesh-list
24709483|NCT01505998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24940908|NCT03996577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24940909|NCT03996577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24463784|NCT00362206|Antimetabolites|antimetabolites|mesh-ancestor
24940910|NCT03996577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24760642|NCT01759524|Lidocaine|lidocaine|mesh-list
24940911|NCT03996577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24940912|NCT03996577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24709484|NCT01505998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709485|NCT01505998|Vasodilator Agents|vasodilator agents|mesh-ancestor
24709486|NCT01505998|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24709539|NCT01506063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709540|NCT01506076|Levocetirizine|levocetirizine|mesh-list
24709541|NCT01506076|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24709542|NCT01506076|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24709543|NCT01506076|Histamine Antagonists|histamine antagonists|mesh-ancestor
24709544|NCT01506076|Histamine Agents|histamine agents|mesh-ancestor
24709545|NCT01506076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24709546|NCT01506076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709547|NCT01506076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709548|NCT01506115|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
24709549|NCT01506115|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
24709551|NCT01506115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24709552|NCT01506115|Dermatologic Agents|dermatologic agents|mesh-ancestor
24709553|NCT01506115|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24709554|NCT01506167|Leucovorin|leucovorin|mesh-list
24709555|NCT01506167|Folic Acid|folic acid|mesh-list
24709556|NCT01506167|Bevacizumab|bevacizumab|mesh-list
24709557|NCT01506167|Fluorouracil|fluorouracil|mesh-list
24709559|NCT01506167|Oxaliplatin|oxaliplatin|mesh-list
24709560|NCT01506167|Irinotecan|irinotecan|mesh-list
24709561|NCT01506167|Levoleucovorin|levoleucovorin|mesh-list
24709562|NCT01506167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24709575|NCT01506167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24709577|NCT01506167|Antidotes|antidotes|mesh-ancestor
24709578|NCT01506167|Protective Agents|protective agents|mesh-ancestor
24709579|NCT01506167|Vitamin B Complex|vitamin b complex|mesh-ancestor
24709580|NCT01506167|Vitamins|vitamins|mesh-ancestor
24709582|NCT01506167|Hematinics|hematinics|mesh-ancestor
24709589|NCT01506336|Growth Inhibitors|growth inhibitors|mesh-ancestor
24709590|NCT01506336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24709591|NCT01506336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709616|NCT01506505|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24709619|NCT01506505|Diuretics|diuretics|mesh-ancestor
24709620|NCT01506505|Natriuretic Agents|natriuretic agents|mesh-ancestor
24709621|NCT01506505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709622|NCT01506505|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24709623|NCT01506505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24709624|NCT01506505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24709625|NCT01506505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24709626|NCT01506505|Analgesics|analgesics|mesh-ancestor
24709630|NCT01506505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24709631|NCT01506505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24709632|NCT01506505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24709633|NCT01506505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24709634|NCT01506505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24709635|NCT01506505|Antipyretics|antipyretics|mesh-ancestor
24709636|NCT01506505|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24709637|NCT01506505|Protease Inhibitors|protease inhibitors|mesh-ancestor
24709638|NCT01506505|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24709639|NCT01506505|Protective Agents|protective agents|mesh-ancestor
24940914|NCT03996603|Estrogens|estrogens|mesh-list
24709667|NCT01506622|Sensory System Agents|sensory system agents|mesh-ancestor
24709682|NCT01506713|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24709683|NCT01506713|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24709684|NCT01506713|Purinergic Agents|purinergic agents|mesh-ancestor
24709685|NCT01506713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24709686|NCT01506713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709687|NCT01506713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709689|NCT01506739|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24709713|NCT01506765|Protective Agents|protective agents|mesh-ancestor
24709714|NCT01506765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709715|NCT01506765|Antidotes|antidotes|mesh-ancestor
24709716|NCT01506791|Pseudoephedrine|pseudoephedrine|mesh-list
24709717|NCT01506791|Ephedrine|ephedrine|mesh-list
24709718|NCT01506791|Desloratadine|desloratadine|mesh-list
24709719|NCT01506791|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24709720|NCT01506791|Cholinergic Agents|cholinergic agents|mesh-ancestor
24709721|NCT01506791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25079677|NCT03346226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24709722|NCT01506791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495839|NCT00502138|Appetite Depressants|appetite depressants|mesh-ancestor
24709723|NCT01506791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709724|NCT01506791|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24709725|NCT01506791|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24709726|NCT01506791|Histamine Antagonists|histamine antagonists|mesh-ancestor
24709727|NCT01506791|Histamine Agents|histamine agents|mesh-ancestor
24709728|NCT01506791|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24709729|NCT01506791|Autonomic Agents|autonomic agents|mesh-ancestor
24709730|NCT01506791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24709731|NCT01506791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24709732|NCT01506791|Respiratory System Agents|respiratory system agents|mesh-ancestor
24709733|NCT01506791|Nasal Decongestants|nasal decongestants|mesh-ancestor
24709734|NCT01506791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24709735|NCT01506791|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25050723|NCT00468975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25050724|NCT00468975|Autonomic Agents|autonomic agents|mesh-ancestor
25050725|NCT00468975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24854239|NCT02272738|Gemcitabine|gemcitabine|mesh-list
24709739|NCT01506804|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24709740|NCT01506804|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24709741|NCT01506804|Prednisolone|prednisolone|mesh-list
24709767|NCT01506895|Darapladib|darapladib|mesh-list
24709768|NCT01506895|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
24709769|NCT01506895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709770|NCT01506895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709771|NCT01506921|Ketamine|ketamine|mesh-list
24709772|NCT01506921|Esketamine|esketamine|mesh-list
24709773|NCT01506921|Analgesics|analgesics|mesh-ancestor
24709774|NCT01506921|Sensory System Agents|sensory system agents|mesh-ancestor
24709775|NCT01506921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24709776|NCT01506921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709777|NCT01506921|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24709780|NCT01506921|Anesthetics|anesthetics|mesh-ancestor
24709792|NCT01507064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709793|NCT01507077|CKD732|ckd732|mesh-list
24709795|NCT01507077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24710444|NCT01510561|Sequestering Agents|sequestering agents|mesh-ancestor
24709797|NCT01507077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709798|NCT01507077|Growth Inhibitors|growth inhibitors|mesh-ancestor
24709799|NCT01507077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24709800|NCT01507194|Ondansetron|ondansetron|mesh-list
24709801|NCT01507194|Vestipitant|vestipitant|mesh-list
24709802|NCT01507194|Antiemetics|antiemetics|mesh-ancestor
24709848|NCT01507363|Anticonvulsants|anticonvulsants|mesh-ancestor
24709849|NCT01507363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24709850|NCT01507363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24709851|NCT01507363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24709852|NCT01507363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24709853|NCT01507363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24709854|NCT01507363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24709855|NCT01507363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24709856|NCT01507363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709857|NCT01507363|Antimanic Agents|antimanic agents|mesh-ancestor
24709858|NCT01507376|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24709859|NCT01507376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24709860|NCT01507376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495978|NCT00502788|Antimetabolites|antimetabolites|mesh-ancestor
24495980|NCT00502788|Antiviral Agents|antiviral agents|mesh-ancestor
24709862|NCT01507389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24709863|NCT01507389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709864|NCT01507389|Incretins|incretins|mesh-ancestor
24709865|NCT01507389|Hormones|hormones|mesh-ancestor
24709866|NCT01507389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25050726|NCT00468975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050727|NCT00468975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25050728|NCT00468975|Respiratory System Agents|respiratory system agents|mesh-ancestor
24709932|NCT01507597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24709933|NCT01507597|Hormones|hormones|mesh-ancestor
24709934|NCT01507597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24709935|NCT01507597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709936|NCT01507597|Incretins|incretins|mesh-ancestor
24709982|NCT01507792|Histamine Agents|histamine agents|mesh-ancestor
24709983|NCT01507792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24709984|NCT01507792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709985|NCT01507792|Histamine Agonists|histamine agonists|mesh-ancestor
24709986|NCT01507857|Vaccines|vaccines|mesh-list
24709987|NCT01507857|Immunologic Factors|immunologic factors|mesh-ancestor
24709988|NCT01507857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709989|NCT01507922|Fenoverine|fenoverine|mesh-list
24709990|NCT01507922|Parasympatholytics|parasympatholytics|mesh-ancestor
24710015|NCT01507974|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24710016|NCT01507974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24710017|NCT01507974|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24614131|NCT01022632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24614132|NCT01022632|Serotonin Agents|serotonin agents|mesh-ancestor
24614133|NCT01022632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614134|NCT01022632|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24614135|NCT01022632|Antidepressive Agents|antidepressive agents|mesh-ancestor
24614136|NCT01022632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24614137|NCT01022632|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24614138|NCT01022632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24614139|NCT01022632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24614140|NCT01022632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24614141|NCT01022632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24614177|NCT01022736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24614178|NCT01022736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24614179|NCT01022736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24614180|NCT01022736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24614181|NCT01022736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24614182|NCT01022736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24614183|NCT01022736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614184|NCT01022736|Antimanic Agents|antimanic agents|mesh-ancestor
24614186|NCT01022749|Immunologic Factors|immunologic factors|mesh-ancestor
24614187|NCT01022749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614188|NCT01022840|Ketamine|ketamine|mesh-list
24679298|NCT01367743|Epinephrine|epinephrine|mesh-list
24679299|NCT01367743|Norepinephrine|norepinephrine|mesh-list
24679300|NCT01367743|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
24679301|NCT01367743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25050730|NCT00468975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25050731|NCT00468975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25050732|NCT00468975|Adrenergic Agents|adrenergic agents|mesh-ancestor
25050733|NCT00468975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050734|NCT00468975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050735|NCT00468442|Sirolimus|sirolimus|mesh-list
25050736|NCT00468442|Rituximab|rituximab|mesh-list
25050737|NCT00468442|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25050738|NCT00468442|Daclizumab|daclizumab|mesh-list
25050739|NCT00468442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25050740|NCT00468442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050741|NCT00468442|Immunologic Factors|immunologic factors|mesh-ancestor
25050742|NCT00468442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050743|NCT00468442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24614189|NCT01022840|Esketamine|esketamine|mesh-list
24614190|NCT01022840|Analgesics|analgesics|mesh-ancestor
24614191|NCT01022840|Sensory System Agents|sensory system agents|mesh-ancestor
24614192|NCT01022840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24614193|NCT01022840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614194|NCT01022840|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24614195|NCT01022840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24614196|NCT01022840|Anesthetics, General|anesthetics, general|mesh-ancestor
24614197|NCT01022840|Anesthetics|anesthetics|mesh-ancestor
24760827|NCT01760148|Antiviral Agents|antiviral agents|mesh-ancestor
24614198|NCT01022840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24614199|NCT01022840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24710018|NCT01508000|Bevacizumab|bevacizumab|mesh-list
24710019|NCT01508000|Panitumumab|panitumumab|mesh-list
24710021|NCT01508000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24710032|NCT01508104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710053|NCT01508182|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24710054|NCT01508182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710081|NCT01508260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710083|NCT01508286|Antimetabolites|antimetabolites|mesh-ancestor
24710084|NCT01508286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710085|NCT01508286|Antiviral Agents|antiviral agents|mesh-ancestor
24710086|NCT01508286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24710088|NCT01508364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24710089|NCT01508364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24710090|NCT01508364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496196|NCT00503659|Methacholine Chloride|methacholine chloride|mesh-list
24710091|NCT01508364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710092|NCT01508429|Misoprostol|misoprostol|mesh-list
24710093|NCT01508429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24710094|NCT01508429|Abortifacient Agents|abortifacient agents|mesh-ancestor
24710097|NCT01508429|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24710098|NCT01508429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24710099|NCT01508429|Oxytocics|oxytocics|mesh-ancestor
24710100|NCT01508468|Rituximab|rituximab|mesh-list
24710101|NCT01508468|Angiotensin II|angiotensin ii|mesh-list
24710102|NCT01508468|Giapreza|giapreza|mesh-list
24710182|NCT01508845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24710183|NCT01508845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24710185|NCT01508858|Levonorgestrel|levonorgestrel|mesh-list
24710186|NCT01508858|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24710187|NCT01508858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24710188|NCT01508858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710189|NCT01508858|Incretins|incretins|mesh-ancestor
24710190|NCT01508858|Hormones|hormones|mesh-ancestor
24710191|NCT01508858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24710192|NCT01508858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24710193|NCT01508858|Contraceptive Agents|contraceptive agents|mesh-ancestor
24645143|NCT01196234|Paclitaxel|paclitaxel|mesh-list
25695220|NCT02043366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25695221|NCT02043366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695222|NCT02043366|Analgesics|analgesics|mesh-ancestor
25695223|NCT02043366|Sensory System Agents|sensory system agents|mesh-ancestor
24710194|NCT01508858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24710195|NCT01508858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24710199|NCT01508858|Estrogens|estrogens|mesh-ancestor
24710221|NCT01508949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710223|NCT01508949|Hormones|hormones|mesh-ancestor
24710224|NCT01508949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24710225|NCT01509001|Metformin|metformin|mesh-list
24710226|NCT01509001|Glimepiride|glimepiride|mesh-list
24710227|NCT01509001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24710228|NCT01509001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710229|NCT01509001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24710230|NCT01509001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24710231|NCT01509001|Immunologic Factors|immunologic factors|mesh-ancestor
24710288|NCT01509300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24710290|NCT01509365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24710293|NCT01509365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24710345|NCT01509755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710346|NCT01509755|Incretins|incretins|mesh-ancestor
24710348|NCT01509755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24710349|NCT01509755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24710350|NCT01509755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24710351|NCT01509755|Immunologic Factors|immunologic factors|mesh-ancestor
24710352|NCT01509911|Gemcitabine|gemcitabine|mesh-list
24710353|NCT01509911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24710354|NCT01509911|Antimetabolites|antimetabolites|mesh-ancestor
24710355|NCT01509911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710356|NCT01509911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24710357|NCT01509911|Antiviral Agents|antiviral agents|mesh-ancestor
24710358|NCT01509911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24710359|NCT01509911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24710360|NCT01509911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24710361|NCT01509911|Immunologic Factors|immunologic factors|mesh-ancestor
24710362|NCT01509911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710373|NCT01510015|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24710374|NCT01510015|Serotonin Agents|serotonin agents|mesh-ancestor
24710375|NCT01510015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24710376|NCT01510015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710377|NCT01510015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710378|NCT01510015|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24710379|NCT01510015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24710380|NCT01510015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24710381|NCT01510015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24710382|NCT01510015|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24710383|NCT01510015|Dopamine Agents|dopamine agents|mesh-ancestor
24710385|NCT01510093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24710390|NCT01510132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24710391|NCT01510132|Adrenergic Agents|adrenergic agents|mesh-ancestor
24710392|NCT01510132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24710393|NCT01510132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710394|NCT01510132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614217|NCT01022983|Simendan|simendan|mesh-list
24614233|NCT01023100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24614234|NCT01023100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24614235|NCT01023100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614236|NCT01023139|Sibutramine|sibutramine|mesh-list
24614237|NCT01023139|Antidepressive Agents|antidepressive agents|mesh-ancestor
24614238|NCT01023139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24614239|NCT01023139|Appetite Depressants|appetite depressants|mesh-ancestor
24614240|NCT01023139|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24614241|NCT01023165|Insulin Lispro|insulin lispro|mesh-list
24614242|NCT01023165|Insulin Aspart|insulin aspart|mesh-list
24614243|NCT01023165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24614244|NCT01023165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710405|NCT01510171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710406|NCT01510171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710407|NCT01510288|Ipilimumab|ipilimumab|mesh-list
24710408|NCT01510288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24710409|NCT01510288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24710420|NCT01510509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24710421|NCT01510509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24710422|NCT01510509|Immunologic Factors|immunologic factors|mesh-ancestor
24710423|NCT01510509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710429|NCT01510548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24710431|NCT01510561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24710432|NCT01510561|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
24710433|NCT01510561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24680622|NCT01375634|Midazolam|midazolam|mesh-list
24710434|NCT01510561|Antimetabolites|antimetabolites|mesh-ancestor
24710435|NCT01510561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710436|NCT01510561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24710437|NCT01510561|Antiviral Agents|antiviral agents|mesh-ancestor
24710438|NCT01510561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24710439|NCT01510561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24710440|NCT01510561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24710441|NCT01510561|Immunologic Factors|immunologic factors|mesh-ancestor
24710442|NCT01510561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710443|NCT01510561|Chelating Agents|chelating agents|mesh-ancestor
24710446|NCT01510574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24710447|NCT01510574|Abortifacient Agents|abortifacient agents|mesh-ancestor
24710448|NCT01510574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24710468|NCT01510613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24710469|NCT01510613|Growth Substances|growth substances|mesh-ancestor
24710470|NCT01510613|Growth Inhibitors|growth inhibitors|mesh-ancestor
24710472|NCT01510626|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24710473|NCT01510626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24710474|NCT01510626|Respiratory System Agents|respiratory system agents|mesh-ancestor
24710475|NCT01510665|Magnesium citrate|magnesium citrate|mesh-list
24710476|NCT01510665|Cathartics|cathartics|mesh-ancestor
24710477|NCT01510665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24710478|NCT01510795|Spironolactone|spironolactone|mesh-list
24710479|NCT01510795|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24710480|NCT01510795|Hormone Antagonists|hormone antagonists|mesh-ancestor
24645188|NCT01196507|Carvedilol|carvedilol|mesh-list
24710523|NCT01511029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25050758|NCT00468403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050759|NCT00468403|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24710524|NCT01511029|Dopamine Agonists|dopamine agonists|mesh-ancestor
24710525|NCT01511029|Dopamine Agents|dopamine agents|mesh-ancestor
24710526|NCT01511029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24710527|NCT01511042|Norepinephrine|norepinephrine|mesh-list
24710528|NCT01511042|Angiotensin II|angiotensin ii|mesh-list
24710529|NCT01511042|Giapreza|giapreza|mesh-list
24710530|NCT01511042|Angiotensinogen|angiotensinogen|mesh-list
24710531|NCT01511042|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24710532|NCT01511042|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24710533|NCT01511042|Adrenergic Agents|adrenergic agents|mesh-ancestor
24710534|NCT01511042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24710535|NCT01511042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710537|NCT01511042|Sympathomimetics|sympathomimetics|mesh-ancestor
24710565|NCT01511159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710644|NCT01511289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710645|NCT01511302|Budesonide|budesonide|mesh-list
24710646|NCT01511302|RNS60|rns60|mesh-list
24710647|NCT01511302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24710648|NCT01511302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24710649|NCT01511302|Autonomic Agents|autonomic agents|mesh-ancestor
24710650|NCT01511302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24710651|NCT01511302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710652|NCT01511302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24710656|NCT01511302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24710657|NCT01511302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24956939|NCT03849027|Anesthetics, General|anesthetics, general|mesh-ancestor
24956940|NCT03849027|Anesthetics|anesthetics|mesh-ancestor
24956941|NCT03849027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24956942|NCT03849027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710688|NCT01511562|Etoposide|etoposide|mesh-list
24710689|NCT01511562|Thiotepa|thiotepa|mesh-list
24710690|NCT01511562|Carmustine|carmustine|mesh-list
24710691|NCT01511562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24710692|NCT01511562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24710693|NCT01511562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24710694|NCT01511562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24614249|NCT01023243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24710790|NCT01511822|Drospirenone|drospirenone|mesh-list
24710791|NCT01511822|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24710842|NCT01511887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24614266|NCT01023334|Anesthetics, Local|anesthetics, local|mesh-ancestor
24710843|NCT01511887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24710844|NCT01511887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24710846|NCT01511887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710881|NCT01512147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24710882|NCT01512147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24710883|NCT01512147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24710884|NCT01512147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24710885|NCT01512147|Adrenergic Agents|adrenergic agents|mesh-ancestor
24710886|NCT01512147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24710887|NCT01512147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710888|NCT01512147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24710890|NCT01512173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24710891|NCT01512173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24710892|NCT01512173|Adrenergic Agents|adrenergic agents|mesh-ancestor
24710893|NCT01512173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24710909|NCT01512199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24710910|NCT01512199|Immunologic Factors|immunologic factors|mesh-ancestor
24710911|NCT01512199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710913|NCT01512316|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24710914|NCT01512316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24710915|NCT01512316|Renal Agents|renal agents|mesh-ancestor
24710916|NCT01512316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24710917|NCT01512316|Antitubercular Agents|antitubercular agents|mesh-ancestor
24710918|NCT01512316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24710919|NCT01512316|Antimetabolites|antimetabolites|mesh-ancestor
24710920|NCT01512316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710921|NCT01512355|Dexmedetomidine|dexmedetomidine|mesh-list
24710922|NCT01512355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24710923|NCT01512355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24710969|NCT01512537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710970|NCT01512537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24710971|NCT01512537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24710972|NCT01512628|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24710973|NCT01512628|Plasma Substitutes|plasma substitutes|mesh-ancestor
24710974|NCT01512628|Blood Substitutes|blood substitutes|mesh-ancestor
24710975|NCT01512680|Insulin|insulin|mesh-list
24710976|NCT01512680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24710978|NCT01512784|Vaccines|vaccines|mesh-list
24710983|NCT01512862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710984|NCT01512862|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24710985|NCT01512862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24710986|NCT01512862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710987|NCT01512862|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24710988|NCT01512862|Vitamins|vitamins|mesh-ancestor
24711011|NCT01512953|Dexlansoprazole|dexlansoprazole|mesh-list
24711012|NCT01512953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24711013|NCT01512953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24711014|NCT01512953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24711015|NCT01512953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711016|NCT01512953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711017|NCT01512966|Aflibercept|aflibercept|mesh-list
24711020|NCT01512966|Growth Substances|growth substances|mesh-ancestor
24711021|NCT01512966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711022|NCT01512966|Growth Inhibitors|growth inhibitors|mesh-ancestor
24711023|NCT01512966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25695224|NCT02043366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24711024|NCT01513044|Mycophenolic Acid|mycophenolic acid|mesh-list
24711025|NCT01513044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24711026|NCT01513044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614294|NCT01023360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24711080|NCT01513174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711081|NCT01513174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24711082|NCT01513174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24956944|NCT03848611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24956945|NCT03848611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711086|NCT01513200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24711089|NCT01513499|Oxytocin|oxytocin|mesh-list
24711090|NCT01513499|Oxytocics|oxytocics|mesh-ancestor
24711091|NCT01513499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24711092|NCT01513499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711118|NCT01513603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711119|NCT01513603|Analgesics|analgesics|mesh-ancestor
24711120|NCT01513603|Sensory System Agents|sensory system agents|mesh-ancestor
24711121|NCT01513603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24711122|NCT01513603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24711123|NCT01513603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24711124|NCT01513603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711125|NCT01513668|Acetaminophen|acetaminophen|mesh-list
24711126|NCT01513668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24711127|NCT01513668|Analgesics|analgesics|mesh-ancestor
24711128|NCT01513668|Sensory System Agents|sensory system agents|mesh-ancestor
24711144|NCT01513720|Lamotrigine|lamotrigine|mesh-list
24711145|NCT01513720|Anticonvulsants|anticonvulsants|mesh-ancestor
24711146|NCT01513720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24711147|NCT01513720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24711148|NCT01513720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711149|NCT01513720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24711150|NCT01513720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711151|NCT01513720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24711152|NCT01513720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24711155|NCT01513720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24711156|NCT01513772|Dexmedetomidine|dexmedetomidine|mesh-list
24711157|NCT01513772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24711158|NCT01513772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24711159|NCT01513772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711160|NCT01513772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24711194|NCT01513941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711197|NCT01514019|Acebutolol|acebutolol|mesh-list
24711198|NCT01514019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24711199|NCT01514019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24711200|NCT01514019|Sympathomimetics|sympathomimetics|mesh-ancestor
24711201|NCT01514019|Autonomic Agents|autonomic agents|mesh-ancestor
24711202|NCT01514019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24711249|NCT01514188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711250|NCT01514227|Aspirin|aspirin|mesh-list
24711251|NCT01514227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24711252|NCT01514227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24711253|NCT01514227|Analgesics|analgesics|mesh-ancestor
24711254|NCT01514227|Sensory System Agents|sensory system agents|mesh-ancestor
24711255|NCT01514227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24711256|NCT01514227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711257|NCT01514227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24711258|NCT01514227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24711259|NCT01514227|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24711260|NCT01514227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24711261|NCT01514227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711262|NCT01514227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24711263|NCT01514227|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24711264|NCT01514227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711277|NCT01514266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711284|NCT01514409|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
25695225|NCT02043366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25695226|NCT02043366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24908438|NCT04320277|Ritonavir|ritonavir|mesh-list
24908439|NCT04320277|Lopinavir|lopinavir|mesh-list
25109212|NCT03126721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25109213|NCT03126721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109214|NCT03126708|Paclitaxel|paclitaxel|mesh-list
25109215|NCT03126708|Cetuximab|cetuximab|mesh-list
25109216|NCT03126708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24908440|NCT04320277|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24908441|NCT04320277|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24908442|NCT04320277|Protease Inhibitors|protease inhibitors|mesh-ancestor
24711285|NCT01514409|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24711286|NCT01514409|Antidepressive Agents|antidepressive agents|mesh-ancestor
24711287|NCT01514409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24711288|NCT01514487|Liraglutide|liraglutide|mesh-list
24711289|NCT01514487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24711290|NCT01514487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711291|NCT01514487|Incretins|incretins|mesh-ancestor
24711293|NCT01514487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24711294|NCT01514695|Fentanyl|fentanyl|mesh-list
24711295|NCT01514695|Midazolam|midazolam|mesh-list
24711335|NCT01514812|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24711336|NCT01514812|Protease Inhibitors|protease inhibitors|mesh-ancestor
24711337|NCT01514812|Anticoagulants|anticoagulants|mesh-ancestor
24711338|NCT01514825|Darexaban|darexaban|mesh-list
24711339|NCT01514825|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24711340|NCT01514825|Antithrombins|antithrombins|mesh-ancestor
24711370|NCT01514929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24711371|NCT01514929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24711372|NCT01514929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24711373|NCT01514929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711374|NCT01514929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711375|NCT01514929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24711376|NCT01514942|Folic Acid|folic acid|mesh-list
24956953|NCT03848806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24956954|NCT03848806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956955|NCT03848806|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24711377|NCT01514942|Vitamin B Complex|vitamin b complex|mesh-list
24711378|NCT01514942|Hydroxocobalamin|hydroxocobalamin|mesh-list
24711379|NCT01514942|Vitamin B 12|vitamin b 12|mesh-list
24711380|NCT01514942|Inositol|inositol|mesh-list
24711381|NCT01514942|Manganese|manganese|mesh-list
24711382|NCT01514942|Hematinics|hematinics|mesh-ancestor
24711383|NCT01514942|Vitamins|vitamins|mesh-ancestor
24614337|NCT01023607|Antimetabolites|antimetabolites|mesh-ancestor
24614338|NCT01023607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614367|NCT01023919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24614368|NCT01023919|Antifungal Agents|antifungal agents|mesh-ancestor
24614369|NCT01023919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24614370|NCT01023919|Immunologic Factors|immunologic factors|mesh-ancestor
24711422|NCT01515137|Analgesics|analgesics|mesh-ancestor
24711423|NCT01515137|Sensory System Agents|sensory system agents|mesh-ancestor
24711424|NCT01515137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24711425|NCT01515137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711440|NCT01515228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711441|NCT01515228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24711443|NCT01515228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24711481|NCT01515592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711484|NCT01515592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24711485|NCT01515683|Anesthetics|anesthetics|mesh-list
24711528|NCT01515826|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24711529|NCT01515826|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25695227|NCT02043366|Anesthetics, General|anesthetics, general|mesh-ancestor
25695228|NCT02043366|Anesthetics|anesthetics|mesh-ancestor
25695229|NCT02043366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25695230|NCT02043366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25695231|NCT02043366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25695232|NCT02043366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25695233|NCT02043366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25695234|NCT02043366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25695235|NCT02043366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695236|NCT02043366|Antitussive Agents|antitussive agents|mesh-ancestor
25695237|NCT02043366|Respiratory System Agents|respiratory system agents|mesh-ancestor
24682044|NCT01383538|Vitamin B Complex|vitamin b complex|mesh-ancestor
24682045|NCT01383538|Vitamins|vitamins|mesh-ancestor
24682046|NCT01383538|Micronutrients|micronutrients|mesh-ancestor
24682047|NCT01383655|Magnesium Sulfate|magnesium sulfate|mesh-list
24682092|NCT01384227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24682093|NCT01384227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24682094|NCT01384240|Proflavine|proflavine|mesh-list
24682095|NCT01384240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24682189|NCT01384643|Anesthetics|anesthetics|mesh-ancestor
24682190|NCT01384656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24682191|NCT01384682|Maraviroc|maraviroc|mesh-list
24682192|NCT01384682|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25090097|NCT03261115|Anesthetics|anesthetics|mesh-list
24711531|NCT01515826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24711532|NCT01515826|Antiemetics|antiemetics|mesh-ancestor
24711533|NCT01515826|Autonomic Agents|autonomic agents|mesh-ancestor
24711534|NCT01515826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24711535|NCT01515826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711536|NCT01515826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24711537|NCT01515826|Glucocorticoids|glucocorticoids|mesh-ancestor
24711538|NCT01515826|Hormones|hormones|mesh-ancestor
24711539|NCT01515826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24711540|NCT01515826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24711541|NCT01515826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24711542|NCT01515826|Protease Inhibitors|protease inhibitors|mesh-ancestor
24711543|NCT01515826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711544|NCT01515826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711545|NCT01515826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24711546|NCT01515826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24711547|NCT01515826|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24711548|NCT01515826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24711549|NCT01515826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24956958|NCT03848806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24956960|NCT03848806|Micronutrients|micronutrients|mesh-ancestor
24956961|NCT03848806|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24956962|NCT03848533|Metformin|metformin|mesh-list
24956963|NCT03848533|Melatonin|melatonin|mesh-list
24956964|NCT03848533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24711810|NCT01517022|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24956967|NCT03848533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956968|NCT03848533|Protective Agents|protective agents|mesh-ancestor
24593755|NCT00930839|Vitamins|vitamins|mesh-ancestor
24940928|NCT03996486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24940929|NCT03996486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24940930|NCT03996486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940931|NCT03996486|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24711553|NCT01515826|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24711554|NCT01515826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24711555|NCT01515839|Thioctic Acid|thioctic acid|mesh-list
24711616|NCT01516255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24711617|NCT01516255|Incretins|incretins|mesh-ancestor
24711619|NCT01516255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24711620|NCT01516372|Moxifloxacin|moxifloxacin|mesh-list
24711621|NCT01516372|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24711622|NCT01516372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24711623|NCT01516372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24711624|NCT01516372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24711625|NCT01516372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24711626|NCT01516372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711627|NCT01516372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695238|NCT02043366|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25695239|NCT02043379|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25695240|NCT02043379|Immunologic Factors|immunologic factors|mesh-ancestor
25695241|NCT02043379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695242|NCT02043652|Chloroquine|chloroquine|mesh-list
25695243|NCT02043652|Primaquine|primaquine|mesh-list
25695244|NCT02043652|Amebicides|amebicides|mesh-ancestor
25695245|NCT02043652|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25695246|NCT02043652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25695247|NCT02043652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25695248|NCT02043652|Antimalarials|antimalarials|mesh-ancestor
25695249|NCT02043652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25695250|NCT02043704|Acetaminophen|acetaminophen|mesh-list
24711628|NCT01516372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908878|NCT04315831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24908879|NCT04315831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24908992|NCT04314193|Hormones|hormones|mesh-ancestor
24908993|NCT04314193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24908994|NCT04314193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24682525|NCT01386593|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24682526|NCT01386593|Antitubercular Agents|antitubercular agents|mesh-ancestor
24682527|NCT01386593|Leprostatic Agents|leprostatic agents|mesh-ancestor
24682538|NCT01386658|Analgesics|analgesics|mesh-ancestor
24711630|NCT01516372|Contraceptive Agents|contraceptive agents|mesh-ancestor
24711657|NCT01516567|Rituximab|rituximab|mesh-list
24711658|NCT01516567|Doxorubicin|doxorubicin|mesh-list
24711661|NCT01516567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24711662|NCT01516567|Immunologic Factors|immunologic factors|mesh-ancestor
24711663|NCT01516567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711664|NCT01516567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24711665|NCT01516567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24711666|NCT01516567|Alkylating Agents|alkylating agents|mesh-ancestor
24940932|NCT03996486|Protease Inhibitors|protease inhibitors|mesh-ancestor
24940933|NCT03996486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24940934|NCT03996486|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24614413|NCT01024192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614414|NCT01024192|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24614415|NCT01024192|GABA Agonists|gaba agonists|mesh-ancestor
24614416|NCT01024192|GABA Agents|gaba agents|mesh-ancestor
24614417|NCT01024192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24711758|NCT01516814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711759|NCT01516840|Heparin|heparin|mesh-list
24711760|NCT01516840|Calcium heparin|calcium heparin|mesh-list
24711761|NCT01516840|Warfarin|warfarin|mesh-list
24711762|NCT01516840|Rivaroxaban|rivaroxaban|mesh-list
24711763|NCT01516840|Anticoagulants|anticoagulants|mesh-ancestor
24711764|NCT01516840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24711765|NCT01516840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24711766|NCT01516840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711767|NCT01516840|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24711768|NCT01516840|Antithrombins|antithrombins|mesh-ancestor
24711769|NCT01516840|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24711770|NCT01516840|Protease Inhibitors|protease inhibitors|mesh-ancestor
24711771|NCT01516840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711772|NCT01516866|Listerine|listerine|mesh-list
24711773|NCT01516866|Fluorides|fluorides|mesh-list
24711774|NCT01516866|Sodium Fluoride|sodium fluoride|mesh-list
24618208|NCT01047098|Iron|iron|mesh-list
24711775|NCT01516866|Cariostatic Agents|cariostatic agents|mesh-ancestor
24711776|NCT01516866|Protective Agents|protective agents|mesh-ancestor
24711777|NCT01516866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711778|NCT01516866|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24940942|NCT03996564|Analgesics|analgesics|mesh-ancestor
24711804|NCT01517022|Nicotine|nicotine|mesh-list
24711805|NCT01517022|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24711806|NCT01517022|Autonomic Agents|autonomic agents|mesh-ancestor
24711807|NCT01517022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24711808|NCT01517022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711809|NCT01517022|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24711825|NCT01517308|Antimetabolites|antimetabolites|mesh-ancestor
24711826|NCT01517308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711827|NCT01517308|Immunologic Factors|immunologic factors|mesh-ancestor
24711828|NCT01517308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711856|NCT01517399|Caffeine|caffeine|mesh-list
24711857|NCT01517399|Omeprazole|omeprazole|mesh-list
24711858|NCT01517399|Warfarin|warfarin|mesh-list
24711859|NCT01517399|Vitamins|vitamins|mesh-ancestor
24711860|NCT01517399|Micronutrients|micronutrients|mesh-ancestor
25695251|NCT02043704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25695252|NCT02043704|Analgesics|analgesics|mesh-ancestor
25695253|NCT02043704|Sensory System Agents|sensory system agents|mesh-ancestor
25695254|NCT02043704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25695255|NCT02043704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695256|NCT02043704|Antipyretics|antipyretics|mesh-ancestor
25695257|NCT02043899|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
25695258|NCT02043899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24711861|NCT01517399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711875|NCT01517399|Anticoagulants|anticoagulants|mesh-ancestor
24711876|NCT01517399|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24711877|NCT01517399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25695259|NCT02043899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611386|NCT01009073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611387|NCT01009073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611392|NCT01009177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711878|NCT01517399|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24711879|NCT01517399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711880|NCT01517399|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24711881|NCT01517399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24711882|NCT01517399|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24711883|NCT01517399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24711913|NCT01517568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24711915|NCT01517607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24711916|NCT01517607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24711917|NCT01517607|Analgesics|analgesics|mesh-ancestor
24711918|NCT01517607|Sensory System Agents|sensory system agents|mesh-ancestor
24711919|NCT01517607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24711920|NCT01517607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711921|NCT01517607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24940943|NCT03996564|Sensory System Agents|sensory system agents|mesh-ancestor
24941056|NCT03995147|Pembrolizumab|pembrolizumab|mesh-list
24711922|NCT01517607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24464381|NCT00364559|Antimetabolites|antimetabolites|mesh-ancestor
24712000|NCT01518101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712001|NCT01518101|Incretins|incretins|mesh-ancestor
24712002|NCT01518101|Hormones|hormones|mesh-ancestor
24712003|NCT01518101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24712050|NCT01518231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24712051|NCT01518231|Antipyretics|antipyretics|mesh-ancestor
24712052|NCT01518231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24712053|NCT01518231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24712054|NCT01518231|Antimetabolites|antimetabolites|mesh-ancestor
24712055|NCT01518231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24712056|NCT01518231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24712058|NCT01518231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24712120|NCT01518621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712121|NCT01518634|Imipramine|imipramine|mesh-list
24712122|NCT01518634|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24712123|NCT01518634|Antidepressive Agents|antidepressive agents|mesh-ancestor
24940945|NCT03996564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712124|NCT01518634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24712141|NCT01518725|Micronutrients|micronutrients|mesh-ancestor
24712142|NCT01518725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614432|NCT01024270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24614433|NCT01024270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614434|NCT01024270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24614435|NCT01024270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24614436|NCT01024270|Oxytocics|oxytocics|mesh-ancestor
24614437|NCT01024322|Diclofenac|diclofenac|mesh-list
24614438|NCT01024322|Prednisolone acetate|prednisolone acetate|mesh-list
24614439|NCT01024322|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24614440|NCT01024322|Methylprednisolone|methylprednisolone|mesh-list
24614441|NCT01024322|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24614442|NCT01024322|Prednisolone|prednisolone|mesh-list
24614443|NCT01024322|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24614444|NCT01024322|Prednisolone phosphate|prednisolone phosphate|mesh-list
24614445|NCT01024322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24614446|NCT01024322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24614447|NCT01024322|Analgesics|analgesics|mesh-ancestor
24614464|NCT01024322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24614466|NCT01024348|Acetaminophen|acetaminophen|mesh-list
24614467|NCT01024348|Tramadol|tramadol|mesh-list
24614468|NCT01024348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24614469|NCT01024348|Analgesics|analgesics|mesh-ancestor
24614470|NCT01024348|Sensory System Agents|sensory system agents|mesh-ancestor
24614471|NCT01024348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24614472|NCT01024348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614473|NCT01024348|Antipyretics|antipyretics|mesh-ancestor
25695260|NCT02043899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695261|NCT02043899|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25695262|NCT02044094|Buprenorphine|buprenorphine|mesh-list
25695263|NCT02044094|Hydromorphone|hydromorphone|mesh-list
25695264|NCT02044094|Naloxone|naloxone|mesh-list
24614474|NCT01024348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24614475|NCT01024348|Narcotics|narcotics|mesh-ancestor
24614476|NCT01024348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24614477|NCT01024413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24614478|NCT01024413|Gefitinib|gefitinib|mesh-list
24614479|NCT01024413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614480|NCT01024413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24614481|NCT01024413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24645374|NCT01198106|Cholinergic Agents|cholinergic agents|mesh-ancestor
24614482|NCT01024413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614483|NCT01024491|Paroxetine|paroxetine|mesh-list
24712144|NCT01518725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24712146|NCT01518790|Laxatives|laxatives|mesh-ancestor
24712147|NCT01518790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24712148|NCT01518855|Amlodipine|amlodipine|mesh-list
24712149|NCT01518855|Nifedipine|nifedipine|mesh-list
24712150|NCT01518855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24712151|NCT01518855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24712152|NCT01518855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24712153|NCT01518855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712154|NCT01518855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24712164|NCT01518933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712165|NCT01518933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24712166|NCT01518933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24712167|NCT01518959|Cholecalciferol|cholecalciferol|mesh-list
24712168|NCT01518959|Vitamin D|vitamin d|mesh-list
24712169|NCT01518959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24712170|NCT01518959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712171|NCT01518959|Vitamins|vitamins|mesh-ancestor
24712172|NCT01518959|Micronutrients|micronutrients|mesh-ancestor
24712173|NCT01518959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24712192|NCT01519037|Hormone Antagonists|hormone antagonists|mesh-ancestor
24712193|NCT01519037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24712194|NCT01519076|Coal Tar|coal tar|mesh-list
24712198|NCT01519102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24712199|NCT01519102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712201|NCT01519128|Digoxin|digoxin|mesh-list
24712202|NCT01519128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24712203|NCT01519128|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24712204|NCT01519128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24712205|NCT01519128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712206|NCT01519128|Protective Agents|protective agents|mesh-ancestor
24712207|NCT01519128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712208|NCT01519128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24712209|NCT01519128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24712213|NCT01519128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24712214|NCT01519154|Ketamine|ketamine|mesh-list
24712215|NCT01519154|Propofol|propofol|mesh-list
24498474|NCT00514982|Adalimumab|adalimumab|mesh-list
24712216|NCT01519154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24712217|NCT01519154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24712224|NCT01519154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24712225|NCT01519154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24712226|NCT01519154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24712227|NCT01519154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24712228|NCT01519154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24712229|NCT01519154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712230|NCT01519297|Irbesartan|irbesartan|mesh-list
24712231|NCT01519297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24712268|NCT01519401|Hormones|hormones|mesh-ancestor
24712269|NCT01519401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24712270|NCT01519401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712271|NCT01519401|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24712272|NCT01519401|Contraceptive Agents|contraceptive agents|mesh-ancestor
24712273|NCT01519401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24712274|NCT01519401|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24712275|NCT01519401|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24712497|NCT01520831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24712498|NCT01520831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712499|NCT01520896|Ketoconazole|ketoconazole|mesh-list
25695265|NCT02044094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24712501|NCT01520896|Antifungal Agents|antifungal agents|mesh-ancestor
24712502|NCT01520896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24614518|NCT01024543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24614550|NCT01024712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24614551|NCT01024712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614552|NCT01024712|Tubulin Modulators|tubulin modulators|mesh-ancestor
24614553|NCT01024712|Antimitotic Agents|antimitotic agents|mesh-ancestor
24614554|NCT01024712|Mitosis Modulators|mitosis modulators|mesh-ancestor
24614555|NCT01024712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614556|NCT01024712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24614557|NCT01024712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24614558|NCT01024777|Vitamin D|vitamin d|mesh-list
24614559|NCT01024777|Ergocalciferols|ergocalciferols|mesh-list
24614560|NCT01024777|Cholecalciferol|cholecalciferol|mesh-list
24614561|NCT01024777|Vitamins|vitamins|mesh-list
24614562|NCT01024777|Micronutrients|micronutrients|mesh-ancestor
24614563|NCT01024777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614564|NCT01024777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24614565|NCT01024777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24614566|NCT01024868|Ropivacaine|ropivacaine|mesh-list
24614567|NCT01024868|Anesthetics, Local|anesthetics, local|mesh-ancestor
24614568|NCT01024868|Anesthetics|anesthetics|mesh-ancestor
24614569|NCT01024868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24712667|NCT01522092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24712818|NCT01522989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24712819|NCT01522989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24712820|NCT01522989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24940951|NCT03996564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24940952|NCT03996564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940954|NCT03996564|Narcotics|narcotics|mesh-ancestor
24940955|NCT03996564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24940957|NCT03996564|Respiratory System Agents|respiratory system agents|mesh-ancestor
24940958|NCT03996564|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24940959|NCT03996564|Anticonvulsants|anticonvulsants|mesh-ancestor
24940960|NCT03996564|Antiemetics|antiemetics|mesh-ancestor
24940961|NCT03996564|Autonomic Agents|autonomic agents|mesh-ancestor
24940962|NCT03996564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24940963|NCT03996564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24940964|NCT03996564|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24940965|NCT03996564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24940966|NCT03996564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24761652|NCT01763658|gamma-Globulins|gamma-globulins|mesh-list
24940967|NCT03996564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24940968|NCT03996564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24940987|NCT03996655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24940988|NCT03996655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940989|NCT03996655|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24940990|NCT03996655|Autonomic Agents|autonomic agents|mesh-ancestor
24940991|NCT03996655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24940992|NCT03996044|Anti-Infective Agents|anti-infective agents|mesh-list
24940993|NCT03996044|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24940994|NCT03996252|Calcitriol|calcitriol|mesh-list
24940995|NCT03996252|Fluorouracil|fluorouracil|mesh-list
24940996|NCT03996252|Calcipotriene|calcipotriene|mesh-list
24940997|NCT03996252|Antimetabolites|antimetabolites|mesh-ancestor
24940998|NCT03996252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940999|NCT03996252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24941000|NCT03996252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24854336|NCT02273258|Insulin Lispro|insulin lispro|mesh-list
24712836|NCT01523002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24712837|NCT01523002|Adrenergic Agents|adrenergic agents|mesh-ancestor
24712901|NCT01523093|Serotonin Agents|serotonin agents|mesh-ancestor
24712902|NCT01523093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24712903|NCT01523093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614579|NCT01025102|Analgesics|analgesics|mesh-ancestor
24614580|NCT01025102|Sensory System Agents|sensory system agents|mesh-ancestor
24614581|NCT01025102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24614582|NCT01025102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24614583|NCT01025102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24614584|NCT01025102|Anesthetics, General|anesthetics, general|mesh-ancestor
24614585|NCT01025102|Anesthetics|anesthetics|mesh-ancestor
24614586|NCT01025102|Anesthetics, Local|anesthetics, local|mesh-ancestor
24614587|NCT01025128|Vitamin D|vitamin d|mesh-list
24614588|NCT01025128|Vitamins|vitamins|mesh-ancestor
24614589|NCT01025128|Micronutrients|micronutrients|mesh-ancestor
24614601|NCT01025349|Docetaxel|docetaxel|mesh-list
24614607|NCT01025349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683501|NCT01392716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24683502|NCT01392716|Immunologic Factors|immunologic factors|mesh-ancestor
24683503|NCT01392716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683504|NCT01392716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24683505|NCT01392755|Ritonavir|ritonavir|mesh-list
24683506|NCT01392755|Omeprazole|omeprazole|mesh-list
24683507|NCT01392755|Ranitidine|ranitidine|mesh-list
24614609|NCT01025349|Tubulin Modulators|tubulin modulators|mesh-ancestor
24645512|NCT01198496|Valsartan|valsartan|mesh-list
24614615|NCT01025466|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24614616|NCT01025466|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24614617|NCT01025466|Dopamine Agents|dopamine agents|mesh-ancestor
24614618|NCT01025466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24614619|NCT01025466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614620|NCT01025466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614624|NCT01025466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24941002|NCT03996252|Immunologic Factors|immunologic factors|mesh-ancestor
24941003|NCT03996252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941004|NCT03996252|Dermatologic Agents|dermatologic agents|mesh-ancestor
24941005|NCT03996252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24941006|NCT03996252|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24941007|NCT03996252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24941008|NCT03996252|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24941009|NCT03996252|Vitamins|vitamins|mesh-ancestor
24941010|NCT03996252|Micronutrients|micronutrients|mesh-ancestor
24941011|NCT03996252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24941012|NCT03996278|Thymoglobulin|thymoglobulin|mesh-list
24941013|NCT03996278|Immunologic Factors|immunologic factors|mesh-ancestor
24941014|NCT03996278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941015|NCT03996278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24854357|NCT02273453|Oxazepam|oxazepam|mesh-list
24614625|NCT01025466|Cholinergic Agents|cholinergic agents|mesh-ancestor
24614626|NCT01025466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24614627|NCT01025466|Protective Agents|protective agents|mesh-ancestor
24614628|NCT01025505|Imatinib Mesylate|imatinib mesylate|mesh-list
24614629|NCT01025505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24712913|NCT01523119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712914|NCT01523119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24712918|NCT01523119|Serotonin Agents|serotonin agents|mesh-ancestor
24712922|NCT01523119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24712923|NCT01523119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24712924|NCT01523119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24712925|NCT01523119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24712926|NCT01523236|Mometasone Furoate|mometasone furoate|mesh-list
24712927|NCT01523236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24712928|NCT01523236|Dermatologic Agents|dermatologic agents|mesh-ancestor
24712929|NCT01523236|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24712930|NCT01523314|Dexamethasone|dexamethasone|mesh-list
24712931|NCT01523314|Bevacizumab|bevacizumab|mesh-list
24712932|NCT01523314|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24712933|NCT01523314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24712934|NCT01523314|Antiemetics|antiemetics|mesh-ancestor
24712935|NCT01523314|Autonomic Agents|autonomic agents|mesh-ancestor
24712936|NCT01523314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24712937|NCT01523314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712938|NCT01523314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24712939|NCT01523314|Glucocorticoids|glucocorticoids|mesh-ancestor
24712940|NCT01523314|Hormones|hormones|mesh-ancestor
24712941|NCT01523314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24712942|NCT01523314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24712943|NCT01523314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24712944|NCT01523314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24712945|NCT01523314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24712946|NCT01523314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24712947|NCT01523314|Growth Substances|growth substances|mesh-ancestor
24712952|NCT01523327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712954|NCT01523327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712955|NCT01523379|Parecoxib|parecoxib|mesh-list
24712956|NCT01523379|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24712995|NCT01523483|Progestins|progestins|mesh-ancestor
25695266|NCT02044094|Narcotics|narcotics|mesh-ancestor
25695267|NCT02044094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25695268|NCT02044094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695269|NCT02044094|Analgesics|analgesics|mesh-ancestor
25695270|NCT02044094|Sensory System Agents|sensory system agents|mesh-ancestor
25695271|NCT02044094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24712996|NCT01523483|Hormones|hormones|mesh-ancestor
24712997|NCT01523483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24712998|NCT01523483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712999|NCT01523548|Carbon Monoxide|carbon monoxide|mesh-list
24713037|NCT01523678|Tubulin Modulators|tubulin modulators|mesh-ancestor
24713038|NCT01523678|Antimitotic Agents|antimitotic agents|mesh-ancestor
24713039|NCT01523678|Mitosis Modulators|mitosis modulators|mesh-ancestor
24713040|NCT01523678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713041|NCT01523847|Doxorubicin|doxorubicin|mesh-list
24713042|NCT01523847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24713043|NCT01523847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24713044|NCT01523847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24713045|NCT01523847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24713046|NCT01523847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24713047|NCT01523847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713048|NCT01523860|Rituximab|rituximab|mesh-list
24713049|NCT01523860|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24713050|NCT01523860|Mitoxantrone|mitoxantrone|mesh-list
24713051|NCT01523860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24713052|NCT01523860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24713053|NCT01523860|Immunologic Factors|immunologic factors|mesh-ancestor
24713054|NCT01523860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713055|NCT01523860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24713056|NCT01523860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24713057|NCT01523860|Alkylating Agents|alkylating agents|mesh-ancestor
24713058|NCT01523860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713059|NCT01523860|Analgesics|analgesics|mesh-ancestor
24713060|NCT01523860|Sensory System Agents|sensory system agents|mesh-ancestor
24713061|NCT01523860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24713106|NCT01524094|Antidotes|antidotes|mesh-ancestor
24713113|NCT01524237|Sensory System Agents|sensory system agents|mesh-ancestor
24713116|NCT01524237|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24713125|NCT01524315|Vitamins|vitamins|mesh-list
24713126|NCT01524315|Thiamine|thiamine|mesh-list
24713127|NCT01524315|Vitamin B Complex|vitamin b complex|mesh-list
24713158|NCT01524432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24765825|NCT01790893|Aflibercept|aflibercept|mesh-list
24941028|NCT03995485|Sofosbuvir|sofosbuvir|mesh-list
24941029|NCT03995485|Antiviral Agents|antiviral agents|mesh-ancestor
24941054|NCT03995147|Cyclophosphamide|cyclophosphamide|mesh-list
24941055|NCT03995147|Doxorubicin|doxorubicin|mesh-list
24941057|NCT03995147|Vincristine|vincristine|mesh-list
24713173|NCT01524497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713174|NCT01524497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24713175|NCT01524497|Serotonin Agents|serotonin agents|mesh-ancestor
24499525|NCT00519909|Calcium|calcium|mesh-list
24833184|NCT02173093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24713176|NCT01524497|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24713210|NCT01524705|Exenatide|exenatide|mesh-list
24713211|NCT01524705|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24713212|NCT01524705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24713213|NCT01524705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713214|NCT01524705|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24713215|NCT01524705|Incretins|incretins|mesh-ancestor
24713216|NCT01524705|Hormones|hormones|mesh-ancestor
24713217|NCT01524705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24713218|NCT01524731|Dexamethasone|dexamethasone|mesh-list
24713219|NCT01524731|Dexamethasone acetate|dexamethasone acetate|mesh-list
24713220|NCT01524731|BB 1101|bb 1101|mesh-list
24645530|NCT01198496|Hormone Antagonists|hormone antagonists|mesh-ancestor
24713221|NCT01524731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24713222|NCT01524731|Antiemetics|antiemetics|mesh-ancestor
24614646|NCT01025570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614648|NCT01025700|Nabilone|nabilone|mesh-list
24614649|NCT01025700|Antiemetics|antiemetics|mesh-ancestor
24614650|NCT01025700|Autonomic Agents|autonomic agents|mesh-ancestor
24614651|NCT01025700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24614652|NCT01025700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941062|NCT03995147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24941063|NCT03995147|Alkylating Agents|alkylating agents|mesh-ancestor
24941064|NCT03995147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941065|NCT03995147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941066|NCT03995147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24941067|NCT03995147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24941068|NCT03995147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24941069|NCT03995147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25695272|NCT02044094|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24684299|NCT01396668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24684300|NCT01396668|Immunologic Factors|immunologic factors|mesh-ancestor
24684301|NCT01396668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684302|NCT01396681|Gemcitabine|gemcitabine|mesh-list
24684303|NCT01396681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684304|NCT01396681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24684305|NCT01396681|Antimetabolites|antimetabolites|mesh-ancestor
24684306|NCT01396681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909884|NCT04304248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909939|NCT04303819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551535|NCT05373264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551536|NCT05373264|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24551537|NCT05373264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24941070|NCT03995147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24941073|NCT03995147|Glucocorticoids|glucocorticoids|mesh-ancestor
24941076|NCT03995147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24941077|NCT03995147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24941078|NCT03995147|Tubulin Modulators|tubulin modulators|mesh-ancestor
24941079|NCT03995147|Antimitotic Agents|antimitotic agents|mesh-ancestor
24941080|NCT03995147|Mitosis Modulators|mitosis modulators|mesh-ancestor
24941081|NCT03995277|Biotin|biotin|mesh-list
24614653|NCT01025700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24614654|NCT01025700|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24614655|NCT01025700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24713238|NCT01524744|Analgesics|analgesics|mesh-ancestor
24713239|NCT01524744|Sensory System Agents|sensory system agents|mesh-ancestor
24713240|NCT01524744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24713241|NCT01524744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713242|NCT01524744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24713243|NCT01524744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24713244|NCT01524744|Dermatologic Agents|dermatologic agents|mesh-ancestor
24713245|NCT01524744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24713246|NCT01524744|Immunologic Factors|immunologic factors|mesh-ancestor
24713260|NCT01524809|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24713262|NCT01524809|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24713263|NCT01524809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24713264|NCT01524809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713265|NCT01524861|Thioctic Acid|thioctic acid|mesh-list
24713266|NCT01524861|Acetylcarnitine|acetylcarnitine|mesh-list
24713267|NCT01524861|Antioxidants|antioxidants|mesh-ancestor
24713268|NCT01524861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713269|NCT01524861|Protective Agents|protective agents|mesh-ancestor
24713270|NCT01524861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713271|NCT01524861|Vitamin B Complex|vitamin b complex|mesh-ancestor
24713272|NCT01524861|Vitamins|vitamins|mesh-ancestor
24713273|NCT01524861|Micronutrients|micronutrients|mesh-ancestor
24713274|NCT01524861|Nootropic Agents|nootropic agents|mesh-ancestor
24713275|NCT01524874|Vitamin D|vitamin d|mesh-list
24941084|NCT03995277|Micronutrients|micronutrients|mesh-ancestor
24941085|NCT03995277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941086|NCT03995134|Remifentanil|remifentanil|mesh-list
24941087|NCT03995134|Propofol|propofol|mesh-list
24941088|NCT03995134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24713504|NCT01526317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24941089|NCT03995134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25695273|NCT02044159|Hydrocortisone|hydrocortisone|mesh-list
25695274|NCT02044159|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25695275|NCT02044159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25695276|NCT02044367|Dabigatran|dabigatran|mesh-list
25695277|NCT02044367|Antithrombins|antithrombins|mesh-ancestor
25695278|NCT02044367|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25695279|NCT02044367|Protease Inhibitors|protease inhibitors|mesh-ancestor
25695280|NCT02044367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25695281|NCT02044367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695282|NCT02044367|Anticoagulants|anticoagulants|mesh-ancestor
25695283|NCT02044380|Afatinib|afatinib|mesh-list
25695284|NCT02044380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25695285|NCT02044380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25695286|NCT02044380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25695287|NCT02044380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695288|NCT02044393|Itraconazole|itraconazole|mesh-list
25695289|NCT02044393|Antifungal Agents|antifungal agents|mesh-ancestor
24611538|NCT01009944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24611539|NCT01009944|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24611540|NCT01009944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24611541|NCT01009944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24611542|NCT01009944|Adrenergic Agents|adrenergic agents|mesh-ancestor
24611543|NCT01009944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24684547|NCT05186558|Antimetabolites|antimetabolites|mesh-ancestor
24684548|NCT05186558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684549|NCT05186558|Antiviral Agents|antiviral agents|mesh-ancestor
24941090|NCT03995134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941091|NCT03995134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24941092|NCT03995134|Anesthetics, General|anesthetics, general|mesh-ancestor
24941093|NCT03995134|Anesthetics|anesthetics|mesh-ancestor
24941094|NCT03995134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24941095|NCT03995134|Narcotics|narcotics|mesh-ancestor
24941096|NCT03995134|Analgesics|analgesics|mesh-ancestor
24941097|NCT03995134|Sensory System Agents|sensory system agents|mesh-ancestor
24941098|NCT03995134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24941099|NCT03994965|Pimavanserin|pimavanserin|mesh-list
24941100|NCT03994965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24941101|NCT03994965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24941102|NCT03994965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24713282|NCT01524874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24713283|NCT01524874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24713284|NCT01524874|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24713285|NCT01524874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24713286|NCT01524874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713287|NCT01524874|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24713288|NCT01524939|Immunoglobulins|immunoglobulins|mesh-list
24713289|NCT01524939|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24713290|NCT01524939|Antibodies|antibodies|mesh-list
24713295|NCT01525004|Immunologic Factors|immunologic factors|mesh-ancestor
24713296|NCT01525004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713298|NCT01525043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24713299|NCT01525043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24713300|NCT01525043|Analgesics|analgesics|mesh-ancestor
24713301|NCT01525043|Sensory System Agents|sensory system agents|mesh-ancestor
24713308|NCT01525043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24452197|NCT00326391|Methylphenidate|methylphenidate|mesh-list
24833255|NCT02173418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24713309|NCT01525043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713323|NCT01525394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24713324|NCT01525537|Sufentanil|sufentanil|mesh-list
24713325|NCT01525537|Dsuvia|dsuvia|mesh-list
24713326|NCT01525537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24713327|NCT01525537|Narcotics|narcotics|mesh-ancestor
24713328|NCT01525537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24713329|NCT01525537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713330|NCT01525537|Analgesics|analgesics|mesh-ancestor
24713331|NCT01525537|Sensory System Agents|sensory system agents|mesh-ancestor
24713332|NCT01525537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24713333|NCT01525537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24713334|NCT01525537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24941103|NCT03994965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24941104|NCT03994965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24941105|NCT03994965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941106|NCT03994965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24941107|NCT03994965|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24941108|NCT03994965|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24941109|NCT03994965|Serotonin Agents|serotonin agents|mesh-ancestor
24941110|NCT03994965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24941111|NCT03994965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941112|NCT03994783|Methylprednisolone|methylprednisolone|mesh-list
24941113|NCT03994783|Rituximab|rituximab|mesh-list
24941114|NCT03994783|Immunoglobulins|immunoglobulins|mesh-list
25695290|NCT02044393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25695291|NCT02044393|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25695292|NCT02044393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25695293|NCT02044393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25695294|NCT02044393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695295|NCT02044393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25695296|NCT02044393|Hormone Antagonists|hormone antagonists|mesh-ancestor
25695297|NCT02044393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24684904|NCT03336983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24684905|NCT03336983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684906|NCT03308578|Atorvastatin|atorvastatin|mesh-list
24684907|NCT03308578|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24684959|NCT03129321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684961|NCT03121534|Blinatumomab|blinatumomab|mesh-list
24684962|NCT03121534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24611549|NCT01009970|Prednisone|prednisone|mesh-list
24629886|NCT01108588|Aspirin|aspirin|mesh-list
24685083|NCT02420912|Nivolumab|nivolumab|mesh-list
24685084|NCT02420912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24685085|NCT02420912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24685086|NCT02420912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24685087|NCT02420912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941115|NCT03994783|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24941116|NCT03994783|Antibodies|antibodies|mesh-list
24941117|NCT03994783|gamma-Globulins|gamma-globulins|mesh-list
24941118|NCT03994783|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24941119|NCT03994783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24766047|NCT01792063|Sevoflurane|sevoflurane|mesh-list
24713341|NCT01525706|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25079877|NCT03344393|Ketamine|ketamine|mesh-list
24713342|NCT01525706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24713343|NCT01525706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24713344|NCT01525706|Tubulin Modulators|tubulin modulators|mesh-ancestor
24713345|NCT01525706|Antimitotic Agents|antimitotic agents|mesh-ancestor
24713346|NCT01525706|Mitosis Modulators|mitosis modulators|mesh-ancestor
24713347|NCT01525706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713348|NCT01525706|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24713349|NCT01525706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24713350|NCT01525706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24713351|NCT01525706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713352|NCT01525719|Everolimus|everolimus|mesh-list
24713353|NCT01525719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24713354|NCT01525719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24713355|NCT01525719|Immunologic Factors|immunologic factors|mesh-ancestor
24713356|NCT01525719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713357|NCT01525771|Cisplatin|cisplatin|mesh-list
24713370|NCT01525836|Rituximab|rituximab|mesh-list
24713371|NCT01525836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24713372|NCT01525836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24713373|NCT01525836|Immunologic Factors|immunologic factors|mesh-ancestor
24766049|NCT01792063|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24766050|NCT01792063|Anesthetics, General|anesthetics, general|mesh-ancestor
24766051|NCT01792063|Anesthetics|anesthetics|mesh-ancestor
24766052|NCT01792063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24766053|NCT01792063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766054|NCT01792102|Dexamethasone|dexamethasone|mesh-list
24766055|NCT01792102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24766056|NCT01792102|Antiemetics|antiemetics|mesh-ancestor
24766057|NCT01792102|Autonomic Agents|autonomic agents|mesh-ancestor
24713397|NCT01525966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713399|NCT01526005|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24713401|NCT01526005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24713412|NCT01526070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713413|NCT01526070|Growth Inhibitors|growth inhibitors|mesh-ancestor
24713414|NCT01526070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24713416|NCT01526083|Warfarin|warfarin|mesh-list
24713417|NCT01526083|Anticoagulants|anticoagulants|mesh-ancestor
24713418|NCT01526083|Anticonvulsants|anticonvulsants|mesh-ancestor
25695298|NCT02044393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695299|NCT02044393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25695300|NCT02044510|Mirabegron|mirabegron|mesh-list
25695301|NCT02044510|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25695302|NCT02044510|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25695303|NCT02044510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25695304|NCT02044510|Adrenergic Agents|adrenergic agents|mesh-ancestor
25695305|NCT02044510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25695306|NCT02044510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695307|NCT02044510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695308|NCT02044510|Urological Agents|urological agents|mesh-ancestor
25695309|NCT02044796|Cytarabine|cytarabine|mesh-list
25695310|NCT02044796|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
25695311|NCT02044796|Mitoxantrone|mitoxantrone|mesh-list
25695312|NCT02044796|Cladribine|cladribine|mesh-list
24685415|NCT05272930|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24685416|NCT05272930|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24685417|NCT05272930|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24685418|NCT05272930|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24713419|NCT01526083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24713420|NCT01526083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24713421|NCT01526083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24713422|NCT01526083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713423|NCT01526096|Plerixafor|plerixafor|mesh-list
24713424|NCT01526096|Melphalan|melphalan|mesh-list
24713425|NCT01526096|Basiliximab|basiliximab|mesh-list
24713426|NCT01526096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24713427|NCT01526096|Alkylating Agents|alkylating agents|mesh-ancestor
24713428|NCT01526096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713429|NCT01526096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24713430|NCT01526096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24713431|NCT01526096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24713432|NCT01526096|Immunologic Factors|immunologic factors|mesh-ancestor
24713433|NCT01526096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713434|NCT01526096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24713435|NCT01526096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24713436|NCT01526096|Antiviral Agents|antiviral agents|mesh-ancestor
24713437|NCT01526096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24713438|NCT01526122|Aspirin|aspirin|mesh-list
24713439|NCT01526122|Clopidogrel|clopidogrel|mesh-list
24713442|NCT01526122|Analgesics|analgesics|mesh-ancestor
24713458|NCT01526122|Purinergic Agents|purinergic agents|mesh-ancestor
24713459|NCT01526122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24713462|NCT01526161|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24713463|NCT01526161|Montelukast|montelukast|mesh-list
24713464|NCT01526161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24441488|NCT00287560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24441489|NCT00287560|Anesthetics, General|anesthetics, general|mesh-ancestor
24441497|NCT00287664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24713465|NCT01526161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24713466|NCT01526161|Autonomic Agents|autonomic agents|mesh-ancestor
24713467|NCT01526161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24713468|NCT01526161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713469|NCT01526161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24713470|NCT01526161|Respiratory System Agents|respiratory system agents|mesh-ancestor
24713471|NCT01526161|Dermatologic Agents|dermatologic agents|mesh-ancestor
24713472|NCT01526161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24766060|NCT01792102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24766061|NCT01792102|Glucocorticoids|glucocorticoids|mesh-ancestor
24766062|NCT01792102|Hormones|hormones|mesh-ancestor
24766063|NCT01792102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24766064|NCT01792102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24766065|NCT01792102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556888|NCT00750178|Vorinostat|vorinostat|mesh-list
24713473|NCT01526161|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24713474|NCT01526161|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24713503|NCT01526317|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24713505|NCT01526317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713506|NCT01526317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24713507|NCT01526317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24713508|NCT01526317|Antimetabolites|antimetabolites|mesh-ancestor
24713509|NCT01526317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713510|NCT01526317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24713512|NCT01526317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24713550|NCT01526499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24713551|NCT01526499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24713552|NCT01526499|Tubulin Modulators|tubulin modulators|mesh-ancestor
24443353|NCT00294593|Protective Agents|protective agents|mesh-ancestor
24614656|NCT01025700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24614657|NCT01025700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24614659|NCT01025765|Pioglitazone|pioglitazone|mesh-list
25695313|NCT02044796|Lenograstim|lenograstim|mesh-list
25695314|NCT02044796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25695315|NCT02044796|Antimetabolites|antimetabolites|mesh-ancestor
25695316|NCT02044796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695317|NCT02044796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614660|NCT01025765|Acarbose|acarbose|mesh-list
24614661|NCT01025765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24685771|NCT05209841|Heparin|heparin|mesh-list
24685772|NCT05209841|Anticoagulants|anticoagulants|mesh-ancestor
24910965|NCT04292704|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24911002|NCT04292314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24911004|NCT04292314|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24911006|NCT04292314|Sequestering Agents|sequestering agents|mesh-ancestor
24911042|NCT04291313|Vitamin D|vitamin d|mesh-list
24614662|NCT01025765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614663|NCT01025765|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24614666|NCT01025778|Cyclophosphamide|cyclophosphamide|mesh-list
24614667|NCT01025778|Thiotepa|thiotepa|mesh-list
24614668|NCT01025778|Etoposide|etoposide|mesh-list
24614669|NCT01025778|Clofarabine|clofarabine|mesh-list
24614670|NCT01025778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24614671|NCT01025778|Immunologic Factors|immunologic factors|mesh-ancestor
24614672|NCT01025778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614673|NCT01025778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24614674|NCT01025778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24614675|NCT01025778|Alkylating Agents|alkylating agents|mesh-ancestor
24614676|NCT01025778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614677|NCT01025778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614698|NCT01025921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24614700|NCT01025934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24625710|NCT01083212|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24625711|NCT01083212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24625712|NCT01083212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625713|NCT01083251|Vitamin D|vitamin d|mesh-list
24625714|NCT01083251|Ergocalciferols|ergocalciferols|mesh-list
24625715|NCT01083251|Cholecalciferol|cholecalciferol|mesh-list
24625716|NCT01083251|Vitamins|vitamins|mesh-list
24625717|NCT01083251|Entecavir|entecavir|mesh-list
24614701|NCT01025934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614702|NCT01025934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24614705|NCT01025934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614709|NCT01026064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24614710|NCT01026064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24614711|NCT01026064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24614712|NCT01026064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614713|NCT01026090|Dronedarone|dronedarone|mesh-list
24614714|NCT01026090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24614715|NCT01026116|Paclitaxel|paclitaxel|mesh-list
24614718|NCT01026116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24614719|NCT01026116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614720|NCT01026116|Tubulin Modulators|tubulin modulators|mesh-ancestor
24614721|NCT01026116|Antimitotic Agents|antimitotic agents|mesh-ancestor
24614722|NCT01026116|Mitosis Modulators|mitosis modulators|mesh-ancestor
24713615|NCT01526694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713616|NCT01526694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24713617|NCT01526694|Immunologic Factors|immunologic factors|mesh-ancestor
24713654|NCT01526941|Insulin|insulin|mesh-list
24713655|NCT01526941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24713656|NCT01526941|Insulin Aspart|insulin aspart|mesh-list
24713657|NCT01526941|Insulin, Long-Acting|insulin, long-acting|mesh-list
24713658|NCT01526941|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24713659|NCT01526941|Biphasic Insulins|biphasic insulins|mesh-list
24713660|NCT01526941|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24713661|NCT01526941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24713662|NCT01526941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713663|NCT01526980|Insulin|insulin|mesh-list
24713664|NCT01526980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24713665|NCT01526980|Insulin Aspart|insulin aspart|mesh-list
24713666|NCT01526980|Insulin, Long-Acting|insulin, long-acting|mesh-list
24713725|NCT01527279|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24713735|NCT01527305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24713736|NCT01527305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713737|NCT01527305|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24713738|NCT01527305|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24713741|NCT01527318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24713742|NCT01527318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25695318|NCT02044796|Antiviral Agents|antiviral agents|mesh-ancestor
25695319|NCT02044796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25695320|NCT02044796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25695321|NCT02044796|Immunologic Factors|immunologic factors|mesh-ancestor
25695322|NCT02044796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695323|NCT02044796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25695324|NCT02044796|Analgesics|analgesics|mesh-ancestor
24713743|NCT01527318|Antimetabolites|antimetabolites|mesh-ancestor
24713744|NCT01527318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713745|NCT01527318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24713747|NCT01527422|Cyclophosphamide|cyclophosphamide|mesh-list
24625718|NCT01083251|Micronutrients|micronutrients|mesh-ancestor
24625719|NCT01083251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625720|NCT01083251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24625721|NCT01083251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24625722|NCT01083251|Antiviral Agents|antiviral agents|mesh-ancestor
24625723|NCT01083251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24625724|NCT01083264|Gestodene|gestodene|mesh-list
24625725|NCT01083264|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24713764|NCT01527422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24713765|NCT01527422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24713766|NCT01527422|Glucocorticoids|glucocorticoids|mesh-ancestor
24713767|NCT01527422|Hormones|hormones|mesh-ancestor
24713768|NCT01527422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24713769|NCT01527422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24713770|NCT01527422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24713771|NCT01527422|Tubulin Modulators|tubulin modulators|mesh-ancestor
24713772|NCT01527422|Antimitotic Agents|antimitotic agents|mesh-ancestor
24713773|NCT01527422|Mitosis Modulators|mitosis modulators|mesh-ancestor
24713774|NCT01527448|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24713775|NCT01527448|Antidepressive Agents|antidepressive agents|mesh-ancestor
24713776|NCT01527448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24500168|NCT00523120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24713783|NCT01527474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24713784|NCT01527474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24713785|NCT01527474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713786|NCT01527474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24713787|NCT01527474|Serotonin Agents|serotonin agents|mesh-ancestor
24713788|NCT01527474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713832|NCT01527734|Anesthetics|anesthetics|mesh-ancestor
24713833|NCT01527734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24713834|NCT01527734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713835|NCT01527734|Sensory System Agents|sensory system agents|mesh-ancestor
24713836|NCT01527734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24713837|NCT01527734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24713838|NCT01527734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24713842|NCT01527747|Hormones|hormones|mesh-ancestor
24713849|NCT01527747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24713850|NCT01527786|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24713851|NCT01527786|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24713852|NCT01527786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24713853|NCT01527786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24713854|NCT01527786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713855|NCT01527786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24713856|NCT01527786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713859|NCT01527864|Paclitaxel|paclitaxel|mesh-list
24625734|NCT01083264|Hormones|hormones|mesh-ancestor
24941128|NCT03994783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24941129|NCT03994783|Glucocorticoids|glucocorticoids|mesh-ancestor
24941130|NCT03994783|Hormones|hormones|mesh-ancestor
24941131|NCT03994783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24614748|NCT01026129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24614749|NCT01026129|Narcotics|narcotics|mesh-ancestor
24614750|NCT01026129|Analgesics|analgesics|mesh-ancestor
24614751|NCT01026233|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24614752|NCT01026233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24614753|NCT01026233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614754|NCT01026285|Risperidone|risperidone|mesh-list
24614755|NCT01026285|Antipsychotic Agents|antipsychotic agents|mesh-list
24614756|NCT01026285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24614757|NCT01026285|Serotonin Agents|serotonin agents|mesh-ancestor
24614758|NCT01026285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24614759|NCT01026285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713897|NCT01527903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24713898|NCT01527903|GABA Modulators|gaba modulators|mesh-ancestor
24713899|NCT01527903|GABA Agents|gaba agents|mesh-ancestor
24713900|NCT01527903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24713901|NCT01527903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713902|NCT01527968|Tranexamic Acid|tranexamic acid|mesh-list
24713903|NCT01527968|Aminocaproic Acid|aminocaproic acid|mesh-list
24713904|NCT01527968|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24713905|NCT01527968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24713922|NCT01528007|Sensory System Agents|sensory system agents|mesh-ancestor
24713949|NCT01528176|Micronutrients|micronutrients|mesh-ancestor
24713950|NCT01528176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24713952|NCT01528371|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24713953|NCT01528371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24713954|NCT01528371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24713955|NCT01528371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941132|NCT03994783|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24941133|NCT03994783|Protective Agents|protective agents|mesh-ancestor
24713956|NCT01528371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24713957|NCT01528371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24713958|NCT01528371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24713959|NCT01528371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24500346|NCT00523952|Tacrolimus|tacrolimus|mesh-list
24713960|NCT01528371|Anesthetics, General|anesthetics, general|mesh-ancestor
24713961|NCT01528371|Anesthetics|anesthetics|mesh-ancestor
24713962|NCT01528371|GABA Modulators|gaba modulators|mesh-ancestor
24713975|NCT01528540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24713976|NCT01528540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713977|NCT01528540|Anticonvulsants|anticonvulsants|mesh-ancestor
24713978|NCT01528540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24713979|NCT01528540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24713980|NCT01528540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713981|NCT01528540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24713982|NCT01528540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24713983|NCT01528540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24713984|NCT01528540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24713985|NCT01528540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24713986|NCT01528540|Protective Agents|protective agents|mesh-ancestor
24713987|NCT01528618|Gemcitabine|gemcitabine|mesh-list
24713988|NCT01528618|Cisplatin|cisplatin|mesh-list
24713989|NCT01528618|Fluorouracil|fluorouracil|mesh-list
24713990|NCT01528618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24713991|NCT01528618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24713992|NCT01528618|Antimetabolites|antimetabolites|mesh-ancestor
24713999|NCT01528618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714000|NCT01528644|Calcium, Dietary|calcium, dietary|mesh-list
24714001|NCT01528644|Iron|iron|mesh-list
24714002|NCT01528644|Ferrous gluconate|ferrous gluconate|mesh-list
24714003|NCT01528644|Calcium|calcium|mesh-list
24714004|NCT01528644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24714007|NCT01528644|Trace Elements|trace elements|mesh-ancestor
24714020|NCT01528800|Micronutrients|micronutrients|mesh-ancestor
24714021|NCT01528800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714022|NCT01528800|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24714023|NCT01528800|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24714024|NCT01528800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714025|NCT01528800|Hemostatics|hemostatics|mesh-ancestor
24714026|NCT01528800|Coagulants|coagulants|mesh-ancestor
24714027|NCT01528813|Amorolfine|amorolfine|mesh-list
24714028|NCT01528813|Antifungal Agents|antifungal agents|mesh-ancestor
24714029|NCT01528813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714030|NCT01528826|Oxaliplatin|oxaliplatin|mesh-list
24714031|NCT01528826|Vinorelbine|vinorelbine|mesh-list
24714032|NCT01528826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24714033|NCT01528826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24714034|NCT01528826|Tubulin Modulators|tubulin modulators|mesh-ancestor
24714035|NCT01528826|Antimitotic Agents|antimitotic agents|mesh-ancestor
24714036|NCT01528826|Mitosis Modulators|mitosis modulators|mesh-ancestor
24714037|NCT01528826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714038|NCT01528852|Chlorhexidine|chlorhexidine|mesh-list
24714039|NCT01528852|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24714040|NCT01528852|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24714041|NCT01528852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714060|NCT01528943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24714062|NCT01529073|Nitazoxanide|nitazoxanide|mesh-list
24714063|NCT01529073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24714064|NCT01529073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714065|NCT01529125|Lamivudine|lamivudine|mesh-list
24714066|NCT01529125|Zidovudine|zidovudine|mesh-list
24714073|NCT01529125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714074|NCT01529125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24714075|NCT01529125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24714076|NCT01529125|Antimetabolites|antimetabolites|mesh-ancestor
24686810|NCT04564612|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24686811|NCT04564612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24819231|NCT02094274|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24819232|NCT02094274|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24819233|NCT02094274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24714077|NCT01529125|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24714078|NCT01529125|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24714079|NCT01529138|Sirolimus|sirolimus|mesh-list
24714080|NCT01529138|Axitinib|axitinib|mesh-list
24714081|NCT01529138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24714082|NCT01529138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714083|NCT01529138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24714084|NCT01529138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24714085|NCT01529138|Antifungal Agents|antifungal agents|mesh-ancestor
24714086|NCT01529138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24714087|NCT01529138|Immunologic Factors|immunologic factors|mesh-ancestor
24714088|NCT01529138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714089|NCT01529138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24714090|NCT01529138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24714091|NCT01529138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714095|NCT01529164|Endostar protein|endostar protein|mesh-list
24714096|NCT01529164|Endostatins|endostatins|mesh-list
24714105|NCT01529164|Protective Agents|protective agents|mesh-ancestor
24714106|NCT01529164|Vitamin B Complex|vitamin b complex|mesh-ancestor
24714107|NCT01529164|Vitamins|vitamins|mesh-ancestor
24714108|NCT01529164|Micronutrients|micronutrients|mesh-ancestor
24714109|NCT01529164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24714110|NCT01529164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24714111|NCT01529164|Growth Substances|growth substances|mesh-ancestor
24714112|NCT01529164|Growth Inhibitors|growth inhibitors|mesh-ancestor
24714113|NCT01529177|Metformin|metformin|mesh-list
24714114|NCT01529177|Citric Acid|citric acid|mesh-list
24714115|NCT01529177|Sodium Citrate|sodium citrate|mesh-list
24714116|NCT01529177|Clomiphene|clomiphene|mesh-list
24714117|NCT01529177|Enclomiphene|enclomiphene|mesh-list
24714118|NCT01529177|Zuclomiphene|zuclomiphene|mesh-list
24714119|NCT01529177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24441498|NCT00287677|Hormones|hormones|mesh-list
24714144|NCT01529190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24714204|NCT01529320|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24714248|NCT01529541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714252|NCT01529541|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24714257|NCT01529554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24714258|NCT01529554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25695325|NCT02044796|Sensory System Agents|sensory system agents|mesh-ancestor
25695326|NCT02044796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25695327|NCT02044796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25695328|NCT02044796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25695329|NCT02044796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25695330|NCT02045264|Icatibant|icatibant|mesh-list
25695331|NCT02045264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25695332|NCT02045264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25695333|NCT02045264|Analgesics|analgesics|mesh-ancestor
25695334|NCT02045264|Sensory System Agents|sensory system agents|mesh-ancestor
25695335|NCT02045264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25695336|NCT02045264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695337|NCT02045264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25695338|NCT02045264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24714259|NCT01529554|Immunologic Factors|immunologic factors|mesh-ancestor
24714260|NCT01529554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687118|NCT04368091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24687119|NCT04368091|Immunologic Factors|immunologic factors|mesh-ancestor
24687120|NCT04368091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687121|NCT04367883|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24687122|NCT04367883|Protease Inhibitors|protease inhibitors|mesh-ancestor
24687123|NCT04367883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24913084|NCT04268303|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24913085|NCT04268303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24913116|NCT04268472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714261|NCT01529619|Rivastigmine|rivastigmine|mesh-list
24714262|NCT01529619|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24714263|NCT01529619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24714264|NCT01529619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714265|NCT01529619|Cholinergic Agents|cholinergic agents|mesh-ancestor
24714266|NCT01529619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24714267|NCT01529619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714268|NCT01529619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24714269|NCT01529619|Protective Agents|protective agents|mesh-ancestor
25050797|NCT00467402|S 20098|s 20098|mesh-list
24714297|NCT01529892|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24714301|NCT01530022|Lacosamide|lacosamide|mesh-list
24714302|NCT01530022|Carbamazepine|carbamazepine|mesh-list
24714303|NCT01530022|Anticonvulsants|anticonvulsants|mesh-ancestor
24714304|NCT01530022|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24714305|NCT01530022|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24714306|NCT01530022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24714307|NCT01530022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714308|NCT01530022|Antimanic Agents|antimanic agents|mesh-ancestor
24714309|NCT01530022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24714310|NCT01530022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24714311|NCT01530022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714312|NCT01530022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24714313|NCT01530022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24714314|NCT01530022|Analgesics|analgesics|mesh-ancestor
24714315|NCT01530022|Sensory System Agents|sensory system agents|mesh-ancestor
24714316|NCT01530022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24714317|NCT01530022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24714318|NCT01530022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24714319|NCT01530048|Insulin Aspart|insulin aspart|mesh-list
24714332|NCT01530152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714333|NCT01530152|Sensory System Agents|sensory system agents|mesh-ancestor
24714334|NCT01530152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24714335|NCT01530152|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24714336|NCT01530152|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24714337|NCT01530152|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24714338|NCT01530152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24714339|NCT01530152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714340|NCT01530217|Ibuprofen|ibuprofen|mesh-list
24714341|NCT01530217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25050799|NCT00467402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25050800|NCT00467402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050803|NCT00467025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050804|NCT00467025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24957186|NCT03846271|Oxytocin|oxytocin|mesh-list
24957187|NCT03846271|Oxytocics|oxytocics|mesh-ancestor
24957188|NCT03846271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24957189|NCT03846271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957190|NCT03846388|Hormones|hormones|mesh-list
24714359|NCT01530295|Antimitotic Agents|antimitotic agents|mesh-ancestor
24714360|NCT01530295|Mitosis Modulators|mitosis modulators|mesh-ancestor
24714361|NCT01530295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714374|NCT01530308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24714375|NCT01530308|Dopamine Agents|dopamine agents|mesh-ancestor
25695339|NCT02045264|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
25695340|NCT02045264|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
25695341|NCT02045264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695342|NCT02045264|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25695343|NCT02045264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25695344|NCT02045264|Immunologic Factors|immunologic factors|mesh-ancestor
25695345|NCT02045836|Vaccines|vaccines|mesh-list
25695346|NCT02045836|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25695347|NCT02045836|Immunologic Factors|immunologic factors|mesh-ancestor
24611720|NCT01010451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611721|NCT01010490|Dipivefrin|dipivefrin|mesh-list
24611722|NCT01010490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24611723|NCT01010490|Adrenergic Agents|adrenergic agents|mesh-ancestor
24611724|NCT01010490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24611725|NCT01010490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611726|NCT01010490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611727|NCT01010516|Niacin|niacin|mesh-list
24611728|NCT01010516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24611729|NCT01010516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
24611730|NCT01010516|Fenofibrate|fenofibrate|mesh-list
24611731|NCT01010516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24611732|NCT01010516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24611733|NCT01010516|Antimetabolites|antimetabolites|mesh-ancestor
24611739|NCT01010516|Vitamins|vitamins|mesh-ancestor
24714376|NCT01530308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24714377|NCT01530308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714378|NCT01530308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24714379|NCT01530308|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24714380|NCT01530308|Sympathomimetics|sympathomimetics|mesh-ancestor
24714381|NCT01530308|Protective Agents|protective agents|mesh-ancestor
24714383|NCT01530386|Anticonvulsants|anticonvulsants|mesh-ancestor
24714384|NCT01530386|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24714385|NCT01530386|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24714386|NCT01530386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24714387|NCT01530386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714388|NCT01530438|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24714389|NCT01530438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24614768|NCT01026311|Micronutrients|micronutrients|mesh-ancestor
24614769|NCT01026311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614771|NCT01026337|Sunitinib|sunitinib|mesh-list
24614772|NCT01026337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24714413|NCT01530503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714414|NCT01530503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24714415|NCT01530503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24714416|NCT01530503|Alkylating Agents|alkylating agents|mesh-ancestor
24714417|NCT01530503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24714418|NCT01530503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24714419|NCT01530542|Oxycodone|oxycodone|mesh-list
24714420|NCT01530542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24714421|NCT01530542|Narcotics|narcotics|mesh-ancestor
24714422|NCT01530542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24714423|NCT01530542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714424|NCT01530542|Analgesics|analgesics|mesh-ancestor
24714446|NCT01530607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24714447|NCT01530607|Alkylating Agents|alkylating agents|mesh-ancestor
24714449|NCT01530607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24714450|NCT01530607|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24714451|NCT01530607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24714452|NCT01530620|Propiverine|propiverine|mesh-list
24714453|NCT01530620|Parasympatholytics|parasympatholytics|mesh-ancestor
24714454|NCT01530620|Autonomic Agents|autonomic agents|mesh-ancestor
24714455|NCT01530620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24957191|NCT03846388|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24957192|NCT03846388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24957193|NCT03846388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957194|NCT03846258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24957196|NCT03846583|Tucatinib|tucatinib|mesh-list
25695348|NCT02045836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695349|NCT02045862|Solifenacin Succinate|solifenacin succinate|mesh-list
25695350|NCT02045862|Mirabegron|mirabegron|mesh-list
25695351|NCT02045862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25695352|NCT02045862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25695353|NCT02045862|Cholinergic Agents|cholinergic agents|mesh-ancestor
25695354|NCT02045862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25695355|NCT02045862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695356|NCT02045862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695357|NCT02045862|Urological Agents|urological agents|mesh-ancestor
25695358|NCT02045862|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25695359|NCT02045862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25695360|NCT02045862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25695361|NCT02045862|Adrenergic Agents|adrenergic agents|mesh-ancestor
24687735|NCT03758170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24687736|NCT03758170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687737|NCT03758170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24687739|NCT03758170|Hormones|hormones|mesh-ancestor
24957197|NCT03846583|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24714471|NCT01530737|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24714472|NCT01530737|Protease Inhibitors|protease inhibitors|mesh-ancestor
24714473|NCT01530737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24714474|NCT01530737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714475|NCT01530737|Anticoagulants|anticoagulants|mesh-ancestor
24714476|NCT01530763|Amoxicillin|amoxicillin|mesh-list
24714477|NCT01530763|Ceftriaxone|ceftriaxone|mesh-list
24714478|NCT01530763|Clavulanic Acid|clavulanic acid|mesh-list
24714479|NCT01530763|Clavulanic Acids|clavulanic acids|mesh-list
24714480|NCT01530763|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
24714481|NCT01530763|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24714500|NCT01530984|Immunologic Factors|immunologic factors|mesh-ancestor
24714501|NCT01530984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714502|NCT01531049|Nicotine|nicotine|mesh-list
24714503|NCT01531049|Varenicline|varenicline|mesh-list
24714504|NCT01531049|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24714505|NCT01531049|Autonomic Agents|autonomic agents|mesh-ancestor
24714506|NCT01531049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24714507|NCT01531049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645661|NCT01199328|Aspirin|aspirin|mesh-list
24714509|NCT01531049|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24714510|NCT01531049|Cholinergic Agents|cholinergic agents|mesh-ancestor
24714511|NCT01531049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24714536|NCT01531166|Immunologic Factors|immunologic factors|mesh-ancestor
24714559|NCT01531244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24714560|NCT01531244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714561|NCT01531244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24714562|NCT01531244|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24714563|NCT01531244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24714564|NCT01531244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24714565|NCT01531309|S 20098|s 20098|mesh-list
24714566|NCT01531309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24714572|NCT01531322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714573|NCT01531361|Sorafenib|sorafenib|mesh-list
24714574|NCT01531361|Vemurafenib|vemurafenib|mesh-list
24714575|NCT01531361|Crizotinib|crizotinib|mesh-list
24714576|NCT01531361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24714577|NCT01531361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24714578|NCT01531361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24714579|NCT01531361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714580|NCT01531452|Oxaliplatin|oxaliplatin|mesh-list
24714581|NCT01531452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24714582|NCT01531517|Pantothenic Acid|pantothenic acid|mesh-list
24714583|NCT01531517|Propolis|propolis|mesh-list
24714584|NCT01531517|Vitamin B Complex|vitamin b complex|mesh-ancestor
24714585|NCT01531517|Vitamins|vitamins|mesh-ancestor
24714586|NCT01531517|Micronutrients|micronutrients|mesh-ancestor
24714587|NCT01531517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714588|NCT01531517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714619|NCT01531647|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24714620|NCT01531647|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24714621|NCT01531647|Protease Inhibitors|protease inhibitors|mesh-ancestor
24714622|NCT01531647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24714623|NCT01531647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714625|NCT01531647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24714626|NCT01531647|Antiviral Agents|antiviral agents|mesh-ancestor
24714627|NCT01531647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714628|NCT01531647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24714629|NCT01531647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24714630|NCT01531647|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24714631|NCT01531647|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24714632|NCT01531712|Gemcitabine|gemcitabine|mesh-list
25695362|NCT02045875|Mometasone Furoate|mometasone furoate|mesh-list
25695363|NCT02045875|Formoterol Fumarate|formoterol fumarate|mesh-list
25695364|NCT02045875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25695365|NCT02045875|Autonomic Agents|autonomic agents|mesh-ancestor
25695366|NCT02045875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24714633|NCT01531712|Oxaliplatin|oxaliplatin|mesh-list
24714634|NCT01531712|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25406511|NCT03555149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25695367|NCT02045875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402830|NCT00158548|Schistosomicides|schistosomicides|mesh-ancestor
24688028|NCT03522584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688029|NCT03517722|Ustekinumab|ustekinumab|mesh-list
24688030|NCT03517722|Dermatologic Agents|dermatologic agents|mesh-ancestor
24688068|NCT03436368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24688069|NCT03436368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688111|NCT03360214|Anesthetics, Local|anesthetics, local|mesh-ancestor
24957205|NCT03846583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24957206|NCT03846583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957207|NCT03846583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24957208|NCT03846180|Octreotide|octreotide|mesh-list
24957209|NCT03846180|Terlipressin|terlipressin|mesh-list
24957210|NCT03846180|Somatostatin|somatostatin|mesh-list
24957211|NCT03846180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24957212|NCT03846180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24957213|NCT03846180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24957214|NCT03846180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24714635|NCT01531712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24714636|NCT01531712|Antimetabolites|antimetabolites|mesh-ancestor
24714637|NCT01531712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714638|NCT01531712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24714639|NCT01531712|Antiviral Agents|antiviral agents|mesh-ancestor
24714640|NCT01531712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714652|NCT01531764|Mitosis Modulators|mitosis modulators|mesh-ancestor
24645664|NCT01199328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24714653|NCT01531764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714654|NCT01531764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24714655|NCT01531764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24714656|NCT01531777|Apatinib|apatinib|mesh-list
24714657|NCT01531777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24714658|NCT01531777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24714659|NCT01531777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24714660|NCT01531777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714661|NCT01531790|Carboplatin|carboplatin|mesh-list
24714662|NCT01531790|Pemetrexed|pemetrexed|mesh-list
24714663|NCT01531790|Endostar protein|endostar protein|mesh-list
24714664|NCT01531790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24714665|NCT01531790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24714666|NCT01531790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714667|NCT01531790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24714668|NCT01531790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24714669|NCT01531790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24714670|NCT01531790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24714671|NCT01531790|Growth Substances|growth substances|mesh-ancestor
24714674|NCT01531829|Heparin|heparin|mesh-list
24714695|NCT01531920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24714696|NCT01531920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714697|NCT01532011|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24714698|NCT01532011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24714763|NCT01532726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714808|NCT01532856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24714809|NCT01532856|Leprostatic Agents|leprostatic agents|mesh-ancestor
24714810|NCT01532856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24714811|NCT01532856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714812|NCT01532856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24714813|NCT01532856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24714814|NCT01532856|Growth Substances|growth substances|mesh-ancestor
24714823|NCT01532895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24714825|NCT01532960|Interferon Inducers|interferon inducers|mesh-ancestor
24714835|NCT01533129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24714836|NCT01533129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714837|NCT01533155|Quinidine|quinidine|mesh-list
24714838|NCT01533155|Quinidine gluconate|quinidine gluconate|mesh-list
24714839|NCT01533155|Morphine|morphine|mesh-list
24714840|NCT01533155|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25695368|NCT02045875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25695369|NCT02045875|Respiratory System Agents|respiratory system agents|mesh-ancestor
25695370|NCT02045875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25695371|NCT02045875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25695372|NCT02045875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25695373|NCT02045875|Adrenergic Agents|adrenergic agents|mesh-ancestor
25695374|NCT02045875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24688261|NCT03215940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714841|NCT01533155|Narcotics|narcotics|mesh-ancestor
24714842|NCT01533155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24714843|NCT01533155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714844|NCT01533155|Analgesics|analgesics|mesh-ancestor
24714845|NCT01533155|Sensory System Agents|sensory system agents|mesh-ancestor
24714846|NCT01533155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24714847|NCT01533155|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24714848|NCT01533155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24714849|NCT01533155|Adrenergic Agents|adrenergic agents|mesh-ancestor
24714850|NCT01533155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24714853|NCT01533155|Antimalarials|antimalarials|mesh-ancestor
24941151|NCT03994744|Metformin|metformin|mesh-list
24941152|NCT03994744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24941153|NCT03994744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24941154|NCT03994744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941155|NCT03994744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941156|NCT03994744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24714879|NCT01533220|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24714880|NCT01533220|Histamine Antagonists|histamine antagonists|mesh-ancestor
24714881|NCT01533220|Histamine Agents|histamine agents|mesh-ancestor
24714882|NCT01533220|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24714883|NCT01533272|Tenofovir|tenofovir|mesh-list
24714884|NCT01533272|Emtricitabine|emtricitabine|mesh-list
24714885|NCT01533272|Lopinavir|lopinavir|mesh-list
24714886|NCT01533272|Maraviroc|maraviroc|mesh-list
24714887|NCT01533272|Antiviral Agents|antiviral agents|mesh-ancestor
24714888|NCT01533272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714889|NCT01533272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24714890|NCT01533272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24714891|NCT01533272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24714892|NCT01533272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714893|NCT01533272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24714897|NCT01533272|Protease Inhibitors|protease inhibitors|mesh-ancestor
24714985|NCT01533662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24645694|NCT01199367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24714986|NCT01533662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714987|NCT01533662|Protective Agents|protective agents|mesh-ancestor
24715008|NCT01533740|Immunologic Factors|immunologic factors|mesh-ancestor
24715009|NCT01533740|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24715010|NCT01533740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24715011|NCT01533740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715013|NCT01533740|Protective Agents|protective agents|mesh-ancestor
24941159|NCT03994211|Antifungal Agents|antifungal agents|mesh-ancestor
24941160|NCT03994211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24941161|NCT03994211|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24941162|NCT03994211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24941163|NCT03994211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24941164|NCT03994211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941165|NCT03994211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24941166|NCT03994211|Hormone Antagonists|hormone antagonists|mesh-ancestor
24854573|NCT02273895|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24715014|NCT01533740|Vitamin B Complex|vitamin b complex|mesh-ancestor
24715016|NCT01533740|Micronutrients|micronutrients|mesh-ancestor
24614794|NCT01026363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24715018|NCT01533818|Amoxicillin|amoxicillin|mesh-list
24715019|NCT01533818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24715020|NCT01533818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24715021|NCT01533870|Rifampin|rifampin|mesh-list
24715022|NCT01533870|Naloxegol|naloxegol|mesh-list
24715023|NCT01533870|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24715024|NCT01533870|Antitubercular Agents|antitubercular agents|mesh-ancestor
24715025|NCT01533870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24715026|NCT01533870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24715027|NCT01533870|Leprostatic Agents|leprostatic agents|mesh-ancestor
24715028|NCT01533870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24715029|NCT01533870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715030|NCT01533870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715031|NCT01533870|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24715032|NCT01533870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24715033|NCT01533870|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24715034|NCT01533870|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25406512|NCT03555149|Growth Substances|growth substances|mesh-ancestor
24787218|NCT01924065|Anticoagulants|anticoagulants|mesh-list
24787219|NCT01924078|Capecitabine|capecitabine|mesh-list
24914327|NCT04255771|Antimetabolites|antimetabolites|mesh-ancestor
24914328|NCT04255771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914329|NCT04255771|Antiviral Agents|antiviral agents|mesh-ancestor
24715035|NCT01533870|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24715051|NCT01534026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24715052|NCT01534026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715053|NCT01534026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24715054|NCT01534026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24715055|NCT01534026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715056|NCT01534026|Antipyretics|antipyretics|mesh-ancestor
24715058|NCT01534169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24715059|NCT01534169|Antiemetics|antiemetics|mesh-ancestor
24715060|NCT01534169|Autonomic Agents|autonomic agents|mesh-ancestor
24715061|NCT01534169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24715062|NCT01534169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715063|NCT01534169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24715064|NCT01534169|Glucocorticoids|glucocorticoids|mesh-ancestor
24715065|NCT01534169|Hormones|hormones|mesh-ancestor
24715066|NCT01534169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24715067|NCT01534169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24715068|NCT01534169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614812|NCT01026415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24614813|NCT01026415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24614814|NCT01026415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24614815|NCT01026415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24715116|NCT01534585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24715117|NCT01534585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715118|NCT01534585|Tubulin Modulators|tubulin modulators|mesh-ancestor
24715119|NCT01534585|Antimitotic Agents|antimitotic agents|mesh-ancestor
24715120|NCT01534585|Mitosis Modulators|mitosis modulators|mesh-ancestor
24715121|NCT01534585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715122|NCT01534702|Cytarabine|cytarabine|mesh-list
24715123|NCT01534702|Clofarabine|clofarabine|mesh-list
24715124|NCT01534702|Idarubicin|idarubicin|mesh-list
24715125|NCT01534702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24715126|NCT01534702|Antimetabolites|antimetabolites|mesh-ancestor
24715127|NCT01534702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715128|NCT01534702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715129|NCT01534702|Antiviral Agents|antiviral agents|mesh-ancestor
24715130|NCT01534702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24715131|NCT01534702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24715132|NCT01534702|Immunologic Factors|immunologic factors|mesh-ancestor
24715133|NCT01534702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715134|NCT01534702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24715135|NCT01534702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24715136|NCT01534702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24715137|NCT01534702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715145|NCT01534754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24715158|NCT01534806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645703|NCT01199432|Fluorouracil|fluorouracil|mesh-list
24715175|NCT01534884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24715176|NCT01534884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941179|NCT03994211|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24941180|NCT03994211|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24941181|NCT03994107|Paclitaxel|paclitaxel|mesh-list
24941182|NCT03994107|Doxorubicin|doxorubicin|mesh-list
24941183|NCT03994107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24941184|NCT03994107|Trastuzumab|trastuzumab|mesh-list
24941185|NCT03994107|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24941186|NCT03994107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24941187|NCT03994107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941188|NCT03994107|Tubulin Modulators|tubulin modulators|mesh-ancestor
24941189|NCT03994107|Antimitotic Agents|antimitotic agents|mesh-ancestor
24941190|NCT03994107|Mitosis Modulators|mitosis modulators|mesh-ancestor
24941191|NCT03994107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941192|NCT03994107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24941193|NCT03994107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25695375|NCT02045875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695376|NCT02045875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25695377|NCT02045875|Dermatologic Agents|dermatologic agents|mesh-ancestor
25695378|NCT02045875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25695379|NCT02045979|Adalimumab|adalimumab|mesh-list
24688652|NCT02810457|Carboplatin|carboplatin|mesh-list
24688653|NCT02810457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25695380|NCT02045979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25695381|NCT02045979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24914367|NCT04255498|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24914368|NCT04255498|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24941194|NCT03994107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24941195|NCT03994107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24941196|NCT03994107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24941198|NCT03994055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941199|NCT03994055|Protective Agents|protective agents|mesh-ancestor
24715177|NCT01534884|Immunologic Factors|immunologic factors|mesh-ancestor
24834038|NCT02176720|Protective Agents|protective agents|mesh-ancestor
24834039|NCT02176720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834040|NCT02176720|Dopamine Agents|dopamine agents|mesh-ancestor
24834041|NCT02176720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24834046|NCT02176733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834047|NCT02176733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24715178|NCT01534884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715179|NCT01534884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24715180|NCT01534949|Rituximab|rituximab|mesh-list
24501628|NCT00530101|Doxorubicin|doxorubicin|mesh-list
24715181|NCT01534949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24715182|NCT01534949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715201|NCT01535079|Sensory System Agents|sensory system agents|mesh-ancestor
24715202|NCT01535079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24715203|NCT01535079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715204|NCT01535079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24715205|NCT01535079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24715206|NCT01535079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24715207|NCT01535079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715208|NCT01535079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715210|NCT01535092|Protective Agents|protective agents|mesh-ancestor
24715211|NCT01535092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941200|NCT03994055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941201|NCT03994393|Durvalumab|durvalumab|mesh-list
24941202|NCT03994393|Tremelimumab|tremelimumab|mesh-list
24941203|NCT03994393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24941204|NCT03994393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941205|NCT03993431|Methamphetamine|methamphetamine|mesh-list
24715212|NCT01535092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24715213|NCT01535092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715214|NCT01535157|Ketoconazole|ketoconazole|mesh-list
24715215|NCT01535157|Fenretinide|fenretinide|mesh-list
24715216|NCT01535157|Retinamide|retinamide|mesh-list
24715217|NCT01535157|Antifungal Agents|antifungal agents|mesh-ancestor
24715218|NCT01535157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24715247|NCT01535417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24715248|NCT01535417|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24715249|NCT01535417|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24715250|NCT01535417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715251|NCT01535417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715252|NCT01535469|Fluconazole|fluconazole|mesh-list
24501705|NCT00530556|Zolpidem|zolpidem|mesh-list
24715253|NCT01535469|Antifungal Agents|antifungal agents|mesh-ancestor
24715254|NCT01535469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24715262|NCT01535469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715263|NCT01535469|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24715264|NCT01535469|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24715266|NCT01535495|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24715267|NCT01535495|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24715272|NCT01535495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24715273|NCT01535495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24715274|NCT01535495|Vasodilator Agents|vasodilator agents|mesh-ancestor
24715275|NCT01535547|Isavuconazole|isavuconazole|mesh-list
24715276|NCT01535547|Tacrolimus|tacrolimus|mesh-list
24715277|NCT01535547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24715278|NCT01535547|Immunologic Factors|immunologic factors|mesh-ancestor
25695382|NCT02046070|Dexamethasone|dexamethasone|mesh-list
25695383|NCT02046070|Cyclophosphamide|cyclophosphamide|mesh-list
25695384|NCT02046070|Ixazomib|ixazomib|mesh-list
25695385|NCT02046070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25695386|NCT02046070|Immunologic Factors|immunologic factors|mesh-ancestor
25695387|NCT02046070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715279|NCT01535547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715280|NCT01535547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24715281|NCT01535547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715282|NCT01535547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715283|NCT01535547|Antifungal Agents|antifungal agents|mesh-ancestor
24715284|NCT01535547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24715294|NCT01535690|Methylene Blue|methylene blue|mesh-list
24715295|NCT01535690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715296|NCT01535690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715320|NCT01535859|Cabergoline|cabergoline|mesh-list
24834142|NCT02177331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24834143|NCT02177331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834145|NCT02177344|Ipratropium|ipratropium|mesh-list
24834146|NCT02177344|Anticonvulsants|anticonvulsants|mesh-ancestor
24715321|NCT01535859|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24715322|NCT01535859|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24715323|NCT01535859|Dopamine Agonists|dopamine agonists|mesh-ancestor
24715324|NCT01535859|Dopamine Agents|dopamine agents|mesh-ancestor
24715325|NCT01535859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24715326|NCT01535859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715327|NCT01535859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941210|NCT03993431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24941211|NCT03993431|Dopamine Agents|dopamine agents|mesh-ancestor
24941212|NCT03993431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24941213|NCT03993431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941214|NCT03993431|Adrenergic Agents|adrenergic agents|mesh-ancestor
24715339|NCT01535989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24715340|NCT01535989|Immunologic Factors|immunologic factors|mesh-ancestor
24715341|NCT01535989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715342|NCT01535989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24715344|NCT01536002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24715345|NCT01536002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24715346|NCT01536002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715347|NCT01536002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24715348|NCT01536002|Anesthetics, General|anesthetics, general|mesh-ancestor
24715349|NCT01536002|Anesthetics|anesthetics|mesh-ancestor
24715365|NCT01536054|Antifungal Agents|antifungal agents|mesh-ancestor
24715366|NCT01536054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24715367|NCT01536054|Immunologic Factors|immunologic factors|mesh-ancestor
24715368|NCT01536054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715369|NCT01536132|Simendan|simendan|mesh-list
24715370|NCT01536132|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24715371|NCT01536132|Vasodilator Agents|vasodilator agents|mesh-ancestor
24715372|NCT01536132|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24715383|NCT01536158|Sensory System Agents|sensory system agents|mesh-ancestor
24715384|NCT01536158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24715385|NCT01536158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715412|NCT01536249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24715413|NCT01536249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715414|NCT01536249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715415|NCT01536249|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24715416|NCT01536249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24715417|NCT01536249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715418|NCT01536249|Antioxidants|antioxidants|mesh-ancestor
24715419|NCT01536249|Protective Agents|protective agents|mesh-ancestor
24715420|NCT01536249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24715421|NCT01536249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24715422|NCT01536249|Dopamine Agonists|dopamine agonists|mesh-ancestor
24715423|NCT01536249|Dopamine Agents|dopamine agents|mesh-ancestor
24715424|NCT01536301|Morphine|morphine|mesh-list
24941215|NCT03993431|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24941216|NCT03993431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24941217|NCT03993431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24941218|NCT03993431|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24941219|NCT03993626|Nivolumab|nivolumab|mesh-list
24941220|NCT03993626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24941221|NCT03993626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941222|NCT03993626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24941260|NCT03992885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941261|NCT03992885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24941262|NCT03992885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941263|NCT03992885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25695388|NCT02046070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24688977|NCT02516657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941264|NCT03992885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24941265|NCT03992911|Carboplatin|carboplatin|mesh-list
24766214|NCT01793350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834223|NCT02177448|Enalapril|enalapril|mesh-list
24614846|NCT01026428|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24614858|NCT01026584|Aripiprazole|aripiprazole|mesh-list
24715442|NCT01536353|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
24715443|NCT01536353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24715444|NCT01536431|Insulin|insulin|mesh-list
24715445|NCT01536431|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24715446|NCT01536431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24715447|NCT01536431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715448|NCT01536470|Norepinephrine|norepinephrine|mesh-list
24715449|NCT01536470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24715450|NCT01536470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24715451|NCT01536470|Adrenergic Agents|adrenergic agents|mesh-ancestor
24715452|NCT01536470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24715453|NCT01536470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715454|NCT01536470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715455|NCT01536470|Sympathomimetics|sympathomimetics|mesh-ancestor
24715456|NCT01536470|Autonomic Agents|autonomic agents|mesh-ancestor
24715457|NCT01536470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24715458|NCT01536470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24715460|NCT01536600|Biphasic Insulins|biphasic insulins|mesh-list
24715461|NCT01536600|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24715467|NCT01536613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24715468|NCT01536613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715469|NCT01536626|Insulin Aspart|insulin aspart|mesh-list
24766217|NCT01793350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766218|NCT01793480|Methadone|methadone|mesh-list
24766219|NCT01793480|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24766220|NCT01793480|Narcotics|narcotics|mesh-ancestor
24766221|NCT01793480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24766222|NCT01793480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766223|NCT01793480|Analgesics|analgesics|mesh-ancestor
24766224|NCT01793480|Sensory System Agents|sensory system agents|mesh-ancestor
24854643|NCT02274337|Abivertinib|abivertinib|mesh-list
24715476|NCT01536639|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24715478|NCT01536639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715480|NCT01536652|Biphasic Insulins|biphasic insulins|mesh-list
24715481|NCT01536652|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24715482|NCT01536652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24715483|NCT01536652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715522|NCT01536743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715524|NCT01536873|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24715525|NCT01536873|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24715526|NCT01536873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715527|NCT01536873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715528|NCT01536873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24715529|NCT01536873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24715530|NCT01536873|Antiviral Agents|antiviral agents|mesh-ancestor
24715531|NCT01536873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24715532|NCT01537055|Amoxicillin|amoxicillin|mesh-list
24715533|NCT01537055|Levofloxacin|levofloxacin|mesh-list
24715558|NCT01537107|Sirolimus|sirolimus|mesh-list
24715559|NCT01537107|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24715560|NCT01537107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24715577|NCT01537250|Levofloxacin|levofloxacin|mesh-list
24715598|NCT01537471|Dimenhydrinate|dimenhydrinate|mesh-list
24715599|NCT01537471|Antiemetics|antiemetics|mesh-ancestor
24715600|NCT01537471|Autonomic Agents|autonomic agents|mesh-ancestor
24715601|NCT01537471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24715602|NCT01537471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766225|NCT01793480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24766226|NCT01793480|Antitussive Agents|antitussive agents|mesh-ancestor
24766227|NCT01793480|Respiratory System Agents|respiratory system agents|mesh-ancestor
24766228|NCT01793519|Adalimumab|adalimumab|mesh-list
24766229|NCT01793519|Etanercept|etanercept|mesh-list
24766230|NCT01793519|Infliximab|infliximab|mesh-list
24766231|NCT01793519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25695389|NCT02046070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24915569|NCT04250831|Micronutrients|micronutrients|mesh-ancestor
24915570|NCT04250831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915571|NCT04250831|Cathartics|cathartics|mesh-ancestor
24915572|NCT04250831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24766232|NCT01793519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24854651|NCT02274454|Oxytocin|oxytocin|mesh-list
24715603|NCT01537471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24715604|NCT01537471|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24715605|NCT01537471|Histamine Antagonists|histamine antagonists|mesh-ancestor
24715606|NCT01537471|Histamine Agents|histamine agents|mesh-ancestor
24715607|NCT01537471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24715608|NCT01537471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715609|NCT01537471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24715610|NCT01537575|Immunoglobulins|immunoglobulins|mesh-list
24715611|NCT01537575|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24715612|NCT01537575|Antibodies|antibodies|mesh-list
24715613|NCT01537575|gamma-Globulins|gamma-globulins|mesh-list
24715614|NCT01537575|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24715615|NCT01537575|Immunologic Factors|immunologic factors|mesh-ancestor
24715616|NCT01537575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614866|NCT01026584|Dopamine Agents|dopamine agents|mesh-ancestor
24614867|NCT01026584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24614868|NCT01026584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614869|NCT01026584|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24614870|NCT01026584|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24614871|NCT01026584|Serotonin Agents|serotonin agents|mesh-ancestor
24614872|NCT01026584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24614873|NCT01026584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24614874|NCT01026584|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24614875|NCT01026584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24614876|NCT01026610|Entecavir|entecavir|mesh-list
24614877|NCT01026610|Antiviral Agents|antiviral agents|mesh-ancestor
24614878|NCT01026610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24614879|NCT01026636|Ceftobiprole|ceftobiprole|mesh-list
24614880|NCT01026636|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
24614881|NCT01026636|Cephalosporins|cephalosporins|mesh-list
24614882|NCT01026636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24614883|NCT01026636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24614884|NCT01026701|Bortezomib|bortezomib|mesh-list
24614885|NCT01026701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614886|NCT01026714|Fluconazole|fluconazole|mesh-list
24614887|NCT01026714|Rifampin|rifampin|mesh-list
24614888|NCT01026714|Flurbiprofen|flurbiprofen|mesh-list
24614889|NCT01026714|Antifungal Agents|antifungal agents|mesh-ancestor
24614890|NCT01026714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24766233|NCT01793519|Dermatologic Agents|dermatologic agents|mesh-ancestor
24766234|NCT01793519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24766235|NCT01793519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24766236|NCT01793519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24766237|NCT01793519|Analgesics|analgesics|mesh-ancestor
24766238|NCT01793519|Sensory System Agents|sensory system agents|mesh-ancestor
24614891|NCT01026714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24614893|NCT01026714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715685|NCT01538095|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24715686|NCT01538095|Growth Substances|growth substances|mesh-ancestor
24715687|NCT01538095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715688|NCT01538095|Growth Inhibitors|growth inhibitors|mesh-ancestor
24715689|NCT01538095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715691|NCT01538108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24715692|NCT01538108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715693|NCT01538108|Tubulin Modulators|tubulin modulators|mesh-ancestor
24715694|NCT01538108|Antimitotic Agents|antimitotic agents|mesh-ancestor
24715695|NCT01538108|Mitosis Modulators|mitosis modulators|mesh-ancestor
24715696|NCT01538108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614920|NCT01026727|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24715699|NCT01538225|Sensory System Agents|sensory system agents|mesh-ancestor
24715700|NCT01538225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24715701|NCT01538225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715702|NCT01538316|Genistein|genistein|mesh-list
24715706|NCT01538316|Protective Agents|protective agents|mesh-ancestor
24715707|NCT01538316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695390|NCT02046070|Alkylating Agents|alkylating agents|mesh-ancestor
25695391|NCT02046070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695392|NCT02046070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715708|NCT01538316|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24715709|NCT01538316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689357|NCT01622998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24689358|NCT01622998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689360|NCT01622998|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24916021|NCT04245774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24715710|NCT01538316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24715711|NCT01538316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715713|NCT01538316|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24715714|NCT01538316|Estrogens|estrogens|mesh-ancestor
24715715|NCT01538316|Hormones|hormones|mesh-ancestor
24715716|NCT01538316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24715717|NCT01538329|Amantadine|amantadine|mesh-list
24715718|NCT01538329|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24715719|NCT01538329|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24715720|NCT01538329|Antiviral Agents|antiviral agents|mesh-ancestor
24715721|NCT01538329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24715722|NCT01538329|Dopamine Agents|dopamine agents|mesh-ancestor
24715723|NCT01538329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24715729|NCT01538329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24715731|NCT01538381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715732|NCT01538381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24715733|NCT01538381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715734|NCT01538381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715735|NCT01538394|Nicotine|nicotine|mesh-list
24715749|NCT01538446|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24715750|NCT01538446|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24766244|NCT01793636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715753|NCT01538446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24715772|NCT01538459|Sensory System Agents|sensory system agents|mesh-ancestor
24715773|NCT01538485|Cholecalciferol|cholecalciferol|mesh-list
24715775|NCT01538485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24715777|NCT01538485|Vitamins|vitamins|mesh-ancestor
24715793|NCT01538537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715795|NCT01538563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715796|NCT01538563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24715797|NCT01538563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715798|NCT01538563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715799|NCT01538576|Insulin Aspart|insulin aspart|mesh-list
24715815|NCT01538641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715816|NCT01538641|Antiviral Agents|antiviral agents|mesh-ancestor
24614921|NCT01026727|Antiviral Agents|antiviral agents|mesh-ancestor
24614922|NCT01026727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24614923|NCT01026740|Ceftobiprole|ceftobiprole|mesh-list
24614924|NCT01026740|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
24614944|NCT01026961|Respiratory System Agents|respiratory system agents|mesh-ancestor
24614945|NCT01026961|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24614946|NCT01026961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24614947|NCT01026961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24614948|NCT01026961|Adrenergic Agents|adrenergic agents|mesh-ancestor
24715831|NCT01538693|Dexetimide|dexetimide|mesh-list
24715832|NCT01538693|Citalopram|citalopram|mesh-list
24715833|NCT01538693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24715834|NCT01538693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24715859|NCT01538732|Alitretinoin|alitretinoin|mesh-list
24715860|NCT01538732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715861|NCT01538732|Dermatologic Agents|dermatologic agents|mesh-ancestor
24715862|NCT01538771|Darbepoetin alfa|darbepoetin alfa|mesh-list
24715863|NCT01538771|Hematinics|hematinics|mesh-ancestor
24715864|NCT01538797|Ranitidine|ranitidine|mesh-list
24715865|NCT01538797|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
24715866|NCT01538797|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24715867|NCT01538797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24715868|NCT01538797|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24715869|NCT01538797|Histamine Antagonists|histamine antagonists|mesh-ancestor
24715870|NCT01538797|Histamine Agents|histamine agents|mesh-ancestor
24715871|NCT01538797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24715872|NCT01538797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695393|NCT02046070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25695394|NCT02046070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25695395|NCT02046070|Antiemetics|antiemetics|mesh-ancestor
25695396|NCT02046070|Autonomic Agents|autonomic agents|mesh-ancestor
25695397|NCT02046070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25695398|NCT02046070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25695399|NCT02046070|Glucocorticoids|glucocorticoids|mesh-ancestor
25695400|NCT02046070|Hormones|hormones|mesh-ancestor
24715873|NCT01538797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715874|NCT01538849|Esomeprazole|esomeprazole|mesh-list
24715875|NCT01538849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24715876|NCT01538849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24715877|NCT01538849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24715878|NCT01538849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715879|NCT01538849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941266|NCT03992911|Etoposide|etoposide|mesh-list
24766246|NCT01793636|Immunologic Factors|immunologic factors|mesh-ancestor
24681649|NCT01381497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24715880|NCT01538875|Labetalol|labetalol|mesh-list
24834443|NCT02178488|Micronutrients|micronutrients|mesh-ancestor
24502415|NCT05108454|Micronutrients|micronutrients|mesh-list
24502416|NCT05108454|Trace Elements|trace elements|mesh-list
24502417|NCT05108454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502418|NCT05096702|Primaquine|primaquine|mesh-list
24715881|NCT01538875|Hydralazine|hydralazine|mesh-list
24715882|NCT01538875|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24715883|NCT01538875|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24715887|NCT01538875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715888|NCT01538875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24715906|NCT01538940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715908|NCT01538953|Disinfectants|disinfectants|mesh-list
24715910|NCT01538953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24715911|NCT01539018|Sorafenib|sorafenib|mesh-list
24715913|NCT01539018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715914|NCT01539018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24715915|NCT01539018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715916|NCT01539018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715917|NCT01539018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24715918|NCT01539018|Antimetabolites|antimetabolites|mesh-ancestor
24715919|NCT01539031|Donepezil|donepezil|mesh-list
24715920|NCT01539031|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24715921|NCT01539031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715922|NCT01539031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715923|NCT01539031|Cholinergic Agents|cholinergic agents|mesh-ancestor
24715928|NCT01539044|Neostigmine|neostigmine|mesh-list
24715929|NCT01539044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24715931|NCT01539044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24715932|NCT01539044|Autonomic Agents|autonomic agents|mesh-ancestor
24715933|NCT01539044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24715934|NCT01539044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715935|NCT01539044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24715936|NCT01539044|Respiratory System Agents|respiratory system agents|mesh-ancestor
24715937|NCT01539044|Mydriatics|mydriatics|mesh-ancestor
24715938|NCT01539044|Parasympatholytics|parasympatholytics|mesh-ancestor
24715939|NCT01539044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24715940|NCT01539044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24715941|NCT01539044|Cholinergic Agents|cholinergic agents|mesh-ancestor
24715942|NCT01539044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24715943|NCT01539044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715944|NCT01539044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24715945|NCT01539044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715946|NCT01539044|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24715947|NCT01539174|Prednisone|prednisone|mesh-list
24715948|NCT01539174|Cyclophosphamide|cyclophosphamide|mesh-list
24715949|NCT01539174|Rituximab|rituximab|mesh-list
24715950|NCT01539174|Doxorubicin|doxorubicin|mesh-list
24715951|NCT01539174|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24715952|NCT01539174|Vincristine|vincristine|mesh-list
24715953|NCT01539174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24715954|NCT01539174|Immunologic Factors|immunologic factors|mesh-ancestor
24715955|NCT01539174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941282|NCT03992586|Methamphetamine|methamphetamine|mesh-list
24941283|NCT03992586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24941284|NCT03992586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941285|NCT03992586|Sympathomimetics|sympathomimetics|mesh-ancestor
24716001|NCT01539408|Abortifacient Agents|abortifacient agents|mesh-ancestor
24716002|NCT01539408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24716003|NCT01539408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716008|NCT01539473|Tedizolid|tedizolid|mesh-list
24716009|NCT01539473|Tyramine|tyramine|mesh-list
24716010|NCT01539473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24716011|NCT01539473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24716012|NCT01539473|Sympathomimetics|sympathomimetics|mesh-ancestor
24716013|NCT01539473|Autonomic Agents|autonomic agents|mesh-ancestor
24716014|NCT01539473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24716015|NCT01539473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716016|NCT01539473|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24716017|NCT01539473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24614956|NCT01026961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24614957|NCT01026987|Plerixafor|plerixafor|mesh-list
24614958|NCT01026987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24614959|NCT01026987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24614960|NCT01026987|Antiviral Agents|antiviral agents|mesh-ancestor
24614961|NCT01026987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24614962|NCT01027065|Tenofovir|tenofovir|mesh-list
24614963|NCT01027065|Entecavir|entecavir|mesh-list
24614964|NCT01027065|Antiviral Agents|antiviral agents|mesh-ancestor
24614965|NCT01027065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24614966|NCT01027065|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24614967|NCT01027065|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24614968|NCT01027065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24614970|NCT01027065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24716083|NCT01539720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24716093|NCT01539733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24716094|NCT01539733|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24716095|NCT01539733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24716096|NCT01539733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24716097|NCT01539733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24716098|NCT01539733|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24716099|NCT01539733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24716100|NCT01539733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24716101|NCT01539733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716102|NCT01539733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24716103|NCT01539733|Serotonin Agents|serotonin agents|mesh-ancestor
24716104|NCT01539733|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24716105|NCT01539733|Dopamine Agents|dopamine agents|mesh-ancestor
24716113|NCT01539902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24716115|NCT01539902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716116|NCT01539902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24716117|NCT01539902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24716118|NCT01540032|Salicylates|salicylates|mesh-list
24716119|NCT01540032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24645815|NCT01200056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716120|NCT01540032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24716121|NCT01540032|Analgesics|analgesics|mesh-ancestor
24716122|NCT01540032|Sensory System Agents|sensory system agents|mesh-ancestor
24716123|NCT01540032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24716124|NCT01540032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803046|NCT01994070|Procainamide|procainamide|mesh-list
24441499|NCT00287677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24716125|NCT01540032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24716126|NCT01540032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24716127|NCT01540032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24716128|NCT01540032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716129|NCT01540032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716131|NCT01540084|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24716132|NCT01540084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24716133|NCT01540084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716160|NCT01540240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24716161|NCT01540240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24716162|NCT01540240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24941297|NCT03992755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24941299|NCT03992170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941305|NCT03992144|Amoxicillin|amoxicillin|mesh-list
24941306|NCT03992144|Metronidazole|metronidazole|mesh-list
24941307|NCT03992144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24941308|NCT03992144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24941309|NCT03992144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24941310|NCT03992144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24941311|NCT03992066|Epoetin Alfa|epoetin alfa|mesh-list
24941312|NCT03992066|Darbepoetin alfa|darbepoetin alfa|mesh-list
24941313|NCT03992066|Hematinics|hematinics|mesh-ancestor
24457261|NCT00333632|Adrenergic Agents|adrenergic agents|mesh-ancestor
24716169|NCT01540435|Bevacizumab|bevacizumab|mesh-list
24716170|NCT01540435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24716171|NCT01540435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24716172|NCT01540435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24716173|NCT01540435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24716174|NCT01540435|Growth Substances|growth substances|mesh-ancestor
24716175|NCT01540435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919048|NCT04214626|Immunologic Factors|immunologic factors|mesh-ancestor
24919049|NCT04214626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716176|NCT01540435|Growth Inhibitors|growth inhibitors|mesh-ancestor
24716177|NCT01540500|Fluvoxamine|fluvoxamine|mesh-list
24716178|NCT01540500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24834607|NCT02179931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24716181|NCT01540500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716182|NCT01540500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24716183|NCT01540500|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24645824|NCT01200108|Glucocorticoids|glucocorticoids|mesh-ancestor
24716187|NCT01540500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24716192|NCT01540500|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24716193|NCT01540500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716194|NCT01540500|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24716196|NCT01540526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24716197|NCT01540526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24716198|NCT01540526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716199|NCT01540526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716200|NCT01540591|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24716201|NCT01540591|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24716202|NCT01540591|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24716203|NCT01540591|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24716204|NCT01540682|Cetuximab|cetuximab|mesh-list
24716205|NCT01540682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24716206|NCT01540682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941334|NCT03992326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24941335|NCT03992326|Analgesics|analgesics|mesh-ancestor
24941336|NCT03992326|Sensory System Agents|sensory system agents|mesh-ancestor
24854712|NCT02274974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24443619|NCT00295542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24615034|NCT01027494|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24615035|NCT01027494|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24615037|NCT01027520|Antifungal Agents|antifungal agents|mesh-ancestor
24615038|NCT01027520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24615039|NCT01027520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24615040|NCT01027520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24615041|NCT01027520|Coccidiostats|coccidiostats|mesh-ancestor
24615042|NCT01027520|Proton Ionophores|proton ionophores|mesh-ancestor
24615043|NCT01027520|Uncoupling Agents|uncoupling agents|mesh-ancestor
24615044|NCT01027520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615045|NCT01027520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615046|NCT01027520|Ionophores|ionophores|mesh-ancestor
24615047|NCT01027520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24615048|NCT01027520|Sodium Ionophores|sodium ionophores|mesh-ancestor
24615049|NCT01027546|Tranexamic Acid|tranexamic acid|mesh-list
24615050|NCT01027546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24615051|NCT01027546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24615052|NCT01027546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716211|NCT01540708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716212|NCT01540708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24716213|NCT01540708|Respiratory System Agents|respiratory system agents|mesh-ancestor
24716214|NCT01540708|Glucocorticoids|glucocorticoids|mesh-ancestor
24716215|NCT01540708|Hormones|hormones|mesh-ancestor
24716216|NCT01540708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24716217|NCT01540708|Sympathomimetics|sympathomimetics|mesh-ancestor
24716218|NCT01540721|Acetaminophen|acetaminophen|mesh-list
24716252|NCT01540812|Idarubicin|idarubicin|mesh-list
24716253|NCT01540812|Methotrexate|methotrexate|mesh-list
24716254|NCT01540812|Pegaspargase|pegaspargase|mesh-list
24716255|NCT01540812|Asparaginase|asparaginase|mesh-list
24716256|NCT01540812|BB 1101|bb 1101|mesh-list
24716257|NCT01540812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24716258|NCT01540812|Antiemetics|antiemetics|mesh-ancestor
24716259|NCT01540812|Autonomic Agents|autonomic agents|mesh-ancestor
24716260|NCT01540812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24716261|NCT01540812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716262|NCT01540812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24834711|NCT02180529|Methylphenidate|methylphenidate|mesh-list
24716276|NCT01540812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24716277|NCT01540812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24716278|NCT01540812|Tubulin Modulators|tubulin modulators|mesh-ancestor
24716279|NCT01540812|Antimitotic Agents|antimitotic agents|mesh-ancestor
24716280|NCT01540812|Mitosis Modulators|mitosis modulators|mesh-ancestor
25695401|NCT02046070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25695402|NCT02046070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24689920|NCT01398072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689921|NCT01398072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689922|NCT01398072|Antimalarials|antimalarials|mesh-ancestor
24689923|NCT01398072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24689924|NCT01398072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24690004|NCT01398371|Protective Agents|protective agents|mesh-ancestor
24690005|NCT01398371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690006|NCT01398384|Nitric Oxide|nitric oxide|mesh-list
24716281|NCT01540812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24716282|NCT01540812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24716283|NCT01540812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24716284|NCT01540812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24716285|NCT01540812|Abortifacient Agents|abortifacient agents|mesh-ancestor
24716286|NCT01540812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24716287|NCT01540812|Dermatologic Agents|dermatologic agents|mesh-ancestor
24716288|NCT01540812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24716289|NCT01540812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24716290|NCT01540812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24716291|NCT01540877|Anesthetics|anesthetics|mesh-list
24716292|NCT01540877|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24716293|NCT01540877|Anesthetics, Local|anesthetics, local|mesh-list
24716324|NCT01541085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24716325|NCT01541085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24716331|NCT01541085|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24716332|NCT01541085|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24716333|NCT01541085|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24716335|NCT01541124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24716336|NCT01541124|Narcotics|narcotics|mesh-ancestor
24716337|NCT01541124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24716338|NCT01541124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716339|NCT01541124|Analgesics|analgesics|mesh-ancestor
24716340|NCT01541124|Sensory System Agents|sensory system agents|mesh-ancestor
24716341|NCT01541124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24716342|NCT01541137|Diclofenac|diclofenac|mesh-list
24716343|NCT01541137|Parecoxib|parecoxib|mesh-list
24716344|NCT01541137|Valdecoxib|valdecoxib|mesh-list
24716345|NCT01541137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24716347|NCT01541137|Analgesics|analgesics|mesh-ancestor
24716348|NCT01541137|Sensory System Agents|sensory system agents|mesh-ancestor
24716349|NCT01541137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24716350|NCT01541137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716351|NCT01541137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24716352|NCT01541137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24716353|NCT01541137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24716354|NCT01541137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716355|NCT01541137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716356|NCT01541137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24716358|NCT01541189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24716359|NCT01541189|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24716360|NCT01541189|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24941370|NCT03991910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24716369|NCT01541280|Antimetabolites|antimetabolites|mesh-ancestor
24716370|NCT01541280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716371|NCT01541280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24716372|NCT01541280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716373|NCT01541293|Lidocaine|lidocaine|mesh-list
24716374|NCT01541293|Anesthetics, Local|anesthetics, local|mesh-ancestor
24716375|NCT01541293|Anesthetics|anesthetics|mesh-ancestor
24716376|NCT01541293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24716377|NCT01541293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716378|NCT01541293|Sensory System Agents|sensory system agents|mesh-ancestor
24716379|NCT01541293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25695403|NCT02046070|Protease Inhibitors|protease inhibitors|mesh-ancestor
25695404|NCT02046070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25695405|NCT02046122|Cytarabine|cytarabine|mesh-list
25695406|NCT02046122|Idarubicin|idarubicin|mesh-list
25695407|NCT02046122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25695408|NCT02046122|Antimetabolites|antimetabolites|mesh-ancestor
25695409|NCT02046122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695410|NCT02046122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25695411|NCT02046122|Antiviral Agents|antiviral agents|mesh-ancestor
24716380|NCT01541293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25109396|NCT03124524|Drospirenone|drospirenone|mesh-list
24716381|NCT01541293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24716382|NCT01541293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24716383|NCT01541293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24716384|NCT01541293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716385|NCT01541332|Dexamethasone|dexamethasone|mesh-list
24716386|NCT01541332|Doxorubicin|doxorubicin|mesh-list
24716400|NCT01541332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24716401|NCT01541332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24716402|NCT01541332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24716403|NCT01541332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716404|NCT01541332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716405|NCT01541332|Immunologic Factors|immunologic factors|mesh-ancestor
24615058|NCT01027611|Anesthetics, Local|anesthetics, local|mesh-ancestor
24615059|NCT01027611|Anesthetics|anesthetics|mesh-ancestor
24615060|NCT01027611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24615061|NCT01027611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615062|NCT01027611|Sensory System Agents|sensory system agents|mesh-ancestor
24615063|NCT01027611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24615064|NCT01027611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24615065|NCT01027611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24716427|NCT01541475|Antidepressive Agents|antidepressive agents|mesh-ancestor
24716428|NCT01541475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24716429|NCT01541475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24716430|NCT01541475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24716431|NCT01541475|Parasympatholytics|parasympatholytics|mesh-ancestor
24716432|NCT01541475|Autonomic Agents|autonomic agents|mesh-ancestor
24716433|NCT01541475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24716434|NCT01541475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24716435|NCT01541475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24716436|NCT01541475|Cholinergic Agents|cholinergic agents|mesh-ancestor
24716437|NCT01541475|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24716438|NCT01541475|Dopamine Agents|dopamine agents|mesh-ancestor
24834746|NCT02180880|Oxcarbazepine|oxcarbazepine|mesh-list
24834819|NCT02181218|Antiviral Agents|antiviral agents|mesh-ancestor
24834820|NCT02181218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24834821|NCT02181218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24834822|NCT02181218|Immunologic Factors|immunologic factors|mesh-ancestor
24834823|NCT02181218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24834824|NCT02181309|Meloxicam|meloxicam|mesh-list
24716439|NCT01541475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24716440|NCT01541475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24716441|NCT01541475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716442|NCT01541605|Methylphenidate|methylphenidate|mesh-list
24716443|NCT01541605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24716444|NCT01541605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716445|NCT01541605|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24716446|NCT01541605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24716447|NCT01541605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24716448|NCT01541605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716449|NCT01541605|Dopamine Agents|dopamine agents|mesh-ancestor
24716450|NCT01541605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24716451|NCT01541631|Albendazole|albendazole|mesh-list
24716452|NCT01541631|Praziquantel|praziquantel|mesh-list
24716453|NCT01541631|Anthelmintics|anthelmintics|mesh-ancestor
24941372|NCT03991442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24941373|NCT03991442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24941374|NCT03991442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24941385|NCT03991364|Dopamine Agents|dopamine agents|mesh-ancestor
24941386|NCT03991364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24941387|NCT03991364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941388|NCT03991364|Adrenergic Agents|adrenergic agents|mesh-ancestor
24941389|NCT03991364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24941390|NCT03991364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24941391|NCT03991364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24941392|NCT03991364|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24941393|NCT03991559|Manganese|manganese|mesh-list
24941394|NCT03991559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24941395|NCT03991559|Antibodies|antibodies|mesh-list
24716454|NCT01541631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24716455|NCT01541631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24716456|NCT01541631|Anticestodal Agents|anticestodal agents|mesh-ancestor
24716457|NCT01541631|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25695412|NCT02046122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24716458|NCT01541631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24716459|NCT01541631|Tubulin Modulators|tubulin modulators|mesh-ancestor
24716460|NCT01541631|Antimitotic Agents|antimitotic agents|mesh-ancestor
24716461|NCT01541631|Mitosis Modulators|mitosis modulators|mesh-ancestor
24716462|NCT01541631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716463|NCT01541631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24716464|NCT01541670|Antibodies|antibodies|mesh-list
24716465|NCT01541670|Immunologic Factors|immunologic factors|mesh-ancestor
24716476|NCT01541943|Atorvastatin|atorvastatin|mesh-list
24716477|NCT01541943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24716478|NCT01541943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24716479|NCT01541943|Antimetabolites|antimetabolites|mesh-ancestor
24716480|NCT01541943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716481|NCT01541943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24941403|NCT03991520|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24941404|NCT03991520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24941406|NCT03991312|Rifampin|rifampin|mesh-list
24941407|NCT03991312|Antifungal Agents|antifungal agents|mesh-ancestor
24941408|NCT03991312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24941409|NCT03991312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24941410|NCT03991312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24941411|NCT03991312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24941412|NCT03991312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941413|NCT03991312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24941414|NCT03991312|Hormone Antagonists|hormone antagonists|mesh-ancestor
24941415|NCT03991312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24941416|NCT03991312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716513|NCT01542138|Nicotinic Acids|nicotinic acids|mesh-list
24716514|NCT01542138|Desonide|desonide|mesh-list
24716515|NCT01542138|Vitamin B Complex|vitamin b complex|mesh-ancestor
24716516|NCT01542138|Vitamins|vitamins|mesh-ancestor
24716517|NCT01542138|Micronutrients|micronutrients|mesh-ancestor
24716518|NCT01542138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716519|NCT01542138|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24716520|NCT01542138|Antimetabolites|antimetabolites|mesh-ancestor
24716521|NCT01542138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716522|NCT01542138|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24716523|NCT01542138|Vasodilator Agents|vasodilator agents|mesh-ancestor
24716524|NCT01542138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24716525|NCT01542190|Ketorolac|ketorolac|mesh-list
24716527|NCT01542190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24716528|NCT01542190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24716529|NCT01542190|Analgesics|analgesics|mesh-ancestor
24716530|NCT01542190|Sensory System Agents|sensory system agents|mesh-ancestor
24716531|NCT01542190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24716532|NCT01542190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716533|NCT01542190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24716534|NCT01542190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24716536|NCT01542190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716538|NCT01542242|Liraglutide|liraglutide|mesh-list
24716551|NCT01542268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716552|NCT01542268|Vasodilator Agents|vasodilator agents|mesh-ancestor
24716553|NCT01542268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24716554|NCT01542268|Antioxidants|antioxidants|mesh-ancestor
24716555|NCT01542294|Oxaliplatin|oxaliplatin|mesh-list
24716556|NCT01542294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24716557|NCT01542424|Insulin|insulin|mesh-list
24941417|NCT03991312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24941418|NCT03991312|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24941419|NCT03991312|Antitubercular Agents|antitubercular agents|mesh-ancestor
24941420|NCT03991312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24941421|NCT03991312|Leprostatic Agents|leprostatic agents|mesh-ancestor
24941422|NCT03991312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24941423|NCT03991312|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24941424|NCT03991312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24941425|NCT03991312|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24941426|NCT03991312|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24941427|NCT03991312|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24941428|NCT03991312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24941429|NCT03990974|Anti-Infective Agents|anti-infective agents|mesh-list
24941430|NCT03990974|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24941431|NCT03991208|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
24941432|NCT03991208|Antimalarials|antimalarials|mesh-ancestor
24941433|NCT03991208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24957468|NCT03844529|Anesthetics|anesthetics|mesh-ancestor
24957469|NCT03844529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24957470|NCT03844529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957471|NCT03844529|Sensory System Agents|sensory system agents|mesh-ancestor
24957472|NCT03844529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24716562|NCT01542424|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24716563|NCT01542424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24716564|NCT01542424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716565|NCT01542437|Afatinib|afatinib|mesh-list
24716566|NCT01542437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24716602|NCT01542697|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24716603|NCT01542697|Tocolytic Agents|tocolytic agents|mesh-ancestor
24957479|NCT03844594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24957480|NCT03844763|Cyclophosphamide|cyclophosphamide|mesh-list
24941434|NCT03991208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24941435|NCT03991208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24941437|NCT03991130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24716611|NCT01542710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24716612|NCT01542710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716613|NCT01542710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716614|NCT01542710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24716615|NCT01542710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24716617|NCT01542723|Anticoagulants|anticoagulants|mesh-ancestor
24716618|NCT01542723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24716635|NCT01542801|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24716636|NCT01542801|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24716638|NCT01542827|Sensory System Agents|sensory system agents|mesh-ancestor
24716639|NCT01542827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24716640|NCT01542827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716648|NCT01542918|Rituximab|rituximab|mesh-list
24716649|NCT01542918|Lenalidomide|lenalidomide|mesh-list
24716650|NCT01542918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24716651|NCT01542918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24716652|NCT01542918|Immunologic Factors|immunologic factors|mesh-ancestor
24716654|NCT01542918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24716673|NCT01543139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24716674|NCT01543139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24716675|NCT01543165|Ketorolac|ketorolac|mesh-list
24615075|NCT01027689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24615076|NCT01027689|GABA Modulators|gaba modulators|mesh-ancestor
24615077|NCT01027689|GABA Agents|gaba agents|mesh-ancestor
24615078|NCT01027689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24615079|NCT01027689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615080|NCT01027715|Anticonvulsants|anticonvulsants|mesh-list
24615081|NCT01027832|Tazobactam|tazobactam|mesh-list
24615082|NCT01027832|Piperacillin|piperacillin|mesh-list
24812653|NCT02053935|Dopamine|dopamine|mesh-list
24941449|NCT03990701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941480|NCT03990129|Analgesics|analgesics|mesh-ancestor
24941481|NCT03990129|Sensory System Agents|sensory system agents|mesh-ancestor
24941482|NCT03990129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812654|NCT02053935|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24615083|NCT01027832|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24615085|NCT01027832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24615086|NCT01027832|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24615087|NCT01027832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615088|NCT01027832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615089|NCT01027923|Cytarabine|cytarabine|mesh-list
24615090|NCT01027923|Plerixafor|plerixafor|mesh-list
24615091|NCT01027923|Etoposide|etoposide|mesh-list
24615092|NCT01027923|Mitoxantrone|mitoxantrone|mesh-list
24615093|NCT01027923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24615094|NCT01027923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24615095|NCT01027923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24615096|NCT01027923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24615097|NCT01027923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615098|NCT01027923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615099|NCT01027923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24615100|NCT01027923|Antimetabolites|antimetabolites|mesh-ancestor
24716684|NCT01543165|Sensory System Agents|sensory system agents|mesh-ancestor
24716685|NCT01543165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24716686|NCT01543165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24716687|NCT01543165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24716688|NCT01543165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24716689|NCT01543165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24716690|NCT01543165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24716691|NCT01543165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716692|NCT01543165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716697|NCT01543321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716699|NCT01543321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24716704|NCT01543386|Curcumin|curcumin|mesh-list
24716705|NCT01543386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24716706|NCT01543386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24716707|NCT01543386|Analgesics|analgesics|mesh-ancestor
24716708|NCT01543386|Sensory System Agents|sensory system agents|mesh-ancestor
24716709|NCT01543386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24716710|NCT01543386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716711|NCT01543386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24716712|NCT01543386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24716713|NCT01543386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24716714|NCT01543386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24941483|NCT03990129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941484|NCT03990129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24716715|NCT01543386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716722|NCT01543399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24716723|NCT01543399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24716724|NCT01543399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24716726|NCT01543399|Hormones|hormones|mesh-ancestor
24716773|NCT01543932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24716774|NCT01543932|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24716775|NCT01543932|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24716776|NCT01543932|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24716810|NCT01543945|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24716811|NCT01543945|Histamine Antagonists|histamine antagonists|mesh-ancestor
24716812|NCT01543945|Histamine Agents|histamine agents|mesh-ancestor
24716813|NCT01543971|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
24716814|NCT01543971|Lenograstim|lenograstim|mesh-list
24716815|NCT01543971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24716816|NCT01543971|Immunologic Factors|immunologic factors|mesh-ancestor
24716817|NCT01543971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716818|NCT01543971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24716819|NCT01543971|Vasodilator Agents|vasodilator agents|mesh-ancestor
24716821|NCT01544140|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24716822|NCT01544140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24645877|NCT01200537|Contraceptive Agents|contraceptive agents|mesh-list
24716857|NCT01544283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24716858|NCT01544283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24716859|NCT01544283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24716860|NCT01544283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24716861|NCT01544283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716862|NCT01544283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24716863|NCT01544283|Glucocorticoids|glucocorticoids|mesh-ancestor
24716864|NCT01544283|Hormones|hormones|mesh-ancestor
24716865|NCT01544283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24716866|NCT01544283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24716867|NCT01544283|Immunologic Factors|immunologic factors|mesh-ancestor
25050806|NCT00467025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050807|NCT00467025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25050808|NCT00467025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25050809|NCT00467025|Growth Substances|growth substances|mesh-ancestor
25050810|NCT00467025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854820|NCT02275806|Irinotecan|irinotecan|mesh-list
24716869|NCT01544439|Salicylic Acid|salicylic acid|mesh-list
24716870|NCT01544439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24716871|NCT01544439|Antifungal Agents|antifungal agents|mesh-ancestor
24716872|NCT01544439|Keratolytic Agents|keratolytic agents|mesh-ancestor
24716873|NCT01544439|Dermatologic Agents|dermatologic agents|mesh-ancestor
24716874|NCT01544504|Norepinephrine|norepinephrine|mesh-list
24716875|NCT01544504|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24716876|NCT01544504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24716877|NCT01544504|Adrenergic Agents|adrenergic agents|mesh-ancestor
24716878|NCT01544504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24716879|NCT01544504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716880|NCT01544504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716881|NCT01544504|Sympathomimetics|sympathomimetics|mesh-ancestor
24716882|NCT01544504|Autonomic Agents|autonomic agents|mesh-ancestor
24716883|NCT01544504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24716885|NCT01544517|Amoxicillin|amoxicillin|mesh-list
24716886|NCT01544517|Levofloxacin|levofloxacin|mesh-list
24716887|NCT01544517|Ofloxacin|ofloxacin|mesh-list
24716888|NCT01544517|Tinidazole|tinidazole|mesh-list
24716889|NCT01544517|Esomeprazole|esomeprazole|mesh-list
24716890|NCT01544517|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24716891|NCT01544517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24716892|NCT01544517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24716893|NCT01544517|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24716894|NCT01544517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24716895|NCT01544517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716896|NCT01544517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716897|NCT01544517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24716899|NCT01544517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24716905|NCT01544517|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25050811|NCT00467025|Growth Inhibitors|growth inhibitors|mesh-ancestor
25050812|NCT00465959|Trospium chloride|trospium chloride|mesh-list
25050813|NCT00465959|Parasympatholytics|parasympatholytics|mesh-ancestor
25050814|NCT00465959|Autonomic Agents|autonomic agents|mesh-ancestor
25050815|NCT00465959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25050816|NCT00465959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050817|NCT00465959|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24941499|NCT03990103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24941500|NCT03990103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941501|NCT03990103|Tubulin Modulators|tubulin modulators|mesh-ancestor
24941502|NCT03990103|Antimitotic Agents|antimitotic agents|mesh-ancestor
24941503|NCT03990103|Mitosis Modulators|mitosis modulators|mesh-ancestor
24941504|NCT03990103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764015|NCT01779206|Epirubicin|epirubicin|mesh-list
24941505|NCT03990103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24941506|NCT03990103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24941507|NCT03990103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24716906|NCT01544517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24716907|NCT01544517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24716908|NCT01544634|Beclomethasone|beclomethasone|mesh-list
24716909|NCT01544634|Propranolol|propranolol|mesh-list
24716920|NCT01544634|Glucocorticoids|glucocorticoids|mesh-ancestor
24716921|NCT01544634|Hormones|hormones|mesh-ancestor
24716923|NCT01544634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24716924|NCT01544634|Respiratory System Agents|respiratory system agents|mesh-ancestor
24716925|NCT01544673|Linezolid|linezolid|mesh-list
24716926|NCT01544673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24716927|NCT01544673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24716928|NCT01544673|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24716929|NCT01544673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716930|NCT01544673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716931|NCT01544725|Ketamine|ketamine|mesh-list
24716932|NCT01544725|Propofol|propofol|mesh-list
24716942|NCT01544725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24716943|NCT01544725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24716944|NCT01544725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24716945|NCT01544725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24716946|NCT01544725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716947|NCT01544751|Metformin|metformin|mesh-list
24716971|NCT01544842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24716972|NCT01544842|Immunologic Factors|immunologic factors|mesh-ancestor
24716973|NCT01544842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716974|NCT01544842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24716975|NCT01544842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716976|NCT01544842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716977|NCT01544842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24716978|NCT01544842|Glucocorticoids|glucocorticoids|mesh-ancestor
24716979|NCT01544842|Hormones|hormones|mesh-ancestor
24716980|NCT01544842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24941508|NCT03990103|Growth Substances|growth substances|mesh-ancestor
24941509|NCT03990103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941510|NCT03990103|Growth Inhibitors|growth inhibitors|mesh-ancestor
24941511|NCT03990103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24941512|NCT03990103|Antimetabolites|antimetabolites|mesh-ancestor
24941513|NCT03990038|Ropivacaine|ropivacaine|mesh-list
24941514|NCT03990038|Anesthetics, Local|anesthetics, local|mesh-ancestor
24941515|NCT03990038|Anesthetics|anesthetics|mesh-ancestor
24941516|NCT03990038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24941517|NCT03990038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941519|NCT03990038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24941520|NCT03990571|Avelumab|avelumab|mesh-list
24941521|NCT03990571|Axitinib|axitinib|mesh-list
24766556|NCT01795313|Imiquimod|imiquimod|mesh-list
24716981|NCT01544881|Insulin|insulin|mesh-list
24716982|NCT01544881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24716983|NCT01544881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503657|NCT00532532|Tolperisone|tolperisone|mesh-list
24716987|NCT01544894|Hormone Antagonists|hormone antagonists|mesh-ancestor
24716988|NCT01544894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24717015|NCT01544959|Adrenergic Agents|adrenergic agents|mesh-ancestor
24717016|NCT01544959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24717017|NCT01544959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717018|NCT01544959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24717020|NCT01544972|Ibuprofen|ibuprofen|mesh-list
24717021|NCT01544972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24717022|NCT01544972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24717023|NCT01544972|Analgesics|analgesics|mesh-ancestor
24717024|NCT01544972|Sensory System Agents|sensory system agents|mesh-ancestor
24717025|NCT01544972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24717026|NCT01544972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717027|NCT01544972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24717028|NCT01544972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24717029|NCT01544972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24717030|NCT01544972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717031|NCT01544972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717032|NCT01544972|Antipyretics|antipyretics|mesh-ancestor
24717033|NCT01545024|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24717034|NCT01545024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24717035|NCT01545024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717036|NCT01545024|Incretins|incretins|mesh-ancestor
24717055|NCT01545297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24717056|NCT01545297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24717057|NCT01545297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717058|NCT01545297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24717059|NCT01545297|Anesthetics, General|anesthetics, general|mesh-ancestor
24615118|NCT01028079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615119|NCT01028079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24717065|NCT01545297|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24717066|NCT01545297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24717067|NCT01545297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24717068|NCT01545297|Adrenergic Agents|adrenergic agents|mesh-ancestor
24717069|NCT01545297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24717070|NCT01545297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717071|NCT01545297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24717073|NCT01545427|Imatinib Mesylate|imatinib mesylate|mesh-list
24717074|NCT01545427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24717075|NCT01545427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24717076|NCT01545427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717084|NCT01545479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717085|NCT01545479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717086|NCT01545479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24717087|NCT01545557|Lidocaine|lidocaine|mesh-list
24717088|NCT01545557|Hyaluronic Acid|hyaluronic acid|mesh-list
24717089|NCT01545557|Anesthetics, Local|anesthetics, local|mesh-ancestor
24717090|NCT01545557|Anesthetics|anesthetics|mesh-ancestor
24717091|NCT01545557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24717125|NCT01545804|Lenalidomide|lenalidomide|mesh-list
24717126|NCT01545804|Immunologic Factors|immunologic factors|mesh-ancestor
24717127|NCT01545804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717128|NCT01545804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24717129|NCT01545804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24717130|NCT01545804|Growth Substances|growth substances|mesh-ancestor
24717131|NCT01545804|Growth Inhibitors|growth inhibitors|mesh-ancestor
24717132|NCT01545804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24717133|NCT01545830|Vitamin D|vitamin d|mesh-list
24717134|NCT01545830|Cholecalciferol|cholecalciferol|mesh-list
24717135|NCT01545830|Vitamins|vitamins|mesh-ancestor
24717136|NCT01545830|Micronutrients|micronutrients|mesh-ancestor
24717137|NCT01545830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645926|NCT01200732|Tadalafil|tadalafil|mesh-list
24717138|NCT01545830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24717139|NCT01545830|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24717141|NCT01545856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24766560|NCT01795313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24766561|NCT01795313|Interferon Inducers|interferon inducers|mesh-ancestor
24717182|NCT01546116|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
24717183|NCT01546116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24717184|NCT01546116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24717185|NCT01546116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717186|NCT01546116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717187|NCT01546116|Antiviral Agents|antiviral agents|mesh-ancestor
24717189|NCT01546116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24717210|NCT01546597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24717211|NCT01546597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717213|NCT01546701|Buprenorphine|buprenorphine|mesh-list
24717214|NCT01546701|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24717215|NCT01546701|Narcotics|narcotics|mesh-ancestor
24717216|NCT01546701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24717217|NCT01546701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717218|NCT01546701|Analgesics|analgesics|mesh-ancestor
24717219|NCT01546701|Sensory System Agents|sensory system agents|mesh-ancestor
24717220|NCT01546701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24717221|NCT01546701|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24717222|NCT01546896|Alprazolam|alprazolam|mesh-list
24717223|NCT01546896|Buspirone|buspirone|mesh-list
24717224|NCT01546896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24717225|NCT01546896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24717226|NCT01546896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717227|NCT01546896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24717228|NCT01546896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24717229|NCT01546896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24717230|NCT01546896|GABA Modulators|gaba modulators|mesh-ancestor
24717231|NCT01546896|GABA Agents|gaba agents|mesh-ancestor
24717232|NCT01546896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24835136|NCT02182336|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24717233|NCT01546896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717234|NCT01546896|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24717235|NCT01546896|Serotonin Agents|serotonin agents|mesh-ancestor
24557472|NCT00752635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24557473|NCT00752635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24557474|NCT00752635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24557475|NCT00752635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24557476|NCT00752635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24557477|NCT00752635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557478|NCT00752635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625735|NCT01083264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24625736|NCT01083290|Spironolactone|spironolactone|mesh-list
24854863|NCT02275975|Fluconazole|fluconazole|mesh-list
24717267|NCT01547091|Antirheumatic Agents|antirheumatic agents|mesh-list
24717268|NCT01547104|Glimepiride|glimepiride|mesh-list
24717269|NCT01547104|Linagliptin|linagliptin|mesh-list
24717270|NCT01547104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24717271|NCT01547104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24717272|NCT01547104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717273|NCT01547104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24717274|NCT01547104|Immunologic Factors|immunologic factors|mesh-ancestor
24717275|NCT01547104|Incretins|incretins|mesh-ancestor
24717297|NCT01547143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24717298|NCT01547143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717302|NCT01547143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24717303|NCT01547143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24717304|NCT01547143|Immunologic Factors|immunologic factors|mesh-ancestor
24717305|NCT01547143|Antifungal Agents|antifungal agents|mesh-ancestor
24717306|NCT01547143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24717307|NCT01547143|Dermatologic Agents|dermatologic agents|mesh-ancestor
24717308|NCT01547143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24717309|NCT01547143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24717310|NCT01547169|Insulin|insulin|mesh-list
24717311|NCT01547169|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24717312|NCT01547169|Insulin Detemir|insulin detemir|mesh-list
24717313|NCT01547169|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24717314|NCT01547169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717315|NCT01547221|Clotrimazole|clotrimazole|mesh-list
24717316|NCT01547221|Miconazole|miconazole|mesh-list
24717317|NCT01547221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24717318|NCT01547221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24717319|NCT01547221|Antifungal Agents|antifungal agents|mesh-ancestor
24717348|NCT01547312|Grazoprevir|grazoprevir|mesh-list
24717349|NCT01547312|Liver Extracts|liver extracts|mesh-list
24717350|NCT01547312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24717351|NCT01547312|Antiviral Agents|antiviral agents|mesh-ancestor
24717352|NCT01547312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24717353|NCT01547312|Antimetabolites|antimetabolites|mesh-ancestor
24717354|NCT01547312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717364|NCT01547377|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24504083|NCT00533962|Anecortave|anecortave|mesh-list
24717365|NCT01547377|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24625737|NCT01083290|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24625738|NCT01083290|Hormone Antagonists|hormone antagonists|mesh-ancestor
24625757|NCT01083381|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24625758|NCT01083381|Serotonin Agents|serotonin agents|mesh-ancestor
24625759|NCT01083381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24625760|NCT01083381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625761|NCT01083381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625762|NCT01083381|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24625763|NCT01083381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24625764|NCT01083381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24625765|NCT01083381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24625766|NCT01083381|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24625767|NCT01083381|Dopamine Agents|dopamine agents|mesh-ancestor
24941522|NCT03990571|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24717366|NCT01547377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24717367|NCT01547377|Antimetabolites|antimetabolites|mesh-ancestor
24717368|NCT01547377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717369|NCT01547377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24717370|NCT01547377|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24717371|NCT01547377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717372|NCT01547377|Trace Elements|trace elements|mesh-ancestor
24717373|NCT01547377|Micronutrients|micronutrients|mesh-ancestor
24717374|NCT01547377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717375|NCT01547377|Antioxidants|antioxidants|mesh-ancestor
24941523|NCT03990571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24941524|NCT03990571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941525|NCT03990571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24941526|NCT03990571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854897|NCT02276014|Carotenoids|carotenoids|mesh-list
24717376|NCT01547377|Protective Agents|protective agents|mesh-ancestor
24717396|NCT01547455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24717397|NCT01547455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24717398|NCT01547455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717408|NCT01547520|Sensory System Agents|sensory system agents|mesh-ancestor
24717409|NCT01547520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24717410|NCT01547520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24717412|NCT01547546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717413|NCT01547546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717414|NCT01547559|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
24717415|NCT01547559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24717416|NCT01547559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24717417|NCT01547559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24717418|NCT01548001|Methotrexate|methotrexate|mesh-list
24717419|NCT01548001|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24717420|NCT01548001|Abortifacient Agents|abortifacient agents|mesh-ancestor
24717421|NCT01548001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24717422|NCT01548001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717423|NCT01548001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24717424|NCT01548001|Antimetabolites|antimetabolites|mesh-ancestor
24717425|NCT01548001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717426|NCT01548001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24717427|NCT01548001|Dermatologic Agents|dermatologic agents|mesh-ancestor
24717428|NCT01548001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717429|NCT01548001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24717430|NCT01548001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24717431|NCT01548001|Immunologic Factors|immunologic factors|mesh-ancestor
24717432|NCT01548001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24717461|NCT01548144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717476|NCT01548170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24717477|NCT01548170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24717478|NCT01548170|Growth Substances|growth substances|mesh-ancestor
25695413|NCT02046122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24717479|NCT01548170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941527|NCT03990571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941529|NCT03990571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625769|NCT01083407|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24625770|NCT01083407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24625771|NCT01083407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24625772|NCT01083407|Disinfectants|disinfectants|mesh-ancestor
24625773|NCT01083407|Dermatologic Agents|dermatologic agents|mesh-ancestor
24625774|NCT01083420|Minocycline|minocycline|mesh-list
24625775|NCT01083420|Dexamethasone|dexamethasone|mesh-list
24625776|NCT01083420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24625777|NCT01083420|Antiemetics|antiemetics|mesh-ancestor
24941575|NCT03989336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24941576|NCT03989336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24941577|NCT03989336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941578|NCT03989336|Tubulin Modulators|tubulin modulators|mesh-ancestor
24941579|NCT03989336|Antimitotic Agents|antimitotic agents|mesh-ancestor
24941580|NCT03989336|Mitosis Modulators|mitosis modulators|mesh-ancestor
24941581|NCT03989336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941582|NCT03989336|Trace Elements|trace elements|mesh-ancestor
24941583|NCT03989336|Micronutrients|micronutrients|mesh-ancestor
24941584|NCT03989336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941585|NCT03989310|Manganese|manganese|mesh-list
24717489|NCT01548170|Hormone Antagonists|hormone antagonists|mesh-ancestor
24717490|NCT01548170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24717491|NCT01548170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24717492|NCT01548209|Dexmedetomidine|dexmedetomidine|mesh-list
24717493|NCT01548209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24717494|NCT01548209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24717495|NCT01548209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717496|NCT01548209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24717497|NCT01548209|Analgesics|analgesics|mesh-ancestor
24717498|NCT01548209|Sensory System Agents|sensory system agents|mesh-ancestor
24717499|NCT01548209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24717500|NCT01548209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24615121|NCT01028079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24615122|NCT01028079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24615124|NCT01028079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24717505|NCT01548209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717506|NCT01548235|Insulin Aspart|insulin aspart|mesh-list
24717507|NCT01548235|Biphasic Insulins|biphasic insulins|mesh-list
24717508|NCT01548235|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24717509|NCT01548235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24717510|NCT01548235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717511|NCT01548248|Insulin|insulin|mesh-list
24717512|NCT01548248|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24717513|NCT01548248|Insulin Aspart|insulin aspart|mesh-list
24717514|NCT01548248|Insulin Detemir|insulin detemir|mesh-list
24504297|NCT00535119|Paclitaxel|paclitaxel|mesh-list
24717566|NCT01548703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24717567|NCT01548703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24717568|NCT01548703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24717569|NCT01548703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717570|NCT01548703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717571|NCT01548794|Lidocaine|lidocaine|mesh-list
24717691|NCT01549431|Antiemetics|antiemetics|mesh-ancestor
24941656|NCT03989037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941657|NCT03989037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24941658|NCT03989024|Clomiphene|clomiphene|mesh-list
24941659|NCT03989024|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24941660|NCT03989024|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24941661|NCT03989024|Hormone Antagonists|hormone antagonists|mesh-ancestor
24941662|NCT03989024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24941663|NCT03989024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941664|NCT03989024|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24717572|NCT01548794|Bupivacaine|bupivacaine|mesh-list
24717573|NCT01548794|Anesthetics|anesthetics|mesh-list
24717574|NCT01548794|Anesthetics, Local|anesthetics, local|mesh-ancestor
24717575|NCT01548794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24717576|NCT01548794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717577|NCT01548794|Sensory System Agents|sensory system agents|mesh-ancestor
24717578|NCT01548794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24717579|NCT01548794|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24717580|NCT01548794|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24717581|NCT01548794|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24717582|NCT01548794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24717583|NCT01548794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717584|NCT01548807|Everolimus|everolimus|mesh-list
24717588|NCT01548807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717590|NCT01548859|Sevoflurane|sevoflurane|mesh-list
24717591|NCT01548859|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24717592|NCT01548859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24717594|NCT01548859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717597|NCT01548859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24717598|NCT01548859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24717599|NCT01548859|Anesthetics, General|anesthetics, general|mesh-ancestor
24717600|NCT01548859|Anesthetics|anesthetics|mesh-ancestor
24717601|NCT01548859|GABA Modulators|gaba modulators|mesh-ancestor
24717602|NCT01548859|GABA Agents|gaba agents|mesh-ancestor
24717603|NCT01548859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24717612|NCT01548911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24717613|NCT01548911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24717637|NCT01549093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717638|NCT01549093|Antiviral Agents|antiviral agents|mesh-ancestor
24717639|NCT01549093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24717640|NCT01549093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717641|NCT01549093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24717642|NCT01549093|Immunologic Factors|immunologic factors|mesh-ancestor
24718039|NCT01551589|Antimitotic Agents|antimitotic agents|mesh-ancestor
24717643|NCT01549093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717644|NCT01549093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24717645|NCT01549093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24717646|NCT01549093|Growth Substances|growth substances|mesh-ancestor
24717647|NCT01549093|Growth Inhibitors|growth inhibitors|mesh-ancestor
24717649|NCT01549158|Furosemide|furosemide|mesh-list
24717650|NCT01549158|Diuretics|diuretics|mesh-ancestor
24717651|NCT01549158|Natriuretic Agents|natriuretic agents|mesh-ancestor
24717652|NCT01549158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717653|NCT01549158|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24717654|NCT01549158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24717655|NCT01549158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717656|NCT01549158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24717657|NCT01549171|Iloprost|iloprost|mesh-list
24941665|NCT03989024|Fertility Agents|fertility agents|mesh-ancestor
24941666|NCT03989024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24717658|NCT01549171|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24717659|NCT01549171|Vasodilator Agents|vasodilator agents|mesh-ancestor
24717665|NCT01549236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24717679|NCT01549418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24717680|NCT01549418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24717681|NCT01549418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24717682|NCT01549418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24717683|NCT01549418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717684|NCT01549418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24717685|NCT01549418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24717686|NCT01549418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717688|NCT01549431|Dexamethasone|dexamethasone|mesh-list
24717689|NCT01549431|Panobinostat|panobinostat|mesh-list
24717690|NCT01549431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24717693|NCT01549431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24717694|NCT01549431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717695|NCT01549431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24717696|NCT01549431|Glucocorticoids|glucocorticoids|mesh-ancestor
24717697|NCT01549431|Hormones|hormones|mesh-ancestor
24717698|NCT01549431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24717699|NCT01549431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24717700|NCT01549431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24717701|NCT01549431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24717702|NCT01549431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717703|NCT01549431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717725|NCT01549574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24717733|NCT01549691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24717734|NCT01549691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695414|NCT02046122|Immunologic Factors|immunologic factors|mesh-ancestor
24693085|NCT01418157|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24693086|NCT01418157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717765|NCT01549743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717766|NCT01549743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24717767|NCT01549743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24717777|NCT01549847|Piracetam|piracetam|mesh-list
24717778|NCT01549847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24717779|NCT01549847|Protective Agents|protective agents|mesh-ancestor
24835383|NCT02182739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24717780|NCT01549847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717781|NCT01549847|Nootropic Agents|nootropic agents|mesh-ancestor
24717782|NCT01549938|Cholecalciferol|cholecalciferol|mesh-list
24717783|NCT01549938|Vitamin D|vitamin d|mesh-list
24717784|NCT01549938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24717785|NCT01549938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717786|NCT01549938|Vitamins|vitamins|mesh-ancestor
24717787|NCT01549938|Micronutrients|micronutrients|mesh-ancestor
24717788|NCT01549938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24717789|NCT01549990|Sevoflurane|sevoflurane|mesh-list
24717790|NCT01549990|Desflurane|desflurane|mesh-list
24717791|NCT01549990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24717792|NCT01549990|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24717793|NCT01549990|Anesthetics, General|anesthetics, general|mesh-ancestor
24717794|NCT01549990|Anesthetics|anesthetics|mesh-ancestor
24717795|NCT01549990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24717796|NCT01549990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717807|NCT01550107|Gout Suppressants|gout suppressants|mesh-ancestor
24717818|NCT01550146|Autonomic Agents|autonomic agents|mesh-ancestor
24717819|NCT01550146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24941667|NCT03989024|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24941670|NCT03988725|Vitamin E|vitamin e|mesh-list
24941671|NCT03988725|Vitamins|vitamins|mesh-ancestor
24941672|NCT03988725|Micronutrients|micronutrients|mesh-ancestor
24717820|NCT01550146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717821|NCT01550146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24717822|NCT01550146|Glucocorticoids|glucocorticoids|mesh-ancestor
24717823|NCT01550146|Hormones|hormones|mesh-ancestor
24717824|NCT01550146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24717827|NCT01550146|Protease Inhibitors|protease inhibitors|mesh-ancestor
24717861|NCT01550419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717862|NCT01550432|Acetylcysteine|acetylcysteine|mesh-list
24717863|NCT01550432|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24717864|NCT01550432|Antiviral Agents|antiviral agents|mesh-ancestor
24717865|NCT01550432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24717867|NCT01550432|Respiratory System Agents|respiratory system agents|mesh-ancestor
24717868|NCT01550432|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24717869|NCT01550432|Antioxidants|antioxidants|mesh-ancestor
24717870|NCT01550432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717871|NCT01550432|Protective Agents|protective agents|mesh-ancestor
24717872|NCT01550432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717873|NCT01550432|Antidotes|antidotes|mesh-ancestor
24717874|NCT01550445|Prednisolone|prednisolone|mesh-list
24717875|NCT01550445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24717876|NCT01550445|Glucocorticoids|glucocorticoids|mesh-ancestor
24717877|NCT01550445|Hormones|hormones|mesh-ancestor
24717878|NCT01550445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24717879|NCT01550445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717880|NCT01550445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24717881|NCT01550445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24717882|NCT01550458|Mibefradil|mibefradil|mesh-list
24717883|NCT01550458|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24717884|NCT01550458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24717885|NCT01550458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24717886|NCT01550458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695415|NCT02046122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695416|NCT02046122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25695417|NCT02046122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25695418|NCT02046122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24717906|NCT01550653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24717908|NCT01550770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25695419|NCT02046122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612279|NCT01013103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24717909|NCT01550770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24717910|NCT01550770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717911|NCT01550770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24717912|NCT01550770|Anesthetics, General|anesthetics, general|mesh-ancestor
24717913|NCT01550770|Anesthetics|anesthetics|mesh-ancestor
24717914|NCT01550848|Gemcitabine|gemcitabine|mesh-list
24717950|NCT01551147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24717951|NCT01551147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717952|NCT01551225|Citalopram|citalopram|mesh-list
24717953|NCT01551225|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24717954|NCT01551225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24717955|NCT01551225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24717956|NCT01551225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717957|NCT01551225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24717958|NCT01551225|Serotonin Agents|serotonin agents|mesh-ancestor
24941673|NCT03988725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941674|NCT03988725|Antioxidants|antioxidants|mesh-ancestor
24941675|NCT03988725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941676|NCT03988725|Protective Agents|protective agents|mesh-ancestor
24941677|NCT03988478|Psychotropic Drugs|psychotropic drugs|mesh-list
24941678|NCT03988530|Scopolamine|scopolamine|mesh-list
24941679|NCT03988530|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24941680|NCT03988530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24941681|NCT03988530|Antiemetics|antiemetics|mesh-ancestor
24941682|NCT03988530|Autonomic Agents|autonomic agents|mesh-ancestor
24717959|NCT01551225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717960|NCT01551225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24717961|NCT01551225|Antidepressive Agents|antidepressive agents|mesh-ancestor
24717962|NCT01551225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24717963|NCT01551290|Infliximab|infliximab|mesh-list
24717964|NCT01551290|Dermatologic Agents|dermatologic agents|mesh-ancestor
24717967|NCT01551329|Ketamine|ketamine|mesh-list
24718004|NCT01551459|Growth Substances|growth substances|mesh-ancestor
24718037|NCT01551589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718038|NCT01551589|Tubulin Modulators|tubulin modulators|mesh-ancestor
24718049|NCT01551641|Immunologic Factors|immunologic factors|mesh-ancestor
24718050|NCT01551641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718051|NCT01551641|Leprostatic Agents|leprostatic agents|mesh-ancestor
24718052|NCT01551641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24718053|NCT01551641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24615151|NCT01028170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615152|NCT01028170|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24615153|NCT01028170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24615154|NCT01028170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615155|NCT01028248|Ranibizumab|ranibizumab|mesh-list
24615156|NCT01028248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24615157|NCT01028248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24615159|NCT01028248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941683|NCT03988530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24718090|NCT01551823|Immunologic Factors|immunologic factors|mesh-ancestor
24718091|NCT01551823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718093|NCT01551836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24718094|NCT01551836|Analgesics|analgesics|mesh-ancestor
24718096|NCT01551836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24718097|NCT01551836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718099|NCT01552005|Saxagliptin|saxagliptin|mesh-list
24718100|NCT01552005|Incretins|incretins|mesh-ancestor
24718101|NCT01552005|Hormones|hormones|mesh-ancestor
24718102|NCT01552005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24718103|NCT01552005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718104|NCT01552005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24718115|NCT01552018|Protease Inhibitors|protease inhibitors|mesh-ancestor
24718116|NCT01552018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718117|NCT01552018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718118|NCT01552018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24718119|NCT01552044|Spironolactone|spironolactone|mesh-list
24718120|NCT01552044|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24718121|NCT01552044|Hormone Antagonists|hormone antagonists|mesh-ancestor
24718122|NCT01552044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25695420|NCT02046200|Ethanol|ethanol|mesh-list
25695421|NCT02046200|Ivermectin|ivermectin|mesh-list
24693554|NCT01421160|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24693555|NCT01421160|Chelating Agents|chelating agents|mesh-ancestor
24693556|NCT01421160|Sequestering Agents|sequestering agents|mesh-ancestor
24693557|NCT01421160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693558|NCT01421173|Gemcitabine|gemcitabine|mesh-list
24693559|NCT01421173|Dexamethasone|dexamethasone|mesh-list
24693560|NCT01421173|Dexamethasone acetate|dexamethasone acetate|mesh-list
24693561|NCT01421173|Rituximab|rituximab|mesh-list
24693562|NCT01421173|Melphalan|melphalan|mesh-list
24926913|NCT04137653|Tubulin Modulators|tubulin modulators|mesh-ancestor
24926914|NCT04137653|Antimitotic Agents|antimitotic agents|mesh-ancestor
24926915|NCT04137653|Mitosis Modulators|mitosis modulators|mesh-ancestor
24718123|NCT01552044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718124|NCT01552044|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24718125|NCT01552044|Diuretics|diuretics|mesh-ancestor
24718126|NCT01552044|Natriuretic Agents|natriuretic agents|mesh-ancestor
24718127|NCT01552122|Vitamin D|vitamin d|mesh-list
24718128|NCT01552122|Cholecalciferol|cholecalciferol|mesh-list
24718129|NCT01552122|Alendronate|alendronate|mesh-list
24718130|NCT01552122|Calcium Carbonate|calcium carbonate|mesh-list
24718131|NCT01552122|Calcium|calcium|mesh-list
24718132|NCT01552122|Vitamins|vitamins|mesh-ancestor
24718133|NCT01552122|Micronutrients|micronutrients|mesh-ancestor
24718134|NCT01552122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718135|NCT01552122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24718136|NCT01552122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24718139|NCT01552122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24718141|NCT01552148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24718142|NCT01552148|Narcotics|narcotics|mesh-ancestor
24718143|NCT01552148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24718144|NCT01552148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941703|NCT03988231|Enoxaparin|enoxaparin|mesh-list
24941704|NCT03988231|Anticoagulants|anticoagulants|mesh-ancestor
24941705|NCT03988231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24941706|NCT03988231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24941707|NCT03988231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478636|NCT00423826|Cytarabine|cytarabine|mesh-list
25050819|NCT00465959|Cholinergic Agents|cholinergic agents|mesh-ancestor
25050821|NCT00465959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050822|NCT00465959|Urological Agents|urological agents|mesh-ancestor
25050823|NCT00465803|Timolol|timolol|mesh-list
25050824|NCT00465803|Travoprost|travoprost|mesh-list
25050825|NCT00465803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25050826|NCT00465803|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25050827|NCT00465803|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25050828|NCT00465803|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25050829|NCT00465803|Adrenergic Agents|adrenergic agents|mesh-ancestor
25050830|NCT00465803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050831|NCT00465803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718157|NCT01552330|Primaquine|primaquine|mesh-list
24718158|NCT01552330|Pyronaridine|pyronaridine|mesh-list
24718159|NCT01552330|Antimalarials|antimalarials|mesh-ancestor
25050842|NCT00464633|Alvocidib|alvocidib|mesh-list
25050843|NCT00464633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855006|NCT02276859|Insulin|insulin|mesh-list
24718160|NCT01552330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24718161|NCT01552330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24718162|NCT01552330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24718163|NCT01552330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718164|NCT01552330|Antiviral Agents|antiviral agents|mesh-ancestor
24718165|NCT01552330|Schistosomicides|schistosomicides|mesh-ancestor
24718166|NCT01552330|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24718167|NCT01552330|Anthelmintics|anthelmintics|mesh-ancestor
24718168|NCT01552629|Cyclosporine|cyclosporine|mesh-list
24718169|NCT01552629|Cyclosporins|cyclosporins|mesh-list
24718170|NCT01552629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718171|NCT01552629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695422|NCT02046200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25695423|NCT02046200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25695424|NCT02046200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25695425|NCT02046200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695426|NCT02046200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25695427|NCT02046369|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25695428|NCT02046369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25695429|NCT02046369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25695430|NCT02046369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25695431|NCT02046369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718172|NCT01552629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24718173|NCT01552629|Immunologic Factors|immunologic factors|mesh-ancestor
24929718|NCT04110340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24929739|NCT04110119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24929771|NCT04109755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787508|NCT01925638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24787533|NCT01925729|Histamine Agonists|histamine agonists|mesh-ancestor
24787535|NCT01925755|Rivaroxaban|rivaroxaban|mesh-list
24718174|NCT01552629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718175|NCT01552629|Antifungal Agents|antifungal agents|mesh-ancestor
24718176|NCT01552629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24718177|NCT01552629|Dermatologic Agents|dermatologic agents|mesh-ancestor
24718178|NCT01552629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24718179|NCT01552629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24718180|NCT01552668|Fidaxomicin|fidaxomicin|mesh-list
24718181|NCT01552668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24718210|NCT01552850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24718211|NCT01552850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718212|NCT01552850|Analgesics|analgesics|mesh-ancestor
24718248|NCT01553019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718249|NCT01553019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24718250|NCT01553019|Immunologic Factors|immunologic factors|mesh-ancestor
24718251|NCT01553019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718252|NCT01553123|Ulipristal acetate|ulipristal acetate|mesh-list
24718253|NCT01553123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24718254|NCT01553123|Contraceptive Agents|contraceptive agents|mesh-ancestor
24718255|NCT01553123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24718256|NCT01553123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718257|NCT01553123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24718258|NCT01553357|Dexamethasone|dexamethasone|mesh-list
24718259|NCT01553357|Lenalidomide|lenalidomide|mesh-list
24718260|NCT01553357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24718262|NCT01553357|Autonomic Agents|autonomic agents|mesh-ancestor
24718263|NCT01553357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24718264|NCT01553357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718265|NCT01553357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24718266|NCT01553357|Glucocorticoids|glucocorticoids|mesh-ancestor
24718267|NCT01553357|Hormones|hormones|mesh-ancestor
24718268|NCT01553357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24718269|NCT01553357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24718270|NCT01553357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718271|NCT01553357|Immunologic Factors|immunologic factors|mesh-ancestor
24718272|NCT01553357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24718327|NCT01553942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718328|NCT01553942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718329|NCT01553942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718330|NCT01553942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24718331|NCT01553942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24718332|NCT01553942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24718334|NCT01553981|Vasodilator Agents|vasodilator agents|mesh-ancestor
24718335|NCT01553981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24718336|NCT01553981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24718337|NCT01553981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718338|NCT01553981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718339|NCT01553981|Urological Agents|urological agents|mesh-ancestor
24718340|NCT01554059|Bevacizumab|bevacizumab|mesh-list
24718341|NCT01554059|Oxaliplatin|oxaliplatin|mesh-list
24718342|NCT01554059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24718343|NCT01554059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718344|NCT01554059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24718345|NCT01554059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24718346|NCT01554059|Growth Substances|growth substances|mesh-ancestor
24718347|NCT01554059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718348|NCT01554059|Growth Inhibitors|growth inhibitors|mesh-ancestor
24718349|NCT01554111|Picosulfate sodium|picosulfate sodium|mesh-list
24718350|NCT01554111|Cathartics|cathartics|mesh-ancestor
24718351|NCT01554111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24718353|NCT01554124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25695432|NCT02046369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25695433|NCT02046369|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25695434|NCT02046369|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25695435|NCT02046369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25695436|NCT02046369|Adrenergic Agents|adrenergic agents|mesh-ancestor
25695437|NCT02046369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24718354|NCT01554124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24693925|NCT01422954|Mefloquine|mefloquine|mesh-list
24441601|NCT00287924|Abortifacient Agents|abortifacient agents|mesh-ancestor
24441605|NCT00287924|Antimetabolites|antimetabolites|mesh-ancestor
24441624|NCT00287937|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24441625|NCT00287937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441627|NCT00287950|Carboplatin|carboplatin|mesh-list
24441628|NCT00287950|Etoposide|etoposide|mesh-list
24441629|NCT00287950|Vincristine|vincristine|mesh-list
24441630|NCT00287950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24441631|NCT00287950|Immunologic Factors|immunologic factors|mesh-ancestor
24441632|NCT00287950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441633|NCT00287950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24441649|NCT00287963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24441650|NCT00287963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718355|NCT01554254|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
24718356|NCT01554254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24718357|NCT01554254|Vasodilator Agents|vasodilator agents|mesh-ancestor
24718358|NCT01554345|Vitamin E|vitamin e|mesh-list
24718359|NCT01554345|Selenium|selenium|mesh-list
24718360|NCT01554345|Vitamins|vitamins|mesh-ancestor
24505233|NCT00540605|Tenofovir|tenofovir|mesh-list
24718361|NCT01554345|Micronutrients|micronutrients|mesh-ancestor
24718362|NCT01554345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615181|NCT01028313|Prednisolone acetate|prednisolone acetate|mesh-list
24615182|NCT01028313|Panobinostat|panobinostat|mesh-list
24615183|NCT01028313|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24615184|NCT01028313|Prednisolone phosphate|prednisolone phosphate|mesh-list
24615185|NCT01028313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24615186|NCT01028313|Antiemetics|antiemetics|mesh-ancestor
24615187|NCT01028313|Autonomic Agents|autonomic agents|mesh-ancestor
24615188|NCT01028313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24615189|NCT01028313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615190|NCT01028313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25050851|NCT00464555|Lisofylline|lisofylline|mesh-list
25050852|NCT00464555|Tacrolimus|tacrolimus|mesh-list
25050853|NCT00464555|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25050854|NCT00464555|Basiliximab|basiliximab|mesh-list
24615191|NCT01028313|Glucocorticoids|glucocorticoids|mesh-ancestor
24615192|NCT01028313|Hormones|hormones|mesh-ancestor
24615193|NCT01028313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24615194|NCT01028313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24615195|NCT01028313|Protective Agents|protective agents|mesh-ancestor
24615196|NCT01028313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24615197|NCT01028313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24615198|NCT01028313|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24615199|NCT01028313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615200|NCT01028313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615202|NCT01028339|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24615203|NCT01028339|Diuretics|diuretics|mesh-ancestor
24615204|NCT01028339|Natriuretic Agents|natriuretic agents|mesh-ancestor
24615206|NCT01028404|Insulin|insulin|mesh-list
24441651|NCT00287963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441652|NCT00287963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441653|NCT00287963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24441654|NCT00287963|Tubulin Modulators|tubulin modulators|mesh-ancestor
24615220|NCT01028443|Immunologic Factors|immunologic factors|mesh-ancestor
24615221|NCT01028443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615222|NCT01028443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24615223|NCT01028443|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24615224|NCT01028482|Sertraline|sertraline|mesh-list
24615225|NCT01028482|Antidepressive Agents|antidepressive agents|mesh-ancestor
24615226|NCT01028482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24615227|NCT01028482|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24615228|NCT01028482|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24615229|NCT01028482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24615245|NCT01028508|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24615246|NCT01028508|Antidepressive Agents|antidepressive agents|mesh-ancestor
24615247|NCT01028508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24615248|NCT01028508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718366|NCT01554345|Trace Elements|trace elements|mesh-ancestor
24718367|NCT01554397|Cisplatin|cisplatin|mesh-list
24718368|NCT01554397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718369|NCT01554540|Treprostinil|treprostinil|mesh-list
24718370|NCT01554540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24718371|NCT01554592|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
24718372|NCT01554592|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24718404|NCT01554852|Immunologic Factors|immunologic factors|mesh-ancestor
25695438|NCT02046369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695439|NCT02046369|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25695441|NCT02046369|Serotonin Agents|serotonin agents|mesh-ancestor
25695442|NCT02046369|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24694240|NCT01424618|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24931705|NCT04085913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24931991|NCT04083209|Sensory System Agents|sensory system agents|mesh-ancestor
24746919|NCT02679144|Eflornithine|eflornithine|mesh-list
25109593|NCT03122561|Antipyretics|antipyretics|mesh-ancestor
24718405|NCT01554852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718406|NCT01554852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24718407|NCT01554852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24718408|NCT01554852|Alkylating Agents|alkylating agents|mesh-ancestor
24718409|NCT01554852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718410|NCT01554852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718411|NCT01554852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24718412|NCT01554852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24718413|NCT01554852|Antiemetics|antiemetics|mesh-ancestor
24718435|NCT01554930|Antibodies|antibodies|mesh-list
24718436|NCT01554930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24718462|NCT01554995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24718463|NCT01554995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24718464|NCT01554995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24718465|NCT01554995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050855|NCT00464555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25050856|NCT00464555|Immunologic Factors|immunologic factors|mesh-ancestor
25050857|NCT00464555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050858|NCT00464555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25050859|NCT00464555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050860|NCT00464555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050861|NCT00464555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25050862|NCT00464555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25050863|NCT00464555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25050864|NCT00464555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050865|NCT00464555|Antifungal Agents|antifungal agents|mesh-ancestor
25050866|NCT00464555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24718502|NCT01555190|Vitamins|vitamins|mesh-ancestor
24718509|NCT01555216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718510|NCT01555216|Sensory System Agents|sensory system agents|mesh-ancestor
24718511|NCT01555216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24505393|NCT00541086|Tamoxifen|tamoxifen|mesh-list
24718527|NCT01555398|Fenofibric acid|fenofibric acid|mesh-list
24718528|NCT01555398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25050871|NCT00464555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25050872|NCT00464555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24718533|NCT01555476|Ibuprofen|ibuprofen|mesh-list
24718534|NCT01555476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24718535|NCT01555476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24718536|NCT01555476|Analgesics|analgesics|mesh-ancestor
24718537|NCT01555476|Sensory System Agents|sensory system agents|mesh-ancestor
24718538|NCT01555476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24718539|NCT01555476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718540|NCT01555476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24718541|NCT01555476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24718542|NCT01555476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24718543|NCT01555476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718544|NCT01555476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718545|NCT01555580|Molgramostim|molgramostim|mesh-list
24718546|NCT01555580|Sargramostim|sargramostim|mesh-list
24718555|NCT01555632|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24718556|NCT01555632|Antimetabolites|antimetabolites|mesh-ancestor
24718557|NCT01555632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718558|NCT01555632|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24718559|NCT01555632|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24718560|NCT01555632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718561|NCT01555658|Heparin|heparin|mesh-list
24718562|NCT01555658|Bivalirudin|bivalirudin|mesh-list
24718565|NCT01555658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25695443|NCT02046369|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25695444|NCT02046369|Dopamine Agents|dopamine agents|mesh-ancestor
25695445|NCT02046382|Acetaminophen|acetaminophen|mesh-list
25695446|NCT02046382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25695447|NCT02046382|Analgesics|analgesics|mesh-ancestor
24718566|NCT01555658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718567|NCT01555658|Antithrombins|antithrombins|mesh-ancestor
24718568|NCT01555658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24718571|NCT01555710|Carboplatin|carboplatin|mesh-list
24718623|NCT01555970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718624|NCT01555970|Antidotes|antidotes|mesh-ancestor
24718625|NCT01556035|Lenalidomide|lenalidomide|mesh-list
24718626|NCT01556035|Immunologic Factors|immunologic factors|mesh-ancestor
24718627|NCT01556035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718628|NCT01556035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24718629|NCT01556035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24718630|NCT01556035|Growth Substances|growth substances|mesh-ancestor
24718631|NCT01556035|Growth Inhibitors|growth inhibitors|mesh-ancestor
24718632|NCT01556035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718633|NCT01556191|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24718634|NCT01556191|Fulvestrant|fulvestrant|mesh-list
24718635|NCT01556191|Gefitinib|gefitinib|mesh-list
24718636|NCT01556191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718637|NCT01556191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24718638|NCT01556191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718639|NCT01556191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718640|NCT01556191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24718641|NCT01556191|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24718642|NCT01556191|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25050873|NCT00464555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25050874|NCT00464243|Volinanserin|volinanserin|mesh-list
25050875|NCT00464243|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24718643|NCT01556191|Hormone Antagonists|hormone antagonists|mesh-ancestor
24718644|NCT01556191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24718645|NCT01556191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718646|NCT01556321|Caffeine|caffeine|mesh-list
24718647|NCT01556321|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24718648|NCT01556321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718649|NCT01556321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24718650|NCT01556321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718651|NCT01556321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718670|NCT01556477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718671|NCT01556477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24718672|NCT01556477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24718673|NCT01556477|Growth Substances|growth substances|mesh-ancestor
24718674|NCT01556477|Growth Inhibitors|growth inhibitors|mesh-ancestor
24718675|NCT01556477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718676|NCT01556477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24718677|NCT01556477|Antimetabolites|antimetabolites|mesh-ancestor
24718678|NCT01556477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718679|NCT01556477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718680|NCT01556529|Unithiol|unithiol|mesh-list
24718681|NCT01556529|Antidotes|antidotes|mesh-ancestor
24718682|NCT01556529|Protective Agents|protective agents|mesh-ancestor
24718683|NCT01556529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718684|NCT01556529|Chelating Agents|chelating agents|mesh-ancestor
24718685|NCT01556529|Sequestering Agents|sequestering agents|mesh-ancestor
24718686|NCT01556529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718687|NCT01556542|Paclitaxel|paclitaxel|mesh-list
24718688|NCT01556542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24718689|NCT01556542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718690|NCT01556542|Tubulin Modulators|tubulin modulators|mesh-ancestor
24718696|NCT01556646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718697|NCT01556646|Natriuretic Agents|natriuretic agents|mesh-ancestor
24718698|NCT01556646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718699|NCT01556659|Acenocoumarol|acenocoumarol|mesh-list
24718700|NCT01556659|Anticoagulants|anticoagulants|mesh-ancestor
24718701|NCT01556672|Adalimumab|adalimumab|mesh-list
24718702|NCT01556672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24718703|NCT01556672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24718704|NCT01556698|Nitric Oxide|nitric oxide|mesh-list
24718718|NCT01556698|Protective Agents|protective agents|mesh-ancestor
24718719|NCT01556737|Genistein|genistein|mesh-list
24718720|NCT01556737|Daidzein|daidzein|mesh-list
24718721|NCT01556737|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24718722|NCT01556737|Protective Agents|protective agents|mesh-ancestor
24718723|NCT01556737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718725|NCT01556737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24718726|NCT01556737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24957734|NCT03842046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934091|NCT04063904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24934093|NCT04063904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24934120|NCT04063527|Carboplatin|carboplatin|mesh-list
24934121|NCT04063527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24957735|NCT03842046|Protective Agents|protective agents|mesh-ancestor
24957737|NCT03842020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24957738|NCT03842020|Vasodilator Agents|vasodilator agents|mesh-ancestor
24718746|NCT01556867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24505679|NCT00541918|Propofol|propofol|mesh-list
24718747|NCT01557075|Atorvastatin|atorvastatin|mesh-list
24718748|NCT01557075|Pravastatin|pravastatin|mesh-list
24718749|NCT01557075|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
24718750|NCT01557075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24718751|NCT01557075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24718752|NCT01557075|Antimetabolites|antimetabolites|mesh-ancestor
24718753|NCT01557075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718754|NCT01557075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24718755|NCT01557075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718756|NCT01557114|Ipilimumab|ipilimumab|mesh-list
24718757|NCT01557114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24718758|NCT01557114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718759|NCT01557114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24718760|NCT01557114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718775|NCT01557140|Protective Agents|protective agents|mesh-ancestor
24718776|NCT01557140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24718777|NCT01557140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24718778|NCT01557140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24718779|NCT01557140|Vasodilator Agents|vasodilator agents|mesh-ancestor
24718780|NCT01557140|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24718781|NCT01557140|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24718782|NCT01557153|Amlodipine|amlodipine|mesh-list
24718783|NCT01557153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24718784|NCT01557153|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24718785|NCT01557153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24718786|NCT01557153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718787|NCT01557153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24718788|NCT01557153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718789|NCT01557153|Vasodilator Agents|vasodilator agents|mesh-ancestor
24718790|NCT01557257|Naltrexone|naltrexone|mesh-list
24718791|NCT01557257|Oxycodone|oxycodone|mesh-list
24718792|NCT01557257|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24718793|NCT01557257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24718794|NCT01557257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718795|NCT01557257|Sensory System Agents|sensory system agents|mesh-ancestor
24718796|NCT01557257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24615250|NCT01028508|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24615251|NCT01028508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24615252|NCT01028508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24615253|NCT01028508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24615254|NCT01028508|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24615255|NCT01028534|Olmesartan|olmesartan|mesh-list
24505758|NCT00542295|Mebeverine|mebeverine|mesh-list
24718811|NCT01557270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24718812|NCT01557270|Adrenergic Agents|adrenergic agents|mesh-ancestor
24718813|NCT01557270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24957739|NCT03842020|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24957740|NCT03842020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24466618|NCT00374348|Aripiprazole|aripiprazole|mesh-list
24957744|NCT03842020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24957745|NCT03842020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855048|NCT02276989|Analgesics|analgesics|mesh-ancestor
24718814|NCT01557270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718815|NCT01557335|Aspirin|aspirin|mesh-list
24718816|NCT01557335|Omeprazole|omeprazole|mesh-list
24718817|NCT01557335|Clopidogrel|clopidogrel|mesh-list
24718818|NCT01557335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24718819|NCT01557335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24718820|NCT01557335|Analgesics|analgesics|mesh-ancestor
25695448|NCT02046382|Sensory System Agents|sensory system agents|mesh-ancestor
25695449|NCT02046382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25695450|NCT02046382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695451|NCT02046382|Antipyretics|antipyretics|mesh-ancestor
25695452|NCT02046603|Methotrexate|methotrexate|mesh-list
25004618|NCT02654132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25004619|NCT02654132|Antiemetics|antiemetics|mesh-ancestor
25004620|NCT02654132|Autonomic Agents|autonomic agents|mesh-ancestor
25004621|NCT02654132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25004622|NCT02654132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004623|NCT02654132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24787692|NCT01926587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787693|NCT01926587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718821|NCT01557335|Sensory System Agents|sensory system agents|mesh-ancestor
24718822|NCT01557335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24718823|NCT01557335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718824|NCT01557335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24718825|NCT01557335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24718827|NCT01557335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24718828|NCT01557335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718829|NCT01557335|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24718830|NCT01557335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24718831|NCT01557335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718833|NCT01557335|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24718834|NCT01557335|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24804825|NCT02005523|RNS60|rns60|mesh-list
24441655|NCT00287963|Antimitotic Agents|antimitotic agents|mesh-ancestor
24441656|NCT00287963|Mitosis Modulators|mitosis modulators|mesh-ancestor
24441657|NCT00287976|Irinotecan|irinotecan|mesh-list
24441658|NCT00287976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24718835|NCT01557335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24718836|NCT01557335|Purinergic Agents|purinergic agents|mesh-ancestor
24718837|NCT01557335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24718838|NCT01557335|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24718839|NCT01557335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24835997|NCT02183701|Diuretics|diuretics|mesh-ancestor
24718840|NCT01557335|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24718842|NCT01557374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24718843|NCT01557374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718859|NCT01557478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718860|NCT01557478|Protective Agents|protective agents|mesh-ancestor
24718879|NCT01557712|Anesthetics|anesthetics|mesh-ancestor
24718880|NCT01557712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24718881|NCT01557712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24718882|NCT01557712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24718883|NCT01557712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24718884|NCT01557712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718885|NCT01557712|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24718886|NCT01557712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24718887|NCT01557712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24718888|NCT01557712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24718889|NCT01557712|Antidepressive Agents|antidepressive agents|mesh-ancestor
24718926|NCT01557985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24718927|NCT01557985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718928|NCT01557985|Sensory System Agents|sensory system agents|mesh-ancestor
24718929|NCT01557985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24718931|NCT01558011|Capecitabine|capecitabine|mesh-list
24718932|NCT01558011|Oxaliplatin|oxaliplatin|mesh-list
24718933|NCT01558011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718934|NCT01558011|Tubulin Modulators|tubulin modulators|mesh-ancestor
24718935|NCT01558011|Antimitotic Agents|antimitotic agents|mesh-ancestor
24718936|NCT01558011|Mitosis Modulators|mitosis modulators|mesh-ancestor
24718991|NCT01558466|Vasodilator Agents|vasodilator agents|mesh-ancestor
24718992|NCT01558466|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24718993|NCT01558466|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25695453|NCT02046603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25695454|NCT02046603|Abortifacient Agents|abortifacient agents|mesh-ancestor
25695455|NCT02046603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25695456|NCT02046603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695457|NCT02046603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25695458|NCT02046603|Antimetabolites|antimetabolites|mesh-ancestor
25695459|NCT02046603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24670871|NCT01457781|Nitric Oxide|nitric oxide|mesh-list
24670872|NCT01457781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24670873|NCT01457781|Autonomic Agents|autonomic agents|mesh-ancestor
24718994|NCT01558466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25695460|NCT02046603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25695461|NCT02046603|Dermatologic Agents|dermatologic agents|mesh-ancestor
24718995|NCT01558466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719068|NCT01558960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24719069|NCT01558960|Alkylating Agents|alkylating agents|mesh-ancestor
24719070|NCT01558960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719071|NCT01558960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719072|NCT01558960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24719073|NCT01558960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24719074|NCT01558960|Immunologic Factors|immunologic factors|mesh-ancestor
24719075|NCT01558960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719076|NCT01558986|Cefazolin|cefazolin|mesh-list
24719077|NCT01558986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24719078|NCT01558986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24719079|NCT01559025|Vildagliptin|vildagliptin|mesh-list
24719080|NCT01559025|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24719081|NCT01559025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24719082|NCT01559025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719083|NCT01559025|Protease Inhibitors|protease inhibitors|mesh-ancestor
24719104|NCT01559272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24719105|NCT01559272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719109|NCT01559272|Serotonin Agents|serotonin agents|mesh-ancestor
24719110|NCT01559272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24719111|NCT01559272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719112|NCT01559272|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24719113|NCT01559272|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24719114|NCT01559272|Dopamine Agents|dopamine agents|mesh-ancestor
24941728|NCT03988452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941730|NCT03988452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24941731|NCT03988452|Antiviral Agents|antiviral agents|mesh-ancestor
24719116|NCT01559285|Anesthetics, Local|anesthetics, local|mesh-ancestor
24506133|NCT00544193|Gemcitabine|gemcitabine|mesh-list
24719118|NCT01559285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24719119|NCT01559285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719123|NCT01559298|Clopidogrel|clopidogrel|mesh-list
24719158|NCT01559545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24719159|NCT01559545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24719160|NCT01559545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24719161|NCT01559584|Triamcinolone|triamcinolone|mesh-list
24719170|NCT01559584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24719171|NCT01559584|Immunologic Factors|immunologic factors|mesh-ancestor
24719172|NCT01559584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615256|NCT01028534|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24615257|NCT01028534|Calcium Channel Blockers|calcium channel blockers|mesh-list
24719250|NCT01560091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24719251|NCT01560091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719252|NCT01560091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719253|NCT01560091|Urological Agents|urological agents|mesh-ancestor
24719255|NCT01560117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24719256|NCT01560117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719261|NCT01560221|Methadone|methadone|mesh-list
24719262|NCT01560221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24719263|NCT01560221|Narcotics|narcotics|mesh-ancestor
24719264|NCT01560221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24719265|NCT01560221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719266|NCT01560221|Analgesics|analgesics|mesh-ancestor
24719267|NCT01560221|Sensory System Agents|sensory system agents|mesh-ancestor
24719268|NCT01560221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24719269|NCT01560221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24719270|NCT01560221|Antitussive Agents|antitussive agents|mesh-ancestor
24719271|NCT01560221|Respiratory System Agents|respiratory system agents|mesh-ancestor
24719272|NCT01560299|Methimazole|methimazole|mesh-list
24719273|NCT01560299|Antithyroid Agents|antithyroid agents|mesh-ancestor
24719274|NCT01560299|Hormone Antagonists|hormone antagonists|mesh-ancestor
24719275|NCT01560299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24719276|NCT01560299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695462|NCT02046603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25695463|NCT02046603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24719306|NCT01560546|Testosterone|testosterone|mesh-list
24719307|NCT01560546|Androgens|androgens|mesh-ancestor
24719308|NCT01560546|Hormones|hormones|mesh-ancestor
24719315|NCT01560663|Antimitotic Agents|antimitotic agents|mesh-ancestor
24719316|NCT01560663|Mitosis Modulators|mitosis modulators|mesh-ancestor
24719317|NCT01560663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719318|NCT01560689|Budesonide|budesonide|mesh-list
24719319|NCT01560689|Formoterol Fumarate|formoterol fumarate|mesh-list
24719320|NCT01560689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24719321|NCT01560689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24719322|NCT01560689|Autonomic Agents|autonomic agents|mesh-ancestor
24719323|NCT01560689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24719324|NCT01560689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719325|NCT01560689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24719326|NCT01560689|Respiratory System Agents|respiratory system agents|mesh-ancestor
24719327|NCT01560689|Glucocorticoids|glucocorticoids|mesh-ancestor
24719328|NCT01560689|Hormones|hormones|mesh-ancestor
24719329|NCT01560689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24719332|NCT01560689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24719349|NCT01560702|Mydriatics|mydriatics|mesh-ancestor
24941736|NCT03988452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24941738|NCT03988452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24941739|NCT03988452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24719351|NCT01560702|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24719352|NCT01560754|Nicotine|nicotine|mesh-list
24719353|NCT01560754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24719354|NCT01560754|Autonomic Agents|autonomic agents|mesh-ancestor
24719355|NCT01560754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24719356|NCT01560754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719357|NCT01560754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24719358|NCT01560754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24719382|NCT01561014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24719384|NCT01561014|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24719385|NCT01561040|Vitamin D|vitamin d|mesh-list
24719386|NCT01561040|Vitamin A|vitamin a|mesh-list
24719387|NCT01561040|Vitamins|vitamins|mesh-ancestor
24719388|NCT01561040|Micronutrients|micronutrients|mesh-ancestor
24719389|NCT01561040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719390|NCT01561040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24719391|NCT01561066|Octreotide|octreotide|mesh-list
24719392|NCT01561066|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24719400|NCT01561092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24719401|NCT01561092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24719402|NCT01561092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719403|NCT01561092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24719404|NCT01561092|Serotonin Agents|serotonin agents|mesh-ancestor
24941741|NCT03988101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24941742|NCT03988101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25695464|NCT02046603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25695465|NCT02046603|Immunologic Factors|immunologic factors|mesh-ancestor
25695466|NCT02046603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25695467|NCT02046603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25695468|NCT02046616|Methotrexate|methotrexate|mesh-list
25695469|NCT02046616|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25695470|NCT02046616|Abortifacient Agents|abortifacient agents|mesh-ancestor
25695471|NCT02046616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25695472|NCT02046616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941743|NCT03988101|Antimetabolites|antimetabolites|mesh-ancestor
24941744|NCT03988101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695473|NCT02046616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24469471|NCT00385970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469472|NCT00385970|Antidotes|antidotes|mesh-ancestor
24518597|NCT04786275|Anesthetics|anesthetics|mesh-ancestor
24941745|NCT03988101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24941746|NCT03988101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24941747|NCT03988101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24941748|NCT03988010|Amantadine|amantadine|mesh-list
24941749|NCT03988010|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24941750|NCT03988010|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24941751|NCT03988010|Antiviral Agents|antiviral agents|mesh-ancestor
24941752|NCT03988010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24941753|NCT03988010|Dopamine Agents|dopamine agents|mesh-ancestor
24941754|NCT03988010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24719420|NCT01561209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719421|NCT01561209|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24719422|NCT01561209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24836136|NCT02184260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719423|NCT01561209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24719424|NCT01561209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719425|NCT01561209|Adrenergic Agents|adrenergic agents|mesh-ancestor
24719426|NCT01561209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24719427|NCT01561222|Calcitriol|calcitriol|mesh-list
24719428|NCT01561222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24719429|NCT01561222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719430|NCT01561222|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24719431|NCT01561222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24719432|NCT01561222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719464|NCT01561482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24719465|NCT01561482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24719466|NCT01561482|Antimetabolites|antimetabolites|mesh-ancestor
24719467|NCT01561482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719468|NCT01561482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24719469|NCT01561482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24719470|NCT01561482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24719471|NCT01561508|Butyric Acid|butyric acid|mesh-list
24719472|NCT01561508|Histamine Antagonists|histamine antagonists|mesh-ancestor
24719473|NCT01561508|Histamine Agents|histamine agents|mesh-ancestor
24719522|NCT01562210|Olaparib|olaparib|mesh-list
24719523|NCT01562210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719524|NCT01562210|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24941755|NCT03988010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941756|NCT03988010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941757|NCT03988010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24493066|NCT00489385|Ribavirin|ribavirin|mesh-list
24719525|NCT01562210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24719526|NCT01562210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719527|NCT01562223|Motexafin gadolinium|motexafin gadolinium|mesh-list
24719528|NCT01562223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719529|NCT01562223|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24719530|NCT01562223|Dermatologic Agents|dermatologic agents|mesh-ancestor
24719531|NCT01562301|Carboplatin|carboplatin|mesh-list
24719532|NCT01562301|Docetaxel|docetaxel|mesh-list
24719533|NCT01562301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719534|NCT01562301|Tubulin Modulators|tubulin modulators|mesh-ancestor
24646104|NCT01202084|Autonomic Agents|autonomic agents|mesh-ancestor
24719556|NCT01562405|Growth Inhibitors|growth inhibitors|mesh-ancestor
24719558|NCT01562483|Hallucinogens|hallucinogens|mesh-ancestor
24719559|NCT01562483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719560|NCT01562483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24719561|NCT01562483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24719562|NCT01562483|Analgesics|analgesics|mesh-ancestor
24719563|NCT01562483|Sensory System Agents|sensory system agents|mesh-ancestor
24719564|NCT01562483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24719565|NCT01562483|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24719566|NCT01562483|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24719567|NCT01562483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24719568|NCT01562483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719569|NCT01562483|Hormones|hormones|mesh-ancestor
25695474|NCT02046616|Antimetabolites|antimetabolites|mesh-ancestor
25695475|NCT02046616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695476|NCT02046616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694966|NCT04930042|Dermatologic Agents|dermatologic agents|mesh-ancestor
24480484|NCT00431145|Niacin|niacin|mesh-list
24694967|NCT04850378|Dalteparin|dalteparin|mesh-list
24694968|NCT04850378|Tinzaparin|tinzaparin|mesh-list
24719570|NCT01562483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24719571|NCT01562561|Repaglinide|repaglinide|mesh-list
24719572|NCT01562561|Isophane Insulin, Human|isophane insulin, human|mesh-list
24615285|NCT01028638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24615286|NCT01028638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24615287|NCT01028638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24615288|NCT01028638|Growth Substances|growth substances|mesh-ancestor
24615289|NCT01028638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719593|NCT01562717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24719594|NCT01562717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24719595|NCT01562717|Analgesics|analgesics|mesh-ancestor
24719596|NCT01562717|Sensory System Agents|sensory system agents|mesh-ancestor
24719599|NCT01562717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24719627|NCT01562808|Serotonin Agents|serotonin agents|mesh-ancestor
24719628|NCT01562808|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24719629|NCT01562808|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24719630|NCT01562808|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24719631|NCT01562808|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24719632|NCT01562951|Adalimumab|adalimumab|mesh-list
24719635|NCT01562977|Gemcitabine|gemcitabine|mesh-list
24941760|NCT03988010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24941761|NCT03987867|Paclitaxel|paclitaxel|mesh-list
24941762|NCT03987867|Carboplatin|carboplatin|mesh-list
24719639|NCT01562977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719640|NCT01562977|Immunologic Factors|immunologic factors|mesh-ancestor
24719641|NCT01562977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719642|NCT01562977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24719643|NCT01562977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24719644|NCT01562977|Antimetabolites|antimetabolites|mesh-ancestor
24719645|NCT01562977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719646|NCT01562977|Antiviral Agents|antiviral agents|mesh-ancestor
24719647|NCT01562977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24719648|NCT01562977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24719649|NCT01562977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24719650|NCT01562990|Gemcitabine|gemcitabine|mesh-list
24719651|NCT01562990|Rituximab|rituximab|mesh-list
24719684|NCT01563289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24719686|NCT01563289|Analgesics|analgesics|mesh-ancestor
24719687|NCT01563289|Sensory System Agents|sensory system agents|mesh-ancestor
24719688|NCT01563289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24719689|NCT01563289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719690|NCT01563289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24719691|NCT01563289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24719735|NCT01563718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719736|NCT01563718|Sensory System Agents|sensory system agents|mesh-ancestor
24719765|NCT01563939|Sensory System Agents|sensory system agents|mesh-ancestor
24719766|NCT01563939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24719767|NCT01563952|Sirolimus|sirolimus|mesh-list
24719768|NCT01563952|Umirolimus|umirolimus|mesh-list
24719769|NCT01563952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24719770|NCT01563952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24719771|NCT01563952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24719772|NCT01563952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719773|NCT01563952|Antifungal Agents|antifungal agents|mesh-ancestor
24719774|NCT01563952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24719775|NCT01563952|Immunologic Factors|immunologic factors|mesh-ancestor
24719776|NCT01563952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719777|NCT01563952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24719778|NCT01564095|Tryptophan|tryptophan|mesh-list
24719779|NCT01564095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24719780|NCT01564095|Tacrolimus|tacrolimus|mesh-list
24719781|NCT01564095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24719782|NCT01564095|Immunologic Factors|immunologic factors|mesh-ancestor
24941763|NCT03987867|Pemetrexed|pemetrexed|mesh-list
24941764|NCT03987867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24941765|NCT03987867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24941766|NCT03987867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941767|NCT03987867|Tubulin Modulators|tubulin modulators|mesh-ancestor
25695477|NCT02046616|Dermatologic Agents|dermatologic agents|mesh-ancestor
25695478|NCT02046616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25695479|NCT02046616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24941768|NCT03987867|Antimitotic Agents|antimitotic agents|mesh-ancestor
24941769|NCT03987867|Mitosis Modulators|mitosis modulators|mesh-ancestor
24855090|NCT02277184|Cisplatin|cisplatin|mesh-list
24477401|NCT00418496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24477402|NCT00418509|Mometasone Furoate|mometasone furoate|mesh-list
24477403|NCT00418509|Formoterol Fumarate|formoterol fumarate|mesh-list
24477404|NCT00418509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24456971|NCT00332787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24456972|NCT00332787|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24456973|NCT00332787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24456974|NCT00332787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855092|NCT02277197|Cetuximab|cetuximab|mesh-list
24719783|NCT01564095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719784|NCT01564095|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24719815|NCT01564238|Calcium, Dietary|calcium, dietary|mesh-list
24719816|NCT01564238|Calcium|calcium|mesh-list
24719817|NCT01564238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24719818|NCT01564238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719819|NCT01564238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24719820|NCT01564251|Gemcitabine|gemcitabine|mesh-list
24719821|NCT01564251|GDC-0575|gdc-0575|mesh-list
24719822|NCT01564251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24719823|NCT01564251|Antimetabolites|antimetabolites|mesh-ancestor
24719824|NCT01564251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719825|NCT01564251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719830|NCT01564251|Immunologic Factors|immunologic factors|mesh-ancestor
24719831|NCT01564251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719832|NCT01564251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24719833|NCT01564303|Acetylcysteine|acetylcysteine|mesh-list
24719834|NCT01564303|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24719835|NCT01564303|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
24719836|NCT01564303|Antiviral Agents|antiviral agents|mesh-ancestor
24719837|NCT01564303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24719838|NCT01564303|Expectorants|expectorants|mesh-ancestor
24719839|NCT01564303|Respiratory System Agents|respiratory system agents|mesh-ancestor
24719840|NCT01564303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24719841|NCT01564303|Antioxidants|antioxidants|mesh-ancestor
24719842|NCT01564303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719843|NCT01564303|Protective Agents|protective agents|mesh-ancestor
24719844|NCT01564303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719851|NCT01564329|Growth Substances|growth substances|mesh-ancestor
24719852|NCT01564329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719853|NCT01564329|Growth Inhibitors|growth inhibitors|mesh-ancestor
24941793|NCT03988075|Respiratory System Agents|respiratory system agents|mesh-ancestor
24941794|NCT03987776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24941795|NCT03988036|Pembrolizumab|pembrolizumab|mesh-list
24941796|NCT03988036|Trastuzumab|trastuzumab|mesh-list
24941798|NCT03988036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24941799|NCT03988036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941800|NCT03988114|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24941801|NCT03988114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24941802|NCT03988114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812668|NCT02053974|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24719866|NCT01564381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24719867|NCT01564381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24719868|NCT01564550|Insulin|insulin|mesh-list
24836197|NCT02184351|Clotrimazole|clotrimazole|mesh-list
24719869|NCT01564550|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24719870|NCT01564550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24719871|NCT01564550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719872|NCT01564576|Bromides|bromides|mesh-list
24719873|NCT01564576|Rocuronium|rocuronium|mesh-list
24719874|NCT01564576|Anticonvulsants|anticonvulsants|mesh-ancestor
24719875|NCT01564576|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24719876|NCT01564576|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24719877|NCT01564576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24719964|NCT01565265|Hormones|hormones|mesh-ancestor
24719878|NCT01564576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25695480|NCT02046616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25695481|NCT02046616|Immunologic Factors|immunologic factors|mesh-ancestor
25695482|NCT02046616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25695483|NCT02046616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25695484|NCT02046772|Morphine|morphine|mesh-list
25695485|NCT02046772|Bupivacaine|bupivacaine|mesh-list
25695486|NCT02046772|Anesthetics, Local|anesthetics, local|mesh-ancestor
25695487|NCT02046772|Anesthetics|anesthetics|mesh-ancestor
25695488|NCT02046772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24719879|NCT01564576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719880|NCT01564680|Acetaminophen|acetaminophen|mesh-list
24719881|NCT01564680|Lornoxicam|lornoxicam|mesh-list
24719896|NCT01564823|Azathioprine|azathioprine|mesh-list
24719897|NCT01564823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24719898|NCT01564823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24719899|NCT01564823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24719900|NCT01564823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24719902|NCT01564823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24719903|NCT01564823|Antimetabolites|antimetabolites|mesh-ancestor
24719904|NCT01564823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719912|NCT01564836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24719913|NCT01564836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24719914|NCT01564836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719915|NCT01564979|Botulinum Toxins|botulinum toxins|mesh-list
24719916|NCT01564979|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24719931|NCT01565018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719935|NCT01565096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24719936|NCT01565096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719937|NCT01565096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24719938|NCT01565096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24719939|NCT01565096|Immunologic Factors|immunologic factors|mesh-ancestor
24719940|NCT01565096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24719941|NCT01565096|Protease Inhibitors|protease inhibitors|mesh-ancestor
24719942|NCT01565096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615291|NCT01028638|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24615292|NCT01028638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615293|NCT01028729|Gemcitabine|gemcitabine|mesh-list
24615294|NCT01028729|Endostar protein|endostar protein|mesh-list
24615295|NCT01028729|Endostatins|endostatins|mesh-list
24615296|NCT01028729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941803|NCT03988114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941804|NCT03988114|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24941805|NCT03988114|Hormone Antagonists|hormone antagonists|mesh-ancestor
24941806|NCT03988114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24957822|NCT03841474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24957823|NCT03841474|Antidepressive Agents|antidepressive agents|mesh-ancestor
24615311|NCT01028768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24615312|NCT01028768|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24615313|NCT01028768|Protective Agents|protective agents|mesh-ancestor
24615314|NCT01028768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615315|NCT01028781|Thalidomide|thalidomide|mesh-list
24615316|NCT01028781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24615319|NCT01028781|Leprostatic Agents|leprostatic agents|mesh-ancestor
24615322|NCT01028781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24615323|NCT01028781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24615324|NCT01028781|Growth Substances|growth substances|mesh-ancestor
24615339|NCT01028950|Protease Inhibitors|protease inhibitors|mesh-ancestor
24615340|NCT01028950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615341|NCT01028950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615342|NCT01028950|Anticoagulants|anticoagulants|mesh-ancestor
24615343|NCT01028963|Pioglitazone|pioglitazone|mesh-list
24615344|NCT01028963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24615345|NCT01028963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615346|NCT01028976|Ascorbic Acid|ascorbic acid|mesh-list
24615347|NCT01028976|Vitamins|vitamins|mesh-ancestor
24615348|NCT01028976|Micronutrients|micronutrients|mesh-ancestor
24615349|NCT01028976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615350|NCT01028976|Antioxidants|antioxidants|mesh-ancestor
24615351|NCT01028976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615352|NCT01028976|Protective Agents|protective agents|mesh-ancestor
24719946|NCT01565109|Tubulin Modulators|tubulin modulators|mesh-ancestor
24719957|NCT01565200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719958|NCT01565239|Thrombin|thrombin|mesh-list
24719959|NCT01565239|Hemostatics|hemostatics|mesh-ancestor
24719960|NCT01565239|Coagulants|coagulants|mesh-ancestor
24719961|NCT01565265|Cetrorelix|cetrorelix|mesh-list
24719962|NCT01565265|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25695489|NCT02046772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695490|NCT02046772|Sensory System Agents|sensory system agents|mesh-ancestor
24719963|NCT01565265|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24719965|NCT01565265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24719966|NCT01565265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719967|NCT01565265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24719981|NCT01565512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24719982|NCT01565590|Dexmedetomidine|dexmedetomidine|mesh-list
24719983|NCT01565590|Propofol|propofol|mesh-list
24719984|NCT01565590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24719994|NCT01565590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24719995|NCT01565590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24719996|NCT01565590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24719997|NCT01565590|Adrenergic Agents|adrenergic agents|mesh-ancestor
24719998|NCT01565590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24719999|NCT01565590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720001|NCT01565720|Isavuconazole|isavuconazole|mesh-list
24720002|NCT01565720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24720003|NCT01565720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24720004|NCT01565720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24720005|NCT01565720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24720035|NCT01565798|Micronutrients|micronutrients|mesh-ancestor
24720036|NCT01565798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720037|NCT01565837|Ipilimumab|ipilimumab|mesh-list
24720038|NCT01565837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24720039|NCT01565837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720040|NCT01565837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24646124|NCT01202097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720041|NCT01565837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720042|NCT01566006|Mycophenolic Acid|mycophenolic acid|mesh-list
24720043|NCT01566006|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
24720044|NCT01566006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24720045|NCT01566006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720046|NCT01566006|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24720047|NCT01566006|Antitubercular Agents|antitubercular agents|mesh-ancestor
24720048|NCT01566006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24720049|NCT01566006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24720050|NCT01566006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720051|NCT01566006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957831|NCT03841136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957832|NCT03840122|Anesthetics|anesthetics|mesh-list
24957833|NCT03840122|Anesthetics, Local|anesthetics, local|mesh-list
24957834|NCT03840122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24957835|NCT03840122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685551|NCT05271058|BB 1101|bb 1101|mesh-list
24720052|NCT01566006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24720053|NCT01566201|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24720054|NCT01566201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24720055|NCT01566253|Acetaminophen|acetaminophen|mesh-list
24720060|NCT01566253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24720094|NCT01566422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24720095|NCT01566474|Melatonin|melatonin|mesh-list
24720096|NCT01566474|Omeprazole|omeprazole|mesh-list
24720097|NCT01566474|Antioxidants|antioxidants|mesh-ancestor
24720098|NCT01566474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720099|NCT01566474|Protective Agents|protective agents|mesh-ancestor
24720100|NCT01566474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720101|NCT01566474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24720110|NCT01566487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24720111|NCT01566487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24720112|NCT01566487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720113|NCT01566552|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24720114|NCT01566552|Antifungal Agents|antifungal agents|mesh-ancestor
24720115|NCT01566552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24720116|NCT01566552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24720117|NCT01566552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24720151|NCT01566656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24720152|NCT01566669|Parecoxib|parecoxib|mesh-list
24720153|NCT01566669|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24720154|NCT01566669|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24720155|NCT01566669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25695491|NCT02046772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24695225|NCT04203472|Glucocorticoids|glucocorticoids|mesh-ancestor
24695226|NCT04203472|Hormones|hormones|mesh-ancestor
24720156|NCT01566669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720157|NCT01566669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24720180|NCT01566825|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24720181|NCT01566825|Antidepressive Agents|antidepressive agents|mesh-ancestor
24720182|NCT01566825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24720183|NCT01566825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24720185|NCT01566825|Sensory System Agents|sensory system agents|mesh-ancestor
24720186|NCT01566825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24720187|NCT01566825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720188|NCT01566825|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24720189|NCT01566825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24720201|NCT01566890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720202|NCT01566942|Oxaliplatin|oxaliplatin|mesh-list
24720204|NCT01566942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720205|NCT01566942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24720206|NCT01566942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24720207|NCT01566942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720208|NCT01566942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720211|NCT01567072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24720234|NCT01567358|Dermatologic Agents|dermatologic agents|mesh-ancestor
24720235|NCT01567358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24720236|NCT01567358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24720237|NCT01567384|Pemetrexed|pemetrexed|mesh-list
24720238|NCT01567384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720239|NCT01567384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720240|NCT01567384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720241|NCT01567384|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24720242|NCT01567384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24720243|NCT01567423|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24720244|NCT01567423|Antimalarials|antimalarials|mesh-ancestor
24720245|NCT01567423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24720246|NCT01567423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24720247|NCT01567423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24720248|NCT01567475|Rituximab|rituximab|mesh-list
24615366|NCT01029132|Autonomic Agents|autonomic agents|mesh-ancestor
24615367|NCT01029132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24615368|NCT01029132|Nootropic Agents|nootropic agents|mesh-ancestor
24615369|NCT01029223|Metoprolol|metoprolol|mesh-list
24957840|NCT03839888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24957841|NCT03839888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24957842|NCT03839888|Autonomic Agents|autonomic agents|mesh-ancestor
24941807|NCT03988114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941808|NCT03987893|Lactulose|lactulose|mesh-list
24941809|NCT03987893|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24799313|NCT01968395|Caspofungin|caspofungin|mesh-list
24941810|NCT03987893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24941812|NCT03987815|Nivolumab|nivolumab|mesh-list
24615372|NCT01029223|Sympatholytics|sympatholytics|mesh-ancestor
24615375|NCT01029223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615376|NCT01029223|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24615377|NCT01029223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24615378|NCT01029223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24720269|NCT01567501|Histamine Agents|histamine agents|mesh-ancestor
24720270|NCT01567501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24720273|NCT01567501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24720283|NCT01567540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720285|NCT01567605|Anesthetics, Local|anesthetics, local|mesh-ancestor
24720286|NCT01567605|Anesthetics|anesthetics|mesh-ancestor
24720287|NCT01567605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24720288|NCT01567605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720289|NCT01567605|Sensory System Agents|sensory system agents|mesh-ancestor
24720290|NCT01567605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24720291|NCT01567605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24720292|NCT01567605|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24720293|NCT01567605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24720294|NCT01567605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24720295|NCT01567605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720296|NCT01567618|Docetaxel|docetaxel|mesh-list
24720297|NCT01567618|Fluorouracil|fluorouracil|mesh-list
24720299|NCT01567618|Tubulin Modulators|tubulin modulators|mesh-ancestor
25695492|NCT02046772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25695493|NCT02046772|Narcotics|narcotics|mesh-ancestor
25695494|NCT02046772|Analgesics|analgesics|mesh-ancestor
25695495|NCT02047032|Solifenacin Succinate|solifenacin succinate|mesh-list
25695496|NCT02047032|Cholinergic Antagonists|cholinergic antagonists|mesh-list
25695497|NCT02047032|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24695241|NCT04166071|Naltrexone|naltrexone|mesh-list
24695242|NCT04166071|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24695243|NCT04166071|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24720300|NCT01567618|Antimitotic Agents|antimitotic agents|mesh-ancestor
24720301|NCT01567618|Mitosis Modulators|mitosis modulators|mesh-ancestor
24720302|NCT01567618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720303|NCT01567618|Antimetabolites|antimetabolites|mesh-ancestor
24720304|NCT01567618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24720305|NCT01567618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24720306|NCT01567618|Immunologic Factors|immunologic factors|mesh-ancestor
24720333|NCT01567670|Sensory System Agents|sensory system agents|mesh-ancestor
24720334|NCT01567670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24720335|NCT01567683|Imiquimod|imiquimod|mesh-list
24720336|NCT01567683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24720337|NCT01567683|Immunologic Factors|immunologic factors|mesh-ancestor
24720338|NCT01567683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720339|NCT01567683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720349|NCT01567735|Protease Inhibitors|protease inhibitors|mesh-ancestor
24720350|NCT01567735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720351|NCT01567735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507551|NCT00550992|Antiviral Agents|antiviral agents|mesh-ancestor
24941813|NCT03987815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24941815|NCT03987815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24941816|NCT03987815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050878|NCT00464243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720353|NCT01567774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24720354|NCT01567774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24720355|NCT01567774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24720356|NCT01567774|Antimetabolites|antimetabolites|mesh-ancestor
24720357|NCT01567774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720358|NCT01567774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24720359|NCT01567774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24720360|NCT01567774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720361|NCT01567800|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
24720362|NCT01567800|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24720363|NCT01567800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720364|NCT01567930|Sirolimus|sirolimus|mesh-list
24720365|NCT01567930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24720366|NCT01567930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24720367|NCT01567930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24720368|NCT01567930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720369|NCT01567930|Antifungal Agents|antifungal agents|mesh-ancestor
24720376|NCT01567995|Hormones|hormones|mesh-ancestor
24720427|NCT01568307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24720428|NCT01568333|Decitabine|decitabine|mesh-list
24720429|NCT01568333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24720430|NCT01568333|Antimetabolites|antimetabolites|mesh-ancestor
25080373|NCT03339700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24720431|NCT01568333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720432|NCT01568333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720433|NCT01568333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720434|NCT01568411|Itraconazole|itraconazole|mesh-list
24720435|NCT01568411|Antifungal Agents|antifungal agents|mesh-ancestor
24720436|NCT01568411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24720437|NCT01568411|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24720438|NCT01568411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24720439|NCT01568411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720440|NCT01568411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720441|NCT01568411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24720442|NCT01568411|Hormone Antagonists|hormone antagonists|mesh-ancestor
25695498|NCT02047032|Cholinergic Agents|cholinergic agents|mesh-ancestor
25695499|NCT02047032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25695500|NCT02047032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695309|NCT03821649|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24695310|NCT03821649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695311|NCT03821649|Sensory System Agents|sensory system agents|mesh-ancestor
24695312|NCT03821649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24720443|NCT01568411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24720444|NCT01568411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720445|NCT01568411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24720448|NCT01568450|Narcotics|narcotics|mesh-ancestor
24720475|NCT01568645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24720479|NCT01568684|Citalopram|citalopram|mesh-list
24720484|NCT01568684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24720485|NCT01568684|Serotonin Agents|serotonin agents|mesh-ancestor
24720486|NCT01568684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720487|NCT01568684|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24720488|NCT01568684|Antidepressive Agents|antidepressive agents|mesh-ancestor
24720489|NCT01568684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24646169|NCT01202331|Azithromycin|azithromycin|mesh-list
24720491|NCT01568749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24720492|NCT01568749|Analgesics|analgesics|mesh-ancestor
24720493|NCT01568749|Sensory System Agents|sensory system agents|mesh-ancestor
24507704|NCT00551512|Cisplatin|cisplatin|mesh-list
24720494|NCT01568749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24720495|NCT01568749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720496|NCT01568749|Antipyretics|antipyretics|mesh-ancestor
24720497|NCT01568788|Vaccines|vaccines|mesh-list
24720498|NCT01568788|Immunologic Factors|immunologic factors|mesh-ancestor
24720499|NCT01568788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720500|NCT01568853|Norepinephrine|norepinephrine|mesh-list
24720501|NCT01568853|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24720502|NCT01568853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24720503|NCT01568853|Adrenergic Agents|adrenergic agents|mesh-ancestor
24720504|NCT01568853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24720505|NCT01568853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720506|NCT01568853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720507|NCT01568853|Sympathomimetics|sympathomimetics|mesh-ancestor
24720508|NCT01568853|Autonomic Agents|autonomic agents|mesh-ancestor
24720509|NCT01568853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24720510|NCT01568853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24720511|NCT01568931|Coal Tar|coal tar|mesh-list
24720512|NCT01568931|Keratolytic Agents|keratolytic agents|mesh-ancestor
24720513|NCT01568931|Dermatologic Agents|dermatologic agents|mesh-ancestor
24720530|NCT01569048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24720531|NCT01569048|Analgesics|analgesics|mesh-ancestor
24720550|NCT01569113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720551|NCT01569113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24720552|NCT01569113|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24720553|NCT01569113|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24720554|NCT01569113|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24720555|NCT01569113|Estrogens|estrogens|mesh-ancestor
24720556|NCT01569113|Hormones|hormones|mesh-ancestor
24720558|NCT01569113|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24720562|NCT01569165|Fluorides|fluorides|mesh-list
25050881|NCT00464061|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25050882|NCT00464061|Serotonin Agents|serotonin agents|mesh-ancestor
25050883|NCT00464061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050884|NCT00464061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050885|NCT00464061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050886|NCT00463242|S 20098|s 20098|mesh-list
25050887|NCT00463242|Paroxetine|paroxetine|mesh-list
25050888|NCT00463242|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24720563|NCT01569165|Fluorides, Topical|fluorides, topical|mesh-list
24720564|NCT01569165|Cariostatic Agents|cariostatic agents|mesh-ancestor
24720565|NCT01569165|Protective Agents|protective agents|mesh-ancestor
24720566|NCT01569165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720567|NCT01569204|Dexamethasone|dexamethasone|mesh-list
24720568|NCT01569204|Prednisone|prednisone|mesh-list
24720569|NCT01569204|Cyclophosphamide|cyclophosphamide|mesh-list
24720571|NCT01569204|Doxorubicin|doxorubicin|mesh-list
24720572|NCT01569204|Etoposide|etoposide|mesh-list
24720573|NCT01569204|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24720574|NCT01569204|Procarbazine|procarbazine|mesh-list
24720575|NCT01569204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25695501|NCT02047032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695502|NCT02047032|Urological Agents|urological agents|mesh-ancestor
25695503|NCT02047045|Prucalopride|prucalopride|mesh-list
25695504|NCT02047045|Serotonin|serotonin|mesh-list
24720576|NCT01569204|Immunologic Factors|immunologic factors|mesh-ancestor
25695505|NCT02047045|Laxatives|laxatives|mesh-ancestor
24612490|NCT01014234|Sirolimus|sirolimus|mesh-list
24720588|NCT01569204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24720589|NCT01569204|Glucocorticoids|glucocorticoids|mesh-ancestor
24615381|NCT01029223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615382|NCT01029275|Octreotide|octreotide|mesh-list
24615405|NCT01029613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24615406|NCT01029613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24615407|NCT01029639|Insulin|insulin|mesh-list
24615408|NCT01029639|Insulin Aspart|insulin aspart|mesh-list
24615409|NCT01029639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24615410|NCT01029639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24615411|NCT01029639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615412|NCT01029678|Vinorelbine|vinorelbine|mesh-list
24615413|NCT01029678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24615414|NCT01029678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24615415|NCT01029678|Tubulin Modulators|tubulin modulators|mesh-ancestor
24615416|NCT01029678|Antimitotic Agents|antimitotic agents|mesh-ancestor
24615418|NCT01029678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720609|NCT01569633|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24720610|NCT01569633|Erythromycin stearate|erythromycin stearate|mesh-list
24720611|NCT01569633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24720612|NCT01569633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24720614|NCT01569633|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24720615|NCT01569633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720656|NCT01569919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24720658|NCT01569919|Autonomic Agents|autonomic agents|mesh-ancestor
24720659|NCT01569919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24720660|NCT01569919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24720661|NCT01569919|Glucocorticoids|glucocorticoids|mesh-ancestor
24720662|NCT01569919|Hormones|hormones|mesh-ancestor
24720663|NCT01569919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24720664|NCT01569919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24720665|NCT01569919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720666|NCT01569919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720667|NCT01569919|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24720668|NCT01569919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24720669|NCT01569919|Hematinics|hematinics|mesh-ancestor
24720670|NCT01569919|Vitamin B Complex|vitamin b complex|mesh-ancestor
24720671|NCT01569945|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24720672|NCT01569945|Clomiphene|clomiphene|mesh-list
24720673|NCT01569945|Menotropins|menotropins|mesh-list
24720674|NCT01569945|Estradiol|estradiol|mesh-list
24720675|NCT01569945|Estrogens|estrogens|mesh-ancestor
24720676|NCT01569945|Hormones|hormones|mesh-ancestor
24720705|NCT01570088|Hematinics|hematinics|mesh-ancestor
24720706|NCT01570088|Vitamin B Complex|vitamin b complex|mesh-ancestor
24720707|NCT01570088|Vitamins|vitamins|mesh-ancestor
24720708|NCT01570088|Micronutrients|micronutrients|mesh-ancestor
24720709|NCT01570088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720710|NCT01570296|Gefitinib|gefitinib|mesh-list
24720711|NCT01570296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24766864|NCT01797315|Sirolimus|sirolimus|mesh-list
24720712|NCT01570296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24720713|NCT01570296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720714|NCT01570296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720715|NCT01570478|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24720716|NCT01570478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24720717|NCT01570478|Autonomic Agents|autonomic agents|mesh-ancestor
24720718|NCT01570478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24720719|NCT01570478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720720|NCT01570478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24720721|NCT01570478|Respiratory System Agents|respiratory system agents|mesh-ancestor
24720722|NCT01570478|Glucocorticoids|glucocorticoids|mesh-ancestor
24720723|NCT01570478|Hormones|hormones|mesh-ancestor
24720724|NCT01570478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24720725|NCT01570478|Sympathomimetics|sympathomimetics|mesh-ancestor
24720726|NCT01570504|Ivermectin|ivermectin|mesh-list
24720727|NCT01570504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24720728|NCT01570504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24720729|NCT01570556|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24720730|NCT01570556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24720731|NCT01570569|Losartan|losartan|mesh-list
24720732|NCT01570569|Midazolam|midazolam|mesh-list
24720733|NCT01570569|Dextromethorphan|dextromethorphan|mesh-list
24720734|NCT01570569|Caffeine|caffeine|mesh-list
24720735|NCT01570569|Omeprazole|omeprazole|mesh-list
24720738|NCT01570569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24720742|NCT01570569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24720743|NCT01570569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24720744|NCT01570569|Anesthetics, General|anesthetics, general|mesh-ancestor
24836432|NCT02185859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836433|NCT02185859|Sensory System Agents|sensory system agents|mesh-ancestor
24720746|NCT01570569|GABA Modulators|gaba modulators|mesh-ancestor
25050892|NCT00463242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050894|NCT00463242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050895|NCT00463242|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25050896|NCT00463242|Antidepressive Agents|antidepressive agents|mesh-ancestor
24720747|NCT01570569|GABA Agents|gaba agents|mesh-ancestor
24720748|NCT01570569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24720966|NCT01571687|Antioxidants|antioxidants|mesh-list
24720749|NCT01570569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720757|NCT01570569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720779|NCT01570582|Antiviral Agents|antiviral agents|mesh-ancestor
24720782|NCT01570582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24720783|NCT01570582|Immunologic Factors|immunologic factors|mesh-ancestor
24720784|NCT01570582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720785|NCT01570608|Ranibizumab|ranibizumab|mesh-list
24720786|NCT01570608|Verteporfin|verteporfin|mesh-list
24720787|NCT01570608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24720788|NCT01570608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24720789|NCT01570608|Growth Substances|growth substances|mesh-ancestor
24720790|NCT01570608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720791|NCT01570608|Growth Inhibitors|growth inhibitors|mesh-ancestor
24720792|NCT01570608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720793|NCT01570608|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24720794|NCT01570608|Dermatologic Agents|dermatologic agents|mesh-ancestor
24720795|NCT01570660|Pioglitazone|pioglitazone|mesh-list
24720796|NCT01570660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24720797|NCT01570660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720798|NCT01570764|Cyclophosphamide|cyclophosphamide|mesh-list
24720799|NCT01570764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24720800|NCT01570764|Immunologic Factors|immunologic factors|mesh-ancestor
24720801|NCT01570764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720802|NCT01570764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24720803|NCT01570764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24720804|NCT01570764|Alkylating Agents|alkylating agents|mesh-ancestor
24720805|NCT01570764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720806|NCT01570764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720807|NCT01570764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24720808|NCT01570790|Fosbretabulin|fosbretabulin|mesh-list
24720809|NCT01570790|Combretastatin|combretastatin|mesh-list
24720810|NCT01570790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24720811|NCT01570790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720812|NCT01570790|Tubulin Modulators|tubulin modulators|mesh-ancestor
24720813|NCT01570790|Antimitotic Agents|antimitotic agents|mesh-ancestor
24720815|NCT01570790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720816|NCT01570894|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24720822|NCT01570894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720823|NCT01570907|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24720831|NCT01570959|Antidepressive Agents|antidepressive agents|mesh-ancestor
24720832|NCT01570959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24720833|NCT01570959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24720834|NCT01570959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24720835|NCT01570959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24720836|NCT01570959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941817|NCT03987698|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24720838|NCT01570985|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24720839|NCT01570985|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24720840|NCT01570985|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24720841|NCT01570985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24720846|NCT01570985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24720859|NCT01571024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720860|NCT01571024|Antidotes|antidotes|mesh-ancestor
24720861|NCT01571024|Protective Agents|protective agents|mesh-ancestor
24720862|NCT01571024|Vitamin B Complex|vitamin b complex|mesh-ancestor
24720863|NCT01571024|Vitamins|vitamins|mesh-ancestor
24720864|NCT01571024|Micronutrients|micronutrients|mesh-ancestor
24720865|NCT01571037|Milrinone|milrinone|mesh-list
24720866|NCT01571037|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24720867|NCT01571037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24720868|NCT01571037|Vasodilator Agents|vasodilator agents|mesh-ancestor
24720869|NCT01571037|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24720870|NCT01571037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24720871|NCT01571037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720872|NCT01571037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720873|NCT01571037|Protective Agents|protective agents|mesh-ancestor
24720874|NCT01571037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720875|NCT01571050|Calcium Carbonate|calcium carbonate|mesh-list
24720876|NCT01571050|Antacids|antacids|mesh-ancestor
24720877|NCT01571050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720885|NCT01571063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24720886|NCT01571167|Varenicline|varenicline|mesh-list
24720887|NCT01571167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24720888|NCT01571167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24720889|NCT01571167|Cholinergic Agents|cholinergic agents|mesh-ancestor
24720890|NCT01571167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24720891|NCT01571167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720892|NCT01571167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720893|NCT01571206|Infliximab|infliximab|mesh-list
24720894|NCT01571206|Dermatologic Agents|dermatologic agents|mesh-ancestor
24720895|NCT01571206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24720898|NCT01571219|Dermatologic Agents|dermatologic agents|mesh-ancestor
24720899|NCT01571219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24720900|NCT01571219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24720901|NCT01571323|Misoprostol|misoprostol|mesh-list
24720902|NCT01571323|Oxytocin|oxytocin|mesh-list
24720903|NCT01571323|Oxytocics|oxytocics|mesh-ancestor
24720904|NCT01571323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24720905|NCT01571323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720906|NCT01571323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24720907|NCT01571323|Abortifacient Agents|abortifacient agents|mesh-ancestor
24720908|NCT01571323|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24720909|NCT01571323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24615440|NCT01029743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24615441|NCT01029743|Protease Inhibitors|protease inhibitors|mesh-ancestor
24615442|NCT01029743|Anticoagulants|anticoagulants|mesh-ancestor
24941826|NCT03987529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24941827|NCT03987529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941828|NCT03987529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24615465|NCT01029821|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24615466|NCT01029821|Tinzaparin|tinzaparin|mesh-list
24615467|NCT01029821|Dalteparin|dalteparin|mesh-list
24615468|NCT01029821|Anticoagulants|anticoagulants|mesh-ancestor
24615469|NCT01029821|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24615470|NCT01029821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24615471|NCT01029821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615472|NCT01029847|Adalimumab|adalimumab|mesh-list
24615473|NCT01029847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24615474|NCT01029847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24615475|NCT01030016|Atenolol|atenolol|mesh-list
24615476|NCT01030016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24615477|NCT01030016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24615478|NCT01030016|Adrenergic Agents|adrenergic agents|mesh-ancestor
24615479|NCT01030016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24615480|NCT01030016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615481|NCT01030016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615482|NCT01030016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24615483|NCT01030016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24615484|NCT01030016|Sympatholytics|sympatholytics|mesh-ancestor
24615485|NCT01030016|Autonomic Agents|autonomic agents|mesh-ancestor
24720922|NCT01571414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24720923|NCT01571414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24720924|NCT01571414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24720925|NCT01571414|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24720926|NCT01571414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24720927|NCT01571414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25695506|NCT02047045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24788180|NCT01929941|Antiviral Agents|antiviral agents|mesh-ancestor
24788181|NCT01929941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24514292|NCT00589316|Micronutrients|micronutrients|mesh-ancestor
24514293|NCT00589381|Fenretinide|fenretinide|mesh-list
24514294|NCT00589381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720928|NCT01571414|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24720929|NCT01571414|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24941829|NCT03987529|Anesthetics, General|anesthetics, general|mesh-ancestor
24941830|NCT03987529|Anesthetics|anesthetics|mesh-ancestor
24941831|NCT03987529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24941832|NCT03987529|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24720930|NCT01571414|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24720931|NCT01571414|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24720932|NCT01571414|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24720933|NCT01571414|Antitubercular Agents|antitubercular agents|mesh-ancestor
24720934|NCT01571414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24720935|NCT01571414|Leprostatic Agents|leprostatic agents|mesh-ancestor
24720936|NCT01571414|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24720937|NCT01571414|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24720938|NCT01571414|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24720940|NCT01571570|Antiviral Agents|antiviral agents|mesh-ancestor
24720941|NCT01571570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24720942|NCT01571570|Protease Inhibitors|protease inhibitors|mesh-ancestor
24720943|NCT01571570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720963|NCT01571648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720964|NCT01571648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720965|NCT01571648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720967|NCT01571687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720968|NCT01571687|Protective Agents|protective agents|mesh-ancestor
24720969|NCT01571687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720971|NCT01571791|Lidocaine|lidocaine|mesh-list
24720972|NCT01571791|Anesthetics, Local|anesthetics, local|mesh-ancestor
24720973|NCT01571791|Anesthetics|anesthetics|mesh-ancestor
24720974|NCT01571791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24720975|NCT01571791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720976|NCT01571791|Sensory System Agents|sensory system agents|mesh-ancestor
24720982|NCT01571791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720983|NCT01571791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24720984|NCT01571791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24720985|NCT01571791|Analgesics|analgesics|mesh-ancestor
24720986|NCT01571791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24720987|NCT01571791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24720988|NCT01571791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24720989|NCT01571791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720990|NCT01571804|Pregabalin|pregabalin|mesh-list
24720991|NCT01571804|Analgesics|analgesics|mesh-ancestor
24720992|NCT01571804|Sensory System Agents|sensory system agents|mesh-ancestor
24720993|NCT01571804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24720994|NCT01571804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720995|NCT01571804|Anticonvulsants|anticonvulsants|mesh-ancestor
24720996|NCT01571804|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24721004|NCT01571856|Zinc Sulfate|zinc sulfate|mesh-list
24721033|NCT01571960|Immunologic Factors|immunologic factors|mesh-ancestor
24721034|NCT01571960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721035|NCT01572012|Ondansetron|ondansetron|mesh-list
24721036|NCT01572012|Antiemetics|antiemetics|mesh-ancestor
24721037|NCT01572012|Autonomic Agents|autonomic agents|mesh-ancestor
24721038|NCT01572012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24721039|NCT01572012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721040|NCT01572012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24721041|NCT01572012|Antipruritics|antipruritics|mesh-ancestor
24721042|NCT01572012|Dermatologic Agents|dermatologic agents|mesh-ancestor
24721043|NCT01572012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24721044|NCT01572012|Serotonin Agents|serotonin agents|mesh-ancestor
24721045|NCT01572012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24721058|NCT01572116|Lidocaine|lidocaine|mesh-list
24721079|NCT01572116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24721080|NCT01572116|Autonomic Agents|autonomic agents|mesh-ancestor
24721081|NCT01572116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24721082|NCT01572116|Respiratory System Agents|respiratory system agents|mesh-ancestor
25695507|NCT02047045|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
25695508|NCT02047045|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25695509|NCT02047045|Serotonin Agents|serotonin agents|mesh-ancestor
25695510|NCT02047045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24518701|NCT04524130|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24518703|NCT04524130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24518982|NCT03710772|Cyclophosphamide|cyclophosphamide|mesh-list
24457783|NCT00335205|Dopamine Agonists|dopamine agonists|mesh-ancestor
24457784|NCT00335205|Dopamine Agents|dopamine agents|mesh-ancestor
24519039|NCT03690089|Respiratory System Agents|respiratory system agents|mesh-ancestor
24519040|NCT03690089|Mydriatics|mydriatics|mesh-ancestor
24519149|NCT03245892|Antimitotic Agents|antimitotic agents|mesh-ancestor
24519150|NCT03245892|Mitosis Modulators|mitosis modulators|mesh-ancestor
24519624|NCT05332028|Propofol|propofol|mesh-list
24721083|NCT01572116|Mydriatics|mydriatics|mesh-ancestor
24721084|NCT01572116|Sympathomimetics|sympathomimetics|mesh-ancestor
24721088|NCT01572116|Analgesics|analgesics|mesh-ancestor
24721089|NCT01572116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24721090|NCT01572116|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24721091|NCT01572116|Anesthetics, General|anesthetics, general|mesh-ancestor
24721092|NCT01572129|Clopidogrel|clopidogrel|mesh-list
24721093|NCT01572129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24721094|NCT01572129|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24721095|NCT01572129|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24721096|NCT01572129|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24721097|NCT01572129|Purinergic Agents|purinergic agents|mesh-ancestor
24721098|NCT01572129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24721099|NCT01572129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721101|NCT01572181|Fludarabine|fludarabine|mesh-list
24721110|NCT01572181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24721111|NCT01572181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24721112|NCT01572259|Hormones|hormones|mesh-list
24721115|NCT01572285|Dexamethasone|dexamethasone|mesh-list
24721119|NCT01572285|Antiemetics|antiemetics|mesh-ancestor
24721120|NCT01572285|Autonomic Agents|autonomic agents|mesh-ancestor
24721121|NCT01572285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24721122|NCT01572285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721123|NCT01572285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24721124|NCT01572285|Glucocorticoids|glucocorticoids|mesh-ancestor
24721125|NCT01572285|Hormones|hormones|mesh-ancestor
24721126|NCT01572285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24721127|NCT01572285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24721128|NCT01572285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24721129|NCT01572285|Protease Inhibitors|protease inhibitors|mesh-ancestor
24721130|NCT01572285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24721131|NCT01572285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721132|NCT01572324|Leucovorin|leucovorin|mesh-list
24721133|NCT01572324|Fluorouracil|fluorouracil|mesh-list
24721134|NCT01572324|Capecitabine|capecitabine|mesh-list
24721135|NCT01572324|Oxaliplatin|oxaliplatin|mesh-list
24721136|NCT01572324|Antimetabolites|antimetabolites|mesh-ancestor
24941834|NCT03987152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24941835|NCT03987152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24941836|NCT03987152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24941837|NCT03987152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941838|NCT03987152|Antifungal Agents|antifungal agents|mesh-ancestor
24721137|NCT01572324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721138|NCT01572324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24721139|NCT01572324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24721140|NCT01572324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24721141|NCT01572324|Immunologic Factors|immunologic factors|mesh-ancestor
24508400|NCT00555373|Sirolimus|sirolimus|mesh-list
24721142|NCT01572324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721143|NCT01572324|Antidotes|antidotes|mesh-ancestor
24721173|NCT01572363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721174|NCT01572363|Urological Agents|urological agents|mesh-ancestor
24721175|NCT01572454|Dexmedetomidine|dexmedetomidine|mesh-list
24721176|NCT01572454|Remifentanil|remifentanil|mesh-list
25695511|NCT02047045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695512|NCT02047045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695513|NCT02047110|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25695514|NCT02047110|Immunologic Factors|immunologic factors|mesh-ancestor
25695515|NCT02047110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695516|NCT02047227|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25695517|NCT02047227|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25695518|NCT02047227|Hormones|hormones|mesh-ancestor
25695519|NCT02047227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24721177|NCT01572454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24721178|NCT01572454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24721179|NCT01572454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721180|NCT01572454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24721181|NCT01572454|Analgesics|analgesics|mesh-ancestor
25695520|NCT02047227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695521|NCT02047227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25695522|NCT02047253|Acyclovir|acyclovir|mesh-list
25695523|NCT02047253|Dexamethasone|dexamethasone|mesh-list
25695524|NCT02047253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25695525|NCT02047253|Antiemetics|antiemetics|mesh-ancestor
25695526|NCT02047253|Autonomic Agents|autonomic agents|mesh-ancestor
25695527|NCT02047253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24721182|NCT01572454|Sensory System Agents|sensory system agents|mesh-ancestor
24721183|NCT01572454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24721184|NCT01572454|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24721185|NCT01572454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24721186|NCT01572454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24721187|NCT01572454|Adrenergic Agents|adrenergic agents|mesh-ancestor
24721188|NCT01572454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24721189|NCT01572454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721190|NCT01572454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24721191|NCT01572454|Narcotics|narcotics|mesh-ancestor
24721192|NCT01572545|Zoledronic Acid|zoledronic acid|mesh-list
24721193|NCT01572545|Denosumab|denosumab|mesh-list
24646383|NCT01203384|Flurbiprofen|flurbiprofen|mesh-list
24721194|NCT01572545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24721195|NCT01572545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721200|NCT01572558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24721201|NCT01572558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24721202|NCT01572558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24721203|NCT01572558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721204|NCT01572558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24721205|NCT01572558|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24721206|NCT01572558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24721207|NCT01572597|Metronidazole|metronidazole|mesh-list
24721208|NCT01572597|Clarithromycin|clarithromycin|mesh-list
24721209|NCT01572597|Acetylcysteine|acetylcysteine|mesh-list
24721210|NCT01572597|Rabeprazole|rabeprazole|mesh-list
24721211|NCT01572597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24721212|NCT01572597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24721213|NCT01572597|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24721214|NCT01572597|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24721215|NCT01572597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24721216|NCT01572597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24721217|NCT01572597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24721218|NCT01572597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24721219|NCT01572597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721220|NCT01572597|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24721221|NCT01572597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24721222|NCT01572597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24721223|NCT01572597|Antiviral Agents|antiviral agents|mesh-ancestor
24721224|NCT01572597|Expectorants|expectorants|mesh-ancestor
24721262|NCT01572805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721268|NCT01572857|Immunoglobulins|immunoglobulins|mesh-list
24721282|NCT01572961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24721283|NCT01572961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24721297|NCT01573143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721298|NCT01573143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24721299|NCT01573143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24721300|NCT01573143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24721328|NCT01573377|Estrogens|estrogens|mesh-ancestor
24721329|NCT01573377|Hormones|hormones|mesh-ancestor
24721330|NCT01573377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24721331|NCT01573377|Androgen Antagonists|androgen antagonists|mesh-ancestor
24721332|NCT01573377|Hormone Antagonists|hormone antagonists|mesh-ancestor
24721333|NCT01573377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24721334|NCT01573377|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24721335|NCT01573468|Capecitabine|capecitabine|mesh-list
24721336|NCT01573468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24721337|NCT01573468|Antimetabolites|antimetabolites|mesh-ancestor
25695528|NCT02047253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695529|NCT02047253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24695589|NCT02786875|Vitamin D|vitamin d|mesh-list
24721338|NCT01573468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721339|NCT01573468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24721340|NCT01573598|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
24721341|NCT01573598|Antidepressive Agents|antidepressive agents|mesh-ancestor
24721342|NCT01573598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24721343|NCT01573598|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24721344|NCT01573598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24721345|NCT01573598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24721346|NCT01573598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721347|NCT01573598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24721348|NCT01573598|Serotonin Agents|serotonin agents|mesh-ancestor
24721349|NCT01573598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721350|NCT01573598|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24721351|NCT01573598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24721352|NCT01573637|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
24721353|NCT01573637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24721354|NCT01573637|Hormone Antagonists|hormone antagonists|mesh-ancestor
24721355|NCT01573637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24721356|NCT01573637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721357|NCT01573637|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24646494|NCT01204125|Paclitaxel|paclitaxel|mesh-list
24721358|NCT01573637|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24508618|NCT00556270|Fentanyl|fentanyl|mesh-list
24721389|NCT01573741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24721390|NCT01573741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721393|NCT01573754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24721394|NCT01573754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24721395|NCT01573754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24721410|NCT01573806|Exenatide|exenatide|mesh-list
24721411|NCT01573806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24721412|NCT01573806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615495|NCT01030042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615496|NCT01030042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615497|NCT01030042|Antidotes|antidotes|mesh-ancestor
24615498|NCT01030042|Protective Agents|protective agents|mesh-ancestor
24615499|NCT01030042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721450|NCT01574261|Vitamin B Complex|vitamin b complex|mesh-ancestor
24721451|NCT01574261|Vitamins|vitamins|mesh-ancestor
24721452|NCT01574261|Micronutrients|micronutrients|mesh-ancestor
24721453|NCT01574261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721454|NCT01574313|Tocopherols|tocopherols|mesh-list
24721455|NCT01574313|Vitamin E|vitamin e|mesh-list
24721456|NCT01574313|Tocotrienols|tocotrienols|mesh-list
24721457|NCT01574313|alpha-Tocopherol|alpha-tocopherol|mesh-list
24721459|NCT01574313|Diphenidol|diphenidol|mesh-list
24721472|NCT01574313|Autonomic Agents|autonomic agents|mesh-ancestor
24721473|NCT01574313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24721474|NCT01574313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24721475|NCT01574508|Insulin|insulin|mesh-list
24721476|NCT01574508|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24721477|NCT01574508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24721478|NCT01574508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721479|NCT01574638|Rifapentine|rifapentine|mesh-list
24721480|NCT01574638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24721481|NCT01574638|Antitubercular Agents|antitubercular agents|mesh-ancestor
24721482|NCT01574638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24721483|NCT01574638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24721484|NCT01574638|Leprostatic Agents|leprostatic agents|mesh-ancestor
24721486|NCT01574742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24721487|NCT01574742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24721488|NCT01574820|Rosiglitazone|rosiglitazone|mesh-list
24721489|NCT01574820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24721490|NCT01574820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721491|NCT01575158|Citalopram|citalopram|mesh-list
24721492|NCT01575158|Clomipramine|clomipramine|mesh-list
24721493|NCT01575158|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24721494|NCT01575158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24721495|NCT01575158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24721496|NCT01575158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721497|NCT01575158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25695530|NCT02047253|Glucocorticoids|glucocorticoids|mesh-ancestor
25695531|NCT02047253|Hormones|hormones|mesh-ancestor
25695532|NCT02047253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24695634|NCT02547662|Growth Inhibitors|growth inhibitors|mesh-ancestor
24695635|NCT02547662|Dermatologic Agents|dermatologic agents|mesh-ancestor
24695637|NCT02547662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24695638|NCT02449161|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24695639|NCT02449161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24695640|NCT02449161|Contraceptive Agents|contraceptive agents|mesh-ancestor
24695641|NCT02449161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24695642|NCT02449161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695643|NCT02449161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24695644|NCT02449161|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24695645|NCT02449161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24695660|NCT02348216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24695661|NCT02348216|Immunologic Factors|immunologic factors|mesh-ancestor
24721498|NCT01575158|Serotonin Agents|serotonin agents|mesh-ancestor
24721499|NCT01575158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721500|NCT01575158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24721501|NCT01575158|Antidepressive Agents|antidepressive agents|mesh-ancestor
24721513|NCT01575301|Hormones|hormones|mesh-ancestor
24721514|NCT01575301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24721515|NCT01575301|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24721516|NCT01575405|Tenofovir|tenofovir|mesh-list
24721517|NCT01575405|Glycerol|glycerol|mesh-list
24721518|NCT01575405|Antiviral Agents|antiviral agents|mesh-ancestor
24721519|NCT01575405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24721520|NCT01575405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24721521|NCT01575405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24721522|NCT01575405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24721523|NCT01575405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721524|NCT01575405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24721525|NCT01575405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24721526|NCT01575405|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24721527|NCT01575405|Protective Agents|protective agents|mesh-ancestor
24721528|NCT01575405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721529|NCT01575418|Tenofovir|tenofovir|mesh-list
24721530|NCT01575418|Glycerol|glycerol|mesh-list
24721531|NCT01575418|Antiviral Agents|antiviral agents|mesh-ancestor
24721553|NCT01575613|Lumefantrine|lumefantrine|mesh-list
24721554|NCT01575613|Artemether|artemether|mesh-list
24721555|NCT01575613|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24721556|NCT01575613|Antimalarials|antimalarials|mesh-ancestor
24721557|NCT01575613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24721558|NCT01575613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24721559|NCT01575613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24721560|NCT01575626|Sevoflurane|sevoflurane|mesh-list
24721561|NCT01575626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24721562|NCT01575626|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24721563|NCT01575626|Anesthetics, General|anesthetics, general|mesh-ancestor
24721564|NCT01575626|Anesthetics|anesthetics|mesh-ancestor
24721565|NCT01575626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24721566|NCT01575626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721570|NCT01575639|Hormones|hormones|mesh-ancestor
24721584|NCT01575652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721586|NCT01575678|Antioxidants|antioxidants|mesh-ancestor
24721587|NCT01575678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721588|NCT01575678|Protective Agents|protective agents|mesh-ancestor
24941861|NCT03986905|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24941862|NCT03986905|Antiemetics|antiemetics|mesh-ancestor
24941874|NCT03986515|Apatinib|apatinib|mesh-list
24941875|NCT03986515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855139|NCT02277678|Morphine|morphine|mesh-list
25695533|NCT02047253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25695534|NCT02047253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25695535|NCT02047253|Antiviral Agents|antiviral agents|mesh-ancestor
25695536|NCT02047253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25695537|NCT02047500|Gemcitabine|gemcitabine|mesh-list
25695538|NCT02047500|Paclitaxel|paclitaxel|mesh-list
25695539|NCT02047500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25695540|NCT02047500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25695541|NCT02047500|Tubulin Modulators|tubulin modulators|mesh-ancestor
25695542|NCT02047500|Antimitotic Agents|antimitotic agents|mesh-ancestor
25695543|NCT02047500|Mitosis Modulators|mitosis modulators|mesh-ancestor
25695544|NCT02047500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646775|NCT01205087|Omeprazole|omeprazole|mesh-list
24721645|NCT01576029|Tubulin Modulators|tubulin modulators|mesh-ancestor
24524244|NCT05109416|Sensory System Agents|sensory system agents|mesh-ancestor
24524245|NCT05109416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24695704|NCT02124941|Protective Agents|protective agents|mesh-ancestor
24695705|NCT02124941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695706|NCT02124941|Antidotes|antidotes|mesh-ancestor
24695707|NCT02094794|Cyclophosphamide|cyclophosphamide|mesh-list
24695708|NCT02094794|Etoposide|etoposide|mesh-list
24695709|NCT02094794|Etoposide phosphate|etoposide phosphate|mesh-list
24695710|NCT02094794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24695711|NCT02094794|Immunologic Factors|immunologic factors|mesh-ancestor
24721646|NCT01576029|Antimitotic Agents|antimitotic agents|mesh-ancestor
24721647|NCT01576029|Mitosis Modulators|mitosis modulators|mesh-ancestor
24721648|NCT01576029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721650|NCT01576094|Milrinone|milrinone|mesh-list
24721651|NCT01576094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24721652|NCT01576094|Vasodilator Agents|vasodilator agents|mesh-ancestor
24721653|NCT01576094|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24721654|NCT01576094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24721655|NCT01576094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24721656|NCT01576094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721657|NCT01576094|Protective Agents|protective agents|mesh-ancestor
24721658|NCT01576094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721659|NCT01576094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24721660|NCT01576185|Sorafenib|sorafenib|mesh-list
24721661|NCT01576185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24721662|NCT01576185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24721663|NCT01576185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24721665|NCT01576263|Ropivacaine|ropivacaine|mesh-list
24721669|NCT01576263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721670|NCT01576263|Sensory System Agents|sensory system agents|mesh-ancestor
24721858|NCT01577550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24721694|NCT01576419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24721695|NCT01576419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721697|NCT01576419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24721698|NCT01576419|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24721699|NCT01576419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24721700|NCT01576419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24721702|NCT01576458|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24441659|NCT00287976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24441660|NCT00287976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441661|NCT00287976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441662|NCT00287976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441663|NCT00288002|Cyclophosphamide|cyclophosphamide|mesh-list
24441664|NCT00288002|Docetaxel|docetaxel|mesh-list
24441665|NCT00288002|Capecitabine|capecitabine|mesh-list
24721708|NCT01576627|Micronutrients|micronutrients|mesh-ancestor
24721709|NCT01576627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721710|NCT01576627|Dermatologic Agents|dermatologic agents|mesh-ancestor
24721711|NCT01576627|Sunscreening Agents|sunscreening agents|mesh-ancestor
24721712|NCT01576627|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24721713|NCT01576627|Protective Agents|protective agents|mesh-ancestor
24721715|NCT01576640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24721716|NCT01576640|Antidepressive Agents|antidepressive agents|mesh-ancestor
24721717|NCT01576640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24941876|NCT03986515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24941877|NCT03986515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24941878|NCT03986515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941879|NCT03986268|Vitamin D|vitamin d|mesh-list
24941880|NCT03986268|Cholecalciferol|cholecalciferol|mesh-list
24941881|NCT03986268|Vitamins|vitamins|mesh-ancestor
24941882|NCT03986268|Micronutrients|micronutrients|mesh-ancestor
24941883|NCT03986268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941884|NCT03986268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25695545|NCT02047500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25695546|NCT02047500|Antimetabolites|antimetabolites|mesh-ancestor
25695547|NCT02047500|Antiviral Agents|antiviral agents|mesh-ancestor
25695548|NCT02047500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25695549|NCT02047500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25695550|NCT02047500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25695551|NCT02047500|Immunologic Factors|immunologic factors|mesh-ancestor
25695552|NCT02047500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695553|NCT02047734|Interferons|interferons|mesh-list
25695554|NCT02047734|Interferon-beta|interferon-beta|mesh-list
25695555|NCT02047734|Interferon beta-1a|interferon beta-1a|mesh-list
25695556|NCT02047734|Ozanimod|ozanimod|mesh-list
24524940|NCT04188873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524941|NCT04188873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524942|NCT04188873|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24524943|NCT04188873|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24524977|NCT04141644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24524978|NCT04141644|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24524979|NCT04141644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525025|NCT04090528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24525052|NCT04032626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24525053|NCT04032626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24525456|NCT03326856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525457|NCT03326856|Cholinergic Agents|cholinergic agents|mesh-ancestor
24525458|NCT03326856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24525459|NCT03326856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525460|NCT03326856|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24525461|NCT03326856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24941885|NCT03986268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24941886|NCT03986385|Capecitabine|capecitabine|mesh-list
24941887|NCT03986385|Oxaliplatin|oxaliplatin|mesh-list
24941888|NCT03986385|Apatinib|apatinib|mesh-list
24941889|NCT03986385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24941890|NCT03986385|Antimetabolites|antimetabolites|mesh-ancestor
24941891|NCT03986385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721718|NCT01576640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24721719|NCT01576640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24721720|NCT01576640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24721721|NCT01576640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721722|NCT01576640|Dopamine Agents|dopamine agents|mesh-ancestor
24721723|NCT01576640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24721769|NCT01576770|Sensory System Agents|sensory system agents|mesh-ancestor
24721770|NCT01576770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24721771|NCT01576770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24721772|NCT01576770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24721773|NCT01576770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24721774|NCT01576770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24721775|NCT01576770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721776|NCT01576848|Caseins|caseins|mesh-list
24721777|NCT01576848|Chelating Agents|chelating agents|mesh-ancestor
24721778|NCT01576848|Sequestering Agents|sequestering agents|mesh-ancestor
24721779|NCT01576848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721780|NCT01577017|Letrozole|letrozole|mesh-list
24721781|NCT01577017|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24721782|NCT01577017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24721790|NCT01577043|Racecadotril|racecadotril|mesh-list
24721791|NCT01577043|Antidiarrheals|antidiarrheals|mesh-ancestor
24721792|NCT01577043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24721793|NCT01577043|Protease Inhibitors|protease inhibitors|mesh-ancestor
24721794|NCT01577043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24721795|NCT01577043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615518|NCT01030094|Anticonvulsants|anticonvulsants|mesh-ancestor
24615519|NCT01030094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25695557|NCT02047734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25695558|NCT02047734|Antiviral Agents|antiviral agents|mesh-ancestor
25695559|NCT02047734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25695560|NCT02047734|Immunologic Factors|immunologic factors|mesh-ancestor
25695561|NCT02047734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695562|NCT02047734|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25695563|NCT02047734|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25695564|NCT02047734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695565|NCT02047734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25695566|NCT02047903|Afatinib|afatinib|mesh-list
25695567|NCT02047903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25695568|NCT02047903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25695569|NCT02047903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25695570|NCT02047903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695571|NCT02047981|Azithromycin|azithromycin|mesh-list
25695572|NCT02047981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25695573|NCT02047981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25695574|NCT02048072|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24526084|NCT01845441|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24526085|NCT01845441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24526086|NCT01845441|Adrenergic Agents|adrenergic agents|mesh-ancestor
24526087|NCT01845441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24526124|NCT01192698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24941892|NCT03986385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941893|NCT03986385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24941894|NCT03986385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615526|NCT01030094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24615527|NCT01030094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24615528|NCT01030094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24615529|NCT01030094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24615531|NCT01030094|Sensory System Agents|sensory system agents|mesh-ancestor
24615532|NCT01030094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24615533|NCT01030094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24615555|NCT01030328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24615556|NCT01030328|Antimetabolites|antimetabolites|mesh-ancestor
24615557|NCT01030328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615558|NCT01030328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24615559|NCT01030393|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24615560|NCT01030393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24615561|NCT01030393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615562|NCT01030510|Rocuronium|rocuronium|mesh-list
24615563|NCT01030510|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24615564|NCT01030510|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24615565|NCT01030510|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24722014|NCT01578265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24615566|NCT01030510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24615567|NCT01030510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615568|NCT01030601|Dexamethasone|dexamethasone|mesh-list
24615569|NCT01030601|Dexamethasone acetate|dexamethasone acetate|mesh-list
24615570|NCT01030601|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24615571|NCT01030601|BB 1101|bb 1101|mesh-list
24615572|NCT01030601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24615573|NCT01030601|Antiemetics|antiemetics|mesh-ancestor
24615574|NCT01030601|Autonomic Agents|autonomic agents|mesh-ancestor
24615575|NCT01030601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24615576|NCT01030601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615577|NCT01030601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24615578|NCT01030601|Glucocorticoids|glucocorticoids|mesh-ancestor
24615579|NCT01030601|Hormones|hormones|mesh-ancestor
24615580|NCT01030601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24615581|NCT01030601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24721800|NCT01577121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24721802|NCT01577121|Analgesics|analgesics|mesh-ancestor
24941907|NCT03986073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24941908|NCT03986073|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24721803|NCT01577121|Sensory System Agents|sensory system agents|mesh-ancestor
24721805|NCT01577121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721828|NCT01577342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24721829|NCT01577342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24721830|NCT01577342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24721831|NCT01577342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24721832|NCT01577342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721833|NCT01577342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24721834|NCT01577368|Tazobactam|tazobactam|mesh-list
24721835|NCT01577368|Piperacillin|piperacillin|mesh-list
24721836|NCT01577368|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24721837|NCT01577368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24721838|NCT01577368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24721840|NCT01577368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24721843|NCT01577407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24721844|NCT01577407|Analgesics|analgesics|mesh-ancestor
24721845|NCT01577407|Sensory System Agents|sensory system agents|mesh-ancestor
24721846|NCT01577407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24721847|NCT01577407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695575|NCT02048072|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25695576|NCT02048072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695577|NCT02048072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25695578|NCT02048072|Immunologic Factors|immunologic factors|mesh-ancestor
25695579|NCT02048072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528223|NCT00620438|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24528224|NCT00620438|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24529740|NCT00627666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24788503|NCT01931683|Narcotics|narcotics|mesh-ancestor
24788504|NCT01931683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24788505|NCT01931683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788506|NCT01931683|Analgesics|analgesics|mesh-ancestor
24788507|NCT01931683|Sensory System Agents|sensory system agents|mesh-ancestor
24721848|NCT01577459|Tedizolid phosphate|tedizolid phosphate|mesh-list
24721849|NCT01577459|Tedizolid|tedizolid|mesh-list
24721850|NCT01577459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24721851|NCT01577459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24721852|NCT01577524|Povidone-Iodine|povidone-iodine|mesh-list
24721853|NCT01577524|Povidone|povidone|mesh-list
24721854|NCT01577524|Plasma Substitutes|plasma substitutes|mesh-ancestor
24721855|NCT01577524|Blood Substitutes|blood substitutes|mesh-ancestor
24721856|NCT01577524|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24441667|NCT00288002|Epirubicin|epirubicin|mesh-list
24441710|NCT00288158|Renal Agents|renal agents|mesh-ancestor
24721857|NCT01577524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24721859|NCT01577550|Immunologic Factors|immunologic factors|mesh-ancestor
24721860|NCT01577550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721873|NCT01577771|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24721874|NCT01577771|Immunologic Factors|immunologic factors|mesh-ancestor
24721875|NCT01577771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721876|NCT01577849|Vitamin D|vitamin d|mesh-list
24721877|NCT01577849|Cholecalciferol|cholecalciferol|mesh-list
24721878|NCT01577849|Vitamins|vitamins|mesh-ancestor
24721879|NCT01577849|Micronutrients|micronutrients|mesh-ancestor
24721880|NCT01577849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721881|NCT01577849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24721882|NCT01577849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24721883|NCT01577862|Rifampin|rifampin|mesh-list
24721884|NCT01577862|Colistin|colistin|mesh-list
24721885|NCT01577862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24721886|NCT01577862|Antitubercular Agents|antitubercular agents|mesh-ancestor
24721887|NCT01577862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24721888|NCT01577862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24721889|NCT01577862|Leprostatic Agents|leprostatic agents|mesh-ancestor
24721890|NCT01577862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24721891|NCT01577862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24721892|NCT01577862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721893|NCT01577862|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24721894|NCT01577862|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24721895|NCT01577862|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24721896|NCT01577862|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24721897|NCT01577862|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24941911|NCT03986073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941913|NCT03985891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24941914|NCT03985891|Immunologic Factors|immunologic factors|mesh-ancestor
24941915|NCT03985891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941916|NCT03986008|Liraglutide|liraglutide|mesh-list
24941917|NCT03986008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24941918|NCT03986008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721905|NCT01577914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721906|NCT01577914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24721907|NCT01577914|Antioxidants|antioxidants|mesh-ancestor
24721908|NCT01577914|Protective Agents|protective agents|mesh-ancestor
24721909|NCT01577914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24721910|NCT01577914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24721926|NCT01577992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25695580|NCT02048241|Guanfacine|guanfacine|mesh-list
25695581|NCT02048241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25695582|NCT02048241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25695583|NCT02048241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25695584|NCT02048241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25695585|NCT02048241|Adrenergic Agents|adrenergic agents|mesh-ancestor
25695586|NCT02048241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25695587|NCT02048241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721928|NCT01577992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721929|NCT01578057|Ethanol|ethanol|mesh-list
24721930|NCT01578057|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24721931|NCT01578057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24721932|NCT01578057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24721933|NCT01578057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721934|NCT01578070|Salicylic Acid|salicylic acid|mesh-list
24721935|NCT01578070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24721936|NCT01578070|Antifungal Agents|antifungal agents|mesh-ancestor
24721937|NCT01578070|Keratolytic Agents|keratolytic agents|mesh-ancestor
24721938|NCT01578070|Dermatologic Agents|dermatologic agents|mesh-ancestor
24721939|NCT01578109|Sorafenib|sorafenib|mesh-list
24721940|NCT01578109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24721941|NCT01578109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24509211|NCT00559351|Fluorouracil|fluorouracil|mesh-list
24721942|NCT01578109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24721944|NCT01578161|Dexmedetomidine|dexmedetomidine|mesh-list
24721961|NCT01578174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721962|NCT01578174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24721963|NCT01578174|Analgesics|analgesics|mesh-ancestor
24721964|NCT01578174|Sensory System Agents|sensory system agents|mesh-ancestor
24721965|NCT01578174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24721966|NCT01578174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24721967|NCT01578174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24721968|NCT01578174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24721969|NCT01578174|Adrenergic Agents|adrenergic agents|mesh-ancestor
24721970|NCT01578174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24721971|NCT01578174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721972|NCT01578200|Calcium Carbonate|calcium carbonate|mesh-list
24721973|NCT01578200|Calcium|calcium|mesh-list
24721974|NCT01578200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24721975|NCT01578200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721976|NCT01578200|Antacids|antacids|mesh-ancestor
24721977|NCT01578200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721978|NCT01578200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24721979|NCT01578213|Imatinib Mesylate|imatinib mesylate|mesh-list
24721980|NCT01578213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24721981|NCT01578213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24941920|NCT03986008|Hormones|hormones|mesh-ancestor
24941921|NCT03986008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25050898|NCT00463242|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24941922|NCT03985969|Indomethacin|indomethacin|mesh-list
24855174|NCT02277847|Cytarabine|cytarabine|mesh-list
24721982|NCT01578213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24721983|NCT01578213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721984|NCT01578252|Ondansetron|ondansetron|mesh-list
24721985|NCT01578252|Antiemetics|antiemetics|mesh-ancestor
24721986|NCT01578252|Autonomic Agents|autonomic agents|mesh-ancestor
24721989|NCT01578252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24722013|NCT01578265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24722015|NCT01578265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24722016|NCT01578265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24722017|NCT01578265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24722018|NCT01578304|Fesoterodine|fesoterodine|mesh-list
24722019|NCT01578304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24722020|NCT01578304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24722021|NCT01578304|Cholinergic Agents|cholinergic agents|mesh-ancestor
24722022|NCT01578304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24722023|NCT01578304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722024|NCT01578304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722025|NCT01578304|Urological Agents|urological agents|mesh-ancestor
24722027|NCT01578343|Dexamethasone|dexamethasone|mesh-list
24722028|NCT01578343|Dexamethasone acetate|dexamethasone acetate|mesh-list
24722029|NCT01578343|Fludarabine|fludarabine|mesh-list
24722042|NCT01578343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24722043|NCT01578343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24722044|NCT01578343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24722045|NCT01578343|Protease Inhibitors|protease inhibitors|mesh-ancestor
24722046|NCT01578343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722047|NCT01578343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722048|NCT01578343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24722049|NCT01578343|Antimetabolites|antimetabolites|mesh-ancestor
24722050|NCT01578343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24722051|NCT01578343|Immunologic Factors|immunologic factors|mesh-ancestor
24722053|NCT01578343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24722054|NCT01578343|Analgesics|analgesics|mesh-ancestor
24722055|NCT01578343|Sensory System Agents|sensory system agents|mesh-ancestor
24722056|NCT01578343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24722057|NCT01578343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24722058|NCT01578343|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24615583|NCT01030601|Protease Inhibitors|protease inhibitors|mesh-ancestor
24722059|NCT01578434|Calcium, Dietary|calcium, dietary|mesh-list
24722064|NCT01578434|Calcium Carbonate|calcium carbonate|mesh-list
24722066|NCT01578434|Micronutrients|micronutrients|mesh-ancestor
24722092|NCT01578473|Testosterone undecanoate|testosterone undecanoate|mesh-list
24722093|NCT01578473|Testosterone enanthate|testosterone enanthate|mesh-list
24722094|NCT01578473|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24722095|NCT01578473|Micronutrients|micronutrients|mesh-ancestor
24722096|NCT01578473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722097|NCT01578473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24722098|NCT01578473|Androgens|androgens|mesh-ancestor
24722099|NCT01578473|Hormones|hormones|mesh-ancestor
24722100|NCT01578473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24941923|NCT03985969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24941924|NCT03985969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24941925|NCT03985969|Analgesics|analgesics|mesh-ancestor
24941926|NCT03985969|Sensory System Agents|sensory system agents|mesh-ancestor
24941927|NCT03985969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24941928|NCT03985969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688215|NCT03276533|Analgesics|analgesics|mesh-ancestor
24722101|NCT01578473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24722102|NCT01578473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24722103|NCT01578473|Anabolic Agents|anabolic agents|mesh-ancestor
24722104|NCT01578473|Antioxidants|antioxidants|mesh-ancestor
24722105|NCT01578473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722106|NCT01578473|Protective Agents|protective agents|mesh-ancestor
24722139|NCT01578629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24722140|NCT01578629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24722141|NCT01578629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722143|NCT01578629|Antioxidants|antioxidants|mesh-ancestor
24722144|NCT01578629|Protective Agents|protective agents|mesh-ancestor
24722145|NCT01578668|Pemetrexed|pemetrexed|mesh-list
24722146|NCT01578668|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24722147|NCT01578668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24722148|NCT01578668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722149|NCT01578668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722150|NCT01578668|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24615584|NCT01030601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615585|NCT01030601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615586|NCT01030614|Dexamethasone|dexamethasone|mesh-list
24615587|NCT01030614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24615588|NCT01030614|Antiemetics|antiemetics|mesh-ancestor
24615589|NCT01030614|Autonomic Agents|autonomic agents|mesh-ancestor
24615590|NCT01030614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24615591|NCT01030614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615592|NCT01030614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24615593|NCT01030614|Glucocorticoids|glucocorticoids|mesh-ancestor
24615595|NCT01030614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24615596|NCT01030614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24615597|NCT01030614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24615598|NCT01030640|Tanezumab|tanezumab|mesh-list
24615599|NCT01030640|Analgesics|analgesics|mesh-ancestor
24615600|NCT01030640|Sensory System Agents|sensory system agents|mesh-ancestor
24615601|NCT01030640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24615602|NCT01030640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615612|NCT01030692|Protective Agents|protective agents|mesh-ancestor
24615613|NCT01030731|Ceftobiprole|ceftobiprole|mesh-list
24615614|NCT01030731|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
24615615|NCT01030731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24615616|NCT01030731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24615617|NCT01030770|Ranibizumab|ranibizumab|mesh-list
24615618|NCT01030770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24647082|NCT01206075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24615619|NCT01030770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24615620|NCT01030770|Growth Substances|growth substances|mesh-ancestor
24615621|NCT01030770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707133|NCT01494311|Anesthetics|anesthetics|mesh-ancestor
24707134|NCT01494311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24707135|NCT01494311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707293|NCT01495117|Povidone|povidone|mesh-list
24707297|NCT01495117|Disinfectants|disinfectants|mesh-ancestor
24615622|NCT01030770|Growth Inhibitors|growth inhibitors|mesh-ancestor
24615624|NCT01030796|Caffeine|caffeine|mesh-list
24941930|NCT03985969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24941931|NCT03985969|Gout Suppressants|gout suppressants|mesh-ancestor
24722189|NCT01579019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24722190|NCT01579019|Antiviral Agents|antiviral agents|mesh-ancestor
24722191|NCT01579019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24722192|NCT01579019|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24722193|NCT01579019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24722194|NCT01579019|Antimetabolites|antimetabolites|mesh-ancestor
24722218|NCT01579110|Antinematodal Agents|antinematodal agents|mesh-ancestor
24722219|NCT01579110|Anthelmintics|anthelmintics|mesh-ancestor
24722220|NCT01579110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24722221|NCT01579110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24722222|NCT01579110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24722224|NCT01579149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24722225|NCT01579149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24722226|NCT01579149|Antiviral Agents|antiviral agents|mesh-ancestor
24722227|NCT01579149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24722228|NCT01579201|Carbetocin|carbetocin|mesh-list
24722229|NCT01579201|Oxytocics|oxytocics|mesh-ancestor
24722230|NCT01579201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24722231|NCT01579201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722232|NCT01579227|Tamoxifen|tamoxifen|mesh-list
24722233|NCT01579227|Tocotrienols|tocotrienols|mesh-list
24722234|NCT01579227|Vitamin E|vitamin e|mesh-list
24722235|NCT01579227|Tocopherols|tocopherols|mesh-list
24722236|NCT01579227|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24722237|NCT01579227|Hormone Antagonists|hormone antagonists|mesh-ancestor
24722238|NCT01579227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24722239|NCT01579227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768303|NCT01807286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24441740|NCT00288197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24441741|NCT00288197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441742|NCT00288197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24441743|NCT00288223|Telithromycin|telithromycin|mesh-list
24722250|NCT01579279|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24722251|NCT01579279|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24722252|NCT01579279|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24722253|NCT01579279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24722254|NCT01579279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722255|NCT01579279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24722256|NCT01579279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722257|NCT01579279|Analgesics|analgesics|mesh-ancestor
24722258|NCT01579279|Sensory System Agents|sensory system agents|mesh-ancestor
24722259|NCT01579279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24722260|NCT01579279|Antidepressive Agents|antidepressive agents|mesh-ancestor
24722261|NCT01579279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25695588|NCT02048241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695589|NCT02048891|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25695590|NCT02048891|Progesterone|progesterone|mesh-list
25695591|NCT02048891|Progestins|progestins|mesh-ancestor
25695592|NCT02048891|Hormones|hormones|mesh-ancestor
25695593|NCT02048891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24722262|NCT01579279|Dopamine Agents|dopamine agents|mesh-ancestor
24722263|NCT01579383|Sumatriptan|sumatriptan|mesh-list
24722264|NCT01579383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24722265|NCT01579383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24722266|NCT01579383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24722267|NCT01579383|Serotonin Agents|serotonin agents|mesh-ancestor
24722268|NCT01579383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24722269|NCT01579383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722270|NCT01579383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441744|NCT00288223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24441745|NCT00288223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24441746|NCT00288236|Rimonabant|rimonabant|mesh-list
24441747|NCT00288236|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24441748|NCT00288236|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24441749|NCT00288236|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24441750|NCT00288236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24441751|NCT00288236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441752|NCT00288236|Hormones|hormones|mesh-ancestor
24441822|NCT00288444|Tubulin Modulators|tubulin modulators|mesh-ancestor
24441823|NCT00288444|Antimitotic Agents|antimitotic agents|mesh-ancestor
24722271|NCT01579448|Vaccines|vaccines|mesh-list
24722272|NCT01579448|Immunologic Factors|immunologic factors|mesh-ancestor
24722273|NCT01579448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722274|NCT01579461|Mirabegron|mirabegron|mesh-list
24722275|NCT01579461|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24941932|NCT03985969|Tocolytic Agents|tocolytic agents|mesh-ancestor
24722276|NCT01579461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24722277|NCT01579461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24722278|NCT01579461|Adrenergic Agents|adrenergic agents|mesh-ancestor
24722279|NCT01579461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24722288|NCT01579500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722289|NCT01579500|Cholinergic Agents|cholinergic agents|mesh-ancestor
24722290|NCT01579500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24722295|NCT01579539|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24722296|NCT01579539|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24722298|NCT01579539|Prednisolone acetate|prednisolone acetate|mesh-list
24722299|NCT01579539|Esomeprazole|esomeprazole|mesh-list
24722300|NCT01579539|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24722301|NCT01579539|Prednisolone phosphate|prednisolone phosphate|mesh-list
24722302|NCT01579539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24722303|NCT01579539|Antiemetics|antiemetics|mesh-ancestor
24722304|NCT01579539|Autonomic Agents|autonomic agents|mesh-ancestor
24722823|NCT01582711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24722308|NCT01579539|Glucocorticoids|glucocorticoids|mesh-ancestor
24722310|NCT01579539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24722311|NCT01579539|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24722312|NCT01579539|Protective Agents|protective agents|mesh-ancestor
24722313|NCT01579539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24722314|NCT01579539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24722315|NCT01579539|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24722316|NCT01579539|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24722317|NCT01579539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722318|NCT01579539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722320|NCT01579630|Gefitinib|gefitinib|mesh-list
24722321|NCT01579630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24722322|NCT01579630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722323|NCT01579630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722324|NCT01579630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24722325|NCT01579630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24722326|NCT01579630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24722327|NCT01579695|Tesamorelin|tesamorelin|mesh-list
24722328|NCT01579695|Growth Substances|growth substances|mesh-ancestor
24722329|NCT01579695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722330|NCT01579734|Tamoxifen|tamoxifen|mesh-list
24722331|NCT01579734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24722332|NCT01579734|Hormone Antagonists|hormone antagonists|mesh-ancestor
24722333|NCT01579734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24722334|NCT01579734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722343|NCT01579760|Growth Substances|growth substances|mesh-ancestor
24722359|NCT01579864|Rocuronium|rocuronium|mesh-list
24722360|NCT01579864|Succinylcholine|succinylcholine|mesh-list
24941933|NCT03985969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24941934|NCT03985969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24941935|NCT03985969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722361|NCT01579864|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24722362|NCT01579864|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24722363|NCT01579864|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24722364|NCT01579864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24722365|NCT01579864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722366|NCT01579864|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
24722367|NCT01579890|Diclofenac|diclofenac|mesh-list
24722368|NCT01579890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24722369|NCT01579890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24722370|NCT01579890|Analgesics|analgesics|mesh-ancestor
24722371|NCT01579890|Sensory System Agents|sensory system agents|mesh-ancestor
24722372|NCT01579890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24615640|NCT01030900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24722373|NCT01579890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722374|NCT01579890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24722375|NCT01579890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24722376|NCT01579890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24722377|NCT01579890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722381|NCT01579929|Etoposide|etoposide|mesh-list
24722407|NCT01580163|Narcotics|narcotics|mesh-ancestor
24722408|NCT01580163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24722409|NCT01580163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722410|NCT01580163|Analgesics|analgesics|mesh-ancestor
24722411|NCT01580163|Sensory System Agents|sensory system agents|mesh-ancestor
24647159|NCT01206569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722412|NCT01580163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24722425|NCT01580228|Ofatumumab|ofatumumab|mesh-list
24722426|NCT01580228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24722427|NCT01580254|Latanoprost|latanoprost|mesh-list
24722428|NCT01580254|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24722429|NCT01580254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24722430|NCT01580371|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
24722454|NCT01580683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722456|NCT01580813|Acipimox|acipimox|mesh-list
24722457|NCT01580813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24722458|NCT01580813|Antimetabolites|antimetabolites|mesh-ancestor
24722459|NCT01580813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722460|NCT01580813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24722461|NCT01580839|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24722463|NCT01580839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24722464|NCT01580839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24722465|NCT01580839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722467|NCT01580865|Tacrolimus|tacrolimus|mesh-list
24615641|NCT01030926|Insulin|insulin|mesh-list
24615642|NCT01030926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24615643|NCT01030926|Insulin Glargine|insulin glargine|mesh-list
24615644|NCT01030926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24615645|NCT01030926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615646|NCT01031017|Progesterone|progesterone|mesh-list
24615647|NCT01031017|Progestins|progestins|mesh-ancestor
24615648|NCT01031017|Hormones|hormones|mesh-ancestor
24615649|NCT01031017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24615650|NCT01031017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615651|NCT01031030|Cyclophosphamide|cyclophosphamide|mesh-list
24615652|NCT01031030|Fluorouracil|fluorouracil|mesh-list
24615653|NCT01031030|Methotrexate|methotrexate|mesh-list
24615654|NCT01031030|Epirubicin|epirubicin|mesh-list
24615655|NCT01031030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24615656|NCT01031030|Immunologic Factors|immunologic factors|mesh-ancestor
24941936|NCT03985969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941937|NCT03985982|Botulinum Toxins|botulinum toxins|mesh-list
24941938|NCT03985982|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24615657|NCT01031030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615658|NCT01031030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24615674|NCT01031030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24615675|NCT01031030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24615676|NCT01031212|Acetic Acid|acetic acid|mesh-list
24615677|NCT01031212|Paclitaxel|paclitaxel|mesh-list
24615678|NCT01031212|Carboplatin|carboplatin|mesh-list
24615679|NCT01031212|Cetuximab|cetuximab|mesh-list
24615680|NCT01031212|Vadimezan|vadimezan|mesh-list
24647200|NCT01206907|Narcotics|narcotics|mesh-ancestor
24615681|NCT01031212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24615682|NCT01031212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24615683|NCT01031212|Tubulin Modulators|tubulin modulators|mesh-ancestor
24836849|NCT02187614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24615684|NCT01031212|Antimitotic Agents|antimitotic agents|mesh-ancestor
24615685|NCT01031212|Mitosis Modulators|mitosis modulators|mesh-ancestor
24615686|NCT01031212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615687|NCT01031212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24615688|NCT01031212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24615689|NCT01031212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24615690|NCT01031355|Calcium, Dietary|calcium, dietary|mesh-list
24615691|NCT01031355|Tetrahydrofolates|tetrahydrofolates|mesh-list
24615695|NCT01031355|Estradiol|estradiol|mesh-list
24615696|NCT01031355|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24615697|NCT01031355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24615698|NCT01031355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615699|NCT01031355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24722472|NCT01580865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722473|NCT01580865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722474|NCT01580865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24441824|NCT00288444|Mitosis Modulators|mitosis modulators|mesh-ancestor
24722476|NCT01580865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24722477|NCT01580865|Antitubercular Agents|antitubercular agents|mesh-ancestor
24722528|NCT01581242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24722529|NCT01581242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24722530|NCT01581242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24722531|NCT01581242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722532|NCT01581242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722533|NCT01581320|Vitamin D|vitamin d|mesh-list
24722534|NCT01581320|Cholecalciferol|cholecalciferol|mesh-list
24722535|NCT01581320|Ibandronic Acid|ibandronic acid|mesh-list
24722536|NCT01581320|Vitamins|vitamins|mesh-ancestor
24722537|NCT01581320|Micronutrients|micronutrients|mesh-ancestor
24722538|NCT01581320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722539|NCT01581320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24722540|NCT01581320|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24722541|NCT01581333|Anti-Infective Agents|anti-infective agents|mesh-list
24722542|NCT01581333|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24722543|NCT01581359|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24722544|NCT01581359|Luteolytic Agents|luteolytic agents|mesh-ancestor
24722545|NCT01581359|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24722546|NCT01581359|Contraceptive Agents|contraceptive agents|mesh-ancestor
24722547|NCT01581359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24941942|NCT03985982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722548|NCT01581359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722549|NCT01581359|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24722590|NCT01581736|Insulin|insulin|mesh-list
24722591|NCT01581736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24722592|NCT01581736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24722593|NCT01581736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722594|NCT01581775|Valproic Acid|valproic acid|mesh-list
24722595|NCT01581775|Anticonvulsants|anticonvulsants|mesh-ancestor
24722596|NCT01581775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722597|NCT01581775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722598|NCT01581775|GABA Agents|gaba agents|mesh-ancestor
24722599|NCT01581775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24722624|NCT01581814|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24722629|NCT01581814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24722631|NCT01581853|Lopinavir|lopinavir|mesh-list
24722632|NCT01581853|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24722633|NCT01581853|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24722634|NCT01581853|Protease Inhibitors|protease inhibitors|mesh-ancestor
24722635|NCT01581853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722636|NCT01581853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722637|NCT01581853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24722638|NCT01581853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24722639|NCT01581853|Antiviral Agents|antiviral agents|mesh-ancestor
24722640|NCT01581853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24722641|NCT01581853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24722642|NCT01581853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24722643|NCT01581866|Ziprasidone|ziprasidone|mesh-list
24722644|NCT01581866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24722645|NCT01581866|Serotonin Agents|serotonin agents|mesh-ancestor
24722646|NCT01581866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24722668|NCT01581918|Anticonvulsants|anticonvulsants|mesh-ancestor
24722676|NCT01581918|Sensory System Agents|sensory system agents|mesh-ancestor
24722677|NCT01581918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24722678|NCT01581918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24722679|NCT01581918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24722680|NCT01581918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722681|NCT01581918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24941943|NCT03985982|Cholinergic Agents|cholinergic agents|mesh-ancestor
24941944|NCT03985982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24941945|NCT03985982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941946|NCT03985982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24941947|NCT03985982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24722682|NCT01581918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24722684|NCT01581944|Hormones|hormones|mesh-list
24722685|NCT01581944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24647331|NCT01208090|Immunologic Factors|immunologic factors|mesh-ancestor
24722686|NCT01581944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722824|NCT01582711|Antimetabolites|antimetabolites|mesh-ancestor
24722687|NCT01581944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24722688|NCT01581944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24722690|NCT01582022|Anesthetics, Local|anesthetics, local|mesh-ancestor
24722691|NCT01582022|Anesthetics|anesthetics|mesh-ancestor
24722692|NCT01582022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24722693|NCT01582022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722694|NCT01582022|Sensory System Agents|sensory system agents|mesh-ancestor
24722695|NCT01582022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24722696|NCT01582113|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
24722697|NCT01582113|Nootropic Agents|nootropic agents|mesh-ancestor
24722698|NCT01582165|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24722705|NCT01582165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722707|NCT01582230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24722708|NCT01582230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722709|NCT01582230|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24722710|NCT01582230|Protease Inhibitors|protease inhibitors|mesh-ancestor
24722711|NCT01582230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722714|NCT01582321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722715|NCT01582321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722716|NCT01582412|Isavuconazole|isavuconazole|mesh-list
24722717|NCT01582412|Digoxin|digoxin|mesh-list
24722718|NCT01582412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24722719|NCT01582412|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24722720|NCT01582412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722721|NCT01582412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722722|NCT01582412|Protective Agents|protective agents|mesh-ancestor
24722723|NCT01582412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722724|NCT01582412|Antifungal Agents|antifungal agents|mesh-ancestor
24722725|NCT01582412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24722726|NCT01582425|Isavuconazole|isavuconazole|mesh-list
24722727|NCT01582425|Methadone|methadone|mesh-list
24722728|NCT01582425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24722729|NCT01582425|Narcotics|narcotics|mesh-ancestor
24722746|NCT01582438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722747|NCT01582438|Vasodilator Agents|vasodilator agents|mesh-ancestor
24722748|NCT01582438|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24722749|NCT01582438|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24722750|NCT01582438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722751|NCT01582438|Urological Agents|urological agents|mesh-ancestor
24722752|NCT01582542|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24722753|NCT01582542|Hemostatics|hemostatics|mesh-ancestor
24722754|NCT01582542|Coagulants|coagulants|mesh-ancestor
24722755|NCT01582542|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24722756|NCT01582542|Natriuretic Agents|natriuretic agents|mesh-ancestor
24722757|NCT01582542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722758|NCT01582555|Acetylcysteine|acetylcysteine|mesh-list
24722759|NCT01582555|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24722760|NCT01582555|Antidotes|antidotes|mesh-ancestor
24722761|NCT01582555|Protective Agents|protective agents|mesh-ancestor
24722762|NCT01582555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722763|NCT01582555|Antioxidants|antioxidants|mesh-ancestor
24722764|NCT01582555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722765|NCT01582555|Antiviral Agents|antiviral agents|mesh-ancestor
24941950|NCT03985865|Antimalarials|antimalarials|mesh-ancestor
24941951|NCT03985865|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24941952|NCT03985865|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24941953|NCT03985865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24855204|NCT02277938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24722769|NCT01582555|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24722770|NCT01582568|Certolizumab Pegol|certolizumab pegol|mesh-list
24722771|NCT01582568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24722772|NCT01582568|Immunologic Factors|immunologic factors|mesh-ancestor
24722773|NCT01582568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722775|NCT01582607|Fentanyl|fentanyl|mesh-list
24722793|NCT01582646|Autonomic Agents|autonomic agents|mesh-ancestor
24722794|NCT01582646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24722795|NCT01582646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722796|NCT01582646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24722797|NCT01582646|Respiratory System Agents|respiratory system agents|mesh-ancestor
24722798|NCT01582646|Sympathomimetics|sympathomimetics|mesh-ancestor
24722816|NCT01582672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722819|NCT01582711|Antitubercular Agents|antitubercular agents|mesh-ancestor
24722820|NCT01582711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24722821|NCT01582711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24722822|NCT01582711|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24615714|NCT01031368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615715|NCT01031368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24615716|NCT01031368|Antiviral Agents|antiviral agents|mesh-ancestor
24615717|NCT01031368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24615718|NCT01031368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24615719|NCT01031368|Immunologic Factors|immunologic factors|mesh-ancestor
24615735|NCT01031589|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24615736|NCT01031589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24615737|NCT01031589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615738|NCT01031589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615739|NCT01031589|Antiviral Agents|antiviral agents|mesh-ancestor
24615760|NCT01031667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615761|NCT01031667|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24615762|NCT01031667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24615763|NCT01031667|Antimetabolites|antimetabolites|mesh-ancestor
24722841|NCT01582997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24722842|NCT01582997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722843|NCT01582997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722844|NCT01583023|Bupropion|bupropion|mesh-list
24722845|NCT01583023|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24722846|NCT01583023|Antidepressive Agents|antidepressive agents|mesh-ancestor
24722847|NCT01583023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24722848|NCT01583023|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24722849|NCT01583023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24722850|NCT01583023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24722851|NCT01583023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722852|NCT01583023|Dopamine Agents|dopamine agents|mesh-ancestor
24722853|NCT01583023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24941954|NCT03985865|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24941955|NCT03985865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941956|NCT03985865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24941957|NCT03985865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24941958|NCT03985865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24722854|NCT01583023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722872|NCT01583062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24722873|NCT01583062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722874|NCT01583062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722880|NCT01583114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722882|NCT01583244|Abatacept|abatacept|mesh-list
24722883|NCT01583244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24722884|NCT01583244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722885|NCT01583244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24722886|NCT01583244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24722887|NCT01583244|Immunologic Factors|immunologic factors|mesh-ancestor
24722888|NCT01583244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722922|NCT01583439|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24722923|NCT01583439|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24722924|NCT01583439|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24722925|NCT01583439|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24722926|NCT01583478|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24722927|NCT01583478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24722928|NCT01583478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24722929|NCT01583478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722930|NCT01583478|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24722931|NCT01583478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24722932|NCT01583478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722933|NCT01583478|Cholinergic Agents|cholinergic agents|mesh-ancestor
24722934|NCT01583478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24722935|NCT01583504|Anesthetics|anesthetics|mesh-list
24722936|NCT01583504|Anesthetics, Local|anesthetics, local|mesh-list
24722937|NCT01583504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24722938|NCT01583504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722939|NCT01583504|Sensory System Agents|sensory system agents|mesh-ancestor
24722940|NCT01583504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24722941|NCT01583621|Cholecalciferol|cholecalciferol|mesh-list
24722961|NCT01583660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24722962|NCT01583660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24722963|NCT01583660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722964|NCT01583660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722965|NCT01583660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24722967|NCT01583660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24722968|NCT01583777|Belinostat|belinostat|mesh-list
24722969|NCT01583777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24722970|NCT01583777|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24722971|NCT01583777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24941960|NCT03985865|Sensory System Agents|sensory system agents|mesh-ancestor
24941961|NCT03985865|Aversive Agents|aversive agents|mesh-ancestor
24941962|NCT03985865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722972|NCT01583777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723021|NCT01584271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24723023|NCT01584297|Antifungal Agents|antifungal agents|mesh-ancestor
24723024|NCT01584297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24723025|NCT01584297|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24723026|NCT01584297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24723027|NCT01584297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24723028|NCT01584297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723029|NCT01584297|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24723030|NCT01584297|Hormone Antagonists|hormone antagonists|mesh-ancestor
24723031|NCT01584297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24723062|NCT01584557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723064|NCT01584557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723065|NCT01584687|Omalizumab|omalizumab|mesh-list
24723078|NCT01584726|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24723090|NCT01584791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24723091|NCT01584791|Analgesics|analgesics|mesh-ancestor
24723092|NCT01584791|Sensory System Agents|sensory system agents|mesh-ancestor
24723093|NCT01584791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24723094|NCT01584791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789114|NCT01935544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24789115|NCT01935544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789116|NCT01935557|Heparin|heparin|mesh-list
24789117|NCT01935557|Calcium heparin|calcium heparin|mesh-list
24789118|NCT01935557|Anticoagulants|anticoagulants|mesh-ancestor
24723095|NCT01584791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24723096|NCT01584791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24723097|NCT01584791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24723098|NCT01584791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24723099|NCT01584791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723100|NCT01584791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24723101|NCT01584791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24723102|NCT01584791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24723103|NCT01584791|Antipyretics|antipyretics|mesh-ancestor
24723104|NCT01584791|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24723105|NCT01584791|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24723106|NCT01584791|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24723107|NCT01584791|Purinergic Agents|purinergic agents|mesh-ancestor
24723108|NCT01584791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24723109|NCT01584804|Antitussive Agents|antitussive agents|mesh-list
24723110|NCT01584804|Respiratory System Agents|respiratory system agents|mesh-ancestor
24723158|NCT01585415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24723159|NCT01585415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24723160|NCT01585415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24723161|NCT01585623|Metoprolol|metoprolol|mesh-list
24723162|NCT01585623|Midazolam|midazolam|mesh-list
24723187|NCT01585753|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24723188|NCT01585753|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24723189|NCT01585753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723190|NCT01585753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24723191|NCT01585753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24723192|NCT01585753|Antiviral Agents|antiviral agents|mesh-ancestor
24723193|NCT01585753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24723194|NCT01585753|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24723197|NCT01585792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24723198|NCT01585792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855217|NCT02278172|Cholecalciferol|cholecalciferol|mesh-list
24689658|NCT00768820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689659|NCT00768820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689660|NCT00768820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24689661|NCT00768820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24689662|NCT00768820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24723199|NCT01585792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24723200|NCT01585792|Immunologic Factors|immunologic factors|mesh-ancestor
24723202|NCT01585870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24723203|NCT01585870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24723204|NCT01585870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24723212|NCT01586013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24723213|NCT01586013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24723214|NCT01586013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723215|NCT01586013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24723216|NCT01586013|Anesthetics, General|anesthetics, general|mesh-ancestor
24723231|NCT01586169|Azithromycin|azithromycin|mesh-list
24723233|NCT01586169|Albendazole|albendazole|mesh-list
24723234|NCT01586169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24723235|NCT01586169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24723236|NCT01586169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24723237|NCT01586169|Anthelmintics|anthelmintics|mesh-ancestor
24723238|NCT01586169|Anticestodal Agents|anticestodal agents|mesh-ancestor
24647584|NCT01209533|Iloprost|iloprost|mesh-list
24723239|NCT01586169|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24723240|NCT01586169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24723241|NCT01586169|Tubulin Modulators|tubulin modulators|mesh-ancestor
24723253|NCT01586208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723254|NCT01586208|Antimanic Agents|antimanic agents|mesh-ancestor
24723255|NCT01586208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24723256|NCT01586208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24723257|NCT01586208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24723258|NCT01586208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24723259|NCT01586208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25695594|NCT02048891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695595|NCT02048891|Luteolytic Agents|luteolytic agents|mesh-ancestor
25695596|NCT02048891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25695597|NCT02048891|Contraceptive Agents|contraceptive agents|mesh-ancestor
25695598|NCT02048891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24717346|NCT01547312|Interferons|interferons|mesh-list
24717378|NCT01547416|Ropivacaine|ropivacaine|mesh-list
24717379|NCT01547416|Anesthetics, Local|anesthetics, local|mesh-ancestor
24717380|NCT01547416|Anesthetics|anesthetics|mesh-ancestor
24717381|NCT01547416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24717382|NCT01547416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717741|NCT01549691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24559000|NCT05343156|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24559001|NCT05343156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24559002|NCT05343156|Antiemetics|antiemetics|mesh-ancestor
24559003|NCT05343156|Autonomic Agents|autonomic agents|mesh-ancestor
24717742|NCT01549704|Ropivacaine|ropivacaine|mesh-list
24717743|NCT01549704|Anesthetics, Local|anesthetics, local|mesh-ancestor
24723260|NCT01586208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24723261|NCT01586208|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24723271|NCT01586286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24723272|NCT01586299|Acetaminophen|acetaminophen|mesh-list
24723274|NCT01586299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24723275|NCT01586299|Analgesics|analgesics|mesh-ancestor
24836976|NCT02188368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836977|NCT02188368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24836978|NCT02188368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24836980|NCT02188368|Antiemetics|antiemetics|mesh-ancestor
24723276|NCT01586299|Sensory System Agents|sensory system agents|mesh-ancestor
24723277|NCT01586299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24723278|NCT01586299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723279|NCT01586299|Antipyretics|antipyretics|mesh-ancestor
24723280|NCT01586299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24723281|NCT01586299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24723282|NCT01586299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24723283|NCT01586299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24723284|NCT01586299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24723295|NCT01586442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24723296|NCT01586494|Tramadol|tramadol|mesh-list
24647629|NCT01209806|Antacids|antacids|mesh-ancestor
24723297|NCT01586494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24723298|NCT01586494|Narcotics|narcotics|mesh-ancestor
24723301|NCT01586494|Analgesics|analgesics|mesh-ancestor
24941963|NCT03985865|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
24941965|NCT03985735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24723327|NCT01586611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24723328|NCT01586611|Antimetabolites|antimetabolites|mesh-ancestor
24723329|NCT01586611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723330|NCT01586611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24723331|NCT01586611|Antiviral Agents|antiviral agents|mesh-ancestor
24723332|NCT01586611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24723333|NCT01586611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24723334|NCT01586611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24723335|NCT01586611|Immunologic Factors|immunologic factors|mesh-ancestor
24723336|NCT01586611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723337|NCT01586611|Antidotes|antidotes|mesh-ancestor
24723338|NCT01586611|Protective Agents|protective agents|mesh-ancestor
24723339|NCT01586611|Vitamin B Complex|vitamin b complex|mesh-ancestor
24723340|NCT01586611|Vitamins|vitamins|mesh-ancestor
24723341|NCT01586611|Micronutrients|micronutrients|mesh-ancestor
24723342|NCT01586845|Cyclosporine|cyclosporine|mesh-list
24723343|NCT01586845|Tacrolimus|tacrolimus|mesh-list
24723344|NCT01586845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24723345|NCT01586845|Immunologic Factors|immunologic factors|mesh-ancestor
24723346|NCT01586845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723347|NCT01586845|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24723348|NCT01586845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24723475|NCT01587508|Cyclobenzaprine|cyclobenzaprine|mesh-list
24723349|NCT01586845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695599|NCT02048891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25695600|NCT02048891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25695601|NCT02048891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25695602|NCT02049151|Cyclophosphamide|cyclophosphamide|mesh-list
25695603|NCT02049151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25695604|NCT02049151|Immunologic Factors|immunologic factors|mesh-ancestor
25695605|NCT02049151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695606|NCT02049151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25695607|NCT02049151|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25695608|NCT02049151|Alkylating Agents|alkylating agents|mesh-ancestor
25695609|NCT02049151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695610|NCT02049151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24723350|NCT01586845|Antifungal Agents|antifungal agents|mesh-ancestor
24723351|NCT01586845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24615769|NCT01031732|Tacrine|tacrine|mesh-list
24723357|NCT01587066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24723358|NCT01587066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24723359|NCT01587066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24723360|NCT01587066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24723361|NCT01587066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723363|NCT01587066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24723364|NCT01587066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723365|NCT01587066|GABA Agents|gaba agents|mesh-ancestor
24723366|NCT01587066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24723368|NCT01587196|Naltrexone|naltrexone|mesh-list
24723373|NCT01587196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24723414|NCT01587326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24723415|NCT01587326|Serotonin Agents|serotonin agents|mesh-ancestor
24723416|NCT01587326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723417|NCT01587326|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24723418|NCT01587326|Antidepressive Agents|antidepressive agents|mesh-ancestor
24723419|NCT01587326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24723420|NCT01587339|Pregabalin|pregabalin|mesh-list
24723421|NCT01587339|Zonisamide|zonisamide|mesh-list
24723422|NCT01587339|Lacosamide|lacosamide|mesh-list
24723423|NCT01587339|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
24723424|NCT01587339|Ezogabine|ezogabine|mesh-list
24723425|NCT01587339|Analgesics|analgesics|mesh-ancestor
24723426|NCT01587339|Sensory System Agents|sensory system agents|mesh-ancestor
24723444|NCT01587430|Daunorubicin|daunorubicin|mesh-list
24941968|NCT03985722|Olaratumab|olaratumab|mesh-list
24941969|NCT03985722|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24941970|NCT03985722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24941971|NCT03985722|Alkylating Agents|alkylating agents|mesh-ancestor
24855223|NCT02278250|Carboplatin|carboplatin|mesh-list
24723445|NCT01587430|Mitoxantrone|mitoxantrone|mesh-list
24723446|NCT01587430|Idarubicin|idarubicin|mesh-list
24723447|NCT01587430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24723448|NCT01587430|Antimetabolites|antimetabolites|mesh-ancestor
24723449|NCT01587430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723450|NCT01587430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24723451|NCT01587430|Antiviral Agents|antiviral agents|mesh-ancestor
24723452|NCT01587430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24441825|NCT00288444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441826|NCT00288444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442158|NCT00290121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24442159|NCT00290121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24442160|NCT00290121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442161|NCT00290121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24442263|NCT00290628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24442264|NCT00290628|Protective Agents|protective agents|mesh-ancestor
24442265|NCT00290641|Cyclosporine|cyclosporine|mesh-list
24442266|NCT00290641|Mycophenolic Acid|mycophenolic acid|mesh-list
24442267|NCT00290641|Cyclophosphamide|cyclophosphamide|mesh-list
24442268|NCT00290641|Fludarabine|fludarabine|mesh-list
24442269|NCT00290641|Fludarabine phosphate|fludarabine phosphate|mesh-list
24442270|NCT00290641|Cyclosporins|cyclosporins|mesh-list
24723453|NCT01587430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24723454|NCT01587430|Immunologic Factors|immunologic factors|mesh-ancestor
24723455|NCT01587430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723456|NCT01587430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24723457|NCT01587430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24723458|NCT01587430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24723459|NCT01587430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24723460|NCT01587430|Analgesics|analgesics|mesh-ancestor
24723461|NCT01587430|Sensory System Agents|sensory system agents|mesh-ancestor
24723462|NCT01587430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24723463|NCT01587482|Paclitaxel|paclitaxel|mesh-list
24723464|NCT01587482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24723465|NCT01587482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24723466|NCT01587482|Tubulin Modulators|tubulin modulators|mesh-ancestor
24723467|NCT01587482|Antimitotic Agents|antimitotic agents|mesh-ancestor
24723468|NCT01587482|Mitosis Modulators|mitosis modulators|mesh-ancestor
24723469|NCT01587482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723470|NCT01587495|Ertapenem|ertapenem|mesh-list
24723471|NCT01587495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24723472|NCT01587495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24723473|NCT01587508|Meloxicam|meloxicam|mesh-list
24723474|NCT01587508|Amitriptyline|amitriptyline|mesh-list
24723478|NCT01587508|Analgesics|analgesics|mesh-ancestor
24723486|NCT01587508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24723487|NCT01587508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723488|NCT01587508|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24723489|NCT01587508|Antidepressive Agents|antidepressive agents|mesh-ancestor
24723490|NCT01587508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24723491|NCT01587508|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24723492|NCT01587508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24723503|NCT01587625|Oxytocin|oxytocin|mesh-list
24723551|NCT01587937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24723552|NCT01587937|Antitubercular Agents|antitubercular agents|mesh-ancestor
24723553|NCT01588002|Ritonavir|ritonavir|mesh-list
24723554|NCT01588002|Efavirenz|efavirenz|mesh-list
24723555|NCT01588002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24723556|NCT01588002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24647740|NCT01210430|Antioxidants|antioxidants|mesh-ancestor
24723557|NCT01588002|Protease Inhibitors|protease inhibitors|mesh-ancestor
24723558|NCT01588002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24723559|NCT01588002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723560|NCT01588002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24723562|NCT01588002|Antiviral Agents|antiviral agents|mesh-ancestor
24723563|NCT01588002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24723564|NCT01588002|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24723565|NCT01588002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24723566|NCT01588002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24723567|NCT01588002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24723568|NCT01588002|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24723569|NCT01588002|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24723570|NCT01588002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24723582|NCT01588314|Gabapentin|gabapentin|mesh-list
24723592|NCT01588314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24723593|NCT01588314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24723594|NCT01588314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24941972|NCT03985722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941973|NCT03985722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941974|NCT03985722|Immunologic Factors|immunologic factors|mesh-ancestor
24941975|NCT03985722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941976|NCT03985319|Esomeprazole|esomeprazole|mesh-list
24855225|NCT02278302|Ethanol|ethanol|mesh-list
24837004|NCT02188394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24723595|NCT01588314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723598|NCT01588522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24723599|NCT01588522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723614|NCT01588587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24723615|NCT01588587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24723616|NCT01588587|Protease Inhibitors|protease inhibitors|mesh-ancestor
24723617|NCT01588587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24723639|NCT01588704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723640|NCT01588704|Growth Inhibitors|growth inhibitors|mesh-ancestor
24723641|NCT01588704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24723642|NCT01588704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723643|NCT01588704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24723644|NCT01588704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24723645|NCT01588717|Glycopyrrolate|glycopyrrolate|mesh-list
24723646|NCT01588717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24941980|NCT03985319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24941981|NCT03985319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941982|NCT03985410|Moxifloxacin|moxifloxacin|mesh-list
24941983|NCT03985410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24941984|NCT03985410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24941985|NCT03985410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24941986|NCT03985410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24941987|NCT03985410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24941988|NCT03985410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941989|NCT03985410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24941990|NCT03985280|Anesthetics|anesthetics|mesh-list
24941991|NCT03985280|Anesthetics, Local|anesthetics, local|mesh-list
24941992|NCT03985280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24723699|NCT01588847|Sensory System Agents|sensory system agents|mesh-ancestor
24723700|NCT01588847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24723701|NCT01588847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24723702|NCT01588847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24723703|NCT01588847|Anesthetics, General|anesthetics, general|mesh-ancestor
24721312|NCT01573338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24721313|NCT01573338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24721314|NCT01573338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24721315|NCT01573338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721316|NCT01573377|Metformin|metformin|mesh-list
24721317|NCT01573377|Cyproterone Acetate|cyproterone acetate|mesh-list
24721318|NCT01573377|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24721319|NCT01573377|Cyproterone|cyproterone|mesh-list
24789333|NCT01936350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24723704|NCT01588847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24723705|NCT01588847|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24723708|NCT01588847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24615788|NCT01031901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24615789|NCT01031901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24615790|NCT01031901|Antifungal Agents|antifungal agents|mesh-ancestor
24615791|NCT01031901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24615792|NCT01031901|Immunologic Factors|immunologic factors|mesh-ancestor
24615793|NCT01031901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615795|NCT01031927|Glycine Agents|glycine agents|mesh-ancestor
24615796|NCT01031927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24941993|NCT03985280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941994|NCT03985280|Sensory System Agents|sensory system agents|mesh-ancestor
24941995|NCT03985280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24855246|NCT02278419|Antiviral Agents|antiviral agents|mesh-ancestor
24615797|NCT01031927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615806|NCT01031992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615807|NCT01031992|Hemostatics|hemostatics|mesh-ancestor
24723711|NCT01588847|Analgesics|analgesics|mesh-ancestor
24723712|NCT01588847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24723713|NCT01588873|Desogestrel|desogestrel|mesh-list
24723714|NCT01588873|NuvaRing|nuvaring|mesh-list
24723715|NCT01588873|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24723716|NCT01588873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24723717|NCT01588873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24723718|NCT01588873|Contraceptive Agents|contraceptive agents|mesh-ancestor
24723719|NCT01588873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24723720|NCT01588873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723749|NCT01588925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24723750|NCT01588925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24723751|NCT01588925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24723752|NCT01588925|Protease Inhibitors|protease inhibitors|mesh-ancestor
24723753|NCT01588925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24723754|NCT01588925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723755|NCT01588925|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24723756|NCT01588925|Immunologic Factors|immunologic factors|mesh-ancestor
24723782|NCT01589068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24723783|NCT01589081|Nicotine|nicotine|mesh-list
24723784|NCT01589081|Progesterone|progesterone|mesh-list
24723785|NCT01589081|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24723786|NCT01589081|Autonomic Agents|autonomic agents|mesh-ancestor
24723787|NCT01589081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24723788|NCT01589081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723789|NCT01589081|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24723790|NCT01589081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24723791|NCT01589081|Cholinergic Agents|cholinergic agents|mesh-ancestor
24723804|NCT01589146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723806|NCT01589159|Etoposide|etoposide|mesh-list
24723819|NCT01589354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723820|NCT01589354|Sensory System Agents|sensory system agents|mesh-ancestor
24723821|NCT01589354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24723822|NCT01589367|Metformin|metformin|mesh-list
24723823|NCT01589367|Letrozole|letrozole|mesh-list
24723824|NCT01589367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25695611|NCT02049151|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25695612|NCT02049307|Losartan|losartan|mesh-list
25695613|NCT02049307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25695614|NCT02049307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25695615|NCT02049307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25695616|NCT02049307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25695617|NCT02049307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695618|NCT02049385|Diazoxide|diazoxide|mesh-list
25695619|NCT02049385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25006389|NCT05123365|Respiratory System Agents|respiratory system agents|mesh-ancestor
25006390|NCT05123365|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25006391|NCT05123365|Antioxidants|antioxidants|mesh-ancestor
25006392|NCT05123365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722521|NCT01581164|Vaccines|vaccines|mesh-list
24723825|NCT01589367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723868|NCT01589471|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24723869|NCT01589471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24723870|NCT01589549|Methylprednisolone|methylprednisolone|mesh-list
24723871|NCT01589549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24723872|NCT01589549|Antiemetics|antiemetics|mesh-ancestor
24723873|NCT01589549|Autonomic Agents|autonomic agents|mesh-ancestor
24723874|NCT01589549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24723875|NCT01589549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723876|NCT01589549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24723877|NCT01589549|Glucocorticoids|glucocorticoids|mesh-ancestor
24723878|NCT01589549|Hormones|hormones|mesh-ancestor
24723879|NCT01589549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24723880|NCT01589549|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24723881|NCT01589549|Protective Agents|protective agents|mesh-ancestor
24723882|NCT01589562|Megestrol|megestrol|mesh-list
24723883|NCT01589562|Megestrol Acetate|megestrol acetate|mesh-list
24723884|NCT01589562|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24723885|NCT01589562|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24723886|NCT01589562|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24723887|NCT01589562|Contraceptive Agents|contraceptive agents|mesh-ancestor
24723888|NCT01589562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24723889|NCT01589562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723926|NCT01589861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24723927|NCT01589861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723929|NCT01589952|Entecavir|entecavir|mesh-list
24723930|NCT01589952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24723931|NCT01589952|Antiviral Agents|antiviral agents|mesh-ancestor
24723932|NCT01589952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24723933|NCT01590173|Prednisolone|prednisolone|mesh-list
24723934|NCT01590173|Heparin|heparin|mesh-list
24723936|NCT01590173|Glucocorticoids|glucocorticoids|mesh-ancestor
24723939|NCT01590173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723940|NCT01590173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24723941|NCT01590173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24723942|NCT01590173|Anticoagulants|anticoagulants|mesh-ancestor
24723943|NCT01590173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24723944|NCT01590173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24723954|NCT01590225|Ribavirin|ribavirin|mesh-list
24723955|NCT01590225|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24723956|NCT01590225|Interferon-alpha|interferon-alpha|mesh-list
24723957|NCT01590225|Antimetabolites|antimetabolites|mesh-ancestor
24723958|NCT01590225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723959|NCT01590225|Antiviral Agents|antiviral agents|mesh-ancestor
24723960|NCT01590225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24723961|NCT01590225|Immunologic Factors|immunologic factors|mesh-ancestor
24723962|NCT01590225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723963|NCT01590277|Ethanol|ethanol|mesh-list
24723964|NCT01590277|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24723965|NCT01590277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24723966|NCT01590277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24723967|NCT01590277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723968|NCT01590303|Ascorbic Acid|ascorbic acid|mesh-list
24723978|NCT01590342|Analgesics|analgesics|mesh-ancestor
24723979|NCT01590342|Sensory System Agents|sensory system agents|mesh-ancestor
24724003|NCT01590654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24724004|NCT01590680|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24724005|NCT01590680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24724006|NCT01590680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724007|NCT01590680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724008|NCT01590680|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24724009|NCT01590693|Botulinum Toxins|botulinum toxins|mesh-list
24724010|NCT01590693|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25695620|NCT02049385|Vasodilator Agents|vasodilator agents|mesh-ancestor
25695621|NCT02049476|Dexamethasone|dexamethasone|mesh-list
25695622|NCT02049476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25695623|NCT02049476|Antiemetics|antiemetics|mesh-ancestor
25695624|NCT02049476|Autonomic Agents|autonomic agents|mesh-ancestor
24724011|NCT01590693|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24724012|NCT01590693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24724013|NCT01590693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24724014|NCT01590693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724015|NCT01590693|Cholinergic Agents|cholinergic agents|mesh-ancestor
24724017|NCT01590693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724018|NCT01590693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24724019|NCT01590693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24724021|NCT01590732|Carboplatin|carboplatin|mesh-list
24724023|NCT01590732|Etoposide phosphate|etoposide phosphate|mesh-list
24724025|NCT01590732|Isophosphamide mustard|isophosphamide mustard|mesh-list
24724026|NCT01590732|Podophyllotoxin|podophyllotoxin|mesh-list
24724027|NCT01590732|Romidepsin|romidepsin|mesh-list
24724028|NCT01590732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24724029|NCT01590732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24724030|NCT01590732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24724031|NCT01590732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24724032|NCT01590732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724033|NCT01590732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724034|NCT01590732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24724035|NCT01590732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24724036|NCT01590732|Alkylating Agents|alkylating agents|mesh-ancestor
24724037|NCT01590732|Keratolytic Agents|keratolytic agents|mesh-ancestor
24724044|NCT01590823|Antithrombins|antithrombins|mesh-ancestor
24724045|NCT01590823|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24724046|NCT01590823|Protease Inhibitors|protease inhibitors|mesh-ancestor
24724047|NCT01590823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724048|NCT01590823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724049|NCT01590823|Anticoagulants|anticoagulants|mesh-ancestor
24724051|NCT01590836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24724052|NCT01590836|Insulin Aspart|insulin aspart|mesh-list
24724053|NCT01590836|Insulin, Long-Acting|insulin, long-acting|mesh-list
24724054|NCT01590836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24724055|NCT01590836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724056|NCT01590849|Contraceptive Agents|contraceptive agents|mesh-list
24442271|NCT00290641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24442272|NCT00290641|Immunologic Factors|immunologic factors|mesh-ancestor
24442273|NCT00290641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442274|NCT00290641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24442275|NCT00290641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24442276|NCT00290641|Alkylating Agents|alkylating agents|mesh-ancestor
24442278|NCT00290641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442304|NCT00290667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442305|NCT00290667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24442306|NCT00290667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24442307|NCT00290667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24724057|NCT01590849|Contraceptives, Oral|contraceptives, oral|mesh-list
24942016|NCT03985358|Narcotics|narcotics|mesh-ancestor
24942017|NCT03985358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24942018|NCT03985358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942019|NCT03985358|Analgesics|analgesics|mesh-ancestor
24942020|NCT03985358|Sensory System Agents|sensory system agents|mesh-ancestor
24942021|NCT03985358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24767105|NCT01798771|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24767106|NCT01798771|Dermatologic Agents|dermatologic agents|mesh-ancestor
24767107|NCT01798836|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24767108|NCT01798836|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24615809|NCT01032031|Ascorbic Acid|ascorbic acid|mesh-list
24615810|NCT01032031|Vitamins|vitamins|mesh-ancestor
24615811|NCT01032031|Micronutrients|micronutrients|mesh-ancestor
24615812|NCT01032031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615813|NCT01032031|Antioxidants|antioxidants|mesh-ancestor
24615814|NCT01032031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615815|NCT01032031|Protective Agents|protective agents|mesh-ancestor
24615816|NCT01032057|Gemcitabine|gemcitabine|mesh-list
24724058|NCT01590849|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
24724059|NCT01590849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24724060|NCT01590849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724061|NCT01590849|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24724062|NCT01590901|Probucol|probucol|mesh-list
24724063|NCT01590901|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24724064|NCT01590901|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24724065|NCT01590901|Antimetabolites|antimetabolites|mesh-ancestor
24724066|NCT01590901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723626|NCT01588626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723627|NCT01588626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723628|NCT01588639|Insulin|insulin|mesh-list
24789490|NCT01937611|Midazolam|midazolam|mesh-list
24724067|NCT01590901|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24724068|NCT01590901|Antioxidants|antioxidants|mesh-ancestor
24724082|NCT01591031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24724083|NCT01591031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724093|NCT01591070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724094|NCT01591070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724095|NCT01591083|Esomeprazole|esomeprazole|mesh-list
24724096|NCT01591083|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24724097|NCT01591083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24724098|NCT01591083|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24724099|NCT01591083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724100|NCT01591083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724102|NCT01591122|Abiraterone Acetate|abiraterone acetate|mesh-list
24724103|NCT01591122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24724104|NCT01591122|Glucocorticoids|glucocorticoids|mesh-ancestor
24724106|NCT01591122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24724107|NCT01591122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724108|NCT01591122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24724109|NCT01591122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24724110|NCT01591122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24724111|NCT01591122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724144|NCT01591226|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24724145|NCT01591226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724146|NCT01591226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24767110|NCT01798836|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24767111|NCT01798836|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24767112|NCT01798836|Estrogens|estrogens|mesh-ancestor
24767113|NCT01798836|Hormones|hormones|mesh-ancestor
24767115|NCT01798836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724161|NCT01591291|Antipruritics|antipruritics|mesh-ancestor
24724162|NCT01591291|Dermatologic Agents|dermatologic agents|mesh-ancestor
24724163|NCT01591291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24724164|NCT01591291|Serotonin Agents|serotonin agents|mesh-ancestor
24724165|NCT01591291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24724166|NCT01591291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724167|NCT01591291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24724168|NCT01591291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24724169|NCT01591291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24724170|NCT01591291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24724171|NCT01591291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24724176|NCT01591434|Laxatives|laxatives|mesh-ancestor
24724177|NCT01591434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24724178|NCT01591551|Natalizumab|natalizumab|mesh-list
24724179|NCT01591551|Immunologic Factors|immunologic factors|mesh-ancestor
24724180|NCT01591551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724181|NCT01591668|Vesatolimod|vesatolimod|mesh-list
24724182|NCT01591668|Antiviral Agents|antiviral agents|mesh-ancestor
24724183|NCT01591668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24724184|NCT01591759|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
24724185|NCT01591759|Nootropic Agents|nootropic agents|mesh-ancestor
24724195|NCT01591850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24724196|NCT01591850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24724197|NCT01591850|Antiviral Agents|antiviral agents|mesh-ancestor
24724198|NCT01591850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24724199|NCT01591850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24724200|NCT01591850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24724201|NCT01591850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24724202|NCT01591850|Antitubercular Agents|antitubercular agents|mesh-ancestor
24724203|NCT01591850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24724204|NCT01591850|Leprostatic Agents|leprostatic agents|mesh-ancestor
24724220|NCT01591889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724222|NCT01591889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24724223|NCT01591889|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
24724224|NCT01591889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24724225|NCT01591889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24724226|NCT01591902|Tesamorelin|tesamorelin|mesh-list
25695625|NCT02049476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25695626|NCT02049476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695627|NCT02049476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25695628|NCT02049476|Glucocorticoids|glucocorticoids|mesh-ancestor
24724230|NCT01591980|Analgesics|analgesics|mesh-ancestor
24724231|NCT01591980|Sensory System Agents|sensory system agents|mesh-ancestor
24724232|NCT01591980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24724233|NCT01591980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724234|NCT01591980|Anticonvulsants|anticonvulsants|mesh-ancestor
24724235|NCT01591980|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24767117|NCT01798836|Contraceptive Agents|contraceptive agents|mesh-ancestor
24767118|NCT01798836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24767119|NCT01798836|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24724236|NCT01591980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24724237|NCT01591980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724238|NCT01591980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24724239|NCT01591980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24724240|NCT01591980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24724241|NCT01591980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24724242|NCT01591980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24724243|NCT01592019|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
24724245|NCT01592019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24724246|NCT01592019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24724247|NCT01592019|Analgesics|analgesics|mesh-ancestor
24724267|NCT01592032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24724268|NCT01592032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24724269|NCT01592032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724270|NCT01592032|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24724271|NCT01592032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724272|NCT01592110|Risperidone|risperidone|mesh-list
24724273|NCT01592110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24724274|NCT01592110|Serotonin Agents|serotonin agents|mesh-ancestor
24724275|NCT01592110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24724276|NCT01592110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724282|NCT01592110|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24724283|NCT01592110|Dopamine Agents|dopamine agents|mesh-ancestor
24724284|NCT01592136|Ponatinib|ponatinib|mesh-list
24724285|NCT01592136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24724286|NCT01592136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24724287|NCT01592136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724315|NCT01592201|Dopamine Agents|dopamine agents|mesh-ancestor
24724316|NCT01592201|Antiemetics|antiemetics|mesh-ancestor
24724317|NCT01592201|Autonomic Agents|autonomic agents|mesh-ancestor
24724318|NCT01592201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24724319|NCT01592201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24724320|NCT01592201|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24724321|NCT01592201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24724322|NCT01592201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24724323|NCT01592201|Antidepressive Agents|antidepressive agents|mesh-ancestor
24724324|NCT01592201|Dopamine Agonists|dopamine agonists|mesh-ancestor
24724325|NCT01592201|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24724326|NCT01592201|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24724327|NCT01592201|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24724328|NCT01592201|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24724329|NCT01592214|Benzocaine|benzocaine|mesh-list
24724330|NCT01592214|Anesthetics, Local|anesthetics, local|mesh-ancestor
24724331|NCT01592214|Anesthetics|anesthetics|mesh-ancestor
24724332|NCT01592214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24724333|NCT01592214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724334|NCT01592214|Sensory System Agents|sensory system agents|mesh-ancestor
24724368|NCT01592305|Antiviral Agents|antiviral agents|mesh-ancestor
24724369|NCT01592305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24724370|NCT01592305|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24724371|NCT01592305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24724372|NCT01592305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24724373|NCT01592305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24767120|NCT01798875|Metformin|metformin|mesh-list
24767121|NCT01798875|Contraceptive Agents|contraceptive agents|mesh-list
24767122|NCT01798875|Contraceptives, Oral|contraceptives, oral|mesh-list
24942049|NCT03984591|Spironolactone|spironolactone|mesh-list
24942050|NCT03984591|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24942051|NCT03984591|Hormone Antagonists|hormone antagonists|mesh-ancestor
24942052|NCT03984591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24942053|NCT03984591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006450|NCT05055947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006451|NCT05055908|Atezolizumab|atezolizumab|mesh-list
25006452|NCT05055908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791403|NCT04487990|Heparin|heparin|mesh-list
24791404|NCT04487990|Calcium heparin|calcium heparin|mesh-list
24560774|NCT01451515|Asparaginase|asparaginase|mesh-list
25006489|NCT04984330|Hormones|hormones|mesh-ancestor
25006490|NCT04984330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25006491|NCT04984330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24942054|NCT03984591|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24942056|NCT03984591|Natriuretic Agents|natriuretic agents|mesh-ancestor
24942057|NCT03984591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24942058|NCT03984526|Atropine|atropine|mesh-list
24942059|NCT03984526|Ephedrine|ephedrine|mesh-list
24942060|NCT03984526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24942061|NCT03984526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24942062|NCT03984526|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24942063|NCT03984526|Autonomic Agents|autonomic agents|mesh-ancestor
24942064|NCT03984526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24942065|NCT03984526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724381|NCT01592318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24724382|NCT01592318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24724383|NCT01592318|Antiviral Agents|antiviral agents|mesh-ancestor
24724384|NCT01592318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24724385|NCT01592318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24615842|NCT01032109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24615843|NCT01032109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24615844|NCT01032109|Growth Substances|growth substances|mesh-ancestor
24615845|NCT01032109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615846|NCT01032109|Growth Inhibitors|growth inhibitors|mesh-ancestor
24615847|NCT01032122|Rituximab|rituximab|mesh-list
24724417|NCT01592981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24724418|NCT01592981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24724420|NCT01593033|Trace Elements|trace elements|mesh-list
24724421|NCT01593033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724422|NCT01593046|Cabotegravir|cabotegravir|mesh-list
24724423|NCT01593046|Rilpivirine|rilpivirine|mesh-list
24724424|NCT01593046|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24724425|NCT01593046|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24724426|NCT01593046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724427|NCT01593046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724428|NCT01593046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24942066|NCT03984526|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24724429|NCT01593046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24724430|NCT01593046|Antiviral Agents|antiviral agents|mesh-ancestor
24724431|NCT01593046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24724432|NCT01593046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24724433|NCT01593046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24724435|NCT01593124|Nonoxynol|nonoxynol|mesh-list
24724436|NCT01593124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24724437|NCT01593124|Immunologic Factors|immunologic factors|mesh-ancestor
24724438|NCT01593124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724439|NCT01593124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24724440|NCT01593124|Interferon Inducers|interferon inducers|mesh-ancestor
24724441|NCT01593124|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
24724442|NCT01593124|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
24724443|NCT01593124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24724444|NCT01593124|Contraceptive Agents|contraceptive agents|mesh-ancestor
24724445|NCT01593124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24724459|NCT01593150|Antithrombins|antithrombins|mesh-ancestor
24724502|NCT01593319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24724503|NCT01593319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724504|NCT01593319|Sensory System Agents|sensory system agents|mesh-ancestor
24724505|NCT01593319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24724507|NCT01593332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24724508|NCT01593332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25695629|NCT02049476|Hormones|hormones|mesh-ancestor
25695630|NCT02049476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25695631|NCT02049476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25695632|NCT02049476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25695633|NCT02049814|Metformin|metformin|mesh-list
25695634|NCT02049814|Acarbose|acarbose|mesh-list
25695635|NCT02049814|Voglibose|voglibose|mesh-list
25695636|NCT02049814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25695637|NCT02049814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724509|NCT01593332|Immunologic Factors|immunologic factors|mesh-ancestor
24725011|NCT01595984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24725015|NCT01595984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24725016|NCT01596010|Norethindrone|norethindrone|mesh-list
24440361|NCT00282503|Hormones|hormones|mesh-ancestor
24725017|NCT01596010|Norethindrone Acetate|norethindrone acetate|mesh-list
24725018|NCT01596010|Estradiol|estradiol|mesh-list
24725019|NCT01596010|Estrogens|estrogens|mesh-ancestor
24725020|NCT01596010|Hormones|hormones|mesh-ancestor
24725021|NCT01596010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24725053|NCT01596166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24725054|NCT01596166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24724510|NCT01593332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724511|NCT01593332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24724513|NCT01593371|Pioglitazone|pioglitazone|mesh-list
24724514|NCT01593371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24724515|NCT01593371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724516|NCT01593397|Fentanyl|fentanyl|mesh-list
24724517|NCT01593397|Propofol|propofol|mesh-list
24724518|NCT01593397|Anesthetics|anesthetics|mesh-list
24724519|NCT01593397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24724520|NCT01593397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24724521|NCT01593397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724522|NCT01593397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24724523|NCT01593397|Anesthetics, General|anesthetics, general|mesh-ancestor
24724524|NCT01593397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24724525|NCT01593397|Narcotics|narcotics|mesh-ancestor
24724526|NCT01593397|Analgesics|analgesics|mesh-ancestor
24724527|NCT01593397|Sensory System Agents|sensory system agents|mesh-ancestor
24724528|NCT01593397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24724529|NCT01593397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24724530|NCT01593410|Dexamethasone|dexamethasone|mesh-list
24724531|NCT01593410|Lenalidomide|lenalidomide|mesh-list
24724532|NCT01593410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24724544|NCT01593410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24442308|NCT00290667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24442319|NCT00290667|Mitosis Modulators|mitosis modulators|mesh-ancestor
24442321|NCT00290680|Bortezomib|bortezomib|mesh-list
24442322|NCT00290680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442323|NCT00290680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24442324|NCT00290680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24442325|NCT00290680|Analgesics|analgesics|mesh-ancestor
24442326|NCT00290680|Sensory System Agents|sensory system agents|mesh-ancestor
24442327|NCT00290680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24442328|NCT00290680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724545|NCT01593410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24724546|NCT01593410|Growth Substances|growth substances|mesh-ancestor
24724547|NCT01593410|Growth Inhibitors|growth inhibitors|mesh-ancestor
24724549|NCT01593488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24724550|NCT01593488|Antimetabolites|antimetabolites|mesh-ancestor
24724551|NCT01593488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724552|NCT01593488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24724553|NCT01593488|Antiviral Agents|antiviral agents|mesh-ancestor
24724565|NCT01593514|Lactitol|lactitol|mesh-list
24724566|NCT01593514|Vaccines|vaccines|mesh-list
24724567|NCT01593514|Immunologic Factors|immunologic factors|mesh-ancestor
24942067|NCT03984526|Respiratory System Agents|respiratory system agents|mesh-ancestor
24942068|NCT03984526|Mydriatics|mydriatics|mesh-ancestor
24724568|NCT01593514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724569|NCT01593514|Cathartics|cathartics|mesh-ancestor
24724570|NCT01593514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24724589|NCT01593644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25695638|NCT02049814|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25695639|NCT02049814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25695640|NCT02049814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695641|NCT02049866|Denosumab|denosumab|mesh-list
25695642|NCT02049866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25695643|NCT02049866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695644|NCT02049944|Cefazolin|cefazolin|mesh-list
25695645|NCT02049944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25695646|NCT02049944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25695647|NCT02049957|Fulvestrant|fulvestrant|mesh-list
25695648|NCT02049957|Exemestane|exemestane|mesh-list
24724590|NCT01593644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724591|NCT01593644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24724609|NCT01593826|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24724611|NCT01593826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24724612|NCT01593826|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24724613|NCT01593826|Autonomic Agents|autonomic agents|mesh-ancestor
24724614|NCT01593826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24724615|NCT01593826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724616|NCT01593826|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24724617|NCT01593826|Respiratory System Agents|respiratory system agents|mesh-ancestor
24724618|NCT01593826|Glucocorticoids|glucocorticoids|mesh-ancestor
24724619|NCT01593826|Hormones|hormones|mesh-ancestor
24615900|NCT01032486|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24615901|NCT01032486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615902|NCT01032486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724621|NCT01593826|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24724622|NCT01593826|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24724623|NCT01593826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24724624|NCT01593826|Adrenergic Agents|adrenergic agents|mesh-ancestor
24724625|NCT01593826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24724626|NCT01593826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724627|NCT01593826|Antidotes|antidotes|mesh-ancestor
24724628|NCT01593826|Protective Agents|protective agents|mesh-ancestor
24724629|NCT01593930|Lidocaine|lidocaine|mesh-list
24724630|NCT01593930|Carticaine|carticaine|mesh-list
24724631|NCT01593930|Anesthetics, Local|anesthetics, local|mesh-ancestor
24724632|NCT01593930|Anesthetics|anesthetics|mesh-ancestor
24724663|NCT01594047|Respiratory System Agents|respiratory system agents|mesh-ancestor
24724664|NCT01594060|Insulin|insulin|mesh-list
24724665|NCT01594060|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24724666|NCT01594060|Insulin Glargine|insulin glargine|mesh-list
24724667|NCT01594060|Insulin glulisine|insulin glulisine|mesh-list
24724668|NCT01594060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24724669|NCT01594060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724677|NCT01594099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724678|NCT01594177|Paclitaxel|paclitaxel|mesh-list
24724679|NCT01594177|Cyclophosphamide|cyclophosphamide|mesh-list
24724680|NCT01594177|Trastuzumab|trastuzumab|mesh-list
24724681|NCT01594177|Epirubicin|epirubicin|mesh-list
24724736|NCT01594346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770052|NCT01817452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24724737|NCT01594346|Protective Agents|protective agents|mesh-ancestor
24512345|NCT00574366|Immunologic Factors|immunologic factors|mesh-ancestor
24724768|NCT01594619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24724774|NCT01594671|Tranexamic Acid|tranexamic acid|mesh-list
24724804|NCT01594866|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24724805|NCT01594866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24724806|NCT01594866|Cholinergic Agents|cholinergic agents|mesh-ancestor
24724807|NCT01594879|Levonorgestrel|levonorgestrel|mesh-list
24724808|NCT01594879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24724809|NCT01594879|Contraceptive Agents|contraceptive agents|mesh-ancestor
24512430|NCT00574925|Esomeprazole|esomeprazole|mesh-list
24724810|NCT01594879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24724811|NCT01594879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837251|NCT02190695|Carboplatin|carboplatin|mesh-list
24724812|NCT01594879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24725049|NCT01596140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724813|NCT01594879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24724814|NCT01594879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24724815|NCT01594905|Tenofovir|tenofovir|mesh-list
24724816|NCT01594905|Entecavir|entecavir|mesh-list
24724817|NCT01594905|Antiviral Agents|antiviral agents|mesh-ancestor
24724818|NCT01594905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24724819|NCT01594905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24724820|NCT01594905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24724821|NCT01594905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724822|NCT01594905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724823|NCT01594905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24724824|NCT01594905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24724825|NCT01594918|Prednisone|prednisone|mesh-list
24724827|NCT01594918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24724828|NCT01594918|Glucocorticoids|glucocorticoids|mesh-ancestor
24724829|NCT01594918|Hormones|hormones|mesh-ancestor
24724847|NCT01595022|Levonorgestrel|levonorgestrel|mesh-list
24724848|NCT01595022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24442329|NCT00290680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24724849|NCT01595022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724850|NCT01595022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24724851|NCT01595022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24942072|NCT03984526|Cholinergic Agents|cholinergic agents|mesh-ancestor
24942073|NCT03984526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24942074|NCT03984526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724852|NCT01595022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24724853|NCT01595022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24724854|NCT01595152|Solifenacin Succinate|solifenacin succinate|mesh-list
24724855|NCT01595152|Fesoterodine|fesoterodine|mesh-list
24724856|NCT01595152|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24724857|NCT01595152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24724858|NCT01595152|Cholinergic Agents|cholinergic agents|mesh-ancestor
24724859|NCT01595152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24724862|NCT01595152|Urological Agents|urological agents|mesh-ancestor
24724887|NCT01595425|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24724888|NCT01595425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24724889|NCT01595425|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24724890|NCT01595425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724891|NCT01595425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724892|NCT01595594|Doxycycline|doxycycline|mesh-list
24724893|NCT01595594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24724894|NCT01595594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24724895|NCT01595594|Antimalarials|antimalarials|mesh-ancestor
24724896|NCT01595594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24724897|NCT01595594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24724898|NCT01595633|Tenofovir|tenofovir|mesh-list
24724899|NCT01595633|Adefovir|adefovir|mesh-list
24724900|NCT01595633|Antiviral Agents|antiviral agents|mesh-ancestor
24724901|NCT01595633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24615941|NCT01033084|Serotonin Agents|serotonin agents|mesh-ancestor
24615942|NCT01033084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615943|NCT01033097|Betamethasone|betamethasone|mesh-list
24615944|NCT01033097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24615948|NCT01033097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615949|NCT01033097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24837394|NCT02191189|Antiviral Agents|antiviral agents|mesh-ancestor
24615950|NCT01033097|Respiratory System Agents|respiratory system agents|mesh-ancestor
24615951|NCT01033149|Acetylcysteine|acetylcysteine|mesh-list
24615952|NCT01033149|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24615953|NCT01033149|Antiviral Agents|antiviral agents|mesh-ancestor
24724906|NCT01595633|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24724907|NCT01595633|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24724909|NCT01595685|Telbivudine|telbivudine|mesh-list
24724910|NCT01595685|Antiviral Agents|antiviral agents|mesh-ancestor
24724911|NCT01595685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24724912|NCT01595685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24724913|NCT01595685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724914|NCT01595685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724916|NCT01595724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24724917|NCT01595724|Contraceptive Agents|contraceptive agents|mesh-ancestor
24724918|NCT01595724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24724919|NCT01595724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724920|NCT01595724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24724921|NCT01595724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24724922|NCT01595724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24724923|NCT01595724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24724924|NCT01595724|Hormone Antagonists|hormone antagonists|mesh-ancestor
24724925|NCT01595724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24724929|NCT01595737|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24724930|NCT01595737|Vasodilator Agents|vasodilator agents|mesh-ancestor
24724931|NCT01595737|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24724932|NCT01595737|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24724933|NCT01595737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724934|NCT01595737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724935|NCT01595737|Protective Agents|protective agents|mesh-ancestor
24724936|NCT01595737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724937|NCT01595763|Fibrin fragment D|fibrin fragment d|mesh-list
24724938|NCT01595763|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24724939|NCT01595763|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24724940|NCT01595763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724941|NCT01595763|Hemostatics|hemostatics|mesh-ancestor
24724942|NCT01595763|Coagulants|coagulants|mesh-ancestor
24724943|NCT01595789|Liraglutide|liraglutide|mesh-list
24724944|NCT01595789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24724945|NCT01595789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724946|NCT01595789|Incretins|incretins|mesh-ancestor
24724948|NCT01595789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24724950|NCT01595815|Ionophores|ionophores|mesh-list
24724951|NCT01595815|Calcium Ionophores|calcium ionophores|mesh-list
24724952|NCT01595815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24724979|NCT01595893|Cholecalciferol|cholecalciferol|mesh-list
24724980|NCT01595893|Vitamins|vitamins|mesh-ancestor
24724988|NCT01595958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724990|NCT01595958|Immunologic Factors|immunologic factors|mesh-ancestor
24724991|NCT01595958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724992|NCT01595958|Antifungal Agents|antifungal agents|mesh-ancestor
24724993|NCT01595958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24724994|NCT01595958|Dermatologic Agents|dermatologic agents|mesh-ancestor
24724995|NCT01595958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24724996|NCT01595958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24724997|NCT01595984|Cyclosporine|cyclosporine|mesh-list
24724998|NCT01595984|Mycophenolic Acid|mycophenolic acid|mesh-list
24724999|NCT01595984|Everolimus|everolimus|mesh-list
24725000|NCT01595984|Cyclosporins|cyclosporins|mesh-list
24725001|NCT01595984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725002|NCT01595984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725003|NCT01595984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24725004|NCT01595984|Immunologic Factors|immunologic factors|mesh-ancestor
24725005|NCT01595984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725006|NCT01595984|Antifungal Agents|antifungal agents|mesh-ancestor
24725007|NCT01595984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24725008|NCT01595984|Dermatologic Agents|dermatologic agents|mesh-ancestor
24725009|NCT01595984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24725022|NCT01596010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725023|NCT01596010|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24444489|NCT00298194|Z 338|z 338|mesh-list
24725024|NCT01596010|Contraceptive Agents|contraceptive agents|mesh-ancestor
24725025|NCT01596010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24725026|NCT01596010|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24725027|NCT01596010|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24725028|NCT01596010|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24725029|NCT01596010|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24725031|NCT01596075|Anticonvulsants|anticonvulsants|mesh-ancestor
24725032|NCT01596114|Tin Fluorides|tin fluorides|mesh-list
24725033|NCT01596114|Cariostatic Agents|cariostatic agents|mesh-ancestor
24725034|NCT01596114|Protective Agents|protective agents|mesh-ancestor
24725035|NCT01596114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725037|NCT01596140|Everolimus|everolimus|mesh-list
24725038|NCT01596140|Vemurafenib|vemurafenib|mesh-list
24725039|NCT01596140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24725040|NCT01596140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24725041|NCT01596140|Immunologic Factors|immunologic factors|mesh-ancestor
24725042|NCT01596140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725043|NCT01596140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725044|NCT01596140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24725045|NCT01596140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24725046|NCT01596140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24725047|NCT01596140|Antifungal Agents|antifungal agents|mesh-ancestor
24725048|NCT01596140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24725051|NCT01596166|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24725052|NCT01596166|Metoclopramide|metoclopramide|mesh-list
24725067|NCT01596166|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24725068|NCT01596166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24725069|NCT01596166|Dopamine Agents|dopamine agents|mesh-ancestor
24725070|NCT01596166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24725071|NCT01596218|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24725072|NCT01596218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24725087|NCT01596400|Autonomic Agents|autonomic agents|mesh-ancestor
24725088|NCT01596400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24725089|NCT01596400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725090|NCT01596400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24725091|NCT01596400|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24725092|NCT01596400|Serotonin Agents|serotonin agents|mesh-ancestor
24725093|NCT01596400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24725094|NCT01596400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725095|NCT01596413|Granisetron|granisetron|mesh-list
24725096|NCT01596413|Antiemetics|antiemetics|mesh-ancestor
24725097|NCT01596413|Autonomic Agents|autonomic agents|mesh-ancestor
24725098|NCT01596413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24725099|NCT01596413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725100|NCT01596413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24725101|NCT01596413|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24725107|NCT01596426|Autonomic Agents|autonomic agents|mesh-ancestor
24725108|NCT01596426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24725109|NCT01596426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725110|NCT01596426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24725111|NCT01596426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24725112|NCT01596426|Serotonin Agents|serotonin agents|mesh-ancestor
24725113|NCT01596426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24725114|NCT01596426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725116|NCT01596517|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24725117|NCT01596517|Interferon-alpha|interferon-alpha|mesh-list
24725118|NCT01596517|Antimetabolites|antimetabolites|mesh-ancestor
24725119|NCT01596517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725120|NCT01596517|Antiviral Agents|antiviral agents|mesh-ancestor
24725121|NCT01596517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24725122|NCT01596517|Immunologic Factors|immunologic factors|mesh-ancestor
24725123|NCT01596517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725124|NCT01596556|Nicotine|nicotine|mesh-list
24725125|NCT01596556|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24725126|NCT01596556|Autonomic Agents|autonomic agents|mesh-ancestor
24725127|NCT01596556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24725128|NCT01596556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725129|NCT01596556|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24725130|NCT01596556|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24725131|NCT01596556|Cholinergic Agents|cholinergic agents|mesh-ancestor
24725132|NCT01596556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24725133|NCT01596556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725134|NCT01596634|Lactoferrin|lactoferrin|mesh-list
24725135|NCT01596634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24725136|NCT01596647|Diclofenac|diclofenac|mesh-list
24725137|NCT01596647|Midazolam|midazolam|mesh-list
24725138|NCT01596647|Caffeine|caffeine|mesh-list
24725152|NCT01596647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24725153|NCT01596647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725154|NCT01596647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24725155|NCT01596647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24725156|NCT01596647|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24725157|NCT01596647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725158|NCT01596647|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24725159|NCT01596647|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24837891|NCT02194179|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24837892|NCT02194179|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24725194|NCT01596738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725195|NCT01596738|Hemostatics|hemostatics|mesh-ancestor
24725196|NCT01596738|Coagulants|coagulants|mesh-ancestor
24725197|NCT01596764|Sulfasalazine|sulfasalazine|mesh-list
24725199|NCT01596764|Methylnaltrexone|methylnaltrexone|mesh-list
24725200|NCT01596764|Loperamide|loperamide|mesh-list
24725201|NCT01596764|Antidiarrheals|antidiarrheals|mesh-list
24725202|NCT01596764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24725203|NCT01596764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725204|NCT01596764|Sensory System Agents|sensory system agents|mesh-ancestor
24942081|NCT03984409|Natriuretic Agents|natriuretic agents|mesh-ancestor
24725205|NCT01596764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24725206|NCT01596764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24725218|NCT01596777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24725219|NCT01596777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24725220|NCT01596777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725221|NCT01596777|Sensory System Agents|sensory system agents|mesh-ancestor
24725222|NCT01596777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24725223|NCT01596777|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24725224|NCT01596777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24725225|NCT01596777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24725226|NCT01596777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24725227|NCT01596777|Analgesics|analgesics|mesh-ancestor
24725239|NCT01596803|Micronutrients|micronutrients|mesh-ancestor
24725240|NCT01596855|Epoetin Alfa|epoetin alfa|mesh-list
24725241|NCT01596855|Hematinics|hematinics|mesh-ancestor
24725242|NCT01596868|Gemcitabine|gemcitabine|mesh-list
24725244|NCT01596868|Docetaxel|docetaxel|mesh-list
24512902|NCT00577369|Desflurane|desflurane|mesh-list
24725260|NCT01596894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24725261|NCT01596894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24725262|NCT01596894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24725263|NCT01596894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24725264|NCT01596907|Ephedrine|ephedrine|mesh-list
24725266|NCT01596907|Caffeine|caffeine|mesh-list
24725267|NCT01596907|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24725270|NCT01596907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615964|NCT01033279|Anticoagulants|anticoagulants|mesh-ancestor
24615965|NCT01033305|Cyclosporine|cyclosporine|mesh-list
24615966|NCT01033305|Cyclosporins|cyclosporins|mesh-list
24615967|NCT01033305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615968|NCT01033305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615969|NCT01033305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24615970|NCT01033305|Immunologic Factors|immunologic factors|mesh-ancestor
24615971|NCT01033305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615972|NCT01033305|Antifungal Agents|antifungal agents|mesh-ancestor
24615973|NCT01033305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24615974|NCT01033305|Dermatologic Agents|dermatologic agents|mesh-ancestor
24615975|NCT01033305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24615977|NCT01033318|Losartan|losartan|mesh-list
24615979|NCT01033318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24615980|NCT01033318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24615981|NCT01033318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24615982|NCT01033318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615983|NCT01033370|Clevidipine|clevidipine|mesh-list
24615984|NCT01033370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24615985|NCT01033370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24647978|NCT01211704|Serotonin Agents|serotonin agents|mesh-ancestor
24615986|NCT01033370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615987|NCT01033370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24616008|NCT01033500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512962|NCT00577837|Etidronic Acid|etidronic acid|mesh-list
24725279|NCT01596907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24725280|NCT01596907|Adrenergic Agents|adrenergic agents|mesh-ancestor
24725281|NCT01596907|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24725282|NCT01596907|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24725283|NCT01596907|Respiratory System Agents|respiratory system agents|mesh-ancestor
24725284|NCT01596907|Nasal Decongestants|nasal decongestants|mesh-ancestor
24725285|NCT01596998|Epinephrine|epinephrine|mesh-list
24725286|NCT01596998|Racepinephrine|racepinephrine|mesh-list
24725287|NCT01596998|Levobupivacaine|levobupivacaine|mesh-list
24725288|NCT01596998|Epinephryl borate|epinephryl borate|mesh-list
24855317|NCT02278913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24725296|NCT01596998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24473368|NCT00402571|Antipyretics|antipyretics|mesh-ancestor
24473375|NCT00402610|Isoniazid|isoniazid|mesh-list
24442330|NCT00290680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24442331|NCT00290680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24442332|NCT00290680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24442333|NCT00290680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442334|NCT00290680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442335|NCT00290719|Irinotecan|irinotecan|mesh-list
24442336|NCT00290719|Gefitinib|gefitinib|mesh-list
24442395|NCT00290849|Protease Inhibitors|protease inhibitors|mesh-ancestor
24442396|NCT00290849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442397|NCT00290849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442400|NCT00290901|Tramadol|tramadol|mesh-list
24442401|NCT00290901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24442402|NCT00290901|Narcotics|narcotics|mesh-ancestor
24442422|NCT00290914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725298|NCT01596998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24725300|NCT01596998|Respiratory System Agents|respiratory system agents|mesh-ancestor
24725301|NCT01596998|Mydriatics|mydriatics|mesh-ancestor
24725302|NCT01596998|Sympathomimetics|sympathomimetics|mesh-ancestor
24725303|NCT01596998|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24725304|NCT01596998|Anesthetics, Local|anesthetics, local|mesh-ancestor
24725305|NCT01596998|Anesthetics|anesthetics|mesh-ancestor
24725306|NCT01596998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24725307|NCT01596998|Sensory System Agents|sensory system agents|mesh-ancestor
24725308|NCT01597011|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24725309|NCT01597011|Hemostatics|hemostatics|mesh-ancestor
24725320|NCT01597167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24725321|NCT01597167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24725322|NCT01597167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725323|NCT01597167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24725324|NCT01597167|Tocolytic Agents|tocolytic agents|mesh-ancestor
24725325|NCT01597167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24725326|NCT01597206|Cobalt|cobalt|mesh-list
24725327|NCT01597206|Trace Elements|trace elements|mesh-ancestor
24725328|NCT01597206|Micronutrients|micronutrients|mesh-ancestor
24725329|NCT01597206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725330|NCT01597232|Chrysarobin|chrysarobin|mesh-list
24725331|NCT01597232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24725332|NCT01597232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24725333|NCT01597232|Analgesics|analgesics|mesh-ancestor
24725334|NCT01597232|Sensory System Agents|sensory system agents|mesh-ancestor
24725335|NCT01597232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24725336|NCT01597232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725337|NCT01597232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24725338|NCT01597232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24725339|NCT01597297|4-Aminopyridine|4-aminopyridine|mesh-list
24725340|NCT01597297|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24725341|NCT01597297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24473424|NCT00402766|Antiemetics|antiemetics|mesh-ancestor
24442424|NCT00290914|Serotonin Agents|serotonin agents|mesh-ancestor
24442425|NCT00290914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442426|NCT00290914|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24725342|NCT01597297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725343|NCT01597310|Pramipexole|pramipexole|mesh-list
24725344|NCT01597310|Warfarin|warfarin|mesh-list
24725345|NCT01597310|Anticoagulants|anticoagulants|mesh-ancestor
24725346|NCT01597310|Antioxidants|antioxidants|mesh-ancestor
24725347|NCT01597310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725348|NCT01597310|Protective Agents|protective agents|mesh-ancestor
24725349|NCT01597310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725362|NCT01597427|Sensory System Agents|sensory system agents|mesh-ancestor
24725363|NCT01597427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24725364|NCT01597427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725365|NCT01597427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24725366|NCT01597427|Sympatholytics|sympatholytics|mesh-ancestor
24725367|NCT01597427|Autonomic Agents|autonomic agents|mesh-ancestor
24725368|NCT01597427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24725369|NCT01597427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24725370|NCT01597427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24725371|NCT01597427|Adrenergic Agents|adrenergic agents|mesh-ancestor
24725372|NCT01597427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24725373|NCT01597427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725374|NCT01597518|Riluzole|riluzole|mesh-list
24725375|NCT01597518|Anticonvulsants|anticonvulsants|mesh-ancestor
24725376|NCT01597518|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24725408|NCT01597648|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25080872|NCT03335098|Glucocorticoids|glucocorticoids|mesh-ancestor
24725409|NCT01597648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24725410|NCT01597648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24725411|NCT01597648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725413|NCT01597661|Antidepressive Agents|antidepressive agents|mesh-list
24725414|NCT01597661|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24725415|NCT01597661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24735542|NCT01657487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24735634|NCT01657864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24735635|NCT01657864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24735636|NCT01657864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24735637|NCT01657864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24735638|NCT01657864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24735639|NCT01657890|Isavuconazole|isavuconazole|mesh-list
24735640|NCT01657890|Antifungal Agents|antifungal agents|mesh-ancestor
24419754|NCT00213590|Cyclosporine|cyclosporine|mesh-list
24725459|NCT01597765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725460|NCT01597765|Protective Agents|protective agents|mesh-ancestor
24725461|NCT01597765|Antidotes|antidotes|mesh-ancestor
24725462|NCT01597765|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24725463|NCT01597765|Chelating Agents|chelating agents|mesh-ancestor
24725464|NCT01597765|Sequestering Agents|sequestering agents|mesh-ancestor
24725465|NCT01597817|Chitosan|chitosan|mesh-list
24725466|NCT01597817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24725467|NCT01597817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24725468|NCT01597817|Antimetabolites|antimetabolites|mesh-ancestor
24473409|NCT00402662|Everolimus|everolimus|mesh-list
24725469|NCT01597817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725470|NCT01597817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24725471|NCT01597817|Chelating Agents|chelating agents|mesh-ancestor
24725472|NCT01597817|Sequestering Agents|sequestering agents|mesh-ancestor
24725481|NCT01597895|Antiviral Agents|antiviral agents|mesh-ancestor
24725482|NCT01597895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24725483|NCT01597895|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24725485|NCT01597934|Entecavir|entecavir|mesh-list
24725486|NCT01597934|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
24725487|NCT01597934|Adefovir|adefovir|mesh-list
24725488|NCT01597934|Lamivudine|lamivudine|mesh-list
24725489|NCT01597934|Telbivudine|telbivudine|mesh-list
24725490|NCT01597934|Antiviral Agents|antiviral agents|mesh-ancestor
24725500|NCT01597986|Norethindrone|norethindrone|mesh-list
24725501|NCT01597986|Norethindrone Acetate|norethindrone acetate|mesh-list
24725502|NCT01597986|Norinyl|norinyl|mesh-list
24725503|NCT01597986|Contraceptive Agents|contraceptive agents|mesh-list
24725504|NCT01597986|Contraceptives, Oral|contraceptives, oral|mesh-list
24725505|NCT01597986|Estradiol|estradiol|mesh-list
24725506|NCT01597986|Estrogens|estrogens|mesh-ancestor
24725507|NCT01597986|Hormones|hormones|mesh-ancestor
24725508|NCT01597986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24725509|NCT01597986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616009|NCT01033500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24616010|NCT01033500|Immunologic Factors|immunologic factors|mesh-ancestor
24616011|NCT01033500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616012|NCT01033500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24616013|NCT01033526|Aspirin|aspirin|mesh-list
24616015|NCT01033526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24616017|NCT01033526|Sensory System Agents|sensory system agents|mesh-ancestor
24616018|NCT01033526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24616019|NCT01033526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616020|NCT01033526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24616021|NCT01033526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24616022|NCT01033526|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24616023|NCT01033526|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24616024|NCT01033526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616025|NCT01033526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24616046|NCT01033656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24616047|NCT01033656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24616048|NCT01033760|Ritonavir|ritonavir|mesh-list
24616049|NCT01033760|Darunavir|darunavir|mesh-list
24616050|NCT01033760|Tenofovir|tenofovir|mesh-list
24725510|NCT01597986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24725511|NCT01597986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24725512|NCT01597986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24725513|NCT01597986|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25695649|NCT02049957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25695650|NCT02049957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25695651|NCT02049957|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25695652|NCT02049957|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25695653|NCT02049957|Hormone Antagonists|hormone antagonists|mesh-ancestor
25695654|NCT02049957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25695655|NCT02049957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725514|NCT01597986|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24725515|NCT01597986|Antifungal Agents|antifungal agents|mesh-ancestor
24725516|NCT01597986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24736102|NCT01660295|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24736302|NCT01661322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24736303|NCT01661322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736304|NCT01661322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24736411|NCT01661985|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24736413|NCT01662037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24736414|NCT01662037|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24736415|NCT01662037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736433|NCT01662089|Trace Elements|trace elements|mesh-ancestor
24736434|NCT01662089|Micronutrients|micronutrients|mesh-ancestor
24736464|NCT01662401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24736465|NCT01662401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736466|NCT01662401|Sensory System Agents|sensory system agents|mesh-ancestor
24736468|NCT01662466|Methyltestosterone|methyltestosterone|mesh-list
24725517|NCT01597986|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24725566|NCT01598337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050902|NCT00463242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24725570|NCT01598337|Antipyretics|antipyretics|mesh-ancestor
24725584|NCT01598363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725585|NCT01598363|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24725586|NCT01598363|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24725587|NCT01598363|Protective Agents|protective agents|mesh-ancestor
24725588|NCT01598363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725589|NCT01598402|Amoxicillin|amoxicillin|mesh-list
24838325|NCT02197156|Analgesics|analgesics|mesh-ancestor
24725590|NCT01598402|Clavulanic Acids|clavulanic acids|mesh-list
24725591|NCT01598402|Clavulanic Acid|clavulanic acid|mesh-list
24725592|NCT01598402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24725595|NCT01598402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725596|NCT01598402|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24725597|NCT01598441|Iloprost|iloprost|mesh-list
24725598|NCT01598441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24725599|NCT01598441|Vasodilator Agents|vasodilator agents|mesh-ancestor
24725600|NCT01598480|Anti-Infective Agents|anti-infective agents|mesh-list
24725601|NCT01598480|Silver Sulfadiazine|silver sulfadiazine|mesh-list
24725602|NCT01598480|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24725603|NCT01598480|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24725604|NCT01598493|Anti-Infective Agents|anti-infective agents|mesh-list
24725605|NCT01598493|Silver Sulfadiazine|silver sulfadiazine|mesh-list
24725606|NCT01598493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24725607|NCT01598493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24725609|NCT01598558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24725619|NCT01598584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24725620|NCT01598584|Antiviral Agents|antiviral agents|mesh-ancestor
24725621|NCT01598584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24725622|NCT01598584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725623|NCT01598584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24725640|NCT01598584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24725641|NCT01598584|Serotonin Agents|serotonin agents|mesh-ancestor
24725643|NCT01598623|Oxytocin|oxytocin|mesh-list
24725656|NCT01598675|Methamphetamine|methamphetamine|mesh-list
24725657|NCT01598675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24725658|NCT01598675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725659|NCT01598675|Sympathomimetics|sympathomimetics|mesh-ancestor
24725660|NCT01598675|Autonomic Agents|autonomic agents|mesh-ancestor
24725661|NCT01598675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24725662|NCT01598675|Dopamine Agents|dopamine agents|mesh-ancestor
24725663|NCT01598675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25695656|NCT02049957|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25695657|NCT02049957|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25695658|NCT02049957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25695659|NCT02049957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695660|NCT02050321|Vemurafenib|vemurafenib|mesh-list
25695661|NCT02050321|Acitretin|acitretin|mesh-list
25695662|NCT02050321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25695663|NCT02050321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25695664|NCT02050321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25695665|NCT02050321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695666|NCT02050321|Keratolytic Agents|keratolytic agents|mesh-ancestor
25695667|NCT02050321|Dermatologic Agents|dermatologic agents|mesh-ancestor
25695668|NCT02050334|Caffeic acid|caffeic acid|mesh-list
25695669|NCT02050334|Antioxidants|antioxidants|mesh-ancestor
25695670|NCT02050334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725664|NCT01598675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725665|NCT01598675|Adrenergic Agents|adrenergic agents|mesh-ancestor
24725666|NCT01598675|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24725667|NCT01598675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24725668|NCT01598675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24725669|NCT01598675|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24725684|NCT01598948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725685|NCT01598948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24725686|NCT01599000|Lumefantrine|lumefantrine|mesh-list
24725687|NCT01599000|Artemether|artemether|mesh-list
24725688|NCT01599000|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24725689|NCT01599000|Antimalarials|antimalarials|mesh-ancestor
24725690|NCT01599000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24725691|NCT01599000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24725692|NCT01599000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24725693|NCT01599013|Gemcitabine|gemcitabine|mesh-list
24725694|NCT01599013|Carboplatin|carboplatin|mesh-list
24725695|NCT01599013|Vinblastine|vinblastine|mesh-list
24725696|NCT01599013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24725697|NCT01599013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24725698|NCT01599013|Antimetabolites|antimetabolites|mesh-ancestor
24725699|NCT01599013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725730|NCT01599273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24725731|NCT01599273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725732|NCT01599312|Cobalt|cobalt|mesh-list
24725733|NCT01599312|Trace Elements|trace elements|mesh-ancestor
24648060|NCT01211925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24725735|NCT01599312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725736|NCT01599338|Liraglutide|liraglutide|mesh-list
24725737|NCT01599338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24725738|NCT01599338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725739|NCT01599338|Incretins|incretins|mesh-ancestor
24725740|NCT01599338|Hormones|hormones|mesh-ancestor
24725741|NCT01599338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24725742|NCT01599364|Ritonavir|ritonavir|mesh-list
24725743|NCT01599364|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24725744|NCT01599364|Lamivudine|lamivudine|mesh-list
24725745|NCT01599364|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24725746|NCT01599364|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24725747|NCT01599364|Protease Inhibitors|protease inhibitors|mesh-ancestor
24725748|NCT01599364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725749|NCT01599364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725750|NCT01599364|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24725751|NCT01599364|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24616051|NCT01033760|Emtricitabine|emtricitabine|mesh-list
24616052|NCT01033760|Raltegravir Potassium|raltegravir potassium|mesh-list
24616053|NCT01033760|Maraviroc|maraviroc|mesh-list
24616054|NCT01033760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24616055|NCT01033760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24616056|NCT01033760|Protease Inhibitors|protease inhibitors|mesh-ancestor
24616057|NCT01033760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616058|NCT01033760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616059|NCT01033760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24616090|NCT01033955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616099|NCT01033981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616100|NCT01033981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616101|NCT01033994|Mitogens|mitogens|mesh-list
24616105|NCT01034020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24616106|NCT01034020|Autonomic Agents|autonomic agents|mesh-ancestor
24616107|NCT01034020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24616108|NCT01034020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616109|NCT01034020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24616110|NCT01034020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24616111|NCT01034020|Cholinergic Agents|cholinergic agents|mesh-ancestor
24616112|NCT01034020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24616113|NCT01034020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616114|NCT01034124|Vitamin K|vitamin k|mesh-list
24616115|NCT01034124|Midazolam|midazolam|mesh-list
24616116|NCT01034124|Warfarin|warfarin|mesh-list
24616117|NCT01034124|Vitamins|vitamins|mesh-ancestor
24616118|NCT01034124|Micronutrients|micronutrients|mesh-ancestor
24597334|NCT00948727|Cyclosporine|cyclosporine|mesh-list
24616119|NCT01034124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616120|NCT01034124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24616121|NCT01034124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24616122|NCT01034124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24616123|NCT01034124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24616124|NCT01034124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24616125|NCT01034124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24616126|NCT01034124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24725770|NCT01599572|Micronutrients|micronutrients|mesh-ancestor
24725771|NCT01599572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725772|NCT01599598|Imidacloprid|imidacloprid|mesh-list
24725773|NCT01599598|Cholinergic Agents|cholinergic agents|mesh-ancestor
24725774|NCT01599598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24725775|NCT01599598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725776|NCT01599598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616136|NCT01034124|Hemostatics|hemostatics|mesh-ancestor
24725797|NCT01599871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725798|NCT01599871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24725799|NCT01599871|Respiratory System Agents|respiratory system agents|mesh-ancestor
24725800|NCT01599871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24725801|NCT01599871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725802|NCT01599871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725803|NCT01599871|Vasodilator Agents|vasodilator agents|mesh-ancestor
24725804|NCT01599871|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24725805|NCT01599871|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24725806|NCT01599871|Purinergic Agents|purinergic agents|mesh-ancestor
24725807|NCT01599871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24725808|NCT01599884|Acetylcysteine|acetylcysteine|mesh-list
24725819|NCT01599884|Antidotes|antidotes|mesh-ancestor
24725847|NCT01600235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24725848|NCT01600235|Mydriatics|mydriatics|mesh-ancestor
24725849|NCT01600235|Autonomic Agents|autonomic agents|mesh-ancestor
24725850|NCT01600235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24725851|NCT01600235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725852|NCT01600235|Sympathomimetics|sympathomimetics|mesh-ancestor
24725853|NCT01600235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24725854|NCT01600235|Nasal Decongestants|nasal decongestants|mesh-ancestor
24725855|NCT01600235|Respiratory System Agents|respiratory system agents|mesh-ancestor
24725856|NCT01600235|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24725857|NCT01600235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24725858|NCT01600235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25050908|NCT00462202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25050909|NCT00462202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25050910|NCT00462202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24725859|NCT01600235|Adrenergic Agents|adrenergic agents|mesh-ancestor
24725875|NCT01600274|Contraceptive Agents|contraceptive agents|mesh-ancestor
24725876|NCT01600274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24616149|NCT01034345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24616150|NCT01034345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24616151|NCT01034345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24616152|NCT01034345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616153|NCT01034345|Antifungal Agents|antifungal agents|mesh-ancestor
24616154|NCT01034345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24616156|NCT01034345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616157|NCT01034345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616158|NCT01034345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616160|NCT01034410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24616161|NCT01034410|Antimetabolites|antimetabolites|mesh-ancestor
24616162|NCT01034410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616163|NCT01034410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616164|NCT01034410|Antiviral Agents|antiviral agents|mesh-ancestor
24616165|NCT01034410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24616175|NCT01034683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725890|NCT01600365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24725891|NCT01600365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24725892|NCT01600365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725893|NCT01600365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725894|NCT01600365|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24725895|NCT01600365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24725896|NCT01600404|Muscarinic Antagonists|muscarinic antagonists|mesh-list
24725897|NCT01600404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24725898|NCT01600404|Cholinergic Agents|cholinergic agents|mesh-ancestor
24725899|NCT01600404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24725900|NCT01600404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725901|NCT01600404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725903|NCT01600430|Ergocalciferols|ergocalciferols|mesh-list
24725904|NCT01600430|Cholecalciferol|cholecalciferol|mesh-list
24725905|NCT01600430|Vitamins|vitamins|mesh-list
24741045|NCT01691456|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24741383|NCT01693718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24741482|NCT05288660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741483|NCT05288465|Cerebrolysin|cerebrolysin|mesh-list
24741550|NCT05288179|Analgesics|analgesics|mesh-ancestor
24741551|NCT05288179|Sensory System Agents|sensory system agents|mesh-ancestor
24741552|NCT05288179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24725906|NCT01600430|Micronutrients|micronutrients|mesh-ancestor
24725907|NCT01600430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725908|NCT01600430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24725909|NCT01600430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24725910|NCT01600456|Sertraline|sertraline|mesh-list
24725911|NCT01600456|Antidepressive Agents|antidepressive agents|mesh-ancestor
24725912|NCT01600456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24725913|NCT01600456|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24725914|NCT01600456|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24725915|NCT01600456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24725916|NCT01600456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725936|NCT01600612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725937|NCT01600625|Minocycline|minocycline|mesh-list
24725938|NCT01600625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24725939|NCT01600625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24725940|NCT01600742|Vorinostat|vorinostat|mesh-list
24725941|NCT01600742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050911|NCT00462202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25050912|NCT00462202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725942|NCT01600742|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24725943|NCT01600742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725944|NCT01600742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725945|NCT01600768|Lactams|lactams|mesh-list
24725946|NCT01600768|beta-Lactams|beta-lactams|mesh-list
24725947|NCT01600768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24725948|NCT01600768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24725949|NCT01600807|Gemcitabine|gemcitabine|mesh-list
24725950|NCT01600807|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24838673|NCT02199418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24838845|NCT02200718|Immunologic Factors|immunologic factors|mesh-ancestor
24725951|NCT01600807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24725952|NCT01600807|Antimetabolites|antimetabolites|mesh-ancestor
24616185|NCT01034878|Growth Substances|growth substances|mesh-ancestor
24725953|NCT01600807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725954|NCT01600807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24725955|NCT01600807|Antiviral Agents|antiviral agents|mesh-ancestor
24725956|NCT01600807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24725957|NCT01600807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725987|NCT01601028|Hydroxychloroquine|hydroxychloroquine|mesh-list
24725988|NCT01601028|Antimalarials|antimalarials|mesh-ancestor
24725989|NCT01601028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24725990|NCT01601028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24725991|NCT01601028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24725992|NCT01601028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725993|NCT01601028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725994|NCT01601028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24725996|NCT01601093|Cefoperazone|cefoperazone|mesh-list
24725997|NCT01601093|Sulperazone|sulperazone|mesh-list
24725998|NCT01601093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24725999|NCT01601093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24726000|NCT01601093|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24726001|NCT01601093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24726002|NCT01601093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726003|NCT01601093|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24726004|NCT01601093|Renal Agents|renal agents|mesh-ancestor
24726005|NCT01601106|Prednisolone|prednisolone|mesh-list
24726006|NCT01601106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24726007|NCT01601106|Glucocorticoids|glucocorticoids|mesh-ancestor
24726008|NCT01601106|Hormones|hormones|mesh-ancestor
24726009|NCT01601106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25695671|NCT02050334|Protective Agents|protective agents|mesh-ancestor
25695672|NCT02050334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695673|NCT02051296|Minocycline|minocycline|mesh-list
25695674|NCT02051296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25695675|NCT02051296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25695676|NCT02051335|Scopolamine|scopolamine|mesh-list
25695677|NCT02051335|Donepezil|donepezil|mesh-list
25695678|NCT02051335|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24742738|NCT05180006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742739|NCT05180006|Growth Inhibitors|growth inhibitors|mesh-ancestor
24742740|NCT05175274|Colchicine|colchicine|mesh-list
24742741|NCT05175274|Gout Suppressants|gout suppressants|mesh-ancestor
24742742|NCT05175274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24742743|NCT05175274|Tubulin Modulators|tubulin modulators|mesh-ancestor
24742744|NCT05175274|Antimitotic Agents|antimitotic agents|mesh-ancestor
24742745|NCT05175274|Mitosis Modulators|mitosis modulators|mesh-ancestor
24742746|NCT05175274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742747|NCT05175274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24726010|NCT01601106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726011|NCT01601106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24726012|NCT01601106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24726042|NCT01601327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726043|NCT01601327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24726044|NCT01601327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24726045|NCT01601327|Anabolic Agents|anabolic agents|mesh-ancestor
24726046|NCT01601327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25050913|NCT00460941|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25050914|NCT00460941|Incretins|incretins|mesh-ancestor
25050915|NCT00460941|Hormones|hormones|mesh-ancestor
25050916|NCT00460941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24855336|NCT02279134|Paclitaxel|paclitaxel|mesh-list
24726047|NCT01601366|Contraceptive Agents|contraceptive agents|mesh-list
24838847|NCT02200757|Topotecan|topotecan|mesh-list
24838959|NCT02201238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24838961|NCT02201238|Antipruritics|antipruritics|mesh-ancestor
24444833|NCT00299247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24839005|NCT02201459|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24839006|NCT02201459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24839007|NCT02201459|Antiviral Agents|antiviral agents|mesh-ancestor
24839008|NCT02201459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24839009|NCT02201459|Immunologic Factors|immunologic factors|mesh-ancestor
24839010|NCT02201459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726048|NCT01601366|Contraceptives, Oral|contraceptives, oral|mesh-list
24726049|NCT01601366|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
24726050|NCT01601366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24726051|NCT01601366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726064|NCT01601730|Citalopram|citalopram|mesh-list
24726065|NCT01601730|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24726066|NCT01601730|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24726067|NCT01601730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24726068|NCT01601730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726069|NCT01601730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24726070|NCT01601730|Serotonin Agents|serotonin agents|mesh-ancestor
24726071|NCT01601730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726072|NCT01601730|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24726073|NCT01601730|Antidepressive Agents|antidepressive agents|mesh-ancestor
24726074|NCT01601730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24726075|NCT01601730|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24726076|NCT01601730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24726077|NCT01601730|Parasympatholytics|parasympatholytics|mesh-ancestor
24726106|NCT01601899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24726107|NCT01601899|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24958069|NCT03837938|Dipropizine|dipropizine|mesh-list
24726108|NCT01601899|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24726109|NCT01601899|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24726110|NCT01601899|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24726111|NCT01601899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24726112|NCT01601899|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24726113|NCT01601899|Antimetabolites|antimetabolites|mesh-ancestor
24726115|NCT01601912|Citalopram|citalopram|mesh-list
24726116|NCT01601912|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24726117|NCT01601912|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25695679|NCT02051335|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25695680|NCT02051335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25695681|NCT02051335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695682|NCT02051335|Cholinergic Agents|cholinergic agents|mesh-ancestor
25695683|NCT02051335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25695684|NCT02051335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695685|NCT02051335|Nootropic Agents|nootropic agents|mesh-ancestor
25695686|NCT02051335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25695687|NCT02051335|Antiemetics|antiemetics|mesh-ancestor
25695688|NCT02051335|Autonomic Agents|autonomic agents|mesh-ancestor
25006846|NCT04606069|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25006847|NCT04606069|Purinergic Agonists|purinergic agonists|mesh-ancestor
25006848|NCT04606069|Purinergic Agents|purinergic agents|mesh-ancestor
25006849|NCT04606069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25095267|NCT03220009|Nivolumab|nivolumab|mesh-list
24743076|NCT05013567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24743077|NCT05013567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743114|NCT04989621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24726118|NCT01601912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24726119|NCT01601912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24726120|NCT01601912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726121|NCT01601912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24726122|NCT01601912|Serotonin Agents|serotonin agents|mesh-ancestor
24726123|NCT01601912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726124|NCT01601912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24726125|NCT01601912|Antidepressive Agents|antidepressive agents|mesh-ancestor
24726126|NCT01601912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24726127|NCT01601912|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24726128|NCT01601912|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24726129|NCT01601912|Parasympatholytics|parasympatholytics|mesh-ancestor
24726130|NCT01601912|Autonomic Agents|autonomic agents|mesh-ancestor
24726131|NCT01601912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24726132|NCT01601912|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24616196|NCT01034917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24616197|NCT01034917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616198|NCT01034917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050917|NCT00460941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958040|NCT03838133|Bupivacaine|bupivacaine|mesh-list
24616201|NCT01034956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24616202|NCT01034956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616203|NCT01034956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24616204|NCT01034956|Immunologic Factors|immunologic factors|mesh-ancestor
24616205|NCT01034956|Viscosupplements|viscosupplements|mesh-ancestor
24616206|NCT01034956|Protective Agents|protective agents|mesh-ancestor
24616207|NCT01034995|Citalopram|citalopram|mesh-list
24616208|NCT01034995|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24616209|NCT01034995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24616210|NCT01034995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24616211|NCT01034995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616212|NCT01034995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24616213|NCT01034995|Serotonin Agents|serotonin agents|mesh-ancestor
24616214|NCT01034995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616215|NCT01034995|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24616216|NCT01034995|Antidepressive Agents|antidepressive agents|mesh-ancestor
24616217|NCT01034995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24616218|NCT01035021|Rocuronium|rocuronium|mesh-list
24616219|NCT01035021|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24616220|NCT01035021|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24616221|NCT01035021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24616232|NCT01035190|Glucocorticoids|glucocorticoids|mesh-ancestor
24513943|NCT00586430|GABA Agents|gaba agents|mesh-ancestor
24726144|NCT01602003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24726146|NCT01602003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726147|NCT01602003|Incretins|incretins|mesh-ancestor
24726148|NCT01602003|Hormones|hormones|mesh-ancestor
24726149|NCT01602003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24726150|NCT01602003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24726151|NCT01602003|Protease Inhibitors|protease inhibitors|mesh-ancestor
24726152|NCT01602003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24726153|NCT01602003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726154|NCT01602029|Ondansetron|ondansetron|mesh-list
24726155|NCT01602029|Simvastatin|simvastatin|mesh-list
24726159|NCT01602029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726160|NCT01602029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25695689|NCT02051335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25695690|NCT02051335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25695691|NCT02051335|Mydriatics|mydriatics|mesh-ancestor
25695692|NCT02051335|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25695693|NCT02051335|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25695694|NCT02051335|Parasympatholytics|parasympatholytics|mesh-ancestor
25695695|NCT02051452|Methylphenidate|methylphenidate|mesh-list
25695696|NCT02051452|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24744410|NCT04291079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744479|NCT04264637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744480|NCT04264637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24744524|NCT04238546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24744525|NCT04238546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24744526|NCT04238546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24744527|NCT04238546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24726161|NCT01602029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24726162|NCT01602029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24726163|NCT01602029|Antiemetics|antiemetics|mesh-ancestor
24726196|NCT01602250|Anesthetics, Local|anesthetics, local|mesh-ancestor
24726197|NCT01602250|Anesthetics|anesthetics|mesh-ancestor
24726198|NCT01602250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24726199|NCT01602250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726200|NCT01602250|Sensory System Agents|sensory system agents|mesh-ancestor
24726201|NCT01602250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24726202|NCT01602250|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24726203|NCT01602250|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24726204|NCT01602250|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24726205|NCT01602289|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24726206|NCT01602289|Gefitinib|gefitinib|mesh-list
24726207|NCT01602289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24726208|NCT01602289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24726209|NCT01602289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24726210|NCT01602289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726211|NCT01602302|Adalimumab|adalimumab|mesh-list
24726212|NCT01602302|Etanercept|etanercept|mesh-list
24726213|NCT01602302|Golimumab|golimumab|mesh-list
24726214|NCT01602302|Abatacept|abatacept|mesh-list
24958045|NCT03838133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958046|NCT03838133|Sensory System Agents|sensory system agents|mesh-ancestor
24958047|NCT03838133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24839214|NCT02202720|Sevoflurane|sevoflurane|mesh-list
24726219|NCT01602302|Dermatologic Agents|dermatologic agents|mesh-ancestor
24726225|NCT01602302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24726226|NCT01602302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726227|NCT01602302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24726228|NCT01602302|Immunologic Factors|immunologic factors|mesh-ancestor
24726229|NCT01602302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24726230|NCT01602302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726237|NCT01602523|Formoterol Fumarate|formoterol fumarate|mesh-list
24726238|NCT01602523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24726239|NCT01602523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24726240|NCT01602523|Autonomic Agents|autonomic agents|mesh-ancestor
24726241|NCT01602523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24726242|NCT01602523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726243|NCT01602523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24726244|NCT01602523|Respiratory System Agents|respiratory system agents|mesh-ancestor
24726245|NCT01602523|Glucocorticoids|glucocorticoids|mesh-ancestor
24726246|NCT01602523|Hormones|hormones|mesh-ancestor
24726247|NCT01602523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24726248|NCT01602523|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24726249|NCT01602523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24726272|NCT01602640|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24726273|NCT01602640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24726274|NCT01602640|Anesthetics, General|anesthetics, general|mesh-ancestor
24726275|NCT01602640|Anesthetics|anesthetics|mesh-ancestor
24726276|NCT01602640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24726277|NCT01602640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24726278|NCT01602640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24726279|NCT01602640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24726280|NCT01602640|GABA Modulators|gaba modulators|mesh-ancestor
24726281|NCT01602640|GABA Agents|gaba agents|mesh-ancestor
24726282|NCT01602640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24726283|NCT01602640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726284|NCT01602757|Lidocaine|lidocaine|mesh-list
24726285|NCT01602757|Tetracaine|tetracaine|mesh-list
25695697|NCT02051452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695698|NCT02051452|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25695699|NCT02051452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25695700|NCT02051452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25695701|NCT02051452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695702|NCT02051452|Dopamine Agents|dopamine agents|mesh-ancestor
25695703|NCT02051452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25006893|NCT04549376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25006894|NCT04549376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25006895|NCT04549376|Trace Elements|trace elements|mesh-ancestor
25006896|NCT04549376|Micronutrients|micronutrients|mesh-ancestor
25006897|NCT04549376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726286|NCT01602757|Anesthetics, Local|anesthetics, local|mesh-ancestor
24442427|NCT00290914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24442428|NCT00290927|Insulin glulisine|insulin glulisine|mesh-list
24442429|NCT00290927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24442430|NCT00290927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442431|NCT00290940|Metformin|metformin|mesh-list
24442432|NCT00290940|Pioglitazone|pioglitazone|mesh-list
24442433|NCT00290940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24442434|NCT00290940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442435|NCT00290979|Insulin glulisine|insulin glulisine|mesh-list
24442436|NCT00290979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24442437|NCT00290979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442438|NCT00290992|Rasburicase|rasburicase|mesh-list
24442439|NCT00290992|Gout Suppressants|gout suppressants|mesh-ancestor
24442440|NCT00290992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24442441|NCT00291005|Docetaxel|docetaxel|mesh-list
24442442|NCT00291005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24726287|NCT01602757|Anesthetics|anesthetics|mesh-ancestor
24839215|NCT02202720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24726288|NCT01602757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24726289|NCT01602757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726290|NCT01602757|Sensory System Agents|sensory system agents|mesh-ancestor
24726291|NCT01602757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24726294|NCT01602757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24726295|NCT01602757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24726296|NCT01602757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726318|NCT01602861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24726319|NCT01602861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726320|NCT01602861|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24726322|NCT01602861|Natriuretic Agents|natriuretic agents|mesh-ancestor
24726323|NCT01602874|Metronidazole|metronidazole|mesh-list
24726324|NCT01602874|Clarithromycin|clarithromycin|mesh-list
24726325|NCT01602874|Ceftriaxone|ceftriaxone|mesh-list
24726326|NCT01602874|Tigecycline|tigecycline|mesh-list
24726327|NCT01602874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24726328|NCT01602874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24726329|NCT01602874|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24726330|NCT01602874|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24726331|NCT01602874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24726332|NCT01602874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24726333|NCT01602874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726334|NCT01602874|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24726335|NCT01602874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24958048|NCT03838029|Etodolac|etodolac|mesh-list
24958049|NCT03838029|Propranolol|propranolol|mesh-list
24958050|NCT03838029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24958051|NCT03838029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24726336|NCT01602887|Palbociclib|palbociclib|mesh-list
24726337|NCT01602887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24726338|NCT01602887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24726339|NCT01602887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24726340|NCT01602887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726341|NCT01602900|Rolipram|rolipram|mesh-list
24726343|NCT01602900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24616234|NCT01035190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24616235|NCT01035216|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
24616236|NCT01035216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24616237|NCT01035216|Immunologic Factors|immunologic factors|mesh-ancestor
24616238|NCT01035216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616239|NCT01035281|Nabilone|nabilone|mesh-list
24616240|NCT01035281|Antiemetics|antiemetics|mesh-ancestor
24616247|NCT01035281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24616248|NCT01035281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25695704|NCT02051595|Vancomycin|vancomycin|mesh-list
25695705|NCT02051595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25695706|NCT02051595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25695707|NCT02051686|Tranexamic Acid|tranexamic acid|mesh-list
25695708|NCT02051686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25695709|NCT02051686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24746143|NCT03325439|Anticonvulsants|anticonvulsants|mesh-ancestor
24746345|NCT05437575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746348|NCT05437575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24746349|NCT05437497|Propofol|propofol|mesh-list
24746350|NCT05437497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24564553|NCT00776724|Docetaxel|docetaxel|mesh-list
24746351|NCT05437497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24616249|NCT01035320|Simvastatin|simvastatin|mesh-list
24616250|NCT01035320|Ezetimibe|ezetimibe|mesh-list
24616251|NCT01035320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24616252|NCT01035320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24616253|NCT01035320|Antimetabolites|antimetabolites|mesh-ancestor
24616254|NCT01035320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616266|NCT01035450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24616267|NCT01035450|Antifungal Agents|antifungal agents|mesh-ancestor
24726344|NCT01602900|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24726345|NCT01602900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24726346|NCT01602900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24726347|NCT01602900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726348|NCT01602913|Paroxetine|paroxetine|mesh-list
24726349|NCT01602913|Pravastatin|pravastatin|mesh-list
24726350|NCT01602913|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24726351|NCT01602913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24726352|NCT01602913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24726353|NCT01602913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726354|NCT01602913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24726355|NCT01602913|Serotonin Agents|serotonin agents|mesh-ancestor
24726356|NCT01602913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726388|NCT01603030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24726389|NCT01603030|Antiemetics|antiemetics|mesh-ancestor
24726390|NCT01603030|Autonomic Agents|autonomic agents|mesh-ancestor
24726394|NCT01603030|Protective Agents|protective agents|mesh-ancestor
24726395|NCT01603030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24726396|NCT01603030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24726397|NCT01603030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24726398|NCT01603030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24726399|NCT01603030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24726400|NCT01603030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726401|NCT01603030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24726402|NCT01603030|Contraceptive Agents|contraceptive agents|mesh-ancestor
24726403|NCT01603030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24726404|NCT01603030|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24726405|NCT01603030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24726406|NCT01603030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24726408|NCT01603108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24726409|NCT01603108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24726410|NCT01603108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24726411|NCT01603134|Allopurinol|allopurinol|mesh-list
24726412|NCT01603134|Antimetabolites|antimetabolites|mesh-ancestor
24726414|NCT01603134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24726417|NCT01603134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24726419|NCT01603134|Protective Agents|protective agents|mesh-ancestor
24726420|NCT01603134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726421|NCT01603173|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24958052|NCT03838029|Adrenergic Agents|adrenergic agents|mesh-ancestor
24958053|NCT03838029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24958054|NCT03838029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958055|NCT03838029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958056|NCT03838029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24958057|NCT03838029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24726422|NCT01603173|Antidepressive Agents|antidepressive agents|mesh-ancestor
24726423|NCT01603173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24726424|NCT01603173|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24726432|NCT01603186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24726433|NCT01603186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25695710|NCT02051686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695711|NCT02051686|Hemostatics|hemostatics|mesh-ancestor
25695712|NCT02051686|Coagulants|coagulants|mesh-ancestor
25695713|NCT02052011|Ranolazine|ranolazine|mesh-list
25695714|NCT02052011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25695715|NCT02052011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25695716|NCT02052011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621713|NCT01063556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24621714|NCT01063556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621715|NCT01063556|Nootropic Agents|nootropic agents|mesh-ancestor
24621716|NCT01063569|Hydrocortisone|hydrocortisone|mesh-list
24726434|NCT01603186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726435|NCT01603212|Interferons|interferons|mesh-list
24726436|NCT01603212|Interferon-alpha|interferon-alpha|mesh-list
24726437|NCT01603212|Interferon alpha-2|interferon alpha-2|mesh-list
24726438|NCT01603212|Aldesleukin|aldesleukin|mesh-list
24726439|NCT01603212|Interleukin-2|interleukin-2|mesh-list
24726440|NCT01603212|Vemurafenib|vemurafenib|mesh-list
24726445|NCT01603212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726446|NCT01603212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24726447|NCT01603212|Analgesics|analgesics|mesh-ancestor
24726448|NCT01603212|Sensory System Agents|sensory system agents|mesh-ancestor
24726449|NCT01603212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24726450|NCT01603212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24726451|NCT01603212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24726452|NCT01603212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24726458|NCT01603251|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24726459|NCT01603251|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24726460|NCT01603251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24726461|NCT01603251|Antimalarials|antimalarials|mesh-ancestor
24726462|NCT01603251|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24726463|NCT01603264|Trastuzumab|trastuzumab|mesh-list
24726464|NCT01603264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24726465|NCT01603264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24726466|NCT01603342|Clopidogrel|clopidogrel|mesh-list
24726467|NCT01603342|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24726468|NCT01603342|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24726469|NCT01603342|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24726470|NCT01603342|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24726471|NCT01603342|Purinergic Agents|purinergic agents|mesh-ancestor
24726472|NCT01603342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24726473|NCT01603342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726475|NCT01603498|Dexamethasone|dexamethasone|mesh-list
24726480|NCT01603498|Prednisolone acetate|prednisolone acetate|mesh-list
24726481|NCT01603498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24726482|NCT01603498|Prednisolone phosphate|prednisolone phosphate|mesh-list
24726483|NCT01603498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24726484|NCT01603498|Antiemetics|antiemetics|mesh-ancestor
24726485|NCT01603498|Autonomic Agents|autonomic agents|mesh-ancestor
24726486|NCT01603498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24726487|NCT01603498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726496|NCT01603511|Charcoal|charcoal|mesh-list
24726502|NCT01603654|Magnesium citrate|magnesium citrate|mesh-list
24726503|NCT01603654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726504|NCT01603654|Antioxidants|antioxidants|mesh-ancestor
24958058|NCT03838029|Vasodilator Agents|vasodilator agents|mesh-ancestor
24958059|NCT03838029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24958060|NCT03838029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24958061|NCT03838029|Analgesics|analgesics|mesh-ancestor
24958062|NCT03838029|Sensory System Agents|sensory system agents|mesh-ancestor
24726505|NCT01603654|Protective Agents|protective agents|mesh-ancestor
24958070|NCT03837938|Antitussive Agents|antitussive agents|mesh-ancestor
24726506|NCT01603654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726507|NCT01603654|Vitamins|vitamins|mesh-ancestor
24726508|NCT01603654|Micronutrients|micronutrients|mesh-ancestor
24726509|NCT01603654|Cathartics|cathartics|mesh-ancestor
24726510|NCT01603654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24726511|NCT01603680|Anesthetics|anesthetics|mesh-list
24726512|NCT01603680|Mepivacaine|mepivacaine|mesh-list
24726513|NCT01603680|Anesthetics, Local|anesthetics, local|mesh-list
24726514|NCT01603680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24726515|NCT01603680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726516|NCT01603680|Sensory System Agents|sensory system agents|mesh-ancestor
24726517|NCT01603680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24726518|NCT01603693|Calcium|calcium|mesh-list
24726519|NCT01603693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24726525|NCT01603758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24726526|NCT01603758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25695717|NCT02052141|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25695718|NCT02052141|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25695719|NCT02052141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25695720|NCT02052141|Immunologic Factors|immunologic factors|mesh-ancestor
24726527|NCT01603758|Antimetabolites|antimetabolites|mesh-ancestor
24621742|NCT01063660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24621743|NCT01063660|Alkylating Agents|alkylating agents|mesh-ancestor
24621744|NCT01063660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621746|NCT01063816|Gemcitabine|gemcitabine|mesh-list
24621747|NCT01063816|Carboplatin|carboplatin|mesh-list
24621748|NCT01063816|Veliparib|veliparib|mesh-list
24789974|NCT01939886|Schistosomicides|schistosomicides|mesh-ancestor
24726528|NCT01603758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442443|NCT00291005|Tubulin Modulators|tubulin modulators|mesh-ancestor
24442444|NCT00291005|Antimitotic Agents|antimitotic agents|mesh-ancestor
24442445|NCT00291005|Mitosis Modulators|mitosis modulators|mesh-ancestor
24726548|NCT01604135|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24726549|NCT01604135|Dermatologic Agents|dermatologic agents|mesh-ancestor
24726550|NCT01604135|Anticoagulants|anticoagulants|mesh-ancestor
24726551|NCT01604135|Plasma Substitutes|plasma substitutes|mesh-ancestor
24726552|NCT01604135|Blood Substitutes|blood substitutes|mesh-ancestor
24726553|NCT01604187|Fentanyl|fentanyl|mesh-list
24726554|NCT01604187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24726555|NCT01604187|Narcotics|narcotics|mesh-ancestor
24726556|NCT01604187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24726557|NCT01604187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726558|NCT01604187|Analgesics|analgesics|mesh-ancestor
24726559|NCT01604187|Sensory System Agents|sensory system agents|mesh-ancestor
24726560|NCT01604187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24726561|NCT01604187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24726562|NCT01604187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24726563|NCT01604187|Anesthetics, General|anesthetics, general|mesh-ancestor
24726564|NCT01604187|Anesthetics|anesthetics|mesh-ancestor
24726565|NCT01604213|Metformin|metformin|mesh-list
24726566|NCT01604213|Vildagliptin|vildagliptin|mesh-list
24726567|NCT01604213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24726568|NCT01604213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726569|NCT01604213|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24726570|NCT01604213|Protease Inhibitors|protease inhibitors|mesh-ancestor
24726571|NCT01604213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24726572|NCT01604213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726573|NCT01604330|Baclofen|baclofen|mesh-list
24726574|NCT01604330|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24726575|NCT01604330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726576|NCT01604330|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24726577|NCT01604330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24726578|NCT01604330|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24726579|NCT01604330|GABA Agonists|gaba agonists|mesh-ancestor
24726592|NCT01604382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24726593|NCT01604382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24726594|NCT01604382|Anesthetics, General|anesthetics, general|mesh-ancestor
24442446|NCT00291005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442447|NCT00291109|Letrozole|letrozole|mesh-list
24442457|NCT00291122|Celecoxib|celecoxib|mesh-list
24442488|NCT00291148|Serotonin Agents|serotonin agents|mesh-ancestor
24726595|NCT01604382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24726596|NCT01604382|Narcotics|narcotics|mesh-ancestor
24726597|NCT01604382|Analgesics|analgesics|mesh-ancestor
24726598|NCT01604629|Adalimumab|adalimumab|mesh-list
24726599|NCT01604629|Etanercept|etanercept|mesh-list
24726600|NCT01604629|Golimumab|golimumab|mesh-list
24726601|NCT01604629|Infliximab|infliximab|mesh-list
24726602|NCT01604629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24726603|NCT01604629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24726604|NCT01604629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24726605|NCT01604629|Dermatologic Agents|dermatologic agents|mesh-ancestor
24726606|NCT01604629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24726607|NCT01604629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24958063|NCT03838029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24958065|NCT03838029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24958066|NCT03838029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24958067|NCT03838029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24958068|NCT03838029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25695721|NCT02052141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695722|NCT02052310|Epoetin Alfa|epoetin alfa|mesh-list
25695723|NCT02052310|Hematinics|hematinics|mesh-ancestor
25695724|NCT02052414|Gabapentin|gabapentin|mesh-list
25695725|NCT02052414|Analgesics|analgesics|mesh-ancestor
25695726|NCT02052414|Sensory System Agents|sensory system agents|mesh-ancestor
25695727|NCT02052414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24942082|NCT03984409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942083|NCT03984409|Expectorants|expectorants|mesh-ancestor
24751633|NCT01705223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751634|NCT01705249|Norethindrone|norethindrone|mesh-list
24942084|NCT03984409|Respiratory System Agents|respiratory system agents|mesh-ancestor
24942085|NCT03984110|Dexamethasone|dexamethasone|mesh-list
24726608|NCT01604629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24726609|NCT01604629|Analgesics|analgesics|mesh-ancestor
24726610|NCT01604629|Sensory System Agents|sensory system agents|mesh-ancestor
24726611|NCT01604629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24726612|NCT01604629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726613|NCT01604629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24726614|NCT01604629|Immunologic Factors|immunologic factors|mesh-ancestor
24726615|NCT01604629|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24726617|NCT01604811|Saw palmetto extract|saw palmetto extract|mesh-list
24726623|NCT01604811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726624|NCT01604811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616268|NCT01035515|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
24840180|NCT02208427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24840182|NCT02208427|Leprostatic Agents|leprostatic agents|mesh-ancestor
24616270|NCT01035515|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24616271|NCT01035515|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24616272|NCT01035515|Purinergic Agents|purinergic agents|mesh-ancestor
24616273|NCT01035515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24616274|NCT01035515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616275|NCT01035515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616276|NCT01035528|Metformin|metformin|mesh-list
24616277|NCT01035528|Insulin Glargine|insulin glargine|mesh-list
24616278|NCT01035528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24616279|NCT01035528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616280|NCT01035580|Curcumin|curcumin|mesh-list
24616281|NCT01035580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24616282|NCT01035580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24616283|NCT01035580|Analgesics|analgesics|mesh-ancestor
24616284|NCT01035580|Sensory System Agents|sensory system agents|mesh-ancestor
24616285|NCT01035580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24616286|NCT01035580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616287|NCT01035580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24648138|NCT01212809|Hyaluronic Acid|hyaluronic acid|mesh-list
24616289|NCT01035580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616290|NCT01035580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616291|NCT01035580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616305|NCT01035671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24616306|NCT01035671|Antioxidants|antioxidants|mesh-ancestor
24616307|NCT01035671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616308|NCT01035671|Protective Agents|protective agents|mesh-ancestor
24616309|NCT01035671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616310|NCT01035671|Vitamins|vitamins|mesh-ancestor
24616311|NCT01035671|Micronutrients|micronutrients|mesh-ancestor
24616312|NCT01035801|Insulin Lispro|insulin lispro|mesh-list
24616313|NCT01035801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24442489|NCT00291148|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24442490|NCT00291148|Antidepressive Agents|antidepressive agents|mesh-ancestor
24442491|NCT00291148|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24942086|NCT03984110|Aflibercept|aflibercept|mesh-list
24942087|NCT03984110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24942088|NCT03984110|Antiemetics|antiemetics|mesh-ancestor
24855376|NCT02279394|Elotuzumab|elotuzumab|mesh-list
24616314|NCT01035801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616315|NCT01035853|Colistin|colistin|mesh-list
24726640|NCT01604928|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24726641|NCT01604928|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24726642|NCT01604928|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24726643|NCT01604928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24726652|NCT01605084|Ritonavir|ritonavir|mesh-list
24726653|NCT01605084|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24726654|NCT01605084|Darunavir|darunavir|mesh-list
24726655|NCT01605084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24726656|NCT01605084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24726657|NCT01605084|Protease Inhibitors|protease inhibitors|mesh-ancestor
24726658|NCT01605084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24726659|NCT01605084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726660|NCT01605084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25695728|NCT02052414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695729|NCT02052414|Anticonvulsants|anticonvulsants|mesh-ancestor
24726673|NCT01605240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726675|NCT01605240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24726676|NCT01605240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24726677|NCT01605240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24726678|NCT01605240|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24726679|NCT01605240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442492|NCT00291148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24442493|NCT00291148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442514|NCT00291369|Contraceptive Agents|contraceptive agents|mesh-ancestor
24442515|NCT00291369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24442516|NCT00291369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24442517|NCT00291369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24442518|NCT00291369|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24442519|NCT00291369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24442520|NCT00291382|Fluticasone|fluticasone|mesh-list
24442521|NCT00291382|Xhance|xhance|mesh-list
24442522|NCT00291382|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24442523|NCT00291382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24442524|NCT00291382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24442525|NCT00291382|Autonomic Agents|autonomic agents|mesh-ancestor
24442915|NCT00293228|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24442916|NCT00293228|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24442917|NCT00293228|Antimetabolites|antimetabolites|mesh-ancestor
24442918|NCT00293228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726680|NCT01605240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726681|NCT01605240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24726682|NCT01605240|Narcotics|narcotics|mesh-ancestor
24726683|NCT01605240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24726684|NCT01605240|Antitussive Agents|antitussive agents|mesh-ancestor
24726685|NCT01605240|Respiratory System Agents|respiratory system agents|mesh-ancestor
24726686|NCT01605253|Eszopiclone|eszopiclone|mesh-list
24726687|NCT01605253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24726688|NCT01605253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24726689|NCT01605253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726691|NCT01605279|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24726692|NCT01605279|Sympathomimetics|sympathomimetics|mesh-ancestor
24726693|NCT01605279|Autonomic Agents|autonomic agents|mesh-ancestor
24726694|NCT01605279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24726695|NCT01605279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726696|NCT01605279|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24726697|NCT01605279|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24726698|NCT01605279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24726699|NCT01605279|Adrenergic Agents|adrenergic agents|mesh-ancestor
24726700|NCT01605279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24726711|NCT01605318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726712|NCT01605318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514488|NCT00590837|Lomustine|lomustine|mesh-list
24726713|NCT01605318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24726714|NCT01605344|Leucovorin|leucovorin|mesh-list
24726715|NCT01605344|Fluorouracil|fluorouracil|mesh-list
24726716|NCT01605344|Irinotecan|irinotecan|mesh-list
24726717|NCT01605344|Atorvastatin|atorvastatin|mesh-list
24726718|NCT01605344|Antimetabolites|antimetabolites|mesh-ancestor
24726720|NCT01605344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24726733|NCT01605344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24726734|NCT01605344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24942089|NCT03984110|Autonomic Agents|autonomic agents|mesh-ancestor
24942090|NCT03984110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24942091|NCT03984110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942092|NCT03984110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24942093|NCT03984110|Glucocorticoids|glucocorticoids|mesh-ancestor
24942094|NCT03984110|Hormones|hormones|mesh-ancestor
24942095|NCT03984110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24942096|NCT03984110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24942097|NCT03984110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942098|NCT03984110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24942099|NCT03984110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24942100|NCT03984110|Growth Substances|growth substances|mesh-ancestor
24942101|NCT03984110|Growth Inhibitors|growth inhibitors|mesh-ancestor
24726736|NCT01605344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24726738|NCT01605357|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24726739|NCT01605357|Diuretics|diuretics|mesh-ancestor
24726740|NCT01605357|Natriuretic Agents|natriuretic agents|mesh-ancestor
24726741|NCT01605357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726754|NCT01605487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24726755|NCT01605513|Interferons|interferons|mesh-list
24726756|NCT01605513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24726757|NCT01605513|Antiviral Agents|antiviral agents|mesh-ancestor
24726758|NCT01605513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24726774|NCT01605734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24726775|NCT01605734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24726776|NCT01605734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726777|NCT01605734|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24726778|NCT01605734|Estrogens|estrogens|mesh-ancestor
24726779|NCT01605734|Hormones|hormones|mesh-ancestor
24726780|NCT01605734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24726781|NCT01605734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726782|NCT01605734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24726783|NCT01605773|Glyburide|glyburide|mesh-list
24726784|NCT01605773|Repaglinide|repaglinide|mesh-list
24726785|NCT01605773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24726786|NCT01605773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726787|NCT01605864|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
24726790|NCT01605929|Mepivacaine|mepivacaine|mesh-list
24726794|NCT01605929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726795|NCT01605929|Sensory System Agents|sensory system agents|mesh-ancestor
24726796|NCT01605929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24942104|NCT03984357|Antibodies, Blocking|antibodies, blocking|mesh-list
24726846|NCT01606345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24726847|NCT01606345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24726848|NCT01606345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24726849|NCT01606345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24726850|NCT01606345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726851|NCT01606358|Carboplatin|carboplatin|mesh-list
24726852|NCT01606358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24726853|NCT01606384|Vasopressins|vasopressins|mesh-list
24726854|NCT01606384|Arginine Vasopressin|arginine vasopressin|mesh-list
24726855|NCT01606384|Hemostatics|hemostatics|mesh-ancestor
24726856|NCT01606384|Coagulants|coagulants|mesh-ancestor
24726857|NCT01606384|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24726858|NCT01606384|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24726859|NCT01606384|Natriuretic Agents|natriuretic agents|mesh-ancestor
24726860|NCT01606384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726861|NCT01606436|Moxifloxacin|moxifloxacin|mesh-list
24726862|NCT01606436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24726863|NCT01606436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24726864|NCT01606436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24726865|NCT01606436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24726866|NCT01606436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24726867|NCT01606436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726875|NCT01606527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24726876|NCT01606527|Analgesics|analgesics|mesh-ancestor
24726877|NCT01606527|Sensory System Agents|sensory system agents|mesh-ancestor
24726878|NCT01606527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24726879|NCT01606527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726880|NCT01606527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24726881|NCT01606527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24726882|NCT01606527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24726893|NCT01606540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24726894|NCT01606540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24726895|NCT01606540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24726896|NCT01606540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726897|NCT01606722|Ritonavir|ritonavir|mesh-list
24942111|NCT03984357|Antiviral Agents|antiviral agents|mesh-ancestor
24942112|NCT03984357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24942113|NCT03984357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24942114|NCT03984357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24726898|NCT01606722|Darunavir|darunavir|mesh-list
24616329|NCT01036035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24616330|NCT01036035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616331|NCT01036035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616332|NCT01036035|Urological Agents|urological agents|mesh-ancestor
24616333|NCT01036035|Miotics|miotics|mesh-ancestor
24616334|NCT01036035|Autonomic Agents|autonomic agents|mesh-ancestor
24616335|NCT01036035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24616336|NCT01036035|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24616337|NCT01036035|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24616338|NCT01036399|Lenalidomide|lenalidomide|mesh-list
24616339|NCT01036399|Immunologic Factors|immunologic factors|mesh-ancestor
24514714|NCT00592527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24756839|NCT01736020|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24726910|NCT01606878|Cyclophosphamide|cyclophosphamide|mesh-list
24726912|NCT01606878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24726913|NCT01606878|Vincristine|vincristine|mesh-list
24726914|NCT01606878|Topotecan|topotecan|mesh-list
24726928|NCT01606878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24726929|NCT01606878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24726930|NCT01606878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24726931|NCT01606878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24726936|NCT01606878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24726937|NCT01606878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24726938|NCT01606878|Protective Agents|protective agents|mesh-ancestor
24726939|NCT01606969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24726957|NCT01607034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24726958|NCT01607086|Lamotrigine|lamotrigine|mesh-list
24726959|NCT01607086|Anticonvulsants|anticonvulsants|mesh-ancestor
24726960|NCT01607086|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24726984|NCT01607125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24726985|NCT01607125|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24726986|NCT01607125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24726987|NCT01607307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24726988|NCT01607333|Lamotrigine|lamotrigine|mesh-list
24726989|NCT01607333|Anticonvulsants|anticonvulsants|mesh-ancestor
24726990|NCT01607333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24726991|NCT01607333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24726992|NCT01607333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726993|NCT01607333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24726994|NCT01607333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726995|NCT01607333|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24726996|NCT01607333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24726997|NCT01607333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24726998|NCT01607333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24727002|NCT01607580|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24727003|NCT01607580|Prednisolone|prednisolone|mesh-list
24727004|NCT01607580|Prednisolone acetate|prednisolone acetate|mesh-list
24727005|NCT01607580|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24727006|NCT01607580|Prednisolone phosphate|prednisolone phosphate|mesh-list
24727007|NCT01607580|Glucocorticoids|glucocorticoids|mesh-list
24727008|NCT01607580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24727009|NCT01607580|Antiemetics|antiemetics|mesh-ancestor
24840857|NCT02212821|Erythromycin|erythromycin|mesh-list
24840858|NCT02212821|Erythromycin Estolate|erythromycin estolate|mesh-list
24727010|NCT01607580|Autonomic Agents|autonomic agents|mesh-ancestor
24727011|NCT01607580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24727012|NCT01607580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727027|NCT01607671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727028|NCT01607671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24727029|NCT01607671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24727030|NCT01607671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24727032|NCT01607762|Risperidone|risperidone|mesh-list
24727033|NCT01607762|Aripiprazole|aripiprazole|mesh-list
24727040|NCT01607762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727041|NCT01607762|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24727042|NCT01607762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24727043|NCT01607762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24727044|NCT01607762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24727045|NCT01607762|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24727046|NCT01607762|Dopamine Agents|dopamine agents|mesh-ancestor
24727047|NCT01607762|Antiemetics|antiemetics|mesh-ancestor
24727048|NCT01607762|Autonomic Agents|autonomic agents|mesh-ancestor
24727093|NCT01607983|Antioxidants|antioxidants|mesh-ancestor
24727104|NCT01608009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24727105|NCT01608009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727106|NCT01608009|Tubulin Modulators|tubulin modulators|mesh-ancestor
24727107|NCT01608009|Antimitotic Agents|antimitotic agents|mesh-ancestor
24727108|NCT01608009|Mitosis Modulators|mitosis modulators|mesh-ancestor
24727109|NCT01608009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727110|NCT01608139|Curcumin|curcumin|mesh-list
24727111|NCT01608139|Sorafenib|sorafenib|mesh-list
24727112|NCT01608139|Vorinostat|vorinostat|mesh-list
24727113|NCT01608139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727117|NCT01608139|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24727118|NCT01608139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25695730|NCT02052414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24727119|NCT01608139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24727121|NCT01608139|Sensory System Agents|sensory system agents|mesh-ancestor
25695731|NCT02052414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24727123|NCT01608139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727124|NCT01608139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24727125|NCT01608139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24727126|NCT01608217|Acetaminophen|acetaminophen|mesh-list
24727127|NCT01608217|Dronabinol|dronabinol|mesh-list
24727128|NCT01608217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24727129|NCT01608217|Analgesics|analgesics|mesh-ancestor
24727130|NCT01608217|Sensory System Agents|sensory system agents|mesh-ancestor
24727131|NCT01608217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24442919|NCT00293228|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24727132|NCT01608217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727133|NCT01608217|Antipyretics|antipyretics|mesh-ancestor
24727134|NCT01608217|Hallucinogens|hallucinogens|mesh-ancestor
24727135|NCT01608217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24727176|NCT01608360|Sensory System Agents|sensory system agents|mesh-ancestor
24727177|NCT01608360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24727178|NCT01608360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24727179|NCT01608360|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24727180|NCT01608360|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24727181|NCT01608360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24727182|NCT01608360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727222|NCT01608555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24727223|NCT01608555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24727224|NCT01608594|Ipilimumab|ipilimumab|mesh-list
24727225|NCT01608594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24442938|NCT00293332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727226|NCT01608594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727227|NCT01608594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24727228|NCT01608594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727230|NCT01608646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727231|NCT01608698|Drospirenone|drospirenone|mesh-list
24616351|NCT01036412|Dermatologic Agents|dermatologic agents|mesh-ancestor
24616353|NCT01036659|Bradykinin|bradykinin|mesh-list
24616354|NCT01036659|Kallikreins|kallikreins|mesh-list
24616355|NCT01036659|Kininogens|kininogens|mesh-list
24616356|NCT01036659|Vasodilator Agents|vasodilator agents|mesh-ancestor
24616357|NCT01036659|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
24616358|NCT01036659|Protease Inhibitors|protease inhibitors|mesh-ancestor
24616359|NCT01036659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616360|NCT01036659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616361|NCT01036659|Analgesics|analgesics|mesh-ancestor
24616362|NCT01036659|Sensory System Agents|sensory system agents|mesh-ancestor
24616363|NCT01036659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24616364|NCT01036659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616365|NCT01036659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24616373|NCT01036841|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24616374|NCT01036841|Hemostatics|hemostatics|mesh-ancestor
24616375|NCT01036841|Coagulants|coagulants|mesh-ancestor
24616376|NCT01036841|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24616377|NCT01036841|Natriuretic Agents|natriuretic agents|mesh-ancestor
24616379|NCT01036854|Ondansetron|ondansetron|mesh-list
24616380|NCT01036854|Antiemetics|antiemetics|mesh-ancestor
24616381|NCT01036854|Autonomic Agents|autonomic agents|mesh-ancestor
24616382|NCT01036854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24757167|NCT01738178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757168|NCT01738178|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24616393|NCT01036854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24616394|NCT01036854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24616395|NCT01036854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24616396|NCT01036893|Prucalopride|prucalopride|mesh-list
24616397|NCT01036893|Laxatives|laxatives|mesh-ancestor
24616398|NCT01036893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24727238|NCT01608698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24727239|NCT01608698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727240|NCT01608698|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24727241|NCT01608698|Estrogens|estrogens|mesh-ancestor
24727243|NCT01608698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24727244|NCT01608698|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24727245|NCT01608698|Hormone Antagonists|hormone antagonists|mesh-ancestor
24727246|NCT01608698|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24727247|NCT01608698|Diuretics|diuretics|mesh-ancestor
24727248|NCT01608698|Natriuretic Agents|natriuretic agents|mesh-ancestor
24727249|NCT01608698|Androgen Antagonists|androgen antagonists|mesh-ancestor
24727250|NCT01608698|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24727251|NCT01608711|Gemcitabine|gemcitabine|mesh-list
24727252|NCT01608711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24727253|NCT01608711|Antimetabolites|antimetabolites|mesh-ancestor
24727255|NCT01608711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727297|NCT01608984|Anesthetics, General|anesthetics, general|mesh-ancestor
24727298|NCT01608984|Anesthetics|anesthetics|mesh-ancestor
24727299|NCT01608984|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24727300|NCT01609049|Ribavirin|ribavirin|mesh-list
24727301|NCT01609049|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24727302|NCT01609049|Antimetabolites|antimetabolites|mesh-ancestor
24727303|NCT01609049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727304|NCT01609049|Antiviral Agents|antiviral agents|mesh-ancestor
24727305|NCT01609049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24727306|NCT01609088|Erythritol|erythritol|mesh-list
24727307|NCT01609088|Vasodilator Agents|vasodilator agents|mesh-ancestor
24727308|NCT01609101|Cobalt|cobalt|mesh-list
24727309|NCT01609101|Trace Elements|trace elements|mesh-ancestor
24727310|NCT01609101|Micronutrients|micronutrients|mesh-ancestor
24727311|NCT01609101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515152|NCT00595049|Bosentan|bosentan|mesh-list
24727312|NCT01609127|Capecitabine|capecitabine|mesh-list
24727313|NCT01609127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24727314|NCT01609127|Antimetabolites|antimetabolites|mesh-ancestor
24727324|NCT01609153|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24727325|NCT01609153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24727347|NCT01609166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727348|NCT01609192|Hydroxyurea|hydroxyurea|mesh-list
24727349|NCT01609192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727350|NCT01609192|Antisickling Agents|antisickling agents|mesh-ancestor
24942140|NCT03983889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24942141|NCT03983889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24942142|NCT03983889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727351|NCT01609192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24727352|NCT01609192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727353|NCT01609192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24727355|NCT01609205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24727356|NCT01609205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24727357|NCT01609335|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24727358|NCT01609335|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24727359|NCT01609335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727360|NCT01609387|Tocopherols|tocopherols|mesh-list
24727361|NCT01609387|Antioxidants|antioxidants|mesh-ancestor
24727362|NCT01609387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727363|NCT01609387|Protective Agents|protective agents|mesh-ancestor
24727389|NCT01609491|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24727390|NCT01609491|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24727391|NCT01609491|Adrenergic Agents|adrenergic agents|mesh-ancestor
25695732|NCT02052414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25695733|NCT02052414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25695734|NCT02052414|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24727392|NCT01609491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24727393|NCT01609491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727394|NCT01609491|Protective Agents|protective agents|mesh-ancestor
24727397|NCT01609517|Anesthetics, Local|anesthetics, local|mesh-ancestor
24727399|NCT01609517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727400|NCT01609517|Sensory System Agents|sensory system agents|mesh-ancestor
24727401|NCT01609517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24727403|NCT01609647|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24727404|NCT01609647|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24727405|NCT01609647|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24727406|NCT01609647|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24727442|NCT01609881|Analgesics|analgesics|mesh-ancestor
24727443|NCT01609881|Sensory System Agents|sensory system agents|mesh-ancestor
24727444|NCT01609881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24727445|NCT01609881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727446|NCT01609881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24727447|NCT01609881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24404627|NCT00164255|Sulfadoxine|sulfadoxine|mesh-list
24727448|NCT01609881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24727449|NCT01609881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24727450|NCT01609881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727451|NCT01609907|Valsartan|valsartan|mesh-list
24727452|NCT01609907|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24727453|NCT01609907|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24727454|NCT01609907|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24727455|NCT01609907|Antimetabolites|antimetabolites|mesh-ancestor
24727456|NCT01609907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616403|NCT01036893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648521|NCT01215149|Vaccines|vaccines|mesh-list
24616404|NCT01036893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616405|NCT01036932|Lenograstim|lenograstim|mesh-list
24616406|NCT01036932|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24616407|NCT01036932|Immunologic Factors|immunologic factors|mesh-ancestor
24616408|NCT01036932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616418|NCT01037101|Renal Agents|renal agents|mesh-ancestor
24616419|NCT01037101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24616440|NCT01037335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24515380|NCT00596557|Everolimus|everolimus|mesh-list
24727474|NCT01610310|Interferon-beta|interferon-beta|mesh-list
24727475|NCT01610310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727476|NCT01610310|Antiviral Agents|antiviral agents|mesh-ancestor
24942143|NCT03983889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24942144|NCT03983889|Anesthetics, General|anesthetics, general|mesh-ancestor
24942145|NCT03983889|Anesthetics|anesthetics|mesh-ancestor
24727477|NCT01610310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24727478|NCT01610310|Immunologic Factors|immunologic factors|mesh-ancestor
24727479|NCT01610310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727480|NCT01610362|Immunoglobulins|immunoglobulins|mesh-list
24727481|NCT01610362|Antibodies|antibodies|mesh-list
24727482|NCT01610362|gamma-Globulins|gamma-globulins|mesh-list
24727483|NCT01610362|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24727484|NCT01610362|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24727485|NCT01610362|Immunoglobulin G|immunoglobulin g|mesh-list
24727486|NCT01610362|Immunologic Factors|immunologic factors|mesh-ancestor
24727487|NCT01610362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727488|NCT01610401|Metformin|metformin|mesh-list
24727489|NCT01610401|Caffeine|caffeine|mesh-list
24648560|NCT01215565|Sunitinib|sunitinib|mesh-list
24727490|NCT01610401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24727491|NCT01610401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727492|NCT01610401|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24727493|NCT01610401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24727529|NCT01610934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24727530|NCT01610934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24727531|NCT01610934|Immunologic Factors|immunologic factors|mesh-ancestor
24727532|NCT01610947|Adalimumab|adalimumab|mesh-list
24727533|NCT01610947|Etanercept|etanercept|mesh-list
24727534|NCT01610947|Golimumab|golimumab|mesh-list
24727535|NCT01610947|Infliximab|infliximab|mesh-list
24790128|NCT01940978|Dermatologic Agents|dermatologic agents|mesh-ancestor
24790129|NCT01940978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24790130|NCT01940978|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24727536|NCT01610947|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24727537|NCT01610947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24727538|NCT01610947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24727539|NCT01610947|Dermatologic Agents|dermatologic agents|mesh-ancestor
24727540|NCT01610947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24727541|NCT01610947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24727542|NCT01610947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24727543|NCT01610947|Analgesics|analgesics|mesh-ancestor
24727544|NCT01610947|Sensory System Agents|sensory system agents|mesh-ancestor
24727547|NCT01610947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24727562|NCT01611077|Candesartan cilexetil|candesartan cilexetil|mesh-list
24727563|NCT01611077|Olmesartan|olmesartan|mesh-list
24727564|NCT01611077|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24727565|NCT01611077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24727566|NCT01611077|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24727567|NCT01611077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24727568|NCT01611077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727569|NCT01611077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24727570|NCT01611077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727571|NCT01611077|Vasodilator Agents|vasodilator agents|mesh-ancestor
24727572|NCT01611077|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24727573|NCT01611077|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24727574|NCT01611142|Mogamulizumab|mogamulizumab|mesh-list
24727575|NCT01611142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727576|NCT01611311|BI 409306|bi 409306|mesh-list
24727577|NCT01611311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24942146|NCT03983889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24942147|NCT03983889|Analgesics|analgesics|mesh-ancestor
24942148|NCT03983889|Sensory System Agents|sensory system agents|mesh-ancestor
24942149|NCT03983889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24855430|NCT02279563|Histamine Agents|histamine agents|mesh-ancestor
24727578|NCT01611311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24727579|NCT01611311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727580|NCT01611324|Epinephrine|epinephrine|mesh-list
24727581|NCT01611324|Mepivacaine|mepivacaine|mesh-list
24727582|NCT01611324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24727583|NCT01611324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24727584|NCT01611324|Adrenergic Agents|adrenergic agents|mesh-ancestor
24727585|NCT01611324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24727586|NCT01611324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727587|NCT01611324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727588|NCT01611324|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24727589|NCT01611324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24727590|NCT01611324|Autonomic Agents|autonomic agents|mesh-ancestor
24727591|NCT01611324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24727592|NCT01611324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24727593|NCT01611324|Respiratory System Agents|respiratory system agents|mesh-ancestor
24727602|NCT01611363|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24727603|NCT01611363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727611|NCT01611415|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24727612|NCT01611415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24727613|NCT01611415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727614|NCT01611415|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24727616|NCT01611428|Ipragliflozin|ipragliflozin|mesh-list
24727617|NCT01611428|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24727618|NCT01611428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727619|NCT01611428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24727620|NCT01611428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727622|NCT01611480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24727623|NCT01611480|Immunologic Factors|immunologic factors|mesh-ancestor
24727624|NCT01611480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727626|NCT01611480|Interferon Inducers|interferon inducers|mesh-ancestor
24727627|NCT01611506|Capecitabine|capecitabine|mesh-list
24727630|NCT01611506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24727631|NCT01611506|Antimetabolites|antimetabolites|mesh-ancestor
25695735|NCT02052414|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25695736|NCT02052414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24439446|NCT00278772|GABA Agents|gaba agents|mesh-ancestor
24727632|NCT01611506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727633|NCT01611506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24727634|NCT01611675|Vemurafenib|vemurafenib|mesh-list
24727635|NCT01611675|Leflunomide|leflunomide|mesh-list
24727636|NCT01611675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450712|NCT00320099|Hydrocortisone|hydrocortisone|mesh-list
24727637|NCT01611675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24727638|NCT01611675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24727639|NCT01611675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727640|NCT01611675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24727641|NCT01611675|Immunologic Factors|immunologic factors|mesh-ancestor
24727642|NCT01611675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727643|NCT01611688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24727644|NCT01611688|Immunologic Factors|immunologic factors|mesh-ancestor
24727645|NCT01611688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727647|NCT01611727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727649|NCT01611896|Antioxidants|antioxidants|mesh-ancestor
24727650|NCT01611896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727651|NCT01611896|Protective Agents|protective agents|mesh-ancestor
24727652|NCT01611896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727653|NCT01611896|Trace Elements|trace elements|mesh-ancestor
24727654|NCT01611896|Micronutrients|micronutrients|mesh-ancestor
24727655|NCT01611909|Terpin|terpin|mesh-list
24727656|NCT01611909|Expectorants|expectorants|mesh-ancestor
24942150|NCT03983889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24727665|NCT01612052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24727666|NCT01612065|Misoprostol|misoprostol|mesh-list
24648608|NCT01216007|Propofol|propofol|mesh-list
24727681|NCT01612247|Immunologic Factors|immunologic factors|mesh-ancestor
24727685|NCT01612247|Alkylating Agents|alkylating agents|mesh-ancestor
24727686|NCT01612247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727687|NCT01612247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727688|NCT01612247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24727689|NCT01612247|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24727690|NCT01612247|Abortifacient Agents|abortifacient agents|mesh-ancestor
24727691|NCT01612247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24727692|NCT01612247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24727693|NCT01612247|Antimetabolites|antimetabolites|mesh-ancestor
24727694|NCT01612247|Dermatologic Agents|dermatologic agents|mesh-ancestor
24727695|NCT01612247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24727696|NCT01612247|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24727697|NCT01612247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24727698|NCT01612247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24727699|NCT01612247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24727700|NCT01612247|Analgesics|analgesics|mesh-ancestor
24727701|NCT01612247|Sensory System Agents|sensory system agents|mesh-ancestor
24727702|NCT01612247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24727703|NCT01612247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24727704|NCT01612247|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24727705|NCT01612247|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24727706|NCT01612247|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24727707|NCT01612247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24727708|NCT01612247|Antipyretics|antipyretics|mesh-ancestor
24727710|NCT01612273|Triflusal|triflusal|mesh-list
24727711|NCT01612273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24727713|NCT01612273|Analgesics|analgesics|mesh-ancestor
24727721|NCT01612273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727722|NCT01612273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24727723|NCT01612273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24727727|NCT01612286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24727728|NCT01612286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24727729|NCT01612286|Growth Substances|growth substances|mesh-ancestor
24727730|NCT01612286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727731|NCT01612286|Growth Inhibitors|growth inhibitors|mesh-ancestor
24727732|NCT01612286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727733|NCT01612299|Everolimus|everolimus|mesh-list
24727734|NCT01612299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727735|NCT01612299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24727736|NCT01612299|Immunologic Factors|immunologic factors|mesh-ancestor
24459864|NCT00346684|Rituximab|rituximab|mesh-list
24727737|NCT01612299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727738|NCT01612377|Prednisone|prednisone|mesh-list
24515632|NCT00598533|Antimetabolites|antimetabolites|mesh-ancestor
24727739|NCT01612377|Prednisolone|prednisolone|mesh-list
24727740|NCT01612377|Dipyridamole|dipyridamole|mesh-list
24727741|NCT01612377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24727742|NCT01612377|Glucocorticoids|glucocorticoids|mesh-ancestor
24727743|NCT01612377|Hormones|hormones|mesh-ancestor
24727744|NCT01612377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24942154|NCT03983889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24942155|NCT03983889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942156|NCT03983889|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24942157|NCT03983889|Narcotics|narcotics|mesh-ancestor
24942158|NCT03983889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24727745|NCT01612377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727746|NCT01612377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24727747|NCT01612377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727748|NCT01612377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24446495|NCT00304980|Artemether|artemether|mesh-list
24727765|NCT01612507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24727766|NCT01612507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24727767|NCT01612728|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24727768|NCT01612728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24727769|NCT01612728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616442|NCT01037348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24616443|NCT01037348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24616444|NCT01037348|Growth Substances|growth substances|mesh-ancestor
24616445|NCT01037348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616456|NCT01037465|Antiviral Agents|antiviral agents|mesh-ancestor
24616457|NCT01037465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24616458|NCT01037465|Expectorants|expectorants|mesh-ancestor
24616459|NCT01037465|Respiratory System Agents|respiratory system agents|mesh-ancestor
24616460|NCT01037465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24616461|NCT01037465|Antioxidants|antioxidants|mesh-ancestor
24616462|NCT01037465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616463|NCT01037465|Protective Agents|protective agents|mesh-ancestor
24616464|NCT01037465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616465|NCT01037465|Antidotes|antidotes|mesh-ancestor
24616466|NCT01037491|Aspirin|aspirin|mesh-list
24616468|NCT01037491|Clopidogrel|clopidogrel|mesh-list
24616480|NCT01037491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24616481|NCT01037491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24727770|NCT01612728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727772|NCT01612728|Hormone Antagonists|hormone antagonists|mesh-ancestor
24727773|NCT01612728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24727774|NCT01612728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727775|NCT01612741|Acarbose|acarbose|mesh-list
24727776|NCT01612741|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24727777|NCT01612741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24727788|NCT01612832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24727789|NCT01612832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727790|NCT01612832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24727791|NCT01612832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24727792|NCT01612832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24727793|NCT01612832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24727810|NCT01612871|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24727811|NCT01612871|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24727812|NCT01612910|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
24727813|NCT01612910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24727814|NCT01612910|Protective Agents|protective agents|mesh-ancestor
24727815|NCT01612910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727816|NCT01612910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727817|NCT01612936|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24727818|NCT01612936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24727819|NCT01612936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942159|NCT03983889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24942160|NCT03983889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24942161|NCT03983889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24457843|NCT00335400|Anesthetics|anesthetics|mesh-list
24727821|NCT01612975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24727822|NCT01612975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24727823|NCT01612975|Analgesics|analgesics|mesh-ancestor
24727830|NCT01612975|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24727832|NCT01612975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727833|NCT01613040|Moxifloxacin|moxifloxacin|mesh-list
24727834|NCT01613040|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24727835|NCT01613040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24727836|NCT01613040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24727837|NCT01613040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24727838|NCT01613040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24727839|NCT01613040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24727840|NCT01613040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727841|NCT01613040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727842|NCT01613040|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24727847|NCT01613040|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24727848|NCT01613040|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24727849|NCT01613053|Imatinib Mesylate|imatinib mesylate|mesh-list
24727850|NCT01613053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727851|NCT01613053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24727852|NCT01613053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24727853|NCT01613053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727854|NCT01613079|Methotrexate|methotrexate|mesh-list
24727855|NCT01613079|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24727856|NCT01613079|Abortifacient Agents|abortifacient agents|mesh-ancestor
24727858|NCT01613079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727859|NCT01613079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24727860|NCT01613079|Antimetabolites|antimetabolites|mesh-ancestor
24727861|NCT01613079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727862|NCT01613079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727863|NCT01613079|Dermatologic Agents|dermatologic agents|mesh-ancestor
24727864|NCT01613079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24727865|NCT01613079|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24727866|NCT01613079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24727867|NCT01613079|Immunologic Factors|immunologic factors|mesh-ancestor
24727868|NCT01613079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24727869|NCT01613079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24727871|NCT01613092|Clindamycin|clindamycin|mesh-list
24727872|NCT01613092|Cefazolin|cefazolin|mesh-list
24727873|NCT01613092|Cephalexin|cephalexin|mesh-list
24727874|NCT01613092|Bacitracin|bacitracin|mesh-list
24727875|NCT01613092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24727876|NCT01613092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24727890|NCT01613170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24727892|NCT01613196|Deoxyglucose|deoxyglucose|mesh-list
24727893|NCT01613196|Antimetabolites|antimetabolites|mesh-ancestor
24727894|NCT01613196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727895|NCT01613196|Antiviral Agents|antiviral agents|mesh-ancestor
24727896|NCT01613196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24727897|NCT01613209|Candesartan|candesartan|mesh-list
24727898|NCT01613209|Candesartan cilexetil|candesartan cilexetil|mesh-list
24727899|NCT01613209|Olmesartan|olmesartan|mesh-list
24727904|NCT01613300|Ofatumumab|ofatumumab|mesh-list
24727905|NCT01613300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727906|NCT01613365|Chlorhexidine|chlorhexidine|mesh-list
24727907|NCT01613365|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24727908|NCT01613365|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24727909|NCT01613365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24727910|NCT01613365|Disinfectants|disinfectants|mesh-ancestor
24727911|NCT01613365|Dermatologic Agents|dermatologic agents|mesh-ancestor
24942162|NCT03983889|GABA Modulators|gaba modulators|mesh-ancestor
24942163|NCT03983889|GABA Agents|gaba agents|mesh-ancestor
24942164|NCT03983915|Dexmedetomidine|dexmedetomidine|mesh-list
24942165|NCT03983915|Remifentanil|remifentanil|mesh-list
24812743|NCT02054299|Sympathomimetics|sympathomimetics|mesh-ancestor
24727912|NCT01613469|Leucovorin|leucovorin|mesh-list
24727913|NCT01613469|Antidotes|antidotes|mesh-ancestor
24727914|NCT01613469|Protective Agents|protective agents|mesh-ancestor
24727915|NCT01613469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727916|NCT01613469|Vitamin B Complex|vitamin b complex|mesh-ancestor
24616482|NCT01037491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24727920|NCT01613482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24727932|NCT01613573|Hormones|hormones|mesh-list
24727938|NCT01613690|Glycopyrrolate|glycopyrrolate|mesh-list
24727939|NCT01613690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24727940|NCT01613690|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24727941|NCT01613690|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24727942|NCT01613690|Cholinergic Agents|cholinergic agents|mesh-ancestor
24727943|NCT01613690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24727944|NCT01613690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727945|NCT01613690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727946|NCT01613729|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24727947|NCT01613729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24727948|NCT01613729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24842031|NCT02219490|Ribavirin|ribavirin|mesh-list
24727949|NCT01613729|Antimetabolites|antimetabolites|mesh-ancestor
24727950|NCT01613729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727951|NCT01613729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24727981|NCT01613820|Analgesics|analgesics|mesh-ancestor
24727982|NCT01613820|Sensory System Agents|sensory system agents|mesh-ancestor
24416106|NCT00202007|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24417087|NCT00205283|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24417088|NCT00205283|Protease Inhibitors|protease inhibitors|mesh-ancestor
24417093|NCT00205283|Antiviral Agents|antiviral agents|mesh-ancestor
24727983|NCT01613820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24727984|NCT01613820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727985|NCT01613820|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24727986|NCT01613820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24727987|NCT01613820|Anesthetics, General|anesthetics, general|mesh-ancestor
24727988|NCT01613820|Anesthetics|anesthetics|mesh-ancestor
24727989|NCT01613820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24727990|NCT01613820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24727991|NCT01613820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24727992|NCT01613820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24727993|NCT01613820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727994|NCT01613820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24727995|NCT01613820|Antiemetics|antiemetics|mesh-ancestor
24727996|NCT01613820|Autonomic Agents|autonomic agents|mesh-ancestor
24727997|NCT01613820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24727998|NCT01613820|Mydriatics|mydriatics|mesh-ancestor
24727999|NCT01613820|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24728000|NCT01613820|Cholinergic Agents|cholinergic agents|mesh-ancestor
24728036|NCT01613963|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24728037|NCT01613963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24728038|NCT01613963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24728039|NCT01613963|Antitubercular Agents|antitubercular agents|mesh-ancestor
24728040|NCT01613963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24728041|NCT01613963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24728042|NCT01613963|Glucocorticoids|glucocorticoids|mesh-ancestor
24728043|NCT01613963|Hormones|hormones|mesh-ancestor
24728044|NCT01613963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24728045|NCT01613963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24728046|NCT01613963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24942167|NCT03983915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24942168|NCT03983915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634225|NCT01132573|Entinostat|entinostat|mesh-list
24728051|NCT01613963|Sensory System Agents|sensory system agents|mesh-ancestor
24728052|NCT01613976|Panobinostat|panobinostat|mesh-list
24728053|NCT01613976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24728054|NCT01613976|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24728055|NCT01613976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728056|NCT01613976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728057|NCT01614041|Tandospirone|tandospirone|mesh-list
24728058|NCT01614041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24728059|NCT01614041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24728060|NCT01614041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24728061|NCT01614041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728062|NCT01614041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24728063|NCT01614041|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24728074|NCT01614132|Mitosis Modulators|mitosis modulators|mesh-ancestor
24728075|NCT01614197|Cytarabine|cytarabine|mesh-list
24728076|NCT01614197|Hydrocortisone|hydrocortisone|mesh-list
24728077|NCT01614197|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24728078|NCT01614197|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24728079|NCT01614197|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24728080|NCT01614197|Cyclophosphamide|cyclophosphamide|mesh-list
24728081|NCT01614197|Methotrexate|methotrexate|mesh-list
24728082|NCT01614197|Etoposide|etoposide|mesh-list
24728083|NCT01614197|Etoposide phosphate|etoposide phosphate|mesh-list
24728084|NCT01614197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24516033|NCT00600366|Insulin Aspart|insulin aspart|mesh-list
24728085|NCT01614197|Immunologic Factors|immunologic factors|mesh-ancestor
24728086|NCT01614197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728087|NCT01614197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24648729|NCT01216605|Oxytocin|oxytocin|mesh-list
24728088|NCT01614197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24728089|NCT01614197|Alkylating Agents|alkylating agents|mesh-ancestor
24728090|NCT01614197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695737|NCT02052414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695738|NCT02052414|Antimanic Agents|antimanic agents|mesh-ancestor
25695739|NCT02052440|Baclofen|baclofen|mesh-list
25695740|NCT02052440|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24424799|NCT00230789|Cholinergic Agents|cholinergic agents|mesh-ancestor
24424800|NCT00230789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24424801|NCT00230789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424802|NCT00230789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728091|NCT01614197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24728092|NCT01614197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24728093|NCT01614197|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24728094|NCT01614197|Abortifacient Agents|abortifacient agents|mesh-ancestor
24728095|NCT01614197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24728096|NCT01614197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24728097|NCT01614197|Antimetabolites|antimetabolites|mesh-ancestor
24728098|NCT01614197|Dermatologic Agents|dermatologic agents|mesh-ancestor
24728099|NCT01614197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728100|NCT01614197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24728101|NCT01614197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24728102|NCT01614197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24728121|NCT01614236|Anticonvulsants|anticonvulsants|mesh-ancestor
24728126|NCT01614236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24728127|NCT01614236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24728128|NCT01614236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24728129|NCT01614236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24728130|NCT01614301|Pioglitazone|pioglitazone|mesh-list
24728131|NCT01614301|Sirolimus|sirolimus|mesh-list
24728132|NCT01614301|Etoricoxib|etoricoxib|mesh-list
24728133|NCT01614301|Dacarbazine|dacarbazine|mesh-list
24728134|NCT01614301|Trofosfamide|trofosfamide|mesh-list
24728135|NCT01614301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24728136|NCT01614301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728137|NCT01614301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24728138|NCT01614301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24942169|NCT03983915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24942170|NCT03983915|Analgesics|analgesics|mesh-ancestor
24728139|NCT01614301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24616484|NCT01037491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24616485|NCT01037491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24616486|NCT01037491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24616487|NCT01037491|Purinergic Agents|purinergic agents|mesh-ancestor
24616488|NCT01037491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24616490|NCT01037491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24616491|NCT01037491|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24616499|NCT01037530|Protease Inhibitors|protease inhibitors|mesh-ancestor
24616500|NCT01037530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616501|NCT01037530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516103|NCT00600626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24728140|NCT01614301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24728141|NCT01614301|Antifungal Agents|antifungal agents|mesh-ancestor
25695741|NCT02052440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695742|NCT02052440|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25695743|NCT02052440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25695744|NCT02052440|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24728142|NCT01614301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25695745|NCT02052440|GABA Agonists|gaba agonists|mesh-ancestor
25695746|NCT02052440|GABA Agents|gaba agents|mesh-ancestor
25695747|NCT02052440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25695748|NCT02052440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007391|NCT03618537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25007392|NCT03618537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728143|NCT01614301|Immunologic Factors|immunologic factors|mesh-ancestor
24728144|NCT01614301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24728145|NCT01614301|Alkylating Agents|alkylating agents|mesh-ancestor
24728146|NCT01614301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728147|NCT01614301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24728148|NCT01614301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24728149|NCT01614301|Analgesics|analgesics|mesh-ancestor
24728150|NCT01614301|Sensory System Agents|sensory system agents|mesh-ancestor
24728151|NCT01614301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24728152|NCT01614301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24728153|NCT01614301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24728154|NCT01614301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24728155|NCT01614301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24728156|NCT01614301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728158|NCT01614366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24728159|NCT01614366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24728160|NCT01614366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24728161|NCT01614366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729091|NCT01619761|Antibodies|antibodies|mesh-list
24728184|NCT01614431|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24728186|NCT01614431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24728187|NCT01614431|Expectorants|expectorants|mesh-ancestor
24728188|NCT01614431|Respiratory System Agents|respiratory system agents|mesh-ancestor
24728189|NCT01614431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24728190|NCT01614431|Antioxidants|antioxidants|mesh-ancestor
24728191|NCT01614431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728192|NCT01614431|Protective Agents|protective agents|mesh-ancestor
24728193|NCT01614431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728194|NCT01614431|Antidotes|antidotes|mesh-ancestor
24728195|NCT01614496|Insulin|insulin|mesh-list
24728196|NCT01614496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24728197|NCT01614496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728198|NCT01614535|Remifentanil|remifentanil|mesh-list
24728199|NCT01614535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24728200|NCT01614535|Narcotics|narcotics|mesh-ancestor
24728201|NCT01614535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24728202|NCT01614535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728203|NCT01614535|Analgesics|analgesics|mesh-ancestor
24728204|NCT01614535|Sensory System Agents|sensory system agents|mesh-ancestor
24728205|NCT01614535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24728207|NCT01614938|Docetaxel|docetaxel|mesh-list
24728208|NCT01614938|Cetuximab|cetuximab|mesh-list
24728209|NCT01614938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942173|NCT03983915|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24942174|NCT03983915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24942175|NCT03983915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24728210|NCT01614938|Tubulin Modulators|tubulin modulators|mesh-ancestor
25695749|NCT02052557|Bupivacaine|bupivacaine|mesh-list
25695750|NCT02052557|Anesthetics, Local|anesthetics, local|mesh-ancestor
24728223|NCT01615016|Respiratory System Agents|respiratory system agents|mesh-ancestor
25695751|NCT02052557|Anesthetics|anesthetics|mesh-ancestor
25695752|NCT02052557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25695753|NCT02052557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695754|NCT02052557|Sensory System Agents|sensory system agents|mesh-ancestor
25695755|NCT02052557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25709361|NCT02265510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25709362|NCT02265510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25709363|NCT02265510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25709364|NCT02265510|Antimetabolites|antimetabolites|mesh-ancestor
25709365|NCT02265510|Antiviral Agents|antiviral agents|mesh-ancestor
25709366|NCT02265510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25709367|NCT02265510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709368|NCT02265510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25709369|NCT02265510|Immunologic Factors|immunologic factors|mesh-ancestor
25709370|NCT02265510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24429644|NCT00244556|Analgesics|analgesics|mesh-ancestor
24728225|NCT01615042|Immunologic Factors|immunologic factors|mesh-ancestor
24728226|NCT01615042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728227|NCT01615042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24728228|NCT01615042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24728229|NCT01615042|Growth Substances|growth substances|mesh-ancestor
24728230|NCT01615042|Growth Inhibitors|growth inhibitors|mesh-ancestor
24728231|NCT01615042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24728232|NCT01615055|Fluoxetine|fluoxetine|mesh-list
24728233|NCT01615055|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24728234|NCT01615055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24728235|NCT01615055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24728236|NCT01615055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728237|NCT01615055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24728238|NCT01615055|Serotonin Agents|serotonin agents|mesh-ancestor
24728239|NCT01615055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728240|NCT01615055|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24728268|NCT01615211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24728288|NCT01615354|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
24728289|NCT01615354|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
24728290|NCT01615354|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24728291|NCT01615354|Contraceptive Agents|contraceptive agents|mesh-ancestor
24728292|NCT01615354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24728293|NCT01615354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728306|NCT01615393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24616502|NCT01037530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24728307|NCT01615445|Resveratrol|resveratrol|mesh-list
24728308|NCT01615445|Antioxidants|antioxidants|mesh-ancestor
24728309|NCT01615445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806018|NCT02013258|Oxytocics|oxytocics|mesh-ancestor
24442994|NCT00293410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24442995|NCT00293410|Antimetabolites|antimetabolites|mesh-ancestor
24442997|NCT00293436|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24442998|NCT00293436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442999|NCT00293436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24443000|NCT00293436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443001|NCT00293436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773046|NCT01837394|Antipyretics|antipyretics|mesh-ancestor
24443002|NCT00293436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24443003|NCT00293436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24443004|NCT00293436|Analgesics|analgesics|mesh-ancestor
24443005|NCT00293436|Sensory System Agents|sensory system agents|mesh-ancestor
24443006|NCT00293436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24728310|NCT01615445|Protective Agents|protective agents|mesh-ancestor
24728311|NCT01615445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728312|NCT01615445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728313|NCT01615445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24942177|NCT03983915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24942178|NCT03983915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842631|NCT02222441|Pioglitazone|pioglitazone|mesh-list
24728349|NCT01615614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728350|NCT01615614|Antiviral Agents|antiviral agents|mesh-ancestor
24728351|NCT01615614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24728352|NCT01615614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24728353|NCT01615614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24728354|NCT01615614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24728355|NCT01615614|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24728356|NCT01615614|Antitubercular Agents|antitubercular agents|mesh-ancestor
24728362|NCT01615757|Antimetabolites|antimetabolites|mesh-ancestor
24728363|NCT01615757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728368|NCT01615757|Immunologic Factors|immunologic factors|mesh-ancestor
24728369|NCT01615757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728393|NCT01615978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24728394|NCT01615978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728396|NCT01615978|Hormones|hormones|mesh-ancestor
24728397|NCT01615978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24728398|NCT01616004|Nitrous Oxide|nitrous oxide|mesh-list
24728399|NCT01616004|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24728400|NCT01616004|Anesthetics, General|anesthetics, general|mesh-ancestor
25695756|NCT02052635|Clopidogrel|clopidogrel|mesh-list
25695757|NCT02052635|Ticagrelor|ticagrelor|mesh-list
25695758|NCT02052635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24431182|NCT00250744|Anticonvulsants|anticonvulsants|mesh-ancestor
24431183|NCT00250744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24431184|NCT00250744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24431185|NCT00250744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24431580|NCT00252317|Trandolapril|trandolapril|mesh-list
24728401|NCT01616004|Anesthetics|anesthetics|mesh-ancestor
24728402|NCT01616004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24728403|NCT01616004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728404|NCT01616004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24728405|NCT01616004|Analgesics|analgesics|mesh-ancestor
24728406|NCT01616004|Sensory System Agents|sensory system agents|mesh-ancestor
24728407|NCT01616004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24728409|NCT01616069|Epinephrine|epinephrine|mesh-list
24728410|NCT01616069|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24728411|NCT01616069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24728420|NCT01616069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24728421|NCT01616069|Respiratory System Agents|respiratory system agents|mesh-ancestor
24728438|NCT01616186|Everolimus|everolimus|mesh-list
24728439|NCT01616186|Sorafenib|sorafenib|mesh-list
24728440|NCT01616186|Sunitinib|sunitinib|mesh-list
24728441|NCT01616186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24728442|NCT01616186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24728443|NCT01616186|Immunologic Factors|immunologic factors|mesh-ancestor
24728444|NCT01616186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728445|NCT01616186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24728446|NCT01616186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24942179|NCT03983915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24942181|NCT03983551|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24728447|NCT01616186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728449|NCT01616186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24728450|NCT01616186|Growth Substances|growth substances|mesh-ancestor
24728451|NCT01616186|Growth Inhibitors|growth inhibitors|mesh-ancestor
24728453|NCT01616225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24728485|NCT01616485|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24728486|NCT01616485|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24728487|NCT01616485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728488|NCT01616485|Urological Agents|urological agents|mesh-ancestor
24728489|NCT01616615|Aspirin|aspirin|mesh-list
24728490|NCT01616615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24773116|NCT01837576|Calcipotriene|calcipotriene|mesh-list
24728491|NCT01616615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24648900|NCT01217294|Morphine|morphine|mesh-list
24728492|NCT01616615|Analgesics|analgesics|mesh-ancestor
25695759|NCT02052635|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25695760|NCT02052635|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25695761|NCT02052635|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25695762|NCT02052635|Purinergic Agents|purinergic agents|mesh-ancestor
25695763|NCT02052635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25695764|NCT02052635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695765|NCT02052635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432579|NCT00255463|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24432580|NCT00255463|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24432581|NCT00255463|Hormone Antagonists|hormone antagonists|mesh-ancestor
24432582|NCT00255463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24433307|NCT00258102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433308|NCT00258102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433309|NCT00258102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433310|NCT00258102|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24433311|NCT00258102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24433439|NCT00258336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433440|NCT00258336|Immunologic Factors|immunologic factors|mesh-ancestor
24433441|NCT00258336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433541|NCT00258791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24728493|NCT01616615|Sensory System Agents|sensory system agents|mesh-ancestor
24728494|NCT01616615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24728495|NCT01616615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728496|NCT01616615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24728497|NCT01616615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24728498|NCT01616615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24728499|NCT01616615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24728500|NCT01616615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728501|NCT01616615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24728502|NCT01616615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24728503|NCT01616615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728504|NCT01616615|Antipyretics|antipyretics|mesh-ancestor
24728505|NCT01616680|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24728532|NCT01616888|Tubulin Modulators|tubulin modulators|mesh-ancestor
24728533|NCT01616888|Antimitotic Agents|antimitotic agents|mesh-ancestor
24728534|NCT01616888|Mitosis Modulators|mitosis modulators|mesh-ancestor
24728535|NCT01616888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728536|NCT01616927|Lanreotide|lanreotide|mesh-list
24728537|NCT01616927|Somatostatin|somatostatin|mesh-list
24728538|NCT01616927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24728539|NCT01616927|Hormones|hormones|mesh-ancestor
24728540|NCT01616927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24728541|NCT01616927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728542|NCT01616966|Remifentanil|remifentanil|mesh-list
24728543|NCT01616966|Propofol|propofol|mesh-list
24728544|NCT01616966|Sevoflurane|sevoflurane|mesh-list
24517707|NCT00609531|Serotonin Agents|serotonin agents|mesh-ancestor
24728545|NCT01616966|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24728546|NCT01616966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24728547|NCT01616966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695766|NCT02052752|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25695767|NCT02052752|Dermatologic Agents|dermatologic agents|mesh-ancestor
25695768|NCT02052960|Cisplatin|cisplatin|mesh-list
25695769|NCT02052960|Fluorouracil|fluorouracil|mesh-list
25695770|NCT02052960|Cetuximab|cetuximab|mesh-list
25695771|NCT02052960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25695772|NCT02052960|Antimetabolites|antimetabolites|mesh-ancestor
25695773|NCT02052960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695774|NCT02052960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25695775|NCT02052960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25695776|NCT02052960|Immunologic Factors|immunologic factors|mesh-ancestor
25695777|NCT02052960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695778|NCT02052960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25695779|NCT02053493|Isosorbide|isosorbide|mesh-list
25695780|NCT02053493|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24439020|NCT00277108|Serotonin Agents|serotonin agents|mesh-ancestor
24439021|NCT00277108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728548|NCT01616966|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24728549|NCT01616966|Anesthetics, General|anesthetics, general|mesh-ancestor
24728550|NCT01616966|Anesthetics|anesthetics|mesh-ancestor
24728559|NCT01616992|Anesthetics, Local|anesthetics, local|mesh-ancestor
24728560|NCT01616992|Anesthetics|anesthetics|mesh-ancestor
24728561|NCT01616992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24728562|NCT01616992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942182|NCT03983551|Protease Inhibitors|protease inhibitors|mesh-ancestor
24942183|NCT03983551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24942184|NCT03983551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616513|NCT01037621|Valacyclovir|valacyclovir|mesh-list
24616514|NCT01037621|Antiviral Agents|antiviral agents|mesh-ancestor
24616515|NCT01037621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24616516|NCT01037634|Oseltamivir|oseltamivir|mesh-list
24616517|NCT01037634|Antiviral Agents|antiviral agents|mesh-ancestor
24616518|NCT01037634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24616519|NCT01037634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616520|NCT01037634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616521|NCT01037660|Metformin|metformin|mesh-list
24616522|NCT01037660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24616523|NCT01037660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616524|NCT01037699|Hormones|hormones|mesh-list
24616525|NCT01037699|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24616526|NCT01037699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24616527|NCT01037699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616528|NCT01037712|Valacyclovir|valacyclovir|mesh-list
24616529|NCT01037712|Antiviral Agents|antiviral agents|mesh-ancestor
24616530|NCT01037712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24616531|NCT01037725|Oxazolidinones|oxazolidinones|mesh-list
24616532|NCT01037725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24616533|NCT01037725|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24616534|NCT01037725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728566|NCT01617057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24728567|NCT01617057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728568|NCT01617135|Levodopa|levodopa|mesh-list
24728569|NCT01617135|Carbidopa|carbidopa|mesh-list
24728581|NCT01617135|Dopamine Agonists|dopamine agonists|mesh-ancestor
24728583|NCT01617200|Asenapine|asenapine|mesh-list
24728584|NCT01617200|Antiemetics|antiemetics|mesh-ancestor
24728585|NCT01617200|Autonomic Agents|autonomic agents|mesh-ancestor
25695781|NCT02053493|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25695782|NCT02053493|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25695783|NCT02053493|Diuretics|diuretics|mesh-ancestor
25695784|NCT02053493|Natriuretic Agents|natriuretic agents|mesh-ancestor
25695785|NCT02053493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695786|NCT02053493|Vasodilator Agents|vasodilator agents|mesh-ancestor
25695787|NCT02053493|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25695788|NCT02053493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695789|NCT02053610|Rituximab|rituximab|mesh-list
25695790|NCT02053610|Obinutuzumab|obinutuzumab|mesh-list
25695791|NCT02053610|Chlorambucil|chlorambucil|mesh-list
25695792|NCT02053610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25695793|NCT02053610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25695794|NCT02053610|Immunologic Factors|immunologic factors|mesh-ancestor
25695795|NCT02053610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695796|NCT02053610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25695797|NCT02053610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25695798|NCT02053610|Alkylating Agents|alkylating agents|mesh-ancestor
25695799|NCT02053610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695800|NCT02053753|Denosumab|denosumab|mesh-list
25695801|NCT02053753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24441053|NCT00285883|Saquinavir|saquinavir|mesh-list
24728586|NCT01617200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24728587|NCT01617200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728588|NCT01617200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24728589|NCT01617200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24728590|NCT01617200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24728591|NCT01617200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24728592|NCT01617200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24728593|NCT01617200|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24728594|NCT01617200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24728595|NCT01617200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24728596|NCT01617200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728601|NCT01617213|Immunologic Factors|immunologic factors|mesh-ancestor
24728602|NCT01617213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728603|NCT01617213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24728604|NCT01617213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24728610|NCT01617213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728611|NCT01617213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24728612|NCT01617213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24728614|NCT01617226|Vorinostat|vorinostat|mesh-list
24728616|NCT01617226|Antimetabolites|antimetabolites|mesh-ancestor
24728622|NCT01617317|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24728623|NCT01617317|Antibodies|antibodies|mesh-list
24728624|NCT01617317|gamma-Globulins|gamma-globulins|mesh-list
24728625|NCT01617317|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24728626|NCT01617317|Immunologic Factors|immunologic factors|mesh-ancestor
24728627|NCT01617317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728628|NCT01617356|Lidocaine|lidocaine|mesh-list
24728629|NCT01617356|Anesthetics, Local|anesthetics, local|mesh-ancestor
24728630|NCT01617356|Anesthetics|anesthetics|mesh-ancestor
24942185|NCT03983551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24942186|NCT03983551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942187|NCT03983460|Betamethasone|betamethasone|mesh-list
24728631|NCT01617356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24728632|NCT01617356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728633|NCT01617356|Sensory System Agents|sensory system agents|mesh-ancestor
24728634|NCT01617356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24728635|NCT01617356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24729092|NCT01619761|Immunoglobulins|immunoglobulins|mesh-list
24728636|NCT01617356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24648948|NCT01217632|Entecavir|entecavir|mesh-list
24728637|NCT01617356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24516634|NCT00602680|Donepezil|donepezil|mesh-list
25695802|NCT02053753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695803|NCT02054156|Azithromycin|azithromycin|mesh-list
25695804|NCT02054156|Tobramycin|tobramycin|mesh-list
25695805|NCT02054156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25695806|NCT02054156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25695807|NCT02054325|Polidocanol|polidocanol|mesh-list
25695808|NCT02054325|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25695809|NCT02054325|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25695810|NCT02054338|Gemcitabine|gemcitabine|mesh-list
25695811|NCT02054338|Paclitaxel|paclitaxel|mesh-list
25695812|NCT02054338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25695813|NCT02054338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25695814|NCT02054338|Tubulin Modulators|tubulin modulators|mesh-ancestor
25695815|NCT02054338|Antimitotic Agents|antimitotic agents|mesh-ancestor
25695816|NCT02054338|Mitosis Modulators|mitosis modulators|mesh-ancestor
25695817|NCT02054338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695818|NCT02054338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25695819|NCT02054338|Antimetabolites|antimetabolites|mesh-ancestor
25695820|NCT02054338|Antiviral Agents|antiviral agents|mesh-ancestor
24728640|NCT01617538|Atorvastatin|atorvastatin|mesh-list
24728664|NCT01617590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24787060|NCT01923545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24787061|NCT01923545|Immunologic Factors|immunologic factors|mesh-ancestor
24443107|NCT00293657|Sensory System Agents|sensory system agents|mesh-ancestor
24443108|NCT00293657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24728673|NCT01617590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24728674|NCT01617590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24728675|NCT01617694|Dexmedetomidine|dexmedetomidine|mesh-list
24728676|NCT01617694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24728677|NCT01617694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24728678|NCT01617694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728679|NCT01617694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24728680|NCT01617694|Analgesics|analgesics|mesh-ancestor
24728681|NCT01617694|Sensory System Agents|sensory system agents|mesh-ancestor
24728682|NCT01617694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24728683|NCT01617694|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24728684|NCT01617694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24728685|NCT01617694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24728686|NCT01617694|Adrenergic Agents|adrenergic agents|mesh-ancestor
24728687|NCT01617694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24728688|NCT01617694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728691|NCT01617707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24728692|NCT01617707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24728699|NCT01617707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24728700|NCT01617707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24728701|NCT01617707|GABA Modulators|gaba modulators|mesh-ancestor
24728702|NCT01617707|GABA Agents|gaba agents|mesh-ancestor
24728703|NCT01617707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24728704|NCT01617707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728705|NCT01617733|Pasireotide|pasireotide|mesh-list
24728706|NCT01617733|Hormones|hormones|mesh-ancestor
24728707|NCT01617733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24728708|NCT01617733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728709|NCT01617746|Bosentan|bosentan|mesh-list
24728710|NCT01617746|Ambrisentan|ambrisentan|mesh-list
24728711|NCT01617746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24728712|NCT01617746|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24728713|NCT01617746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728714|NCT01617772|Atorvastatin|atorvastatin|mesh-list
24728715|NCT01617772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24728716|NCT01617772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24728717|NCT01617772|Antimetabolites|antimetabolites|mesh-ancestor
24728817|NCT01618474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24728824|NCT01618513|Octreotide|octreotide|mesh-list
24728848|NCT01618591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728849|NCT01618591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24728850|NCT01618591|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24728851|NCT01618591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24728852|NCT01618591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24728853|NCT01618643|Acetic Acid|acetic acid|mesh-list
24728854|NCT01618643|Retinol acetate|retinol acetate|mesh-list
24728855|NCT01618643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24728856|NCT01618643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24728857|NCT01618643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24728858|NCT01618643|Immunologic Factors|immunologic factors|mesh-ancestor
24516857|NCT00604253|Isophane insulin, beef|isophane insulin, beef|mesh-list
25695821|NCT02054338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25695822|NCT02054338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25695823|NCT02054338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25695824|NCT02054338|Immunologic Factors|immunologic factors|mesh-ancestor
25695825|NCT02054338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695826|NCT02054481|Ustekinumab|ustekinumab|mesh-list
25695827|NCT02054481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25695828|NCT02054481|Dermatologic Agents|dermatologic agents|mesh-ancestor
25695829|NCT02054481|Immunologic Factors|immunologic factors|mesh-ancestor
25695830|NCT02054481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695831|NCT02054520|Pembrolizumab|pembrolizumab|mesh-list
25695832|NCT02054520|Nivolumab|nivolumab|mesh-list
24790522|NCT01943409|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25097526|NCT03203408|Hylan|hylan|mesh-list
24728859|NCT01618643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616535|NCT01037725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616536|NCT01037842|Mitiglinide|mitiglinide|mesh-list
24616537|NCT01037842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24616538|NCT01037842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616539|NCT01037959|Norfloxacin|norfloxacin|mesh-list
24616540|NCT01037959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24616541|NCT01037959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24616542|NCT01037959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24616543|NCT01037959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24616557|NCT01038024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616559|NCT01038037|Vinorelbine|vinorelbine|mesh-list
24616560|NCT01038037|Panitumumab|panitumumab|mesh-list
24616561|NCT01038037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843481|NCT02227901|Temozolomide|temozolomide|mesh-list
24616562|NCT01038037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24616563|NCT01038037|Tubulin Modulators|tubulin modulators|mesh-ancestor
24616568|NCT01038063|Lumefantrine|lumefantrine|mesh-list
24616581|NCT01038089|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24616583|NCT01038154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24616584|NCT01038154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24616585|NCT01038154|Antimetabolites|antimetabolites|mesh-ancestor
24855443|NCT02279615|Tamsulosin|tamsulosin|mesh-list
24616586|NCT01038154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616587|NCT01038154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24616588|NCT01038154|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24616589|NCT01038154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616590|NCT01038167|Cyclosporine|cyclosporine|mesh-list
24616591|NCT01038167|Tacrolimus|tacrolimus|mesh-list
24616592|NCT01038167|Cyclosporins|cyclosporins|mesh-list
24616593|NCT01038167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24616594|NCT01038167|Immunologic Factors|immunologic factors|mesh-ancestor
24616595|NCT01038167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616596|NCT01038167|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24616597|NCT01038167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616598|NCT01038167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616599|NCT01038167|Antifungal Agents|antifungal agents|mesh-ancestor
24616600|NCT01038167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24616601|NCT01038167|Dermatologic Agents|dermatologic agents|mesh-ancestor
24616602|NCT01038167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24616604|NCT01038349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24728869|NCT01618760|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24728870|NCT01618760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24728871|NCT01618760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24728872|NCT01618760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24728873|NCT01618760|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24728874|NCT01618760|Dopamine Agents|dopamine agents|mesh-ancestor
24728875|NCT01618773|Adapalene|adapalene|mesh-list
24728876|NCT01618773|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24728877|NCT01618773|Dermatologic Agents|dermatologic agents|mesh-ancestor
24728878|NCT01618773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24728879|NCT01618773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24728880|NCT01618773|Analgesics|analgesics|mesh-ancestor
24728881|NCT01618773|Sensory System Agents|sensory system agents|mesh-ancestor
24728882|NCT01618773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24728883|NCT01618773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728884|NCT01618773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24728885|NCT01618773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24728887|NCT01618799|Anticonvulsants|anticonvulsants|mesh-list
25695833|NCT02054520|Ipilimumab|ipilimumab|mesh-list
25695834|NCT02054520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25695835|NCT02054520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25695836|NCT02054520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25695837|NCT02054520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695838|NCT02054702|Aripiprazole|aripiprazole|mesh-list
24728888|NCT01618799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25695839|NCT02054702|Brexpiprazole|brexpiprazole|mesh-list
25695840|NCT02054702|Antidepressive Agents|antidepressive agents|mesh-ancestor
24728889|NCT01618799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24728890|NCT01618799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728891|NCT01618799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24728892|NCT01618799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728893|NCT01618799|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24728894|NCT01618799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24728895|NCT01618799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24728896|NCT01618799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24728897|NCT01618799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24728914|NCT01618890|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24728915|NCT01618890|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24728916|NCT01618890|Adrenergic Agents|adrenergic agents|mesh-ancestor
24728917|NCT01618890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24728918|NCT01618890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728919|NCT01618890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728920|NCT01618890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24728933|NCT01618929|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24728940|NCT01619007|Protease Inhibitors|protease inhibitors|mesh-ancestor
24728941|NCT01619007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24942195|NCT03983460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24728943|NCT01619007|Anticoagulants|anticoagulants|mesh-ancestor
24728944|NCT01619046|Factor VIII|factor viii|mesh-list
24728945|NCT01619046|Coagulants|coagulants|mesh-ancestor
24728946|NCT01619072|Misoprostol|misoprostol|mesh-list
24728951|NCT01619072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24728952|NCT01619072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24728953|NCT01619072|Oxytocics|oxytocics|mesh-ancestor
24728959|NCT01619137|Povidone-Iodine|povidone-iodine|mesh-list
24728960|NCT01619137|Povidone|povidone|mesh-list
24728961|NCT01619137|Plasma Substitutes|plasma substitutes|mesh-ancestor
24728962|NCT01619137|Blood Substitutes|blood substitutes|mesh-ancestor
24728963|NCT01619137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24728964|NCT01619137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24728965|NCT01619150|Etoricoxib|etoricoxib|mesh-list
24649045|NCT01218425|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24728966|NCT01619150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24728967|NCT01619150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24728968|NCT01619150|Analgesics|analgesics|mesh-ancestor
24728969|NCT01619150|Sensory System Agents|sensory system agents|mesh-ancestor
24728970|NCT01619150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24728971|NCT01619150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728972|NCT01619150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24728973|NCT01619150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24728974|NCT01619150|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24728996|NCT01619176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728997|NCT01619176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24728998|NCT01619176|Dermatologic Agents|dermatologic agents|mesh-ancestor
24728999|NCT01619176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729000|NCT01619176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24729012|NCT01619280|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24729013|NCT01619280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729015|NCT01619436|Analgesics|analgesics|mesh-ancestor
24729016|NCT01619436|Sensory System Agents|sensory system agents|mesh-ancestor
24729017|NCT01619436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24729018|NCT01619436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729019|NCT01619436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24729020|NCT01619436|Sympatholytics|sympatholytics|mesh-ancestor
24729021|NCT01619436|Autonomic Agents|autonomic agents|mesh-ancestor
24729022|NCT01619436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24729023|NCT01619436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24729024|NCT01619436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24729025|NCT01619436|Adrenergic Agents|adrenergic agents|mesh-ancestor
24729038|NCT01619527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24729039|NCT01619527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25695841|NCT02054702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25695842|NCT02054702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25695843|NCT02054702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24443456|NCT00294996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24443232|NCT00294099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443233|NCT00294099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24729040|NCT01619527|Antiviral Agents|antiviral agents|mesh-ancestor
24729041|NCT01619527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24729042|NCT01619527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24729043|NCT01619527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24729044|NCT01619566|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24729045|NCT01619566|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24729046|NCT01619566|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24843630|NCT02228512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24729047|NCT01619566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24729048|NCT01619566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729049|NCT01619566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24729050|NCT01619566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729052|NCT01619566|Sensory System Agents|sensory system agents|mesh-ancestor
24729053|NCT01619566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24942196|NCT03983460|Respiratory System Agents|respiratory system agents|mesh-ancestor
24729058|NCT01619644|Anticonvulsants|anticonvulsants|mesh-ancestor
24729059|NCT01619644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729060|NCT01619644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729061|NCT01619644|GABA Agents|gaba agents|mesh-ancestor
24729084|NCT01619761|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
24729085|NCT01619761|Rituximab|rituximab|mesh-list
24729086|NCT01619761|Fludarabine|fludarabine|mesh-list
24729087|NCT01619761|Fludarabine phosphate|fludarabine phosphate|mesh-list
24729088|NCT01619761|Lenalidomide|lenalidomide|mesh-list
24729089|NCT01619761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24729090|NCT01619761|Tacrolimus|tacrolimus|mesh-list
24729093|NCT01619761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24729094|NCT01619761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24729095|NCT01619761|Immunologic Factors|immunologic factors|mesh-ancestor
24729096|NCT01619761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729097|NCT01619761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24729098|NCT01619761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24729099|NCT01619761|Alkylating Agents|alkylating agents|mesh-ancestor
24729100|NCT01619761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729101|NCT01619761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24729102|NCT01619761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24729103|NCT01619761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24729104|NCT01619761|Antimetabolites|antimetabolites|mesh-ancestor
24729105|NCT01619761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24729106|NCT01619761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729107|NCT01619761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24729108|NCT01619761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24729109|NCT01619761|Growth Substances|growth substances|mesh-ancestor
24729110|NCT01619761|Growth Inhibitors|growth inhibitors|mesh-ancestor
24729385|NCT01621373|Propofol|propofol|mesh-list
25695844|NCT02054702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25695845|NCT02054702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695846|NCT02054702|Dopamine Agonists|dopamine agonists|mesh-ancestor
25695847|NCT02054702|Dopamine Agents|dopamine agents|mesh-ancestor
25695848|NCT02054702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25695849|NCT02054702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695850|NCT02054702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25695851|NCT02054702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25097755|NCT03201393|Naltrexone|naltrexone|mesh-list
24695966|NCT01426802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460499|NCT00348504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729111|NCT01619761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24729112|NCT01619761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24729113|NCT01619761|Antitubercular Agents|antitubercular agents|mesh-ancestor
24729114|NCT01619761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24729125|NCT01619813|Hormones|hormones|mesh-ancestor
24729126|NCT01619813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24729127|NCT01619813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729128|NCT01619813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24729129|NCT01619891|Vitamin D|vitamin d|mesh-list
24729130|NCT01619891|Vitamins|vitamins|mesh-ancestor
24729131|NCT01619891|Micronutrients|micronutrients|mesh-ancestor
24729132|NCT01619891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729133|NCT01619891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24729134|NCT01620112|Lidocaine|lidocaine|mesh-list
24729135|NCT01620112|Clonidine|clonidine|mesh-list
24729136|NCT01620112|Anesthetics, Local|anesthetics, local|mesh-ancestor
24729137|NCT01620112|Anesthetics|anesthetics|mesh-ancestor
24729138|NCT01620112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24729139|NCT01620112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729140|NCT01620112|Sensory System Agents|sensory system agents|mesh-ancestor
24729141|NCT01620112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24729142|NCT01620112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24729143|NCT01620112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24729144|NCT01620112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24729145|NCT01620112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24729146|NCT01620112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729147|NCT01620112|Analgesics|analgesics|mesh-ancestor
24729148|NCT01620112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24729156|NCT01620229|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24729157|NCT01620229|Antibodies|antibodies|mesh-list
24729158|NCT01620229|Immunoglobulins|immunoglobulins|mesh-list
24729159|NCT01620229|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24729160|NCT01620229|Immunoconjugates|immunoconjugates|mesh-list
24729161|NCT01620229|Immunologic Factors|immunologic factors|mesh-ancestor
24729162|NCT01620229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729163|NCT01620229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24729164|NCT01620229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24729165|NCT01620268|Leflunomide|leflunomide|mesh-list
24729166|NCT01620268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729167|NCT01620268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729168|NCT01620268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24729169|NCT01620268|Immunologic Factors|immunologic factors|mesh-ancestor
24729170|NCT01620268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729171|NCT01620307|Sirolimus|sirolimus|mesh-list
24729172|NCT01620307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24729173|NCT01620307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24729174|NCT01620307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24729176|NCT01620307|Antifungal Agents|antifungal agents|mesh-ancestor
24843745|NCT02229175|Growth Substances|growth substances|mesh-ancestor
25695852|NCT02054702|Serotonin Agents|serotonin agents|mesh-ancestor
25695853|NCT02054702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25695854|NCT02054702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25695855|NCT02054702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25695856|NCT02054702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25695857|NCT02054754|HU 211|hu 211|mesh-list
25695858|NCT02054754|Dronabinol|dronabinol|mesh-list
25081215|NCT03332316|Ropivacaine|ropivacaine|mesh-list
25695859|NCT02054754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25695860|NCT02054754|Antiemetics|antiemetics|mesh-ancestor
25695861|NCT02054754|Autonomic Agents|autonomic agents|mesh-ancestor
25695862|NCT02054754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25695863|NCT02054754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695864|NCT02054754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24729184|NCT01620320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24729185|NCT01620320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729186|NCT01620320|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24649106|NCT01218620|GABA Modulators|gaba modulators|mesh-ancestor
24649107|NCT01218620|GABA Agents|gaba agents|mesh-ancestor
24729187|NCT01620320|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24729188|NCT01620320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24729189|NCT01620320|Adrenergic Agents|adrenergic agents|mesh-ancestor
24729190|NCT01620320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24729232|NCT01620684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729234|NCT01620736|Raltegravir Potassium|raltegravir potassium|mesh-list
24729235|NCT01620736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24729236|NCT01620736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24729237|NCT01620736|Antiviral Agents|antiviral agents|mesh-ancestor
24729238|NCT01620736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24729239|NCT01620736|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24729240|NCT01620736|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24729241|NCT01620736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729242|NCT01620736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729279|NCT01620944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729280|NCT01620944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942233|NCT03982862|Sensory System Agents|sensory system agents|mesh-ancestor
24400126|NCT00149903|Antitubercular Agents|antitubercular agents|mesh-ancestor
24729282|NCT01620944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24729283|NCT01620944|Antiviral Agents|antiviral agents|mesh-ancestor
24729284|NCT01620944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24729285|NCT01620944|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24729286|NCT01620944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24729287|NCT01620944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24729294|NCT01621022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729295|NCT01621022|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24843824|NCT02229760|Tipranavir|tipranavir|mesh-list
24729296|NCT01621022|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24729297|NCT01621022|Cholinergic Agents|cholinergic agents|mesh-ancestor
24729298|NCT01621022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24729299|NCT01621022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729300|NCT01621022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24729301|NCT01621022|Antidepressive Agents|antidepressive agents|mesh-ancestor
24729302|NCT01621022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24729303|NCT01621022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24729304|NCT01621022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24729317|NCT01621100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24729318|NCT01621113|4-Aminopyridine|4-aminopyridine|mesh-list
24729319|NCT01621113|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24729320|NCT01621113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24729321|NCT01621113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729322|NCT01621165|Prazosin|prazosin|mesh-list
24729331|NCT01621204|Immunoglobulins|immunoglobulins|mesh-list
24729334|NCT01621204|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24729335|NCT01621204|Immunologic Factors|immunologic factors|mesh-ancestor
24729336|NCT01621204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729337|NCT01621217|Cetuximab|cetuximab|mesh-list
24729338|NCT01621217|Mitomycins|mitomycins|mesh-list
24729339|NCT01621217|Mitomycin|mitomycin|mesh-list
24729340|NCT01621217|Fluorouracil|fluorouracil|mesh-list
24729341|NCT01621217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24729342|NCT01621217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24729343|NCT01621217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24729344|NCT01621217|Alkylating Agents|alkylating agents|mesh-ancestor
24729345|NCT01621217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729346|NCT01621217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24729347|NCT01621217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729348|NCT01621217|Antimetabolites|antimetabolites|mesh-ancestor
24729349|NCT01621217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24729350|NCT01621217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24729351|NCT01621217|Immunologic Factors|immunologic factors|mesh-ancestor
24729355|NCT01621256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24729356|NCT01621256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24729357|NCT01621256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729358|NCT01621269|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24729359|NCT01621269|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24729360|NCT01621269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729414|NCT01621451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24729415|NCT01621451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729416|NCT01621451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24729420|NCT01621451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729421|NCT01621451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24942234|NCT03982862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24942235|NCT03982862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24942236|NCT03982862|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24942237|NCT03982862|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24942238|NCT03982862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24942239|NCT03982862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942240|NCT03982862|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24942242|NCT03982862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24942243|NCT03982862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24729422|NCT01621451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24729423|NCT01621451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729425|NCT01621451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24729426|NCT01621451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24729427|NCT01621451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24729428|NCT01621451|Purinergic Agents|purinergic agents|mesh-ancestor
24729429|NCT01621451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24729431|NCT01621620|Mydriatics|mydriatics|mesh-ancestor
24729432|NCT01621620|Autonomic Agents|autonomic agents|mesh-ancestor
24729433|NCT01621620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24729434|NCT01621620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729435|NCT01621620|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24729436|NCT01621620|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24729437|NCT01621620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24729438|NCT01621620|Adrenergic Agents|adrenergic agents|mesh-ancestor
24729439|NCT01621620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24729440|NCT01621620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729441|NCT01621620|Urological Agents|urological agents|mesh-ancestor
24616648|NCT01038453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24616650|NCT01038505|Mycophenolic Acid|mycophenolic acid|mesh-list
24616651|NCT01038505|Tacrolimus|tacrolimus|mesh-list
24616652|NCT01038505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24616653|NCT01038505|Immunologic Factors|immunologic factors|mesh-ancestor
24616654|NCT01038505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616655|NCT01038505|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24616656|NCT01038505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616657|NCT01038505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616658|NCT01038505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24616659|NCT01038505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24616660|NCT01038505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24616661|NCT01038505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616662|NCT01038505|Antifungal Agents|antifungal agents|mesh-ancestor
24649356|NCT01219582|Metformin|metformin|mesh-list
24843980|NCT02230371|Autonomic Agents|autonomic agents|mesh-ancestor
24616663|NCT01038505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24616664|NCT01038505|Antitubercular Agents|antitubercular agents|mesh-ancestor
24616665|NCT01038570|Oxytocin|oxytocin|mesh-list
24616666|NCT01038570|Oxytocics|oxytocics|mesh-ancestor
24616691|NCT01038648|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24616692|NCT01038648|Protease Inhibitors|protease inhibitors|mesh-ancestor
24942244|NCT03982862|Glucocorticoids|glucocorticoids|mesh-ancestor
24942245|NCT03982862|Hormones|hormones|mesh-ancestor
24855458|NCT02279628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25695865|NCT02054754|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25695866|NCT02054754|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25695867|NCT02054754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25695868|NCT02054754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695869|NCT02054754|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25695870|NCT02054754|Protective Agents|protective agents|mesh-ancestor
25695871|NCT02054754|Hallucinogens|hallucinogens|mesh-ancestor
25695872|NCT02054754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24460580|NCT00348972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24616693|NCT01038648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616694|NCT01038648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616695|NCT01038661|Docetaxel|docetaxel|mesh-list
24616696|NCT01038661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616697|NCT01038661|Tubulin Modulators|tubulin modulators|mesh-ancestor
24616698|NCT01038661|Antimitotic Agents|antimitotic agents|mesh-ancestor
24616699|NCT01038661|Mitosis Modulators|mitosis modulators|mesh-ancestor
24517646|NCT00609011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24729461|NCT01621698|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24729462|NCT01621698|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24729463|NCT01621698|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24729464|NCT01621698|Cholinergic Agents|cholinergic agents|mesh-ancestor
24729465|NCT01621698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24729466|NCT01621698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729468|NCT01621750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24729469|NCT01621750|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24729470|NCT01621750|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24729479|NCT01621763|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24729481|NCT01621763|Purinergic Agents|purinergic agents|mesh-ancestor
24729482|NCT01621763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24729483|NCT01621763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729484|NCT01621763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729485|NCT01621789|Diminazene aceturate|diminazene aceturate|mesh-list
24729486|NCT01621789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24729487|NCT01621789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24729488|NCT01621789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24729489|NCT01621789|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24729490|NCT01621893|Calcium|calcium|mesh-list
24729491|NCT01621893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24729492|NCT01621893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729496|NCT01621971|Milrinone|milrinone|mesh-list
24729497|NCT01621971|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24729498|NCT01621971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24729499|NCT01621971|Vasodilator Agents|vasodilator agents|mesh-ancestor
24729500|NCT01621971|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24729501|NCT01621971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24729502|NCT01621971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729503|NCT01621971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729506|NCT01622075|Paclitaxel|paclitaxel|mesh-list
24729529|NCT01622322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729530|NCT01622322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24729540|NCT01622361|Immunologic Factors|immunologic factors|mesh-ancestor
24729541|NCT01622361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729542|NCT01622361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24729543|NCT01622361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24729544|NCT01622361|Alkylating Agents|alkylating agents|mesh-ancestor
24729545|NCT01622361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729546|NCT01622361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24729547|NCT01622361|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24729548|NCT01622361|Tubulin Modulators|tubulin modulators|mesh-ancestor
24729549|NCT01622361|Antimitotic Agents|antimitotic agents|mesh-ancestor
24729550|NCT01622361|Mitosis Modulators|mitosis modulators|mesh-ancestor
24729551|NCT01622361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24729552|NCT01622361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24729553|NCT01622361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24729554|NCT01622361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729570|NCT01622439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729571|NCT01622439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24942246|NCT03982862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24942247|NCT03982862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24636586|NCT01146106|Pravastatin|pravastatin|mesh-list
24729572|NCT01622439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24729573|NCT01622439|Alkylating Agents|alkylating agents|mesh-ancestor
24729574|NCT01622439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729575|NCT01622439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24729576|NCT01622439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24729577|NCT01622439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25695873|NCT02054754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24427696|NCT00238784|Budesonide|budesonide|mesh-list
24729578|NCT01622439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24443121|NCT00293696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24729664|NCT01623102|Gemcitabine|gemcitabine|mesh-list
24729588|NCT01622439|Tubulin Modulators|tubulin modulators|mesh-ancestor
24729589|NCT01622439|Antimitotic Agents|antimitotic agents|mesh-ancestor
24729590|NCT01622439|Mitosis Modulators|mitosis modulators|mesh-ancestor
24729591|NCT01622439|Anticonvulsants|anticonvulsants|mesh-ancestor
24729592|NCT01622439|GABA Agents|gaba agents|mesh-ancestor
24729593|NCT01622439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24729594|NCT01622439|Antimanic Agents|antimanic agents|mesh-ancestor
24729595|NCT01622439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24729596|NCT01622439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24729597|NCT01622439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24729598|NCT01622504|Naloxone|naloxone|mesh-list
24729599|NCT01622504|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24729600|NCT01622504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729601|NCT01622504|Sensory System Agents|sensory system agents|mesh-ancestor
24729608|NCT01622556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24729610|NCT01622556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729611|NCT01622556|Alkylating Agents|alkylating agents|mesh-ancestor
24729612|NCT01622556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24729613|NCT01622556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24729614|NCT01622777|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24729615|NCT01622777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24729616|NCT01622777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24729617|NCT01622777|Antimetabolites|antimetabolites|mesh-ancestor
24649197|NCT01218750|Bevacizumab|bevacizumab|mesh-list
24729631|NCT01622790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24729632|NCT01622790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24729633|NCT01622790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24729634|NCT01622790|Antimetabolites|antimetabolites|mesh-ancestor
24729635|NCT01622790|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24729636|NCT01622790|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24729637|NCT01622881|Nefopam|nefopam|mesh-list
24729638|NCT01622881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24729652|NCT01622946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24729653|NCT01622946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729654|NCT01622946|Hemostatics|hemostatics|mesh-ancestor
24729655|NCT01622946|Coagulants|coagulants|mesh-ancestor
24729656|NCT01622972|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24729657|NCT01622972|Laxatives|laxatives|mesh-ancestor
24729658|NCT01622972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24729659|NCT01623024|Vitamin D|vitamin d|mesh-list
25695877|NCT02054754|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25695878|NCT02054754|Hormones|hormones|mesh-ancestor
25695879|NCT02054754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24729673|NCT01623102|Growth Inhibitors|growth inhibitors|mesh-ancestor
24942249|NCT03982771|Bortezomib|bortezomib|mesh-list
24942250|NCT03982771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24942251|NCT03982771|Immunologic Factors|immunologic factors|mesh-ancestor
24942252|NCT03982771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729674|NCT01623102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24729675|NCT01623102|Antimetabolites|antimetabolites|mesh-ancestor
24729676|NCT01623102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729677|NCT01623102|Antiviral Agents|antiviral agents|mesh-ancestor
24729678|NCT01623102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24729679|NCT01623102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729683|NCT01623206|Hemostatics|hemostatics|mesh-ancestor
24729701|NCT01623349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729702|NCT01623349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24729703|NCT01623362|Fluorides|fluorides|mesh-list
24844288|NCT02232139|GABA Modulators|gaba modulators|mesh-ancestor
24844289|NCT02232139|GABA Agents|gaba agents|mesh-ancestor
24844290|NCT02232139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24844291|NCT02232139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844292|NCT02232269|Felodipine|felodipine|mesh-list
24729704|NCT01623362|Cariostatic Agents|cariostatic agents|mesh-ancestor
24729705|NCT01623362|Protective Agents|protective agents|mesh-ancestor
24729706|NCT01623362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729707|NCT01623375|Insulin|insulin|mesh-list
25109158|NCT03126864|Fludarabine phosphate|fludarabine phosphate|mesh-list
24517879|NCT00610506|Dexetimide|dexetimide|mesh-list
24729710|NCT01623375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24729711|NCT01623375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729712|NCT01623401|Tedizolid phosphate|tedizolid phosphate|mesh-list
24729713|NCT01623401|Tedizolid|tedizolid|mesh-list
24729714|NCT01623401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24729715|NCT01623401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24729736|NCT01623570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24729737|NCT01623570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729738|NCT01623609|Naloxegol|naloxegol|mesh-list
24729739|NCT01623609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24729740|NCT01623609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729741|NCT01623609|Sensory System Agents|sensory system agents|mesh-ancestor
24729742|NCT01623609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24729743|NCT01623635|Ropivacaine|ropivacaine|mesh-list
24729744|NCT01623635|Anesthetics, Local|anesthetics, local|mesh-ancestor
24729751|NCT01623713|Iloperidone|iloperidone|mesh-list
24844293|NCT02232269|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24729752|NCT01623713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24729754|NCT01623713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24729755|NCT01623713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729756|NCT01623713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729757|NCT01623713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24729759|NCT01623713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24729760|NCT01623713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24729761|NCT01623713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24729788|NCT01623921|Analgesics|analgesics|mesh-ancestor
24729789|NCT01623921|Sensory System Agents|sensory system agents|mesh-ancestor
24729790|NCT01623921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24729791|NCT01623921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729792|NCT01623921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24729793|NCT01623921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24729794|NCT01623921|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24729795|NCT01623921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24729797|NCT01624025|Epirubicin|epirubicin|mesh-list
24729798|NCT01624025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24729799|NCT01624025|Tubulin Modulators|tubulin modulators|mesh-ancestor
24729800|NCT01624025|Antimitotic Agents|antimitotic agents|mesh-ancestor
24729801|NCT01624025|Mitosis Modulators|mitosis modulators|mesh-ancestor
24729802|NCT01624025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729803|NCT01624025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24729804|NCT01624025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24729805|NCT01624025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24942253|NCT03982771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24942254|NCT03982771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24942255|NCT03982771|Alkylating Agents|alkylating agents|mesh-ancestor
24942256|NCT03982771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942257|NCT03982771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942258|NCT03982771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24942260|NCT03982849|Hydroquinone|hydroquinone|mesh-list
24942261|NCT03982849|Antioxidants|antioxidants|mesh-ancestor
24855464|NCT02279628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24855465|NCT02279628|Anesthetics, Local|anesthetics, local|mesh-ancestor
24855466|NCT02279628|Anesthetics|anesthetics|mesh-ancestor
24855467|NCT02279758|Metformin|metformin|mesh-list
24855468|NCT02279758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24855469|NCT02279758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855470|NCT02279875|Rifampin|rifampin|mesh-list
24855471|NCT02279875|Isoniazid|isoniazid|mesh-list
24636861|NCT01147705|Gout Suppressants|gout suppressants|mesh-ancestor
24636862|NCT01147705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24636865|NCT01147705|Protective Agents|protective agents|mesh-ancestor
24636866|NCT01147705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636867|NCT01147718|Digoxin|digoxin|mesh-list
24636868|NCT01147718|rGLP-1 protein|rglp-1 protein|mesh-list
24636875|NCT01147718|Incretins|incretins|mesh-ancestor
24729806|NCT01624025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729807|NCT01624038|Hydroxyurea|hydroxyurea|mesh-list
24729808|NCT01624038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24729826|NCT01624103|Lidocaine|lidocaine|mesh-list
24729827|NCT01624103|Levobupivacaine|levobupivacaine|mesh-list
24729828|NCT01624103|Anesthetics, Local|anesthetics, local|mesh-ancestor
24729829|NCT01624103|Anesthetics|anesthetics|mesh-ancestor
24729830|NCT01624103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24729832|NCT01624103|Sensory System Agents|sensory system agents|mesh-ancestor
24729833|NCT01624103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24729834|NCT01624103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24729835|NCT01624103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24729836|NCT01624103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24616700|NCT01038661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616701|NCT01038817|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
24616702|NCT01038817|Cariostatic Agents|cariostatic agents|mesh-ancestor
24616703|NCT01038817|Protective Agents|protective agents|mesh-ancestor
24616704|NCT01038817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616706|NCT01038882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24616707|NCT01038882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24616708|NCT01038882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24616709|NCT01038882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636947|NCT01148160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616714|NCT01038882|Anesthetics, General|anesthetics, general|mesh-ancestor
24616715|NCT01038882|Anesthetics|anesthetics|mesh-ancestor
24616716|NCT01038882|GABA Modulators|gaba modulators|mesh-ancestor
24616717|NCT01038882|GABA Agents|gaba agents|mesh-ancestor
24616718|NCT01038882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24729838|NCT01624103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729839|NCT01624116|Metformin|metformin|mesh-list
24729840|NCT01624116|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24729841|NCT01624116|Acarbose|acarbose|mesh-list
25695880|NCT02055157|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
24729842|NCT01624116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24729843|NCT01624116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729844|NCT01624116|Incretins|incretins|mesh-ancestor
24729845|NCT01624116|Hormones|hormones|mesh-ancestor
24729846|NCT01624116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24729847|NCT01624116|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24729848|NCT01624116|Protease Inhibitors|protease inhibitors|mesh-ancestor
24729849|NCT01624116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729850|NCT01624116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729882|NCT01624337|Piperaquine|piperaquine|mesh-list
24729883|NCT01624337|Antimalarials|antimalarials|mesh-ancestor
24729884|NCT01624337|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24729885|NCT01624337|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24729886|NCT01624337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24729887|NCT01624428|Varenicline|varenicline|mesh-list
24729888|NCT01624428|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24729889|NCT01624428|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24729890|NCT01624428|Cholinergic Agents|cholinergic agents|mesh-ancestor
24729891|NCT01624428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24729908|NCT01624493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24729909|NCT01624493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729910|NCT01624493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24729911|NCT01624493|Immunologic Factors|immunologic factors|mesh-ancestor
24729912|NCT01624493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729913|NCT01624649|Methylphenidate|methylphenidate|mesh-list
24729914|NCT01624649|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24729915|NCT01624649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24729916|NCT01624649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729917|NCT01624649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24729918|NCT01624649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24729919|NCT01624649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24729920|NCT01624649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729921|NCT01624649|Dopamine Agents|dopamine agents|mesh-ancestor
24729922|NCT01624649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24729923|NCT01624649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24729924|NCT01624649|Adrenergic Agents|adrenergic agents|mesh-ancestor
24729925|NCT01624675|Risperidone|risperidone|mesh-list
24729926|NCT01624675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24729927|NCT01624675|Serotonin Agents|serotonin agents|mesh-ancestor
24729928|NCT01624675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24729929|NCT01624675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729959|NCT01624805|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24729960|NCT01624805|Prednisolone phosphate|prednisolone phosphate|mesh-list
24729961|NCT01624805|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24729962|NCT01624805|Immunologic Factors|immunologic factors|mesh-ancestor
24729963|NCT01624805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729964|NCT01624805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729965|NCT01624805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729966|NCT01624805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24729967|NCT01624805|Antifungal Agents|antifungal agents|mesh-ancestor
24729998|NCT01625156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24729999|NCT01625156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730000|NCT01625156|Antifungal Agents|antifungal agents|mesh-ancestor
24730001|NCT01625156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24730002|NCT01625156|Immunologic Factors|immunologic factors|mesh-ancestor
24730003|NCT01625156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730005|NCT01625260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24730006|NCT01625260|Antimetabolites|antimetabolites|mesh-ancestor
24730007|NCT01625260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730008|NCT01625260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050926|NCT00460317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050927|NCT00460317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25050928|NCT00460317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050929|NCT00459745|Fenofibrate|fenofibrate|mesh-list
25050930|NCT00459745|Pravastatin|pravastatin|mesh-list
25050931|NCT00459745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25050932|NCT00459745|Antimetabolites|antimetabolites|mesh-ancestor
25050933|NCT00459745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695881|NCT02055157|Natriuretic Agents|natriuretic agents|mesh-ancestor
25695882|NCT02055157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695883|NCT02055352|Fluticasone|fluticasone|mesh-list
24460985|NCT00350454|Sirolimus|sirolimus|mesh-list
24461481|NCT00352430|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25050934|NCT00459745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25050935|NCT00459745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24730009|NCT01625260|Antiviral Agents|antiviral agents|mesh-ancestor
24730010|NCT01625260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24730016|NCT01625351|Fludarabine|fludarabine|mesh-list
24730017|NCT01625351|Melphalan|melphalan|mesh-list
24730018|NCT01625351|Busulfan|busulfan|mesh-list
24730019|NCT01625351|Mechlorethamine|mechlorethamine|mesh-list
24730020|NCT01625351|Alemtuzumab|alemtuzumab|mesh-list
24730021|NCT01625351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730022|NCT01625351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730023|NCT01625351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24730024|NCT01625351|Immunologic Factors|immunologic factors|mesh-ancestor
24730025|NCT01625351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730026|NCT01625351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24730027|NCT01625351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24730040|NCT01625429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616733|NCT01039025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24616734|NCT01039025|Alkylating Agents|alkylating agents|mesh-ancestor
24616735|NCT01039025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616736|NCT01039025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616737|NCT01039025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24616738|NCT01039025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24616748|NCT01039090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24616749|NCT01039090|Dopamine Agents|dopamine agents|mesh-ancestor
24616750|NCT01039090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24730041|NCT01625494|Amlodipine|amlodipine|mesh-list
24730042|NCT01625494|Irbesartan|irbesartan|mesh-list
24730043|NCT01625494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24730044|NCT01625494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24730045|NCT01625494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24730046|NCT01625494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730048|NCT01625494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730070|NCT01625715|Dermatologic Agents|dermatologic agents|mesh-ancestor
24730071|NCT01625715|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24730072|NCT01625715|Histamine Antagonists|histamine antagonists|mesh-ancestor
25050936|NCT00459745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25050937|NCT00459745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050938|NCT00459277|Fentanyl|fentanyl|mesh-list
25050939|NCT00459277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25050940|NCT00459277|Narcotics|narcotics|mesh-ancestor
25050941|NCT00459277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25050942|NCT00459277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050943|NCT00459277|Analgesics|analgesics|mesh-ancestor
24730073|NCT01625715|Histamine Agents|histamine agents|mesh-ancestor
24730074|NCT01625715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24730075|NCT01625715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730076|NCT01625715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730077|NCT01625715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24730078|NCT01625741|Rituximab|rituximab|mesh-list
24730079|NCT01625741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24730080|NCT01625741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730081|NCT01625741|Immunologic Factors|immunologic factors|mesh-ancestor
24730082|NCT01625741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730083|NCT01625741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24730084|NCT01625793|Interferons|interferons|mesh-list
24730085|NCT01625793|Interferon-alpha|interferon-alpha|mesh-list
24730086|NCT01625793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730087|NCT01625793|Antiviral Agents|antiviral agents|mesh-ancestor
24730088|NCT01625793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24730089|NCT01625793|Immunologic Factors|immunologic factors|mesh-ancestor
24730090|NCT01625793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730091|NCT01625806|Ketoconazole|ketoconazole|mesh-list
24730105|NCT01625871|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24730106|NCT01625871|Antimalarials|antimalarials|mesh-ancestor
25695884|NCT02055352|Budesonide|budesonide|mesh-list
25695885|NCT02055352|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25695886|NCT02055352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25695887|NCT02055352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25695888|NCT02055352|Autonomic Agents|autonomic agents|mesh-ancestor
24790808|NCT01945450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25007931|NCT02519738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25007932|NCT02519738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24551236|NCT00724672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24551237|NCT00724672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24730107|NCT01625871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24730108|NCT01625871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24730109|NCT01625871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24730114|NCT01625936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24730115|NCT01625936|Growth Substances|growth substances|mesh-ancestor
24730116|NCT01625936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730126|NCT01626222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24730127|NCT01626222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730128|NCT01626222|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24730129|NCT01626222|Hormone Antagonists|hormone antagonists|mesh-ancestor
24730130|NCT01626222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24730131|NCT01626339|Bevacizumab|bevacizumab|mesh-list
24730132|NCT01626339|Ranibizumab|ranibizumab|mesh-list
24730133|NCT01626339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24730134|NCT01626339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730135|NCT01626339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24730136|NCT01626339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24730137|NCT01626339|Growth Substances|growth substances|mesh-ancestor
24730138|NCT01626339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616751|NCT01039090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616753|NCT01039090|Sympathomimetics|sympathomimetics|mesh-ancestor
24616754|NCT01039090|Protective Agents|protective agents|mesh-ancestor
24616755|NCT01039103|Methylprednisolone|methylprednisolone|mesh-list
24616756|NCT01039103|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24616757|NCT01039103|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24616758|NCT01039103|Prednisolone|prednisolone|mesh-list
24616759|NCT01039103|Prednisolone acetate|prednisolone acetate|mesh-list
24616760|NCT01039103|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24616761|NCT01039103|Prednisolone phosphate|prednisolone phosphate|mesh-list
24616763|NCT01039103|Antiemetics|antiemetics|mesh-ancestor
24450909|NCT00320892|Parasympatholytics|parasympatholytics|mesh-ancestor
24616773|NCT01039103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24616774|NCT01039103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616775|NCT01039142|Acitretin|acitretin|mesh-list
24616776|NCT01039142|Keratolytic Agents|keratolytic agents|mesh-ancestor
24616777|NCT01039142|Dermatologic Agents|dermatologic agents|mesh-ancestor
24616778|NCT01039155|Oxaliplatin|oxaliplatin|mesh-list
24616779|NCT01039155|Azacitidine|azacitidine|mesh-list
24616780|NCT01039155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616781|NCT01039155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24616782|NCT01039155|Antimetabolites|antimetabolites|mesh-ancestor
24616783|NCT01039155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616784|NCT01039155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616785|NCT01039181|Vitamin D|vitamin d|mesh-list
24616796|NCT01039194|Galantamine|galantamine|mesh-list
24616797|NCT01039194|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24616798|NCT01039194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616799|NCT01039194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616800|NCT01039194|Cholinergic Agents|cholinergic agents|mesh-ancestor
24518422|NCT05069740|Analgesics|analgesics|mesh-ancestor
25050953|NCT00458978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050955|NCT00458978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25050956|NCT00458601|Temozolomide|temozolomide|mesh-list
25050957|NCT00458601|Molgramostim|molgramostim|mesh-list
25050958|NCT00458601|Rindopepimut|rindopepimut|mesh-list
25050959|NCT00458601|Sargramostim|sargramostim|mesh-list
24907939|NCT04326166|Metformin|metformin|mesh-list
25050960|NCT00458601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25050961|NCT00458601|Alkylating Agents|alkylating agents|mesh-ancestor
24855489|NCT02279875|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24855491|NCT02279875|Antimetabolites|antimetabolites|mesh-ancestor
24855492|NCT02279875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24855493|NCT02279875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25695889|NCT02055352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25695890|NCT02055352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695891|NCT02055352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25695892|NCT02055352|Respiratory System Agents|respiratory system agents|mesh-ancestor
25695893|NCT02055352|Dermatologic Agents|dermatologic agents|mesh-ancestor
24855494|NCT02279914|Misoprostol|misoprostol|mesh-list
24551512|NCT05373680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551513|NCT05373680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24551514|NCT05373680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551515|NCT05373277|Ticagrelor|ticagrelor|mesh-list
24551516|NCT05373277|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24551517|NCT05373277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24551518|NCT05373277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24551519|NCT05373277|Antimetabolites|antimetabolites|mesh-ancestor
24551520|NCT05373277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551524|NCT05373277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24551525|NCT05373277|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24551526|NCT05373277|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24551527|NCT05373277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24730164|NCT01626560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24730169|NCT01626651|Antifungal Agents|antifungal agents|mesh-ancestor
24730170|NCT01626651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24730171|NCT01626651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24730172|NCT01626651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24730173|NCT01626651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24730174|NCT01626651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730175|NCT01626651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24730176|NCT01626651|Hormone Antagonists|hormone antagonists|mesh-ancestor
24730177|NCT01626651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24730178|NCT01626651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730179|NCT01626651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24730180|NCT01626911|Heparin|heparin|mesh-list
24730181|NCT01626911|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24730182|NCT01626911|Tinzaparin|tinzaparin|mesh-list
24730183|NCT01626911|Dalteparin|dalteparin|mesh-list
24730184|NCT01626911|Anticoagulants|anticoagulants|mesh-ancestor
24730185|NCT01626911|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24730186|NCT01626911|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24730188|NCT01627041|Cytarabine|cytarabine|mesh-list
24730192|NCT01627041|Antimetabolites|antimetabolites|mesh-ancestor
24730217|NCT01627132|Dasatinib|dasatinib|mesh-list
24730236|NCT01627158|Autonomic Agents|autonomic agents|mesh-ancestor
24730237|NCT01627158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24730238|NCT01627158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730239|NCT01627158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24730240|NCT01627158|Respiratory System Agents|respiratory system agents|mesh-ancestor
24730241|NCT01627158|Glucocorticoids|glucocorticoids|mesh-ancestor
24730242|NCT01627158|Hormones|hormones|mesh-ancestor
24730243|NCT01627158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24730244|NCT01627158|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24730245|NCT01627158|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24730246|NCT01627158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24730247|NCT01627158|Adrenergic Agents|adrenergic agents|mesh-ancestor
25050962|NCT00458601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050963|NCT00458601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730248|NCT01627158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24730249|NCT01627158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730250|NCT01627158|Antidotes|antidotes|mesh-ancestor
24730251|NCT01627158|Protective Agents|protective agents|mesh-ancestor
24730252|NCT01627171|Bisacodyl|bisacodyl|mesh-list
24730253|NCT01627171|Picosulfate sodium|picosulfate sodium|mesh-list
24730254|NCT01627171|Cathartics|cathartics|mesh-ancestor
24730255|NCT01627171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25695894|NCT02055352|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25695895|NCT02055352|Glucocorticoids|glucocorticoids|mesh-ancestor
25695896|NCT02055352|Hormones|hormones|mesh-ancestor
25695897|NCT02055352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25695898|NCT02055352|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25695899|NCT02055352|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25695900|NCT02055352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25695901|NCT02055352|Adrenergic Agents|adrenergic agents|mesh-ancestor
25695902|NCT02055352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25695903|NCT02055352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695904|NCT02055638|SRX246|srx246|mesh-list
25695905|NCT02055638|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25695906|NCT02055638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007984|NCT02410343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25007985|NCT02410343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552317|NCT03520569|Octreotide|octreotide|mesh-list
24552318|NCT03520569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24552319|NCT03520569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24552320|NCT03520569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552324|NCT03512418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24730256|NCT01627171|Laxatives|laxatives|mesh-ancestor
24730257|NCT01627223|Lamivudine|lamivudine|mesh-list
24730258|NCT01627223|Entecavir|entecavir|mesh-list
24730259|NCT01627223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24730260|NCT01627223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24730261|NCT01627223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24730262|NCT01627223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730263|NCT01627223|Antiviral Agents|antiviral agents|mesh-ancestor
24730264|NCT01627223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24730265|NCT01627223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24730266|NCT01627223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24730267|NCT01627236|Methylprednisolone|methylprednisolone|mesh-list
24730268|NCT01627236|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24730269|NCT01627236|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24730270|NCT01627236|Prednisolone|prednisolone|mesh-list
24730271|NCT01627236|Prednisolone acetate|prednisolone acetate|mesh-list
24730302|NCT01627353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24730303|NCT01627353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730304|NCT01627353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24730305|NCT01627353|Glucocorticoids|glucocorticoids|mesh-ancestor
24730306|NCT01627353|Hormones|hormones|mesh-ancestor
24616835|NCT01039363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24730307|NCT01627353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24730376|NCT01627639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730377|NCT01627639|Diuretics|diuretics|mesh-ancestor
24730378|NCT01627639|Natriuretic Agents|natriuretic agents|mesh-ancestor
24730379|NCT01627639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730380|NCT01627678|Molgramostim|molgramostim|mesh-list
24730381|NCT01627678|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24730382|NCT01627678|Sargramostim|sargramostim|mesh-list
24730383|NCT01627678|Immunologic Factors|immunologic factors|mesh-ancestor
24730384|NCT01627678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730385|NCT01627678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730386|NCT01627678|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24730388|NCT01627678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730389|NCT01627678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24730390|NCT01627717|Maraviroc|maraviroc|mesh-list
24730391|NCT01627717|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24730392|NCT01627717|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24730393|NCT01627717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730394|NCT01627717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24730395|NCT01627717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24730396|NCT01627717|Antiviral Agents|antiviral agents|mesh-ancestor
24730397|NCT01627717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24730398|NCT01627717|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24730478|NCT01628354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24730479|NCT01628354|Growth Substances|growth substances|mesh-ancestor
24730480|NCT01628354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730481|NCT01628354|Growth Inhibitors|growth inhibitors|mesh-ancestor
24730482|NCT01628354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730483|NCT01628445|Liraglutide|liraglutide|mesh-list
24730484|NCT01628445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24730485|NCT01628445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730486|NCT01628445|Incretins|incretins|mesh-ancestor
24730488|NCT01628445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24730489|NCT01628471|Decitabine|decitabine|mesh-list
24730490|NCT01628471|Genistein|genistein|mesh-list
24730491|NCT01628471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25695907|NCT02055638|Natriuretic Agents|natriuretic agents|mesh-ancestor
25695908|NCT02055638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695909|NCT02055820|Prednisone|prednisone|mesh-list
25695910|NCT02055820|Cyclophosphamide|cyclophosphamide|mesh-list
25695911|NCT02055820|Rituximab|rituximab|mesh-list
25695912|NCT02055820|Doxorubicin|doxorubicin|mesh-list
25695913|NCT02055820|Vincristine|vincristine|mesh-list
25695914|NCT02055820|Venetoclax|venetoclax|mesh-list
25695915|NCT02055820|Obinutuzumab|obinutuzumab|mesh-list
25008031|NCT02339740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25008032|NCT02339740|Antimetabolites|antimetabolites|mesh-ancestor
25008033|NCT02339740|Antiviral Agents|antiviral agents|mesh-ancestor
24730492|NCT01628471|Antimetabolites|antimetabolites|mesh-ancestor
25050968|NCT00458276|Vasodilator Agents|vasodilator agents|mesh-ancestor
24730493|NCT01628471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730494|NCT01628471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730495|NCT01628471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24730496|NCT01628471|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24730497|NCT01628471|Protective Agents|protective agents|mesh-ancestor
24730498|NCT01628471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730500|NCT01628471|Phytoestrogens|phytoestrogens|mesh-ancestor
24730501|NCT01628471|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24730546|NCT01628783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24730547|NCT01628783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24730548|NCT01628783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24730549|NCT01628783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730550|NCT01628783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24730551|NCT01628783|Serotonin Agents|serotonin agents|mesh-ancestor
24730552|NCT01628783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730553|NCT01628783|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24730554|NCT01628783|Antidepressive Agents|antidepressive agents|mesh-ancestor
24730555|NCT01628783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24730557|NCT01628952|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24730558|NCT01628952|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24730559|NCT01628952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24730560|NCT01628952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24730561|NCT01628952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730562|NCT01628952|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24730563|NCT01628952|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24730567|NCT01629082|Lenalidomide|lenalidomide|mesh-list
24616824|NCT01039363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616825|NCT01039363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616828|NCT01039363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24616829|NCT01039363|Immunologic Factors|immunologic factors|mesh-ancestor
24616830|NCT01039363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616832|NCT01039363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616833|NCT01039363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24616834|NCT01039363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24616836|NCT01039363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24616838|NCT01039441|Anesthetics, Local|anesthetics, local|mesh-ancestor
25050969|NCT00457457|Tamsulosin|tamsulosin|mesh-list
25050970|NCT00457457|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25050971|NCT00457457|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25050972|NCT00457457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25050973|NCT00457457|Adrenergic Agents|adrenergic agents|mesh-ancestor
25050974|NCT00457457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24958211|NCT03835442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958212|NCT03835442|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24958213|NCT03835442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24958214|NCT03835442|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24616839|NCT01039441|Anesthetics|anesthetics|mesh-ancestor
24616840|NCT01039441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24616841|NCT01039441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616842|NCT01039441|Sensory System Agents|sensory system agents|mesh-ancestor
24616843|NCT01039441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24616844|NCT01039506|Irinotecan|irinotecan|mesh-list
24616845|NCT01039506|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24616846|NCT01039506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24616847|NCT01039506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616848|NCT01039506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616849|NCT01039506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616850|NCT01039545|Norfloxacin|norfloxacin|mesh-list
24730579|NCT01629173|Ethylene|ethylene|mesh-list
24730580|NCT01629173|Plant Growth Regulators|plant growth regulators|mesh-ancestor
24730583|NCT01629199|Mitogens|mitogens|mesh-list
24730597|NCT01629212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24730598|NCT01629212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24730613|NCT01629277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730614|NCT01629368|Carbamazepine|carbamazepine|mesh-list
25695916|NCT02055820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25695917|NCT02055820|Immunologic Factors|immunologic factors|mesh-ancestor
25695918|NCT02055820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552854|NCT00727987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24730615|NCT01629368|Anticonvulsants|anticonvulsants|mesh-ancestor
24730616|NCT01629368|Antimanic Agents|antimanic agents|mesh-ancestor
24730617|NCT01629368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24730618|NCT01629368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24730619|NCT01629368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730620|NCT01629368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24730621|NCT01629368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24730623|NCT01629368|Sensory System Agents|sensory system agents|mesh-ancestor
24730624|NCT01629368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24730625|NCT01629368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24730626|NCT01629368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24730627|NCT01629368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730630|NCT01629394|Neostigmine|neostigmine|mesh-list
24730637|NCT01629394|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24394608|NCT00133731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24730638|NCT01629394|Autonomic Agents|autonomic agents|mesh-ancestor
24730639|NCT01629394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24730640|NCT01629446|Lofexidine|lofexidine|mesh-list
24730641|NCT01629446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24730642|NCT01629446|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24958215|NCT03835442|GABA Agonists|gaba agonists|mesh-ancestor
24958216|NCT03835442|GABA Agents|gaba agents|mesh-ancestor
24958217|NCT03835442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24855509|NCT02279953|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24730643|NCT01629446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730658|NCT01629511|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24730660|NCT01629511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24730661|NCT01629511|Antimetabolites|antimetabolites|mesh-ancestor
24730663|NCT01629511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730686|NCT01629628|Antimetabolites|antimetabolites|mesh-ancestor
24730687|NCT01629628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730688|NCT01629628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24730689|NCT01629628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730690|NCT01629628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24730691|NCT01629628|Immunologic Factors|immunologic factors|mesh-ancestor
24730692|NCT01629628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730693|NCT01629628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24730694|NCT01629628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24730695|NCT01629680|Moxaverine|moxaverine|mesh-list
24730696|NCT01629680|Parasympatholytics|parasympatholytics|mesh-ancestor
24730697|NCT01629680|Autonomic Agents|autonomic agents|mesh-ancestor
24730698|NCT01629680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24730699|NCT01629680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730700|NCT01629732|Ribavirin|ribavirin|mesh-list
24730701|NCT01629732|Antimetabolites|antimetabolites|mesh-ancestor
24730702|NCT01629732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730703|NCT01629732|Antiviral Agents|antiviral agents|mesh-ancestor
24730704|NCT01629732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24730705|NCT01629758|Nivolumab|nivolumab|mesh-list
24730720|NCT01630018|Topotecan|topotecan|mesh-list
24958219|NCT03835871|Beclomethasone|beclomethasone|mesh-list
24958220|NCT03835871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24958221|NCT03835871|Glucocorticoids|glucocorticoids|mesh-ancestor
24958222|NCT03835871|Hormones|hormones|mesh-ancestor
24958223|NCT03835871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24958224|NCT03835871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958225|NCT03835871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24958226|NCT03835871|Respiratory System Agents|respiratory system agents|mesh-ancestor
24855520|NCT02279966|Paroxetine|paroxetine|mesh-list
24730778|NCT01630343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24730779|NCT01630343|Analgesics|analgesics|mesh-ancestor
24730780|NCT01630343|Sensory System Agents|sensory system agents|mesh-ancestor
24730781|NCT01630343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24730782|NCT01630343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730783|NCT01630343|Antipyretics|antipyretics|mesh-ancestor
24730784|NCT01630343|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24730785|NCT01630343|Narcotics|narcotics|mesh-ancestor
24730786|NCT01630343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24730787|NCT01630369|Insulin|insulin|mesh-list
24730788|NCT01630369|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24730789|NCT01630369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25695919|NCT02055820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24730790|NCT01630369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730791|NCT01630538|Cyclophosphamide|cyclophosphamide|mesh-list
24730792|NCT01630538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24730793|NCT01630538|Immunologic Factors|immunologic factors|mesh-ancestor
25695920|NCT02055820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25695921|NCT02055820|Alkylating Agents|alkylating agents|mesh-ancestor
24553140|NCT00729742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553142|NCT00729768|Cyclosporine|cyclosporine|mesh-list
24730794|NCT01630538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730795|NCT01630538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24730796|NCT01630538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24730797|NCT01630538|Alkylating Agents|alkylating agents|mesh-ancestor
24730801|NCT01630564|Aldesleukin|aldesleukin|mesh-list
24730812|NCT01630564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24730813|NCT01630642|Clopidogrel|clopidogrel|mesh-list
24730830|NCT01630655|Vasodilator Agents|vasodilator agents|mesh-ancestor
24730831|NCT01630720|Vitamin D|vitamin d|mesh-list
24730832|NCT01630720|Vitamins|vitamins|mesh-list
24730833|NCT01630720|Ascorbic Acid|ascorbic acid|mesh-list
24730834|NCT01630720|Micronutrients|micronutrients|mesh-ancestor
24730835|NCT01630720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730836|NCT01630720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24730837|NCT01630720|Antioxidants|antioxidants|mesh-ancestor
24730838|NCT01630720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730858|NCT01630915|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24730859|NCT01630915|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24730860|NCT01630915|Purinergic Agents|purinergic agents|mesh-ancestor
24730861|NCT01630915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24730862|NCT01630915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730863|NCT01630915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730864|NCT01630941|Denosumab|denosumab|mesh-list
24730865|NCT01630941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24730866|NCT01630941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730867|NCT01631058|Prednisone|prednisone|mesh-list
24730868|NCT01631058|Everolimus|everolimus|mesh-list
24958227|NCT03835507|Epoetin Alfa|epoetin alfa|mesh-list
24799908|NCT01971801|Vitamins|vitamins|mesh-ancestor
24855521|NCT02279966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24730869|NCT01631058|Lactitol|lactitol|mesh-list
24730870|NCT01631058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24730914|NCT01631357|Antimetabolites|antimetabolites|mesh-ancestor
24730915|NCT01631357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730916|NCT01631357|Antiviral Agents|antiviral agents|mesh-ancestor
24730917|NCT01631357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24730918|NCT01631357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24730919|NCT01631357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24616851|NCT01039545|Diclofenac|diclofenac|mesh-list
24730920|NCT01631357|Immunologic Factors|immunologic factors|mesh-ancestor
24730921|NCT01631357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730922|NCT01631383|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
24730923|NCT01631383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24730924|NCT01631383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24730925|NCT01631383|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24730926|NCT01631383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24730927|NCT01631383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730928|NCT01631383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24730929|NCT01631383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730954|NCT01631409|Enalapril|enalapril|mesh-list
24730955|NCT01631409|Enalaprilat|enalaprilat|mesh-list
24730956|NCT01631409|Amlodipine|amlodipine|mesh-list
24730957|NCT01631409|Isosorbide|isosorbide|mesh-list
24730958|NCT01631409|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24730959|NCT01631409|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
24730960|NCT01631409|Nitroglycerin|nitroglycerin|mesh-list
24730961|NCT01631409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24730962|NCT01631409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24730963|NCT01631409|Analgesics|analgesics|mesh-ancestor
24730964|NCT01631409|Sensory System Agents|sensory system agents|mesh-ancestor
24909138|NCT04312243|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24909142|NCT04312438|Caseins|caseins|mesh-list
24730965|NCT01631409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24730966|NCT01631409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730967|NCT01631409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24730968|NCT01631409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25695922|NCT02055820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730969|NCT01631409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24730970|NCT01631409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24730971|NCT01631409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730972|NCT01631409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24730973|NCT01631409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24730974|NCT01631409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24730975|NCT01631409|Antipyretics|antipyretics|mesh-ancestor
24730980|NCT01631409|Sympatholytics|sympatholytics|mesh-ancestor
24730993|NCT01631409|Natriuretic Agents|natriuretic agents|mesh-ancestor
25050975|NCT00457457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050976|NCT00457457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050977|NCT00457457|Urological Agents|urological agents|mesh-ancestor
24730994|NCT01631409|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24730995|NCT01631448|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24730996|NCT01631448|Hemostatics|hemostatics|mesh-ancestor
24730997|NCT01631448|Coagulants|coagulants|mesh-ancestor
24730999|NCT01631513|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24731000|NCT01631513|Narcotics|narcotics|mesh-ancestor
24731001|NCT01631513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24731002|NCT01631513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731003|NCT01631513|Analgesics|analgesics|mesh-ancestor
24731010|NCT01631513|Adrenergic Agents|adrenergic agents|mesh-ancestor
24731054|NCT01631838|Micronutrients|micronutrients|mesh-ancestor
24731055|NCT01631877|Enoxaparin|enoxaparin|mesh-list
24731056|NCT01631877|Acenocoumarol|acenocoumarol|mesh-list
24731057|NCT01631877|Anticoagulants|anticoagulants|mesh-ancestor
24731058|NCT01631877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24731059|NCT01631877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24731072|NCT01631994|Dopamine Agents|dopamine agents|mesh-ancestor
24731073|NCT01631994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24731074|NCT01631994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731076|NCT01632007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24731077|NCT01632007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731078|NCT01632007|Incretins|incretins|mesh-ancestor
24731079|NCT01632007|Hormones|hormones|mesh-ancestor
24731080|NCT01632007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24731081|NCT01632007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24731083|NCT01632007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731084|NCT01632007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731085|NCT01632046|Dialysis Solutions|dialysis solutions|mesh-list
24731086|NCT01632046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24731087|NCT01632163|Lixisenatide|lixisenatide|mesh-list
24731088|NCT01632163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24731089|NCT01632163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731090|NCT01632189|Varenicline|varenicline|mesh-list
24731091|NCT01632189|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24731092|NCT01632189|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24731133|NCT01632605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731134|NCT01632605|Antifungal Agents|antifungal agents|mesh-ancestor
24731135|NCT01632605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24731136|NCT01632605|Immunologic Factors|immunologic factors|mesh-ancestor
24731137|NCT01632605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731139|NCT01632657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24731140|NCT01632657|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24731141|NCT01632657|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24731155|NCT01632761|Ergocalciferols|ergocalciferols|mesh-list
24731156|NCT01632761|Cholecalciferol|cholecalciferol|mesh-list
24731158|NCT01632761|Micronutrients|micronutrients|mesh-ancestor
24731159|NCT01632761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731160|NCT01632761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24731161|NCT01632761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24731162|NCT01632826|Pomalidomide|pomalidomide|mesh-list
24731168|NCT01632826|Growth Inhibitors|growth inhibitors|mesh-ancestor
24731169|NCT01632826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731170|NCT01633086|Nitric Oxide|nitric oxide|mesh-list
24731171|NCT01633086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24731172|NCT01633086|Autonomic Agents|autonomic agents|mesh-ancestor
24731173|NCT01633086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24731174|NCT01633086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731175|NCT01633086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24731176|NCT01633086|Respiratory System Agents|respiratory system agents|mesh-ancestor
24731177|NCT01633086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24731178|NCT01633086|Antioxidants|antioxidants|mesh-ancestor
24731179|NCT01633086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731180|NCT01633086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24731199|NCT01633203|Capecitabine|capecitabine|mesh-list
24731200|NCT01633203|Epirubicin|epirubicin|mesh-list
24731201|NCT01633203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519515|NCT05332821|Growth Substances|growth substances|mesh-ancestor
24731211|NCT01633294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24731212|NCT01633294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24731213|NCT01633294|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24731222|NCT01633359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24731224|NCT01633450|Zinc|zinc|mesh-list
24731225|NCT01633450|Trace Elements|trace elements|mesh-ancestor
24731226|NCT01633450|Micronutrients|micronutrients|mesh-ancestor
24845770|NCT02238717|GABA Agents|gaba agents|mesh-ancestor
24731227|NCT01633450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731228|NCT01633476|Valacyclovir|valacyclovir|mesh-list
24731229|NCT01633476|Antiviral Agents|antiviral agents|mesh-ancestor
24731230|NCT01633476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24731231|NCT01633593|Donepezil|donepezil|mesh-list
24731232|NCT01633593|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24731233|NCT01633593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050979|NCT00455559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731234|NCT01633593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731235|NCT01633593|Cholinergic Agents|cholinergic agents|mesh-ancestor
24731236|NCT01633593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24731237|NCT01633593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731238|NCT01633593|Nootropic Agents|nootropic agents|mesh-ancestor
24731239|NCT01633645|Gemcitabine|gemcitabine|mesh-list
24731240|NCT01633645|Bortezomib|bortezomib|mesh-list
24731241|NCT01633645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616862|NCT01039545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616863|NCT01039545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24616864|NCT01039545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24616865|NCT01039545|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24616866|NCT01039545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24616867|NCT01039545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616868|NCT01039545|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24616869|NCT01039545|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24616870|NCT01039558|Ecabet|ecabet|mesh-list
24616871|NCT01039558|Lansoprazole|lansoprazole|mesh-list
24616872|NCT01039558|Dexlansoprazole|dexlansoprazole|mesh-list
24616874|NCT01039558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24616875|NCT01039558|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24616876|NCT01039558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616877|NCT01039558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616878|NCT01039558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24616879|NCT01039558|Protease Inhibitors|protease inhibitors|mesh-ancestor
24616880|NCT01039558|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24616881|NCT01039558|Protective Agents|protective agents|mesh-ancestor
24731893|NCT01636999|Nitrous Oxide|nitrous oxide|mesh-list
24616882|NCT01039558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616883|NCT01039558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616884|NCT01039610|Moxifloxacin|moxifloxacin|mesh-list
24616885|NCT01039610|Linezolid|linezolid|mesh-list
24845839|NCT02239523|Denosumab|denosumab|mesh-list
24616886|NCT01039610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24616887|NCT01039610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24616888|NCT01039610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24731259|NCT01633749|Immunologic Factors|immunologic factors|mesh-ancestor
24731260|NCT01633749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731261|NCT01633762|Vancomycin|vancomycin|mesh-list
24731262|NCT01633762|Gentamicins|gentamicins|mesh-list
24731263|NCT01633762|Meropenem|meropenem|mesh-list
24731264|NCT01633762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24731265|NCT01633762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24731266|NCT01633762|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24731267|NCT01633762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731268|NCT01633762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731269|NCT01633957|Warfarin|warfarin|mesh-list
24731270|NCT01633957|Anticoagulants|anticoagulants|mesh-ancestor
24731271|NCT01633970|Leucovorin|leucovorin|mesh-list
24731272|NCT01633970|Paclitaxel|paclitaxel|mesh-list
24731276|NCT01633970|Oxaliplatin|oxaliplatin|mesh-list
24731308|NCT01633983|Dermatologic Agents|dermatologic agents|mesh-ancestor
24731309|NCT01633983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731310|NCT01633983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24731311|NCT01633983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24731312|NCT01633983|Immunologic Factors|immunologic factors|mesh-ancestor
24731313|NCT01633983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25050980|NCT00455559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25050981|NCT00455559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050982|NCT00455559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555469|NCT00741741|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24731314|NCT01633983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24731315|NCT01634061|Dactolisib|dactolisib|mesh-list
24731316|NCT01634061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731317|NCT01634230|Phenylacetic acid|phenylacetic acid|mesh-list
24731318|NCT01634230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24731319|NCT01634230|Antimetabolites|antimetabolites|mesh-ancestor
24731320|NCT01634230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731321|NCT01634230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731322|NCT01634295|Niacin|niacin|mesh-list
24731323|NCT01634295|Amlodipine|amlodipine|mesh-list
24731324|NCT01634295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24731325|NCT01634295|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24731326|NCT01634295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24731327|NCT01634295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731328|NCT01634295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24731329|NCT01634295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731330|NCT01634295|Vasodilator Agents|vasodilator agents|mesh-ancestor
24731331|NCT01634295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24731332|NCT01634295|Antimetabolites|antimetabolites|mesh-ancestor
24731334|NCT01634295|Vitamin B Complex|vitamin b complex|mesh-ancestor
24731350|NCT01634347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846027|NCT02240641|Adrenergic Agents|adrenergic agents|mesh-ancestor
24846028|NCT02240641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24846029|NCT02240641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731351|NCT01634347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24731352|NCT01634347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24731353|NCT01634347|Vasodilator Agents|vasodilator agents|mesh-ancestor
24731354|NCT01634373|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24731708|NCT01636128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24731377|NCT01634412|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24731379|NCT01634412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24731380|NCT01634412|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24731381|NCT01634412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731387|NCT01634412|Analgesics|analgesics|mesh-ancestor
24731390|NCT01634412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24731391|NCT01634412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24731392|NCT01634412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731393|NCT01634412|Adrenergic Agents|adrenergic agents|mesh-ancestor
24731394|NCT01634412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24616895|NCT01039740|Antidepressive Agents|antidepressive agents|mesh-ancestor
24616896|NCT01039740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24616897|NCT01039740|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24616898|NCT01039740|Histamine Antagonists|histamine antagonists|mesh-ancestor
24616899|NCT01039740|Histamine Agents|histamine agents|mesh-ancestor
24616900|NCT01039740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24616929|NCT01039948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616930|NCT01039948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24616931|NCT01039948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731400|NCT01634438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731401|NCT01634594|Nicardipine|nicardipine|mesh-list
24731402|NCT01634594|Dexmedetomidine|dexmedetomidine|mesh-list
24731403|NCT01634594|Remifentanil|remifentanil|mesh-list
24731404|NCT01634594|Sevoflurane|sevoflurane|mesh-list
24731405|NCT01634594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24731406|NCT01634594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24731407|NCT01634594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731408|NCT01634594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24731409|NCT01634594|Analgesics|analgesics|mesh-ancestor
24731410|NCT01634594|Sensory System Agents|sensory system agents|mesh-ancestor
24731411|NCT01634594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24731412|NCT01634594|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24731413|NCT01634594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24731414|NCT01634594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24731415|NCT01634594|Adrenergic Agents|adrenergic agents|mesh-ancestor
24731416|NCT01634594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24731417|NCT01634594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731431|NCT01634685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24731432|NCT01634685|Antimetabolites|antimetabolites|mesh-ancestor
25695923|NCT02055820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25695924|NCT02055820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25695925|NCT02055820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24612621|NCT01014637|Antifungal Agents|antifungal agents|mesh-list
25008246|NCT00826462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25008247|NCT00826462|Gout Suppressants|gout suppressants|mesh-ancestor
25008248|NCT00826462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25008250|NCT00710970|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25008251|NCT00710970|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25008252|NCT00710970|Hormone Antagonists|hormone antagonists|mesh-ancestor
25008253|NCT00710970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25008254|NCT00710970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008255|NCT00710970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25008256|NCT00710970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008257|NCT00710970|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25008258|NCT00710970|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24731433|NCT01634685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731434|NCT01634685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731476|NCT01634906|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24731477|NCT01634906|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24731478|NCT01634906|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24731479|NCT01634906|Antimetabolites|antimetabolites|mesh-ancestor
24731480|NCT01634906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731481|NCT01634906|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24731482|NCT01634906|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24731483|NCT01634906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050990|NCT00455156|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25050992|NCT00455156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25050993|NCT00455156|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25050994|NCT00455156|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25050995|NCT00455156|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24855541|NCT02279992|Carboplatin|carboplatin|mesh-list
24731484|NCT01634932|Iron|iron|mesh-list
24731485|NCT01634932|Trace Elements|trace elements|mesh-ancestor
24731486|NCT01634932|Micronutrients|micronutrients|mesh-ancestor
24731487|NCT01634932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731488|NCT01634945|Amodiaquine|amodiaquine|mesh-list
24731489|NCT01634945|Antimalarials|antimalarials|mesh-ancestor
24731490|NCT01634945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24731491|NCT01634945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24731492|NCT01634945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24731493|NCT01634958|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24731495|NCT01634958|Immunologic Factors|immunologic factors|mesh-ancestor
24395546|NCT00136370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24395547|NCT00136370|Disinfectants|disinfectants|mesh-ancestor
24731518|NCT01635296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731532|NCT01635426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24731533|NCT01635426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24731534|NCT01635426|Analgesics|analgesics|mesh-ancestor
24731535|NCT01635426|Sensory System Agents|sensory system agents|mesh-ancestor
24846144|NCT02241460|Anesthetics, Local|anesthetics, local|mesh-ancestor
24731536|NCT01635426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24731537|NCT01635426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731538|NCT01635426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24731539|NCT01635426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24731566|NCT01635608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731567|NCT01635608|Antipyretics|antipyretics|mesh-ancestor
24731568|NCT01635608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24731569|NCT01635608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24731570|NCT01635608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24731571|NCT01635608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24731572|NCT01635608|Adrenergic Agents|adrenergic agents|mesh-ancestor
24731573|NCT01635608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25695926|NCT02055820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25695927|NCT02055820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25695928|NCT02055820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25695929|NCT02055820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25695930|NCT02055820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25695931|NCT02055820|Glucocorticoids|glucocorticoids|mesh-ancestor
25695932|NCT02055820|Hormones|hormones|mesh-ancestor
25695933|NCT02055820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25695934|NCT02055820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25695935|NCT02055820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25695936|NCT02055820|Tubulin Modulators|tubulin modulators|mesh-ancestor
25695937|NCT02055820|Antimitotic Agents|antimitotic agents|mesh-ancestor
25695938|NCT02055820|Mitosis Modulators|mitosis modulators|mesh-ancestor
25695939|NCT02055898|Sodium Oxybate|sodium oxybate|mesh-list
24731574|NCT01635608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731575|NCT01635608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24731576|NCT01635608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24731577|NCT01635686|Etanercept|etanercept|mesh-list
24731634|NCT01635829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24731635|NCT01635829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24731636|NCT01635829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731637|NCT01635829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24731638|NCT01635829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24731640|NCT01635829|Sensory System Agents|sensory system agents|mesh-ancestor
24731641|NCT01635829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24731642|NCT01635829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24731643|NCT01635829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24731644|NCT01635829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731645|NCT01635829|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24731646|NCT01635829|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24731652|NCT01635946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24731653|NCT01635946|Antimetabolites|antimetabolites|mesh-ancestor
24731654|NCT01635946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731655|NCT01635946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24731656|NCT01635946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24731657|NCT01635946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731658|NCT01635946|Antifungal Agents|antifungal agents|mesh-ancestor
24731659|NCT01635946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24731661|NCT01635972|Bupropion|bupropion|mesh-list
24731662|NCT01635972|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24731663|NCT01635972|Antidepressive Agents|antidepressive agents|mesh-ancestor
24731664|NCT01635972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25051009|NCT00451152|Growth Inhibitors|growth inhibitors|mesh-ancestor
25051010|NCT00451152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051011|NCT00451152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25051013|NCT00450970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051015|NCT00449605|Glimepiride|glimepiride|mesh-list
25051016|NCT00449605|Rimonabant|rimonabant|mesh-list
25051017|NCT00449605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25051018|NCT00449605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958229|NCT03835286|Ascorbic Acid|ascorbic acid|mesh-list
24958230|NCT03835286|Vitamins|vitamins|mesh-ancestor
24731695|NCT01636128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24731696|NCT01636128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24731697|NCT01636128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24731698|NCT01636128|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
24731699|NCT01636128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731700|NCT01636128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731701|NCT01636128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24731702|NCT01636128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24731703|NCT01636128|Analgesics|analgesics|mesh-ancestor
24731704|NCT01636128|Sensory System Agents|sensory system agents|mesh-ancestor
24731705|NCT01636128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24731706|NCT01636128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731707|NCT01636128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24731715|NCT01636180|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24731716|NCT01636180|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24731717|NCT01636180|Purinergic Agents|purinergic agents|mesh-ancestor
24731718|NCT01636180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24731720|NCT01636180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731727|NCT01636271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731729|NCT01636310|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24731730|NCT01636310|Autonomic Agents|autonomic agents|mesh-ancestor
24731731|NCT01636310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24731732|NCT01636310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731733|NCT01636310|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24731734|NCT01636310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24731739|NCT01636323|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24731740|NCT01636323|Autonomic Agents|autonomic agents|mesh-ancestor
24731741|NCT01636323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24731742|NCT01636323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731743|NCT01636323|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24731744|NCT01636323|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24731745|NCT01636323|Cholinergic Agents|cholinergic agents|mesh-ancestor
24731746|NCT01636323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24942390|NCT03981523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24557942|NCT00754884|Protective Agents|protective agents|mesh-ancestor
24731747|NCT01636323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731750|NCT01636336|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24958231|NCT03835286|Micronutrients|micronutrients|mesh-ancestor
24958232|NCT03835286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958233|NCT03835286|Antioxidants|antioxidants|mesh-ancestor
24958234|NCT03835286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958235|NCT03835286|Protective Agents|protective agents|mesh-ancestor
24958236|NCT03834766|Amphetamine|amphetamine|mesh-list
24958237|NCT03834766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24958238|NCT03834766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958239|NCT03834766|Sympathomimetics|sympathomimetics|mesh-ancestor
24958240|NCT03834766|Autonomic Agents|autonomic agents|mesh-ancestor
24958241|NCT03834766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24731751|NCT01636336|Autonomic Agents|autonomic agents|mesh-ancestor
24731752|NCT01636336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24731753|NCT01636336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731754|NCT01636336|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24731755|NCT01636336|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24731756|NCT01636336|Cholinergic Agents|cholinergic agents|mesh-ancestor
24731757|NCT01636336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24731759|NCT01636336|Progestins|progestins|mesh-ancestor
24731771|NCT01636505|Hormone Antagonists|hormone antagonists|mesh-ancestor
24731772|NCT01636505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24731773|NCT01636531|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24731774|NCT01636531|Immunologic Factors|immunologic factors|mesh-ancestor
24731775|NCT01636531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731777|NCT01636557|Midazolam|midazolam|mesh-list
24731778|NCT01636557|Caffeine|caffeine|mesh-list
24731779|NCT01636557|Omeprazole|omeprazole|mesh-list
24731780|NCT01636557|Warfarin|warfarin|mesh-list
24731781|NCT01636557|Vitamins|vitamins|mesh-ancestor
24731782|NCT01636557|Micronutrients|micronutrients|mesh-ancestor
24731783|NCT01636557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731784|NCT01636557|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24731787|NCT01636557|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24731834|NCT01636609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731835|NCT01636609|Glycine Agents|glycine agents|mesh-ancestor
24731836|NCT01636609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24731837|NCT01636622|Paclitaxel|paclitaxel|mesh-list
24731838|NCT01636622|Carboplatin|carboplatin|mesh-list
24731863|NCT01636895|Pyrimethamine|pyrimethamine|mesh-list
24958242|NCT03834766|Dopamine Agents|dopamine agents|mesh-ancestor
24958243|NCT03834766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24958244|NCT03834766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958245|NCT03834766|Adrenergic Agents|adrenergic agents|mesh-ancestor
24958246|NCT03834766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24958247|NCT03834766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24958248|NCT03834766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24958249|NCT03834766|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24958250|NCT03834831|Selenium|selenium|mesh-list
24958251|NCT03834831|Ubiquinone|ubiquinone|mesh-list
24958252|NCT03834831|Coenzyme Q10|coenzyme q10|mesh-list
24958253|NCT03834831|Antioxidants|antioxidants|mesh-ancestor
24958254|NCT03834831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958255|NCT03834831|Protective Agents|protective agents|mesh-ancestor
24958256|NCT03834831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958257|NCT03834831|Trace Elements|trace elements|mesh-ancestor
24731864|NCT01636895|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24731865|NCT01636895|Sulfadoxine|sulfadoxine|mesh-list
24731866|NCT01636895|Antimalarials|antimalarials|mesh-ancestor
24731867|NCT01636895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24731868|NCT01636895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24731869|NCT01636895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24731870|NCT01636895|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24731871|NCT01636895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731872|NCT01636895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731888|NCT01636908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731889|NCT01636908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24731890|NCT01636908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24731891|NCT01636908|Growth Substances|growth substances|mesh-ancestor
24731892|NCT01636908|Growth Inhibitors|growth inhibitors|mesh-ancestor
24558496|NCT00757523|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
24558497|NCT00757523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24558498|NCT00757523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24558500|NCT00757523|Sensory System Agents|sensory system agents|mesh-ancestor
24558501|NCT00757523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24558502|NCT00757523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558503|NCT00757523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24558720|NCT05435560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24791245|NCT04887389|Sodium Fluoride|sodium fluoride|mesh-list
24791246|NCT04887389|Fluorides, Topical|fluorides, topical|mesh-list
24791247|NCT04887389|Cariostatic Agents|cariostatic agents|mesh-ancestor
24791248|NCT04887389|Protective Agents|protective agents|mesh-ancestor
24791249|NCT04887389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791282|NCT04812028|Anesthetics|anesthetics|mesh-ancestor
24791283|NCT04812028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24552977|NCT00728663|Docetaxel|docetaxel|mesh-list
24731909|NCT01637155|Micronutrients|micronutrients|mesh-ancestor
24731910|NCT01637155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731911|NCT01637155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24731912|NCT01637155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24731913|NCT01637194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24731915|NCT01637194|Everolimus|everolimus|mesh-list
24731916|NCT01637194|Antibodies|antibodies|mesh-list
24731917|NCT01637194|Immunoglobulins|immunoglobulins|mesh-list
24731918|NCT01637194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24731919|NCT01637194|Immunologic Factors|immunologic factors|mesh-ancestor
24731920|NCT01637194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731921|NCT01637194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731922|NCT01637194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24958258|NCT03834831|Micronutrients|micronutrients|mesh-ancestor
24958259|NCT03834831|Vitamins|vitamins|mesh-ancestor
24942270|NCT03982537|Acetylcysteine|acetylcysteine|mesh-list
24767391|NCT01800526|Antiviral Agents|antiviral agents|mesh-ancestor
24767392|NCT01800526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24731923|NCT01637233|Ritonavir|ritonavir|mesh-list
24731924|NCT01637233|Lopinavir|lopinavir|mesh-list
24731925|NCT01637233|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24731926|NCT01637233|Darunavir|darunavir|mesh-list
24731927|NCT01637233|Fosamprenavir|fosamprenavir|mesh-list
24731928|NCT01637233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
24731929|NCT01637233|Tenofovir|tenofovir|mesh-list
24731930|NCT01637233|Lamivudine|lamivudine|mesh-list
24731931|NCT01637233|Zidovudine|zidovudine|mesh-list
24731932|NCT01637233|Emtricitabine|emtricitabine|mesh-list
24731933|NCT01637233|Maraviroc|maraviroc|mesh-list
24731934|NCT01637233|Abacavir|abacavir|mesh-list
24731935|NCT01637233|Dideoxynucleosides|dideoxynucleosides|mesh-list
24731943|NCT01637233|Antiviral Agents|antiviral agents|mesh-ancestor
24731944|NCT01637233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24731945|NCT01637233|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24731946|NCT01637233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24731947|NCT01637233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24731949|NCT01637233|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24731950|NCT01637233|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24731951|NCT01637233|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24731952|NCT01637259|Ritonavir|ritonavir|mesh-list
24731953|NCT01637259|Lopinavir|lopinavir|mesh-list
24731954|NCT01637259|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24731955|NCT01637259|Darunavir|darunavir|mesh-list
25695940|NCT02055898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25695941|NCT02055898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25695942|NCT02055898|Anesthetics, General|anesthetics, general|mesh-ancestor
25695943|NCT02055898|Anesthetics|anesthetics|mesh-ancestor
25695944|NCT02055898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25695945|NCT02055898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695946|NCT02055976|Ezetimibe|ezetimibe|mesh-list
25695947|NCT02055976|Bococizumab|bococizumab|mesh-list
25695948|NCT02055976|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25695949|NCT02055976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25695950|NCT02055976|Antimetabolites|antimetabolites|mesh-ancestor
25695951|NCT02055976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695952|NCT02055976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25695953|NCT02056171|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25695954|NCT02056171|Antidepressive Agents|antidepressive agents|mesh-ancestor
25695955|NCT02056171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24731956|NCT01637259|Fosamprenavir|fosamprenavir|mesh-list
24731957|NCT01637259|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
25695956|NCT02056171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24558968|NCT05382338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24559005|NCT05343156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24559007|NCT05343156|Glucocorticoids|glucocorticoids|mesh-ancestor
24559008|NCT05343156|Hormones|hormones|mesh-ancestor
24559009|NCT05343156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24559010|NCT05343156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24731958|NCT01637259|Tenofovir|tenofovir|mesh-list
24731959|NCT01637259|Lamivudine|lamivudine|mesh-list
24731960|NCT01637259|Zidovudine|zidovudine|mesh-list
24731961|NCT01637259|Emtricitabine|emtricitabine|mesh-list
24731962|NCT01637259|Maraviroc|maraviroc|mesh-list
24731963|NCT01637259|Abacavir|abacavir|mesh-list
24731964|NCT01637259|Dideoxynucleosides|dideoxynucleosides|mesh-list
24731965|NCT01637259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
24767395|NCT01800526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24558369|NCT00756873|Analgesics|analgesics|mesh-ancestor
24558370|NCT00756873|Sensory System Agents|sensory system agents|mesh-ancestor
24558371|NCT00756873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24942291|NCT03982381|Dapagliflozin|dapagliflozin|mesh-list
24942292|NCT03982381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24942293|NCT03982381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942294|NCT03982381|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24942295|NCT03982381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942296|NCT03982680|Gemcitabine|gemcitabine|mesh-list
24942297|NCT03982680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24942298|NCT03982680|Antimetabolites|antimetabolites|mesh-ancestor
24855597|NCT02280083|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24616971|NCT01040195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616972|NCT01040195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24616973|NCT01040195|Antimetabolites|antimetabolites|mesh-ancestor
24616974|NCT01040195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616975|NCT01040195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616976|NCT01040195|Dermatologic Agents|dermatologic agents|mesh-ancestor
24616977|NCT01040195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616978|NCT01040195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24616979|NCT01040195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24732065|NCT01637636|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24732066|NCT01637636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24732067|NCT01637636|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24732089|NCT01637675|Analgesics|analgesics|mesh-ancestor
24732090|NCT01637675|Sensory System Agents|sensory system agents|mesh-ancestor
24732091|NCT01637675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24942299|NCT03982680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942300|NCT03982680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942301|NCT03982680|Antiviral Agents|antiviral agents|mesh-ancestor
24942302|NCT03982680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24942303|NCT03982680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24942304|NCT03982680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24942305|NCT03982680|Immunologic Factors|immunologic factors|mesh-ancestor
24942306|NCT03982680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732092|NCT01637675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732093|NCT01637675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24732094|NCT01637675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24732095|NCT01637675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24732096|NCT01637675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732097|NCT01637675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24732098|NCT01637675|Immunologic Factors|immunologic factors|mesh-ancestor
24732099|NCT01637753|Carmustine|carmustine|mesh-list
25695957|NCT02056171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25695958|NCT02056171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25695959|NCT02056171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695960|NCT02056288|Fentanyl|fentanyl|mesh-list
25695961|NCT02056288|Ropivacaine|ropivacaine|mesh-list
25695962|NCT02056288|Anesthetics, Local|anesthetics, local|mesh-ancestor
25695963|NCT02056288|Anesthetics|anesthetics|mesh-ancestor
25695964|NCT02056288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25695965|NCT02056288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732100|NCT01637753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25695966|NCT02056288|Sensory System Agents|sensory system agents|mesh-ancestor
24696071|NCT01427127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25695967|NCT02056288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25695968|NCT02056288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25695969|NCT02056288|Narcotics|narcotics|mesh-ancestor
25695970|NCT02056288|Analgesics|analgesics|mesh-ancestor
25695971|NCT02056288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24696072|NCT01427127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696073|NCT01427192|Acetazolamide|acetazolamide|mesh-list
24696074|NCT01427192|Anticonvulsants|anticonvulsants|mesh-ancestor
24696075|NCT01427192|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24696076|NCT01427192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732101|NCT01637753|Alkylating Agents|alkylating agents|mesh-ancestor
24732139|NCT01638026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732140|NCT01638026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24649459|NCT01220063|Irinotecan|irinotecan|mesh-list
24732141|NCT01638026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24732142|NCT01638026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732143|NCT01638078|Thalidomide|thalidomide|mesh-list
24732144|NCT01638078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24732145|NCT01638078|Immunologic Factors|immunologic factors|mesh-ancestor
24732146|NCT01638078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732147|NCT01638078|Leprostatic Agents|leprostatic agents|mesh-ancestor
24732148|NCT01638078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24732149|NCT01638078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24732152|NCT01638078|Growth Substances|growth substances|mesh-ancestor
24732153|NCT01638078|Growth Inhibitors|growth inhibitors|mesh-ancestor
24732154|NCT01638078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732155|NCT01638182|Vitamins|vitamins|mesh-list
24732156|NCT01638182|Vitamin K|vitamin k|mesh-list
24732169|NCT01638234|Protective Agents|protective agents|mesh-ancestor
24732170|NCT01638234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732200|NCT01638273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616994|NCT01040273|Bupivacaine|bupivacaine|mesh-list
24616998|NCT01040273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616999|NCT01040273|Sensory System Agents|sensory system agents|mesh-ancestor
24617000|NCT01040273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24617003|NCT01040286|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24617004|NCT01040286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24617005|NCT01040286|Disinfectants|disinfectants|mesh-ancestor
24617007|NCT01040286|Sensory System Agents|sensory system agents|mesh-ancestor
24617008|NCT01040286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24617009|NCT01040286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617010|NCT01040286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24617011|NCT01040286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24617012|NCT01040286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24617013|NCT01040286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24617014|NCT01040286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24617015|NCT01040286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617016|NCT01040286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732256|NCT01638650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732257|NCT01638650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732258|NCT01638650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24732259|NCT01638650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25695972|NCT02056288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25695973|NCT02056288|Anesthetics, General|anesthetics, general|mesh-ancestor
25695974|NCT02056301|Morphine|morphine|mesh-list
25695975|NCT02056301|Hydromorphone|hydromorphone|mesh-list
25695976|NCT02056301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25695977|NCT02056301|Narcotics|narcotics|mesh-ancestor
25695978|NCT02056301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25695979|NCT02056301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25695980|NCT02056301|Analgesics|analgesics|mesh-ancestor
25695981|NCT02056301|Sensory System Agents|sensory system agents|mesh-ancestor
25695982|NCT02056301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25695983|NCT02056340|Atorvastatin|atorvastatin|mesh-list
25695984|NCT02056340|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25695985|NCT02056340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24559567|NCT04643574|Cyclophosphamide|cyclophosphamide|mesh-list
24559568|NCT04643574|Fludarabine|fludarabine|mesh-list
24559569|NCT04643574|Interleukin-2|interleukin-2|mesh-list
24559570|NCT04643574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24559571|NCT04643574|Immunologic Factors|immunologic factors|mesh-ancestor
24571387|NCT00809692|Histamine|histamine|mesh-list
24671010|NCT01323244|Simeprevir|simeprevir|mesh-list
24559782|NCT04401059|Gefitinib|gefitinib|mesh-list
24559783|NCT04401059|Osimertinib|osimertinib|mesh-list
24559784|NCT04401059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24559785|NCT04401059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24559786|NCT04401059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24559787|NCT04401059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732260|NCT01638650|Antiviral Agents|antiviral agents|mesh-ancestor
24732261|NCT01638650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24732262|NCT01638650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24732263|NCT01638650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24732264|NCT01638650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24732265|NCT01638663|Tolvaptan|tolvaptan|mesh-list
24732266|NCT01638663|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24732775|NCT01641406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24732269|NCT01638663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732270|NCT01638676|Metformin|metformin|mesh-list
24732271|NCT01638676|Vemurafenib|vemurafenib|mesh-list
24732272|NCT01638676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24732273|NCT01638676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732274|NCT01638676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732275|NCT01638676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24732276|NCT01638676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732277|NCT01638676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732278|NCT01638689|Citalopram|citalopram|mesh-list
24732279|NCT01638689|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24732280|NCT01638689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24732281|NCT01638689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24732288|NCT01638689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24942334|NCT03982173|Durvalumab|durvalumab|mesh-list
24942335|NCT03982173|Tremelimumab|tremelimumab|mesh-list
24942336|NCT03982173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24942337|NCT03982173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942338|NCT03982238|Metformin|metformin|mesh-list
24477812|NCT00420355|Antiviral Agents|antiviral agents|mesh-ancestor
24942339|NCT03982238|Dapagliflozin|dapagliflozin|mesh-list
24942340|NCT03982238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24942341|NCT03982238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617066|NCT01040585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617067|NCT01040585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617068|NCT01040598|Omalizumab|omalizumab|mesh-list
24617069|NCT01040598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24617070|NCT01040598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24617071|NCT01040598|Respiratory System Agents|respiratory system agents|mesh-ancestor
24617072|NCT01040702|Methylphenidate|methylphenidate|mesh-list
24617084|NCT01040936|Antimetabolites|antimetabolites|mesh-ancestor
24617085|NCT01040936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617086|NCT01040936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24617087|NCT01040936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24617088|NCT01040936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617089|NCT01041027|Paclitaxel|paclitaxel|mesh-list
24617090|NCT01041027|Carboplatin|carboplatin|mesh-list
24617091|NCT01041027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24617092|NCT01041027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617093|NCT01041027|Tubulin Modulators|tubulin modulators|mesh-ancestor
24617094|NCT01041027|Antimitotic Agents|antimitotic agents|mesh-ancestor
24617095|NCT01041027|Mitosis Modulators|mitosis modulators|mesh-ancestor
25695986|NCT02056340|Antimetabolites|antimetabolites|mesh-ancestor
25695987|NCT02056340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25695988|NCT02056340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25695989|NCT02056340|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25695990|NCT02056340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25695991|NCT02056392|Moxifloxacin|moxifloxacin|mesh-list
25695992|NCT02056392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25695993|NCT02056392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25695994|NCT02056392|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25695995|NCT02056392|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25695996|NCT02056392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617097|NCT01041040|Gemtuzumab|gemtuzumab|mesh-list
24617102|NCT01041066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25695997|NCT02056392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560202|NCT03245450|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24560203|NCT03245450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24560321|NCT02927847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24560322|NCT02927847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24560323|NCT02927847|Cholinergic Agents|cholinergic agents|mesh-ancestor
24560324|NCT02927847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24560326|NCT02915224|Obinutuzumab|obinutuzumab|mesh-list
24732290|NCT01638715|Abatacept|abatacept|mesh-list
24732291|NCT01638715|Infliximab|infliximab|mesh-list
24732292|NCT01638715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24732293|NCT01638715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732294|NCT01638715|Immunologic Factors|immunologic factors|mesh-ancestor
24732295|NCT01638715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732296|NCT01638715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24732297|NCT01638715|Dermatologic Agents|dermatologic agents|mesh-ancestor
24732298|NCT01638715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24732299|NCT01638715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24732300|NCT01638715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732301|NCT01638715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24732306|NCT01638767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732307|NCT01638767|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24732308|NCT01638767|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24732309|NCT01638780|Resveratrol|resveratrol|mesh-list
24732310|NCT01638780|Antioxidants|antioxidants|mesh-ancestor
24732311|NCT01638780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942342|NCT03982238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24942343|NCT03982238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942344|NCT03982121|Nivolumab|nivolumab|mesh-list
24942345|NCT03982121|Ipilimumab|ipilimumab|mesh-list
24942346|NCT03982121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24942347|NCT03982121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942348|NCT03982121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24942349|NCT03982121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732329|NCT01638936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732330|NCT01638962|Acetaminophen|acetaminophen|mesh-list
24732331|NCT01638962|Aspirin|aspirin|mesh-list
24732332|NCT01638962|Ibuprofen|ibuprofen|mesh-list
24732356|NCT01638962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732357|NCT01638962|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24732358|NCT01638962|Gout Suppressants|gout suppressants|mesh-ancestor
24732375|NCT01638988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24732376|NCT01638988|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24732377|NCT01638988|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24732378|NCT01639027|Drotaverin|drotaverin|mesh-list
24732379|NCT01639027|Analgesics|analgesics|mesh-ancestor
24732380|NCT01639027|Sensory System Agents|sensory system agents|mesh-ancestor
24732381|NCT01639027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24732421|NCT01639261|Interferons|interferons|mesh-list
24732422|NCT01639261|Interferon-gamma|interferon-gamma|mesh-list
24732423|NCT01639261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732424|NCT01639261|Antiviral Agents|antiviral agents|mesh-ancestor
24732425|NCT01639261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24942352|NCT03982004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24784328|NCT01907373|Renal Agents|renal agents|mesh-ancestor
24942353|NCT03982004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942354|NCT03982004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24942355|NCT03982004|Immunologic Factors|immunologic factors|mesh-ancestor
24942356|NCT03982004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942357|NCT03982004|Interferon Inducers|interferon inducers|mesh-ancestor
24942358|NCT03981887|Nafithromycin|nafithromycin|mesh-list
24942359|NCT03981887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24617109|NCT01041066|Sympathomimetics|sympathomimetics|mesh-ancestor
24617110|NCT01041066|Autonomic Agents|autonomic agents|mesh-ancestor
24617111|NCT01041066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24617112|NCT01041066|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25695998|NCT02056392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25695999|NCT02056626|Carvedilol|carvedilol|mesh-list
25696000|NCT02056626|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25696001|NCT02056626|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25696002|NCT02056626|Adrenergic Agents|adrenergic agents|mesh-ancestor
25696003|NCT02056626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25696004|NCT02056626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617113|NCT01041066|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24617114|NCT01041066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24617132|NCT01041170|Hormones|hormones|mesh-ancestor
24617133|NCT01041170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24617139|NCT01041183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617141|NCT01041183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24617142|NCT01041183|Serotonin Agents|serotonin agents|mesh-ancestor
24617143|NCT01041183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24617144|NCT01041183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732461|NCT01639521|Immunologic Factors|immunologic factors|mesh-ancestor
24732462|NCT01639521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732463|NCT01639521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24732464|NCT01639521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24732465|NCT01639521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24732466|NCT01639521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24732467|NCT01639521|Abortifacient Agents|abortifacient agents|mesh-ancestor
24732468|NCT01639521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24732469|NCT01639521|Dermatologic Agents|dermatologic agents|mesh-ancestor
24732485|NCT01639573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732486|NCT01639794|Solifenacin Succinate|solifenacin succinate|mesh-list
24732487|NCT01639794|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24732488|NCT01639794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24732489|NCT01639794|Cholinergic Agents|cholinergic agents|mesh-ancestor
24732490|NCT01639794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24732491|NCT01639794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732492|NCT01639794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732493|NCT01639794|Urological Agents|urological agents|mesh-ancestor
24732494|NCT01639807|Latanoprost|latanoprost|mesh-list
24732495|NCT01639807|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24732496|NCT01639807|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24732497|NCT01639885|Interferons|interferons|mesh-list
24732498|NCT01639885|Interferon-alpha|interferon-alpha|mesh-list
24732499|NCT01639885|Interferon alpha-2|interferon alpha-2|mesh-list
24942364|NCT03981601|Lovastatin|lovastatin|mesh-list
24942365|NCT03981601|L 647318|l 647318|mesh-list
24942366|NCT03981601|Dihydromevinolin|dihydromevinolin|mesh-list
24942367|NCT03981601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24942368|NCT03981601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24942369|NCT03981601|Antimetabolites|antimetabolites|mesh-ancestor
24942370|NCT03981601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942371|NCT03981601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24942372|NCT03981601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24942373|NCT03981601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732500|NCT01639885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732555|NCT01640275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732556|NCT01640275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24732557|NCT01640275|Anesthetics, General|anesthetics, general|mesh-ancestor
24732558|NCT01640275|Anesthetics|anesthetics|mesh-ancestor
24732559|NCT01640275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24732560|NCT01640405|Bevacizumab|bevacizumab|mesh-list
24732561|NCT01640405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24732562|NCT01640405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732563|NCT01640405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24732568|NCT01640444|Bevacizumab|bevacizumab|mesh-list
24732580|NCT01640496|Micronutrients|micronutrients|mesh-ancestor
24732581|NCT01640496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732582|NCT01640496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24732583|NCT01640496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24732584|NCT01640535|Cetirizine|cetirizine|mesh-list
24732585|NCT01640535|Montelukast|montelukast|mesh-list
24732586|NCT01640535|Levocetirizine|levocetirizine|mesh-list
24732587|NCT01640535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24732588|NCT01640535|Respiratory System Agents|respiratory system agents|mesh-ancestor
24732589|NCT01640535|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24732590|NCT01640535|Hormone Antagonists|hormone antagonists|mesh-ancestor
24732591|NCT01640535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24732592|NCT01640535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732593|NCT01640535|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24732594|NCT01640535|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24563145|NCT00770354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24563146|NCT00770354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563147|NCT00770406|Botulinum Toxins|botulinum toxins|mesh-list
24563148|NCT00770406|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24563226|NCT00770666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24732595|NCT01640535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732596|NCT01640535|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24732597|NCT01640535|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24732598|NCT01640535|Histamine Antagonists|histamine antagonists|mesh-ancestor
24732600|NCT01640535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24732601|NCT01640535|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24732602|NCT01640574|Chloroquine|chloroquine|mesh-list
24732603|NCT01640574|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24732604|NCT01640574|Piperaquine|piperaquine|mesh-list
24732606|NCT01640574|Artemisinins|artemisinins|mesh-list
24732607|NCT01640574|Amebicides|amebicides|mesh-ancestor
24732608|NCT01640574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24942375|NCT03981627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24942376|NCT03981627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942377|NCT03981770|Anesthetics|anesthetics|mesh-list
24942378|NCT03981770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24942379|NCT03981770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942380|NCT03981484|Thrombin|thrombin|mesh-list
24942381|NCT03981484|Hemostatics|hemostatics|mesh-ancestor
24942382|NCT03981484|Coagulants|coagulants|mesh-ancestor
24942383|NCT03981523|Benzonidazole|benzonidazole|mesh-list
24942384|NCT03981523|Nifurtimox|nifurtimox|mesh-list
24942385|NCT03981523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24942386|NCT03981523|Immunologic Factors|immunologic factors|mesh-ancestor
24942387|NCT03981523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942388|NCT03981523|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24942392|NCT03981458|Hyaluronic Acid|hyaluronic acid|mesh-list
24942393|NCT03981458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24942394|NCT03981458|Immunologic Factors|immunologic factors|mesh-ancestor
24942395|NCT03981458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942396|NCT03981458|Viscosupplements|viscosupplements|mesh-ancestor
24942397|NCT03981458|Protective Agents|protective agents|mesh-ancestor
24732609|NCT01640574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24732611|NCT01640574|Antimalarials|antimalarials|mesh-ancestor
24732623|NCT01640587|Artesunate|artesunate|mesh-list
24732624|NCT01640587|Piperaquine|piperaquine|mesh-list
24732625|NCT01640587|Artenimol|artenimol|mesh-list
24732626|NCT01640587|Mefloquine|mefloquine|mesh-list
24732645|NCT01640639|Growth Substances|growth substances|mesh-ancestor
24732646|NCT01640639|Growth Inhibitors|growth inhibitors|mesh-ancestor
24787258|NCT01924234|Morphine|morphine|mesh-list
24732649|NCT01640665|Sorafenib|sorafenib|mesh-list
24732650|NCT01640665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24732651|NCT01640665|Antimetabolites|antimetabolites|mesh-ancestor
24732652|NCT01640665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732653|NCT01640665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732671|NCT01640743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24732672|NCT01640743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732673|NCT01640743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732674|NCT01640743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732675|NCT01640743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24649515|NCT01220232|Lamivudine|lamivudine|mesh-list
24732676|NCT01640743|Antiemetics|antiemetics|mesh-ancestor
24732677|NCT01640743|Autonomic Agents|autonomic agents|mesh-ancestor
24732678|NCT01640743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24732679|NCT01640743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24732680|NCT01640743|Glucocorticoids|glucocorticoids|mesh-ancestor
24942403|NCT03981068|Nimorazole|nimorazole|mesh-list
25696005|NCT02056626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696006|NCT02056626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25696007|NCT02056626|Antioxidants|antioxidants|mesh-ancestor
25696008|NCT02056626|Protective Agents|protective agents|mesh-ancestor
25696009|NCT02056626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24942404|NCT03981068|Cisplatin|cisplatin|mesh-list
24942405|NCT03981068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942406|NCT03981068|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
24942407|NCT03981068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24942408|NCT03981068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24462791|NCT00357604|Hormones|hormones|mesh-ancestor
24942409|NCT03981068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24942410|NCT03981081|Prednisone|prednisone|mesh-list
24942411|NCT03981081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24732681|NCT01640743|Hormones|hormones|mesh-ancestor
24732682|NCT01640743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24732683|NCT01640743|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24520983|NCT05210764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24732684|NCT01640743|Protective Agents|protective agents|mesh-ancestor
24732685|NCT01640743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24732686|NCT01640782|Leucovorin|leucovorin|mesh-list
24732687|NCT01640782|Docetaxel|docetaxel|mesh-list
24732688|NCT01640782|Fluorouracil|fluorouracil|mesh-list
24732691|NCT01640782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732692|NCT01640782|Tubulin Modulators|tubulin modulators|mesh-ancestor
24732693|NCT01640782|Antimitotic Agents|antimitotic agents|mesh-ancestor
24732694|NCT01640782|Mitosis Modulators|mitosis modulators|mesh-ancestor
24732695|NCT01640782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732696|NCT01640782|Antimetabolites|antimetabolites|mesh-ancestor
24732707|NCT01640782|Vitamins|vitamins|mesh-ancestor
24732716|NCT01640990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732717|NCT01641016|Efavirenz|efavirenz|mesh-list
24732729|NCT01641016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24732731|NCT01641224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24732732|NCT01641224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24732733|NCT01641224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732736|NCT01641224|Parasympatholytics|parasympatholytics|mesh-ancestor
24732769|NCT01641406|Trastuzumab|trastuzumab|mesh-list
24732770|NCT01641406|Epirubicin|epirubicin|mesh-list
24732771|NCT01641406|Vinorelbine|vinorelbine|mesh-list
24732772|NCT01641406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24732773|NCT01641406|Immunologic Factors|immunologic factors|mesh-ancestor
24732774|NCT01641406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732776|NCT01641406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24617164|NCT01041378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24617165|NCT01041378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617166|NCT01041378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24617167|NCT01041378|Glucocorticoids|glucocorticoids|mesh-ancestor
24617168|NCT01041378|Hormones|hormones|mesh-ancestor
24617170|NCT01041378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24617184|NCT01041508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24649545|NCT01220362|Fentanyl|fentanyl|mesh-list
24617185|NCT01041508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942412|NCT03981081|Glucocorticoids|glucocorticoids|mesh-ancestor
24942413|NCT03981081|Hormones|hormones|mesh-ancestor
24942414|NCT03981081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24942415|NCT03981081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942416|NCT03981081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24942417|NCT03981081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942418|NCT03981094|Pirfenidone|pirfenidone|mesh-list
24942419|NCT03981094|Analgesics|analgesics|mesh-ancestor
24942420|NCT03981094|Sensory System Agents|sensory system agents|mesh-ancestor
24942421|NCT03981094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24942422|NCT03981094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812777|NCT02054468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24617186|NCT01041508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24617187|NCT01041508|Immunologic Factors|immunologic factors|mesh-ancestor
24617188|NCT01041508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617189|NCT01041508|Antifungal Agents|antifungal agents|mesh-ancestor
24617190|NCT01041508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24617191|NCT01041508|Dermatologic Agents|dermatologic agents|mesh-ancestor
24617193|NCT01041508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24617194|NCT01041508|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24617195|NCT01041508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617196|NCT01041508|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24617197|NCT01041508|Antitubercular Agents|antitubercular agents|mesh-ancestor
24732813|NCT01641458|Capecitabine|capecitabine|mesh-list
24732863|NCT01641718|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24732864|NCT01641718|Hemostatics|hemostatics|mesh-ancestor
24732865|NCT01641718|Coagulants|coagulants|mesh-ancestor
24732866|NCT01641783|Paclitaxel|paclitaxel|mesh-list
24732880|NCT01642030|Hydromorphone|hydromorphone|mesh-list
24732881|NCT01642030|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24732882|NCT01642030|Narcotics|narcotics|mesh-ancestor
24732883|NCT01642030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24732884|NCT01642030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732886|NCT01642030|Sensory System Agents|sensory system agents|mesh-ancestor
24732887|NCT01642030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24732888|NCT01642030|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24732889|NCT01642108|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24732890|NCT01642108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24732891|NCT01642108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732892|NCT01642108|Incretins|incretins|mesh-ancestor
24732893|NCT01642108|Hormones|hormones|mesh-ancestor
24732909|NCT01642134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24732910|NCT01642134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24732912|NCT01642134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24942423|NCT03981094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24942425|NCT03981094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24942426|NCT03981094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25051019|NCT00449605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24958361|NCT03834129|Adrenergic Agents|adrenergic agents|mesh-ancestor
24942427|NCT03981094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942429|NCT03981029|Hematinics|hematinics|mesh-ancestor
24942430|NCT03981029|Vitamin B Complex|vitamin b complex|mesh-ancestor
24942431|NCT03981029|Vitamins|vitamins|mesh-ancestor
24942432|NCT03981029|Micronutrients|micronutrients|mesh-ancestor
24942433|NCT03981029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942434|NCT03980847|Alendronate|alendronate|mesh-list
24942435|NCT03980847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24942436|NCT03980847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942437|NCT03980951|Analgesics, Opioid|analgesics, opioid|mesh-list
24732922|NCT01642186|Letrozole|letrozole|mesh-list
24732923|NCT01642186|Leuprolide|leuprolide|mesh-list
24732924|NCT01642186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732925|NCT01642186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24732926|NCT01642186|Immunologic Factors|immunologic factors|mesh-ancestor
24732927|NCT01642186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732939|NCT01642433|Prazosin|prazosin|mesh-list
24732940|NCT01642433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24732941|NCT01642433|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24732942|NCT01642433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24732943|NCT01642433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24732944|NCT01642433|Adrenergic Agents|adrenergic agents|mesh-ancestor
24732945|NCT01642433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24732946|NCT01642433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732947|NCT01642433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732948|NCT01642472|Ulipristal acetate|ulipristal acetate|mesh-list
24732954|NCT01642524|Dextrans|dextrans|mesh-list
24732966|NCT01642745|Natriuretic Agents|natriuretic agents|mesh-ancestor
24732967|NCT01642745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732968|NCT01642745|Miotics|miotics|mesh-ancestor
24732969|NCT01642745|Autonomic Agents|autonomic agents|mesh-ancestor
24732970|NCT01642745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24732971|NCT01642745|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24617226|NCT01041729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942438|NCT03980951|Narcotics|narcotics|mesh-ancestor
24767543|NCT01801774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24767544|NCT01801774|Immunologic Factors|immunologic factors|mesh-ancestor
24767545|NCT01801774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767546|NCT01801774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767548|NCT01801904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24767549|NCT01801904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767550|NCT01802255|Midazolam|midazolam|mesh-list
24617227|NCT01041729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24617238|NCT01041872|Anesthetics, Local|anesthetics, local|mesh-ancestor
24617240|NCT01041872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24617241|NCT01041872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617257|NCT01041963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24617268|NCT01042028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24617269|NCT01042028|Antimetabolites|antimetabolites|mesh-ancestor
24733032|NCT01642979|Immunologic Factors|immunologic factors|mesh-ancestor
24733033|NCT01642979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733034|NCT01642979|Antifungal Agents|antifungal agents|mesh-ancestor
24733035|NCT01642979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24733036|NCT01642979|Dermatologic Agents|dermatologic agents|mesh-ancestor
24733037|NCT01642979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24733038|NCT01642979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24733040|NCT01642979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24733048|NCT01643031|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24733049|NCT01643031|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24733050|NCT01643031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24733051|NCT01643031|Purinergic Agents|purinergic agents|mesh-ancestor
24733052|NCT01643031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24733053|NCT01643031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733054|NCT01643031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733055|NCT01643070|Capecitabine|capecitabine|mesh-list
24733056|NCT01643070|Oxaliplatin|oxaliplatin|mesh-list
24733057|NCT01643070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24733058|NCT01643070|Antimetabolites|antimetabolites|mesh-ancestor
24733210|NCT01644071|Parasympatholytics|parasympatholytics|mesh-ancestor
24733059|NCT01643070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733060|NCT01643070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733063|NCT01643083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24733064|NCT01643083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24733065|NCT01643135|Tranylcypromine|tranylcypromine|mesh-list
24767551|NCT01802255|Sevoflurane|sevoflurane|mesh-list
24767552|NCT01802255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24767553|NCT01802255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24767554|NCT01802255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24767555|NCT01802255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767556|NCT01802255|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24767557|NCT01802255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24767558|NCT01802255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24767559|NCT01802255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24767560|NCT01802255|Anesthetics, General|anesthetics, general|mesh-ancestor
24767561|NCT01802255|Anesthetics|anesthetics|mesh-ancestor
24767562|NCT01802255|GABA Modulators|gaba modulators|mesh-ancestor
24767563|NCT01802255|GABA Agents|gaba agents|mesh-ancestor
24767564|NCT01802255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24767565|NCT01802255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733066|NCT01643135|Tranexamic Acid|tranexamic acid|mesh-list
24733067|NCT01643135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24733068|NCT01643135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24733069|NCT01643135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733070|NCT01643135|Hemostatics|hemostatics|mesh-ancestor
24572538|NCT00815373|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24572539|NCT00815373|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24572540|NCT00815373|Adrenergic Agents|adrenergic agents|mesh-ancestor
24572552|NCT00815399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24572553|NCT00815399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584526|NCT00880815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24584529|NCT00880815|Dermatologic Agents|dermatologic agents|mesh-ancestor
24733071|NCT01643135|Coagulants|coagulants|mesh-ancestor
24733072|NCT01643135|Antidepressive Agents|antidepressive agents|mesh-ancestor
24733073|NCT01643135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24733074|NCT01643135|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24733075|NCT01643135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733093|NCT01643265|Chelating Agents|chelating agents|mesh-ancestor
24733094|NCT01643265|Sequestering Agents|sequestering agents|mesh-ancestor
24733095|NCT01643265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733117|NCT01643434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24733118|NCT01643434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733141|NCT01643499|Antimetabolites|antimetabolites|mesh-ancestor
24733142|NCT01643499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733143|NCT01643499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24733144|NCT01643499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733145|NCT01643499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24733146|NCT01643499|Immunologic Factors|immunologic factors|mesh-ancestor
24733147|NCT01643499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24733148|NCT01643499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24733149|NCT01643499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733150|NCT01643499|Antidotes|antidotes|mesh-ancestor
24733151|NCT01643499|Protective Agents|protective agents|mesh-ancestor
24733152|NCT01643499|Vitamin B Complex|vitamin b complex|mesh-ancestor
24733153|NCT01643499|Vitamins|vitamins|mesh-ancestor
24733154|NCT01643499|Micronutrients|micronutrients|mesh-ancestor
24521545|NCT04690322|Factor VIII|factor viii|mesh-list
24733155|NCT01643603|Dasatinib|dasatinib|mesh-list
24733156|NCT01643603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733157|NCT01643603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24733158|NCT01643603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733159|NCT01643603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733160|NCT01643629|Minoxidil|minoxidil|mesh-list
24733161|NCT01643629|Finasteride|finasteride|mesh-list
24733162|NCT01643629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24733163|NCT01643629|Vasodilator Agents|vasodilator agents|mesh-ancestor
24733164|NCT01643629|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24733165|NCT01643629|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24733166|NCT01643629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733167|NCT01643629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733168|NCT01643629|Hormone Antagonists|hormone antagonists|mesh-ancestor
24767566|NCT01802255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24767567|NCT01802255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24942452|NCT03980756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942455|NCT03980379|Rituximab|rituximab|mesh-list
24855716|NCT02280694|Methotrexate|methotrexate|mesh-list
24733169|NCT01643629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24733170|NCT01643629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733171|NCT01643629|Urological Agents|urological agents|mesh-ancestor
24733181|NCT01643889|Moxifloxacin|moxifloxacin|mesh-list
24733209|NCT01644071|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24733212|NCT01644071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24733213|NCT01644071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733214|NCT01644071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24733215|NCT01644071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24733220|NCT01644071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24733221|NCT01644071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24733223|NCT01644071|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24733224|NCT01644071|Antidepressive Agents|antidepressive agents|mesh-ancestor
25696010|NCT02056626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25696011|NCT02056626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25696012|NCT02056626|Vasodilator Agents|vasodilator agents|mesh-ancestor
25696013|NCT02056626|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25696014|NCT02056626|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25696015|NCT02057198|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25696016|NCT02057198|Metronidazole|metronidazole|mesh-list
25696017|NCT02057198|Vancomycin|vancomycin|mesh-list
24733225|NCT01644071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24733226|NCT01644084|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24733227|NCT01644084|Plasma Substitutes|plasma substitutes|mesh-ancestor
24733228|NCT01644084|Blood Substitutes|blood substitutes|mesh-ancestor
24733229|NCT01644110|Pomalidomide|pomalidomide|mesh-list
24733230|NCT01644110|Immunologic Factors|immunologic factors|mesh-ancestor
24733231|NCT01644110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733232|NCT01644110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24733233|NCT01644110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24733234|NCT01644110|Growth Substances|growth substances|mesh-ancestor
24733235|NCT01644110|Growth Inhibitors|growth inhibitors|mesh-ancestor
24733236|NCT01644110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733237|NCT01644253|Rituximab|rituximab|mesh-list
24617290|NCT01042041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24617291|NCT01042041|Alkylating Agents|alkylating agents|mesh-ancestor
24617292|NCT01042041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24617294|NCT01042314|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24617295|NCT01042314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617296|NCT01042314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617297|NCT01042314|Cholinergic Agents|cholinergic agents|mesh-ancestor
24617298|NCT01042314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24617299|NCT01042314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617300|NCT01042314|Nootropic Agents|nootropic agents|mesh-ancestor
24617301|NCT01042457|Mycophenolic Acid|mycophenolic acid|mesh-list
24617302|NCT01042457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24617303|NCT01042457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617304|NCT01042457|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24617305|NCT01042457|Antitubercular Agents|antitubercular agents|mesh-ancestor
24617306|NCT01042457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24617307|NCT01042457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24617308|NCT01042457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617309|NCT01042457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617311|NCT01042561|Ergocalciferols|ergocalciferols|mesh-list
24617312|NCT01042561|Cholecalciferol|cholecalciferol|mesh-list
24617313|NCT01042561|Vitamins|vitamins|mesh-list
24617314|NCT01042561|Micronutrients|micronutrients|mesh-ancestor
24617315|NCT01042561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617316|NCT01042561|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24617317|NCT01042561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24942456|NCT03980379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24942457|NCT03980379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942458|NCT03980379|Immunologic Factors|immunologic factors|mesh-ancestor
24942461|NCT03980496|Omeprazole|omeprazole|mesh-list
24942468|NCT03980223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24942469|NCT03980223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24942470|NCT03980223|Antimalarials|antimalarials|mesh-ancestor
24942471|NCT03980223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24942472|NCT03980223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24617318|NCT01042574|Clevidipine|clevidipine|mesh-list
24617319|NCT01042574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24617320|NCT01042574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24617321|NCT01042574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397443|NCT00141570|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
24733429|NCT01646229|Polymyxins|polymyxins|mesh-list
24617322|NCT01042574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24617323|NCT01042574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617324|NCT01042652|Raltegravir Potassium|raltegravir potassium|mesh-list
24617325|NCT01042652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24521690|NCT04597333|Dinoprostone|dinoprostone|mesh-list
24733252|NCT01644773|Crizotinib|crizotinib|mesh-list
24733253|NCT01644773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733254|NCT01644773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24733255|NCT01644773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733256|NCT01644773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733258|NCT01644799|Idelalisib|idelalisib|mesh-list
24733274|NCT01644825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733275|NCT01644838|Promethazine|promethazine|mesh-list
24733276|NCT01644838|Diphenhydramine|diphenhydramine|mesh-list
24733277|NCT01644838|Scopolamine|scopolamine|mesh-list
24733278|NCT01644838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24733279|NCT01644838|Antiemetics|antiemetics|mesh-ancestor
24733280|NCT01644838|Autonomic Agents|autonomic agents|mesh-ancestor
25109918|NCT03121222|Acetylcysteine|acetylcysteine|mesh-list
24649617|NCT01220648|Interferon-alpha|interferon-alpha|mesh-list
24733281|NCT01644838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24733282|NCT01644838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733290|NCT01644838|Antipruritics|antipruritics|mesh-ancestor
24733291|NCT01644838|Dermatologic Agents|dermatologic agents|mesh-ancestor
24733292|NCT01644838|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24733293|NCT01644838|Histamine Antagonists|histamine antagonists|mesh-ancestor
24733294|NCT01644838|Histamine Agents|histamine agents|mesh-ancestor
24733295|NCT01644838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24733296|NCT01644838|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24942473|NCT03980249|Carvedilol|carvedilol|mesh-list
24942474|NCT03980249|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24942475|NCT03980249|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24942476|NCT03980249|Adrenergic Agents|adrenergic agents|mesh-ancestor
24942477|NCT03980249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24942478|NCT03980249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855737|NCT02280694|Analgesics|analgesics|mesh-ancestor
24733297|NCT01644838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24733298|NCT01644838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24733299|NCT01644838|Anesthetics, Local|anesthetics, local|mesh-ancestor
24733300|NCT01644838|Anesthetics|anesthetics|mesh-ancestor
24733301|NCT01644838|Sensory System Agents|sensory system agents|mesh-ancestor
24733302|NCT01644864|Ropivacaine|ropivacaine|mesh-list
24733303|NCT01644864|Anesthetics, Local|anesthetics, local|mesh-ancestor
24733304|NCT01644864|Anesthetics|anesthetics|mesh-ancestor
24733305|NCT01644864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24733306|NCT01644864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733307|NCT01644864|Sensory System Agents|sensory system agents|mesh-ancestor
24733333|NCT01645254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24733334|NCT01645254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24733335|NCT01645384|Atorvastatin|atorvastatin|mesh-list
24733336|NCT01645384|Calcium|calcium|mesh-list
24733337|NCT01645384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24733338|NCT01645384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733339|NCT01645384|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24733409|NCT01645800|Muramidase|muramidase|mesh-list
24649650|NCT01221103|Ofatumumab|ofatumumab|mesh-list
24397550|NCT00141830|Dermatologic Agents|dermatologic agents|mesh-ancestor
24733411|NCT01645826|Diltiazem|diltiazem|mesh-list
24733412|NCT01645826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24733413|NCT01645826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24733414|NCT01645826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24733415|NCT01645826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733416|NCT01645826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24733417|NCT01645826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733418|NCT01645826|Vasodilator Agents|vasodilator agents|mesh-ancestor
24733419|NCT01645839|Cytarabine|cytarabine|mesh-list
24733420|NCT01645839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24733421|NCT01645839|Antimetabolites|antimetabolites|mesh-ancestor
24733422|NCT01645839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733423|NCT01645839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733424|NCT01645839|Antiviral Agents|antiviral agents|mesh-ancestor
24733425|NCT01645839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24733426|NCT01645839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24733427|NCT01645839|Immunologic Factors|immunologic factors|mesh-ancestor
24733428|NCT01645839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733433|NCT01646281|Flecainide|flecainide|mesh-list
24733434|NCT01646281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24443185|NCT00293891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24443186|NCT00293891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443199|NCT00293930|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24443200|NCT00293930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24942479|NCT03980249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942481|NCT03980249|Antioxidants|antioxidants|mesh-ancestor
24942482|NCT03980249|Protective Agents|protective agents|mesh-ancestor
24942483|NCT03980249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24942484|NCT03980249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24942485|NCT03980249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24942486|NCT03980249|Vasodilator Agents|vasodilator agents|mesh-ancestor
25051020|NCT00449605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24942487|NCT03980249|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25051021|NCT00449605|Immunologic Factors|immunologic factors|mesh-ancestor
24641515|NCT01174017|Iodine|iodine|mesh-list
24733438|NCT01646281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733439|NCT01646294|Mirabegron|mirabegron|mesh-list
24733440|NCT01646294|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24733441|NCT01646294|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24733442|NCT01646294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24733443|NCT01646294|Adrenergic Agents|adrenergic agents|mesh-ancestor
24733444|NCT01646294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24733445|NCT01646294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733446|NCT01646294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733448|NCT01646307|Atorvastatin|atorvastatin|mesh-list
24733449|NCT01646307|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24733450|NCT01646307|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24733451|NCT01646307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24733452|NCT01646307|Antimetabolites|antimetabolites|mesh-ancestor
24733453|NCT01646307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733465|NCT01646437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24733466|NCT01646437|Analgesics|analgesics|mesh-ancestor
24733467|NCT01646437|Sensory System Agents|sensory system agents|mesh-ancestor
24733468|NCT01646437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24733474|NCT01646437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24733476|NCT01646437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733491|NCT01646554|Growth Inhibitors|growth inhibitors|mesh-ancestor
24733492|NCT01646567|Betamethasone|betamethasone|mesh-list
24733493|NCT01646567|Betamethasone Valerate|betamethasone valerate|mesh-list
24733494|NCT01646567|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24733495|NCT01646567|Betamethasone benzoate|betamethasone benzoate|mesh-list
24733496|NCT01646567|Calcipotriene|calcipotriene|mesh-list
24733497|NCT01646567|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24733498|NCT01646567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24733499|NCT01646567|Glucocorticoids|glucocorticoids|mesh-ancestor
24733500|NCT01646567|Hormones|hormones|mesh-ancestor
24733501|NCT01646567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24733502|NCT01646567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846740|NCT02243618|Antioxidants|antioxidants|mesh-ancestor
24733503|NCT01646567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24733504|NCT01646567|Respiratory System Agents|respiratory system agents|mesh-ancestor
24733505|NCT01646567|Dermatologic Agents|dermatologic agents|mesh-ancestor
24733506|NCT01646580|Ciclopirox|ciclopirox|mesh-list
24733507|NCT01646580|Antifungal Agents|antifungal agents|mesh-ancestor
24733508|NCT01646580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24733509|NCT01646619|Magnesium Sulfate|magnesium sulfate|mesh-list
24733510|NCT01646619|Analgesics|analgesics|mesh-ancestor
24733511|NCT01646619|Sensory System Agents|sensory system agents|mesh-ancestor
24733512|NCT01646619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24733513|NCT01646619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733514|NCT01646619|Anesthetics|anesthetics|mesh-ancestor
25051022|NCT00449605|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25051023|NCT00449605|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
25051041|NCT00448058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051042|NCT00448058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25051043|NCT00448058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051044|NCT00448058|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24855753|NCT02280850|Nitroglycerin|nitroglycerin|mesh-list
24733515|NCT01646619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24733516|NCT01646619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24733517|NCT01646619|Anticonvulsants|anticonvulsants|mesh-ancestor
24733518|NCT01646619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24733519|NCT01646619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24733520|NCT01646619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733521|NCT01646619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24733533|NCT01646736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24733534|NCT01646736|Alkylating Agents|alkylating agents|mesh-ancestor
24649666|NCT01221103|Immunologic Factors|immunologic factors|mesh-ancestor
24733535|NCT01646736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733536|NCT01646736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733537|NCT01646736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24733538|NCT01646775|Fentanyl|fentanyl|mesh-list
24733539|NCT01646775|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24733540|NCT01646775|Narcotics|narcotics|mesh-ancestor
24733541|NCT01646775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24733548|NCT01646775|Anesthetics, General|anesthetics, general|mesh-ancestor
24733549|NCT01646775|Anesthetics|anesthetics|mesh-ancestor
24733550|NCT01646788|Paclitaxel|paclitaxel|mesh-list
25051045|NCT00448058|Antidepressive Agents|antidepressive agents|mesh-ancestor
25051046|NCT00448058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25051047|NCT00447564|Buprenorphine|buprenorphine|mesh-list
25051048|NCT00447564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25051049|NCT00447564|Narcotics|narcotics|mesh-ancestor
25051050|NCT00447564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24733556|NCT01646788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733557|NCT01646853|Fluorouracil|fluorouracil|mesh-list
24733558|NCT01646853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733559|NCT01646853|Antimetabolites|antimetabolites|mesh-ancestor
24733579|NCT01647165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24617326|NCT01042652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24617327|NCT01042652|Antiviral Agents|antiviral agents|mesh-ancestor
24617328|NCT01042652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24617329|NCT01042652|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24617330|NCT01042652|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24617331|NCT01042652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617332|NCT01042652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617333|NCT01042665|Latanoprost|latanoprost|mesh-list
24617334|NCT01042665|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24617335|NCT01042665|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24617336|NCT01042691|Oxaliplatin|oxaliplatin|mesh-list
24617337|NCT01042691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617338|NCT01042704|Aspirin|aspirin|mesh-list
24617339|NCT01042704|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24617340|NCT01042704|Dexamethasone|dexamethasone|mesh-list
24617341|NCT01042704|Lenalidomide|lenalidomide|mesh-list
24617342|NCT01042704|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24617343|NCT01042704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24617344|NCT01042704|Antiemetics|antiemetics|mesh-ancestor
24617345|NCT01042704|Autonomic Agents|autonomic agents|mesh-ancestor
24617346|NCT01042704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24617347|NCT01042704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617348|NCT01042704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24617350|NCT01042704|Hormones|hormones|mesh-ancestor
24649678|NCT01221129|Micronutrients|micronutrients|mesh-ancestor
24617351|NCT01042704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24617352|NCT01042704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24617353|NCT01042704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617354|NCT01042704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24617355|NCT01042704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24918028|NCT04224103|Nitric Oxide|nitric oxide|mesh-list
24617373|NCT01042704|Alkylating Agents|alkylating agents|mesh-ancestor
24617375|NCT01042717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24617376|NCT01042717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24617377|NCT01042717|Antiviral Agents|antiviral agents|mesh-ancestor
24617378|NCT01042717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24617379|NCT01042730|Pitavastatin|pitavastatin|mesh-list
25051057|NCT00445198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051058|NCT00443287|Cilostazol|cilostazol|mesh-list
25051059|NCT00443287|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
25051060|NCT00443287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25051061|NCT00443287|Autonomic Agents|autonomic agents|mesh-ancestor
25051062|NCT00443287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24617384|NCT01042730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447273|NCT00307775|Estrogens|estrogens|mesh-ancestor
24733588|NCT01647256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24733589|NCT01647256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25067419|NCT03443843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24733592|NCT01647347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24733593|NCT01647347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24733594|NCT01647412|Curcumin|curcumin|mesh-list
24733595|NCT01647412|Hormones|hormones|mesh-list
24649688|NCT01221376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733596|NCT01647412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24733597|NCT01647412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733598|NCT01647412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24733599|NCT01647412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24733600|NCT01647412|Analgesics|analgesics|mesh-ancestor
24733601|NCT01647412|Sensory System Agents|sensory system agents|mesh-ancestor
24733602|NCT01647412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24733603|NCT01647412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24733604|NCT01647412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24568811|NCT00797745|Ritonavir|ritonavir|mesh-list
24568812|NCT00797745|Ribavirin|ribavirin|mesh-list
24568813|NCT00797745|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24568814|NCT00797745|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24568815|NCT00797745|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24568816|NCT00797745|Protease Inhibitors|protease inhibitors|mesh-ancestor
24568817|NCT00797745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24568882|NCT00797927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24568883|NCT00797927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24568884|NCT00797927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24568885|NCT00797927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568886|NCT00797953|Cardiotonic Agents|cardiotonic agents|mesh-list
24733605|NCT01647412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733606|NCT01647412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733607|NCT01647412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733608|NCT01647529|Ganciclovir|ganciclovir|mesh-list
24733609|NCT01647529|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
24733610|NCT01647529|Antiviral Agents|antiviral agents|mesh-ancestor
24733611|NCT01647529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24733612|NCT01647529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24733613|NCT01647529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733614|NCT01647529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733615|NCT01647555|Cetuximab|cetuximab|mesh-list
24733616|NCT01647555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24733617|NCT01647555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733618|NCT01647633|Calcium|calcium|mesh-list
24733619|NCT01647633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24733620|NCT01647633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733621|NCT01647646|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24733622|NCT01647646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24733634|NCT01647659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24733635|NCT01647659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733636|NCT01647659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733637|NCT01647672|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24733638|NCT01647672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051071|NCT00443287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24958436|NCT03833362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958437|NCT03833362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24958438|NCT03833362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24958439|NCT03833362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24733641|NCT01647685|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24733642|NCT01647685|Prednisolone|prednisolone|mesh-list
24733643|NCT01647685|Prednisolone acetate|prednisolone acetate|mesh-list
24733644|NCT01647685|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24522097|NCT04275661|Magnesium Sulfate|magnesium sulfate|mesh-list
24733653|NCT01647685|Hormones|hormones|mesh-ancestor
24733654|NCT01647685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24733655|NCT01647685|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24733696|NCT01647984|Vitamins|vitamins|mesh-list
24733706|NCT01648010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24733707|NCT01648010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733708|NCT01648010|Alkylating Agents|alkylating agents|mesh-ancestor
24733709|NCT01648010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733710|NCT01648010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24733711|NCT01648010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733712|NCT01648036|Heparin|heparin|mesh-list
24733713|NCT01648036|Calcium heparin|calcium heparin|mesh-list
24958440|NCT03833362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24918628|NCT04217265|Letrozole|letrozole|mesh-list
25696018|NCT02057198|Fidaxomicin|fidaxomicin|mesh-list
25696019|NCT02057198|Amebicides|amebicides|mesh-list
25696020|NCT02057198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25696021|NCT02057198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25696022|NCT02057198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25696023|NCT02057250|Hydroxychloroquine|hydroxychloroquine|mesh-list
25696024|NCT02057250|Sulfasalazine|sulfasalazine|mesh-list
25696025|NCT02057250|Methotrexate|methotrexate|mesh-list
25696026|NCT02057250|Leflunomide|leflunomide|mesh-list
25696027|NCT02057250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25696028|NCT02057250|Abortifacient Agents|abortifacient agents|mesh-ancestor
25696029|NCT02057250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25008999|NCT03716609|Magnesium citrate|magnesium citrate|mesh-list
24958441|NCT03833362|Antimetabolites|antimetabolites|mesh-ancestor
24958442|NCT03833362|Immunologic Factors|immunologic factors|mesh-ancestor
24958443|NCT03833362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733714|NCT01648036|Dalteparin|dalteparin|mesh-list
24733715|NCT01648036|Tinzaparin|tinzaparin|mesh-list
24733716|NCT01648036|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24733717|NCT01648036|Anticoagulants|anticoagulants|mesh-ancestor
24733718|NCT01648036|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24733719|NCT01648036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24733720|NCT01648036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733721|NCT01648127|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
24733723|NCT01648127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24733725|NCT01648218|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24733726|NCT01648218|Insulin Glargine|insulin glargine|mesh-list
24733727|NCT01648218|Insulin Aspart|insulin aspart|mesh-list
24617396|NCT01042782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24617397|NCT01042782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617398|NCT01042873|Dobutamine|dobutamine|mesh-list
24617399|NCT01042873|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24617400|NCT01042873|Sympathomimetics|sympathomimetics|mesh-ancestor
24617401|NCT01042873|Autonomic Agents|autonomic agents|mesh-ancestor
24617402|NCT01042873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24617403|NCT01042873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617404|NCT01042873|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24617405|NCT01042873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24617406|NCT01042873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24617407|NCT01042873|Adrenergic Agents|adrenergic agents|mesh-ancestor
24958452|NCT03833388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24958453|NCT03833388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24958467|NCT03832894|Estradiol|estradiol|mesh-list
24942488|NCT03980249|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24942489|NCT03980041|Nivolumab|nivolumab|mesh-list
24942490|NCT03980041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24942491|NCT03980041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942492|NCT03980041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24942493|NCT03980041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617408|NCT01042873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24617410|NCT01042873|Protective Agents|protective agents|mesh-ancestor
24617443|NCT01043211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24733768|NCT01648517|Antimetabolites|antimetabolites|mesh-ancestor
24733780|NCT01648556|Prednisone|prednisone|mesh-list
24733795|NCT01648595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24733796|NCT01648595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24733797|NCT01648595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24733798|NCT01648595|Anesthetics, General|anesthetics, general|mesh-ancestor
24733808|NCT01648608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24733809|NCT01648608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733810|NCT01648634|Nebivolol|nebivolol|mesh-list
24733811|NCT01648634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24733812|NCT01648634|Vasodilator Agents|vasodilator agents|mesh-ancestor
24733813|NCT01648634|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24733814|NCT01648634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24733815|NCT01648634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24733816|NCT01648634|Adrenergic Agents|adrenergic agents|mesh-ancestor
24733817|NCT01648634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24733818|NCT01648634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733819|NCT01648634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733820|NCT01648712|Heparin|heparin|mesh-list
24733821|NCT01648712|Anticoagulants|anticoagulants|mesh-ancestor
24733822|NCT01648712|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24733823|NCT01648712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24733824|NCT01648712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733825|NCT01648777|Bupivacaine|bupivacaine|mesh-list
24733826|NCT01648777|Anesthetics, Local|anesthetics, local|mesh-ancestor
24733827|NCT01648777|Anesthetics|anesthetics|mesh-ancestor
24733847|NCT01649024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733848|NCT01649037|Terlipressin|terlipressin|mesh-list
24733849|NCT01649037|Epinephrine|epinephrine|mesh-list
24733850|NCT01649037|Racepinephrine|racepinephrine|mesh-list
24733851|NCT01649037|Norepinephrine|norepinephrine|mesh-list
24733852|NCT01649037|Epinephryl borate|epinephryl borate|mesh-list
25696030|NCT02057250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569617|NCT00801281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24569618|NCT00801281|Glucocorticoids|glucocorticoids|mesh-ancestor
24569620|NCT00801281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24569621|NCT00801281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24569622|NCT00801281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24569623|NCT00801281|Tubulin Modulators|tubulin modulators|mesh-ancestor
24569624|NCT00801281|Antimitotic Agents|antimitotic agents|mesh-ancestor
24569628|NCT00801294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24569629|NCT00801294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24733853|NCT01649037|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24733854|NCT01649037|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24733855|NCT01649037|Adrenergic Agents|adrenergic agents|mesh-ancestor
24733856|NCT01649037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24733857|NCT01649037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733858|NCT01649037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733859|NCT01649037|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24733860|NCT01649037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24733861|NCT01649037|Autonomic Agents|autonomic agents|mesh-ancestor
24733862|NCT01649037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24733863|NCT01649037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24733899|NCT01649466|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24733900|NCT01649466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24617447|NCT01043211|Mydriatics|mydriatics|mesh-ancestor
24617448|NCT01043211|Sympathomimetics|sympathomimetics|mesh-ancestor
24617449|NCT01043211|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24617450|NCT01043224|Clobetasol|clobetasol|mesh-list
24617451|NCT01043224|Calcipotriene|calcipotriene|mesh-list
24617452|NCT01043224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24733911|NCT01649544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733912|NCT01649544|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24733913|NCT01649544|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24733914|NCT01649544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24733915|NCT01649544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733941|NCT01649635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733942|NCT01649635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733943|NCT01649635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24733944|NCT01649635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24942504|NCT03979976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24942505|NCT03979976|Enzyme Inhibitors|enzyme inhibitors|mesh-list
24942506|NCT03979976|Protease Inhibitors|protease inhibitors|mesh-ancestor
24942507|NCT03979976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942508|NCT03979976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24942509|NCT03980171|Lenalidomide|lenalidomide|mesh-list
24942510|NCT03980171|Venetoclax|venetoclax|mesh-list
24942511|NCT03980171|Obinutuzumab|obinutuzumab|mesh-list
24733945|NCT01649635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24733946|NCT01649635|Immunologic Factors|immunologic factors|mesh-ancestor
24733947|NCT01649674|Picosulfate sodium|picosulfate sodium|mesh-list
24733948|NCT01649674|Magnesium citrate|magnesium citrate|mesh-list
24733949|NCT01649674|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24733950|NCT01649674|Cathartics|cathartics|mesh-ancestor
24733951|NCT01649674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24733952|NCT01649739|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24733953|NCT01649739|Vasodilator Agents|vasodilator agents|mesh-ancestor
24733954|NCT01649739|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24733955|NCT01649739|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24733956|NCT01649739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733957|NCT01649739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733958|NCT01649739|Urological Agents|urological agents|mesh-ancestor
24734001|NCT01650129|Biphasic Insulins|biphasic insulins|mesh-list
24734002|NCT01650129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25696031|NCT02057250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25696032|NCT02057250|Antimetabolites|antimetabolites|mesh-ancestor
25696033|NCT02057250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696034|NCT02057250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25696035|NCT02057250|Dermatologic Agents|dermatologic agents|mesh-ancestor
25696036|NCT02057250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25696037|NCT02057250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25696038|NCT02057250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25696039|NCT02057250|Immunologic Factors|immunologic factors|mesh-ancestor
24734003|NCT01650129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734014|NCT01650181|Vitamin B Complex|vitamin b complex|mesh-ancestor
24734015|NCT01650181|Vitamins|vitamins|mesh-ancestor
24734016|NCT01650272|Minoxidil|minoxidil|mesh-list
24734017|NCT01650272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24734018|NCT01650272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24734019|NCT01650272|Vasodilator Agents|vasodilator agents|mesh-ancestor
24734020|NCT01650376|Paclitaxel|paclitaxel|mesh-list
24734021|NCT01650376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24734022|NCT01650376|Carboplatin|carboplatin|mesh-list
24734023|NCT01650376|Olaparib|olaparib|mesh-list
24734024|NCT01650376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24734025|NCT01650376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24734026|NCT01650376|Tubulin Modulators|tubulin modulators|mesh-ancestor
24734027|NCT01650376|Antimitotic Agents|antimitotic agents|mesh-ancestor
24734028|NCT01650376|Mitosis Modulators|mitosis modulators|mesh-ancestor
24734029|NCT01650376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734030|NCT01650376|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24734031|NCT01650376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24942512|NCT03980171|Immunologic Factors|immunologic factors|mesh-ancestor
24942513|NCT03980171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942514|NCT03980171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24942515|NCT03980171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24942516|NCT03980171|Growth Substances|growth substances|mesh-ancestor
24942517|NCT03980171|Growth Inhibitors|growth inhibitors|mesh-ancestor
24942518|NCT03980171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942519|NCT03980171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24942520|NCT03980002|Thalidomide|thalidomide|mesh-list
24942521|NCT03980002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24942522|NCT03980002|Immunologic Factors|immunologic factors|mesh-ancestor
24734032|NCT01650389|BCG Vaccine|bcg vaccine|mesh-list
24734033|NCT01650389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24734034|NCT01650389|Immunologic Factors|immunologic factors|mesh-ancestor
24734035|NCT01650389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734036|NCT01650415|Epoetin Alfa|epoetin alfa|mesh-list
24734037|NCT01650415|Hematinics|hematinics|mesh-ancestor
24734038|NCT01650428|Bevacizumab|bevacizumab|mesh-list
24734039|NCT01650428|Fluorouracil|fluorouracil|mesh-list
24734040|NCT01650428|Oxaliplatin|oxaliplatin|mesh-list
24734042|NCT01650428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24734043|NCT01650428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24734060|NCT01650441|Autonomic Agents|autonomic agents|mesh-ancestor
24734061|NCT01650441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24734062|NCT01650441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734063|NCT01650441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24734064|NCT01650441|Respiratory System Agents|respiratory system agents|mesh-ancestor
24734065|NCT01650441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24734066|NCT01650441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24734067|NCT01650441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24734068|NCT01650441|Adrenergic Agents|adrenergic agents|mesh-ancestor
24734069|NCT01650441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24734070|NCT01650441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734071|NCT01650441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24734072|NCT01650441|Glucocorticoids|glucocorticoids|mesh-ancestor
24734073|NCT01650441|Hormones|hormones|mesh-ancestor
24734074|NCT01650441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24734075|NCT01650493|Listerine|listerine|mesh-list
24734076|NCT01650493|Sodium Fluoride|sodium fluoride|mesh-list
24734077|NCT01650493|Cariostatic Agents|cariostatic agents|mesh-ancestor
24734078|NCT01650493|Protective Agents|protective agents|mesh-ancestor
24920942|NCT04195997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734079|NCT01650493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734080|NCT01650493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24734081|NCT01650493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24734082|NCT01650506|Metformin|metformin|mesh-list
24734083|NCT01650506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24734084|NCT01650506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24734097|NCT01650649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734098|NCT01650649|Sensory System Agents|sensory system agents|mesh-ancestor
24734099|NCT01650649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24734100|NCT01650649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24570201|NCT00803803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570202|NCT00803816|Everolimus|everolimus|mesh-list
24570203|NCT00803816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570247|NCT00803946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24570248|NCT00803946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24570249|NCT00803946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24570250|NCT00803946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24570251|NCT00803946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570253|NCT00803972|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24570254|NCT00803972|Insulin Lispro|insulin lispro|mesh-list
24734101|NCT01650649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24734102|NCT01650649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24734103|NCT01650649|Adrenergic Agents|adrenergic agents|mesh-ancestor
24734104|NCT01650649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24734105|NCT01650649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942526|NCT03980002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24942527|NCT03980002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24942528|NCT03980002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24942529|NCT03980002|Growth Substances|growth substances|mesh-ancestor
24942530|NCT03980002|Growth Inhibitors|growth inhibitors|mesh-ancestor
24942531|NCT03980002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24734106|NCT01650649|Analgesics|analgesics|mesh-ancestor
24734107|NCT01650649|Sympatholytics|sympatholytics|mesh-ancestor
24734108|NCT01650649|Autonomic Agents|autonomic agents|mesh-ancestor
24734109|NCT01650662|Cyclosporine|cyclosporine|mesh-list
24734110|NCT01650662|Cyclosporins|cyclosporins|mesh-list
24734111|NCT01650662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734112|NCT01650662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734113|NCT01650662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24617462|NCT01043380|Ezetimibe|ezetimibe|mesh-list
24617468|NCT01043380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24617469|NCT01043380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617471|NCT01043419|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24617472|NCT01043419|Anesthetics, General|anesthetics, general|mesh-ancestor
24617473|NCT01043419|Anesthetics|anesthetics|mesh-ancestor
24617492|NCT01043510|Insulin|insulin|mesh-list
24617493|NCT01043510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24617494|NCT01043510|Insulin Detemir|insulin detemir|mesh-list
24617495|NCT01043510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24617496|NCT01043510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617497|NCT01043536|Temozolomide|temozolomide|mesh-list
24617498|NCT01043536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24617499|NCT01043536|Alkylating Agents|alkylating agents|mesh-ancestor
24617500|NCT01043536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617501|NCT01043536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617502|NCT01043575|Rifampin|rifampin|mesh-list
24617503|NCT01043575|Rifapentine|rifapentine|mesh-list
24734155|NCT01650792|Aspirin|aspirin|mesh-list
24734156|NCT01650792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24734157|NCT01650792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24734158|NCT01650792|Analgesics|analgesics|mesh-ancestor
24734159|NCT01650792|Sensory System Agents|sensory system agents|mesh-ancestor
24734160|NCT01650792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24734161|NCT01650792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734162|NCT01650792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24734163|NCT01650792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24734164|NCT01650792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24734165|NCT01650792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24734166|NCT01650792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734167|NCT01650792|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24734168|NCT01650792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24734169|NCT01650792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734170|NCT01650792|Antipyretics|antipyretics|mesh-ancestor
25696040|NCT02057250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25696041|NCT02057250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25696042|NCT02057250|Antimalarials|antimalarials|mesh-ancestor
25696043|NCT02057250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25696044|NCT02057250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25696045|NCT02057250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25696046|NCT02057250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25696047|NCT02057250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25696048|NCT02057250|Analgesics|analgesics|mesh-ancestor
25696049|NCT02057250|Sensory System Agents|sensory system agents|mesh-ancestor
24570502|NCT00805064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24570504|NCT00805090|Diclofenac|diclofenac|mesh-list
24734171|NCT01650870|Lactulose|lactulose|mesh-list
24734172|NCT01650870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24734177|NCT01650883|Micronutrients|micronutrients|mesh-ancestor
24734178|NCT01650883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942532|NCT03979859|Nafithromycin|nafithromycin|mesh-list
24942533|NCT03979859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24942534|NCT03979859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24942535|NCT03979859|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24942536|NCT03979859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24942537|NCT03979859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942538|NCT03980015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24942539|NCT03980015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24942540|NCT03979989|Tapentadol|tapentadol|mesh-list
24942541|NCT03979989|Omeprazole|omeprazole|mesh-list
24942542|NCT03979989|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24942543|NCT03979989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24942544|NCT03979989|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24942545|NCT03979989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24942546|NCT03979989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942547|NCT03979989|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24942548|NCT03979989|Narcotics|narcotics|mesh-ancestor
24942549|NCT03979989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24942550|NCT03979989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942551|NCT03979989|Analgesics|analgesics|mesh-ancestor
24734184|NCT01650961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24734185|NCT01650961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734186|NCT01650961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24734197|NCT01651156|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24734198|NCT01651156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734199|NCT01651156|Natriuretic Agents|natriuretic agents|mesh-ancestor
24734200|NCT01651156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734201|NCT01651169|Methylphenidate|methylphenidate|mesh-list
24734202|NCT01651169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24734203|NCT01651169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734211|NCT01651182|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24734212|NCT01651182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24734213|NCT01651182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734214|NCT01651182|Hemostatics|hemostatics|mesh-ancestor
24734215|NCT01651182|Coagulants|coagulants|mesh-ancestor
24734220|NCT01651312|Adrenergic Agents|adrenergic agents|mesh-ancestor
24734221|NCT01651312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24734222|NCT01651312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734223|NCT01651312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734224|NCT01651312|Urological Agents|urological agents|mesh-ancestor
24734226|NCT01651325|Dextromethorphan|dextromethorphan|mesh-list
24734227|NCT01651325|Antitussive Agents|antitussive agents|mesh-ancestor
24522750|NCT03254654|Apatinib|apatinib|mesh-list
24734228|NCT01651325|Respiratory System Agents|respiratory system agents|mesh-ancestor
24734229|NCT01651325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24942552|NCT03979989|Sensory System Agents|sensory system agents|mesh-ancestor
24942553|NCT03979989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24942554|NCT03979989|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24942555|NCT03979989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24942556|NCT03979989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24942557|NCT03979989|Adrenergic Agents|adrenergic agents|mesh-ancestor
24942558|NCT03979989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24942559|NCT03979664|Dexamethasone|dexamethasone|mesh-list
25051072|NCT00443287|Protective Agents|protective agents|mesh-ancestor
24942560|NCT03979664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24942561|NCT03979664|Antiemetics|antiemetics|mesh-ancestor
24942562|NCT03979664|Autonomic Agents|autonomic agents|mesh-ancestor
24942563|NCT03979664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24734230|NCT01651325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24734231|NCT01651325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24734232|NCT01651325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734233|NCT01651325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734234|NCT01651325|Antifungal Agents|antifungal agents|mesh-ancestor
24734235|NCT01651325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24734241|NCT01651364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25696050|NCT02057250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25696051|NCT02057250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24570952|NCT00807443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571036|NCT00807859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24571037|NCT00807859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24571079|NCT00808054|Sensory System Agents|sensory system agents|mesh-ancestor
24571080|NCT00808054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24571081|NCT00808054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24734242|NCT01651364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734243|NCT01651364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734244|NCT01651377|Pramipexole|pramipexole|mesh-list
24734245|NCT01651377|Antioxidants|antioxidants|mesh-ancestor
24734246|NCT01651377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734247|NCT01651377|Protective Agents|protective agents|mesh-ancestor
24734266|NCT01651390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24734267|NCT01651390|Immunologic Factors|immunologic factors|mesh-ancestor
24734268|NCT01651390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734269|NCT01651416|Lumefantrine|lumefantrine|mesh-list
24734270|NCT01651416|Artemether|artemether|mesh-list
24734271|NCT01651416|Pyrimethamine|pyrimethamine|mesh-list
24734272|NCT01651416|Piperaquine|piperaquine|mesh-list
24734273|NCT01651416|Sulfadoxine|sulfadoxine|mesh-list
24734282|NCT01651416|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24734283|NCT01651416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734284|NCT01651416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734285|NCT01651416|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24734286|NCT01651416|Renal Agents|renal agents|mesh-ancestor
24734287|NCT01651481|Montelukast|montelukast|mesh-list
24734288|NCT01651481|Levocetirizine|levocetirizine|mesh-list
24734289|NCT01651481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24734290|NCT01651481|Respiratory System Agents|respiratory system agents|mesh-ancestor
24734291|NCT01651481|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24734292|NCT01651481|Hormone Antagonists|hormone antagonists|mesh-ancestor
24734293|NCT01651481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24734294|NCT01651481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734295|NCT01651481|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24734296|NCT01651481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24942568|NCT03979664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24734313|NCT01651572|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24734314|NCT01651572|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24734315|NCT01651572|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24734316|NCT01651572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24734317|NCT01651572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734318|NCT01651585|Valacyclovir|valacyclovir|mesh-list
24734319|NCT01651585|Antiviral Agents|antiviral agents|mesh-ancestor
24734320|NCT01651585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24734321|NCT01651637|Pulmonary Surfactants|pulmonary surfactants|mesh-list
24734322|NCT01651637|Respiratory System Agents|respiratory system agents|mesh-ancestor
24734323|NCT01651715|Antibodies|antibodies|mesh-list
24734324|NCT01651715|Immunologic Factors|immunologic factors|mesh-ancestor
24734325|NCT01651715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734326|NCT01651728|Simvastatin|simvastatin|mesh-list
24734327|NCT01651728|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24734328|NCT01651728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24734329|NCT01651728|Antimetabolites|antimetabolites|mesh-ancestor
24734330|NCT01651728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734331|NCT01651728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24734332|NCT01651728|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24734356|NCT01651962|Respiratory System Agents|respiratory system agents|mesh-ancestor
24734357|NCT01651962|Sympathomimetics|sympathomimetics|mesh-ancestor
24734358|NCT01651962|Tocolytic Agents|tocolytic agents|mesh-ancestor
24734359|NCT01651962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24649805|NCT01221935|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25696052|NCT02057250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25696053|NCT02057393|Methylene Blue|methylene blue|mesh-list
25696054|NCT02057393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25696055|NCT02057393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696056|NCT02057458|Sildenafil Citrate|sildenafil citrate|mesh-list
25696057|NCT02057458|Vasodilator Agents|vasodilator agents|mesh-ancestor
25696058|NCT02057458|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25696059|NCT02057458|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25696060|NCT02057458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571710|NCT00811408|Cidofovir|cidofovir|mesh-list
24734360|NCT01651962|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24734361|NCT01651962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24734362|NCT01651962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24734363|NCT01651962|Adrenergic Agents|adrenergic agents|mesh-ancestor
24734364|NCT01651962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24734365|NCT01651962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734374|NCT01652014|Cyclophosphamide|cyclophosphamide|mesh-list
24734375|NCT01652014|Fludarabine|fludarabine|mesh-list
24734376|NCT01652014|Fludarabine phosphate|fludarabine phosphate|mesh-list
24522973|NCT02990338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24734378|NCT01652014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24734379|NCT01652014|Immunologic Factors|immunologic factors|mesh-ancestor
24734380|NCT01652014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734382|NCT01652014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24734401|NCT01652118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734402|NCT01652118|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24734403|NCT01652118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24734404|NCT01652157|Pancrelipase|pancrelipase|mesh-list
24734405|NCT01652157|Pancreatin|pancreatin|mesh-list
24734406|NCT01652157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24734407|NCT01652183|Acetaminophen|acetaminophen|mesh-list
24734408|NCT01652183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24734409|NCT01652183|Analgesics|analgesics|mesh-ancestor
24734410|NCT01652183|Sensory System Agents|sensory system agents|mesh-ancestor
24734411|NCT01652183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24734412|NCT01652183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734413|NCT01652183|Antipyretics|antipyretics|mesh-ancestor
24734414|NCT01652196|Leucovorin|leucovorin|mesh-list
24734415|NCT01652196|Fluorouracil|fluorouracil|mesh-list
24734416|NCT01652196|Oxaliplatin|oxaliplatin|mesh-list
24942569|NCT03979664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24942570|NCT03979664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24734417|NCT01652196|Aflibercept|aflibercept|mesh-list
24734418|NCT01652196|Endothelial Growth Factors|endothelial growth factors|mesh-list
24734419|NCT01652196|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24734420|NCT01652196|Antimetabolites|antimetabolites|mesh-ancestor
24734421|NCT01652196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734422|NCT01652196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24734423|NCT01652196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24734424|NCT01652196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24734425|NCT01652196|Immunologic Factors|immunologic factors|mesh-ancestor
24734426|NCT01652196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734427|NCT01652196|Antidotes|antidotes|mesh-ancestor
24734450|NCT01652326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734451|NCT01652326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24734452|NCT01652326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24734453|NCT01652326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24734454|NCT01652326|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24734455|NCT01652326|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24734456|NCT01652326|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24734457|NCT01652326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24734458|NCT01652326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24734459|NCT01652326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24734460|NCT01652326|Anesthetics, General|anesthetics, general|mesh-ancestor
24734461|NCT01652326|Anesthetics|anesthetics|mesh-ancestor
24734462|NCT01652326|GABA Modulators|gaba modulators|mesh-ancestor
24734463|NCT01652326|GABA Agents|gaba agents|mesh-ancestor
24734464|NCT01652326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24734465|NCT01652326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734467|NCT01652339|Valsartan|valsartan|mesh-list
24734468|NCT01652339|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
24734469|NCT01652339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24734470|NCT01652339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24734471|NCT01652339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24734472|NCT01652339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617512|NCT01043575|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24617513|NCT01043575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24617514|NCT01043575|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24617515|NCT01043575|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24617516|NCT01043575|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24617517|NCT01043575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24617518|NCT01043601|Formoterol Fumarate|formoterol fumarate|mesh-list
24617519|NCT01043601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24617520|NCT01043601|Autonomic Agents|autonomic agents|mesh-ancestor
24617521|NCT01043601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24617522|NCT01043601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617523|NCT01043601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24617524|NCT01043601|Respiratory System Agents|respiratory system agents|mesh-ancestor
24617525|NCT01043601|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24617526|NCT01043601|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24617527|NCT01043601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24617528|NCT01043601|Adrenergic Agents|adrenergic agents|mesh-ancestor
24617529|NCT01043601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24942571|NCT03979651|Hydroxychloroquine|hydroxychloroquine|mesh-list
24942572|NCT03979651|Trametinib|trametinib|mesh-list
24942573|NCT03979651|Antimalarials|antimalarials|mesh-ancestor
24942574|NCT03979651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24642732|NCT01181154|Rituximab|rituximab|mesh-list
24617530|NCT01043601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734493|NCT01652378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24734494|NCT01652378|Antipruritics|antipruritics|mesh-ancestor
24518539|NCT04871412|Vitamin D|vitamin d|mesh-list
24734499|NCT01652378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24734500|NCT01652378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24734501|NCT01652378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24734502|NCT01652378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24734503|NCT01652417|Methylprednisolone|methylprednisolone|mesh-list
24734504|NCT01652417|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24734505|NCT01652417|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24734506|NCT01652417|Prednisolone|prednisolone|mesh-list
24734507|NCT01652417|Prednisolone acetate|prednisolone acetate|mesh-list
24734508|NCT01652417|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24734509|NCT01652417|Prednisolone phosphate|prednisolone phosphate|mesh-list
24734510|NCT01652417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24734511|NCT01652417|Antiemetics|antiemetics|mesh-ancestor
24734512|NCT01652417|Autonomic Agents|autonomic agents|mesh-ancestor
24734513|NCT01652417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24734514|NCT01652417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734522|NCT01652417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24734524|NCT01652534|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24734525|NCT01652534|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24734526|NCT01652534|Antiviral Agents|antiviral agents|mesh-ancestor
24734533|NCT01652534|Analgesics|analgesics|mesh-ancestor
24734534|NCT01652534|Sensory System Agents|sensory system agents|mesh-ancestor
24734535|NCT01652534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24734536|NCT01652547|Pasireotide|pasireotide|mesh-list
24734537|NCT01652547|Somatostatin|somatostatin|mesh-list
24734538|NCT01652547|Hormones|hormones|mesh-ancestor
24734539|NCT01652547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24734540|NCT01652547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734541|NCT01652560|Bevacizumab|bevacizumab|mesh-list
24734542|NCT01652560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24734543|NCT01652560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24734544|NCT01652560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24734545|NCT01652560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24734546|NCT01652560|Growth Substances|growth substances|mesh-ancestor
24734547|NCT01652560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572233|NCT00813735|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24572234|NCT00813735|Antidepressive Agents|antidepressive agents|mesh-ancestor
24572235|NCT00813735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24734548|NCT01652560|Growth Inhibitors|growth inhibitors|mesh-ancestor
24734549|NCT01652586|Midazolam|midazolam|mesh-list
24734550|NCT01652586|Dexmedetomidine|dexmedetomidine|mesh-list
24734551|NCT01652586|Remifentanil|remifentanil|mesh-list
24734552|NCT01652586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24734553|NCT01652586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24734554|NCT01652586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734555|NCT01652586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24734556|NCT01652586|Analgesics|analgesics|mesh-ancestor
24734557|NCT01652586|Sensory System Agents|sensory system agents|mesh-ancestor
24734558|NCT01652586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24734559|NCT01652586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24734560|NCT01652586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24734561|NCT01652586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24734562|NCT01652586|Adrenergic Agents|adrenergic agents|mesh-ancestor
24734563|NCT01652586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24734564|NCT01652586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734565|NCT01652586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24734577|NCT01652599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24734578|NCT01652599|Antiemetics|antiemetics|mesh-ancestor
24734579|NCT01652599|Autonomic Agents|autonomic agents|mesh-ancestor
24734580|NCT01652599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24734581|NCT01652599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734582|NCT01652599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24734583|NCT01652599|Glucocorticoids|glucocorticoids|mesh-ancestor
24734584|NCT01652599|Hormones|hormones|mesh-ancestor
24942575|NCT03979651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24942576|NCT03979651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24942577|NCT03979651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25067420|NCT03443843|Respiratory System Agents|respiratory system agents|mesh-ancestor
24518936|NCT03889756|Anesthetics, General|anesthetics, general|mesh-ancestor
24942578|NCT03979651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942579|NCT03979651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24734585|NCT01652599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24734586|NCT01652599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24734587|NCT01652599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24734588|NCT01652638|Heparin|heparin|mesh-list
24734589|NCT01652638|Calcium heparin|calcium heparin|mesh-list
24734590|NCT01652638|Anticoagulants|anticoagulants|mesh-ancestor
24734591|NCT01652638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24734592|NCT01652638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24734593|NCT01652638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734594|NCT01652781|Azacitidine|azacitidine|mesh-list
24734595|NCT01652781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24734596|NCT01652781|Antimetabolites|antimetabolites|mesh-ancestor
24734597|NCT01652781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523175|NCT02403310|Cytarabine|cytarabine|mesh-list
24734607|NCT01652794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24734608|NCT01652794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734609|NCT01652794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24734617|NCT01652820|Antimetabolites|antimetabolites|mesh-ancestor
24734619|NCT01652820|Antiviral Agents|antiviral agents|mesh-ancestor
24923357|NCT04170855|Natriuretic Agents|natriuretic agents|mesh-ancestor
24923358|NCT04170855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923359|NCT04170855|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24923360|NCT04170855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24734673|NCT01653067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24617535|NCT01043666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24734675|NCT01653067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24734763|NCT01653639|Factor VIII|factor viii|mesh-list
24734764|NCT01653639|Coagulants|coagulants|mesh-ancestor
24734801|NCT01653990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734802|NCT01653990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25696061|NCT02057458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696062|NCT02057458|Urological Agents|urological agents|mesh-ancestor
25696063|NCT02057523|Hormones|hormones|mesh-list
25696064|NCT02057523|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24572985|NCT00817375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24572986|NCT00817375|Analgesics|analgesics|mesh-ancestor
24572987|NCT00817375|Sensory System Agents|sensory system agents|mesh-ancestor
24572988|NCT00817375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24572989|NCT00817375|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24572990|NCT00817375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24573020|NCT00817583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24573021|NCT00817583|Immunologic Factors|immunologic factors|mesh-ancestor
25103343|NCT03162562|Oregovomab|oregovomab|mesh-list
24734803|NCT01653990|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24734804|NCT01653990|Contraceptive Agents|contraceptive agents|mesh-ancestor
24734805|NCT01653990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24734806|NCT01653990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734817|NCT01654120|Liraglutide|liraglutide|mesh-list
24734842|NCT01654185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734844|NCT01654211|Lactams|lactams|mesh-list
24453161|NCT05238831|Vinorelbine|vinorelbine|mesh-list
24734845|NCT01654211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24734846|NCT01654211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24734847|NCT01654211|Protease Inhibitors|protease inhibitors|mesh-ancestor
24734848|NCT01654211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734849|NCT01654211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734850|NCT01654211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24734851|NCT01654211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24734852|NCT01654211|Antiviral Agents|antiviral agents|mesh-ancestor
24734853|NCT01654211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673088|NCT01335321|Viscosupplements|viscosupplements|mesh-ancestor
24734854|NCT01654211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24734855|NCT01654211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24734856|NCT01654211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24734857|NCT01654367|Zoledronic Acid|zoledronic acid|mesh-list
24734858|NCT01654367|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24617552|NCT01043744|Artemether|artemether|mesh-list
24617553|NCT01043744|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24617554|NCT01043744|Antimalarials|antimalarials|mesh-ancestor
24617555|NCT01043744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24617556|NCT01043744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24734867|NCT01654497|HU 211|hu 211|mesh-list
24734868|NCT01654497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24734869|NCT01654497|Antiemetics|antiemetics|mesh-ancestor
24734870|NCT01654497|Autonomic Agents|autonomic agents|mesh-ancestor
24734871|NCT01654497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24734872|NCT01654497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734873|NCT01654497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24734874|NCT01654497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24734883|NCT01654562|Antimetabolites|antimetabolites|mesh-ancestor
24734884|NCT01654562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734885|NCT01654562|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24942589|NCT03979469|Dexmedetomidine|dexmedetomidine|mesh-list
24942591|NCT03979469|Remifentanil|remifentanil|mesh-list
24942592|NCT03979469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24942593|NCT03979469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24942594|NCT03979469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942595|NCT03979469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24942596|NCT03979469|Analgesics|analgesics|mesh-ancestor
24942597|NCT03979469|Sensory System Agents|sensory system agents|mesh-ancestor
24942598|NCT03979469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25696065|NCT02057523|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
25696066|NCT02057523|beta-Endorphin|beta-endorphin|mesh-list
25696067|NCT02057523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25696068|NCT02057523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696069|NCT02057523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25696070|NCT02057523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696071|NCT02057549|Haloperidol|haloperidol|mesh-list
25696072|NCT02057549|Haloperidol decanoate|haloperidol decanoate|mesh-list
25696073|NCT02057549|Antiemetics|antiemetics|mesh-ancestor
24735507|NCT01657409|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24942608|NCT03979469|Anesthetics|anesthetics|mesh-ancestor
24573556|NCT00820690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009491|NCT05214391|Zanubrutinib|zanubrutinib|mesh-list
25009492|NCT05214391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009493|NCT05214391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25009494|NCT05214391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25009495|NCT05214391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942609|NCT03979469|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24942610|NCT03979469|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24942611|NCT03979469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25696074|NCT02057549|Autonomic Agents|autonomic agents|mesh-ancestor
25696075|NCT02057549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25696076|NCT02057549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696077|NCT02057549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25696078|NCT02057549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24399225|NCT00146926|Analgesics|analgesics|mesh-ancestor
24734891|NCT01654575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24734896|NCT01654575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24734897|NCT01654575|Dermatologic Agents|dermatologic agents|mesh-ancestor
24734898|NCT01654575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734899|NCT01654575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24734900|NCT01654575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24734901|NCT01654575|Immunologic Factors|immunologic factors|mesh-ancestor
24734902|NCT01654575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24734903|NCT01654575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24734904|NCT01654640|Metformin|metformin|mesh-list
24734905|NCT01654640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24734906|NCT01654640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734907|NCT01654692|Ipilimumab|ipilimumab|mesh-list
24734908|NCT01654692|Fotemustine|fotemustine|mesh-list
24734909|NCT01654692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24734910|NCT01654692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942613|NCT03979469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24942615|NCT03979248|Rabeprazole|rabeprazole|mesh-list
24942616|NCT03979248|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24942617|NCT03979248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24942618|NCT03979248|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24942619|NCT03979248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734911|NCT01654692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24734912|NCT01654692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734913|NCT01654705|Pantoprazole|pantoprazole|mesh-list
24734914|NCT01654705|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24624209|NCT01075425|Belinostat|belinostat|mesh-list
24734915|NCT01654705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24734916|NCT01654705|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24734917|NCT01654705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734918|NCT01654705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734919|NCT01654718|Pantoprazole|pantoprazole|mesh-list
24734920|NCT01654718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24734921|NCT01654718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24734922|NCT01654718|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24734923|NCT01654718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734928|NCT01654731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734930|NCT01654809|Vaccines|vaccines|mesh-list
25696079|NCT02057549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25696080|NCT02057549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25696081|NCT02057549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25696082|NCT02057549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25696083|NCT02057549|Dopamine Agents|dopamine agents|mesh-ancestor
25696084|NCT02057549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24734939|NCT01654913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734940|NCT01654913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24734941|NCT01654913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24734942|NCT01654939|Rifaximin|rifaximin|mesh-list
24734943|NCT01654939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24734944|NCT01654939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24734945|NCT01654939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24734946|NCT01654965|Topotecan|topotecan|mesh-list
24734947|NCT01654965|Lenograstim|lenograstim|mesh-list
24734949|NCT01654965|Immunologic Factors|immunologic factors|mesh-ancestor
24734950|NCT01654965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734951|NCT01654965|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24734952|NCT01654965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24734953|NCT01654965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734954|NCT01654965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734955|NCT01654965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24734956|NCT01655004|Exemestane|exemestane|mesh-list
24734957|NCT01655004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24734958|NCT01655004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24734959|NCT01655004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24734961|NCT01655004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734962|NCT01655004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24734963|NCT01655004|Hormone Antagonists|hormone antagonists|mesh-ancestor
24734964|NCT01655004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24734965|NCT01655004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734967|NCT01655056|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24734968|NCT01655056|Antithrombins|antithrombins|mesh-ancestor
24734969|NCT01655056|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24734970|NCT01655056|Protease Inhibitors|protease inhibitors|mesh-ancestor
24734971|NCT01655056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734972|NCT01655056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734973|NCT01655056|Anticoagulants|anticoagulants|mesh-ancestor
24734974|NCT01655082|Nicotine|nicotine|mesh-list
24734975|NCT01655082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24734976|NCT01655082|Autonomic Agents|autonomic agents|mesh-ancestor
24942620|NCT03979248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942621|NCT03979248|Dermatologic Agents|dermatologic agents|mesh-ancestor
24942622|NCT03979248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24942623|NCT03979586|Hyaluronic Acid|hyaluronic acid|mesh-list
24942624|NCT03979586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24942625|NCT03979586|Immunologic Factors|immunologic factors|mesh-ancestor
24942626|NCT03979586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734977|NCT01655082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24650213|NCT01224509|Hormone Antagonists|hormone antagonists|mesh-ancestor
24734978|NCT01655082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734979|NCT01655082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24734980|NCT01655082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24734981|NCT01655082|Cholinergic Agents|cholinergic agents|mesh-ancestor
24734982|NCT01655082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24734983|NCT01655082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734985|NCT01655095|Bisacodyl|bisacodyl|mesh-list
24734986|NCT01655095|Laxatives|laxatives|mesh-ancestor
24735019|NCT01655147|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24735021|NCT01655199|Ipratropium|ipratropium|mesh-list
24735022|NCT01655199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24735023|NCT01655199|Autonomic Agents|autonomic agents|mesh-ancestor
24735024|NCT01655199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24735025|NCT01655199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735026|NCT01655199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24735027|NCT01655199|Respiratory System Agents|respiratory system agents|mesh-ancestor
24735028|NCT01655199|Tocolytic Agents|tocolytic agents|mesh-ancestor
24735029|NCT01655199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24735030|NCT01655199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24735031|NCT01655199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24735032|NCT01655199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24735043|NCT01655303|Verapamil|verapamil|mesh-list
24735044|NCT01655303|Diltiazem|diltiazem|mesh-list
24735045|NCT01655303|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24735046|NCT01655303|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24735047|NCT01655303|Adrenergic Agents|adrenergic agents|mesh-ancestor
24735048|NCT01655303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24735049|NCT01655303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735050|NCT01655303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735051|NCT01655303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24735052|NCT01655303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24735053|NCT01655303|Vasodilator Agents|vasodilator agents|mesh-ancestor
24735054|NCT01655303|Sympatholytics|sympatholytics|mesh-ancestor
24735063|NCT01655316|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24735064|NCT01655316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24735065|NCT01655316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735066|NCT01655316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24735067|NCT01655316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735068|NCT01655316|Vasodilator Agents|vasodilator agents|mesh-ancestor
24735070|NCT01655524|Aminophylline|aminophylline|mesh-list
24735085|NCT01655524|Protective Agents|protective agents|mesh-ancestor
24735086|NCT01655628|Gemcitabine|gemcitabine|mesh-list
24735088|NCT01655628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24735089|NCT01655628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24735090|NCT01655628|Antimetabolites|antimetabolites|mesh-ancestor
24735091|NCT01655628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735092|NCT01655628|Antiviral Agents|antiviral agents|mesh-ancestor
24735093|NCT01655628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24735094|NCT01655628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735095|NCT01655628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24735096|NCT01655628|Immunologic Factors|immunologic factors|mesh-ancestor
24735097|NCT01655628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735098|NCT01655641|Tranexamic Acid|tranexamic acid|mesh-list
24735099|NCT01655641|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24735100|NCT01655641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24735101|NCT01655641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942627|NCT03979586|Viscosupplements|viscosupplements|mesh-ancestor
24942628|NCT03979586|Protective Agents|protective agents|mesh-ancestor
24942629|NCT03979599|Magnesium Sulfate|magnesium sulfate|mesh-list
24942630|NCT03979599|Levobupivacaine|levobupivacaine|mesh-list
24735103|NCT01655641|Coagulants|coagulants|mesh-ancestor
24735104|NCT01655706|Aripiprazole|aripiprazole|mesh-list
24735105|NCT01655706|Citalopram|citalopram|mesh-list
24735106|NCT01655706|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24735107|NCT01655706|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24735108|NCT01655706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24735109|NCT01655706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735110|NCT01655706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24735111|NCT01655706|Serotonin Agents|serotonin agents|mesh-ancestor
24575924|NCT00835627|Sertraline|sertraline|mesh-list
24575925|NCT00835627|Antidepressive Agents|antidepressive agents|mesh-ancestor
24575926|NCT00835627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24735112|NCT01655706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735113|NCT01655706|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24735114|NCT01655706|Antidepressive Agents|antidepressive agents|mesh-ancestor
24735115|NCT01655706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24735116|NCT01655706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24735117|NCT01655706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24617564|NCT01043952|Anesthetics, General|anesthetics, general|mesh-ancestor
24617565|NCT01043952|Anesthetics|anesthetics|mesh-ancestor
24617566|NCT01043952|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24617567|NCT01043952|Narcotics|narcotics|mesh-ancestor
24617568|NCT01043952|Analgesics|analgesics|mesh-ancestor
24617569|NCT01043952|Sensory System Agents|sensory system agents|mesh-ancestor
24617570|NCT01043952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24617571|NCT01043965|Metformin|metformin|mesh-list
24617572|NCT01043965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24617573|NCT01043965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617574|NCT01043991|Darbepoetin alfa|darbepoetin alfa|mesh-list
24617575|NCT01043991|Hematinics|hematinics|mesh-ancestor
24617576|NCT01044004|Modafinil|modafinil|mesh-list
24617577|NCT01044004|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24617578|NCT01044004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617579|NCT01044004|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24735129|NCT01655745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735130|NCT01655758|Timolol|timolol|mesh-list
24735131|NCT01655758|Bimatoprost|bimatoprost|mesh-list
24735132|NCT01655758|Travoprost|travoprost|mesh-list
24735133|NCT01655758|Dorzolamide|dorzolamide|mesh-list
24735134|NCT01655758|Latanoprost|latanoprost|mesh-list
24735135|NCT01655758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24735136|NCT01655758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24735137|NCT01655758|Adrenergic Agents|adrenergic agents|mesh-ancestor
24735138|NCT01655758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24735139|NCT01655758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735140|NCT01655758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735141|NCT01655758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24735142|NCT01655758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24735143|NCT01655758|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24735144|NCT01655758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24735145|NCT01655758|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24735146|NCT01655758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735147|NCT01655810|Vitamin D|vitamin d|mesh-list
24735148|NCT01655810|Ergocalciferols|ergocalciferols|mesh-list
24735149|NCT01655810|Cholecalciferol|cholecalciferol|mesh-list
24735150|NCT01655810|Vitamins|vitamins|mesh-list
24735151|NCT01655810|Calcium Carbonate|calcium carbonate|mesh-list
24735152|NCT01655810|Micronutrients|micronutrients|mesh-ancestor
24735153|NCT01655810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735154|NCT01655810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24735155|NCT01655810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24735156|NCT01655810|Antacids|antacids|mesh-ancestor
24399543|NCT00148031|Ribavirin|ribavirin|mesh-list
24735168|NCT01655862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24735169|NCT01655862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24735170|NCT01655875|Plerixafor|plerixafor|mesh-list
24735171|NCT01655875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24735172|NCT01655875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24735174|NCT01655875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24735177|NCT01655914|Flumazenil|flumazenil|mesh-list
24942634|NCT03979599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735192|NCT01655966|Interferons|interferons|mesh-list
24735193|NCT01655966|Ribavirin|ribavirin|mesh-list
24735194|NCT01655966|Vitamins|vitamins|mesh-ancestor
24735195|NCT01655966|Micronutrients|micronutrients|mesh-ancestor
24735196|NCT01655966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735197|NCT01655966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24735198|NCT01655966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24735199|NCT01655966|Antiviral Agents|antiviral agents|mesh-ancestor
24735200|NCT01655966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24735201|NCT01655966|Antimetabolites|antimetabolites|mesh-ancestor
25696085|NCT02057549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696086|NCT02057549|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24735202|NCT01655966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735203|NCT01655992|Capecitabine|capecitabine|mesh-list
24735204|NCT01655992|Tegafur|tegafur|mesh-list
24735205|NCT01655992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24576412|NCT00838357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24576413|NCT00838357|Antiviral Agents|antiviral agents|mesh-ancestor
24576414|NCT00838357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24576415|NCT00838370|Fluorouracil|fluorouracil|mesh-list
24576416|NCT00838370|Capecitabine|capecitabine|mesh-list
24576417|NCT00838370|Antimetabolites|antimetabolites|mesh-ancestor
24735206|NCT01655992|Antimetabolites|antimetabolites|mesh-ancestor
24847028|NCT02244710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24735207|NCT01655992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735208|NCT01655992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24735209|NCT01656005|Beclomethasone|beclomethasone|mesh-list
24735210|NCT01656005|Carvedilol|carvedilol|mesh-list
24735211|NCT01656005|Bisoprolol|bisoprolol|mesh-list
24735212|NCT01656005|Formoterol Fumarate|formoterol fumarate|mesh-list
24735213|NCT01656005|Tiotropium Bromide|tiotropium bromide|mesh-list
24735214|NCT01656005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24735215|NCT01656005|Autonomic Agents|autonomic agents|mesh-ancestor
24735216|NCT01656005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24735217|NCT01656005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735218|NCT01656005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24735219|NCT01656005|Respiratory System Agents|respiratory system agents|mesh-ancestor
24735220|NCT01656005|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24735221|NCT01656005|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24735222|NCT01656005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24735235|NCT01656005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24735236|NCT01656005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24735237|NCT01656005|Vasodilator Agents|vasodilator agents|mesh-ancestor
24735238|NCT01656005|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24735239|NCT01656005|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24735252|NCT01656018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24735253|NCT01656018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24735254|NCT01656018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24735255|NCT01656057|Acetaminophen|acetaminophen|mesh-list
24735256|NCT01656057|Metformin|metformin|mesh-list
24735257|NCT01656057|Cholecystokinin|cholecystokinin|mesh-list
24735258|NCT01656057|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
24735259|NCT01656057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24735260|NCT01656057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735261|NCT01656057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24735262|NCT01656057|Analgesics|analgesics|mesh-ancestor
24735263|NCT01656057|Sensory System Agents|sensory system agents|mesh-ancestor
24735264|NCT01656057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24735291|NCT01656122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24735292|NCT01656122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24735293|NCT01656122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735294|NCT01656122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735295|NCT01656122|Antiviral Agents|antiviral agents|mesh-ancestor
24735296|NCT01656122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24735314|NCT01656330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735315|NCT01656330|Anticoagulants|anticoagulants|mesh-ancestor
24650402|NCT01225653|Latanoprost|latanoprost|mesh-list
24735326|NCT01656512|Vitamin D|vitamin d|mesh-list
24735327|NCT01656512|Diphosphonates|diphosphonates|mesh-list
24735328|NCT01656512|Calcium|calcium|mesh-list
24735329|NCT01656512|Vitamins|vitamins|mesh-ancestor
24735330|NCT01656512|Micronutrients|micronutrients|mesh-ancestor
24735331|NCT01656512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847076|NCT02245022|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24735332|NCT01656512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25696087|NCT02057575|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25696088|NCT02057575|Latanoprost|latanoprost|mesh-list
25696089|NCT02057575|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25696090|NCT02057640|Dexamethasone|dexamethasone|mesh-list
25696091|NCT02057640|Ixazomib|ixazomib|mesh-list
25696092|NCT02057640|Panobinostat|panobinostat|mesh-list
25696093|NCT02057640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24735333|NCT01656512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25009734|NCT05209217|Ketamine|ketamine|mesh-list
25009760|NCT05190627|Immunologic Factors|immunologic factors|mesh-ancestor
25009761|NCT05190627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009762|NCT05190627|Antipruritics|antipruritics|mesh-ancestor
25009763|NCT05190627|Dermatologic Agents|dermatologic agents|mesh-ancestor
25009764|NCT05190627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25009765|NCT05190627|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25009766|NCT05190627|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25009767|NCT05190627|Histamine Antagonists|histamine antagonists|mesh-ancestor
25009768|NCT05190627|Histamine Agents|histamine agents|mesh-ancestor
25009774|NCT05188417|Tirofiban|tirofiban|mesh-list
24735334|NCT01656525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24735340|NCT01656538|Tubulin Modulators|tubulin modulators|mesh-ancestor
24735341|NCT01656538|Antimitotic Agents|antimitotic agents|mesh-ancestor
24735342|NCT01656538|Mitosis Modulators|mitosis modulators|mesh-ancestor
24735368|NCT01656668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24735369|NCT01656668|Autonomic Agents|autonomic agents|mesh-ancestor
24735370|NCT01656668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24735371|NCT01656668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735372|NCT01656668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24735373|NCT01656668|Respiratory System Agents|respiratory system agents|mesh-ancestor
24735374|NCT01656668|Vasodilator Agents|vasodilator agents|mesh-ancestor
24735376|NCT01656720|Sympathomimetics|sympathomimetics|mesh-ancestor
24735377|NCT01656720|Autonomic Agents|autonomic agents|mesh-ancestor
24942648|NCT03979209|Dermatologic Agents|dermatologic agents|mesh-ancestor
24942649|NCT03979209|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25067422|NCT03443843|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24443215|NCT00294008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443216|NCT00294008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24735378|NCT01656720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24735379|NCT01656720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735380|NCT01656720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24735381|NCT01656720|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24735382|NCT01656720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24735383|NCT01656720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24735384|NCT01656720|Adrenergic Agents|adrenergic agents|mesh-ancestor
24735385|NCT01656720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24735386|NCT01656720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735387|NCT01656798|Sildenafil Citrate|sildenafil citrate|mesh-list
24735388|NCT01656798|Citric Acid|citric acid|mesh-list
24735389|NCT01656798|Sodium Citrate|sodium citrate|mesh-list
24735390|NCT01656798|Anticoagulants|anticoagulants|mesh-ancestor
24735391|NCT01656798|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24735392|NCT01656798|Chelating Agents|chelating agents|mesh-ancestor
24735393|NCT01656798|Sequestering Agents|sequestering agents|mesh-ancestor
24617608|NCT01044251|Serotonin Agents|serotonin agents|mesh-ancestor
24735394|NCT01656798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735395|NCT01656798|Vasodilator Agents|vasodilator agents|mesh-ancestor
24735396|NCT01656798|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24735397|NCT01656798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24735414|NCT01656811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735415|NCT01656980|Carmustine|carmustine|mesh-list
24735416|NCT01656980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24735417|NCT01656980|Alkylating Agents|alkylating agents|mesh-ancestor
24735418|NCT01656980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735419|NCT01656980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24735420|NCT01657058|Dimenhydrinate|dimenhydrinate|mesh-list
24925339|NCT04150965|Elotuzumab|elotuzumab|mesh-list
24443217|NCT00294008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24443218|NCT00294008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25696094|NCT02057640|Antiemetics|antiemetics|mesh-ancestor
25696095|NCT02057640|Autonomic Agents|autonomic agents|mesh-ancestor
25696096|NCT02057640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25696097|NCT02057640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696098|NCT02057640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25696099|NCT02057640|Glucocorticoids|glucocorticoids|mesh-ancestor
25696100|NCT02057640|Hormones|hormones|mesh-ancestor
25696101|NCT02057640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25696102|NCT02057640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25696103|NCT02057640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25696104|NCT02057640|Protease Inhibitors|protease inhibitors|mesh-ancestor
25696105|NCT02057640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735422|NCT01657058|Autonomic Agents|autonomic agents|mesh-ancestor
24735423|NCT01657058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24735424|NCT01657058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735425|NCT01657058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24735426|NCT01657058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24735427|NCT01657058|Histamine Antagonists|histamine antagonists|mesh-ancestor
24735428|NCT01657058|Histamine Agents|histamine agents|mesh-ancestor
24735429|NCT01657058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24735430|NCT01657058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735431|NCT01657071|Aspirin|aspirin|mesh-list
24735432|NCT01657071|Clopidogrel|clopidogrel|mesh-list
24735433|NCT01657071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24735434|NCT01657071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24735435|NCT01657071|Analgesics|analgesics|mesh-ancestor
24735436|NCT01657071|Sensory System Agents|sensory system agents|mesh-ancestor
24735437|NCT01657071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24735438|NCT01657071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735439|NCT01657071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24735440|NCT01657071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24617613|NCT01044329|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24617614|NCT01044329|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24617615|NCT01044329|Bevacizumab|bevacizumab|mesh-list
24617616|NCT01044329|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24617617|NCT01044329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24617618|NCT01044329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617619|NCT01044329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24617620|NCT01044329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24617621|NCT01044329|Growth Substances|growth substances|mesh-ancestor
24617622|NCT01044329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617623|NCT01044329|Growth Inhibitors|growth inhibitors|mesh-ancestor
24617624|NCT01044329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24617625|NCT01044329|Glucocorticoids|glucocorticoids|mesh-ancestor
24617626|NCT01044329|Hormones|hormones|mesh-ancestor
24942653|NCT03978988|Analgesics|analgesics|mesh-ancestor
24942654|NCT03978988|Sensory System Agents|sensory system agents|mesh-ancestor
24644369|NCT01190553|Analgesics|analgesics|mesh-ancestor
24617627|NCT01044329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24617628|NCT01044329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24617629|NCT01044329|Immunologic Factors|immunologic factors|mesh-ancestor
24617630|NCT01044329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617631|NCT01044329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735443|NCT01657071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735444|NCT01657071|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24735445|NCT01657071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24735446|NCT01657071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735447|NCT01657071|Antipyretics|antipyretics|mesh-ancestor
24735448|NCT01657071|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24735449|NCT01657071|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24735453|NCT01657110|Tea Tree Oil|tea tree oil|mesh-list
24735482|NCT01657240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735483|NCT01657240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24735484|NCT01657240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24650500|NCT01226017|Oxytocin|oxytocin|mesh-list
24735485|NCT01657240|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24735486|NCT01657240|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24735487|NCT01657240|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24735488|NCT01657240|Histamine Antagonists|histamine antagonists|mesh-ancestor
24735489|NCT01657240|Histamine Agents|histamine agents|mesh-ancestor
24735490|NCT01657240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24735491|NCT01657240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735492|NCT01657318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
24735493|NCT01657318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24735494|NCT01657331|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24735501|NCT01657396|Chlorhexidine|chlorhexidine|mesh-list
24624356|NCT01075828|Cetuximab|cetuximab|mesh-list
25009811|NCT05186454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25009812|NCT05186454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25009813|NCT05186454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25009814|NCT05186454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24577420|NCT00844012|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24735508|NCT01657409|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24735509|NCT01657409|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24735510|NCT01657409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24735511|NCT01657409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735512|NCT01657409|Cholinergic Agents|cholinergic agents|mesh-ancestor
24735513|NCT01657409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24735519|NCT01657448|Methenamine mandelate|methenamine mandelate|mesh-list
24735521|NCT01657448|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24735522|NCT01657448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24735523|NCT01657448|Renal Agents|renal agents|mesh-ancestor
24735524|NCT01657448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24735525|NCT01657448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735526|NCT01657448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735527|NCT01657487|Fluticasone|fluticasone|mesh-list
24735529|NCT01657487|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24735530|NCT01657487|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24735531|NCT01657487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24735532|NCT01657487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24735533|NCT01657487|Autonomic Agents|autonomic agents|mesh-ancestor
24735534|NCT01657487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24735549|NCT01657487|Sympathomimetics|sympathomimetics|mesh-ancestor
24735561|NCT01657669|Aflibercept|aflibercept|mesh-list
24735562|NCT01657669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24735563|NCT01657669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24735564|NCT01657669|Growth Substances|growth substances|mesh-ancestor
24735565|NCT01657669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735566|NCT01657669|Growth Inhibitors|growth inhibitors|mesh-ancestor
24735567|NCT01657669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24735568|NCT01657682|Crenolanib|crenolanib|mesh-list
24735569|NCT01657682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24735570|NCT01657747|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24735571|NCT01657747|Parasympatholytics|parasympatholytics|mesh-ancestor
24942655|NCT03978988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24942656|NCT03978988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942657|NCT03978988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24735572|NCT01657747|Autonomic Agents|autonomic agents|mesh-ancestor
24735573|NCT01657747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24735574|NCT01657747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735575|NCT01657747|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25696106|NCT02057640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696107|NCT02057640|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25696108|NCT02057757|Nitazoxanide|nitazoxanide|mesh-list
25696109|NCT02057757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25696110|NCT02057757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25696111|NCT02057939|Leuprolide|leuprolide|mesh-list
25009830|NCT05162898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009831|NCT05162898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25009832|NCT05162898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735576|NCT01657747|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24399984|NCT00149188|Lanreotide|lanreotide|mesh-list
24735594|NCT01657825|Isavuconazole|isavuconazole|mesh-list
24735596|NCT01657825|Anticoagulants|anticoagulants|mesh-ancestor
24735597|NCT01657825|Antifungal Agents|antifungal agents|mesh-ancestor
24735598|NCT01657825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24735599|NCT01657838|Ketoconazole|ketoconazole|mesh-list
24735600|NCT01657838|Isavuconazole|isavuconazole|mesh-list
24735601|NCT01657838|Antifungal Agents|antifungal agents|mesh-ancestor
24735614|NCT01657851|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24735616|NCT01657851|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24735617|NCT01657851|Adrenergic Agents|adrenergic agents|mesh-ancestor
24735618|NCT01657851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24735619|NCT01657851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735620|NCT01657851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735621|NCT01657851|Urological Agents|urological agents|mesh-ancestor
24735622|NCT01657851|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24735623|NCT01657851|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24735624|NCT01657851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735625|NCT01657851|Hormone Antagonists|hormone antagonists|mesh-ancestor
24617637|NCT01044342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24617638|NCT01044342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617639|NCT01044342|Nootropic Agents|nootropic agents|mesh-ancestor
24617651|NCT01044485|Antimitotic Agents|antimitotic agents|mesh-ancestor
24617652|NCT01044485|Mitosis Modulators|mitosis modulators|mesh-ancestor
24617653|NCT01044485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617654|NCT01044485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24617655|NCT01044485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735628|NCT01657864|Anticonvulsants|anticonvulsants|mesh-ancestor
24735629|NCT01657864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24735630|NCT01657864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24735631|NCT01657864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735632|NCT01657864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24735660|NCT01657513|Dermatologic Agents|dermatologic agents|mesh-ancestor
24735661|NCT01657513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24735662|NCT01657513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24735663|NCT01657513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24926755|NCT04138836|Midazolam|midazolam|mesh-list
24735664|NCT01657513|Analgesics|analgesics|mesh-ancestor
24735665|NCT01657513|Sensory System Agents|sensory system agents|mesh-ancestor
24735666|NCT01657513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24735667|NCT01657513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735668|NCT01657513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24735669|NCT01657513|Immunologic Factors|immunologic factors|mesh-ancestor
24735670|NCT01657981|Darexaban|darexaban|mesh-list
24735671|NCT01657981|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24735672|NCT01657981|Antithrombins|antithrombins|mesh-ancestor
24735673|NCT01657981|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24735674|NCT01657981|Protease Inhibitors|protease inhibitors|mesh-ancestor
24942658|NCT03978988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24942659|NCT03978988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24942660|NCT03978988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24735675|NCT01657981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735676|NCT01657981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735677|NCT01657981|Anticoagulants|anticoagulants|mesh-ancestor
24735678|NCT01658007|Sirolimus|sirolimus|mesh-list
24735679|NCT01658007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24735680|NCT01658007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24735681|NCT01658007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24735682|NCT01658007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24735683|NCT01658007|Antifungal Agents|antifungal agents|mesh-ancestor
24735684|NCT01658007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24735685|NCT01658007|Immunologic Factors|immunologic factors|mesh-ancestor
24735686|NCT01658007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735687|NCT01658033|Leucovorin|leucovorin|mesh-list
24735688|NCT01658033|Oxaliplatin|oxaliplatin|mesh-list
25696112|NCT02057939|Androgens|androgens|mesh-list
25696113|NCT02057939|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25696114|NCT02057939|Fertility Agents|fertility agents|mesh-ancestor
24577923|NCT00846339|Bupropion|bupropion|mesh-list
24735689|NCT01658033|Bevacizumab|bevacizumab|mesh-list
24735727|NCT01658202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735728|NCT01658215|Nicotine|nicotine|mesh-list
24735729|NCT01658215|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24735730|NCT01658215|Autonomic Agents|autonomic agents|mesh-ancestor
24735731|NCT01658215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24735732|NCT01658215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735738|NCT01658319|Fludarabine|fludarabine|mesh-list
24735748|NCT01658358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24735750|NCT01658358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24735751|NCT01658358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24735752|NCT01658358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24735753|NCT01658358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24735754|NCT01658358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735755|NCT01658358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735756|NCT01658358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24735757|NCT01658410|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
24735758|NCT01658410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24735759|NCT01658410|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24735760|NCT01658410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735761|NCT01658449|Hyaluronic Acid|hyaluronic acid|mesh-list
24735762|NCT01658449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24735763|NCT01658449|Immunologic Factors|immunologic factors|mesh-ancestor
24735764|NCT01658449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735765|NCT01658449|Viscosupplements|viscosupplements|mesh-ancestor
24735766|NCT01658449|Protective Agents|protective agents|mesh-ancestor
24735768|NCT01658462|Nintedanib|nintedanib|mesh-list
24735769|NCT01658462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24735770|NCT01658462|Tubulin Modulators|tubulin modulators|mesh-ancestor
24735771|NCT01658462|Antimitotic Agents|antimitotic agents|mesh-ancestor
24735772|NCT01658462|Mitosis Modulators|mitosis modulators|mesh-ancestor
24735773|NCT01658462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735774|NCT01658462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24735775|NCT01658462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735776|NCT01658527|Bicalutamide|bicalutamide|mesh-list
24735777|NCT01658527|Androgen Antagonists|androgen antagonists|mesh-ancestor
24942661|NCT03978988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942662|NCT03978988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24942663|NCT03978988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24942664|NCT03978988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24942665|NCT03978988|Antipyretics|antipyretics|mesh-ancestor
24942666|NCT03979105|Ketamine|ketamine|mesh-list
24942667|NCT03979105|Analgesics|analgesics|mesh-ancestor
24942668|NCT03979105|Sensory System Agents|sensory system agents|mesh-ancestor
24684665|NCT04835129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24735779|NCT01658527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24735781|NCT01658527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24735787|NCT01658774|Ascorbic Acid|ascorbic acid|mesh-list
24735788|NCT01658774|Albendazole|albendazole|mesh-list
24735789|NCT01658774|Vitamins|vitamins|mesh-ancestor
24735790|NCT01658774|Micronutrients|micronutrients|mesh-ancestor
24735791|NCT01658774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735792|NCT01658774|Antioxidants|antioxidants|mesh-ancestor
24735793|NCT01658774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735794|NCT01658774|Protective Agents|protective agents|mesh-ancestor
24735795|NCT01658774|Anthelmintics|anthelmintics|mesh-ancestor
24735796|NCT01658774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24735797|NCT01658774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24735798|NCT01658774|Anticestodal Agents|anticestodal agents|mesh-ancestor
24735799|NCT01658774|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24735800|NCT01658774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24735801|NCT01658774|Tubulin Modulators|tubulin modulators|mesh-ancestor
24735802|NCT01658774|Antimitotic Agents|antimitotic agents|mesh-ancestor
24735803|NCT01658774|Mitosis Modulators|mitosis modulators|mesh-ancestor
24735804|NCT01658774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24735805|NCT01658852|Metronidazole|metronidazole|mesh-list
24735806|NCT01658852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24735807|NCT01658852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24735808|NCT01658852|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24735809|NCT01658852|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24735810|NCT01658878|Nivolumab|nivolumab|mesh-list
24735811|NCT01658878|Ipilimumab|ipilimumab|mesh-list
24735835|NCT01658891|Hormones|hormones|mesh-ancestor
25109504|NCT03123718|Antimetabolites|antimetabolites|mesh-ancestor
25696115|NCT02057939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24578085|NCT00846859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735839|NCT01659008|Hormones|hormones|mesh-ancestor
24735840|NCT01659008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24735841|NCT01659008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735855|NCT01659099|Bleomycin|bleomycin|mesh-list
24735856|NCT01659099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24735857|NCT01659099|Immunologic Factors|immunologic factors|mesh-ancestor
24735858|NCT01659099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735859|NCT01659099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24735860|NCT01659099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24735861|NCT01659099|Alkylating Agents|alkylating agents|mesh-ancestor
24735862|NCT01659099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735863|NCT01659099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24735864|NCT01659099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24617665|NCT01044810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617666|NCT01044810|Antiviral Agents|antiviral agents|mesh-ancestor
24617667|NCT01044810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24617668|NCT01044810|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24942669|NCT03979105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24942670|NCT03979105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942671|NCT03979105|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24942672|NCT03979105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24942673|NCT03979105|Anesthetics, General|anesthetics, general|mesh-ancestor
24942675|NCT03979105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24942676|NCT03979105|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24942677|NCT03979105|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24942678|NCT03979105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24942679|NCT03979105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942680|NCT03978884|Losartan|losartan|mesh-list
24942681|NCT03978884|Amlodipine|amlodipine|mesh-list
24617683|NCT01044992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24617684|NCT01044992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617685|NCT01044992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617686|NCT01045018|Mesalamine|mesalamine|mesh-list
24617687|NCT01045018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24617688|NCT01045018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24617689|NCT01045018|Analgesics|analgesics|mesh-ancestor
24617690|NCT01045018|Sensory System Agents|sensory system agents|mesh-ancestor
24617691|NCT01045018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24617692|NCT01045018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617740|NCT01045304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24617741|NCT01045304|Immunologic Factors|immunologic factors|mesh-ancestor
24735873|NCT01659099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24735874|NCT01659099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24735875|NCT01659099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24735876|NCT01659099|Tubulin Modulators|tubulin modulators|mesh-ancestor
24735892|NCT01659242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735894|NCT01659242|Dermatologic Agents|dermatologic agents|mesh-ancestor
24735895|NCT01659242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735896|NCT01659242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24735897|NCT01659242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24735898|NCT01659242|Immunologic Factors|immunologic factors|mesh-ancestor
24735899|NCT01659242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24735900|NCT01659242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24735901|NCT01659242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24735912|NCT01659281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24735913|NCT01659281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24735917|NCT01659281|Schistosomicides|schistosomicides|mesh-ancestor
24735918|NCT01659281|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24735919|NCT01659281|Anthelmintics|anthelmintics|mesh-ancestor
24735962|NCT01659359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24735963|NCT01659359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735964|NCT01659372|Naproxen|naproxen|mesh-list
24735965|NCT01659372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24735966|NCT01659372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24735967|NCT01659372|Analgesics|analgesics|mesh-ancestor
24735968|NCT01659372|Sensory System Agents|sensory system agents|mesh-ancestor
25696116|NCT02057939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110044|NCT03120468|Protective Agents|protective agents|mesh-ancestor
24735969|NCT01659372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24735970|NCT01659372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735993|NCT01659476|Respiratory System Agents|respiratory system agents|mesh-ancestor
24735994|NCT01659476|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24735995|NCT01659476|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24735996|NCT01659476|Cholinergic Agents|cholinergic agents|mesh-ancestor
24735997|NCT01659476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25051099|NCT00441896|GABA Agents|gaba agents|mesh-ancestor
24735998|NCT01659476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735999|NCT01659515|Arbekacin|arbekacin|mesh-list
24736000|NCT01659515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24736001|NCT01659619|Erythromycin|erythromycin|mesh-list
24736002|NCT01659619|Erythromycin Estolate|erythromycin estolate|mesh-list
24736003|NCT01659619|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24736004|NCT01659619|Erythromycin stearate|erythromycin stearate|mesh-list
24736005|NCT01659619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24736006|NCT01659619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24736007|NCT01659619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24736008|NCT01659619|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24736009|NCT01659619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24736010|NCT01659619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736011|NCT01659684|Immunoglobulins|immunoglobulins|mesh-list
24736013|NCT01659684|Antibodies|antibodies|mesh-list
24736015|NCT01659684|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24736016|NCT01659684|Immunologic Factors|immunologic factors|mesh-ancestor
24736017|NCT01659684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736019|NCT01659775|Antiemetics|antiemetics|mesh-ancestor
24736020|NCT01659775|Autonomic Agents|autonomic agents|mesh-ancestor
24942685|NCT03978884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24942686|NCT03978884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942687|NCT03978884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24942688|NCT03978884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942689|NCT03978884|Vasodilator Agents|vasodilator agents|mesh-ancestor
24617784|NCT01045681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24617795|NCT01045837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24617796|NCT01045837|Glucocorticoids|glucocorticoids|mesh-ancestor
24617797|NCT01045837|Hormones|hormones|mesh-ancestor
24617798|NCT01045837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24617799|NCT01045837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617800|NCT01045837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24617801|NCT01045837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617802|NCT01045876|Dexamethasone|dexamethasone|mesh-list
24617803|NCT01045876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24617805|NCT01045876|Autonomic Agents|autonomic agents|mesh-ancestor
24617806|NCT01045876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24617807|NCT01045876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617808|NCT01045876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24617809|NCT01045876|Glucocorticoids|glucocorticoids|mesh-ancestor
24617810|NCT01045876|Hormones|hormones|mesh-ancestor
24617811|NCT01045876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24736035|NCT01659788|Ubiquinone|ubiquinone|mesh-list
24617812|NCT01045876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24736036|NCT01659788|Coenzyme Q10|coenzyme q10|mesh-list
24736037|NCT01659788|Micronutrients|micronutrients|mesh-ancestor
24736039|NCT01659788|Vitamins|vitamins|mesh-ancestor
24942704|NCT03978845|Sensory System Agents|sensory system agents|mesh-ancestor
24942705|NCT03978845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24942706|NCT03978845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24942707|NCT03978845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24942708|NCT03978845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25051073|NCT00443287|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25051074|NCT00443287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25051075|NCT00443287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051076|NCT00443287|Enzyme Activators|enzyme activators|mesh-ancestor
25051077|NCT00442104|Ganaxolone|ganaxolone|mesh-list
25051078|NCT00442104|Neurosteroids|neurosteroids|mesh-ancestor
25051079|NCT00442104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25051080|NCT00442104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051081|NCT00442104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051082|NCT00442104|GABA Modulators|gaba modulators|mesh-ancestor
25051083|NCT00442104|GABA Agents|gaba agents|mesh-ancestor
25051084|NCT00442039|Lithium Carbonate|lithium carbonate|mesh-list
25696117|NCT02057939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24578630|NCT00850005|gamma-Globulins|gamma-globulins|mesh-list
24578631|NCT00850005|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25051085|NCT00442039|Antidepressive Agents|antidepressive agents|mesh-ancestor
25051086|NCT00442039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25051087|NCT00442039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051088|NCT00442039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051089|NCT00442039|Antimanic Agents|antimanic agents|mesh-ancestor
25051090|NCT00442039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25051093|NCT00441896|Ganaxolone|ganaxolone|mesh-list
25051097|NCT00441896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051098|NCT00441896|GABA Modulators|gaba modulators|mesh-ancestor
25051100|NCT00440531|Vaccines|vaccines|mesh-list
25051101|NCT00440531|Immunologic Factors|immunologic factors|mesh-ancestor
24787537|NCT01925755|Antithrombins|antithrombins|mesh-ancestor
25051102|NCT00440531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051103|NCT00440388|Rituximab|rituximab|mesh-list
25051104|NCT00440388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25051105|NCT00440388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051106|NCT00440388|Immunologic Factors|immunologic factors|mesh-ancestor
24812843|NCT02054949|Acetylcysteine|acetylcysteine|mesh-list
24736081|NCT01659931|Hormone Antagonists|hormone antagonists|mesh-ancestor
24736082|NCT01659931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24736083|NCT01659931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736087|NCT01659944|Metoprolol|metoprolol|mesh-list
24736105|NCT01660295|Anticoagulants|anticoagulants|mesh-ancestor
24736106|NCT01660295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24524794|NCT04321668|Hylan|hylan|mesh-list
24736108|NCT01660295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736109|NCT01660295|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24736110|NCT01660295|Dopamine Agonists|dopamine agonists|mesh-ancestor
24736111|NCT01660295|Dopamine Agents|dopamine agents|mesh-ancestor
24736112|NCT01660295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24736113|NCT01660295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736114|NCT01660295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24736115|NCT01660295|Analgesics|analgesics|mesh-ancestor
24736116|NCT01660295|Sensory System Agents|sensory system agents|mesh-ancestor
24736117|NCT01660295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24736118|NCT01660373|Tirofiban|tirofiban|mesh-list
24736119|NCT01660373|Ticagrelor|ticagrelor|mesh-list
24736120|NCT01660373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24736121|NCT01660373|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24736122|NCT01660373|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24736123|NCT01660373|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24736124|NCT01660373|Purinergic Agents|purinergic agents|mesh-ancestor
24736125|NCT01660373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24736126|NCT01660373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736127|NCT01660373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736128|NCT01660373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24736129|NCT01660373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24736130|NCT01660386|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24736133|NCT01660386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24736134|NCT01660386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736135|NCT01660386|Incretins|incretins|mesh-ancestor
24736136|NCT01660386|Hormones|hormones|mesh-ancestor
24736137|NCT01660386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24736138|NCT01660386|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24736144|NCT01660386|Immunologic Factors|immunologic factors|mesh-ancestor
24736145|NCT01660399|Docetaxel|docetaxel|mesh-list
24736146|NCT01660399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24736147|NCT01660399|Tubulin Modulators|tubulin modulators|mesh-ancestor
24736148|NCT01660399|Antimitotic Agents|antimitotic agents|mesh-ancestor
24736149|NCT01660399|Mitosis Modulators|mitosis modulators|mesh-ancestor
24736150|NCT01660399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736151|NCT01660477|Ritonavir|ritonavir|mesh-list
24736152|NCT01660477|Lopinavir|lopinavir|mesh-list
24736153|NCT01660477|Isavuconazole|isavuconazole|mesh-list
24736154|NCT01660477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24736155|NCT01660477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24736160|NCT01660477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25696118|NCT02057939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25696119|NCT02057939|Hormones|hormones|mesh-ancestor
25696120|NCT02057939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24736161|NCT01660477|Antiviral Agents|antiviral agents|mesh-ancestor
24578852|NCT00852332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578853|NCT00852332|Tubulin Modulators|tubulin modulators|mesh-ancestor
24578854|NCT00852332|Antimitotic Agents|antimitotic agents|mesh-ancestor
24578855|NCT00852332|Mitosis Modulators|mitosis modulators|mesh-ancestor
24578856|NCT00852332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578857|NCT00852332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24578913|NCT00852423|Artesunate|artesunate|mesh-list
24736162|NCT01660477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24736163|NCT01660477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24736164|NCT01660477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25051107|NCT00440388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051108|NCT00440388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25051109|NCT00439738|Amlodipine|amlodipine|mesh-list
25051110|NCT00439738|Valsartan|valsartan|mesh-list
25051111|NCT00439738|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25051112|NCT00439738|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25051113|NCT00439738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25051114|NCT00439738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25051115|NCT00439738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051125|NCT00437112|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25051126|NCT00437112|Insulin Glargine|insulin glargine|mesh-list
24736173|NCT01660594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24736174|NCT01660594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736186|NCT01660620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736187|NCT01660750|Dexamethasone|dexamethasone|mesh-list
24736188|NCT01660750|Cyclophosphamide|cyclophosphamide|mesh-list
24736189|NCT01660750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24736190|NCT01660750|Immunologic Factors|immunologic factors|mesh-ancestor
25051136|NCT00435916|Dacetuzumab|dacetuzumab|mesh-list
25051137|NCT00435916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25051138|NCT00435916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051139|NCT00434850|Gusperimus|gusperimus|mesh-list
25051140|NCT00434850|Sirolimus|sirolimus|mesh-list
25051141|NCT00434850|Etanercept|etanercept|mesh-list
25051142|NCT00434850|Tacrolimus|tacrolimus|mesh-list
25051143|NCT00434850|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25051144|NCT00434850|Basiliximab|basiliximab|mesh-list
25051145|NCT00434850|Daclizumab|daclizumab|mesh-list
25051146|NCT00434850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25051147|NCT00434850|Immunologic Factors|immunologic factors|mesh-ancestor
25051148|NCT00434850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942709|NCT03978845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24942710|NCT03978845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942728|NCT03978494|Tacrolimus|tacrolimus|mesh-list
24942735|NCT03978559|Trimethoprim|trimethoprim|mesh-list
24942737|NCT03978559|Sulfisoxazole|sulfisoxazole|mesh-list
24942738|NCT03978559|Methylprednisolone|methylprednisolone|mesh-list
24942739|NCT03978559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24942740|NCT03978559|Antiemetics|antiemetics|mesh-ancestor
24942741|NCT03978559|Autonomic Agents|autonomic agents|mesh-ancestor
24942742|NCT03978559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24942743|NCT03978559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942745|NCT03978559|Glucocorticoids|glucocorticoids|mesh-ancestor
24736195|NCT01660750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736196|NCT01660750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24736197|NCT01660750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24736198|NCT01660750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24736199|NCT01660750|Antiemetics|antiemetics|mesh-ancestor
24736200|NCT01660750|Autonomic Agents|autonomic agents|mesh-ancestor
24736201|NCT01660750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24736202|NCT01660750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24736203|NCT01660750|Glucocorticoids|glucocorticoids|mesh-ancestor
24736204|NCT01660750|Hormones|hormones|mesh-ancestor
24736205|NCT01660750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25696121|NCT02058095|Tadalafil|tadalafil|mesh-list
25696122|NCT02058095|Vasodilator Agents|vasodilator agents|mesh-ancestor
25696123|NCT02058095|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25696124|NCT02058095|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25696125|NCT02058095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25696126|NCT02058095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696127|NCT02058095|Urological Agents|urological agents|mesh-ancestor
25696128|NCT02058108|Telbivudine|telbivudine|mesh-list
24579082|NCT00853216|Analgesics|analgesics|mesh-ancestor
24736206|NCT01660750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24736207|NCT01660854|Proguanil|proguanil|mesh-list
24736208|NCT01660854|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
24736209|NCT01660854|Antimalarials|antimalarials|mesh-ancestor
24736215|NCT01660867|Dexamethasone|dexamethasone|mesh-list
24736233|NCT01660919|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24736234|NCT01660919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24736235|NCT01660945|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
24736236|NCT01660945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24736237|NCT01660945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24736238|NCT01660945|Antimetabolites|antimetabolites|mesh-ancestor
24736239|NCT01660945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736240|NCT01660945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24736241|NCT01660997|Dexamethasone|dexamethasone|mesh-list
24736242|NCT01660997|Ixazomib|ixazomib|mesh-list
24736243|NCT01660997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24736244|NCT01660997|Antiemetics|antiemetics|mesh-ancestor
24736245|NCT01660997|Autonomic Agents|autonomic agents|mesh-ancestor
24736246|NCT01660997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24736247|NCT01660997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736248|NCT01660997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24736249|NCT01660997|Glucocorticoids|glucocorticoids|mesh-ancestor
24736250|NCT01660997|Hormones|hormones|mesh-ancestor
24736251|NCT01660997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24736254|NCT01660997|Protease Inhibitors|protease inhibitors|mesh-ancestor
24736255|NCT01660997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24736256|NCT01660997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736257|NCT01661101|Omeprazole|omeprazole|mesh-list
24736263|NCT01661101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736264|NCT01661101|Antithrombins|antithrombins|mesh-ancestor
24736265|NCT01661101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24736266|NCT01661101|Protease Inhibitors|protease inhibitors|mesh-ancestor
24736267|NCT01661101|Anticoagulants|anticoagulants|mesh-ancestor
24736268|NCT01661192|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
24736270|NCT01661192|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24942748|NCT03978559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24942749|NCT03978559|Protective Agents|protective agents|mesh-ancestor
24942750|NCT03978559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24942751|NCT03978559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24942752|NCT03978559|Renal Agents|renal agents|mesh-ancestor
24942753|NCT03978559|Antimalarials|antimalarials|mesh-ancestor
24942754|NCT03978559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24942755|NCT03978559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24942756|NCT03978559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24942757|NCT03978559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24942758|NCT03978559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942759|NCT03978559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24942760|NCT03978559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24942761|NCT03978559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24953639|NCT03883204|Dopamine Agonists|dopamine agonists|mesh-ancestor
24767870|NCT01804127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767871|NCT01804127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24625780|NCT01083420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625781|NCT01083420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24625782|NCT01083420|Glucocorticoids|glucocorticoids|mesh-ancestor
24625783|NCT01083420|Hormones|hormones|mesh-ancestor
24625784|NCT01083420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24625785|NCT01083420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24625810|NCT01083784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625811|NCT01083784|GABA Agents|gaba agents|mesh-ancestor
24625812|NCT01083784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24625813|NCT01083784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625814|NCT01083784|Antimanic Agents|antimanic agents|mesh-ancestor
24625815|NCT01083784|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24625816|NCT01083784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24625817|NCT01083784|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24625818|NCT01083784|GABA Modulators|gaba modulators|mesh-ancestor
24625819|NCT01083797|Dexmedetomidine|dexmedetomidine|mesh-list
24625827|NCT01083797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24625828|NCT01083797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24625829|NCT01083797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24625830|NCT01083797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24625831|NCT01083797|Adrenergic Agents|adrenergic agents|mesh-ancestor
25696129|NCT02058108|Antiviral Agents|antiviral agents|mesh-ancestor
24579261|NCT00854139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24579262|NCT00854139|Immunologic Factors|immunologic factors|mesh-ancestor
24579263|NCT00854139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579264|NCT00854139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24579273|NCT00854139|Dermatologic Agents|dermatologic agents|mesh-ancestor
24579274|NCT00854139|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25009949|NCT04827979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579275|NCT00854178|Anesthetics|anesthetics|mesh-list
24579278|NCT00854178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579279|NCT00854178|Anesthetics, General|anesthetics, general|mesh-ancestor
24579280|NCT00854178|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24579282|NCT00854204|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24579313|NCT00854451|Amoxicillin|amoxicillin|mesh-list
24579344|NCT00854633|Lactoferrin|lactoferrin|mesh-list
24579345|NCT00854633|Talactoferrin alfa|talactoferrin alfa|mesh-list
24579346|NCT00854633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24579347|NCT00854633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579348|NCT00854646|ON 01910|on 01910|mesh-list
24625832|NCT01083797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24930728|NCT04097847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24625833|NCT01083797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625834|NCT01083875|Amlexanox|amlexanox|mesh-list
24625839|NCT01083953|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24625840|NCT01083953|Anesthetics, General|anesthetics, general|mesh-ancestor
24625841|NCT01083953|Anesthetics|anesthetics|mesh-ancestor
24625844|NCT01083966|Bevacizumab|bevacizumab|mesh-list
24942808|NCT03978052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24942809|NCT03978156|Dronabinol|dronabinol|mesh-list
24942810|NCT03978156|Hallucinogens|hallucinogens|mesh-ancestor
24942811|NCT03978156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942812|NCT03978156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24942813|NCT03978156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24942814|NCT03978156|Analgesics|analgesics|mesh-ancestor
24942815|NCT03978156|Sensory System Agents|sensory system agents|mesh-ancestor
24942816|NCT03978156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24942817|NCT03978156|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24942818|NCT03978156|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24942819|NCT03978156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24942820|NCT03978156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942821|NCT03978156|Hormones|hormones|mesh-ancestor
24942822|NCT03978156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24942823|NCT03978234|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24942824|NCT03978234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24942825|NCT03978234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24736271|NCT01661192|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24736272|NCT01661192|Protease Inhibitors|protease inhibitors|mesh-ancestor
24736273|NCT01661192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24942826|NCT03978234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24942827|NCT03978234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942843|NCT03977675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24942844|NCT03977675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24942845|NCT03977675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24736274|NCT01661192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736275|NCT01661257|Infliximab|infliximab|mesh-list
24736276|NCT01661257|Dermatologic Agents|dermatologic agents|mesh-ancestor
24736277|NCT01661257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25696130|NCT02058108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25696131|NCT02058108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25696132|NCT02058108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25696133|NCT02058108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696134|NCT02058147|Insulin|insulin|mesh-list
25696135|NCT02058147|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25696136|NCT02058147|Metformin|metformin|mesh-list
25696137|NCT02058147|Insulin Glargine|insulin glargine|mesh-list
25696138|NCT02058147|Lixisenatide|lixisenatide|mesh-list
25696139|NCT02058147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25696140|NCT02058147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696141|NCT02058160|Insulin|insulin|mesh-list
25696142|NCT02058160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25696143|NCT02058160|Metformin|metformin|mesh-list
25696144|NCT02058160|Insulin Glargine|insulin glargine|mesh-list
25696145|NCT02058160|Lixisenatide|lixisenatide|mesh-list
25696146|NCT02058160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25696147|NCT02058160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696148|NCT02058251|Oxytocin|oxytocin|mesh-list
25009995|NCT04814355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25009996|NCT04814355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25009997|NCT04814355|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25110066|NCT03120403|Narcotics|narcotics|mesh-ancestor
25110067|NCT03120403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25110068|NCT03120403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110069|NCT03120403|Analgesics|analgesics|mesh-ancestor
25110070|NCT03120403|Sensory System Agents|sensory system agents|mesh-ancestor
24736278|NCT01661257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24736279|NCT01661296|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
24736280|NCT01661296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24736281|NCT01661296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24736282|NCT01661296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24736283|NCT01661296|Schistosomicides|schistosomicides|mesh-ancestor
24736284|NCT01661296|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24736285|NCT01661296|Anthelmintics|anthelmintics|mesh-ancestor
24736286|NCT01661309|Vitamin B 12|vitamin b 12|mesh-list
24736287|NCT01661309|Vitamins|vitamins|mesh-ancestor
24736288|NCT01661309|Micronutrients|micronutrients|mesh-ancestor
24736289|NCT01661309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736290|NCT01661309|Vitamin B Complex|vitamin b complex|mesh-ancestor
24736291|NCT01661322|Aspirin|aspirin|mesh-list
24736292|NCT01661322|Clopidogrel|clopidogrel|mesh-list
24736293|NCT01661322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24736294|NCT01661322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24736295|NCT01661322|Analgesics|analgesics|mesh-ancestor
24736296|NCT01661322|Sensory System Agents|sensory system agents|mesh-ancestor
24633991|NCT01131780|Ephedrine|ephedrine|mesh-list
24736297|NCT01661322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24736298|NCT01661322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736299|NCT01661322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24736300|NCT01661322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24736301|NCT01661322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24736314|NCT01661335|Dexamethasone acetate|dexamethasone acetate|mesh-list
24736315|NCT01661335|Ondansetron|ondansetron|mesh-list
24736316|NCT01661335|Aprepitant|aprepitant|mesh-list
24736317|NCT01661335|Fosaprepitant|fosaprepitant|mesh-list
24736318|NCT01661335|BB 1101|bb 1101|mesh-list
24736319|NCT01661335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24617813|NCT01045876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942849|NCT03977792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24942850|NCT03977649|Erenumab|erenumab|mesh-list
24942851|NCT03977649|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
24942852|NCT03977649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942853|NCT03977649|Analgesics|analgesics|mesh-ancestor
24942854|NCT03977649|Sensory System Agents|sensory system agents|mesh-ancestor
24942855|NCT03977649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24617814|NCT01045889|Prednisone|prednisone|mesh-list
24617815|NCT01045889|Cyclophosphamide|cyclophosphamide|mesh-list
24617816|NCT01045889|Melphalan|melphalan|mesh-list
24617817|NCT01045889|Rituximab|rituximab|mesh-list
24617818|NCT01045889|Etoposide|etoposide|mesh-list
24617819|NCT01045889|Vincristine|vincristine|mesh-list
24617820|NCT01045889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24617821|NCT01045889|Immunologic Factors|immunologic factors|mesh-ancestor
24524992|NCT04140266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24736320|NCT01661335|Antiemetics|antiemetics|mesh-ancestor
24736321|NCT01661335|Autonomic Agents|autonomic agents|mesh-ancestor
24736322|NCT01661335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24736323|NCT01661335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736324|NCT01661335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24736325|NCT01661335|Glucocorticoids|glucocorticoids|mesh-ancestor
24736327|NCT01661335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24736328|NCT01661335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24736329|NCT01661335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25696149|NCT02058251|Oxytocics|oxytocics|mesh-ancestor
25696150|NCT02058251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25696151|NCT02058251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696152|NCT02058290|Morphine|morphine|mesh-list
25696153|NCT02058290|Bupivacaine|bupivacaine|mesh-list
25696154|NCT02058290|Anesthetics, Local|anesthetics, local|mesh-ancestor
25696155|NCT02058290|Anesthetics|anesthetics|mesh-ancestor
25696156|NCT02058290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24736330|NCT01661335|Protease Inhibitors|protease inhibitors|mesh-ancestor
24736340|NCT01661335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24736348|NCT01661439|Anticoagulants|anticoagulants|mesh-ancestor
24736369|NCT01661556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24736370|NCT01661556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579823|NCT00857987|Expectorants|expectorants|mesh-list
24736371|NCT01661556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24736372|NCT01661556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24736373|NCT01661556|Antioxidants|antioxidants|mesh-ancestor
24736374|NCT01661556|Protective Agents|protective agents|mesh-ancestor
24736375|NCT01661556|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24736376|NCT01661647|Anesthetics|anesthetics|mesh-list
24736377|NCT01661647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24736378|NCT01661647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736379|NCT01661751|Vaccines|vaccines|mesh-list
24736380|NCT01661751|Immunologic Factors|immunologic factors|mesh-ancestor
24736382|NCT01661777|Diuretics|diuretics|mesh-list
24736386|NCT01661777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736388|NCT01661777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24942856|NCT03977649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942857|NCT03977610|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
24942858|NCT03977610|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24942859|NCT03977610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767887|NCT01804218|Nadolol|nadolol|mesh-list
24942860|NCT03977493|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24942861|NCT03977493|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24942862|NCT03977493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24942863|NCT03977493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942864|NCT03977493|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24942865|NCT03977493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24942866|NCT03977493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736389|NCT01661777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736390|NCT01661855|Riluzole|riluzole|mesh-list
24736391|NCT01661855|Anticonvulsants|anticonvulsants|mesh-ancestor
24736392|NCT01661855|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24736393|NCT01661855|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24736394|NCT01661855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24736399|NCT01661868|Olaparib|olaparib|mesh-list
24736400|NCT01661868|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24736401|NCT01661868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24736402|NCT01661868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736403|NCT01661868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24736404|NCT01661985|Azithromycin|azithromycin|mesh-list
24736405|NCT01661985|Doxycycline|doxycycline|mesh-list
24736406|NCT01661985|Lymecycline|lymecycline|mesh-list
24736445|NCT01662193|Calcium, Dietary|calcium, dietary|mesh-list
24736446|NCT01662193|Vitamin D|vitamin d|mesh-list
24736447|NCT01662193|Ergocalciferols|ergocalciferols|mesh-list
24736448|NCT01662193|Cholecalciferol|cholecalciferol|mesh-list
24736449|NCT01662193|Vitamins|vitamins|mesh-list
24736450|NCT01662193|Calcium Carbonate|calcium carbonate|mesh-list
24736451|NCT01662193|Calcium|calcium|mesh-list
24736452|NCT01662193|Micronutrients|micronutrients|mesh-ancestor
24736453|NCT01662193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736454|NCT01662193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24736455|NCT01662193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24736456|NCT01662193|Antacids|antacids|mesh-ancestor
24736457|NCT01662193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736458|NCT01662193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24736459|NCT01662349|Anti-Infective Agents|anti-infective agents|mesh-list
24736460|NCT01662349|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24736461|NCT01662401|Bupivacaine|bupivacaine|mesh-list
24736462|NCT01662401|Anesthetics, Local|anesthetics, local|mesh-ancestor
24736481|NCT01662466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24736482|NCT01662466|Immunologic Factors|immunologic factors|mesh-ancestor
24736483|NCT01662518|Dexamethasone|dexamethasone|mesh-list
24736484|NCT01662518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24736485|NCT01662518|Antiemetics|antiemetics|mesh-ancestor
24736486|NCT01662518|Autonomic Agents|autonomic agents|mesh-ancestor
24736487|NCT01662518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24736488|NCT01662518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736489|NCT01662518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24736490|NCT01662518|Glucocorticoids|glucocorticoids|mesh-ancestor
24942867|NCT03977493|Cholinergic Agents|cholinergic agents|mesh-ancestor
24942868|NCT03977493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24942869|NCT03977441|Pramipexole|pramipexole|mesh-list
24942870|NCT03977441|S 20098|s 20098|mesh-list
24942871|NCT03977441|Antioxidants|antioxidants|mesh-ancestor
24942872|NCT03977441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942873|NCT03977441|Protective Agents|protective agents|mesh-ancestor
24942874|NCT03977441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580061|NCT00859885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580062|NCT00859885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24580063|NCT00859885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24580064|NCT00859885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24580065|NCT00859885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24580120|NCT00860366|Uric Acid|uric acid|mesh-list
24942875|NCT03977441|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24942876|NCT03977441|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24942877|NCT03977441|Dopamine Agonists|dopamine agonists|mesh-ancestor
24942878|NCT03977441|Dopamine Agents|dopamine agents|mesh-ancestor
24942879|NCT03977441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24942880|NCT03977441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24847285|NCT02245932|Protective Agents|protective agents|mesh-ancestor
24942881|NCT03977441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24958842|NCT03829566|Hormones|hormones|mesh-ancestor
24942882|NCT03977298|Chlorhexidine|chlorhexidine|mesh-list
24942883|NCT03977298|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24942884|NCT03977298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24942885|NCT03977298|Disinfectants|disinfectants|mesh-ancestor
24942886|NCT03977220|Paclitaxel|paclitaxel|mesh-list
24942887|NCT03977220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24942888|NCT03977220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942889|NCT03977220|Tubulin Modulators|tubulin modulators|mesh-ancestor
24942890|NCT03977220|Antimitotic Agents|antimitotic agents|mesh-ancestor
24942891|NCT03977220|Mitosis Modulators|mitosis modulators|mesh-ancestor
24942892|NCT03977220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942893|NCT03977324|Chlorhexidine|chlorhexidine|mesh-list
24942894|NCT03977324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24942895|NCT03977324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24942896|NCT03977324|Disinfectants|disinfectants|mesh-ancestor
24942897|NCT03977285|Chlorhexidine|chlorhexidine|mesh-list
24942898|NCT03977285|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24942899|NCT03977285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24942900|NCT03977285|Disinfectants|disinfectants|mesh-ancestor
24958898|NCT03829150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24736500|NCT01662622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24736501|NCT01662622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942902|NCT03977012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24942903|NCT03977012|Narcotics|narcotics|mesh-ancestor
24942904|NCT03977012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24942905|NCT03977012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942906|NCT03977012|Analgesics|analgesics|mesh-ancestor
24942907|NCT03977012|Sensory System Agents|sensory system agents|mesh-ancestor
24942908|NCT03977012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24942909|NCT03977012|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24942910|NCT03976713|Bromides|bromides|mesh-list
24942911|NCT03976713|Tiotropium Bromide|tiotropium bromide|mesh-list
24942912|NCT03976713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24942913|NCT03976713|Autonomic Agents|autonomic agents|mesh-ancestor
24942914|NCT03976713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24942915|NCT03976713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942916|NCT03976713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24942917|NCT03976713|Respiratory System Agents|respiratory system agents|mesh-ancestor
24942918|NCT03976713|Parasympatholytics|parasympatholytics|mesh-ancestor
24942919|NCT03976713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24942920|NCT03976713|Cholinergic Agents|cholinergic agents|mesh-ancestor
24942922|NCT03976713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942923|NCT03976713|Anticonvulsants|anticonvulsants|mesh-ancestor
24942924|NCT03976518|Atezolizumab|atezolizumab|mesh-list
24942925|NCT03976518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942926|NCT03976544|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24942927|NCT03976544|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24942928|NCT03976544|Estradiol|estradiol|mesh-list
24942929|NCT03976544|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24942930|NCT03976544|Progesterone|progesterone|mesh-list
24942931|NCT03976544|Estrogens|estrogens|mesh-ancestor
24942932|NCT03976544|Hormones|hormones|mesh-ancestor
24767953|NCT01804413|Insulin|insulin|mesh-list
24942933|NCT03976544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25696157|NCT02058290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696158|NCT02058290|Sensory System Agents|sensory system agents|mesh-ancestor
25696159|NCT02058290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25696160|NCT02058290|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25696161|NCT02058290|Narcotics|narcotics|mesh-ancestor
25696162|NCT02058290|Analgesics|analgesics|mesh-ancestor
25696163|NCT02058368|Tamsulosin|tamsulosin|mesh-list
24580354|NCT00861419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580355|NCT00861419|Vitamin B Complex|vitamin b complex|mesh-ancestor
24942957|NCT03976037|Misoprostol|misoprostol|mesh-list
24942958|NCT03976037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24942959|NCT03976037|Abortifacient Agents|abortifacient agents|mesh-ancestor
24942960|NCT03976037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24942961|NCT03976037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942962|NCT03976037|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25051149|NCT00434850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24958887|NCT03829124|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24958888|NCT03829124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24958889|NCT03829124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24958890|NCT03829124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24958891|NCT03829124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958892|NCT03829150|Amoxicillin|amoxicillin|mesh-list
24958893|NCT03829150|Metronidazole|metronidazole|mesh-list
24958894|NCT03829150|Clarithromycin|clarithromycin|mesh-list
24958895|NCT03829150|Dexlansoprazole|dexlansoprazole|mesh-list
24958896|NCT03829150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24958897|NCT03829150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25051150|NCT00434850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051151|NCT00434850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051152|NCT00434850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25051153|NCT00434850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25051154|NCT00434850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24736503|NCT01662674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24736504|NCT01662674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736538|NCT01662869|Leucovorin|leucovorin|mesh-list
25051170|NCT00434811|Tacrolimus|tacrolimus|mesh-list
25051171|NCT00434811|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25051172|NCT00434811|Basiliximab|basiliximab|mesh-list
25051173|NCT00434811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25051174|NCT00434811|Immunologic Factors|immunologic factors|mesh-ancestor
25051175|NCT00434811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051176|NCT00434811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25051177|NCT00434811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051178|NCT00434811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051179|NCT00434811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25051180|NCT00434811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25051181|NCT00434811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24736545|NCT01662869|Protective Agents|protective agents|mesh-ancestor
24736548|NCT01662869|Vitamins|vitamins|mesh-ancestor
24847313|NCT02246049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24736549|NCT01662869|Micronutrients|micronutrients|mesh-ancestor
24736550|NCT01662869|Hematinics|hematinics|mesh-ancestor
24736551|NCT01662869|Antimetabolites|antimetabolites|mesh-ancestor
24736552|NCT01662869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736553|NCT01662869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24736554|NCT01662869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24736555|NCT01662869|Immunologic Factors|immunologic factors|mesh-ancestor
24736556|NCT01662921|Insulin|insulin|mesh-list
24736557|NCT01662921|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24736558|NCT01662921|Insulin Lispro|insulin lispro|mesh-list
24736559|NCT01662921|Insulin glulisine|insulin glulisine|mesh-list
24736560|NCT01662921|Isophane Insulin, Human|isophane insulin, human|mesh-list
24736561|NCT01662921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24958900|NCT03829150|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24958901|NCT03829150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24958902|NCT03829150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958903|NCT03829150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24958904|NCT03829150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24958905|NCT03829150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24736577|NCT01663038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24736578|NCT01663038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24942973|NCT03975374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942974|NCT03975374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24942975|NCT03975374|Glucocorticoids|glucocorticoids|mesh-ancestor
24942976|NCT03975374|Hormones|hormones|mesh-ancestor
24942977|NCT03975374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24942978|NCT03975374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24942979|NCT03975374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942980|NCT03975374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25696164|NCT02058368|Dutasteride|dutasteride|mesh-list
25696165|NCT02058368|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24942981|NCT03975374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24942982|NCT03975374|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24942983|NCT03975283|Bupivacaine|bupivacaine|mesh-list
24942984|NCT03975283|Anesthetics, Local|anesthetics, local|mesh-ancestor
24942985|NCT03975283|Anesthetics|anesthetics|mesh-ancestor
24942986|NCT03975283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24942987|NCT03975283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942988|NCT03975283|Sensory System Agents|sensory system agents|mesh-ancestor
24942989|NCT03975283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24942991|NCT03975270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24942992|NCT03975270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942993|NCT03975270|Tubulin Modulators|tubulin modulators|mesh-ancestor
24942994|NCT03975270|Antimitotic Agents|antimitotic agents|mesh-ancestor
24942995|NCT03975270|Mitosis Modulators|mitosis modulators|mesh-ancestor
24942996|NCT03975270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942997|NCT03975114|Durvalumab|durvalumab|mesh-list
24942998|NCT03975114|Tremelimumab|tremelimumab|mesh-list
24942999|NCT03975114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24943000|NCT03975114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943001|NCT03975088|Ranibizumab|ranibizumab|mesh-list
24625177|NCT01080742|Bisoprolol|bisoprolol|mesh-list
24736593|NCT01663077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24943032|NCT03975205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24943033|NCT03975205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943034|NCT03975205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24943035|NCT03975205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24943036|NCT03975205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24943037|NCT03975205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943039|NCT03975036|Immunologic Factors|immunologic factors|mesh-ancestor
24943040|NCT03975036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943041|NCT03975010|Naltrexone|naltrexone|mesh-list
24943042|NCT03975010|Buprenorphine|buprenorphine|mesh-list
24943043|NCT03975010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24943044|NCT03975010|Narcotics|narcotics|mesh-ancestor
24943045|NCT03975010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24943046|NCT03975010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943048|NCT03975010|Sensory System Agents|sensory system agents|mesh-ancestor
24943049|NCT03975010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24943050|NCT03975010|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24943051|NCT03975010|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24943052|NCT03975062|Dabigatran|dabigatran|mesh-list
24943053|NCT03975062|Antithrombins|antithrombins|mesh-ancestor
24943054|NCT03975062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24943055|NCT03975062|Protease Inhibitors|protease inhibitors|mesh-ancestor
24943056|NCT03975062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24943057|NCT03975062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943058|NCT03975062|Anticoagulants|anticoagulants|mesh-ancestor
24943059|NCT03974984|Anesthetics|anesthetics|mesh-list
25069520|NCT03425747|Antacids|antacids|mesh-ancestor
24943060|NCT03974984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24943063|NCT03974789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24943065|NCT03974789|Autonomic Agents|autonomic agents|mesh-ancestor
24943066|NCT03974789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24943073|NCT03974789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943074|NCT03974932|Acetaminophen|acetaminophen|mesh-list
24943075|NCT03974932|Ibuprofen|ibuprofen|mesh-list
24943076|NCT03974932|Celecoxib|celecoxib|mesh-list
24943077|NCT03974932|Bupivacaine|bupivacaine|mesh-list
24943078|NCT03974932|Anesthetics, Local|anesthetics, local|mesh-ancestor
24943079|NCT03974932|Anesthetics|anesthetics|mesh-ancestor
24943080|NCT03974932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24943081|NCT03974932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943082|NCT03974932|Sensory System Agents|sensory system agents|mesh-ancestor
24943083|NCT03974932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24943084|NCT03974932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24768144|NCT01805856|Cefazolin|cefazolin|mesh-list
24736579|NCT01663038|Antipyretics|antipyretics|mesh-ancestor
24736580|NCT01663038|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24736581|NCT01663038|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24736582|NCT01663038|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24736583|NCT01663038|Purinergic Agents|purinergic agents|mesh-ancestor
24736584|NCT01663038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25010123|NCT04623567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010126|NCT04617821|Gemcitabine|gemcitabine|mesh-list
24736585|NCT01663077|Clozapine|clozapine|mesh-list
24736586|NCT01663077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24736587|NCT01663077|Serotonin Agents|serotonin agents|mesh-ancestor
24736588|NCT01663077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24736589|NCT01663077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736590|NCT01663077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736591|NCT01663077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24736592|NCT01663077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24932865|NCT04075955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24525379|NCT03593655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24525380|NCT03593655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24525381|NCT03593655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24525382|NCT03593655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525386|NCT03562871|Carboplatin|carboplatin|mesh-list
24736606|NCT01663441|Oprelvekin|oprelvekin|mesh-list
24736607|NCT01663441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24736608|NCT01663558|Imiquimod|imiquimod|mesh-list
24736609|NCT01663558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24736610|NCT01663558|Immunologic Factors|immunologic factors|mesh-ancestor
24736611|NCT01663558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736612|NCT01663558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24736613|NCT01663558|Interferon Inducers|interferon inducers|mesh-ancestor
24736614|NCT01663662|Tolvaptan|tolvaptan|mesh-list
24736615|NCT01663662|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24736616|NCT01663662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736617|NCT01663662|Natriuretic Agents|natriuretic agents|mesh-ancestor
24736622|NCT01663805|Everolimus|everolimus|mesh-list
24736623|NCT01663805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24736624|NCT01663805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24736625|NCT01663805|Immunologic Factors|immunologic factors|mesh-ancestor
24736626|NCT01663805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736627|NCT01663961|Digoxin|digoxin|mesh-list
24736628|NCT01663961|Mirabegron|mirabegron|mesh-list
24736629|NCT01663961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24736630|NCT01663961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24736631|NCT01663961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24736635|NCT01663961|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24943086|NCT03974932|Antipyretics|antipyretics|mesh-ancestor
24943105|NCT03974685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24943106|NCT03974685|Vasodilator Agents|vasodilator agents|mesh-ancestor
24943107|NCT03974685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943108|NCT03974867|Prednisone|prednisone|mesh-list
24943109|NCT03974867|Methylprednisolone|methylprednisolone|mesh-list
24943110|NCT03974867|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24943111|NCT03974867|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24943112|NCT03974867|Prednisolone|prednisolone|mesh-list
24943113|NCT03974867|Prednisolone acetate|prednisolone acetate|mesh-list
24943114|NCT03974867|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24943115|NCT03974867|Prednisolone phosphate|prednisolone phosphate|mesh-list
24943116|NCT03974867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24943117|NCT03974867|Glucocorticoids|glucocorticoids|mesh-ancestor
24943118|NCT03974867|Hormones|hormones|mesh-ancestor
24943119|NCT03974867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24943120|NCT03974867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736636|NCT01663961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24736637|NCT01663961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24736638|NCT01663961|Adrenergic Agents|adrenergic agents|mesh-ancestor
24736639|NCT01663961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24736640|NCT01663961|Urological Agents|urological agents|mesh-ancestor
25696166|NCT02058368|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24736642|NCT01664013|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24736644|NCT01664013|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24736663|NCT01664260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24736664|NCT01664260|Expectorants|expectorants|mesh-ancestor
24736665|NCT01664260|Respiratory System Agents|respiratory system agents|mesh-ancestor
24736666|NCT01664260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24736667|NCT01664260|Antioxidants|antioxidants|mesh-ancestor
24736668|NCT01664260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736669|NCT01664260|Protective Agents|protective agents|mesh-ancestor
24736670|NCT01664260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736671|NCT01664260|Antidotes|antidotes|mesh-ancestor
24736672|NCT01664520|Dexmedetomidine|dexmedetomidine|mesh-list
24736673|NCT01664520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24736674|NCT01664520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24736675|NCT01664520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736676|NCT01664520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24736677|NCT01664520|Analgesics|analgesics|mesh-ancestor
24736678|NCT01664520|Sensory System Agents|sensory system agents|mesh-ancestor
24736679|NCT01664520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24736680|NCT01664520|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24736681|NCT01664520|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24736682|NCT01664520|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24736683|NCT01664520|Adrenergic Agents|adrenergic agents|mesh-ancestor
24736684|NCT01664520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24736685|NCT01664520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736687|NCT01664650|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24736688|NCT01664650|Protective Agents|protective agents|mesh-ancestor
24736689|NCT01664650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943121|NCT03974867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24943122|NCT03974867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943123|NCT03974867|Antiemetics|antiemetics|mesh-ancestor
24943124|NCT03974867|Autonomic Agents|autonomic agents|mesh-ancestor
24943125|NCT03974867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24943126|NCT03974867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24943127|NCT03974867|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24943128|NCT03974867|Protective Agents|protective agents|mesh-ancestor
24943129|NCT03974360|Erenumab|erenumab|mesh-list
24943130|NCT03974360|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
24943131|NCT03974360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943132|NCT03974360|Analgesics|analgesics|mesh-ancestor
24943133|NCT03974360|Sensory System Agents|sensory system agents|mesh-ancestor
24943134|NCT03974360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24943135|NCT03974360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943136|NCT03974425|Aflibercept|aflibercept|mesh-list
24943137|NCT03974425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24943138|NCT03974425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24800471|NCT01975805|Chlorhexidine|chlorhexidine|mesh-list
24943139|NCT03974425|Growth Substances|growth substances|mesh-ancestor
24943140|NCT03974425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943141|NCT03974425|Growth Inhibitors|growth inhibitors|mesh-ancestor
24943142|NCT03974425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768221|NCT01806415|Imidazole|imidazole|mesh-list
24943143|NCT03973840|Methyltestosterone|methyltestosterone|mesh-list
24943144|NCT03973840|Testosterone|testosterone|mesh-list
24943145|NCT03973840|Testosterone undecanoate|testosterone undecanoate|mesh-list
24943146|NCT03973840|Testosterone enanthate|testosterone enanthate|mesh-list
24943147|NCT03973840|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24943148|NCT03973840|Androgens|androgens|mesh-ancestor
24943149|NCT03973840|Hormones|hormones|mesh-ancestor
24856458|NCT02284490|Pemetrexed|pemetrexed|mesh-list
24856467|NCT02284503|Antimetabolites|antimetabolites|mesh-ancestor
24943151|NCT03973840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943152|NCT03973840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24943153|NCT03973840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943154|NCT03973840|Anabolic Agents|anabolic agents|mesh-ancestor
24943155|NCT03973775|Permethrin|permethrin|mesh-list
24943156|NCT03973775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24736708|NCT01664728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24736709|NCT01664728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24736710|NCT01664728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736711|NCT01664728|Hormone Antagonists|hormone antagonists|mesh-ancestor
24736712|NCT01664728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24736713|NCT01664728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736714|NCT01664728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24736715|NCT01664728|Hormones|hormones|mesh-ancestor
24736716|NCT01664754|Carboplatin|carboplatin|mesh-list
24736717|NCT01664754|Pemetrexed|pemetrexed|mesh-list
24736731|NCT01664819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736739|NCT01664845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736740|NCT01664845|Antiviral Agents|antiviral agents|mesh-ancestor
24736741|NCT01664845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24736742|NCT01664871|Fluorides|fluorides|mesh-list
24736743|NCT01664871|Cariostatic Agents|cariostatic agents|mesh-ancestor
24736744|NCT01664871|Protective Agents|protective agents|mesh-ancestor
24736745|NCT01664871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736746|NCT01664936|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25004603|NCT02726659|Analgesics|analgesics|mesh-ancestor
24736747|NCT01664936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24736748|NCT01664936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736749|NCT01665066|Nicotine|nicotine|mesh-list
24736750|NCT01665066|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24736751|NCT01665066|Autonomic Agents|autonomic agents|mesh-ancestor
24736752|NCT01665066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24736753|NCT01665066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736754|NCT01665066|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24736755|NCT01665066|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24736756|NCT01665066|Cholinergic Agents|cholinergic agents|mesh-ancestor
24736757|NCT01665066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24736758|NCT01665066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736759|NCT01665079|Propofol|propofol|mesh-list
24736760|NCT01665079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24736761|NCT01665079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24736762|NCT01665079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736763|NCT01665079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24736764|NCT01665079|Anesthetics, General|anesthetics, general|mesh-ancestor
24736765|NCT01665079|Anesthetics|anesthetics|mesh-ancestor
24736766|NCT01665196|Deoxyglucose|deoxyglucose|mesh-list
24736767|NCT01665196|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24736768|NCT01665196|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24736769|NCT01665196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736770|NCT01665196|Antimetabolites|antimetabolites|mesh-ancestor
24736781|NCT01665222|Morphine|morphine|mesh-list
24959083|NCT03827070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24959084|NCT03827070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24959085|NCT03827070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24959086|NCT03827070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959087|NCT03827122|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24959088|NCT03827122|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24959089|NCT03827122|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24959090|NCT03827122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24959091|NCT03827122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617857|NCT01045902|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24617858|NCT01045902|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24617876|NCT01045941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24617877|NCT01045941|Antimetabolites|antimetabolites|mesh-ancestor
24617878|NCT01045941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736784|NCT01665222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24736785|NCT01665222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736787|NCT01665222|Sensory System Agents|sensory system agents|mesh-ancestor
24736788|NCT01665222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24736789|NCT01665235|Aspirin|aspirin|mesh-list
24736790|NCT01665235|Amlodipine|amlodipine|mesh-list
24736791|NCT01665235|Clopidogrel|clopidogrel|mesh-list
24736792|NCT01665235|Atorvastatin|atorvastatin|mesh-list
24736793|NCT01665235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24736794|NCT01665235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24736795|NCT01665235|Analgesics|analgesics|mesh-ancestor
24736796|NCT01665235|Sensory System Agents|sensory system agents|mesh-ancestor
24943228|NCT03973411|Serotonin Agents|serotonin agents|mesh-ancestor
24959093|NCT03827122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24959094|NCT03827122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943162|NCT03973957|Narcotics|narcotics|mesh-ancestor
24943163|NCT03973957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24581572|NCT00865501|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24581573|NCT00865501|Hormone Antagonists|hormone antagonists|mesh-ancestor
24581574|NCT00865501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24581575|NCT00865501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581576|NCT00865501|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24581602|NCT00865540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24581604|NCT00865540|Analgesics|analgesics|mesh-ancestor
24581663|NCT00865696|Antidepressive Agents|antidepressive agents|mesh-ancestor
24581664|NCT00865696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24581665|NCT00865696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24581666|NCT00865696|Histamine Antagonists|histamine antagonists|mesh-ancestor
24976045|NCT01842035|Regadenoson|regadenoson|mesh-list
24943164|NCT03973957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943165|NCT03973957|Analgesics|analgesics|mesh-ancestor
24736821|NCT01665235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24736822|NCT01665235|Vasodilator Agents|vasodilator agents|mesh-ancestor
24736824|NCT01665248|Fluorides|fluorides|mesh-list
24736825|NCT01665248|Sodium Fluoride|sodium fluoride|mesh-list
24736826|NCT01665248|Cariostatic Agents|cariostatic agents|mesh-ancestor
24736827|NCT01665248|Protective Agents|protective agents|mesh-ancestor
24736828|NCT01665248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736829|NCT01665248|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24736830|NCT01665248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24736831|NCT01665274|Capecitabine|capecitabine|mesh-list
24736832|NCT01665274|Oxaliplatin|oxaliplatin|mesh-list
24736833|NCT01665274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24736834|NCT01665274|Antimetabolites|antimetabolites|mesh-ancestor
24736836|NCT01665274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24736838|NCT01665378|Vitamin B Complex|vitamin b complex|mesh-list
24736839|NCT01665378|Micronutrients|micronutrients|mesh-list
24736840|NCT01665378|Trace Elements|trace elements|mesh-list
24736841|NCT01665378|Hematinics|hematinics|mesh-ancestor
24736842|NCT01665378|Vitamins|vitamins|mesh-ancestor
24736843|NCT01665378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736844|NCT01665404|Fluvoxamine|fluvoxamine|mesh-list
24736845|NCT01665404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24736846|NCT01665404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24736847|NCT01665404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24736848|NCT01665404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736849|NCT01665404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24736854|NCT01665404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24736861|NCT01665404|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24736862|NCT01665417|Docetaxel|docetaxel|mesh-list
24736863|NCT01665417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24736864|NCT01665417|Tubulin Modulators|tubulin modulators|mesh-ancestor
24736865|NCT01665417|Antimitotic Agents|antimitotic agents|mesh-ancestor
24736866|NCT01665417|Mitosis Modulators|mitosis modulators|mesh-ancestor
24736867|NCT01665417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736868|NCT01665469|Lycopene|lycopene|mesh-list
24736869|NCT01665469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24736870|NCT01665469|Antioxidants|antioxidants|mesh-ancestor
24736871|NCT01665469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736872|NCT01665469|Protective Agents|protective agents|mesh-ancestor
24736873|NCT01665469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736874|NCT01665469|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24736875|NCT01665469|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24736876|NCT01665469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24736877|NCT01664507|Epinephrine|epinephrine|mesh-list
24736878|NCT01664507|Racepinephrine|racepinephrine|mesh-list
24736879|NCT01664507|Epinephryl borate|epinephryl borate|mesh-list
24736880|NCT01664507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25696167|NCT02058368|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25696168|NCT02058368|Adrenergic Agents|adrenergic agents|mesh-ancestor
25696169|NCT02058368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25696170|NCT02058368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696171|NCT02058368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696172|NCT02058368|Urological Agents|urological agents|mesh-ancestor
25696173|NCT02058368|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25696174|NCT02058368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25696175|NCT02058368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25696176|NCT02058368|Hormone Antagonists|hormone antagonists|mesh-ancestor
25696177|NCT02058368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25696178|NCT02058511|Anesthetics|anesthetics|mesh-list
24736881|NCT01664507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24736882|NCT01664507|Adrenergic Agents|adrenergic agents|mesh-ancestor
24736883|NCT01664507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24943166|NCT03973957|Sensory System Agents|sensory system agents|mesh-ancestor
24943167|NCT03973957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24943168|NCT03973957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24943169|NCT03973957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24943170|NCT03973957|Anesthetics, General|anesthetics, general|mesh-ancestor
24943171|NCT03973957|Anesthetics|anesthetics|mesh-ancestor
24943172|NCT03974035|Ropivacaine|ropivacaine|mesh-list
25051195|NCT00434226|Sunitinib|sunitinib|mesh-list
24736890|NCT01664507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24736891|NCT01664507|Respiratory System Agents|respiratory system agents|mesh-ancestor
24736892|NCT01664507|Mydriatics|mydriatics|mesh-ancestor
24736893|NCT01664507|Sympathomimetics|sympathomimetics|mesh-ancestor
25051200|NCT00434226|Mitosis Modulators|mitosis modulators|mesh-ancestor
25051201|NCT00434226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051202|NCT00434226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24943178|NCT03974035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24943193|NCT03973567|Norepinephrine|norepinephrine|mesh-list
24943194|NCT03973567|Antidepressive Agents|antidepressive agents|mesh-list
24943195|NCT03973567|Serotonin|serotonin|mesh-list
24847487|NCT02247362|Immunologic Factors|immunologic factors|mesh-ancestor
24943196|NCT03973567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
24943197|NCT03973567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24943198|NCT03973567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24943199|NCT03973567|Serotonin Agents|serotonin agents|mesh-ancestor
24943200|NCT03973567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24943201|NCT03973567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943202|NCT03973567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943203|NCT03973567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24943204|NCT03973567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24943205|NCT03973567|Adrenergic Agents|adrenergic agents|mesh-ancestor
24736894|NCT01664507|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24736895|NCT01665586|Dexmedetomidine|dexmedetomidine|mesh-list
24736896|NCT01665586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24736897|NCT01665586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24736898|NCT01665586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736899|NCT01665586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24736930|NCT01665703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736931|NCT01665742|Tocopherols|tocopherols|mesh-list
24943206|NCT03973567|Sympathomimetics|sympathomimetics|mesh-ancestor
24943207|NCT03973567|Autonomic Agents|autonomic agents|mesh-ancestor
24943211|NCT03973567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24943213|NCT03973138|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24943214|NCT03973138|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24943215|NCT03973138|Growth Substances|growth substances|mesh-ancestor
24943216|NCT03973138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943217|NCT03973138|Growth Inhibitors|growth inhibitors|mesh-ancestor
24943218|NCT03973138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943219|NCT03973411|Ondansetron|ondansetron|mesh-list
24943220|NCT03973411|Antiemetics|antiemetics|mesh-ancestor
24736933|NCT01665742|alpha-Tocopherol|alpha-tocopherol|mesh-list
24736934|NCT01665742|Lycopene|lycopene|mesh-list
24736935|NCT01665742|Vitamins|vitamins|mesh-ancestor
24736936|NCT01665742|Micronutrients|micronutrients|mesh-ancestor
24736937|NCT01665742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736939|NCT01665742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736940|NCT01665742|Protective Agents|protective agents|mesh-ancestor
24736941|NCT01665742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24736942|NCT01665742|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24736943|NCT01665742|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24736944|NCT01665742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24736945|NCT01665781|Epoetin Alfa|epoetin alfa|mesh-list
24736946|NCT01665781|Hematinics|hematinics|mesh-ancestor
24736947|NCT01665846|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24736948|NCT01665846|Hematinics|hematinics|mesh-ancestor
24736949|NCT01665846|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24736950|NCT01665846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24736951|NCT01666041|Fenofibrate|fenofibrate|mesh-list
24736952|NCT01666041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24736953|NCT01666041|Antimetabolites|antimetabolites|mesh-ancestor
24736954|NCT01666041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581927|NCT00866684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581928|NCT00866684|Antifungal Agents|antifungal agents|mesh-ancestor
24581929|NCT00866684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24581930|NCT00866684|Dermatologic Agents|dermatologic agents|mesh-ancestor
24581931|NCT00866684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24581932|NCT00866684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24581933|NCT00866684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24581934|NCT00866684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24635582|NCT01140399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24736955|NCT01666041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24736956|NCT01666067|Simvastatin|simvastatin|mesh-list
24736994|NCT01666236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24736995|NCT01666236|Growth Substances|growth substances|mesh-ancestor
24736996|NCT01666236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736997|NCT01666236|Growth Inhibitors|growth inhibitors|mesh-ancestor
24736998|NCT01666236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24736999|NCT01666236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24737000|NCT01666236|Glucocorticoids|glucocorticoids|mesh-ancestor
24943221|NCT03973411|Autonomic Agents|autonomic agents|mesh-ancestor
24943222|NCT03973411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24943223|NCT03973411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943224|NCT03973411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24943225|NCT03973411|Antipruritics|antipruritics|mesh-ancestor
24943226|NCT03973411|Dermatologic Agents|dermatologic agents|mesh-ancestor
24943227|NCT03973411|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24943229|NCT03973411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24943230|NCT03973411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943231|NCT03973411|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24943232|NCT03973411|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24943233|NCT03973411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24943234|NCT03973411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24943235|NCT03973411|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24943237|NCT03973203|Nicotinic Acids|nicotinic acids|mesh-list
24943238|NCT03973203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24943239|NCT03973203|Antimetabolites|antimetabolites|mesh-ancestor
24943240|NCT03973203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943241|NCT03973203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24943242|NCT03973203|Vasodilator Agents|vasodilator agents|mesh-ancestor
24943243|NCT03973203|Vitamin B Complex|vitamin b complex|mesh-ancestor
24943245|NCT03973203|Micronutrients|micronutrients|mesh-ancestor
24943246|NCT03973203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943247|NCT03973086|Cardiac Glycosides|cardiac glycosides|mesh-list
24943248|NCT03973086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24943249|NCT03973086|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24943250|NCT03973086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24943251|NCT03973086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943252|NCT03973086|Protective Agents|protective agents|mesh-ancestor
24943253|NCT03973086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943254|NCT03972748|Itraconazole|itraconazole|mesh-list
24943255|NCT03972748|Antifungal Agents|antifungal agents|mesh-ancestor
24943256|NCT03972748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24737001|NCT01666236|Hormones|hormones|mesh-ancestor
24737002|NCT01666236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24737003|NCT01666236|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24737004|NCT01666236|Dermatologic Agents|dermatologic agents|mesh-ancestor
24943257|NCT03972748|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24943258|NCT03972748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24943262|NCT03972748|Hormone Antagonists|hormone antagonists|mesh-ancestor
24943263|NCT03972748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25696179|NCT02058511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25696180|NCT02058511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696181|NCT02058628|Clindamycin|clindamycin|mesh-list
25696182|NCT02058628|Clindamycin palmitate|clindamycin palmitate|mesh-list
25696183|NCT02058628|Clindamycin phosphate|clindamycin phosphate|mesh-list
25696184|NCT02058628|Azelaic acid|azelaic acid|mesh-list
25696185|NCT02058628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25696186|NCT02058628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25696187|NCT02058628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25696188|NCT02058628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24793253|NCT03690011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793254|NCT03690011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010209|NCT04530305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943264|NCT03972748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943265|NCT03972748|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24943266|NCT03972982|Insulin|insulin|mesh-list
24943267|NCT03972982|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24943268|NCT03972982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24943269|NCT03972982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943270|NCT03973047|Ondansetron|ondansetron|mesh-list
24943271|NCT03973047|Antiemetics|antiemetics|mesh-ancestor
24959169|NCT03826602|Metformin|metformin|mesh-list
24943272|NCT03973047|Autonomic Agents|autonomic agents|mesh-ancestor
24943273|NCT03973047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24943274|NCT03973047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856629|NCT02285751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737005|NCT01666249|Immunoglobulins|immunoglobulins|mesh-list
24737006|NCT01666249|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24737007|NCT01666249|Antibodies|antibodies|mesh-list
24737008|NCT01666249|Immunologic Factors|immunologic factors|mesh-ancestor
24737009|NCT01666249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737010|NCT01666262|Vaccines|vaccines|mesh-list
24737011|NCT01666262|Immunologic Factors|immunologic factors|mesh-ancestor
24737016|NCT01666353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24737017|NCT01666353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737018|NCT01666379|Fentanyl|fentanyl|mesh-list
24737019|NCT01666379|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24737020|NCT01666379|Narcotics|narcotics|mesh-ancestor
24737021|NCT01666379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24737022|NCT01666379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737023|NCT01666379|Analgesics|analgesics|mesh-ancestor
24737024|NCT01666379|Sensory System Agents|sensory system agents|mesh-ancestor
24737025|NCT01666379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737026|NCT01666379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24737027|NCT01666379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24737028|NCT01666379|Anesthetics, General|anesthetics, general|mesh-ancestor
24737029|NCT01666379|Anesthetics|anesthetics|mesh-ancestor
24737030|NCT01666418|Paclitaxel|paclitaxel|mesh-list
24737031|NCT01666418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24737032|NCT01666418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737033|NCT01666418|Tubulin Modulators|tubulin modulators|mesh-ancestor
24737034|NCT01666418|Antimitotic Agents|antimitotic agents|mesh-ancestor
24737035|NCT01666418|Mitosis Modulators|mitosis modulators|mesh-ancestor
24737036|NCT01666418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24669298|NCT04116112|Sympathomimetics|sympathomimetics|mesh-ancestor
24669299|NCT04116112|Autonomic Agents|autonomic agents|mesh-ancestor
24669370|NCT04058717|Nicotine|nicotine|mesh-list
24669371|NCT04058717|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24669372|NCT04058717|Autonomic Agents|autonomic agents|mesh-ancestor
24669373|NCT04058717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737037|NCT01666431|Lapatinib|lapatinib|mesh-list
24737038|NCT01666431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737039|NCT01666431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24737040|NCT01666431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737041|NCT01666431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737042|NCT01666522|Vitamin D|vitamin d|mesh-list
24943275|NCT03973047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24943276|NCT03973047|Antipruritics|antipruritics|mesh-ancestor
24943277|NCT03973047|Dermatologic Agents|dermatologic agents|mesh-ancestor
24692798|NCT01416558|Paclitaxel|paclitaxel|mesh-list
24943278|NCT03973047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24943279|NCT03973047|Serotonin Agents|serotonin agents|mesh-ancestor
24943280|NCT03973047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24768351|NCT01807494|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24768352|NCT01807494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24768353|NCT01807494|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24768354|NCT01807494|Histamine Antagonists|histamine antagonists|mesh-ancestor
25696189|NCT02058628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696190|NCT02058628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25696191|NCT02058628|Dermatologic Agents|dermatologic agents|mesh-ancestor
24768355|NCT01807494|Histamine Agents|histamine agents|mesh-ancestor
24768356|NCT01807494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25696192|NCT02058836|Botulinum Toxins|botulinum toxins|mesh-list
24582189|NCT00868491|Immunologic Factors|immunologic factors|mesh-ancestor
24582190|NCT00868491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582191|NCT00868491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24582193|NCT00868569|Fluorouracil|fluorouracil|mesh-list
24582194|NCT00868569|Oxaliplatin|oxaliplatin|mesh-list
24582195|NCT00868569|Antimetabolites|antimetabolites|mesh-ancestor
24582196|NCT00868569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582197|NCT00868569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24582198|NCT00868569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582241|NCT00868829|Chromium|chromium|mesh-list
24943313|NCT03972683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24943314|NCT03972683|Adrenergic Agents|adrenergic agents|mesh-ancestor
24943315|NCT03972683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24943316|NCT03972683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943317|NCT03972683|Protective Agents|protective agents|mesh-ancestor
24943318|NCT03972683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24943331|NCT03972683|Purinergic Agents|purinergic agents|mesh-ancestor
24943332|NCT03972683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24943333|NCT03972683|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24737043|NCT01666522|Cholecalciferol|cholecalciferol|mesh-list
24737044|NCT01666522|Vitamins|vitamins|mesh-ancestor
24737045|NCT01666522|Micronutrients|micronutrients|mesh-ancestor
24737046|NCT01666522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737047|NCT01666522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24737048|NCT01666522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24737049|NCT01666587|Ibuprofen|ibuprofen|mesh-list
24737050|NCT01666587|Antioxidants|antioxidants|mesh-list
24737051|NCT01666587|Prostaglandin Antagonists|prostaglandin antagonists|mesh-list
24943334|NCT03972683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24943335|NCT03972397|Bupivacaine|bupivacaine|mesh-list
24943336|NCT03972397|Anesthetics, Local|anesthetics, local|mesh-ancestor
24943337|NCT03972397|Anesthetics|anesthetics|mesh-ancestor
24943338|NCT03972397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24943339|NCT03972397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943340|NCT03972397|Sensory System Agents|sensory system agents|mesh-ancestor
24943341|NCT03972397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24943342|NCT03972358|Misoprostol|misoprostol|mesh-list
24943343|NCT03972358|Mifepristone|mifepristone|mesh-list
24943344|NCT03972358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24943345|NCT03972358|Abortifacient Agents|abortifacient agents|mesh-ancestor
24943346|NCT03972358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24943347|NCT03972358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943348|NCT03972358|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24943349|NCT03972358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24943350|NCT03972358|Oxytocics|oxytocics|mesh-ancestor
24943351|NCT03972358|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24943352|NCT03972358|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24943353|NCT03972358|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24768385|NCT01807741|Asenapine|asenapine|mesh-list
24943354|NCT03972358|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24943355|NCT03972358|Contraceptive Agents|contraceptive agents|mesh-ancestor
24943382|NCT03971604|Vitamin E|vitamin e|mesh-list
24943383|NCT03971604|Vitamin A|vitamin a|mesh-list
24943384|NCT03971604|Micronutrients|micronutrients|mesh-ancestor
24943385|NCT03971604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943386|NCT03971604|Antioxidants|antioxidants|mesh-ancestor
24943387|NCT03971604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943388|NCT03971604|Protective Agents|protective agents|mesh-ancestor
24943389|NCT03971370|Vaccines|vaccines|mesh-list
24943390|NCT03971370|Immunologic Factors|immunologic factors|mesh-ancestor
24737056|NCT01666587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737057|NCT01666587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737059|NCT01666587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24737060|NCT01666587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24737061|NCT01666587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737062|NCT01666587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696193|NCT02058836|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25696194|NCT02058836|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25696195|NCT02058836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25696196|NCT02058836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696197|NCT02058836|Cholinergic Agents|cholinergic agents|mesh-ancestor
25696198|NCT02058836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25696199|NCT02058836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696200|NCT02058836|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25696201|NCT02058836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25010225|NCT04477265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25010226|NCT04477265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582414|NCT00869596|Xhance|xhance|mesh-list
24737063|NCT01666587|Protective Agents|protective agents|mesh-ancestor
25696202|NCT02058940|Exenatide|exenatide|mesh-list
25696203|NCT02058940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24737064|NCT01666587|Hormone Antagonists|hormone antagonists|mesh-ancestor
24737065|NCT01666587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24737066|NCT01666600|Nintedanib|nintedanib|mesh-list
24737067|NCT01666600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737068|NCT01666600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24943391|NCT03971370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943393|NCT03971487|Immunologic Factors|immunologic factors|mesh-ancestor
24943394|NCT03971487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943395|NCT03971201|Sorafenib|sorafenib|mesh-list
24943396|NCT03971201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943397|NCT03971201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25051203|NCT00434226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24943399|NCT03971201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943400|NCT03971279|Dexamethasone|dexamethasone|mesh-list
24943401|NCT03971279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24943402|NCT03971279|Antiemetics|antiemetics|mesh-ancestor
24943403|NCT03971279|Autonomic Agents|autonomic agents|mesh-ancestor
24737073|NCT01666665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737074|NCT01666678|Diphenhydramine|diphenhydramine|mesh-list
24737075|NCT01666678|Promethazine|promethazine|mesh-list
24737076|NCT01666678|Naproxen|naproxen|mesh-list
24737077|NCT01666678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24737078|NCT01666678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24737079|NCT01666678|Analgesics|analgesics|mesh-ancestor
24737080|NCT01666678|Sensory System Agents|sensory system agents|mesh-ancestor
24737081|NCT01666678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737083|NCT01666678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24737093|NCT01666678|Anesthetics|anesthetics|mesh-ancestor
24737095|NCT01666678|Autonomic Agents|autonomic agents|mesh-ancestor
24737096|NCT01666678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24737097|NCT01666678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24737098|NCT01666678|Histamine Antagonists|histamine antagonists|mesh-ancestor
24737099|NCT01666678|Histamine Agents|histamine agents|mesh-ancestor
24737100|NCT01666678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24737101|NCT01666678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24737102|NCT01666678|Antipruritics|antipruritics|mesh-ancestor
24737103|NCT01666678|Dermatologic Agents|dermatologic agents|mesh-ancestor
24737105|NCT01666691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24737106|NCT01666691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24737107|NCT01666691|Growth Substances|growth substances|mesh-ancestor
24737108|NCT01666691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737109|NCT01666691|Growth Inhibitors|growth inhibitors|mesh-ancestor
24737110|NCT01666691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943416|NCT03970798|Caffeine|caffeine|mesh-list
24693424|NCT01420367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25004711|NCT02034422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004712|NCT02034422|Protective Agents|protective agents|mesh-ancestor
24943431|NCT03970798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943432|NCT03970798|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24943433|NCT03970798|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24737111|NCT01666743|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
24737112|NCT01666743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24737113|NCT01666743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24737114|NCT01666756|Sorafenib|sorafenib|mesh-list
24737115|NCT01666756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737116|NCT01666756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24737117|NCT01666756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617879|NCT01045941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25696204|NCT02058940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696205|NCT02058940|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25696206|NCT02058940|Incretins|incretins|mesh-ancestor
25696207|NCT02058940|Hormones|hormones|mesh-ancestor
25696208|NCT02058940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25696209|NCT02058966|Entacapone|entacapone|mesh-list
25696210|NCT02058966|Methamphetamine|methamphetamine|mesh-list
25696211|NCT02058966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25696212|NCT02058966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24737120|NCT01666769|Antifungal Agents|antifungal agents|mesh-ancestor
24847810|NCT05353673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24737121|NCT01666769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24737122|NCT01667094|Meropenem|meropenem|mesh-list
24737123|NCT01667094|Tazobactam|tazobactam|mesh-list
24737124|NCT01667094|Piperacillin|piperacillin|mesh-list
24737125|NCT01667094|Clavulanic Acid|clavulanic acid|mesh-list
24737126|NCT01667094|Clavulanic Acids|clavulanic acids|mesh-list
24737152|NCT01667211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24737153|NCT01667211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737154|NCT01667211|Tubulin Modulators|tubulin modulators|mesh-ancestor
24737155|NCT01667211|Antimitotic Agents|antimitotic agents|mesh-ancestor
24737156|NCT01667211|Mitosis Modulators|mitosis modulators|mesh-ancestor
24737157|NCT01667211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737159|NCT01667263|Danazol|danazol|mesh-list
24737160|NCT01667263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737161|NCT01667263|Keratolytic Agents|keratolytic agents|mesh-ancestor
24737162|NCT01667263|Dermatologic Agents|dermatologic agents|mesh-ancestor
24737163|NCT01667263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24443267|NCT00294359|Mitomycin|mitomycin|mesh-list
24737166|NCT01667263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737176|NCT01667445|Narcotics|narcotics|mesh-ancestor
24737177|NCT01667445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24737178|NCT01667445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737179|NCT01667445|Analgesics|analgesics|mesh-ancestor
24737180|NCT01667445|Sensory System Agents|sensory system agents|mesh-ancestor
24943434|NCT03970798|Antimetabolites|antimetabolites|mesh-ancestor
24943435|NCT03970798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24943436|NCT03970798|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24943437|NCT03970798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456570|NCT00331708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24456572|NCT00331708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456573|NCT00331708|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24456575|NCT00331747|Glatiramer Acetate|glatiramer acetate|mesh-list
24862098|NCT02323139|Azacitidine|azacitidine|mesh-list
24670546|NCT02442349|Osimertinib|osimertinib|mesh-list
24737223|NCT01667614|Losartan|losartan|mesh-list
25696213|NCT02058966|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25696214|NCT02058966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25696215|NCT02058966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696216|NCT02058966|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25696217|NCT02058966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696218|NCT02058966|Sympathomimetics|sympathomimetics|mesh-ancestor
25696219|NCT02058966|Autonomic Agents|autonomic agents|mesh-ancestor
25696220|NCT02058966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737224|NCT01667614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24737225|NCT01667614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24737226|NCT01667614|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24737227|NCT01667614|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24737228|NCT01667614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737229|NCT01667692|Azithromycin|azithromycin|mesh-list
24737230|NCT01667692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24650925|NCT01228409|Acitretin|acitretin|mesh-list
24737231|NCT01667692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24737232|NCT01667718|Amoxicillin|amoxicillin|mesh-list
24737233|NCT01667718|Levofloxacin|levofloxacin|mesh-list
24737235|NCT01667718|Potassium Citrate|potassium citrate|mesh-list
24737236|NCT01667718|Lansoprazole|lansoprazole|mesh-list
24737237|NCT01667718|Dexlansoprazole|dexlansoprazole|mesh-list
24737238|NCT01667718|Bismuth|bismuth|mesh-list
24737239|NCT01667718|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24737240|NCT01667718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737241|NCT01667718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24737242|NCT01667718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24737243|NCT01667718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24737244|NCT01667718|Renal Agents|renal agents|mesh-ancestor
24737245|NCT01667718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24737246|NCT01667718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24737247|NCT01667718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737248|NCT01667718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768626|NCT01809444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768627|NCT01809444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24768628|NCT01809444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24768629|NCT01809444|Antimalarials|antimalarials|mesh-ancestor
24768630|NCT01809444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24943463|NCT03971019|Calcium, Dietary|calcium, dietary|mesh-list
24943464|NCT03971019|Atorvastatin|atorvastatin|mesh-list
24943465|NCT03971019|Simvastatin|simvastatin|mesh-list
24943466|NCT03971019|Calcium|calcium|mesh-list
24459263|NCT00344123|Ritonavir|ritonavir|mesh-list
24737249|NCT01667718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24737250|NCT01667718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24737251|NCT01667718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24737253|NCT01667718|Antacids|antacids|mesh-ancestor
24737254|NCT01667718|Diuretics|diuretics|mesh-ancestor
24737255|NCT01667718|Natriuretic Agents|natriuretic agents|mesh-ancestor
24737256|NCT01667718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737257|NCT01667718|Expectorants|expectorants|mesh-ancestor
24737258|NCT01667718|Respiratory System Agents|respiratory system agents|mesh-ancestor
24737259|NCT01667744|Citalopram|citalopram|mesh-list
24737260|NCT01667744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24737261|NCT01667744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24737262|NCT01667744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24737263|NCT01667744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737264|NCT01667744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24737265|NCT01667744|Serotonin Agents|serotonin agents|mesh-ancestor
24737266|NCT01667744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737267|NCT01667744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24737275|NCT01667874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737277|NCT01668043|Antibodies|antibodies|mesh-list
24737278|NCT01668043|Immunologic Factors|immunologic factors|mesh-ancestor
24737279|NCT01668043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737280|NCT01668043|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24737281|NCT01668043|Antiviral Agents|antiviral agents|mesh-ancestor
24737282|NCT01668043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24737283|NCT01668056|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24737286|NCT01668069|Ondansetron|ondansetron|mesh-list
24737296|NCT01668069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24943474|NCT03971019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24943475|NCT03971019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24943476|NCT03971019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24943477|NCT03970759|Fluorides|fluorides|mesh-list
24943478|NCT03970759|Tin Fluorides|tin fluorides|mesh-list
24943479|NCT03970759|Cariostatic Agents|cariostatic agents|mesh-ancestor
24943480|NCT03970759|Protective Agents|protective agents|mesh-ancestor
24856809|NCT02286986|Anticonvulsants|anticonvulsants|mesh-ancestor
24626402|NCT01087203|Tanezumab|tanezumab|mesh-list
24737297|NCT01668069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737298|NCT01668069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24737299|NCT01668069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24737300|NCT01668069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24737301|NCT01668069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24737302|NCT01668069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24582974|NCT00872781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24582975|NCT00872781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582976|NCT00872781|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24582977|NCT00872781|Protease Inhibitors|protease inhibitors|mesh-ancestor
24582978|NCT00872781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24582979|NCT00872924|Sumatriptan|sumatriptan|mesh-list
24582980|NCT00872924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24582981|NCT00872924|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24582982|NCT00872924|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24582983|NCT00872924|Serotonin Agents|serotonin agents|mesh-ancestor
24583012|NCT00873197|Serotonin Agents|serotonin agents|mesh-ancestor
24737304|NCT01668121|Formoterol Fumarate|formoterol fumarate|mesh-list
24737305|NCT01668121|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24737306|NCT01668121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24737307|NCT01668121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24737308|NCT01668121|Autonomic Agents|autonomic agents|mesh-ancestor
24737309|NCT01668121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737310|NCT01668121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737311|NCT01668121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24737312|NCT01668121|Respiratory System Agents|respiratory system agents|mesh-ancestor
24737313|NCT01668121|Glucocorticoids|glucocorticoids|mesh-ancestor
24737314|NCT01668121|Hormones|hormones|mesh-ancestor
24737315|NCT01668121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24737316|NCT01668121|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24737317|NCT01668121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24737318|NCT01668121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24737319|NCT01668121|Adrenergic Agents|adrenergic agents|mesh-ancestor
24737320|NCT01668121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24737321|NCT01668121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737322|NCT01668433|Primaquine|primaquine|mesh-list
24737328|NCT01668433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737331|NCT01668446|Estradiol|estradiol|mesh-list
24737332|NCT01668446|Estrogens|estrogens|mesh-ancestor
24737333|NCT01668446|Hormones|hormones|mesh-ancestor
24943481|NCT03970759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943483|NCT03970577|Rituximab|rituximab|mesh-list
24943502|NCT03970668|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24943503|NCT03970668|Protease Inhibitors|protease inhibitors|mesh-ancestor
24943504|NCT03970668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24943505|NCT03970668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943507|NCT03970213|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24943508|NCT03970213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24943509|NCT03970213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943510|NCT03970213|Hemostatics|hemostatics|mesh-ancestor
24943511|NCT03970213|Coagulants|coagulants|mesh-ancestor
24943512|NCT03970239|Ketanserin|ketanserin|mesh-list
24943513|NCT03970239|Fluorides|fluorides|mesh-list
24737360|NCT01668550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737361|NCT01668550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737363|NCT01668615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737364|NCT01668615|Keratolytic Agents|keratolytic agents|mesh-ancestor
24737365|NCT01668615|Dermatologic Agents|dermatologic agents|mesh-ancestor
24737367|NCT01668680|Capecitabine|capecitabine|mesh-list
24737368|NCT01668680|Methotrexate|methotrexate|mesh-list
24943523|NCT03970239|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24943526|NCT03970044|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25696221|NCT02058966|Dopamine Agents|dopamine agents|mesh-ancestor
25696222|NCT02058966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25696223|NCT02058966|Adrenergic Agents|adrenergic agents|mesh-ancestor
25696224|NCT02058966|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25696225|NCT02058966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25696226|NCT02058966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25696227|NCT02058966|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25696228|NCT02059070|Bupivacaine|bupivacaine|mesh-list
25696229|NCT02059070|Ropivacaine|ropivacaine|mesh-list
25696230|NCT02059070|Anesthetics, Local|anesthetics, local|mesh-ancestor
25696231|NCT02059070|Anesthetics|anesthetics|mesh-ancestor
25696232|NCT02059070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24737369|NCT01668680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24737370|NCT01668680|Antimetabolites|antimetabolites|mesh-ancestor
24737371|NCT01668680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737372|NCT01668680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737373|NCT01668680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24737374|NCT01668680|Abortifacient Agents|abortifacient agents|mesh-ancestor
24737375|NCT01668680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24737376|NCT01668680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737377|NCT01668680|Dermatologic Agents|dermatologic agents|mesh-ancestor
24737378|NCT01668680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737379|NCT01668680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24737380|NCT01668680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24737381|NCT01668680|Immunologic Factors|immunologic factors|mesh-ancestor
24737382|NCT01668680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24737383|NCT01668680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24737384|NCT01668680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24737423|NCT01668901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24737424|NCT01668901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737425|NCT01668901|Antipyretics|antipyretics|mesh-ancestor
24737426|NCT01668901|Anticoagulants|anticoagulants|mesh-ancestor
24737427|NCT01668927|Amoxicillin|amoxicillin|mesh-list
24737428|NCT01668927|Metronidazole|metronidazole|mesh-list
24737429|NCT01668927|Tetracycline|tetracycline|mesh-list
24514268|NCT00589316|Tacrolimus|tacrolimus|mesh-list
24737430|NCT01668927|Furazolidone|furazolidone|mesh-list
24737431|NCT01668927|Potassium Citrate|potassium citrate|mesh-list
24737432|NCT01668927|Lansoprazole|lansoprazole|mesh-list
24617881|NCT01045941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24617895|NCT01045980|Micronutrients|micronutrients|mesh-ancestor
24526261|NCT00290511|Mitoxantrone|mitoxantrone|mesh-list
24737434|NCT01668927|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24737435|NCT01668927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737436|NCT01668927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24737437|NCT01668927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24737438|NCT01668927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24737439|NCT01668927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24737440|NCT01668927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24737441|NCT01668927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24737442|NCT01668927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737443|NCT01668927|Antacids|antacids|mesh-ancestor
24737444|NCT01668927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24737445|NCT01668927|Diuretics|diuretics|mesh-ancestor
24737446|NCT01668927|Natriuretic Agents|natriuretic agents|mesh-ancestor
24737447|NCT01668927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737448|NCT01668927|Expectorants|expectorants|mesh-ancestor
24737449|NCT01668927|Respiratory System Agents|respiratory system agents|mesh-ancestor
24737450|NCT01668927|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24959414|NCT03825133|Immunologic Factors|immunologic factors|mesh-ancestor
24737451|NCT01668927|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24737452|NCT01668927|Renal Agents|renal agents|mesh-ancestor
24737453|NCT01668927|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
24737454|NCT01668927|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24526319|NCT00611143|Atorvastatin|atorvastatin|mesh-list
24737455|NCT01669044|Dexmedetomidine|dexmedetomidine|mesh-list
24737457|NCT01669044|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24737458|NCT01669044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24737467|NCT01669044|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24959422|NCT03824847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737472|NCT01669044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737475|NCT01669083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24737476|NCT01669135|Anesthetics|anesthetics|mesh-list
24694532|NCT05386290|Vedolizumab|vedolizumab|mesh-list
24737477|NCT01669135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24737478|NCT01669135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737479|NCT01669213|Ondansetron|ondansetron|mesh-list
24737480|NCT01669213|Ramosetron|ramosetron|mesh-list
24737481|NCT01669213|Antiemetics|antiemetics|mesh-ancestor
24943527|NCT03970044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943528|NCT03970044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24943529|NCT03970044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943530|NCT03970044|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24785456|NCT01914432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24943531|NCT03970044|Incretins|incretins|mesh-ancestor
24943532|NCT03970044|Hormones|hormones|mesh-ancestor
24943533|NCT03970044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24943534|NCT03969823|Osimertinib|osimertinib|mesh-list
24943535|NCT03969823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943536|NCT03969823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24943537|NCT03969823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24943538|NCT03969823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768632|NCT01809626|Zolpidem|zolpidem|mesh-list
24943539|NCT03969758|Metronidazole|metronidazole|mesh-list
24943540|NCT03969758|Ciprofloxacin|ciprofloxacin|mesh-list
24943541|NCT03969758|Cefixime|cefixime|mesh-list
24943559|NCT03968835|Bacitracin|bacitracin|mesh-list
24943590|NCT03968263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24943591|NCT03968263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943593|NCT03968263|Sensory System Agents|sensory system agents|mesh-ancestor
24943594|NCT03968263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24943595|NCT03968263|Antitussive Agents|antitussive agents|mesh-ancestor
24943596|NCT03968263|Respiratory System Agents|respiratory system agents|mesh-ancestor
24943597|NCT03968185|Analgesics|analgesics|mesh-list
24943598|NCT03968185|Sensory System Agents|sensory system agents|mesh-ancestor
24943599|NCT03968185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737482|NCT01669213|Autonomic Agents|autonomic agents|mesh-ancestor
24737483|NCT01669213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737484|NCT01669213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737485|NCT01669213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24737486|NCT01669213|Antipruritics|antipruritics|mesh-ancestor
24737487|NCT01669213|Dermatologic Agents|dermatologic agents|mesh-ancestor
24737488|NCT01669213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24737489|NCT01669213|Serotonin Agents|serotonin agents|mesh-ancestor
24737490|NCT01669213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24737491|NCT01669213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737492|NCT01669213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24737493|NCT01669213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24737494|NCT01669213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24737495|NCT01669213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24737496|NCT01669213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24737497|NCT01669226|Taxane|taxane|mesh-list
24737518|NCT01669291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24737521|NCT01669304|Antidepressive Agents|antidepressive agents|mesh-ancestor
24737522|NCT01669304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24737523|NCT01669304|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24943600|NCT03968185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943601|NCT03968146|Acetaminophen|acetaminophen|mesh-list
24943602|NCT03968146|Ketorolac|ketorolac|mesh-list
24943604|NCT03968146|Meperidine|meperidine|mesh-list
24943605|NCT03968146|Morphine|morphine|mesh-list
25051204|NCT00434226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24959411|NCT03825328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959413|NCT03825133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24737526|NCT01669304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737528|NCT01669304|Serotonin Agents|serotonin agents|mesh-ancestor
25070065|NCT03422055|Fucoidan|fucoidan|mesh-list
24737529|NCT01669304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737530|NCT01669304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24737531|NCT01669304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24737532|NCT01669304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24737533|NCT01669304|Vasodilator Agents|vasodilator agents|mesh-ancestor
24737534|NCT01669369|Lithium Carbonate|lithium carbonate|mesh-list
24737535|NCT01669369|Antidepressive Agents|antidepressive agents|mesh-ancestor
24650961|NCT01228604|Dopamine Agents|dopamine agents|mesh-ancestor
24737536|NCT01669369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24737537|NCT01669369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737538|NCT01669369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737539|NCT01669369|Antimanic Agents|antimanic agents|mesh-ancestor
24737540|NCT01669369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24737542|NCT01669369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793479|NCT03427736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24793480|NCT03427736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793481|NCT03427736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24793482|NCT03427736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25010338|NCT04218240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010339|NCT04218240|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25010340|NCT04218240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24696397|NCT01429181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737543|NCT01669447|Ranibizumab|ranibizumab|mesh-list
24737544|NCT01669447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24737545|NCT01669447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24737546|NCT01669447|Growth Substances|growth substances|mesh-ancestor
24737547|NCT01669447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737548|NCT01669447|Growth Inhibitors|growth inhibitors|mesh-ancestor
24737549|NCT01669447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737550|NCT01669499|Dexamethasone|dexamethasone|mesh-list
24737551|NCT01669499|Dexamethasone acetate|dexamethasone acetate|mesh-list
24737552|NCT01669499|BB 1101|bb 1101|mesh-list
24737553|NCT01669499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24737554|NCT01669499|Antiemetics|antiemetics|mesh-ancestor
24737555|NCT01669499|Autonomic Agents|autonomic agents|mesh-ancestor
24737556|NCT01669499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737557|NCT01669499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447727|NCT00309517|Leucovorin|leucovorin|mesh-list
24737567|NCT01669707|Endostar protein|endostar protein|mesh-list
24737574|NCT01669824|Aspirin|aspirin|mesh-list
24737587|NCT01669824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24737588|NCT01669824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737589|NCT01669824|Antipyretics|antipyretics|mesh-ancestor
24737590|NCT01669941|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24737591|NCT01669941|Antimalarials|antimalarials|mesh-ancestor
24737592|NCT01669941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24737593|NCT01669941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24737594|NCT01669941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24737595|NCT01669967|Diphenhydramine|diphenhydramine|mesh-list
24737596|NCT01669967|Promethazine|promethazine|mesh-list
24737597|NCT01669967|Lidocaine|lidocaine|mesh-list
24737598|NCT01669967|Anesthetics, Local|anesthetics, local|mesh-ancestor
24959420|NCT03824847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24959421|NCT03824847|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24959424|NCT03824847|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24959425|NCT03824847|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25051205|NCT00434226|Growth Substances|growth substances|mesh-ancestor
25051206|NCT00434226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051207|NCT00434226|Growth Inhibitors|growth inhibitors|mesh-ancestor
25051208|NCT00434226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25051209|NCT00434226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051210|NCT00431873|Mocetinostat|mocetinostat|mesh-list
25051211|NCT00431873|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24737599|NCT01669967|Anesthetics|anesthetics|mesh-ancestor
24737600|NCT01669967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24737601|NCT01669967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737602|NCT01669967|Sensory System Agents|sensory system agents|mesh-ancestor
24737603|NCT01669967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737604|NCT01669967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24943607|NCT03968146|Narcotics|narcotics|mesh-ancestor
24737605|NCT01669967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24737606|NCT01669967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24737607|NCT01669967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24737608|NCT01669967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737609|NCT01669967|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24737610|NCT01669967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24737611|NCT01669967|Antiemetics|antiemetics|mesh-ancestor
24737612|NCT01669967|Autonomic Agents|autonomic agents|mesh-ancestor
24737613|NCT01669967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24737614|NCT01669967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25696233|NCT02059070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696234|NCT02059070|Sensory System Agents|sensory system agents|mesh-ancestor
25696235|NCT02059070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25696236|NCT02059135|Antithrombins|antithrombins|mesh-list
25696237|NCT02059135|Antithrombin III|antithrombin iii|mesh-list
25696238|NCT02059135|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25696239|NCT02059135|Protease Inhibitors|protease inhibitors|mesh-ancestor
25696240|NCT02059135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25696241|NCT02059135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737615|NCT01669967|Histamine Antagonists|histamine antagonists|mesh-ancestor
24737616|NCT01669967|Histamine Agents|histamine agents|mesh-ancestor
24737617|NCT01669967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24737618|NCT01669967|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24737619|NCT01669967|Antipruritics|antipruritics|mesh-ancestor
24737635|NCT01670071|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24737637|NCT01670084|Cytarabine|cytarabine|mesh-list
24737638|NCT01670084|Dexamethasone|dexamethasone|mesh-list
24737639|NCT01670084|Prednisone|prednisone|mesh-list
24737640|NCT01670084|Cyclophosphamide|cyclophosphamide|mesh-list
24737641|NCT01670084|Rituximab|rituximab|mesh-list
24737642|NCT01670084|Doxorubicin|doxorubicin|mesh-list
24737643|NCT01670084|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24737644|NCT01670084|Methotrexate|methotrexate|mesh-list
24737646|NCT01670084|Levoleucovorin|levoleucovorin|mesh-list
24737647|NCT01670084|Mesna|mesna|mesh-list
24737648|NCT01670084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24737649|NCT01670084|Immunologic Factors|immunologic factors|mesh-ancestor
24737650|NCT01670084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737651|NCT01670084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24737652|NCT01670084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24737666|NCT01670084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24737668|NCT01670084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25051212|NCT00431873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051213|NCT00431873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051214|NCT00430950|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25051215|NCT00430950|Olmesartan|olmesartan|mesh-list
25051216|NCT00430950|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25051217|NCT00430950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25051218|NCT00430950|Diuretics|diuretics|mesh-ancestor
25051219|NCT00430950|Natriuretic Agents|natriuretic agents|mesh-ancestor
25051220|NCT00430950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051221|NCT00430950|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25051222|NCT00430950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25051223|NCT00430950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051224|NCT00430950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25051225|NCT00430950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25051226|NCT00430508|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25051227|NCT00430508|Olmesartan|olmesartan|mesh-list
25051228|NCT00430508|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24959428|NCT03824743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24959430|NCT03824925|Zinc Sulfate|zinc sulfate|mesh-list
24959431|NCT03824925|Trace Elements|trace elements|mesh-ancestor
24959432|NCT03824925|Micronutrients|micronutrients|mesh-ancestor
24959433|NCT03824925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959434|NCT03824925|Astringents|astringents|mesh-ancestor
24959435|NCT03824925|Dermatologic Agents|dermatologic agents|mesh-ancestor
24695141|NCT04425902|Purinergic Agents|purinergic agents|mesh-ancestor
24959436|NCT03825081|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24959437|NCT03825081|Pilocarpine|pilocarpine|mesh-list
24737669|NCT01670084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24737670|NCT01670084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737671|NCT01670084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24737672|NCT01670084|Abortifacient Agents|abortifacient agents|mesh-ancestor
24737673|NCT01670084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24737674|NCT01670084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24737675|NCT01670084|Antimetabolites|antimetabolites|mesh-ancestor
24737676|NCT01670084|Dermatologic Agents|dermatologic agents|mesh-ancestor
24737677|NCT01670084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24737678|NCT01670084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24737679|NCT01670084|Antiviral Agents|antiviral agents|mesh-ancestor
24737680|NCT01670084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24959438|NCT03825081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24959439|NCT03825081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24959440|NCT03825081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24943606|NCT03968146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24943610|NCT03968146|Analgesics|analgesics|mesh-ancestor
24737681|NCT01670084|Antidotes|antidotes|mesh-ancestor
24737682|NCT01670084|Protective Agents|protective agents|mesh-ancestor
24737683|NCT01670084|Vitamin B Complex|vitamin b complex|mesh-ancestor
24737685|NCT01670084|Micronutrients|micronutrients|mesh-ancestor
24737686|NCT01670084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24737687|NCT01670084|Tubulin Modulators|tubulin modulators|mesh-ancestor
24737688|NCT01670084|Antimitotic Agents|antimitotic agents|mesh-ancestor
24737689|NCT01670084|Mitosis Modulators|mitosis modulators|mesh-ancestor
24737690|NCT01670136|Sildenafil Citrate|sildenafil citrate|mesh-list
24737691|NCT01670136|Vasodilator Agents|vasodilator agents|mesh-ancestor
24737692|NCT01670136|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24583709|NCT00876434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583711|NCT00876577|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24583712|NCT00876577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24583713|NCT00876577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24583714|NCT00876577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24737693|NCT01670136|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24737694|NCT01670136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737695|NCT01670136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737696|NCT01670136|Urological Agents|urological agents|mesh-ancestor
24737698|NCT01670149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24737699|NCT01670149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24737700|NCT01670149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24737701|NCT01670162|Aflibercept|aflibercept|mesh-list
24943630|NCT03968224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943631|NCT03968237|Buprenorphine|buprenorphine|mesh-list
24943632|NCT03968237|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
24943633|NCT03968237|Naloxone|naloxone|mesh-list
24943634|NCT03968237|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24943635|NCT03968237|Narcotics|narcotics|mesh-ancestor
24943636|NCT03968237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24943637|NCT03968237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943638|NCT03968237|Analgesics|analgesics|mesh-ancestor
24943639|NCT03968237|Sensory System Agents|sensory system agents|mesh-ancestor
24943640|NCT03968237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737707|NCT01670162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737709|NCT01670175|Cyclophosphamide|cyclophosphamide|mesh-list
24737710|NCT01670175|Topotecan|topotecan|mesh-list
24737711|NCT01670175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24737712|NCT01670175|Immunologic Factors|immunologic factors|mesh-ancestor
24737713|NCT01670175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737714|NCT01670175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24737715|NCT01670175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24737716|NCT01670175|Alkylating Agents|alkylating agents|mesh-ancestor
24737717|NCT01670175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737725|NCT01670175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24737727|NCT01670240|Adalimumab|adalimumab|mesh-list
24737728|NCT01670240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24737729|NCT01670240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24737730|NCT01670305|Photosensitizing Agents|photosensitizing agents|mesh-list
24737731|NCT01670305|Dermatologic Agents|dermatologic agents|mesh-ancestor
24737732|NCT01670318|Chromium|chromium|mesh-list
25070127|NCT03421743|Immunologic Factors|immunologic factors|mesh-ancestor
24737733|NCT01670318|Everolimus|everolimus|mesh-list
24737734|NCT01670318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737735|NCT01670318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24737736|NCT01670318|Immunologic Factors|immunologic factors|mesh-ancestor
24737738|NCT01670318|Trace Elements|trace elements|mesh-ancestor
24737752|NCT01670435|Ciprofloxacin|ciprofloxacin|mesh-list
24737753|NCT01670435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24737754|NCT01670435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24737755|NCT01670435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24943669|NCT03967886|Esomeprazole|esomeprazole|mesh-list
24943670|NCT03967886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24943672|NCT03967886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24943673|NCT03967886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24943674|NCT03967886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943676|NCT03968042|Edaravone|edaravone|mesh-list
24943677|NCT03968042|Mitogens|mitogens|mesh-list
24943678|NCT03968042|Vitamins|vitamins|mesh-ancestor
24737760|NCT01670435|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24737761|NCT01670435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24737762|NCT01670474|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24737763|NCT01670474|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24737764|NCT01670474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24737765|NCT01670474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737766|NCT01670552|Naproxen|naproxen|mesh-list
24737767|NCT01670552|Nimesulide|nimesulide|mesh-list
25696242|NCT02059135|Anticoagulants|anticoagulants|mesh-ancestor
25696243|NCT02059161|Insulin|insulin|mesh-list
25696244|NCT02059161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25696245|NCT02059161|Insulin Glargine|insulin glargine|mesh-list
25696246|NCT02059161|MK-1293|mk-1293|mesh-list
24737768|NCT01670552|Esomeprazole|esomeprazole|mesh-list
24737769|NCT01670552|Pantoprazole|pantoprazole|mesh-list
24737770|NCT01670552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25696247|NCT02059161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25696248|NCT02059161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737772|NCT01670552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24737773|NCT01670552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737774|NCT01670552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737775|NCT01670552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24737776|NCT01670552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24737778|NCT01670552|Sensory System Agents|sensory system agents|mesh-ancestor
24737779|NCT01670552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737780|NCT01670552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737781|NCT01670552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24737782|NCT01670552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24737783|NCT01670552|Gout Suppressants|gout suppressants|mesh-ancestor
24943679|NCT03968042|Micronutrients|micronutrients|mesh-ancestor
24943680|NCT03968042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943681|NCT03968042|Mitosis Modulators|mitosis modulators|mesh-ancestor
24943682|NCT03968042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943683|NCT03968042|Vitamin B Complex|vitamin b complex|mesh-ancestor
24943686|NCT03968042|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24943687|NCT03968042|Protective Agents|protective agents|mesh-ancestor
24943689|NCT03967938|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24943690|NCT03967938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24943691|NCT03967938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943692|NCT03967938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768906|NCT01811251|Autonomic Agents|autonomic agents|mesh-ancestor
24768907|NCT01811251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24768908|NCT01811251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856972|NCT02288208|Entecavir|entecavir|mesh-list
24737784|NCT01670552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24737785|NCT01670565|Mycophenolic Acid|mycophenolic acid|mesh-list
24737791|NCT01670565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24737792|NCT01670565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24737793|NCT01670565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737794|NCT01670565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737795|NCT01670565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24737796|NCT01670565|Immunologic Factors|immunologic factors|mesh-ancestor
24737797|NCT01670565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737798|NCT01670578|Hyaluronic Acid|hyaluronic acid|mesh-list
24737799|NCT01670578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24737800|NCT01670578|Immunologic Factors|immunologic factors|mesh-ancestor
24737801|NCT01670578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737802|NCT01670578|Viscosupplements|viscosupplements|mesh-ancestor
24737803|NCT01670578|Protective Agents|protective agents|mesh-ancestor
24737804|NCT01670669|Prucalopride|prucalopride|mesh-list
24737811|NCT01670669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737812|NCT01670669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737813|NCT01670773|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
24617896|NCT01045980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617897|NCT01045980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24737817|NCT01670773|Sensory System Agents|sensory system agents|mesh-ancestor
24737818|NCT01670773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737819|NCT01670773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651042|NCT01229072|Anticoagulants|anticoagulants|mesh-ancestor
24737820|NCT01670773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24737821|NCT01670773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24737823|NCT01670799|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24737824|NCT01670799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24737825|NCT01670799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24768909|NCT01811251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24768910|NCT01811251|Glucocorticoids|glucocorticoids|mesh-ancestor
24768911|NCT01811251|Hormones|hormones|mesh-ancestor
24959537|NCT03824314|Anesthetics|anesthetics|mesh-ancestor
24768912|NCT01811251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24768913|NCT01811251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24768914|NCT01811251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768915|NCT01811251|Analgesics|analgesics|mesh-ancestor
24768916|NCT01811251|Sensory System Agents|sensory system agents|mesh-ancestor
24768917|NCT01811251|Anticonvulsants|anticonvulsants|mesh-ancestor
24768918|NCT01811251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24768919|NCT01811251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24768920|NCT01811251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583911|NCT00877591|Rifabutin|rifabutin|mesh-list
24583912|NCT00877591|Buprenorphine|buprenorphine|mesh-list
24583957|NCT00877760|Entecavir|entecavir|mesh-list
24768921|NCT01811251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24768922|NCT01811251|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24768923|NCT01811251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24768924|NCT01811251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24768925|NCT01811251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24559959|NCT03989466|Alemtuzumab|alemtuzumab|mesh-list
24625869|NCT01084031|Anesthetics|anesthetics|mesh-ancestor
24625870|NCT01084044|Urinastatin|urinastatin|mesh-list
24625871|NCT01084044|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24625872|NCT01084044|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24625873|NCT01084044|Protease Inhibitors|protease inhibitors|mesh-ancestor
24737827|NCT01670799|Sensory System Agents|sensory system agents|mesh-ancestor
24737828|NCT01670799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737829|NCT01670799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737830|NCT01670799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24737831|NCT01670799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24737832|NCT01670799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24737833|NCT01670799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737834|NCT01670799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737835|NCT01670812|Methylprednisolone|methylprednisolone|mesh-list
24737836|NCT01670812|Rituximab|rituximab|mesh-list
24737837|NCT01670812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24625881|NCT01084057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625882|NCT01084057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625883|NCT01084057|Tubulin Modulators|tubulin modulators|mesh-ancestor
24625884|NCT01084057|Antimitotic Agents|antimitotic agents|mesh-ancestor
24625885|NCT01084057|Mitosis Modulators|mitosis modulators|mesh-ancestor
25070177|NCT03421275|Narcotics|narcotics|mesh-ancestor
24625886|NCT01084122|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24625887|NCT01084122|Hematinics|hematinics|mesh-ancestor
24625888|NCT01084187|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24625889|NCT01084187|Vasodilator Agents|vasodilator agents|mesh-ancestor
24625890|NCT01084187|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24737865|NCT01670955|Vitamin B Complex|vitamin b complex|mesh-ancestor
24737867|NCT01670955|Micronutrients|micronutrients|mesh-ancestor
24737868|NCT01670955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737869|NCT01671384|Valproic Acid|valproic acid|mesh-list
24737870|NCT01671384|Anticonvulsants|anticonvulsants|mesh-ancestor
24737871|NCT01671384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737872|NCT01671384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737873|NCT01671384|GABA Agents|gaba agents|mesh-ancestor
24737874|NCT01671384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24737875|NCT01671384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737876|NCT01671384|Antimanic Agents|antimanic agents|mesh-ancestor
24943734|NCT03967496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24943735|NCT03967496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24943736|NCT03967496|Antimetabolites|antimetabolites|mesh-ancestor
24943737|NCT03967496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943738|NCT03967496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24943739|NCT03967496|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24943740|NCT03967496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24943741|NCT03967496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24943742|NCT03967496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24943743|NCT03967496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24943744|NCT03967496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24943745|NCT03967496|Vasodilator Agents|vasodilator agents|mesh-ancestor
24943749|NCT03967496|Protective Agents|protective agents|mesh-ancestor
24943750|NCT03967496|Sympatholytics|sympatholytics|mesh-ancestor
24943751|NCT03967496|Autonomic Agents|autonomic agents|mesh-ancestor
24943752|NCT03967496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24943753|NCT03967496|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24943754|NCT03967496|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25051233|NCT00430508|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24943755|NCT03967496|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24943757|NCT03967496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24943758|NCT03967548|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24943759|NCT03967548|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24943760|NCT03967327|Morphine|morphine|mesh-list
24943761|NCT03967327|Buprenorphine|buprenorphine|mesh-list
24737877|NCT01671384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24737909|NCT01671722|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25696249|NCT02059161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25696250|NCT02059161|Antimetabolites|antimetabolites|mesh-ancestor
24584168|NCT00878904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24584169|NCT00878904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584170|NCT00878904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24584171|NCT00878904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24737910|NCT01671722|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24737911|NCT01671722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737912|NCT01671774|Zoledronic Acid|zoledronic acid|mesh-list
24737913|NCT01671774|Interleukin-2|interleukin-2|mesh-list
24737914|NCT01671774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737915|NCT01671774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24737917|NCT01671774|Sensory System Agents|sensory system agents|mesh-ancestor
24737918|NCT01671774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737919|NCT01671774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737920|NCT01671774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24737945|NCT01671852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24737946|NCT01671852|Dermatologic Agents|dermatologic agents|mesh-ancestor
24737947|NCT01671852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24737949|NCT01671891|Oxaliplatin|oxaliplatin|mesh-list
24737950|NCT01671891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24737951|NCT01671891|Antimetabolites|antimetabolites|mesh-ancestor
24737952|NCT01671891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943795|NCT03966560|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24943796|NCT03966560|Bimatoprost|bimatoprost|mesh-list
24943797|NCT03966560|Travoprost|travoprost|mesh-list
24943798|NCT03966560|Dorzolamide|dorzolamide|mesh-list
24943799|NCT03966560|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24943800|NCT03966560|Latanoprost|latanoprost|mesh-list
24943801|NCT03966560|Brinzolamide|brinzolamide|mesh-list
24943802|NCT03966560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24943803|NCT03966560|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24943805|NCT03966560|Adrenergic Agents|adrenergic agents|mesh-ancestor
24737953|NCT01671891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737954|NCT01671904|Rituximab|rituximab|mesh-list
24737955|NCT01671904|Obinutuzumab|obinutuzumab|mesh-list
24737956|NCT01671904|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24737957|NCT01671904|Venetoclax|venetoclax|mesh-list
24737958|NCT01671904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24737959|NCT01671904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737960|NCT01671904|Immunologic Factors|immunologic factors|mesh-ancestor
24737961|NCT01671904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737962|NCT01671904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24737963|NCT01671904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24737964|NCT01671904|Alkylating Agents|alkylating agents|mesh-ancestor
24737965|NCT01671904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737978|NCT01672047|Micronutrients|micronutrients|mesh-ancestor
24737979|NCT01672047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526898|NCT00613717|Vitamin A|vitamin a|mesh-list
24737986|NCT01672112|Oxycodone|oxycodone|mesh-list
24737987|NCT01672112|Codeine|codeine|mesh-list
24737988|NCT01672112|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24737989|NCT01672112|Narcotics|narcotics|mesh-ancestor
24737990|NCT01672112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24737991|NCT01672112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737992|NCT01672112|Analgesics|analgesics|mesh-ancestor
24737993|NCT01672112|Sensory System Agents|sensory system agents|mesh-ancestor
24737994|NCT01672112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737995|NCT01672112|Antitussive Agents|antitussive agents|mesh-ancestor
24737996|NCT01672112|Respiratory System Agents|respiratory system agents|mesh-ancestor
24737997|NCT01672151|Sirolimus|sirolimus|mesh-list
24737998|NCT01672151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24737999|NCT01672151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24738000|NCT01672151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24738001|NCT01672151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738002|NCT01672151|Antifungal Agents|antifungal agents|mesh-ancestor
24738003|NCT01672151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25696251|NCT02059161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696252|NCT02059161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25696253|NCT02059174|Insulin Aspart|insulin aspart|mesh-list
25696254|NCT02059174|MK-1293|mk-1293|mesh-list
24738004|NCT01672151|Immunologic Factors|immunologic factors|mesh-ancestor
24738005|NCT01672151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738006|NCT01672229|Bortezomib|bortezomib|mesh-list
24738007|NCT01672229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738008|NCT01672307|Minoxidil|minoxidil|mesh-list
24738025|NCT01672359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24584306|NCT00879723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584307|NCT00879788|Ramipril|ramipril|mesh-list
24584309|NCT00879788|Protease Inhibitors|protease inhibitors|mesh-ancestor
24738026|NCT01672359|Antimetabolites|antimetabolites|mesh-ancestor
24738027|NCT01672359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738028|NCT01672359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24738029|NCT01672359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24738030|NCT01672359|Nootropic Agents|nootropic agents|mesh-ancestor
24738032|NCT01672450|Interleukin-2|interleukin-2|mesh-list
24738033|NCT01672450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24738034|NCT01672450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943806|NCT03966560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24943817|NCT03966859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24943818|NCT03966859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24943819|NCT03966859|Antimetabolites|antimetabolites|mesh-ancestor
24943820|NCT03966859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943822|NCT03966859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24943823|NCT03966859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24943824|NCT03966950|Melatonin|melatonin|mesh-list
24943825|NCT03966950|Antioxidants|antioxidants|mesh-ancestor
24943826|NCT03966950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943827|NCT03966950|Protective Agents|protective agents|mesh-ancestor
24943828|NCT03966950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943829|NCT03966950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24943830|NCT03966547|Anesthetics|anesthetics|mesh-list
24959674|NCT03823274|Antipyretics|antipyretics|mesh-ancestor
24959675|NCT03823274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24959676|NCT03823274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24943839|NCT03966378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24943840|NCT03966378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943841|NCT03966378|Chelating Agents|chelating agents|mesh-ancestor
24943842|NCT03966378|Sequestering Agents|sequestering agents|mesh-ancestor
24943843|NCT03966378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943844|NCT03966378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24943845|NCT03966378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943846|NCT03966378|Antioxidants|antioxidants|mesh-ancestor
24943847|NCT03966378|Protective Agents|protective agents|mesh-ancestor
24943848|NCT03966898|Letrozole|letrozole|mesh-list
24943849|NCT03966898|Anastrozole|anastrozole|mesh-list
24943850|NCT03966898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943851|NCT03966898|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24943852|NCT03966898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24943853|NCT03966898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24943855|NCT03966898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24943860|NCT03966170|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
24943861|NCT03966170|Nootropic Agents|nootropic agents|mesh-ancestor
24943862|NCT03966326|Fentanyl|fentanyl|mesh-list
24943863|NCT03966326|Anesthetics|anesthetics|mesh-list
24943864|NCT03966326|Sevoflurane|sevoflurane|mesh-list
24943865|NCT03966326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24943872|NCT03966326|Analgesics|analgesics|mesh-ancestor
24943873|NCT03966326|Sensory System Agents|sensory system agents|mesh-ancestor
24943874|NCT03966326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24943875|NCT03966326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24943876|NCT03966326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24943878|NCT03966235|Antioxidants|antioxidants|mesh-ancestor
24943879|NCT03966235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943880|NCT03966235|Protective Agents|protective agents|mesh-ancestor
24943881|NCT03966235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943882|NCT03966235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24943883|NCT03966079|Plasminogen|plasminogen|mesh-list
24943884|NCT03966079|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24943885|NCT03966079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25696255|NCT02059174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25696256|NCT02059174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696257|NCT02059174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25696258|NCT02059174|Antimetabolites|antimetabolites|mesh-ancestor
25696259|NCT02059174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696260|NCT02059174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24738038|NCT01672450|Analgesics|analgesics|mesh-ancestor
24738039|NCT01672450|Sensory System Agents|sensory system agents|mesh-ancestor
24738040|NCT01672450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24738041|NCT01672450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738043|NCT01672476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24738044|NCT01672476|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24738045|NCT01672476|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24738046|NCT01672476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738047|NCT01672554|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24738048|NCT01672554|Antidepressive Agents|antidepressive agents|mesh-ancestor
24738049|NCT01672554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24738050|NCT01672554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24738051|NCT01672554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24738052|NCT01672554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24738053|NCT01672554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738054|NCT01672580|Vitamins|vitamins|mesh-list
24738055|NCT01672580|Micronutrients|micronutrients|mesh-ancestor
24738056|NCT01672580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738057|NCT01672593|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24943888|NCT03966209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24738090|NCT01673087|Metyrapone|metyrapone|mesh-list
24738092|NCT01673087|Antiemetics|antiemetics|mesh-ancestor
24738093|NCT01673087|Autonomic Agents|autonomic agents|mesh-ancestor
24738094|NCT01673087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24617914|NCT01046006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24617915|NCT01046006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24617916|NCT01046032|Metformin|metformin|mesh-list
24617917|NCT01046032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24617918|NCT01046032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617919|NCT01046045|Everolimus|everolimus|mesh-list
24617920|NCT01046045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617921|NCT01046045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24617922|NCT01046045|Immunologic Factors|immunologic factors|mesh-ancestor
24617923|NCT01046045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617924|NCT01046058|Simeprevir|simeprevir|mesh-list
24617925|NCT01046058|Antiviral Agents|antiviral agents|mesh-ancestor
24738095|NCT01673087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738096|NCT01673087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24738097|NCT01673087|Glucocorticoids|glucocorticoids|mesh-ancestor
24738098|NCT01673087|Hormones|hormones|mesh-ancestor
24738099|NCT01673087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24738100|NCT01673087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24738113|NCT01673204|Micronutrients|micronutrients|mesh-ancestor
24738114|NCT01673204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24738184|NCT01673997|Autonomic Agents|autonomic agents|mesh-ancestor
24738185|NCT01673997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24738186|NCT01673997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738187|NCT01673997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24738188|NCT01673997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24738193|NCT01674127|Methyldopa|methyldopa|mesh-list
24651109|NCT01229592|Ethanol|ethanol|mesh-list
24738194|NCT01674127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24738195|NCT01674127|Sympatholytics|sympatholytics|mesh-ancestor
24738196|NCT01674127|Autonomic Agents|autonomic agents|mesh-ancestor
24738197|NCT01674127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24738198|NCT01674127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738199|NCT01674127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24738200|NCT01674127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24738201|NCT01674127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24738202|NCT01674127|Adrenergic Agents|adrenergic agents|mesh-ancestor
24943890|NCT03966209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738203|NCT01674127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24738205|NCT01674166|Prucalopride|prucalopride|mesh-list
24738208|NCT01674166|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24584663|NCT00881231|Cilostazol|cilostazol|mesh-list
24738209|NCT01674166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24738210|NCT01674166|Serotonin Agents|serotonin agents|mesh-ancestor
24738211|NCT01674166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24738212|NCT01674166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738213|NCT01674166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738214|NCT01674192|Prucalopride|prucalopride|mesh-list
24738215|NCT01674192|Laxatives|laxatives|mesh-ancestor
24738216|NCT01674192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24738217|NCT01674192|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24738218|NCT01674192|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24738219|NCT01674192|Serotonin Agents|serotonin agents|mesh-ancestor
24738220|NCT01674192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24738221|NCT01674192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738222|NCT01674192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738223|NCT01674205|Vaccines|vaccines|mesh-list
24522277|NCT04020913|Hormones|hormones|mesh-list
24738224|NCT01674205|Immunologic Factors|immunologic factors|mesh-ancestor
24738225|NCT01674205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738226|NCT01674218|Moxifloxacin|moxifloxacin|mesh-list
24738254|NCT01674413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24738255|NCT01674413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24738257|NCT01674504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24738258|NCT01674504|Respiratory System Agents|respiratory system agents|mesh-ancestor
24738259|NCT01674504|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24738260|NCT01674504|Hormone Antagonists|hormone antagonists|mesh-ancestor
24738261|NCT01674504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24651111|NCT01229592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24738262|NCT01674504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738263|NCT01674504|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24738264|NCT01674504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24738265|NCT01674504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738266|NCT01674517|Montelukast|montelukast|mesh-list
24738291|NCT01674686|Sarpogrelate|sarpogrelate|mesh-list
24738335|NCT01674868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738337|NCT01674868|Serotonin Agents|serotonin agents|mesh-ancestor
24738338|NCT01674868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738339|NCT01674868|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24738340|NCT01674868|Antidepressive Agents|antidepressive agents|mesh-ancestor
24738341|NCT01674868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24738342|NCT01674868|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24738343|NCT01674868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24738344|NCT01674868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24738345|NCT01674933|Listerine|listerine|mesh-list
24738346|NCT01674933|Fluorides|fluorides|mesh-list
24738347|NCT01674933|Fluorides, Topical|fluorides, topical|mesh-list
24738348|NCT01674933|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
24738349|NCT01674933|Sodium Fluoride|sodium fluoride|mesh-list
24738350|NCT01674933|Cariostatic Agents|cariostatic agents|mesh-ancestor
24738351|NCT01674933|Protective Agents|protective agents|mesh-ancestor
24738352|NCT01674933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738353|NCT01674933|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24738354|NCT01674933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24738355|NCT01674946|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
24738356|NCT01674946|Bile Acids and Salts|bile acids and salts|mesh-list
24738357|NCT01674946|Cathartics|cathartics|mesh-ancestor
24738358|NCT01674946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24738359|NCT01675024|Rotigotine|rotigotine|mesh-list
24738360|NCT01675024|Dopamine Agonists|dopamine agonists|mesh-ancestor
24738361|NCT01675024|Dopamine Agents|dopamine agents|mesh-ancestor
24738362|NCT01675024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24738364|NCT01675024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738366|NCT01675076|Apixaban|apixaban|mesh-list
24738367|NCT01675076|Dabigatran|dabigatran|mesh-list
24738368|NCT01675076|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24738369|NCT01675076|Antithrombins|antithrombins|mesh-ancestor
24738370|NCT01675076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24738371|NCT01675076|Protease Inhibitors|protease inhibitors|mesh-ancestor
24738394|NCT01675206|Vitamin K|vitamin k|mesh-list
25696261|NCT02059187|Insulin|insulin|mesh-list
24738395|NCT01675206|Vitamin K 2|vitamin k 2|mesh-list
24738396|NCT01675206|Vitamins|vitamins|mesh-ancestor
24738397|NCT01675206|Micronutrients|micronutrients|mesh-ancestor
24651121|NCT01229605|Alkylating Agents|alkylating agents|mesh-ancestor
24738398|NCT01675206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738399|NCT01675206|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24738400|NCT01675206|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24738401|NCT01675206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738403|NCT01675206|Coagulants|coagulants|mesh-ancestor
24738404|NCT01675219|Mitomycins|mitomycins|mesh-list
24738405|NCT01675219|Mitomycin|mitomycin|mesh-list
24738406|NCT01675219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24738407|NCT01675219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738424|NCT01675362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24738425|NCT01675362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24738438|NCT01675518|Hormone Antagonists|hormone antagonists|mesh-ancestor
24738439|NCT01675518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24738440|NCT01675518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738442|NCT01675557|Ergocalciferols|ergocalciferols|mesh-list
24617926|NCT01046058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24617927|NCT01046058|Protease Inhibitors|protease inhibitors|mesh-ancestor
24617928|NCT01046058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617929|NCT01046058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617930|NCT01046162|Alprazolam|alprazolam|mesh-list
24617931|NCT01046162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24943894|NCT03965871|Esketamine|esketamine|mesh-list
24617940|NCT01046162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617942|NCT01046214|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24617943|NCT01046214|Antidepressive Agents|antidepressive agents|mesh-ancestor
24617944|NCT01046214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24617945|NCT01046214|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24617946|NCT01046214|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24617947|NCT01046214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24617948|NCT01046214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738457|NCT01675648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738458|NCT01675648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24738459|NCT01675648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24738460|NCT01675648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24738461|NCT01675648|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24738462|NCT01675648|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24738463|NCT01675648|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24738464|NCT01675648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24738465|NCT01675648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24738466|NCT01675648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24738467|NCT01675648|Anesthetics, General|anesthetics, general|mesh-ancestor
24738468|NCT01675648|Anesthetics|anesthetics|mesh-ancestor
24738469|NCT01675648|GABA Modulators|gaba modulators|mesh-ancestor
24738487|NCT01675804|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24738488|NCT01675804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24738489|NCT01675804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24738490|NCT01675804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738491|NCT01675804|Dopamine Agents|dopamine agents|mesh-ancestor
24738492|NCT01675804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24738493|NCT01675895|Lidocaine|lidocaine|mesh-list
24738494|NCT01675895|Levobupivacaine|levobupivacaine|mesh-list
24738495|NCT01675895|Anesthetics|anesthetics|mesh-list
24738496|NCT01675895|Anesthetics, Local|anesthetics, local|mesh-ancestor
24738497|NCT01675895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24738500|NCT01675895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24738502|NCT01675895|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24738503|NCT01675895|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24738504|NCT01675895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24738505|NCT01675895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738507|NCT01675947|Lidocaine|lidocaine|mesh-list
24738508|NCT01675947|Anesthetics, Local|anesthetics, local|mesh-ancestor
24738509|NCT01675947|Anesthetics|anesthetics|mesh-ancestor
24738510|NCT01675947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24738511|NCT01675947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738512|NCT01675947|Sensory System Agents|sensory system agents|mesh-ancestor
24738513|NCT01675947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24738514|NCT01675947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24738515|NCT01675947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24738516|NCT01675947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24738518|NCT01675947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527531|NCT00617045|Analgesics|analgesics|mesh-ancestor
24738519|NCT01675947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24738520|NCT01675947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24738521|NCT01675947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24738522|NCT01675947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738523|NCT01675947|Antifungal Agents|antifungal agents|mesh-ancestor
24738524|NCT01675947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24738537|NCT01675986|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24943895|NCT03965871|Antidepressive Agents|antidepressive agents|mesh-ancestor
24943896|NCT03965871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24943897|NCT03966118|Paclitaxel|paclitaxel|mesh-list
24738538|NCT01675986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24738539|NCT01675986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738540|NCT01675986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24738541|NCT01675986|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24738545|NCT01675986|Antipruritics|antipruritics|mesh-ancestor
24738546|NCT01675986|Dermatologic Agents|dermatologic agents|mesh-ancestor
24738547|NCT01675986|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24738548|NCT01675986|Histamine Antagonists|histamine antagonists|mesh-ancestor
24738549|NCT01675986|Histamine Agents|histamine agents|mesh-ancestor
24697436|NCT01434862|Pramlintide|pramlintide|mesh-list
24738550|NCT01675986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24738551|NCT01675999|Leucovorin|leucovorin|mesh-list
24738552|NCT01675999|Cetuximab|cetuximab|mesh-list
24738553|NCT01675999|Fluorouracil|fluorouracil|mesh-list
24738555|NCT01675999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24738557|NCT01675999|Antimetabolites|antimetabolites|mesh-ancestor
24738559|NCT01675999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24738565|NCT01675999|Vitamin B Complex|vitamin b complex|mesh-ancestor
24738566|NCT01675999|Vitamins|vitamins|mesh-ancestor
24738567|NCT01675999|Micronutrients|micronutrients|mesh-ancestor
24738568|NCT01676233|Insulin|insulin|mesh-list
24738569|NCT01676233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24738570|NCT01676233|Insulin Glargine|insulin glargine|mesh-list
24738571|NCT01676233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24738572|NCT01676233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738573|NCT01676246|Flupirtine|flupirtine|mesh-list
24738574|NCT01676246|Analgesics|analgesics|mesh-ancestor
24738575|NCT01676246|Sensory System Agents|sensory system agents|mesh-ancestor
24738576|NCT01676246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24738577|NCT01676246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738662|NCT01676571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24738663|NCT01676597|Rifaximin|rifaximin|mesh-list
24738664|NCT01676597|Pentoxifylline|pentoxifylline|mesh-list
24943898|NCT03966118|Avelumab|avelumab|mesh-list
24943899|NCT03966118|Ramucirumab|ramucirumab|mesh-list
24857219|NCT02289768|Analgesics|analgesics|mesh-ancestor
24738665|NCT01676597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24738666|NCT01676597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24738667|NCT01676597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24738668|NCT01676597|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24738669|NCT01676597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24738670|NCT01676597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738712|NCT01676987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24738713|NCT01676987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24738715|NCT01676987|Adrenergic Agents|adrenergic agents|mesh-ancestor
24738716|NCT01676987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24443272|NCT00294359|Growth Substances|growth substances|mesh-ancestor
24443273|NCT00294359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738717|NCT01676987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738719|NCT01677039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24738736|NCT01677104|Incretins|incretins|mesh-ancestor
24738738|NCT01677104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24738739|NCT01677104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24738740|NCT01677143|Bupivacaine|bupivacaine|mesh-list
24738741|NCT01677143|Anesthetics, Local|anesthetics, local|mesh-ancestor
24738742|NCT01677143|Anesthetics|anesthetics|mesh-ancestor
24738743|NCT01677143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24738744|NCT01677143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738745|NCT01677143|Sensory System Agents|sensory system agents|mesh-ancestor
24738746|NCT01677143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24738747|NCT01677221|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24738748|NCT01677221|Dermatologic Agents|dermatologic agents|mesh-ancestor
24738749|NCT01677247|Glimepiride|glimepiride|mesh-list
24738750|NCT01677247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24585159|NCT00883870|Plasma-lyte 148|plasma-lyte 148|mesh-list
24738751|NCT01677247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24738752|NCT01677247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738753|NCT01677247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24738754|NCT01677247|Immunologic Factors|immunologic factors|mesh-ancestor
24738763|NCT01677351|Analgesics|analgesics|mesh-ancestor
24738764|NCT01677351|Sensory System Agents|sensory system agents|mesh-ancestor
24738765|NCT01677351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24738766|NCT01677351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738767|NCT01677351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24738768|NCT01677351|Sympatholytics|sympatholytics|mesh-ancestor
24738769|NCT01677351|Autonomic Agents|autonomic agents|mesh-ancestor
24738770|NCT01677351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24738771|NCT01677351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24738772|NCT01677351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24738773|NCT01677351|Adrenergic Agents|adrenergic agents|mesh-ancestor
24738774|NCT01677351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24738775|NCT01677351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738776|NCT01677364|Oxytocin|oxytocin|mesh-list
24738777|NCT01677364|Oxytocics|oxytocics|mesh-ancestor
24738778|NCT01677364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24738782|NCT01677390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24738783|NCT01677390|Immunologic Factors|immunologic factors|mesh-ancestor
24738784|NCT01677390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738786|NCT01677403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24738787|NCT01677403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24738788|NCT01677442|Anesthetics|anesthetics|mesh-list
24738805|NCT01677546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738807|NCT01677559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24738808|NCT01677559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738809|NCT01677559|Tubulin Modulators|tubulin modulators|mesh-ancestor
24738810|NCT01677559|Antimitotic Agents|antimitotic agents|mesh-ancestor
24738811|NCT01677559|Mitosis Modulators|mitosis modulators|mesh-ancestor
24738812|NCT01677559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738814|NCT01677572|Immunologic Factors|immunologic factors|mesh-ancestor
24738815|NCT01677572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738816|NCT01677598|Ustekinumab|ustekinumab|mesh-list
24738817|NCT01677598|Dermatologic Agents|dermatologic agents|mesh-ancestor
24738818|NCT01677611|Resveratrol|resveratrol|mesh-list
24738819|NCT01677611|Antioxidants|antioxidants|mesh-ancestor
24738820|NCT01677611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738821|NCT01677611|Protective Agents|protective agents|mesh-ancestor
24738822|NCT01677611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738823|NCT01677611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24738824|NCT01677611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24738825|NCT01677650|Methadone|methadone|mesh-list
24738826|NCT01677650|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24738827|NCT01677650|Narcotics|narcotics|mesh-ancestor
24738830|NCT01677650|Analgesics|analgesics|mesh-ancestor
24738835|NCT01677702|Lactoferrin|lactoferrin|mesh-list
24738836|NCT01677702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24738837|NCT01677884|Bevacizumab|bevacizumab|mesh-list
24738839|NCT01677884|Irinotecan|irinotecan|mesh-list
24738840|NCT01677884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24738841|NCT01677884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738842|NCT01677884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24738843|NCT01677884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24738844|NCT01677884|Growth Substances|growth substances|mesh-ancestor
24738845|NCT01677884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738846|NCT01677884|Growth Inhibitors|growth inhibitors|mesh-ancestor
24738847|NCT01677884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24738848|NCT01677884|Antimetabolites|antimetabolites|mesh-ancestor
24943900|NCT03966118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24943901|NCT03966118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943902|NCT03966118|Tubulin Modulators|tubulin modulators|mesh-ancestor
24738849|NCT01677884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738850|NCT01677884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24738851|NCT01677884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24738852|NCT01677884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24738853|NCT01677897|Metformin|metformin|mesh-list
24738854|NCT01677897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25696262|NCT02059187|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24738866|NCT01677949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25696263|NCT02059187|Insulin Glargine|insulin glargine|mesh-list
24633308|NCT01128322|Niacin|niacin|mesh-list
24585323|NCT00884884|Antidepressive Agents|antidepressive agents|mesh-ancestor
24585324|NCT00884884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24585340|NCT00884884|Anticonvulsants|anticonvulsants|mesh-ancestor
24585341|NCT00884884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24585342|NCT00885066|Gemcitabine|gemcitabine|mesh-list
24585343|NCT00885066|Capecitabine|capecitabine|mesh-list
24585344|NCT00885066|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24585345|NCT00885066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24585346|NCT00885066|Antimetabolites|antimetabolites|mesh-ancestor
24585347|NCT00885066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738867|NCT01677949|Alkylating Agents|alkylating agents|mesh-ancestor
24738869|NCT01677949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617954|NCT01046214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617959|NCT01046240|Antiemetics|antiemetics|mesh-ancestor
24617960|NCT01046240|Autonomic Agents|autonomic agents|mesh-ancestor
24617961|NCT01046240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24617962|NCT01046240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617963|NCT01046240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24617964|NCT01046240|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24617965|NCT01046240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24617966|NCT01046240|Serotonin Agents|serotonin agents|mesh-ancestor
24617967|NCT01046240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24617968|NCT01046240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617969|NCT01046266|Cetuximab|cetuximab|mesh-list
24617970|NCT01046266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24617979|NCT01046279|Growth Inhibitors|growth inhibitors|mesh-ancestor
24617981|NCT01046383|Chelating Agents|chelating agents|mesh-ancestor
24617982|NCT01046383|Sequestering Agents|sequestering agents|mesh-ancestor
24651180|NCT01229930|Tubulin Modulators|tubulin modulators|mesh-ancestor
24617983|NCT01046383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617985|NCT01046435|Metronidazole|metronidazole|mesh-list
24617986|NCT01046435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24617987|NCT01046435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24617988|NCT01046435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24617989|NCT01046435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24617990|NCT01046461|Dexamethasone|dexamethasone|mesh-list
24617992|NCT01046461|Ramosetron|ramosetron|mesh-list
24617993|NCT01046461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24617994|NCT01046461|Antiemetics|antiemetics|mesh-ancestor
24738870|NCT01677949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24403487|NCT00160537|Levocetirizine|levocetirizine|mesh-list
24738873|NCT01677949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24738874|NCT01677949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24738875|NCT01677949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24738876|NCT01677949|Antimetabolites|antimetabolites|mesh-ancestor
24738878|NCT01677962|Interferon Inducers|interferon inducers|mesh-ancestor
24738879|NCT01677962|Immunologic Factors|immunologic factors|mesh-ancestor
24738880|NCT01677962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738881|NCT01678001|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24738882|NCT01678001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24738883|NCT01678001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24738893|NCT01678053|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24738894|NCT01678053|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24738895|NCT01678053|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24738896|NCT01678053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24738897|NCT01678053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738898|NCT01678053|Cholinergic Agents|cholinergic agents|mesh-ancestor
24738899|NCT01678053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24943903|NCT03966118|Antimitotic Agents|antimitotic agents|mesh-ancestor
24943904|NCT03966118|Mitosis Modulators|mitosis modulators|mesh-ancestor
24812989|NCT02055703|Cholinergic Agents|cholinergic agents|mesh-ancestor
25696264|NCT02059187|MK-1293|mk-1293|mesh-list
25696265|NCT02059187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25696266|NCT02059187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696267|NCT02059187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25696268|NCT02059187|Antimetabolites|antimetabolites|mesh-ancestor
25696269|NCT02059187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696270|NCT02059187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25696271|NCT02059213|Palbociclib|palbociclib|mesh-list
25696272|NCT02059213|Leuprolide|leuprolide|mesh-list
25696273|NCT02059213|Goserelin|goserelin|mesh-list
25696274|NCT02059213|Bicalutamide|bicalutamide|mesh-list
25696275|NCT02059213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738900|NCT01678053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738901|NCT01678053|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24738902|NCT01678053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24738903|NCT01678053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24738904|NCT01678053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24738905|NCT01678053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24738906|NCT01678079|Calcium, Dietary|calcium, dietary|mesh-list
24738907|NCT01678079|Calcium|calcium|mesh-list
24403522|NCT00160745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24403523|NCT00160745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24403525|NCT00160849|Lopinavir|lopinavir|mesh-list
24738908|NCT01678079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24738909|NCT01678079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738910|NCT01678079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24738911|NCT01678092|Omalizumab|omalizumab|mesh-list
24738912|NCT01678092|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24738913|NCT01678092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24738914|NCT01678092|Respiratory System Agents|respiratory system agents|mesh-ancestor
24738915|NCT01678235|Insulin|insulin|mesh-list
24738916|NCT01678235|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24738917|NCT01678235|Insulin Aspart|insulin aspart|mesh-list
24738918|NCT01678235|Insulin glulisine|insulin glulisine|mesh-list
24738919|NCT01678235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24738920|NCT01678235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738921|NCT01678287|Ipragliflozin|ipragliflozin|mesh-list
24738922|NCT01678287|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24738923|NCT01678287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738924|NCT01678287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24738925|NCT01678287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738926|NCT01678352|Imiquimod|imiquimod|mesh-list
24738927|NCT01678352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24738928|NCT01678352|Immunologic Factors|immunologic factors|mesh-ancestor
24738929|NCT01678352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738930|NCT01678352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738931|NCT01678352|Interferon Inducers|interferon inducers|mesh-ancestor
24738932|NCT01678365|Metronidazole|metronidazole|mesh-list
24738933|NCT01678365|Gentamicins|gentamicins|mesh-list
24738934|NCT01678365|Ceftriaxone|ceftriaxone|mesh-list
24738935|NCT01678365|Ampicillin|ampicillin|mesh-list
24738936|NCT01678365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24738943|NCT01678404|Rituximab|rituximab|mesh-list
24738947|NCT01678404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738948|NCT01678404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24738950|NCT01678417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24738951|NCT01678417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739311|NCT01680406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24738967|NCT01678573|Abiraterone Acetate|abiraterone acetate|mesh-list
24738968|NCT01678573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738969|NCT01678573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24738970|NCT01678573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24738971|NCT01678573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738972|NCT01678573|Hormone Antagonists|hormone antagonists|mesh-ancestor
24738973|NCT01678573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24738974|NCT01678573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738975|NCT01678573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24738976|NCT01678599|Benzonidazole|benzonidazole|mesh-list
24943905|NCT03966118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943906|NCT03966118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24738977|NCT01678599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24738978|NCT01678599|Immunologic Factors|immunologic factors|mesh-ancestor
24403551|NCT00160888|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24738984|NCT01678612|Copper|copper|mesh-list
24738995|NCT01678664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738996|NCT01678664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24738998|NCT01678664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24738999|NCT01678664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739000|NCT01678664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24739001|NCT01678664|Immunologic Factors|immunologic factors|mesh-ancestor
24739002|NCT01678664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739003|NCT01678677|Vaccines|vaccines|mesh-list
24739004|NCT01678677|Immunologic Factors|immunologic factors|mesh-ancestor
24585665|NCT00886574|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24585666|NCT00886574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24585667|NCT00886574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24739005|NCT01678677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739006|NCT01678690|Gemcitabine|gemcitabine|mesh-list
24739007|NCT01678690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24739008|NCT01678690|Antimetabolites|antimetabolites|mesh-ancestor
24739009|NCT01678690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739010|NCT01678690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739011|NCT01678690|Antiviral Agents|antiviral agents|mesh-ancestor
24739012|NCT01678690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24739021|NCT01678703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739022|NCT01678703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24739023|NCT01678703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24739044|NCT01678937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739045|NCT01678937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24739060|NCT01679041|Fludarabine|fludarabine|mesh-list
24739061|NCT01679041|Alemtuzumab|alemtuzumab|mesh-list
24739062|NCT01679041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25005000|NCT05180214|Ketorolac|ketorolac|mesh-list
24523104|NCT02588248|Antiemetics|antiemetics|mesh-ancestor
24739312|NCT01680406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24698174|NCT01439399|Ketamine|ketamine|mesh-list
24943908|NCT03965949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24943909|NCT03965949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943910|NCT03965767|Tranexamic Acid|tranexamic acid|mesh-list
24739064|NCT01679041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739065|NCT01679041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24739066|NCT01679041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24739067|NCT01679041|Alkylating Agents|alkylating agents|mesh-ancestor
24739068|NCT01679041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739069|NCT01679041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739070|NCT01679041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24739071|NCT01679041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24739072|NCT01679080|Zoledronic Acid|zoledronic acid|mesh-list
24739073|NCT01679080|Teriparatide|teriparatide|mesh-list
24739074|NCT01679080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24739075|NCT01679080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739076|NCT01679080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24739077|NCT01679093|Dexamethasone|dexamethasone|mesh-list
24739079|NCT01679093|Ondansetron|ondansetron|mesh-list
24739080|NCT01679093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24739081|NCT01679093|Antiemetics|antiemetics|mesh-ancestor
24739082|NCT01679093|Autonomic Agents|autonomic agents|mesh-ancestor
24739083|NCT01679093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24739084|NCT01679093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739085|NCT01679093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24739086|NCT01679093|Glucocorticoids|glucocorticoids|mesh-ancestor
24739088|NCT01679093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24739089|NCT01679093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24739090|NCT01679093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739091|NCT01679093|Antipruritics|antipruritics|mesh-ancestor
24739092|NCT01679093|Dermatologic Agents|dermatologic agents|mesh-ancestor
24739093|NCT01679093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24739094|NCT01679093|Serotonin Agents|serotonin agents|mesh-ancestor
24739095|NCT01679093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25696276|NCT02059213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25696277|NCT02059213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25696278|NCT02059213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696279|NCT02059213|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25696280|NCT02059213|Fertility Agents|fertility agents|mesh-ancestor
25696281|NCT02059213|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25696282|NCT02059213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696283|NCT02059213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25696284|NCT02059213|Androgen Antagonists|androgen antagonists|mesh-ancestor
24585861|NCT00887380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739096|NCT01679093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739097|NCT01679093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24739098|NCT01679093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24739099|NCT01679093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24739100|NCT01679093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24739101|NCT01679093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24739102|NCT01679093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24739103|NCT01679093|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24739104|NCT01679093|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24739105|NCT01679093|Dopamine Agents|dopamine agents|mesh-ancestor
24739107|NCT01679106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24739108|NCT01679106|Narcotics|narcotics|mesh-ancestor
24739109|NCT01679106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24739110|NCT01679106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739111|NCT01679106|Analgesics|analgesics|mesh-ancestor
24739112|NCT01679106|Sensory System Agents|sensory system agents|mesh-ancestor
24739113|NCT01679106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24739114|NCT01679106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24739115|NCT01679106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24739116|NCT01679106|Anesthetics, General|anesthetics, general|mesh-ancestor
24739117|NCT01679106|Anesthetics|anesthetics|mesh-ancestor
24739118|NCT01679327|Calcium, Dietary|calcium, dietary|mesh-list
24739119|NCT01679327|Leucovorin|leucovorin|mesh-list
24403719|NCT00161304|Anabolic Agents|anabolic agents|mesh-ancestor
24739121|NCT01679327|Oxaliplatin|oxaliplatin|mesh-list
24739122|NCT01679327|Calcium|calcium|mesh-list
24739123|NCT01679327|Levoleucovorin|levoleucovorin|mesh-list
24739124|NCT01679327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24739125|NCT01679327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739126|NCT01679327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24739127|NCT01679327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24739128|NCT01679327|Growth Substances|growth substances|mesh-ancestor
24739129|NCT01679327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739130|NCT01679327|Growth Inhibitors|growth inhibitors|mesh-ancestor
24739145|NCT01679392|Sensory System Agents|sensory system agents|mesh-ancestor
24739146|NCT01679392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24739147|NCT01679561|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24739148|NCT01679561|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24739160|NCT01679574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739161|NCT01679574|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24739162|NCT01679574|Hormone Antagonists|hormone antagonists|mesh-ancestor
24739163|NCT01679574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24739164|NCT01679574|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24739165|NCT01679574|Fertility Agents|fertility agents|mesh-ancestor
24739166|NCT01679574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24488077|NCT00466518|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24739167|NCT01679574|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24739168|NCT01679574|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24739169|NCT01679639|Rifampin|rifampin|mesh-list
24739170|NCT01679639|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24739171|NCT01679639|Antitubercular Agents|antitubercular agents|mesh-ancestor
24739172|NCT01679639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24739173|NCT01679639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24739177|NCT01679639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739178|NCT01679639|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24739179|NCT01679639|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24739180|NCT01679639|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24739181|NCT01679639|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24739182|NCT01679639|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24739183|NCT01679639|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24739184|NCT01679652|Nebivolol|nebivolol|mesh-list
24739185|NCT01679652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24739186|NCT01679652|Vasodilator Agents|vasodilator agents|mesh-ancestor
24739187|NCT01679652|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24739188|NCT01679652|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24739189|NCT01679652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24739190|NCT01679652|Adrenergic Agents|adrenergic agents|mesh-ancestor
24739191|NCT01679652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24739192|NCT01679652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696285|NCT02059213|Hormone Antagonists|hormone antagonists|mesh-ancestor
24696805|NCT01431326|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24696806|NCT01431326|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24739195|NCT01679691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24739196|NCT01679691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739198|NCT01679743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24739199|NCT01679743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739200|NCT01679795|Tibolone|tibolone|mesh-list
24739201|NCT01679795|Androgen Antagonists|androgen antagonists|mesh-ancestor
24739208|NCT01679795|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24739209|NCT01679795|Anabolic Agents|anabolic agents|mesh-ancestor
24739211|NCT01679860|Alemtuzumab|alemtuzumab|mesh-list
24739212|NCT01679860|Immunologic Factors|immunologic factors|mesh-list
24739213|NCT01679860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739214|NCT01679860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24739216|NCT01679899|Vildagliptin|vildagliptin|mesh-list
24739242|NCT01680081|Analgesics|analgesics|mesh-ancestor
24739243|NCT01680081|Sensory System Agents|sensory system agents|mesh-ancestor
24739244|NCT01680081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24739245|NCT01680081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739246|NCT01680081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24739247|NCT01680081|Vasodilator Agents|vasodilator agents|mesh-ancestor
24739248|NCT01680081|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24739249|NCT01680081|Purinergic Agonists|purinergic agonists|mesh-ancestor
24739250|NCT01680081|Purinergic Agents|purinergic agents|mesh-ancestor
24739251|NCT01680081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24739252|NCT01680081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739253|NCT01680094|Panobinostat|panobinostat|mesh-list
24739254|NCT01680094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739255|NCT01680094|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24739256|NCT01680094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24739257|NCT01680094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739258|NCT01680107|Cycloserine|cycloserine|mesh-list
24739259|NCT01680107|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24739260|NCT01680107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24739261|NCT01680107|Renal Agents|renal agents|mesh-ancestor
24739262|NCT01680107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24739263|NCT01680107|Antitubercular Agents|antitubercular agents|mesh-ancestor
24739264|NCT01680107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24739265|NCT01680107|Antimetabolites|antimetabolites|mesh-ancestor
24739266|NCT01680107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739267|NCT01680120|Anesthetics|anesthetics|mesh-list
24739268|NCT01680120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24739269|NCT01680120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739270|NCT01680146|Caseins|caseins|mesh-list
24739285|NCT01680198|Micronutrients|micronutrients|mesh-ancestor
24739286|NCT01680198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739287|NCT01680198|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24739288|NCT01680250|Sirolimus|sirolimus|mesh-list
24739289|NCT01680250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24739290|NCT01680250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24739291|NCT01680250|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24739294|NCT01680250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24739295|NCT01680250|Immunologic Factors|immunologic factors|mesh-ancestor
24739296|NCT01680250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739297|NCT01680263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24739298|NCT01680263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
24739299|NCT01680263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24739300|NCT01680263|Analgesics|analgesics|mesh-ancestor
24739301|NCT01680263|Sensory System Agents|sensory system agents|mesh-ancestor
24618014|NCT01046487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24618015|NCT01046487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24618016|NCT01046487|Alkylating Agents|alkylating agents|mesh-ancestor
24618017|NCT01046487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618018|NCT01046487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618019|NCT01046487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24618020|NCT01046487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25696286|NCT02059213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25696287|NCT02059239|Cytarabine|cytarabine|mesh-list
25696288|NCT02059239|Rituximab|rituximab|mesh-list
25696289|NCT02059239|Alemtuzumab|alemtuzumab|mesh-list
24618021|NCT01046487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618022|NCT01046500|Inositol|inositol|mesh-list
24618023|NCT01046500|Metformin|metformin|mesh-list
24488034|NCT00466232|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24618024|NCT01046500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24943919|NCT03965819|Acetaminophen|acetaminophen|mesh-list
24943920|NCT03965819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24943921|NCT03965819|Analgesics|analgesics|mesh-ancestor
24652435|NCT01238185|Antipyretics|antipyretics|mesh-ancestor
24618025|NCT01046500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618026|NCT01046500|Vitamin B Complex|vitamin b complex|mesh-ancestor
24618027|NCT01046500|Vitamins|vitamins|mesh-ancestor
24618028|NCT01046500|Micronutrients|micronutrients|mesh-ancestor
24618029|NCT01046539|Buprenorphine|buprenorphine|mesh-list
24618030|NCT01046539|ALKS-33|alks-33|mesh-list
24618031|NCT01046539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24618032|NCT01046539|Narcotics|narcotics|mesh-ancestor
24618033|NCT01046539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24618034|NCT01046539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618035|NCT01046539|Analgesics|analgesics|mesh-ancestor
24618036|NCT01046539|Sensory System Agents|sensory system agents|mesh-ancestor
24618039|NCT01046578|Letrozole|letrozole|mesh-list
24618040|NCT01046578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618041|NCT01046578|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24618042|NCT01046578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24618043|NCT01046578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618044|NCT01046578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618045|NCT01046578|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24618046|NCT01046578|Hormone Antagonists|hormone antagonists|mesh-ancestor
24618048|NCT01046578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618053|NCT01046630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618054|NCT01046630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24739309|NCT01680406|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24739317|NCT01680471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24739333|NCT01680536|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24739334|NCT01680536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739335|NCT01680536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24739340|NCT01680679|Vaccines|vaccines|mesh-list
24739355|NCT01680796|Bortezomib|bortezomib|mesh-list
24488073|NCT00466479|Adrenergic Agents|adrenergic agents|mesh-ancestor
24488074|NCT00466479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24488075|NCT00466479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739356|NCT01680796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24739357|NCT01680796|Antiemetics|antiemetics|mesh-ancestor
24739358|NCT01680796|Autonomic Agents|autonomic agents|mesh-ancestor
24739359|NCT01680796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24739360|NCT01680796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739361|NCT01680796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24739362|NCT01680796|Glucocorticoids|glucocorticoids|mesh-ancestor
24739363|NCT01680796|Hormones|hormones|mesh-ancestor
24739364|NCT01680796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24739365|NCT01680796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24739366|NCT01680796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739367|NCT01680913|Anesthetics|anesthetics|mesh-list
24739368|NCT01680913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24739369|NCT01680913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739370|NCT01680939|Ibuprofen|ibuprofen|mesh-list
24739371|NCT01680939|Morphine|morphine|mesh-list
25696290|NCT02059239|Etoposide|etoposide|mesh-list
24739372|NCT01680939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24739373|NCT01680939|Narcotics|narcotics|mesh-ancestor
24739374|NCT01680939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24739375|NCT01680939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739376|NCT01680939|Analgesics|analgesics|mesh-ancestor
24739377|NCT01680939|Sensory System Agents|sensory system agents|mesh-ancestor
24739378|NCT01680939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24739379|NCT01680939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24739380|NCT01680939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24739381|NCT01680939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24739382|NCT01680939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24739383|NCT01680939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24528462|NCT00621361|Etoposide|etoposide|mesh-list
24739399|NCT01680952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24739400|NCT01680952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24739401|NCT01680952|Antifungal Agents|antifungal agents|mesh-ancestor
24943922|NCT03965819|Sensory System Agents|sensory system agents|mesh-ancestor
24943923|NCT03965819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24943924|NCT03965819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739405|NCT01681134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739406|NCT01681134|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24739407|NCT01681134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24739408|NCT01681134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739410|NCT01681446|Interferon-alpha|interferon-alpha|mesh-list
24739411|NCT01681446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739436|NCT01681537|Growth Inhibitors|growth inhibitors|mesh-ancestor
24739437|NCT01681537|Analgesics|analgesics|mesh-ancestor
24739438|NCT01681537|Sensory System Agents|sensory system agents|mesh-ancestor
24739439|NCT01681537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24739441|NCT01681550|Hormones|hormones|mesh-ancestor
24739442|NCT01681550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24739443|NCT01681550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739444|NCT01681563|Cyclophosphamide|cyclophosphamide|mesh-list
24739445|NCT01681563|Ofatumumab|ofatumumab|mesh-list
24739446|NCT01681563|Pentostatin|pentostatin|mesh-list
24739447|NCT01681563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24739448|NCT01681563|Immunologic Factors|immunologic factors|mesh-ancestor
24739449|NCT01681563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739450|NCT01681563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24739451|NCT01681563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24739452|NCT01681563|Alkylating Agents|alkylating agents|mesh-ancestor
24739453|NCT01681563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739454|NCT01681563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739455|NCT01681563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24739456|NCT01681563|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
24739457|NCT01681563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24739458|NCT01681667|Ibuprofen|ibuprofen|mesh-list
24739459|NCT01681667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24528612|NCT00621998|Olanzapine|olanzapine|mesh-list
24739484|NCT01681875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24739485|NCT01681875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739486|NCT01681966|Ropivacaine|ropivacaine|mesh-list
24739487|NCT01681966|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24739488|NCT01681966|Anesthetics, Local|anesthetics, local|mesh-ancestor
24739489|NCT01681966|Anesthetics|anesthetics|mesh-ancestor
24739490|NCT01681966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24739491|NCT01681966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739492|NCT01681966|Sensory System Agents|sensory system agents|mesh-ancestor
24739493|NCT01681966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24739494|NCT01681979|Fluticasone|fluticasone|mesh-list
24739496|NCT01681979|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24739519|NCT01682161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739520|NCT01682161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24739521|NCT01682161|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24739522|NCT01682161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24739523|NCT01682161|Serotonin Agents|serotonin agents|mesh-ancestor
24739524|NCT01682161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24739525|NCT01682161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739526|NCT01682161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24739527|NCT01682161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25110180|NCT05464979|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24739528|NCT01682161|Dopamine Agents|dopamine agents|mesh-ancestor
24739603|NCT01682733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739604|NCT01682746|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
24739605|NCT01682746|Trioxsalen|trioxsalen|mesh-list
24848895|NCT03283488|Megestrol|megestrol|mesh-list
24739606|NCT01682746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739607|NCT01682746|Dermatologic Agents|dermatologic agents|mesh-ancestor
24739608|NCT01682746|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24943927|NCT03966066|Erythromycin Estolate|erythromycin estolate|mesh-list
24943928|NCT03966066|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24943929|NCT03966066|Erythromycin stearate|erythromycin stearate|mesh-list
24943930|NCT03966066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24739609|NCT01682772|Olaparib|olaparib|mesh-list
24651263|NCT01230775|Anagrelide|anagrelide|mesh-list
24493944|NCT00493129|Interleukin-2|interleukin-2|mesh-list
24739611|NCT01682772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24739612|NCT01682772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739613|NCT01682772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739615|NCT01682902|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24739616|NCT01682902|Insulin Aspart|insulin aspart|mesh-list
24739618|NCT01682902|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24739620|NCT01682902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739621|NCT01683006|Rocuronium|rocuronium|mesh-list
24739622|NCT01683006|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24618070|NCT01046721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618071|NCT01046721|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24618072|NCT01046721|Incretins|incretins|mesh-ancestor
24618073|NCT01046721|Hormones|hormones|mesh-ancestor
24618074|NCT01046721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24618075|NCT01046773|Cholecalciferol|cholecalciferol|mesh-list
24618076|NCT01046773|Vitamin D|vitamin d|mesh-list
24618077|NCT01046773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24618078|NCT01046773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618079|NCT01046773|Vitamins|vitamins|mesh-ancestor
24739636|NCT01683149|Sorafenib|sorafenib|mesh-list
24739637|NCT01683149|Topotecan|topotecan|mesh-list
24739638|NCT01683149|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
24739639|NCT01683149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739640|NCT01683149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24739642|NCT01683149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739644|NCT01683162|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24523468|NCT00467142|Antidotes|antidotes|mesh-ancestor
24443301|NCT00294463|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24443302|NCT00294463|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24739716|NCT01683656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739717|NCT01683656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24739718|NCT01683656|Vasodilator Agents|vasodilator agents|mesh-ancestor
24739719|NCT01683656|Vitamin B Complex|vitamin b complex|mesh-ancestor
24739721|NCT01683656|Micronutrients|micronutrients|mesh-ancestor
24739722|NCT01683656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739723|NCT01683682|Carboplatin|carboplatin|mesh-list
24739724|NCT01683682|Vinorelbine|vinorelbine|mesh-list
24739726|NCT01683682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25696291|NCT02059239|Melphalan|melphalan|mesh-list
25696292|NCT02059239|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25696293|NCT02059239|Carmustine|carmustine|mesh-list
25696294|NCT02059239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25696295|NCT02059239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25696296|NCT02059239|Immunologic Factors|immunologic factors|mesh-ancestor
24739764|NCT01684059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943931|NCT03966066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24813039|NCT02056223|Acetaminophen|acetaminophen|mesh-list
24739765|NCT01684059|Dermatologic Agents|dermatologic agents|mesh-ancestor
24739766|NCT01684072|Vaccines|vaccines|mesh-list
24739808|NCT01684319|Caseins|caseins|mesh-list
24739844|NCT01684683|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24739845|NCT01684683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24739846|NCT01684683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739847|NCT01684683|Vasodilator Agents|vasodilator agents|mesh-ancestor
24739848|NCT01684683|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24739849|NCT01684683|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24739850|NCT01684683|Purinergic Agents|purinergic agents|mesh-ancestor
24739851|NCT01684683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24739852|NCT01684774|Bupivacaine|bupivacaine|mesh-list
24739879|NCT01684813|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24739880|NCT01684813|Purinergic Agents|purinergic agents|mesh-ancestor
24739881|NCT01684813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24739882|NCT01684813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739883|NCT01684813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739885|NCT01684865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24739886|NCT01684865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739887|NCT01684865|Immunologic Factors|immunologic factors|mesh-ancestor
24739888|NCT01684865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739889|NCT01684865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24739904|NCT01684969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739905|NCT01684969|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24739906|NCT01684982|Sirolimus|sirolimus|mesh-list
24739907|NCT01684982|Everolimus|everolimus|mesh-list
24739908|NCT01684982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739909|NCT01684982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24739910|NCT01684982|Immunologic Factors|immunologic factors|mesh-ancestor
24739911|NCT01684982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739912|NCT01684982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24739913|NCT01684982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24739914|NCT01684982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24739915|NCT01684982|Antifungal Agents|antifungal agents|mesh-ancestor
24739916|NCT01684995|Nicotine|nicotine|mesh-list
24739917|NCT01684995|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24739918|NCT01684995|Autonomic Agents|autonomic agents|mesh-ancestor
24739919|NCT01684995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24739920|NCT01684995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739921|NCT01684995|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24739922|NCT01684995|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24739923|NCT01684995|Cholinergic Agents|cholinergic agents|mesh-ancestor
24739924|NCT01684995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24739925|NCT01684995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739926|NCT01685125|Prednisone|prednisone|mesh-list
24739927|NCT01685125|Dasatinib|dasatinib|mesh-list
24739928|NCT01685125|Abiraterone Acetate|abiraterone acetate|mesh-list
24739929|NCT01685125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24739930|NCT01685125|Glucocorticoids|glucocorticoids|mesh-ancestor
24739931|NCT01685125|Hormones|hormones|mesh-ancestor
24404587|NCT00164112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24618143|NCT01046942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24618144|NCT01046942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24618145|NCT01046942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618146|NCT01046942|Antipyretics|antipyretics|mesh-ancestor
24618147|NCT01046942|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24739980|NCT01685502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739981|NCT01685515|Decitabine|decitabine|mesh-list
24739982|NCT01685515|Tetrahydrouridine|tetrahydrouridine|mesh-list
24739983|NCT01685515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24739984|NCT01685515|Antimetabolites|antimetabolites|mesh-ancestor
24739985|NCT01685515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739986|NCT01685515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739987|NCT01685515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24739988|NCT01685658|Acetaminophen|acetaminophen|mesh-list
24739989|NCT01685658|Ketoprofen|ketoprofen|mesh-list
24739990|NCT01685658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24739991|NCT01685658|Analgesics|analgesics|mesh-ancestor
24739992|NCT01685658|Sensory System Agents|sensory system agents|mesh-ancestor
24739993|NCT01685658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24739994|NCT01685658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739995|NCT01685658|Antipyretics|antipyretics|mesh-ancestor
24739996|NCT01685658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24739997|NCT01685658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24739998|NCT01685658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24739999|NCT01685658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24740039|NCT01685970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24740040|NCT01686009|Ketamine|ketamine|mesh-list
24740041|NCT01686009|Analgesics|analgesics|mesh-ancestor
24740042|NCT01686009|Sensory System Agents|sensory system agents|mesh-ancestor
24740043|NCT01686009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740079|NCT01686321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24740080|NCT01686321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24740081|NCT01686321|Immunologic Factors|immunologic factors|mesh-ancestor
24740082|NCT01686321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740083|NCT01686321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24740084|NCT01686321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24740085|NCT01686321|Alkylating Agents|alkylating agents|mesh-ancestor
24740086|NCT01686321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740087|NCT01686347|Ropivacaine|ropivacaine|mesh-list
24740088|NCT01686347|Anesthetics, Local|anesthetics, local|mesh-ancestor
24740090|NCT01686347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24740091|NCT01686347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740092|NCT01686347|Sensory System Agents|sensory system agents|mesh-ancestor
24740093|NCT01686347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740094|NCT01686386|Dexamethasone|dexamethasone|mesh-list
24740095|NCT01686386|Lenalidomide|lenalidomide|mesh-list
24740096|NCT01686386|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24740097|NCT01686386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24740098|NCT01686386|Antiemetics|antiemetics|mesh-ancestor
24740099|NCT01686386|Autonomic Agents|autonomic agents|mesh-ancestor
24740119|NCT01686464|Glucocorticoids|glucocorticoids|mesh-ancestor
24740120|NCT01686464|Hormones|hormones|mesh-ancestor
24740121|NCT01686464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24740122|NCT01686464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740123|NCT01686464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24740124|NCT01686464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24740125|NCT01686464|Antiviral Agents|antiviral agents|mesh-ancestor
24740126|NCT01686464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24740127|NCT01686529|Bevacizumab|bevacizumab|mesh-list
24740128|NCT01686529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24943934|NCT03966066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813043|NCT02056223|Analgesics|analgesics|mesh-ancestor
24740129|NCT01686529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24740130|NCT01686529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24740131|NCT01686529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24740132|NCT01686529|Growth Substances|growth substances|mesh-ancestor
24740133|NCT01686529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740134|NCT01686529|Growth Inhibitors|growth inhibitors|mesh-ancestor
24740135|NCT01686555|Venetoclax|venetoclax|mesh-list
24740136|NCT01686555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24740137|NCT01686594|Methoxsalen|methoxsalen|mesh-list
24740138|NCT01686594|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24740139|NCT01686594|Dermatologic Agents|dermatologic agents|mesh-ancestor
24740140|NCT01686607|Itraconazole|itraconazole|mesh-list
24740141|NCT01686607|Fluconazole|fluconazole|mesh-list
24740142|NCT01686607|Voriconazole|voriconazole|mesh-list
24740143|NCT01686607|Amphotericin B|amphotericin b|mesh-list
24740144|NCT01686607|Caspofungin|caspofungin|mesh-list
24740145|NCT01686607|Micafungin|micafungin|mesh-list
24740146|NCT01686607|Antifungal Agents|antifungal agents|mesh-list
24740147|NCT01686607|Clotrimazole|clotrimazole|mesh-list
24740148|NCT01686607|Miconazole|miconazole|mesh-list
24740161|NCT01686607|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24740162|NCT01686607|Amebicides|amebicides|mesh-ancestor
24740163|NCT01686607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24740164|NCT01686607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24740165|NCT01686607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24740166|NCT01686607|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24740167|NCT01686659|Chrysarobin|chrysarobin|mesh-list
24740168|NCT01686659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24740169|NCT01686659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24740171|NCT01686659|Sensory System Agents|sensory system agents|mesh-ancestor
24740172|NCT01686659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740173|NCT01686659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740202|NCT01686802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24740203|NCT01686802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740205|NCT01687049|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24740206|NCT01687049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24740207|NCT01687049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24740208|NCT01687049|Antimetabolites|antimetabolites|mesh-ancestor
24740209|NCT01687049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740210|NCT01687049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24740211|NCT01687049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24740212|NCT01687062|Fe(III)-EDTA|fe(iii)-edta|mesh-list
24740213|NCT01687062|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24740214|NCT01687062|Chelating Agents|chelating agents|mesh-ancestor
24740215|NCT01687062|Sequestering Agents|sequestering agents|mesh-ancestor
24740216|NCT01687062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740218|NCT01687127|Vitamin B Complex|vitamin b complex|mesh-list
24740219|NCT01687127|Calcium|calcium|mesh-list
24740220|NCT01687127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24740359|NCT01687894|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24740222|NCT01687127|Hematinics|hematinics|mesh-ancestor
24740223|NCT01687127|Vitamins|vitamins|mesh-ancestor
24740224|NCT01687127|Micronutrients|micronutrients|mesh-ancestor
24740225|NCT01687140|Cycloserine|cycloserine|mesh-list
24740226|NCT01687140|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24740227|NCT01687140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24740228|NCT01687140|Renal Agents|renal agents|mesh-ancestor
24740259|NCT01687374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24740260|NCT01687426|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24740295|NCT01687582|Hormones|hormones|mesh-ancestor
24740296|NCT01687582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24740297|NCT01687582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24740299|NCT01687699|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24740300|NCT01687699|Hormone Antagonists|hormone antagonists|mesh-ancestor
24740301|NCT01687699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24740302|NCT01687699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740303|NCT01687699|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24740304|NCT01687699|Diuretics|diuretics|mesh-ancestor
24740305|NCT01687699|Natriuretic Agents|natriuretic agents|mesh-ancestor
24740306|NCT01687751|Midazolam|midazolam|mesh-list
24740307|NCT01687751|Dexmedetomidine|dexmedetomidine|mesh-list
24740310|NCT01687751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740311|NCT01687751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24618169|NCT01046994|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24618170|NCT01046994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618171|NCT01047059|Bevacizumab|bevacizumab|mesh-list
24618172|NCT01047059|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24618173|NCT01047059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24618174|NCT01047059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618175|NCT01047059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24618176|NCT01047059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24618177|NCT01047059|Growth Substances|growth substances|mesh-ancestor
24618178|NCT01047059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618179|NCT01047059|Growth Inhibitors|growth inhibitors|mesh-ancestor
24618180|NCT01047059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24618181|NCT01047059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618182|NCT01047059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740312|NCT01687751|Analgesics|analgesics|mesh-ancestor
24740323|NCT01687751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24740324|NCT01687751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24740325|NCT01687751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24740326|NCT01687751|Anesthetics, General|anesthetics, general|mesh-ancestor
24740327|NCT01687751|Anesthetics|anesthetics|mesh-ancestor
24740328|NCT01687751|GABA Modulators|gaba modulators|mesh-ancestor
24740329|NCT01687751|GABA Agents|gaba agents|mesh-ancestor
24943935|NCT03966066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943937|NCT03965546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24523737|NCT05340803|Tocolytic Agents|tocolytic agents|mesh-ancestor
24740332|NCT01687868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24740343|NCT01687868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740344|NCT01687894|Vasopressins|vasopressins|mesh-list
24740345|NCT01687894|Arginine Vasopressin|arginine vasopressin|mesh-list
24740346|NCT01687894|Propofol|propofol|mesh-list
24740347|NCT01687894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
24740348|NCT01687894|Anesthetics|anesthetics|mesh-list
24740349|NCT01687894|Sevoflurane|sevoflurane|mesh-list
24740350|NCT01687894|Anesthetics, General|anesthetics, general|mesh-list
24740351|NCT01687894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24651312|NCT01230983|Vitamins|vitamins|mesh-ancestor
24740352|NCT01687894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24740353|NCT01687894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740354|NCT01687894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24740355|NCT01687894|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24740356|NCT01687894|Hemostatics|hemostatics|mesh-ancestor
24740357|NCT01687894|Coagulants|coagulants|mesh-ancestor
24740358|NCT01687894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24740366|NCT01688024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740436|NCT01688518|Sensory System Agents|sensory system agents|mesh-ancestor
24500740|NCT00525642|Docetaxel|docetaxel|mesh-list
24740459|NCT01688570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24740460|NCT01688570|Dopamine Agents|dopamine agents|mesh-ancestor
24740461|NCT01688570|Antipruritics|antipruritics|mesh-ancestor
24740462|NCT01688570|Dermatologic Agents|dermatologic agents|mesh-ancestor
24740463|NCT01688570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24740464|NCT01688570|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24740465|NCT01688570|Histamine Antagonists|histamine antagonists|mesh-ancestor
24740466|NCT01688570|Histamine Agents|histamine agents|mesh-ancestor
24740467|NCT01688570|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24740468|NCT01688570|Serotonin Agents|serotonin agents|mesh-ancestor
24740469|NCT01688570|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24740471|NCT01688583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24740472|NCT01688583|Narcotics|narcotics|mesh-ancestor
24943938|NCT03965546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24943939|NCT03965546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24943941|NCT03965624|Ixazomib|ixazomib|mesh-list
24943942|NCT03965624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943943|NCT03965624|Protease Inhibitors|protease inhibitors|mesh-ancestor
24943944|NCT03965624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813047|NCT02056223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24740473|NCT01688583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24740474|NCT01688583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740475|NCT01688583|Analgesics|analgesics|mesh-ancestor
24740476|NCT01688583|Sensory System Agents|sensory system agents|mesh-ancestor
24740477|NCT01688583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740478|NCT01688583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24740479|NCT01688583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24740480|NCT01688583|Anesthetics, General|anesthetics, general|mesh-ancestor
24740481|NCT01688583|Anesthetics|anesthetics|mesh-ancestor
24740482|NCT01688648|Lidocaine|lidocaine|mesh-list
24740483|NCT01688648|Dexmedetomidine|dexmedetomidine|mesh-list
24740484|NCT01688648|Anesthetics, Local|anesthetics, local|mesh-ancestor
24740485|NCT01688648|Anesthetics|anesthetics|mesh-ancestor
24740486|NCT01688648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24740487|NCT01688648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740488|NCT01688648|Sensory System Agents|sensory system agents|mesh-ancestor
24740489|NCT01688648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740490|NCT01688648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24740553|NCT01688960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448228|NCT00310778|Sympatholytics|sympatholytics|mesh-ancestor
24740585|NCT01689116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24740586|NCT01689116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740587|NCT01689116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24740588|NCT01689116|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24740589|NCT01689116|Contraceptive Agents|contraceptive agents|mesh-ancestor
24740590|NCT01689116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24740591|NCT01689116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740592|NCT01689116|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24740593|NCT01689116|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24740611|NCT01689259|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24740614|NCT01689259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740615|NCT01689259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24740616|NCT01689259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24740617|NCT01689285|Valacyclovir|valacyclovir|mesh-list
24740618|NCT01689285|Antiviral Agents|antiviral agents|mesh-ancestor
24740619|NCT01689285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24740620|NCT01689298|Oxytocin|oxytocin|mesh-list
24740621|NCT01689298|Carbetocin|carbetocin|mesh-list
24740626|NCT01689311|Misoprostol|misoprostol|mesh-list
24740627|NCT01689311|Oxytocin|oxytocin|mesh-list
24740628|NCT01689311|Ergonovine|ergonovine|mesh-list
24740629|NCT01689311|Dinoprost|dinoprost|mesh-list
24740630|NCT01689311|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
24740631|NCT01689311|Oxytocics|oxytocics|mesh-ancestor
24740632|NCT01689311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24740633|NCT01689311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740634|NCT01689311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24740635|NCT01689311|Abortifacient Agents|abortifacient agents|mesh-ancestor
24740636|NCT01689311|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24740637|NCT01689311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24740638|NCT01689311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24740639|NCT01689311|Vasodilator Agents|vasodilator agents|mesh-ancestor
24943945|NCT03965624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943946|NCT03965442|Esmolol|esmolol|mesh-list
24943947|NCT03965442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24740640|NCT01689311|Urological Agents|urological agents|mesh-ancestor
24740641|NCT01689558|Endostatins|endostatins|mesh-list
24740642|NCT01689558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24740649|NCT01689597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24740650|NCT01689597|Narcotics|narcotics|mesh-ancestor
24740651|NCT01689597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24740652|NCT01689597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740653|NCT01689597|Analgesics|analgesics|mesh-ancestor
24740654|NCT01689597|Sensory System Agents|sensory system agents|mesh-ancestor
24740686|NCT01689753|Sequestering Agents|sequestering agents|mesh-ancestor
24740687|NCT01689753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740688|NCT01689766|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
24740689|NCT01689766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24618184|NCT01047072|Cyclophosphamide|cyclophosphamide|mesh-list
24618186|NCT01047072|Fludarabine|fludarabine|mesh-list
24618187|NCT01047072|Fludarabine phosphate|fludarabine phosphate|mesh-list
24618188|NCT01047072|Tacrolimus|tacrolimus|mesh-list
24651337|NCT01231126|Misoprostol|misoprostol|mesh-list
24618189|NCT01047072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24618190|NCT01047072|Immunologic Factors|immunologic factors|mesh-ancestor
24618191|NCT01047072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618192|NCT01047072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24618193|NCT01047072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24618194|NCT01047072|Alkylating Agents|alkylating agents|mesh-ancestor
24618195|NCT01047072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618196|NCT01047072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618197|NCT01047072|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24618198|NCT01047072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24618199|NCT01047072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24740693|NCT01689870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24740694|NCT01689870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24740695|NCT01689870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618230|NCT01047215|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24740697|NCT01689896|Androgens|androgens|mesh-ancestor
24740698|NCT01689896|Hormones|hormones|mesh-ancestor
24740699|NCT01689896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24740719|NCT01689987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25071030|NCT03413410|Metoprolol|metoprolol|mesh-list
24740720|NCT01689987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24740722|NCT01689987|Autonomic Agents|autonomic agents|mesh-ancestor
24740723|NCT01689987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740724|NCT01689987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24740725|NCT01689987|Glucocorticoids|glucocorticoids|mesh-ancestor
24943948|NCT03965442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24943949|NCT03965442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24740726|NCT01689987|Hormones|hormones|mesh-ancestor
24740727|NCT01689987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24740728|NCT01689987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24740729|NCT01689987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24657447|NCT01267383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24740755|NCT01690104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24740757|NCT01690104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24740758|NCT01690104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24740759|NCT01690104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740760|NCT01690104|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24740761|NCT01690104|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24740762|NCT01690104|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24740763|NCT01690104|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24740764|NCT01690104|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24740765|NCT01690104|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24740792|NCT01690325|Trastuzumab|trastuzumab|mesh-list
24740793|NCT01690325|Epirubicin|epirubicin|mesh-list
24740794|NCT01690325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24740795|NCT01690325|Immunologic Factors|immunologic factors|mesh-ancestor
24740796|NCT01690325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740797|NCT01690325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24740798|NCT01690325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24740799|NCT01690325|Alkylating Agents|alkylating agents|mesh-ancestor
24740800|NCT01690325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740812|NCT01690325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24740813|NCT01690325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24740815|NCT01690338|Bromides|bromides|mesh-list
24740816|NCT01690338|Rocuronium|rocuronium|mesh-list
24740817|NCT01690338|Vecuronium Bromide|vecuronium bromide|mesh-list
24740818|NCT01690338|Cisatracurium|cisatracurium|mesh-list
24740819|NCT01690338|Anticonvulsants|anticonvulsants|mesh-ancestor
24505615|NCT00541567|Hormones|hormones|mesh-ancestor
24505617|NCT00541567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740835|NCT01690364|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24740836|NCT01690364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24740856|NCT01690507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24740858|NCT01690507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740859|NCT01690507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24740860|NCT01690507|Antiviral Agents|antiviral agents|mesh-ancestor
24740861|NCT01690507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24740862|NCT01690507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24740863|NCT01690507|Immunologic Factors|immunologic factors|mesh-ancestor
24740864|NCT01690507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740865|NCT01690507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24740866|NCT01690507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24740867|NCT01690507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24740868|NCT01690533|Moxifloxacin|moxifloxacin|mesh-list
24943964|NCT03965286|Antiviral Agents|antiviral agents|mesh-ancestor
24740919|NCT01690637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740921|NCT01690702|Docetaxel|docetaxel|mesh-list
24740922|NCT01690702|Cyclophosphamide|cyclophosphamide|mesh-list
24740923|NCT01690702|Epirubicin|epirubicin|mesh-list
24740924|NCT01690702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24740925|NCT01690702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24740926|NCT01690702|Tubulin Modulators|tubulin modulators|mesh-ancestor
24740927|NCT01690702|Antimitotic Agents|antimitotic agents|mesh-ancestor
24740928|NCT01690702|Mitosis Modulators|mitosis modulators|mesh-ancestor
24740929|NCT01690702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740930|NCT01690702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24740931|NCT01690702|Immunologic Factors|immunologic factors|mesh-ancestor
24405612|NCT00167739|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24740960|NCT01690780|Sensory System Agents|sensory system agents|mesh-ancestor
24740961|NCT01690780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740962|NCT01690780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24943966|NCT03965117|Norepinephrine|norepinephrine|mesh-list
24741025|NCT01691209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24741027|NCT01691365|Vitamin B Complex|vitamin b complex|mesh-list
24943969|NCT03965117|Adrenergic Agents|adrenergic agents|mesh-ancestor
24943970|NCT03965117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24405758|NCT00168350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741053|NCT01691469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24741054|NCT01691469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696297|NCT02059239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696298|NCT02059239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24741063|NCT01691495|Protease Inhibitors|protease inhibitors|mesh-ancestor
24741064|NCT01691495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24741065|NCT01691495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741066|NCT01691495|Anticoagulants|anticoagulants|mesh-ancestor
24741067|NCT01691495|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24741068|NCT01691495|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24741069|NCT01691651|Botulinum Toxins|botulinum toxins|mesh-list
24741070|NCT01691651|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24741071|NCT01691651|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24943972|NCT03965117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618234|NCT01047423|Simvastatin|simvastatin|mesh-list
24618235|NCT01047423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24742282|NCT05288062|Dexamethasone acetate|dexamethasone acetate|mesh-list
24443306|NCT00294463|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24741151|NCT01692210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24741152|NCT01692210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24741153|NCT01692210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24741154|NCT01692210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24741155|NCT01692210|Adrenergic Agents|adrenergic agents|mesh-ancestor
24741156|NCT01692210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24741157|NCT01692210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741158|NCT01692457|Golimumab|golimumab|mesh-list
24741159|NCT01692457|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25005158|NCT04712851|Pembrolizumab|pembrolizumab|mesh-list
24741164|NCT01692483|Prednisone|prednisone|mesh-list
24741165|NCT01692483|Abiraterone Acetate|abiraterone acetate|mesh-list
24741166|NCT01692483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24741167|NCT01692483|Glucocorticoids|glucocorticoids|mesh-ancestor
24741190|NCT01692704|Antimetabolites|antimetabolites|mesh-ancestor
24741191|NCT01692704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741192|NCT01692704|Antiviral Agents|antiviral agents|mesh-ancestor
24741193|NCT01692704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24741208|NCT01692717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24741209|NCT01692717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24741210|NCT01692717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24741211|NCT01692717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24741212|NCT01692717|Diuretics|diuretics|mesh-ancestor
25696299|NCT02059239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24741213|NCT01692717|Natriuretic Agents|natriuretic agents|mesh-ancestor
24741214|NCT01692717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696300|NCT02059239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24657600|NCT01268631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657601|NCT01268631|Anticonvulsants|anticonvulsants|mesh-ancestor
24657602|NCT01268631|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24741215|NCT01692717|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24741216|NCT01692717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24943975|NCT03965117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24943976|NCT03965117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24943977|NCT03965078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24741218|NCT01692808|Ergocalciferols|ergocalciferols|mesh-list
24741219|NCT01692808|Cholecalciferol|cholecalciferol|mesh-list
24741221|NCT01692808|Micronutrients|micronutrients|mesh-ancestor
24741222|NCT01692808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741223|NCT01692808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24741224|NCT01692808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24741225|NCT01692834|Cyclosporine|cyclosporine|mesh-list
24741226|NCT01692834|Cyclosporins|cyclosporins|mesh-list
24741227|NCT01692834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24741228|NCT01692834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741229|NCT01692834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24741230|NCT01692834|Immunologic Factors|immunologic factors|mesh-ancestor
24741231|NCT01692834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741232|NCT01692834|Antifungal Agents|antifungal agents|mesh-ancestor
24741233|NCT01692834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24741234|NCT01692834|Dermatologic Agents|dermatologic agents|mesh-ancestor
24741235|NCT01692834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24741236|NCT01692834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24741237|NCT01692886|Vaccines|vaccines|mesh-list
24741238|NCT01692886|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24741239|NCT01692886|Immunologic Factors|immunologic factors|mesh-ancestor
24741240|NCT01692886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741241|NCT01692925|Factor VIII|factor viii|mesh-list
25005149|NCT04742673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25005150|NCT04742673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005151|NCT04742673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005159|NCT04712851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25005160|NCT04712851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24741262|NCT01693081|Dopamine Agents|dopamine agents|mesh-ancestor
24741263|NCT01693081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24741264|NCT01693081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741265|NCT01693159|Ethyl 2-cyanoacrylate|ethyl 2-cyanoacrylate|mesh-list
24741310|NCT01693328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24741311|NCT01693328|Anesthetics, General|anesthetics, general|mesh-ancestor
24741313|NCT01693380|Vaccines|vaccines|mesh-list
24741314|NCT01693380|Immunologic Factors|immunologic factors|mesh-ancestor
24741315|NCT01693380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741316|NCT01693393|Cyclosporine|cyclosporine|mesh-list
24741317|NCT01693393|Cyclosporins|cyclosporins|mesh-list
24741318|NCT01693393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24741319|NCT01693393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741320|NCT01693393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24741321|NCT01693393|Immunologic Factors|immunologic factors|mesh-ancestor
24741322|NCT01693393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741388|NCT01693718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24741389|NCT01693718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24741391|NCT01693809|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24741392|NCT01693809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741393|NCT01693809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24741394|NCT01693809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24741395|NCT01693809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741509|NCT05288374|Celecoxib|celecoxib|mesh-list
25696301|NCT02059239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25696302|NCT02059239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25696303|NCT02059239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741510|NCT05288374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24741511|NCT05288374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24741512|NCT05288374|Analgesics|analgesics|mesh-ancestor
24741513|NCT05288374|Sensory System Agents|sensory system agents|mesh-ancestor
24741514|NCT05288374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24741515|NCT05288374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741516|NCT05288374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24741517|NCT05288374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24741518|NCT05288374|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24741519|NCT05288374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24741520|NCT05288374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24741521|NCT05288374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741522|NCT05288335|Methamphetamine|methamphetamine|mesh-list
24741523|NCT05288335|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24741524|NCT05288335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741525|NCT05288335|Sympathomimetics|sympathomimetics|mesh-ancestor
24741526|NCT05288335|Autonomic Agents|autonomic agents|mesh-ancestor
24741576|NCT05291455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741577|NCT05291455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24741578|NCT05291455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24741579|NCT05291455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24741580|NCT05291455|GABA Modulators|gaba modulators|mesh-ancestor
24741581|NCT05291455|GABA Agents|gaba agents|mesh-ancestor
24741582|NCT05291455|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24741583|NCT05291455|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24741620|NCT05291052|Lenvatinib|lenvatinib|mesh-list
24741621|NCT05291052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24741622|NCT05291052|Antimetabolites|antimetabolites|mesh-ancestor
25071285|NCT03411798|Antimetabolites|antimetabolites|mesh-ancestor
24741623|NCT05291052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741624|NCT05291052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24741625|NCT05291052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24741626|NCT05291052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24741627|NCT05291039|Adalimumab|adalimumab|mesh-list
24741628|NCT05291039|Infliximab|infliximab|mesh-list
24741629|NCT05291039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24741630|NCT05291039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24741631|NCT05291039|Dermatologic Agents|dermatologic agents|mesh-ancestor
24741632|NCT05291039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24741633|NCT05290948|Bevacizumab|bevacizumab|mesh-list
24741634|NCT05290948|Acetazolamide|acetazolamide|mesh-list
24741635|NCT05290948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24741636|NCT05290948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24741637|NCT05290948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24741638|NCT05290948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24741639|NCT05290948|Growth Substances|growth substances|mesh-ancestor
24741640|NCT05290948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741641|NCT05290948|Growth Inhibitors|growth inhibitors|mesh-ancestor
24741688|NCT05290324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24741689|NCT05290324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24741813|NCT05292586|Beclomethasone|beclomethasone|mesh-list
24741814|NCT05292586|Formoterol Fumarate|formoterol fumarate|mesh-list
24741815|NCT05292586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24741816|NCT05292586|Autonomic Agents|autonomic agents|mesh-ancestor
24741817|NCT05292586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24741818|NCT05292586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741819|NCT05292586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24741820|NCT05292586|Respiratory System Agents|respiratory system agents|mesh-ancestor
24943984|NCT03965247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943985|NCT03965247|Antimanic Agents|antimanic agents|mesh-ancestor
24943986|NCT03965247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24741821|NCT05292586|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24741822|NCT05292586|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24741823|NCT05292586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24741824|NCT05292586|Adrenergic Agents|adrenergic agents|mesh-ancestor
24741825|NCT05292586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24741826|NCT05292586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741827|NCT05292586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24741828|NCT05292586|Glucocorticoids|glucocorticoids|mesh-ancestor
24741830|NCT05292586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24741831|NCT05292573|Metformin|metformin|mesh-list
24741832|NCT05292573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24741833|NCT05292573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618238|NCT01047423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618256|NCT01047488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24618257|NCT01047488|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24618258|NCT01047488|Antidepressive Agents|antidepressive agents|mesh-ancestor
24618259|NCT01047488|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24618260|NCT01047488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24618261|NCT01047488|Adrenergic Agents|adrenergic agents|mesh-ancestor
24618262|NCT01047488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24618264|NCT01047566|Dronedarone|dronedarone|mesh-list
24618265|NCT01047566|Calcium Channel Blockers|calcium channel blockers|mesh-list
24618266|NCT01047566|Calcium|calcium|mesh-list
24618272|NCT01047566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618273|NCT01047566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618274|NCT01047566|Protective Agents|protective agents|mesh-ancestor
24618275|NCT01047566|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24618276|NCT01047566|Adrenergic Agents|adrenergic agents|mesh-ancestor
24618277|NCT01047566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24618278|NCT01047566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24618279|NCT01047579|Rivastigmine|rivastigmine|mesh-list
24618280|NCT01047579|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24618281|NCT01047579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618282|NCT01047579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618283|NCT01047579|Cholinergic Agents|cholinergic agents|mesh-ancestor
24618284|NCT01047579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24618285|NCT01047579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618286|NCT01047579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24943987|NCT03965247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25071382|NCT03410784|Carboplatin|carboplatin|mesh-list
24943988|NCT03965247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741859|NCT05291910|Antimitotic Agents|antimitotic agents|mesh-ancestor
24741860|NCT05291910|Mitosis Modulators|mitosis modulators|mesh-ancestor
24741861|NCT05291910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741865|NCT05291793|Methylprednisolone|methylprednisolone|mesh-list
24741866|NCT05291793|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24741867|NCT05291793|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24741868|NCT05291793|Prednisolone|prednisolone|mesh-list
24741869|NCT05291793|Prednisolone acetate|prednisolone acetate|mesh-list
24741870|NCT05291793|Tenoxicam|tenoxicam|mesh-list
24741871|NCT05291793|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24741872|NCT05291793|Prednisolone phosphate|prednisolone phosphate|mesh-list
24741873|NCT05291793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24741874|NCT05291793|Antiemetics|antiemetics|mesh-ancestor
24741875|NCT05291793|Autonomic Agents|autonomic agents|mesh-ancestor
24741876|NCT05291793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24741877|NCT05291793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741878|NCT05291793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24741879|NCT05291793|Glucocorticoids|glucocorticoids|mesh-ancestor
24741880|NCT05291793|Hormones|hormones|mesh-ancestor
24741886|NCT05291793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24741887|NCT05291793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24741888|NCT05291793|Analgesics|analgesics|mesh-ancestor
24741889|NCT05291793|Sensory System Agents|sensory system agents|mesh-ancestor
24741890|NCT05291793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24741891|NCT05291793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24741892|NCT05291793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24741893|NCT05291793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741894|NCT05294926|Rocuronium|rocuronium|mesh-list
24741895|NCT05294926|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24741896|NCT05294926|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24741897|NCT05294926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25696305|NCT02059239|Antimetabolites|antimetabolites|mesh-ancestor
24741898|NCT05294926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24741899|NCT05294926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741900|NCT05294887|Diltiazem|diltiazem|mesh-list
24741901|NCT05294887|Bisoprolol|bisoprolol|mesh-list
24943990|NCT03965208|Calcium heparin|calcium heparin|mesh-list
24943991|NCT03965208|Bivalirudin|bivalirudin|mesh-list
24943992|NCT03965208|Anticoagulants|anticoagulants|mesh-ancestor
24943993|NCT03965208|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24943994|NCT03965208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24943995|NCT03965208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943996|NCT03965208|Antithrombins|antithrombins|mesh-ancestor
24741902|NCT05294887|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24741903|NCT05294887|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24741904|NCT05294887|Adrenergic Agents|adrenergic agents|mesh-ancestor
24651499|NCT01231802|Micronutrients|micronutrients|mesh-ancestor
24741905|NCT05294887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24741909|NCT05294887|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24741910|NCT05294887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24741911|NCT05294887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24741912|NCT05294887|Vasodilator Agents|vasodilator agents|mesh-ancestor
24741913|NCT05294887|Sympatholytics|sympatholytics|mesh-ancestor
24741914|NCT05294887|Autonomic Agents|autonomic agents|mesh-ancestor
24741915|NCT05294887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24741916|NCT05294887|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24741918|NCT05294822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24741919|NCT05294822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741920|NCT05294744|Acetylcysteine|acetylcysteine|mesh-list
24406619|NCT00170898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24741946|NCT05294666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24741947|NCT05294666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741948|NCT05294666|Antifungal Agents|antifungal agents|mesh-ancestor
24741949|NCT05294666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24741950|NCT05294666|Dermatologic Agents|dermatologic agents|mesh-ancestor
24741951|NCT05294666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24741952|NCT05294640|Lidocaine|lidocaine|mesh-list
24741953|NCT05294640|Epinephrine|epinephrine|mesh-list
24741969|NCT05294640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24741970|NCT05294640|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24741971|NCT05294640|Autonomic Agents|autonomic agents|mesh-ancestor
24741972|NCT05294640|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24741973|NCT05294640|Respiratory System Agents|respiratory system agents|mesh-ancestor
24741974|NCT05294640|Mydriatics|mydriatics|mesh-ancestor
24741975|NCT05294640|Sympathomimetics|sympathomimetics|mesh-ancestor
24741976|NCT05294640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24741977|NCT05294536|Liraglutide|liraglutide|mesh-list
24741978|NCT05294536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24741979|NCT05294536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741980|NCT05294536|Incretins|incretins|mesh-ancestor
24741981|NCT05294536|Hormones|hormones|mesh-ancestor
24741982|NCT05294536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24741983|NCT05294523|Rocuronium|rocuronium|mesh-list
24741984|NCT05294523|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24741985|NCT05294523|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24742010|NCT05294393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24742011|NCT05294393|Analgesics|analgesics|mesh-ancestor
24742015|NCT05294393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24742016|NCT05294393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742017|NCT05294393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24742018|NCT05294393|Tocolytic Agents|tocolytic agents|mesh-ancestor
24742033|NCT05294055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24742035|NCT05294055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406717|NCT00171067|Protective Agents|protective agents|mesh-ancestor
24406718|NCT00171067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742048|NCT05293808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24742049|NCT05293808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24742115|NCT05293574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742116|NCT05293574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24742117|NCT05293574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24742135|NCT05293171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24742136|NCT05293171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24742137|NCT05293171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24742138|NCT05293171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517579|NCT00608712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24657812|NCT01269294|Contraceptive Agents|contraceptive agents|mesh-ancestor
24657813|NCT01269294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24657816|NCT01269294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24517580|NCT00608712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527139|NCT00615173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24396740|NCT00139841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25005196|NCT04400838|Vaccines|vaccines|mesh-list
24742139|NCT05293171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742140|NCT05293171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24742141|NCT05293132|Coenzyme Q10|coenzyme q10|mesh-list
24618298|NCT01047670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24618299|NCT01047722|Aspirin|aspirin|mesh-list
24618300|NCT01047722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24618301|NCT01047722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24618302|NCT01047722|Analgesics|analgesics|mesh-ancestor
24943999|NCT03965208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24742193|NCT05296564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24742194|NCT05296369|Folic Acid|folic acid|mesh-list
24742195|NCT05296369|Hematinics|hematinics|mesh-ancestor
24742196|NCT05296369|Vitamin B Complex|vitamin b complex|mesh-ancestor
24742197|NCT05296369|Vitamins|vitamins|mesh-ancestor
24406903|NCT00171535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24406904|NCT00171535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406905|NCT00171535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24742265|NCT05294900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24742266|NCT05294900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24742267|NCT05294900|Tubulin Modulators|tubulin modulators|mesh-ancestor
24742268|NCT05294900|Antimitotic Agents|antimitotic agents|mesh-ancestor
24742269|NCT05294900|Mitosis Modulators|mitosis modulators|mesh-ancestor
24742270|NCT05294900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742271|NCT05289349|Propofol|propofol|mesh-list
24742272|NCT05289349|Sevoflurane|sevoflurane|mesh-list
24742273|NCT05289349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24742274|NCT05289349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24742275|NCT05289349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742276|NCT05289349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24742277|NCT05289349|Anesthetics, General|anesthetics, general|mesh-ancestor
24742278|NCT05289349|Anesthetics|anesthetics|mesh-ancestor
24742279|NCT05289349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24742280|NCT05289349|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24742281|NCT05288062|Dexamethasone|dexamethasone|mesh-list
24742427|NCT05267431|Abortifacient Agents|abortifacient agents|mesh-ancestor
24742428|NCT05267431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24742429|NCT05267431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742430|NCT05267431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24742431|NCT05267431|Antimetabolites|antimetabolites|mesh-ancestor
24742432|NCT05267431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742433|NCT05267431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24742434|NCT05267431|Dermatologic Agents|dermatologic agents|mesh-ancestor
24742435|NCT05267431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24742436|NCT05267431|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24742467|NCT05264896|Micronutrients|micronutrients|mesh-ancestor
24742468|NCT05264584|Acetylcysteine|acetylcysteine|mesh-list
24742469|NCT05264584|Febuxostat|febuxostat|mesh-list
24742470|NCT05264584|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24742471|NCT05264584|Antiviral Agents|antiviral agents|mesh-ancestor
24742472|NCT05264584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24742473|NCT05264584|Expectorants|expectorants|mesh-ancestor
24742474|NCT05264584|Respiratory System Agents|respiratory system agents|mesh-ancestor
24742475|NCT05264584|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24742489|NCT05262686|Sensory System Agents|sensory system agents|mesh-ancestor
24742492|NCT05262686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24742521|NCT05249920|Edaravone|edaravone|mesh-list
24742522|NCT05249920|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24742523|NCT05249920|Antioxidants|antioxidants|mesh-ancestor
24742524|NCT05249920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742525|NCT05249920|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24742526|NCT05249920|Protective Agents|protective agents|mesh-ancestor
24742552|NCT05236608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742554|NCT05225402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24742555|NCT05225402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24742556|NCT05225402|Adrenergic Agents|adrenergic agents|mesh-ancestor
25696306|NCT02059239|Antiviral Agents|antiviral agents|mesh-ancestor
25696307|NCT02059239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24742557|NCT05225402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25696308|NCT02059239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24657882|NCT01269463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24657883|NCT01269463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657884|NCT01269463|Dopamine Agents|dopamine agents|mesh-ancestor
24657885|NCT01269463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24657886|NCT01269476|Fluorides|fluorides|mesh-list
24742558|NCT05225402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944003|NCT03964935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24849741|NCT02250118|Bevacizumab|bevacizumab|mesh-list
24944004|NCT03964935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24944005|NCT03964935|Antioxidants|antioxidants|mesh-ancestor
24742559|NCT05225402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742560|NCT05225402|Sympathomimetics|sympathomimetics|mesh-ancestor
24742561|NCT05225402|Autonomic Agents|autonomic agents|mesh-ancestor
24742562|NCT05225402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24742563|NCT05225402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24742600|NCT05219799|Autonomic Agents|autonomic agents|mesh-ancestor
24742601|NCT05219799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24742602|NCT05219799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24742603|NCT05219799|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24742604|NCT05219799|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24742605|NCT05219799|Cholinergic Agents|cholinergic agents|mesh-ancestor
24742606|NCT05219799|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24742607|NCT05219799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24742608|NCT05219799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24742609|NCT05219799|Respiratory System Agents|respiratory system agents|mesh-ancestor
24742610|NCT05219799|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24742611|NCT05219799|Protective Agents|protective agents|mesh-ancestor
24651705|NCT01233492|Mannitol|mannitol|mesh-list
24618376|NCT01048047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618377|NCT01048047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24742700|NCT05192629|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24742701|NCT05192629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24742702|NCT05192629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24944006|NCT03964935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944007|NCT03964935|Protective Agents|protective agents|mesh-ancestor
24944008|NCT03964935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944009|NCT03964935|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24944010|NCT03964935|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24944011|NCT03964935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24944013|NCT03965013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24742703|NCT05192629|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24742704|NCT05192629|Anesthetics, General|anesthetics, general|mesh-ancestor
24742706|NCT05192629|GABA Modulators|gaba modulators|mesh-ancestor
24742708|NCT05189444|Amoxicillin|amoxicillin|mesh-list
24742709|NCT05189444|Clarithromycin|clarithromycin|mesh-list
24742710|NCT05189444|Potassium Citrate|potassium citrate|mesh-list
24742711|NCT05189444|Esomeprazole|esomeprazole|mesh-list
24742712|NCT05189444|Bismuth|bismuth|mesh-list
24742713|NCT05189444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742714|NCT05189444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24742715|NCT05189444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24742716|NCT05189444|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24742717|NCT05189444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24742768|NCT05169268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24742769|NCT05169268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24742770|NCT05169268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742771|NCT05169268|Dopamine Agonists|dopamine agonists|mesh-ancestor
24742775|NCT05169268|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24742776|NCT05169268|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24742777|NCT05169268|Serotonin Agents|serotonin agents|mesh-ancestor
24742778|NCT05169268|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24742779|NCT05169268|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24742780|NCT05169268|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24742781|NCT05169268|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24742782|NCT05217706|Ketamine|ketamine|mesh-list
25696309|NCT02059239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25696310|NCT02059239|Alkylating Agents|alkylating agents|mesh-ancestor
25696311|NCT02059239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25696312|NCT02059278|Latanoprost|latanoprost|mesh-list
25696313|NCT02059278|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25696314|NCT02059278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24658056|NCT01270178|Antiviral Agents|antiviral agents|mesh-ancestor
24658057|NCT01270178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24658058|NCT01270191|Exenatide|exenatide|mesh-list
24658059|NCT01270191|Isophane Insulin, Human|isophane insulin, human|mesh-list
24658060|NCT01270191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24658061|NCT01270191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658062|NCT01270191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24658063|NCT01270191|Incretins|incretins|mesh-ancestor
24743340|NCT04871425|Analgesics|analgesics|mesh-ancestor
24407709|NCT00175123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743040|NCT05030025|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24743041|NCT05027646|Granisetron|granisetron|mesh-list
24743042|NCT05027646|Antiemetics|antiemetics|mesh-ancestor
24743043|NCT05027646|Autonomic Agents|autonomic agents|mesh-ancestor
24743044|NCT05027646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24743045|NCT05027646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743046|NCT05027646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24743047|NCT05027646|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24743048|NCT05027646|Serotonin Agents|serotonin agents|mesh-ancestor
24743049|NCT05027646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24743050|NCT05027646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743051|NCT05022901|Melphalan|melphalan|mesh-list
24743053|NCT05022901|Alkylating Agents|alkylating agents|mesh-ancestor
24743054|NCT05022901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743055|NCT05022901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407735|NCT00175266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24743081|NCT05013502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24743268|NCT04921527|Mitosis Modulators|mitosis modulators|mesh-ancestor
24743269|NCT04921527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743270|NCT04921527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24743271|NCT04921527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24743290|NCT04899843|Dermatologic Agents|dermatologic agents|mesh-ancestor
24743291|NCT04899687|Dextromethorphan|dextromethorphan|mesh-list
24743292|NCT04899687|Fluoxetine|fluoxetine|mesh-list
24743293|NCT04899687|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24743294|NCT04899687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24743295|NCT04899687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24944020|NCT03964753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24944021|NCT03964753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661044|NCT01287663|Permethrin|permethrin|mesh-list
24743296|NCT04899687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743297|NCT04899687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24743298|NCT04899687|Serotonin Agents|serotonin agents|mesh-ancestor
24743299|NCT04899687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743300|NCT04899687|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24743301|NCT04899687|Antidepressive Agents|antidepressive agents|mesh-ancestor
24743302|NCT04899687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24743303|NCT04899687|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24743304|NCT04899687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24743309|NCT04899687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24407966|NCT00175981|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24407967|NCT00175981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24407968|NCT00175981|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24407971|NCT00176020|Niacinamide|niacinamide|mesh-list
24407973|NCT00176020|Vitamins|vitamins|mesh-ancestor
24743344|NCT04871425|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24743345|NCT04871425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24743346|NCT04871425|Anesthetics, General|anesthetics, general|mesh-ancestor
24743347|NCT04871425|Anesthetics|anesthetics|mesh-ancestor
25696315|NCT02059434|Tiotropium Bromide|tiotropium bromide|mesh-list
25696316|NCT02059434|LAS190792|las190792|mesh-list
25696317|NCT02059434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25696318|NCT02059434|Autonomic Agents|autonomic agents|mesh-ancestor
25696319|NCT02059434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25696320|NCT02059434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696321|NCT02059434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25696322|NCT02059434|Respiratory System Agents|respiratory system agents|mesh-ancestor
24743394|NCT04847193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24743395|NCT04847193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24743396|NCT04847193|Growth Substances|growth substances|mesh-ancestor
24743397|NCT04847193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743398|NCT04847193|Growth Inhibitors|growth inhibitors|mesh-ancestor
24743421|NCT04815967|Botulinum Toxins|botulinum toxins|mesh-list
24743422|NCT04815967|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24743423|NCT04815967|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24743424|NCT04815967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24743425|NCT04815967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24743426|NCT04815967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743427|NCT04815967|Cholinergic Agents|cholinergic agents|mesh-ancestor
24743428|NCT04815967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24743429|NCT04815967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743430|NCT04815967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24618439|NCT01048307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24618440|NCT01048307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24618441|NCT01048307|Lipotropic Agents|lipotropic agents|mesh-ancestor
24618442|NCT01048307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24618443|NCT01048307|Antimetabolites|antimetabolites|mesh-ancestor
24618444|NCT01048307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618445|NCT01048307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24618447|NCT01048307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24618449|NCT01048320|Oxaliplatin|oxaliplatin|mesh-list
24618450|NCT01048320|Imatinib Mesylate|imatinib mesylate|mesh-list
24618451|NCT01048320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24618452|NCT01048320|Antimetabolites|antimetabolites|mesh-ancestor
24618453|NCT01048320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618454|NCT01048320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618455|NCT01048320|Antiviral Agents|antiviral agents|mesh-ancestor
24618456|NCT01048320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24618457|NCT01048320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618458|NCT01048320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24618459|NCT01048320|Immunologic Factors|immunologic factors|mesh-ancestor
24743512|NCT04761159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24743513|NCT04761159|Anesthetics, General|anesthetics, general|mesh-ancestor
24944022|NCT03964753|Tubulin Modulators|tubulin modulators|mesh-ancestor
24944023|NCT03964753|Antimitotic Agents|antimitotic agents|mesh-ancestor
24678887|NCT01364961|Resveratrol|resveratrol|mesh-list
24743514|NCT04761159|Anesthetics|anesthetics|mesh-ancestor
24743685|NCT04659382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24743687|NCT04659382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24743688|NCT04659382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24743689|NCT04659382|Growth Substances|growth substances|mesh-ancestor
24743690|NCT04659382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743691|NCT04659382|Growth Inhibitors|growth inhibitors|mesh-ancestor
24743692|NCT04658823|Vitamin E|vitamin e|mesh-list
24743693|NCT04658823|Tocopherols|tocopherols|mesh-list
24743694|NCT04658823|Tocotrienols|tocotrienols|mesh-list
24743695|NCT04658823|Tocovid|tocovid|mesh-list
24743696|NCT04658823|Vitamins|vitamins|mesh-ancestor
24743697|NCT04658823|Micronutrients|micronutrients|mesh-ancestor
24743698|NCT04658823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743699|NCT04658823|Antioxidants|antioxidants|mesh-ancestor
24743717|NCT04655144|Glucocorticoids|glucocorticoids|mesh-ancestor
24743718|NCT04655144|Hormones|hormones|mesh-ancestor
24743719|NCT04655144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24743720|NCT04655144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24743721|NCT04655144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24743758|NCT04635098|Sensory System Agents|sensory system agents|mesh-ancestor
24743759|NCT04635098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24743760|NCT04635098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24743761|NCT04635098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24743762|NCT04635098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24743855|NCT04588857|Hormones|hormones|mesh-ancestor
24743916|NCT04570436|GABA Agents|gaba agents|mesh-ancestor
24743825|NCT04602078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24743827|NCT04602078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743828|NCT04602078|Antiviral Agents|antiviral agents|mesh-ancestor
24743829|NCT04602078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24743830|NCT04602078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24944024|NCT03964753|Mitosis Modulators|mitosis modulators|mesh-ancestor
24743832|NCT04602078|Immunologic Factors|immunologic factors|mesh-ancestor
24743833|NCT04602078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743847|NCT04588857|Dexamethasone|dexamethasone|mesh-list
24743848|NCT04588857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24743849|NCT04588857|Antiemetics|antiemetics|mesh-ancestor
24743850|NCT04588857|Autonomic Agents|autonomic agents|mesh-ancestor
24743851|NCT04588857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24743852|NCT04588857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743853|NCT04588857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24743854|NCT04588857|Glucocorticoids|glucocorticoids|mesh-ancestor
24743881|NCT04577001|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24743882|NCT04577001|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24743883|NCT04577001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24743884|NCT04577001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743885|NCT04577001|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24743886|NCT04577001|Hormone Antagonists|hormone antagonists|mesh-ancestor
24743887|NCT04577001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24743888|NCT04577001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743889|NCT04570436|Diazepam|diazepam|mesh-list
24743890|NCT04570436|Gabapentin|gabapentin|mesh-list
24743891|NCT04570436|Analgesics|analgesics|mesh-ancestor
24743894|NCT04570436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743895|NCT04570436|Anticonvulsants|anticonvulsants|mesh-ancestor
24743896|NCT04570436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24743897|NCT04570436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24743898|NCT04570436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24743899|NCT04570436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24743900|NCT04570436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24743901|NCT04570436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24743902|NCT04570436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24743903|NCT04570436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743904|NCT04570436|Antimanic Agents|antimanic agents|mesh-ancestor
24743905|NCT04570436|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24743906|NCT04570436|Antiemetics|antiemetics|mesh-ancestor
24743907|NCT04570436|Autonomic Agents|autonomic agents|mesh-ancestor
24743908|NCT04570436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24743909|NCT04570436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24743910|NCT04570436|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24743911|NCT04570436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24743912|NCT04570436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24944025|NCT03964753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944026|NCT03964779|Antibodies|antibodies|mesh-list
24944027|NCT03964779|Immunoglobulins|immunoglobulins|mesh-list
24944028|NCT03964779|Immunologic Factors|immunologic factors|mesh-ancestor
24743913|NCT04570436|Anesthetics, General|anesthetics, general|mesh-ancestor
24743914|NCT04570436|Anesthetics|anesthetics|mesh-ancestor
24743915|NCT04570436|GABA Modulators|gaba modulators|mesh-ancestor
24743958|NCT04561375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24743959|NCT04561375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743960|NCT04561375|Analgesics|analgesics|mesh-ancestor
24743961|NCT04561375|Sensory System Agents|sensory system agents|mesh-ancestor
24743962|NCT04561375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24743963|NCT04561375|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24743964|NCT04561375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24743965|NCT04561375|Anesthetics, General|anesthetics, general|mesh-ancestor
24743966|NCT04561375|Anesthetics|anesthetics|mesh-ancestor
24743967|NCT04560972|Carboplatin|carboplatin|mesh-list
24743968|NCT04560972|Etoposide|etoposide|mesh-list
24743969|NCT04560972|Etoposide phosphate|etoposide phosphate|mesh-list
24743970|NCT04560972|Atezolizumab|atezolizumab|mesh-list
24743971|NCT04560972|Podophyllotoxin|podophyllotoxin|mesh-list
24744082|NCT04516317|Quinine|quinine|mesh-list
24744083|NCT04516317|Antimalarials|antimalarials|mesh-ancestor
24744084|NCT04516317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24744085|NCT04516317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24658327|NCT01271179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24658328|NCT01271179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744112|NCT04505280|Anesthetics|anesthetics|mesh-ancestor
24744113|NCT04505280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24744114|NCT04505280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744115|NCT04505280|Sensory System Agents|sensory system agents|mesh-ancestor
24744116|NCT04505280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24744117|NCT04505280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24744118|NCT04505280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24744119|NCT04505280|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24744120|NCT04505280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24744121|NCT04505280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744146|NCT04490707|Lenalidomide|lenalidomide|mesh-list
24744147|NCT04490707|Azacitidine|azacitidine|mesh-list
24525462|NCT03326791|Aspirin|aspirin|mesh-list
24744172|NCT04484350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744173|NCT04484350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24744174|NCT04484350|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24744175|NCT04484350|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24744176|NCT04484350|Adrenergic Agents|adrenergic agents|mesh-ancestor
24444210|NCT00296972|Interferons|interferons|mesh-list
24744177|NCT04484350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24744178|NCT04484350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744180|NCT04484350|Autonomic Agents|autonomic agents|mesh-ancestor
24744222|NCT04430517|Vitamin B Complex|vitamin b complex|mesh-ancestor
24744223|NCT04430517|Vitamins|vitamins|mesh-ancestor
24744224|NCT04430517|Micronutrients|micronutrients|mesh-ancestor
24744225|NCT04430517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744226|NCT04430517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24744233|NCT04417361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744234|NCT04417361|Analgesics|analgesics|mesh-ancestor
24744235|NCT04417361|Sensory System Agents|sensory system agents|mesh-ancestor
24744236|NCT04417361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24744237|NCT04417361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744238|NCT04402658|Albuterol|albuterol|mesh-list
24744239|NCT04402658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24744240|NCT04402658|Autonomic Agents|autonomic agents|mesh-ancestor
24744241|NCT04402658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24744248|NCT04402658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24744249|NCT04402658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24744250|NCT04402658|Adrenergic Agents|adrenergic agents|mesh-ancestor
24744251|NCT04402658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24744252|NCT04402658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744253|NCT04391179|Dipyridamole|dipyridamole|mesh-list
24744254|NCT04391179|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24744255|NCT04391179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24744258|NCT04391179|Vasodilator Agents|vasodilator agents|mesh-ancestor
24744263|NCT04387110|Ocrelizumab|ocrelizumab|mesh-list
24744264|NCT04387110|Immunologic Factors|immunologic factors|mesh-ancestor
25005316|NCT04232423|Serotonin Agents|serotonin agents|mesh-ancestor
24443377|NCT00294606|Protective Agents|protective agents|mesh-ancestor
24744365|NCT04321993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744374|NCT04305444|Pomalidomide|pomalidomide|mesh-list
24744375|NCT04305444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24744376|NCT04305444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24744377|NCT04305444|Immunologic Factors|immunologic factors|mesh-ancestor
24744378|NCT04305444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744379|NCT04305444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24744380|NCT04305444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24744381|NCT04305444|Growth Substances|growth substances|mesh-ancestor
24744382|NCT04305444|Growth Inhibitors|growth inhibitors|mesh-ancestor
24744383|NCT04298983|Androgens|androgens|mesh-list
24744384|NCT04298983|Hormones|hormones|mesh-ancestor
25696323|NCT02059434|Parasympatholytics|parasympatholytics|mesh-ancestor
25696324|NCT02059434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25696325|NCT02059434|Cholinergic Agents|cholinergic agents|mesh-ancestor
25696326|NCT02059434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24744397|NCT04294147|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
24744398|NCT04294147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744400|NCT04294147|Sensory System Agents|sensory system agents|mesh-ancestor
24744401|NCT04294147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24744402|NCT04294147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744403|NCT04292873|Vitamin D|vitamin d|mesh-list
24849959|NCT02251158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24849960|NCT02251158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24643865|NCT01187862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24744420|NCT04273932|Lithium Carbonate|lithium carbonate|mesh-list
24744421|NCT04273932|Antidepressive Agents|antidepressive agents|mesh-ancestor
24744422|NCT04273932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24744423|NCT04273932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24744424|NCT04273932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744425|NCT04273932|Antimanic Agents|antimanic agents|mesh-ancestor
24744433|NCT04272606|Hemostatics|hemostatics|mesh-ancestor
24744475|NCT04264637|Azelastine|azelastine|mesh-list
24744476|NCT04264637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24744477|NCT04264637|Autonomic Agents|autonomic agents|mesh-ancestor
24744478|NCT04264637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24744495|NCT04262687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24744497|NCT04262687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24744498|NCT04262687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24744499|NCT04262687|Growth Substances|growth substances|mesh-ancestor
24744500|NCT04262687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744501|NCT04262687|Growth Inhibitors|growth inhibitors|mesh-ancestor
24744884|NCT04096066|Glucocorticoids|glucocorticoids|mesh-ancestor
24744504|NCT04262687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944061|NCT03963752|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24744557|NCT04233112|Melatonin|melatonin|mesh-list
24744558|NCT04233112|Antioxidants|antioxidants|mesh-ancestor
24744571|NCT04230304|Daratumumab|daratumumab|mesh-list
24744589|NCT04224558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744590|NCT04224558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24744591|NCT04224558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24744592|NCT04224558|Alkylating Agents|alkylating agents|mesh-ancestor
24744593|NCT04224558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744594|NCT04224558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24744595|NCT04224558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24744603|NCT04224558|Autonomic Agents|autonomic agents|mesh-ancestor
24744604|NCT04224558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24744605|NCT04224558|Glucocorticoids|glucocorticoids|mesh-ancestor
24744607|NCT04224558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24744609|NCT04224558|Protective Agents|protective agents|mesh-ancestor
24744611|NCT04224558|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24744612|NCT04224558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24744613|NCT04224558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24744614|NCT04224558|Anesthetics, Local|anesthetics, local|mesh-ancestor
24744616|NCT04224558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24953932|NCT03880448|Metronidazole|metronidazole|mesh-list
24744617|NCT04224558|Histamine Antagonists|histamine antagonists|mesh-ancestor
24744618|NCT04224558|Histamine Agents|histamine agents|mesh-ancestor
24744624|NCT04223570|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24744625|NCT04223570|Levulinic acid|levulinic acid|mesh-list
24744626|NCT04223570|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24744627|NCT04223570|Dermatologic Agents|dermatologic agents|mesh-ancestor
24744628|NCT04223570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653308|NCT01243281|Antiviral Agents|antiviral agents|mesh-ancestor
24744629|NCT04223570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744630|NCT04219774|Aspirin|aspirin|mesh-list
24744631|NCT04219774|Clopidogrel|clopidogrel|mesh-list
24744632|NCT04219774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24525253|NCT03737253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744643|NCT04219774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24744644|NCT04219774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24744645|NCT04219774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25696327|NCT02059434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744646|NCT04219774|Antipyretics|antipyretics|mesh-ancestor
24744647|NCT04219774|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24744648|NCT04219774|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24744649|NCT04219774|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24744650|NCT04219774|Purinergic Agents|purinergic agents|mesh-ancestor
24744651|NCT04219774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24618490|NCT01048554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24618491|NCT01048554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618492|NCT01048554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24618493|NCT01048554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24618494|NCT01048554|Growth Substances|growth substances|mesh-ancestor
24618495|NCT01048554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618496|NCT01048554|Growth Inhibitors|growth inhibitors|mesh-ancestor
24618497|NCT01048554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24618498|NCT01048554|Alkylating Agents|alkylating agents|mesh-ancestor
24618500|NCT01048580|Capecitabine|capecitabine|mesh-list
24744690|NCT04198428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744708|NCT04183205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744709|NCT04183205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24744710|NCT04183205|Serotonin Agents|serotonin agents|mesh-ancestor
24744885|NCT04096066|Hormones|hormones|mesh-ancestor
24744720|NCT04169451|Letrozole|letrozole|mesh-list
24744721|NCT04169451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24744722|NCT04169451|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24744723|NCT04169451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24744724|NCT04169451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24744737|NCT04160494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744738|NCT04159818|Doxorubicin|doxorubicin|mesh-list
24744739|NCT04159818|Nivolumab|nivolumab|mesh-list
24744740|NCT04159818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24744741|NCT04159818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24744742|NCT04159818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24744743|NCT04159818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24744750|NCT04157881|Antithrombins|antithrombins|mesh-ancestor
24744751|NCT04157881|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24744752|NCT04157881|Protease Inhibitors|protease inhibitors|mesh-ancestor
24744753|NCT04157881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24744755|NCT04157881|Anticoagulants|anticoagulants|mesh-ancestor
24744782|NCT04143711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24744783|NCT04143711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24744791|NCT04136262|Methotrexate|methotrexate|mesh-list
24944066|NCT03963752|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24744806|NCT04136262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24744809|NCT04133922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744828|NCT04124497|Pomalidomide|pomalidomide|mesh-list
24744829|NCT04124497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24744830|NCT04124497|Antiemetics|antiemetics|mesh-ancestor
24744831|NCT04124497|Autonomic Agents|autonomic agents|mesh-ancestor
24744832|NCT04124497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25072210|NCT03402295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24744833|NCT04124497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744834|NCT04124497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24744835|NCT04124497|Glucocorticoids|glucocorticoids|mesh-ancestor
24744836|NCT04124497|Hormones|hormones|mesh-ancestor
24744837|NCT04124497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24744838|NCT04124497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24744839|NCT04124497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24744840|NCT04124497|Immunologic Factors|immunologic factors|mesh-ancestor
24744841|NCT04124497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24744842|NCT04124497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24744843|NCT04124497|Growth Substances|growth substances|mesh-ancestor
24744844|NCT04124497|Growth Inhibitors|growth inhibitors|mesh-ancestor
24744846|NCT04123314|Hallucinogens|hallucinogens|mesh-ancestor
24744847|NCT04123314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744848|NCT04123314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24744849|NCT04115059|Dasatinib|dasatinib|mesh-list
24744850|NCT04115059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24744851|NCT04115059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24744852|NCT04115059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24744854|NCT04114890|Tenofovir|tenofovir|mesh-list
24744878|NCT04096066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25696328|NCT02059434|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24744880|NCT04096066|Autonomic Agents|autonomic agents|mesh-ancestor
24744881|NCT04096066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24744882|NCT04096066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744883|NCT04096066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24744931|NCT04083495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24744933|NCT04083495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744934|NCT04083495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24744935|NCT04083495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24744937|NCT04082676|Anesthetics, Local|anesthetics, local|mesh-ancestor
24744938|NCT04082676|Anesthetics|anesthetics|mesh-ancestor
24744939|NCT04082676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24744941|NCT04082676|Sensory System Agents|sensory system agents|mesh-ancestor
24944067|NCT03963752|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24944068|NCT03963752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24944069|NCT03963752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24944070|NCT03963752|Appetite Stimulants|appetite stimulants|mesh-ancestor
24944071|NCT03963752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24944072|NCT03963752|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24944073|NCT03963752|Fertility Agents|fertility agents|mesh-ancestor
24944074|NCT03963648|Nitric Oxide|nitric oxide|mesh-list
24944075|NCT03963648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24944076|NCT03963648|Autonomic Agents|autonomic agents|mesh-ancestor
24944077|NCT03963648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24944078|NCT03963648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944079|NCT03963648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24944080|NCT03963648|Respiratory System Agents|respiratory system agents|mesh-ancestor
24944081|NCT03963648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24944082|NCT03963648|Antioxidants|antioxidants|mesh-ancestor
24857321|NCT02290717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744968|NCT04067648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24744969|NCT04067648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744970|NCT04067648|Analgesics|analgesics|mesh-ancestor
24744971|NCT04067648|Sensory System Agents|sensory system agents|mesh-ancestor
24744972|NCT04067648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24744973|NCT04067648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24744974|NCT04067648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24744975|NCT04067648|Anesthetics, General|anesthetics, general|mesh-ancestor
24744976|NCT04067648|Anesthetics|anesthetics|mesh-ancestor
24528278|NCT00620646|Cilostazol|cilostazol|mesh-list
24850076|NCT02251600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24850077|NCT02251600|Immunologic Factors|immunologic factors|mesh-ancestor
24944083|NCT03963648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443504|NCT00295308|Clonidine|clonidine|mesh-list
24850079|NCT02251626|Ubiquinone|ubiquinone|mesh-list
24745029|NCT04022200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745031|NCT04020848|Antioxidants|antioxidants|mesh-ancestor
24745032|NCT04020848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745033|NCT04020848|Protective Agents|protective agents|mesh-ancestor
24700720|NCT01454609|Analgesics|analgesics|mesh-ancestor
24745034|NCT04020848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745035|NCT04020848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24745036|NCT04012177|Niacinamide|niacinamide|mesh-list
24745038|NCT04012177|Nicotinic Acids|nicotinic acids|mesh-list
24745039|NCT04012177|Azithromycin|azithromycin|mesh-list
24745041|NCT04012177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24526989|NCT00614159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745081|NCT04002934|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24745082|NCT04002934|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24745083|NCT04002934|Hormone Antagonists|hormone antagonists|mesh-ancestor
24745084|NCT04002934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24745085|NCT04002934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745086|NCT04002934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24745087|NCT04002518|Cimetidine|cimetidine|mesh-list
24745088|NCT04002518|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24745089|NCT04002518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24745090|NCT04002518|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24745091|NCT04002518|Histamine Antagonists|histamine antagonists|mesh-ancestor
24745094|NCT04002518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745095|NCT04002518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745096|NCT04002518|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24745097|NCT04002518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24745098|NCT04002518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24745099|NCT04000529|Spartalizumab|spartalizumab|mesh-list
24745110|NCT03993249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745112|NCT03990883|Anesthetics, Local|anesthetics, local|mesh-ancestor
24745113|NCT03990883|Anesthetics|anesthetics|mesh-ancestor
24745152|NCT03930615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24745153|NCT03928847|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24745155|NCT03928847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745156|NCT03928847|Protective Agents|protective agents|mesh-ancestor
24745157|NCT03928847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944084|NCT03963648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24944085|NCT03963648|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24745158|NCT03928847|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24745159|NCT03928847|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24745160|NCT03928847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745161|NCT03928847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24745162|NCT03928600|Misoprostol|misoprostol|mesh-list
24745163|NCT03928600|Dinoprostone|dinoprostone|mesh-list
24745164|NCT03928600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24745165|NCT03928600|Abortifacient Agents|abortifacient agents|mesh-ancestor
24443620|NCT00295542|Sympatholytics|sympatholytics|mesh-ancestor
24443621|NCT00295542|Autonomic Agents|autonomic agents|mesh-ancestor
24745166|NCT03928600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24745195|NCT03924427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24745196|NCT03924427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745198|NCT03922451|Tazobactam|tazobactam|mesh-list
24745199|NCT03922451|Piperacillin|piperacillin|mesh-list
24745200|NCT03922451|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24745201|NCT03922451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24745202|NCT03922451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24745203|NCT03922451|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24745204|NCT03922451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24745205|NCT03922451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745206|NCT03913442|Colchicine|colchicine|mesh-list
24745207|NCT03913442|Gout Suppressants|gout suppressants|mesh-ancestor
24745208|NCT03913442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24745209|NCT03913442|Tubulin Modulators|tubulin modulators|mesh-ancestor
24745210|NCT03913442|Antimitotic Agents|antimitotic agents|mesh-ancestor
24745211|NCT03913442|Mitosis Modulators|mitosis modulators|mesh-ancestor
24745212|NCT03913442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745213|NCT03913442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745271|NCT03846570|Adrenergic Agents|adrenergic agents|mesh-ancestor
24745272|NCT03846570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24745273|NCT03846570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745274|NCT03846570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24745275|NCT03846570|Glucocorticoids|glucocorticoids|mesh-ancestor
24745287|NCT03838367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745289|NCT03838367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24745290|NCT03838367|Antiviral Agents|antiviral agents|mesh-ancestor
24745291|NCT03838367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24745292|NCT03838367|Immunologic Factors|immunologic factors|mesh-ancestor
24745293|NCT03838367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745294|NCT03837925|Atorvastatin|atorvastatin|mesh-list
24745295|NCT03837925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24745296|NCT03837925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24745297|NCT03837925|Antimetabolites|antimetabolites|mesh-ancestor
24745298|NCT03837925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745299|NCT03837925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24788352|NCT01930877|Lidocaine|lidocaine|mesh-list
24850235|NCT02252419|Dexamethasone|dexamethasone|mesh-list
24443651|NCT00295607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24745305|NCT03836144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745306|NCT03836144|Expectorants|expectorants|mesh-ancestor
24745307|NCT03836144|Respiratory System Agents|respiratory system agents|mesh-ancestor
24944086|NCT03963648|Vasodilator Agents|vasodilator agents|mesh-ancestor
24944087|NCT03963648|Gasotransmitters|gasotransmitters|mesh-ancestor
24665123|NCT01310296|Clonidine|clonidine|mesh-list
25005384|NCT04178993|Analgesics|analgesics|mesh-ancestor
24529629|NCT00627081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24745317|NCT03826563|Melatonin|melatonin|mesh-list
24745318|NCT03826563|Antioxidants|antioxidants|mesh-ancestor
24745319|NCT03826563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745320|NCT03826563|Protective Agents|protective agents|mesh-ancestor
24745321|NCT03826563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745322|NCT03826563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24745323|NCT03825536|Methamphetamine|methamphetamine|mesh-list
24745324|NCT03825536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24745325|NCT03825536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745326|NCT03825536|Sympathomimetics|sympathomimetics|mesh-ancestor
24745327|NCT03825536|Autonomic Agents|autonomic agents|mesh-ancestor
24745328|NCT03825536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24745355|NCT03809923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535237|NCT00648817|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24535239|NCT00648830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24535246|NCT00648843|Oxybutynin|oxybutynin|mesh-list
24745356|NCT03809923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24866211|NCT02892604|Insulin|insulin|mesh-list
24745371|NCT03808961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24745372|NCT03808961|Antimetabolites|antimetabolites|mesh-ancestor
24745373|NCT03808961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745374|NCT03808961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24745375|NCT03808961|Vasodilator Agents|vasodilator agents|mesh-ancestor
24745376|NCT03806452|Hydroxyurea|hydroxyurea|mesh-list
24745377|NCT03806452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850612|NCT02253797|Antiviral Agents|antiviral agents|mesh-ancestor
24850613|NCT02253797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24850614|NCT02253797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24850615|NCT02253797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24850616|NCT02253810|Tranexamic Acid|tranexamic acid|mesh-list
24647258|NCT01207245|Tobramycin|tobramycin|mesh-list
24745379|NCT03806452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24745380|NCT03806452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745381|NCT03806452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24618517|NCT01048684|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24618526|NCT01048827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618527|NCT01048827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24618529|NCT01048827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24618530|NCT01048892|Cyclophosphamide|cyclophosphamide|mesh-list
24618531|NCT01048892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24618532|NCT01048892|Immunologic Factors|immunologic factors|mesh-ancestor
24618533|NCT01048892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944088|NCT03963648|Protective Agents|protective agents|mesh-ancestor
24618534|NCT01048892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24618535|NCT01048892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24618536|NCT01048892|Alkylating Agents|alkylating agents|mesh-ancestor
24618537|NCT01048892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618538|NCT01048892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618539|NCT01048892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24618540|NCT01048983|Minocycline|minocycline|mesh-list
24618542|NCT01048983|Modafinil|modafinil|mesh-list
24618543|NCT01048983|Bupropion|bupropion|mesh-list
24618544|NCT01048983|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24618545|NCT01048983|Antidepressive Agents|antidepressive agents|mesh-ancestor
24618546|NCT01048983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24618547|NCT01048983|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24618548|NCT01048983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24618549|NCT01048983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24530302|NCT00629824|Ribavirin|ribavirin|mesh-list
24618556|NCT01048983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618557|NCT01048983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24618558|NCT01048983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24745384|NCT03796416|Abortifacient Agents|abortifacient agents|mesh-ancestor
24745385|NCT03796416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24745386|NCT03796416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745387|NCT03796416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24745388|NCT03796416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24745389|NCT03796416|Oxytocics|oxytocics|mesh-ancestor
24745390|NCT03785106|Vitamins|vitamins|mesh-list
24745391|NCT03785106|Pyridoxine|pyridoxine|mesh-list
24745400|NCT03785106|Antitubercular Agents|antitubercular agents|mesh-ancestor
24528922|NCT00623376|Hormones|hormones|mesh-ancestor
24745401|NCT03785106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24745402|NCT03785106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24745511|NCT03748784|Growth Substances|growth substances|mesh-ancestor
24745512|NCT03748784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745513|NCT03748784|Growth Inhibitors|growth inhibitors|mesh-ancestor
24745514|NCT03748784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24443772|NCT00295971|Thiotepa|thiotepa|mesh-list
24850718|NCT02253901|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24745566|NCT03693677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24745567|NCT03693677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24535462|NCT00649181|Metolazone|metolazone|mesh-list
24745568|NCT03693677|Tubulin Modulators|tubulin modulators|mesh-ancestor
24745569|NCT03693677|Antimitotic Agents|antimitotic agents|mesh-ancestor
24745570|NCT03693677|Mitosis Modulators|mitosis modulators|mesh-ancestor
24745571|NCT03693677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745572|NCT03693677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24745573|NCT03693677|Antimetabolites|antimetabolites|mesh-ancestor
24745574|NCT03693677|Antiviral Agents|antiviral agents|mesh-ancestor
24745575|NCT03693677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24745576|NCT03693677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24745578|NCT03693677|Immunologic Factors|immunologic factors|mesh-ancestor
24745629|NCT03673826|Lenalidomide|lenalidomide|mesh-list
24745630|NCT03673826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24745631|NCT03673826|Antiemetics|antiemetics|mesh-ancestor
24745632|NCT03673826|Autonomic Agents|autonomic agents|mesh-ancestor
24745633|NCT03673826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24745634|NCT03673826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745635|NCT03673826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24745636|NCT03673826|Glucocorticoids|glucocorticoids|mesh-ancestor
24944095|NCT03963466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24944096|NCT03963466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24745638|NCT03673826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24745639|NCT03673826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24745640|NCT03673826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745641|NCT03673826|Immunologic Factors|immunologic factors|mesh-ancestor
24745642|NCT03673826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24745643|NCT03673826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24745644|NCT03673826|Growth Substances|growth substances|mesh-ancestor
24745645|NCT03673826|Growth Inhibitors|growth inhibitors|mesh-ancestor
24745647|NCT03662919|Infliximab|infliximab|mesh-list
24745648|NCT03662919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24745649|NCT03662919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24745715|NCT03649802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24745716|NCT03643198|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24745717|NCT03643198|Metronidazole|metronidazole|mesh-list
24535597|NCT00649415|Analgesics|analgesics|mesh-ancestor
24745718|NCT03643198|Ciprofloxacin|ciprofloxacin|mesh-list
24745719|NCT03643198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24745720|NCT03643198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24745721|NCT03643198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24745722|NCT03643198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24745723|NCT03643198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24745725|NCT03643198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745726|NCT03643198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745727|NCT03643198|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24745728|NCT03643198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25005463|NCT03997097|Vasodilator Agents|vasodilator agents|mesh-ancestor
24745732|NCT03620578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24745733|NCT03620578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745734|NCT03606980|Dexamethasone|dexamethasone|mesh-list
24745735|NCT03606980|Dexamethasone acetate|dexamethasone acetate|mesh-list
24745736|NCT03606980|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24745737|NCT03606980|BB 1101|bb 1101|mesh-list
24745738|NCT03606980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24745740|NCT03606980|Autonomic Agents|autonomic agents|mesh-ancestor
24745741|NCT03606980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24745742|NCT03606980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745743|NCT03606980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24745744|NCT03606980|Glucocorticoids|glucocorticoids|mesh-ancestor
24745745|NCT03606980|Hormones|hormones|mesh-ancestor
24745746|NCT03606980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24745747|NCT03606980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24745748|NCT03606980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745749|NCT03606980|Protease Inhibitors|protease inhibitors|mesh-ancestor
24745750|NCT03606980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24745751|NCT03606980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745753|NCT03596385|Atenolol|atenolol|mesh-list
24944101|NCT03963479|Pyridoxal|pyridoxal|mesh-list
24944102|NCT03963479|Pyridoxine|pyridoxine|mesh-list
24944103|NCT03963479|Vitamins|vitamins|mesh-ancestor
24944104|NCT03963479|Micronutrients|micronutrients|mesh-ancestor
24944105|NCT03963479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944106|NCT03963479|Vitamin B Complex|vitamin b complex|mesh-ancestor
24944107|NCT03963336|Acetazolamide|acetazolamide|mesh-list
24944108|NCT03963336|Anticonvulsants|anticonvulsants|mesh-ancestor
24944109|NCT03963336|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24944110|NCT03963336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857354|NCT02291341|Analgesics|analgesics|mesh-ancestor
24745754|NCT03596385|Carvedilol|carvedilol|mesh-list
24745755|NCT03596385|Bisoprolol|bisoprolol|mesh-list
24745756|NCT03596385|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24745757|NCT03596385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24745783|NCT03590652|Daratumumab|daratumumab|mesh-list
24745784|NCT03590652|Pomalidomide|pomalidomide|mesh-list
24850938|NCT02254447|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24850939|NCT02254447|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24850940|NCT02254447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745785|NCT03590652|Ixazomib|ixazomib|mesh-list
24745786|NCT03590652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24745787|NCT03590652|Antiemetics|antiemetics|mesh-ancestor
24745788|NCT03590652|Autonomic Agents|autonomic agents|mesh-ancestor
24745789|NCT03590652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24745790|NCT03590652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745791|NCT03590652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24745792|NCT03590652|Glucocorticoids|glucocorticoids|mesh-ancestor
24745793|NCT03590652|Hormones|hormones|mesh-ancestor
24535671|NCT00649532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24745794|NCT03590652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24745795|NCT03590652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24745796|NCT03590652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745798|NCT03590652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24745799|NCT03590652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24745800|NCT03590652|Growth Substances|growth substances|mesh-ancestor
24745801|NCT03590652|Growth Inhibitors|growth inhibitors|mesh-ancestor
24745802|NCT03590652|Protease Inhibitors|protease inhibitors|mesh-ancestor
24745803|NCT03590652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24745828|NCT03576417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745829|NCT03576417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24745830|NCT03576417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24745835|NCT03573115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24745836|NCT03573115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24745838|NCT03573115|Sensory System Agents|sensory system agents|mesh-ancestor
24745844|NCT03569475|Fluoxetine|fluoxetine|mesh-list
24410362|NCT00185133|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24745845|NCT03569475|Levomilnacipran|levomilnacipran|mesh-list
24745846|NCT03569475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24745847|NCT03569475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24745848|NCT03569475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24745849|NCT03569475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745850|NCT03569475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24745851|NCT03569475|Serotonin Agents|serotonin agents|mesh-ancestor
24745852|NCT03569475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745853|NCT03569475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24745854|NCT03569475|Antidepressive Agents|antidepressive agents|mesh-ancestor
24745855|NCT03569475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24745890|NCT03529396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24745892|NCT03529396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24850948|NCT02254525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24850949|NCT02254525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24850950|NCT02254525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24444828|NCT00299247|Antimalarials|antimalarials|mesh-ancestor
24745893|NCT03529396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24745898|NCT03529396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745899|NCT03529396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24659531|NCT01278264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24659532|NCT01278264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659533|NCT01278264|Sensory System Agents|sensory system agents|mesh-ancestor
24659534|NCT01278264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24659536|NCT01278290|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24659537|NCT01278290|Luteolytic Agents|luteolytic agents|mesh-ancestor
24659538|NCT01278290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24659539|NCT01278290|Contraceptive Agents|contraceptive agents|mesh-ancestor
24745900|NCT03529396|Filaricides|filaricides|mesh-ancestor
24745901|NCT03529396|Antinematodal Agents|antinematodal agents|mesh-ancestor
24745902|NCT03529396|Anthelmintics|anthelmintics|mesh-ancestor
24745903|NCT03523520|Naltrexone|naltrexone|mesh-list
24745904|NCT03523520|Bromides|bromides|mesh-list
24745905|NCT03523520|Methylnaltrexone|methylnaltrexone|mesh-list
24745906|NCT03523520|Naloxegol|naloxegol|mesh-list
24745910|NCT03523520|Sensory System Agents|sensory system agents|mesh-ancestor
24745935|NCT03518242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24745936|NCT03518242|Dermatologic Agents|dermatologic agents|mesh-ancestor
24745937|NCT03518242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24745938|NCT03518242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24745939|NCT03518242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24745941|NCT03500549|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24745942|NCT03500549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24745943|NCT03500549|Immunologic Factors|immunologic factors|mesh-ancestor
24745944|NCT03500549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745969|NCT03469960|Nivolumab|nivolumab|mesh-list
24745970|NCT03469960|Ipilimumab|ipilimumab|mesh-list
24745971|NCT03469960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24745972|NCT03469960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745973|NCT03469960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24745974|NCT03469960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745975|NCT03460379|Citalopram|citalopram|mesh-list
24745976|NCT03460379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24745977|NCT03460379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24745978|NCT03460379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24494244|NCT00494572|Respiratory System Agents|respiratory system agents|mesh-ancestor
24850955|NCT02254577|Hormones|hormones|mesh-ancestor
24745991|NCT03460366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24410473|NCT00185445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24410474|NCT00185445|Immunologic Factors|immunologic factors|mesh-ancestor
24745992|NCT03460353|Dextroamphetamine|dextroamphetamine|mesh-list
24745993|NCT03460353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24745994|NCT03460353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745995|NCT03460353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24745996|NCT03460353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24745997|NCT03460353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24944150|NCT03963128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459871|NCT00346749|Xhance|xhance|mesh-list
24745998|NCT03460353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745999|NCT03460353|Dopamine Agents|dopamine agents|mesh-ancestor
24746000|NCT03460353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24654055|NCT01247337|Cetuximab|cetuximab|mesh-list
24746001|NCT03460327|Candesartan|candesartan|mesh-list
24746002|NCT03460327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24746003|NCT03460327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24746004|NCT03460327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24746005|NCT03460327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746006|NCT03460314|Buprenorphine|buprenorphine|mesh-list
24746007|NCT03460314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24746008|NCT03460314|Narcotics|narcotics|mesh-ancestor
24746014|NCT03460314|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24746015|NCT03460210|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24746027|NCT03456700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25696329|NCT02059434|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25696330|NCT02059434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25696331|NCT02059434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25696332|NCT02059434|Adrenergic Agents|adrenergic agents|mesh-ancestor
25696333|NCT02059642|Metadoxine|metadoxine|mesh-list
25696334|NCT02059642|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25696335|NCT02059902|Lidocaine|lidocaine|mesh-list
25696336|NCT02059902|Anesthetics, Local|anesthetics, local|mesh-ancestor
25696337|NCT02059902|Anesthetics|anesthetics|mesh-ancestor
25696338|NCT02059902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24593224|NCT00927524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775285|NCT01851473|Anesthetics, Local|anesthetics, local|mesh-ancestor
24950089|NCT02655692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24746028|NCT03456700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746029|NCT03456700|Antifungal Agents|antifungal agents|mesh-ancestor
24746039|NCT03449472|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24746040|NCT03449472|Antidepressive Agents|antidepressive agents|mesh-ancestor
24494250|NCT00494572|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24494251|NCT00494572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746041|NCT03449472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24746042|NCT03449472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24746043|NCT03449472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24746044|NCT03449472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24746045|NCT03449472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746047|NCT03435185|Anesthetics, Local|anesthetics, local|mesh-ancestor
24746048|NCT03435185|Anesthetics|anesthetics|mesh-ancestor
24746049|NCT03435185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24746050|NCT03435185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746051|NCT03435185|Sensory System Agents|sensory system agents|mesh-ancestor
24410505|NCT00185575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24746058|NCT03430219|Calcium|calcium|mesh-list
24746059|NCT03430219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24746060|NCT03430219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944151|NCT03963128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24944152|NCT03963128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24746061|NCT03426293|Heparin|heparin|mesh-list
24746062|NCT03426293|Anticoagulants|anticoagulants|mesh-ancestor
24746063|NCT03426293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24746064|NCT03426293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24746065|NCT03426293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746072|NCT03408574|Mecamylamine|mecamylamine|mesh-list
24746073|NCT03408574|Nicotine|nicotine|mesh-list
24660713|NCT01285388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24944158|NCT03962920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24944159|NCT03962920|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24944160|NCT03962920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24944161|NCT03962920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944162|NCT03962907|Chlorhexidine|chlorhexidine|mesh-list
24944163|NCT03962907|Mupirocin|mupirocin|mesh-list
24944164|NCT03962907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24944165|NCT03962907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24444837|NCT00299286|Lapatinib|lapatinib|mesh-list
24444838|NCT00299286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24851071|NCT02255162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24851072|NCT02255162|Growth Substances|growth substances|mesh-ancestor
24851073|NCT02255162|Growth Inhibitors|growth inhibitors|mesh-ancestor
24649289|NCT01219153|Hormones|hormones|mesh-ancestor
24944166|NCT03962907|Disinfectants|disinfectants|mesh-ancestor
24944167|NCT03962907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24618572|NCT01049022|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25696339|NCT02059902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696340|NCT02059902|Sensory System Agents|sensory system agents|mesh-ancestor
25696341|NCT02059902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25696342|NCT02059902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25696343|NCT02059902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25696344|NCT02059902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25696345|NCT02059902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25709371|NCT02265510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24618573|NCT01049022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24618574|NCT01049022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24618575|NCT01049022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24618576|NCT01049022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24618577|NCT01049022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618578|NCT01049022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618579|NCT01049022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618580|NCT01049022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24618581|NCT01049022|Contraceptive Agents|contraceptive agents|mesh-ancestor
24618582|NCT01049022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24618583|NCT01049022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618600|NCT01049178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618601|NCT01049204|Maraviroc|maraviroc|mesh-list
24618602|NCT01049204|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24618603|NCT01049204|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24618604|NCT01049204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618606|NCT01049204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24618607|NCT01049204|Antiviral Agents|antiviral agents|mesh-ancestor
24618608|NCT01049204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24618609|NCT01049204|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24944168|NCT03962907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24944169|NCT03962907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857367|NCT02291367|Analgesics|analgesics|mesh-ancestor
24618610|NCT01049347|Amitriptyline|amitriptyline|mesh-list
24746121|NCT03358030|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24746122|NCT03358030|Dermatologic Agents|dermatologic agents|mesh-ancestor
24746157|NCT03260504|Immunoglobulins|immunoglobulins|mesh-list
24746158|NCT03260504|Immunoglobulin G|immunoglobulin g|mesh-list
24746159|NCT03260504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24746160|NCT03260504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746161|NCT03260504|Immunologic Factors|immunologic factors|mesh-ancestor
24747970|NCT03006432|Antimitotic Agents|antimitotic agents|mesh-ancestor
24746167|NCT03260504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24746168|NCT03260504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24746169|NCT03260504|Antiviral Agents|antiviral agents|mesh-ancestor
24746181|NCT03251924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746186|NCT03242772|Amphetamine|amphetamine|mesh-list
24746187|NCT03242772|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24746188|NCT03242772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746189|NCT03242772|Sympathomimetics|sympathomimetics|mesh-ancestor
24746190|NCT03242772|Autonomic Agents|autonomic agents|mesh-ancestor
24746191|NCT03242772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24746192|NCT03242772|Dopamine Agents|dopamine agents|mesh-ancestor
24746193|NCT03242772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24746194|NCT03242772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746195|NCT03242772|Adrenergic Agents|adrenergic agents|mesh-ancestor
24746196|NCT03242772|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24443889|NCT00296062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443891|NCT00296062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24443892|NCT00296062|Antimetabolites|antimetabolites|mesh-ancestor
24443893|NCT00296062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443894|NCT00296062|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24443895|NCT00296062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24746208|NCT03236311|Sensory System Agents|sensory system agents|mesh-ancestor
24746209|NCT03236311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24746210|NCT03236311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746211|NCT03236311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24746212|NCT03236311|Vasodilator Agents|vasodilator agents|mesh-ancestor
24746213|NCT03236311|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24746214|NCT03236311|Purinergic Agonists|purinergic agonists|mesh-ancestor
25709372|NCT02265510|Growth Substances|growth substances|mesh-ancestor
25709373|NCT02265510|Growth Inhibitors|growth inhibitors|mesh-ancestor
25709374|NCT02265744|Antibodies|antibodies|mesh-list
25709375|NCT02265744|Immunologic Factors|immunologic factors|mesh-ancestor
25709376|NCT02265744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709377|NCT02265796|Ranolazine|ranolazine|mesh-list
25709378|NCT02265796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25709379|NCT02265796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24944170|NCT03962907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746217|NCT03236311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746218|NCT03236311|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
24746219|NCT03234686|Deferiprone|deferiprone|mesh-list
24746220|NCT03234686|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24746221|NCT03234686|Chelating Agents|chelating agents|mesh-ancestor
24746222|NCT03234686|Sequestering Agents|sequestering agents|mesh-ancestor
24746223|NCT03234686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532906|NCT00641602|Esomeprazole|esomeprazole|mesh-list
24443945|NCT00296309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746237|NCT03201939|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24746238|NCT03201939|Protease Inhibitors|protease inhibitors|mesh-ancestor
24746239|NCT03201939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24746240|NCT03201939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746241|NCT03201939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24746242|NCT03201939|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24746243|NCT03201939|Protective Agents|protective agents|mesh-ancestor
24746244|NCT03201939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746245|NCT03192046|Carbon Fiber|carbon fiber|mesh-list
24746293|NCT05438186|Liraglutide|liraglutide|mesh-list
24746294|NCT05438186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24746295|NCT05438186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746296|NCT05438186|Incretins|incretins|mesh-ancestor
24746297|NCT05438186|Hormones|hormones|mesh-ancestor
24746298|NCT05438186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24746299|NCT05438108|Bevacizumab|bevacizumab|mesh-list
24746300|NCT05438108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24746301|NCT05438108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746302|NCT05438108|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24746303|NCT05438108|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24746306|NCT05438108|Growth Inhibitors|growth inhibitors|mesh-ancestor
24746307|NCT05438082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24746308|NCT05438082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24746326|NCT05437718|Anesthetics|anesthetics|mesh-ancestor
24746327|NCT05437718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24746328|NCT05437718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746329|NCT05437718|Sensory System Agents|sensory system agents|mesh-ancestor
24746330|NCT05437718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24746332|NCT05437575|Ketamine|ketamine|mesh-list
24746333|NCT05437575|Analgesics|analgesics|mesh-ancestor
24746335|NCT05437575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24944175|NCT03962829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746342|NCT05437575|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24746343|NCT05437575|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24746364|NCT05437471|Hormone Antagonists|hormone antagonists|mesh-ancestor
24618612|NCT01049347|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24746375|NCT05437432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24746376|NCT05437432|Dopamine Agents|dopamine agents|mesh-ancestor
24443954|NCT00296348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443955|NCT00296348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24443956|NCT00296348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24443957|NCT00296348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24746380|NCT05437432|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24746381|NCT05437432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24746382|NCT05437432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24746394|NCT05436990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746395|NCT05436964|Dexmedetomidine|dexmedetomidine|mesh-list
24746396|NCT05436964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24746397|NCT05436964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24746398|NCT05436964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746399|NCT05436964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24746400|NCT05436964|Analgesics|analgesics|mesh-ancestor
24746401|NCT05436964|Sensory System Agents|sensory system agents|mesh-ancestor
24746402|NCT05436964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24746403|NCT05436964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24746404|NCT05436964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24746405|NCT05436964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24746406|NCT05436964|Adrenergic Agents|adrenergic agents|mesh-ancestor
24746407|NCT05436964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24654344|NCT01248923|Lenograstim|lenograstim|mesh-list
24746408|NCT05436964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944176|NCT03962829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746486|NCT05426811|Antimetabolites|antimetabolites|mesh-ancestor
24746487|NCT05426811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746488|NCT05426811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746489|NCT05426811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24746490|NCT05426811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654411|NCT01249430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24746515|NCT05357859|Cholecalciferol|cholecalciferol|mesh-list
24746516|NCT05357859|Vitamins|vitamins|mesh-ancestor
24746517|NCT05357859|Micronutrients|micronutrients|mesh-ancestor
24746518|NCT05357859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746519|NCT05357859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24746520|NCT05357859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24746521|NCT05351086|Dihydroergotamine|dihydroergotamine|mesh-list
24746522|NCT05351086|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24746523|NCT05351086|Dopamine Agonists|dopamine agonists|mesh-ancestor
24746524|NCT05351086|Dopamine Agents|dopamine agents|mesh-ancestor
24746534|NCT05239169|Capecitabine|capecitabine|mesh-list
24746535|NCT05239169|Durvalumab|durvalumab|mesh-list
24746536|NCT05239169|Tremelimumab|tremelimumab|mesh-list
24746537|NCT05239169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24746538|NCT05239169|Antimetabolites|antimetabolites|mesh-ancestor
24746539|NCT05239169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746540|NCT05239169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659976|NCT01281228|Exenatide|exenatide|mesh-list
24659977|NCT01281228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24659978|NCT01281228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659979|NCT01281228|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24799393|NCT01968798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24799394|NCT01968798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24799395|NCT01968798|Antipyretics|antipyretics|mesh-ancestor
24799396|NCT01968850|Vitamin D|vitamin d|mesh-list
24799397|NCT01968850|Alendronate|alendronate|mesh-list
24950649|NCT03913468|Antioxidants|antioxidants|mesh-ancestor
24950651|NCT03913468|Protective Agents|protective agents|mesh-ancestor
24746541|NCT05239169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24746545|NCT05145764|Suvorexant|suvorexant|mesh-list
24746552|NCT05145764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746553|NCT05120596|Pembrolizumab|pembrolizumab|mesh-list
24746554|NCT05120596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24746555|NCT05120596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746563|NCT05080556|Carboplatin|carboplatin|mesh-list
24746564|NCT05080556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746565|NCT05006079|Morphine|morphine|mesh-list
24746566|NCT05006079|Alprazolam|alprazolam|mesh-list
24746567|NCT05006079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24746568|NCT05006079|Narcotics|narcotics|mesh-ancestor
24458063|NCT00336414|Azathioprine|azathioprine|mesh-list
24746570|NCT05006079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746571|NCT05006079|Analgesics|analgesics|mesh-ancestor
24746572|NCT05006079|Sensory System Agents|sensory system agents|mesh-ancestor
24746573|NCT05006079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24746574|NCT05006079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24746581|NCT05006079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746582|NCT04970381|Rivaroxaban|rivaroxaban|mesh-list
24746583|NCT04970381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24746584|NCT04970381|Antithrombins|antithrombins|mesh-ancestor
24746585|NCT04970381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24746586|NCT04970381|Protease Inhibitors|protease inhibitors|mesh-ancestor
24746587|NCT04970381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24746588|NCT04970381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746589|NCT04970381|Anticoagulants|anticoagulants|mesh-ancestor
24746590|NCT04950270|Arginine Vasopressin|arginine vasopressin|mesh-list
24746591|NCT04950270|Hemostatics|hemostatics|mesh-ancestor
24746592|NCT04950270|Coagulants|coagulants|mesh-ancestor
24746593|NCT04950270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24746594|NCT04950270|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24746595|NCT04950270|Natriuretic Agents|natriuretic agents|mesh-ancestor
24746596|NCT04950270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746598|NCT04895046|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24746599|NCT04895046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24746600|NCT04895046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746601|NCT04895046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746602|NCT04830592|Pembrolizumab|pembrolizumab|mesh-list
24746603|NCT04830592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24746604|NCT04830592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746646|NCT04590586|Analgesics|analgesics|mesh-ancestor
24618619|NCT01049347|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24618620|NCT01049347|Antidepressive Agents|antidepressive agents|mesh-ancestor
24618621|NCT01049347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24618622|NCT01049347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25696346|NCT02059902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709380|NCT02265796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709381|NCT02265913|Acyclovir|acyclovir|mesh-list
25709382|NCT02265913|Antiviral Agents|antiviral agents|mesh-ancestor
25709383|NCT02265913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25709384|NCT02265965|Nitroglycerin|nitroglycerin|mesh-list
25709385|NCT02265965|Vasodilator Agents|vasodilator agents|mesh-ancestor
25709386|NCT02266433|Dexamethasone|dexamethasone|mesh-list
25709387|NCT02266433|Ketorolac|ketorolac|mesh-list
25709388|NCT02266433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25709389|NCT02266433|Antiemetics|antiemetics|mesh-ancestor
24799417|NCT01969019|Methylprednisolone|methylprednisolone|mesh-list
24618623|NCT01049347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24618624|NCT01049347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618625|NCT01049347|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24618626|NCT01049347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24618627|NCT01049347|Analgesics|analgesics|mesh-ancestor
24618628|NCT01049347|Sensory System Agents|sensory system agents|mesh-ancestor
24618629|NCT01049347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24618630|NCT01049347|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24746667|NCT04561557|Fludarabine|fludarabine|mesh-list
24746668|NCT04561557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24746669|NCT04561557|Immunologic Factors|immunologic factors|mesh-ancestor
24746670|NCT04561557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746678|NCT04511416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24746679|NCT04511416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746684|NCT04485949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746685|NCT04427293|Pembrolizumab|pembrolizumab|mesh-list
24746700|NCT04201262|Ravulizumab|ravulizumab|mesh-list
24746701|NCT04201262|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24746702|NCT04201262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24746703|NCT04201262|Immunologic Factors|immunologic factors|mesh-ancestor
24746704|NCT04201262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746705|NCT04191382|Letrozole|letrozole|mesh-list
24746706|NCT04191382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746707|NCT04191382|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24746708|NCT04191382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24746709|NCT04191382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24746764|NCT03819296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24746765|NCT03819296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746766|NCT03819296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24746767|NCT03819296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746768|NCT03819296|Immunologic Factors|immunologic factors|mesh-ancestor
24746769|NCT03819296|Dermatologic Agents|dermatologic agents|mesh-ancestor
24746770|NCT03819296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24746771|NCT03819296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24746775|NCT03563742|Tenofovir|tenofovir|mesh-list
24746776|NCT03563742|Lamivudine|lamivudine|mesh-list
24746777|NCT03563742|Rilpivirine|rilpivirine|mesh-list
24746778|NCT03563742|Antiviral Agents|antiviral agents|mesh-ancestor
24746779|NCT03563742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24746780|NCT03563742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24746781|NCT03563742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24746782|NCT03563742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24746783|NCT03563742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746784|NCT03563742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24746785|NCT03563742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24746786|NCT03537014|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
24746787|NCT03537014|Hallucinogens|hallucinogens|mesh-ancestor
25051245|NCT00429923|Fluprednisolone|fluprednisolone|mesh-list
24746860|NCT03230097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24746861|NCT03230097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746862|NCT03065621|Palbociclib|palbociclib|mesh-list
24746863|NCT03065621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746864|NCT03065621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24746865|NCT03065621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24746866|NCT03065621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746867|NCT03029780|Nivolumab|nivolumab|mesh-list
24746868|NCT03029780|Ipilimumab|ipilimumab|mesh-list
24746869|NCT03029780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24746870|NCT03029780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746871|NCT03029780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24746873|NCT02968940|Avelumab|avelumab|mesh-list
24747027|NCT02203773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24747028|NCT02203773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24747029|NCT02203773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24747030|NCT02203773|Antifungal Agents|antifungal agents|mesh-ancestor
24747044|NCT02175030|Contraceptive Agents|contraceptive agents|mesh-ancestor
24747045|NCT02175030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25696347|NCT02060370|Sunitinib|sunitinib|mesh-list
24747046|NCT02175030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696348|NCT02060370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25696349|NCT02060370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25696350|NCT02060370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24747047|NCT02175030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24747048|NCT02175030|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24747049|NCT02175030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24747050|NCT02175030|Trace Elements|trace elements|mesh-ancestor
24747051|NCT02175030|Micronutrients|micronutrients|mesh-ancestor
24411514|NCT00189345|Muromonab-CD3|muromonab-cd3|mesh-list
24613292|NCT01017939|Autonomic Agents|autonomic agents|mesh-ancestor
24944193|NCT03962725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24944194|NCT03962725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24747057|NCT02017717|Bevacizumab|bevacizumab|mesh-list
24747058|NCT02017717|Nivolumab|nivolumab|mesh-list
24747059|NCT02017717|Ipilimumab|ipilimumab|mesh-list
24747060|NCT02017717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24747061|NCT02017717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24747062|NCT02017717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24747063|NCT02017717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24747064|NCT02017717|Growth Substances|growth substances|mesh-ancestor
24747065|NCT02017717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24747066|NCT02017717|Growth Inhibitors|growth inhibitors|mesh-ancestor
24747067|NCT02017717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24747068|NCT02017717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24747137|NCT01746173|Plerixafor|plerixafor|mesh-list
24747144|NCT01746173|Etoposide phosphate|etoposide phosphate|mesh-list
24747146|NCT01746173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24618632|NCT01049425|Cyclophosphamide|cyclophosphamide|mesh-list
24618634|NCT01049425|Epirubicin|epirubicin|mesh-list
24618635|NCT01049425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24618636|NCT01049425|Immunologic Factors|immunologic factors|mesh-ancestor
24618637|NCT01049425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618638|NCT01049425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24747166|NCT01746173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24747167|NCT01746173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24747168|NCT01746173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24747169|NCT01746173|Tubulin Modulators|tubulin modulators|mesh-ancestor
24747170|NCT01746173|Antimitotic Agents|antimitotic agents|mesh-ancestor
24747171|NCT01746173|Mitosis Modulators|mitosis modulators|mesh-ancestor
24747172|NCT01746173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24654742|NCT01251172|Melphalan|melphalan|mesh-list
24747173|NCT01746173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24747175|NCT01734512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24747176|NCT01734512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24747177|NCT01734512|Immunologic Factors|immunologic factors|mesh-ancestor
24747178|NCT01734512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24747231|NCT01349959|Azacitidine|azacitidine|mesh-list
24747232|NCT01349959|Entinostat|entinostat|mesh-list
24411708|NCT00189761|Tacrolimus|tacrolimus|mesh-list
24747233|NCT01349959|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
24747234|NCT01349959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24747235|NCT01349959|Antimetabolites|antimetabolites|mesh-ancestor
24944203|NCT03962725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24944205|NCT03962725|Adrenergic Agents|adrenergic agents|mesh-ancestor
24702337|NCT01465152|Metformin|metformin|mesh-list
24532007|NCT00637858|Lycopene|lycopene|mesh-list
24654768|NCT01251263|Estradiol|estradiol|mesh-list
24944208|NCT03962725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24944209|NCT03962725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24660120|NCT01281787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24747505|NCT00700882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24747506|NCT00700882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944210|NCT03962725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24747702|NCT03164889|Antiviral Agents|antiviral agents|mesh-ancestor
24747703|NCT03164889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24747704|NCT03164889|Immunologic Factors|immunologic factors|mesh-ancestor
24747705|NCT03164889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944212|NCT03962725|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24944213|NCT03962777|Chlorhexidine|chlorhexidine|mesh-list
24944214|NCT03962777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24944215|NCT03962777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24944216|NCT03962777|Disinfectants|disinfectants|mesh-ancestor
24944218|NCT03962803|Immunologic Factors|immunologic factors|mesh-ancestor
24944219|NCT03962803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944220|NCT03962816|Vaccines|vaccines|mesh-list
24944221|NCT03962816|Immunologic Factors|immunologic factors|mesh-ancestor
24944222|NCT03962816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459903|NCT00346801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24407084|NCT00171808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24407085|NCT00171808|Hormone Antagonists|hormone antagonists|mesh-ancestor
24407086|NCT00171808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24407087|NCT00171808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407088|NCT00171821|Deferasirox|deferasirox|mesh-list
24407105|NCT00171860|Imatinib Mesylate|imatinib mesylate|mesh-list
24747706|NCT03164889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412146|NCT00190892|Olanzapine|olanzapine|mesh-list
24618669|NCT01049438|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24747906|NCT03026972|Immunologic Factors|immunologic factors|mesh-ancestor
24618673|NCT01049451|Methylprednisolone|methylprednisolone|mesh-list
24618674|NCT01049451|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24618675|NCT01049451|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24618676|NCT01049451|Prednisolone|prednisolone|mesh-list
24618677|NCT01049451|Prednisolone acetate|prednisolone acetate|mesh-list
24618678|NCT01049451|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24618679|NCT01049451|Prednisolone phosphate|prednisolone phosphate|mesh-list
24618680|NCT01049451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24618681|NCT01049451|Antiemetics|antiemetics|mesh-ancestor
24618682|NCT01049451|Autonomic Agents|autonomic agents|mesh-ancestor
24618683|NCT01049451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24618687|NCT01049451|Hormones|hormones|mesh-ancestor
24618688|NCT01049451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24618689|NCT01049451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24618690|NCT01049451|Protective Agents|protective agents|mesh-ancestor
24618691|NCT01049451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24618700|NCT01049464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24618702|NCT01049464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24747725|NCT03133260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24747726|NCT03133260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24747727|NCT03133260|Analgesics|analgesics|mesh-ancestor
24747728|NCT03133260|Sensory System Agents|sensory system agents|mesh-ancestor
24747729|NCT03133260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24747730|NCT03133260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24747731|NCT03133260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24747732|NCT03133260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24747733|NCT03133260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24747734|NCT03133260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24747735|NCT03133260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24747736|NCT03133260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24747737|NCT03133260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24747738|NCT03133260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24747739|NCT03133260|Antipyretics|antipyretics|mesh-ancestor
24747743|NCT03126812|Paclitaxel|paclitaxel|mesh-list
24747744|NCT03126812|Carboplatin|carboplatin|mesh-list
24747745|NCT03126812|Pembrolizumab|pembrolizumab|mesh-list
24747746|NCT03126812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25696351|NCT02060370|Growth Substances|growth substances|mesh-ancestor
25696352|NCT02060370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696353|NCT02060370|Growth Inhibitors|growth inhibitors|mesh-ancestor
25696354|NCT02060370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25696355|NCT02060370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25696356|NCT02060370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696357|NCT02060383|Metformin|metformin|mesh-list
24660177|NCT01281943|Sirolimus|sirolimus|mesh-list
24747747|NCT03126812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24747748|NCT03126812|Tubulin Modulators|tubulin modulators|mesh-ancestor
24747749|NCT03126812|Antimitotic Agents|antimitotic agents|mesh-ancestor
24445230|NCT00300846|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24445231|NCT00300911|Rosiglitazone|rosiglitazone|mesh-list
24445232|NCT00300911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24445233|NCT00300911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445234|NCT00300924|Acetaminophen|acetaminophen|mesh-list
24445235|NCT00300924|Rizatriptan|rizatriptan|mesh-list
24445236|NCT00300924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24445237|NCT00300924|Analgesics|analgesics|mesh-ancestor
24532340|NCT00639496|Acetylcysteine|acetylcysteine|mesh-list
24747752|NCT03126812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24747755|NCT03110432|Ezetimibe|ezetimibe|mesh-list
24747756|NCT03110432|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
24747757|NCT03110432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24747758|NCT03110432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24747759|NCT03110432|Antimetabolites|antimetabolites|mesh-ancestor
24747760|NCT03110432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412211|NCT00190970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24747785|NCT03089203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24747787|NCT03089203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24747795|NCT03086993|Gemcitabine|gemcitabine|mesh-list
24857397|NCT02291536|Sensory System Agents|sensory system agents|mesh-ancestor
24747796|NCT03086993|Melphalan|melphalan|mesh-list
24747797|NCT03086993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24747798|NCT03086993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24747799|NCT03086993|Antimetabolites|antimetabolites|mesh-ancestor
24747800|NCT03086993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24747801|NCT03086993|Antiviral Agents|antiviral agents|mesh-ancestor
24747802|NCT03086993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24747803|NCT03086993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24747804|NCT03086993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24747805|NCT03086993|Immunologic Factors|immunologic factors|mesh-ancestor
24747806|NCT03086993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24747807|NCT03086993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24747808|NCT03086993|Alkylating Agents|alkylating agents|mesh-ancestor
24747809|NCT03086993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24445312|NCT00301210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24445313|NCT00301210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445315|NCT00301210|Sensory System Agents|sensory system agents|mesh-ancestor
24445316|NCT00301210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24747810|NCT03085485|Ivacaftor|ivacaftor|mesh-list
24747811|NCT03085485|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24537842|NCT00656526|Lidocaine|lidocaine|mesh-list
24412252|NCT00191035|Adrenergic Agents|adrenergic agents|mesh-ancestor
24747830|NCT03070392|Pembrolizumab|pembrolizumab|mesh-list
24747831|NCT03070392|Ipilimumab|ipilimumab|mesh-list
24747832|NCT03070392|Dacarbazine|dacarbazine|mesh-list
24747833|NCT03070392|Imidazole|imidazole|mesh-list
24747834|NCT03070392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24747835|NCT03070392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24747836|NCT03070392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24747837|NCT03070392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24747838|NCT03070392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24747839|NCT03070392|Alkylating Agents|alkylating agents|mesh-ancestor
24747840|NCT03070392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445449|NCT00301587|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24445451|NCT00301587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24445452|NCT00301587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24445453|NCT00301587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24445454|NCT00301587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24445455|NCT00301587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24445456|NCT00301587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445457|NCT00301587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445532|NCT00301782|Tubulin Modulators|tubulin modulators|mesh-ancestor
25696358|NCT02060383|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24747863|NCT03064490|Pembrolizumab|pembrolizumab|mesh-list
24747864|NCT03064490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24747865|NCT03064490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24747866|NCT03056014|Acetylcysteine|acetylcysteine|mesh-list
24747867|NCT03056014|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24747868|NCT03056014|Antiviral Agents|antiviral agents|mesh-ancestor
24747869|NCT03056014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24747870|NCT03056014|Expectorants|expectorants|mesh-ancestor
24747871|NCT03056014|Respiratory System Agents|respiratory system agents|mesh-ancestor
24747872|NCT03056014|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24747874|NCT03056014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24747875|NCT03056014|Protective Agents|protective agents|mesh-ancestor
24747876|NCT03056014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24747877|NCT03056014|Antidotes|antidotes|mesh-ancestor
24747879|NCT03054363|Palbociclib|palbociclib|mesh-list
24747880|NCT03054363|Tucatinib|tucatinib|mesh-list
24747881|NCT03054363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24747882|NCT03054363|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24747883|NCT03054363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24747903|NCT03048578|Hormones|hormones|mesh-ancestor
24747904|NCT03048578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24747905|NCT03026972|Vaccines|vaccines|mesh-list
24747912|NCT03015792|Dexamethasone acetate|dexamethasone acetate|mesh-list
24747916|NCT03015792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24747917|NCT03015792|Antiemetics|antiemetics|mesh-ancestor
24747918|NCT03015792|Autonomic Agents|autonomic agents|mesh-ancestor
24747924|NCT03015792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24747925|NCT03015792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24747926|NCT03015792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24747927|NCT03015792|Immunologic Factors|immunologic factors|mesh-ancestor
24747928|NCT03015792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24747929|NCT03015792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24747930|NCT03015792|Growth Substances|growth substances|mesh-ancestor
24747931|NCT03015792|Growth Inhibitors|growth inhibitors|mesh-ancestor
24747932|NCT03015792|Protease Inhibitors|protease inhibitors|mesh-ancestor
24747933|NCT03015792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24747934|NCT03015792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24747935|NCT03015792|Dermatologic Agents|dermatologic agents|mesh-ancestor
24747936|NCT03012815|Chlordiazepoxide|chlordiazepoxide|mesh-list
24747937|NCT03012815|Gabapentin|gabapentin|mesh-list
24747938|NCT03012815|Lorazepam|lorazepam|mesh-list
24747940|NCT03012815|Analgesics|analgesics|mesh-ancestor
24747941|NCT03012815|Sensory System Agents|sensory system agents|mesh-ancestor
24446948|NCT00306722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24446949|NCT00306722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24446950|NCT00306722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24747953|NCT03012815|Antimanic Agents|antimanic agents|mesh-ancestor
24747954|NCT03012815|Antiemetics|antiemetics|mesh-ancestor
24747955|NCT03012815|Autonomic Agents|autonomic agents|mesh-ancestor
24747956|NCT03012815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24593492|NCT00929812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593493|NCT00929851|Formoterol Fumarate|formoterol fumarate|mesh-list
24747957|NCT03012815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24747958|NCT03012815|GABA Modulators|gaba modulators|mesh-ancestor
24747959|NCT03012815|GABA Agents|gaba agents|mesh-ancestor
24747960|NCT03012815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24747961|NCT03012815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24747962|NCT03006432|Leucovorin|leucovorin|mesh-list
24747963|NCT03006432|Folic Acid|folic acid|mesh-list
24747964|NCT03006432|Docetaxel|docetaxel|mesh-list
24747965|NCT03006432|Fluorouracil|fluorouracil|mesh-list
24747966|NCT03006432|Oxaliplatin|oxaliplatin|mesh-list
24537989|NCT00657059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24747967|NCT03006432|Levoleucovorin|levoleucovorin|mesh-list
24703950|NCT01475617|Hydroxocobalamin|hydroxocobalamin|mesh-list
24747971|NCT03006432|Mitosis Modulators|mitosis modulators|mesh-ancestor
24747972|NCT03006432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24747973|NCT03006432|Antimetabolites|antimetabolites|mesh-ancestor
24747974|NCT03006432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24747975|NCT03006432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24747991|NCT03001011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24747992|NCT02999633|Acetaminophen|acetaminophen|mesh-list
24747993|NCT02999633|Diphenhydramine|diphenhydramine|mesh-list
24747994|NCT02999633|Promethazine|promethazine|mesh-list
24747995|NCT02999633|Dexamethasone|dexamethasone|mesh-list
24747996|NCT02999633|Dexamethasone acetate|dexamethasone acetate|mesh-list
24747997|NCT02999633|Ranitidine|ranitidine|mesh-list
24747998|NCT02999633|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
24747999|NCT02999633|BB 1101|bb 1101|mesh-list
24851887|NCT02259790|Amlodipine|amlodipine|mesh-list
24532950|NCT00641693|Hormones|hormones|mesh-ancestor
24748002|NCT02999633|Autonomic Agents|autonomic agents|mesh-ancestor
24944238|NCT03962296|Calcium Dobesilate|calcium dobesilate|mesh-list
24944240|NCT03962296|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24857401|NCT02291536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24748003|NCT02999633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24748004|NCT02999633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748005|NCT02999633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24748006|NCT02999633|Glucocorticoids|glucocorticoids|mesh-ancestor
24748007|NCT02999633|Hormones|hormones|mesh-ancestor
24748008|NCT02999633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24748016|NCT02999633|Sensory System Agents|sensory system agents|mesh-ancestor
24748017|NCT02999633|Antipyretics|antipyretics|mesh-ancestor
24748018|NCT02999633|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24748019|NCT02999633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25696359|NCT02060383|Liraglutide|liraglutide|mesh-list
25696360|NCT02060383|Pasireotide|pasireotide|mesh-list
24748020|NCT02999633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24748021|NCT02999633|Anesthetics, Local|anesthetics, local|mesh-ancestor
24748022|NCT02999633|Anesthetics|anesthetics|mesh-ancestor
24748023|NCT02999633|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25696361|NCT02060383|Somatostatin|somatostatin|mesh-list
25696362|NCT02060383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25696363|NCT02060383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748024|NCT02999633|Histamine Antagonists|histamine antagonists|mesh-ancestor
24748034|NCT02993757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748036|NCT02992418|Immunologic Factors|immunologic factors|mesh-ancestor
24748037|NCT02992418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748038|NCT02979535|Vaccines|vaccines|mesh-list
24748039|NCT02979535|Immunologic Factors|immunologic factors|mesh-ancestor
24748040|NCT02979535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748041|NCT02978716|Gemcitabine|gemcitabine|mesh-list
24748042|NCT02978716|Carboplatin|carboplatin|mesh-list
24748043|NCT02978716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748044|NCT02978716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24748059|NCT02975934|Abiraterone Acetate|abiraterone acetate|mesh-list
24748061|NCT02975934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748062|NCT02975934|Tubulin Modulators|tubulin modulators|mesh-ancestor
24748063|NCT02975934|Antimitotic Agents|antimitotic agents|mesh-ancestor
24748064|NCT02975934|Mitosis Modulators|mitosis modulators|mesh-ancestor
24748065|NCT02975934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748066|NCT02975934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24748067|NCT02975934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24748068|NCT02975934|Hormone Antagonists|hormone antagonists|mesh-ancestor
24748070|NCT02975934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748074|NCT02973321|Liraglutide|liraglutide|mesh-list
24748075|NCT02973321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24748076|NCT02973321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748077|NCT02973321|Incretins|incretins|mesh-ancestor
24748078|NCT02973321|Hormones|hormones|mesh-ancestor
24748079|NCT02973321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24748080|NCT02967250|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24748081|NCT02967250|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24748082|NCT02967250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24748083|NCT02964585|Canagliflozin|canagliflozin|mesh-list
24748084|NCT02964585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24748085|NCT02964585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944241|NCT03962296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748086|NCT02964585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24748089|NCT02950766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24812326|NCT02051413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24812327|NCT02051413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24812328|NCT02051413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748090|NCT02950766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748123|NCT02901067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748124|NCT02901067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24748125|NCT02901067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24748126|NCT02901067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24748127|NCT02901067|Antipyretics|antipyretics|mesh-ancestor
24748128|NCT02901067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24748131|NCT02901067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24748132|NCT02901067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24618704|NCT01049464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618705|NCT01049464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24618706|NCT01049464|Tocolytic Agents|tocolytic agents|mesh-ancestor
24618707|NCT01049464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24618709|NCT01049542|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24618710|NCT01049542|Protective Agents|protective agents|mesh-ancestor
24618711|NCT01049542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618712|NCT01049620|Capecitabine|capecitabine|mesh-list
24618713|NCT01049620|Oxaliplatin|oxaliplatin|mesh-list
24618714|NCT01049620|Everolimus|everolimus|mesh-list
24618715|NCT01049620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24618716|NCT01049620|Antimetabolites|antimetabolites|mesh-ancestor
24618717|NCT01049620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618718|NCT01049620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618719|NCT01049620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24618720|NCT01049620|Immunologic Factors|immunologic factors|mesh-ancestor
24618721|NCT01049620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618722|NCT01049633|Aspirin|aspirin|mesh-list
24618723|NCT01049633|Sirolimus|sirolimus|mesh-list
24618724|NCT01049633|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24618725|NCT01049633|Clotrimazole|clotrimazole|mesh-list
24618726|NCT01049633|Miconazole|miconazole|mesh-list
24618727|NCT01049633|Antifungal Agents|antifungal agents|mesh-list
24618728|NCT01049633|Trimethoprim|trimethoprim|mesh-list
24412526|NCT00191555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24660256|NCT01282398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24618729|NCT01049633|Sulfamethoxazole|sulfamethoxazole|mesh-list
24618730|NCT01049633|Valganciclovir|valganciclovir|mesh-list
24618731|NCT01049633|Antiviral Agents|antiviral agents|mesh-list
24618732|NCT01049633|Heparin|heparin|mesh-list
24618733|NCT01049633|Enoxaparin|enoxaparin|mesh-list
24618734|NCT01049633|Pentoxifylline|pentoxifylline|mesh-list
24618735|NCT01049633|Tacrolimus|tacrolimus|mesh-list
24618736|NCT01049633|Basiliximab|basiliximab|mesh-list
24618740|NCT01049633|Sensory System Agents|sensory system agents|mesh-ancestor
24618741|NCT01049633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24618742|NCT01049633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618743|NCT01049633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24618744|NCT01049633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24618745|NCT01049633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24748134|NCT02886286|Morphine|morphine|mesh-list
24748135|NCT02886286|Hydromorphone|hydromorphone|mesh-list
24748136|NCT02886286|Bupivacaine|bupivacaine|mesh-list
24748137|NCT02886286|Anesthetics, Local|anesthetics, local|mesh-ancestor
24748138|NCT02886286|Anesthetics|anesthetics|mesh-ancestor
24748139|NCT02886286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24748140|NCT02886286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748141|NCT02886286|Sensory System Agents|sensory system agents|mesh-ancestor
24748142|NCT02886286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24748158|NCT02865187|Vitamins|vitamins|mesh-ancestor
24748159|NCT02865187|Micronutrients|micronutrients|mesh-ancestor
24748160|NCT02865187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748161|NCT02865187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24944242|NCT03962296|Hemostatics|hemostatics|mesh-ancestor
24944243|NCT03962296|Coagulants|coagulants|mesh-ancestor
24748209|NCT02787551|Lixisenatide|lixisenatide|mesh-list
24748210|NCT02787551|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24748211|NCT02787551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
24748212|NCT02787551|rGLP-1 protein|rglp-1 protein|mesh-list
24748213|NCT02787551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748214|NCT02787551|Incretins|incretins|mesh-ancestor
24748215|NCT02787551|Hormones|hormones|mesh-ancestor
24748216|NCT02787551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24748218|NCT02787551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655043|NCT01253694|Ranibizumab|ranibizumab|mesh-list
24412609|NCT00191672|Docetaxel|docetaxel|mesh-list
24944248|NCT03961867|Docetaxel|docetaxel|mesh-list
24445871|NCT00302822|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24748260|NCT02754011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748261|NCT02754011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748262|NCT02753998|Paclitaxel|paclitaxel|mesh-list
24748263|NCT02753998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24748264|NCT02753998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748265|NCT02753998|Tubulin Modulators|tubulin modulators|mesh-ancestor
24748266|NCT02753998|Antimitotic Agents|antimitotic agents|mesh-ancestor
24748267|NCT02753998|Mitosis Modulators|mitosis modulators|mesh-ancestor
24538536|NCT00659750|Hormones|hormones|mesh-ancestor
24748287|NCT02750319|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24748288|NCT02750319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24748289|NCT02750319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24748290|NCT02750319|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24748291|NCT02750319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24748292|NCT02750319|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24748293|NCT02736656|Viloxazine|viloxazine|mesh-list
24748294|NCT02736656|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24748295|NCT02736656|Antidepressive Agents|antidepressive agents|mesh-ancestor
24748296|NCT02736656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24748297|NCT02736656|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24748298|NCT02736656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24748299|NCT02736656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24748300|NCT02736656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696364|NCT02060383|Incretins|incretins|mesh-ancestor
24748301|NCT02736656|Adrenergic Agents|adrenergic agents|mesh-ancestor
24748302|NCT02736656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24748303|NCT02736656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696365|NCT02060383|Hormones|hormones|mesh-ancestor
24748305|NCT02735044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24748306|NCT02735044|Insulin Glargine|insulin glargine|mesh-list
24748307|NCT02735044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24748308|NCT02735044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944250|NCT03961867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24944251|NCT03961867|Tubulin Modulators|tubulin modulators|mesh-ancestor
24944252|NCT03961867|Antimitotic Agents|antimitotic agents|mesh-ancestor
24944253|NCT03961867|Mitosis Modulators|mitosis modulators|mesh-ancestor
24944254|NCT03961867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944256|NCT03961958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24944257|NCT03961958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24944258|NCT03961958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944259|NCT03961958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24944260|NCT03961958|Anesthetics, General|anesthetics, general|mesh-ancestor
24748315|NCT02713867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24748326|NCT02688712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748373|NCT02674061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24748374|NCT02674061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748376|NCT02656706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24748377|NCT02656706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748378|NCT02656706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24748379|NCT02656706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748381|NCT02654314|Antioxidants|antioxidants|mesh-ancestor
24621542|NCT01062958|Hematinics|hematinics|mesh-ancestor
24748382|NCT02654314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944261|NCT03961958|Anesthetics|anesthetics|mesh-ancestor
24944268|NCT03961841|Oxaliplatin|oxaliplatin|mesh-list
24944269|NCT03961841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24944270|NCT03961828|Sofosbuvir|sofosbuvir|mesh-list
24944271|NCT03961828|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
24944272|NCT03961828|Ledipasvir|ledipasvir|mesh-list
24944273|NCT03961828|Antiviral Agents|antiviral agents|mesh-ancestor
24944274|NCT03961828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24944275|NCT03961659|Metformin|metformin|mesh-list
24944276|NCT03961659|Dapagliflozin|dapagliflozin|mesh-list
24748383|NCT02654314|Protective Agents|protective agents|mesh-ancestor
24748384|NCT02654314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748385|NCT02654314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24748386|NCT02626962|Nivolumab|nivolumab|mesh-list
24748387|NCT02626962|Ipilimumab|ipilimumab|mesh-list
24748388|NCT02626962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24748389|NCT02626962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748390|NCT02626962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24748391|NCT02626962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748392|NCT02623998|Metformin|metformin|mesh-list
24748393|NCT02623998|Insulin Glargine|insulin glargine|mesh-list
24748394|NCT02623998|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24748395|NCT02623998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24748416|NCT02608684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24748417|NCT02603887|Pembrolizumab|pembrolizumab|mesh-list
24748418|NCT02603887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24748419|NCT02603887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748421|NCT02599324|Docetaxel|docetaxel|mesh-list
24748422|NCT02599324|Pembrolizumab|pembrolizumab|mesh-list
24748423|NCT02599324|Cetuximab|cetuximab|mesh-list
24748424|NCT02599324|Everolimus|everolimus|mesh-list
24748445|NCT02595892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748447|NCT02587520|Immunologic Factors|immunologic factors|mesh-ancestor
24748460|NCT02559856|Apixaban|apixaban|mesh-list
24748461|NCT02559856|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24748462|NCT02559856|Antithrombins|antithrombins|mesh-ancestor
24748463|NCT02559856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24748464|NCT02559856|Protease Inhibitors|protease inhibitors|mesh-ancestor
24748465|NCT02559856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24748466|NCT02559856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748467|NCT02559856|Anticoagulants|anticoagulants|mesh-ancestor
24748468|NCT02557321|Pembrolizumab|pembrolizumab|mesh-list
24748469|NCT02557321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24748470|NCT02557321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748471|NCT02514083|Fludarabine|fludarabine|mesh-list
24748472|NCT02514083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748477|NCT02512172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24748478|NCT02512172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748479|NCT02512172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24748480|NCT02512172|Antimetabolites|antimetabolites|mesh-ancestor
24748481|NCT02512172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944277|NCT03961659|Acarbose|acarbose|mesh-list
24944278|NCT03961659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24944279|NCT03961659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748482|NCT02512172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618776|NCT01049633|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24618777|NCT01049633|Hormone Antagonists|hormone antagonists|mesh-ancestor
24618778|NCT01049633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24618779|NCT01049633|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24618780|NCT01049633|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24618781|NCT01049646|Angiotensin II|angiotensin ii|mesh-list
24618792|NCT01049672|Narcotics|narcotics|mesh-ancestor
24618793|NCT01049672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24618794|NCT01049672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618795|NCT01049672|Analgesics|analgesics|mesh-ancestor
24618796|NCT01049672|Sensory System Agents|sensory system agents|mesh-ancestor
24618797|NCT01049672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24412892|NCT00192621|Protease Inhibitors|protease inhibitors|mesh-ancestor
24748493|NCT02499367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748494|NCT02499367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748495|NCT02499367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24748496|NCT02499367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24748497|NCT02499367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24748498|NCT02499367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24748499|NCT02499367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24748500|NCT02499367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24748501|NCT02499367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24748502|NCT02497612|Artefenomel|artefenomel|mesh-list
24748503|NCT02497612|Ferroquine|ferroquine|mesh-list
24748504|NCT02497612|Antimalarials|antimalarials|mesh-ancestor
24748505|NCT02497612|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24748506|NCT02497612|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24748524|NCT02452268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748525|NCT02452268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748526|NCT02449031|Tobramycin|tobramycin|mesh-list
24944281|NCT03961659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944282|NCT03961659|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24944283|NCT03961659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24944284|NCT03961464|Cycloserine|cycloserine|mesh-list
24944285|NCT03961464|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24944286|NCT03961464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24944287|NCT03961464|Renal Agents|renal agents|mesh-ancestor
24944288|NCT03961464|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24944289|NCT03961464|Antitubercular Agents|antitubercular agents|mesh-ancestor
24944290|NCT03961464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24748533|NCT02404935|Cetuximab|cetuximab|mesh-list
24748534|NCT02404935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24748535|NCT02404935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748538|NCT02381652|Triamcinolone|triamcinolone|mesh-list
24748539|NCT02381652|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24748540|NCT02381652|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24748541|NCT02381652|Hyaluronic Acid|hyaluronic acid|mesh-list
24748542|NCT02381652|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24748543|NCT02381652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24748544|NCT02381652|Glucocorticoids|glucocorticoids|mesh-ancestor
24660631|NCT01284868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748545|NCT02381652|Hormones|hormones|mesh-ancestor
24748546|NCT02381652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24748547|NCT02381652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748552|NCT02381652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24748553|NCT02381652|Viscosupplements|viscosupplements|mesh-ancestor
24852364|NCT02262325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748579|NCT02367794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24748580|NCT02367794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748581|NCT02367794|Tubulin Modulators|tubulin modulators|mesh-ancestor
24748582|NCT02367794|Antimitotic Agents|antimitotic agents|mesh-ancestor
24748583|NCT02367794|Mitosis Modulators|mitosis modulators|mesh-ancestor
24748584|NCT02367794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748585|NCT02367794|Immunologic Factors|immunologic factors|mesh-ancestor
24748586|NCT02367794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748588|NCT02363998|Clonidine|clonidine|mesh-list
24748589|NCT02363998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24748590|NCT02363998|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24748591|NCT02363998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748592|NCT02363998|Sensory System Agents|sensory system agents|mesh-ancestor
24748593|NCT02363998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24748594|NCT02363998|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24748595|NCT02363998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24748596|NCT02363998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24748597|NCT02363998|Adrenergic Agents|adrenergic agents|mesh-ancestor
24748629|NCT02325466|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24748630|NCT02325466|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24748631|NCT02325466|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24748632|NCT02325466|Purinergic Agents|purinergic agents|mesh-ancestor
24944291|NCT03961464|Antimetabolites|antimetabolites|mesh-ancestor
24944292|NCT03961464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944293|NCT03961607|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24944294|NCT03961607|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24944295|NCT03961607|Dermatologic Agents|dermatologic agents|mesh-ancestor
24944332|NCT03960970|Cefoxitin|cefoxitin|mesh-list
24944333|NCT03960970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24944334|NCT03960970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24944335|NCT03961334|Aspirin|aspirin|mesh-list
24944336|NCT03961334|Dabigatran|dabigatran|mesh-list
24944337|NCT03961334|Apixaban|apixaban|mesh-list
24857436|NCT02291666|Anesthetics, General|anesthetics, general|mesh-ancestor
24707650|NCT01497093|Immunologic Factors|immunologic factors|mesh-ancestor
24707651|NCT01497093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24707652|NCT01497093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24748633|NCT02325466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24748634|NCT02323100|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
24748635|NCT02323100|Glycerol|glycerol|mesh-list
24748636|NCT02323100|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24748637|NCT02323100|Protective Agents|protective agents|mesh-ancestor
24748638|NCT02323100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748639|NCT02323100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748640|NCT02322710|Petrolatum|petrolatum|mesh-list
24748641|NCT02322710|Emollients|emollients|mesh-ancestor
24748642|NCT02322710|Dermatologic Agents|dermatologic agents|mesh-ancestor
24748643|NCT02285179|Tamoxifen|tamoxifen|mesh-list
24748644|NCT02285179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24538708|NCT00660582|Leucovorin|leucovorin|mesh-list
24748645|NCT02285179|Hormone Antagonists|hormone antagonists|mesh-ancestor
24748646|NCT02285179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24748647|NCT02285179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748648|NCT02285179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24748649|NCT02285179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748650|NCT02285179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24748651|NCT02285179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24748652|NCT02285179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24748655|NCT02283281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748656|NCT02283281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24748671|NCT02251548|Immunologic Factors|immunologic factors|mesh-ancestor
25696366|NCT02060383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24799737|NCT01970904|Antimetabolites|antimetabolites|mesh-ancestor
24799738|NCT01970904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799739|NCT01970904|Antiviral Agents|antiviral agents|mesh-ancestor
24799740|NCT01970904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24799741|NCT01970917|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24799742|NCT01970917|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24748672|NCT02251548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748673|NCT02251548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24748674|NCT02251548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24748675|NCT02251548|Alkylating Agents|alkylating agents|mesh-ancestor
24748676|NCT02251548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748677|NCT02251548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748680|NCT02240498|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24748681|NCT02240498|Methylene Blue|methylene blue|mesh-list
24748682|NCT02240498|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24748683|NCT02240498|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24748718|NCT02204241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24748719|NCT02204241|Alkylating Agents|alkylating agents|mesh-ancestor
24748720|NCT02204241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748722|NCT02204241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24748723|NCT02204241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24748724|NCT02204241|Antiemetics|antiemetics|mesh-ancestor
24748725|NCT02204241|Autonomic Agents|autonomic agents|mesh-ancestor
24748726|NCT02204241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24748727|NCT02204241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24748728|NCT02204241|Glucocorticoids|glucocorticoids|mesh-ancestor
24748730|NCT02204241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24748731|NCT02204241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24748732|NCT02185820|Dexamethasone|dexamethasone|mesh-list
24944339|NCT03961334|Clopidogrel|clopidogrel|mesh-list
24944340|NCT03961334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24749029|NCT01857115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24944341|NCT03961334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24748733|NCT02185820|Pomalidomide|pomalidomide|mesh-list
24748734|NCT02185820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24748735|NCT02185820|Antiemetics|antiemetics|mesh-ancestor
24748736|NCT02185820|Autonomic Agents|autonomic agents|mesh-ancestor
24748737|NCT02185820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24748738|NCT02185820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748739|NCT02185820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24748740|NCT02185820|Glucocorticoids|glucocorticoids|mesh-ancestor
24748769|NCT02168829|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24748771|NCT02168829|Anticoagulants|anticoagulants|mesh-ancestor
24748772|NCT02162563|Leucovorin|leucovorin|mesh-list
24748773|NCT02162563|Bevacizumab|bevacizumab|mesh-list
24748774|NCT02162563|Panitumumab|panitumumab|mesh-list
24748775|NCT02162563|Fluorouracil|fluorouracil|mesh-list
24748776|NCT02162563|Oxaliplatin|oxaliplatin|mesh-list
24748777|NCT02162563|Irinotecan|irinotecan|mesh-list
24748778|NCT02162563|Levoleucovorin|levoleucovorin|mesh-list
24748779|NCT02162563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24748780|NCT02162563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748781|NCT02162563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24748782|NCT02162563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24748783|NCT02162563|Growth Substances|growth substances|mesh-ancestor
24748784|NCT02162563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748785|NCT02162563|Growth Inhibitors|growth inhibitors|mesh-ancestor
24748786|NCT02162563|Antimetabolites|antimetabolites|mesh-ancestor
24748787|NCT02162563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748788|NCT02162563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24748789|NCT02162563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24748790|NCT02162563|Immunologic Factors|immunologic factors|mesh-ancestor
25696367|NCT02060383|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25696368|NCT02060383|Protease Inhibitors|protease inhibitors|mesh-ancestor
25696369|NCT02060383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25696370|NCT02060383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696371|NCT02061202|Mometasone Furoate|mometasone furoate|mesh-list
25696372|NCT02061202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25696373|NCT02061202|Dermatologic Agents|dermatologic agents|mesh-ancestor
25696374|NCT02061202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25696375|NCT02061280|Fluticasone|fluticasone|mesh-list
24748818|NCT02127086|Analgesics|analgesics|mesh-list
24748819|NCT02127086|Sensory System Agents|sensory system agents|mesh-ancestor
24590284|NCT00911651|Tocolytic Agents|tocolytic agents|mesh-ancestor
24748820|NCT02127086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24748822|NCT02120079|Loteprednol Etabonate|loteprednol etabonate|mesh-list
24944344|NCT03961334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24748833|NCT02102243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24748834|NCT02102243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748835|NCT02075177|Ketoconazole|ketoconazole|mesh-list
24748836|NCT02075177|Fenretinide|fenretinide|mesh-list
24748837|NCT02075177|Antifungal Agents|antifungal agents|mesh-ancestor
24748838|NCT02075177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24748839|NCT02075177|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24748849|NCT02075177|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24748850|NCT02075177|Protective Agents|protective agents|mesh-ancestor
24748851|NCT02050919|Sorafenib|sorafenib|mesh-list
24748852|NCT02050919|Epirubicin|epirubicin|mesh-list
24748853|NCT02050919|Ifosfamide|ifosfamide|mesh-list
24748854|NCT02050919|Isophosphamide mustard|isophosphamide mustard|mesh-list
24748855|NCT02050919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748856|NCT02050919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24748857|NCT02050919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24748858|NCT02050919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748859|NCT02050919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24748860|NCT02050919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24748861|NCT02050919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24748862|NCT02050919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24748863|NCT02050919|Alkylating Agents|alkylating agents|mesh-ancestor
24748864|NCT02040857|Tamoxifen|tamoxifen|mesh-list
24748865|NCT02040857|Letrozole|letrozole|mesh-list
24748866|NCT02040857|Palbociclib|palbociclib|mesh-list
24748867|NCT02040857|Anastrozole|anastrozole|mesh-list
24748870|NCT02040857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748871|NCT02040857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24748872|NCT02040857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708153|NCT01500161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24748873|NCT02040857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748874|NCT02040857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24748875|NCT02040857|Hormone Antagonists|hormone antagonists|mesh-ancestor
24749030|NCT01857115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24748876|NCT02040857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24748877|NCT02040857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748878|NCT02040857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24748879|NCT02040857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24748880|NCT02040857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24748881|NCT02040857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24748882|NCT02040857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24748884|NCT01997463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24748885|NCT01997463|Autonomic Agents|autonomic agents|mesh-ancestor
24748886|NCT01997463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24748887|NCT01997463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748888|NCT01997463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24748889|NCT01997463|Respiratory System Agents|respiratory system agents|mesh-ancestor
24748890|NCT01997463|Tocolytic Agents|tocolytic agents|mesh-ancestor
24748891|NCT01997463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24748892|NCT01997463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24748893|NCT01997463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24748894|NCT01997463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24748895|NCT01997463|Adrenergic Agents|adrenergic agents|mesh-ancestor
24748915|NCT01996267|Alkylating Agents|alkylating agents|mesh-ancestor
24748916|NCT01996267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24748918|NCT01996267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24748919|NCT01996267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24748920|NCT01976754|Dexmedetomidine|dexmedetomidine|mesh-list
24748921|NCT01976754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24748922|NCT01976754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24748923|NCT01976754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944347|NCT03961334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24944348|NCT03961334|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24944349|NCT03961334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24618807|NCT01049763|Antiviral Agents|antiviral agents|mesh-ancestor
24618808|NCT01049763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24748932|NCT01976754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24748933|NCT01976754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748934|NCT01943825|Vaccines|vaccines|mesh-list
24748935|NCT01943825|Immunologic Factors|immunologic factors|mesh-ancestor
24748936|NCT01943825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748937|NCT01916317|Lidocaine|lidocaine|mesh-list
24748938|NCT01916317|Anesthetics, Local|anesthetics, local|mesh-ancestor
24748939|NCT01916317|Anesthetics|anesthetics|mesh-ancestor
24748940|NCT01916317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24748941|NCT01916317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748942|NCT01916317|Sensory System Agents|sensory system agents|mesh-ancestor
24748943|NCT01916317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24748944|NCT01916317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24748945|NCT01916317|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24748946|NCT01916317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24748947|NCT01916317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24748948|NCT01916317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748950|NCT01913951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24748951|NCT01913951|Antimetabolites|antimetabolites|mesh-ancestor
24748952|NCT01913951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748953|NCT01913951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748954|NCT01913951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24748955|NCT01913730|Dexamethasone|dexamethasone|mesh-list
24748956|NCT01913730|Bortezomib|bortezomib|mesh-list
24749603|NCT00579527|Glucocorticoids|glucocorticoids|mesh-ancestor
24748957|NCT01913730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24748958|NCT01913730|Antiemetics|antiemetics|mesh-ancestor
24748959|NCT01913730|Autonomic Agents|autonomic agents|mesh-ancestor
24748960|NCT01913730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24748964|NCT01913730|Hormones|hormones|mesh-ancestor
24748988|NCT01898117|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24749027|NCT01857115|Immunologic Factors|immunologic factors|mesh-ancestor
24749028|NCT01857115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944351|NCT03961334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24944352|NCT03961334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24944353|NCT03961334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24944355|NCT03961334|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24749032|NCT01857115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749033|NCT01857115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749034|NCT01857115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24749035|NCT01857115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24749036|NCT01857115|Antiemetics|antiemetics|mesh-ancestor
24590881|NCT00914121|Moxifloxacin|moxifloxacin|mesh-list
24749037|NCT01857115|Autonomic Agents|autonomic agents|mesh-ancestor
24749038|NCT01857115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24749039|NCT01857115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24749040|NCT01857115|Glucocorticoids|glucocorticoids|mesh-ancestor
24749041|NCT01857115|Hormones|hormones|mesh-ancestor
24749042|NCT01857115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24749043|NCT01857115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24749044|NCT01853748|Paclitaxel|paclitaxel|mesh-list
24749045|NCT01853748|Maytansine|maytansine|mesh-list
24749046|NCT01853748|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24749047|NCT01853748|Trastuzumab|trastuzumab|mesh-list
24749048|NCT01853748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24749049|NCT01853748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749050|NCT01853748|Tubulin Modulators|tubulin modulators|mesh-ancestor
24749051|NCT01853748|Antimitotic Agents|antimitotic agents|mesh-ancestor
24749052|NCT01853748|Mitosis Modulators|mitosis modulators|mesh-ancestor
24749053|NCT01853748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749054|NCT01853748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24749062|NCT01828840|Analgesics|analgesics|mesh-ancestor
24749066|NCT01828840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24749067|NCT01828840|Anesthetics, General|anesthetics, general|mesh-ancestor
24749068|NCT01828840|Anesthetics|anesthetics|mesh-ancestor
24749069|NCT01828840|Antitussive Agents|antitussive agents|mesh-ancestor
24749070|NCT01828840|Respiratory System Agents|respiratory system agents|mesh-ancestor
24749071|NCT01817751|Sorafenib|sorafenib|mesh-list
24749072|NCT01817751|Sildenafil Citrate|sildenafil citrate|mesh-list
24749073|NCT01817751|Valproic Acid|valproic acid|mesh-list
24749074|NCT01817751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749075|NCT01817751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749076|NCT01817751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24749085|NCT01817751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749086|NCT01817751|Antimanic Agents|antimanic agents|mesh-ancestor
24749087|NCT01817751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24749088|NCT01817751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24749089|NCT01817751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24749090|NCT01817426|Infliximab|infliximab|mesh-list
24749091|NCT01817426|Dermatologic Agents|dermatologic agents|mesh-ancestor
24749092|NCT01817426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24749093|NCT01817426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24749094|NCT01741103|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24749095|NCT01741103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24749096|NCT01741103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749097|NCT01741103|Incretins|incretins|mesh-ancestor
24749098|NCT01741103|Hormones|hormones|mesh-ancestor
24749099|NCT01741103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24749109|NCT01716117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749110|NCT01716117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24944356|NCT03961334|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24944357|NCT03961334|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24944358|NCT03961334|Purinergic Agents|purinergic agents|mesh-ancestor
24852550|NCT02262767|Antiemetics|antiemetics|mesh-ancestor
24944359|NCT03961334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24944360|NCT03961334|Antithrombins|antithrombins|mesh-ancestor
24944361|NCT03961334|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24944362|NCT03961334|Protease Inhibitors|protease inhibitors|mesh-ancestor
24813063|NCT02056249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24749116|NCT01646034|Gemcitabine|gemcitabine|mesh-list
24749117|NCT01646034|Paclitaxel|paclitaxel|mesh-list
24749118|NCT01646034|Docetaxel|docetaxel|mesh-list
24749119|NCT01646034|Cyclophosphamide|cyclophosphamide|mesh-list
24749120|NCT01646034|Carboplatin|carboplatin|mesh-list
24749130|NCT01646034|Immunologic Factors|immunologic factors|mesh-ancestor
24749131|NCT01646034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749132|NCT01646034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24749133|NCT01646034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24749134|NCT01646034|Alkylating Agents|alkylating agents|mesh-ancestor
24749135|NCT01646034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24749136|NCT01646034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24749137|NCT01646034|Antimetabolites|antimetabolites|mesh-ancestor
24749138|NCT01646034|Antiviral Agents|antiviral agents|mesh-ancestor
24749139|NCT01646034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24749140|NCT01646034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24749141|NCT01646034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24749142|NCT01646034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24749143|NCT01646034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24749144|NCT01630590|Androgens|androgens|mesh-list
24749145|NCT01630590|Hormones|hormones|mesh-ancestor
24749147|NCT01630590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749148|NCT01619085|Nintedanib|nintedanib|mesh-list
24749149|NCT01619085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749150|NCT01619085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24749151|NCT01619085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24749604|NCT00579527|Hormones|hormones|mesh-ancestor
24749167|NCT01499082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24749168|NCT01499082|Insulin Glargine|insulin glargine|mesh-list
24625899|NCT01084200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625900|NCT01084200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24749169|NCT01499082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24749170|NCT01499082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749248|NCT01396408|Growth Inhibitors|growth inhibitors|mesh-ancestor
24749249|NCT01396408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24749250|NCT01396408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24749262|NCT01380938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749264|NCT01380938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24749265|NCT01380938|Immunologic Factors|immunologic factors|mesh-ancestor
24749275|NCT01346787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24749276|NCT01346787|Immunologic Factors|immunologic factors|mesh-ancestor
24749277|NCT01346787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749278|NCT01346787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24749279|NCT01346787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24749280|NCT01346787|Alkylating Agents|alkylating agents|mesh-ancestor
24749281|NCT01346787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749282|NCT01346787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749283|NCT01346787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24749284|NCT01346787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24618809|NCT01049763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625901|NCT01084200|Anesthetics, General|anesthetics, general|mesh-ancestor
24625903|NCT01084200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24813083|NCT02056379|Glucocorticoids|glucocorticoids|mesh-ancestor
24618810|NCT01049763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618811|NCT01049815|Calcium Carbonate|calcium carbonate|mesh-list
24618814|NCT01049815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24618815|NCT01049815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618848|NCT01049854|Antiviral Agents|antiviral agents|mesh-ancestor
24618849|NCT01049854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24749286|NCT01346787|Autonomic Agents|autonomic agents|mesh-ancestor
24749287|NCT01346787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24625907|NCT01084213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24625908|NCT01084213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24625909|NCT01084213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24625910|NCT01084291|Vaccines|vaccines|mesh-list
24655368|NCT01256151|Alprazolam|alprazolam|mesh-list
24749288|NCT01346787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24749289|NCT01346787|Glucocorticoids|glucocorticoids|mesh-ancestor
24749290|NCT01346787|Hormones|hormones|mesh-ancestor
24749291|NCT01346787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24749292|NCT01346787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24749293|NCT01254422|Vaccines|vaccines|mesh-list
24749294|NCT01254422|Immunologic Factors|immunologic factors|mesh-ancestor
24749295|NCT01254422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749296|NCT01229878|Vitamin D|vitamin d|mesh-list
24749297|NCT01229878|Cholecalciferol|cholecalciferol|mesh-list
24749298|NCT01229878|Vitamins|vitamins|mesh-ancestor
24749299|NCT01229878|Micronutrients|micronutrients|mesh-ancestor
24749300|NCT01229878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749301|NCT01229878|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24749302|NCT01229878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24749303|NCT01204242|Lidocaine|lidocaine|mesh-list
24749304|NCT01204242|Anesthetics, Local|anesthetics, local|mesh-ancestor
24749305|NCT01204242|Anesthetics|anesthetics|mesh-ancestor
24749306|NCT01204242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24749367|NCT01160107|Alkylating Agents|alkylating agents|mesh-ancestor
24749368|NCT01160107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749369|NCT01160107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24749378|NCT01150045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24749379|NCT01150045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749380|NCT01150045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24749381|NCT01150045|Immunologic Factors|immunologic factors|mesh-ancestor
24749382|NCT01150045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749384|NCT01150045|Protective Agents|protective agents|mesh-ancestor
24749385|NCT01150045|Vitamin B Complex|vitamin b complex|mesh-ancestor
24749387|NCT01150045|Micronutrients|micronutrients|mesh-ancestor
24749388|NCT01150045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24749389|NCT01150045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24749390|NCT01150045|Analgesics|analgesics|mesh-ancestor
24749391|NCT01150045|Sensory System Agents|sensory system agents|mesh-ancestor
24749392|NCT01150045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24749393|NCT01150045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24749394|NCT01150045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24749395|NCT01150045|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24749396|NCT01150045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24749397|NCT01150045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24749398|NCT01098032|Acetylcysteine|acetylcysteine|mesh-list
24749399|NCT01098032|Antiviral Agents|antiviral agents|mesh-ancestor
24749400|NCT01098032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24749401|NCT01098032|Expectorants|expectorants|mesh-ancestor
24749402|NCT01098032|Respiratory System Agents|respiratory system agents|mesh-ancestor
24749403|NCT01098032|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24749404|NCT01098032|Antioxidants|antioxidants|mesh-ancestor
24749407|NCT01098032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749409|NCT01096368|Cisplatin|cisplatin|mesh-list
24749410|NCT01096368|Carboplatin|carboplatin|mesh-list
24749411|NCT01096368|Etoposide|etoposide|mesh-list
24749412|NCT01096368|Vincristine|vincristine|mesh-list
24749413|NCT01096368|Etoposide phosphate|etoposide phosphate|mesh-list
24749414|NCT01096368|Podophyllotoxin|podophyllotoxin|mesh-list
24749415|NCT01096368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24749416|NCT01096368|Immunologic Factors|immunologic factors|mesh-ancestor
24749417|NCT01096368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749418|NCT01096368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24749419|NCT01096368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24749430|NCT01096368|Mitosis Modulators|mitosis modulators|mesh-ancestor
24749431|NCT01096368|Keratolytic Agents|keratolytic agents|mesh-ancestor
24749432|NCT01096368|Dermatologic Agents|dermatologic agents|mesh-ancestor
24749434|NCT01093196|Prednisone|prednisone|mesh-list
24749435|NCT01093196|Cyclophosphamide|cyclophosphamide|mesh-list
24749436|NCT01093196|Melphalan|melphalan|mesh-list
24749437|NCT01093196|Lenalidomide|lenalidomide|mesh-list
24749438|NCT01093196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24749439|NCT01093196|Immunologic Factors|immunologic factors|mesh-ancestor
24749440|NCT01093196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749441|NCT01093196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24749442|NCT01093196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24655420|NCT01256619|Desogestrel|desogestrel|mesh-list
24749443|NCT01093196|Alkylating Agents|alkylating agents|mesh-ancestor
24749444|NCT01093196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749445|NCT01093196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749446|NCT01093196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24749447|NCT01093196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24749449|NCT01093196|Autonomic Agents|autonomic agents|mesh-ancestor
24749450|NCT01093196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24749451|NCT01093196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24749452|NCT01093196|Glucocorticoids|glucocorticoids|mesh-ancestor
24749453|NCT01093196|Hormones|hormones|mesh-ancestor
24749454|NCT01093196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24625916|NCT01084369|Testosterone undecanoate|testosterone undecanoate|mesh-list
24625917|NCT01084369|Testosterone enanthate|testosterone enanthate|mesh-list
24625918|NCT01084369|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24625919|NCT01084369|Androgens|androgens|mesh-ancestor
24625920|NCT01084369|Hormones|hormones|mesh-ancestor
24749455|NCT01093196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24749456|NCT01093196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24749457|NCT01093196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24749459|NCT01093196|Growth Inhibitors|growth inhibitors|mesh-ancestor
24749461|NCT01054248|Piperaquine|piperaquine|mesh-list
24749462|NCT01054248|Artenimol|artenimol|mesh-list
24749463|NCT01054248|Mefloquine|mefloquine|mesh-list
24749466|NCT01054248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24749467|NCT01054248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24749468|NCT01054248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749469|NCT01054248|Antiviral Agents|antiviral agents|mesh-ancestor
24592455|NCT00921765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24749470|NCT01054248|Schistosomicides|schistosomicides|mesh-ancestor
24749576|NCT00579527|Prednisolone|prednisolone|mesh-list
24749475|NCT01050855|Alkylating Agents|alkylating agents|mesh-ancestor
24749476|NCT01050855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749477|NCT01050855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24749478|NCT01050855|Immunologic Factors|immunologic factors|mesh-ancestor
24749479|NCT01050855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749480|NCT01050855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24749481|NCT01050855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749482|NCT01050855|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24749483|NCT01050855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24749509|NCT00945009|Antimitotic Agents|antimitotic agents|mesh-ancestor
24539596|NCT00664677|Analgesics|analgesics|mesh-ancestor
24749510|NCT00945009|Mitosis Modulators|mitosis modulators|mesh-ancestor
24749511|NCT00945009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24749512|NCT00945009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24749513|NCT00945009|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24749514|NCT00945009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24749515|NCT00942877|Cediranib|cediranib|mesh-list
24625921|NCT01084369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24625922|NCT01084369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625923|NCT01084369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24625924|NCT01084369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24625926|NCT01084369|Vasodilator Agents|vasodilator agents|mesh-ancestor
24625927|NCT01084369|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24625928|NCT01084369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24625929|NCT01084369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857457|NCT02291666|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24749551|NCT00866918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24749552|NCT00866918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749553|NCT00866918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24749554|NCT00866918|Antimetabolites|antimetabolites|mesh-ancestor
24749555|NCT00866918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749556|NCT00866918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749557|NCT00866918|Dermatologic Agents|dermatologic agents|mesh-ancestor
24749558|NCT00866918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24749559|NCT00866918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24749560|NCT00866918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24749561|NCT00866918|Immunologic Factors|immunologic factors|mesh-ancestor
24749563|NCT00866918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24749564|NCT00866918|Antiviral Agents|antiviral agents|mesh-ancestor
24749565|NCT00866918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24749566|NCT00866918|Analgesics|analgesics|mesh-ancestor
24749567|NCT00866918|Sensory System Agents|sensory system agents|mesh-ancestor
24749568|NCT00866918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24749569|NCT00866918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24749570|NCT00866918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24799836|NCT01971515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625930|NCT01084369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625931|NCT01084369|Urological Agents|urological agents|mesh-ancestor
24625933|NCT01084408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24749571|NCT00866918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24749572|NCT00866918|Keratolytic Agents|keratolytic agents|mesh-ancestor
24539672|NCT00664898|Bortezomib|bortezomib|mesh-list
24749574|NCT00579527|Mycophenolic Acid|mycophenolic acid|mesh-list
24749575|NCT00579527|Methylprednisolone|methylprednisolone|mesh-list
24749582|NCT00579527|Parathyroid Hormone|parathyroid hormone|mesh-list
24749583|NCT00579527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24749584|NCT00579527|Immunologic Factors|immunologic factors|mesh-ancestor
24749585|NCT00579527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749586|NCT00579527|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24749596|NCT00579527|Antitubercular Agents|antitubercular agents|mesh-ancestor
24749597|NCT00579527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24749598|NCT00579527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24749599|NCT00579527|Antiemetics|antiemetics|mesh-ancestor
24749600|NCT00579527|Autonomic Agents|autonomic agents|mesh-ancestor
24749601|NCT00579527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24749602|NCT00579527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24749695|NCT00551928|Lenalidomide|lenalidomide|mesh-list
24749696|NCT00551928|Melphalan|melphalan|mesh-list
24749697|NCT00551928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24749698|NCT00551928|Glucocorticoids|glucocorticoids|mesh-ancestor
24749699|NCT00551928|Hormones|hormones|mesh-ancestor
24749700|NCT00551928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24749701|NCT00551928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749702|NCT00551928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24414112|NCT00195988|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24414148|NCT00196378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749703|NCT00551928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749704|NCT00551928|Immunologic Factors|immunologic factors|mesh-ancestor
24749705|NCT00551928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24749706|NCT00551928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24749707|NCT00551928|Growth Substances|growth substances|mesh-ancestor
24749708|NCT00551928|Growth Inhibitors|growth inhibitors|mesh-ancestor
24749709|NCT00551928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24749710|NCT00551928|Alkylating Agents|alkylating agents|mesh-ancestor
24749711|NCT00551928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749712|NCT00551928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24749713|NCT00551928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24749714|NCT00531232|Clofarabine|clofarabine|mesh-list
24749715|NCT00531232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24749716|NCT00531232|Antimetabolites|antimetabolites|mesh-ancestor
24749717|NCT00531232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749718|NCT00531232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749719|NCT00476606|Ritonavir|ritonavir|mesh-list
24749720|NCT00476606|Nelfinavir|nelfinavir|mesh-list
24749734|NCT00476606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24749735|NCT00476606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24749736|NCT00476606|Antiviral Agents|antiviral agents|mesh-ancestor
24749737|NCT00476606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24749738|NCT00476606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24749739|NCT00476606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24749742|NCT00476606|Antimetabolites|antimetabolites|mesh-ancestor
24749755|NCT00379340|Etoposide phosphate|etoposide phosphate|mesh-list
24749756|NCT00379340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24749757|NCT00379340|Immunologic Factors|immunologic factors|mesh-ancestor
24749758|NCT00379340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749759|NCT00379340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24749760|NCT00379340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24749761|NCT00379340|Alkylating Agents|alkylating agents|mesh-ancestor
24749762|NCT00379340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749763|NCT00379340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749766|NCT00379340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24749767|NCT00379340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24749768|NCT00379340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24749769|NCT00379340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24749770|NCT00379340|Tubulin Modulators|tubulin modulators|mesh-ancestor
24749771|NCT00379340|Antimitotic Agents|antimitotic agents|mesh-ancestor
24749772|NCT00379340|Mitosis Modulators|mitosis modulators|mesh-ancestor
25696376|NCT02061280|Xhance|xhance|mesh-list
24749773|NCT00379340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24749774|NCT00379340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24749780|NCT00304070|Etoposide phosphate|etoposide phosphate|mesh-list
24749781|NCT00304070|Mitotane|mitotane|mesh-list
24749786|NCT00304070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24749787|NCT00304070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749788|NCT00304070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24749789|NCT00304070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24749791|NCT00066950|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24749792|NCT00066950|Fluorides|fluorides|mesh-list
24749793|NCT00066950|Fluorides, Topical|fluorides, topical|mesh-list
24749794|NCT00066950|Cariostatic Agents|cariostatic agents|mesh-ancestor
24749795|NCT00066950|Protective Agents|protective agents|mesh-ancestor
24625948|NCT01084473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24625949|NCT01084473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24625950|NCT01084473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24625951|NCT01084473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24749796|NCT00066950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749797|NCT00066950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24749798|NCT00066950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24749799|NCT00066950|Disinfectants|disinfectants|mesh-ancestor
24749800|NCT00066950|Dermatologic Agents|dermatologic agents|mesh-ancestor
24749802|NCT00004935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24749803|NCT00004935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749804|NCT00001322|Leuprolide|leuprolide|mesh-list
24749805|NCT00001322|Estradiol|estradiol|mesh-list
24749806|NCT00001322|Progesterone|progesterone|mesh-list
24749807|NCT00001322|Estrogens|estrogens|mesh-ancestor
24749808|NCT00001322|Hormones|hormones|mesh-ancestor
24710552|NCT01511146|Antiviral Agents|antiviral agents|mesh-ancestor
24749815|NCT00001322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24749816|NCT00001322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749817|NCT01694134|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24749818|NCT01694134|Methylprednisolone|methylprednisolone|mesh-list
24749819|NCT01694134|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24749820|NCT01694134|Prednisolone|prednisolone|mesh-list
24749821|NCT01694134|Prednisolone acetate|prednisolone acetate|mesh-list
24749822|NCT01694134|Lidocaine|lidocaine|mesh-list
24749823|NCT01694134|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24749824|NCT01694134|Prednisolone phosphate|prednisolone phosphate|mesh-list
24749825|NCT01694134|Anesthetics, Local|anesthetics, local|mesh-ancestor
24749826|NCT01694134|Anesthetics|anesthetics|mesh-ancestor
24749827|NCT01694134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24749828|NCT01694134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749829|NCT01694134|Sensory System Agents|sensory system agents|mesh-ancestor
24749830|NCT01694134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24749831|NCT01694134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24749832|NCT01694134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24749833|NCT01694134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24749834|NCT01694134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24710601|NCT01511211|Glucocorticoids|glucocorticoids|mesh-ancestor
24625953|NCT01084473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24749862|NCT01694264|Antiviral Agents|antiviral agents|mesh-ancestor
24749863|NCT01694264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24749864|NCT01694355|Vitamin D|vitamin d|mesh-list
24749865|NCT01694355|Vitamins|vitamins|mesh-ancestor
24749866|NCT01694355|Micronutrients|micronutrients|mesh-ancestor
24749867|NCT01694355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749868|NCT01694355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24749869|NCT01694381|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
24749870|NCT01694381|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24749871|NCT01694381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24749872|NCT01694381|Immunologic Factors|immunologic factors|mesh-ancestor
24749873|NCT01694381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749874|NCT01694407|Tenofovir|tenofovir|mesh-list
24749875|NCT01694407|Emtricitabine|emtricitabine|mesh-list
24749901|NCT01694576|Antimitotic Agents|antimitotic agents|mesh-ancestor
24749902|NCT01694576|Mitosis Modulators|mitosis modulators|mesh-ancestor
24625954|NCT01084473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625956|NCT01084473|Narcotics|narcotics|mesh-ancestor
24625957|NCT01084486|Metformin|metformin|mesh-list
24625958|NCT01084486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24534669|NCT00647816|Propranolol|propranolol|mesh-list
24749903|NCT01694576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749904|NCT01694693|Abatacept|abatacept|mesh-list
24749905|NCT01694693|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24655576|NCT01257334|Empagliflozin|empagliflozin|mesh-list
24749906|NCT01694693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749912|NCT01694732|Varenicline|varenicline|mesh-list
24749979|NCT01695187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24749980|NCT01695187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749981|NCT01695226|Celecoxib|celecoxib|mesh-list
24749982|NCT01695226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24749985|NCT01695226|Sensory System Agents|sensory system agents|mesh-ancestor
24749986|NCT01695226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24749987|NCT01695226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434923|NCT00264355|Cyclosporine|cyclosporine|mesh-list
24749988|NCT01695226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24625959|NCT01084486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625960|NCT01084577|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24625961|NCT01084577|Laxatives|laxatives|mesh-ancestor
24625962|NCT01084577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24625963|NCT01084720|V0034CR|v0034cr|mesh-list
24944365|NCT03961126|Clobetasol|clobetasol|mesh-list
24944366|NCT03961126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24944367|NCT03961126|Glucocorticoids|glucocorticoids|mesh-ancestor
24749989|NCT01695226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24749990|NCT01695226|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24749991|NCT01695226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24749992|NCT01695226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24749993|NCT01695226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540100|NCT00666627|Alendronate|alendronate|mesh-list
24749994|NCT01695356|Sunscreening Agents|sunscreening agents|mesh-list
24749995|NCT01695356|Zinc Oxide|zinc oxide|mesh-list
24749996|NCT01695356|Titanium dioxide|titanium dioxide|mesh-list
24749997|NCT01695356|Avobenzone|avobenzone|mesh-list
24848091|NCT05147233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24662200|NCT01293162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662201|NCT01293162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24662202|NCT01293162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24662203|NCT01293266|Propofol|propofol|mesh-list
24662204|NCT01293266|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24662235|NCT01293630|Mitosis Modulators|mitosis modulators|mesh-ancestor
24662236|NCT01293630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662237|NCT01293643|Clindamycin|clindamycin|mesh-list
24750004|NCT01695356|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24750020|NCT01695798|Immunologic Factors|immunologic factors|mesh-ancestor
24750021|NCT01695798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750022|NCT01695824|Warfarin|warfarin|mesh-list
24750023|NCT01695824|Anticoagulants|anticoagulants|mesh-ancestor
24750024|NCT01695850|Sennosides|sennosides|mesh-list
24750025|NCT01695850|Laxatives|laxatives|mesh-ancestor
24750026|NCT01695850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24750027|NCT01695902|Levonorgestrel|levonorgestrel|mesh-list
24750028|NCT01695902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24750029|NCT01695902|Contraceptive Agents|contraceptive agents|mesh-ancestor
24750030|NCT01695902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24750031|NCT01695902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750032|NCT01695902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24750033|NCT01695902|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24750034|NCT01695902|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24750035|NCT01696110|Heparin|heparin|mesh-list
24750036|NCT01696110|Calcium heparin|calcium heparin|mesh-list
24750037|NCT01696110|Tirofiban|tirofiban|mesh-list
24750038|NCT01696110|Bivalirudin|bivalirudin|mesh-list
24750039|NCT01696110|Anticoagulants|anticoagulants|mesh-ancestor
24750040|NCT01696110|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24750041|NCT01696110|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24750042|NCT01696110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750044|NCT01696110|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24750045|NCT01696110|Protease Inhibitors|protease inhibitors|mesh-ancestor
24750046|NCT01696110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750047|NCT01696110|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24750048|NCT01696240|Udenafil|udenafil|mesh-list
24750049|NCT01696240|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24750050|NCT01696240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24750051|NCT01696240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750052|NCT01696240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750055|NCT01696383|Timolol|timolol|mesh-list
24750056|NCT01696383|Travoprost|travoprost|mesh-list
24750057|NCT01696383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24750058|NCT01696383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24750059|NCT01696383|Adrenergic Agents|adrenergic agents|mesh-ancestor
24750060|NCT01696383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24750061|NCT01696383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750062|NCT01696383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750063|NCT01696383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25696377|NCT02061280|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25696378|NCT02061280|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25696379|NCT02061280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25696380|NCT02061280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25696381|NCT02061280|Autonomic Agents|autonomic agents|mesh-ancestor
25696382|NCT02061280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25696383|NCT02061280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696384|NCT02061280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25696385|NCT02061280|Respiratory System Agents|respiratory system agents|mesh-ancestor
25696386|NCT02061280|Dermatologic Agents|dermatologic agents|mesh-ancestor
24750064|NCT01696383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24750081|NCT01696448|Vitamin B Complex|vitamin b complex|mesh-ancestor
24799917|NCT01971918|Antibodies|antibodies|mesh-list
24848094|NCT05124457|Insulin|insulin|mesh-list
24662312|NCT01293942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24662313|NCT01293942|Growth Substances|growth substances|mesh-ancestor
24750082|NCT01696448|Vitamins|vitamins|mesh-ancestor
24750083|NCT01696448|Micronutrients|micronutrients|mesh-ancestor
24750094|NCT01696500|gamma-Globulins|gamma-globulins|mesh-list
24750095|NCT01696500|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24750096|NCT01696500|Immunologic Factors|immunologic factors|mesh-ancestor
24750097|NCT01696500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750098|NCT01696526|Vitamin D|vitamin d|mesh-list
24750099|NCT01696526|Vitamins|vitamins|mesh-ancestor
24750100|NCT01696526|Micronutrients|micronutrients|mesh-ancestor
24750101|NCT01696526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655609|NCT01257399|Analgesics|analgesics|mesh-ancestor
24750124|NCT01696617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24750125|NCT01696617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750126|NCT01696617|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24750131|NCT01696617|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24750132|NCT01696617|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24750133|NCT01696630|Desflurane|desflurane|mesh-list
24750134|NCT01696630|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24750135|NCT01696630|Anesthetics, General|anesthetics, general|mesh-ancestor
24750136|NCT01696630|Anesthetics|anesthetics|mesh-ancestor
24750137|NCT01696630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24750138|NCT01696630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750139|NCT01696656|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24750140|NCT01696656|Gastrointestinal Agents|gastrointestinal agents|mesh-list
24750141|NCT01696656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24750142|NCT01696799|Econazole|econazole|mesh-list
24750143|NCT01696799|Antifungal Agents|antifungal agents|mesh-ancestor
24750144|NCT01696799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24750145|NCT01696799|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24750146|NCT01696799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24750153|NCT01696825|Diazepam|diazepam|mesh-list
24750154|NCT01696825|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24750155|NCT01696825|Anticonvulsants|anticonvulsants|mesh-ancestor
24750156|NCT01696825|Antiemetics|antiemetics|mesh-ancestor
24944377|NCT03961048|Sensory System Agents|sensory system agents|mesh-ancestor
24944378|NCT03961048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24944380|NCT03960905|Ceftazidime|ceftazidime|mesh-list
24944381|NCT03960905|Cefepime|cefepime|mesh-list
24944382|NCT03960905|Anti-Infective Agents|anti-infective agents|mesh-list
24750157|NCT01696825|Autonomic Agents|autonomic agents|mesh-ancestor
24750158|NCT01696825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24750159|NCT01696825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750160|NCT01696825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25696387|NCT02061280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25696388|NCT02061280|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25696389|NCT02061280|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25696390|NCT02061280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25696391|NCT02061280|Adrenergic Agents|adrenergic agents|mesh-ancestor
25696392|NCT02061280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25696393|NCT02061280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696394|NCT02061280|Glucocorticoids|glucocorticoids|mesh-ancestor
25049860|NCT00560183|Sensory System Agents|sensory system agents|mesh-ancestor
25049861|NCT00560183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25049862|NCT00559247|Asunaprevir|asunaprevir|mesh-list
25049880|NCT00557973|Baclofen|baclofen|mesh-list
24750161|NCT01696825|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24750162|NCT01696825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24750163|NCT01696825|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24750164|NCT01696825|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24750165|NCT01696825|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24750166|NCT01696825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24750167|NCT01696825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24750168|NCT01696825|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24750169|NCT01696825|Anesthetics, General|anesthetics, general|mesh-ancestor
24750171|NCT01696825|GABA Modulators|gaba modulators|mesh-ancestor
24750172|NCT01696825|GABA Agents|gaba agents|mesh-ancestor
24750173|NCT01696825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24750174|NCT01696825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750175|NCT01697020|Mercaptopurine|mercaptopurine|mesh-list
24750176|NCT01697020|Antimetabolites|antimetabolites|mesh-ancestor
24750249|NCT01697293|Tubulin Modulators|tubulin modulators|mesh-ancestor
24750177|NCT01697020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750178|NCT01697020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24750179|NCT01697020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24750180|NCT01697020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24618923|NCT01050270|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24618924|NCT01050270|Antioxidants|antioxidants|mesh-ancestor
24618925|NCT01050270|Protective Agents|protective agents|mesh-ancestor
24618926|NCT01050270|Antidotes|antidotes|mesh-ancestor
24618927|NCT01050322|Gemcitabine|gemcitabine|mesh-list
24618928|NCT01050322|Capecitabine|capecitabine|mesh-list
24618929|NCT01050322|Vinorelbine|vinorelbine|mesh-list
24618931|NCT01050322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24618932|NCT01050322|Antimetabolites|antimetabolites|mesh-ancestor
24618933|NCT01050322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618934|NCT01050322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618955|NCT01050348|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24618956|NCT01050348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618957|NCT01050374|Albendazole|albendazole|mesh-list
24618958|NCT01050374|Praziquantel|praziquantel|mesh-list
24618959|NCT01050374|Mebendazole|mebendazole|mesh-list
24618961|NCT01050374|Piperazine citrate|piperazine citrate|mesh-list
24618962|NCT01050374|DMP 777|dmp 777|mesh-list
24618963|NCT01050374|Anthelmintics|anthelmintics|mesh-ancestor
24618964|NCT01050374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24618965|NCT01050374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24618966|NCT01050374|Anticestodal Agents|anticestodal agents|mesh-ancestor
24618977|NCT01050387|Vitamins|vitamins|mesh-ancestor
24618978|NCT01050387|Micronutrients|micronutrients|mesh-ancestor
24618979|NCT01050387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618980|NCT01050387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24618981|NCT01050426|Leucovorin|leucovorin|mesh-list
24618982|NCT01050426|Cetuximab|cetuximab|mesh-list
24618983|NCT01050426|Levoleucovorin|levoleucovorin|mesh-list
24618984|NCT01050426|Antidotes|antidotes|mesh-ancestor
24618985|NCT01050426|Protective Agents|protective agents|mesh-ancestor
24618986|NCT01050426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619005|NCT01050452|Antimitotic Agents|antimitotic agents|mesh-ancestor
24619006|NCT01050452|Mitosis Modulators|mitosis modulators|mesh-ancestor
24540388|NCT00667771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24750207|NCT01697098|Glucocorticoids|glucocorticoids|mesh-list
24750209|NCT01697098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24750210|NCT01697098|Antiemetics|antiemetics|mesh-ancestor
24750211|NCT01697098|Autonomic Agents|autonomic agents|mesh-ancestor
24944390|NCT03961087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24944391|NCT03961087|Protective Agents|protective agents|mesh-ancestor
24944392|NCT03961087|Nootropic Agents|nootropic agents|mesh-ancestor
24944393|NCT03960775|Dexmedetomidine|dexmedetomidine|mesh-list
24944394|NCT03960775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24944395|NCT03960775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24750212|NCT01697098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25696395|NCT02061280|Hormones|hormones|mesh-ancestor
25696396|NCT02061280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25696397|NCT02061280|Sympathomimetics|sympathomimetics|mesh-ancestor
24750213|NCT01697098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750214|NCT01697098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24750215|NCT01697098|Hormones|hormones|mesh-ancestor
24750216|NCT01697098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25696398|NCT02061384|Calcitriol|calcitriol|mesh-list
24750221|NCT01697098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750222|NCT01697111|Dienogest|dienogest|mesh-list
24750223|NCT01697111|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24750224|NCT01697111|Contraceptive Agents|contraceptive agents|mesh-ancestor
24750225|NCT01697111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24750226|NCT01697111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750227|NCT01697111|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24750228|NCT01697111|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24750229|NCT01697111|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24750230|NCT01697111|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24750231|NCT01697111|Hormone Antagonists|hormone antagonists|mesh-ancestor
24750232|NCT01697111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24750233|NCT01697111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24750234|NCT01697111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24750235|NCT01697150|Pancrelipase|pancrelipase|mesh-list
24750236|NCT01697150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24750237|NCT01697228|Vitamin D|vitamin d|mesh-list
24750238|NCT01697228|Vitamins|vitamins|mesh-ancestor
24750239|NCT01697228|Micronutrients|micronutrients|mesh-ancestor
24750240|NCT01697228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750247|NCT01697293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24750248|NCT01697293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24750250|NCT01697293|Antimitotic Agents|antimitotic agents|mesh-ancestor
24750251|NCT01697293|Mitosis Modulators|mitosis modulators|mesh-ancestor
24750252|NCT01697293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655665|NCT01257529|Pregabalin|pregabalin|mesh-list
24750259|NCT01697293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24750260|NCT01697293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24750261|NCT01697293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24750262|NCT01697293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24750263|NCT01697293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750264|NCT01697306|Gemcitabine|gemcitabine|mesh-list
24750265|NCT01697306|BCG Vaccine|bcg vaccine|mesh-list
24750266|NCT01697306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24750267|NCT01697306|Antimetabolites|antimetabolites|mesh-ancestor
24750268|NCT01697306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750269|NCT01697306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24750270|NCT01697306|Antiviral Agents|antiviral agents|mesh-ancestor
24750271|NCT01697306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24750272|NCT01697306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750273|NCT01697306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24750274|NCT01697306|Immunologic Factors|immunologic factors|mesh-ancestor
24750275|NCT01697306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750276|NCT01697306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24750277|NCT01697410|Terlipressin|terlipressin|mesh-list
24540389|NCT00667797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24944396|NCT03960775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944397|NCT03960775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24944399|NCT03960775|Sensory System Agents|sensory system agents|mesh-ancestor
24750278|NCT01697410|Norepinephrine|norepinephrine|mesh-list
24750279|NCT01697410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24750280|NCT01697410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24750281|NCT01697410|Adrenergic Agents|adrenergic agents|mesh-ancestor
24750282|NCT01697410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24750283|NCT01697410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750284|NCT01697410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750285|NCT01697410|Sympathomimetics|sympathomimetics|mesh-ancestor
24750286|NCT01697410|Autonomic Agents|autonomic agents|mesh-ancestor
24750287|NCT01697410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24750310|NCT01697631|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24750312|NCT01697631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750313|NCT01697657|Insulin|insulin|mesh-list
24750314|NCT01697657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24750315|NCT01697657|Insulin Aspart|insulin aspart|mesh-list
24750316|NCT01697657|Insulin Detemir|insulin detemir|mesh-list
24750317|NCT01697657|Isophane Insulin, Human|isophane insulin, human|mesh-list
24750318|NCT01697657|Insulin, Isophane|insulin, isophane|mesh-list
24750319|NCT01697657|Isophane insulin, beef|isophane insulin, beef|mesh-list
24750320|NCT01697657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24750321|NCT01697657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750322|NCT01697670|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25696399|NCT02061384|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
25696400|NCT02061384|Tretinoin|tretinoin|mesh-list
24750353|NCT01697787|Schistosomicides|schistosomicides|mesh-ancestor
24750354|NCT01697787|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24750355|NCT01697787|Anthelmintics|anthelmintics|mesh-ancestor
24750356|NCT01697826|Clindamycin|clindamycin|mesh-list
24750357|NCT01697826|Clindamycin palmitate|clindamycin palmitate|mesh-list
24750358|NCT01697826|Clindamycin phosphate|clindamycin phosphate|mesh-list
24750368|NCT01697826|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24750369|NCT01697826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24750370|NCT01697826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24750371|NCT01697826|Hormone Antagonists|hormone antagonists|mesh-ancestor
24750372|NCT01697826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24750373|NCT01697826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750374|NCT01697826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24788850|NCT01934127|Vaccines|vaccines|mesh-list
24750377|NCT01698138|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24750378|NCT01698138|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24750379|NCT01698138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24750380|NCT01698138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750381|NCT01698138|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24750382|NCT01698138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24750383|NCT01698138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750388|NCT01698164|Estradiol|estradiol|mesh-list
24750393|NCT01698164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24750394|NCT01698164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750395|NCT01698164|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24750396|NCT01698164|Contraceptive Agents|contraceptive agents|mesh-ancestor
24750397|NCT01698164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24750398|NCT01698164|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24750399|NCT01698164|Progestins|progestins|mesh-ancestor
24750400|NCT01698177|Vaccines|vaccines|mesh-list
24750401|NCT01698177|Immunologic Factors|immunologic factors|mesh-ancestor
24750404|NCT01698203|Anesthetics, Local|anesthetics, local|mesh-ancestor
24750405|NCT01698203|Anesthetics|anesthetics|mesh-ancestor
24750407|NCT01698203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750408|NCT01698203|Sensory System Agents|sensory system agents|mesh-ancestor
24750409|NCT01698203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24750411|NCT01698476|Cholecalciferol|cholecalciferol|mesh-list
24750412|NCT01698476|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
24750413|NCT01698476|Vitamins|vitamins|mesh-ancestor
24750414|NCT01698476|Micronutrients|micronutrients|mesh-ancestor
24750415|NCT01698476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750416|NCT01698476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24750417|NCT01698476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24750418|NCT01698476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24750419|NCT01698541|Tacrolimus|tacrolimus|mesh-list
24750420|NCT01698541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24414853|NCT00198978|Antimetabolites|antimetabolites|mesh-ancestor
24447049|NCT00307255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24447050|NCT00307255|Antimetabolites|antimetabolites|mesh-ancestor
24447051|NCT00307255|Antiviral Agents|antiviral agents|mesh-ancestor
24447052|NCT00307255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24750425|NCT01698541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750427|NCT01698567|Antithrombin III|antithrombin iii|mesh-list
24540529|NCT00668304|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24750428|NCT01698567|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24750429|NCT01698567|Protease Inhibitors|protease inhibitors|mesh-ancestor
24750430|NCT01698567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750431|NCT01698567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750432|NCT01698567|Anticoagulants|anticoagulants|mesh-ancestor
24750433|NCT01698593|Epinephrine|epinephrine|mesh-list
24750434|NCT01698593|Bupivacaine|bupivacaine|mesh-list
24750435|NCT01698593|Anesthetics, Local|anesthetics, local|mesh-ancestor
24750436|NCT01698593|Anesthetics|anesthetics|mesh-ancestor
24750437|NCT01698593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24750438|NCT01698593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750461|NCT01698645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24750462|NCT01698645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24750463|NCT01698645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24750464|NCT01698645|Anesthetics, General|anesthetics, general|mesh-ancestor
24750465|NCT01698645|Anesthetics|anesthetics|mesh-ancestor
24750466|NCT01698697|Insulin Aspart|insulin aspart|mesh-list
24750467|NCT01698697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24750468|NCT01698697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750469|NCT01698723|Ribavirin|ribavirin|mesh-list
24750470|NCT01698723|Antimetabolites|antimetabolites|mesh-ancestor
24750471|NCT01698723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750472|NCT01698723|Antiviral Agents|antiviral agents|mesh-ancestor
24750473|NCT01698723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24447053|NCT00307255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750478|NCT01698749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24750479|NCT01698749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750480|NCT01698749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24750481|NCT01698749|Glucocorticoids|glucocorticoids|mesh-ancestor
24750482|NCT01698749|Hormones|hormones|mesh-ancestor
24944402|NCT03960775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24944403|NCT03960775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24944404|NCT03960775|Adrenergic Agents|adrenergic agents|mesh-ancestor
24944405|NCT03960775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24944406|NCT03960775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750483|NCT01698749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24750484|NCT01698749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24750485|NCT01698749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24750486|NCT01698788|Dexamethasone|dexamethasone|mesh-list
24750487|NCT01698788|Dexamethasone acetate|dexamethasone acetate|mesh-list
24750488|NCT01698788|BB 1101|bb 1101|mesh-list
24750489|NCT01698788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24750490|NCT01698788|Antiemetics|antiemetics|mesh-ancestor
24750491|NCT01698788|Autonomic Agents|autonomic agents|mesh-ancestor
24750492|NCT01698788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24750493|NCT01698788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750494|NCT01698788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24750496|NCT01698788|Hormones|hormones|mesh-ancestor
24750497|NCT01698788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24614539|NCT01024660|Donepezil|donepezil|mesh-list
24750551|NCT01699360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24750552|NCT01699360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24750553|NCT01699360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24750554|NCT01699412|Dexamethasone|dexamethasone|mesh-list
24750556|NCT01699412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24750557|NCT01699412|Antiemetics|antiemetics|mesh-ancestor
24750558|NCT01699412|Autonomic Agents|autonomic agents|mesh-ancestor
24751533|NCT01704716|Cyclophosphamide|cyclophosphamide|mesh-list
24750559|NCT01699412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24750560|NCT01699412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750561|NCT01699412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24750562|NCT01699412|Glucocorticoids|glucocorticoids|mesh-ancestor
24750563|NCT01699412|Hormones|hormones|mesh-ancestor
24750564|NCT01699412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24750565|NCT01699412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24750566|NCT01699412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24750567|NCT01699438|Mesalamine|mesalamine|mesh-list
24750568|NCT01699438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24750569|NCT01699438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24750570|NCT01699438|Analgesics|analgesics|mesh-ancestor
24750571|NCT01699438|Sensory System Agents|sensory system agents|mesh-ancestor
24750572|NCT01699438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24750573|NCT01699438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750574|NCT01699438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24750575|NCT01699438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24447054|NCT00307255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24750581|NCT01699490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750583|NCT01699490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24750584|NCT01699490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24750586|NCT01699490|Serotonin Agents|serotonin agents|mesh-ancestor
24944408|NCT03960866|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24944409|NCT03960866|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24944410|NCT03960866|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24750587|NCT01699490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750588|NCT01699490|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24750589|NCT01699490|Antidepressive Agents|antidepressive agents|mesh-ancestor
24750590|NCT01699490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24750605|NCT01699594|Respiratory System Agents|respiratory system agents|mesh-ancestor
24750606|NCT01699594|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25696401|NCT02061384|Isotretinoin|isotretinoin|mesh-list
24750607|NCT01699594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25696402|NCT02061384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25696403|NCT02061384|Keratolytic Agents|keratolytic agents|mesh-ancestor
25696404|NCT02061384|Dermatologic Agents|dermatologic agents|mesh-ancestor
24663079|NCT01298271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24663080|NCT01298271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24663081|NCT01298271|Vasodilator Agents|vasodilator agents|mesh-ancestor
24663082|NCT01298284|Propranolol|propranolol|mesh-list
24663092|NCT01298297|Morphine|morphine|mesh-list
24750608|NCT01699594|Cholinergic Agents|cholinergic agents|mesh-ancestor
24750609|NCT01699594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24750610|NCT01699594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750611|NCT01699711|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24750612|NCT01699711|Antioxidants|antioxidants|mesh-ancestor
25074416|NCT03388580|Sequestering Agents|sequestering agents|mesh-ancestor
24750613|NCT01699711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750614|NCT01699711|Protective Agents|protective agents|mesh-ancestor
24750615|NCT01699711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750616|NCT01699711|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24750617|NCT01699711|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24750618|NCT01699711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24750619|NCT01699711|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24447104|NCT00307502|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24594154|NCT00932867|Telmisartan|telmisartan|mesh-list
24750621|NCT01699724|Antidepressive Agents|antidepressive agents|mesh-ancestor
24750622|NCT01699724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24750623|NCT01699724|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24750624|NCT01699724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24750625|NCT01699724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24750626|NCT01699724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750627|NCT01699724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24750628|NCT01699724|Serotonin Agents|serotonin agents|mesh-ancestor
24750629|NCT01699724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750630|NCT01699776|Digoxin|digoxin|mesh-list
24750631|NCT01699776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24750632|NCT01699776|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24750633|NCT01699776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750638|NCT01699802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24619007|NCT01050452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619008|NCT01050452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24750701|NCT01700270|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24750702|NCT01700270|Antidepressive Agents|antidepressive agents|mesh-ancestor
24713072|NCT01524081|Metronidazole|metronidazole|mesh-list
24750703|NCT01700270|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24750704|NCT01700270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24750705|NCT01700270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750706|NCT01700270|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24750707|NCT01700322|Clopidogrel|clopidogrel|mesh-list
24750709|NCT01700322|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24750710|NCT01700322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24750711|NCT01700322|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24750712|NCT01700322|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24750713|NCT01700322|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24750714|NCT01700322|Purinergic Agents|purinergic agents|mesh-ancestor
24750715|NCT01700322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24750716|NCT01700322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750717|NCT01700322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750718|NCT01700400|Bevacizumab|bevacizumab|mesh-list
24750719|NCT01700400|Carboplatin|carboplatin|mesh-list
24750720|NCT01700400|Pemetrexed|pemetrexed|mesh-list
24750721|NCT01700400|Everolimus|everolimus|mesh-list
24750722|NCT01700400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24750723|NCT01700400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24750724|NCT01700400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24750725|NCT01700400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24750726|NCT01700400|Growth Substances|growth substances|mesh-ancestor
24750727|NCT01700400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750728|NCT01700400|Growth Inhibitors|growth inhibitors|mesh-ancestor
24750729|NCT01700400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750732|NCT01700400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24750733|NCT01700400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25696405|NCT02061384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25696406|NCT02061384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696407|NCT02061384|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25696408|NCT02061384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25696409|NCT02061384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663174|NCT01298713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24944416|NCT03960866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24944418|NCT03960801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24944419|NCT03960801|Narcotics|narcotics|mesh-ancestor
25051247|NCT00429923|Glucocorticoids|glucocorticoids|mesh-ancestor
25051251|NCT00429923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25051253|NCT00427856|Obatoclax|obatoclax|mesh-list
25051254|NCT00427856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25051255|NCT00427856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051256|NCT00427856|Immunologic Factors|immunologic factors|mesh-ancestor
24750734|NCT01700400|Immunologic Factors|immunologic factors|mesh-ancestor
24750736|NCT01700413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24750737|NCT01700413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24750738|NCT01700413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24750739|NCT01700413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24750740|NCT01700413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750741|NCT01700413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750743|NCT01700426|Vitamin E|vitamin e|mesh-list
24750744|NCT01700426|Tocopherols|tocopherols|mesh-list
24750745|NCT01700426|Tocotrienols|tocotrienols|mesh-list
24750746|NCT01700426|alpha-Tocopherol|alpha-tocopherol|mesh-list
24750747|NCT01700426|Micronutrients|micronutrients|mesh-ancestor
24750748|NCT01700426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750749|NCT01700426|Antioxidants|antioxidants|mesh-ancestor
24750750|NCT01700426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750751|NCT01700426|Protective Agents|protective agents|mesh-ancestor
24750752|NCT01700478|Vasopressins|vasopressins|mesh-list
24750753|NCT01700478|Arginine Vasopressin|arginine vasopressin|mesh-list
24750754|NCT01700478|Misoprostol|misoprostol|mesh-list
24750755|NCT01700478|Diuretics|diuretics|mesh-list
24750756|NCT01700478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656153|NCT01260233|Nicotine|nicotine|mesh-list
24750757|NCT01700478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24750759|NCT01700478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24713367|NCT01525823|Metformin|metformin|mesh-list
24750760|NCT01700478|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24750761|NCT01700478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24750762|NCT01700478|Oxytocics|oxytocics|mesh-ancestor
24750763|NCT01700478|Natriuretic Agents|natriuretic agents|mesh-ancestor
24750764|NCT01700478|Hemostatics|hemostatics|mesh-ancestor
24750765|NCT01700478|Coagulants|coagulants|mesh-ancestor
24750766|NCT01700478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24750767|NCT01700478|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24750768|NCT01700491|Ropivacaine|ropivacaine|mesh-list
24750769|NCT01700491|Anesthetics, Local|anesthetics, local|mesh-ancestor
25051257|NCT00427856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750810|NCT01700790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750812|NCT01700790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24750813|NCT01700790|Antiviral Agents|antiviral agents|mesh-ancestor
24750814|NCT01700790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24750815|NCT01700790|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24750816|NCT01700790|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24750818|NCT01700803|Cadexomer iodine|cadexomer iodine|mesh-list
24750819|NCT01700803|Povidone-Iodine|povidone-iodine|mesh-list
24750820|NCT01700803|Povidone|povidone|mesh-list
24750821|NCT01700803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24750822|NCT01700803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24415335|NCT00199212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415336|NCT00199225|Moxifloxacin|moxifloxacin|mesh-list
24415337|NCT00199225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24656265|NCT01260727|Vaccines|vaccines|mesh-list
24750926|NCT01701089|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24750927|NCT01701089|Protective Agents|protective agents|mesh-ancestor
24750928|NCT01701089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750930|NCT01701180|Oxytocics|oxytocics|mesh-ancestor
25696410|NCT02061384|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24750931|NCT01701180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24750932|NCT01701180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750933|NCT01701219|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
24750934|NCT01701219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25696411|NCT02061384|Vitamins|vitamins|mesh-ancestor
25696412|NCT02061384|Micronutrients|micronutrients|mesh-ancestor
25696413|NCT02061384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25696414|NCT02061397|Sirolimus|sirolimus|mesh-list
25696415|NCT02061397|Everolimus|everolimus|mesh-list
25696416|NCT02061397|Simvastatin|simvastatin|mesh-list
25696417|NCT02061397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051275|NCT00427154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25051276|NCT00427154|Immunologic Factors|immunologic factors|mesh-ancestor
25051278|NCT00425100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25051279|NCT00425100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25051280|NCT00425100|Cholinergic Agents|cholinergic agents|mesh-ancestor
25051281|NCT00425100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25051282|NCT00425100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051283|NCT00425100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051284|NCT00425100|Urological Agents|urological agents|mesh-ancestor
25051285|NCT00424697|Lorazepam|lorazepam|mesh-list
25051286|NCT00424697|Anticonvulsants|anticonvulsants|mesh-ancestor
24960234|NCT03818919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24960235|NCT03818919|Antimanic Agents|antimanic agents|mesh-ancestor
24960236|NCT03818919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24960237|NCT03818919|Narcotics|narcotics|mesh-ancestor
24960238|NCT03818919|Antitussive Agents|antitussive agents|mesh-ancestor
24960239|NCT03818919|Respiratory System Agents|respiratory system agents|mesh-ancestor
24960240|NCT03818919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24960241|NCT03818919|Antiemetics|antiemetics|mesh-ancestor
24960242|NCT03818919|Autonomic Agents|autonomic agents|mesh-ancestor
24960243|NCT03818919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24960244|NCT03818919|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24960245|NCT03818919|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24960246|NCT03818919|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24857560|NCT02292472|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24750987|NCT01701466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24750989|NCT01701479|Aldesleukin|aldesleukin|mesh-list
24750990|NCT01701479|Interleukin-2|interleukin-2|mesh-list
24750991|NCT01701479|Dinutuximab|dinutuximab|mesh-list
24750992|NCT01701479|Isotretinoin|isotretinoin|mesh-list
24656371|NCT01261234|Cilostazol|cilostazol|mesh-list
24750993|NCT01701479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24750994|NCT01701479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24619020|NCT01050478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24619021|NCT01050478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619025|NCT01050491|Sitaxsentan|sitaxsentan|mesh-list
24619026|NCT01050491|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24619028|NCT01050517|Ivermectin|ivermectin|mesh-list
24619042|NCT01050556|Folic Acid|folic acid|mesh-list
24619043|NCT01050556|Vitamin B Complex|vitamin b complex|mesh-list
24960265|NCT03818581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960266|NCT03818581|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
24960267|NCT03818581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24960268|NCT03818581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051287|NCT00424697|Antiemetics|antiemetics|mesh-ancestor
24944422|NCT03960801|Analgesics|analgesics|mesh-ancestor
24751035|NCT01701778|Sensory System Agents|sensory system agents|mesh-ancestor
24751036|NCT01701778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24751037|NCT01701778|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24751045|NCT01701778|Anesthetics, General|anesthetics, general|mesh-ancestor
24751047|NCT01701778|Anesthetics, Local|anesthetics, local|mesh-ancestor
24751048|NCT01701843|Cromolyn Sodium|cromolyn sodium|mesh-list
24751049|NCT01701843|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
24751050|NCT01701843|Immunologic Factors|immunologic factors|mesh-ancestor
24751051|NCT01701843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751052|NCT01701843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24751053|NCT01701843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24751054|NCT01701843|Respiratory System Agents|respiratory system agents|mesh-ancestor
24751055|NCT01701856|Interferons|interferons|mesh-list
24751056|NCT01701856|Interferon-beta|interferon-beta|mesh-list
24751057|NCT01701856|Interferon beta-1b|interferon beta-1b|mesh-list
24751058|NCT01701856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751059|NCT01701856|Antiviral Agents|antiviral agents|mesh-ancestor
24751060|NCT01701856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24751061|NCT01701856|Immunologic Factors|immunologic factors|mesh-ancestor
24751094|NCT01702038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24751095|NCT01702090|Ritonavir|ritonavir|mesh-list
24751096|NCT01702090|Darunavir|darunavir|mesh-list
24751097|NCT01702090|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24751098|NCT01702090|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24751099|NCT01702090|Protease Inhibitors|protease inhibitors|mesh-ancestor
24751100|NCT01702090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24751101|NCT01702090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751102|NCT01702090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24751103|NCT01702090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24751104|NCT01702090|Antiviral Agents|antiviral agents|mesh-ancestor
24751105|NCT01702090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24751106|NCT01702090|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24751107|NCT01702090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24751116|NCT01702129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24751117|NCT01702129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24751118|NCT01702129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643154|NCT01184144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24751119|NCT01702129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751125|NCT01702181|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24751126|NCT01702181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24751127|NCT01702181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751129|NCT01702207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24751130|NCT01702207|Immunologic Factors|immunologic factors|mesh-ancestor
24751131|NCT01702207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751132|NCT01702207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24751133|NCT01702207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594744|NCT00935363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24751134|NCT01702207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751135|NCT01702376|Moxifloxacin|moxifloxacin|mesh-list
24751136|NCT01702376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24714174|NCT01529242|Glucocorticoids|glucocorticoids|mesh-ancestor
24447106|NCT00307502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24447107|NCT00307502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24447109|NCT00307502|Antitubercular Agents|antitubercular agents|mesh-ancestor
24447110|NCT00307502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24447111|NCT00307515|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24447112|NCT00307515|Hemostatics|hemostatics|mesh-ancestor
24751137|NCT01702376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24751138|NCT01702376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24751139|NCT01702376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24751140|NCT01702376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24751141|NCT01702376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751142|NCT01702376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751144|NCT01702389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24751145|NCT01702389|Narcotics|narcotics|mesh-ancestor
24751146|NCT01702389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24751147|NCT01702389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751148|NCT01702389|Analgesics|analgesics|mesh-ancestor
24751149|NCT01702389|Sensory System Agents|sensory system agents|mesh-ancestor
24751150|NCT01702389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24751151|NCT01702415|Zoledronic Acid|zoledronic acid|mesh-list
24944444|NCT03960671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944446|NCT03960671|Antiemetics|antiemetics|mesh-ancestor
24944447|NCT03960671|Autonomic Agents|autonomic agents|mesh-ancestor
24944448|NCT03960671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24751152|NCT01702415|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24751153|NCT01702415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751155|NCT01702506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751156|NCT01702506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24751157|NCT01702610|Temozolomide|temozolomide|mesh-list
24751158|NCT01702610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24751159|NCT01702610|Alkylating Agents|alkylating agents|mesh-ancestor
24751164|NCT01702623|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24751165|NCT01702623|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24751166|NCT01702623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24751167|NCT01702623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751168|NCT01702623|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24751169|NCT01702623|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24751170|NCT01702636|Tranexamic Acid|tranexamic acid|mesh-list
24751171|NCT01702636|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24751172|NCT01702636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25696419|NCT02061397|Immunologic Factors|immunologic factors|mesh-ancestor
24751173|NCT01702636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751174|NCT01702636|Hemostatics|hemostatics|mesh-ancestor
24751175|NCT01702636|Coagulants|coagulants|mesh-ancestor
24751177|NCT01702649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24751178|NCT01702688|Angiotensin II|angiotensin ii|mesh-list
24751179|NCT01702688|Giapreza|giapreza|mesh-list
24660018|NCT01281553|Cisapride|cisapride|mesh-list
24751180|NCT01702688|Angiotensinogen|angiotensinogen|mesh-list
24751181|NCT01702688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24751182|NCT01702688|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24751183|NCT01702688|Protease Inhibitors|protease inhibitors|mesh-ancestor
24751184|NCT01702688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24751185|NCT01702688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751191|NCT01702701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24751192|NCT01702701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751193|NCT01702701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25074797|NCT03385967|Analgesics|analgesics|mesh-ancestor
24751194|NCT01702701|Respiratory System Agents|respiratory system agents|mesh-ancestor
24751195|NCT01702701|Dermatologic Agents|dermatologic agents|mesh-ancestor
24751196|NCT01702701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24944450|NCT03960671|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24944451|NCT03960671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24944452|NCT03960268|Brodalumab|brodalumab|mesh-list
24751250|NCT01702974|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
24751251|NCT01702974|Vitamins|vitamins|mesh-ancestor
24751252|NCT01702974|Micronutrients|micronutrients|mesh-ancestor
24751253|NCT01702974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751254|NCT01702974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24751255|NCT01702974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24751256|NCT01702974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751257|NCT01703104|Folic Acid|folic acid|mesh-list
24751258|NCT01703104|Vitamin B Complex|vitamin b complex|mesh-list
24751259|NCT01703104|Proguanil|proguanil|mesh-list
24751260|NCT01703104|Hematinics|hematinics|mesh-ancestor
24751261|NCT01703104|Vitamins|vitamins|mesh-ancestor
24751262|NCT01703104|Micronutrients|micronutrients|mesh-ancestor
24751265|NCT01703104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24751266|NCT01703104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24751286|NCT01703312|Respiratory System Agents|respiratory system agents|mesh-ancestor
24751288|NCT01703325|Clobetasol|clobetasol|mesh-list
24751289|NCT01703325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24751290|NCT01703325|Glucocorticoids|glucocorticoids|mesh-ancestor
24751291|NCT01703325|Hormones|hormones|mesh-ancestor
24751292|NCT01703325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24541441|NCT00672776|Serotonin Agents|serotonin agents|mesh-ancestor
24751293|NCT01703325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751294|NCT01703351|Fentanyl|fentanyl|mesh-list
24751295|NCT01703351|Ropivacaine|ropivacaine|mesh-list
24751296|NCT01703351|Anesthetics, Local|anesthetics, local|mesh-ancestor
24751297|NCT01703351|Anesthetics|anesthetics|mesh-ancestor
24751298|NCT01703351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24751299|NCT01703351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751300|NCT01703351|Sensory System Agents|sensory system agents|mesh-ancestor
24751301|NCT01703351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24751302|NCT01703351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24751303|NCT01703351|Narcotics|narcotics|mesh-ancestor
24751304|NCT01703351|Analgesics|analgesics|mesh-ancestor
24751305|NCT01703351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24751306|NCT01703351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24751307|NCT01703351|Anesthetics, General|anesthetics, general|mesh-ancestor
24751308|NCT01703364|Lenalidomide|lenalidomide|mesh-list
24751309|NCT01703364|Immunologic Factors|immunologic factors|mesh-ancestor
24751310|NCT01703364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751311|NCT01703364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24944453|NCT03960268|Dermatologic Agents|dermatologic agents|mesh-ancestor
24944454|NCT03960411|Doxycycline|doxycycline|mesh-list
24944455|NCT03960411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24751312|NCT01703364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24751313|NCT01703364|Growth Substances|growth substances|mesh-ancestor
24751314|NCT01703364|Growth Inhibitors|growth inhibitors|mesh-ancestor
24751315|NCT01703364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751316|NCT01703390|Cetuximab|cetuximab|mesh-list
24751317|NCT01703390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24751328|NCT01703468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24751329|NCT01703468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751330|NCT01703468|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24751331|NCT01703468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24751332|NCT01703559|Phentolamine|phentolamine|mesh-list
24751333|NCT01703559|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24751334|NCT01703559|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24751335|NCT01703559|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24751336|NCT01703559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24751337|NCT01703559|Adrenergic Agents|adrenergic agents|mesh-ancestor
24751338|NCT01703559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24751339|NCT01703559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751340|NCT01703559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751341|NCT01703559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24751342|NCT01703624|Glycopyrrolate|glycopyrrolate|mesh-list
24751350|NCT01703624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751351|NCT01703624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870254|NCT02896855|Docetaxel|docetaxel|mesh-list
24751352|NCT01703637|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24751353|NCT01703637|Vildagliptin|vildagliptin|mesh-list
24751354|NCT01703637|Saxagliptin|saxagliptin|mesh-list
24751355|NCT01703637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24751356|NCT01703637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751357|NCT01703637|Incretins|incretins|mesh-ancestor
24751358|NCT01703637|Hormones|hormones|mesh-ancestor
24751359|NCT01703637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24751360|NCT01703637|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24751361|NCT01703637|Protease Inhibitors|protease inhibitors|mesh-ancestor
24751362|NCT01703637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24751363|NCT01703637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751364|NCT01703728|Menotropins|menotropins|mesh-list
24751534|NCT01704716|Melphalan|melphalan|mesh-list
24751366|NCT01703728|Fertility Agents|fertility agents|mesh-ancestor
24751367|NCT01703728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24751368|NCT01703728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751369|NCT01703754|Isophosphamide mustard|isophosphamide mustard|mesh-list
24751370|NCT01703754|Ifosfamide|ifosfamide|mesh-list
24751371|NCT01703754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24595100|NCT00936793|Glucocorticoids|glucocorticoids|mesh-ancestor
24751372|NCT01703754|Alkylating Agents|alkylating agents|mesh-ancestor
24751373|NCT01703754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751374|NCT01703754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751375|NCT01703910|Gemcitabine|gemcitabine|mesh-list
24751385|NCT01703910|Capecitabine|capecitabine|mesh-list
24751386|NCT01703910|Oxaliplatin|oxaliplatin|mesh-list
24751387|NCT01703910|Irinotecan|irinotecan|mesh-list
24751388|NCT01703910|Etoposide phosphate|etoposide phosphate|mesh-list
24751390|NCT01703910|Cetuximab|cetuximab|mesh-list
24751394|NCT01703910|Dasatinib|dasatinib|mesh-list
24751395|NCT01703910|Mitomycins|mitomycins|mesh-list
24751396|NCT01703910|Mitomycin|mitomycin|mesh-list
24751397|NCT01703910|Raltitrexed|raltitrexed|mesh-list
24944456|NCT03960411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24944457|NCT03960411|Antimalarials|antimalarials|mesh-ancestor
24751398|NCT01703910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24751399|NCT01703910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751400|NCT01703910|Tubulin Modulators|tubulin modulators|mesh-ancestor
24751401|NCT01703910|Antimitotic Agents|antimitotic agents|mesh-ancestor
24751402|NCT01703910|Mitosis Modulators|mitosis modulators|mesh-ancestor
24751403|NCT01703910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751404|NCT01703910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24751405|NCT01703910|Antimetabolites|antimetabolites|mesh-ancestor
24751406|NCT01703910|Antiviral Agents|antiviral agents|mesh-ancestor
24751407|NCT01703910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24751408|NCT01703910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24751409|NCT01703910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24751432|NCT01704092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24751433|NCT01704092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24751434|NCT01704092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24751435|NCT01704092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24751436|NCT01704092|Adrenergic Agents|adrenergic agents|mesh-ancestor
24751437|NCT01704092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24751438|NCT01704092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541637|NCT00674232|Oxytocics|oxytocics|mesh-ancestor
24751439|NCT01704248|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24751440|NCT01704248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24751441|NCT01704339|Capsaicin|capsaicin|mesh-list
24751442|NCT01704339|Antipruritics|antipruritics|mesh-ancestor
24751443|NCT01704339|Dermatologic Agents|dermatologic agents|mesh-ancestor
24751444|NCT01704339|Sensory System Agents|sensory system agents|mesh-ancestor
24751445|NCT01704339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24751446|NCT01704339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751447|NCT01704378|Insulin Aspart|insulin aspart|mesh-list
24751448|NCT01704378|Biphasic Insulins|biphasic insulins|mesh-list
24751449|NCT01704378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24751450|NCT01704378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751451|NCT01704417|Insulin|insulin|mesh-list
24751452|NCT01704417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24751453|NCT01704417|Insulin Glargine|insulin glargine|mesh-list
24751454|NCT01704417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24751455|NCT01704417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656906|NCT01264588|Calcium|calcium|mesh-list
24751456|NCT01704469|Anesthetics|anesthetics|mesh-list
24751457|NCT01704469|Anesthetics, Local|anesthetics, local|mesh-list
25075079|NCT03383393|Sensory System Agents|sensory system agents|mesh-ancestor
24751458|NCT01704469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24757282|NCT01738893|Antimanic Agents|antimanic agents|mesh-ancestor
24751477|NCT01704508|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24751478|NCT01704508|Artenimol|artenimol|mesh-list
24751479|NCT01704508|Antimalarials|antimalarials|mesh-ancestor
24751480|NCT01704508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24751482|NCT01704508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24751483|NCT01704534|Ustekinumab|ustekinumab|mesh-list
24751484|NCT01704534|Dermatologic Agents|dermatologic agents|mesh-ancestor
24751485|NCT01704612|Ropivacaine|ropivacaine|mesh-list
24944458|NCT03960411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24944459|NCT03960411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24944460|NCT03960151|Dexamethasone|dexamethasone|mesh-list
24751486|NCT01704612|Anesthetics, Local|anesthetics, local|mesh-ancestor
24447176|NCT00307645|Alkylating Agents|alkylating agents|mesh-ancestor
24751521|NCT01704690|Antimitotic Agents|antimitotic agents|mesh-ancestor
24751522|NCT01704690|Mitosis Modulators|mitosis modulators|mesh-ancestor
24751523|NCT01704690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751524|NCT01704690|Antimetabolites|antimetabolites|mesh-ancestor
24751525|NCT01704690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24751526|NCT01704690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24751527|NCT01704690|Immunologic Factors|immunologic factors|mesh-ancestor
24751528|NCT01704690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751529|NCT01704703|Panitumumab|panitumumab|mesh-list
24751530|NCT01704703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24751531|NCT01704703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751532|NCT01704716|Aldesleukin|aldesleukin|mesh-list
24751535|NCT01704716|Busulfan|busulfan|mesh-list
24751536|NCT01704716|Carboplatin|carboplatin|mesh-list
24751537|NCT01704716|Doxorubicin|doxorubicin|mesh-list
24751538|NCT01704716|Etoposide|etoposide|mesh-list
24751539|NCT01704716|Vincristine|vincristine|mesh-list
24751540|NCT01704716|Interleukin-2|interleukin-2|mesh-list
24751541|NCT01704716|Dinutuximab|dinutuximab|mesh-list
24751542|NCT01704716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24751543|NCT01704716|Immunologic Factors|immunologic factors|mesh-ancestor
24751544|NCT01704716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751545|NCT01704716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24751546|NCT01704716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24751551|NCT01704716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24751552|NCT01704716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24751553|NCT01704716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24751554|NCT01704716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24751555|NCT01704716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24751556|NCT01704716|Tubulin Modulators|tubulin modulators|mesh-ancestor
24751557|NCT01704716|Antimitotic Agents|antimitotic agents|mesh-ancestor
24751558|NCT01704716|Mitosis Modulators|mitosis modulators|mesh-ancestor
24751559|NCT01704716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24751560|NCT01704716|Analgesics|analgesics|mesh-ancestor
24751564|NCT01704716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24751565|NCT01704716|Antiviral Agents|antiviral agents|mesh-ancestor
24751566|NCT01704716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24751567|NCT01704794|Folic Acid|folic acid|mesh-list
24751575|NCT01704794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24751576|NCT01704794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24751577|NCT01704794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24751578|NCT01704794|Antimetabolites|antimetabolites|mesh-ancestor
24751580|NCT01704872|Dinutuximab|dinutuximab|mesh-list
24751599|NCT01705002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24751600|NCT01705002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24751601|NCT01705002|Growth Substances|growth substances|mesh-ancestor
24751602|NCT01705002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751603|NCT01705002|Growth Inhibitors|growth inhibitors|mesh-ancestor
24751604|NCT01705002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24619076|NCT01050699|Analgesics|analgesics|mesh-ancestor
24751606|NCT01705002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751607|NCT01705041|Liver Extracts|liver extracts|mesh-list
24751608|NCT01705041|Hematinics|hematinics|mesh-ancestor
24619077|NCT01050699|Sensory System Agents|sensory system agents|mesh-ancestor
24619078|NCT01050699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24619079|NCT01050699|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24619081|NCT01050699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24619082|NCT01050699|Adrenergic Agents|adrenergic agents|mesh-ancestor
24619083|NCT01050699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24619084|NCT01050699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619085|NCT01050699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24619086|NCT01050699|Narcotics|narcotics|mesh-ancestor
24944463|NCT03960151|Rolapitant|rolapitant|mesh-list
24944464|NCT03960151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24944465|NCT03960151|Antiemetics|antiemetics|mesh-ancestor
24944466|NCT03960151|Autonomic Agents|autonomic agents|mesh-ancestor
24619087|NCT01050699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24751609|NCT01705158|Carboplatin|carboplatin|mesh-list
24619090|NCT01050699|Anesthetics|anesthetics|mesh-ancestor
24619114|NCT01050842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24619115|NCT01050842|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24619116|NCT01050842|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24619117|NCT01050842|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24619118|NCT01050842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24657144|NCT01265927|Imetelstat|imetelstat|mesh-list
24619120|NCT01050933|Antimetabolites|antimetabolites|mesh-ancestor
24751612|NCT01705158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751613|NCT01705158|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24751614|NCT01705158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24751615|NCT01705158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24751616|NCT01705158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24751617|NCT01705158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751618|NCT01705184|Bevacizumab|bevacizumab|mesh-list
24751619|NCT01705184|Pemetrexed|pemetrexed|mesh-list
24751620|NCT01705184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24751621|NCT01705184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751622|NCT01705184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24751623|NCT01705184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24751624|NCT01705184|Growth Substances|growth substances|mesh-ancestor
24751625|NCT01705184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751626|NCT01705184|Growth Inhibitors|growth inhibitors|mesh-ancestor
24751627|NCT01705184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24751628|NCT01705184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751629|NCT01705184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24751630|NCT01705184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24751632|NCT01705223|Immunologic Factors|immunologic factors|mesh-ancestor
24751645|NCT01705249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24751646|NCT01705249|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24657170|NCT01266031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24751647|NCT01705249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24751650|NCT01705314|Micronutrients|micronutrients|mesh-ancestor
24751651|NCT01705314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751656|NCT01705340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751657|NCT01705340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24751658|NCT01705340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24751659|NCT01705340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751660|NCT01705379|Lactitol|lactitol|mesh-list
24751661|NCT01705379|Cathartics|cathartics|mesh-ancestor
24751662|NCT01705379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24751663|NCT01705392|Bevacizumab|bevacizumab|mesh-list
24751664|NCT01705392|Dacarbazine|dacarbazine|mesh-list
24751665|NCT01705392|Propranolol|propranolol|mesh-list
24751666|NCT01705392|Enalapril|enalapril|mesh-list
24751667|NCT01705392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24751668|NCT01705392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751669|NCT01705392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24751670|NCT01705392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24751671|NCT01705392|Growth Substances|growth substances|mesh-ancestor
24751672|NCT01705392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751673|NCT01705392|Growth Inhibitors|growth inhibitors|mesh-ancestor
24751674|NCT01705392|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24751675|NCT01705392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24751676|NCT01705392|Adrenergic Agents|adrenergic agents|mesh-ancestor
24751677|NCT01705392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24751678|NCT01705392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751679|NCT01705392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24751684|NCT01705392|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24751685|NCT01705392|Protease Inhibitors|protease inhibitors|mesh-ancestor
24751686|NCT01705392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24944467|NCT03960151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24944468|NCT03960151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709390|NCT02266433|Autonomic Agents|autonomic agents|mesh-ancestor
24664155|NCT01305551|Saxagliptin|saxagliptin|mesh-list
24664156|NCT01305551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24664157|NCT01305551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944469|NCT03960151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24751691|NCT01705457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751692|NCT01705457|Antioxidants|antioxidants|mesh-ancestor
24751693|NCT01705457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751694|NCT01705457|Protective Agents|protective agents|mesh-ancestor
24751695|NCT01705457|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24751696|NCT01705457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751697|NCT01705470|Furosemide|furosemide|mesh-list
24751698|NCT01705470|Diuretics|diuretics|mesh-ancestor
24751699|NCT01705470|Natriuretic Agents|natriuretic agents|mesh-ancestor
24751700|NCT01705470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751701|NCT01705470|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24751702|NCT01705470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24751703|NCT01705470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751704|NCT01705483|Paclitaxel|paclitaxel|mesh-list
24751705|NCT01705483|Docetaxel|docetaxel|mesh-list
24751706|NCT01705483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24751707|NCT01705483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751708|NCT01705483|Tubulin Modulators|tubulin modulators|mesh-ancestor
24751709|NCT01705483|Antimitotic Agents|antimitotic agents|mesh-ancestor
24751710|NCT01705483|Mitosis Modulators|mitosis modulators|mesh-ancestor
24751780|NCT01706120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751781|NCT01706120|Growth Inhibitors|growth inhibitors|mesh-ancestor
24751783|NCT01706172|Anesthetics, Local|anesthetics, local|mesh-ancestor
24751784|NCT01706172|Anesthetics|anesthetics|mesh-ancestor
24751785|NCT01706172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24751786|NCT01706172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751787|NCT01706172|Sensory System Agents|sensory system agents|mesh-ancestor
24751788|NCT01706172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24751789|NCT01706172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24751790|NCT01706172|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24944470|NCT03960151|Glucocorticoids|glucocorticoids|mesh-ancestor
24944471|NCT03960151|Hormones|hormones|mesh-ancestor
24944472|NCT03960151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24751791|NCT01706172|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24751792|NCT01706172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24751793|NCT01706172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751794|NCT01706211|Rosiglitazone|rosiglitazone|mesh-list
24751795|NCT01706211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24751825|NCT01706510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24751826|NCT01706510|Purinergic Agents|purinergic agents|mesh-ancestor
24751827|NCT01706510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24751828|NCT01706510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751829|NCT01706510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751830|NCT01706562|Itraconazole|itraconazole|mesh-list
24751831|NCT01706562|Antifungal Agents|antifungal agents|mesh-ancestor
24751832|NCT01706562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24751833|NCT01706562|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24751834|NCT01706562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24751835|NCT01706562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24751836|NCT01706562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751837|NCT01706562|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24751838|NCT01706562|Hormone Antagonists|hormone antagonists|mesh-ancestor
24715354|NCT01536028|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24751839|NCT01706562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24751840|NCT01706562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751841|NCT01706562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24751842|NCT01706627|Melatonin|melatonin|mesh-list
24751843|NCT01706627|Antioxidants|antioxidants|mesh-ancestor
24751844|NCT01706627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751845|NCT01706627|Protective Agents|protective agents|mesh-ancestor
24751846|NCT01706627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751847|NCT01706627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24751848|NCT01706679|Moxifloxacin|moxifloxacin|mesh-list
25696420|NCT02061397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696421|NCT02061397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25696422|NCT02061397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24664376|NCT01306461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24751849|NCT01706679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24751850|NCT01706679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24751851|NCT01706679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24751852|NCT01706679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24751853|NCT01706679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24751854|NCT01706679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751855|NCT01706679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751866|NCT01706887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715501|NCT01536691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24715502|NCT01536691|Serotonin Agents|serotonin agents|mesh-ancestor
24715503|NCT01536691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24715505|NCT01536691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24447235|NCT00307671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24751869|NCT01707082|Midazolam|midazolam|mesh-list
24751870|NCT01707082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24751871|NCT01707082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24751872|NCT01707082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24751873|NCT01707082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751874|NCT01707082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24751875|NCT01707082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24751876|NCT01707082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24751877|NCT01707082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24751878|NCT01707082|Anesthetics, General|anesthetics, general|mesh-ancestor
24751879|NCT01707082|Anesthetics|anesthetics|mesh-ancestor
24751880|NCT01707082|GABA Modulators|gaba modulators|mesh-ancestor
24812452|NCT02052258|Oxytocin|oxytocin|mesh-list
24751881|NCT01707082|GABA Agents|gaba agents|mesh-ancestor
24751882|NCT01707082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24751883|NCT01707082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751884|NCT01707134|Insulin|insulin|mesh-list
24751885|NCT01707134|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24751886|NCT01707134|Insulin Aspart|insulin aspart|mesh-list
24751887|NCT01707134|Isophane Insulin, Human|isophane insulin, human|mesh-list
24751888|NCT01707134|Insulin, Isophane|insulin, isophane|mesh-list
24657433|NCT01267344|Cetuximab|cetuximab|mesh-list
24751892|NCT01707160|Insulin|insulin|mesh-list
24447236|NCT00307671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24447238|NCT00307671|Dermatologic Agents|dermatologic agents|mesh-ancestor
24447239|NCT00307671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24447240|NCT00307671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24447241|NCT00307671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25696423|NCT02061397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25696424|NCT02061397|Antifungal Agents|antifungal agents|mesh-ancestor
25696425|NCT02061397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25696426|NCT02061397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24664479|NCT01307189|Parasympatholytics|parasympatholytics|mesh-ancestor
24664480|NCT01307189|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24664481|NCT01307189|Cholinergic Agents|cholinergic agents|mesh-ancestor
24800275|NCT01974518|Immunologic Factors|immunologic factors|mesh-ancestor
24416421|NCT00203073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24751896|NCT01707160|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24751897|NCT01707160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24944473|NCT03960151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24944474|NCT03960151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24944475|NCT03960151|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24944476|NCT03960151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24751898|NCT01707160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751900|NCT01707199|Pyrimethamine|pyrimethamine|mesh-list
24751901|NCT01707199|Sulfadoxine|sulfadoxine|mesh-list
24751902|NCT01707199|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24751903|NCT01707199|Antimalarials|antimalarials|mesh-ancestor
24751904|NCT01707199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24751905|NCT01707199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24751906|NCT01707199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24751907|NCT01707199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751908|NCT01707199|Antiviral Agents|antiviral agents|mesh-ancestor
24751909|NCT01707199|Schistosomicides|schistosomicides|mesh-ancestor
24751910|NCT01707199|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24751911|NCT01707199|Anthelmintics|anthelmintics|mesh-ancestor
24751912|NCT01707199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24751913|NCT01707199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24751914|NCT01707199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751915|NCT01707199|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24751916|NCT01707199|Renal Agents|renal agents|mesh-ancestor
24751917|NCT01707251|Ibuprofen|ibuprofen|mesh-list
24788984|NCT01935089|Interferons|interferons|mesh-list
24751918|NCT01707251|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24751919|NCT01707251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24751920|NCT01707251|Analgesics|analgesics|mesh-ancestor
24751921|NCT01707251|Sensory System Agents|sensory system agents|mesh-ancestor
24751922|NCT01707251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24751923|NCT01707251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751924|NCT01707251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24751925|NCT01707251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24751928|NCT01707251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751929|NCT01707316|Canagliflozin|canagliflozin|mesh-list
24751930|NCT01707316|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24751931|NCT01707316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751932|NCT01707316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24751933|NCT01707316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751934|NCT01707342|Simeprevir|simeprevir|mesh-list
24751935|NCT01707342|Antiviral Agents|antiviral agents|mesh-ancestor
25696427|NCT02061397|Antimetabolites|antimetabolites|mesh-ancestor
25696428|NCT02061397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696429|NCT02061397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25709391|NCT02266433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24664544|NCT01307592|Gemcitabine|gemcitabine|mesh-list
24664545|NCT01307592|Rituximab|rituximab|mesh-list
24664546|NCT01307592|Oxaliplatin|oxaliplatin|mesh-list
24751936|NCT01707342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24751937|NCT01707342|Protease Inhibitors|protease inhibitors|mesh-ancestor
24751938|NCT01707342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24751939|NCT01707342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751940|NCT01707394|Apixaban|apixaban|mesh-list
24751941|NCT01707394|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24751942|NCT01707394|Antithrombins|antithrombins|mesh-ancestor
24751943|NCT01707394|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24751944|NCT01707394|Protease Inhibitors|protease inhibitors|mesh-ancestor
24751945|NCT01707394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24751946|NCT01707394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751947|NCT01707394|Anticoagulants|anticoagulants|mesh-ancestor
24751948|NCT01707407|Ketoconazole|ketoconazole|mesh-list
24751949|NCT01707407|Pomalidomide|pomalidomide|mesh-list
24751950|NCT01707407|Carbamazepine|carbamazepine|mesh-list
24751951|NCT01707407|Fluvoxamine|fluvoxamine|mesh-list
24751952|NCT01707407|Immunologic Factors|immunologic factors|mesh-ancestor
24751953|NCT01707407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751954|NCT01707407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24751958|NCT01707407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751959|NCT01707407|Antifungal Agents|antifungal agents|mesh-ancestor
24657509|NCT01267734|Everolimus|everolimus|mesh-list
24751968|NCT01707407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24751969|NCT01707407|Anticonvulsants|anticonvulsants|mesh-ancestor
24751970|NCT01707407|Antimanic Agents|antimanic agents|mesh-ancestor
24751971|NCT01707407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24751972|NCT01707407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24944477|NCT03960151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24944478|NCT03960151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24944479|NCT03960151|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24944480|NCT03960151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24812476|NCT02052388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24944481|NCT03960151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24751973|NCT01707407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24751974|NCT01707407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24751976|NCT01707407|Sensory System Agents|sensory system agents|mesh-ancestor
24751977|NCT01707407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24751978|NCT01707407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24751979|NCT01707407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24751980|NCT01707407|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24751981|NCT01707407|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24751982|NCT01707407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24751983|NCT01707407|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24751984|NCT01707407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24751985|NCT01707407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24751986|NCT01707407|Serotonin Agents|serotonin agents|mesh-ancestor
24751987|NCT01707407|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24619148|NCT01051102|Insulin Aspart|insulin aspart|mesh-list
24619149|NCT01051102|Insulin, Long-Acting|insulin, long-acting|mesh-list
24619150|NCT01051102|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24619151|NCT01051102|Biphasic Insulins|biphasic insulins|mesh-list
24619152|NCT01051102|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24619153|NCT01051102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24998531|NCT02566304|Tacrolimus|tacrolimus|mesh-list
25696430|NCT02061397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25696431|NCT02061397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25696432|NCT02061683|Bimatoprost|bimatoprost|mesh-list
25696433|NCT02061683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25696434|NCT02061774|Acetaminophen|acetaminophen|mesh-list
24619162|NCT01051167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24619163|NCT01051193|Oxcarbazepine|oxcarbazepine|mesh-list
24619164|NCT01051193|Anticonvulsants|anticonvulsants|mesh-ancestor
24619165|NCT01051193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24619166|NCT01051193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24619167|NCT01051193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24619168|NCT01051193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751992|NCT01707537|Immunologic Factors|immunologic factors|mesh-ancestor
24416548|NCT00203372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24416549|NCT00203372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24751993|NCT01707537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751994|NCT01707615|Proanthocyanidin|proanthocyanidin|mesh-list
24751996|NCT01707615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751997|NCT01707615|Protective Agents|protective agents|mesh-ancestor
24751998|NCT01707615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751999|NCT01707615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24752000|NCT01707615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24752001|NCT01707615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24752003|NCT01707732|Anticoagulants|anticoagulants|mesh-ancestor
24752017|NCT01707823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24752018|NCT01707823|Analgesics|analgesics|mesh-ancestor
24752019|NCT01707823|Sensory System Agents|sensory system agents|mesh-ancestor
24944482|NCT03960151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596704|NCT00944957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752020|NCT01707823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24752021|NCT01707823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752045|NCT01707940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24752046|NCT01707940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752047|NCT01707940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24752049|NCT01707953|Sympathomimetics|sympathomimetics|mesh-ancestor
24752050|NCT01707953|Autonomic Agents|autonomic agents|mesh-ancestor
24752051|NCT01707953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24752052|NCT01707953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752053|NCT01707953|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24752054|NCT01707953|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24752055|NCT01707953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24752056|NCT01707953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24752057|NCT01707953|Adrenergic Agents|adrenergic agents|mesh-ancestor
24752058|NCT01707953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24752059|NCT01707953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715789|NCT01538537|ON 01910|on 01910|mesh-list
24447274|NCT00307775|Hormones|hormones|mesh-ancestor
24447275|NCT00307775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24447277|NCT00307814|Epoetin Alfa|epoetin alfa|mesh-list
24752068|NCT01708044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24752069|NCT01708044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752070|NCT01708239|Fibrin fragment D|fibrin fragment d|mesh-list
24752071|NCT01708239|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25696435|NCT02061774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25696436|NCT02061774|Analgesics|analgesics|mesh-ancestor
25696437|NCT02061774|Sensory System Agents|sensory system agents|mesh-ancestor
25696438|NCT02061774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25696439|NCT02061774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696440|NCT02061774|Antipyretics|antipyretics|mesh-ancestor
25696441|NCT02061969|Insulin Glargine|insulin glargine|mesh-list
25696442|NCT02061969|Linagliptin|linagliptin|mesh-list
24664640|NCT01308086|Protective Agents|protective agents|mesh-ancestor
24664641|NCT01308086|Vitamin B Complex|vitamin b complex|mesh-ancestor
24664643|NCT01308086|Micronutrients|micronutrients|mesh-ancestor
24752072|NCT01708239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24752073|NCT01708239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752074|NCT01708239|Hemostatics|hemostatics|mesh-ancestor
24752075|NCT01708239|Coagulants|coagulants|mesh-ancestor
24752076|NCT01708330|Lidocaine|lidocaine|mesh-list
24752078|NCT01708330|Anesthetics|anesthetics|mesh-ancestor
24752079|NCT01708330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24752080|NCT01708330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752081|NCT01708330|Sensory System Agents|sensory system agents|mesh-ancestor
24752082|NCT01708330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24752083|NCT01708330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24752084|NCT01708330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24752085|NCT01708330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24752086|NCT01708330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24715927|NCT01539044|Atropine|atropine|mesh-list
24752103|NCT01708369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24752104|NCT01708369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752105|NCT01708369|Antipyretics|antipyretics|mesh-ancestor
24752106|NCT01708369|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24752107|NCT01708369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24752108|NCT01708369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24752109|NCT01708369|Antiviral Agents|antiviral agents|mesh-ancestor
24752111|NCT01708447|Anesthetics, Local|anesthetics, local|mesh-list
24944483|NCT03960151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24944484|NCT03960151|Serotonin Agents|serotonin agents|mesh-ancestor
24944485|NCT03960151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24944486|NCT03960151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24944487|NCT03960151|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24944488|NCT03959852|Fentanyl|fentanyl|mesh-list
24944489|NCT03959852|Ketamine|ketamine|mesh-list
24944490|NCT03959852|Analgesics|analgesics|mesh-ancestor
24944491|NCT03959852|Sensory System Agents|sensory system agents|mesh-ancestor
24944492|NCT03959852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24752112|NCT01708447|Anesthetics|anesthetics|mesh-list
24752113|NCT01708447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24752114|NCT01708447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752115|NCT01708447|Sensory System Agents|sensory system agents|mesh-ancestor
24752116|NCT01708447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24752117|NCT01708447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24752118|NCT01708447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24752119|NCT01708447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24752120|NCT01708447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24752121|NCT01708447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752122|NCT01708616|Risperidone|risperidone|mesh-list
24752123|NCT01708616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24752124|NCT01708616|Serotonin Agents|serotonin agents|mesh-ancestor
24752137|NCT01708642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24752138|NCT01708642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24752139|NCT01708642|Adrenergic Agents|adrenergic agents|mesh-ancestor
24752140|NCT01708642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24752141|NCT01708642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752142|NCT01708642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752143|NCT01708642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24752144|NCT01708642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24752145|NCT01708642|Autonomic Agents|autonomic agents|mesh-ancestor
24752146|NCT01708642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25696443|NCT02061969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25696444|NCT02061969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696445|NCT02061969|Incretins|incretins|mesh-ancestor
25696446|NCT02061969|Hormones|hormones|mesh-ancestor
25696447|NCT02061969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25696448|NCT02061969|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25696449|NCT02061969|Protease Inhibitors|protease inhibitors|mesh-ancestor
24664701|NCT01308255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24759646|NCT01753349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24752150|NCT01708642|Sympathomimetics|sympathomimetics|mesh-ancestor
24752151|NCT01708642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24752153|NCT01708707|Buprenorphine|buprenorphine|mesh-list
24752164|NCT01708720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752166|NCT01708798|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24752167|NCT01708798|Hormone Antagonists|hormone antagonists|mesh-ancestor
24752171|NCT01708798|Diuretics|diuretics|mesh-ancestor
24416762|NCT00203905|Growth Inhibitors|growth inhibitors|mesh-ancestor
24416763|NCT00203905|Antimetabolites|antimetabolites|mesh-ancestor
24752182|NCT01708850|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24752183|NCT01708850|Antithrombins|antithrombins|mesh-ancestor
24752184|NCT01708850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24752185|NCT01708850|Protease Inhibitors|protease inhibitors|mesh-ancestor
24752186|NCT01708850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752187|NCT01708850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752188|NCT01708850|Anticoagulants|anticoagulants|mesh-ancestor
24752189|NCT01708876|Artesunate|artesunate|mesh-list
24752190|NCT01708876|Chloroquine|chloroquine|mesh-list
24752191|NCT01708876|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24752192|NCT01708876|Primaquine|primaquine|mesh-list
24752193|NCT01708876|Mefloquine|mefloquine|mesh-list
24752194|NCT01708876|Antimalarials|antimalarials|mesh-ancestor
24752195|NCT01708876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24752196|NCT01708876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24752197|NCT01708876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24944493|NCT03959852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944495|NCT03959852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24944496|NCT03959852|Anesthetics, General|anesthetics, general|mesh-ancestor
24752200|NCT01708876|Schistosomicides|schistosomicides|mesh-ancestor
24752201|NCT01708876|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24752202|NCT01708876|Anthelmintics|anthelmintics|mesh-ancestor
24752203|NCT01708876|Amebicides|amebicides|mesh-ancestor
24752204|NCT01708876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24716185|NCT01540500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24752205|NCT01708876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24752206|NCT01708876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24752207|NCT01708876|Analgesics|analgesics|mesh-ancestor
24752208|NCT01708876|Sensory System Agents|sensory system agents|mesh-ancestor
24752209|NCT01708876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24752210|NCT01708876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752211|NCT01708876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24752212|NCT01708876|Filaricides|filaricides|mesh-ancestor
24752213|NCT01708876|Antinematodal Agents|antinematodal agents|mesh-ancestor
24416771|NCT00203957|Istradefylline|istradefylline|mesh-list
24752214|NCT01708993|Docetaxel|docetaxel|mesh-list
24752215|NCT01708993|Pemetrexed|pemetrexed|mesh-list
24752216|NCT01708993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24752217|NCT01708993|Tubulin Modulators|tubulin modulators|mesh-ancestor
24752218|NCT01708993|Antimitotic Agents|antimitotic agents|mesh-ancestor
24752219|NCT01708993|Mitosis Modulators|mitosis modulators|mesh-ancestor
24752220|NCT01708993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752221|NCT01708993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752222|NCT01708993|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24752223|NCT01708993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25696450|NCT02061969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25696451|NCT02061969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696452|NCT02062177|Midazolam|midazolam|mesh-list
24935216|NCT04053699|Factor VIII|factor viii|mesh-list
24935217|NCT04053699|Coagulants|coagulants|mesh-ancestor
24935218|NCT04053621|Thiamine|thiamine|mesh-list
24935219|NCT04053621|Thiamine Pyrophosphate|thiamine pyrophosphate|mesh-list
24752235|NCT01709370|Letrozole|letrozole|mesh-list
24752236|NCT01709370|Palbociclib|palbociclib|mesh-list
24752237|NCT01709370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24752238|NCT01709370|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24752239|NCT01709370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24752263|NCT01709656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24752264|NCT01709656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24752266|NCT01709656|Sensory System Agents|sensory system agents|mesh-ancestor
24752267|NCT01709656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24752268|NCT01709656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752269|NCT01709656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24752270|NCT01709656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24752271|NCT01709656|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24752272|NCT01709656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24752273|NCT01709656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752274|NCT01709656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619169|NCT01051193|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24752275|NCT01709682|Amiodarone|amiodarone|mesh-list
24752276|NCT01709682|Sotalol|sotalol|mesh-list
24752281|NCT01709682|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25006052|NCT05205837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752282|NCT01709682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24752283|NCT01709682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752284|NCT01709682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24752285|NCT01709682|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24752286|NCT01709682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24752287|NCT01709682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752288|NCT01709682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24752289|NCT01709682|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24752290|NCT01709682|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24752291|NCT01709682|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24944497|NCT03959852|Anesthetics|anesthetics|mesh-ancestor
25051288|NCT00424697|Autonomic Agents|autonomic agents|mesh-ancestor
24944498|NCT03959852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24944499|NCT03959852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24944500|NCT03959852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24944501|NCT03959852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24944502|NCT03959852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944503|NCT03959852|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25696453|NCT02062177|Propofol|propofol|mesh-list
25696454|NCT02062177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25696455|NCT02062177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25696456|NCT02062177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696457|NCT02062177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25696458|NCT02062177|Anesthetics, General|anesthetics, general|mesh-ancestor
24944504|NCT03959852|Narcotics|narcotics|mesh-ancestor
24944505|NCT03959852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24944507|NCT03959761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24944508|NCT03959761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24944509|NCT03959761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24944510|NCT03959761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944511|NCT03959969|Ibuprofen|ibuprofen|mesh-list
24944512|NCT03959969|Oxycodone|oxycodone|mesh-list
24944513|NCT03959969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24944514|NCT03959969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24944515|NCT03959969|Analgesics|analgesics|mesh-ancestor
24944516|NCT03959969|Sensory System Agents|sensory system agents|mesh-ancestor
24752292|NCT01709682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24752300|NCT01709734|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
24752301|NCT01709734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657909|NCT01269528|Nitric Oxide|nitric oxide|mesh-list
24752302|NCT01709734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752303|NCT01709760|Methotrexate|methotrexate|mesh-list
24752304|NCT01709760|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24752305|NCT01709760|Abortifacient Agents|abortifacient agents|mesh-ancestor
24752309|NCT01709760|Antimetabolites|antimetabolites|mesh-ancestor
24752310|NCT01709760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752311|NCT01709760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24752312|NCT01709760|Dermatologic Agents|dermatologic agents|mesh-ancestor
24752313|NCT01709760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24619180|NCT01051271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24619181|NCT01051271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752327|NCT01709929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24752328|NCT01709929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752330|NCT01709942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24752331|NCT01709942|Fertility Agents|fertility agents|mesh-ancestor
24752332|NCT01709942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24752333|NCT01709942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752334|NCT01709942|Hormone Antagonists|hormone antagonists|mesh-ancestor
24944518|NCT03959969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752360|NCT01710007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752362|NCT01710007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24752363|NCT01710007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752364|NCT01710059|Adrenergic Agents|adrenergic agents|mesh-list
24752365|NCT01710059|Adrenergic Agonists|adrenergic agonists|mesh-list
24752366|NCT01710059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24752367|NCT01710059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752368|NCT01710059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752369|NCT01710072|Aspirin|aspirin|mesh-list
24752370|NCT01710072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24752371|NCT01710072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24752372|NCT01710072|Analgesics|analgesics|mesh-ancestor
24716424|NCT01541475|Serotonin Agents|serotonin agents|mesh-ancestor
24999740|NCT03426657|Durvalumab|durvalumab|mesh-list
24752400|NCT01710163|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24752401|NCT01710163|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24752402|NCT01710163|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24752403|NCT01710202|Hydrocortisone|hydrocortisone|mesh-list
24752404|NCT01710202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24752405|NCT01710228|Methylprednisolone|methylprednisolone|mesh-list
24752406|NCT01710228|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24752407|NCT01710228|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24752408|NCT01710228|Prednisolone|prednisolone|mesh-list
24752409|NCT01710228|Prednisolone acetate|prednisolone acetate|mesh-list
24752410|NCT01710228|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24752411|NCT01710228|Prednisolone phosphate|prednisolone phosphate|mesh-list
24752412|NCT01710228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24752413|NCT01710228|Antiemetics|antiemetics|mesh-ancestor
24752414|NCT01710228|Autonomic Agents|autonomic agents|mesh-ancestor
24752415|NCT01710228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24752416|NCT01710228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752417|NCT01710228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24752418|NCT01710228|Glucocorticoids|glucocorticoids|mesh-ancestor
24752431|NCT01710384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24752432|NCT01710384|Respiratory System Agents|respiratory system agents|mesh-ancestor
24752433|NCT01710462|Domperidone|domperidone|mesh-list
24752434|NCT01710462|Pantoprazole|pantoprazole|mesh-list
24752435|NCT01710462|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24752436|NCT01710462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24944519|NCT03959969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24944520|NCT03959969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24944521|NCT03959969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24944522|NCT03959969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857684|NCT02293525|Analgesics|analgesics|mesh-ancestor
24752437|NCT01710462|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24752438|NCT01710462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417030|NCT00204789|Eflornithine|eflornithine|mesh-list
24752455|NCT01710488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24752456|NCT01710488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752457|NCT01710488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752458|NCT01710488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24752459|NCT01710488|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24752460|NCT01710488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24752473|NCT01710566|Abortifacient Agents|abortifacient agents|mesh-ancestor
24752474|NCT01710566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24752475|NCT01710566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24752476|NCT01710592|Docetaxel|docetaxel|mesh-list
24752477|NCT01710592|Capecitabine|capecitabine|mesh-list
24752478|NCT01710592|Oxaliplatin|oxaliplatin|mesh-list
24752479|NCT01710592|Epirubicin|epirubicin|mesh-list
24752480|NCT01710592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24752481|NCT01710592|Tubulin Modulators|tubulin modulators|mesh-ancestor
24752505|NCT01710696|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24752506|NCT01710696|Estrogens|estrogens|mesh-ancestor
24944525|NCT03959969|Narcotics|narcotics|mesh-ancestor
24944526|NCT03959969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24944528|NCT03959865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24944529|NCT03959865|Incretins|incretins|mesh-ancestor
24944530|NCT03959865|Hormones|hormones|mesh-ancestor
24944531|NCT03959865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25696459|NCT02062177|Anesthetics|anesthetics|mesh-ancestor
25696460|NCT02062177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25696461|NCT02062177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25696462|NCT02062177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25696463|NCT02062177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25696464|NCT02062177|GABA Modulators|gaba modulators|mesh-ancestor
25696465|NCT02062177|GABA Agents|gaba agents|mesh-ancestor
25696466|NCT02062177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25696467|NCT02062177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696468|NCT02062359|Aldesleukin|aldesleukin|mesh-list
25696469|NCT02062359|Cyclophosphamide|cyclophosphamide|mesh-list
25696470|NCT02062359|Fludarabine|fludarabine|mesh-list
24944532|NCT03959865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857687|NCT02293525|Anesthetics, Local|anesthetics, local|mesh-ancestor
24752534|NCT01710722|Nasal Decongestants|nasal decongestants|mesh-ancestor
24752535|NCT01710748|Everolimus|everolimus|mesh-list
24752536|NCT01710748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24658127|NCT01270672|Carvedilol|carvedilol|mesh-list
24752546|NCT01710761|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24752547|NCT01710761|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24752548|NCT01710761|Purinergic Agents|purinergic agents|mesh-ancestor
24752549|NCT01710761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24752550|NCT01710904|Oxycodone|oxycodone|mesh-list
24752551|NCT01710904|Naloxone|naloxone|mesh-list
24752552|NCT01710904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24752553|NCT01710904|Narcotics|narcotics|mesh-ancestor
24752554|NCT01710904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24752555|NCT01710904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752556|NCT01710904|Analgesics|analgesics|mesh-ancestor
24752557|NCT01710904|Sensory System Agents|sensory system agents|mesh-ancestor
24752558|NCT01710904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24752559|NCT01710904|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24752572|NCT01711073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24752576|NCT01711086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658166|NCT01270737|Daidzein|daidzein|mesh-list
24752577|NCT01711086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752579|NCT01711086|Respiratory System Agents|respiratory system agents|mesh-ancestor
24752580|NCT01711086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24752581|NCT01711086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24752582|NCT01711086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24752583|NCT01711086|Adrenergic Agents|adrenergic agents|mesh-ancestor
24752584|NCT01711086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24752585|NCT01711086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752586|NCT01711112|Docetaxel|docetaxel|mesh-list
24752587|NCT01711112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24752588|NCT01711112|Tubulin Modulators|tubulin modulators|mesh-ancestor
24752589|NCT01711112|Antimitotic Agents|antimitotic agents|mesh-ancestor
24752590|NCT01711112|Mitosis Modulators|mitosis modulators|mesh-ancestor
24752591|NCT01711112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752592|NCT01711125|Baclofen|baclofen|mesh-list
24752593|NCT01711125|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24752594|NCT01711125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752595|NCT01711125|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24752596|NCT01711125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24752597|NCT01711125|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24944533|NCT03959865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24944534|NCT03959527|Azithromycin|azithromycin|mesh-list
24944535|NCT03959527|Ceftriaxone|ceftriaxone|mesh-list
24944536|NCT03959527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24944537|NCT03959527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24944538|NCT03959436|Carbetocin|carbetocin|mesh-list
24944539|NCT03959436|Oxytocics|oxytocics|mesh-ancestor
24944540|NCT03959436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24752612|NCT01711320|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24752613|NCT01711320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752614|NCT01711320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752615|NCT01711437|Ascorbic Acid|ascorbic acid|mesh-list
24752616|NCT01711437|Simethicone|simethicone|mesh-list
24752617|NCT01711437|Picosulfate sodium|picosulfate sodium|mesh-list
24752618|NCT01711437|Magnesium Oxide|magnesium oxide|mesh-list
24752619|NCT01711437|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24752620|NCT01711437|Citric Acid|citric acid|mesh-list
24752621|NCT01711437|Sodium Citrate|sodium citrate|mesh-list
24752622|NCT01711437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24752623|NCT01711437|Anticoagulants|anticoagulants|mesh-ancestor
24752624|NCT01711437|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24752625|NCT01711437|Chelating Agents|chelating agents|mesh-ancestor
24752626|NCT01711437|Sequestering Agents|sequestering agents|mesh-ancestor
24542855|NCT00680602|Sertraline|sertraline|mesh-list
24752627|NCT01711437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752628|NCT01711437|Antioxidants|antioxidants|mesh-ancestor
24752629|NCT01711437|Protective Agents|protective agents|mesh-ancestor
24752630|NCT01711437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752631|NCT01711437|Vitamins|vitamins|mesh-ancestor
24752632|NCT01711437|Micronutrients|micronutrients|mesh-ancestor
24752633|NCT01711437|Antifoaming Agents|antifoaming agents|mesh-ancestor
24752634|NCT01711437|Emollients|emollients|mesh-ancestor
24752635|NCT01711437|Dermatologic Agents|dermatologic agents|mesh-ancestor
24752636|NCT01711437|Cathartics|cathartics|mesh-ancestor
24752637|NCT01711437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24752638|NCT01711437|Antacids|antacids|mesh-ancestor
24752639|NCT01711437|Laxatives|laxatives|mesh-ancestor
24752652|NCT01711476|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24752653|NCT01711476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24752654|NCT01711476|Immunologic Factors|immunologic factors|mesh-ancestor
24752655|NCT01711476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944545|NCT03959540|Opicapone|opicapone|mesh-list
24944546|NCT03959540|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24944547|NCT03959540|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24944548|NCT03959540|Dopamine Agents|dopamine agents|mesh-ancestor
24944549|NCT03959540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24944550|NCT03959540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752656|NCT01711489|Mycophenolic Acid|mycophenolic acid|mesh-list
24752657|NCT01711489|Isavuconazole|isavuconazole|mesh-list
24752658|NCT01711489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24752659|NCT01711489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24752660|NCT01711489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24752661|NCT01711489|Antitubercular Agents|antitubercular agents|mesh-ancestor
24752662|NCT01711489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24752663|NCT01711489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24752664|NCT01711489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752665|NCT01711489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752666|NCT01711489|Antifungal Agents|antifungal agents|mesh-ancestor
24752668|NCT01711515|Ipilimumab|ipilimumab|mesh-list
24752669|NCT01711515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24752670|NCT01711515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24752671|NCT01711515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24752672|NCT01711515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752674|NCT01711528|Dexamethasone acetate|dexamethasone acetate|mesh-list
24752675|NCT01711528|Bortezomib|bortezomib|mesh-list
24752676|NCT01711528|Ichthammol|ichthammol|mesh-list
24752677|NCT01711528|BB 1101|bb 1101|mesh-list
24944558|NCT03959501|Incretins|incretins|mesh-ancestor
24944559|NCT03959501|Hormones|hormones|mesh-ancestor
24752703|NCT01711593|Dimercaprol|dimercaprol|mesh-list
24752704|NCT01711593|Chelating Agents|chelating agents|mesh-ancestor
24752705|NCT01711593|Sequestering Agents|sequestering agents|mesh-ancestor
24752706|NCT01711593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752707|NCT01711671|Dexamethasone|dexamethasone|mesh-list
24752708|NCT01711671|Lenalidomide|lenalidomide|mesh-list
24417327|NCT00206193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24752712|NCT01711671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24752713|NCT01711671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752734|NCT01711723|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
24752735|NCT01711723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752736|NCT01711723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752737|NCT01711749|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24752738|NCT01711749|Calcium|calcium|mesh-list
24752739|NCT01711749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24752740|NCT01711749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752741|NCT01711749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24752742|NCT01711749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24752743|NCT01711749|Antimetabolites|antimetabolites|mesh-ancestor
24752744|NCT01711749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752745|NCT01711749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24752746|NCT01711749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24752747|NCT01711749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752748|NCT01711814|Peficitinib|peficitinib|mesh-list
24752749|NCT01711814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752750|NCT01711814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752751|NCT01711814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24752752|NCT01711814|Immunologic Factors|immunologic factors|mesh-ancestor
24944566|NCT03959514|Insulin Aspart|insulin aspart|mesh-list
24944567|NCT03959514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24944568|NCT03959514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944569|NCT03959384|Poractant alfa|poractant alfa|mesh-list
24944570|NCT03959384|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
24857725|NCT02293694|Contraceptive Agents|contraceptive agents|mesh-ancestor
24752753|NCT01711814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752761|NCT01711827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24752762|NCT01711827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24752763|NCT01711827|Antifungal Agents|antifungal agents|mesh-ancestor
24752764|NCT01711827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24752765|NCT01711905|Vitamin D|vitamin d|mesh-list
24752766|NCT01711905|Cholecalciferol|cholecalciferol|mesh-list
24752767|NCT01711905|Vitamins|vitamins|mesh-ancestor
25048838|NCT00662740|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25048839|NCT00662740|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25048840|NCT00662740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25048878|NCT00659061|Micronutrients|micronutrients|mesh-list
24752768|NCT01711905|Micronutrients|micronutrients|mesh-ancestor
24752769|NCT01711905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752770|NCT01711905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24752771|NCT01711905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24752772|NCT01711931|Everolimus|everolimus|mesh-list
24752773|NCT01711931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24752774|NCT01711931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24752775|NCT01711931|Immunologic Factors|immunologic factors|mesh-ancestor
24417368|NCT00206258|Glucagon|glucagon|mesh-list
24447413|NCT00308425|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24447414|NCT00308425|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24447415|NCT00308438|Teduglutide|teduglutide|mesh-list
24447416|NCT00308438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24447417|NCT00308438|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24447418|NCT00308438|Protective Agents|protective agents|mesh-ancestor
24752778|NCT01711957|Hematinics|hematinics|mesh-ancestor
24543001|NCT00681460|Metformin|metformin|mesh-list
24752779|NCT01711970|Paclitaxel|paclitaxel|mesh-list
24752780|NCT01711970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24752781|NCT01711970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24752782|NCT01711970|Tubulin Modulators|tubulin modulators|mesh-ancestor
24752783|NCT01711970|Antimitotic Agents|antimitotic agents|mesh-ancestor
24752784|NCT01711970|Mitosis Modulators|mitosis modulators|mesh-ancestor
24752785|NCT01711970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752786|NCT01712100|Irbesartan|irbesartan|mesh-list
24752787|NCT01712100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24752788|NCT01712100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24752789|NCT01712100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24752790|NCT01712100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752791|NCT01712113|Irbesartan|irbesartan|mesh-list
24752792|NCT01712113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24944571|NCT03959384|Respiratory System Agents|respiratory system agents|mesh-ancestor
24460237|NCT00347815|Analgesics|analgesics|mesh-ancestor
24752793|NCT01712113|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24752794|NCT01712113|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24752795|NCT01712113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752796|NCT01712126|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24752797|NCT01712126|Irbesartan|irbesartan|mesh-list
24417383|NCT00206310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24447419|NCT00308438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447420|NCT00308451|Chromium|chromium|mesh-list
24447421|NCT00308451|Biotin|biotin|mesh-list
24598834|NCT00958451|Vitamin D|vitamin d|mesh-list
24665149|NCT01310452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24935434|NCT04050488|Zinc Sulfate|zinc sulfate|mesh-list
24752803|NCT01712126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24752804|NCT01712126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752805|NCT01712126|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24752806|NCT01712126|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24752809|NCT01712139|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24752810|NCT01712139|Diuretics|diuretics|mesh-ancestor
24752811|NCT01712139|Natriuretic Agents|natriuretic agents|mesh-ancestor
24752812|NCT01712139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752813|NCT01712139|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24752814|NCT01712139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24752815|NCT01712139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752838|NCT01712321|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24752839|NCT01712321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24752841|NCT01712321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752842|NCT01712321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24752843|NCT01712321|Serotonin Agents|serotonin agents|mesh-ancestor
24752844|NCT01712321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417413|NCT00206453|Docetaxel|docetaxel|mesh-list
24417439|NCT00206492|Tamoxifen|tamoxifen|mesh-list
24449467|NCT00315744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24938348|NCT04019782|Hylan|hylan|mesh-list
24752867|NCT01712477|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24752868|NCT01712477|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24752869|NCT01712477|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24752870|NCT01712477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24752871|NCT01712477|GABA Modulators|gaba modulators|mesh-ancestor
24752872|NCT01712477|GABA Agents|gaba agents|mesh-ancestor
24752873|NCT01712477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24752874|NCT01712477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752875|NCT01712568|Ropinirole|ropinirole|mesh-list
24752876|NCT01712568|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24752877|NCT01712568|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24752878|NCT01712568|Dopamine Agonists|dopamine agonists|mesh-ancestor
24752902|NCT01712828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24752903|NCT01712828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24752904|NCT01712828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24752905|NCT01712828|Antifungal Agents|antifungal agents|mesh-ancestor
24752906|NCT01712828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24752907|NCT01712828|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24752908|NCT01712828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24752909|NCT01712828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24752910|NCT01712828|Anesthetics, Local|anesthetics, local|mesh-ancestor
24752911|NCT01712828|Anesthetics|anesthetics|mesh-ancestor
24944580|NCT03959397|Tubulin Modulators|tubulin modulators|mesh-ancestor
24944581|NCT03959397|Antimitotic Agents|antimitotic agents|mesh-ancestor
24944582|NCT03959397|Mitosis Modulators|mitosis modulators|mesh-ancestor
24944583|NCT03959397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543133|NCT00681993|Alkylating Agents|alkylating agents|mesh-ancestor
24752925|NCT01712828|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24752926|NCT01712828|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24752927|NCT01712828|Adrenergic Agents|adrenergic agents|mesh-ancestor
24752928|NCT01712828|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24752929|NCT01712828|Antimalarials|antimalarials|mesh-ancestor
24752930|NCT01712828|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24752931|NCT01712828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24752932|NCT01712828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417489|NCT00206622|Levonorgestrel|levonorgestrel|mesh-list
25696471|NCT02062359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25696472|NCT02062359|Immunologic Factors|immunologic factors|mesh-ancestor
24452624|NCT05457959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24452625|NCT05457959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24752935|NCT01712828|Cholinergic Agents|cholinergic agents|mesh-ancestor
24752936|NCT01712828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24752937|NCT01712828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24752938|NCT01712828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24752939|NCT01712828|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24752940|NCT01712828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24752942|NCT01712893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24752943|NCT01712893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24752944|NCT01712919|Paclitaxel|paclitaxel|mesh-list
24752945|NCT01712919|Cetuximab|cetuximab|mesh-list
24752946|NCT01712919|Nedaplatin|nedaplatin|mesh-list
24752947|NCT01712919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24752948|NCT01712919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24752949|NCT01712919|Tubulin Modulators|tubulin modulators|mesh-ancestor
24752950|NCT01712919|Antimitotic Agents|antimitotic agents|mesh-ancestor
24752951|NCT01712919|Mitosis Modulators|mitosis modulators|mesh-ancestor
24752952|NCT01712919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752953|NCT01712919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24752954|NCT01712945|Alemtuzumab|alemtuzumab|mesh-list
24752955|NCT01712945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24752956|NCT01712945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24752957|NCT01712997|Bosentan|bosentan|mesh-list
24658563|NCT01272557|Sorafenib|sorafenib|mesh-list
24752959|NCT01712997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24752960|NCT01712997|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24417512|NCT00206648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24944584|NCT03959176|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24944585|NCT03959176|Phenylephrine|phenylephrine|mesh-list
24944586|NCT03959176|Oxymetazoline|oxymetazoline|mesh-list
24944587|NCT03959176|Tropicamide|tropicamide|mesh-list
24944588|NCT03959176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24769723|NCT01815437|Vitamin D|vitamin d|mesh-list
24944589|NCT03959176|Mydriatics|mydriatics|mesh-ancestor
24752961|NCT01712997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752963|NCT01712997|Vasodilator Agents|vasodilator agents|mesh-ancestor
24752964|NCT01713049|Alovudine|alovudine|mesh-list
24752969|NCT01713101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
24752970|NCT01713101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24752971|NCT01713101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752972|NCT01713101|Hemostatics|hemostatics|mesh-ancestor
24752973|NCT01713101|Coagulants|coagulants|mesh-ancestor
24752974|NCT01713101|Antidepressive Agents|antidepressive agents|mesh-ancestor
24752975|NCT01713101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24752976|NCT01713101|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24752977|NCT01713101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752989|NCT01713127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24752991|NCT01713153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24752992|NCT01713153|Abortifacient Agents|abortifacient agents|mesh-ancestor
24752993|NCT01713153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24752994|NCT01713153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543187|NCT00682292|Thymoglobulin|thymoglobulin|mesh-list
24752995|NCT01713153|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24752996|NCT01713153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24752997|NCT01713153|Oxytocics|oxytocics|mesh-ancestor
24752998|NCT01713166|Plasma-lyte 148|plasma-lyte 148|mesh-list
24752999|NCT01713166|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24753000|NCT01713166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24753001|NCT01713179|Ambroxol|ambroxol|mesh-list
24753002|NCT01713179|Expectorants|expectorants|mesh-ancestor
24753003|NCT01713179|Respiratory System Agents|respiratory system agents|mesh-ancestor
24753004|NCT01713218|Gemcitabine|gemcitabine|mesh-list
24753005|NCT01713218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24753006|NCT01713218|Antimetabolites|antimetabolites|mesh-ancestor
25696473|NCT02062359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696474|NCT02062359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25696475|NCT02062359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24753007|NCT01713218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753008|NCT01713218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24753009|NCT01713218|Antiviral Agents|antiviral agents|mesh-ancestor
24753010|NCT01713218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24753011|NCT01713218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753012|NCT01713218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24753013|NCT01713218|Immunologic Factors|immunologic factors|mesh-ancestor
24753014|NCT01713218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753015|NCT01713231|Vitamin D|vitamin d|mesh-list
24753021|NCT01713231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24753022|NCT01713231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24753023|NCT01713309|Lenograstim|lenograstim|mesh-list
24753024|NCT01713309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24753025|NCT01713309|Immunologic Factors|immunologic factors|mesh-ancestor
24753026|NCT01713309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753027|NCT01713361|Enoxaparin|enoxaparin|mesh-list
24417576|NCT00206778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24753031|NCT01713361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753033|NCT01713387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24753034|NCT01713387|Antimetabolites|antimetabolites|mesh-ancestor
24658632|NCT01273298|Adrenergic Agents|adrenergic agents|mesh-ancestor
24753035|NCT01713387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753036|NCT01713387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24753037|NCT01713387|Antiviral Agents|antiviral agents|mesh-ancestor
24753038|NCT01713387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24753039|NCT01713387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753041|NCT01713387|Immunologic Factors|immunologic factors|mesh-ancestor
24753042|NCT01713387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543274|NCT00682955|Zinc|zinc|mesh-list
24753043|NCT01713426|Pregabalin|pregabalin|mesh-list
24753044|NCT01713426|Capsaicin|capsaicin|mesh-list
24753045|NCT01713426|Analgesics|analgesics|mesh-ancestor
24619227|NCT01051479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619228|NCT01051479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24619229|NCT01051479|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24619230|NCT01051479|Nootropic Agents|nootropic agents|mesh-ancestor
24619231|NCT01051531|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24619232|NCT01051531|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24619233|NCT01051531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24619234|NCT01051531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24619235|NCT01051531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619236|NCT01051531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24619237|NCT01051531|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24619238|NCT01051531|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24619239|NCT01051531|Serotonin Agents|serotonin agents|mesh-ancestor
24619240|NCT01051531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24615213|NCT01028443|Cyclosporine|cyclosporine|mesh-list
24665407|NCT01312298|Propofol|propofol|mesh-list
24665408|NCT01312298|Succinylcholine|succinylcholine|mesh-list
24665409|NCT01312298|Anesthetics, Local|anesthetics, local|mesh-ancestor
24665424|NCT01312311|Mitosis Modulators|mitosis modulators|mesh-ancestor
24600011|NCT02879409|Pioglitazone|pioglitazone|mesh-list
24417641|NCT00206986|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24753213|NCT01714154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24619241|NCT01051531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619242|NCT01051531|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24619243|NCT01051531|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24619266|NCT01051648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619267|NCT01051648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24619268|NCT01051648|Immunologic Factors|immunologic factors|mesh-ancestor
24619269|NCT01051648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24619270|NCT01051648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619271|NCT01051687|Botulinum Toxins|botulinum toxins|mesh-list
24619272|NCT01051687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24619273|NCT01051687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24619274|NCT01051687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24619275|NCT01051687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24619276|NCT01051687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619277|NCT01051687|Cholinergic Agents|cholinergic agents|mesh-ancestor
24619278|NCT01051687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24619279|NCT01051687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619280|NCT01051687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24619281|NCT01051687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24619283|NCT01051765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24619284|NCT01051765|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24619285|NCT01051765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24658709|NCT01273571|Metformin|metformin|mesh-list
24619295|NCT01051934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24753056|NCT01713426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24753058|NCT01713426|Antipruritics|antipruritics|mesh-ancestor
24753059|NCT01713426|Dermatologic Agents|dermatologic agents|mesh-ancestor
24753060|NCT01713556|Propranolol|propranolol|mesh-list
24753061|NCT01713556|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24753062|NCT01713556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24753063|NCT01713556|Adrenergic Agents|adrenergic agents|mesh-ancestor
24753064|NCT01713556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24753065|NCT01713556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753066|NCT01713556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753067|NCT01713556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24753068|NCT01713556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24753069|NCT01713556|Vasodilator Agents|vasodilator agents|mesh-ancestor
24753070|NCT01713647|Losartan|losartan|mesh-list
24753071|NCT01713647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24753072|NCT01713647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24753075|NCT01713647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753076|NCT01713725|Omalizumab|omalizumab|mesh-list
24753077|NCT01713725|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24769802|NCT01816334|Prednisolone phosphate|prednisolone phosphate|mesh-list
25696476|NCT02062359|Alkylating Agents|alkylating agents|mesh-ancestor
25696477|NCT02062359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696478|NCT02062359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25696479|NCT02062359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25696480|NCT02062359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25696481|NCT02062359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25696482|NCT02062359|Antiviral Agents|antiviral agents|mesh-ancestor
25696483|NCT02062359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25696484|NCT02062632|Doxepin|doxepin|mesh-list
25696485|NCT02062632|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24753079|NCT01713725|Respiratory System Agents|respiratory system agents|mesh-ancestor
24753080|NCT01713738|Rituximab|rituximab|mesh-list
24417703|NCT00207363|Interferons|interferons|mesh-list
24938734|NCT04016246|Propofol|propofol|mesh-list
24753081|NCT01713738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24753082|NCT01713738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24753085|NCT01713738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24753086|NCT01713777|Lamotrigine|lamotrigine|mesh-list
24753087|NCT01713777|Anticonvulsants|anticonvulsants|mesh-list
24753088|NCT01713777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24753089|NCT01713777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24753097|NCT01713777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24753099|NCT01713803|Naloxone|naloxone|mesh-list
24753100|NCT01713803|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24753101|NCT01713803|Narcotics|narcotics|mesh-ancestor
24753102|NCT01713803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24753103|NCT01713803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753104|NCT01713803|Analgesics|analgesics|mesh-ancestor
24753105|NCT01713803|Sensory System Agents|sensory system agents|mesh-ancestor
24753106|NCT01713803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24753107|NCT01713803|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24753109|NCT01713920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24753110|NCT01713920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24753111|NCT01713920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24753112|NCT01713920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753113|NCT01713920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24753114|NCT01713920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753115|NCT01713920|Vasodilator Agents|vasodilator agents|mesh-ancestor
24753116|NCT01713972|Dabrafenib|dabrafenib|mesh-list
24753117|NCT01713972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24753118|NCT01713972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24753119|NCT01713972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753120|NCT01713972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753137|NCT01714011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24753138|NCT01714011|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24753139|NCT01714011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24753140|NCT01714037|Gemcitabine|gemcitabine|mesh-list
24753141|NCT01714037|Docetaxel|docetaxel|mesh-list
24753142|NCT01714037|Pemetrexed|pemetrexed|mesh-list
24753143|NCT01714037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24753144|NCT01714037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24753145|NCT01714037|Antimetabolites|antimetabolites|mesh-ancestor
24753146|NCT01714037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753147|NCT01714037|Antiviral Agents|antiviral agents|mesh-ancestor
24753148|NCT01714037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24753149|NCT01714037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753150|NCT01714037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24417770|NCT00207688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24417772|NCT00207701|Infliximab|infliximab|mesh-list
24753151|NCT01714037|Immunologic Factors|immunologic factors|mesh-ancestor
24753158|NCT01714089|Interferons|interferons|mesh-list
24600717|NCT00960284|Capecitabine|capecitabine|mesh-list
24753159|NCT01714089|Interferon-beta|interferon-beta|mesh-list
24753160|NCT01714089|Interferon beta-1a|interferon beta-1a|mesh-list
24753200|NCT01714128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24753201|NCT01714128|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24753202|NCT01714154|Ritonavir|ritonavir|mesh-list
24753203|NCT01714154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24753204|NCT01714154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24753205|NCT01714154|Protease Inhibitors|protease inhibitors|mesh-ancestor
24753206|NCT01714154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753207|NCT01714154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753208|NCT01714154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24753209|NCT01714154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24753210|NCT01714154|Antiviral Agents|antiviral agents|mesh-ancestor
24753211|NCT01714154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24753212|NCT01714154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24753214|NCT01714193|Canagliflozin|canagliflozin|mesh-list
24753215|NCT01714193|Contraceptive Agents|contraceptive agents|mesh-list
24753216|NCT01714193|Contraceptives, Oral|contraceptives, oral|mesh-list
24944602|NCT03959176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944603|NCT03959176|Protective Agents|protective agents|mesh-ancestor
24944604|NCT03959176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24769801|NCT01816334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24753252|NCT01714401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048988|NCT00650702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24753253|NCT01714401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24753257|NCT01714401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24417878|NCT00208143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24753258|NCT01714401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24753259|NCT01714401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24753260|NCT01714401|Adrenergic Agents|adrenergic agents|mesh-ancestor
24753261|NCT01714401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24753262|NCT01714401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753263|NCT01714414|Lamivudine|lamivudine|mesh-list
24753264|NCT01714414|Zidovudine|zidovudine|mesh-list
24753265|NCT01714414|Efavirenz|efavirenz|mesh-list
24753266|NCT01714414|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24753267|NCT01714414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24753268|NCT01714414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753269|NCT01714414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753270|NCT01714414|Antiviral Agents|antiviral agents|mesh-ancestor
24753271|NCT01714414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24753272|NCT01714414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24753273|NCT01714414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24769807|NCT01816334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769808|NCT01816334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24769809|NCT01816334|Glucocorticoids|glucocorticoids|mesh-ancestor
24753274|NCT01714414|Antimetabolites|antimetabolites|mesh-ancestor
24753275|NCT01714414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24753276|NCT01714414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24753277|NCT01714414|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24753278|NCT01714414|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24753279|NCT01714414|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24753280|NCT01714414|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24753281|NCT01714427|Dexamethasone|dexamethasone|mesh-list
24753311|NCT01714596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24753312|NCT01714648|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24753313|NCT01714648|Luteolytic Agents|luteolytic agents|mesh-ancestor
24753314|NCT01714648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24753315|NCT01714648|Contraceptive Agents|contraceptive agents|mesh-ancestor
24753316|NCT01714648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24753317|NCT01714648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006185|NCT05204173|Paclitaxel|paclitaxel|mesh-list
25696486|NCT02062632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25696487|NCT02062632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25696488|NCT02062632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753318|NCT01714648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24753319|NCT01714648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24753320|NCT01714648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24753322|NCT01714765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24753323|NCT01714765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24753324|NCT01714765|Immunologic Factors|immunologic factors|mesh-ancestor
24753325|NCT01714765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753326|NCT01714817|Mycophenolic Acid|mycophenolic acid|mesh-list
24753327|NCT01714817|Prednisone|prednisone|mesh-list
24753328|NCT01714817|Abatacept|abatacept|mesh-list
24753329|NCT01714817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24753330|NCT01714817|Glucocorticoids|glucocorticoids|mesh-ancestor
24753331|NCT01714817|Hormones|hormones|mesh-ancestor
24753332|NCT01714817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24753333|NCT01714817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753334|NCT01714817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24753335|NCT01714817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24753336|NCT01714817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24753337|NCT01714817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24601370|NCT00964106|Caffeine|caffeine|mesh-list
24753338|NCT01714817|Antitubercular Agents|antitubercular agents|mesh-ancestor
24753339|NCT01714817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24659137|NCT01275885|Vitamin D|vitamin d|mesh-list
24417955|NCT00208221|Ramipril|ramipril|mesh-list
24753340|NCT01714817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24644671|NCT01192490|Anesthetics, Local|anesthetics, local|mesh-ancestor
24644672|NCT01192490|Anesthetics|anesthetics|mesh-ancestor
24644686|NCT01192503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24644693|NCT01192529|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24644694|NCT01192529|Sympathomimetics|sympathomimetics|mesh-ancestor
24753341|NCT01714817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753342|NCT01714817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753343|NCT01714817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24753344|NCT01714817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24753345|NCT01714817|Immunologic Factors|immunologic factors|mesh-ancestor
24753346|NCT01714817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24753347|NCT01714843|Linaclotide|linaclotide|mesh-list
24753348|NCT01714843|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
24753349|NCT01714843|Enzyme Activators|enzyme activators|mesh-ancestor
24753350|NCT01714843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753354|NCT01714856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24753355|NCT01714856|Dopamine Agonists|dopamine agonists|mesh-ancestor
24753356|NCT01714856|Dopamine Agents|dopamine agents|mesh-ancestor
24659182|NCT01276067|Donepezil|donepezil|mesh-list
24753357|NCT01714856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24753358|NCT01714856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753359|NCT01714856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753360|NCT01714895|Insulin|insulin|mesh-list
24753361|NCT01714895|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24753362|NCT01714895|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24753363|NCT01714895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753364|NCT01714908|Etoposide|etoposide|mesh-list
24753365|NCT01714908|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24753366|NCT01714908|Cisplatin|cisplatin|mesh-list
24769810|NCT01816334|Hormones|hormones|mesh-ancestor
24769811|NCT01816334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24769812|NCT01816334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24769813|NCT01816334|Protective Agents|protective agents|mesh-ancestor
24769814|NCT01816334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24769815|NCT01816334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24944613|NCT03959150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24944614|NCT03958942|Bupivacaine|bupivacaine|mesh-list
24944615|NCT03958942|Anesthetics, Local|anesthetics, local|mesh-ancestor
24944616|NCT03958942|Anesthetics|anesthetics|mesh-ancestor
24753367|NCT01714908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24753368|NCT01714908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25696489|NCT02062632|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25696490|NCT02062632|Antidepressive Agents|antidepressive agents|mesh-ancestor
25696491|NCT02062632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25696492|NCT02062632|Histamine Antagonists|histamine antagonists|mesh-ancestor
25696493|NCT02062632|Histamine Agents|histamine agents|mesh-ancestor
25696494|NCT02062632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24753379|NCT01715077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24753381|NCT01715090|Insulin|insulin|mesh-list
24753389|NCT01715142|Tubulin Modulators|tubulin modulators|mesh-ancestor
24753390|NCT01715142|Antimitotic Agents|antimitotic agents|mesh-ancestor
24753391|NCT01715142|Mitosis Modulators|mitosis modulators|mesh-ancestor
24753392|NCT01715142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418015|NCT00208312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418016|NCT00208312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24418017|NCT00208312|Vasodilator Agents|vasodilator agents|mesh-ancestor
24418018|NCT00208312|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24853193|NCT02266511|Tamsulosin|tamsulosin|mesh-list
24753393|NCT01715142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24753394|NCT01715142|Antimetabolites|antimetabolites|mesh-ancestor
24753395|NCT01715142|Antiviral Agents|antiviral agents|mesh-ancestor
24753396|NCT01715142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24753397|NCT01715142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051289|NCT00424697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25051290|NCT00424697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051291|NCT00424697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25051292|NCT00424697|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25051293|NCT00424697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25051294|NCT00424697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25051295|NCT00424697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25051296|NCT00424697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24753398|NCT01715142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24753399|NCT01715142|Immunologic Factors|immunologic factors|mesh-ancestor
24753406|NCT01715168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24753407|NCT01715168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753408|NCT01715168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753409|NCT01715220|Nitroglycerin|nitroglycerin|mesh-list
24753410|NCT01715220|Vasodilator Agents|vasodilator agents|mesh-ancestor
24418032|NCT00208442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418033|NCT00208442|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24602283|NCT00967967|Desloratadine|desloratadine|mesh-list
24753411|NCT01715259|Abiraterone Acetate|abiraterone acetate|mesh-list
24753412|NCT01715259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24753413|NCT01715259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24753414|NCT01715259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753415|NCT01715259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753416|NCT01715259|Hormone Antagonists|hormone antagonists|mesh-ancestor
24753417|NCT01715259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24753421|NCT01715311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24753422|NCT01715311|Autonomic Agents|autonomic agents|mesh-ancestor
24753423|NCT01715311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24753424|NCT01715311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753425|NCT01715311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24753426|NCT01715311|Respiratory System Agents|respiratory system agents|mesh-ancestor
24753427|NCT01715311|Parasympatholytics|parasympatholytics|mesh-ancestor
24753428|NCT01715311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24944617|NCT03958942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24944618|NCT03958942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944619|NCT03958942|Sensory System Agents|sensory system agents|mesh-ancestor
24753429|NCT01715311|Cholinergic Agents|cholinergic agents|mesh-ancestor
24753430|NCT01715311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24753431|NCT01715311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753434|NCT01715363|Oxaliplatin|oxaliplatin|mesh-list
24753435|NCT01715363|Levoleucovorin|levoleucovorin|mesh-list
24753436|NCT01715363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24753438|NCT01715363|Protective Agents|protective agents|mesh-ancestor
24753439|NCT01715363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619307|NCT01051947|Nebivolol|nebivolol|mesh-list
24619308|NCT01051947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24619309|NCT01051947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24619310|NCT01051947|Sympatholytics|sympatholytics|mesh-ancestor
24619311|NCT01051947|Autonomic Agents|autonomic agents|mesh-ancestor
24619312|NCT01051947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24619313|NCT01051947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619314|NCT01051947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24619315|NCT01051947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24619316|NCT01051947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24619317|NCT01051947|Adrenergic Agents|adrenergic agents|mesh-ancestor
24619318|NCT01051947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24619319|NCT01051947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619320|NCT01051947|Vasodilator Agents|vasodilator agents|mesh-ancestor
24619321|NCT01051947|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24753456|NCT01715519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24753488|NCT01715610|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24753489|NCT01715610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24753490|NCT01715610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24753491|NCT01715610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24753492|NCT01715610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753493|NCT01715610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753494|NCT01715610|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24753496|NCT01715636|Emtricitabine|emtricitabine|mesh-list
24753497|NCT01715636|Rilpivirine|rilpivirine|mesh-list
24753498|NCT01715636|Antiviral Agents|antiviral agents|mesh-ancestor
24753499|NCT01715636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24753500|NCT01715636|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24753506|NCT01715688|Lidocaine|lidocaine|mesh-list
24753507|NCT01715688|Anesthetics, Local|anesthetics, local|mesh-ancestor
24753508|NCT01715688|Anesthetics|anesthetics|mesh-ancestor
24753509|NCT01715688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24753510|NCT01715688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753511|NCT01715688|Sensory System Agents|sensory system agents|mesh-ancestor
24753512|NCT01715688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24753513|NCT01715688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24753514|NCT01715688|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24753515|NCT01715688|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24753516|NCT01715688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24753517|NCT01715688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753536|NCT01715909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24753537|NCT01715909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753538|NCT01715909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753539|NCT01715922|Fluconazole|fluconazole|mesh-list
24753540|NCT01715922|Flucytosine|flucytosine|mesh-list
24753541|NCT01715922|Antifungal Agents|antifungal agents|mesh-ancestor
24753542|NCT01715922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24753543|NCT01715922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24753544|NCT01715922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24753552|NCT01715922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24753570|NCT01715987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753572|NCT01715987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24753594|NCT01716377|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24753595|NCT01716377|Antidepressive Agents|antidepressive agents|mesh-ancestor
24753596|NCT01716377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24753597|NCT01716416|Cetuximab|cetuximab|mesh-list
24753598|NCT01716416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24753599|NCT01716416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24753600|NCT01716442|Rituximab|rituximab|mesh-list
24753601|NCT01716442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24753602|NCT01716442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24753603|NCT01716442|Immunologic Factors|immunologic factors|mesh-ancestor
24944650|NCT03958344|Methylprednisolone|methylprednisolone|mesh-list
24944651|NCT03958344|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24944652|NCT03958344|Prednisolone acetate|prednisolone acetate|mesh-list
24944653|NCT03958344|Triamcinolone|triamcinolone|mesh-list
24753604|NCT01716442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753605|NCT01716442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24753606|NCT01716572|Erythromycin|erythromycin|mesh-list
24753607|NCT01716572|Erythromycin Estolate|erythromycin estolate|mesh-list
24753608|NCT01716572|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24753609|NCT01716572|Erythromycin stearate|erythromycin stearate|mesh-list
24753610|NCT01716572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24753611|NCT01716572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24753612|NCT01716572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24418244|NCT00209079|Imatinib Mesylate|imatinib mesylate|mesh-list
24753613|NCT01716572|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24753614|NCT01716572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753615|NCT01716572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753617|NCT01716611|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24753618|NCT01716611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753619|NCT01716611|Natriuretic Agents|natriuretic agents|mesh-ancestor
24753620|NCT01716611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753621|NCT01716624|Oxybutynin|oxybutynin|mesh-list
24753622|NCT01716624|Botulinum Toxins|botulinum toxins|mesh-list
24753623|NCT01716624|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24753624|NCT01716624|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24753626|NCT01716624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24753627|NCT01716624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753628|NCT01716624|Cholinergic Agents|cholinergic agents|mesh-ancestor
24753629|NCT01716624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24753630|NCT01716624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753631|NCT01716624|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24753632|NCT01716624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24753633|NCT01716624|Parasympatholytics|parasympatholytics|mesh-ancestor
24753634|NCT01716624|Autonomic Agents|autonomic agents|mesh-ancestor
24753635|NCT01716624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24753636|NCT01716624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24753637|NCT01716624|Urological Agents|urological agents|mesh-ancestor
24753638|NCT01716637|Etanercept|etanercept|mesh-list
24753639|NCT01716637|Curcumin|curcumin|mesh-list
24753640|NCT01716637|Resveratrol|resveratrol|mesh-list
24753641|NCT01716637|Quercetin|quercetin|mesh-list
24753642|NCT01716637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24753643|NCT01716637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24753644|NCT01716637|Analgesics|analgesics|mesh-ancestor
24753668|NCT01716689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24753669|NCT01716767|Analgesics|analgesics|mesh-list
24753670|NCT01716767|Menthol|menthol|mesh-list
24753671|NCT01716767|Sensory System Agents|sensory system agents|mesh-ancestor
24753680|NCT01716858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543968|NCT00686179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24753681|NCT01716949|Fluorouracil|fluorouracil|mesh-list
24753682|NCT01716949|Capecitabine|capecitabine|mesh-list
24753683|NCT01716949|Oxaliplatin|oxaliplatin|mesh-list
24753684|NCT01716949|Antimetabolites|antimetabolites|mesh-ancestor
24753685|NCT01716949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753686|NCT01716949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24753687|NCT01716949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24753688|NCT01716949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24753689|NCT01716949|Immunologic Factors|immunologic factors|mesh-ancestor
24753690|NCT01716949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753691|NCT01717027|Oxycodone|oxycodone|mesh-list
24753692|NCT01717027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24753693|NCT01717027|Narcotics|narcotics|mesh-ancestor
24753694|NCT01717027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24753695|NCT01717027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753696|NCT01717027|Analgesics|analgesics|mesh-ancestor
24753697|NCT01717027|Sensory System Agents|sensory system agents|mesh-ancestor
24753698|NCT01717027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24753699|NCT01717066|Ginsenoside Rg3|ginsenoside rg3|mesh-list
24753700|NCT01717066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24753720|NCT01717222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24753721|NCT01717222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753723|NCT01717222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24753724|NCT01717222|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24753725|NCT01717222|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24753726|NCT01717222|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24753727|NCT01717222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24753728|NCT01717222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753730|NCT01717235|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24753731|NCT01717235|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24753732|NCT01717235|Dopamine Agonists|dopamine agonists|mesh-ancestor
24753733|NCT01717235|Dopamine Agents|dopamine agents|mesh-ancestor
24753734|NCT01717235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24447555|NCT00308945|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24447558|NCT00308971|Vitamin E|vitamin e|mesh-list
24753736|NCT01717235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753737|NCT01717300|Oxazolidinones|oxazolidinones|mesh-list
24753738|NCT01717300|Anacetrapib|anacetrapib|mesh-list
24753739|NCT01717300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24753740|NCT01717300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24753741|NCT01717300|Antimetabolites|antimetabolites|mesh-ancestor
24753742|NCT01717300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753743|NCT01717300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24753744|NCT01717300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24659579|NCT01278576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24753745|NCT01717300|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24753746|NCT01717300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753748|NCT01717404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24753749|NCT01717404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24753750|NCT01717404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24753751|NCT01717404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24753752|NCT01717404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619322|NCT01051947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24619323|NCT01051947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24753754|NCT01717599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24753755|NCT01717599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24753769|NCT01717625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24753770|NCT01717625|Respiratory System Agents|respiratory system agents|mesh-ancestor
24753771|NCT01717625|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24753772|NCT01717625|Hormone Antagonists|hormone antagonists|mesh-ancestor
24944661|NCT03958344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24944662|NCT03958344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24944663|NCT03958344|Antiemetics|antiemetics|mesh-ancestor
24944664|NCT03958344|Autonomic Agents|autonomic agents|mesh-ancestor
24944665|NCT03958344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24753773|NCT01717625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24619324|NCT01052025|Curcumin|curcumin|mesh-list
24619325|NCT01052025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24659612|NCT01278849|Vadimezan|vadimezan|mesh-list
24619327|NCT01052025|Analgesics|analgesics|mesh-ancestor
24619328|NCT01052025|Sensory System Agents|sensory system agents|mesh-ancestor
24619329|NCT01052025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24619330|NCT01052025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935716|NCT04047706|Nivolumab|nivolumab|mesh-list
24753774|NCT01717625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753775|NCT01717625|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24619331|NCT01052025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24619332|NCT01052025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24619333|NCT01052025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24619334|NCT01052025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24619335|NCT01052025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619336|NCT01052051|Vitamin D|vitamin d|mesh-list
24753776|NCT01717625|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24753777|NCT01717625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619337|NCT01052051|Cholecalciferol|cholecalciferol|mesh-list
24619338|NCT01052051|Calcium Carbonate|calcium carbonate|mesh-list
24619339|NCT01052051|Calcium|calcium|mesh-list
24619340|NCT01052051|Vitamins|vitamins|mesh-ancestor
24619341|NCT01052051|Micronutrients|micronutrients|mesh-ancestor
24619342|NCT01052051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418423|NCT00209612|Paclitaxel|paclitaxel|mesh-list
24603621|NCT00974792|Cytarabine|cytarabine|mesh-list
24753843|NCT01718093|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24447602|NCT00309192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418444|NCT00209625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24753778|NCT01717690|Chlorhexidine|chlorhexidine|mesh-list
24619343|NCT01052051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24753779|NCT01717690|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24753780|NCT01717690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
24619372|NCT01052246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24619373|NCT01052246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24619374|NCT01052246|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24619375|NCT01052246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24619376|NCT01052246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619377|NCT01052246|Dermatologic Agents|dermatologic agents|mesh-ancestor
24619379|NCT01052259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24619380|NCT01052259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24619381|NCT01052259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24619382|NCT01052259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619383|NCT01052259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24619384|NCT01052259|Immunologic Factors|immunologic factors|mesh-ancestor
24418445|NCT00209625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24418450|NCT00209625|Vitamins|vitamins|mesh-ancestor
24418469|NCT00209664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24619385|NCT01052259|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24619386|NCT01052259|Protective Agents|protective agents|mesh-ancestor
24619388|NCT01052298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24753782|NCT01717690|Disinfectants|disinfectants|mesh-ancestor
24753783|NCT01717690|Dermatologic Agents|dermatologic agents|mesh-ancestor
24753784|NCT01717729|Iodine|iodine|mesh-list
24753785|NCT01717729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24753786|NCT01717729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24753787|NCT01717729|Trace Elements|trace elements|mesh-ancestor
24753788|NCT01717729|Micronutrients|micronutrients|mesh-ancestor
24753789|NCT01717729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696495|NCT02062632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696496|NCT02062645|Amlodipine|amlodipine|mesh-list
25696497|NCT02062645|Valsartan|valsartan|mesh-list
25696498|NCT02062645|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
25696499|NCT02062645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25696500|NCT02062645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25696501|NCT02062645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24666061|NCT01316952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24753790|NCT01717807|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24753791|NCT01717807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24753792|NCT01717807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24753793|NCT01717807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753794|NCT01717807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753796|NCT01717846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24753797|NCT01717846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753798|NCT01717846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24754058|NCT01718899|Immunologic Factors|immunologic factors|mesh-ancestor
24753829|NCT01717963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753831|NCT01717963|Sensory System Agents|sensory system agents|mesh-ancestor
24753832|NCT01717963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24753833|NCT01717963|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24753834|NCT01717963|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24753836|NCT01718054|Amebicides|amebicides|mesh-ancestor
24753837|NCT01718054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24753838|NCT01718054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24753839|NCT01718054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24753840|NCT01718054|Antimalarials|antimalarials|mesh-ancestor
24753841|NCT01718054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24753842|NCT01718093|Metformin|metformin|mesh-list
24753847|NCT01718093|Hormones|hormones|mesh-ancestor
24753848|NCT01718093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24753849|NCT01718093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24753850|NCT01718093|Protease Inhibitors|protease inhibitors|mesh-ancestor
24944676|NCT03958201|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24944677|NCT03958201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24944678|NCT03958201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944679|NCT03958201|Cholinergic Agents|cholinergic agents|mesh-ancestor
24944680|NCT03958201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24944681|NCT03958201|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24944682|NCT03958201|Autonomic Agents|autonomic agents|mesh-ancestor
24944683|NCT03958123|Moxifloxacin|moxifloxacin|mesh-list
24434573|NCT00262808|Antidotes|antidotes|mesh-ancestor
24538917|NCT00661180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753851|NCT01718093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753852|NCT01718093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753853|NCT01718223|Temoporfin|temoporfin|mesh-list
24753854|NCT01718223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24753855|NCT01718223|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24753860|NCT01718236|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24753867|NCT01718236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753868|NCT01718236|Cholinergic Agents|cholinergic agents|mesh-ancestor
24753869|NCT01718236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24753870|NCT01718236|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24753871|NCT01718236|Autonomic Agents|autonomic agents|mesh-ancestor
24753872|NCT01718236|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
24753873|NCT01718288|Aspirin|aspirin|mesh-list
24753874|NCT01718288|Iloprost|iloprost|mesh-list
24753875|NCT01718288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24753876|NCT01718288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24753877|NCT01718288|Analgesics|analgesics|mesh-ancestor
24753878|NCT01718288|Sensory System Agents|sensory system agents|mesh-ancestor
24753879|NCT01718288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24753880|NCT01718288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753881|NCT01718288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24753882|NCT01718288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24753883|NCT01718288|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24753884|NCT01718288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24753885|NCT01718288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753886|NCT01718288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24418556|NCT00209781|Sulfadoxine|sulfadoxine|mesh-list
24418557|NCT00209781|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24418566|NCT00209781|Renal Agents|renal agents|mesh-ancestor
24449820|NCT00317135|Vaccines|vaccines|mesh-list
25696502|NCT02062645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696503|NCT02062645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25696504|NCT02062645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696505|NCT02062645|Vasodilator Agents|vasodilator agents|mesh-ancestor
24753899|NCT01718314|Misoprostol|misoprostol|mesh-list
24753900|NCT01718314|Anesthetics, Local|anesthetics, local|mesh-ancestor
24753901|NCT01718314|Anesthetics|anesthetics|mesh-ancestor
24753902|NCT01718314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24753903|NCT01718314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753904|NCT01718314|Sensory System Agents|sensory system agents|mesh-ancestor
24753905|NCT01718314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24753906|NCT01718314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24857817|NCT02294162|Anesthetics, General|anesthetics, general|mesh-ancestor
24753907|NCT01718314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24753908|NCT01718314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24753910|NCT01718314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109756|NCT03122002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25109761|NCT03122002|Antipyretics|antipyretics|mesh-ancestor
24544186|NCT00687661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24753913|NCT01718314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24753914|NCT01718314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24753915|NCT01718314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24753916|NCT01718314|Oxytocics|oxytocics|mesh-ancestor
24753917|NCT01718327|Sunitinib|sunitinib|mesh-list
24753918|NCT01718327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24753919|NCT01718327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24418586|NCT00209807|Serotonin Agents|serotonin agents|mesh-ancestor
24753920|NCT01718327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24753921|NCT01718327|Growth Substances|growth substances|mesh-ancestor
24753922|NCT01718327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753923|NCT01718327|Growth Inhibitors|growth inhibitors|mesh-ancestor
24753924|NCT01718327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24753925|NCT01718327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753926|NCT01718327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753928|NCT01718340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24753929|NCT01718340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753931|NCT01718366|Azacitidine|azacitidine|mesh-list
24753932|NCT01718366|Deferasirox|deferasirox|mesh-list
24753933|NCT01718366|Vitamins|vitamins|mesh-ancestor
24753934|NCT01718366|Micronutrients|micronutrients|mesh-ancestor
24753935|NCT01718366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753936|NCT01718366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24753937|NCT01718366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24753957|NCT01718496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753959|NCT01718496|Sensory System Agents|sensory system agents|mesh-ancestor
24753960|NCT01718496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24753961|NCT01718587|Lamivudine|lamivudine|mesh-list
24753962|NCT01718587|Antiviral Agents|antiviral agents|mesh-list
24753963|NCT01718587|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24753964|NCT01718587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24753965|NCT01718587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753966|NCT01718587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753967|NCT01718587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24753968|NCT01718587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24753969|NCT01718587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24544232|NCT00687999|Ribavirin|ribavirin|mesh-list
24544233|NCT00687999|Interferon-alpha|interferon-alpha|mesh-list
24544235|NCT00687999|Antiviral Agents|antiviral agents|mesh-ancestor
24753970|NCT01718613|Vasopressins|vasopressins|mesh-list
24753971|NCT01718613|Arginine Vasopressin|arginine vasopressin|mesh-list
24753972|NCT01718613|Norepinephrine|norepinephrine|mesh-list
24753973|NCT01718613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24753976|NCT01718613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24753977|NCT01718613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753978|NCT01718613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753979|NCT01718613|Sympathomimetics|sympathomimetics|mesh-ancestor
24753980|NCT01718613|Autonomic Agents|autonomic agents|mesh-ancestor
24753981|NCT01718613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24753982|NCT01718613|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24753983|NCT01718613|Hemostatics|hemostatics|mesh-ancestor
24754017|NCT01718717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24754018|NCT01718717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754019|NCT01718717|Analgesics|analgesics|mesh-ancestor
24754020|NCT01718717|Sensory System Agents|sensory system agents|mesh-ancestor
24754021|NCT01718717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24754023|NCT01718808|Cetuximab|cetuximab|mesh-list
24754024|NCT01718808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24754025|NCT01718808|Antimetabolites|antimetabolites|mesh-ancestor
24754026|NCT01718808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754027|NCT01718808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24754029|NCT01718834|Vaccines|vaccines|mesh-list
24754035|NCT01718873|Fluorouracil|fluorouracil|mesh-list
24754036|NCT01718873|Capecitabine|capecitabine|mesh-list
24754037|NCT01718873|Oxaliplatin|oxaliplatin|mesh-list
24754038|NCT01718873|Levoleucovorin|levoleucovorin|mesh-list
24754039|NCT01718873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24754040|NCT01718873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544298|NCT00688402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24754041|NCT01718873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24853360|NCT02267707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24754042|NCT01718873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24754043|NCT01718873|Growth Substances|growth substances|mesh-ancestor
24754044|NCT01718873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754048|NCT01718873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24754049|NCT01718873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24754050|NCT01718873|Immunologic Factors|immunologic factors|mesh-ancestor
24754051|NCT01718873|Antidotes|antidotes|mesh-ancestor
24754052|NCT01718873|Protective Agents|protective agents|mesh-ancestor
24754053|NCT01718873|Vitamin B Complex|vitamin b complex|mesh-ancestor
24754054|NCT01718873|Vitamins|vitamins|mesh-ancestor
24754055|NCT01718873|Micronutrients|micronutrients|mesh-ancestor
24754056|NCT01718873|Hematinics|hematinics|mesh-ancestor
24754057|NCT01718899|Lenalidomide|lenalidomide|mesh-list
24754059|NCT01718899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754060|NCT01718899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24754061|NCT01718899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24754062|NCT01718899|Growth Substances|growth substances|mesh-ancestor
25709392|NCT02266433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666308|NCT01318369|GABA Agents|gaba agents|mesh-ancestor
24754063|NCT01718899|Growth Inhibitors|growth inhibitors|mesh-ancestor
24754064|NCT01718899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24754065|NCT01718912|Metronidazole|metronidazole|mesh-list
24754066|NCT01718912|Nystatin|nystatin|mesh-list
24944685|NCT03958123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24944686|NCT03958123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24944687|NCT03958123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24754067|NCT01718912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24754068|NCT01718912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24754069|NCT01718912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24754070|NCT01718912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25006308|NCT05172050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25006311|NCT05167370|Amifostine|amifostine|mesh-list
24754077|NCT01718951|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24754078|NCT01718951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24754079|NCT01718951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24754080|NCT01718951|Immunologic Factors|immunologic factors|mesh-ancestor
24754100|NCT01719042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24754101|NCT01719042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754102|NCT01719042|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24754103|NCT01719042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24754104|NCT01719042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24754105|NCT01719042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24754106|NCT01719042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24754108|NCT01719133|Histamine phosphate|histamine phosphate|mesh-list
24754109|NCT01719133|Histamine Agonists|histamine agonists|mesh-ancestor
24754110|NCT01719133|Histamine Agents|histamine agents|mesh-ancestor
24754111|NCT01719133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24754112|NCT01719133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754113|NCT01719133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754114|NCT01719159|Rituximab|rituximab|mesh-list
24754115|NCT01719159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24754116|NCT01719159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24754117|NCT01719159|Immunologic Factors|immunologic factors|mesh-ancestor
24754120|NCT01719185|Vitamin B 12|vitamin b 12|mesh-list
24544348|NCT00688493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24754121|NCT01719185|Phentermine|phentermine|mesh-list
24754122|NCT01719185|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24754123|NCT01719185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754124|NCT01719185|Appetite Depressants|appetite depressants|mesh-ancestor
24754125|NCT01719185|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24754127|NCT01719185|Autonomic Agents|autonomic agents|mesh-ancestor
24754128|NCT01719185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24754129|NCT01719185|Adrenergic Agents|adrenergic agents|mesh-ancestor
24754159|NCT01719419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24754160|NCT01719419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754161|NCT01719419|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24754162|NCT01719419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24754163|NCT01719588|Tapentadol|tapentadol|mesh-list
24754164|NCT01719588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24754165|NCT01719588|Narcotics|narcotics|mesh-ancestor
24754166|NCT01719588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24754167|NCT01719588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696506|NCT02062645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25696507|NCT02062645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24754168|NCT01719588|Analgesics|analgesics|mesh-ancestor
24418839|NCT00210327|Bortezomib|bortezomib|mesh-list
25696508|NCT02062658|Ketamine|ketamine|mesh-list
25696509|NCT02062658|Analgesics|analgesics|mesh-ancestor
25696510|NCT02062658|Sensory System Agents|sensory system agents|mesh-ancestor
25696511|NCT02062658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25696512|NCT02062658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696513|NCT02062658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25050135|NCT00539721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25050136|NCT00539721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25050137|NCT00539721|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25050139|NCT00537043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25050140|NCT00537043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25050141|NCT00537043|Adrenergic Agents|adrenergic agents|mesh-ancestor
25050142|NCT00537043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24666421|NCT01319240|Insulin|insulin|mesh-list
24754170|NCT01719588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24754171|NCT01719588|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24754172|NCT01719588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24754173|NCT01719588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24754174|NCT01719588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754177|NCT01719601|Tapentadol|tapentadol|mesh-list
24754178|NCT01719601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24754179|NCT01719601|Narcotics|narcotics|mesh-ancestor
24754180|NCT01719601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24754181|NCT01719601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754182|NCT01719601|Analgesics|analgesics|mesh-ancestor
24754183|NCT01719601|Sensory System Agents|sensory system agents|mesh-ancestor
24754184|NCT01719601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24754185|NCT01719601|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24754186|NCT01719601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24754187|NCT01719601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24754188|NCT01719601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754189|NCT01719601|Adrenergic Agents|adrenergic agents|mesh-ancestor
24660144|NCT01281813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24754248|NCT01719835|Immunologic Factors|immunologic factors|mesh-ancestor
24754249|NCT01719835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754250|NCT01719835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24754251|NCT01719835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24754252|NCT01719835|Alkylating Agents|alkylating agents|mesh-ancestor
24754253|NCT01719835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754254|NCT01719835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24754255|NCT01719835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24604811|NCT00981851|Albuterol|albuterol|mesh-list
24754256|NCT01719835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24944696|NCT03958123|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24944697|NCT03958123|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24944698|NCT03958123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24944699|NCT03958058|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24944700|NCT03958058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24944701|NCT03958058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24944702|NCT03958058|Antitubercular Agents|antitubercular agents|mesh-ancestor
24857829|NCT02294240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857830|NCT02294266|Ethanol|ethanol|mesh-list
24857831|NCT02294266|Methamphetamine|methamphetamine|mesh-list
24857832|NCT02294266|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24857833|NCT02294266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24857834|NCT02294266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24857835|NCT02294266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857836|NCT02294266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24540437|NCT00667979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540438|NCT00667979|Urological Agents|urological agents|mesh-ancestor
24540439|NCT00668005|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24540440|NCT00668005|Vasodilator Agents|vasodilator agents|mesh-ancestor
24540441|NCT00668005|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24754260|NCT01719835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24754261|NCT01719835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24754262|NCT01719835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24754263|NCT01719835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24944704|NCT03958396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24646478|NCT01204112|Tofacitinib|tofacitinib|mesh-list
24646480|NCT01204112|Antitubercular Agents|antitubercular agents|mesh-ancestor
24462921|NCT00357890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696514|NCT02062658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25696515|NCT02062658|Anesthetics, General|anesthetics, general|mesh-ancestor
25696516|NCT02062658|Anesthetics|anesthetics|mesh-ancestor
25696517|NCT02062658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25696518|NCT02062658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25696519|NCT02062658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25696520|NCT02062658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24952245|NCT03895892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24952247|NCT03896217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24952248|NCT03896217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24952249|NCT03896217|Antimetabolites|antimetabolites|mesh-ancestor
24952250|NCT03896217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952251|NCT03896217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24952252|NCT03896217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24944705|NCT03958396|Narcotics|narcotics|mesh-ancestor
24944706|NCT03958396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24944707|NCT03958396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944708|NCT03958396|Analgesics|analgesics|mesh-ancestor
24540592|NCT00668603|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24540638|NCT00668759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24540639|NCT00668759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24540640|NCT00668837|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24540641|NCT00668837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24540642|NCT00668837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24754264|NCT01719835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24754266|NCT01719835|Antimitotic Agents|antimitotic agents|mesh-ancestor
24754267|NCT01719835|Mitosis Modulators|mitosis modulators|mesh-ancestor
24619394|NCT01052298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24418936|NCT00210561|Antipyretics|antipyretics|mesh-ancestor
24619395|NCT01052298|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24619396|NCT01052298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24619398|NCT01052311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24619399|NCT01052311|Antimetabolites|antimetabolites|mesh-ancestor
24619400|NCT01052311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619401|NCT01052311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24619402|NCT01052311|Vasodilator Agents|vasodilator agents|mesh-ancestor
24619403|NCT01052311|Vitamin B Complex|vitamin b complex|mesh-ancestor
24619404|NCT01052311|Vitamins|vitamins|mesh-ancestor
24619405|NCT01052311|Micronutrients|micronutrients|mesh-ancestor
24619406|NCT01052311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619407|NCT01052324|Remifentanil|remifentanil|mesh-list
24619408|NCT01052324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24619409|NCT01052324|Narcotics|narcotics|mesh-ancestor
24619410|NCT01052324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24619411|NCT01052324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619412|NCT01052324|Analgesics|analgesics|mesh-ancestor
24619421|NCT01052363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24619422|NCT01052363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25696521|NCT02062658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696522|NCT02062710|Diphenhydramine|diphenhydramine|mesh-list
25696523|NCT02062710|Promethazine|promethazine|mesh-list
25696524|NCT02062710|Phenylephrine|phenylephrine|mesh-list
25696525|NCT02062710|Oxymetazoline|oxymetazoline|mesh-list
25696526|NCT02062710|Dextromethorphan|dextromethorphan|mesh-list
25696527|NCT02062710|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25696528|NCT02062710|Mydriatics|mydriatics|mesh-ancestor
25696529|NCT02062710|Autonomic Agents|autonomic agents|mesh-ancestor
24666548|NCT01319825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24666549|NCT01319838|Isotretinoin|isotretinoin|mesh-list
24666550|NCT01319838|Dermatologic Agents|dermatologic agents|mesh-ancestor
24666551|NCT01319864|Plerixafor|plerixafor|mesh-list
24666552|NCT01319864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24935864|NCT04047017|Apatinib|apatinib|mesh-list
24935922|NCT04046679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24666648|NCT01320254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24666649|NCT01320254|Antimetabolites|antimetabolites|mesh-ancestor
24666650|NCT01320254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666651|NCT01320254|Antiviral Agents|antiviral agents|mesh-ancestor
24666652|NCT01320254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24666653|NCT01320254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666654|NCT01320254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24666655|NCT01320254|Immunologic Factors|immunologic factors|mesh-ancestor
24666656|NCT01320254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666657|NCT01320254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24666658|NCT01320345|Fenofibrate|fenofibrate|mesh-list
24666659|NCT01320345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24666667|NCT01320397|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24666668|NCT01320397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619441|NCT01052389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24754408|NCT01720459|Resveratrol|resveratrol|mesh-list
24619443|NCT01052389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25696530|NCT02062710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25696531|NCT02062710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696532|NCT02062710|Sympathomimetics|sympathomimetics|mesh-ancestor
25696533|NCT02062710|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25696534|NCT02062710|Nasal Decongestants|nasal decongestants|mesh-ancestor
25696535|NCT02062710|Respiratory System Agents|respiratory system agents|mesh-ancestor
25696536|NCT02062710|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25696537|NCT02062710|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25696538|NCT02062710|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25696539|NCT02062710|Adrenergic Agents|adrenergic agents|mesh-ancestor
25696540|NCT02062710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25696541|NCT02062710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696542|NCT02062710|Protective Agents|protective agents|mesh-ancestor
25696543|NCT02062710|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25696544|NCT02062710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25696545|NCT02062710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25696546|NCT02062710|Anesthetics, Local|anesthetics, local|mesh-ancestor
25696547|NCT02062710|Anesthetics|anesthetics|mesh-ancestor
25696548|NCT02062710|Sensory System Agents|sensory system agents|mesh-ancestor
25696549|NCT02062710|Antiemetics|antiemetics|mesh-ancestor
25696550|NCT02062710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25696551|NCT02062710|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25696552|NCT02062710|Histamine Antagonists|histamine antagonists|mesh-ancestor
25696553|NCT02062710|Histamine Agents|histamine agents|mesh-ancestor
25696554|NCT02062710|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25696555|NCT02062710|Antipruritics|antipruritics|mesh-ancestor
25696556|NCT02062710|Dermatologic Agents|dermatologic agents|mesh-ancestor
25696557|NCT02062710|Antitussive Agents|antitussive agents|mesh-ancestor
25696558|NCT02062710|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25696559|NCT02062710|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25696560|NCT02062801|Ephedrine|ephedrine|mesh-list
25696561|NCT02062801|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25696562|NCT02062801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696563|NCT02062801|Sympathomimetics|sympathomimetics|mesh-ancestor
25696564|NCT02062801|Autonomic Agents|autonomic agents|mesh-ancestor
24666670|NCT01320436|Curcumin|curcumin|mesh-list
24619444|NCT01052389|Serotonin Agents|serotonin agents|mesh-ancestor
24619445|NCT01052389|Antidepressive Agents|antidepressive agents|mesh-ancestor
24619446|NCT01052389|Dopamine Agonists|dopamine agonists|mesh-ancestor
24619447|NCT01052389|Dopamine Agents|dopamine agents|mesh-ancestor
24619448|NCT01052389|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24619449|NCT01052389|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24619450|NCT01052389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24754275|NCT01719835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24544528|NCT00689416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24544529|NCT00689416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24544530|NCT00689416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544531|NCT00689442|Atorvastatin|atorvastatin|mesh-list
24754276|NCT01719835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24754277|NCT01719835|Protective Agents|protective agents|mesh-ancestor
24754278|NCT01719835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24754283|NCT01719926|Sensory System Agents|sensory system agents|mesh-ancestor
24754284|NCT01719926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24754285|NCT01719926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754286|NCT01719926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24754287|NCT01719926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24754288|NCT01719926|Gout Suppressants|gout suppressants|mesh-ancestor
24754289|NCT01719926|Tocolytic Agents|tocolytic agents|mesh-ancestor
24944717|NCT03957902|Analgesics|analgesics|mesh-ancestor
24754317|NCT01719978|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24754318|NCT01719978|Anesthetics, Local|anesthetics, local|mesh-ancestor
24754319|NCT01719978|Anesthetics|anesthetics|mesh-ancestor
24419023|NCT00210847|Tramadol|tramadol|mesh-list
24754320|NCT01719978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24754321|NCT01719978|Sensory System Agents|sensory system agents|mesh-ancestor
24754323|NCT01720030|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24754324|NCT01720030|Vasodilator Agents|vasodilator agents|mesh-ancestor
24754325|NCT01720030|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24754326|NCT01720030|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24754327|NCT01720030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660271|NCT01282528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24754328|NCT01720030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754329|NCT01720030|Protective Agents|protective agents|mesh-ancestor
24754330|NCT01720030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754331|NCT01720056|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24754333|NCT01720056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24754334|NCT01720056|Glucocorticoids|glucocorticoids|mesh-ancestor
24754335|NCT01720056|Hormones|hormones|mesh-ancestor
24754336|NCT01720056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24544532|NCT00689442|Dalcetrapib|dalcetrapib|mesh-list
24754379|NCT01720238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24754381|NCT01720238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754382|NCT01720238|Antiviral Agents|antiviral agents|mesh-ancestor
24754383|NCT01720238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24754384|NCT01720238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24944718|NCT03957902|Sensory System Agents|sensory system agents|mesh-ancestor
24944719|NCT03957902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24944720|NCT03957902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944721|NCT03957902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24944722|NCT03957902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24944723|NCT03957902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24666795|NCT01321021|Anesthetics|anesthetics|mesh-ancestor
24447726|NCT00309491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447728|NCT00309517|Edrecolomab|edrecolomab|mesh-list
24447729|NCT00309517|Antidotes|antidotes|mesh-ancestor
24447730|NCT00309517|Protective Agents|protective agents|mesh-ancestor
24944728|NCT03957902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24754385|NCT01720238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24754386|NCT01720290|Metformin|metformin|mesh-list
24754387|NCT01720290|Repaglinide|repaglinide|mesh-list
24754392|NCT01720303|Repaglinide|repaglinide|mesh-list
24754393|NCT01720303|Isophane Insulin, Human|isophane insulin, human|mesh-list
24754394|NCT01720303|Insulin, Isophane|insulin, isophane|mesh-list
24754395|NCT01720303|Isophane insulin, beef|isophane insulin, beef|mesh-list
24754396|NCT01720303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24754397|NCT01720303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544599|NCT00689624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544600|NCT00689624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24544601|NCT00689624|Immunologic Factors|immunologic factors|mesh-ancestor
24447731|NCT00309517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447732|NCT00309517|Vitamin B Complex|vitamin b complex|mesh-ancestor
24447733|NCT00309517|Vitamins|vitamins|mesh-ancestor
24447734|NCT00309517|Micronutrients|micronutrients|mesh-ancestor
24447735|NCT00309517|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24447736|NCT00309517|Immunologic Factors|immunologic factors|mesh-ancestor
24447737|NCT00309530|Interferons|interferons|mesh-list
24544603|NCT00689624|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24544604|NCT00689624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24544605|NCT00689624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24754400|NCT01720394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24754401|NCT01720394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754402|NCT01720407|Imiquimod|imiquimod|mesh-list
24754403|NCT01720407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24754404|NCT01720407|Immunologic Factors|immunologic factors|mesh-ancestor
24754405|NCT01720407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754406|NCT01720407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24754407|NCT01720407|Interferon Inducers|interferon inducers|mesh-ancestor
24754439|NCT01720498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24754440|NCT01720498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754442|NCT01720498|Sensory System Agents|sensory system agents|mesh-ancestor
24754455|NCT01720615|Sevoflurane|sevoflurane|mesh-list
24754456|NCT01720615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24605281|NCT00984386|Contraceptive Agents|contraceptive agents|mesh-ancestor
24754457|NCT01720615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24754458|NCT01720615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754459|NCT01720615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24754460|NCT01720615|Anesthetics, General|anesthetics, general|mesh-ancestor
24754462|NCT01720615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24754481|NCT01720719|Antimetabolites|antimetabolites|mesh-ancestor
24754482|NCT01720719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754483|NCT01720719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24754484|NCT01720719|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24754485|NCT01720719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24754486|NCT01720719|Antioxidants|antioxidants|mesh-ancestor
24754487|NCT01720719|Protective Agents|protective agents|mesh-ancestor
24754488|NCT01720875|Dexamethasone|dexamethasone|mesh-list
24754489|NCT01720875|Bortezomib|bortezomib|mesh-list
24754490|NCT01720875|Vorinostat|vorinostat|mesh-list
24541959|NCT00676117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24541960|NCT00676117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24541961|NCT00676117|Analgesics|analgesics|mesh-ancestor
24541969|NCT00676156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541970|NCT00676156|Protective Agents|protective agents|mesh-ancestor
24446094|NCT00303784|Estradiol|estradiol|mesh-list
24541981|NCT00676221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24541982|NCT00676221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541983|NCT00676221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541984|NCT00676260|Pioglitazone|pioglitazone|mesh-list
24541985|NCT00676260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24541986|NCT00676260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944750|NCT03957668|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24944752|NCT03957668|Laxatives|laxatives|mesh-ancestor
24944753|NCT03957499|Dexamethasone|dexamethasone|mesh-list
24944754|NCT03957499|Magnesium Sulfate|magnesium sulfate|mesh-list
24944755|NCT03957499|Bupivacaine|bupivacaine|mesh-list
24944756|NCT03957499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24944757|NCT03957499|Antiemetics|antiemetics|mesh-ancestor
24944758|NCT03957499|Autonomic Agents|autonomic agents|mesh-ancestor
24944759|NCT03957499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24944760|NCT03957499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857852|NCT02294279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24857853|NCT02294279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857854|NCT02294279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24857855|NCT02294279|Respiratory System Agents|respiratory system agents|mesh-ancestor
24857856|NCT02294292|Carvedilol|carvedilol|mesh-list
24857857|NCT02294292|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24541999|NCT00676377|Cholinergic Agents|cholinergic agents|mesh-ancestor
24542000|NCT00676377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24857858|NCT02294292|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24542152|NCT00677261|Anesthetics, Local|anesthetics, local|mesh-list
24944767|NCT03957499|Anesthetics, Local|anesthetics, local|mesh-ancestor
24857860|NCT02294292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24460354|NCT00348244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542087|NCT00676819|Insulin Aspart|insulin aspart|mesh-list
24754531|NCT01721135|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24754533|NCT01721291|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24754534|NCT01721291|Autonomic Agents|autonomic agents|mesh-ancestor
24754535|NCT01721291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24754539|NCT01721291|Tocolytic Agents|tocolytic agents|mesh-ancestor
24542138|NCT00677144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24542139|NCT00677144|Antimetabolites|antimetabolites|mesh-ancestor
24542140|NCT00677144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542141|NCT00677144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542142|NCT00677170|Pevonedistat|pevonedistat|mesh-list
24542143|NCT00677170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542144|NCT00677170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542146|NCT00677248|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24542147|NCT00677248|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24542148|NCT00677248|Antimetabolites|antimetabolites|mesh-ancestor
24542149|NCT00677248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542150|NCT00677248|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24542151|NCT00677261|Anesthetics|anesthetics|mesh-list
24542153|NCT00677261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24542154|NCT00677261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542251|NCT00677755|Hormone Antagonists|hormone antagonists|mesh-ancestor
24542252|NCT00677755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24542253|NCT00677755|Luteolytic Agents|luteolytic agents|mesh-ancestor
24542254|NCT00677755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24542255|NCT00677755|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24542256|NCT00678106|Dalbavancin|dalbavancin|mesh-list
24542257|NCT00678106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24944785|NCT03957629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24944790|NCT03957629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857865|NCT02294292|Protective Agents|protective agents|mesh-ancestor
24857866|NCT02294292|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24857867|NCT02294292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24754548|NCT01721382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24754549|NCT01721382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754551|NCT01721382|Hormones|hormones|mesh-ancestor
24754570|NCT01721525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24754571|NCT01721525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24754572|NCT01721525|Tubulin Modulators|tubulin modulators|mesh-ancestor
24754573|NCT01721525|Antimitotic Agents|antimitotic agents|mesh-ancestor
24754574|NCT01721525|Mitosis Modulators|mitosis modulators|mesh-ancestor
24754575|NCT01721525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754576|NCT01721525|Antimetabolites|antimetabolites|mesh-ancestor
24754577|NCT01721525|Antiviral Agents|antiviral agents|mesh-ancestor
24754578|NCT01721525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24660513|NCT01284049|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24754589|NCT01721655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754590|NCT01721655|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24754592|NCT01721655|Natriuretic Agents|natriuretic agents|mesh-ancestor
24754593|NCT01721694|Loteprednol Etabonate|loteprednol etabonate|mesh-list
24754594|NCT01721694|Azithromycin|azithromycin|mesh-list
24754595|NCT01721694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24754596|NCT01721694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24754597|NCT01721694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24754598|NCT01721707|Latanoprost|latanoprost|mesh-list
24754635|NCT01722110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24754636|NCT01722110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24754637|NCT01722110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24754638|NCT01722110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544875|NCT00690768|Bevacizumab|bevacizumab|mesh-list
24754640|NCT01722201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24754641|NCT01722201|Serotonin Agents|serotonin agents|mesh-ancestor
24754642|NCT01722201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24754643|NCT01722201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754644|NCT01722201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754645|NCT01722201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24754646|NCT01722201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24754647|NCT01722201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24754648|NCT01722201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24754665|NCT01722240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24754667|NCT01722305|Dexamethasone acetate|dexamethasone acetate|mesh-list
24754668|NCT01722305|Pomalidomide|pomalidomide|mesh-list
24754669|NCT01722305|Ichthammol|ichthammol|mesh-list
24754670|NCT01722305|BB 1101|bb 1101|mesh-list
24754671|NCT01722305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24619451|NCT01052389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24619452|NCT01052389|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24619453|NCT01052389|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24619454|NCT01052389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24619466|NCT01052597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24944825|NCT03956966|Dexamethasone|dexamethasone|mesh-list
24944826|NCT03956966|Bupivacaine|bupivacaine|mesh-list
24944827|NCT03956966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24944828|NCT03956966|Antiemetics|antiemetics|mesh-ancestor
24944829|NCT03956966|Autonomic Agents|autonomic agents|mesh-ancestor
24542440|NCT00678743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24944838|NCT03956966|Anesthetics, Local|anesthetics, local|mesh-ancestor
24944839|NCT03956966|Anesthetics|anesthetics|mesh-ancestor
25051301|NCT00422019|Rilotumumab|rilotumumab|mesh-list
24857884|NCT02294305|Serotonin Agents|serotonin agents|mesh-ancestor
24857885|NCT02294305|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24542507|NCT00679068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542508|NCT00679120|Cimetidine|cimetidine|mesh-list
24542509|NCT00679120|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24542510|NCT00679120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24542511|NCT00679120|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24542512|NCT00679120|Histamine Antagonists|histamine antagonists|mesh-ancestor
24542513|NCT00679120|Histamine Agents|histamine agents|mesh-ancestor
24754676|NCT01722305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24754678|NCT01722305|Hormones|hormones|mesh-ancestor
24754679|NCT01722305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24754690|NCT01722305|Dermatologic Agents|dermatologic agents|mesh-ancestor
24754692|NCT01722396|Vitamins|vitamins|mesh-ancestor
24754693|NCT01722396|Micronutrients|micronutrients|mesh-ancestor
24754694|NCT01722396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754695|NCT01722396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24944858|NCT03956732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944859|NCT03956823|Amlodipine|amlodipine|mesh-list
24944860|NCT03956823|Telmisartan|telmisartan|mesh-list
24944861|NCT03956823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24944871|NCT03957083|Oxytocics|oxytocics|mesh-ancestor
24944872|NCT03957083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24944873|NCT03957083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857894|NCT02294344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24857897|NCT02294344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24857898|NCT02294344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24857900|NCT02294357|Dexamethasone acetate|dexamethasone acetate|mesh-list
24857901|NCT02294357|Prednisone|prednisone|mesh-list
24857904|NCT02294357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24857905|NCT02294357|Prednisolone|prednisolone|mesh-list
24857906|NCT02294357|Prednisolone acetate|prednisolone acetate|mesh-list
24857907|NCT02294357|Lenalidomide|lenalidomide|mesh-list
24542671|NCT00679666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542714|NCT00679900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542715|NCT00679900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24754736|NCT01722539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24754737|NCT01722539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24754738|NCT01722539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24754739|NCT01722539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754740|NCT01722539|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24754741|NCT01722539|Renal Agents|renal agents|mesh-ancestor
24754742|NCT01722539|Anthelmintics|anthelmintics|mesh-ancestor
24754743|NCT01722539|Anticestodal Agents|anticestodal agents|mesh-ancestor
24754744|NCT01722539|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24754745|NCT01722539|Tubulin Modulators|tubulin modulators|mesh-ancestor
24754746|NCT01722539|Antimitotic Agents|antimitotic agents|mesh-ancestor
24754747|NCT01722539|Mitosis Modulators|mitosis modulators|mesh-ancestor
24544967|NCT00691236|Zoledronic Acid|zoledronic acid|mesh-list
24754748|NCT01722539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24754749|NCT01722578|N-Methylaspartate|n-methylaspartate|mesh-list
24944893|NCT03956303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944894|NCT03956303|Sensory System Agents|sensory system agents|mesh-ancestor
24944895|NCT03956303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24944897|NCT03956212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24770074|NCT01817803|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24770075|NCT01817816|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24542770|NCT00680329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542775|NCT00680355|Antioxidants|antioxidants|mesh-ancestor
24542776|NCT00680355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542777|NCT00680355|Protective Agents|protective agents|mesh-ancestor
24542778|NCT00680355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542779|NCT00680394|Misoprostol|misoprostol|mesh-list
24542780|NCT00680394|Mifepristone|mifepristone|mesh-list
24542781|NCT00680394|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24542782|NCT00680394|Abortifacient Agents|abortifacient agents|mesh-ancestor
24542783|NCT00680394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24754750|NCT01722578|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
24770078|NCT01817816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24770079|NCT01817816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770080|NCT01817816|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24770081|NCT01817816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24770082|NCT01817816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770083|NCT01817816|Cholinergic Agents|cholinergic agents|mesh-ancestor
24770084|NCT01817816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24770085|NCT01817829|Acetaminophen|acetaminophen|mesh-list
24770086|NCT01817829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24770087|NCT01817829|Analgesics|analgesics|mesh-ancestor
24770088|NCT01817829|Sensory System Agents|sensory system agents|mesh-ancestor
24460401|NCT00348361|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24754751|NCT01722578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24754752|NCT01722578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24754753|NCT01722578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754754|NCT01722578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754756|NCT01722630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24754757|NCT01722630|Sympathomimetics|sympathomimetics|mesh-ancestor
24667157|NCT01322711|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24667158|NCT01322711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24667161|NCT01322776|Bortezomib|bortezomib|mesh-list
24754758|NCT01722630|Autonomic Agents|autonomic agents|mesh-ancestor
24754759|NCT01722630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24754760|NCT01722630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754762|NCT01722630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24754763|NCT01722630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754764|NCT01722630|Protective Agents|protective agents|mesh-ancestor
24754765|NCT01722656|Aflibercept|aflibercept|mesh-list
24754766|NCT01722656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24770089|NCT01817829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24770090|NCT01817829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770092|NCT01817868|Factor VIII|factor viii|mesh-list
24770093|NCT01817868|Coagulants|coagulants|mesh-ancestor
24447767|NCT00309556|Tubulin Modulators|tubulin modulators|mesh-ancestor
24447768|NCT00309556|Antimitotic Agents|antimitotic agents|mesh-ancestor
24447769|NCT00309556|Mitosis Modulators|mitosis modulators|mesh-ancestor
24857918|NCT02294357|Glucocorticoids|glucocorticoids|mesh-ancestor
24542820|NCT00680485|Ketoconazole|ketoconazole|mesh-list
24542821|NCT00680485|Antifungal Agents|antifungal agents|mesh-ancestor
24542822|NCT00680485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24542823|NCT00680485|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24542824|NCT00680485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24542825|NCT00680485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542826|NCT00680485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542827|NCT00680485|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24542828|NCT00680485|Hormone Antagonists|hormone antagonists|mesh-ancestor
24542829|NCT00680485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24542830|NCT00680485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542836|NCT00680498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944901|NCT03956212|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24944902|NCT03956017|Ubiquinone|ubiquinone|mesh-list
24944903|NCT03956017|Coenzyme Q10|coenzyme q10|mesh-list
24944904|NCT03956017|Micronutrients|micronutrients|mesh-ancestor
24944908|NCT03955939|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24944909|NCT03955939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24857919|NCT02294357|Hormones|hormones|mesh-ancestor
24857920|NCT02294357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24857921|NCT02294357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25696565|NCT02062801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25696566|NCT02062801|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25696567|NCT02062801|Adrenergic Agents|adrenergic agents|mesh-ancestor
25696568|NCT02062801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25696569|NCT02062801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696570|NCT02062879|Ketamine|ketamine|mesh-list
25696571|NCT02062879|Hydromorphone|hydromorphone|mesh-list
25696572|NCT02062879|Analgesics|analgesics|mesh-ancestor
24667226|NCT05460858|Expectorants|expectorants|mesh-ancestor
24667229|NCT05460858|Antioxidants|antioxidants|mesh-ancestor
24667247|NCT05460416|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24667248|NCT05460416|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24667249|NCT05460416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24667250|NCT05460416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24667251|NCT05460416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24667252|NCT05460416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24667253|NCT05460416|Antipyretics|antipyretics|mesh-ancestor
24936029|NCT04045431|Hylan|hylan|mesh-list
24754771|NCT01722656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24754801|NCT01722942|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24754802|NCT01722942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24754804|NCT01722968|Bevacizumab|bevacizumab|mesh-list
24754805|NCT01722968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24754806|NCT01722968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24754807|NCT01722968|Tubulin Modulators|tubulin modulators|mesh-ancestor
24944928|NCT03955809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24944929|NCT03955809|Anesthetics, General|anesthetics, general|mesh-ancestor
24944931|NCT03955809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24944932|NCT03955809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24944933|NCT03955809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24857925|NCT02294357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857926|NCT02294357|Immunologic Factors|immunologic factors|mesh-ancestor
24857927|NCT02294357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24857928|NCT02294357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24857929|NCT02294357|Growth Substances|growth substances|mesh-ancestor
24857930|NCT02294357|Growth Inhibitors|growth inhibitors|mesh-ancestor
24857931|NCT02294357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24857932|NCT02294357|Protective Agents|protective agents|mesh-ancestor
24754846|NCT01723150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24754847|NCT01723150|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24754848|NCT01723150|Renal Agents|renal agents|mesh-ancestor
24754849|NCT01723150|Antimalarials|antimalarials|mesh-ancestor
24754850|NCT01723150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24754851|NCT01723150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24754852|NCT01723150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24754853|NCT01723150|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24754854|NCT01723150|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24660801|NCT01285817|Antimetabolites|antimetabolites|mesh-ancestor
24754856|NCT01723371|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24754857|NCT01723371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24754858|NCT01723371|Adrenergic Agents|adrenergic agents|mesh-ancestor
24754859|NCT01723371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24754860|NCT01723371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754861|NCT01723371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754862|NCT01723371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24754863|NCT01723371|Antioxidants|antioxidants|mesh-ancestor
24754864|NCT01723371|Protective Agents|protective agents|mesh-ancestor
24754868|NCT01723371|Vasodilator Agents|vasodilator agents|mesh-ancestor
24754869|NCT01723371|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24754870|NCT01723371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24754871|NCT01723501|Chlorhexidine|chlorhexidine|mesh-list
24754887|NCT01723553|Corticosterone|corticosterone|mesh-list
24754888|NCT01723553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24754889|NCT01723657|Gemtuzumab|gemtuzumab|mesh-list
24754890|NCT01723657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24754891|NCT01723657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24754892|NCT01723670|Flurbiprofen|flurbiprofen|mesh-list
25696573|NCT02062879|Sensory System Agents|sensory system agents|mesh-ancestor
25696574|NCT02062879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25696575|NCT02062879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696576|NCT02062879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25696577|NCT02062879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25696578|NCT02062879|Anesthetics, General|anesthetics, general|mesh-ancestor
25696579|NCT02062879|Anesthetics|anesthetics|mesh-ancestor
25696580|NCT02062879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25696581|NCT02062879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24667319|NCT05459649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24667320|NCT05459649|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24667321|NCT05459597|Anticonvulsants|anticonvulsants|mesh-list
24667346|NCT05459441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24667347|NCT05459441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24667348|NCT05459441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24667361|NCT05455697|Prednisone|prednisone|mesh-list
24667362|NCT05455697|Cyclophosphamide|cyclophosphamide|mesh-list
24667376|NCT05455697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24754893|NCT01723670|Analgesics|analgesics|mesh-ancestor
24944934|NCT03955809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24944935|NCT03955809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944937|NCT03956134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24944938|NCT03956134|Narcotics|narcotics|mesh-ancestor
24754894|NCT01723670|Sensory System Agents|sensory system agents|mesh-ancestor
24754895|NCT01723670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24754896|NCT01723670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754897|NCT01723670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24754898|NCT01723670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24754899|NCT01723670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24754900|NCT01723670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24754901|NCT01723670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24754902|NCT01723670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24754903|NCT01723670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754904|NCT01723683|Pulmonary Surfactants|pulmonary surfactants|mesh-list
24754905|NCT01723683|Respiratory System Agents|respiratory system agents|mesh-ancestor
24754907|NCT01723735|Fenofibrate|fenofibrate|mesh-list
24754908|NCT01723735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24754909|NCT01723735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24754910|NCT01723735|Antimetabolites|antimetabolites|mesh-ancestor
24754911|NCT01723735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619527|NCT01052896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24619528|NCT01052896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619529|NCT01052896|Anticonvulsants|anticonvulsants|mesh-ancestor
24619530|NCT01052896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24619531|NCT01052896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24619532|NCT01052896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24619533|NCT01052896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24619542|NCT01052909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619543|NCT01052909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24619544|NCT01052909|Immunologic Factors|immunologic factors|mesh-ancestor
24619545|NCT01052961|Oseltamivir|oseltamivir|mesh-list
24619546|NCT01052961|Antiviral Agents|antiviral agents|mesh-ancestor
24754947|NCT01724086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24754948|NCT01724086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24944939|NCT03956134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24944941|NCT03956134|Analgesics|analgesics|mesh-ancestor
24944942|NCT03956134|Sensory System Agents|sensory system agents|mesh-ancestor
24944943|NCT03956134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24944944|NCT03956134|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25696582|NCT02062879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25696583|NCT02062879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25696584|NCT02062879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696585|NCT02062879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25696586|NCT02062879|Narcotics|narcotics|mesh-ancestor
25696587|NCT02062905|Dexamethasone|dexamethasone|mesh-list
25696588|NCT02062905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25696589|NCT02062905|Antiemetics|antiemetics|mesh-ancestor
25696590|NCT02062905|Autonomic Agents|autonomic agents|mesh-ancestor
25696591|NCT02062905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25696592|NCT02062905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754949|NCT01724086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24754950|NCT01724086|Antimetabolites|antimetabolites|mesh-ancestor
24754951|NCT01724086|Immunologic Factors|immunologic factors|mesh-ancestor
24754952|NCT01724086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754953|NCT01724138|Deferasirox|deferasirox|mesh-list
24754970|NCT01724229|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24754971|NCT01724229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24754972|NCT01724229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24754973|NCT01724229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754974|NCT01724229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24754975|NCT01724229|Hormone Antagonists|hormone antagonists|mesh-ancestor
24754976|NCT01724229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24754977|NCT01724229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754978|NCT01724229|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24754979|NCT01724229|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24754981|NCT01724268|Methotrexate|methotrexate|mesh-list
24754982|NCT01724268|Methamphetamine|methamphetamine|mesh-list
24754983|NCT01724268|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24754984|NCT01724268|Abortifacient Agents|abortifacient agents|mesh-ancestor
24754985|NCT01724268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24754986|NCT01724268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754987|NCT01724268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24754988|NCT01724268|Antimetabolites|antimetabolites|mesh-ancestor
24754989|NCT01724268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24754990|NCT01724268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24754991|NCT01724268|Dermatologic Agents|dermatologic agents|mesh-ancestor
24755003|NCT01724268|Autonomic Agents|autonomic agents|mesh-ancestor
25696593|NCT02062905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25696594|NCT02062905|Glucocorticoids|glucocorticoids|mesh-ancestor
25696596|NCT02062905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25696597|NCT02062905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25696598|NCT02062905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25696599|NCT02063035|Tranexamic Acid|tranexamic acid|mesh-list
25696600|NCT02063035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25696601|NCT02063035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25696606|NCT02063217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25696607|NCT02063217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25696608|NCT02063217|Anesthetics, General|anesthetics, general|mesh-ancestor
24667557|NCT05384496|Ipilimumab|ipilimumab|mesh-list
24667559|NCT05384496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24667560|NCT05384496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755004|NCT01724268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24755005|NCT01724268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24755006|NCT01724268|Sympathomimetics|sympathomimetics|mesh-ancestor
24755007|NCT01724268|Dopamine Agents|dopamine agents|mesh-ancestor
24755008|NCT01724268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24755442|NCT01726582|Gemcitabine|gemcitabine|mesh-list
24755010|NCT01724268|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24755025|NCT01724372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24755026|NCT01724372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755028|NCT01724372|Dopamine Agents|dopamine agents|mesh-ancestor
24755029|NCT01724372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24755030|NCT01724372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755031|NCT01724372|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24755032|NCT01724372|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24755033|NCT01724372|Serotonin Agents|serotonin agents|mesh-ancestor
24944946|NCT03956134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24944947|NCT03956134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944948|NCT03956134|Adrenergic Agents|adrenergic agents|mesh-ancestor
24944949|NCT03956134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24944950|NCT03956121|Magnesium Sulfate|magnesium sulfate|mesh-list
24944951|NCT03956121|Analgesics|analgesics|mesh-ancestor
24944952|NCT03956121|Sensory System Agents|sensory system agents|mesh-ancestor
24944953|NCT03956121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857942|NCT02294539|Vasodilator Agents|vasodilator agents|mesh-ancestor
24755048|NCT01724385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24755049|NCT01724385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24755050|NCT01724385|Growth Substances|growth substances|mesh-ancestor
24755051|NCT01724385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755052|NCT01724385|Growth Inhibitors|growth inhibitors|mesh-ancestor
24755054|NCT01724424|Antioxidants|antioxidants|mesh-ancestor
24755055|NCT01724424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755056|NCT01724424|Protective Agents|protective agents|mesh-ancestor
24755057|NCT01724424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755058|NCT01724424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24755059|NCT01724450|Carvedilol|carvedilol|mesh-list
24755060|NCT01724450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24755061|NCT01724450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24755075|NCT01724554|Aflibercept|aflibercept|mesh-list
24755076|NCT01724554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24755077|NCT01724554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24755078|NCT01724554|Growth Substances|growth substances|mesh-ancestor
24755079|NCT01724554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755089|NCT01724658|Testosterone undecanoate|testosterone undecanoate|mesh-list
24755091|NCT01724658|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24755092|NCT01724658|Androgens|androgens|mesh-ancestor
24755093|NCT01724658|Hormones|hormones|mesh-ancestor
24755094|NCT01724658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24755095|NCT01724658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755096|NCT01724658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24755097|NCT01724658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755098|NCT01724658|Anabolic Agents|anabolic agents|mesh-ancestor
25696609|NCT02063217|Anesthetics|anesthetics|mesh-ancestor
25696610|NCT02063217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25696611|NCT02063217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696612|NCT02063698|Auranofin|auranofin|mesh-list
25696613|NCT02063698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25696614|NCT02063854|Risedronic Acid|risedronic acid|mesh-list
25696615|NCT02063854|Etidronic Acid|etidronic acid|mesh-list
25696616|NCT02063854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25696617|NCT02063854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25696618|NCT02063854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696619|NCT02063854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25696620|NCT02063854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696621|NCT02063854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25696622|NCT02064166|Insulin|insulin|mesh-list
24667638|NCT05352815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050175|NCT00535366|Adrenergic Agents|adrenergic agents|mesh-ancestor
25050176|NCT00535366|Glucocorticoids|glucocorticoids|mesh-ancestor
24952497|NCT03893591|Anticoagulants|anticoagulants|mesh-ancestor
24755099|NCT01724723|Entecavir|entecavir|mesh-list
24755100|NCT01724723|Antiviral Agents|antiviral agents|mesh-ancestor
24755102|NCT01724788|Furosemide|furosemide|mesh-list
24755105|NCT01724788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755106|NCT01724788|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24755107|NCT01724788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24755109|NCT01724814|Insulin|insulin|mesh-list
24755116|NCT01724892|Autonomic Agents|autonomic agents|mesh-ancestor
24755117|NCT01724892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24755118|NCT01724892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755119|NCT01724892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24755120|NCT01724892|Glucocorticoids|glucocorticoids|mesh-ancestor
24755121|NCT01724892|Hormones|hormones|mesh-ancestor
24755122|NCT01724892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24755123|NCT01724892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24755124|NCT01724892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755125|NCT01724892|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24755126|NCT01724918|Lacosamide|lacosamide|mesh-list
24755127|NCT01724918|Anticonvulsants|anticonvulsants|mesh-ancestor
24755128|NCT01724918|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24755129|NCT01724918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24755130|NCT01724918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24755131|NCT01724918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755132|NCT01724931|Aminopterin|aminopterin|mesh-list
24755133|NCT01724931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24755134|NCT01724931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24755135|NCT01724931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755136|NCT01724983|Fentanyl|fentanyl|mesh-list
24755137|NCT01724983|Ketamine|ketamine|mesh-list
24755138|NCT01724983|Analgesics|analgesics|mesh-ancestor
24755139|NCT01724983|Sensory System Agents|sensory system agents|mesh-ancestor
24755140|NCT01724983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24755141|NCT01724983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755142|NCT01724983|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24755143|NCT01724983|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24755157|NCT01725048|Mirtazapine|mirtazapine|mesh-list
24755158|NCT01725048|Citalopram|citalopram|mesh-list
24755159|NCT01725048|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24755160|NCT01725048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24755161|NCT01725048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24755162|NCT01725048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755163|NCT01725048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24755164|NCT01725048|Serotonin Agents|serotonin agents|mesh-ancestor
24755165|NCT01725048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755166|NCT01725048|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24755167|NCT01725048|Antidepressive Agents|antidepressive agents|mesh-ancestor
24755168|NCT01725048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24755169|NCT01725048|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24944963|NCT03956121|Tocolytic Agents|tocolytic agents|mesh-ancestor
24944964|NCT03956121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24944965|NCT03955601|Cyclophosphamide|cyclophosphamide|mesh-list
24944966|NCT03955601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24944967|NCT03955601|Immunologic Factors|immunologic factors|mesh-ancestor
24944968|NCT03955601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944969|NCT03955601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24944970|NCT03955601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24944971|NCT03955601|Alkylating Agents|alkylating agents|mesh-ancestor
24944972|NCT03955601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857948|NCT02294539|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24857949|NCT02294552|Mycophenolic Acid|mycophenolic acid|mesh-list
25696623|NCT02064166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25696624|NCT02064166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696625|NCT02064439|Rivaroxaban|rivaroxaban|mesh-list
24667871|NCT05261516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24667872|NCT05261516|Anticonvulsants|anticonvulsants|mesh-ancestor
24625500|NCT01082276|Dopamine Agents|dopamine agents|mesh-ancestor
24857950|NCT02294552|Cyclophosphamide|cyclophosphamide|mesh-list
24857951|NCT02294552|Busulfan|busulfan|mesh-list
24441378|NCT00287313|Vitamins|vitamins|mesh-ancestor
24543127|NCT00681993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24755176|NCT01725048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24755177|NCT01725048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24755178|NCT01725048|Adrenergic Agents|adrenergic agents|mesh-ancestor
24755179|NCT01725048|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24755189|NCT01725087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24755190|NCT01725087|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24755191|NCT01725087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24755192|NCT01725087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24755193|NCT01725087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755194|NCT01725087|Adrenergic Agents|adrenergic agents|mesh-ancestor
24755195|NCT01725087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24755197|NCT01725100|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
24755198|NCT01725100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755199|NCT01725100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24755200|NCT01725100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24944973|NCT03955601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24944974|NCT03955601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24944975|NCT03955705|Nefopam|nefopam|mesh-list
24944976|NCT03955705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24944977|NCT03955705|Analgesics|analgesics|mesh-ancestor
24944978|NCT03955705|Sensory System Agents|sensory system agents|mesh-ancestor
24944979|NCT03955705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24944980|NCT03955705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857952|NCT02294552|Fludarabine|fludarabine|mesh-list
24857953|NCT02294552|Fludarabine phosphate|fludarabine phosphate|mesh-list
24543166|NCT00682149|Vitamins|vitamins|mesh-ancestor
24755217|NCT01725204|Dasatinib|dasatinib|mesh-list
24755218|NCT01725204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755219|NCT01725204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24755220|NCT01725204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24755233|NCT01725243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24755234|NCT01725243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755235|NCT01725256|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24755236|NCT01725360|Montelukast|montelukast|mesh-list
24755443|NCT01726582|Paclitaxel|paclitaxel|mesh-list
24755237|NCT01725360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24755238|NCT01725360|Respiratory System Agents|respiratory system agents|mesh-ancestor
24755239|NCT01725360|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24755240|NCT01725360|Hormone Antagonists|hormone antagonists|mesh-ancestor
24755241|NCT01725360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24755242|NCT01725360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755243|NCT01725360|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24755244|NCT01725360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24755245|NCT01725360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755247|NCT01725412|Vitamin B Complex|vitamin b complex|mesh-ancestor
24755248|NCT01725412|Vitamins|vitamins|mesh-ancestor
24543211|NCT00682487|Hydrocortisone|hydrocortisone|mesh-list
25696626|NCT02064439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25696627|NCT02064439|Antithrombins|antithrombins|mesh-ancestor
25696628|NCT02064439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25696629|NCT02064439|Protease Inhibitors|protease inhibitors|mesh-ancestor
25696630|NCT02064439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25696631|NCT02064439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696632|NCT02064439|Anticoagulants|anticoagulants|mesh-ancestor
25696633|NCT02064582|Leuprolide|leuprolide|mesh-list
25696634|NCT02064582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25696635|NCT02064582|Fertility Agents|fertility agents|mesh-ancestor
24625504|NCT01082289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24625505|NCT01082289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696636|NCT02064582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24625506|NCT01082289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24625507|NCT01082289|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24625508|NCT01082289|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24625509|NCT01082289|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24625510|NCT01082289|Adrenergic Agents|adrenergic agents|mesh-ancestor
24543212|NCT00682487|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24543213|NCT00682487|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24543214|NCT00682487|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24543215|NCT00682487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24543216|NCT00682500|Calfactant|calfactant|mesh-list
24543217|NCT00682500|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
24543218|NCT00682500|Respiratory System Agents|respiratory system agents|mesh-ancestor
24543219|NCT00682578|Artesunate|artesunate|mesh-list
24543220|NCT00682578|Chloroquine|chloroquine|mesh-list
24543221|NCT00682578|Pyrimethamine|pyrimethamine|mesh-list
24543222|NCT00682578|Piperaquine|piperaquine|mesh-list
24543223|NCT00682578|Artenimol|artenimol|mesh-list
24543224|NCT00682578|Antimalarials|antimalarials|mesh-ancestor
24543225|NCT00682578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24543226|NCT00682578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24755256|NCT01725490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755257|NCT01725542|Ribavirin|ribavirin|mesh-list
24755258|NCT01725542|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24755259|NCT01725542|Asunaprevir|asunaprevir|mesh-list
24755260|NCT01725542|Antimetabolites|antimetabolites|mesh-ancestor
24755273|NCT01725555|Mitosis Modulators|mitosis modulators|mesh-ancestor
24755274|NCT01725555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755275|NCT01725607|Dexmedetomidine|dexmedetomidine|mesh-list
24755276|NCT01725607|Anesthetics|anesthetics|mesh-list
24755277|NCT01725607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24755278|NCT01725607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755279|NCT01725607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24755280|NCT01725607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24755281|NCT01725607|Analgesics|analgesics|mesh-ancestor
24543296|NCT00683111|Histamine Antagonists|histamine antagonists|mesh-ancestor
24543297|NCT00683111|Histamine Agents|histamine agents|mesh-ancestor
24543298|NCT00683111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24543299|NCT00683111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543300|NCT00683124|Losartan|losartan|mesh-list
24543301|NCT00683124|Nebivolol|nebivolol|mesh-list
24543302|NCT00683124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24857958|NCT02294552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24543315|NCT00683137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24543316|NCT00683137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24755305|NCT01725672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755306|NCT01725672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24755307|NCT01725672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24755308|NCT01725672|Immunologic Factors|immunologic factors|mesh-ancestor
24755309|NCT01725776|Milrinone|milrinone|mesh-list
25696637|NCT02064582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696638|NCT02064582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25696639|NCT02064582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25696640|NCT02064816|Interferon beta-1a|interferon beta-1a|mesh-list
25696641|NCT02064816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25696642|NCT02064816|Immunologic Factors|immunologic factors|mesh-ancestor
25696643|NCT02064816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696644|NCT02064816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25696645|NCT02064816|Antiviral Agents|antiviral agents|mesh-ancestor
25696646|NCT02064816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25696647|NCT02064894|Ibuprofen|ibuprofen|mesh-list
25696648|NCT02064894|Morphine|morphine|mesh-list
24755310|NCT01725776|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25696649|NCT02064894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25696650|NCT02064894|Narcotics|narcotics|mesh-ancestor
24668115|NCT05084378|Chlorhexidine|chlorhexidine|mesh-list
24668116|NCT05084378|Povidone-Iodine|povidone-iodine|mesh-list
25696651|NCT02064894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25696652|NCT02064894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24668117|NCT05084378|Povidone|povidone|mesh-list
24668121|NCT05084378|Disinfectants|disinfectants|mesh-ancestor
24755311|NCT01725776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24755312|NCT01725776|Vasodilator Agents|vasodilator agents|mesh-ancestor
24420093|NCT00215163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857962|NCT02294552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24857963|NCT02294552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24857964|NCT02294552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24857965|NCT02294552|Antimetabolites|antimetabolites|mesh-ancestor
24857966|NCT02294552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24543356|NCT00683267|Dermatologic Agents|dermatologic agents|mesh-ancestor
24543357|NCT00683267|Sensory System Agents|sensory system agents|mesh-ancestor
24543358|NCT00683267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24543359|NCT00683267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543360|NCT00683306|Gefitinib|gefitinib|mesh-list
24543365|NCT00683319|Cyclophosphamide|cyclophosphamide|mesh-list
24543367|NCT00683319|Methotrexate|methotrexate|mesh-list
24543368|NCT00683319|Vincristine|vincristine|mesh-list
24543369|NCT00683319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24543370|NCT00683319|Immunologic Factors|immunologic factors|mesh-ancestor
24543371|NCT00683319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543372|NCT00683319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24755339|NCT01726075|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24755340|NCT01726075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24755341|NCT01726075|Adrenergic Agents|adrenergic agents|mesh-ancestor
24755342|NCT01726075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24755343|NCT01726075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755344|NCT01726075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619548|NCT01052961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24619565|NCT01052987|Antioxidants|antioxidants|mesh-ancestor
24619566|NCT01052987|Protective Agents|protective agents|mesh-ancestor
24619567|NCT01052987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619568|NCT01052987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24619570|NCT01052987|Analgesics|analgesics|mesh-ancestor
24619571|NCT01052987|Sensory System Agents|sensory system agents|mesh-ancestor
24619572|NCT01052987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24619573|NCT01052987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24619574|NCT01052987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24619575|NCT01052987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24619576|NCT01052987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24619577|NCT01052987|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24619578|NCT01052987|Histamine Antagonists|histamine antagonists|mesh-ancestor
24619579|NCT01052987|Histamine Agents|histamine agents|mesh-ancestor
24619580|NCT01052987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24619581|NCT01052987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24619582|NCT01052987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24619584|NCT01053026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24619585|NCT01053026|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24619586|NCT01053026|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24619587|NCT01053026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755360|NCT01726192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24755361|NCT01726205|Pregabalin|pregabalin|mesh-list
24755366|NCT01726205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755367|NCT01726205|Sensory System Agents|sensory system agents|mesh-ancestor
24755368|NCT01726205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24755369|NCT01726205|Analgesics|analgesics|mesh-ancestor
24755370|NCT01726205|Anticonvulsants|anticonvulsants|mesh-ancestor
24755371|NCT01726205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24755372|NCT01726205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24755444|NCT01726582|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25696653|NCT02064894|Analgesics|analgesics|mesh-ancestor
25696654|NCT02064894|Sensory System Agents|sensory system agents|mesh-ancestor
25696655|NCT02064894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25696656|NCT02064894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25696657|NCT02064894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24936076|NCT04044417|Simvastatin|simvastatin|mesh-list
24625520|NCT01082315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24625521|NCT01082315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24625522|NCT01082341|Vaccines|vaccines|mesh-list
24625523|NCT01082341|Immunologic Factors|immunologic factors|mesh-ancestor
24936078|NCT04044417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24936079|NCT04044417|Antimetabolites|antimetabolites|mesh-ancestor
24849864|NCT02250924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945043|NCT03954756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24945044|NCT03954756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24945045|NCT03954756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24945046|NCT03954756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857968|NCT02294552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24857969|NCT02294552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24543443|NCT00683865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543444|NCT00683865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543445|NCT00683865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543446|NCT00683865|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24543447|NCT00683865|Contraceptive Agents|contraceptive agents|mesh-ancestor
24543449|NCT00683865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543450|NCT00683865|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24543451|NCT00683865|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24543452|NCT00683865|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24755380|NCT01726283|Vitamins|vitamins|mesh-ancestor
24755381|NCT01726283|Micronutrients|micronutrients|mesh-ancestor
24755382|NCT01726283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755383|NCT01726283|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24755390|NCT01726400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24755404|NCT01726465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24755406|NCT01726465|Autonomic Agents|autonomic agents|mesh-ancestor
24755407|NCT01726465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24755408|NCT01726465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755409|NCT01726465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24755410|NCT01726465|Glucocorticoids|glucocorticoids|mesh-ancestor
24755411|NCT01726465|Hormones|hormones|mesh-ancestor
24755412|NCT01726465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24755413|NCT01726465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24755414|NCT01726465|Protective Agents|protective agents|mesh-ancestor
24755415|NCT01726465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24755416|NCT01726465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755417|NCT01726465|Antiviral Agents|antiviral agents|mesh-ancestor
24755418|NCT01726465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24755419|NCT01726465|Expectorants|expectorants|mesh-ancestor
24755420|NCT01726465|Respiratory System Agents|respiratory system agents|mesh-ancestor
24755421|NCT01726465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24755424|NCT01726465|Antidotes|antidotes|mesh-ancestor
24755425|NCT01726478|Oxytocin|oxytocin|mesh-list
24755426|NCT01726478|Oxytocics|oxytocics|mesh-ancestor
24755427|NCT01726478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24755428|NCT01726478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755439|NCT01726530|Anesthetics, General|anesthetics, general|mesh-ancestor
24755441|NCT01726582|Leucovorin|leucovorin|mesh-list
24755455|NCT01726582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755456|NCT01726582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24755457|NCT01726582|Antimetabolites|antimetabolites|mesh-ancestor
24755458|NCT01726582|Antiviral Agents|antiviral agents|mesh-ancestor
24755459|NCT01726582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24755460|NCT01726582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24755461|NCT01726582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24755468|NCT01726582|Vitamin B Complex|vitamin b complex|mesh-ancestor
24755469|NCT01726582|Vitamins|vitamins|mesh-ancestor
25696658|NCT02064894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25696659|NCT02064894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25696660|NCT02064894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25696661|NCT02064894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25696662|NCT02064894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696663|NCT02064907|Dexlansoprazole|dexlansoprazole|mesh-list
25696664|NCT02064907|Lansoprazole|lansoprazole|mesh-list
25696665|NCT02064907|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25696666|NCT02064907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25696667|NCT02064907|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24668448|NCT04918147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24668449|NCT04918147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24755470|NCT01726582|Micronutrients|micronutrients|mesh-ancestor
24755491|NCT01726777|Micronutrients|micronutrients|mesh-ancestor
24755492|NCT01726777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755493|NCT01726777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24755494|NCT01726777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24755495|NCT01726816|Probucol|probucol|mesh-list
24945061|NCT03954197|Hormones|hormones|mesh-list
24945062|NCT03954197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24945063|NCT03954197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945064|NCT03953989|Ranolazine|ranolazine|mesh-list
24945065|NCT03953989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24857973|NCT02294591|Acetylcysteine|acetylcysteine|mesh-list
24857974|NCT02294591|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24442768|NCT00292695|Ifosfamide|ifosfamide|mesh-list
24755496|NCT01726816|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24755497|NCT01726816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24755498|NCT01726816|Antimetabolites|antimetabolites|mesh-ancestor
24755499|NCT01726816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755500|NCT01726816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24755501|NCT01726816|Antioxidants|antioxidants|mesh-ancestor
24755502|NCT01726816|Protective Agents|protective agents|mesh-ancestor
24755503|NCT01726816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755504|NCT01726829|Pancrelipase|pancrelipase|mesh-list
24755505|NCT01726829|Pancreatin|pancreatin|mesh-list
24755506|NCT01726829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24755507|NCT01726920|Naproxen|naproxen|mesh-list
24755508|NCT01726920|Naratriptan|naratriptan|mesh-list
24755509|NCT01726920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24755510|NCT01726920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24755511|NCT01726920|Analgesics|analgesics|mesh-ancestor
24755512|NCT01726920|Sensory System Agents|sensory system agents|mesh-ancestor
24755517|NCT01726920|Gout Suppressants|gout suppressants|mesh-ancestor
24755518|NCT01726920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24755520|NCT01726920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755522|NCT01726920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24755523|NCT01726920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24755524|NCT01726920|Serotonin Agents|serotonin agents|mesh-ancestor
24755525|NCT01726920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24755526|NCT01726933|Dimethyl Fumarate|dimethyl fumarate|mesh-list
24755527|NCT01726933|Dermatologic Agents|dermatologic agents|mesh-ancestor
24755537|NCT01727271|Interferon alpha-2|interferon alpha-2|mesh-list
24755538|NCT01727271|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24755539|NCT01727271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755540|NCT01727271|Antiviral Agents|antiviral agents|mesh-ancestor
24755541|NCT01727271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24755542|NCT01727271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24755543|NCT01727271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24755545|NCT01727271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755546|NCT01727271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24755547|NCT01727271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24755548|NCT01727271|Immunologic Factors|immunologic factors|mesh-ancestor
24755549|NCT01727271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755551|NCT01727401|Fondaparinux|fondaparinux|mesh-list
24755552|NCT01727401|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24755553|NCT01727401|Antithrombins|antithrombins|mesh-ancestor
24755554|NCT01727401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25696668|NCT02064907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25696669|NCT02064907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696670|NCT02064920|Donepezil|donepezil|mesh-list
25696671|NCT02064920|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25696672|NCT02064920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24936175|NCT04043624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24755555|NCT01727401|Protease Inhibitors|protease inhibitors|mesh-ancestor
24755556|NCT01727401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24755557|NCT01727401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755558|NCT01727401|Anticoagulants|anticoagulants|mesh-ancestor
24755559|NCT01727401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24755560|NCT01727401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24755561|NCT01727427|Aspirin|aspirin|mesh-list
24755562|NCT01727427|Vitamin K|vitamin k|mesh-list
24755563|NCT01727427|Heparin|heparin|mesh-list
24755564|NCT01727427|Enoxaparin|enoxaparin|mesh-list
24755565|NCT01727427|Dalteparin|dalteparin|mesh-list
24755578|NCT01727427|Micronutrients|micronutrients|mesh-ancestor
24755579|NCT01727427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755580|NCT01727427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24755581|NCT01727427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24755582|NCT01727427|Analgesics|analgesics|mesh-ancestor
24755583|NCT01727427|Sensory System Agents|sensory system agents|mesh-ancestor
24755584|NCT01727427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24755585|NCT01727427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24755586|NCT01727427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24755587|NCT01727427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24755588|NCT01727427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24755589|NCT01727427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755590|NCT01727427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24945071|NCT03953950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24755591|NCT01727427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24755592|NCT01727427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24755594|NCT01727427|Anticoagulants|anticoagulants|mesh-ancestor
24755595|NCT01727427|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24755596|NCT01727427|Antithrombins|antithrombins|mesh-ancestor
24755597|NCT01727427|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24755598|NCT01727427|Protease Inhibitors|protease inhibitors|mesh-ancestor
24755599|NCT01727427|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24755600|NCT01727427|Hemostatics|hemostatics|mesh-ancestor
24755601|NCT01727427|Coagulants|coagulants|mesh-ancestor
24755603|NCT01727453|Anticoagulants|anticoagulants|mesh-ancestor
24755604|NCT01727531|Chloroquine|chloroquine|mesh-list
24755605|NCT01727531|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24755606|NCT01727531|Amebicides|amebicides|mesh-ancestor
24755607|NCT01727531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24755609|NCT01727531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24755610|NCT01727531|Antimalarials|antimalarials|mesh-ancestor
24755611|NCT01727531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24755612|NCT01727531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24661602|NCT01290133|Vestipitant|vestipitant|mesh-list
24755613|NCT01727531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24755614|NCT01727531|Analgesics|analgesics|mesh-ancestor
24755615|NCT01727531|Sensory System Agents|sensory system agents|mesh-ancestor
24755616|NCT01727531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24755617|NCT01727531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755618|NCT01727531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24755619|NCT01727531|Filaricides|filaricides|mesh-ancestor
24755620|NCT01727531|Antinematodal Agents|antinematodal agents|mesh-ancestor
24755624|NCT01727557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755625|NCT01727622|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24755626|NCT01727622|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24755627|NCT01727622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755629|NCT01727778|Immunoglobulin M|immunoglobulin m|mesh-list
24755630|NCT01727778|Immunologic Factors|immunologic factors|mesh-ancestor
24755631|NCT01727778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755632|NCT01727843|Tranexamic Acid|tranexamic acid|mesh-list
24755636|NCT01727843|Hemostatics|hemostatics|mesh-ancestor
24755653|NCT01728025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24755654|NCT01728025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755656|NCT01728051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24755657|NCT01728051|Alkylating Agents|alkylating agents|mesh-ancestor
24755658|NCT01728051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755659|NCT01728051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755660|NCT01728051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24755661|NCT01728051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24755662|NCT01728051|Immunologic Factors|immunologic factors|mesh-ancestor
25696673|NCT02064920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755663|NCT01728051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755664|NCT01728090|Hand Sanitizers|hand sanitizers|mesh-list
24755665|NCT01728090|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24755666|NCT01728090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24755667|NCT01728090|Disinfectants|disinfectants|mesh-ancestor
24755668|NCT01728181|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24755669|NCT01728181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755670|NCT01728181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24755671|NCT01728181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24755672|NCT01728181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755679|NCT01728272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755680|NCT01728272|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24755681|NCT01728272|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24755682|NCT01728272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24945072|NCT03953950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24945073|NCT03953950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24424174|NCT00228046|Anticonvulsants|anticonvulsants|mesh-ancestor
24755683|NCT01728272|Adrenergic Agents|adrenergic agents|mesh-ancestor
24755684|NCT01728272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24755685|NCT01728272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755686|NCT01728363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24755687|NCT01728363|Rifampin|rifampin|mesh-list
24755688|NCT01728363|Clindamycin|clindamycin|mesh-list
24755704|NCT01728363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24755705|NCT01728363|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24755706|NCT01728363|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24755707|NCT01728441|Paclitaxel|paclitaxel|mesh-list
24755708|NCT01728441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24755709|NCT01728441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24755710|NCT01728441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661718|NCT01290458|Antioxidants|antioxidants|mesh-list
24755711|NCT01728441|Tubulin Modulators|tubulin modulators|mesh-ancestor
24755712|NCT01728441|Antimitotic Agents|antimitotic agents|mesh-ancestor
24755713|NCT01728441|Mitosis Modulators|mitosis modulators|mesh-ancestor
24755714|NCT01728441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755716|NCT01728480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755717|NCT01728571|Vitamin D|vitamin d|mesh-list
24755718|NCT01728571|Ergocalciferols|ergocalciferols|mesh-list
24755719|NCT01728571|Cholecalciferol|cholecalciferol|mesh-list
24755720|NCT01728571|Vitamins|vitamins|mesh-list
24755721|NCT01728571|Micronutrients|micronutrients|mesh-ancestor
24755722|NCT01728571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755723|NCT01728571|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24755724|NCT01728571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24755725|NCT01728740|Metformin|metformin|mesh-list
24755726|NCT01728740|Acarbose|acarbose|mesh-list
24755727|NCT01728740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24755728|NCT01728740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755729|NCT01728740|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24755730|NCT01728740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24755731|NCT01728740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755732|NCT01728818|Gemcitabine|gemcitabine|mesh-list
24755733|NCT01728818|Afatinib|afatinib|mesh-list
24755734|NCT01728818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24755735|NCT01728818|Antimetabolites|antimetabolites|mesh-ancestor
24755736|NCT01728818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755758|NCT01728935|Antiviral Agents|antiviral agents|mesh-ancestor
24755759|NCT01728935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24755760|NCT01728935|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24755761|NCT01728935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24755762|NCT01728935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24755763|NCT01728935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755764|NCT01728935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24755765|NCT01728935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24755766|NCT01728948|Sorafenib|sorafenib|mesh-list
24755767|NCT01728948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755768|NCT01728948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24755769|NCT01728948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24755770|NCT01728948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755772|NCT01728961|Artemether|artemether|mesh-list
24755773|NCT01728961|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24755774|NCT01728961|Antimalarials|antimalarials|mesh-ancestor
24755775|NCT01728961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24755776|NCT01728961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24755777|NCT01728961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24755778|NCT01728974|Anesthetics|anesthetics|mesh-list
24755779|NCT01728974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24755780|NCT01728974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755781|NCT01728987|Cholecalciferol|cholecalciferol|mesh-list
24945074|NCT03953950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945075|NCT03953950|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24945076|NCT03953950|Hormone Antagonists|hormone antagonists|mesh-ancestor
24462858|NCT00357682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24755782|NCT01728987|Vitamin D|vitamin d|mesh-list
24619620|NCT01053208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24755784|NCT01728987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755786|NCT01728987|Micronutrients|micronutrients|mesh-ancestor
24755787|NCT01728987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24755788|NCT01729104|Rituximab|rituximab|mesh-list
24755789|NCT01729104|Lenalidomide|lenalidomide|mesh-list
24755790|NCT01729104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24755791|NCT01729104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420601|NCT00216411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24420602|NCT00216411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755796|NCT01729104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24755798|NCT01729104|Growth Inhibitors|growth inhibitors|mesh-ancestor
24755799|NCT01729195|Ciprofloxacin|ciprofloxacin|mesh-list
24755809|NCT01729260|Mebendazole|mebendazole|mesh-list
24755826|NCT01729468|Analgesics|analgesics|mesh-ancestor
24755827|NCT01729468|Sensory System Agents|sensory system agents|mesh-ancestor
24755828|NCT01729468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24755829|NCT01729468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755830|NCT01729468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24755831|NCT01729468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24755832|NCT01729468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24755834|NCT01729468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755835|NCT01729468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24755836|NCT01729468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24755837|NCT01729468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24755838|NCT01729468|Antipyretics|antipyretics|mesh-ancestor
24755839|NCT01729481|Leucovorin|leucovorin|mesh-list
24755840|NCT01729481|Folic Acid|folic acid|mesh-list
25696674|NCT02064920|Cholinergic Agents|cholinergic agents|mesh-ancestor
25696675|NCT02064920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24755841|NCT01729481|Gemcitabine|gemcitabine|mesh-list
24755842|NCT01729481|Oxaliplatin|oxaliplatin|mesh-list
24755843|NCT01729481|Irinotecan|irinotecan|mesh-list
24755844|NCT01729481|Levoleucovorin|levoleucovorin|mesh-list
24755845|NCT01729481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24755846|NCT01729481|Antimetabolites|antimetabolites|mesh-ancestor
24755847|NCT01729481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755848|NCT01729481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755849|NCT01729481|Antiviral Agents|antiviral agents|mesh-ancestor
24755850|NCT01729481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24755851|NCT01729481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24755853|NCT01729481|Immunologic Factors|immunologic factors|mesh-ancestor
24755854|NCT01729481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755855|NCT01729481|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24755856|NCT01729481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24755857|NCT01729481|Antidotes|antidotes|mesh-ancestor
24755858|NCT01729481|Protective Agents|protective agents|mesh-ancestor
24755859|NCT01729481|Vitamin B Complex|vitamin b complex|mesh-ancestor
24755860|NCT01729481|Vitamins|vitamins|mesh-ancestor
24650587|NCT01226680|Tofacitinib|tofacitinib|mesh-list
24755871|NCT01729663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24755872|NCT01729663|Immunologic Factors|immunologic factors|mesh-ancestor
24755873|NCT01729663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755874|NCT01729663|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24755875|NCT01729767|Acyclovir|acyclovir|mesh-list
24755876|NCT01729767|Antiviral Agents|antiviral agents|mesh-ancestor
24755879|NCT01729806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24755880|NCT01729806|Ipilimumab|ipilimumab|mesh-list
24755881|NCT01729806|Antibodies|antibodies|mesh-list
24755882|NCT01729806|Immunoglobulins|immunoglobulins|mesh-list
24945079|NCT03953950|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24533558|NCT00644384|Acitretin|acitretin|mesh-list
24631710|NCT01119599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24631711|NCT01119599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24945080|NCT03953950|Diuretics|diuretics|mesh-ancestor
24945081|NCT03953950|Natriuretic Agents|natriuretic agents|mesh-ancestor
24857976|NCT02294591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24857977|NCT02294591|Expectorants|expectorants|mesh-ancestor
24755900|NCT01729897|Narcotics|narcotics|mesh-ancestor
24755901|NCT01729897|Analgesics|analgesics|mesh-ancestor
24755902|NCT01729897|Sensory System Agents|sensory system agents|mesh-ancestor
24755903|NCT01729897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24755904|NCT01729897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24755905|NCT01730014|Insulin Glargine|insulin glargine|mesh-list
24755906|NCT01730014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24755907|NCT01730014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755908|NCT01730157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24447847|NCT00309699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25696676|NCT02064920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696677|NCT02064920|Nootropic Agents|nootropic agents|mesh-ancestor
25696678|NCT02064985|Ticagrelor|ticagrelor|mesh-list
25696679|NCT02064985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25696680|NCT02064985|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25696681|NCT02064985|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25696682|NCT02064985|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25696683|NCT02064985|Purinergic Agents|purinergic agents|mesh-ancestor
24755913|NCT01730157|Immunologic Factors|immunologic factors|mesh-ancestor
24755914|NCT01730157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755915|NCT01730157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755916|NCT01730157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24755917|NCT01730157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755919|NCT01730209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755920|NCT01730209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24755921|NCT01730209|Immunologic Factors|immunologic factors|mesh-ancestor
24755922|NCT01730209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755924|NCT01730222|Paclitaxel|paclitaxel|mesh-list
24755925|NCT01730222|Capecitabine|capecitabine|mesh-list
24755926|NCT01730222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24755927|NCT01730222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755928|NCT01730222|Tubulin Modulators|tubulin modulators|mesh-ancestor
24755929|NCT01730222|Antimitotic Agents|antimitotic agents|mesh-ancestor
24755930|NCT01730222|Mitosis Modulators|mitosis modulators|mesh-ancestor
24661879|NCT01291433|Antioxidants|antioxidants|mesh-ancestor
24755931|NCT01730222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755932|NCT01730222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24755934|NCT01730222|Antiviral Agents|antiviral agents|mesh-ancestor
24755935|NCT01730222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24755936|NCT01730222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24755937|NCT01730222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24755939|NCT01730222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755940|NCT01730287|Calcium, Dietary|calcium, dietary|mesh-list
24755941|NCT01730287|Calcium|calcium|mesh-list
24755942|NCT01730287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24755943|NCT01730287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755955|NCT01730326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24755956|NCT01730417|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24755957|NCT01730417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755958|NCT01730417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24755959|NCT01730417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755960|NCT01730417|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24755961|NCT01730495|Etanercept|etanercept|mesh-list
24755962|NCT01730495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24755963|NCT01730495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24755964|NCT01730495|Analgesics|analgesics|mesh-ancestor
24755965|NCT01730495|Sensory System Agents|sensory system agents|mesh-ancestor
24755966|NCT01730495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24755967|NCT01730495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755968|NCT01730495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24755978|NCT01730508|Immunologic Factors|immunologic factors|mesh-ancestor
24755979|NCT01730508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945086|NCT03954262|Propofol|propofol|mesh-list
24755980|NCT01730612|Histamine|histamine|mesh-list
24755981|NCT01730612|Glycine|glycine|mesh-list
24619621|NCT01053208|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24619622|NCT01053208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24619623|NCT01053208|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24619624|NCT01053208|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24619625|NCT01053208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24619626|NCT01053208|Anesthetics, Local|anesthetics, local|mesh-ancestor
24619627|NCT01053208|Anesthetics|anesthetics|mesh-ancestor
24619628|NCT01053208|Antiemetics|antiemetics|mesh-ancestor
24619629|NCT01053208|Autonomic Agents|autonomic agents|mesh-ancestor
24619630|NCT01053208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24619631|NCT01053208|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24727965|NCT01613794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24447848|NCT00309699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447850|NCT00309699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24447875|NCT00309725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24447876|NCT00309725|Nootropic Agents|nootropic agents|mesh-ancestor
24447877|NCT00309790|Sildenafil Citrate|sildenafil citrate|mesh-list
24447878|NCT00309790|Vasodilator Agents|vasodilator agents|mesh-ancestor
24447879|NCT00309790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24447880|NCT00309790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24447881|NCT00309790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25696684|NCT02064985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25696685|NCT02064985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696686|NCT02064985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619632|NCT01053208|Histamine Antagonists|histamine antagonists|mesh-ancestor
24619633|NCT01053208|Histamine Agents|histamine agents|mesh-ancestor
24619634|NCT01053208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24619635|NCT01053208|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24619636|NCT01053208|Antipruritics|antipruritics|mesh-ancestor
24619637|NCT01053208|Dermatologic Agents|dermatologic agents|mesh-ancestor
24619647|NCT01053338|Promethazine|promethazine|mesh-list
24619648|NCT01053338|Ibuprofen|ibuprofen|mesh-list
24619649|NCT01053338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619650|NCT01053338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24619655|NCT01053338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619656|NCT01053338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24619657|NCT01053338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24755982|NCT01730612|Histamine Agonists|histamine agonists|mesh-ancestor
24755983|NCT01730612|Histamine Agents|histamine agents|mesh-ancestor
24755987|NCT01730612|Glycine Agents|glycine agents|mesh-ancestor
24945087|NCT03954262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24945088|NCT03954262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24945089|NCT03954262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945090|NCT03954262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24945091|NCT03954262|Anesthetics, General|anesthetics, general|mesh-ancestor
24945092|NCT03954262|Anesthetics|anesthetics|mesh-ancestor
24945093|NCT03953781|Levetiracetam|levetiracetam|mesh-list
24945094|NCT03953781|Anticonvulsants|anticonvulsants|mesh-ancestor
24945095|NCT03953781|Nootropic Agents|nootropic agents|mesh-ancestor
24945096|NCT03953677|Dexmedetomidine|dexmedetomidine|mesh-list
24857984|NCT02294591|Antidotes|antidotes|mesh-ancestor
24756013|NCT01730976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24756014|NCT01731067|Fexofenadine|fexofenadine|mesh-list
24756015|NCT01731067|Flurbiprofen|flurbiprofen|mesh-list
24756016|NCT01731067|Midazolam|midazolam|mesh-list
24756017|NCT01731067|Dextromethorphan|dextromethorphan|mesh-list
24756018|NCT01731067|Caffeine|caffeine|mesh-list
24756019|NCT01731067|Bupropion|bupropion|mesh-list
24756020|NCT01731067|Omeprazole|omeprazole|mesh-list
24756028|NCT01731067|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24756029|NCT01731067|Anesthetics, General|anesthetics, general|mesh-ancestor
24756030|NCT01731067|Anesthetics|anesthetics|mesh-ancestor
24756031|NCT01731067|GABA Modulators|gaba modulators|mesh-ancestor
24756032|NCT01731067|GABA Agents|gaba agents|mesh-ancestor
24756033|NCT01731067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24756035|NCT01731067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24420791|NCT00216788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420792|NCT00216827|Betamethasone|betamethasone|mesh-list
24420793|NCT00216827|Betamethasone Valerate|betamethasone valerate|mesh-list
24756044|NCT01731067|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24756046|NCT01731067|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24756047|NCT01731067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24756048|NCT01731067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24756049|NCT01731067|Dopamine Agents|dopamine agents|mesh-ancestor
24756050|NCT01731067|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24756051|NCT01731067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24756052|NCT01731067|Antitussive Agents|antitussive agents|mesh-ancestor
24756053|NCT01731067|Respiratory System Agents|respiratory system agents|mesh-ancestor
24756054|NCT01731067|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24756055|NCT01731067|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24756056|NCT01731067|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24756057|NCT01731067|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24756058|NCT01731067|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25696688|NCT02065245|Streptomycin|streptomycin|mesh-list
25696689|NCT02065245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24756059|NCT01731067|Histamine Antagonists|histamine antagonists|mesh-ancestor
25696690|NCT02065245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25696691|NCT02065245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25696692|NCT02065245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756072|NCT01731132|Contraceptive Agents|contraceptive agents|mesh-ancestor
24756073|NCT01731132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24756074|NCT01731132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756085|NCT01731158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24756086|NCT01731158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24756087|NCT01731158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24756088|NCT01731158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24756089|NCT01731158|Growth Substances|growth substances|mesh-ancestor
24728379|NCT01615913|Ketoconazole|ketoconazole|mesh-list
24756148|NCT01731275|Quetmolimab|quetmolimab|mesh-list
24662004|NCT01291641|Antimetabolites|antimetabolites|mesh-ancestor
24756149|NCT01731275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24756150|NCT01731275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24756155|NCT01731301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756156|NCT01731301|Antiviral Agents|antiviral agents|mesh-ancestor
24756157|NCT01731301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24756159|NCT01731327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24756160|NCT01731327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756192|NCT01731574|Antiviral Agents|antiviral agents|mesh-ancestor
24756193|NCT01731574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24756194|NCT01731574|Antifungal Agents|antifungal agents|mesh-ancestor
24756195|NCT01731574|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24420908|NCT00217243|Lidocaine|lidocaine|mesh-list
24420909|NCT00217243|Anesthetics, Local|anesthetics, local|mesh-ancestor
24756196|NCT01731574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24756197|NCT01731574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756198|NCT01731574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696693|NCT02065245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696694|NCT02065336|Chlorpheniramine|chlorpheniramine|mesh-list
25696695|NCT02065336|Entecavir|entecavir|mesh-list
25696696|NCT02065336|Antiviral Agents|antiviral agents|mesh-ancestor
24756199|NCT01731574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25696697|NCT02065336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25696698|NCT02065336|Antipruritics|antipruritics|mesh-ancestor
25696699|NCT02065336|Dermatologic Agents|dermatologic agents|mesh-ancestor
24756200|NCT01731574|Hormone Antagonists|hormone antagonists|mesh-ancestor
24756201|NCT01731574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24756202|NCT01731574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756203|NCT01731574|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24756204|NCT01731574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24756205|NCT01731587|Cyclophosphamide|cyclophosphamide|mesh-list
24756215|NCT01731652|Imiquimod|imiquimod|mesh-list
24945104|NCT03953677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24945105|NCT03953677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24945107|NCT03953677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24756250|NCT01731795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24756251|NCT01731795|Antiemetics|antiemetics|mesh-ancestor
24756252|NCT01731795|Autonomic Agents|autonomic agents|mesh-ancestor
24756253|NCT01731795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24756254|NCT01731795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756255|NCT01731795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24756256|NCT01731795|Glucocorticoids|glucocorticoids|mesh-ancestor
24756257|NCT01731795|Hormones|hormones|mesh-ancestor
24756258|NCT01731795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24756259|NCT01731795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24756260|NCT01731795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24756261|NCT01731795|Protease Inhibitors|protease inhibitors|mesh-ancestor
24756262|NCT01731795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756277|NCT01731925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756278|NCT01731925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756279|NCT01732055|Antidepressive Agents|antidepressive agents|mesh-list
24756280|NCT01732055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24756288|NCT01732068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24756289|NCT01732068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421026|NCT00217503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24421027|NCT00217503|Antiviral Agents|antiviral agents|mesh-ancestor
24421028|NCT00217503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24421029|NCT00217503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24421030|NCT00217503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24421031|NCT00217516|Selenium|selenium|mesh-list
24756290|NCT01732094|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24756291|NCT01732094|Luteolytic Agents|luteolytic agents|mesh-ancestor
24756292|NCT01732094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24756293|NCT01732094|Contraceptive Agents|contraceptive agents|mesh-ancestor
24756294|NCT01732094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24756299|NCT01732146|Epoetin Alfa|epoetin alfa|mesh-list
24421063|NCT00217542|Protective Agents|protective agents|mesh-ancestor
24756323|NCT01732328|Vitamin D|vitamin d|mesh-list
24756324|NCT01732328|Calcium|calcium|mesh-list
24756325|NCT01732328|Vitamins|vitamins|mesh-ancestor
24756326|NCT01732328|Micronutrients|micronutrients|mesh-ancestor
24756327|NCT01732328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756328|NCT01732328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24756329|NCT01732328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24421066|NCT00217555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24421067|NCT00217555|Antimetabolites|antimetabolites|mesh-ancestor
24421068|NCT00217555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421069|NCT00217555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421070|NCT00217555|Antiviral Agents|antiviral agents|mesh-ancestor
24756338|NCT01732367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756340|NCT01732367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24756341|NCT01732380|Oxaliplatin|oxaliplatin|mesh-list
24756361|NCT01732666|Sensory System Agents|sensory system agents|mesh-ancestor
24756370|NCT01732744|Cathartics|cathartics|mesh-ancestor
24756371|NCT01732744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24756372|NCT01732861|Lenalidomide|lenalidomide|mesh-list
24756373|NCT01732861|Immunologic Factors|immunologic factors|mesh-ancestor
24756374|NCT01732861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756375|NCT01732861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24756376|NCT01732861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24756377|NCT01732861|Growth Substances|growth substances|mesh-ancestor
24756378|NCT01732861|Growth Inhibitors|growth inhibitors|mesh-ancestor
24756381|NCT01733017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24756382|NCT01733017|Antioxidants|antioxidants|mesh-ancestor
24756383|NCT01733017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756384|NCT01733017|Protective Agents|protective agents|mesh-ancestor
24756385|NCT01733017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760908|NCT01760330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24760909|NCT01760330|Analgesics|analgesics|mesh-ancestor
24760913|NCT01760330|Antipyretics|antipyretics|mesh-ancestor
24756386|NCT01733017|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24756387|NCT01733017|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24756388|NCT01733017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24756389|NCT01733030|Cycloserine|cycloserine|mesh-list
24756390|NCT01733030|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24756391|NCT01733030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24756392|NCT01733030|Renal Agents|renal agents|mesh-ancestor
24756393|NCT01733030|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24756394|NCT01733030|Antitubercular Agents|antitubercular agents|mesh-ancestor
24756395|NCT01733030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24756396|NCT01733030|Antimetabolites|antimetabolites|mesh-ancestor
24421119|NCT00217698|Immunologic Factors|immunologic factors|mesh-ancestor
24421120|NCT00217698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421121|NCT00217698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24421122|NCT00217711|Capecitabine|capecitabine|mesh-list
24756397|NCT01733030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756398|NCT01733043|Dexmedetomidine|dexmedetomidine|mesh-list
24756399|NCT01733043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24756400|NCT01733043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24756401|NCT01733043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756402|NCT01733043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24756403|NCT01733043|Analgesics|analgesics|mesh-ancestor
24756404|NCT01733043|Sensory System Agents|sensory system agents|mesh-ancestor
24756409|NCT01733043|Adrenergic Agents|adrenergic agents|mesh-ancestor
24756410|NCT01733043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24756411|NCT01733043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756413|NCT01733095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24756414|NCT01733108|Canagliflozin|canagliflozin|mesh-list
24756416|NCT01733108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24756417|NCT01733108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756418|NCT01733108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24756419|NCT01733108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756420|NCT01733134|Tolvaptan|tolvaptan|mesh-list
24756421|NCT01733134|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24756422|NCT01733134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756423|NCT01733134|Natriuretic Agents|natriuretic agents|mesh-ancestor
24756424|NCT01733134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756425|NCT01733290|Botulinum Toxins|botulinum toxins|mesh-list
24756426|NCT01733290|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24756428|NCT01733290|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24756429|NCT01733290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24945109|NCT03953677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24770346|NCT01819870|Carvedilol|carvedilol|mesh-list
24770347|NCT01819870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24770348|NCT01819870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24770349|NCT01819870|Adrenergic Agents|adrenergic agents|mesh-ancestor
24770350|NCT01819870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24770351|NCT01819870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770352|NCT01819870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756430|NCT01733290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756431|NCT01733290|Cholinergic Agents|cholinergic agents|mesh-ancestor
24756432|NCT01733290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24756433|NCT01733290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756434|NCT01733290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24756435|NCT01733290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24756437|NCT01733342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24756438|NCT01733342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756439|NCT01733394|Lamotrigine|lamotrigine|mesh-list
24756440|NCT01733394|Anticonvulsants|anticonvulsants|mesh-list
24756441|NCT01733394|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24756442|NCT01733394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24756443|NCT01733394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756444|NCT01733394|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25696700|NCT02065336|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25696701|NCT02065336|Histamine Antagonists|histamine antagonists|mesh-ancestor
25696702|NCT02065336|Histamine Agents|histamine agents|mesh-ancestor
25696703|NCT02065336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24756445|NCT01733394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756446|NCT01733394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24756447|NCT01733394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24756448|NCT01733394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24756450|NCT01733394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24756452|NCT01733459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24756453|NCT01733459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756455|NCT01733485|Indomethacin|indomethacin|mesh-list
24756456|NCT01733485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24756457|NCT01733485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24756458|NCT01733485|Analgesics|analgesics|mesh-ancestor
24756468|NCT01733485|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24756469|NCT01733485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756470|NCT01733485|Antipyretics|antipyretics|mesh-ancestor
24756471|NCT01733485|Gout Suppressants|gout suppressants|mesh-ancestor
24756472|NCT01733485|Tocolytic Agents|tocolytic agents|mesh-ancestor
24756473|NCT01733485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24756474|NCT01733589|Etoposide|etoposide|mesh-list
24756475|NCT01733589|Cisplatin|cisplatin|mesh-list
24756476|NCT01733589|Endostatins|endostatins|mesh-list
24756477|NCT01733589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24756478|NCT01733589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24756479|NCT01733589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24756480|NCT01733589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24756481|NCT01733589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770353|NCT01819870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24770354|NCT01819870|Antioxidants|antioxidants|mesh-ancestor
24770355|NCT01819870|Protective Agents|protective agents|mesh-ancestor
24756513|NCT01733966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24756514|NCT01733966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756515|NCT01733966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756516|NCT01733966|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24756517|NCT01733966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24756518|NCT01733966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24756519|NCT01733966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24756520|NCT01733966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24756521|NCT01733966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24756522|NCT01733966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24756523|NCT01733966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24756525|NCT01733979|Trace Elements|trace elements|mesh-ancestor
24756526|NCT01733979|Micronutrients|micronutrients|mesh-ancestor
24756527|NCT01733979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756528|NCT01733992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24756529|NCT01733992|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24756547|NCT01734057|Dexamethasone|dexamethasone|mesh-list
24770356|NCT01819870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24770357|NCT01819870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24770358|NCT01819870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24770359|NCT01819870|Vasodilator Agents|vasodilator agents|mesh-ancestor
24770360|NCT01819870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24756548|NCT01734057|Rituximab|rituximab|mesh-list
24756549|NCT01734057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24756550|NCT01734057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24756551|NCT01734057|Immunologic Factors|immunologic factors|mesh-ancestor
24756552|NCT01734057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756553|NCT01734057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24756557|NCT01734057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24756558|NCT01734057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24756559|NCT01734057|Glucocorticoids|glucocorticoids|mesh-ancestor
24756560|NCT01734057|Hormones|hormones|mesh-ancestor
24756561|NCT01734057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24756562|NCT01734057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24756563|NCT01734096|Candesartan|candesartan|mesh-list
24756564|NCT01734096|Candesartan cilexetil|candesartan cilexetil|mesh-list
24756565|NCT01734096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24756566|NCT01734096|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24756569|NCT01734252|Argatroban|argatroban|mesh-list
24619665|NCT01053338|Antiemetics|antiemetics|mesh-ancestor
24619666|NCT01053338|Autonomic Agents|autonomic agents|mesh-ancestor
24619667|NCT01053338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24619668|NCT01053338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24619669|NCT01053338|Histamine Antagonists|histamine antagonists|mesh-ancestor
24619670|NCT01053338|Histamine Agents|histamine agents|mesh-ancestor
24619671|NCT01053338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24619672|NCT01053338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24619679|NCT01053377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619680|NCT01053390|Leucovorin|leucovorin|mesh-list
24619681|NCT01053390|Fluorouracil|fluorouracil|mesh-list
24619682|NCT01053390|Epirubicin|epirubicin|mesh-list
24619683|NCT01053390|Somatostatin|somatostatin|mesh-list
24619684|NCT01053390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24619685|NCT01053390|Antimetabolites|antimetabolites|mesh-ancestor
24619686|NCT01053390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619687|NCT01053390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24619688|NCT01053390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24619689|NCT01053390|Immunologic Factors|immunologic factors|mesh-ancestor
24619690|NCT01053390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619691|NCT01053390|Antidotes|antidotes|mesh-ancestor
24619692|NCT01053390|Protective Agents|protective agents|mesh-ancestor
24619693|NCT01053390|Vitamin B Complex|vitamin b complex|mesh-ancestor
24770361|NCT01819870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24770362|NCT01819961|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24770363|NCT01819961|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24770364|NCT01819961|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24619695|NCT01053390|Micronutrients|micronutrients|mesh-ancestor
24619696|NCT01053390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24619697|NCT01053390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24619698|NCT01053390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24619699|NCT01053390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24846596|NCT02243137|Antipyretics|antipyretics|mesh-ancestor
24756598|NCT01734473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756600|NCT01734564|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24756601|NCT01734564|Poly ICLC|poly iclc|mesh-list
24756602|NCT01734564|Interferon Inducers|interferon inducers|mesh-ancestor
24756603|NCT01734564|Immunologic Factors|immunologic factors|mesh-ancestor
24756604|NCT01734564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756605|NCT01734564|Laxatives|laxatives|mesh-ancestor
24756606|NCT01734564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24756607|NCT01734564|Antiviral Agents|antiviral agents|mesh-ancestor
24756608|NCT01734564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24756609|NCT01734694|Vancomycin|vancomycin|mesh-list
24756610|NCT01734694|Linezolid|linezolid|mesh-list
24756611|NCT01734694|Daptomycin|daptomycin|mesh-list
24756612|NCT01734694|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
24756613|NCT01734694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24756614|NCT01734694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24756615|NCT01734694|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24756616|NCT01734694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729411|NCT01621451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24756628|NCT01734798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756629|NCT01734824|Denosumab|denosumab|mesh-list
24756648|NCT01734954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24616675|NCT01038583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616676|NCT01038583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24616677|NCT01038583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25696704|NCT02065336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696705|NCT02065336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696706|NCT02065336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25696707|NCT02065479|Ticagrelor|ticagrelor|mesh-list
25696708|NCT02065479|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25696709|NCT02065479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25696710|NCT02065479|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25696711|NCT02065479|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24936381|NCT04041167|Thioctic Acid|thioctic acid|mesh-list
24756649|NCT01734954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24756650|NCT01734954|Anesthetics, General|anesthetics, general|mesh-ancestor
24756651|NCT01734954|GABA Modulators|gaba modulators|mesh-ancestor
24756652|NCT01734954|GABA Agents|gaba agents|mesh-ancestor
24756680|NCT01735071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24756681|NCT01735071|Growth Substances|growth substances|mesh-ancestor
24756682|NCT01735071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756683|NCT01735071|Growth Inhibitors|growth inhibitors|mesh-ancestor
24756684|NCT01735071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24756685|NCT01735071|Alkylating Agents|alkylating agents|mesh-ancestor
24756686|NCT01735071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756687|NCT01735084|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24756688|NCT01735084|Immunologic Factors|immunologic factors|mesh-ancestor
24561441|NCT00760370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24561442|NCT00760370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561444|NCT00760448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24756689|NCT01735084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756690|NCT01735097|Vitamin E|vitamin e|mesh-list
24756691|NCT01735097|Vitamins|vitamins|mesh-ancestor
24756692|NCT01735097|Micronutrients|micronutrients|mesh-ancestor
24756693|NCT01735097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756694|NCT01735097|Antioxidants|antioxidants|mesh-ancestor
24756695|NCT01735097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756696|NCT01735097|Protective Agents|protective agents|mesh-ancestor
24756697|NCT01735123|Caseins|caseins|mesh-list
24756698|NCT01735123|Chelating Agents|chelating agents|mesh-ancestor
24756699|NCT01735123|Sequestering Agents|sequestering agents|mesh-ancestor
24756700|NCT01735123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756701|NCT01735227|Omeprazole|omeprazole|mesh-list
24756702|NCT01735227|Pantoprazole|pantoprazole|mesh-list
24756703|NCT01735227|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24756704|NCT01735227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24756705|NCT01735227|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24756706|NCT01735227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756707|NCT01735227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756708|NCT01735240|Ketoconazole|ketoconazole|mesh-list
24756709|NCT01735240|Antifungal Agents|antifungal agents|mesh-ancestor
24756710|NCT01735240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24756730|NCT01735344|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24756731|NCT01735344|Protease Inhibitors|protease inhibitors|mesh-ancestor
24756732|NCT01735344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756733|NCT01735344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756734|NCT01735344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24756735|NCT01735344|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24756736|NCT01735344|Protective Agents|protective agents|mesh-ancestor
24756737|NCT01735344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756738|NCT01735370|Etodolac|etodolac|mesh-list
24756739|NCT01735370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24756740|NCT01735370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24756741|NCT01735370|Analgesics|analgesics|mesh-ancestor
24756750|NCT01735370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756751|NCT01735383|Etodolac|etodolac|mesh-list
24662451|NCT01294969|Histamine Agents|histamine agents|mesh-ancestor
24756752|NCT01735383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24756753|NCT01735383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24756754|NCT01735383|Analgesics|analgesics|mesh-ancestor
24756755|NCT01735383|Sensory System Agents|sensory system agents|mesh-ancestor
24756756|NCT01735383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24756757|NCT01735383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756773|NCT01735487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756774|NCT01735669|Remifentanil|remifentanil|mesh-list
24756775|NCT01735669|Nitrous Oxide|nitrous oxide|mesh-list
24625965|NCT01084720|Dermatologic Agents|dermatologic agents|mesh-ancestor
24625966|NCT01084824|Cantharidin|cantharidin|mesh-list
24756783|NCT01735669|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24756784|NCT01735669|Anesthetics, General|anesthetics, general|mesh-ancestor
24756785|NCT01735669|Anesthetics|anesthetics|mesh-ancestor
24662476|NCT01295073|Trientine|trientine|mesh-list
24756786|NCT01735669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24756787|NCT01735747|Vincristine|vincristine|mesh-list
24756788|NCT01735747|Temozolomide|temozolomide|mesh-list
24756789|NCT01735747|Nedaplatin|nedaplatin|mesh-list
24756790|NCT01735747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24756793|NCT01735747|Antimitotic Agents|antimitotic agents|mesh-ancestor
24756794|NCT01735747|Mitosis Modulators|mitosis modulators|mesh-ancestor
24756796|NCT01735747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24756797|NCT01735747|Alkylating Agents|alkylating agents|mesh-ancestor
24756798|NCT01735825|Paclitaxel|paclitaxel|mesh-list
24756799|NCT01735825|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24756822|NCT01735890|Vasodilator Agents|vasodilator agents|mesh-ancestor
24756823|NCT01735890|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24756824|NCT01735890|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24756825|NCT01736020|Dexmedetomidine|dexmedetomidine|mesh-list
24756826|NCT01736020|Nitrous Oxide|nitrous oxide|mesh-list
24756827|NCT01736020|Ketamine|ketamine|mesh-list
24756828|NCT01736020|Propofol|propofol|mesh-list
24756829|NCT01736020|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24756882|NCT01736410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24756883|NCT01736410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24756884|NCT01736423|Ramosetron|ramosetron|mesh-list
24756885|NCT01736423|Antiemetics|antiemetics|mesh-ancestor
24756886|NCT01736423|Autonomic Agents|autonomic agents|mesh-ancestor
24756887|NCT01736423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24756888|NCT01736423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756889|NCT01736423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24756890|NCT01736423|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24756891|NCT01736423|Serotonin Agents|serotonin agents|mesh-ancestor
24756892|NCT01736423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24756893|NCT01736423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756894|NCT01736449|Bevacizumab|bevacizumab|mesh-list
24756895|NCT01736449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24850144|NCT02251925|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24850145|NCT02251925|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24756896|NCT01736449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24756897|NCT01736449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24756899|NCT01736449|Growth Substances|growth substances|mesh-ancestor
24756924|NCT01736514|Protective Agents|protective agents|mesh-ancestor
24756925|NCT01736514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756926|NCT01736670|Triamcinolone|triamcinolone|mesh-list
24756927|NCT01736670|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24756928|NCT01736670|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24756929|NCT01736670|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24756930|NCT01736670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24756931|NCT01736670|Glucocorticoids|glucocorticoids|mesh-ancestor
24756932|NCT01736670|Hormones|hormones|mesh-ancestor
24756933|NCT01736670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24756934|NCT01736670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756935|NCT01736670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24756936|NCT01736670|Immunologic Factors|immunologic factors|mesh-ancestor
24756937|NCT01736670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757519|NCT01740921|Aspirin|aspirin|mesh-list
24756938|NCT01736670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756940|NCT01736761|Darunavir|darunavir|mesh-list
24756941|NCT01736761|Rilpivirine|rilpivirine|mesh-list
24756942|NCT01736761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24756943|NCT01736761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24756944|NCT01736761|Protease Inhibitors|protease inhibitors|mesh-ancestor
24756945|NCT01736761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756946|NCT01736761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756947|NCT01736761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24756948|NCT01736761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24625967|NCT01084824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640160|NCT01166451|Iron|iron|mesh-list
24640302|NCT01167530|Everolimus|everolimus|mesh-list
24640379|NCT01167803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756949|NCT01736761|Antiviral Agents|antiviral agents|mesh-ancestor
24756954|NCT01736761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24756955|NCT01736800|Temozolomide|temozolomide|mesh-list
24756956|NCT01736800|Topotecan|topotecan|mesh-list
24757016|NCT01737203|Sildenafil Citrate|sildenafil citrate|mesh-list
24757017|NCT01737203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757018|NCT01737203|Vasodilator Agents|vasodilator agents|mesh-ancestor
24757019|NCT01737203|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24757020|NCT01737203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24757021|NCT01737203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757022|NCT01737203|Urological Agents|urological agents|mesh-ancestor
24757023|NCT01737216|Zoledronic Acid|zoledronic acid|mesh-list
24757024|NCT01737216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24757025|NCT01737216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757026|NCT01737294|Capsaicin|capsaicin|mesh-list
24757027|NCT01737294|Antipruritics|antipruritics|mesh-ancestor
24757028|NCT01737294|Dermatologic Agents|dermatologic agents|mesh-ancestor
24757029|NCT01737294|Sensory System Agents|sensory system agents|mesh-ancestor
24757030|NCT01737294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24619730|NCT01053585|Baclofen|baclofen|mesh-list
24619731|NCT01053585|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24619732|NCT01053585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619733|NCT01053585|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24619734|NCT01053585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24619735|NCT01053585|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24619736|NCT01053585|GABA Agonists|gaba agonists|mesh-ancestor
24619737|NCT01053585|GABA Agents|gaba agents|mesh-ancestor
24619738|NCT01053585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24619739|NCT01053585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696712|NCT02065479|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25696713|NCT02065479|Purinergic Agents|purinergic agents|mesh-ancestor
24619740|NCT01053611|Remifentanil|remifentanil|mesh-list
24619741|NCT01053611|Propofol|propofol|mesh-list
24619742|NCT01053611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24757055|NCT01737359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24936487|NCT04039815|Ascorbic Acid|ascorbic acid|mesh-list
24757056|NCT01737411|Solifenacin Succinate|solifenacin succinate|mesh-list
24757057|NCT01737411|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24757058|NCT01737411|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24757059|NCT01737411|Cholinergic Agents|cholinergic agents|mesh-ancestor
24757060|NCT01737411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24757061|NCT01737411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757062|NCT01737411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757063|NCT01737411|Urological Agents|urological agents|mesh-ancestor
24757064|NCT01737541|Fluoxetine|fluoxetine|mesh-list
24757065|NCT01737541|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24757066|NCT01737541|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24757067|NCT01737541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24757068|NCT01737541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757069|NCT01737541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24757070|NCT01737541|Serotonin Agents|serotonin agents|mesh-ancestor
24757071|NCT01737541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757072|NCT01737541|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24757073|NCT01737541|Antidepressive Agents|antidepressive agents|mesh-ancestor
24757074|NCT01737541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24757075|NCT01737541|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24757134|NCT01738087|Adrenergic Agents|adrenergic agents|mesh-ancestor
24757135|NCT01738087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24625968|NCT01084824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757162|NCT01738178|Caffeine|caffeine|mesh-list
24757171|NCT01738178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24757172|NCT01738243|Hyaluronic Acid|hyaluronic acid|mesh-list
24757179|NCT01738282|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24757180|NCT01738282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757182|NCT01738282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24757183|NCT01738282|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24757184|NCT01738282|GABA Agonists|gaba agonists|mesh-ancestor
24757185|NCT01738282|GABA Agents|gaba agents|mesh-ancestor
24757186|NCT01738282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24757187|NCT01738282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757188|NCT01738295|Donepezil|donepezil|mesh-list
24757189|NCT01738295|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24757190|NCT01738295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757192|NCT01738295|Cholinergic Agents|cholinergic agents|mesh-ancestor
24757218|NCT01738607|Psyllium|psyllium|mesh-list
24757219|NCT01738607|Laxatives|laxatives|mesh-ancestor
24757220|NCT01738607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24757221|NCT01738607|Cathartics|cathartics|mesh-ancestor
24757222|NCT01738724|Goserelin|goserelin|mesh-list
24757223|NCT01738724|Dienogest|dienogest|mesh-list
24757224|NCT01738724|Desogestrel|desogestrel|mesh-list
24757225|NCT01738724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24757226|NCT01738724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24757227|NCT01738724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24757228|NCT01738724|Contraceptive Agents|contraceptive agents|mesh-ancestor
24757229|NCT01738724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24757230|NCT01738724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662681|NCT01296256|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24757231|NCT01738724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24757233|NCT01738724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24757234|NCT01738724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24757254|NCT01738815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757255|NCT01738815|GABA Agents|gaba agents|mesh-ancestor
24757256|NCT01738815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24757257|NCT01738815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945115|NCT03953729|Sensory System Agents|sensory system agents|mesh-ancestor
24945116|NCT03953729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24945117|NCT03953729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945118|NCT03953729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24625975|NCT01084863|Tubulin Modulators|tubulin modulators|mesh-ancestor
24625976|NCT01084863|Antimitotic Agents|antimitotic agents|mesh-ancestor
24625977|NCT01084863|Mitosis Modulators|mitosis modulators|mesh-ancestor
24757261|NCT01738815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24757262|NCT01738867|Naltrexone|naltrexone|mesh-list
24757263|NCT01738867|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24757264|NCT01738867|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24757265|NCT01738867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757266|NCT01738867|Sensory System Agents|sensory system agents|mesh-ancestor
24757267|NCT01738867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24757268|NCT01738893|Gabapentin|gabapentin|mesh-list
24757269|NCT01738893|Analgesics|analgesics|mesh-ancestor
24757270|NCT01738893|Sensory System Agents|sensory system agents|mesh-ancestor
24757271|NCT01738893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24757272|NCT01738893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757273|NCT01738893|Anticonvulsants|anticonvulsants|mesh-ancestor
24757274|NCT01738893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24757275|NCT01738893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24757276|NCT01738893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24757277|NCT01738893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24757278|NCT01738893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24757279|NCT01738893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24757280|NCT01738893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24421949|NCT00220649|Vitamins|vitamins|mesh-ancestor
24757292|NCT01739049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24757293|NCT01739049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757295|NCT01739049|Hormones|hormones|mesh-ancestor
24757296|NCT01739049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24757297|NCT01739127|Risperidone|risperidone|mesh-list
24945120|NCT03953729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24945121|NCT03953729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24945122|NCT03953729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757298|NCT01739127|Aripiprazole|aripiprazole|mesh-list
24757299|NCT01739127|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24757300|NCT01739127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24757301|NCT01739127|Serotonin Agents|serotonin agents|mesh-ancestor
24757302|NCT01739127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24757303|NCT01739127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757304|NCT01739127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757305|NCT01739127|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24757306|NCT01739127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24757307|NCT01739127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24757308|NCT01739127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24757309|NCT01739127|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24757310|NCT01739127|Dopamine Agents|dopamine agents|mesh-ancestor
24757311|NCT01739127|Antidepressive Agents|antidepressive agents|mesh-ancestor
24757312|NCT01739127|Dopamine Agonists|dopamine agonists|mesh-ancestor
24757313|NCT01739127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24757314|NCT01739127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24757315|NCT01739127|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24757316|NCT01739127|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24757317|NCT01739192|Bupropion|bupropion|mesh-list
24757318|NCT01739192|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24757319|NCT01739192|Antidepressive Agents|antidepressive agents|mesh-ancestor
24757320|NCT01739192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24757321|NCT01739192|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24757322|NCT01739192|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24757323|NCT01739192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24757324|NCT01739192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757325|NCT01739192|Dopamine Agents|dopamine agents|mesh-ancestor
24757326|NCT01739192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24757327|NCT01739192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757328|NCT01739192|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24757329|NCT01739192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24757330|NCT01739192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757336|NCT01739218|Tubulin Modulators|tubulin modulators|mesh-ancestor
24757337|NCT01739218|Antimitotic Agents|antimitotic agents|mesh-ancestor
24757338|NCT01739218|Mitosis Modulators|mitosis modulators|mesh-ancestor
24757339|NCT01739218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757340|NCT01739218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24757341|NCT01739218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24757342|NCT01739218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24757344|NCT01739218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757345|NCT01739218|Growth Inhibitors|growth inhibitors|mesh-ancestor
24757346|NCT01739413|Anesthetics|anesthetics|mesh-list
24757347|NCT01739413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24757348|NCT01739413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757349|NCT01739439|Gemcitabine|gemcitabine|mesh-list
24757350|NCT01739439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24757351|NCT01739439|Antimetabolites|antimetabolites|mesh-ancestor
24945123|NCT03953716|Desogestrel|desogestrel|mesh-list
24945124|NCT03953716|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24945125|NCT03953716|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24757352|NCT01739439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757353|NCT01739439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24757354|NCT01739439|Antiviral Agents|antiviral agents|mesh-ancestor
24757355|NCT01739439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24757356|NCT01739439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757357|NCT01739439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24757362|NCT01739504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757365|NCT01739556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24757366|NCT01739556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24757367|NCT01739556|Analgesics|analgesics|mesh-ancestor
24757368|NCT01739556|Sensory System Agents|sensory system agents|mesh-ancestor
24757369|NCT01739556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24757374|NCT01739556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24757382|NCT01739556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24757383|NCT01739556|Purinergic Agents|purinergic agents|mesh-ancestor
24757384|NCT01739556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24757385|NCT01739582|Enclomiphene|enclomiphene|mesh-list
24757386|NCT01739582|Clomiphene|clomiphene|mesh-list
24757387|NCT01739582|Zuclomiphene|zuclomiphene|mesh-list
24757388|NCT01739582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24757389|NCT01739582|Hormone Antagonists|hormone antagonists|mesh-ancestor
24757390|NCT01739582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24757391|NCT01739582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757392|NCT01739582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24757393|NCT01739582|Fertility Agents|fertility agents|mesh-ancestor
24757394|NCT01739582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24757395|NCT01739582|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24757396|NCT01739582|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24757397|NCT01739634|Antidiarrheals|antidiarrheals|mesh-list
24757398|NCT01739634|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
24757399|NCT01739634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24757400|NCT01739673|Riboflavin|riboflavin|mesh-list
24757401|NCT01739673|Vitamin B Complex|vitamin b complex|mesh-ancestor
24757402|NCT01739673|Vitamins|vitamins|mesh-ancestor
24757403|NCT01739673|Micronutrients|micronutrients|mesh-ancestor
24757404|NCT01739673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422094|NCT00221416|Aripiprazole|aripiprazole|mesh-list
24757405|NCT01739673|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24619755|NCT01053637|Hydrocodone|hydrocodone|mesh-list
24619756|NCT01053637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24619757|NCT01053637|Analgesics|analgesics|mesh-ancestor
24619758|NCT01053637|Sensory System Agents|sensory system agents|mesh-ancestor
24619759|NCT01053637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24619760|NCT01053637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619761|NCT01053637|Antipyretics|antipyretics|mesh-ancestor
24619762|NCT01053637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24619763|NCT01053637|Narcotics|narcotics|mesh-ancestor
24619764|NCT01053637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24619765|NCT01053637|Antitussive Agents|antitussive agents|mesh-ancestor
24619766|NCT01053637|Respiratory System Agents|respiratory system agents|mesh-ancestor
24619767|NCT01053637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24619768|NCT01053637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25696714|NCT02065479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25696715|NCT02065479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696716|NCT02065479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696717|NCT02065557|Adalimumab|adalimumab|mesh-list
25696718|NCT02065557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25696719|NCT02065557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25696720|NCT02065570|Adalimumab|adalimumab|mesh-list
25696721|NCT02065570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24619769|NCT01053637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24619770|NCT01053650|Acetaminophen|acetaminophen|mesh-list
24945126|NCT03953716|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24945127|NCT03953716|Contraceptive Agents|contraceptive agents|mesh-ancestor
24544644|NCT00689780|Anesthetics|anesthetics|mesh-ancestor
24619771|NCT01053650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24619772|NCT01053650|Analgesics|analgesics|mesh-ancestor
24619773|NCT01053650|Sensory System Agents|sensory system agents|mesh-ancestor
24619798|NCT01053806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24619799|NCT01053871|Fentanyl|fentanyl|mesh-list
24619800|NCT01053871|Midazolam|midazolam|mesh-list
24619801|NCT01053871|Propofol|propofol|mesh-list
24619802|NCT01053871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24619803|NCT01053871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24619804|NCT01053871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619805|NCT01053871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24619806|NCT01053871|Anesthetics, General|anesthetics, general|mesh-ancestor
24619807|NCT01053871|Anesthetics|anesthetics|mesh-ancestor
24619808|NCT01053871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24619813|NCT01053871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24619814|NCT01053871|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24757406|NCT01739673|Dermatologic Agents|dermatologic agents|mesh-ancestor
24757407|NCT01739855|Ergocalciferols|ergocalciferols|mesh-list
24757408|NCT01739855|Calcium Carbonate|calcium carbonate|mesh-list
24757409|NCT01739855|Calcium|calcium|mesh-list
24757410|NCT01739855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24757411|NCT01739855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757412|NCT01739855|Antacids|antacids|mesh-ancestor
24757413|NCT01739855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757414|NCT01739855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24757415|NCT01739855|Vitamins|vitamins|mesh-ancestor
24757416|NCT01739855|Micronutrients|micronutrients|mesh-ancestor
24757417|NCT01739855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24757418|NCT01739894|Paclitaxel|paclitaxel|mesh-list
24757419|NCT01739894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24757420|NCT01739894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24757421|NCT01739894|Tubulin Modulators|tubulin modulators|mesh-ancestor
24757422|NCT01739894|Antimitotic Agents|antimitotic agents|mesh-ancestor
24757423|NCT01739894|Mitosis Modulators|mitosis modulators|mesh-ancestor
24757424|NCT01739894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757425|NCT01739907|Vitamin D|vitamin d|mesh-list
24757426|NCT01739907|Vitamins|vitamins|mesh-ancestor
24757427|NCT01739907|Micronutrients|micronutrients|mesh-ancestor
24757428|NCT01739907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757429|NCT01739907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24757430|NCT01739920|Povidone-Iodine|povidone-iodine|mesh-list
24757431|NCT01739920|Povidone|povidone|mesh-list
24422141|NCT00221481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24422142|NCT00221481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757489|NCT01740336|Mitosis Modulators|mitosis modulators|mesh-ancestor
24945140|NCT03953326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945141|NCT03953326|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24945142|NCT03953326|Cholinergic Agents|cholinergic agents|mesh-ancestor
24945143|NCT03953326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24731203|NCT01633203|Antimetabolites|antimetabolites|mesh-ancestor
24945149|NCT03953235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24945150|NCT03953235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945152|NCT03953170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24945153|NCT03953170|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24945154|NCT03953170|Protective Agents|protective agents|mesh-ancestor
24945155|NCT03953170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945156|NCT03953001|Lidocaine|lidocaine|mesh-list
24945157|NCT03953001|Epinephrine|epinephrine|mesh-list
24945158|NCT03953001|Anesthetics, Local|anesthetics, local|mesh-list
24945159|NCT03953001|Anesthetics|anesthetics|mesh-list
24945160|NCT03953001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24858032|NCT02294656|Glucocorticoids|glucocorticoids|mesh-ancestor
24757490|NCT01740336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757491|NCT01740453|Ropivacaine|ropivacaine|mesh-list
24757492|NCT01740453|Anesthetics, Local|anesthetics, local|mesh-ancestor
24757493|NCT01740453|Anesthetics|anesthetics|mesh-ancestor
24757494|NCT01740453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24757495|NCT01740453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757496|NCT01740453|Sensory System Agents|sensory system agents|mesh-ancestor
24757497|NCT01740453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24757514|NCT01740518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757515|NCT01740518|Protective Agents|protective agents|mesh-ancestor
24757516|NCT01740518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757517|NCT01740518|Vitamins|vitamins|mesh-ancestor
24757518|NCT01740518|Micronutrients|micronutrients|mesh-ancestor
24945165|NCT03953001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24757521|NCT01740921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24757522|NCT01740921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24757524|NCT01740921|Sensory System Agents|sensory system agents|mesh-ancestor
24757525|NCT01740921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24757526|NCT01740921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757527|NCT01740921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24757528|NCT01740921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24757530|NCT01740921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24757531|NCT01740921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757532|NCT01740921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24757533|NCT01740921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24757534|NCT01740921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757535|NCT01740921|Antipyretics|antipyretics|mesh-ancestor
24757536|NCT01740921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24449918|NCT00317408|Immunologic Factors|immunologic factors|mesh-ancestor
25696722|NCT02065570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25696724|NCT02065622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25696725|NCT02065622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25696726|NCT02065687|Metformin|metformin|mesh-list
24812047|NCT02049411|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24757538|NCT01740921|Hormones|hormones|mesh-ancestor
24757539|NCT01740921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24757540|NCT01740947|Tobramycin|tobramycin|mesh-list
24757541|NCT01740947|Amphotericin B|amphotericin b|mesh-list
24757542|NCT01740947|Colistin|colistin|mesh-list
24757543|NCT01740947|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24757544|NCT01740947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24757545|NCT01740947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24757546|NCT01740947|Amebicides|amebicides|mesh-ancestor
24757547|NCT01740947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24757548|NCT01740947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24757549|NCT01740947|Antifungal Agents|antifungal agents|mesh-ancestor
24757550|NCT01740960|Dronabinol|dronabinol|mesh-list
24757552|NCT01740960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757553|NCT01740960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24757554|NCT01740960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24757555|NCT01740960|Analgesics|analgesics|mesh-ancestor
24757556|NCT01740960|Sensory System Agents|sensory system agents|mesh-ancestor
24757557|NCT01740960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24757558|NCT01740960|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24757559|NCT01740960|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24757560|NCT01740960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24757561|NCT01740960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757562|NCT01740960|Hormones|hormones|mesh-ancestor
24757563|NCT01740960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24757564|NCT01741038|Cetuximab|cetuximab|mesh-list
24757565|NCT01741038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24757566|NCT01741038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24757567|NCT01741077|Folic Acid|folic acid|mesh-list
24757568|NCT01741077|Hematinics|hematinics|mesh-ancestor
24757569|NCT01741077|Vitamin B Complex|vitamin b complex|mesh-ancestor
24757570|NCT01741077|Vitamins|vitamins|mesh-ancestor
24757571|NCT01741077|Micronutrients|micronutrients|mesh-ancestor
24757572|NCT01741077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757573|NCT01741142|Citalopram|citalopram|mesh-list
24757574|NCT01741142|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24422250|NCT00221754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24422251|NCT00221754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24422252|NCT00221754|Antimetabolites|antimetabolites|mesh-ancestor
24422275|NCT00221871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422276|NCT00221962|Aripiprazole|aripiprazole|mesh-list
24422277|NCT00221962|Antidepressive Agents|antidepressive agents|mesh-ancestor
24757577|NCT01741142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757578|NCT01741142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24757579|NCT01741142|Serotonin Agents|serotonin agents|mesh-ancestor
24757580|NCT01741142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757581|NCT01741142|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24757582|NCT01741142|Antidepressive Agents|antidepressive agents|mesh-ancestor
24757583|NCT01741142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24757584|NCT01741181|Vitamin D|vitamin d|mesh-list
24757585|NCT01741181|Ergocalciferols|ergocalciferols|mesh-list
24731511|NCT01635205|Anesthetics|anesthetics|mesh-list
25696727|NCT02065687|Paclitaxel|paclitaxel|mesh-list
25696728|NCT02065687|Carboplatin|carboplatin|mesh-list
25696729|NCT02065687|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25696730|NCT02065687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24936558|NCT04038970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24936559|NCT04038853|Vitamin D|vitamin d|mesh-list
25696731|NCT02065687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24757586|NCT01741181|Cholecalciferol|cholecalciferol|mesh-list
24757587|NCT01741181|Vitamins|vitamins|mesh-list
24757588|NCT01741181|Micronutrients|micronutrients|mesh-ancestor
24757589|NCT01741181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757590|NCT01741181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24757591|NCT01741181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24757593|NCT01741285|Beclomethasone|beclomethasone|mesh-list
24757594|NCT01741285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24757595|NCT01741285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24757596|NCT01741285|Autonomic Agents|autonomic agents|mesh-ancestor
24757597|NCT01741285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24757598|NCT01741285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757599|NCT01741285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24757600|NCT01741285|Respiratory System Agents|respiratory system agents|mesh-ancestor
24757601|NCT01741285|Dermatologic Agents|dermatologic agents|mesh-ancestor
24757602|NCT01741285|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24757603|NCT01741285|Glucocorticoids|glucocorticoids|mesh-ancestor
24757604|NCT01741285|Hormones|hormones|mesh-ancestor
24757606|NCT01741324|Vitamin D|vitamin d|mesh-list
24757614|NCT01741376|Progesterone|progesterone|mesh-list
24757615|NCT01741376|Progestins|progestins|mesh-ancestor
24757616|NCT01741376|Hormones|hormones|mesh-ancestor
24757617|NCT01741376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24757618|NCT01741376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757619|NCT01741389|Melatonin|melatonin|mesh-list
24757620|NCT01741389|Antioxidants|antioxidants|mesh-ancestor
24757621|NCT01741389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757622|NCT01741389|Protective Agents|protective agents|mesh-ancestor
24757623|NCT01741389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757624|NCT01741389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24757625|NCT01741493|Upadacitinib|upadacitinib|mesh-list
24757626|NCT01741493|Tofacitinib|tofacitinib|mesh-list
24757627|NCT01741493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24757631|NCT01741493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24757645|NCT01741519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24757646|NCT01741519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757647|NCT01741519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757648|NCT01741519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24757649|NCT01741558|Riboflavin|riboflavin|mesh-list
24757650|NCT01741558|Methotrexate|methotrexate|mesh-list
24757651|NCT01741558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24945169|NCT03953001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24945170|NCT03953001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24945171|NCT03953001|Adrenergic Agents|adrenergic agents|mesh-ancestor
24945172|NCT03953001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24945173|NCT03953001|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24945174|NCT03953001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24945175|NCT03953001|Autonomic Agents|autonomic agents|mesh-ancestor
24945176|NCT03953001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24858049|NCT02294955|Dronedarone|dronedarone|mesh-list
24757652|NCT01741558|Abortifacient Agents|abortifacient agents|mesh-ancestor
24757674|NCT01741623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24757675|NCT01741623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757676|NCT01741623|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24757678|NCT01741623|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24757679|NCT01741623|Adrenergic Agents|adrenergic agents|mesh-ancestor
24757682|NCT01741649|Povidone|povidone|mesh-list
24422369|NCT00222235|Glycine Agents|glycine agents|mesh-ancestor
24757689|NCT01741753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24757690|NCT01741753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757691|NCT01741753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24757692|NCT01741753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24757694|NCT01741831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25696732|NCT02065687|Tubulin Modulators|tubulin modulators|mesh-ancestor
25696733|NCT02065687|Antimitotic Agents|antimitotic agents|mesh-ancestor
25696734|NCT02065687|Mitosis Modulators|mitosis modulators|mesh-ancestor
25696735|NCT02065687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696736|NCT02065687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24850286|NCT02252614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24850287|NCT02252614|Analgesics|analgesics|mesh-ancestor
24757695|NCT01741831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24757696|NCT01741831|Protease Inhibitors|protease inhibitors|mesh-ancestor
24548243|NCT00708578|Metformin|metformin|mesh-list
24757697|NCT01741831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757708|NCT01742247|Sensory System Agents|sensory system agents|mesh-ancestor
24757709|NCT01742247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24619815|NCT01053871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24619816|NCT01053871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24619817|NCT01053871|GABA Modulators|gaba modulators|mesh-ancestor
24619818|NCT01053871|GABA Agents|gaba agents|mesh-ancestor
24619819|NCT01053871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24619820|NCT01053871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619821|NCT01053884|Anidulafungin|anidulafungin|mesh-list
24619822|NCT01053884|Antifungal Agents|antifungal agents|mesh-ancestor
24619823|NCT01053884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24619824|NCT01053910|Ramipril|ramipril|mesh-list
24619825|NCT01053910|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24619826|NCT01053910|Protease Inhibitors|protease inhibitors|mesh-ancestor
24619827|NCT01053910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24619828|NCT01053910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619829|NCT01053910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24619830|NCT01053949|Thalidomide|thalidomide|mesh-list
24619831|NCT01053949|Pomalidomide|pomalidomide|mesh-list
24619832|NCT01053949|Immunologic Factors|immunologic factors|mesh-ancestor
24619833|NCT01053949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619834|NCT01053949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24619842|NCT01053949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24619844|NCT01054001|Vasodilator Agents|vasodilator agents|mesh-ancestor
24619845|NCT01054001|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24619846|NCT01054001|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24619847|NCT01054001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422403|NCT00222469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24422404|NCT00222469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24422405|NCT00222469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24422406|NCT00222469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24422407|NCT00222469|Growth Substances|growth substances|mesh-ancestor
24422408|NCT00222469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732023|NCT01637558|Ritonavir|ritonavir|mesh-list
24619848|NCT01054001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619849|NCT01054001|Urological Agents|urological agents|mesh-ancestor
24619850|NCT01054027|Phenylephrine|phenylephrine|mesh-list
24619851|NCT01054027|Oxymetazoline|oxymetazoline|mesh-list
24619852|NCT01054027|Cyclopentolate|cyclopentolate|mesh-list
24619853|NCT01054027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24619854|NCT01054027|Mydriatics|mydriatics|mesh-ancestor
24619855|NCT01054027|Autonomic Agents|autonomic agents|mesh-ancestor
24619856|NCT01054027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24619857|NCT01054027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619858|NCT01054027|Sympathomimetics|sympathomimetics|mesh-ancestor
24619859|NCT01054027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24619860|NCT01054027|Nasal Decongestants|nasal decongestants|mesh-ancestor
24619861|NCT01054027|Respiratory System Agents|respiratory system agents|mesh-ancestor
24619862|NCT01054027|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24619863|NCT01054027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24619864|NCT01054027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24619865|NCT01054027|Adrenergic Agents|adrenergic agents|mesh-ancestor
25696737|NCT02065687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696738|NCT02065713|Golimumab|golimumab|mesh-list
25696739|NCT02065713|Methotrexate|methotrexate|mesh-list
25696740|NCT02065713|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25696741|NCT02065713|Abortifacient Agents|abortifacient agents|mesh-ancestor
25696742|NCT02065713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25696743|NCT02065713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696744|NCT02065713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25696745|NCT02065713|Antimetabolites|antimetabolites|mesh-ancestor
25696746|NCT02065713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696747|NCT02065713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25696748|NCT02065713|Dermatologic Agents|dermatologic agents|mesh-ancestor
24619866|NCT01054027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24619867|NCT01054027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619868|NCT01054027|Protective Agents|protective agents|mesh-ancestor
24619869|NCT01054027|Parasympatholytics|parasympatholytics|mesh-ancestor
24619870|NCT01054027|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24619871|NCT01054027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24619872|NCT01054027|Cholinergic Agents|cholinergic agents|mesh-ancestor
24619873|NCT01054092|Ipragliflozin|ipragliflozin|mesh-list
24422418|NCT00222482|Valproic Acid|valproic acid|mesh-list
24945178|NCT03953001|Mydriatics|mydriatics|mesh-ancestor
24945181|NCT03953287|Acetaminophen|acetaminophen|mesh-list
24945182|NCT03953287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24945183|NCT03953287|Analgesics|analgesics|mesh-ancestor
24619874|NCT01054092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24619875|NCT01054092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619876|NCT01054092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24619877|NCT01054092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619879|NCT01054105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24757710|NCT01742247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757711|NCT01742247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24757712|NCT01742247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24757713|NCT01742247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24757714|NCT01742247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24757716|NCT01742247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24757728|NCT01742273|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24757729|NCT01742273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24757730|NCT01742273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757731|NCT01742273|Hemostatics|hemostatics|mesh-ancestor
24757732|NCT01742273|Coagulants|coagulants|mesh-ancestor
24757733|NCT01742338|Prednisone|prednisone|mesh-list
24757734|NCT01742338|Methylprednisolone|methylprednisolone|mesh-list
24757735|NCT01742338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24757736|NCT01742338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24757737|NCT01742338|Prednisolone|prednisolone|mesh-list
24757738|NCT01742338|Prednisolone acetate|prednisolone acetate|mesh-list
24422469|NCT00222547|Anthelmintics|anthelmintics|mesh-ancestor
24422470|NCT00222547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24422471|NCT00222547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24757739|NCT01742338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24757740|NCT01742338|Prednisolone phosphate|prednisolone phosphate|mesh-list
24757741|NCT01742338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24757742|NCT01742338|Glucocorticoids|glucocorticoids|mesh-ancestor
24757743|NCT01742338|Hormones|hormones|mesh-ancestor
24757744|NCT01742338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24757745|NCT01742338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757746|NCT01742338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24757747|NCT01742338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24757748|NCT01742338|Antiemetics|antiemetics|mesh-ancestor
24757749|NCT01742338|Autonomic Agents|autonomic agents|mesh-ancestor
24757750|NCT01742338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24757751|NCT01742338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24757752|NCT01742338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24757753|NCT01742338|Protective Agents|protective agents|mesh-ancestor
24757754|NCT01742390|Risperidone|risperidone|mesh-list
24757755|NCT01742390|Aripiprazole|aripiprazole|mesh-list
24757756|NCT01742390|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24757757|NCT01742390|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24757758|NCT01742390|Serotonin Agents|serotonin agents|mesh-ancestor
24757759|NCT01742390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24757760|NCT01742390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757782|NCT01742429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24757783|NCT01742429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24757784|NCT01742429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24757785|NCT01742429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24757786|NCT01742429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24757788|NCT01742429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24757800|NCT01742533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24757801|NCT01742533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757804|NCT01742624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24757805|NCT01742624|Immunologic Factors|immunologic factors|mesh-ancestor
24757806|NCT01742624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757807|NCT01742624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24757808|NCT01742624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757809|NCT01742624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757810|NCT01742624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24757811|NCT01742624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24757812|NCT01742624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24757813|NCT01742624|Antitubercular Agents|antitubercular agents|mesh-ancestor
24757814|NCT01742624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24757815|NCT01742624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24757816|NCT01742637|Adapalene|adapalene|mesh-list
24757817|NCT01742637|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24757818|NCT01742637|Dermatologic Agents|dermatologic agents|mesh-ancestor
24757819|NCT01742637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24757820|NCT01742637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24732477|NCT01639547|Ribavirin|ribavirin|mesh-list
24757826|NCT01742637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24757827|NCT01742663|Diclofenac|diclofenac|mesh-list
24757828|NCT01742663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24757832|NCT01742663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24757839|NCT01742676|Tacrolimus|tacrolimus|mesh-list
24757840|NCT01742676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24757843|NCT01742676|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24757868|NCT01742702|Nitroglycerin|nitroglycerin|mesh-list
24757869|NCT01742702|Albuterol|albuterol|mesh-list
24757870|NCT01742702|Caseins|caseins|mesh-list
24757871|NCT01742702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24757872|NCT01742702|Autonomic Agents|autonomic agents|mesh-ancestor
24757873|NCT01742702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24757874|NCT01742702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757875|NCT01742702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24757876|NCT01742702|Respiratory System Agents|respiratory system agents|mesh-ancestor
24757877|NCT01742702|Tocolytic Agents|tocolytic agents|mesh-ancestor
24757878|NCT01742702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24757879|NCT01742702|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24757880|NCT01742702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24757881|NCT01742702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24757883|NCT01742702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24757884|NCT01742702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757886|NCT01742702|Chelating Agents|chelating agents|mesh-ancestor
24757887|NCT01742702|Sequestering Agents|sequestering agents|mesh-ancestor
24757888|NCT01742702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24757889|NCT01742702|Sympatholytics|sympatholytics|mesh-ancestor
24422601|NCT00223054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24757890|NCT01742702|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24757891|NCT01742702|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24757906|NCT01742793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24757907|NCT01742793|Growth Substances|growth substances|mesh-ancestor
24757908|NCT01742793|Growth Inhibitors|growth inhibitors|mesh-ancestor
24757909|NCT01742793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24757910|NCT01742793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24757911|NCT01742845|Ropivacaine|ropivacaine|mesh-list
24945192|NCT03953209|Spironolactone|spironolactone|mesh-list
24945193|NCT03953209|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24945194|NCT03953209|Hormone Antagonists|hormone antagonists|mesh-ancestor
24945195|NCT03953209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25051303|NCT00422019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25051304|NCT00422019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858065|NCT02294955|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24757912|NCT01742845|Anesthetics, Local|anesthetics, local|mesh-ancestor
24757913|NCT01742845|Anesthetics|anesthetics|mesh-ancestor
24757914|NCT01742845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24757917|NCT01742845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24757918|NCT01742988|Rituximab|rituximab|mesh-list
24757919|NCT01742988|Venetoclax|venetoclax|mesh-list
25696749|NCT02065713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757925|NCT01743014|Ramipril|ramipril|mesh-list
24757934|NCT01743014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757935|NCT01743014|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24757936|NCT01743014|Protease Inhibitors|protease inhibitors|mesh-ancestor
24757937|NCT01743014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757938|NCT01743014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24757939|NCT01743066|Vitamin E|vitamin e|mesh-list
24757949|NCT01743079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24757951|NCT01743079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757952|NCT01743079|Antiviral Agents|antiviral agents|mesh-ancestor
24757953|NCT01743079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24757954|NCT01743079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24757955|NCT01743079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24757974|NCT01743157|Ipilimumab|ipilimumab|mesh-list
24757986|NCT01743157|Analgesics|analgesics|mesh-ancestor
24757987|NCT01743157|Sensory System Agents|sensory system agents|mesh-ancestor
24757988|NCT01743157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24757989|NCT01743235|Buspirone|buspirone|mesh-list
24757990|NCT01743235|Testosterone|testosterone|mesh-list
24757991|NCT01743235|Androgens|androgens|mesh-ancestor
24757992|NCT01743235|Hormones|hormones|mesh-ancestor
24732741|NCT01641250|Antimetabolites|antimetabolites|mesh-ancestor
24757994|NCT01743235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758000|NCT01743235|Serotonin Agents|serotonin agents|mesh-ancestor
24758001|NCT01743235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24758002|NCT01743235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758003|NCT01743300|Sunitinib|sunitinib|mesh-list
24758004|NCT01743300|Midazolam|midazolam|mesh-list
24758005|NCT01743300|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24758006|NCT01743300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24758007|NCT01743300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24758008|NCT01743300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758009|NCT01743300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24758010|NCT01743300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24619880|NCT01054105|Vasodilator Agents|vasodilator agents|mesh-ancestor
24619881|NCT01054118|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24619882|NCT01054118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24619883|NCT01054118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619884|NCT01054118|Incretins|incretins|mesh-ancestor
25051305|NCT00422019|Immunologic Factors|immunologic factors|mesh-ancestor
25051306|NCT00422019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051307|NCT00420888|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25051308|NCT00420888|Immunoconjugates|immunoconjugates|mesh-list
25051309|NCT00420888|Immunologic Factors|immunologic factors|mesh-ancestor
25051310|NCT00420888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051311|NCT00417209|Fluorouracil|fluorouracil|mesh-list
25051312|NCT00417209|Capecitabine|capecitabine|mesh-list
25696750|NCT02065713|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25696751|NCT02065713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24936685|NCT04037657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24936686|NCT04037657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24936687|NCT04037657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936688|NCT04037657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24850441|NCT02253004|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24850442|NCT02253004|Respiratory System Agents|respiratory system agents|mesh-ancestor
24850443|NCT02253004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25051313|NCT00417209|Antimetabolites|antimetabolites|mesh-ancestor
24619886|NCT01054118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24619887|NCT01054118|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24619888|NCT01054118|Protease Inhibitors|protease inhibitors|mesh-ancestor
24619889|NCT01054118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24619891|NCT01054313|Sirolimus|sirolimus|mesh-list
24619892|NCT01054313|Prednisone|prednisone|mesh-list
24619893|NCT01054313|Docetaxel|docetaxel|mesh-list
24619894|NCT01054313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24619895|NCT01054313|Tubulin Modulators|tubulin modulators|mesh-ancestor
24619896|NCT01054313|Antimitotic Agents|antimitotic agents|mesh-ancestor
24619897|NCT01054313|Mitosis Modulators|mitosis modulators|mesh-ancestor
24619898|NCT01054313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619899|NCT01054313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24619900|NCT01054313|Glucocorticoids|glucocorticoids|mesh-ancestor
24619901|NCT01054313|Hormones|hormones|mesh-ancestor
24619902|NCT01054313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24619903|NCT01054313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619904|NCT01054313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24619905|NCT01054313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24619906|NCT01054313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24619907|NCT01054313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24619908|NCT01054313|Antifungal Agents|antifungal agents|mesh-ancestor
24619909|NCT01054313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24619910|NCT01054313|Immunologic Factors|immunologic factors|mesh-ancestor
24619912|NCT01054469|Anesthetics, Local|anesthetics, local|mesh-ancestor
24619913|NCT01054469|Anesthetics|anesthetics|mesh-ancestor
24619914|NCT01054469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24619915|NCT01054469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619916|NCT01054469|Sensory System Agents|sensory system agents|mesh-ancestor
24758257|NCT01744587|Protective Agents|protective agents|mesh-ancestor
24619917|NCT01054469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24619919|NCT01054508|Niacin|niacin|mesh-list
24619920|NCT01054508|Niacinamide|niacinamide|mesh-list
24619921|NCT01054508|Vitamin B Complex|vitamin b complex|mesh-ancestor
24619922|NCT01054508|Vitamins|vitamins|mesh-ancestor
24619936|NCT01054547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24619937|NCT01054651|Artesunate|artesunate|mesh-list
24619938|NCT01054651|Pyrimethamine|pyrimethamine|mesh-list
24619939|NCT01054651|Sulfalene|sulfalene|mesh-list
24619940|NCT01054651|Praziquantel|praziquantel|mesh-list
24619941|NCT01054651|Antimalarials|antimalarials|mesh-ancestor
24619942|NCT01054651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24758011|NCT01743300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24758012|NCT01743300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24758013|NCT01743300|Anesthetics, General|anesthetics, general|mesh-ancestor
24758015|NCT01743300|GABA Modulators|gaba modulators|mesh-ancestor
24758016|NCT01743300|GABA Agents|gaba agents|mesh-ancestor
24758017|NCT01743300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24758018|NCT01743300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696752|NCT02065713|Immunologic Factors|immunologic factors|mesh-ancestor
25696753|NCT02065713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25696754|NCT02065713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25696755|NCT02065713|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25696756|NCT02065713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25696757|NCT02065791|Canagliflozin|canagliflozin|mesh-list
25696758|NCT02065791|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24758019|NCT01743300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758020|NCT01743300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24758031|NCT01743365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24758032|NCT01743365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758033|NCT01743365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758034|NCT01743378|Ropivacaine|ropivacaine|mesh-list
24758035|NCT01743378|Anesthetics, Local|anesthetics, local|mesh-ancestor
24758036|NCT01743378|Anesthetics|anesthetics|mesh-ancestor
25051314|NCT00417209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051315|NCT00417209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25051316|NCT00417209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051317|NCT00417209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24758037|NCT01743378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24758045|NCT01743508|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24758046|NCT01743508|Abortifacient Agents|abortifacient agents|mesh-ancestor
24758047|NCT01743508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24758058|NCT01743690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758059|NCT01743690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24758060|NCT01743690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24758061|NCT01743690|Antifungal Agents|antifungal agents|mesh-ancestor
24758062|NCT01743690|Ionophores|ionophores|mesh-ancestor
24663516|NCT01302002|Metformin|metformin|mesh-list
24758063|NCT01743690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24758064|NCT01743690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758065|NCT01743755|Dexamethasone|dexamethasone|mesh-list
24758066|NCT01743755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24758067|NCT01743755|Antiemetics|antiemetics|mesh-ancestor
24758068|NCT01743755|Autonomic Agents|autonomic agents|mesh-ancestor
24758069|NCT01743755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24758070|NCT01743755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758071|NCT01743755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24758072|NCT01743755|Glucocorticoids|glucocorticoids|mesh-ancestor
24758073|NCT01743755|Hormones|hormones|mesh-ancestor
24758074|NCT01743755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24758088|NCT01743820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24758089|NCT01743820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24758090|NCT01743820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24758091|NCT01743885|Propranolol|propranolol|mesh-list
24758092|NCT01743885|Acebutolol|acebutolol|mesh-list
24758093|NCT01743885|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24758094|NCT01743885|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24758095|NCT01743885|Adrenergic Agents|adrenergic agents|mesh-ancestor
24758096|NCT01743885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24758097|NCT01743885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758098|NCT01743885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758099|NCT01743885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24758100|NCT01743885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24758101|NCT01743885|Vasodilator Agents|vasodilator agents|mesh-ancestor
24758102|NCT01743885|Sympathomimetics|sympathomimetics|mesh-ancestor
24758130|NCT01744106|Ephedrine|ephedrine|mesh-list
24758131|NCT01744106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24758132|NCT01744106|Autonomic Agents|autonomic agents|mesh-ancestor
24758133|NCT01744106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24758134|NCT01744106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758135|NCT01744106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24758136|NCT01744106|Respiratory System Agents|respiratory system agents|mesh-ancestor
24758137|NCT01744106|Nasal Decongestants|nasal decongestants|mesh-ancestor
24758138|NCT01744106|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25051319|NCT00417209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847025|NCT02244710|Ticagrelor|ticagrelor|mesh-list
24758139|NCT01744106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24758140|NCT01744106|Sympathomimetics|sympathomimetics|mesh-ancestor
24758141|NCT01744106|Adrenergic Agents|adrenergic agents|mesh-ancestor
24758142|NCT01744106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24923008|NCT04174131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24758143|NCT01744106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758144|NCT01744184|Midazolam|midazolam|mesh-list
24758145|NCT01744184|Nitrous Oxide|nitrous oxide|mesh-list
24758146|NCT01744184|Entonox|entonox|mesh-list
24758147|NCT01744184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24758148|NCT01744184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24758149|NCT01744184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24758150|NCT01744184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758151|NCT01744184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24758179|NCT01744236|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25709393|NCT02266433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24812126|NCT02049801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24812127|NCT02049801|Antimetabolites|antimetabolites|mesh-ancestor
24812128|NCT02049801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812129|NCT02049801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812131|NCT02049801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24758180|NCT01744249|Axitinib|axitinib|mesh-list
24758181|NCT01744249|Octreotide|octreotide|mesh-list
24758182|NCT01744249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758183|NCT01744249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24758184|NCT01744249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758185|NCT01744249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758186|NCT01744249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24758191|NCT01744288|Clopidogrel|clopidogrel|mesh-list
24758193|NCT01744288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24758194|NCT01744288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24758195|NCT01744288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24758196|NCT01744288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24758197|NCT01744288|Purinergic Agents|purinergic agents|mesh-ancestor
24758225|NCT01744379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24758226|NCT01744379|Uricosuric Agents|uricosuric agents|mesh-ancestor
24758227|NCT01744379|Renal Agents|renal agents|mesh-ancestor
24758228|NCT01744444|Gabapentin|gabapentin|mesh-list
24758229|NCT01744444|Memantine|memantine|mesh-list
24758230|NCT01744444|Analgesics|analgesics|mesh-ancestor
24758231|NCT01744444|Sensory System Agents|sensory system agents|mesh-ancestor
24758232|NCT01744444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24758233|NCT01744444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758234|NCT01744444|Anticonvulsants|anticonvulsants|mesh-ancestor
24758235|NCT01744444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24758236|NCT01744444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24758237|NCT01744444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24758238|NCT01744444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24758239|NCT01744444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24758240|NCT01744444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24758241|NCT01744444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24758242|NCT01744444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758244|NCT01744444|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24758245|NCT01744444|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24758246|NCT01744444|Dopamine Agents|dopamine agents|mesh-ancestor
24758247|NCT01744470|Tacrolimus|tacrolimus|mesh-list
24758248|NCT01744470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24758249|NCT01744470|Immunologic Factors|immunologic factors|mesh-ancestor
24758250|NCT01744470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758251|NCT01744470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24758252|NCT01744470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758255|NCT01744587|Antioxidants|antioxidants|mesh-ancestor
24758256|NCT01744587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758258|NCT01744587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758259|NCT01744587|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24758260|NCT01744587|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24758261|NCT01744587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051321|NCT00417118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25051322|NCT00417118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24758262|NCT01744587|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24758264|NCT01744626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24758265|NCT01744626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758266|NCT01744626|Immunologic Factors|immunologic factors|mesh-ancestor
24758267|NCT01744626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758268|NCT01744626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24758269|NCT01744756|Bevacizumab|bevacizumab|mesh-list
24758270|NCT01744756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24758271|NCT01744756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758272|NCT01744756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24758273|NCT01744756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24758274|NCT01744756|Growth Substances|growth substances|mesh-ancestor
24758275|NCT01744756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696759|NCT02065791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696760|NCT02065791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25696761|NCT02065791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696762|NCT02066129|Fluticasone|fluticasone|mesh-list
25696763|NCT02066129|Xhance|xhance|mesh-list
25696764|NCT02066129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24758276|NCT01744756|Growth Inhibitors|growth inhibitors|mesh-ancestor
24758293|NCT01744886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758294|NCT01744886|Sensory System Agents|sensory system agents|mesh-ancestor
24758295|NCT01744886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24758296|NCT01744964|Apomorphine|apomorphine|mesh-list
24758298|NCT01744964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758299|NCT01744964|Autonomic Agents|autonomic agents|mesh-ancestor
24758300|NCT01744964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24758301|NCT01744964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24758302|NCT01744964|Dopamine Agonists|dopamine agonists|mesh-ancestor
24758303|NCT01744964|Dopamine Agents|dopamine agents|mesh-ancestor
24758304|NCT01744964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24758305|NCT01744964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758306|NCT01745081|Mannitol|mannitol|mesh-list
24758307|NCT01745081|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24758314|NCT01745159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758316|NCT01745159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758317|NCT01745159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758318|NCT01745263|Vitamin D|vitamin d|mesh-list
24758319|NCT01745263|Cholecalciferol|cholecalciferol|mesh-list
24758320|NCT01745263|Vitamins|vitamins|mesh-ancestor
24758321|NCT01745263|Micronutrients|micronutrients|mesh-ancestor
24758322|NCT01745263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758323|NCT01745263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24758324|NCT01745263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24758325|NCT01745302|Gefitinib|gefitinib|mesh-list
24758326|NCT01745302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758327|NCT01745302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24758328|NCT01745302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758329|NCT01745302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758330|NCT01745328|Amoxicillin|amoxicillin|mesh-list
24758331|NCT01745328|Levofloxacin|levofloxacin|mesh-list
24758332|NCT01745328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24758333|NCT01745328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24758334|NCT01745328|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24758335|NCT01745328|Renal Agents|renal agents|mesh-ancestor
24758336|NCT01745328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24758337|NCT01745328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24758347|NCT01745562|Alprazolam|alprazolam|mesh-list
24758364|NCT01745575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24758365|NCT01745575|GABA Modulators|gaba modulators|mesh-ancestor
24758366|NCT01745575|GABA Agents|gaba agents|mesh-ancestor
24758367|NCT01745575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24758368|NCT01745575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758369|NCT01745601|Dexetimide|dexetimide|mesh-list
24758370|NCT01745601|Citalopram|citalopram|mesh-list
24758371|NCT01745601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24758372|NCT01745601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24758373|NCT01745601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25051323|NCT00417118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25051324|NCT00417118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051325|NCT00417118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25051326|NCT00417118|Serotonin Agents|serotonin agents|mesh-ancestor
24758374|NCT01745601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758375|NCT01745601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24758376|NCT01745601|Serotonin Agents|serotonin agents|mesh-ancestor
24758377|NCT01745601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758378|NCT01745601|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24656101|NCT01259934|Antiviral Agents|antiviral agents|mesh-ancestor
24758379|NCT01745601|Antidepressive Agents|antidepressive agents|mesh-ancestor
24619943|NCT01054651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24448082|NCT00310154|Gefitinib|gefitinib|mesh-list
24448083|NCT00310154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448084|NCT00310154|Tubulin Modulators|tubulin modulators|mesh-ancestor
24448085|NCT00310154|Antimitotic Agents|antimitotic agents|mesh-ancestor
25709394|NCT02266433|Glucocorticoids|glucocorticoids|mesh-ancestor
25709395|NCT02266433|Hormones|hormones|mesh-ancestor
24812170|NCT02050074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812171|NCT02050074|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24812172|NCT02050074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24812173|NCT02050074|Antimetabolites|antimetabolites|mesh-ancestor
25696765|NCT02066129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24619945|NCT01054651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24619946|NCT01054651|Antiviral Agents|antiviral agents|mesh-ancestor
24619947|NCT01054651|Schistosomicides|schistosomicides|mesh-ancestor
24619948|NCT01054651|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24619949|NCT01054651|Anthelmintics|anthelmintics|mesh-ancestor
24758382|NCT01745601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24423147|NCT00224809|Purinergic Agents|purinergic agents|mesh-ancestor
24423148|NCT00224809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24423149|NCT00224809|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24758383|NCT01745601|Parasympatholytics|parasympatholytics|mesh-ancestor
24758384|NCT01745601|Autonomic Agents|autonomic agents|mesh-ancestor
24758385|NCT01745601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24758386|NCT01745601|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24758387|NCT01745601|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24758388|NCT01745601|Cholinergic Agents|cholinergic agents|mesh-ancestor
24758390|NCT01745614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24758391|NCT01745614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24758392|NCT01745614|Analgesics|analgesics|mesh-ancestor
24758393|NCT01745614|Sensory System Agents|sensory system agents|mesh-ancestor
24758394|NCT01745614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24758395|NCT01745614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758396|NCT01745614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24758397|NCT01745614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24758771|NCT01747668|Protective Agents|protective agents|mesh-ancestor
24923581|NCT04169269|Antithrombins|antithrombins|mesh-ancestor
24758401|NCT01745640|Dexamethasone|dexamethasone|mesh-list
24758402|NCT01745640|Pomalidomide|pomalidomide|mesh-list
24758403|NCT01745640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24758404|NCT01745640|Antiemetics|antiemetics|mesh-ancestor
24758405|NCT01745640|Autonomic Agents|autonomic agents|mesh-ancestor
24758406|NCT01745640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24758407|NCT01745640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758408|NCT01745640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24758409|NCT01745640|Glucocorticoids|glucocorticoids|mesh-ancestor
24758410|NCT01745640|Hormones|hormones|mesh-ancestor
24758411|NCT01745640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24663855|NCT01303887|Alkylating Agents|alkylating agents|mesh-ancestor
24758412|NCT01745640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24758413|NCT01745640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758422|NCT01745666|Adrenergic Agents|adrenergic agents|mesh-ancestor
25696766|NCT02066129|Autonomic Agents|autonomic agents|mesh-ancestor
25696767|NCT02066129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25696768|NCT02066129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696769|NCT02066129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25696770|NCT02066129|Respiratory System Agents|respiratory system agents|mesh-ancestor
25696771|NCT02066129|Dermatologic Agents|dermatologic agents|mesh-ancestor
25696772|NCT02066129|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25696773|NCT02066298|Mometasone Furoate|mometasone furoate|mesh-list
25696774|NCT02066298|Tiotropium Bromide|tiotropium bromide|mesh-list
25696775|NCT02066298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25696776|NCT02066298|Autonomic Agents|autonomic agents|mesh-ancestor
25051327|NCT00417118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051328|NCT00417118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25051329|NCT00417118|Antidepressive Agents|antidepressive agents|mesh-ancestor
25051332|NCT00415623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25051333|NCT00415623|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25051334|NCT00415623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25051335|NCT00415623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051336|NCT00415623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25051337|NCT00415623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051338|NCT00415623|Vasodilator Agents|vasodilator agents|mesh-ancestor
24858084|NCT02295046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24858085|NCT02295046|Antimetabolites|antimetabolites|mesh-ancestor
24858087|NCT02295046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24758424|NCT01745666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758425|NCT01745666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758426|NCT01745666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24758427|NCT01745666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24758428|NCT01745666|Autonomic Agents|autonomic agents|mesh-ancestor
24758429|NCT01745666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24758430|NCT01745666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24758431|NCT01745666|Respiratory System Agents|respiratory system agents|mesh-ancestor
24758432|NCT01745666|Mydriatics|mydriatics|mesh-ancestor
24758433|NCT01745666|Sympathomimetics|sympathomimetics|mesh-ancestor
24758434|NCT01745666|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24758435|NCT01745679|Ceftriaxone|ceftriaxone|mesh-list
24758436|NCT01745679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24758437|NCT01745679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24758438|NCT01745692|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24758439|NCT01745692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24758440|NCT01745692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24758441|NCT01745692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758443|NCT01745770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24758444|NCT01745770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24758445|NCT01745770|Analgesics|analgesics|mesh-ancestor
24758446|NCT01745770|Sensory System Agents|sensory system agents|mesh-ancestor
24758447|NCT01745770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24758472|NCT01746199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758473|NCT01746199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758474|NCT01746199|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24924050|NCT04164264|Propofol|propofol|mesh-list
24758475|NCT01746199|Renal Agents|renal agents|mesh-ancestor
24758476|NCT01746199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24758477|NCT01746251|Afatinib|afatinib|mesh-list
24758478|NCT01746251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758479|NCT01746251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24758480|NCT01746251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758481|NCT01746251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758482|NCT01746277|Docetaxel|docetaxel|mesh-list
24758483|NCT01746277|Pemetrexed|pemetrexed|mesh-list
24936911|NCT04034771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936912|NCT04034771|Protective Agents|protective agents|mesh-ancestor
24936914|NCT04034836|Ropivacaine|ropivacaine|mesh-list
24936915|NCT04034836|Anesthetics, Local|anesthetics, local|mesh-ancestor
24936916|NCT04034836|Anesthetics|anesthetics|mesh-ancestor
24936917|NCT04034836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24936918|NCT04034836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758484|NCT01746277|Gefitinib|gefitinib|mesh-list
24758485|NCT01746277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758486|NCT01746277|Tubulin Modulators|tubulin modulators|mesh-ancestor
24758487|NCT01746277|Antimitotic Agents|antimitotic agents|mesh-ancestor
24758488|NCT01746277|Mitosis Modulators|mitosis modulators|mesh-ancestor
24758489|NCT01746277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051340|NCT00415142|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25051341|NCT00415142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25051342|NCT00415142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25051343|NCT00415142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051344|NCT00415142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25051345|NCT00415142|Serotonin Agents|serotonin agents|mesh-ancestor
25051346|NCT00415142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051347|NCT00415142|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25051348|NCT00415142|Antidepressive Agents|antidepressive agents|mesh-ancestor
25051349|NCT00415142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25051350|NCT00413114|Obatoclax|obatoclax|mesh-list
25051351|NCT00413114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051352|NCT00413114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051353|NCT00412932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25051354|NCT00412932|Olmesartan|olmesartan|mesh-list
25051355|NCT00412932|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25051356|NCT00412932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25051357|NCT00412932|Diuretics|diuretics|mesh-ancestor
25051358|NCT00412932|Natriuretic Agents|natriuretic agents|mesh-ancestor
25051359|NCT00412932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051360|NCT00412932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25051361|NCT00412932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24961032|NCT03812562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24961033|NCT03812562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24679683|NCT01370031|Charcoal|charcoal|mesh-list
24858094|NCT02295124|Oxycodone|oxycodone|mesh-list
24758506|NCT01746602|Adrenergic Agents|adrenergic agents|mesh-ancestor
24758507|NCT01746602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24758508|NCT01746602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758519|NCT01746641|Anesthetics|anesthetics|mesh-ancestor
24758520|NCT01746641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24758521|NCT01746641|Narcotics|narcotics|mesh-ancestor
24758522|NCT01746641|Analgesics|analgesics|mesh-ancestor
24758523|NCT01746641|Sensory System Agents|sensory system agents|mesh-ancestor
24758524|NCT01746641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24758525|NCT01746680|Methotrexate|methotrexate|mesh-list
24758526|NCT01746680|Tacrolimus|tacrolimus|mesh-list
24758527|NCT01746680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24758528|NCT01746680|Abortifacient Agents|abortifacient agents|mesh-ancestor
24758529|NCT01746680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24499793|NCT00521157|Naltrexone|naltrexone|mesh-list
24758544|NCT01746719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24758545|NCT01746719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24758547|NCT01746719|Sensory System Agents|sensory system agents|mesh-ancestor
24758548|NCT01746719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24758549|NCT01746719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758550|NCT01746719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24758551|NCT01746719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24758552|NCT01746719|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24758553|NCT01746719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24758554|NCT01746719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758555|NCT01746719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758556|NCT01746771|Paclitaxel|paclitaxel|mesh-list
25696777|NCT02066298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25696778|NCT02066298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696779|NCT02066298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25696780|NCT02066298|Respiratory System Agents|respiratory system agents|mesh-ancestor
25696781|NCT02066298|Parasympatholytics|parasympatholytics|mesh-ancestor
25696782|NCT02066298|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25696783|NCT02066298|Cholinergic Agents|cholinergic agents|mesh-ancestor
24758599|NCT01746992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24758601|NCT01746992|Alkylating Agents|alkylating agents|mesh-ancestor
24758602|NCT01746992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758603|NCT01746992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758604|NCT01746992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24758605|NCT01746992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24758606|NCT01746992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24758607|NCT01746992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24758608|NCT01746992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758609|NCT01746992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24758610|NCT01746992|Glucocorticoids|glucocorticoids|mesh-ancestor
24758612|NCT01746992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24758613|NCT01746992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24758614|NCT01746992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24758615|NCT01746992|Abortifacient Agents|abortifacient agents|mesh-ancestor
24758616|NCT01746992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24426993|NCT00237133|Letrozole|letrozole|mesh-list
24545150|NCT00692120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24545152|NCT00692159|Pemetrexed|pemetrexed|mesh-list
24758617|NCT01746992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24758618|NCT01746992|Antimetabolites|antimetabolites|mesh-ancestor
24758619|NCT01746992|Dermatologic Agents|dermatologic agents|mesh-ancestor
24758620|NCT01746992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24758621|NCT01746992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24758622|NCT01746992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24758623|NCT01746992|Tubulin Modulators|tubulin modulators|mesh-ancestor
24758624|NCT01746992|Antimitotic Agents|antimitotic agents|mesh-ancestor
24758627|NCT01747044|Levomilnacipran|levomilnacipran|mesh-list
24758628|NCT01747044|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24758629|NCT01747044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24758630|NCT01747044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24758631|NCT01747044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758632|NCT01747044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24758633|NCT01747044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758634|NCT01747044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24758635|NCT01747044|Analgesics|analgesics|mesh-ancestor
24758636|NCT01747044|Sensory System Agents|sensory system agents|mesh-ancestor
24758637|NCT01747044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24758664|NCT01747174|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24758665|NCT01747174|Purinergic Agonists|purinergic agonists|mesh-ancestor
24758666|NCT01747174|Purinergic Agents|purinergic agents|mesh-ancestor
24758667|NCT01747174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24758668|NCT01747174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758669|NCT01747174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24758670|NCT01747174|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24758672|NCT01747226|Cariostatic Agents|cariostatic agents|mesh-ancestor
24758673|NCT01747226|Protective Agents|protective agents|mesh-ancestor
24924320|NCT04161053|Rifaximin|rifaximin|mesh-list
24619980|NCT01055041|Hormone Antagonists|hormone antagonists|mesh-ancestor
24619981|NCT01055041|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24619982|NCT01055041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24620000|NCT01055145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24620003|NCT01055236|Dermatologic Agents|dermatologic agents|mesh-ancestor
24620004|NCT01055236|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24620005|NCT01055236|Histamine Antagonists|histamine antagonists|mesh-ancestor
24620006|NCT01055236|Histamine Agents|histamine agents|mesh-ancestor
25696784|NCT02066298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25696785|NCT02066298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696786|NCT02066298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24620008|NCT01055236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620009|NCT01055236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620011|NCT01055249|Hydrocortisone|hydrocortisone|mesh-list
24620012|NCT01055249|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24620013|NCT01055249|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24620014|NCT01055249|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24620015|NCT01055249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24620016|NCT01055249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24961034|NCT03812562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961035|NCT03812419|Esomeprazole|esomeprazole|mesh-list
24961036|NCT03812419|Pantoprazole|pantoprazole|mesh-list
24961037|NCT03812419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24961038|NCT03812419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24961039|NCT03812419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24961040|NCT03812419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24961041|NCT03812419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579314|NCT00854451|Omeprazole|omeprazole|mesh-list
24945196|NCT03953209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945197|NCT03953209|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24945198|NCT03953209|Diuretics|diuretics|mesh-ancestor
24945199|NCT03953209|Natriuretic Agents|natriuretic agents|mesh-ancestor
24945200|NCT03953066|Melatonin|melatonin|mesh-list
24945201|NCT03953066|Antioxidants|antioxidants|mesh-ancestor
24945202|NCT03953066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945203|NCT03953066|Protective Agents|protective agents|mesh-ancestor
24945204|NCT03953066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945205|NCT03953066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24466760|NCT00374881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24466761|NCT00374881|Narcotics|narcotics|mesh-ancestor
24466762|NCT00374881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24466764|NCT00374881|Analgesics|analgesics|mesh-ancestor
24945207|NCT03952715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24945208|NCT03952715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24945210|NCT03952715|Sensory System Agents|sensory system agents|mesh-ancestor
24620017|NCT01055249|Analgesics|analgesics|mesh-ancestor
24620018|NCT01055249|Sensory System Agents|sensory system agents|mesh-ancestor
24620019|NCT01055249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24620020|NCT01055249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620021|NCT01055249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24620022|NCT01055249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24620023|NCT01055249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24620024|NCT01055249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620025|NCT01055249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758715|NCT01747590|Caffeine|caffeine|mesh-list
24758748|NCT01747616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758749|NCT01747616|Antidotes|antidotes|mesh-ancestor
24758750|NCT01747616|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24758751|NCT01747616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24758752|NCT01747616|Antimetabolites|antimetabolites|mesh-ancestor
24758753|NCT01747616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24758766|NCT01747668|Vitamins|vitamins|mesh-ancestor
24758767|NCT01747668|Micronutrients|micronutrients|mesh-ancestor
24758768|NCT01747668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758769|NCT01747668|Antioxidants|antioxidants|mesh-ancestor
24758770|NCT01747668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758779|NCT01747720|Cholecalciferol|cholecalciferol|mesh-list
24758780|NCT01747720|Vitamins|vitamins|mesh-ancestor
24758794|NCT01747746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758796|NCT01747746|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24758797|NCT01747798|Auranofin|auranofin|mesh-list
24758798|NCT01747798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24758799|NCT01747993|Tamsulosin|tamsulosin|mesh-list
24758800|NCT01747993|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24758801|NCT01747993|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24758802|NCT01747993|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24758803|NCT01747993|Adrenergic Agents|adrenergic agents|mesh-ancestor
24758804|NCT01747993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24758805|NCT01747993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758806|NCT01747993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696787|NCT02066298|Dermatologic Agents|dermatologic agents|mesh-ancestor
25696788|NCT02066298|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25696789|NCT02066311|Nelfinavir|nelfinavir|mesh-list
24758807|NCT01747993|Urological Agents|urological agents|mesh-ancestor
24758808|NCT01748019|Namitecan|namitecan|mesh-list
24758809|NCT01748019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24758810|NCT01748019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758811|NCT01748084|Rituximab|rituximab|mesh-list
24758812|NCT01748084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24758813|NCT01748084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758823|NCT01748123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24758824|NCT01748123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24620033|NCT01055301|Lenalidomide|lenalidomide|mesh-list
24664105|NCT01305057|Vitamins|vitamins|mesh-ancestor
24758825|NCT01748123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758826|NCT01748253|Amlodipine|amlodipine|mesh-list
24758827|NCT01748253|Telmisartan|telmisartan|mesh-list
24758828|NCT01748253|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
24758836|NCT01748253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24758837|NCT01748253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24945211|NCT03952715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24945212|NCT03952715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945213|NCT03952715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24945228|NCT03952572|Cyclophosphamide|cyclophosphamide|mesh-list
24945229|NCT03952572|Doxorubicin|doxorubicin|mesh-list
24945230|NCT03952572|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24945231|NCT03952572|Vincristine|vincristine|mesh-list
24945232|NCT03952572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24945233|NCT03952572|Immunologic Factors|immunologic factors|mesh-ancestor
24945234|NCT03952572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945235|NCT03952572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24945236|NCT03952572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24945237|NCT03952572|Alkylating Agents|alkylating agents|mesh-ancestor
24945238|NCT03952572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945239|NCT03952572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24945281|NCT03951558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24945282|NCT03951558|Diuretics|diuretics|mesh-ancestor
24945283|NCT03951558|Natriuretic Agents|natriuretic agents|mesh-ancestor
24758847|NCT01748279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24758849|NCT01748279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24758850|NCT01748279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758851|NCT01748279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24758852|NCT01748279|Respiratory System Agents|respiratory system agents|mesh-ancestor
24758853|NCT01748279|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24758854|NCT01748279|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24758855|NCT01748279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24758856|NCT01748279|Adrenergic Agents|adrenergic agents|mesh-ancestor
24758857|NCT01748279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24758858|NCT01748318|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24758859|NCT01748318|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24758860|NCT01748318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24758862|NCT01748318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24758863|NCT01748318|Antimalarials|antimalarials|mesh-ancestor
24758864|NCT01748318|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24758865|NCT01748318|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24758867|NCT01748344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24758868|NCT01748344|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24758869|NCT01748344|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24758870|NCT01748344|Histamine Antagonists|histamine antagonists|mesh-ancestor
24758891|NCT01748396|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24758892|NCT01748396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24758893|NCT01748396|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24758894|NCT01748396|Vitamins|vitamins|mesh-ancestor
24758895|NCT01748396|Micronutrients|micronutrients|mesh-ancestor
24758896|NCT01748396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24961122|NCT03811223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24961123|NCT03811054|Apatinib|apatinib|mesh-list
24961124|NCT03811054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24961125|NCT03811054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24961126|NCT03811054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24961127|NCT03811054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961128|NCT03811197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
24961129|NCT03811197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961130|NCT03811197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961131|NCT03810703|Amphetamine|amphetamine|mesh-list
24961132|NCT03810703|Dextroamphetamine|dextroamphetamine|mesh-list
24961133|NCT03810703|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24961134|NCT03810703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961135|NCT03810703|Sympathomimetics|sympathomimetics|mesh-ancestor
24961136|NCT03810703|Autonomic Agents|autonomic agents|mesh-ancestor
24961137|NCT03810703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961138|NCT03810703|Dopamine Agents|dopamine agents|mesh-ancestor
24961139|NCT03810703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24961140|NCT03810703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961146|NCT03810742|Irinotecan|irinotecan|mesh-list
24945284|NCT03951558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945285|NCT03951558|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24945286|NCT03951558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24945287|NCT03951558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051362|NCT00412932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051363|NCT00412932|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24735290|NCT01656122|Abacavir|abacavir|mesh-list
24617607|NCT01044251|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24758899|NCT01748422|Dermatologic Agents|dermatologic agents|mesh-ancestor
24758900|NCT01748422|Sensory System Agents|sensory system agents|mesh-ancestor
24758901|NCT01748422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24758902|NCT01748422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758903|NCT01748435|Capsaicin|capsaicin|mesh-list
24758904|NCT01748435|Antipruritics|antipruritics|mesh-ancestor
24758905|NCT01748435|Dermatologic Agents|dermatologic agents|mesh-ancestor
24758906|NCT01748435|Sensory System Agents|sensory system agents|mesh-ancestor
25051367|NCT00412828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051368|NCT00411892|Insulin|insulin|mesh-list
25051369|NCT00411892|Pioglitazone|pioglitazone|mesh-list
25051370|NCT00411892|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25051371|NCT00411892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25051372|NCT00411892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945338|NCT03951402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24945339|NCT03951402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24945340|NCT03951402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24945341|NCT03951402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758907|NCT01748435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24758908|NCT01748435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758909|NCT01748487|Dexamethasone|dexamethasone|mesh-list
24758910|NCT01748487|Dexamethasone acetate|dexamethasone acetate|mesh-list
24758911|NCT01748487|BB 1101|bb 1101|mesh-list
24758912|NCT01748487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24758913|NCT01748487|Antiemetics|antiemetics|mesh-ancestor
24758914|NCT01748487|Autonomic Agents|autonomic agents|mesh-ancestor
24758915|NCT01748487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24758916|NCT01748487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758917|NCT01748487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24758918|NCT01748487|Glucocorticoids|glucocorticoids|mesh-ancestor
24758919|NCT01748487|Hormones|hormones|mesh-ancestor
24758920|NCT01748487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24758931|NCT01748500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758933|NCT01748526|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24758934|NCT01748526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758935|NCT01748526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24758936|NCT01748526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758937|NCT01748539|Brodalumab|brodalumab|mesh-list
24758938|NCT01748539|Dermatologic Agents|dermatologic agents|mesh-ancestor
24758939|NCT01748630|Fentanyl|fentanyl|mesh-list
24758940|NCT01748630|Midazolam|midazolam|mesh-list
24758941|NCT01748630|Dexmedetomidine|dexmedetomidine|mesh-list
24758942|NCT01748630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24758943|NCT01748630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24758944|NCT01748630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758945|NCT01748630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24758946|NCT01748630|Analgesics|analgesics|mesh-ancestor
24758947|NCT01748630|Sensory System Agents|sensory system agents|mesh-ancestor
24758948|NCT01748630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24758949|NCT01748630|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24758959|NCT01748630|Anesthetics, General|anesthetics, general|mesh-ancestor
24758960|NCT01748630|Anesthetics|anesthetics|mesh-ancestor
24937169|NCT04032132|Curcumin|curcumin|mesh-list
24937170|NCT04032132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24758961|NCT01748630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24758962|NCT01748630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24620035|NCT01055301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24620036|NCT01055301|Immunologic Factors|immunologic factors|mesh-ancestor
24620037|NCT01055301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620038|NCT01055301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24620039|NCT01055301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24620040|NCT01055301|Alkylating Agents|alkylating agents|mesh-ancestor
24620042|NCT01055301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24620059|NCT01055301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24945342|NCT03951402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945343|NCT03951402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24945344|NCT03951402|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24945345|NCT03951402|Contraceptive Agents|contraceptive agents|mesh-ancestor
24945346|NCT03951402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24945347|NCT03951402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945348|NCT03951402|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24945350|NCT03951402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24945351|NCT03951402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24620060|NCT01055301|Growth Substances|growth substances|mesh-ancestor
24620061|NCT01055301|Growth Inhibitors|growth inhibitors|mesh-ancestor
24620062|NCT01055301|Leprostatic Agents|leprostatic agents|mesh-ancestor
24620063|NCT01055301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24620064|NCT01055301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24620066|NCT01055327|Anticonvulsants|anticonvulsants|mesh-list
24620067|NCT01055327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24620068|NCT01055327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24620069|NCT01055327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620070|NCT01055327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24620071|NCT01055327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620072|NCT01055327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24620073|NCT01055327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24924693|NCT04157478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24620074|NCT01055327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24657012|NCT01265108|Iron|iron|mesh-list
24620075|NCT01055327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24620076|NCT01055327|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24620077|NCT01055379|Rasagiline|rasagiline|mesh-list
24620078|NCT01055379|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24620079|NCT01055379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620080|NCT01055379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620084|NCT01055392|Lithium Carbonate|lithium carbonate|mesh-list
24758968|NCT01748669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758969|NCT01748669|Protective Agents|protective agents|mesh-ancestor
24394404|NCT00133237|Tubulin Modulators|tubulin modulators|mesh-ancestor
24758970|NCT01748669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758971|NCT01748669|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24758972|NCT01748669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758973|NCT01748669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24758974|NCT01748669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758975|NCT01748721|Antibodies|antibodies|mesh-list
24758976|NCT01748721|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24758977|NCT01748721|Immunologic Factors|immunologic factors|mesh-ancestor
24758978|NCT01748721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758979|NCT01748747|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
24758980|NCT01748747|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24758981|NCT01748747|Immunologic Factors|immunologic factors|mesh-ancestor
24945369|NCT03951207|Atorvastatin|atorvastatin|mesh-list
24758982|NCT01748747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758983|NCT01748773|Capecitabine|capecitabine|mesh-list
24758984|NCT01748773|Oxaliplatin|oxaliplatin|mesh-list
24758985|NCT01748773|Trastuzumab|trastuzumab|mesh-list
24758986|NCT01748773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24758994|NCT01748838|Natriuretic Agents|natriuretic agents|mesh-ancestor
24758995|NCT01748838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758996|NCT01748929|Albendazole|albendazole|mesh-list
24945353|NCT03951402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25696790|NCT02066311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25696791|NCT02066311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25696792|NCT02066311|Protease Inhibitors|protease inhibitors|mesh-ancestor
25696793|NCT02066311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24945355|NCT03951402|Sensory System Agents|sensory system agents|mesh-ancestor
24459764|NCT00346359|Antimetabolites|antimetabolites|mesh-ancestor
24459765|NCT00346359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410513|NCT00185705|Telmisartan|telmisartan|mesh-list
24945356|NCT03951402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24945357|NCT03951402|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24945358|NCT03951402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24945359|NCT03951402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24945360|NCT03951402|Adrenergic Agents|adrenergic agents|mesh-ancestor
24945361|NCT03951402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24945362|NCT03951285|Niacinamide|niacinamide|mesh-list
24945363|NCT03951285|Vitamin B Complex|vitamin b complex|mesh-ancestor
24945364|NCT03951285|Vitamins|vitamins|mesh-ancestor
24945365|NCT03951285|Micronutrients|micronutrients|mesh-ancestor
24945366|NCT03951285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945367|NCT03951207|Amlodipine|amlodipine|mesh-list
24945368|NCT03951207|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
25696794|NCT02066311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696795|NCT02066311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25696796|NCT02066311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25696797|NCT02066311|Antiviral Agents|antiviral agents|mesh-ancestor
25696798|NCT02066311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25696799|NCT02066389|Upadacitinib|upadacitinib|mesh-list
25696800|NCT02066389|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
24500593|NCT00525096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24945371|NCT03951207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24945372|NCT03951207|Antimetabolites|antimetabolites|mesh-ancestor
24945373|NCT03951207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945374|NCT03951207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24945375|NCT03951207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24945376|NCT03951207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24945377|NCT03951207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24945378|NCT03951207|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24799167|NCT01967524|Botulinum Toxins|botulinum toxins|mesh-list
24945379|NCT03951207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24770588|NCT01821248|Cisplatin|cisplatin|mesh-list
24813117|NCT02056587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813118|NCT02056600|Metformin|metformin|mesh-list
24813119|NCT02056600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24758997|NCT01748929|Anthelmintics|anthelmintics|mesh-ancestor
24770589|NCT01821248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24770590|NCT01821248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24770591|NCT01821248|Antimetabolites|antimetabolites|mesh-ancestor
24770592|NCT01821248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770593|NCT01821248|Antiviral Agents|antiviral agents|mesh-ancestor
24770594|NCT01821248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24770595|NCT01821248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770596|NCT01821248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24770597|NCT01821248|Immunologic Factors|immunologic factors|mesh-ancestor
24770598|NCT01821248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770599|NCT01821261|Chlorhexidine|chlorhexidine|mesh-list
24770601|NCT01821261|Cariostatic Agents|cariostatic agents|mesh-ancestor
24770602|NCT01821261|Protective Agents|protective agents|mesh-ancestor
24770603|NCT01821261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770604|NCT01821261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24770605|NCT01821261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24770606|NCT01821261|Disinfectants|disinfectants|mesh-ancestor
24945380|NCT03951207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24945381|NCT03951207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945382|NCT03951207|Vasodilator Agents|vasodilator agents|mesh-ancestor
24945384|NCT03950830|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24945387|NCT03950830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945388|NCT03950960|Itraconazole|itraconazole|mesh-list
24945389|NCT03950960|Antifungal Agents|antifungal agents|mesh-ancestor
24945390|NCT03950960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24945391|NCT03950960|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24523181|NCT02403310|Antiviral Agents|antiviral agents|mesh-ancestor
24945392|NCT03950960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24945393|NCT03950960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813140|NCT02056717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24758998|NCT01748929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24945394|NCT03950960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945395|NCT03950960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24945396|NCT03950960|Hormone Antagonists|hormone antagonists|mesh-ancestor
24945397|NCT03950960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24945398|NCT03950960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945399|NCT03950960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24945405|NCT03951051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945407|NCT03950700|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
24945408|NCT03950700|Bupivacaine|bupivacaine|mesh-list
25696801|NCT02066389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25696802|NCT02066389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25696803|NCT02066389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696804|NCT02066389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25696805|NCT02066402|Linezolid|linezolid|mesh-list
25696806|NCT02066402|Tedizolid|tedizolid|mesh-list
25696807|NCT02066402|Oxazolidinones|oxazolidinones|mesh-list
25696808|NCT02066402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25696809|NCT02066402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25696810|NCT02066402|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24937313|NCT04030442|Analgesics|analgesics|mesh-ancestor
24937314|NCT04030442|Sensory System Agents|sensory system agents|mesh-ancestor
24937315|NCT04030442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937316|NCT04030533|Ustekinumab|ustekinumab|mesh-list
24937317|NCT04030533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24937318|NCT04030533|Dermatologic Agents|dermatologic agents|mesh-ancestor
24533967|NCT00645580|Fluvoxamine|fluvoxamine|mesh-list
24945415|NCT03950700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24945416|NCT03950700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24945417|NCT03950700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24945418|NCT03950700|Adrenergic Agents|adrenergic agents|mesh-ancestor
24945419|NCT03950700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24945420|NCT03950700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945421|NCT03950700|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24945422|NCT03950700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24945423|NCT03950700|Autonomic Agents|autonomic agents|mesh-ancestor
24945424|NCT03950700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24858320|NCT02296333|Autonomic Agents|autonomic agents|mesh-ancestor
24411020|NCT00187408|Anticoagulants|anticoagulants|mesh-ancestor
24945425|NCT03950700|Respiratory System Agents|respiratory system agents|mesh-ancestor
24945426|NCT03950700|Mydriatics|mydriatics|mesh-ancestor
24945427|NCT03950700|Sympathomimetics|sympathomimetics|mesh-ancestor
24945429|NCT03950804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24945430|NCT03950804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25696811|NCT02066402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25696812|NCT02066402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696813|NCT02066727|Dexmedetomidine|dexmedetomidine|mesh-list
25696814|NCT02066727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25696815|NCT02066727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25696816|NCT02066727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945431|NCT03950804|Immunologic Factors|immunologic factors|mesh-ancestor
24945432|NCT03950804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945433|NCT03950505|Pioglitazone|pioglitazone|mesh-list
24945434|NCT03950505|Alogliptin|alogliptin|mesh-list
24945435|NCT03950505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24945436|NCT03950505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945437|NCT03950505|Incretins|incretins|mesh-ancestor
24945438|NCT03950505|Hormones|hormones|mesh-ancestor
24945439|NCT03950505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24945440|NCT03950505|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24945441|NCT03950505|Protease Inhibitors|protease inhibitors|mesh-ancestor
24945442|NCT03950505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24945443|NCT03950505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945445|NCT03950518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24394733|NCT00134069|Cetuximab|cetuximab|mesh-list
24450900|NCT00320892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24450901|NCT00320892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24450902|NCT00320892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24450903|NCT00320892|Autonomic Agents|autonomic agents|mesh-ancestor
24450904|NCT00320892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24450905|NCT00320892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450906|NCT00320892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24450907|NCT00320892|Respiratory System Agents|respiratory system agents|mesh-ancestor
24450908|NCT00320892|Mydriatics|mydriatics|mesh-ancestor
24394283|NCT00132821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24394284|NCT00132821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394285|NCT00132821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24394310|NCT00132899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394312|NCT00132899|Dermatologic Agents|dermatologic agents|mesh-ancestor
24394313|NCT00132899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394314|NCT00132899|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24394315|NCT00132899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24394316|NCT00132899|Immunologic Factors|immunologic factors|mesh-ancestor
24394317|NCT00132899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24394318|NCT00132899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24394320|NCT00132912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24394321|NCT00132925|Triamcinolone|triamcinolone|mesh-list
24394322|NCT00132925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24394323|NCT00132925|Glucocorticoids|glucocorticoids|mesh-ancestor
24925108|NCT04153487|Antioxidants|antioxidants|mesh-ancestor
24394325|NCT00132925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24394326|NCT00132925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394327|NCT00132938|Telithromycin|telithromycin|mesh-list
24394328|NCT00132938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24394329|NCT00132938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24394330|NCT00132951|Azithromycin|azithromycin|mesh-list
24394331|NCT00132951|Telithromycin|telithromycin|mesh-list
24394332|NCT00132951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24394369|NCT00133185|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24737295|NCT01668069|Serotonin Agents|serotonin agents|mesh-ancestor
24937372|NCT04029675|Antioxidants|antioxidants|mesh-ancestor
24937373|NCT04029675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394370|NCT00133185|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24394371|NCT00133185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394405|NCT00133237|Antimitotic Agents|antimitotic agents|mesh-ancestor
24459789|NCT00346463|Antioxidants|antioxidants|mesh-ancestor
24459790|NCT00346463|Protective Agents|protective agents|mesh-ancestor
24394412|NCT00133237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24394438|NCT00133315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24945542|NCT03949842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858393|NCT02296762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24394439|NCT00133315|Dermatologic Agents|dermatologic agents|mesh-ancestor
24394440|NCT00133315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24394441|NCT00133315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24394442|NCT00133315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24394443|NCT00133315|Analgesics|analgesics|mesh-ancestor
24394444|NCT00133315|Sensory System Agents|sensory system agents|mesh-ancestor
24394445|NCT00133315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24394446|NCT00133315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394447|NCT00133315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24394448|NCT00133315|Immunologic Factors|immunologic factors|mesh-ancestor
24925179|NCT04152655|Protective Agents|protective agents|mesh-ancestor
24394557|NCT00133562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24394558|NCT00133562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394559|NCT00133562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394561|NCT00133627|Antipruritics|antipruritics|mesh-ancestor
24394562|NCT00133627|Dermatologic Agents|dermatologic agents|mesh-ancestor
24394563|NCT00133627|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24394564|NCT00133627|Histamine Antagonists|histamine antagonists|mesh-ancestor
24394565|NCT00133627|Histamine Agents|histamine agents|mesh-ancestor
24394566|NCT00133627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24394567|NCT00133627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394568|NCT00133627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394569|NCT00133627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24394570|NCT00133640|Cholecalciferol|cholecalciferol|mesh-list
24394571|NCT00133640|Vitamin D|vitamin d|mesh-list
24394572|NCT00133640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24394573|NCT00133640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394574|NCT00133640|Vitamins|vitamins|mesh-ancestor
24394575|NCT00133640|Micronutrients|micronutrients|mesh-ancestor
24394576|NCT00133640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24455260|NCT02062944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24455261|NCT02062944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24455262|NCT02062944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24455263|NCT02062944|Antifungal Agents|antifungal agents|mesh-ancestor
24455264|NCT02062944|Immunologic Factors|immunologic factors|mesh-ancestor
24455265|NCT02062944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417370|NCT00206258|Hormones|hormones|mesh-ancestor
24945543|NCT03949842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696817|NCT02066727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25696818|NCT02066727|Analgesics|analgesics|mesh-ancestor
25696819|NCT02066727|Sensory System Agents|sensory system agents|mesh-ancestor
25696820|NCT02066727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25696821|NCT02066727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25696822|NCT02066727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25696823|NCT02066727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25696824|NCT02066727|Adrenergic Agents|adrenergic agents|mesh-ancestor
25696825|NCT02066727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25696826|NCT02066727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945545|NCT03949842|Respiratory System Agents|respiratory system agents|mesh-ancestor
24945546|NCT03949842|Dermatologic Agents|dermatologic agents|mesh-ancestor
24945547|NCT03949842|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24945548|NCT03949842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24394734|NCT00134069|Irinotecan|irinotecan|mesh-list
24945558|NCT03949517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24945559|NCT03949517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24945560|NCT03949517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24945561|NCT03949374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24945562|NCT03949374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24945563|NCT03949374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24945564|NCT03949374|Antimetabolites|antimetabolites|mesh-ancestor
24945565|NCT03949374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945566|NCT03949374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24945567|NCT03949374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24945568|NCT03949374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24945569|NCT03949634|Paclitaxel|paclitaxel|mesh-list
24945570|NCT03949634|Docetaxel|docetaxel|mesh-list
24945571|NCT03949634|Doxorubicin|doxorubicin|mesh-list
24945572|NCT03949634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24945573|NCT03949634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24945574|NCT03949634|Tubulin Modulators|tubulin modulators|mesh-ancestor
24945575|NCT03949634|Antimitotic Agents|antimitotic agents|mesh-ancestor
24945576|NCT03949634|Mitosis Modulators|mitosis modulators|mesh-ancestor
24945577|NCT03949634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945578|NCT03949634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24945579|NCT03949634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24945580|NCT03949634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24945581|NCT03949634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24945583|NCT03949478|Nifedipine|nifedipine|mesh-list
24945584|NCT03949478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24945585|NCT03949478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24945586|NCT03949478|Analgesics|analgesics|mesh-ancestor
24945587|NCT03949478|Sensory System Agents|sensory system agents|mesh-ancestor
24945588|NCT03949478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24945589|NCT03949478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945590|NCT03949478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24945591|NCT03949478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24945592|NCT03949478|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24945593|NCT03949478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24945594|NCT03949478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858433|NCT02297477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24858434|NCT02297477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24455266|NCT01972217|Prednisone|prednisone|mesh-list
24455267|NCT01972217|Prednisolone|prednisolone|mesh-list
24455268|NCT01972217|Olaparib|olaparib|mesh-list
24455305|NCT01820910|Doxycycline|doxycycline|mesh-list
24455306|NCT01820910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24455307|NCT01820910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24394604|NCT00133731|Calcium heparin|calcium heparin|mesh-list
24394605|NCT00133731|Otamixaban|otamixaban|mesh-list
24394640|NCT00133770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394642|NCT00133796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24394643|NCT00133796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24394728|NCT00134030|Keratolytic Agents|keratolytic agents|mesh-ancestor
24394729|NCT00134030|Tubulin Modulators|tubulin modulators|mesh-ancestor
24394730|NCT00134030|Antimitotic Agents|antimitotic agents|mesh-ancestor
24394731|NCT00134030|Mitosis Modulators|mitosis modulators|mesh-ancestor
24394732|NCT00134069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24394736|NCT00134069|Antibodies|antibodies|mesh-list
24394737|NCT00134069|Immunoglobulins|immunoglobulins|mesh-list
24394738|NCT00134069|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24394739|NCT00134069|Immunologic Factors|immunologic factors|mesh-ancestor
24394740|NCT00134069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394771|NCT00134160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24394772|NCT00134173|Atorvastatin|atorvastatin|mesh-list
25696828|NCT02066792|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25696829|NCT02066792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25696830|NCT02066792|Renal Agents|renal agents|mesh-ancestor
25696831|NCT02066792|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25696832|NCT02066792|Antitubercular Agents|antitubercular agents|mesh-ancestor
24394773|NCT00134173|Torcetrapib|torcetrapib|mesh-list
24945595|NCT03949478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24945596|NCT03949478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24945597|NCT03949478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24945598|NCT03949478|Vasodilator Agents|vasodilator agents|mesh-ancestor
24945599|NCT03949478|Tocolytic Agents|tocolytic agents|mesh-ancestor
24945600|NCT03949478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24945601|NCT03949101|Atropine|atropine|mesh-list
24945602|NCT03949101|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24945603|NCT03949101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24945604|NCT03949101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24945605|NCT03949101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24945606|NCT03949101|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24945607|NCT03949101|Autonomic Agents|autonomic agents|mesh-ancestor
24945608|NCT03949101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24945609|NCT03949101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945610|NCT03949101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24858449|NCT02297568|Vitamins|vitamins|mesh-ancestor
24527339|NCT00616031|Paclitaxel|paclitaxel|mesh-list
24394774|NCT00134173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24394775|NCT00134173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24394776|NCT00134173|Antimetabolites|antimetabolites|mesh-ancestor
24394777|NCT00134173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394778|NCT00134173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24394779|NCT00134173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24394780|NCT00134173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394781|NCT00134186|Motexafin gadolinium|motexafin gadolinium|mesh-list
24394782|NCT00134186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24394810|NCT00134212|Dopamine Agents|dopamine agents|mesh-ancestor
24394811|NCT00134290|Metformin|metformin|mesh-list
24394812|NCT00134290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24394813|NCT00134290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394814|NCT00134303|Metformin|metformin|mesh-list
24394815|NCT00134303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24459791|NCT00346463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394816|NCT00134303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394817|NCT00134355|Vatalanib|vatalanib|mesh-list
24394818|NCT00134355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24394819|NCT00134355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394820|NCT00134355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394822|NCT00134368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24394823|NCT00134368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24394824|NCT00134368|Analgesics|analgesics|mesh-ancestor
24394869|NCT00134485|Antimetabolites|antimetabolites|mesh-ancestor
24394870|NCT00134485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394871|NCT00134485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24394872|NCT00134485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24394901|NCT00134641|Vinorelbine|vinorelbine|mesh-list
24394902|NCT00134641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24945611|NCT03949101|Respiratory System Agents|respiratory system agents|mesh-ancestor
24945613|NCT03949101|Parasympatholytics|parasympatholytics|mesh-ancestor
24945614|NCT03949101|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24945615|NCT03949101|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24945616|NCT03949101|Cholinergic Agents|cholinergic agents|mesh-ancestor
24945617|NCT03949101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24945618|NCT03949101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945619|NCT03949049|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
24945620|NCT03949049|Nootropic Agents|nootropic agents|mesh-ancestor
24945621|NCT03949062|Rituximab|rituximab|mesh-list
24945622|NCT03949062|Lenalidomide|lenalidomide|mesh-list
24945623|NCT03949062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24945624|NCT03949062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24945625|NCT03949062|Immunologic Factors|immunologic factors|mesh-ancestor
24945626|NCT03949062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945627|NCT03949062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24945628|NCT03949062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24945629|NCT03949062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24945630|NCT03949062|Growth Substances|growth substances|mesh-ancestor
24945631|NCT03949062|Growth Inhibitors|growth inhibitors|mesh-ancestor
24945632|NCT03949075|Enalapril|enalapril|mesh-list
24534190|NCT00646386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24945633|NCT03949075|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24945634|NCT03949075|Protease Inhibitors|protease inhibitors|mesh-ancestor
24945635|NCT03949075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24945636|NCT03949075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945637|NCT03949075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24945638|NCT03948685|Carvedilol|carvedilol|mesh-list
24945639|NCT03948685|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24945640|NCT03948685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24945641|NCT03948685|Adrenergic Agents|adrenergic agents|mesh-ancestor
24945642|NCT03948685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24858465|NCT02297763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24394907|NCT00134641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24394908|NCT00134641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24945643|NCT03948685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051386|NCT00411528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25051388|NCT00411385|Ribavirin|ribavirin|mesh-list
25051389|NCT00411385|Interferon-alpha|interferon-alpha|mesh-list
25051390|NCT00411385|Interferon alpha-2|interferon alpha-2|mesh-list
25051391|NCT00411385|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25051392|NCT00411385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051394|NCT00411385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25051395|NCT00411385|Antimetabolites|antimetabolites|mesh-ancestor
25051396|NCT00411385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051397|NCT00411385|Immunologic Factors|immunologic factors|mesh-ancestor
25051398|NCT00411385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051399|NCT00411242|S 20098|s 20098|mesh-list
25051400|NCT00411242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25051401|NCT00411242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24394909|NCT00134641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24394910|NCT00134641|Immunologic Factors|immunologic factors|mesh-ancestor
24394911|NCT00134641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394912|NCT00134641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24394913|NCT00134641|Tubulin Modulators|tubulin modulators|mesh-ancestor
24394914|NCT00134641|Antimitotic Agents|antimitotic agents|mesh-ancestor
24394915|NCT00134641|Mitosis Modulators|mitosis modulators|mesh-ancestor
24394943|NCT00134693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24394945|NCT00134693|Hormones|hormones|mesh-ancestor
24394946|NCT00134693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24394947|NCT00134693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394948|NCT00134693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24394999|NCT00134888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395001|NCT00134888|Sensory System Agents|sensory system agents|mesh-ancestor
24395004|NCT00134914|Buprenorphine|buprenorphine|mesh-list
24395010|NCT00134914|Sensory System Agents|sensory system agents|mesh-ancestor
24395011|NCT00134914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24395013|NCT00134953|Rivastigmine|rivastigmine|mesh-list
24395077|NCT00135018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24395078|NCT00135018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395091|NCT00135070|Insulin Detemir|insulin detemir|mesh-list
24395092|NCT00135070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24395093|NCT00135070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395133|NCT00135135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24395134|NCT00135135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24395135|NCT00135135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24395136|NCT00135135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24455330|NCT01785459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24455331|NCT01785459|Antiemetics|antiemetics|mesh-ancestor
24455332|NCT01785459|Autonomic Agents|autonomic agents|mesh-ancestor
24455333|NCT01785459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24455334|NCT01785459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25051402|NCT00411242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051403|NCT00411099|S 20098|s 20098|mesh-list
25051404|NCT00411099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24395281|NCT00135603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395282|NCT00135603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395284|NCT00135668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24395285|NCT00135668|Vasodilator Agents|vasodilator agents|mesh-ancestor
24395286|NCT00135668|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24395313|NCT00135720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24395314|NCT00135720|Immunologic Factors|immunologic factors|mesh-ancestor
24395315|NCT00135733|Alefacept|alefacept|mesh-list
24395316|NCT00135733|Dermatologic Agents|dermatologic agents|mesh-ancestor
24395317|NCT00135733|Immunologic Factors|immunologic factors|mesh-ancestor
24395318|NCT00135733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395320|NCT00135746|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24395443|NCT00135967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24395445|NCT00135967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24395446|NCT00135967|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24395447|NCT00135967|Antitubercular Agents|antitubercular agents|mesh-ancestor
24395448|NCT00135967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24395449|NCT00135967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24395450|NCT00135967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395451|NCT00135967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395453|NCT00135967|Autonomic Agents|autonomic agents|mesh-ancestor
24395454|NCT00135967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24459801|NCT00346489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459802|NCT00346489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24395493|NCT00136175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051410|NCT00407303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925558|NCT04149067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24395525|NCT00136266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24395526|NCT00136292|Daptomycin|daptomycin|mesh-list
24395527|NCT00136292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24395528|NCT00136292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24395529|NCT00136344|Levofloxacin|levofloxacin|mesh-list
24395530|NCT00136344|Ofloxacin|ofloxacin|mesh-list
24395540|NCT00136344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395542|NCT00136344|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24395543|NCT00136344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24395544|NCT00136370|Chlorhexidine|chlorhexidine|mesh-list
24395545|NCT00136370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24395569|NCT00136396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24395573|NCT00136396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24395574|NCT00136409|Imatinib Mesylate|imatinib mesylate|mesh-list
24395575|NCT00136409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24395576|NCT00136409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24395577|NCT00136409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395579|NCT00136448|Cytarabine|cytarabine|mesh-list
25051421|NCT00405951|Docetaxel|docetaxel|mesh-list
25051422|NCT00405951|Obatoclax|obatoclax|mesh-list
25051423|NCT00405951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051424|NCT00405951|Tubulin Modulators|tubulin modulators|mesh-ancestor
25051425|NCT00405951|Antimitotic Agents|antimitotic agents|mesh-ancestor
25051426|NCT00405951|Mitosis Modulators|mitosis modulators|mesh-ancestor
25051427|NCT00405951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051428|NCT00405951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051429|NCT00405743|Cytarabine|cytarabine|mesh-list
25051430|NCT00405743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24858529|NCT02298166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858530|NCT02298166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858531|NCT02298166|Antiviral Agents|antiviral agents|mesh-ancestor
24395742|NCT00136773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24395774|NCT00136851|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24395812|NCT00136981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24452243|NCT00326508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459814|NCT00346502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24459815|NCT00346502|Antimalarials|antimalarials|mesh-ancestor
24395853|NCT00137033|Sensory System Agents|sensory system agents|mesh-ancestor
24395854|NCT00137033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24395855|NCT00137033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395887|NCT00137085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24395889|NCT00137085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24395973|NCT00137462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24396035|NCT00137709|Valproic Acid|valproic acid|mesh-list
24396036|NCT00137709|Anticonvulsants|anticonvulsants|mesh-ancestor
24396037|NCT00137709|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24396038|NCT00137709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24396039|NCT00137709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396040|NCT00137709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24396041|NCT00137709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396042|NCT00137709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24396043|NCT00137709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24396044|NCT00137709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24396045|NCT00137709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24396046|NCT00137709|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24396047|NCT00137709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396048|NCT00137709|GABA Agents|gaba agents|mesh-ancestor
24396049|NCT00137709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24396050|NCT00137709|Antimanic Agents|antimanic agents|mesh-ancestor
24396051|NCT00137735|Gabapentin|gabapentin|mesh-list
24459816|NCT00346502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24459817|NCT00346502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24425033|NCT00231673|Topiramate|topiramate|mesh-list
24396193|NCT00138099|Tinzaparin|tinzaparin|mesh-list
24396194|NCT00138099|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24396195|NCT00138099|Anticoagulants|anticoagulants|mesh-ancestor
24396196|NCT00138099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24396197|NCT00138099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24396198|NCT00138099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396199|NCT00138112|Vancomycin|vancomycin|mesh-list
24396200|NCT00138112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24396201|NCT00138112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24396202|NCT00138138|Methylphenidate|methylphenidate|mesh-list
24396203|NCT00138138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24396204|NCT00138138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396205|NCT00138138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24396206|NCT00138138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24396207|NCT00138138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24396233|NCT00138177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396235|NCT00138216|Vincristine|vincristine|mesh-list
24396236|NCT00138216|Temozolomide|temozolomide|mesh-list
24396237|NCT00138216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24396238|NCT00138216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24396239|NCT00138216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396240|NCT00138216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396241|NCT00138216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24945646|NCT03948685|Antioxidants|antioxidants|mesh-ancestor
24945647|NCT03948685|Protective Agents|protective agents|mesh-ancestor
24945648|NCT03948685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24945649|NCT03948685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24945650|NCT03948685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24945651|NCT03948685|Vasodilator Agents|vasodilator agents|mesh-ancestor
24945652|NCT03948685|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24945653|NCT03948685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24945658|NCT03948737|Antioxidants|antioxidants|mesh-ancestor
24945659|NCT03948737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945660|NCT03948737|Protective Agents|protective agents|mesh-ancestor
24945661|NCT03948737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945662|NCT03948737|Vitamins|vitamins|mesh-ancestor
24945663|NCT03948737|Micronutrients|micronutrients|mesh-ancestor
24945664|NCT03948620|Penicillins|penicillins|mesh-list
24945665|NCT03948620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24945667|NCT03948477|Pantoprazole|pantoprazole|mesh-list
24945668|NCT03948477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24945669|NCT03948477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24945670|NCT03948477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24945671|NCT03948477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24945672|NCT03948477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945673|NCT03948321|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24945674|NCT03948321|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24945675|NCT03948321|Dermatologic Agents|dermatologic agents|mesh-ancestor
24945676|NCT03948243|Tolbutamide|tolbutamide|mesh-list
24945677|NCT03948243|Dextromethorphan|dextromethorphan|mesh-list
24858591|NCT02298283|Tubulin Modulators|tubulin modulators|mesh-ancestor
24396251|NCT00138229|Fludarabine phosphate|fludarabine phosphate|mesh-list
24396252|NCT00138229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24396253|NCT00138229|Immunologic Factors|immunologic factors|mesh-ancestor
24396254|NCT00138229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396255|NCT00138229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24396333|NCT00138593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396334|NCT00138606|Vildagliptin|vildagliptin|mesh-list
24396368|NCT00138801|Ceftriaxone|ceftriaxone|mesh-list
24396369|NCT00138801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24396370|NCT00138801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24396371|NCT00138801|Antimalarials|antimalarials|mesh-ancestor
24396372|NCT00138801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24396399|NCT00138970|Daclizumab|daclizumab|mesh-list
24396400|NCT00138970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24396401|NCT00138970|Glucocorticoids|glucocorticoids|mesh-ancestor
24396402|NCT00138970|Hormones|hormones|mesh-ancestor
24396403|NCT00138970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24396404|NCT00138970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396405|NCT00138970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24396406|NCT00138970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396407|NCT00138970|Antiemetics|antiemetics|mesh-ancestor
24396408|NCT00138970|Autonomic Agents|autonomic agents|mesh-ancestor
24396409|NCT00138970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24396410|NCT00138970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24396411|NCT00138970|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24396413|NCT00138970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24925828|NCT04147286|Atorvastatin|atorvastatin|mesh-list
24396414|NCT00138970|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24396415|NCT00138970|Antitubercular Agents|antitubercular agents|mesh-ancestor
24396416|NCT00138970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24396441|NCT00139009|Antifungal Agents|antifungal agents|mesh-ancestor
24396442|NCT00139009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24945687|NCT03948243|Purinergic Agents|purinergic agents|mesh-ancestor
24396456|NCT00139035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24396457|NCT00139035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24396458|NCT00139061|Atorvastatin|atorvastatin|mesh-list
24396459|NCT00139061|Torcetrapib|torcetrapib|mesh-list
24396460|NCT00139061|Fenofibrate|fenofibrate|mesh-list
24396461|NCT00139061|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24396462|NCT00139061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24396463|NCT00139061|Antimetabolites|antimetabolites|mesh-ancestor
24396464|NCT00139061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396499|NCT00139204|Carbon-11 methionine|carbon-11 methionine|mesh-list
24396500|NCT00139204|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24396631|NCT00139555|Vasodilator Agents|vasodilator agents|mesh-ancestor
24396632|NCT00139555|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24396633|NCT00139555|Protease Inhibitors|protease inhibitors|mesh-ancestor
24396634|NCT00139555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396636|NCT00139568|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24396637|NCT00139568|Serotonin Agents|serotonin agents|mesh-ancestor
24396638|NCT00139568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24396667|NCT00139646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24396668|NCT00139646|Analgesics|analgesics|mesh-ancestor
24396669|NCT00139646|Sensory System Agents|sensory system agents|mesh-ancestor
24396670|NCT00139646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24396671|NCT00139646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741048|NCT01691469|Montelukast|montelukast|mesh-list
24925906|NCT04146493|Heparin|heparin|mesh-list
24396672|NCT00139646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24396673|NCT00139646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24396674|NCT00139646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24396675|NCT00139646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396676|NCT00139646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396677|NCT00139646|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24396764|NCT00139867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396765|NCT00139880|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24396766|NCT00139880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24396767|NCT00139880|Immunologic Factors|immunologic factors|mesh-ancestor
25696834|NCT02066792|Antimetabolites|antimetabolites|mesh-ancestor
25696835|NCT02066792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709396|NCT02266433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25709397|NCT02266433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25709398|NCT02266433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396768|NCT00139880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396769|NCT00139880|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24396770|NCT00139880|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24396771|NCT00139880|Dopamine Agonists|dopamine agonists|mesh-ancestor
24396772|NCT00139880|Dopamine Agents|dopamine agents|mesh-ancestor
24396798|NCT00139932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396800|NCT00139971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24396801|NCT00139971|Antimetabolites|antimetabolites|mesh-ancestor
24925954|NCT04145856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925955|NCT04146116|Povidone-Iodine|povidone-iodine|mesh-list
24925956|NCT04146116|Povidone|povidone|mesh-list
24925957|NCT04146116|Plasma Substitutes|plasma substitutes|mesh-ancestor
24396802|NCT00139971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396803|NCT00139971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396804|NCT00139971|Antiviral Agents|antiviral agents|mesh-ancestor
24396805|NCT00139971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24396806|NCT00139971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396807|NCT00139971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24396808|NCT00139971|Immunologic Factors|immunologic factors|mesh-ancestor
24396809|NCT00139971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945688|NCT03948243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24945689|NCT03948243|Antitussive Agents|antitussive agents|mesh-ancestor
24945690|NCT03948243|Respiratory System Agents|respiratory system agents|mesh-ancestor
24396869|NCT00140218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396870|NCT00140218|Protective Agents|protective agents|mesh-ancestor
24396871|NCT00140218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396907|NCT00140309|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24396908|NCT00140309|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24396925|NCT00140361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24396935|NCT00140361|Renal Agents|renal agents|mesh-ancestor
24396990|NCT00140530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24396991|NCT00140530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396992|NCT00140530|Tubulin Modulators|tubulin modulators|mesh-ancestor
24396993|NCT00140530|Antimitotic Agents|antimitotic agents|mesh-ancestor
24397023|NCT00140582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24397024|NCT00140582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24397026|NCT00140582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397027|NCT00140582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24397028|NCT00140595|Cyclophosphamide|cyclophosphamide|mesh-list
24397030|NCT00140595|Doxorubicin|doxorubicin|mesh-list
24397031|NCT00140595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24397032|NCT00140595|Immunologic Factors|immunologic factors|mesh-ancestor
24397033|NCT00140595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397034|NCT00140595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24397035|NCT00140595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24945697|NCT03948243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24945698|NCT03948243|GABA Modulators|gaba modulators|mesh-ancestor
24945699|NCT03948243|GABA Agents|gaba agents|mesh-ancestor
24945700|NCT03948243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24945701|NCT03948191|Methylene diphosphonate|methylene diphosphonate|mesh-list
24945702|NCT03948191|Methylprednisolone|methylprednisolone|mesh-list
24945703|NCT03948191|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24945704|NCT03948191|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24945705|NCT03948191|Prednisolone|prednisolone|mesh-list
24945706|NCT03948191|Prednisolone acetate|prednisolone acetate|mesh-list
24945707|NCT03948191|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24945708|NCT03948191|Prednisolone phosphate|prednisolone phosphate|mesh-list
24945709|NCT03948191|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
24945710|NCT03948191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24813173|NCT02056743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813174|NCT02056743|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24813175|NCT02056743|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24813176|NCT02056743|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24813177|NCT02056743|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24813178|NCT02056743|Purinergic Agents|purinergic agents|mesh-ancestor
24813179|NCT02056743|Antitussive Agents|antitussive agents|mesh-ancestor
24461094|NCT00351026|Methadone|methadone|mesh-list
24925981|NCT04145492|Vitamin D|vitamin d|mesh-list
24397317|NCT00141336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24397318|NCT00141336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24459826|NCT00346502|Antiviral Agents|antiviral agents|mesh-ancestor
24459827|NCT00346567|Tenofovir|tenofovir|mesh-list
24459828|NCT00346567|Lamivudine|lamivudine|mesh-list
24459829|NCT00346567|Zidovudine|zidovudine|mesh-list
24459830|NCT00346567|Emtricitabine|emtricitabine|mesh-list
24459831|NCT00346567|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24459832|NCT00346567|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
24459833|NCT00346567|Antiviral Agents|antiviral agents|mesh-ancestor
24459834|NCT00346567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24459835|NCT00346567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24459836|NCT00346567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24459838|NCT00346567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459839|NCT00346567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24459840|NCT00346567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24397398|NCT00141427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397399|NCT00141427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24397432|NCT00141557|Testosterone enanthate|testosterone enanthate|mesh-list
24397433|NCT00141557|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24945751|NCT03947242|Mitosis Modulators|mitosis modulators|mesh-ancestor
24397435|NCT00141557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24397436|NCT00141557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397437|NCT00141557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24945711|NCT03948191|Antiemetics|antiemetics|mesh-ancestor
24945712|NCT03948191|Autonomic Agents|autonomic agents|mesh-ancestor
24945713|NCT03948191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24945714|NCT03948191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945715|NCT03948191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24945716|NCT03948191|Glucocorticoids|glucocorticoids|mesh-ancestor
24945717|NCT03948191|Hormones|hormones|mesh-ancestor
24945718|NCT03948191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24945719|NCT03948191|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24945720|NCT03948191|Protective Agents|protective agents|mesh-ancestor
24945721|NCT03948191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24945722|NCT03948191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24945723|NCT03948191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24945724|NCT03948191|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24397439|NCT00141557|Anabolic Agents|anabolic agents|mesh-ancestor
24397660|NCT00142207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397661|NCT00142207|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24397737|NCT00142480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24397868|NCT00142896|Morphine|morphine|mesh-list
24397869|NCT00142896|Tramadol|tramadol|mesh-list
24397870|NCT00142896|Naloxone|naloxone|mesh-list
24397871|NCT00142896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24397872|NCT00142896|Narcotics|narcotics|mesh-ancestor
24397873|NCT00142896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24624392|NCT01076062|Misoprostol|misoprostol|mesh-list
24397902|NCT00142987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24397903|NCT00142987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397904|NCT00142987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397906|NCT00143000|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24397907|NCT00143000|Antimetabolites|antimetabolites|mesh-ancestor
24455465|NCT00107198|Cortisone|cortisone|mesh-list
24397908|NCT00143000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397915|NCT00143026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24397916|NCT00143026|Dopamine Agents|dopamine agents|mesh-ancestor
24397917|NCT00143026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24397986|NCT00143169|Parecoxib|parecoxib|mesh-list
24398046|NCT00143299|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24398083|NCT00143377|Cholinergic Agents|cholinergic agents|mesh-ancestor
24398084|NCT00143377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24398104|NCT00143481|Cholinergic Agents|cholinergic agents|mesh-ancestor
24398105|NCT00143481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24398106|NCT00143481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398108|NCT00143481|Urological Agents|urological agents|mesh-ancestor
24398109|NCT00143520|Pioglitazone|pioglitazone|mesh-list
24398110|NCT00143520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24398111|NCT00143520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945725|NCT03948191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770881|NCT01822951|Cholinergic Agents|cholinergic agents|mesh-ancestor
24945727|NCT03948178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24945728|NCT03948178|Vasodilator Agents|vasodilator agents|mesh-ancestor
24945733|NCT03948178|Protective Agents|protective agents|mesh-ancestor
24945734|NCT03948178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945735|NCT03947528|Sarpogrelate|sarpogrelate|mesh-list
24945736|NCT03947528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24945737|NCT03947528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25406513|NCT03555149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937694|NCT04026074|Sympatholytics|sympatholytics|mesh-ancestor
24945738|NCT03947528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945739|NCT03947528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24945740|NCT03947528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24945741|NCT03947528|Serotonin Agents|serotonin agents|mesh-ancestor
24945742|NCT03947528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24945743|NCT03947528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945744|NCT03947242|Trastuzumab|trastuzumab|mesh-list
24945745|NCT03947242|Vinorelbine|vinorelbine|mesh-list
24945746|NCT03947242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24945747|NCT03947242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24945748|NCT03947242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24926151|NCT04144218|Lacosamide|lacosamide|mesh-list
24945749|NCT03947242|Tubulin Modulators|tubulin modulators|mesh-ancestor
24945750|NCT03947242|Antimitotic Agents|antimitotic agents|mesh-ancestor
24945779|NCT03947125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24945780|NCT03947125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945781|NCT03947125|Analgesics|analgesics|mesh-ancestor
24945782|NCT03947125|Sensory System Agents|sensory system agents|mesh-ancestor
24945783|NCT03947125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24945784|NCT03947125|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24398219|NCT00143806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398253|NCT00143975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24398254|NCT00143975|Immunologic Factors|immunologic factors|mesh-ancestor
24398255|NCT00143975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398256|NCT00143975|Analgesics|analgesics|mesh-ancestor
24398257|NCT00143975|Sensory System Agents|sensory system agents|mesh-ancestor
24398258|NCT00143975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24398259|NCT00143975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24398260|NCT00143975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24398298|NCT00144144|Calcium|calcium|mesh-list
24398299|NCT00144144|Angiotensinogen|angiotensinogen|mesh-list
24398300|NCT00144144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24398331|NCT00144183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24398332|NCT00144183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24398333|NCT00144183|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24398334|NCT00144183|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24398335|NCT00144196|Tiotropium Bromide|tiotropium bromide|mesh-list
24398336|NCT00144196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24398337|NCT00144196|Autonomic Agents|autonomic agents|mesh-ancestor
24398338|NCT00144196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24398339|NCT00144196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398362|NCT00144222|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24945797|NCT03946826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24398370|NCT00144248|Antiviral Agents|antiviral agents|mesh-ancestor
24398371|NCT00144248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24398372|NCT00144248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24398373|NCT00144248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24398374|NCT00144248|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24945838|NCT03945539|JNJ-56136379|jnj-56136379|mesh-list
24858683|NCT02299063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24398633|NCT00145171|Dopamine Agonists|dopamine agonists|mesh-ancestor
24398634|NCT00145171|Dopamine Agents|dopamine agents|mesh-ancestor
24398635|NCT00145171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24398636|NCT00145171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398637|NCT00145184|Vitamins|vitamins|mesh-list
24398638|NCT00145184|Vitamin B Complex|vitamin b complex|mesh-list
24398895|NCT00146068|Immunologic Factors|immunologic factors|mesh-ancestor
24945839|NCT03945539|Antifungal Agents|antifungal agents|mesh-ancestor
24945840|NCT03945539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24945841|NCT03945539|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24945842|NCT03945539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24945843|NCT03945539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24945844|NCT03945539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945845|NCT03945539|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24945846|NCT03945539|Hormone Antagonists|hormone antagonists|mesh-ancestor
24945847|NCT03945539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24945848|NCT03945539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858699|NCT02299115|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24858700|NCT02299115|Prednisolone acetate|prednisolone acetate|mesh-list
24398896|NCT00146068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398931|NCT00146159|Analgesics|analgesics|mesh-ancestor
24399136|NCT00146627|Eflornithine|eflornithine|mesh-list
24399137|NCT00146627|Nifurtimox|nifurtimox|mesh-list
24399138|NCT00146627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399139|NCT00146627|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24945849|NCT03945539|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24945850|NCT03945539|Antiviral Agents|antiviral agents|mesh-ancestor
24427134|NCT00237510|Terazosin|terazosin|mesh-list
24945881|NCT03945344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24945882|NCT03945344|Autonomic Agents|autonomic agents|mesh-ancestor
24945883|NCT03945344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24945884|NCT03945344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945885|NCT03945344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24399182|NCT00146783|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24399183|NCT00146783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24399184|NCT00146783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24399185|NCT00146783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24399186|NCT00146783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399187|NCT00146783|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24399188|NCT00146783|Renal Agents|renal agents|mesh-ancestor
24399189|NCT00146835|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24399190|NCT00146835|Immunologic Factors|immunologic factors|mesh-ancestor
24399191|NCT00146835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399193|NCT00146900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24399290|NCT00147355|Autonomic Agents|autonomic agents|mesh-ancestor
24399291|NCT00147355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24399323|NCT00147394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459863|NCT00346645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399494|NCT00147901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399495|NCT00147901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24399496|NCT00147901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24399497|NCT00147901|Alkylating Agents|alkylating agents|mesh-ancestor
24399498|NCT00147901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399499|NCT00147901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399531|NCT00148018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24399532|NCT00148018|Antiemetics|antiemetics|mesh-ancestor
24399533|NCT00148018|Autonomic Agents|autonomic agents|mesh-ancestor
24399534|NCT00148018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24399535|NCT00148018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399536|NCT00148018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24399537|NCT00148018|Glucocorticoids|glucocorticoids|mesh-ancestor
24399538|NCT00148018|Hormones|hormones|mesh-ancestor
24399539|NCT00148018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24399540|NCT00148018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24399541|NCT00148018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24425946|NCT00234858|Diuretics|diuretics|mesh-ancestor
24945889|NCT03945344|Cholinergic Agents|cholinergic agents|mesh-ancestor
24926615|NCT04140136|Vitamins|vitamins|mesh-ancestor
24945890|NCT03945344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24945891|NCT03945344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945892|NCT03945396|Calcium Carbonate|calcium carbonate|mesh-list
24945893|NCT03945396|Antacids|antacids|mesh-ancestor
24945894|NCT03945396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945895|NCT03945396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24945896|NCT03944980|Docetaxel|docetaxel|mesh-list
24945897|NCT03944980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24945898|NCT03944980|Tubulin Modulators|tubulin modulators|mesh-ancestor
24945900|NCT03944980|Mitosis Modulators|mitosis modulators|mesh-ancestor
25051436|NCT00405743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25051437|NCT00405743|Immunologic Factors|immunologic factors|mesh-ancestor
25051438|NCT00405743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945901|NCT03944980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945906|NCT03944889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24945907|NCT03944889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945909|NCT03944733|Trace Elements|trace elements|mesh-ancestor
24945910|NCT03944733|Micronutrients|micronutrients|mesh-ancestor
24945911|NCT03944733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945912|NCT03944863|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24945913|NCT03944863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24945914|NCT03944655|Anesthetics|anesthetics|mesh-list
24945915|NCT03944655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24444859|NCT00299390|Sagopilone|sagopilone|mesh-list
24858744|NCT02299271|Ropivacaine|ropivacaine|mesh-list
24858745|NCT02299271|Anesthetics, Local|anesthetics, local|mesh-ancestor
24858746|NCT02299271|Anesthetics|anesthetics|mesh-ancestor
24459866|NCT00346684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399644|NCT00148330|Triamcinolone|triamcinolone|mesh-list
24399739|NCT00148551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24399740|NCT00148551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399741|NCT00148551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24399742|NCT00148551|Immunologic Factors|immunologic factors|mesh-ancestor
24399743|NCT00148551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24399744|NCT00148551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399745|NCT00148564|Olanzapine|olanzapine|mesh-list
24399746|NCT00148564|Ziprasidone|ziprasidone|mesh-list
24399747|NCT00148564|Antiemetics|antiemetics|mesh-ancestor
24399748|NCT00148564|Autonomic Agents|autonomic agents|mesh-ancestor
24399781|NCT00148603|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24399782|NCT00148603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24399783|NCT00148603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399784|NCT00148616|Memantine|memantine|mesh-list
24399785|NCT00148616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24399786|NCT00148616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24399820|NCT00148720|Capecitabine|capecitabine|mesh-list
24399821|NCT00148720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24399953|NCT00149110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399954|NCT00149110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24399955|NCT00149110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399956|NCT00149110|Analgesics|analgesics|mesh-ancestor
24399957|NCT00149110|Sensory System Agents|sensory system agents|mesh-ancestor
24399958|NCT00149110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24399959|NCT00149110|Antidepressive Agents|antidepressive agents|mesh-ancestor
24399960|NCT00149110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24399990|NCT00149201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399991|NCT00149201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24399992|NCT00149201|Immunologic Factors|immunologic factors|mesh-ancestor
24400004|NCT00149240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24400042|NCT00149539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24400043|NCT00149539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400070|NCT00149604|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
24400071|NCT00149604|Estrogens|estrogens|mesh-list
24400072|NCT00149604|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24400073|NCT00149604|Hormones|hormones|mesh-ancestor
24400074|NCT00149604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24400075|NCT00149604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400076|NCT00149604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24945917|NCT03944681|Droperidol|droperidol|mesh-list
24945918|NCT03944681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24945919|NCT03944681|Antiemetics|antiemetics|mesh-ancestor
24945920|NCT03944681|Autonomic Agents|autonomic agents|mesh-ancestor
24945921|NCT03944681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24945922|NCT03944681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945923|NCT03944681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24945924|NCT03944681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24945925|NCT03944681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24945926|NCT03944681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24945927|NCT03944681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24945928|NCT03944681|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24945929|NCT03944681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24945931|NCT03944681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24945932|NCT03944681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945933|NCT03944473|Neostigmine|neostigmine|mesh-list
24945934|NCT03944473|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24945935|NCT03944473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24945936|NCT03944473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945937|NCT03944473|Cholinergic Agents|cholinergic agents|mesh-ancestor
24945938|NCT03944473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24927036|NCT04136639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24400084|NCT00149617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24400123|NCT00149903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24400130|NCT00149903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400131|NCT00149916|Mycophenolic Acid|mycophenolic acid|mesh-list
24400132|NCT00149916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24400133|NCT00149916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25696836|NCT02067663|Levonorgestrel|levonorgestrel|mesh-list
25696837|NCT02067663|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24937813|NCT04025203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24400134|NCT00149916|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24400135|NCT00149916|Antitubercular Agents|antitubercular agents|mesh-ancestor
24400163|NCT00149968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24400164|NCT00149968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24400165|NCT00149968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400166|NCT00149968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400168|NCT00149981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24945945|NCT03944317|Sulfadoxine|sulfadoxine|mesh-list
24771143|NCT01825031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24771144|NCT01825031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24771145|NCT01825031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24771146|NCT01825031|Antiviral Agents|antiviral agents|mesh-ancestor
24771147|NCT01825031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24771148|NCT01825031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24771149|NCT01825031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771150|NCT01825031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771151|NCT01825031|Antifungal Agents|antifungal agents|mesh-ancestor
24771152|NCT01825031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24771153|NCT01825031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24771154|NCT01825031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24771155|NCT01825031|Hormone Antagonists|hormone antagonists|mesh-ancestor
24771186|NCT01825083|Ketamine|ketamine|mesh-list
24945946|NCT03944317|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24400171|NCT00149981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400172|NCT00150007|Mycophenolic Acid|mycophenolic acid|mesh-list
24400173|NCT00150007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24400174|NCT00150007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24400175|NCT00150007|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24400176|NCT00150007|Antitubercular Agents|antitubercular agents|mesh-ancestor
24400177|NCT00150007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24400178|NCT00150007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24400211|NCT00150072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24400212|NCT00150072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24400213|NCT00150072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400214|NCT00150072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400216|NCT00150085|Cyclosporins|cyclosporins|mesh-list
24400248|NCT00150215|Antiemetics|antiemetics|mesh-ancestor
24400260|NCT00150215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400261|NCT00150215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24400263|NCT00150228|Varenicline|varenicline|mesh-list
24400290|NCT00150280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24459873|NCT00346749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24945956|NCT03944317|Renal Agents|renal agents|mesh-ancestor
24945957|NCT03944291|Bupivacaine|bupivacaine|mesh-list
24945958|NCT03944291|Anesthetics, Local|anesthetics, local|mesh-ancestor
24945959|NCT03944291|Anesthetics|anesthetics|mesh-ancestor
24945982|NCT03943888|Atropine|atropine|mesh-list
24945983|NCT03943888|Neostigmine|neostigmine|mesh-list
24945984|NCT03943888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24945985|NCT03943888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24961781|NCT03805282|Lidocaine|lidocaine|mesh-list
24945986|NCT03943888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24945987|NCT03943888|Autonomic Agents|autonomic agents|mesh-ancestor
24945988|NCT03943888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24945989|NCT03943888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945990|NCT03943888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24945991|NCT03943888|Respiratory System Agents|respiratory system agents|mesh-ancestor
24945999|NCT03943888|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24946001|NCT03943888|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24946002|NCT03944005|Anesthetics|anesthetics|mesh-list
24946003|NCT03944005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24946004|NCT03944005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946005|NCT03943992|Esomeprazole|esomeprazole|mesh-list
24413044|NCT00193024|Docetaxel|docetaxel|mesh-list
24400291|NCT00150280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400292|NCT00150280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24400293|NCT00150280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24400385|NCT00150436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24400403|NCT00150449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24400404|NCT00150527|Dexamethasone|dexamethasone|mesh-list
25696838|NCT02067663|Contraceptive Agents|contraceptive agents|mesh-ancestor
24534328|NCT00646711|Anticonvulsants|anticonvulsants|mesh-ancestor
24400406|NCT00150527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24400407|NCT00150527|Antiemetics|antiemetics|mesh-ancestor
24400409|NCT00150527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24400410|NCT00150527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400411|NCT00150527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24400412|NCT00150527|Glucocorticoids|glucocorticoids|mesh-ancestor
24400413|NCT00150527|Hormones|hormones|mesh-ancestor
24400414|NCT00150527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24400415|NCT00150527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24946006|NCT03943992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24946007|NCT03943992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24946008|NCT03943992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24946009|NCT03943992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24946010|NCT03943992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400416|NCT00150527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24400417|NCT00150527|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24400448|NCT00150579|Autonomic Agents|autonomic agents|mesh-ancestor
24400532|NCT00150774|Anticonvulsants|anticonvulsants|mesh-ancestor
24400533|NCT00150774|Nootropic Agents|nootropic agents|mesh-ancestor
24400534|NCT00150787|Levetiracetam|levetiracetam|mesh-list
24400535|NCT00150787|Anticonvulsants|anticonvulsants|mesh-ancestor
24400536|NCT00150787|Nootropic Agents|nootropic agents|mesh-ancestor
24400538|NCT00150826|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24400539|NCT00150826|Protease Inhibitors|protease inhibitors|mesh-ancestor
24400540|NCT00150826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400567|NCT00150839|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24400569|NCT00150852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24400611|NCT00150995|Growth Substances|growth substances|mesh-ancestor
24400612|NCT00150995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400613|NCT00150995|Growth Inhibitors|growth inhibitors|mesh-ancestor
24400614|NCT00150995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24400630|NCT00151034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24400631|NCT00151034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400666|NCT00151073|Mitosis Modulators|mitosis modulators|mesh-ancestor
24946012|NCT03943459|Quercetin|quercetin|mesh-list
24946013|NCT03943459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24946014|NCT03943459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24946015|NCT03943459|Antimetabolites|antimetabolites|mesh-ancestor
24946016|NCT03943459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946017|NCT03943459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24946018|NCT03943459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24946019|NCT03943459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24946073|NCT03943407|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24946074|NCT03943407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24946075|NCT03943407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24946076|NCT03943407|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24946077|NCT03943407|Antidepressive Agents|antidepressive agents|mesh-ancestor
24946078|NCT03943407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24946079|NCT03943407|Histamine Antagonists|histamine antagonists|mesh-ancestor
24946080|NCT03943043|Gemcitabine|gemcitabine|mesh-list
24946081|NCT03943043|Paclitaxel|paclitaxel|mesh-list
24946082|NCT03943043|Oxaliplatin|oxaliplatin|mesh-list
25696839|NCT02067663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25696840|NCT02067663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696841|NCT02067663|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25696842|NCT02067663|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25696843|NCT02067663|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25696844|NCT02067676|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25696845|NCT02067676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25696846|NCT02067676|Immunologic Factors|immunologic factors|mesh-ancestor
24803085|NCT01994642|BB 1101|bb 1101|mesh-list
24946083|NCT03943043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24946084|NCT03943043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24946085|NCT03943043|Tubulin Modulators|tubulin modulators|mesh-ancestor
24771350|NCT01826279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771351|NCT01826279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534414|NCT00646932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24534415|NCT00646932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771352|NCT01826279|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24771354|NCT01826396|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24771355|NCT01826396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24771356|NCT01826396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771357|NCT01826396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771358|NCT01826396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771359|NCT01826526|Taurolidine|taurolidine|mesh-list
24771360|NCT01826526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24771365|NCT01826747|Hormones|hormones|mesh-ancestor
24858908|NCT02300376|Edetic Acid|edetic acid|mesh-list
24400830|NCT00151463|Sildenafil Citrate|sildenafil citrate|mesh-list
24400831|NCT00151463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400832|NCT00151463|Vasodilator Agents|vasodilator agents|mesh-ancestor
24401035|NCT00152022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771370|NCT01826773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771371|NCT01826786|JNJ-42165279|jnj-42165279|mesh-list
24771372|NCT01826786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771373|NCT01826786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771374|NCT01826864|Sargramostim|sargramostim|mesh-list
24771375|NCT01826864|Immunologic Factors|immunologic factors|mesh-ancestor
24771376|NCT01826864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625982|NCT01084876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24625983|NCT01084876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24625984|NCT01084876|Tubulin Modulators|tubulin modulators|mesh-ancestor
24625985|NCT01084876|Antimitotic Agents|antimitotic agents|mesh-ancestor
24625986|NCT01084876|Mitosis Modulators|mitosis modulators|mesh-ancestor
24625987|NCT01084876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625988|NCT01084876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24625989|NCT01084902|Latanoprost|latanoprost|mesh-list
24625990|NCT01084902|Brinzolamide|brinzolamide|mesh-list
24625991|NCT01084902|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24625992|NCT01084902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24625993|NCT01084902|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24625994|NCT01084902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625995|NCT01084902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625997|NCT01084980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24961936|NCT03804177|Viscosupplements|viscosupplements|mesh-ancestor
24961937|NCT03804177|Vitamins|vitamins|mesh-ancestor
24961938|NCT03804177|Micronutrients|micronutrients|mesh-ancestor
24961939|NCT03804229|3-n-butylphthalide|3-n-butylphthalide|mesh-list
24961940|NCT03804229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24626000|NCT01084980|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24946086|NCT03943043|Antimitotic Agents|antimitotic agents|mesh-ancestor
24946087|NCT03943043|Mitosis Modulators|mitosis modulators|mesh-ancestor
24858966|NCT02300701|Omalizumab|omalizumab|mesh-list
24401036|NCT00152022|Sympathomimetics|sympathomimetics|mesh-ancestor
24401037|NCT00152022|Autonomic Agents|autonomic agents|mesh-ancestor
24401038|NCT00152022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24401039|NCT00152022|Dopamine Agents|dopamine agents|mesh-ancestor
24401040|NCT00152022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24401041|NCT00152022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401042|NCT00152022|Adrenergic Agents|adrenergic agents|mesh-ancestor
24401044|NCT00152022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24401045|NCT00152022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24401046|NCT00152022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24401074|NCT00152100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24401076|NCT00152126|Busulfan|busulfan|mesh-list
24401125|NCT00152191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24401126|NCT00152191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24401127|NCT00152191|Alkylating Agents|alkylating agents|mesh-ancestor
24401128|NCT00152191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401129|NCT00152191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24401130|NCT00152191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25696847|NCT02067676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696848|NCT02067676|Antacids|antacids|mesh-ancestor
25696849|NCT02067676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696850|NCT02067676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24401131|NCT00152191|Antimetabolites|antimetabolites|mesh-ancestor
24401132|NCT00152191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24401167|NCT00152295|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24401168|NCT00152295|Estrogens|estrogens|mesh-ancestor
24401169|NCT00152295|Hormones|hormones|mesh-ancestor
24927344|NCT04133974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24401170|NCT00152295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24401242|NCT00152581|Interferon alpha-2|interferon alpha-2|mesh-list
24401243|NCT00152581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24401244|NCT00152581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24401281|NCT00152620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24401282|NCT00152620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24401283|NCT00152620|Protective Agents|protective agents|mesh-ancestor
24401284|NCT00152633|Losartan|losartan|mesh-list
24401285|NCT00152633|Metoprolol|metoprolol|mesh-list
24401316|NCT00152724|Indomethacin|indomethacin|mesh-list
24401317|NCT00152724|Nitroprusside|nitroprusside|mesh-list
24401318|NCT00152724|Acetylcholine|acetylcholine|mesh-list
24401319|NCT00152724|Capsaicin|capsaicin|mesh-list
24946088|NCT03943043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946089|NCT03943043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24946091|NCT03943043|Antiviral Agents|antiviral agents|mesh-ancestor
24946092|NCT03943043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24946093|NCT03943043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24946094|NCT03943043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24946095|NCT03943043|Immunologic Factors|immunologic factors|mesh-ancestor
24946096|NCT03943043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946097|NCT03942861|Methylprednisolone|methylprednisolone|mesh-list
24946098|NCT03942861|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24946099|NCT03942861|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24946100|NCT03942861|Prednisolone|prednisolone|mesh-list
24946101|NCT03942861|Prednisolone acetate|prednisolone acetate|mesh-list
24946102|NCT03942861|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24946103|NCT03942861|Prednisolone phosphate|prednisolone phosphate|mesh-list
24946104|NCT03942861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24946105|NCT03942861|Antiemetics|antiemetics|mesh-ancestor
24946106|NCT03942861|Autonomic Agents|autonomic agents|mesh-ancestor
24946107|NCT03942861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858982|NCT02300818|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24401320|NCT00152724|Clopidogrel|clopidogrel|mesh-list
24401321|NCT00152724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24401322|NCT00152724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24401323|NCT00152724|Analgesics|analgesics|mesh-ancestor
24401324|NCT00152724|Sensory System Agents|sensory system agents|mesh-ancestor
24401325|NCT00152724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24401351|NCT00152724|Cholinergic Agents|cholinergic agents|mesh-ancestor
24401354|NCT00152750|Sensory System Agents|sensory system agents|mesh-ancestor
24401358|NCT00152750|Sympatholytics|sympatholytics|mesh-ancestor
24401359|NCT00152750|Autonomic Agents|autonomic agents|mesh-ancestor
24401360|NCT00152750|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24401361|NCT00152750|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24401362|NCT00152750|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24401363|NCT00152750|Adrenergic Agents|adrenergic agents|mesh-ancestor
24401364|NCT00152750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24401365|NCT00152750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401366|NCT00152802|Vaccines|vaccines|mesh-list
24401400|NCT00152854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24401401|NCT00152854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401403|NCT00152867|Dexamethasone|dexamethasone|mesh-list
24401404|NCT00152867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24401405|NCT00152867|Antiemetics|antiemetics|mesh-ancestor
24401406|NCT00152867|Autonomic Agents|autonomic agents|mesh-ancestor
24401407|NCT00152867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24401408|NCT00152867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401444|NCT00152932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401506|NCT00153075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24401508|NCT00153075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24946108|NCT03942861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946109|NCT03942861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24946110|NCT03942861|Glucocorticoids|glucocorticoids|mesh-ancestor
24946111|NCT03942861|Hormones|hormones|mesh-ancestor
24946112|NCT03942861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24946113|NCT03942861|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24946114|NCT03942861|Protective Agents|protective agents|mesh-ancestor
24946115|NCT03942861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24946116|NCT03942861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24946118|NCT03942991|Carticaine|carticaine|mesh-list
24946119|NCT03942991|Anesthetics, Local|anesthetics, local|mesh-ancestor
24946120|NCT03942991|Anesthetics|anesthetics|mesh-ancestor
24946126|NCT03942757|Antioxidants|antioxidants|mesh-ancestor
24946127|NCT03942757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946128|NCT03942757|Protective Agents|protective agents|mesh-ancestor
24946129|NCT03942757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946130|NCT03942926|Sirolimus|sirolimus|mesh-list
24946131|NCT03942926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24946132|NCT03942926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24946133|NCT03942926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24946134|NCT03942926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24946135|NCT03942926|Antifungal Agents|antifungal agents|mesh-ancestor
24946136|NCT03942926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24946137|NCT03942926|Immunologic Factors|immunologic factors|mesh-ancestor
24946138|NCT03942926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946139|NCT03942796|Pregabalin|pregabalin|mesh-list
24946140|NCT03942796|Analgesics|analgesics|mesh-ancestor
24946141|NCT03942796|Sensory System Agents|sensory system agents|mesh-ancestor
24946142|NCT03942796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24946143|NCT03942796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800385|NCT01975363|Analgesics|analgesics|mesh-ancestor
24401676|NCT00153660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24401710|NCT00153725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24401711|NCT00153725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24401712|NCT00153725|Antipyretics|antipyretics|mesh-ancestor
24401753|NCT00153946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401755|NCT00153972|Cabergoline|cabergoline|mesh-list
24401756|NCT00153972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24401795|NCT00154024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401796|NCT00154024|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24401862|NCT00154167|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24401863|NCT00154167|Adrenergic Agents|adrenergic agents|mesh-ancestor
24401864|NCT00154167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24401865|NCT00154167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401866|NCT00154167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402274|NCT00156299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24402275|NCT00156299|Nootropic Agents|nootropic agents|mesh-ancestor
24402306|NCT00156377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402308|NCT00156403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24426566|NCT00236327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24402312|NCT00156403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24402313|NCT00156403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402314|NCT00156403|Vasodilator Agents|vasodilator agents|mesh-ancestor
24402315|NCT00156520|Aminocaproic Acid|aminocaproic acid|mesh-list
24402316|NCT00156520|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24402317|NCT00156520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24402352|NCT00156858|Immunologic Factors|immunologic factors|mesh-ancestor
24402353|NCT00156858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402354|NCT00156858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24402355|NCT00156858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402356|NCT00156858|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24402358|NCT00156884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402392|NCT00157066|Micronutrients|micronutrients|mesh-ancestor
24402393|NCT00157066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24402394|NCT00157079|Immunoglobulins|immunoglobulins|mesh-list
24402395|NCT00157079|Antibodies|antibodies|mesh-list
24402396|NCT00157079|gamma-Globulins|gamma-globulins|mesh-list
24402397|NCT00157079|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24402398|NCT00157079|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24402399|NCT00157079|Immunologic Factors|immunologic factors|mesh-ancestor
24402400|NCT00157079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402401|NCT00157092|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
24402402|NCT00157092|Protein C Inhibitor|protein c inhibitor|mesh-list
24402403|NCT00157092|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24402559|NCT00157859|Sulfadoxine|sulfadoxine|mesh-list
24402560|NCT00157859|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24402561|NCT00157859|Amebicides|amebicides|mesh-ancestor
24402562|NCT00157859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24402563|NCT00157859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24402564|NCT00157859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402602|NCT00157898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24402603|NCT00157898|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24402694|NCT00158171|Hematinics|hematinics|mesh-ancestor
24402695|NCT00158171|Vitamin B Complex|vitamin b complex|mesh-ancestor
24402697|NCT00158171|Micronutrients|micronutrients|mesh-ancestor
24402698|NCT00158210|Rivastigmine|rivastigmine|mesh-list
24402699|NCT00158210|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24402700|NCT00158210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402701|NCT00158210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402702|NCT00158210|Cholinergic Agents|cholinergic agents|mesh-ancestor
24402703|NCT00158210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24402704|NCT00158210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402705|NCT00158210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24402706|NCT00158210|Protective Agents|protective agents|mesh-ancestor
24402819|NCT00158522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402820|NCT00158548|Artesunate|artesunate|mesh-list
24402821|NCT00158548|Chloroquine|chloroquine|mesh-list
24402822|NCT00158548|Primaquine|primaquine|mesh-list
24402823|NCT00158548|Amodiaquine|amodiaquine|mesh-list
24402824|NCT00158548|Antimalarials|antimalarials|mesh-ancestor
24946166|NCT03942601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24946167|NCT03942601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24946168|NCT03942601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24404203|NCT00162734|Interferon alfacon-1|interferon alfacon-1|mesh-list
24946169|NCT03942601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24946170|NCT03942601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24946171|NCT03942601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24946172|NCT03942601|Antifungal Agents|antifungal agents|mesh-ancestor
24946173|NCT03942601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24402825|NCT00158548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24403050|NCT00159133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24403051|NCT00159133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403053|NCT00159133|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24403061|NCT00159133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403134|NCT00159458|Antimetabolites|antimetabolites|mesh-ancestor
24403135|NCT00159458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403136|NCT00159458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403192|NCT00159510|Protective Agents|protective agents|mesh-ancestor
24403193|NCT00159510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403194|NCT00159536|Metformin|metformin|mesh-list
24403195|NCT00159536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24403196|NCT00159536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403197|NCT00159575|Metformin|metformin|mesh-list
24403198|NCT00159575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24403199|NCT00159575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459890|NCT00346801|Irinotecan|irinotecan|mesh-list
24413689|NCT00194948|Citalopram|citalopram|mesh-list
24403200|NCT00159614|Rolofylline|rolofylline|mesh-list
24403201|NCT00159614|Diuretics|diuretics|mesh-ancestor
24403202|NCT00159614|Natriuretic Agents|natriuretic agents|mesh-ancestor
24403203|NCT00159614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403204|NCT00159627|Rolofylline|rolofylline|mesh-list
24946204|NCT03941951|Anti-Infective Agents|anti-infective agents|mesh-list
24946205|NCT03941951|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24946207|NCT03941925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24946208|NCT03941990|Nitrous Oxide|nitrous oxide|mesh-list
24946209|NCT03941990|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24946210|NCT03941990|Anesthetics, General|anesthetics, general|mesh-ancestor
24946211|NCT03941990|Anesthetics|anesthetics|mesh-ancestor
24946212|NCT03941990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24946213|NCT03941990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946214|NCT03941990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24946215|NCT03941990|Analgesics|analgesics|mesh-ancestor
24946216|NCT03941990|Sensory System Agents|sensory system agents|mesh-ancestor
24946217|NCT03941990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24946218|NCT03942029|Fluconazole|fluconazole|mesh-list
24946219|NCT03942029|Antifungal Agents|antifungal agents|mesh-ancestor
24946220|NCT03942029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24946221|NCT03942029|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24927712|NCT04130230|Choline|choline|mesh-list
24946222|NCT03942029|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24946223|NCT03942029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24946224|NCT03942029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403239|NCT00159679|Anticonvulsants|anticonvulsants|mesh-ancestor
24403240|NCT00159679|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24403241|NCT00159679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25406514|NCT03555149|Growth Inhibitors|growth inhibitors|mesh-ancestor
24403242|NCT00159679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946226|NCT03942029|Hormone Antagonists|hormone antagonists|mesh-ancestor
24946227|NCT03942029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24946228|NCT03942029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946229|NCT03942029|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24946230|NCT03942029|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24946231|NCT03941899|Levobupivacaine|levobupivacaine|mesh-list
24946232|NCT03941899|Anesthetics, Local|anesthetics, local|mesh-ancestor
24946234|NCT03941899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24946235|NCT03941899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800505|NCT01976078|Anesthetics, General|anesthetics, general|mesh-ancestor
24403243|NCT00159679|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24403244|NCT00159679|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24403245|NCT00159679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24403246|NCT00159679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24403247|NCT00159679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24403303|NCT00159757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403337|NCT00159809|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24403338|NCT00159809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24403339|NCT00159809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403340|NCT00159809|Urological Agents|urological agents|mesh-ancestor
24403341|NCT00159835|Atorvastatin|atorvastatin|mesh-list
24403377|NCT00160069|Epothilones|epothilones|mesh-list
24403875|NCT00161902|Hemostatics|hemostatics|mesh-ancestor
24403876|NCT00161902|Coagulants|coagulants|mesh-ancestor
24403877|NCT00161915|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24403878|NCT00161915|Hemostatics|hemostatics|mesh-ancestor
24403879|NCT00161915|Coagulants|coagulants|mesh-ancestor
24403880|NCT00161980|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24403881|NCT00161980|Hemostatics|hemostatics|mesh-ancestor
24403913|NCT00162149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24403914|NCT00162149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24403915|NCT00162149|Antiviral Agents|antiviral agents|mesh-ancestor
24403916|NCT00162149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24404198|NCT00162721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404199|NCT00162721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24946236|NCT03941899|Sensory System Agents|sensory system agents|mesh-ancestor
24946237|NCT03941899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24946238|NCT03941886|Aspirin|aspirin|mesh-list
24946239|NCT03941886|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24946240|NCT03941886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24946241|NCT03941886|Analgesics|analgesics|mesh-ancestor
24946242|NCT03941886|Sensory System Agents|sensory system agents|mesh-ancestor
24946243|NCT03941886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24946244|NCT03941886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946245|NCT03941886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24946246|NCT03941886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24946247|NCT03941886|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24404200|NCT00162721|Alkylating Agents|alkylating agents|mesh-ancestor
25696851|NCT02067806|Chloroprocaine|chloroprocaine|mesh-list
25696852|NCT02067806|Anesthetics, Local|anesthetics, local|mesh-ancestor
25696853|NCT02067806|Anesthetics|anesthetics|mesh-ancestor
25696854|NCT02067806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25696855|NCT02067806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696856|NCT02067806|Sensory System Agents|sensory system agents|mesh-ancestor
24404240|NCT00162851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24404241|NCT00162851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24404242|NCT00162864|Montelukast|montelukast|mesh-list
24404243|NCT00162864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24404277|NCT00162968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24404278|NCT00162968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24404279|NCT00162968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404314|NCT00163111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24404315|NCT00163111|Antifungal Agents|antifungal agents|mesh-ancestor
24404679|NCT00164450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24927778|NCT04129710|Rituximab|rituximab|mesh-list
24404680|NCT00164450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24404681|NCT00164450|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24404682|NCT00164450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24404683|NCT00164450|Antimetabolites|antimetabolites|mesh-ancestor
24404772|NCT00164788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24404773|NCT00164788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24404774|NCT00164788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24404810|NCT00164892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24404811|NCT00164892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24404843|NCT00165048|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24404844|NCT00165048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24404846|NCT00165048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404847|NCT00165048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24404848|NCT00165048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24404849|NCT00165048|Analgesics|analgesics|mesh-ancestor
24404850|NCT00165048|Sensory System Agents|sensory system agents|mesh-ancestor
24404851|NCT00165048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24404852|NCT00165048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404853|NCT00165048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24404854|NCT00165048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24404855|NCT00165074|Calfactant|calfactant|mesh-list
24946248|NCT03941886|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24946249|NCT03941886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946250|NCT03941886|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24946251|NCT03941886|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24946252|NCT03941886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24946253|NCT03941886|Antipyretics|antipyretics|mesh-ancestor
24946254|NCT03942068|Paclitaxel|paclitaxel|mesh-list
24405197|NCT00165763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405198|NCT00165763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405199|NCT00165763|Cholinergic Agents|cholinergic agents|mesh-ancestor
24405200|NCT00165763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24405201|NCT00165763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405226|NCT00165867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24946286|NCT03941587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25696857|NCT02067806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25696858|NCT02068027|Clonidine|clonidine|mesh-list
25696859|NCT02068027|Analgesics|analgesics|mesh-ancestor
25696860|NCT02068027|Sensory System Agents|sensory system agents|mesh-ancestor
24946287|NCT03941587|Growth Substances|growth substances|mesh-ancestor
24946288|NCT03941587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946289|NCT03941587|Growth Inhibitors|growth inhibitors|mesh-ancestor
24946290|NCT03941587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962097|NCT03802318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24962098|NCT03802318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24927805|NCT04129424|Insulin|insulin|mesh-list
24962099|NCT03802318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24946353|NCT03940391|GABA Modulators|gaba modulators|mesh-ancestor
24405227|NCT00165867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405228|NCT00165880|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
24405229|NCT00165880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405230|NCT00165880|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24405231|NCT00165880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405232|NCT00165880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405233|NCT00166010|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24405234|NCT00166010|Natriuretic Agents|natriuretic agents|mesh-ancestor
24405235|NCT00166010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405237|NCT00166127|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24405238|NCT00166127|Vasodilator Agents|vasodilator agents|mesh-ancestor
24405239|NCT00166127|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24405240|NCT00166127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24405242|NCT00166127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459897|NCT00346801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24414056|NCT00195871|Glucocorticoids|glucocorticoids|mesh-ancestor
24405355|NCT00166595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24406032|NCT00169026|GABA Antagonists|gaba antagonists|mesh-ancestor
24406033|NCT00169026|GABA Agents|gaba agents|mesh-ancestor
24406034|NCT00169039|Chlorpromazine|chlorpromazine|mesh-list
24406035|NCT00169039|Clozapine|clozapine|mesh-list
24406036|NCT00169039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24406037|NCT00169039|Serotonin Agents|serotonin agents|mesh-ancestor
24406038|NCT00169039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24406746|NCT00171119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406747|NCT00171132|Atenolol|atenolol|mesh-list
24406748|NCT00171132|Valsartan|valsartan|mesh-list
24406749|NCT00171132|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24406918|NCT00171561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406919|NCT00171561|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24406920|NCT00171561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24406923|NCT00171574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24406924|NCT00171574|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24406925|NCT00171574|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24406926|NCT00171574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946354|NCT03940391|GABA Agents|gaba agents|mesh-ancestor
24946355|NCT03940391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24946356|NCT03940391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051448|NCT00403169|Lenalidomide|lenalidomide|mesh-list
25051449|NCT00403169|Immunologic Factors|immunologic factors|mesh-ancestor
25051450|NCT00403169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946357|NCT03940391|Antipruritics|antipruritics|mesh-ancestor
24771592|NCT01828359|Losartan|losartan|mesh-list
24946358|NCT03940391|Dermatologic Agents|dermatologic agents|mesh-ancestor
24406927|NCT00171574|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24406928|NCT00171574|Protease Inhibitors|protease inhibitors|mesh-ancestor
24406929|NCT00171574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24406930|NCT00171574|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24406934|NCT00171587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24406937|NCT00171600|Valsartan|valsartan|mesh-list
24407154|NCT00172055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407155|NCT00172068|Vitamin D|vitamin d|mesh-list
24407156|NCT00172068|Zoledronic Acid|zoledronic acid|mesh-list
24407157|NCT00172068|Calcium|calcium|mesh-list
24407158|NCT00172068|Vitamins|vitamins|mesh-ancestor
24407159|NCT00172068|Micronutrients|micronutrients|mesh-ancestor
24407160|NCT00172068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407161|NCT00172068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24407162|NCT00172068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24407163|NCT00172107|Parathyroid Hormone|parathyroid hormone|mesh-list
25406515|NCT03554473|Temozolomide|temozolomide|mesh-list
25696861|NCT02068027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24407214|NCT00173667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407215|NCT00173667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24407216|NCT00173667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407217|NCT00173667|Vasodilator Agents|vasodilator agents|mesh-ancestor
24407218|NCT00173667|Tocolytic Agents|tocolytic agents|mesh-ancestor
24407219|NCT00173667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24407220|NCT00173745|Botulinum Toxins|botulinum toxins|mesh-list
24407221|NCT00173745|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24407222|NCT00173745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24407223|NCT00173745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24407224|NCT00173745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24407225|NCT00173745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407226|NCT00173745|Cholinergic Agents|cholinergic agents|mesh-ancestor
24771665|NCT01828606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407514|NCT00174642|Secretagogues|secretagogues|mesh-list
24407515|NCT00174642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24407516|NCT00174642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407517|NCT00174655|Cyclophosphamide|cyclophosphamide|mesh-list
24407547|NCT00174694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24407548|NCT00174694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24407550|NCT00174707|Docetaxel|docetaxel|mesh-list
24407551|NCT00174707|Methotrexate|methotrexate|mesh-list
24407552|NCT00174707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24407553|NCT00174707|Immunologic Factors|immunologic factors|mesh-ancestor
24407554|NCT00174707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407555|NCT00174707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24407556|NCT00174707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24407557|NCT00174707|Alkylating Agents|alkylating agents|mesh-ancestor
24408126|NCT00176618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24771685|NCT01828736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24771686|NCT01828736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771687|NCT01828736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24771688|NCT01828736|Immunologic Factors|immunologic factors|mesh-ancestor
24771689|NCT01828736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407857|NCT00175734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24407858|NCT00175734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24407860|NCT00175747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24407861|NCT00175747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24407862|NCT00175747|Autonomic Agents|autonomic agents|mesh-ancestor
24407863|NCT00175747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24407864|NCT00175747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407865|NCT00175747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24407866|NCT00175747|Respiratory System Agents|respiratory system agents|mesh-ancestor
24459908|NCT00346827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427515|NCT00238316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800615|NCT01976923|Growth Inhibitors|growth inhibitors|mesh-ancestor
24407961|NCT00175981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24407962|NCT00175981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24407964|NCT00175981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24407965|NCT00175981|Antidepressive Agents|antidepressive agents|mesh-ancestor
24408054|NCT00176332|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24408055|NCT00176332|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24408056|NCT00176332|Antimetabolites|antimetabolites|mesh-ancestor
24408057|NCT00176332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408058|NCT00176332|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24408059|NCT00176332|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24408060|NCT00176332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427529|NCT00238329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25696862|NCT02068027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696863|NCT02068027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25696864|NCT02068027|Sympatholytics|sympatholytics|mesh-ancestor
25696865|NCT02068027|Autonomic Agents|autonomic agents|mesh-ancestor
25696866|NCT02068027|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25696867|NCT02068027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25696868|NCT02068027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25696869|NCT02068027|Adrenergic Agents|adrenergic agents|mesh-ancestor
25696870|NCT02068027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25696871|NCT02068027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696872|NCT02068157|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
24427530|NCT00238329|Antiviral Agents|antiviral agents|mesh-ancestor
24408061|NCT00176449|Bupropion|bupropion|mesh-list
24408071|NCT00176449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408072|NCT00176449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24408073|NCT00176449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24408074|NCT00176449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408076|NCT00176475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24408077|NCT00176475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408078|NCT00176475|Immunologic Factors|immunologic factors|mesh-ancestor
24408115|NCT00176553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408116|NCT00176553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408118|NCT00176618|Sulindac|sulindac|mesh-list
24408119|NCT00176618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24408120|NCT00176618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24408121|NCT00176618|Analgesics|analgesics|mesh-ancestor
24408122|NCT00176618|Sensory System Agents|sensory system agents|mesh-ancestor
24408123|NCT00176618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24408124|NCT00176618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408125|NCT00176618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24408127|NCT00176618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408128|NCT00176618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408129|NCT00176618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408130|NCT00176618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24408131|NCT00176670|Midazolam|midazolam|mesh-list
24408132|NCT00176670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24408133|NCT00176670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24408134|NCT00176670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24408135|NCT00176670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408162|NCT00176774|Antimetabolites|antimetabolites|mesh-ancestor
24408163|NCT00176774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408164|NCT00176774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24408165|NCT00176774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408166|NCT00176774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24771690|NCT01828736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24626001|NCT01084980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626002|NCT01084980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626003|NCT01084993|Heparin|heparin|mesh-list
24626004|NCT01084993|Bivalirudin|bivalirudin|mesh-list
24626005|NCT01084993|Anticoagulants|anticoagulants|mesh-ancestor
24626006|NCT01084993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24626007|NCT01084993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24626008|NCT01084993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626009|NCT01084993|Antithrombins|antithrombins|mesh-ancestor
24626010|NCT01084993|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24626011|NCT01084993|Protease Inhibitors|protease inhibitors|mesh-ancestor
24626012|NCT01084993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626013|NCT01085032|Nicotine|nicotine|mesh-list
24626014|NCT01085032|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24626015|NCT01085032|Autonomic Agents|autonomic agents|mesh-ancestor
24626018|NCT01085032|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24408213|NCT00176943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408214|NCT00176943|Interferon Inducers|interferon inducers|mesh-ancestor
24408215|NCT00176969|Capsaicin|capsaicin|mesh-list
24408216|NCT00176969|Antipruritics|antipruritics|mesh-ancestor
24408217|NCT00176969|Dermatologic Agents|dermatologic agents|mesh-ancestor
24408218|NCT00176969|Sensory System Agents|sensory system agents|mesh-ancestor
24408219|NCT00176969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24526437|NCT00611689|Imatinib Mesylate|imatinib mesylate|mesh-list
24408220|NCT00176969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408221|NCT00176982|Hydroxychloroquine|hydroxychloroquine|mesh-list
24408255|NCT00177008|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24408257|NCT00177021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24408258|NCT00177021|Immunologic Factors|immunologic factors|mesh-ancestor
24408259|NCT00177021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459911|NCT00346827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24459912|NCT00346827|Dopamine Agonists|dopamine agonists|mesh-ancestor
24459914|NCT00346827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24408260|NCT00177021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408261|NCT00177021|Interferon Inducers|interferon inducers|mesh-ancestor
24762805|NCT01769820|Dexamethasone|dexamethasone|mesh-list
24938137|NCT04021992|Vinorelbine|vinorelbine|mesh-list
24938139|NCT04021992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408262|NCT00177060|Hydromorphone|hydromorphone|mesh-list
24427646|NCT00238667|Clopidogrel|clopidogrel|mesh-list
24408263|NCT00177060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24408266|NCT00177060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408267|NCT00177060|Analgesics|analgesics|mesh-ancestor
24408268|NCT00177060|Sensory System Agents|sensory system agents|mesh-ancestor
24408269|NCT00177060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24408271|NCT00177086|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24408272|NCT00177086|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24408273|NCT00177086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24408274|NCT00177086|Adrenergic Agents|adrenergic agents|mesh-ancestor
24408275|NCT00177086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24408276|NCT00177086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408277|NCT00177086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408278|NCT00177086|Urological Agents|urological agents|mesh-ancestor
24408279|NCT00177099|Tacrolimus|tacrolimus|mesh-list
24408280|NCT00177099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24408281|NCT00177099|Immunologic Factors|immunologic factors|mesh-ancestor
24408282|NCT00177099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408291|NCT00177138|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24946369|NCT03940469|Antiemetics|antiemetics|mesh-ancestor
24946439|NCT03939975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24946440|NCT03939975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946441|NCT03939871|Vinorelbine|vinorelbine|mesh-list
24946442|NCT03939871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24946443|NCT03939871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24946444|NCT03939871|Tubulin Modulators|tubulin modulators|mesh-ancestor
24408981|NCT00180128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24408982|NCT00180128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24409072|NCT00180843|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25109785|NCT03122314|Analgesics|analgesics|mesh-ancestor
24409075|NCT00180843|Adrenergic Agents|adrenergic agents|mesh-ancestor
24459915|NCT00346827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459917|NCT00346840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24459918|NCT00346840|Abortifacient Agents|abortifacient agents|mesh-ancestor
24459919|NCT00346840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24459920|NCT00346840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459921|NCT00346840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24459922|NCT00346840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24459923|NCT00346840|Oxytocics|oxytocics|mesh-ancestor
24459924|NCT00346853|Fomepizole|fomepizole|mesh-list
24409076|NCT00180843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24409077|NCT00180843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409103|NCT00180908|Abortifacient Agents|abortifacient agents|mesh-ancestor
24409104|NCT00180908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24409138|NCT00180973|Antisickling Agents|antisickling agents|mesh-ancestor
24409242|NCT00181571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24409244|NCT00181584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24409245|NCT00181584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409287|NCT00181675|Autonomic Agents|autonomic agents|mesh-ancestor
24459931|NCT00346866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24459932|NCT00346866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24409306|NCT00181727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409338|NCT00181779|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24409339|NCT00181779|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24409340|NCT00181818|Bupropion|bupropion|mesh-list
24409341|NCT00181818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24409342|NCT00181818|Antidepressive Agents|antidepressive agents|mesh-ancestor
25696873|NCT02068157|Trioxsalen|trioxsalen|mesh-list
25696874|NCT02068157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25696875|NCT02068157|Dermatologic Agents|dermatologic agents|mesh-ancestor
25696876|NCT02068157|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25696877|NCT02068222|Ritonavir|ritonavir|mesh-list
24409343|NCT00181818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24409344|NCT00181818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24946445|NCT03939871|Antimitotic Agents|antimitotic agents|mesh-ancestor
24946446|NCT03939871|Mitosis Modulators|mitosis modulators|mesh-ancestor
24946447|NCT03939871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946449|NCT03940001|Carboplatin|carboplatin|mesh-list
24409345|NCT00181818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24626027|NCT01085149|Simvastatin|simvastatin|mesh-list
24409346|NCT00181818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24409347|NCT00181818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409349|NCT00181818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24409350|NCT00181818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409351|NCT00181818|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24409352|NCT00181818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24409353|NCT00181818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24749496|NCT00945009|Dactinomycin|dactinomycin|mesh-list
24409355|NCT00181870|Anticonvulsants|anticonvulsants|mesh-ancestor
24409377|NCT00181896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409378|NCT00181896|Dopamine Agents|dopamine agents|mesh-ancestor
24409379|NCT00181896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24409380|NCT00181896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409381|NCT00181896|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24409382|NCT00181896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24409384|NCT00181922|Ziprasidone|ziprasidone|mesh-list
24409385|NCT00181922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24409386|NCT00181922|Serotonin Agents|serotonin agents|mesh-ancestor
24409387|NCT00181922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24409388|NCT00181922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409389|NCT00181922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409390|NCT00181922|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24409391|NCT00181922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24409392|NCT00181922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24409393|NCT00181922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24409394|NCT00181922|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24409395|NCT00181922|Dopamine Agents|dopamine agents|mesh-ancestor
24409396|NCT00181935|Olanzapine|olanzapine|mesh-list
24409397|NCT00181935|Risperidone|risperidone|mesh-list
24409398|NCT00181935|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24409399|NCT00181935|Serotonin Agents|serotonin agents|mesh-ancestor
24409568|NCT00182494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409569|NCT00182507|Olanzapine|olanzapine|mesh-list
24409570|NCT00182507|Antiemetics|antiemetics|mesh-ancestor
24409571|NCT00182507|Autonomic Agents|autonomic agents|mesh-ancestor
24409572|NCT00182507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24409573|NCT00182507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409574|NCT00182507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24409575|NCT00182507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24409576|NCT00182507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24946450|NCT03940001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24946451|NCT03940001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24946452|NCT03940001|Tubulin Modulators|tubulin modulators|mesh-ancestor
25696878|NCT02068222|Ribavirin|ribavirin|mesh-list
25696879|NCT02068222|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25696880|NCT02068222|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25696881|NCT02068222|Protease Inhibitors|protease inhibitors|mesh-ancestor
25696882|NCT02068222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25696883|NCT02068222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696884|NCT02068222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25696885|NCT02068222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25696886|NCT02068222|Antiviral Agents|antiviral agents|mesh-ancestor
25696887|NCT02068222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24946453|NCT03940001|Antimitotic Agents|antimitotic agents|mesh-ancestor
24946454|NCT03940001|Mitosis Modulators|mitosis modulators|mesh-ancestor
24946455|NCT03940001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946456|NCT03939806|Oxytocin|oxytocin|mesh-list
24946457|NCT03939806|Carbetocin|carbetocin|mesh-list
24946458|NCT03939806|Oxytocics|oxytocics|mesh-ancestor
24946462|NCT03939624|Protease Inhibitors|protease inhibitors|mesh-ancestor
24946463|NCT03939624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24946464|NCT03939624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946465|NCT03939624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24946471|NCT03939273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24946472|NCT03939273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24946473|NCT03939273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24946474|NCT03939273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24409578|NCT00182507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24409724|NCT00182741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24409775|NCT00183040|Testosterone|testosterone|mesh-list
24409776|NCT00183040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24409840|NCT00183612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409841|NCT00183612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24409842|NCT00183612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24409843|NCT00183612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24459934|NCT00346866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459935|NCT00346866|Growth Inhibitors|growth inhibitors|mesh-ancestor
24459936|NCT00346866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409844|NCT00183612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24409845|NCT00183612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24409846|NCT00183612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24409847|NCT00183612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24409848|NCT00183612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24946476|NCT03939273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24946477|NCT03939273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24946478|NCT03939273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946509|NCT03938662|Nootropic Agents|nootropic agents|mesh-ancestor
24504179|NCT00534456|Darbepoetin alfa|darbepoetin alfa|mesh-list
24800784|NCT01978431|Anesthetics|anesthetics|mesh-ancestor
24409982|NCT00183989|Fludarabine|fludarabine|mesh-list
24409983|NCT00183989|Mitoxantrone|mitoxantrone|mesh-list
24409984|NCT00183989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24409985|NCT00183989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409986|NCT00183989|Immunologic Factors|immunologic factors|mesh-ancestor
24409987|NCT00183989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409988|NCT00183989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24409991|NCT00183989|Sensory System Agents|sensory system agents|mesh-ancestor
24409992|NCT00183989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24409993|NCT00183989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24409994|NCT00183989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24409998|NCT00184015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24410016|NCT00184041|Glucocorticoids|glucocorticoids|mesh-ancestor
24410017|NCT00184041|Hormones|hormones|mesh-ancestor
24410018|NCT00184041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24410019|NCT00184041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410020|NCT00184041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24410021|NCT00184041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24410022|NCT00184041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24410023|NCT00184041|Abortifacient Agents|abortifacient agents|mesh-ancestor
24410024|NCT00184041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24410025|NCT00184041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24410026|NCT00184041|Antimetabolites|antimetabolites|mesh-ancestor
24410027|NCT00184041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410028|NCT00184041|Dermatologic Agents|dermatologic agents|mesh-ancestor
24410029|NCT00184041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24410030|NCT00184041|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24410031|NCT00184041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24410032|NCT00184041|Immunologic Factors|immunologic factors|mesh-ancestor
24410056|NCT00184106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24410057|NCT00184106|Serotonin Agents|serotonin agents|mesh-ancestor
24410058|NCT00184106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938243|NCT04020653|Micronutrients|micronutrients|mesh-ancestor
24938244|NCT04020653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762950|NCT01770236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24762951|NCT01770236|Analgesics|analgesics|mesh-ancestor
24762952|NCT01770236|Sensory System Agents|sensory system agents|mesh-ancestor
24762953|NCT01770236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24762954|NCT01770236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762955|NCT01770236|Antipyretics|antipyretics|mesh-ancestor
24762956|NCT01770301|Paclitaxel|paclitaxel|mesh-list
24410059|NCT00184106|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24408762|NCT00179283|Serotonin Agents|serotonin agents|mesh-ancestor
24459938|NCT00346879|Fondaparinux|fondaparinux|mesh-list
24410065|NCT00184171|Budesonide|budesonide|mesh-list
24410066|NCT00184171|Bismuth|bismuth|mesh-list
24410067|NCT00184171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24410068|NCT00184171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24410069|NCT00184171|Autonomic Agents|autonomic agents|mesh-ancestor
24410070|NCT00184171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24410071|NCT00184171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410072|NCT00184171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24946516|NCT03938467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
24946517|NCT03938467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24946518|NCT03938363|Botulinum Toxins|botulinum toxins|mesh-list
24946519|NCT03938363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24946520|NCT03938363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24946521|NCT03938363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410073|NCT00184171|Respiratory System Agents|respiratory system agents|mesh-ancestor
24410074|NCT00184171|Glucocorticoids|glucocorticoids|mesh-ancestor
24410076|NCT00184171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24410077|NCT00184171|Antacids|antacids|mesh-ancestor
24410078|NCT00184171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410079|NCT00184171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24410162|NCT00184795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24410164|NCT00184821|Adenosine|adenosine|mesh-list
24410361|NCT00185133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24410411|NCT00185198|Androgens|androgens|mesh-ancestor
24410412|NCT00185198|Hormones|hormones|mesh-ancestor
24410413|NCT00185198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24410414|NCT00185198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410415|NCT00185224|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
24410426|NCT00185224|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24410587|NCT00186277|Tubulin Modulators|tubulin modulators|mesh-ancestor
24410588|NCT00186277|Antimitotic Agents|antimitotic agents|mesh-ancestor
24410589|NCT00186277|Mitosis Modulators|mitosis modulators|mesh-ancestor
24410649|NCT00186849|Etoposide|etoposide|mesh-list
24410650|NCT00186849|Topotecan|topotecan|mesh-list
24410651|NCT00186849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24410652|NCT00186849|Immunologic Factors|immunologic factors|mesh-ancestor
24410653|NCT00186849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410654|NCT00186849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24410655|NCT00186849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24410656|NCT00186849|Alkylating Agents|alkylating agents|mesh-ancestor
24428111|NCT00239512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25696888|NCT02068222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25696889|NCT02068222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25696890|NCT02068222|Antimetabolites|antimetabolites|mesh-ancestor
25696891|NCT02068443|Metformin|metformin|mesh-list
25696892|NCT02068443|Alogliptin|alogliptin|mesh-list
25696893|NCT02068443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25696894|NCT02068443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696895|NCT02068443|Incretins|incretins|mesh-ancestor
25696896|NCT02068443|Hormones|hormones|mesh-ancestor
25696897|NCT02068443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25696898|NCT02068443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24946523|NCT03938363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24946524|NCT03938363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771814|NCT01830101|Temozolomide|temozolomide|mesh-list
24771886|NCT01830400|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
24771887|NCT01830400|Anticonvulsants|anticonvulsants|mesh-ancestor
24771888|NCT01830400|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24771889|NCT01830400|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24771890|NCT01830400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24771891|NCT01830400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626025|NCT01085058|Immunologic Factors|immunologic factors|mesh-ancestor
24626026|NCT01085058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626034|NCT01085149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626035|NCT01085383|Aripiprazole|aripiprazole|mesh-list
24626036|NCT01085383|Antidepressive Agents|antidepressive agents|mesh-ancestor
24928527|NCT04121091|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24428122|NCT00239538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24428123|NCT00239538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410657|NCT00186849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410658|NCT00186849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24410659|NCT00186849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24626037|NCT01085383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24626038|NCT01085383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24626039|NCT01085383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24410949|NCT00187122|Abortifacient Agents|abortifacient agents|mesh-ancestor
24626041|NCT01085383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626042|NCT01085383|Dopamine Agonists|dopamine agonists|mesh-ancestor
24626043|NCT01085383|Dopamine Agents|dopamine agents|mesh-ancestor
24626044|NCT01085383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24626045|NCT01085383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626046|NCT01085383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24626047|NCT01085383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24626048|NCT01085383|Serotonin Agents|serotonin agents|mesh-ancestor
24626049|NCT01085383|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24626050|NCT01085383|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24626051|NCT01085383|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24626052|NCT01085383|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24962345|NCT03800433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24962346|NCT03800433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962347|NCT03800433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24962348|NCT03800433|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24962367|NCT03799536|Sotalol|sotalol|mesh-list
24626053|NCT01085422|Temozolomide|temozolomide|mesh-list
24626055|NCT01085422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24626056|NCT01085422|Alkylating Agents|alkylating agents|mesh-ancestor
24626057|NCT01085422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626058|NCT01085422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626059|NCT01085422|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24619062|NCT01050621|Ascorbic Acid|ascorbic acid|mesh-list
24626060|NCT01085422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626061|NCT01085487|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
24626062|NCT01085487|Levonorgestrel|levonorgestrel|mesh-list
24626063|NCT01085487|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24626064|NCT01085487|Contraceptive Agents|contraceptive agents|mesh-ancestor
24626072|NCT01085487|Hemostatics|hemostatics|mesh-ancestor
24626073|NCT01085487|Coagulants|coagulants|mesh-ancestor
24626074|NCT01085526|Immunologic Factors|immunologic factors|mesh-list
24626075|NCT01085526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626077|NCT01085552|Hematinics|hematinics|mesh-ancestor
24626078|NCT01085617|Cytarabine|cytarabine|mesh-list
24626079|NCT01085617|Cyclophosphamide|cyclophosphamide|mesh-list
24626080|NCT01085617|Melphalan|melphalan|mesh-list
24626081|NCT01085617|Rituximab|rituximab|mesh-list
24626082|NCT01085617|Methotrexate|methotrexate|mesh-list
24626083|NCT01085617|Fludarabine|fludarabine|mesh-list
24626084|NCT01085617|Fludarabine phosphate|fludarabine phosphate|mesh-list
24626085|NCT01085617|Etoposide|etoposide|mesh-list
24626086|NCT01085617|Vincristine|vincristine|mesh-list
24626087|NCT01085617|Imatinib Mesylate|imatinib mesylate|mesh-list
25696899|NCT02068443|Protease Inhibitors|protease inhibitors|mesh-ancestor
25696900|NCT02068443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25696901|NCT02068443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696902|NCT02068495|Amlodipine|amlodipine|mesh-list
25696903|NCT02068495|Candesartan|candesartan|mesh-list
25696904|NCT02068495|Candesartan cilexetil|candesartan cilexetil|mesh-list
24851694|NCT02258204|Anesthetics|anesthetics|mesh-ancestor
24851695|NCT02258204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24851696|NCT02258204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24652858|NCT01240655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24946533|NCT03938259|Fentanyl|fentanyl|mesh-list
24946534|NCT03938259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24946535|NCT03938259|Narcotics|narcotics|mesh-ancestor
24800871|NCT01978873|Antioxidants|antioxidants|mesh-ancestor
24772114|NCT01831674|Metformin|metformin|mesh-list
24410662|NCT00186849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24410663|NCT00186849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24410664|NCT00186849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24410665|NCT00186849|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24410836|NCT00187070|Immunologic Factors|immunologic factors|mesh-ancestor
24410870|NCT00187070|Mitosis Modulators|mitosis modulators|mesh-ancestor
24410871|NCT00187070|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24410908|NCT00187083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24410909|NCT00187083|Immunologic Factors|immunologic factors|mesh-ancestor
24410910|NCT00187083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24410911|NCT00187083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24410915|NCT00187083|Tubulin Modulators|tubulin modulators|mesh-ancestor
24410916|NCT00187083|Antimitotic Agents|antimitotic agents|mesh-ancestor
24410941|NCT00187122|Autonomic Agents|autonomic agents|mesh-ancestor
24410942|NCT00187122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24410943|NCT00187122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24410944|NCT00187122|Glucocorticoids|glucocorticoids|mesh-ancestor
24410946|NCT00187122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24410947|NCT00187122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24410948|NCT00187122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24410950|NCT00187122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24410971|NCT00187161|Vincristine|vincristine|mesh-list
24411063|NCT00187551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24411064|NCT00187551|Antiviral Agents|antiviral agents|mesh-ancestor
24411065|NCT00187551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24411066|NCT00187564|Thioctic Acid|thioctic acid|mesh-list
24411067|NCT00187564|Antioxidants|antioxidants|mesh-ancestor
24411068|NCT00187564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411069|NCT00187564|Protective Agents|protective agents|mesh-ancestor
24411070|NCT00187564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411071|NCT00187564|Vitamin B Complex|vitamin b complex|mesh-ancestor
24946536|NCT03938259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24946537|NCT03938259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946538|NCT03938259|Analgesics|analgesics|mesh-ancestor
24946565|NCT03937609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24946566|NCT03937544|Cyclophosphamide|cyclophosphamide|mesh-list
24946567|NCT03937544|Fludarabine|fludarabine|mesh-list
24946568|NCT03937544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24946569|NCT03937544|Immunologic Factors|immunologic factors|mesh-ancestor
24946570|NCT03937544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751596|NCT01705002|Capecitabine|capecitabine|mesh-list
24946576|NCT03937544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24946577|NCT03937648|Lasmiditan|lasmiditan|mesh-list
24946578|NCT03937648|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24946579|NCT03937648|Serotonin Agents|serotonin agents|mesh-ancestor
24946580|NCT03937648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24946581|NCT03937648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946582|NCT03937648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946583|NCT03937401|Oxytocin|oxytocin|mesh-list
24946584|NCT03937401|Oxytocics|oxytocics|mesh-ancestor
24411161|NCT00188045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24411162|NCT00188045|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24411199|NCT00188227|Anesthetics, General|anesthetics, general|mesh-ancestor
24411200|NCT00188227|Anesthetics|anesthetics|mesh-ancestor
24411201|NCT00188227|GABA Modulators|gaba modulators|mesh-ancestor
24411202|NCT00188227|GABA Agents|gaba agents|mesh-ancestor
25696905|NCT02068495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25696906|NCT02068495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25696907|NCT02068495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25696908|NCT02068495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411203|NCT00188227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24411335|NCT00188773|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24411371|NCT00188864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24411373|NCT00188864|Hormones|hormones|mesh-ancestor
24411374|NCT00188864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24411375|NCT00188864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24459944|NCT00346879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459945|NCT00346879|Anticoagulants|anticoagulants|mesh-ancestor
24415353|NCT00199316|Morphine|morphine|mesh-list
24411442|NCT00189033|Cathartics|cathartics|mesh-ancestor
24411477|NCT00189085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24411478|NCT00189085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24411479|NCT00189085|Antimetabolites|antimetabolites|mesh-ancestor
24411480|NCT00189085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411549|NCT00189384|Penicillin G Benzathine|penicillin g benzathine|mesh-list
24411551|NCT00189384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24411552|NCT00189384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24411553|NCT00189384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24411554|NCT00189384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051452|NCT00403169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25051453|NCT00403169|Growth Substances|growth substances|mesh-ancestor
25051454|NCT00403169|Growth Inhibitors|growth inhibitors|mesh-ancestor
25051455|NCT00403169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24946585|NCT03937401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24946586|NCT03937401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946589|NCT03937258|Uricosuric Agents|uricosuric agents|mesh-ancestor
24946590|NCT03937258|Gout Suppressants|gout suppressants|mesh-ancestor
24946591|NCT03937258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24946592|NCT03937258|Renal Agents|renal agents|mesh-ancestor
24528321|NCT00620789|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25051456|NCT00402428|Interferons|interferons|mesh-list
25051457|NCT00402428|Ribavirin|ribavirin|mesh-list
24946593|NCT03937258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24946594|NCT03937258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24946595|NCT03937258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946597|NCT03936907|Analgesics|analgesics|mesh-ancestor
24946598|NCT03936907|Sensory System Agents|sensory system agents|mesh-ancestor
24946599|NCT03936907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24946600|NCT03936907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946601|NCT03936517|Prednisolone|prednisolone|mesh-list
24946602|NCT03936517|Hydrocortisone|hydrocortisone|mesh-list
24946603|NCT03936517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24946604|NCT03936517|Glucocorticoids|glucocorticoids|mesh-ancestor
24946605|NCT03936517|Hormones|hormones|mesh-ancestor
24946606|NCT03936517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24946607|NCT03936517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946608|NCT03936517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24598170|NCT00954278|Sorafenib|sorafenib|mesh-list
24946623|NCT03936426|Trace Elements|trace elements|mesh-ancestor
24946630|NCT03936062|Hormones|hormones|mesh-ancestor
24946635|NCT03936062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946636|NCT03936166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24946637|NCT03936374|Omeprazole|omeprazole|mesh-list
24946638|NCT03936374|Linrodostat|linrodostat|mesh-list
24946639|NCT03936374|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24946640|NCT03936374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24946641|NCT03936374|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24946642|NCT03936374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24946643|NCT03936374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946644|NCT03936205|Dexmedetomidine|dexmedetomidine|mesh-list
24946645|NCT03936205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24946646|NCT03936205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24946647|NCT03936205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946648|NCT03936205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24946649|NCT03936205|Analgesics|analgesics|mesh-ancestor
24946650|NCT03936205|Sensory System Agents|sensory system agents|mesh-ancestor
24946651|NCT03936205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24946652|NCT03936205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24800954|NCT01979679|Serotonin Agents|serotonin agents|mesh-ancestor
24411555|NCT00189384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411556|NCT00189384|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24411557|NCT00189384|Renal Agents|renal agents|mesh-ancestor
24411567|NCT00189397|Azathioprine|azathioprine|mesh-list
24411568|NCT00189397|Antimetabolites|antimetabolites|mesh-ancestor
24946669|NCT03936153|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24946670|NCT03936153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24946671|NCT03936153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946673|NCT03936140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24946674|NCT03936140|Vasodilator Agents|vasodilator agents|mesh-ancestor
24946675|NCT03936036|Linagliptin|linagliptin|mesh-list
24946676|NCT03936036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24946679|NCT03936036|Hormones|hormones|mesh-ancestor
24946680|NCT03936036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24946681|NCT03936036|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24946682|NCT03936036|Protease Inhibitors|protease inhibitors|mesh-ancestor
24946683|NCT03936036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411571|NCT00189397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411572|NCT00189397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24411573|NCT00189397|Immunologic Factors|immunologic factors|mesh-ancestor
24411574|NCT00189397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411575|NCT00189397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24411576|NCT00189410|Carboplatin|carboplatin|mesh-list
24411577|NCT00189410|Doxorubicin|doxorubicin|mesh-list
24411578|NCT00189410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24411579|NCT00189410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411580|NCT00189410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24946684|NCT03936036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548211|NCT00708344|Irbesartan|irbesartan|mesh-list
24411581|NCT00189410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24411582|NCT00189410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24411583|NCT00189410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411784|NCT00189995|GABA Antagonists|gaba antagonists|mesh-ancestor
24428235|NCT00239993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428236|NCT00239993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24428237|NCT00239993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24411786|NCT00190008|Piracetam|piracetam|mesh-list
24411787|NCT00190008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24411788|NCT00190008|Protective Agents|protective agents|mesh-ancestor
24411789|NCT00190008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411820|NCT00190099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24411821|NCT00190099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411822|NCT00190099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24411823|NCT00190099|Glucocorticoids|glucocorticoids|mesh-ancestor
24411824|NCT00190099|Hormones|hormones|mesh-ancestor
24411825|NCT00190099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24411826|NCT00190099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24411827|NCT00190099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411828|NCT00190151|Ciprofloxacin|ciprofloxacin|mesh-list
24411829|NCT00190151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24411830|NCT00190151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24411831|NCT00190151|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24411832|NCT00190151|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24411833|NCT00190151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411834|NCT00190151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411835|NCT00190151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411836|NCT00190151|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24411837|NCT00190151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24411838|NCT00190229|Cyclophosphamide|cyclophosphamide|mesh-list
24411839|NCT00190229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24459955|NCT00346918|Immunologic Factors|immunologic factors|mesh-ancestor
24459956|NCT00346918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459957|NCT00346957|Hydrocortisone|hydrocortisone|mesh-list
24412401|NCT00191373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412402|NCT00191373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24412403|NCT00191373|Immunologic Factors|immunologic factors|mesh-ancestor
24412404|NCT00191373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412405|NCT00191373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24412407|NCT00191399|Fluoxetine|fluoxetine|mesh-list
24412408|NCT00191399|Antiemetics|antiemetics|mesh-ancestor
24412409|NCT00191399|Autonomic Agents|autonomic agents|mesh-ancestor
24412442|NCT00191425|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24412443|NCT00191425|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24412444|NCT00191438|Gemcitabine|gemcitabine|mesh-list
24412445|NCT00191438|Capecitabine|capecitabine|mesh-list
24412471|NCT00191490|Antimetabolites|antimetabolites|mesh-ancestor
24412472|NCT00191490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412473|NCT00191490|Antiviral Agents|antiviral agents|mesh-ancestor
24412474|NCT00191490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24412475|NCT00191490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412476|NCT00191490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24412477|NCT00191490|Immunologic Factors|immunologic factors|mesh-ancestor
24412478|NCT00191490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412874|NCT00192608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24929754|NCT04109742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24946705|NCT03935685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24946706|NCT03935685|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24946707|NCT03935685|Histamine Antagonists|histamine antagonists|mesh-ancestor
24946708|NCT03935685|Histamine Agents|histamine agents|mesh-ancestor
24946709|NCT03935685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24946710|NCT03935685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946711|NCT03935685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946712|NCT03935685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24946713|NCT03935685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24946714|NCT03935685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24946715|NCT03935685|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24946716|NCT03935685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24946717|NCT03935685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24946718|NCT03935685|Adrenergic Agents|adrenergic agents|mesh-ancestor
24946719|NCT03935685|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24946720|NCT03935685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24946721|NCT03935685|Serotonin Agents|serotonin agents|mesh-ancestor
24946722|NCT03935685|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24946723|NCT03935815|Ropivacaine|ropivacaine|mesh-list
24946724|NCT03935815|Anesthetics, Local|anesthetics, local|mesh-ancestor
24946725|NCT03935815|Anesthetics|anesthetics|mesh-ancestor
24946726|NCT03935815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24412479|NCT00191490|Tubulin Modulators|tubulin modulators|mesh-ancestor
24412603|NCT00191659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946727|NCT03935815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946728|NCT03935815|Sensory System Agents|sensory system agents|mesh-ancestor
24801019|NCT01980407|Vitamin B Complex|vitamin b complex|mesh-ancestor
24412604|NCT00191659|Adrenergic Agents|adrenergic agents|mesh-ancestor
24412605|NCT00191659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412606|NCT00191659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412722|NCT00191880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412723|NCT00191880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772115|NCT01831674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24412757|NCT00191971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412758|NCT00191971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412759|NCT00191971|Antiviral Agents|antiviral agents|mesh-ancestor
24412760|NCT00191971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24412761|NCT00191971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412787|NCT00192049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412788|NCT00192049|Antiviral Agents|antiviral agents|mesh-ancestor
24412789|NCT00192049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24412790|NCT00192049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412791|NCT00192049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24412792|NCT00192049|Immunologic Factors|immunologic factors|mesh-ancestor
24412793|NCT00192049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412794|NCT00192049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24412795|NCT00192049|Alkylating Agents|alkylating agents|mesh-ancestor
24412796|NCT00192049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24412797|NCT00192062|Gemcitabine|gemcitabine|mesh-list
24459968|NCT00346970|Antimetabolites|antimetabolites|mesh-ancestor
24459969|NCT00346970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459970|NCT00346970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24459971|NCT00346970|Vasodilator Agents|vasodilator agents|mesh-ancestor
24412876|NCT00192608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24412878|NCT00192621|Zidovudine|zidovudine|mesh-list
24412879|NCT00192621|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
24428461|NCT00240552|Protease Inhibitors|protease inhibitors|mesh-ancestor
24428462|NCT00240552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428463|NCT00240552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412881|NCT00192621|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24412882|NCT00192621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24412883|NCT00192621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24946729|NCT03935815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24946730|NCT03935984|Calcitonin|calcitonin|mesh-list
24772047|NCT01831323|Rifaximin|rifaximin|mesh-list
24946760|NCT03935217|Secnidazole|secnidazole|mesh-list
24946761|NCT03935217|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24946762|NCT03935217|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24946763|NCT03935217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24753822|NCT01717963|Naltrexone|naltrexone|mesh-list
24930188|NCT04104204|Morphine|morphine|mesh-list
24962562|NCT03797625|Irinotecan|irinotecan|mesh-list
24962563|NCT03797625|Endostar protein|endostar protein|mesh-list
24962564|NCT03797625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962565|NCT03797625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24962566|NCT03797625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24962567|NCT03797625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24962568|NCT03797625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962569|NCT03797625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24962570|NCT03797625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24962571|NCT03797625|Growth Substances|growth substances|mesh-ancestor
24962572|NCT03797625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962573|NCT03797625|Growth Inhibitors|growth inhibitors|mesh-ancestor
24962574|NCT03799445|Nivolumab|nivolumab|mesh-list
24962575|NCT03799445|Ipilimumab|ipilimumab|mesh-list
24962576|NCT03799445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24962577|NCT03799445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051458|NCT00402428|Interferon-alpha|interferon-alpha|mesh-list
25051459|NCT00402428|Interferon alpha-2|interferon alpha-2|mesh-list
25051460|NCT00402428|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25051461|NCT00402428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051463|NCT00402428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25051464|NCT00402428|Antimetabolites|antimetabolites|mesh-ancestor
24801022|NCT01980472|Paclitaxel|paclitaxel|mesh-list
24412886|NCT00192621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24412887|NCT00192621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24413000|NCT00192842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24413024|NCT00193011|Immunologic Factors|immunologic factors|mesh-ancestor
24413025|NCT00193011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413026|NCT00193011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24413027|NCT00193011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24413028|NCT00193011|Alkylating Agents|alkylating agents|mesh-ancestor
24413029|NCT00193011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962578|NCT03799445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24962579|NCT03799445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962580|NCT03797508|Progesterone|progesterone|mesh-list
24962581|NCT03797508|Progestins|progestins|mesh-ancestor
24962582|NCT03797508|Hormones|hormones|mesh-ancestor
24413423|NCT00193856|Fertility Agents|fertility agents|mesh-ancestor
24946776|NCT03935074|Alkylating Agents|alkylating agents|mesh-ancestor
25051466|NCT00402428|Immunologic Factors|immunologic factors|mesh-ancestor
25051467|NCT00402428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051468|NCT00401570|Gemcitabine|gemcitabine|mesh-list
25051469|NCT00401570|Volociximab|volociximab|mesh-list
25051470|NCT00401570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25051471|NCT00401570|Antimetabolites|antimetabolites|mesh-ancestor
25051472|NCT00401570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051473|NCT00401570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051474|NCT00401570|Antiviral Agents|antiviral agents|mesh-ancestor
25051475|NCT00401570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24413035|NCT00193011|Antimetabolites|antimetabolites|mesh-ancestor
24413036|NCT00193011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24413037|NCT00193011|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24413038|NCT00193011|Abortifacient Agents|abortifacient agents|mesh-ancestor
24413039|NCT00193011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24413040|NCT00193011|Dermatologic Agents|dermatologic agents|mesh-ancestor
24413041|NCT00193011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413042|NCT00193011|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24413043|NCT00193011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24413046|NCT00193024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413047|NCT00193024|Tubulin Modulators|tubulin modulators|mesh-ancestor
24413048|NCT00193024|Antimitotic Agents|antimitotic agents|mesh-ancestor
24413049|NCT00193024|Mitosis Modulators|mitosis modulators|mesh-ancestor
24413050|NCT00193024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413051|NCT00193024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24413052|NCT00193024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24413053|NCT00193024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24413054|NCT00193024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413104|NCT00193115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428518|NCT00240656|Natriuretic Agents|natriuretic agents|mesh-ancestor
24428519|NCT00240656|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24428520|NCT00240656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24413105|NCT00193115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413106|NCT00193115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24413107|NCT00193115|Tubulin Modulators|tubulin modulators|mesh-ancestor
24413108|NCT00193115|Antimitotic Agents|antimitotic agents|mesh-ancestor
24413109|NCT00193115|Mitosis Modulators|mitosis modulators|mesh-ancestor
24413110|NCT00193115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24413111|NCT00193115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24413112|NCT00193115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24413113|NCT00193115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413115|NCT00193141|Carboplatin|carboplatin|mesh-list
24413116|NCT00193141|Fluorouracil|fluorouracil|mesh-list
24413117|NCT00193141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24413119|NCT00193141|Tubulin Modulators|tubulin modulators|mesh-ancestor
24413120|NCT00193141|Antimitotic Agents|antimitotic agents|mesh-ancestor
24413121|NCT00193141|Mitosis Modulators|mitosis modulators|mesh-ancestor
24413122|NCT00193141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413123|NCT00193141|Antimetabolites|antimetabolites|mesh-ancestor
24413124|NCT00193141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24413125|NCT00193141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24413126|NCT00193141|Immunologic Factors|immunologic factors|mesh-ancestor
24413127|NCT00193141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413128|NCT00193154|Bevacizumab|bevacizumab|mesh-list
24413129|NCT00193154|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24413130|NCT00193154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24413131|NCT00193154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413132|NCT00193154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24413133|NCT00193154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24413134|NCT00193154|Growth Substances|growth substances|mesh-ancestor
24413135|NCT00193154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051477|NCT00401570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25051478|NCT00401570|Immunologic Factors|immunologic factors|mesh-ancestor
24946780|NCT03935074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24946781|NCT03935074|Immunologic Factors|immunologic factors|mesh-ancestor
25051485|NCT00401388|Antiemetics|antiemetics|mesh-list
25051486|NCT00401388|Loperamide|loperamide|mesh-list
25051487|NCT00401388|Antidiarrheals|antidiarrheals|mesh-list
24946782|NCT03935074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946784|NCT03935347|Aldesleukin|aldesleukin|mesh-list
24946785|NCT03935347|Cyclophosphamide|cyclophosphamide|mesh-list
24946806|NCT03935347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24946807|NCT03935347|Analgesics|analgesics|mesh-ancestor
24946808|NCT03935347|Sensory System Agents|sensory system agents|mesh-ancestor
24946809|NCT03935347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24946810|NCT03935347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24946811|NCT03935347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24946812|NCT03935256|Paclitaxel|paclitaxel|mesh-list
24946813|NCT03935256|Carboplatin|carboplatin|mesh-list
24946814|NCT03935256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24946815|NCT03935256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24946816|NCT03935256|Tubulin Modulators|tubulin modulators|mesh-ancestor
24946817|NCT03935256|Antimitotic Agents|antimitotic agents|mesh-ancestor
24946818|NCT03935256|Mitosis Modulators|mitosis modulators|mesh-ancestor
24946819|NCT03935256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946820|NCT03934710|Serotonin|serotonin|mesh-list
24946821|NCT03934710|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-list
24946822|NCT03934710|Serotonin Agents|serotonin agents|mesh-ancestor
24946823|NCT03934710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24801092|NCT01980810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413170|NCT00193245|Mitosis Modulators|mitosis modulators|mesh-ancestor
24946824|NCT03934710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413172|NCT00193245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24413208|NCT00193297|Mitosis Modulators|mitosis modulators|mesh-ancestor
24413209|NCT00193297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413210|NCT00193297|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24413211|NCT00193297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24413212|NCT00193297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413213|NCT00193310|Paclitaxel|paclitaxel|mesh-list
24413214|NCT00193310|Carboplatin|carboplatin|mesh-list
24413318|NCT00193531|Mitosis Modulators|mitosis modulators|mesh-ancestor
24413319|NCT00193531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413320|NCT00193531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24413321|NCT00193531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24413322|NCT00193531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413324|NCT00193544|Arsenic Trioxide|arsenic trioxide|mesh-list
24413412|NCT00193739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24413413|NCT00193739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413414|NCT00193739|Tubulin Modulators|tubulin modulators|mesh-ancestor
24413415|NCT00193739|Antimitotic Agents|antimitotic agents|mesh-ancestor
24413416|NCT00193739|Mitosis Modulators|mitosis modulators|mesh-ancestor
24413417|NCT00193739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459974|NCT00346970|Micronutrients|micronutrients|mesh-ancestor
24415764|NCT00200629|Adenosine|adenosine|mesh-list
24413419|NCT00193856|Leuprolide|leuprolide|mesh-list
24413420|NCT00193856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24413421|NCT00193856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413469|NCT00193973|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24413470|NCT00193973|Abortifacient Agents|abortifacient agents|mesh-ancestor
24931679|NCT04086186|Anesthetics|anesthetics|mesh-ancestor
24413560|NCT00194324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24946825|NCT03934710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946827|NCT03934450|Antimalarials|antimalarials|mesh-ancestor
24946828|NCT03934450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24946829|NCT03934450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24946830|NCT03934450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24946831|NCT03934411|Tramadol|tramadol|mesh-list
24413562|NCT00194324|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24413587|NCT00194480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24413588|NCT00194519|Acyclovir|acyclovir|mesh-list
24413589|NCT00194519|Antiviral Agents|antiviral agents|mesh-ancestor
24413590|NCT00194519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24413601|NCT00194623|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24413602|NCT00194623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24413603|NCT00194623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413604|NCT00194623|Cholinergic Agents|cholinergic agents|mesh-ancestor
24413638|NCT00194753|Cyclophosphamide|cyclophosphamide|mesh-list
24413639|NCT00194753|Doxorubicin|doxorubicin|mesh-list
24413640|NCT00194753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24413641|NCT00194753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413642|NCT00194753|Tubulin Modulators|tubulin modulators|mesh-ancestor
24413643|NCT00194753|Antimitotic Agents|antimitotic agents|mesh-ancestor
24413644|NCT00194753|Mitosis Modulators|mitosis modulators|mesh-ancestor
24459975|NCT00346970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459977|NCT00346996|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24459978|NCT00346996|Insulin Detemir|insulin detemir|mesh-list
24414071|NCT00195871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24414072|NCT00195871|Tubulin Modulators|tubulin modulators|mesh-ancestor
24946832|NCT03934411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24946833|NCT03934411|Narcotics|narcotics|mesh-ancestor
24772116|NCT01831674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772117|NCT01831687|Etodolac|etodolac|mesh-list
24772118|NCT01831687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24772119|NCT01831687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24946834|NCT03934411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24772120|NCT01831687|Analgesics|analgesics|mesh-ancestor
24803816|NCT01998685|GABA Modulators|gaba modulators|mesh-ancestor
24946835|NCT03934411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946836|NCT03934411|Analgesics|analgesics|mesh-ancestor
24946837|NCT03934411|Sensory System Agents|sensory system agents|mesh-ancestor
24946838|NCT03934411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24946839|NCT03934203|Moxifloxacin|moxifloxacin|mesh-list
24946840|NCT03934203|BI 409306|bi 409306|mesh-list
24946841|NCT03934203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24946842|NCT03934203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24946843|NCT03934203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24946844|NCT03934203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24414073|NCT00195871|Antimitotic Agents|antimitotic agents|mesh-ancestor
24414378|NCT00197340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414379|NCT00197340|Sensory System Agents|sensory system agents|mesh-ancestor
24414380|NCT00197340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24414381|NCT00197353|Bupivacaine|bupivacaine|mesh-list
24414382|NCT00197353|Anesthetics, Local|anesthetics, local|mesh-ancestor
24414383|NCT00197353|Anesthetics|anesthetics|mesh-ancestor
25696909|NCT02068495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25696910|NCT02068495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696911|NCT02068495|Vasodilator Agents|vasodilator agents|mesh-ancestor
25696912|NCT02068495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25696913|NCT02068495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25696914|NCT02068508|Pioglitazone|pioglitazone|mesh-list
25696915|NCT02068508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25696916|NCT02068508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414384|NCT00197353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24414508|NCT00197834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414517|NCT00197886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24414518|NCT00197886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414519|NCT00197886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414521|NCT00197886|Autonomic Agents|autonomic agents|mesh-ancestor
24414522|NCT00197886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24414523|NCT00197886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24414524|NCT00197912|Celecoxib|celecoxib|mesh-list
24414525|NCT00197912|Cyclophosphamide|cyclophosphamide|mesh-list
24520190|NCT03576885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520201|NCT03573648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414780|NCT00198614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414783|NCT00198614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24414784|NCT00198614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24414785|NCT00198614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24946845|NCT03934203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24946846|NCT03934203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946847|NCT03934203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24946848|NCT03934203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24946849|NCT03934047|Tranexamic Acid|tranexamic acid|mesh-list
24946850|NCT03934047|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24946851|NCT03934047|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24414786|NCT00198614|Vasodilator Agents|vasodilator agents|mesh-ancestor
24414787|NCT00198614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24414788|NCT00198614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24414789|NCT00198627|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24414790|NCT00198627|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24414791|NCT00198627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24414792|NCT00198627|Renal Agents|renal agents|mesh-ancestor
24414793|NCT00198627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24414847|NCT00198978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24414848|NCT00198978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24414849|NCT00198978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24414850|NCT00198978|Abortifacient Agents|abortifacient agents|mesh-ancestor
24414851|NCT00198978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24414963|NCT00199004|Tubulin Modulators|tubulin modulators|mesh-ancestor
24414964|NCT00199004|Antimitotic Agents|antimitotic agents|mesh-ancestor
24414965|NCT00199004|Mitosis Modulators|mitosis modulators|mesh-ancestor
24414966|NCT00199004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24414967|NCT00199004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24414968|NCT00199004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24414969|NCT00199017|Cytarabine|cytarabine|mesh-list
24428795|NCT00241189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24415104|NCT00199069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24415114|NCT00199069|Glucocorticoids|glucocorticoids|mesh-ancestor
24415115|NCT00199069|Hormones|hormones|mesh-ancestor
24415116|NCT00199069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24415117|NCT00199069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24415118|NCT00199069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24415294|NCT00199186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24415326|NCT00199186|Antiviral Agents|antiviral agents|mesh-ancestor
24415327|NCT00199186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24415328|NCT00199186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24415329|NCT00199186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24415330|NCT00199186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24459985|NCT00347035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24459986|NCT00347035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24459987|NCT00347035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24415331|NCT00199186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24415333|NCT00199212|Bortezomib|bortezomib|mesh-list
24415408|NCT00199407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24415409|NCT00199407|Purinergic Agents|purinergic agents|mesh-ancestor
24415410|NCT00199407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24932463|NCT04079231|Aflibercept|aflibercept|mesh-list
24415411|NCT00199407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428877|NCT00241436|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24946855|NCT03934294|Metoclopramide|metoclopramide|mesh-list
25696917|NCT02068820|Fluorophosphate|fluorophosphate|mesh-list
24946856|NCT03934294|Antiemetics|antiemetics|mesh-ancestor
24946857|NCT03934294|Autonomic Agents|autonomic agents|mesh-ancestor
24801186|NCT01981525|Metformin|metformin|mesh-list
24756658|NCT01735006|Immunologic Factors|immunologic factors|mesh-ancestor
24415412|NCT00199407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415413|NCT00199420|Istradefylline|istradefylline|mesh-list
24415414|NCT00199420|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
24415415|NCT00199420|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24415416|NCT00199420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24415417|NCT00199420|Purinergic Agents|purinergic agents|mesh-ancestor
24415418|NCT00199420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24415419|NCT00199420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415420|NCT00199420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415421|NCT00199433|Istradefylline|istradefylline|mesh-list
24415422|NCT00199433|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
24415423|NCT00199433|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24415424|NCT00199433|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24415425|NCT00199433|Purinergic Agents|purinergic agents|mesh-ancestor
24415455|NCT00199576|Prednisolone|prednisolone|mesh-list
24415456|NCT00199576|Prednisolone acetate|prednisolone acetate|mesh-list
24415458|NCT00199576|Prednisolone phosphate|prednisolone phosphate|mesh-list
24428928|NCT00241540|Esomeprazole|esomeprazole|mesh-list
24946858|NCT03934294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24946859|NCT03934294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946860|NCT03934294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24946861|NCT03934294|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24946862|NCT03934294|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24946863|NCT03934294|Dopamine Agents|dopamine agents|mesh-ancestor
24946864|NCT03934294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24946865|NCT03934294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946866|NCT03933956|Empagliflozin|empagliflozin|mesh-list
24415975|NCT00201695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24415976|NCT00201695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415977|NCT00201695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24415978|NCT00201695|Glucocorticoids|glucocorticoids|mesh-ancestor
24415979|NCT00201695|Hormones|hormones|mesh-ancestor
24415980|NCT00201695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24459996|NCT00347048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415981|NCT00201695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24946867|NCT03933956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24946868|NCT03933956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962659|NCT03796403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24946869|NCT03933956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24415982|NCT00201695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415983|NCT00201695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24415985|NCT00201695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24415986|NCT00201695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24415987|NCT00201695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415988|NCT00201695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24415989|NCT00201695|Tubulin Modulators|tubulin modulators|mesh-ancestor
24415990|NCT00201695|Antimitotic Agents|antimitotic agents|mesh-ancestor
24415991|NCT00201695|Mitosis Modulators|mitosis modulators|mesh-ancestor
24416027|NCT00201747|Mitomycin|mitomycin|mesh-list
24416028|NCT00201747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24416029|NCT00201747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24416057|NCT00201812|Tubulin Modulators|tubulin modulators|mesh-ancestor
24416058|NCT00201812|Antimitotic Agents|antimitotic agents|mesh-ancestor
24416059|NCT00201812|Mitosis Modulators|mitosis modulators|mesh-ancestor
25406516|NCT03554473|Topotecan|topotecan|mesh-list
25696918|NCT02068820|Cariostatic Agents|cariostatic agents|mesh-ancestor
25696919|NCT02068820|Protective Agents|protective agents|mesh-ancestor
25696920|NCT02068820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696921|NCT02068846|Ciprofloxacin|ciprofloxacin|mesh-list
25696922|NCT02068846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24416060|NCT00201812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416061|NCT00201812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24416062|NCT00201812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24416063|NCT00201812|Analgesics|analgesics|mesh-ancestor
24416071|NCT00201955|Antioxidants|antioxidants|mesh-ancestor
24416072|NCT00201955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416073|NCT00201955|Protective Agents|protective agents|mesh-ancestor
24529961|NCT00628550|Mydriatics|mydriatics|mesh-ancestor
24416074|NCT00201955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416075|NCT00201955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416077|NCT00201981|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24416112|NCT00202020|Analgesics|analgesics|mesh-ancestor
24416113|NCT00202020|Sensory System Agents|sensory system agents|mesh-ancestor
24416114|NCT00202020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24416115|NCT00202020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416116|NCT00202020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24416117|NCT00202020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24416122|NCT00202020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24416124|NCT00202020|Antipyretics|antipyretics|mesh-ancestor
24416156|NCT00202176|Cholinergic Agents|cholinergic agents|mesh-ancestor
24416157|NCT00202176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24416158|NCT00202176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416159|NCT00202189|Budesonide|budesonide|mesh-list
24416160|NCT00202189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24416161|NCT00202189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24416162|NCT00202189|Autonomic Agents|autonomic agents|mesh-ancestor
24416163|NCT00202189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24416164|NCT00202189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416165|NCT00202189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24416166|NCT00202189|Respiratory System Agents|respiratory system agents|mesh-ancestor
24459997|NCT00347048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24459998|NCT00347048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459999|NCT00347048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460000|NCT00347087|Irbesartan|irbesartan|mesh-list
24416167|NCT00202189|Glucocorticoids|glucocorticoids|mesh-ancestor
24946871|NCT03934333|Budesonide|budesonide|mesh-list
24946872|NCT03934333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24946873|NCT03934333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24946874|NCT03934333|Autonomic Agents|autonomic agents|mesh-ancestor
24946875|NCT03934333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24553308|NCT00730249|Dopamine Agents|dopamine agents|mesh-ancestor
24416204|NCT00202293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24416205|NCT00202293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416207|NCT00202293|Serotonin Agents|serotonin agents|mesh-ancestor
24416265|NCT00202553|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24416266|NCT00202553|Protease Inhibitors|protease inhibitors|mesh-ancestor
24416267|NCT00202553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416268|NCT00202553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416269|NCT00202553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24416270|NCT00202592|Perindopril|perindopril|mesh-list
24416271|NCT00202592|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24946877|NCT03934333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24946878|NCT03934333|Respiratory System Agents|respiratory system agents|mesh-ancestor
24946881|NCT03934333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24946882|NCT03933982|Vinorelbine|vinorelbine|mesh-list
24946883|NCT03933982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24946884|NCT03933982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24946885|NCT03933982|Tubulin Modulators|tubulin modulators|mesh-ancestor
24946886|NCT03933982|Antimitotic Agents|antimitotic agents|mesh-ancestor
24946887|NCT03933982|Mitosis Modulators|mitosis modulators|mesh-ancestor
24946888|NCT03933982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946889|NCT03933865|Ketamine|ketamine|mesh-list
24946890|NCT03933865|Hydromorphone|hydromorphone|mesh-list
24946891|NCT03933865|Analgesics|analgesics|mesh-ancestor
24946892|NCT03933865|Sensory System Agents|sensory system agents|mesh-ancestor
24946893|NCT03933865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24946894|NCT03933865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946895|NCT03933865|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24946898|NCT03933865|Anesthetics|anesthetics|mesh-ancestor
24416485|NCT00203177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24416486|NCT00203177|Protective Agents|protective agents|mesh-ancestor
24416487|NCT00203177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416489|NCT00203190|Anticonvulsants|anticonvulsants|mesh-ancestor
24416490|NCT00203190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24416491|NCT00203190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416492|NCT00203281|Mycophenolic Acid|mycophenolic acid|mesh-list
24416525|NCT00203359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24416526|NCT00203359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24946903|NCT03933865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416717|NCT00203801|Pyrimethamine|pyrimethamine|mesh-list
24416718|NCT00203801|Sulfadoxine|sulfadoxine|mesh-list
24416750|NCT00203814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416752|NCT00203814|Renal Agents|renal agents|mesh-ancestor
24416753|NCT00203905|Bevacizumab|bevacizumab|mesh-list
24530053|NCT00628810|Vitamins|vitamins|mesh-ancestor
24416754|NCT00203905|Fluorouracil|fluorouracil|mesh-list
24416755|NCT00203905|Hydroxyurea|hydroxyurea|mesh-list
24416756|NCT00203905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24460002|NCT00347087|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24460003|NCT00347087|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24416410|NCT00203073|Analgesics|analgesics|mesh-ancestor
24416757|NCT00203905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24416758|NCT00203905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24416759|NCT00203905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24416760|NCT00203905|Growth Substances|growth substances|mesh-ancestor
24416813|NCT00204074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24416814|NCT00204074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416815|NCT00204074|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24416817|NCT00204074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24416819|NCT00204191|Tacrolimus|tacrolimus|mesh-list
24417023|NCT00204737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417024|NCT00204776|Capecitabine|capecitabine|mesh-list
24417025|NCT00204776|Oxaliplatin|oxaliplatin|mesh-list
24417075|NCT00205231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24417076|NCT00205231|Analgesics|analgesics|mesh-ancestor
24417077|NCT00205231|Sensory System Agents|sensory system agents|mesh-ancestor
24417078|NCT00205231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24460004|NCT00347087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460006|NCT00347100|Insulin Glargine|insulin glargine|mesh-list
24460007|NCT00347100|Glyburide|glyburide|mesh-list
24460008|NCT00347100|Glipizide|glipizide|mesh-list
24460009|NCT00347100|Gliclazide|gliclazide|mesh-list
24417079|NCT00205231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417080|NCT00205231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24417081|NCT00205231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24417082|NCT00205231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24417083|NCT00205231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24417084|NCT00205231|Immunologic Factors|immunologic factors|mesh-ancestor
24417085|NCT00205283|Nelfinavir|nelfinavir|mesh-list
24417133|NCT00205725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24417134|NCT00205725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417135|NCT00205725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24417136|NCT00205725|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24417137|NCT00205725|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24417227|NCT00205946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417228|NCT00206024|Esomeprazole|esomeprazole|mesh-list
24417229|NCT00206024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24417230|NCT00206024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24417835|NCT00208065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24417836|NCT00208065|Autonomic Agents|autonomic agents|mesh-ancestor
24417837|NCT00208065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24417838|NCT00208065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417934|NCT00208195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417948|NCT00208208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24418080|NCT00208546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24418083|NCT00208546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24418984|NCT00210756|Hematinics|hematinics|mesh-ancestor
24418985|NCT00210769|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24418986|NCT00210769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24946937|NCT03933787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24946938|NCT03933787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946939|NCT03933787|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24946940|NCT03933787|Protease Inhibitors|protease inhibitors|mesh-ancestor
24946941|NCT03933787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051488|NCT00401388|Antimetabolites|antimetabolites|mesh-ancestor
24962734|NCT03795571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24962735|NCT03795571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25696923|NCT02068846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24535855|NCT00649831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24962736|NCT03795571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24418991|NCT00210769|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24418992|NCT00210769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24418994|NCT00210769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24418995|NCT00210769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418996|NCT00210769|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24418997|NCT00210769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24419097|NCT00211250|Valproic Acid|valproic acid|mesh-list
24419098|NCT00211250|Anticonvulsants|anticonvulsants|mesh-ancestor
24419330|NCT00211744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24419331|NCT00211744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419332|NCT00211796|Valproic Acid|valproic acid|mesh-list
24419333|NCT00211796|Anticonvulsants|anticonvulsants|mesh-ancestor
24419334|NCT00211796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419335|NCT00211796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419407|NCT00212043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419408|NCT00212043|Antiviral Agents|antiviral agents|mesh-ancestor
24419500|NCT00212277|Estradiol|estradiol|mesh-list
24419501|NCT00212277|Estrogens|estrogens|mesh-ancestor
24419502|NCT00212277|Hormones|hormones|mesh-ancestor
24419503|NCT00212277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24419504|NCT00212277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419505|NCT00212277|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24419506|NCT00212277|Contraceptive Agents|contraceptive agents|mesh-ancestor
24419507|NCT00212277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24419581|NCT00212680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419656|NCT00213252|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24419658|NCT00213252|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24419659|NCT00213252|Prednisolone acetate|prednisolone acetate|mesh-list
24419660|NCT00213252|Montelukast|montelukast|mesh-list
24419661|NCT00213252|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24420197|NCT00215371|Autonomic Agents|autonomic agents|mesh-ancestor
24419666|NCT00213252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24419668|NCT00213252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24419669|NCT00213252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419670|NCT00213252|Antiemetics|antiemetics|mesh-ancestor
24419696|NCT00213486|Irinotecan|irinotecan|mesh-list
24419697|NCT00213486|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24962737|NCT03795571|Antimetabolites|antimetabolites|mesh-ancestor
24962738|NCT03795571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962739|NCT03795571|Antiviral Agents|antiviral agents|mesh-ancestor
24962740|NCT03795571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24962741|NCT03795571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24946942|NCT03933787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946943|NCT03933787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24946944|NCT03933748|Teicoplanin|teicoplanin|mesh-list
24946945|NCT03933748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24946946|NCT03933748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24946947|NCT03933501|Amoxicillin|amoxicillin|mesh-list
24946948|NCT03933501|Metronidazole|metronidazole|mesh-list
24946949|NCT03933501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24946950|NCT03933501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24946951|NCT03933501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24946952|NCT03933501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24946953|NCT03933280|Dexmedetomidine|dexmedetomidine|mesh-list
24946954|NCT03933280|Nalbuphine|nalbuphine|mesh-list
24946955|NCT03933280|Propofol|propofol|mesh-list
24946956|NCT03933280|Benoxinate|benoxinate|mesh-list
24460019|NCT00347113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25696924|NCT02068846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25696925|NCT02068846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25696926|NCT02068846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25696927|NCT02068846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696928|NCT02068846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25696929|NCT02068846|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25696930|NCT02068846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25696931|NCT02069041|Leucovorin|leucovorin|mesh-list
24446524|NCT00305019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24419710|NCT00213538|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24419712|NCT00213538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24419713|NCT00213538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419714|NCT00213538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24419741|NCT00213564|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24419755|NCT00213590|Cyclosporins|cyclosporins|mesh-list
24419756|NCT00213590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419758|NCT00213590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24946962|NCT03933280|Anesthetics, General|anesthetics, general|mesh-ancestor
24946963|NCT03933280|Anesthetics|anesthetics|mesh-ancestor
24946964|NCT03933280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24946965|NCT03933280|Analgesics|analgesics|mesh-ancestor
24946966|NCT03933280|Sensory System Agents|sensory system agents|mesh-ancestor
24419989|NCT00214851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24419990|NCT00214864|Docetaxel|docetaxel|mesh-list
24419991|NCT00214864|Capecitabine|capecitabine|mesh-list
24419994|NCT00214864|Antimitotic Agents|antimitotic agents|mesh-ancestor
24419995|NCT00214864|Mitosis Modulators|mitosis modulators|mesh-ancestor
24420032|NCT00214981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420033|NCT00214994|Tiagabine|tiagabine|mesh-list
24420034|NCT00214994|Anticonvulsants|anticonvulsants|mesh-ancestor
24420181|NCT00215345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420182|NCT00215358|Formoterol Fumarate|formoterol fumarate|mesh-list
24420183|NCT00215358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24420184|NCT00215358|Autonomic Agents|autonomic agents|mesh-ancestor
24420185|NCT00215358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24420186|NCT00215358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420187|NCT00215358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24420188|NCT00215358|Respiratory System Agents|respiratory system agents|mesh-ancestor
24420189|NCT00215358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24420190|NCT00215358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24420191|NCT00215358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24420192|NCT00215358|Adrenergic Agents|adrenergic agents|mesh-ancestor
24420193|NCT00215358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24420194|NCT00215358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420195|NCT00215371|Formoterol Fumarate|formoterol fumarate|mesh-list
24420196|NCT00215371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24420203|NCT00215371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24420204|NCT00215371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24420205|NCT00215371|Adrenergic Agents|adrenergic agents|mesh-ancestor
24420206|NCT00215371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24420207|NCT00215371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420208|NCT00215384|Formoterol Fumarate|formoterol fumarate|mesh-list
24420209|NCT00215384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24420210|NCT00215384|Autonomic Agents|autonomic agents|mesh-ancestor
24420211|NCT00215384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24420212|NCT00215384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420213|NCT00215384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24420243|NCT00215410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24420244|NCT00215410|Adrenergic Agents|adrenergic agents|mesh-ancestor
24420245|NCT00215410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24420246|NCT00215410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420247|NCT00215423|Formoterol Fumarate|formoterol fumarate|mesh-list
24420248|NCT00215423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24420249|NCT00215423|Autonomic Agents|autonomic agents|mesh-ancestor
24420250|NCT00215423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24460029|NCT00347139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460030|NCT00347139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24420471|NCT00216112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420472|NCT00216112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24420473|NCT00216112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420475|NCT00216138|Capecitabine|capecitabine|mesh-list
24420476|NCT00216138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420477|NCT00216138|Tubulin Modulators|tubulin modulators|mesh-ancestor
24420478|NCT00216138|Antimitotic Agents|antimitotic agents|mesh-ancestor
24420479|NCT00216138|Mitosis Modulators|mitosis modulators|mesh-ancestor
25696933|NCT02069041|Oxaliplatin|oxaliplatin|mesh-list
25696934|NCT02069041|Ramucirumab|ramucirumab|mesh-list
25696935|NCT02069041|Antimetabolites|antimetabolites|mesh-ancestor
24536010|NCT00650182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24420636|NCT00216502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420638|NCT00216502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24420639|NCT00216502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420640|NCT00216502|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24420641|NCT00216502|Autonomic Agents|autonomic agents|mesh-ancestor
24420642|NCT00216502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25051494|NCT00401388|Antioxidants|antioxidants|mesh-ancestor
25051495|NCT00401388|Protective Agents|protective agents|mesh-ancestor
25051496|NCT00401388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420869|NCT00217048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24420870|NCT00217048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420871|NCT00217048|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24420872|NCT00217048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24420873|NCT00217048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24420874|NCT00217048|Adrenergic Agents|adrenergic agents|mesh-ancestor
24420875|NCT00217048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24429651|NCT00244608|Formoterol Fumarate|formoterol fumarate|mesh-list
24420876|NCT00217048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420878|NCT00217152|Mycophenolic Acid|mycophenolic acid|mesh-list
24420879|NCT00217152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24420880|NCT00217152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420881|NCT00217152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24420882|NCT00217152|Antitubercular Agents|antitubercular agents|mesh-ancestor
24420971|NCT00217412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420972|NCT00217412|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24420974|NCT00217412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420975|NCT00217412|Dermatologic Agents|dermatologic agents|mesh-ancestor
24420976|NCT00217451|Clindamycin|clindamycin|mesh-list
24421046|NCT00217529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24421057|NCT00217542|Antimetabolites|antimetabolites|mesh-ancestor
24421058|NCT00217542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421059|NCT00217542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421060|NCT00217542|Immunologic Factors|immunologic factors|mesh-ancestor
24421061|NCT00217542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421062|NCT00217542|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24947028|NCT03932916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24460033|NCT00347139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24460034|NCT00347139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24421386|NCT00218504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24421387|NCT00218504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421388|NCT00218504|Hormones|hormones|mesh-ancestor
24421389|NCT00218504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24421390|NCT00218517|Selegiline|selegiline|mesh-list
24421391|NCT00218517|Antidepressive Agents|antidepressive agents|mesh-ancestor
24421392|NCT00218517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24421393|NCT00218517|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24421394|NCT00218517|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24421395|NCT00218517|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24421396|NCT00218517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421397|NCT00218517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421398|NCT00218517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24421399|NCT00218517|Protective Agents|protective agents|mesh-ancestor
24421400|NCT00218517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421401|NCT00218530|Lofexidine|lofexidine|mesh-list
24421402|NCT00218530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24421403|NCT00218530|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24421404|NCT00218530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421405|NCT00218530|Sensory System Agents|sensory system agents|mesh-ancestor
24933423|NCT04070794|Metformin|metformin|mesh-list
24421406|NCT00218530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24421538|NCT00219479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24421539|NCT00219479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421540|NCT00219479|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24421541|NCT00219479|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24421542|NCT00219570|Clindamycin|clindamycin|mesh-list
24421543|NCT00219570|Clindamycin palmitate|clindamycin palmitate|mesh-list
24421544|NCT00219570|Clindamycin phosphate|clindamycin phosphate|mesh-list
24421545|NCT00219570|Nadifloxacin|nadifloxacin|mesh-list
24421546|NCT00219570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24421547|NCT00219570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24421548|NCT00219570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24421549|NCT00219570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421558|NCT00219596|Adrenergic Agents|adrenergic agents|mesh-ancestor
24421559|NCT00219596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24421560|NCT00219596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421561|NCT00219596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421562|NCT00219596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24421563|NCT00219596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24947040|NCT03932825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24622323|NCT01066663|Antimalarials|antimalarials|mesh-ancestor
24421564|NCT00219596|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24421565|NCT00219596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24421591|NCT00219726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421617|NCT00219765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421618|NCT00219765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421619|NCT00219765|Antiviral Agents|antiviral agents|mesh-ancestor
24421620|NCT00219765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24421621|NCT00219765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24421622|NCT00219765|Immunologic Factors|immunologic factors|mesh-ancestor
24421623|NCT00219765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421624|NCT00219765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24421625|NCT00219765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421626|NCT00219765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24421627|NCT00219765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24421628|NCT00219765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24421630|NCT00219778|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24421631|NCT00219778|Abortifacient Agents|abortifacient agents|mesh-ancestor
24421632|NCT00219778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24421633|NCT00219778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421634|NCT00219778|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24421635|NCT00219778|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24421675|NCT00219882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421676|NCT00219882|Protective Agents|protective agents|mesh-ancestor
24421677|NCT00219882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421681|NCT00219895|Analgesics|analgesics|mesh-ancestor
24421682|NCT00219895|Sensory System Agents|sensory system agents|mesh-ancestor
24421683|NCT00219895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24421684|NCT00219895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421685|NCT00219895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24421695|NCT00219908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421696|NCT00219908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24421697|NCT00219908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24421698|NCT00219908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421699|NCT00219908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421700|NCT00219921|Morphine|morphine|mesh-list
24421701|NCT00219921|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24421702|NCT00219921|Narcotics|narcotics|mesh-ancestor
24421703|NCT00219921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24421704|NCT00219921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423999|NCT00227669|Tubulin Modulators|tubulin modulators|mesh-ancestor
24460037|NCT00347139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460038|NCT00347152|Valproic Acid|valproic acid|mesh-list
24460039|NCT00347152|Anticonvulsants|anticonvulsants|mesh-ancestor
24460040|NCT00347152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417121|NCT00205634|Clarithromycin|clarithromycin|mesh-list
24421717|NCT00220051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421718|NCT00220051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421720|NCT00220064|Fluorouracil|fluorouracil|mesh-list
24421742|NCT00220103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421743|NCT00220103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24421744|NCT00220103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24421745|NCT00220103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24421746|NCT00220103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25696936|NCT02069041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536079|NCT00650299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24536080|NCT00650299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536081|NCT00650312|Metformin|metformin|mesh-list
24536082|NCT00650312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24536083|NCT00650312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536084|NCT00650325|Sertraline|sertraline|mesh-list
24421747|NCT00220116|Capecitabine|capecitabine|mesh-list
24421748|NCT00220116|Oxaliplatin|oxaliplatin|mesh-list
24421749|NCT00220116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24421750|NCT00220116|Antimetabolites|antimetabolites|mesh-ancestor
24421751|NCT00220116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421752|NCT00220116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421826|NCT00220259|Dermatologic Agents|dermatologic agents|mesh-ancestor
24421827|NCT00220259|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24421828|NCT00220285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24421829|NCT00220285|Immunologic Factors|immunologic factors|mesh-ancestor
24421830|NCT00220285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421831|NCT00220298|Methyltestosterone|methyltestosterone|mesh-list
24947041|NCT03932825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947042|NCT03932825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24947043|NCT03932825|Analgesics|analgesics|mesh-ancestor
24947044|NCT03932825|Sensory System Agents|sensory system agents|mesh-ancestor
24421832|NCT00220298|Testosterone|testosterone|mesh-list
24421833|NCT00220298|Testosterone undecanoate|testosterone undecanoate|mesh-list
24421834|NCT00220298|Testosterone enanthate|testosterone enanthate|mesh-list
24421836|NCT00220298|Androgens|androgens|mesh-ancestor
24460045|NCT00347152|Antimanic Agents|antimanic agents|mesh-ancestor
24460046|NCT00347152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24460047|NCT00347152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24460048|NCT00347152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24460049|NCT00347165|Bevacizumab|bevacizumab|mesh-list
24460050|NCT00347165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24460051|NCT00347165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460052|NCT00347165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24460053|NCT00347165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24460054|NCT00347165|Growth Substances|growth substances|mesh-ancestor
24460055|NCT00347165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421839|NCT00220298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421840|NCT00220298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24421865|NCT00220337|Lacosamide|lacosamide|mesh-list
24421870|NCT00220337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421872|NCT00220350|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24422055|NCT00221260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24422056|NCT00221260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422161|NCT00221494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24422162|NCT00221494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24422165|NCT00221494|Serotonin Agents|serotonin agents|mesh-ancestor
24422179|NCT00221520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24422180|NCT00221520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422181|NCT00221520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24422182|NCT00221520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24422183|NCT00221520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24422563|NCT00222976|Analgesics|analgesics|mesh-ancestor
24422564|NCT00222976|Sensory System Agents|sensory system agents|mesh-ancestor
24422566|NCT00222976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422567|NCT00222976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25696937|NCT02069041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25696938|NCT02069041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25696939|NCT02069041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25696940|NCT02069041|Immunologic Factors|immunologic factors|mesh-ancestor
25696941|NCT02069041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696942|NCT02069041|Antidotes|antidotes|mesh-ancestor
25696943|NCT02069041|Protective Agents|protective agents|mesh-ancestor
25696944|NCT02069041|Vitamin B Complex|vitamin b complex|mesh-ancestor
25696945|NCT02069041|Vitamins|vitamins|mesh-ancestor
25696946|NCT02069041|Micronutrients|micronutrients|mesh-ancestor
24460056|NCT00347165|Growth Inhibitors|growth inhibitors|mesh-ancestor
24422568|NCT00222976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24422683|NCT00223509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24422684|NCT00223548|Mesna|mesna|mesh-list
24422685|NCT00223548|Protective Agents|protective agents|mesh-ancestor
24422686|NCT00223548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422687|NCT00223561|Methylphenidate|methylphenidate|mesh-list
24422688|NCT00223561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24422689|NCT00223561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422690|NCT00223561|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24422691|NCT00223561|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24422692|NCT00223561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24422736|NCT00223691|Analgesics|analgesics|mesh-ancestor
24422754|NCT00223691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24422760|NCT00223691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24422761|NCT00223691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24422762|NCT00223691|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24422763|NCT00223691|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24947045|NCT03932825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24947046|NCT03932981|Temozolomide|temozolomide|mesh-list
24947047|NCT03932981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24947048|NCT03932981|Alkylating Agents|alkylating agents|mesh-ancestor
24422764|NCT00223691|Adrenergic Agents|adrenergic agents|mesh-ancestor
24460063|NCT00347204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24460064|NCT00347204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460065|NCT00347204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24460066|NCT00347204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24417304|NCT00206167|Glucocorticoids|glucocorticoids|mesh-ancestor
24422765|NCT00223691|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24422766|NCT00223691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24422801|NCT00223691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24422802|NCT00223691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24422803|NCT00223691|Respiratory System Agents|respiratory system agents|mesh-ancestor
24422804|NCT00223691|Nasal Decongestants|nasal decongestants|mesh-ancestor
24422805|NCT00223691|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24422806|NCT00223691|Mydriatics|mydriatics|mesh-ancestor
24422845|NCT00223717|Sensory System Agents|sensory system agents|mesh-ancestor
24422846|NCT00223717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24422847|NCT00223717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422848|NCT00223717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24422849|NCT00223717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24422850|NCT00223717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24422851|NCT00223717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24422852|NCT00223717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422853|NCT00223717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24422914|NCT00223860|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24422916|NCT00223860|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24422917|NCT00223860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24422918|NCT00223860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422919|NCT00223860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24422920|NCT00223925|Maribavir|maribavir|mesh-list
24422930|NCT00224081|Ferric gluconate|ferric gluconate|mesh-list
24422931|NCT00224081|Hematinics|hematinics|mesh-ancestor
24422932|NCT00224094|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24422933|NCT00224094|Estrogens|estrogens|mesh-ancestor
24422934|NCT00224094|Hormones|hormones|mesh-ancestor
24423391|NCT00225797|Sensory System Agents|sensory system agents|mesh-ancestor
24422935|NCT00224094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24422957|NCT00224302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24422958|NCT00224302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422960|NCT00224302|Sensory System Agents|sensory system agents|mesh-ancestor
24625307|NCT01081561|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24422961|NCT00224302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24422962|NCT00224302|Antidepressive Agents|antidepressive agents|mesh-ancestor
24947074|NCT03932578|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24423080|NCT00224588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423081|NCT00224588|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24423082|NCT00224588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24423083|NCT00224588|Anesthetics, General|anesthetics, general|mesh-ancestor
25696947|NCT02069093|Dexamethasone|dexamethasone|mesh-list
25696948|NCT02069093|Everolimus|everolimus|mesh-list
25696949|NCT02069093|Exemestane|exemestane|mesh-list
24423084|NCT00224588|Anesthetics|anesthetics|mesh-ancestor
24423086|NCT00224588|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24423087|NCT00224588|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24423088|NCT00224588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24423089|NCT00224588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423090|NCT00224640|Iron Chelating Agents|iron chelating agents|mesh-list
24423091|NCT00224640|Chelating Agents|chelating agents|mesh-ancestor
24423092|NCT00224640|Sequestering Agents|sequestering agents|mesh-ancestor
24423093|NCT00224640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460094|NCT00347399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24460095|NCT00347399|Growth Substances|growth substances|mesh-ancestor
24460096|NCT00347399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460097|NCT00347399|Growth Inhibitors|growth inhibitors|mesh-ancestor
24460098|NCT00347399|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24460099|NCT00347399|Dermatologic Agents|dermatologic agents|mesh-ancestor
24947075|NCT03932578|Dopamine Agents|dopamine agents|mesh-ancestor
24947076|NCT03932435|Bepotastine besilate|bepotastine besilate|mesh-list
24947077|NCT03932435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24947079|NCT03932721|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24947080|NCT03932721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24947081|NCT03932721|Antimetabolites|antimetabolites|mesh-ancestor
24947082|NCT03932721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801293|NCT01982734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24460123|NCT00347425|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24460124|NCT00347425|Dopamine Agents|dopamine agents|mesh-ancestor
24460125|NCT00347425|Antiemetics|antiemetics|mesh-ancestor
24460126|NCT00347425|Autonomic Agents|autonomic agents|mesh-ancestor
24460127|NCT00347425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24460128|NCT00347425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24423095|NCT00224679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24423096|NCT00224679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24423097|NCT00224679|Analgesics|analgesics|mesh-ancestor
24423098|NCT00224679|Sensory System Agents|sensory system agents|mesh-ancestor
24423099|NCT00224679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24423100|NCT00224679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460129|NCT00347425|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24460130|NCT00347425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24460131|NCT00347425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24460132|NCT00347425|Antidepressive Agents|antidepressive agents|mesh-ancestor
24701997|NCT01463332|Dexmedetomidine|dexmedetomidine|mesh-list
24772483|NCT01833819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24772485|NCT01833819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24772486|NCT01833819|Adrenergic Agents|adrenergic agents|mesh-ancestor
24772487|NCT01833819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24772488|NCT01833819|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24772489|NCT01833819|Narcotics|narcotics|mesh-ancestor
24423257|NCT00225173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24423258|NCT00225173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24423259|NCT00225173|Tubulin Modulators|tubulin modulators|mesh-ancestor
24423260|NCT00225173|Antimitotic Agents|antimitotic agents|mesh-ancestor
24423263|NCT00225225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24423298|NCT00225342|Gliclazide|gliclazide|mesh-list
24423380|NCT00225706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24423381|NCT00225706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24423382|NCT00225706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24423383|NCT00225706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423384|NCT00225706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423385|NCT00225797|Oxymorphone|oxymorphone|mesh-list
24423386|NCT00225797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24423387|NCT00225797|Narcotics|narcotics|mesh-ancestor
24423388|NCT00225797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24423389|NCT00225797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423390|NCT00225797|Analgesics|analgesics|mesh-ancestor
24423429|NCT00225914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24423459|NCT00226096|Nitroprusside|nitroprusside|mesh-list
24423470|NCT00226096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24772490|NCT01833858|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24772491|NCT01833858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24772492|NCT01833858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460134|NCT00347425|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24460135|NCT00347425|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24423472|NCT00226096|Autonomic Agents|autonomic agents|mesh-ancestor
24423473|NCT00226096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24430216|NCT00246467|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24423474|NCT00226096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423475|NCT00226096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24423504|NCT00226109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24423506|NCT00226109|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24423507|NCT00226109|Diuretics|diuretics|mesh-ancestor
24423508|NCT00226109|Natriuretic Agents|natriuretic agents|mesh-ancestor
24423509|NCT00226122|Indomethacin|indomethacin|mesh-list
24423510|NCT00226122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24423511|NCT00226122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24423512|NCT00226122|Analgesics|analgesics|mesh-ancestor
24423513|NCT00226122|Sensory System Agents|sensory system agents|mesh-ancestor
24423514|NCT00226122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24423515|NCT00226122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423516|NCT00226122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24423517|NCT00226122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24423518|NCT00226122|Gout Suppressants|gout suppressants|mesh-ancestor
24423519|NCT00226122|Tocolytic Agents|tocolytic agents|mesh-ancestor
24423520|NCT00226122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24423521|NCT00226122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24423556|NCT00226317|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24423557|NCT00226317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24423559|NCT00226330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24423560|NCT00226330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423561|NCT00226343|Valproic Acid|valproic acid|mesh-list
24423562|NCT00226343|Anticonvulsants|anticonvulsants|mesh-ancestor
24423563|NCT00226343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423564|NCT00226343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423565|NCT00226343|GABA Agents|gaba agents|mesh-ancestor
24423566|NCT00226343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24423567|NCT00226343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423568|NCT00226343|Antimanic Agents|antimanic agents|mesh-ancestor
24423569|NCT00226343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24423661|NCT00226538|Hormone Antagonists|hormone antagonists|mesh-ancestor
24423780|NCT00226824|Autonomic Agents|autonomic agents|mesh-ancestor
24423781|NCT00226824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24423782|NCT00226824|Nootropic Agents|nootropic agents|mesh-ancestor
24423851|NCT00227123|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24423853|NCT00227123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24423854|NCT00227123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423855|NCT00227123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423856|NCT00227123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24423857|NCT00227123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24423858|NCT00227123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24423859|NCT00227123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24423914|NCT00227409|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24423915|NCT00227409|Chelating Agents|chelating agents|mesh-ancestor
24460136|NCT00347425|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24423916|NCT00227409|Sequestering Agents|sequestering agents|mesh-ancestor
24423951|NCT00227500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772495|NCT01834014|Fluorouracil|fluorouracil|mesh-list
24947114|NCT03932123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24947115|NCT03932123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24947116|NCT03932123|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24947117|NCT03932123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398136|NCT00143624|Rosiglitazone|rosiglitazone|mesh-list
24947119|NCT03932344|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24947120|NCT03932344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24947121|NCT03932266|Docetaxel|docetaxel|mesh-list
24423953|NCT00227500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24423993|NCT00227669|Antiviral Agents|antiviral agents|mesh-ancestor
24423994|NCT00227669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24423995|NCT00227669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423996|NCT00227669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24423997|NCT00227669|Immunologic Factors|immunologic factors|mesh-ancestor
24423998|NCT00227669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424000|NCT00227669|Antimitotic Agents|antimitotic agents|mesh-ancestor
24424001|NCT00227669|Mitosis Modulators|mitosis modulators|mesh-ancestor
24424002|NCT00227682|Ascorbic Acid|ascorbic acid|mesh-list
24424003|NCT00227682|Thalidomide|thalidomide|mesh-list
24424004|NCT00227682|Dexamethasone|dexamethasone|mesh-list
24424081|NCT00227812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424082|NCT00227812|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24424083|NCT00227812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24424084|NCT00227812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24424085|NCT00227942|Zolpidem|zolpidem|mesh-list
24424433|NCT00229385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24424434|NCT00229385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24424435|NCT00229385|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24772496|NCT01834014|Oxaliplatin|oxaliplatin|mesh-list
24772497|NCT01834014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24772498|NCT01834014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772499|NCT01834014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24772500|NCT01834014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24772501|NCT01834014|Growth Substances|growth substances|mesh-ancestor
24772502|NCT01834014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947122|NCT03932266|Endostar protein|endostar protein|mesh-list
24947123|NCT03932266|Endostatins|endostatins|mesh-list
24947124|NCT03932266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24947125|NCT03932266|Tubulin Modulators|tubulin modulators|mesh-ancestor
24947126|NCT03932266|Antimitotic Agents|antimitotic agents|mesh-ancestor
24801331|NCT01982799|Respiratory System Agents|respiratory system agents|mesh-ancestor
24424438|NCT00229424|Lafutidine|lafutidine|mesh-list
24424439|NCT00229424|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24424440|NCT00229424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24424467|NCT00229515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24424476|NCT00229515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24424477|NCT00229515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424478|NCT00229515|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24424479|NCT00229515|Antiviral Agents|antiviral agents|mesh-ancestor
24424602|NCT00229996|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24424604|NCT00230035|Methylprednisolone|methylprednisolone|mesh-list
24424605|NCT00230035|Rituximab|rituximab|mesh-list
24424606|NCT00230035|Methotrexate|methotrexate|mesh-list
24424607|NCT00230035|Azathioprine|azathioprine|mesh-list
24424608|NCT00230035|Immunoglobulins|immunoglobulins|mesh-list
24424609|NCT00230035|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24424610|NCT00230035|Antibodies|antibodies|mesh-list
24424611|NCT00230035|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24424612|NCT00230035|gamma-Globulins|gamma-globulins|mesh-list
24424613|NCT00230035|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24424614|NCT00230035|Leflunomide|leflunomide|mesh-list
24424615|NCT00230035|Thymoglobulin|thymoglobulin|mesh-list
24424622|NCT00230035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24424623|NCT00230035|Abortifacient Agents|abortifacient agents|mesh-ancestor
24424624|NCT00230035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24424625|NCT00230035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24424626|NCT00230035|Antimetabolites|antimetabolites|mesh-ancestor
24424627|NCT00230035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424628|NCT00230035|Dermatologic Agents|dermatologic agents|mesh-ancestor
24424759|NCT00230568|Nootropic Agents|nootropic agents|mesh-ancestor
24424760|NCT00230594|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24424761|NCT00230594|Hemostatics|hemostatics|mesh-ancestor
24424787|NCT00230776|Anticonvulsants|anticonvulsants|mesh-ancestor
24424788|NCT00230776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24424972|NCT00231517|Narcotics|narcotics|mesh-ancestor
24424973|NCT00231517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24424974|NCT00231517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424975|NCT00231517|Analgesics|analgesics|mesh-ancestor
24424976|NCT00231517|Sensory System Agents|sensory system agents|mesh-ancestor
24424977|NCT00231517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24424978|NCT00231530|Topiramate|topiramate|mesh-list
24424979|NCT00231530|Anticonvulsants|anticonvulsants|mesh-ancestor
24424980|NCT00231530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24424981|NCT00231530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424982|NCT00231556|Topiramate|topiramate|mesh-list
24425005|NCT00231582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24425006|NCT00231582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24425007|NCT00231582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24425195|NCT00232206|Docetaxel|docetaxel|mesh-list
24425196|NCT00232206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24425197|NCT00232206|Tubulin Modulators|tubulin modulators|mesh-ancestor
24425198|NCT00232206|Antimitotic Agents|antimitotic agents|mesh-ancestor
24425199|NCT00232206|Mitosis Modulators|mitosis modulators|mesh-ancestor
24460141|NCT00347490|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24460142|NCT00347490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425200|NCT00232206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425202|NCT00232271|Anticoagulants|anticoagulants|mesh-ancestor
24425203|NCT00232271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24425204|NCT00232271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24425205|NCT00232271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425206|NCT00232284|Sertraline|sertraline|mesh-list
24425207|NCT00232284|Antidepressive Agents|antidepressive agents|mesh-ancestor
24425208|NCT00232284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24425209|NCT00232284|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24425210|NCT00232284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24947132|NCT03932266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947133|NCT03932266|Growth Inhibitors|growth inhibitors|mesh-ancestor
24947134|NCT03931915|Leuprolide|leuprolide|mesh-list
24530553|NCT00630981|Citalopram|citalopram|mesh-list
24947135|NCT03931915|Relugolix|relugolix|mesh-list
24947136|NCT03931915|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24947137|NCT03931915|Fertility Agents|fertility agents|mesh-ancestor
24947138|NCT03931915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24801349|NCT01982929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24425211|NCT00232284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24425212|NCT00232284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425213|NCT00232284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24425214|NCT00232284|Serotonin Agents|serotonin agents|mesh-ancestor
24425239|NCT00232375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24425240|NCT00232375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425289|NCT00232648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425290|NCT00232648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24425291|NCT00232648|Respiratory System Agents|respiratory system agents|mesh-ancestor
24425292|NCT00232648|Glucocorticoids|glucocorticoids|mesh-ancestor
24425301|NCT00232661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24425314|NCT00232674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24425315|NCT00232674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425316|NCT00232674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24425317|NCT00232674|Respiratory System Agents|respiratory system agents|mesh-ancestor
24425319|NCT00232674|Hormones|hormones|mesh-ancestor
24425321|NCT00232687|Aripiprazole|aripiprazole|mesh-list
24460145|NCT00347503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24425327|NCT00232687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425328|NCT00232687|Dopamine Agonists|dopamine agonists|mesh-ancestor
24425341|NCT00232700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24425342|NCT00232700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24425343|NCT00232700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425344|NCT00232700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24425345|NCT00232700|Serotonin Agents|serotonin agents|mesh-ancestor
24425346|NCT00232700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739831|NCT01684657|Asenapine|asenapine|mesh-list
24425347|NCT00232700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24425348|NCT00232700|Antidepressive Agents|antidepressive agents|mesh-ancestor
24425372|NCT00232856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24425373|NCT00232856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24425374|NCT00232856|Antifungal Agents|antifungal agents|mesh-ancestor
24425375|NCT00232856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24425376|NCT00232856|Immunologic Factors|immunologic factors|mesh-ancestor
24425377|NCT00232856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425378|NCT00232882|Atenolol|atenolol|mesh-list
24425379|NCT00232882|Candesartan|candesartan|mesh-list
24425380|NCT00232882|Candesartan cilexetil|candesartan cilexetil|mesh-list
24425381|NCT00232882|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
24425382|NCT00232882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24425383|NCT00232882|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24425384|NCT00232882|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24425385|NCT00232882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425386|NCT00232882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24425406|NCT00232908|Enfuvirtide|enfuvirtide|mesh-list
24790150|NCT01941134|Estradiol|estradiol|mesh-list
24425425|NCT00232934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24425427|NCT00232947|Immunologic Factors|immunologic factors|mesh-ancestor
24425428|NCT00232947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425429|NCT00233012|Topiramate|topiramate|mesh-list
24425430|NCT00233012|Anticonvulsants|anticonvulsants|mesh-ancestor
24938695|NCT04016389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24938696|NCT04016389|Tubulin Modulators|tubulin modulators|mesh-ancestor
24938697|NCT04016389|Antimitotic Agents|antimitotic agents|mesh-ancestor
24852003|NCT02259985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24425431|NCT00233012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24425432|NCT00233012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425433|NCT00233025|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24425434|NCT00233025|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24425435|NCT00233025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24425436|NCT00233025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24425460|NCT00233051|Dermatologic Agents|dermatologic agents|mesh-ancestor
24425461|NCT00233051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24425462|NCT00233051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24425463|NCT00233051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24425471|NCT00233155|Sensory System Agents|sensory system agents|mesh-ancestor
24425472|NCT00233155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24425475|NCT00233337|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24425477|NCT00233337|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24425478|NCT00233337|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24425479|NCT00233337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24425480|NCT00233376|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24425481|NCT00233376|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24425482|NCT00233376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24425483|NCT00233376|Antitubercular Agents|antitubercular agents|mesh-ancestor
24425484|NCT00233532|Verapamil|verapamil|mesh-list
24425485|NCT00233532|Trandolapril|trandolapril|mesh-list
24425510|NCT00233558|Antimetabolites|antimetabolites|mesh-ancestor
24425511|NCT00233558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425512|NCT00233558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460149|NCT00347503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24425513|NCT00233558|Dermatologic Agents|dermatologic agents|mesh-ancestor
24425514|NCT00233558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24425515|NCT00233558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24425516|NCT00233558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24425517|NCT00233558|Immunologic Factors|immunologic factors|mesh-ancestor
24425518|NCT00233558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24554649|NCT00737373|Antidotes|antidotes|mesh-ancestor
24425519|NCT00233558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24530600|NCT00631124|Diuretics|diuretics|mesh-ancestor
24425520|NCT00233558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24425525|NCT00233584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24425553|NCT00233623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24425566|NCT00233623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24425567|NCT00233636|Gefitinib|gefitinib|mesh-list
24425568|NCT00233636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24425569|NCT00233636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24425570|NCT00233636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24425571|NCT00233636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425572|NCT00233662|Alefacept|alefacept|mesh-list
24425587|NCT00233714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24425588|NCT00233714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24425589|NCT00233714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24425590|NCT00233714|Antifungal Agents|antifungal agents|mesh-ancestor
24425591|NCT00233714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24425592|NCT00233714|Immunologic Factors|immunologic factors|mesh-ancestor
24425593|NCT00233714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425621|NCT00233792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24425622|NCT00233792|Antifungal Agents|antifungal agents|mesh-ancestor
24425623|NCT00233792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24425624|NCT00233792|Immunologic Factors|immunologic factors|mesh-ancestor
24430826|NCT00249366|GABA Agents|gaba agents|mesh-ancestor
24430829|NCT00249405|Citalopram|citalopram|mesh-list
24425714|NCT00234091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24425793|NCT00234390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25696950|NCT02069093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25696951|NCT02069093|Antiemetics|antiemetics|mesh-ancestor
25696952|NCT02069093|Autonomic Agents|autonomic agents|mesh-ancestor
25696953|NCT02069093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25696954|NCT02069093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696955|NCT02069093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25696956|NCT02069093|Glucocorticoids|glucocorticoids|mesh-ancestor
25696957|NCT02069093|Hormones|hormones|mesh-ancestor
24425794|NCT00234390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425796|NCT00234390|Respiratory System Agents|respiratory system agents|mesh-ancestor
24425798|NCT00234390|Hormones|hormones|mesh-ancestor
24425799|NCT00234390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24425800|NCT00234403|Fulvestrant|fulvestrant|mesh-list
24425801|NCT00234403|Gefitinib|gefitinib|mesh-list
24425802|NCT00234403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24425803|NCT00234403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24947142|NCT03931915|Androgen Antagonists|androgen antagonists|mesh-ancestor
24947143|NCT03931915|Hormone Antagonists|hormone antagonists|mesh-ancestor
24947150|NCT03931668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947152|NCT03931863|Antiemetics|antiemetics|mesh-ancestor
24947153|NCT03931863|Autonomic Agents|autonomic agents|mesh-ancestor
24947154|NCT03931863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24448238|NCT00310843|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24448239|NCT00310843|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24425807|NCT00234403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24425835|NCT00234442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24425836|NCT00234442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24425837|NCT00234442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24425838|NCT00234442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425839|NCT00234455|Sirolimus|sirolimus|mesh-list
24425840|NCT00234455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24425841|NCT00234455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24425842|NCT00234455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24425843|NCT00234455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24425844|NCT00234455|Antifungal Agents|antifungal agents|mesh-ancestor
24425845|NCT00234455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24425846|NCT00234455|Immunologic Factors|immunologic factors|mesh-ancestor
24460154|NCT00347503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24425847|NCT00234455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425848|NCT00234468|Gefitinib|gefitinib|mesh-list
24425849|NCT00234468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24425850|NCT00234468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24425851|NCT00234468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24425930|NCT00234845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24425931|NCT00234845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24934752|NCT04059198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24448241|NCT00310843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448242|NCT00310843|Antiviral Agents|antiviral agents|mesh-ancestor
24448243|NCT00310843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24448244|NCT00310843|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24448245|NCT00310843|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24448246|NCT00310843|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24448247|NCT00310843|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24448248|NCT00310895|Imetelstat|imetelstat|mesh-list
24448249|NCT00310895|Motesanib diphosphate|motesanib diphosphate|mesh-list
24448250|NCT00310895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448251|NCT00310895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448252|NCT00310895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24448253|NCT00310908|Tramadol|tramadol|mesh-list
24448254|NCT00310908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24448270|NCT00310934|Methadone|methadone|mesh-list
24426129|NCT00235092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24426130|NCT00235092|Antifungal Agents|antifungal agents|mesh-ancestor
24426131|NCT00235092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24426132|NCT00235092|Immunologic Factors|immunologic factors|mesh-ancestor
24426133|NCT00235092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460155|NCT00347503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050420|NCT00508625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24426135|NCT00235105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24426136|NCT00235105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24426137|NCT00235144|Sirolimus|sirolimus|mesh-list
24426138|NCT00235144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24426139|NCT00235144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24426140|NCT00235144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24426141|NCT00235144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24426142|NCT00235144|Antifungal Agents|antifungal agents|mesh-ancestor
24426143|NCT00235144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24426144|NCT00235144|Immunologic Factors|immunologic factors|mesh-ancestor
24426145|NCT00235144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426173|NCT00235235|Vinorelbine|vinorelbine|mesh-list
24426174|NCT00235235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24426175|NCT00235235|Immunologic Factors|immunologic factors|mesh-ancestor
24426176|NCT00235235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426177|NCT00235235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24426178|NCT00235235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24426179|NCT00235235|Alkylating Agents|alkylating agents|mesh-ancestor
24426180|NCT00235235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426181|NCT00235235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24426182|NCT00235235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24426209|NCT00235248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24426210|NCT00235248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24426221|NCT00235261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24426222|NCT00235261|Antiemetics|antiemetics|mesh-ancestor
24426223|NCT00235261|Autonomic Agents|autonomic agents|mesh-ancestor
24426224|NCT00235261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24947156|NCT03931863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24947158|NCT03931863|Dermatologic Agents|dermatologic agents|mesh-ancestor
24947159|NCT03931863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24947160|NCT03931863|Serotonin Agents|serotonin agents|mesh-ancestor
24947161|NCT03931863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24947162|NCT03931863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947163|NCT03931863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24426225|NCT00235261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426226|NCT00235261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24426266|NCT00235313|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24426267|NCT00235313|Autonomic Agents|autonomic agents|mesh-ancestor
24426302|NCT00235729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24426338|NCT00235859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24426339|NCT00235859|Dermatologic Agents|dermatologic agents|mesh-ancestor
24426340|NCT00235859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24426341|NCT00235859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24426342|NCT00235859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24426343|NCT00235859|Immunologic Factors|immunologic factors|mesh-ancestor
24426344|NCT00235859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24426345|NCT00235859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24426346|NCT00235859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24426348|NCT00235885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24426349|NCT00235885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24426350|NCT00235898|Leucovorin|leucovorin|mesh-list
24426351|NCT00235898|Fluorouracil|fluorouracil|mesh-list
24426352|NCT00235898|Antimetabolites|antimetabolites|mesh-ancestor
24426353|NCT00235898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426354|NCT00235898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24426355|NCT00235898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24426356|NCT00235898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24426357|NCT00235898|Immunologic Factors|immunologic factors|mesh-ancestor
24426358|NCT00235898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426359|NCT00235898|Antidotes|antidotes|mesh-ancestor
24426966|NCT00236912|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24426967|NCT00236912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24536747|NCT00652184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24426969|NCT00236925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24426971|NCT00236964|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24426972|NCT00236964|Hematinics|hematinics|mesh-ancestor
24426973|NCT00236990|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
24426974|NCT00236990|Anticoagulants|anticoagulants|mesh-ancestor
24426975|NCT00237016|Doxycycline|doxycycline|mesh-list
24426976|NCT00237016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24426977|NCT00237016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24426978|NCT00237016|Antimalarials|antimalarials|mesh-ancestor
24426979|NCT00237016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24426980|NCT00237016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24426981|NCT00237068|Lansoprazole|lansoprazole|mesh-list
24426982|NCT00237068|Dexlansoprazole|dexlansoprazole|mesh-list
24426983|NCT00237068|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24426984|NCT00237068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24460168|NCT00347581|Methamphetamine|methamphetamine|mesh-list
24427180|NCT00237588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427181|NCT00237588|Vasodilator Agents|vasodilator agents|mesh-ancestor
24427182|NCT00237588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24427183|NCT00237588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24427184|NCT00237588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24427341|NCT00238004|Niacinamide|niacinamide|mesh-list
24427342|NCT00238004|Vitamin B Complex|vitamin b complex|mesh-ancestor
24427343|NCT00238004|Vitamins|vitamins|mesh-ancestor
24427344|NCT00238004|Micronutrients|micronutrients|mesh-ancestor
24427345|NCT00238004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427346|NCT00238004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24427347|NCT00238004|Antimetabolites|antimetabolites|mesh-ancestor
24427348|NCT00238004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427349|NCT00238004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24427350|NCT00238004|Vasodilator Agents|vasodilator agents|mesh-ancestor
24427354|NCT00238017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24427355|NCT00238017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24427356|NCT00238017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24427357|NCT00238017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427358|NCT00238017|Antiviral Agents|antiviral agents|mesh-ancestor
24427359|NCT00238017|Schistosomicides|schistosomicides|mesh-ancestor
24427360|NCT00238017|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24427361|NCT00238017|Anthelmintics|anthelmintics|mesh-ancestor
24427362|NCT00238043|Epoetin Alfa|epoetin alfa|mesh-list
24427390|NCT00238147|Antimitotic Agents|antimitotic agents|mesh-ancestor
24427391|NCT00238147|Mitosis Modulators|mitosis modulators|mesh-ancestor
24427392|NCT00238147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427393|NCT00238147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24427394|NCT00238147|Antimetabolites|antimetabolites|mesh-ancestor
24427395|NCT00238160|Fluorouracil|fluorouracil|mesh-list
24427396|NCT00238160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427397|NCT00238160|Antimetabolites|antimetabolites|mesh-ancestor
24947171|NCT03931928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24947172|NCT03931928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428575|NCT00240760|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24947173|NCT03931928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24947174|NCT03931928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24947175|NCT03931928|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24947176|NCT03931928|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24427410|NCT00238173|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24427411|NCT00238173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24427412|NCT00238173|Immunologic Factors|immunologic factors|mesh-ancestor
24427449|NCT00238199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24427450|NCT00238199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24460189|NCT00347685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24427452|NCT00238199|Micronutrients|micronutrients|mesh-ancestor
24427453|NCT00238199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24427454|NCT00238212|Sorafenib|sorafenib|mesh-list
24427455|NCT00238212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427491|NCT00238251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24427711|NCT00238784|Adrenergic Agents|adrenergic agents|mesh-ancestor
24427712|NCT00238784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24427713|NCT00238784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427714|NCT00238797|Gefitinib|gefitinib|mesh-list
24427715|NCT00238797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427829|NCT00239070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24938781|NCT04015908|Oxycodone|oxycodone|mesh-list
24938782|NCT04015908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24938783|NCT04015908|Analgesics|analgesics|mesh-ancestor
24938784|NCT04015908|Sensory System Agents|sensory system agents|mesh-ancestor
24938785|NCT04015908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24938787|NCT04015908|Antipyretics|antipyretics|mesh-ancestor
24938796|NCT04015908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24427859|NCT00239109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24427860|NCT00239109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460190|NCT00347685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460191|NCT00347685|Analgesics|analgesics|mesh-ancestor
24460192|NCT00347685|Sensory System Agents|sensory system agents|mesh-ancestor
24460193|NCT00347685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24460194|NCT00347698|Bevacizumab|bevacizumab|mesh-list
24460195|NCT00347698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24460196|NCT00347698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460197|NCT00347698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24460198|NCT00347698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24427861|NCT00239109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24427862|NCT00239109|Serotonin Agents|serotonin agents|mesh-ancestor
24947177|NCT03931928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24947179|NCT03931889|Cholecalciferol|cholecalciferol|mesh-list
24947181|NCT03931889|Micronutrients|micronutrients|mesh-ancestor
24427993|NCT00239408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428064|NCT00239473|Respiratory System Agents|respiratory system agents|mesh-ancestor
24428099|NCT00239499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24428100|NCT00239499|Adrenergic Agents|adrenergic agents|mesh-ancestor
24428103|NCT00239512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24428104|NCT00239512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24428105|NCT00239512|Analgesics|analgesics|mesh-ancestor
24428300|NCT00240058|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24428310|NCT00240123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428311|NCT00240123|Anesthetics, Local|anesthetics, local|mesh-ancestor
24428312|NCT00240123|Anesthetics|anesthetics|mesh-ancestor
24428313|NCT00240123|Sensory System Agents|sensory system agents|mesh-ancestor
24428314|NCT00240123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24428315|NCT00240123|Antiemetics|antiemetics|mesh-ancestor
24428404|NCT00240422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24428431|NCT00240448|Diuretics|diuretics|mesh-ancestor
24428432|NCT00240448|Natriuretic Agents|natriuretic agents|mesh-ancestor
24428433|NCT00240448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428434|NCT00240448|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24428435|NCT00240448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24460199|NCT00347698|Growth Substances|growth substances|mesh-ancestor
24460200|NCT00347698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460201|NCT00347698|Growth Inhibitors|growth inhibitors|mesh-ancestor
24460202|NCT00347724|Tramadol|tramadol|mesh-list
24460203|NCT00347724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24460204|NCT00347724|Narcotics|narcotics|mesh-ancestor
24460205|NCT00347724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24460206|NCT00347724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460207|NCT00347724|Analgesics|analgesics|mesh-ancestor
24428573|NCT00240747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428574|NCT00240760|Memantine|memantine|mesh-list
24428576|NCT00240760|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24428723|NCT00241046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24428724|NCT00241046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428725|NCT00241059|Mycophenolic Acid|mycophenolic acid|mesh-list
24429039|NCT00242411|Hormones|hormones|mesh-ancestor
24429248|NCT00243009|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24429249|NCT00243009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25696958|NCT02069093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25696959|NCT02069093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25696960|NCT02069093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25696961|NCT02069093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25696962|NCT02069093|Immunologic Factors|immunologic factors|mesh-ancestor
25696963|NCT02069093|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25696964|NCT02069093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24938829|NCT04015596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24938844|NCT04015557|Acetaminophen|acetaminophen|mesh-list
24938845|NCT04015557|Acetylcysteine|acetylcysteine|mesh-list
24938846|NCT04015557|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24938847|NCT04015557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24938848|NCT04015557|Analgesics|analgesics|mesh-ancestor
24704540|NCT01478685|Cc-486|cc-486|mesh-list
24938849|NCT04015557|Sensory System Agents|sensory system agents|mesh-ancestor
24938850|NCT04015557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24938851|NCT04015557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938852|NCT04015557|Antipyretics|antipyretics|mesh-ancestor
24938853|NCT04015557|Antiviral Agents|antiviral agents|mesh-ancestor
24947182|NCT03931889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947183|NCT03931889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24947184|NCT03931889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24947185|NCT03931343|Epinephrine|epinephrine|mesh-list
24947186|NCT03931343|Racepinephrine|racepinephrine|mesh-list
24625468|NCT01082263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24962885|NCT03794492|Antiemetics|antiemetics|mesh-ancestor
24947187|NCT03931343|Bupivacaine|bupivacaine|mesh-list
24947188|NCT03931343|Epinephryl borate|epinephryl borate|mesh-list
24947189|NCT03931343|Anesthetics, Local|anesthetics, local|mesh-ancestor
24947190|NCT03931343|Anesthetics|anesthetics|mesh-ancestor
24801393|NCT01983449|Hormones|hormones|mesh-ancestor
24801394|NCT01983449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24801395|NCT01983449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24801396|NCT01983449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24801397|NCT01983449|Protease Inhibitors|protease inhibitors|mesh-ancestor
24429250|NCT00243009|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24429251|NCT00243009|Antitubercular Agents|antitubercular agents|mesh-ancestor
24429280|NCT00243178|Purinergic Agents|purinergic agents|mesh-ancestor
24429281|NCT00243178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24429282|NCT00243178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429283|NCT00243178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429284|NCT00243204|Docetaxel|docetaxel|mesh-list
24460210|NCT00347737|Teriparatide|teriparatide|mesh-list
24460214|NCT00347750|Lopinavir|lopinavir|mesh-list
24429337|NCT00243672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24429338|NCT00243672|Antimetabolites|antimetabolites|mesh-ancestor
24429339|NCT00243672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429371|NCT00243750|Abortifacient Agents|abortifacient agents|mesh-ancestor
24429372|NCT00243750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24429373|NCT00243750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429374|NCT00243750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24429375|NCT00243750|Antimetabolites|antimetabolites|mesh-ancestor
24429419|NCT00243880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429456|NCT00244127|Cyclophosphamide|cyclophosphamide|mesh-list
24429457|NCT00244127|Rituximab|rituximab|mesh-list
24429458|NCT00244127|Vincristine|vincristine|mesh-list
24429528|NCT00244296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947191|NCT03931343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24947192|NCT03931343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429529|NCT00244296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24429530|NCT00244296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429532|NCT00244296|Sensory System Agents|sensory system agents|mesh-ancestor
24429568|NCT00244426|Indobufen|indobufen|mesh-list
24429569|NCT00244426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24429603|NCT00244517|Desflurane|desflurane|mesh-list
24429648|NCT00244556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24429650|NCT00244608|Terbutaline|terbutaline|mesh-list
24429711|NCT00244920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24429712|NCT00244920|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24429772|NCT00245024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460223|NCT00347750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25696966|NCT02069093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696967|NCT02069093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25696968|NCT02069093|Hormone Antagonists|hormone antagonists|mesh-ancestor
25696969|NCT02069184|Acetaminophen|acetaminophen|mesh-list
25696970|NCT02069184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25696971|NCT02069184|Analgesics|analgesics|mesh-ancestor
25696972|NCT02069184|Sensory System Agents|sensory system agents|mesh-ancestor
25696973|NCT02069184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25696974|NCT02069184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696975|NCT02069184|Antipyretics|antipyretics|mesh-ancestor
25696976|NCT02069379|Metformin|metformin|mesh-list
25050437|NCT00507936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050438|NCT00507936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050439|NCT00507936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050440|NCT00507936|Analgesics|analgesics|mesh-ancestor
24460224|NCT00347750|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24418958|NCT00210691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429773|NCT00245024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24431633|NCT00252603|Galantamine|galantamine|mesh-list
24429780|NCT00245089|Immunologic Factors|immunologic factors|mesh-ancestor
24429781|NCT00245089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429782|NCT00245089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24429783|NCT00245089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24429784|NCT00245089|Alkylating Agents|alkylating agents|mesh-ancestor
24429785|NCT00245089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429786|NCT00245089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429819|NCT00245141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429820|NCT00245141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24429821|NCT00245141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24429822|NCT00245141|Tubulin Modulators|tubulin modulators|mesh-ancestor
24429849|NCT00245206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429851|NCT00245206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24429852|NCT00245206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24429853|NCT00245206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24429854|NCT00245206|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24429855|NCT00245206|Dopamine Agents|dopamine agents|mesh-ancestor
24429856|NCT00245206|Antiemetics|antiemetics|mesh-ancestor
24429857|NCT00245206|Autonomic Agents|autonomic agents|mesh-ancestor
24429858|NCT00245206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24429859|NCT00245206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24429949|NCT00245609|Alprazolam|alprazolam|mesh-list
24460225|NCT00347750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24460226|NCT00347763|Permethrin|permethrin|mesh-list
24460227|NCT00347763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460228|NCT00347763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460229|NCT00347802|Bimatoprost|bimatoprost|mesh-list
24460230|NCT00347802|Travoprost|travoprost|mesh-list
24460231|NCT00347802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24460232|NCT00347815|Buprenorphine|buprenorphine|mesh-list
24460233|NCT00347815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24460234|NCT00347815|Narcotics|narcotics|mesh-ancestor
24460235|NCT00347815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24419030|NCT00210847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24429977|NCT00245661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429978|NCT00245674|Amisulpride|amisulpride|mesh-list
24429979|NCT00245674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24429980|NCT00245674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24429981|NCT00245674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24431673|NCT00252668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24431674|NCT00252668|Immunologic Factors|immunologic factors|mesh-ancestor
24429982|NCT00245674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429983|NCT00245674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24429984|NCT00245674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24429985|NCT00245674|Dopamine Agents|dopamine agents|mesh-ancestor
24429986|NCT00245674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24429987|NCT00245674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429988|NCT00245674|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24429989|NCT00245674|Antidepressive Agents|antidepressive agents|mesh-ancestor
24429990|NCT00245713|Levetiracetam|levetiracetam|mesh-list
24429991|NCT00245713|Anticonvulsants|anticonvulsants|mesh-ancestor
24429992|NCT00245713|Nootropic Agents|nootropic agents|mesh-ancestor
24429993|NCT00245739|Darunavir|darunavir|mesh-list
24429994|NCT00245739|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24429995|NCT00245739|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24429996|NCT00245739|Protease Inhibitors|protease inhibitors|mesh-ancestor
24429997|NCT00245739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429998|NCT00245739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431172|NCT00250692|Analgesics|analgesics|mesh-ancestor
25696977|NCT02069379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25696978|NCT02069379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696979|NCT02069392|Nicotine|nicotine|mesh-list
25696980|NCT02069392|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25696981|NCT02069392|Autonomic Agents|autonomic agents|mesh-ancestor
24429999|NCT00245739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24430284|NCT00246974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430319|NCT00247117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430321|NCT00247130|Ranitidine|ranitidine|mesh-list
24430322|NCT00247130|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
24430323|NCT00247130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24430357|NCT00247403|Antiviral Agents|antiviral agents|mesh-ancestor
24430358|NCT00247403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24430359|NCT00247481|Docetaxel|docetaxel|mesh-list
24430360|NCT00247481|Gefitinib|gefitinib|mesh-list
24430361|NCT00247481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24430362|NCT00247481|Tubulin Modulators|tubulin modulators|mesh-ancestor
24430406|NCT00247572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430407|NCT00247572|Dopamine Agents|dopamine agents|mesh-ancestor
24430408|NCT00247572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430410|NCT00247585|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24430411|NCT00247585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24430412|NCT00247585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24430413|NCT00247585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430414|NCT00247650|Zoledronic Acid|zoledronic acid|mesh-list
24430496|NCT00248092|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
24430497|NCT00248092|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24430498|NCT00248092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430499|NCT00248092|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24430500|NCT00248092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24430501|NCT00248092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24430548|NCT00248209|Dopamine Agents|dopamine agents|mesh-ancestor
24947195|NCT03931343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24430549|NCT00248209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430550|NCT00248209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430551|NCT00248209|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24430552|NCT00248209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24430553|NCT00248209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430554|NCT00248248|Doxorubicin|doxorubicin|mesh-list
24430555|NCT00248248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24430556|NCT00248248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24430557|NCT00248248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24430562|NCT00248261|Ziprasidone|ziprasidone|mesh-list
24430620|NCT00248456|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24460241|NCT00347828|Moxifloxacin|moxifloxacin|mesh-list
24460242|NCT00347828|Gatifloxacin|gatifloxacin|mesh-list
24419247|NCT00211562|Vitamin E|vitamin e|mesh-list
24430621|NCT00248456|Betamethasone benzoate|betamethasone benzoate|mesh-list
24430622|NCT00248456|Calcipotriene|calcipotriene|mesh-list
24430623|NCT00248456|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24430624|NCT00248456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24430671|NCT00248963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24430672|NCT00248963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24430673|NCT00248963|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24430698|NCT00249119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430699|NCT00249119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430701|NCT00249119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24430702|NCT00249119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24430703|NCT00249119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24430704|NCT00249119|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24430705|NCT00249119|Dopamine Agents|dopamine agents|mesh-ancestor
24430706|NCT00249132|Risperidone|risperidone|mesh-list
24430771|NCT00249210|Renal Agents|renal agents|mesh-ancestor
24430772|NCT00249210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24430773|NCT00249210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24430774|NCT00249210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24430775|NCT00249210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430776|NCT00249210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430777|NCT00249210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24430799|NCT00249236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24430800|NCT00249236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24430801|NCT00249236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24430809|NCT00249353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24430810|NCT00249353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430811|NCT00249353|Dopamine Agents|dopamine agents|mesh-ancestor
24430812|NCT00249353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25696982|NCT02069392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24430954|NCT00249860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24531195|NCT00634413|Vasodilator Agents|vasodilator agents|mesh-ancestor
24430955|NCT00249860|Antimetabolites|antimetabolites|mesh-ancestor
24430956|NCT00249860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430957|NCT00249860|Immunologic Factors|immunologic factors|mesh-ancestor
24430958|NCT00249860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430959|NCT00249860|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24430961|NCT00249886|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24430962|NCT00249886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24430963|NCT00249886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24430964|NCT00249886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430965|NCT00249886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430966|NCT00249886|Serotonin Agents|serotonin agents|mesh-ancestor
24430980|NCT00249899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431040|NCT00250081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431042|NCT00250094|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24431043|NCT00250094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24460248|NCT00347828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24947196|NCT03931343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24947197|NCT03931343|Adrenergic Agents|adrenergic agents|mesh-ancestor
24947198|NCT03931343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24947199|NCT03931343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431332|NCT00251368|9-aminocamptothecin|9-aminocamptothecin|mesh-list
24431053|NCT00250120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431054|NCT00250120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431056|NCT00250172|Antidepressive Agents|antidepressive agents|mesh-ancestor
24431057|NCT00250172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24431058|NCT00250172|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24431059|NCT00250172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24431060|NCT00250172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431061|NCT00250172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431062|NCT00250185|Acetylcholine|acetylcholine|mesh-list
24431063|NCT00250185|Vasodilator Agents|vasodilator agents|mesh-ancestor
24431064|NCT00250185|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24431065|NCT00250185|Cholinergic Agents|cholinergic agents|mesh-ancestor
24431105|NCT00250354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24431106|NCT00250354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24431107|NCT00250354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24431108|NCT00250354|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24431109|NCT00250354|Dopamine Agents|dopamine agents|mesh-ancestor
24431110|NCT00250367|Risperidone|risperidone|mesh-list
24431111|NCT00250367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24431112|NCT00250367|Serotonin Agents|serotonin agents|mesh-ancestor
24431113|NCT00250367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431114|NCT00250367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431115|NCT00250367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431116|NCT00250367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24431157|NCT00250575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24947204|NCT03931343|Respiratory System Agents|respiratory system agents|mesh-ancestor
24947205|NCT03931343|Mydriatics|mydriatics|mesh-ancestor
24947206|NCT03931343|Sympathomimetics|sympathomimetics|mesh-ancestor
24947207|NCT03931343|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24947208|NCT03931239|Vaccines|vaccines|mesh-list
24431158|NCT00250575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24431159|NCT00250575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24431160|NCT00250575|GABA Antagonists|gaba antagonists|mesh-ancestor
24431161|NCT00250575|GABA Agents|gaba agents|mesh-ancestor
24431162|NCT00250640|Iloprost|iloprost|mesh-list
24431163|NCT00250640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24431164|NCT00250640|Vasodilator Agents|vasodilator agents|mesh-ancestor
24431165|NCT00250692|Nitrous Oxide|nitrous oxide|mesh-list
24431166|NCT00250692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24431167|NCT00250692|Anesthetics, General|anesthetics, general|mesh-ancestor
24431168|NCT00250692|Anesthetics|anesthetics|mesh-ancestor
24431169|NCT00250692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24431170|NCT00250692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431171|NCT00250692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24431213|NCT00250796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24431214|NCT00250796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24431215|NCT00250861|Aldesleukin|aldesleukin|mesh-list
24431216|NCT00250861|Rituximab|rituximab|mesh-list
24431217|NCT00250861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24625598|NCT01082679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24625599|NCT01082679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625600|NCT01082679|Analgesics|analgesics|mesh-ancestor
24431218|NCT00250861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431219|NCT00250861|Immunologic Factors|immunologic factors|mesh-ancestor
24431220|NCT00250861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431221|NCT00250861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24431222|NCT00250861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24431223|NCT00250861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24431224|NCT00250861|Antiviral Agents|antiviral agents|mesh-ancestor
24431225|NCT00250861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24431227|NCT00250874|Doxorubicin|doxorubicin|mesh-list
24431228|NCT00250874|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24431308|NCT00251186|Cetuximab|cetuximab|mesh-list
24431333|NCT00251368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431334|NCT00251381|Cetuximab|cetuximab|mesh-list
24431335|NCT00251381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24431336|NCT00251381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431337|NCT00251394|Rituximab|rituximab|mesh-list
24431338|NCT00251394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24431339|NCT00251394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431341|NCT00251394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431342|NCT00251394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24431343|NCT00251407|Docetaxel|docetaxel|mesh-list
24431344|NCT00251407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431345|NCT00251407|Tubulin Modulators|tubulin modulators|mesh-ancestor
24431346|NCT00251407|Antimitotic Agents|antimitotic agents|mesh-ancestor
24431347|NCT00251407|Mitosis Modulators|mitosis modulators|mesh-ancestor
24431348|NCT00251407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431349|NCT00251459|Ranibizumab|ranibizumab|mesh-list
24431350|NCT00251459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24431351|NCT00251459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24431352|NCT00251459|Growth Substances|growth substances|mesh-ancestor
24431353|NCT00251459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431541|NCT00252122|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24431542|NCT00252122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431543|NCT00252122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431579|NCT00252317|Captopril|captopril|mesh-list
24431594|NCT00252343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24431628|NCT00252434|Adrenergic Agents|adrenergic agents|mesh-ancestor
24431629|NCT00252434|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24431630|NCT00252434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24431631|NCT00252434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24431632|NCT00252434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24431664|NCT00252668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24431665|NCT00252668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431666|NCT00252668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24431667|NCT00252668|Antimetabolites|antimetabolites|mesh-ancestor
24431668|NCT00252668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431669|NCT00252668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431670|NCT00252668|Dermatologic Agents|dermatologic agents|mesh-ancestor
24431671|NCT00252668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431672|NCT00252668|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24431743|NCT00252824|Glucocorticoids|glucocorticoids|mesh-ancestor
24431744|NCT00252824|Hormones|hormones|mesh-ancestor
24431780|NCT00252863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431781|NCT00252863|Tocolytic Agents|tocolytic agents|mesh-ancestor
24431782|NCT00252863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24460072|NCT00347295|Estazolam|estazolam|mesh-list
24431842|NCT00253123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24947223|NCT03931135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24431843|NCT00253123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431855|NCT00253136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431856|NCT00253136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696983|NCT02069392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25696984|NCT02069392|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25696985|NCT02069392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25696986|NCT02069392|Cholinergic Agents|cholinergic agents|mesh-ancestor
25696987|NCT02069392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25696988|NCT02069392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25696989|NCT02069704|Leucovorin|leucovorin|mesh-list
25696990|NCT02069704|Folic Acid|folic acid|mesh-list
24431857|NCT00253136|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24431858|NCT00253136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24431859|NCT00253136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24431860|NCT00253136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24431861|NCT00253136|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24431862|NCT00253136|Dopamine Agents|dopamine agents|mesh-ancestor
24431863|NCT00253149|Risperidone|risperidone|mesh-list
24431864|NCT00253149|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24431865|NCT00253149|Serotonin Agents|serotonin agents|mesh-ancestor
24431866|NCT00253149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24947212|NCT03931317|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24947213|NCT03931317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24431867|NCT00253149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431868|NCT00253149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431869|NCT00253149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24431870|NCT00253149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24431871|NCT00253149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24431897|NCT00253188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431898|NCT00253188|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24431899|NCT00253188|Autonomic Agents|autonomic agents|mesh-ancestor
24431900|NCT00253188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24432102|NCT00253552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24432103|NCT00253552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24432104|NCT00253552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24432105|NCT00253552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24432106|NCT00253552|Antifungal Agents|antifungal agents|mesh-ancestor
24432107|NCT00253552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24432108|NCT00253552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24432190|NCT00253929|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24432191|NCT00253929|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24432192|NCT00253929|Cholinergic Agents|cholinergic agents|mesh-ancestor
24460260|NCT00347854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24460262|NCT00347854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24460263|NCT00347867|Sildenafil Citrate|sildenafil citrate|mesh-list
24460264|NCT00347867|Vasodilator Agents|vasodilator agents|mesh-ancestor
24460265|NCT00347867|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24460266|NCT00347867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24460267|NCT00347867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460268|NCT00347867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432193|NCT00253955|Levofloxacin|levofloxacin|mesh-list
24432194|NCT00253955|Ofloxacin|ofloxacin|mesh-list
24432195|NCT00253955|Tazobactam|tazobactam|mesh-list
24432211|NCT00254007|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24432212|NCT00254007|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24432213|NCT00254007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24432214|NCT00254007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432215|NCT00254007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24432216|NCT00254007|Serotonin Agents|serotonin agents|mesh-ancestor
24432217|NCT00254007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432219|NCT00254007|Antidepressive Agents|antidepressive agents|mesh-ancestor
24432250|NCT00254085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24432251|NCT00254085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432252|NCT00254137|Capecitabine|capecitabine|mesh-list
24432253|NCT00254137|Oxaliplatin|oxaliplatin|mesh-list
24432255|NCT00254137|Cetuximab|cetuximab|mesh-list
24424838|NCT00230997|Galantamine|galantamine|mesh-list
24424846|NCT00230997|Autonomic Agents|autonomic agents|mesh-ancestor
24432336|NCT00254449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432338|NCT00254475|Simvastatin|simvastatin|mesh-list
24432339|NCT00254475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24947214|NCT03931317|Adrenergic Agents|adrenergic agents|mesh-ancestor
24947215|NCT03931317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24947216|NCT03931317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947217|NCT03931317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947218|NCT03931317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24947219|NCT03931317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24947220|NCT03931135|Dexamethasone|dexamethasone|mesh-list
24947221|NCT03931135|Morphine|morphine|mesh-list
24947222|NCT03931135|Cyclizine|cyclizine|mesh-list
25696991|NCT02069704|Bevacizumab|bevacizumab|mesh-list
25696992|NCT02069704|Fluorouracil|fluorouracil|mesh-list
25696993|NCT02069704|Oxaliplatin|oxaliplatin|mesh-list
25696994|NCT02069704|Irinotecan|irinotecan|mesh-list
25696995|NCT02069704|Levoleucovorin|levoleucovorin|mesh-list
24801416|NCT01983462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24915811|NCT04247984|Antimetabolites|antimetabolites|mesh-ancestor
24432340|NCT00254475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24432341|NCT00254475|Antimetabolites|antimetabolites|mesh-ancestor
24432342|NCT00254475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432343|NCT00254475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24432344|NCT00254475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24432345|NCT00254475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432346|NCT00254475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24432347|NCT00254475|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24432465|NCT00254813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24432466|NCT00254813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432469|NCT00254865|Contraceptive Agents|contraceptive agents|mesh-list
24432471|NCT00254865|Estrogens|estrogens|mesh-ancestor
24432472|NCT00254865|Hormones|hormones|mesh-ancestor
24432473|NCT00254865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24432474|NCT00254865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432505|NCT00254956|Glucocorticoids|glucocorticoids|mesh-ancestor
24432506|NCT00254956|Hormones|hormones|mesh-ancestor
24432507|NCT00254956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24432508|NCT00254956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947224|NCT03931135|Antiemetics|antiemetics|mesh-ancestor
24947225|NCT03931135|Autonomic Agents|autonomic agents|mesh-ancestor
24947226|NCT03931135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24947227|NCT03931135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947228|NCT03931135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24947229|NCT03931135|Glucocorticoids|glucocorticoids|mesh-ancestor
24420013|NCT00214942|Anesthetics|anesthetics|mesh-ancestor
24432695|NCT00255710|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24432696|NCT00255710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24432697|NCT00255710|Antimetabolites|antimetabolites|mesh-ancestor
24432698|NCT00255710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24432699|NCT00255710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432743|NCT00255879|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24432745|NCT00255879|Antiemetics|antiemetics|mesh-ancestor
24432746|NCT00255879|Autonomic Agents|autonomic agents|mesh-ancestor
24432747|NCT00255879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24432748|NCT00255879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24432749|NCT00255879|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24432750|NCT00255879|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24432751|NCT00255879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24432752|NCT00255879|Antidepressive Agents|antidepressive agents|mesh-ancestor
24432790|NCT00256178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24432791|NCT00256178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24432793|NCT00256230|Disulfiram|disulfiram|mesh-list
24432794|NCT00256230|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24432795|NCT00256230|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
24947236|NCT03931135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24947238|NCT03931135|Sensory System Agents|sensory system agents|mesh-ancestor
24947239|NCT03931135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24947240|NCT03931135|Histamine Antagonists|histamine antagonists|mesh-ancestor
24947241|NCT03931135|Histamine Agents|histamine agents|mesh-ancestor
24947242|NCT03931135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24432797|NCT00256230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432798|NCT00256256|Glucagon|glucagon|mesh-list
24432799|NCT00256256|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24432800|NCT00256256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24432801|NCT00256256|Hormones|hormones|mesh-ancestor
24432802|NCT00256256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24432900|NCT00256828|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24432937|NCT00257036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24432972|NCT00257075|Serotonin Agents|serotonin agents|mesh-ancestor
24432973|NCT00257075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24433079|NCT00257465|Immunologic Factors|immunologic factors|mesh-ancestor
24433081|NCT00257491|Telmisartan|telmisartan|mesh-list
24433181|NCT00257816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25696996|NCT02069704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25696997|NCT02069704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25696998|NCT02069704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25696999|NCT02069704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25697000|NCT02069704|Growth Substances|growth substances|mesh-ancestor
24433182|NCT00257816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433183|NCT00257829|Methazolamide|methazolamide|mesh-list
24433184|NCT00257829|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24433185|NCT00257829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433186|NCT00257829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433187|NCT00257829|Diuretics|diuretics|mesh-ancestor
24433188|NCT00257829|Natriuretic Agents|natriuretic agents|mesh-ancestor
24433189|NCT00257829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531457|NCT00635921|Dopamine Agents|dopamine agents|mesh-ancestor
24433190|NCT00257855|Lamotrigine|lamotrigine|mesh-list
24433191|NCT00257855|Anticonvulsants|anticonvulsants|mesh-ancestor
24433192|NCT00257855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24433193|NCT00257855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24460283|NCT00348010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460284|NCT00348010|Analgesics|analgesics|mesh-ancestor
24460286|NCT00348010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24460288|NCT00348023|Bimatoprost|bimatoprost|mesh-list
24460289|NCT00348023|Travoprost|travoprost|mesh-list
24433288|NCT00258089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24433289|NCT00258089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24433291|NCT00258089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24433292|NCT00258089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24433294|NCT00258089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433295|NCT00258089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433367|NCT00258245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24433368|NCT00258245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433370|NCT00258245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433371|NCT00258245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460295|NCT00348023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460296|NCT00348023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24433372|NCT00258245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24433373|NCT00258245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24433375|NCT00258245|Sensory System Agents|sensory system agents|mesh-ancestor
24433376|NCT00258245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24433422|NCT00258297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24433423|NCT00258297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433425|NCT00258323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433427|NCT00258323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433428|NCT00258323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24433429|NCT00258323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24433430|NCT00258323|Immunologic Factors|immunologic factors|mesh-ancestor
24433431|NCT00258323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433432|NCT00258336|Rituximab|rituximab|mesh-list
24433433|NCT00258336|Immunoglobulins|immunoglobulins|mesh-list
24433434|NCT00258336|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24433435|NCT00258336|Antibodies|antibodies|mesh-list
24433436|NCT00258336|Sargramostim|sargramostim|mesh-list
24433437|NCT00258336|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
24433438|NCT00258336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24433623|NCT00259220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433624|NCT00259363|Oxaliplatin|oxaliplatin|mesh-list
24947259|NCT03930875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24433625|NCT00259363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433661|NCT00259662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433662|NCT00259675|Gemcitabine|gemcitabine|mesh-list
24433699|NCT00259766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24433734|NCT00259792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24433735|NCT00259792|Respiratory System Agents|respiratory system agents|mesh-ancestor
24433736|NCT00259792|Glucocorticoids|glucocorticoids|mesh-ancestor
24433766|NCT00259870|Serotonin Agents|serotonin agents|mesh-ancestor
24433773|NCT00259883|Serotonin Agents|serotonin agents|mesh-ancestor
24433774|NCT00259883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433775|NCT00259883|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24433776|NCT00259883|Antidepressive Agents|antidepressive agents|mesh-ancestor
24433777|NCT00259883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24433778|NCT00259883|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24433825|NCT00260143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24433826|NCT00260143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433827|NCT00260143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25697001|NCT02069704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433828|NCT00260143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433858|NCT00260325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24433859|NCT00260325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433860|NCT00260325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433861|NCT00260325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24433862|NCT00260325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24433863|NCT00260325|Analgesics|analgesics|mesh-ancestor
24433864|NCT00260325|Sensory System Agents|sensory system agents|mesh-ancestor
24433865|NCT00260325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24433866|NCT00260325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433867|NCT00260325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24433868|NCT00260325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24433891|NCT00260364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24433895|NCT00260390|Anabolic Agents|anabolic agents|mesh-ancestor
24433897|NCT00260390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24433898|NCT00260390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433899|NCT00260416|Abciximab|abciximab|mesh-list
24433900|NCT00260416|Anticoagulants|anticoagulants|mesh-ancestor
24433907|NCT00260520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24433908|NCT00260520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433910|NCT00260611|Oxaliplatin|oxaliplatin|mesh-list
24433911|NCT00260611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433912|NCT00260611|Tubulin Modulators|tubulin modulators|mesh-ancestor
24433913|NCT00260611|Antimitotic Agents|antimitotic agents|mesh-ancestor
24433914|NCT00260611|Mitosis Modulators|mitosis modulators|mesh-ancestor
24433915|NCT00260611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460301|NCT00348101|Esmolol|esmolol|mesh-list
24460302|NCT00348101|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24433916|NCT00260624|Citalopram|citalopram|mesh-list
24434026|NCT00261261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24434027|NCT00261261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24434028|NCT00261261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24434029|NCT00261261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24434030|NCT00261261|Anesthetics, General|anesthetics, general|mesh-ancestor
24434031|NCT00261261|Anesthetics|anesthetics|mesh-ancestor
24434032|NCT00261261|GABA Modulators|gaba modulators|mesh-ancestor
24434033|NCT00261261|GABA Agents|gaba agents|mesh-ancestor
24434034|NCT00261261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24434035|NCT00261261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434036|NCT00261287|Ciclesonide|ciclesonide|mesh-list
24434037|NCT00261287|Glucocorticoids|glucocorticoids|mesh-ancestor
24434054|NCT00261326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434055|NCT00261326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24434056|NCT00261326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24434057|NCT00261326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434058|NCT00261339|Pantoprazole|pantoprazole|mesh-list
24434059|NCT00261339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24434062|NCT00261339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434063|NCT00261339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434075|NCT00261365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24434076|NCT00261365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434077|NCT00261378|Doxorubicin|doxorubicin|mesh-list
24434078|NCT00261378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24434079|NCT00261378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24962955|NCT03794154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24962956|NCT03794154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24962957|NCT03794154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962958|NCT03794154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24962959|NCT03794154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962960|NCT03794154|Analgesics|analgesics|mesh-ancestor
24434080|NCT00261378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24434081|NCT00261378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24434082|NCT00261378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24434083|NCT00261378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434084|NCT00261378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434085|NCT00261391|Marimastat|marimastat|mesh-list
24434086|NCT00261391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434087|NCT00261391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434088|NCT00261469|Topiramate|topiramate|mesh-list
24434089|NCT00261469|Anticonvulsants|anticonvulsants|mesh-ancestor
24434090|NCT00261469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25697002|NCT02069704|Growth Inhibitors|growth inhibitors|mesh-ancestor
25697003|NCT02069704|Antimetabolites|antimetabolites|mesh-ancestor
25697004|NCT02069704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434091|NCT00261469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434092|NCT00261482|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24434093|NCT00261482|Norelgestromin|norelgestromin|mesh-list
24434094|NCT00261482|Estradiol|estradiol|mesh-list
24434129|NCT00261560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24434130|NCT00261560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434133|NCT00261573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24434134|NCT00261573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434188|NCT00261612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434189|NCT00261612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24434190|NCT00261612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24434191|NCT00261612|Antiemetics|antiemetics|mesh-ancestor
24434192|NCT00261612|Autonomic Agents|autonomic agents|mesh-ancestor
24947270|NCT03931161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24947271|NCT03931161|Antimetabolites|antimetabolites|mesh-ancestor
24947272|NCT03931161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947273|NCT03931161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24947274|NCT03930706|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24947275|NCT03930706|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24801474|NCT01983735|Vitamin B Complex|vitamin b complex|mesh-ancestor
24801475|NCT01983735|Vitamins|vitamins|mesh-ancestor
24801476|NCT01983735|Micronutrients|micronutrients|mesh-ancestor
24801477|NCT01983761|Vidarabine|vidarabine|mesh-list
24801478|NCT01983761|Mycophenolic Acid|mycophenolic acid|mesh-list
24801479|NCT01983761|Fludarabine|fludarabine|mesh-list
24801480|NCT01983761|Fludarabine phosphate|fludarabine phosphate|mesh-list
24801481|NCT01983761|Melphalan|melphalan|mesh-list
24801482|NCT01983761|Busulfan|busulfan|mesh-list
24801483|NCT01983761|Clofarabine|clofarabine|mesh-list
24434216|NCT00261703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460307|NCT00348101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460308|NCT00348101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434225|NCT00261729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434226|NCT00261729|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24434227|NCT00261729|Antidepressive Agents|antidepressive agents|mesh-ancestor
24434228|NCT00261729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24434258|NCT00261820|Antitubercular Agents|antitubercular agents|mesh-ancestor
24434259|NCT00261820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24434260|NCT00261820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24434261|NCT00261820|Antifungal Agents|antifungal agents|mesh-ancestor
24434262|NCT00261820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24434263|NCT00261820|Antiemetics|antiemetics|mesh-ancestor
24434264|NCT00261820|Autonomic Agents|autonomic agents|mesh-ancestor
24427786|NCT00239018|Mycophenolic Acid|mycophenolic acid|mesh-list
24434300|NCT00262015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434302|NCT00262054|Calcium heparin|calcium heparin|mesh-list
24434303|NCT00262054|Bivalirudin|bivalirudin|mesh-list
24434304|NCT00262054|Anticoagulants|anticoagulants|mesh-ancestor
24434305|NCT00262054|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24434306|NCT00262054|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24434307|NCT00262054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434308|NCT00262054|Antithrombins|antithrombins|mesh-ancestor
24434309|NCT00262054|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24434349|NCT00262275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24434350|NCT00262275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24434351|NCT00262275|Analgesics|analgesics|mesh-ancestor
24434352|NCT00262275|Sensory System Agents|sensory system agents|mesh-ancestor
24434353|NCT00262275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24434354|NCT00262275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434355|NCT00262275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24434356|NCT00262275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24434357|NCT00262275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25697005|NCT02069704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24434358|NCT00262275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24434359|NCT00262275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460311|NCT00348101|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24460312|NCT00348101|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24460314|NCT00348101|Protective Agents|protective agents|mesh-ancestor
24460315|NCT00348153|Adalimumab|adalimumab|mesh-list
24420483|NCT00216151|Zoledronic Acid|zoledronic acid|mesh-list
24434366|NCT00262275|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24434368|NCT00262275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24434369|NCT00262288|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
24531971|NCT00637715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24669378|NCT04058717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24434370|NCT00262288|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24434371|NCT00262288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24434372|NCT00262288|Immunologic Factors|immunologic factors|mesh-ancestor
24434408|NCT00262405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434409|NCT00262405|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24434410|NCT00262405|Hormone Antagonists|hormone antagonists|mesh-ancestor
24434412|NCT00262418|Permethrin|permethrin|mesh-list
24434500|NCT00262483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24434502|NCT00262548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24434503|NCT00262548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24434504|NCT00262548|Antimetabolites|antimetabolites|mesh-ancestor
24434505|NCT00262548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434506|NCT00262548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24434507|NCT00262548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24434508|NCT00262548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434560|NCT00262808|Fluorouracil|fluorouracil|mesh-list
24434561|NCT00262808|Oxaliplatin|oxaliplatin|mesh-list
24434563|NCT00262808|Sargramostim|sargramostim|mesh-list
24434644|NCT00263068|Dopamine Agonists|dopamine agonists|mesh-ancestor
24434645|NCT00263068|Dopamine Agents|dopamine agents|mesh-ancestor
24434646|NCT00263068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24434647|NCT00263068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434648|NCT00263068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434649|NCT00263094|Rofecoxib|rofecoxib|mesh-list
24434650|NCT00263094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24947298|NCT03930433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24947299|NCT03930433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24947301|NCT03930069|Arginine Vasopressin|arginine vasopressin|mesh-list
24947302|NCT03930069|Misoprostol|misoprostol|mesh-list
24947303|NCT03930069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24947304|NCT03930069|Abortifacient Agents|abortifacient agents|mesh-ancestor
24947305|NCT03930069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24801499|NCT01983761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24801500|NCT01983761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24801501|NCT01983761|Alkylating Agents|alkylating agents|mesh-ancestor
24434651|NCT00263094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24434652|NCT00263094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434653|NCT00263094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434654|NCT00263094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24434655|NCT00263094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24434656|NCT00263094|Analgesics|analgesics|mesh-ancestor
24434697|NCT00263263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24434698|NCT00263263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24434699|NCT00263263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24434700|NCT00263263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24434701|NCT00263263|Antifungal Agents|antifungal agents|mesh-ancestor
24434702|NCT00263263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24434703|NCT00263263|Immunologic Factors|immunologic factors|mesh-ancestor
24434704|NCT00263263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434705|NCT00263276|Metformin|metformin|mesh-list
24434706|NCT00263276|Dapagliflozin|dapagliflozin|mesh-list
24460316|NCT00348153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24434753|NCT00263393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434754|NCT00263406|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24434755|NCT00263406|Protease Inhibitors|protease inhibitors|mesh-ancestor
24434756|NCT00263406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434766|NCT00263458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24434767|NCT00263484|Zoledronic Acid|zoledronic acid|mesh-list
24434768|NCT00263484|Thalidomide|thalidomide|mesh-list
24434769|NCT00263484|Dexamethasone|dexamethasone|mesh-list
24434842|NCT00264069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24434907|NCT00264225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24434908|NCT00264225|Antitussive Agents|antitussive agents|mesh-ancestor
24434909|NCT00264225|Respiratory System Agents|respiratory system agents|mesh-ancestor
24947306|NCT03930069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947307|NCT03930069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24435027|NCT00264719|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24435028|NCT00264719|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24435029|NCT00264719|Dopamine Agents|dopamine agents|mesh-ancestor
24435030|NCT00264719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24435031|NCT00264719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435063|NCT00264953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435064|NCT00264953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435065|NCT00264953|Tubulin Modulators|tubulin modulators|mesh-ancestor
24435066|NCT00264953|Antimitotic Agents|antimitotic agents|mesh-ancestor
24435093|NCT00265031|Bleomycin|bleomycin|mesh-list
24435094|NCT00265031|Procarbazine|procarbazine|mesh-list
24435095|NCT00265031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24435108|NCT00265031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24435109|NCT00265031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24435110|NCT00265031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24435111|NCT00265031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24435112|NCT00265031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24801512|NCT01983800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24435283|NCT00265863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435284|NCT00265863|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24435285|NCT00265863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435286|NCT00265876|Gemcitabine|gemcitabine|mesh-list
24435287|NCT00265876|Saracatinib|saracatinib|mesh-list
24435288|NCT00265876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24435289|NCT00265876|Antimetabolites|antimetabolites|mesh-ancestor
24435290|NCT00265876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435291|NCT00265876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435292|NCT00265876|Antiviral Agents|antiviral agents|mesh-ancestor
24435293|NCT00265876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24435294|NCT00265876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435295|NCT00265876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24435296|NCT00265876|Immunologic Factors|immunologic factors|mesh-ancestor
24435347|NCT00266058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24435349|NCT00266058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24435350|NCT00266058|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24435351|NCT00266058|Antimalarials|antimalarials|mesh-ancestor
24435352|NCT00266058|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24435353|NCT00266058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24435362|NCT00266097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24435363|NCT00266097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435364|NCT00266097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24435365|NCT00266097|Immunologic Factors|immunologic factors|mesh-ancestor
24435366|NCT00266097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435367|NCT00266097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24435368|NCT00266123|Sirolimus|sirolimus|mesh-list
24435369|NCT00266123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24435370|NCT00266123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24435371|NCT00266123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24435372|NCT00266123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435373|NCT00266123|Antifungal Agents|antifungal agents|mesh-ancestor
24435374|NCT00266123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24435375|NCT00266123|Immunologic Factors|immunologic factors|mesh-ancestor
24435377|NCT00266136|Cytarabine|cytarabine|mesh-list
24947312|NCT03930069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24947313|NCT03930069|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24947314|NCT03930069|Natriuretic Agents|natriuretic agents|mesh-ancestor
24947315|NCT03930212|Progesterone|progesterone|mesh-list
24947316|NCT03930212|Progestins|progestins|mesh-ancestor
24947317|NCT03930212|Hormones|hormones|mesh-ancestor
24801523|NCT01983943|Antioxidants|antioxidants|mesh-ancestor
24460320|NCT00348166|Autonomic Agents|autonomic agents|mesh-ancestor
24460321|NCT00348166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24460322|NCT00348166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460323|NCT00348166|Parasympatholytics|parasympatholytics|mesh-ancestor
24460324|NCT00348166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24460325|NCT00348166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24420860|NCT00216931|Iloprost|iloprost|mesh-list
24435536|NCT00266747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24435537|NCT00266747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24435538|NCT00266747|Adrenergic Agents|adrenergic agents|mesh-ancestor
24435609|NCT00267254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24435758|NCT00268151|Oxaliplatin|oxaliplatin|mesh-list
24435759|NCT00268151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24435761|NCT00268151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435762|NCT00268151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435763|NCT00268177|Fluticasone|fluticasone|mesh-list
24435764|NCT00268177|Xhance|xhance|mesh-list
24435808|NCT00268229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24460326|NCT00348166|Cholinergic Agents|cholinergic agents|mesh-ancestor
24460327|NCT00348166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24460328|NCT00348166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460329|NCT00348192|Donepezil|donepezil|mesh-list
24460330|NCT00348192|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24460331|NCT00348192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460332|NCT00348192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460333|NCT00348192|Cholinergic Agents|cholinergic agents|mesh-ancestor
24435810|NCT00268229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435811|NCT00268229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24435812|NCT00268229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435813|NCT00268229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24947318|NCT03930212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24947319|NCT03930212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947320|NCT03929861|Fluconazole|fluconazole|mesh-list
24435845|NCT00268359|Growth Substances|growth substances|mesh-ancestor
24435846|NCT00268359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435847|NCT00268359|Growth Inhibitors|growth inhibitors|mesh-ancestor
24435848|NCT00268359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24435849|NCT00268359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24435850|NCT00268359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435851|NCT00268359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435853|NCT00268372|Fluorouracil|fluorouracil|mesh-list
24435854|NCT00268372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435855|NCT00268372|Tubulin Modulators|tubulin modulators|mesh-ancestor
24435856|NCT00268372|Antimitotic Agents|antimitotic agents|mesh-ancestor
24435857|NCT00268372|Mitosis Modulators|mitosis modulators|mesh-ancestor
24435858|NCT00268372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435859|NCT00268372|Antimetabolites|antimetabolites|mesh-ancestor
24435860|NCT00268372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24435861|NCT00268372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24435862|NCT00268372|Immunologic Factors|immunologic factors|mesh-ancestor
24435863|NCT00268372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435897|NCT00268411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435898|NCT00268489|Bevacizumab|bevacizumab|mesh-list
24435899|NCT00268489|Pemetrexed|pemetrexed|mesh-list
24435900|NCT00268489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24435901|NCT00268489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435942|NCT00268528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435944|NCT00268528|Dermatologic Agents|dermatologic agents|mesh-ancestor
24435945|NCT00268528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435946|NCT00268528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24435947|NCT00268528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24435979|NCT00268593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435980|NCT00268593|Tubulin Modulators|tubulin modulators|mesh-ancestor
24420979|NCT00217451|Fosmidomycin|fosmidomycin|mesh-list
24435981|NCT00268593|Antimitotic Agents|antimitotic agents|mesh-ancestor
24435982|NCT00268593|Mitosis Modulators|mitosis modulators|mesh-ancestor
24435983|NCT00268593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435984|NCT00268593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24435985|NCT00268593|Glucocorticoids|glucocorticoids|mesh-ancestor
24435986|NCT00268593|Hormones|hormones|mesh-ancestor
24435987|NCT00268593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24435988|NCT00268593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435989|NCT00268593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24435990|NCT00268619|Ramipril|ramipril|mesh-list
24435991|NCT00268619|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24435992|NCT00268619|Protease Inhibitors|protease inhibitors|mesh-ancestor
24435993|NCT00268619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24436033|NCT00268723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24436034|NCT00268723|Autonomic Agents|autonomic agents|mesh-ancestor
24451264|NCT00322907|Sensory System Agents|sensory system agents|mesh-ancestor
24451266|NCT00322920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451267|NCT00322920|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24451268|NCT00322920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24451360|NCT00323323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24436035|NCT00268723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24669718|NCT03702725|Glucocorticoids|glucocorticoids|mesh-ancestor
24436036|NCT00268723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436037|NCT00268723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24947321|NCT03929861|Antifungal Agents|antifungal agents|mesh-ancestor
24947322|NCT03929861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24947323|NCT03929861|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24436080|NCT00268840|Immunologic Factors|immunologic factors|mesh-ancestor
24436081|NCT00268840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436194|NCT00269334|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24436195|NCT00269334|Antidepressive Agents|antidepressive agents|mesh-ancestor
24436228|NCT00269555|Phytoestrogens|phytoestrogens|mesh-ancestor
24436229|NCT00269555|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24436230|NCT00269555|Estrogens|estrogens|mesh-ancestor
24436231|NCT00269555|Hormones|hormones|mesh-ancestor
24436232|NCT00269555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24436233|NCT00269568|Misoprostol|misoprostol|mesh-list
24436234|NCT00269568|Mifepristone|mifepristone|mesh-list
24436235|NCT00269568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24436236|NCT00269568|Abortifacient Agents|abortifacient agents|mesh-ancestor
24436237|NCT00269568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24436238|NCT00269568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421065|NCT00217555|Topotecan|topotecan|mesh-list
24436263|NCT00269594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24436264|NCT00269594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24436265|NCT00269594|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24436266|NCT00269607|Naltrexone|naltrexone|mesh-list
24436267|NCT00269607|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24436268|NCT00269607|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24436269|NCT00269607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436270|NCT00269607|Sensory System Agents|sensory system agents|mesh-ancestor
24436271|NCT00269607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24436272|NCT00269620|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24436275|NCT00269620|Etonogestrel|etonogestrel|mesh-list
24436378|NCT00269815|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24436379|NCT00269815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24436380|NCT00269815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24436422|NCT00269867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24947326|NCT03929861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947327|NCT03929861|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24947328|NCT03929861|Hormone Antagonists|hormone antagonists|mesh-ancestor
24947329|NCT03929861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24947330|NCT03929861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947331|NCT03929861|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24947332|NCT03929861|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24947333|NCT03929835|Chlorophyllin|chlorophyllin|mesh-list
24947334|NCT03929835|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24947335|NCT03929835|Protective Agents|protective agents|mesh-ancestor
24436423|NCT00269867|Dermatologic Agents|dermatologic agents|mesh-ancestor
24436424|NCT00269867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24436425|NCT00269867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24436427|NCT00269880|Abciximab|abciximab|mesh-list
24436428|NCT00269880|Anticoagulants|anticoagulants|mesh-ancestor
24436429|NCT00269880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24436430|NCT00269880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24436469|NCT00270049|Hematinics|hematinics|mesh-ancestor
24436470|NCT00270062|Epoetin Alfa|epoetin alfa|mesh-list
24436471|NCT00270062|Hematinics|hematinics|mesh-ancestor
24436502|NCT00270322|Narcotics|narcotics|mesh-ancestor
25697006|NCT02069704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25697007|NCT02069704|Immunologic Factors|immunologic factors|mesh-ancestor
25697008|NCT02069704|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25697009|NCT02069704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25697010|NCT02069704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697011|NCT02069704|Antidotes|antidotes|mesh-ancestor
24436543|NCT00270413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436544|NCT00270413|Growth Inhibitors|growth inhibitors|mesh-ancestor
24436547|NCT00270413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436549|NCT00270426|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24436550|NCT00270426|Protease Inhibitors|protease inhibitors|mesh-ancestor
24436551|NCT00270426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24436552|NCT00270426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436553|NCT00270426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24947336|NCT03929835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947337|NCT03929419|Insulin|insulin|mesh-list
24947338|NCT03929419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24947339|NCT03929419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434719|NCT00263302|Hormones|hormones|mesh-ancestor
24801544|NCT01984073|Antimetabolites|antimetabolites|mesh-ancestor
24801545|NCT01984073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801546|NCT01984073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24801547|NCT01984073|Vasodilator Agents|vasodilator agents|mesh-ancestor
24801548|NCT01984073|Vitamin B Complex|vitamin b complex|mesh-ancestor
24801549|NCT01984073|Vitamins|vitamins|mesh-ancestor
24801550|NCT01984073|Micronutrients|micronutrients|mesh-ancestor
24436562|NCT00270491|Paclitaxel|paclitaxel|mesh-list
24436563|NCT00270491|Capecitabine|capecitabine|mesh-list
24436564|NCT00270491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24436565|NCT00270491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24436597|NCT00270543|Antidotes|antidotes|mesh-ancestor
24436598|NCT00270543|Protective Agents|protective agents|mesh-ancestor
24436599|NCT00270543|Vitamin B Complex|vitamin b complex|mesh-ancestor
24436600|NCT00270543|Vitamins|vitamins|mesh-ancestor
24436602|NCT00270543|Tubulin Modulators|tubulin modulators|mesh-ancestor
24436603|NCT00270543|Antimitotic Agents|antimitotic agents|mesh-ancestor
24436604|NCT00270543|Mitosis Modulators|mitosis modulators|mesh-ancestor
24436605|NCT00270556|Tenofovir|tenofovir|mesh-list
24436606|NCT00270556|Abacavir|abacavir|mesh-list
24436607|NCT00270556|Antiviral Agents|antiviral agents|mesh-ancestor
24436608|NCT00270556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24436609|NCT00270556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24436610|NCT00270556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24436611|NCT00270556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460337|NCT00348231|Insulin|insulin|mesh-list
24460338|NCT00348231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24421198|NCT00218114|GABA Agents|gaba agents|mesh-ancestor
24436714|NCT00270907|Immunologic Factors|immunologic factors|mesh-ancestor
24436716|NCT00271050|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24436717|NCT00271050|Immunologic Factors|immunologic factors|mesh-ancestor
24436718|NCT00271050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436780|NCT00271349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24436785|NCT00271349|Hormones|hormones|mesh-ancestor
24436808|NCT00271427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947354|NCT03929744|Midazolam|midazolam|mesh-list
24947355|NCT03929744|Atorvastatin|atorvastatin|mesh-list
24947356|NCT03929744|Simvastatin|simvastatin|mesh-list
24947357|NCT03929744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24532982|NCT00641927|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24436810|NCT00271427|Micronutrients|micronutrients|mesh-ancestor
24436811|NCT00271440|Chlorhexidine|chlorhexidine|mesh-list
24436812|NCT00271440|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24436813|NCT00271440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24436814|NCT00271440|Disinfectants|disinfectants|mesh-ancestor
24436815|NCT00271453|Fentanyl|fentanyl|mesh-list
24436816|NCT00271453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24436817|NCT00271453|Narcotics|narcotics|mesh-ancestor
24436818|NCT00271453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24436849|NCT00271557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697012|NCT02069704|Protective Agents|protective agents|mesh-ancestor
24436851|NCT00271583|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24436852|NCT00271583|Contraceptive Agents|contraceptive agents|mesh-ancestor
25697013|NCT02069704|Vitamin B Complex|vitamin b complex|mesh-ancestor
25697014|NCT02069704|Vitamins|vitamins|mesh-ancestor
24436853|NCT00271583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24436854|NCT00271583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436884|NCT00271804|Bortezomib|bortezomib|mesh-list
24436885|NCT00271804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24436886|NCT00271973|Oxycodone|oxycodone|mesh-list
24460339|NCT00348231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460340|NCT00348244|Prednisolone|prednisolone|mesh-list
24460341|NCT00348244|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24436887|NCT00271973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24436888|NCT00271973|Narcotics|narcotics|mesh-ancestor
24436891|NCT00271973|Analgesics|analgesics|mesh-ancestor
24436900|NCT00272025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24436901|NCT00272025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436947|NCT00272207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24436950|NCT00272285|Antiemetics|antiemetics|mesh-ancestor
24436951|NCT00272285|Autonomic Agents|autonomic agents|mesh-ancestor
24436952|NCT00272285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24436953|NCT00272285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436954|NCT00272285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24436955|NCT00272285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24436956|NCT00272285|Serotonin Agents|serotonin agents|mesh-ancestor
24436957|NCT00272285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24436958|NCT00272285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436959|NCT00272324|Aspirin|aspirin|mesh-list
24436960|NCT00272324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24436961|NCT00272324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24436962|NCT00272324|Analgesics|analgesics|mesh-ancestor
24436967|NCT00272324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24436968|NCT00272324|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24436969|NCT00272324|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24947358|NCT03929744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24532996|NCT00641979|Budesonide|budesonide|mesh-list
24947386|NCT03929094|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24947387|NCT03929094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24947388|NCT03929094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24947389|NCT03929094|Tubulin Modulators|tubulin modulators|mesh-ancestor
24947390|NCT03929094|Antimitotic Agents|antimitotic agents|mesh-ancestor
24947391|NCT03929094|Mitosis Modulators|mitosis modulators|mesh-ancestor
24947392|NCT03929094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947393|NCT03929094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24947394|NCT03929094|Antimetabolites|antimetabolites|mesh-ancestor
24947395|NCT03929094|Antiviral Agents|antiviral agents|mesh-ancestor
24801565|NCT01984086|Adrenergic Agents|adrenergic agents|mesh-ancestor
24801566|NCT01984086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24801568|NCT01984086|Antidotes|antidotes|mesh-ancestor
24436970|NCT00272324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436971|NCT00272324|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24436972|NCT00272324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24436973|NCT00272324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24436975|NCT00272415|Temozolomide|temozolomide|mesh-list
24437040|NCT00272493|Vaccines|vaccines|mesh-list
24437041|NCT00272493|Immunologic Factors|immunologic factors|mesh-ancestor
24437042|NCT00272493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437043|NCT00272558|Carboplatin|carboplatin|mesh-list
24437044|NCT00272558|Vinorelbine|vinorelbine|mesh-list
24437045|NCT00272558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460342|NCT00348244|Methylprednisolone|methylprednisolone|mesh-list
24460343|NCT00348244|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24421358|NCT00218374|Gabapentin|gabapentin|mesh-list
24437046|NCT00272558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24437048|NCT00272558|Antimitotic Agents|antimitotic agents|mesh-ancestor
24437049|NCT00272558|Mitosis Modulators|mitosis modulators|mesh-ancestor
25697015|NCT02069704|Micronutrients|micronutrients|mesh-ancestor
25697016|NCT02069704|Hematinics|hematinics|mesh-ancestor
24437050|NCT00272558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437051|NCT00272584|Risperidone|risperidone|mesh-list
24437052|NCT00272584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25697017|NCT02069847|Budesonide|budesonide|mesh-list
25697018|NCT02069847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25697019|NCT02069847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25697020|NCT02069847|Autonomic Agents|autonomic agents|mesh-ancestor
25697021|NCT02069847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25697022|NCT02069847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697023|NCT02069847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25697024|NCT02069847|Respiratory System Agents|respiratory system agents|mesh-ancestor
25697025|NCT02069847|Glucocorticoids|glucocorticoids|mesh-ancestor
25697026|NCT02069847|Hormones|hormones|mesh-ancestor
24538764|NCT00660751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24437053|NCT00272584|Serotonin Agents|serotonin agents|mesh-ancestor
24437165|NCT00272831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24437167|NCT00272831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24437168|NCT00272831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437169|NCT00272831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24437170|NCT00272831|Respiratory System Agents|respiratory system agents|mesh-ancestor
24437171|NCT00272831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24437172|NCT00272831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24437173|NCT00272831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947396|NCT03929094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24947397|NCT03929094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772731|NCT01835340|Propofol|propofol|mesh-list
24437182|NCT00272870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433960|NCT00261053|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
24437254|NCT00273065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24437255|NCT00273065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437257|NCT00273247|Interferon-alpha|interferon-alpha|mesh-list
24437258|NCT00273247|Interferon alpha-2|interferon alpha-2|mesh-list
24438559|NCT00276172|Immunologic Factors|immunologic factors|mesh-ancestor
24437259|NCT00273247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24437261|NCT00273247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24437262|NCT00273247|Immunologic Factors|immunologic factors|mesh-ancestor
24437294|NCT00273338|Micronutrients|micronutrients|mesh-ancestor
24437295|NCT00273338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24437296|NCT00273377|Dexamethasone|dexamethasone|mesh-list
24437297|NCT00273377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24437298|NCT00273377|Antiemetics|antiemetics|mesh-ancestor
24437299|NCT00273377|Autonomic Agents|autonomic agents|mesh-ancestor
24437300|NCT00273377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24437301|NCT00273377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437352|NCT00273455|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24437353|NCT00273455|Adrenergic Agents|adrenergic agents|mesh-ancestor
24437354|NCT00273455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24437355|NCT00273455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437356|NCT00273455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437357|NCT00273455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24437358|NCT00273455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24437359|NCT00273455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24437360|NCT00273455|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24437362|NCT00273468|Antiemetics|antiemetics|mesh-ancestor
24437620|NCT00274066|Tiotropium Bromide|tiotropium bromide|mesh-list
24437399|NCT00273533|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24437400|NCT00273533|Protease Inhibitors|protease inhibitors|mesh-ancestor
24437401|NCT00273533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24437402|NCT00273533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437403|NCT00273533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24437405|NCT00273546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24437406|NCT00273546|Tubulin Modulators|tubulin modulators|mesh-ancestor
24437407|NCT00273546|Antimitotic Agents|antimitotic agents|mesh-ancestor
24437408|NCT00273546|Mitosis Modulators|mitosis modulators|mesh-ancestor
24437409|NCT00273546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437411|NCT00273559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24437704|NCT00274235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24437734|NCT00274391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437735|NCT00274391|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24437736|NCT00274391|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24437737|NCT00274391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24772732|NCT01835340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25697027|NCT02069847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25697028|NCT02070237|Enoxaparin|enoxaparin|mesh-list
25697029|NCT02070237|Anticoagulants|anticoagulants|mesh-ancestor
25697030|NCT02070237|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24772733|NCT01835340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772734|NCT01835340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24437738|NCT00274391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437739|NCT00274391|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24437740|NCT00274391|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24437742|NCT00274404|Antiviral Agents|antiviral agents|mesh-ancestor
24437743|NCT00274404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24437744|NCT00274417|Dutasteride|dutasteride|mesh-list
24437745|NCT00274417|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24437746|NCT00274417|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24438044|NCT00274911|Alkylating Agents|alkylating agents|mesh-ancestor
24438045|NCT00274950|Carboplatin|carboplatin|mesh-list
24438046|NCT00274950|Etoposide|etoposide|mesh-list
24438047|NCT00274950|Ifosfamide|ifosfamide|mesh-list
24438048|NCT00274950|Bleomycin|bleomycin|mesh-list
24438049|NCT00274950|Vinblastine|vinblastine|mesh-list
24438050|NCT00274950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438051|NCT00274950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24438059|NCT00274950|Tubulin Modulators|tubulin modulators|mesh-ancestor
24438060|NCT00274950|Antimitotic Agents|antimitotic agents|mesh-ancestor
24438061|NCT00274950|Mitosis Modulators|mitosis modulators|mesh-ancestor
24438062|NCT00274963|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24438063|NCT00274963|Mitoxantrone|mitoxantrone|mesh-list
24438064|NCT00274963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24438092|NCT00275015|Carmustine|carmustine|mesh-list
24438093|NCT00275015|Fludarabine|fludarabine|mesh-list
24438094|NCT00275015|Fludarabine phosphate|fludarabine phosphate|mesh-list
24438095|NCT00275015|Etoposide|etoposide|mesh-list
24438162|NCT00275093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438163|NCT00275093|Antifungal Agents|antifungal agents|mesh-ancestor
24438164|NCT00275093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24438165|NCT00275093|Immunologic Factors|immunologic factors|mesh-ancestor
24438166|NCT00275093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438168|NCT00275106|Cytarabine|cytarabine|mesh-list
24438169|NCT00275106|Dexamethasone|dexamethasone|mesh-list
24438170|NCT00275106|Prednisolone|prednisolone|mesh-list
24438171|NCT00275106|Cyclophosphamide|cyclophosphamide|mesh-list
24438172|NCT00275106|Doxorubicin|doxorubicin|mesh-list
24460355|NCT00348244|Antiemetics|antiemetics|mesh-ancestor
24460356|NCT00348244|Autonomic Agents|autonomic agents|mesh-ancestor
24438173|NCT00275106|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24544863|NCT00690560|Hormones|hormones|mesh-ancestor
24438174|NCT00275106|Methotrexate|methotrexate|mesh-list
24438175|NCT00275106|Vincristine|vincristine|mesh-list
24438176|NCT00275106|Daunorubicin|daunorubicin|mesh-list
24438177|NCT00275106|Asparaginase|asparaginase|mesh-list
24438178|NCT00275106|Mercaptopurine|mercaptopurine|mesh-list
24438179|NCT00275106|Thioguanine|thioguanine|mesh-list
24438180|NCT00275106|Levoleucovorin|levoleucovorin|mesh-list
24438181|NCT00275106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24772735|NCT01835340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24772736|NCT01835340|Anesthetics, General|anesthetics, general|mesh-ancestor
24772737|NCT01835353|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24438182|NCT00275106|Immunologic Factors|immunologic factors|mesh-ancestor
24438183|NCT00275106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438184|NCT00275106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24438185|NCT00275106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24438531|NCT00276081|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24438532|NCT00276081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24438533|NCT00276081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438535|NCT00276081|Hormones|hormones|mesh-ancestor
24438536|NCT00276081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24438537|NCT00276107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24438538|NCT00276107|Immunologic Factors|immunologic factors|mesh-ancestor
24438539|NCT00276107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438540|NCT00276133|Atorvastatin|atorvastatin|mesh-list
24438541|NCT00276133|Probucol|probucol|mesh-list
24438593|NCT00276315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438595|NCT00276315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24438596|NCT00276315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438598|NCT00276315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24438599|NCT00276393|Insulin|insulin|mesh-list
24438600|NCT00276393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24438601|NCT00276393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438602|NCT00276445|Beta-1,3-glucan|beta-1,3-glucan|mesh-list
24438603|NCT00276445|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24772740|NCT01835418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24772747|NCT01835561|Thalidomide|thalidomide|mesh-list
24947401|NCT03929211|Hydroxychloroquine|hydroxychloroquine|mesh-list
24947402|NCT03929211|Antimalarials|antimalarials|mesh-ancestor
24947403|NCT03929211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24947404|NCT03929211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24947405|NCT03929211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24947406|NCT03929211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24947407|NCT03929211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947408|NCT03929211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24801587|NCT01984099|Immunologic Factors|immunologic factors|mesh-ancestor
24801606|NCT01984255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438762|NCT00276731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438773|NCT00276757|Prednisolone|prednisolone|mesh-list
24438781|NCT00276757|Abortifacient Agents|abortifacient agents|mesh-ancestor
24438782|NCT00276757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24438783|NCT00276757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24438784|NCT00276757|Antimetabolites|antimetabolites|mesh-ancestor
24438785|NCT00276757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438786|NCT00276757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438787|NCT00276757|Dermatologic Agents|dermatologic agents|mesh-ancestor
24438788|NCT00276757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438789|NCT00276757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24438790|NCT00276757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24438791|NCT00276757|Immunologic Factors|immunologic factors|mesh-ancestor
24438792|NCT00276757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24438793|NCT00276757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24438799|NCT00276757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24438800|NCT00276757|Glucocorticoids|glucocorticoids|mesh-ancestor
24947410|NCT03928496|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24947411|NCT03928496|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24947412|NCT03928496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24947413|NCT03928496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438801|NCT00276757|Hormones|hormones|mesh-ancestor
24438802|NCT00276757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24438803|NCT00276757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24438804|NCT00276757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24438805|NCT00276757|Tubulin Modulators|tubulin modulators|mesh-ancestor
24438806|NCT00276757|Antimitotic Agents|antimitotic agents|mesh-ancestor
24438807|NCT00276757|Mitosis Modulators|mitosis modulators|mesh-ancestor
24438808|NCT00276770|Fluorides|fluorides|mesh-list
24438809|NCT00276770|Cariostatic Agents|cariostatic agents|mesh-ancestor
24438894|NCT00276848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438895|NCT00276848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24438896|NCT00276848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24438897|NCT00276848|Alkylating Agents|alkylating agents|mesh-ancestor
24438898|NCT00276848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438899|NCT00276848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438900|NCT00276848|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24438901|NCT00276848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25697031|NCT02070237|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25697032|NCT02070237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538821|NCT00660894|Levoleucovorin|levoleucovorin|mesh-list
24438902|NCT00276848|Antimetabolites|antimetabolites|mesh-ancestor
24438903|NCT00276848|Antiviral Agents|antiviral agents|mesh-ancestor
24438904|NCT00276848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24438905|NCT00276874|Aripiprazole|aripiprazole|mesh-list
24438906|NCT00276874|Antidepressive Agents|antidepressive agents|mesh-ancestor
24438907|NCT00276874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24438908|NCT00276874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24438909|NCT00276874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24438910|NCT00276874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24438911|NCT00276874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438913|NCT00276874|Dopamine Agents|dopamine agents|mesh-ancestor
24438914|NCT00276874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24438915|NCT00276874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438918|NCT00276874|Serotonin Agents|serotonin agents|mesh-ancestor
24438935|NCT00276926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24438936|NCT00276926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438951|NCT00276965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24438952|NCT00276965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24947414|NCT03928496|Cholinergic Agents|cholinergic agents|mesh-ancestor
24947415|NCT03928496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24947416|NCT03928496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947417|NCT03928496|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24947418|NCT03928496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24947419|NCT03928691|Magnesium Sulfate|magnesium sulfate|mesh-list
24947420|NCT03928691|Analgesics|analgesics|mesh-ancestor
24947421|NCT03928691|Sensory System Agents|sensory system agents|mesh-ancestor
24947422|NCT03928691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24801620|NCT01984463|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24801621|NCT01984463|Anesthetics, General|anesthetics, general|mesh-ancestor
24801622|NCT01984463|Anesthetics|anesthetics|mesh-ancestor
24460375|NCT00348296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460376|NCT00348322|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24460377|NCT00348322|Lubricant Eye Drops|lubricant eye drops|mesh-list
24439028|NCT00277199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439029|NCT00277199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24439030|NCT00277199|Immunologic Factors|immunologic factors|mesh-ancestor
24439031|NCT00277199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439032|NCT00277199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24439033|NCT00277225|Abatacept|abatacept|mesh-list
24439034|NCT00277225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24439040|NCT00277225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24439041|NCT00277251|Alendronate|alendronate|mesh-list
24947423|NCT03928691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947424|NCT03928691|Anesthetics|anesthetics|mesh-ancestor
24439042|NCT00277251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24439043|NCT00277251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439044|NCT00277264|Tiotropium Bromide|tiotropium bromide|mesh-list
24670297|NCT03101748|Alkylating Agents|alkylating agents|mesh-ancestor
24439045|NCT00277264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24439046|NCT00277264|Autonomic Agents|autonomic agents|mesh-ancestor
24439047|NCT00277264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24439048|NCT00277264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439068|NCT00277472|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24439069|NCT00277472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24439070|NCT00277498|Timolol|timolol|mesh-list
24439071|NCT00277498|Latanoprost|latanoprost|mesh-list
24439075|NCT00277498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25697033|NCT02070302|Botulinum Toxins|botulinum toxins|mesh-list
25697034|NCT02070302|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24439076|NCT00277498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439077|NCT00277498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697035|NCT02070302|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25697036|NCT02070302|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25697037|NCT02070302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24439078|NCT00277498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24439079|NCT00277498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24439080|NCT00277498|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24439081|NCT00277498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24439082|NCT00277511|Levofloxacin|levofloxacin|mesh-list
24439083|NCT00277511|Ofloxacin|ofloxacin|mesh-list
24439084|NCT00277511|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24439085|NCT00277511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24439086|NCT00277511|Renal Agents|renal agents|mesh-ancestor
24439087|NCT00277511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24439088|NCT00277511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24439089|NCT00277511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24439090|NCT00277511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24439091|NCT00277511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439095|NCT00277537|Mannitol|mannitol|mesh-list
24439145|NCT00277667|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24439146|NCT00277667|Antidepressive Agents|antidepressive agents|mesh-ancestor
24439147|NCT00277667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24439148|NCT00277667|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24439149|NCT00277667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24439150|NCT00277667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24670298|NCT03101748|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24439151|NCT00277667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439152|NCT00277693|Spironolactone|spironolactone|mesh-list
24439153|NCT00277693|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24439154|NCT00277693|Hormone Antagonists|hormone antagonists|mesh-ancestor
24439155|NCT00277693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24439836|NCT00280501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24439837|NCT00280501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439244|NCT00278187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439245|NCT00278187|Growth Inhibitors|growth inhibitors|mesh-ancestor
24439246|NCT00278213|Cyclophosphamide|cyclophosphamide|mesh-list
24439275|NCT00278252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439277|NCT00278265|Methotrexate|methotrexate|mesh-list
24439278|NCT00278265|Fludarabine phosphate|fludarabine phosphate|mesh-list
24439279|NCT00278265|Fludarabine|fludarabine|mesh-list
24439280|NCT00278265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24439281|NCT00278265|Abortifacient Agents|abortifacient agents|mesh-ancestor
24439282|NCT00278265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24439283|NCT00278265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439284|NCT00278265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24439285|NCT00278265|Antimetabolites|antimetabolites|mesh-ancestor
24439322|NCT00278278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24439323|NCT00278278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24439348|NCT00278369|Denileukin diftitox|denileukin diftitox|mesh-list
24439349|NCT00278369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439350|NCT00278369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24439352|NCT00278369|Sensory System Agents|sensory system agents|mesh-ancestor
24947425|NCT03928691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24439353|NCT00278369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24439354|NCT00278369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439355|NCT00278369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24439356|NCT00278369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24439357|NCT00278369|Antiviral Agents|antiviral agents|mesh-ancestor
24439358|NCT00278369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24439359|NCT00278382|Sorafenib|sorafenib|mesh-list
24439360|NCT00278382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439361|NCT00278382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24439364|NCT00278408|Prednisone|prednisone|mesh-list
24439405|NCT00278421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439424|NCT00278434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439426|NCT00278460|Docetaxel|docetaxel|mesh-list
24439429|NCT00278460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439430|NCT00278460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439431|NCT00278460|Antiviral Agents|antiviral agents|mesh-ancestor
24439432|NCT00278460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24439433|NCT00278460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460382|NCT00348335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439434|NCT00278460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24439435|NCT00278460|Immunologic Factors|immunologic factors|mesh-ancestor
24439436|NCT00278460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439437|NCT00278460|Tubulin Modulators|tubulin modulators|mesh-ancestor
24439438|NCT00278460|Antimitotic Agents|antimitotic agents|mesh-ancestor
24439439|NCT00278460|Mitosis Modulators|mitosis modulators|mesh-ancestor
24439440|NCT00278694|Oxaliplatin|oxaliplatin|mesh-list
24439441|NCT00278694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439442|NCT00278772|Valproic Acid|valproic acid|mesh-list
24439443|NCT00278772|Anticonvulsants|anticonvulsants|mesh-ancestor
24439444|NCT00278772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24439445|NCT00278772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439447|NCT00278772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24439448|NCT00278772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439449|NCT00278772|Antimanic Agents|antimanic agents|mesh-ancestor
24439450|NCT00278772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24439452|NCT00278772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24439503|NCT00279084|Sensory System Agents|sensory system agents|mesh-ancestor
24439504|NCT00279084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24947426|NCT03928691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24947427|NCT03928691|Anticonvulsants|anticonvulsants|mesh-ancestor
24947428|NCT03928691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24947429|NCT03928691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24947430|NCT03928691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439568|NCT00279435|Immunologic Factors|immunologic factors|mesh-ancestor
24439569|NCT00279435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439571|NCT00279448|Exemestane|exemestane|mesh-list
24439572|NCT00279448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24439573|NCT00279448|Hormone Antagonists|hormone antagonists|mesh-ancestor
24439598|NCT00279487|Anticonvulsants|anticonvulsants|mesh-ancestor
24439606|NCT00279487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439608|NCT00279539|Mitogens|mitogens|mesh-list
24439609|NCT00279539|Endothelial Growth Factors|endothelial growth factors|mesh-list
24439610|NCT00279539|Mitosis Modulators|mitosis modulators|mesh-ancestor
24439611|NCT00279539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439612|NCT00279539|Growth Substances|growth substances|mesh-ancestor
24439613|NCT00279539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439615|NCT00279565|Ribavirin|ribavirin|mesh-list
24439616|NCT00279565|Interferon-alpha|interferon-alpha|mesh-list
24439617|NCT00279565|Interferon alpha-2|interferon alpha-2|mesh-list
24439639|NCT00279578|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24439640|NCT00279578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24439641|NCT00279578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439642|NCT00279578|Hemostatics|hemostatics|mesh-ancestor
24439643|NCT00279578|Coagulants|coagulants|mesh-ancestor
24439644|NCT00279617|Levetiracetam|levetiracetam|mesh-list
24439645|NCT00279617|Anticonvulsants|anticonvulsants|mesh-ancestor
24947431|NCT03928691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24947433|NCT03928691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24947434|NCT03928340|Metformin|metformin|mesh-list
24947435|NCT03928340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24439646|NCT00279617|Nootropic Agents|nootropic agents|mesh-ancestor
24439647|NCT00279734|Abatacept|abatacept|mesh-list
24439648|NCT00279734|Vaccines|vaccines|mesh-list
24439649|NCT00279734|Immunologic Factors|immunologic factors|mesh-ancestor
24439650|NCT00279734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460388|NCT00348335|Dermatologic Agents|dermatologic agents|mesh-ancestor
24439660|NCT00279747|Analgesics|analgesics|mesh-ancestor
24439661|NCT00279747|Sensory System Agents|sensory system agents|mesh-ancestor
24439662|NCT00279747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24439663|NCT00279747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439664|NCT00279747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24439665|NCT00279747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24439666|NCT00279747|Gout Suppressants|gout suppressants|mesh-ancestor
24439667|NCT00279747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24439668|NCT00279747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24439669|NCT00279747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439670|NCT00279747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24439671|NCT00279760|Abatacept|abatacept|mesh-list
24439672|NCT00279760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24439707|NCT00280007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24439708|NCT00280007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439709|NCT00280007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24439710|NCT00280007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24439711|NCT00280007|Growth Substances|growth substances|mesh-ancestor
24439712|NCT00280007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439713|NCT00280007|Growth Inhibitors|growth inhibitors|mesh-ancestor
24439714|NCT00280033|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24439764|NCT00280280|GABA Agonists|gaba agonists|mesh-ancestor
24439765|NCT00280280|GABA Agents|gaba agents|mesh-ancestor
24439766|NCT00280280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24439767|NCT00280280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439778|NCT00280358|Dermatologic Agents|dermatologic agents|mesh-ancestor
24439779|NCT00280358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24439780|NCT00280358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24439844|NCT00280514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24439845|NCT00280514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24439846|NCT00280514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439847|NCT00280514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439849|NCT00280540|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24439850|NCT00280540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24947436|NCT03928340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947437|NCT03928353|Ticagrelor|ticagrelor|mesh-list
24947438|NCT03928353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24947439|NCT03928353|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24947440|NCT03928353|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24947441|NCT03928353|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24947442|NCT03928353|Purinergic Agents|purinergic agents|mesh-ancestor
24947443|NCT03928353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24557596|NCT00753051|GABA Agents|gaba agents|mesh-ancestor
24439932|NCT00280878|Antimitotic Agents|antimitotic agents|mesh-ancestor
24439933|NCT00280878|Mitosis Modulators|mitosis modulators|mesh-ancestor
24439934|NCT00280878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24439935|NCT00280878|Alkylating Agents|alkylating agents|mesh-ancestor
24439937|NCT00280930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440082|NCT00281619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24440083|NCT00281619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24440084|NCT00281619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460399|NCT00348361|Respiratory System Agents|respiratory system agents|mesh-ancestor
24460400|NCT00348361|Dermatologic Agents|dermatologic agents|mesh-ancestor
24947444|NCT03928353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947445|NCT03928353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440085|NCT00281619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440086|NCT00281645|Analgesics|analgesics|mesh-list
24440087|NCT00281645|Sensory System Agents|sensory system agents|mesh-ancestor
24440088|NCT00281645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24440089|NCT00281645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440124|NCT00281866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24440125|NCT00281866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440127|NCT00281892|Fludarabine|fludarabine|mesh-list
24440128|NCT00281892|Fludarabine phosphate|fludarabine phosphate|mesh-list
24440157|NCT00281905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24440158|NCT00281905|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24440159|NCT00281905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24440160|NCT00281905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24440161|NCT00281905|Tubulin Modulators|tubulin modulators|mesh-ancestor
24440162|NCT00281905|Antimitotic Agents|antimitotic agents|mesh-ancestor
24440163|NCT00281905|Mitosis Modulators|mitosis modulators|mesh-ancestor
24440164|NCT00281931|Cyclophosphamide|cyclophosphamide|mesh-list
24440215|NCT00281983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24440216|NCT00281983|Immunologic Factors|immunologic factors|mesh-ancestor
24440246|NCT00281996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440247|NCT00281996|Antiviral Agents|antiviral agents|mesh-ancestor
24440248|NCT00281996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24440249|NCT00281996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24440252|NCT00281996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440253|NCT00281996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24440254|NCT00282061|Melatonin|melatonin|mesh-list
24440255|NCT00282061|Antioxidants|antioxidants|mesh-ancestor
24440256|NCT00282061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456630|NCT00331825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24440276|NCT00282139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24440277|NCT00282139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440278|NCT00282139|Dopamine Agonists|dopamine agonists|mesh-ancestor
24440279|NCT00282139|Dopamine Agents|dopamine agents|mesh-ancestor
25007504|NCT03447262|Ivacaftor|ivacaftor|mesh-list
25697038|NCT02070302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697039|NCT02070302|Cholinergic Agents|cholinergic agents|mesh-ancestor
25697040|NCT02070302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25697041|NCT02070302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697042|NCT02070302|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25697043|NCT02070302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25697044|NCT02070692|Tamoxifen|tamoxifen|mesh-list
25697045|NCT02070692|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25697046|NCT02070692|Hormone Antagonists|hormone antagonists|mesh-ancestor
25697047|NCT02070692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25697048|NCT02070692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440281|NCT00282139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440282|NCT00282139|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24440283|NCT00282139|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24440284|NCT00282139|Serotonin Agents|serotonin agents|mesh-ancestor
24440285|NCT00282139|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24440286|NCT00282139|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24440287|NCT00282139|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24440288|NCT00282139|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24440289|NCT00282165|Naratriptan|naratriptan|mesh-list
24440290|NCT00282165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24440291|NCT00282165|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24440292|NCT00282165|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24440293|NCT00282165|Serotonin Agents|serotonin agents|mesh-ancestor
24440294|NCT00282165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24440296|NCT00282165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440297|NCT00282178|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24440324|NCT00282386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24440326|NCT00282386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24440327|NCT00282386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24440328|NCT00282386|Analgesics|analgesics|mesh-ancestor
24440329|NCT00282386|Sensory System Agents|sensory system agents|mesh-ancestor
24440330|NCT00282386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24440331|NCT00282386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24440333|NCT00282399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24440334|NCT00282399|Antimetabolites|antimetabolites|mesh-ancestor
24440335|NCT00282399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440336|NCT00282399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440337|NCT00282399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24440338|NCT00282451|Insulin|insulin|mesh-list
24440339|NCT00282451|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24440377|NCT00282698|Insulin|insulin|mesh-list
24440431|NCT00283036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007521|NCT03342196|Fludarabine|fludarabine|mesh-list
24440488|NCT00283309|Protective Agents|protective agents|mesh-ancestor
24440490|NCT00283335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24440491|NCT00283335|Antimetabolites|antimetabolites|mesh-ancestor
24947461|NCT03928145|Amiloride|amiloride|mesh-list
24947462|NCT03928145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24947463|NCT03928145|Diuretics|diuretics|mesh-ancestor
24456633|NCT00331838|Enoxaparin|enoxaparin|mesh-list
24456634|NCT00331838|Semuloparin|semuloparin|mesh-list
24456635|NCT00331838|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24456636|NCT00331838|Enoxaparin sodium|enoxaparin sodium|mesh-list
24456637|NCT00331838|Anticoagulants|anticoagulants|mesh-ancestor
24456639|NCT00331838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24947464|NCT03928145|Natriuretic Agents|natriuretic agents|mesh-ancestor
24947465|NCT03928145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947466|NCT03928145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24947467|NCT03928145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24947468|NCT03928145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947469|NCT03928145|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24801639|NCT01984606|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24801640|NCT01984606|Protease Inhibitors|protease inhibitors|mesh-ancestor
25697050|NCT02070692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25697051|NCT02070692|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25697052|NCT02070692|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25697053|NCT02070692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25697054|NCT02070744|Ivacaftor|ivacaftor|mesh-list
25697055|NCT02070744|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25697056|NCT02070744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24440551|NCT00283660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440553|NCT00283699|Anthelmintics|anthelmintics|mesh-ancestor
24440554|NCT00283699|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24440555|NCT00283699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24440556|NCT00283699|Anticestodal Agents|anticestodal agents|mesh-ancestor
24440557|NCT00283699|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24440558|NCT00283699|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24440665|NCT00284258|Irinotecan|irinotecan|mesh-list
24440671|NCT00284271|Prednisone|prednisone|mesh-list
24440673|NCT00284271|Vincristine|vincristine|mesh-list
24440674|NCT00284271|Bleomycin|bleomycin|mesh-list
24440675|NCT00284271|Epoetin Alfa|epoetin alfa|mesh-list
24440676|NCT00284271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24440677|NCT00284271|Immunologic Factors|immunologic factors|mesh-ancestor
24440678|NCT00284271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440679|NCT00284271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24440680|NCT00284271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24440681|NCT00284271|Alkylating Agents|alkylating agents|mesh-ancestor
24440714|NCT00284336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24440715|NCT00284336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24440716|NCT00284336|Alkylating Agents|alkylating agents|mesh-ancestor
24440717|NCT00284336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440718|NCT00284336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440719|NCT00284336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24440720|NCT00284336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24440752|NCT00284583|Sensory System Agents|sensory system agents|mesh-ancestor
24440755|NCT00284583|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24440756|NCT00284583|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24435388|NCT00266136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440757|NCT00284583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24440758|NCT00284583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460408|NCT00348400|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24460409|NCT00348400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24462855|NCT00357682|Antipyretics|antipyretics|mesh-ancestor
24947470|NCT03928145|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24947471|NCT03928145|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24947472|NCT03928145|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24947473|NCT03928262|Benralizumab|benralizumab|mesh-list
25051509|NCT00401011|Hormones|hormones|mesh-ancestor
24440759|NCT00284687|Artesunate|artesunate|mesh-list
24440760|NCT00284687|Antimalarials|antimalarials|mesh-ancestor
24440761|NCT00284687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24440762|NCT00284687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24440763|NCT00284687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24440764|NCT00284687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440765|NCT00284687|Antiviral Agents|antiviral agents|mesh-ancestor
24440802|NCT00284791|Anticonvulsants|anticonvulsants|mesh-ancestor
24440831|NCT00284947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24440832|NCT00284947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24440833|NCT00284947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24440834|NCT00284947|Protective Agents|protective agents|mesh-ancestor
24440835|NCT00284947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24440836|NCT00284947|Immunologic Factors|immunologic factors|mesh-ancestor
24440837|NCT00284973|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
24440838|NCT00284973|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24440839|NCT00284973|Immunologic Factors|immunologic factors|mesh-ancestor
24440846|NCT00285051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24440848|NCT00285051|Dermatologic Agents|dermatologic agents|mesh-ancestor
24440849|NCT00285051|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24440850|NCT00285051|Serotonin Agents|serotonin agents|mesh-ancestor
24440851|NCT00285051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24440852|NCT00285051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440853|NCT00285051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24440854|NCT00285051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24440855|NCT00285051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24440856|NCT00285051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24440868|NCT00285142|Rosiglitazone|rosiglitazone|mesh-list
24440869|NCT00285142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24440870|NCT00285142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440871|NCT00285155|Bupropion|bupropion|mesh-list
24440872|NCT00285155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24440873|NCT00285155|Antidepressive Agents|antidepressive agents|mesh-ancestor
24440874|NCT00285155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24440875|NCT00285155|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24440876|NCT00285155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24440877|NCT00285155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24440878|NCT00285155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460416|NCT00348400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460417|NCT00348400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440880|NCT00285155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24440881|NCT00285155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440882|NCT00285155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24440883|NCT00285155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24440897|NCT00285298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24947499|NCT03928210|Digoxin|digoxin|mesh-list
24947500|NCT03928210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24440898|NCT00285298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24440900|NCT00285298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440957|NCT00285389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24440958|NCT00285389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24440960|NCT00285415|Docetaxel|docetaxel|mesh-list
24441042|NCT00285805|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24441043|NCT00285805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24441044|NCT00285805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441045|NCT00285805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24441046|NCT00285805|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24441047|NCT00285805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24441048|NCT00285805|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24441138|NCT00286208|Mifepristone|mifepristone|mesh-list
24441139|NCT00286208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24441140|NCT00286208|Abortifacient Agents|abortifacient agents|mesh-ancestor
24441148|NCT00286208|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24441149|NCT00286208|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24441150|NCT00286208|Contraceptive Agents|contraceptive agents|mesh-ancestor
24441151|NCT00286208|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24441152|NCT00286208|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24441153|NCT00286208|Hormone Antagonists|hormone antagonists|mesh-ancestor
24947508|NCT03927963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24441173|NCT00286273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24441174|NCT00286273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24441175|NCT00286312|Atorvastatin|atorvastatin|mesh-list
24441176|NCT00286312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24441177|NCT00286312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24441178|NCT00286312|Antimetabolites|antimetabolites|mesh-ancestor
24441179|NCT00286312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441193|NCT00286351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24441194|NCT00286351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441196|NCT00286364|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24441197|NCT00286364|Hormones|hormones|mesh-ancestor
24441198|NCT00286364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24441199|NCT00286364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441200|NCT00286364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24441201|NCT00286364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441202|NCT00286364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441203|NCT00286364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24441204|NCT00286364|Hormone Antagonists|hormone antagonists|mesh-ancestor
24441205|NCT00286403|Fenoldopam|fenoldopam|mesh-list
24460421|NCT00348413|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24441255|NCT00286780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24441256|NCT00286780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441257|NCT00286780|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24441258|NCT00286780|Contraceptive Agents|contraceptive agents|mesh-ancestor
24441259|NCT00286780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24441327|NCT00287170|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24505759|NCT00542295|Alverine|alverine|mesh-list
24441328|NCT00287170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24441329|NCT00287170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441330|NCT00287170|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24947509|NCT03927963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24947511|NCT03927963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24947512|NCT03927963|Anesthetics, General|anesthetics, general|mesh-ancestor
24441332|NCT00287170|Micronutrients|micronutrients|mesh-ancestor
24441333|NCT00287170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24441334|NCT00287170|Antimetabolites|antimetabolites|mesh-ancestor
24441335|NCT00287170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24441336|NCT00287170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441337|NCT00287170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24441338|NCT00287170|Immunologic Factors|immunologic factors|mesh-ancestor
24441339|NCT00287170|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24441340|NCT00287170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441342|NCT00287209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24441343|NCT00287209|Vasodilator Agents|vasodilator agents|mesh-ancestor
24441344|NCT00287209|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24441345|NCT00287209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24441346|NCT00287209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441679|NCT00288002|Mitosis Modulators|mitosis modulators|mesh-ancestor
24441680|NCT00288002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24441681|NCT00288002|Antimetabolites|antimetabolites|mesh-ancestor
24441682|NCT00288002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24441803|NCT00288379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24441892|NCT00288769|Hydroxocobalamin|hydroxocobalamin|mesh-list
24441893|NCT00288769|Vitamins|vitamins|mesh-ancestor
24441894|NCT00288769|Micronutrients|micronutrients|mesh-ancestor
24441895|NCT00288769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441896|NCT00288769|Vitamin B Complex|vitamin b complex|mesh-ancestor
24441897|NCT00288769|Hematinics|hematinics|mesh-ancestor
24441898|NCT00288782|Mirtazapine|mirtazapine|mesh-list
24441899|NCT00288782|Antidepressive Agents|antidepressive agents|mesh-ancestor
24441900|NCT00288782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24442036|NCT00289588|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24442037|NCT00289588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442038|NCT00289588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442039|NCT00289601|Eptifibatide|eptifibatide|mesh-list
24442057|NCT00289835|Mitosis Modulators|mitosis modulators|mesh-ancestor
24442058|NCT00289835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442059|NCT00289861|Risperidone|risperidone|mesh-list
24442060|NCT00289861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24442061|NCT00289861|Serotonin Agents|serotonin agents|mesh-ancestor
24442062|NCT00289861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24442063|NCT00289861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442064|NCT00289861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442065|NCT00289861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24442066|NCT00289861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24442067|NCT00289861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24442068|NCT00289861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24442069|NCT00289861|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24442070|NCT00289861|Dopamine Agents|dopamine agents|mesh-ancestor
24442071|NCT00289926|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24442072|NCT00289926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24442073|NCT00289926|Immunologic Factors|immunologic factors|mesh-ancestor
24442074|NCT00289926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442075|NCT00289952|Valproic Acid|valproic acid|mesh-list
24442076|NCT00289952|Anticonvulsants|anticonvulsants|mesh-ancestor
24442118|NCT00290069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24442119|NCT00290069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442120|NCT00290069|Antifungal Agents|antifungal agents|mesh-ancestor
24442121|NCT00290082|Midazolam|midazolam|mesh-list
24442122|NCT00290082|Loxapine|loxapine|mesh-list
24442123|NCT00290082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24442124|NCT00290082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24442125|NCT00290082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24442126|NCT00290082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442127|NCT00290082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25697057|NCT02070744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697058|NCT02070757|Meropenem|meropenem|mesh-list
25697059|NCT02070757|Tazobactam|tazobactam|mesh-list
25697060|NCT02070757|Ceftolozane|ceftolozane|mesh-list
24505927|NCT00543244|Ribavirin|ribavirin|mesh-list
24442128|NCT00290082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24442129|NCT00290082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24442130|NCT00290082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24442131|NCT00290082|Anesthetics, General|anesthetics, general|mesh-ancestor
24442133|NCT00290082|GABA Modulators|gaba modulators|mesh-ancestor
24442134|NCT00290082|GABA Agents|gaba agents|mesh-ancestor
24442135|NCT00290082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24442137|NCT00290082|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24460441|NCT00348413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24460442|NCT00348413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24460443|NCT00348413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24460444|NCT00348413|Antiemetics|antiemetics|mesh-ancestor
24442139|NCT00290082|Dopamine Agents|dopamine agents|mesh-ancestor
24442140|NCT00290108|Propofol|propofol|mesh-list
24442141|NCT00290108|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24442178|NCT00290264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24442179|NCT00290264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24442181|NCT00290264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24442182|NCT00290264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442183|NCT00290264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24442184|NCT00290264|Respiratory System Agents|respiratory system agents|mesh-ancestor
24442185|NCT00290264|Glucocorticoids|glucocorticoids|mesh-ancestor
24442186|NCT00290264|Hormones|hormones|mesh-ancestor
24442197|NCT00290420|Chloroquine|chloroquine|mesh-list
24442198|NCT00290420|Amebicides|amebicides|mesh-ancestor
24442199|NCT00290420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24442216|NCT00290602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24442218|NCT00290602|Autonomic Agents|autonomic agents|mesh-ancestor
24442219|NCT00290602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24442220|NCT00290602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442221|NCT00290602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24442222|NCT00290602|Glucocorticoids|glucocorticoids|mesh-ancestor
24442224|NCT00290602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24442225|NCT00290602|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24442226|NCT00290602|Protective Agents|protective agents|mesh-ancestor
24442227|NCT00290602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24442228|NCT00290602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442229|NCT00290628|Cyclosporine|cyclosporine|mesh-list
24442230|NCT00290628|Mycophenolic Acid|mycophenolic acid|mesh-list
24442231|NCT00290628|Methylprednisolone|methylprednisolone|mesh-list
24442232|NCT00290628|Cyclophosphamide|cyclophosphamide|mesh-list
24442233|NCT00290628|Melphalan|melphalan|mesh-list
24442234|NCT00290628|Busulfan|busulfan|mesh-list
24442235|NCT00290628|Cyclosporins|cyclosporins|mesh-list
24423737|NCT00226746|Gemcitabine|gemcitabine|mesh-list
24442236|NCT00290628|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24442237|NCT00290628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24442238|NCT00290628|Immunologic Factors|immunologic factors|mesh-ancestor
24442239|NCT00290628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442240|NCT00290628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24442241|NCT00290628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24442242|NCT00290628|Alkylating Agents|alkylating agents|mesh-ancestor
24442285|NCT00290641|Dermatologic Agents|dermatologic agents|mesh-ancestor
24442286|NCT00290641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24442287|NCT00290641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24442288|NCT00290641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24442292|NCT00290667|Cyclophosphamide|cyclophosphamide|mesh-list
24442302|NCT00290667|Alkylating Agents|alkylating agents|mesh-ancestor
24442303|NCT00290667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442340|NCT00290719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442368|NCT00290823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24442369|NCT00290823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442371|NCT00290823|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24442372|NCT00290823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442373|NCT00290823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442374|NCT00290823|Anthelmintics|anthelmintics|mesh-ancestor
25697061|NCT02070757|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
25697062|NCT02070757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24442375|NCT00290823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24442376|NCT00290823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24442377|NCT00290823|Anticestodal Agents|anticestodal agents|mesh-ancestor
24442378|NCT00290823|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24442379|NCT00290823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24442380|NCT00290823|Tubulin Modulators|tubulin modulators|mesh-ancestor
24442381|NCT00290823|Antimitotic Agents|antimitotic agents|mesh-ancestor
24442382|NCT00290823|Mitosis Modulators|mitosis modulators|mesh-ancestor
24442385|NCT00290836|Hemostatics|hemostatics|mesh-ancestor
24442454|NCT00291109|Hormone Antagonists|hormone antagonists|mesh-ancestor
24442455|NCT00291109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24442456|NCT00291109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442458|NCT00291122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24460446|NCT00348413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24442468|NCT00291122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442494|NCT00291213|Levetiracetam|levetiracetam|mesh-list
24442495|NCT00291213|Anticonvulsants|anticonvulsants|mesh-ancestor
24442496|NCT00291213|Nootropic Agents|nootropic agents|mesh-ancestor
24442497|NCT00291369|Interferons|interferons|mesh-list
24442498|NCT00291369|Interferon-alpha|interferon-alpha|mesh-list
24442499|NCT00291369|Interleukin-2|interleukin-2|mesh-list
24442501|NCT00291369|Medroxyprogesterone|medroxyprogesterone|mesh-list
24442511|NCT00291369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24442512|NCT00291369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24442513|NCT00291369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24442537|NCT00291382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442539|NCT00291408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24442540|NCT00291408|Autonomic Agents|autonomic agents|mesh-ancestor
24442541|NCT00291408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24442542|NCT00291408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442543|NCT00291408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24442544|NCT00291408|Respiratory System Agents|respiratory system agents|mesh-ancestor
24442545|NCT00291408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24947520|NCT03927963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24442547|NCT00291408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442548|NCT00291408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24442549|NCT00291408|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24442550|NCT00291408|Vasodilator Agents|vasodilator agents|mesh-ancestor
24442551|NCT00291408|Gasotransmitters|gasotransmitters|mesh-ancestor
24442552|NCT00291408|Protective Agents|protective agents|mesh-ancestor
24442553|NCT00291538|Bortezomib|bortezomib|mesh-list
24442554|NCT00291538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442555|NCT00291616|Interferons|interferons|mesh-list
24442556|NCT00291616|Interferon-alpha|interferon-alpha|mesh-list
24442557|NCT00291616|Interferon alpha-2|interferon alpha-2|mesh-list
24442559|NCT00291616|Thymalfasin|thymalfasin|mesh-list
24442601|NCT00291759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24947535|NCT03928093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24947536|NCT03928093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24947537|NCT03928093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24947538|NCT03927807|Misoprostol|misoprostol|mesh-list
24442743|NCT00292409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24442744|NCT00292409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24442745|NCT00292409|Serotonin Agents|serotonin agents|mesh-ancestor
24442746|NCT00292409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24455697|NCT00328718|Montelukast|montelukast|mesh-list
25697063|NCT02070757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25697064|NCT02070757|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25697065|NCT02070757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697066|NCT02070757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697067|NCT02070757|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25697068|NCT02070757|Renal Agents|renal agents|mesh-ancestor
25697069|NCT02070991|Macitentan|macitentan|mesh-list
25697070|NCT02070991|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25697071|NCT02070991|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25697072|NCT02070991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442985|NCT00293410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24917424|NCT04230070|Levonorgestrel|levonorgestrel|mesh-list
24442986|NCT00293410|Immunologic Factors|immunologic factors|mesh-ancestor
24442987|NCT00293410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442988|NCT00293410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24455835|NCT00329147|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24947586|NCT03927118|Dexamethasone|dexamethasone|mesh-list
24947587|NCT03927118|Dexamethasone acetate|dexamethasone acetate|mesh-list
25697073|NCT02070991|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25697074|NCT02071082|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25697075|NCT02071082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25697076|NCT02071082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25697077|NCT02071082|Antiviral Agents|antiviral agents|mesh-ancestor
25697078|NCT02071082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24947589|NCT03927118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24452824|NCT05420402|Propofol|propofol|mesh-list
24947591|NCT03927118|Autonomic Agents|autonomic agents|mesh-ancestor
24947592|NCT03927118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24947593|NCT03927118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443022|NCT00293475|Immunologic Factors|immunologic factors|mesh-ancestor
24443023|NCT00293475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443024|NCT00293475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24443025|NCT00293475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24443026|NCT00293475|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24462859|NCT00357708|Decitabine|decitabine|mesh-list
25697079|NCT02071095|Poly I-C|poly i-c|mesh-list
25697080|NCT02071095|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25697081|NCT02071095|Poly ICLC|poly iclc|mesh-list
25697082|NCT02071095|Interferon Inducers|interferon inducers|mesh-ancestor
25697083|NCT02071095|Immunologic Factors|immunologic factors|mesh-ancestor
25697084|NCT02071095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697085|NCT02071095|Laxatives|laxatives|mesh-ancestor
25697086|NCT02071095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24947621|NCT03927313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24947622|NCT03927313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773029|NCT01837329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24773030|NCT01837329|Growth Substances|growth substances|mesh-ancestor
24773031|NCT01837329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773032|NCT01837329|Growth Inhibitors|growth inhibitors|mesh-ancestor
24773033|NCT01837329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626089|NCT01085617|Mercaptopurine|mercaptopurine|mesh-list
24626090|NCT01085617|Pegaspargase|pegaspargase|mesh-list
24626101|NCT01085617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24626102|NCT01085617|Abortifacient Agents|abortifacient agents|mesh-ancestor
24443073|NCT00293592|Hormones|hormones|mesh-ancestor
24626107|NCT01085617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626108|NCT01085617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24626109|NCT01085617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24626110|NCT01085617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24626111|NCT01085617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24626112|NCT01085617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24443063|NCT00293527|Immunologic Factors|immunologic factors|mesh-ancestor
24443064|NCT00293527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443065|NCT00293592|Dexamethasone|dexamethasone|mesh-list
24443066|NCT00293592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24443067|NCT00293592|Antiemetics|antiemetics|mesh-ancestor
24443068|NCT00293592|Autonomic Agents|autonomic agents|mesh-ancestor
24443069|NCT00293592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24443070|NCT00293592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443071|NCT00293592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24443072|NCT00293592|Glucocorticoids|glucocorticoids|mesh-ancestor
24443081|NCT00293631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24626117|NCT01085617|Mitosis Modulators|mitosis modulators|mesh-ancestor
24443098|NCT00293644|Histamine Antagonists|histamine antagonists|mesh-ancestor
24443099|NCT00293644|Histamine Agents|histamine agents|mesh-ancestor
24443100|NCT00293644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24443101|NCT00293644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443102|NCT00293657|Lornoxicam|lornoxicam|mesh-list
24443103|NCT00293657|Piroxicam|piroxicam|mesh-list
25697087|NCT02071095|Antiviral Agents|antiviral agents|mesh-ancestor
24626118|NCT01085617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24460476|NCT00348452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24460478|NCT00348452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24437649|NCT00274079|Cholinergic Agents|cholinergic agents|mesh-ancestor
24437650|NCT00274079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24641629|NCT01174524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24626126|NCT01085656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626127|NCT01085695|Rabeprazole|rabeprazole|mesh-list
24626128|NCT01085695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24626129|NCT01085695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24626130|NCT01085695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25697088|NCT02071095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25697089|NCT02071225|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25697090|NCT02071225|Obinutuzumab|obinutuzumab|mesh-list
25697091|NCT02071225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25697092|NCT02071225|Alkylating Agents|alkylating agents|mesh-ancestor
25697093|NCT02071225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697094|NCT02071225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25697095|NCT02071225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25697096|NCT02071810|Opicapone|opicapone|mesh-list
25697097|NCT02071810|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24437816|NCT00274534|Respiratory System Agents|respiratory system agents|mesh-ancestor
24437818|NCT00274534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24437819|NCT00274534|Cholinergic Agents|cholinergic agents|mesh-ancestor
24437820|NCT00274534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24437824|NCT00274534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24456161|NCT00330304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24626132|NCT01085695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460817|NCT00349583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25007740|NCT02837029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25007741|NCT02837029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007742|NCT02837029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25007743|NCT02837029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007753|NCT02740127|Dexamethasone|dexamethasone|mesh-list
25007754|NCT02740127|Clonidine|clonidine|mesh-list
25007755|NCT02740127|Epinephrine|epinephrine|mesh-list
25007756|NCT02740127|Propofol|propofol|mesh-list
25697098|NCT02071810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697099|NCT02071810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697100|NCT02071810|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25697101|NCT02071810|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25697102|NCT02071823|Opicapone|opicapone|mesh-list
25697103|NCT02071823|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25697104|NCT02071823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697105|NCT02071823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697106|NCT02071823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25697107|NCT02071823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25697108|NCT02072096|Metformin|metformin|mesh-list
25697109|NCT02072096|Insulin Glargine|insulin glargine|mesh-list
24539216|NCT00662805|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24539217|NCT00662805|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24539218|NCT00662805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24443242|NCT00294190|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24443247|NCT00294203|Epoetin Alfa|epoetin alfa|mesh-list
24443248|NCT00294203|Hematinics|hematinics|mesh-ancestor
24443249|NCT00294255|Risperidone|risperidone|mesh-list
24443250|NCT00294255|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24443251|NCT00294255|Serotonin Agents|serotonin agents|mesh-ancestor
24443252|NCT00294255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24443253|NCT00294255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443254|NCT00294255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443255|NCT00294255|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24443256|NCT00294255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24443261|NCT00294294|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24460495|NCT00348504|Vasodilator Agents|vasodilator agents|mesh-ancestor
24460496|NCT00348504|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24947664|NCT03927248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24947665|NCT03927248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24560181|NCT03336619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25697110|NCT02072096|Pioglitazone|pioglitazone|mesh-list
25697111|NCT02072096|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25697112|NCT02072096|Liraglutide|liraglutide|mesh-list
25697113|NCT02072096|Exenatide|exenatide|mesh-list
25697114|NCT02072096|Glimepiride|glimepiride|mesh-list
25697115|NCT02072096|Linagliptin|linagliptin|mesh-list
25697116|NCT02072096|Acarbose|acarbose|mesh-list
25697117|NCT02072096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25697118|NCT02072096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697119|NCT02072096|Incretins|incretins|mesh-ancestor
24536443|NCT00651300|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24443303|NCT00294463|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25051514|NCT00398879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25051515|NCT00398879|Antimetabolites|antimetabolites|mesh-ancestor
24801708|NCT01985152|Lipotropic Agents|lipotropic agents|mesh-ancestor
24438641|NCT00276588|Gemcitabine|gemcitabine|mesh-list
24460773|NCT00349453|Chelating Agents|chelating agents|mesh-ancestor
24460913|NCT00350155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443375|NCT00294606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24443376|NCT00294606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051516|NCT00398879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051517|NCT00398879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051518|NCT00397293|Topotecan|topotecan|mesh-list
25051519|NCT00397293|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24560391|NCT02726997|Paclitaxel|paclitaxel|mesh-list
25697120|NCT02072096|Hormones|hormones|mesh-ancestor
25697121|NCT02072096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25697122|NCT02072096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25697123|NCT02072096|Protease Inhibitors|protease inhibitors|mesh-ancestor
25697124|NCT02072096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697125|NCT02072096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697126|NCT02072096|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25697127|NCT02072096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24460656|NCT00349180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460658|NCT00349206|Sorafenib|sorafenib|mesh-list
24460659|NCT00349206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460660|NCT00349206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24460661|NCT00349206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460662|NCT00349206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460663|NCT00349206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24460664|NCT00349206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24460665|NCT00349206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24460666|NCT00349206|Antifungal Agents|antifungal agents|mesh-ancestor
24427252|NCT00237874|Aripiprazole|aripiprazole|mesh-list
25051521|NCT00397293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051522|NCT00397293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051523|NCT00397293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460768|NCT00349440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24460769|NCT00349440|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24460770|NCT00349453|Deferiprone|deferiprone|mesh-list
24460771|NCT00349453|Deferoxamine|deferoxamine|mesh-list
24460772|NCT00349453|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24443529|NCT00295347|Antidepressive Agents|antidepressive agents|mesh-ancestor
24443531|NCT00295347|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24443532|NCT00295347|Hormone Antagonists|hormone antagonists|mesh-ancestor
24443533|NCT00295347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24443534|NCT00295347|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24443535|NCT00295347|Diuretics|diuretics|mesh-ancestor
24443536|NCT00295347|Natriuretic Agents|natriuretic agents|mesh-ancestor
24443537|NCT00295347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24443538|NCT00295373|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24443539|NCT00295373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24443540|NCT00295373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24539327|NCT00663286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24443543|NCT00295373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25051534|NCT00396357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24460855|NCT00349674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24460856|NCT00349726|Inositol|inositol|mesh-list
24460857|NCT00349726|Vitamin B Complex|vitamin b complex|mesh-ancestor
24460858|NCT00349726|Vitamins|vitamins|mesh-ancestor
24460859|NCT00349726|Micronutrients|micronutrients|mesh-ancestor
24460860|NCT00349726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460861|NCT00349739|Anecortave|anecortave|mesh-list
24460862|NCT00349739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24460863|NCT00349739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24460864|NCT00349739|Growth Substances|growth substances|mesh-ancestor
24460869|NCT00349791|Androgens|androgens|mesh-ancestor
25697130|NCT02072096|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24660090|NCT01281748|Hormones|hormones|mesh-ancestor
25697131|NCT02072200|Prednisone|prednisone|mesh-list
25697132|NCT02072200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24460883|NCT00350038|Antimetabolites|antimetabolites|mesh-ancestor
24460885|NCT00350051|Prednisone|prednisone|mesh-list
24460914|NCT00350155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460915|NCT00350155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24460916|NCT00350155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24460917|NCT00350155|Analgesics|analgesics|mesh-ancestor
24460918|NCT00350155|Sensory System Agents|sensory system agents|mesh-ancestor
24460919|NCT00350155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24460920|NCT00350155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460921|NCT00350155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24460922|NCT00350155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24460923|NCT00350168|Amlodipine|amlodipine|mesh-list
24460924|NCT00350168|Valsartan|valsartan|mesh-list
24460925|NCT00350168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25051543|NCT00394199|Fluticasone|fluticasone|mesh-list
25051545|NCT00394199|Formoterol Fumarate|formoterol fumarate|mesh-list
25051546|NCT00394199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25051547|NCT00394199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25051548|NCT00394199|Autonomic Agents|autonomic agents|mesh-ancestor
25051552|NCT00394199|Respiratory System Agents|respiratory system agents|mesh-ancestor
24460926|NCT00350168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25697133|NCT02072200|Glucocorticoids|glucocorticoids|mesh-ancestor
25697134|NCT02072200|Hormones|hormones|mesh-ancestor
25697135|NCT02072200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25697136|NCT02072200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697137|NCT02072200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25697138|NCT02072200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25697139|NCT02072226|Aspirin|aspirin|mesh-list
25697140|NCT02072226|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25697141|NCT02072226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24460928|NCT00350168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460929|NCT00350168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24460930|NCT00350168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460931|NCT00350168|Vasodilator Agents|vasodilator agents|mesh-ancestor
24460932|NCT00350168|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24460933|NCT00350168|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24460934|NCT00350181|Mycophenolic Acid|mycophenolic acid|mesh-list
24460935|NCT00350181|Sirolimus|sirolimus|mesh-list
24460936|NCT00350181|Cyclophosphamide|cyclophosphamide|mesh-list
24460937|NCT00350181|Busulfan|busulfan|mesh-list
24460938|NCT00350181|Carmustine|carmustine|mesh-list
25051554|NCT00394199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25051555|NCT00394199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25051556|NCT00394199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25051557|NCT00394199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25051558|NCT00394199|Adrenergic Agents|adrenergic agents|mesh-ancestor
25051559|NCT00394199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24801741|NCT01985477|Hormones|hormones|mesh-ancestor
24460953|NCT00350181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24460986|NCT00350454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24460988|NCT00350454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24460989|NCT00350454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051560|NCT00394199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051561|NCT00394121|Fluticasone|fluticasone|mesh-list
25051562|NCT00394121|Xhance|xhance|mesh-list
25051563|NCT00394121|Formoterol Fumarate|formoterol fumarate|mesh-list
25697142|NCT02072226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25697143|NCT02072226|Analgesics|analgesics|mesh-ancestor
25697144|NCT02072226|Sensory System Agents|sensory system agents|mesh-ancestor
25697145|NCT02072226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25697146|NCT02072226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697147|NCT02072226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25697148|NCT02072226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24461011|NCT00350467|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24461012|NCT00350467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24461013|NCT00350467|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24461014|NCT00350467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24461015|NCT00350467|Dopamine Agents|dopamine agents|mesh-ancestor
24461016|NCT00350480|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24443622|NCT00295542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24538268|NCT00658255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24963362|NCT03791515|Salmon calcitonin|salmon calcitonin|mesh-list
24963363|NCT03791515|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
24963364|NCT03791515|Katacalcin|katacalcin|mesh-list
24963365|NCT03791515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24963366|NCT03791515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461022|NCT00350480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461023|NCT00350480|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24443623|NCT00295542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24461060|NCT00350857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24461061|NCT00350857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24461062|NCT00350857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461063|NCT00350857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24461064|NCT00350857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24461065|NCT00350857|Analgesics|analgesics|mesh-ancestor
24461066|NCT00350857|Sensory System Agents|sensory system agents|mesh-ancestor
24461067|NCT00350857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25697149|NCT02072226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25697150|NCT02072226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25697151|NCT02072226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697152|NCT02072226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25697153|NCT02072226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25697154|NCT02072226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697156|NCT02072434|Enoxaparin|enoxaparin|mesh-list
25697157|NCT02072434|Warfarin|warfarin|mesh-list
24461069|NCT00350857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24461070|NCT00350857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461071|NCT00350857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24461072|NCT00350857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24461073|NCT00350948|Doxorubicin|doxorubicin|mesh-list
24461077|NCT00350948|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24461078|NCT00350948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24461079|NCT00350948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461080|NCT00350948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461081|NCT00350961|Gemcitabine|gemcitabine|mesh-list
24461082|NCT00350961|Capecitabine|capecitabine|mesh-list
24461083|NCT00350961|Oxaliplatin|oxaliplatin|mesh-list
24461084|NCT00350961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24461085|NCT00350961|Antimetabolites|antimetabolites|mesh-ancestor
24443624|NCT00295542|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24963368|NCT03791515|Vasodilator Agents|vasodilator agents|mesh-ancestor
24561217|NCT00759070|Ritonavir|ritonavir|mesh-list
25697158|NCT02072434|Edoxaban|edoxaban|mesh-list
25697159|NCT02072434|Anticoagulants|anticoagulants|mesh-ancestor
25697160|NCT02072434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25697161|NCT02072434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25697162|NCT02072434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697163|NCT02072434|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25697164|NCT02072434|Antithrombins|antithrombins|mesh-ancestor
25697165|NCT02072434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25697166|NCT02072434|Protease Inhibitors|protease inhibitors|mesh-ancestor
24461098|NCT00351026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461099|NCT00351026|Analgesics|analgesics|mesh-ancestor
24461100|NCT00351026|Sensory System Agents|sensory system agents|mesh-ancestor
24461101|NCT00351026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24461102|NCT00351026|Antitussive Agents|antitussive agents|mesh-ancestor
24461103|NCT00351026|Respiratory System Agents|respiratory system agents|mesh-ancestor
24461104|NCT00351052|Pimecrolimus|pimecrolimus|mesh-list
24461105|NCT00351052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24448319|NCT00311129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24461169|NCT00351169|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24461170|NCT00351169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24461171|NCT00351169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24461172|NCT00351169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461173|NCT00351169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24461174|NCT00351169|Serotonin Agents|serotonin agents|mesh-ancestor
24461175|NCT00351169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461176|NCT00351169|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24461177|NCT00351169|Antidepressive Agents|antidepressive agents|mesh-ancestor
24947668|NCT03927079|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24947669|NCT03927079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24947671|NCT03927079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24947672|NCT03927079|Antitubercular Agents|antitubercular agents|mesh-ancestor
24947673|NCT03927079|Chelating Agents|chelating agents|mesh-ancestor
24947674|NCT03927079|Sequestering Agents|sequestering agents|mesh-ancestor
24947675|NCT03927079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947676|NCT03926780|Warfarin|warfarin|mesh-list
24947677|NCT03926780|Rivaroxaban|rivaroxaban|mesh-list
24947678|NCT03926780|Anticoagulants|anticoagulants|mesh-ancestor
24947679|NCT03926780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24461184|NCT00351182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24461185|NCT00351182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24461186|NCT00351182|Antimalarials|antimalarials|mesh-ancestor
24461187|NCT00351182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24461188|NCT00351182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24461189|NCT00351195|Capecitabine|capecitabine|mesh-list
24461190|NCT00351195|Oxaliplatin|oxaliplatin|mesh-list
24461192|NCT00351195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24461193|NCT00351195|Antimetabolites|antimetabolites|mesh-ancestor
24461194|NCT00351195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461195|NCT00351195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461196|NCT00351195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24461206|NCT00351286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24461221|NCT00351403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461222|NCT00351403|Antiviral Agents|antiviral agents|mesh-ancestor
24947695|NCT03926936|Fulvestrant|fulvestrant|mesh-list
24461253|NCT00351637|Antitussive Agents|antitussive agents|mesh-ancestor
24461254|NCT00351637|Respiratory System Agents|respiratory system agents|mesh-ancestor
24461256|NCT00351663|Anticoagulants|anticoagulants|mesh-ancestor
24461257|NCT00351663|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24461258|NCT00351663|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24461259|NCT00351663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461260|NCT00351702|Isoniazid|isoniazid|mesh-list
24461261|NCT00351702|Ethambutol|ethambutol|mesh-list
24461262|NCT00351702|Antitubercular Agents|antitubercular agents|mesh-ancestor
24461263|NCT00351702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24461264|NCT00351702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24461265|NCT00351702|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24461266|NCT00351702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24461290|NCT00351871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461291|NCT00351871|Antiviral Agents|antiviral agents|mesh-ancestor
24510849|NCT00565968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24947697|NCT03926936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24947698|NCT03926936|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24947699|NCT03926936|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24461318|NCT00351910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24461319|NCT00351910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24461417|NCT00352287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24461418|NCT00352287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461476|NCT00352430|Respiratory System Agents|respiratory system agents|mesh-ancestor
24539821|NCT00665717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24550724|NCT00722033|Indomethacin|indomethacin|mesh-list
24550725|NCT00722033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24550726|NCT00722033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24550727|NCT00722033|Analgesics|analgesics|mesh-ancestor
24947700|NCT03926936|Hormone Antagonists|hormone antagonists|mesh-ancestor
24947701|NCT03926936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24947702|NCT03926936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550728|NCT00722033|Sensory System Agents|sensory system agents|mesh-ancestor
24550729|NCT00722033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24550730|NCT00722033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550731|NCT00722033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24550732|NCT00722033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24550733|NCT00722033|Gout Suppressants|gout suppressants|mesh-ancestor
24550784|NCT00722293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24550785|NCT00722293|Epirubicin|epirubicin|mesh-list
24550786|NCT00722293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24550787|NCT00722293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550788|NCT00722293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24550789|NCT00722293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24550790|NCT00722293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550791|NCT00722293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550792|NCT00722475|Immunoglobulins|immunoglobulins|mesh-list
24550793|NCT00722475|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24550794|NCT00722475|Antibodies|antibodies|mesh-list
24550795|NCT00722475|gamma-Globulins|gamma-globulins|mesh-list
24461539|NCT00352625|Ketoprofen|ketoprofen|mesh-list
24550796|NCT00722475|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24550797|NCT00722475|Immunologic Factors|immunologic factors|mesh-ancestor
24550858|NCT00722956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24550859|NCT00722956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24550860|NCT00722956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550869|NCT00722969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24550870|NCT00722969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550871|NCT00722969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550872|NCT00723047|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25697167|NCT02072434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697168|NCT02072668|Rivaroxaban|rivaroxaban|mesh-list
25697169|NCT02072668|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25697170|NCT02072668|Antithrombins|antithrombins|mesh-ancestor
25697171|NCT02072668|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25697172|NCT02072668|Protease Inhibitors|protease inhibitors|mesh-ancestor
25697173|NCT02072668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697174|NCT02072668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697175|NCT02072668|Anticoagulants|anticoagulants|mesh-ancestor
25697176|NCT02072824|Pregabalin|pregabalin|mesh-list
25697177|NCT02072824|Analgesics|analgesics|mesh-ancestor
25697178|NCT02072824|Sensory System Agents|sensory system agents|mesh-ancestor
25697179|NCT02072824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25697180|NCT02072824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550876|NCT00723060|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24550877|NCT00723060|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24441566|NCT00287820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24550879|NCT00723060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550881|NCT00723060|Serotonin Agents|serotonin agents|mesh-ancestor
24550885|NCT00723060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24550954|NCT00723385|Micronutrients|micronutrients|mesh-ancestor
24550955|NCT00723385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550956|NCT00723385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24947707|NCT03926663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24550962|NCT00723424|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
24550964|NCT00723424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24550965|NCT00723424|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24550966|NCT00723424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550967|NCT00723424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550968|NCT00723424|Protective Agents|protective agents|mesh-ancestor
24550969|NCT00723424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550970|NCT00723424|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24550971|NCT00723424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24551052|NCT00723866|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24551053|NCT00723866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24551054|NCT00723866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551055|NCT00723866|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24551056|NCT00723866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24551057|NCT00723866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947708|NCT03926663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947709|NCT03926663|Sensory System Agents|sensory system agents|mesh-ancestor
24551159|NCT00724178|Vitamins|vitamins|mesh-ancestor
24551160|NCT00724178|Micronutrients|micronutrients|mesh-ancestor
24551164|NCT00724178|Antacids|antacids|mesh-ancestor
24551469|NCT00726726|Midazolam|midazolam|mesh-list
24551470|NCT00726726|Dextromethorphan|dextromethorphan|mesh-list
24551471|NCT00726726|Caffeine|caffeine|mesh-list
24551472|NCT00726726|Omeprazole|omeprazole|mesh-list
24551473|NCT00726726|Warfarin|warfarin|mesh-list
24551474|NCT00726726|Vitamins|vitamins|mesh-ancestor
24551475|NCT00726726|Micronutrients|micronutrients|mesh-ancestor
24551476|NCT00726726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551477|NCT00726726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24551478|NCT00726726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24551479|NCT00726726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24551480|NCT00726726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24551481|NCT00726726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24551482|NCT00726726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24546457|NCT00698607|Immunologic Factors|immunologic factors|mesh-ancestor
24551483|NCT00726726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24551558|NCT05373134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24551559|NCT05373134|Antioxidants|antioxidants|mesh-ancestor
24551560|NCT05373108|Macitentan|macitentan|mesh-list
24551561|NCT05373108|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
24551562|NCT05373108|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24551563|NCT05373108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551564|NCT05373108|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
24551565|NCT05373004|Empagliflozin|empagliflozin|mesh-list
24551566|NCT05373004|Enalapril|enalapril|mesh-list
24551567|NCT05373004|Enalaprilat|enalaprilat|mesh-list
24551734|NCT05072236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24551735|NCT05072236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24947717|NCT03926663|Adrenergic Agents|adrenergic agents|mesh-ancestor
24947718|NCT03926663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24801810|NCT01985789|Autonomic Agents|autonomic agents|mesh-ancestor
24551736|NCT05072236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24551737|NCT05072236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24551738|NCT05072236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24551739|NCT05072236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442389|NCT00290836|Protease Inhibitors|protease inhibitors|mesh-ancestor
24551812|NCT04956627|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24551813|NCT04956627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24551814|NCT04956627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24551815|NCT04956627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551816|NCT04956627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24551821|NCT04956627|Anticonvulsants|anticonvulsants|mesh-ancestor
24551822|NCT04956627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24551823|NCT04956627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24551878|NCT04781972|Dopamine Agents|dopamine agents|mesh-ancestor
24551879|NCT04781972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24551928|NCT04577404|Edaravone|edaravone|mesh-list
24551929|NCT04577404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24551935|NCT04541407|Temozolomide|temozolomide|mesh-list
24551936|NCT04541407|Osimertinib|osimertinib|mesh-list
24551937|NCT04541407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24551938|NCT04541407|Alkylating Agents|alkylating agents|mesh-ancestor
24551939|NCT04541407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551971|NCT04406727|Antiviral Agents|antiviral agents|mesh-ancestor
24551972|NCT04406727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24551973|NCT04390217|Tranexamic Acid|tranexamic acid|mesh-list
24551974|NCT04390217|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24551975|NCT04390217|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24551976|NCT04390217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551977|NCT04390217|Hemostatics|hemostatics|mesh-ancestor
24551978|NCT04390217|Coagulants|coagulants|mesh-ancestor
24551979|NCT04318210|Tenofovir|tenofovir|mesh-list
24551980|NCT04318210|Emtricitabine|emtricitabine|mesh-list
24551981|NCT04318210|Antiviral Agents|antiviral agents|mesh-ancestor
24551982|NCT04318210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24551983|NCT04318210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24551984|NCT04318210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24551985|NCT04318210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24551986|NCT04318210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551988|NCT04318210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24551992|NCT04286867|Ethanol|ethanol|mesh-list
24551993|NCT04286867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24551994|NCT04286867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24551995|NCT04286867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24551996|NCT04286867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551997|NCT04261790|Ocrelizumab|ocrelizumab|mesh-list
24551998|NCT04261790|Immunologic Factors|immunologic factors|mesh-ancestor
24552025|NCT04254627|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24552026|NCT04254627|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24553768|NCT00732810|Antimetabolites|antimetabolites|mesh-ancestor
24552085|NCT04183062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24552086|NCT04183062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24552087|NCT04183062|Immunologic Factors|immunologic factors|mesh-ancestor
24552104|NCT04176419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24553978|NCT00733564|Anesthetics, General|anesthetics, general|mesh-ancestor
24552129|NCT04163952|Panitumumab|panitumumab|mesh-list
24947723|NCT03926559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24947724|NCT03926559|Narcotics|narcotics|mesh-ancestor
24947725|NCT03926559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24947758|NCT03926000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24552131|NCT04163952|Antibodies|antibodies|mesh-list
24552186|NCT04098003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24552187|NCT04098003|Antimetabolites|antimetabolites|mesh-ancestor
24552188|NCT04098003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461899|NCT00354302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552199|NCT04042935|Micronutrients|micronutrients|mesh-ancestor
24552209|NCT03958565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24552210|NCT03958565|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24552211|NCT03958565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552215|NCT03924804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24552216|NCT03900793|Sunitinib|sunitinib|mesh-list
24552217|NCT03900793|Losartan|losartan|mesh-list
24552218|NCT03900793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552219|NCT03900793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24552220|NCT03900793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24552221|NCT03900793|Growth Substances|growth substances|mesh-ancestor
24552222|NCT03900793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552223|NCT03900793|Growth Inhibitors|growth inhibitors|mesh-ancestor
24552224|NCT03900793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24947759|NCT03926000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24947760|NCT03926000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562312|NCT00765973|Topotecan|topotecan|mesh-list
24552225|NCT03900793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24552226|NCT03900793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444069|NCT00296686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24552227|NCT03900793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24552228|NCT03900793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24552229|NCT03900793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24552230|NCT03900793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24552231|NCT03853746|Ocrelizumab|ocrelizumab|mesh-list
24552232|NCT03853746|Immunologic Factors|immunologic factors|mesh-ancestor
24552233|NCT03853746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552267|NCT03728478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24552268|NCT03728478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24552269|NCT03728478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24552270|NCT03728478|Immunologic Factors|immunologic factors|mesh-ancestor
24552271|NCT03728478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24552280|NCT03702283|Penicillins|penicillins|mesh-list
24552283|NCT03655821|Pemetrexed|pemetrexed|mesh-list
24552309|NCT03583957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552310|NCT03583957|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24552328|NCT03512418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24552329|NCT03512418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24552330|NCT03504241|Mycophenolic Acid|mycophenolic acid|mesh-list
24552331|NCT03504241|Sirolimus|sirolimus|mesh-list
24552332|NCT03504241|Prednisone|prednisone|mesh-list
24552333|NCT03504241|Alemtuzumab|alemtuzumab|mesh-list
24947761|NCT03926000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24552334|NCT03504241|Abatacept|abatacept|mesh-list
24552335|NCT03504241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24442920|NCT00293280|Lomustine|lomustine|mesh-list
24552373|NCT03499899|Carboplatin|carboplatin|mesh-list
24552374|NCT03499899|Spartalizumab|spartalizumab|mesh-list
24552375|NCT03499899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552440|NCT03068624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552441|NCT03068624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24552442|NCT03068624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24552443|NCT03068624|Alkylating Agents|alkylating agents|mesh-ancestor
24552444|NCT03068624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552445|NCT03068624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552446|NCT03068624|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24552447|NCT03068624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24552448|NCT03068624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24552449|NCT03068624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24552450|NCT03068624|Analgesics|analgesics|mesh-ancestor
24552451|NCT03068624|Sensory System Agents|sensory system agents|mesh-ancestor
24552452|NCT03068624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24552453|NCT03068624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24552454|NCT03068624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24552455|NCT03068624|Antiviral Agents|antiviral agents|mesh-ancestor
24552532|NCT02704156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24552533|NCT02704156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24552549|NCT02688530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24552550|NCT02688530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24552602|NCT02073565|Everolimus|everolimus|mesh-list
24552603|NCT02073565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552604|NCT02073565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24552605|NCT02073565|Immunologic Factors|immunologic factors|mesh-ancestor
25697182|NCT02072824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25697183|NCT02072824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25697184|NCT02072824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697185|NCT02072824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25697186|NCT02072824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25697187|NCT02072824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25697188|NCT02072824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24552606|NCT02073565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552644|NCT01951274|Serlopitant|serlopitant|mesh-list
24939419|NCT04009759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24552970|NCT00728585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552971|NCT00728611|Hyaluronic Acid|hyaluronic acid|mesh-list
24947783|NCT03925714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24947784|NCT03925714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947785|NCT03925779|Dexmedetomidine|dexmedetomidine|mesh-list
24947786|NCT03925779|Remifentanil|remifentanil|mesh-list
24552972|NCT00728611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24552973|NCT00728611|Immunologic Factors|immunologic factors|mesh-ancestor
24552974|NCT00728611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552975|NCT00728611|Viscosupplements|viscosupplements|mesh-ancestor
24552976|NCT00728611|Protective Agents|protective agents|mesh-ancestor
24552978|NCT00728663|Cetuximab|cetuximab|mesh-list
24552979|NCT00728663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552980|NCT00728663|Tubulin Modulators|tubulin modulators|mesh-ancestor
24552981|NCT00728663|Antimitotic Agents|antimitotic agents|mesh-ancestor
24552982|NCT00728663|Mitosis Modulators|mitosis modulators|mesh-ancestor
24552983|NCT00728663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552984|NCT00728663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24552985|NCT00728715|Budesonide|budesonide|mesh-list
24552986|NCT00728715|Formoterol Fumarate|formoterol fumarate|mesh-list
24552987|NCT00728715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24552988|NCT00728715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24552989|NCT00728715|Autonomic Agents|autonomic agents|mesh-ancestor
24553067|NCT00729313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24553102|NCT00729495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553103|NCT00729495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553104|NCT00729573|Tenofovir|tenofovir|mesh-list
24553105|NCT00729573|Emtricitabine|emtricitabine|mesh-list
24553106|NCT00729573|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24553107|NCT00729573|Antiviral Agents|antiviral agents|mesh-ancestor
24553108|NCT00729573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24553111|NCT00729573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553265|NCT00730093|Vitamin B Complex|vitamin b complex|mesh-ancestor
24553266|NCT00730093|Hematinics|hematinics|mesh-ancestor
24553267|NCT00730197|Albuterol|albuterol|mesh-list
24553269|NCT00730197|Autonomic Agents|autonomic agents|mesh-ancestor
24553270|NCT00730197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24553271|NCT00730197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553360|NCT00730509|Hematinics|hematinics|mesh-ancestor
24553361|NCT00730535|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24553362|NCT00730535|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24553363|NCT00730535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24553364|NCT00730535|Cholinergic Agents|cholinergic agents|mesh-ancestor
24553366|NCT00730535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553367|NCT00730535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553377|NCT00730769|Valganciclovir|valganciclovir|mesh-list
24553378|NCT00730769|Ganciclovir|ganciclovir|mesh-list
24553379|NCT00730769|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
24553380|NCT00730769|Antiviral Agents|antiviral agents|mesh-ancestor
24553381|NCT00730769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24553382|NCT00730769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24553383|NCT00730769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553384|NCT00730769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553385|NCT00730821|Nintedanib|nintedanib|mesh-list
24553386|NCT00730821|Afatinib|afatinib|mesh-list
24553422|NCT00731172|Glatiramer Acetate|glatiramer acetate|mesh-list
24553423|NCT00731172|(T,G)-A-L|(t,g)-a-l|mesh-list
24553424|NCT00731172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24553425|NCT00731172|Immunologic Factors|immunologic factors|mesh-ancestor
24553426|NCT00731172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553427|NCT00731172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24553428|NCT00731172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24553429|NCT00731224|Rivastigmine|rivastigmine|mesh-list
25697189|NCT02072824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24553430|NCT00731224|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25697190|NCT02072928|Botulinum Toxins|botulinum toxins|mesh-list
25697191|NCT02072928|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25697192|NCT02072928|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25697193|NCT02072928|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25697194|NCT02072928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25697195|NCT02072928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553431|NCT00731224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553432|NCT00731224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553433|NCT00731224|Cholinergic Agents|cholinergic agents|mesh-ancestor
24553434|NCT00731224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24553435|NCT00731224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553436|NCT00731224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24553437|NCT00731224|Protective Agents|protective agents|mesh-ancestor
24947797|NCT03925779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24947806|NCT03925740|Listerine|listerine|mesh-list
24553546|NCT00731926|Vitamin E|vitamin e|mesh-list
24553547|NCT00731926|Micronutrients|micronutrients|mesh-ancestor
24553548|NCT00731926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553569|NCT00732108|Topiramate|topiramate|mesh-list
24553570|NCT00732108|Lactulose|lactulose|mesh-list
24553571|NCT00732108|Anticonvulsants|anticonvulsants|mesh-ancestor
24553572|NCT00732108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24553573|NCT00732108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553574|NCT00732108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24553575|NCT00732121|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24553576|NCT00732121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24553577|NCT00732121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553578|NCT00732121|Incretins|incretins|mesh-ancestor
24553579|NCT00732121|Hormones|hormones|mesh-ancestor
24553580|NCT00732121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24553581|NCT00732121|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24553582|NCT00732121|Protease Inhibitors|protease inhibitors|mesh-ancestor
24462274|NCT00355628|Fentanyl|fentanyl|mesh-list
24553585|NCT00732147|Pramlintide|pramlintide|mesh-list
24553639|NCT00732446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553640|NCT00732446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24553641|NCT00732446|Glucocorticoids|glucocorticoids|mesh-ancestor
24553642|NCT00732446|Hormones|hormones|mesh-ancestor
24553648|NCT00732446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553649|NCT00732446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24553650|NCT00732446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24947814|NCT03925701|Metformin|metformin|mesh-list
24947815|NCT03925701|Vildagliptin|vildagliptin|mesh-list
24947816|NCT03925701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24947817|NCT03925701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947818|NCT03925701|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24947819|NCT03925701|Protease Inhibitors|protease inhibitors|mesh-ancestor
24947820|NCT03925701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24947821|NCT03925701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947822|NCT03925662|Mebendazole|mebendazole|mesh-list
24553651|NCT00732446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24553686|NCT00732524|Glipizide|glipizide|mesh-list
24553687|NCT00732524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24553688|NCT00732524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553689|NCT00732537|Nitric Oxide|nitric oxide|mesh-list
24553690|NCT00732537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24553691|NCT00732537|Autonomic Agents|autonomic agents|mesh-ancestor
24553692|NCT00732537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24553693|NCT00732537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553694|NCT00732537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24553695|NCT00732537|Respiratory System Agents|respiratory system agents|mesh-ancestor
24553696|NCT00732537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24553698|NCT00732537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553699|NCT00732537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24553700|NCT00732537|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24553701|NCT00732537|Vasodilator Agents|vasodilator agents|mesh-ancestor
24553704|NCT00732563|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24553705|NCT00732563|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24553706|NCT00732563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553707|NCT00732576|Vitamin K 2|vitamin k 2|mesh-list
24553708|NCT00732576|Vitamin K|vitamin k|mesh-list
24553709|NCT00732576|Vitamin MK 7|vitamin mk 7|mesh-list
24553710|NCT00732576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24553711|NCT00732576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24553712|NCT00732576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697196|NCT02072928|Cholinergic Agents|cholinergic agents|mesh-ancestor
25697197|NCT02072928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25697198|NCT02072928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050507|NCT00489203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25050508|NCT00489203|Immunologic Factors|immunologic factors|mesh-ancestor
24553717|NCT00732576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553718|NCT00732589|Lidocaine|lidocaine|mesh-list
24553719|NCT00732589|Anesthetics, Local|anesthetics, local|mesh-ancestor
24553720|NCT00732589|Anesthetics|anesthetics|mesh-ancestor
24553721|NCT00732589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24553722|NCT00732589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553723|NCT00732589|Sensory System Agents|sensory system agents|mesh-ancestor
24553724|NCT00732589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24553742|NCT00732693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24553743|NCT00732693|Progestins|progestins|mesh-ancestor
24553744|NCT00732693|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24553745|NCT00732693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24553746|NCT00732693|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24553753|NCT00732745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553754|NCT00732784|Imatinib Mesylate|imatinib mesylate|mesh-list
24553755|NCT00732784|Calcium Carbonate|calcium carbonate|mesh-list
24553757|NCT00732784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24553758|NCT00732784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553759|NCT00732784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24553760|NCT00732784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24553761|NCT00732784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553762|NCT00732784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553763|NCT00732784|Antacids|antacids|mesh-ancestor
24553764|NCT00732784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24553765|NCT00732810|Capecitabine|capecitabine|mesh-list
24553766|NCT00732810|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24553767|NCT00732810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24553769|NCT00732810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553770|NCT00732810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24553771|NCT00732810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24553772|NCT00732810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553773|NCT00732836|Paclitaxel|paclitaxel|mesh-list
24553774|NCT00732836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24553775|NCT00732836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24553776|NCT00732836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24553777|NCT00732836|Tubulin Modulators|tubulin modulators|mesh-ancestor
24553778|NCT00732836|Antimitotic Agents|antimitotic agents|mesh-ancestor
24553779|NCT00732836|Mitosis Modulators|mitosis modulators|mesh-ancestor
24553780|NCT00732836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553781|NCT00732888|Calcium Carbonate|calcium carbonate|mesh-list
24553782|NCT00732888|Calcium|calcium|mesh-list
24553784|NCT00732888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553785|NCT00732888|Antacids|antacids|mesh-ancestor
24553786|NCT00732888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553787|NCT00732888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24553788|NCT00732914|Sorafenib|sorafenib|mesh-list
24553789|NCT00732914|Sunitinib|sunitinib|mesh-list
24553790|NCT00732914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24553791|NCT00732914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24553792|NCT00732914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553796|NCT00732914|Growth Substances|growth substances|mesh-ancestor
24553797|NCT00732914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553798|NCT00732914|Growth Inhibitors|growth inhibitors|mesh-ancestor
24947826|NCT03925662|DMP 777|dmp 777|mesh-list
24947827|NCT03925662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24553799|NCT00732927|Aspirin|aspirin|mesh-list
24553800|NCT00732927|Parnaparin|parnaparin|mesh-list
24549042|NCT00713167|Grape Seed Extract|grape seed extract|mesh-list
24553811|NCT00732927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553813|NCT00732927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24553814|NCT00732927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553815|NCT00732927|Antipyretics|antipyretics|mesh-ancestor
24553830|NCT00732966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24553831|NCT00733031|Gemcitabine|gemcitabine|mesh-list
24553832|NCT00733031|Pemetrexed|pemetrexed|mesh-list
25697199|NCT02072928|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25697200|NCT02072928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25697201|NCT02073448|Adapalene|adapalene|mesh-list
25697202|NCT02073448|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25697203|NCT02073448|Dermatologic Agents|dermatologic agents|mesh-ancestor
24553833|NCT00733031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24553835|NCT00733031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553836|NCT00733031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24553837|NCT00733031|Antiviral Agents|antiviral agents|mesh-ancestor
24553838|NCT00733031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24553839|NCT00733031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553840|NCT00733031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24553841|NCT00733031|Immunologic Factors|immunologic factors|mesh-ancestor
24553842|NCT00733031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553843|NCT00733031|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24553845|NCT00733057|Minocycline|minocycline|mesh-list
24553846|NCT00733057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24553847|NCT00733057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24553848|NCT00733083|Dexamethasone|dexamethasone|mesh-list
24553849|NCT00733083|Morphine|morphine|mesh-list
24553873|NCT00733239|Cycloserine|cycloserine|mesh-list
24553874|NCT00733239|Verapamil|verapamil|mesh-list
24553875|NCT00733239|Diltiazem|diltiazem|mesh-list
24553876|NCT00733239|Isradipine|isradipine|mesh-list
24553877|NCT00733239|Nifedipine|nifedipine|mesh-list
24553878|NCT00733239|Gabapentin|gabapentin|mesh-list
24553879|NCT00733239|Naloxone|naloxone|mesh-list
24553880|NCT00733239|Analgesics|analgesics|mesh-ancestor
24553890|NCT00733239|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24553906|NCT00733239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24553907|NCT00733239|Antimetabolites|antimetabolites|mesh-ancestor
24553908|NCT00733239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24553909|NCT00733239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24553910|NCT00733265|Ticagrelor|ticagrelor|mesh-list
24553911|NCT00733265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24553912|NCT00733265|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24553913|NCT00733265|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24553914|NCT00733265|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24553915|NCT00733265|Purinergic Agents|purinergic agents|mesh-ancestor
24553916|NCT00733265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24553917|NCT00733265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553918|NCT00733265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553919|NCT00733317|Budesonide|budesonide|mesh-list
24553920|NCT00733317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24553967|NCT00733564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24553976|NCT00733564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24553977|NCT00733564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24947829|NCT03925662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24947830|NCT03925662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24947831|NCT03925662|Growth Substances|growth substances|mesh-ancestor
24947832|NCT03925662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947833|NCT03925662|Growth Inhibitors|growth inhibitors|mesh-ancestor
24554039|NCT00733889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554040|NCT00733889|Antimetabolites|antimetabolites|mesh-ancestor
24554041|NCT00733889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24554042|NCT00733889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24554043|NCT00733889|Immunologic Factors|immunologic factors|mesh-ancestor
24554044|NCT00733889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554045|NCT00733889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24554046|NCT00733967|Varenicline|varenicline|mesh-list
24554053|NCT00734123|Aspirin|aspirin|mesh-list
24554057|NCT00734123|Atorvastatin|atorvastatin|mesh-list
24554058|NCT00734123|Simvastatin|simvastatin|mesh-list
24554059|NCT00734123|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24554061|NCT00734123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24554062|NCT00734123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24554063|NCT00734123|Analgesics|analgesics|mesh-ancestor
24554064|NCT00734123|Sensory System Agents|sensory system agents|mesh-ancestor
24554065|NCT00734123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24554066|NCT00734123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554067|NCT00734123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24554068|NCT00734123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24554070|NCT00734123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24554071|NCT00734123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554072|NCT00734123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24554073|NCT00734123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24554075|NCT00734123|Antipyretics|antipyretics|mesh-ancestor
24554076|NCT00734123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24947839|NCT03925662|Antimitotic Agents|antimitotic agents|mesh-ancestor
24947840|NCT03925662|Mitosis Modulators|mitosis modulators|mesh-ancestor
24554077|NCT00734123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24554122|NCT00734383|Propofol|propofol|mesh-list
24554123|NCT00734383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24448320|NCT00311129|Antimetabolites|antimetabolites|mesh-ancestor
24448321|NCT00311129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448322|NCT00311129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24448323|NCT00311259|Melatonin|melatonin|mesh-list
24448324|NCT00311259|Antioxidants|antioxidants|mesh-ancestor
24448325|NCT00311259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448326|NCT00311259|Protective Agents|protective agents|mesh-ancestor
24448327|NCT00311259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554124|NCT00734383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24554125|NCT00734383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554126|NCT00734383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24554132|NCT00734448|Micronutrients|micronutrients|mesh-ancestor
24554133|NCT00734448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554134|NCT00734526|Temozolomide|temozolomide|mesh-list
24554135|NCT00734526|Sorafenib|sorafenib|mesh-list
24554136|NCT00734526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24554137|NCT00734526|Alkylating Agents|alkylating agents|mesh-ancestor
24554138|NCT00734526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554139|NCT00734526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24554140|NCT00734526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24554142|NCT00734669|Glyburide|glyburide|mesh-list
24554143|NCT00734669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24554231|NCT00734890|Bevacizumab|bevacizumab|mesh-list
24554232|NCT00734890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24554233|NCT00734890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24947841|NCT03925662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947842|NCT03925662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24947843|NCT03925233|Tamoxifen|tamoxifen|mesh-list
24554234|NCT00734890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24554235|NCT00734890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24554236|NCT00734890|Growth Substances|growth substances|mesh-ancestor
24554238|NCT00734890|Growth Inhibitors|growth inhibitors|mesh-ancestor
24554239|NCT00734916|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24554240|NCT00734916|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24554241|NCT00734916|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24554242|NCT00734916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24554244|NCT00735020|Immunologic Factors|immunologic factors|mesh-ancestor
24554245|NCT00735020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554246|NCT00735124|Gabapentin|gabapentin|mesh-list
24554247|NCT00735124|Analgesics|analgesics|mesh-ancestor
24554248|NCT00735124|Sensory System Agents|sensory system agents|mesh-ancestor
24554249|NCT00735124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24554298|NCT00735345|Antimitotic Agents|antimitotic agents|mesh-ancestor
24554299|NCT00735345|Mitosis Modulators|mitosis modulators|mesh-ancestor
24554300|NCT00735345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554301|NCT00735345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24554302|NCT00735501|Insulin Detemir|insulin detemir|mesh-list
24554309|NCT00735527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24554310|NCT00735527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554311|NCT00735527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24554312|NCT00735527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24554313|NCT00735527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24554314|NCT00735527|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24554315|NCT00735527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24554316|NCT00735527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24554317|NCT00735527|GABA Modulators|gaba modulators|mesh-ancestor
24554318|NCT00735527|GABA Agents|gaba agents|mesh-ancestor
24554319|NCT00735527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24554321|NCT00735748|Tramadol|tramadol|mesh-list
24947860|NCT03925233|Fulvestrant|fulvestrant|mesh-list
24947861|NCT03925233|Anastrozole|anastrozole|mesh-list
24947862|NCT03925233|Exemestane|exemestane|mesh-list
24947863|NCT03925233|Endostatins|endostatins|mesh-list
24947864|NCT03925233|Pirarubicin|pirarubicin|mesh-list
24801913|NCT01986309|Lidocaine|lidocaine|mesh-list
24554428|NCT00736515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24554429|NCT00736515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554430|NCT00736541|Acetylcysteine|acetylcysteine|mesh-list
24554431|NCT00736541|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24554432|NCT00736541|Cystatins|cystatins|mesh-list
24554433|NCT00736541|Antiviral Agents|antiviral agents|mesh-ancestor
24554434|NCT00736541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24554486|NCT00736814|Gemcitabine|gemcitabine|mesh-list
24554487|NCT00736814|Carboplatin|carboplatin|mesh-list
24554488|NCT00736814|Docetaxel|docetaxel|mesh-list
24554489|NCT00736814|Vinorelbine|vinorelbine|mesh-list
24554490|NCT00736814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24554491|NCT00736814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24554492|NCT00736814|Antimetabolites|antimetabolites|mesh-ancestor
24554493|NCT00736814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554494|NCT00736814|Antiviral Agents|antiviral agents|mesh-ancestor
24554495|NCT00736814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24554496|NCT00736814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24554497|NCT00736814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24554498|NCT00736814|Immunologic Factors|immunologic factors|mesh-ancestor
24554499|NCT00736814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554500|NCT00736814|Tubulin Modulators|tubulin modulators|mesh-ancestor
24554501|NCT00736814|Antimitotic Agents|antimitotic agents|mesh-ancestor
24554502|NCT00736814|Mitosis Modulators|mitosis modulators|mesh-ancestor
24554503|NCT00736814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24554504|NCT00736866|Acetylcysteine|acetylcysteine|mesh-list
24554505|NCT00736866|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24554506|NCT00736866|Antiviral Agents|antiviral agents|mesh-ancestor
24554507|NCT00736866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24554508|NCT00736866|Expectorants|expectorants|mesh-ancestor
24554509|NCT00736866|Respiratory System Agents|respiratory system agents|mesh-ancestor
24448328|NCT00311259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24448329|NCT00311285|Hydrocortisone|hydrocortisone|mesh-list
24448330|NCT00311285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24554519|NCT00736905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462388|NCT00355953|Estrogens|estrogens|mesh-ancestor
24947865|NCT03925233|Citric Acid|citric acid|mesh-list
24947866|NCT03925233|Sodium Citrate|sodium citrate|mesh-list
24947867|NCT03925233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24947868|NCT03925233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24947869|NCT03925233|Tubulin Modulators|tubulin modulators|mesh-ancestor
24947870|NCT03925233|Antimitotic Agents|antimitotic agents|mesh-ancestor
24947871|NCT03925233|Mitosis Modulators|mitosis modulators|mesh-ancestor
24947872|NCT03925233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947873|NCT03925233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24947874|NCT03925233|Immunologic Factors|immunologic factors|mesh-ancestor
24947875|NCT03925233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947876|NCT03925233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24947877|NCT03925233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24947878|NCT03925233|Alkylating Agents|alkylating agents|mesh-ancestor
24947879|NCT03925233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24947880|NCT03925233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24947881|NCT03925233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24947882|NCT03925233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24947883|NCT03925233|Growth Substances|growth substances|mesh-ancestor
24947884|NCT03925233|Growth Inhibitors|growth inhibitors|mesh-ancestor
24947886|NCT03925233|Antimetabolites|antimetabolites|mesh-ancestor
24554528|NCT00736931|Anticonvulsants|anticonvulsants|mesh-ancestor
24554529|NCT00736931|Nootropic Agents|nootropic agents|mesh-ancestor
24554530|NCT00736931|Antiemetics|antiemetics|mesh-ancestor
24554531|NCT00736931|Autonomic Agents|autonomic agents|mesh-ancestor
24554540|NCT00736931|GABA Modulators|gaba modulators|mesh-ancestor
25697204|NCT02073448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24554560|NCT00736983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24554561|NCT00736983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24554562|NCT00736983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24554563|NCT00736983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24554564|NCT00736983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554565|NCT00736983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24554566|NCT00736983|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24554567|NCT00736983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24554568|NCT00737113|Hormones|hormones|mesh-list
24554569|NCT00737113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24947888|NCT03925233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24947889|NCT03925233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24947911|NCT03925233|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24947912|NCT03925233|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24947913|NCT03925233|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24947914|NCT03925233|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24947915|NCT03925285|Bevacizumab|bevacizumab|mesh-list
24947916|NCT03925285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24554587|NCT00737139|Autonomic Agents|autonomic agents|mesh-ancestor
24554588|NCT00737139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24554589|NCT00737139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24554590|NCT00737139|Respiratory System Agents|respiratory system agents|mesh-ancestor
24554591|NCT00737139|Mydriatics|mydriatics|mesh-ancestor
24554592|NCT00737139|Sympathomimetics|sympathomimetics|mesh-ancestor
24554593|NCT00737139|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24554594|NCT00737139|Anesthetics, Local|anesthetics, local|mesh-ancestor
24554595|NCT00737139|Anesthetics|anesthetics|mesh-ancestor
24554596|NCT00737139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24554597|NCT00737139|Sensory System Agents|sensory system agents|mesh-ancestor
24554600|NCT00737191|Autonomic Agents|autonomic agents|mesh-ancestor
24947938|NCT03925051|Denosumab|denosumab|mesh-list
24947921|NCT03925285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947922|NCT03925285|Growth Inhibitors|growth inhibitors|mesh-ancestor
24947923|NCT03925428|Entinostat|entinostat|mesh-list
24947924|NCT03925428|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
24947925|NCT03925428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24947926|NCT03925428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24947927|NCT03925428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947928|NCT03925090|Cisplatin|cisplatin|mesh-list
24801954|NCT01986556|Lesinurad|lesinurad|mesh-list
24554694|NCT00737724|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24554695|NCT00737724|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24554696|NCT00737724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462405|NCT00356005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24554708|NCT00737724|Antitubercular Agents|antitubercular agents|mesh-ancestor
24554709|NCT00737724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24554710|NCT00737724|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24554735|NCT00737867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24554736|NCT00737867|Antimetabolites|antimetabolites|mesh-ancestor
24554737|NCT00737867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554738|NCT00737867|Antiviral Agents|antiviral agents|mesh-ancestor
24554739|NCT00737867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24554740|NCT00737867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24554741|NCT00737867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24554742|NCT00737867|Immunologic Factors|immunologic factors|mesh-ancestor
24554743|NCT00737867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554744|NCT00737867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24554745|NCT00737867|Tubulin Modulators|tubulin modulators|mesh-ancestor
24554746|NCT00737867|Antimitotic Agents|antimitotic agents|mesh-ancestor
24554747|NCT00737867|Mitosis Modulators|mitosis modulators|mesh-ancestor
24554749|NCT00737880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24554750|NCT00737971|Triamcinolone|triamcinolone|mesh-list
24554782|NCT00738153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24554783|NCT00738153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554784|NCT00738192|Fentanyl|fentanyl|mesh-list
24554785|NCT00738192|Sufentanil|sufentanil|mesh-list
24554787|NCT00738192|Butorphanol|butorphanol|mesh-list
24554790|NCT00738192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24554792|NCT00738192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25697205|NCT02073448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25697206|NCT02073448|Analgesics|analgesics|mesh-ancestor
25697207|NCT02073448|Sensory System Agents|sensory system agents|mesh-ancestor
25697208|NCT02073448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25697209|NCT02073448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947931|NCT03925155|Chlorhexidine|chlorhexidine|mesh-list
24947932|NCT03925155|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24947933|NCT03925155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24554824|NCT00738335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24554825|NCT00738335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24554826|NCT00738335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554827|NCT00738413|Deferasirox|deferasirox|mesh-list
24554828|NCT00738413|Deferoxamine|deferoxamine|mesh-list
24554829|NCT00738413|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24554830|NCT00738413|Chelating Agents|chelating agents|mesh-ancestor
24554831|NCT00738413|Sequestering Agents|sequestering agents|mesh-ancestor
24554832|NCT00738413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554833|NCT00738413|Siderophores|siderophores|mesh-ancestor
24554834|NCT00738452|Antibodies|antibodies|mesh-list
24554835|NCT00738452|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24554836|NCT00738452|Immunologic Factors|immunologic factors|mesh-ancestor
24554837|NCT00738452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554838|NCT00738517|Immunoglobulins|immunoglobulins|mesh-list
24554839|NCT00738517|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24554840|NCT00738517|Antibodies|antibodies|mesh-list
24554841|NCT00738517|Immunologic Factors|immunologic factors|mesh-ancestor
24554842|NCT00738517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554864|NCT00738569|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24947942|NCT03924544|Mitomycin|mitomycin|mesh-list
24947943|NCT03924544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24947945|NCT03924544|Alkylating Agents|alkylating agents|mesh-ancestor
24947946|NCT03924544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947947|NCT03924544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24554865|NCT00738569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24554866|NCT00738569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554913|NCT00738660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554914|NCT00738660|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24554916|NCT00738660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24554917|NCT00738751|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24554918|NCT00738751|Panobinostat|panobinostat|mesh-list
24554919|NCT00738751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
24554920|NCT00738751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24554921|NCT00738751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24554922|NCT00738751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24554955|NCT00738829|Antiviral Agents|antiviral agents|mesh-ancestor
24554956|NCT00738829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24554957|NCT00738829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24554968|NCT00738842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554969|NCT00738842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554970|NCT00738868|Cetuximab|cetuximab|mesh-list
24554971|NCT00738868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24554972|NCT00738868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24554973|NCT00738985|Simvastatin|simvastatin|mesh-list
24554974|NCT00738985|Ezetimibe|ezetimibe|mesh-list
24554975|NCT00738985|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
24554976|NCT00738985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24554977|NCT00738985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24554978|NCT00738985|Antimetabolites|antimetabolites|mesh-ancestor
24554979|NCT00738985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554980|NCT00738985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24947948|NCT03924544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24947949|NCT03924596|Boswellic acid|boswellic acid|mesh-list
24947950|NCT03924596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24947951|NCT03924596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24554984|NCT00739128|Immunologic Factors|immunologic factors|mesh-ancestor
24554985|NCT00739128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554986|NCT00739141|Cyclophosphamide|cyclophosphamide|mesh-list
24554987|NCT00739141|Thiotepa|thiotepa|mesh-list
24554988|NCT00739141|Fludarabine|fludarabine|mesh-list
24554989|NCT00739141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25697210|NCT02073448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25697211|NCT02073448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25697212|NCT02073461|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25697213|NCT02073461|Dermatologic Agents|dermatologic agents|mesh-ancestor
25697214|NCT02073487|Paclitaxel|paclitaxel|mesh-list
24541853|NCT00675701|Moxifloxacin|moxifloxacin|mesh-list
24505100|NCT00539799|Hormones|hormones|mesh-ancestor
24552540|NCT02688530|BB 1101|bb 1101|mesh-list
24552541|NCT02688530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24552542|NCT02688530|Antiemetics|antiemetics|mesh-ancestor
24554991|NCT00739141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554992|NCT00739141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24554993|NCT00739141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24554994|NCT00739141|Alkylating Agents|alkylating agents|mesh-ancestor
24555010|NCT00739193|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24555012|NCT00739388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24555013|NCT00739388|Antimetabolites|antimetabolites|mesh-ancestor
24555014|NCT00739388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555054|NCT00739622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24555056|NCT00739622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555057|NCT00739622|Antiviral Agents|antiviral agents|mesh-ancestor
24947955|NCT03924596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947956|NCT03924596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24947957|NCT03924596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24947958|NCT03924323|Citalopram|citalopram|mesh-list
24947959|NCT03924323|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24947960|NCT03924323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24947961|NCT03924323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24555062|NCT00739830|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24555063|NCT00739830|Megestrol|megestrol|mesh-list
24555064|NCT00739830|Megestrol Acetate|megestrol acetate|mesh-list
24555065|NCT00739830|Medroxyprogesterone|medroxyprogesterone|mesh-list
24555067|NCT00739830|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24555068|NCT00739830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24555069|NCT00739830|Contraceptive Agents|contraceptive agents|mesh-ancestor
24555070|NCT00739830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24555071|NCT00739830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555072|NCT00739830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24555073|NCT00739830|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24555074|NCT00739830|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24555075|NCT00739830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24555076|NCT00739830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24555077|NCT00739830|Appetite Stimulants|appetite stimulants|mesh-ancestor
24555078|NCT00739830|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24555079|NCT00739830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24555080|NCT00739830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24947966|NCT03924323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24947967|NCT03924323|Antidepressive Agents|antidepressive agents|mesh-ancestor
24947968|NCT03924323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24947970|NCT03924245|Entinostat|entinostat|mesh-list
24947971|NCT03924245|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24947972|NCT03924245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24947973|NCT03924245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947974|NCT03924245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24947976|NCT03924492|Pregnanolone|pregnanolone|mesh-list
24555126|NCT00740103|Immunologic Factors|immunologic factors|mesh-ancestor
24449753|NCT00316875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555127|NCT00740142|Lactulose|lactulose|mesh-list
24555128|NCT00740142|N-Methylaspartate|n-methylaspartate|mesh-list
24555129|NCT00740142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24555130|NCT00740142|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
24555131|NCT00740142|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24555132|NCT00740142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24555133|NCT00740142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555156|NCT00740259|Histamine Antagonists|histamine antagonists|mesh-ancestor
24555157|NCT00740259|Histamine Agents|histamine agents|mesh-ancestor
24555158|NCT00740259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24555159|NCT00740259|Vasodilator Agents|vasodilator agents|mesh-ancestor
24555161|NCT00740285|Anesthetics, Local|anesthetics, local|mesh-ancestor
24555162|NCT00740285|Anesthetics|anesthetics|mesh-ancestor
24555163|NCT00740285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24555196|NCT00740415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555197|NCT00740415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24555198|NCT00740415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24555199|NCT00740415|Antiemetics|antiemetics|mesh-ancestor
24555200|NCT00740415|Autonomic Agents|autonomic agents|mesh-ancestor
25697215|NCT02073487|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25697216|NCT02073487|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24764345|NCT01780740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24555206|NCT00740415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24555207|NCT00740415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24555208|NCT00740415|Alkylating Agents|alkylating agents|mesh-ancestor
24555513|NCT00741884|Varenicline|varenicline|mesh-list
24555219|NCT00740467|Immunologic Factors|immunologic factors|mesh-ancestor
25051574|NCT00394121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25051575|NCT00394121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25051576|NCT00394121|Adrenergic Agents|adrenergic agents|mesh-ancestor
25051577|NCT00394121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25051578|NCT00394121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051580|NCT00393991|Xhance|xhance|mesh-list
25051581|NCT00393991|Formoterol Fumarate|formoterol fumarate|mesh-list
24622462|NCT01067118|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24558428|NCT00757185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24555351|NCT00741221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549775|NCT00717561|Azithromycin|azithromycin|mesh-list
24555352|NCT00741221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24555353|NCT00741221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24555354|NCT00741221|Growth Substances|growth substances|mesh-ancestor
24555355|NCT00741221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555356|NCT00741221|Growth Inhibitors|growth inhibitors|mesh-ancestor
24555357|NCT00741221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24555358|NCT00741221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555359|NCT00741221|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24555360|NCT00741221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24555362|NCT00741234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24555383|NCT00741351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24555384|NCT00741351|Anesthetics, General|anesthetics, general|mesh-ancestor
24555385|NCT00741351|Anesthetics|anesthetics|mesh-ancestor
24555386|NCT00741351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24555387|NCT00741351|Narcotics|narcotics|mesh-ancestor
24555388|NCT00741351|Analgesics|analgesics|mesh-ancestor
24555389|NCT00741351|Sensory System Agents|sensory system agents|mesh-ancestor
24555390|NCT00741351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24555391|NCT00741351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24555392|NCT00741351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24555393|NCT00741351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24555394|NCT00741364|Vitamin D|vitamin d|mesh-list
24555437|NCT00741585|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24555438|NCT00741585|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24555439|NCT00741585|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24555440|NCT00741585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24555484|NCT00741767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555485|NCT00741767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24555486|NCT00741767|Respiratory System Agents|respiratory system agents|mesh-ancestor
24555487|NCT00741767|Dermatologic Agents|dermatologic agents|mesh-ancestor
24555488|NCT00741767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24555489|NCT00741767|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24555490|NCT00741767|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24555491|NCT00741767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24555492|NCT00741767|Adrenergic Agents|adrenergic agents|mesh-ancestor
24555493|NCT00741767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24555494|NCT00741767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555495|NCT00741767|Glucocorticoids|glucocorticoids|mesh-ancestor
24555506|NCT00741780|Antiviral Agents|antiviral agents|mesh-ancestor
24555507|NCT00741780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24555508|NCT00741845|Metronidazole|metronidazole|mesh-list
24555509|NCT00741845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24555510|NCT00741845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24555511|NCT00741845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24555512|NCT00741845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24555590|NCT00742248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25051595|NCT00393991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24555636|NCT00742339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24555638|NCT00742404|Doxorubicin|doxorubicin|mesh-list
24555639|NCT00742404|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25697217|NCT02073487|Trastuzumab|trastuzumab|mesh-list
25697218|NCT02073487|Lapatinib|lapatinib|mesh-list
25697219|NCT02073487|Pertuzumab|pertuzumab|mesh-list
25697220|NCT02073487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25697221|NCT02073487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24555640|NCT00742404|Bortezomib|bortezomib|mesh-list
24555641|NCT00742404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24555656|NCT00742404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555659|NCT00742638|Antidepressive Agents|antidepressive agents|mesh-ancestor
24555660|NCT00742638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24555661|NCT00742638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24555662|NCT00742638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24555765|NCT00743470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24555766|NCT00743470|Antiviral Agents|antiviral agents|mesh-ancestor
24555767|NCT00743470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24555768|NCT00743470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24462460|NCT00356356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24555769|NCT00743470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24555770|NCT00743470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24555771|NCT00743470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24555817|NCT00743834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24555818|NCT00743834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555819|NCT00743834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24555875|NCT00744081|Topotecan|topotecan|mesh-list
24555934|NCT00744354|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24555936|NCT00744354|Vorinostat|vorinostat|mesh-list
24555937|NCT00744354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24555938|NCT00744354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24555939|NCT00744354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24555940|NCT00744354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24555941|NCT00744354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24555942|NCT00744354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555943|NCT00744354|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24555944|NCT00744393|Sodium Oxybate|sodium oxybate|mesh-list
24555945|NCT00744393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24555946|NCT00744393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24555947|NCT00744393|Anesthetics, General|anesthetics, general|mesh-ancestor
24555948|NCT00744393|Anesthetics|anesthetics|mesh-ancestor
24555949|NCT00744393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24555950|NCT00744393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555951|NCT00744406|Sertraline|sertraline|mesh-list
24555952|NCT00744406|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24555953|NCT00744406|Antidepressive Agents|antidepressive agents|mesh-list
24555954|NCT00744406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24555955|NCT00744406|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24963644|NCT03790007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24963645|NCT03790007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963646|NCT03790007|Sensory System Agents|sensory system agents|mesh-ancestor
24963647|NCT03790007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24963648|NCT03789695|Dabigatran|dabigatran|mesh-list
24963649|NCT03789695|Antithrombins|antithrombins|mesh-ancestor
24555978|NCT00744536|Growth Substances|growth substances|mesh-ancestor
24555979|NCT00744536|Growth Inhibitors|growth inhibitors|mesh-ancestor
24555980|NCT00744536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24555981|NCT00744536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24555982|NCT00744536|Alkylating Agents|alkylating agents|mesh-ancestor
24555983|NCT00744536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555984|NCT00744536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24555985|NCT00744536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24555989|NCT00744549|Vitamin E|vitamin e|mesh-list
24556008|NCT00744640|Antimetabolites|antimetabolites|mesh-ancestor
24556009|NCT00744640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556010|NCT00744640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556013|NCT00744640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556014|NCT00744640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24556015|NCT00744640|Immunologic Factors|immunologic factors|mesh-ancestor
24556016|NCT00744640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556017|NCT00744666|Prednisolone|prednisolone|mesh-list
24556018|NCT00744666|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24556019|NCT00744666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24556020|NCT00744666|Glucocorticoids|glucocorticoids|mesh-ancestor
24556021|NCT00744666|Hormones|hormones|mesh-ancestor
24556022|NCT00744666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24556023|NCT00744666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697222|NCT02073487|Tubulin Modulators|tubulin modulators|mesh-ancestor
25697223|NCT02073487|Antimitotic Agents|antimitotic agents|mesh-ancestor
24556024|NCT00744666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24556025|NCT00744666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556026|NCT00744666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24556027|NCT00744679|Natalizumab|natalizumab|mesh-list
24556028|NCT00744679|Immunologic Factors|immunologic factors|mesh-ancestor
24556029|NCT00744679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556030|NCT00744718|Bevacizumab|bevacizumab|mesh-list
24556031|NCT00744718|Carboplatin|carboplatin|mesh-list
24556032|NCT00744718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24556033|NCT00744718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556043|NCT00744770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556044|NCT00744770|Antiviral Agents|antiviral agents|mesh-ancestor
24556046|NCT00744770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24556047|NCT00744770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24556048|NCT00744809|Moxifloxacin|moxifloxacin|mesh-list
24556049|NCT00744809|Efavirenz|efavirenz|mesh-list
24556050|NCT00744809|Rilpivirine|rilpivirine|mesh-list
24556051|NCT00744809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24556052|NCT00744809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24963650|NCT03789695|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24963651|NCT03789695|Protease Inhibitors|protease inhibitors|mesh-ancestor
24963652|NCT03789695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24963654|NCT03789695|Anticoagulants|anticoagulants|mesh-ancestor
24556053|NCT00744809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24556054|NCT00744809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24556055|NCT00744809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556056|NCT00744809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556057|NCT00744809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556058|NCT00744809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24556059|NCT00744809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24556060|NCT00744809|Antiviral Agents|antiviral agents|mesh-ancestor
24556061|NCT00744809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24556071|NCT00744887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24556072|NCT00744887|Protease Inhibitors|protease inhibitors|mesh-ancestor
24556073|NCT00744887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24670998|NCT01323062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556082|NCT00744900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556083|NCT00744900|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24556084|NCT00744900|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24556086|NCT00744913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24556141|NCT00745173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556143|NCT00745186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24556144|NCT00745186|Hormones|hormones|mesh-ancestor
24556189|NCT00745810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556191|NCT00745914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24556192|NCT00745914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556193|NCT00745953|Valsartan|valsartan|mesh-list
24556194|NCT00745953|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24556195|NCT00745953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24556196|NCT00745953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24556197|NCT00745953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24556199|NCT00745953|Diuretics|diuretics|mesh-ancestor
24556216|NCT00746070|Spironolactone|spironolactone|mesh-list
24556217|NCT00746070|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24556218|NCT00746070|Hormone Antagonists|hormone antagonists|mesh-ancestor
24556219|NCT00746070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24556220|NCT00746070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556221|NCT00746070|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24556222|NCT00746070|Diuretics|diuretics|mesh-ancestor
24556224|NCT00746174|Rosiglitazone|rosiglitazone|mesh-list
24556225|NCT00746174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24556226|NCT00746174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556227|NCT00746447|Mesalamine|mesalamine|mesh-list
24556228|NCT00746447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24556229|NCT00746447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24556230|NCT00746447|Analgesics|analgesics|mesh-ancestor
24556231|NCT00746447|Sensory System Agents|sensory system agents|mesh-ancestor
24556232|NCT00746447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25697224|NCT02073487|Mitosis Modulators|mitosis modulators|mesh-ancestor
25697225|NCT02073487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556233|NCT00746447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556234|NCT00746447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24556235|NCT00746447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24556237|NCT00746486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24556238|NCT00746486|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24556239|NCT00746486|Autonomic Agents|autonomic agents|mesh-ancestor
24556242|NCT00746486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24556246|NCT00746486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24948015|NCT03923556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24948017|NCT03923829|Zinc Sulfate|zinc sulfate|mesh-list
24556247|NCT00746499|Raltegravir Potassium|raltegravir potassium|mesh-list
24556269|NCT00746681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24556270|NCT00746681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24556271|NCT00746681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24556272|NCT00746681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24556273|NCT00746681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24556274|NCT00746681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24556275|NCT00746681|Cholinergic Agents|cholinergic agents|mesh-ancestor
24556276|NCT00746681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24556277|NCT00746681|Urological Agents|urological agents|mesh-ancestor
24556278|NCT00746720|Etoricoxib|etoricoxib|mesh-list
24556279|NCT00746720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24556280|NCT00746720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24556281|NCT00746720|Analgesics|analgesics|mesh-ancestor
24556282|NCT00746720|Sensory System Agents|sensory system agents|mesh-ancestor
24556283|NCT00746720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24556284|NCT00746720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24559795|NCT04387136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556349|NCT00747279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556350|NCT00747305|Sunitinib|sunitinib|mesh-list
24556351|NCT00747305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556352|NCT00747305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24556353|NCT00747305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24556354|NCT00747305|Growth Substances|growth substances|mesh-ancestor
24556355|NCT00747305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556356|NCT00747305|Growth Inhibitors|growth inhibitors|mesh-ancestor
24556357|NCT00747305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24556358|NCT00747305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556359|NCT00747305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556361|NCT00747331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24556362|NCT00747331|Vasodilator Agents|vasodilator agents|mesh-ancestor
24556363|NCT00747331|Dopamine Agonists|dopamine agonists|mesh-ancestor
24556364|NCT00747331|Dopamine Agents|dopamine agents|mesh-ancestor
24556365|NCT00747331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24556372|NCT00747383|Incretins|incretins|mesh-ancestor
25697228|NCT02073487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697229|NCT02073656|Sofosbuvir|sofosbuvir|mesh-list
25697230|NCT02073656|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25697231|NCT02073656|Ledipasvir|ledipasvir|mesh-list
25697232|NCT02073656|Antiviral Agents|antiviral agents|mesh-ancestor
25697233|NCT02073656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24556402|NCT00747526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556403|NCT00747526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556404|NCT00747539|Interferons|interferons|mesh-list
24556405|NCT00747539|Ribavirin|ribavirin|mesh-list
24556406|NCT00747539|Interferon-alpha|interferon-alpha|mesh-list
24556407|NCT00747539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556408|NCT00747539|Antiviral Agents|antiviral agents|mesh-ancestor
24556409|NCT00747539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24556410|NCT00747539|Antimetabolites|antimetabolites|mesh-ancestor
24556411|NCT00747539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556412|NCT00747539|Immunologic Factors|immunologic factors|mesh-ancestor
24556413|NCT00747539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556414|NCT00747604|Mecasermin|mecasermin|mesh-list
24556415|NCT00747604|Growth Substances|growth substances|mesh-ancestor
24556416|NCT00747604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556417|NCT00747669|Lidocaine|lidocaine|mesh-list
24556418|NCT00747669|Tetracaine|tetracaine|mesh-list
24556419|NCT00747669|Anesthetics, Local|anesthetics, local|mesh-ancestor
24556420|NCT00747669|Anesthetics|anesthetics|mesh-ancestor
24556421|NCT00747669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24556422|NCT00747669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556423|NCT00747669|Sensory System Agents|sensory system agents|mesh-ancestor
24556424|NCT00747669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24556425|NCT00747669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24556426|NCT00747669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24556435|NCT00747695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556436|NCT00747708|Lenograstim|lenograstim|mesh-list
24556471|NCT00747877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24556472|NCT00747877|Alkylating Agents|alkylating agents|mesh-ancestor
24556513|NCT00748059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556514|NCT00748059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24556515|NCT00748059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24556516|NCT00748059|Vasodilator Agents|vasodilator agents|mesh-ancestor
24556517|NCT00748059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24556519|NCT00748059|Autonomic Agents|autonomic agents|mesh-ancestor
24556520|NCT00748059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24556521|NCT00748059|Sympathomimetics|sympathomimetics|mesh-ancestor
24556522|NCT00748059|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24556523|NCT00748059|Nasal Decongestants|nasal decongestants|mesh-ancestor
24948020|NCT03923829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948022|NCT03923829|Dermatologic Agents|dermatologic agents|mesh-ancestor
24556524|NCT00748059|Respiratory System Agents|respiratory system agents|mesh-ancestor
24556525|NCT00748059|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24556526|NCT00748059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24556527|NCT00748059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24556528|NCT00748059|Protective Agents|protective agents|mesh-ancestor
24556529|NCT00748059|Analgesics|analgesics|mesh-ancestor
24556530|NCT00748059|Sensory System Agents|sensory system agents|mesh-ancestor
24556531|NCT00748059|Sympatholytics|sympatholytics|mesh-ancestor
24556546|NCT00748059|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24556547|NCT00748059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24556549|NCT00748059|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24556550|NCT00748059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24556551|NCT00748059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24556552|NCT00748059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24556553|NCT00748059|Antidotes|antidotes|mesh-ancestor
24556554|NCT00748059|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24556555|NCT00748059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556557|NCT00748150|Immunologic Factors|immunologic factors|mesh-ancestor
24556558|NCT00748150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556559|NCT00748163|Paclitaxel|paclitaxel|mesh-list
24556560|NCT00748163|Sunitinib|sunitinib|mesh-list
24556561|NCT00748163|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24556562|NCT00748163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24556563|NCT00748163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556564|NCT00748163|Tubulin Modulators|tubulin modulators|mesh-ancestor
24556619|NCT00748423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24556620|NCT00748423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556621|NCT00748423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24556622|NCT00748423|Respiratory System Agents|respiratory system agents|mesh-ancestor
24556623|NCT00748423|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24556624|NCT00748423|Antioxidants|antioxidants|mesh-ancestor
24556627|NCT00748423|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24556628|NCT00748423|Vasodilator Agents|vasodilator agents|mesh-ancestor
24556630|NCT00748423|Protective Agents|protective agents|mesh-ancestor
24948023|NCT03923751|Anesthetics|anesthetics|mesh-list
24948024|NCT03923751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24948025|NCT03923751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948026|NCT03923114|Exenatide|exenatide|mesh-list
24948027|NCT03923114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24948028|NCT03923114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948029|NCT03923114|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24948030|NCT03923114|Incretins|incretins|mesh-ancestor
24948031|NCT03923114|Hormones|hormones|mesh-ancestor
24556644|NCT00748527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556645|NCT00748618|Vitamin D|vitamin d|mesh-list
24556646|NCT00748618|Ergocalciferols|ergocalciferols|mesh-list
24556647|NCT00748618|Cholecalciferol|cholecalciferol|mesh-list
24556648|NCT00748618|Vitamins|vitamins|mesh-list
24556649|NCT00748618|Micronutrients|micronutrients|mesh-ancestor
24556650|NCT00748618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556651|NCT00748618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24556652|NCT00748618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24556671|NCT00748891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24556672|NCT00748891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556673|NCT00748891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556674|NCT00748943|Chlorine dioxide|chlorine dioxide|mesh-list
24556703|NCT00749138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24556752|NCT00749450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24556754|NCT00749450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462563|NCT00356954|Protective Agents|protective agents|mesh-ancestor
24556757|NCT00749502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556758|NCT00749502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556759|NCT00749502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556760|NCT00749567|Bevacizumab|bevacizumab|mesh-list
24556761|NCT00749567|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24556762|NCT00749567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24556763|NCT00749567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556764|NCT00749567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24556765|NCT00749567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24556766|NCT00749567|Growth Substances|growth substances|mesh-ancestor
24556767|NCT00749567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556768|NCT00749567|Growth Inhibitors|growth inhibitors|mesh-ancestor
24556769|NCT00749567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24556824|NCT00749736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24556826|NCT00749814|Antioxidants|antioxidants|mesh-ancestor
24556827|NCT00749814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556828|NCT00749814|Protective Agents|protective agents|mesh-ancestor
24948045|NCT03923218|Vitamin D|vitamin d|mesh-list
24556833|NCT00749853|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24556834|NCT00749853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24556835|NCT00749853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556836|NCT00749853|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24447857|NCT00309712|Simvastatin|simvastatin|mesh-list
24556837|NCT00749853|Fertility Agents|fertility agents|mesh-ancestor
24556838|NCT00749853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24556839|NCT00749866|Gentamicins|gentamicins|mesh-list
24556840|NCT00749866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24556881|NCT00750126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556882|NCT00750126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24556883|NCT00750126|Immunologic Factors|immunologic factors|mesh-ancestor
24556884|NCT00750126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556885|NCT00750126|Alkylating Agents|alkylating agents|mesh-ancestor
24759013|NCT01749072|Tubulin Modulators|tubulin modulators|mesh-ancestor
25697234|NCT02073682|Heparin|heparin|mesh-list
25697235|NCT02073682|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24556898|NCT00750217|Analgesics|analgesics|mesh-ancestor
24556899|NCT00750217|Sensory System Agents|sensory system agents|mesh-ancestor
24556900|NCT00750217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24556901|NCT00750217|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24556902|NCT00750334|Clofarabine|clofarabine|mesh-list
24556903|NCT00750334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24556904|NCT00750334|Antimetabolites|antimetabolites|mesh-ancestor
24556905|NCT00750334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556906|NCT00750334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556907|NCT00750347|Acetaminophen|acetaminophen|mesh-list
24560660|NCT02018861|Ifosfamide|ifosfamide|mesh-list
24560687|NCT01737502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24560688|NCT01737502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24560689|NCT01737502|Antifungal Agents|antifungal agents|mesh-ancestor
24560690|NCT01737502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24560691|NCT01737502|Immunologic Factors|immunologic factors|mesh-ancestor
24560692|NCT01737502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24560693|NCT01737502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24560695|NCT01721759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24556912|NCT00750347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24556913|NCT00750347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556914|NCT00750347|Antipyretics|antipyretics|mesh-ancestor
24556915|NCT00750347|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24556916|NCT00750347|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24556931|NCT00750399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24556932|NCT00750399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24556933|NCT00750399|Growth Substances|growth substances|mesh-ancestor
24556934|NCT00750399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556935|NCT00750399|Growth Inhibitors|growth inhibitors|mesh-ancestor
24556936|NCT00750399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556938|NCT00750425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556939|NCT00750425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24556940|NCT00750425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556941|NCT00750425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556942|NCT00750451|Heparin|heparin|mesh-list
24556943|NCT00750451|Enoxaparin|enoxaparin|mesh-list
24556944|NCT00750451|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24556945|NCT00750451|Tinzaparin|tinzaparin|mesh-list
24556946|NCT00750451|Dalteparin|dalteparin|mesh-list
24556968|NCT00750581|Sensory System Agents|sensory system agents|mesh-ancestor
24556969|NCT00750581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24556972|NCT00750581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24556973|NCT00750581|Gout Suppressants|gout suppressants|mesh-ancestor
24556974|NCT00750581|Tocolytic Agents|tocolytic agents|mesh-ancestor
24556975|NCT00750581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24556976|NCT00750581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24948061|NCT03923140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24948062|NCT03923140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24557044|NCT00751127|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24557051|NCT00751127|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24557052|NCT00751127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24557053|NCT00751153|Raltegravir Potassium|raltegravir potassium|mesh-list
24557054|NCT00751153|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24557055|NCT00751153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24557057|NCT00751153|Antiviral Agents|antiviral agents|mesh-ancestor
25406517|NCT03554473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25697237|NCT02073682|Dalteparin|dalteparin|mesh-list
24557082|NCT00751205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24557083|NCT00751205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24462597|NCT00357084|Methylprednisolone|methylprednisolone|mesh-list
24557124|NCT00751478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24557125|NCT00751478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557126|NCT00751478|Analgesics|analgesics|mesh-ancestor
24557127|NCT00751478|Sensory System Agents|sensory system agents|mesh-ancestor
24948063|NCT03923140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948064|NCT03923140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24948065|NCT03923140|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24557128|NCT00751478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24557129|NCT00751478|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24557130|NCT00751478|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24557132|NCT00751491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24557133|NCT00751491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24557134|NCT00751491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24557135|NCT00751491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24557136|NCT00751491|Purinergic Agents|purinergic agents|mesh-ancestor
24557137|NCT00751491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24557176|NCT00751556|Gout Suppressants|gout suppressants|mesh-ancestor
24557182|NCT00751699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24557183|NCT00751699|Analgesics|analgesics|mesh-ancestor
24557184|NCT00751699|Sensory System Agents|sensory system agents|mesh-ancestor
24557185|NCT00751699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24557186|NCT00751699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557187|NCT00751699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24557188|NCT00751699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24557190|NCT00751738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24557191|NCT00751738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24557192|NCT00751738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24557193|NCT00751738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557194|NCT00751738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24557195|NCT00751738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557196|NCT00751751|Losartan|losartan|mesh-list
24557197|NCT00751751|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24557198|NCT00751751|Olmesartan|olmesartan|mesh-list
24557199|NCT00751751|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24557200|NCT00751751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24557201|NCT00751751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24557206|NCT00751751|Natriuretic Agents|natriuretic agents|mesh-ancestor
24557207|NCT00751751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557208|NCT00751751|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24557209|NCT00751751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24557210|NCT00751764|Moxidectin|moxidectin|mesh-list
24557211|NCT00751764|Anthelmintics|anthelmintics|mesh-ancestor
24557212|NCT00751764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24557213|NCT00751764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24557214|NCT00751764|Antinematodal Agents|antinematodal agents|mesh-ancestor
24557215|NCT00751829|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24557216|NCT00751829|Olmesartan|olmesartan|mesh-list
24557217|NCT00751829|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24557218|NCT00751829|Nitrendipine|nitrendipine|mesh-list
24557221|NCT00751829|Natriuretic Agents|natriuretic agents|mesh-ancestor
24557222|NCT00751829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557223|NCT00751829|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24557224|NCT00751829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24557229|NCT00751829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24557230|NCT00751829|Vasodilator Agents|vasodilator agents|mesh-ancestor
24948066|NCT03923140|Histamine Antagonists|histamine antagonists|mesh-ancestor
24948068|NCT03923140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24948069|NCT03923140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24948070|NCT03923140|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24948072|NCT03923075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24557231|NCT00751855|Hydrocortisone|hydrocortisone|mesh-list
24557232|NCT00751855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24557233|NCT00751907|Atorvastatin|atorvastatin|mesh-list
24557234|NCT00751907|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24557235|NCT00751907|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24557236|NCT00751907|Antimetabolites|antimetabolites|mesh-ancestor
24557237|NCT00751907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456819|NCT00332319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557239|NCT00751907|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24557240|NCT00751907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557242|NCT00751959|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
24448346|NCT00311467|Interferons|interferons|mesh-list
24448354|NCT00311545|Siltuximab|siltuximab|mesh-list
24448405|NCT00311636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24448406|NCT00311636|Contraceptive Agents|contraceptive agents|mesh-ancestor
24448407|NCT00311636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24448408|NCT00311636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24557246|NCT00752024|Hemostatics|hemostatics|mesh-list
24557247|NCT00752024|Coagulants|coagulants|mesh-ancestor
24557248|NCT00752037|Ritonavir|ritonavir|mesh-list
24557249|NCT00752037|Lopinavir|lopinavir|mesh-list
24557250|NCT00752037|Raltegravir Potassium|raltegravir potassium|mesh-list
24557251|NCT00752037|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24557252|NCT00752037|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24557253|NCT00752037|Protease Inhibitors|protease inhibitors|mesh-ancestor
24557254|NCT00752037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557255|NCT00752037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557269|NCT00752063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697238|NCT02073682|Edoxaban|edoxaban|mesh-list
25697239|NCT02073682|Anticoagulants|anticoagulants|mesh-ancestor
25697240|NCT02073682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25697241|NCT02073682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25697242|NCT02073682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406518|NCT03554473|Alkylating Agents|alkylating agents|mesh-ancestor
25697243|NCT02073682|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25697244|NCT02073682|Antithrombins|antithrombins|mesh-ancestor
25697245|NCT02073682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25697246|NCT02073682|Protease Inhibitors|protease inhibitors|mesh-ancestor
25697247|NCT02073682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697248|NCT02073747|Albuterol|albuterol|mesh-list
24955794|NCT03860870|Clenbuterol|clenbuterol|mesh-list
24557297|NCT00752141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557299|NCT00752141|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24557300|NCT00752141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24557301|NCT00752141|Renal Agents|renal agents|mesh-ancestor
24557302|NCT00752154|Curcumin|curcumin|mesh-list
24759015|NCT01749072|Mitosis Modulators|mitosis modulators|mesh-ancestor
24557303|NCT00752154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24557304|NCT00752154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24557305|NCT00752154|Analgesics|analgesics|mesh-ancestor
24557306|NCT00752154|Sensory System Agents|sensory system agents|mesh-ancestor
24557307|NCT00752154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24557308|NCT00752154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557309|NCT00752154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24557310|NCT00752154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24557320|NCT00752310|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24557321|NCT00752310|Protease Inhibitors|protease inhibitors|mesh-ancestor
24557322|NCT00752310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557323|NCT00752310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557324|NCT00752310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24557325|NCT00752310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24557326|NCT00752310|Antiviral Agents|antiviral agents|mesh-ancestor
24557327|NCT00752310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24557328|NCT00752323|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24557329|NCT00752323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24557332|NCT00752375|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24557333|NCT00752375|Sulfamethoxazole|sulfamethoxazole|mesh-list
24557334|NCT00752375|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24557335|NCT00752375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24557336|NCT00752375|Renal Agents|renal agents|mesh-ancestor
24557337|NCT00752375|Antimalarials|antimalarials|mesh-ancestor
24557338|NCT00752375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24557339|NCT00752375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24557340|NCT00752375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24557341|NCT00752375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557342|NCT00752375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557343|NCT00752375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24919640|NCT04209426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24557344|NCT00752375|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24948114|NCT03923010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948115|NCT03923010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24948116|NCT03923010|Hormone Antagonists|hormone antagonists|mesh-ancestor
24948117|NCT03923010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24948118|NCT03923010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557345|NCT00752375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24557346|NCT00752375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24557347|NCT00752401|Vitamin D|vitamin d|mesh-list
24557348|NCT00752401|Cholecalciferol|cholecalciferol|mesh-list
24557359|NCT00752414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24557360|NCT00752414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24557361|NCT00752414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24557362|NCT00752414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557363|NCT00752414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557364|NCT00752414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24557365|NCT00752414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24557366|NCT00752414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24557367|NCT00752427|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24557368|NCT00752427|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24557369|NCT00752427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24557370|NCT00752427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24557371|NCT00752427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557380|NCT00752427|Dopamine Agents|dopamine agents|mesh-ancestor
24557382|NCT00752466|Flunarizine|flunarizine|mesh-list
24557404|NCT00752479|Thymoglobulin|thymoglobulin|mesh-list
24557405|NCT00752479|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24557406|NCT00752479|Prednisolone phosphate|prednisolone phosphate|mesh-list
24557407|NCT00752479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557408|NCT00752479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557409|NCT00752479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24948119|NCT03923010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24948122|NCT03922815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25697249|NCT02073747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24544275|NCT00688272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544276|NCT00688272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544279|NCT00688298|Imidacloprid|imidacloprid|mesh-list
24557417|NCT00752479|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24557419|NCT00752479|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24557420|NCT00752479|Antitubercular Agents|antitubercular agents|mesh-ancestor
24557421|NCT00752479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24449872|NCT00317343|Protease Inhibitors|protease inhibitors|mesh-ancestor
24449873|NCT00317343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449874|NCT00317343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557428|NCT00752479|Hormones|hormones|mesh-ancestor
24557445|NCT00752596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557446|NCT00752596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24557447|NCT00752596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557448|NCT00752635|Moxifloxacin|moxifloxacin|mesh-list
24557466|NCT00752635|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24557467|NCT00752635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24557468|NCT00752635|Androgen Antagonists|androgen antagonists|mesh-ancestor
24557469|NCT00752635|Hormone Antagonists|hormone antagonists|mesh-ancestor
24557470|NCT00752635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24948123|NCT03922815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24948124|NCT03922815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948125|NCT03922815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24557479|NCT00752635|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24557481|NCT00752648|Antiviral Agents|antiviral agents|mesh-ancestor
24557492|NCT00752661|Sensory System Agents|sensory system agents|mesh-ancestor
24557493|NCT00752661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24557494|NCT00752739|Selenium|selenium|mesh-list
24557495|NCT00752739|Antioxidants|antioxidants|mesh-ancestor
24557496|NCT00752739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557497|NCT00752739|Protective Agents|protective agents|mesh-ancestor
24557498|NCT00752739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557499|NCT00752739|Trace Elements|trace elements|mesh-ancestor
24557500|NCT00752739|Micronutrients|micronutrients|mesh-ancestor
24557501|NCT00752843|Mifepristone|mifepristone|mesh-list
24557502|NCT00752843|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24557503|NCT00752843|Abortifacient Agents|abortifacient agents|mesh-ancestor
24557504|NCT00752843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24557516|NCT00752843|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24557518|NCT00752869|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24557519|NCT00752869|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24557520|NCT00752869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557521|NCT00752869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557522|NCT00752869|Hormone Antagonists|hormone antagonists|mesh-ancestor
25697250|NCT02073747|Autonomic Agents|autonomic agents|mesh-ancestor
25697251|NCT02073747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25697252|NCT02073747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697253|NCT02073747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25697254|NCT02073747|Respiratory System Agents|respiratory system agents|mesh-ancestor
25697255|NCT02073747|Tocolytic Agents|tocolytic agents|mesh-ancestor
25697256|NCT02073747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25697257|NCT02073747|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25697258|NCT02073747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25697259|NCT02073747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25697260|NCT02073747|Adrenergic Agents|adrenergic agents|mesh-ancestor
25697261|NCT02073747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24948136|NCT03922919|Cefoxitin|cefoxitin|mesh-list
24948137|NCT03922919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24802088|NCT01987297|Idarubicin|idarubicin|mesh-list
24557534|NCT00752921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557535|NCT00752921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24557536|NCT00752921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24557537|NCT00752921|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24557538|NCT00752921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24557539|NCT00752921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557540|NCT00752921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557541|NCT00752934|Baclofen|baclofen|mesh-list
24443184|NCT00293891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109867|NCT03121352|Antimitotic Agents|antimitotic agents|mesh-ancestor
24557542|NCT00752934|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24557543|NCT00752934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557564|NCT00752947|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24557566|NCT00752947|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24557567|NCT00752947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24557568|NCT00753038|Paclitaxel|paclitaxel|mesh-list
24948138|NCT03922919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24948141|NCT03923036|Aflibercept|aflibercept|mesh-list
24948142|NCT03923036|Capecitabine|capecitabine|mesh-list
24557604|NCT00753064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557605|NCT00753064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557606|NCT00753103|Mycophenolic Acid|mycophenolic acid|mesh-list
24557607|NCT00753103|Methylprednisolone|methylprednisolone|mesh-list
24557608|NCT00753103|Prednisolone|prednisolone|mesh-list
24557609|NCT00753103|Cyclophosphamide|cyclophosphamide|mesh-list
24557613|NCT00753103|Immunologic Factors|immunologic factors|mesh-ancestor
24557614|NCT00753103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557615|NCT00753103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24557694|NCT00753467|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
24557695|NCT00753467|Interferon-gamma|interferon-gamma|mesh-list
24557696|NCT00753467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24557697|NCT00753467|Antiviral Agents|antiviral agents|mesh-ancestor
24557698|NCT00753467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24557699|NCT00753467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24557700|NCT00753467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24557701|NCT00753467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557702|NCT00753467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557703|NCT00753493|Topiramate|topiramate|mesh-list
24557704|NCT00753493|Anticonvulsants|anticonvulsants|mesh-ancestor
24557705|NCT00753493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24557706|NCT00753493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557707|NCT00753558|Gentamicins|gentamicins|mesh-list
24557708|NCT00753558|Polymyxins|polymyxins|mesh-list
24557709|NCT00753558|Colistin|colistin|mesh-list
24557710|NCT00753558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24557711|NCT00753558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24557712|NCT00753558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24557713|NCT00753558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24801563|NCT01984086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24557714|NCT00753558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557715|NCT00753571|Cardiac Glycosides|cardiac glycosides|mesh-list
24557739|NCT00753740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24557740|NCT00753740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24557741|NCT00753740|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24557742|NCT00753740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25697262|NCT02073747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697263|NCT02073929|Liraglutide|liraglutide|mesh-list
24557743|NCT00753740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557744|NCT00753740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557749|NCT00753779|Antimetabolites|antimetabolites|mesh-ancestor
24557750|NCT00753779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421662|NCT00219869|Galantamine|galantamine|mesh-list
24421663|NCT00219869|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24557790|NCT00753909|Mitosis Modulators|mitosis modulators|mesh-ancestor
24557791|NCT00753909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557792|NCT00753909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24557794|NCT00753909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24557795|NCT00753909|Growth Substances|growth substances|mesh-ancestor
24557796|NCT00753909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557797|NCT00753909|Growth Inhibitors|growth inhibitors|mesh-ancestor
24557800|NCT00754039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24557801|NCT00754039|Antimetabolites|antimetabolites|mesh-ancestor
24557802|NCT00754039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557803|NCT00754039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24557804|NCT00754039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24557805|NCT00754104|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24557806|NCT00754104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24557807|NCT00754104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24557808|NCT00754104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557809|NCT00754104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557810|NCT00754143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24557811|NCT00754143|Immunologic Factors|immunologic factors|mesh-ancestor
24557812|NCT00754143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557814|NCT00754351|Bevacizumab|bevacizumab|mesh-list
24557815|NCT00754351|Docetaxel|docetaxel|mesh-list
24557816|NCT00754351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24557817|NCT00754351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24557829|NCT00754351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24557830|NCT00754351|Immunologic Factors|immunologic factors|mesh-ancestor
24557831|NCT00754351|Tubulin Modulators|tubulin modulators|mesh-ancestor
24557832|NCT00754351|Antimitotic Agents|antimitotic agents|mesh-ancestor
24557833|NCT00754351|Mitosis Modulators|mitosis modulators|mesh-ancestor
24557859|NCT00754429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24462628|NCT00357084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24557860|NCT00754429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557861|NCT00754429|Vasodilator Agents|vasodilator agents|mesh-ancestor
24557862|NCT00754429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24557863|NCT00754429|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24557864|NCT00754429|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24557865|NCT00754507|Atorvastatin|atorvastatin|mesh-list
24558016|NCT00755118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25697264|NCT02073929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25697265|NCT02073929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697266|NCT02073929|Incretins|incretins|mesh-ancestor
25697267|NCT02073929|Hormones|hormones|mesh-ancestor
25697268|NCT02073929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25697269|NCT02074358|Apixaban|apixaban|mesh-list
25697270|NCT02074358|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24558053|NCT00755170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558055|NCT00755209|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24558056|NCT00755209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24558057|NCT00755209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558058|NCT00755209|Hemostatics|hemostatics|mesh-ancestor
24558059|NCT00755209|Coagulants|coagulants|mesh-ancestor
24558060|NCT00755313|Cyclophosphamide|cyclophosphamide|mesh-list
24558061|NCT00755313|Carboplatin|carboplatin|mesh-list
24558063|NCT00755313|Doxorubicin|doxorubicin|mesh-list
24558064|NCT00755313|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24558065|NCT00755313|Trastuzumab|trastuzumab|mesh-list
24558066|NCT00755313|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24558067|NCT00755313|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24558068|NCT00755313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24558109|NCT00755495|Histamine Antagonists|histamine antagonists|mesh-ancestor
24558110|NCT00755495|Histamine Agents|histamine agents|mesh-ancestor
24948166|NCT03922373|Respiratory System Agents|respiratory system agents|mesh-ancestor
24948167|NCT03921684|Capecitabine|capecitabine|mesh-list
24558169|NCT00755573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558171|NCT00755573|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24558172|NCT00755573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24558173|NCT00755573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558174|NCT00755573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24558175|NCT00755573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24558176|NCT00755573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24948169|NCT03921684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24802123|NCT01987570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24558177|NCT00755573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24558178|NCT00755573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24558179|NCT00755664|Vitamins|vitamins|mesh-list
24558190|NCT00755781|Antifungal Agents|antifungal agents|mesh-ancestor
24558191|NCT00755781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24558192|NCT00755781|Dermatologic Agents|dermatologic agents|mesh-ancestor
24558193|NCT00755781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24558194|NCT00755781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24558196|NCT00755820|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24558197|NCT00755820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24558198|NCT00755820|Renal Agents|renal agents|mesh-ancestor
24558199|NCT00755820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24558200|NCT00755820|Antitubercular Agents|antitubercular agents|mesh-ancestor
24558201|NCT00755820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24558202|NCT00755820|Antimetabolites|antimetabolites|mesh-ancestor
24558203|NCT00755820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558204|NCT00755833|Insulin Aspart|insulin aspart|mesh-list
24558211|NCT00755859|Methylprednisolone|methylprednisolone|mesh-list
24558212|NCT00755859|Prednisolone|prednisolone|mesh-list
24558213|NCT00755859|Prednisolone acetate|prednisolone acetate|mesh-list
24558214|NCT00755859|Azathioprine|azathioprine|mesh-list
24558215|NCT00755859|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24558216|NCT00755859|Prednisolone phosphate|prednisolone phosphate|mesh-list
24558217|NCT00755859|Antimetabolites|antimetabolites|mesh-ancestor
24558219|NCT00755859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24558220|NCT00755859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25697271|NCT02074358|Antithrombins|antithrombins|mesh-ancestor
25697272|NCT02074358|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25697273|NCT02074358|Protease Inhibitors|protease inhibitors|mesh-ancestor
24558221|NCT00755859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24558222|NCT00755859|Immunologic Factors|immunologic factors|mesh-ancestor
24558223|NCT00755859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558224|NCT00755859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24558226|NCT00755859|Glucocorticoids|glucocorticoids|mesh-ancestor
24558227|NCT00755859|Hormones|hormones|mesh-ancestor
24558228|NCT00755859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24558229|NCT00755859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24558243|NCT00755872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24558245|NCT00755885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24558246|NCT00755885|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24558247|NCT00755885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24558248|NCT00755885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558249|NCT00755885|Hormone Antagonists|hormone antagonists|mesh-ancestor
24558250|NCT00755885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24558264|NCT00755898|Sensory System Agents|sensory system agents|mesh-ancestor
24558265|NCT00755898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24558266|NCT00755924|Acetic Acid|acetic acid|mesh-list
24558267|NCT00755924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24558268|NCT00755924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24558269|NCT00755950|Silymarin|silymarin|mesh-list
24558271|NCT00755950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558272|NCT00755950|Protective Agents|protective agents|mesh-ancestor
24558273|NCT00755950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558274|NCT00755963|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24558275|NCT00755963|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24558276|NCT00755963|Estradiol|estradiol|mesh-list
24948171|NCT03921684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948172|NCT03921684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24948173|NCT03921684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24948174|NCT03921684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24948175|NCT03921736|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24948176|NCT03921736|Perindopril|perindopril|mesh-list
24558277|NCT00755963|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24558278|NCT00755963|Progesterone|progesterone|mesh-list
24558279|NCT00755963|Estrogens|estrogens|mesh-ancestor
24558281|NCT00755963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24558282|NCT00755963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558283|NCT00755963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24558289|NCT00755976|Epirubicin|epirubicin|mesh-list
24558290|NCT00755976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24558291|NCT00755976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24558292|NCT00755976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24558293|NCT00755976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24558294|NCT00755976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24558295|NCT00755976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558296|NCT00755976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24558297|NCT00755976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24558298|NCT00755976|Analgesics|analgesics|mesh-ancestor
24558299|NCT00755976|Sensory System Agents|sensory system agents|mesh-ancestor
24558300|NCT00755976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24558301|NCT00755976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558302|NCT00755976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24558303|NCT00755976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24558304|NCT00755976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24558306|NCT00755989|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24558307|NCT00755989|Narcotics|narcotics|mesh-ancestor
24558308|NCT00755989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24558309|NCT00755989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558310|NCT00755989|Analgesics|analgesics|mesh-ancestor
24558311|NCT00755989|Sensory System Agents|sensory system agents|mesh-ancestor
24558320|NCT00756171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558321|NCT00756171|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24558333|NCT00756301|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24558334|NCT00756301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24558335|NCT00756301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558341|NCT00756340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24558342|NCT00756340|Growth Substances|growth substances|mesh-ancestor
24558343|NCT00756340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558344|NCT00756340|Growth Inhibitors|growth inhibitors|mesh-ancestor
24558345|NCT00756340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24558346|NCT00756340|Immunologic Factors|immunologic factors|mesh-ancestor
24558347|NCT00756405|Antioxidants|antioxidants|mesh-list
24558348|NCT00756405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558349|NCT00756405|Protective Agents|protective agents|mesh-ancestor
24558350|NCT00756405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558351|NCT00756691|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
24558352|NCT00756691|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24948178|NCT03921736|Diuretics|diuretics|mesh-ancestor
24948179|NCT03921736|Natriuretic Agents|natriuretic agents|mesh-ancestor
24558353|NCT00756691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558354|NCT00756847|Paclitaxel|paclitaxel|mesh-list
24558355|NCT00756847|Carboplatin|carboplatin|mesh-list
24558400|NCT00757029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24558401|NCT00757029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558402|NCT00757029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25697274|NCT02074358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697275|NCT02074358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558403|NCT00757029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24558404|NCT00757029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24558405|NCT00757029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558407|NCT00757029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24558408|NCT00757029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24558409|NCT00757029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24558410|NCT00757029|Adrenergic Agents|adrenergic agents|mesh-ancestor
24558411|NCT00757029|Sympathomimetics|sympathomimetics|mesh-ancestor
24558412|NCT00757029|Autonomic Agents|autonomic agents|mesh-ancestor
24558413|NCT00757029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24558414|NCT00757029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24558422|NCT00757185|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24558423|NCT00757185|Ganirelix|ganirelix|mesh-list
24558424|NCT00757185|Androgens|androgens|mesh-ancestor
24558425|NCT00757185|Hormones|hormones|mesh-ancestor
24558426|NCT00757185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24558427|NCT00757185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558458|NCT00757380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24558459|NCT00757380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24558460|NCT00757380|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24558461|NCT00757393|Calcium, Dietary|calcium, dietary|mesh-list
24558462|NCT00757393|Vitamin D|vitamin d|mesh-list
24558463|NCT00757393|Ergocalciferols|ergocalciferols|mesh-list
24948181|NCT03921736|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24948182|NCT03921736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24948183|NCT03921736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948184|NCT03921736|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24948185|NCT03921736|Protease Inhibitors|protease inhibitors|mesh-ancestor
24948186|NCT03921736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24948187|NCT03921645|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24802132|NCT01987739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24558464|NCT00757393|Cholecalciferol|cholecalciferol|mesh-list
24558465|NCT00757393|Vitamins|vitamins|mesh-list
24558466|NCT00757393|Calcium|calcium|mesh-list
24558467|NCT00757393|Micronutrients|micronutrients|mesh-ancestor
24558468|NCT00757393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558469|NCT00757393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24558470|NCT00757393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24558471|NCT00757419|Lesogaberan|lesogaberan|mesh-list
24558472|NCT00757419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24558473|NCT00757419|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24558474|NCT00757419|GABA Agonists|gaba agonists|mesh-ancestor
24558475|NCT00757419|GABA Agents|gaba agents|mesh-ancestor
24558480|NCT00757458|Edetic Acid|edetic acid|mesh-list
24558486|NCT00757458|Anesthetics, General|anesthetics, general|mesh-ancestor
24558487|NCT00757458|Anesthetics|anesthetics|mesh-ancestor
24558515|NCT00757679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24558516|NCT00757679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24558517|NCT00757679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558518|NCT00757679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24558519|NCT00757679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558520|NCT00757679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24558522|NCT00757679|Sensory System Agents|sensory system agents|mesh-ancestor
24558523|NCT00757679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24558524|NCT00757679|Antidepressive Agents|antidepressive agents|mesh-ancestor
24558525|NCT00757679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24558526|NCT00757692|Bicalutamide|bicalutamide|mesh-list
24558527|NCT00757692|Androgen Antagonists|androgen antagonists|mesh-ancestor
24558528|NCT00757692|Hormone Antagonists|hormone antagonists|mesh-ancestor
24558531|NCT00757692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24558532|NCT00757731|Milnacipran|milnacipran|mesh-list
24558533|NCT00757731|Levomilnacipran|levomilnacipran|mesh-list
24558534|NCT00757731|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24448422|NCT00311740|Diuretics|diuretics|mesh-ancestor
24448423|NCT00311740|Natriuretic Agents|natriuretic agents|mesh-ancestor
24448424|NCT00311740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448425|NCT00311740|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24448426|NCT00311740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24448427|NCT00311753|Heparin|heparin|mesh-list
24448428|NCT00311753|Certoparin|certoparin|mesh-list
24448429|NCT00311753|Anticoagulants|anticoagulants|mesh-ancestor
24558565|NCT00757874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948188|NCT03921645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24948189|NCT03921671|Paclitaxel|paclitaxel|mesh-list
24948191|NCT03921671|Ramucirumab|ramucirumab|mesh-list
24948192|NCT03921671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24948193|NCT03921671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24948194|NCT03921671|Tubulin Modulators|tubulin modulators|mesh-ancestor
24948195|NCT03921671|Antimitotic Agents|antimitotic agents|mesh-ancestor
24948196|NCT03921671|Mitosis Modulators|mitosis modulators|mesh-ancestor
24564040|NCT00774904|Losartan|losartan|mesh-list
24422430|NCT00222495|Risperidone|risperidone|mesh-list
24422431|NCT00222495|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24422432|NCT00222495|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24449927|NCT00317408|Protective Agents|protective agents|mesh-ancestor
24449928|NCT00317408|Vitamin B Complex|vitamin b complex|mesh-ancestor
24449930|NCT00317408|Micronutrients|micronutrients|mesh-ancestor
24449931|NCT00317408|Antifungal Agents|antifungal agents|mesh-ancestor
24449932|NCT00317408|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24449937|NCT00317408|Sensory System Agents|sensory system agents|mesh-ancestor
24449938|NCT00317408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24449942|NCT00317421|Sildenafil Citrate|sildenafil citrate|mesh-list
24948200|NCT03921567|Lidocaine|lidocaine|mesh-list
24948201|NCT03921567|Ketamine|ketamine|mesh-list
24948202|NCT03921567|Anesthetics, Local|anesthetics, local|mesh-ancestor
24558566|NCT00757874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24558567|NCT00757874|Glucocorticoids|glucocorticoids|mesh-ancestor
24558568|NCT00757874|Hormones|hormones|mesh-ancestor
24558569|NCT00757874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24558570|NCT00757978|Memantine|memantine|mesh-list
24558571|NCT00757978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24558572|NCT00757978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24558573|NCT00757978|Dopamine Agents|dopamine agents|mesh-ancestor
24558574|NCT00757978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24558575|NCT00757978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558576|NCT00757978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558577|NCT00757978|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24558579|NCT00758004|Atorvastatin|atorvastatin|mesh-list
24558583|NCT00758004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558584|NCT00758004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24558585|NCT00758004|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24558586|NCT00758004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24558587|NCT00758030|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24558588|NCT00758030|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24558589|NCT00758030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24558595|NCT00758030|Serotonin Agents|serotonin agents|mesh-ancestor
24558596|NCT00758030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24558597|NCT00758030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558598|NCT00758030|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24558599|NCT00758030|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24558600|NCT00758030|Dopamine Agents|dopamine agents|mesh-ancestor
24558601|NCT00758134|Trastuzumab|trastuzumab|mesh-list
24558602|NCT00758134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24558603|NCT00758134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24558604|NCT00758199|Moxifloxacin|moxifloxacin|mesh-list
24558605|NCT00758199|Prednisolone|prednisolone|mesh-list
24558606|NCT00758199|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24558607|NCT00758199|Methylprednisolone|methylprednisolone|mesh-list
24948204|NCT03921567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24558608|NCT00758199|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24558611|NCT00758199|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24558612|NCT00758199|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24558613|NCT00758199|Prednisolone phosphate|prednisolone phosphate|mesh-list
24558614|NCT00758199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24558615|NCT00758199|Glucocorticoids|glucocorticoids|mesh-ancestor
24558617|NCT00758199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24558618|NCT00758199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558619|NCT00758199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24558620|NCT00758199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465619|NCT00370318|Vaccines|vaccines|mesh-list
24558621|NCT00758199|Antiemetics|antiemetics|mesh-ancestor
24558622|NCT00758199|Autonomic Agents|autonomic agents|mesh-ancestor
24558623|NCT00758199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24558624|NCT00758199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24558625|NCT00758199|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24558626|NCT00758199|Protective Agents|protective agents|mesh-ancestor
24558627|NCT00758199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24558640|NCT00758199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24558641|NCT00758199|Analgesics|analgesics|mesh-ancestor
24558642|NCT00758199|Sensory System Agents|sensory system agents|mesh-ancestor
24558643|NCT00758199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24558645|NCT00758212|Immunologic Factors|immunologic factors|mesh-ancestor
24558646|NCT00758212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558647|NCT00758225|Idebenone|idebenone|mesh-list
24558648|NCT00758225|Antioxidants|antioxidants|mesh-ancestor
24558649|NCT00758225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558650|NCT00758225|Protective Agents|protective agents|mesh-ancestor
24558651|NCT00758225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558652|NCT00758277|Levetiracetam|levetiracetam|mesh-list
24558653|NCT00758277|Anticonvulsants|anticonvulsants|mesh-ancestor
24558654|NCT00758277|Nootropic Agents|nootropic agents|mesh-ancestor
24558655|NCT00758368|Apomorphine|apomorphine|mesh-list
24558656|NCT00758368|Emetics|emetics|mesh-ancestor
24558657|NCT00758368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558658|NCT00758368|Autonomic Agents|autonomic agents|mesh-ancestor
24564178|NCT00775489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24560151|NCT03486197|Pembrolizumab|pembrolizumab|mesh-list
24558659|NCT00758368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24558660|NCT00758368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24558661|NCT00758368|Dopamine Agonists|dopamine agonists|mesh-ancestor
24558662|NCT00758368|Dopamine Agents|dopamine agents|mesh-ancestor
24558663|NCT00758368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24558664|NCT00758368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558665|NCT00758381|Sorafenib|sorafenib|mesh-list
24558666|NCT00758381|Cisplatin|cisplatin|mesh-list
24558667|NCT00758381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24558668|NCT00758381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24558669|NCT00758381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24558670|NCT00758381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558671|NCT05436093|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24558672|NCT05436093|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24558673|NCT05436093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558674|NCT05436054|Picosulfate sodium|picosulfate sodium|mesh-list
24558675|NCT05436054|Cathartics|cathartics|mesh-ancestor
24558676|NCT05436054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24558677|NCT05436002|Hyaluronic Acid|hyaluronic acid|mesh-list
24558678|NCT05436002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24558679|NCT05436002|Immunologic Factors|immunologic factors|mesh-ancestor
24558681|NCT05436002|Viscosupplements|viscosupplements|mesh-ancestor
24558697|NCT05435781|Hydrocortisone|hydrocortisone|mesh-list
24948205|NCT03921567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948207|NCT03921567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24948208|NCT03921567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24948209|NCT03921567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24948210|NCT03921567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24948211|NCT03921567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25697276|NCT02074358|Anticoagulants|anticoagulants|mesh-ancestor
25697277|NCT02074514|Sofosbuvir|sofosbuvir|mesh-list
25697278|NCT02074514|Antiviral Agents|antiviral agents|mesh-ancestor
25406595|NCT03547908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697279|NCT02074514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25697280|NCT02074709|Bupivacaine|bupivacaine|mesh-list
25697281|NCT02074709|Anesthetics, Local|anesthetics, local|mesh-ancestor
25697282|NCT02074709|Anesthetics|anesthetics|mesh-ancestor
25697283|NCT02074709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25050543|NCT00486512|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
25050544|NCT00486512|Calcium Carbonate|calcium carbonate|mesh-list
25050545|NCT00486512|Calcium|calcium|mesh-list
24853223|NCT02266589|Hydrocortisone|hydrocortisone|mesh-list
24948212|NCT03921567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948213|NCT03921567|Analgesics|analgesics|mesh-ancestor
24802144|NCT01988077|Ipilimumab|ipilimumab|mesh-list
24802145|NCT01988077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24802146|NCT01988077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24802147|NCT01988077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24558698|NCT05435781|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24558699|NCT05435781|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24558700|NCT05435781|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24558701|NCT05435781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24558719|NCT05435560|Dexmedetomidine|dexmedetomidine|mesh-list
24558745|NCT05435378|Vitamins|vitamins|mesh-list
24558746|NCT05435378|Folic Acid|folic acid|mesh-list
24558747|NCT05435378|Niacinamide|niacinamide|mesh-list
24558830|NCT05430126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
24558831|NCT05430126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24558832|NCT05430126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558834|NCT05428306|Ibuprofen|ibuprofen|mesh-list
24773571|NCT01840683|Anticoagulants|anticoagulants|mesh-ancestor
24773572|NCT01840683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24773573|NCT01840683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24773574|NCT01840683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773576|NCT01840696|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
24773577|NCT01840696|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24773578|NCT01840696|Purinergic Agonists|purinergic agonists|mesh-ancestor
24773579|NCT01840696|Purinergic Agents|purinergic agents|mesh-ancestor
24773580|NCT01840696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24773581|NCT01840696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558861|NCT05427825|Anesthetics|anesthetics|mesh-list
24558862|NCT05427825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24558863|NCT05427825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558864|NCT05427266|Bupivacaine|bupivacaine|mesh-list
24558865|NCT05427266|Anesthetics, Local|anesthetics, local|mesh-ancestor
24558866|NCT05427266|Anesthetics|anesthetics|mesh-ancestor
24558867|NCT05427266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24558868|NCT05427266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558869|NCT05427266|Sensory System Agents|sensory system agents|mesh-ancestor
24558870|NCT05427266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24448442|NCT00311857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697284|NCT02074709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697285|NCT02074709|Sensory System Agents|sensory system agents|mesh-ancestor
25697286|NCT02074709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25697287|NCT02074735|Choline|choline|mesh-list
25697288|NCT02074735|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
25697289|NCT02074735|Lipotropic Agents|lipotropic agents|mesh-ancestor
25697290|NCT02074735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25697291|NCT02074735|Antimetabolites|antimetabolites|mesh-ancestor
24773589|NCT01840774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24773590|NCT01840774|Anesthetics, General|anesthetics, general|mesh-ancestor
24773592|NCT01840774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24773593|NCT01840774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24773594|NCT01840774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24773595|NCT01840774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24773596|NCT01840774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626152|NCT01085721|Nasal Decongestants|nasal decongestants|mesh-ancestor
24802188|NCT01988545|Glucagon|glucagon|mesh-list
24802189|NCT01988545|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24802190|NCT01988545|Incretins|incretins|mesh-ancestor
24802191|NCT01988545|Hormones|hormones|mesh-ancestor
24802192|NCT01988545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24802193|NCT01988545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802194|NCT01988545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24558920|NCT05414305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24558921|NCT05414305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24558922|NCT05414305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558923|NCT05414305|Anticoagulants|anticoagulants|mesh-ancestor
24558924|NCT05414305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24558925|NCT05414305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24558926|NCT05396898|Tacrolimus|tacrolimus|mesh-list
24558927|NCT05396898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24558928|NCT05396898|Immunologic Factors|immunologic factors|mesh-ancestor
24558929|NCT05396898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558930|NCT05396898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24558931|NCT05396898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24558932|NCT05396898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558974|NCT05382338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24558975|NCT05382338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24558976|NCT05382338|Tubulin Modulators|tubulin modulators|mesh-ancestor
24558977|NCT05382338|Antimitotic Agents|antimitotic agents|mesh-ancestor
24558978|NCT05382338|Mitosis Modulators|mitosis modulators|mesh-ancestor
24558979|NCT05382338|Protective Agents|protective agents|mesh-ancestor
24558980|NCT05382338|Antidotes|antidotes|mesh-ancestor
24558981|NCT05382338|Antioxidants|antioxidants|mesh-ancestor
24558982|NCT05382338|Antitubercular Agents|antitubercular agents|mesh-ancestor
24558983|NCT05382338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24558984|NCT05382338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24558985|NCT05382338|Chelating Agents|chelating agents|mesh-ancestor
24626153|NCT01085721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24626154|NCT01085721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24626155|NCT01085721|Sympathomimetics|sympathomimetics|mesh-ancestor
24948214|NCT03921567|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24948215|NCT03921567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24948216|NCT03921567|Anesthetics, General|anesthetics, general|mesh-ancestor
24948217|NCT03921567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24948218|NCT03921567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24948219|NCT03921567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24948220|NCT03921775|Propofol|propofol|mesh-list
24558986|NCT05382338|Sequestering Agents|sequestering agents|mesh-ancestor
24559119|NCT05291221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24559120|NCT05291221|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24559121|NCT05291221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24559122|NCT05291221|Analgesics|analgesics|mesh-ancestor
24559123|NCT05291221|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24559124|NCT05291221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24559125|NCT05291221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24559126|NCT05291221|Adrenergic Agents|adrenergic agents|mesh-ancestor
24559127|NCT05291221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24559128|NCT05289193|Nivolumab|nivolumab|mesh-list
24559129|NCT05289193|Ipilimumab|ipilimumab|mesh-list
24559130|NCT05289193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24559131|NCT05289193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24559132|NCT05289193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24559133|NCT05289193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24559134|NCT05271071|Lidocaine|lidocaine|mesh-list
24559135|NCT05271071|Anesthetics, Local|anesthetics, local|mesh-ancestor
24559136|NCT05271071|Anesthetics|anesthetics|mesh-ancestor
24462681|NCT00357240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24559156|NCT05249569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24559157|NCT05249569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24559158|NCT05249569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24559159|NCT05249569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24559160|NCT05249569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24559164|NCT05230901|Hormone Antagonists|hormone antagonists|mesh-ancestor
24948241|NCT03921099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948242|NCT03921099|Antioxidants|antioxidants|mesh-ancestor
24948243|NCT03921099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948244|NCT03921099|Protective Agents|protective agents|mesh-ancestor
24948245|NCT03920657|Deferasirox|deferasirox|mesh-list
24564816|NCT00778011|Autonomic Agents|autonomic agents|mesh-ancestor
24564817|NCT00778011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24559253|NCT05167864|Cholinergic Agents|cholinergic agents|mesh-ancestor
24559254|NCT05167864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24559269|NCT05122221|Immunologic Factors|immunologic factors|mesh-ancestor
24559270|NCT05122221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24559271|NCT05122221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24559272|NCT05122221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24559273|NCT05122221|Alkylating Agents|alkylating agents|mesh-ancestor
24559274|NCT05122221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948246|NCT03920657|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24948247|NCT03920657|Chelating Agents|chelating agents|mesh-ancestor
24948248|NCT03920657|Sequestering Agents|sequestering agents|mesh-ancestor
24948249|NCT03920657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948250|NCT03920631|Nivolumab|nivolumab|mesh-list
24948251|NCT03920631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24948252|NCT03920631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24559275|NCT05122221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24559276|NCT05122221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24559277|NCT05122221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24559278|NCT05122221|Analgesics|analgesics|mesh-ancestor
24559329|NCT05022927|Atezolizumab|atezolizumab|mesh-list
24559330|NCT05022927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24559337|NCT05011760|Amphetamine|amphetamine|mesh-list
24559344|NCT05011760|Dopamine Agents|dopamine agents|mesh-ancestor
24559350|NCT05011760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24559351|NCT05011760|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24559352|NCT05008146|Hydrocortisone|hydrocortisone|mesh-list
24559353|NCT05008146|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24559354|NCT05008146|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24559355|NCT05008146|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25697292|NCT02074735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697293|NCT02074735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25697294|NCT02074735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25697295|NCT02074735|Nootropic Agents|nootropic agents|mesh-ancestor
25697296|NCT02074982|Ustekinumab|ustekinumab|mesh-list
25697297|NCT02074982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25697298|NCT02074982|Immunologic Factors|immunologic factors|mesh-ancestor
25697299|NCT02074982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697300|NCT02074982|Dermatologic Agents|dermatologic agents|mesh-ancestor
24564858|NCT00778050|Amoxicillin|amoxicillin|mesh-list
24448445|NCT00311870|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24448446|NCT00311870|Protease Inhibitors|protease inhibitors|mesh-ancestor
24448447|NCT00311870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448448|NCT00311870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448449|NCT00311870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24448500|NCT00312000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24448501|NCT00312000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448503|NCT00312013|Anticoagulants|anticoagulants|mesh-ancestor
24448504|NCT00312013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24448505|NCT00312013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24448510|NCT00312039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24448512|NCT00312039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448513|NCT00312039|Antiviral Agents|antiviral agents|mesh-ancestor
24448514|NCT00312039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24948266|NCT03920878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24948267|NCT03920878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24948268|NCT03920878|Growth Substances|growth substances|mesh-ancestor
24559414|NCT04875728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24559415|NCT04875728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24559485|NCT04757584|Carvedilol|carvedilol|mesh-list
24559486|NCT04757584|Nebivolol|nebivolol|mesh-list
24559487|NCT04757584|Bisoprolol|bisoprolol|mesh-list
24559488|NCT04757584|Labetalol|labetalol|mesh-list
24559499|NCT04757584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24559500|NCT04757584|Vasodilator Agents|vasodilator agents|mesh-ancestor
24559501|NCT04757584|Sympatholytics|sympatholytics|mesh-ancestor
24948279|NCT03920618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948280|NCT03920618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24948281|NCT03920618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25697301|NCT02075047|Ziprasidone|ziprasidone|mesh-list
24948282|NCT03920839|Gemcitabine|gemcitabine|mesh-list
24948283|NCT03920839|Paclitaxel|paclitaxel|mesh-list
24948284|NCT03920839|Carboplatin|carboplatin|mesh-list
24948285|NCT03920839|Pemetrexed|pemetrexed|mesh-list
25697302|NCT02075047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25697303|NCT02075047|Serotonin Agents|serotonin agents|mesh-ancestor
25697304|NCT02075047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25697305|NCT02075047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697306|NCT02075047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697307|NCT02075047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25697308|NCT02075047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24525422|NCT03405090|Anesthetics|anesthetics|mesh-ancestor
24948286|NCT03920839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24802238|NCT01989000|Antimetabolites|antimetabolites|mesh-ancestor
24559592|NCT04640168|Hormones|hormones|mesh-ancestor
24559640|NCT04581824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24948287|NCT03920839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24948289|NCT03920839|Antimitotic Agents|antimitotic agents|mesh-ancestor
24948290|NCT03920839|Mitosis Modulators|mitosis modulators|mesh-ancestor
24559641|NCT04581824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24559875|NCT04187144|Nitrofurantoin|nitrofurantoin|mesh-list
24948291|NCT03920839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948292|NCT03920839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24559893|NCT04128748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24559978|NCT03897348|Lacosamide|lacosamide|mesh-list
24559979|NCT03897348|Anticonvulsants|anticonvulsants|mesh-ancestor
24559980|NCT03897348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24559981|NCT03897348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24559982|NCT03897348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24559983|NCT03897348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469378|NCT00385606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24469379|NCT00385606|Antimetabolites|antimetabolites|mesh-ancestor
24469380|NCT00385606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469833|NCT00387504|Protective Agents|protective agents|mesh-ancestor
24469834|NCT00387504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24560077|NCT03617458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24560083|NCT03584009|Venetoclax|venetoclax|mesh-list
24560084|NCT03584009|Fulvestrant|fulvestrant|mesh-list
24560099|NCT03583359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24560100|NCT03583359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24560101|NCT03583359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24560102|NCT03583359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24560103|NCT03583359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560142|NCT03492463|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24560144|NCT03492463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24560145|NCT03492463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24560146|NCT03492463|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24560147|NCT03492463|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24560148|NCT03492463|Cholinergic Agents|cholinergic agents|mesh-ancestor
24560152|NCT03486197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24560153|NCT03486197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470361|NCT00389935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948300|NCT03920839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24948301|NCT03920839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24560172|NCT03417687|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24560173|NCT03417687|Anesthetics, General|anesthetics, general|mesh-ancestor
24560215|NCT03205137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560216|NCT03205137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24560217|NCT03205137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24560220|NCT03205137|Natriuretic Agents|natriuretic agents|mesh-ancestor
24560221|NCT03205137|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24560222|NCT03205137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24560223|NCT03205137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24560227|NCT03168256|Apremilast|apremilast|mesh-list
24560228|NCT03168256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24470362|NCT00389935|Leprostatic Agents|leprostatic agents|mesh-ancestor
24470445|NCT00390195|Everolimus|everolimus|mesh-list
24470550|NCT00390520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470551|NCT00390598|Sennosides|sennosides|mesh-list
25697309|NCT02075047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25697310|NCT02075047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24470552|NCT00390598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24470553|NCT00390598|Laxatives|laxatives|mesh-ancestor
24470554|NCT00390598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24470555|NCT00390624|Mannitol|mannitol|mesh-list
24470556|NCT00390624|Ularitide|ularitide|mesh-list
24470557|NCT00390624|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24470558|NCT00390624|Diuretics|diuretics|mesh-ancestor
24470559|NCT00390624|Natriuretic Agents|natriuretic agents|mesh-ancestor
24560229|NCT03168256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24560230|NCT03168256|Analgesics|analgesics|mesh-ancestor
24560231|NCT03168256|Sensory System Agents|sensory system agents|mesh-ancestor
24560232|NCT03168256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24560233|NCT03168256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24560234|NCT03168256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24560235|NCT03168256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24560236|NCT03168256|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24560237|NCT03168256|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24560238|NCT03168256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24560239|NCT03168256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560240|NCT03086369|Gemcitabine|gemcitabine|mesh-list
24560241|NCT03086369|Paclitaxel|paclitaxel|mesh-list
24560245|NCT03086369|Tubulin Modulators|tubulin modulators|mesh-ancestor
24560246|NCT03086369|Antimitotic Agents|antimitotic agents|mesh-ancestor
24560247|NCT03086369|Mitosis Modulators|mitosis modulators|mesh-ancestor
24560248|NCT03086369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560250|NCT03086369|Antimetabolites|antimetabolites|mesh-ancestor
24560254|NCT03086369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24560255|NCT03086369|Immunologic Factors|immunologic factors|mesh-ancestor
24560256|NCT03086369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24560257|NCT03083808|Pembrolizumab|pembrolizumab|mesh-list
24560258|NCT03083808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24560259|NCT03083808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24560261|NCT03078010|Piperacillin|piperacillin|mesh-list
24560263|NCT03078010|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24560264|NCT03078010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24560265|NCT03078010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24560266|NCT03078010|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24560267|NCT03078010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24560268|NCT03078010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478262|NCT00421967|Sympathomimetics|sympathomimetics|mesh-ancestor
24560404|NCT02726997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24560406|NCT02726997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24560407|NCT02720523|Upadacitinib|upadacitinib|mesh-list
24560408|NCT02720523|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
24560409|NCT02720523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24560410|NCT02720523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24948307|NCT03920644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24948308|NCT03920644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24560411|NCT02720523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560412|NCT02720523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24560413|NCT02689440|Dasatinib|dasatinib|mesh-list
24560414|NCT02689440|Venetoclax|venetoclax|mesh-list
24560415|NCT02689440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24560416|NCT02689440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24560417|NCT02689440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24560418|NCT02689440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560419|NCT02677545|Aspirin|aspirin|mesh-list
24560420|NCT02677545|Clopidogrel|clopidogrel|mesh-list
24560421|NCT02677545|Ticagrelor|ticagrelor|mesh-list
24560422|NCT02677545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24560423|NCT02677545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24560424|NCT02677545|Analgesics|analgesics|mesh-ancestor
24560425|NCT02677545|Sensory System Agents|sensory system agents|mesh-ancestor
24560426|NCT02677545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24560432|NCT02677545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671015|NCT01323244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671018|NCT01323257|Erythromycin|erythromycin|mesh-list
25697311|NCT02075047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25697312|NCT02075047|Dopamine Agents|dopamine agents|mesh-ancestor
24671019|NCT01323257|Erythromycin Estolate|erythromycin estolate|mesh-list
24671020|NCT01323257|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24671021|NCT01323257|Erythromycin stearate|erythromycin stearate|mesh-list
24560433|NCT02677545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24560434|NCT02677545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24560435|NCT02677545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671022|NCT01323257|Simeprevir|simeprevir|mesh-list
24560436|NCT02677545|Antipyretics|antipyretics|mesh-ancestor
24560437|NCT02677545|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24560438|NCT02677545|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24560439|NCT02677545|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24560440|NCT02677545|Purinergic Agents|purinergic agents|mesh-ancestor
24560441|NCT02677545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24560442|NCT02669680|Lenograstim|lenograstim|mesh-list
24560443|NCT02669680|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24560444|NCT02669680|Immunologic Factors|immunologic factors|mesh-ancestor
24560445|NCT02669680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24560553|NCT02312245|Immunoglobulin G|immunoglobulin g|mesh-list
24560554|NCT02312245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24560555|NCT02312245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24560556|NCT02312245|Tubulin Modulators|tubulin modulators|mesh-ancestor
24560557|NCT02312245|Antimitotic Agents|antimitotic agents|mesh-ancestor
24560560|NCT02312245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24560561|NCT02312245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24560562|NCT02312245|Growth Substances|growth substances|mesh-ancestor
24444923|NCT00299676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24405617|NCT00167765|Abciximab|abciximab|mesh-list
24456944|NCT00332761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456945|NCT00332774|Ketorolac|ketorolac|mesh-list
24456946|NCT00332774|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24456947|NCT00332774|Nepafenac|nepafenac|mesh-list
24456948|NCT00332774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24456949|NCT00332774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24477535|NCT00418925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24477536|NCT00418925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24560563|NCT02312245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24560564|NCT02312245|Growth Inhibitors|growth inhibitors|mesh-ancestor
24560565|NCT02312245|Immunologic Factors|immunologic factors|mesh-ancestor
24560566|NCT02312245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24560567|NCT02312245|Antimetabolites|antimetabolites|mesh-ancestor
24560568|NCT02312245|Antiviral Agents|antiviral agents|mesh-ancestor
24560569|NCT02312245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24560570|NCT02312245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24560571|NCT02312245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24560573|NCT02312245|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24560574|NCT02312245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24560575|NCT02312245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24560576|NCT02311478|Copper|copper|mesh-list
24560577|NCT02311478|Contraceptive Agents|contraceptive agents|mesh-list
24560578|NCT02311478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24560579|NCT02311478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24560581|NCT02311478|Micronutrients|micronutrients|mesh-ancestor
24560582|NCT02303028|Topotecan|topotecan|mesh-list
24560583|NCT02303028|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24456980|NCT00332852|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24477580|NCT00419172|Deferasirox|deferasirox|mesh-list
24477992|NCT00421109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24478029|NCT00421200|Blood Substitutes|blood substitutes|mesh-ancestor
24478117|NCT00421512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24478118|NCT00421512|Growth Substances|growth substances|mesh-ancestor
24478119|NCT00421512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478260|NCT00421967|Respiratory System Agents|respiratory system agents|mesh-ancestor
24478261|NCT00421967|Mydriatics|mydriatics|mesh-ancestor
25697313|NCT02075073|Trastuzumab|trastuzumab|mesh-list
25697314|NCT02075073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25697315|NCT02075073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25697316|NCT02075125|Ticagrelor|ticagrelor|mesh-list
25697317|NCT02075125|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25697318|NCT02075125|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24625658|NCT01082809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24625659|NCT01082809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24560611|NCT02218164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24560612|NCT02218164|Immunologic Factors|immunologic factors|mesh-ancestor
24560613|NCT02218164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24560614|NCT02218164|Antiviral Agents|antiviral agents|mesh-ancestor
24560615|NCT02218164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24478267|NCT00421980|Analgesics|analgesics|mesh-ancestor
24560630|NCT02106988|Dexamethasone|dexamethasone|mesh-list
24560631|NCT02106988|Carboplatin|carboplatin|mesh-list
24560632|NCT02106988|Etoposide|etoposide|mesh-list
24560633|NCT02106988|Ifosfamide|ifosfamide|mesh-list
24560634|NCT02106988|Etoposide phosphate|etoposide phosphate|mesh-list
24560635|NCT02106988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24560642|NCT02106988|Hormones|hormones|mesh-ancestor
24560661|NCT02018861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24560662|NCT02018861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24560663|NCT02018861|Immunologic Factors|immunologic factors|mesh-ancestor
24560664|NCT02018861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24560665|NCT02018861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24560666|NCT02018861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24560667|NCT02018861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24560668|NCT02018861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24560669|NCT02018861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24560670|NCT02018861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560671|NCT02018861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24560672|NCT02018861|Alkylating Agents|alkylating agents|mesh-ancestor
24560806|NCT01451515|Dermatologic Agents|dermatologic agents|mesh-ancestor
24560807|NCT01451515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24560858|NCT01302834|Cetuximab|cetuximab|mesh-list
24560859|NCT01302834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24561323|NCT00759421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24561010|NCT00662792|Autonomic Agents|autonomic agents|mesh-ancestor
24561011|NCT00662792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24561012|NCT00662792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561013|NCT00662792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24561014|NCT00662792|Respiratory System Agents|respiratory system agents|mesh-ancestor
25051629|NCT00393068|Growth Substances|growth substances|mesh-ancestor
24948322|NCT03920605|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24948328|NCT03920553|Hyaluronic Acid|hyaluronic acid|mesh-list
24561156|NCT00758407|Methylphenidate|methylphenidate|mesh-list
24561157|NCT00758407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24561158|NCT00758407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561159|NCT00758407|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24561160|NCT00758407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24561161|NCT00758407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25697319|NCT02075125|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25697320|NCT02075125|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25697321|NCT02075125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25697322|NCT02075125|Purinergic Agents|purinergic agents|mesh-ancestor
24561162|NCT00758407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561163|NCT00758407|Dopamine Agents|dopamine agents|mesh-ancestor
24561164|NCT00758407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25697323|NCT02075125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25697324|NCT02075125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697325|NCT02075125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561166|NCT00758433|Antipruritics|antipruritics|mesh-ancestor
24561167|NCT00758433|Dermatologic Agents|dermatologic agents|mesh-ancestor
24561168|NCT00758433|Sensory System Agents|sensory system agents|mesh-ancestor
24457072|NCT00333047|Letrozole|letrozole|mesh-list
24457073|NCT00333047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479155|NCT00425724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24479261|NCT00426101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24561169|NCT00758433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24561170|NCT00758433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561171|NCT00758693|Rituximab|rituximab|mesh-list
24561172|NCT00758693|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24561173|NCT00758693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24561181|NCT00758732|Carboplatin|carboplatin|mesh-list
24561223|NCT00759070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24561224|NCT00759070|Protease Inhibitors|protease inhibitors|mesh-ancestor
24561225|NCT00759070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24561226|NCT00759070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561227|NCT00759070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24561228|NCT00759070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24561236|NCT00759070|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24561237|NCT00759070|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24561238|NCT00759070|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24561239|NCT00759070|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24561241|NCT00759083|Antithrombins|antithrombins|mesh-ancestor
24561242|NCT00759083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24561243|NCT00759083|Protease Inhibitors|protease inhibitors|mesh-ancestor
24948330|NCT03920553|Immunologic Factors|immunologic factors|mesh-ancestor
24948331|NCT03920553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561281|NCT00759226|Protective Agents|protective agents|mesh-ancestor
24561282|NCT00759226|Vitamin B Complex|vitamin b complex|mesh-ancestor
24561283|NCT00759226|Vitamins|vitamins|mesh-ancestor
24561284|NCT00759226|Micronutrients|micronutrients|mesh-ancestor
24561327|NCT00759421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561328|NCT00759421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24561329|NCT00759421|Serotonin Agents|serotonin agents|mesh-ancestor
24561330|NCT00759460|Olanzapine|olanzapine|mesh-list
24561331|NCT00759460|Sertindole|sertindole|mesh-list
24561332|NCT00759460|Antiemetics|antiemetics|mesh-ancestor
24561333|NCT00759460|Autonomic Agents|autonomic agents|mesh-ancestor
24561334|NCT00759460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24561335|NCT00759460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561336|NCT00759460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24561337|NCT00759460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24561338|NCT00759460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25051609|NCT00393952|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25051610|NCT00393952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25051611|NCT00393952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24596643|NCT00944606|Vitamin D|vitamin d|mesh-list
24561339|NCT00759460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24561340|NCT00759460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24561341|NCT00759460|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24561342|NCT00759460|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24561343|NCT00759460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24561344|NCT00759460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440263|NCT00282100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24561355|NCT00759720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561357|NCT00759733|Natriuretic Agents|natriuretic agents|mesh-ancestor
24561358|NCT00759733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561359|NCT00759824|Cyclophosphamide|cyclophosphamide|mesh-list
24561365|NCT00759824|Immunologic Factors|immunologic factors|mesh-ancestor
24561367|NCT00759824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24561368|NCT00759824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24561369|NCT00759824|Alkylating Agents|alkylating agents|mesh-ancestor
24561370|NCT00759824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561371|NCT00759824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24561372|NCT00759824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24561373|NCT00759824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24561374|NCT00759824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24561375|NCT00759824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24561376|NCT00759824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406745|NCT03536039|Tubulin Modulators|tubulin modulators|mesh-ancestor
25051613|NCT00393952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25051614|NCT00393952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561446|NCT00760448|Isophane Insulin, Human|isophane insulin, human|mesh-list
24561447|NCT00760448|Insulin, Isophane|insulin, isophane|mesh-list
24561448|NCT00760448|Isophane insulin, beef|isophane insulin, beef|mesh-list
24561449|NCT00760448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24561450|NCT00760448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561451|NCT00760695|Dronabinol|dronabinol|mesh-list
24561452|NCT00760695|Hallucinogens|hallucinogens|mesh-ancestor
24561453|NCT00760695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561454|NCT00760695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24561455|NCT00760695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24561456|NCT00760695|Analgesics|analgesics|mesh-ancestor
24561457|NCT00760695|Sensory System Agents|sensory system agents|mesh-ancestor
24561458|NCT00760695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24561459|NCT00760695|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24561460|NCT00760695|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24561461|NCT00760695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24561462|NCT00760695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561464|NCT00760695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24561465|NCT00760864|Methotrexate|methotrexate|mesh-list
24561466|NCT00760864|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24561467|NCT00760864|Abortifacient Agents|abortifacient agents|mesh-ancestor
24561468|NCT00760864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24561473|NCT00760864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24561474|NCT00760864|Dermatologic Agents|dermatologic agents|mesh-ancestor
24561475|NCT00760864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24561476|NCT00760864|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24561534|NCT00761241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561536|NCT00761241|Antimitotic Agents|antimitotic agents|mesh-ancestor
24561537|NCT00761241|Mitosis Modulators|mitosis modulators|mesh-ancestor
24561539|NCT00761254|Antiemetics|antiemetics|mesh-ancestor
24561540|NCT00761254|Autonomic Agents|autonomic agents|mesh-ancestor
24561541|NCT00761254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24561542|NCT00761254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561558|NCT00761332|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24561560|NCT00761358|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24561561|NCT00761358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24561563|NCT00761358|Cholinergic Agents|cholinergic agents|mesh-ancestor
24561566|NCT00761358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24561567|NCT00761449|Lenalidomide|lenalidomide|mesh-list
24561568|NCT00761449|Immunologic Factors|immunologic factors|mesh-ancestor
24561569|NCT00761449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561570|NCT00761449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24561571|NCT00761449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24561572|NCT00761449|Growth Substances|growth substances|mesh-ancestor
24561573|NCT00761449|Growth Inhibitors|growth inhibitors|mesh-ancestor
24561574|NCT00761449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24561575|NCT00761501|Naproxen|naproxen|mesh-list
24561576|NCT00761501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24561577|NCT00761501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24561578|NCT00761501|Analgesics|analgesics|mesh-ancestor
24561579|NCT00761501|Sensory System Agents|sensory system agents|mesh-ancestor
24561580|NCT00761501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24561581|NCT00761501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561582|NCT00761501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24561583|NCT00761501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24561584|NCT00761501|Gout Suppressants|gout suppressants|mesh-ancestor
24561585|NCT00761501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24561586|NCT00761501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24561594|NCT00761644|Sirolimus|sirolimus|mesh-list
24561595|NCT00761644|Bevacizumab|bevacizumab|mesh-list
24561598|NCT00761644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24561599|NCT00761644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24561600|NCT00761644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24561601|NCT00761644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24561603|NCT00761644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561604|NCT00761644|Growth Inhibitors|growth inhibitors|mesh-ancestor
24561605|NCT00761644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24561618|NCT00761670|Serotonin Agents|serotonin agents|mesh-ancestor
24561619|NCT00761670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24561646|NCT00761904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24561647|NCT00761904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24561648|NCT00761904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24561650|NCT00761904|Natriuretic Agents|natriuretic agents|mesh-ancestor
24457169|NCT00333281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457170|NCT00333281|Urological Agents|urological agents|mesh-ancestor
24457171|NCT00333294|Vinorelbine|vinorelbine|mesh-list
24480929|NCT00432653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561651|NCT00761904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561652|NCT00761904|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24561653|NCT00761904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24561654|NCT00762060|Anesthetics|anesthetics|mesh-list
24561655|NCT00762060|Anesthetics, Local|anesthetics, local|mesh-list
24561656|NCT00762060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24561657|NCT00762060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561659|NCT00762060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24561661|NCT00762099|Analgesics|analgesics|mesh-ancestor
24561662|NCT00762099|Sensory System Agents|sensory system agents|mesh-ancestor
24561663|NCT00762099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24561664|NCT00762099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561665|NCT00762099|Anticonvulsants|anticonvulsants|mesh-ancestor
24561666|NCT00762099|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24561667|NCT00762099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24561668|NCT00762099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561669|NCT00762099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24561670|NCT00762099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24561671|NCT00762099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24561672|NCT00762099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24561674|NCT00762151|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24561675|NCT00762151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24561676|NCT00762190|Insulin|insulin|mesh-list
24561677|NCT00762190|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24561678|NCT00762190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25051625|NCT00393068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051626|NCT00393068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25051627|NCT00393068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25051628|NCT00393068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24561722|NCT00762567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24561723|NCT00762567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561724|NCT00762567|Protective Agents|protective agents|mesh-ancestor
24561726|NCT00762632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24561727|NCT00762632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24561728|NCT00762632|Immunologic Factors|immunologic factors|mesh-ancestor
24561729|NCT00762632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561730|NCT00762658|Betamethasone|betamethasone|mesh-list
24561731|NCT00762658|Tacrolimus|tacrolimus|mesh-list
24561732|NCT00762658|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24561733|NCT00762658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24561734|NCT00762658|Immunologic Factors|immunologic factors|mesh-ancestor
24561735|NCT00762658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561736|NCT00762658|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24561737|NCT00762658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547387|NCT00703703|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24561739|NCT00762658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24561761|NCT00762671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24561762|NCT00762736|Pioglitazone|pioglitazone|mesh-list
24561764|NCT00762736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24561765|NCT00762736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561766|NCT00762736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24561767|NCT00762736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24561778|NCT00762749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24561780|NCT00762749|Autonomic Agents|autonomic agents|mesh-ancestor
24561781|NCT00762749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24561782|NCT00762749|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24561783|NCT00762749|Histamine Antagonists|histamine antagonists|mesh-ancestor
24561784|NCT00762749|Histamine Agents|histamine agents|mesh-ancestor
24561785|NCT00762749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24561786|NCT00762749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561787|NCT00762749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24561788|NCT00762749|Antipruritics|antipruritics|mesh-ancestor
24561789|NCT00762749|Dermatologic Agents|dermatologic agents|mesh-ancestor
24561790|NCT00762775|Vitamin D|vitamin d|mesh-list
24561791|NCT00762775|Calcium|calcium|mesh-list
24561792|NCT00762775|Vitamins|vitamins|mesh-ancestor
24561824|NCT00762983|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24561825|NCT00762983|Histamine Antagonists|histamine antagonists|mesh-ancestor
24561826|NCT00762983|Histamine Agents|histamine agents|mesh-ancestor
24453784|NCT04790513|Evolocumab|evolocumab|mesh-list
24566647|NCT00787007|Equol|equol|mesh-list
24561838|NCT00763165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24561839|NCT00763165|Antimetabolites|antimetabolites|mesh-ancestor
24561840|NCT00763165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561841|NCT00763165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24561842|NCT00763178|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24561843|NCT00763178|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24561844|NCT00763178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24561845|NCT00763178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24561846|NCT00763178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561847|NCT00763178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24561848|NCT00763178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561849|NCT00763178|Analgesics|analgesics|mesh-ancestor
24561850|NCT00763178|Sensory System Agents|sensory system agents|mesh-ancestor
24561851|NCT00763178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24561852|NCT00763178|Antidepressive Agents|antidepressive agents|mesh-ancestor
24561853|NCT00763178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24561854|NCT00763178|Dopamine Agents|dopamine agents|mesh-ancestor
25051641|NCT00392574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25051642|NCT00392574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25051643|NCT00392574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051644|NCT00392574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051645|NCT00392574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051647|NCT00391209|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25697326|NCT02075203|BCG Vaccine|bcg vaccine|mesh-list
25697327|NCT02075203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25697328|NCT02075203|Immunologic Factors|immunologic factors|mesh-ancestor
25697329|NCT02075203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697330|NCT02075255|Benralizumab|benralizumab|mesh-list
25697331|NCT02075255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25697332|NCT02075255|Respiratory System Agents|respiratory system agents|mesh-ancestor
25697333|NCT02075515|Vaccines|vaccines|mesh-list
25051648|NCT00391209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24561859|NCT00763204|Hormones|hormones|mesh-ancestor
24561860|NCT00763204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24561861|NCT00763204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561862|NCT00763204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24561905|NCT00763646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561906|NCT00763685|Etoricoxib|etoricoxib|mesh-list
24561907|NCT00763685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24561908|NCT00763685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24561909|NCT00763685|Analgesics|analgesics|mesh-ancestor
24561910|NCT00763685|Sensory System Agents|sensory system agents|mesh-ancestor
24561911|NCT00763685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24561912|NCT00763685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561913|NCT00763685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24561914|NCT00763685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24561915|NCT00763685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24561916|NCT00763685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24561917|NCT00763685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24561918|NCT00763685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561919|NCT00763763|Interferons|interferons|mesh-list
24457251|NCT00333632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24561928|NCT00763763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24482255|NCT00438269|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24482377|NCT00438841|Thalidomide|thalidomide|mesh-list
24561929|NCT00763763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561930|NCT00763763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24561931|NCT00763763|Glucocorticoids|glucocorticoids|mesh-ancestor
24561933|NCT00763763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24561934|NCT00763763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24561935|NCT00763763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24561936|NCT00763763|Antiviral Agents|antiviral agents|mesh-ancestor
24561937|NCT00763763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24561938|NCT00763763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25051657|NCT00389779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25051658|NCT00389779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051659|NCT00389779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051660|NCT00389779|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25051662|NCT00389675|Darusentan|darusentan|mesh-list
25051663|NCT00389675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25051664|NCT00389675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25051665|NCT00389675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24963932|NCT03787550|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24963933|NCT03787550|Analgesics|analgesics|mesh-list
24963934|NCT03787550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
24963935|NCT03787550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24963937|NCT03787550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24963938|NCT03787550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963939|NCT03787550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24948332|NCT03920553|Viscosupplements|viscosupplements|mesh-ancestor
24948333|NCT03920553|Protective Agents|protective agents|mesh-ancestor
24948334|NCT03920514|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24948335|NCT03920514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24948336|NCT03920514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948338|NCT03920150|Ergocalciferols|ergocalciferols|mesh-list
24948339|NCT03920150|Cholecalciferol|cholecalciferol|mesh-list
24948340|NCT03920150|Vitamins|vitamins|mesh-list
24561979|NCT00763906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561981|NCT00763906|Autonomic Agents|autonomic agents|mesh-ancestor
24561982|NCT00763906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24948346|NCT03920137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25697334|NCT02075515|Immunologic Factors|immunologic factors|mesh-ancestor
24948347|NCT03920137|Autonomic Agents|autonomic agents|mesh-ancestor
24948348|NCT03920137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24948349|NCT03920137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948350|NCT03920137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24948351|NCT03920137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24948352|NCT03920137|Cholinergic Agents|cholinergic agents|mesh-ancestor
24948353|NCT03920137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24948354|NCT03920137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948356|NCT03920475|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24948357|NCT03920475|Antidepressive Agents|antidepressive agents|mesh-ancestor
24948358|NCT03920475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24948359|NCT03920475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24948360|NCT03920475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24948361|NCT03920475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24948362|NCT03920475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948363|NCT03920475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24948364|NCT03920475|Serotonin Agents|serotonin agents|mesh-ancestor
24482854|NCT00440778|Anticoagulants|anticoagulants|mesh-ancestor
24482855|NCT00440778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24948365|NCT03920475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805153|NCT02007915|Pamidronate|pamidronate|mesh-list
24948367|NCT03920475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24948368|NCT03920319|Bupropion|bupropion|mesh-list
24948369|NCT03920319|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24948370|NCT03920319|Antidepressive Agents|antidepressive agents|mesh-ancestor
24948371|NCT03920319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24802342|NCT01989676|Paclitaxel|paclitaxel|mesh-list
24561983|NCT00763906|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24561984|NCT00763997|Acetaminophen|acetaminophen|mesh-list
24561985|NCT00763997|Dipyrone|dipyrone|mesh-list
24561986|NCT00763997|Ibuprofen|ibuprofen|mesh-list
24462720|NCT00357318|Immunoglobulins|immunoglobulins|mesh-list
24561987|NCT00763997|Parecoxib|parecoxib|mesh-list
24561991|NCT00763997|Sensory System Agents|sensory system agents|mesh-ancestor
24561992|NCT00763997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24561993|NCT00763997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561994|NCT00763997|Antipyretics|antipyretics|mesh-ancestor
24561995|NCT00763997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24561996|NCT00763997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24561997|NCT00763997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24561998|NCT00763997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24561999|NCT00763997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562000|NCT00763997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948372|NCT03920319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24948373|NCT03920319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24948374|NCT03920319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24948375|NCT03920319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948376|NCT03920319|Dopamine Agents|dopamine agents|mesh-ancestor
24948377|NCT03920319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24562348|NCT00766155|Oxaliplatin|oxaliplatin|mesh-list
24482960|NCT00441155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24948379|NCT03920319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24948380|NCT03920319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24948381|NCT03920319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24948382|NCT03920397|Cholecalciferol|cholecalciferol|mesh-list
24948384|NCT03920397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24948385|NCT03920397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948386|NCT03920397|Vitamins|vitamins|mesh-ancestor
24948387|NCT03920397|Micronutrients|micronutrients|mesh-ancestor
24948388|NCT03920397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24948389|NCT03920449|Botulinum Toxins|botulinum toxins|mesh-list
24948390|NCT03920449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24562026|NCT00764166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562027|NCT00764166|Hormones|hormones|mesh-ancestor
24562028|NCT00764166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24562081|NCT00764439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24562082|NCT00764439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24562083|NCT00764439|Cholinergic Agents|cholinergic agents|mesh-ancestor
24562084|NCT00764439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24562085|NCT00764439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562087|NCT00764556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24562088|NCT00764556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562089|NCT00764582|Moxifloxacin|moxifloxacin|mesh-list
24562090|NCT00764582|Levofloxacin|levofloxacin|mesh-list
24562091|NCT00764582|Ofloxacin|ofloxacin|mesh-list
24562092|NCT00764582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24562093|NCT00764582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24562094|NCT00764582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24948391|NCT03920449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24948392|NCT03920449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483402|NCT00443235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24948393|NCT03920449|Cholinergic Agents|cholinergic agents|mesh-ancestor
24948394|NCT03920449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24948395|NCT03920449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948396|NCT03920059|Mycophenolic Acid|mycophenolic acid|mesh-list
24948397|NCT03920059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24948398|NCT03920059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562101|NCT00764582|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24562103|NCT00764582|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24562104|NCT00764582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24562106|NCT00764595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562107|NCT00764595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24562109|NCT00764595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562111|NCT00764712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24562112|NCT00764712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562113|NCT00764725|Sulfasalazine|sulfasalazine|mesh-list
24562114|NCT00764725|Methotrexate|methotrexate|mesh-list
24562115|NCT00764725|Infliximab|infliximab|mesh-list
24562116|NCT00764725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24562117|NCT00764725|Abortifacient Agents|abortifacient agents|mesh-ancestor
24562118|NCT00764725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24562119|NCT00764725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562120|NCT00764725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24562156|NCT00764907|Doxorubicin|doxorubicin|mesh-list
24562157|NCT00764907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24562158|NCT00764907|Methotrexate|methotrexate|mesh-list
24562159|NCT00764907|Etoposide|etoposide|mesh-list
24773753|NCT01841775|Interferons|interferons|mesh-list
24948399|NCT03920059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24948400|NCT03920059|Antitubercular Agents|antitubercular agents|mesh-ancestor
24948401|NCT03920059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24948402|NCT03920059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24948403|NCT03920059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565104|NCT00778739|Cefprozil|cefprozil|mesh-list
24562164|NCT00764907|Thioguanine|thioguanine|mesh-list
24484192|NCT00446953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484193|NCT00446953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24457461|NCT00334438|Immunologic Factors|immunologic factors|mesh-ancestor
24562214|NCT00764972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24562215|NCT00764972|Tubulin Modulators|tubulin modulators|mesh-ancestor
24562216|NCT00764972|Antimitotic Agents|antimitotic agents|mesh-ancestor
24485699|NCT00454519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562273|NCT00765271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24562274|NCT00765271|Antiviral Agents|antiviral agents|mesh-ancestor
24562275|NCT00765271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24562276|NCT00765271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24562277|NCT00765271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24562278|NCT00765271|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24562279|NCT00765271|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24562280|NCT00765271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24671025|NCT01323257|Protease Inhibitors|protease inhibitors|mesh-ancestor
24562281|NCT00765271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24562300|NCT00765934|Tetracaine|tetracaine|mesh-list
24562301|NCT00765934|Anesthetics, Local|anesthetics, local|mesh-ancestor
24562302|NCT00765934|Anesthetics|anesthetics|mesh-ancestor
24562315|NCT00765973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562335|NCT00766064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24562336|NCT00766064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24562337|NCT00766064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562338|NCT00766064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24562339|NCT00766064|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24562340|NCT00766064|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24562341|NCT00766064|Serotonin Agents|serotonin agents|mesh-ancestor
24562342|NCT00766064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24562343|NCT00766064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562344|NCT00766064|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24562345|NCT00766064|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24562346|NCT00766064|Dopamine Agents|dopamine agents|mesh-ancestor
24565105|NCT00778739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24562349|NCT00766155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24562351|NCT00766155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562385|NCT00766246|Mitosis Modulators|mitosis modulators|mesh-ancestor
24562389|NCT00766285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562391|NCT00766337|Ranibizumab|ranibizumab|mesh-list
24562392|NCT00766337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24562393|NCT00766337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24562394|NCT00766337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24562395|NCT00766337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562396|NCT00766337|Antifungal Agents|antifungal agents|mesh-ancestor
24562397|NCT00766337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24562398|NCT00766337|Immunologic Factors|immunologic factors|mesh-ancestor
24562399|NCT00766337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562400|NCT00766337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24562401|NCT00766337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24562402|NCT00766337|Growth Substances|growth substances|mesh-ancestor
24562403|NCT00766337|Growth Inhibitors|growth inhibitors|mesh-ancestor
24562404|NCT00766350|Amitriptyline|amitriptyline|mesh-list
24562405|NCT00766350|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24562406|NCT00766350|Antidepressive Agents|antidepressive agents|mesh-ancestor
24562407|NCT00766350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24562412|NCT00766350|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24562414|NCT00766350|Analgesics|analgesics|mesh-ancestor
24562415|NCT00766350|Sensory System Agents|sensory system agents|mesh-ancestor
24562416|NCT00766350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24562417|NCT00766350|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24562424|NCT00766402|Diclofenac|diclofenac|mesh-list
24940046|NCT04004234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24940048|NCT04004234|Micronutrients|micronutrients|mesh-ancestor
24562425|NCT00766402|Tramadol|tramadol|mesh-list
24562426|NCT00766402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24562427|NCT00766402|Analgesics|analgesics|mesh-ancestor
24562428|NCT00766402|Sensory System Agents|sensory system agents|mesh-ancestor
24562429|NCT00766402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24562430|NCT00766402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562431|NCT00766402|Antipyretics|antipyretics|mesh-ancestor
24562432|NCT00766402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24562433|NCT00766402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24562434|NCT00766402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24562435|NCT00766402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24562436|NCT00766402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487505|NCT00463541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24489052|NCT00471289|Mitosis Modulators|mitosis modulators|mesh-ancestor
24489053|NCT00471289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562437|NCT00766402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562438|NCT00766402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24562439|NCT00766402|Narcotics|narcotics|mesh-ancestor
24562440|NCT00766402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24791800|NCT03073694|Mitomycin|mitomycin|mesh-list
24448525|NCT00312130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24448526|NCT00312130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448527|NCT00312130|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24448528|NCT00312130|Protease Inhibitors|protease inhibitors|mesh-ancestor
24562441|NCT00766441|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24562442|NCT00766441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24562443|NCT00766441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562444|NCT00766441|Incretins|incretins|mesh-ancestor
24562445|NCT00766441|Hormones|hormones|mesh-ancestor
24462738|NCT00357422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24562450|NCT00766441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562452|NCT00766480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562453|NCT00766480|Antimetabolites|antimetabolites|mesh-ancestor
24562454|NCT00766480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562455|NCT00766480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24948426|NCT03919942|Chlorhexidine|chlorhexidine|mesh-list
24562456|NCT00766480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24562457|NCT00766480|Immunologic Factors|immunologic factors|mesh-ancestor
24562458|NCT00766480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562462|NCT00766545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24562464|NCT00766545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24562465|NCT00766545|Respiratory System Agents|respiratory system agents|mesh-ancestor
24562466|NCT00766545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24562467|NCT00766545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24562468|NCT00766545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562469|NCT00766545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24562470|NCT00766545|Vasodilator Agents|vasodilator agents|mesh-ancestor
24562471|NCT00766545|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24562472|NCT00766545|Protective Agents|protective agents|mesh-ancestor
24567153|NCT00789763|Sorafenib|sorafenib|mesh-list
24448529|NCT00312130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448530|NCT00312130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448531|NCT00312143|Mycophenolic Acid|mycophenolic acid|mesh-list
24448532|NCT00312143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24448533|NCT00312143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448534|NCT00312143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24448535|NCT00312143|Antitubercular Agents|antitubercular agents|mesh-ancestor
24448536|NCT00312143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25697335|NCT02075515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709399|NCT02266433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25709400|NCT02266433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25709401|NCT02266433|Analgesics|analgesics|mesh-ancestor
25709402|NCT02266433|Sensory System Agents|sensory system agents|mesh-ancestor
25709403|NCT02266433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24448537|NCT00312143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24562474|NCT00766545|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24562476|NCT00766662|Pyrimethamine|pyrimethamine|mesh-list
24562477|NCT00766662|Sulfadoxine|sulfadoxine|mesh-list
24562478|NCT00766662|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24562479|NCT00766662|Antimalarials|antimalarials|mesh-ancestor
24562480|NCT00766662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24562481|NCT00766662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24562482|NCT00766662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24562483|NCT00766662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24562527|NCT00766870|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24562528|NCT00766870|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24562529|NCT00766870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24562540|NCT00766896|Analgesics|analgesics|mesh-ancestor
24562541|NCT00766896|Sensory System Agents|sensory system agents|mesh-ancestor
24562542|NCT00766896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24562543|NCT00766896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562544|NCT00766896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24562545|NCT00766896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24562546|NCT00766896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24562547|NCT00766896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24562549|NCT00766896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24562587|NCT00767117|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24562588|NCT00767117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24562589|NCT00767117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24562590|NCT00767117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24562591|NCT00767169|Ibandronic Acid|ibandronic acid|mesh-list
24562592|NCT00767169|Pamidronate|pamidronate|mesh-list
24562593|NCT00767169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24562594|NCT00767169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562601|NCT00767221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24562602|NCT00767221|Respiratory System Agents|respiratory system agents|mesh-ancestor
24448538|NCT00312143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448539|NCT00312143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448540|NCT00312156|Insulin|insulin|mesh-list
24448541|NCT00312156|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24448555|NCT00312182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24448556|NCT00312182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24448557|NCT00312182|Antiviral Agents|antiviral agents|mesh-ancestor
24448574|NCT00312260|Antimanic Agents|antimanic agents|mesh-ancestor
24448575|NCT00312260|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24448576|NCT00312260|Antidepressive Agents|antidepressive agents|mesh-ancestor
24562611|NCT00767286|Flutamide|flutamide|mesh-list
24490336|NCT00477776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24490337|NCT00477776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490338|NCT00477776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24490339|NCT00477776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25697336|NCT02075606|Lanreotide|lanreotide|mesh-list
25697337|NCT02075606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25697338|NCT02075632|Alclometasone dipropionate|alclometasone dipropionate|mesh-list
24562612|NCT00767286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24562615|NCT00767286|Micronutrients|micronutrients|mesh-ancestor
24562621|NCT00767468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562622|NCT00767468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24567387|NCT00790998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24450210|NCT00317993|Ezetimibe|ezetimibe|mesh-list
24562628|NCT00767481|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24562629|NCT00767481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562630|NCT00767481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562632|NCT00767494|Brinzolamide|brinzolamide|mesh-list
24562633|NCT00767494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24802435|NCT01990079|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24802436|NCT01990079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24802437|NCT01990079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24802438|NCT01990079|Dopamine Agents|dopamine agents|mesh-ancestor
24562656|NCT00767598|Sildenafil Citrate|sildenafil citrate|mesh-list
24562657|NCT00767598|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24562658|NCT00767598|Udenafil|udenafil|mesh-list
24562659|NCT00767598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
24562660|NCT00767598|Vasodilator Agents|vasodilator agents|mesh-ancestor
24562661|NCT00767598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24562662|NCT00767598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562663|NCT00767598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562664|NCT00767598|Urological Agents|urological agents|mesh-ancestor
24562665|NCT00767663|Dipyridamole|dipyridamole|mesh-list
24562666|NCT00767663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24562667|NCT00767663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562668|NCT00767663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562669|NCT00767663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24562670|NCT00767663|Vasodilator Agents|vasodilator agents|mesh-ancestor
24562671|NCT00767689|Vitamin B 6|vitamin b 6|mesh-list
24562672|NCT00767689|Pyridoxal|pyridoxal|mesh-list
24562673|NCT00767689|Pyridoxine|pyridoxine|mesh-list
24562674|NCT00767689|Vitamins|vitamins|mesh-ancestor
25697339|NCT02075632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25697340|NCT02075632|Glucocorticoids|glucocorticoids|mesh-ancestor
25697341|NCT02075632|Hormones|hormones|mesh-ancestor
24562739|NCT00767975|Leprostatic Agents|leprostatic agents|mesh-ancestor
24562677|NCT00767689|Vitamin B Complex|vitamin b complex|mesh-ancestor
24948446|NCT03919552|Tubulin Modulators|tubulin modulators|mesh-ancestor
24562679|NCT00767715|Olanzapine|olanzapine|mesh-list
24562680|NCT00767715|Haloperidol decanoate|haloperidol decanoate|mesh-list
24562704|NCT00767728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24496025|NCT00503152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496026|NCT00503152|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24496027|NCT00503152|Protease Inhibitors|protease inhibitors|mesh-ancestor
24496028|NCT00503152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496029|NCT00503204|Cediranib|cediranib|mesh-list
24496030|NCT00503204|Lomustine|lomustine|mesh-list
24496031|NCT00503204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496032|NCT00503204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24496033|NCT00503204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496034|NCT00503204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496035|NCT00503204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24496292|NCT00504140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496293|NCT00504140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496295|NCT00504140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24562705|NCT00767728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562713|NCT00767754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24562715|NCT00767754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562717|NCT00767754|Antidepressive Agents|antidepressive agents|mesh-ancestor
24562718|NCT00767754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24562719|NCT00767754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24562720|NCT00767754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24562721|NCT00767754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562722|NCT00767871|Citalopram|citalopram|mesh-list
24562723|NCT00767871|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24562724|NCT00767871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24567561|NCT00791531|Immunologic Factors|immunologic factors|mesh-ancestor
24562725|NCT00767871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24562726|NCT00767871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697342|NCT02075632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25697343|NCT02075632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697344|NCT02076100|Ruzasvir|ruzasvir|mesh-list
25697345|NCT02076100|Antiviral Agents|antiviral agents|mesh-ancestor
25697346|NCT02076100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25697347|NCT02076152|Bevacizumab|bevacizumab|mesh-list
25697348|NCT02076152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25697349|NCT02076152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562738|NCT00767975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24562740|NCT00767975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24562741|NCT00767975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562742|NCT00767975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562743|NCT00767975|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24562744|NCT00767975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24562745|NCT00767975|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24562746|NCT00767975|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24562747|NCT00767975|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24562748|NCT00767975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24562749|NCT00767975|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24562750|NCT00767975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24562751|NCT00767975|Antimetabolites|antimetabolites|mesh-ancestor
24562752|NCT00767975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24562753|NCT00768131|Paclitaxel|paclitaxel|mesh-list
24562754|NCT00768131|Carboplatin|carboplatin|mesh-list
24562755|NCT00768131|Cetuximab|cetuximab|mesh-list
24562756|NCT00768131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24562757|NCT00768131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562758|NCT00768131|Tubulin Modulators|tubulin modulators|mesh-ancestor
24562759|NCT00768131|Antimitotic Agents|antimitotic agents|mesh-ancestor
24562760|NCT00768131|Mitosis Modulators|mitosis modulators|mesh-ancestor
24562761|NCT00768131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562762|NCT00768131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24562764|NCT00768157|Entecavir|entecavir|mesh-list
24562765|NCT00768157|Antiviral Agents|antiviral agents|mesh-list
24562766|NCT00768157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24948448|NCT03919552|Mitosis Modulators|mitosis modulators|mesh-ancestor
24948449|NCT03919552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948450|NCT03919565|Tenofovir|tenofovir|mesh-list
24948451|NCT03919565|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24948452|NCT03919565|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24569665|NCT00801450|Hormones|hormones|mesh-ancestor
24562767|NCT00768157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24562769|NCT00768157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562777|NCT00768183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24562778|NCT00768183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562779|NCT00768183|Analgesics|analgesics|mesh-ancestor
24791820|NCT03049189|Edotreotide|edotreotide|mesh-list
24562782|NCT00768183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24562783|NCT00768183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24562784|NCT00768209|Topiramate|topiramate|mesh-list
24562785|NCT00768209|Phentermine|phentermine|mesh-list
24562786|NCT00768209|Anticonvulsants|anticonvulsants|mesh-ancestor
24562787|NCT00768209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24562788|NCT00768209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562789|NCT00768209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24562792|NCT00768209|Sympathomimetics|sympathomimetics|mesh-ancestor
24562793|NCT00768209|Autonomic Agents|autonomic agents|mesh-ancestor
24562794|NCT00768209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24562796|NCT00768209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24562797|NCT00768209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562798|NCT00768391|Olaratumab|olaratumab|mesh-list
24562799|NCT00768391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562800|NCT00768404|Phentermine|phentermine|mesh-list
24562801|NCT00768404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24562802|NCT00768404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562803|NCT00768404|Appetite Depressants|appetite depressants|mesh-ancestor
24562804|NCT00768404|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24562805|NCT00768404|Sympathomimetics|sympathomimetics|mesh-ancestor
24562806|NCT00768404|Autonomic Agents|autonomic agents|mesh-ancestor
24562807|NCT00768404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24562808|NCT00768404|Adrenergic Agents|adrenergic agents|mesh-ancestor
24562809|NCT00768404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24562810|NCT00768404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562812|NCT00768456|Anesthetics, Local|anesthetics, local|mesh-ancestor
24562813|NCT00768456|Anesthetics|anesthetics|mesh-ancestor
24562814|NCT00768456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24562815|NCT00768456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562816|NCT00768456|Sensory System Agents|sensory system agents|mesh-ancestor
24562818|NCT00768508|Naltrexone|naltrexone|mesh-list
24562840|NCT00768573|Vasodilator Agents|vasodilator agents|mesh-ancestor
24562841|NCT00768573|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24562842|NCT00768573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24562843|NCT00768573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24948453|NCT03919565|Antiviral Agents|antiviral agents|mesh-ancestor
24948454|NCT03919565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24948455|NCT03919565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24948456|NCT03919565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24948457|NCT03919565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24948458|NCT03919565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948460|NCT03919565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24948462|NCT03919253|Maleic acid|maleic acid|mesh-list
24948463|NCT03919253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24802451|NCT01990118|Dermatologic Agents|dermatologic agents|mesh-ancestor
24562844|NCT00768573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562845|NCT00768573|Urological Agents|urological agents|mesh-ancestor
24562846|NCT00768612|Risperidone|risperidone|mesh-list
24562854|NCT00768612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24562856|NCT00768612|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24562857|NCT00768612|Dopamine Agents|dopamine agents|mesh-ancestor
24562858|NCT00768638|Atorvastatin|atorvastatin|mesh-list
24562859|NCT00768638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24562860|NCT00768638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24462760|NCT00357474|Ethanol|ethanol|mesh-list
24562861|NCT00768638|Antimetabolites|antimetabolites|mesh-ancestor
24562863|NCT00768638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24562864|NCT00768638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24562865|NCT00768638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562866|NCT00768677|Topiramate|topiramate|mesh-list
24562879|NCT00768690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24562889|NCT00768729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24562890|NCT00768729|Immunologic Factors|immunologic factors|mesh-ancestor
24562891|NCT00768729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562892|NCT00768729|Antimetabolites|antimetabolites|mesh-ancestor
24562893|NCT00768729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562896|NCT00768768|Terbinafine|terbinafine|mesh-list
24562897|NCT00768768|Antifungal Agents|antifungal agents|mesh-ancestor
24506181|NCT00544232|Tubulin Modulators|tubulin modulators|mesh-ancestor
24562898|NCT00768768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24562899|NCT00768768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562900|NCT00768768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562902|NCT00768859|Carboplatin|carboplatin|mesh-list
24562903|NCT00768859|Trastuzumab|trastuzumab|mesh-list
24562915|NCT00768911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562916|NCT00768937|Sorafenib|sorafenib|mesh-list
24562917|NCT00768937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562918|NCT00768937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24562919|NCT00768937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562931|NCT00769041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24562932|NCT00769041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24562933|NCT00769041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562934|NCT00769041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562935|NCT00769041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562937|NCT00769054|Anesthetics, Local|anesthetics, local|mesh-ancestor
24562938|NCT00769054|Anesthetics|anesthetics|mesh-ancestor
24562939|NCT00769054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24562940|NCT00769054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562941|NCT00769054|Sensory System Agents|sensory system agents|mesh-ancestor
24562949|NCT00769145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24562950|NCT00769145|Growth Substances|growth substances|mesh-ancestor
24562979|NCT00769171|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24562980|NCT00769171|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24562981|NCT00769171|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24562982|NCT00769171|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24562984|NCT00769210|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24948467|NCT03919253|Mitosis Modulators|mitosis modulators|mesh-ancestor
24948468|NCT03919253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948469|NCT03919253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24948470|NCT03919383|Lenvatinib|lenvatinib|mesh-list
24565107|NCT00778752|Lenalidomide|lenalidomide|mesh-list
24948471|NCT03919383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24948472|NCT03919383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24948473|NCT03919383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562985|NCT00769210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24562986|NCT00769210|Antimetabolites|antimetabolites|mesh-ancestor
24562987|NCT00769210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562988|NCT00769210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24562989|NCT00769210|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24562990|NCT00769210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562991|NCT00769288|2'-fluoro-5-ethylarabinosyluracil|2'-fluoro-5-ethylarabinosyluracil|mesh-list
24562992|NCT00769288|Deoxyuridine|deoxyuridine|mesh-list
24562993|NCT00769288|Antimetabolites|antimetabolites|mesh-ancestor
24562994|NCT00769288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562995|NCT00769288|Antiviral Agents|antiviral agents|mesh-ancestor
24562996|NCT00769288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24562997|NCT00769288|Growth Inhibitors|growth inhibitors|mesh-ancestor
24562998|NCT00769288|Growth Substances|growth substances|mesh-ancestor
24562999|NCT00769288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563000|NCT00769405|Leucovorin|leucovorin|mesh-list
24563001|NCT00769405|Fluorouracil|fluorouracil|mesh-list
24563002|NCT00769405|Oxaliplatin|oxaliplatin|mesh-list
24563003|NCT00769405|Calcium|calcium|mesh-list
24563004|NCT00769405|Levoleucovorin|levoleucovorin|mesh-list
24563005|NCT00769405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24563006|NCT00769405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563007|NCT00769405|Antimetabolites|antimetabolites|mesh-ancestor
24563008|NCT00769405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563009|NCT00769405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24563020|NCT00769470|Trastuzumab|trastuzumab|mesh-list
24563021|NCT00769470|Lapatinib|lapatinib|mesh-list
24563022|NCT00769470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24563023|NCT00769470|Tubulin Modulators|tubulin modulators|mesh-ancestor
24563024|NCT00769470|Antimitotic Agents|antimitotic agents|mesh-ancestor
24563025|NCT00769470|Mitosis Modulators|mitosis modulators|mesh-ancestor
24563026|NCT00769470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563027|NCT00769470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24563028|NCT00769470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24563029|NCT00769470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563030|NCT00769522|Cyclophosphamide|cyclophosphamide|mesh-list
24563031|NCT00769522|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24563033|NCT00769522|Fludarabine|fludarabine|mesh-list
24563034|NCT00769522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24563035|NCT00769522|Immunologic Factors|immunologic factors|mesh-ancestor
25697350|NCT02076152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25697351|NCT02076152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24563036|NCT00769522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563037|NCT00769522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24563038|NCT00769522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24563039|NCT00769522|Alkylating Agents|alkylating agents|mesh-ancestor
24563040|NCT00769522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563041|NCT00769522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24563042|NCT00769522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24563043|NCT00769522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24563044|NCT00769548|Goserelin|goserelin|mesh-list
24563045|NCT00769548|Flutamide|flutamide|mesh-list
24563046|NCT00769548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24563047|NCT00769548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24948474|NCT03919383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563048|NCT00769548|Androgen Antagonists|androgen antagonists|mesh-ancestor
24563049|NCT00769548|Hormone Antagonists|hormone antagonists|mesh-ancestor
24563050|NCT00769548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24563051|NCT00769548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563052|NCT00769587|Thalidomide|thalidomide|mesh-list
24563053|NCT00769587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24563054|NCT00769587|Immunologic Factors|immunologic factors|mesh-ancestor
24563055|NCT00769587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563056|NCT00769587|Leprostatic Agents|leprostatic agents|mesh-ancestor
24563057|NCT00769587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24563058|NCT00769587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24563059|NCT00769587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24563060|NCT00769587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24563061|NCT00769587|Growth Substances|growth substances|mesh-ancestor
24563062|NCT00769587|Growth Inhibitors|growth inhibitors|mesh-ancestor
24563063|NCT00769587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24563064|NCT00769873|Heparin|heparin|mesh-list
24563065|NCT00769873|Enoxaparin|enoxaparin|mesh-list
24563066|NCT00769873|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24563067|NCT00769873|Tinzaparin|tinzaparin|mesh-list
24563068|NCT00769873|Dalteparin|dalteparin|mesh-list
24563085|NCT00769990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24563086|NCT00770042|Ritonavir|ritonavir|mesh-list
24563088|NCT00770042|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24563089|NCT00770042|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24563090|NCT00770042|Protease Inhibitors|protease inhibitors|mesh-ancestor
24563091|NCT00770042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563099|NCT00770042|Antifungal Agents|antifungal agents|mesh-ancestor
24563100|NCT00770042|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24563101|NCT00770042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24563106|NCT00770107|Vitamin B Complex|vitamin b complex|mesh-ancestor
24563107|NCT00770107|Vitamins|vitamins|mesh-ancestor
24563108|NCT00770107|Micronutrients|micronutrients|mesh-ancestor
24563109|NCT00770107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563110|NCT00770172|Lenograstim|lenograstim|mesh-list
24563111|NCT00770172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24563113|NCT00770172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563114|NCT00770263|Sirolimus|sirolimus|mesh-list
24563115|NCT00770263|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24563116|NCT00770263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24563117|NCT00770263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24563118|NCT00770263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563119|NCT00770263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563120|NCT00770263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24563121|NCT00770263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24563122|NCT00770263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24563123|NCT00770263|Antifungal Agents|antifungal agents|mesh-ancestor
24563124|NCT00770263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24563125|NCT00770263|Immunologic Factors|immunologic factors|mesh-ancestor
24563126|NCT00770263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563127|NCT00770302|Saxagliptin|saxagliptin|mesh-list
24563128|NCT00770302|Incretins|incretins|mesh-ancestor
24563129|NCT00770302|Hormones|hormones|mesh-ancestor
24563130|NCT00770302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25406746|NCT03536039|Antimitotic Agents|antimitotic agents|mesh-ancestor
24548651|NCT00711178|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24548652|NCT00711178|Dermatologic Agents|dermatologic agents|mesh-ancestor
24563131|NCT00770302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563133|NCT00770302|Protease Inhibitors|protease inhibitors|mesh-ancestor
24563153|NCT00770406|Cholinergic Agents|cholinergic agents|mesh-ancestor
24563154|NCT00770406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24563155|NCT00770406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563156|NCT00770406|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24563157|NCT00770406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24563159|NCT00770445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24563160|NCT00770445|Metformin|metformin|mesh-list
24563161|NCT00770445|Pioglitazone|pioglitazone|mesh-list
24563162|NCT00770445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24563163|NCT00770445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563164|NCT00770471|Temozolomide|temozolomide|mesh-list
24563165|NCT00770471|Veliparib|veliparib|mesh-list
24563166|NCT00770471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24563167|NCT00770471|Alkylating Agents|alkylating agents|mesh-ancestor
24563179|NCT00770497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563180|NCT00770497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24563181|NCT00770536|Doxorubicin|doxorubicin|mesh-list
24563182|NCT00770536|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24563183|NCT00770536|Topotecan|topotecan|mesh-list
24563184|NCT00770536|Trebananib|trebananib|mesh-list
24563185|NCT00770536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24563194|NCT00770536|Growth Substances|growth substances|mesh-ancestor
25051681|NCT00389155|Immunologic Factors|immunologic factors|mesh-ancestor
25051682|NCT00389155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563218|NCT00770666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563219|NCT00770666|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24563220|NCT00770666|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24563221|NCT00770666|Cholinergic Agents|cholinergic agents|mesh-ancestor
24563222|NCT00770666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24563223|NCT00770666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563224|NCT00770666|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24563225|NCT00770666|Antidepressive Agents|antidepressive agents|mesh-ancestor
24563228|NCT00770666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24563229|NCT00770666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24563231|NCT00770666|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24563232|NCT00770666|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24563233|NCT00770666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563234|NCT00770705|Phenoxybenzamine|phenoxybenzamine|mesh-list
24563235|NCT00770705|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24563236|NCT00770705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24563237|NCT00770705|Adrenergic Agents|adrenergic agents|mesh-ancestor
24563238|NCT00770705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24563250|NCT00770731|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24563251|NCT00770731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24563252|NCT00770731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563253|NCT00770731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563254|NCT00770731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24563255|NCT00770731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24563256|NCT00770731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24563257|NCT00770731|Antifungal Agents|antifungal agents|mesh-ancestor
24563258|NCT00770731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24563259|NCT00770731|Immunologic Factors|immunologic factors|mesh-ancestor
24563260|NCT00770731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563262|NCT00770744|Antiemetics|antiemetics|mesh-ancestor
24563263|NCT00770744|Autonomic Agents|autonomic agents|mesh-ancestor
24563264|NCT00770744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24563265|NCT00770744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563270|NCT00770744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24563271|NCT00770744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24563272|NCT00770744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25697352|NCT02076152|Growth Substances|growth substances|mesh-ancestor
25697353|NCT02076152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563273|NCT00770744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25697354|NCT02076152|Growth Inhibitors|growth inhibitors|mesh-ancestor
24563274|NCT00770744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563277|NCT00770796|Atorvastatin|atorvastatin|mesh-list
24563278|NCT00770796|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24563279|NCT00770796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24563280|NCT00770796|Antimetabolites|antimetabolites|mesh-ancestor
24563346|NCT00771199|Anesthetics|anesthetics|mesh-ancestor
24563403|NCT00771394|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24563404|NCT00771394|Cholinergic Agents|cholinergic agents|mesh-ancestor
24563405|NCT00771420|Mavrilimumab|mavrilimumab|mesh-list
24563406|NCT00771420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24563407|NCT00771420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24563408|NCT00771420|Immunologic Factors|immunologic factors|mesh-ancestor
24563409|NCT00771420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563410|NCT00771433|Lenograstim|lenograstim|mesh-list
24566776|NCT00787813|Antioxidants|antioxidants|mesh-ancestor
24448688|NCT00312598|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24448690|NCT00312598|Serotonin Agents|serotonin agents|mesh-ancestor
24563426|NCT00771498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563428|NCT00771498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24563429|NCT00771498|Antiviral Agents|antiviral agents|mesh-ancestor
24563431|NCT00771498|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24563432|NCT00771498|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24563433|NCT00771511|Capsaicin|capsaicin|mesh-list
24563434|NCT00771511|Antipruritics|antipruritics|mesh-ancestor
24563435|NCT00771511|Dermatologic Agents|dermatologic agents|mesh-ancestor
24563436|NCT00771511|Sensory System Agents|sensory system agents|mesh-ancestor
25051698|NCT00384904|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25051700|NCT00384904|Famotidine|famotidine|mesh-list
25051701|NCT00384904|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25051702|NCT00384904|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24522892|NCT03071926|Doxorubicin|doxorubicin|mesh-list
24563450|NCT00771563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563451|NCT00771563|Anticoagulants|anticoagulants|mesh-ancestor
24563480|NCT00771823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24563481|NCT00771823|Antiviral Agents|antiviral agents|mesh-ancestor
24563482|NCT00771823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24563483|NCT00771823|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24563484|NCT00771888|Lanreotide|lanreotide|mesh-list
24563485|NCT00771888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24563486|NCT00771979|Saracatinib|saracatinib|mesh-list
24563487|NCT00771979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24563488|NCT00771979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563489|NCT00771979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563491|NCT00772057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24563493|NCT00772057|Adrenergic Agents|adrenergic agents|mesh-ancestor
24563495|NCT00772057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563497|NCT00772057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24563498|NCT00772057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24563499|NCT00772057|Vasodilator Agents|vasodilator agents|mesh-ancestor
24563501|NCT00772122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24563503|NCT00772122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563505|NCT00772135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563506|NCT00772135|Vasodilator Agents|vasodilator agents|mesh-ancestor
24563507|NCT00772135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24563508|NCT00772135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25051711|NCT00384904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25051712|NCT00384904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25051713|NCT00384904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25051714|NCT00384904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25051715|NCT00384904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25051716|NCT00384904|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25051717|NCT00384904|Histamine Antagonists|histamine antagonists|mesh-ancestor
25051718|NCT00384904|Histamine Agents|histamine agents|mesh-ancestor
25051719|NCT00384904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25051720|NCT00384904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051721|NCT00384150|Galiximab|galiximab|mesh-list
25051722|NCT00384150|Rituximab|rituximab|mesh-list
25051723|NCT00384150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25051724|NCT00384150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24563525|NCT00772187|Morphine|morphine|mesh-list
24563526|NCT00772187|Anesthetics|anesthetics|mesh-ancestor
24563528|NCT00772187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671027|NCT01323257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563573|NCT00772499|Amlodipine|amlodipine|mesh-list
24563574|NCT00772499|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24563575|NCT00772499|Olmesartan|olmesartan|mesh-list
24563576|NCT00772499|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24563588|NCT00772499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24563589|NCT00772499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24563590|NCT00772499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24563623|NCT00772616|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24563625|NCT00772616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24563626|NCT00772616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563628|NCT00772616|Sensory System Agents|sensory system agents|mesh-ancestor
24563629|NCT00772616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24563630|NCT00772616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24563631|NCT00772616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24563632|NCT00772616|Anesthetics, General|anesthetics, general|mesh-ancestor
24563633|NCT00772616|Anesthetics|anesthetics|mesh-ancestor
24563634|NCT00772655|Rituximab|rituximab|mesh-list
25697357|NCT02076243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25697358|NCT02076243|Tubulin Modulators|tubulin modulators|mesh-ancestor
25697359|NCT02076243|Antimitotic Agents|antimitotic agents|mesh-ancestor
25697360|NCT02076243|Mitosis Modulators|mitosis modulators|mesh-ancestor
25697361|NCT02076243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697362|NCT02076321|Acetaminophen|acetaminophen|mesh-list
25406747|NCT03536039|Mitosis Modulators|mitosis modulators|mesh-ancestor
24563636|NCT00772655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24563637|NCT00772655|Immunologic Factors|immunologic factors|mesh-ancestor
24563638|NCT00772655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563639|NCT00772655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24563641|NCT00772681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24563642|NCT00772681|Tubulin Modulators|tubulin modulators|mesh-ancestor
24563643|NCT00772681|Antimitotic Agents|antimitotic agents|mesh-ancestor
24563644|NCT00772681|Mitosis Modulators|mitosis modulators|mesh-ancestor
24563645|NCT00772681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563646|NCT00772694|Sorafenib|sorafenib|mesh-list
24563647|NCT00772694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051725|NCT00384150|Immunologic Factors|immunologic factors|mesh-ancestor
25051727|NCT00384150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24563648|NCT00772694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24563649|NCT00772694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563650|NCT00772694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563651|NCT00772720|Raltegravir Potassium|raltegravir potassium|mesh-list
24563666|NCT00772759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563667|NCT00772759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563668|NCT00772798|Paclitaxel|paclitaxel|mesh-list
24563669|NCT00772798|Carboplatin|carboplatin|mesh-list
24563670|NCT00772798|Vorinostat|vorinostat|mesh-list
24563671|NCT00772798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24563672|NCT00772798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24563673|NCT00772798|Tubulin Modulators|tubulin modulators|mesh-ancestor
24563674|NCT00772798|Antimitotic Agents|antimitotic agents|mesh-ancestor
24563675|NCT00772798|Mitosis Modulators|mitosis modulators|mesh-ancestor
24563676|NCT00772798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563677|NCT00772798|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24563678|NCT00772798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563679|NCT00772837|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24563680|NCT00772837|Amoxicillin|amoxicillin|mesh-list
24563681|NCT00772837|Clarithromycin|clarithromycin|mesh-list
24563682|NCT00772837|Omeprazole|omeprazole|mesh-list
24563729|NCT00773149|Alemtuzumab|alemtuzumab|mesh-list
24563730|NCT00773149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24563739|NCT00773188|Bevacizumab|bevacizumab|mesh-list
24563740|NCT00773188|Vinorelbine|vinorelbine|mesh-list
24563741|NCT00773188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24563742|NCT00773188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24563743|NCT00773188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24563744|NCT00773188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24563745|NCT00773188|Growth Substances|growth substances|mesh-ancestor
24563786|NCT00773578|Vasodilator Agents|vasodilator agents|mesh-ancestor
24563787|NCT00773578|Gasotransmitters|gasotransmitters|mesh-ancestor
24563797|NCT00773591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563798|NCT00773591|Cholinergic Agents|cholinergic agents|mesh-ancestor
24563799|NCT00773591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24563800|NCT00773630|Cilostazol|cilostazol|mesh-list
24563801|NCT00773630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24563802|NCT00773630|Autonomic Agents|autonomic agents|mesh-ancestor
24563803|NCT00773630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24563804|NCT00773630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563805|NCT00773630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24563806|NCT00773630|Respiratory System Agents|respiratory system agents|mesh-ancestor
24563807|NCT00773630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24563808|NCT00773630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24563809|NCT00773630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563810|NCT00773630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24563811|NCT00773630|Vasodilator Agents|vasodilator agents|mesh-ancestor
24563812|NCT00773630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24563813|NCT00773630|Protective Agents|protective agents|mesh-ancestor
24563814|NCT00773630|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24563815|NCT00773630|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24563816|NCT00773630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563817|NCT00773708|Raltegravir Potassium|raltegravir potassium|mesh-list
24563828|NCT00773812|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
24563830|NCT00773812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24563831|NCT00773812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563832|NCT00773812|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24563833|NCT00773812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24563834|NCT00773812|Cholinergic Agents|cholinergic agents|mesh-ancestor
24802527|NCT01990781|Glucocorticoids|glucocorticoids|mesh-ancestor
24563835|NCT00773812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24563836|NCT00773812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563837|NCT00773916|Methylphenidate|methylphenidate|mesh-list
24563838|NCT00773916|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24563839|NCT00773916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563841|NCT00773916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24563887|NCT00774241|Tubulin Modulators|tubulin modulators|mesh-ancestor
24563888|NCT00774241|Antimitotic Agents|antimitotic agents|mesh-ancestor
24563889|NCT00774241|Mitosis Modulators|mitosis modulators|mesh-ancestor
24563890|NCT00774241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563891|NCT00774280|Cyclophosphamide|cyclophosphamide|mesh-list
24563951|NCT00774527|Fludarabine|fludarabine|mesh-list
24563952|NCT00774527|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24563953|NCT00774527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24563954|NCT00774527|Immunologic Factors|immunologic factors|mesh-ancestor
24563955|NCT00774527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563956|NCT00774527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24563957|NCT00774527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24563958|NCT00774527|Alkylating Agents|alkylating agents|mesh-ancestor
24563959|NCT00774527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563960|NCT00774527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24563961|NCT00774527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24563962|NCT00774540|Ketorolac|ketorolac|mesh-list
24563963|NCT00774540|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24563964|NCT00774540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24563965|NCT00774540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24563966|NCT00774540|Analgesics|analgesics|mesh-ancestor
25008918|NCT03837873|Hormones|hormones|mesh-ancestor
24527103|NCT00614978|Lapatinib|lapatinib|mesh-list
24450285|NCT00318513|Growth Substances|growth substances|mesh-ancestor
24563967|NCT00774540|Sensory System Agents|sensory system agents|mesh-ancestor
24563968|NCT00774540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24563969|NCT00774540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563970|NCT00774540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24563971|NCT00774540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24563972|NCT00774540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24563973|NCT00774540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563974|NCT00774540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563975|NCT00774605|Varenicline|varenicline|mesh-list
24563976|NCT00774605|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24563997|NCT00774683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563998|NCT00774683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563999|NCT00774696|Clarithromycin|clarithromycin|mesh-list
24564000|NCT00774696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24564001|NCT00774696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24564002|NCT00774696|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24564003|NCT00774696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406975|NCT03524898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564004|NCT00774696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564005|NCT00774696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24564006|NCT00774696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24564007|NCT00774722|Metronidazole|metronidazole|mesh-list
24564122|NCT00775151|Vasodilator Agents|vasodilator agents|mesh-ancestor
24564125|NCT00775164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24564126|NCT00775164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564127|NCT00775177|Doxycycline|doxycycline|mesh-list
24564128|NCT00775177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24564129|NCT00775177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24564130|NCT00775177|Antimalarials|antimalarials|mesh-ancestor
24564165|NCT00775359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24564166|NCT00775359|Antimetabolites|antimetabolites|mesh-ancestor
24564167|NCT00775359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564168|NCT00775359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24564169|NCT00775372|Clarithromycin|clarithromycin|mesh-list
24564170|NCT00775372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24564171|NCT00775372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24564172|NCT00775372|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24564173|NCT00775372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564174|NCT00775372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564230|NCT00775632|Antimetabolites|antimetabolites|mesh-ancestor
24564231|NCT00775632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564232|NCT00775632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24564233|NCT00775632|Dermatologic Agents|dermatologic agents|mesh-ancestor
24564276|NCT00775762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24564277|NCT00775762|Analgesics|analgesics|mesh-ancestor
24564278|NCT00775762|Sensory System Agents|sensory system agents|mesh-ancestor
24564378|NCT00776113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24564379|NCT00776113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24564381|NCT00776139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24564382|NCT00776139|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24564383|NCT00776139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24564384|NCT00776139|Histamine Antagonists|histamine antagonists|mesh-ancestor
24564385|NCT00776139|Histamine Agents|histamine agents|mesh-ancestor
24564386|NCT00776139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24564387|NCT00776139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564435|NCT00776477|Clopidogrel|clopidogrel|mesh-list
24564436|NCT00776477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24564437|NCT00776477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24564438|NCT00776477|Analgesics|analgesics|mesh-ancestor
24564439|NCT00776477|Sensory System Agents|sensory system agents|mesh-ancestor
24564440|NCT00776477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24964095|NCT03785613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24528448|NCT00621166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24564441|NCT00776477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564445|NCT00776477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24564446|NCT00776477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564447|NCT00776477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24564448|NCT00776477|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24564449|NCT00776477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564451|NCT00776477|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24564452|NCT00776477|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24564453|NCT00776477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24564454|NCT00776477|Purinergic Agents|purinergic agents|mesh-ancestor
24564507|NCT00776633|Analgesics|analgesics|mesh-ancestor
24564508|NCT00776633|Sensory System Agents|sensory system agents|mesh-ancestor
24564509|NCT00776633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24564510|NCT00776633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564534|NCT00776672|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24564536|NCT00776672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564538|NCT00776672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24564539|NCT00776698|Bevacizumab|bevacizumab|mesh-list
24564540|NCT00776698|Etoposide|etoposide|mesh-list
24564541|NCT00776698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24564622|NCT00777218|Topiramate|topiramate|mesh-list
24564623|NCT00777218|Propranolol|propranolol|mesh-list
24564624|NCT00777218|Zonisamide|zonisamide|mesh-list
24564625|NCT00777218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25697363|NCT02076321|Ibuprofen|ibuprofen|mesh-list
25697364|NCT02076321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25697365|NCT02076321|Analgesics|analgesics|mesh-ancestor
25697366|NCT02076321|Sensory System Agents|sensory system agents|mesh-ancestor
25697367|NCT02076321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25697368|NCT02076321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697369|NCT02076321|Antipyretics|antipyretics|mesh-ancestor
24419147|NCT00211354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24419171|NCT00211380|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24564626|NCT00777218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24564627|NCT00777218|Adrenergic Agents|adrenergic agents|mesh-ancestor
24564628|NCT00777218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24564629|NCT00777218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528892|NCT00623285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24529004|NCT00624143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564630|NCT00777218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564631|NCT00777218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24564633|NCT00777218|Vasodilator Agents|vasodilator agents|mesh-ancestor
24569072|NCT00798954|Mitosis Modulators|mitosis modulators|mesh-ancestor
24564684|NCT00777517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24564685|NCT00777517|Antimetabolites|antimetabolites|mesh-ancestor
24564686|NCT00777517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564688|NCT00777517|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24564689|NCT00777517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564690|NCT00777543|Ferulic acid|ferulic acid|mesh-list
24564691|NCT00777543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24564746|NCT00777673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24964096|NCT03785613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964097|NCT03785613|Analgesics|analgesics|mesh-ancestor
24964098|NCT03785613|Sensory System Agents|sensory system agents|mesh-ancestor
24802531|NCT01990781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24564748|NCT00777673|Growth Inhibitors|growth inhibitors|mesh-ancestor
24564749|NCT00777673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24564750|NCT00777673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24564751|NCT00777673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24564752|NCT00777673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564753|NCT00777699|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24564754|NCT00777699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24564755|NCT00777699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24564756|NCT00777699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564757|NCT00777699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564760|NCT00777933|Cyclosporine|cyclosporine|mesh-list
24564808|NCT00777998|Growth Substances|growth substances|mesh-ancestor
24565008|NCT00778427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24565009|NCT00778427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565010|NCT00778466|Metformin|metformin|mesh-list
24565011|NCT00778466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24565012|NCT00778466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565013|NCT00778505|Remifentanil|remifentanil|mesh-list
24565014|NCT00778505|Propofol|propofol|mesh-list
24565015|NCT00778505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24565016|NCT00778505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24565017|NCT00778505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565018|NCT00778505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24565019|NCT00778505|Anesthetics, General|anesthetics, general|mesh-ancestor
24565020|NCT00778505|Anesthetics|anesthetics|mesh-ancestor
24565021|NCT00778505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24565022|NCT00778505|Narcotics|narcotics|mesh-ancestor
24565023|NCT00778505|Analgesics|analgesics|mesh-ancestor
24565024|NCT00778505|Sensory System Agents|sensory system agents|mesh-ancestor
24529461|NCT00626080|Insulin Detemir|insulin detemir|mesh-list
24565066|NCT00778661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25697370|NCT02076321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24565067|NCT00778661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24978282|NCT04939636|Vitamin D|vitamin d|mesh-list
24978283|NCT04939636|Ergocalciferols|ergocalciferols|mesh-list
25105775|NCT04930107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978287|NCT04939636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565139|NCT00778973|Antidepressive Agents|antidepressive agents|mesh-ancestor
25697371|NCT02076321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24565140|NCT00778973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24565141|NCT00778973|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24565142|NCT00778973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24565143|NCT00778973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24565144|NCT00778973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565145|NCT00778973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24565146|NCT00778973|Serotonin Agents|serotonin agents|mesh-ancestor
24565152|NCT00779051|Zolpidem|zolpidem|mesh-list
24565153|NCT00779051|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24565154|NCT00779051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24565155|NCT00779051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24565156|NCT00779051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565157|NCT00779051|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24565158|NCT00779051|GABA Agonists|gaba agonists|mesh-ancestor
24964100|NCT03785613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24964101|NCT03785522|Insulin|insulin|mesh-list
24565202|NCT00779220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565204|NCT00779220|Dermatologic Agents|dermatologic agents|mesh-ancestor
24565205|NCT00779220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565206|NCT00779220|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24565207|NCT00779220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24565208|NCT00779220|Immunologic Factors|immunologic factors|mesh-ancestor
24565209|NCT00779220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24565210|NCT00779220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24565212|NCT00779233|Antimetabolites|antimetabolites|mesh-ancestor
24565213|NCT00779233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565214|NCT00779233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24565215|NCT00779233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24565221|NCT00779350|Sertraline|sertraline|mesh-list
24565246|NCT00779389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565247|NCT00779441|Zolpidem|zolpidem|mesh-list
24565248|NCT00779441|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24565249|NCT00779441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24565250|NCT00779441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24565251|NCT00779441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565252|NCT00779441|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24565261|NCT00779454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24565307|NCT00779714|Alkylating Agents|alkylating agents|mesh-ancestor
24565308|NCT00779753|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
24565309|NCT00779753|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24565310|NCT00779753|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24565311|NCT00779792|Triamcinolone|triamcinolone|mesh-list
24565312|NCT00779792|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24565313|NCT00779792|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24565314|NCT00779792|Clobetasol|clobetasol|mesh-list
24565315|NCT00779792|Mineral Oil|mineral oil|mesh-list
24565316|NCT00779792|Tacrolimus|tacrolimus|mesh-list
24565317|NCT00779792|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24565318|NCT00779792|Glycerol|glycerol|mesh-list
24565369|NCT00779922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24565372|NCT00779922|Growth Inhibitors|growth inhibitors|mesh-ancestor
24565373|NCT00779922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24565374|NCT00779935|Infliximab|infliximab|mesh-list
24565375|NCT00779935|Dermatologic Agents|dermatologic agents|mesh-ancestor
24565376|NCT00779935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24565391|NCT00780104|Sirolimus|sirolimus|mesh-list
24565392|NCT00780104|Etoposide|etoposide|mesh-list
24565393|NCT00780104|Mitoxantrone|mitoxantrone|mesh-list
24565396|NCT00780104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25697372|NCT02076321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25697373|NCT02076321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25697374|NCT02076321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697375|NCT02076321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565422|NCT00780325|Naproxen|naproxen|mesh-list
24565423|NCT00780325|Acetazolamide|acetazolamide|mesh-list
24565424|NCT00780325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24565425|NCT00780325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24565426|NCT00780325|Analgesics|analgesics|mesh-ancestor
24565533|NCT00781131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565534|NCT00781131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24565536|NCT00781131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24565570|NCT00781287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24565571|NCT00781287|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24565574|NCT00781287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565575|NCT00781300|Loteprednol Etabonate|loteprednol etabonate|mesh-list
24565576|NCT00781300|Dexamethasone|dexamethasone|mesh-list
24565577|NCT00781300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24565626|NCT00781482|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24671029|NCT01323257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24565627|NCT00781482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24565629|NCT00781482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565630|NCT00781482|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24565631|NCT00781482|GABA Agonists|gaba agonists|mesh-ancestor
24565632|NCT00781482|GABA Agents|gaba agents|mesh-ancestor
24565633|NCT00781482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24565634|NCT00781482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565635|NCT00781521|Ofloxacin|ofloxacin|mesh-list
24565691|NCT00781846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24565716|NCT00782041|Antidotes|antidotes|mesh-ancestor
24565760|NCT00782327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24565862|NCT00783081|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24565863|NCT00783081|Protective Agents|protective agents|mesh-ancestor
24565864|NCT00783081|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24565865|NCT00783081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24565866|NCT00783081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565867|NCT00783107|Cyclosporine|cyclosporine|mesh-list
24565868|NCT00783107|Cyclosporins|cyclosporins|mesh-list
24565915|NCT00783380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565916|NCT00783393|Temozolomide|temozolomide|mesh-list
24565917|NCT00783393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24565918|NCT00783393|Alkylating Agents|alkylating agents|mesh-ancestor
24565919|NCT00783393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565920|NCT00783393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24948481|NCT03919448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948482|NCT03919448|Growth Inhibitors|growth inhibitors|mesh-ancestor
24948483|NCT03919084|Nicotine|nicotine|mesh-list
24948484|NCT03919084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24948485|NCT03919084|Autonomic Agents|autonomic agents|mesh-ancestor
24948486|NCT03919084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24948487|NCT03919084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948488|NCT03919084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24948489|NCT03919084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24948490|NCT03919084|Cholinergic Agents|cholinergic agents|mesh-ancestor
24948491|NCT03919084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24948492|NCT03919084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948493|NCT03919461|Etodolac|etodolac|mesh-list
24948494|NCT03919461|Propranolol|propranolol|mesh-list
24948495|NCT03919461|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24531585|NCT00636493|Hormones|hormones|mesh-ancestor
24948496|NCT03919461|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24948497|NCT03919461|Adrenergic Agents|adrenergic agents|mesh-ancestor
24948498|NCT03919461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24660859|NCT01286688|Terbinafine|terbinafine|mesh-list
24565921|NCT00783471|Docetaxel|docetaxel|mesh-list
24565922|NCT00783471|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24565981|NCT00783653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24565987|NCT00783731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24565989|NCT00783731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24565999|NCT00783744|Insulin|insulin|mesh-list
24566046|NCT00784186|Oxytocics|oxytocics|mesh-ancestor
24566055|NCT00784186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24566056|NCT00784186|Luteolytic Agents|luteolytic agents|mesh-ancestor
24566057|NCT00784186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24566058|NCT00784186|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24566059|NCT00784290|Orantinib|orantinib|mesh-list
24566061|NCT00784290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419398|NCT00212030|Vitamin B Complex|vitamin b complex|mesh-ancestor
24419399|NCT00212030|Vitamins|vitamins|mesh-ancestor
24419400|NCT00212030|Micronutrients|micronutrients|mesh-ancestor
24419401|NCT00212030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566062|NCT00784290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566063|NCT00784316|Metoprolol|metoprolol|mesh-list
24566064|NCT00784316|Amiodarone|amiodarone|mesh-list
24566065|NCT00784316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24566066|NCT00784316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24566067|NCT00784316|Sympatholytics|sympatholytics|mesh-ancestor
24566068|NCT00784316|Autonomic Agents|autonomic agents|mesh-ancestor
24566069|NCT00784316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24566070|NCT00784316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566071|NCT00784316|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24566072|NCT00784316|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24566073|NCT00784316|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24566074|NCT00784316|Adrenergic Agents|adrenergic agents|mesh-ancestor
24566075|NCT00784316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24566076|NCT00784316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532173|NCT00638326|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24532174|NCT00638326|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24532310|NCT00639262|Alkylating Agents|alkylating agents|mesh-ancestor
24532311|NCT00639262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532312|NCT00639262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566080|NCT00784316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24948499|NCT03919461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566082|NCT00784316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24566083|NCT00784316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566084|NCT00784316|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24566085|NCT00784316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24566086|NCT00784316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24566087|NCT00784394|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
24566088|NCT00784394|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24566089|NCT00784394|Protective Agents|protective agents|mesh-ancestor
24566090|NCT00784394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566091|NCT00784394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566092|NCT00784420|Raltegravir Potassium|raltegravir potassium|mesh-list
24566093|NCT00784420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24566094|NCT00784420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24566095|NCT00784420|Antiviral Agents|antiviral agents|mesh-ancestor
24566104|NCT00784446|Imatinib Mesylate|imatinib mesylate|mesh-list
24566105|NCT00784446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24566106|NCT00784446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566107|NCT00784446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24566108|NCT00784446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24566109|NCT00784446|Growth Substances|growth substances|mesh-ancestor
24566111|NCT00784446|Growth Inhibitors|growth inhibitors|mesh-ancestor
24566140|NCT00784498|Sensory System Agents|sensory system agents|mesh-ancestor
24566141|NCT00784498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24566142|NCT00784498|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24566143|NCT00784498|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25697377|NCT02076919|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25697378|NCT02076919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25697379|NCT02076919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25697380|NCT02076919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697381|NCT02076919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697382|NCT02076997|Methotrexate|methotrexate|mesh-list
25697383|NCT02076997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25697384|NCT02076997|Abortifacient Agents|abortifacient agents|mesh-ancestor
25697385|NCT02076997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25697386|NCT02076997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566144|NCT00784498|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24566145|NCT00784498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24566206|NCT00784797|Mifepristone|mifepristone|mesh-list
24566207|NCT00784797|Oxytocics|oxytocics|mesh-ancestor
24566208|NCT00784797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24566209|NCT00784797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566211|NCT00784797|Abortifacient Agents|abortifacient agents|mesh-ancestor
24566247|NCT00784862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566248|NCT00784888|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24566249|NCT00784888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24566250|NCT00784888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566251|NCT00784888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566252|NCT00784888|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24566253|NCT00784888|Hormone Antagonists|hormone antagonists|mesh-ancestor
24566254|NCT00784888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24566255|NCT00784888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566256|NCT00784914|Sirolimus|sirolimus|mesh-list
24566257|NCT00784914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24566258|NCT00784914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24566259|NCT00784914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24566260|NCT00784914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566261|NCT00784914|Antifungal Agents|antifungal agents|mesh-ancestor
24566262|NCT00784914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24566316|NCT00785122|Imiquimod|imiquimod|mesh-list
24566359|NCT00785421|Gemcitabine|gemcitabine|mesh-list
24566360|NCT00785421|Cisplatin|cisplatin|mesh-list
24566361|NCT00785421|Enoxaparin|enoxaparin|mesh-list
24566362|NCT00785421|Enoxaparin sodium|enoxaparin sodium|mesh-list
24566363|NCT00785421|Levoleucovorin|levoleucovorin|mesh-list
24566364|NCT00785421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566365|NCT00785421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24566366|NCT00785421|Antimetabolites|antimetabolites|mesh-ancestor
24566419|NCT00785551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629023|NCT01102608|Alkylating Agents|alkylating agents|mesh-ancestor
24566421|NCT00785551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24566422|NCT00785551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24566423|NCT00785551|Analgesics|analgesics|mesh-ancestor
24566424|NCT00785551|Sensory System Agents|sensory system agents|mesh-ancestor
24566425|NCT00785603|Tramadol|tramadol|mesh-list
24566426|NCT00785603|Paroxetine|paroxetine|mesh-list
24566427|NCT00785603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24566428|NCT00785603|Narcotics|narcotics|mesh-ancestor
24566429|NCT00785603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24566430|NCT00785603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566431|NCT00785603|Analgesics|analgesics|mesh-ancestor
24566432|NCT00785603|Sensory System Agents|sensory system agents|mesh-ancestor
24566433|NCT00785603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24566434|NCT00785603|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24566435|NCT00785603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24566436|NCT00785603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24773841|NCT01842256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24773842|NCT01842256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773843|NCT01842256|Vasodilator Agents|vasodilator agents|mesh-ancestor
24596975|NCT00946621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24566483|NCT00786058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566484|NCT00786110|Paclitaxel|paclitaxel|mesh-list
24566485|NCT00786110|Sorafenib|sorafenib|mesh-list
24566486|NCT00786110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24566552|NCT00786370|Dexmedetomidine|dexmedetomidine|mesh-list
24566553|NCT00786370|Propofol|propofol|mesh-list
24566554|NCT00786370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24566555|NCT00786370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24566556|NCT00786370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566557|NCT00786370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24566558|NCT00786370|Anesthetics, General|anesthetics, general|mesh-ancestor
24566559|NCT00786370|Anesthetics|anesthetics|mesh-ancestor
24566560|NCT00786370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24566561|NCT00786370|Analgesics|analgesics|mesh-ancestor
24566562|NCT00786370|Sensory System Agents|sensory system agents|mesh-ancestor
24566563|NCT00786370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24566564|NCT00786370|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25697387|NCT02076997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25697388|NCT02076997|Antimetabolites|antimetabolites|mesh-ancestor
24795403|NCT02807454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24795404|NCT02807454|Immunologic Factors|immunologic factors|mesh-ancestor
24795405|NCT02807454|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24795406|NCT02807454|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24795407|NCT02807454|Growth Substances|growth substances|mesh-ancestor
24795408|NCT02807454|Growth Inhibitors|growth inhibitors|mesh-ancestor
24795410|NCT02775812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566565|NCT00786370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24566595|NCT00786552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566596|NCT00786552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566597|NCT00786552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24566598|NCT00786552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24566599|NCT00786669|Cefixime|cefixime|mesh-list
24566600|NCT00786669|Cefpodoxime|cefpodoxime|mesh-list
24566601|NCT00786669|Bevacizumab|bevacizumab|mesh-list
24566602|NCT00786669|Irinotecan|irinotecan|mesh-list
24566603|NCT00786669|Vincristine|vincristine|mesh-list
24566604|NCT00786669|Temozolomide|temozolomide|mesh-list
24566605|NCT00786669|Camptothecin|camptothecin|mesh-list
24566606|NCT00786669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24566612|NCT00786669|Growth Inhibitors|growth inhibitors|mesh-ancestor
24566613|NCT00786669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24566614|NCT00786669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24566615|NCT00786669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532883|NCT00641472|Montelukast|montelukast|mesh-list
24566616|NCT00786669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566617|NCT00786669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24566618|NCT00786669|Tubulin Modulators|tubulin modulators|mesh-ancestor
24566619|NCT00786669|Antimitotic Agents|antimitotic agents|mesh-ancestor
24566620|NCT00786669|Mitosis Modulators|mitosis modulators|mesh-ancestor
24566621|NCT00786669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24566622|NCT00786669|Alkylating Agents|alkylating agents|mesh-ancestor
24566623|NCT00786669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24566625|NCT00786695|Esomeprazole|esomeprazole|mesh-list
24566636|NCT00786734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566637|NCT00786734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566638|NCT00786734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24566639|NCT00786851|Lenalidomide|lenalidomide|mesh-list
24566640|NCT00786851|Immunologic Factors|immunologic factors|mesh-ancestor
24566697|NCT00787436|Growth Inhibitors|growth inhibitors|mesh-ancestor
24566698|NCT00787436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24773844|NCT01842256|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24773845|NCT01842256|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24773846|NCT01842269|Mycophenolic Acid|mycophenolic acid|mesh-list
24773847|NCT01842269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24596987|NCT00946725|Atenolol|atenolol|mesh-list
24566768|NCT00787774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566769|NCT00787813|Acetylcysteine|acetylcysteine|mesh-list
24566770|NCT00787813|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24566771|NCT00787813|Antiviral Agents|antiviral agents|mesh-ancestor
24566772|NCT00787813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24566773|NCT00787813|Expectorants|expectorants|mesh-ancestor
24566774|NCT00787813|Respiratory System Agents|respiratory system agents|mesh-ancestor
24566775|NCT00787813|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24566777|NCT00787813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566778|NCT00787813|Protective Agents|protective agents|mesh-ancestor
24566779|NCT00787813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566780|NCT00787813|Antidotes|antidotes|mesh-ancestor
24566781|NCT00787826|Vaccines|vaccines|mesh-list
24566782|NCT00787826|Immunologic Factors|immunologic factors|mesh-ancestor
24566783|NCT00787826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566784|NCT00787969|Sirolimus|sirolimus|mesh-list
24566785|NCT00787969|Rituximab|rituximab|mesh-list
24566792|NCT00787969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24566793|NCT00787969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24566794|NCT00787969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24566796|NCT00787969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24566797|NCT00788034|Vortioxetine|vortioxetine|mesh-list
24566798|NCT00788034|Antidepressive Agents|antidepressive agents|mesh-ancestor
25697389|NCT02076997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697390|NCT02076997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25697391|NCT02076997|Dermatologic Agents|dermatologic agents|mesh-ancestor
25697392|NCT02076997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697393|NCT02076997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25697394|NCT02076997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25697395|NCT02076997|Immunologic Factors|immunologic factors|mesh-ancestor
24978593|NCT03849443|Hemostatics|hemostatics|mesh-ancestor
24978594|NCT03849443|Coagulants|coagulants|mesh-ancestor
24978595|NCT03849443|Antioxidants|antioxidants|mesh-ancestor
24978596|NCT03849443|Protective Agents|protective agents|mesh-ancestor
24566799|NCT00788034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24566800|NCT00788034|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24566801|NCT00788034|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24566814|NCT00788047|Dextromethorphan|dextromethorphan|mesh-list
24566833|NCT00788060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566834|NCT00788060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566835|NCT00788099|Gemcitabine|gemcitabine|mesh-list
24566836|NCT00788099|Sorafenib|sorafenib|mesh-list
24566837|NCT00788099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24566838|NCT00788099|Antimetabolites|antimetabolites|mesh-ancestor
24566839|NCT00788099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566840|NCT00788099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566841|NCT00788099|Antiviral Agents|antiviral agents|mesh-ancestor
24566842|NCT00788099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24566843|NCT00788099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566844|NCT00788099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24566882|NCT00788333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24566883|NCT00788333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566885|NCT00788424|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
24566886|NCT00788424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24566887|NCT00788424|Immunologic Factors|immunologic factors|mesh-ancestor
24566888|NCT00788424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566889|NCT00788424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566890|NCT00788424|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24566891|NCT00788424|Protective Agents|protective agents|mesh-ancestor
24566892|NCT00788424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24566893|NCT00788424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24566894|NCT00788424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566895|NCT00788424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566975|NCT00788931|Panobinostat|panobinostat|mesh-list
24566976|NCT00788931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24566977|NCT00788931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566978|NCT00788931|Tubulin Modulators|tubulin modulators|mesh-ancestor
24566979|NCT00788931|Antimitotic Agents|antimitotic agents|mesh-ancestor
24566980|NCT00788931|Mitosis Modulators|mitosis modulators|mesh-ancestor
24566981|NCT00788931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566982|NCT00788931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24567389|NCT00790998|Anthelmintics|anthelmintics|mesh-ancestor
24566983|NCT00788931|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24567007|NCT00789165|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24567008|NCT00789165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24567009|NCT00789165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24567010|NCT00789165|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24567011|NCT00789165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24567068|NCT00789386|Analgesics|analgesics|mesh-ancestor
24948514|NCT03919175|Rituximab|rituximab|mesh-list
24567126|NCT00789620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24567127|NCT00789620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24567128|NCT00789620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24567129|NCT00789620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24567130|NCT00789620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24567131|NCT00789620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567133|NCT00789646|Anesthetics, Local|anesthetics, local|mesh-ancestor
24567134|NCT00789646|Anesthetics|anesthetics|mesh-ancestor
24567135|NCT00789646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24567136|NCT00789646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567137|NCT00789646|Sensory System Agents|sensory system agents|mesh-ancestor
24567175|NCT00789971|Hormones|hormones|mesh-ancestor
24567451|NCT00791232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24567176|NCT00789971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24567177|NCT00789971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948531|NCT03918616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24567178|NCT00789971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24567179|NCT00789971|Immunologic Factors|immunologic factors|mesh-ancestor
24567182|NCT00790075|Risperidone|risperidone|mesh-list
25697396|NCT02076997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25697397|NCT02076997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25697398|NCT02077465|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24567222|NCT00790114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567223|NCT00790114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24567224|NCT00790114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24567225|NCT00790114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567226|NCT00790114|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24567228|NCT00790114|Purinergic Agents|purinergic agents|mesh-ancestor
24567230|NCT00790153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24567231|NCT00790153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567233|NCT00790179|Anesthetics, Local|anesthetics, local|mesh-ancestor
24567251|NCT00790387|Heparin|heparin|mesh-list
24567252|NCT00790387|Enoxaparin|enoxaparin|mesh-list
24567253|NCT00790387|Calcium heparin|calcium heparin|mesh-list
24567286|NCT00790439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24567287|NCT00790439|Immunologic Factors|immunologic factors|mesh-ancestor
24567288|NCT00790439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567289|NCT00790439|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24567290|NCT00790439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567291|NCT00790439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567292|NCT00790439|Antifungal Agents|antifungal agents|mesh-ancestor
24567293|NCT00790439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24567294|NCT00790439|Dermatologic Agents|dermatologic agents|mesh-ancestor
24567295|NCT00790439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24567296|NCT00790439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24567297|NCT00790439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24567298|NCT00790439|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24567299|NCT00790439|Antitubercular Agents|antitubercular agents|mesh-ancestor
24567300|NCT00790439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24567309|NCT00790595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24567311|NCT00790595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567333|NCT00790777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24567334|NCT00790777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24567335|NCT00790777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567336|NCT00790777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24567337|NCT00790777|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24567338|NCT00790777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24567339|NCT00790777|Serotonin Agents|serotonin agents|mesh-ancestor
24567340|NCT00790777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24567341|NCT00790777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567342|NCT00790777|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24567343|NCT00790777|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24567344|NCT00790777|Dopamine Agents|dopamine agents|mesh-ancestor
24567388|NCT00790998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24567394|NCT00791011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24567395|NCT00791011|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24567397|NCT00791011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567398|NCT00791011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24567399|NCT00791024|Lidocaine|lidocaine|mesh-list
24567400|NCT00791024|Anesthetics, Local|anesthetics, local|mesh-ancestor
24567401|NCT00791024|Anesthetics|anesthetics|mesh-ancestor
24567411|NCT00791141|Cetuximab|cetuximab|mesh-list
24567440|NCT00791193|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24567441|NCT00791193|Dopamine Agents|dopamine agents|mesh-ancestor
24567442|NCT00791232|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24567443|NCT00791232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24567444|NCT00791232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24567445|NCT00791232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24567446|NCT00791232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567447|NCT00791232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24567448|NCT00791232|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24567449|NCT00791232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24567450|NCT00791232|Serotonin Agents|serotonin agents|mesh-ancestor
24567546|NCT00791505|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24567547|NCT00791505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24567548|NCT00791531|Methotrexate|methotrexate|mesh-list
24567549|NCT00791531|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24567551|NCT00791531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24629088|NCT01103154|Antioxidants|antioxidants|mesh-ancestor
24567594|NCT00791713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567595|NCT00791713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24420368|NCT00215774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24420373|NCT00215800|Antiviral Agents|antiviral agents|mesh-ancestor
24420374|NCT00215800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24420375|NCT00215826|Interferon-alpha|interferon-alpha|mesh-list
24420376|NCT00215826|Antiviral Agents|antiviral agents|mesh-ancestor
24450281|NCT00318513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24420377|NCT00215826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24978725|NCT03125642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24978726|NCT03106415|Pembrolizumab|pembrolizumab|mesh-list
24978727|NCT03106415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24567596|NCT00791713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24567600|NCT00791739|Analgesics|analgesics|mesh-ancestor
24567601|NCT00791739|Sensory System Agents|sensory system agents|mesh-ancestor
24567602|NCT00791739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24567603|NCT00791739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567604|NCT00791739|Anticonvulsants|anticonvulsants|mesh-ancestor
24567605|NCT00791739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24567606|NCT00791739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24567607|NCT00791739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567608|NCT00791739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24567609|NCT00791739|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24567611|NCT00791739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24567612|NCT00791739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24567613|NCT00791739|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24567614|NCT00791739|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24567615|NCT00791739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24567616|NCT00791739|Serotonin Agents|serotonin agents|mesh-ancestor
24948533|NCT03918616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24569827|NCT00802009|Dexamethasone|dexamethasone|mesh-list
24458044|NCT00336375|Lumefantrine|lumefantrine|mesh-list
24458045|NCT00336375|Artemether|artemether|mesh-list
24458046|NCT00336375|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24458047|NCT00336375|Antimalarials|antimalarials|mesh-ancestor
24948534|NCT03918616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948535|NCT03918616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948536|NCT03918616|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24948537|NCT03918616|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24948538|NCT03918616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24948539|NCT03918616|Sympathomimetics|sympathomimetics|mesh-ancestor
24948540|NCT03918616|Autonomic Agents|autonomic agents|mesh-ancestor
24567617|NCT00791739|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24567618|NCT00791739|Antidepressive Agents|antidepressive agents|mesh-ancestor
24567642|NCT00791856|Hormones|hormones|mesh-ancestor
24567643|NCT00791856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24567644|NCT00791856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567645|NCT00791856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25697399|NCT02077465|Immunologic Factors|immunologic factors|mesh-ancestor
25697400|NCT02077465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697401|NCT02078102|Meloxicam|meloxicam|mesh-list
25697402|NCT02078102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697403|NCT02078102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25697404|NCT02078102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25697405|NCT02078102|Analgesics|analgesics|mesh-ancestor
25697406|NCT02078102|Sensory System Agents|sensory system agents|mesh-ancestor
25697407|NCT02078102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25697408|NCT02078102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24567711|NCT00792246|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24567712|NCT00792246|Hormone Antagonists|hormone antagonists|mesh-ancestor
24567753|NCT00792376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24567754|NCT00792376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24567755|NCT00792376|Analgesics|analgesics|mesh-ancestor
24567756|NCT00792376|Sensory System Agents|sensory system agents|mesh-ancestor
24567757|NCT00792376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24567758|NCT00792376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567759|NCT00792376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24567766|NCT00792584|Etravirine|etravirine|mesh-list
24567816|NCT00792818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24567817|NCT00792818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567818|NCT00792818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24567819|NCT00792818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24567820|NCT00792818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24567829|NCT00792857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567830|NCT00792857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24567832|NCT00793052|Etoricoxib|etoricoxib|mesh-list
24567873|NCT00793234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24567874|NCT00793234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567876|NCT00793273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24567877|NCT00793273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567878|NCT00793338|Sildenafil Citrate|sildenafil citrate|mesh-list
24567879|NCT00793338|Vasodilator Agents|vasodilator agents|mesh-ancestor
24567880|NCT00793338|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24567881|NCT00793338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24567882|NCT00793338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24629112|NCT01103193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24567883|NCT00793338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567884|NCT00793338|Urological Agents|urological agents|mesh-ancestor
24567886|NCT00793377|Cyclophosphamide|cyclophosphamide|mesh-list
24567887|NCT00793377|Docetaxel|docetaxel|mesh-list
24567888|NCT00793377|Doxorubicin|doxorubicin|mesh-list
24458096|NCT00336531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24567904|NCT00793377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24567905|NCT00793377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567906|NCT00793377|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24567907|NCT00793377|Hormone Antagonists|hormone antagonists|mesh-ancestor
24802572|NCT01990937|GABA Agents|gaba agents|mesh-ancestor
24567950|NCT00793663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24567959|NCT00793663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24567960|NCT00793663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567962|NCT00793663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24567963|NCT00793663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24567964|NCT00793663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24567965|NCT00793741|Somatostatin|somatostatin|mesh-list
24567966|NCT00793741|Hormones|hormones|mesh-ancestor
24567967|NCT00793741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24567968|NCT00793741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567969|NCT00793754|Aspirin|aspirin|mesh-list
24567970|NCT00793754|Atorvastatin|atorvastatin|mesh-list
24567971|NCT00793754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24567972|NCT00793754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24567973|NCT00793754|Analgesics|analgesics|mesh-ancestor
24568000|NCT00793845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568001|NCT00793845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24568002|NCT00793845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24568003|NCT00793845|Alkylating Agents|alkylating agents|mesh-ancestor
24568004|NCT00793845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568005|NCT00793845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24568079|NCT00794625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24568080|NCT00794625|Serotonin Agents|serotonin agents|mesh-ancestor
24568081|NCT00794625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24568082|NCT00794625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568083|NCT00794625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568147|NCT00794885|Micronutrients|micronutrients|mesh-ancestor
24568148|NCT00794885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568149|NCT00794885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24568154|NCT00794898|Infliximab|infliximab|mesh-list
24568203|NCT00795223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24568204|NCT00795223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568205|NCT00795223|Sensory System Agents|sensory system agents|mesh-ancestor
24568206|NCT00795223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24568207|NCT00795223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24568208|NCT00795223|Narcotics|narcotics|mesh-ancestor
24568209|NCT00795223|Analgesics|analgesics|mesh-ancestor
24568210|NCT00795262|Thioctic Acid|thioctic acid|mesh-list
24568211|NCT00795262|Quinapril|quinapril|mesh-list
24568212|NCT00795262|Antioxidants|antioxidants|mesh-ancestor
24568213|NCT00795262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568214|NCT00795262|Protective Agents|protective agents|mesh-ancestor
24568215|NCT00795262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568216|NCT00795262|Vitamin B Complex|vitamin b complex|mesh-ancestor
24568217|NCT00795262|Vitamins|vitamins|mesh-ancestor
24948541|NCT03918616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24948542|NCT03918616|Protective Agents|protective agents|mesh-ancestor
24948544|NCT03918590|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24948545|NCT03918590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24568225|NCT00795301|Cetuximab|cetuximab|mesh-list
24568263|NCT00795457|Poly ICLC|poly iclc|mesh-list
24568322|NCT00795678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24568323|NCT00795678|Tubulin Modulators|tubulin modulators|mesh-ancestor
24568324|NCT00795678|Antimitotic Agents|antimitotic agents|mesh-ancestor
24568325|NCT00795678|Mitosis Modulators|mitosis modulators|mesh-ancestor
24568326|NCT00795678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568327|NCT00795678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24568328|NCT00795678|Immunologic Factors|immunologic factors|mesh-ancestor
24568373|NCT00795808|Fertility Agents|fertility agents|mesh-ancestor
24568374|NCT00795808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24568375|NCT00795808|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24568376|NCT00795808|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24568377|NCT00795847|Losartan|losartan|mesh-list
24568378|NCT00795847|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24568379|NCT00795847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24568380|NCT00795847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24568381|NCT00795847|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24568382|NCT00795847|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24568383|NCT00795847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568384|NCT00795847|Diuretics|diuretics|mesh-ancestor
24568421|NCT00795925|Autonomic Agents|autonomic agents|mesh-ancestor
24568422|NCT00795925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24568423|NCT00795925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568424|NCT00795925|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24568425|NCT00795925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24568430|NCT00795938|Sildenafil Citrate|sildenafil citrate|mesh-list
24568441|NCT00796029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24568442|NCT00796029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24568443|NCT00796029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421185|NCT00218101|Buprenorphine|buprenorphine|mesh-list
24948546|NCT03918590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24948548|NCT03918590|Sensory System Agents|sensory system agents|mesh-ancestor
24948549|NCT03918590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24948550|NCT03918590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568444|NCT00796029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24568445|NCT00796029|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24568463|NCT00796081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568465|NCT00796081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24568468|NCT00796159|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24568469|NCT00796159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24568470|NCT00796159|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24568471|NCT00796159|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24568472|NCT00796159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568473|NCT00796185|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24568474|NCT00796185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24568475|NCT00796185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24568476|NCT00796185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24568477|NCT00796185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568478|NCT00796185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24568479|NCT00796185|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24568480|NCT00796185|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24568481|NCT00796185|Serotonin Agents|serotonin agents|mesh-ancestor
24568515|NCT00796250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24568516|NCT00796250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568517|NCT00796250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24568518|NCT00796250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24568519|NCT00796250|Antiemetics|antiemetics|mesh-ancestor
24568521|NCT00796250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24568522|NCT00796250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24568523|NCT00796250|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24568524|NCT00796250|Protective Agents|protective agents|mesh-ancestor
24568525|NCT00796250|Dermatologic Agents|dermatologic agents|mesh-ancestor
24568526|NCT00796250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24568527|NCT00796250|Antimetabolites|antimetabolites|mesh-ancestor
24568528|NCT00796250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568529|NCT00796250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24568530|NCT00796250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24568531|NCT00796250|Immunologic Factors|immunologic factors|mesh-ancestor
24568558|NCT00796432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24568559|NCT00796432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568562|NCT00796432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24568688|NCT00797030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568689|NCT00797030|Antifungal Agents|antifungal agents|mesh-ancestor
24568690|NCT00797030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24568691|NCT00797030|Dermatologic Agents|dermatologic agents|mesh-ancestor
24568692|NCT00797030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24568693|NCT00797030|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24568695|NCT00797056|Clopidogrel|clopidogrel|mesh-list
24568696|NCT00797056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24568697|NCT00797056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24568698|NCT00797056|Analgesics|analgesics|mesh-ancestor
24568699|NCT00797056|Sensory System Agents|sensory system agents|mesh-ancestor
24568700|NCT00797056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24568710|NCT00797056|Antipyretics|antipyretics|mesh-ancestor
24568734|NCT00797264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24568735|NCT00797264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24568736|NCT00797264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24568737|NCT00797264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568738|NCT00797264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24568739|NCT00797264|Narcotics|narcotics|mesh-ancestor
24568848|NCT00797810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24568849|NCT00797810|Immunologic Factors|immunologic factors|mesh-ancestor
24568850|NCT00797810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568851|NCT00797810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24568852|NCT00797810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24568853|NCT00797810|Alkylating Agents|alkylating agents|mesh-ancestor
24568854|NCT00797810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568855|NCT00797810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421460|NCT00219232|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24421461|NCT00219232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24568856|NCT00797810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24568857|NCT00797810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24568858|NCT00797810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24568860|NCT00797810|Autonomic Agents|autonomic agents|mesh-ancestor
24568861|NCT00797810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24568862|NCT00797810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24568863|NCT00797810|Glucocorticoids|glucocorticoids|mesh-ancestor
24569069|NCT00798954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24569070|NCT00798954|Tubulin Modulators|tubulin modulators|mesh-ancestor
24569071|NCT00798954|Antimitotic Agents|antimitotic agents|mesh-ancestor
24569075|NCT00798954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24569076|NCT00798954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24569077|NCT00798954|Antifungal Agents|antifungal agents|mesh-ancestor
24569078|NCT00798954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24569079|NCT00798954|Immunologic Factors|immunologic factors|mesh-ancestor
24569080|NCT00798954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569081|NCT00798980|Levonorgestrel|levonorgestrel|mesh-list
24569116|NCT00799071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569118|NCT00799071|Hormone Antagonists|hormone antagonists|mesh-ancestor
24569119|NCT00799071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24569120|NCT00799071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569121|NCT00799136|Prednisone|prednisone|mesh-list
24569122|NCT00799136|Vincristine|vincristine|mesh-list
24569123|NCT00799136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24569124|NCT00799136|Glucocorticoids|glucocorticoids|mesh-ancestor
24569125|NCT00799136|Hormones|hormones|mesh-ancestor
24569135|NCT00799149|Etoricoxib|etoricoxib|mesh-list
24569171|NCT00799175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569174|NCT00799175|Autonomic Agents|autonomic agents|mesh-ancestor
24569297|NCT00800137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569298|NCT00800150|Fludarabine|fludarabine|mesh-list
24629285|NCT01104259|Veliparib|veliparib|mesh-list
24569299|NCT00800150|Fludarabine phosphate|fludarabine phosphate|mesh-list
24569347|NCT00800293|Glucocorticoids|glucocorticoids|mesh-ancestor
24569349|NCT00800293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24569350|NCT00800293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569351|NCT00800293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24569352|NCT00800293|Respiratory System Agents|respiratory system agents|mesh-ancestor
24569353|NCT00800306|Simendan|simendan|mesh-list
24569354|NCT00800306|Dobutamine|dobutamine|mesh-list
24569355|NCT00800306|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24569356|NCT00800306|Vasodilator Agents|vasodilator agents|mesh-ancestor
24569357|NCT00800306|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24569405|NCT00800462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24569406|NCT00800462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569407|NCT00800462|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24569468|NCT00800709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569469|NCT00800709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948562|NCT03918889|Midazolam|midazolam|mesh-list
24948563|NCT03918889|Dexmedetomidine|dexmedetomidine|mesh-list
24569515|NCT00800826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24569517|NCT00800826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25697410|NCT02078102|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25697411|NCT02078102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25697412|NCT02078102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697413|NCT02078102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697414|NCT02078180|Bupropion|bupropion|mesh-list
25697415|NCT02078180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25697416|NCT02078180|Antidepressive Agents|antidepressive agents|mesh-ancestor
25697417|NCT02078180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24422255|NCT00221754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24569518|NCT00800826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569520|NCT00800917|Bevacizumab|bevacizumab|mesh-list
24569521|NCT00800917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24569522|NCT00800917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24569523|NCT00800917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24569566|NCT00801086|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24569567|NCT00801086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24569568|NCT00801086|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24569569|NCT00801086|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24569570|NCT00801125|Natalizumab|natalizumab|mesh-list
24569571|NCT00801125|Immunologic Factors|immunologic factors|mesh-ancestor
24569572|NCT00801125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569814|NCT00801957|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24569815|NCT00801957|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24569816|NCT00801957|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24569877|NCT00802139|Micronutrients|micronutrients|mesh-ancestor
24569878|NCT00802139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569879|NCT00802139|Hematinics|hematinics|mesh-ancestor
24569880|NCT00802217|Capsaicin|capsaicin|mesh-list
24569881|NCT00802217|Antipruritics|antipruritics|mesh-ancestor
24569882|NCT00802217|Dermatologic Agents|dermatologic agents|mesh-ancestor
24569883|NCT00802217|Sensory System Agents|sensory system agents|mesh-ancestor
24569884|NCT00802217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24569885|NCT00802217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569908|NCT00802282|Psilocybin|psilocybin|mesh-list
24569909|NCT00802282|Hallucinogens|hallucinogens|mesh-ancestor
24569910|NCT00802282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569911|NCT00802282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24569912|NCT00802308|Morphine|morphine|mesh-list
24569913|NCT00802308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24569914|NCT00802308|Narcotics|narcotics|mesh-ancestor
24569915|NCT00802308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24569917|NCT00802308|Analgesics|analgesics|mesh-ancestor
24569957|NCT00802451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24569958|NCT00802451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24569959|NCT00802568|Fludarabine|fludarabine|mesh-list
24569960|NCT00802568|Fludarabine phosphate|fludarabine phosphate|mesh-list
24569961|NCT00802568|Busulfan|busulfan|mesh-list
24569962|NCT00802568|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24569963|NCT00802568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24569979|NCT00802594|Pafuramidine|pafuramidine|mesh-list
24569980|NCT00802594|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24569984|NCT00802646|Epinephrine|epinephrine|mesh-list
24569985|NCT00802646|Fentanyl|fentanyl|mesh-list
24569986|NCT00802646|Bupivacaine|bupivacaine|mesh-list
24569987|NCT00802646|Anesthetics, Local|anesthetics, local|mesh-ancestor
24569988|NCT00802646|Anesthetics|anesthetics|mesh-ancestor
24569989|NCT00802646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24443726|NCT00295893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24443727|NCT00295893|Alkylating Agents|alkylating agents|mesh-ancestor
24443728|NCT00295893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24443729|NCT00295893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24570000|NCT00802646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24570001|NCT00802646|Adrenergic Agents|adrenergic agents|mesh-ancestor
24570002|NCT00802646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24570003|NCT00802646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570004|NCT00802646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24570005|NCT00802646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24570006|NCT00802646|Autonomic Agents|autonomic agents|mesh-ancestor
24570007|NCT00802646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24570008|NCT00802646|Respiratory System Agents|respiratory system agents|mesh-ancestor
24570010|NCT00802646|Sympathomimetics|sympathomimetics|mesh-ancestor
24570011|NCT00802646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25697418|NCT02078180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24570013|NCT00802802|Rifampin|rifampin|mesh-list
24570014|NCT00802802|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24570016|NCT00802802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697419|NCT02078180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25697420|NCT02078180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25709404|NCT02266433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24795440|NCT02679170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795441|NCT02640534|Metformin|metformin|mesh-list
24795442|NCT02640534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24795443|NCT02640534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795449|NCT02581943|Paclitaxel|paclitaxel|mesh-list
24570051|NCT00802828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24570052|NCT00802828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570053|NCT00802828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570054|NCT00802906|Bevacizumab|bevacizumab|mesh-list
24570055|NCT00802906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24948584|NCT03918889|GABA Modulators|gaba modulators|mesh-ancestor
24948585|NCT03918889|GABA Agents|gaba agents|mesh-ancestor
24570056|NCT00802906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570057|NCT00802906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24570110|NCT00803335|Estrogens|estrogens|mesh-list
24570111|NCT00803335|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24570113|NCT00803335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24571268|NCT00808951|Antiviral Agents|antiviral agents|mesh-ancestor
24570114|NCT00803335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570116|NCT00803374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24570117|NCT00803374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24570118|NCT00803374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570119|NCT00803374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24570120|NCT00803374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570121|NCT00803374|Immunologic Factors|immunologic factors|mesh-ancestor
24570153|NCT00803556|Tubulin Modulators|tubulin modulators|mesh-ancestor
24570154|NCT00803556|Antimitotic Agents|antimitotic agents|mesh-ancestor
24570155|NCT00803556|Mitosis Modulators|mitosis modulators|mesh-ancestor
24948589|NCT03918499|Cyclophosphamide|cyclophosphamide|mesh-list
24948591|NCT03918499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24570327|NCT00804388|Protective Agents|protective agents|mesh-ancestor
24570328|NCT00804401|Naproxen|naproxen|mesh-list
24570329|NCT00804401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24570330|NCT00804401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24671056|NCT01323374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671057|NCT01323374|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24671058|NCT01323374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671059|NCT01323452|Entecavir|entecavir|mesh-list
24570332|NCT00804401|Sensory System Agents|sensory system agents|mesh-ancestor
24570333|NCT00804401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24570334|NCT00804401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570335|NCT00804401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24570336|NCT00804401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24570337|NCT00804401|Gout Suppressants|gout suppressants|mesh-ancestor
24570338|NCT00804401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24570339|NCT00804401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24570380|NCT00804622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570381|NCT00804622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24570382|NCT00804622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24570383|NCT00804674|Bupivacaine|bupivacaine|mesh-list
24570384|NCT00804674|Anesthetics, Local|anesthetics, local|mesh-ancestor
24570385|NCT00804674|Anesthetics|anesthetics|mesh-ancestor
24570386|NCT00804674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24570387|NCT00804674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570390|NCT00804752|Vitamin D|vitamin d|mesh-list
24570405|NCT00804830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24570406|NCT00804830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24570411|NCT00804830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24570412|NCT00804830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24570413|NCT00804830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24570414|NCT00804830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570415|NCT00804856|Cytarabine|cytarabine|mesh-list
24570416|NCT00804856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24570417|NCT00804856|Antimetabolites|antimetabolites|mesh-ancestor
24570420|NCT00804856|Antiviral Agents|antiviral agents|mesh-ancestor
24570477|NCT00804960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24570478|NCT00804960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24570479|NCT00804960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697421|NCT02078180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697422|NCT02078180|Dopamine Agents|dopamine agents|mesh-ancestor
25697423|NCT02078180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25697424|NCT02078180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422819|NCT00223691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24570480|NCT00804960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24570481|NCT00804960|Hormone Antagonists|hormone antagonists|mesh-ancestor
24629383|NCT01104896|Cholinergic Agents|cholinergic agents|mesh-ancestor
24570482|NCT00804960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24570483|NCT00804960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570485|NCT00805012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570486|NCT00805012|Tubulin Modulators|tubulin modulators|mesh-ancestor
24570487|NCT00805012|Antimitotic Agents|antimitotic agents|mesh-ancestor
24570488|NCT00805012|Mitosis Modulators|mitosis modulators|mesh-ancestor
24948592|NCT03918499|Immunologic Factors|immunologic factors|mesh-ancestor
24948593|NCT03918499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948594|NCT03918499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24948595|NCT03918499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24948596|NCT03918499|Alkylating Agents|alkylating agents|mesh-ancestor
24948597|NCT03918499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948598|NCT03918499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24948599|NCT03918499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24802594|NCT01991158|Methotrexate|methotrexate|mesh-list
24802595|NCT01991158|Pegaspargase|pegaspargase|mesh-list
24802596|NCT01991158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24802597|NCT01991158|Antiemetics|antiemetics|mesh-ancestor
24802598|NCT01991158|Autonomic Agents|autonomic agents|mesh-ancestor
24465028|NCT00367562|Protease Inhibitors|protease inhibitors|mesh-ancestor
24570489|NCT00805012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570490|NCT00805064|Triamcinolone|triamcinolone|mesh-list
24570491|NCT00805064|Bevacizumab|bevacizumab|mesh-list
24570492|NCT00805064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24570493|NCT00805064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570494|NCT00805064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24570495|NCT00805064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24570496|NCT00805064|Growth Substances|growth substances|mesh-ancestor
24570497|NCT00805064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570498|NCT00805064|Growth Inhibitors|growth inhibitors|mesh-ancestor
24802237|NCT01989000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24393316|NCT00129597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24393515|NCT00130195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24570536|NCT00805233|Growth Substances|growth substances|mesh-ancestor
24570537|NCT00805233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570538|NCT00805233|Growth Inhibitors|growth inhibitors|mesh-ancestor
24570539|NCT00805233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570540|NCT00805233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24570541|NCT00805233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24570542|NCT00805233|Analgesics|analgesics|mesh-ancestor
24570543|NCT00805233|Sensory System Agents|sensory system agents|mesh-ancestor
24570544|NCT00805233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24570545|NCT00805233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24570573|NCT00805298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24570576|NCT00805311|Amlodipine|amlodipine|mesh-list
24570647|NCT00805558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24570648|NCT00805558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24570649|NCT00805558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24570650|NCT00805558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570651|NCT00805558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570652|NCT00805558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24570653|NCT00805558|Contraceptive Agents|contraceptive agents|mesh-ancestor
24570654|NCT00805558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24570655|NCT00805558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570656|NCT00805558|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24570657|NCT00805558|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24570658|NCT00805558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24570659|NCT00805558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24570660|NCT00805558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25697425|NCT02078180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25709405|NCT02266433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423484|NCT00226096|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24423612|NCT00226421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24423613|NCT00226421|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24570661|NCT00805558|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24570662|NCT00805558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24570663|NCT00805649|Dexamethasone|dexamethasone|mesh-list
24570664|NCT00805649|Bevacizumab|bevacizumab|mesh-list
24570665|NCT00805649|Temazepam|temazepam|mesh-list
24570728|NCT00806247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24570729|NCT00806247|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24570730|NCT00806247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24570731|NCT00806247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24570732|NCT00806247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570733|NCT00806247|Adrenergic Agents|adrenergic agents|mesh-ancestor
24570734|NCT00806247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24570744|NCT00806481|Sevelamer|sevelamer|mesh-list
24570774|NCT00806741|Respiratory System Agents|respiratory system agents|mesh-ancestor
24948620|NCT03918187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948622|NCT03918187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24948623|NCT03918187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24948624|NCT03918187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24948625|NCT03918187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24948626|NCT03918187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24948627|NCT03918187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24948628|NCT03918187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24948630|NCT03918187|GABA Modulators|gaba modulators|mesh-ancestor
24948631|NCT03918187|GABA Agents|gaba agents|mesh-ancestor
24948632|NCT03918187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24948633|NCT03918187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948634|NCT03918187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24948635|NCT03918187|Narcotics|narcotics|mesh-ancestor
24948636|NCT03918187|Analgesics|analgesics|mesh-ancestor
24948637|NCT03917914|Bisoprolol|bisoprolol|mesh-list
24948638|NCT03917914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24948639|NCT03917914|Sympatholytics|sympatholytics|mesh-ancestor
24948640|NCT03917914|Autonomic Agents|autonomic agents|mesh-ancestor
24948641|NCT03917914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24948642|NCT03917914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948643|NCT03917914|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24948644|NCT03917914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24728360|NCT01615757|Cytarabine|cytarabine|mesh-list
24948645|NCT03917914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24948646|NCT03917914|Adrenergic Agents|adrenergic agents|mesh-ancestor
24948647|NCT03917914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24802622|NCT01991275|Morphine|morphine|mesh-list
24570826|NCT00806871|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24570827|NCT00806871|Prednisolone phosphate|prednisolone phosphate|mesh-list
24570828|NCT00806871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24570829|NCT00806871|Antiemetics|antiemetics|mesh-ancestor
24570830|NCT00806871|Autonomic Agents|autonomic agents|mesh-ancestor
24570831|NCT00806871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24570832|NCT00806871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570833|NCT00806871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24570834|NCT00806871|Glucocorticoids|glucocorticoids|mesh-ancestor
24570835|NCT00806871|Hormones|hormones|mesh-ancestor
24570836|NCT00806871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24570837|NCT00806871|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25697426|NCT02078180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25697427|NCT02078180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697428|NCT02078193|Abatacept|abatacept|mesh-list
25697429|NCT02078193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24979215|NCT05135312|Sensory System Agents|sensory system agents|mesh-ancestor
24423852|NCT00227123|Serotonin Agents|serotonin agents|mesh-ancestor
24423860|NCT00227123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24423861|NCT00227123|Dopamine Agents|dopamine agents|mesh-ancestor
24979236|NCT05089123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621206|NCT01060969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621207|NCT01060969|Urological Agents|urological agents|mesh-ancestor
24621208|NCT01060969|Anticonvulsants|anticonvulsants|mesh-ancestor
24621209|NCT01060969|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24621210|NCT01060969|Diuretics|diuretics|mesh-ancestor
24621211|NCT01060969|Natriuretic Agents|natriuretic agents|mesh-ancestor
24424035|NCT00227695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424036|NCT00227695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24424037|NCT00227708|Docetaxel|docetaxel|mesh-list
24424038|NCT00227708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424039|NCT00227708|Tubulin Modulators|tubulin modulators|mesh-ancestor
24424040|NCT00227708|Antimitotic Agents|antimitotic agents|mesh-ancestor
24424041|NCT00227708|Mitosis Modulators|mitosis modulators|mesh-ancestor
24424042|NCT00227708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424043|NCT00227734|Capecitabine|capecitabine|mesh-list
24424044|NCT00227734|Oxaliplatin|oxaliplatin|mesh-list
24424045|NCT00227734|Cetuximab|cetuximab|mesh-list
24570838|NCT00806871|Protective Agents|protective agents|mesh-ancestor
24570839|NCT00806871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24570840|NCT00806871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24948648|NCT03917914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948649|NCT03918135|Acetaminophen|acetaminophen|mesh-list
24948650|NCT03918135|Ibuprofen|ibuprofen|mesh-list
24802642|NCT01991288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24570841|NCT00806897|Insulin Detemir|insulin detemir|mesh-list
24570842|NCT00806897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24570843|NCT00806897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570844|NCT00806910|Conivaptan|conivaptan|mesh-list
24570845|NCT00806910|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24570846|NCT00806910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570847|NCT00806910|Natriuretic Agents|natriuretic agents|mesh-ancestor
24570877|NCT00807053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570931|NCT00807261|Immunologic Factors|immunologic factors|mesh-ancestor
24570932|NCT00807261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570933|NCT00807261|Tubulin Modulators|tubulin modulators|mesh-ancestor
24570934|NCT00807261|Antimitotic Agents|antimitotic agents|mesh-ancestor
24458274|NCT00337298|Protease Inhibitors|protease inhibitors|mesh-ancestor
24570935|NCT00807261|Mitosis Modulators|mitosis modulators|mesh-ancestor
24570936|NCT00807326|Simethicone|simethicone|mesh-list
24570937|NCT00807326|Loperamide|loperamide|mesh-list
24570938|NCT00807326|Antidiarrheals|antidiarrheals|mesh-list
24570939|NCT00807326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24570940|NCT00807326|Antifoaming Agents|antifoaming agents|mesh-ancestor
24570941|NCT00807326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570942|NCT00807326|Emollients|emollients|mesh-ancestor
24570943|NCT00807326|Dermatologic Agents|dermatologic agents|mesh-ancestor
24570944|NCT00807443|Raltegravir Potassium|raltegravir potassium|mesh-list
24570969|NCT00807534|Autonomic Agents|autonomic agents|mesh-ancestor
24570970|NCT00807534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25697430|NCT02078193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697431|NCT02078193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25697432|NCT02078193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25697433|NCT02078193|Immunologic Factors|immunologic factors|mesh-ancestor
25697434|NCT02078193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697435|NCT02078193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25697436|NCT02078219|Allopurinol|allopurinol|mesh-list
25697437|NCT02078219|Verinurad|verinurad|mesh-list
25697438|NCT02078219|Antimetabolites|antimetabolites|mesh-ancestor
25697439|NCT02078219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697440|NCT02078219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697441|NCT02078219|Gout Suppressants|gout suppressants|mesh-ancestor
25697442|NCT02078219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25697443|NCT02078219|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25697444|NCT02078219|Antioxidants|antioxidants|mesh-ancestor
25697445|NCT02078219|Protective Agents|protective agents|mesh-ancestor
25697446|NCT02078219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697447|NCT02078284|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
25697448|NCT02078284|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25697449|NCT02078284|Protective Agents|protective agents|mesh-ancestor
25697450|NCT02078284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570971|NCT00807534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570972|NCT00807534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24570973|NCT00807534|Respiratory System Agents|respiratory system agents|mesh-ancestor
24570974|NCT00807534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24570975|NCT00807534|Cholinergic Agents|cholinergic agents|mesh-ancestor
24570976|NCT00807534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24570985|NCT00807625|Contraceptive Agents|contraceptive agents|mesh-ancestor
24570986|NCT00807625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24570987|NCT00807625|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24570988|NCT00807625|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24570989|NCT00807625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24571049|NCT00807950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571050|NCT00807950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24571102|NCT00808171|Anesthetics, Local|anesthetics, local|mesh-list
24571104|NCT00808171|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24571105|NCT00808171|Anesthetics|anesthetics|mesh-list
24571106|NCT00808171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24571107|NCT00808171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571108|NCT00808171|Sensory System Agents|sensory system agents|mesh-ancestor
24571109|NCT00808171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24571110|NCT00808171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24571111|NCT00808171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24571112|NCT00808171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24571113|NCT00808171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24571114|NCT00808171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571115|NCT00808171|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24571116|NCT00808171|Anesthetics, General|anesthetics, general|mesh-ancestor
24571117|NCT00808171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24571118|NCT00808171|Analgesics|analgesics|mesh-ancestor
24948661|NCT03918135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948663|NCT03917940|Glimepiride|glimepiride|mesh-list
24948664|NCT03917940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24948665|NCT03917940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24948666|NCT03917940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571211|NCT00808678|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24571212|NCT00808678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571213|NCT00808704|Epoetin Alfa|epoetin alfa|mesh-list
24571214|NCT00808704|Hematinics|hematinics|mesh-ancestor
24571215|NCT00808717|Atorvastatin|atorvastatin|mesh-list
24571216|NCT00808717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24571217|NCT00808717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24571218|NCT00808717|Antimetabolites|antimetabolites|mesh-ancestor
24571219|NCT00808717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571220|NCT00808717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24601766|NCT00965900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24571221|NCT00808717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24571222|NCT00808717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571223|NCT00808743|Celecoxib|celecoxib|mesh-list
24571224|NCT00808743|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24571227|NCT00808743|Analgesics|analgesics|mesh-ancestor
24571249|NCT00808795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571251|NCT00808912|Sildenafil Citrate|sildenafil citrate|mesh-list
24571252|NCT00808912|Vasodilator Agents|vasodilator agents|mesh-ancestor
24571253|NCT00808912|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24571254|NCT00808912|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24571255|NCT00808912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571256|NCT00808912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571257|NCT00808912|Urological Agents|urological agents|mesh-ancestor
24571258|NCT00808951|Artesunate|artesunate|mesh-list
24571259|NCT00808951|Lumefantrine|lumefantrine|mesh-list
24571260|NCT00808951|Artemether|artemether|mesh-list
24571261|NCT00808951|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25009205|NCT02953093|Acarbose|acarbose|mesh-list
24571263|NCT00808951|Antimalarials|antimalarials|mesh-ancestor
24571264|NCT00808951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24571265|NCT00808951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24571266|NCT00808951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571267|NCT00808951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24571269|NCT00808951|Schistosomicides|schistosomicides|mesh-ancestor
24571270|NCT00808951|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24571287|NCT00809029|Hormones|hormones|mesh-ancestor
24571305|NCT00809068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571306|NCT00809068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24571307|NCT00809068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24571308|NCT00809068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24571309|NCT00809068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24571310|NCT00809068|Anabolic Agents|anabolic agents|mesh-ancestor
24571311|NCT00809068|Hormones|hormones|mesh-ancestor
24571312|NCT00809107|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24571313|NCT00809107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24571314|NCT00809107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571315|NCT00809172|Cyclosporine|cyclosporine|mesh-list
24571316|NCT00809172|Methotrexate|methotrexate|mesh-list
24571317|NCT00809172|Cyclosporins|cyclosporins|mesh-list
24571318|NCT00809172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24571319|NCT00809172|Abortifacient Agents|abortifacient agents|mesh-ancestor
24571323|NCT00809172|Antimetabolites|antimetabolites|mesh-ancestor
24571355|NCT00809237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24571356|NCT00809289|Moxifloxacin|moxifloxacin|mesh-list
24571357|NCT00809289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24571358|NCT00809289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571359|NCT00809289|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24571360|NCT00809289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24571361|NCT00809289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24948667|NCT03917940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24571362|NCT00809289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571363|NCT00809289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24571364|NCT00809393|Tranexamic Acid|tranexamic acid|mesh-list
24571418|NCT00809718|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24571419|NCT00809718|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24571420|NCT00809718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24571421|NCT00809744|Cholecalciferol|cholecalciferol|mesh-list
24571422|NCT00809744|Vitamin D|vitamin d|mesh-list
24571423|NCT00809744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24571424|NCT00809744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571425|NCT00809744|Vitamins|vitamins|mesh-ancestor
24571426|NCT00809744|Micronutrients|micronutrients|mesh-ancestor
24571427|NCT00809744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24571428|NCT00809796|Pentamidine|pentamidine|mesh-list
24571429|NCT00809796|Antifungal Agents|antifungal agents|mesh-ancestor
24571430|NCT00809796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571431|NCT00809796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24571432|NCT00809796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24571478|NCT00810316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571479|NCT00810316|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24571480|NCT00810316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24571481|NCT00810316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24571482|NCT00810316|GABA Modulators|gaba modulators|mesh-ancestor
24571483|NCT00810316|GABA Agents|gaba agents|mesh-ancestor
24571484|NCT00810316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24571485|NCT00810316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571486|NCT00810316|Anticonvulsants|anticonvulsants|mesh-ancestor
24571487|NCT00810381|Nitroprusside|nitroprusside|mesh-list
24571488|NCT00810381|Isosorbide|isosorbide|mesh-list
24571489|NCT00810381|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24571490|NCT00810381|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
24571696|NCT00811356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571697|NCT00811356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24571698|NCT00811356|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24571699|NCT00811356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571700|NCT00811356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25697451|NCT02078284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24571747|NCT00811486|Spironolactone|spironolactone|mesh-list
25697452|NCT02078284|Antioxidants|antioxidants|mesh-ancestor
25697453|NCT02078284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697454|NCT02078492|Ketorolac|ketorolac|mesh-list
25697455|NCT02078492|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24571749|NCT00811486|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24571750|NCT00811486|Hormone Antagonists|hormone antagonists|mesh-ancestor
24571751|NCT00811486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24571752|NCT00811486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571753|NCT00811486|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24571755|NCT00811486|Natriuretic Agents|natriuretic agents|mesh-ancestor
24571756|NCT00811486|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24571979|NCT00812422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571980|NCT00812435|Eptifibatide|eptifibatide|mesh-list
24571981|NCT00812435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24571982|NCT00812448|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24571983|NCT00812448|Antioxidants|antioxidants|mesh-ancestor
24571984|NCT00812448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571985|NCT00812448|Protective Agents|protective agents|mesh-ancestor
24571986|NCT00812448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571987|NCT00812448|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24571988|NCT00812448|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24571989|NCT00812448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24571990|NCT00812448|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24571991|NCT00812513|Becaplermin|becaplermin|mesh-list
24572040|NCT00812786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572041|NCT00812786|Antifungal Agents|antifungal agents|mesh-ancestor
24572103|NCT00813072|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24572105|NCT00813072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24572106|NCT00813137|Endostar protein|endostar protein|mesh-list
24572107|NCT00813137|Endostatins|endostatins|mesh-list
24572108|NCT00813137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24572109|NCT00813137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24572110|NCT00813137|Growth Substances|growth substances|mesh-ancestor
24572111|NCT00813137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572112|NCT00813137|Growth Inhibitors|growth inhibitors|mesh-ancestor
24572113|NCT00813137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572114|NCT00813202|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24572115|NCT00813202|Natriuretic Agents|natriuretic agents|mesh-ancestor
24572116|NCT00813202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572117|NCT00813228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24572150|NCT00813332|Growth Substances|growth substances|mesh-ancestor
24572151|NCT00813332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572186|NCT00813696|Gemcitabine|gemcitabine|mesh-list
24572187|NCT00813696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572188|NCT00813696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24572189|NCT00813696|Antimetabolites|antimetabolites|mesh-ancestor
24572191|NCT00813696|Antiviral Agents|antiviral agents|mesh-ancestor
24572244|NCT00813735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24572245|NCT00813735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24572246|NCT00813774|Certolizumab Pegol|certolizumab pegol|mesh-list
24572247|NCT00813774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24572248|NCT00813774|Immunologic Factors|immunologic factors|mesh-ancestor
24572249|NCT00813774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572250|NCT00813774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24572251|NCT00813891|Ranibizumab|ranibizumab|mesh-list
24572252|NCT00813891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24572253|NCT00813891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24572254|NCT00813891|Growth Substances|growth substances|mesh-ancestor
24572255|NCT00813891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572256|NCT00813891|Growth Inhibitors|growth inhibitors|mesh-ancestor
24572257|NCT00813891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572258|NCT00814008|Insulin|insulin|mesh-list
24572259|NCT00814008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24572260|NCT00814008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572297|NCT00814125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24572298|NCT00814125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572352|NCT00814281|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24572353|NCT00814281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572354|NCT00814359|Benzydamine|benzydamine|mesh-list
24572355|NCT00814359|Sucralfate|sucralfate|mesh-list
24572356|NCT00814359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24426548|NCT00236288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24572357|NCT00814359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24572358|NCT00814359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24572359|NCT00814515|Cyclosporine|cyclosporine|mesh-list
24572360|NCT00814515|Cyclosporins|cyclosporins|mesh-list
24572361|NCT00814515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24572362|NCT00814515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572363|NCT00814515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24572364|NCT00814515|Immunologic Factors|immunologic factors|mesh-ancestor
24572365|NCT00814515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572366|NCT00814515|Antifungal Agents|antifungal agents|mesh-ancestor
24572367|NCT00814515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24572368|NCT00814515|Dermatologic Agents|dermatologic agents|mesh-ancestor
24572399|NCT00814593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572400|NCT00814593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572401|NCT00814606|Ribavirin|ribavirin|mesh-list
24572402|NCT00814606|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24572403|NCT00814606|Antimetabolites|antimetabolites|mesh-ancestor
24572404|NCT00814606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572405|NCT00814606|Antiviral Agents|antiviral agents|mesh-ancestor
24572406|NCT00814606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24572407|NCT00814619|Capecitabine|capecitabine|mesh-list
24572408|NCT00814619|Panitumumab|panitumumab|mesh-list
24572409|NCT00814619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24572410|NCT00814619|Antimetabolites|antimetabolites|mesh-ancestor
24572412|NCT00814619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572517|NCT00815256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572518|NCT00815256|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24572519|NCT00815256|Dermatologic Agents|dermatologic agents|mesh-ancestor
24572520|NCT00815269|Sevoflurane|sevoflurane|mesh-list
24572521|NCT00815269|Desflurane|desflurane|mesh-list
24572522|NCT00815269|Isoflurane|isoflurane|mesh-list
24572523|NCT00815269|Halothane|halothane|mesh-list
24572524|NCT00815269|Enflurane|enflurane|mesh-list
24572527|NCT00815269|Anesthetics, General|anesthetics, general|mesh-ancestor
24572574|NCT00815568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572576|NCT00815568|Immunologic Factors|immunologic factors|mesh-ancestor
24572577|NCT00815568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572578|NCT00815568|Antiviral Agents|antiviral agents|mesh-ancestor
24572579|NCT00815568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24572580|NCT00815568|Alkylating Agents|alkylating agents|mesh-ancestor
24572581|NCT00815568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24572582|NCT00815568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24572583|NCT00815594|Bevacizumab|bevacizumab|mesh-list
24572584|NCT00815594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24572585|NCT00815594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572586|NCT00815594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24572587|NCT00815594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24572588|NCT00815594|Growth Substances|growth substances|mesh-ancestor
24572589|NCT00815594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572590|NCT00815594|Growth Inhibitors|growth inhibitors|mesh-ancestor
24572635|NCT00815945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572636|NCT00815945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24572637|NCT00815945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24572638|NCT00815945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24572639|NCT00815945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24572640|NCT00815945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572641|NCT00816049|Mercaptopurine|mercaptopurine|mesh-list
24572642|NCT00816049|Antimetabolites|antimetabolites|mesh-ancestor
24572643|NCT00816049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572652|NCT00816127|Hemostatics|hemostatics|mesh-ancestor
24572662|NCT00816140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802292|NCT01989312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24572663|NCT00816140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24572664|NCT00816140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24572666|NCT00816205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24572667|NCT00816205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24948673|NCT03917784|Sensory System Agents|sensory system agents|mesh-ancestor
24948674|NCT03917784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24948675|NCT03917784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979363|NCT04639466|Vaccines|vaccines|mesh-list
24427318|NCT00237939|Aripiprazole|aripiprazole|mesh-list
24427319|NCT00237939|Antidepressive Agents|antidepressive agents|mesh-ancestor
24427363|NCT00238043|Hematinics|hematinics|mesh-ancestor
24427423|NCT00238173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427424|NCT00238173|Antiviral Agents|antiviral agents|mesh-ancestor
24427425|NCT00238173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24427426|NCT00238173|Expectorants|expectorants|mesh-ancestor
24948676|NCT03917784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24948677|NCT03917784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24572668|NCT00816205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572669|NCT00816205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24572670|NCT00816205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572671|NCT00816205|Vasodilator Agents|vasodilator agents|mesh-ancestor
24572672|NCT00816205|Tocolytic Agents|tocolytic agents|mesh-ancestor
24572673|NCT00816205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24572674|NCT00816218|Pioglitazone|pioglitazone|mesh-list
24572726|NCT00816426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572727|NCT00816426|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24572728|NCT00816426|Antitubercular Agents|antitubercular agents|mesh-ancestor
24572729|NCT00816426|Leprostatic Agents|leprostatic agents|mesh-ancestor
24572730|NCT00816426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24572731|NCT00816426|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24572732|NCT00816426|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24572742|NCT00816517|Botulinum Toxins|botulinum toxins|mesh-list
24572743|NCT00816517|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24572744|NCT00816517|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24572745|NCT00816517|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24572746|NCT00816517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24443858|NCT00296023|Abortifacient Agents|abortifacient agents|mesh-ancestor
24443859|NCT00296023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24572747|NCT00816517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572748|NCT00816517|Cholinergic Agents|cholinergic agents|mesh-ancestor
24572749|NCT00816517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24572750|NCT00816517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572751|NCT00816517|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24572752|NCT00816517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24572754|NCT00816543|Oxaliplatin|oxaliplatin|mesh-list
24572755|NCT00816543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572756|NCT00816543|Tubulin Modulators|tubulin modulators|mesh-ancestor
24572757|NCT00816543|Antimitotic Agents|antimitotic agents|mesh-ancestor
24572809|NCT00816816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24572810|NCT00816816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24572811|NCT00816816|Immunologic Factors|immunologic factors|mesh-ancestor
24572812|NCT00816816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572813|NCT00816855|Docetaxel|docetaxel|mesh-list
24572814|NCT00816855|Fluorouracil|fluorouracil|mesh-list
24572815|NCT00816855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572834|NCT00816894|Antiemetics|antiemetics|mesh-ancestor
24572835|NCT00816894|Autonomic Agents|autonomic agents|mesh-ancestor
24572836|NCT00816894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24572837|NCT00816894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572884|NCT00817011|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24572885|NCT00817011|Analgesics|analgesics|mesh-ancestor
24572886|NCT00817011|Sensory System Agents|sensory system agents|mesh-ancestor
24572887|NCT00817011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24572888|NCT00817011|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24572889|NCT00817011|Serotonin Agents|serotonin agents|mesh-ancestor
24572890|NCT00817011|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24572891|NCT00817011|Histamine Antagonists|histamine antagonists|mesh-ancestor
25697456|NCT02078492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25697457|NCT02078492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25697458|NCT02078492|Analgesics|analgesics|mesh-ancestor
24463276|NCT00359814|Cyclosporine|cyclosporine|mesh-list
24463281|NCT00359814|Immunologic Factors|immunologic factors|mesh-ancestor
25697459|NCT02078492|Sensory System Agents|sensory system agents|mesh-ancestor
25697460|NCT02078492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25697461|NCT02078492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697462|NCT02078492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25697463|NCT02078492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25697464|NCT02078492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24979388|NCT04540380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979389|NCT04540380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24979390|NCT04540380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24979391|NCT04540380|Alkylating Agents|alkylating agents|mesh-ancestor
24458390|NCT00337740|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24572892|NCT00817011|Histamine Agents|histamine agents|mesh-ancestor
24572893|NCT00817011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24572894|NCT00817011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24572895|NCT00817011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24572896|NCT00817011|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24572897|NCT00817011|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24572898|NCT00817011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24572899|NCT00817011|Adrenergic Agents|adrenergic agents|mesh-ancestor
24572900|NCT00817011|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24572912|NCT00817037|Vasodilator Agents|vasodilator agents|mesh-ancestor
24572913|NCT00817037|Tocolytic Agents|tocolytic agents|mesh-ancestor
24572920|NCT00817245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24443878|NCT00296049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24572921|NCT00817245|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24572922|NCT00817245|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24572923|NCT00817245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24572924|NCT00817245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24572925|NCT00817245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24572926|NCT00817245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573972|NCT00822809|Prednisolone|prednisolone|mesh-list
24572927|NCT00817245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572929|NCT00817258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572930|NCT00817271|Glucagon|glucagon|mesh-list
24572931|NCT00817271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24573069|NCT00817713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573070|NCT00817713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24573072|NCT00817739|Flutamide|flutamide|mesh-list
24573074|NCT00817739|Fertility Agents|fertility agents|mesh-ancestor
24573075|NCT00817739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24573076|NCT00817739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948681|NCT03917758|Dapagliflozin|dapagliflozin|mesh-list
24948682|NCT03917758|Empagliflozin|empagliflozin|mesh-list
24948683|NCT03917758|Canagliflozin|canagliflozin|mesh-list
24948684|NCT03917758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
24948685|NCT03917758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573077|NCT00817739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24573079|NCT00817739|Androgen Antagonists|androgen antagonists|mesh-ancestor
24573080|NCT00817739|Hormone Antagonists|hormone antagonists|mesh-ancestor
24573081|NCT00817739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24573082|NCT00817765|Ritonavir|ritonavir|mesh-list
24573114|NCT00817934|Bisacodyl|bisacodyl|mesh-list
24573115|NCT00817934|Cathartics|cathartics|mesh-ancestor
24573116|NCT00817934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24573117|NCT00817934|Laxatives|laxatives|mesh-ancestor
24573118|NCT00817960|Methylphenidate|methylphenidate|mesh-list
24573119|NCT00817960|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24573120|NCT00817960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573121|NCT00817960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24573122|NCT00817960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24573123|NCT00817960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24573124|NCT00817960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573165|NCT00818194|Cyclosporins|cyclosporins|mesh-list
24573166|NCT00818194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24573167|NCT00818194|Immunologic Factors|immunologic factors|mesh-ancestor
24573238|NCT00818675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573239|NCT00818701|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24573241|NCT00818701|Vasodilator Agents|vasodilator agents|mesh-ancestor
25697465|NCT02078492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697466|NCT02078492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697467|NCT02078713|Contraceptive Agents|contraceptive agents|mesh-list
25697468|NCT02078713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25697469|NCT02078713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573242|NCT00818701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24427923|NCT00239291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428011|NCT00239421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24428012|NCT00239421|Adrenergic Agents|adrenergic agents|mesh-ancestor
24428013|NCT00239421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24428014|NCT00239421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428015|NCT00239421|Parasympatholytics|parasympatholytics|mesh-ancestor
24428016|NCT00239421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24979403|NCT04469595|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
24573243|NCT00818701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24573244|NCT00818701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24948703|NCT03917628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24948704|NCT03917628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24573245|NCT00818701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573246|NCT00818701|Urological Agents|urological agents|mesh-ancestor
24573247|NCT00818701|Natriuretic Agents|natriuretic agents|mesh-ancestor
24573248|NCT00818701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573249|NCT00818818|Meglumine Antimoniate|meglumine antimoniate|mesh-list
24573255|NCT00818870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24573256|NCT00818870|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24573257|NCT00818870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573258|NCT00818870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573259|NCT00819000|Interferon-beta|interferon-beta|mesh-list
24573260|NCT00819000|Glatiramer Acetate|glatiramer acetate|mesh-list
24573261|NCT00819000|Interferon beta-1b|interferon beta-1b|mesh-list
24573262|NCT00819000|(T,G)-A-L|(t,g)-a-l|mesh-list
24573263|NCT00819000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24573264|NCT00819000|Immunologic Factors|immunologic factors|mesh-ancestor
24629530|NCT01105910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24573282|NCT00819078|Bupropion|bupropion|mesh-list
24573283|NCT00819078|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24573284|NCT00819078|Antidepressive Agents|antidepressive agents|mesh-ancestor
24573285|NCT00819078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24573349|NCT00819520|Cholinergic Agents|cholinergic agents|mesh-ancestor
24573350|NCT00819520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24573351|NCT00819520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573971|NCT00822783|Respiratory System Agents|respiratory system agents|mesh-ancestor
24671070|NCT01323465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802719|NCT01991873|Micronutrients|micronutrients|mesh-ancestor
24671071|NCT01323465|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24573394|NCT00819754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573395|NCT00819754|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24573396|NCT00819754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24573397|NCT00819754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573398|NCT00819806|Cyclophosphamide|cyclophosphamide|mesh-list
24573399|NCT00819806|Vaccines|vaccines|mesh-list
24573400|NCT00819806|Immunologic Factors|immunologic factors|mesh-ancestor
24573401|NCT00819806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573402|NCT00819806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24573403|NCT00819806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24573404|NCT00819806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24573405|NCT00819806|Alkylating Agents|alkylating agents|mesh-ancestor
24573406|NCT00819806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573407|NCT00819806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24573408|NCT00819806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24573409|NCT00819845|Carvedilol|carvedilol|mesh-list
24573410|NCT00819845|Ramipril|ramipril|mesh-list
24671077|NCT01323465|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24573411|NCT00819845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24573418|NCT00819845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24573420|NCT00819845|Protective Agents|protective agents|mesh-ancestor
25697470|NCT02078726|Glucagon|glucagon|mesh-list
25697471|NCT02078726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25697472|NCT02078726|Hormones|hormones|mesh-ancestor
25697473|NCT02078726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25697474|NCT02078726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697475|NCT02078817|Ketamine|ketamine|mesh-list
25697476|NCT02078817|Analgesics|analgesics|mesh-ancestor
25697477|NCT02078817|Sensory System Agents|sensory system agents|mesh-ancestor
25697478|NCT02078817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24783876|NCT01904643|Antimetabolites|antimetabolites|mesh-ancestor
24573598|NCT00820963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573599|NCT00820963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24573600|NCT00821028|Paclitaxel|paclitaxel|mesh-list
24572025|NCT00812760|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24572027|NCT00812760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24572028|NCT00812760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573601|NCT00821028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24573602|NCT00821028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24573626|NCT00821262|Propofol|propofol|mesh-list
24573627|NCT00821262|Sevoflurane|sevoflurane|mesh-list
24573628|NCT00821262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24573629|NCT00821262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24573630|NCT00821262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573631|NCT00821262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24573632|NCT00821262|Anesthetics, General|anesthetics, general|mesh-ancestor
24573633|NCT00821262|Anesthetics|anesthetics|mesh-ancestor
24573634|NCT00821262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24573635|NCT00821262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24573636|NCT00821301|Fluphenazine|fluphenazine|mesh-list
24573637|NCT00821301|Fluphenazine depot|fluphenazine depot|mesh-list
24573701|NCT00821574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24573702|NCT00821574|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24573703|NCT00821574|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24573740|NCT00821782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24573780|NCT00822055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24573781|NCT00822055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573782|NCT00822055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24573783|NCT00822055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24573784|NCT00822055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24573785|NCT00822055|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24573835|NCT00822263|Expectorants|expectorants|mesh-ancestor
24573836|NCT00822263|Respiratory System Agents|respiratory system agents|mesh-ancestor
24629789|NCT01107951|Dexamethasone|dexamethasone|mesh-list
24573843|NCT00822315|Efavirenz|efavirenz|mesh-list
24573844|NCT00822315|Raltegravir Potassium|raltegravir potassium|mesh-list
24671088|NCT01323465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24671089|NCT01323465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573847|NCT00822315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573960|NCT00822744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24573961|NCT00822744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573962|NCT00822744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24948708|NCT03917420|Antiviral Agents|antiviral agents|mesh-ancestor
24948709|NCT03917420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24948710|NCT03917420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24948711|NCT03917420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24948712|NCT03917420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573973|NCT00822809|Catumaxomab|catumaxomab|mesh-list
24573974|NCT00822809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24573975|NCT00822809|Glucocorticoids|glucocorticoids|mesh-ancestor
24573976|NCT00822809|Hormones|hormones|mesh-ancestor
24573977|NCT00822809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24573978|NCT00822809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573979|NCT00822809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24573980|NCT00822809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24574005|NCT00823004|Contraceptive Agents|contraceptive agents|mesh-list
24574006|NCT00823004|Contraceptives, Oral|contraceptives, oral|mesh-list
24574007|NCT00823004|Buserelin|buserelin|mesh-list
24574008|NCT00823004|Ganirelix|ganirelix|mesh-list
24574009|NCT00823004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24574010|NCT00823004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24574011|NCT00823004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24574012|NCT00823004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574013|NCT00823004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574014|NCT00823004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24574015|NCT00823004|Hormone Antagonists|hormone antagonists|mesh-ancestor
24574021|NCT00823004|Fertility Agents|fertility agents|mesh-ancestor
24574039|NCT00823121|Fertility Agents|fertility agents|mesh-ancestor
24574041|NCT00823186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25697479|NCT02078817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429358|NCT00243737|Artesunate|artesunate|mesh-list
24574042|NCT00823186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629933|NCT01108744|Diuretics|diuretics|mesh-ancestor
24574043|NCT00823186|Tubulin Modulators|tubulin modulators|mesh-ancestor
24574044|NCT00823186|Antimitotic Agents|antimitotic agents|mesh-ancestor
24574045|NCT00823186|Mitosis Modulators|mitosis modulators|mesh-ancestor
24574046|NCT00823186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574047|NCT00823238|Tobramycin|tobramycin|mesh-list
24574048|NCT00823238|Ceftazidime|ceftazidime|mesh-list
24574049|NCT00823238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24574050|NCT00823238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24574051|NCT00823290|Sorafenib|sorafenib|mesh-list
24574052|NCT00823290|Panobinostat|panobinostat|mesh-list
24574053|NCT00823290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24574054|NCT00823290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24574055|NCT00823290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574058|NCT00823342|Tenofovir|tenofovir|mesh-list
24948738|NCT03917134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24948739|NCT03917134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24948740|NCT03917134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24948742|NCT03917082|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24948743|NCT03917082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948744|NCT03917082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24948745|NCT03917082|Hormone Antagonists|hormone antagonists|mesh-ancestor
24948746|NCT03917082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24574085|NCT00823550|Antiviral Agents|antiviral agents|mesh-ancestor
24574086|NCT00823550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24574087|NCT00823550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24574088|NCT00823550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24574089|NCT00823576|Ropivacaine|ropivacaine|mesh-list
24574090|NCT00823576|Anesthetics, Local|anesthetics, local|mesh-ancestor
24574091|NCT00823576|Anesthetics|anesthetics|mesh-ancestor
24574092|NCT00823576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24948747|NCT03917082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948748|NCT03917082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24948749|NCT03917082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24948750|NCT03917082|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24948751|NCT03917082|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24948752|NCT03917082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24948753|NCT03917082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24774110|NCT01843868|Tropisetron|tropisetron|mesh-list
24948779|NCT05402735|Uric Acid|uric acid|mesh-list
24948780|NCT05402735|Antioxidants|antioxidants|mesh-ancestor
24948781|NCT05402735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948782|NCT05402735|Protective Agents|protective agents|mesh-ancestor
24948783|NCT05402735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948784|NCT05402722|Antibodies|antibodies|mesh-list
24948785|NCT05402722|Immunologic Factors|immunologic factors|mesh-ancestor
24948786|NCT05402722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948787|NCT05402553|Ondansetron|ondansetron|mesh-list
24948794|NCT05402553|Dermatologic Agents|dermatologic agents|mesh-ancestor
24948795|NCT05402553|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24948796|NCT05402553|Serotonin Agents|serotonin agents|mesh-ancestor
24948797|NCT05402553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24948798|NCT05402553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948799|NCT05402553|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24948805|NCT05402319|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24948935|NCT05401058|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24948814|NCT05402189|Sensory System Agents|sensory system agents|mesh-ancestor
24948815|NCT05402189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24948816|NCT05402189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24948817|NCT05402189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24948818|NCT05402189|Anesthetics, General|anesthetics, general|mesh-ancestor
24948819|NCT05402189|Anesthetics|anesthetics|mesh-ancestor
24948821|NCT05402124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24948822|NCT05402124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24948823|NCT05402124|Analgesics|analgesics|mesh-ancestor
24948824|NCT05402124|Sensory System Agents|sensory system agents|mesh-ancestor
24948825|NCT05402124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24948826|NCT05402124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430547|NCT00248209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430585|NCT00248313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24430586|NCT00248313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24430587|NCT00248313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24430590|NCT00248313|Immunologic Factors|immunologic factors|mesh-ancestor
24948827|NCT05402124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24574172|NCT00824057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24574173|NCT00824057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24574174|NCT00824057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24629996|NCT01109030|Dexetimide|dexetimide|mesh-list
24629997|NCT01109030|Citalopram|citalopram|mesh-list
24574175|NCT00824057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24574176|NCT00824057|Anesthetics, General|anesthetics, general|mesh-ancestor
24574177|NCT00824057|Anesthetics|anesthetics|mesh-ancestor
24574178|NCT00824057|GABA Modulators|gaba modulators|mesh-ancestor
24533413|NCT00643799|Analgesics|analgesics|mesh-ancestor
24574179|NCT00824057|GABA Agents|gaba agents|mesh-ancestor
24574180|NCT00824057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24574181|NCT00824057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574182|NCT00824057|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24574183|NCT00824057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24574236|NCT00824239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24948828|NCT05402124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24948829|NCT05402124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24948830|NCT05402124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24948831|NCT05402124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948832|NCT05402124|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24948833|NCT05402124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24948834|NCT05402124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24948835|NCT05402124|Antipyretics|antipyretics|mesh-ancestor
24948836|NCT05401812|Glucocorticoids|glucocorticoids|mesh-list
25051728|NCT00384150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25051729|NCT00383578|Metformin|metformin|mesh-list
25051730|NCT00383578|Vildagliptin|vildagliptin|mesh-list
25051731|NCT00383578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25051732|NCT00383578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051733|NCT00383578|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25051734|NCT00383578|Protease Inhibitors|protease inhibitors|mesh-ancestor
25051735|NCT00383578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051737|NCT00383513|Epratuzumab|epratuzumab|mesh-list
24948840|NCT05401786|Ipilimumab|ipilimumab|mesh-list
24948841|NCT05401786|Cemiplimab|cemiplimab|mesh-list
24948842|NCT05401786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24948843|NCT05401786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24948844|NCT05401786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24948845|NCT05401786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948847|NCT05401721|Hemostatics|hemostatics|mesh-ancestor
24948934|NCT05401058|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24948936|NCT05401058|Dopamine Agents|dopamine agents|mesh-ancestor
24948937|NCT05401058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24948938|NCT05401058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948940|NCT05401032|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24948941|NCT05401032|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24574237|NCT00824239|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24574238|NCT00824239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24574239|NCT00824239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24574240|NCT00824239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24574241|NCT00824239|GABA Modulators|gaba modulators|mesh-ancestor
24574253|NCT00824317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24574254|NCT00824668|Insulin|insulin|mesh-list
24574255|NCT00824668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24574256|NCT00824668|Insulin Glargine|insulin glargine|mesh-list
24574257|NCT00824668|Insulin Aspart|insulin aspart|mesh-list
24574258|NCT00824668|Biphasic Insulins|biphasic insulins|mesh-list
25697480|NCT02078817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25697481|NCT02078817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25697482|NCT02078817|Anesthetics, General|anesthetics, general|mesh-ancestor
25697483|NCT02078817|Anesthetics|anesthetics|mesh-ancestor
25697484|NCT02078817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25697485|NCT02078817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25697486|NCT02078817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25697487|NCT02078817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24574259|NCT00824668|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24574321|NCT00825019|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24574322|NCT00825019|Antidepressive Agents|antidepressive agents|mesh-ancestor
24574323|NCT00825019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24574324|NCT00825019|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24574325|NCT00825019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24574326|NCT00825019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574327|NCT00825019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24574328|NCT00825019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24574329|NCT00825019|Adrenergic Agents|adrenergic agents|mesh-ancestor
24574330|NCT00825045|Risperidone|risperidone|mesh-list
24948949|NCT05401019|Risperidone|risperidone|mesh-list
24948950|NCT05401019|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24948951|NCT05401019|Serotonin Agents|serotonin agents|mesh-ancestor
24948952|NCT05401019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24948953|NCT05401019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948954|NCT05401019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948955|NCT05401019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24948956|NCT05401019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24948957|NCT05401019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24948958|NCT05401019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24948959|NCT05401019|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24948960|NCT05401019|Dopamine Agents|dopamine agents|mesh-ancestor
24948962|NCT05401019|Protective Agents|protective agents|mesh-ancestor
24948963|NCT05401019|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24948964|NCT05401019|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24948965|NCT05401019|Dopamine Agonists|dopamine agonists|mesh-ancestor
24948966|NCT05401006|Acitretin|acitretin|mesh-list
24948967|NCT05401006|Keratolytic Agents|keratolytic agents|mesh-ancestor
24948968|NCT05401006|Dermatologic Agents|dermatologic agents|mesh-ancestor
24948969|NCT05400915|Paclitaxel|paclitaxel|mesh-list
24948970|NCT05400915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24948971|NCT05400915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24802888|NCT01993134|Cefazolin|cefazolin|mesh-list
24574465|NCT00825396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24574467|NCT00825422|Anesthetics, Local|anesthetics, local|mesh-ancestor
24574468|NCT00825422|Anesthetics|anesthetics|mesh-ancestor
24574469|NCT00825422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24574470|NCT00825422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574471|NCT00825422|Sensory System Agents|sensory system agents|mesh-ancestor
24574472|NCT00825422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24574473|NCT00825552|Risperidone|risperidone|mesh-list
24574474|NCT00825552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24574475|NCT00825552|Serotonin Agents|serotonin agents|mesh-ancestor
24574476|NCT00825552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24574477|NCT00825552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574478|NCT00825552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574479|NCT00825552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24574480|NCT00825552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24948972|NCT05400915|Tubulin Modulators|tubulin modulators|mesh-ancestor
24948973|NCT05400915|Antimitotic Agents|antimitotic agents|mesh-ancestor
24948974|NCT05400915|Mitosis Modulators|mitosis modulators|mesh-ancestor
24948975|NCT05400915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948977|NCT05400902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24948989|NCT05400148|Anesthetics, Local|anesthetics, local|mesh-ancestor
24948990|NCT05400148|Anesthetics|anesthetics|mesh-ancestor
24948993|NCT05400148|Sensory System Agents|sensory system agents|mesh-ancestor
24574481|NCT00825552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24574482|NCT00825552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24574521|NCT00825864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24574522|NCT00825864|Antiemetics|antiemetics|mesh-ancestor
24574523|NCT00825864|Autonomic Agents|autonomic agents|mesh-ancestor
24574524|NCT00825864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24574525|NCT00825864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574526|NCT00825864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24574527|NCT00825864|Glucocorticoids|glucocorticoids|mesh-ancestor
24671102|NCT01323491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24574528|NCT00825864|Hormones|hormones|mesh-ancestor
24574529|NCT00825864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24574530|NCT00825864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24574535|NCT00825864|Analgesics|analgesics|mesh-ancestor
24979526|NCT04042831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
24979527|NCT04042831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574536|NCT00825864|Sensory System Agents|sensory system agents|mesh-ancestor
24574537|NCT00825864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24574538|NCT00825864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24574539|NCT00825864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574540|NCT00825864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574541|NCT00825864|Protease Inhibitors|protease inhibitors|mesh-ancestor
24574640|NCT00826644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24574641|NCT00826644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24949042|NCT05350943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24949043|NCT05350943|Immunologic Factors|immunologic factors|mesh-ancestor
24949044|NCT05350943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949045|NCT05335018|Lenalidomide|lenalidomide|mesh-list
24949046|NCT05335018|Immunologic Factors|immunologic factors|mesh-ancestor
24949047|NCT05335018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949048|NCT05335018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24949049|NCT05335018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24949050|NCT05335018|Growth Substances|growth substances|mesh-ancestor
24949051|NCT05335018|Growth Inhibitors|growth inhibitors|mesh-ancestor
24949052|NCT05335018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24949053|NCT05327556|Epinephrine|epinephrine|mesh-list
24949056|NCT05327556|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24949057|NCT05327556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24949058|NCT05327556|Adrenergic Agents|adrenergic agents|mesh-ancestor
24949059|NCT05327556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24949060|NCT05327556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949061|NCT05327556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949062|NCT05327556|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24949063|NCT05327556|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24450031|NCT00317655|Ibuprofen|ibuprofen|mesh-list
24949064|NCT05327556|Autonomic Agents|autonomic agents|mesh-ancestor
24949065|NCT05327556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24949066|NCT05327556|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24949067|NCT05327556|Respiratory System Agents|respiratory system agents|mesh-ancestor
24949068|NCT05327556|Mydriatics|mydriatics|mesh-ancestor
24949101|NCT05282940|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
24949102|NCT05282940|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24949103|NCT05282940|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24574656|NCT00826787|Levetiracetam|levetiracetam|mesh-list
24574657|NCT00826787|Anticonvulsants|anticonvulsants|mesh-ancestor
24574697|NCT00826891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24574698|NCT00826891|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24574738|NCT00827216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24574739|NCT00827216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24574740|NCT00827216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24574741|NCT00827216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574742|NCT00827216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574743|NCT00827281|Cycloserine|cycloserine|mesh-list
24574744|NCT00827281|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24574745|NCT00827281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24574746|NCT00827281|Renal Agents|renal agents|mesh-ancestor
24574747|NCT00827281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24574748|NCT00827281|Antitubercular Agents|antitubercular agents|mesh-ancestor
24574749|NCT00827281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24574794|NCT00827411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24574795|NCT00827411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24574796|NCT00827411|Purinergic Agents|purinergic agents|mesh-ancestor
24574797|NCT00827411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24574799|NCT00827450|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24574800|NCT00827450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574801|NCT00827450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24574802|NCT00827450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574803|NCT00827450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574837|NCT00827814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574838|NCT00827814|Hormone Antagonists|hormone antagonists|mesh-ancestor
25406976|NCT03524898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25697488|NCT02078817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697489|NCT02078882|Abatacept|abatacept|mesh-list
25697490|NCT02078882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25697491|NCT02078882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697493|NCT02078882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24574839|NCT00827814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24574840|NCT00827814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574841|NCT00827840|Risperidone|risperidone|mesh-list
24574842|NCT00827840|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24574843|NCT00827840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24574844|NCT00827840|Serotonin Agents|serotonin agents|mesh-ancestor
24574845|NCT00827840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24574846|NCT00827840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574847|NCT00827840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574848|NCT00827840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24574849|NCT00827840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24574907|NCT00828477|Sensory System Agents|sensory system agents|mesh-ancestor
24671104|NCT01323569|Nabiximols|nabiximols|mesh-list
24574908|NCT00828477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24574910|NCT00828477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24949168|NCT05189457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24949169|NCT05189457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949170|NCT05189457|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24949172|NCT05189457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24949173|NCT05189457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24949174|NCT05189457|Luteolytic Agents|luteolytic agents|mesh-ancestor
25051744|NCT00383422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051745|NCT00383422|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25051746|NCT00383422|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24574990|NCT00828958|Risperidone|risperidone|mesh-list
24574991|NCT00828958|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24574992|NCT00828958|Serotonin Agents|serotonin agents|mesh-ancestor
24574993|NCT00828958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24575053|NCT00829205|Carboplatin|carboplatin|mesh-list
24575055|NCT00829205|Ifosfamide|ifosfamide|mesh-list
24575056|NCT00829205|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
24575057|NCT00829205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24575058|NCT00829205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24575095|NCT00829322|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25051756|NCT00382460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25051757|NCT00382460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051759|NCT00382096|Vildagliptin|vildagliptin|mesh-list
25051760|NCT00382096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25051761|NCT00382096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051762|NCT00382096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25051763|NCT00382096|Protease Inhibitors|protease inhibitors|mesh-ancestor
25051764|NCT00382096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051765|NCT00382096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051766|NCT00380159|Lamivudine|lamivudine|mesh-list
25051767|NCT00380159|Emtricitabine|emtricitabine|mesh-list
25051768|NCT00380159|Dexelvucitabine|dexelvucitabine|mesh-list
25051769|NCT00380159|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25051770|NCT00380159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25051771|NCT00380159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051772|NCT00380159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051773|NCT00380159|Antiviral Agents|antiviral agents|mesh-ancestor
25051774|NCT00380159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25051775|NCT00380159|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25051776|NCT00380159|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25051777|NCT00379990|Prednisolone|prednisolone|mesh-list
25051778|NCT00379990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25051779|NCT00379990|Glucocorticoids|glucocorticoids|mesh-ancestor
25051780|NCT00379990|Hormones|hormones|mesh-ancestor
25697494|NCT02078882|Immunologic Factors|immunologic factors|mesh-ancestor
25697495|NCT02078882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697496|NCT02078882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25697497|NCT02078960|Homoharringtonine|homoharringtonine|mesh-list
25697498|NCT02078960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25697499|NCT02078960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432724|NCT00255762|Growth Inhibitors|growth inhibitors|mesh-ancestor
25051781|NCT00379990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25051782|NCT00379990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575193|NCT00830193|Acetylcysteine|acetylcysteine|mesh-list
24575194|NCT00830193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24575195|NCT00830193|Antiviral Agents|antiviral agents|mesh-ancestor
25051783|NCT00379990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25051784|NCT00379990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051785|NCT00377182|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25051786|NCT00377182|Antiviral Agents|antiviral agents|mesh-ancestor
25051787|NCT00377182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25051788|NCT00375791|Dexamethasone|dexamethasone|mesh-list
25051791|NCT00375791|Autonomic Agents|autonomic agents|mesh-ancestor
25051792|NCT00375791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25051793|NCT00375791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051794|NCT00375791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25051795|NCT00375791|Glucocorticoids|glucocorticoids|mesh-ancestor
25051796|NCT00375791|Hormones|hormones|mesh-ancestor
25051797|NCT00375791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25051798|NCT00375791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25051799|NCT00375791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051800|NCT00375193|Amrubicin|amrubicin|mesh-list
25051801|NCT00375193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051802|NCT00374296|Mocetinostat|mocetinostat|mesh-list
25051803|NCT00374296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24964697|NCT03781258|Warfarin|warfarin|mesh-list
24964698|NCT03781258|Anticoagulants|anticoagulants|mesh-ancestor
24964699|NCT03781063|Fulvestrant|fulvestrant|mesh-list
24964700|NCT03781063|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24964701|NCT03781063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24949193|NCT05161156|Autonomic Agents|autonomic agents|mesh-ancestor
24949194|NCT05161156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24949195|NCT05161156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949196|NCT05161156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24949197|NCT05161156|Respiratory System Agents|respiratory system agents|mesh-ancestor
24949198|NCT05161156|Parasympatholytics|parasympatholytics|mesh-ancestor
24949199|NCT05161156|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24949200|NCT05161156|Cholinergic Agents|cholinergic agents|mesh-ancestor
24949201|NCT05161156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24949202|NCT05161156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949203|NCT05161156|Anticonvulsants|anticonvulsants|mesh-ancestor
24575200|NCT00830193|Antioxidants|antioxidants|mesh-ancestor
24575201|NCT00830193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575202|NCT00830193|Protective Agents|protective agents|mesh-ancestor
24575203|NCT00830193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575204|NCT00830193|Antidotes|antidotes|mesh-ancestor
24575216|NCT00830323|Oseltamivir|oseltamivir|mesh-list
24575253|NCT00830414|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24575254|NCT00830414|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24575255|NCT00830414|Contraceptive Agents|contraceptive agents|mesh-ancestor
24949254|NCT05055024|Mazindol|mazindol|mesh-list
25697500|NCT02078960|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25697501|NCT02078960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697502|NCT02078960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697503|NCT02079077|Aspirin|aspirin|mesh-list
25697504|NCT02079077|Hydroxychloroquine|hydroxychloroquine|mesh-list
25697505|NCT02079077|Antimalarials|antimalarials|mesh-ancestor
25697506|NCT02079077|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25697507|NCT02079077|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25697508|NCT02079077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25697509|NCT02079077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697510|NCT02079077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979615|NCT03493425|Cisplatin|cisplatin|mesh-list
24979616|NCT03493425|Carboplatin|carboplatin|mesh-list
24979617|NCT03493425|Docetaxel|docetaxel|mesh-list
24979618|NCT03493425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979619|NCT03493425|Tubulin Modulators|tubulin modulators|mesh-ancestor
24979620|NCT03493425|Antimitotic Agents|antimitotic agents|mesh-ancestor
24979621|NCT03493425|Mitosis Modulators|mitosis modulators|mesh-ancestor
24979622|NCT03493425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979623|NCT03455439|Rivaroxaban|rivaroxaban|mesh-list
24979636|NCT03373188|Antibodies|antibodies|mesh-list
24949255|NCT05055024|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24949256|NCT05055024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949257|NCT05055024|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24949258|NCT05055024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24949259|NCT05055024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24949260|NCT05055024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949261|NCT05055024|Adrenergic Agents|adrenergic agents|mesh-ancestor
24949262|NCT05055024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24949263|NCT05055024|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24949264|NCT05055024|Dopamine Agents|dopamine agents|mesh-ancestor
24949265|NCT05047445|Vaccines|vaccines|mesh-list
24949266|NCT05047445|Immunologic Factors|immunologic factors|mesh-ancestor
24949267|NCT05047445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949301|NCT05026125|Sensory System Agents|sensory system agents|mesh-ancestor
24949302|NCT05026125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24949304|NCT05000047|Trace Elements|trace elements|mesh-ancestor
24949305|NCT05000047|Micronutrients|micronutrients|mesh-ancestor
24949306|NCT05000047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949307|NCT04982146|Acetylcysteine|acetylcysteine|mesh-list
24949308|NCT04982146|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24949309|NCT04982146|Antiviral Agents|antiviral agents|mesh-ancestor
24949310|NCT04982146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24949316|NCT04982146|Protective Agents|protective agents|mesh-ancestor
24949317|NCT04982146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949318|NCT04982146|Antidotes|antidotes|mesh-ancestor
24949319|NCT04971746|Pirfenidone|pirfenidone|mesh-list
24949320|NCT04971746|Nintedanib|nintedanib|mesh-list
24949321|NCT04971746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24949417|NCT04813016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24949322|NCT04971746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24949323|NCT04971746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24949324|NCT04971746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051804|NCT00374296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24949325|NCT04971746|Analgesics|analgesics|mesh-ancestor
24949326|NCT04971746|Sensory System Agents|sensory system agents|mesh-ancestor
24949327|NCT04971746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24949328|NCT04971746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949329|NCT04971746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24949330|NCT04971746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24949331|NCT04971746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24774683|NCT01847339|Bupivacaine|bupivacaine|mesh-list
24774758|NCT01847677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24774759|NCT01847677|Growth Substances|growth substances|mesh-ancestor
24774760|NCT01847677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774761|NCT01847677|Growth Inhibitors|growth inhibitors|mesh-ancestor
24774762|NCT01847690|Hydrocortisone|hydrocortisone|mesh-list
24774765|NCT01847768|Dimercaprol|dimercaprol|mesh-list
24774768|NCT01847768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774769|NCT01847768|Miotics|miotics|mesh-ancestor
24774770|NCT01847768|Autonomic Agents|autonomic agents|mesh-ancestor
24774771|NCT01847768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25697511|NCT02079077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25697512|NCT02079077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25697513|NCT02079077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25697514|NCT02079077|Analgesics|analgesics|mesh-ancestor
25697515|NCT02079077|Sensory System Agents|sensory system agents|mesh-ancestor
25697516|NCT02079077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25697517|NCT02079077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697518|NCT02079077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25697519|NCT02079077|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24433602|NCT00259168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774772|NCT01847768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774773|NCT01847768|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24774774|NCT01847768|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
24774775|NCT01847768|Respiratory System Agents|respiratory system agents|mesh-ancestor
24774776|NCT01847768|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24774777|NCT01847768|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24774778|NCT01847768|Cholinergic Agents|cholinergic agents|mesh-ancestor
24774779|NCT01847768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24803270|NCT01995344|Interleukin-2|interleukin-2|mesh-list
24575264|NCT00830466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24575265|NCT00830466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24575266|NCT00830466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24575267|NCT00830466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24575268|NCT00830466|Antifungal Agents|antifungal agents|mesh-ancestor
24575269|NCT00830466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24575399|NCT00831350|Ranibizumab|ranibizumab|mesh-list
24575400|NCT00831350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24575401|NCT00831350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24575402|NCT00831350|Growth Substances|growth substances|mesh-ancestor
24575403|NCT00831350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575404|NCT00831350|Growth Inhibitors|growth inhibitors|mesh-ancestor
24575405|NCT00831350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24575406|NCT00831376|Albuterol|albuterol|mesh-list
24575591|NCT00832481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24774780|NCT01847781|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24774781|NCT01847781|Immunologic Factors|immunologic factors|mesh-ancestor
24774782|NCT01847781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774783|NCT01847872|Vaccines|vaccines|mesh-list
24774784|NCT01847872|Immunologic Factors|immunologic factors|mesh-ancestor
24626157|NCT01085721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24626158|NCT01085721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626159|NCT01085721|Expectorants|expectorants|mesh-ancestor
24626160|NCT01085721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24949353|NCT04958746|Anesthetics, General|anesthetics, general|mesh-ancestor
24949354|NCT04958746|Anesthetics|anesthetics|mesh-ancestor
24949365|NCT04916392|Bupivacaine|bupivacaine|mesh-list
24603739|NCT00975325|Yohimbine|yohimbine|mesh-list
24949366|NCT04916392|Anesthetics, Local|anesthetics, local|mesh-ancestor
24949371|NCT04916392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24949372|NCT04904978|Listerine|listerine|mesh-list
24949373|NCT04904978|Sodium Fluoride|sodium fluoride|mesh-list
24949374|NCT04904978|Cariostatic Agents|cariostatic agents|mesh-ancestor
24949375|NCT04904978|Protective Agents|protective agents|mesh-ancestor
24949376|NCT04904978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949379|NCT04896489|Hydrocortisone|hydrocortisone|mesh-list
24949410|NCT04813016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24949411|NCT04813016|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24949412|NCT04813016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24949413|NCT04813016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24949414|NCT04813016|Adrenergic Agents|adrenergic agents|mesh-ancestor
24949415|NCT04813016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24949416|NCT04813016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949423|NCT04778982|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24949424|NCT04778982|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24949425|NCT04778982|Hormone Antagonists|hormone antagonists|mesh-ancestor
24949426|NCT04778982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24949427|NCT04778982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949428|NCT04778982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24949429|NCT04778982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24949430|NCT04778982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949431|NCT04776447|Carboplatin|carboplatin|mesh-list
24949432|NCT04776447|Atezolizumab|atezolizumab|mesh-list
24949433|NCT04776447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24949434|NCT04744480|Anesthetics|anesthetics|mesh-list
24949435|NCT04744480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24949436|NCT04744480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949442|NCT04729543|Azacitidine|azacitidine|mesh-list
24949443|NCT04729543|Interleukin-2|interleukin-2|mesh-list
24949444|NCT04729543|Valproic Acid|valproic acid|mesh-list
24949445|NCT04729543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25697520|NCT02079077|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25697521|NCT02079077|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24450222|NCT00318084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450223|NCT00318084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450225|NCT00318162|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24450226|NCT00318162|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24433982|NCT00261118|Immunologic Factors|immunologic factors|mesh-ancestor
24434100|NCT00261482|Contraceptive Agents|contraceptive agents|mesh-ancestor
24434101|NCT00261482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24434102|NCT00261482|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24434103|NCT00261482|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24434104|NCT00261482|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24949446|NCT04729543|Antimetabolites|antimetabolites|mesh-ancestor
24949447|NCT04729543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949448|NCT04729543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24949449|NCT04729543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24949454|NCT04729543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949455|NCT04729543|Anticonvulsants|anticonvulsants|mesh-ancestor
24949456|NCT04729543|GABA Agents|gaba agents|mesh-ancestor
24949457|NCT04729543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24949458|NCT04729543|Antimanic Agents|antimanic agents|mesh-ancestor
24949459|NCT04729543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24575592|NCT00832481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575593|NCT00832494|Paclitaxel|paclitaxel|mesh-list
24575594|NCT00832494|Carboplatin|carboplatin|mesh-list
24575595|NCT00832494|Vadimezan|vadimezan|mesh-list
24575596|NCT00832494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24575597|NCT00832494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24575598|NCT00832494|Tubulin Modulators|tubulin modulators|mesh-ancestor
24575599|NCT00832494|Antimitotic Agents|antimitotic agents|mesh-ancestor
24575600|NCT00832494|Mitosis Modulators|mitosis modulators|mesh-ancestor
24575601|NCT00832494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949460|NCT04729543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24949461|NCT04729543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24949463|NCT04718792|Hallucinogens|hallucinogens|mesh-ancestor
24949464|NCT04718792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949465|NCT04718792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24701614|NCT01459887|Doxorubicin|doxorubicin|mesh-list
24949466|NCT04707391|Vaccines|vaccines|mesh-list
24949467|NCT04707391|Immunologic Factors|immunologic factors|mesh-ancestor
24949527|NCT04603911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24949528|NCT04603911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24949529|NCT04603911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24949530|NCT04603911|Anesthetics, Local|anesthetics, local|mesh-ancestor
24949531|NCT04603911|Anesthetics|anesthetics|mesh-ancestor
24949532|NCT04603911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24949533|NCT04603911|Sensory System Agents|sensory system agents|mesh-ancestor
24949534|NCT04603911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24949535|NCT04603911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24774931|NCT01848769|Beclomethasone|beclomethasone|mesh-list
24949536|NCT04603911|Adrenergic Agents|adrenergic agents|mesh-ancestor
24949537|NCT04603911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24775002|NCT01849211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775003|NCT01849406|Budesonide|budesonide|mesh-list
24775004|NCT01849406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24775005|NCT01849406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24775006|NCT01849406|Autonomic Agents|autonomic agents|mesh-ancestor
24775007|NCT01849406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24775008|NCT01849406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775009|NCT01849406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24775010|NCT01849406|Respiratory System Agents|respiratory system agents|mesh-ancestor
24775011|NCT01849406|Glucocorticoids|glucocorticoids|mesh-ancestor
24775014|NCT01849640|Piperaquine|piperaquine|mesh-list
24775015|NCT01849640|Primaquine|primaquine|mesh-list
24775016|NCT01849640|Antimalarials|antimalarials|mesh-ancestor
24775017|NCT01849640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25697522|NCT02079077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25697523|NCT02079077|Antipyretics|antipyretics|mesh-ancestor
25697524|NCT02079519|Bevacizumab|bevacizumab|mesh-list
25697525|NCT02079519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25697526|NCT02079519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25697527|NCT02079519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25697528|NCT02079519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25697529|NCT02079519|Growth Substances|growth substances|mesh-ancestor
25697530|NCT02079519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697531|NCT02079519|Growth Inhibitors|growth inhibitors|mesh-ancestor
25697532|NCT02079532|Rituximab|rituximab|mesh-list
24783891|NCT01904682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24783892|NCT01904682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783893|NCT01904682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775018|NCT01849640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24775030|NCT01849835|Menthol|menthol|mesh-list
24775032|NCT01849835|Dermatologic Agents|dermatologic agents|mesh-ancestor
24566302|NCT00785083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24626164|NCT01085721|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24626173|NCT01085838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626174|NCT01085838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626176|NCT01085851|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
24949539|NCT04603911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24949540|NCT04603911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24949541|NCT04603911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24949542|NCT04603911|Respiratory System Agents|respiratory system agents|mesh-ancestor
24949543|NCT04603911|Mydriatics|mydriatics|mesh-ancestor
24949544|NCT04603911|Sympathomimetics|sympathomimetics|mesh-ancestor
24949545|NCT04603911|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24949546|NCT04603911|Analgesics|analgesics|mesh-ancestor
24949547|NCT04603911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24949548|NCT04603911|Sympatholytics|sympatholytics|mesh-ancestor
24949549|NCT04603911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24949550|NCT04564157|Paclitaxel|paclitaxel|mesh-list
24949552|NCT04564157|Nivolumab|nivolumab|mesh-list
25051832|NCT00372437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25051833|NCT00372437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051834|NCT00372437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25051835|NCT00372437|Immunologic Factors|immunologic factors|mesh-ancestor
25051836|NCT00372437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051837|NCT00372437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24701695|NCT01460420|Growth Inhibitors|growth inhibitors|mesh-ancestor
24701696|NCT01460420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701697|NCT01460498|Azacitidine|azacitidine|mesh-list
24701698|NCT01460498|Decitabine|decitabine|mesh-list
24701699|NCT01460498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24701700|NCT01460498|Antimetabolites|antimetabolites|mesh-ancestor
25051838|NCT00370383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25051840|NCT00370383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051841|NCT00370383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24575609|NCT00832689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24575610|NCT00832689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575611|NCT00832689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24575612|NCT00832689|Immunologic Factors|immunologic factors|mesh-ancestor
24575613|NCT00832689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575614|NCT00832689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24575616|NCT00832806|Varenicline|varenicline|mesh-list
24575641|NCT00833157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24575642|NCT00833157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575744|NCT00833768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575745|NCT00833807|Paclitaxel|paclitaxel|mesh-list
24575746|NCT00833807|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24575747|NCT00833807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24575814|NCT00834470|Respiratory System Agents|respiratory system agents|mesh-ancestor
25051852|NCT00369070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25051853|NCT00369070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25051854|NCT00369070|Tubulin Modulators|tubulin modulators|mesh-ancestor
25051855|NCT00369070|Antimitotic Agents|antimitotic agents|mesh-ancestor
25051856|NCT00369070|Mitosis Modulators|mitosis modulators|mesh-ancestor
25051857|NCT00369070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051858|NCT00369070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25051859|NCT00369070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25051860|NCT00369070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25051861|NCT00369070|Growth Substances|growth substances|mesh-ancestor
25051862|NCT00369070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051863|NCT00369070|Growth Inhibitors|growth inhibitors|mesh-ancestor
24701717|NCT01460563|Sensory System Agents|sensory system agents|mesh-ancestor
24701718|NCT01460563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24965025|NCT03779360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965026|NCT03779347|Praziquantel|praziquantel|mesh-list
25697533|NCT02079532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25697534|NCT02079532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25697535|NCT02079532|Immunologic Factors|immunologic factors|mesh-ancestor
24965027|NCT03779347|Anthelmintics|anthelmintics|mesh-ancestor
24965028|NCT03779347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24965029|NCT03779347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24965030|NCT03779178|Landiolol|landiolol|mesh-list
24965031|NCT03779178|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24965032|NCT03779178|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24448722|NCT00312806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24448723|NCT00312806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24448724|NCT00312806|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24448725|NCT00312806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24949619|NCT04006288|Aspirin|aspirin|mesh-list
24949620|NCT04006288|Rivaroxaban|rivaroxaban|mesh-list
24949621|NCT04006288|Clopidogrel|clopidogrel|mesh-list
24949622|NCT04006288|Ticagrelor|ticagrelor|mesh-list
24949623|NCT04006288|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24949714|NCT03807765|Nivolumab|nivolumab|mesh-list
24949715|NCT03807765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24949716|NCT03807765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24949717|NCT03807765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24575816|NCT00834470|Parasympatholytics|parasympatholytics|mesh-ancestor
24575817|NCT00834470|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24575842|NCT00834665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24575844|NCT00834730|Analgesics|analgesics|mesh-ancestor
24575845|NCT00834730|Sensory System Agents|sensory system agents|mesh-ancestor
24575846|NCT00834730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24575847|NCT00834730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575848|NCT00834730|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24575849|NCT00834730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24575850|NCT00834730|Anesthetics, General|anesthetics, general|mesh-ancestor
24575851|NCT00834730|Anesthetics|anesthetics|mesh-ancestor
24575852|NCT00834730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24575853|NCT00834730|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24575854|NCT00834730|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24575855|NCT00834730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24575856|NCT00834730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575857|NCT00834847|Pravastatin|pravastatin|mesh-list
24575858|NCT00834847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24575859|NCT00834847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24575860|NCT00834847|Antimetabolites|antimetabolites|mesh-ancestor
24575861|NCT00834847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464176|NCT00363701|Esomeprazole|esomeprazole|mesh-list
24464177|NCT00363701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24575891|NCT00835029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575892|NCT00835029|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24575893|NCT00835029|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24949816|NCT03585465|Tubulin Modulators|tubulin modulators|mesh-ancestor
24949817|NCT03585465|Antimitotic Agents|antimitotic agents|mesh-ancestor
24949818|NCT03585465|Mitosis Modulators|mitosis modulators|mesh-ancestor
24949820|NCT03585452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24949821|NCT03585452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24949822|NCT03585452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949823|NCT03585452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24949824|NCT03585452|Analgesics|analgesics|mesh-ancestor
24949825|NCT03585452|Sensory System Agents|sensory system agents|mesh-ancestor
24949826|NCT03585452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24949827|NCT03585452|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24949828|NCT03585452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24949829|NCT03585452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24949830|NCT03585452|Adrenergic Agents|adrenergic agents|mesh-ancestor
24949831|NCT03585452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24949832|NCT03585452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775286|NCT01851473|Anesthetics|anesthetics|mesh-ancestor
24631637|NCT01119196|Dialysis Solutions|dialysis solutions|mesh-list
24575897|NCT00835107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24575898|NCT00835107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575899|NCT00835107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575900|NCT00835107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24575901|NCT00835107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24575902|NCT00835107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24575903|NCT00835107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24575904|NCT00835107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24575905|NCT00835107|Dopamine Agents|dopamine agents|mesh-ancestor
25406977|NCT03524898|Immunologic Factors|immunologic factors|mesh-ancestor
24436128|NCT00269126|Xhance|xhance|mesh-list
24775293|NCT01851473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24775294|NCT01851473|Dopamine Agents|dopamine agents|mesh-ancestor
24775295|NCT01851473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24775296|NCT01851473|Antimalarials|antimalarials|mesh-ancestor
24775297|NCT01851473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24775298|NCT01851473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24775299|NCT01851473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24775300|NCT01851473|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24775301|NCT01851473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24775302|NCT01851473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24775304|NCT01851486|Clonidine|clonidine|mesh-list
24775305|NCT01851486|Naloxone|naloxone|mesh-list
24775306|NCT01851486|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24775307|NCT01851486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775308|NCT01851486|Sensory System Agents|sensory system agents|mesh-ancestor
25051865|NCT00369070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051866|NCT00367887|Ribavirin|ribavirin|mesh-list
24775309|NCT01851486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24775311|NCT01851486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24949843|NCT03530800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24949844|NCT03530800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949845|NCT03530800|Hormones|hormones|mesh-ancestor
24949846|NCT03530800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24949847|NCT03518606|Durvalumab|durvalumab|mesh-list
24949848|NCT03518606|Vinorelbine|vinorelbine|mesh-list
24949849|NCT03518606|Tremelimumab|tremelimumab|mesh-list
24949850|NCT03518606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24949851|NCT03518606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24949852|NCT03518606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24949853|NCT03518606|Tubulin Modulators|tubulin modulators|mesh-ancestor
24949854|NCT03518606|Antimitotic Agents|antimitotic agents|mesh-ancestor
24949855|NCT03518606|Mitosis Modulators|mitosis modulators|mesh-ancestor
24949856|NCT03518606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949857|NCT03477175|Sorafenib|sorafenib|mesh-list
24949858|NCT03477175|Lenvatinib|lenvatinib|mesh-list
24949859|NCT03477175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24949860|NCT03477175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24949861|NCT03477175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24949863|NCT03439891|Nivolumab|nivolumab|mesh-list
24949890|NCT03412643|Paclitaxel|paclitaxel|mesh-list
24949891|NCT03412643|Cyclophosphamide|cyclophosphamide|mesh-list
24949892|NCT03412643|Doxorubicin|doxorubicin|mesh-list
24949893|NCT03412643|Trastuzumab|trastuzumab|mesh-list
24949894|NCT03412643|Pertuzumab|pertuzumab|mesh-list
24949895|NCT03412643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24702028|NCT01463592|Trace Elements|trace elements|mesh-ancestor
24949896|NCT03412643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24949897|NCT03412643|Tubulin Modulators|tubulin modulators|mesh-ancestor
24949898|NCT03412643|Antimitotic Agents|antimitotic agents|mesh-ancestor
24949903|NCT03412643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949904|NCT03412643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24949905|NCT03412643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24576103|NCT00836823|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24576104|NCT00836823|Adrenergic Agents|adrenergic agents|mesh-ancestor
24576105|NCT00836823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576106|NCT00836823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576107|NCT00836823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576108|NCT00836823|Urological Agents|urological agents|mesh-ancestor
24576110|NCT00836849|Antidepressive Agents|antidepressive agents|mesh-ancestor
24576111|NCT00836849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24949948|NCT03270462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24949949|NCT03270462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949950|NCT03250325|Cyclophosphamide|cyclophosphamide|mesh-list
24949951|NCT03250325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24949952|NCT03250325|Immunologic Factors|immunologic factors|mesh-ancestor
24949953|NCT03250325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949954|NCT03250325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24949955|NCT03250325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24949956|NCT03250325|Alkylating Agents|alkylating agents|mesh-ancestor
24949957|NCT03250325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949958|NCT03250325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24949959|NCT03250325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24949961|NCT03172624|Ipilimumab|ipilimumab|mesh-list
24949962|NCT03172624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24949963|NCT03172624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24436140|NCT00269126|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24436141|NCT00269126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24949964|NCT03172624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24949965|NCT03172624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949971|NCT03114527|Everolimus|everolimus|mesh-list
24576113|NCT00836849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24576114|NCT00836849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24576180|NCT00837317|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
24576181|NCT00837317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24576182|NCT00837343|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24576183|NCT00837343|Antidepressive Agents|antidepressive agents|mesh-ancestor
24576184|NCT00837343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24576185|NCT00837343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24576186|NCT00837343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24576187|NCT00837343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24949979|NCT03113123|Antiviral Agents|antiviral agents|mesh-ancestor
24949980|NCT03113123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24702223|NCT01464606|Alkylating Agents|alkylating agents|mesh-ancestor
24949981|NCT03113123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24949982|NCT03113123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24949983|NCT03113123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24949984|NCT03113123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949985|NCT03113123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24950012|NCT03015896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950013|NCT03015896|Immunologic Factors|immunologic factors|mesh-ancestor
24950014|NCT03015896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950015|NCT03015896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24950016|NCT03015896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24950028|NCT02890784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803937|NCT01999829|Caffeine|caffeine|mesh-list
24576188|NCT00837343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950043|NCT02780310|Lenvatinib|lenvatinib|mesh-list
24950044|NCT02780310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950045|NCT02780310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24950046|NCT02780310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950047|NCT02780310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950048|NCT02741128|Vaccines|vaccines|mesh-list
24950049|NCT02741128|Immunologic Factors|immunologic factors|mesh-ancestor
24950050|NCT02741128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576271|NCT00837915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24576272|NCT00837915|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24576273|NCT00837915|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24576274|NCT00837915|Histamine Antagonists|histamine antagonists|mesh-ancestor
24576275|NCT00837915|Histamine Agents|histamine agents|mesh-ancestor
24576276|NCT00837915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576277|NCT00837915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576278|NCT00837915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576279|NCT00837915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24576280|NCT00837915|Autonomic Agents|autonomic agents|mesh-ancestor
24576281|NCT00837915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24443990|NCT00296465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576314|NCT00837941|Antidepressive Agents|antidepressive agents|mesh-ancestor
24576315|NCT00837941|Dopamine Agents|dopamine agents|mesh-ancestor
24576316|NCT00837941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24576317|NCT00837941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24576318|NCT00837941|Anesthetics, Local|anesthetics, local|mesh-ancestor
24576319|NCT00837941|Anesthetics|anesthetics|mesh-ancestor
24576320|NCT00837941|Antiemetics|antiemetics|mesh-ancestor
24576321|NCT00837941|Autonomic Agents|autonomic agents|mesh-ancestor
24950051|NCT02722941|Panobinostat|panobinostat|mesh-list
24950052|NCT02722941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950053|NCT02722941|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24950054|NCT02722941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950055|NCT02722941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950057|NCT02713386|Carboplatin|carboplatin|mesh-list
24950058|NCT02713386|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24950059|NCT02713386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24950060|NCT02713386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950061|NCT02713386|Tubulin Modulators|tubulin modulators|mesh-ancestor
24950062|NCT02713386|Antimitotic Agents|antimitotic agents|mesh-ancestor
25697536|NCT02079532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697537|NCT02079532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24795515|NCT01968213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795517|NCT01968213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950069|NCT02671890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950070|NCT02671890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950071|NCT02671890|Antiviral Agents|antiviral agents|mesh-ancestor
24950072|NCT02671890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24950073|NCT02671890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950074|NCT02671890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24950075|NCT02671890|Immunologic Factors|immunologic factors|mesh-ancestor
24950076|NCT02671890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950077|NCT02671890|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24950078|NCT02671890|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
24950080|NCT02655692|Analgesics|analgesics|mesh-ancestor
24950081|NCT02655692|Sensory System Agents|sensory system agents|mesh-ancestor
24576322|NCT00837941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24576323|NCT00837941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24576324|NCT00837941|Histamine Antagonists|histamine antagonists|mesh-ancestor
24576325|NCT00837941|Histamine Agents|histamine agents|mesh-ancestor
24576352|NCT00838071|Antibodies|antibodies|mesh-list
24576370|NCT00838227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24576371|NCT00838227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576372|NCT00838227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24576373|NCT00838227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24950082|NCT02655692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24950083|NCT02655692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950084|NCT02655692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24950085|NCT02655692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24950086|NCT02655692|Anesthetics, General|anesthetics, general|mesh-ancestor
24950087|NCT02655692|Anesthetics|anesthetics|mesh-ancestor
24950088|NCT02655692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24950111|NCT02633059|Protease Inhibitors|protease inhibitors|mesh-ancestor
24950112|NCT02633059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950122|NCT02623205|Serotonin Agents|serotonin agents|mesh-ancestor
24950123|NCT02623205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950124|NCT02623205|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24950125|NCT02623205|Antidepressive Agents|antidepressive agents|mesh-ancestor
24950126|NCT02623205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24950127|NCT02558465|Rivaroxaban|rivaroxaban|mesh-list
24950128|NCT02558465|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24950129|NCT02558465|Antithrombins|antithrombins|mesh-ancestor
24950130|NCT02558465|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24950131|NCT02558465|Protease Inhibitors|protease inhibitors|mesh-ancestor
24950132|NCT02558465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950133|NCT02558465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950134|NCT02558465|Anticoagulants|anticoagulants|mesh-ancestor
24950135|NCT02526004|Tobramycin|tobramycin|mesh-list
24950136|NCT02526004|Ceftazidime|ceftazidime|mesh-list
24950137|NCT02526004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24576374|NCT00838227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24576375|NCT00838227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576376|NCT00838240|Cytarabine|cytarabine|mesh-list
24576377|NCT00838240|Clofarabine|clofarabine|mesh-list
24576434|NCT00838396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702690|NCT01467258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702691|NCT01467258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702692|NCT01467258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24702693|NCT01467258|Analgesics|analgesics|mesh-ancestor
24702694|NCT01467258|Sensory System Agents|sensory system agents|mesh-ancestor
24702695|NCT01467258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24576435|NCT00838656|Gemcitabine|gemcitabine|mesh-list
24950138|NCT02526004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24775510|NCT01852604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24775511|NCT01852604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24775512|NCT01852604|Antimetabolites|antimetabolites|mesh-ancestor
24950140|NCT02452983|Antidepressive Agents|antidepressive agents|mesh-ancestor
24950141|NCT02452983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25697538|NCT02079636|Gemcitabine|gemcitabine|mesh-list
24950142|NCT02452983|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24950147|NCT02452983|Serotonin Agents|serotonin agents|mesh-ancestor
25697539|NCT02079636|Pembrolizumab|pembrolizumab|mesh-list
25697540|NCT02079636|Pemetrexed|pemetrexed|mesh-list
25697541|NCT02079636|Ramucirumab|ramucirumab|mesh-list
25697542|NCT02079636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25697543|NCT02079636|Antimetabolites|antimetabolites|mesh-ancestor
24437282|NCT00273338|Docetaxel|docetaxel|mesh-list
24795533|NCT01812252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825463|NCT02128425|Protective Agents|protective agents|mesh-ancestor
24437414|NCT00273559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24437415|NCT00273559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437416|NCT00273559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24437417|NCT00273559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24437419|NCT00273611|Vitamins|vitamins|mesh-ancestor
24437420|NCT00273611|Micronutrients|micronutrients|mesh-ancestor
24437421|NCT00273611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437422|NCT00273611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24950158|NCT02348203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24950159|NCT02348203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24950160|NCT02348203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24950161|NCT02348203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697544|NCT02079636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051867|NCT00367887|Interferon alpha-2|interferon alpha-2|mesh-list
25051868|NCT00367887|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25051869|NCT00367887|Interferon-alpha|interferon-alpha|mesh-list
24576437|NCT00838656|Carboplatin|carboplatin|mesh-list
24576438|NCT00838656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24576439|NCT00838656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24576440|NCT00838656|Tubulin Modulators|tubulin modulators|mesh-ancestor
24576441|NCT00838656|Antimitotic Agents|antimitotic agents|mesh-ancestor
24576442|NCT00838656|Mitosis Modulators|mitosis modulators|mesh-ancestor
24576443|NCT00838656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576444|NCT00838656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24576445|NCT00838656|Antimetabolites|antimetabolites|mesh-ancestor
24576446|NCT00838656|Antiviral Agents|antiviral agents|mesh-ancestor
24576447|NCT00838656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24702772|NCT01467596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702773|NCT01467596|Sensory System Agents|sensory system agents|mesh-ancestor
24702774|NCT01467596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24702791|NCT01467804|Sertraline|sertraline|mesh-list
25406978|NCT03524898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697545|NCT02079636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25697546|NCT02079636|Antiviral Agents|antiviral agents|mesh-ancestor
25697547|NCT02079636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25697548|NCT02079636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697549|NCT02079636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25697550|NCT02079636|Immunologic Factors|immunologic factors|mesh-ancestor
25697551|NCT02079636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697552|NCT02079636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25697553|NCT02079636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25697554|NCT02079636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25051888|NCT00366704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25051889|NCT00366704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25051890|NCT00366704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25051891|NCT00366704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25051892|NCT00366704|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25051893|NCT00366704|Dopamine Agents|dopamine agents|mesh-ancestor
25051894|NCT00366145|Remestemcel-l|remestemcel-l|mesh-list
25051895|NCT00366145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25051896|NCT00366145|Antiviral Agents|antiviral agents|mesh-ancestor
25051897|NCT00366145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25051898|NCT00364546|Tapentadol|tapentadol|mesh-list
25051899|NCT00364546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25051900|NCT00364546|Narcotics|narcotics|mesh-ancestor
25051901|NCT00364546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25051902|NCT00364546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051903|NCT00364546|Analgesics|analgesics|mesh-ancestor
25051909|NCT00364546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051911|NCT00364546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25051912|NCT00364247|Tapentadol|tapentadol|mesh-list
25051913|NCT00364247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24965397|NCT03777488|Coagulants|coagulants|mesh-ancestor
24965398|NCT03777514|Ascorbic Acid|ascorbic acid|mesh-list
24965399|NCT03777514|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24965400|NCT03777514|Vitamins|vitamins|mesh-ancestor
24965402|NCT03777514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965403|NCT03777514|Antioxidants|antioxidants|mesh-ancestor
24965404|NCT03777514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965405|NCT03777514|Protective Agents|protective agents|mesh-ancestor
24965406|NCT03777514|Hematinics|hematinics|mesh-ancestor
24965407|NCT03777514|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24965408|NCT03777514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24965409|NCT03777085|Rituximab|rituximab|mesh-list
24965410|NCT03777085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24965411|NCT03777085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965412|NCT03777085|Immunologic Factors|immunologic factors|mesh-ancestor
24965413|NCT03777085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965414|NCT03777085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24965415|NCT03777124|Carboplatin|carboplatin|mesh-list
24965416|NCT03777124|Pemetrexed|pemetrexed|mesh-list
24965417|NCT03777124|Apatinib|apatinib|mesh-list
24965418|NCT03777124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965419|NCT03777124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24965420|NCT03777124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965421|NCT03777124|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24965422|NCT03777124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24965423|NCT03777124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25051914|NCT00364247|Narcotics|narcotics|mesh-ancestor
24979939|NCT04926571|Dexamethasone|dexamethasone|mesh-list
24950162|NCT02348203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24950165|NCT02348203|Antipyretics|antipyretics|mesh-ancestor
24598743|NCT00957879|Calcitriol|calcitriol|mesh-list
24576531|NCT00839111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576532|NCT00839111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24576533|NCT00839111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24576534|NCT00839163|Vitamin K|vitamin k|mesh-list
24576535|NCT00839163|Enoxaparin|enoxaparin|mesh-list
24576536|NCT00839163|Rivaroxaban|rivaroxaban|mesh-list
24576537|NCT00839163|Vitamins|vitamins|mesh-ancestor
24576538|NCT00839163|Micronutrients|micronutrients|mesh-ancestor
24576539|NCT00839163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576540|NCT00839163|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24576541|NCT00839163|Antithrombins|antithrombins|mesh-ancestor
24576542|NCT00839163|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24576543|NCT00839163|Protease Inhibitors|protease inhibitors|mesh-ancestor
24632043|NCT01121770|Anticoagulants|anticoagulants|mesh-ancestor
24632044|NCT01121770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24632045|NCT01121770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24576544|NCT00839163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24576564|NCT00839293|Fenofibric acid|fenofibric acid|mesh-list
24576565|NCT00839293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24576566|NCT00839293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24576567|NCT00839293|Antimetabolites|antimetabolites|mesh-ancestor
24576568|NCT00839293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576569|NCT00839293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24576570|NCT00839345|Clopidogrel|clopidogrel|mesh-list
24950239|NCT01883297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24950240|NCT01883297|Alkylating Agents|alkylating agents|mesh-ancestor
24950241|NCT01883297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950242|NCT01883297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950243|NCT01883297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24950244|NCT01883297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24950246|NCT01883297|Sensory System Agents|sensory system agents|mesh-ancestor
24950248|NCT01883297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24950270|NCT01864109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24950271|NCT01864109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24950272|NCT01864109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24950273|NCT01864109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950274|NCT01864109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24950275|NCT01864109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24950276|NCT01864109|Tubulin Modulators|tubulin modulators|mesh-ancestor
24950277|NCT01864109|Antimitotic Agents|antimitotic agents|mesh-ancestor
24950278|NCT01864109|Mitosis Modulators|mitosis modulators|mesh-ancestor
24950279|NCT01864109|Protective Agents|protective agents|mesh-ancestor
24950280|NCT01864109|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24950281|NCT01862315|Gemcitabine|gemcitabine|mesh-list
24950282|NCT01862315|Dexamethasone|dexamethasone|mesh-list
24950283|NCT01862315|Oxaliplatin|oxaliplatin|mesh-list
24950284|NCT01862315|Floxuridine|floxuridine|mesh-list
24950285|NCT01862315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24950286|NCT01862315|Antiemetics|antiemetics|mesh-ancestor
24775663|NCT01854086|Diphosphonates|diphosphonates|mesh-list
24950287|NCT01862315|Autonomic Agents|autonomic agents|mesh-ancestor
24950288|NCT01862315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24950289|NCT01862315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950290|NCT01862315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24950291|NCT01862315|Glucocorticoids|glucocorticoids|mesh-ancestor
24950294|NCT01862315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24950295|NCT01862315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950296|NCT01862315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24950297|NCT01862315|Antimetabolites|antimetabolites|mesh-ancestor
24950298|NCT01862315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950299|NCT01862315|Antiviral Agents|antiviral agents|mesh-ancestor
24950301|NCT01862315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950318|NCT01560637|Treprostinil|treprostinil|mesh-list
24950319|NCT01560637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24950320|NCT00999804|Trastuzumab|trastuzumab|mesh-list
24950322|NCT00999804|Lapatinib|lapatinib|mesh-list
24950323|NCT00999804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24950324|NCT00999804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950325|NCT00999804|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24950326|NCT00999804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24950327|NCT00999804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950328|NCT00999804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950329|NCT00999804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25697555|NCT02079649|Dexamethasone|dexamethasone|mesh-list
24950330|NCT00999804|Hormone Antagonists|hormone antagonists|mesh-ancestor
24950331|NCT00999804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24950358|NCT00458003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950360|NCT00458003|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24576578|NCT00839345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950374|NCT03916679|Cyclophosphamide|cyclophosphamide|mesh-list
24950375|NCT03916679|Fludarabine|fludarabine|mesh-list
24950376|NCT03916679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24950391|NCT03916250|Dermatologic Agents|dermatologic agents|mesh-ancestor
24950392|NCT03916250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24950393|NCT03916250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950394|NCT03916250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950395|NCT03916328|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24950396|NCT03916328|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24950397|NCT03916328|Contraceptive Agents|contraceptive agents|mesh-ancestor
24950398|NCT03916328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24950399|NCT03916328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775823|NCT01855061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24950423|NCT03916406|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24950424|NCT03916406|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24965626|NCT03775746|Purinergic Agents|purinergic agents|mesh-ancestor
24965627|NCT03775746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24965628|NCT03775746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965629|NCT03775746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965630|NCT03775746|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24965631|NCT03775746|Antithrombins|antithrombins|mesh-ancestor
24965632|NCT03775746|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24965633|NCT03775746|Protease Inhibitors|protease inhibitors|mesh-ancestor
24965634|NCT03775746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24965635|NCT03775746|Anticoagulants|anticoagulants|mesh-ancestor
24965637|NCT03775928|Apatinib|apatinib|mesh-list
24965638|NCT03775928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24965639|NCT03775928|Antimetabolites|antimetabolites|mesh-ancestor
24950425|NCT03916406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24950426|NCT03916406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24804347|NCT02002156|Vaccines|vaccines|mesh-list
24576580|NCT00839358|Sympathomimetics|sympathomimetics|mesh-ancestor
24576581|NCT00839358|Autonomic Agents|autonomic agents|mesh-ancestor
24576590|NCT00839358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950427|NCT03916406|Anesthetics, General|anesthetics, general|mesh-ancestor
24950428|NCT03916406|Anesthetics|anesthetics|mesh-ancestor
24950429|NCT03916406|GABA Modulators|gaba modulators|mesh-ancestor
24950430|NCT03916406|GABA Agents|gaba agents|mesh-ancestor
24950431|NCT03916406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24950432|NCT03916406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574984|NCT00828919|Axitinib|axitinib|mesh-list
24950447|NCT03915938|Ketamine|ketamine|mesh-list
24950448|NCT03915938|Analgesics|analgesics|mesh-ancestor
24950449|NCT03915938|Sensory System Agents|sensory system agents|mesh-ancestor
24950450|NCT03915938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24950451|NCT03915938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950452|NCT03915938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24950453|NCT03915938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24950454|NCT03915938|Anesthetics, General|anesthetics, general|mesh-ancestor
24950455|NCT03915938|Anesthetics|anesthetics|mesh-ancestor
24703255|NCT01470456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703382|NCT01471470|Mitosis Modulators|mitosis modulators|mesh-ancestor
24950456|NCT03915938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25051915|NCT00364247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25051916|NCT00364247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051917|NCT00364247|Analgesics|analgesics|mesh-ancestor
25051918|NCT00364247|Sensory System Agents|sensory system agents|mesh-ancestor
25051919|NCT00364247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25051920|NCT00364247|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24576593|NCT00839371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24576594|NCT00839371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24576595|NCT00839371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051921|NCT00364247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25051922|NCT00364247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25051923|NCT00364247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051924|NCT00364247|Adrenergic Agents|adrenergic agents|mesh-ancestor
24437971|NCT00274820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24437972|NCT00274820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24437978|NCT00274833|Temozolomide|temozolomide|mesh-list
24448764|NCT00313079|Vincristine|vincristine|mesh-list
24950460|NCT03915938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950462|NCT03915366|Antitubercular Agents|antitubercular agents|mesh-list
24950463|NCT03915366|Antiviral Agents|antiviral agents|mesh-ancestor
24950464|NCT03915366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24950465|NCT03915366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24950466|NCT03915444|Gemcitabine|gemcitabine|mesh-list
24950467|NCT03915444|Paclitaxel|paclitaxel|mesh-list
24950468|NCT03915444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24950469|NCT03915444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950470|NCT03915444|Tubulin Modulators|tubulin modulators|mesh-ancestor
24950471|NCT03915444|Antimitotic Agents|antimitotic agents|mesh-ancestor
24950508|NCT03914755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950509|NCT03914755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24950510|NCT03914755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950511|NCT03914755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950512|NCT03914690|Epoetin Alfa|epoetin alfa|mesh-list
24950513|NCT03914690|Hematinics|hematinics|mesh-ancestor
24657203|NCT01266187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703404|NCT01471678|Tamsulosin|tamsulosin|mesh-list
24703442|NCT01471821|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24703443|NCT01471821|Antiviral Agents|antiviral agents|mesh-ancestor
24703444|NCT01471821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24950514|NCT03914638|Albuterol|albuterol|mesh-list
24950515|NCT03914638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24950516|NCT03914638|Autonomic Agents|autonomic agents|mesh-ancestor
24950517|NCT03914638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24950518|NCT03914638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697556|NCT02079649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25697557|NCT02079649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25697558|NCT02079649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25697559|NCT02079649|Antiemetics|antiemetics|mesh-ancestor
25697560|NCT02079649|Autonomic Agents|autonomic agents|mesh-ancestor
25697561|NCT02079649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25697562|NCT02079649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697563|NCT02079649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25697564|NCT02079649|Glucocorticoids|glucocorticoids|mesh-ancestor
25697565|NCT02079649|Hormones|hormones|mesh-ancestor
25697566|NCT02079649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24438022|NCT00274898|Mitosis Modulators|mitosis modulators|mesh-ancestor
24950519|NCT03914638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24950520|NCT03914638|Respiratory System Agents|respiratory system agents|mesh-ancestor
24950521|NCT03914638|Tocolytic Agents|tocolytic agents|mesh-ancestor
24950522|NCT03914638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24950523|NCT03914638|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24950524|NCT03914638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24950525|NCT03914638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24950526|NCT03914638|Adrenergic Agents|adrenergic agents|mesh-ancestor
24950527|NCT03914638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24950528|NCT03914638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950529|NCT03914404|Thioctic Acid|thioctic acid|mesh-list
24950530|NCT03914404|Antioxidants|antioxidants|mesh-ancestor
24950531|NCT03914404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950532|NCT03914404|Protective Agents|protective agents|mesh-ancestor
24950533|NCT03914404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950534|NCT03914404|Vitamin B Complex|vitamin b complex|mesh-ancestor
24950535|NCT03914404|Vitamins|vitamins|mesh-ancestor
24950536|NCT03914404|Micronutrients|micronutrients|mesh-ancestor
24950537|NCT03914677|Mecamylamine|mecamylamine|mesh-list
24950538|NCT03914677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24950539|NCT03914677|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
24950540|NCT03914677|Autonomic Agents|autonomic agents|mesh-ancestor
24703445|NCT01471847|Capecitabine|capecitabine|mesh-list
24703446|NCT01471847|Trastuzumab|trastuzumab|mesh-list
24703471|NCT01471899|Ketorolac|ketorolac|mesh-list
24703472|NCT01471899|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24703473|NCT01471899|Naproxen|naproxen|mesh-list
24703474|NCT01471899|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24703475|NCT01471899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24703476|NCT01471899|Analgesics|analgesics|mesh-ancestor
24703477|NCT01471899|Sensory System Agents|sensory system agents|mesh-ancestor
24703478|NCT01471899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489150|NCT00471588|Pramipexole|pramipexole|mesh-list
24644288|NCT01190241|Immunologic Factors|immunologic factors|mesh-ancestor
24950541|NCT03914677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24950542|NCT03914677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950547|NCT03914677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950548|NCT03914534|Valproic Acid|valproic acid|mesh-list
24950549|NCT03914534|Anticonvulsants|anticonvulsants|mesh-ancestor
24950550|NCT03914534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950559|NCT03914352|Antibodies|antibodies|mesh-list
24950560|NCT03914352|Immunologic Factors|immunologic factors|mesh-ancestor
24950561|NCT03914352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950562|NCT03914118|Modafinil|modafinil|mesh-list
24950563|NCT03914118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24950564|NCT03914118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950565|NCT03914118|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24950566|NCT03914118|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24950567|NCT03914118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24950568|NCT03914118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950569|NCT03914092|Triamcinolone|triamcinolone|mesh-list
24950571|NCT03914092|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24950572|NCT03914092|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24950573|NCT03914092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24950574|NCT03914092|Glucocorticoids|glucocorticoids|mesh-ancestor
24950575|NCT03914092|Hormones|hormones|mesh-ancestor
24950576|NCT03914092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24950577|NCT03914092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950578|NCT03914092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24950579|NCT03914092|Immunologic Factors|immunologic factors|mesh-ancestor
24950580|NCT03914092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950581|NCT03914092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950583|NCT03913884|Mitosis Modulators|mitosis modulators|mesh-ancestor
24950584|NCT03913884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950586|NCT03914235|Anesthetics, Local|anesthetics, local|mesh-ancestor
24950587|NCT03914235|Anesthetics|anesthetics|mesh-ancestor
24950588|NCT03914235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24950589|NCT03914235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697567|NCT02079649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24950590|NCT03914235|Sensory System Agents|sensory system agents|mesh-ancestor
24438194|NCT00275106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24980017|NCT04724447|Valganciclovir|valganciclovir|mesh-list
24438246|NCT00275184|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24438249|NCT00275184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24438250|NCT00275184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438251|NCT00275197|Sertraline|sertraline|mesh-list
24950591|NCT03914235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24950592|NCT03914235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24950593|NCT03914235|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24950594|NCT03914235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24950595|NCT03914235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24950597|NCT03913858|Anesthetics|anesthetics|mesh-list
24950598|NCT03913858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24950599|NCT03913858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950600|NCT03913650|Bupivacaine|bupivacaine|mesh-list
24950601|NCT03913650|Anesthetics, Local|anesthetics, local|mesh-ancestor
24950602|NCT03913650|Anesthetics|anesthetics|mesh-ancestor
24950603|NCT03913650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24950604|NCT03913650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950605|NCT03913650|Sensory System Agents|sensory system agents|mesh-ancestor
24950606|NCT03913650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24950607|NCT03913702|Methylprednisolone|methylprednisolone|mesh-list
24950608|NCT03913702|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24950610|NCT03913702|Prednisolone|prednisolone|mesh-list
24950630|NCT03913702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24950631|NCT03913702|Analgesics|analgesics|mesh-ancestor
24950632|NCT03913702|Sensory System Agents|sensory system agents|mesh-ancestor
24950633|NCT03913702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24950634|NCT03913702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24950635|NCT03913702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950636|NCT03913702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950637|NCT03913806|Bevacizumab|bevacizumab|mesh-list
24950638|NCT03913806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24950639|NCT03913806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950640|NCT03913806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24950641|NCT03913806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24950642|NCT03913806|Growth Substances|growth substances|mesh-ancestor
24626179|NCT01085851|Histamine Agents|histamine agents|mesh-ancestor
24626180|NCT01085851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24626181|NCT01085851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626182|NCT01085851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626183|NCT01085851|Antipruritics|antipruritics|mesh-ancestor
24626184|NCT01085851|Dermatologic Agents|dermatologic agents|mesh-ancestor
24626185|NCT01085851|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24626186|NCT01085877|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24626187|NCT01085877|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24626188|NCT01085877|Estradiol|estradiol|mesh-list
24626189|NCT01085877|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24626190|NCT01085877|Estrogens|estrogens|mesh-ancestor
24626191|NCT01085877|Hormones|hormones|mesh-ancestor
24641949|NCT01176799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24626192|NCT01085877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24576596|NCT00839371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24576597|NCT00839371|Anesthetics, General|anesthetics, general|mesh-ancestor
24576598|NCT00839371|Anesthetics|anesthetics|mesh-ancestor
24576599|NCT00839371|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24576600|NCT00839371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24576601|NCT00839371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24576602|NCT00839371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24576603|NCT00839371|GABA Modulators|gaba modulators|mesh-ancestor
24576604|NCT00839371|GABA Agents|gaba agents|mesh-ancestor
24576615|NCT00839397|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24576617|NCT00839397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24576618|NCT00839397|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24576619|NCT00839397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24576620|NCT00839397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703652|NCT01473147|Exenatide|exenatide|mesh-list
24703697|NCT01473303|Levoleucovorin|levoleucovorin|mesh-list
24644313|NCT01190293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25697568|NCT02079649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25697569|NCT02079805|Telmisartan|telmisartan|mesh-list
25697570|NCT02079805|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25697571|NCT02079805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25697572|NCT02079805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25697573|NCT02079805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24438820|NCT00276796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24438821|NCT00276796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439051|NCT00277264|Parasympatholytics|parasympatholytics|mesh-ancestor
24439052|NCT00277264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24703699|NCT01473303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703700|NCT01473303|Antimetabolites|antimetabolites|mesh-ancestor
24703705|NCT01473303|Immunologic Factors|immunologic factors|mesh-ancestor
24576623|NCT00839449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24626193|NCT01085877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626194|NCT01085877|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24626195|NCT01085877|Contraceptive Agents|contraceptive agents|mesh-ancestor
24626196|NCT01085877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24626197|NCT01085877|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24626199|NCT01085981|Niacinamide|niacinamide|mesh-list
24576637|NCT00839488|Histamine Antagonists|histamine antagonists|mesh-ancestor
24576638|NCT00839488|Histamine Agents|histamine agents|mesh-ancestor
24576639|NCT00839488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576640|NCT00839488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576642|NCT00839501|Anticonvulsants|anticonvulsants|mesh-ancestor
24576643|NCT00839501|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24576644|NCT00839501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24576645|NCT00839501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576646|NCT00839501|Diuretics|diuretics|mesh-ancestor
24576647|NCT00839501|Natriuretic Agents|natriuretic agents|mesh-ancestor
24576648|NCT00839501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576649|NCT00839553|Minocycline|minocycline|mesh-list
24576650|NCT00839553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24576675|NCT00839683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24576676|NCT00839683|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24576677|NCT00839683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24576678|NCT00839683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24576679|NCT00839683|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24626218|NCT01086020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626219|NCT01086046|Heparin|heparin|mesh-list
24626220|NCT01086046|Enoxaparin|enoxaparin|mesh-list
25051931|NCT00363636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051932|NCT00363636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25051933|NCT00363636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25051935|NCT00361582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25051936|NCT00361582|Narcotics|narcotics|mesh-ancestor
25051937|NCT00361582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25051938|NCT00361582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051939|NCT00361582|Analgesics|analgesics|mesh-ancestor
25051940|NCT00361582|Sensory System Agents|sensory system agents|mesh-ancestor
25051941|NCT00361582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25051942|NCT00361582|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24804560|NCT02003209|Antibodies|antibodies|mesh-list
24576683|NCT00839683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576685|NCT00839761|Trace Elements|trace elements|mesh-ancestor
24576686|NCT00839761|Micronutrients|micronutrients|mesh-ancestor
24576687|NCT00839761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576688|NCT00839787|Morphine|morphine|mesh-list
24576689|NCT00839787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24576690|NCT00839787|Narcotics|narcotics|mesh-ancestor
25051943|NCT00361582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25051944|NCT00361582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25051945|NCT00361582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051946|NCT00361582|Adrenergic Agents|adrenergic agents|mesh-ancestor
25051947|NCT00361582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25051948|NCT00360867|Motesanib diphosphate|motesanib diphosphate|mesh-list
25051949|NCT00360867|Imetelstat|imetelstat|mesh-list
25051950|NCT00360867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25051951|NCT00360867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051952|NCT00360867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051953|NCT00360035|Obatoclax|obatoclax|mesh-list
25051954|NCT00360035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051956|NCT00359450|Taxane|taxane|mesh-list
25051965|NCT00359086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697574|NCT02079805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697575|NCT02079844|Antipsychotic Agents|antipsychotic agents|mesh-list
25697576|NCT02079844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25697577|NCT02079844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25697578|NCT02079844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439336|NCT00278330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439337|NCT00278330|Growth Inhibitors|growth inhibitors|mesh-ancestor
24439338|NCT00278330|Growth Substances|growth substances|mesh-ancestor
24439339|NCT00278330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051966|NCT00359086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051967|NCT00358982|Mocetinostat|mocetinostat|mesh-list
25051968|NCT00358982|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25051969|NCT00358982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24965879|NCT03773588|Propofol|propofol|mesh-list
24965880|NCT03773588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24965881|NCT03773588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24965901|NCT03773367|Antimetabolites|antimetabolites|mesh-ancestor
24965902|NCT03773367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965903|NCT03773367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24965904|NCT03773367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965905|NCT03773367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24965906|NCT03773367|Immunologic Factors|immunologic factors|mesh-ancestor
24965907|NCT03773367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965908|NCT03773367|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24965909|NCT03773367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24950701|NCT03912766|Arginine Vasopressin|arginine vasopressin|mesh-list
24950702|NCT03912766|Hemostatics|hemostatics|mesh-ancestor
24950703|NCT03912766|Coagulants|coagulants|mesh-ancestor
24950704|NCT03912766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24950705|NCT03912766|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24950706|NCT03912766|Natriuretic Agents|natriuretic agents|mesh-ancestor
24950707|NCT03912766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950708|NCT03912727|Thioctic Acid|thioctic acid|mesh-list
24950709|NCT03912727|Antioxidants|antioxidants|mesh-ancestor
24950711|NCT03912727|Protective Agents|protective agents|mesh-ancestor
24950732|NCT03912740|Narcotics|narcotics|mesh-ancestor
24950733|NCT03912402|Paclitaxel|paclitaxel|mesh-list
24950734|NCT03912402|Bevacizumab|bevacizumab|mesh-list
24950735|NCT03912402|Carboplatin|carboplatin|mesh-list
24950736|NCT03912402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24950737|NCT03912402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950738|NCT03912402|Tubulin Modulators|tubulin modulators|mesh-ancestor
24950739|NCT03912402|Antimitotic Agents|antimitotic agents|mesh-ancestor
24950740|NCT03912402|Mitosis Modulators|mitosis modulators|mesh-ancestor
24950741|NCT03912402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950742|NCT03912402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24950743|NCT03912402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24950744|NCT03912402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24950745|NCT03912402|Growth Substances|growth substances|mesh-ancestor
24950746|NCT03912402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950747|NCT03912402|Growth Inhibitors|growth inhibitors|mesh-ancestor
24950748|NCT03912389|Carboplatin|carboplatin|mesh-list
24950749|NCT03912389|Pemetrexed|pemetrexed|mesh-list
24950750|NCT03912389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950751|NCT03912389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950752|NCT03912389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950753|NCT03912389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24950754|NCT03912389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24950755|NCT03912415|Paclitaxel|paclitaxel|mesh-list
24950756|NCT03912415|Bevacizumab|bevacizumab|mesh-list
24950757|NCT03912415|Carboplatin|carboplatin|mesh-list
24950758|NCT03912415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24950759|NCT03912415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950760|NCT03912415|Tubulin Modulators|tubulin modulators|mesh-ancestor
24950761|NCT03912415|Antimitotic Agents|antimitotic agents|mesh-ancestor
24950762|NCT03912415|Mitosis Modulators|mitosis modulators|mesh-ancestor
24950763|NCT03912415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950764|NCT03912415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24950765|NCT03912415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24950766|NCT03912415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24950771|NCT03912285|Amlodipine|amlodipine|mesh-list
24950772|NCT03912285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24950773|NCT03912285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25697579|NCT02079844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25697580|NCT02080195|Mycophenolic Acid|mycophenolic acid|mesh-list
25697581|NCT02080195|Cyclophosphamide|cyclophosphamide|mesh-list
25697582|NCT02080195|Fludarabine|fludarabine|mesh-list
24950774|NCT03912285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25697583|NCT02080195|Tacrolimus|tacrolimus|mesh-list
25697584|NCT02080195|Thymoglobulin|thymoglobulin|mesh-list
24950775|NCT03912285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950776|NCT03912285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24950777|NCT03912285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950778|NCT03912285|Vasodilator Agents|vasodilator agents|mesh-ancestor
24950779|NCT03912285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24950780|NCT03912285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24950781|NCT03912285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24950782|NCT03911817|Midodrine|midodrine|mesh-list
24950783|NCT03911817|Sympathomimetics|sympathomimetics|mesh-ancestor
24950784|NCT03911817|Autonomic Agents|autonomic agents|mesh-ancestor
24950785|NCT03911817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24950786|NCT03911817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950787|NCT03911817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24950788|NCT03911817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24950789|NCT03911817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24950790|NCT03911817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24950791|NCT03911817|Adrenergic Agents|adrenergic agents|mesh-ancestor
24804717|NCT02004769|Capecitabine|capecitabine|mesh-list
24576691|NCT00839787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24576692|NCT00839787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576693|NCT00839787|Analgesics|analgesics|mesh-ancestor
24576694|NCT00839787|Sensory System Agents|sensory system agents|mesh-ancestor
24444026|NCT00296530|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24576714|NCT00840112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576715|NCT00840112|Protective Agents|protective agents|mesh-ancestor
24576716|NCT00840125|Docetaxel|docetaxel|mesh-list
24576717|NCT00840125|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24576829|NCT00840606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24950792|NCT03911817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24950795|NCT03911648|Bupivacaine|bupivacaine|mesh-list
24950796|NCT03911648|Anesthetics, Local|anesthetics, local|mesh-ancestor
24950797|NCT03911648|Anesthetics|anesthetics|mesh-ancestor
24950798|NCT03911648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24950799|NCT03911648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950800|NCT03911648|Sensory System Agents|sensory system agents|mesh-ancestor
24950801|NCT03911648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24950802|NCT03911648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24950803|NCT03911648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24950804|NCT03911648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24950805|NCT03911648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24950806|NCT03911648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950807|NCT03911440|Azithromycin|azithromycin|mesh-list
24950808|NCT03911440|Doxycycline|doxycycline|mesh-list
24950809|NCT03911440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24950810|NCT03911440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24950811|NCT03911440|Antimalarials|antimalarials|mesh-ancestor
24950812|NCT03911440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24950813|NCT03911440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24950814|NCT03911570|Acetaminophen|acetaminophen|mesh-list
24950815|NCT03911570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24950816|NCT03911570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
24950817|NCT03911570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24950818|NCT03911570|Analgesics|analgesics|mesh-ancestor
24950819|NCT03911570|Sensory System Agents|sensory system agents|mesh-ancestor
24950829|NCT03911271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24950830|NCT03911271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24950831|NCT03911271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24950832|NCT03911271|Autonomic Agents|autonomic agents|mesh-ancestor
24950833|NCT03911271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24950834|NCT03911271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950835|NCT03911271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25697585|NCT02080195|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25697586|NCT02080195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25697587|NCT02080195|Immunologic Factors|immunologic factors|mesh-ancestor
25697588|NCT02080195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697589|NCT02080195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24950836|NCT03911271|Respiratory System Agents|respiratory system agents|mesh-ancestor
24950837|NCT03911271|Mydriatics|mydriatics|mesh-ancestor
24950838|NCT03911271|Parasympatholytics|parasympatholytics|mesh-ancestor
24950839|NCT03911271|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24950840|NCT03911271|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24950841|NCT03911271|Cholinergic Agents|cholinergic agents|mesh-ancestor
24950842|NCT03911271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24950843|NCT03911271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950886|NCT03910543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950887|NCT03910361|Pioglitazone|pioglitazone|mesh-list
24950888|NCT03910361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24950889|NCT03910361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950890|NCT03910504|Rocuronium|rocuronium|mesh-list
24950891|NCT03910504|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25051970|NCT00358982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051971|NCT00358878|Satavaptan|satavaptan|mesh-list
25051972|NCT00358878|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25051973|NCT00358878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051974|NCT00358878|Natriuretic Agents|natriuretic agents|mesh-ancestor
25051975|NCT00358878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25051976|NCT00357279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25051977|NCT00356681|Niacinamide|niacinamide|mesh-list
25051978|NCT00356681|Paclitaxel|paclitaxel|mesh-list
25051982|NCT00356681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25051984|NCT00356681|Tubulin Modulators|tubulin modulators|mesh-ancestor
25051985|NCT00356681|Antimitotic Agents|antimitotic agents|mesh-ancestor
25051986|NCT00356681|Mitosis Modulators|mitosis modulators|mesh-ancestor
25051987|NCT00356681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25051988|NCT00356681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24950892|NCT03910504|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24950893|NCT03910504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24950894|NCT03910504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24950895|NCT03910504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950896|NCT03910231|Tolvaptan|tolvaptan|mesh-list
24950897|NCT03910231|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24576841|NCT00840645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576842|NCT00840645|Urological Agents|urological agents|mesh-ancestor
24576844|NCT00840671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24576845|NCT00840671|Protective Agents|protective agents|mesh-ancestor
24576846|NCT00840671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576847|NCT00840671|Nootropic Agents|nootropic agents|mesh-ancestor
24576848|NCT00840684|Cytarabine|cytarabine|mesh-list
24576859|NCT00840684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24576860|NCT00840684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24576861|NCT00840684|Immunologic Factors|immunologic factors|mesh-ancestor
24950898|NCT03910231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950900|NCT03910231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950901|NCT03910088|Acetaminophen|acetaminophen|mesh-list
24576867|NCT00840684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24576868|NCT00840684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24576869|NCT00840684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950929|NCT03910088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24950930|NCT03910088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24950931|NCT03910088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24950933|NCT03909776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950934|NCT03909594|Ketamine|ketamine|mesh-list
24950935|NCT03909594|Bupivacaine|bupivacaine|mesh-list
24950936|NCT03909594|Anesthetics, Local|anesthetics, local|mesh-ancestor
24950937|NCT03909594|Anesthetics|anesthetics|mesh-ancestor
24950938|NCT03909594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24950939|NCT03909594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950940|NCT03909594|Sensory System Agents|sensory system agents|mesh-ancestor
24950941|NCT03909594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24950942|NCT03909594|Analgesics|analgesics|mesh-ancestor
24950943|NCT03909594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24950944|NCT03909594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24575668|NCT00833300|Serotonin Agents|serotonin agents|mesh-ancestor
24950945|NCT03909594|Anesthetics, General|anesthetics, general|mesh-ancestor
24950946|NCT03909594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24950947|NCT03909594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24605592|NCT00986284|Gefitinib|gefitinib|mesh-list
25697590|NCT02080195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24950948|NCT03909594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24776494|NCT01858155|Melatonin|melatonin|mesh-list
24950949|NCT03909594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950950|NCT03909477|Xenon|xenon|mesh-list
24950951|NCT03909477|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24950952|NCT03909477|Anesthetics, General|anesthetics, general|mesh-ancestor
24950953|NCT03909477|Anesthetics|anesthetics|mesh-ancestor
24950954|NCT03909477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24950955|NCT03909477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704277|NCT01477489|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24704278|NCT01477489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704279|NCT01477489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704280|NCT01477489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24704281|NCT01477580|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24950956|NCT03909724|Sunitinib|sunitinib|mesh-list
24576912|NCT00840931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950957|NCT03909724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950958|NCT03909724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24950959|NCT03909724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24950960|NCT03909724|Growth Substances|growth substances|mesh-ancestor
24950961|NCT03909724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950962|NCT03909724|Growth Inhibitors|growth inhibitors|mesh-ancestor
24950964|NCT03909724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950965|NCT03909724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950967|NCT03909737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24950968|NCT03909737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24950970|NCT03909529|Spironolactone|spironolactone|mesh-list
24950971|NCT03909529|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24950972|NCT03909529|Hormone Antagonists|hormone antagonists|mesh-ancestor
24950973|NCT03909529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24950974|NCT03909529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950975|NCT03909529|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24950976|NCT03909529|Diuretics|diuretics|mesh-ancestor
24950977|NCT03909529|Natriuretic Agents|natriuretic agents|mesh-ancestor
24950978|NCT03909529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24950979|NCT03909529|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24950980|NCT03909529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950981|NCT03909529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950982|NCT03909529|Protective Agents|protective agents|mesh-ancestor
24576955|NCT00841139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24576956|NCT00841139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25697591|NCT02080195|Alkylating Agents|alkylating agents|mesh-ancestor
25697592|NCT02080195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697593|NCT02080195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25697594|NCT02080195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25697595|NCT02080195|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25697596|NCT02080195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697597|NCT02080195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25697598|NCT02080195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25697599|NCT02080195|Antitubercular Agents|antitubercular agents|mesh-ancestor
25697600|NCT02080195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25697601|NCT02080195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25697602|NCT02080273|Listerine|listerine|mesh-list
25697603|NCT02080273|Sodium Fluoride|sodium fluoride|mesh-list
25697604|NCT02080273|Cariostatic Agents|cariostatic agents|mesh-ancestor
25697605|NCT02080273|Protective Agents|protective agents|mesh-ancestor
24980117|NCT05441761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24980118|NCT05441761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24980119|NCT05441761|Immunologic Factors|immunologic factors|mesh-ancestor
24980120|NCT05441761|Analgesics|analgesics|mesh-ancestor
24980121|NCT05441761|Sensory System Agents|sensory system agents|mesh-ancestor
24980122|NCT05441761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24980123|NCT05441761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24576957|NCT00841139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576958|NCT00841139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24576959|NCT00841139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576960|NCT00841139|Vasodilator Agents|vasodilator agents|mesh-ancestor
24576961|NCT00841191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24576963|NCT00841191|Antibodies|antibodies|mesh-list
24576977|NCT00841373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576978|NCT00841373|Growth Inhibitors|growth inhibitors|mesh-ancestor
24576979|NCT00841373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24576980|NCT00841386|Riboflavin|riboflavin|mesh-list
24576981|NCT00841386|Flavin Mononucleotide|flavin mononucleotide|mesh-list
24576982|NCT00841386|Vitamin B Complex|vitamin b complex|mesh-ancestor
24576983|NCT00841386|Vitamins|vitamins|mesh-ancestor
24576984|NCT00841386|Micronutrients|micronutrients|mesh-ancestor
24576985|NCT00841386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576986|NCT00841386|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24576987|NCT00841386|Dermatologic Agents|dermatologic agents|mesh-ancestor
24576988|NCT00841438|Abciximab|abciximab|mesh-list
24576989|NCT00841438|Anticoagulants|anticoagulants|mesh-ancestor
24576990|NCT00841438|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24576991|NCT00841477|Vaccines|vaccines|mesh-list
24576992|NCT00841477|Immunologic Factors|immunologic factors|mesh-ancestor
24576993|NCT00841477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576994|NCT00841581|Ranibizumab|ranibizumab|mesh-list
24576995|NCT00841581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24576996|NCT00841581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24576997|NCT00841581|Growth Substances|growth substances|mesh-ancestor
24576998|NCT00841581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804990|NCT02006498|Silymarin|silymarin|mesh-list
24577001|NCT00841594|Nitroglycerin|nitroglycerin|mesh-list
24577002|NCT00841594|Vasodilator Agents|vasodilator agents|mesh-ancestor
24577004|NCT00841633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24577005|NCT00841633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24577006|NCT00841633|Adrenergic Agents|adrenergic agents|mesh-ancestor
24577007|NCT00841633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24577008|NCT00841633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577009|NCT00841633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577086|NCT00841893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577087|NCT00841893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24577088|NCT00841893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577090|NCT00841919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24577091|NCT00841919|Insulin Glargine|insulin glargine|mesh-list
24577092|NCT00841919|Insulin, Isophane|insulin, isophane|mesh-list
24577093|NCT00841919|Isophane Insulin, Human|isophane insulin, human|mesh-list
24577094|NCT00841919|Isophane insulin, beef|isophane insulin, beef|mesh-list
24577095|NCT00841919|Insulin Lispro|insulin lispro|mesh-list
24577096|NCT00841919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24577097|NCT00841919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577098|NCT00841945|Prednisone|prednisone|mesh-list
24577099|NCT00841945|Rituximab|rituximab|mesh-list
24577100|NCT00841945|Doxorubicin|doxorubicin|mesh-list
24577101|NCT00841945|Vincristine|vincristine|mesh-list
24577102|NCT00841945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24577103|NCT00841945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25697606|NCT02080273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697607|NCT02080273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25697608|NCT02080273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25697609|NCT02080455|Atorvastatin|atorvastatin|mesh-list
25697610|NCT02080455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25697611|NCT02080455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25697612|NCT02080455|Antimetabolites|antimetabolites|mesh-ancestor
25697613|NCT02080455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697614|NCT02080455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25697615|NCT02080455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25697616|NCT02080455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697617|NCT02080468|Norgestimate|norgestimate|mesh-list
25697618|NCT02080468|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25697619|NCT02080468|Contraceptive Agents|contraceptive agents|mesh-ancestor
25697620|NCT02080468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25697621|NCT02080468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577104|NCT00841945|Immunologic Factors|immunologic factors|mesh-ancestor
24577142|NCT00842114|Tubulin Modulators|tubulin modulators|mesh-ancestor
24577161|NCT00842140|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24951058|NCT03908580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951060|NCT03908580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24776615|NCT01858649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776616|NCT01858662|Leucovorin|leucovorin|mesh-list
24776617|NCT01858662|Oxaliplatin|oxaliplatin|mesh-list
24776618|NCT01858662|Irinotecan|irinotecan|mesh-list
24776619|NCT01858662|Cetuximab|cetuximab|mesh-list
24776620|NCT01858662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577189|NCT00842491|Cisplatin|cisplatin|mesh-list
24577190|NCT00842491|Capecitabine|capecitabine|mesh-list
24577191|NCT00842491|Endostar protein|endostar protein|mesh-list
24577201|NCT00842504|Micafungin|micafungin|mesh-list
24577202|NCT00842504|Antifungal Agents|antifungal agents|mesh-ancestor
24577203|NCT00842504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24577204|NCT00842556|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24577205|NCT00842556|Dapagliflozin|dapagliflozin|mesh-list
24577206|NCT00842556|Glimepiride|glimepiride|mesh-list
24577207|NCT00842556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24577208|NCT00842556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577209|NCT00842556|Incretins|incretins|mesh-ancestor
24577210|NCT00842556|Hormones|hormones|mesh-ancestor
24577211|NCT00842556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24577212|NCT00842556|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24577213|NCT00842556|Protease Inhibitors|protease inhibitors|mesh-ancestor
24577214|NCT00842556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577215|NCT00842556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577765|NCT00845819|Nystatin|nystatin|mesh-list
24577216|NCT00842556|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24577217|NCT00842556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24577218|NCT00842556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24577246|NCT00842595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24577247|NCT00842595|Alkylating Agents|alkylating agents|mesh-ancestor
24577258|NCT00842660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577267|NCT00842686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24577268|NCT00842686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776621|NCT01858662|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24776622|NCT01858662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24776623|NCT01858662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776624|NCT01858662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776626|NCT01858662|Protective Agents|protective agents|mesh-ancestor
24776627|NCT01858662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776628|NCT01858662|Vitamin B Complex|vitamin b complex|mesh-ancestor
24776629|NCT01858662|Vitamins|vitamins|mesh-ancestor
24776630|NCT01858662|Micronutrients|micronutrients|mesh-ancestor
24776631|NCT01858662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24577315|NCT00842933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24577316|NCT00842933|Protective Agents|protective agents|mesh-ancestor
24577319|NCT00842998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24577320|NCT00842998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577321|NCT00842998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24704445|NCT01478308|Metformin|metformin|mesh-list
24704565|NCT01478737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24704566|NCT01478737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24704567|NCT01478737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24704571|NCT01478997|Acetaminophen|acetaminophen|mesh-list
24704587|NCT01479036|Mitosis Modulators|mitosis modulators|mesh-ancestor
25697622|NCT02080468|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25697623|NCT02080468|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25406980|NCT03524820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25697624|NCT02080468|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25697625|NCT02080637|Ambrisentan|ambrisentan|mesh-list
25697626|NCT02080637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25697627|NCT02080780|Clarithromycin|clarithromycin|mesh-list
25697628|NCT02080780|Diltiazem|diltiazem|mesh-list
25697629|NCT02080780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25697630|NCT02080780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25697631|NCT02080780|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24704588|NCT01479036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704589|NCT01479036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24704621|NCT01479231|Lansoprazole|lansoprazole|mesh-list
24577322|NCT00842998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776632|NCT01858792|Belimumab|belimumab|mesh-list
24776636|NCT01858831|Atovaquone|atovaquone|mesh-list
24951061|NCT03908528|Thioctic Acid|thioctic acid|mesh-list
24951062|NCT03908528|Cyclophosphamide|cyclophosphamide|mesh-list
24951063|NCT03908528|Doxorubicin|doxorubicin|mesh-list
24951064|NCT03908528|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24951065|NCT03908528|Paclitaxel|paclitaxel|mesh-list
24805037|NCT02007005|Viscum album peptide|viscum album peptide|mesh-list
24577323|NCT00842998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577383|NCT00843661|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24577384|NCT00843661|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24577385|NCT00843661|Antimetabolites|antimetabolites|mesh-ancestor
24577386|NCT00843661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577394|NCT00843895|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24577395|NCT00843895|Immunologic Factors|immunologic factors|mesh-ancestor
24577410|NCT00844012|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24577411|NCT00844012|Estradiol|estradiol|mesh-list
24577412|NCT00844012|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24577413|NCT00844012|Estrogens|estrogens|mesh-ancestor
24577414|NCT00844012|Hormones|hormones|mesh-ancestor
24577415|NCT00844012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24577416|NCT00844012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577417|NCT00844012|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24577418|NCT00844012|Contraceptive Agents|contraceptive agents|mesh-ancestor
24577433|NCT00844142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24577434|NCT00844142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24577435|NCT00844142|Immunologic Factors|immunologic factors|mesh-ancestor
24577436|NCT00844142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24577437|NCT00844155|Oseltamivir|oseltamivir|mesh-list
24577438|NCT00844155|Antiviral Agents|antiviral agents|mesh-ancestor
24577439|NCT00844155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24577440|NCT00844155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951066|NCT03908528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24951067|NCT03908528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24951068|NCT03908528|Immunologic Factors|immunologic factors|mesh-ancestor
24951069|NCT03908528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951070|NCT03908528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24951071|NCT03908528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24951072|NCT03908528|Alkylating Agents|alkylating agents|mesh-ancestor
24951073|NCT03908528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951074|NCT03908528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577491|NCT00844337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24577492|NCT00844337|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24577493|NCT00844337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577494|NCT00844337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577496|NCT00844350|Oxytocin|oxytocin|mesh-list
24577497|NCT00844350|Clomiphene|clomiphene|mesh-list
24577498|NCT00844350|Enclomiphene|enclomiphene|mesh-list
24577499|NCT00844350|Zuclomiphene|zuclomiphene|mesh-list
24577500|NCT00844350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577502|NCT00844350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24704642|NCT01479361|Antimalarials|antimalarials|mesh-ancestor
24577503|NCT00844350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577504|NCT00844350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577505|NCT00844350|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24577506|NCT00844350|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24577507|NCT00844350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577508|NCT00844350|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24577509|NCT00844350|Hormone Antagonists|hormone antagonists|mesh-ancestor
24577510|NCT00844350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25697632|NCT02080780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951109|NCT03908333|Mitosis Modulators|mitosis modulators|mesh-ancestor
24951110|NCT03908333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951111|NCT03908333|Vitamins|vitamins|mesh-ancestor
24980263|NCT05420467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24980264|NCT05420467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24951112|NCT03908333|Micronutrients|micronutrients|mesh-ancestor
24577639|NCT00845338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577640|NCT00845338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577641|NCT00845338|Urological Agents|urological agents|mesh-ancestor
24577643|NCT00845351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577644|NCT00845364|Perhexiline|perhexiline|mesh-list
24577651|NCT00845533|Piperaquine|piperaquine|mesh-list
24951127|NCT03908242|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24951128|NCT03908060|Morphine|morphine|mesh-list
24951129|NCT03908060|Methadone|methadone|mesh-list
24951130|NCT03908060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24951131|NCT03908060|Narcotics|narcotics|mesh-ancestor
24951132|NCT03908060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24951133|NCT03908060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951134|NCT03908060|Analgesics|analgesics|mesh-ancestor
24951135|NCT03908060|Sensory System Agents|sensory system agents|mesh-ancestor
24951136|NCT03908060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24951137|NCT03908060|Antitussive Agents|antitussive agents|mesh-ancestor
24951138|NCT03908060|Respiratory System Agents|respiratory system agents|mesh-ancestor
24951139|NCT03908372|Docetaxel|docetaxel|mesh-list
24805072|NCT02007330|Lidocaine|lidocaine|mesh-list
24577714|NCT00845598|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24577715|NCT00845598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24577716|NCT00845598|Histamine Antagonists|histamine antagonists|mesh-ancestor
24577717|NCT00845598|Histamine Agents|histamine agents|mesh-ancestor
24577718|NCT00845598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24577719|NCT00845611|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
24577720|NCT00845611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24577721|NCT00845611|Immunologic Factors|immunologic factors|mesh-ancestor
24577722|NCT00845611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577723|NCT00845689|Adenosine|adenosine|mesh-list
24577726|NCT00845689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24577727|NCT00845689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577728|NCT00845689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24577747|NCT00845780|Amiodarone|amiodarone|mesh-list
24577752|NCT00845780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577753|NCT00845780|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24577754|NCT00845780|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24577755|NCT00845780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24577756|NCT00845780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577757|NCT00845780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24577758|NCT00845780|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24577759|NCT00845780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24577761|NCT00845819|Chlorhexidine|chlorhexidine|mesh-list
24577762|NCT00845819|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24577763|NCT00845819|Cadexomer iodine|cadexomer iodine|mesh-list
24704643|NCT01479361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24577764|NCT00845819|Povidone-Iodine|povidone-iodine|mesh-list
24951149|NCT03908008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24951150|NCT03908008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951152|NCT03908008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24951153|NCT03908008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951154|NCT03908008|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24951155|NCT03908008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24951157|NCT03907800|Carboplatin|carboplatin|mesh-list
24951158|NCT03907800|Trastuzumab|trastuzumab|mesh-list
24951159|NCT03907800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24951160|NCT03907800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951161|NCT03907800|Tubulin Modulators|tubulin modulators|mesh-ancestor
24951162|NCT03907800|Antimitotic Agents|antimitotic agents|mesh-ancestor
24951163|NCT03907800|Mitosis Modulators|mitosis modulators|mesh-ancestor
24951164|NCT03907800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951165|NCT03907800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25697633|NCT02080780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697634|NCT02080780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25697635|NCT02080780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24951166|NCT03907813|Bupivacaine|bupivacaine|mesh-list
24783952|NCT01905059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24783953|NCT01905059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783954|NCT01905059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697636|NCT02080780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24783956|NCT01905059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783957|NCT01905059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24783958|NCT01905059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24577895|NCT00846274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577896|NCT00846274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577897|NCT00846274|Anticoagulants|anticoagulants|mesh-ancestor
24577898|NCT00846326|Fluticasone|fluticasone|mesh-list
24577937|NCT00846430|Interferons|interferons|mesh-list
24577938|NCT00846430|Interferon-alpha|interferon-alpha|mesh-list
24577939|NCT00846430|Interferon alpha-2|interferon alpha-2|mesh-list
24577941|NCT00846430|Celecoxib|celecoxib|mesh-list
24951167|NCT03907813|Anesthetics, Local|anesthetics, local|mesh-ancestor
24951168|NCT03907813|Anesthetics|anesthetics|mesh-ancestor
24951169|NCT03907813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24951170|NCT03907813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951171|NCT03907813|Sensory System Agents|sensory system agents|mesh-ancestor
24951172|NCT03907813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24951173|NCT03907423|Metformin|metformin|mesh-list
24951174|NCT03907423|Glimepiride|glimepiride|mesh-list
24951175|NCT03907423|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24951176|NCT03907423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24951177|NCT03907423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951178|NCT03907423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24951179|NCT03907423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24951180|NCT03907423|Antimetabolites|antimetabolites|mesh-ancestor
24951181|NCT03907423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951182|NCT03907423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24951183|NCT03907423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24951184|NCT03907423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951185|NCT03907423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24951189|NCT03907371|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24951191|NCT03907371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951192|NCT03907371|Cholinergic Agents|cholinergic agents|mesh-ancestor
24951193|NCT03907371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24951194|NCT03907371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951195|NCT03907371|Nootropic Agents|nootropic agents|mesh-ancestor
24951196|NCT03907098|Endostar protein|endostar protein|mesh-list
24951197|NCT03907098|Endostatins|endostatins|mesh-list
24578110|NCT00846911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24578111|NCT00846950|Lorazepam|lorazepam|mesh-list
24578112|NCT00846950|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
24578113|NCT00846950|Anticonvulsants|anticonvulsants|mesh-ancestor
24578114|NCT00846950|Antiemetics|antiemetics|mesh-ancestor
24578115|NCT00846950|Autonomic Agents|autonomic agents|mesh-ancestor
24578139|NCT00846976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578277|NCT00847860|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24578278|NCT00847860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24578320|NCT00848523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951198|NCT03907098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24951199|NCT03907098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24951200|NCT03907098|Growth Substances|growth substances|mesh-ancestor
24951201|NCT03907098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578614|NCT00849966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578615|NCT00849966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25697637|NCT02080780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25697638|NCT02080780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25697639|NCT02080780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25697640|NCT02080780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697641|NCT02080780|Vasodilator Agents|vasodilator agents|mesh-ancestor
25697642|NCT02080819|Levodopa|levodopa|mesh-list
25697643|NCT02080819|Carbidopa|carbidopa|mesh-list
25697644|NCT02080819|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25697645|NCT02080819|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25697646|NCT02080819|Dopamine Agents|dopamine agents|mesh-ancestor
25697647|NCT02080819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24578645|NCT00850044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24980337|NCT05353829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25697648|NCT02080819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980339|NCT05353829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980340|NCT05353829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980341|NCT05353829|Dermatologic Agents|dermatologic agents|mesh-ancestor
24980342|NCT05353829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24980343|NCT05353829|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24980344|NCT05353829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24980345|NCT05353829|Immunologic Factors|immunologic factors|mesh-ancestor
24980346|NCT05353829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25106072|NCT04542135|Sensory System Agents|sensory system agents|mesh-ancestor
25106073|NCT04542135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25106074|NCT04542135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106075|NCT04542135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25106076|NCT04542135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24578647|NCT00850122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24578648|NCT00850122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24578649|NCT00850161|Insulin|insulin|mesh-list
24578650|NCT00850161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24578651|NCT00850161|Insulin Aspart|insulin aspart|mesh-list
24951202|NCT03907098|Growth Inhibitors|growth inhibitors|mesh-ancestor
24951203|NCT03907098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951204|NCT03906916|Micafungin|micafungin|mesh-list
24951205|NCT03906916|Antifungal Agents|antifungal agents|mesh-ancestor
24951206|NCT03906916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24578758|NCT00851513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24578811|NCT00852059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24578812|NCT00852059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24578813|NCT00852059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24578814|NCT00852059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578815|NCT00852059|Dopamine Agents|dopamine agents|mesh-ancestor
24578822|NCT00852163|Immunologic Factors|immunologic factors|mesh-ancestor
24578823|NCT00852163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578824|NCT00852163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24578825|NCT00852163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951213|NCT03907215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24578955|NCT00852670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578957|NCT00852670|Immunologic Factors|immunologic factors|mesh-ancestor
24578958|NCT00852670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578959|NCT00852683|Pregabalin|pregabalin|mesh-list
24578960|NCT00852683|Analgesics|analgesics|mesh-ancestor
24578999|NCT00852956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579000|NCT00852956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579001|NCT00853008|Cytarabine|cytarabine|mesh-list
24579002|NCT00853008|Dexamethasone|dexamethasone|mesh-list
24579003|NCT00853008|Prednisone|prednisone|mesh-list
24579004|NCT00853008|Hydrocortisone|hydrocortisone|mesh-list
25051995|NCT00356681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25051996|NCT00356681|Vitamin B Complex|vitamin b complex|mesh-ancestor
25051997|NCT00356681|Vitamins|vitamins|mesh-ancestor
25051998|NCT00356681|Micronutrients|micronutrients|mesh-ancestor
25051999|NCT00356109|Insulin|insulin|mesh-list
24579177|NCT00853697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24579178|NCT00853697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697649|NCT02080819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697650|NCT02080819|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25697651|NCT02080819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697652|NCT02080832|Dexetimide|dexetimide|mesh-list
25697653|NCT02080832|Citalopram|citalopram|mesh-list
25697654|NCT02080832|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25697655|NCT02080832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25697656|NCT02080832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25697657|NCT02080832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697658|NCT02080832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25697659|NCT02080832|Serotonin Agents|serotonin agents|mesh-ancestor
25697660|NCT02080832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697661|NCT02080832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25697662|NCT02080832|Antidepressive Agents|antidepressive agents|mesh-ancestor
25697663|NCT02080832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25697664|NCT02080832|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25697665|NCT02080832|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24579179|NCT00853697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24579181|NCT00853697|Anabolic Agents|anabolic agents|mesh-ancestor
24579182|NCT00853697|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24579183|NCT00853697|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24579184|NCT00853697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579185|NCT00853697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579186|NCT00853697|Hormone Antagonists|hormone antagonists|mesh-ancestor
24579187|NCT00853736|Oxycodone|oxycodone|mesh-list
25052011|NCT00355355|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25052012|NCT00355355|Dermatologic Agents|dermatologic agents|mesh-ancestor
25052013|NCT00353574|Darusentan|darusentan|mesh-list
25052014|NCT00353574|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25052015|NCT00353574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579188|NCT00853736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24579189|NCT00853736|Narcotics|narcotics|mesh-ancestor
24579190|NCT00853736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24579228|NCT00853944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24579229|NCT00853944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24632463|NCT01124058|Dalteparin|dalteparin|mesh-list
24579230|NCT00853944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579231|NCT00853944|Incretins|incretins|mesh-ancestor
24579232|NCT00853944|Hormones|hormones|mesh-ancestor
24579359|NCT00854711|Respiratory System Agents|respiratory system agents|mesh-ancestor
24579360|NCT00854711|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24579361|NCT00854711|Antioxidants|antioxidants|mesh-ancestor
24579362|NCT00854711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579363|NCT00854711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24579364|NCT00854711|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24579365|NCT00854711|Vasodilator Agents|vasodilator agents|mesh-ancestor
24671116|NCT01323569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579366|NCT00854711|Gasotransmitters|gasotransmitters|mesh-ancestor
24579367|NCT00854711|Protective Agents|protective agents|mesh-ancestor
24579368|NCT00854750|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24579369|NCT00854750|Hormones|hormones|mesh-ancestor
24579372|NCT00854763|Olmesartan|olmesartan|mesh-list
24579413|NCT00854919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579414|NCT00854919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24579415|NCT00854932|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24444669|NCT00298857|Antimanic Agents|antimanic agents|mesh-ancestor
24579482|NCT00855361|Rabeprazole|rabeprazole|mesh-list
24579483|NCT00855361|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24580990|NCT00864162|Protease Inhibitors|protease inhibitors|mesh-ancestor
24579484|NCT00855361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24579485|NCT00855361|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24579527|NCT00855777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24579528|NCT00855777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579529|NCT00855777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579530|NCT00855777|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24579532|NCT00855881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24579533|NCT00855881|Antimetabolites|antimetabolites|mesh-ancestor
24579534|NCT00855881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579535|NCT00855881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579536|NCT00855972|Naltrexone|naltrexone|mesh-list
25697666|NCT02080832|Parasympatholytics|parasympatholytics|mesh-ancestor
25697667|NCT02080832|Autonomic Agents|autonomic agents|mesh-ancestor
25697668|NCT02080832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25697669|NCT02080832|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25697670|NCT02080832|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25697671|NCT02080832|Cholinergic Agents|cholinergic agents|mesh-ancestor
25697672|NCT02081001|Glucagon|glucagon|mesh-list
25697673|NCT02081001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25697674|NCT02081001|Hormones|hormones|mesh-ancestor
24579589|NCT00856362|GABA Modulators|gaba modulators|mesh-ancestor
24579714|NCT00857142|Analgesics|analgesics|mesh-ancestor
24579715|NCT00857142|Sensory System Agents|sensory system agents|mesh-ancestor
24579805|NCT00857870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579808|NCT00857909|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24579809|NCT00857909|Hormone Antagonists|hormone antagonists|mesh-ancestor
24579810|NCT00857909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24579862|NCT00858377|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24579863|NCT00858377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24579864|NCT00858377|Immunologic Factors|immunologic factors|mesh-ancestor
24579865|NCT00858377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579866|NCT00858429|Capecitabine|capecitabine|mesh-list
24579867|NCT00858429|Doxifluridine|doxifluridine|mesh-list
24579927|NCT00858715|Antipyretics|antipyretics|mesh-ancestor
24966310|NCT03769818|Sensory System Agents|sensory system agents|mesh-ancestor
24966311|NCT03769714|Bupivacaine|bupivacaine|mesh-list
24966312|NCT03769714|Anesthetics, Local|anesthetics, local|mesh-ancestor
24966313|NCT03769714|Anesthetics|anesthetics|mesh-ancestor
24966314|NCT03769714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24966315|NCT03769714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966316|NCT03769714|Sensory System Agents|sensory system agents|mesh-ancestor
24966317|NCT03769714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24580221|NCT00861029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24580222|NCT00861029|Contraceptive Agents|contraceptive agents|mesh-ancestor
24580223|NCT00861029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24580224|NCT00861029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580225|NCT00861029|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24580226|NCT00861029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24580279|NCT00861250|Glucocorticoids|glucocorticoids|mesh-ancestor
24580281|NCT00861250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24580282|NCT00861250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24580283|NCT00861250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24580285|NCT00861276|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24580298|NCT00861328|Irinotecan|irinotecan|mesh-list
24951232|NCT03907163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24951234|NCT03907111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24951235|NCT03907111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24951236|NCT03907111|Antimetabolites|antimetabolites|mesh-ancestor
24951237|NCT03907111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951238|NCT03907111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24580736|NCT00863460|Thiotepa|thiotepa|mesh-list
24580737|NCT00863460|Carmustine|carmustine|mesh-list
24580738|NCT00863460|Methotrexate|methotrexate|mesh-list
24580739|NCT00863460|Etoposide|etoposide|mesh-list
24580740|NCT00863460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24580741|NCT00863460|Immunologic Factors|immunologic factors|mesh-ancestor
24580742|NCT00863460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580743|NCT00863460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24580744|NCT00863460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24580934|NCT00864045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25697675|NCT02081001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25697676|NCT02081001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697677|NCT02081014|Glucagon|glucagon|mesh-list
25697678|NCT02081014|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25697679|NCT02081014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25697680|NCT02081014|Hormones|hormones|mesh-ancestor
25697681|NCT02081014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25697682|NCT02081014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697683|NCT02081014|Incretins|incretins|mesh-ancestor
25697684|NCT02081079|Sofosbuvir|sofosbuvir|mesh-list
25697685|NCT02081079|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25697686|NCT02081079|Ledipasvir|ledipasvir|mesh-list
24580935|NCT00864045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24580936|NCT00864045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580938|NCT00864045|Serotonin Agents|serotonin agents|mesh-ancestor
24580986|NCT00864149|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24580988|NCT00864162|Ramipril|ramipril|mesh-list
24580989|NCT00864162|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24580991|NCT00864162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580993|NCT00864162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24581139|NCT00864526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24581140|NCT00864526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581187|NCT00864604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581188|NCT00864617|Nifedipine|nifedipine|mesh-list
24581189|NCT00864617|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24581190|NCT00864617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24581191|NCT00864617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581192|NCT00864617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24581193|NCT00864617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581194|NCT00864617|Vasodilator Agents|vasodilator agents|mesh-ancestor
24581195|NCT00864617|Tocolytic Agents|tocolytic agents|mesh-ancestor
24581909|NCT00866645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24581196|NCT00864617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24581197|NCT00864643|Atorvastatin|atorvastatin|mesh-list
24581198|NCT00864643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24581287|NCT00864838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24581288|NCT00864838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24581289|NCT00864838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24581291|NCT00864838|Adrenergic Agents|adrenergic agents|mesh-ancestor
24581292|NCT00864838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581294|NCT00864838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581547|NCT00865436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24581548|NCT00865436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581549|NCT00865449|Spironolactone|spironolactone|mesh-list
24581550|NCT00865449|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24581551|NCT00865449|Hormone Antagonists|hormone antagonists|mesh-ancestor
24581552|NCT00865449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24581553|NCT00865449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581554|NCT00865449|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24581555|NCT00865449|Diuretics|diuretics|mesh-ancestor
24581556|NCT00865449|Natriuretic Agents|natriuretic agents|mesh-ancestor
24581557|NCT00865462|Bupropion|bupropion|mesh-list
24581558|NCT00865462|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24581559|NCT00865462|Antidepressive Agents|antidepressive agents|mesh-ancestor
24581560|NCT00865462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24581561|NCT00865462|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24581562|NCT00865462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24581563|NCT00865462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24581564|NCT00865462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581565|NCT00865462|Dopamine Agents|dopamine agents|mesh-ancestor
24581566|NCT00865462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581578|NCT00865501|Natriuretic Agents|natriuretic agents|mesh-ancestor
25697687|NCT02081079|Antiviral Agents|antiviral agents|mesh-ancestor
25697688|NCT02081079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25697689|NCT02081443|Ticagrelor|ticagrelor|mesh-list
25697690|NCT02081443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25697691|NCT02081443|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25697692|NCT02081443|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25697693|NCT02081443|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25697694|NCT02081443|Purinergic Agents|purinergic agents|mesh-ancestor
25697695|NCT02081443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581579|NCT00865540|Prednisolone|prednisolone|mesh-list
24581689|NCT00865761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24581690|NCT00865761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24581691|NCT00865761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24581692|NCT00865761|GABA Modulators|gaba modulators|mesh-ancestor
24581693|NCT00865761|GABA Agents|gaba agents|mesh-ancestor
24581694|NCT00865761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581695|NCT00865761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581696|NCT00865839|Metformin|metformin|mesh-list
24705242|NCT01483053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24705243|NCT01483053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24705244|NCT01483053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24705245|NCT01483248|Interferons|interferons|mesh-list
24581697|NCT00865839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24581698|NCT00865839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581699|NCT00865852|Metformin|metformin|mesh-list
24951290|NCT03905837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951291|NCT03905837|Sensory System Agents|sensory system agents|mesh-ancestor
24951292|NCT03905837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24951293|NCT03905837|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24951294|NCT03905837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24581700|NCT00865852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24581701|NCT00865852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581727|NCT00865943|Dexetimide|dexetimide|mesh-list
24581757|NCT00866008|Ganirelix|ganirelix|mesh-list
24581758|NCT00866008|Luteolytic Agents|luteolytic agents|mesh-ancestor
24581759|NCT00866008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24581795|NCT00866073|Decitabine|decitabine|mesh-list
24581842|NCT00866515|Antifungal Agents|antifungal agents|mesh-ancestor
24581843|NCT00866515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24581844|NCT00866515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24581845|NCT00866515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24581846|NCT00866515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581899|NCT00866645|Sulpiride|sulpiride|mesh-list
24581900|NCT00866645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24581901|NCT00866645|Antiemetics|antiemetics|mesh-ancestor
24581902|NCT00866645|Autonomic Agents|autonomic agents|mesh-ancestor
24581903|NCT00866645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24581904|NCT00866645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581905|NCT00866645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24581906|NCT00866645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24581907|NCT00866645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24581908|NCT00866645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24582016|NCT00867126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582017|NCT00867152|Ritonavir|ritonavir|mesh-list
24582018|NCT00867152|Lopinavir|lopinavir|mesh-list
24582019|NCT00867152|Darunavir|darunavir|mesh-list
24582020|NCT00867152|Dolutegravir|dolutegravir|mesh-list
24582021|NCT00867152|Etravirine|etravirine|mesh-list
24582022|NCT00867152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24582023|NCT00867152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24582024|NCT00867152|Protease Inhibitors|protease inhibitors|mesh-ancestor
24582025|NCT00867152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24582026|NCT00867152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582027|NCT00867152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24582051|NCT00867672|GABA Agents|gaba agents|mesh-ancestor
25697696|NCT02081443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697697|NCT02081443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697698|NCT02081599|Insulin|insulin|mesh-list
25697699|NCT02081599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25697700|NCT02081599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697701|NCT02081638|Aspirin|aspirin|mesh-list
25697702|NCT02081638|Atorvastatin|atorvastatin|mesh-list
25697703|NCT02081638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25697704|NCT02081638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25697705|NCT02081638|Analgesics|analgesics|mesh-ancestor
25697706|NCT02081638|Sensory System Agents|sensory system agents|mesh-ancestor
24632831|NCT01125787|Immunologic Factors|immunologic factors|mesh-ancestor
24582165|NCT00868426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582166|NCT00868426|Antidotes|antidotes|mesh-ancestor
24582167|NCT00868426|Protective Agents|protective agents|mesh-ancestor
24582168|NCT00868465|Lumefantrine|lumefantrine|mesh-list
24582169|NCT00868465|Artemether|artemether|mesh-list
24582170|NCT00868465|Piperaquine|piperaquine|mesh-list
24582171|NCT00868465|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24582231|NCT00868764|Autonomic Agents|autonomic agents|mesh-ancestor
24582232|NCT00868764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24582233|NCT00868764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582236|NCT00868764|Serotonin Agents|serotonin agents|mesh-ancestor
24582244|NCT00868829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24705246|NCT01483248|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24582245|NCT00868829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24582246|NCT00868829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582247|NCT00868829|Antifungal Agents|antifungal agents|mesh-ancestor
24582248|NCT00868829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24582249|NCT00868829|Immunologic Factors|immunologic factors|mesh-ancestor
24582250|NCT00868829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582251|NCT00868829|Trace Elements|trace elements|mesh-ancestor
24582374|NCT00869310|Aprepitant|aprepitant|mesh-list
24582435|NCT00869700|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24582452|NCT00869765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24582489|NCT00869973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582490|NCT00869973|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24582491|NCT00869973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24582492|NCT00869973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582493|NCT00870025|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24582655|NCT00870987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582656|NCT00871039|Midazolam|midazolam|mesh-list
24582657|NCT00871039|Propofol|propofol|mesh-list
24582658|NCT00871039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24582659|NCT00871039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24582660|NCT00871039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582672|NCT00871052|Vitamin D|vitamin d|mesh-list
24582692|NCT00871156|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24582693|NCT00871156|Tafenoquine|tafenoquine|mesh-list
24582694|NCT00871156|Amebicides|amebicides|mesh-ancestor
24582695|NCT00871156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24582696|NCT00871156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24582697|NCT00871156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24582698|NCT00871156|Antimalarials|antimalarials|mesh-ancestor
24582699|NCT00871156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24582700|NCT00871156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24582701|NCT00871156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24582874|NCT00872274|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24582879|NCT00872274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582880|NCT00872365|Micronutrients|micronutrients|mesh-list
24582881|NCT00872365|Trace Elements|trace elements|mesh-list
24582882|NCT00872365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582883|NCT00872378|Exenatide|exenatide|mesh-list
24613595|NCT01019850|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24613596|NCT01019850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24582884|NCT00872378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24582885|NCT00872378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582886|NCT00872378|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24776982|NCT01860833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776984|NCT01860833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24776985|NCT01860833|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24805323|NCT02008968|Antimetabolites|antimetabolites|mesh-ancestor
24632956|NCT01126450|Antibodies|antibodies|mesh-list
24632957|NCT01126450|Immunoglobulins|immunoglobulins|mesh-list
24632958|NCT01126450|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24632959|NCT01126450|Immunologic Factors|immunologic factors|mesh-ancestor
24632960|NCT01126450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776989|NCT01860911|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
24776990|NCT01860911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776991|NCT01860911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626221|NCT01086046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24583183|NCT00873626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24583184|NCT00873626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24583185|NCT00873626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24583186|NCT00873626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24583187|NCT00873626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24583188|NCT00873626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583189|NCT00873626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583193|NCT00873626|Renal Agents|renal agents|mesh-ancestor
24583476|NCT00874679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583477|NCT00874679|Urological Agents|urological agents|mesh-ancestor
24583478|NCT00874744|Triamcinolone|triamcinolone|mesh-list
24583479|NCT00874744|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24583480|NCT00874744|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24583481|NCT00874744|Bevacizumab|bevacizumab|mesh-list
24583482|NCT00874744|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24583483|NCT00874744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24583484|NCT00874744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583485|NCT00874744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24583486|NCT00874744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24583487|NCT00874744|Growth Substances|growth substances|mesh-ancestor
24583704|NCT00876434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24583705|NCT00876434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583706|NCT00876434|Antifungal Agents|antifungal agents|mesh-ancestor
24583707|NCT00876434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24583708|NCT00876434|Immunologic Factors|immunologic factors|mesh-ancestor
24583710|NCT00876577|Moxifloxacin|moxifloxacin|mesh-list
24583750|NCT00876772|Autonomic Agents|autonomic agents|mesh-ancestor
24583751|NCT00876772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24583752|NCT00876772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583753|NCT00876772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24583948|NCT00877734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583949|NCT00877734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24583950|NCT00877734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24583951|NCT00877734|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24583952|NCT00877734|GABA Agonists|gaba agonists|mesh-ancestor
24584059|NCT00878345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24584060|NCT00878345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24584061|NCT00878345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24442967|NCT00293371|Prednisone|prednisone|mesh-list
24584062|NCT00878345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24584063|NCT00878345|Adrenergic Agents|adrenergic agents|mesh-ancestor
24584064|NCT00878345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24951345|NCT03905317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951346|NCT03905317|Growth Inhibitors|growth inhibitors|mesh-ancestor
24951347|NCT03905486|Pregabalin|pregabalin|mesh-list
24951348|NCT03905486|Analgesics|analgesics|mesh-ancestor
24951349|NCT03905486|Sensory System Agents|sensory system agents|mesh-ancestor
24951350|NCT03905486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24805389|NCT02009280|Propofol|propofol|mesh-list
24584381|NCT00880243|Mitoxantrone|mitoxantrone|mesh-list
24584382|NCT00880243|Daunorubicin|daunorubicin|mesh-list
24584383|NCT00880243|Molgramostim|molgramostim|mesh-list
24584384|NCT00880243|Sargramostim|sargramostim|mesh-list
24584385|NCT00880243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24584386|NCT00880243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584387|NCT00880243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24584388|NCT00880243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24584389|NCT00880243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584390|NCT00880243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951522|NCT03903718|MEDI8852|medi8852|mesh-list
24584394|NCT00880243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24584431|NCT00880373|Ibuprofen|ibuprofen|mesh-list
24584432|NCT00880373|Morphine|morphine|mesh-list
24584434|NCT00880373|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24584435|NCT00880373|Narcotics|narcotics|mesh-ancestor
24584437|NCT00880373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584649|NCT00881179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24584650|NCT00881179|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24584651|NCT00881179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584655|NCT00881218|Regadenoson|regadenoson|mesh-list
24584860|NCT00881816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24584861|NCT00881816|Antimetabolites|antimetabolites|mesh-ancestor
24584863|NCT00881855|Cephalosporins|cephalosporins|mesh-list
24584924|NCT00882232|Protective Agents|protective agents|mesh-ancestor
24584926|NCT00882323|Fludarabine|fludarabine|mesh-list
24584927|NCT00882323|Thymoglobulin|thymoglobulin|mesh-list
24584928|NCT00882323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24584929|NCT00882323|Immunologic Factors|immunologic factors|mesh-ancestor
24584930|NCT00882323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584931|NCT00882323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24585011|NCT00882739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24585012|NCT00882739|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24585013|NCT00882739|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24951429|NCT03904745|Hormone Antagonists|hormone antagonists|mesh-ancestor
24805426|NCT02009436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585104|NCT00883298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24585105|NCT00883298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24585106|NCT00883298|Growth Substances|growth substances|mesh-ancestor
24585107|NCT00883298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585108|NCT00883298|Growth Inhibitors|growth inhibitors|mesh-ancestor
24585109|NCT00883298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24585110|NCT00883298|Alkylating Agents|alkylating agents|mesh-ancestor
24585111|NCT00883298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585112|NCT00883506|Lisinopril|lisinopril|mesh-list
24585113|NCT00883506|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24585114|NCT00883506|Protease Inhibitors|protease inhibitors|mesh-ancestor
24585115|NCT00883506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24585118|NCT00883506|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24585138|NCT00883623|Growth Substances|growth substances|mesh-ancestor
24951465|NCT03904368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24966525|NCT03767296|Autonomic Agents|autonomic agents|mesh-ancestor
24966526|NCT03767296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24966527|NCT03767296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966543|NCT03767218|Hormones|hormones|mesh-ancestor
24585336|NCT00884884|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24585337|NCT00884884|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24585338|NCT00884884|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24585339|NCT00884884|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24585358|NCT00885274|Antacids|antacids|mesh-ancestor
24951466|NCT03904368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951468|NCT03903952|Hydroxocobalamin|hydroxocobalamin|mesh-list
24951469|NCT03903952|Vitamins|vitamins|mesh-ancestor
24951470|NCT03903952|Micronutrients|micronutrients|mesh-ancestor
24471675|NCT00396513|Metformin|metformin|mesh-list
24585529|NCT00885924|Hemostatics|hemostatics|mesh-ancestor
24585530|NCT00885924|Coagulants|coagulants|mesh-ancestor
24585531|NCT00885924|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24585532|NCT00885924|Natriuretic Agents|natriuretic agents|mesh-ancestor
24585533|NCT00885924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585534|NCT00886002|Fentanyl|fentanyl|mesh-list
24585535|NCT00886002|Buprenorphine|buprenorphine|mesh-list
24585536|NCT00886002|Naloxone|naloxone|mesh-list
24585537|NCT00886002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24585538|NCT00886002|Narcotics|narcotics|mesh-ancestor
24585691|NCT00886717|Mitosis Modulators|mitosis modulators|mesh-ancestor
24633642|NCT01130506|Decitabine|decitabine|mesh-list
24585695|NCT00886860|Abortifacient Agents|abortifacient agents|mesh-ancestor
24585696|NCT00886860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24585697|NCT00886860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585698|NCT00886860|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24585699|NCT00886860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24585701|NCT00886873|Mifepristone|mifepristone|mesh-list
24585702|NCT00886873|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24585703|NCT00886873|Abortifacient Agents|abortifacient agents|mesh-ancestor
24951471|NCT03903952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951472|NCT03903952|Vitamin B Complex|vitamin b complex|mesh-ancestor
24951473|NCT03903952|Hematinics|hematinics|mesh-ancestor
24951474|NCT03904225|Tegafur|tegafur|mesh-list
24471803|NCT00396786|Enoxaparin|enoxaparin|mesh-list
25697707|NCT02081638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25697708|NCT02081638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697709|NCT02081638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25697710|NCT02081638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25697711|NCT02081638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24585704|NCT00886873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24585755|NCT00887003|Autonomic Agents|autonomic agents|mesh-ancestor
24585756|NCT00887003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24448499|NCT00312000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24585904|NCT00887770|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24585905|NCT00887770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24585906|NCT00887770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24585907|NCT00887770|Antiviral Agents|antiviral agents|mesh-ancestor
24585908|NCT00888043|Bevacizumab|bevacizumab|mesh-list
24585909|NCT00888043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24585910|NCT00888043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585911|NCT00888043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24585912|NCT00888043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24585913|NCT00888043|Growth Substances|growth substances|mesh-ancestor
24585914|NCT00888043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585915|NCT00888043|Growth Inhibitors|growth inhibitors|mesh-ancestor
24585916|NCT00888082|Goserelin|goserelin|mesh-list
24585917|NCT00888082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24633786|NCT01131195|Bevacizumab|bevacizumab|mesh-list
24633787|NCT01131195|Capecitabine|capecitabine|mesh-list
24633788|NCT01131195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24633790|NCT01131195|Tubulin Modulators|tubulin modulators|mesh-ancestor
24585990|NCT00888784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585991|NCT00888784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24585992|NCT00888784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24585993|NCT00888784|Vasodilator Agents|vasodilator agents|mesh-ancestor
24585994|NCT00888797|Etodolac|etodolac|mesh-list
24585995|NCT00888797|Propranolol|propranolol|mesh-list
24585996|NCT00888797|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24633803|NCT01131195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24633804|NCT01131195|Growth Substances|growth substances|mesh-ancestor
24633805|NCT01131195|Growth Inhibitors|growth inhibitors|mesh-ancestor
24585997|NCT00888797|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24585998|NCT00888797|Adrenergic Agents|adrenergic agents|mesh-ancestor
24585999|NCT00888797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24586000|NCT00888797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586001|NCT00888797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586002|NCT00888797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24586003|NCT00888797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24586004|NCT00888797|Vasodilator Agents|vasodilator agents|mesh-ancestor
24586005|NCT00888797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24586006|NCT00888797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24586007|NCT00888797|Analgesics|analgesics|mesh-ancestor
24586036|NCT00888901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24586037|NCT00888901|Prednisolone|prednisolone|mesh-list
24586038|NCT00888901|Prednisolone acetate|prednisolone acetate|mesh-list
24586039|NCT00888901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24586040|NCT00888901|Prednisolone phosphate|prednisolone phosphate|mesh-list
24586041|NCT00888901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24586042|NCT00888901|Antiemetics|antiemetics|mesh-ancestor
24586043|NCT00888901|Autonomic Agents|autonomic agents|mesh-ancestor
24586044|NCT00888901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24586045|NCT00888901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586046|NCT00888901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24586110|NCT00889213|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24586111|NCT00889213|Hemostatics|hemostatics|mesh-ancestor
24586112|NCT00889213|Coagulants|coagulants|mesh-ancestor
24586118|NCT00889343|Antimetabolites|antimetabolites|mesh-ancestor
24586147|NCT00889356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24586148|NCT00889356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24586149|NCT00889356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25697712|NCT02081638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25697713|NCT02081638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697714|NCT02081638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25697715|NCT02081638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25697716|NCT02081638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697717|NCT02081638|Antipyretics|antipyretics|mesh-ancestor
25697718|NCT02081638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25697719|NCT02081638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24586150|NCT00889356|Hormone Antagonists|hormone antagonists|mesh-ancestor
25697720|NCT02081638|Antimetabolites|antimetabolites|mesh-ancestor
24981014|NCT04551144|Testosterone undecanoate|testosterone undecanoate|mesh-list
24981015|NCT04551144|Testosterone enanthate|testosterone enanthate|mesh-list
24981016|NCT04551144|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24981018|NCT04551144|Hormones|hormones|mesh-ancestor
24981019|NCT04551144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24981020|NCT04551144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981021|NCT04551144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24586194|NCT00889525|Dopamine Agents|dopamine agents|mesh-ancestor
24586195|NCT00889525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24586196|NCT00889525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586197|NCT00889525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705765|NCT01486706|Analgesics|analgesics|mesh-ancestor
24705766|NCT01486706|Sensory System Agents|sensory system agents|mesh-ancestor
24705767|NCT01486706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24705768|NCT01486706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586198|NCT00889590|Zoledronic Acid|zoledronic acid|mesh-list
24446962|NCT00306748|Linaclotide|linaclotide|mesh-list
24586487|NCT00890942|Sensory System Agents|sensory system agents|mesh-ancestor
24586488|NCT00890942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24586489|NCT00890955|Cyclophosphamide|cyclophosphamide|mesh-list
24586490|NCT00890955|Amrubicin|amrubicin|mesh-list
24586494|NCT00890955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24586495|NCT00890955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24586496|NCT00890955|Alkylating Agents|alkylating agents|mesh-ancestor
24586497|NCT00890955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586498|NCT00890955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586499|NCT00890955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24586500|NCT00891033|Bortezomib|bortezomib|mesh-list
24586501|NCT00891033|Panobinostat|panobinostat|mesh-list
24586502|NCT00891033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586503|NCT00891033|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24586504|NCT00891033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24586505|NCT00891033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951504|NCT03904056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24951505|NCT03904056|Growth Substances|growth substances|mesh-ancestor
24951506|NCT03904056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586576|NCT00891306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586577|NCT00891306|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24586578|NCT00891306|Antitubercular Agents|antitubercular agents|mesh-ancestor
24586637|NCT00891475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24586638|NCT00891475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586639|NCT00891540|Ropivacaine|ropivacaine|mesh-list
24586640|NCT00891540|Anesthetics, Local|anesthetics, local|mesh-ancestor
24586641|NCT00891540|Anesthetics|anesthetics|mesh-ancestor
24586653|NCT00891579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24586654|NCT00891605|Paclitaxel|paclitaxel|mesh-list
24586655|NCT00891605|Navitoclax|navitoclax|mesh-list
24586656|NCT00891605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24586657|NCT00891605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586658|NCT00891605|Tubulin Modulators|tubulin modulators|mesh-ancestor
24586659|NCT00891605|Antimitotic Agents|antimitotic agents|mesh-ancestor
24586676|NCT00891670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24586677|NCT00891670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25697721|NCT02081638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25697722|NCT02081638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25697723|NCT02081690|Macitentan|macitentan|mesh-list
25697724|NCT02081690|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25697725|NCT02081690|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25697726|NCT02081690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697727|NCT02081690|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25697728|NCT02081950|Enoxaparin|enoxaparin|mesh-list
25697729|NCT02081950|Enoxaparin sodium|enoxaparin sodium|mesh-list
25697730|NCT02081950|Anticoagulants|anticoagulants|mesh-ancestor
25697731|NCT02081950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25697732|NCT02081950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25697733|NCT02081950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981212|NCT04278846|Bupivacaine|bupivacaine|mesh-list
24981213|NCT04278846|Anesthetics, Local|anesthetics, local|mesh-ancestor
24981214|NCT04278846|Anesthetics|anesthetics|mesh-ancestor
24981215|NCT04278846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24981217|NCT04278846|Sensory System Agents|sensory system agents|mesh-ancestor
24784015|NCT01905371|Autonomic Agents|autonomic agents|mesh-ancestor
24784016|NCT01905371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24586678|NCT00891670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24586679|NCT00891670|Antipyretics|antipyretics|mesh-ancestor
24586680|NCT00891670|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24805512|NCT02009787|Vitamin D|vitamin d|mesh-list
24951509|NCT03903887|Antibodies|antibodies|mesh-list
24951515|NCT03904004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951516|NCT03904004|Cholinergic Agents|cholinergic agents|mesh-ancestor
24951517|NCT03904004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24951518|NCT03904004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951521|NCT03903718|Oseltamivir|oseltamivir|mesh-list
24951523|NCT03903718|Antiviral Agents|antiviral agents|mesh-ancestor
24951524|NCT03903718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25052026|NCT00352560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25052027|NCT00352560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24586681|NCT00891670|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24586682|NCT00891670|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24586683|NCT00891670|Purinergic Agents|purinergic agents|mesh-ancestor
24586684|NCT00891670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24586685|NCT00891670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24586686|NCT00891670|Autonomic Agents|autonomic agents|mesh-ancestor
24586687|NCT00891670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24586688|NCT00891670|Respiratory System Agents|respiratory system agents|mesh-ancestor
24586689|NCT00891670|Vasodilator Agents|vasodilator agents|mesh-ancestor
24586690|NCT00891670|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24586691|NCT00891670|Protective Agents|protective agents|mesh-ancestor
24586692|NCT00891670|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24586693|NCT00891670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24586694|NCT00891696|Sirolimus|sirolimus|mesh-list
24586695|NCT00891696|Nitroprusside|nitroprusside|mesh-list
24586696|NCT00891696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24586697|NCT00891696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24586698|NCT00891696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24586699|NCT00891696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586700|NCT00891696|Antifungal Agents|antifungal agents|mesh-ancestor
24586701|NCT00891696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24586702|NCT00891696|Immunologic Factors|immunologic factors|mesh-ancestor
24586703|NCT00891696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586704|NCT00891696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24586705|NCT00891696|Vasodilator Agents|vasodilator agents|mesh-ancestor
25052028|NCT00352560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951525|NCT03903718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951526|NCT03903718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951527|NCT03903783|Ceftriaxone|ceftriaxone|mesh-list
24951528|NCT03903783|Cefotaxime|cefotaxime|mesh-list
24951529|NCT03903783|Cefoxitin|cefoxitin|mesh-list
24951530|NCT03903783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24951531|NCT03903783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24951532|NCT03903419|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
24951533|NCT03903419|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24951534|NCT03903419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951535|NCT03903367|Fentanyl|fentanyl|mesh-list
24777162|NCT01862497|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24777163|NCT01862497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24777164|NCT01862497|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25697734|NCT02081963|Amikacin|amikacin|mesh-list
25697735|NCT02081963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25697736|NCT02081963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25697737|NCT02082210|Ramucirumab|ramucirumab|mesh-list
25697738|NCT02082210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25697739|NCT02082392|Citalopram|citalopram|mesh-list
25697740|NCT02082392|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25697741|NCT02082392|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25697742|NCT02082392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25697743|NCT02082392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106182|NCT04229095|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24981227|NCT04216017|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24981228|NCT04216017|Lidocaine|lidocaine|mesh-list
24981229|NCT04216017|Anesthetics, Local|anesthetics, local|mesh-ancestor
24981230|NCT04216017|Anesthetics|anesthetics|mesh-ancestor
24981231|NCT04216017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24777165|NCT01862497|Vasodilator Agents|vasodilator agents|mesh-ancestor
24600191|NCT02008292|Miotics|miotics|mesh-ancestor
24586727|NCT00891761|Antipruritics|antipruritics|mesh-ancestor
24586774|NCT00892125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24586783|NCT00892190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586784|NCT00892190|Keratolytic Agents|keratolytic agents|mesh-ancestor
24586785|NCT00892190|Dermatologic Agents|dermatologic agents|mesh-ancestor
24586786|NCT00892229|Misoprostol|misoprostol|mesh-list
24586787|NCT00892229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24586788|NCT00892229|Abortifacient Agents|abortifacient agents|mesh-ancestor
24586789|NCT00892229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24586790|NCT00892229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586791|NCT00892229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24586792|NCT00892229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24586793|NCT00892229|Oxytocics|oxytocics|mesh-ancestor
24586794|NCT00892242|Zoledronic Acid|zoledronic acid|mesh-list
24586795|NCT00892242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24586816|NCT00892320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24586817|NCT00892320|Serotonin Agents|serotonin agents|mesh-ancestor
24586818|NCT00892320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24586819|NCT00892320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634062|NCT01131949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24634063|NCT01131949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24634064|NCT01131949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634065|NCT01131949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24586929|NCT00892801|Immunologic Factors|immunologic factors|mesh-ancestor
24586930|NCT00892801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586932|NCT00892827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24586933|NCT00892827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586934|NCT00892827|Immunologic Factors|immunologic factors|mesh-ancestor
24586935|NCT00892827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586958|NCT00892918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24586959|NCT00892918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24586960|NCT00892918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24586975|NCT00892996|Hormones|hormones|mesh-ancestor
24587002|NCT00893048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587003|NCT00893048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24587004|NCT00893048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587005|NCT00893061|Tamoxifen|tamoxifen|mesh-list
24587006|NCT00893061|Letrozole|letrozole|mesh-list
24587007|NCT00893061|Anastrozole|anastrozole|mesh-list
24587008|NCT00893061|Exemestane|exemestane|mesh-list
24587009|NCT00893061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587045|NCT00893256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587046|NCT00893256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25697744|NCT02082392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25697745|NCT02082392|Serotonin Agents|serotonin agents|mesh-ancestor
25697746|NCT02082392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697747|NCT02082392|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25697748|NCT02082392|Antidepressive Agents|antidepressive agents|mesh-ancestor
25697749|NCT02082392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25697750|NCT02082522|Gemcitabine|gemcitabine|mesh-list
25697751|NCT02082522|Cisplatin|cisplatin|mesh-list
25697752|NCT02082522|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
25697753|NCT02082522|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
25697754|NCT02082522|Trioxsalen|trioxsalen|mesh-list
25697755|NCT02082522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25697756|NCT02082522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25697757|NCT02082522|Antimetabolites|antimetabolites|mesh-ancestor
25697758|NCT02082522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697759|NCT02082522|Antiviral Agents|antiviral agents|mesh-ancestor
24981353|NCT03648892|Dopamine Agents|dopamine agents|mesh-ancestor
24981354|NCT03648892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24634102|NCT01132040|GABA Modulators|gaba modulators|mesh-ancestor
24634103|NCT01132040|GABA Agents|gaba agents|mesh-ancestor
24634104|NCT01132040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24634105|NCT01132040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634107|NCT01132157|Propofol|propofol|mesh-list
24587213|NCT00893841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587214|NCT00893841|Antioxidants|antioxidants|mesh-ancestor
24568653|NCT00796887|Niacin|niacin|mesh-list
24626267|NCT01086332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24626268|NCT01086332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24626269|NCT01086345|Bevacizumab|bevacizumab|mesh-list
24626270|NCT01086345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24626271|NCT01086345|Irinotecan|irinotecan|mesh-list
24587310|NCT00894231|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24587311|NCT00894231|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24587312|NCT00894231|Histamine Antagonists|histamine antagonists|mesh-ancestor
24587313|NCT00894231|Histamine Agents|histamine agents|mesh-ancestor
24587314|NCT00894231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24587315|NCT00894231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587316|NCT00894231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587317|NCT00894283|Enoxaparin|enoxaparin|mesh-list
24587318|NCT00894283|PENTA|penta|mesh-list
24587319|NCT00894283|Fondaparinux|fondaparinux|mesh-list
24587320|NCT00894283|Anticoagulants|anticoagulants|mesh-ancestor
24587321|NCT00894283|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24587322|NCT00894283|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24587323|NCT00894283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587324|NCT00894283|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24587325|NCT00894283|Antithrombins|antithrombins|mesh-ancestor
24587326|NCT00894283|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24587327|NCT00894283|Protease Inhibitors|protease inhibitors|mesh-ancestor
24626286|NCT01086345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626287|NCT01086345|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24626289|NCT01086527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24626290|NCT01086527|Respiratory System Agents|respiratory system agents|mesh-ancestor
24626298|NCT01086553|Budesonide|budesonide|mesh-list
24587416|NCT00894751|Adrenergic Agents|adrenergic agents|mesh-ancestor
24587417|NCT00894751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24613679|NCT01020292|Nelfinavir|nelfinavir|mesh-list
24587418|NCT00894751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587419|NCT00894829|Heparin|heparin|mesh-list
24587420|NCT00894829|Calcium heparin|calcium heparin|mesh-list
25697760|NCT02082522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25697761|NCT02082522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697762|NCT02082522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25697763|NCT02082522|Immunologic Factors|immunologic factors|mesh-ancestor
25697764|NCT02082522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697765|NCT02082522|Dermatologic Agents|dermatologic agents|mesh-ancestor
25697766|NCT02082522|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25697767|NCT02082678|Ondansetron|ondansetron|mesh-list
25697768|NCT02082678|Antiemetics|antiemetics|mesh-ancestor
25697769|NCT02082678|Autonomic Agents|autonomic agents|mesh-ancestor
25697770|NCT02082678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25697771|NCT02082678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587421|NCT00894829|Anticoagulants|anticoagulants|mesh-ancestor
25697772|NCT02082678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24981456|NCT03284424|Pembrolizumab|pembrolizumab|mesh-list
24981457|NCT03284424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24981458|NCT03284424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587422|NCT00894829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24587423|NCT00894829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24587424|NCT00894829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587426|NCT00894920|Vitamin B Complex|vitamin b complex|mesh-ancestor
24587427|NCT00894920|Vitamins|vitamins|mesh-ancestor
24587428|NCT00894920|Micronutrients|micronutrients|mesh-ancestor
24587429|NCT00894920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587430|NCT00894946|Ethiodized Oil|ethiodized oil|mesh-list
24587431|NCT00894946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587432|NCT00894959|Heparin|heparin|mesh-list
24587508|NCT00895167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587509|NCT00895167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587510|NCT00895167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587512|NCT00895297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587513|NCT00895297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24587514|NCT00895297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587515|NCT00895297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587517|NCT00895323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24587518|NCT00895323|Antibodies, Bispecific|antibodies, bispecific|mesh-list
24587521|NCT00895362|Cetuximab|cetuximab|mesh-list
24587743|NCT00896571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24587744|NCT00896571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587745|NCT00896571|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24587746|NCT00896571|Estrogens|estrogens|mesh-ancestor
24587747|NCT00896571|Hormones|hormones|mesh-ancestor
24587748|NCT00896571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24587749|NCT00896714|Anesthetics|anesthetics|mesh-list
24587750|NCT00896714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24587751|NCT00896714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587778|NCT00896987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24587779|NCT00896987|Analgesics|analgesics|mesh-ancestor
24587780|NCT00896987|Sensory System Agents|sensory system agents|mesh-ancestor
24587781|NCT00896987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24587782|NCT00896987|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24587783|NCT00896987|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24587793|NCT00897026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587794|NCT00897026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24587795|NCT00897026|Immunologic Factors|immunologic factors|mesh-ancestor
24587796|NCT00897026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587797|NCT00897026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24587798|NCT00897026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24587799|NCT00897026|Alkylating Agents|alkylating agents|mesh-ancestor
24587800|NCT00897026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24587801|NCT00897026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24587851|NCT00897871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24951536|NCT03903367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24951538|NCT03903367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25697773|NCT02082678|Antipruritics|antipruritics|mesh-ancestor
25697774|NCT02082678|Dermatologic Agents|dermatologic agents|mesh-ancestor
25697775|NCT02082678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25697776|NCT02082678|Serotonin Agents|serotonin agents|mesh-ancestor
25697777|NCT02082678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25697778|NCT02082678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697779|NCT02082678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25697780|NCT02082678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25697781|NCT02082678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25697782|NCT02082678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25697783|NCT02082678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25697784|NCT02082769|Allopurinol|allopurinol|mesh-list
25697785|NCT02082769|Febuxostat|febuxostat|mesh-list
25697786|NCT02082769|Antimetabolites|antimetabolites|mesh-ancestor
25697787|NCT02082769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697788|NCT02082769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951539|NCT03903367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951540|NCT03903367|Analgesics|analgesics|mesh-ancestor
24951541|NCT03903367|Sensory System Agents|sensory system agents|mesh-ancestor
24951542|NCT03903367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24951543|NCT03903367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24951544|NCT03903367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24951545|NCT03903367|Anesthetics, General|anesthetics, general|mesh-ancestor
24951546|NCT03903367|Anesthetics|anesthetics|mesh-ancestor
24951547|NCT03903458|Nivolumab|nivolumab|mesh-list
24587979|NCT00899821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24951550|NCT03903458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24951551|NCT03903458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951552|NCT03903302|Valproic Acid|valproic acid|mesh-list
24951553|NCT03903302|Anticonvulsants|anticonvulsants|mesh-ancestor
24951554|NCT03903302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951555|NCT03903302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951556|NCT03903302|GABA Agents|gaba agents|mesh-ancestor
24951557|NCT03903302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24805589|NCT02010970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24805590|NCT02010970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805591|NCT02010970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24805592|NCT02010970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24588097|NCT00900887|Analgesics|analgesics|mesh-ancestor
24588098|NCT00900887|Sensory System Agents|sensory system agents|mesh-ancestor
24951558|NCT03903302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951559|NCT03903302|Antimanic Agents|antimanic agents|mesh-ancestor
24951560|NCT03903302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24951561|NCT03903302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24588099|NCT00900887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588100|NCT00900887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588101|NCT00900887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24588102|NCT00900887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24588104|NCT00900887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588105|NCT00900887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588106|NCT00900913|Ropivacaine|ropivacaine|mesh-list
24588107|NCT00900913|Anesthetics, Local|anesthetics, local|mesh-ancestor
24588108|NCT00900913|Anesthetics|anesthetics|mesh-ancestor
24588109|NCT00900913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24588111|NCT00900913|Sensory System Agents|sensory system agents|mesh-ancestor
24588211|NCT00901550|Abortifacient Agents|abortifacient agents|mesh-ancestor
24588212|NCT00901550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24588213|NCT00901550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588214|NCT00901550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24588216|NCT00901550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588217|NCT00901550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588261|NCT00901745|Adrenergic Agents|adrenergic agents|mesh-ancestor
24588262|NCT00901745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24588263|NCT00901745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588264|NCT00901745|Sympathomimetics|sympathomimetics|mesh-ancestor
24588265|NCT00901745|Autonomic Agents|autonomic agents|mesh-ancestor
24588266|NCT00901745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588267|NCT00901758|Nitroglycerin|nitroglycerin|mesh-list
24588268|NCT00901758|Vasodilator Agents|vasodilator agents|mesh-ancestor
24588269|NCT00901784|Topiramate|topiramate|mesh-list
24951562|NCT03903302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24951563|NCT03903653|Botulinum Toxins|botulinum toxins|mesh-list
24951564|NCT03903653|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24951565|NCT03903653|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24951566|NCT03903653|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25697789|NCT02082769|Gout Suppressants|gout suppressants|mesh-ancestor
24951567|NCT03903653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25406981|NCT03524820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951568|NCT03903653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951569|NCT03903653|Cholinergic Agents|cholinergic agents|mesh-ancestor
24951570|NCT03903653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24805602|NCT02010970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24588270|NCT00901784|Anticonvulsants|anticonvulsants|mesh-ancestor
24588271|NCT00901784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24588272|NCT00901784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588273|NCT00901823|Diazoxide|diazoxide|mesh-list
24588274|NCT00901823|Choline|choline|mesh-list
24588275|NCT00901823|Lipotropic Agents|lipotropic agents|mesh-ancestor
24588276|NCT00901823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24588289|NCT00901849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588290|NCT00901849|Antifungal Agents|antifungal agents|mesh-ancestor
24588291|NCT00901849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24588292|NCT00901849|Immunologic Factors|immunologic factors|mesh-ancestor
24588293|NCT00901849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588313|NCT00902031|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
24588315|NCT00902031|Senna Extract|senna extract|mesh-list
24588316|NCT00902031|Antidiarrheals|antidiarrheals|mesh-ancestor
24588326|NCT00902070|Rocuronium|rocuronium|mesh-list
24588346|NCT00902187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588347|NCT00902187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588348|NCT00902187|Urological Agents|urological agents|mesh-ancestor
24588350|NCT00902395|Ketamine|ketamine|mesh-list
24473089|NCT00401804|Hormones|hormones|mesh-ancestor
24473090|NCT00401804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24473091|NCT00401804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24473092|NCT00401804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473093|NCT00401804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24473094|NCT00401804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24473095|NCT00401804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24473096|NCT00401804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473114|NCT00402012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473116|NCT00402038|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24951582|NCT03903029|Antimetabolites|antimetabolites|mesh-ancestor
24951583|NCT03903029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951584|NCT03903029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24951585|NCT03903029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24951586|NCT03903029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951587|NCT03903133|Vitamin E|vitamin e|mesh-list
24951588|NCT03903133|Antioxidants|antioxidants|mesh-list
24951589|NCT03903133|Vitamins|vitamins|mesh-ancestor
24951590|NCT03903133|Micronutrients|micronutrients|mesh-ancestor
24589496|NCT00907894|Telbivudine|telbivudine|mesh-list
24951591|NCT03903133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805619|NCT02011126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805620|NCT02011126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24951593|NCT03903133|Protective Agents|protective agents|mesh-ancestor
24951595|NCT03902912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24951596|NCT03902912|Glucocorticoids|glucocorticoids|mesh-ancestor
25406982|NCT03524508|Fluorouracil|fluorouracil|mesh-list
25697790|NCT02082769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25697791|NCT02082769|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25697792|NCT02082769|Antioxidants|antioxidants|mesh-ancestor
25697793|NCT02082769|Protective Agents|protective agents|mesh-ancestor
25697794|NCT02082769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697795|NCT02082912|Cycloserine|cycloserine|mesh-list
25697796|NCT02082912|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25697797|NCT02082912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25697798|NCT02082912|Renal Agents|renal agents|mesh-ancestor
25697799|NCT02082912|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25697800|NCT02082912|Antitubercular Agents|antitubercular agents|mesh-ancestor
25697801|NCT02082912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24951598|NCT03902912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24951599|NCT03902912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951600|NCT03902912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24951601|NCT03902912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951602|NCT03902925|Lidocaine|lidocaine|mesh-list
24951603|NCT03902925|Ropivacaine|ropivacaine|mesh-list
24951604|NCT03902925|Anesthetics, Local|anesthetics, local|mesh-ancestor
24951605|NCT03902925|Anesthetics|anesthetics|mesh-ancestor
24951606|NCT03902925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24805633|NCT02011347|Analgesics|analgesics|mesh-ancestor
24805634|NCT02011347|Sensory System Agents|sensory system agents|mesh-ancestor
24805635|NCT02011347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24805639|NCT02011347|Anesthetics, General|anesthetics, general|mesh-ancestor
24588405|NCT00902512|Sildenafil Citrate|sildenafil citrate|mesh-list
24588406|NCT00902512|Vasodilator Agents|vasodilator agents|mesh-ancestor
24588407|NCT00902512|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24588408|NCT00902512|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24588409|NCT00902512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588410|NCT00902512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588411|NCT00902512|Urological Agents|urological agents|mesh-ancestor
24588412|NCT00902525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24634212|NCT01132443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24588413|NCT00902525|Immunologic Factors|immunologic factors|mesh-ancestor
24588431|NCT00902681|Urological Agents|urological agents|mesh-ancestor
24588432|NCT00902707|Phenylpropanolamine|phenylpropanolamine|mesh-list
24588433|NCT00902707|Guaifenesin|guaifenesin|mesh-list
24588434|NCT00902707|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
24588435|NCT00902707|Expectorants|expectorants|mesh-ancestor
24588436|NCT00902707|Respiratory System Agents|respiratory system agents|mesh-ancestor
24473240|NCT00402454|Rifampin|rifampin|mesh-list
24473241|NCT00402454|Isoniazid|isoniazid|mesh-list
24588454|NCT00902772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588480|NCT00902837|Narcotics|narcotics|mesh-ancestor
24588481|NCT00902837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24588482|NCT00902837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588483|NCT00902837|Analgesics|analgesics|mesh-ancestor
24588484|NCT00902837|Sensory System Agents|sensory system agents|mesh-ancestor
24588485|NCT00902837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24951670|NCT03902340|Sensory System Agents|sensory system agents|mesh-ancestor
24951671|NCT03902340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24951672|NCT03902340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951673|NCT03902249|Dexamethasone|dexamethasone|mesh-list
24951674|NCT03902249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24951675|NCT03902249|Antiemetics|antiemetics|mesh-ancestor
24951676|NCT03902249|Autonomic Agents|autonomic agents|mesh-ancestor
24951677|NCT03902249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24805681|NCT02011737|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24805682|NCT02011737|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24473369|NCT00402584|Sibutramine|sibutramine|mesh-list
24473370|NCT00402584|Antidepressive Agents|antidepressive agents|mesh-ancestor
24473371|NCT00402584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24473372|NCT00402584|Appetite Depressants|appetite depressants|mesh-ancestor
24473373|NCT00402584|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24588504|NCT00902915|Growth Inhibitors|growth inhibitors|mesh-ancestor
24588505|NCT00902941|Rasagiline|rasagiline|mesh-list
24588506|NCT00902941|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24588507|NCT00902941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588508|NCT00902941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588509|NCT00902941|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24588510|NCT00902941|Protective Agents|protective agents|mesh-ancestor
24634253|NCT01132599|Lipotropic Agents|lipotropic agents|mesh-ancestor
24634254|NCT01132599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24634261|NCT01132638|Pantoprazole|pantoprazole|mesh-list
24588512|NCT00902954|Letrozole|letrozole|mesh-list
24951684|NCT03902249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951686|NCT03901716|Midazolam|midazolam|mesh-list
24951687|NCT03901716|Sufentanil|sufentanil|mesh-list
24951688|NCT03901716|Remifentanil|remifentanil|mesh-list
24805683|NCT02011737|Adrenergic Agents|adrenergic agents|mesh-ancestor
24805684|NCT02011737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24589281|NCT00906451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24805685|NCT02011737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473493|NCT00403039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473494|NCT00403039|Growth Inhibitors|growth inhibitors|mesh-ancestor
24473499|NCT00403052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473507|NCT00403065|Glucocorticoids|glucocorticoids|mesh-ancestor
24473508|NCT00403065|Hormones|hormones|mesh-ancestor
24588564|NCT00903188|Prednisolone phosphate|prednisolone phosphate|mesh-list
24588565|NCT00903188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588567|NCT00903188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24588625|NCT00903656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588626|NCT00903656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588627|NCT00903734|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24588628|NCT00903734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588629|NCT00903734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24588630|NCT00903734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588631|NCT00903734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588632|NCT00903747|Moxifloxacin|moxifloxacin|mesh-list
24588633|NCT00903747|Prucalopride|prucalopride|mesh-list
24588634|NCT00903747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24588659|NCT00903825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600407|NCT00346164|Ifosfamide|ifosfamide|mesh-list
24588668|NCT00903838|Dopamine Agents|dopamine agents|mesh-ancestor
24588669|NCT00903838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24588670|NCT00903851|Lidocaine|lidocaine|mesh-list
24588671|NCT00903851|Anesthetics, Local|anesthetics, local|mesh-ancestor
24588672|NCT00903851|Anesthetics|anesthetics|mesh-ancestor
24588673|NCT00903851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25052037|NCT00345618|Biotin|biotin|mesh-list
24805715|NCT02011841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24805716|NCT02011841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588750|NCT00904176|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24588751|NCT00904176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588753|NCT00904176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588911|NCT00904644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24588942|NCT00904852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24588943|NCT00904852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588944|NCT00904852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25052058|NCT00344045|Sensory System Agents|sensory system agents|mesh-ancestor
25052059|NCT00344045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25052060|NCT00344045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052061|NCT00344045|Antipyretics|antipyretics|mesh-ancestor
25052062|NCT00343109|Sargramostim|sargramostim|mesh-list
25052063|NCT00343109|Vaccines|vaccines|mesh-list
25052064|NCT00343109|Immunologic Factors|immunologic factors|mesh-ancestor
25052078|NCT00337532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25406983|NCT03524508|Irinotecan|irinotecan|mesh-list
25697803|NCT02082912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697804|NCT02083107|Misoprostol|misoprostol|mesh-list
25697805|NCT02083107|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25697806|NCT02083107|Abortifacient Agents|abortifacient agents|mesh-ancestor
25697807|NCT02083107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25697808|NCT02083107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697809|NCT02083107|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25697810|NCT02083107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25697811|NCT02083107|Oxytocics|oxytocics|mesh-ancestor
25709406|NCT02266433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709407|NCT02266472|Metformin|metformin|mesh-list
25709408|NCT02266472|Empagliflozin|empagliflozin|mesh-list
25709409|NCT02266472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25709410|NCT02266472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697812|NCT02083185|Leuprolide|leuprolide|mesh-list
25697813|NCT02083185|Relugolix|relugolix|mesh-list
25697814|NCT02083185|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24706824|NCT01492556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706825|NCT01492608|Magnesium Sulfate|magnesium sulfate|mesh-list
24706826|NCT01492608|Analgesics|analgesics|mesh-ancestor
25052079|NCT00337454|Dasatinib|dasatinib|mesh-list
25052080|NCT00337454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24805725|NCT02011880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805726|NCT02011880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24805727|NCT02011880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24805728|NCT02011880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24805729|NCT02011906|Vitamins|vitamins|mesh-list
24805730|NCT02011906|Vitamin E|vitamin e|mesh-list
24805731|NCT02011906|Tocopherols|tocopherols|mesh-list
24805732|NCT02011906|Tocotrienols|tocotrienols|mesh-list
24589235|NCT00906139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24589236|NCT00906139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589237|NCT00906269|Sildenafil Citrate|sildenafil citrate|mesh-list
24589238|NCT00906269|Vasodilator Agents|vasodilator agents|mesh-ancestor
24589239|NCT00906269|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24589244|NCT00906295|Chrysarobin|chrysarobin|mesh-list
24589280|NCT00906451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589292|NCT00906529|Insulin Aspart|insulin aspart|mesh-list
24589497|NCT00907894|Antiviral Agents|antiviral agents|mesh-ancestor
24589498|NCT00907894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24589499|NCT00907894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24589500|NCT00907894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589502|NCT00907972|Vitamin D|vitamin d|mesh-list
24589538|NCT00908050|Cholinergic Agents|cholinergic agents|mesh-ancestor
24589539|NCT00908050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24589540|NCT00908050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589541|NCT00908050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24589542|NCT00908050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24589543|NCT00908089|Sulfasalazine|sulfasalazine|mesh-list
24589544|NCT00908089|Hydroxychloroquine|hydroxychloroquine|mesh-list
24589545|NCT00908089|Prednisolone|prednisolone|mesh-list
24589546|NCT00908089|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24589547|NCT00908089|Methylprednisolone|methylprednisolone|mesh-list
24589716|NCT00908713|Antiemetics|antiemetics|mesh-ancestor
24589717|NCT00908713|Autonomic Agents|autonomic agents|mesh-ancestor
24589735|NCT00908817|Chlorhexidine|chlorhexidine|mesh-list
24589736|NCT00908817|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24589737|NCT00908817|Triamcinolone|triamcinolone|mesh-list
24589738|NCT00908817|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24589752|NCT00908817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589753|NCT00908817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589754|NCT00908869|Interferons|interferons|mesh-list
24589777|NCT00908921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589778|NCT00908921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24589779|NCT00908921|Immunologic Factors|immunologic factors|mesh-ancestor
24589781|NCT00908986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24589782|NCT00908986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589783|NCT00908986|Immunologic Factors|immunologic factors|mesh-ancestor
24589784|NCT00908986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589785|NCT00908986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24966800|NCT03765021|Hemostatics|hemostatics|mesh-ancestor
24966801|NCT03765021|Coagulants|coagulants|mesh-ancestor
25052089|NCT00333502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951743|NCT03901690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951744|NCT03901690|Interferon Inducers|interferon inducers|mesh-ancestor
24951746|NCT03901378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24805767|NCT02012075|Metoprolol|metoprolol|mesh-list
24589888|NCT00909519|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25697815|NCT02083185|Fertility Agents|fertility agents|mesh-ancestor
25697816|NCT02083185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25697817|NCT02083185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697818|NCT02083185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25697819|NCT02083185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589889|NCT00909571|Tacrolimus|tacrolimus|mesh-list
24589892|NCT00909571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589893|NCT00909571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24589894|NCT00909571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589895|NCT00909571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589896|NCT00909688|BLI-489|bli-489|mesh-list
24589903|NCT00909831|Sirolimus|sirolimus|mesh-list
24634740|NCT01134848|Autonomic Agents|autonomic agents|mesh-ancestor
24589923|NCT00909883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24589924|NCT00909883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589925|NCT00909935|Dexmedetomidine|dexmedetomidine|mesh-list
24589926|NCT00909935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24589927|NCT00909935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24589928|NCT00909935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589929|NCT00909935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24589930|NCT00909935|Analgesics|analgesics|mesh-ancestor
24589931|NCT00909935|Sensory System Agents|sensory system agents|mesh-ancestor
24589932|NCT00909935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24589933|NCT00909935|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24589934|NCT00909935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24589935|NCT00909935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24589936|NCT00909935|Adrenergic Agents|adrenergic agents|mesh-ancestor
24589937|NCT00909935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24589938|NCT00909935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589939|NCT00909948|Fludarabine|fludarabine|mesh-list
24589972|NCT00910065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24589973|NCT00910065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24589975|NCT00910065|Sensory System Agents|sensory system agents|mesh-ancestor
24589976|NCT00910065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24589977|NCT00910065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589978|NCT00910065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24589979|NCT00910065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24589980|NCT00910065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24589981|NCT00910065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24589982|NCT00910065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591070|NCT00914888|Metronidazole|metronidazole|mesh-list
24634748|NCT01134861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24589984|NCT00910065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24589985|NCT00910065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589986|NCT00910065|Antipyretics|antipyretics|mesh-ancestor
24589987|NCT00910117|Nimotuzumab|nimotuzumab|mesh-list
24589988|NCT00910117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951747|NCT03901378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951749|NCT03901118|Etoposide|etoposide|mesh-list
24951750|NCT03901118|Chiauranib|chiauranib|mesh-list
24951751|NCT03901118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24951752|NCT03901118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951753|NCT03901118|Tubulin Modulators|tubulin modulators|mesh-ancestor
24951754|NCT03901118|Antimitotic Agents|antimitotic agents|mesh-ancestor
24951755|NCT03901118|Mitosis Modulators|mitosis modulators|mesh-ancestor
24951756|NCT03901118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805770|NCT02012075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24634762|NCT01134926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24634763|NCT01134926|Oxytocics|oxytocics|mesh-ancestor
24634764|NCT01134965|Digoxin|digoxin|mesh-list
24634765|NCT01134965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24634766|NCT01134965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24634767|NCT01134965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634768|NCT01134965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634769|NCT01134965|Protective Agents|protective agents|mesh-ancestor
24634770|NCT01134965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634771|NCT01134991|Minocycline|minocycline|mesh-list
24590028|NCT00910416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24590030|NCT00910416|Anesthetics|anesthetics|mesh-ancestor
24590031|NCT00910416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24590032|NCT00910416|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24590033|NCT00910416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24590034|NCT00910416|Narcotics|narcotics|mesh-ancestor
24590035|NCT00910416|Analgesics|analgesics|mesh-ancestor
24590036|NCT00910416|Sensory System Agents|sensory system agents|mesh-ancestor
24590037|NCT00910416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24590038|NCT00910416|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24590039|NCT00910416|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24590041|NCT00910416|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24590042|NCT00910416|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24590043|NCT00910416|Cholinergic Agents|cholinergic agents|mesh-ancestor
25106233|NCT04031729|Analgesics|analgesics|mesh-ancestor
25106234|NCT04031729|Sensory System Agents|sensory system agents|mesh-ancestor
25106235|NCT04031729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25106236|NCT04031729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106245|NCT04031729|Antipyretics|antipyretics|mesh-ancestor
24590044|NCT00910416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24951769|NCT03901170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24805780|NCT02012075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805781|NCT02012075|Antioxidants|antioxidants|mesh-ancestor
24805782|NCT02012075|Protective Agents|protective agents|mesh-ancestor
24805783|NCT02012075|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24805784|NCT02012075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24805785|NCT02012075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24805786|NCT02012075|Vasodilator Agents|vasodilator agents|mesh-ancestor
24805787|NCT02012075|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24805788|NCT02012075|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24590050|NCT00910442|Expectorants|expectorants|mesh-ancestor
24592783|NCT00925028|Anticoagulants|anticoagulants|mesh-ancestor
24590051|NCT00910442|Respiratory System Agents|respiratory system agents|mesh-ancestor
24590052|NCT00910442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24590053|NCT00910442|Antioxidants|antioxidants|mesh-ancestor
24590273|NCT00911573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590288|NCT00911651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24590289|NCT00911651|Adrenergic Agents|adrenergic agents|mesh-ancestor
24590290|NCT00911651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24590291|NCT00911651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590292|NCT00911651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24590293|NCT00911651|Cholinergic Agents|cholinergic agents|mesh-ancestor
24590294|NCT00911664|Vitamin D|vitamin d|mesh-list
24590295|NCT00911664|Ergocalciferols|ergocalciferols|mesh-list
24590312|NCT00911716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24590313|NCT00911716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24590314|NCT00911716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24590315|NCT00911716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24590336|NCT00912145|GABA Agents|gaba agents|mesh-ancestor
24590421|NCT00912457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590442|NCT00912548|Hormone Antagonists|hormone antagonists|mesh-ancestor
24590443|NCT00912548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24590444|NCT00912548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590445|NCT00912548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24590446|NCT00912548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24590447|NCT00912548|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24613799|NCT01020734|Antifungal Agents|antifungal agents|mesh-ancestor
24707170|NCT01494402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24590448|NCT00912548|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24590449|NCT00912548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24590450|NCT00912574|Molgramostim|molgramostim|mesh-list
24590451|NCT00912574|Sargramostim|sargramostim|mesh-list
24590458|NCT00912639|Paclitaxel|paclitaxel|mesh-list
24590459|NCT00912639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24590460|NCT00912639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24590461|NCT00912639|Tubulin Modulators|tubulin modulators|mesh-ancestor
24590462|NCT00912639|Antimitotic Agents|antimitotic agents|mesh-ancestor
24590573|NCT00913237|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24590574|NCT00913237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24590575|NCT00913237|Adrenergic Agents|adrenergic agents|mesh-ancestor
24590576|NCT00913237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24590577|NCT00913237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406984|NCT03524508|Antimetabolites|antimetabolites|mesh-ancestor
25697820|NCT02083185|Androgen Antagonists|androgen antagonists|mesh-ancestor
25697821|NCT02083185|Hormone Antagonists|hormone antagonists|mesh-ancestor
25697822|NCT02083185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25697823|NCT02083380|Piperaquine|piperaquine|mesh-list
25697824|NCT02083380|Artefenomel|artefenomel|mesh-list
25697825|NCT02083380|Antimalarials|antimalarials|mesh-ancestor
25697826|NCT02083380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25697827|NCT02083380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24795689|NCT01042379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24795690|NCT01042379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795691|NCT01042379|Tubulin Modulators|tubulin modulators|mesh-ancestor
24795692|NCT01042379|Antimitotic Agents|antimitotic agents|mesh-ancestor
24795693|NCT01042379|Mitosis Modulators|mitosis modulators|mesh-ancestor
24795694|NCT01042379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795695|NCT01042379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24795696|NCT01042379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795697|NCT01042379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24590683|NCT00913562|Antimetabolites|antimetabolites|mesh-ancestor
24590684|NCT00913562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590685|NCT00913562|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24590759|NCT00913809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590760|NCT00913809|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24590761|NCT00913809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24590786|NCT00913848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24590787|NCT00913848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24590788|NCT00913848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24590789|NCT00913861|Fentanyl|fentanyl|mesh-list
24590790|NCT00913861|Propofol|propofol|mesh-list
24590791|NCT00913861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24590809|NCT00913874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590811|NCT00913874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24590812|NCT00913874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24590813|NCT00913874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24590815|NCT00913887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24590816|NCT00913887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24590817|NCT00913887|Analgesics|analgesics|mesh-ancestor
24590818|NCT00913887|Sensory System Agents|sensory system agents|mesh-ancestor
24590898|NCT00914160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24590899|NCT00914160|Analgesics|analgesics|mesh-ancestor
24777481|NCT01864213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24777482|NCT01864252|Nitroglycerin|nitroglycerin|mesh-list
24777483|NCT01864252|Vasodilator Agents|vasodilator agents|mesh-ancestor
24590961|NCT00914498|Lidocaine|lidocaine|mesh-list
24590962|NCT00914498|Anesthetics, Local|anesthetics, local|mesh-ancestor
24590963|NCT00914498|Anesthetics|anesthetics|mesh-ancestor
24591065|NCT00914836|Hormones|hormones|mesh-ancestor
24591066|NCT00914836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24591067|NCT00914836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591068|NCT00914836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24591069|NCT00914836|Respiratory System Agents|respiratory system agents|mesh-ancestor
24591071|NCT00914888|Clarithromycin|clarithromycin|mesh-list
24707370|NCT01495338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24707372|NCT01495351|Bortezomib|bortezomib|mesh-list
25697828|NCT02083380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25697829|NCT02083406|Artefenomel|artefenomel|mesh-list
25697830|NCT02083406|Antimalarials|antimalarials|mesh-ancestor
25697831|NCT02083406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25697832|NCT02083406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25697833|NCT02083406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25697834|NCT02083653|Fluorouracil|fluorouracil|mesh-list
25697835|NCT02083653|Capecitabine|capecitabine|mesh-list
25697836|NCT02083653|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25697837|NCT02083653|Antimetabolites|antimetabolites|mesh-ancestor
25697838|NCT02083653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697839|NCT02083653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25697840|NCT02083653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25697841|NCT02083653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25697842|NCT02083653|Immunologic Factors|immunologic factors|mesh-ancestor
24981889|NCT01156220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981890|NCT01156220|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24981891|NCT01156220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24981892|NCT01156220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981893|NCT01081951|Paclitaxel|paclitaxel|mesh-list
24591072|NCT00914888|Ceftriaxone|ceftriaxone|mesh-list
24626317|NCT01086631|Rituximab|rituximab|mesh-list
24626318|NCT01086631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24626319|NCT01086631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626320|NCT01086631|Immunologic Factors|immunologic factors|mesh-ancestor
24626321|NCT01086631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626322|NCT01086631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24626323|NCT01086774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24626324|NCT01086774|Lubricant Eye Drops|lubricant eye drops|mesh-list
24626325|NCT01086774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24626326|NCT01086826|Cisplatin|cisplatin|mesh-list
24626327|NCT01086826|Docetaxel|docetaxel|mesh-list
24626328|NCT01086826|Fluorouracil|fluorouracil|mesh-list
24626329|NCT01086826|Cetuximab|cetuximab|mesh-list
24951797|NCT03900871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24951798|NCT03900871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24591193|NCT00915512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24591195|NCT00915512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24591196|NCT00915512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591200|NCT00915564|Simeprevir|simeprevir|mesh-list
24591218|NCT00915577|Interferon beta-1a|interferon beta-1a|mesh-list
24591219|NCT00915577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591220|NCT00915577|Antiviral Agents|antiviral agents|mesh-ancestor
24591221|NCT00915577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24591222|NCT00915577|Immunologic Factors|immunologic factors|mesh-ancestor
24591223|NCT00915577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591224|NCT00915577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24951799|NCT03900871|Analgesics|analgesics|mesh-ancestor
24951800|NCT03900871|Sensory System Agents|sensory system agents|mesh-ancestor
24951801|NCT03900871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24951802|NCT03900871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697843|NCT02083653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697844|NCT02083679|Gemcitabine|gemcitabine|mesh-list
25697845|NCT02083679|Paclitaxel|paclitaxel|mesh-list
25697846|NCT02083679|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25697847|NCT02083679|Cisplatin|cisplatin|mesh-list
25697848|NCT02083679|Carboplatin|carboplatin|mesh-list
25697849|NCT02083679|Pemetrexed|pemetrexed|mesh-list
25697850|NCT02083679|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25697851|NCT02083679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25697852|NCT02083679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25697853|NCT02083679|Tubulin Modulators|tubulin modulators|mesh-ancestor
25697854|NCT02083679|Antimitotic Agents|antimitotic agents|mesh-ancestor
25697855|NCT02083679|Mitosis Modulators|mitosis modulators|mesh-ancestor
25697856|NCT02083679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697857|NCT02083679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25697858|NCT02083679|Antimetabolites|antimetabolites|mesh-ancestor
25697859|NCT02083679|Antiviral Agents|antiviral agents|mesh-ancestor
25697860|NCT02083679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25697861|NCT02083679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951803|NCT03900871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24951804|NCT03900871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24951805|NCT03900871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24951806|NCT03900871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24805850|NCT02012309|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24591226|NCT00915616|Antioxidants|antioxidants|mesh-ancestor
24591227|NCT00915616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591228|NCT00915616|Protective Agents|protective agents|mesh-ancestor
24591269|NCT00915733|Autonomic Agents|autonomic agents|mesh-ancestor
24591270|NCT00915733|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24591271|NCT00915733|Respiratory System Agents|respiratory system agents|mesh-ancestor
24591332|NCT00915915|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24591333|NCT00915915|Contraceptive Agents|contraceptive agents|mesh-ancestor
24591334|NCT00915915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24591335|NCT00915915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591336|NCT00915915|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24591340|NCT00915915|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24707893|NCT01498796|Analgesics|analgesics|mesh-ancestor
24591486|NCT00916942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24591487|NCT00916942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591509|NCT00917059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24591511|NCT00917059|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24591512|NCT00917059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24591513|NCT00917059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591514|NCT00917163|Sirolimus|sirolimus|mesh-list
24591515|NCT00917163|Everolimus|everolimus|mesh-list
24591516|NCT00917163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591517|NCT00917163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24591524|NCT00917241|Dexamethasone|dexamethasone|mesh-list
24591717|NCT00918307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591727|NCT00918320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591728|NCT00918411|Ramosetron|ramosetron|mesh-list
24591729|NCT00918411|Antiemetics|antiemetics|mesh-ancestor
24591730|NCT00918411|Autonomic Agents|autonomic agents|mesh-ancestor
24591731|NCT00918411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24591732|NCT00918411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591737|NCT00918411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591738|NCT00918424|Oxcarbazepine|oxcarbazepine|mesh-list
24591739|NCT00918424|Anticonvulsants|anticonvulsants|mesh-ancestor
24591740|NCT00918424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24591741|NCT00918424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24591742|NCT00918424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24591743|NCT00918424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591744|NCT00918424|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24591745|NCT00918424|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24591746|NCT00918450|Navitoclax|navitoclax|mesh-list
24591747|NCT00918450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951864|NCT03900377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600637|NCT00959621|Sensory System Agents|sensory system agents|mesh-ancestor
24600638|NCT00959621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24591760|NCT00918528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24591761|NCT00918528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591762|NCT00918528|Alkylating Agents|alkylating agents|mesh-ancestor
24591763|NCT00918528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635221|NCT01137903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24591764|NCT00918528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24591765|NCT00918528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591766|NCT00918554|Methotrexate|methotrexate|mesh-list
24591767|NCT00918554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24591768|NCT00918554|Abortifacient Agents|abortifacient agents|mesh-ancestor
24674722|NCT04736394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591769|NCT00918554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24591770|NCT00918554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591817|NCT00919243|Hormones|hormones|mesh-ancestor
24591930|NCT00919607|Antidepressive Agents|antidepressive agents|mesh-ancestor
24591931|NCT00919607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24591932|NCT00919607|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24591933|NCT00919607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24591934|NCT00919607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24591935|NCT00919607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591936|NCT00919776|Cyclosporine|cyclosporine|mesh-list
24591937|NCT00919776|Prednisolone|prednisolone|mesh-list
24591938|NCT00919776|Cyclosporins|cyclosporins|mesh-list
24591939|NCT00919776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24777490|NCT01864551|Olanzapine|olanzapine|mesh-list
24951866|NCT03900026|Evolocumab|evolocumab|mesh-list
24951867|NCT03900026|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24951868|NCT03900026|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24951869|NCT03900026|Antimetabolites|antimetabolites|mesh-ancestor
24951870|NCT03900026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951871|NCT03900026|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24592054|NCT00920153|Melphalan|melphalan|mesh-list
24592055|NCT00920153|Vinorelbine|vinorelbine|mesh-list
24592056|NCT00920153|Ifosfamide|ifosfamide|mesh-list
24592083|NCT00920153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24592084|NCT00920153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24592085|NCT00920153|Tubulin Modulators|tubulin modulators|mesh-ancestor
24592086|NCT00920153|Antimitotic Agents|antimitotic agents|mesh-ancestor
24592102|NCT00920244|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24592134|NCT00920296|Cabotegravir|cabotegravir|mesh-list
24592135|NCT00920296|Etravirine|etravirine|mesh-list
24592136|NCT00920296|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24592137|NCT00920296|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24592138|NCT00920296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951879|NCT03899675|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24951880|NCT03899675|Purinergic Agents|purinergic agents|mesh-ancestor
24951881|NCT03899675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24951882|NCT03899805|Pembrolizumab|pembrolizumab|mesh-list
24951883|NCT03899805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24951884|NCT03899805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24592220|NCT00920868|Growth Inhibitors|growth inhibitors|mesh-ancestor
24592237|NCT00920998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592238|NCT00920998|Cholinergic Agents|cholinergic agents|mesh-ancestor
24592239|NCT00920998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24592240|NCT00920998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592241|NCT00920998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24592264|NCT00921102|Analgesics|analgesics|mesh-ancestor
24592265|NCT00921102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24592266|NCT00921102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24592267|NCT00921102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24592268|NCT00921102|Autonomic Agents|autonomic agents|mesh-ancestor
24592269|NCT00921102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24592270|NCT00921102|Respiratory System Agents|respiratory system agents|mesh-ancestor
24592397|NCT00921622|Ascorbic Acid|ascorbic acid|mesh-list
24592398|NCT00921622|Micronutrients|micronutrients|mesh-ancestor
24592399|NCT00921622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592400|NCT00921622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24592401|NCT00921622|Antioxidants|antioxidants|mesh-ancestor
24592402|NCT00921622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592403|NCT00921622|Protective Agents|protective agents|mesh-ancestor
24592404|NCT00921661|Aflibercept|aflibercept|mesh-list
24592405|NCT00921661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24592406|NCT00921661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24592407|NCT00921661|Growth Substances|growth substances|mesh-ancestor
24592408|NCT00921661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592632|NCT00923390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24592633|NCT00923390|Antiviral Agents|antiviral agents|mesh-ancestor
24592634|NCT00923390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24592635|NCT00923494|Ropivacaine|ropivacaine|mesh-list
24592636|NCT00923494|Anesthetics, Local|anesthetics, local|mesh-ancestor
24592637|NCT00923494|Anesthetics|anesthetics|mesh-ancestor
24592638|NCT00923494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24592639|NCT00923494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592640|NCT00923494|Sensory System Agents|sensory system agents|mesh-ancestor
24707598|NCT01496911|Hydroxyzine|hydroxyzine|mesh-list
24592641|NCT00923494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24592642|NCT00923533|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24592643|NCT00923533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24592679|NCT00923806|Aldesleukin|aldesleukin|mesh-list
24592680|NCT00923806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24592681|NCT00923806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24592682|NCT00923806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24592748|NCT00924586|Adrenergic Agents|adrenergic agents|mesh-ancestor
24592749|NCT00924586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24592750|NCT00924586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592751|NCT00924586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592752|NCT00924586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24592753|NCT00924742|Tazobactam|tazobactam|mesh-list
24592770|NCT00924963|Lidocaine|lidocaine|mesh-list
24592771|NCT00924963|Anesthetics, Local|anesthetics, local|mesh-ancestor
24592772|NCT00924963|Anesthetics|anesthetics|mesh-ancestor
24592773|NCT00924963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24592774|NCT00924963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592775|NCT00924963|Sensory System Agents|sensory system agents|mesh-ancestor
24592776|NCT00924963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24592777|NCT00924963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24592778|NCT00924963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24592779|NCT00924963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24592780|NCT00924963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24592781|NCT00924963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592782|NCT00925028|Warfarin|warfarin|mesh-list
24951924|NCT03899337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24805919|NCT02012920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24592857|NCT00925873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592858|NCT00925873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24592859|NCT00925873|Immunologic Factors|immunologic factors|mesh-ancestor
24592860|NCT00925873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592861|NCT00925873|Antiviral Agents|antiviral agents|mesh-ancestor
24592895|NCT00926055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592896|NCT00926055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24592897|NCT00926055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24592898|NCT00926055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592899|NCT00926107|Sirolimus|sirolimus|mesh-list
24592900|NCT00926107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24592996|NCT00926705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24592997|NCT00926705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24592998|NCT00926705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24592999|NCT00926705|Adrenergic Agents|adrenergic agents|mesh-ancestor
24593000|NCT00926705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24593001|NCT00926705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593002|NCT00926705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24593003|NCT00926705|Narcotics|narcotics|mesh-ancestor
24593004|NCT00926705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24593005|NCT00926705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24593006|NCT00926705|Anesthetics, General|anesthetics, general|mesh-ancestor
24593007|NCT00926705|Anesthetics|anesthetics|mesh-ancestor
24593008|NCT00926718|Remifentanil|remifentanil|mesh-list
24593009|NCT00926718|Rocuronium|rocuronium|mesh-list
24593024|NCT00926731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951929|NCT03899337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24951930|NCT03899337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24951931|NCT03899337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24593442|NCT00929058|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24593443|NCT00929058|Growth Substances|growth substances|mesh-ancestor
24593444|NCT00929058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593445|NCT00929058|Growth Inhibitors|growth inhibitors|mesh-ancestor
24593446|NCT00929279|Abciximab|abciximab|mesh-list
24593447|NCT00929279|Anticoagulants|anticoagulants|mesh-ancestor
24593448|NCT00929279|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24593449|NCT00929370|Glycine|glycine|mesh-list
24593450|NCT00929370|Glycine Agents|glycine agents|mesh-ancestor
24593451|NCT00929370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24593455|NCT00929591|Tamoxifen|tamoxifen|mesh-list
24593589|NCT00930189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24593615|NCT00930306|Anesthetics|anesthetics|mesh-ancestor
24593616|NCT00930306|GABA Modulators|gaba modulators|mesh-ancestor
24593617|NCT00930306|GABA Agents|gaba agents|mesh-ancestor
24593618|NCT00930306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24593619|NCT00930306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593620|NCT00930306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24593621|NCT00930306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24593622|NCT00930306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24593623|NCT00930306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593624|NCT00930306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24593625|NCT00930306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24593626|NCT00930306|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24593627|NCT00930306|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24593628|NCT00930306|Purinergic Agents|purinergic agents|mesh-ancestor
25697862|NCT02083679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25697863|NCT02083679|Immunologic Factors|immunologic factors|mesh-ancestor
25697864|NCT02083679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697865|NCT02083679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25697866|NCT02083679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25697867|NCT02083783|Amphetamine|amphetamine|mesh-list
25697868|NCT02083783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25697869|NCT02083783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697870|NCT02083783|Sympathomimetics|sympathomimetics|mesh-ancestor
24593629|NCT00930306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24593630|NCT00930332|Methadone|methadone|mesh-list
24593631|NCT00930332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24593632|NCT00930332|Narcotics|narcotics|mesh-ancestor
24593633|NCT00930332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24593634|NCT00930332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593635|NCT00930332|Analgesics|analgesics|mesh-ancestor
24593636|NCT00930332|Sensory System Agents|sensory system agents|mesh-ancestor
24593637|NCT00930332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24593729|NCT00930722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593730|NCT00930722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593731|NCT00930722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24593733|NCT00930839|Niacin|niacin|mesh-list
24593734|NCT00930839|Nicotinic Acids|nicotinic acids|mesh-list
24593735|NCT00930839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24593736|NCT00930839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24593737|NCT00930839|Analgesics|analgesics|mesh-ancestor
24593738|NCT00930839|Sensory System Agents|sensory system agents|mesh-ancestor
24593739|NCT00930839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24593740|NCT00930839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593763|NCT00930865|Diuretics|diuretics|mesh-ancestor
24593764|NCT00930865|Natriuretic Agents|natriuretic agents|mesh-ancestor
24593765|NCT00930865|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24593766|NCT00930865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24593767|NCT00930891|Bevacizumab|bevacizumab|mesh-list
24635732|NCT01140984|Antiemetics|antiemetics|mesh-ancestor
24635733|NCT01140984|Autonomic Agents|autonomic agents|mesh-ancestor
24635734|NCT01140984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24593992|NCT00931827|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24593993|NCT00931840|Irinotecan|irinotecan|mesh-list
24593994|NCT00931840|Cetuximab|cetuximab|mesh-list
24593995|NCT00931840|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24593996|NCT00931840|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24593997|NCT00931840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593999|NCT00931840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24594029|NCT00931957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24594030|NCT00931957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24594031|NCT00931957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24594032|NCT00931957|Glucocorticoids|glucocorticoids|mesh-ancestor
24594033|NCT00931957|Hormones|hormones|mesh-ancestor
24594034|NCT00931957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24594035|NCT00931957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24594118|NCT00932685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24594119|NCT00932685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594120|NCT00932685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24594121|NCT00932685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24594122|NCT00932685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24594123|NCT00932685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24594124|NCT00932685|Anesthetics, General|anesthetics, general|mesh-ancestor
24594125|NCT00932685|Anesthetics|anesthetics|mesh-ancestor
24594126|NCT00932685|GABA Modulators|gaba modulators|mesh-ancestor
24594168|NCT00932971|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24594183|NCT00933023|Hydrocortisone|hydrocortisone|mesh-list
24594207|NCT00933179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24594208|NCT00933179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594209|NCT00933179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24594210|NCT00933179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24594275|NCT00933309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24594276|NCT00933309|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24594277|NCT00933309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24594278|NCT00933309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594279|NCT00933309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594280|NCT00933309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24594370|NCT00933582|Analgesics|analgesics|mesh-ancestor
24594371|NCT00933582|Sensory System Agents|sensory system agents|mesh-ancestor
24594372|NCT00933582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25697871|NCT02083783|Autonomic Agents|autonomic agents|mesh-ancestor
24594373|NCT00933582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697872|NCT02083783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24594374|NCT00933582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24594376|NCT00933582|Gout Suppressants|gout suppressants|mesh-ancestor
24594377|NCT00933582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24594378|NCT00933582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594379|NCT00933582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594380|NCT00933634|Propafenone|propafenone|mesh-list
24594381|NCT00933634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24594386|NCT00933777|Everolimus|everolimus|mesh-list
24594422|NCT00933816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594423|NCT00933894|Citalopram|citalopram|mesh-list
24594424|NCT00933894|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24594425|NCT00933894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24594426|NCT00933894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24594427|NCT00933894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594428|NCT00933894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24594433|NCT00933894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24594434|NCT00933985|Doxorubicin|doxorubicin|mesh-list
24594435|NCT00933985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24594436|NCT00933985|Dexrazoxane|dexrazoxane|mesh-list
24594437|NCT00933985|Vincristine|vincristine|mesh-list
24594483|NCT00934154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24594484|NCT00934154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24594485|NCT00934154|Leprostatic Agents|leprostatic agents|mesh-ancestor
24594539|NCT00934323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24594540|NCT00934323|Immunologic Factors|immunologic factors|mesh-ancestor
24594542|NCT00934414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24594543|NCT00934414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594545|NCT00934427|Vasodilator Agents|vasodilator agents|mesh-ancestor
24967049|NCT03763123|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24967050|NCT03763123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24951956|NCT03899571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951957|NCT03899571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657204|NCT01266187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24708293|NCT01500915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708294|NCT01500928|Insulin|insulin|mesh-list
25052090|NCT00333502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052091|NCT00333216|Hydrocortisone|hydrocortisone|mesh-list
24805981|NCT02013115|Glucocorticoids|glucocorticoids|mesh-ancestor
24805982|NCT02013115|Hormones|hormones|mesh-ancestor
24805983|NCT02013115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24805984|NCT02013154|Paclitaxel|paclitaxel|mesh-list
24805985|NCT02013154|Pembrolizumab|pembrolizumab|mesh-list
24594717|NCT00935298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052092|NCT00333216|Anecortave|anecortave|mesh-list
25052093|NCT00333216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25052094|NCT00333216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25052095|NCT00333216|Growth Substances|growth substances|mesh-ancestor
25052096|NCT00333216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052097|NCT00333216|Growth Inhibitors|growth inhibitors|mesh-ancestor
25052098|NCT00333216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052099|NCT00333216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25052100|NCT00332956|Vaccines|vaccines|mesh-list
25052101|NCT00332956|Immunologic Factors|immunologic factors|mesh-ancestor
25052102|NCT00332956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052103|NCT00332748|Taxane|taxane|mesh-list
25052104|NCT00332748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052105|NCT00332657|Hydrocortisone|hydrocortisone|mesh-list
24805989|NCT02013154|Antimitotic Agents|antimitotic agents|mesh-ancestor
24600737|NCT00960310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24805990|NCT02013154|Mitosis Modulators|mitosis modulators|mesh-ancestor
24805991|NCT02013154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805994|NCT02013219|Atezolizumab|atezolizumab|mesh-list
25052111|NCT00332657|Growth Inhibitors|growth inhibitors|mesh-ancestor
24594845|NCT00935675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24594846|NCT00935675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24594847|NCT00935675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594848|NCT00935675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24594849|NCT00935675|Serotonin Agents|serotonin agents|mesh-ancestor
25697873|NCT02083783|Dopamine Agents|dopamine agents|mesh-ancestor
24594850|NCT00935675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594851|NCT00935675|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24594852|NCT00935675|Antidepressive Agents|antidepressive agents|mesh-ancestor
24594853|NCT00935675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24594854|NCT00935805|Insulin|insulin|mesh-list
24594855|NCT00935805|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24594857|NCT00935805|Insulin, Isophane|insulin, isophane|mesh-list
24594858|NCT00935805|Isophane Insulin, Human|isophane insulin, human|mesh-list
24594859|NCT00935805|Isophane insulin, beef|isophane insulin, beef|mesh-list
24594860|NCT00935805|Glyburide|glyburide|mesh-list
24594861|NCT00935805|Propranolol|propranolol|mesh-list
24594862|NCT00935805|Amlodipine|amlodipine|mesh-list
24594863|NCT00935805|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24594864|NCT00935805|Captopril|captopril|mesh-list
24594865|NCT00935805|Diuretics|diuretics|mesh-list
24594866|NCT00935805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24594867|NCT00935805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594967|NCT00936234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594968|NCT00936234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594969|NCT00936247|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24594970|NCT00936260|Alendronate|alendronate|mesh-list
24594971|NCT00936260|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24594972|NCT00936260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594973|NCT00936390|Leuprolide|leuprolide|mesh-list
24594974|NCT00936390|Goserelin|goserelin|mesh-list
25052113|NCT00332657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24951964|NCT03899597|Oxytocics|oxytocics|mesh-ancestor
24951965|NCT03899597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24951966|NCT03899597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951967|NCT03899324|Bumetanide|bumetanide|mesh-list
24951968|NCT03899324|Diuretics|diuretics|mesh-ancestor
24595140|NCT00936923|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24595141|NCT00936923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24595142|NCT00936923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595143|NCT00936962|Vaccines|vaccines|mesh-list
24595144|NCT00936962|Immunologic Factors|immunologic factors|mesh-ancestor
24595145|NCT00936962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595146|NCT00936988|Cinacalcet|cinacalcet|mesh-list
24595184|NCT00937144|Sildenafil Citrate|sildenafil citrate|mesh-list
24595203|NCT00937261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24595204|NCT00937261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24595205|NCT00937261|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24595206|NCT00937261|Dopamine Agents|dopamine agents|mesh-ancestor
24595207|NCT00937261|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24595208|NCT00937261|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24595210|NCT00937300|Cyclophosphamide|cyclophosphamide|mesh-list
24595211|NCT00937300|Fludarabine|fludarabine|mesh-list
24595221|NCT00937300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24595258|NCT00937625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24595259|NCT00937625|Alkylating Agents|alkylating agents|mesh-ancestor
24595260|NCT00937625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595379|NCT00938262|Leprostatic Agents|leprostatic agents|mesh-ancestor
24595380|NCT00938262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24595381|NCT00938262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595382|NCT00938262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595383|NCT00938262|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24595384|NCT00938262|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24595385|NCT00938262|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24595386|NCT00938262|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24595387|NCT00938262|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24595388|NCT00938262|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25697874|NCT02083783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25697875|NCT02083783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697876|NCT02083783|Adrenergic Agents|adrenergic agents|mesh-ancestor
25697877|NCT02083783|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25697878|NCT02083783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24595389|NCT00938262|Antifungal Agents|antifungal agents|mesh-ancestor
24595426|NCT00938522|Cilostazol|cilostazol|mesh-list
24595427|NCT00938522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24595428|NCT00938522|Autonomic Agents|autonomic agents|mesh-ancestor
24595429|NCT00938522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24595430|NCT00938522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595431|NCT00938522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24595432|NCT00938522|Respiratory System Agents|respiratory system agents|mesh-ancestor
24595433|NCT00938522|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24595631|NCT00939848|Antiviral Agents|antiviral agents|mesh-ancestor
24595699|NCT00940238|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24595700|NCT00940238|Cholinergic Agents|cholinergic agents|mesh-ancestor
24595747|NCT00940498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595748|NCT00940524|Cytarabine|cytarabine|mesh-list
24595749|NCT00940524|Cyclophosphamide|cyclophosphamide|mesh-list
24595750|NCT00940524|Methotrexate|methotrexate|mesh-list
24595751|NCT00940524|Etoposide|etoposide|mesh-list
24595752|NCT00940524|Dasatinib|dasatinib|mesh-list
24595753|NCT00940524|Asparaginase|asparaginase|mesh-list
24595754|NCT00940524|Mitoxantrone|mitoxantrone|mesh-list
24595755|NCT00940524|Pegaspargase|pegaspargase|mesh-list
24595756|NCT00940524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24595757|NCT00940524|Immunologic Factors|immunologic factors|mesh-ancestor
24595758|NCT00940524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595760|NCT00940524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24595761|NCT00940524|Alkylating Agents|alkylating agents|mesh-ancestor
24595978|NCT00941096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24595979|NCT00941096|Adrenergic Agents|adrenergic agents|mesh-ancestor
24595980|NCT00941096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24595981|NCT00941096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595982|NCT00941096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595983|NCT00941096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24595984|NCT00941096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24595985|NCT00941109|Decitabine|decitabine|mesh-list
24595986|NCT00941109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24595987|NCT00941109|Antimetabolites|antimetabolites|mesh-ancestor
24595988|NCT00941109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595989|NCT00941109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24595991|NCT00941135|Docetaxel|docetaxel|mesh-list
24596023|NCT00941174|Vitamins|vitamins|mesh-ancestor
24596024|NCT00941174|Micronutrients|micronutrients|mesh-ancestor
24596098|NCT00941499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24596099|NCT00941499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24596100|NCT00941499|Antidotes|antidotes|mesh-ancestor
24596101|NCT00941499|Protective Agents|protective agents|mesh-ancestor
24596102|NCT00941499|Vitamin B Complex|vitamin b complex|mesh-ancestor
24596103|NCT00941499|Vitamins|vitamins|mesh-ancestor
24596104|NCT00941499|Micronutrients|micronutrients|mesh-ancestor
24596105|NCT00941525|Latanoprost|latanoprost|mesh-list
24596106|NCT00941525|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24596107|NCT00941525|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24596108|NCT00941616|Factor VIII|factor viii|mesh-list
24596109|NCT00941616|Coagulants|coagulants|mesh-ancestor
24596110|NCT00941785|Amodiaquine|amodiaquine|mesh-list
24596111|NCT00941785|Antimalarials|antimalarials|mesh-ancestor
24596112|NCT00941785|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24596113|NCT00941785|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24596180|NCT00942201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596181|NCT00942214|Natalizumab|natalizumab|mesh-list
24596182|NCT00942214|Immunologic Factors|immunologic factors|mesh-ancestor
24952006|NCT03899077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24952007|NCT03899077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24952008|NCT03899077|Fertility Agents|fertility agents|mesh-ancestor
24952009|NCT03899038|Anesthetics|anesthetics|mesh-list
24808590|NCT02028078|Insulin|insulin|mesh-list
24952040|NCT03898583|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24952041|NCT03898583|Betamethasone benzoate|betamethasone benzoate|mesh-list
24952042|NCT03898583|Calcipotriene|calcipotriene|mesh-list
24952058|NCT03898583|Micronutrients|micronutrients|mesh-ancestor
24952059|NCT03898583|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24952061|NCT03898193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24952062|NCT03898193|Respiratory System Agents|respiratory system agents|mesh-ancestor
24952063|NCT03898193|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25697879|NCT02083783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25106269|NCT03573817|Autonomic Agents|autonomic agents|mesh-ancestor
25106270|NCT03573817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24952064|NCT03898193|Hormone Antagonists|hormone antagonists|mesh-ancestor
24952065|NCT03898193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24952066|NCT03898193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052116|NCT00330473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24596282|NCT00942617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24596283|NCT00942617|Analgesics|analgesics|mesh-ancestor
24596342|NCT00943137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596343|NCT00943137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24596344|NCT00943137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596345|NCT00943137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24596346|NCT00943137|Immunologic Factors|immunologic factors|mesh-ancestor
24596347|NCT00943137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596348|NCT00943176|Modafinil|modafinil|mesh-list
24596349|NCT00943176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24596350|NCT00943176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596351|NCT00943176|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24596352|NCT00943176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24596355|NCT00943228|Mycophenolic Acid|mycophenolic acid|mesh-list
24952084|NCT03898011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24952085|NCT03898011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952086|NCT03898011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24952087|NCT03898011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596400|NCT00943449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596445|NCT00943566|Sensory System Agents|sensory system agents|mesh-ancestor
24596446|NCT00943566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24596447|NCT00943566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24596493|NCT00943930|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24596495|NCT00943930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24596496|NCT00943943|Plerixafor|plerixafor|mesh-list
24596497|NCT00943943|Sorafenib|sorafenib|mesh-list
24596498|NCT00943943|Lenograstim|lenograstim|mesh-list
24596499|NCT00943943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24596500|NCT00943943|Immunologic Factors|immunologic factors|mesh-ancestor
24596501|NCT00943943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596502|NCT00943943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596503|NCT00943943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24952091|NCT03898011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24952092|NCT03898011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24952093|NCT03898128|Immunotoxins|immunotoxins|mesh-list
24952094|NCT03898128|Immunologic Factors|immunologic factors|mesh-ancestor
24952095|NCT03898128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952096|NCT03898336|Micronutrients|micronutrients|mesh-list
24952097|NCT03898336|Trace Elements|trace elements|mesh-list
24952098|NCT03898336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597123|NCT00947141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597124|NCT00947141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24597125|NCT00947323|Simvastatin|simvastatin|mesh-list
24597126|NCT00947323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24597127|NCT00947323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24597128|NCT00947323|Antimetabolites|antimetabolites|mesh-ancestor
24597129|NCT00947323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597130|NCT00947323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25697880|NCT02083783|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25697881|NCT02083809|Oxytocin|oxytocin|mesh-list
25697882|NCT02083809|Oxytocics|oxytocics|mesh-ancestor
25697883|NCT02083809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25697884|NCT02083809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697885|NCT02083861|Oxymetazoline|oxymetazoline|mesh-list
25697886|NCT02083861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25697887|NCT02083861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25697888|NCT02083861|Adrenergic Agents|adrenergic agents|mesh-ancestor
25697889|NCT02083861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24599135|NCT05119894|Dopamine Agents|dopamine agents|mesh-ancestor
24597131|NCT00947323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24597132|NCT00947323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597134|NCT00947336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24597135|NCT00947336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24597136|NCT00947336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24597137|NCT00947336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24597138|NCT00947336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597173|NCT00947388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597174|NCT00947388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24597587|NCT00950105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24671143|NCT01324063|Antimetabolites|antimetabolites|mesh-ancestor
24597636|NCT00950404|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24597637|NCT00950404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24597802|NCT00952016|Methotrexate|methotrexate|mesh-list
24597803|NCT00952016|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24597804|NCT00952016|Abortifacient Agents|abortifacient agents|mesh-ancestor
24597805|NCT00952016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24597806|NCT00952016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597807|NCT00952016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24597808|NCT00952016|Antimetabolites|antimetabolites|mesh-ancestor
24597809|NCT00952016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952112|NCT03897413|Antacids|antacids|mesh-list
24952113|NCT03897413|Calcium Carbonate|calcium carbonate|mesh-list
24952114|NCT03897413|Calcium|calcium|mesh-list
24597966|NCT00953108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24597967|NCT00953108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24598087|NCT00953641|Abortifacient Agents|abortifacient agents|mesh-ancestor
24598088|NCT00953641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24598089|NCT00953641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598090|NCT00953641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24598603|NCT00956982|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24598604|NCT00956982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598605|NCT00956982|Antiviral Agents|antiviral agents|mesh-ancestor
24598606|NCT00956982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24598607|NCT00956982|Antimetabolites|antimetabolites|mesh-ancestor
24598608|NCT00956982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598609|NCT00956982|Immunologic Factors|immunologic factors|mesh-ancestor
24598665|NCT00957190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24598666|NCT00957190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24598667|NCT00957190|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24598842|NCT05352373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952141|NCT03896971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24952142|NCT03896971|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24952143|NCT03896932|Immunoglobulins|immunoglobulins|mesh-list
24952144|NCT03896932|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24952145|NCT03896932|Antibodies|antibodies|mesh-list
24952146|NCT03896932|gamma-Globulins|gamma-globulins|mesh-list
24952147|NCT03896932|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24598951|NCT05351502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24598952|NCT05351502|Autonomic Agents|autonomic agents|mesh-ancestor
24598953|NCT05351502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24598954|NCT05351502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598955|NCT05351502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24598956|NCT05351502|Respiratory System Agents|respiratory system agents|mesh-ancestor
24598957|NCT05351502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24598958|NCT05351502|Antioxidants|antioxidants|mesh-ancestor
24599034|NCT05350384|Methylprednisolone|methylprednisolone|mesh-list
24599035|NCT05350384|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24599036|NCT05350384|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24599037|NCT05350384|Prednisolone|prednisolone|mesh-list
24599038|NCT05350384|Prednisolone acetate|prednisolone acetate|mesh-list
24599039|NCT05350384|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24599040|NCT05350384|Prednisolone phosphate|prednisolone phosphate|mesh-list
24599041|NCT05350384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24599042|NCT05350384|Antiemetics|antiemetics|mesh-ancestor
24599132|NCT05119894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599134|NCT05119894|Dopamine Agonists|dopamine agonists|mesh-ancestor
24600278|NCT01529593|Antifungal Agents|antifungal agents|mesh-ancestor
24600279|NCT01529593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24863068|NCT03601455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24863069|NCT03601455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542856|NCT00680602|Fluoxetine|fluoxetine|mesh-list
24863077|NCT03594162|Immunologic Factors|immunologic factors|mesh-ancestor
24863079|NCT03594162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24626352|NCT01086878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626353|NCT01086878|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24708686|NCT01502046|Dronabinol|dronabinol|mesh-list
25697890|NCT02083861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697891|NCT02083861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697892|NCT02083861|Sympathomimetics|sympathomimetics|mesh-ancestor
25697893|NCT02083861|Autonomic Agents|autonomic agents|mesh-ancestor
25697894|NCT02083861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24863129|NCT03065244|Dermatologic Agents|dermatologic agents|mesh-ancestor
24863130|NCT03065244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25697895|NCT02083861|Nasal Decongestants|nasal decongestants|mesh-ancestor
25697896|NCT02083861|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24863278|NCT02086552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863279|NCT02086552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24863280|NCT02086552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24863300|NCT00838981|Methadone|methadone|mesh-list
24863301|NCT00838981|Modafinil|modafinil|mesh-list
24863302|NCT00838981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24863303|NCT00838981|Narcotics|narcotics|mesh-ancestor
24863304|NCT00838981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24863305|NCT00838981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863306|NCT00838981|Analgesics|analgesics|mesh-ancestor
24863307|NCT00838981|Sensory System Agents|sensory system agents|mesh-ancestor
24863308|NCT00838981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24863309|NCT00838981|Antitussive Agents|antitussive agents|mesh-ancestor
24543060|NCT00681785|Anticoagulants|anticoagulants|mesh-ancestor
24543061|NCT00681785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24543062|NCT00681785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24543063|NCT00681785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543064|NCT00681876|Bevacizumab|bevacizumab|mesh-list
24863322|NCT00363038|Vitamin K|vitamin k|mesh-list
24863323|NCT00363038|Vitamin A|vitamin a|mesh-list
24863324|NCT00363038|Petrolatum|petrolatum|mesh-list
24863325|NCT00363038|Micronutrients|micronutrients|mesh-ancestor
24863326|NCT00363038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863327|NCT00363038|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24863328|NCT00363038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24863329|NCT00363038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863330|NCT00363038|Hemostatics|hemostatics|mesh-ancestor
24813635|NCT02059694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24813636|NCT02059694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24813637|NCT02059694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24813641|NCT02059694|Mydriatics|mydriatics|mesh-ancestor
24813642|NCT02059694|Sympathomimetics|sympathomimetics|mesh-ancestor
24813643|NCT02059694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24813644|NCT02059759|Aldesleukin|aldesleukin|mesh-list
25697899|NCT02083926|Analgesics|analgesics|mesh-ancestor
25697900|NCT02083926|Sensory System Agents|sensory system agents|mesh-ancestor
25697901|NCT02083926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25697902|NCT02083926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697903|NCT02083926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25697904|NCT02083926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25697905|NCT02083926|Anesthetics, General|anesthetics, general|mesh-ancestor
25697906|NCT02083926|Anesthetics|anesthetics|mesh-ancestor
24863487|NCT04826354|Ezetimibe|ezetimibe|mesh-list
24863488|NCT04826354|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24863489|NCT04826354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25052139|NCT00325650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25052140|NCT00325650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052142|NCT00325650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25052143|NCT00325650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052144|NCT00325364|Insulin|insulin|mesh-list
25052145|NCT00325364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25052146|NCT00325364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25052148|NCT00324220|Mocetinostat|mocetinostat|mesh-list
25052187|NCT00320203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25052188|NCT00320203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25052189|NCT00320203|Growth Substances|growth substances|mesh-ancestor
25052190|NCT00320203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052191|NCT00320203|Growth Inhibitors|growth inhibitors|mesh-ancestor
25052192|NCT00320203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052193|NCT00320203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25052194|NCT00319969|Topotecan|topotecan|mesh-list
25052195|NCT00319969|Amrubicin|amrubicin|mesh-list
25052204|NCT00318656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25052205|NCT00318656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052206|NCT00318656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25052207|NCT00318656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25052208|NCT00318656|Immunologic Factors|immunologic factors|mesh-ancestor
25052209|NCT00317486|Bosentan|bosentan|mesh-list
25052210|NCT00317486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25052211|NCT00317486|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25052264|NCT00313248|Antimitotic Agents|antimitotic agents|mesh-ancestor
24709012|NCT01503788|Midazolam|midazolam|mesh-list
25052265|NCT00313248|Mitosis Modulators|mitosis modulators|mesh-ancestor
25052266|NCT00313248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935326|NCT04051853|Anesthetics|anesthetics|mesh-ancestor
24935357|NCT04051580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25052705|NCT00215852|Immunologic Factors|immunologic factors|mesh-ancestor
25052270|NCT00313222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052272|NCT00313196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25052275|NCT00312975|Tremelimumab|tremelimumab|mesh-list
25052276|NCT00312975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052277|NCT00312091|Lamivudine|lamivudine|mesh-list
25052324|NCT00305188|Xaliproden|xaliproden|mesh-list
25697907|NCT02083926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25697908|NCT02083926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25697909|NCT02083926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25052325|NCT00305188|Antimetabolites|antimetabolites|mesh-ancestor
25052326|NCT00305188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052327|NCT00305188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25052328|NCT00305188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052329|NCT00305188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25052330|NCT00305188|Immunologic Factors|immunologic factors|mesh-ancestor
25052331|NCT00305188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052332|NCT00305188|Antidotes|antidotes|mesh-ancestor
25052333|NCT00305188|Protective Agents|protective agents|mesh-ancestor
25052334|NCT00305188|Vitamin B Complex|vitamin b complex|mesh-ancestor
25052335|NCT00305188|Vitamins|vitamins|mesh-ancestor
25052336|NCT00305188|Micronutrients|micronutrients|mesh-ancestor
25052382|NCT00299325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052383|NCT00298987|Dasatinib|dasatinib|mesh-list
25052384|NCT00298987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052385|NCT00298987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25052387|NCT00298987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052388|NCT00297401|Ruboxistaurin|ruboxistaurin|mesh-list
25052389|NCT00297401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052390|NCT00297401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052391|NCT00297310|Tacrolimus|tacrolimus|mesh-list
25052392|NCT00297310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25052393|NCT00297310|Immunologic Factors|immunologic factors|mesh-ancestor
25052394|NCT00297310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052395|NCT00297310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25052396|NCT00297310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052397|NCT00297310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052398|NCT00297089|Pemetrexed|pemetrexed|mesh-list
25052399|NCT00297089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052400|NCT00297089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052402|NCT00297089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24863515|NCT04785261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24863516|NCT04743570|Methylnaltrexone|methylnaltrexone|mesh-list
24863517|NCT04743570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24863518|NCT04743570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813680|NCT02059876|Antimitotic Agents|antimitotic agents|mesh-ancestor
24813681|NCT02059876|Mitosis Modulators|mitosis modulators|mesh-ancestor
24543288|NCT00683111|Esomeprazole|esomeprazole|mesh-list
24543289|NCT00683111|Famotidine|famotidine|mesh-list
24813693|NCT02059915|Narcotics|narcotics|mesh-ancestor
25052480|NCT00265655|Satraplatin|satraplatin|mesh-list
25052481|NCT00265655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052482|NCT00263341|Contraceptive Agents|contraceptive agents|mesh-list
25052483|NCT00263341|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25052484|NCT00263341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25052485|NCT00263341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052486|NCT00263341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25052487|NCT00263341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25052488|NCT00263341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25052489|NCT00263341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25052490|NCT00263341|Estrogens|estrogens|mesh-ancestor
25052492|NCT00263341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25052493|NCT00263042|Rimonabant|rimonabant|mesh-list
25052494|NCT00263042|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25052495|NCT00263042|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
25052496|NCT00263042|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25052497|NCT00263042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25052498|NCT00263042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052528|NCT00260078|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25052529|NCT00260078|Protease Inhibitors|protease inhibitors|mesh-ancestor
24813709|NCT02060006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24813710|NCT02060006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24813712|NCT02060006|Sensory System Agents|sensory system agents|mesh-ancestor
25052789|NCT00141284|Antiviral Agents|antiviral agents|mesh-ancestor
24863520|NCT04743570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25052556|NCT00255099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052557|NCT00255099|Antiviral Agents|antiviral agents|mesh-ancestor
25052558|NCT00255099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25052559|NCT00254904|Gemcitabine|gemcitabine|mesh-list
25052560|NCT00254904|Cisplatin|cisplatin|mesh-list
25052561|NCT00254904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052562|NCT00254904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25052563|NCT00254904|Antimetabolites|antimetabolites|mesh-ancestor
25106367|NCT02919683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052564|NCT00254904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052565|NCT00254904|Antiviral Agents|antiviral agents|mesh-ancestor
25052566|NCT00254904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25052567|NCT00254904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052568|NCT00254904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25052569|NCT00254904|Immunologic Factors|immunologic factors|mesh-ancestor
25052570|NCT00254904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863620|NCT04182997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863621|NCT04182997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24709370|NCT01505283|Lidocaine|lidocaine|mesh-list
24863654|NCT04002037|Triamcinolone|triamcinolone|mesh-list
24863657|NCT04002037|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24863658|NCT04002037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24952229|NCT03896074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24952230|NCT03896074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24952231|NCT03896074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24952232|NCT03896074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24952233|NCT03896074|Growth Substances|growth substances|mesh-ancestor
24952234|NCT03896074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952235|NCT03896074|Growth Inhibitors|growth inhibitors|mesh-ancestor
24952236|NCT03895892|Caffeine|caffeine|mesh-list
24952237|NCT03895892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24952238|NCT03895892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952271|NCT03895671|Azacitidine|azacitidine|mesh-list
24952272|NCT03895671|Ponatinib|ponatinib|mesh-list
24952273|NCT03895671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24952274|NCT03895671|Antimetabolites|antimetabolites|mesh-ancestor
24952275|NCT03895671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052639|NCT00232141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25052640|NCT00232141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052641|NCT00232141|Anticonvulsants|anticonvulsants|mesh-ancestor
25052642|NCT00232141|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25052643|NCT00232141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25052644|NCT00232141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806926|NCT02018796|Luteolytic Agents|luteolytic agents|mesh-ancestor
24863703|NCT03734016|Zanubrutinib|zanubrutinib|mesh-list
24709457|NCT01505855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863732|NCT03546829|Vancomycin|vancomycin|mesh-list
24863733|NCT03546829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24863734|NCT03546829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24863735|NCT03543839|Belimumab|belimumab|mesh-list
24863736|NCT03543839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25052645|NCT00232141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25052646|NCT00232141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25052647|NCT00232141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25052648|NCT00232141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25052649|NCT00232141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25052685|NCT00219297|Epothilone B|epothilone b|mesh-list
25052686|NCT00219297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052687|NCT00219297|Tubulin Modulators|tubulin modulators|mesh-ancestor
25052688|NCT00219297|Antimitotic Agents|antimitotic agents|mesh-ancestor
25052689|NCT00219297|Mitosis Modulators|mitosis modulators|mesh-ancestor
25052690|NCT00219297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052691|NCT00216593|Galantamine|galantamine|mesh-list
25052692|NCT00216593|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25052693|NCT00216593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052694|NCT00216593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052695|NCT00216593|Cholinergic Agents|cholinergic agents|mesh-ancestor
25052696|NCT00216593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25052697|NCT00216593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052698|NCT00216593|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25052699|NCT00216593|Autonomic Agents|autonomic agents|mesh-ancestor
25052700|NCT00216593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25052701|NCT00216593|Nootropic Agents|nootropic agents|mesh-ancestor
25052702|NCT00215852|Interferon-alpha|interferon-alpha|mesh-list
25052703|NCT00215852|Antiviral Agents|antiviral agents|mesh-ancestor
25052704|NCT00215852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25052707|NCT00214968|Modafinil|modafinil|mesh-list
25052708|NCT00214968|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25407059|NCT03521232|Antinematodal Agents|antinematodal agents|mesh-ancestor
25697910|NCT02083926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24982405|NCT02703623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24982406|NCT02703623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24982407|NCT02703623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24982408|NCT02703623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982409|NCT02703623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24982410|NCT02703623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052709|NCT00214968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052710|NCT00214968|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25052711|NCT00214968|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25052712|NCT00214968|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25052713|NCT00214968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863737|NCT03543839|Immunologic Factors|immunologic factors|mesh-ancestor
24863738|NCT03543839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863739|NCT03499119|Erenumab|erenumab|mesh-list
24543556|NCT00684216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25052714|NCT00210964|Linezolid|linezolid|mesh-list
25052719|NCT00210964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25052720|NCT00210964|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25052721|NCT00210964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052722|NCT00210964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052723|NCT00198276|Bleomycin|bleomycin|mesh-list
25052724|NCT00198276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25052725|NCT00198276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052726|NCT00198263|Bleomycin|bleomycin|mesh-list
25052727|NCT00198263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25052728|NCT00198263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052729|NCT00196339|Cyproterone Acetate|cyproterone acetate|mesh-list
25052730|NCT00196339|Cyproterone|cyproterone|mesh-list
25052731|NCT00196339|Androgen Antagonists|androgen antagonists|mesh-ancestor
24863763|NCT03439046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863764|NCT03439046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24863765|NCT03439046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24863766|NCT03439046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24863767|NCT03439046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863768|NCT03439046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24863769|NCT03439046|Hormone Antagonists|hormone antagonists|mesh-ancestor
24609396|NCT00996424|Respiratory System Agents|respiratory system agents|mesh-ancestor
24609397|NCT00996424|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25052752|NCT00162292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25052753|NCT00162292|Dermatologic Agents|dermatologic agents|mesh-ancestor
25052754|NCT00162292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052755|NCT00162292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25052787|NCT00141284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052788|NCT00141284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052790|NCT00141284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25052792|NCT00141284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24813750|NCT02060201|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24813751|NCT02060201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813752|NCT02060201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24813753|NCT02060201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697911|NCT02083926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697912|NCT02083965|Factor VIII|factor viii|mesh-list
25697913|NCT02083965|Coagulants|coagulants|mesh-ancestor
25697914|NCT02084056|Metformin|metformin|mesh-list
25697915|NCT02084056|Linagliptin|linagliptin|mesh-list
25697916|NCT02084056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25697917|NCT02084056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697918|NCT02084056|Incretins|incretins|mesh-ancestor
25697919|NCT02084056|Hormones|hormones|mesh-ancestor
25697920|NCT02084056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25697921|NCT02084056|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25697922|NCT02084056|Protease Inhibitors|protease inhibitors|mesh-ancestor
25697923|NCT02084056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697924|NCT02084056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106402|NCT02797275|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25106403|NCT02797275|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25106404|NCT02797275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25106405|NCT02797275|Adrenergic Agents|adrenergic agents|mesh-ancestor
25106408|NCT02790138|Ciprofloxacin|ciprofloxacin|mesh-list
24813754|NCT02060201|Incretins|incretins|mesh-ancestor
24813755|NCT02060201|Hormones|hormones|mesh-ancestor
24813756|NCT02060201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24813757|NCT02060201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24813758|NCT02060201|Protease Inhibitors|protease inhibitors|mesh-ancestor
24813759|NCT02060201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813760|NCT02060253|Paclitaxel|paclitaxel|mesh-list
24813761|NCT02060253|Trastuzumab|trastuzumab|mesh-list
24813762|NCT02060253|Pertuzumab|pertuzumab|mesh-list
24600304|NCT01095003|Capecitabine|capecitabine|mesh-list
24863810|NCT03284047|Cholinergic Agents|cholinergic agents|mesh-ancestor
24863811|NCT03284047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24863812|NCT03284047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863813|NCT03284047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24863814|NCT03284047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24863816|NCT03277261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24863817|NCT03277261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24863818|NCT03277261|Analgesics|analgesics|mesh-ancestor
24863819|NCT03277261|Sensory System Agents|sensory system agents|mesh-ancestor
24863820|NCT03277261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25011656|NCT04489108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011657|NCT04489108|Hemostatics|hemostatics|mesh-ancestor
24863931|NCT02922985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24863932|NCT02922985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24863933|NCT02922985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24863934|NCT02922985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24863935|NCT02922985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543809|NCT00685568|Sensory System Agents|sensory system agents|mesh-ancestor
24543810|NCT00685568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24543812|NCT00685568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25052809|NCT00135421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25052810|NCT00135421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052826|NCT00135395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24807116|NCT02019875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24807117|NCT02019875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24807118|NCT02019875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24807119|NCT02019875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476620|NCT00415922|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24476621|NCT00415922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24476622|NCT00415922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24813802|NCT02060396|Antipyretics|antipyretics|mesh-ancestor
24813823|NCT02060604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24813824|NCT02060604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24813825|NCT02060604|Growth Substances|growth substances|mesh-ancestor
24813826|NCT02060604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813827|NCT02060604|Growth Inhibitors|growth inhibitors|mesh-ancestor
25052828|NCT00135395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25052829|NCT00135395|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25052830|NCT00135395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25052831|NCT00135382|Efavirenz|efavirenz|mesh-list
25052832|NCT00135382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25052833|NCT00135382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25052834|NCT00135382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052835|NCT00135382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697925|NCT02084069|Atorvastatin|atorvastatin|mesh-list
25697926|NCT02084069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25697927|NCT02084069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25697928|NCT02084069|Antimetabolites|antimetabolites|mesh-ancestor
25697929|NCT02084069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697930|NCT02084069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25697931|NCT02084069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25697932|NCT02084069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697933|NCT02084082|Metformin|metformin|mesh-list
25052838|NCT00135382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25052839|NCT00135382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24807120|NCT02019875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807121|NCT02019875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24476749|NCT00416390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602121|NCT00967252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602122|NCT00967252|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24864059|NCT01388491|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24864061|NCT01388491|Hormones|hormones|mesh-ancestor
24864062|NCT01388491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24864063|NCT01388491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864064|NCT01388491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24864065|NCT01388491|Contraceptive Agents|contraceptive agents|mesh-ancestor
24864066|NCT01388491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24864067|NCT01388491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24864068|NCT01388491|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24864069|NCT01388491|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24864080|NCT01373151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864082|NCT01373151|Dermatologic Agents|dermatologic agents|mesh-ancestor
24544008|NCT00686439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25052848|NCT00135369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25052849|NCT00135369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052850|NCT00135369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052851|NCT00135369|Antiviral Agents|antiviral agents|mesh-ancestor
25052852|NCT00135369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25052853|NCT00135369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25052854|NCT00135369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25052855|NCT00135369|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25052856|NCT00135369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24602126|NCT00967291|Mitomycins|mitomycins|mesh-list
24602127|NCT00967291|Mitomycin|mitomycin|mesh-list
24602128|NCT00967291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24602129|NCT00967291|Alkylating Agents|alkylating agents|mesh-ancestor
24602130|NCT00967291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602135|NCT00967382|Dalteparin|dalteparin|mesh-list
24864084|NCT01373151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24864085|NCT01373151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24864086|NCT01373151|Immunologic Factors|immunologic factors|mesh-ancestor
24864087|NCT01373151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24864088|NCT01373151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24864142|NCT00602667|Etoposide phosphate|etoposide phosphate|mesh-list
24864143|NCT00602667|Vincristine|vincristine|mesh-list
24864147|NCT00602667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24864149|NCT00602667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864150|NCT00602667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25697934|NCT02084082|Linagliptin|linagliptin|mesh-list
25697935|NCT02084082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25697936|NCT02084082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697937|NCT02084082|Incretins|incretins|mesh-ancestor
25697938|NCT02084082|Hormones|hormones|mesh-ancestor
25697939|NCT02084082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25697940|NCT02084082|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25697941|NCT02084082|Protease Inhibitors|protease inhibitors|mesh-ancestor
25697942|NCT02084082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697943|NCT02084082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697944|NCT02084134|Dexamethasone|dexamethasone|mesh-list
25697945|NCT02084134|Dexamethasone acetate|dexamethasone acetate|mesh-list
25697946|NCT02084134|Hydrocortisone|hydrocortisone|mesh-list
25697947|NCT02084134|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24864151|NCT00602667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24864152|NCT00602667|Alkylating Agents|alkylating agents|mesh-ancestor
24864153|NCT00602667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864154|NCT00602667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864155|NCT00602667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24864156|NCT00602667|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24864157|NCT00602667|Abortifacient Agents|abortifacient agents|mesh-ancestor
24864158|NCT00602667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24864160|NCT00602667|Antimetabolites|antimetabolites|mesh-ancestor
24908285|NCT04321785|Caffeine|caffeine|mesh-list
24710720|NCT01511705|Ondansetron|ondansetron|mesh-list
25052877|NCT00135343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25052878|NCT00135343|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25052879|NCT00135343|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24864254|NCT05116800|Immunologic Factors|immunologic factors|mesh-ancestor
24864255|NCT05116800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864256|NCT05116800|Tubulin Modulators|tubulin modulators|mesh-ancestor
24864257|NCT05116800|Antimitotic Agents|antimitotic agents|mesh-ancestor
24864258|NCT05116800|Mitosis Modulators|mitosis modulators|mesh-ancestor
24864259|NCT05112861|Bevacizumab|bevacizumab|mesh-list
24864260|NCT05112861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24864261|NCT05112861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864262|NCT05112861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24864263|NCT05112861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24864264|NCT05112861|Growth Substances|growth substances|mesh-ancestor
24544193|NCT00687700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445084|NCT00300339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24864267|NCT05089565|Interferons|interferons|mesh-list
24864268|NCT05089565|Interferon-gamma|interferon-gamma|mesh-list
25052881|NCT00135343|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25052883|NCT00134264|Atorvastatin|atorvastatin|mesh-list
24686232|NCT04968522|Methylphenidate|methylphenidate|mesh-list
25052888|NCT00134264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052889|NCT00134264|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25052890|NCT00134264|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25052899|NCT00134238|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25052901|NCT00131924|Estrogens|estrogens|mesh-list
25052902|NCT00131924|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
25052903|NCT00131924|Hormones|hormones|mesh-ancestor
25697948|NCT02084134|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25697949|NCT02084134|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25697950|NCT02084134|BB 1101|bb 1101|mesh-list
25697951|NCT02084134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25697952|NCT02084134|Antiemetics|antiemetics|mesh-ancestor
25697953|NCT02084134|Autonomic Agents|autonomic agents|mesh-ancestor
25697954|NCT02084134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25697955|NCT02084134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697956|NCT02084134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25697957|NCT02084134|Glucocorticoids|glucocorticoids|mesh-ancestor
25697958|NCT02084134|Hormones|hormones|mesh-ancestor
25697959|NCT02084134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25697960|NCT02084134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25697961|NCT02084134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25697962|NCT02084134|Protease Inhibitors|protease inhibitors|mesh-ancestor
24865558|NCT00112411|Bronchodilator Agents|bronchodilator agents|mesh-list
25052904|NCT00131924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25052905|NCT00131924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052906|NCT00130312|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
25052907|NCT00130312|Anticoagulants|anticoagulants|mesh-ancestor
25052908|NCT00130312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25052909|NCT00130312|Antimetabolites|antimetabolites|mesh-ancestor
24864372|NCT04742140|Sensory System Agents|sensory system agents|mesh-ancestor
24864373|NCT04742140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24864374|NCT04742140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614300|NCT01023399|Artesunate|artesunate|mesh-list
24864375|NCT04742140|Anesthetics|anesthetics|mesh-ancestor
24864376|NCT04742140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24864377|NCT04742140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24864378|NCT04742140|Anticonvulsants|anticonvulsants|mesh-ancestor
24864379|NCT04742140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24864380|NCT04742140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24864381|NCT04742140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864383|NCT04742140|Tocolytic Agents|tocolytic agents|mesh-ancestor
24864412|NCT04643379|Carboplatin|carboplatin|mesh-list
24864413|NCT04643379|Pembrolizumab|pembrolizumab|mesh-list
24864414|NCT04643379|Olaparib|olaparib|mesh-list
24864415|NCT04643379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864416|NCT04643379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24864417|NCT04643379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24864418|NCT04643379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864419|NCT04643379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864420|NCT04604067|Acalabrutinib|acalabrutinib|mesh-list
24544296|NCT00688402|GABA Agonists|gaba agonists|mesh-ancestor
24544297|NCT00688402|GABA Agents|gaba agents|mesh-ancestor
24864421|NCT04604067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544332|NCT00688493|Moxifloxacin|moxifloxacin|mesh-list
24544333|NCT00688493|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24544336|NCT00688493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24544337|NCT00688493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24544338|NCT00688493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544339|NCT00688493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544340|NCT00688493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544341|NCT00688493|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24544342|NCT00688493|Contraceptive Agents|contraceptive agents|mesh-ancestor
24544343|NCT00688493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24544344|NCT00688493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864422|NCT04590274|Azithromycin|azithromycin|mesh-list
24864423|NCT04590274|Hydroxychloroquine|hydroxychloroquine|mesh-list
24711170|NCT01513785|Amoxicillin|amoxicillin|mesh-list
24864424|NCT04590274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24864425|NCT04590274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24864426|NCT04590274|Antimalarials|antimalarials|mesh-ancestor
24864427|NCT04590274|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24864428|NCT04590274|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24864429|NCT04590274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813907|NCT02060955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24813908|NCT02060955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813909|NCT02060955|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24813910|NCT02060955|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24813911|NCT02060955|Growth Substances|growth substances|mesh-ancestor
24813912|NCT02060955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052924|NCT00125970|Vaccines|vaccines|mesh-list
25052925|NCT00125970|Immunologic Factors|immunologic factors|mesh-ancestor
25052926|NCT00125970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052927|NCT00120393|Ritonavir|ritonavir|mesh-list
25052928|NCT00120393|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25052929|NCT00120393|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25052930|NCT00120393|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25052931|NCT00120393|Protease Inhibitors|protease inhibitors|mesh-ancestor
24544352|NCT00688558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24544353|NCT00688558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24544354|NCT00688558|Antimetabolites|antimetabolites|mesh-ancestor
24864449|NCT04192994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25697963|NCT02084134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864451|NCT04182321|Entecavir|entecavir|mesh-list
24864452|NCT04182321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24864453|NCT04182321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864454|NCT04182321|Antiviral Agents|antiviral agents|mesh-ancestor
24864455|NCT04182321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24864456|NCT04146142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25052934|NCT00120393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25052935|NCT00120393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25052936|NCT00120393|Antiviral Agents|antiviral agents|mesh-ancestor
25052937|NCT00120393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24760606|NCT01758913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760607|NCT01758913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864512|NCT03686306|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24864513|NCT03686306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24864514|NCT03686306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864515|NCT03686306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864516|NCT03686306|Urological Agents|urological agents|mesh-ancestor
24686421|NCT04818957|Vitamin D|vitamin d|mesh-list
24686500|NCT04760691|Tenofovir|tenofovir|mesh-list
24864588|NCT03260881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24864590|NCT03238495|Carboplatin|carboplatin|mesh-list
24864591|NCT03238495|Docetaxel|docetaxel|mesh-list
24864592|NCT03238495|Trastuzumab|trastuzumab|mesh-list
24864593|NCT03238495|Pertuzumab|pertuzumab|mesh-list
24864594|NCT03238495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864595|NCT03238495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24864596|NCT03238495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864597|NCT03238495|Tubulin Modulators|tubulin modulators|mesh-ancestor
24864598|NCT03238495|Antimitotic Agents|antimitotic agents|mesh-ancestor
24864599|NCT03238495|Mitosis Modulators|mitosis modulators|mesh-ancestor
24864600|NCT03238495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864601|NCT03238495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24551440|NCT00726700|Cyclophosphamide|cyclophosphamide|mesh-list
24551441|NCT00726700|Rituximab|rituximab|mesh-list
24551442|NCT00726700|Doxorubicin|doxorubicin|mesh-list
24551443|NCT00726700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24551444|NCT00726700|Vincristine|vincristine|mesh-list
24551445|NCT00726700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24551446|NCT00726700|Immunologic Factors|immunologic factors|mesh-ancestor
24551447|NCT00726700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625485|NCT01082276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24864628|NCT03072628|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24864629|NCT03072628|Autonomic Agents|autonomic agents|mesh-ancestor
24864630|NCT03072628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24864641|NCT02907983|Anesthetics, Local|anesthetics, local|mesh-ancestor
24864642|NCT02907983|Anesthetics|anesthetics|mesh-ancestor
24864643|NCT02907983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24864644|NCT02907983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864645|NCT02907983|Sensory System Agents|sensory system agents|mesh-ancestor
24864646|NCT02907983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24864647|NCT02880540|Fentanyl|fentanyl|mesh-list
24864648|NCT02880540|Dexmedetomidine|dexmedetomidine|mesh-list
24864649|NCT02880540|Morphine|morphine|mesh-list
24864650|NCT02880540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24864651|NCT02880540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24864652|NCT02880540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864653|NCT02880540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24864654|NCT02880540|Analgesics|analgesics|mesh-ancestor
24864655|NCT02880540|Sensory System Agents|sensory system agents|mesh-ancestor
24864656|NCT02880540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24864657|NCT02880540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24865559|NCT00112411|Autonomic Agents|autonomic agents|mesh-ancestor
24864733|NCT02741388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864735|NCT02741388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24864772|NCT02229136|Hydrocortisone|hydrocortisone|mesh-list
24864773|NCT02229136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24864774|NCT02229136|Glucocorticoids|glucocorticoids|mesh-ancestor
24814009|NCT02061800|Alkylating Agents|alkylating agents|mesh-ancestor
25052940|NCT00120042|Misoprostol|misoprostol|mesh-list
25052941|NCT00120042|Oxytocin|oxytocin|mesh-list
25052942|NCT00120042|Oxytocics|oxytocics|mesh-ancestor
25052943|NCT00120042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25052944|NCT00120042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25052945|NCT00120042|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25052946|NCT00120042|Abortifacient Agents|abortifacient agents|mesh-ancestor
25052947|NCT00120042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25052948|NCT00120042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25052984|NCT00117650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25052985|NCT00117650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25052986|NCT00117650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052987|NCT00116415|Lamivudine|lamivudine|mesh-list
25052988|NCT00116415|Efavirenz|efavirenz|mesh-list
25052989|NCT00116415|Didanosine|didanosine|mesh-list
24807281|NCT02020980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24807282|NCT02021097|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24807283|NCT02021097|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24864836|NCT05149378|Venetoclax|venetoclax|mesh-list
24864837|NCT05149378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24864838|NCT05149378|Antimetabolites|antimetabolites|mesh-ancestor
25052993|NCT00116415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25052994|NCT00116415|Antiviral Agents|antiviral agents|mesh-ancestor
25052995|NCT00116415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25052996|NCT00116415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25052997|NCT00116415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25052998|NCT00116415|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25052999|NCT00116415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25053000|NCT00116415|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25053001|NCT00116415|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25053002|NCT00116415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25053006|NCT00116298|Efavirenz|efavirenz|mesh-list
25053021|NCT00116298|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25053022|NCT00116298|Antimetabolites|antimetabolites|mesh-ancestor
25053024|NCT00116116|Efavirenz|efavirenz|mesh-list
25053025|NCT00116116|Stavudine|stavudine|mesh-list
24625490|NCT01082276|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25053026|NCT00116116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25053027|NCT00116116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25053028|NCT00116116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053029|NCT00116116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053030|NCT00116116|Antiviral Agents|antiviral agents|mesh-ancestor
25053031|NCT00116116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25053032|NCT00116116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25053033|NCT00116116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25053034|NCT00116116|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24864916|NCT05148143|Raltitrexed|raltitrexed|mesh-list
24864917|NCT05148143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24864918|NCT05148143|Antimetabolites|antimetabolites|mesh-ancestor
24864919|NCT05148143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864920|NCT05148143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864921|NCT05148143|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24864922|NCT05148143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864923|NCT05148026|Heparin|heparin|mesh-list
24864924|NCT05148026|Calcium heparin|calcium heparin|mesh-list
24864925|NCT05148026|Dialysis Solutions|dialysis solutions|mesh-list
24864926|NCT05148026|Anticoagulants|anticoagulants|mesh-ancestor
24864940|NCT05136040|Anesthetics|anesthetics|mesh-ancestor
24864944|NCT05136040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25053049|NCT00115050|Antiviral Agents|antiviral agents|mesh-ancestor
25053050|NCT00115050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25053051|NCT00113438|Paclitaxel|paclitaxel|mesh-list
25053052|NCT00113438|Fosbretabulin|fosbretabulin|mesh-list
25053053|NCT00113438|Combretastatin|combretastatin|mesh-list
25053054|NCT00113438|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25053055|NCT00113438|Carboplatin|carboplatin|mesh-list
25053056|NCT00113438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25053057|NCT00113438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053058|NCT00113438|Tubulin Modulators|tubulin modulators|mesh-ancestor
25053059|NCT00113438|Antimitotic Agents|antimitotic agents|mesh-ancestor
25053060|NCT00113438|Mitosis Modulators|mitosis modulators|mesh-ancestor
25053061|NCT00113438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053062|NCT00110422|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25053064|NCT00110422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25053065|NCT00110422|Diuretics|diuretics|mesh-ancestor
25053066|NCT00110422|Natriuretic Agents|natriuretic agents|mesh-ancestor
25053067|NCT00110422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407060|NCT03521193|Aspirin|aspirin|mesh-list
24795807|NCT01946256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053068|NCT00110422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25053069|NCT00110422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25053070|NCT00110422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053071|NCT00110422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24865644|NCT05151614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25053087|NCT00108810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25053088|NCT00108810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25053089|NCT00108810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053090|NCT00108810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053091|NCT00106808|Pioglitazone|pioglitazone|mesh-list
25053092|NCT00106808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25053093|NCT00106808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053094|NCT00106626|Pemetrexed|pemetrexed|mesh-list
25053095|NCT00106626|Vorinostat|vorinostat|mesh-list
25053096|NCT00106626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544825|NCT00690521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24544826|NCT00690521|Diuretics|diuretics|mesh-ancestor
24544827|NCT00690521|Natriuretic Agents|natriuretic agents|mesh-ancestor
24544828|NCT00690521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864985|NCT05012631|Losartan|losartan|mesh-list
24864986|NCT05012631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25053097|NCT00106626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053098|NCT00106626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053099|NCT00106626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25053100|NCT00106626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25053101|NCT00106626|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25053103|NCT00106340|Glimepiride|glimepiride|mesh-list
25053104|NCT00106340|Vildagliptin|vildagliptin|mesh-list
25053105|NCT00106340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25053106|NCT00106340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864987|NCT05012631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24864988|NCT05012631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24711792|NCT01516996|Mitosis Modulators|mitosis modulators|mesh-ancestor
24711793|NCT01516996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544864|NCT00690560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24544865|NCT00690560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24544866|NCT00690560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24544867|NCT00690560|Tubulin Modulators|tubulin modulators|mesh-ancestor
24865645|NCT05151614|Tubulin Modulators|tubulin modulators|mesh-ancestor
24865063|NCT04682288|Levofloxacin|levofloxacin|mesh-list
24865065|NCT04682288|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24814014|NCT02061800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24814047|NCT02062034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814049|NCT02062047|Chlorhexidine|chlorhexidine|mesh-list
24544948|NCT00691145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24544949|NCT00691145|Immunologic Factors|immunologic factors|mesh-ancestor
24602524|NCT00969176|Acetaminophen|acetaminophen|mesh-list
24865072|NCT04682288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865073|NCT04682288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865076|NCT04652375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24865077|NCT04608409|Paclitaxel|paclitaxel|mesh-list
24865078|NCT04608409|Lapatinib|lapatinib|mesh-list
24865079|NCT04608409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25053188|NCT00089141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25053189|NCT00089141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053190|NCT00089141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053192|NCT00086723|Plasminogen|plasminogen|mesh-list
25053193|NCT00086723|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25053194|NCT00086723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25053195|NCT00086723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25053196|NCT00086723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053197|NCT00086723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25053198|NCT00086723|Protease Inhibitors|protease inhibitors|mesh-ancestor
25697964|NCT02084134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697965|NCT02084238|Interleukin-2|interleukin-2|mesh-list
25697966|NCT02084238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25697967|NCT02084238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25697968|NCT02084238|Analgesics|analgesics|mesh-ancestor
25697969|NCT02084238|Sensory System Agents|sensory system agents|mesh-ancestor
25106481|NCT02669173|Bevacizumab|bevacizumab|mesh-list
25053199|NCT00086723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24865092|NCT04580992|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25053210|NCT00084344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053211|NCT00084344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24865107|NCT04455178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053219|NCT00084253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053220|NCT00084253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053221|NCT00084253|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25053222|NCT00084253|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25053223|NCT00084253|Antiviral Agents|antiviral agents|mesh-ancestor
25053224|NCT00084253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25053225|NCT00084253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25053226|NCT00084253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24622759|NCT01068353|Etanercept|etanercept|mesh-list
24622760|NCT01068353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25053235|NCT00083941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053236|NCT00083759|Natalizumab|natalizumab|mesh-list
25053237|NCT00083759|Immunologic Factors|immunologic factors|mesh-ancestor
25053238|NCT00083759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053239|NCT00081510|Anastrozole|anastrozole|mesh-list
24712093|NCT01518465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24712094|NCT01518465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712126|NCT01518634|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24712127|NCT01518634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24712128|NCT01518634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712129|NCT01518634|Adrenergic Agents|adrenergic agents|mesh-ancestor
24712130|NCT01518634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24712132|NCT01518712|Metformin|metformin|mesh-list
24445915|NCT00303017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053240|NCT00081510|Lonafarnib|lonafarnib|mesh-list
25053241|NCT00081510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25053242|NCT00081510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053243|NCT00081510|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25053244|NCT00081510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25053245|NCT00081510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053246|NCT00081510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053247|NCT00081510|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25053248|NCT00081510|Hormone Antagonists|hormone antagonists|mesh-ancestor
25053249|NCT00081510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25053250|NCT00081510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053251|NCT00080106|Vaccines|vaccines|mesh-list
24936369|NCT04041427|Albendazole|albendazole|mesh-list
25053278|NCT00073866|Antimitotic Agents|antimitotic agents|mesh-ancestor
25053279|NCT00073866|Mitosis Modulators|mitosis modulators|mesh-ancestor
25053280|NCT00073866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053281|NCT00073866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25053282|NCT00073866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25053283|NCT00073866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053284|NCT00073866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25053285|NCT00073866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25053286|NCT00073866|Analgesics|analgesics|mesh-ancestor
25053287|NCT00073866|Sensory System Agents|sensory system agents|mesh-ancestor
25053288|NCT00073866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25053289|NCT00073866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697970|NCT02084238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25697971|NCT02084238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697972|NCT02084511|Celecoxib|celecoxib|mesh-list
25697973|NCT02084511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25697974|NCT02084511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25697975|NCT02084511|Analgesics|analgesics|mesh-ancestor
25697976|NCT02084511|Sensory System Agents|sensory system agents|mesh-ancestor
25697977|NCT02084511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25053290|NCT00073866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25053291|NCT00073866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25053292|NCT00073866|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25053312|NCT00067782|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25053313|NCT00067782|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25053314|NCT00067782|Protease Inhibitors|protease inhibitors|mesh-ancestor
25053315|NCT00067782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053316|NCT00067782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053317|NCT00067782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25053318|NCT00067782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25053319|NCT00067782|Antiviral Agents|antiviral agents|mesh-ancestor
25053320|NCT00067782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25053351|NCT00057993|Trastuzumab|trastuzumab|mesh-list
25053408|NCT00052598|Sensory System Agents|sensory system agents|mesh-ancestor
25053409|NCT00052598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25053410|NCT00052598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053411|NCT00052598|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25053412|NCT00052598|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25053413|NCT00052598|Antiviral Agents|antiviral agents|mesh-ancestor
25053414|NCT00052598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24443276|NCT00294359|Antimetabolites|antimetabolites|mesh-ancestor
24445936|NCT00303160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445937|NCT00303160|Protective Agents|protective agents|mesh-ancestor
24445938|NCT00303264|Esomeprazole|esomeprazole|mesh-list
24445939|NCT00303264|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24445940|NCT00303264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24445941|NCT00303264|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24445942|NCT00303264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445944|NCT00303277|Simvastatin|simvastatin|mesh-list
24445968|NCT00303381|Interferon-beta|interferon-beta|mesh-list
24445969|NCT00303381|Interferon beta-1a|interferon beta-1a|mesh-list
24865186|NCT04298034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24865187|NCT04298034|Sympathomimetics|sympathomimetics|mesh-ancestor
24865188|NCT04298034|Autonomic Agents|autonomic agents|mesh-ancestor
24865189|NCT04298034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24865190|NCT04298034|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24865191|NCT04298034|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24445970|NCT00303381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865230|NCT04177654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865231|NCT04177654|Antinematodal Agents|antinematodal agents|mesh-ancestor
25053510|NCT00013897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053511|NCT00013897|Antiviral Agents|antiviral agents|mesh-ancestor
25053512|NCT00013897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25053513|NCT00013897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25053514|NCT00013897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25053515|NCT00013897|Antimetabolites|antimetabolites|mesh-ancestor
25053516|NCT00013897|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25053517|NCT00013897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25053518|NCT00013897|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25053519|NCT00013897|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25053520|NCT00013897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25053521|NCT00013897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25053528|NCT00006225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053529|NCT00006225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25053531|NCT00005918|Lamivudine|lamivudine|mesh-list
25053532|NCT00005918|Efavirenz|efavirenz|mesh-list
25053533|NCT00005918|Stavudine|stavudine|mesh-list
25053534|NCT00005918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25053535|NCT00005918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25053536|NCT00005918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053564|NCT00005608|Protective Agents|protective agents|mesh-ancestor
25053565|NCT00005608|Vitamin B Complex|vitamin b complex|mesh-ancestor
25697978|NCT02084511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697979|NCT02084511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25053566|NCT00005608|Vitamins|vitamins|mesh-ancestor
25053567|NCT00005608|Micronutrients|micronutrients|mesh-ancestor
25697980|NCT02084511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25697981|NCT02084511|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24982930|NCT00157963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24982931|NCT00157963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24982932|NCT00157963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24982933|NCT00157963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982934|NCT00157963|Diuretics|diuretics|mesh-ancestor
24394555|NCT00133562|Glycine|glycine|mesh-list
25053568|NCT00005608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25053569|NCT00005608|Antimetabolites|antimetabolites|mesh-ancestor
25053607|NCT00004912|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25053608|NCT00004912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25053609|NCT00004912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053611|NCT00004912|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25053613|NCT00004908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25053614|NCT00004908|Immunologic Factors|immunologic factors|mesh-ancestor
25053615|NCT00004908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053616|NCT00004908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24865418|NCT03087656|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24865420|NCT03087656|Renal Agents|renal agents|mesh-ancestor
24865421|NCT03087656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24545309|NCT00693030|Antimitotic Agents|antimitotic agents|mesh-ancestor
24545310|NCT00693030|Mitosis Modulators|mitosis modulators|mesh-ancestor
24545311|NCT00693030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545312|NCT00693030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24545313|NCT00693030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24865422|NCT03087656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25053661|NCT00004898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25053662|NCT00004898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25053663|NCT00004898|Alkylating Agents|alkylating agents|mesh-ancestor
24807915|NCT02024308|Cytarabine|cytarabine|mesh-list
24865429|NCT03033069|Sertraline|sertraline|mesh-list
24865430|NCT03033069|Brexpiprazole|brexpiprazole|mesh-list
24865431|NCT03033069|Antidepressive Agents|antidepressive agents|mesh-ancestor
24865432|NCT03033069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24865433|NCT03033069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24865434|NCT03033069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24865435|NCT03033069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24865436|NCT03033069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865437|NCT03033069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24865438|NCT03033069|Serotonin Agents|serotonin agents|mesh-ancestor
24865439|NCT03033069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865440|NCT03033069|Dopamine Agonists|dopamine agonists|mesh-ancestor
24865441|NCT03033069|Dopamine Agents|dopamine agents|mesh-ancestor
24865442|NCT02946424|Simvastatin|simvastatin|mesh-list
24865443|NCT02946424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24865444|NCT02946424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24865445|NCT02946424|Antimetabolites|antimetabolites|mesh-ancestor
24545328|NCT00693043|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24865646|NCT05151614|Antimitotic Agents|antimitotic agents|mesh-ancestor
25053699|NCT00004896|Immunologic Factors|immunologic factors|mesh-ancestor
25053700|NCT00004896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053701|NCT00004896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25053702|NCT00004896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25053703|NCT00004896|Alkylating Agents|alkylating agents|mesh-ancestor
25053704|NCT00004896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053705|NCT00004896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053706|NCT00004896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25053708|NCT00004895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25053709|NCT00004895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25053710|NCT00004895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053711|NCT00004584|Ritonavir|ritonavir|mesh-list
25053712|NCT00004584|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25053713|NCT00004584|Saquinavir|saquinavir|mesh-list
25053714|NCT00004584|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25053715|NCT00004584|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25697982|NCT02084511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25697983|NCT02084511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25697984|NCT02084511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25697985|NCT02084706|Triamcinolone|triamcinolone|mesh-list
25697986|NCT02084706|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25697987|NCT02084706|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25697988|NCT02084706|Lidocaine|lidocaine|mesh-list
25697989|NCT02084706|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25697990|NCT02084706|Anesthetics, Local|anesthetics, local|mesh-ancestor
25053716|NCT00004584|Protease Inhibitors|protease inhibitors|mesh-ancestor
25053717|NCT00004584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053718|NCT00004584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053719|NCT00004584|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25053720|NCT00004584|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25053721|NCT00004584|Antiviral Agents|antiviral agents|mesh-ancestor
25053722|NCT00004584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25053725|NCT00004231|Leucovorin|leucovorin|mesh-list
24865469|NCT02587598|Immunologic Factors|immunologic factors|mesh-ancestor
24865470|NCT02587598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865471|NCT02587598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24865472|NCT02485574|Calcium|calcium|mesh-list
24865473|NCT02485574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24865474|NCT02485574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865475|NCT02350764|Nivolumab|nivolumab|mesh-list
24865476|NCT02350764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24865477|NCT02350764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865478|NCT02350764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24865479|NCT02350764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865480|NCT02091934|Dipivefrin|dipivefrin|mesh-list
24865481|NCT02091934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24936932|NCT04035031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936933|NCT04035031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24936934|NCT04035031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936935|NCT04034524|Insulin|insulin|mesh-list
24936936|NCT04034524|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24936937|NCT04034524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24936938|NCT04034524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952341|NCT03894826|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24952342|NCT03894826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24545447|NCT00693433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24545449|NCT00693433|Autonomic Agents|autonomic agents|mesh-ancestor
24545450|NCT00693433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24545451|NCT00693433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952351|NCT03894748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24952352|NCT03894748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952353|NCT03894748|Cholinergic Agents|cholinergic agents|mesh-ancestor
24952354|NCT03894748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24952355|NCT03894748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952356|NCT03894748|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24952357|NCT03894748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24952359|NCT03894800|Methoxyflurane|methoxyflurane|mesh-list
24952360|NCT03894800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24952361|NCT03894800|Narcotics|narcotics|mesh-ancestor
24712463|NCT01520766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712563|NCT01521455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24712564|NCT01521455|Respiratory System Agents|respiratory system agents|mesh-ancestor
24712565|NCT01521455|Glucocorticoids|glucocorticoids|mesh-ancestor
24952362|NCT03894800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24952364|NCT03894800|Analgesics|analgesics|mesh-ancestor
24865498|NCT01460160|Dasatinib|dasatinib|mesh-list
24865499|NCT01460160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865500|NCT01460160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24865501|NCT01460160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24865502|NCT01460160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865503|NCT01291004|Drospirenone|drospirenone|mesh-list
24865504|NCT01291004|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24865505|NCT01291004|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24865506|NCT01291004|Levonorgestrel|levonorgestrel|mesh-list
24865507|NCT01291004|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24865508|NCT01291004|Desogestrel|desogestrel|mesh-list
24865509|NCT01291004|Contraceptive Agents|contraceptive agents|mesh-list
24865510|NCT01291004|Contraceptives, Oral|contraceptives, oral|mesh-list
24865515|NCT01291004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24865516|NCT01291004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952366|NCT03894800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24952368|NCT03894800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24952369|NCT03894800|Anesthetics, General|anesthetics, general|mesh-ancestor
25697991|NCT02084706|Anesthetics|anesthetics|mesh-ancestor
25697992|NCT02084706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24952370|NCT03894800|Anesthetics|anesthetics|mesh-ancestor
24952371|NCT03894800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24952372|NCT03894683|Melatonin|melatonin|mesh-list
24952373|NCT03894683|Antioxidants|antioxidants|mesh-ancestor
25053727|NCT00004231|Cytarabine|cytarabine|mesh-list
25053728|NCT00004231|Interferon-alpha|interferon-alpha|mesh-list
25053729|NCT00004231|Aldesleukin|aldesleukin|mesh-list
25053734|NCT00004231|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25053735|NCT00004231|Methotrexate|methotrexate|mesh-list
25053736|NCT00004231|Vincristine|vincristine|mesh-list
25053737|NCT00004231|Teniposide|teniposide|mesh-list
25053738|NCT00004231|Levoleucovorin|levoleucovorin|mesh-list
25053739|NCT00004231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25053740|NCT00004231|Immunologic Factors|immunologic factors|mesh-ancestor
25053741|NCT00004231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865517|NCT01291004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24865518|NCT01291004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24865519|NCT01291004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24865520|NCT01291004|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24865521|NCT01291004|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24865532|NCT01170702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865533|NCT01170702|Sensory System Agents|sensory system agents|mesh-ancestor
24865534|NCT01170702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24865535|NCT01018563|Farletuzumab|farletuzumab|mesh-list
24545477|NCT00693524|Mycophenolic Acid|mycophenolic acid|mesh-list
24545478|NCT00693524|Prednisone|prednisone|mesh-list
24545479|NCT00693524|Tacrolimus|tacrolimus|mesh-list
24545480|NCT00693524|Daclizumab|daclizumab|mesh-list
24545481|NCT00693524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24545482|NCT00693524|Glucocorticoids|glucocorticoids|mesh-ancestor
24545483|NCT00693524|Hormones|hormones|mesh-ancestor
25053742|NCT00004231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25053743|NCT00004231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25053744|NCT00004231|Alkylating Agents|alkylating agents|mesh-ancestor
25053745|NCT00004231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053746|NCT00004231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053747|NCT00004231|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25053748|NCT00004231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25053749|NCT00004231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25053750|NCT00004231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25053751|NCT00004231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053752|NCT00004231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25053753|NCT00004231|Glucocorticoids|glucocorticoids|mesh-ancestor
24545498|NCT00693576|Simvastatin|simvastatin|mesh-list
24865556|NCT00374660|Alkylating Agents|alkylating agents|mesh-ancestor
24865557|NCT00374660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446028|NCT00303615|Hormone Antagonists|hormone antagonists|mesh-ancestor
24446029|NCT00303615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24865584|NCT05152355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24865586|NCT05152355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24865587|NCT05152355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053775|NCT00004231|Mitosis Modulators|mitosis modulators|mesh-ancestor
25053776|NCT00004231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25053777|NCT00004231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25053778|NCT00004230|Cyclophosphamide|cyclophosphamide|mesh-list
25053780|NCT00004230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25053781|NCT00004230|Immunologic Factors|immunologic factors|mesh-ancestor
25053782|NCT00004230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053783|NCT00004230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25053784|NCT00004230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25053785|NCT00004230|Alkylating Agents|alkylating agents|mesh-ancestor
25053786|NCT00004230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053787|NCT00004230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053788|NCT00004230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25053789|NCT00004230|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25053790|NCT00004230|Protease Inhibitors|protease inhibitors|mesh-ancestor
24865620|NCT05151796|Sensory System Agents|sensory system agents|mesh-ancestor
24865621|NCT05151796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24865622|NCT05151796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865623|NCT05151796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24865624|NCT05151796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24865625|NCT05151796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24865626|NCT05151796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24865627|NCT05151796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865628|NCT05151796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24545562|NCT00693771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24545563|NCT00693771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545565|NCT00693849|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24545566|NCT00693849|Sertraline|sertraline|mesh-list
24545567|NCT00693849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24603195|NCT00972855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545571|NCT00693849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24545572|NCT00693849|Serotonin Agents|serotonin agents|mesh-ancestor
24545573|NCT00693849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865639|NCT05151679|Chelating Agents|chelating agents|mesh-ancestor
24865640|NCT05151679|Sequestering Agents|sequestering agents|mesh-ancestor
24865641|NCT05151679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865642|NCT05151614|Colchicine|colchicine|mesh-list
24865643|NCT05151614|Gout Suppressants|gout suppressants|mesh-ancestor
24545583|NCT00693862|Dopamine Agents|dopamine agents|mesh-ancestor
25053821|NCT00004175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053822|NCT00004175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25053823|NCT00004175|Tubulin Modulators|tubulin modulators|mesh-ancestor
25053824|NCT00004175|Antimitotic Agents|antimitotic agents|mesh-ancestor
25053825|NCT00004175|Mitosis Modulators|mitosis modulators|mesh-ancestor
25053826|NCT00004175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25053827|NCT00004175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25053828|NCT00004175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25053829|NCT00004175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053830|NCT00004172|Cyclophosphamide|cyclophosphamide|mesh-list
25053831|NCT00004172|Ifosfamide|ifosfamide|mesh-list
24865647|NCT05151614|Mitosis Modulators|mitosis modulators|mesh-ancestor
24865648|NCT05151614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865649|NCT05151614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865650|NCT05151549|Carboplatin|carboplatin|mesh-list
24865651|NCT05151549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865652|NCT05151510|Lidocaine|lidocaine|mesh-list
24865653|NCT05151510|Anesthetics, Local|anesthetics, local|mesh-ancestor
24865654|NCT05151510|Anesthetics|anesthetics|mesh-ancestor
24545591|NCT00693927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24545593|NCT00693966|Immunologic Factors|immunologic factors|mesh-ancestor
24545594|NCT00693966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053840|NCT00004172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053842|NCT00004172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25053843|NCT00004171|Cyclophosphamide|cyclophosphamide|mesh-list
25053844|NCT00004171|Busulfan|busulfan|mesh-list
25053845|NCT00004171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25053846|NCT00004171|Immunologic Factors|immunologic factors|mesh-ancestor
24808142|NCT02025361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24808143|NCT02025361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24808144|NCT02025361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24865655|NCT05151510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24865656|NCT05151510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865657|NCT05151510|Sensory System Agents|sensory system agents|mesh-ancestor
24865658|NCT05151510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24865659|NCT05151510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24865660|NCT05151510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24865661|NCT05151510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24808152|NCT02025374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24808153|NCT02025374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865682|NCT05151016|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24865683|NCT05151016|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24865684|NCT05151016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24865685|NCT05151016|Contraceptive Agents|contraceptive agents|mesh-ancestor
24865686|NCT05151016|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24865687|NCT05151016|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24865688|NCT05151016|Hormone Antagonists|hormone antagonists|mesh-ancestor
24795868|NCT01946555|Buprenorphine|buprenorphine|mesh-list
24983167|NCT02083250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983169|NCT02083250|Immunologic Factors|immunologic factors|mesh-ancestor
24983170|NCT02083250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865689|NCT05151016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24865690|NCT05151016|Luteolytic Agents|luteolytic agents|mesh-ancestor
24865691|NCT05151016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24865692|NCT05151016|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25053910|NCT00004093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053911|NCT00004093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25053912|NCT00004093|Immunologic Factors|immunologic factors|mesh-ancestor
24712967|NCT01523379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25053913|NCT00004093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25053915|NCT00002479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25053916|NCT00002479|Keratolytic Agents|keratolytic agents|mesh-ancestor
25053917|NCT00002479|Dermatologic Agents|dermatologic agents|mesh-ancestor
25053918|NCT00002429|Lamivudine|lamivudine|mesh-list
25053919|NCT00002429|Zidovudine|zidovudine|mesh-list
24625556|NCT01082458|Remifentanil|remifentanil|mesh-list
24625557|NCT01082458|Anesthetics, Local|anesthetics, local|mesh-ancestor
24625558|NCT01082458|Anesthetics|anesthetics|mesh-ancestor
24446048|NCT00303745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24937141|NCT04032548|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24937142|NCT04032548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24937143|NCT04032548|Disinfectants|disinfectants|mesh-ancestor
24937144|NCT04032236|Caffeine|caffeine|mesh-list
24937145|NCT04032236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24937146|NCT04032236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446057|NCT00303758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24446085|NCT00303771|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24446086|NCT00303771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24952377|NCT03894683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24952378|NCT03894189|Theophylline|theophylline|mesh-list
24952379|NCT03894189|Doxapram|doxapram|mesh-list
24952380|NCT03894189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24952382|NCT03894189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24952383|NCT03894189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952384|NCT03894189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24952385|NCT03894189|Respiratory System Agents|respiratory system agents|mesh-ancestor
24952386|NCT03894189|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24952387|NCT03894189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952388|NCT03894189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808224|NCT02025868|Antiviral Agents|antiviral agents|mesh-ancestor
24545704|NCT00694460|Immunologic Factors|immunologic factors|mesh-ancestor
25054161|NCT03531437|Estrogens|estrogens|mesh-ancestor
24865777|NCT04991350|Growth Inhibitors|growth inhibitors|mesh-ancestor
25697993|NCT02084706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25697994|NCT02084706|Sensory System Agents|sensory system agents|mesh-ancestor
25697995|NCT02084706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25697996|NCT02084706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25697997|NCT02084706|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25106562|NCT02383251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106563|NCT02383251|Tubulin Modulators|tubulin modulators|mesh-ancestor
25106564|NCT02383251|Antimitotic Agents|antimitotic agents|mesh-ancestor
25106565|NCT02383251|Mitosis Modulators|mitosis modulators|mesh-ancestor
25106566|NCT02383251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865778|NCT04971031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24865779|NCT04971031|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24865781|NCT04940572|Anticonvulsants|anticonvulsants|mesh-ancestor
24865782|NCT04940572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24865783|NCT04940572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865788|NCT04940572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24865800|NCT04933058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24865801|NCT04933058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24865802|NCT04933058|Anesthetics, General|anesthetics, general|mesh-ancestor
24865803|NCT04933058|Anesthetics|anesthetics|mesh-ancestor
24865804|NCT04933058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24865805|NCT04933058|Antipyretics|antipyretics|mesh-ancestor
24952397|NCT03894085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24952398|NCT03894085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24952399|NCT03894085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952400|NCT03894085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24952401|NCT03894085|Serotonin Agents|serotonin agents|mesh-ancestor
24952402|NCT03894085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952403|NCT03894085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24952404|NCT03894085|Antidepressive Agents|antidepressive agents|mesh-ancestor
24952405|NCT03894085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25053920|NCT00002429|Stavudine|stavudine|mesh-list
25053921|NCT00002429|Didanosine|didanosine|mesh-list
25053922|NCT00002429|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
25053923|NCT00002429|Nelfinavir|nelfinavir|mesh-list
25053924|NCT00002429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25053925|NCT00002429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25053926|NCT00002429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808240|NCT02025881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24808242|NCT02025881|Alkylating Agents|alkylating agents|mesh-ancestor
25053927|NCT00002429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053928|NCT00002429|Antiviral Agents|antiviral agents|mesh-ancestor
25053929|NCT00002429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25053930|NCT00002429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25053936|NCT00002411|Lamivudine|lamivudine|mesh-list
25053947|NCT00002411|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25053956|NCT00002371|Indinavir|indinavir|mesh-list
25053957|NCT00002371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25697998|NCT02084706|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25697999|NCT02084706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25698000|NCT02084706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698001|NCT02084706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25698002|NCT02084706|Glucocorticoids|glucocorticoids|mesh-ancestor
25698003|NCT02084706|Hormones|hormones|mesh-ancestor
25698004|NCT02084706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25698005|NCT02084706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25698006|NCT02084706|Immunologic Factors|immunologic factors|mesh-ancestor
25698007|NCT02084706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25698008|NCT02084797|Tolvaptan|tolvaptan|mesh-list
25698009|NCT02084797|Vasopressins|vasopressins|mesh-list
25698010|NCT02084797|Arginine Vasopressin|arginine vasopressin|mesh-list
25698011|NCT02084797|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25698012|NCT02084797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698013|NCT02084797|Natriuretic Agents|natriuretic agents|mesh-ancestor
25698014|NCT02084797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698015|NCT02084797|Hemostatics|hemostatics|mesh-ancestor
24983285|NCT01453946|Respiratory System Agents|respiratory system agents|mesh-ancestor
24983288|NCT01453946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24983290|NCT01444092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24983291|NCT01444092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24983292|NCT01444092|Autonomic Agents|autonomic agents|mesh-ancestor
25053958|NCT00002371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25053959|NCT00002371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053960|NCT00002371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25053961|NCT00002371|Antiviral Agents|antiviral agents|mesh-ancestor
25053962|NCT00002371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25053963|NCT00002371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25053964|NCT00002371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25053965|NCT00002371|Antimetabolites|antimetabolites|mesh-ancestor
25053966|NCT00002371|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25053967|NCT00002371|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25053968|NCT00002371|Protease Inhibitors|protease inhibitors|mesh-ancestor
25053969|NCT00002246|Stavudine|stavudine|mesh-list
25053970|NCT00002246|Antimetabolites|antimetabolites|mesh-ancestor
25053971|NCT00002246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808277|NCT02026050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25015758|NCT00963469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015759|NCT00963469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015760|NCT00963469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25053972|NCT00002246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25053973|NCT00002246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25053974|NCT00002246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25053975|NCT00002246|Antiviral Agents|antiviral agents|mesh-ancestor
25053976|NCT00002246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25053977|NCT00002246|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25053978|NCT00002246|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24713646|NCT01526850|Hormones|hormones|mesh-ancestor
25053979|NCT00002240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25053980|NCT00002240|Nelfinavir|nelfinavir|mesh-list
25053981|NCT00002240|Stavudine|stavudine|mesh-list
25054001|NCT00002224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25054002|NCT00002224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25054003|NCT00002224|Antiviral Agents|antiviral agents|mesh-ancestor
25054004|NCT00002224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25054005|NCT00002224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25054006|NCT00002224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25054007|NCT00002224|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25054008|NCT00002224|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25054009|NCT00002224|Protease Inhibitors|protease inhibitors|mesh-ancestor
24446090|NCT00303771|Vitamin B Complex|vitamin b complex|mesh-ancestor
24865855|NCT04750759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865856|NCT04750759|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24865857|NCT04750759|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24865858|NCT04750759|Anticestodal Agents|anticestodal agents|mesh-ancestor
24865859|NCT04750759|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24865860|NCT04750759|Anthelmintics|anthelmintics|mesh-ancestor
24865877|NCT04597372|Tamsulosin|tamsulosin|mesh-list
24865878|NCT04597372|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25054010|NCT00002207|Stavudine|stavudine|mesh-list
25054011|NCT00002207|Didanosine|didanosine|mesh-list
25054012|NCT00002207|Antimetabolites|antimetabolites|mesh-ancestor
25054013|NCT00002207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054014|NCT00002207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25054015|NCT00002207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25054016|NCT00002207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25054017|NCT00002207|Antiviral Agents|antiviral agents|mesh-ancestor
25698016|NCT02084797|Coagulants|coagulants|mesh-ancestor
25698017|NCT02084797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25698018|NCT02084797|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25698019|NCT02085070|Pembrolizumab|pembrolizumab|mesh-list
25698020|NCT02085070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25698021|NCT02085070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25698022|NCT02085161|Tiotropium Bromide|tiotropium bromide|mesh-list
25698023|NCT02085161|Olodaterol|olodaterol|mesh-list
25698024|NCT02085161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25698025|NCT02085161|Autonomic Agents|autonomic agents|mesh-ancestor
25698026|NCT02085161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24983376|NCT00116220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983377|NCT00116220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24983378|NCT00116220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24983379|NCT00116220|Androgen Antagonists|androgen antagonists|mesh-ancestor
24983380|NCT00116220|Hormone Antagonists|hormone antagonists|mesh-ancestor
25698027|NCT02085161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698028|NCT02085161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24983381|NCT00116220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25054018|NCT00002207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24808337|NCT02026583|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24808338|NCT02026583|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24808339|NCT02026583|Antimetabolites|antimetabolites|mesh-ancestor
24592210|NCT00920868|Bevacizumab|bevacizumab|mesh-list
24484120|NCT00446680|Mannitol|mannitol|mesh-list
25054162|NCT03531437|Hormones|hormones|mesh-ancestor
24865892|NCT04558866|Testosterone enanthate|testosterone enanthate|mesh-list
24865893|NCT04558866|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24713648|NCT01526876|Clevidipine|clevidipine|mesh-list
24713790|NCT01527474|Antidepressive Agents|antidepressive agents|mesh-ancestor
25054108|NCT03531970|Mydriatics|mydriatics|mesh-ancestor
25054020|NCT00002207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25054021|NCT03532620|Calcium, Dietary|calcium, dietary|mesh-list
25054022|NCT03532620|Atorvastatin|atorvastatin|mesh-list
25054023|NCT03532620|Pitavastatin|pitavastatin|mesh-list
25054024|NCT03532620|Calcium|calcium|mesh-list
25054025|NCT03532620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25054026|NCT03532620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054027|NCT03532620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25054028|NCT03532620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25054029|NCT03532620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25054030|NCT03532620|Antimetabolites|antimetabolites|mesh-ancestor
25054031|NCT03532620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054042|NCT03532464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24808340|NCT02026583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808341|NCT02026583|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24808342|NCT02026583|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24808343|NCT02026583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808345|NCT02026765|Anticoagulants|anticoagulants|mesh-ancestor
24808346|NCT02026765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24808347|NCT02026765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24808348|NCT02026765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808349|NCT02026778|Betahistine|betahistine|mesh-list
24808350|NCT02026778|Ondansetron|ondansetron|mesh-list
24808351|NCT02026778|Antiemetics|antiemetics|mesh-ancestor
24808352|NCT02026778|Autonomic Agents|autonomic agents|mesh-ancestor
24808356|NCT02026778|Antipruritics|antipruritics|mesh-ancestor
24865904|NCT04556370|Adrenergic Agents|adrenergic agents|mesh-ancestor
24865905|NCT04556370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25054059|NCT03532178|Rocuronium|rocuronium|mesh-list
25054060|NCT03532178|Succinylcholine|succinylcholine|mesh-list
25054065|NCT03532178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054066|NCT03532178|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
25054067|NCT03532087|Denosumab|denosumab|mesh-list
25054068|NCT03532087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25054069|NCT03532087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054070|NCT03532035|Brincidofovir|brincidofovir|mesh-list
25054071|NCT03532035|Antiviral Agents|antiviral agents|mesh-ancestor
25054072|NCT03532035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25054073|NCT03531970|Dexamethasone|dexamethasone|mesh-list
25054074|NCT03531970|Dexamethasone acetate|dexamethasone acetate|mesh-list
25054075|NCT03531970|Lidocaine|lidocaine|mesh-list
25698029|NCT02085161|Respiratory System Agents|respiratory system agents|mesh-ancestor
25698030|NCT02085161|Parasympatholytics|parasympatholytics|mesh-ancestor
25698031|NCT02085161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25698032|NCT02085161|Cholinergic Agents|cholinergic agents|mesh-ancestor
25698033|NCT02085161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25698034|NCT02085161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698035|NCT02085252|Bicalutamide|bicalutamide|mesh-list
25698036|NCT02085252|Leuprolide|leuprolide|mesh-list
25698037|NCT02085252|Androgen Antagonists|androgen antagonists|mesh-ancestor
25698038|NCT02085252|Hormone Antagonists|hormone antagonists|mesh-ancestor
25698039|NCT02085252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25698040|NCT02085252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698041|NCT02085252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808363|NCT02026778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25054076|NCT03531970|Epinephrine|epinephrine|mesh-list
25054077|NCT03531970|BB 1101|bb 1101|mesh-list
25054078|NCT03531970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25054079|NCT03531970|Antiemetics|antiemetics|mesh-ancestor
25054080|NCT03531970|Autonomic Agents|autonomic agents|mesh-ancestor
25054084|NCT03531970|Glucocorticoids|glucocorticoids|mesh-ancestor
25054105|NCT03531970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25054106|NCT03531970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25054107|NCT03531970|Respiratory System Agents|respiratory system agents|mesh-ancestor
25054133|NCT03531918|Sensory System Agents|sensory system agents|mesh-ancestor
24808454|NCT02027324|Chlorhexidine|chlorhexidine|mesh-list
25054149|NCT03531749|Ascorbic Acid|ascorbic acid|mesh-list
25054150|NCT03531749|Antioxidants|antioxidants|mesh-ancestor
25054151|NCT03531749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054152|NCT03531749|Protective Agents|protective agents|mesh-ancestor
25054153|NCT03531749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054154|NCT03531749|Vitamins|vitamins|mesh-ancestor
25054155|NCT03531749|Micronutrients|micronutrients|mesh-ancestor
25054156|NCT03531697|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25054157|NCT03531697|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25054158|NCT03531437|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25054159|NCT03531437|Gestodene|gestodene|mesh-list
25054160|NCT03531437|Estradiol|estradiol|mesh-list
25054168|NCT03531437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25054169|NCT03531437|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25054170|NCT03531437|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24622867|NCT01068925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622868|NCT01068925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24622869|NCT01068925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24622870|NCT01068925|Antiviral Agents|antiviral agents|mesh-ancestor
24622871|NCT01068925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24814181|NCT02063100|Losartan|losartan|mesh-list
24814195|NCT02063139|Respiratory System Agents|respiratory system agents|mesh-ancestor
24814196|NCT02063139|Dermatologic Agents|dermatologic agents|mesh-ancestor
24814197|NCT02063139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24814200|NCT02063139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24814201|NCT02063269|Rivastigmine|rivastigmine|mesh-list
24814202|NCT02063269|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24814203|NCT02063269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24814204|NCT02063269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609843|NCT00998556|Bromocriptine|bromocriptine|mesh-list
24814205|NCT02063269|Cholinergic Agents|cholinergic agents|mesh-ancestor
24814206|NCT02063269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24865921|NCT04365088|Immunologic Factors|immunologic factors|mesh-ancestor
24865922|NCT04365088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865923|NCT04349579|Rifamycins|rifamycins|mesh-list
24865924|NCT04349579|Rifamycin SV|rifamycin sv|mesh-list
24865925|NCT04349579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24865926|NCT04349579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24865927|NCT04349579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24865928|NCT04234529|Caffeine|caffeine|mesh-list
24865929|NCT04234529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24865930|NCT04234529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865931|NCT04234529|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24865932|NCT04234529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24865933|NCT04234529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865934|NCT04234529|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24865935|NCT04234529|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24865936|NCT04234529|Purinergic Agents|purinergic agents|mesh-ancestor
24865938|NCT04217954|Bevacizumab|bevacizumab|mesh-list
24808526|NCT02027753|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24484606|NCT00449423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24484607|NCT00449423|Antimetabolites|antimetabolites|mesh-ancestor
24484608|NCT00449423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484609|NCT00449423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24484610|NCT00449436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
24484611|NCT00449436|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
24484612|NCT00449436|Protease Inhibitors|protease inhibitors|mesh-list
24865946|NCT04192110|Diuretics|diuretics|mesh-list
25698042|NCT02085252|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25698043|NCT02085252|Fertility Agents|fertility agents|mesh-ancestor
25698044|NCT02085252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24865947|NCT04192110|Natriuretic Agents|natriuretic agents|mesh-ancestor
24865948|NCT04192110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865949|NCT04182100|Aspirin|aspirin|mesh-list
24865950|NCT04182100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24865951|NCT04182100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24865980|NCT04056182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24865981|NCT04056182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865982|NCT04056182|Sensory System Agents|sensory system agents|mesh-ancestor
24865983|NCT04056182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24865984|NCT04056182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24865985|NCT04056182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24865986|NCT04056182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24865987|NCT04056182|Adrenergic Agents|adrenergic agents|mesh-ancestor
24865988|NCT04056182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25054256|NCT03530488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24808531|NCT02027753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866016|NCT03948867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24546004|NCT00696475|Choline|choline|mesh-list
24446158|NCT00303836|Analgesics|analgesics|mesh-ancestor
24446159|NCT00303836|Sensory System Agents|sensory system agents|mesh-ancestor
25054270|NCT03530462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25054271|NCT03530462|Immunologic Factors|immunologic factors|mesh-ancestor
25054272|NCT03530462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054273|NCT03530462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25054274|NCT03530462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25054275|NCT03530462|Alkylating Agents|alkylating agents|mesh-ancestor
24808539|NCT02027792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24808540|NCT02027792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24808541|NCT02027792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24808542|NCT02027792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866050|NCT03789591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866052|NCT03789591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866053|NCT03789591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866054|NCT03789591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24546026|NCT00696540|Albuterol|albuterol|mesh-list
24546027|NCT00696540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24546028|NCT00696540|Autonomic Agents|autonomic agents|mesh-ancestor
25054297|NCT03530436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054298|NCT03530436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25054299|NCT03530436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25054300|NCT03530436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25054301|NCT03530436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25054302|NCT03530436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937527|NCT04027972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24446192|NCT00304018|Fludarabine phosphate|fludarabine phosphate|mesh-list
24446194|NCT00304018|Busulfan|busulfan|mesh-list
24446195|NCT00304018|Tacrolimus|tacrolimus|mesh-list
24446196|NCT00304018|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24446197|NCT00304018|Sargramostim|sargramostim|mesh-list
24446198|NCT00304018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24446199|NCT00304018|Glucocorticoids|glucocorticoids|mesh-ancestor
24446200|NCT00304018|Hormones|hormones|mesh-ancestor
24446201|NCT00304018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24446202|NCT00304018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446203|NCT00304018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24446204|NCT00304018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866111|NCT03574792|Oxycodone|oxycodone|mesh-list
24866112|NCT03574792|Methadone|methadone|mesh-list
24866113|NCT03574792|Gabapentin|gabapentin|mesh-list
24866114|NCT03574792|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24866115|NCT03574792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24866116|NCT03574792|Narcotics|narcotics|mesh-ancestor
24866117|NCT03574792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24866118|NCT03574792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866119|NCT03574792|Analgesics|analgesics|mesh-ancestor
24866120|NCT03574792|Sensory System Agents|sensory system agents|mesh-ancestor
24866121|NCT03574792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24866122|NCT03574792|Anticonvulsants|anticonvulsants|mesh-ancestor
24866123|NCT03574792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24866124|NCT03574792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25698045|NCT02085252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25698046|NCT02085447|Haloperidol|haloperidol|mesh-list
25698047|NCT02085447|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24866125|NCT03574792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24866155|NCT03356483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866156|NCT03356483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25054387|NCT03530033|Sensory System Agents|sensory system agents|mesh-ancestor
25054388|NCT03530033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25054389|NCT03530033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24866167|NCT03289650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866168|NCT03289650|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25054417|NCT03530007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25054418|NCT03530007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25054419|NCT03530007|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24866170|NCT03289650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866172|NCT03276052|Anticonvulsants|anticonvulsants|mesh-ancestor
24814262|NCT02063529|Antimetabolites|antimetabolites|mesh-ancestor
24814263|NCT02063529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814264|NCT02063529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24546156|NCT00696982|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25054427|NCT03529955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25054428|NCT03529955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25054429|NCT03529955|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25054430|NCT03529955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25054431|NCT03529955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25054432|NCT03529955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054433|NCT03529929|Methylprednisolone|methylprednisolone|mesh-list
25054434|NCT03529929|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25054435|NCT03529929|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25054436|NCT03529929|Prednisolone|prednisolone|mesh-list
25054437|NCT03529929|Prednisolone acetate|prednisolone acetate|mesh-list
25054438|NCT03529929|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25054439|NCT03529929|Prednisolone phosphate|prednisolone phosphate|mesh-list
25054440|NCT03529929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25054441|NCT03529929|Antiemetics|antiemetics|mesh-ancestor
25054442|NCT03529929|Autonomic Agents|autonomic agents|mesh-ancestor
25054443|NCT03529929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24808754|NCT02028949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24814280|NCT02063568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24546178|NCT00697021|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24546179|NCT00697021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24546180|NCT00697021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24546181|NCT00697021|Antipyretics|antipyretics|mesh-ancestor
24546182|NCT00697021|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24546183|NCT00697021|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24546184|NCT00697021|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24546185|NCT00697021|Purinergic Agents|purinergic agents|mesh-ancestor
24546187|NCT00697034|Capsaicin|capsaicin|mesh-list
25016802|NCT04356495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016803|NCT04356495|Glucocorticoids|glucocorticoids|mesh-ancestor
24814285|NCT02063620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24866176|NCT03219437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24866177|NCT03219437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866178|NCT03219437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25054980|NCT03525821|Anesthetics|anesthetics|mesh-ancestor
24866260|NCT02269917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866261|NCT02269917|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24866268|NCT01331616|Bevacizumab|bevacizumab|mesh-list
24446073|NCT00303771|Fluorouracil|fluorouracil|mesh-list
24866269|NCT01331616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24866270|NCT01331616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866271|NCT01331616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24866272|NCT01331616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24866273|NCT01331616|Growth Substances|growth substances|mesh-ancestor
24866274|NCT01331616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698048|NCT02085447|Haloperidol decanoate|haloperidol decanoate|mesh-list
25698049|NCT02085447|Antipsychotic Agents|antipsychotic agents|mesh-list
24866275|NCT01331616|Growth Inhibitors|growth inhibitors|mesh-ancestor
24866278|NCT01109004|Bortezomib|bortezomib|mesh-list
25698050|NCT02085447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24866279|NCT01109004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24866280|NCT01109004|Antiemetics|antiemetics|mesh-ancestor
24866281|NCT01109004|Autonomic Agents|autonomic agents|mesh-ancestor
24866282|NCT01109004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24866283|NCT01109004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866284|NCT01109004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24866285|NCT01109004|Glucocorticoids|glucocorticoids|mesh-ancestor
24866286|NCT01109004|Hormones|hormones|mesh-ancestor
24866287|NCT01109004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24866288|NCT01109004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24866289|NCT01109004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866290|NCT01109004|Immunologic Factors|immunologic factors|mesh-ancestor
24866291|NCT01109004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25054532|NCT03529201|Sensory System Agents|sensory system agents|mesh-ancestor
25054533|NCT03529201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25054534|NCT03529201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25054535|NCT03529201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25054536|NCT03529201|Anesthetics, General|anesthetics, general|mesh-ancestor
25054537|NCT03529201|Anesthetics|anesthetics|mesh-ancestor
25054538|NCT03529201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25054539|NCT03529201|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25054540|NCT03529201|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24603970|NCT00976326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054567|NCT03529149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054568|NCT03529149|Vasodilator Agents|vasodilator agents|mesh-ancestor
25054569|NCT03529149|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25054570|NCT03529149|Serotonin Agents|serotonin agents|mesh-ancestor
25054571|NCT03529149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25054572|NCT03529149|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25054574|NCT03529149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25054575|NCT03529149|Adrenergic Agents|adrenergic agents|mesh-ancestor
25054577|NCT03529097|Diclofenac|diclofenac|mesh-list
25054578|NCT03529097|Morphine|morphine|mesh-list
25054579|NCT03529097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25054580|NCT03529097|Narcotics|narcotics|mesh-ancestor
25054581|NCT03529097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25054582|NCT03529097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054583|NCT03529097|Analgesics|analgesics|mesh-ancestor
25054584|NCT03529097|Sensory System Agents|sensory system agents|mesh-ancestor
25054585|NCT03529097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25054586|NCT03529097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24808832|NCT02029482|Ponesimod|ponesimod|mesh-list
25054609|NCT03529032|Antitussive Agents|antitussive agents|mesh-ancestor
25054610|NCT03529032|Respiratory System Agents|respiratory system agents|mesh-ancestor
25054611|NCT03528967|Aspirin|aspirin|mesh-list
25054612|NCT03528967|Enoxaparin|enoxaparin|mesh-list
25054613|NCT03528967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25054614|NCT03528967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25054615|NCT03528967|Analgesics|analgesics|mesh-ancestor
25054616|NCT03528967|Sensory System Agents|sensory system agents|mesh-ancestor
25054617|NCT03528967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25054618|NCT03528967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054626|NCT03528967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866321|NCT05153928|Contraceptive Agents|contraceptive agents|mesh-ancestor
24866322|NCT05153928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25054658|NCT03528785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25054659|NCT03528785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25054660|NCT03528785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25054661|NCT03528785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808889|NCT02029612|Autonomic Agents|autonomic agents|mesh-ancestor
24446264|NCT00304252|Interferon-beta|interferon-beta|mesh-list
24446265|NCT00304252|Interferon beta-1a|interferon beta-1a|mesh-list
24446266|NCT00304252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446267|NCT00304252|Antiviral Agents|antiviral agents|mesh-ancestor
24866334|NCT05153785|Sensory System Agents|sensory system agents|mesh-ancestor
25698051|NCT02085447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25698052|NCT02085447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698053|NCT02085447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25698054|NCT02085447|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25698055|NCT02085447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24866335|NCT05153785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24866336|NCT05153785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24866337|NCT05153785|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25054697|NCT03528616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25054698|NCT03528616|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24808930|NCT02029950|Cytarabine|cytarabine|mesh-list
24866338|NCT05153785|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25054699|NCT03528616|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25054700|NCT03528616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24808992|NCT02030483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24808993|NCT02030483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24808994|NCT02030483|Growth Substances|growth substances|mesh-ancestor
24808999|NCT02030561|Trastuzumab|trastuzumab|mesh-list
24809000|NCT02030561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24809001|NCT02030561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866370|NCT05153070|Immunologic Factors|immunologic factors|mesh-ancestor
24866371|NCT05153070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866372|NCT05153070|Antifungal Agents|antifungal agents|mesh-ancestor
24866417|NCT05152511|Pentoxifylline|pentoxifylline|mesh-list
24866418|NCT05152511|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24866419|NCT05152511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866420|NCT05152511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866421|NCT05152511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24866422|NCT05152511|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24866423|NCT05152511|Protective Agents|protective agents|mesh-ancestor
24866424|NCT05152511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866425|NCT05152511|Vasodilator Agents|vasodilator agents|mesh-ancestor
24866426|NCT05152511|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24866428|NCT05132985|Carboplatin|carboplatin|mesh-list
24866430|NCT05132985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866431|NCT05132985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866432|NCT05132985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866433|NCT05132985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24867067|NCT03655197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24814324|NCT02063945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24866468|NCT04947631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866473|NCT04884893|Nitrous Oxide|nitrous oxide|mesh-list
24866474|NCT04884893|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24866475|NCT04884893|Anesthetics, General|anesthetics, general|mesh-ancestor
24866476|NCT04884893|Anesthetics|anesthetics|mesh-ancestor
24446095|NCT00303784|Estrogens|estrogens|mesh-ancestor
24866487|NCT04778267|Antiemetics|antiemetics|mesh-ancestor
24866488|NCT04778267|Autonomic Agents|autonomic agents|mesh-ancestor
24866570|NCT05259007|Propolis|propolis|mesh-list
24866571|NCT05259007|Lansoprazole|lansoprazole|mesh-list
24486748|NCT00459836|Tubulin Modulators|tubulin modulators|mesh-ancestor
24866572|NCT05259007|Dexlansoprazole|dexlansoprazole|mesh-list
24866573|NCT05259007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24866574|NCT05259007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24866575|NCT05259007|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24866576|NCT05259007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866577|NCT05259007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866578|NCT05259007|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24866579|NCT05259007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24866580|NCT05259007|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24866581|NCT05259007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24866582|NCT05259007|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24866583|NCT05258955|Chlorhexidine|chlorhexidine|mesh-list
24866584|NCT05258955|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24866585|NCT05258955|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24866586|NCT05258955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24866588|NCT05258955|Dermatologic Agents|dermatologic agents|mesh-ancestor
24866650|NCT05258136|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24866651|NCT05258136|Immunologic Factors|immunologic factors|mesh-ancestor
24866652|NCT05258136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866653|NCT05258045|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24866654|NCT05258045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25407136|NCT03516981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25698056|NCT02085447|Serotonin Agents|serotonin agents|mesh-ancestor
25698057|NCT02085447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25698058|NCT02085447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866655|NCT05258045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866656|NCT05257148|Nebivolol|nebivolol|mesh-list
24866657|NCT05257148|Zofenopril|zofenopril|mesh-list
24866658|NCT05257148|Captopril|captopril|mesh-list
24866659|NCT05257148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24866660|NCT05257148|Vasodilator Agents|vasodilator agents|mesh-ancestor
24866725|NCT05033808|Epirubicin|epirubicin|mesh-list
24866726|NCT05033808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24866727|NCT05033808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866731|NCT05033808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866732|NCT05012644|Palbociclib|palbociclib|mesh-list
24866733|NCT05012644|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24866734|NCT05012644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866735|NCT05012644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24866736|NCT05012644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866737|NCT05012644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866738|NCT05012644|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24866739|NCT05012644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24866743|NCT05008003|Vitamin D|vitamin d|mesh-list
24866831|NCT04482673|Vitamin D|vitamin d|mesh-list
24866832|NCT04482673|Ergocalciferols|ergocalciferols|mesh-list
24866833|NCT04482673|Cholecalciferol|cholecalciferol|mesh-list
24866834|NCT04482673|Vitamins|vitamins|mesh-list
24866835|NCT04482673|Micronutrients|micronutrients|mesh-ancestor
24866836|NCT04482673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866837|NCT04482673|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24866838|NCT04482673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24866839|NCT04472299|Ropivacaine|ropivacaine|mesh-list
24546852|NCT00700687|Antipyretics|antipyretics|mesh-ancestor
24446334|NCT00304473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24866841|NCT04472299|Anesthetics|anesthetics|mesh-ancestor
24866842|NCT04472299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24866843|NCT04472299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866844|NCT04472299|Sensory System Agents|sensory system agents|mesh-ancestor
25054776|NCT03527628|Dacarbazine|dacarbazine|mesh-list
24866858|NCT04401553|Cephalosporins|cephalosporins|mesh-list
24866859|NCT04401553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24866860|NCT04390646|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24866861|NCT04390646|Hormones|hormones|mesh-ancestor
24866862|NCT04390646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24866863|NCT04390646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866864|NCT04379011|Brivaracetam|brivaracetam|mesh-list
24866865|NCT04379011|Anticonvulsants|anticonvulsants|mesh-ancestor
24866866|NCT04370418|Fluorouracil|fluorouracil|mesh-list
25054795|NCT03527628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25054796|NCT03527628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25054797|NCT03527628|Tubulin Modulators|tubulin modulators|mesh-ancestor
25054798|NCT03527628|Antimitotic Agents|antimitotic agents|mesh-ancestor
25054799|NCT03527628|Mitosis Modulators|mitosis modulators|mesh-ancestor
25054801|NCT03527381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25054802|NCT03527381|Autonomic Agents|autonomic agents|mesh-ancestor
25054803|NCT03527381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25054804|NCT03527381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054805|NCT03527381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25054806|NCT03527381|Respiratory System Agents|respiratory system agents|mesh-ancestor
25054807|NCT03527381|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25054808|NCT03527381|Antioxidants|antioxidants|mesh-ancestor
25054809|NCT03527381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054810|NCT03527381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25054811|NCT03527381|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25054812|NCT03527381|Vasodilator Agents|vasodilator agents|mesh-ancestor
25054813|NCT03527381|Gasotransmitters|gasotransmitters|mesh-ancestor
25054814|NCT03527381|Protective Agents|protective agents|mesh-ancestor
25054815|NCT03527355|Vaccines|vaccines|mesh-list
24866869|NCT04370418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24866870|NCT04370418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866871|NCT04370418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25054831|NCT03527134|Amantadine|amantadine|mesh-list
25054832|NCT03527134|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25054833|NCT03527134|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25054834|NCT03527134|Antiviral Agents|antiviral agents|mesh-ancestor
25698059|NCT02085447|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25698060|NCT02085447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25698061|NCT02085447|Dopamine Agents|dopamine agents|mesh-ancestor
25054835|NCT03527134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25054836|NCT03527134|Dopamine Agents|dopamine agents|mesh-ancestor
25054837|NCT03527134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25054838|NCT03527134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054839|NCT03527134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25054840|NCT03527134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25054841|NCT03527134|Analgesics|analgesics|mesh-ancestor
24569764|NCT00801866|Growth Inhibitors|growth inhibitors|mesh-ancestor
24569766|NCT00801879|Calcium|calcium|mesh-list
24569767|NCT00801879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24569768|NCT00801879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569769|NCT00801879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24569770|NCT00801879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24569771|NCT00801879|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24952408|NCT03894085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952409|NCT03894345|Prazosin|prazosin|mesh-list
24952410|NCT03894345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24952411|NCT03894345|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24952413|NCT03894345|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24814394|NCT02064465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24814395|NCT02064465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814396|NCT02064465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24610145|NCT00999986|Immunologic Factors|immunologic factors|mesh-ancestor
24610146|NCT00999986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610147|NCT00999986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24610148|NCT00999986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24610149|NCT00999986|Alkylating Agents|alkylating agents|mesh-ancestor
24610150|NCT00999986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610151|NCT00999986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610152|NCT00999986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24866968|NCT03792750|Linrodostat|linrodostat|mesh-list
24866969|NCT03792750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24866970|NCT03792750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866971|NCT03792750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24866972|NCT03792750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952443|NCT03894280|Protective Agents|protective agents|mesh-ancestor
24952444|NCT03894046|Imipenem|imipenem|mesh-list
24952445|NCT03894046|Colistin|colistin|mesh-list
24952446|NCT03894046|Sulbactam|sulbactam|mesh-list
24952447|NCT03894046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24952448|NCT03894046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24867064|NCT03655197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24867065|NCT03655197|Antimalarials|antimalarials|mesh-ancestor
24867066|NCT03655197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24867075|NCT03614728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24867076|NCT03614728|Antimetabolites|antimetabolites|mesh-ancestor
24547154|NCT00702728|Furosemide|furosemide|mesh-list
24867077|NCT03614728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867078|NCT03614728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24952454|NCT03894007|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24952456|NCT03894007|Carboplatin|carboplatin|mesh-list
24952457|NCT03894007|Trastuzumab|trastuzumab|mesh-list
24952458|NCT03894007|Atezolizumab|atezolizumab|mesh-list
24952459|NCT03894007|Epirubicin|epirubicin|mesh-list
24952460|NCT03894007|Pertuzumab|pertuzumab|mesh-list
24952461|NCT03894007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24952462|NCT03894007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24867164|NCT03306979|Acetylcysteine|acetylcysteine|mesh-list
25054932|NCT03526107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054933|NCT03526107|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25054935|NCT03526107|Purinergic Agents|purinergic agents|mesh-ancestor
25054936|NCT03526107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25054937|NCT03526107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25054938|NCT03526107|Autonomic Agents|autonomic agents|mesh-ancestor
25698062|NCT02085447|Antiemetics|antiemetics|mesh-ancestor
25698063|NCT02085447|Autonomic Agents|autonomic agents|mesh-ancestor
25698064|NCT02085447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25698065|NCT02085447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25054939|NCT03526107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25054940|NCT03526107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25054941|NCT03526107|Respiratory System Agents|respiratory system agents|mesh-ancestor
25054942|NCT03526107|Vasodilator Agents|vasodilator agents|mesh-ancestor
25054943|NCT03526042|Losartan|losartan|mesh-list
24867228|NCT02940496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867229|NCT02940496|Antiviral Agents|antiviral agents|mesh-ancestor
24867230|NCT02940496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24867264|NCT02549092|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25054944|NCT03526042|Enalapril|enalapril|mesh-list
25054945|NCT03526042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
25054946|NCT03526042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25054947|NCT03526042|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25054948|NCT03526042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25054949|NCT03526042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25054950|NCT03526042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24809250|NCT02032134|Antioxidants|antioxidants|mesh-ancestor
24809251|NCT02032134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809252|NCT02032186|Magnesium citrate|magnesium citrate|mesh-list
24809253|NCT02032186|Cathartics|cathartics|mesh-ancestor
24809254|NCT02032186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24809256|NCT02032290|Ticagrelor|ticagrelor|mesh-list
24867389|NCT00585195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24867390|NCT00585195|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24867391|NCT00585195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24867392|NCT00585195|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24867393|NCT00585195|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24867394|NCT00585195|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24867395|NCT00585195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24867396|NCT00585195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24867397|NCT00585195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24867423|NCT04527003|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25054951|NCT03526042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054952|NCT03526042|Protease Inhibitors|protease inhibitors|mesh-ancestor
25054954|NCT03525925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25054955|NCT03525925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25054956|NCT03525925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25054958|NCT03525912|Ketamine|ketamine|mesh-list
25054979|NCT03525821|Anesthetics, General|anesthetics, general|mesh-ancestor
24867424|NCT04527003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867425|NCT04527003|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24867426|NCT04527003|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24867429|NCT04457323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24867430|NCT04457323|Sympatholytics|sympatholytics|mesh-ancestor
24867431|NCT04457323|Autonomic Agents|autonomic agents|mesh-ancestor
24867432|NCT04457323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24867433|NCT04457323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867434|NCT04457323|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25054981|NCT03525821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25054982|NCT03525821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25054983|NCT03525821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25054984|NCT03525821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25054985|NCT03525821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054986|NCT03525730|Pyrimethamine|pyrimethamine|mesh-list
25054987|NCT03525730|Valproic Acid|valproic acid|mesh-list
24809289|NCT02032654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24809291|NCT02032784|Octreotide|octreotide|mesh-list
24867449|NCT04448431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24867479|NCT04339049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24867480|NCT04339049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24867481|NCT04339049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24867482|NCT04339049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24867483|NCT04339049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25054989|NCT03525730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25054990|NCT03525730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25054991|NCT03525730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24445099|NCT00300378|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25054992|NCT03525730|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25054993|NCT03525730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25054994|NCT03525730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25054995|NCT03525730|Anticonvulsants|anticonvulsants|mesh-ancestor
24809294|NCT02032784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809295|NCT02032797|Progesterone|progesterone|mesh-list
24809296|NCT02032797|Progestins|progestins|mesh-ancestor
24809297|NCT02032797|Hormones|hormones|mesh-ancestor
24809298|NCT02032797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24809299|NCT02032797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809300|NCT02032836|Iloprost|iloprost|mesh-list
24867541|NCT04070573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24867542|NCT04070573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867543|NCT04070573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24867544|NCT04070573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24867545|NCT04070573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24867546|NCT04070573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24867547|NCT04070573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867548|NCT04070573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24867549|NCT04070573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24867550|NCT04070573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24867557|NCT04070443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867558|NCT03990077|Docetaxel|docetaxel|mesh-list
24867559|NCT03990077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24867560|NCT03990077|Tubulin Modulators|tubulin modulators|mesh-ancestor
24867561|NCT03990077|Antimitotic Agents|antimitotic agents|mesh-ancestor
24867562|NCT03990077|Mitosis Modulators|mitosis modulators|mesh-ancestor
24867569|NCT03842696|Tacrolimus|tacrolimus|mesh-list
24867570|NCT03842696|Cyclosporins|cyclosporins|mesh-list
24867571|NCT03842696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24867572|NCT03842696|Immunologic Factors|immunologic factors|mesh-ancestor
24867573|NCT03842696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055024|NCT03525522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24867577|NCT03842696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867578|NCT03842696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24867579|NCT03842696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24867580|NCT03842696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24867581|NCT03842696|Abortifacient Agents|abortifacient agents|mesh-ancestor
24867582|NCT03842696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24867583|NCT03842696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24867584|NCT03842696|Antimetabolites|antimetabolites|mesh-ancestor
24867585|NCT03842696|Dermatologic Agents|dermatologic agents|mesh-ancestor
24867586|NCT03842696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24867587|NCT03842696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24867588|NCT03842696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24867607|NCT03729258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24867608|NCT03729258|Antiviral Agents|antiviral agents|mesh-ancestor
24867616|NCT03729258|Sensory System Agents|sensory system agents|mesh-ancestor
24867617|NCT03729258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25055026|NCT03525522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25055027|NCT03525522|Respiratory System Agents|respiratory system agents|mesh-ancestor
24867636|NCT03490864|Melatonin|melatonin|mesh-list
24867645|NCT03455764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24867646|NCT03455764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24867647|NCT03455764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698066|NCT02085447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25698067|NCT02085460|Rebamipide|rebamipide|mesh-list
25698068|NCT02085460|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25698069|NCT02085460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25698070|NCT02085460|Antioxidants|antioxidants|mesh-ancestor
25698071|NCT02085460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698072|NCT02085460|Protective Agents|protective agents|mesh-ancestor
25698073|NCT02085460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445385|NCT00301457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698074|NCT02085460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445386|NCT00301483|Chrysarobin|chrysarobin|mesh-list
24445389|NCT00301483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24983694|NCT05177939|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24983695|NCT05177939|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24983696|NCT05177939|Prednisolone|prednisolone|mesh-list
24784497|NCT01908296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24867649|NCT03380507|Hydrocortisone|hydrocortisone|mesh-list
24867650|NCT03380507|Vitamins|vitamins|mesh-ancestor
25055038|NCT03525509|Respiratory System Agents|respiratory system agents|mesh-ancestor
24867714|NCT02777372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24867715|NCT02777372|Serotonin Agents|serotonin agents|mesh-ancestor
24867716|NCT02777372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867717|NCT02682901|Bromocriptine|bromocriptine|mesh-list
24867718|NCT02682901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24867719|NCT02682901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24867720|NCT02682901|Hormone Antagonists|hormone antagonists|mesh-ancestor
24867721|NCT02682901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24867722|NCT02682901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867723|NCT02682901|Dopamine Agonists|dopamine agonists|mesh-ancestor
24867724|NCT02682901|Dopamine Agents|dopamine agents|mesh-ancestor
24867725|NCT02682901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24547794|NCT00705770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24547795|NCT00705770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24547796|NCT00705770|Growth Substances|growth substances|mesh-ancestor
24547797|NCT00705770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547798|NCT00705770|Growth Inhibitors|growth inhibitors|mesh-ancestor
24867813|NCT02325960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24867815|NCT05155592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24867816|NCT05155592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24867817|NCT05155215|Cyclophosphamide|cyclophosphamide|mesh-list
24867818|NCT05155215|Fludarabine|fludarabine|mesh-list
24867819|NCT05155215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24867820|NCT05155215|Immunologic Factors|immunologic factors|mesh-ancestor
24867821|NCT05155215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867822|NCT05155215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24938300|NCT04020263|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25055048|NCT03524950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25055049|NCT03524950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25055050|NCT03524950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24446553|NCT00305370|Aripiprazole|aripiprazole|mesh-list
24446554|NCT00305370|Antidepressive Agents|antidepressive agents|mesh-ancestor
24446555|NCT00305370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24446556|NCT00305370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24446557|NCT00305370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25055054|NCT03524950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719021|NCT01558648|Analgesics|analgesics|mesh-list
25055056|NCT03524937|Antioxidants|antioxidants|mesh-ancestor
25055057|NCT03524937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868087|NCT03829462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24868088|NCT03801278|Bemarituzumab|bemarituzumab|mesh-list
24868089|NCT03801278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24868090|NCT03801278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24868091|NCT03774641|Lamotrigine|lamotrigine|mesh-list
24868092|NCT03774641|Anticonvulsants|anticonvulsants|mesh-ancestor
24868093|NCT03774641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24868094|NCT03774641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24868095|NCT03774641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868096|NCT03774641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25055074|NCT03524833|Lansoprazole|lansoprazole|mesh-list
25055075|NCT03524833|Dexlansoprazole|dexlansoprazole|mesh-list
25055076|NCT03524833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25055077|NCT03524833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24868257|NCT01489813|Estrogens|estrogens|mesh-ancestor
24868258|NCT01489813|Hormones|hormones|mesh-ancestor
24868259|NCT01489813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25698075|NCT02086500|Tranexamic Acid|tranexamic acid|mesh-list
25698076|NCT02086500|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25698077|NCT02086500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25698078|NCT02086500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698079|NCT02086500|Hemostatics|hemostatics|mesh-ancestor
25698080|NCT02086500|Coagulants|coagulants|mesh-ancestor
25698081|NCT02086591|Doxycycline|doxycycline|mesh-list
24445728|NCT00302367|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24445729|NCT00302367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24868260|NCT01375959|Resveratrol|resveratrol|mesh-list
24868261|NCT01375959|Antioxidants|antioxidants|mesh-ancestor
24868263|NCT01375959|Protective Agents|protective agents|mesh-ancestor
25018716|NCT03697655|Daratumumab|daratumumab|mesh-list
25018717|NCT03697655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018725|NCT03697564|Gemcitabine|gemcitabine|mesh-list
24868289|NCT00354835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24868290|NCT00354835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24868291|NCT00354835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24868292|NCT00354835|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24868293|NCT00354835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24868294|NCT05157269|Nitazoxanide|nitazoxanide|mesh-list
24868295|NCT05157269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24868296|NCT05157269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24719573|NCT01562561|Insulin, Isophane|insulin, isophane|mesh-list
24719574|NCT01562561|Isophane insulin, beef|isophane insulin, beef|mesh-list
24868326|NCT05156892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868338|NCT05156749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868393|NCT05112913|Vaccines|vaccines|mesh-list
25055103|NCT03524313|Gasotransmitters|gasotransmitters|mesh-ancestor
25055104|NCT03524313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25055105|NCT03524313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055106|NCT03524274|Antibodies|antibodies|mesh-list
25055107|NCT03524274|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25055108|NCT03524274|Immunologic Factors|immunologic factors|mesh-ancestor
25055109|NCT03524274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055110|NCT03524261|Antibodies|antibodies|mesh-list
25055111|NCT03524261|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25055112|NCT03524261|Immunologic Factors|immunologic factors|mesh-ancestor
24548370|NCT00709254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868399|NCT05112549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24868400|NCT05112549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868402|NCT04952324|Vitamin B 12|vitamin b 12|mesh-list
24868403|NCT04952324|Hydroxocobalamin|hydroxocobalamin|mesh-list
24868404|NCT04952324|Vitamins|vitamins|mesh-ancestor
24868405|NCT04952324|Micronutrients|micronutrients|mesh-ancestor
24868406|NCT04952324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868407|NCT04952324|Hematinics|hematinics|mesh-ancestor
24868408|NCT04952324|Vitamin B Complex|vitamin b complex|mesh-ancestor
24548392|NCT00709332|Estrogens|estrogens|mesh-ancestor
24548393|NCT00709332|Hormones|hormones|mesh-ancestor
24548394|NCT00709332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24548395|NCT00709332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868461|NCT04560725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868462|NCT04560725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24868554|NCT04325659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24868555|NCT04325659|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24868556|NCT04325659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24868557|NCT04325659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24868558|NCT04325659|Adrenergic Agents|adrenergic agents|mesh-ancestor
24868559|NCT04325659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24868560|NCT04325659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868562|NCT04321174|Lopinavir|lopinavir|mesh-list
24868563|NCT04321174|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24868564|NCT04321174|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24868565|NCT04321174|Protease Inhibitors|protease inhibitors|mesh-ancestor
24868566|NCT04321174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24868568|NCT04321174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25019115|NCT03693560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019116|NCT03693560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25019117|NCT03693560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25019118|NCT03693560|Immunologic Factors|immunologic factors|mesh-ancestor
25019119|NCT03693560|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25019120|NCT03693560|Protease Inhibitors|protease inhibitors|mesh-ancestor
25019124|NCT03693508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24548597|NCT00710437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548598|NCT00710437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24548599|NCT00710437|Analgesics|analgesics|mesh-ancestor
24548600|NCT00710437|Sensory System Agents|sensory system agents|mesh-ancestor
25698082|NCT02086591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25698083|NCT02086591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25698084|NCT02086591|Antimalarials|antimalarials|mesh-ancestor
24983725|NCT05171166|Antimetabolites|antimetabolites|mesh-ancestor
24983726|NCT05171166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983727|NCT05171166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24983728|NCT05171166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24983729|NCT05171166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24548601|NCT00710437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24548627|NCT00710788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868673|NCT03600714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24868674|NCT03600714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24868675|NCT03600714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24868676|NCT03600714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24868677|NCT03530124|Vaccines|vaccines|mesh-list
24868678|NCT03530124|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24868679|NCT03530124|Immunologic Factors|immunologic factors|mesh-ancestor
24868680|NCT03530124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868681|NCT03518203|Eculizumab|eculizumab|mesh-list
24868682|NCT03518203|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24868726|NCT03379389|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24491738|NCT00483834|Capecitabine|capecitabine|mesh-list
24491739|NCT00483834|Irinotecan|irinotecan|mesh-list
24491743|NCT00483834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24491744|NCT00483834|Growth Substances|growth substances|mesh-ancestor
24868738|NCT03257254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24809433|NCT02033707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809435|NCT02033707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24809436|NCT02033707|Cholinergic Agents|cholinergic agents|mesh-ancestor
24809437|NCT02033707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24809438|NCT02033707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868767|NCT02944578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24868768|NCT02944578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24868769|NCT02944578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868770|NCT02938624|Pembrolizumab|pembrolizumab|mesh-list
24868771|NCT02938624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24868772|NCT02938624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24868773|NCT02866838|Tranexamic Acid|tranexamic acid|mesh-list
24868774|NCT02866838|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24868775|NCT02866838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24868776|NCT02866838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868777|NCT02866838|Hemostatics|hemostatics|mesh-ancestor
24868778|NCT02866838|Coagulants|coagulants|mesh-ancestor
24868835|NCT01147822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868836|NCT01147822|Growth Inhibitors|growth inhibitors|mesh-ancestor
24868837|NCT01147822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24868838|NCT01147822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24868839|NCT01147822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868840|NCT01090154|Certolizumab Pegol|certolizumab pegol|mesh-list
24868841|NCT01090154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24868842|NCT01090154|Immunologic Factors|immunologic factors|mesh-ancestor
24868843|NCT01090154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868844|NCT01090154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24868845|NCT00695279|Vaccines|vaccines|mesh-list
24868846|NCT00695279|Immunologic Factors|immunologic factors|mesh-ancestor
24868847|NCT00695279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698085|NCT02086591|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25698086|NCT02086591|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25698087|NCT02086786|Risperidone|risperidone|mesh-list
25698088|NCT02086786|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25698089|NCT02086786|Serotonin Agents|serotonin agents|mesh-ancestor
24868848|NCT00521846|Cimetidine|cimetidine|mesh-list
25698090|NCT02086786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25698091|NCT02086786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698092|NCT02086786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698093|NCT02086786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24983765|NCT05166291|Anesthetics|anesthetics|mesh-list
24983766|NCT05166291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24868849|NCT00521846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24868850|NCT00521846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25698094|NCT02086786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25698095|NCT02086786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24868851|NCT00521846|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24868852|NCT00521846|Histamine Antagonists|histamine antagonists|mesh-ancestor
24868853|NCT00521846|Histamine Agents|histamine agents|mesh-ancestor
24868854|NCT00521846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24868855|NCT00521846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548774|NCT00712049|Niacin|niacin|mesh-list
24868859|NCT00521846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24868860|NCT00328653|Cyclosporine|cyclosporine|mesh-list
24868861|NCT00328653|Cyclosporins|cyclosporins|mesh-list
24868862|NCT00328653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24868864|NCT00328653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24868865|NCT00328653|Immunologic Factors|immunologic factors|mesh-ancestor
24868898|NCT05158699|Protease Inhibitors|protease inhibitors|mesh-ancestor
24868899|NCT05158699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24868900|NCT05158699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868901|NCT05158699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24868902|NCT05158699|Immunologic Factors|immunologic factors|mesh-ancestor
24868903|NCT05158699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24868904|NCT05158699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24868905|NCT05158699|Analgesics|analgesics|mesh-ancestor
24868906|NCT05158699|Sensory System Agents|sensory system agents|mesh-ancestor
24868943|NCT05158426|Anesthetics, General|anesthetics, general|mesh-ancestor
24868944|NCT05158426|Anesthetics|anesthetics|mesh-ancestor
24868945|NCT05158348|Lidocaine|lidocaine|mesh-list
24868946|NCT05158348|Dexmedetomidine|dexmedetomidine|mesh-list
24814603|NCT02065752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24548876|NCT00712491|Sirolimus|sirolimus|mesh-list
25055183|NCT03523572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24868987|NCT05157360|Micronutrients|micronutrients|mesh-ancestor
24868988|NCT05157360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868989|NCT05157360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24869014|NCT05080946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24869031|NCT04983498|Autonomic Agents|autonomic agents|mesh-ancestor
24869032|NCT04983498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24869033|NCT04983498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869034|NCT04983498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24869035|NCT04983498|Antipruritics|antipruritics|mesh-ancestor
24869036|NCT04983498|Dermatologic Agents|dermatologic agents|mesh-ancestor
24869053|NCT04947592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24869054|NCT04947592|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24869055|NCT04947592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25698096|NCT02086786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25698097|NCT02086786|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25698098|NCT02086786|Dopamine Agents|dopamine agents|mesh-ancestor
25698099|NCT02087085|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25698100|NCT02087085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25698101|NCT02087085|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25698102|NCT02087085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25698103|NCT02087085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25698104|NCT02087085|Adrenergic Agents|adrenergic agents|mesh-ancestor
24869057|NCT04947592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869058|NCT04947592|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24869059|NCT04947592|Hormone Antagonists|hormone antagonists|mesh-ancestor
24549151|NCT00713687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24869061|NCT04947592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055213|NCT03522987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055214|NCT03522987|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25055215|NCT03522987|Antidepressive Agents|antidepressive agents|mesh-ancestor
24869069|NCT04865939|Antiviral Agents|antiviral agents|mesh-ancestor
24869070|NCT04865939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24869071|NCT04865939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24869072|NCT04865939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24869073|NCT04865939|Immunologic Factors|immunologic factors|mesh-ancestor
24869074|NCT04865939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869076|NCT04831892|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24869077|NCT04831892|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
24446711|NCT00305734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24869171|NCT04579783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24869179|NCT04559347|Sensory System Agents|sensory system agents|mesh-ancestor
24869180|NCT04559347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24869181|NCT04523857|Hydroxychloroquine|hydroxychloroquine|mesh-list
24869182|NCT04523857|Antimalarials|antimalarials|mesh-ancestor
24869183|NCT04523857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24869184|NCT04523857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24869185|NCT04523857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24869186|NCT04523857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24869187|NCT04523857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869188|NCT04523857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24869190|NCT04345861|Hydroxychloroquine|hydroxychloroquine|mesh-list
24869191|NCT04345861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24869192|NCT04345861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24869193|NCT04345861|Antimalarials|antimalarials|mesh-ancestor
24814622|NCT02065843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24814623|NCT02065843|Anesthetics, General|anesthetics, general|mesh-ancestor
24814624|NCT02065843|Anesthetics|anesthetics|mesh-ancestor
24814625|NCT02065843|GABA Modulators|gaba modulators|mesh-ancestor
24814626|NCT02065843|GABA Agents|gaba agents|mesh-ancestor
25698105|NCT02087085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25698106|NCT02087085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698107|NCT02087085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698108|NCT02087176|Antimitotic Agents|antimitotic agents|mesh-list
25698109|NCT02087176|Adavosertib|adavosertib|mesh-list
24983892|NCT05111262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983893|NCT05099107|Albuterol|albuterol|mesh-list
24814627|NCT02065843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24814628|NCT02065843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814629|NCT02065947|Lidocaine|lidocaine|mesh-list
24814630|NCT02065947|Epinephrine|epinephrine|mesh-list
24814650|NCT02065947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814651|NCT02065947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24814652|NCT02065947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24814653|NCT02065947|Anesthetics, General|anesthetics, general|mesh-ancestor
24869194|NCT04345861|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24869195|NCT04345861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24869196|NCT04345861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055240|NCT03522688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25055241|NCT03522688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25055242|NCT03522688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25055243|NCT03522688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25055244|NCT03522688|Adrenergic Agents|adrenergic agents|mesh-ancestor
25055245|NCT03522688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25055246|NCT03522688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622963|NCT01069302|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24622964|NCT01069302|Purinergic Agents|purinergic agents|mesh-ancestor
24622965|NCT01069302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24622966|NCT01069302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622969|NCT01069328|Bevacizumab|bevacizumab|mesh-list
24446720|NCT00305786|Oxaliplatin|oxaliplatin|mesh-list
24869211|NCT04278404|Fosfomycin|fosfomycin|mesh-list
24869212|NCT04278404|Cefepime|cefepime|mesh-list
24869213|NCT04278404|Cefdinir|cefdinir|mesh-list
24869214|NCT04278404|Dexamethasone|dexamethasone|mesh-list
24869215|NCT04278404|Budesonide|budesonide|mesh-list
24869216|NCT04278404|Hydrocortisone|hydrocortisone|mesh-list
24869217|NCT04278404|Colchicine|colchicine|mesh-list
24869218|NCT04278404|Amiodarone|amiodarone|mesh-list
24869219|NCT04278404|Bosentan|bosentan|mesh-list
24869228|NCT04278404|Oxycodone|oxycodone|mesh-list
24869229|NCT04278404|Gabapentin|gabapentin|mesh-list
24869230|NCT04278404|Nalbuphine|nalbuphine|mesh-list
24869231|NCT04278404|Clobazam|clobazam|mesh-list
24869232|NCT04278404|Zolpidem|zolpidem|mesh-list
24869233|NCT04278404|Risperidone|risperidone|mesh-list
24869234|NCT04278404|Amphetamine|amphetamine|mesh-list
24869235|NCT04278404|Dextroamphetamine|dextroamphetamine|mesh-list
24869293|NCT04278404|Antimanic Agents|antimanic agents|mesh-ancestor
24721261|NCT01572805|Protective Agents|protective agents|mesh-ancestor
24869294|NCT04278404|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24869295|NCT04278404|Serotonin Agents|serotonin agents|mesh-ancestor
24869296|NCT04278404|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24869297|NCT04278404|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25698110|NCT02087176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25698111|NCT02087176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698112|NCT02087176|Mitosis Modulators|mitosis modulators|mesh-ancestor
25698113|NCT02087176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25698114|NCT02087241|Carboplatin|carboplatin|mesh-list
25698115|NCT02087241|Pemetrexed|pemetrexed|mesh-list
24869298|NCT04278404|Dopamine Agents|dopamine agents|mesh-ancestor
24869299|NCT04278404|Antidepressive Agents|antidepressive agents|mesh-ancestor
24869300|NCT04278404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25698116|NCT02087241|Adavosertib|adavosertib|mesh-list
25698117|NCT02087241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25698118|NCT02087241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25698119|NCT02087241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869301|NCT04278404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24869359|NCT04240093|Sensory System Agents|sensory system agents|mesh-ancestor
24869360|NCT04240093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24869361|NCT04234477|Metoprolol|metoprolol|mesh-list
24869362|NCT04234477|Verapamil|verapamil|mesh-list
24869363|NCT04234477|Diltiazem|diltiazem|mesh-list
24869364|NCT04234477|Calcium Channel Blockers|calcium channel blockers|mesh-list
24869365|NCT04234477|Calcium|calcium|mesh-list
24869366|NCT04234477|Esmolol|esmolol|mesh-list
24869367|NCT04234477|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24869368|NCT04234477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24869369|NCT04234477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869370|NCT04234477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24869371|NCT04234477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24549325|NCT00714623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24549326|NCT00714623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24549327|NCT00714623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549328|NCT00714623|Antifungal Agents|antifungal agents|mesh-ancestor
24549329|NCT00714623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24549330|NCT00714623|Immunologic Factors|immunologic factors|mesh-ancestor
24869491|NCT03287050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24869492|NCT03254667|Brodalumab|brodalumab|mesh-list
24869493|NCT03254667|Dermatologic Agents|dermatologic agents|mesh-ancestor
25055292|NCT03522207|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25055297|NCT03522207|Serotonin Agents|serotonin agents|mesh-ancestor
24446731|NCT00305812|Dexamethasone|dexamethasone|mesh-list
24814659|NCT02065947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24814660|NCT02065947|Narcotics|narcotics|mesh-ancestor
24869508|NCT03197467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809484|NCT02034071|Choline|choline|mesh-list
24809485|NCT02034071|Lipotropic Agents|lipotropic agents|mesh-ancestor
24809486|NCT02034071|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24809487|NCT02034071|Antimetabolites|antimetabolites|mesh-ancestor
24809488|NCT02034071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809489|NCT02034071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24809490|NCT02034071|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24809491|NCT02034071|Nootropic Agents|nootropic agents|mesh-ancestor
24598564|NCT00956696|Topiramate|topiramate|mesh-list
24494096|NCT00493766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494097|NCT00493766|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24494100|NCT00493831|Nicotine|nicotine|mesh-list
24598643|NCT00957177|Pregabalin|pregabalin|mesh-list
24494258|NCT00494598|Sensory System Agents|sensory system agents|mesh-ancestor
24494259|NCT00494598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24494260|NCT00494598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24494275|NCT00494663|Ketoconazole|ketoconazole|mesh-list
24869552|NCT02891538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869553|NCT02891538|Protective Agents|protective agents|mesh-ancestor
24869554|NCT02891538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869555|NCT02891538|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24869556|NCT02891538|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24869588|NCT02804932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24869589|NCT02804932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869590|NCT02804932|Adrenergic Agents|adrenergic agents|mesh-ancestor
24869591|NCT02804932|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24869592|NCT02804932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24869593|NCT02804932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24446758|NCT00305825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24869594|NCT02804932|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24869636|NCT02334722|Nootropic Agents|nootropic agents|mesh-ancestor
24869637|NCT01966731|Hydroxyurea|hydroxyurea|mesh-list
25698120|NCT02087241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25698121|NCT02087241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24869638|NCT01966731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24869639|NCT01966731|Antisickling Agents|antisickling agents|mesh-ancestor
24869640|NCT01966731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25698122|NCT02087306|Brincidofovir|brincidofovir|mesh-list
25698123|NCT02087306|Antiviral Agents|antiviral agents|mesh-ancestor
25698124|NCT02087306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25698125|NCT02087748|Diclofenac|diclofenac|mesh-list
25698126|NCT02087748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25698127|NCT02087748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25698129|NCT02087748|Sensory System Agents|sensory system agents|mesh-ancestor
25698130|NCT02087748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25698131|NCT02087748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610466|NCT01002300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24610467|NCT01002300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623264|NCT01070732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623277|NCT01070745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623278|NCT01070745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623279|NCT01070745|Gout Suppressants|gout suppressants|mesh-ancestor
24623280|NCT01070745|Tocolytic Agents|tocolytic agents|mesh-ancestor
24623281|NCT01070745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24869660|NCT01717586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24869661|NCT01717586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24494668|NCT00496301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494669|NCT00496301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494670|NCT00496301|Antiviral Agents|antiviral agents|mesh-ancestor
24494671|NCT00496301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25055336|NCT03522051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25055337|NCT03522051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055340|NCT03521960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25055341|NCT03521960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25055342|NCT03521960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055343|NCT03521960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25055344|NCT03521960|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25055345|NCT03521960|Serotonin Agents|serotonin agents|mesh-ancestor
24809564|NCT02034604|Urological Agents|urological agents|mesh-ancestor
24809565|NCT02034630|Busulfan|busulfan|mesh-list
24809566|NCT02034630|Alkylating Agents|alkylating agents|mesh-ancestor
24809567|NCT02034630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809568|NCT02034630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24809569|NCT02034630|Immunologic Factors|immunologic factors|mesh-ancestor
24809570|NCT02034630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809571|NCT02034630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24809572|NCT02034630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809573|NCT02034630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24494684|NCT00496392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24494688|NCT00496392|Anesthetics|anesthetics|mesh-ancestor
25055354|NCT03521895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25055355|NCT03521726|Amoxicillin|amoxicillin|mesh-list
25055356|NCT03521726|Rabeprazole|rabeprazole|mesh-list
25055357|NCT03521726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25055358|NCT03521726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25055359|NCT03521726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25055360|NCT03521726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24809574|NCT02034838|Ritonavir|ritonavir|mesh-list
24809575|NCT02034838|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24809576|NCT02034838|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24809577|NCT02034838|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24809578|NCT02034838|Protease Inhibitors|protease inhibitors|mesh-ancestor
24809579|NCT02034838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809580|NCT02034838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809581|NCT02034838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24809582|NCT02034838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24869665|NCT01717586|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24869667|NCT01023737|Hydroxychloroquine|hydroxychloroquine|mesh-list
24869669|NCT01023737|Antimalarials|antimalarials|mesh-ancestor
25698132|NCT02087748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25698133|NCT02087748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25698134|NCT02087748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25698135|NCT02087748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24983986|NCT04952389|Autonomic Agents|autonomic agents|mesh-ancestor
24983987|NCT04952389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24983988|NCT04952389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983989|NCT04952389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24983990|NCT04952389|Respiratory System Agents|respiratory system agents|mesh-ancestor
24983991|NCT04952389|Glucocorticoids|glucocorticoids|mesh-ancestor
24983993|NCT04952389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25055387|NCT03521414|Anesthetics, General|anesthetics, general|mesh-ancestor
25055388|NCT03521414|Anesthetics|anesthetics|mesh-ancestor
25055389|NCT03521414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24809599|NCT02035020|Antiviral Agents|antiviral agents|mesh-ancestor
24869714|NCT00563576|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24869715|NCT00563576|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24869716|NCT00563576|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24869717|NCT00563576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24869718|NCT00563576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24869721|NCT00455403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24869722|NCT00455403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24869723|NCT00455403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24869724|NCT00455403|Antimalarials|antimalarials|mesh-ancestor
24869725|NCT00455403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24869760|NCT05160285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24869761|NCT05160285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24869762|NCT05160285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24869763|NCT05160285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869764|NCT05160220|Psilocybin|psilocybin|mesh-list
24869765|NCT05160220|Hallucinogens|hallucinogens|mesh-ancestor
24722115|NCT01578603|Calcium|calcium|mesh-list
24722341|NCT01579760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24722417|NCT01580202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24722418|NCT01580202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24869766|NCT05160220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869767|NCT05160220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24869768|NCT05160051|FAPI-46|fapi-46|mesh-list
24869769|NCT05160051|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24869770|NCT05160051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869771|NCT05159882|Dapagliflozin|dapagliflozin|mesh-list
24869772|NCT05159882|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24869779|NCT05159674|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25021067|NCT03674866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25021068|NCT03674866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021076|NCT03674671|Ketamine|ketamine|mesh-list
25055475|NCT03520985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25055476|NCT03520985|Growth Substances|growth substances|mesh-ancestor
24809683|NCT02035904|Sensory System Agents|sensory system agents|mesh-ancestor
24809684|NCT02035904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24809685|NCT02035904|Anesthetics, Local|anesthetics, local|mesh-ancestor
24495620|NCT00501267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24495667|NCT00501514|Hormones|hormones|mesh-list
24495668|NCT00501514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24495669|NCT00501514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495670|NCT00501566|Satavaptan|satavaptan|mesh-list
24495671|NCT00501566|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24809702|NCT02035943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24809703|NCT02035943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24495836|NCT00502138|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
24495837|NCT00502138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25055511|NCT03520543|Urological Agents|urological agents|mesh-ancestor
25055512|NCT03520478|Bicalutamide|bicalutamide|mesh-list
25055513|NCT03520478|Androgen Antagonists|androgen antagonists|mesh-ancestor
25055514|NCT03520478|Hormone Antagonists|hormone antagonists|mesh-ancestor
25021293|NCT03673280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25021294|NCT03673280|Narcotics|narcotics|mesh-ancestor
25698136|NCT02087748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698137|NCT02087943|Thalidomide|thalidomide|mesh-list
25698138|NCT02087943|Apremilast|apremilast|mesh-list
25698139|NCT02087943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25698140|NCT02087943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25698141|NCT02087943|Analgesics|analgesics|mesh-ancestor
25698142|NCT02087943|Sensory System Agents|sensory system agents|mesh-ancestor
24984124|NCT04787562|Protease Inhibitors|protease inhibitors|mesh-ancestor
24984125|NCT04787562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25021295|NCT03673280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25021296|NCT03673280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021297|NCT03673280|Analgesics|analgesics|mesh-ancestor
25021298|NCT03673280|Sensory System Agents|sensory system agents|mesh-ancestor
25021299|NCT03673280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24869932|NCT05070650|Acetylcysteine|acetylcysteine|mesh-list
24869933|NCT05070650|Phenylephrine|phenylephrine|mesh-list
24869934|NCT05070650|Oxymetazoline|oxymetazoline|mesh-list
24869935|NCT05070650|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24869954|NCT05070650|Sympathomimetics|sympathomimetics|mesh-ancestor
24869955|NCT05070650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24869956|NCT05070650|Nasal Decongestants|nasal decongestants|mesh-ancestor
24869957|NCT05070650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24623283|NCT01070758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623284|NCT01070823|Natalizumab|natalizumab|mesh-list
24623285|NCT01070823|Immunologic Factors|immunologic factors|mesh-ancestor
24495921|NCT00502567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495922|NCT00502567|Tubulin Modulators|tubulin modulators|mesh-ancestor
24495923|NCT00502567|Antimitotic Agents|antimitotic agents|mesh-ancestor
24495924|NCT00502567|Mitosis Modulators|mitosis modulators|mesh-ancestor
24495925|NCT00502567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495926|NCT00502567|Antimetabolites|antimetabolites|mesh-ancestor
24495927|NCT00502567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24495934|NCT00502567|Antidotes|antidotes|mesh-ancestor
24623299|NCT01070862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24623300|NCT01070862|Antiemetics|antiemetics|mesh-ancestor
24623301|NCT01070862|Autonomic Agents|autonomic agents|mesh-ancestor
24869964|NCT05025293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869965|NCT04859582|Pembrolizumab|pembrolizumab|mesh-list
24869966|NCT04859582|Fluorouracil|fluorouracil|mesh-list
24869967|NCT04859582|Capecitabine|capecitabine|mesh-list
24869968|NCT04859582|Oxaliplatin|oxaliplatin|mesh-list
24869969|NCT04859582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24869970|NCT04859582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24869971|NCT04859582|Antimetabolites|antimetabolites|mesh-ancestor
24869972|NCT04859582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869973|NCT04859582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24869974|NCT04859582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25055542|NCT03520062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055544|NCT03520062|Hormones|hormones|mesh-ancestor
24870012|NCT04491526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550006|NCT00718536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25055569|NCT03519724|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25055570|NCT03519724|Autonomic Agents|autonomic agents|mesh-ancestor
25055571|NCT03519724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25055572|NCT03519685|Contraceptive Agents|contraceptive agents|mesh-list
25055573|NCT03519685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25055574|NCT03519685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722613|NCT01581788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24870019|NCT04328961|Ascorbic Acid|ascorbic acid|mesh-list
24809845|NCT02036489|Vincristine|vincristine|mesh-list
24809846|NCT02036489|Daunorubicin|daunorubicin|mesh-list
24809847|NCT02036489|Asparaginase|asparaginase|mesh-list
24870086|NCT03945448|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25055664|NCT03518502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25055665|NCT03518502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055666|NCT03518502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055668|NCT03518489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25055669|NCT03518489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25055670|NCT03518489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25055671|NCT03518489|Analgesics|analgesics|mesh-ancestor
25055672|NCT03518489|Sensory System Agents|sensory system agents|mesh-ancestor
25055673|NCT03518489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25055674|NCT03518489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939074|NCT04013386|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24809858|NCT02036489|Antimitotic Agents|antimitotic agents|mesh-ancestor
25698143|NCT02087943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25698144|NCT02087943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809859|NCT02036489|Mitosis Modulators|mitosis modulators|mesh-ancestor
25698145|NCT02087943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25698146|NCT02087943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25698147|NCT02087943|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24809860|NCT02036489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809861|NCT02036489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24809889|NCT02036554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24809890|NCT02036554|Immunologic Factors|immunologic factors|mesh-ancestor
24809891|NCT02036554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809892|NCT02036554|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24809893|NCT02036554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809894|NCT02036554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952567|NCT03893032|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24952568|NCT03893032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952569|NCT03893032|Sympathomimetics|sympathomimetics|mesh-ancestor
24952570|NCT03893032|Autonomic Agents|autonomic agents|mesh-ancestor
24952571|NCT03893032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24952597|NCT03892902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952598|NCT03892668|Tranexamic Acid|tranexamic acid|mesh-list
24952599|NCT03892668|Oxytocin|oxytocin|mesh-list
24952600|NCT03892668|Oxytocics|oxytocics|mesh-ancestor
24952601|NCT03892668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24952602|NCT03892668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952603|NCT03892668|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24952604|NCT03892668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24952605|NCT03892668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952606|NCT03892668|Hemostatics|hemostatics|mesh-ancestor
25055675|NCT03518320|Gemcitabine|gemcitabine|mesh-list
25055676|NCT03518320|Nivolumab|nivolumab|mesh-list
25055677|NCT03518320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25055690|NCT03518112|Leucovorin|leucovorin|mesh-list
25055715|NCT03518112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25055716|NCT03518112|Alkylating Agents|alkylating agents|mesh-ancestor
25055717|NCT03518112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055718|NCT03518112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25055719|NCT03518112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25055720|NCT03518112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25055721|NCT03518112|Antiemetics|antiemetics|mesh-ancestor
25055722|NCT03518112|Autonomic Agents|autonomic agents|mesh-ancestor
25055751|NCT03518112|Antimitotic Agents|antimitotic agents|mesh-ancestor
25055752|NCT03518112|Mitosis Modulators|mitosis modulators|mesh-ancestor
25055753|NCT03518112|Hematinics|hematinics|mesh-ancestor
25055754|NCT03518021|Naloxone|naloxone|mesh-list
25055755|NCT03518021|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25055756|NCT03518021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055757|NCT03518021|Sensory System Agents|sensory system agents|mesh-ancestor
25055758|NCT03518021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25055759|NCT03517995|Sulforaphane|sulforaphane|mesh-list
25055760|NCT03517995|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25055761|NCT03517995|Protective Agents|protective agents|mesh-ancestor
25055762|NCT03517995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810035|NCT02037503|Anesthetics|anesthetics|mesh-ancestor
24810036|NCT02037503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25055827|NCT03517683|Dopamine Agents|dopamine agents|mesh-ancestor
24810037|NCT02037503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24814757|NCT02066610|Micronutrients|micronutrients|mesh-ancestor
24814758|NCT02066649|Carvedilol|carvedilol|mesh-list
24814759|NCT02066649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25055764|NCT03517982|Mycophenolic Acid|mycophenolic acid|mesh-list
25055765|NCT03517982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25055766|NCT03517982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25055767|NCT03517982|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25055768|NCT03517982|Antitubercular Agents|antitubercular agents|mesh-ancestor
25055769|NCT03517982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25055770|NCT03517982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25055771|NCT03517982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24810051|NCT02037633|Fentanyl|fentanyl|mesh-list
24870147|NCT03703778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870188|NCT03320070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870190|NCT03294304|Nivolumab|nivolumab|mesh-list
24870191|NCT03294304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870192|NCT03294304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24870193|NCT03294304|Antimetabolites|antimetabolites|mesh-ancestor
24870194|NCT03294304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870195|NCT03294304|Antiviral Agents|antiviral agents|mesh-ancestor
24870196|NCT03294304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25055772|NCT03517982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055774|NCT03517943|Pseudoephedrine|pseudoephedrine|mesh-list
25055775|NCT03517943|Ephedrine|ephedrine|mesh-list
24984294|NCT04684953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984295|NCT04682483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
24984296|NCT04674020|Erenumab|erenumab|mesh-list
25698148|NCT02087943|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24984297|NCT04674020|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25055776|NCT03517943|Antipruritics|antipruritics|mesh-ancestor
25055777|NCT03517943|Dermatologic Agents|dermatologic agents|mesh-ancestor
25055778|NCT03517943|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25055779|NCT03517943|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25055780|NCT03517943|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25055781|NCT03517943|Histamine Antagonists|histamine antagonists|mesh-ancestor
25055800|NCT03517930|Dermatologic Agents|dermatologic agents|mesh-ancestor
25055801|NCT03517930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25055802|NCT03517930|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25055803|NCT03517930|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25055804|NCT03517930|Histamine Antagonists|histamine antagonists|mesh-ancestor
25055805|NCT03517930|Histamine Agents|histamine agents|mesh-ancestor
25055806|NCT03517930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25055807|NCT03517930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810086|NCT02037737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24810087|NCT02037802|Fentanyl|fentanyl|mesh-list
24810088|NCT02037802|Meperidine|meperidine|mesh-list
24810089|NCT02037802|Bupivacaine|bupivacaine|mesh-list
24810090|NCT02037802|Propofol|propofol|mesh-list
24810091|NCT02037802|Anesthetics, Local|anesthetics, local|mesh-ancestor
24810092|NCT02037802|Anesthetics|anesthetics|mesh-ancestor
24810093|NCT02037802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24810094|NCT02037802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810095|NCT02037802|Sensory System Agents|sensory system agents|mesh-ancestor
24601348|NCT00964080|Leucovorin|leucovorin|mesh-list
25055815|NCT03517930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25055816|NCT03517930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25055817|NCT03517930|Sympathomimetics|sympathomimetics|mesh-ancestor
25055818|NCT03517930|Adrenergic Agents|adrenergic agents|mesh-ancestor
25055819|NCT03517748|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25055820|NCT03517748|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24810096|NCT02037802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24870250|NCT02982083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870251|NCT02982083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24870252|NCT02982083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24870253|NCT02982083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24870256|NCT02896855|Pertuzumab|pertuzumab|mesh-list
24870257|NCT02896855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870258|NCT02896855|Tubulin Modulators|tubulin modulators|mesh-ancestor
24870259|NCT02896855|Antimitotic Agents|antimitotic agents|mesh-ancestor
24870260|NCT02896855|Mitosis Modulators|mitosis modulators|mesh-ancestor
24870282|NCT02621151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25055821|NCT03517683|Methamphetamine|methamphetamine|mesh-list
24723374|NCT01587222|Octreotide|octreotide|mesh-list
25055822|NCT03517683|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24723683|NCT01588795|Vitamins|vitamins|mesh-ancestor
25055823|NCT03517683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055824|NCT03517683|Sympathomimetics|sympathomimetics|mesh-ancestor
25055825|NCT03517683|Autonomic Agents|autonomic agents|mesh-ancestor
25055826|NCT03517683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25055834|NCT03517683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25055835|NCT03517670|Milrinone|milrinone|mesh-list
25055836|NCT03517670|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25055837|NCT03517670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25055838|NCT03517670|Vasodilator Agents|vasodilator agents|mesh-ancestor
25055839|NCT03517670|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25055840|NCT03517670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25055841|NCT03517670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24870283|NCT02421341|Fentanyl|fentanyl|mesh-list
25055844|NCT03517670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25055846|NCT03517631|Alkylating Agents|alkylating agents|mesh-ancestor
25698149|NCT02087943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25698150|NCT02087943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698151|NCT02087943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25698152|NCT02087943|Immunologic Factors|immunologic factors|mesh-ancestor
25698153|NCT02087943|Leprostatic Agents|leprostatic agents|mesh-ancestor
25698154|NCT02087943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25055847|NCT03517631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698155|NCT02087943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25055848|NCT03517631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24870290|NCT02421341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24870291|NCT02421341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24870292|NCT02421341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24870293|NCT02421341|Anesthetics, General|anesthetics, general|mesh-ancestor
24870294|NCT02421341|Anesthetics|anesthetics|mesh-ancestor
24870295|NCT02149121|Rituximab|rituximab|mesh-list
24870296|NCT02149121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24870297|NCT02149121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870298|NCT02149121|Immunologic Factors|immunologic factors|mesh-ancestor
24870299|NCT02149121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870300|NCT02149121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24870301|NCT01889186|Venetoclax|venetoclax|mesh-list
24870302|NCT01889186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870303|NCT01850004|Dasatinib|dasatinib|mesh-list
24870304|NCT01850004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870305|NCT01850004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24870306|NCT01850004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24870307|NCT01850004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870358|NCT01471444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055905|NCT03517020|Vasodilator Agents|vasodilator agents|mesh-ancestor
24870747|NCT04017442|Morphine|morphine|mesh-list
24870401|NCT05162430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24870402|NCT05162430|Anesthetics, General|anesthetics, general|mesh-ancestor
24870403|NCT05162430|Anesthetics|anesthetics|mesh-ancestor
24870404|NCT05162417|Tolonium Chloride|tolonium chloride|mesh-list
24870405|NCT05162417|Methylene Blue|methylene blue|mesh-list
24870406|NCT05162417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24870407|NCT05162417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870408|NCT05162417|Hemostatics|hemostatics|mesh-ancestor
24810156|NCT02038335|Estrogens|estrogens|mesh-ancestor
24870438|NCT05161572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870439|NCT05161572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24870440|NCT05161572|Antimetabolites|antimetabolites|mesh-ancestor
24870441|NCT05161572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870442|NCT05161403|Hyaluronic Acid|hyaluronic acid|mesh-list
24870504|NCT05067270|Chelating Agents|chelating agents|mesh-ancestor
24870505|NCT05067270|Sequestering Agents|sequestering agents|mesh-ancestor
24870545|NCT04998786|Dexamethasone|dexamethasone|mesh-list
24870546|NCT04998786|Ixazomib|ixazomib|mesh-list
24870547|NCT04998786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25055930|NCT03516903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25055931|NCT03516903|Dermatologic Agents|dermatologic agents|mesh-ancestor
25055932|NCT03516903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055933|NCT03516903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25055934|NCT03516903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25055935|NCT03516903|Immunologic Factors|immunologic factors|mesh-ancestor
25055936|NCT03516903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24871052|NCT05163405|Bortezomib|bortezomib|mesh-list
24870655|NCT04606394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814835|NCT02066870|Arsenic Trioxide|arsenic trioxide|mesh-list
24814836|NCT02066870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24814837|NCT02067013|Ranibizumab|ranibizumab|mesh-list
24814838|NCT02067013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24814839|NCT02067013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24814840|NCT02067013|Growth Substances|growth substances|mesh-ancestor
24814841|NCT02067013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814842|NCT02067013|Growth Inhibitors|growth inhibitors|mesh-ancestor
24814843|NCT02067013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870676|NCT04577690|Mydriatics|mydriatics|mesh-ancestor
24870677|NCT04577690|Sympathomimetics|sympathomimetics|mesh-ancestor
25055937|NCT03516903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24497517|NCT00510367|Doxorubicin|doxorubicin|mesh-list
24870678|NCT04577690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24870679|NCT04574856|Temozolomide|temozolomide|mesh-list
24870680|NCT04574856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24870702|NCT04447053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24870703|NCT04447053|Immunologic Factors|immunologic factors|mesh-ancestor
24870704|NCT04447053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870746|NCT04101890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870854|NCT03296033|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24870855|NCT03296033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25698156|NCT02087943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24870856|NCT03296033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984541|NCT04418427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24984542|NCT04418427|Growth Substances|growth substances|mesh-ancestor
24984571|NCT04386616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24984573|NCT04385433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24870896|NCT03106688|Carfentanil|carfentanil|mesh-list
24870897|NCT03106688|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24870898|NCT03106688|Narcotics|narcotics|mesh-ancestor
24870899|NCT03106688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24870900|NCT03106688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870901|NCT03106688|Analgesics|analgesics|mesh-ancestor
24623318|NCT01070862|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24623319|NCT01070862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24724753|NCT01594489|Protective Agents|protective agents|mesh-ancestor
24870935|NCT02281955|Cisplatin|cisplatin|mesh-list
24870936|NCT02281955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623320|NCT01070862|Immunologic Factors|immunologic factors|mesh-ancestor
24870937|NCT01588431|Bevacizumab|bevacizumab|mesh-list
24870939|NCT01588431|Cisplatin|cisplatin|mesh-list
24870940|NCT01588431|Docetaxel|docetaxel|mesh-list
24870941|NCT01588431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24870942|NCT01588431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870943|NCT01588431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24870944|NCT01588431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24870945|NCT01588431|Growth Substances|growth substances|mesh-ancestor
24870946|NCT01588431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870947|NCT01588431|Growth Inhibitors|growth inhibitors|mesh-ancestor
24870948|NCT01588431|Tubulin Modulators|tubulin modulators|mesh-ancestor
24870949|NCT01588431|Antimitotic Agents|antimitotic agents|mesh-ancestor
24870950|NCT01588431|Mitosis Modulators|mitosis modulators|mesh-ancestor
24692269|NCT01412437|Vasodilator Agents|vasodilator agents|mesh-ancestor
24870951|NCT01588431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870952|NCT01230242|Levonorgestrel|levonorgestrel|mesh-list
24870953|NCT01230242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24870966|NCT00983437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870967|NCT00893789|Modafinil|modafinil|mesh-list
24870970|NCT00893789|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24870971|NCT00893789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24870972|NCT00893789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24870973|NCT00893789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870974|NCT00805129|Everolimus|everolimus|mesh-list
24871039|NCT05163704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871040|NCT05163691|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
24871041|NCT05163691|Hallucinogens|hallucinogens|mesh-ancestor
24871042|NCT05163691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871043|NCT05163691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24871044|NCT05163691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24871045|NCT05163691|Serotonin Agents|serotonin agents|mesh-ancestor
24871046|NCT05163691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24871047|NCT05163691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871048|NCT05163691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24871053|NCT05163405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871054|NCT05163366|Ketamine|ketamine|mesh-list
24871055|NCT05163366|Morphine|morphine|mesh-list
24871056|NCT05163366|Analgesics|analgesics|mesh-ancestor
24871057|NCT05163366|Sensory System Agents|sensory system agents|mesh-ancestor
24871058|NCT05163366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24871059|NCT05163366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871061|NCT05163366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25055949|NCT03516747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25055950|NCT03516669|Amoxicillin|amoxicillin|mesh-list
25055951|NCT03516669|Clarithromycin|clarithromycin|mesh-list
24871075|NCT05163249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871077|NCT05162937|Immunologic Factors|immunologic factors|mesh-ancestor
24871078|NCT05162937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698157|NCT02087943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25698158|NCT02087943|Growth Substances|growth substances|mesh-ancestor
25698159|NCT02087943|Growth Inhibitors|growth inhibitors|mesh-ancestor
25698160|NCT02087943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25698161|NCT02088034|Metformin|metformin|mesh-list
25698162|NCT02088034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25698163|NCT02088034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698164|NCT02088177|Naltrexone|naltrexone|mesh-list
25698165|NCT02088177|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25698166|NCT02088177|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25698167|NCT02088177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871121|NCT05040360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871122|NCT05040360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24871123|NCT05040360|Alkylating Agents|alkylating agents|mesh-ancestor
24871125|NCT04820179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871127|NCT04809051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24871128|NCT04809051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24871129|NCT04809051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24871131|NCT04735367|Letrozole|letrozole|mesh-list
24871135|NCT04735367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24871136|NCT04735367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055952|NCT03516669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25055953|NCT03516669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25055954|NCT03516669|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25055955|NCT03516669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25055956|NCT03516669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25055957|NCT03516669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25055958|NCT03516669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25055959|NCT03516656|Heparin|heparin|mesh-list
25055960|NCT03516656|Calcium heparin|calcium heparin|mesh-list
25055961|NCT03516656|Anticoagulants|anticoagulants|mesh-ancestor
24871137|NCT04735367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871138|NCT04735367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24871139|NCT04735367|Hormone Antagonists|hormone antagonists|mesh-ancestor
24615904|NCT01032486|Protective Agents|protective agents|mesh-ancestor
24871140|NCT04735367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24871141|NCT04735367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871142|NCT04735367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24871143|NCT04698603|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
24871144|NCT04698603|Hallucinogens|hallucinogens|mesh-ancestor
24871145|NCT04698603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871295|NCT04002362|Hormones|hormones|mesh-ancestor
24871296|NCT04002362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24871297|NCT04002362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871298|NCT04002362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24871299|NCT04002362|Immunologic Factors|immunologic factors|mesh-ancestor
24871300|NCT04002362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24871301|NCT04002362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871302|NCT03963518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24871303|NCT03963518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871304|NCT03963518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871305|NCT03940690|Bevacizumab|bevacizumab|mesh-list
24871313|NCT03901144|Glycerol|glycerol|mesh-list
24871350|NCT03548246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24871351|NCT03548246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871352|NCT03548246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24871353|NCT03519295|Atezolizumab|atezolizumab|mesh-list
24871354|NCT03519295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871355|NCT03462459|Vancomycin|vancomycin|mesh-list
24871356|NCT03462459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24871357|NCT03462459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24871358|NCT03457948|Pembrolizumab|pembrolizumab|mesh-list
24871359|NCT03457948|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
24871360|NCT03457948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24871361|NCT03457948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871362|NCT03457948|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24871363|NCT03457948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871366|NCT03166085|Paclitaxel|paclitaxel|mesh-list
24600307|NCT01095003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871371|NCT03166085|Antimitotic Agents|antimitotic agents|mesh-ancestor
24871392|NCT03161054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24871393|NCT03161054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25698168|NCT02088177|Sensory System Agents|sensory system agents|mesh-ancestor
25698169|NCT02088177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25698170|NCT02088216|Acetylcysteine|acetylcysteine|mesh-list
25698171|NCT02088216|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25698172|NCT02088216|Antiviral Agents|antiviral agents|mesh-ancestor
24871394|NCT03161054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24871395|NCT03161054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24871396|NCT03161054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24871397|NCT03161054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24871398|NCT03161054|Tubulin Modulators|tubulin modulators|mesh-ancestor
24871399|NCT03161054|Antimitotic Agents|antimitotic agents|mesh-ancestor
24871400|NCT03161054|Mitosis Modulators|mitosis modulators|mesh-ancestor
24871401|NCT03050814|Leucovorin|leucovorin|mesh-list
24871403|NCT03050814|Avelumab|avelumab|mesh-list
24871404|NCT03050814|Fluorouracil|fluorouracil|mesh-list
24871405|NCT03050814|Capecitabine|capecitabine|mesh-list
24871406|NCT03050814|Oxaliplatin|oxaliplatin|mesh-list
24693784|NCT01422291|Morphine|morphine|mesh-list
24871407|NCT03050814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24871408|NCT03050814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871409|NCT03050814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24871410|NCT03050814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24871411|NCT03050814|Growth Substances|growth substances|mesh-ancestor
24871412|NCT03050814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871413|NCT03050814|Growth Inhibitors|growth inhibitors|mesh-ancestor
24871458|NCT02492867|Mitosis Modulators|mitosis modulators|mesh-ancestor
24871459|NCT02492867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871461|NCT02458313|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
24871462|NCT02458313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24871463|NCT02458313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24871464|NCT02458313|Cholinergic Agents|cholinergic agents|mesh-ancestor
24871465|NCT02458313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24871467|NCT02458313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871484|NCT02375555|Autonomic Agents|autonomic agents|mesh-ancestor
24871485|NCT02375555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24871486|NCT02375555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871487|NCT02375555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24871488|NCT02375555|Glucocorticoids|glucocorticoids|mesh-ancestor
24693021|NCT01417858|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24871490|NCT02375555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25056001|NCT03516526|Natalizumab|natalizumab|mesh-list
24871491|NCT02375555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24871492|NCT02375555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871493|NCT02375555|Immunologic Factors|immunologic factors|mesh-ancestor
24871494|NCT02375555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24871495|NCT02375555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24871496|NCT02375555|Growth Substances|growth substances|mesh-ancestor
24871497|NCT02375555|Growth Inhibitors|growth inhibitors|mesh-ancestor
24871498|NCT02322593|Oxaliplatin|oxaliplatin|mesh-list
24871499|NCT02322593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871500|NCT02124824|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
24871501|NCT02124824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24871502|NCT02124824|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24871523|NCT01285102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871524|NCT01285102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871525|NCT00952692|Lapatinib|lapatinib|mesh-list
24871526|NCT00952692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871527|NCT00952692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24871528|NCT00952692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24871529|NCT00952692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871530|NCT00424099|Methylphenidate|methylphenidate|mesh-list
24871531|NCT00424099|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24871532|NCT00424099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623330|NCT01070862|Tubulin Modulators|tubulin modulators|mesh-ancestor
24623331|NCT01070862|Antimitotic Agents|antimitotic agents|mesh-ancestor
24623332|NCT01070862|Mitosis Modulators|mitosis modulators|mesh-ancestor
24623333|NCT01070875|Heparin|heparin|mesh-list
24623334|NCT01070875|Calcium heparin|calcium heparin|mesh-list
24623335|NCT01070875|Anticoagulants|anticoagulants|mesh-ancestor
24623336|NCT01070875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24623338|NCT01070875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623340|NCT01070927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24871577|NCT05165303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24871578|NCT05165303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871579|NCT05165303|Sensory System Agents|sensory system agents|mesh-ancestor
24871580|NCT05165303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24871581|NCT05165303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25698173|NCT02088216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25698174|NCT02088216|Expectorants|expectorants|mesh-ancestor
24984911|NCT03922880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24984912|NCT03922880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984919|NCT03902314|Lidocaine|lidocaine|mesh-list
24871582|NCT05165303|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24871583|NCT05165303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24871584|NCT05165303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24871585|NCT05165303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871586|NCT05165303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24871587|NCT05165303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24871588|NCT05165303|Anesthetics, General|anesthetics, general|mesh-ancestor
24871589|NCT05165277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24871590|NCT05164952|Zoledronic Acid|zoledronic acid|mesh-list
24871591|NCT05164952|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24871601|NCT05164770|Vincristine|vincristine|mesh-list
24871607|NCT05164770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24871608|NCT05164770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871609|NCT05164770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24871610|NCT05164770|Immunologic Factors|immunologic factors|mesh-ancestor
24871611|NCT05164770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871612|NCT05164770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24871636|NCT05164627|Sensory System Agents|sensory system agents|mesh-ancestor
24871637|NCT05164627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24616195|NCT01034917|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24616199|NCT01034956|Calcium|calcium|mesh-list
24871647|NCT05164627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24871648|NCT05164627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24871649|NCT05164627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24871650|NCT05164627|Tocolytic Agents|tocolytic agents|mesh-ancestor
24871651|NCT05164627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24871652|NCT05164263|Empagliflozin|empagliflozin|mesh-list
24871653|NCT05164263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24871654|NCT05164263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871655|NCT05164263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24871656|NCT05164263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871657|NCT05161741|Insulin|insulin|mesh-list
24871658|NCT05161741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24871659|NCT05161741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056007|NCT03516188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871660|NCT05153590|Liraglutide|liraglutide|mesh-list
24871661|NCT05153590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24871662|NCT05153590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871672|NCT05146479|Fluorides, Topical|fluorides, topical|mesh-list
24871673|NCT05146479|Cariostatic Agents|cariostatic agents|mesh-ancestor
24871674|NCT05146479|Protective Agents|protective agents|mesh-ancestor
24871675|NCT05146479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871676|NCT05145621|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24871677|NCT05145621|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24871680|NCT05145621|Immunologic Factors|immunologic factors|mesh-ancestor
24871687|NCT05110209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24871689|NCT05110209|Growth Substances|growth substances|mesh-ancestor
24871703|NCT05072444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24871705|NCT05039944|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24871706|NCT05039944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24871707|NCT05039944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24871708|NCT05039944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871709|NCT05039944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871710|NCT05023343|Ropivacaine|ropivacaine|mesh-list
24871711|NCT05023343|Anesthetics, Local|anesthetics, local|mesh-ancestor
24871712|NCT05023343|Anesthetics|anesthetics|mesh-ancestor
25698175|NCT02088216|Respiratory System Agents|respiratory system agents|mesh-ancestor
25698176|NCT02088216|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25698177|NCT02088216|Antioxidants|antioxidants|mesh-ancestor
25698178|NCT02088216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698179|NCT02088216|Protective Agents|protective agents|mesh-ancestor
25698180|NCT02088216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698181|NCT02088216|Antidotes|antidotes|mesh-ancestor
25698182|NCT02088541|Cytarabine|cytarabine|mesh-list
25698183|NCT02088541|Hydroxyurea|hydroxyurea|mesh-list
24984973|NCT03829007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24984974|NCT03829007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24871713|NCT05023343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24871714|NCT05023343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871715|NCT05023343|Sensory System Agents|sensory system agents|mesh-ancestor
24871716|NCT05023343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24871717|NCT05007145|Paclitaxel|paclitaxel|mesh-list
24871718|NCT05007145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24871719|NCT05007145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24871720|NCT05007145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24871721|NCT05007145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871722|NCT05007145|Tubulin Modulators|tubulin modulators|mesh-ancestor
24871723|NCT05007145|Antimitotic Agents|antimitotic agents|mesh-ancestor
24871724|NCT05007145|Mitosis Modulators|mitosis modulators|mesh-ancestor
24871758|NCT04821830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871759|NCT04821830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871760|NCT04821830|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24871762|NCT04821830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24726164|NCT01602029|Autonomic Agents|autonomic agents|mesh-ancestor
24871763|NCT04821830|Immunologic Factors|immunologic factors|mesh-ancestor
24871764|NCT04821830|Dopamine Agonists|dopamine agonists|mesh-ancestor
24871765|NCT04803994|Bevacizumab|bevacizumab|mesh-list
24871766|NCT04803994|Atezolizumab|atezolizumab|mesh-list
24871767|NCT04803994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24871768|NCT04803994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871769|NCT04803994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24871770|NCT04803994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24871771|NCT04803994|Growth Substances|growth substances|mesh-ancestor
24871772|NCT04803994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871773|NCT04803994|Growth Inhibitors|growth inhibitors|mesh-ancestor
24694156|NCT01424137|Hormones|hormones|mesh-ancestor
24871774|NCT04615286|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24871775|NCT04615286|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24871776|NCT04615286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24871777|NCT04615286|Antitubercular Agents|antitubercular agents|mesh-ancestor
24871779|NCT04527289|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24871825|NCT04282070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871826|NCT04282070|Tubulin Modulators|tubulin modulators|mesh-ancestor
24871827|NCT04282070|Antimitotic Agents|antimitotic agents|mesh-ancestor
24871828|NCT04282070|Mitosis Modulators|mitosis modulators|mesh-ancestor
24871829|NCT04282070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871830|NCT04282070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24871831|NCT04282070|Antimetabolites|antimetabolites|mesh-ancestor
24871832|NCT04282070|Antiviral Agents|antiviral agents|mesh-ancestor
24871833|NCT04282070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24871834|NCT04282070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24871835|NCT04282070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24871836|NCT04282070|Immunologic Factors|immunologic factors|mesh-ancestor
24871894|NCT03679091|Clopidogrel|clopidogrel|mesh-list
24871895|NCT03679091|Ticagrelor|ticagrelor|mesh-list
24871896|NCT03679091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24871897|NCT03679091|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24871898|NCT03679091|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24871899|NCT03679091|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24871900|NCT03679091|Purinergic Agents|purinergic agents|mesh-ancestor
24871901|NCT03679091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24871902|NCT03679091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871903|NCT03679091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871904|NCT03651518|Rituximab|rituximab|mesh-list
24871905|NCT03651518|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24871906|NCT03651518|Ustekinumab|ustekinumab|mesh-list
24871907|NCT03651518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24871933|NCT03592212|Adrenergic Agents|adrenergic agents|mesh-ancestor
24871934|NCT03592212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24871935|NCT03592212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698184|NCT02088541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25698185|NCT02088541|Antimetabolites|antimetabolites|mesh-ancestor
25698186|NCT02088541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871936|NCT03475381|Ivacaftor|ivacaftor|mesh-list
24871937|NCT03475381|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25698187|NCT02088541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985033|NCT03730051|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
24985034|NCT03730051|Chelating Agents|chelating agents|mesh-ancestor
24985035|NCT03730051|Sequestering Agents|sequestering agents|mesh-ancestor
24985036|NCT03730051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985045|NCT03721328|Vancomycin|vancomycin|mesh-list
24871938|NCT03475381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24871939|NCT03475381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871940|NCT03465540|Dexamethasone|dexamethasone|mesh-list
24871941|NCT03465540|Azacitidine|azacitidine|mesh-list
24871942|NCT03465540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24871943|NCT03465540|Antiemetics|antiemetics|mesh-ancestor
24871944|NCT03465540|Autonomic Agents|autonomic agents|mesh-ancestor
24871945|NCT03465540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24871946|NCT03465540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871947|NCT03465540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24871948|NCT03465540|Glucocorticoids|glucocorticoids|mesh-ancestor
25056025|NCT03515798|Tubulin Modulators|tubulin modulators|mesh-ancestor
25056026|NCT03515798|Antimitotic Agents|antimitotic agents|mesh-ancestor
25056027|NCT03515798|Mitosis Modulators|mitosis modulators|mesh-ancestor
24810289|NCT02039453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872008|NCT03217136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24872009|NCT03217136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872010|NCT03217136|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24872011|NCT03217136|Renal Agents|renal agents|mesh-ancestor
24872012|NCT05400603|Zoledronic Acid|zoledronic acid|mesh-list
24872014|NCT05400603|Temozolomide|temozolomide|mesh-list
24872015|NCT05400603|Dinutuximab|dinutuximab|mesh-list
24872016|NCT05400603|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24872024|NCT05400603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872063|NCT05399576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872065|NCT05399576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24872066|NCT05399576|Vitamin B Complex|vitamin b complex|mesh-ancestor
24872067|NCT05399576|Vitamins|vitamins|mesh-ancestor
24872068|NCT05399576|Micronutrients|micronutrients|mesh-ancestor
25056028|NCT03515798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056029|NCT03515798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25056030|NCT03515798|Immunologic Factors|immunologic factors|mesh-ancestor
25056031|NCT03515798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056032|NCT03515798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25056033|NCT03515798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24814940|NCT02067416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814941|NCT02067416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24814942|NCT02067416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24814943|NCT02067416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24814944|NCT02067416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24814945|NCT02067442|Acetaminophen|acetaminophen|mesh-list
24814946|NCT02067442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24814952|NCT02067520|Hydromorphone|hydromorphone|mesh-list
24814953|NCT02067520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24814954|NCT02067520|Narcotics|narcotics|mesh-ancestor
24814955|NCT02067520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24814956|NCT02067520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814957|NCT02067520|Analgesics|analgesics|mesh-ancestor
24814958|NCT02067520|Sensory System Agents|sensory system agents|mesh-ancestor
24814959|NCT02067520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24814960|NCT02067715|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25698188|NCT02088541|Antiviral Agents|antiviral agents|mesh-ancestor
25698189|NCT02088541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25698190|NCT02088541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25698191|NCT02088541|Immunologic Factors|immunologic factors|mesh-ancestor
25698192|NCT02088541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698193|NCT02088541|Antisickling Agents|antisickling agents|mesh-ancestor
25698194|NCT02088541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25698195|NCT02088541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25698196|NCT02089113|Dexamethasone|dexamethasone|mesh-list
25698197|NCT02089113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25698198|NCT02089113|Antiemetics|antiemetics|mesh-ancestor
25698199|NCT02089113|Autonomic Agents|autonomic agents|mesh-ancestor
25698200|NCT02089113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24814961|NCT02067715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24814962|NCT02067715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24814964|NCT02067767|Abacavir|abacavir|mesh-list
24814965|NCT02067767|Dolutegravir|dolutegravir|mesh-list
24814966|NCT02067767|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24814967|NCT02067767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24814968|NCT02067767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24872122|NCT05398757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24872123|NCT05398757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24872124|NCT05398757|GABA Modulators|gaba modulators|mesh-ancestor
24872125|NCT05398757|GABA Agents|gaba agents|mesh-ancestor
24872126|NCT05398757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24616350|NCT01036412|Disinfectants|disinfectants|mesh-ancestor
24872127|NCT05398757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872128|NCT05398757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24872129|NCT05398757|Analgesics|analgesics|mesh-ancestor
24872130|NCT05398757|Sensory System Agents|sensory system agents|mesh-ancestor
24872131|NCT05398757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24872132|NCT05398757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24872133|NCT05398757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24872134|NCT05398757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24872135|NCT05398757|Adrenergic Agents|adrenergic agents|mesh-ancestor
24872136|NCT05398679|Amoxicillin|amoxicillin|mesh-list
24872186|NCT05398679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24872187|NCT05398679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25056041|NCT03515772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25056042|NCT03515772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056043|NCT03515772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24872188|NCT05398679|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24872189|NCT05398679|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24872190|NCT05398653|Cyclosporine|cyclosporine|mesh-list
24872191|NCT05398653|Cyclosporins|cyclosporins|mesh-list
24872192|NCT05398653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24872276|NCT05397834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24872277|NCT05397834|Autonomic Agents|autonomic agents|mesh-ancestor
24872278|NCT05397834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24872279|NCT05397834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872280|NCT05397834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24872281|NCT05397834|Respiratory System Agents|respiratory system agents|mesh-ancestor
25056044|NCT03515772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25056045|NCT03515772|Antiviral Agents|antiviral agents|mesh-ancestor
25056046|NCT03515772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25056048|NCT03515707|Podophyllotoxin|podophyllotoxin|mesh-list
25056049|NCT03515707|Etoposide phosphate|etoposide phosphate|mesh-list
25056050|NCT03515707|Busulfan|busulfan|mesh-list
25056051|NCT03515707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24872282|NCT05397834|Dermatologic Agents|dermatologic agents|mesh-ancestor
24872283|NCT05397834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24872284|NCT05397795|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24872285|NCT05397795|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24872286|NCT05397795|Luteolytic Agents|luteolytic agents|mesh-ancestor
25698201|NCT02089113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698202|NCT02089113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25698203|NCT02089113|Glucocorticoids|glucocorticoids|mesh-ancestor
25698204|NCT02089113|Hormones|hormones|mesh-ancestor
25698205|NCT02089113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25698206|NCT02089113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25698207|NCT02089113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25698208|NCT02089347|Vaccines|vaccines|mesh-list
25698209|NCT02089347|Immunologic Factors|immunologic factors|mesh-ancestor
25698210|NCT02089347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698211|NCT02089737|Panitumumab|panitumumab|mesh-list
25698212|NCT02089737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25698213|NCT02089737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872307|NCT05397262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872308|NCT05397236|Dexamethasone|dexamethasone|mesh-list
24872309|NCT05397236|Bupivacaine|bupivacaine|mesh-list
24872310|NCT05397236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24872311|NCT05397236|Antiemetics|antiemetics|mesh-ancestor
24872315|NCT05397236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24872316|NCT05397236|Glucocorticoids|glucocorticoids|mesh-ancestor
24815004|NCT02067936|Anesthetics|anesthetics|mesh-ancestor
24815005|NCT02067936|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24815006|NCT02067936|Narcotics|narcotics|mesh-ancestor
24815007|NCT02067936|Analgesics|analgesics|mesh-ancestor
24727423|NCT01609855|Bromides|bromides|mesh-list
24815008|NCT02067936|Sensory System Agents|sensory system agents|mesh-ancestor
24815009|NCT02067936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24815010|NCT02067949|Simvastatin|simvastatin|mesh-list
24815012|NCT02067949|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24815013|NCT02067949|Antimetabolites|antimetabolites|mesh-ancestor
24815014|NCT02067949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815015|NCT02067949|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24694739|NCT05375708|Bevacizumab|bevacizumab|mesh-list
24872317|NCT05397236|Hormones|hormones|mesh-ancestor
24872318|NCT05397236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24872319|NCT05397236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24872320|NCT05397236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872321|NCT05397236|Anesthetics, Local|anesthetics, local|mesh-ancestor
24872340|NCT05396859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24872341|NCT05396859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24872342|NCT05396742|Ravulizumab|ravulizumab|mesh-list
24872343|NCT05396742|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24872344|NCT05396742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24872345|NCT05396742|Immunologic Factors|immunologic factors|mesh-ancestor
24872346|NCT05396742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872347|NCT05396677|Acetaminophen|acetaminophen|mesh-list
24872348|NCT05396677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24872349|NCT05396677|Analgesics|analgesics|mesh-ancestor
24872350|NCT05396677|Sensory System Agents|sensory system agents|mesh-ancestor
24872351|NCT05396677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24872352|NCT05396677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872353|NCT05396677|Antipyretics|antipyretics|mesh-ancestor
24872354|NCT05396326|Oxaliplatin|oxaliplatin|mesh-list
24872355|NCT05396326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872356|NCT05396209|Dimenhydrinate|dimenhydrinate|mesh-list
24872357|NCT05396209|Antiemetics|antiemetics|mesh-ancestor
24872363|NCT05396209|Histamine Antagonists|histamine antagonists|mesh-ancestor
24872364|NCT05396209|Histamine Agents|histamine agents|mesh-ancestor
24872365|NCT05396209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24872366|NCT05396209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872367|NCT05396144|Nitrous Oxide|nitrous oxide|mesh-list
24872368|NCT05396144|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24872369|NCT05396144|Anesthetics, General|anesthetics, general|mesh-ancestor
24872370|NCT05396144|Anesthetics|anesthetics|mesh-ancestor
24872371|NCT05396144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24872372|NCT05396144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872373|NCT05396144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24872374|NCT05396144|Analgesics|analgesics|mesh-ancestor
24872390|NCT05394337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872391|NCT05392634|Amoxicillin|amoxicillin|mesh-list
24872392|NCT05392634|Meropenem|meropenem|mesh-list
24872393|NCT05392634|Clavulanic Acids|clavulanic acids|mesh-list
24872394|NCT05392634|Clavulanic Acid|clavulanic acid|mesh-list
24872395|NCT05392634|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24616454|NCT01037465|Acetylcysteine|acetylcysteine|mesh-list
24872396|NCT05392634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24872397|NCT05392634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24872398|NCT05392634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24872399|NCT05392634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872400|NCT05392634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24872401|NCT05389527|Pembrolizumab|pembrolizumab|mesh-list
25698214|NCT02089997|Risedronic Acid|risedronic acid|mesh-list
25698215|NCT02089997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25698216|NCT02089997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25698217|NCT02089997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056075|NCT03515668|Dopamine Agents|dopamine agents|mesh-ancestor
25056076|NCT03515668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25106935|NCT03143452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25698218|NCT02089997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25698219|NCT02089997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106938|NCT03143465|Calcitonin|calcitonin|mesh-list
24860362|NCT02309385|Protease Inhibitors|protease inhibitors|mesh-ancestor
24985176|NCT03592693|Protective Agents|protective agents|mesh-ancestor
24985178|NCT03589105|Immunologic Factors|immunologic factors|mesh-ancestor
24985179|NCT03589105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056077|NCT03515629|Pembrolizumab|pembrolizumab|mesh-list
25056078|NCT03515629|Cemiplimab|cemiplimab|mesh-list
25056079|NCT03515629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25056080|NCT03515629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056081|NCT03515577|Edetic Acid|edetic acid|mesh-list
25056082|NCT03515577|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
24815017|NCT02067949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815018|NCT02068079|Vemurafenib|vemurafenib|mesh-list
24815019|NCT02068079|Trientine|trientine|mesh-list
24815020|NCT02068079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815021|NCT02068079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24815022|NCT02068079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815023|NCT02068079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815024|NCT02068079|Chelating Agents|chelating agents|mesh-ancestor
24872455|NCT05385523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24872456|NCT05385523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872458|NCT05385523|Glucocorticoids|glucocorticoids|mesh-ancestor
24872476|NCT05370716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24872477|NCT05370716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056089|NCT03515538|Cisplatin|cisplatin|mesh-list
25056090|NCT03515538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056091|NCT03515382|Itraconazole|itraconazole|mesh-list
25056092|NCT03515382|Voriconazole|voriconazole|mesh-list
25056093|NCT03515382|Antifungal Agents|antifungal agents|mesh-ancestor
25056094|NCT03515382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24810355|NCT02039765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24872478|NCT05370716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24872479|NCT05370716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24872480|NCT05370716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24872481|NCT05370716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24872482|NCT05370716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24872483|NCT05363553|Caseins|caseins|mesh-list
24872528|NCT05325580|Magnesium Sulfate|magnesium sulfate|mesh-list
24872529|NCT05325580|Analgesics|analgesics|mesh-ancestor
24872530|NCT05325580|Sensory System Agents|sensory system agents|mesh-ancestor
24872531|NCT05325580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24872532|NCT05325580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872533|NCT05325580|Anesthetics|anesthetics|mesh-ancestor
24872545|NCT05315479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24872551|NCT05315479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24872552|NCT05315479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24872593|NCT05309460|Sympathomimetics|sympathomimetics|mesh-ancestor
24872594|NCT05309460|Autonomic Agents|autonomic agents|mesh-ancestor
24872595|NCT05309460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24872596|NCT05309460|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24872597|NCT05309460|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24872598|NCT05306899|Ketamine|ketamine|mesh-list
24872599|NCT05306899|Analgesics|analgesics|mesh-ancestor
24872600|NCT05306899|Sensory System Agents|sensory system agents|mesh-ancestor
24872601|NCT05306899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24872602|NCT05306899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872603|NCT05306899|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24872604|NCT05306899|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24872605|NCT05306899|Anesthetics, General|anesthetics, general|mesh-ancestor
24872606|NCT05306899|Anesthetics|anesthetics|mesh-ancestor
24872607|NCT05306899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24872608|NCT05306899|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24872609|NCT05306899|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24872610|NCT05306899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25698220|NCT02089997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25698221|NCT02090075|Warfarin|warfarin|mesh-list
25698222|NCT02090075|Apixaban|apixaban|mesh-list
25698223|NCT02090075|Anticoagulants|anticoagulants|mesh-ancestor
25698224|NCT02090075|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25698225|NCT02090075|Antithrombins|antithrombins|mesh-ancestor
25698226|NCT02090075|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25698227|NCT02090075|Protease Inhibitors|protease inhibitors|mesh-ancestor
25056100|NCT03515382|Hormone Antagonists|hormone antagonists|mesh-ancestor
24815037|NCT02068131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815038|NCT02068170|Azithromycin|azithromycin|mesh-list
24815039|NCT02068170|Moxifloxacin|moxifloxacin|mesh-list
24815040|NCT02068170|Clarithromycin|clarithromycin|mesh-list
24815042|NCT02068170|Erythromycin|erythromycin|mesh-list
24815048|NCT02068170|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
24815049|NCT02068170|Fluconazole|fluconazole|mesh-list
24815050|NCT02068170|Ketoconazole|ketoconazole|mesh-list
24815051|NCT02068170|Voriconazole|voriconazole|mesh-list
24815053|NCT02068170|Methadone|methadone|mesh-list
24872634|NCT05298670|Interferons|interferons|mesh-list
24872635|NCT05298670|Interferon-beta|interferon-beta|mesh-list
24872636|NCT05298670|Interferon beta-1a|interferon beta-1a|mesh-list
24872715|NCT05238844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24872716|NCT05238844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24872717|NCT05238844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24872718|NCT05238844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872730|NCT05232734|Purinergic Agents|purinergic agents|mesh-ancestor
24872731|NCT05232734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24872733|NCT05232461|Celecoxib|celecoxib|mesh-list
24872784|NCT05226897|Metformin|metformin|mesh-list
24872786|NCT05226897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24872787|NCT05226897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872788|NCT05226897|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24872789|NCT05226897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872790|NCT05210582|Afamelanotide|afamelanotide|mesh-list
24872791|NCT05210582|Dermatologic Agents|dermatologic agents|mesh-ancestor
24872792|NCT05209347|Carbon Fiber|carbon fiber|mesh-list
24872793|NCT05209347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25056110|NCT03515213|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25056112|NCT03515200|Dexamethasone|dexamethasone|mesh-list
25056113|NCT03515200|Hydrocortisone|hydrocortisone|mesh-list
25056114|NCT03515200|Doxorubicin|doxorubicin|mesh-list
25056115|NCT03515200|Methotrexate|methotrexate|mesh-list
24872813|NCT05439798|Dexamethasone|dexamethasone|mesh-list
24872814|NCT05439798|Dexamethasone acetate|dexamethasone acetate|mesh-list
24872815|NCT05439798|Ondansetron|ondansetron|mesh-list
24872816|NCT05439798|Palonosetron|palonosetron|mesh-list
24872817|NCT05439798|BB 1101|bb 1101|mesh-list
24934758|NCT04058899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694707|NCT05379374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24872818|NCT05439798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24872819|NCT05439798|Antiemetics|antiemetics|mesh-ancestor
24872820|NCT05439798|Autonomic Agents|autonomic agents|mesh-ancestor
24872823|NCT05439798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24872824|NCT05439798|Glucocorticoids|glucocorticoids|mesh-ancestor
24872825|NCT05439798|Hormones|hormones|mesh-ancestor
24872826|NCT05439798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24872827|NCT05439798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24872828|NCT05439798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872829|NCT05439798|Protease Inhibitors|protease inhibitors|mesh-ancestor
24872830|NCT05439798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24872831|NCT05439798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698229|NCT02090075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872832|NCT05439798|Antipruritics|antipruritics|mesh-ancestor
24872849|NCT05439772|Antipruritics|antipruritics|mesh-ancestor
24872850|NCT05439772|Dermatologic Agents|dermatologic agents|mesh-ancestor
24872851|NCT05439772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25698230|NCT02090374|Vitamin D|vitamin d|mesh-list
25698231|NCT02090374|Poly ICLC|poly iclc|mesh-list
25698232|NCT02090374|Vitamins|vitamins|mesh-ancestor
25698233|NCT02090374|Micronutrients|micronutrients|mesh-ancestor
25698234|NCT02090374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698235|NCT02090374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25698237|NCT02090374|Immunologic Factors|immunologic factors|mesh-ancestor
25698238|NCT02090413|Aspirin|aspirin|mesh-list
24872852|NCT05439772|Serotonin Agents|serotonin agents|mesh-ancestor
25698239|NCT02090413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25698240|NCT02090413|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25698241|NCT02090413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25698242|NCT02090413|Analgesics|analgesics|mesh-ancestor
25056119|NCT03515200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25056120|NCT03515200|Antiemetics|antiemetics|mesh-ancestor
25056121|NCT03515200|Autonomic Agents|autonomic agents|mesh-ancestor
24604272|NCT00978211|Octreotide|octreotide|mesh-list
24815056|NCT02068170|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24815057|NCT02068170|Tacrolimus|tacrolimus|mesh-list
24815058|NCT02068170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24815060|NCT02068170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815061|NCT02068170|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24815062|NCT02068170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815063|NCT02068170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815085|NCT02068170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24815086|NCT02068170|Hormone Antagonists|hormone antagonists|mesh-ancestor
24815087|NCT02068170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24815088|NCT02068170|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24815089|NCT02068170|Renal Agents|renal agents|mesh-ancestor
24815102|NCT02068170|Autonomic Agents|autonomic agents|mesh-ancestor
24815113|NCT02068170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24815114|NCT02068196|Ipilimumab|ipilimumab|mesh-list
24815115|NCT02068196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24446773|NCT00305838|Hormone Antagonists|hormone antagonists|mesh-ancestor
24446774|NCT00305838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24446775|NCT00305838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446776|NCT00305838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24446777|NCT00305838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056122|NCT03515200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25056123|NCT03515200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446778|NCT00305838|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24446779|NCT00305838|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24446780|NCT00305838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24446782|NCT00305903|Rivastigmine|rivastigmine|mesh-list
24446783|NCT00305903|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24446784|NCT00305903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24446785|NCT00305903|Dopamine Agents|dopamine agents|mesh-ancestor
24446786|NCT00305903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24446787|NCT00305903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872919|NCT05439213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24872920|NCT05439213|Adrenergic Agents|adrenergic agents|mesh-ancestor
24872921|NCT05439213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24872922|NCT05439213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872923|NCT05439213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872924|NCT05439213|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25698243|NCT02090413|Sensory System Agents|sensory system agents|mesh-ancestor
25698244|NCT02090413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24985288|NCT03514121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872925|NCT05439213|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24872926|NCT05439213|Autonomic Agents|autonomic agents|mesh-ancestor
24872976|NCT05438706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24872979|NCT05438550|Amoxicillin|amoxicillin|mesh-list
24872980|NCT05438550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24872981|NCT05438550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24872982|NCT05438420|Pembrolizumab|pembrolizumab|mesh-list
24872983|NCT05438420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24872984|NCT05438420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872986|NCT05438394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24872987|NCT05438394|Alkylating Agents|alkylating agents|mesh-ancestor
24872988|NCT05438394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872989|NCT05438394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872990|NCT05438394|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24872991|NCT05438394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24872993|NCT05438394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056140|NCT03515200|Dermatologic Agents|dermatologic agents|mesh-ancestor
25056141|NCT03515200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24500733|NCT00525616|Rituximab|rituximab|mesh-list
24872994|NCT05434624|Midazolam|midazolam|mesh-list
24872995|NCT05434624|Propofol|propofol|mesh-list
24872996|NCT05434624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24872997|NCT05434624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24872998|NCT05434624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24873012|NCT05432804|Alkylating Agents|alkylating agents|mesh-ancestor
24873013|NCT05432804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24873014|NCT05432804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24873015|NCT05431920|Vitamin D|vitamin d|mesh-list
24873016|NCT05431920|Ergocalciferols|ergocalciferols|mesh-list
24873017|NCT05431920|Cholecalciferol|cholecalciferol|mesh-list
24873018|NCT05431920|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
24873019|NCT05431920|Calcifediol|calcifediol|mesh-list
24873020|NCT05431920|Vitamins|vitamins|mesh-list
24873021|NCT05431920|Micronutrients|micronutrients|mesh-ancestor
24873022|NCT05431920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24873023|NCT05431920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24873024|NCT05431920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24873025|NCT05430893|Botulinum Toxins|botulinum toxins|mesh-list
24873026|NCT05430893|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24873033|NCT05430893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24873034|NCT05430893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24873035|NCT05430893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24730230|NCT01627158|Budesonide|budesonide|mesh-list
25056156|NCT03515187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056157|NCT03515187|Viscosupplements|viscosupplements|mesh-ancestor
24873070|NCT05424315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24873072|NCT05424315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695636|NCT02547662|Glycine Agents|glycine agents|mesh-ancestor
25698245|NCT02090413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698246|NCT02090413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25698247|NCT02090413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25698248|NCT02090413|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25698249|NCT02090413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25698250|NCT02090413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698251|NCT02090413|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25698252|NCT02090413|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25698253|NCT02090413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25698254|NCT02090413|Antipyretics|antipyretics|mesh-ancestor
25698255|NCT02090413|Dermatologic Agents|dermatologic agents|mesh-ancestor
24873217|NCT05320380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24873218|NCT05320380|Antimetabolites|antimetabolites|mesh-ancestor
24873219|NCT05320380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24873220|NCT05320380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24873221|NCT05320380|Dermatologic Agents|dermatologic agents|mesh-ancestor
24873222|NCT05320380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24873223|NCT05320380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24873224|NCT05320380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24873225|NCT05320380|Immunologic Factors|immunologic factors|mesh-ancestor
24873226|NCT05320380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24873227|NCT05320380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24873228|NCT05320380|Antiviral Agents|antiviral agents|mesh-ancestor
24873229|NCT05320380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24873230|NCT05320380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24873231|NCT05320380|Glucocorticoids|glucocorticoids|mesh-ancestor
24873232|NCT05320380|Hormones|hormones|mesh-ancestor
24873233|NCT05320380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24873235|NCT05320380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24873242|NCT05319015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24873243|NCT05319015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24873283|NCT05312671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24873284|NCT05312671|Keratolytic Agents|keratolytic agents|mesh-ancestor
24873285|NCT05312671|Dermatologic Agents|dermatologic agents|mesh-ancestor
24873286|NCT05312671|Tubulin Modulators|tubulin modulators|mesh-ancestor
25056172|NCT03514836|Immunologic Factors|immunologic factors|mesh-ancestor
25056173|NCT03514836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056174|NCT03514836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25056175|NCT03514836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25056176|NCT03514836|Alkylating Agents|alkylating agents|mesh-ancestor
24623039|NCT01069822|Anesthetics|anesthetics|mesh-ancestor
24873287|NCT05312671|Antimitotic Agents|antimitotic agents|mesh-ancestor
24873288|NCT05312671|Mitosis Modulators|mitosis modulators|mesh-ancestor
25056180|NCT03514810|Ketoprofen|ketoprofen|mesh-list
25056185|NCT03514810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25056186|NCT03514810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24873601|NCT05118776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24873603|NCT05118776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24873604|NCT05118776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24873605|NCT05118776|Growth Substances|growth substances|mesh-ancestor
24873606|NCT05118776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24873607|NCT05118776|Growth Inhibitors|growth inhibitors|mesh-ancestor
25056203|NCT03514771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25056214|NCT03514667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056215|NCT03514667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24810411|NCT02040064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24873760|NCT05033756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24873761|NCT05030155|Cyclophosphamide|cyclophosphamide|mesh-list
24873762|NCT05030155|Azathioprine|azathioprine|mesh-list
24873763|NCT05030155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24873764|NCT05030155|Immunologic Factors|immunologic factors|mesh-ancestor
24873765|NCT05030155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24873766|NCT05030155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24873768|NCT05030155|Alkylating Agents|alkylating agents|mesh-ancestor
25056230|NCT03514550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24873813|NCT05015387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24873827|NCT04996719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815159|NCT02068404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815160|NCT02068404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24815161|NCT02068404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815162|NCT02068404|Vasodilator Agents|vasodilator agents|mesh-ancestor
24815163|NCT02068404|Tocolytic Agents|tocolytic agents|mesh-ancestor
24815164|NCT02068404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24815165|NCT02068430|Riboflavin|riboflavin|mesh-list
24815166|NCT02068430|Vitamin B Complex|vitamin b complex|mesh-ancestor
24815167|NCT02068430|Vitamins|vitamins|mesh-ancestor
24815168|NCT02068430|Micronutrients|micronutrients|mesh-ancestor
24815169|NCT02068430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815170|NCT02068430|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24815171|NCT02068430|Dermatologic Agents|dermatologic agents|mesh-ancestor
24815172|NCT02068482|Rifaximin|rifaximin|mesh-list
24815173|NCT02068482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24815174|NCT02068482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25056251|NCT03514342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056252|NCT03514342|Sensory System Agents|sensory system agents|mesh-ancestor
25056253|NCT03514342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24617119|NCT01041092|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24873936|NCT04960618|Pembrolizumab|pembrolizumab|mesh-list
24873937|NCT04960618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24873938|NCT04960618|Antimetabolites|antimetabolites|mesh-ancestor
24873939|NCT04960618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24873940|NCT04960618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24873941|NCT04960618|Antiviral Agents|antiviral agents|mesh-ancestor
24873942|NCT04960618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25056273|NCT03514030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056274|NCT03513874|Metformin|metformin|mesh-list
25056275|NCT03513874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25056276|NCT03513874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056277|NCT03513822|Midazolam|midazolam|mesh-list
25056278|NCT03513822|Ketamine|ketamine|mesh-list
25056279|NCT03513822|Analgesics|analgesics|mesh-ancestor
25056280|NCT03513822|Sensory System Agents|sensory system agents|mesh-ancestor
25056281|NCT03513822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24810485|NCT02040441|Natriuretic Agents|natriuretic agents|mesh-ancestor
25056287|NCT03513822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25056288|NCT03513822|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25056289|NCT03513822|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25056290|NCT03513822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25056291|NCT03513822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056298|NCT03513822|GABA Agents|gaba agents|mesh-ancestor
25056300|NCT03513601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24810543|NCT02040662|Analgesics|analgesics|mesh-ancestor
24810544|NCT02040662|Sensory System Agents|sensory system agents|mesh-ancestor
24810545|NCT02040662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25698256|NCT02090413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25698257|NCT02090413|Immunologic Factors|immunologic factors|mesh-ancestor
25698258|NCT02091362|Metformin|metformin|mesh-list
25056319|NCT03513484|Azacitidine|azacitidine|mesh-list
25056320|NCT03513484|Nintedanib|nintedanib|mesh-list
25056321|NCT03513484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25056322|NCT03513484|Antimetabolites|antimetabolites|mesh-ancestor
24874206|NCT04879225|Menthol|menthol|mesh-list
24874207|NCT04879225|Antipruritics|antipruritics|mesh-ancestor
24874221|NCT04864743|Coagulants|coagulants|mesh-ancestor
24874252|NCT04860141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24874253|NCT04860141|Antimanic Agents|antimanic agents|mesh-ancestor
24874259|NCT04857385|Hemostatics|hemostatics|mesh-list
24874260|NCT04857385|Coagulants|coagulants|mesh-ancestor
24874261|NCT04857307|Alprazolam|alprazolam|mesh-list
24874262|NCT04857307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24874263|NCT04857307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24874264|NCT04857307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24874265|NCT04857307|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24874266|NCT04857307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24874267|NCT04857307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24874268|NCT04857307|GABA Modulators|gaba modulators|mesh-ancestor
24874270|NCT04857307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24874271|NCT04857307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24874338|NCT04812535|Vilobelimab|vilobelimab|mesh-list
24874341|NCT04812535|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24874342|NCT04812535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24874343|NCT04812535|Immunologic Factors|immunologic factors|mesh-ancestor
24874344|NCT04812535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24874345|NCT04810078|Nivolumab|nivolumab|mesh-list
24874346|NCT04810078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24874347|NCT04810078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24874348|NCT04810078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24471876|NCT00397241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471877|NCT00397241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471878|NCT00397241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24471879|NCT00397241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24874349|NCT04810078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056331|NCT03513432|Ethanol|ethanol|mesh-list
25056332|NCT03513432|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25056333|NCT03513432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25056334|NCT03513432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25056335|NCT03513432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056336|NCT03513393|Velpatasvir|velpatasvir|mesh-list
24874392|NCT04774965|Histamine Antagonists|histamine antagonists|mesh-ancestor
24874393|NCT04774965|Histamine Agents|histamine agents|mesh-ancestor
24874394|NCT04774965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24874396|NCT04774965|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25112394|NCT04135846|Doxazosin|doxazosin|mesh-list
25112395|NCT04135846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25112396|NCT04135846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25112397|NCT04135846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25112398|NCT04135846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25112399|NCT04135846|Adrenergic Agents|adrenergic agents|mesh-ancestor
25112400|NCT04135846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25112401|NCT04135846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112402|NCT04135846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056343|NCT03513393|Antiviral Agents|antiviral agents|mesh-ancestor
25056344|NCT03513393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24623369|NCT01071122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24623370|NCT01071122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24623371|NCT01071122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056361|NCT03513276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056362|NCT03513276|Sensory System Agents|sensory system agents|mesh-ancestor
25056368|NCT03513276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056369|NCT03513276|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25056370|NCT03513276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25698259|NCT02091362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25698260|NCT02091362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698261|NCT02091414|Cyclosporine|cyclosporine|mesh-list
25698262|NCT02091414|Mycophenolic Acid|mycophenolic acid|mesh-list
25698263|NCT02091414|Cyclosporins|cyclosporins|mesh-list
25698264|NCT02091414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25698265|NCT02091414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698266|NCT02091414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25106964|NCT03143244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106965|NCT03143244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25056371|NCT03513276|Autonomic Agents|autonomic agents|mesh-ancestor
25056372|NCT03513276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24939750|NCT04007341|Analgesics|analgesics|mesh-ancestor
25056373|NCT03513276|Respiratory System Agents|respiratory system agents|mesh-ancestor
25056374|NCT03513276|Mydriatics|mydriatics|mesh-ancestor
25056375|NCT03513276|Sympathomimetics|sympathomimetics|mesh-ancestor
25056376|NCT03513276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24625628|NCT01082731|Artemether|artemether|mesh-list
25056377|NCT03513172|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24810592|NCT02040883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24815261|NCT02069301|Fluoxetine|fluoxetine|mesh-list
24815262|NCT02069301|Antidepressive Agents|antidepressive agents|mesh-list
24815263|NCT02069301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24815264|NCT02069301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24815265|NCT02069301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24815266|NCT02069301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815267|NCT02069301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24815271|NCT02069301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24874784|NCT04563507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24874909|NCT04505774|Heparin|heparin|mesh-list
24874910|NCT04505774|Calcium heparin|calcium heparin|mesh-list
24874911|NCT04505774|Enoxaparin|enoxaparin|mesh-list
24874912|NCT04505774|Dalteparin|dalteparin|mesh-list
24874913|NCT04505774|Tinzaparin|tinzaparin|mesh-list
24874914|NCT04505774|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24874915|NCT04505774|Enoxaparin sodium|enoxaparin sodium|mesh-list
24874916|NCT04505774|Clopidogrel|clopidogrel|mesh-list
24874917|NCT04505774|Ticagrelor|ticagrelor|mesh-list
24874918|NCT04505774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24874919|NCT04505774|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24874920|NCT04505774|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24874977|NCT04488978|Vasodilator Agents|vasodilator agents|mesh-ancestor
24874978|NCT04488978|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24874979|NCT04488978|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24875007|NCT04481204|Antiviral Agents|antiviral agents|mesh-ancestor
24875008|NCT04481204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24875009|NCT04481204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24875010|NCT04481204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24875011|NCT04481204|Immunologic Factors|immunologic factors|mesh-ancestor
24875012|NCT04481204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24875013|NCT04481204|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24617453|NCT01043224|Glucocorticoids|glucocorticoids|mesh-ancestor
24875014|NCT04481204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24875015|NCT04481204|Antidotes|antidotes|mesh-ancestor
24875016|NCT04481204|Protective Agents|protective agents|mesh-ancestor
24875017|NCT04481204|Vitamin B Complex|vitamin b complex|mesh-ancestor
24875025|NCT04480372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24875026|NCT04480372|Antiviral Agents|antiviral agents|mesh-ancestor
24875027|NCT04480372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24875028|NCT04480372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25056405|NCT03512873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25056406|NCT03512873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25056407|NCT03512873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056408|NCT03512873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25056409|NCT03512873|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25056410|NCT03512873|Histamine Antagonists|histamine antagonists|mesh-ancestor
25056412|NCT03512873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25056413|NCT03512873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25056414|NCT03512873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25056416|NCT03512860|Anticonvulsants|anticonvulsants|mesh-ancestor
24875029|NCT04480372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24875030|NCT04480372|Immunologic Factors|immunologic factors|mesh-ancestor
24875031|NCT04480372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698267|NCT02091414|Immunologic Factors|immunologic factors|mesh-ancestor
25698268|NCT02091414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698269|NCT02091414|Antifungal Agents|antifungal agents|mesh-ancestor
24875119|NCT04439136|Afatinib|afatinib|mesh-list
25698270|NCT02091414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25698271|NCT02091414|Dermatologic Agents|dermatologic agents|mesh-ancestor
25698272|NCT02091414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25698273|NCT02091414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24875189|NCT04345913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24875191|NCT04343248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24875192|NCT04343248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25056442|NCT03512574|Dexmedetomidine|dexmedetomidine|mesh-list
25056443|NCT03512574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25056444|NCT03512574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24815308|NCT02069665|Ibuprofen|ibuprofen|mesh-list
24815309|NCT02069665|Phenylpropanolamine|phenylpropanolamine|mesh-list
24815310|NCT02069665|Albuterol|albuterol|mesh-list
24734843|NCT01654211|Ritonavir|ritonavir|mesh-list
24815311|NCT02069665|Guaifenesin|guaifenesin|mesh-list
24815312|NCT02069665|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
24815315|NCT02069665|Antiviral Agents|antiviral agents|mesh-ancestor
24815316|NCT02069665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24815317|NCT02069665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24815318|NCT02069665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24815319|NCT02069665|Analgesics|analgesics|mesh-ancestor
24815320|NCT02069665|Sensory System Agents|sensory system agents|mesh-ancestor
24815321|NCT02069665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24815322|NCT02069665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815323|NCT02069665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24815324|NCT02069665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24815325|NCT02069665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24815326|NCT02069665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815327|NCT02069665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24815328|NCT02069665|Autonomic Agents|autonomic agents|mesh-ancestor
24815329|NCT02069665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24815330|NCT02069665|Respiratory System Agents|respiratory system agents|mesh-ancestor
24815331|NCT02069665|Tocolytic Agents|tocolytic agents|mesh-ancestor
24815332|NCT02069665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24625630|NCT01082731|Mefloquine|mefloquine|mesh-list
25056448|NCT03512574|Sensory System Agents|sensory system agents|mesh-ancestor
24939923|NCT04005664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24939924|NCT04005664|Adrenergic Agents|adrenergic agents|mesh-ancestor
24939925|NCT04005664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24939926|NCT04005664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939927|NCT04005664|Protective Agents|protective agents|mesh-ancestor
24815339|NCT02069665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24815345|NCT02069808|Leuprolide|leuprolide|mesh-list
24815347|NCT02069808|Ganirelix|ganirelix|mesh-list
24815348|NCT02069808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24815349|NCT02069808|Fertility Agents|fertility agents|mesh-ancestor
24815350|NCT02069808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24875206|NCT04329325|Blinatumomab|blinatumomab|mesh-list
24815351|NCT02069808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24875207|NCT04329325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24875216|NCT04329325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24875217|NCT04329325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24875218|NCT04329325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24875219|NCT04329325|Abortifacient Agents|abortifacient agents|mesh-ancestor
24875220|NCT04329325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24875221|NCT04329325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24875222|NCT04329325|Antimetabolites|antimetabolites|mesh-ancestor
24875223|NCT04329325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697789|NCT01437306|Lofexidine|lofexidine|mesh-list
24875325|NCT04222595|Vaccines|vaccines|mesh-list
24875545|NCT04080271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875547|NCT04079712|Ipilimumab|ipilimumab|mesh-list
24875548|NCT04079712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24875549|NCT04079712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24875550|NCT04079712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24875551|NCT04079712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875566|NCT04043806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056460|NCT03512574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25056461|NCT03512574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25056462|NCT03512574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25056463|NCT03512548|Itraconazole|itraconazole|mesh-list
24875701|NCT03907475|Tubulin Modulators|tubulin modulators|mesh-ancestor
24875831|NCT03819465|Carboplatin|carboplatin|mesh-list
25407137|NCT03516981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24875850|NCT03819465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25056468|NCT03512548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24875892|NCT03816332|Immunologic Factors|immunologic factors|mesh-ancestor
24875893|NCT03816332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24875894|NCT03816332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24875896|NCT03813147|Hydrocortisone|hydrocortisone|mesh-list
24877447|NCT02627443|Antimetabolites|antimetabolites|mesh-ancestor
24876040|NCT03766126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24876042|NCT03766126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25056485|NCT03512236|Insulin Lispro|insulin lispro|mesh-list
25056486|NCT03512236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25056487|NCT03512236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056488|NCT03512171|Amphetamine|amphetamine|mesh-list
25056489|NCT03512171|Dextroamphetamine|dextroamphetamine|mesh-list
25056490|NCT03512171|Fallypride|fallypride|mesh-list
25056491|NCT03512171|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25056492|NCT03512171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056493|NCT03512171|Sympathomimetics|sympathomimetics|mesh-ancestor
25056494|NCT03512171|Autonomic Agents|autonomic agents|mesh-ancestor
25056495|NCT03512171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25056496|NCT03512171|Dopamine Agents|dopamine agents|mesh-ancestor
25056497|NCT03512171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25056498|NCT03512171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056499|NCT03512171|Adrenergic Agents|adrenergic agents|mesh-ancestor
25056500|NCT03512171|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24876072|NCT03738228|Cisplatin|cisplatin|mesh-list
24876073|NCT03738228|Atezolizumab|atezolizumab|mesh-list
24876074|NCT03738228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24876075|NCT03738228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056503|NCT03512171|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25056504|NCT03512171|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25056505|NCT03512171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24810719|NCT02042196|Hormones|hormones|mesh-ancestor
24815397|NCT02070120|Alkylating Agents|alkylating agents|mesh-ancestor
24876166|NCT03704298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24876167|NCT03704298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24876219|NCT03661320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24876220|NCT03661320|Antiviral Agents|antiviral agents|mesh-ancestor
24876221|NCT03661320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24876222|NCT03661320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24876223|NCT03661320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24876224|NCT03661320|Immunologic Factors|immunologic factors|mesh-ancestor
24876225|NCT03661320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24876228|NCT03656068|Nitazoxanide|nitazoxanide|mesh-list
25056522|NCT03511846|Antipruritics|antipruritics|mesh-ancestor
24876248|NCT03646123|Doxorubicin|doxorubicin|mesh-list
24876259|NCT03646123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24876262|NCT03646123|Alkylating Agents|alkylating agents|mesh-ancestor
24876418|NCT03555916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24876421|NCT03555916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24876422|NCT03555916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24876423|NCT03555916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24876424|NCT03555916|Cholinergic Agents|cholinergic agents|mesh-ancestor
24876425|NCT03555916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24876426|NCT03548584|Brexpiprazole|brexpiprazole|mesh-list
24876427|NCT03548584|Serotonin Agents|serotonin agents|mesh-ancestor
24876428|NCT03548584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24876429|NCT03548584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24876430|NCT03548584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24876462|NCT03512756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24876464|NCT03512756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24876465|NCT03512756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24876466|NCT03512756|Antiviral Agents|antiviral agents|mesh-ancestor
24876478|NCT03512756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24876479|NCT03512756|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24876480|NCT03512756|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24876481|NCT03512756|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24876482|NCT03512756|Dermatologic Agents|dermatologic agents|mesh-ancestor
24815385|NCT02069990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24815386|NCT02070003|Analgesics, Opioid|analgesics, opioid|mesh-list
24815387|NCT02070003|Narcotics|narcotics|mesh-ancestor
25026673|NCT03625830|Paclitaxel|paclitaxel|mesh-list
24815389|NCT02070003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815391|NCT02070003|Sensory System Agents|sensory system agents|mesh-ancestor
24815392|NCT02070003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24815393|NCT02070120|Mitomycins|mitomycins|mesh-list
25056528|NCT03511833|Morphine|morphine|mesh-list
25056529|NCT03511833|Analgesics|analgesics|mesh-ancestor
25056530|NCT03511833|Sensory System Agents|sensory system agents|mesh-ancestor
25056531|NCT03511833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25056532|NCT03511833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056533|NCT03511833|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24448849|NCT00313274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24448883|NCT00313508|Fludarabine|fludarabine|mesh-list
24448884|NCT00313508|Fludarabine phosphate|fludarabine phosphate|mesh-list
24448885|NCT00313508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448886|NCT00313508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24448887|NCT00313508|Antimetabolites|antimetabolites|mesh-ancestor
24815395|NCT02070120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24815396|NCT02070120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815411|NCT02070159|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24815412|NCT02070159|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24876511|NCT03484819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24876512|NCT03484819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24876567|NCT03378479|Posaconazole|posaconazole|mesh-list
24876568|NCT03378479|Antifungal Agents|antifungal agents|mesh-ancestor
25056534|NCT03511833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25056535|NCT03511833|Anesthetics, General|anesthetics, general|mesh-ancestor
25056536|NCT03511833|Anesthetics|anesthetics|mesh-ancestor
24504961|NCT00538720|Vitamins|vitamins|mesh-ancestor
24876569|NCT03378479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24876570|NCT03378479|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24876571|NCT03378479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24876572|NCT03378479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24876573|NCT03378479|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24876574|NCT03378479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24876575|NCT03378479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24876654|NCT03323658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24876785|NCT03218826|Docetaxel|docetaxel|mesh-list
24876787|NCT03218826|Tubulin Modulators|tubulin modulators|mesh-ancestor
24876788|NCT03218826|Antimitotic Agents|antimitotic agents|mesh-ancestor
24876789|NCT03218826|Mitosis Modulators|mitosis modulators|mesh-ancestor
24876790|NCT03218826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24876799|NCT03206047|Poly I-C|poly i-c|mesh-list
24876800|NCT03206047|Atezolizumab|atezolizumab|mesh-list
24876801|NCT03206047|Guadecitabine|guadecitabine|mesh-list
24876802|NCT03206047|Azacitidine|azacitidine|mesh-list
24876803|NCT03206047|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25698274|NCT02091414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24876804|NCT03206047|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24876805|NCT03206047|Poly ICLC|poly iclc|mesh-list
25698275|NCT02091414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25698276|NCT02091414|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25698277|NCT02091414|Antitubercular Agents|antitubercular agents|mesh-ancestor
25698278|NCT02091414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25709411|NCT02266472|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25709412|NCT02266472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709413|NCT02266706|Tazobactam|tazobactam|mesh-list
25709414|NCT02266706|Ceftolozane|ceftolozane|mesh-list
25709415|NCT02266706|Cephalosporins|cephalosporins|mesh-list
25709416|NCT02266706|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
25709417|NCT02266706|Penicillanic Acid|penicillanic acid|mesh-list
25709418|NCT02266706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25709419|NCT02266706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25709420|NCT02266706|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25709421|NCT02266706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709422|NCT02266706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709423|NCT02266706|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24623405|NCT01071291|Vitamins|vitamins|mesh-ancestor
24623406|NCT01071291|Micronutrients|micronutrients|mesh-ancestor
24623407|NCT01071291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623408|NCT01071304|Midazolam|midazolam|mesh-list
24623409|NCT01071304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24623410|NCT01071304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24876806|NCT03206047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623411|NCT01071304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24876807|NCT03206047|Immunologic Factors|immunologic factors|mesh-ancestor
24876808|NCT03206047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24876809|NCT03206047|Interferon Inducers|interferon inducers|mesh-ancestor
24876810|NCT03206047|Laxatives|laxatives|mesh-ancestor
24876811|NCT03206047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24876812|NCT03206047|Antiviral Agents|antiviral agents|mesh-ancestor
24876813|NCT03206047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24876814|NCT03206047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24876815|NCT03206047|Antimetabolites|antimetabolites|mesh-ancestor
24876838|NCT03199053|Saxagliptin|saxagliptin|mesh-list
24876839|NCT03199053|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24876840|NCT03199053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24876841|NCT03199053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24876842|NCT03199053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056547|NCT03511820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25056548|NCT03511820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25056549|NCT03511820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25056550|NCT03511820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25056551|NCT03511820|Antifungal Agents|antifungal agents|mesh-ancestor
24876843|NCT03199053|Incretins|incretins|mesh-ancestor
24876844|NCT03199053|Hormones|hormones|mesh-ancestor
24876845|NCT03199053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24876859|NCT03148275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24876861|NCT03148275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24876862|NCT03141684|Bevacizumab|bevacizumab|mesh-list
24876863|NCT03141684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24876864|NCT03141684|Atezolizumab|atezolizumab|mesh-list
24876865|NCT03141684|Endothelial Growth Factors|endothelial growth factors|mesh-list
24876866|NCT03141684|Antibodies|antibodies|mesh-list
24876886|NCT03126539|Sulforaphane|sulforaphane|mesh-list
24600308|NCT01095003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815515|NCT02070679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815517|NCT02070679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815518|NCT02070679|Protective Agents|protective agents|mesh-ancestor
24815519|NCT02070718|Pentazocine|pentazocine|mesh-list
24815520|NCT02070718|Naloxone|naloxone|mesh-list
24815521|NCT02070718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24815522|NCT02070718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24877144|NCT02922777|Docetaxel|docetaxel|mesh-list
24877145|NCT02922777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24877146|NCT02922777|Tubulin Modulators|tubulin modulators|mesh-ancestor
24877147|NCT02922777|Antimitotic Agents|antimitotic agents|mesh-ancestor
24877148|NCT02922777|Mitosis Modulators|mitosis modulators|mesh-ancestor
24877149|NCT02922777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24877434|NCT02692339|Immunologic Factors|immunologic factors|mesh-ancestor
24877435|NCT02692339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24877436|NCT02692339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24877437|NCT02692339|Growth Substances|growth substances|mesh-ancestor
24877438|NCT02692339|Growth Inhibitors|growth inhibitors|mesh-ancestor
24877443|NCT02627443|Gemcitabine|gemcitabine|mesh-list
24877444|NCT02627443|Carboplatin|carboplatin|mesh-list
24877445|NCT02627443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24877446|NCT02627443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24877449|NCT02627443|Antiviral Agents|antiviral agents|mesh-ancestor
24877450|NCT02627443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24877451|NCT02627443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24877452|NCT02627443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24877453|NCT02627443|Immunologic Factors|immunologic factors|mesh-ancestor
24877454|NCT02627443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700068|NCT01450384|Pemetrexed|pemetrexed|mesh-list
25056600|NCT03511222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25056601|NCT03511222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25698279|NCT02091739|Botulinum Toxins|botulinum toxins|mesh-list
25698280|NCT02091739|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24877750|NCT02473042|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24877751|NCT02473042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24877752|NCT02460588|Prednisolone|prednisolone|mesh-list
24877753|NCT02460588|Cyclophosphamide|cyclophosphamide|mesh-list
24877754|NCT02460588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24877755|NCT02460588|Immunologic Factors|immunologic factors|mesh-ancestor
24877756|NCT02460588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24877757|NCT02460588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24877758|NCT02460588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24877759|NCT02460588|Alkylating Agents|alkylating agents|mesh-ancestor
24700083|NCT01450410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24877760|NCT02460588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24877761|NCT02460588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24877762|NCT02460588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24633483|NCT01129518|Vaccines|vaccines|mesh-list
24877763|NCT02460588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25056616|NCT03510962|Chlorhexidine|chlorhexidine|mesh-list
25056617|NCT03510962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24877789|NCT02417103|Incretins|incretins|mesh-ancestor
24877830|NCT02314169|Nivolumab|nivolumab|mesh-list
24877831|NCT02314169|Ipilimumab|ipilimumab|mesh-list
24877832|NCT02314169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24877833|NCT02314169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24877834|NCT02314169|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24877835|NCT02314169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056628|NCT03510793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056630|NCT03510611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24940160|NCT04003350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24940162|NCT04003350|Analgesics|analgesics|mesh-ancestor
25027463|NCT03620032|Tubulin Modulators|tubulin modulators|mesh-ancestor
25027464|NCT03620032|Antimitotic Agents|antimitotic agents|mesh-ancestor
25027465|NCT03620032|Mitosis Modulators|mitosis modulators|mesh-ancestor
25027466|NCT03620032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027467|NCT03620032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25027477|NCT03619876|Adalimumab|adalimumab|mesh-list
25027478|NCT03619876|Abatacept|abatacept|mesh-list
25027479|NCT03619876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25027480|NCT03619876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24877894|NCT02231749|Nivolumab|nivolumab|mesh-list
24877895|NCT02231749|Ipilimumab|ipilimumab|mesh-list
24877896|NCT02231749|Sunitinib|sunitinib|mesh-list
24877897|NCT02231749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24877898|NCT02231749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24877899|NCT02231749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24877900|NCT02231749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24877901|NCT02231749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24877902|NCT02231749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25112728|NCT03919526|Fludarabine|fludarabine|mesh-list
25112729|NCT03919526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25112730|NCT03919526|Immunologic Factors|immunologic factors|mesh-ancestor
24940176|NCT04003350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24940177|NCT04003350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952607|NCT03892668|Coagulants|coagulants|mesh-ancestor
25698285|NCT02091739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698286|NCT02091739|Cholinergic Agents|cholinergic agents|mesh-ancestor
25698287|NCT02091739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25698288|NCT02091739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985978|NCT02422368|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24985979|NCT02422368|Prednisolone|prednisolone|mesh-list
24985980|NCT02422368|Prednisolone acetate|prednisolone acetate|mesh-list
24985986|NCT02422368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24985987|NCT02422368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985988|NCT02422368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24985989|NCT02422368|Glucocorticoids|glucocorticoids|mesh-ancestor
24985990|NCT02422368|Hormones|hormones|mesh-ancestor
24985992|NCT02422368|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24878135|NCT02142803|Immunologic Factors|immunologic factors|mesh-ancestor
24815656|NCT02071433|Trace Elements|trace elements|mesh-ancestor
24952632|NCT03892499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24952633|NCT03892499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952634|NCT03892499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952635|NCT03892499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24952636|NCT03892499|Hormone Antagonists|hormone antagonists|mesh-ancestor
24952637|NCT03892499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24952638|NCT03892499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952639|NCT03892499|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24952640|NCT03892447|Ferulic acid|ferulic acid|mesh-list
24952641|NCT03892447|Dopamine|dopamine|mesh-list
25056653|NCT03510351|Ceftolozane|ceftolozane|mesh-list
25056654|NCT03510351|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
25056655|NCT03510351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24878316|NCT01935921|Immunoglobulins|immunoglobulins|mesh-list
24878317|NCT01935921|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24878318|NCT01935921|Immunologic Factors|immunologic factors|mesh-ancestor
24878319|NCT01935921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24878320|NCT01935921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24878321|NCT01935921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24878322|NCT01935921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878326|NCT01915810|Nicotine|nicotine|mesh-list
25056656|NCT03510351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25056657|NCT03510351|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25056658|NCT03510351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25056659|NCT03510351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056660|NCT03510351|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24878449|NCT01744652|Dasatinib|dasatinib|mesh-list
24878450|NCT01744652|Crizotinib|crizotinib|mesh-list
24878451|NCT01744652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24878452|NCT01744652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24878453|NCT01744652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24878454|NCT01744652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056663|NCT03510338|Vasodilator Agents|vasodilator agents|mesh-ancestor
25056664|NCT03510338|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25056665|NCT03510338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25056666|NCT03510338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24878497|NCT01660971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24878498|NCT01660971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24878499|NCT01660971|Immunologic Factors|immunologic factors|mesh-ancestor
24878500|NCT01660971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24878501|NCT01660971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24878545|NCT01479842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24878546|NCT01479842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24700832|NCT01455337|Vasodilator Agents|vasodilator agents|mesh-ancestor
24878547|NCT01479842|Alkylating Agents|alkylating agents|mesh-ancestor
24878548|NCT01479842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878550|NCT01434316|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24878551|NCT01434316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407138|NCT03516981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25698289|NCT02091739|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25698290|NCT02091739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25698291|NCT02091882|Aripiprazole|aripiprazole|mesh-list
25698292|NCT02091882|Antidepressive Agents|antidepressive agents|mesh-ancestor
25698293|NCT02091882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25698294|NCT02091882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25698295|NCT02091882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25698296|NCT02091882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25698297|NCT02091882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24878552|NCT01434316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878553|NCT01434316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24878555|NCT01430572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24878556|NCT01430572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25056681|NCT03510325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25056682|NCT03510325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25056683|NCT03510325|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25056684|NCT03510325|Dopamine Agents|dopamine agents|mesh-ancestor
25056687|NCT03510325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25056688|NCT03510325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25056689|NCT03510325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25056690|NCT03510325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24815681|NCT02071537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24815682|NCT02071537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24815684|NCT02071537|Sensory System Agents|sensory system agents|mesh-ancestor
24815685|NCT02071537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24815686|NCT02071537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24815687|NCT02071537|Filaricides|filaricides|mesh-ancestor
24815688|NCT02071537|Antinematodal Agents|antinematodal agents|mesh-ancestor
24815689|NCT02071537|Anthelmintics|anthelmintics|mesh-ancestor
24815690|NCT02071589|Nifedipine|nifedipine|mesh-list
24815691|NCT02071589|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24815692|NCT02071589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24611479|NCT01009788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611480|NCT01009788|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24611481|NCT01009788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611482|NCT01009801|Doxorubicin|doxorubicin|mesh-list
25056691|NCT03510325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25056692|NCT03510325|Antidepressive Agents|antidepressive agents|mesh-ancestor
25056693|NCT03510325|Dopamine Agonists|dopamine agonists|mesh-ancestor
24611483|NCT01009801|Everolimus|everolimus|mesh-list
24878814|NCT00740805|Doxorubicin|doxorubicin|mesh-list
24878815|NCT00740805|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24878816|NCT00740805|Veliparib|veliparib|mesh-list
24878843|NCT00669734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878845|NCT00669734|Antiviral Agents|antiviral agents|mesh-ancestor
24878846|NCT00669734|Growth Inhibitors|growth inhibitors|mesh-ancestor
24878847|NCT00669734|Growth Substances|growth substances|mesh-ancestor
24878848|NCT00669734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24878849|NCT00669734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24878850|NCT00588991|Carboplatin|carboplatin|mesh-list
24878851|NCT00588991|Topotecan|topotecan|mesh-list
24878852|NCT00588991|Veliparib|veliparib|mesh-list
24878853|NCT00588991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24878854|NCT00588991|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24878900|NCT00336063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24878902|NCT00336063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878903|NCT00336063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24878904|NCT00336063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24878905|NCT00336063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25056698|NCT03510325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25056699|NCT03510221|Antioxidants|antioxidants|mesh-list
25407139|NCT03516981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24878999|NCT05174845|Antioxidants|antioxidants|mesh-ancestor
24879000|NCT05174845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739876|NCT01684813|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24739878|NCT01684813|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24879002|NCT05174845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879004|NCT05174845|Micronutrients|micronutrients|mesh-ancestor
24879005|NCT05171374|Trametinib|trametinib|mesh-list
24879006|NCT05171374|Dabrafenib|dabrafenib|mesh-list
24879007|NCT05171374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24879008|NCT05171374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25056706|NCT03510208|Immunoglobulins|immunoglobulins|mesh-list
25056707|NCT03510208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24815708|NCT02071615|Dopamine Agents|dopamine agents|mesh-ancestor
24815709|NCT02071615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24815710|NCT02071615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24815711|NCT02071615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815712|NCT02071615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24815713|NCT02071615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24815714|NCT02071615|Purinergic Agents|purinergic agents|mesh-ancestor
24815715|NCT02071615|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24815716|NCT02071615|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24815717|NCT02071615|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24879043|NCT05102071|Empagliflozin|empagliflozin|mesh-list
24879044|NCT05102071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24879045|NCT05102071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879046|NCT05102071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24879047|NCT05102071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879050|NCT05089370|Nivolumab|nivolumab|mesh-list
24879051|NCT05089370|Decitabine|decitabine|mesh-list
24879052|NCT05089370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24879053|NCT05089370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24879055|NCT05089370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879056|NCT05089370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24879057|NCT05089370|Antimetabolites|antimetabolites|mesh-ancestor
24879058|NCT05089370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24879059|NCT05082259|Pembrolizumab|pembrolizumab|mesh-list
24879080|NCT05062174|Abortifacient Agents|abortifacient agents|mesh-ancestor
24879081|NCT05062174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24879082|NCT05062174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879083|NCT05062174|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24879084|NCT05062174|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24879103|NCT05054868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25056717|NCT03510013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25056718|NCT03510013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606440|NCT00990444|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24879192|NCT04962893|Immunologic Factors|immunologic factors|mesh-ancestor
25056719|NCT03510013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25056720|NCT03510013|Anesthetics, General|anesthetics, general|mesh-ancestor
25056738|NCT03509922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056740|NCT03509831|Nizatidine|nizatidine|mesh-list
25056741|NCT03509831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056742|NCT03509831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25056743|NCT03509831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25056744|NCT03509831|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25056745|NCT03509831|Histamine Antagonists|histamine antagonists|mesh-ancestor
25056746|NCT03509831|Histamine Agents|histamine agents|mesh-ancestor
25056747|NCT03509831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24879238|NCT04937543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24879239|NCT04937543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24879240|NCT04937543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24879241|NCT04937543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24879242|NCT04937543|Cholinergic Agents|cholinergic agents|mesh-ancestor
24879243|NCT04923737|Dexmedetomidine|dexmedetomidine|mesh-list
24879244|NCT04923737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24879245|NCT04923737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24879247|NCT04923737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24879254|NCT04923737|Adrenergic Agents|adrenergic agents|mesh-ancestor
24815801|NCT02072083|Sensory System Agents|sensory system agents|mesh-ancestor
24815802|NCT02072083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24815803|NCT02072083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24815804|NCT02072083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24879450|NCT04752813|Vitamin K|vitamin k|mesh-list
25056788|NCT03509662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056789|NCT03509662|Antioxidants|antioxidants|mesh-ancestor
25056790|NCT03509662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056791|NCT03509662|Protective Agents|protective agents|mesh-ancestor
24879487|NCT04727229|Bupivacaine|bupivacaine|mesh-list
24879488|NCT04727229|Anesthetics, Local|anesthetics, local|mesh-ancestor
24879493|NCT04727229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24879495|NCT04715633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24879496|NCT04715633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24879497|NCT04715633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24879498|NCT04715633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24879534|NCT04679402|Carbon Monoxide|carbon monoxide|mesh-list
24879535|NCT04679402|Antimetabolites|antimetabolites|mesh-ancestor
24879536|NCT04679402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879537|NCT04679402|Gasotransmitters|gasotransmitters|mesh-ancestor
24879538|NCT04679402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24879539|NCT04679402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698298|NCT02091882|Dopamine Agonists|dopamine agonists|mesh-ancestor
25698299|NCT02091882|Dopamine Agents|dopamine agents|mesh-ancestor
24520339|NCT02771249|Isoniazid|isoniazid|mesh-list
25698300|NCT02091882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25698301|NCT02091882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698302|NCT02091882|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25698303|NCT02091882|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25698304|NCT02091882|Serotonin Agents|serotonin agents|mesh-ancestor
25698305|NCT02091882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24879541|NCT04673786|Dermatologic Agents|dermatologic agents|mesh-ancestor
24879542|NCT04670068|Cyclophosphamide|cyclophosphamide|mesh-list
24879544|NCT04670068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24879545|NCT04670068|Immunologic Factors|immunologic factors|mesh-ancestor
24600312|NCT01026220|Doxorubicin|doxorubicin|mesh-list
24879572|NCT04660240|Antifungal Agents|antifungal agents|mesh-ancestor
24879573|NCT04660240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25028453|NCT03610685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25028454|NCT03610685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056829|NCT03509246|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25056830|NCT03509246|Bortezomib|bortezomib|mesh-list
25056831|NCT03509246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25056832|NCT03509246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056833|NCT03509246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24879592|NCT04640402|Vaccines|vaccines|mesh-list
24879647|NCT04594005|Antimitotic Agents|antimitotic agents|mesh-ancestor
24879648|NCT04594005|Mitosis Modulators|mitosis modulators|mesh-ancestor
24879649|NCT04594005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879651|NCT04580277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24879652|NCT04580277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24879653|NCT04580277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879654|NCT04562467|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
24879655|NCT04562467|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24879656|NCT04562467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24879658|NCT04560660|Ketamine|ketamine|mesh-list
24879659|NCT04560660|Analgesics|analgesics|mesh-ancestor
24879660|NCT04560660|Sensory System Agents|sensory system agents|mesh-ancestor
24879661|NCT04560660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24879683|NCT04551521|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24879684|NCT04551521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24879685|NCT04551521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24879686|NCT04551521|Immunologic Factors|immunologic factors|mesh-ancestor
24879687|NCT04551521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879688|NCT04551521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24606458|NCT00990535|Octreotide|octreotide|mesh-list
24879751|NCT04489433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24879752|NCT04489433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24879753|NCT04489433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879767|NCT04439799|Testosterone undecanoate|testosterone undecanoate|mesh-list
24879781|NCT04422652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24879782|NCT04422652|Antidepressive Agents|antidepressive agents|mesh-ancestor
24879783|NCT04422652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24879784|NCT04422652|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24879785|NCT04422652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24879786|NCT04422652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24879787|NCT04422652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879788|NCT04422652|Dopamine Agents|dopamine agents|mesh-ancestor
24879789|NCT04422652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24879790|NCT04422652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879791|NCT04422652|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24879792|NCT04422652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24879793|NCT04422652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25056898|NCT03508882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25056899|NCT03508882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25056900|NCT03508869|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25056901|NCT03508869|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24811140|NCT02045030|Aflibercept|aflibercept|mesh-list
24879850|NCT04360629|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24879851|NCT04360629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24879852|NCT04360629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879865|NCT04327024|Allopurinol|allopurinol|mesh-list
24879866|NCT04327024|Verinurad|verinurad|mesh-list
24879867|NCT04327024|Antimetabolites|antimetabolites|mesh-ancestor
24879873|NCT04327024|Antioxidants|antioxidants|mesh-ancestor
24879926|NCT04294225|Letrozole|letrozole|mesh-list
25056902|NCT03508869|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25056903|NCT03508869|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25056904|NCT03508869|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25056905|NCT03508869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25056906|NCT03508869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25056907|NCT03508869|Adrenergic Agents|adrenergic agents|mesh-ancestor
25056908|NCT03508869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25056909|NCT03508869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056910|NCT03508869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056911|NCT03508869|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25056912|NCT03508869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25056913|NCT03508869|Cholinergic Agents|cholinergic agents|mesh-ancestor
25056929|NCT03508817|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25056930|NCT03508817|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25056931|NCT03508817|Cholinergic Agents|cholinergic agents|mesh-ancestor
25056932|NCT03508817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25056933|NCT03508817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25056935|NCT03508804|Prilocaine|prilocaine|mesh-list
25056936|NCT03508804|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25056937|NCT03508804|Anesthetics, Local|anesthetics, local|mesh-ancestor
24940485|NCT04001348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24940486|NCT04001348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940487|NCT04001348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24940488|NCT04001348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24940489|NCT04001348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24940490|NCT04001348|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24940491|NCT04001348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24631434|NCT01118039|Sunitinib|sunitinib|mesh-list
24879999|NCT04245280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24880000|NCT04245280|Anesthetics, Local|anesthetics, local|mesh-ancestor
24880001|NCT04245280|Anesthetics|anesthetics|mesh-ancestor
24880002|NCT04245280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24952652|NCT03892447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24952653|NCT03892447|Vasodilator Agents|vasodilator agents|mesh-ancestor
24952654|NCT03892447|Urological Agents|urological agents|mesh-ancestor
24952655|NCT03892447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24952656|NCT03892447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24952657|NCT03892447|Analgesics|analgesics|mesh-ancestor
24952658|NCT03892447|Sensory System Agents|sensory system agents|mesh-ancestor
24952659|NCT03892447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24952660|NCT03892447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24952661|NCT03892447|Anticoagulants|anticoagulants|mesh-ancestor
24952662|NCT03892447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24880130|NCT04072770|Caseins|caseins|mesh-list
24880131|NCT04072770|Chelating Agents|chelating agents|mesh-ancestor
24880132|NCT04072770|Sequestering Agents|sequestering agents|mesh-ancestor
24880133|NCT04072770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880134|NCT04055688|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24880135|NCT04055688|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24880136|NCT04055688|Dermatologic Agents|dermatologic agents|mesh-ancestor
24880137|NCT04048343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24880138|NCT04048343|Immunologic Factors|immunologic factors|mesh-ancestor
24880169|NCT03988933|Rifampin|rifampin|mesh-list
24740577|NCT01689090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24880256|NCT03943173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880257|NCT03943173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880388|NCT03802071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880389|NCT03802071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24880390|NCT03802071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24880391|NCT03802071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24880396|NCT03799835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880397|NCT03799835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24880399|NCT03799835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056963|NCT03508635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25056964|NCT03508635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25056965|NCT03508635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25056966|NCT03508635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509683|NCT00561613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24509685|NCT00561613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25056967|NCT03508635|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25056968|NCT03508635|Abortifacient Agents|abortifacient agents|mesh-ancestor
24880482|NCT03654274|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24880483|NCT03654274|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24618229|NCT01047215|Serotonin Agents|serotonin agents|mesh-ancestor
25056974|NCT03508635|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25056975|NCT03508635|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25056976|NCT03508635|Hormone Antagonists|hormone antagonists|mesh-ancestor
25056977|NCT03508635|Luteolytic Agents|luteolytic agents|mesh-ancestor
25056978|NCT03508635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25056979|NCT03508635|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24880491|NCT03625648|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24880492|NCT03625648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24880493|NCT03625648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880494|NCT03625648|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24880516|NCT03608358|Incretins|incretins|mesh-ancestor
24880518|NCT03608358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24880910|NCT03179904|Paclitaxel|paclitaxel|mesh-list
24880745|NCT03395314|Ketamine|ketamine|mesh-list
24880746|NCT03395314|Analgesics|analgesics|mesh-ancestor
24880747|NCT03395314|Sensory System Agents|sensory system agents|mesh-ancestor
24880748|NCT03395314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24880749|NCT03395314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880750|NCT03395314|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24740780|NCT01690286|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24740781|NCT01690286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24740782|NCT01690286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24740783|NCT01690286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740784|NCT01690286|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24740785|NCT01690286|Hormone Antagonists|hormone antagonists|mesh-ancestor
24740787|NCT01690286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880751|NCT03395314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24880752|NCT03395314|Anesthetics, General|anesthetics, general|mesh-ancestor
24880753|NCT03395314|Anesthetics|anesthetics|mesh-ancestor
24880754|NCT03395314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24880755|NCT03395314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24880756|NCT03395314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25056988|NCT03508440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25056989|NCT03508102|Remifentanil|remifentanil|mesh-list
25056990|NCT03508102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25056991|NCT03508102|Narcotics|narcotics|mesh-ancestor
24880877|NCT03224104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880879|NCT03221257|Mycophenolic Acid|mycophenolic acid|mesh-list
24880880|NCT03221257|Pirfenidone|pirfenidone|mesh-list
24880881|NCT03221257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24880882|NCT03221257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880904|NCT03213158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880906|NCT03203642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880907|NCT03203642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24880908|NCT03203642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24880909|NCT03203642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880969|NCT03174275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880971|NCT03174275|Antimitotic Agents|antimitotic agents|mesh-ancestor
24881002|NCT03173053|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24881003|NCT03173053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24881004|NCT03173053|Antitubercular Agents|antitubercular agents|mesh-ancestor
24881005|NCT03173053|Leprostatic Agents|leprostatic agents|mesh-ancestor
24881006|NCT03173053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24881007|NCT03173053|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24881010|NCT03173053|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24881011|NCT03173053|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24881012|NCT03173053|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25407218|NCT03511196|Hormones|hormones|mesh-ancestor
25698306|NCT02091882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25698307|NCT02091882|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25698308|NCT02091882|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24796354|NCT01949519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796355|NCT01949519|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24881017|NCT03173053|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24881021|NCT03122639|Antimetabolites|antimetabolites|mesh-ancestor
24881033|NCT03109795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24881034|NCT03109795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881036|NCT03109795|Sensory System Agents|sensory system agents|mesh-ancestor
24881037|NCT03109795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24881038|NCT03109795|Sympatholytics|sympatholytics|mesh-ancestor
24881039|NCT03109795|Autonomic Agents|autonomic agents|mesh-ancestor
24881041|NCT03109795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24600316|NCT01026220|Vinorelbine|vinorelbine|mesh-list
24703486|NCT01471925|Esomeprazole|esomeprazole|mesh-list
24881164|NCT02948660|Zolpidem|zolpidem|mesh-list
24881165|NCT02948660|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24881166|NCT02948660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24881167|NCT02948660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24881168|NCT02948660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881169|NCT02948660|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24881172|NCT02948660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24740850|NCT01690468|Carboplatin|carboplatin|mesh-list
24881173|NCT02948660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881177|NCT02944019|Edoxaban|edoxaban|mesh-list
24881178|NCT02944019|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24881179|NCT02944019|Antithrombins|antithrombins|mesh-ancestor
24881180|NCT02944019|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25057039|NCT03507634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25057040|NCT03507634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25057041|NCT03507634|Analgesics|analgesics|mesh-ancestor
25057042|NCT03507634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24881246|NCT02900443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815995|NCT02073357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24815996|NCT02073357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815997|NCT02073474|Nabiximols|nabiximols|mesh-list
25057043|NCT03507634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24881276|NCT02780609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881278|NCT02780609|Glucocorticoids|glucocorticoids|mesh-ancestor
24881279|NCT02780609|Hormones|hormones|mesh-ancestor
24881280|NCT02780609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24881281|NCT02780609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24881379|NCT02576574|Immunologic Factors|immunologic factors|mesh-ancestor
24881380|NCT02576574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881381|NCT02576574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25698309|NCT02091921|Ticagrelor|ticagrelor|mesh-list
25698310|NCT02091921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25698311|NCT02091921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25698312|NCT02091921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25698313|NCT02091921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25698314|NCT02091921|Purinergic Agents|purinergic agents|mesh-ancestor
25698315|NCT02091921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25698316|NCT02091921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698317|NCT02091921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698318|NCT02091986|Budesonide|budesonide|mesh-list
25698319|NCT02091986|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25698320|NCT02091986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25698321|NCT02091986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25698322|NCT02091986|Autonomic Agents|autonomic agents|mesh-ancestor
24796400|NCT01949818|Vincristine|vincristine|mesh-list
24881382|NCT02576574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24881383|NCT02576574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24881385|NCT02564263|Docetaxel|docetaxel|mesh-list
24881386|NCT02564263|Pembrolizumab|pembrolizumab|mesh-list
24881387|NCT02564263|Irinotecan|irinotecan|mesh-list
24881388|NCT02564263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24881389|NCT02564263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881390|NCT02564263|Tubulin Modulators|tubulin modulators|mesh-ancestor
24881391|NCT02564263|Antimitotic Agents|antimitotic agents|mesh-ancestor
24526346|NCT00611286|Paclitaxel|paclitaxel|mesh-list
24881392|NCT02564263|Mitosis Modulators|mitosis modulators|mesh-ancestor
24881393|NCT02564263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881394|NCT02564263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24881397|NCT02564263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881399|NCT02546232|Carboplatin|carboplatin|mesh-list
24881400|NCT02546232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24881401|NCT02546232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881402|NCT02546232|Tubulin Modulators|tubulin modulators|mesh-ancestor
24881403|NCT02546232|Antimitotic Agents|antimitotic agents|mesh-ancestor
24881404|NCT02546232|Mitosis Modulators|mitosis modulators|mesh-ancestor
24881405|NCT02546232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881406|NCT02537197|Naltrexone|naltrexone|mesh-list
24741170|NCT01692483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741171|NCT01692483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24741172|NCT01692483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24741173|NCT01692483|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24741174|NCT01692483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24741175|NCT01692483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741176|NCT01692483|Hormone Antagonists|hormone antagonists|mesh-ancestor
24741194|NCT01692704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881480|NCT02204254|Doxycycline|doxycycline|mesh-list
24881481|NCT02204254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24881482|NCT02204254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24881483|NCT02204254|Antimalarials|antimalarials|mesh-ancestor
24881484|NCT02204254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24881485|NCT02204254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24881486|NCT02170090|Gemcitabine|gemcitabine|mesh-list
24881487|NCT02170090|Capecitabine|capecitabine|mesh-list
25057089|NCT03507465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25057090|NCT03507465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881488|NCT02170090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881489|NCT02170090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24881490|NCT02170090|Antimetabolites|antimetabolites|mesh-ancestor
25113307|NCT03086343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741244|NCT01693003|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24741245|NCT01693003|Autonomic Agents|autonomic agents|mesh-ancestor
25113308|NCT03086343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25113309|NCT03086343|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25113310|NCT03086343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25113311|NCT03086343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816060|NCT02073916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24816062|NCT02073916|Tubulin Modulators|tubulin modulators|mesh-ancestor
24816063|NCT02073916|Antimitotic Agents|antimitotic agents|mesh-ancestor
24816064|NCT02073916|Mitosis Modulators|mitosis modulators|mesh-ancestor
24816065|NCT02073916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816066|NCT02073916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24816067|NCT02073916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24816068|NCT02073916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816069|NCT02074137|Prednisone|prednisone|mesh-list
24816070|NCT02074137|Prednisolone|prednisolone|mesh-list
24703824|NCT01474499|Sorbitol|sorbitol|mesh-list
24881501|NCT02101853|Cytarabine|cytarabine|mesh-list
24881502|NCT02101853|Dexamethasone|dexamethasone|mesh-list
24881503|NCT02101853|Dexamethasone acetate|dexamethasone acetate|mesh-list
24881504|NCT02101853|Hydrocortisone|hydrocortisone|mesh-list
24881505|NCT02101853|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24881535|NCT02101853|Alkylating Agents|alkylating agents|mesh-ancestor
25407297|NCT03508921|Cholinergic Agents|cholinergic agents|mesh-ancestor
25709424|NCT02266706|Renal Agents|renal agents|mesh-ancestor
25698323|NCT02091986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24881536|NCT02101853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881537|NCT02101853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881538|NCT02101853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25057100|NCT03507426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25057101|NCT03507426|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25057102|NCT03507426|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25057103|NCT03507426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24881581|NCT02065596|Fludarabine|fludarabine|mesh-list
24881582|NCT02065596|Fludarabine phosphate|fludarabine phosphate|mesh-list
24881583|NCT02065596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881584|NCT02065596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25057110|NCT03507387|Bupivacaine|bupivacaine|mesh-list
25057111|NCT03507387|Anesthetics, Local|anesthetics, local|mesh-ancestor
25057112|NCT03507387|Anesthetics|anesthetics|mesh-ancestor
25057113|NCT03507387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25057114|NCT03507387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057115|NCT03507387|Sensory System Agents|sensory system agents|mesh-ancestor
25057116|NCT03507387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25057117|NCT03507387|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25057118|NCT03507387|Mydriatics|mydriatics|mesh-ancestor
25057119|NCT03507387|Autonomic Agents|autonomic agents|mesh-ancestor
25057120|NCT03507387|Sympathomimetics|sympathomimetics|mesh-ancestor
25057121|NCT03507387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25057142|NCT03507244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25057143|NCT03507244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057146|NCT03507244|Hormones|hormones|mesh-ancestor
24940717|NCT03998982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24940718|NCT03998982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24940719|NCT03998969|Pantoprazole|pantoprazole|mesh-list
24940720|NCT03998969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24940721|NCT03998969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24741423|NCT05289063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24741445|NCT05288829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741446|NCT05288816|Ravulizumab|ravulizumab|mesh-list
24741447|NCT05288816|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24778472|NCT01871129|Adrenergic Agents|adrenergic agents|mesh-ancestor
24778473|NCT01871129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24778474|NCT01871129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811408|NCT02046577|Vitamin D|vitamin d|mesh-list
24881798|NCT01239797|BB 1101|bb 1101|mesh-list
24881800|NCT01239797|Antiemetics|antiemetics|mesh-ancestor
24626393|NCT01087190|Isoniazid|isoniazid|mesh-list
24626394|NCT01087190|Antitubercular Agents|antitubercular agents|mesh-ancestor
24881837|NCT01092143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24881838|NCT01092143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881839|NCT01092143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24881840|NCT01092143|Respiratory System Agents|respiratory system agents|mesh-ancestor
24881841|NCT01092143|Dermatologic Agents|dermatologic agents|mesh-ancestor
24881842|NCT01092143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24881843|NCT01025089|Cyclophosphamide|cyclophosphamide|mesh-list
24881844|NCT01025089|Doxorubicin|doxorubicin|mesh-list
24881845|NCT01025089|Cetuximab|cetuximab|mesh-list
24881846|NCT01025089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24881847|NCT01025089|Immunologic Factors|immunologic factors|mesh-ancestor
24881848|NCT01025089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741543|NCT05288192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24741544|NCT05288192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741545|NCT05288192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24741546|NCT05288192|Immunologic Factors|immunologic factors|mesh-ancestor
24741547|NCT05288192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24741548|NCT05288192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741585|NCT05291338|Doxorubicin|doxorubicin|mesh-list
24881849|NCT01025089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24952677|NCT03892512|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24952678|NCT03892512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25698324|NCT02091986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698325|NCT02091986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25698326|NCT02091986|Respiratory System Agents|respiratory system agents|mesh-ancestor
25698327|NCT02091986|Glucocorticoids|glucocorticoids|mesh-ancestor
25698328|NCT02091986|Hormones|hormones|mesh-ancestor
24952680|NCT03892512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24952681|NCT03892512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881877|NCT00754260|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24881878|NCT00754260|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24881879|NCT00754260|Purinergic Agents|purinergic agents|mesh-ancestor
24881880|NCT00754260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24881881|NCT00715988|Methadone|methadone|mesh-list
24881882|NCT00715988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24881883|NCT00715988|Narcotics|narcotics|mesh-ancestor
24881884|NCT00715988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24881885|NCT00715988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881886|NCT00715988|Analgesics|analgesics|mesh-ancestor
24881887|NCT00715988|Sensory System Agents|sensory system agents|mesh-ancestor
24881888|NCT00715988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24881889|NCT00715988|Antitussive Agents|antitussive agents|mesh-ancestor
24883070|NCT04588818|Antimetabolites|antimetabolites|mesh-ancestor
24882022|NCT00006455|Micronutrients|micronutrients|mesh-ancestor
24882023|NCT00006455|Tubulin Modulators|tubulin modulators|mesh-ancestor
24882024|NCT00006455|Antimitotic Agents|antimitotic agents|mesh-ancestor
24882025|NCT00006455|Mitosis Modulators|mitosis modulators|mesh-ancestor
24882067|NCT02855229|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24741615|NCT05291104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24741616|NCT05291104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24741617|NCT05291104|Nootropic Agents|nootropic agents|mesh-ancestor
24741618|NCT05291052|Capecitabine|capecitabine|mesh-list
24741619|NCT05291052|Oxaliplatin|oxaliplatin|mesh-list
24741643|NCT05290948|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24741645|NCT05290948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741646|NCT05290948|Diuretics|diuretics|mesh-ancestor
24741647|NCT05290948|Natriuretic Agents|natriuretic agents|mesh-ancestor
24741648|NCT05290935|Paclitaxel|paclitaxel|mesh-list
24741649|NCT05290935|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24882095|NCT02743923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24882096|NCT02743923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24882097|NCT02743923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24882098|NCT02743923|Growth Substances|growth substances|mesh-ancestor
24882099|NCT02743923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816123|NCT02074267|Sensory System Agents|sensory system agents|mesh-ancestor
24816124|NCT02074267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24611987|NCT01011621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24612059|NCT01011751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612060|NCT01011751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24612062|NCT01011751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24612063|NCT01011751|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24612064|NCT01011751|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24612065|NCT01011751|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24612066|NCT01011751|Contraceptive Agents|contraceptive agents|mesh-ancestor
24612067|NCT01011751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24612068|NCT01011751|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24612069|NCT01011751|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24612070|NCT01011751|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24612071|NCT01011751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24882174|NCT02735707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24882175|NCT02735707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24882176|NCT02735707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24882177|NCT02735707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24882178|NCT02735707|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24882179|NCT02735707|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24882180|NCT02735707|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24882181|NCT02735707|Purinergic Agents|purinergic agents|mesh-ancestor
24882182|NCT02735707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24882187|NCT02735707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24882249|NCT02345850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24882250|NCT02345850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24882251|NCT02345850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25057174|NCT03506919|Gout Suppressants|gout suppressants|mesh-ancestor
25057175|NCT03506919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24882299|NCT01546948|Hydromorphone|hydromorphone|mesh-list
24882300|NCT01546948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24882301|NCT01546948|Narcotics|narcotics|mesh-ancestor
24882302|NCT01546948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24882303|NCT01546948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882304|NCT01546948|Analgesics|analgesics|mesh-ancestor
24882305|NCT01546948|Sensory System Agents|sensory system agents|mesh-ancestor
24882306|NCT01546948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24882307|NCT01546948|Antitussive Agents|antitussive agents|mesh-ancestor
24882309|NCT01495676|Gemcitabine|gemcitabine|mesh-list
24882363|NCT01111565|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24882364|NCT01111565|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24882365|NCT01111565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24882366|NCT01111565|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24882367|NCT01111565|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24882368|NCT00950989|Folic Acid|folic acid|mesh-list
24882369|NCT00950989|Methotrexate|methotrexate|mesh-list
24882370|NCT00950989|Brodalumab|brodalumab|mesh-list
24882371|NCT00950989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24882376|NCT00950989|Antimetabolites|antimetabolites|mesh-ancestor
24882404|NCT00489307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24882405|NCT00489307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882406|NCT00072410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24882407|NCT00072410|Antibodies|antibodies|mesh-list
24882408|NCT00072410|Immunoglobulins|immunoglobulins|mesh-list
24882409|NCT00072410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24882410|NCT00072410|Immunologic Factors|immunologic factors|mesh-ancestor
24882440|NCT05170828|Sirolimus|sirolimus|mesh-list
24882441|NCT05170828|Cyclophosphamide|cyclophosphamide|mesh-list
24505254|NCT00540787|Flecainide|flecainide|mesh-list
24882498|NCT05170061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882499|NCT05170061|Vasodilator Agents|vasodilator agents|mesh-ancestor
24882500|NCT05170061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24882501|NCT05170061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24882502|NCT05170061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24882503|NCT05170061|Adrenergic Agents|adrenergic agents|mesh-ancestor
24882504|NCT05170061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24882505|NCT05170061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882507|NCT05169801|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24882508|NCT05169801|Carboplatin|carboplatin|mesh-list
24882509|NCT05169801|Bevacizumab|bevacizumab|mesh-list
24882511|NCT05169801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25057211|NCT03506802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25057212|NCT03506802|Growth Substances|growth substances|mesh-ancestor
25057213|NCT03506802|Growth Inhibitors|growth inhibitors|mesh-ancestor
25057214|NCT03506802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25057215|NCT03506802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25057216|NCT03506802|Alkylating Agents|alkylating agents|mesh-ancestor
25057217|NCT03506802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057218|NCT03506802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24882536|NCT05169554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24882537|NCT05169554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24882538|NCT05169554|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24882539|NCT05169554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24882540|NCT05169554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882541|NCT05169554|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24882552|NCT05169554|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24882553|NCT05169554|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24882554|NCT05169255|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24882555|NCT05169255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24882556|NCT05169229|Vancomycin|vancomycin|mesh-list
24882557|NCT05169229|Tobramycin|tobramycin|mesh-list
24882558|NCT05169229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24882559|NCT05169229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24882560|NCT05169125|Dialysis Solutions|dialysis solutions|mesh-list
24882561|NCT05169125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24882562|NCT05169112|Leuprolide|leuprolide|mesh-list
24882603|NCT05168176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24882604|NCT05168176|Antiviral Agents|antiviral agents|mesh-ancestor
24882605|NCT05168176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24882606|NCT05168137|Colchicine|colchicine|mesh-list
24882607|NCT05168137|Gout Suppressants|gout suppressants|mesh-ancestor
24882608|NCT05168137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24882609|NCT05168137|Tubulin Modulators|tubulin modulators|mesh-ancestor
24882610|NCT05168137|Antimitotic Agents|antimitotic agents|mesh-ancestor
24882611|NCT05168137|Mitosis Modulators|mitosis modulators|mesh-ancestor
24882612|NCT05168137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882613|NCT05168137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816133|NCT02074267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24816134|NCT02074267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816135|NCT02074267|Antimanic Agents|antimanic agents|mesh-ancestor
24816136|NCT02074280|Rifaximin|rifaximin|mesh-list
24816137|NCT02074280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24882768|NCT05002244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24882770|NCT05002244|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24882771|NCT05002244|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25057258|NCT03506620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24882792|NCT04957368|Midazolam|midazolam|mesh-list
25057261|NCT03506542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24882828|NCT04933682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24882829|NCT04933682|Antifungal Agents|antifungal agents|mesh-ancestor
24882830|NCT04933682|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24882831|NCT04933682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24882832|NCT04933682|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24882833|NCT04933682|Hormone Antagonists|hormone antagonists|mesh-ancestor
24816151|NCT02074319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24816152|NCT02074319|Abortifacient Agents|abortifacient agents|mesh-ancestor
25057285|NCT03506399|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24882925|NCT04757090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24882926|NCT04757090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882939|NCT04726969|Albendazole|albendazole|mesh-list
24882940|NCT04726969|Moxidectin|moxidectin|mesh-list
24882941|NCT04726969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24882977|NCT04679012|Glucocorticoids|glucocorticoids|mesh-ancestor
24882978|NCT04679012|Hormones|hormones|mesh-ancestor
24393358|NCT00129844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882979|NCT04679012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24882980|NCT04679012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24882981|NCT04679012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24882982|NCT04673617|Cyclophosphamide|cyclophosphamide|mesh-list
24882984|NCT04673617|Fludarabine|fludarabine|mesh-list
24883009|NCT04653207|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25057302|NCT03506256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25057303|NCT03506256|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25057304|NCT03506256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25057305|NCT03506178|Phenylephrine|phenylephrine|mesh-list
25057306|NCT03506178|Oxymetazoline|oxymetazoline|mesh-list
25057308|NCT03506178|Antipruritics|antipruritics|mesh-ancestor
24883034|NCT04645212|Aflibercept|aflibercept|mesh-list
24883035|NCT04645212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24742320|NCT05275491|Calcium|calcium|mesh-list
24883067|NCT04588818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24883068|NCT04588818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883069|NCT04588818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24506958|NCT00547664|Morphine|morphine|mesh-list
24883109|NCT04484675|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24883110|NCT04484675|Vasodilator Agents|vasodilator agents|mesh-ancestor
24883111|NCT04484675|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24883112|NCT04484675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24883113|NCT04484675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24883114|NCT04484675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883115|NCT04484675|Protective Agents|protective agents|mesh-ancestor
24883116|NCT04484675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883194|NCT04330183|Analgesics|analgesics|mesh-ancestor
24883195|NCT04330183|Sensory System Agents|sensory system agents|mesh-ancestor
24883196|NCT04330183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24883197|NCT04330183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698329|NCT02091986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25698330|NCT02092025|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25698331|NCT02092025|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25698332|NCT02092025|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25698333|NCT02092025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698334|NCT02092116|Romidepsin|romidepsin|mesh-list
25698335|NCT02092116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24511938|NCT00571740|Fluorouracil|fluorouracil|mesh-list
24511939|NCT00571740|Oxaliplatin|oxaliplatin|mesh-list
24511940|NCT00571740|Calcium|calcium|mesh-list
24511941|NCT00571740|Levoleucovorin|levoleucovorin|mesh-list
24883198|NCT04330183|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24883199|NCT04330183|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24883200|NCT04330183|Anesthetics, General|anesthetics, general|mesh-ancestor
24742528|NCT05245669|Denosumab|denosumab|mesh-list
24883254|NCT04191928|Apixaban|apixaban|mesh-list
24883255|NCT04191928|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24883256|NCT04191928|Antithrombins|antithrombins|mesh-ancestor
24883257|NCT04191928|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24883258|NCT04191928|Protease Inhibitors|protease inhibitors|mesh-ancestor
24883259|NCT04191928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24883260|NCT04191928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883261|NCT04191928|Anticoagulants|anticoagulants|mesh-ancestor
24883264|NCT04167761|Glipizide|glipizide|mesh-list
24883317|NCT03991403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990088|NCT03875378|Estrogens|estrogens|mesh-list
24990089|NCT03875378|Hormones|hormones|mesh-ancestor
24990090|NCT03875378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24816248|NCT02075294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816249|NCT02075333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24816250|NCT02075528|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24816251|NCT02075528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24393800|NCT00131027|Antiemetics|antiemetics|mesh-ancestor
25033340|NCT03574285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033341|NCT03574246|Chlorhexidine|chlorhexidine|mesh-list
25033342|NCT03574246|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25033343|NCT03574246|Benzydamine|benzydamine|mesh-list
25033344|NCT03574246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25033345|NCT03574246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25033346|NCT03574246|Disinfectants|disinfectants|mesh-ancestor
25033347|NCT03574246|Dermatologic Agents|dermatologic agents|mesh-ancestor
25113792|NCT02189798|Imidacloprid|imidacloprid|mesh-list
25113793|NCT02189798|Cholinergic Agents|cholinergic agents|mesh-ancestor
25113794|NCT02189798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25113795|NCT02189798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113797|NCT02167945|Ritonavir|ritonavir|mesh-list
24883373|NCT03926624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24883374|NCT03926624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24883375|NCT03926624|Antimetabolites|antimetabolites|mesh-ancestor
24883376|NCT03926624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883377|NCT03926624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24883378|NCT03926624|Immunologic Factors|immunologic factors|mesh-ancestor
24883379|NCT03926624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698336|NCT02092116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25698337|NCT02092168|Opicapone|opicapone|mesh-list
25698338|NCT02092168|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25698339|NCT02092168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057389|NCT03505502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698340|NCT02092168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698341|NCT02092168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25698342|NCT02092168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25698343|NCT02092181|Mirabegron|mirabegron|mesh-list
25698344|NCT02092181|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25057390|NCT03505502|Hemostatics|hemostatics|mesh-ancestor
25057391|NCT03505502|Coagulants|coagulants|mesh-ancestor
25057392|NCT03505489|Mannitol|mannitol|mesh-list
24883380|NCT03926624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24883391|NCT03905902|Immunologic Factors|immunologic factors|mesh-ancestor
24883392|NCT03905902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883393|NCT03878927|Gemtuzumab|gemtuzumab|mesh-list
24883450|NCT03840148|Cefepime|cefepime|mesh-list
24883451|NCT03840148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24883452|NCT03840148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24883453|NCT03832127|Fludarabine|fludarabine|mesh-list
24883454|NCT03832127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24883455|NCT03824522|BAX 855|bax 855|mesh-list
24883456|NCT03824522|Coagulants|coagulants|mesh-ancestor
24883457|NCT03823365|Blinatumomab|blinatumomab|mesh-list
24883458|NCT03823365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24883459|NCT03819114|Levonorgestrel|levonorgestrel|mesh-list
24883460|NCT03819114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24883461|NCT03819114|Contraceptive Agents|contraceptive agents|mesh-ancestor
24883462|NCT03819114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24883463|NCT03819114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057411|NCT03505411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057412|NCT03505411|Protective Agents|protective agents|mesh-ancestor
25057434|NCT03505008|Methotrexate|methotrexate|mesh-list
25057435|NCT03505008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25057436|NCT03505008|Abortifacient Agents|abortifacient agents|mesh-ancestor
25057437|NCT03505008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25057438|NCT03505008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057439|NCT03505008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25057440|NCT03505008|Antimetabolites|antimetabolites|mesh-ancestor
25057441|NCT03505008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057443|NCT03505008|Dermatologic Agents|dermatologic agents|mesh-ancestor
24811651|NCT02047539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25698345|NCT02092181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25698346|NCT02092181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25698347|NCT02092181|Adrenergic Agents|adrenergic agents|mesh-ancestor
25698348|NCT02092181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25698349|NCT02092181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698350|NCT02092181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698351|NCT02092181|Urological Agents|urological agents|mesh-ancestor
25698352|NCT02092220|Pancrelipase|pancrelipase|mesh-list
25698353|NCT02092220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24952735|NCT03892421|Dexamethasone|dexamethasone|mesh-list
25057473|NCT03504865|Anesthetics, Local|anesthetics, local|mesh-ancestor
25057474|NCT03504865|Anesthetics|anesthetics|mesh-ancestor
25057475|NCT03504865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25057476|NCT03504865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057477|NCT03504865|Sensory System Agents|sensory system agents|mesh-ancestor
25057478|NCT03504865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24883542|NCT05238064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24883545|NCT05238064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883546|NCT05238064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24883547|NCT05238064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24743244|NCT04936854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24796423|NCT01949857|Vaccines|vaccines|mesh-list
24796424|NCT01949857|Immunologic Factors|immunologic factors|mesh-ancestor
24796426|NCT01949909|Aluminum sulfate|aluminum sulfate|mesh-list
25057515|NCT03504527|Budesonide|budesonide|mesh-list
24952712|NCT03892330|Vincristine|vincristine|mesh-list
24952713|NCT03892330|Pirarubicin|pirarubicin|mesh-list
24952714|NCT03892330|Epirubicin|epirubicin|mesh-list
24952715|NCT03892330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24952716|NCT03892330|Immunologic Factors|immunologic factors|mesh-ancestor
24952717|NCT03892330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952719|NCT03892330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24952720|NCT03892330|Alkylating Agents|alkylating agents|mesh-ancestor
24883563|NCT05238012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883564|NCT05238012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24883565|NCT05238012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24883566|NCT05238012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24883567|NCT05237843|Aspirin|aspirin|mesh-list
24883568|NCT05237843|Hydroxychloroquine|hydroxychloroquine|mesh-list
24883569|NCT05237843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24883570|NCT05237843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24952733|NCT03892330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24952734|NCT03892421|Cytarabine|cytarabine|mesh-list
24883584|NCT05237843|Antimalarials|antimalarials|mesh-ancestor
24883585|NCT05237843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24883586|NCT05237843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24883587|NCT05237843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24883588|NCT05237791|Magnesium Sulfate|magnesium sulfate|mesh-list
24883589|NCT05237791|Analgesics|analgesics|mesh-ancestor
24883590|NCT05237791|Sensory System Agents|sensory system agents|mesh-ancestor
24883591|NCT05237791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24883592|NCT05237791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883593|NCT05237791|Anesthetics|anesthetics|mesh-ancestor
24883595|NCT05237791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24883600|NCT05237791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24883601|NCT05237791|Tocolytic Agents|tocolytic agents|mesh-ancestor
24883602|NCT05237791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24952740|NCT03892421|Immunologic Factors|immunologic factors|mesh-ancestor
24952741|NCT03892421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952742|NCT03892421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24952743|NCT03892421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24952744|NCT03892421|Antiemetics|antiemetics|mesh-ancestor
24883622|NCT05237323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24883623|NCT05237323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24883625|NCT05237323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883626|NCT05237323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24743739|NCT04640818|Cladribine|cladribine|mesh-list
24743740|NCT04640818|Ocrelizumab|ocrelizumab|mesh-list
25698354|NCT02092285|Golimumab|golimumab|mesh-list
25698355|NCT02092285|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25698356|NCT02092285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25698357|NCT02092285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25698358|NCT02092285|Immunologic Factors|immunologic factors|mesh-ancestor
25698359|NCT02092285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698360|NCT02092298|Sodium thiosulfate|sodium thiosulfate|mesh-list
25698361|NCT02092298|Cisplatin|cisplatin|mesh-list
25698362|NCT02092298|Mitomycins|mitomycins|mesh-list
25698363|NCT02092298|Mitomycin|mitomycin|mesh-list
25698364|NCT02092298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25698365|NCT02092298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24883647|NCT05215990|Metformin|metformin|mesh-list
24883648|NCT05215990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24883649|NCT05215990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883650|NCT05215834|Remifentanil|remifentanil|mesh-list
24883651|NCT05215834|Propofol|propofol|mesh-list
24883652|NCT05215834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24883653|NCT05215834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24883654|NCT05215834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883655|NCT05215834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24883656|NCT05215834|Anesthetics, General|anesthetics, general|mesh-ancestor
24883657|NCT05215834|Anesthetics|anesthetics|mesh-ancestor
24883658|NCT05215834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24883659|NCT05215834|Narcotics|narcotics|mesh-ancestor
24883660|NCT05215834|Analgesics|analgesics|mesh-ancestor
24883661|NCT05215834|Sensory System Agents|sensory system agents|mesh-ancestor
24883662|NCT05215834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24883663|NCT05214183|Rituximab|rituximab|mesh-list
24883664|NCT05214183|Acalabrutinib|acalabrutinib|mesh-list
24883665|NCT05214183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24883666|NCT05214183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24883667|NCT05214183|Immunologic Factors|immunologic factors|mesh-ancestor
24883668|NCT05214183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394104|NCT00132119|Nalmefene|nalmefene|mesh-list
24743741|NCT04640818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25057532|NCT03504527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057533|NCT03504527|Anticonvulsants|anticonvulsants|mesh-ancestor
24883670|NCT05189509|Plasminogen|plasminogen|mesh-list
24883671|NCT05189509|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24883672|NCT05189509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24816256|NCT02075528|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24816257|NCT02075528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24883673|NCT05189509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25698366|NCT02092298|Alkylating Agents|alkylating agents|mesh-ancestor
25698367|NCT02092298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698368|NCT02092298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25698369|NCT02092298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25698370|NCT02092298|Antidotes|antidotes|mesh-ancestor
25698371|NCT02092298|Protective Agents|protective agents|mesh-ancestor
25698372|NCT02092298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698373|NCT02092298|Antioxidants|antioxidants|mesh-ancestor
25698374|NCT02092298|Antitubercular Agents|antitubercular agents|mesh-ancestor
25698375|NCT02092298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25698376|NCT02092298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25698377|NCT02092298|Chelating Agents|chelating agents|mesh-ancestor
25698378|NCT02092298|Sequestering Agents|sequestering agents|mesh-ancestor
25698379|NCT02092350|Grazoprevir|grazoprevir|mesh-list
25698380|NCT02092350|Antiviral Agents|antiviral agents|mesh-ancestor
25698381|NCT02092350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25698382|NCT02092467|Adalimumab|adalimumab|mesh-list
24883713|NCT05097768|Sensory System Agents|sensory system agents|mesh-ancestor
24883714|NCT05097768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24883715|NCT05097768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24883716|NCT05097768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24883717|NCT05097768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883718|NCT05097768|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25057540|NCT03504475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25057541|NCT03504475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057542|NCT03504475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25057543|NCT03504475|Serotonin Agents|serotonin agents|mesh-ancestor
24883725|NCT05093582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24883726|NCT05093582|Respiratory System Agents|respiratory system agents|mesh-ancestor
24883727|NCT05093582|Parasympatholytics|parasympatholytics|mesh-ancestor
24883728|NCT05093582|Vasodilator Agents|vasodilator agents|mesh-ancestor
24883753|NCT04978272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24883754|NCT04978272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24883755|NCT04978272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24883760|NCT04874480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24883765|NCT04861584|Gemcitabine|gemcitabine|mesh-list
25057554|NCT03504345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25057555|NCT03504345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057556|NCT03504280|Cholecalciferol|cholecalciferol|mesh-list
25057557|NCT03504280|Vitamin D|vitamin d|mesh-list
25057558|NCT03504280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25057559|NCT03504280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057560|NCT03504280|Vitamins|vitamins|mesh-ancestor
25057561|NCT03504280|Micronutrients|micronutrients|mesh-ancestor
25057562|NCT03504280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25057563|NCT03504202|Trimetazidine|trimetazidine|mesh-list
25057564|NCT03504202|Vasodilator Agents|vasodilator agents|mesh-ancestor
25057565|NCT03504072|Etanercept|etanercept|mesh-list
25057566|NCT03504072|Tofacitinib|tofacitinib|mesh-list
25057568|NCT03504072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24883785|NCT04809376|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
24883786|NCT04809376|Anticoagulants|anticoagulants|mesh-ancestor
25057587|NCT03504033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25057588|NCT03504033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057589|NCT03503994|Beclomethasone|beclomethasone|mesh-list
25057590|NCT03503994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25057591|NCT03503994|Glucocorticoids|glucocorticoids|mesh-ancestor
25057592|NCT03503994|Hormones|hormones|mesh-ancestor
25057593|NCT03503994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25057594|NCT03503994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057595|NCT03503994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25057596|NCT03503994|Respiratory System Agents|respiratory system agents|mesh-ancestor
25057597|NCT03503864|Arsenic Trioxide|arsenic trioxide|mesh-list
25057598|NCT03503864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25057599|NCT03503786|Paclitaxel|paclitaxel|mesh-list
25057600|NCT03503786|Carboplatin|carboplatin|mesh-list
25057601|NCT03503786|Avelumab|avelumab|mesh-list
25057602|NCT03503786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25057603|NCT03503786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25057604|NCT03503786|Tubulin Modulators|tubulin modulators|mesh-ancestor
25057605|NCT03503786|Antimitotic Agents|antimitotic agents|mesh-ancestor
25057606|NCT03503786|Mitosis Modulators|mitosis modulators|mesh-ancestor
25057607|NCT03503786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811841|NCT02048540|Growth Inhibitors|growth inhibitors|mesh-ancestor
24509232|NCT00559455|Fluorouracil|fluorouracil|mesh-list
25057608|NCT03503786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25057609|NCT03503604|Leucovorin|leucovorin|mesh-list
25057610|NCT03503604|Gemcitabine|gemcitabine|mesh-list
25057611|NCT03503604|Paclitaxel|paclitaxel|mesh-list
25057612|NCT03503604|Carboplatin|carboplatin|mesh-list
25057613|NCT03503604|Fluorouracil|fluorouracil|mesh-list
25057614|NCT03503604|Oxaliplatin|oxaliplatin|mesh-list
25057615|NCT03503604|Irinotecan|irinotecan|mesh-list
25057616|NCT03503604|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25057617|NCT03503604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25057618|NCT03503604|Tubulin Modulators|tubulin modulators|mesh-ancestor
24744266|NCT04375683|HH-GV-678|hh-gv-678|mesh-list
24409019|NCT00180622|Nitric Oxide|nitric oxide|mesh-list
25057619|NCT03503604|Antimitotic Agents|antimitotic agents|mesh-ancestor
25057620|NCT03503604|Mitosis Modulators|mitosis modulators|mesh-ancestor
24941158|NCT03994211|Rifampin|rifampin|mesh-list
25057621|NCT03503604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057622|NCT03503604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25057623|NCT03503604|Antimetabolites|antimetabolites|mesh-ancestor
25057624|NCT03503604|Antiviral Agents|antiviral agents|mesh-ancestor
25057625|NCT03503604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25057626|NCT03503604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057627|NCT03503604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25057629|NCT03503604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057630|NCT03503604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25057631|NCT03503604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25057632|NCT03503604|Antidotes|antidotes|mesh-ancestor
24811865|NCT02048683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25698383|NCT02092467|Etanercept|etanercept|mesh-list
25698384|NCT02092467|Tofacitinib|tofacitinib|mesh-list
25698385|NCT02092467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24883793|NCT04770012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24883794|NCT04770012|Analgesics|analgesics|mesh-ancestor
24883795|NCT04770012|Sensory System Agents|sensory system agents|mesh-ancestor
25057648|NCT03503227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25057649|NCT03503227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057650|NCT03503227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25057651|NCT03503227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25057652|NCT03503227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25057653|NCT03503227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25057654|NCT03503227|Antifungal Agents|antifungal agents|mesh-ancestor
25057655|NCT03503227|Keratolytic Agents|keratolytic agents|mesh-ancestor
25057656|NCT03503227|Dermatologic Agents|dermatologic agents|mesh-ancestor
25057657|NCT03503227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25057658|NCT03503227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25057659|NCT03503227|Analgesics|analgesics|mesh-ancestor
25057660|NCT03503227|Sensory System Agents|sensory system agents|mesh-ancestor
25057661|NCT03503227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25057662|NCT03503227|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25057663|NCT03503227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057664|NCT03503227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057665|NCT03503227|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25057666|NCT03503227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25057667|NCT03503227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25057668|NCT03503227|Antipyretics|antipyretics|mesh-ancestor
25057669|NCT03503201|Chromium|chromium|mesh-list
25057670|NCT03503201|Trace Elements|trace elements|mesh-ancestor
25057671|NCT03503201|Micronutrients|micronutrients|mesh-ancestor
25057672|NCT03503201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057673|NCT03503136|Cisplatin|cisplatin|mesh-list
25057674|NCT03503136|Docetaxel|docetaxel|mesh-list
25057675|NCT03503136|Fluorouracil|fluorouracil|mesh-list
25057676|NCT03503136|Capecitabine|capecitabine|mesh-list
25057677|NCT03503136|Nedaplatin|nedaplatin|mesh-list
25057681|NCT03503136|Mitosis Modulators|mitosis modulators|mesh-ancestor
25057682|NCT03503136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057684|NCT03503136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25057685|NCT03503136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25057686|NCT03503136|Immunologic Factors|immunologic factors|mesh-ancestor
25057687|NCT03503136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057688|NCT03502993|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25057689|NCT03502993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25057690|NCT03502889|Ropivacaine|ropivacaine|mesh-list
25057691|NCT03502889|Anesthetics, Local|anesthetics, local|mesh-ancestor
25057692|NCT03502889|Anesthetics|anesthetics|mesh-ancestor
25057693|NCT03502889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25057694|NCT03502889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057695|NCT03502889|Sensory System Agents|sensory system agents|mesh-ancestor
25057696|NCT03502889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25057697|NCT03502824|Anti-Infective Agents|anti-infective agents|mesh-list
25057719|NCT03502551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25057720|NCT03502551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057721|NCT03502551|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25057723|NCT03502551|Anesthetics, General|anesthetics, general|mesh-ancestor
25057724|NCT03502551|Anesthetics|anesthetics|mesh-ancestor
25057725|NCT03502551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25057726|NCT03502551|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25057727|NCT03502551|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25057728|NCT03502551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25057729|NCT03502551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057731|NCT03502434|Emollients|emollients|mesh-ancestor
25057732|NCT03502434|Dermatologic Agents|dermatologic agents|mesh-ancestor
25057733|NCT03502421|Ketamine|ketamine|mesh-list
25057734|NCT03502421|Analgesics|analgesics|mesh-ancestor
25057735|NCT03502421|Sensory System Agents|sensory system agents|mesh-ancestor
25057736|NCT03502421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25057746|NCT03502421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057747|NCT03502395|Lidocaine|lidocaine|mesh-list
25057748|NCT03502395|Anesthetics, Local|anesthetics, local|mesh-ancestor
25057749|NCT03502395|Anesthetics|anesthetics|mesh-ancestor
25057750|NCT03502395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25057751|NCT03502395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057752|NCT03502395|Sensory System Agents|sensory system agents|mesh-ancestor
25057753|NCT03502395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25057754|NCT03502395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24883826|NCT04755972|Protective Agents|protective agents|mesh-ancestor
24883827|NCT04755972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883828|NCT04755972|Antidotes|antidotes|mesh-ancestor
24883829|NCT04747561|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24883830|NCT04747561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24883831|NCT04747561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883832|NCT04709250|Bupivacaine|bupivacaine|mesh-list
24883839|NCT04702022|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24883840|NCT04702022|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24883841|NCT04702022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706222|NCT01489319|Analgesics|analgesics|mesh-ancestor
24883842|NCT04652245|Fluticasone|fluticasone|mesh-list
24883843|NCT04652245|Xhance|xhance|mesh-list
24883844|NCT04652245|Azelastine|azelastine|mesh-list
24883848|NCT04652245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24883849|NCT04652245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883850|NCT04652245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24883851|NCT04652245|Respiratory System Agents|respiratory system agents|mesh-ancestor
24883852|NCT04652245|Dermatologic Agents|dermatologic agents|mesh-ancestor
24883853|NCT04652245|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24883854|NCT04652245|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25057755|NCT03502395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25057756|NCT03502395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25057757|NCT03502395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25057758|NCT03502395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057759|NCT03502356|Azithromycin|azithromycin|mesh-list
25057760|NCT03502356|Cefazolin|cefazolin|mesh-list
25057761|NCT03502356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25057762|NCT03502356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25057763|NCT03502343|Gemcitabine|gemcitabine|mesh-list
25057764|NCT03502343|Paclitaxel|paclitaxel|mesh-list
25057765|NCT03502343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25057766|NCT03502343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25057767|NCT03502343|Tubulin Modulators|tubulin modulators|mesh-ancestor
25057768|NCT03502343|Antimitotic Agents|antimitotic agents|mesh-ancestor
25057769|NCT03502343|Mitosis Modulators|mitosis modulators|mesh-ancestor
24607403|NCT04665037|Antifungal Agents|antifungal agents|mesh-ancestor
25698386|NCT02092467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25709425|NCT02266810|Mometasone Furoate|mometasone furoate|mesh-list
25709426|NCT02266810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25709427|NCT02266810|Dermatologic Agents|dermatologic agents|mesh-ancestor
25709428|NCT02266810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25709429|NCT02266888|Rituximab|rituximab|mesh-list
25709430|NCT02266888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25709431|NCT02266888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25709432|NCT02266888|Immunologic Factors|immunologic factors|mesh-ancestor
25709433|NCT02266888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709434|NCT02266888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25709435|NCT02267083|Doxorubicin|doxorubicin|mesh-list
25709436|NCT02267083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25709437|NCT02267083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25709438|NCT02267083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25709439|NCT02267083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25709440|NCT02267083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709441|NCT02267083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709442|NCT02267187|Anesthetics|anesthetics|mesh-list
25709443|NCT02267187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25709444|NCT02267187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709445|NCT02267538|Dexmedetomidine|dexmedetomidine|mesh-list
25709446|NCT02267538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25709447|NCT02267538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25709448|NCT02267538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709449|NCT02267538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25709450|NCT02267538|Analgesics|analgesics|mesh-ancestor
24925091|NCT04154033|Naltrexone|naltrexone|mesh-list
25034727|NCT03562923|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25034728|NCT03562923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25034729|NCT03562923|Autonomic Agents|autonomic agents|mesh-ancestor
24883859|NCT04652245|Histamine Antagonists|histamine antagonists|mesh-ancestor
24883860|NCT04652245|Histamine Agents|histamine agents|mesh-ancestor
24745190|NCT03926091|Antimitotic Agents|antimitotic agents|mesh-ancestor
24745191|NCT03926091|Mitosis Modulators|mitosis modulators|mesh-ancestor
24745193|NCT03924427|Dermatologic Agents|dermatologic agents|mesh-ancestor
24745232|NCT03889314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24883861|NCT04652245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24883862|NCT04647643|Paclitaxel|paclitaxel|mesh-list
24883863|NCT04647643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24883864|NCT04647643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25057770|NCT03502343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883877|NCT04631536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883878|NCT04631536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24883880|NCT04631536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24883888|NCT04631536|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24883889|NCT04631536|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24883890|NCT04631536|Adrenergic Agents|adrenergic agents|mesh-ancestor
24883891|NCT04631536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24883892|NCT04631536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24618516|NCT01048684|Mannitol|mannitol|mesh-list
25057777|NCT03502343|Immunologic Factors|immunologic factors|mesh-ancestor
25057778|NCT03502343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057779|NCT03502135|Phenylephrine|phenylephrine|mesh-list
25057780|NCT03502135|Oxymetazoline|oxymetazoline|mesh-list
25709451|NCT02267538|Sensory System Agents|sensory system agents|mesh-ancestor
25709452|NCT02267538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25709453|NCT02267538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25709454|NCT02267538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25709455|NCT02267538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25709456|NCT02267538|Adrenergic Agents|adrenergic agents|mesh-ancestor
25709457|NCT02267538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25709458|NCT02267538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709459|NCT02267746|Nicotinic Acids|nicotinic acids|mesh-list
25709460|NCT02267746|Tazarotene|tazarotene|mesh-list
25709461|NCT02267746|Dermatologic Agents|dermatologic agents|mesh-ancestor
25709462|NCT02267746|Keratolytic Agents|keratolytic agents|mesh-ancestor
25709463|NCT02267746|Vitamin B Complex|vitamin b complex|mesh-ancestor
25709464|NCT02267746|Vitamins|vitamins|mesh-ancestor
25709465|NCT02267746|Micronutrients|micronutrients|mesh-ancestor
25709466|NCT02267746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709467|NCT02267772|Acetaminophen|acetaminophen|mesh-list
25709468|NCT02267772|Morphine|morphine|mesh-list
25709469|NCT02267772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25709470|NCT02267772|Narcotics|narcotics|mesh-ancestor
25709471|NCT02267772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25709472|NCT02267772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709473|NCT02267772|Analgesics|analgesics|mesh-ancestor
25709474|NCT02267772|Sensory System Agents|sensory system agents|mesh-ancestor
25709475|NCT02267772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25709476|NCT02267772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25709477|NCT02267772|Antipyretics|antipyretics|mesh-ancestor
25709478|NCT02268045|Rituximab|rituximab|mesh-list
25709479|NCT02268045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25709480|NCT02268045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25709481|NCT02268045|Immunologic Factors|immunologic factors|mesh-ancestor
25709482|NCT02268045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709483|NCT02268045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25709484|NCT02268058|Acetaminophen|acetaminophen|mesh-list
25709485|NCT02268058|Ibuprofen|ibuprofen|mesh-list
25709486|NCT02268058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25709487|NCT02268058|Analgesics|analgesics|mesh-ancestor
25709488|NCT02268058|Sensory System Agents|sensory system agents|mesh-ancestor
25709489|NCT02268058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25709490|NCT02268058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709491|NCT02268058|Antipyretics|antipyretics|mesh-ancestor
25709492|NCT02268058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25709493|NCT02268058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25709494|NCT02268058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24796659|NCT01951430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24796660|NCT01951430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24557456|NCT00752635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24557457|NCT00752635|Cyproterone|cyproterone|mesh-list
24557603|NCT00753064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25057781|NCT03502135|Tetracaine|tetracaine|mesh-list
25057782|NCT03502135|Anesthetics, Local|anesthetics, local|mesh-ancestor
25057783|NCT03502135|Anesthetics|anesthetics|mesh-ancestor
25057784|NCT03502135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25057785|NCT03502135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057786|NCT03502135|Sensory System Agents|sensory system agents|mesh-ancestor
25057787|NCT03502135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25057788|NCT03502135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25057789|NCT03502135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25057790|NCT03502135|Adrenergic Agents|adrenergic agents|mesh-ancestor
25057791|NCT03502135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25057792|NCT03502135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057793|NCT03502135|Sympathomimetics|sympathomimetics|mesh-ancestor
25057794|NCT03502135|Autonomic Agents|autonomic agents|mesh-ancestor
25057795|NCT03502135|Nasal Decongestants|nasal decongestants|mesh-ancestor
25057796|NCT03502135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25057797|NCT03502135|Respiratory System Agents|respiratory system agents|mesh-ancestor
25057798|NCT03502135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25057799|NCT03502135|Mydriatics|mydriatics|mesh-ancestor
25057800|NCT03502135|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24941379|NCT03991364|Methamphetamine|methamphetamine|mesh-list
25057801|NCT03502135|Protective Agents|protective agents|mesh-ancestor
24941451|NCT03990922|Ropivacaine|ropivacaine|mesh-list
24941452|NCT03990922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24941453|NCT03990922|Narcotics|narcotics|mesh-ancestor
24941454|NCT03990922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24941455|NCT03990922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941456|NCT03990922|Analgesics|analgesics|mesh-ancestor
24941471|NCT03990480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24941474|NCT03990636|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24941475|NCT03990636|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24941476|NCT03990636|Dermatologic Agents|dermatologic agents|mesh-ancestor
24941477|NCT03990129|Dipyrone|dipyrone|mesh-list
24561894|NCT00763633|Vitamin B 6|vitamin b 6|mesh-list
24883909|NCT04565600|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25057810|NCT03502005|Emtricitabine|emtricitabine|mesh-list
25057811|NCT03502005|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25057812|NCT03502005|Antiviral Agents|antiviral agents|mesh-ancestor
24883964|NCT03987919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24883922|NCT04501211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883923|NCT04435808|Hydroxychloroquine|hydroxychloroquine|mesh-list
24883924|NCT04435808|Antimalarials|antimalarials|mesh-ancestor
24883925|NCT04435808|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24883926|NCT04435808|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25057822|NCT03501680|Insulin|insulin|mesh-list
25057858|NCT03501251|Mitosis Modulators|mitosis modulators|mesh-ancestor
24657205|NCT01266187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24745782|NCT03590652|Dexamethasone|dexamethasone|mesh-list
25057859|NCT03501251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564330|NCT00775905|Vasodilator Agents|vasodilator agents|mesh-ancestor
24883945|NCT04315636|Respiratory System Agents|respiratory system agents|mesh-ancestor
24883946|NCT04219540|Buprenorphine|buprenorphine|mesh-list
24463000|NCT00358319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698387|NCT02092467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25698388|NCT02092467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25698389|NCT02092467|Analgesics|analgesics|mesh-ancestor
25698390|NCT02092467|Sensory System Agents|sensory system agents|mesh-ancestor
25698391|NCT02092467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25698392|NCT02092467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698393|NCT02092467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25698394|NCT02092467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25698395|NCT02092467|Immunologic Factors|immunologic factors|mesh-ancestor
25698396|NCT02092467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25698397|NCT02092467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25698398|NCT02092467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698399|NCT02092961|Adalimumab|adalimumab|mesh-list
25698400|NCT02092961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25698401|NCT02092961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24514802|NCT00593008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514803|NCT00593008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514804|NCT00593008|Antiviral Agents|antiviral agents|mesh-ancestor
24514805|NCT00593008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24514806|NCT00593008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24514807|NCT00593008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24514808|NCT00593008|Immunologic Factors|immunologic factors|mesh-ancestor
24514859|NCT00593151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514861|NCT00593164|Analgesics|analgesics|mesh-ancestor
24514862|NCT00593164|Sensory System Agents|sensory system agents|mesh-ancestor
24514863|NCT00593164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24514864|NCT00593164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883947|NCT04219540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24883948|NCT04219540|Narcotics|narcotics|mesh-ancestor
24883949|NCT04219540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24883950|NCT04219540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883951|NCT04219540|Analgesics|analgesics|mesh-ancestor
24883952|NCT04219540|Sensory System Agents|sensory system agents|mesh-ancestor
24883953|NCT04219540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24883954|NCT04219540|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24883955|NCT03994146|Remifentanil|remifentanil|mesh-list
24883956|NCT03994146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24883957|NCT03994146|Narcotics|narcotics|mesh-ancestor
24883958|NCT03994146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24883959|NCT03994146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883960|NCT03994146|Analgesics|analgesics|mesh-ancestor
24463008|NCT00358358|Fluticasone|fluticasone|mesh-list
25057885|NCT03500874|Oxaliplatin|oxaliplatin|mesh-list
25057886|NCT03500874|Antimetabolites|antimetabolites|mesh-ancestor
25057887|NCT03500874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057888|NCT03500874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25057889|NCT03500874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25057894|NCT03500874|Protective Agents|protective agents|mesh-ancestor
25057895|NCT03500874|Vitamin B Complex|vitamin b complex|mesh-ancestor
25057897|NCT03500874|Micronutrients|micronutrients|mesh-ancestor
25057898|NCT03500848|Mycophenolic Acid|mycophenolic acid|mesh-list
25057899|NCT03500848|Sirolimus|sirolimus|mesh-list
25057900|NCT03500848|Tacrolimus|tacrolimus|mesh-list
25057901|NCT03500848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25057902|NCT03500848|Immunologic Factors|immunologic factors|mesh-ancestor
25057903|NCT03500848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057904|NCT03500848|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25057905|NCT03500848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057906|NCT03500848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057907|NCT03500848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25057908|NCT03500848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25057909|NCT03500848|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25698402|NCT02093026|Folic Acid|folic acid|mesh-list
25698403|NCT02093026|Methylprednisolone|methylprednisolone|mesh-list
25698404|NCT02093026|Rituximab|rituximab|mesh-list
25698405|NCT02093026|Methotrexate|methotrexate|mesh-list
25698406|NCT02093026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25698407|NCT02093026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25698408|NCT02093026|Immunologic Factors|immunologic factors|mesh-ancestor
25698409|NCT02093026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698410|NCT02093026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25698411|NCT02093026|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25698412|NCT02093026|Abortifacient Agents|abortifacient agents|mesh-ancestor
25698413|NCT02093026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25698414|NCT02093026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24883977|NCT03861039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883979|NCT03861039|Hormones|hormones|mesh-ancestor
24883980|NCT03861039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24883981|NCT03759587|Niraparib|niraparib|mesh-list
24463031|NCT00358371|Floxacillin|floxacillin|mesh-list
24463032|NCT00358371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25057910|NCT03500848|Antitubercular Agents|antitubercular agents|mesh-ancestor
25057911|NCT03500848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25057912|NCT03500848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25057914|NCT03500783|Nitric Oxide|nitric oxide|mesh-list
25057915|NCT03500783|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25057916|NCT03500783|Autonomic Agents|autonomic agents|mesh-ancestor
25057917|NCT03500783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25057918|NCT03500783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057919|NCT03500783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25057920|NCT03500783|Respiratory System Agents|respiratory system agents|mesh-ancestor
24883993|NCT03717623|Posaconazole|posaconazole|mesh-list
24883994|NCT03717623|Antifungal Agents|antifungal agents|mesh-ancestor
24883995|NCT03717623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24883996|NCT03717623|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24883997|NCT03717623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24883998|NCT03717623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24883999|NCT03717623|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24884000|NCT03717623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24884001|NCT03717623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816258|NCT02075528|Serotonin Agents|serotonin agents|mesh-ancestor
24816259|NCT02075528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24816260|NCT02075528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816261|NCT02075528|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24816262|NCT02075528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24816263|NCT02075528|Dopamine Agents|dopamine agents|mesh-ancestor
24816264|NCT02075619|Amlodipine|amlodipine|mesh-list
24816265|NCT02075619|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24816266|NCT02075619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24816267|NCT02075619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24816268|NCT02075619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24816269|NCT02075619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509995|NCT00563056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25057930|NCT03500653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25057931|NCT03500653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25057932|NCT03500653|Analgesics|analgesics|mesh-ancestor
25057933|NCT03500653|Sensory System Agents|sensory system agents|mesh-ancestor
25057934|NCT03500653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25057935|NCT03500653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057936|NCT03500653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25057937|NCT03500653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25057938|NCT03500653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25057939|NCT03500653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057940|NCT03500653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057941|NCT03500445|Dexamethasone|dexamethasone|mesh-list
25057942|NCT03500445|Lenalidomide|lenalidomide|mesh-list
25057943|NCT03500445|Daratumumab|daratumumab|mesh-list
25057944|NCT03500445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25057945|NCT03500445|Antiemetics|antiemetics|mesh-ancestor
25057946|NCT03500445|Autonomic Agents|autonomic agents|mesh-ancestor
25057947|NCT03500445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816271|NCT02075619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816272|NCT02075619|Vasodilator Agents|vasodilator agents|mesh-ancestor
24816273|NCT02075619|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24816274|NCT02075619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24816275|NCT02075619|Antimetabolites|antimetabolites|mesh-ancestor
24816276|NCT02075619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24816277|NCT02075619|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24816278|NCT02075619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25057948|NCT03500445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057949|NCT03500445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25057950|NCT03500445|Glucocorticoids|glucocorticoids|mesh-ancestor
25057968|NCT03500432|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25057970|NCT03500432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25057971|NCT03500432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057973|NCT03500367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25057974|NCT03500367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25057975|NCT03500367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25057976|NCT03500367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25057977|NCT03500367|Antifungal Agents|antifungal agents|mesh-ancestor
25057978|NCT03500367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25057979|NCT03500367|Immunologic Factors|immunologic factors|mesh-ancestor
25057980|NCT03500367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057981|NCT03500146|Cholinergic Antagonists|cholinergic antagonists|mesh-list
24884005|NCT03717623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25057982|NCT03500146|Cholinergic Agents|cholinergic agents|mesh-ancestor
25057983|NCT03500146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25057984|NCT03500146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698415|NCT02093026|Antimetabolites|antimetabolites|mesh-ancestor
25698416|NCT02093026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698417|NCT02093026|Dermatologic Agents|dermatologic agents|mesh-ancestor
25698418|NCT02093026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25698419|NCT02093026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25698420|NCT02093026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25698421|NCT02093026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25698422|NCT02093026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25698423|NCT02093026|Antiemetics|antiemetics|mesh-ancestor
25698424|NCT02093026|Autonomic Agents|autonomic agents|mesh-ancestor
25698425|NCT02093026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24515410|NCT00596986|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24515422|NCT00597064|Prednisone|prednisone|mesh-list
24515477|NCT00597597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25057985|NCT03500146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25057986|NCT03500133|Cytarabine|cytarabine|mesh-list
25057987|NCT03500133|Methylprednisolone|methylprednisolone|mesh-list
25057988|NCT03500133|Cisplatin|cisplatin|mesh-list
25057989|NCT03500133|Etoposide|etoposide|mesh-list
25057990|NCT03500133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25057991|NCT03500133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25057992|NCT03500133|Antimetabolites|antimetabolites|mesh-ancestor
25057994|NCT03500133|Antiviral Agents|antiviral agents|mesh-ancestor
24746729|NCT04058743|Nickel|nickel|mesh-list
25058001|NCT03500133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25058002|NCT03500133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058003|NCT03500133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25058004|NCT03500133|Antiemetics|antiemetics|mesh-ancestor
25058005|NCT03500133|Autonomic Agents|autonomic agents|mesh-ancestor
25058008|NCT03500133|Glucocorticoids|glucocorticoids|mesh-ancestor
25058009|NCT03500133|Hormones|hormones|mesh-ancestor
24820026|NCT02098499|Promethazine|promethazine|mesh-list
24884009|NCT03683355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884011|NCT03613506|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24884012|NCT03613506|Protease Inhibitors|protease inhibitors|mesh-ancestor
24884013|NCT03613506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24884014|NCT03613506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058013|NCT03500120|Fludrocortisone|fludrocortisone|mesh-list
25058014|NCT03500120|Captopril|captopril|mesh-list
25058015|NCT03500120|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25058016|NCT03500120|Protease Inhibitors|protease inhibitors|mesh-ancestor
25058017|NCT03500120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058018|NCT03500120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058019|NCT03500120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25058020|NCT03500120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24820036|NCT02098499|Sensory System Agents|sensory system agents|mesh-ancestor
24884035|NCT03521570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698426|NCT02093026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25698427|NCT02093026|Glucocorticoids|glucocorticoids|mesh-ancestor
25698428|NCT02093026|Hormones|hormones|mesh-ancestor
25698429|NCT02093026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25698430|NCT02093026|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25698431|NCT02093026|Protective Agents|protective agents|mesh-ancestor
25698432|NCT02093026|Hematinics|hematinics|mesh-ancestor
25698433|NCT02093026|Vitamin B Complex|vitamin b complex|mesh-ancestor
25698434|NCT02093026|Vitamins|vitamins|mesh-ancestor
25698435|NCT02093026|Micronutrients|micronutrients|mesh-ancestor
25698436|NCT02093221|Protease Inhibitors|protease inhibitors|mesh-list
25698437|NCT02093221|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25698438|NCT02093221|Protein C Inhibitor|protein c inhibitor|mesh-list
25698439|NCT02093221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24987747|NCT05042947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24987748|NCT05042947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987749|NCT05033847|Vaccines|vaccines|mesh-list
25058021|NCT03500029|Antidepressive Agents|antidepressive agents|mesh-list
25058022|NCT03500029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25058023|NCT03499886|Ketamine|ketamine|mesh-list
25058024|NCT03499886|Analgesics|analgesics|mesh-ancestor
25058025|NCT03499886|Sensory System Agents|sensory system agents|mesh-ancestor
25058026|NCT03499886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25058027|NCT03499886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058028|NCT03499886|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25058029|NCT03499886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25058031|NCT03499886|Anesthetics|anesthetics|mesh-ancestor
25058032|NCT03499886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25058033|NCT03499886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25058034|NCT03499886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25058035|NCT03499886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24505213|NCT00540410|Antimalarials|antimalarials|mesh-ancestor
24505138|NCT00540098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505140|NCT00540098|Antidepressive Agents|antidepressive agents|mesh-ancestor
24884062|NCT03433183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24884063|NCT03433183|Immunologic Factors|immunologic factors|mesh-ancestor
24884064|NCT03433183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505146|NCT00540137|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24505148|NCT00540137|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24505149|NCT00540137|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24884083|NCT03367156|Ichthammol|ichthammol|mesh-list
24884084|NCT03367156|BB 1101|bb 1101|mesh-list
24884085|NCT03367156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24510474|NCT00564655|Epinephrine|epinephrine|mesh-list
24505187|NCT00540280|Antimetabolites|antimetabolites|mesh-ancestor
24505188|NCT00540280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505189|NCT00540280|Antiviral Agents|antiviral agents|mesh-ancestor
24505190|NCT00540280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24505191|NCT00540280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505192|NCT00540280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24505193|NCT00540280|Immunologic Factors|immunologic factors|mesh-ancestor
25698440|NCT02093221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698441|NCT02093221|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25698442|NCT02093221|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25698443|NCT02093351|Tamoxifen|tamoxifen|mesh-list
25698444|NCT02093351|Letrozole|letrozole|mesh-list
25698445|NCT02093351|Olaparib|olaparib|mesh-list
25698446|NCT02093351|Anastrozole|anastrozole|mesh-list
25698447|NCT02093351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25698448|NCT02093351|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25698449|NCT02093351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25698450|NCT02093351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515612|NCT00598403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515640|NCT00598572|Chelating Agents|chelating agents|mesh-ancestor
24515641|NCT00598572|Sequestering Agents|sequestering agents|mesh-ancestor
24987755|NCT05019560|Anesthetics, General|anesthetics, general|mesh-ancestor
24987756|NCT05019560|Anesthetics|anesthetics|mesh-ancestor
24987757|NCT05019560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25058045|NCT03499743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25058046|NCT03499743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058047|NCT03499743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25058048|NCT03499743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25058049|NCT03499743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25058050|NCT03499743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25058051|NCT03499743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058052|NCT03499743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820068|NCT02098590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24505199|NCT00540345|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24505200|NCT00540345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505201|NCT00540345|Antiviral Agents|antiviral agents|mesh-ancestor
24748549|NCT02381652|Immunologic Factors|immunologic factors|mesh-ancestor
24505202|NCT00540345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24505203|NCT00540345|Antimetabolites|antimetabolites|mesh-ancestor
24505204|NCT00540345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505205|NCT00540345|Immunologic Factors|immunologic factors|mesh-ancestor
24505206|NCT00540345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505207|NCT00540384|Darbepoetin alfa|darbepoetin alfa|mesh-list
24505208|NCT00540384|Hematinics|hematinics|mesh-ancestor
24505209|NCT00540410|Artesunate|artesunate|mesh-list
24505210|NCT00540410|Lumefantrine|lumefantrine|mesh-list
24505211|NCT00540410|Amodiaquine|amodiaquine|mesh-list
24505212|NCT00540410|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24505215|NCT00540410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24505216|NCT00540410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24505217|NCT00540410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505218|NCT00540410|Antiviral Agents|antiviral agents|mesh-ancestor
24505219|NCT00540410|Schistosomicides|schistosomicides|mesh-ancestor
24510591|NCT00565123|Levofloxacin|levofloxacin|mesh-list
24505221|NCT00540410|Anthelmintics|anthelmintics|mesh-ancestor
24505222|NCT00540501|Oseltamivir|oseltamivir|mesh-list
24505224|NCT00540501|Antiviral Agents|antiviral agents|mesh-ancestor
24505225|NCT00540501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24505226|NCT00540501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505238|NCT00540605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505239|NCT00540605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884094|NCT03367156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24884095|NCT03367156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24884096|NCT03367156|Protease Inhibitors|protease inhibitors|mesh-ancestor
25058053|NCT03499743|Anticonvulsants|anticonvulsants|mesh-ancestor
25698451|NCT02093351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698452|NCT02093351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25698453|NCT02093351|Hormone Antagonists|hormone antagonists|mesh-ancestor
25698454|NCT02093351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25698455|NCT02093351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698456|NCT02093351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25698457|NCT02093351|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25698458|NCT02093351|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25698459|NCT02093351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25058054|NCT03499743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25058055|NCT03499743|Antiemetics|antiemetics|mesh-ancestor
24407537|NCT00174668|Insulin|insulin|mesh-list
24505248|NCT00540748|Oxytocics|oxytocics|mesh-ancestor
24505273|NCT00540787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24505274|NCT00540787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24505276|NCT00540787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24505277|NCT00540787|Sympatholytics|sympatholytics|mesh-ancestor
24505278|NCT00540787|Autonomic Agents|autonomic agents|mesh-ancestor
24505279|NCT00540787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24505280|NCT00540787|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24505281|NCT00540787|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24505282|NCT00540787|Antimalarials|antimalarials|mesh-ancestor
24505283|NCT00540787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24505284|NCT00540787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24505285|NCT00540787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24505286|NCT00540787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24505287|NCT00540787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24505288|NCT00540787|Cholinergic Agents|cholinergic agents|mesh-ancestor
24505289|NCT00540800|Docetaxel|docetaxel|mesh-list
24820082|NCT02098629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24820083|NCT02098629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820084|NCT02098629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820085|NCT02098629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24884114|NCT03092453|Cyclophosphamide|cyclophosphamide|mesh-list
24884115|NCT03092453|Pembrolizumab|pembrolizumab|mesh-list
24884116|NCT03092453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24505296|NCT00540800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505308|NCT00540826|Adrenergic Agents|adrenergic agents|mesh-ancestor
24505317|NCT00540891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505318|NCT00540891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505319|NCT00540891|Urological Agents|urological agents|mesh-ancestor
24505320|NCT00540930|Ranibizumab|ranibizumab|mesh-list
24723859|NCT01589471|Botulinum Toxins|botulinum toxins|mesh-list
24505321|NCT00540930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24505322|NCT00540930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24618790|NCT01049672|Heroin|heroin|mesh-list
24618791|NCT01049672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24748548|NCT02381652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24505332|NCT00540943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505334|NCT00540943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24505335|NCT00540956|Cytarabine|cytarabine|mesh-list
24884121|NCT03092453|Alkylating Agents|alkylating agents|mesh-ancestor
24884122|NCT03092453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884123|NCT03092453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24884124|NCT03092453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24884125|NCT03092453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24884126|NCT02976337|Naloxone|naloxone|mesh-list
24452344|NCT00327184|PENTA|penta|mesh-list
24884132|NCT02963714|Immunologic Factors|immunologic factors|mesh-ancestor
24884133|NCT02963714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884134|NCT02959918|Sirolimus|sirolimus|mesh-list
24884135|NCT02959918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24884136|NCT02959918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24505421|NCT00541112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24505422|NCT00541112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505423|NCT00541112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24505424|NCT00541112|Immunologic Factors|immunologic factors|mesh-ancestor
24505425|NCT00541112|Antidotes|antidotes|mesh-ancestor
24505426|NCT00541112|Protective Agents|protective agents|mesh-ancestor
24505427|NCT00541112|Vitamin B Complex|vitamin b complex|mesh-ancestor
24505428|NCT00541112|Vitamins|vitamins|mesh-ancestor
24505429|NCT00541112|Micronutrients|micronutrients|mesh-ancestor
25709495|NCT02268058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25709496|NCT02268058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505436|NCT00541125|Levoleucovorin|levoleucovorin|mesh-list
24505437|NCT00541125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24505438|NCT00541125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505439|NCT00541125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24505440|NCT00541125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24505441|NCT00541125|Growth Substances|growth substances|mesh-ancestor
24505442|NCT00541125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505443|NCT00541125|Growth Inhibitors|growth inhibitors|mesh-ancestor
24505445|NCT00541125|Antimetabolites|antimetabolites|mesh-ancestor
24884137|NCT02959918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24884138|NCT02959918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24884139|NCT02959918|Antifungal Agents|antifungal agents|mesh-ancestor
24884140|NCT02959918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24884141|NCT02959918|Immunologic Factors|immunologic factors|mesh-ancestor
24505463|NCT00541138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24505464|NCT00541138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24505466|NCT00541138|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24505467|NCT00541138|Hormone Antagonists|hormone antagonists|mesh-ancestor
24505468|NCT00541138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24505469|NCT00541138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505470|NCT00541138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24505471|NCT00541138|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25058091|NCT03499639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25058092|NCT03499639|Antimetabolites|antimetabolites|mesh-ancestor
25058093|NCT03499457|Amoxicillin|amoxicillin|mesh-list
25058094|NCT03499457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25058095|NCT03499457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25058096|NCT03499444|Rucaparib|rucaparib|mesh-list
24941772|NCT03987867|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24941773|NCT03987867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24941774|NCT03988075|Acetaminophen|acetaminophen|mesh-list
24505473|NCT00541138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24505474|NCT00541164|Ubiquinone|ubiquinone|mesh-list
24505475|NCT00541164|Coenzyme Q10|coenzyme q10|mesh-list
24505476|NCT00541164|Micronutrients|micronutrients|mesh-ancestor
24505477|NCT00541164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505587|NCT00541489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505588|NCT00541489|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24505589|NCT00541515|Insulin|insulin|mesh-list
24505590|NCT00541515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24505591|NCT00541515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505601|NCT00541554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24505602|NCT00541554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505603|NCT00541554|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24505604|NCT00541554|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24505605|NCT00541554|Serotonin Agents|serotonin agents|mesh-ancestor
24505609|NCT00541554|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24748972|NCT01898117|Paclitaxel|paclitaxel|mesh-list
24505645|NCT00541814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505646|NCT00541814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24505647|NCT00541814|Immunologic Factors|immunologic factors|mesh-ancestor
24505648|NCT00541814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505649|NCT00541814|Antifungal Agents|antifungal agents|mesh-ancestor
24505650|NCT00541814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24505658|NCT00541840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505659|NCT00541853|Candesartan|candesartan|mesh-list
24505660|NCT00541853|Candesartan cilexetil|candesartan cilexetil|mesh-list
24505661|NCT00541853|Cilnidipine|cilnidipine|mesh-list
24505662|NCT00541853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24505685|NCT00541918|Anesthetics, General|anesthetics, general|mesh-ancestor
24505686|NCT00541918|Anesthetics|anesthetics|mesh-ancestor
24505687|NCT00541918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24505688|NCT00541918|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24505689|NCT00542022|Oxymetazoline|oxymetazoline|mesh-list
24505690|NCT00542022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25698460|NCT02093351|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25698461|NCT02093390|Fluconazole|fluconazole|mesh-list
24516159|NCT00600730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516161|NCT00600769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24516162|NCT00600769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24796741|NCT01951872|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24796742|NCT01951872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796743|NCT01951872|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24796744|NCT01951872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24884178|NCT02813200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24884179|NCT02813200|Cholinergic Agents|cholinergic agents|mesh-ancestor
24941784|NCT03988075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24941785|NCT03988075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24505719|NCT00542139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24505720|NCT00542139|Glucocorticoids|glucocorticoids|mesh-ancestor
24505721|NCT00542139|Hormones|hormones|mesh-ancestor
24505722|NCT00542139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24884190|NCT02744742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24511018|NCT00566904|Antipyretics|antipyretics|mesh-ancestor
24884194|NCT02744742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24505746|NCT00542165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505747|NCT00542165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505748|NCT00542165|Urological Agents|urological agents|mesh-ancestor
24505750|NCT00542243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24505751|NCT00542243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24749594|NCT00579527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618857|NCT01049880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24618858|NCT01049880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618859|NCT01049880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24618860|NCT01049880|Immunologic Factors|immunologic factors|mesh-ancestor
25698462|NCT02093390|Atorvastatin|atorvastatin|mesh-list
25698463|NCT02093390|Relugolix|relugolix|mesh-list
25698464|NCT02093390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25698465|NCT02093390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25698466|NCT02093390|Antimetabolites|antimetabolites|mesh-ancestor
25698467|NCT02093390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698468|NCT02093390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25698469|NCT02093390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25058121|NCT03499223|Ranibizumab|ranibizumab|mesh-list
24884215|NCT02678143|Cyclophosphamide|cyclophosphamide|mesh-list
24884231|NCT02678143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24884232|NCT02678143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24884233|NCT02678143|Antifungal Agents|antifungal agents|mesh-ancestor
24884234|NCT02678143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24884235|NCT02628405|Rituximab|rituximab|mesh-list
24749846|NCT01694134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749847|NCT01694212|Diclofenac|diclofenac|mesh-list
24884236|NCT02628405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24884237|NCT02628405|Carboplatin|carboplatin|mesh-list
24884238|NCT02628405|Etoposide|etoposide|mesh-list
24884239|NCT02628405|Lenalidomide|lenalidomide|mesh-list
24505897|NCT00543114|Lenalidomide|lenalidomide|mesh-list
24505898|NCT00543114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24505899|NCT00543114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505900|NCT00543114|Immunologic Factors|immunologic factors|mesh-ancestor
24884255|NCT02628405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884256|NCT02628405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24884257|NCT02628405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24884258|NCT02628405|Growth Substances|growth substances|mesh-ancestor
24884259|NCT02628405|Growth Inhibitors|growth inhibitors|mesh-ancestor
24884260|NCT02628405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24884261|NCT02628405|Alkylating Agents|alkylating agents|mesh-ancestor
24884262|NCT02628405|Keratolytic Agents|keratolytic agents|mesh-ancestor
24884263|NCT02628405|Dermatologic Agents|dermatologic agents|mesh-ancestor
24505944|NCT00543361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505945|NCT00543413|Enalapril|enalapril|mesh-list
24505946|NCT00543413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24505947|NCT00543413|Protease Inhibitors|protease inhibitors|mesh-ancestor
24505972|NCT00543608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24505973|NCT00543608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24749932|NCT01695005|Prednisone|prednisone|mesh-list
24505974|NCT00543608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505975|NCT00543634|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24505976|NCT00543634|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24505977|NCT00543634|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24505978|NCT00543634|Contraceptive Agents|contraceptive agents|mesh-ancestor
24506001|NCT00543686|Respiratory System Agents|respiratory system agents|mesh-ancestor
24884280|NCT02472964|Docetaxel|docetaxel|mesh-list
24884281|NCT02472964|Trastuzumab|trastuzumab|mesh-list
24884282|NCT02472964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24884283|NCT02472964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24884284|NCT02472964|Tubulin Modulators|tubulin modulators|mesh-ancestor
24884285|NCT02472964|Antimitotic Agents|antimitotic agents|mesh-ancestor
24884286|NCT02472964|Mitosis Modulators|mitosis modulators|mesh-ancestor
24884289|NCT02467868|Lenograstim|lenograstim|mesh-list
24506013|NCT00543829|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24506014|NCT00543829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506015|NCT00543829|Tubulin Modulators|tubulin modulators|mesh-ancestor
24506016|NCT00543829|Antimitotic Agents|antimitotic agents|mesh-ancestor
25058140|NCT03499171|Serotonin Agents|serotonin agents|mesh-ancestor
25058141|NCT03499171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058142|NCT03499171|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25058143|NCT03499171|Antidepressive Agents|antidepressive agents|mesh-ancestor
25058144|NCT03499171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25058145|NCT03499132|Anesthetics|anesthetics|mesh-list
25698470|NCT02093390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25698471|NCT02093390|Antifungal Agents|antifungal agents|mesh-ancestor
25698472|NCT02093390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25698473|NCT02093390|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25698474|NCT02093390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25698475|NCT02093390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25698476|NCT02093390|Hormone Antagonists|hormone antagonists|mesh-ancestor
25698477|NCT02093390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25698478|NCT02093390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698479|NCT02093390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25698480|NCT02093390|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25698481|NCT02093390|Androgen Antagonists|androgen antagonists|mesh-ancestor
25698482|NCT02093663|Mesalamine|mesalamine|mesh-list
25058146|NCT03499132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25058147|NCT03499132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058149|NCT03499106|Praliciguat|praliciguat|mesh-list
25058150|NCT03499106|Antifungal Agents|antifungal agents|mesh-ancestor
25058151|NCT03499106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25058162|NCT03499106|Enzyme Activators|enzyme activators|mesh-ancestor
25058163|NCT03499106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25058165|NCT03498963|Chelating Agents|chelating agents|mesh-ancestor
25058167|NCT03498963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058168|NCT03498898|Adrenergic Agents|adrenergic agents|mesh-list
25058169|NCT03498898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25058170|NCT03498898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058171|NCT03498898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058173|NCT03498820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24884292|NCT02467868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884293|NCT02421263|Psilocybin|psilocybin|mesh-list
24884294|NCT02421263|Hallucinogens|hallucinogens|mesh-ancestor
24884295|NCT02421263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884296|NCT02421263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24884297|NCT02402920|Cisplatin|cisplatin|mesh-list
24463334|NCT00360178|Amlodipine|amlodipine|mesh-list
24506114|NCT00544128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24506115|NCT00544128|Antiviral Agents|antiviral agents|mesh-ancestor
24506116|NCT00544128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24506117|NCT00544128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24506118|NCT00544128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24506119|NCT00544128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24506120|NCT00544128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24506121|NCT00544154|Certolizumab Pegol|certolizumab pegol|mesh-list
24506123|NCT00544154|Immunologic Factors|immunologic factors|mesh-ancestor
24506136|NCT00544193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506137|NCT00544193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506138|NCT00544193|Antiviral Agents|antiviral agents|mesh-ancestor
24506139|NCT00544193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24506140|NCT00544193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506141|NCT00544193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24506142|NCT00544193|Immunologic Factors|immunologic factors|mesh-ancestor
24506143|NCT00544193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506209|NCT00544284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506211|NCT00544349|Leucovorin|leucovorin|mesh-list
24506212|NCT00544349|Fluorouracil|fluorouracil|mesh-list
24506213|NCT00544349|Oxaliplatin|oxaliplatin|mesh-list
24506214|NCT00544349|Cetuximab|cetuximab|mesh-list
24884298|NCT02402920|Carboplatin|carboplatin|mesh-list
24884299|NCT02402920|Pembrolizumab|pembrolizumab|mesh-list
25058174|NCT03498820|Narcotics|narcotics|mesh-ancestor
25058175|NCT03498820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25058176|NCT03498820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058177|NCT03498820|Analgesics|analgesics|mesh-ancestor
25058178|NCT03498820|Sensory System Agents|sensory system agents|mesh-ancestor
25058179|NCT03498820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25058180|NCT03498703|Azathioprine|azathioprine|mesh-list
25058181|NCT03498703|Antimetabolites|antimetabolites|mesh-ancestor
25058182|NCT03498703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058183|NCT03498703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25058184|NCT03498703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25058185|NCT03498703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25058186|NCT03498703|Immunologic Factors|immunologic factors|mesh-ancestor
25058187|NCT03498703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058188|NCT03498703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25058189|NCT03498534|Isoniazid|isoniazid|mesh-list
25058190|NCT03498534|Antitubercular Agents|antitubercular agents|mesh-ancestor
25058191|NCT03498534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24820229|NCT02099240|Paromomycin|paromomycin|mesh-list
24884304|NCT02402920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24884305|NCT02402920|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24884306|NCT02402920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24884307|NCT02402920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25698483|NCT02093663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25107193|NCT03141658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25107195|NCT03141658|Anesthetics|anesthetics|mesh-ancestor
24884308|NCT02402920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24884309|NCT02402920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884310|NCT02402920|Keratolytic Agents|keratolytic agents|mesh-ancestor
24884311|NCT02402920|Dermatologic Agents|dermatologic agents|mesh-ancestor
24884312|NCT02402920|Tubulin Modulators|tubulin modulators|mesh-ancestor
24884313|NCT02402920|Antimitotic Agents|antimitotic agents|mesh-ancestor
24884314|NCT02402920|Mitosis Modulators|mitosis modulators|mesh-ancestor
24884315|NCT02178722|Pembrolizumab|pembrolizumab|mesh-list
24884316|NCT02178722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24884317|NCT02178722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506215|NCT00544349|Calcium|calcium|mesh-list
24506220|NCT00544349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506221|NCT00544349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24506222|NCT00544349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506223|NCT00544349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24506224|NCT00544349|Immunologic Factors|immunologic factors|mesh-ancestor
24506225|NCT00544349|Antidotes|antidotes|mesh-ancestor
25058195|NCT03498534|Antimetabolites|antimetabolites|mesh-ancestor
25058196|NCT03498534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058197|NCT03498534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25058198|NCT03498456|Amoxicillin|amoxicillin|mesh-list
24820257|NCT02099240|Sultamicillin|sultamicillin|mesh-list
24511357|NCT00568347|Glucocorticoids|glucocorticoids|mesh-ancestor
24506228|NCT00544349|Vitamins|vitamins|mesh-ancestor
24506229|NCT00544349|Micronutrients|micronutrients|mesh-ancestor
24506230|NCT00544349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24506231|NCT00544362|Fluorouracil|fluorouracil|mesh-list
24506232|NCT00544362|Cetuximab|cetuximab|mesh-list
24506233|NCT00544362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506242|NCT00544388|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24506244|NCT00544388|Histamine Antagonists|histamine antagonists|mesh-ancestor
24506245|NCT00544388|Histamine Agents|histamine agents|mesh-ancestor
24506246|NCT00544388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24506247|NCT00544388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506248|NCT00544388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506249|NCT00544505|Cyclophosphamide|cyclophosphamide|mesh-list
24506250|NCT00544505|Fluorouracil|fluorouracil|mesh-list
24506251|NCT00544505|Epirubicin|epirubicin|mesh-list
24506252|NCT00544505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24506253|NCT00544505|Immunologic Factors|immunologic factors|mesh-ancestor
24506266|NCT00544505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506268|NCT00544518|Benfluorex|benfluorex|mesh-list
24506269|NCT00544518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24506270|NCT00544518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506271|NCT00544518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24506272|NCT00544518|Antimetabolites|antimetabolites|mesh-ancestor
24506273|NCT00544518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506359|NCT00544986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24506360|NCT00544986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506361|NCT00544986|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24506362|NCT00544986|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24506363|NCT00544986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506379|NCT00544999|Immunologic Factors|immunologic factors|mesh-ancestor
24506380|NCT00544999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506381|NCT00544999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24506382|NCT00544999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24506383|NCT00544999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24506384|NCT00544999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506385|NCT00545012|Levetiracetam|levetiracetam|mesh-list
24506386|NCT00545012|Anticonvulsants|anticonvulsants|mesh-ancestor
24506387|NCT00545012|Nootropic Agents|nootropic agents|mesh-ancestor
24506388|NCT00545090|Ibandronic Acid|ibandronic acid|mesh-list
24506389|NCT00545090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24506390|NCT00545090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698484|NCT02093663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25698485|NCT02093663|Analgesics|analgesics|mesh-ancestor
24506391|NCT00545129|Tanezumab|tanezumab|mesh-list
24506392|NCT00545129|Analgesics|analgesics|mesh-ancestor
24506393|NCT00545129|Sensory System Agents|sensory system agents|mesh-ancestor
25698486|NCT02093663|Sensory System Agents|sensory system agents|mesh-ancestor
25698487|NCT02093663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25698488|NCT02093663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698489|NCT02093663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25698490|NCT02093663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25698491|NCT02093897|Factor VIII|factor viii|mesh-list
25698492|NCT02093897|Coagulants|coagulants|mesh-ancestor
25698493|NCT02093962|Pemetrexed|pemetrexed|mesh-list
25698494|NCT02093962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25698495|NCT02093962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506394|NCT00545129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24506428|NCT00545246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506429|NCT00545246|Tubulin Modulators|tubulin modulators|mesh-ancestor
24506430|NCT00545246|Antimitotic Agents|antimitotic agents|mesh-ancestor
25058251|NCT03498248|Lenograstim|lenograstim|mesh-list
24820321|NCT02099240|Cilastatin|cilastatin|mesh-list
24884342|NCT01258803|Formoterol Fumarate|formoterol fumarate|mesh-list
24884343|NCT01258803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24884344|NCT01258803|Autonomic Agents|autonomic agents|mesh-ancestor
24884345|NCT01258803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24884346|NCT01258803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884347|NCT01258803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24884348|NCT01258803|Respiratory System Agents|respiratory system agents|mesh-ancestor
24884349|NCT01258803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24884350|NCT01258803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24884351|NCT01258803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24884352|NCT01258803|Adrenergic Agents|adrenergic agents|mesh-ancestor
24884353|NCT01258803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24884354|NCT01258803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884355|NCT01258803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24884356|NCT01258803|Dermatologic Agents|dermatologic agents|mesh-ancestor
24884357|NCT01258803|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24506431|NCT00545246|Mitosis Modulators|mitosis modulators|mesh-ancestor
24463393|NCT00360607|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24506464|NCT00545467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24506465|NCT00545467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506466|NCT00545467|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24506467|NCT00545467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24506468|NCT00545467|Serotonin Agents|serotonin agents|mesh-ancestor
24506469|NCT00545467|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24506470|NCT00545467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24443720|NCT00295893|Mitosis Modulators|mitosis modulators|mesh-ancestor
24506471|NCT00545467|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24506472|NCT00545467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24506474|NCT00545480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24506475|NCT00545480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506477|NCT00545493|Immunoglobulins|immunoglobulins|mesh-list
24506478|NCT00545493|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24506479|NCT00545493|Antibodies|antibodies|mesh-list
25058290|NCT03498118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25058291|NCT03498118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058292|NCT03498118|Sensory System Agents|sensory system agents|mesh-ancestor
25058293|NCT03498118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24820346|NCT02099240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24820347|NCT02099240|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24820348|NCT02099240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24820349|NCT02099240|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24884372|NCT00783263|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24884374|NCT00783263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24884375|NCT00783263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24884376|NCT00783263|Antimetabolites|antimetabolites|mesh-ancestor
24751573|NCT01704794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751574|NCT01704794|Antimalarials|antimalarials|mesh-ancestor
24751652|NCT01705314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24884377|NCT00783263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884378|NCT00783263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24884379|NCT00783263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24884380|NCT00783263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058310|NCT03498092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058311|NCT03497988|Oxytocin|oxytocin|mesh-list
25058312|NCT03497988|Oxytocics|oxytocics|mesh-ancestor
25698496|NCT02093962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698497|NCT02093962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25698498|NCT02093962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25698499|NCT02094443|Ribavirin|ribavirin|mesh-list
25698500|NCT02094443|Antimetabolites|antimetabolites|mesh-ancestor
25058313|NCT03497988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24884385|NCT00782184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24884386|NCT00782184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24884387|NCT00782184|Antimetabolites|antimetabolites|mesh-ancestor
24884388|NCT00782184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884389|NCT00782184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24884390|NCT00782184|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24884391|NCT00782184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24884392|NCT00664937|Montelukast|montelukast|mesh-list
24884393|NCT00664937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24884394|NCT00664937|Respiratory System Agents|respiratory system agents|mesh-ancestor
24884395|NCT00664937|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24884396|NCT00664937|Hormone Antagonists|hormone antagonists|mesh-ancestor
24884397|NCT00664937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24884398|NCT00664937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884399|NCT00664937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25058326|NCT03497923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058327|NCT03497923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25058328|NCT03497923|Tocolytic Agents|tocolytic agents|mesh-ancestor
25058329|NCT03497923|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25058330|NCT03497767|Osimertinib|osimertinib|mesh-list
25058331|NCT03497767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25058332|NCT03497767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25058333|NCT03497767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058334|NCT03497767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506559|NCT00545935|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24506560|NCT00545935|Anthelmintics|anthelmintics|mesh-ancestor
24506561|NCT00545961|Amoxicillin|amoxicillin|mesh-list
24506562|NCT00545961|Clavulanic Acid|clavulanic acid|mesh-list
24506563|NCT00545961|Clavulanic Acids|clavulanic acids|mesh-list
24506564|NCT00545961|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24884403|NCT00635882|Formoterol Fumarate|formoterol fumarate|mesh-list
24884404|NCT00635882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24884405|NCT00635882|Autonomic Agents|autonomic agents|mesh-ancestor
24884406|NCT00635882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24884407|NCT00635882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884408|NCT00635882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24463448|NCT00361023|Losartan|losartan|mesh-list
24506565|NCT00545961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24506566|NCT00545961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24506567|NCT00545961|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24506568|NCT00545961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506569|NCT00545961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506570|NCT00546039|Genistein|genistein|mesh-list
24506571|NCT00546039|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24506572|NCT00546039|Protective Agents|protective agents|mesh-ancestor
24506591|NCT00546130|Irinotecan|irinotecan|mesh-list
24506592|NCT00546130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506593|NCT00546130|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24506594|NCT00546130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24506597|NCT00546130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24506598|NCT00546130|Immunologic Factors|immunologic factors|mesh-ancestor
24506599|NCT00546130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058336|NCT03497715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25058337|NCT03497715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25058338|NCT03497715|Analgesics|analgesics|mesh-ancestor
25058339|NCT03497715|Sensory System Agents|sensory system agents|mesh-ancestor
25058340|NCT03497715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25058341|NCT03497715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058343|NCT03497715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25058355|NCT03497702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25058356|NCT03497702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25058357|NCT03497702|Alkylating Agents|alkylating agents|mesh-ancestor
24820415|NCT02099396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24884416|NCT00635882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24884417|NCT00635882|Dermatologic Agents|dermatologic agents|mesh-ancestor
24884418|NCT00635882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24506676|NCT00546507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25698501|NCT02094443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698502|NCT02094443|Antiviral Agents|antiviral agents|mesh-ancestor
25698503|NCT02094443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24506677|NCT00546507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506678|NCT00546507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24506679|NCT00546507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24752048|NCT01707953|Midodrine|midodrine|mesh-list
24506680|NCT00546507|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24752321|NCT01709825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24752322|NCT01709825|Renal Agents|renal agents|mesh-ancestor
24752323|NCT01709825|Antimalarials|antimalarials|mesh-ancestor
24506681|NCT00546507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24506682|NCT00546507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506697|NCT00546533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24506698|NCT00546533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24506699|NCT00546533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24506700|NCT00546533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24506701|NCT00546533|Immunologic Factors|immunologic factors|mesh-ancestor
24506702|NCT00546546|Methotrexate|methotrexate|mesh-list
24506703|NCT00546546|Azathioprine|azathioprine|mesh-list
24506704|NCT00546546|Immunosuppressive Agents|immunosuppressive agents|mesh-list
24506710|NCT00546546|Antimetabolites|antimetabolites|mesh-ancestor
24506711|NCT00546546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506712|NCT00546546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506713|NCT00546546|Dermatologic Agents|dermatologic agents|mesh-ancestor
24506714|NCT00546546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506715|NCT00546546|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24506716|NCT00546546|Immunologic Factors|immunologic factors|mesh-ancestor
24506730|NCT00546650|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24506731|NCT00546650|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24506733|NCT00546650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24506735|NCT00546650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506742|NCT00546741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506747|NCT00546832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24506748|NCT00546832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24506749|NCT00546832|Analgesics|analgesics|mesh-ancestor
24506750|NCT00546832|Sensory System Agents|sensory system agents|mesh-ancestor
24884420|NCT00586391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24884421|NCT00586391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24884422|NCT00586391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24884423|NCT00586391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884424|NCT00545324|Fluticasone|fluticasone|mesh-list
24884425|NCT00545324|Montelukast|montelukast|mesh-list
24884426|NCT00545324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24884427|NCT00545324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24884428|NCT00545324|Autonomic Agents|autonomic agents|mesh-ancestor
24884429|NCT00545324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24884430|NCT00545324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884431|NCT00545324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24463457|NCT00361075|Hormones|hormones|mesh-ancestor
25058358|NCT03497702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058359|NCT03497702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25058360|NCT03497702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25058361|NCT03497702|Tubulin Modulators|tubulin modulators|mesh-ancestor
25058362|NCT03497702|Antimitotic Agents|antimitotic agents|mesh-ancestor
25058363|NCT03497702|Mitosis Modulators|mitosis modulators|mesh-ancestor
25058364|NCT03497702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24820426|NCT02099474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24506797|NCT00547092|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24506798|NCT00547092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24752324|NCT01709825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24506799|NCT00547092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506800|NCT00547092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506801|NCT00547092|Urological Agents|urological agents|mesh-ancestor
24506802|NCT00547131|Temozolomide|temozolomide|mesh-list
24506803|NCT00547131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24506804|NCT00547131|Alkylating Agents|alkylating agents|mesh-ancestor
24506805|NCT00547131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506806|NCT00547131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506807|NCT00547144|Gemcitabine|gemcitabine|mesh-list
24506808|NCT00547144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24506809|NCT00547144|Antimetabolites|antimetabolites|mesh-ancestor
24506810|NCT00547144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506811|NCT00547144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506812|NCT00547144|Antiviral Agents|antiviral agents|mesh-ancestor
24506813|NCT00547144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24506814|NCT00547144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988027|NCT04471597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24988029|NCT04420455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24988030|NCT04420455|Vasodilator Agents|vasodilator agents|mesh-ancestor
24506815|NCT00547144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24884432|NCT00545324|Respiratory System Agents|respiratory system agents|mesh-ancestor
24884433|NCT00545324|Dermatologic Agents|dermatologic agents|mesh-ancestor
24884434|NCT00545324|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24884435|NCT00545324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884436|NCT00545324|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24884437|NCT00545324|Hormone Antagonists|hormone antagonists|mesh-ancestor
24884439|NCT00545324|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25058369|NCT03497702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25058370|NCT03497702|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25058371|NCT03497702|Hormone Antagonists|hormone antagonists|mesh-ancestor
25058378|NCT03497442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25058379|NCT03497442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24506816|NCT00547144|Immunologic Factors|immunologic factors|mesh-ancestor
24506817|NCT00547144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506818|NCT00547170|Doxycycline|doxycycline|mesh-list
24506819|NCT00547170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24506820|NCT00547170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24506821|NCT00547170|Antimalarials|antimalarials|mesh-ancestor
24506822|NCT00547170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24506823|NCT00547170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24506825|NCT00547183|Vasodilator Agents|vasodilator agents|mesh-ancestor
24506826|NCT00547183|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24752608|NCT01711229|Antipyretics|antipyretics|mesh-ancestor
24752609|NCT01711320|Omeprazole|omeprazole|mesh-list
24511784|NCT00570895|Ascorbic Acid|ascorbic acid|mesh-list
24506879|NCT00547352|Vasodilator Agents|vasodilator agents|mesh-ancestor
24506880|NCT00547352|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24506881|NCT00547352|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24506882|NCT00547352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506883|NCT00547352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506884|NCT00547352|Urological Agents|urological agents|mesh-ancestor
24506885|NCT00547417|Tadalafil|tadalafil|mesh-list
24942055|NCT03984591|Diuretics|diuretics|mesh-ancestor
25058398|NCT03497351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25058399|NCT03497351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058400|NCT03497351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25058401|NCT03497351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058402|NCT03497351|Vasodilator Agents|vasodilator agents|mesh-ancestor
25058403|NCT03497351|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25058404|NCT03497351|Serotonin Agents|serotonin agents|mesh-ancestor
25058405|NCT03497351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25058406|NCT03497351|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25058407|NCT03497351|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25058408|NCT03497351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25058409|NCT03497351|Adrenergic Agents|adrenergic agents|mesh-ancestor
24942200|NCT03983239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24942201|NCT03983239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24942202|NCT03983239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942203|NCT03983239|Antiviral Agents|antiviral agents|mesh-ancestor
24942204|NCT03983239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24942205|NCT03983239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24942206|NCT03983239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24942207|NCT03983239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24942208|NCT03983239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24942209|NCT03983239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24942216|NCT03983239|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24942217|NCT03983239|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24942218|NCT03982992|Blinatumomab|blinatumomab|mesh-list
24942219|NCT03982992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942220|NCT03983057|Antibodies|antibodies|mesh-list
24942221|NCT03983057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24942222|NCT03983057|Immunologic Factors|immunologic factors|mesh-ancestor
24884467|NCT00535405|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24884468|NCT00535405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24884469|NCT00496730|Atorvastatin|atorvastatin|mesh-list
25698504|NCT02094534|Insulin|insulin|mesh-list
25698505|NCT02094534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25698506|NCT02094534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988057|NCT04251715|Dexamethasone|dexamethasone|mesh-list
25698507|NCT02094885|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24884472|NCT00496730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24884473|NCT00496730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24884474|NCT00496730|Antimetabolites|antimetabolites|mesh-ancestor
24884475|NCT00496730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884476|NCT00496730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24884477|NCT00496730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24884478|NCT00496730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24884479|NCT00462748|Atorvastatin|atorvastatin|mesh-list
24884480|NCT00462748|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24884481|NCT00462748|Simvastatin|simvastatin|mesh-list
24506938|NCT00547573|Urological Agents|urological agents|mesh-ancestor
24506939|NCT00547599|Tadalafil|tadalafil|mesh-list
24506940|NCT00547599|Vasodilator Agents|vasodilator agents|mesh-ancestor
24506941|NCT00547599|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24506942|NCT00547599|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24506943|NCT00547599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506944|NCT00547599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506945|NCT00547599|Urological Agents|urological agents|mesh-ancestor
24506946|NCT00547612|Substance P|substance p|mesh-list
24506947|NCT00547612|Neurokinin A|neurokinin a|mesh-list
24506948|NCT00547612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24506949|NCT00547612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506950|NCT00547612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506951|NCT00547625|Tadalafil|tadalafil|mesh-list
24506962|NCT00547664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506963|NCT00547664|Analgesics|analgesics|mesh-ancestor
24942223|NCT03983057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942225|NCT03982862|Lidocaine|lidocaine|mesh-list
24942226|NCT03982862|Botulinum Toxins|botulinum toxins|mesh-list
24942227|NCT03982862|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24942228|NCT03982862|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24942229|NCT03982862|Anesthetics, Local|anesthetics, local|mesh-ancestor
24942230|NCT03982862|Anesthetics|anesthetics|mesh-ancestor
24942231|NCT03982862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24507018|NCT00548067|Natriuretic Agents|natriuretic agents|mesh-ancestor
24507019|NCT00548067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24507020|NCT00548080|Caspofungin|caspofungin|mesh-list
24884497|NCT00446186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24884499|NCT00446186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24884500|NCT00445107|Montelukast|montelukast|mesh-list
24884501|NCT00445107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24884502|NCT00445107|Respiratory System Agents|respiratory system agents|mesh-ancestor
24884503|NCT00445107|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25058422|NCT03496870|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25058423|NCT03496870|Immunologic Factors|immunologic factors|mesh-ancestor
25058425|NCT03496870|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25058427|NCT03496831|Etanercept|etanercept|mesh-list
25058428|NCT03496831|Golimumab|golimumab|mesh-list
25058429|NCT03496831|Abatacept|abatacept|mesh-list
25058430|NCT03496831|Infliximab|infliximab|mesh-list
25058454|NCT03496779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25058455|NCT03496779|Antiviral Agents|antiviral agents|mesh-ancestor
25058456|NCT03496779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25058457|NCT03496779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058458|NCT03496779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25058459|NCT03496779|Immunologic Factors|immunologic factors|mesh-ancestor
25058460|NCT03496779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058461|NCT03496779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25058464|NCT03496740|Bupivacaine|bupivacaine|mesh-list
25058465|NCT03496740|Anesthetics, Local|anesthetics, local|mesh-ancestor
25058466|NCT03496740|Anesthetics|anesthetics|mesh-ancestor
25058467|NCT03496740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25058468|NCT03496740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058469|NCT03496740|Sensory System Agents|sensory system agents|mesh-ancestor
25698508|NCT02094885|Hemostatics|hemostatics|mesh-ancestor
25058470|NCT03496740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25058471|NCT03496649|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25698509|NCT02094885|Coagulants|coagulants|mesh-ancestor
25058472|NCT03496649|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25058473|NCT03496649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25058474|NCT03496649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058475|NCT03496649|Cholinergic Agents|cholinergic agents|mesh-ancestor
25058476|NCT03496649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25058477|NCT03496649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058478|NCT03496519|Durvalumab|durvalumab|mesh-list
25058479|NCT03496519|Trabectedin|trabectedin|mesh-list
25058480|NCT03496519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25058483|NCT03496519|Immunologic Factors|immunologic factors|mesh-ancestor
25058495|NCT03496506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25058496|NCT03496506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058497|NCT03496506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058498|NCT03496506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25058499|NCT03496389|Acetaminophen|acetaminophen|mesh-list
25058500|NCT03496389|Gabapentin|gabapentin|mesh-list
25058501|NCT03496389|Tramadol|tramadol|mesh-list
25058502|NCT03496389|Analgesics|analgesics|mesh-ancestor
25058503|NCT03496389|Sensory System Agents|sensory system agents|mesh-ancestor
25058504|NCT03496389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25058505|NCT03496389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058506|NCT03496389|Anticonvulsants|anticonvulsants|mesh-ancestor
24507069|NCT00548561|Razoxane|razoxane|mesh-list
24507070|NCT00548561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24753155|NCT01714037|Mitosis Modulators|mitosis modulators|mesh-ancestor
24753156|NCT01714037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24753157|NCT01714037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25058529|NCT03496246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25058530|NCT03496233|Grazoprevir|grazoprevir|mesh-list
24820628|NCT02100488|Insulin|insulin|mesh-list
24507146|NCT00548964|Anesthetics|anesthetics|mesh-ancestor
24507147|NCT00548964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24507148|NCT00548964|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24507149|NCT00548964|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24507150|NCT00548964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24507177|NCT00549120|Ipratropium|ipratropium|mesh-list
24507178|NCT00549120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24507212|NCT00549146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507213|NCT00549146|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24507214|NCT00549146|Respiratory System Agents|respiratory system agents|mesh-ancestor
24507215|NCT00549146|Dermatologic Agents|dermatologic agents|mesh-ancestor
24507216|NCT00549146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24507217|NCT00549146|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24507218|NCT00549146|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24507245|NCT00549341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507246|NCT00549419|Dobutamine|dobutamine|mesh-list
24507247|NCT00549419|Norepinephrine|norepinephrine|mesh-list
24507248|NCT00549419|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24507249|NCT00549419|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24507250|NCT00549419|Adrenergic Agents|adrenergic agents|mesh-ancestor
24507251|NCT00549419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24507494|NCT00550927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24507252|NCT00549419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507253|NCT00549419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058556|NCT03495466|Anesthetics|anesthetics|mesh-list
25058557|NCT03495466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25058559|NCT03495232|Cimetidine|cimetidine|mesh-list
25058585|NCT03495063|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25058586|NCT03495063|Purinergic Agents|purinergic agents|mesh-ancestor
25058587|NCT03495063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25058589|NCT03495024|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25058590|NCT03495024|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25058591|NCT03495024|Cholinergic Agents|cholinergic agents|mesh-ancestor
25058592|NCT03495024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25058593|NCT03495024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058594|NCT03495024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058595|NCT03494972|Tetracycline|tetracycline|mesh-list
25058596|NCT03494972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25058597|NCT03494972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25698510|NCT02094898|Ketamine|ketamine|mesh-list
25698511|NCT02094898|Analgesics|analgesics|mesh-ancestor
25698512|NCT02094898|Sensory System Agents|sensory system agents|mesh-ancestor
25698513|NCT02094898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25058598|NCT03494972|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24884517|NCT00418834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24507275|NCT00549536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24507428|NCT00550485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24507429|NCT00550485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24507430|NCT00550485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507431|NCT00550485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24884552|NCT00380705|Montelukast|montelukast|mesh-list
25058638|NCT03494426|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
25058639|NCT03494426|Analgesics|analgesics|mesh-ancestor
25058640|NCT03494426|Sensory System Agents|sensory system agents|mesh-ancestor
25058641|NCT03494426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25058642|NCT03494426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058643|NCT03494426|Anticonvulsants|anticonvulsants|mesh-ancestor
25058644|NCT03494426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25058645|NCT03494426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25058646|NCT03494426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753466|NCT01715584|Nitrous Oxide|nitrous oxide|mesh-list
24753672|NCT01716767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25058647|NCT03494426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24767570|NCT01802268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24767571|NCT01802268|Immunologic Factors|immunologic factors|mesh-ancestor
24942448|NCT03980756|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24942449|NCT03980756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24942450|NCT03980756|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24942451|NCT03980756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952762|NCT03892122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952763|NCT03892122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24952766|NCT03892122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24952767|NCT03892122|Analgesics|analgesics|mesh-ancestor
24952768|NCT03892122|Sensory System Agents|sensory system agents|mesh-ancestor
24952769|NCT03892122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24952770|NCT03892122|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24952771|NCT03892122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24952772|NCT03892122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24952773|NCT03892122|Adrenergic Agents|adrenergic agents|mesh-ancestor
24952774|NCT03892122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24952775|NCT03892122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576591|NCT00839371|Midazolam|midazolam|mesh-list
24952781|NCT03892213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24952782|NCT03892213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24952783|NCT03892213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24952798|NCT03891979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24952799|NCT03891979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24952800|NCT03891979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25698514|NCT02094898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698515|NCT02094898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25698516|NCT02094898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25698517|NCT02094898|Anesthetics, General|anesthetics, general|mesh-ancestor
25698518|NCT02094898|Anesthetics|anesthetics|mesh-ancestor
25698519|NCT02094898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25698520|NCT02094898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24988182|NCT04118387|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25107228|NCT03141918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835310|NCT02182622|Glucocorticoids|glucocorticoids|mesh-ancestor
24952801|NCT03891979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24952802|NCT03891979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24952803|NCT03891979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24952804|NCT03891979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24952805|NCT03891979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952806|NCT03891979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507746|NCT00551824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507748|NCT00551850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507749|NCT00551850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24507750|NCT00551850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507751|NCT00551850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507752|NCT00551889|Celecoxib|celecoxib|mesh-list
24507753|NCT00551889|Cyclophosphamide|cyclophosphamide|mesh-list
24507754|NCT00551889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24507755|NCT00551889|Immunologic Factors|immunologic factors|mesh-ancestor
24507756|NCT00551889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507757|NCT00551889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24507759|NCT00551889|Alkylating Agents|alkylating agents|mesh-ancestor
24952816|NCT03892161|Rifampin|rifampin|mesh-list
24952817|NCT03892161|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24952818|NCT03892161|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24952819|NCT03892161|Protease Inhibitors|protease inhibitors|mesh-ancestor
24952820|NCT03892161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952821|NCT03892161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952822|NCT03892161|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24952823|NCT03892161|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24952824|NCT03892161|Antiviral Agents|antiviral agents|mesh-ancestor
25058648|NCT03494426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25058649|NCT03494426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25058650|NCT03494426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25058651|NCT03494426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25058652|NCT03494426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25058653|NCT03494426|Narcotics|narcotics|mesh-ancestor
25058654|NCT03494387|Ascorbic Acid|ascorbic acid|mesh-list
25058655|NCT03494387|Acetylcysteine|acetylcysteine|mesh-list
25058656|NCT03494387|Antioxidants|antioxidants|mesh-list
25058657|NCT03494387|Antiviral Agents|antiviral agents|mesh-ancestor
25058658|NCT03494387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25058659|NCT03494387|Expectorants|expectorants|mesh-ancestor
25058660|NCT03494387|Respiratory System Agents|respiratory system agents|mesh-ancestor
24816347|NCT02076594|Tubulin Modulators|tubulin modulators|mesh-ancestor
24816348|NCT02076594|Antimitotic Agents|antimitotic agents|mesh-ancestor
24816349|NCT02076594|Mitosis Modulators|mitosis modulators|mesh-ancestor
24816350|NCT02076594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816351|NCT02076594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24816352|NCT02076594|Antimetabolites|antimetabolites|mesh-ancestor
24816353|NCT02076594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24816354|NCT02076594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24816355|NCT02076594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25698521|NCT02094898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25698522|NCT02094898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25698523|NCT02094898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698524|NCT02094937|Fluticasone|fluticasone|mesh-list
25698525|NCT02094937|Xhance|xhance|mesh-list
25698526|NCT02094937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25698527|NCT02094937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25698528|NCT02094937|Autonomic Agents|autonomic agents|mesh-ancestor
25698529|NCT02094937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816356|NCT02076594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507818|NCT00552500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24507819|NCT00552500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24507820|NCT00552526|Anticonvulsants|anticonvulsants|mesh-list
24507821|NCT00552630|Penicillamine|penicillamine|mesh-list
24507822|NCT00552630|Antidotes|antidotes|mesh-ancestor
25698530|NCT02094937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698531|NCT02094937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24988323|NCT03229382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24988324|NCT03229382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507864|NCT00552838|Anti-Infective Agents|anti-infective agents|mesh-list
24507865|NCT00552838|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24507866|NCT00552864|Ropivacaine|ropivacaine|mesh-list
24507867|NCT00552864|Levobupivacaine|levobupivacaine|mesh-list
24507868|NCT00552864|Anesthetics, Local|anesthetics, local|mesh-ancestor
24507869|NCT00552864|Anesthetics|anesthetics|mesh-ancestor
24507870|NCT00552864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25058722|NCT03493490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058723|NCT03493490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058725|NCT03493412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25058726|NCT03493412|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25058727|NCT03493412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25058728|NCT03493412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058729|NCT03493412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25058730|NCT03493412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058731|NCT03493412|Vasodilator Agents|vasodilator agents|mesh-ancestor
25058732|NCT03493269|Midazolam|midazolam|mesh-list
25058733|NCT03493269|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25058734|NCT03493269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25058735|NCT03493269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25058736|NCT03493269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058740|NCT03493269|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25058741|NCT03493269|Anesthetics, General|anesthetics, general|mesh-ancestor
25058742|NCT03493269|Anesthetics|anesthetics|mesh-ancestor
25058743|NCT03493269|GABA Modulators|gaba modulators|mesh-ancestor
25058744|NCT03493269|GABA Agents|gaba agents|mesh-ancestor
24820892|NCT02102555|Acetaminophen|acetaminophen|mesh-list
24507871|NCT00552864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507872|NCT00552864|Sensory System Agents|sensory system agents|mesh-ancestor
24507873|NCT00552864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816358|NCT02076659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25058745|NCT03493269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25058746|NCT03493269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058752|NCT03493087|Vitamin K|vitamin k|mesh-list
25058753|NCT03493087|Vitamins|vitamins|mesh-ancestor
25058754|NCT03493087|Micronutrients|micronutrients|mesh-ancestor
24507875|NCT00553020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24507876|NCT00553020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507877|NCT00553072|Magnesium Sulfate|magnesium sulfate|mesh-list
24507878|NCT00553072|Analgesics|analgesics|mesh-ancestor
24507879|NCT00553072|Sensory System Agents|sensory system agents|mesh-ancestor
24507880|NCT00553072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24507881|NCT00553072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507882|NCT00553072|Anesthetics|anesthetics|mesh-ancestor
24507883|NCT00553072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24507884|NCT00553072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24507885|NCT00553072|Anticonvulsants|anticonvulsants|mesh-ancestor
24507886|NCT00553072|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24507887|NCT00553072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24507934|NCT00553345|Trace Elements|trace elements|mesh-ancestor
24507935|NCT00553423|Lactulose|lactulose|mesh-list
25698532|NCT02094937|Respiratory System Agents|respiratory system agents|mesh-ancestor
25698533|NCT02094937|Dermatologic Agents|dermatologic agents|mesh-ancestor
25698534|NCT02094937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25698535|NCT02095106|Calpastatin|calpastatin|mesh-list
25698536|NCT02095106|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25698537|NCT02095106|Protease Inhibitors|protease inhibitors|mesh-ancestor
25698538|NCT02095106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813515|NCT02058823|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24813516|NCT02058823|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24813517|NCT02058875|Cyclosporine|cyclosporine|mesh-list
24813518|NCT02058875|Mycophenolic Acid|mycophenolic acid|mesh-list
24813519|NCT02058875|Prednisone|prednisone|mesh-list
24813520|NCT02058875|Cyclosporins|cyclosporins|mesh-list
24507936|NCT00553423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24507937|NCT00553449|Rabeprazole|rabeprazole|mesh-list
24507938|NCT00553449|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24507939|NCT00553449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24507940|NCT00553449|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24507941|NCT00553449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507942|NCT00553449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507943|NCT00553488|Insulin|insulin|mesh-list
24507944|NCT00553488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24507945|NCT00553488|Insulin Lispro|insulin lispro|mesh-list
24507946|NCT00553488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24507947|NCT00553488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507948|NCT00553553|Morphine|morphine|mesh-list
24507949|NCT00553553|Remifentanil|remifentanil|mesh-list
24507950|NCT00553553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24507951|NCT00553553|Narcotics|narcotics|mesh-ancestor
24507952|NCT00553553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24507953|NCT00553553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507954|NCT00553553|Analgesics|analgesics|mesh-ancestor
25058764|NCT03493061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25058765|NCT03493061|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25058766|NCT03493061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25058767|NCT03493061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058768|NCT03493061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058769|NCT03493061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25058770|NCT03493061|Antimetabolites|antimetabolites|mesh-ancestor
25058771|NCT03493048|Leucovorin|leucovorin|mesh-list
25058772|NCT03493048|Fluorouracil|fluorouracil|mesh-list
25058773|NCT03493048|Oxaliplatin|oxaliplatin|mesh-list
25058774|NCT03493048|Irinotecan|irinotecan|mesh-list
25058775|NCT03493048|Cetuximab|cetuximab|mesh-list
25058776|NCT03493048|Antimetabolites|antimetabolites|mesh-ancestor
25058777|NCT03493048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058778|NCT03493048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25058779|NCT03493048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25058780|NCT03493048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24820931|NCT02102698|Ecopipam|ecopipam|mesh-list
24507966|NCT00553618|Antiviral Agents|antiviral agents|mesh-ancestor
24507967|NCT00553618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24507968|NCT00553618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24507969|NCT00553618|Analgesics|analgesics|mesh-ancestor
24507970|NCT00553618|Sensory System Agents|sensory system agents|mesh-ancestor
24507971|NCT00553618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24507972|NCT00553618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507973|NCT00553683|Cyclophosphamide|cyclophosphamide|mesh-list
24507986|NCT00553709|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24508005|NCT00553748|Antiviral Agents|antiviral agents|mesh-ancestor
24508006|NCT00553748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24508007|NCT00553878|Dutasteride|dutasteride|mesh-list
24508026|NCT00553930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508028|NCT00553943|Rituximab|rituximab|mesh-list
25058783|NCT03493048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25058784|NCT03493048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25058785|NCT03493048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058786|NCT03493048|Antidotes|antidotes|mesh-ancestor
25058787|NCT03493048|Protective Agents|protective agents|mesh-ancestor
25058788|NCT03493048|Vitamin B Complex|vitamin b complex|mesh-ancestor
25058789|NCT03493048|Vitamins|vitamins|mesh-ancestor
25058790|NCT03493048|Micronutrients|micronutrients|mesh-ancestor
25058791|NCT03493048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25058792|NCT03492996|Delpazolid|delpazolid|mesh-list
25058793|NCT03492996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25058794|NCT03492996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24754270|NCT01719835|Autonomic Agents|autonomic agents|mesh-ancestor
25058795|NCT03492996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25058796|NCT03492996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25698539|NCT02095106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698540|NCT02095158|Phenylephrine|phenylephrine|mesh-list
25698541|NCT02095158|Oxymetazoline|oxymetazoline|mesh-list
25698542|NCT02095158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25698543|NCT02095158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25698544|NCT02095158|Adrenergic Agents|adrenergic agents|mesh-ancestor
25058797|NCT03492996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058798|NCT03492970|Melatonin|melatonin|mesh-list
25058799|NCT03492970|Antioxidants|antioxidants|mesh-ancestor
25058800|NCT03492970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058801|NCT03492970|Protective Agents|protective agents|mesh-ancestor
25058802|NCT03492970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058803|NCT03492970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25058804|NCT03492931|Ticagrelor|ticagrelor|mesh-list
25058805|NCT03492931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25058806|NCT03492931|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25058807|NCT03492931|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25058809|NCT03492931|Purinergic Agents|purinergic agents|mesh-ancestor
25058814|NCT03492866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25058815|NCT03492866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25058816|NCT03492866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25058817|NCT03492866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058818|NCT03492866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058819|NCT03492827|Chlorhexidine|chlorhexidine|mesh-list
25058820|NCT03492827|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25058821|NCT03492827|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25058822|NCT03492827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25058823|NCT03492827|Disinfectants|disinfectants|mesh-ancestor
25058824|NCT03492827|Dermatologic Agents|dermatologic agents|mesh-ancestor
25058825|NCT03492775|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25058826|NCT03492775|Obinutuzumab|obinutuzumab|mesh-list
24820975|NCT02102789|Protective Agents|protective agents|mesh-ancestor
24508046|NCT00553995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508047|NCT00553995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24508048|NCT00553995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24508049|NCT00554086|Bicalutamide|bicalutamide|mesh-list
24508050|NCT00554086|Androgen Antagonists|androgen antagonists|mesh-ancestor
24508051|NCT00554086|Hormone Antagonists|hormone antagonists|mesh-ancestor
24508052|NCT00554086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24508053|NCT00554086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508054|NCT00554086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508087|NCT00554164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24508088|NCT00554164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508089|NCT00554164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24508090|NCT00554164|Glucocorticoids|glucocorticoids|mesh-ancestor
24508091|NCT00554164|Hormones|hormones|mesh-ancestor
24508092|NCT00554164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24508093|NCT00554164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24884623|NCT00127647|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24884624|NCT00127647|Hormone Antagonists|hormone antagonists|mesh-ancestor
24884625|NCT00127647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24884626|NCT00127647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884627|NCT00127647|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24884628|NCT00127647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24508152|NCT00554398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24508153|NCT00554398|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24508154|NCT00554398|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25058827|NCT03492775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25058828|NCT03492775|Alkylating Agents|alkylating agents|mesh-ancestor
25058829|NCT03492775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058830|NCT03492775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25058831|NCT03492775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25058833|NCT03492736|Antioxidants|antioxidants|mesh-ancestor
24942614|NCT03979248|BMS-986165|bms-986165|mesh-list
24942674|NCT03979105|Anesthetics|anesthetics|mesh-ancestor
25058834|NCT03492736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820990|NCT02102815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508155|NCT00554398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508156|NCT00554398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508158|NCT00554424|Anesthetics, Local|anesthetics, local|mesh-ancestor
24508160|NCT00554424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24508161|NCT00554424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508162|NCT00554424|Sensory System Agents|sensory system agents|mesh-ancestor
24508163|NCT00554424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24508164|NCT00554424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24508166|NCT00554424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24508178|NCT00554476|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24508179|NCT00554476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24508180|NCT00554476|Glucocorticoids|glucocorticoids|mesh-ancestor
24988719|NCT00882895|Prednisolone|prednisolone|mesh-list
24884647|NCT00092144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24884649|NCT00092144|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24884650|NCT03754153|Atropine|atropine|mesh-list
24884651|NCT03754153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24884652|NCT03754153|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24884653|NCT03754153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24884654|NCT03754153|Autonomic Agents|autonomic agents|mesh-ancestor
24508181|NCT00554476|Hormones|hormones|mesh-ancestor
24508182|NCT00554476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24508192|NCT00554476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24508194|NCT00554476|Gout Suppressants|gout suppressants|mesh-ancestor
24508195|NCT00554476|Tocolytic Agents|tocolytic agents|mesh-ancestor
24508196|NCT00554476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24508197|NCT00554476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24508205|NCT00554528|Meloxicam|meloxicam|mesh-list
25058862|NCT03492632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25058863|NCT03492632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058865|NCT03492593|Lycopene|lycopene|mesh-list
25058866|NCT03492593|Carotenoids|carotenoids|mesh-list
25058867|NCT03492593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24508208|NCT00554528|Analgesics|analgesics|mesh-ancestor
24508209|NCT00554528|Sensory System Agents|sensory system agents|mesh-ancestor
24625835|NCT01083875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24508210|NCT00554528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24508211|NCT00554528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058870|NCT03492593|Protective Agents|protective agents|mesh-ancestor
25058871|NCT03492593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058872|NCT03492593|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25058873|NCT03492593|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25058874|NCT03492593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25058875|NCT03492593|Provitamins|provitamins|mesh-ancestor
25058877|NCT03492593|Micronutrients|micronutrients|mesh-ancestor
24884661|NCT03754153|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24884662|NCT03754153|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24884663|NCT03754153|Cholinergic Agents|cholinergic agents|mesh-ancestor
24884664|NCT03754153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24884665|NCT03754153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884667|NCT03753074|Antiviral Agents|antiviral agents|mesh-ancestor
24884668|NCT03753074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24884669|NCT03753074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24884670|NCT03753074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25058893|NCT03492580|Protease Inhibitors|protease inhibitors|mesh-ancestor
25058894|NCT03492580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25058895|NCT03492541|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25058896|NCT03492541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25058897|NCT03492489|Cemiplimab|cemiplimab|mesh-list
25058898|NCT03492489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25058899|NCT03492489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508231|NCT00554632|Contraceptive Agents|contraceptive agents|mesh-ancestor
25058915|NCT03492385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25058916|NCT03492385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058917|NCT03492385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058918|NCT03492255|Mycophenolic Acid|mycophenolic acid|mesh-list
25058920|NCT03492255|Methylprednisolone|methylprednisolone|mesh-list
25058921|NCT03492255|Cyclophosphamide|cyclophosphamide|mesh-list
25058922|NCT03492255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25058923|NCT03492255|Immunologic Factors|immunologic factors|mesh-ancestor
25058924|NCT03492255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25058925|NCT03492255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25058926|NCT03492255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25058927|NCT03492255|Alkylating Agents|alkylating agents|mesh-ancestor
25058928|NCT03492255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25058929|NCT03492255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25058930|NCT03492255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25698545|NCT02095158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25698546|NCT02095158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698547|NCT02095158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698548|NCT02095158|Sympathomimetics|sympathomimetics|mesh-ancestor
25698549|NCT02095158|Autonomic Agents|autonomic agents|mesh-ancestor
25698550|NCT02095158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25058931|NCT03492255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25058932|NCT03492255|Glucocorticoids|glucocorticoids|mesh-ancestor
25058933|NCT03492255|Hormones|hormones|mesh-ancestor
25058934|NCT03492255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25058935|NCT03492255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25058938|NCT03492255|Antitubercular Agents|antitubercular agents|mesh-ancestor
24884681|NCT03746301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884683|NCT03731923|Liver Extracts|liver extracts|mesh-list
24884684|NCT03731923|Hematinics|hematinics|mesh-ancestor
24884685|NCT03727633|Idarubicin|idarubicin|mesh-list
24508232|NCT00554632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24508233|NCT00554632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24508234|NCT00554632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24508235|NCT00554632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24508236|NCT00554632|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24508237|NCT00554658|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24508238|NCT00554658|Antidepressive Agents|antidepressive agents|mesh-ancestor
24508239|NCT00554658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24512783|NCT00576602|Hematinics|hematinics|mesh-ancestor
24508267|NCT00554710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24508275|NCT00554827|Vitamins|vitamins|mesh-list
25058981|NCT03492047|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24508317|NCT00555087|Methyltestosterone|methyltestosterone|mesh-list
24508318|NCT00555087|Testosterone|testosterone|mesh-list
24508319|NCT00555087|Testosterone undecanoate|testosterone undecanoate|mesh-list
24508320|NCT00555087|Testosterone enanthate|testosterone enanthate|mesh-list
24508354|NCT00555139|GABA Modulators|gaba modulators|mesh-ancestor
24508355|NCT00555139|GABA Agents|gaba agents|mesh-ancestor
24508356|NCT00555139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24508357|NCT00555139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508358|NCT00555230|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24884700|NCT03713086|Vaccines|vaccines|mesh-list
24884703|NCT03699540|Ethanol|ethanol|mesh-list
24512881|NCT00577200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24508386|NCT00555334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24508387|NCT00555334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952825|NCT03892161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24952826|NCT03892161|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24952827|NCT03892161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24952828|NCT03892161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24952829|NCT03892161|Antitubercular Agents|antitubercular agents|mesh-ancestor
24952830|NCT03892161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24952831|NCT03892161|Leprostatic Agents|leprostatic agents|mesh-ancestor
24884711|NCT03697876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884713|NCT03697876|Protective Agents|protective agents|mesh-ancestor
24884714|NCT03690765|Dydrogesterone|dydrogesterone|mesh-list
24884715|NCT03690765|Progestins|progestins|mesh-ancestor
24884716|NCT03690765|Hormones|hormones|mesh-ancestor
24884717|NCT03690765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24884718|NCT03690765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884719|NCT03686813|Sildenafil Citrate|sildenafil citrate|mesh-list
24884720|NCT03686813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884721|NCT03686813|Vasodilator Agents|vasodilator agents|mesh-ancestor
24799176|NCT01967524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24952898|NCT03890952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24952899|NCT03890952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24952900|NCT03890952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24952901|NCT03890952|Growth Substances|growth substances|mesh-ancestor
24952902|NCT03890952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952903|NCT03890952|Growth Inhibitors|growth inhibitors|mesh-ancestor
24952904|NCT03890952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24952905|NCT03890952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508419|NCT00555399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24508420|NCT00555399|Alkylating Agents|alkylating agents|mesh-ancestor
24508421|NCT00555399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508446|NCT00555594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24508447|NCT00555594|Growth Substances|growth substances|mesh-ancestor
24508448|NCT00555594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508449|NCT00555594|Growth Inhibitors|growth inhibitors|mesh-ancestor
24508451|NCT00555607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24508452|NCT00555607|Glucocorticoids|glucocorticoids|mesh-ancestor
24508454|NCT00555607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24508455|NCT00555607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508456|NCT00555607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24508457|NCT00555607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508458|NCT00555776|Gabapentin|gabapentin|mesh-list
24508459|NCT00555776|Analgesics|analgesics|mesh-ancestor
24508460|NCT00555776|Sensory System Agents|sensory system agents|mesh-ancestor
24508461|NCT00555776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24508462|NCT00555776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884751|NCT03636451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24884752|NCT03636451|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24884753|NCT03636451|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24884754|NCT03636451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24884755|NCT03636451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884757|NCT03629340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24755745|NCT01728909|Oxytocin|oxytocin|mesh-list
25059041|NCT03491527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059042|NCT03491527|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25059043|NCT03491527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25059044|NCT03491527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25059045|NCT03491527|Antifungal Agents|antifungal agents|mesh-ancestor
25059046|NCT03491527|Keratolytic Agents|keratolytic agents|mesh-ancestor
25059047|NCT03491527|Dermatologic Agents|dermatologic agents|mesh-ancestor
25059048|NCT03491475|Ajmaline|ajmaline|mesh-list
25059049|NCT03491475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25059050|NCT03491475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25059051|NCT03491475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25059052|NCT03491475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25059053|NCT03491475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508488|NCT00555867|Hormone Antagonists|hormone antagonists|mesh-ancestor
24508489|NCT00555867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24508490|NCT00555867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059089|NCT03491098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25059090|NCT03491098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059091|NCT03491098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25059092|NCT03491098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25059094|NCT03491098|Autonomic Agents|autonomic agents|mesh-ancestor
25059095|NCT03491098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25059096|NCT03491098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25059097|NCT03491098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25059098|NCT03491098|Protective Agents|protective agents|mesh-ancestor
25059099|NCT03491098|Dermatologic Agents|dermatologic agents|mesh-ancestor
25059100|NCT03491098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25059101|NCT03491085|Amoxicillin|amoxicillin|mesh-list
25059102|NCT03491085|Clavulanic Acid|clavulanic acid|mesh-list
25059103|NCT03491085|Clavulanic Acids|clavulanic acids|mesh-list
25059104|NCT03491085|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25059105|NCT03491085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25059106|NCT03491085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25059107|NCT03491085|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25059108|NCT03491085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508580|NCT00556127|Antimitotic Agents|antimitotic agents|mesh-ancestor
24884768|NCT03618134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24884769|NCT03618134|Immunologic Factors|immunologic factors|mesh-ancestor
24884770|NCT03618134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518012|NCT00611039|Antiviral Agents|antiviral agents|mesh-ancestor
24989021|NCT05103631|Alkylating Agents|alkylating agents|mesh-ancestor
24989022|NCT05103631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989023|NCT05103631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24989024|NCT05103631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24989025|NCT05103631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24989026|NCT05103631|Antimetabolites|antimetabolites|mesh-ancestor
24542896|NCT00680732|Hematinics|hematinics|mesh-ancestor
24884771|NCT03618134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25038419|NCT05175001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25038420|NCT05175001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25038421|NCT05175001|Respiratory System Agents|respiratory system agents|mesh-ancestor
25038422|NCT05172167|Antibodies|antibodies|mesh-list
25038423|NCT05172167|Immunologic Factors|immunologic factors|mesh-ancestor
25038424|NCT05172167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038425|NCT05164978|Antibodies|antibodies|mesh-list
25038426|NCT05164978|Immunologic Factors|immunologic factors|mesh-ancestor
25038427|NCT05164978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884778|NCT03580161|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
24508527|NCT00556088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508528|NCT00556088|Tubulin Modulators|tubulin modulators|mesh-ancestor
24508529|NCT00556088|Antimitotic Agents|antimitotic agents|mesh-ancestor
24508530|NCT00556088|Mitosis Modulators|mitosis modulators|mesh-ancestor
24508531|NCT00556088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508532|NCT00556088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24508533|NCT00556088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24508534|NCT00556088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24508535|NCT00556088|Growth Substances|growth substances|mesh-ancestor
24508536|NCT00556088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508537|NCT00556088|Growth Inhibitors|growth inhibitors|mesh-ancestor
24508538|NCT00556088|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24884797|NCT03493126|Estradiol|estradiol|mesh-list
24884798|NCT03493126|Estrogens|estrogens|mesh-ancestor
24884799|NCT03493126|Hormones|hormones|mesh-ancestor
24463856|NCT00362544|Antifungal Agents|antifungal agents|mesh-ancestor
24508539|NCT00556088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508540|NCT00556127|Cytarabine|cytarabine|mesh-list
24508541|NCT00556127|Dexamethasone|dexamethasone|mesh-list
25059133|NCT03490825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059134|NCT03490825|Protective Agents|protective agents|mesh-ancestor
25059135|NCT03490825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059136|NCT03490825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25059137|NCT03490708|Tranilast|tranilast|mesh-list
25114654|NCT00390325|Sorafenib|sorafenib|mesh-list
25059155|NCT03490708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25059156|NCT03490617|Misoprostol|misoprostol|mesh-list
25059157|NCT03490617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24508543|NCT00556127|Cyclophosphamide|cyclophosphamide|mesh-list
24508561|NCT00556127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24508562|NCT00556127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24508564|NCT00556127|Autonomic Agents|autonomic agents|mesh-ancestor
24508565|NCT00556127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24508566|NCT00556127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24508567|NCT00556127|Glucocorticoids|glucocorticoids|mesh-ancestor
24508568|NCT00556127|Hormones|hormones|mesh-ancestor
24508569|NCT00556127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24508570|NCT00556127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24508571|NCT00556127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24508572|NCT00556127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24508573|NCT00556127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24508574|NCT00556127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508576|NCT00556127|Antimetabolites|antimetabolites|mesh-ancestor
25059191|NCT03490487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25059192|NCT03490487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25059193|NCT03490487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25059194|NCT03490487|Nootropic Agents|nootropic agents|mesh-ancestor
25698551|NCT02095158|Nasal Decongestants|nasal decongestants|mesh-ancestor
25698552|NCT02095158|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25698553|NCT02095158|Respiratory System Agents|respiratory system agents|mesh-ancestor
25698554|NCT02095158|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25698555|NCT02095158|Mydriatics|mydriatics|mesh-ancestor
25698556|NCT02095158|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25698557|NCT02095158|Protective Agents|protective agents|mesh-ancestor
25698558|NCT02095197|Triamcinolone|triamcinolone|mesh-list
24518177|NCT05330377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24518178|NCT05330377|Antiviral Agents|antiviral agents|mesh-ancestor
24518179|NCT05330377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24518180|NCT05330377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24518184|NCT05330377|Analgesics|analgesics|mesh-ancestor
24508581|NCT00556127|Mitosis Modulators|mitosis modulators|mesh-ancestor
25059195|NCT03490487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421223|NCT00218153|Naltrexone|naltrexone|mesh-list
25059196|NCT03490487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059197|NCT03490487|GABA Agents|gaba agents|mesh-ancestor
25059198|NCT03490487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25059199|NCT03490487|Antimanic Agents|antimanic agents|mesh-ancestor
25059200|NCT03490487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24942921|NCT03976713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25059201|NCT03490487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24943002|NCT03975088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24943003|NCT03975088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24943004|NCT03975088|Growth Substances|growth substances|mesh-ancestor
24943005|NCT03975088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943006|NCT03975088|Growth Inhibitors|growth inhibitors|mesh-ancestor
24943007|NCT03975088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508587|NCT00556153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508590|NCT00556192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508605|NCT00556205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508606|NCT00556257|Cyclosporine|cyclosporine|mesh-list
24508638|NCT00556296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24508639|NCT00556348|Bevacizumab|bevacizumab|mesh-list
24508644|NCT00556348|Growth Substances|growth substances|mesh-ancestor
24508645|NCT00556348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508646|NCT00556348|Growth Inhibitors|growth inhibitors|mesh-ancestor
24508648|NCT00556361|Analgesics|analgesics|mesh-ancestor
24508649|NCT00556361|Sensory System Agents|sensory system agents|mesh-ancestor
24508650|NCT00556361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24508651|NCT00556361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508652|NCT00556361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24508653|NCT00556361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24508654|NCT00556361|Anesthetics, General|anesthetics, general|mesh-ancestor
24508655|NCT00556361|Anesthetics|anesthetics|mesh-ancestor
24508656|NCT00556361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24508657|NCT00556361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24508659|NCT00556361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24943008|NCT03975166|Fluticasone|fluticasone|mesh-list
24943010|NCT03975166|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24508660|NCT00556361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508661|NCT00556387|Ketamine|ketamine|mesh-list
24508662|NCT00556387|Analgesics|analgesics|mesh-ancestor
24508663|NCT00556387|Sensory System Agents|sensory system agents|mesh-ancestor
24508664|NCT00556387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24508665|NCT00556387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508666|NCT00556387|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24508667|NCT00556387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24508668|NCT00556387|Anesthetics, General|anesthetics, general|mesh-ancestor
24508681|NCT00556413|Levoleucovorin|levoleucovorin|mesh-list
24508682|NCT00556413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24508683|NCT00556413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508684|NCT00556413|Antimetabolites|antimetabolites|mesh-ancestor
24508685|NCT00556413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508686|NCT00556413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24508687|NCT00556413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508688|NCT00556413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24508689|NCT00556413|Immunologic Factors|immunologic factors|mesh-ancestor
24508690|NCT00556413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24508691|NCT00556413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24508692|NCT00556413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508720|NCT00556621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25698559|NCT02095197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25698560|NCT02095197|Glucocorticoids|glucocorticoids|mesh-ancestor
25698561|NCT02095197|Hormones|hormones|mesh-ancestor
25698562|NCT02095197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25698563|NCT02095197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698564|NCT02095535|Chlorhexidine|chlorhexidine|mesh-list
25698565|NCT02095535|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25698566|NCT02095535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24989122|NCT04559139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24508721|NCT00556621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24508723|NCT00556621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508724|NCT00556621|Antiviral Agents|antiviral agents|mesh-ancestor
24508725|NCT00556621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24508726|NCT00556621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508727|NCT00556621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24508728|NCT00556621|Immunologic Factors|immunologic factors|mesh-ancestor
24508734|NCT00556634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508735|NCT00556634|Antiviral Agents|antiviral agents|mesh-ancestor
24508736|NCT00556634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24508737|NCT00556634|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24508738|NCT00556634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24508739|NCT00556634|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24508740|NCT00556634|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24508741|NCT00556634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24508742|NCT00556634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24508744|NCT00556699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24508745|NCT00556699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508746|NCT00556699|Immunologic Factors|immunologic factors|mesh-ancestor
25038631|NCT04806386|Psyllium|psyllium|mesh-list
24508770|NCT00557011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24508771|NCT00557011|Dopamine Agents|dopamine agents|mesh-ancestor
24508772|NCT00557011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24508773|NCT00557011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508774|NCT00557011|Adrenergic Agents|adrenergic agents|mesh-ancestor
24508775|NCT00557011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24768093|NCT01805700|Purinergic Agents|purinergic agents|mesh-ancestor
24768094|NCT01805700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24943014|NCT03975166|Autonomic Agents|autonomic agents|mesh-ancestor
24943015|NCT03975166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24943016|NCT03975166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943017|NCT03975166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24943018|NCT03975166|Respiratory System Agents|respiratory system agents|mesh-ancestor
25059237|NCT03490019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25059238|NCT03490019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059239|NCT03489928|Misoprostol|misoprostol|mesh-list
25059240|NCT03489928|Dinoprostone|dinoprostone|mesh-list
25059241|NCT03489928|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25059242|NCT03489928|Abortifacient Agents|abortifacient agents|mesh-ancestor
25059243|NCT03489928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24508781|NCT00557102|Irinotecan|irinotecan|mesh-list
24508782|NCT00557102|Cetuximab|cetuximab|mesh-list
24508783|NCT00557102|Calcium|calcium|mesh-list
24508784|NCT00557102|Levoleucovorin|levoleucovorin|mesh-list
24508785|NCT00557102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24508786|NCT00557102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508787|NCT00557102|Antimetabolites|antimetabolites|mesh-ancestor
24508788|NCT00557102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508789|NCT00557102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24508790|NCT00557102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508791|NCT00557102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24884858|NCT03339284|Dexamethasone|dexamethasone|mesh-list
25059251|NCT03489837|Dipropizine|dipropizine|mesh-list
25059252|NCT03489837|Antitussive Agents|antitussive agents|mesh-ancestor
25059253|NCT03489837|Respiratory System Agents|respiratory system agents|mesh-ancestor
25059254|NCT03489798|Alprostadil|alprostadil|mesh-list
25059255|NCT03489798|Misoprostol|misoprostol|mesh-list
25698567|NCT02095535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25698568|NCT02095535|Disinfectants|disinfectants|mesh-ancestor
25698569|NCT02095535|Dermatologic Agents|dermatologic agents|mesh-ancestor
25698570|NCT02095873|Resveratrol|resveratrol|mesh-list
25698571|NCT02095873|Antioxidants|antioxidants|mesh-ancestor
25698572|NCT02095873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796953|NCT01953445|Tubulin Modulators|tubulin modulators|mesh-ancestor
24796954|NCT01953445|Antimitotic Agents|antimitotic agents|mesh-ancestor
24796955|NCT01953445|Mitosis Modulators|mitosis modulators|mesh-ancestor
24796956|NCT01953445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796961|NCT01953536|Folic Acid|folic acid|mesh-list
24796962|NCT01953536|Paclitaxel|paclitaxel|mesh-list
25059256|NCT03489798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25059257|NCT03489798|Abortifacient Agents|abortifacient agents|mesh-ancestor
25059258|NCT03489798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25059259|NCT03489798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059260|NCT03489798|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25059261|NCT03489798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25059262|NCT03489798|Oxytocics|oxytocics|mesh-ancestor
25059263|NCT03489798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25059264|NCT03489798|Vasodilator Agents|vasodilator agents|mesh-ancestor
25059265|NCT03489798|Urological Agents|urological agents|mesh-ancestor
25059266|NCT03489668|Metformin|metformin|mesh-list
25059267|NCT03489668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25059268|NCT03489668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059269|NCT03489629|Chlorhexidine|chlorhexidine|mesh-list
25059270|NCT03489629|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25059271|NCT03489629|Minocycline|minocycline|mesh-list
24508871|NCT00557544|Ketoprofen|ketoprofen|mesh-list
24508872|NCT00557544|Metoclopramide|metoclopramide|mesh-list
24508873|NCT00557544|Antiemetics|antiemetics|mesh-ancestor
24508874|NCT00557544|Autonomic Agents|autonomic agents|mesh-ancestor
24884866|NCT03339284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24884867|NCT03339284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884868|NCT03339284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24884869|NCT03339284|Glucocorticoids|glucocorticoids|mesh-ancestor
24884871|NCT03339284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24884872|NCT03339284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24884873|NCT03339284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24756657|NCT01735006|Vaccines|vaccines|mesh-list
24884874|NCT03339284|Anesthetics, Local|anesthetics, local|mesh-ancestor
24884875|NCT03339284|Anesthetics|anesthetics|mesh-ancestor
24884882|NCT03316586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24884884|NCT03316586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24508875|NCT00557544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24508876|NCT00557544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059300|NCT03489395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25059301|NCT03489395|Antithrombins|antithrombins|mesh-ancestor
25059302|NCT03489395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25059303|NCT03489395|Protease Inhibitors|protease inhibitors|mesh-ancestor
25059304|NCT03489395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059305|NCT03489395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059306|NCT03489395|Anticoagulants|anticoagulants|mesh-ancestor
25059307|NCT03489317|Metformin|metformin|mesh-list
24508917|NCT00557739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24508918|NCT00557739|Dermatologic Agents|dermatologic agents|mesh-ancestor
24508919|NCT00557739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24508920|NCT00557739|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24508921|NCT00557739|Antidepressive Agents|antidepressive agents|mesh-ancestor
24508922|NCT00557739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24508923|NCT00557739|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24884886|NCT03301857|Denosumab|denosumab|mesh-list
25059327|NCT03489239|Antiviral Agents|antiviral agents|mesh-ancestor
25059328|NCT03489239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24821551|NCT02106468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24821552|NCT02106481|Ropivacaine|ropivacaine|mesh-list
24821553|NCT02106481|Anesthetics, Local|anesthetics, local|mesh-ancestor
24821554|NCT02106481|Anesthetics|anesthetics|mesh-ancestor
24508986|NCT00557960|Amphetamine|amphetamine|mesh-list
24508987|NCT00557960|Adderall|adderall|mesh-list
24508988|NCT00557960|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24508989|NCT00557960|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24508990|NCT00557960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25698573|NCT02095873|Protective Agents|protective agents|mesh-ancestor
25698574|NCT02095873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698575|NCT02095873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25698576|NCT02095873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25698577|NCT02095951|Ethanol|ethanol|mesh-list
25698578|NCT02095951|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25698579|NCT02095951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25698580|NCT02095951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24520885|NCT05246007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24509084|NCT00558337|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24612379|NCT01013571|Insulin glulisine|insulin glulisine|mesh-list
24612380|NCT01013571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24612381|NCT01013571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612382|NCT01013584|Cholecalciferol|cholecalciferol|mesh-list
25059376|NCT03488719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059377|NCT03488719|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25059378|NCT03488719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25059379|NCT03488719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25059380|NCT03488719|Adrenergic Agents|adrenergic agents|mesh-ancestor
25059381|NCT03488719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25059438|NCT03487874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059439|NCT03487874|Sensory System Agents|sensory system agents|mesh-ancestor
25059440|NCT03487874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25059441|NCT03487809|Budesonide|budesonide|mesh-list
25059442|NCT03487809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24821659|NCT02107118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24821660|NCT02107118|Immunologic Factors|immunologic factors|mesh-ancestor
24821661|NCT02107118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821662|NCT02107144|Trimetazidine|trimetazidine|mesh-list
24821663|NCT02107144|Vasodilator Agents|vasodilator agents|mesh-ancestor
24821665|NCT02107170|Propofol|propofol|mesh-list
24509126|NCT00558662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24509127|NCT00558662|Coccidiostats|coccidiostats|mesh-ancestor
24509128|NCT00558662|Proton Ionophores|proton ionophores|mesh-ancestor
24509129|NCT00558662|Uncoupling Agents|uncoupling agents|mesh-ancestor
24509130|NCT00558662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623458|NCT01071525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25059443|NCT03487809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25059444|NCT03487809|Autonomic Agents|autonomic agents|mesh-ancestor
25059445|NCT03487809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25059446|NCT03487809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821685|NCT02107365|Interferons|interferons|mesh-list
24509131|NCT00558662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509137|NCT00558818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24509139|NCT00558883|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24509140|NCT00558883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24509141|NCT00558883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509142|NCT00558883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24509143|NCT00558883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509145|NCT00558961|Chlorambucil|chlorambucil|mesh-list
24623495|NCT01071889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623496|NCT01071889|GABA Modulators|gaba modulators|mesh-ancestor
24623497|NCT01071889|GABA Agents|gaba agents|mesh-ancestor
24623498|NCT01071889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24623499|NCT01071889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816370|NCT02076659|Immunologic Factors|immunologic factors|mesh-ancestor
24816371|NCT02076659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24943310|NCT03972683|Respiratory System Agents|respiratory system agents|mesh-ancestor
24943311|NCT03972683|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24943312|NCT03972683|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24952913|NCT03891121|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25059449|NCT03487809|Glucocorticoids|glucocorticoids|mesh-ancestor
25059450|NCT03487809|Hormones|hormones|mesh-ancestor
25059455|NCT03487783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25059473|NCT03487770|Antidepressive Agents|antidepressive agents|mesh-ancestor
25059474|NCT03487770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25059475|NCT03487770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25059476|NCT03487770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25059477|NCT03487770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25698581|NCT02095951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698582|NCT02096003|Morphine|morphine|mesh-list
25698583|NCT02096003|Hydromorphone|hydromorphone|mesh-list
25698584|NCT02096003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25698585|NCT02096003|Narcotics|narcotics|mesh-ancestor
25698586|NCT02096003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25698587|NCT02096003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698588|NCT02096003|Analgesics|analgesics|mesh-ancestor
25698589|NCT02096003|Sensory System Agents|sensory system agents|mesh-ancestor
25059478|NCT03487770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059480|NCT03487770|Dopamine Agents|dopamine agents|mesh-ancestor
25059481|NCT03487770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25059482|NCT03487770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059483|NCT03487770|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24821753|NCT02107729|Sensory System Agents|sensory system agents|mesh-ancestor
24509228|NCT00559429|Sensory System Agents|sensory system agents|mesh-ancestor
24509229|NCT00559429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24509242|NCT00559455|Protective Agents|protective agents|mesh-ancestor
24509243|NCT00559455|Vitamin B Complex|vitamin b complex|mesh-ancestor
24509244|NCT00559455|Vitamins|vitamins|mesh-ancestor
24509245|NCT00559455|Micronutrients|micronutrients|mesh-ancestor
24509246|NCT00559481|Ketoconazole|ketoconazole|mesh-list
24509247|NCT00559481|Dexamethasone|dexamethasone|mesh-list
24509248|NCT00559481|Hydrocortisone|hydrocortisone|mesh-list
24509249|NCT00559481|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24509250|NCT00559481|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24509251|NCT00559481|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24509252|NCT00559481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24509253|NCT00559481|Antiemetics|antiemetics|mesh-ancestor
24509254|NCT00559481|Autonomic Agents|autonomic agents|mesh-ancestor
24509255|NCT00559481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24509256|NCT00559481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509276|NCT00559546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24509277|NCT00559546|Respiratory System Agents|respiratory system agents|mesh-ancestor
24509278|NCT00559546|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24509279|NCT00559546|Hormone Antagonists|hormone antagonists|mesh-ancestor
24509280|NCT00559546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24509281|NCT00559546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884920|NCT03207347|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24884922|NCT03207347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884923|NCT03207347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24884925|NCT03193333|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24884926|NCT03193333|Dorzolamide|dorzolamide|mesh-list
24884927|NCT03193333|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25059484|NCT03487770|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25059485|NCT03487770|Serotonin Agents|serotonin agents|mesh-ancestor
25059516|NCT03487406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059517|NCT03487406|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25059518|NCT03487406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25059519|NCT03487406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059520|NCT03487406|Antipyretics|antipyretics|mesh-ancestor
25059521|NCT03487406|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25059522|NCT03487406|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25059523|NCT03487406|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25059524|NCT03487406|Purinergic Agents|purinergic agents|mesh-ancestor
25059525|NCT03487406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25059526|NCT03487354|Misoprostol|misoprostol|mesh-list
25059527|NCT03487354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25059540|NCT03487211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25059541|NCT03487211|Serotonin Agents|serotonin agents|mesh-ancestor
25059542|NCT03487211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059543|NCT03487211|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24884931|NCT03193333|Adrenergic Agents|adrenergic agents|mesh-ancestor
24884932|NCT03193333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24884933|NCT03193333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884943|NCT03142334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24884944|NCT03142334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24884945|NCT03110744|Palbociclib|palbociclib|mesh-list
24884946|NCT03110744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24884947|NCT03110744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24509303|NCT00559676|Antidotes|antidotes|mesh-ancestor
24509304|NCT00559676|Protective Agents|protective agents|mesh-ancestor
24509305|NCT00559676|Vitamin B Complex|vitamin b complex|mesh-ancestor
24509307|NCT00559676|Micronutrients|micronutrients|mesh-ancestor
24509308|NCT00559689|Budesonide|budesonide|mesh-list
25059553|NCT03487198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25059554|NCT03487198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059555|NCT03487198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059556|NCT03487198|Dopamine Agonists|dopamine agonists|mesh-ancestor
25059557|NCT03487198|Dopamine Agents|dopamine agents|mesh-ancestor
25059558|NCT03487172|Mannitol|mannitol|mesh-list
25698590|NCT02096003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24797016|NCT01953744|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24797017|NCT01953744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25107314|NCT03140553|Mitosis Modulators|mitosis modulators|mesh-ancestor
24797043|NCT01953770|Hormones|hormones|mesh-ancestor
25059559|NCT03487172|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25059560|NCT03487172|Diuretics|diuretics|mesh-ancestor
25059561|NCT03487172|Natriuretic Agents|natriuretic agents|mesh-ancestor
24625852|NCT01083992|Vitamin D|vitamin d|mesh-list
24625854|NCT01083992|Vitamins|vitamins|mesh-ancestor
24509372|NCT00560079|Antioxidants|antioxidants|mesh-ancestor
24509373|NCT00560079|Protective Agents|protective agents|mesh-ancestor
24757772|NCT01742390|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24509374|NCT00560079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509375|NCT00560079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24509376|NCT00560079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24509377|NCT00560079|Vasodilator Agents|vasodilator agents|mesh-ancestor
24509378|NCT00560092|Magnesium Sulfate|magnesium sulfate|mesh-list
24509380|NCT00560092|Sensory System Agents|sensory system agents|mesh-ancestor
24884972|NCT03090997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884973|NCT03090997|Protective Agents|protective agents|mesh-ancestor
24884974|NCT03090997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24884975|NCT03090997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24509399|NCT00560170|Ezetimibe|ezetimibe|mesh-list
24509400|NCT00560170|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
24509426|NCT00560300|Calcitriol|calcitriol|mesh-list
24884991|NCT02970500|Dopamine Agents|dopamine agents|mesh-ancestor
24884992|NCT02970500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24884993|NCT02969928|Amoxicillin|amoxicillin|mesh-list
24884994|NCT02969928|Metronidazole|metronidazole|mesh-list
24884995|NCT02969928|Clarithromycin|clarithromycin|mesh-list
24884996|NCT02969928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24884997|NCT02969928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24884998|NCT02969928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24884999|NCT02969928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24885004|NCT02969928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25059626|NCT03486925|Oxytocics|oxytocics|mesh-ancestor
25059627|NCT03486925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25059628|NCT03486925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059629|NCT03486626|Metformin|metformin|mesh-list
25059630|NCT03486626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25059631|NCT03486626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059632|NCT03486561|Ranolazine|ranolazine|mesh-list
24885015|NCT02968446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24885016|NCT02968446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885018|NCT02955758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24509449|NCT00560326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24509450|NCT00560326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059642|NCT03486548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25059643|NCT03486548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059644|NCT03486548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25059645|NCT03486548|Glucocorticoids|glucocorticoids|mesh-ancestor
25059684|NCT03486184|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25059685|NCT03486184|Protease Inhibitors|protease inhibitors|mesh-ancestor
25059686|NCT03486184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059687|NCT03486184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509474|NCT00560443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24509479|NCT00560443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24509480|NCT00560495|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
24509482|NCT00560495|Chelating Agents|chelating agents|mesh-ancestor
25059709|NCT03485846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059710|NCT03485846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25059711|NCT03485846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25698591|NCT02096029|Nicotine|nicotine|mesh-list
25698592|NCT02096029|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25698593|NCT02096029|Autonomic Agents|autonomic agents|mesh-ancestor
25698594|NCT02096029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25059712|NCT03485846|Antiviral Agents|antiviral agents|mesh-ancestor
25059713|NCT03485846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25698595|NCT02096029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989519|NCT05133531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989522|NCT05132699|Anticonvulsants|anticonvulsants|mesh-ancestor
24543403|NCT00683436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543404|NCT00683436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24543405|NCT00683436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24863566|NCT04355728|Calcium heparin|calcium heparin|mesh-list
24863567|NCT04355728|Anticoagulants|anticoagulants|mesh-ancestor
25059714|NCT03485846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25059715|NCT03485846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24509522|NCT00560690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24509523|NCT00560690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509524|NCT00560690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509526|NCT00560690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24509553|NCT00561054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509554|NCT00561067|Methylprednisolone|methylprednisolone|mesh-list
24509555|NCT00561067|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24509556|NCT00561067|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24509557|NCT00561067|Prednisolone|prednisolone|mesh-list
24509566|NCT00561067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509567|NCT00561067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24509568|NCT00561067|Glucocorticoids|glucocorticoids|mesh-ancestor
24509569|NCT00561067|Hormones|hormones|mesh-ancestor
24509571|NCT00561067|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24509572|NCT00561067|Protective Agents|protective agents|mesh-ancestor
24509573|NCT00561067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24509574|NCT00561067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509576|NCT00561093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24509577|NCT00561093|Pentoxifylline|pentoxifylline|mesh-list
24509578|NCT00561093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24509579|NCT00561093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24509580|NCT00561093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509581|NCT00561093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24509582|NCT00561093|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24509583|NCT00561093|Protective Agents|protective agents|mesh-ancestor
24509613|NCT00561119|Immunologic Factors|immunologic factors|mesh-ancestor
24509614|NCT00561119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509615|NCT00561132|Vanadyl sulfate|vanadyl sulfate|mesh-list
24885061|NCT02710331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24885062|NCT02710331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24885063|NCT02710331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24885064|NCT02710331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885065|NCT02710331|Hallucinogens|hallucinogens|mesh-ancestor
24885066|NCT02710331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24885067|NCT02710331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24885068|NCT02710331|Analgesics|analgesics|mesh-ancestor
24885069|NCT02710331|Sensory System Agents|sensory system agents|mesh-ancestor
24885070|NCT02710331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24885071|NCT02710331|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24885072|NCT02710331|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24885073|NCT02710331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24509636|NCT00561223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24509645|NCT00561327|Losartan|losartan|mesh-list
25059740|NCT03485625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059741|NCT03485482|Bisoprolol|bisoprolol|mesh-list
25059742|NCT03485482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25059743|NCT03485482|Sympatholytics|sympatholytics|mesh-ancestor
25059744|NCT03485482|Autonomic Agents|autonomic agents|mesh-ancestor
25059745|NCT03485482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25059746|NCT03485482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698596|NCT02096029|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25698597|NCT02096029|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25698598|NCT02096029|Cholinergic Agents|cholinergic agents|mesh-ancestor
25698599|NCT02096029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25698600|NCT02096029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698601|NCT02096081|Botulinum Toxins|botulinum toxins|mesh-list
25698602|NCT02096081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25698603|NCT02096081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24989646|NCT04959760|Immunoglobulin G|immunoglobulin g|mesh-list
24989647|NCT04959760|Immunologic Factors|immunologic factors|mesh-ancestor
24989648|NCT04959760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989649|NCT04944771|Rabeprazole|rabeprazole|mesh-list
24509669|NCT00561522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24509670|NCT00561522|Antimetabolites|antimetabolites|mesh-ancestor
24509735|NCT00561899|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24509737|NCT00561899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24509747|NCT00562055|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24509748|NCT00562055|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24509749|NCT00562055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24509791|NCT00562172|Metformin|metformin|mesh-list
24885124|NCT02591147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885125|NCT02527798|Furosemide|furosemide|mesh-list
24885126|NCT02527798|Diuretics|diuretics|mesh-ancestor
24885127|NCT02527798|Natriuretic Agents|natriuretic agents|mesh-ancestor
24464182|NCT00363727|Ropinirole|ropinirole|mesh-list
24509803|NCT00562185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24509804|NCT00562185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24509805|NCT00562185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24509806|NCT00562185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510043|NCT00563160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24509809|NCT00562198|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24509811|NCT00562198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24509812|NCT00562198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24509813|NCT00562198|Dopamine Agents|dopamine agents|mesh-ancestor
24509814|NCT00562198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24509849|NCT00562289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24509861|NCT00562289|Purinergic Agents|purinergic agents|mesh-ancestor
24509862|NCT00562289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24509863|NCT00562289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24509864|NCT00562289|Antithrombins|antithrombins|mesh-ancestor
24509865|NCT00562289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24509872|NCT00562406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24509873|NCT00562406|Growth Substances|growth substances|mesh-ancestor
24509874|NCT00562406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509875|NCT00562406|Growth Inhibitors|growth inhibitors|mesh-ancestor
24509876|NCT00562406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509877|NCT00562419|Irinotecan|irinotecan|mesh-list
24943712|NCT03967392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24943713|NCT03967392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24943714|NCT03967392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24943715|NCT03967392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24943716|NCT03967392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943720|NCT03967171|Oxytocin|oxytocin|mesh-list
24943721|NCT03967171|Oxytocics|oxytocics|mesh-ancestor
24943722|NCT03967171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24943723|NCT03967171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943724|NCT03967496|Metformin|metformin|mesh-list
24943725|NCT03967496|Amlodipine|amlodipine|mesh-list
24943726|NCT03967496|Lisinopril|lisinopril|mesh-list
24943727|NCT03967496|Bisoprolol|bisoprolol|mesh-list
24952914|NCT03891121|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24952915|NCT03891121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24952941|NCT03890341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25059777|NCT03485404|Vitamin B 12|vitamin b 12|mesh-list
24758578|NCT01746875|Verteporfin|verteporfin|mesh-list
24758579|NCT01746875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25698604|NCT02096081|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25698605|NCT02096081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25698606|NCT02096081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25698607|NCT02096081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698608|NCT02096081|Cholinergic Agents|cholinergic agents|mesh-ancestor
25698609|NCT02096081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25698610|NCT02096081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698611|NCT02096081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25698612|NCT02096081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25698613|NCT02096107|Everolimus|everolimus|mesh-list
25698614|NCT02096107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25698615|NCT02096107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25698616|NCT02096107|Immunologic Factors|immunologic factors|mesh-ancestor
24758580|NCT01746875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24758581|NCT01746875|Growth Substances|growth substances|mesh-ancestor
24758582|NCT01746875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509889|NCT00562458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509890|NCT00562458|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24509891|NCT00562458|Hormone Antagonists|hormone antagonists|mesh-ancestor
24509892|NCT00562458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24509952|NCT00562913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24509953|NCT00562913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509954|NCT00562939|Vaccines|vaccines|mesh-list
24509955|NCT00562939|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24509956|NCT00562939|Immunologic Factors|immunologic factors|mesh-ancestor
24885172|NCT01907360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885173|NCT01907360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24885174|NCT01907360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24885175|NCT01907360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24885176|NCT01907360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885185|NCT01873170|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
24885186|NCT01873170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24885187|NCT01873170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816376|NCT02076685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24816377|NCT02076685|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24510020|NCT00563095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24510021|NCT00563108|Basiliximab|basiliximab|mesh-list
24510022|NCT00563108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24510023|NCT00563108|Immunologic Factors|immunologic factors|mesh-ancestor
24510039|NCT00563160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510040|NCT00563160|Antiviral Agents|antiviral agents|mesh-ancestor
24510041|NCT00563160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24510042|NCT00563160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510044|NCT00563160|Immunologic Factors|immunologic factors|mesh-ancestor
24510045|NCT00563160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510046|NCT00563212|Interferons|interferons|mesh-list
24510047|NCT00563212|Interferon-gamma|interferon-gamma|mesh-list
24816378|NCT02076685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24816379|NCT02076685|Antimetabolites|antimetabolites|mesh-ancestor
24816381|NCT02076685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24510084|NCT00563394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24510085|NCT00563394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24510086|NCT00563394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510087|NCT00563394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510088|NCT00563394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510089|NCT00563394|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24510090|NCT00563394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24510091|NCT00563433|Ofloxacin|ofloxacin|mesh-list
24510092|NCT00563433|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24510093|NCT00563433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24510094|NCT00563433|Renal Agents|renal agents|mesh-ancestor
24510095|NCT00563433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24510096|NCT00563433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24510097|NCT00563433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24510098|NCT00563433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510099|NCT00563433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510106|NCT00563472|Progesterone|progesterone|mesh-list
24510107|NCT00563472|Progestins|progestins|mesh-ancestor
24510108|NCT00563472|Hormones|hormones|mesh-ancestor
24510109|NCT00563472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24510110|NCT00563472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510111|NCT00563472|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24816387|NCT02076750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24816388|NCT02076750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24816389|NCT02076815|Anagrelide|anagrelide|mesh-list
24816390|NCT02076815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24816391|NCT02076815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24816392|NCT02076815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885188|NCT01873170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24885189|NCT01873170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24529839|NCT00627965|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24530229|NCT00629473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24530230|NCT00629473|Glucocorticoids|glucocorticoids|mesh-ancestor
24885190|NCT01873170|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24885191|NCT01873170|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24464248|NCT00363909|Parasympatholytics|parasympatholytics|mesh-ancestor
24510169|NCT00563654|Adrenergic Agents|adrenergic agents|mesh-ancestor
24510170|NCT00563654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24510171|NCT00563654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510172|NCT00563654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510173|NCT00563654|Urological Agents|urological agents|mesh-ancestor
24510174|NCT00563758|Tegaserod|tegaserod|mesh-list
24510175|NCT00563758|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24510176|NCT00563758|Serotonin Agents|serotonin agents|mesh-ancestor
24510180|NCT00563771|Rasburicase|rasburicase|mesh-list
25059817|NCT03484754|Botulinum Toxins|botulinum toxins|mesh-list
25059818|NCT03484754|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25059819|NCT03484754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25059820|NCT03484754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059821|NCT03484754|Cholinergic Agents|cholinergic agents|mesh-ancestor
25059822|NCT03484754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25059823|NCT03484754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059825|NCT03484650|Anesthetics, Local|anesthetics, local|mesh-ancestor
25059826|NCT03484650|Anesthetics|anesthetics|mesh-ancestor
25059827|NCT03484650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24758778|NCT01747720|Vitamin D|vitamin d|mesh-list
24620048|NCT01055301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24620049|NCT01055301|Glucocorticoids|glucocorticoids|mesh-ancestor
24510282|NCT00564174|Aspirin|aspirin|mesh-list
24510283|NCT00564174|Heparin|heparin|mesh-list
24510284|NCT00564174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24510285|NCT00564174|Tinzaparin|tinzaparin|mesh-list
24510286|NCT00564174|Dalteparin|dalteparin|mesh-list
24510287|NCT00564174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24510289|NCT00564174|Analgesics|analgesics|mesh-ancestor
24510358|NCT00564408|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24510359|NCT00564408|Cholinergic Agents|cholinergic agents|mesh-ancestor
25059834|NCT03484650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25059835|NCT03484650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059836|NCT03484611|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25059838|NCT03484611|Menotropins|menotropins|mesh-list
25059839|NCT03484611|Progesterone|progesterone|mesh-list
25059840|NCT03484611|Progestins|progestins|mesh-ancestor
25059841|NCT03484611|Hormones|hormones|mesh-ancestor
25059842|NCT03484611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25059843|NCT03484611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059844|NCT03484611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25059845|NCT03484611|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25059846|NCT03484611|Fertility Agents|fertility agents|mesh-ancestor
25059847|NCT03484611|Hormone Antagonists|hormone antagonists|mesh-ancestor
25059848|NCT03484507|Chlorhexidine|chlorhexidine|mesh-list
25059849|NCT03484507|Povidone-Iodine|povidone-iodine|mesh-list
25059850|NCT03484507|Prednisolone|prednisolone|mesh-list
25059851|NCT03484507|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24822171|NCT02110303|Ticagrelor|ticagrelor|mesh-list
24510360|NCT00564408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24510371|NCT00564460|Hormone Antagonists|hormone antagonists|mesh-ancestor
24510372|NCT00564460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25698617|NCT02096107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698618|NCT02096263|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25698619|NCT02096263|Immunologic Factors|immunologic factors|mesh-ancestor
24510373|NCT00564460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510374|NCT00564460|Urological Agents|urological agents|mesh-ancestor
24510375|NCT00564512|Cyclophosphamide|cyclophosphamide|mesh-list
25698620|NCT02096263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698621|NCT02096458|Dexlansoprazole|dexlansoprazole|mesh-list
25698622|NCT02096458|Lansoprazole|lansoprazole|mesh-list
25698623|NCT02096458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25698624|NCT02096458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25698625|NCT02096458|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25698626|NCT02096458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864016|NCT02229149|Pertuzumab|pertuzumab|mesh-list
24864017|NCT02229149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24864018|NCT02229149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531296|NCT00634959|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24531297|NCT00634959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510391|NCT00564525|Antidepressive Agents|antidepressive agents|mesh-ancestor
24510392|NCT00564525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24510393|NCT00564525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24510394|NCT00564525|Analgesics|analgesics|mesh-ancestor
24510395|NCT00564525|Sensory System Agents|sensory system agents|mesh-ancestor
24510396|NCT00564525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24885243|NCT01380028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24885244|NCT01380028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885246|NCT01305460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24885247|NCT01305460|Antimetabolites|antimetabolites|mesh-ancestor
24885248|NCT01305460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885249|NCT01305460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885250|NCT01305460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885251|NCT01300143|Chlorotrianisene|chlorotrianisene|mesh-list
24464299|NCT00364143|Irinotecan|irinotecan|mesh-list
24464720|NCT00366236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24510399|NCT00564525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24510400|NCT00564525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24510401|NCT00564525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510402|NCT00564525|Adrenergic Agents|adrenergic agents|mesh-ancestor
24510403|NCT00564525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25059852|NCT03484507|Methylprednisolone|methylprednisolone|mesh-list
25059853|NCT03484507|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25059854|NCT03484507|Prednisolone acetate|prednisolone acetate|mesh-list
25059855|NCT03484507|Povidone|povidone|mesh-list
25059856|NCT03484507|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25059857|NCT03484507|Prednisolone phosphate|prednisolone phosphate|mesh-list
25059858|NCT03484507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25059859|NCT03484507|Glucocorticoids|glucocorticoids|mesh-ancestor
25059860|NCT03484507|Hormones|hormones|mesh-ancestor
25059861|NCT03484507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25059862|NCT03484507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059863|NCT03484507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25059864|NCT03484507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25059865|NCT03484507|Antiemetics|antiemetics|mesh-ancestor
25059866|NCT03484507|Autonomic Agents|autonomic agents|mesh-ancestor
25059867|NCT03484507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25059868|NCT03484507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25059869|NCT03484507|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25059870|NCT03484507|Protective Agents|protective agents|mesh-ancestor
25059871|NCT03484507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25059882|NCT03484416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25059883|NCT03484416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25059884|NCT03484416|Antacids|antacids|mesh-ancestor
25059885|NCT03484416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059886|NCT03484416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25059887|NCT03484299|Gemcitabine|gemcitabine|mesh-list
25059888|NCT03484299|Folfirinox|folfirinox|mesh-list
25059889|NCT03484299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25059890|NCT03484299|Antimetabolites|antimetabolites|mesh-ancestor
25059891|NCT03484299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059892|NCT03484299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25059893|NCT03484299|Antiviral Agents|antiviral agents|mesh-ancestor
25059894|NCT03484299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25059895|NCT03484299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059896|NCT03484299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25059897|NCT03484299|Immunologic Factors|immunologic factors|mesh-ancestor
25059898|NCT03484299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059899|NCT03484260|Testosterone|testosterone|mesh-list
25698627|NCT02096458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698628|NCT02096575|Nitrous Oxide|nitrous oxide|mesh-list
25698629|NCT02096575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25698630|NCT02096575|Anesthetics, General|anesthetics, general|mesh-ancestor
25698631|NCT02096575|Anesthetics|anesthetics|mesh-ancestor
25698632|NCT02096575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25698633|NCT02096575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864048|NCT01802086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24864049|NCT01802086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24864050|NCT01802086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864051|NCT01802086|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25059900|NCT03484260|Androgens|androgens|mesh-ancestor
25059901|NCT03484260|Hormones|hormones|mesh-ancestor
25059902|NCT03484260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25059903|NCT03484260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059904|NCT03484221|Fluorouracil|fluorouracil|mesh-list
25059905|NCT03484221|Capecitabine|capecitabine|mesh-list
25059911|NCT03484221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25059912|NCT03484221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25059913|NCT03484221|Immunologic Factors|immunologic factors|mesh-ancestor
25059914|NCT03484221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059915|NCT03484221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25059916|NCT03484221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25059917|NCT03484221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059918|NCT03484195|Fluorouracil|fluorouracil|mesh-list
25059919|NCT03484195|Oxaliplatin|oxaliplatin|mesh-list
25059920|NCT03484195|Irinotecan|irinotecan|mesh-list
25059921|NCT03484195|Antimetabolites|antimetabolites|mesh-ancestor
25059922|NCT03484195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25059923|NCT03484195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24948337|NCT03920150|Vitamin D|vitamin d|mesh-list
25059927|NCT03484195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059928|NCT03484195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25059929|NCT03484195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25059930|NCT03484195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25059932|NCT03484091|Viscosupplements|viscosupplements|mesh-ancestor
24510417|NCT00564551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25040549|NCT03012165|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25040550|NCT03012165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25040551|NCT03011450|Fenofibrate|fenofibrate|mesh-list
24510418|NCT00564564|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24510419|NCT00564564|Clomipramine|clomipramine|mesh-list
24510420|NCT00564564|Antidepressive Agents|antidepressive agents|mesh-ancestor
24510421|NCT00564564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24510422|NCT00564564|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24510423|NCT00564564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24510424|NCT00564564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24510425|NCT00564564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510446|NCT00564603|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24510452|NCT00564603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510453|NCT00564603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24510454|NCT00564603|Glucocorticoids|glucocorticoids|mesh-ancestor
24510455|NCT00564603|Hormones|hormones|mesh-ancestor
24510456|NCT00564603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24510457|NCT00564603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24510458|NCT00564603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510459|NCT00564603|Protease Inhibitors|protease inhibitors|mesh-ancestor
25059959|NCT03483870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25059960|NCT03483870|Analgesics|analgesics|mesh-ancestor
25059961|NCT03483870|Sensory System Agents|sensory system agents|mesh-ancestor
25059962|NCT03483870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25059963|NCT03483870|Antiemetics|antiemetics|mesh-ancestor
25059964|NCT03483870|Autonomic Agents|autonomic agents|mesh-ancestor
25059965|NCT03483870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25059967|NCT03483870|Serotonin Agents|serotonin agents|mesh-ancestor
24510465|NCT00564642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24510466|NCT00564642|Expectorants|expectorants|mesh-ancestor
24510467|NCT00564642|Respiratory System Agents|respiratory system agents|mesh-ancestor
24510468|NCT00564642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24510469|NCT00564642|Antioxidants|antioxidants|mesh-ancestor
24510470|NCT00564642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510471|NCT00564642|Protective Agents|protective agents|mesh-ancestor
25698634|NCT02096575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25698635|NCT02096575|Analgesics|analgesics|mesh-ancestor
25698636|NCT02096575|Sensory System Agents|sensory system agents|mesh-ancestor
25698637|NCT02096575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25698638|NCT02096679|Osimertinib|osimertinib|mesh-list
25698639|NCT02096679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25698640|NCT02096679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25698641|NCT02096679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24990238|NCT03403205|Lipotropic Agents|lipotropic agents|mesh-ancestor
24813869|NCT02060669|Capecitabine|capecitabine|mesh-list
24785349|NCT01913964|Acetylcarnitine|acetylcarnitine|mesh-list
24837698|NCT02192723|Autonomic Agents|autonomic agents|mesh-ancestor
24990324|NCT03256045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990325|NCT03256045|Protease Inhibitors|protease inhibitors|mesh-ancestor
24990326|NCT03256045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885280|NCT01123707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24885281|NCT01123707|Dopamine Agonists|dopamine agonists|mesh-ancestor
24885282|NCT01123707|Dopamine Agents|dopamine agents|mesh-ancestor
25698642|NCT02096679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698643|NCT02096705|Dapagliflozin|dapagliflozin|mesh-list
25698644|NCT02096705|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24885283|NCT01123707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24510514|NCT00564720|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24510515|NCT00564720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24510516|NCT00564720|Antimetabolites|antimetabolites|mesh-ancestor
24510517|NCT00564720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510518|NCT00564720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510519|NCT00564720|Antiviral Agents|antiviral agents|mesh-ancestor
24510520|NCT00564720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24510521|NCT00564720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510522|NCT00564720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24510523|NCT00564720|Immunologic Factors|immunologic factors|mesh-ancestor
24510524|NCT00564720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510608|NCT00565162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510610|NCT00565175|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24510611|NCT00565175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24510612|NCT00565175|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24510624|NCT00565188|Vasodilator Agents|vasodilator agents|mesh-ancestor
24510625|NCT00565188|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24510626|NCT00565188|Purinergic Agonists|purinergic agonists|mesh-ancestor
24885306|NCT00725127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24885307|NCT00725127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24885308|NCT00725127|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24885309|NCT00725127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24885310|NCT00725127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885311|NCT00725127|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24885312|NCT00725127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24885313|NCT00725127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885315|NCT00476554|Sapacitabine|sapacitabine|mesh-list
24885316|NCT00476554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885317|NCT00462943|Homoharringtonine|homoharringtonine|mesh-list
24885318|NCT00462943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24511123|NCT00567528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24885319|NCT00462943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885320|NCT00462943|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24510627|NCT00565188|Purinergic Agents|purinergic agents|mesh-ancestor
24510643|NCT00565227|Antimitotic Agents|antimitotic agents|mesh-ancestor
24510644|NCT00565227|Mitosis Modulators|mitosis modulators|mesh-ancestor
24510645|NCT00565227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510655|NCT00565240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510656|NCT00565240|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24510657|NCT00565240|Hormone Antagonists|hormone antagonists|mesh-ancestor
24510658|NCT00565240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24510659|NCT00565240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510660|NCT00565240|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24510661|NCT00565240|Contraceptive Agents|contraceptive agents|mesh-ancestor
24510662|NCT00565240|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24510663|NCT00565240|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24510664|NCT00565240|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24510665|NCT00565240|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24885322|NCT00462943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885324|NCT00372073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885325|NCT00372073|Antiviral Agents|antiviral agents|mesh-ancestor
25698645|NCT02096705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698646|NCT02096705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25698647|NCT02096705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698648|NCT02096718|Afatinib|afatinib|mesh-list
25698649|NCT02096718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25698650|NCT02096718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25698651|NCT02096718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885326|NCT00372073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24885327|NCT00372073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24885328|NCT00372073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885329|NCT00372073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885330|NCT00248287|Carboplatin|carboplatin|mesh-list
24885331|NCT00248287|Irinotecan|irinotecan|mesh-list
24885332|NCT00248287|Cetuximab|cetuximab|mesh-list
24885333|NCT00248287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885334|NCT00248287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24510684|NCT00565292|Anacetrapib|anacetrapib|mesh-list
25060025|NCT03483350|Midazolam|midazolam|mesh-list
25060026|NCT03483350|Granisetron|granisetron|mesh-list
25060027|NCT03483350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25060028|NCT03483350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25060029|NCT03483350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25060030|NCT03483350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060031|NCT03483350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25060032|NCT03483350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25060033|NCT03483350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25060034|NCT03483350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25060035|NCT03483350|Anesthetics, General|anesthetics, general|mesh-ancestor
25060036|NCT03483350|Anesthetics|anesthetics|mesh-ancestor
25060037|NCT03483350|GABA Modulators|gaba modulators|mesh-ancestor
25060038|NCT03483350|GABA Agents|gaba agents|mesh-ancestor
25060039|NCT03483350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25060040|NCT03483350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060047|NCT03483207|Heparin|heparin|mesh-list
24952961|NCT03890341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24952962|NCT03890341|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24952963|NCT03890341|Hormone Antagonists|hormone antagonists|mesh-ancestor
24952964|NCT03890341|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24952966|NCT03890341|Natriuretic Agents|natriuretic agents|mesh-ancestor
24952967|NCT03890341|Sequestering Agents|sequestering agents|mesh-ancestor
24952969|NCT03890406|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24952970|NCT03890406|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24952971|NCT03890406|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24510685|NCT00565292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24510686|NCT00565292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24510687|NCT00565292|Antimetabolites|antimetabolites|mesh-ancestor
24510688|NCT00565292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510689|NCT00565292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24510690|NCT00565318|Benphothiamine|benphothiamine|mesh-list
24510691|NCT00565318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24510723|NCT00565396|Protease Inhibitors|protease inhibitors|mesh-ancestor
24510724|NCT00565396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510725|NCT00565422|Citalopram|citalopram|mesh-list
24510731|NCT00565422|Serotonin Agents|serotonin agents|mesh-ancestor
24510732|NCT00565422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510733|NCT00565422|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24510734|NCT00565422|Antidepressive Agents|antidepressive agents|mesh-ancestor
24510735|NCT00565422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24510736|NCT00565461|Vaccines|vaccines|mesh-list
24510737|NCT00565461|Immunologic Factors|immunologic factors|mesh-ancestor
25060059|NCT03483181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25060060|NCT03483181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510842|NCT00565955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510843|NCT00565968|Sorafenib|sorafenib|mesh-list
24510844|NCT00565968|Melphalan|melphalan|mesh-list
24510845|NCT00565968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510846|NCT00565968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24510847|NCT00565968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394212|NCT00132561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25060067|NCT03483142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24459798|NCT00346489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459799|NCT00346489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24459800|NCT00346489|Immunologic Factors|immunologic factors|mesh-ancestor
24395531|NCT00136344|Cefuroxime|cefuroxime|mesh-list
25698652|NCT02096718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698653|NCT02096744|Clonidine|clonidine|mesh-list
25698654|NCT02096744|Analgesics|analgesics|mesh-ancestor
25698655|NCT02096744|Sensory System Agents|sensory system agents|mesh-ancestor
25698656|NCT02096744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25698657|NCT02096744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060073|NCT03482960|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24510909|NCT00566553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24510910|NCT00566553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510911|NCT00566553|Antioxidants|antioxidants|mesh-ancestor
24510912|NCT00566553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510913|NCT00566553|Protective Agents|protective agents|mesh-ancestor
24510914|NCT00566553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060115|NCT03482440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25060116|NCT03482440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25060117|NCT03482362|Vinorelbine|vinorelbine|mesh-list
25060118|NCT03482362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25060119|NCT03482362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25060120|NCT03482362|Tubulin Modulators|tubulin modulators|mesh-ancestor
25060121|NCT03482362|Antimitotic Agents|antimitotic agents|mesh-ancestor
24395532|NCT00136344|Cefuroxime axetil|cefuroxime axetil|mesh-list
24395534|NCT00136344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24511026|NCT00567047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25060123|NCT03482362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060125|NCT03482232|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25060126|NCT03482232|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25060127|NCT03482232|Anti-Infective Agents|anti-infective agents|mesh-list
25060128|NCT03482232|Ibuprofen|ibuprofen|mesh-list
25060143|NCT03482232|Antipyretics|antipyretics|mesh-ancestor
25060144|NCT03482232|Antimetabolites|antimetabolites|mesh-ancestor
25060145|NCT03482232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25060148|NCT03482180|Calcium|calcium|mesh-list
25060149|NCT03482180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25060150|NCT03482180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885613|NCT05030272|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24885614|NCT05030272|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24885615|NCT05030272|Cholinergic Agents|cholinergic agents|mesh-ancestor
24885616|NCT05030272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24885617|NCT05030272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885619|NCT05027425|Tremelimumab|tremelimumab|mesh-list
24885620|NCT05027425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24885622|NCT05024513|Fluorouracil|fluorouracil|mesh-list
24885664|NCT04991662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885666|NCT04947072|Anesthetics|anesthetics|mesh-list
24885667|NCT04947072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24885672|NCT04942158|Sunscreening Agents|sunscreening agents|mesh-ancestor
24885673|NCT04942158|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24885674|NCT04942158|Protective Agents|protective agents|mesh-ancestor
24885675|NCT04942158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885676|NCT04942158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24885677|NCT04941703|Magnesium citrate|magnesium citrate|mesh-list
24885678|NCT04941703|Cathartics|cathartics|mesh-ancestor
24398386|NCT00144261|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24464668|NCT00365820|Tegaserod|tegaserod|mesh-list
24511065|NCT00567177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24511066|NCT00567177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24511067|NCT00567216|Nadolol|nadolol|mesh-list
24511068|NCT00567216|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24511069|NCT00567216|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24511070|NCT00567216|Adrenergic Agents|adrenergic agents|mesh-ancestor
24885703|NCT04810208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885706|NCT04671030|Glycopyrrolate|glycopyrrolate|mesh-list
24885707|NCT04671030|Neostigmine|neostigmine|mesh-list
24885708|NCT04671030|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24885729|NCT04660890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24885730|NCT04660890|Contraceptive Agents|contraceptive agents|mesh-ancestor
24885731|NCT04660890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24885732|NCT04660890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885733|NCT04660890|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24885734|NCT04660890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24885735|NCT04660890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24885737|NCT04652206|Paclitaxel|paclitaxel|mesh-list
24885738|NCT04652206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24885739|NCT04652206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885740|NCT04652206|Tubulin Modulators|tubulin modulators|mesh-ancestor
24885741|NCT04652206|Antimitotic Agents|antimitotic agents|mesh-ancestor
24885742|NCT04652206|Mitosis Modulators|mitosis modulators|mesh-ancestor
24885743|NCT04652206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885756|NCT04647903|Sympathomimetics|sympathomimetics|mesh-ancestor
24885757|NCT04647903|Autonomic Agents|autonomic agents|mesh-ancestor
24885758|NCT04647903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24885759|NCT04647903|Dopamine Agents|dopamine agents|mesh-ancestor
24885760|NCT04647903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24398387|NCT00144274|Ambroxol|ambroxol|mesh-list
24398390|NCT00144287|Ritonavir|ritonavir|mesh-list
24399133|NCT00146614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24399134|NCT00146614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24399328|NCT00147394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24399330|NCT00147394|Dopamine Agents|dopamine agents|mesh-ancestor
24885761|NCT04647903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885762|NCT04647903|Adrenergic Agents|adrenergic agents|mesh-ancestor
24885763|NCT04647903|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24885764|NCT04647903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24464717|NCT00366119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464718|NCT00366119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24464719|NCT00366236|Nitazoxanide|nitazoxanide|mesh-list
24511125|NCT00567528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24511126|NCT00567528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511167|NCT00567658|Esomeprazole|esomeprazole|mesh-list
25060186|NCT03481998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885790|NCT04607928|Pirfenidone|pirfenidone|mesh-list
24885791|NCT04607928|Analgesics|analgesics|mesh-ancestor
24885792|NCT04607928|Sensory System Agents|sensory system agents|mesh-ancestor
24885793|NCT04607928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24885794|NCT04607928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885795|NCT04607928|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24885796|NCT04607928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24885797|NCT04607928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24464755|NCT00366652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24464756|NCT00366652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464757|NCT00366652|Analgesics|analgesics|mesh-ancestor
24885809|NCT04537026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24885810|NCT04537026|Antiemetics|antiemetics|mesh-ancestor
24885811|NCT04537026|Autonomic Agents|autonomic agents|mesh-ancestor
24885812|NCT04537026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24885813|NCT04537026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885815|NCT04537026|Glucocorticoids|glucocorticoids|mesh-ancestor
24885822|NCT04537026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885824|NCT04498780|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24885825|NCT04498780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24885826|NCT04498780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24885827|NCT04498780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24885836|NCT04420741|Vasodilator Agents|vasodilator agents|mesh-ancestor
24885838|NCT04409041|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24885841|NCT04409041|Sensory System Agents|sensory system agents|mesh-ancestor
24885842|NCT04409041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25698658|NCT02096744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25698659|NCT02096744|Sympatholytics|sympatholytics|mesh-ancestor
24885843|NCT04407286|Vitamin D|vitamin d|mesh-list
24885844|NCT04407286|Cholecalciferol|cholecalciferol|mesh-list
24885845|NCT04407286|Vitamins|vitamins|mesh-ancestor
24885846|NCT04407286|Micronutrients|micronutrients|mesh-ancestor
24885847|NCT04407286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885848|NCT04407286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24885849|NCT04407286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24885850|NCT04317404|Triamcinolone|triamcinolone|mesh-list
24885851|NCT04317404|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24885852|NCT04317404|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24885853|NCT04317404|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24885854|NCT04317404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24885855|NCT04317404|Glucocorticoids|glucocorticoids|mesh-ancestor
24885856|NCT04317404|Hormones|hormones|mesh-ancestor
24885857|NCT04317404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24885858|NCT04317404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885859|NCT04317404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24885860|NCT04317404|Immunologic Factors|immunologic factors|mesh-ancestor
24885861|NCT04317404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464771|NCT00366730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25060224|NCT03480997|Anticonvulsants|anticonvulsants|mesh-ancestor
25060225|NCT03480997|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25060226|NCT03480997|Autonomic Agents|autonomic agents|mesh-ancestor
25060227|NCT03480997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060228|NCT03480997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060229|NCT03480997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25060230|NCT03480997|Respiratory System Agents|respiratory system agents|mesh-ancestor
25060231|NCT03480997|Tocolytic Agents|tocolytic agents|mesh-ancestor
25060232|NCT03480997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25060233|NCT03480997|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25060234|NCT03480997|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25060235|NCT03480997|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25060236|NCT03480997|Adrenergic Agents|adrenergic agents|mesh-ancestor
25060237|NCT03480997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25060239|NCT03480997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24511188|NCT00567710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24511189|NCT00567710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24511190|NCT00567710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24511191|NCT00567710|Dopamine Agents|dopamine agents|mesh-ancestor
24464795|NCT00366834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24885863|NCT04282239|Lidocaine|lidocaine|mesh-list
24885864|NCT04282239|Epinephrine|epinephrine|mesh-list
24885865|NCT04282239|Dexmedetomidine|dexmedetomidine|mesh-list
24885866|NCT04282239|Ropivacaine|ropivacaine|mesh-list
24885867|NCT04282239|Anesthetics, Local|anesthetics, local|mesh-ancestor
24400833|NCT00151463|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24885868|NCT04282239|Anesthetics|anesthetics|mesh-ancestor
24885869|NCT04282239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24885870|NCT04282239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885871|NCT04282239|Sensory System Agents|sensory system agents|mesh-ancestor
24885872|NCT04282239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24885873|NCT04282239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24885874|NCT04282239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24816439|NCT02076945|Anesthetics|anesthetics|mesh-ancestor
24464797|NCT00366834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24464798|NCT00366834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25060276|NCT03480789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25060277|NCT03480789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25060278|NCT03480789|Adrenergic Agents|adrenergic agents|mesh-ancestor
25060279|NCT03480789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24822668|NCT02112916|Calcium|calcium|mesh-list
24816497|NCT02077478|Propofol|propofol|mesh-list
24816498|NCT02077478|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24816499|NCT02077478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24816500|NCT02077478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885894|NCT04232072|Ibuprofen|ibuprofen|mesh-list
24885895|NCT04232072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25698660|NCT02096744|Autonomic Agents|autonomic agents|mesh-ancestor
25698661|NCT02096744|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24885896|NCT04232072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24885897|NCT04232072|Analgesics|analgesics|mesh-ancestor
24885898|NCT04232072|Sensory System Agents|sensory system agents|mesh-ancestor
25698662|NCT02096744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24885899|NCT04232072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24464830|NCT00367081|Sulfadiazine|sulfadiazine|mesh-list
25060293|NCT03480607|Dexmedetomidine|dexmedetomidine|mesh-list
25060294|NCT03480607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25060295|NCT03480607|Antiemetics|antiemetics|mesh-ancestor
25060296|NCT03480607|Autonomic Agents|autonomic agents|mesh-ancestor
25060297|NCT03480607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060298|NCT03480607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060299|NCT03480607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25060300|NCT03480607|Glucocorticoids|glucocorticoids|mesh-ancestor
25060301|NCT03480607|Hormones|hormones|mesh-ancestor
25060302|NCT03480607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25060303|NCT03480607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24822717|NCT02112929|Xenon|xenon|mesh-list
24511209|NCT00567814|Metyrapone|metyrapone|mesh-list
24511210|NCT00567814|Antimetabolites|antimetabolites|mesh-ancestor
24511211|NCT00567814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511212|NCT00567814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24511213|NCT00567814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24511214|NCT00567814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24402148|NCT00155233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511215|NCT00567814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511216|NCT00567814|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24511217|NCT00567814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24511218|NCT00567814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24511219|NCT00567814|GABA Modulators|gaba modulators|mesh-ancestor
24511220|NCT00567814|GABA Agents|gaba agents|mesh-ancestor
24511221|NCT00567814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24511222|NCT00567866|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24511227|NCT00567866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25060308|NCT03480607|Analgesics|analgesics|mesh-ancestor
25060309|NCT03480607|Sensory System Agents|sensory system agents|mesh-ancestor
25060310|NCT03480607|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25060311|NCT03480607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25060312|NCT03480607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25060313|NCT03480607|Adrenergic Agents|adrenergic agents|mesh-ancestor
25060314|NCT03480607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25060315|NCT03480607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060316|NCT03480568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25060317|NCT03480568|Immunologic Factors|immunologic factors|mesh-ancestor
25060319|NCT03480516|Fluorides|fluorides|mesh-list
24885925|NCT04132427|Anticoagulants|anticoagulants|mesh-ancestor
24885926|NCT04132427|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24885927|NCT04132427|Chelating Agents|chelating agents|mesh-ancestor
24885928|NCT04132427|Sequestering Agents|sequestering agents|mesh-ancestor
24885929|NCT04132427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885930|NCT04132427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24885931|NCT04132427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24885932|NCT04132427|Cathartics|cathartics|mesh-ancestor
24885933|NCT04132427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24885934|NCT04122755|Buprenorphine|buprenorphine|mesh-list
24885935|NCT04122755|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24885936|NCT04122755|Narcotics|narcotics|mesh-ancestor
24885937|NCT04122755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24885938|NCT04122755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885939|NCT04122755|Analgesics|analgesics|mesh-ancestor
24885942|NCT04122755|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24885943|NCT04097470|Decitabine|decitabine|mesh-list
24885944|NCT04097470|Midostaurin|midostaurin|mesh-list
24885945|NCT04097470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24885946|NCT04097470|Antimetabolites|antimetabolites|mesh-ancestor
24885949|NCT04097470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24885960|NCT04054999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885961|NCT03896984|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
24885962|NCT03896984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885963|NCT03857542|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24885964|NCT03857542|Pilocarpine|pilocarpine|mesh-list
24885965|NCT03857542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24885966|NCT03857542|Miotics|miotics|mesh-ancestor
24885967|NCT03857542|Autonomic Agents|autonomic agents|mesh-ancestor
24885968|NCT03857542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24885969|NCT03857542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698663|NCT02096744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25698664|NCT02096744|Adrenergic Agents|adrenergic agents|mesh-ancestor
25698665|NCT02096744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24511241|NCT00567957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24511242|NCT00567957|Narcotics|narcotics|mesh-ancestor
24511243|NCT00567957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24511244|NCT00567957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511245|NCT00567957|Analgesics|analgesics|mesh-ancestor
24511246|NCT00567957|Sensory System Agents|sensory system agents|mesh-ancestor
24511247|NCT00567957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24464911|NCT00367276|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24886009|NCT03700541|Morphine|morphine|mesh-list
24886010|NCT03700541|Pirinitramide|pirinitramide|mesh-list
24886011|NCT03700541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25060376|NCT03480308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060377|NCT03480308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25060378|NCT03480308|Glucocorticoids|glucocorticoids|mesh-ancestor
24886015|NCT03700541|Analgesics|analgesics|mesh-ancestor
24886016|NCT03700541|Sensory System Agents|sensory system agents|mesh-ancestor
24886017|NCT03700541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24886018|NCT03700411|Morphine|morphine|mesh-list
24403959|NCT00162227|Efavirenz|efavirenz|mesh-list
24403960|NCT00162227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24886019|NCT03700411|Pirinitramide|pirinitramide|mesh-list
24886020|NCT03700411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24886021|NCT03700411|Narcotics|narcotics|mesh-ancestor
24886022|NCT03700411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24886023|NCT03700411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886024|NCT03700411|Analgesics|analgesics|mesh-ancestor
24886025|NCT03700411|Sensory System Agents|sensory system agents|mesh-ancestor
24886026|NCT03700411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24886049|NCT03595917|Hormones|hormones|mesh-ancestor
25060391|NCT03480308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25060392|NCT03480308|Anesthetics, General|anesthetics, general|mesh-ancestor
25060393|NCT03480295|Hyaluronic Acid|hyaluronic acid|mesh-list
25060394|NCT03480295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25060395|NCT03480295|Immunologic Factors|immunologic factors|mesh-ancestor
25060396|NCT03480295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060397|NCT03480295|Viscosupplements|viscosupplements|mesh-ancestor
25060398|NCT03480295|Protective Agents|protective agents|mesh-ancestor
25060399|NCT03480191|Daptomycin|daptomycin|mesh-list
25060400|NCT03480191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25060401|NCT03480191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25060402|NCT03480165|Parecoxib|parecoxib|mesh-list
25060403|NCT03480165|Ropivacaine|ropivacaine|mesh-list
24511257|NCT00567983|Dermatologic Agents|dermatologic agents|mesh-ancestor
24511258|NCT00567983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24511259|NCT00567983|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24511260|NCT00568048|Bevacizumab|bevacizumab|mesh-list
24511261|NCT00568048|Temozolomide|temozolomide|mesh-list
24511262|NCT00568048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24886130|NCT02997358|Doxorubicin|doxorubicin|mesh-list
24886131|NCT02997358|Trabectedin|trabectedin|mesh-list
24886132|NCT02997358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25698666|NCT02096744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698667|NCT02096835|Dexamethasone|dexamethasone|mesh-list
25698668|NCT02096835|Tropisetron|tropisetron|mesh-list
24886136|NCT02997358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25698669|NCT02096835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25698670|NCT02096835|Antiemetics|antiemetics|mesh-ancestor
25698671|NCT02096835|Autonomic Agents|autonomic agents|mesh-ancestor
25698672|NCT02096835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24991065|NCT02891798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24991066|NCT02891798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24991067|NCT02891798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24991068|NCT02891798|Protease Inhibitors|protease inhibitors|mesh-ancestor
24991069|NCT02891798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991070|NCT02891798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533454|NCT00644085|Analgesics|analgesics|mesh-ancestor
24511312|NCT00568217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24511313|NCT00568217|Analgesics|analgesics|mesh-ancestor
24511314|NCT00568217|Sensory System Agents|sensory system agents|mesh-ancestor
24511315|NCT00568217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24511316|NCT00568217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511317|NCT00568217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24511318|NCT00568217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24511319|NCT00568217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24511320|NCT00568217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24511321|NCT00568217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511322|NCT00568217|Antipyretics|antipyretics|mesh-ancestor
24511323|NCT00568295|Acetaminophen|acetaminophen|mesh-list
24511324|NCT00568295|Rofecoxib|rofecoxib|mesh-list
24511325|NCT00568295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24511326|NCT00568295|Analgesics|analgesics|mesh-ancestor
24511327|NCT00568295|Sensory System Agents|sensory system agents|mesh-ancestor
24511328|NCT00568295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24511329|NCT00568295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511330|NCT00568295|Antipyretics|antipyretics|mesh-ancestor
24511331|NCT00568295|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24511332|NCT00568295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24511333|NCT00568295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24511334|NCT00568295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511335|NCT00568295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24511336|NCT00568295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24511337|NCT00568295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24511338|NCT00568347|Fluticasone|fluticasone|mesh-list
24511339|NCT00568347|Xhance|xhance|mesh-list
24511340|NCT00568347|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24511388|NCT00568503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25060448|NCT03479918|Vincristine|vincristine|mesh-list
25060449|NCT03479918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25060450|NCT03479918|Immunologic Factors|immunologic factors|mesh-ancestor
25060451|NCT03479918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060452|NCT03479918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25060453|NCT03479918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25060454|NCT03479918|Alkylating Agents|alkylating agents|mesh-ancestor
25060455|NCT03479918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822866|NCT02113891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822867|NCT02113904|Adalimumab|adalimumab|mesh-list
24822868|NCT02113904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24822869|NCT02113904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24822870|NCT02113943|Citalopram|citalopram|mesh-list
24822871|NCT02113943|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24822872|NCT02113943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24511400|NCT00568529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511401|NCT00568529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511402|NCT00568542|Epoetin Alfa|epoetin alfa|mesh-list
24511403|NCT00568542|Hematinics|hematinics|mesh-ancestor
24886183|NCT02814695|Antioxidants|antioxidants|mesh-ancestor
24886184|NCT02814695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060461|NCT03479918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25060462|NCT03479918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25060463|NCT03479918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25698673|NCT02096835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698674|NCT02096835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25698675|NCT02096835|Glucocorticoids|glucocorticoids|mesh-ancestor
25698676|NCT02096835|Hormones|hormones|mesh-ancestor
25698677|NCT02096835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25698678|NCT02096835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25698679|NCT02096835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25698680|NCT02096835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25698681|NCT02096835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25698682|NCT02096835|Serotonin Agents|serotonin agents|mesh-ancestor
24822873|NCT02113943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24822874|NCT02113943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886186|NCT02814695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886187|NCT02814695|Vitamins|vitamins|mesh-ancestor
24886188|NCT02814695|Micronutrients|micronutrients|mesh-ancestor
24511450|NCT00568763|Immunologic Factors|immunologic factors|mesh-ancestor
24511451|NCT00568763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511452|NCT00568789|Zolpidem|zolpidem|mesh-list
24511453|NCT00568789|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24511454|NCT00568789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24511455|NCT00568789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24511456|NCT00568789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511457|NCT00568789|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24511458|NCT00568789|GABA Agonists|gaba agonists|mesh-ancestor
24511459|NCT00568789|GABA Agents|gaba agents|mesh-ancestor
24511460|NCT00568789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24511461|NCT00568789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511462|NCT00568815|Rituximab|rituximab|mesh-list
24511489|NCT00568971|Mitosis Modulators|mitosis modulators|mesh-ancestor
24886217|NCT02675439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886218|NCT02675439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24886219|NCT02675439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886220|NCT02651740|Rifaximin|rifaximin|mesh-list
24886221|NCT02651740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24886222|NCT02651740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24886223|NCT02651740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24886224|NCT02617550|Nitroglycerin|nitroglycerin|mesh-list
24886225|NCT02617550|Vasodilator Agents|vasodilator agents|mesh-ancestor
24886226|NCT02606136|Mitogens|mitogens|mesh-list
24886227|NCT02606136|Mitosis Modulators|mitosis modulators|mesh-ancestor
24404413|NCT00163384|Hormones|hormones|mesh-ancestor
24886228|NCT02606136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060480|NCT03479879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25060481|NCT03479879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25060482|NCT03479879|Oxytocics|oxytocics|mesh-ancestor
25060483|NCT03479762|Liraglutide|liraglutide|mesh-list
25060484|NCT03479762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25060485|NCT03479762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060486|NCT03479762|Incretins|incretins|mesh-ancestor
25060487|NCT03479762|Hormones|hormones|mesh-ancestor
25007579|NCT03221751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25060488|NCT03479762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24822894|NCT02114021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24886229|NCT02493426|Oxytocin|oxytocin|mesh-list
24886230|NCT02493426|Oxytocics|oxytocics|mesh-ancestor
24886231|NCT02493426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24511532|NCT00569400|Insulin|insulin|mesh-list
24511549|NCT00569465|Protective Agents|protective agents|mesh-ancestor
24511550|NCT00569465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511551|NCT00569465|Antidotes|antidotes|mesh-ancestor
24511552|NCT00569621|Moxaverine|moxaverine|mesh-list
24511553|NCT00569621|Parasympatholytics|parasympatholytics|mesh-ancestor
24511554|NCT00569621|Autonomic Agents|autonomic agents|mesh-ancestor
24511555|NCT00569621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24511556|NCT00569621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465009|NCT00367497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24511635|NCT00569920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24511636|NCT00569920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24511637|NCT00569920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511638|NCT00569920|Protease Inhibitors|protease inhibitors|mesh-ancestor
24511644|NCT00569985|Etoposide phosphate|etoposide phosphate|mesh-list
24511645|NCT00569985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24511646|NCT00569985|Immunologic Factors|immunologic factors|mesh-ancestor
24511647|NCT00569985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511652|NCT00569985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511653|NCT00569985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24511654|NCT00569985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24511655|NCT00569985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24511656|NCT00569985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24511657|NCT00569985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886254|NCT02090998|Amitriptyline|amitriptyline|mesh-list
24886255|NCT02090998|Anesthetics, Local|anesthetics, local|mesh-ancestor
24511660|NCT00570050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24991260|NCT05197101|Oxytocics|oxytocics|mesh-ancestor
24405082|NCT00165451|Analgesics|analgesics|mesh-ancestor
24511661|NCT00570050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511662|NCT00570180|Bortezomib|bortezomib|mesh-list
24511663|NCT00570180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511664|NCT00570193|Ranibizumab|ranibizumab|mesh-list
24511665|NCT00570193|Verteporfin|verteporfin|mesh-list
24511666|NCT00570193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24511667|NCT00570193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24511678|NCT00570219|GABA Agents|gaba agents|mesh-ancestor
24511679|NCT00570219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24511680|NCT00570219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511681|NCT00570219|Antimanic Agents|antimanic agents|mesh-ancestor
24511682|NCT00570219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25060506|NCT03479411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060508|NCT03479411|Hormone Antagonists|hormone antagonists|mesh-ancestor
25060509|NCT03479411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25060510|NCT03479411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060511|NCT03479411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25060512|NCT03479372|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25060513|NCT03479372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25060514|NCT03479320|Lidocaine|lidocaine|mesh-list
25060515|NCT03479320|Anesthetics, Local|anesthetics, local|mesh-ancestor
25060517|NCT03479320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25060518|NCT03479320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060519|NCT03479320|Sensory System Agents|sensory system agents|mesh-ancestor
25060520|NCT03479320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24511730|NCT00570479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511731|NCT00570544|Tiotropium Bromide|tiotropium bromide|mesh-list
24511732|NCT00570544|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24511733|NCT00570544|Autonomic Agents|autonomic agents|mesh-ancestor
24511734|NCT00570544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24511735|NCT00570544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511736|NCT00570544|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24511737|NCT00570544|Respiratory System Agents|respiratory system agents|mesh-ancestor
24511738|NCT00570544|Parasympatholytics|parasympatholytics|mesh-ancestor
24406742|NCT00171119|Valsartan|valsartan|mesh-list
24407109|NCT00171860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407111|NCT00171886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24407112|NCT00171886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24511741|NCT00570544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24511742|NCT00570544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511743|NCT00570622|Pioglitazone|pioglitazone|mesh-list
24511756|NCT00570726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511758|NCT00570726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511759|NCT00570830|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
24511760|NCT00570830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24511761|NCT00570830|Glucocorticoids|glucocorticoids|mesh-ancestor
24511762|NCT00570830|Hormones|hormones|mesh-ancestor
24511763|NCT00570830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24511764|NCT00570830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511765|NCT00570843|Lubricant Eye Drops|lubricant eye drops|mesh-list
24511766|NCT00570843|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24511767|NCT00570843|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24511768|NCT00570856|Folic Acid|folic acid|mesh-list
24886276|NCT02051309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24886277|NCT02051309|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24886278|NCT02051309|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24886279|NCT02051309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24886284|NCT02001623|Tisotumab vedotin|tisotumab vedotin|mesh-list
24449707|NCT00316745|Irinotecan|irinotecan|mesh-list
25698683|NCT02096835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24797315|NCT01955174|Botulinum Toxins|botulinum toxins|mesh-list
24797316|NCT01955174|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24511807|NCT00571116|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
24511808|NCT00571116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24511809|NCT00571116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511810|NCT00571129|Mitomycins|mitomycins|mesh-list
24511811|NCT00571129|Mitomycin|mitomycin|mesh-list
24511812|NCT00571129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24511813|NCT00571129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511814|NCT00571129|Alkylating Agents|alkylating agents|mesh-ancestor
24511817|NCT00571129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886307|NCT00902044|Immunologic Factors|immunologic factors|mesh-ancestor
24886308|NCT00902044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886309|NCT00902044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24407295|NCT00174226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24886310|NCT00902044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24886311|NCT00902044|Alkylating Agents|alkylating agents|mesh-ancestor
24886312|NCT00902044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886313|NCT00902044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816520|NCT02077556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816521|NCT02077556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816522|NCT02077556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24816523|NCT02077556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24816524|NCT02077556|Antitubercular Agents|antitubercular agents|mesh-ancestor
24816525|NCT02077556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24816526|NCT02077556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24886318|NCT00165724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886319|NCT00165724|Cholinergic Agents|cholinergic agents|mesh-ancestor
24465084|NCT00367874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511911|NCT00571675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511912|NCT00571675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24511913|NCT00571675|Glucocorticoids|glucocorticoids|mesh-ancestor
24511914|NCT00571675|Hormones|hormones|mesh-ancestor
24886321|NCT00165724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886323|NCT04527042|Rivaroxaban|rivaroxaban|mesh-list
24886324|NCT04527042|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24886325|NCT04527042|Antithrombins|antithrombins|mesh-ancestor
24886326|NCT04527042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24886327|NCT04527042|Protease Inhibitors|protease inhibitors|mesh-ancestor
24886328|NCT04527042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886329|NCT04527042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886330|NCT04527042|Anticoagulants|anticoagulants|mesh-ancestor
24886331|NCT04527133|Aprotinin|aprotinin|mesh-list
24886332|NCT04527133|Hemostatics|hemostatics|mesh-ancestor
24886333|NCT04527133|Coagulants|coagulants|mesh-ancestor
24886334|NCT04527133|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24512009|NCT00572065|Antiviral Agents|antiviral agents|mesh-ancestor
24512010|NCT00572065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24512011|NCT00572065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24512012|NCT00572065|Immunologic Factors|immunologic factors|mesh-ancestor
24443274|NCT00294359|Growth Inhibitors|growth inhibitors|mesh-ancestor
25698684|NCT02096835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698685|NCT02096861|Infliximab|infliximab|mesh-list
25698686|NCT02096861|Dermatologic Agents|dermatologic agents|mesh-ancestor
25698687|NCT02096861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25698688|NCT02096861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25698689|NCT02096900|Midazolam|midazolam|mesh-list
24944609|NCT03959150|Capecitabine|capecitabine|mesh-list
25698690|NCT02096900|Zolpidem|zolpidem|mesh-list
25698691|NCT02096900|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25698692|NCT02096900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25698693|NCT02096900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24944610|NCT03959150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24944611|NCT03959150|Antimetabolites|antimetabolites|mesh-ancestor
24944612|NCT03959150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769789|NCT01816191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769790|NCT01816191|Vasodilator Agents|vasodilator agents|mesh-ancestor
24769791|NCT01816321|Ganirelix|ganirelix|mesh-list
24769792|NCT01816321|Hormone Antagonists|hormone antagonists|mesh-ancestor
24769793|NCT01816321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24886394|NCT04526353|Cholinergic Agents|cholinergic agents|mesh-ancestor
24465123|NCT00367939|Valsartan|valsartan|mesh-list
24512043|NCT00572299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24512044|NCT00572312|Atorvastatin|atorvastatin|mesh-list
24512045|NCT00572312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24512046|NCT00572312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24512047|NCT00572312|Antimetabolites|antimetabolites|mesh-ancestor
24886395|NCT04526353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24769796|NCT01816334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24769797|NCT01816334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24769798|NCT01816334|Prednisolone|prednisolone|mesh-list
24769799|NCT01816334|Prednisolone acetate|prednisolone acetate|mesh-list
24769800|NCT01816334|Ketoprofen|ketoprofen|mesh-list
25060546|NCT03478605|Dexamethasone|dexamethasone|mesh-list
25060547|NCT03478605|Ondansetron|ondansetron|mesh-list
24886396|NCT04526353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886397|NCT04526353|Urological Agents|urological agents|mesh-ancestor
24886398|NCT04526210|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
24886399|NCT04526210|Choline|choline|mesh-list
24886400|NCT04526210|Bupropion|bupropion|mesh-list
24886401|NCT04526210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24512076|NCT00572650|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24512078|NCT00572650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512080|NCT00572663|Acetylcysteine|acetylcysteine|mesh-list
24512086|NCT00572663|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24512087|NCT00572663|Antioxidants|antioxidants|mesh-ancestor
24512088|NCT00572663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512089|NCT00572663|Protective Agents|protective agents|mesh-ancestor
24512090|NCT00572663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512091|NCT00572663|Antidotes|antidotes|mesh-ancestor
24886424|NCT04526210|Growth Substances|growth substances|mesh-ancestor
24886425|NCT04526210|Growth Inhibitors|growth inhibitors|mesh-ancestor
24886426|NCT04526210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886427|NCT04526028|Fulvestrant|fulvestrant|mesh-list
24886428|NCT04526028|Palbociclib|palbociclib|mesh-list
24886429|NCT04526028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24886430|NCT04526028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886431|NCT04526028|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24886432|NCT04526028|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24886433|NCT04526028|Hormone Antagonists|hormone antagonists|mesh-ancestor
24886434|NCT04526028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24886435|NCT04526028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886436|NCT04526028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24886437|NCT04526028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823031|NCT02114645|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24886438|NCT04526028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886440|NCT04526119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25060549|NCT03478605|Aprepitant|aprepitant|mesh-list
25060550|NCT03478605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25060551|NCT03478605|Antiemetics|antiemetics|mesh-ancestor
25060552|NCT03478605|Autonomic Agents|autonomic agents|mesh-ancestor
25060553|NCT03478605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060554|NCT03478605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060555|NCT03478605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24886444|NCT04526119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24886445|NCT04526119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886446|NCT04526119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24886447|NCT04526236|Methadone|methadone|mesh-list
24886448|NCT04526236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24886449|NCT04526236|Narcotics|narcotics|mesh-ancestor
24886450|NCT04526236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24886451|NCT04526236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512095|NCT00572689|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24512096|NCT00572689|Incretins|incretins|mesh-ancestor
24512097|NCT00572689|Hormones|hormones|mesh-ancestor
24512098|NCT00572689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24512099|NCT00572741|Ascorbic Acid|ascorbic acid|mesh-list
25107514|NCT03139253|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24512100|NCT00572741|Cod Liver Oil|cod liver oil|mesh-list
24512101|NCT00572741|Vitamins|vitamins|mesh-ancestor
24512102|NCT00572741|Micronutrients|micronutrients|mesh-ancestor
24886452|NCT04526236|Analgesics|analgesics|mesh-ancestor
24886453|NCT04526236|Sensory System Agents|sensory system agents|mesh-ancestor
24886454|NCT04526236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24465160|NCT00368056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24886455|NCT04526236|Antitussive Agents|antitussive agents|mesh-ancestor
24886456|NCT04526236|Respiratory System Agents|respiratory system agents|mesh-ancestor
24886457|NCT04525820|Vitamin D|vitamin d|mesh-list
24886507|NCT04525066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24886508|NCT04525066|Immunologic Factors|immunologic factors|mesh-ancestor
24886509|NCT04525066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886510|NCT04525066|Viscosupplements|viscosupplements|mesh-ancestor
24886511|NCT04525066|Protective Agents|protective agents|mesh-ancestor
25060556|NCT03478605|Glucocorticoids|glucocorticoids|mesh-ancestor
25060557|NCT03478605|Hormones|hormones|mesh-ancestor
25060558|NCT03478605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25060559|NCT03478605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25060560|NCT03478605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25060561|NCT03478605|Antipruritics|antipruritics|mesh-ancestor
25060562|NCT03478605|Dermatologic Agents|dermatologic agents|mesh-ancestor
25060563|NCT03478605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24886512|NCT04525235|Tolbutamide|tolbutamide|mesh-list
24886513|NCT04525235|Rifampin|rifampin|mesh-list
24886514|NCT04525235|Digoxin|digoxin|mesh-list
24886515|NCT04525235|Midazolam|midazolam|mesh-list
24886516|NCT04525235|Dextromethorphan|dextromethorphan|mesh-list
24886517|NCT04525235|Caffeine|caffeine|mesh-list
24886518|NCT04525235|Omeprazole|omeprazole|mesh-list
24886519|NCT04525235|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24886520|NCT04525235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24886521|NCT04525235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24886522|NCT04525235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886523|NCT04525235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24886545|NCT04525235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24886546|NCT04525235|Leprostatic Agents|leprostatic agents|mesh-ancestor
24886547|NCT04525235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24886548|NCT04525235|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24886549|NCT04525235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24886550|NCT04525235|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24886551|NCT04525235|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24886552|NCT04525235|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24886553|NCT04525235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24886554|NCT04525235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24886567|NCT04525274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24886568|NCT04525274|Analgesics|analgesics|mesh-ancestor
24886577|NCT04525274|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24886578|NCT04525274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24886579|NCT04525274|Anesthetics, General|anesthetics, general|mesh-ancestor
24886580|NCT04525274|Anesthetics|anesthetics|mesh-ancestor
24886581|NCT04525274|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24886582|NCT04525274|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25060564|NCT03478605|Serotonin Agents|serotonin agents|mesh-ancestor
25060565|NCT03478605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25060566|NCT03478605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060567|NCT03478605|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25060568|NCT03478605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25060569|NCT03478605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25060570|NCT03478605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25060571|NCT03478605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25060572|NCT03478605|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25060576|NCT03478540|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24512139|NCT00573001|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24512140|NCT00573001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24512141|NCT00573001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24512142|NCT00573001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25698694|NCT02096900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698695|NCT02096900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25698696|NCT02096900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24512144|NCT00573001|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24512145|NCT00573001|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24865317|NCT03832010|Glucocorticoids|glucocorticoids|mesh-ancestor
24991526|NCT05143489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991528|NCT05143073|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24991529|NCT05143073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24991530|NCT05143073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24991531|NCT05143073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512146|NCT00573001|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24512147|NCT00573001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24512148|NCT00573001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24512149|NCT00573222|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24512150|NCT00573222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24512151|NCT00573222|Respiratory System Agents|respiratory system agents|mesh-ancestor
24512152|NCT00573326|Imatinib Mesylate|imatinib mesylate|mesh-list
24512153|NCT00573326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886591|NCT04525326|Growth Inhibitors|growth inhibitors|mesh-ancestor
24886592|NCT04525300|Liraglutide|liraglutide|mesh-list
24512169|NCT00573404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886618|NCT04524897|Glucocorticoids|glucocorticoids|mesh-ancestor
24886620|NCT04524897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24886621|NCT04524897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886622|NCT04524897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24886623|NCT04524897|Immunologic Factors|immunologic factors|mesh-ancestor
24886624|NCT04524897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886625|NCT04524897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886626|NCT04524260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24886627|NCT04524169|Thymalfasin|thymalfasin|mesh-list
24886628|NCT04524169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24886629|NCT04524169|Immunologic Factors|immunologic factors|mesh-ancestor
24886630|NCT04524169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886631|NCT04523987|Ciprofloxacin|ciprofloxacin|mesh-list
24886632|NCT04523987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24886633|NCT04523987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24886634|NCT04523987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25060587|NCT03478436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25060588|NCT03478436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25060589|NCT03478436|Antimalarials|antimalarials|mesh-ancestor
25060590|NCT03478436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24512194|NCT00573547|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24512214|NCT00573599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512215|NCT00573599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24816527|NCT02077556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24886635|NCT04523987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24886636|NCT04523987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886637|NCT04523987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886638|NCT04523987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886639|NCT04523987|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24886640|NCT04523987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24886641|NCT04524026|Letrozole|letrozole|mesh-list
24886642|NCT04524026|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24886643|NCT04524026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886644|NCT04524026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24886645|NCT04524026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512243|NCT00573690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512244|NCT00573690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25698697|NCT02096900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25698698|NCT02096900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25698699|NCT02096900|Anesthetics, General|anesthetics, general|mesh-ancestor
25698700|NCT02096900|Anesthetics|anesthetics|mesh-ancestor
25698701|NCT02096900|GABA Modulators|gaba modulators|mesh-ancestor
25698702|NCT02096900|GABA Agents|gaba agents|mesh-ancestor
25698703|NCT02096900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25698704|NCT02096900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060596|NCT03478423|Narcotics|narcotics|mesh-ancestor
25060597|NCT03478423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24408935|NCT00180089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25060598|NCT03478423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060599|NCT03478423|Analgesics|analgesics|mesh-ancestor
25060600|NCT03478423|Sensory System Agents|sensory system agents|mesh-ancestor
25060601|NCT03478423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060602|NCT03478423|Antitussive Agents|antitussive agents|mesh-ancestor
24816579|NCT02077777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24816580|NCT02077777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24816581|NCT02077777|Antitubercular Agents|antitubercular agents|mesh-ancestor
24816582|NCT02077777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24816583|NCT02077777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24816584|NCT02077803|Metformin|metformin|mesh-list
24816585|NCT02077803|Canagliflozin|canagliflozin|mesh-list
24816586|NCT02077803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24816587|NCT02077803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816588|NCT02077803|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24886647|NCT04524026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24886648|NCT04524026|Hormone Antagonists|hormone antagonists|mesh-ancestor
24886649|NCT04524026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24886650|NCT04524026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465297|NCT00368862|Memantine|memantine|mesh-list
24886666|NCT04523818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886667|NCT04523818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24886668|NCT04523818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886669|NCT04523818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24886670|NCT04523818|Immunologic Factors|immunologic factors|mesh-ancestor
24512275|NCT00573950|Autonomic Agents|autonomic agents|mesh-ancestor
24512276|NCT00573950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24512277|NCT00573950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512280|NCT00573950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24512281|NCT00573950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24512302|NCT00574015|Anesthetics|anesthetics|mesh-ancestor
24512303|NCT00574015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24512304|NCT00574015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512305|NCT00574015|Sensory System Agents|sensory system agents|mesh-ancestor
24512306|NCT00574015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24512307|NCT00574015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24512308|NCT00574015|Analgesics|analgesics|mesh-ancestor
24410009|NCT00184041|Vincristine|vincristine|mesh-list
24886671|NCT04523818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886672|NCT04523792|Buprenorphine|buprenorphine|mesh-list
25060612|NCT03478345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060613|NCT03478332|Nitroglycerin|nitroglycerin|mesh-list
25060614|NCT03478332|Vasodilator Agents|vasodilator agents|mesh-ancestor
25060615|NCT03478306|Melatonin|melatonin|mesh-list
25060616|NCT03478306|Antioxidants|antioxidants|mesh-ancestor
24823032|NCT02114645|Estradiol|estradiol|mesh-list
24823033|NCT02114645|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24823036|NCT02114645|Hormones|hormones|mesh-ancestor
24886716|NCT04523675|Antioxidants|antioxidants|mesh-ancestor
24886718|NCT04523675|Protective Agents|protective agents|mesh-ancestor
24512312|NCT00574015|Antitussive Agents|antitussive agents|mesh-ancestor
24512313|NCT00574015|Respiratory System Agents|respiratory system agents|mesh-ancestor
24512314|NCT00574015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24590913|NCT00914277|Sildenafil Citrate|sildenafil citrate|mesh-list
24590914|NCT00914277|Vasodilator Agents|vasodilator agents|mesh-ancestor
24512315|NCT00574015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24512316|NCT00574015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24512318|NCT00574041|Interferon-beta|interferon-beta|mesh-list
24512319|NCT00574041|Interferon beta-1a|interferon beta-1a|mesh-list
24512320|NCT00574041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512321|NCT00574041|Antiviral Agents|antiviral agents|mesh-ancestor
24512322|NCT00574041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24512323|NCT00574041|Immunologic Factors|immunologic factors|mesh-ancestor
24512324|NCT00574041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060617|NCT03478306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060618|NCT03478306|Protective Agents|protective agents|mesh-ancestor
24512325|NCT00574041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24512326|NCT00574093|Ranibizumab|ranibizumab|mesh-list
24512327|NCT00574093|Verteporfin|verteporfin|mesh-list
24512328|NCT00574093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24512329|NCT00574093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24512330|NCT00574093|Growth Substances|growth substances|mesh-ancestor
24512339|NCT00574353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24512340|NCT00574353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24512342|NCT00574366|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24886783|NCT04522336|Docetaxel|docetaxel|mesh-list
24709232|NCT01504646|Hormone Antagonists|hormone antagonists|mesh-ancestor
24886784|NCT04522336|Pembrolizumab|pembrolizumab|mesh-list
24886785|NCT04522336|Fluorouracil|fluorouracil|mesh-list
24886786|NCT04522336|Oxaliplatin|oxaliplatin|mesh-list
24512356|NCT00574470|Immunologic Factors|immunologic factors|mesh-ancestor
24512357|NCT00574470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512359|NCT00574483|Anticestodal Agents|anticestodal agents|mesh-ancestor
24512360|NCT00574483|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24512361|NCT00574483|Anthelmintics|anthelmintics|mesh-ancestor
24512362|NCT00574483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24512363|NCT00574483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24512364|NCT00574483|Antimalarials|antimalarials|mesh-ancestor
24512365|NCT00574483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24512366|NCT00574483|Antinematodal Agents|antinematodal agents|mesh-ancestor
24512367|NCT00574483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512368|NCT00574483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886827|NCT04522297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886828|NCT04522297|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24886830|NCT04521868|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24886840|NCT04522050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24886841|NCT04522050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886842|NCT04522050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24886843|NCT04522050|Immunologic Factors|immunologic factors|mesh-ancestor
24886844|NCT04522050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886889|NCT04522037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24886891|NCT04522037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24886892|NCT04522037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886893|NCT04522037|Analgesics|analgesics|mesh-ancestor
24886894|NCT04522037|Sensory System Agents|sensory system agents|mesh-ancestor
24886895|NCT04522037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24886896|NCT04521400|Interferons|interferons|mesh-list
24886897|NCT04521400|Ritonavir|ritonavir|mesh-list
24886898|NCT04521400|Lopinavir|lopinavir|mesh-list
24886899|NCT04521400|Interferon-beta|interferon-beta|mesh-list
24886911|NCT04521400|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24886912|NCT04521400|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24886913|NCT04521400|Immunologic Factors|immunologic factors|mesh-ancestor
24886914|NCT04521400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886915|NCT04521400|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24886916|NCT04521569|Regadenoson|regadenoson|mesh-list
24886917|NCT04521569|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
24886918|NCT04521569|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24886919|NCT04521569|Purinergic Agonists|purinergic agonists|mesh-ancestor
24886920|NCT04521569|Purinergic Agents|purinergic agents|mesh-ancestor
24886944|NCT04521751|Acarbose|acarbose|mesh-list
24886945|NCT04521751|Orlistat|orlistat|mesh-list
25060642|NCT03478111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25060643|NCT03478111|Immunologic Factors|immunologic factors|mesh-ancestor
25060644|NCT03478111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24415708|NCT00200538|Dopamine Agents|dopamine agents|mesh-ancestor
25060646|NCT03478111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25698705|NCT02096900|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25698706|NCT02096900|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25060647|NCT03478033|Rifampin|rifampin|mesh-list
25060648|NCT03478033|Rifabutin|rifabutin|mesh-list
25060649|NCT03478033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24991622|NCT05105750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991623|NCT05105750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24991624|NCT05105750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24991625|NCT05105750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24991626|NCT05105750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24991627|NCT05105750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991628|NCT05105750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24991629|NCT05105750|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24991630|NCT05105750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991631|NCT05105750|Antipyretics|antipyretics|mesh-ancestor
25060650|NCT03478033|Antitubercular Agents|antitubercular agents|mesh-ancestor
24886946|NCT04521751|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24465391|NCT00369408|Naltrexone|naltrexone|mesh-list
24886947|NCT04521751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886957|NCT04521517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886959|NCT04521491|Fluorouracil|fluorouracil|mesh-list
24886960|NCT04521491|Oxaliplatin|oxaliplatin|mesh-list
24886961|NCT04521491|Antimetabolites|antimetabolites|mesh-ancestor
24886962|NCT04521491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886963|NCT04521491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24886964|NCT04521491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512408|NCT00574743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886969|NCT04521491|Protective Agents|protective agents|mesh-ancestor
24886970|NCT04521491|Vitamin B Complex|vitamin b complex|mesh-ancestor
24886972|NCT04521491|Micronutrients|micronutrients|mesh-ancestor
24886973|NCT04521387|Hyaluronic Acid|hyaluronic acid|mesh-list
24886974|NCT04521387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24886975|NCT04521387|Immunologic Factors|immunologic factors|mesh-ancestor
24886976|NCT04521387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886977|NCT04521387|Viscosupplements|viscosupplements|mesh-ancestor
24886978|NCT04521387|Protective Agents|protective agents|mesh-ancestor
24886980|NCT04521075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24886981|NCT04521075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886982|NCT04521075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24886983|NCT04521075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060651|NCT03478033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25060652|NCT03478033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25060653|NCT03478033|Leprostatic Agents|leprostatic agents|mesh-ancestor
24887020|NCT04521049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887021|NCT04521049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887022|NCT04521049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24887024|NCT04520646|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24887025|NCT04520646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887026|NCT04520646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24887027|NCT04520646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887028|NCT04520620|Enoxaparin|enoxaparin|mesh-list
24887029|NCT04520620|Anticoagulants|anticoagulants|mesh-ancestor
24887030|NCT04520620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24887031|NCT04520620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24887032|NCT04520620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887033|NCT04520880|Antibodies|antibodies|mesh-list
24887034|NCT04520880|Immunoglobulins|immunoglobulins|mesh-list
25698707|NCT02096900|GABA Agonists|gaba agonists|mesh-ancestor
25698708|NCT02096952|Methylphenidate|methylphenidate|mesh-list
25698709|NCT02096952|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25698710|NCT02096952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698711|NCT02096952|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25698712|NCT02096952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25698713|NCT02096952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25698714|NCT02096952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698715|NCT02096952|Dopamine Agents|dopamine agents|mesh-ancestor
25698716|NCT02096952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25698717|NCT02097056|Donepezil|donepezil|mesh-list
25698718|NCT02097056|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25698719|NCT02097056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25698720|NCT02097056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698721|NCT02097056|Cholinergic Agents|cholinergic agents|mesh-ancestor
24991665|NCT05068661|Anesthetics, General|anesthetics, general|mesh-ancestor
24991666|NCT05064800|Ritonavir|ritonavir|mesh-list
24887035|NCT04520880|Antibodies, Blocking|antibodies, blocking|mesh-list
24816596|NCT02077933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816597|NCT02077933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24816598|NCT02077933|Immunologic Factors|immunologic factors|mesh-ancestor
24816599|NCT02077933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816600|NCT02077933|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24816601|NCT02077933|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24816602|NCT02077933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25060658|NCT03478033|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25060659|NCT03478033|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25060660|NCT03478033|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25060661|NCT03478033|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25060662|NCT03478033|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24816603|NCT02077933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887051|NCT04520230|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24887052|NCT04520230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24887053|NCT04520230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24887055|NCT04520230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24887056|NCT04520230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887057|NCT04520230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24887058|NCT04520230|Respiratory System Agents|respiratory system agents|mesh-ancestor
24887059|NCT04520230|Glucocorticoids|glucocorticoids|mesh-ancestor
24887060|NCT04520230|Hormones|hormones|mesh-ancestor
24887061|NCT04520230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24415810|NCT00201253|Sequestering Agents|sequestering agents|mesh-ancestor
24887062|NCT04520230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24887063|NCT04520230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24887064|NCT04520230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24887065|NCT04520230|Adrenergic Agents|adrenergic agents|mesh-ancestor
24887066|NCT04520230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24887067|NCT04520230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887068|NCT04520230|Parasympatholytics|parasympatholytics|mesh-ancestor
24887069|NCT04520230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25060668|NCT03478020|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25060669|NCT03477994|Clonidine|clonidine|mesh-list
25060670|NCT03477994|Dexmedetomidine|dexmedetomidine|mesh-list
25060671|NCT03477994|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25060672|NCT03477994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24823080|NCT02114736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512482|NCT00575406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512483|NCT00575406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512484|NCT00575406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24512485|NCT00575406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24512486|NCT00575406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24512487|NCT00575406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24512488|NCT00575406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24512489|NCT00575406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512490|NCT00575406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24512492|NCT00575406|Hormones|hormones|mesh-ancestor
24512493|NCT00575406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24512494|NCT00575406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24512495|NCT00575406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24887115|NCT04520139|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24887116|NCT04520139|Antiviral Agents|antiviral agents|mesh-ancestor
24887117|NCT04520139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24887119|NCT04520139|Respiratory System Agents|respiratory system agents|mesh-ancestor
24887120|NCT04520139|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24887121|NCT04520139|Antioxidants|antioxidants|mesh-ancestor
24516079|NCT00600548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887123|NCT04520139|Protective Agents|protective agents|mesh-ancestor
24887124|NCT04520139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887125|NCT04520139|Antidotes|antidotes|mesh-ancestor
24887126|NCT04519983|Osimertinib|osimertinib|mesh-list
24887137|NCT04520035|Antimitotic Agents|antimitotic agents|mesh-ancestor
24887138|NCT04520035|Mitosis Modulators|mitosis modulators|mesh-ancestor
25407298|NCT03508921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25698722|NCT02097056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25698723|NCT02097056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449903|NCT00317408|Glucocorticoids|glucocorticoids|mesh-ancestor
24449904|NCT00317408|Hormones|hormones|mesh-ancestor
24887139|NCT04520035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887140|NCT04519463|Lidocaine|lidocaine|mesh-list
24887141|NCT04519463|Anesthetics, Local|anesthetics, local|mesh-ancestor
24887142|NCT04519463|Anesthetics|anesthetics|mesh-ancestor
24887143|NCT04519463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24887144|NCT04519463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887145|NCT04519463|Sensory System Agents|sensory system agents|mesh-ancestor
24887146|NCT04519463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24887152|NCT04519762|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24887156|NCT04519710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24887157|NCT04519710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887158|NCT04519710|Immunologic Factors|immunologic factors|mesh-ancestor
24887159|NCT04519710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887160|NCT04519710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24887161|NCT04519125|Tenofovir|tenofovir|mesh-list
24428958|NCT00241722|Alvimopan|alvimopan|mesh-list
25060673|NCT03477994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060674|NCT03477994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25060675|NCT03477994|Analgesics|analgesics|mesh-ancestor
25060676|NCT03477994|Sensory System Agents|sensory system agents|mesh-ancestor
25060677|NCT03477994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060678|NCT03477994|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25060679|NCT03477994|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24887166|NCT04519125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24887167|NCT04519125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887168|NCT04519125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887169|NCT04519125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24887170|NCT04519125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24887172|NCT04519151|Lenvatinib|lenvatinib|mesh-list
24887173|NCT04519151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24887174|NCT04519151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887175|NCT04519151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24887176|NCT04519151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887177|NCT04519151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887179|NCT04519281|Vitamins|vitamins|mesh-ancestor
24887180|NCT04519281|Micronutrients|micronutrients|mesh-ancestor
25060702|NCT03477864|Antibodies|antibodies|mesh-list
25060703|NCT03477864|Immunoglobulins|immunoglobulins|mesh-list
25060704|NCT03477864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25060705|NCT03477864|Immunologic Factors|immunologic factors|mesh-ancestor
25060706|NCT03477864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060707|NCT03477864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25060708|NCT03477864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25060709|NCT03477864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060710|NCT03477461|Terlipressin|terlipressin|mesh-list
24887181|NCT04519281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887182|NCT04519281|Antioxidants|antioxidants|mesh-ancestor
24887183|NCT04519281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887184|NCT04519281|Protective Agents|protective agents|mesh-ancestor
24887185|NCT04519385|Dexamethasone|dexamethasone|mesh-list
24887186|NCT04519385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24887199|NCT04518852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24887222|NCT04518982|Growth Substances|growth substances|mesh-ancestor
24887223|NCT04518982|Growth Inhibitors|growth inhibitors|mesh-ancestor
24887224|NCT04518982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512507|NCT00575419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698725|NCT02097108|Raltegravir Potassium|raltegravir potassium|mesh-list
25698726|NCT02097108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25698727|NCT02097108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25698728|NCT02097108|Antiviral Agents|antiviral agents|mesh-ancestor
25698729|NCT02097108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25698730|NCT02097108|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25698731|NCT02097108|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25698732|NCT02097108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991753|NCT05032950|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24991754|NCT05032950|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24991755|NCT05032950|Protease Inhibitors|protease inhibitors|mesh-ancestor
24991756|NCT05032950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991757|NCT05032950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24865537|NCT00805961|Bevacizumab|bevacizumab|mesh-list
24512508|NCT00575419|Protective Agents|protective agents|mesh-ancestor
24512509|NCT00575419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512510|NCT00575419|Antidotes|antidotes|mesh-ancestor
24512512|NCT00575523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24512513|NCT00575523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24512514|NCT00575523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24417931|NCT00208195|Valproic Acid|valproic acid|mesh-list
24512515|NCT00575523|Autonomic Agents|autonomic agents|mesh-ancestor
24512516|NCT00575523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24512517|NCT00575523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512518|NCT00575523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24512519|NCT00575523|Respiratory System Agents|respiratory system agents|mesh-ancestor
24887244|NCT04518475|Rituximab|rituximab|mesh-list
24887245|NCT04518475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24887246|NCT04518475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887247|NCT04518475|Immunologic Factors|immunologic factors|mesh-ancestor
24887248|NCT04518475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887249|NCT04518475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24887257|NCT04518202|Lidocaine|lidocaine|mesh-list
24887258|NCT04518202|Anesthetics, Local|anesthetics, local|mesh-ancestor
24887259|NCT04518202|Anesthetics|anesthetics|mesh-ancestor
24887260|NCT04518202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24887261|NCT04518202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516115|NCT00600639|Prednisolone|prednisolone|mesh-list
24887273|NCT04518189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887274|NCT04518189|Sensory System Agents|sensory system agents|mesh-ancestor
24887275|NCT04518189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24887276|NCT04518189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24887277|NCT04518189|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24887278|NCT04518189|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24887279|NCT04518189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24887280|NCT04518189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887281|NCT04517890|Lidocaine|lidocaine|mesh-list
24887331|NCT04517292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887333|NCT04517227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24887334|NCT04517227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887335|NCT04517214|Gemcitabine|gemcitabine|mesh-list
24887336|NCT04517214|Capecitabine|capecitabine|mesh-list
24887337|NCT04517214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887338|NCT04517214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24887339|NCT04517214|Antimetabolites|antimetabolites|mesh-ancestor
24887340|NCT04517214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887341|NCT04517214|Antiviral Agents|antiviral agents|mesh-ancestor
24887342|NCT04517214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24887343|NCT04517214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887344|NCT04517214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24887345|NCT04517214|Immunologic Factors|immunologic factors|mesh-ancestor
24887346|NCT04517214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887347|NCT04517201|Insulin|insulin|mesh-list
24887348|NCT04517201|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24887349|NCT04517201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24887350|NCT04517201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816618|NCT02077959|Lenalidomide|lenalidomide|mesh-list
24816619|NCT02077959|Pidilizumab|pidilizumab|mesh-list
24816620|NCT02077959|Immunologic Factors|immunologic factors|mesh-ancestor
24816621|NCT02077959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698733|NCT02097108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698734|NCT02097238|Halichondrin B|halichondrin b|mesh-list
25698735|NCT02097238|Tubulin Modulators|tubulin modulators|mesh-ancestor
25698736|NCT02097238|Antimitotic Agents|antimitotic agents|mesh-ancestor
25698737|NCT02097238|Mitosis Modulators|mitosis modulators|mesh-ancestor
25698738|NCT02097238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698739|NCT02097238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25698740|NCT02097303|Prednisone|prednisone|mesh-list
25698741|NCT02097303|Abiraterone Acetate|abiraterone acetate|mesh-list
24991786|NCT05005312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929610|NCT04110808|Phentolamine|phentolamine|mesh-list
24991787|NCT05005312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24991788|NCT05005312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24991789|NCT05005312|Antiviral Agents|antiviral agents|mesh-ancestor
24991790|NCT05005312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24865562|NCT00112411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24816622|NCT02077959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24816623|NCT02077959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24887407|NCT04516616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887408|NCT04516681|Ascorbic Acid|ascorbic acid|mesh-list
24887409|NCT04516681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887410|NCT04516681|Vitamins|vitamins|mesh-ancestor
24887411|NCT04516681|Micronutrients|micronutrients|mesh-ancestor
24887412|NCT04516681|Antioxidants|antioxidants|mesh-ancestor
24887779|NCT04512638|Dermatologic Agents|dermatologic agents|mesh-ancestor
24887413|NCT04516681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887414|NCT04516681|Protective Agents|protective agents|mesh-ancestor
24887415|NCT04516655|Rituximab|rituximab|mesh-list
24887416|NCT04516655|Methotrexate|methotrexate|mesh-list
24887417|NCT04516655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24887418|NCT04516655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887419|NCT04516655|Immunologic Factors|immunologic factors|mesh-ancestor
24887420|NCT04516655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887533|NCT04515420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24887534|NCT04515420|Adrenergic Agents|adrenergic agents|mesh-ancestor
24887535|NCT04515420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24887536|NCT04515420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887537|NCT04515420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887538|NCT04515420|Sympathomimetics|sympathomimetics|mesh-ancestor
24887539|NCT04515420|Autonomic Agents|autonomic agents|mesh-ancestor
24887540|NCT04515420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24887541|NCT04515420|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24887542|NCT04515641|Islatravir|islatravir|mesh-list
24887543|NCT04515641|Antiviral Agents|antiviral agents|mesh-ancestor
24887544|NCT04515641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24887545|NCT04515641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887546|NCT04515641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887547|NCT04515641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24887548|NCT04515641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24887604|NCT04514588|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24887605|NCT04514588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887606|NCT04514588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24887607|NCT04514588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887608|NCT04514588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887626|NCT04514029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887628|NCT04514029|Glucocorticoids|glucocorticoids|mesh-ancestor
24887629|NCT04514029|Hormones|hormones|mesh-ancestor
24887630|NCT04514029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24887703|NCT04513509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24887704|NCT04513509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24887705|NCT04513509|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24887706|NCT04513509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887707|NCT04513509|Protective Agents|protective agents|mesh-ancestor
24887709|NCT04513509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24887721|NCT04513626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887722|NCT04513626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887723|NCT04513457|Liver Extracts|liver extracts|mesh-list
24887724|NCT04513457|Hematinics|hematinics|mesh-ancestor
24887726|NCT04513340|Carbidopa|carbidopa|mesh-list
24887727|NCT04513340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24887728|NCT04513340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24887729|NCT04513340|Dopamine Agents|dopamine agents|mesh-ancestor
24887746|NCT04513379|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24887747|NCT04513379|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24887748|NCT04513015|Antioxidants|antioxidants|mesh-list
24887752|NCT04513184|Dexamethasone|dexamethasone|mesh-list
25698742|NCT02097303|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25698743|NCT02097303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25698744|NCT02097303|Glucocorticoids|glucocorticoids|mesh-ancestor
25698745|NCT02097303|Hormones|hormones|mesh-ancestor
25698746|NCT02097303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25698747|NCT02097303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698748|NCT02097303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24991833|NCT04885881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24887764|NCT04513184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24887765|NCT04513184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816625|NCT02077959|Growth Inhibitors|growth inhibitors|mesh-ancestor
24816626|NCT02077959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816627|NCT02077959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24816628|NCT02077998|Oxaliplatin|oxaliplatin|mesh-list
24816629|NCT02077998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816630|NCT02078063|Mepivacaine|mepivacaine|mesh-list
24887769|NCT04512872|Denosumab|denosumab|mesh-list
25060750|NCT03477136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060751|NCT03477136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25060752|NCT03477110|Temozolomide|temozolomide|mesh-list
25060753|NCT03477110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25060754|NCT03477110|Alkylating Agents|alkylating agents|mesh-ancestor
25060755|NCT03477110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060756|NCT03477110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25060757|NCT03476941|Clindamycin|clindamycin|mesh-list
25060758|NCT03476941|Clindamycin palmitate|clindamycin palmitate|mesh-list
25060759|NCT03476941|Clindamycin phosphate|clindamycin phosphate|mesh-list
25060760|NCT03476941|Gentamicins|gentamicins|mesh-list
25060761|NCT03476941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24823159|NCT02115360|Calcitonin|calcitonin|mesh-list
24823162|NCT02115360|Fentanyl|fentanyl|mesh-list
24887778|NCT04512638|Disinfectants|disinfectants|mesh-ancestor
24887782|NCT04512404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24512549|NCT00575614|Laxatives|laxatives|mesh-ancestor
24512550|NCT00575614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24887787|NCT04512313|Rocuronium|rocuronium|mesh-list
24944783|NCT03957629|Interferon alpha-2|interferon alpha-2|mesh-list
25060767|NCT03476772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25060769|NCT03476772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25060770|NCT03476772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060771|NCT03476772|Analgesics|analgesics|mesh-ancestor
25060772|NCT03476772|Sensory System Agents|sensory system agents|mesh-ancestor
25060773|NCT03476772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060774|NCT03476616|Valsartan|valsartan|mesh-list
25060775|NCT03476616|Eplerenone|eplerenone|mesh-list
25060776|NCT03476616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24424475|NCT00229515|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24887903|NCT04511195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887904|NCT04510870|Ferric Compounds|ferric compounds|mesh-list
24887905|NCT04510870|Hematinics|hematinics|mesh-ancestor
24887909|NCT04510623|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24887910|NCT04510623|Protease Inhibitors|protease inhibitors|mesh-ancestor
24887911|NCT04510623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887913|NCT04510649|Rifampin|rifampin|mesh-list
24512602|NCT00575861|Zileuton|zileuton|mesh-list
24816663|NCT02078167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816664|NCT02078167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24516267|NCT00601289|Alkylating Agents|alkylating agents|mesh-ancestor
24816665|NCT02078167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24816666|NCT02078167|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24816667|NCT02078167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816668|NCT02078232|Pancrelipase|pancrelipase|mesh-list
24816669|NCT02078232|Pancreatin|pancreatin|mesh-list
24816670|NCT02078232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24816671|NCT02078323|Linaclotide|linaclotide|mesh-list
24816672|NCT02078323|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
24816673|NCT02078323|Enzyme Activators|enzyme activators|mesh-ancestor
24816674|NCT02078323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816675|NCT02078323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24816676|NCT02078336|Atropine|atropine|mesh-list
24816677|NCT02078336|Midazolam|midazolam|mesh-list
24816678|NCT02078336|Droperidol|droperidol|mesh-list
24816691|NCT02078336|GABA Modulators|gaba modulators|mesh-ancestor
24816698|NCT02078336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816699|NCT02078336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24816700|NCT02078336|Respiratory System Agents|respiratory system agents|mesh-ancestor
24816702|NCT02078336|Parasympatholytics|parasympatholytics|mesh-ancestor
24816703|NCT02078336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24816704|NCT02078336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24816705|NCT02078336|Cholinergic Agents|cholinergic agents|mesh-ancestor
25060791|NCT03476564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25060792|NCT03476564|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25060794|NCT03476564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060795|NCT03476564|Vasodilator Agents|vasodilator agents|mesh-ancestor
25060798|NCT03476356|Clomiphene|clomiphene|mesh-list
24887991|NCT04509466|Mitoxantrone|mitoxantrone|mesh-list
24887992|NCT04509466|Pegaspargase|pegaspargase|mesh-list
24887993|NCT04509466|Asparaginase|asparaginase|mesh-list
24887997|NCT04509466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887998|NCT04509466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887999|NCT04509466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24888000|NCT04509466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24888001|NCT04509466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24888008|NCT04509583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888009|NCT04509583|Protective Agents|protective agents|mesh-ancestor
24888010|NCT04509661|Bronchodilator Agents|bronchodilator agents|mesh-list
24888011|NCT04509661|Autonomic Agents|autonomic agents|mesh-ancestor
25060799|NCT03476356|Enclomiphene|enclomiphene|mesh-list
25060800|NCT03476356|Zuclomiphene|zuclomiphene|mesh-list
25060801|NCT03476356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25060802|NCT03476356|Hormone Antagonists|hormone antagonists|mesh-ancestor
25060831|NCT03476083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25060803|NCT03476356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24888067|NCT04509219|Prednisolone phosphate|prednisolone phosphate|mesh-list
24888068|NCT04509219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24888069|NCT04509219|Antiemetics|antiemetics|mesh-ancestor
24888070|NCT04509219|Autonomic Agents|autonomic agents|mesh-ancestor
24888071|NCT04509219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24888072|NCT04509219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888073|NCT04509219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25060806|NCT03476356|Fertility Agents|fertility agents|mesh-ancestor
25060807|NCT03476356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25060808|NCT03476356|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25060809|NCT03476356|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25060810|NCT03476174|Pembrolizumab|pembrolizumab|mesh-list
25060811|NCT03476174|Interleukin-2|interleukin-2|mesh-list
25060812|NCT03476174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25060813|NCT03476174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823212|NCT02115659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24823213|NCT02115659|Immunologic Factors|immunologic factors|mesh-ancestor
24823214|NCT02115659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24823215|NCT02115659|Alkylating Agents|alkylating agents|mesh-ancestor
24888074|NCT04509219|Glucocorticoids|glucocorticoids|mesh-ancestor
24888076|NCT04509219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24888077|NCT04509219|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24888078|NCT04509219|Protective Agents|protective agents|mesh-ancestor
24888079|NCT04509219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24888080|NCT04509219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24888081|NCT04509232|Fluorides|fluorides|mesh-list
24888082|NCT04509232|Cariostatic Agents|cariostatic agents|mesh-ancestor
24888083|NCT04509232|Protective Agents|protective agents|mesh-ancestor
24888101|NCT04509258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24888102|NCT04509258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24888103|NCT04509258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24888104|NCT04509258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24888116|NCT04509258|Micronutrients|micronutrients|mesh-ancestor
24888117|NCT04509258|Nootropic Agents|nootropic agents|mesh-ancestor
24888118|NCT04509258|Emollients|emollients|mesh-ancestor
24888120|NCT04508829|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24888121|NCT04508829|Immunologic Factors|immunologic factors|mesh-ancestor
24888122|NCT04508829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888123|NCT04508816|Cetuximab|cetuximab|mesh-list
24888124|NCT04508816|Nimotuzumab|nimotuzumab|mesh-list
24429240|NCT00243009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24888125|NCT04508816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24888126|NCT04508816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24888127|NCT04508894|Dexmedetomidine|dexmedetomidine|mesh-list
24888128|NCT04508894|Ketamine|ketamine|mesh-list
24888129|NCT04508894|Bupivacaine|bupivacaine|mesh-list
24888130|NCT04508894|Anesthetics, Local|anesthetics, local|mesh-ancestor
24888131|NCT04508894|Anesthetics|anesthetics|mesh-ancestor
24888132|NCT04508894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24888133|NCT04508894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888134|NCT04508894|Sensory System Agents|sensory system agents|mesh-ancestor
24888135|NCT04508894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24888136|NCT04508894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24888137|NCT04508894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24888138|NCT04508894|Analgesics|analgesics|mesh-ancestor
24785525|NCT01914939|Oxytocin|oxytocin|mesh-list
24785526|NCT01914939|Oxytocics|oxytocics|mesh-ancestor
24785527|NCT01914939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24785528|NCT01914939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060814|NCT03476174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25060815|NCT03476174|Analgesics|analgesics|mesh-ancestor
25060816|NCT03476174|Sensory System Agents|sensory system agents|mesh-ancestor
25060817|NCT03476174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060818|NCT03476174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060819|NCT03476109|Omalizumab|omalizumab|mesh-list
24888151|NCT04508686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24888152|NCT04508686|Antimetabolites|antimetabolites|mesh-ancestor
24888154|NCT04508686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466236|NCT00372658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24888176|NCT04508400|Glucocorticoids|glucocorticoids|mesh-ancestor
24888177|NCT04508400|Hormones|hormones|mesh-ancestor
24888178|NCT04508400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24888179|NCT04508400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24888180|NCT04508400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24888181|NCT04508400|Protease Inhibitors|protease inhibitors|mesh-ancestor
24888182|NCT04508400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24888183|NCT04508400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888184|NCT04508400|Antipruritics|antipruritics|mesh-ancestor
24888185|NCT04508400|Dermatologic Agents|dermatologic agents|mesh-ancestor
24823230|NCT02115763|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24823232|NCT02115763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24888232|NCT04508140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24888264|NCT04507607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888265|NCT04507607|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24888266|NCT04507607|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24430976|NCT00249899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24430977|NCT00249899|Antimetabolites|antimetabolites|mesh-ancestor
24888273|NCT04507750|Apatinib|apatinib|mesh-list
24888278|NCT04507217|Carboplatin|carboplatin|mesh-list
24579441|NCT00855101|Antifungal Agents|antifungal agents|mesh-ancestor
24579442|NCT00855101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24579452|NCT00855114|Everolimus|everolimus|mesh-list
24823241|NCT02115776|Clavulanic Acids|clavulanic acids|mesh-list
24512750|NCT00576433|Dermatologic Agents|dermatologic agents|mesh-ancestor
24512751|NCT00576433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24888289|NCT04507165|Narcotics|narcotics|mesh-ancestor
24888290|NCT04507165|Analgesics|analgesics|mesh-ancestor
24888373|NCT04505995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24888379|NCT04505644|Anesthetics|anesthetics|mesh-ancestor
24888380|NCT04505644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24888381|NCT04505644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888382|NCT04505644|Sensory System Agents|sensory system agents|mesh-ancestor
24888383|NCT04505644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24888384|NCT04505644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24816707|NCT02078336|Antiemetics|antiemetics|mesh-ancestor
24816735|NCT02078583|Narcotics|narcotics|mesh-ancestor
24816736|NCT02078583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24816737|NCT02078583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816738|NCT02078583|Analgesics|analgesics|mesh-ancestor
24816739|NCT02078583|Sensory System Agents|sensory system agents|mesh-ancestor
24816740|NCT02078583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24888386|NCT04505644|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24888387|NCT04505644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24888388|NCT04505644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888389|NCT04505475|Hemostatics|hemostatics|mesh-list
24888390|NCT04505475|Coagulants|coagulants|mesh-ancestor
24888391|NCT04505800|Tryptophan|tryptophan|mesh-list
24888392|NCT04505800|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24888393|NCT04505800|Antidepressive Agents|antidepressive agents|mesh-ancestor
24888394|NCT04505800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24888395|NCT04505917|Misoprostol|misoprostol|mesh-list
24888396|NCT04505917|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24888397|NCT04505917|Abortifacient Agents|abortifacient agents|mesh-ancestor
25698749|NCT02097303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25698750|NCT02097303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25698751|NCT02097303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25698752|NCT02097303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698753|NCT02097303|Hormone Antagonists|hormone antagonists|mesh-ancestor
24888398|NCT04505917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24888399|NCT04505917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888400|NCT04505917|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24888401|NCT04505917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24888415|NCT04505657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24888418|NCT04505657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888419|NCT04505657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24888420|NCT04505657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24888421|NCT04505657|Analgesics|analgesics|mesh-ancestor
24888422|NCT04505657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24888423|NCT04505657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24888424|NCT04505657|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24888425|NCT04505657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24888426|NCT04505657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466400|NCT00373464|Sensory System Agents|sensory system agents|mesh-ancestor
24466401|NCT00373464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953023|NCT03890003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953024|NCT03889470|Nitroglycerin|nitroglycerin|mesh-list
24953025|NCT03889470|Vasodilator Agents|vasodilator agents|mesh-ancestor
24888509|NCT04503629|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24888510|NCT04503629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24888511|NCT04503629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888512|NCT04503460|Fluticasone|fluticasone|mesh-list
24888513|NCT04503460|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24888514|NCT04503460|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24888515|NCT04503460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24888516|NCT04503460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24888517|NCT04503460|Autonomic Agents|autonomic agents|mesh-ancestor
24888518|NCT04503460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24888519|NCT04503460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888520|NCT04503460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24888521|NCT04503460|Respiratory System Agents|respiratory system agents|mesh-ancestor
24888522|NCT04503460|Dermatologic Agents|dermatologic agents|mesh-ancestor
24953065|NCT03888924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778870|NCT01872858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24778871|NCT01872858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24778872|NCT01872858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24778873|NCT01872858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778874|NCT01872858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24778875|NCT01872858|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24778876|NCT01872858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24778877|NCT01872858|Antipyretics|antipyretics|mesh-ancestor
24512763|NCT00576511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24512764|NCT00576511|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24512765|NCT00576511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24512766|NCT00576511|Serotonin Agents|serotonin agents|mesh-ancestor
24512767|NCT00576511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24466456|NCT00373581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466457|NCT00373581|Dopamine Agents|dopamine agents|mesh-ancestor
24466458|NCT00373581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24888523|NCT04503460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24888524|NCT04503460|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24888525|NCT04503460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24888526|NCT04503460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24888527|NCT04503460|Adrenergic Agents|adrenergic agents|mesh-ancestor
24888528|NCT04503460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24888529|NCT04503460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888530|NCT04503460|Glucocorticoids|glucocorticoids|mesh-ancestor
24888570|NCT04502641|Docetaxel|docetaxel|mesh-list
24888604|NCT04502277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24888605|NCT04502277|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24711068|NCT01513083|Maytansine|maytansine|mesh-list
24888606|NCT04502277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24888607|NCT04502277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24888608|NCT04502277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888609|NCT04502277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24888610|NCT04502277|Hormone Antagonists|hormone antagonists|mesh-ancestor
24888611|NCT04502277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24888612|NCT04502277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698754|NCT02097303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24888613|NCT04502277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24888614|NCT04502277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24888615|NCT04502251|Naltrexone|naltrexone|mesh-list
24888616|NCT04502251|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24888617|NCT04502251|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24888618|NCT04502251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888619|NCT04502251|Sensory System Agents|sensory system agents|mesh-ancestor
24888620|NCT04502251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24888621|NCT04502017|Clopidogrel|clopidogrel|mesh-list
24888622|NCT04502017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24888623|NCT04502017|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24823289|NCT02116400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888644|NCT04501900|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24888645|NCT04501900|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24888646|NCT04501900|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24888648|NCT04501900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24888649|NCT04501900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888650|NCT04501900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888654|NCT04501809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24888655|NCT04501809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888665|NCT04501523|Antimetabolites|antimetabolites|mesh-ancestor
24823338|NCT02116790|Gout Suppressants|gout suppressants|mesh-ancestor
24888666|NCT04501523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953070|NCT03888846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24953071|NCT03888846|Tubulin Modulators|tubulin modulators|mesh-ancestor
24953072|NCT03888846|Antimitotic Agents|antimitotic agents|mesh-ancestor
24953073|NCT03888846|Mitosis Modulators|mitosis modulators|mesh-ancestor
24953074|NCT03888846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953075|NCT03888846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24953076|NCT03888846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24823299|NCT02116465|Dopamine Agents|dopamine agents|mesh-ancestor
24823300|NCT02116465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24823301|NCT02116465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823302|NCT02116465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823303|NCT02116465|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24888706|NCT04501367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24888707|NCT04501367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24888708|NCT04501367|Protease Inhibitors|protease inhibitors|mesh-ancestor
24888709|NCT04501367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816741|NCT02078583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24816742|NCT02078583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25060842|NCT03475862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25060843|NCT03475862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060845|NCT03475862|Sensory System Agents|sensory system agents|mesh-ancestor
25060846|NCT03475862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25060848|NCT03475810|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25060849|NCT03475810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25060850|NCT03475810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25060851|NCT03475810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25060852|NCT03475810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25060853|NCT03475810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25060854|NCT03475810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25060855|NCT03475810|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25060856|NCT03475810|Anesthetics, General|anesthetics, general|mesh-ancestor
25060857|NCT03475810|Anesthetics|anesthetics|mesh-ancestor
24823313|NCT02116556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24888752|NCT04500496|Antimetabolites|antimetabolites|mesh-ancestor
24888753|NCT04500496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888754|NCT04500496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24888755|NCT04500704|Carboplatin|carboplatin|mesh-list
25060859|NCT03475810|GABA Agents|gaba agents|mesh-ancestor
25060860|NCT03475810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25060861|NCT03475810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060862|NCT03475758|Goserelin|goserelin|mesh-list
25060863|NCT03475758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25060864|NCT03475758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25060865|NCT03475693|Acetaminophen|acetaminophen|mesh-list
25060866|NCT03475693|Ondansetron|ondansetron|mesh-list
24888797|NCT04500561|Immunologic Factors|immunologic factors|mesh-ancestor
24466658|NCT00374465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466659|NCT00374465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24991890|NCT04796948|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24991891|NCT04796948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24991892|NCT04796948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991893|NCT04796948|Antidotes|antidotes|mesh-ancestor
24991894|NCT04796948|Protective Agents|protective agents|mesh-ancestor
24991895|NCT04796948|Vitamin B Complex|vitamin b complex|mesh-ancestor
24991896|NCT04796948|Vitamins|vitamins|mesh-ancestor
24466660|NCT00374465|Antioxidants|antioxidants|mesh-ancestor
24466661|NCT00374465|Protective Agents|protective agents|mesh-ancestor
24466662|NCT00374465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24466663|NCT00374465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24466664|NCT00374465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24466665|NCT00374465|Vasodilator Agents|vasodilator agents|mesh-ancestor
24466666|NCT00374465|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24466667|NCT00374465|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24466668|NCT00374465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24888878|NCT04499586|Irinotecan|irinotecan|mesh-list
24888883|NCT04499586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888884|NCT04499586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24888885|NCT04499586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24888886|NCT04499586|Antimetabolites|antimetabolites|mesh-ancestor
24888887|NCT04499586|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25060874|NCT03475693|Antiemetics|antiemetics|mesh-ancestor
25060875|NCT03475693|Autonomic Agents|autonomic agents|mesh-ancestor
25060876|NCT03475693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25060877|NCT03475693|Antipruritics|antipruritics|mesh-ancestor
25060878|NCT03475693|Dermatologic Agents|dermatologic agents|mesh-ancestor
25060879|NCT03475693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25060880|NCT03475693|Serotonin Agents|serotonin agents|mesh-ancestor
25060881|NCT03475693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24888910|NCT04499573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24888912|NCT04499573|Autonomic Agents|autonomic agents|mesh-ancestor
24888913|NCT04499573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24888914|NCT04499573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24888915|NCT04499573|Glucocorticoids|glucocorticoids|mesh-ancestor
24888916|NCT04499573|Hormones|hormones|mesh-ancestor
24888917|NCT04499573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24888918|NCT04499573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24888919|NCT04499573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24888920|NCT04499573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24888921|NCT04499573|Antimetabolites|antimetabolites|mesh-ancestor
24888922|NCT04499573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24888923|NCT04499573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24888924|NCT04499573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24888925|NCT04499573|Antiviral Agents|antiviral agents|mesh-ancestor
24888926|NCT04499573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24888927|NCT04499976|Misoprostol|misoprostol|mesh-list
24888928|NCT04499976|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24888929|NCT04499976|Abortifacient Agents|abortifacient agents|mesh-ancestor
24888964|NCT04499235|Mometasone Furoate|mometasone furoate|mesh-list
24888965|NCT04499235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24888966|NCT04499235|Dermatologic Agents|dermatologic agents|mesh-ancestor
24888967|NCT04499235|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24888969|NCT04499209|Pregabalin|pregabalin|mesh-list
24888970|NCT04499209|Analgesics|analgesics|mesh-ancestor
24888971|NCT04499209|Sensory System Agents|sensory system agents|mesh-ancestor
24888972|NCT04499209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24466756|NCT00374881|Phenylephrine|phenylephrine|mesh-list
24512780|NCT00576550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24888994|NCT04498936|Antiviral Agents|antiviral agents|mesh-ancestor
24888995|NCT04498936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24888996|NCT04498936|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24888997|NCT04498897|Acamprosate|acamprosate|mesh-list
24888998|NCT04498897|Vortioxetine|vortioxetine|mesh-list
24888999|NCT04498897|Antidepressive Agents|antidepressive agents|mesh-ancestor
24889000|NCT04498897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24889001|NCT04498897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24889002|NCT04498897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24889003|NCT04498897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24889004|NCT04498897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698755|NCT02097472|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25698756|NCT02097472|Immunologic Factors|immunologic factors|mesh-ancestor
25698757|NCT02097472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698758|NCT02097537|Methacholine Chloride|methacholine chloride|mesh-list
25698759|NCT02097537|Miotics|miotics|mesh-ancestor
25698760|NCT02097537|Autonomic Agents|autonomic agents|mesh-ancestor
25698761|NCT02097537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24889005|NCT04498897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24889006|NCT04498897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24889007|NCT04498897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24889008|NCT04498897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889009|NCT04498897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24889010|NCT04498897|Serotonin Agents|serotonin agents|mesh-ancestor
24889011|NCT04498897|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24889012|NCT04498897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24889013|NCT04498897|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24889014|NCT04498897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24889023|NCT04498689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889024|NCT04498689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24889025|NCT04498689|Antimetabolites|antimetabolites|mesh-ancestor
24889026|NCT04498689|Antiviral Agents|antiviral agents|mesh-ancestor
24889027|NCT04498689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24889028|NCT04498689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889029|NCT04498689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25060908|NCT03475615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25060909|NCT03475615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25060910|NCT03475615|Tubulin Modulators|tubulin modulators|mesh-ancestor
24889039|NCT04498793|Antimitotic Agents|antimitotic agents|mesh-ancestor
24512858|NCT00577109|Micronutrients|micronutrients|mesh-ancestor
24512859|NCT00577161|Vidarabine|vidarabine|mesh-list
24512860|NCT00577161|Rituximab|rituximab|mesh-list
24512861|NCT00577161|Fludarabine|fludarabine|mesh-list
24512862|NCT00577161|Fludarabine phosphate|fludarabine phosphate|mesh-list
24512863|NCT00577161|Pixantrone|pixantrone|mesh-list
24512864|NCT00577161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24512865|NCT00577161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24889041|NCT04498793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889042|NCT04498793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24889043|NCT04498793|Immunologic Factors|immunologic factors|mesh-ancestor
24889044|NCT04498793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889045|NCT04498793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24889046|NCT04498793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24889047|NCT04498793|Alkylating Agents|alkylating agents|mesh-ancestor
24889048|NCT04498793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24889049|NCT04498793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24889050|NCT04498793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24889051|NCT04498793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24512899|NCT00577200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24512900|NCT00577304|Nitroglycerin|nitroglycerin|mesh-list
24512901|NCT00577304|Vasodilator Agents|vasodilator agents|mesh-ancestor
24512903|NCT00577369|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24512904|NCT00577369|Anesthetics, General|anesthetics, general|mesh-ancestor
24512905|NCT00577369|Anesthetics|anesthetics|mesh-ancestor
25060911|NCT03475615|Antimitotic Agents|antimitotic agents|mesh-ancestor
25060912|NCT03475615|Mitosis Modulators|mitosis modulators|mesh-ancestor
25060913|NCT03475615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25060914|NCT03475615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24512906|NCT00577369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24512907|NCT00577369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512908|NCT00577421|Risedronic Acid|risedronic acid|mesh-list
24889058|NCT04498325|Immunologic Factors|immunologic factors|mesh-ancestor
24889059|NCT04498325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816768|NCT02078648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24816769|NCT02078648|Growth Substances|growth substances|mesh-ancestor
24816770|NCT02078648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816771|NCT02078648|Growth Inhibitors|growth inhibitors|mesh-ancestor
24816772|NCT02078648|Interferon Inducers|interferon inducers|mesh-ancestor
24889076|NCT04498520|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24889078|NCT04498234|Anesthetics, Local|anesthetics, local|mesh-ancestor
24889079|NCT04498234|Anesthetics|anesthetics|mesh-ancestor
24466886|NCT00375466|Hemostatics|hemostatics|mesh-ancestor
24889080|NCT04498234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24889081|NCT04498234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889082|NCT04498234|Sensory System Agents|sensory system agents|mesh-ancestor
24889083|NCT04498234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24889084|NCT04498260|Triamcinolone|triamcinolone|mesh-list
24889085|NCT04498260|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24889086|NCT04498260|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24889087|NCT04498260|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24889088|NCT04498260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24889089|NCT04498260|Glucocorticoids|glucocorticoids|mesh-ancestor
24889090|NCT04498260|Hormones|hormones|mesh-ancestor
24889115|NCT04497766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24889116|NCT04497766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889117|NCT04497766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25060917|NCT03475589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25060918|NCT03475589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24889125|NCT04497792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889126|NCT04497649|Sofosbuvir|sofosbuvir|mesh-list
24889127|NCT04497649|Antiviral Agents|antiviral agents|mesh-ancestor
24889128|NCT04497649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24889131|NCT04497012|Micronutrients|micronutrients|mesh-ancestor
24889132|NCT04497012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512930|NCT00577668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24512931|NCT00577668|Alkylating Agents|alkylating agents|mesh-ancestor
24512932|NCT00577668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512933|NCT00577668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24512934|NCT00577668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24512935|NCT00577668|Immunologic Factors|immunologic factors|mesh-ancestor
24512936|NCT00577668|Leprostatic Agents|leprostatic agents|mesh-ancestor
24512937|NCT00577668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25060941|NCT03475407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25060942|NCT03475407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25060943|NCT03475407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25060944|NCT03475407|Protease Inhibitors|protease inhibitors|mesh-ancestor
24945030|NCT03954873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889166|NCT04496492|Protective Agents|protective agents|mesh-ancestor
24889167|NCT04496492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889168|NCT04496492|Vitamins|vitamins|mesh-ancestor
24889169|NCT04496492|Micronutrients|micronutrients|mesh-ancestor
24711681|NCT01516580|Rituximab|rituximab|mesh-list
24889170|NCT04496141|Antibodies|antibodies|mesh-list
24889171|NCT04496141|Immunologic Factors|immunologic factors|mesh-ancestor
24889172|NCT04496141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889173|NCT04496037|Rituximab|rituximab|mesh-list
24889174|NCT04496037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24889175|NCT04496037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24889176|NCT04496037|Immunologic Factors|immunologic factors|mesh-ancestor
24889177|NCT04496037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889178|NCT04496037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24889179|NCT04496050|Alprostadil|alprostadil|mesh-list
24889180|NCT04496050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24889183|NCT04495894|Ketorolac|ketorolac|mesh-list
25060969|NCT03475160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25060970|NCT03475160|Urological Agents|urological agents|mesh-ancestor
25060971|NCT03475121|Topotecan|topotecan|mesh-list
25060972|NCT03475121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24512973|NCT00577850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24512974|NCT00577850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24512975|NCT00577850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512976|NCT00577850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24512977|NCT00577967|Gabapentin|gabapentin|mesh-list
24889192|NCT04495894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24889193|NCT04495894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889194|NCT04495894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889195|NCT04495881|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24889196|NCT04495881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24889197|NCT04495881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889198|NCT04495881|Incretins|incretins|mesh-ancestor
24889199|NCT04495881|Hormones|hormones|mesh-ancestor
24889200|NCT04495881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25061001|NCT03474939|Anesthetics|anesthetics|mesh-ancestor
25061002|NCT03474939|GABA Modulators|gaba modulators|mesh-ancestor
25061003|NCT03474939|GABA Agents|gaba agents|mesh-ancestor
25061004|NCT03474939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25061005|NCT03474939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823439|NCT02117401|Midazolam|midazolam|mesh-list
24889219|NCT04496024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889220|NCT04496024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25698762|NCT02097537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513021|NCT00578149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513022|NCT00578149|Growth Inhibitors|growth inhibitors|mesh-ancestor
24513023|NCT00578201|Cetuximab|cetuximab|mesh-list
24513024|NCT00578201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24513025|NCT00578201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513026|NCT00578266|Cyclophosphamide|cyclophosphamide|mesh-list
24513027|NCT00578266|Alemtuzumab|alemtuzumab|mesh-list
24513028|NCT00578266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24889243|NCT04495101|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25061018|NCT03474614|Adrenergic Agents|adrenergic agents|mesh-ancestor
25061019|NCT03474614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25061133|NCT03473600|Immunologic Factors|immunologic factors|mesh-ancestor
25061027|NCT03474601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061028|NCT03474510|Bupivacaine|bupivacaine|mesh-list
25061029|NCT03474510|Ropivacaine|ropivacaine|mesh-list
25061030|NCT03474510|Anesthetics, Local|anesthetics, local|mesh-ancestor
25061031|NCT03474510|Anesthetics|anesthetics|mesh-ancestor
25061032|NCT03474510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25061033|NCT03474510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061034|NCT03474510|Sensory System Agents|sensory system agents|mesh-ancestor
25061035|NCT03474510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25061036|NCT03474341|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24945137|NCT03953326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24945138|NCT03953326|Vasodilator Agents|vasodilator agents|mesh-ancestor
25061044|NCT03474237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25061045|NCT03474237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061046|NCT03474198|Levofloxacin|levofloxacin|mesh-list
25061047|NCT03474198|Rifampin|rifampin|mesh-list
25061048|NCT03474198|Isoniazid|isoniazid|mesh-list
25061049|NCT03474198|Linezolid|linezolid|mesh-list
25061104|NCT03473639|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25061105|NCT03473639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25061107|NCT03473626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25061108|NCT03473626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25061109|NCT03473626|Immunologic Factors|immunologic factors|mesh-ancestor
25061110|NCT03473626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061111|NCT03473613|Calcium, Dietary|calcium, dietary|mesh-list
25061112|NCT03473613|Cabergoline|cabergoline|mesh-list
25061114|NCT03473613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25061115|NCT03473613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061118|NCT03473613|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25061119|NCT03473613|Dopamine Agonists|dopamine agonists|mesh-ancestor
25061120|NCT03473613|Dopamine Agents|dopamine agents|mesh-ancestor
25061121|NCT03473613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25061122|NCT03473613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061123|NCT03473600|Triamcinolone|triamcinolone|mesh-list
25061124|NCT03473600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25061125|NCT03473600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25061126|NCT03473600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25061127|NCT03473600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25061128|NCT03473600|Glucocorticoids|glucocorticoids|mesh-ancestor
25061129|NCT03473600|Hormones|hormones|mesh-ancestor
24889291|NCT04494828|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24889292|NCT04494828|Adrenergic Agents|adrenergic agents|mesh-ancestor
24889293|NCT04494828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24889294|NCT04494828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889295|NCT04494529|Betamethasone|betamethasone|mesh-list
24889296|NCT04494529|Betamethasone Valerate|betamethasone valerate|mesh-list
24889297|NCT04494529|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24889298|NCT04494529|Betamethasone benzoate|betamethasone benzoate|mesh-list
24889315|NCT04494321|Budesonide|budesonide|mesh-list
24441023|NCT00285727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441024|NCT00285727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889316|NCT04494321|Formoterol Fumarate|formoterol fumarate|mesh-list
25698763|NCT02097537|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25698764|NCT02097537|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
25698765|NCT02097537|Respiratory System Agents|respiratory system agents|mesh-ancestor
25698766|NCT02097537|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24889333|NCT04494100|Lidocaine|lidocaine|mesh-list
24889334|NCT04494100|Epinephrine|epinephrine|mesh-list
24992050|NCT04523961|Sensory System Agents|sensory system agents|mesh-ancestor
24992051|NCT04523961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24992052|NCT04523961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24889335|NCT04494100|Ropivacaine|ropivacaine|mesh-list
24889336|NCT04494100|Anesthetics, Local|anesthetics, local|mesh-ancestor
25061130|NCT03473600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25061131|NCT03473600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061132|NCT03473600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25061134|NCT03473600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25061135|NCT03473600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061136|NCT03473431|Ketamine|ketamine|mesh-list
25061137|NCT03473431|Analgesics|analgesics|mesh-ancestor
25061138|NCT03473431|Sensory System Agents|sensory system agents|mesh-ancestor
25061139|NCT03473431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25061140|NCT03473431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061141|NCT03473431|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25061142|NCT03473431|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24823613|NCT02118090|Analgesics|analgesics|mesh-ancestor
24889337|NCT04494100|Anesthetics|anesthetics|mesh-ancestor
24889344|NCT04494100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24889345|NCT04494100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24889346|NCT04494100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889347|NCT04494100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24889348|NCT04494100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24889349|NCT04494100|Adrenergic Agents|adrenergic agents|mesh-ancestor
24889350|NCT04494100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24889351|NCT04494100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24889352|NCT04494100|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24889353|NCT04494100|Autonomic Agents|autonomic agents|mesh-ancestor
24889354|NCT04494100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24889355|NCT04494100|Respiratory System Agents|respiratory system agents|mesh-ancestor
24889356|NCT04494100|Mydriatics|mydriatics|mesh-ancestor
24889357|NCT04494100|Sympathomimetics|sympathomimetics|mesh-ancestor
24889358|NCT04494100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24889359|NCT04494438|Rituximab|rituximab|mesh-list
24889360|NCT04494438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24889361|NCT04494438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24889362|NCT04494438|Immunologic Factors|immunologic factors|mesh-ancestor
24889363|NCT04494438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889364|NCT04494438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24889365|NCT04494243|Rabeprazole|rabeprazole|mesh-list
24889366|NCT04494243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24441187|NCT00286351|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24441188|NCT00286351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24441206|NCT00286403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623501|NCT01071928|Vadimezan|vadimezan|mesh-list
24623502|NCT01071928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623503|NCT01071928|Tubulin Modulators|tubulin modulators|mesh-ancestor
24623504|NCT01071928|Antimitotic Agents|antimitotic agents|mesh-ancestor
24623505|NCT01071928|Mitosis Modulators|mitosis modulators|mesh-ancestor
24889389|NCT04493554|Vasopressins|vasopressins|mesh-list
24889390|NCT04493554|Arginine Vasopressin|arginine vasopressin|mesh-list
24889391|NCT04493554|Hemostatics|hemostatics|mesh-ancestor
24889392|NCT04493554|Coagulants|coagulants|mesh-ancestor
24889393|NCT04493554|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24889394|NCT04493554|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24889395|NCT04493554|Natriuretic Agents|natriuretic agents|mesh-ancestor
24889396|NCT04493554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889397|NCT04493515|Oxytocin|oxytocin|mesh-list
24889398|NCT04493515|Oxytocics|oxytocics|mesh-ancestor
25061154|NCT03473418|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25061155|NCT03473418|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25061156|NCT03473418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25061157|NCT03473418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698767|NCT02097537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25698768|NCT02097537|Cholinergic Agents|cholinergic agents|mesh-ancestor
25698769|NCT02097537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25061158|NCT03473418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25698770|NCT02097537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061159|NCT03473418|Hormone Antagonists|hormone antagonists|mesh-ancestor
25061160|NCT03473418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25061161|NCT03473418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061162|NCT03473418|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25061211|NCT03473093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25061212|NCT03473093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061213|NCT03473093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24889444|NCT04493463|Anesthetics, Local|anesthetics, local|mesh-ancestor
24889445|NCT04493463|Anesthetics|anesthetics|mesh-ancestor
24889446|NCT04493463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25061230|NCT03472963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25061231|NCT03472963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25061232|NCT03472963|Antiviral Agents|antiviral agents|mesh-ancestor
25061233|NCT03472963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25061234|NCT03472950|Ranolazine|ranolazine|mesh-list
25061235|NCT03472950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25061236|NCT03472950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25061237|NCT03472950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061238|NCT03472872|Acetaminophen|acetaminophen|mesh-list
25061239|NCT03472872|Ketorolac|ketorolac|mesh-list
25061240|NCT03472872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25061241|NCT03472872|Analgesics|analgesics|mesh-ancestor
25061242|NCT03472872|Sensory System Agents|sensory system agents|mesh-ancestor
24889506|NCT04492813|Anesthetics, General|anesthetics, general|mesh-ancestor
24889507|NCT04492813|Anesthetics|anesthetics|mesh-ancestor
24889508|NCT04492813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24889509|NCT04492813|Narcotics|narcotics|mesh-ancestor
25061252|NCT03472846|Teriparatide|teriparatide|mesh-list
25061253|NCT03472846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25061254|NCT03472846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061255|NCT03472846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25061256|NCT03472677|Capsaicin|capsaicin|mesh-list
25061257|NCT03472677|Antipruritics|antipruritics|mesh-ancestor
25061258|NCT03472677|Dermatologic Agents|dermatologic agents|mesh-ancestor
25061259|NCT03472677|Sensory System Agents|sensory system agents|mesh-ancestor
25061260|NCT03472677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25061261|NCT03472677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061262|NCT03472651|Flupenthixol|flupenthixol|mesh-list
24945354|NCT03951402|Analgesics|analgesics|mesh-ancestor
25061289|NCT03472508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061290|NCT03472508|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25061292|NCT03472508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25061293|NCT03472456|Eugenol|eugenol|mesh-list
25061294|NCT03472456|Carticaine|carticaine|mesh-list
25061295|NCT03472456|Anesthetics, Local|anesthetics, local|mesh-ancestor
25061296|NCT03472456|Anesthetics|anesthetics|mesh-ancestor
25061297|NCT03472456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25061298|NCT03472456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061299|NCT03472456|Sensory System Agents|sensory system agents|mesh-ancestor
25061300|NCT03472456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25061301|NCT03472456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24889531|NCT04492319|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24889532|NCT04492319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889536|NCT04492319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889538|NCT04492319|Autonomic Agents|autonomic agents|mesh-ancestor
24889618|NCT04491474|Anesthetics|anesthetics|mesh-ancestor
24889619|NCT04491474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24889620|NCT04491474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889621|NCT04491474|Sensory System Agents|sensory system agents|mesh-ancestor
24889622|NCT04491474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24889623|NCT04491474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24889624|NCT04491474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24889625|NCT04491474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24889626|NCT04491474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24889627|NCT04491474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061306|NCT03472378|Sensory System Agents|sensory system agents|mesh-ancestor
25061307|NCT03472378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25061308|NCT03472378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061309|NCT03472378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24513091|NCT00578721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513092|NCT00578721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24513093|NCT00578721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24513096|NCT00578721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513097|NCT00578721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25061340|NCT03472144|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24513098|NCT00578721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24513124|NCT00578825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061310|NCT03472378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25061311|NCT03472378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25061312|NCT03472378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25061313|NCT03472378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25061314|NCT03472378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061315|NCT03472339|Diclofenac|diclofenac|mesh-list
25061316|NCT03472339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25061317|NCT03472339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24513126|NCT00578825|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24513127|NCT00578825|Antiviral Agents|antiviral agents|mesh-ancestor
24513128|NCT00578825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24889674|NCT04490967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24889675|NCT04490967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24889677|NCT04490967|Sensory System Agents|sensory system agents|mesh-ancestor
24889678|NCT04490967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24889679|NCT04490967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24889680|NCT04490967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24889681|NCT04490967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24889682|NCT04490967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889683|NCT04490967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24889684|NCT04490967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24889685|NCT04490837|Antibodies|antibodies|mesh-list
24513143|NCT00579085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24513144|NCT00579085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24513145|NCT00579085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24513146|NCT00579085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24513147|NCT00579085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513148|NCT00579475|Mifepristone|mifepristone|mesh-list
24513149|NCT00579475|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24513150|NCT00579475|Abortifacient Agents|abortifacient agents|mesh-ancestor
24513151|NCT00579475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24513152|NCT00579475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513153|NCT00579475|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24889689|NCT04490681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24889690|NCT04490681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889692|NCT04490681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698771|NCT02097641|Plasma-lyte 148|plasma-lyte 148|mesh-list
25698772|NCT02097641|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25698773|NCT02097641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25709497|NCT02268058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709498|NCT02268214|Dapagliflozin|dapagliflozin|mesh-list
25709499|NCT02268214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25709500|NCT02268214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709501|NCT02268214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24992162|NCT04226833|Entrectinib|entrectinib|mesh-list
24992166|NCT04214860|Azacitidine|azacitidine|mesh-list
24992183|NCT04197310|Nivolumab|nivolumab|mesh-list
24992184|NCT04197310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24992185|NCT04197310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992186|NCT04197310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24992190|NCT04168112|Dexamethasone|dexamethasone|mesh-list
24513166|NCT00579592|Alemtuzumab|alemtuzumab|mesh-list
24513167|NCT00579592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24513168|NCT00579592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513169|NCT00579592|Immunologic Factors|immunologic factors|mesh-ancestor
24513170|NCT00579592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513171|NCT00579592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24513172|NCT00579592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24513173|NCT00579592|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24513174|NCT00579592|Antitubercular Agents|antitubercular agents|mesh-ancestor
24513175|NCT00579592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24513176|NCT00579592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25061337|NCT03472261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25061338|NCT03472170|Lactoferrin|lactoferrin|mesh-list
25061339|NCT03472170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25061349|NCT03472144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24623515|NCT01072045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623516|NCT01072045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24623517|NCT01072045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24623518|NCT01072045|Adrenergic Agents|adrenergic agents|mesh-ancestor
24623519|NCT01072045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24623571|NCT01072318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24513187|NCT00579644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513188|NCT00579644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25061355|NCT03472040|Berotralstat|berotralstat|mesh-list
25061356|NCT03472040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25061357|NCT03472040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061358|NCT03471988|Voriconazole|voriconazole|mesh-list
25061359|NCT03471988|Antifungal Agents|antifungal agents|mesh-ancestor
25061360|NCT03471988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25061361|NCT03471988|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24945514|NCT03949985|Hemostatics|hemostatics|mesh-list
24945515|NCT03949985|Contraceptive Agents|contraceptive agents|mesh-list
24945516|NCT03949985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24945517|NCT03949985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945518|NCT03949985|Coagulants|coagulants|mesh-ancestor
24823835|NCT02119234|Hormones|hormones|mesh-ancestor
24889754|NCT04490031|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24889755|NCT04490031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24889756|NCT04490031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889779|NCT04490213|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24889780|NCT04490213|Laxatives|laxatives|mesh-ancestor
24889781|NCT04490213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24889782|NCT04489706|Arsenic Trioxide|arsenic trioxide|mesh-list
24889783|NCT04489706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24945528|NCT03949686|Anesthetics, Local|anesthetics, local|mesh-ancestor
24945530|NCT03949686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24945531|NCT03949686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945532|NCT03949686|Sensory System Agents|sensory system agents|mesh-ancestor
24945533|NCT03949686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24945534|NCT03949842|Fluticasone|fluticasone|mesh-list
24945535|NCT03949842|Xhance|xhance|mesh-list
24945536|NCT03949842|Adrenergic Agents|adrenergic agents|mesh-list
24953078|NCT03888846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24953079|NCT03888846|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24953080|NCT03888846|Protective Agents|protective agents|mesh-ancestor
24953081|NCT03888846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953082|NCT03888846|Vasodilator Agents|vasodilator agents|mesh-ancestor
24953083|NCT03888846|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24953084|NCT03888846|Antioxidants|antioxidants|mesh-ancestor
24953086|NCT03889145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25698774|NCT02097719|Timolol|timolol|mesh-list
25698775|NCT02097719|Bimatoprost|bimatoprost|mesh-list
25698776|NCT02097719|Travoprost|travoprost|mesh-list
25698777|NCT02097719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25698778|NCT02097719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25698779|NCT02097719|Adrenergic Agents|adrenergic agents|mesh-ancestor
25698780|NCT02097719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25709502|NCT02268214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797547|NCT01956474|Vitamin B Complex|vitamin b complex|mesh-ancestor
24797548|NCT01956474|Vitamins|vitamins|mesh-ancestor
24797549|NCT01956474|Micronutrients|micronutrients|mesh-ancestor
24797550|NCT01956474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797551|NCT01956474|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24797552|NCT01956474|Dermatologic Agents|dermatologic agents|mesh-ancestor
24797553|NCT01956487|Propafenone|propafenone|mesh-list
24797554|NCT01956487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24953087|NCT03889145|Telmisartan|telmisartan|mesh-list
25061365|NCT03471988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25061366|NCT03471988|Hormone Antagonists|hormone antagonists|mesh-ancestor
25061367|NCT03471988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25061368|NCT03471988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061369|NCT03471988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25061373|NCT03471819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25061374|NCT03471819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061375|NCT03471819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061377|NCT03471585|Hallucinogens|hallucinogens|mesh-ancestor
25061378|NCT03471585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061379|NCT03471585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25061380|NCT03471585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25061381|NCT03471585|Analgesics|analgesics|mesh-ancestor
25061382|NCT03471585|Sensory System Agents|sensory system agents|mesh-ancestor
25061383|NCT03471585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24889857|NCT04488705|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24889858|NCT04488705|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24889859|NCT04488705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24889860|NCT04488705|Adrenergic Agents|adrenergic agents|mesh-ancestor
24889861|NCT04488705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24889862|NCT04488705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889863|NCT04488744|Nicotine|nicotine|mesh-list
24889864|NCT04488744|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24889865|NCT04488744|Autonomic Agents|autonomic agents|mesh-ancestor
24889884|NCT04488926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889885|NCT04488926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24889886|NCT04488926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24889887|NCT04488926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24889888|NCT04488926|Antiviral Agents|antiviral agents|mesh-ancestor
24889889|NCT04488926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24889890|NCT04488926|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24889896|NCT04488601|Sirolimus|sirolimus|mesh-list
25061439|NCT03471325|Autonomic Agents|autonomic agents|mesh-ancestor
25061440|NCT03471325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25061441|NCT03471325|Dopamine Agents|dopamine agents|mesh-ancestor
24889899|NCT04488601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24889911|NCT04488107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25061442|NCT03471325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25061443|NCT03471325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061444|NCT03471325|Adrenergic Agents|adrenergic agents|mesh-ancestor
25061445|NCT03471325|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25061446|NCT03471325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25061447|NCT03471325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25061448|NCT03471325|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25061471|NCT03471117|Pioglitazone|pioglitazone|mesh-list
25061472|NCT03471117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25061473|NCT03471117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061474|NCT03471039|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
25061475|NCT03471039|Growth Substances|growth substances|mesh-ancestor
25061476|NCT03471039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061477|NCT03471039|Vasodilator Agents|vasodilator agents|mesh-ancestor
25061478|NCT03471039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25061479|NCT03471039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061480|NCT03470961|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25061481|NCT03470961|Immunologic Factors|immunologic factors|mesh-ancestor
25061482|NCT03470961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698781|NCT02097719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698782|NCT02097719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698783|NCT02097719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25698784|NCT02097719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25698785|NCT02097732|Ipilimumab|ipilimumab|mesh-list
25698786|NCT02097732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24824000|NCT02120703|Pregabalin|pregabalin|mesh-list
24889941|NCT04488081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24889942|NCT04488081|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24889943|NCT04488081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24889944|NCT04488081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24889945|NCT04488081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24513222|NCT00579995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513223|NCT00579995|Protective Agents|protective agents|mesh-ancestor
24889985|NCT04487236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889986|NCT04487236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24889988|NCT04487444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24889989|NCT04487444|Immunologic Factors|immunologic factors|mesh-ancestor
24889990|NCT04487444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890745|NCT04480281|Anesthetics, Local|anesthetics, local|mesh-ancestor
24889993|NCT04487392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24889994|NCT04487392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889995|NCT04487106|Azacitidine|azacitidine|mesh-list
24889996|NCT04487106|Venetoclax|venetoclax|mesh-list
24889997|NCT04487106|Trametinib|trametinib|mesh-list
24889998|NCT04487106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24889999|NCT04487106|Antimetabolites|antimetabolites|mesh-ancestor
24890000|NCT04487106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890001|NCT04487106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24890002|NCT04487106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24890003|NCT04487106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24890004|NCT04487093|Vaccines|vaccines|mesh-list
24513227|NCT00580060|Sargramostim|sargramostim|mesh-list
24513228|NCT00580060|Immunologic Factors|immunologic factors|mesh-ancestor
24513229|NCT00580060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513230|NCT00580060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513231|NCT00580112|Dexamethasone|dexamethasone|mesh-list
24513232|NCT00580112|Trabectedin|trabectedin|mesh-list
24513233|NCT00580112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24513234|NCT00580112|Antiemetics|antiemetics|mesh-ancestor
24513235|NCT00580112|Autonomic Agents|autonomic agents|mesh-ancestor
24513236|NCT00580112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24513237|NCT00580112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623580|NCT01072578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24623581|NCT01072578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623582|NCT01072604|Aspirin|aspirin|mesh-list
24623583|NCT01072604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24623584|NCT01072604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24623585|NCT01072604|Analgesics|analgesics|mesh-ancestor
24623586|NCT01072604|Sensory System Agents|sensory system agents|mesh-ancestor
24623587|NCT01072604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24623588|NCT01072604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623589|NCT01072604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24623590|NCT01072604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24623591|NCT01072604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24623592|NCT01072604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24816795|NCT02078895|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24513251|NCT00580190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24513252|NCT00580190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24513253|NCT00580190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24890021|NCT04486690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24890022|NCT04486690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890023|NCT04486651|Irinotecan|irinotecan|mesh-list
24890024|NCT04486651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24890025|NCT04486651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24890026|NCT04486651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24890027|NCT04486651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890028|NCT04486651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24890029|NCT04486508|Heparin|heparin|mesh-list
24890030|NCT04486508|Calcium heparin|calcium heparin|mesh-list
24890031|NCT04486508|Enoxaparin|enoxaparin|mesh-list
24513277|NCT00580359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513278|NCT00580424|Norethindrone|norethindrone|mesh-list
24890069|NCT04486092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25698787|NCT02097732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25698788|NCT02097732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25698789|NCT02097732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698790|NCT02097745|Rituximab|rituximab|mesh-list
25698791|NCT02097745|Methotrexate|methotrexate|mesh-list
24992274|NCT04032301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24992275|NCT04032301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890070|NCT04486092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890071|NCT04486092|Antimanic Agents|antimanic agents|mesh-ancestor
24890072|NCT04486092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24890073|NCT04486092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24890074|NCT04486092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24890075|NCT04485845|Metformin|metformin|mesh-list
24890076|NCT04485845|Vildagliptin|vildagliptin|mesh-list
24890077|NCT04485845|Captopril|captopril|mesh-list
24890078|NCT04485845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24890079|NCT04485845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890080|NCT04485845|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24890081|NCT04485845|Protease Inhibitors|protease inhibitors|mesh-ancestor
24890082|NCT04485845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25061518|NCT03470532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25061519|NCT03470532|Autonomic Agents|autonomic agents|mesh-ancestor
24892899|NCT04457180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25061520|NCT03470532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25061521|NCT03470532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24513290|NCT00580437|Sympathomimetics|sympathomimetics|mesh-ancestor
24513291|NCT00580437|Autonomic Agents|autonomic agents|mesh-ancestor
24513292|NCT00580437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24890097|NCT04485780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890099|NCT04485780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24890100|NCT04485780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890101|NCT04485780|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24890102|NCT04485780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24890104|NCT04485702|Ketamine|ketamine|mesh-list
24890105|NCT04485702|Analgesics|analgesics|mesh-ancestor
24890106|NCT04485702|Sensory System Agents|sensory system agents|mesh-ancestor
24945770|NCT03947489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945771|NCT03947411|Oseltamivir|oseltamivir|mesh-list
25061531|NCT03470480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25061532|NCT03470480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890124|NCT04485702|GABA Agents|gaba agents|mesh-ancestor
24890125|NCT04485585|Tamsulosin|tamsulosin|mesh-list
24890126|NCT04485585|Mirabegron|mirabegron|mesh-list
24890127|NCT04485585|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24890128|NCT04485585|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24890129|NCT04485585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25061545|NCT03470454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25061546|NCT03470454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061547|NCT03470454|Incretins|incretins|mesh-ancestor
25061549|NCT03470454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25061550|NCT03470454|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25061572|NCT03470350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25061573|NCT03470350|Antimetabolites|antimetabolites|mesh-ancestor
25061574|NCT03470350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061575|NCT03470350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25061576|NCT03470337|Wobenzym|wobenzym|mesh-list
25061597|NCT03470077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25061598|NCT03470038|Mitogens|mitogens|mesh-list
25061599|NCT03470038|Mitosis Modulators|mitosis modulators|mesh-ancestor
25061600|NCT03470038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061601|NCT03469947|Tranexamic Acid|tranexamic acid|mesh-list
24824114|NCT02121951|Lidocaine|lidocaine|mesh-list
24467653|NCT00378417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467654|NCT00378443|Prednisone|prednisone|mesh-list
24467655|NCT00378443|Losartan|losartan|mesh-list
24890167|NCT04485429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24890168|NCT04485429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25698792|NCT02097745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25698793|NCT02097745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25698794|NCT02097745|Immunologic Factors|immunologic factors|mesh-ancestor
25698795|NCT02097745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698796|NCT02097745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25698797|NCT02097745|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25698798|NCT02097745|Abortifacient Agents|abortifacient agents|mesh-ancestor
25698799|NCT02097745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25698800|NCT02097745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24992394|NCT03818802|Vasodilator Agents|vasodilator agents|mesh-ancestor
24992402|NCT03806335|Anesthetics|anesthetics|mesh-list
24992403|NCT03806335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24992404|NCT03806335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992412|NCT03796156|Aspirin|aspirin|mesh-list
24992464|NCT03631446|Citric Acid|citric acid|mesh-list
24992465|NCT03631446|Sodium Citrate|sodium citrate|mesh-list
24992466|NCT03631446|Anticoagulants|anticoagulants|mesh-ancestor
24992467|NCT03631446|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24992468|NCT03631446|Chelating Agents|chelating agents|mesh-ancestor
24992469|NCT03631446|Sequestering Agents|sequestering agents|mesh-ancestor
24785616|NCT01915472|Irinotecan|irinotecan|mesh-list
24890170|NCT04485429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24890171|NCT04485429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24890172|NCT04485429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890173|NCT04485299|Listerine|listerine|mesh-list
24890174|NCT04485299|Fluorides|fluorides|mesh-list
24890175|NCT04485299|Sodium Fluoride|sodium fluoride|mesh-list
24890176|NCT04485299|Fluorides, Topical|fluorides, topical|mesh-list
24890196|NCT04485312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24890197|NCT04485312|Disinfectants|disinfectants|mesh-ancestor
24890198|NCT04485117|Anesthetics|anesthetics|mesh-list
25061602|NCT03469947|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25061603|NCT03469947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25061604|NCT03469947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061605|NCT03469947|Hemostatics|hemostatics|mesh-ancestor
25061606|NCT03469947|Coagulants|coagulants|mesh-ancestor
25061607|NCT03469895|Idelalisib|idelalisib|mesh-list
25061620|NCT03469583|Antiviral Agents|antiviral agents|mesh-ancestor
25061621|NCT03469583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25061622|NCT03469557|Capecitabine|capecitabine|mesh-list
25061623|NCT03469557|Oxaliplatin|oxaliplatin|mesh-list
25061624|NCT03469557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25061625|NCT03469557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25061626|NCT03469557|Antimetabolites|antimetabolites|mesh-ancestor
24893038|NCT04455126|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25061627|NCT03469557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061628|NCT03469544|Hormones|hormones|mesh-list
25061629|NCT03469544|Antibodies|antibodies|mesh-list
25061633|NCT03469531|Cisplatin|cisplatin|mesh-list
24890322|NCT04484259|Aspirin|aspirin|mesh-list
24890323|NCT04484259|Clopidogrel|clopidogrel|mesh-list
24890324|NCT04484259|Ticagrelor|ticagrelor|mesh-list
24890325|NCT04484259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24890326|NCT04484259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24890327|NCT04484259|Analgesics|analgesics|mesh-ancestor
24890328|NCT04484259|Sensory System Agents|sensory system agents|mesh-ancestor
24890329|NCT04484259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24890330|NCT04484259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890332|NCT04484259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24890339|NCT04484259|Antipyretics|antipyretics|mesh-ancestor
25061651|NCT03469310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25061652|NCT03469310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061654|NCT03469310|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25698801|NCT02097745|Antimetabolites|antimetabolites|mesh-ancestor
25698802|NCT02097745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698803|NCT02097745|Dermatologic Agents|dermatologic agents|mesh-ancestor
25698804|NCT02097745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25698805|NCT02097745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25698806|NCT02097745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25698807|NCT02097745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25698808|NCT02097823|Olanzapine|olanzapine|mesh-list
25698809|NCT02097823|Aprepitant|aprepitant|mesh-list
25698810|NCT02097823|Antiemetics|antiemetics|mesh-ancestor
25698811|NCT02097823|Autonomic Agents|autonomic agents|mesh-ancestor
25698812|NCT02097823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25698813|NCT02097823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061655|NCT03469310|Narcotics|narcotics|mesh-ancestor
25061656|NCT03469310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25061657|NCT03469310|Antitussive Agents|antitussive agents|mesh-ancestor
25061658|NCT03469310|Respiratory System Agents|respiratory system agents|mesh-ancestor
25061659|NCT03469271|Calcitriol|calcitriol|mesh-list
25061660|NCT03469271|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
25061661|NCT03469271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25061662|NCT03469271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061663|NCT03469271|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24824166|NCT02122055|Dexmedetomidine|dexmedetomidine|mesh-list
24824168|NCT02122055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24513339|NCT00580814|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25061684|NCT03469167|Mydriatics|mydriatics|mesh-ancestor
25061685|NCT03469167|Sympathomimetics|sympathomimetics|mesh-ancestor
25061686|NCT03469167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25061687|NCT03469167|Hemostatics|hemostatics|mesh-ancestor
25061688|NCT03469167|Coagulants|coagulants|mesh-ancestor
25061690|NCT03469128|Antidepressive Agents|antidepressive agents|mesh-ancestor
25061691|NCT03469128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25061692|NCT03469128|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25061693|NCT03469128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24945930|NCT03944681|Dopamine Agents|dopamine agents|mesh-ancestor
25061694|NCT03469128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25061695|NCT03469128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061697|NCT03469128|Serotonin Agents|serotonin agents|mesh-ancestor
25061698|NCT03469128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061699|NCT03469089|Ketamine|ketamine|mesh-list
25061700|NCT03469089|Modafinil|modafinil|mesh-list
25061701|NCT03469089|Analgesics|analgesics|mesh-ancestor
25061702|NCT03469089|Sensory System Agents|sensory system agents|mesh-ancestor
25061703|NCT03469089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25061707|NCT03469089|Anesthetics, General|anesthetics, general|mesh-ancestor
25061738|NCT03468946|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25061739|NCT03468946|Chelating Agents|chelating agents|mesh-ancestor
24890472|NCT04482907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24890473|NCT04482907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890474|NCT04482842|Warfarin|warfarin|mesh-list
24890475|NCT04482842|Anticoagulants|anticoagulants|mesh-ancestor
24890476|NCT04482881|Isosorbide|isosorbide|mesh-list
24513340|NCT00580814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890477|NCT04482881|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24890478|NCT04482881|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
24890480|NCT04482881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24517221|NCT00606775|Carvedilol|carvedilol|mesh-list
24890609|NCT04481724|Analgesics|analgesics|mesh-ancestor
24890637|NCT04481750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890638|NCT04481789|Furosemide|furosemide|mesh-list
24890639|NCT04481789|Sildenafil Citrate|sildenafil citrate|mesh-list
24890640|NCT04481789|Edaravone|edaravone|mesh-list
24890641|NCT04481789|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24890643|NCT04481789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24890644|NCT04481789|Antimetabolites|antimetabolites|mesh-ancestor
24467989|NCT00379431|Antiemetics|antiemetics|mesh-ancestor
24890645|NCT04481789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890646|NCT04481789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24890647|NCT04481789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24890648|NCT04481789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24890649|NCT04481789|Vasodilator Agents|vasodilator agents|mesh-ancestor
24890650|NCT04481789|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24890651|NCT04481789|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24890652|NCT04481789|Urological Agents|urological agents|mesh-ancestor
24890653|NCT04481789|Diuretics|diuretics|mesh-ancestor
24443355|NCT00294593|Vitamin B Complex|vitamin b complex|mesh-ancestor
24890726|NCT04480775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890727|NCT04480775|Sensory System Agents|sensory system agents|mesh-ancestor
24890728|NCT04480775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24890729|NCT04480775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24890730|NCT04480775|Antiemetics|antiemetics|mesh-ancestor
24890731|NCT04480775|Autonomic Agents|autonomic agents|mesh-ancestor
24890732|NCT04480775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24890733|NCT04480775|Glucocorticoids|glucocorticoids|mesh-ancestor
24890734|NCT04480775|Hormones|hormones|mesh-ancestor
24890735|NCT04480775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24890736|NCT04480775|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24890737|NCT04480775|Protective Agents|protective agents|mesh-ancestor
24890739|NCT04480775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24890740|NCT04480593|Propolis|propolis|mesh-list
24890741|NCT04480593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24816847|NCT02079220|Growth Substances|growth substances|mesh-ancestor
24890744|NCT04480281|Lidocaine|lidocaine|mesh-list
24890746|NCT04480281|Anesthetics|anesthetics|mesh-ancestor
24890747|NCT04480281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25061766|NCT03468790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061768|NCT03468790|Respiratory System Agents|respiratory system agents|mesh-ancestor
25061769|NCT03468790|Dermatologic Agents|dermatologic agents|mesh-ancestor
25061770|NCT03468790|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24890828|NCT04479891|Antifungal Agents|antifungal agents|mesh-ancestor
24470063|NCT00388700|Growth Substances|growth substances|mesh-ancestor
24513385|NCT00581009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24513386|NCT00581009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513387|NCT00581009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24513389|NCT00581009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513390|NCT00581009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24513391|NCT00581009|Antimanic Agents|antimanic agents|mesh-ancestor
24513392|NCT00581009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24513393|NCT00581009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24513394|NCT00581035|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24468185|NCT00380380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891000|NCT04477590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24891065|NCT04477083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891066|NCT04477083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24891067|NCT04477018|Ascorbic Acid|ascorbic acid|mesh-list
24891068|NCT04477018|Iron|iron|mesh-list
24816863|NCT02079298|Antifungal Agents|antifungal agents|mesh-ancestor
24816864|NCT02079298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24816865|NCT02079298|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24816866|NCT02079298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24816867|NCT02079298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24816868|NCT02079298|Hormone Antagonists|hormone antagonists|mesh-ancestor
25709503|NCT02268396|Glycopyrrolate|glycopyrrolate|mesh-list
25709504|NCT02268396|Formoterol Fumarate|formoterol fumarate|mesh-list
24816869|NCT02079298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24816870|NCT02079298|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24517528|NCT00608595|Celecoxib|celecoxib|mesh-list
24891144|NCT04475276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891146|NCT04475276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061771|NCT03468790|Glucocorticoids|glucocorticoids|mesh-ancestor
25061772|NCT03468790|Hormones|hormones|mesh-ancestor
24891291|NCT04473820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24891308|NCT04473417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891309|NCT04473274|Pioglitazone|pioglitazone|mesh-list
24891310|NCT04473274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24891311|NCT04473274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891313|NCT04473261|Cadexomer iodine|cadexomer iodine|mesh-list
24891314|NCT04473261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24891315|NCT04473261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24891316|NCT04473261|Trace Elements|trace elements|mesh-ancestor
24891317|NCT04473261|Micronutrients|micronutrients|mesh-ancestor
24891318|NCT04473261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891319|NCT04473053|Nafamostat|nafamostat|mesh-list
24891320|NCT04473053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24891321|NCT04473053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24891322|NCT04473053|Analgesics|analgesics|mesh-ancestor
24891323|NCT04473053|Sensory System Agents|sensory system agents|mesh-ancestor
25061779|NCT03468790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061780|NCT03468790|Tocolytic Agents|tocolytic agents|mesh-ancestor
25061781|NCT03468790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24891442|NCT04470479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891444|NCT04470752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24891445|NCT04470752|Antipruritics|antipruritics|mesh-ancestor
24891446|NCT04470752|Dermatologic Agents|dermatologic agents|mesh-ancestor
24891447|NCT04470752|Sensory System Agents|sensory system agents|mesh-ancestor
24891448|NCT04470752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891449|NCT04470752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891450|NCT04470531|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24891451|NCT04470531|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24891452|NCT04470531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24891461|NCT04470557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891463|NCT04470557|Coagulants|coagulants|mesh-ancestor
24891464|NCT04470414|Antibodies|antibodies|mesh-list
24891465|NCT04470414|Immunoglobulin G|immunoglobulin g|mesh-list
24891466|NCT04470414|Immunologic Factors|immunologic factors|mesh-ancestor
24891467|NCT04470414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513541|NCT00583258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24513542|NCT00583258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517682|NCT00609284|Carboplatin|carboplatin|mesh-list
24891529|NCT04470310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24891530|NCT04470310|Immunologic Factors|immunologic factors|mesh-ancestor
24891531|NCT04470310|Incretins|incretins|mesh-ancestor
24891532|NCT04470310|Hormones|hormones|mesh-ancestor
24891533|NCT04470310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24891534|NCT04470310|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24891535|NCT04470310|Protease Inhibitors|protease inhibitors|mesh-ancestor
24891536|NCT04470310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24891537|NCT04470310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698814|NCT02097823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25698815|NCT02097823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25698816|NCT02097823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25698817|NCT02097823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25698818|NCT02097823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25698819|NCT02097823|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25698820|NCT02097823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25698821|NCT02097823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24891538|NCT04470115|Anesthetics|anesthetics|mesh-list
24891539|NCT04470115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24891541|NCT04470050|Dexmedetomidine|dexmedetomidine|mesh-list
24891545|NCT04470050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24891798|NCT04467931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24891800|NCT04467931|Natriuretic Agents|natriuretic agents|mesh-ancestor
24891802|NCT04467931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25061792|NCT03468777|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25061793|NCT03468777|Histamine Antagonists|histamine antagonists|mesh-ancestor
25061794|NCT03468777|Histamine Agents|histamine agents|mesh-ancestor
25061795|NCT03468777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25061796|NCT03468777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061797|NCT05391360|Entecavir|entecavir|mesh-list
25061798|NCT05391360|Antiviral Agents|antiviral agents|mesh-ancestor
25061799|NCT05391360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24891931|NCT04466670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891932|NCT04466670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24891933|NCT04466670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24891934|NCT04466670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24891980|NCT04466254|Cetuximab|cetuximab|mesh-list
24891981|NCT04466254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24891982|NCT04466254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24891983|NCT04466176|Fluticasone|fluticasone|mesh-list
24891985|NCT04466176|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24891986|NCT04466176|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24891987|NCT04466176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24891988|NCT04466176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24891989|NCT04466176|Autonomic Agents|autonomic agents|mesh-ancestor
24892037|NCT04466085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892038|NCT04465916|Tenofovir|tenofovir|mesh-list
24892039|NCT04465916|Entecavir|entecavir|mesh-list
24892040|NCT04465916|Antiviral Agents|antiviral agents|mesh-ancestor
24892041|NCT04465916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24892042|NCT04465916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24892043|NCT04465916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24892046|NCT04465916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24892048|NCT04465942|Paclitaxel|paclitaxel|mesh-list
24892051|NCT04465942|Pemetrexed|pemetrexed|mesh-list
24892052|NCT04465942|Atezolizumab|atezolizumab|mesh-list
24892176|NCT04465383|Propofol|propofol|mesh-list
24892379|NCT04463953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24892380|NCT04463953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892381|NCT04463953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24892382|NCT04463953|Glucocorticoids|glucocorticoids|mesh-ancestor
24892383|NCT04463953|Hormones|hormones|mesh-ancestor
24892384|NCT04463953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24892385|NCT04463953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24892386|NCT04463953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24892387|NCT04463953|Protease Inhibitors|protease inhibitors|mesh-ancestor
24892388|NCT04463953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24892389|NCT04463953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892390|NCT04463953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24892391|NCT04463901|Mitomycins|mitomycins|mesh-list
24892392|NCT04463901|Mitomycin|mitomycin|mesh-list
24694309|NCT01424891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24817088|NCT02080845|Vasodilator Agents|vasodilator agents|mesh-ancestor
24892399|NCT04463459|Vitamins|vitamins|mesh-list
24892400|NCT04463459|Ascorbic Acid|ascorbic acid|mesh-list
24892401|NCT04463459|Vitamin E|vitamin e|mesh-list
24892402|NCT04463459|Micronutrients|micronutrients|mesh-ancestor
24892403|NCT04463459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892404|NCT04463459|Antioxidants|antioxidants|mesh-ancestor
24892436|NCT04462926|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
24892437|NCT04462926|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24892438|NCT04462926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892439|NCT04462939|Micronutrients|micronutrients|mesh-list
24715069|NCT01534247|Metronidazole|metronidazole|mesh-list
24892440|NCT04462939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892441|NCT04462757|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24992772|NCT02891811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24992773|NCT02891811|Growth Substances|growth substances|mesh-ancestor
24992774|NCT02891811|Growth Inhibitors|growth inhibitors|mesh-ancestor
24992775|NCT02891811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24992776|NCT02891811|Leprostatic Agents|leprostatic agents|mesh-ancestor
24992778|NCT02891811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24992780|NCT02876510|Aldesleukin|aldesleukin|mesh-list
24992782|NCT02876510|Fludarabine|fludarabine|mesh-list
24892442|NCT04462757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24892482|NCT04462809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892485|NCT04462666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24892486|NCT04462666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24892487|NCT04462666|Analgesics|analgesics|mesh-ancestor
24892488|NCT04462666|Sensory System Agents|sensory system agents|mesh-ancestor
24892491|NCT04462666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24892503|NCT04462250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24518167|NCT05330390|Levetiracetam|levetiracetam|mesh-list
24892538|NCT04462094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24892540|NCT04462003|Enoxaparin|enoxaparin|mesh-list
25061825|NCT05390749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25061826|NCT05390749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25061827|NCT05390749|Immunologic Factors|immunologic factors|mesh-ancestor
24824326|NCT02122809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24892628|NCT04461340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892629|NCT04461041|Empagliflozin|empagliflozin|mesh-list
24892630|NCT04461041|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24892631|NCT04461041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892632|NCT04461041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24892633|NCT04461041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061832|NCT05390749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25061833|NCT05390749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25061834|NCT05390749|Antimetabolites|antimetabolites|mesh-ancestor
25061835|NCT05390749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892710|NCT04460001|Triamcinolone|triamcinolone|mesh-list
24892711|NCT04460001|Ranibizumab|ranibizumab|mesh-list
24892712|NCT04460001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24892713|NCT04460001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24892714|NCT04460001|Growth Substances|growth substances|mesh-ancestor
24892727|NCT04460079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24892728|NCT04460079|Immunologic Factors|immunologic factors|mesh-ancestor
25061836|NCT05390749|Dermatologic Agents|dermatologic agents|mesh-ancestor
25061837|NCT05390749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24892800|NCT04459026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24892801|NCT04459026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892802|NCT04459026|Sensory System Agents|sensory system agents|mesh-ancestor
24892803|NCT04459026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24892805|NCT04458454|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24892806|NCT04458454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892807|NCT04458454|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24892808|NCT04458454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24892810|NCT04458558|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24892811|NCT04458558|Abortifacient Agents|abortifacient agents|mesh-ancestor
24892812|NCT04458558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24892825|NCT04458636|Prednisolone|prednisolone|mesh-list
24892888|NCT04457050|Antiviral Agents|antiviral agents|mesh-ancestor
24892889|NCT04457050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24892890|NCT04457180|Repaglinide|repaglinide|mesh-list
24892891|NCT04457180|Apatinib|apatinib|mesh-list
24892892|NCT04457180|Bupropion|bupropion|mesh-list
24892893|NCT04457180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24892894|NCT04457180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24892895|NCT04457180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24892896|NCT04457180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892897|NCT04457180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25698822|NCT02097823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698823|NCT02097823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25698824|NCT02097823|Serotonin Agents|serotonin agents|mesh-ancestor
25698825|NCT02097823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25698826|NCT02097849|Interferons|interferons|mesh-list
25698827|NCT02097849|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25698828|NCT02097849|Vaccines|vaccines|mesh-list
25698829|NCT02097849|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24892898|NCT04457180|Antidepressive Agents|antidepressive agents|mesh-ancestor
25061838|NCT05390749|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25061839|NCT05390749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25061840|NCT05390749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25061841|NCT05390749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25061842|NCT05390749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25061844|NCT05390749|Growth Inhibitors|growth inhibitors|mesh-ancestor
24513597|NCT00583986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513598|NCT00583986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24513599|NCT00583986|Respiratory System Agents|respiratory system agents|mesh-ancestor
24513622|NCT00584155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24513623|NCT00584155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24513625|NCT00584155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513626|NCT00584155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513627|NCT00584155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24513628|NCT00584155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24513629|NCT00584168|Dexamethasone|dexamethasone|mesh-list
24513630|NCT00584168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24513631|NCT00584168|Antiemetics|antiemetics|mesh-ancestor
24513632|NCT00584168|Autonomic Agents|autonomic agents|mesh-ancestor
24513633|NCT00584168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24513634|NCT00584168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892947|NCT04456712|Ofloxacin|ofloxacin|mesh-list
24892974|NCT04455802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24892975|NCT04455802|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24892976|NCT04456088|Nitric Oxide|nitric oxide|mesh-list
24892977|NCT04456088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24892978|NCT04456088|Autonomic Agents|autonomic agents|mesh-ancestor
24892979|NCT04456088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24892980|NCT04456088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892981|NCT04456088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24892982|NCT04456088|Respiratory System Agents|respiratory system agents|mesh-ancestor
24892983|NCT04456088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24892984|NCT04456088|Antioxidants|antioxidants|mesh-ancestor
24892985|NCT04456088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892986|NCT04456088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24892987|NCT04456088|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24892988|NCT04456088|Vasodilator Agents|vasodilator agents|mesh-ancestor
24892989|NCT04456088|Gasotransmitters|gasotransmitters|mesh-ancestor
24892990|NCT04456088|Protective Agents|protective agents|mesh-ancestor
24892991|NCT04455711|Lidocaine|lidocaine|mesh-list
24892992|NCT04455711|Remifentanil|remifentanil|mesh-list
24892993|NCT04455711|Anesthetics, Local|anesthetics, local|mesh-ancestor
24892994|NCT04455711|Anesthetics|anesthetics|mesh-ancestor
24470969|NCT00392691|Tubulin Modulators|tubulin modulators|mesh-ancestor
24892995|NCT04455711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24892996|NCT04455711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892997|NCT04455711|Sensory System Agents|sensory system agents|mesh-ancestor
24892998|NCT04455711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24470049|NCT00388661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470050|NCT00388661|Protective Agents|protective agents|mesh-ancestor
24550861|NCT00722956|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24470051|NCT00388661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893016|NCT04455594|Carboplatin|carboplatin|mesh-list
25061855|NCT05390710|Antimitotic Agents|antimitotic agents|mesh-ancestor
25061856|NCT05390710|Mitosis Modulators|mitosis modulators|mesh-ancestor
25061857|NCT05390710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061858|NCT05390515|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25061859|NCT05390515|Immunologic Factors|immunologic factors|mesh-ancestor
25061860|NCT05390515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946188|NCT03942354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24893023|NCT04455594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24893024|NCT04455594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24470064|NCT00388700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470065|NCT00388700|Growth Inhibitors|growth inhibitors|mesh-ancestor
24893039|NCT04455126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24816977|NCT02080104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816978|NCT02080169|Fentanyl|fentanyl|mesh-list
24816979|NCT02080169|Midazolam|midazolam|mesh-list
24816980|NCT02080169|Dexmedetomidine|dexmedetomidine|mesh-list
24816981|NCT02080169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24816982|NCT02080169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24816983|NCT02080169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816984|NCT02080169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24816989|NCT02080169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24816991|NCT02080169|Adrenergic Agents|adrenergic agents|mesh-ancestor
24816992|NCT02080169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24816993|NCT02080169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816994|NCT02080169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24816995|NCT02080169|Narcotics|narcotics|mesh-ancestor
24816996|NCT02080169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24816997|NCT02080169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24816998|NCT02080169|Anesthetics, General|anesthetics, general|mesh-ancestor
24893070|NCT04454840|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24893071|NCT04454840|Protective Agents|protective agents|mesh-ancestor
24893072|NCT04454788|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24893073|NCT04454788|Tenecteplase|tenecteplase|mesh-list
24893074|NCT04454788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24893075|NCT04454788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24893076|NCT04454788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893077|NCT04454619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24893078|NCT04454580|Azacitidine|azacitidine|mesh-list
24893079|NCT04454580|Decitabine|decitabine|mesh-list
24893080|NCT04454580|Venetoclax|venetoclax|mesh-list
24893081|NCT04454580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24893082|NCT04454580|Antimetabolites|antimetabolites|mesh-ancestor
24893083|NCT04454580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893084|NCT04454580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24893085|NCT04454580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893086|NCT04454307|Tramadol|tramadol|mesh-list
24946197|NCT03942289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24946198|NCT03942289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946199|NCT03942289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946200|NCT03942289|Sympathomimetics|sympathomimetics|mesh-ancestor
24946201|NCT03942289|Autonomic Agents|autonomic agents|mesh-ancestor
24953126|NCT03888534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24953127|NCT03888534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953128|NCT03888183|Lubricant Eye Drops|lubricant eye drops|mesh-list
24893104|NCT04453930|Antibodies|antibodies|mesh-list
24893105|NCT04453930|Immunologic Factors|immunologic factors|mesh-ancestor
24893106|NCT04453930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893107|NCT04453930|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24893108|NCT04453930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24893109|NCT04453930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893110|NCT04453930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893111|NCT04453930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24893112|NCT04453930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24715697|NCT01538225|Nabiximols|nabiximols|mesh-list
24893113|NCT04453735|Atorvastatin|atorvastatin|mesh-list
24893114|NCT04453735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24893115|NCT04453735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24893117|NCT04453735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893118|NCT04453735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24513635|NCT00584168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24513636|NCT00584168|Glucocorticoids|glucocorticoids|mesh-ancestor
24513637|NCT00584168|Hormones|hormones|mesh-ancestor
24513641|NCT00584298|Octreotide|octreotide|mesh-list
24893135|NCT04453306|Topiramate|topiramate|mesh-list
24893136|NCT04453306|Anticonvulsants|anticonvulsants|mesh-ancestor
24893137|NCT04453306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24893138|NCT04453306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893139|NCT04453371|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24893141|NCT04453371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24893142|NCT04453371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24893143|NCT04453371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893144|NCT04453345|Thalidomide|thalidomide|mesh-list
24893145|NCT04453345|Prednisone|prednisone|mesh-list
24893146|NCT04453345|Methotrexate|methotrexate|mesh-list
24893147|NCT04453345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24893149|NCT04453345|Hormones|hormones|mesh-ancestor
24953132|NCT03888157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24953133|NCT03888157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953134|NCT03888157|Incretins|incretins|mesh-ancestor
24953135|NCT03888157|Hormones|hormones|mesh-ancestor
24953136|NCT03888157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24953137|NCT03888144|Ketorolac|ketorolac|mesh-list
24953138|NCT03888144|Oxycodone|oxycodone|mesh-list
24953139|NCT03888144|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24953140|NCT03888144|Narcotics|narcotics|mesh-ancestor
24513675|NCT00584532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24513676|NCT00584532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24513677|NCT00584532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513678|NCT00584532|Phytoestrogens|phytoestrogens|mesh-ancestor
24513679|NCT00584532|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24552261|NCT03728478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513680|NCT00584532|Estrogens|estrogens|mesh-ancestor
24513681|NCT00584532|Hormones|hormones|mesh-ancestor
24513683|NCT00584571|Dexetimide|dexetimide|mesh-list
24893267|NCT04452370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24893268|NCT04452370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24893269|NCT04452370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24893270|NCT04452370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893271|NCT04452370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953141|NCT03888144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24426477|NCT00236145|Fentanyl|fentanyl|mesh-list
24893368|NCT04450680|beta-Lactams|beta-lactams|mesh-list
24893369|NCT04450680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24893370|NCT04450680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24893371|NCT04450576|Chrysarobin|chrysarobin|mesh-list
24893372|NCT04450576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24953150|NCT03888144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24953151|NCT03888144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24953152|NCT03888144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953153|NCT03887884|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24953154|NCT03887884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24426557|NCT00236301|Estrogens|estrogens|mesh-ancestor
24893443|NCT04449224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24893444|NCT04449224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893445|NCT04449224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24893446|NCT04449224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24893447|NCT04449224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24893448|NCT04449224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24893449|NCT04449224|Immunologic Factors|immunologic factors|mesh-ancestor
24893450|NCT04449224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24893522|NCT04448496|Autonomic Agents|autonomic agents|mesh-ancestor
24893523|NCT04448496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24893524|NCT04448496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893525|NCT04448496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24893526|NCT04448496|Glucocorticoids|glucocorticoids|mesh-ancestor
24893527|NCT04448496|Hormones|hormones|mesh-ancestor
24893528|NCT04448496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24824381|NCT02123069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824382|NCT02123069|Protective Agents|protective agents|mesh-ancestor
24824383|NCT02123069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24824384|NCT02123069|Vasodilator Agents|vasodilator agents|mesh-ancestor
24953166|NCT03887650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24953167|NCT03887650|Antiemetics|antiemetics|mesh-ancestor
24953168|NCT03887650|Autonomic Agents|autonomic agents|mesh-ancestor
25061861|NCT05390359|Oxymetazoline|oxymetazoline|mesh-list
25061862|NCT05390359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25061863|NCT05390359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25061864|NCT05390359|Adrenergic Agents|adrenergic agents|mesh-ancestor
24893537|NCT04448457|Analgesics|analgesics|mesh-ancestor
24893538|NCT04448457|Sensory System Agents|sensory system agents|mesh-ancestor
24893539|NCT04448457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24893540|NCT04448457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24893541|NCT04448457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25698830|NCT02097849|Immunologic Factors|immunologic factors|mesh-ancestor
24993159|NCT00186888|Topotecan|topotecan|mesh-list
24993160|NCT00186888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24993164|NCT00186888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24893542|NCT04448457|Anesthetics, General|anesthetics, general|mesh-ancestor
24893543|NCT04448457|Anesthetics|anesthetics|mesh-ancestor
24893544|NCT04448379|Osimertinib|osimertinib|mesh-list
24893553|NCT04448223|Latanoprost|latanoprost|mesh-list
24893554|NCT04448223|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24552337|NCT03504241|Hormones|hormones|mesh-ancestor
24893555|NCT04448223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24893556|NCT04448119|Favipiravir|favipiravir|mesh-list
24893557|NCT04448119|Antiviral Agents|antiviral agents|mesh-ancestor
24893558|NCT04448119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24893559|NCT04448015|Analgesics, Opioid|analgesics, opioid|mesh-list
24893560|NCT04448015|Narcotics|narcotics|mesh-ancestor
24893561|NCT04448015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24513711|NCT00584610|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25061899|NCT05390203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25061900|NCT05390203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061901|NCT05390073|Hormones|hormones|mesh-list
25061902|NCT05390073|Mitogens|mitogens|mesh-list
25061903|NCT05390073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061904|NCT05390073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24426814|NCT00236704|Anticonvulsants|anticonvulsants|mesh-ancestor
24513712|NCT00584610|Trace Elements|trace elements|mesh-ancestor
24513713|NCT00584610|Micronutrients|micronutrients|mesh-ancestor
24893623|NCT04447209|Chrysarobin|chrysarobin|mesh-list
24893624|NCT04447209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24893625|NCT04447209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24893626|NCT04447209|Analgesics|analgesics|mesh-ancestor
24893657|NCT04447092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24893659|NCT04447092|Tubulin Modulators|tubulin modulators|mesh-ancestor
24893660|NCT04447092|Antimitotic Agents|antimitotic agents|mesh-ancestor
24513714|NCT00584636|Budesonide|budesonide|mesh-list
24893663|NCT04447092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24893664|NCT04447092|Antimetabolites|antimetabolites|mesh-ancestor
24893665|NCT04447092|Antiviral Agents|antiviral agents|mesh-ancestor
24893666|NCT04447092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24893667|NCT04447092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893668|NCT04447092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24893669|NCT04447092|Immunologic Factors|immunologic factors|mesh-ancestor
24552883|NCT00728013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893670|NCT04447092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893671|NCT04447092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24893708|NCT04446923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893709|NCT04446923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893710|NCT04446923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24893711|NCT04446923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24893712|NCT04446923|Vasodilator Agents|vasodilator agents|mesh-ancestor
24893716|NCT04446663|Paclitaxel|paclitaxel|mesh-list
24893717|NCT04446663|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24893718|NCT04446663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24893719|NCT04446663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24893720|NCT04446663|Tubulin Modulators|tubulin modulators|mesh-ancestor
24893721|NCT04446663|Antimitotic Agents|antimitotic agents|mesh-ancestor
24893750|NCT04446533|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24893751|NCT04446533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24893759|NCT04446637|Albuterol|albuterol|mesh-list
24613161|NCT01017393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24613162|NCT01017393|Anesthetics, General|anesthetics, general|mesh-ancestor
24613164|NCT01017393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24613165|NCT01017393|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24613166|NCT01017393|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24613167|NCT01017393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24613168|NCT01017393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613169|NCT01017458|Methyltestosterone|methyltestosterone|mesh-list
24613170|NCT01017458|Testosterone|testosterone|mesh-list
24613171|NCT01017458|Testosterone undecanoate|testosterone undecanoate|mesh-list
24613172|NCT01017458|Testosterone enanthate|testosterone enanthate|mesh-list
24613173|NCT01017458|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24613174|NCT01017458|Androgens|androgens|mesh-ancestor
24613175|NCT01017458|Hormones|hormones|mesh-ancestor
25698831|NCT02097849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698832|NCT02097849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25698833|NCT02097849|Antiviral Agents|antiviral agents|mesh-ancestor
24613176|NCT01017458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24817083|NCT02080845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24817084|NCT02080845|Autonomic Agents|autonomic agents|mesh-ancestor
24817085|NCT02080845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24817086|NCT02080845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24817087|NCT02080845|Respiratory System Agents|respiratory system agents|mesh-ancestor
24817091|NCT02080858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25061949|NCT05389813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24824454|NCT02123498|Histamine Agents|histamine agents|mesh-ancestor
24824455|NCT02123498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24553469|NCT00731302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24553470|NCT00731302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24824456|NCT02123498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824457|NCT02123524|Rivaroxaban|rivaroxaban|mesh-list
24824458|NCT02123524|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24824459|NCT02123524|Antithrombins|antithrombins|mesh-ancestor
24824460|NCT02123524|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24427114|NCT00237484|Interferons|interferons|mesh-list
24893973|NCT04445636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24893974|NCT04445636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893975|NCT04445636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24893976|NCT04445636|Analgesics|analgesics|mesh-ancestor
24893977|NCT04445636|Sensory System Agents|sensory system agents|mesh-ancestor
24893978|NCT04445636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24893979|NCT04445636|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24894019|NCT04444635|Narcotics|narcotics|mesh-ancestor
24894020|NCT04444635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24894021|NCT04444635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894022|NCT04444635|Analgesics|analgesics|mesh-ancestor
24894023|NCT04444635|Sensory System Agents|sensory system agents|mesh-ancestor
24894024|NCT04444635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24894025|NCT04444635|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25061950|NCT05389813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25061951|NCT05389813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24894033|NCT04444726|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24894034|NCT04444726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24894035|NCT04444726|Glucocorticoids|glucocorticoids|mesh-ancestor
24894036|NCT04444726|Hormones|hormones|mesh-ancestor
24894039|NCT04444726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24894040|NCT04444726|Respiratory System Agents|respiratory system agents|mesh-ancestor
24894060|NCT04444167|Lenvatinib|lenvatinib|mesh-list
24513760|NCT00584779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24513761|NCT00584779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24513762|NCT00584779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24894084|NCT04444193|Lenvatinib|lenvatinib|mesh-list
24894085|NCT04444193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24894086|NCT04444193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24894087|NCT04444193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894088|NCT04444193|Immunologic Factors|immunologic factors|mesh-ancestor
24894089|NCT04444193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894090|NCT04444193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24894100|NCT04443946|Propofol|propofol|mesh-list
24894101|NCT04443946|Sevoflurane|sevoflurane|mesh-list
24894102|NCT04443946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24553729|NCT00732589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894126|NCT04443868|Nitric Oxide|nitric oxide|mesh-list
24894127|NCT04443868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24894128|NCT04443868|Autonomic Agents|autonomic agents|mesh-ancestor
24894129|NCT04443868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24894130|NCT04443868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894131|NCT04443868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24894132|NCT04443868|Respiratory System Agents|respiratory system agents|mesh-ancestor
24894133|NCT04443868|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24894134|NCT04443868|Antioxidants|antioxidants|mesh-ancestor
24894135|NCT04443868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894136|NCT04443868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24894137|NCT04443868|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24894138|NCT04443868|Vasodilator Agents|vasodilator agents|mesh-ancestor
24894139|NCT04443868|Gasotransmitters|gasotransmitters|mesh-ancestor
24894140|NCT04443868|Protective Agents|protective agents|mesh-ancestor
24894141|NCT04443556|Tramadol|tramadol|mesh-list
24894142|NCT04443556|Anesthetics|anesthetics|mesh-list
24817123|NCT02081144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817125|NCT02081287|Lamotrigine|lamotrigine|mesh-list
24894163|NCT04443517|Propofol|propofol|mesh-list
24894164|NCT04443517|Anesthetics|anesthetics|mesh-ancestor
24894165|NCT04443517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24894166|NCT04443517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894167|NCT04443517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24894168|NCT04443517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24894169|NCT04443517|Anesthetics, General|anesthetics, general|mesh-ancestor
24894170|NCT04444011|Amoxicillin|amoxicillin|mesh-list
24894171|NCT04444011|Clarithromycin|clarithromycin|mesh-list
24894172|NCT04444011|Bismuth|bismuth|mesh-list
24894173|NCT04444011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24894174|NCT04444011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24894175|NCT04444011|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24894176|NCT04444011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24894177|NCT04444011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894178|NCT04444011|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24894179|NCT04444011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24894180|NCT04444011|Antacids|antacids|mesh-ancestor
24894181|NCT04444011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24894182|NCT04443647|Oxytocin|oxytocin|mesh-list
24894183|NCT04443647|Oxytocics|oxytocics|mesh-ancestor
24513767|NCT00585091|Phenylephrine|phenylephrine|mesh-list
24513768|NCT00585091|Oxymetazoline|oxymetazoline|mesh-list
24513769|NCT00585091|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24513770|NCT00585091|Mydriatics|mydriatics|mesh-ancestor
24513771|NCT00585091|Autonomic Agents|autonomic agents|mesh-ancestor
24513772|NCT00585091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24513773|NCT00585091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894205|NCT04443543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24894206|NCT04443543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24894207|NCT04443270|Chloroquine|chloroquine|mesh-list
24894208|NCT04443270|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24894209|NCT04443270|Amebicides|amebicides|mesh-ancestor
24894234|NCT04443322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061966|NCT05389722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25061967|NCT05389722|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25061968|NCT05389722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25061969|NCT05389722|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25061970|NCT05389722|Hormone Antagonists|hormone antagonists|mesh-ancestor
24894235|NCT04443036|Paclitaxel|paclitaxel|mesh-list
24894356|NCT04441918|Immunologic Factors|immunologic factors|mesh-ancestor
24894357|NCT04441918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894358|NCT04441385|Maraviroc|maraviroc|mesh-list
24894359|NCT04441385|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24894360|NCT04441385|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24894380|NCT04441528|Hyaluronic Acid|hyaluronic acid|mesh-list
24894381|NCT04441528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24894382|NCT04441528|Immunologic Factors|immunologic factors|mesh-ancestor
24894383|NCT04441528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894384|NCT04441528|Viscosupplements|viscosupplements|mesh-ancestor
24894385|NCT04441528|Protective Agents|protective agents|mesh-ancestor
24894386|NCT04441112|Triamcinolone|triamcinolone|mesh-list
24894387|NCT04441112|Ketorolac|ketorolac|mesh-list
25061972|NCT05389722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513790|NCT00585143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24513791|NCT00585143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24894438|NCT04440280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24894439|NCT04440280|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24894440|NCT04440280|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24894442|NCT04440280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24894443|NCT04440280|Expectorants|expectorants|mesh-ancestor
24894444|NCT04440280|Respiratory System Agents|respiratory system agents|mesh-ancestor
24894445|NCT04440280|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24894446|NCT04440280|Antioxidants|antioxidants|mesh-ancestor
24894447|NCT04440280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894448|NCT04440280|Protective Agents|protective agents|mesh-ancestor
24894449|NCT04440280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894450|NCT04440280|Antidotes|antidotes|mesh-ancestor
25698834|NCT02097849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24894451|NCT04440267|Dexamethasone|dexamethasone|mesh-list
24894452|NCT04440267|Prednisone|prednisone|mesh-list
24894453|NCT04440267|Cyclophosphamide|cyclophosphamide|mesh-list
24894454|NCT04440267|Methotrexate|methotrexate|mesh-list
24894455|NCT04440267|Vincristine|vincristine|mesh-list
24894456|NCT04440267|Daunorubicin|daunorubicin|mesh-list
24894457|NCT04440267|Asparaginase|asparaginase|mesh-list
24513804|NCT00585156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25061992|NCT05389514|Immunologic Factors|immunologic factors|mesh-ancestor
25061993|NCT05389514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25061994|NCT05389514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25061995|NCT05389514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25061996|NCT05389514|Alkylating Agents|alkylating agents|mesh-ancestor
25061997|NCT05389514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25061998|NCT05389514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25061999|NCT05389514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25062000|NCT05389514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25062001|NCT05389514|Antimetabolites|antimetabolites|mesh-ancestor
25062002|NCT05389514|Antiviral Agents|antiviral agents|mesh-ancestor
25062086|NCT05323149|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25062087|NCT05323149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062089|NCT05323149|Coagulants|coagulants|mesh-ancestor
24513810|NCT00585260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513811|NCT00585442|Vitamin D|vitamin d|mesh-list
24513812|NCT00585442|Calcitriol|calcitriol|mesh-list
24513813|NCT00585442|Vitamins|vitamins|mesh-ancestor
25062121|NCT05282706|Antiemetics|antiemetics|mesh-ancestor
24946480|NCT03939273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24946481|NCT03939273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24946482|NCT03939273|Antifungal Agents|antifungal agents|mesh-ancestor
24946483|NCT03939273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24946484|NCT03939273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24946485|NCT03939273|Hormone Antagonists|hormone antagonists|mesh-ancestor
24946490|NCT03938740|Insulin|insulin|mesh-list
24953182|NCT03887650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24953183|NCT03887650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24953184|NCT03887650|Adrenergic Agents|adrenergic agents|mesh-ancestor
24953185|NCT03887650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24953186|NCT03887650|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25062122|NCT05282706|Autonomic Agents|autonomic agents|mesh-ancestor
25062123|NCT05282706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25062124|NCT05282706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062125|NCT05282706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25062126|NCT05282706|Parasympatholytics|parasympatholytics|mesh-ancestor
25062127|NCT05272683|Itraconazole|itraconazole|mesh-list
25062128|NCT05272683|Antifungal Agents|antifungal agents|mesh-ancestor
25062129|NCT05272683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25062130|NCT05272683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25062131|NCT05272683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25062132|NCT05272683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25062133|NCT05272683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062134|NCT05272683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25062135|NCT05272683|Hormone Antagonists|hormone antagonists|mesh-ancestor
24513821|NCT00585442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24513822|NCT00585455|Sertraline|sertraline|mesh-list
24514331|NCT00589901|Antimetabolites|antimetabolites|mesh-ancestor
24513844|NCT00585559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698836|NCT02097849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25698837|NCT02098109|Plerixafor|plerixafor|mesh-list
25698838|NCT02098109|Lenograstim|lenograstim|mesh-list
25698839|NCT02098109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25698840|NCT02098109|Immunologic Factors|immunologic factors|mesh-ancestor
25698841|NCT02098109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698842|NCT02098109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25698843|NCT02098109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25698844|NCT02098109|Antiviral Agents|antiviral agents|mesh-ancestor
24867629|NCT03527238|Tacrolimus|tacrolimus|mesh-list
24867630|NCT03527238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24993541|NCT05416827|Antiemetics|antiemetics|mesh-ancestor
24993542|NCT05416827|Autonomic Agents|autonomic agents|mesh-ancestor
24993543|NCT05416827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25062176|NCT05234697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24520640|NCT05335837|Anesthetics|anesthetics|mesh-list
25062204|NCT05165290|Latanoprost|latanoprost|mesh-list
24513871|NCT00585871|Sympatholytics|sympatholytics|mesh-ancestor
24513872|NCT00585871|Autonomic Agents|autonomic agents|mesh-ancestor
24513873|NCT00585871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24520736|NCT05333744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894508|NCT04440085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894509|NCT04440085|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24894510|NCT04440085|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24894511|NCT04440085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24894512|NCT04440085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24894513|NCT04440085|Adrenergic Agents|adrenergic agents|mesh-ancestor
24894514|NCT04440085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24894516|NCT04439929|Adalimumab|adalimumab|mesh-list
24824773|NCT02125344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894541|NCT04439825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894542|NCT04439825|Cholinergic Agents|cholinergic agents|mesh-ancestor
24894543|NCT04439825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24894544|NCT04439825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824786|NCT02125357|Abiraterone Acetate|abiraterone acetate|mesh-list
24824787|NCT02125357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24824788|NCT02125357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24894629|NCT04438733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24894630|NCT04438733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894632|NCT04438811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24894633|NCT04438811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894635|NCT04438850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24513929|NCT00586365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894643|NCT04438720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24894644|NCT04438720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062232|NCT05085782|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25062233|NCT05085782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24894717|NCT05388448|Leprostatic Agents|leprostatic agents|mesh-ancestor
25698845|NCT02098109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25698846|NCT02098395|Liraglutide|liraglutide|mesh-list
25698847|NCT02098395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25698848|NCT02098395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698849|NCT02098395|Incretins|incretins|mesh-ancestor
25698850|NCT02098395|Hormones|hormones|mesh-ancestor
25698851|NCT02098395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25698852|NCT02098733|Pioglitazone|pioglitazone|mesh-list
25698853|NCT02098733|Glimepiride|glimepiride|mesh-list
25698854|NCT02098733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24993619|NCT05415917|Capecitabine|capecitabine|mesh-list
24894718|NCT05388448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24894719|NCT05388448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24894720|NCT05388448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894721|NCT05388448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24894722|NCT05388448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24894723|NCT05388448|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24471828|NCT00396929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24471829|NCT00396929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894774|NCT05387941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894775|NCT05387876|Vitamin D|vitamin d|mesh-list
24894776|NCT05387876|Vitamins|vitamins|mesh-ancestor
24894777|NCT05387876|Micronutrients|micronutrients|mesh-ancestor
25062251|NCT05038228|Vitamin K|vitamin k|mesh-list
25062252|NCT05038228|Rivaroxaban|rivaroxaban|mesh-list
24894778|NCT05387876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894912|NCT05374057|Analgesics|analgesics|mesh-ancestor
24894913|NCT05374057|Sensory System Agents|sensory system agents|mesh-ancestor
24894914|NCT05374057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24894915|NCT05374057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514073|NCT00587665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24514074|NCT00587665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24514075|NCT00587665|Anesthetics, General|anesthetics, general|mesh-ancestor
24514076|NCT00587665|Anesthetics|anesthetics|mesh-ancestor
24894937|NCT05373433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24894938|NCT05373433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894939|NCT05373433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24894940|NCT05373433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24894941|NCT05373433|Antiviral Agents|antiviral agents|mesh-ancestor
24894942|NCT05373433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24894943|NCT05373433|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24514088|NCT00587717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24514089|NCT00587717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24514091|NCT00587873|Methotrexate|methotrexate|mesh-list
24514131|NCT00588016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24817222|NCT02082054|Autonomic Agents|autonomic agents|mesh-ancestor
24817223|NCT02082054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24817224|NCT02082054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817225|NCT02082054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24817226|NCT02082054|Respiratory System Agents|respiratory system agents|mesh-ancestor
24817245|NCT02082067|Ketorolac|ketorolac|mesh-list
24514250|NCT00589238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24514251|NCT00589238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24514252|NCT00589238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24514253|NCT00589238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24514254|NCT00589251|Penicillins|penicillins|mesh-list
24514255|NCT00589251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24514256|NCT00589251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24514257|NCT00589264|Copper|copper|mesh-list
24514258|NCT00589264|Trace Elements|trace elements|mesh-ancestor
24514259|NCT00589264|Micronutrients|micronutrients|mesh-ancestor
24514328|NCT00589901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514329|NCT00589901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24514330|NCT00589901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25062297|NCT04936399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25062298|NCT04936399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062299|NCT04928183|Nitroprusside|nitroprusside|mesh-list
25062300|NCT04928183|Phenylephrine|phenylephrine|mesh-list
25062301|NCT04928183|Oxymetazoline|oxymetazoline|mesh-list
25062302|NCT04928183|Carbon Monoxide|carbon monoxide|mesh-list
25062303|NCT04928183|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25062304|NCT04928183|Mydriatics|mydriatics|mesh-ancestor
25698855|NCT02098733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698856|NCT02098733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25698857|NCT02098733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25698858|NCT02098733|Immunologic Factors|immunologic factors|mesh-ancestor
25698859|NCT02098746|Pioglitazone|pioglitazone|mesh-list
25698860|NCT02098746|Glimepiride|glimepiride|mesh-list
25698861|NCT02098746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25698862|NCT02098746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698863|NCT02098746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24993806|NCT05400109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24993807|NCT05392361|Gabapentin|gabapentin|mesh-list
24993808|NCT05392361|Baclofen|baclofen|mesh-list
24993809|NCT05392361|Analgesics|analgesics|mesh-ancestor
24993810|NCT05392361|Sensory System Agents|sensory system agents|mesh-ancestor
24993811|NCT05392361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24993812|NCT05392361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062305|NCT04928183|Autonomic Agents|autonomic agents|mesh-ancestor
24895025|NCT05214599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24895026|NCT05214599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895027|NCT05214599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24895028|NCT05214599|Respiratory System Agents|respiratory system agents|mesh-ancestor
24895029|NCT05214599|Glucocorticoids|glucocorticoids|mesh-ancestor
24514342|NCT00589927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24514343|NCT00589927|Vasodilator Agents|vasodilator agents|mesh-ancestor
24514344|NCT00589927|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24514345|NCT00589927|Protective Agents|protective agents|mesh-ancestor
24514346|NCT00589927|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24514347|NCT00589927|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24514348|NCT00589927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25062306|NCT04928183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25062307|NCT04928183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062308|NCT04928183|Sympathomimetics|sympathomimetics|mesh-ancestor
25062309|NCT04928183|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25062310|NCT04928183|Nasal Decongestants|nasal decongestants|mesh-ancestor
25062311|NCT04928183|Respiratory System Agents|respiratory system agents|mesh-ancestor
24824862|NCT02125643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24514376|NCT00590122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514377|NCT00590122|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24514378|NCT00590122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24514379|NCT00590122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25062350|NCT04923659|Sensory System Agents|sensory system agents|mesh-ancestor
24895056|NCT05184712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24895057|NCT05184712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24895058|NCT05184712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895059|NCT05184712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24895060|NCT05184712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24895061|NCT05170711|Antihypertensive Agents|antihypertensive agents|mesh-list
24895062|NCT05170711|Anesthetics|anesthetics|mesh-list
24895063|NCT05170711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24472054|NCT00397800|Antimetabolites|antimetabolites|mesh-ancestor
24472055|NCT00397826|Simvastatin|simvastatin|mesh-list
24472056|NCT00397826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24514402|NCT00590174|Purinergic Agents|purinergic agents|mesh-ancestor
25062330|NCT04923659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25062331|NCT04923659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25062332|NCT04923659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25062333|NCT04923659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514427|NCT00590447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24514428|NCT00590447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25698864|NCT02098746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25698865|NCT02098746|Immunologic Factors|immunologic factors|mesh-ancestor
25698866|NCT02098993|Heparin|heparin|mesh-list
25698867|NCT02098993|Calcium heparin|calcium heparin|mesh-list
25698868|NCT02098993|Anticoagulants|anticoagulants|mesh-ancestor
25698869|NCT02098993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25698870|NCT02098993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25698871|NCT02098993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993921|NCT05199311|Autonomic Agents|autonomic agents|mesh-ancestor
24993922|NCT05199311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24993924|NCT05199311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24993925|NCT05199311|Glucocorticoids|glucocorticoids|mesh-ancestor
24993926|NCT05199311|Hormones|hormones|mesh-ancestor
24993927|NCT05199311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24993928|NCT05199311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24993929|NCT05199311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993930|NCT05188170|Niclosamide|niclosamide|mesh-list
24514429|NCT00590447|Immunologic Factors|immunologic factors|mesh-ancestor
24895064|NCT05170711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514446|NCT00590629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895091|NCT05029960|Anticonvulsants|anticonvulsants|mesh-ancestor
24895092|NCT05016076|Dexamethasone|dexamethasone|mesh-list
24895093|NCT05016076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24895094|NCT05016076|Antiemetics|antiemetics|mesh-ancestor
24895095|NCT05016076|Autonomic Agents|autonomic agents|mesh-ancestor
24895096|NCT05016076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24895097|NCT05016076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895098|NCT05016076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24895099|NCT05016076|Glucocorticoids|glucocorticoids|mesh-ancestor
24895101|NCT05016076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24895102|NCT05016076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24895103|NCT05016076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24895104|NCT05014919|Vortioxetine|vortioxetine|mesh-list
24895105|NCT05014919|Antidepressive Agents|antidepressive agents|mesh-ancestor
24895106|NCT05014919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24895107|NCT05014919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24895108|NCT05014919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24514486|NCT00590785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24514487|NCT00590785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24514489|NCT00590837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24514490|NCT00590837|Alkylating Agents|alkylating agents|mesh-ancestor
24514491|NCT00590837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514492|NCT00590837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514494|NCT00590915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514495|NCT00590928|Esomeprazole|esomeprazole|mesh-list
24514496|NCT00590928|Ranitidine|ranitidine|mesh-list
24514497|NCT00590928|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
24514498|NCT00590928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25062339|NCT04923659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25062340|NCT04923659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25062341|NCT04923659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25062342|NCT04923659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25062345|NCT04923659|GABA Modulators|gaba modulators|mesh-ancestor
25062346|NCT04923659|GABA Agents|gaba agents|mesh-ancestor
25062347|NCT04923659|Antimanic Agents|antimanic agents|mesh-ancestor
24824889|NCT02125890|Coagulants|coagulants|mesh-ancestor
24824890|NCT02125903|Ropivacaine|ropivacaine|mesh-list
24824891|NCT02125903|Anesthetics, Local|anesthetics, local|mesh-ancestor
24824892|NCT02125903|Anesthetics|anesthetics|mesh-ancestor
25062348|NCT04923659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24514531|NCT00591357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24895139|NCT04955470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895140|NCT04955470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24895141|NCT04955470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24895142|NCT04955470|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24895143|NCT04955470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24895144|NCT04955470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24895145|NCT04955470|GABA Modulators|gaba modulators|mesh-ancestor
24895146|NCT04955470|GABA Agents|gaba agents|mesh-ancestor
24817272|NCT02082236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24817273|NCT02082236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25698872|NCT02099006|Ketoprofen|ketoprofen|mesh-list
25698873|NCT02099006|Ketamine|ketamine|mesh-list
25698874|NCT02099006|Gabapentin|gabapentin|mesh-list
25698875|NCT02099006|Amitriptyline|amitriptyline|mesh-list
25698876|NCT02099006|Baclofen|baclofen|mesh-list
25698877|NCT02099006|Loperamide|loperamide|mesh-list
25698878|NCT02099006|Antidiarrheals|antidiarrheals|mesh-list
25698879|NCT02099006|Analgesics|analgesics|mesh-ancestor
25698880|NCT02099006|Sensory System Agents|sensory system agents|mesh-ancestor
25698881|NCT02099006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25698882|NCT02099006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817274|NCT02082236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24817275|NCT02082236|Anesthetics, General|anesthetics, general|mesh-ancestor
24817276|NCT02082236|Anesthetics|anesthetics|mesh-ancestor
24817277|NCT02082327|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
24817278|NCT02082327|Antiviral Agents|antiviral agents|mesh-ancestor
24817279|NCT02082327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24895148|NCT04950608|Hallucinogens|hallucinogens|mesh-ancestor
24895149|NCT04950608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895150|NCT04950608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24895151|NCT04944953|Botulinum Toxins|botulinum toxins|mesh-list
24895152|NCT04944953|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24895153|NCT04944953|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24514539|NCT00591487|Anesthetics|anesthetics|mesh-ancestor
24895154|NCT04944953|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24895155|NCT04944953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24895156|NCT04944953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895157|NCT04944953|Cholinergic Agents|cholinergic agents|mesh-ancestor
24895158|NCT04944953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24895159|NCT04944953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895160|NCT04944953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24895161|NCT04944953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24895165|NCT04939623|Benzoic Acid|benzoic acid|mesh-list
24895166|NCT04939623|Probenecid|probenecid|mesh-list
24895167|NCT04939623|Uricosuric Agents|uricosuric agents|mesh-ancestor
24895168|NCT04939623|Gout Suppressants|gout suppressants|mesh-ancestor
24895169|NCT04939623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24895170|NCT04939623|Renal Agents|renal agents|mesh-ancestor
24514544|NCT00591487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24514545|NCT00591487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24514546|NCT00591487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24514547|NCT00591487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24514548|NCT00591487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514604|NCT00591916|Thrombin|thrombin|mesh-list
24895198|NCT04831398|Melatonin|melatonin|mesh-list
24895199|NCT04831398|Antioxidants|antioxidants|mesh-ancestor
24895200|NCT04831398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895201|NCT04831398|Protective Agents|protective agents|mesh-ancestor
24895202|NCT04831398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895203|NCT04831398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24895204|NCT04821856|Cannabidiol|cannabidiol|mesh-list
24895255|NCT04650074|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24895256|NCT04650074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24895257|NCT04650074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895258|NCT04650074|Analgesics|analgesics|mesh-ancestor
24895259|NCT04650074|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24895260|NCT04650074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24895261|NCT04650074|Anesthetics, General|anesthetics, general|mesh-ancestor
24895262|NCT04650074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24895263|NCT04650074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24895264|NCT04650074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24895265|NCT04647721|Hyaluronic Acid|hyaluronic acid|mesh-list
25062381|NCT04862650|Cemiplimab|cemiplimab|mesh-list
24824919|NCT02126137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24895306|NCT04585711|Immunologic Factors|immunologic factors|mesh-ancestor
24895307|NCT04569084|Edaravone|edaravone|mesh-list
24895308|NCT04569084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25698883|NCT02099006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25698884|NCT02099006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25698885|NCT02099006|Anesthetics, General|anesthetics, general|mesh-ancestor
24895309|NCT04569084|Antioxidants|antioxidants|mesh-ancestor
25698886|NCT02099006|Anesthetics|anesthetics|mesh-ancestor
24574206|NCT00824135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25698887|NCT02099006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25698888|NCT02099006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25698889|NCT02099006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25698890|NCT02099006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25698891|NCT02099006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698892|NCT02099006|Anticonvulsants|anticonvulsants|mesh-ancestor
25698893|NCT02099006|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25698894|NCT02099006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24895310|NCT04569084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895311|NCT04569084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24895312|NCT04569084|Protective Agents|protective agents|mesh-ancestor
24895313|NCT04569084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895314|NCT04552782|Ethanol|ethanol|mesh-list
24895315|NCT04552782|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24895326|NCT04537715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895327|NCT04537715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24895328|NCT04537715|Hormone Antagonists|hormone antagonists|mesh-ancestor
24895364|NCT04447755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24895365|NCT04447755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895369|NCT04427241|Amantadine|amantadine|mesh-list
25062382|NCT04862650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25062383|NCT04862650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25062385|NCT04862650|Antimitotic Agents|antimitotic agents|mesh-ancestor
25062386|NCT04862650|Mitosis Modulators|mitosis modulators|mesh-ancestor
25062387|NCT04862650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514810|NCT00593008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24514811|NCT00593008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24514812|NCT00593008|Antifungal Agents|antifungal agents|mesh-ancestor
24514815|NCT00593060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25062390|NCT04838301|Anesthetics|anesthetics|mesh-ancestor
25062391|NCT04838301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24613463|NCT01019174|Growth Substances|growth substances|mesh-ancestor
24613464|NCT01019174|Growth Inhibitors|growth inhibitors|mesh-ancestor
24623593|NCT01072604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623594|NCT01072604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24623595|NCT01072604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24623596|NCT01072604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623597|NCT01072604|Antipyretics|antipyretics|mesh-ancestor
24623599|NCT01072695|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24623600|NCT01072695|Antimetabolites|antimetabolites|mesh-ancestor
24623601|NCT01072695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895398|NCT04369469|Immunologic Factors|immunologic factors|mesh-ancestor
24895399|NCT04369469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514913|NCT00593463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514914|NCT00593463|Anticonvulsants|anticonvulsants|mesh-ancestor
24514915|NCT00593463|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24514916|NCT00593463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24514938|NCT00593463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24514939|NCT00593463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24514941|NCT00593502|Antiviral Agents|antiviral agents|mesh-ancestor
24514942|NCT00593502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24514952|NCT00593580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24514955|NCT00593619|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24514956|NCT00593619|Iron-Dextran Complex|iron-dextran complex|mesh-list
24514957|NCT00593619|Trace Elements|trace elements|mesh-ancestor
24515011|NCT00593879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24515012|NCT00593879|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
24515013|NCT00593879|Autonomic Agents|autonomic agents|mesh-ancestor
24515014|NCT00593879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24515015|NCT00593879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895495|NCT04019093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24895496|NCT04019093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24895497|NCT04019093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25698895|NCT02099006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25698896|NCT02099006|Antimanic Agents|antimanic agents|mesh-ancestor
25698897|NCT02099006|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25698898|NCT02099006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25698899|NCT02099006|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25698900|NCT02099006|GABA Agonists|gaba agonists|mesh-ancestor
25698901|NCT02099006|GABA Agents|gaba agents|mesh-ancestor
25698902|NCT02099006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25698903|NCT02099006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25698904|NCT02099006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24895498|NCT04019093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895501|NCT04006210|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24895502|NCT04006210|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24824991|NCT02126683|Antimalarials|antimalarials|mesh-ancestor
24824992|NCT02126683|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24824993|NCT02126683|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24824994|NCT02126683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24817339|NCT02082665|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24895565|NCT03895099|Hormones|hormones|mesh-ancestor
24895595|NCT03820466|Atorvastatin|atorvastatin|mesh-list
24515124|NCT00594633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895678|NCT03598426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24895679|NCT03533452|Ropivacaine|ropivacaine|mesh-list
24895680|NCT03533452|Anesthetics, Local|anesthetics, local|mesh-ancestor
24895681|NCT03533452|Anesthetics|anesthetics|mesh-ancestor
24895682|NCT03533452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24895750|NCT03215706|Nivolumab|nivolumab|mesh-list
24895751|NCT03215706|Pemetrexed|pemetrexed|mesh-list
24515201|NCT00595543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24515202|NCT00595543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515204|NCT00595543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24515205|NCT00595543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24515206|NCT00595543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24895824|NCT03006705|Antimetabolites|antimetabolites|mesh-ancestor
24895825|NCT03006705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895826|NCT03006705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25062472|NCT04594915|Antithrombins|antithrombins|mesh-ancestor
25062480|NCT04586062|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25062481|NCT04586062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062484|NCT04559217|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
25062485|NCT04559217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062486|NCT04550520|Glucagon|glucagon|mesh-list
25062487|NCT04550520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25062488|NCT04550520|Hormones|hormones|mesh-ancestor
24515259|NCT00596050|GABA Agents|gaba agents|mesh-ancestor
25062489|NCT04550520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25062490|NCT04550520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825049|NCT02127047|Hormones|hormones|mesh-ancestor
24895869|NCT02960763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24895870|NCT02960763|Adrenergic Agents|adrenergic agents|mesh-ancestor
25698905|NCT02099006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25698906|NCT02099006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25698907|NCT02099006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25698908|NCT02099006|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25698909|NCT02099006|Antidepressive Agents|antidepressive agents|mesh-ancestor
25698910|NCT02099006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25698911|NCT02099006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25698912|NCT02099006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25698913|NCT02099006|Adrenergic Agents|adrenergic agents|mesh-ancestor
25698914|NCT02099006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24515322|NCT00596219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24515323|NCT00596219|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24515324|NCT00596219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24515325|NCT00596219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515326|NCT00596219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515327|NCT00596297|Bevacizumab|bevacizumab|mesh-list
24523896|NCT05338723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24515336|NCT00596336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24515337|NCT00596336|Immunologic Factors|immunologic factors|mesh-ancestor
24895927|NCT02819479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24895928|NCT02819479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24895929|NCT02819479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24895930|NCT02819479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24895931|NCT02819479|Growth Substances|growth substances|mesh-ancestor
24895932|NCT02819479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895933|NCT02819479|Growth Inhibitors|growth inhibitors|mesh-ancestor
24895934|NCT02819479|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25062507|NCT04502589|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25062508|NCT04502589|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25062509|NCT04502589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25062510|NCT04502589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062512|NCT04481919|Natriuretic Agents|natriuretic agents|mesh-ancestor
25062513|NCT04481919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062514|NCT04459065|Nimotuzumab|nimotuzumab|mesh-list
25062516|NCT04459065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825066|NCT02127138|Sirolimus|sirolimus|mesh-list
24825067|NCT02127138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24825068|NCT02127138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24825069|NCT02127138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24895935|NCT02819479|Diuretics|diuretics|mesh-ancestor
24895936|NCT02819479|Natriuretic Agents|natriuretic agents|mesh-ancestor
24895937|NCT02816424|TEMPO|tempo|mesh-list
24895938|NCT02816424|Antioxidants|antioxidants|mesh-ancestor
24895939|NCT02816424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698916|NCT02099084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25698917|NCT02099084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25698918|NCT02099084|Protective Agents|protective agents|mesh-ancestor
25698919|NCT02099084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698920|NCT02099110|Metformin|metformin|mesh-list
25698921|NCT02099110|Insulin Glargine|insulin glargine|mesh-list
25698922|NCT02099110|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25698923|NCT02099110|Glimepiride|glimepiride|mesh-list
25698924|NCT02099110|Ertugliflozin|ertugliflozin|mesh-list
25698925|NCT02099110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25698926|NCT02099110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994465|NCT04096170|Anesthetics|anesthetics|mesh-ancestor
25062539|NCT04370301|Cyclophosphamide|cyclophosphamide|mesh-list
25062541|NCT04370301|Mechlorethamine|mechlorethamine|mesh-list
25062542|NCT04370301|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25062543|NCT04370301|Fludarabine|fludarabine|mesh-list
24895983|NCT02693184|Vitamin D|vitamin d|mesh-list
24895984|NCT02693184|Calcium|calcium|mesh-list
24896030|NCT02601313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896031|NCT02601313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24896032|NCT02601313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24896033|NCT02601313|Alkylating Agents|alkylating agents|mesh-ancestor
25062545|NCT04370301|Lenograstim|lenograstim|mesh-list
25062546|NCT04370301|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
25062547|NCT04370301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25062548|NCT04370301|Immunologic Factors|immunologic factors|mesh-ancestor
25062549|NCT04370301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825101|NCT02127489|Anesthetics|anesthetics|mesh-ancestor
24896034|NCT02601313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896035|NCT02601313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473037|NCT00401609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515488|NCT00597857|Hydrocortisone|hydrocortisone|mesh-list
24515489|NCT00597857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24515490|NCT00598013|Pioglitazone|pioglitazone|mesh-list
24515493|NCT00598052|Citalopram|citalopram|mesh-list
24896061|NCT02520076|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
24896062|NCT02520076|Protein C Inhibitor|protein c inhibitor|mesh-list
24896063|NCT02520076|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24558181|NCT00755664|Micronutrients|micronutrients|mesh-ancestor
24896064|NCT02520076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24896065|NCT02520076|Protease Inhibitors|protease inhibitors|mesh-ancestor
24896066|NCT02520076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896067|NCT02520076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817364|NCT02083068|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
24515517|NCT00598156|Bevacizumab|bevacizumab|mesh-list
25062551|NCT04370301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24817379|NCT02083315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24817380|NCT02083315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896190|NCT01404754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25062571|NCT04347122|Tranexamic Acid|tranexamic acid|mesh-list
24515541|NCT00598169|Antiemetics|antiemetics|mesh-ancestor
24515542|NCT00598169|Autonomic Agents|autonomic agents|mesh-ancestor
24515543|NCT00598169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24515544|NCT00598169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24515545|NCT00598169|Glucocorticoids|glucocorticoids|mesh-ancestor
25698927|NCT02099110|Incretins|incretins|mesh-ancestor
25698928|NCT02099110|Hormones|hormones|mesh-ancestor
25698929|NCT02099110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25698930|NCT02099110|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25698931|NCT02099110|Protease Inhibitors|protease inhibitors|mesh-ancestor
25698932|NCT02099110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25698933|NCT02099110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473166|NCT00402259|Esomeprazole|esomeprazole|mesh-list
24896087|NCT02382445|Anesthetics|anesthetics|mesh-list
24896089|NCT02382445|Sevoflurane|sevoflurane|mesh-list
24896090|NCT02382445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24896091|NCT02382445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896092|NCT02382445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24896093|NCT02382445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24896094|NCT02382445|Anesthetics, General|anesthetics, general|mesh-ancestor
24896103|NCT02378805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24896104|NCT02378805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896106|NCT02378805|Diuretics|diuretics|mesh-ancestor
24896107|NCT02378805|Natriuretic Agents|natriuretic agents|mesh-ancestor
24896108|NCT02378805|Protease Inhibitors|protease inhibitors|mesh-ancestor
24896109|NCT02378805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896110|NCT02378805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896111|NCT02378805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24896112|NCT02378805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24896113|NCT02133872|Minocycline|minocycline|mesh-list
24896114|NCT02133872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24896115|NCT02133872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25062595|NCT04311489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25062596|NCT04311489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896150|NCT01668719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24896151|NCT01668719|Glucocorticoids|glucocorticoids|mesh-ancestor
24896153|NCT01668719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24896189|NCT01404754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473235|NCT00402441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24473236|NCT00402441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896192|NCT01404754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24896193|NCT01404754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896194|NCT01404754|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24896197|NCT01404754|Adrenergic Agents|adrenergic agents|mesh-ancestor
24896255|NCT01117441|Dermatologic Agents|dermatologic agents|mesh-ancestor
24896256|NCT01117441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24896257|NCT01117441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24896258|NCT01117441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24896259|NCT01117441|Antiviral Agents|antiviral agents|mesh-ancestor
24896260|NCT01117441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24896261|NCT01117441|Tubulin Modulators|tubulin modulators|mesh-ancestor
24896262|NCT01117441|Antimitotic Agents|antimitotic agents|mesh-ancestor
24896263|NCT01117441|Mitosis Modulators|mitosis modulators|mesh-ancestor
25062597|NCT04311489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25062598|NCT04311489|Respiratory System Agents|respiratory system agents|mesh-ancestor
24896264|NCT01101451|Cisplatin|cisplatin|mesh-list
24896265|NCT01101451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24896268|NCT00127673|Sertraline|sertraline|mesh-list
24515624|NCT00598533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24515626|NCT00598533|Antifungal Agents|antifungal agents|mesh-ancestor
24515627|NCT00598533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24515628|NCT00598533|Immunologic Factors|immunologic factors|mesh-ancestor
25107959|NCT03135795|Narcotics|narcotics|mesh-ancestor
25107960|NCT03135795|Anticonvulsants|anticonvulsants|mesh-ancestor
24896296|NCT04438577|Sensory System Agents|sensory system agents|mesh-ancestor
24896297|NCT04438577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24896298|NCT04438577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24896299|NCT04438577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24896300|NCT04438577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24896301|NCT04438577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24896302|NCT04438577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896303|NCT04438187|Anti-Infective Agents|anti-infective agents|mesh-list
24896304|NCT04438187|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24896306|NCT04438434|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24896307|NCT04438434|Hydrogen Peroxide|hydrogen peroxide|mesh-list
24896308|NCT04438434|Hyaluronic Acid|hyaluronic acid|mesh-list
24896309|NCT04438434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24896310|NCT04438434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24896311|NCT04438434|Disinfectants|disinfectants|mesh-ancestor
24896312|NCT04438434|Dermatologic Agents|dermatologic agents|mesh-ancestor
24896313|NCT04438434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24817413|NCT02083536|Mitosis Modulators|mitosis modulators|mesh-ancestor
24817476|NCT02084303|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24817477|NCT02084303|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24817478|NCT02084342|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25062602|NCT04308304|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25062603|NCT04308304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817479|NCT02084342|Tranexamic Acid|tranexamic acid|mesh-list
24817480|NCT02084342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24817481|NCT02084342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24817482|NCT02084342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473396|NCT00402623|Antioxidants|antioxidants|mesh-ancestor
24473400|NCT00402636|Sirolimus|sirolimus|mesh-list
25698934|NCT02099110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25698935|NCT02099110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25698936|NCT02099110|Immunologic Factors|immunologic factors|mesh-ancestor
25698937|NCT02099110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25698938|NCT02099461|Denosumab|denosumab|mesh-list
25698939|NCT02099461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25698940|NCT02099461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698941|NCT02099682|Lansoprazole|lansoprazole|mesh-list
25698942|NCT02099682|Dexlansoprazole|dexlansoprazole|mesh-list
25698943|NCT02099682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24515651|NCT00598611|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24515652|NCT00598611|Histamine Antagonists|histamine antagonists|mesh-ancestor
24896355|NCT04437654|Anticoagulants|anticoagulants|mesh-ancestor
24896356|NCT04437004|Fenfluramine|fenfluramine|mesh-list
24896357|NCT04437004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24896358|NCT04437004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24896359|NCT04437004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24473445|NCT00402792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24515658|NCT00598624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24515659|NCT00598624|Alkylating Agents|alkylating agents|mesh-ancestor
24515660|NCT00598624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515665|NCT00598637|Immunologic Factors|immunologic factors|mesh-ancestor
24515676|NCT00598676|Antifungal Agents|antifungal agents|mesh-ancestor
24515677|NCT00598715|Sirolimus|sirolimus|mesh-list
24515678|NCT00598715|Paclitaxel|paclitaxel|mesh-list
24515679|NCT00598715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24515680|NCT00598715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24515688|NCT00598715|Antifungal Agents|antifungal agents|mesh-ancestor
24515689|NCT00598715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24515690|NCT00598715|Immunologic Factors|immunologic factors|mesh-ancestor
25062616|NCT04280848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24515695|NCT00598793|Insulin Glargine|insulin glargine|mesh-list
24560318|NCT02927847|Autonomic Agents|autonomic agents|mesh-ancestor
25062618|NCT04280848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062619|NCT04280848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825171|NCT02127736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25698944|NCT02099682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25698945|NCT02099682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25698946|NCT02099682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25698947|NCT02099682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698948|NCT02099708|Lansoprazole|lansoprazole|mesh-list
25698949|NCT02099708|Dexlansoprazole|dexlansoprazole|mesh-list
25698950|NCT02099708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25698951|NCT02099708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25698952|NCT02099708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25698953|NCT02099708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107994|NCT03136120|Respiratory System Agents|respiratory system agents|mesh-ancestor
25107995|NCT03136120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25107996|NCT03136120|Cholinergic Agents|cholinergic agents|mesh-ancestor
25107997|NCT03136120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25107998|NCT03136120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896400|NCT04437160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24896401|NCT04437160|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24896535|NCT04435314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24515735|NCT00598923|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24515743|NCT00598962|Antitubercular Agents|antitubercular agents|mesh-ancestor
24515744|NCT00598962|Leprostatic Agents|leprostatic agents|mesh-ancestor
24896429|NCT04436536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24896430|NCT04436536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24896431|NCT04436536|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24896432|NCT04436172|Anesthetics|anesthetics|mesh-list
24896433|NCT04436172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24473511|NCT00403065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25062630|NCT04270877|Naltrexone|naltrexone|mesh-list
25062631|NCT04270877|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24515767|NCT00599235|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24515768|NCT00599235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24515769|NCT00599235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515770|NCT00599235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515771|NCT00599235|Urological Agents|urological agents|mesh-ancestor
24515772|NCT00599235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24515773|NCT00599274|Interferons|interferons|mesh-list
24515774|NCT00599274|Interferon-beta|interferon-beta|mesh-list
24515775|NCT00599274|Interferon beta-1a|interferon beta-1a|mesh-list
24515776|NCT00599274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24515777|NCT00599274|Antiviral Agents|antiviral agents|mesh-ancestor
24515778|NCT00599274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24515779|NCT00599274|Immunologic Factors|immunologic factors|mesh-ancestor
24515798|NCT00599287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24515799|NCT00599287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24515800|NCT00599287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24515801|NCT00599287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24515802|NCT00599287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24515803|NCT00599287|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25698954|NCT02099708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698955|NCT02099838|Metformin|metformin|mesh-list
25698956|NCT02099838|Pioglitazone|pioglitazone|mesh-list
25698957|NCT02099838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25698958|NCT02099838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698959|NCT02100007|Topotecan|topotecan|mesh-list
25698960|NCT02100007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25698961|NCT02100007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25698962|NCT02100007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515809|NCT00599417|Broncho-Vaxom|broncho-vaxom|mesh-list
24515810|NCT00599417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24515811|NCT00599417|Immunologic Factors|immunologic factors|mesh-ancestor
25062641|NCT04231877|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25062643|NCT04231877|Daunorubicin|daunorubicin|mesh-list
25062644|NCT04231877|Podophyllotoxin|podophyllotoxin|mesh-list
25062645|NCT04231877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25062646|NCT04231877|Antibodies|antibodies|mesh-list
24896472|NCT04435925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24515814|NCT00599534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24515815|NCT00599534|Respiratory System Agents|respiratory system agents|mesh-ancestor
24515816|NCT00599534|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24515817|NCT00599534|Hormone Antagonists|hormone antagonists|mesh-ancestor
24515818|NCT00599534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25062654|NCT04231877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25062655|NCT04231877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25062656|NCT04231877|Alkylating Agents|alkylating agents|mesh-ancestor
24825193|NCT02127749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825194|NCT02127749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25062657|NCT04231877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062659|NCT04231877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24896518|NCT04435652|Antimitotic Agents|antimitotic agents|mesh-ancestor
24896519|NCT04435652|Mitosis Modulators|mitosis modulators|mesh-ancestor
24896520|NCT04435652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896521|NCT04435483|Acalabrutinib|acalabrutinib|mesh-list
24896522|NCT04435483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24896523|NCT04435522|Maraviroc|maraviroc|mesh-list
24896524|NCT04435522|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24896525|NCT04435522|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24896526|NCT04435522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896527|NCT04435522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24896528|NCT04435522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24896529|NCT04435522|Antiviral Agents|antiviral agents|mesh-ancestor
24896530|NCT04435522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24473596|NCT00403364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24994987|NCT05418660|Nivolumab|nivolumab|mesh-list
24994988|NCT05418660|Atezolizumab|atezolizumab|mesh-list
24994989|NCT05418660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24562197|NCT00764907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24686409|NCT04870333|Antinematodal Agents|antinematodal agents|mesh-ancestor
24686410|NCT04859829|Immunoglobulins|immunoglobulins|mesh-list
24686446|NCT04791761|Acetaminophen|acetaminophen|mesh-list
24515827|NCT00599560|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24515828|NCT00599560|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24515829|NCT00599560|Natriuretic Agents|natriuretic agents|mesh-ancestor
24515830|NCT00599560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515831|NCT00599573|Ondansetron|ondansetron|mesh-list
24896531|NCT04435522|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24896532|NCT04435574|Lactoferrin|lactoferrin|mesh-list
24896533|NCT04435574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24896534|NCT04435314|Nitazoxanide|nitazoxanide|mesh-list
24515840|NCT00599573|Serotonin Agents|serotonin agents|mesh-ancestor
24515841|NCT00599573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24515842|NCT00599573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515843|NCT00599573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24515844|NCT00599573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24562531|NCT00766870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562532|NCT00766870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24562533|NCT00766870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562534|NCT00766870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24562535|NCT00766870|Antidepressive Agents|antidepressive agents|mesh-ancestor
24562536|NCT00766870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24562538|NCT00766896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24896551|NCT04435028|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24473623|NCT00403533|Antimetabolites|antimetabolites|mesh-ancestor
25062660|NCT04231877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25062661|NCT04231877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25062662|NCT04231877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25698963|NCT02100007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698964|NCT02100007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25698965|NCT02100124|Contraceptive Agents|contraceptive agents|mesh-list
25698966|NCT02100124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25698967|NCT02100124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698968|NCT02100228|Vitamin K|vitamin k|mesh-list
25698969|NCT02100228|Heparin|heparin|mesh-list
25698970|NCT02100228|Apixaban|apixaban|mesh-list
25698971|NCT02100228|Vitamins|vitamins|mesh-ancestor
25698972|NCT02100228|Micronutrients|micronutrients|mesh-ancestor
25698973|NCT02100228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698974|NCT02100228|Anticoagulants|anticoagulants|mesh-ancestor
25698975|NCT02100228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25698976|NCT02100228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25698977|NCT02100228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995032|NCT05418556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24995033|NCT05418556|Purinergic Agents|purinergic agents|mesh-ancestor
24995034|NCT05418556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24995035|NCT05418465|Dapagliflozin|dapagliflozin|mesh-list
24995036|NCT05418465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24995037|NCT05418465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995038|NCT05418465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24995039|NCT05418465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995040|NCT05418452|Metformin|metformin|mesh-list
24995041|NCT05418452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24995042|NCT05418452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995043|NCT05418361|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24995070|NCT05418244|Dermatologic Agents|dermatologic agents|mesh-ancestor
24995071|NCT05418244|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25062663|NCT04231877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896552|NCT04435028|Histamine Antagonists|histamine antagonists|mesh-ancestor
24896553|NCT04435028|Histamine Agents|histamine agents|mesh-ancestor
24896554|NCT04435028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24896555|NCT04435028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896556|NCT04435028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896557|NCT04435028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24896558|NCT04435210|Hydralazine|hydralazine|mesh-list
24896559|NCT04435210|Nifedipine|nifedipine|mesh-list
24896560|NCT04435210|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24896565|NCT04435210|Vasodilator Agents|vasodilator agents|mesh-ancestor
24896571|NCT04434482|Alkylating Agents|alkylating agents|mesh-ancestor
24896572|NCT04434482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896573|NCT04434482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473649|NCT00403663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24515846|NCT00599573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24515847|NCT00599573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24515848|NCT00599625|Pravastatin|pravastatin|mesh-list
24515849|NCT00599625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24515850|NCT00599625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24515851|NCT00599625|Antimetabolites|antimetabolites|mesh-ancestor
24896580|NCT04434378|Tamsulosin|tamsulosin|mesh-list
25698978|NCT02100228|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25698979|NCT02100228|Antithrombins|antithrombins|mesh-ancestor
25698980|NCT02100228|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25698981|NCT02100228|Protease Inhibitors|protease inhibitors|mesh-ancestor
25698982|NCT02100228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25698983|NCT02100228|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25698984|NCT02100228|Hemostatics|hemostatics|mesh-ancestor
25698985|NCT02100228|Coagulants|coagulants|mesh-ancestor
25698986|NCT02100319|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25698987|NCT02100319|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25698988|NCT02100319|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25698989|NCT02100319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25698990|NCT02100475|Insulin|insulin|mesh-list
25698991|NCT02100475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25698992|NCT02100475|Insulin Aspart|insulin aspart|mesh-list
25698993|NCT02100475|Liraglutide|liraglutide|mesh-list
25698994|NCT02100475|Xultophy|xultophy|mesh-list
25698995|NCT02100475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24995118|NCT05418010|Immunologic Factors|immunologic factors|mesh-ancestor
24995119|NCT05418010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995120|NCT05417997|Clarithromycin|clarithromycin|mesh-list
24995121|NCT05417997|Ceftriaxone|ceftriaxone|mesh-list
24995122|NCT05417997|Favipiravir|favipiravir|mesh-list
24995123|NCT05417997|Methylprednisolone|methylprednisolone|mesh-list
24995125|NCT05417997|Lansoprazole|lansoprazole|mesh-list
24995126|NCT05417997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24995136|NCT05417997|Protective Agents|protective agents|mesh-ancestor
24896588|NCT04434378|Urological Agents|urological agents|mesh-ancestor
24473691|NCT00403806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24896593|NCT04434404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896594|NCT04434430|Gabapentin|gabapentin|mesh-list
24896595|NCT04434430|Analgesics|analgesics|mesh-ancestor
24896596|NCT04434430|Sensory System Agents|sensory system agents|mesh-ancestor
24896597|NCT04434430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24896598|NCT04434430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896599|NCT04434430|Anticonvulsants|anticonvulsants|mesh-ancestor
24896600|NCT04434430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24562773|NCT00768183|Ethanol|ethanol|mesh-list
25062670|NCT04231877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25062671|NCT04231877|Keratolytic Agents|keratolytic agents|mesh-ancestor
25062672|NCT04231877|Dermatologic Agents|dermatologic agents|mesh-ancestor
25698996|NCT02100475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25698997|NCT02100475|Incretins|incretins|mesh-ancestor
25698998|NCT02100475|Hormones|hormones|mesh-ancestor
25698999|NCT02100475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25699000|NCT02100514|Bococizumab|bococizumab|mesh-list
25699001|NCT02100514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25699002|NCT02100514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25699003|NCT02100514|Antimetabolites|antimetabolites|mesh-ancestor
25699004|NCT02100514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515888|NCT00599898|Nifedipine|nifedipine|mesh-list
24515914|NCT00599937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24515915|NCT00599937|Keratolytic Agents|keratolytic agents|mesh-ancestor
24515916|NCT00599937|Dermatologic Agents|dermatologic agents|mesh-ancestor
24515918|NCT00599950|Mitomycin|mitomycin|mesh-list
24515919|NCT00599950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24515920|NCT00599950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24515921|NCT00599950|Alkylating Agents|alkylating agents|mesh-ancestor
24515922|NCT00599950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515923|NCT00599950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24515924|NCT00599950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515925|NCT00600041|Pantoprazole|pantoprazole|mesh-list
24515926|NCT00600041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24515927|NCT00600041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24515928|NCT00600041|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24515929|NCT00600041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433986|NCT00261131|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24433988|NCT00261131|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24433989|NCT00261131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24515940|NCT00600093|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24515941|NCT00600093|Antiviral Agents|antiviral agents|mesh-ancestor
24515942|NCT00600093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24515943|NCT00600093|Dopamine Agents|dopamine agents|mesh-ancestor
24515944|NCT00600093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24515945|NCT00600093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515946|NCT00600093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515947|NCT00600093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24855143|NCT02277678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24855144|NCT02277678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687264|NCT04164199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24687265|NCT04164199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24687266|NCT04164199|Alkylating Agents|alkylating agents|mesh-ancestor
24687274|NCT04148937|Pembrolizumab|pembrolizumab|mesh-list
24515949|NCT00600093|Sensory System Agents|sensory system agents|mesh-ancestor
25699005|NCT02100514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25699006|NCT02100579|Bupivacaine|bupivacaine|mesh-list
25699007|NCT02100579|Anesthetics, Local|anesthetics, local|mesh-ancestor
25699008|NCT02100579|Anesthetics|anesthetics|mesh-ancestor
25699009|NCT02100579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25699010|NCT02100579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699011|NCT02100579|Sensory System Agents|sensory system agents|mesh-ancestor
25699012|NCT02100579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699013|NCT02100644|Lamotrigine|lamotrigine|mesh-list
25699015|NCT02100644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25699016|NCT02100644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25699017|NCT02100644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699018|NCT02100644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25699019|NCT02100644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699020|NCT02100644|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25699021|NCT02100644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25699022|NCT02100644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25699023|NCT02100644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25699024|NCT02100644|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24515950|NCT00600093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24515951|NCT00600145|Mirtazapine|mirtazapine|mesh-list
24515952|NCT00600145|Antidepressive Agents|antidepressive agents|mesh-ancestor
24515953|NCT00600145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24515954|NCT00600145|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24953197|NCT03887754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953198|NCT03887754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953199|NCT03887754|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24896649|NCT04434248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24896651|NCT04434248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24473734|NCT00403962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24423447|NCT00226005|Vatalanib|vatalanib|mesh-list
24515968|NCT00600145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24515969|NCT00600145|Serotonin Agents|serotonin agents|mesh-ancestor
24515970|NCT00600145|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24515973|NCT00600158|Bupivacaine|bupivacaine|mesh-list
24515974|NCT00600158|Anesthetics, Local|anesthetics, local|mesh-ancestor
24515975|NCT00600158|Anesthetics|anesthetics|mesh-ancestor
24515976|NCT00600158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24515977|NCT00600158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515978|NCT00600158|Sensory System Agents|sensory system agents|mesh-ancestor
24473743|NCT00403988|Tubulin Modulators|tubulin modulators|mesh-ancestor
24473744|NCT00403988|Antimitotic Agents|antimitotic agents|mesh-ancestor
24473745|NCT00403988|Mitosis Modulators|mitosis modulators|mesh-ancestor
24473747|NCT00404040|Lactulose|lactulose|mesh-list
24516152|NCT00600691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24953200|NCT03887754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24953201|NCT03887754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25699025|NCT02100657|Dexamethasone|dexamethasone|mesh-list
24809654|NCT02035709|Hydromorphone|hydromorphone|mesh-list
25699026|NCT02100657|Bortezomib|bortezomib|mesh-list
25699027|NCT02100657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25110029|NCT03120442|Narcotics|narcotics|mesh-ancestor
24515995|NCT00600210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515996|NCT00600210|Growth Inhibitors|growth inhibitors|mesh-ancestor
24515997|NCT00600249|Docetaxel|docetaxel|mesh-list
24515998|NCT00600249|Cetuximab|cetuximab|mesh-list
24515999|NCT00600249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516000|NCT00600249|Tubulin Modulators|tubulin modulators|mesh-ancestor
24516001|NCT00600249|Antimitotic Agents|antimitotic agents|mesh-ancestor
24516002|NCT00600249|Mitosis Modulators|mitosis modulators|mesh-ancestor
24896661|NCT04434105|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24896662|NCT04434105|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24896668|NCT04434105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24896669|NCT04434105|Immunologic Factors|immunologic factors|mesh-ancestor
24896670|NCT04434105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896671|NCT04434105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896672|NCT04434118|Antirheumatic Agents|antirheumatic agents|mesh-list
24896673|NCT04434144|Azithromycin|azithromycin|mesh-list
24473750|NCT00404040|Laxatives|laxatives|mesh-ancestor
24473751|NCT00404053|Clopidogrel|clopidogrel|mesh-list
24473762|NCT00404157|Rituximab|rituximab|mesh-list
24825284|NCT02128061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825285|NCT02128061|Immunologic Factors|immunologic factors|mesh-ancestor
24516003|NCT00600249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516004|NCT00600249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24516005|NCT00600262|Bevacizumab|bevacizumab|mesh-list
24516006|NCT00600262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24516007|NCT00600262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516008|NCT00600262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24516009|NCT00600262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24516010|NCT00600262|Growth Substances|growth substances|mesh-ancestor
24516011|NCT00600262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516012|NCT00600262|Growth Inhibitors|growth inhibitors|mesh-ancestor
24516013|NCT00600301|Triamcinolone|triamcinolone|mesh-list
24516014|NCT00600301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24516015|NCT00600301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24516016|NCT00600301|Bevacizumab|bevacizumab|mesh-list
25062747|NCT04099355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25062748|NCT04092894|Suvorexant|suvorexant|mesh-list
25062749|NCT04092894|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25062750|NCT04092894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25062751|NCT04092894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25062752|NCT04092894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25062753|NCT04092894|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25062754|NCT04092894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25062755|NCT04092894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825309|NCT02128100|Vitamin B Complex|vitamin b complex|mesh-ancestor
24896674|NCT04434144|Doxycycline|doxycycline|mesh-list
24896686|NCT04434170|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24896688|NCT04434170|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25699028|NCT02100657|Antiemetics|antiemetics|mesh-ancestor
25699029|NCT02100657|Autonomic Agents|autonomic agents|mesh-ancestor
25699030|NCT02100657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699031|NCT02100657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699032|NCT02100657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25699033|NCT02100657|Glucocorticoids|glucocorticoids|mesh-ancestor
25699034|NCT02100657|Hormones|hormones|mesh-ancestor
24995309|NCT05285566|Bupivacaine|bupivacaine|mesh-list
24995310|NCT05285566|Anesthetics, Local|anesthetics, local|mesh-ancestor
24995311|NCT05285566|Anesthetics|anesthetics|mesh-ancestor
24995312|NCT05285566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24995313|NCT05285566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995314|NCT05285566|Sensory System Agents|sensory system agents|mesh-ancestor
24995339|NCT05270057|Prednisone|prednisone|mesh-list
24995340|NCT05270057|Cyclophosphamide|cyclophosphamide|mesh-list
24896689|NCT04434170|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24896690|NCT04434170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896691|NCT04433533|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25062756|NCT04073615|Trifluridine|trifluridine|mesh-list
25062757|NCT04073615|Apatinib|apatinib|mesh-list
25062758|NCT04073615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25062759|NCT04073615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24578599|NCT00849615|Antidotes|antidotes|mesh-ancestor
25062760|NCT04073615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25062761|NCT04073615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062762|NCT04073615|Antimetabolites|antimetabolites|mesh-ancestor
25062763|NCT04073615|Antiviral Agents|antiviral agents|mesh-ancestor
25062764|NCT04073615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25062765|NCT04072042|Apatinib|apatinib|mesh-list
25062766|NCT04072042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25062767|NCT04072042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25062768|NCT04072042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473765|NCT00404157|Immunologic Factors|immunologic factors|mesh-ancestor
24473766|NCT00404157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473767|NCT00404157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24473771|NCT00404183|Oxycodone|oxycodone|mesh-list
24516018|NCT00600301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24516028|NCT00600301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24516030|NCT00600301|Immunologic Factors|immunologic factors|mesh-ancestor
24516043|NCT00600405|Analgesics|analgesics|mesh-ancestor
24516044|NCT00600405|Sensory System Agents|sensory system agents|mesh-ancestor
24516045|NCT00600405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24516046|NCT00600405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896706|NCT04433611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24896707|NCT04433611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24896708|NCT04433611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24817518|NCT02084433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817519|NCT02084446|Mycophenolic Acid|mycophenolic acid|mesh-list
24817520|NCT02084446|Prednisone|prednisone|mesh-list
24817521|NCT02084446|Methylprednisolone|methylprednisolone|mesh-list
24817522|NCT02084446|Everolimus|everolimus|mesh-list
24817523|NCT02084446|Tacrolimus|tacrolimus|mesh-list
24817524|NCT02084446|Thymoglobulin|thymoglobulin|mesh-list
24817534|NCT02084446|Immunologic Factors|immunologic factors|mesh-ancestor
24817535|NCT02084446|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24516049|NCT00600405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24516050|NCT00600405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516051|NCT00600405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516052|NCT00600405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24473814|NCT00404261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24516064|NCT00600535|Abiraterone Acetate|abiraterone acetate|mesh-list
24516065|NCT00600535|Glucocorticoids|glucocorticoids|mesh-list
24516066|NCT00600535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516067|NCT00600535|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24516068|NCT00600535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566922|NCT00788567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566923|NCT00788567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516069|NCT00600535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516070|NCT00600535|Hormone Antagonists|hormone antagonists|mesh-ancestor
24516071|NCT00600535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24516072|NCT00600535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516073|NCT00600535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25699035|NCT02100657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25699036|NCT02100657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25699037|NCT02100657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25699038|NCT02100670|Diclofenac|diclofenac|mesh-list
25699039|NCT02100670|Menthol|menthol|mesh-list
25699040|NCT02100670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25699041|NCT02100670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25699042|NCT02100670|Analgesics|analgesics|mesh-ancestor
24516074|NCT00600535|Hormones|hormones|mesh-ancestor
25062819|NCT03912831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25062820|NCT03912831|Immunologic Factors|immunologic factors|mesh-ancestor
25062828|NCT03910621|Miglustat|miglustat|mesh-list
24817550|NCT02084472|Mineral Oil|mineral oil|mesh-list
24817552|NCT02084472|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24817553|NCT02084472|Protective Agents|protective agents|mesh-ancestor
24817554|NCT02084472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817555|NCT02084472|Emollients|emollients|mesh-ancestor
24473822|NCT00404261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24473823|NCT00404261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817556|NCT02084472|Dermatologic Agents|dermatologic agents|mesh-ancestor
24817557|NCT02084550|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
24817569|NCT02084563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24817570|NCT02084563|Immunologic Factors|immunologic factors|mesh-ancestor
24817571|NCT02084563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817572|NCT02084563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817573|NCT02084563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24817574|NCT02084563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24817575|NCT02084563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24817577|NCT02084576|Nepafenac|nepafenac|mesh-list
24817578|NCT02084576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24817579|NCT02084576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24817580|NCT02084576|Analgesics|analgesics|mesh-ancestor
24817581|NCT02084576|Sensory System Agents|sensory system agents|mesh-ancestor
24817582|NCT02084576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24473828|NCT00404274|Casopitant|casopitant|mesh-list
24473829|NCT00404274|Warfarin|warfarin|mesh-list
24473830|NCT00404274|Anticoagulants|anticoagulants|mesh-ancestor
24473831|NCT00404274|Antiemetics|antiemetics|mesh-ancestor
24473832|NCT00404274|Autonomic Agents|autonomic agents|mesh-ancestor
24473833|NCT00404274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24473834|NCT00404274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473835|NCT00404274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24473836|NCT00404274|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24473837|NCT00404274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24817583|NCT02084576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817584|NCT02084576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24896711|NCT04433481|Dabigatran|dabigatran|mesh-list
24896712|NCT04433481|Antithrombins|antithrombins|mesh-ancestor
24896713|NCT04433481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24896714|NCT04433481|Protease Inhibitors|protease inhibitors|mesh-ancestor
24473856|NCT00404378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24473857|NCT00404378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24896726|NCT04433572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24896727|NCT04433572|Antifungal Agents|antifungal agents|mesh-ancestor
24896728|NCT04433572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24896729|NCT04433572|Immunologic Factors|immunologic factors|mesh-ancestor
24896730|NCT04433572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896731|NCT04433546|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
24896732|NCT04433546|Vasodilator Agents|vasodilator agents|mesh-ancestor
24896733|NCT04433559|Tadalafil|tadalafil|mesh-list
24896734|NCT04433559|Vasodilator Agents|vasodilator agents|mesh-ancestor
24473863|NCT00404378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25062850|NCT03866252|Hallucinogens|hallucinogens|mesh-ancestor
25699043|NCT02100670|Sensory System Agents|sensory system agents|mesh-ancestor
25699044|NCT02100670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699045|NCT02100670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699046|NCT02100670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25699047|NCT02100670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25699048|NCT02100670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24995427|NCT05197270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24995428|NCT05197270|Growth Substances|growth substances|mesh-ancestor
24516144|NCT00600639|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24516145|NCT00600639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24516146|NCT00600639|Adrenergic Agents|adrenergic agents|mesh-ancestor
24516147|NCT00600639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24516148|NCT00600639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516150|NCT00600691|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24516151|NCT00600691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25062866|NCT03664024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25062867|NCT03664024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25062868|NCT03664024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25062869|NCT03664024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062870|NCT03664024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25062871|NCT03664024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25062878|NCT03530995|Itraconazole|itraconazole|mesh-list
25062879|NCT03530995|Rifampin|rifampin|mesh-list
25062880|NCT03530995|Omeprazole|omeprazole|mesh-list
25062881|NCT03530995|Rabeprazole|rabeprazole|mesh-list
25062882|NCT03530995|Belumosudil|belumosudil|mesh-list
25062883|NCT03530995|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25062884|NCT03530995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24689201|NCT02293109|Tubulin Modulators|tubulin modulators|mesh-ancestor
24689202|NCT02293109|Antimitotic Agents|antimitotic agents|mesh-ancestor
24689203|NCT02293109|Mitosis Modulators|mitosis modulators|mesh-ancestor
24689259|NCT01891747|Ascorbic Acid|ascorbic acid|mesh-list
24689260|NCT01891747|Bevacizumab|bevacizumab|mesh-list
24689261|NCT01891747|Temozolomide|temozolomide|mesh-list
24579087|NCT00853268|Narcotics|narcotics|mesh-ancestor
24516154|NCT00600691|Hormone Antagonists|hormone antagonists|mesh-ancestor
24516155|NCT00600691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24516156|NCT00600691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516163|NCT00600769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24516164|NCT00600769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516165|NCT00600769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516166|NCT00600769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24516167|NCT00600769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24516169|NCT00600847|Desloratadine|desloratadine|mesh-list
24516170|NCT00600847|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24516171|NCT00600847|Cholinergic Agents|cholinergic agents|mesh-ancestor
25699049|NCT02100670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25699050|NCT02100670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699051|NCT02100670|Antipruritics|antipruritics|mesh-ancestor
25108096|NCT03134612|Ondansetron|ondansetron|mesh-list
25108097|NCT03134612|Anesthetics, Local|anesthetics, local|mesh-ancestor
25108098|NCT03134612|Anesthetics|anesthetics|mesh-ancestor
24516172|NCT00600847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24516173|NCT00600847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516174|NCT00600847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473929|NCT00404482|Antifungal Agents|antifungal agents|mesh-ancestor
24896796|NCT04432714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25062890|NCT03530995|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24516246|NCT00601211|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24896819|NCT04432688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24896829|NCT04432688|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24896830|NCT04432688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24896831|NCT04432688|Dopamine Agents|dopamine agents|mesh-ancestor
25062917|NCT03449901|Docetaxel|docetaxel|mesh-list
24896848|NCT04432415|Fluorides, Topical|fluorides, topical|mesh-list
24896849|NCT04432415|Cariostatic Agents|cariostatic agents|mesh-ancestor
24896850|NCT04432415|Protective Agents|protective agents|mesh-ancestor
24896851|NCT04432415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896852|NCT04432558|Acetaminophen|acetaminophen|mesh-list
24896853|NCT04432558|Diclofenac|diclofenac|mesh-list
24896854|NCT04432558|Tramadol|tramadol|mesh-list
24896855|NCT04432558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24896856|NCT04432558|Analgesics|analgesics|mesh-ancestor
24896857|NCT04432558|Sensory System Agents|sensory system agents|mesh-ancestor
25062930|NCT03449901|Mitosis Modulators|mitosis modulators|mesh-ancestor
25062931|NCT03442972|Teduglutide|teduglutide|mesh-list
25062932|NCT03442972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24896858|NCT04432558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24896859|NCT04432558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896860|NCT04432558|Antipyretics|antipyretics|mesh-ancestor
24896861|NCT04432558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24896862|NCT04432558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24896863|NCT04432558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24473976|NCT00404586|Dermatologic Agents|dermatologic agents|mesh-ancestor
24473977|NCT00404586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24473978|NCT00404599|Simvastatin|simvastatin|mesh-list
24473979|NCT00404599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24473980|NCT00404599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24473981|NCT00404599|Antimetabolites|antimetabolites|mesh-ancestor
24473983|NCT00404599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24896865|NCT04432558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896866|NCT04432558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896867|NCT04432558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24896868|NCT04432558|Narcotics|narcotics|mesh-ancestor
24896869|NCT04432558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24896870|NCT04432402|Gemcitabine|gemcitabine|mesh-list
24896871|NCT04432402|Oxaliplatin|oxaliplatin|mesh-list
24896872|NCT04432402|Lenalidomide|lenalidomide|mesh-list
24896873|NCT04432402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24896874|NCT04432402|Immunologic Factors|immunologic factors|mesh-ancestor
25699052|NCT02100670|Dermatologic Agents|dermatologic agents|mesh-ancestor
25699053|NCT02100696|Etrolizumab|etrolizumab|mesh-list
25699054|NCT02100696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25699055|NCT02100696|Immunologic Factors|immunologic factors|mesh-ancestor
25699056|NCT02100696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699057|NCT02100748|Morphine|morphine|mesh-list
25699058|NCT02100748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24896875|NCT04432402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896876|NCT04432402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24896877|NCT04432402|Antimetabolites|antimetabolites|mesh-ancestor
24896878|NCT04432402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896879|NCT04432402|Antiviral Agents|antiviral agents|mesh-ancestor
24995452|NCT05166096|Analgesics|analgesics|mesh-ancestor
24995453|NCT05166096|Sensory System Agents|sensory system agents|mesh-ancestor
24896880|NCT04432402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24896881|NCT04432402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896882|NCT04432402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24896883|NCT04432402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24473990|NCT00404703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473991|NCT00404703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24473996|NCT00404716|Cilostazol|cilostazol|mesh-list
24516224|NCT00601042|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24516225|NCT00601042|Cholinergic Agents|cholinergic agents|mesh-ancestor
24516226|NCT00601042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24516241|NCT00601211|Pilocarpine|pilocarpine|mesh-list
24516242|NCT00601211|Miotics|miotics|mesh-ancestor
24516243|NCT00601211|Autonomic Agents|autonomic agents|mesh-ancestor
24516244|NCT00601211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24516245|NCT00601211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516247|NCT00601211|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24516248|NCT00601211|Cholinergic Agents|cholinergic agents|mesh-ancestor
24896884|NCT04432402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24896885|NCT04432402|Growth Substances|growth substances|mesh-ancestor
24896886|NCT04432402|Growth Inhibitors|growth inhibitors|mesh-ancestor
24896888|NCT04432428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24896889|NCT04432428|Narcotics|narcotics|mesh-ancestor
24516249|NCT00601211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24516250|NCT00601211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516252|NCT00601276|Cyproterone Acetate|cyproterone acetate|mesh-list
24474013|NCT00404729|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
24474014|NCT00404729|Nootropic Agents|nootropic agents|mesh-ancestor
24474016|NCT00404781|Cilostazol|cilostazol|mesh-list
24896890|NCT04432428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24896891|NCT04432428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896892|NCT04432428|Analgesics|analgesics|mesh-ancestor
25062937|NCT03440216|Ceftriaxone|ceftriaxone|mesh-list
25062938|NCT03440216|Temocillin|temocillin|mesh-list
25062939|NCT03440216|Penicillins|penicillins|mesh-list
25062940|NCT03440216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25062941|NCT03440216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25062942|NCT03428126|Durvalumab|durvalumab|mesh-list
25062943|NCT03428126|Trametinib|trametinib|mesh-list
25062944|NCT03428126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25062945|NCT03428126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25062946|NCT03428126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25062947|NCT03428126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25062948|NCT03428126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25062949|NCT03425292|Bevacizumab|bevacizumab|mesh-list
24896893|NCT04432428|Sensory System Agents|sensory system agents|mesh-ancestor
24896894|NCT04432428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699059|NCT02100748|Narcotics|narcotics|mesh-ancestor
25699060|NCT02100748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25699061|NCT02100748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699062|NCT02100748|Analgesics|analgesics|mesh-ancestor
24896895|NCT04432428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24896896|NCT04432428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25699063|NCT02100748|Sensory System Agents|sensory system agents|mesh-ancestor
25699064|NCT02100748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699065|NCT02100826|Cephalexin|cephalexin|mesh-list
25699066|NCT02100826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25699067|NCT02100826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25699068|NCT02100930|Molgramostim|molgramostim|mesh-list
25699069|NCT02100930|Isotretinoin|isotretinoin|mesh-list
25699070|NCT02100930|Antibodies|antibodies|mesh-list
25699071|NCT02100930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25699072|NCT02100930|Sargramostim|sargramostim|mesh-list
25699073|NCT02100930|Immunologic Factors|immunologic factors|mesh-ancestor
25699074|NCT02100930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995521|NCT05101564|Letrozole|letrozole|mesh-list
24896897|NCT04432428|Anesthetics, General|anesthetics, general|mesh-ancestor
24896898|NCT04432428|Anesthetics|anesthetics|mesh-ancestor
24896899|NCT04432324|Immunoglobulins|immunoglobulins|mesh-list
24896900|NCT04432324|Antibodies|antibodies|mesh-list
24896901|NCT04432324|gamma-Globulins|gamma-globulins|mesh-list
24570532|NCT00805233|Bromfenac|bromfenac|mesh-list
24516265|NCT00601289|Temozolomide|temozolomide|mesh-list
25063030|NCT03234491|Insulin|insulin|mesh-list
24896938|NCT04432233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896939|NCT04432233|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24896946|NCT04432155|Xenon|xenon|mesh-list
25062979|NCT03343431|Antiviral Agents|antiviral agents|mesh-list
24825550|NCT02129101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825551|NCT02129101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825552|NCT02129101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896959|NCT04431713|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24896960|NCT04431713|Incretins|incretins|mesh-ancestor
24896961|NCT04431713|Hormones|hormones|mesh-ancestor
24474051|NCT00404794|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24474052|NCT00404794|Prednisolone acetate|prednisolone acetate|mesh-list
24896962|NCT04431713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24817586|NCT02084576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24817587|NCT02084576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817588|NCT02084576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817589|NCT02084589|Fentanyl|fentanyl|mesh-list
24817590|NCT02084589|Ropivacaine|ropivacaine|mesh-list
24817591|NCT02084589|Anesthetics, Local|anesthetics, local|mesh-ancestor
24817592|NCT02084589|Anesthetics|anesthetics|mesh-ancestor
24817593|NCT02084589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24817594|NCT02084589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817595|NCT02084589|Sensory System Agents|sensory system agents|mesh-ancestor
24817596|NCT02084589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24817597|NCT02084589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24817598|NCT02084589|Narcotics|narcotics|mesh-ancestor
24817599|NCT02084589|Analgesics|analgesics|mesh-ancestor
24817600|NCT02084589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24817601|NCT02084589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24817602|NCT02084589|Anesthetics, General|anesthetics, general|mesh-ancestor
24817603|NCT02084602|Artesunate|artesunate|mesh-list
24817604|NCT02084602|Mefloquine|mefloquine|mesh-list
24817605|NCT02084602|Antimalarials|antimalarials|mesh-ancestor
24817606|NCT02084602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24817607|NCT02084602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24817608|NCT02084602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24817609|NCT02084602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25699075|NCT02100930|Dermatologic Agents|dermatologic agents|mesh-ancestor
25699076|NCT02100930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25699077|NCT02100969|Immunoglobulins|immunoglobulins|mesh-list
24817610|NCT02084602|Antiviral Agents|antiviral agents|mesh-ancestor
24817611|NCT02084602|Schistosomicides|schistosomicides|mesh-ancestor
24995582|NCT05026905|Leucovorin|leucovorin|mesh-list
24817612|NCT02084602|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25062996|NCT03307759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25062997|NCT03307759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25062998|NCT03247712|Nivolumab|nivolumab|mesh-list
24825576|NCT02129166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825577|NCT02129166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825578|NCT02129179|Glucagon|glucagon|mesh-list
24896971|NCT04431349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896972|NCT04431349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474087|NCT00404833|Prednisolone phosphate|prednisolone phosphate|mesh-list
24474088|NCT00404833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24474089|NCT00404833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474090|NCT00404833|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24474104|NCT00404833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24474105|NCT00404833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24474106|NCT00404833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24474107|NCT00404833|Protective Agents|protective agents|mesh-ancestor
24474108|NCT00404833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24474109|NCT00404833|Alkylating Agents|alkylating agents|mesh-ancestor
25062999|NCT03247712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25063000|NCT03247712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063001|NCT03247712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24947409|NCT03928496|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25063002|NCT03247712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063003|NCT03237611|Dexamethasone|dexamethasone|mesh-list
25063010|NCT03237611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24896983|NCT04431193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896984|NCT04431245|Entecavir|entecavir|mesh-list
24896985|NCT04431245|Antiviral Agents|antiviral agents|mesh-ancestor
24896986|NCT04431245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24896987|NCT04431206|Oxytocin|oxytocin|mesh-list
24896988|NCT04431206|Oxytocics|oxytocics|mesh-ancestor
24896989|NCT04431206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24896990|NCT04431206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896991|NCT04430777|Tranexamic Acid|tranexamic acid|mesh-list
24896992|NCT04430777|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24896993|NCT04430777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25063012|NCT03237611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25063013|NCT03237611|Glucocorticoids|glucocorticoids|mesh-ancestor
25063014|NCT03237611|Hormones|hormones|mesh-ancestor
24825593|NCT02129231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896994|NCT04430777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896995|NCT04430777|Hemostatics|hemostatics|mesh-ancestor
24897001|NCT04430933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24897002|NCT04430933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24897003|NCT04430933|Tubulin Modulators|tubulin modulators|mesh-ancestor
24897004|NCT04430933|Antimitotic Agents|antimitotic agents|mesh-ancestor
24516396|NCT00601887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516397|NCT00601887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24516398|NCT00601887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25699078|NCT02100969|gamma-Globulins|gamma-globulins|mesh-list
25699079|NCT02100969|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25699080|NCT02100969|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25699081|NCT02100969|Immunologic Factors|immunologic factors|mesh-ancestor
25699082|NCT02100969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699083|NCT02101008|Disulfiram|disulfiram|mesh-list
25699084|NCT02101008|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25699085|NCT02101008|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25699086|NCT02101008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24869687|NCT00568997|Pimecrolimus|pimecrolimus|mesh-list
24869688|NCT00568997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24869689|NCT00568997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24869690|NCT00568997|Analgesics|analgesics|mesh-ancestor
24516399|NCT00601887|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24516400|NCT00601887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24474127|NCT00405080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25699087|NCT02101008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699088|NCT02101021|Gemcitabine|gemcitabine|mesh-list
25699090|NCT02101021|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
25699091|NCT02101021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24474128|NCT00405080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24474129|NCT00405080|Leprostatic Agents|leprostatic agents|mesh-ancestor
24474130|NCT00405080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24572471|NCT00815048|Atropine|atropine|mesh-list
24572821|NCT00816855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24897013|NCT04430998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25063029|NCT03237611|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25063031|NCT03234491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25063032|NCT03234491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25063033|NCT03234491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897046|NCT04430361|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24897047|NCT04430361|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24897048|NCT04430361|Contraceptive Agents|contraceptive agents|mesh-ancestor
24897049|NCT04430361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24897050|NCT04430361|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24516430|NCT00601991|Growth Inhibitors|growth inhibitors|mesh-ancestor
24516431|NCT00601991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516432|NCT00602004|Losartan|losartan|mesh-list
24516433|NCT00602004|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24516434|NCT00602004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25063040|NCT03229408|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
25063041|NCT03229408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25063042|NCT03229408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25699092|NCT02101021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25699093|NCT02101021|Tubulin Modulators|tubulin modulators|mesh-ancestor
25699094|NCT02101021|Antimitotic Agents|antimitotic agents|mesh-ancestor
25063044|NCT03229408|Sensory System Agents|sensory system agents|mesh-ancestor
25063045|NCT03229408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25063046|NCT03229408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516448|NCT00601159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516450|NCT00602017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24897051|NCT04430361|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24897053|NCT04430361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24897054|NCT04430166|Antibodies|antibodies|mesh-list
24474177|NCT00405171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24474178|NCT00405171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474180|NCT00405171|Antiviral Agents|antiviral agents|mesh-ancestor
24897063|NCT04429867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24897064|NCT04429867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24897065|NCT04429867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24897066|NCT04429867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24897067|NCT04429867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897068|NCT04429867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25063048|NCT03229408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25063049|NCT03225417|Sirolimus|sirolimus|mesh-list
25063050|NCT03225417|Cyclophosphamide|cyclophosphamide|mesh-list
25063051|NCT03225417|Ixazomib|ixazomib|mesh-list
25063052|NCT03225417|Tacrolimus|tacrolimus|mesh-list
25063053|NCT03225417|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25063054|NCT03225417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24897069|NCT04430179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24897070|NCT04430179|Immunologic Factors|immunologic factors|mesh-ancestor
24897073|NCT04429711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24897074|NCT04429711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24516484|NCT00602134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516485|NCT00602134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24516486|NCT00602134|Immunologic Factors|immunologic factors|mesh-ancestor
24516487|NCT00602134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516488|NCT00602134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24516489|NCT00602134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063055|NCT03225417|Immunologic Factors|immunologic factors|mesh-ancestor
25063056|NCT03225417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063057|NCT03225417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25063058|NCT03225417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25063059|NCT03225417|Alkylating Agents|alkylating agents|mesh-ancestor
24516492|NCT00602173|Autonomic Agents|autonomic agents|mesh-ancestor
24516493|NCT00602173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24445688|NCT00302289|Caffeine|caffeine|mesh-list
24516498|NCT00602173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24516499|NCT00602173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516500|NCT00602173|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24516501|NCT00602173|Vasodilator Agents|vasodilator agents|mesh-ancestor
24516502|NCT00602173|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24516503|NCT00602173|Protective Agents|protective agents|mesh-ancestor
24516504|NCT00602173|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24516505|NCT00602173|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24516506|NCT00602173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516507|NCT00602186|Prazosin|prazosin|mesh-list
24516508|NCT00602186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25063068|NCT03225417|Antifungal Agents|antifungal agents|mesh-ancestor
24516531|NCT00602316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516533|NCT00602342|Antifungal Agents|antifungal agents|mesh-ancestor
24516534|NCT00602342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24516535|NCT00602342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516536|NCT00602342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699095|NCT02101021|Mitosis Modulators|mitosis modulators|mesh-ancestor
24516537|NCT00602381|Lithium Carbonate|lithium carbonate|mesh-list
24516538|NCT00602381|Antidepressive Agents|antidepressive agents|mesh-ancestor
24516539|NCT00602381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24516540|NCT00602381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24897139|NCT04428879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897140|NCT04428879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24897141|NCT04428814|Ustekinumab|ustekinumab|mesh-list
24897142|NCT04428814|Dermatologic Agents|dermatologic agents|mesh-ancestor
24897143|NCT04428437|Lenvatinib|lenvatinib|mesh-list
24897144|NCT04428437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24897145|NCT04428437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24897146|NCT04428437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474238|NCT00405301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25063072|NCT03217071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063074|NCT03204812|Ipilimumab|ipilimumab|mesh-list
25063075|NCT03204812|Tremelimumab|tremelimumab|mesh-list
25063076|NCT03204812|Immunoglobulins|immunoglobulins|mesh-list
25063077|NCT03204812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25063078|NCT03204812|Immunoglobulin G|immunoglobulin g|mesh-list
25063079|NCT03204812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25063080|NCT03204812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063081|NCT03204812|Immunologic Factors|immunologic factors|mesh-ancestor
24897147|NCT04428437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897149|NCT04428684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24897151|NCT04428268|Chloroquine|chloroquine|mesh-list
24897174|NCT04428268|Anthelmintics|anthelmintics|mesh-ancestor
24516556|NCT00602407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24897191|NCT04428632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897198|NCT04427826|Narcotics|narcotics|mesh-ancestor
24897199|NCT04427826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24897200|NCT04427826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699096|NCT02101021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699097|NCT02101021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25699098|NCT02101021|Antimetabolites|antimetabolites|mesh-ancestor
25699099|NCT02101021|Antiviral Agents|antiviral agents|mesh-ancestor
25699100|NCT02101021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25699101|NCT02101021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25699102|NCT02101021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24897201|NCT04427826|Analgesics|analgesics|mesh-ancestor
24606427|NCT00990418|Fentanyl|fentanyl|mesh-list
25699103|NCT02101021|Immunologic Factors|immunologic factors|mesh-ancestor
24995816|NCT04638881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24995817|NCT04638881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995819|NCT04638881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24995820|NCT04638881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24995821|NCT04638881|Anticonvulsants|anticonvulsants|mesh-ancestor
24995822|NCT04638881|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24995823|NCT04638881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24995824|NCT04638881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995825|NCT04638881|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24995826|NCT04638881|Tocolytic Agents|tocolytic agents|mesh-ancestor
24995827|NCT04638881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24995828|NCT04624633|Acalabrutinib|acalabrutinib|mesh-list
24995829|NCT04624633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24995833|NCT04608344|Atorvastatin|atorvastatin|mesh-list
24995834|NCT04608344|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24995835|NCT04608344|Pravastatin|pravastatin|mesh-list
24995836|NCT04608344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24995837|NCT04608344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24897202|NCT04427826|Sensory System Agents|sensory system agents|mesh-ancestor
24897203|NCT04427826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24897204|NCT04427865|Lactoferrin|lactoferrin|mesh-list
24897205|NCT04427865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24897206|NCT04427787|Lanreotide|lanreotide|mesh-list
24897207|NCT04427787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24897208|NCT04427618|Tranexamic Acid|tranexamic acid|mesh-list
24897209|NCT04427618|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24897214|NCT04427540|Oxytocin|oxytocin|mesh-list
24897215|NCT04427540|Oxytocics|oxytocics|mesh-ancestor
24897216|NCT04427540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24897217|NCT04427540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817619|NCT02084615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24817620|NCT02084615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817621|NCT02084615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24474304|NCT00405457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474305|NCT00405457|Antifungal Agents|antifungal agents|mesh-ancestor
24474306|NCT00405457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24474307|NCT00405457|Dermatologic Agents|dermatologic agents|mesh-ancestor
25699104|NCT02101021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699105|NCT02101021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25699106|NCT02101112|Apixaban|apixaban|mesh-list
25699107|NCT02101112|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25699108|NCT02101112|Antithrombins|antithrombins|mesh-ancestor
25699109|NCT02101112|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25699110|NCT02101112|Protease Inhibitors|protease inhibitors|mesh-ancestor
25699111|NCT02101112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25699112|NCT02101112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699113|NCT02101112|Anticoagulants|anticoagulants|mesh-ancestor
25699114|NCT02101190|Opicapone|opicapone|mesh-list
25699115|NCT02101190|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25699116|NCT02101190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25699117|NCT02101190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699118|NCT02101190|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25699119|NCT02101190|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25699120|NCT02101281|Mitogens|mitogens|mesh-list
25699121|NCT02101281|Mitosis Modulators|mitosis modulators|mesh-ancestor
25699122|NCT02101281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699123|NCT02101359|Tetracaine|tetracaine|mesh-list
25699124|NCT02101359|Tropicamide|tropicamide|mesh-list
25699125|NCT02101359|Mydriatics|mydriatics|mesh-list
25699126|NCT02101359|Anesthetics, Local|anesthetics, local|mesh-ancestor
25699127|NCT02101359|Anesthetics|anesthetics|mesh-ancestor
25699128|NCT02101359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24995913|NCT04492072|Misoprostol|misoprostol|mesh-list
24995914|NCT04492072|Oxytocin|oxytocin|mesh-list
24623295|NCT01070862|Melphalan|melphalan|mesh-list
24798093|NCT01960543|Anesthetics|anesthetics|mesh-ancestor
24798094|NCT01960543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24995917|NCT04492072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995918|NCT04492072|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24995919|NCT04492072|Abortifacient Agents|abortifacient agents|mesh-ancestor
24995920|NCT04492072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24995921|NCT04492072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24817627|NCT02084615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24817628|NCT02084615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817630|NCT02084654|Exenatide|exenatide|mesh-list
24474317|NCT00405535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24474318|NCT00405535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474319|NCT00405535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474320|NCT00405574|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
24474321|NCT00405574|Chelating Agents|chelating agents|mesh-ancestor
24474322|NCT00405574|Sequestering Agents|sequestering agents|mesh-ancestor
24474323|NCT00405574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474324|NCT00405574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474325|NCT00405574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24516597|NCT00602524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817640|NCT02084732|Sorafenib|sorafenib|mesh-list
24474328|NCT00405574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474330|NCT00405574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474331|NCT00405717|Atorvastatin|atorvastatin|mesh-list
24474332|NCT00405717|Pravastatin|pravastatin|mesh-list
24439249|NCT00278213|Mitoxantrone|mitoxantrone|mesh-list
24516609|NCT00602550|Antiviral Agents|antiviral agents|mesh-ancestor
24516610|NCT00602550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24516611|NCT00602550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24516612|NCT00602550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24516613|NCT00602589|Levofloxacin|levofloxacin|mesh-list
24516614|NCT00602589|Ofloxacin|ofloxacin|mesh-list
25699129|NCT02101359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699130|NCT02101359|Sensory System Agents|sensory system agents|mesh-ancestor
25699131|NCT02101359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699132|NCT02101359|Autonomic Agents|autonomic agents|mesh-ancestor
25699133|NCT02101359|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25699134|NCT02101359|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25699135|NCT02101359|Cholinergic Agents|cholinergic agents|mesh-ancestor
25699136|NCT02101359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25699137|NCT02101359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447105|NCT00307502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25699138|NCT02101918|Aflibercept|aflibercept|mesh-list
24516615|NCT00602589|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24516616|NCT00602589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24516617|NCT00602589|Renal Agents|renal agents|mesh-ancestor
24516618|NCT00602589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24516619|NCT00602589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24516620|NCT00602589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24516621|NCT00602589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516622|NCT00602589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516623|NCT00602589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516624|NCT00602589|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24516625|NCT00602589|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24897244|NCT04426734|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24897245|NCT04426734|Prednisolone phosphate|prednisolone phosphate|mesh-list
24897246|NCT04426734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24897247|NCT04426734|Antiemetics|antiemetics|mesh-ancestor
24897248|NCT04426734|Autonomic Agents|autonomic agents|mesh-ancestor
24897249|NCT04426734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24897250|NCT04426734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897251|NCT04426734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24897252|NCT04426734|Glucocorticoids|glucocorticoids|mesh-ancestor
24897253|NCT04426734|Hormones|hormones|mesh-ancestor
24897254|NCT04426734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24897255|NCT04426734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24897256|NCT04426734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24897257|NCT04426734|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24474364|NCT00405808|Rimonabant|rimonabant|mesh-list
24474365|NCT00405808|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24474366|NCT00405808|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24474367|NCT00405808|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24474368|NCT00405808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24474369|NCT00405808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474370|NCT00405808|Hormones|hormones|mesh-ancestor
25063123|NCT03158805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24574230|NCT00824239|Anesthetics, General|anesthetics, general|mesh-ancestor
24897270|NCT04426552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24897271|NCT04426552|Analgesics|analgesics|mesh-ancestor
24897272|NCT04426552|Sensory System Agents|sensory system agents|mesh-ancestor
24897273|NCT04426552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24897274|NCT04426552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24897275|NCT04426552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24897276|NCT04426552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24897277|NCT04426552|Adrenergic Agents|adrenergic agents|mesh-ancestor
24897278|NCT04426552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24897279|NCT04426552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897280|NCT04426552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24897281|NCT04426552|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24897282|NCT04426552|Anesthetics, General|anesthetics, general|mesh-ancestor
24897283|NCT04426552|Anesthetics|anesthetics|mesh-ancestor
24897288|NCT04426578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24897289|NCT04426578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699139|NCT02101918|Endothelial Growth Factors|endothelial growth factors|mesh-list
25699140|NCT02101918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25699141|NCT02101918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25699142|NCT02101918|Growth Substances|growth substances|mesh-ancestor
25699143|NCT02101918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699144|NCT02101918|Growth Inhibitors|growth inhibitors|mesh-ancestor
25699145|NCT02101918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516694|NCT00602849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24516731|NCT00603031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24516732|NCT00603031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516734|NCT00603083|Ketorolac|ketorolac|mesh-list
24574421|NCT00825149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25063131|NCT03112044|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25063132|NCT03112044|Velpatasvir|velpatasvir|mesh-list
24825696|NCT02129634|Mitosis Modulators|mitosis modulators|mesh-ancestor
24702969|NCT01468740|Bleomycin|bleomycin|mesh-list
24439793|NCT00280371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24439794|NCT00280371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24439795|NCT00280371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24439796|NCT00280371|Adrenergic Agents|adrenergic agents|mesh-ancestor
24439797|NCT00280371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24439798|NCT00280371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439799|NCT00280423|Casopitant|casopitant|mesh-list
24439800|NCT00280423|Antiemetics|antiemetics|mesh-ancestor
24439801|NCT00280423|Autonomic Agents|autonomic agents|mesh-ancestor
24897358|NCT04425993|Natriuretic Agents|natriuretic agents|mesh-ancestor
24897359|NCT04425993|Vasodilator Agents|vasodilator agents|mesh-ancestor
24897360|NCT04425993|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24897362|NCT04426955|Cisplatin|cisplatin|mesh-list
24897363|NCT04426955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24897364|NCT04426955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24897365|NCT04426955|Tubulin Modulators|tubulin modulators|mesh-ancestor
24897366|NCT04426955|Antimitotic Agents|antimitotic agents|mesh-ancestor
24897367|NCT04426955|Mitosis Modulators|mitosis modulators|mesh-ancestor
24474478|NCT00406146|Schistosomicides|schistosomicides|mesh-ancestor
24825700|NCT02129673|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24474485|NCT00406172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24474486|NCT00406172|Growth Substances|growth substances|mesh-ancestor
24897371|NCT04426123|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24897372|NCT04426123|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24897373|NCT04426123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24897374|NCT04426123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897375|NCT04426123|Cholinergic Agents|cholinergic agents|mesh-ancestor
24897376|NCT04426123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24897377|NCT04426123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897378|NCT04426123|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24897379|NCT04426123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24897380|NCT04425564|Capecitabine|capecitabine|mesh-list
24897381|NCT04425564|Oxaliplatin|oxaliplatin|mesh-list
24897382|NCT04425564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24897383|NCT04425564|Antimetabolites|antimetabolites|mesh-ancestor
24897384|NCT04425564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897385|NCT04425564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24897386|NCT04425590|Aspirin|aspirin|mesh-list
24897387|NCT04425590|Atorvastatin|atorvastatin|mesh-list
24897388|NCT04425590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24574693|NCT00826865|Levetiracetam|levetiracetam|mesh-list
24532228|NCT00638729|Anesthetics, General|anesthetics, general|mesh-ancestor
24897405|NCT04425590|Antimetabolites|antimetabolites|mesh-ancestor
24897406|NCT04425590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24897407|NCT04425590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24897410|NCT04425460|Favipiravir|favipiravir|mesh-list
24897411|NCT04425460|Antiviral Agents|antiviral agents|mesh-ancestor
24897412|NCT04425460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24897413|NCT04425642|Methamphetamine|methamphetamine|mesh-list
24474492|NCT00406237|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24474494|NCT00406237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063161|NCT02949284|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25063162|NCT02949284|Androgens|androgens|mesh-list
25063163|NCT02949284|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
25063164|NCT02949284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25063165|NCT02949284|Glucocorticoids|glucocorticoids|mesh-ancestor
25063166|NCT02949284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25063167|NCT02949284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063168|NCT02949284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24695351|NCT03759028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695352|NCT03759028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24695353|NCT03759028|Narcotics|narcotics|mesh-ancestor
24532368|NCT00639587|Cetirizine|cetirizine|mesh-list
24474519|NCT00406341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063169|NCT02949284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063170|NCT02949284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25063171|NCT02949284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063172|NCT02949284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063173|NCT02949284|Hormone Antagonists|hormone antagonists|mesh-ancestor
25063174|NCT02949284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25063175|NCT02949284|Androgen Antagonists|androgen antagonists|mesh-ancestor
24516773|NCT00603343|Autonomic Agents|autonomic agents|mesh-ancestor
24516774|NCT00603343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24516775|NCT00603343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516776|NCT00603343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24516777|NCT00603343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24516778|NCT00603343|Cholinergic Agents|cholinergic agents|mesh-ancestor
24516779|NCT00603343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25063184|NCT02889159|Histamine Agonists|histamine agonists|mesh-ancestor
25063185|NCT02889159|Histamine Agents|histamine agents|mesh-ancestor
25063186|NCT02889159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25063187|NCT02889159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063188|NCT02874144|Mometasone Furoate|mometasone furoate|mesh-list
25063189|NCT02874144|Fluticasone|fluticasone|mesh-list
25063190|NCT02874144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24897454|NCT04425824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24897455|NCT04425824|Immunologic Factors|immunologic factors|mesh-ancestor
24897456|NCT04425824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897457|NCT04425824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24897459|NCT04425187|Gefitinib|gefitinib|mesh-list
24996221|NCT04066023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897469|NCT04425187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897470|NCT04425473|Esketamine|esketamine|mesh-list
24897471|NCT04425473|Antidepressive Agents|antidepressive agents|mesh-ancestor
24897472|NCT04425473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24474532|NCT00406432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474533|NCT00406432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24474534|NCT00406432|Serotonin Agents|serotonin agents|mesh-ancestor
24474542|NCT00406471|Ranibizumab|ranibizumab|mesh-list
24532484|NCT00640081|Immunologic Factors|immunologic factors|mesh-ancestor
24613778|NCT01020734|Fludarabine phosphate|fludarabine phosphate|mesh-list
24613780|NCT01020734|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24613781|NCT01020734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24575485|NCT00832039|Micronutrients|micronutrients|mesh-ancestor
24575486|NCT00832039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063211|NCT02620306|Losartan|losartan|mesh-list
25063216|NCT02620306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063217|NCT02616055|XL647|xl647|mesh-list
25063218|NCT02616055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063219|NCT02616055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25063220|NCT02616055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24897516|NCT04425226|Lenvatinib|lenvatinib|mesh-list
24581786|NCT00866060|Cholinergic Agents|cholinergic agents|mesh-ancestor
24897517|NCT04425226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24532660|NCT00640744|Antimetabolites|antimetabolites|mesh-ancestor
24897540|NCT04424420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897541|NCT04424420|Antipyretics|antipyretics|mesh-ancestor
24897542|NCT04424420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24897543|NCT04424420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24897544|NCT04424420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24897545|NCT04424420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24897546|NCT04424420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063234|NCT02557139|Belumosudil|belumosudil|mesh-list
25063238|NCT02546921|Immunoglobulin E|immunoglobulin e|mesh-list
25063239|NCT02546921|Immunologic Factors|immunologic factors|mesh-ancestor
25063240|NCT02546921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063241|NCT02477826|Gemcitabine|gemcitabine|mesh-list
25063242|NCT02477826|Paclitaxel|paclitaxel|mesh-list
25063243|NCT02477826|Carboplatin|carboplatin|mesh-list
25699146|NCT02101983|Cytarabine|cytarabine|mesh-list
25699147|NCT02101983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25699148|NCT02101983|Antimetabolites|antimetabolites|mesh-ancestor
25699149|NCT02101983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699150|NCT02101983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25699151|NCT02101983|Antiviral Agents|antiviral agents|mesh-ancestor
25699152|NCT02101983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25699153|NCT02101983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25699154|NCT02101983|Immunologic Factors|immunologic factors|mesh-ancestor
24996353|NCT03639558|Promethazine|promethazine|mesh-list
24996354|NCT03639558|Diphenhydramine|diphenhydramine|mesh-list
24996355|NCT03639558|Haloperidol|haloperidol|mesh-list
24996356|NCT03639558|Chlorpromazine|chlorpromazine|mesh-list
24996357|NCT03639558|Haloperidol decanoate|haloperidol decanoate|mesh-list
25063244|NCT02477826|Nivolumab|nivolumab|mesh-list
25063245|NCT02477826|Pemetrexed|pemetrexed|mesh-list
25063246|NCT02477826|Ipilimumab|ipilimumab|mesh-list
25063247|NCT02477826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25063248|NCT02477826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063249|NCT02477826|Tubulin Modulators|tubulin modulators|mesh-ancestor
25063252|NCT02477826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897562|NCT04424459|Sensory System Agents|sensory system agents|mesh-ancestor
24897563|NCT04424459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24897564|NCT04424381|Rivaroxaban|rivaroxaban|mesh-list
24897565|NCT04424381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24897566|NCT04424381|Antithrombins|antithrombins|mesh-ancestor
24897567|NCT04424381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24897568|NCT04424381|Protease Inhibitors|protease inhibitors|mesh-ancestor
24897569|NCT04424381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24897570|NCT04424381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897577|NCT04423926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24897578|NCT04423926|Immunologic Factors|immunologic factors|mesh-ancestor
24897579|NCT04423926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897580|NCT04423926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24897581|NCT04423926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24474653|NCT00406978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24474655|NCT00406991|Clopidogrel|clopidogrel|mesh-list
24474656|NCT00406991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24474657|NCT00406991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24474658|NCT00406991|Analgesics|analgesics|mesh-ancestor
24474659|NCT00406991|Sensory System Agents|sensory system agents|mesh-ancestor
24474660|NCT00406991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24897582|NCT04423926|Alkylating Agents|alkylating agents|mesh-ancestor
24897584|NCT04423926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24947726|NCT03926559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897619|NCT04423627|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24897621|NCT04423627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24897622|NCT04423627|Diuretics|diuretics|mesh-ancestor
24897623|NCT04423627|Natriuretic Agents|natriuretic agents|mesh-ancestor
24897624|NCT04423627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897625|NCT04423627|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24897626|NCT04423627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24897627|NCT04423627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897628|NCT04423627|Analgesics|analgesics|mesh-ancestor
24897629|NCT04423627|Sensory System Agents|sensory system agents|mesh-ancestor
24897630|NCT04423627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24897631|NCT04423627|Sympatholytics|sympatholytics|mesh-ancestor
24897632|NCT04423627|Autonomic Agents|autonomic agents|mesh-ancestor
24474708|NCT00407082|Glucocorticoids|glucocorticoids|mesh-ancestor
24474709|NCT00407082|Hormones|hormones|mesh-ancestor
24474710|NCT00407082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24474711|NCT00407082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474712|NCT00407121|Bevacizumab|bevacizumab|mesh-list
24474729|NCT00407186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24474730|NCT00407186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474731|NCT00407199|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24474732|NCT00407199|Antidepressive Agents|antidepressive agents|mesh-ancestor
24474733|NCT00407199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24516797|NCT00603759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24516799|NCT00603759|Analgesics|analgesics|mesh-ancestor
25699155|NCT02101983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699156|NCT02102100|Menthol|menthol|mesh-list
25699157|NCT02102100|Nicotine|nicotine|mesh-list
25699158|NCT02102100|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25699159|NCT02102100|Autonomic Agents|autonomic agents|mesh-ancestor
25699160|NCT02102100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699161|NCT02102100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996380|NCT03639558|Anesthetics, Local|anesthetics, local|mesh-ancestor
24996385|NCT03568708|Estradiol|estradiol|mesh-list
24947737|NCT03926403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24947738|NCT03926403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947740|NCT03926182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24947741|NCT03926182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24947742|NCT03926182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24947743|NCT03926156|Warfarin|warfarin|mesh-list
24947744|NCT03926156|Rivaroxaban|rivaroxaban|mesh-list
24947745|NCT03926156|Anticoagulants|anticoagulants|mesh-ancestor
24947746|NCT03926156|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24947747|NCT03926156|Antithrombins|antithrombins|mesh-ancestor
24947748|NCT03926156|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24897733|NCT04422275|Respiratory System Agents|respiratory system agents|mesh-ancestor
24897734|NCT04422275|Glucocorticoids|glucocorticoids|mesh-ancestor
24897735|NCT04422275|Hormones|hormones|mesh-ancestor
24897736|NCT04422275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24720570|NCT01569204|Dacarbazine|dacarbazine|mesh-list
24897737|NCT04422197|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24897739|NCT04422197|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24897740|NCT04422197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24897741|NCT04422197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897742|NCT04422197|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24897743|NCT04422197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24474825|NCT00407459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24897744|NCT04422197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897745|NCT04422197|Cholinergic Agents|cholinergic agents|mesh-ancestor
24897746|NCT04422197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24897749|NCT04422392|Pemetrexed|pemetrexed|mesh-list
24897750|NCT04422392|Antibodies|antibodies|mesh-list
24897751|NCT04422392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24947753|NCT03926000|Analgesics|analgesics|mesh-ancestor
24817707|NCT02085291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817708|NCT02085291|Sympathomimetics|sympathomimetics|mesh-ancestor
24817709|NCT02085291|Autonomic Agents|autonomic agents|mesh-ancestor
24817710|NCT02085291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24817711|NCT02085291|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24817712|NCT02085304|Temozolomide|temozolomide|mesh-list
24817713|NCT02085304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24817714|NCT02085304|Alkylating Agents|alkylating agents|mesh-ancestor
24817715|NCT02085304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817716|NCT02085304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24817717|NCT02085317|Nitroprusside|nitroprusside|mesh-list
24817718|NCT02085317|Acetylcholine|acetylcholine|mesh-list
24817719|NCT02085317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24817720|NCT02085317|Vasodilator Agents|vasodilator agents|mesh-ancestor
24817721|NCT02085317|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24817722|NCT02085317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576731|NCT00840229|Hormones|hormones|mesh-ancestor
25699162|NCT02102100|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25699163|NCT02102100|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25699164|NCT02102100|Cholinergic Agents|cholinergic agents|mesh-ancestor
25699165|NCT02102100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25699166|NCT02102100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699167|NCT02102100|Antipruritics|antipruritics|mesh-ancestor
25699168|NCT02102100|Dermatologic Agents|dermatologic agents|mesh-ancestor
25699169|NCT02102932|Metformin|metformin|mesh-list
25699170|NCT02102932|Empagliflozin|empagliflozin|mesh-list
24934392|NCT04061512|Rituximab|rituximab|mesh-list
24934393|NCT04061512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24934394|NCT04061512|Immunologic Factors|immunologic factors|mesh-ancestor
24934395|NCT04061512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934396|NCT04061512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24934397|NCT04061512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24934398|NCT04061512|Alkylating Agents|alkylating agents|mesh-ancestor
24934399|NCT04061512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934400|NCT04061512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934401|NCT04061512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24934402|NCT04061512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24996450|NCT03463265|Growth Substances|growth substances|mesh-ancestor
24817728|NCT02085408|Decitabine|decitabine|mesh-list
24817729|NCT02085408|Clofarabine|clofarabine|mesh-list
24817730|NCT02085408|Azacitidine|azacitidine|mesh-list
24817731|NCT02085408|Daunorubicin|daunorubicin|mesh-list
24817732|NCT02085408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24817733|NCT02085408|Antimetabolites|antimetabolites|mesh-ancestor
24947757|NCT03926000|Anticonvulsants|anticonvulsants|mesh-ancestor
25063266|NCT02457221|Cyclophosphamide|cyclophosphamide|mesh-list
25063267|NCT02457221|Tacrolimus|tacrolimus|mesh-list
25063268|NCT02457221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25063269|NCT02457221|Immunologic Factors|immunologic factors|mesh-ancestor
25063270|NCT02457221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063271|NCT02457221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25063272|NCT02457221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25063273|NCT02457221|Alkylating Agents|alkylating agents|mesh-ancestor
25063274|NCT02457221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063275|NCT02457221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063276|NCT02457221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25063277|NCT02457221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25063278|NCT02457221|Glucocorticoids|glucocorticoids|mesh-ancestor
24817735|NCT02085408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24817736|NCT02085408|Antiviral Agents|antiviral agents|mesh-ancestor
24817737|NCT02085408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24817738|NCT02085408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24817739|NCT02085408|Immunologic Factors|immunologic factors|mesh-ancestor
24817740|NCT02085408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474857|NCT00407771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24474858|NCT00407771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474863|NCT00407784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24474864|NCT00407784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474865|NCT00407784|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24516805|NCT00603759|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24516806|NCT00603759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24516807|NCT00603759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516808|NCT00603759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516809|NCT00603772|Tretinoin|tretinoin|mesh-list
24897755|NCT04422392|Mitosis Modulators|mitosis modulators|mesh-ancestor
24897756|NCT04422392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897757|NCT04422392|Immunologic Factors|immunologic factors|mesh-ancestor
24897758|NCT04422392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063280|NCT02457221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25063281|NCT02457221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25063282|NCT02457221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25063283|NCT02457221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25699171|NCT02102932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25699172|NCT02102932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699173|NCT02102932|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25699174|NCT02102932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699175|NCT02103062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25699176|NCT02103062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25699177|NCT02103114|Antithrombin III|antithrombin iii|mesh-list
25699178|NCT02103114|Antithrombins|antithrombins|mesh-list
25699179|NCT02103114|Thrombin|thrombin|mesh-list
25699180|NCT02103114|Hemostatics|hemostatics|mesh-ancestor
25699181|NCT02103114|Coagulants|coagulants|mesh-ancestor
25699182|NCT02103114|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25699183|NCT02103114|Protease Inhibitors|protease inhibitors|mesh-ancestor
25699184|NCT02103114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996490|NCT03422666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24996491|NCT03422666|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24996492|NCT03422666|Protective Agents|protective agents|mesh-ancestor
24996493|NCT03422666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996494|NCT03417882|Pembrolizumab|pembrolizumab|mesh-list
24996495|NCT03417882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24996496|NCT03417882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996498|NCT03387852|Xhance|xhance|mesh-list
24825835|NCT02130739|Narcotics|narcotics|mesh-ancestor
24897759|NCT04422392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24897760|NCT04422392|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24897761|NCT04422392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24897762|NCT04422028|Desogestrel|desogestrel|mesh-list
24897763|NCT04422028|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24897764|NCT04422028|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24474869|NCT00407849|Triamcinolone|triamcinolone|mesh-list
24474870|NCT00407849|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24474871|NCT00407849|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24474872|NCT00407849|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24474873|NCT00407849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24474874|NCT00407849|Glucocorticoids|glucocorticoids|mesh-ancestor
24474875|NCT00407849|Hormones|hormones|mesh-ancestor
24516816|NCT00603785|Respiratory System Agents|respiratory system agents|mesh-ancestor
24516819|NCT00603824|Fondaparinux|fondaparinux|mesh-list
24516820|NCT00603824|Argatroban|argatroban|mesh-list
24897765|NCT04422028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24897766|NCT04422028|Contraceptive Agents|contraceptive agents|mesh-ancestor
24897767|NCT04422028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24897768|NCT04422028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897769|NCT04422028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24897770|NCT04422028|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24897772|NCT04422028|Hormones|hormones|mesh-ancestor
24897774|NCT04422184|Potassium Citrate|potassium citrate|mesh-list
24897784|NCT04421716|Curcumin|curcumin|mesh-list
24897785|NCT04421716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24897786|NCT04421716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24897787|NCT04421716|Analgesics|analgesics|mesh-ancestor
24897788|NCT04421716|Sensory System Agents|sensory system agents|mesh-ancestor
24897789|NCT04421716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24897790|NCT04421716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897791|NCT04421716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24897792|NCT04421716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24897793|NCT04421716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24897794|NCT04421716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24897800|NCT04421911|Ketoprofen|ketoprofen|mesh-list
24897801|NCT04421911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24897803|NCT04421911|Analgesics|analgesics|mesh-ancestor
25699185|NCT02103114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699186|NCT02103114|Anticoagulants|anticoagulants|mesh-ancestor
25699187|NCT02103439|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25699188|NCT02103439|Antiviral Agents|antiviral agents|mesh-ancestor
25699189|NCT02103439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25699190|NCT02103478|Decitabine|decitabine|mesh-list
25699191|NCT02103478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25699192|NCT02103478|Antimetabolites|antimetabolites|mesh-ancestor
25699193|NCT02103478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699194|NCT02103478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25699195|NCT02103478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25699196|NCT02103855|Abatacept|abatacept|mesh-list
25699197|NCT02103855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24996652|NCT03033095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24996653|NCT03033095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24996654|NCT03033095|Immunologic Factors|immunologic factors|mesh-ancestor
24996655|NCT03023319|Pemetrexed|pemetrexed|mesh-list
24996656|NCT03023319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996657|NCT03023319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996658|NCT03023319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996659|NCT03023319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24996661|NCT02921789|Mycophenolic Acid|mycophenolic acid|mesh-list
24996669|NCT02921789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516838|NCT00604006|Natriuretic Agents|natriuretic agents|mesh-ancestor
24516839|NCT00604032|Tretinoin|tretinoin|mesh-list
24516840|NCT00604032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516841|NCT00604032|Keratolytic Agents|keratolytic agents|mesh-ancestor
24897834|NCT04421547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24897835|NCT04421547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897836|NCT04421547|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24897837|NCT04421547|Hormone Antagonists|hormone antagonists|mesh-ancestor
24897838|NCT04421547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24897839|NCT04421547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897840|NCT04421534|Lactoferrin|lactoferrin|mesh-list
24897841|NCT04421534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24897842|NCT04421300|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25063306|NCT02101034|Cetuximab|cetuximab|mesh-list
24516869|NCT00604357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24516870|NCT00604357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24516871|NCT00604357|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24516872|NCT00604357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516873|NCT00604357|Antifungal Agents|antifungal agents|mesh-ancestor
24516874|NCT00604357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24516875|NCT00604357|Immunologic Factors|immunologic factors|mesh-ancestor
24516876|NCT00604357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516877|NCT00604396|Insulin|insulin|mesh-list
24516878|NCT00604396|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24516879|NCT00604396|Insulin Detemir|insulin detemir|mesh-list
24516880|NCT00604396|Isophane Insulin, Human|isophane insulin, human|mesh-list
24516881|NCT00604396|Insulin, Isophane|insulin, isophane|mesh-list
24897868|NCT04421105|Hallucinogens|hallucinogens|mesh-ancestor
24474979|NCT00408330|Azelaic acid|azelaic acid|mesh-list
24516929|NCT00604682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24516930|NCT00604682|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24516931|NCT00604682|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24516932|NCT00604682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516933|NCT00604682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516934|NCT00604864|Infliximab|infliximab|mesh-list
24516935|NCT00604864|Antibodies|antibodies|mesh-list
24516936|NCT00604864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24516937|NCT00604864|Immunologic Factors|immunologic factors|mesh-ancestor
24516938|NCT00604864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516939|NCT00604864|Dermatologic Agents|dermatologic agents|mesh-ancestor
24516940|NCT00604864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24516941|NCT00604864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24516942|NCT00604942|Domperidone|domperidone|mesh-list
24516943|NCT00604942|Esomeprazole|esomeprazole|mesh-list
24516944|NCT00604942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24897873|NCT04421105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25699198|NCT02103855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699199|NCT02103855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25699200|NCT02103855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25699201|NCT02103855|Immunologic Factors|immunologic factors|mesh-ancestor
25699202|NCT02103855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699203|NCT02103855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25699204|NCT02104414|Epinephrine|epinephrine|mesh-list
25699205|NCT02104414|Bupivacaine|bupivacaine|mesh-list
25699206|NCT02104414|Anesthetics, Local|anesthetics, local|mesh-ancestor
25699207|NCT02104414|Anesthetics|anesthetics|mesh-ancestor
24516958|NCT00604955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24996743|NCT02163694|Paclitaxel|paclitaxel|mesh-list
24516959|NCT00604955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24516960|NCT00604955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24516961|NCT00605020|Insulin|insulin|mesh-list
24516962|NCT00605020|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24516963|NCT00605020|Insulin Aspart|insulin aspart|mesh-list
24516964|NCT00605020|Insulin, Long-Acting|insulin, long-acting|mesh-list
24516965|NCT00605020|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24897884|NCT04420871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24897885|NCT04420871|Antimetabolites|antimetabolites|mesh-ancestor
24897886|NCT04420871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897887|NCT04420871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24897888|NCT04420260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
24897889|NCT04420260|Immunologic Factors|immunologic factors|mesh-ancestor
24897890|NCT04420260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897891|NCT04420533|Mirabegron|mirabegron|mesh-list
24897892|NCT04420533|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24897908|NCT04419948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24897909|NCT04419948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24897910|NCT04419948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24897911|NCT04419948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475029|NCT00408551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475030|NCT00408551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25063310|NCT02101034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25063311|NCT02101034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063312|NCT02101034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516978|NCT00605098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24516979|NCT00605098|Antiviral Agents|antiviral agents|mesh-ancestor
24516980|NCT00605098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24516981|NCT00605098|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24516982|NCT00605098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24516984|NCT00605111|Biphasic Insulins|biphasic insulins|mesh-list
24897923|NCT04420351|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24897924|NCT04420351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897925|NCT04420351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24897926|NCT04420351|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24897927|NCT04420351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24897929|NCT04420351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24897930|NCT04420351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24475058|NCT00408772|Bevacizumab|bevacizumab|mesh-list
24897944|NCT04419662|Phenylephrine|phenylephrine|mesh-list
24897945|NCT04419662|Oxymetazoline|oxymetazoline|mesh-list
24897946|NCT04419662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24897947|NCT04419662|Mydriatics|mydriatics|mesh-ancestor
24897948|NCT04419662|Autonomic Agents|autonomic agents|mesh-ancestor
24897949|NCT04419662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24897950|NCT04419662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897951|NCT04419662|Sympathomimetics|sympathomimetics|mesh-ancestor
24897952|NCT04419662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24475069|NCT00408772|Antimetabolites|antimetabolites|mesh-ancestor
24475070|NCT00408772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897970|NCT04419441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897971|NCT04419441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24897985|NCT04419259|Erenumab|erenumab|mesh-list
24475130|NCT00409097|Rosiglitazone|rosiglitazone|mesh-list
24475131|NCT00409097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24578210|NCT00847483|Latanoprost|latanoprost|mesh-list
24578363|NCT00848770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24578364|NCT00848770|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24578365|NCT00848770|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24578366|NCT00848770|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24578367|NCT00848796|Heparin|heparin|mesh-list
24578368|NCT00848796|Calcium heparin|calcium heparin|mesh-list
24996832|NCT01465334|Methylprednisolone|methylprednisolone|mesh-list
24996833|NCT01465334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24996834|NCT01465334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24996835|NCT01465334|Prednisolone|prednisolone|mesh-list
24996836|NCT01465334|Prednisolone acetate|prednisolone acetate|mesh-list
24996837|NCT01465334|Alemtuzumab|alemtuzumab|mesh-list
24475132|NCT00409097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475133|NCT00409201|Reboxetine|reboxetine|mesh-list
24475134|NCT00409201|Antidepressive Agents|antidepressive agents|mesh-ancestor
24475140|NCT00409201|Adrenergic Agents|adrenergic agents|mesh-ancestor
24475141|NCT00409201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24475142|NCT00409201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475143|NCT00409214|Talaporfin|talaporfin|mesh-list
24475144|NCT00409214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063320|NCT02097121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25063321|NCT02097121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063322|NCT02097121|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25063323|NCT02097121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24825869|NCT02130817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24475145|NCT00409214|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24475146|NCT00409214|Dermatologic Agents|dermatologic agents|mesh-ancestor
24475147|NCT00409227|Alfuzosin|alfuzosin|mesh-list
24475148|NCT00409227|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
24475149|NCT00409227|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24475150|NCT00409227|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24475151|NCT00409227|Adrenergic Agents|adrenergic agents|mesh-ancestor
24898045|NCT04418908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24898046|NCT04418908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898047|NCT04418908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24475152|NCT00409227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24517060|NCT00605774|Adrenergic Agents|adrenergic agents|mesh-ancestor
24898050|NCT04418908|Hormone Antagonists|hormone antagonists|mesh-ancestor
24898054|NCT04418674|Fentanyl|fentanyl|mesh-list
24898055|NCT04418674|Ketamine|ketamine|mesh-list
24898056|NCT04418674|Analgesics|analgesics|mesh-ancestor
24898057|NCT04418674|Sensory System Agents|sensory system agents|mesh-ancestor
24898058|NCT04418674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24898059|NCT04418674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578369|NCT00848796|Anticoagulants|anticoagulants|mesh-ancestor
24578370|NCT00848796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24898060|NCT04418674|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24579056|NCT00853177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24898061|NCT04418674|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24898062|NCT04418674|Anesthetics, General|anesthetics, general|mesh-ancestor
24898063|NCT04418674|Anesthetics|anesthetics|mesh-ancestor
24898064|NCT04418674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24898065|NCT04418674|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24898066|NCT04418674|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24898067|NCT04418674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24475173|NCT00409305|Vasodilator Agents|vasodilator agents|mesh-ancestor
24475174|NCT00409305|Histamine Agonists|histamine agonists|mesh-ancestor
24475175|NCT00409305|Histamine Agents|histamine agents|mesh-ancestor
24475176|NCT00409305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24475177|NCT00409305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699208|NCT02104414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25699209|NCT02104414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699210|NCT02104414|Sensory System Agents|sensory system agents|mesh-ancestor
25699211|NCT02104414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699212|NCT02104414|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25699213|NCT02104414|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25699214|NCT02104414|Adrenergic Agents|adrenergic agents|mesh-ancestor
25699215|NCT02104414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25699216|NCT02104414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699217|NCT02104414|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24475178|NCT00409305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699218|NCT02104414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25699219|NCT02104414|Autonomic Agents|autonomic agents|mesh-ancestor
24475179|NCT00409318|Etanercept|etanercept|mesh-list
24475180|NCT00409318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24898085|NCT04418154|Mitosis Modulators|mitosis modulators|mesh-ancestor
24898086|NCT04418154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898087|NCT04418154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24898088|NCT04418154|Immunologic Factors|immunologic factors|mesh-ancestor
24898089|NCT04418154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898090|NCT04418154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24475197|NCT00409357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475198|NCT00409357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475199|NCT00409357|Urological Agents|urological agents|mesh-ancestor
24475201|NCT00409383|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24475202|NCT00409383|Temozolomide|temozolomide|mesh-list
24475203|NCT00409383|Oblimersen|oblimersen|mesh-list
24475204|NCT00409383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24475205|NCT00409383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24475206|NCT00409383|Tubulin Modulators|tubulin modulators|mesh-ancestor
24475207|NCT00409383|Antimitotic Agents|antimitotic agents|mesh-ancestor
24475208|NCT00409383|Mitosis Modulators|mitosis modulators|mesh-ancestor
24475209|NCT00409383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898098|NCT04418180|Fenofibrate|fenofibrate|mesh-list
24898099|NCT04418180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24898100|NCT04418180|Antimetabolites|antimetabolites|mesh-ancestor
24898101|NCT04418180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898102|NCT04418180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24898103|NCT04418219|Interferons|interferons|mesh-list
24898104|NCT04418219|Interferon-alpha|interferon-alpha|mesh-list
24898105|NCT04418219|Interferon alpha-2|interferon alpha-2|mesh-list
24898106|NCT04418219|Cyclophosphamide|cyclophosphamide|mesh-list
24898107|NCT04418219|Pembrolizumab|pembrolizumab|mesh-list
24898108|NCT04418219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24898109|NCT04418219|Immunologic Factors|immunologic factors|mesh-ancestor
24898110|NCT04418219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898111|NCT04418219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24898112|NCT04418219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24898113|NCT04418219|Alkylating Agents|alkylating agents|mesh-ancestor
24898114|NCT04418219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898115|NCT04418219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898116|NCT04418219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24898132|NCT04418128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475235|NCT00409591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24475237|NCT00409591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24475238|NCT00409591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24517000|NCT00605371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24517024|NCT00605605|Antitussive Agents|antitussive agents|mesh-ancestor
24517025|NCT00605605|Respiratory System Agents|respiratory system agents|mesh-ancestor
24517026|NCT00605605|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24475247|NCT00409591|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24898134|NCT04418128|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24898135|NCT04418128|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24898136|NCT04418128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24898137|NCT04418128|Immunologic Factors|immunologic factors|mesh-ancestor
24517027|NCT00605605|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24517028|NCT00605605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24898151|NCT04417985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898153|NCT04418089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24898155|NCT04418089|Antimetabolites|antimetabolites|mesh-ancestor
24898156|NCT04418089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898157|NCT04418089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24898158|NCT04418089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24898159|NCT04418089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24898160|NCT04417582|Liraglutide|liraglutide|mesh-list
24898161|NCT04417582|Orlistat|orlistat|mesh-list
24898162|NCT04417582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24898163|NCT04417582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898164|NCT04417582|Incretins|incretins|mesh-ancestor
24898165|NCT04417582|Hormones|hormones|mesh-ancestor
25699220|NCT02104414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25699221|NCT02104414|Respiratory System Agents|respiratory system agents|mesh-ancestor
25699222|NCT02104414|Mydriatics|mydriatics|mesh-ancestor
24996944|NCT05420948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996945|NCT05420948|Tubulin Modulators|tubulin modulators|mesh-ancestor
24996946|NCT05420948|Antimitotic Agents|antimitotic agents|mesh-ancestor
24996947|NCT05420948|Mitosis Modulators|mitosis modulators|mesh-ancestor
24996948|NCT05420948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898167|NCT04417582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580113|NCT00860340|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24580166|NCT00860925|Analgesics|analgesics|mesh-ancestor
24580167|NCT00860925|Sensory System Agents|sensory system agents|mesh-ancestor
24898168|NCT04417582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898169|NCT04417582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24898170|NCT04417582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24517051|NCT00605683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24517052|NCT00605683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24517053|NCT00605683|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24517054|NCT00605683|Serotonin Agents|serotonin agents|mesh-ancestor
24517055|NCT00605774|Epinephrine|epinephrine|mesh-list
24517056|NCT00605774|Racepinephrine|racepinephrine|mesh-list
24517057|NCT00605774|Epinephryl borate|epinephryl borate|mesh-list
24898177|NCT04417335|Immunologic Factors|immunologic factors|mesh-ancestor
24898178|NCT04417335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898179|NCT04417192|Pembrolizumab|pembrolizumab|mesh-list
24898180|NCT04417192|Olaparib|olaparib|mesh-list
24898181|NCT04417192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24898182|NCT04417192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898183|NCT04417192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24898184|NCT04417192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24898185|NCT04417192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898186|NCT04417114|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24898187|NCT04417114|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24475272|NCT00409656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475273|NCT00409695|Thymoglobulin|thymoglobulin|mesh-list
24475274|NCT00409695|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24475275|NCT00409695|Immunologic Factors|immunologic factors|mesh-ancestor
24517058|NCT00605774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24517059|NCT00605774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24580168|NCT00860925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24898206|NCT04417543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24898207|NCT04416750|Imatinib Mesylate|imatinib mesylate|mesh-list
24898208|NCT04416750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898209|NCT04416750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24898210|NCT04416750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24898211|NCT04416750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898212|NCT04416334|Acetaminophen|acetaminophen|mesh-list
24898213|NCT04416334|Colchicine|colchicine|mesh-list
24898214|NCT04416334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25699223|NCT02104414|Sympathomimetics|sympathomimetics|mesh-ancestor
25699224|NCT02104414|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25699225|NCT02104505|Tocopherols|tocopherols|mesh-list
25699226|NCT02104505|Vitamin E|vitamin e|mesh-list
25699227|NCT02104505|Tocotrienols|tocotrienols|mesh-list
25699228|NCT02104505|alpha-Tocopherol|alpha-tocopherol|mesh-list
24898215|NCT04416334|Analgesics|analgesics|mesh-ancestor
24898216|NCT04416334|Sensory System Agents|sensory system agents|mesh-ancestor
24898217|NCT04416334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699229|NCT02104505|gamma-Tocopherol|gamma-tocopherol|mesh-list
25699230|NCT02104505|Antioxidants|antioxidants|mesh-ancestor
25709505|NCT02268396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24997029|NCT05419674|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24997030|NCT05419674|Antacids|antacids|mesh-ancestor
24997031|NCT05419466|Melatonin|melatonin|mesh-list
24997032|NCT05419466|Antioxidants|antioxidants|mesh-ancestor
24898218|NCT04416334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898219|NCT04416334|Antipyretics|antipyretics|mesh-ancestor
24898220|NCT04416334|Gout Suppressants|gout suppressants|mesh-ancestor
24898221|NCT04416334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24898222|NCT04416334|Tubulin Modulators|tubulin modulators|mesh-ancestor
24898223|NCT04416334|Antimitotic Agents|antimitotic agents|mesh-ancestor
24898226|NCT04416334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898228|NCT04416399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24898229|NCT04416399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24898230|NCT04416399|Autonomic Agents|autonomic agents|mesh-ancestor
24898231|NCT04416399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24898232|NCT04416399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898233|NCT04416399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24898241|NCT04416607|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24898242|NCT04416607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898243|NCT04416165|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24898244|NCT04416165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24898245|NCT04416165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475321|NCT00409890|Cholinergic Agents|cholinergic agents|mesh-ancestor
24475322|NCT00409890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24517075|NCT00605787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517076|NCT00605787|Protective Agents|protective agents|mesh-ancestor
24517077|NCT00605787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898268|NCT04416035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24898269|NCT04416035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24898300|NCT04415567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898303|NCT04415320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24898304|NCT04415320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24898305|NCT04415320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898307|NCT04415385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898308|NCT04415385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24898309|NCT04415385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24898310|NCT04415385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898311|NCT04415476|Mycophenolic Acid|mycophenolic acid|mesh-list
24898312|NCT04415476|Sirolimus|sirolimus|mesh-list
24898313|NCT04415476|Prednisone|prednisone|mesh-list
24898314|NCT04415476|Tacrolimus|tacrolimus|mesh-list
24898315|NCT04415476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24898316|NCT04415476|Glucocorticoids|glucocorticoids|mesh-ancestor
24898339|NCT04414995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24517138|NCT00606203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898351|NCT04414852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898353|NCT04415008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24898354|NCT04415008|Antimetabolites|antimetabolites|mesh-ancestor
24898355|NCT04415008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898356|NCT04415008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898357|NCT04415008|Antiviral Agents|antiviral agents|mesh-ancestor
24898358|NCT04415008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24898359|NCT04415008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24898360|NCT04415008|Immunologic Factors|immunologic factors|mesh-ancestor
24580980|NCT00864149|Antioxidants|antioxidants|mesh-ancestor
24898361|NCT04415008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898362|NCT04414969|Asparaginase|asparaginase|mesh-list
25699231|NCT02104505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699232|NCT02104505|Protective Agents|protective agents|mesh-ancestor
25699233|NCT02104505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699234|NCT02104505|Vitamins|vitamins|mesh-ancestor
25699235|NCT02104505|Micronutrients|micronutrients|mesh-ancestor
25699236|NCT02104739|Exenatide|exenatide|mesh-list
25699237|NCT02104739|Saxagliptin|saxagliptin|mesh-list
25699238|NCT02104739|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25699239|NCT02104739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699240|NCT02104739|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24997084|NCT05416840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24997085|NCT05416840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997098|NCT05416840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24997105|NCT05411991|Acetazolamide|acetazolamide|mesh-list
24997106|NCT05411991|Bumetanide|bumetanide|mesh-list
24898363|NCT04414969|Pegaspargase|pegaspargase|mesh-list
24898364|NCT04414969|Antibodies|antibodies|mesh-list
24898365|NCT04414969|Immunoglobulins|immunoglobulins|mesh-list
24898366|NCT04414969|Immunologic Factors|immunologic factors|mesh-ancestor
24898367|NCT04414969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898368|NCT04414969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898369|NCT04415060|Sevoflurane|sevoflurane|mesh-list
24898370|NCT04415060|Isoflurane|isoflurane|mesh-list
24898371|NCT04415060|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24817753|NCT02085577|Morphine|morphine|mesh-list
24817754|NCT02085577|Dsuvia|dsuvia|mesh-list
24898372|NCT04415060|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24898373|NCT04415060|Anesthetics, General|anesthetics, general|mesh-ancestor
24898374|NCT04415060|Anesthetics|anesthetics|mesh-ancestor
24898375|NCT04415060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24898376|NCT04415060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898377|NCT04414956|Vitamin K|vitamin k|mesh-list
24898378|NCT04414956|Agglutinins|agglutinins|mesh-list
24898379|NCT04414956|Vitamins|vitamins|mesh-ancestor
24898380|NCT04414956|Micronutrients|micronutrients|mesh-ancestor
24898381|NCT04414956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634627|NCT01134432|Rituximab|rituximab|mesh-list
24898383|NCT04414956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24517139|NCT00606203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24517140|NCT00606203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475452|NCT00410540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24898384|NCT04414956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898386|NCT04414956|Coagulants|coagulants|mesh-ancestor
24898388|NCT04414800|Fentanyl|fentanyl|mesh-list
24898389|NCT04414800|Ketamine|ketamine|mesh-list
24898390|NCT04414800|Analgesics|analgesics|mesh-ancestor
24898444|NCT04414566|Immunologic Factors|immunologic factors|mesh-ancestor
24898445|NCT04414566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699241|NCT02104739|Incretins|incretins|mesh-ancestor
25699242|NCT02104739|Hormones|hormones|mesh-ancestor
25699243|NCT02104739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25699244|NCT02104739|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25699245|NCT02104739|Protease Inhibitors|protease inhibitors|mesh-ancestor
25699246|NCT02104739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25699247|NCT02104739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699248|NCT02104752|Curcumin|curcumin|mesh-list
25699249|NCT02104752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25699250|NCT02104752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25699251|NCT02104752|Analgesics|analgesics|mesh-ancestor
25699252|NCT02104752|Sensory System Agents|sensory system agents|mesh-ancestor
25709506|NCT02268396|Autonomic Agents|autonomic agents|mesh-ancestor
24898446|NCT04414566|Tubulin Modulators|tubulin modulators|mesh-ancestor
24898447|NCT04414566|Antimitotic Agents|antimitotic agents|mesh-ancestor
24898448|NCT04414566|Mitosis Modulators|mitosis modulators|mesh-ancestor
24854930|NCT02276365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854931|NCT02276378|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24854933|NCT02276378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24854934|NCT02276378|Diuretics|diuretics|mesh-ancestor
24854935|NCT02276378|Natriuretic Agents|natriuretic agents|mesh-ancestor
24854936|NCT02276378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898450|NCT04414579|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24898451|NCT04414579|Insulin Aspart|insulin aspart|mesh-list
24898452|NCT04414579|Insulin, Long-Acting|insulin, long-acting|mesh-list
24898453|NCT04414579|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24898454|NCT04414579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24898455|NCT04414579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898456|NCT04414254|Cefprozil|cefprozil|mesh-list
24898457|NCT04414254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24898458|NCT04414254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24898459|NCT04414267|Vaccines|vaccines|mesh-list
24898460|NCT04414267|BCG Vaccine|bcg vaccine|mesh-list
24898461|NCT04414267|Immunologic Factors|immunologic factors|mesh-ancestor
24898498|NCT04414020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24898499|NCT04414020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581979|NCT00866944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582009|NCT00867061|ON 01910|on 01910|mesh-list
24898501|NCT04414137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24898502|NCT04414137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24898503|NCT04413890|Dinoprostone|dinoprostone|mesh-list
24898504|NCT04413890|Oxytocics|oxytocics|mesh-ancestor
24898505|NCT04413890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24898506|NCT04413890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898507|NCT04413396|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24898508|NCT04413396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24444226|NCT00297050|Peramivir|peramivir|mesh-list
24517147|NCT00606242|Fluticasone|fluticasone|mesh-list
24517148|NCT00606242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24517149|NCT00606242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24517150|NCT00606242|Autonomic Agents|autonomic agents|mesh-ancestor
24517151|NCT00606242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24517152|NCT00606242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517153|NCT00606242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24517154|NCT00606242|Respiratory System Agents|respiratory system agents|mesh-ancestor
24517155|NCT00606242|Dermatologic Agents|dermatologic agents|mesh-ancestor
24898509|NCT04413422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
24898510|NCT04413422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24898511|NCT04413422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898512|NCT04413292|BIRC5 protein, human|birc5 protein, human|mesh-list
24898513|NCT04413292|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25063384|NCT01828112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25063386|NCT01733888|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24898552|NCT04412850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24898553|NCT04412850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24898554|NCT04412850|Anticonvulsants|anticonvulsants|mesh-ancestor
24898555|NCT04412850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24898582|NCT04412291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24898583|NCT04412291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24898584|NCT04412148|Triamcinolone|triamcinolone|mesh-list
24898585|NCT04412148|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25699253|NCT02104752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699254|NCT02104752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699255|NCT02104752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25699256|NCT02104752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25699257|NCT02104752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25699258|NCT02104752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25699259|NCT02104752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898586|NCT04412148|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24898587|NCT04412148|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24898588|NCT04412148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24898605|NCT04411875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898606|NCT04411875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24898607|NCT04411875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898608|NCT04411875|Vasodilator Agents|vasodilator agents|mesh-ancestor
24898610|NCT04411693|Aflibercept|aflibercept|mesh-list
24898611|NCT04411693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24898612|NCT04411693|Antiemetics|antiemetics|mesh-ancestor
24898613|NCT04411693|Autonomic Agents|autonomic agents|mesh-ancestor
24898614|NCT04411693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24898615|NCT04411693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898616|NCT04411693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24898617|NCT04411693|Glucocorticoids|glucocorticoids|mesh-ancestor
24898618|NCT04411693|Hormones|hormones|mesh-ancestor
24898619|NCT04411693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24898620|NCT04411693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24898621|NCT04411693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898622|NCT04411693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24898623|NCT04411693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24898624|NCT04411693|Growth Substances|growth substances|mesh-ancestor
24898625|NCT04411693|Growth Inhibitors|growth inhibitors|mesh-ancestor
24898626|NCT04411706|Capecitabine|capecitabine|mesh-list
24898627|NCT04411706|Apatinib|apatinib|mesh-list
24898628|NCT04411706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24898629|NCT04411706|Antimetabolites|antimetabolites|mesh-ancestor
24898630|NCT04411706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898631|NCT04411706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898632|NCT04411706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24898633|NCT04411706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24898634|NCT04411524|Capecitabine|capecitabine|mesh-list
24898635|NCT04411524|Irinotecan|irinotecan|mesh-list
24898636|NCT04411524|Antibodies|antibodies|mesh-list
24898637|NCT04411524|Immunologic Factors|immunologic factors|mesh-ancestor
24898638|NCT04411524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898643|NCT04411524|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24898644|NCT04411524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24898645|NCT04411524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24898646|NCT04411862|Choline|choline|mesh-list
24898647|NCT04411862|Lipotropic Agents|lipotropic agents|mesh-ancestor
24898648|NCT04411862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24898649|NCT04411862|Antimetabolites|antimetabolites|mesh-ancestor
24898650|NCT04411862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898651|NCT04411862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24898652|NCT04411862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24898653|NCT04411862|Nootropic Agents|nootropic agents|mesh-ancestor
24898656|NCT04411537|Capecitabine|capecitabine|mesh-list
24898657|NCT04411537|Irinotecan|irinotecan|mesh-list
25063394|NCT01709981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063395|NCT01709981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898658|NCT04411537|Antibodies|antibodies|mesh-list
24898659|NCT04411537|Immunologic Factors|immunologic factors|mesh-ancestor
24898660|NCT04411537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898661|NCT04411537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24898662|NCT04411537|Antimetabolites|antimetabolites|mesh-ancestor
24898663|NCT04411537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898664|NCT04411537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898665|NCT04411537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24898666|NCT04411537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24898667|NCT04411537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24898668|NCT04411901|Cholecalciferol|cholecalciferol|mesh-list
24898669|NCT04411901|Vitamin D|vitamin d|mesh-list
24898670|NCT04411901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24898671|NCT04411901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898672|NCT04411901|Vitamins|vitamins|mesh-ancestor
24898673|NCT04411901|Micronutrients|micronutrients|mesh-ancestor
24475694|NCT00411190|Ibuprofen|ibuprofen|mesh-list
24858244|NCT02296021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24898700|NCT04411329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24898705|NCT04411329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24898706|NCT04411329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24898707|NCT04411329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898708|NCT04411329|Anesthetics, Local|anesthetics, local|mesh-ancestor
24898710|NCT04411329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24898711|NCT04411329|Sensory System Agents|sensory system agents|mesh-ancestor
24517170|NCT00606333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24475754|NCT00411307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24898712|NCT04411329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24898713|NCT04411329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24898715|NCT04411329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24898716|NCT04411329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24898717|NCT04411329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24898718|NCT04411329|Adrenergic Agents|adrenergic agents|mesh-ancestor
24898719|NCT04411329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24898720|NCT04411329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898721|NCT04411225|Cannabidiol|cannabidiol|mesh-list
24898722|NCT04411225|Anticonvulsants|anticonvulsants|mesh-ancestor
24898723|NCT04411160|Ascorbic Acid|ascorbic acid|mesh-list
25063403|NCT01670500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24825928|NCT02130869|Analgesics|analgesics|mesh-ancestor
24898740|NCT04411160|Gasotransmitters|gasotransmitters|mesh-ancestor
24817760|NCT02085577|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24817761|NCT02085577|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24721643|NCT01576029|Docetaxel|docetaxel|mesh-list
24898741|NCT04411212|Lenograstim|lenograstim|mesh-list
24898742|NCT04411212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24898743|NCT04411212|Immunologic Factors|immunologic factors|mesh-ancestor
24898748|NCT04411069|Autonomic Agents|autonomic agents|mesh-ancestor
24898749|NCT04411069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24898767|NCT04410887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898768|NCT04410887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898770|NCT04411030|Midazolam|midazolam|mesh-list
24898771|NCT04411030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24898772|NCT04411030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24898773|NCT04411030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24583786|NCT00876889|Protective Agents|protective agents|mesh-ancestor
24898774|NCT04411030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898775|NCT04411030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24898776|NCT04411030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24898777|NCT04411030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24898778|NCT04411030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24898779|NCT04411030|Anesthetics, General|anesthetics, general|mesh-ancestor
24898780|NCT04411030|Anesthetics|anesthetics|mesh-ancestor
24898781|NCT04411030|GABA Modulators|gaba modulators|mesh-ancestor
24898782|NCT04411030|GABA Agents|gaba agents|mesh-ancestor
24898783|NCT04411030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24898784|NCT04411030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898787|NCT04411030|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24898788|NCT04411030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24517197|NCT00606450|Immunologic Factors|immunologic factors|mesh-ancestor
24517198|NCT00606450|Leprostatic Agents|leprostatic agents|mesh-ancestor
24517199|NCT00606450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24517200|NCT00606450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24517201|NCT00606450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24517202|NCT00606450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24517203|NCT00606450|Growth Substances|growth substances|mesh-ancestor
24517204|NCT00606450|Growth Inhibitors|growth inhibitors|mesh-ancestor
24898789|NCT04411030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24898797|NCT04410588|Narcotics|narcotics|mesh-ancestor
24898798|NCT04410588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24898799|NCT04410588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898800|NCT04410588|Analgesics|analgesics|mesh-ancestor
25699260|NCT02104804|Insulin|insulin|mesh-list
24858947|NCT02300623|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24858948|NCT02300623|Protease Inhibitors|protease inhibitors|mesh-ancestor
24898801|NCT04410588|Sensory System Agents|sensory system agents|mesh-ancestor
25063404|NCT01670500|Alkylating Agents|alkylating agents|mesh-ancestor
25063405|NCT01670500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063406|NCT01670500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584027|NCT00878306|Ritonavir|ritonavir|mesh-list
24584058|NCT00878345|Sensory System Agents|sensory system agents|mesh-ancestor
24584281|NCT00879385|Decitabine|decitabine|mesh-list
24584282|NCT00879385|Panitumumab|panitumumab|mesh-list
24584283|NCT00879385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24584284|NCT00879385|Antimetabolites|antimetabolites|mesh-ancestor
24584285|NCT00879385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584318|NCT00879892|Xenon|xenon|mesh-list
25063407|NCT01670500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25063418|NCT01553032|Cetuximab|cetuximab|mesh-list
25063419|NCT01553032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24825938|NCT02131012|Celecoxib|celecoxib|mesh-list
24898802|NCT04410588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24898803|NCT04410588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24898804|NCT04410588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24898805|NCT04410588|Anesthetics, General|anesthetics, general|mesh-ancestor
24898806|NCT04410588|Anesthetics|anesthetics|mesh-ancestor
24898807|NCT04410588|Anesthetics, Local|anesthetics, local|mesh-ancestor
24898808|NCT04410354|Remdesivir|remdesivir|mesh-list
24898809|NCT04410354|Antimetabolites|antimetabolites|mesh-ancestor
24898810|NCT04410354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898811|NCT04410354|Antiviral Agents|antiviral agents|mesh-ancestor
24898812|NCT04410354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24898813|NCT04410263|Dimercaprol|dimercaprol|mesh-list
24898814|NCT04410263|Chelating Agents|chelating agents|mesh-ancestor
24898815|NCT04410263|Sequestering Agents|sequestering agents|mesh-ancestor
24898816|NCT04410263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898818|NCT04409912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24898819|NCT04409912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24898820|NCT04409912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24898821|NCT04409912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898822|NCT04409912|Antifungal Agents|antifungal agents|mesh-ancestor
24898823|NCT04409912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24898824|NCT04409912|Immunologic Factors|immunologic factors|mesh-ancestor
24898825|NCT04409912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898827|NCT04410081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24898828|NCT04410081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24898829|NCT04410081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898830|NCT04410094|Itraconazole|itraconazole|mesh-list
24898831|NCT04410094|Rifampin|rifampin|mesh-list
24898832|NCT04410094|Lazertinib|lazertinib|mesh-list
24898833|NCT04410094|Antifungal Agents|antifungal agents|mesh-ancestor
24898834|NCT04410094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24898835|NCT04410094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24898836|NCT04410094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24898838|NCT04410094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898839|NCT04410094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24898840|NCT04410094|Hormone Antagonists|hormone antagonists|mesh-ancestor
24898841|NCT04410094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24898842|NCT04410094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063420|NCT01553032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063421|NCT01453101|Fludarabine|fludarabine|mesh-list
24898843|NCT04410094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24898844|NCT04410094|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24898845|NCT04410094|Antitubercular Agents|antitubercular agents|mesh-ancestor
24898846|NCT04410094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24898847|NCT04410094|Leprostatic Agents|leprostatic agents|mesh-ancestor
24898848|NCT04410094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24584932|NCT00882323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24584998|NCT00882609|Protective Agents|protective agents|mesh-ancestor
25699261|NCT02104804|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25699262|NCT02104804|Metformin|metformin|mesh-list
25699263|NCT02104804|Saxagliptin|saxagliptin|mesh-list
25699264|NCT02104804|Insulin, Short-Acting|insulin, short-acting|mesh-list
25699265|NCT02104804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24584999|NCT00882609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898849|NCT04410094|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24898850|NCT04410094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24898851|NCT04410094|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24898852|NCT04410094|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24898853|NCT04410094|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24898854|NCT04410094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24898855|NCT04410094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24898883|NCT04409431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24898884|NCT04409431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24898885|NCT04409431|Adrenergic Agents|adrenergic agents|mesh-ancestor
24517206|NCT00606515|Paclitaxel|paclitaxel|mesh-list
24517233|NCT00606775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24517234|NCT00606775|Vasodilator Agents|vasodilator agents|mesh-ancestor
24517235|NCT00606775|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24517236|NCT00606775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24517237|NCT00606814|Docetaxel|docetaxel|mesh-list
24517238|NCT00606814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517239|NCT00606814|Tubulin Modulators|tubulin modulators|mesh-ancestor
24517240|NCT00606814|Antimitotic Agents|antimitotic agents|mesh-ancestor
24517241|NCT00606814|Mitosis Modulators|mitosis modulators|mesh-ancestor
24517242|NCT00606814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517243|NCT00606866|Sorafenib|sorafenib|mesh-list
24475911|NCT00411996|Antiviral Agents|antiviral agents|mesh-ancestor
24475912|NCT00411996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24475913|NCT00411996|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24475914|NCT00411996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24898895|NCT04409431|Mydriatics|mydriatics|mesh-ancestor
24898953|NCT04408911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24898954|NCT04408911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24898955|NCT04408911|Anesthetics, General|anesthetics, general|mesh-ancestor
24898956|NCT04408911|Anesthetics|anesthetics|mesh-ancestor
24898957|NCT04408911|GABA Modulators|gaba modulators|mesh-ancestor
24898958|NCT04408911|GABA Agents|gaba agents|mesh-ancestor
24475933|NCT00412022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24475934|NCT00412022|Contraceptive Agents|contraceptive agents|mesh-ancestor
24475935|NCT00412022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24475936|NCT00412022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24475954|NCT00412100|Analgesics|analgesics|mesh-ancestor
24475955|NCT00412100|Sensory System Agents|sensory system agents|mesh-ancestor
24475956|NCT00412100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24475957|NCT00412100|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24898968|NCT04408313|Sensory System Agents|sensory system agents|mesh-ancestor
24898969|NCT04408313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24898970|NCT04408313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24898971|NCT04408313|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24898972|NCT04408326|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24898973|NCT04408326|Angiotensin II|angiotensin ii|mesh-list
24898974|NCT04408326|Giapreza|giapreza|mesh-list
24898975|NCT04408326|Angiotensinogen|angiotensinogen|mesh-list
24898976|NCT04408326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24585284|NCT00884767|Leucovorin|leucovorin|mesh-list
24585285|NCT00884767|Fluorouracil|fluorouracil|mesh-list
24585286|NCT00884767|Oxaliplatin|oxaliplatin|mesh-list
24585287|NCT00884767|Calcium|calcium|mesh-list
24898977|NCT04408326|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24898978|NCT04408326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24898979|NCT04408326|Protease Inhibitors|protease inhibitors|mesh-ancestor
24898980|NCT04408326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24898982|NCT04408144|Dydrogesterone|dydrogesterone|mesh-list
24899013|NCT04407715|Anesthetics|anesthetics|mesh-list
24899014|NCT04407715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24899015|NCT04407715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899016|NCT04407312|Aspirin|aspirin|mesh-list
24825943|NCT02131012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24475977|NCT00412191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24475981|NCT00412204|Bromides|bromides|mesh-list
24517244|NCT00606866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517245|NCT00606866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24517246|NCT00606866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517247|NCT00606866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517248|NCT00606957|Vitamin D|vitamin d|mesh-list
24517249|NCT00606957|Cholecalciferol|cholecalciferol|mesh-list
24517250|NCT00606957|Vitamins|vitamins|mesh-ancestor
24517251|NCT00606957|Micronutrients|micronutrients|mesh-ancestor
24517253|NCT00606957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24803519|NCT01996683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108217|NCT03134001|Sensory System Agents|sensory system agents|mesh-ancestor
24449560|NCT00315965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24899019|NCT04407312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24899021|NCT04407312|Analgesics|analgesics|mesh-ancestor
24899022|NCT04407312|Sensory System Agents|sensory system agents|mesh-ancestor
24899023|NCT04407312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24899024|NCT04407312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899025|NCT04407312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24899026|NCT04407312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24585300|NCT00884767|Vitamins|vitamins|mesh-ancestor
24585707|NCT00886873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24899039|NCT04407312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24899040|NCT04407312|Autonomic Agents|autonomic agents|mesh-ancestor
24899041|NCT04407312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24899042|NCT04407312|Respiratory System Agents|respiratory system agents|mesh-ancestor
24899043|NCT04407312|Vasodilator Agents|vasodilator agents|mesh-ancestor
24899044|NCT04407312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24899045|NCT04407312|Protective Agents|protective agents|mesh-ancestor
24476006|NCT00412347|Insulin|insulin|mesh-list
24476023|NCT00412555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24476024|NCT00412555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899046|NCT04407312|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24899047|NCT04407312|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24899049|NCT04407234|Tirzepatide|tirzepatide|mesh-list
24899050|NCT04407234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24899051|NCT04407234|Analgesics|analgesics|mesh-ancestor
24517345|NCT00607542|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24517347|NCT00607542|GABA Agents|gaba agents|mesh-ancestor
24517348|NCT00607542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24517349|NCT00607542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517350|NCT00607568|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24517351|NCT00607568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24517352|NCT00607568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24517353|NCT00607568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24517354|NCT00607568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517355|NCT00607568|Adrenergic Agents|adrenergic agents|mesh-ancestor
24517356|NCT00607568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24517357|NCT00607568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899072|NCT04407078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24476065|NCT00412698|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24476066|NCT00412698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24476067|NCT00412698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476069|NCT00412698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25063426|NCT01453101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25063427|NCT01453101|Antimetabolites|antimetabolites|mesh-ancestor
25063428|NCT01453101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063429|NCT01453101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25063430|NCT01453101|Immunologic Factors|immunologic factors|mesh-ancestor
25699266|NCT02104804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699267|NCT02104804|Incretins|incretins|mesh-ancestor
25699268|NCT02104804|Hormones|hormones|mesh-ancestor
25699269|NCT02104804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25699270|NCT02104804|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25699271|NCT02104804|Protease Inhibitors|protease inhibitors|mesh-ancestor
25699272|NCT02104804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25699273|NCT02104804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699274|NCT02104830|Lenograstim|lenograstim|mesh-list
24586161|NCT00889369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586162|NCT00889369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25063431|NCT01453101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517359|NCT00607581|Cyclophosphamide|cyclophosphamide|mesh-list
24517360|NCT00607581|Lenalidomide|lenalidomide|mesh-list
24517361|NCT00607581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24517362|NCT00607581|Immunologic Factors|immunologic factors|mesh-ancestor
24517363|NCT00607581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517364|NCT00607581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24517365|NCT00607581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24517366|NCT00607581|Alkylating Agents|alkylating agents|mesh-ancestor
24517367|NCT00607581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517368|NCT00607581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517369|NCT00607581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24517370|NCT00607581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24899073|NCT04407078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899074|NCT04407078|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24899075|NCT04407078|Autonomic Agents|autonomic agents|mesh-ancestor
24899076|NCT04407078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24476081|NCT00412789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476083|NCT00412802|Enoxaparin sodium|enoxaparin sodium|mesh-list
24476084|NCT00412802|Anticoagulants|anticoagulants|mesh-ancestor
24476085|NCT00412802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24476088|NCT00412919|Azacitidine|azacitidine|mesh-list
24517624|NCT00608816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24517626|NCT00608816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699275|NCT02104830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25699276|NCT02104830|Immunologic Factors|immunologic factors|mesh-ancestor
25699277|NCT02104830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699278|NCT02105272|Carteolol|carteolol|mesh-list
25699279|NCT02105272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25699280|NCT02105272|Latanoprost|latanoprost|mesh-list
25699281|NCT02105272|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25699282|NCT02105272|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25063446|NCT00753532|Micronutrients|micronutrients|mesh-ancestor
25063447|NCT00753532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517775|NCT00609960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24517776|NCT00609960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24517777|NCT00609960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517778|NCT00609960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24517779|NCT00609960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24517780|NCT00609960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24517795|NCT00610038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24517796|NCT00610038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517797|NCT00610077|Letrozole|letrozole|mesh-list
24517798|NCT00610077|Clomiphene|clomiphene|mesh-list
24587147|NCT00893594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517799|NCT00610077|Enclomiphene|enclomiphene|mesh-list
24517800|NCT00610077|Zuclomiphene|zuclomiphene|mesh-list
24517801|NCT00610077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063455|NCT00003857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063456|NCT00003857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25063457|NCT00003857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063458|NCT00003857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25063459|NCT00003857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25063460|NCT00003857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24899124|NCT04406883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24476112|NCT00413075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476113|NCT00413088|Bemiparin|bemiparin|mesh-list
24476114|NCT00413088|Anticoagulants|anticoagulants|mesh-ancestor
24476115|NCT00413101|Epoetin Alfa|epoetin alfa|mesh-list
24476116|NCT00413101|Hematinics|hematinics|mesh-ancestor
24476122|NCT00413127|Sensory System Agents|sensory system agents|mesh-ancestor
24476123|NCT00413127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24476124|NCT00413127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24476125|NCT00413127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24476126|NCT00413127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24476127|NCT00413127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24899150|NCT04406246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24899170|NCT04406025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24899171|NCT04406025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899172|NCT04406051|Norepinephrine|norepinephrine|mesh-list
24899173|NCT04406051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25063462|NCT03468595|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25063463|NCT03468595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25063464|NCT03468478|Mycophenolic Acid|mycophenolic acid|mesh-list
25063465|NCT03468478|Sirolimus|sirolimus|mesh-list
25063466|NCT03468478|Everolimus|everolimus|mesh-list
25063467|NCT03468478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063468|NCT03468478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25063469|NCT03468478|Immunologic Factors|immunologic factors|mesh-ancestor
25063470|NCT03468478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622697|NCT01068054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622698|NCT01068054|Antifungal Agents|antifungal agents|mesh-ancestor
24622699|NCT01068054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25063471|NCT03468478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25063472|NCT03468478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25063473|NCT03468478|Antitubercular Agents|antitubercular agents|mesh-ancestor
25063474|NCT03468478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24899194|NCT04405921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24899195|NCT04405921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24899196|NCT04405921|Antimalarials|antimalarials|mesh-ancestor
24899197|NCT04405921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24899198|NCT04405921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24899199|NCT04405921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899216|NCT04405505|Paclitaxel|paclitaxel|mesh-list
24899217|NCT04405505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24899218|NCT04405505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24899219|NCT04405505|Tubulin Modulators|tubulin modulators|mesh-ancestor
24899220|NCT04405505|Antimitotic Agents|antimitotic agents|mesh-ancestor
24899221|NCT04405505|Mitosis Modulators|mitosis modulators|mesh-ancestor
24899222|NCT04405505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899223|NCT04405375|Dexamethasone|dexamethasone|mesh-list
24899224|NCT04405375|Etoposide|etoposide|mesh-list
24899225|NCT04405375|Pegaspargase|pegaspargase|mesh-list
24899226|NCT04405375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24899227|NCT04405375|Antiemetics|antiemetics|mesh-ancestor
24899228|NCT04405375|Autonomic Agents|autonomic agents|mesh-ancestor
24426108|NCT00235053|Hormones|hormones|mesh-ancestor
24476173|NCT00413387|Formoterol Fumarate|formoterol fumarate|mesh-list
24476174|NCT00413387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24476175|NCT00413387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24476177|NCT00413387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24476178|NCT00413387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899232|NCT04405375|Glucocorticoids|glucocorticoids|mesh-ancestor
24899233|NCT04405375|Hormones|hormones|mesh-ancestor
24899234|NCT04405375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24899235|NCT04405375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24899236|NCT04405375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24899237|NCT04405375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24899238|NCT04405375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24899239|NCT04405375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24899240|NCT04405375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899241|NCT04405375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899242|NCT04405206|Capecitabine|capecitabine|mesh-list
24899243|NCT04405206|Oxaliplatin|oxaliplatin|mesh-list
24899244|NCT04405206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24899245|NCT04405206|Antimetabolites|antimetabolites|mesh-ancestor
24899246|NCT04405206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899247|NCT04405206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24899248|NCT04405193|Acetylcysteine|acetylcysteine|mesh-list
24899249|NCT04405193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25699283|NCT02105272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25699284|NCT02105272|Adrenergic Agents|adrenergic agents|mesh-ancestor
24584766|NCT00881556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25699285|NCT02105272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25699286|NCT02105272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699287|NCT02105272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699288|NCT02105272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25699289|NCT02105272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25699290|NCT02105272|Sympatholytics|sympatholytics|mesh-ancestor
25699291|NCT02105272|Autonomic Agents|autonomic agents|mesh-ancestor
25699292|NCT02105272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699293|NCT02105285|Carteolol|carteolol|mesh-list
25699294|NCT02105285|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24899250|NCT04405193|Antiviral Agents|antiviral agents|mesh-ancestor
24804667|NCT02004301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24899251|NCT04405193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24899252|NCT04405193|Expectorants|expectorants|mesh-ancestor
24899253|NCT04405193|Respiratory System Agents|respiratory system agents|mesh-ancestor
24899254|NCT04405193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24476179|NCT00413387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24517916|NCT00610584|Cetirizine|cetirizine|mesh-list
24517917|NCT00610584|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24517918|NCT00610584|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25063484|NCT03468465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063485|NCT03468465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063486|NCT03468465|Urological Agents|urological agents|mesh-ancestor
25063487|NCT03468439|Phenol|phenol|mesh-list
24517919|NCT00610584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24517920|NCT00610584|Histamine Antagonists|histamine antagonists|mesh-ancestor
24899310|NCT04404946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899311|NCT04404946|Protective Agents|protective agents|mesh-ancestor
24899312|NCT04404881|Bevacizumab|bevacizumab|mesh-list
24899313|NCT04404881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24899321|NCT04404855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24899322|NCT04404751|Folic Acid|folic acid|mesh-list
24899323|NCT04404751|Vitamin B 12|vitamin b 12|mesh-list
24899324|NCT04404751|Hydroxocobalamin|hydroxocobalamin|mesh-list
24899325|NCT04404751|Iron|iron|mesh-list
24899326|NCT04404751|Vitamins|vitamins|mesh-ancestor
24899327|NCT04404751|Micronutrients|micronutrients|mesh-ancestor
24899328|NCT04404751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899329|NCT04404751|Trace Elements|trace elements|mesh-ancestor
24899330|NCT04404751|Hematinics|hematinics|mesh-ancestor
24899331|NCT04404751|Vitamin B Complex|vitamin b complex|mesh-ancestor
24899332|NCT04404686|Indomethacin|indomethacin|mesh-list
24899333|NCT04404686|Nifedipine|nifedipine|mesh-list
24899334|NCT04404686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24899335|NCT04404686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24899336|NCT04404686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899337|NCT04404686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24817794|NCT02085655|Gemcitabine|gemcitabine|mesh-list
25063496|NCT03468348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24825985|NCT02131350|Growth Inhibitors|growth inhibitors|mesh-ancestor
24825986|NCT02131350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476258|NCT00413712|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24476259|NCT00413712|Purinergic Agonists|purinergic agonists|mesh-ancestor
24588613|NCT00903279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24588614|NCT00903292|Pemetrexed|pemetrexed|mesh-list
24588615|NCT00903292|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24517945|NCT00610792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24517946|NCT00610792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517947|NCT00610792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24517948|NCT00610792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24517949|NCT00610792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476267|NCT00413751|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24476268|NCT00413751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24476269|NCT00413751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24476270|NCT00413751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24476271|NCT00413751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24817824|NCT02085655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24518150|NCT05331053|Atorvastatin|atorvastatin|mesh-list
24518151|NCT05331053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24518152|NCT05331053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24518153|NCT05331053|Antimetabolites|antimetabolites|mesh-ancestor
24518154|NCT05331053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518155|NCT05331053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24518156|NCT05331053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24518157|NCT05331053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24518158|NCT05330871|Vaccines|vaccines|mesh-list
25699295|NCT02105285|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24518159|NCT05330871|Immunologic Factors|immunologic factors|mesh-ancestor
25699296|NCT02105285|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25699297|NCT02105285|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25699298|NCT02105285|Adrenergic Agents|adrenergic agents|mesh-ancestor
25699299|NCT02105285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25699300|NCT02105285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699301|NCT02105285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518160|NCT05330871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518196|NCT05330273|Antiviral Agents|antiviral agents|mesh-ancestor
24518197|NCT05330273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24518198|NCT05330273|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24899421|NCT04403724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24899422|NCT04403724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24899424|NCT04403724|Analgesics|analgesics|mesh-ancestor
24899425|NCT04403724|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24588940|NCT00904852|Bevacizumab|bevacizumab|mesh-list
24899426|NCT04403724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24899427|NCT04403724|Anesthetics, General|anesthetics, general|mesh-ancestor
24899428|NCT04403568|Ursolic acid|ursolic acid|mesh-list
24899430|NCT04403568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24899431|NCT04403568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24899432|NCT04403568|Analgesics|analgesics|mesh-ancestor
25063525|NCT03468231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24947944|NCT03924544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063526|NCT03468231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063527|NCT03468231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25063529|NCT03468231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063531|NCT03468231|Protective Agents|protective agents|mesh-ancestor
25063532|NCT03468231|Vitamin B Complex|vitamin b complex|mesh-ancestor
25063533|NCT03468231|Vitamins|vitamins|mesh-ancestor
25063534|NCT03468231|Micronutrients|micronutrients|mesh-ancestor
25063535|NCT03468231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25063536|NCT03468231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063537|NCT03468140|Eculizumab|eculizumab|mesh-list
24899442|NCT04403568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24899443|NCT04403568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24899444|NCT04403555|Ivermectin|ivermectin|mesh-list
24899445|NCT04403555|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24817795|NCT02085655|Thalidomide|thalidomide|mesh-list
24817796|NCT02085655|Dexamethasone|dexamethasone|mesh-list
24817797|NCT02085655|Oxaliplatin|oxaliplatin|mesh-list
24817798|NCT02085655|Methotrexate|methotrexate|mesh-list
24817799|NCT02085655|Pegaspargase|pegaspargase|mesh-list
24817800|NCT02085655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24817801|NCT02085655|Antiemetics|antiemetics|mesh-ancestor
24476330|NCT00414180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24476331|NCT00414180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25063544|NCT03468062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25063545|NCT03468062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063546|NCT03468062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24518230|NCT05330000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24518231|NCT05330000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476341|NCT00414245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476342|NCT00414323|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24817803|NCT02085655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24817804|NCT02085655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817823|NCT02085655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24476351|NCT00414323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24446759|NCT00305825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24817852|NCT02085967|Rifampin|rifampin|mesh-list
24817858|NCT02085967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817859|NCT02085967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24817860|NCT02085967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24476353|NCT00414323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24476354|NCT00414323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24476355|NCT00414323|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24476356|NCT00414323|Analgesics|analgesics|mesh-ancestor
24476357|NCT00414323|Sensory System Agents|sensory system agents|mesh-ancestor
24476358|NCT00414323|Dopamine Agents|dopamine agents|mesh-ancestor
24476359|NCT00414336|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24476360|NCT00414336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24476361|NCT00414336|Immunologic Factors|immunologic factors|mesh-ancestor
24476362|NCT00414336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063558|NCT03468023|Protease Inhibitors|protease inhibitors|mesh-ancestor
24811956|NCT02049034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679042|NCT01366235|Amebicides|amebicides|mesh-ancestor
24576733|NCT00840229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682636|NCT01387295|Oxaliplatin|oxaliplatin|mesh-list
24821184|NCT02103738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821287|NCT02104284|Autonomic Agents|autonomic agents|mesh-ancestor
24821288|NCT02104284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24821289|NCT02104284|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24821655|NCT02107079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063559|NCT03468023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826025|NCT02131818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24826026|NCT02131818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24826027|NCT02131922|Chlorhexidine|chlorhexidine|mesh-list
24826028|NCT02131922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24826029|NCT02131922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24826030|NCT02131922|Disinfectants|disinfectants|mesh-ancestor
24706545|NCT01490476|Everolimus|everolimus|mesh-list
24899484|NCT04403100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24899485|NCT04403243|Colchicine|colchicine|mesh-list
24899486|NCT04403243|Gout Suppressants|gout suppressants|mesh-ancestor
24899487|NCT04403243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24899488|NCT04403243|Tubulin Modulators|tubulin modulators|mesh-ancestor
24518408|NCT05069935|Immunoglobulins|immunoglobulins|mesh-list
24476399|NCT00414739|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24476400|NCT00414739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24476401|NCT00414921|Clonidine|clonidine|mesh-list
24476402|NCT00414921|Methylphenidate|methylphenidate|mesh-list
24476409|NCT00414921|Dopamine Agents|dopamine agents|mesh-ancestor
24518344|NCT05214807|Antimetabolites|antimetabolites|mesh-ancestor
24518345|NCT05214807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518346|NCT05214807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24518347|NCT05214807|Chelating Agents|chelating agents|mesh-ancestor
24518348|NCT05214807|Sequestering Agents|sequestering agents|mesh-ancestor
24443206|NCT00293969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899500|NCT04403282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899501|NCT04403282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899502|NCT04403191|Ondansetron|ondansetron|mesh-list
24899503|NCT04403191|Antiemetics|antiemetics|mesh-ancestor
24899504|NCT04403191|Autonomic Agents|autonomic agents|mesh-ancestor
24899505|NCT04403191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24899506|NCT04403191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899507|NCT04403191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24476413|NCT00414921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24476414|NCT00414921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24476415|NCT00414921|Sympatholytics|sympatholytics|mesh-ancestor
24476416|NCT00414921|Autonomic Agents|autonomic agents|mesh-ancestor
24476417|NCT00414921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24476418|NCT00414921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24476419|NCT00414921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24476420|NCT00414921|Adrenergic Agents|adrenergic agents|mesh-ancestor
24476421|NCT00414947|Vildagliptin|vildagliptin|mesh-list
24476422|NCT00414947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24476423|NCT00414947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476425|NCT00414947|Protease Inhibitors|protease inhibitors|mesh-ancestor
24476435|NCT00415064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24476436|NCT00415064|Glucocorticoids|glucocorticoids|mesh-ancestor
24476437|NCT00415064|Hormones|hormones|mesh-ancestor
24476440|NCT00415064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657210|NCT01266187|Vitamin B Complex|vitamin b complex|mesh-ancestor
24590022|NCT00910416|Propofol|propofol|mesh-list
25699302|NCT02105285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25699303|NCT02105285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25699304|NCT02105285|Sympatholytics|sympatholytics|mesh-ancestor
25699305|NCT02105285|Autonomic Agents|autonomic agents|mesh-ancestor
25699306|NCT02105285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25709507|NCT02268396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25709508|NCT02268396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709509|NCT02268396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25709510|NCT02268396|Respiratory System Agents|respiratory system agents|mesh-ancestor
24590023|NCT00910416|Sevoflurane|sevoflurane|mesh-list
24590024|NCT00910416|Atracurium|atracurium|mesh-list
25407299|NCT03508921|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24590054|NCT00910442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590055|NCT00910442|Protective Agents|protective agents|mesh-ancestor
25063560|NCT03468023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948086|NCT03923257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24948087|NCT03923257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948090|NCT03923231|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24948091|NCT03923231|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24948092|NCT03923231|Protease Inhibitors|protease inhibitors|mesh-ancestor
24948093|NCT03923231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24948094|NCT03923231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948095|NCT03923231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24948096|NCT03923231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24948097|NCT03923231|Antiviral Agents|antiviral agents|mesh-ancestor
24948098|NCT03923231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24948099|NCT03923231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24948100|NCT03923231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24948101|NCT03923179|Etoposide|etoposide|mesh-list
24948102|NCT03923179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24948103|NCT03923179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24948104|NCT03923179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24948105|NCT03923179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24948106|NCT03923179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24948107|NCT03923179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948108|NCT03923010|Itraconazole|itraconazole|mesh-list
25063564|NCT03468010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063565|NCT03468010|Tubulin Modulators|tubulin modulators|mesh-ancestor
25063566|NCT03468010|Antimitotic Agents|antimitotic agents|mesh-ancestor
25063567|NCT03468010|Mitosis Modulators|mitosis modulators|mesh-ancestor
24826073|NCT02132234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24826077|NCT02132260|Naftifine|naftifine|mesh-list
24899536|NCT04402892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899537|NCT04402892|Antimanic Agents|antimanic agents|mesh-ancestor
24899538|NCT04402892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24899539|NCT04402892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24899540|NCT04402892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899541|NCT04402762|Enoxaparin|enoxaparin|mesh-list
24899542|NCT04402762|Enoxaparin sodium|enoxaparin sodium|mesh-list
24899543|NCT04402762|Anticoagulants|anticoagulants|mesh-ancestor
24899544|NCT04402762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24899545|NCT04402762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24899546|NCT04402762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899547|NCT04402580|Mycophenolic Acid|mycophenolic acid|mesh-list
24899548|NCT04402580|Rituximab|rituximab|mesh-list
24899549|NCT04402580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24899550|NCT04402580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24899551|NCT04402580|Immunologic Factors|immunologic factors|mesh-ancestor
24899552|NCT04402580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899553|NCT04402580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24899554|NCT04402580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24899555|NCT04402580|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24476447|NCT00415090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24476448|NCT00415090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24476449|NCT00415090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063571|NCT03467984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063572|NCT03467932|Insulin|insulin|mesh-list
25063573|NCT03467932|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25063574|NCT03467932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25063575|NCT03467932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063576|NCT03467893|Antacids|antacids|mesh-list
25063577|NCT03467893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063578|NCT03467893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24899566|NCT04402723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24899567|NCT04402723|Antimetabolites|antimetabolites|mesh-ancestor
24899568|NCT04402723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899569|NCT04402723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24899570|NCT04402723|Antiviral Agents|antiviral agents|mesh-ancestor
24899571|NCT04402723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24476471|NCT00415116|Carboplatin|carboplatin|mesh-list
24476472|NCT00415116|Docetaxel|docetaxel|mesh-list
24476473|NCT00415116|Lenalidomide|lenalidomide|mesh-list
25699307|NCT02105324|Pancrelipase|pancrelipase|mesh-list
25699308|NCT02105324|Pancreatin|pancreatin|mesh-list
24823692|NCT02118532|Paclitaxel|paclitaxel|mesh-list
24476474|NCT00415116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24899584|NCT04402320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24476482|NCT00415116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24476483|NCT00415116|Growth Substances|growth substances|mesh-ancestor
24476484|NCT00415116|Growth Inhibitors|growth inhibitors|mesh-ancestor
24476485|NCT00415233|Hormones|hormones|mesh-list
24476486|NCT00415233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24476487|NCT00415233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476488|NCT00415246|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24476489|NCT00415246|Luteolytic Agents|luteolytic agents|mesh-ancestor
24476490|NCT00415246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24476491|NCT00415246|Contraceptive Agents|contraceptive agents|mesh-ancestor
24476492|NCT00415246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24657212|NCT01266187|Micronutrients|micronutrients|mesh-ancestor
24476493|NCT00415246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476494|NCT00415246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24476495|NCT00415246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24476496|NCT00415246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476497|NCT00415285|Docetaxel|docetaxel|mesh-list
24476498|NCT00415285|Capecitabine|capecitabine|mesh-list
24899607|NCT04402411|Sensory System Agents|sensory system agents|mesh-ancestor
24899608|NCT04402411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24899612|NCT04402203|Favipiravir|favipiravir|mesh-list
24899613|NCT04402203|Antiviral Agents|antiviral agents|mesh-ancestor
24899614|NCT04402203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24899615|NCT04402047|Diclofenac|diclofenac|mesh-list
24899616|NCT04402047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24899617|NCT04402047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24899624|NCT04402047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24899625|NCT04402047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476499|NCT00415285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476525|NCT00415402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476526|NCT00415402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24518406|NCT05069935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24518409|NCT05069935|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24518410|NCT05069935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24518411|NCT05069935|Immunologic Factors|immunologic factors|mesh-ancestor
24518412|NCT05069935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518413|NCT05069935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24518433|NCT05059626|Antimetabolites|antimetabolites|mesh-ancestor
24518434|NCT05059626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518435|NCT05059626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24518436|NCT05059626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24518437|NCT05059626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24518439|NCT05059626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24518440|NCT05059626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899642|NCT04401878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24899643|NCT04401878|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24899644|NCT04401878|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24899645|NCT04401878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24899646|NCT04401878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899648|NCT04401852|Analgesics|analgesics|mesh-ancestor
24899649|NCT04401852|Sensory System Agents|sensory system agents|mesh-ancestor
24899650|NCT04401852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24899651|NCT04401852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899652|NCT04401852|Anesthetics|anesthetics|mesh-ancestor
24899653|NCT04401852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24899654|NCT04401852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24899655|NCT04401852|Anticonvulsants|anticonvulsants|mesh-ancestor
24899656|NCT04401852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24899657|NCT04401852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24476536|NCT00415701|Etomidate|etomidate|mesh-list
24476537|NCT00415701|Cosyntropin|cosyntropin|mesh-list
24476538|NCT00415701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24518441|NCT05059626|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24591324|NCT00915850|Antimitotic Agents|antimitotic agents|mesh-ancestor
24591325|NCT00915850|Mitosis Modulators|mitosis modulators|mesh-ancestor
24518442|NCT05059626|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24518443|NCT05059626|Hormone Antagonists|hormone antagonists|mesh-ancestor
24518444|NCT05059626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25699309|NCT02105324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25699310|NCT02105415|Ketamine|ketamine|mesh-list
24786214|NCT01918527|Capecitabine|capecitabine|mesh-list
24786215|NCT01918527|Oxaliplatin|oxaliplatin|mesh-list
24846884|NCT02244242|Tamsulosin|tamsulosin|mesh-list
24444534|NCT00298415|Gemcitabine|gemcitabine|mesh-list
24518451|NCT04981041|Clopidogrel|clopidogrel|mesh-list
24518452|NCT04981041|Ticagrelor|ticagrelor|mesh-list
24518453|NCT04981041|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24518454|NCT04981041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24518478|NCT04939467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24518479|NCT04939467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24518480|NCT04939467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24518481|NCT04938232|Nivolumab|nivolumab|mesh-list
24518482|NCT04938232|Ipilimumab|ipilimumab|mesh-list
24518483|NCT04938232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24899661|NCT04401852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24899663|NCT04401839|Oxytocics|oxytocics|mesh-ancestor
24899664|NCT04401839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24899665|NCT04401839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899666|NCT04401774|Nivolumab|nivolumab|mesh-list
24899667|NCT04401774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24899668|NCT04401774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24899673|NCT04401488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899674|NCT04401657|Adenosine|adenosine|mesh-list
24899675|NCT04401657|Analgesics|analgesics|mesh-ancestor
24899676|NCT04401657|Sensory System Agents|sensory system agents|mesh-ancestor
24899677|NCT04401657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24899678|NCT04401657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899679|NCT04401657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24476555|NCT00415740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476556|NCT00415740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476557|NCT00415740|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24476558|NCT00415740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657213|NCT01266213|Fulvestrant|fulvestrant|mesh-list
24591328|NCT00915915|Gestodene|gestodene|mesh-list
24476559|NCT00415740|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24476560|NCT00415740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24476561|NCT00415740|Immunologic Factors|immunologic factors|mesh-ancestor
24476562|NCT00415740|Dopamine Agonists|dopamine agonists|mesh-ancestor
24476563|NCT00415753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24476569|NCT00415779|Docetaxel|docetaxel|mesh-list
24899680|NCT04401657|Vasodilator Agents|vasodilator agents|mesh-ancestor
24899681|NCT04401657|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24899682|NCT04401657|Purinergic Agonists|purinergic agonists|mesh-ancestor
24899683|NCT04401657|Purinergic Agents|purinergic agents|mesh-ancestor
24899684|NCT04401657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24899716|NCT04401007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24899717|NCT04401007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899718|NCT04400747|Vitamin D|vitamin d|mesh-list
24899719|NCT04400747|Cholecalciferol|cholecalciferol|mesh-list
24899720|NCT04400747|Vitamins|vitamins|mesh-ancestor
24899721|NCT04400747|Micronutrients|micronutrients|mesh-ancestor
24899722|NCT04400747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899723|NCT04400747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24899724|NCT04400747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24899725|NCT04400721|Ropivacaine|ropivacaine|mesh-list
24899726|NCT04400721|Anesthetics, Local|anesthetics, local|mesh-ancestor
25063598|NCT03467438|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25063599|NCT03467438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25063600|NCT03467334|Simethicone|simethicone|mesh-list
25063601|NCT03467334|Antifoaming Agents|antifoaming agents|mesh-ancestor
25063602|NCT03467334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063603|NCT03467334|Emollients|emollients|mesh-ancestor
25063604|NCT03467334|Dermatologic Agents|dermatologic agents|mesh-ancestor
25063605|NCT03467256|Cyclophosphamide|cyclophosphamide|mesh-list
25063606|NCT03467256|Fludarabine|fludarabine|mesh-list
24899727|NCT04400721|Anesthetics|anesthetics|mesh-ancestor
24899728|NCT04400721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24899729|NCT04400721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899730|NCT04400721|Sensory System Agents|sensory system agents|mesh-ancestor
24899731|NCT04400721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699311|NCT02105415|Propofol|propofol|mesh-list
25699312|NCT02105415|Etomidate|etomidate|mesh-list
25699313|NCT02105415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25699314|NCT02105415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24828203|NCT02144064|Calcium heparin|calcium heparin|mesh-list
24721438|NCT01574092|Irinotecan|irinotecan|mesh-list
24899732|NCT04400916|Tranexamic Acid|tranexamic acid|mesh-list
24899733|NCT04400916|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24899797|NCT04399213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899798|NCT04399226|Dexmedetomidine|dexmedetomidine|mesh-list
24899799|NCT04399226|Ketamine|ketamine|mesh-list
24899800|NCT04399226|Propofol|propofol|mesh-list
24899801|NCT04399226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24899802|NCT04399226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24899803|NCT04399226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899804|NCT04399226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24899805|NCT04399226|Anesthetics, General|anesthetics, general|mesh-ancestor
24899806|NCT04399226|Anesthetics|anesthetics|mesh-ancestor
24899807|NCT04399226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24899808|NCT04399226|Analgesics|analgesics|mesh-ancestor
24899809|NCT04399226|Sensory System Agents|sensory system agents|mesh-ancestor
24899810|NCT04399226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24899811|NCT04399226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24899812|NCT04399226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24899813|NCT04399226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24899814|NCT04399226|Adrenergic Agents|adrenergic agents|mesh-ancestor
24899815|NCT04399226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24899816|NCT04399226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899817|NCT04399226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24899818|NCT04399226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24899834|NCT04399395|Dopamine Agents|dopamine agents|mesh-ancestor
24899835|NCT04399395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24899836|NCT04399395|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24899837|NCT04399395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24899838|NCT04399395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899839|NCT04399434|Insulin|insulin|mesh-list
24899840|NCT04399434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25063608|NCT03467256|Immunologic Factors|immunologic factors|mesh-ancestor
25063609|NCT03467256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899842|NCT04399525|Cetirizine|cetirizine|mesh-list
24899850|NCT04399525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24899851|NCT04399525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899852|NCT04399525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899853|NCT04399525|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24899854|NCT04399525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24899855|NCT04399525|Cholinergic Agents|cholinergic agents|mesh-ancestor
24899856|NCT04399525|Antipruritics|antipruritics|mesh-ancestor
24899857|NCT04399525|Dermatologic Agents|dermatologic agents|mesh-ancestor
24899858|NCT04399343|Dexmedetomidine|dexmedetomidine|mesh-list
24899859|NCT04399343|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24900056|NCT04397692|Autonomic Agents|autonomic agents|mesh-ancestor
24899860|NCT04399343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24899861|NCT04399343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899862|NCT04399343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24899880|NCT04399148|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24899891|NCT04399148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24899892|NCT04398823|Polidocanol|polidocanol|mesh-list
24899893|NCT04398823|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
24899894|NCT04398823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24899896|NCT04399070|Esketamine|esketamine|mesh-list
24476718|NCT00416325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476719|NCT00416377|Prednisolone|prednisolone|mesh-list
24476720|NCT00416377|Doxorubicin|doxorubicin|mesh-list
24476721|NCT00416377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24476722|NCT00416377|Bleomycin|bleomycin|mesh-list
24476723|NCT00416377|Vincristine|vincristine|mesh-list
24518494|NCT04908605|Melatonin|melatonin|mesh-list
24518497|NCT04908605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899897|NCT04399070|Analgesics|analgesics|mesh-ancestor
24899898|NCT04399070|Sensory System Agents|sensory system agents|mesh-ancestor
24899899|NCT04399070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24899900|NCT04399070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899901|NCT04399070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24899902|NCT04399070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25699315|NCT02105415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476735|NCT00416377|Tubulin Modulators|tubulin modulators|mesh-ancestor
24899903|NCT04399070|Anesthetics, General|anesthetics, general|mesh-ancestor
24899904|NCT04399070|Anesthetics|anesthetics|mesh-ancestor
25063610|NCT03467256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25063611|NCT03467256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25063612|NCT03467256|Alkylating Agents|alkylating agents|mesh-ancestor
25063613|NCT03467256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063614|NCT03467256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063615|NCT03467256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24899962|NCT04398589|Adrenergic Agents|adrenergic agents|mesh-ancestor
24592309|NCT00921219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24899963|NCT04398589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24899964|NCT04398589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899965|NCT04398589|Anesthetics, Local|anesthetics, local|mesh-ancestor
24899966|NCT04398589|Anesthetics|anesthetics|mesh-ancestor
24899967|NCT04398251|Febuxostat|febuxostat|mesh-list
24899968|NCT04398251|Gout Suppressants|gout suppressants|mesh-ancestor
24899969|NCT04398251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24899974|NCT04398290|Autonomic Agents|autonomic agents|mesh-ancestor
24899975|NCT04398290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24899976|NCT04398290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899977|NCT04398290|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25063622|NCT03467178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25063623|NCT03467178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063624|NCT03467178|Tubulin Modulators|tubulin modulators|mesh-ancestor
25063625|NCT03467178|Antimitotic Agents|antimitotic agents|mesh-ancestor
24899993|NCT04398316|Sensory System Agents|sensory system agents|mesh-ancestor
24899994|NCT04398316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24899995|NCT04398316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24899996|NCT04398316|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24899997|NCT04398316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24899998|NCT04398316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24899999|NCT04398316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900000|NCT04398316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24900001|NCT04398316|Narcotics|narcotics|mesh-ancestor
24900002|NCT04398316|Analgesics|analgesics|mesh-ancestor
24900003|NCT04398004|Clarithromycin|clarithromycin|mesh-list
24900004|NCT04398004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24900005|NCT04398004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24900006|NCT04398004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24900007|NCT04398004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900008|NCT04398004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900009|NCT04398004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24900010|NCT04398004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24900011|NCT04397770|Temozolomide|temozolomide|mesh-list
24900012|NCT04397770|Apatinib|apatinib|mesh-list
24900013|NCT04397770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24900014|NCT04397770|Alkylating Agents|alkylating agents|mesh-ancestor
24900035|NCT04397653|Ezetimibe|ezetimibe|mesh-list
24900054|NCT04397692|Nitric Oxide|nitric oxide|mesh-list
24900055|NCT04397692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24900057|NCT04397692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24900058|NCT04397692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900059|NCT04397692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24900060|NCT04397692|Respiratory System Agents|respiratory system agents|mesh-ancestor
24900061|NCT04397692|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24900062|NCT04397692|Antioxidants|antioxidants|mesh-ancestor
24476815|NCT00416637|Bevacizumab|bevacizumab|mesh-list
24476816|NCT00416637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24476817|NCT00416637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476818|NCT00416637|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24476819|NCT00416637|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24476820|NCT00416637|Growth Substances|growth substances|mesh-ancestor
24476821|NCT00416637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476822|NCT00416637|Growth Inhibitors|growth inhibitors|mesh-ancestor
24476823|NCT00416650|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24518507|NCT04908605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24900102|NCT04397458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24900103|NCT04397458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900105|NCT04397458|Glucocorticoids|glucocorticoids|mesh-ancestor
24900106|NCT04397458|Hormones|hormones|mesh-ancestor
24900158|NCT04397328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900159|NCT04397328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900160|NCT04397328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24900161|NCT04396990|Prednisolone|prednisolone|mesh-list
24900162|NCT04396990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24817934|NCT02086032|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24817935|NCT02086032|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24817936|NCT02086032|Estradiol|estradiol|mesh-list
24817937|NCT02086032|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25063631|NCT03467178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25063632|NCT03467178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063633|NCT03467178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25063634|NCT03467178|Immunologic Factors|immunologic factors|mesh-ancestor
25063635|NCT03467178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063636|NCT03467178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24817939|NCT02086032|Progesterone|progesterone|mesh-list
24817940|NCT02086032|Dydrogesterone|dydrogesterone|mesh-list
24817941|NCT02086032|Hormones|hormones|mesh-ancestor
24817942|NCT02086032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24817943|NCT02086032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900207|NCT04396977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24900208|NCT04396977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900209|NCT04396977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900210|NCT04396457|Pembrolizumab|pembrolizumab|mesh-list
24900211|NCT04396457|Pemetrexed|pemetrexed|mesh-list
24900217|NCT04396457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24900220|NCT04396548|Midodrine|midodrine|mesh-list
24900221|NCT04396548|Anesthetics|anesthetics|mesh-list
24900222|NCT04396548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24900223|NCT04396548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900224|NCT04396548|Sympathomimetics|sympathomimetics|mesh-ancestor
24900225|NCT04396548|Autonomic Agents|autonomic agents|mesh-ancestor
24900226|NCT04396548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24900227|NCT04396548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24900228|NCT04396548|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24900229|NCT04396548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24900230|NCT04396548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24900231|NCT04396548|Adrenergic Agents|adrenergic agents|mesh-ancestor
24900232|NCT04396548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24900233|NCT04396548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900234|NCT04396223|Methotrexate|methotrexate|mesh-list
24900235|NCT04396223|Avelumab|avelumab|mesh-list
24900236|NCT04396223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24900237|NCT04396223|Abortifacient Agents|abortifacient agents|mesh-ancestor
24900238|NCT04396223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24900241|NCT04396223|Antimetabolites|antimetabolites|mesh-ancestor
24900272|NCT04395768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24900273|NCT04395768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24900274|NCT04395768|Antimalarials|antimalarials|mesh-ancestor
24900275|NCT04395768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24900276|NCT04395768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24900277|NCT04395768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900278|NCT04395768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24900279|NCT04395768|Antioxidants|antioxidants|mesh-ancestor
24900283|NCT04395989|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24900284|NCT04395989|Capecitabine|capecitabine|mesh-list
24900285|NCT04395989|Everolimus|everolimus|mesh-list
24900286|NCT04395989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24900287|NCT04395989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24900288|NCT04395989|Tubulin Modulators|tubulin modulators|mesh-ancestor
24900289|NCT04395989|Antimitotic Agents|antimitotic agents|mesh-ancestor
24900290|NCT04395989|Mitosis Modulators|mitosis modulators|mesh-ancestor
24900291|NCT04395989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900292|NCT04395989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24900301|NCT04395612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24900302|NCT04395638|Vitamin D|vitamin d|mesh-list
24900303|NCT04395638|Ergocalciferols|ergocalciferols|mesh-list
24900304|NCT04395638|Cholecalciferol|cholecalciferol|mesh-list
24900305|NCT04395638|Vitamins|vitamins|mesh-list
24900334|NCT04395105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24900335|NCT04395105|Glucocorticoids|glucocorticoids|mesh-ancestor
24900336|NCT04395105|Hormones|hormones|mesh-ancestor
24900337|NCT04395105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24900338|NCT04395105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24900339|NCT04395105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24723286|NCT01586442|Eplerenone|eplerenone|mesh-list
24900340|NCT04394975|Sunitinib|sunitinib|mesh-list
24900341|NCT04394975|Axitinib|axitinib|mesh-list
24817970|NCT02086188|Urological Agents|urological agents|mesh-ancestor
25699316|NCT02105415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24817971|NCT02086227|Glucagon|glucagon|mesh-list
24817972|NCT02086227|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25699317|NCT02105415|Anesthetics, General|anesthetics, general|mesh-ancestor
24817973|NCT02086227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24817975|NCT02086227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24817976|NCT02086227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817977|NCT02086227|Incretins|incretins|mesh-ancestor
24817978|NCT02086253|BQ 788|bq 788|mesh-list
24817979|NCT02086253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24817980|NCT02086253|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24817982|NCT02086253|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
24817988|NCT02086292|Anesthetics|anesthetics|mesh-ancestor
25063640|NCT03467022|Vitamins|vitamins|mesh-ancestor
25063641|NCT03467022|Micronutrients|micronutrients|mesh-ancestor
25063642|NCT03467022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063643|NCT03467022|Antioxidants|antioxidants|mesh-ancestor
25063644|NCT03467022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063645|NCT03467022|Protective Agents|protective agents|mesh-ancestor
25063646|NCT03466983|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25063647|NCT03466983|Hematinics|hematinics|mesh-ancestor
25063648|NCT03466775|Angiotensin II|angiotensin ii|mesh-list
25063649|NCT03466775|Giapreza|giapreza|mesh-list
25063650|NCT03466775|Antibodies|antibodies|mesh-list
25063651|NCT03466775|Angiotensinogen|angiotensinogen|mesh-list
24826130|NCT02132416|Antipyretics|antipyretics|mesh-ancestor
24826131|NCT02132442|Vitamin D|vitamin d|mesh-list
24826132|NCT02132442|Ergocalciferols|ergocalciferols|mesh-list
24817989|NCT02086292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24817990|NCT02086292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817991|NCT02086292|Sensory System Agents|sensory system agents|mesh-ancestor
24817992|NCT02086292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24817993|NCT02086292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24817994|NCT02086292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24817995|NCT02086292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24817996|NCT02086292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24817997|NCT02086292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817999|NCT02086409|Vitamin D|vitamin d|mesh-list
24818001|NCT02086409|Cholecalciferol|cholecalciferol|mesh-list
24818002|NCT02086409|Vitamins|vitamins|mesh-list
24818003|NCT02086409|Calcium|calcium|mesh-list
24818004|NCT02086409|Micronutrients|micronutrients|mesh-ancestor
24818005|NCT02086409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818006|NCT02086409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24818007|NCT02086409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24818008|NCT02086474|Bupivacaine|bupivacaine|mesh-list
24900360|NCT04394897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900361|NCT04394897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24900362|NCT04394897|Anesthetics, General|anesthetics, general|mesh-ancestor
24900363|NCT04394897|Anesthetics|anesthetics|mesh-ancestor
24900364|NCT04394897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24900365|NCT04394897|Narcotics|narcotics|mesh-ancestor
24900366|NCT04394897|Analgesics|analgesics|mesh-ancestor
24900367|NCT04394897|Sensory System Agents|sensory system agents|mesh-ancestor
24697333|NCT01434160|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24900368|NCT04394897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24900369|NCT04394728|Trabectedin|trabectedin|mesh-list
24900370|NCT04394728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24900371|NCT04394728|Alkylating Agents|alkylating agents|mesh-ancestor
24900372|NCT04394728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900373|NCT04394728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24900374|NCT04394598|Capecitabine|capecitabine|mesh-list
24900375|NCT04394598|Irinotecan|irinotecan|mesh-list
24900376|NCT04394598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24900377|NCT04394598|Antimetabolites|antimetabolites|mesh-ancestor
24900378|NCT04394598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900379|NCT04394598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24900380|NCT04394598|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24900381|NCT04394598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24900382|NCT04394598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900383|NCT04394533|Bupivacaine|bupivacaine|mesh-list
24900384|NCT04394533|Prilocaine|prilocaine|mesh-list
24900385|NCT04394533|Anesthetics, Local|anesthetics, local|mesh-ancestor
25063657|NCT03466775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063658|NCT03466775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063659|NCT03466749|Paclitaxel|paclitaxel|mesh-list
25063660|NCT03466749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25063661|NCT03466749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063662|NCT03466749|Tubulin Modulators|tubulin modulators|mesh-ancestor
24900402|NCT04394442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24900403|NCT04394442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635387|NCT01138852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24635388|NCT01138852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24900404|NCT04394442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900405|NCT04394442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24900406|NCT04394390|Vitamin D|vitamin d|mesh-list
24900407|NCT04394390|Ergocalciferols|ergocalciferols|mesh-list
24900408|NCT04394390|Cholecalciferol|cholecalciferol|mesh-list
24900409|NCT04394390|Vitamins|vitamins|mesh-list
24900410|NCT04394390|Micronutrients|micronutrients|mesh-ancestor
24900411|NCT04394390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900412|NCT04394390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24594945|NCT00936195|Protease Inhibitors|protease inhibitors|mesh-ancestor
24594946|NCT00936195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900413|NCT04394390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24900419|NCT04394377|Heparin|heparin|mesh-list
24900420|NCT04394377|Enoxaparin|enoxaparin|mesh-list
24900421|NCT04394377|Calcium heparin|calcium heparin|mesh-list
24900422|NCT04394377|Rivaroxaban|rivaroxaban|mesh-list
24900423|NCT04394377|Enoxaparin sodium|enoxaparin sodium|mesh-list
24900424|NCT04394377|Anticoagulants|anticoagulants|mesh-ancestor
24900425|NCT04394377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24900426|NCT04394377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24900427|NCT04394377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900428|NCT04394377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24900429|NCT04394377|Antithrombins|antithrombins|mesh-ancestor
24900443|NCT04393805|Tinzaparin|tinzaparin|mesh-list
24900444|NCT04393805|Dalteparin|dalteparin|mesh-list
24900445|NCT04393805|Anticoagulants|anticoagulants|mesh-ancestor
24900446|NCT04393805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24900447|NCT04393805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24900449|NCT04393792|Povidone-Iodine|povidone-iodine|mesh-list
24900460|NCT04393610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24900461|NCT04393610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900463|NCT04393610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24900464|NCT04393610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24900465|NCT04393610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24900466|NCT04393610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24900480|NCT04393506|Apatinib|apatinib|mesh-list
24900481|NCT04393506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24900482|NCT04393506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24900483|NCT04393506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24900484|NCT04393506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900485|NCT04393506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900486|NCT04393584|Leucovorin|leucovorin|mesh-list
25063664|NCT03466749|Mitosis Modulators|mitosis modulators|mesh-ancestor
25063665|NCT03466749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063666|NCT03466736|Flutemetamol|flutemetamol|mesh-list
24948120|NCT03922815|Fentanyl|fentanyl|mesh-list
25063667|NCT03466736|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24855627|NCT02280239|Analgesics|analgesics|mesh-ancestor
24900688|NCT04391998|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25063668|NCT03466736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063671|NCT03466645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25063672|NCT03466645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25063673|NCT03466632|Dexmedetomidine|dexmedetomidine|mesh-list
25063674|NCT03466632|Propofol|propofol|mesh-list
25063675|NCT03466632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25063676|NCT03466632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25063677|NCT03466632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699318|NCT02105415|Anesthetics|anesthetics|mesh-ancestor
25699319|NCT02105415|Analgesics|analgesics|mesh-ancestor
25063678|NCT03466632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25063679|NCT03466632|Anesthetics, General|anesthetics, general|mesh-ancestor
25699320|NCT02105415|Sensory System Agents|sensory system agents|mesh-ancestor
25699321|NCT02105415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699322|NCT02105415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25699323|NCT02105415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24900487|NCT04393584|Docetaxel|docetaxel|mesh-list
24900488|NCT04393584|Oxaliplatin|oxaliplatin|mesh-list
24900489|NCT04393584|Irinotecan|irinotecan|mesh-list
24900490|NCT04393584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24900491|NCT04393584|Tubulin Modulators|tubulin modulators|mesh-ancestor
24900492|NCT04393584|Antimitotic Agents|antimitotic agents|mesh-ancestor
24900493|NCT04393584|Mitosis Modulators|mitosis modulators|mesh-ancestor
24900494|NCT04393584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900495|NCT04393584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24900496|NCT04393584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24900497|NCT04393584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900498|NCT04393584|Antidotes|antidotes|mesh-ancestor
24900499|NCT04393584|Protective Agents|protective agents|mesh-ancestor
24900500|NCT04393584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900501|NCT04393584|Vitamin B Complex|vitamin b complex|mesh-ancestor
24518510|NCT04908605|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24518511|NCT04908605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24518512|NCT04908605|Adrenergic Agents|adrenergic agents|mesh-ancestor
25063680|NCT03466632|Anesthetics|anesthetics|mesh-ancestor
25063681|NCT03466632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25063682|NCT03466632|Analgesics|analgesics|mesh-ancestor
25063683|NCT03466632|Sensory System Agents|sensory system agents|mesh-ancestor
25063684|NCT03466632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25063685|NCT03466632|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25063686|NCT03466632|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25063687|NCT03466632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25063688|NCT03466632|Adrenergic Agents|adrenergic agents|mesh-ancestor
25063689|NCT03466632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25063690|NCT03466632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063691|NCT03466567|Cyclosporine|cyclosporine|mesh-list
25063693|NCT03466567|Cyclosporins|cyclosporins|mesh-list
25063694|NCT03466567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063695|NCT03466567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063696|NCT03466567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25063697|NCT03466567|Immunologic Factors|immunologic factors|mesh-ancestor
24596090|NCT00941499|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25063698|NCT03466567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063699|NCT03466567|Antifungal Agents|antifungal agents|mesh-ancestor
25063700|NCT03466567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25063701|NCT03466567|Dermatologic Agents|dermatologic agents|mesh-ancestor
25063702|NCT03466567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25063703|NCT03466567|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25063704|NCT03466567|Uricosuric Agents|uricosuric agents|mesh-ancestor
25063728|NCT03466502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25063729|NCT03466437|Methamphetamine|methamphetamine|mesh-list
25063730|NCT03466437|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25063731|NCT03466437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063732|NCT03466437|Sympathomimetics|sympathomimetics|mesh-ancestor
25063733|NCT03466437|Autonomic Agents|autonomic agents|mesh-ancestor
25063734|NCT03466437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25063735|NCT03466437|Dopamine Agents|dopamine agents|mesh-ancestor
25063736|NCT03466437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25063737|NCT03466437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063738|NCT03466437|Adrenergic Agents|adrenergic agents|mesh-ancestor
25063739|NCT03466437|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25063740|NCT03466437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25063741|NCT03466437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24518513|NCT04908605|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24518514|NCT04908605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24518515|NCT04908605|Serotonin Agents|serotonin agents|mesh-ancestor
24518516|NCT04908605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24518517|NCT04901689|Leronlimab|leronlimab|mesh-list
24518518|NCT04901689|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24518519|NCT04901689|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24518520|NCT04901689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900550|NCT04393025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24900551|NCT04392973|Hydroxychloroquine|hydroxychloroquine|mesh-list
24900552|NCT04392973|Favipiravir|favipiravir|mesh-list
24900553|NCT04392973|Antimalarials|antimalarials|mesh-ancestor
24900554|NCT04392973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24900555|NCT04392973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24900556|NCT04392973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24900557|NCT04392973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900558|NCT04392973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518552|NCT04871412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25063742|NCT03466437|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24948225|NCT03921775|Anesthetics, General|anesthetics, general|mesh-ancestor
24948227|NCT03921086|Antihypertensive Agents|antihypertensive agents|mesh-list
24948228|NCT03921177|Micronutrients|micronutrients|mesh-list
24948229|NCT03921177|Trace Elements|trace elements|mesh-list
24596603|NCT00944463|Gemcitabine|gemcitabine|mesh-list
24948230|NCT03921177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948231|NCT03921034|Ropivacaine|ropivacaine|mesh-list
24948232|NCT03921034|Anesthetics, Local|anesthetics, local|mesh-ancestor
24948233|NCT03921034|Anesthetics|anesthetics|mesh-ancestor
24948234|NCT03921034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24948235|NCT03921034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948236|NCT03921034|Sensory System Agents|sensory system agents|mesh-ancestor
24948237|NCT03921034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25063743|NCT03466359|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
25063744|NCT03466359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063745|NCT03466359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063747|NCT03466333|Enalaprilat|enalaprilat|mesh-list
25063748|NCT03466333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063749|NCT03466333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063750|NCT03466333|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25063755|NCT03466320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25063756|NCT03466320|Immunologic Factors|immunologic factors|mesh-ancestor
25063757|NCT03466320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063758|NCT03466320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24900581|NCT04392648|Bortezomib|bortezomib|mesh-list
25063770|NCT03466242|Analgesics|analgesics|mesh-ancestor
25063771|NCT03466242|Sensory System Agents|sensory system agents|mesh-ancestor
25063772|NCT03466242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25063773|NCT03466242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24826265|NCT02133755|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24826266|NCT02133755|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24826267|NCT02133755|Hormone Antagonists|hormone antagonists|mesh-ancestor
24826268|NCT02133755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24826269|NCT02133755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826270|NCT02133755|Dopamine Agonists|dopamine agonists|mesh-ancestor
24826271|NCT02133755|Dopamine Agents|dopamine agents|mesh-ancestor
24826272|NCT02133755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24900675|NCT04392037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24900676|NCT04392037|Antiemetics|antiemetics|mesh-ancestor
24900677|NCT04392037|Autonomic Agents|autonomic agents|mesh-ancestor
24900678|NCT04392037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24900679|NCT04392037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24900680|NCT04392037|Glucocorticoids|glucocorticoids|mesh-ancestor
24900681|NCT04392037|Hormones|hormones|mesh-ancestor
24657276|NCT01266681|Amiodarone|amiodarone|mesh-list
24657289|NCT01266681|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24900682|NCT04392037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24900683|NCT04392037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24900684|NCT04391998|Metronidazole|metronidazole|mesh-list
24900685|NCT04391998|Albendazole|albendazole|mesh-list
24900686|NCT04391998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24900687|NCT04391998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24900690|NCT04391998|Anthelmintics|anthelmintics|mesh-ancestor
25063787|NCT03466216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25063788|NCT03466216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063790|NCT03466021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25063791|NCT03466021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063792|NCT03466021|Incretins|incretins|mesh-ancestor
25063793|NCT03466021|Hormones|hormones|mesh-ancestor
25063794|NCT03466021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25063795|NCT03465969|Tacrolimus|tacrolimus|mesh-list
25063796|NCT03465969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25063797|NCT03465969|Immunologic Factors|immunologic factors|mesh-ancestor
25063798|NCT03465969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063799|NCT03465969|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25063800|NCT03465969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25699324|NCT02105415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25699325|NCT02105415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25063801|NCT03465969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900727|NCT04391621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900742|NCT04391764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25063828|NCT03465488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25063830|NCT03465488|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25063831|NCT03465488|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25063832|NCT03465488|Tubulin Modulators|tubulin modulators|mesh-ancestor
25063833|NCT03465488|Antimitotic Agents|antimitotic agents|mesh-ancestor
25063834|NCT03465488|Mitosis Modulators|mitosis modulators|mesh-ancestor
25063835|NCT03465488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063836|NCT03465488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063837|NCT03465423|Propofol|propofol|mesh-list
24826317|NCT02133989|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24826320|NCT02134002|Disulfiram|disulfiram|mesh-list
24477502|NCT00418860|Sensory System Agents|sensory system agents|mesh-ancestor
24518600|NCT04785651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24518601|NCT04785651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518602|NCT04785651|Hemostatics|hemostatics|mesh-ancestor
24518603|NCT04785651|Coagulants|coagulants|mesh-ancestor
24518604|NCT04721548|Minoxidil|minoxidil|mesh-list
24518605|NCT04721548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24518606|NCT04721548|Vasodilator Agents|vasodilator agents|mesh-ancestor
24518607|NCT04675866|Paclitaxel|paclitaxel|mesh-list
24518608|NCT04675866|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24518609|NCT04675866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24518610|NCT04675866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24518611|NCT04675866|Tubulin Modulators|tubulin modulators|mesh-ancestor
24518613|NCT04675866|Mitosis Modulators|mitosis modulators|mesh-ancestor
24518614|NCT04675866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518641|NCT04623944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24518642|NCT04623944|Antimetabolites|antimetabolites|mesh-ancestor
24518643|NCT04623944|Antiviral Agents|antiviral agents|mesh-ancestor
24518644|NCT04623944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24518655|NCT04607460|Coal Tar|coal tar|mesh-list
24900730|NCT04391621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063838|NCT03465423|Anesthetics|anesthetics|mesh-ancestor
25063839|NCT03465423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25063840|NCT03465423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063841|NCT03465423|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25063842|NCT03465423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25063843|NCT03465423|Anesthetics, General|anesthetics, general|mesh-ancestor
25063844|NCT03465410|Tacrolimus|tacrolimus|mesh-list
25063845|NCT03465410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25063846|NCT03465410|Immunologic Factors|immunologic factors|mesh-ancestor
25063847|NCT03465410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063848|NCT03465410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25063849|NCT03465410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063850|NCT03465410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826350|NCT02134093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24900731|NCT04391621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900732|NCT04391660|Ethanol|ethanol|mesh-list
24900733|NCT04391660|Sodium Hypochlorite|sodium hypochlorite|mesh-list
24900735|NCT04391660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24900736|NCT04391660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24900737|NCT04391660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24900738|NCT04391660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24900739|NCT04391660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900740|NCT04391660|Disinfectants|disinfectants|mesh-ancestor
24900741|NCT04391764|Naltrexone|naltrexone|mesh-list
24900743|NCT04391764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24900744|NCT04391764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900745|NCT04391764|Sensory System Agents|sensory system agents|mesh-ancestor
24900746|NCT04391764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24900748|NCT04391569|Neurosteroids|neurosteroids|mesh-ancestor
24900749|NCT04391569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24818030|NCT02086656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24900761|NCT04391478|Urological Agents|urological agents|mesh-ancestor
24900762|NCT04391478|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24900763|NCT04391478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24900764|NCT04391478|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24900793|NCT04391361|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25407300|NCT03508921|Renal Agents|renal agents|mesh-ancestor
24900795|NCT04391361|Cholinergic Agents|cholinergic agents|mesh-ancestor
24900796|NCT04391361|Antiemetics|antiemetics|mesh-ancestor
24900797|NCT04391361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24900798|NCT04391361|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24900799|NCT04391361|Antioxidants|antioxidants|mesh-ancestor
24900800|NCT04391361|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24900801|NCT04391361|Protective Agents|protective agents|mesh-ancestor
24900802|NCT04391231|Pentoxifylline|pentoxifylline|mesh-list
24900803|NCT04391231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24900804|NCT04391231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900805|NCT04391231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900806|NCT04391231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24900807|NCT04391231|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24900808|NCT04391231|Protective Agents|protective agents|mesh-ancestor
24900809|NCT04391231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900810|NCT04391231|Vasodilator Agents|vasodilator agents|mesh-ancestor
24900811|NCT04391231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24900812|NCT04391231|Antioxidants|antioxidants|mesh-ancestor
24900813|NCT04391283|Osimertinib|osimertinib|mesh-list
24900823|NCT04391127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24900824|NCT04391127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900826|NCT04391127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24900833|NCT04390984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24900834|NCT04390984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900835|NCT04390984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900837|NCT04390854|Miconazole|miconazole|mesh-list
24900838|NCT04390854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24900839|NCT04390854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24900840|NCT04390854|Antifungal Agents|antifungal agents|mesh-ancestor
24900841|NCT04390854|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24900842|NCT04390854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24900843|NCT04390854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900844|NCT04390854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900845|NCT04390854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24900846|NCT04390854|Hormone Antagonists|hormone antagonists|mesh-ancestor
24900847|NCT04390854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24900848|NCT04390854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900849|NCT04390854|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25063860|NCT03465345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063862|NCT03465345|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25063863|NCT03465345|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25063864|NCT03465345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25063865|NCT03465202|Capecitabine|capecitabine|mesh-list
24900850|NCT04390854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24900851|NCT04390815|Insulin|insulin|mesh-list
24657426|NCT01267305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900852|NCT04390815|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24900853|NCT04390815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24900854|NCT04390815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900855|NCT04390464|Ravulizumab|ravulizumab|mesh-list
24900856|NCT04390464|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24900857|NCT04390464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24900858|NCT04390464|Immunologic Factors|immunologic factors|mesh-ancestor
24900859|NCT04390464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900860|NCT04390685|Tacrolimus|tacrolimus|mesh-list
24900861|NCT04390685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24900862|NCT04390685|Immunologic Factors|immunologic factors|mesh-ancestor
24900863|NCT04390685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900864|NCT04390685|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24900865|NCT04390685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598291|NCT00955149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24598368|NCT00955773|Everolimus|everolimus|mesh-list
24900874|NCT04391439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24900875|NCT04391439|Antiemetics|antiemetics|mesh-ancestor
24900876|NCT04391439|Autonomic Agents|autonomic agents|mesh-ancestor
24900877|NCT04391439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24900878|NCT04391439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900879|NCT04391439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24900885|NCT04391439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24900886|NCT04391439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24900887|NCT04390334|Efavirenz|efavirenz|mesh-list
24900888|NCT04390334|Famotidine|famotidine|mesh-list
24900889|NCT04390334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24900901|NCT04390334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24477696|NCT00419718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900910|NCT04390594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24900912|NCT04390594|Sensory System Agents|sensory system agents|mesh-ancestor
24900913|NCT04390594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24900914|NCT04390594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900915|NCT04390594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24900916|NCT04390594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24900917|NCT04390594|Anticoagulants|anticoagulants|mesh-ancestor
24900918|NCT04390594|Protease Inhibitors|protease inhibitors|mesh-ancestor
24900919|NCT04390594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900920|NCT04390594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900921|NCT04390594|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24900922|NCT04390594|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24900923|NCT04390594|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24900924|NCT04390594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24900925|NCT04390594|Immunologic Factors|immunologic factors|mesh-ancestor
24900926|NCT04390295|Metformin|metformin|mesh-list
24900927|NCT04390295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24900928|NCT04390295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900931|NCT04390061|Hydroxychloroquine|hydroxychloroquine|mesh-list
24900932|NCT04390061|Tofacitinib|tofacitinib|mesh-list
24900933|NCT04390061|Antimalarials|antimalarials|mesh-ancestor
24900934|NCT04390061|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25063877|NCT03465085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25063878|NCT03465085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25063879|NCT03465085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063880|NCT03465059|Zanubrutinib|zanubrutinib|mesh-list
25063881|NCT03465059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25063882|NCT03465059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24900937|NCT04390061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900938|NCT04390061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900939|NCT04390061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24818060|NCT02086903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24818061|NCT02086903|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24818062|NCT02086903|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24818064|NCT02086903|Purinergic Agents|purinergic agents|mesh-ancestor
24818065|NCT02086903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24818066|NCT02086903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818067|NCT02086903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818068|NCT02086929|Trazodone|trazodone|mesh-list
24818069|NCT02086929|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24818070|NCT02086929|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24818071|NCT02086929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24818072|NCT02086929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24657215|NCT01266213|Goserelin|goserelin|mesh-list
24598616|NCT00957060|Hormones|hormones|mesh-ancestor
24818073|NCT02086929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818074|NCT02086929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25063885|NCT03465007|Hydrocortisone|hydrocortisone|mesh-list
25063886|NCT03465007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25063887|NCT03464968|Leucovorin|leucovorin|mesh-list
25063888|NCT03464968|Oxaliplatin|oxaliplatin|mesh-list
25063889|NCT03464968|Irinotecan|irinotecan|mesh-list
25063890|NCT03464968|Fluorouracil|fluorouracil|mesh-list
25063891|NCT03464968|Levoleucovorin|levoleucovorin|mesh-list
25063892|NCT03464968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24900942|NCT04389866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24900943|NCT04389866|Immunologic Factors|immunologic factors|mesh-ancestor
24900944|NCT04389866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900945|NCT04389866|Viscosupplements|viscosupplements|mesh-ancestor
24900946|NCT04389866|Protective Agents|protective agents|mesh-ancestor
24900947|NCT04390152|Ritonavir|ritonavir|mesh-list
24900948|NCT04390152|Lopinavir|lopinavir|mesh-list
24900949|NCT04390152|Azithromycin|azithromycin|mesh-list
24900950|NCT04390152|Hydroxychloroquine|hydroxychloroquine|mesh-list
24900951|NCT04390152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24900952|NCT04390152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24900953|NCT04390152|Protease Inhibitors|protease inhibitors|mesh-ancestor
24900954|NCT04390152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900955|NCT04390152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900956|NCT04390152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24900957|NCT04390152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24900958|NCT04390152|Antiviral Agents|antiviral agents|mesh-ancestor
24900959|NCT04390152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24900982|NCT04389554|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24900983|NCT04389554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24900984|NCT04389554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900986|NCT04389554|Coagulants|coagulants|mesh-ancestor
24900987|NCT04389567|Famotidine|famotidine|mesh-list
24900988|NCT04389567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24900989|NCT04389567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24900990|NCT04389567|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24900991|NCT04389567|Histamine Antagonists|histamine antagonists|mesh-ancestor
24518677|NCT04559906|Sensory System Agents|sensory system agents|mesh-ancestor
24518678|NCT04559906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25063894|NCT03464968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25063896|NCT03464968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063897|NCT03464968|Antidotes|antidotes|mesh-ancestor
25063898|NCT03464968|Protective Agents|protective agents|mesh-ancestor
25063899|NCT03464968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063900|NCT03464968|Vitamin B Complex|vitamin b complex|mesh-ancestor
25063901|NCT03464968|Vitamins|vitamins|mesh-ancestor
25063902|NCT03464968|Micronutrients|micronutrients|mesh-ancestor
25063903|NCT03464968|Antimetabolites|antimetabolites|mesh-ancestor
25063904|NCT03464968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25063905|NCT03464968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25063906|NCT03464968|Immunologic Factors|immunologic factors|mesh-ancestor
25063907|NCT03464864|Treprostinil|treprostinil|mesh-list
24900992|NCT04389567|Histamine Agents|histamine agents|mesh-ancestor
24599389|NCT04619082|Tenofovir|tenofovir|mesh-list
24600078|NCT02711137|Immunologic Factors|immunologic factors|mesh-ancestor
24600079|NCT02711137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600080|NCT02711137|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24600081|NCT02703584|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24900993|NCT04389567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24900994|NCT04389567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900995|NCT04389567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900996|NCT04389801|Deferoxamine|deferoxamine|mesh-list
24900997|NCT04389801|Siderophores|siderophores|mesh-ancestor
24900998|NCT04389801|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24900999|NCT04389801|Chelating Agents|chelating agents|mesh-ancestor
24901000|NCT04389801|Sequestering Agents|sequestering agents|mesh-ancestor
24901001|NCT04389801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901002|NCT04389580|Tamoxifen|tamoxifen|mesh-list
24901003|NCT04389580|Isotretinoin|isotretinoin|mesh-list
24901004|NCT04389580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24901005|NCT04389580|Hormone Antagonists|hormone antagonists|mesh-ancestor
24600325|NCT01026220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901019|NCT04389424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24901020|NCT04389424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477777|NCT00419991|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24518692|NCT04524130|Sensory System Agents|sensory system agents|mesh-ancestor
24901068|NCT04389229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901069|NCT04389229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24901070|NCT04389229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24901071|NCT04389229|Alkylating Agents|alkylating agents|mesh-ancestor
24901092|NCT04388774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901093|NCT04388709|Interferons|interferons|mesh-list
24901094|NCT04388709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24901095|NCT04388709|Antiviral Agents|antiviral agents|mesh-ancestor
24901096|NCT04388709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24901097|NCT04388176|Compound 21|compound 21|mesh-list
24901098|NCT04388176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24901100|NCT04388904|Emtricitabine|emtricitabine|mesh-list
24901101|NCT04388904|Darunavir|darunavir|mesh-list
24901102|NCT04388904|Cobicistat|cobicistat|mesh-list
24901103|NCT04388904|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
24901104|NCT04388904|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
24901105|NCT04388904|Antiviral Agents|antiviral agents|mesh-ancestor
24901120|NCT04388202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24901121|NCT04388202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24901122|NCT04388202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24901123|NCT04388202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901124|NCT04388202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24901125|NCT04388202|Serotonin Agents|serotonin agents|mesh-ancestor
24534574|NCT00647634|GABA Modulators|gaba modulators|mesh-ancestor
24901126|NCT04388202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901127|NCT04388202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24901128|NCT04388202|Antidepressive Agents|antidepressive agents|mesh-ancestor
24901129|NCT04388202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24901131|NCT04388124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24901132|NCT04388124|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24901133|NCT04388124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901134|NCT04388189|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24901147|NCT04388189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24901148|NCT04388189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901149|NCT04388189|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24901150|NCT04388189|Analgesics|analgesics|mesh-ancestor
24901151|NCT04388189|Sensory System Agents|sensory system agents|mesh-ancestor
24901152|NCT04388189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24901153|NCT04388111|Morphine|morphine|mesh-list
24477911|NCT00420693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477912|NCT00420797|Phenylephrine|phenylephrine|mesh-list
24478120|NCT00421512|Growth Inhibitors|growth inhibitors|mesh-ancestor
25063925|NCT03464682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25063926|NCT03464682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063927|NCT03464656|Antioxidants|antioxidants|mesh-list
25063928|NCT03464656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063929|NCT03464656|Protective Agents|protective agents|mesh-ancestor
25063930|NCT03464656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063931|NCT03464552|Celecoxib|celecoxib|mesh-list
24826419|NCT02134327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24477913|NCT00420797|Oxymetazoline|oxymetazoline|mesh-list
24518763|NCT04372927|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24518764|NCT04372927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24518765|NCT04372927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24518766|NCT04372927|Immunologic Factors|immunologic factors|mesh-ancestor
24518767|NCT04372927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518768|NCT04372927|Keratolytic Agents|keratolytic agents|mesh-ancestor
24518769|NCT04372927|Dermatologic Agents|dermatologic agents|mesh-ancestor
24518770|NCT04372927|Tubulin Modulators|tubulin modulators|mesh-ancestor
24518771|NCT04372927|Antimitotic Agents|antimitotic agents|mesh-ancestor
24518772|NCT04372927|Mitosis Modulators|mitosis modulators|mesh-ancestor
24518773|NCT04356599|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24518774|NCT04356599|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24518775|NCT04356599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518777|NCT04291703|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24518778|NCT04291703|Immunologic Factors|immunologic factors|mesh-ancestor
24518779|NCT04291703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518780|NCT04291703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24518782|NCT04246437|Entacapone|entacapone|mesh-list
24518783|NCT04246437|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24518799|NCT04186442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24901156|NCT04388111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24901157|NCT04388111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901158|NCT04388111|Analgesics|analgesics|mesh-ancestor
24901159|NCT04388111|Sensory System Agents|sensory system agents|mesh-ancestor
24901160|NCT04388111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24901161|NCT04387786|Albuterol|albuterol|mesh-list
24901162|NCT04387786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24901163|NCT04387786|Autonomic Agents|autonomic agents|mesh-ancestor
24901164|NCT04387786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24477922|NCT00420797|Respiratory System Agents|respiratory system agents|mesh-ancestor
24477923|NCT00420797|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24477924|NCT00420797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24477925|NCT00420797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24477926|NCT00420797|Adrenergic Agents|adrenergic agents|mesh-ancestor
24477927|NCT00420797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24477929|NCT00420797|Protective Agents|protective agents|mesh-ancestor
24518800|NCT04186442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518801|NCT04186442|Cholinergic Agents|cholinergic agents|mesh-ancestor
24518802|NCT04186442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24518803|NCT04186442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518804|NCT04186442|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24518805|NCT04186442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24518806|NCT04177953|Carboplatin|carboplatin|mesh-list
24518808|NCT04177953|Pemetrexed|pemetrexed|mesh-list
24451782|NCT00324779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25063939|NCT03464552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25063940|NCT03464552|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25063941|NCT03464552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25063942|NCT03464552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25063943|NCT03464552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063944|NCT03464539|Chitosan|chitosan|mesh-list
25063945|NCT03464539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24826428|NCT02134366|Clonazepam|clonazepam|mesh-list
24518849|NCT04145076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518853|NCT04145076|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24518855|NCT04133948|Ipilimumab|ipilimumab|mesh-list
24901165|NCT04387786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901166|NCT04387786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24901167|NCT04387786|Respiratory System Agents|respiratory system agents|mesh-ancestor
24901168|NCT04387786|Tocolytic Agents|tocolytic agents|mesh-ancestor
24901169|NCT04387786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24901170|NCT04387786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24901171|NCT04387786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24901172|NCT04387786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24901173|NCT04387786|Adrenergic Agents|adrenergic agents|mesh-ancestor
24901174|NCT04387786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24901175|NCT04387786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901177|NCT04387929|Immunologic Factors|immunologic factors|mesh-ancestor
24901178|NCT04387929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901179|NCT04387695|Sorafenib|sorafenib|mesh-list
24901180|NCT04387695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24901181|NCT04387695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24901182|NCT04387695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901183|NCT04387695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901187|NCT04388033|Temozolomide|temozolomide|mesh-list
24477931|NCT00420836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24477932|NCT00420836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24477933|NCT00420901|Sildenafil Citrate|sildenafil citrate|mesh-list
24477934|NCT00420901|Vasodilator Agents|vasodilator agents|mesh-ancestor
24477935|NCT00420901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24477936|NCT00420901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24518901|NCT04052490|Antifungal Agents|antifungal agents|mesh-ancestor
24901190|NCT04388033|Immunologic Factors|immunologic factors|mesh-ancestor
24657737|NCT01269099|Analgesics|analgesics|mesh-ancestor
24901191|NCT04388033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657216|NCT01266213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24901194|NCT04388033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063947|NCT03464539|Antimetabolites|antimetabolites|mesh-ancestor
25063948|NCT03464539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063949|NCT03464539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25063950|NCT03464539|Chelating Agents|chelating agents|mesh-ancestor
25063951|NCT03464539|Sequestering Agents|sequestering agents|mesh-ancestor
25063952|NCT03464539|Hemostatics|hemostatics|mesh-ancestor
25063953|NCT03464539|Coagulants|coagulants|mesh-ancestor
24901200|NCT04388033|Growth Inhibitors|growth inhibitors|mesh-ancestor
24901202|NCT04387604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24901203|NCT04387604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24901204|NCT04387604|Growth Substances|growth substances|mesh-ancestor
25063979|NCT03464305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25063980|NCT03464305|Analgesics|analgesics|mesh-ancestor
25063981|NCT03464305|Sensory System Agents|sensory system agents|mesh-ancestor
25063982|NCT03464305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25063983|NCT03464305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25063984|NCT03464305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25063985|NCT03464305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25063986|NCT03464305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25063987|NCT03464305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24901206|NCT04387604|Growth Inhibitors|growth inhibitors|mesh-ancestor
24901207|NCT04387604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24901209|NCT04387539|Simeprevir|simeprevir|mesh-list
24901210|NCT04387539|Antiviral Agents|antiviral agents|mesh-ancestor
24901211|NCT04387539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24901212|NCT04387539|Protease Inhibitors|protease inhibitors|mesh-ancestor
24901213|NCT04387539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901993|NCT04378972|Curcumin|curcumin|mesh-list
24901275|NCT04386850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24724290|NCT01592162|Propofol|propofol|mesh-list
25063988|NCT03464305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25063989|NCT03464305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25063990|NCT03464305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25063991|NCT03464305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24518916|NCT03929601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24518917|NCT03929601|Immunologic Factors|immunologic factors|mesh-ancestor
24518918|NCT03929601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518931|NCT03889756|Sensory System Agents|sensory system agents|mesh-ancestor
24518932|NCT03889756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24518933|NCT03889756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518934|NCT03889756|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24518961|NCT03851627|Anabolic Agents|anabolic agents|mesh-ancestor
24901291|NCT04387097|Remifentanil|remifentanil|mesh-list
24901292|NCT04387097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24863173|NCT02934529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24863174|NCT02934529|Growth Substances|growth substances|mesh-ancestor
24863175|NCT02934529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863176|NCT02934529|Growth Inhibitors|growth inhibitors|mesh-ancestor
24863177|NCT02934529|Antimetabolites|antimetabolites|mesh-ancestor
24901293|NCT04387097|Narcotics|narcotics|mesh-ancestor
24901294|NCT04387097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24901295|NCT04387097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901296|NCT04387097|Analgesics|analgesics|mesh-ancestor
24901297|NCT04387097|Sensory System Agents|sensory system agents|mesh-ancestor
24901298|NCT04387097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24901299|NCT04386499|Folic Acid|folic acid|mesh-list
24901300|NCT04386499|Resveratrol|resveratrol|mesh-list
24901301|NCT04386499|Hematinics|hematinics|mesh-ancestor
24478046|NCT00421369|Antidepressive Agents|antidepressive agents|mesh-ancestor
24478047|NCT00421369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24478048|NCT00421369|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24478049|NCT00421369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24478050|NCT00421369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24641779|NCT01175291|Levoleucovorin|levoleucovorin|mesh-list
24478051|NCT00421369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518971|NCT03773445|Golimumab|golimumab|mesh-list
24518972|NCT03773445|Antibodies|antibodies|mesh-list
24518973|NCT03773445|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24518974|NCT03773445|Immunologic Factors|immunologic factors|mesh-ancestor
24518975|NCT03773445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657768|NCT01269203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24518996|NCT03710772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518997|NCT03710772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24518998|NCT03710772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25063992|NCT03464305|Antipyretics|antipyretics|mesh-ancestor
25063993|NCT03464279|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25063994|NCT03464279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25063995|NCT03464058|Rabeprazole|rabeprazole|mesh-list
25063996|NCT03464058|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24518999|NCT03710772|Alkylating Agents|alkylating agents|mesh-ancestor
24901323|NCT04386577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25407301|NCT03508921|Antimalarials|antimalarials|mesh-ancestor
24901325|NCT04386122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24901326|NCT04386122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24901327|NCT04386122|Analgesics|analgesics|mesh-ancestor
24901328|NCT04386122|Sensory System Agents|sensory system agents|mesh-ancestor
24901329|NCT04386122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24901330|NCT04386122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901331|NCT04386122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24478056|NCT00421369|Adrenergic Agents|adrenergic agents|mesh-ancestor
24478057|NCT00421395|Epratuzumab|epratuzumab|mesh-list
24478058|NCT00421395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24478059|NCT00421395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478060|NCT00421421|Dutasteride|dutasteride|mesh-list
24478061|NCT00421421|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24519019|NCT03710772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24519020|NCT03710772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24519021|NCT03710772|Antimetabolites|antimetabolites|mesh-ancestor
24901332|NCT04386122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24901333|NCT04386447|Oxytocin|oxytocin|mesh-list
24901334|NCT04386447|Oxytocics|oxytocics|mesh-ancestor
24901335|NCT04386447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24901336|NCT04386447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901344|NCT04385719|Remdesivir|remdesivir|mesh-list
24901345|NCT04385719|Antimetabolites|antimetabolites|mesh-ancestor
24901346|NCT04385719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901347|NCT04385719|Antiviral Agents|antiviral agents|mesh-ancestor
24724361|NCT01592305|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25064000|NCT03464058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064001|NCT03464019|Etripamil|etripamil|mesh-list
25064002|NCT03464019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25064003|NCT03464019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25064004|NCT03464019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064005|NCT03464019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25064006|NCT03464019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064008|NCT03463967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25064009|NCT03463967|Antioxidants|antioxidants|mesh-ancestor
25064010|NCT03463967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064011|NCT03463967|Protective Agents|protective agents|mesh-ancestor
25064012|NCT03463967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064013|NCT03463967|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25064014|NCT03463967|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25064015|NCT03463967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826483|NCT02134470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519022|NCT03710772|Dermatologic Agents|dermatologic agents|mesh-ancestor
24519041|NCT03690089|Parasympatholytics|parasympatholytics|mesh-ancestor
24519042|NCT03690089|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24519046|NCT03690089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519048|NCT03690037|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24519049|NCT03690037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24519050|NCT03690037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863281|NCT02086552|Growth Substances|growth substances|mesh-ancestor
24863282|NCT02086552|Growth Inhibitors|growth inhibitors|mesh-ancestor
24863283|NCT02086552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519051|NCT03690037|Hemostatics|hemostatics|mesh-ancestor
24818100|NCT02086942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24818101|NCT02086942|Glucocorticoids|glucocorticoids|mesh-ancestor
24818102|NCT02086942|Hormones|hormones|mesh-ancestor
24818103|NCT02086942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25064017|NCT03463733|Hydroxyurea|hydroxyurea|mesh-list
25064018|NCT03463733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25064019|NCT03463733|Alkylating Agents|alkylating agents|mesh-ancestor
25064020|NCT03463733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064021|NCT03463733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25064022|NCT03463733|Antisickling Agents|antisickling agents|mesh-ancestor
25064023|NCT03463733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25064024|NCT03463733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25699326|NCT02105415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699327|NCT02105454|Ribavirin|ribavirin|mesh-list
24826503|NCT02134717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24826504|NCT02134717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24826505|NCT02134717|Antiviral Agents|antiviral agents|mesh-ancestor
24818104|NCT02086942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24818105|NCT02086994|Misoprostol|misoprostol|mesh-list
24818106|NCT02086994|Carbetocin|carbetocin|mesh-list
24818107|NCT02086994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24818108|NCT02086994|Abortifacient Agents|abortifacient agents|mesh-ancestor
24818109|NCT02086994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24818110|NCT02086994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818111|NCT02086994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24818112|NCT02086994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24818113|NCT02086994|Oxytocics|oxytocics|mesh-ancestor
24818114|NCT02087007|Cilostazol|cilostazol|mesh-list
24818115|NCT02087007|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24818116|NCT02087007|Autonomic Agents|autonomic agents|mesh-ancestor
24818117|NCT02087007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24818118|NCT02087007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818119|NCT02087007|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24614262|NCT01023243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24818145|NCT02087111|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24818146|NCT02087111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24724388|NCT01592526|Nicotine|nicotine|mesh-list
24901372|NCT04385836|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24813610|NCT02059655|Benzalkonium Compounds|benzalkonium compounds|mesh-list
24901373|NCT04385836|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24901374|NCT04385836|Protease Inhibitors|protease inhibitors|mesh-ancestor
24901375|NCT04385836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901376|NCT04385836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478121|NCT00421512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24478123|NCT00421512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519054|NCT03686332|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24519055|NCT03686332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519056|NCT03686332|Immunologic Factors|immunologic factors|mesh-ancestor
24901377|NCT04385654|Axitinib|axitinib|mesh-list
24901378|NCT04385654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24901379|NCT04385654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24901380|NCT04385654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901382|NCT04385563|Docetaxel|docetaxel|mesh-list
24901405|NCT04385290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901406|NCT04385290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24901407|NCT04385290|Antiviral Agents|antiviral agents|mesh-ancestor
24901408|NCT04385290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24901409|NCT04385290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24901410|NCT04385290|Immunologic Factors|immunologic factors|mesh-ancestor
24901411|NCT04385290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901412|NCT04385290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24901413|NCT04385290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24901414|NCT04385290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24901416|NCT04385290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24901417|NCT04385290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24901418|NCT04385173|Temozolomide|temozolomide|mesh-list
24901419|NCT04385173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24901420|NCT04385173|Alkylating Agents|alkylating agents|mesh-ancestor
24901421|NCT04385173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901422|NCT04385173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24901456|NCT04384666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24901457|NCT04384666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901458|NCT04384666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901459|NCT04384380|Hydroxychloroquine|hydroxychloroquine|mesh-list
24901460|NCT04384380|Antimalarials|antimalarials|mesh-ancestor
24901461|NCT04384380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24901462|NCT04384380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24657838|NCT01269333|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24901463|NCT04384380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24901464|NCT04384380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901465|NCT04384380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901483|NCT04384458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901484|NCT04384458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901485|NCT04384458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24901486|NCT04384133|Nitric Oxide|nitric oxide|mesh-list
24901487|NCT04384133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24901488|NCT04384133|Autonomic Agents|autonomic agents|mesh-ancestor
24901489|NCT04384133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24948570|NCT03918889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24948571|NCT03918889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24948572|NCT03918889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24948573|NCT03918889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24948574|NCT03918889|Adrenergic Agents|adrenergic agents|mesh-ancestor
24948575|NCT03918889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24948576|NCT03918889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826510|NCT02134886|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24826511|NCT02134886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826512|NCT02134886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24826513|NCT02134886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443449|NCT00294944|Adrenergic Agents|adrenergic agents|mesh-ancestor
24443451|NCT00294944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443452|NCT00294944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443453|NCT00294996|Doxorubicin|doxorubicin|mesh-list
24443454|NCT00294996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24901994|NCT04378972|Tramiprosate|tramiprosate|mesh-list
24901539|NCT04383717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24901540|NCT04383717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24901541|NCT04383717|Antimalarials|antimalarials|mesh-ancestor
24901542|NCT04383717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24901543|NCT04383717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24901544|NCT04383717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901545|NCT04383717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901546|NCT04383717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24901547|NCT04383717|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24901548|NCT04383717|Immunologic Factors|immunologic factors|mesh-ancestor
24901549|NCT04383717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901550|NCT04383717|Antinematodal Agents|antinematodal agents|mesh-ancestor
24901551|NCT04383717|Anthelmintics|anthelmintics|mesh-ancestor
24901552|NCT04383717|Antiviral Agents|antiviral agents|mesh-ancestor
24901553|NCT04383418|Dexmedetomidine|dexmedetomidine|mesh-list
24901619|NCT04382950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24901620|NCT04382950|Keratolytic Agents|keratolytic agents|mesh-ancestor
24901621|NCT04382950|Dermatologic Agents|dermatologic agents|mesh-ancestor
24901622|NCT04382859|Bupivacaine|bupivacaine|mesh-list
25064030|NCT03463642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064031|NCT03463642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25064032|NCT03463642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25064034|NCT03463642|Dermatologic Agents|dermatologic agents|mesh-ancestor
25064035|NCT03463564|Insulin|insulin|mesh-list
25064036|NCT03463564|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25064037|NCT03463564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25064038|NCT03463564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064039|NCT03463525|Osimertinib|osimertinib|mesh-list
25064040|NCT03463525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25064041|NCT03463525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25064042|NCT03463525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826515|NCT02134899|Everolimus|everolimus|mesh-list
24826516|NCT02134899|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
24826517|NCT02134899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708956|NCT01503502|HH-GV-678|hh-gv-678|mesh-list
25699330|NCT02105454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699331|NCT02105454|Antiviral Agents|antiviral agents|mesh-ancestor
25699332|NCT02105454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25699333|NCT02105467|Grazoprevir|grazoprevir|mesh-list
24657905|NCT01269515|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24657906|NCT01269515|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25699334|NCT02105467|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25699335|NCT02105467|Antiviral Agents|antiviral agents|mesh-ancestor
25699336|NCT02105467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24901623|NCT04382859|Anesthetics, Local|anesthetics, local|mesh-ancestor
24901624|NCT04382859|Anesthetics|anesthetics|mesh-ancestor
24901625|NCT04382859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25064043|NCT03463525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064044|NCT03463499|Hyaluronic Acid|hyaluronic acid|mesh-list
25064045|NCT03463499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25064046|NCT03463499|Immunologic Factors|immunologic factors|mesh-ancestor
25064047|NCT03463499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064048|NCT03463499|Viscosupplements|viscosupplements|mesh-ancestor
25064049|NCT03463499|Protective Agents|protective agents|mesh-ancestor
25064050|NCT03463382|Bupivacaine|bupivacaine|mesh-list
25064051|NCT03463382|Anesthetics, Local|anesthetics, local|mesh-ancestor
25064052|NCT03463382|Anesthetics|anesthetics|mesh-ancestor
25064053|NCT03463382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25064054|NCT03463382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064055|NCT03463382|Sensory System Agents|sensory system agents|mesh-ancestor
24901626|NCT04382859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901627|NCT04382859|Sensory System Agents|sensory system agents|mesh-ancestor
24901628|NCT04382859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24818174|NCT02087202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24901675|NCT04382209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24901676|NCT04382209|Narcotics|narcotics|mesh-ancestor
24901677|NCT04382209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24901678|NCT04382209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901679|NCT04382209|Analgesics|analgesics|mesh-ancestor
24901680|NCT04382209|Sensory System Agents|sensory system agents|mesh-ancestor
24901681|NCT04382209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24901682|NCT04382209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24724762|NCT01594619|Diltiazem|diltiazem|mesh-list
24901684|NCT04382300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24901685|NCT04382300|Immunologic Factors|immunologic factors|mesh-ancestor
24901686|NCT04382300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901687|NCT04382300|Leprostatic Agents|leprostatic agents|mesh-ancestor
24901688|NCT04382300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24901689|NCT04382300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24901733|NCT04382014|Sensory System Agents|sensory system agents|mesh-ancestor
25064056|NCT03463382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25064057|NCT03463317|Aspirin|aspirin|mesh-list
25064058|NCT03463317|Warfarin|warfarin|mesh-list
25064059|NCT03463317|Rivaroxaban|rivaroxaban|mesh-list
25064060|NCT03463317|Dabigatran|dabigatran|mesh-list
25064061|NCT03463317|Apixaban|apixaban|mesh-list
25064062|NCT03463317|Edoxaban|edoxaban|mesh-list
25064063|NCT03463317|Phenprocoumon|phenprocoumon|mesh-list
25064064|NCT03463317|Clopidogrel|clopidogrel|mesh-list
24902725|NCT04371146|Methylphenidate|methylphenidate|mesh-list
25064065|NCT03463317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25064066|NCT03463317|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24826530|NCT02134990|Tubulin Modulators|tubulin modulators|mesh-ancestor
24709082|NCT01503983|Oxaliplatin|oxaliplatin|mesh-list
24901734|NCT04382014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24901735|NCT04382014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901753|NCT04381234|Chelating Agents|chelating agents|mesh-ancestor
24519095|NCT03432949|Dexamethasone acetate|dexamethasone acetate|mesh-list
24519097|NCT03432949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24519098|NCT03432949|Antiemetics|antiemetics|mesh-ancestor
24519099|NCT03432949|Autonomic Agents|autonomic agents|mesh-ancestor
24519100|NCT03432949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699337|NCT02105558|Anesthetics|anesthetics|mesh-list
25699338|NCT02105558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24519101|NCT03432949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699339|NCT02105558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699340|NCT02105662|Grazoprevir|grazoprevir|mesh-list
25699341|NCT02105662|Antiviral Agents|antiviral agents|mesh-ancestor
25699342|NCT02105662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25699343|NCT02105688|Grazoprevir|grazoprevir|mesh-list
25699344|NCT02105688|Antiviral Agents|antiviral agents|mesh-ancestor
25699345|NCT02105688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25699346|NCT02105701|Ribavirin|ribavirin|mesh-list
25699347|NCT02105701|Grazoprevir|grazoprevir|mesh-list
25699348|NCT02105701|Antimetabolites|antimetabolites|mesh-ancestor
25699349|NCT02105701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699350|NCT02105701|Antiviral Agents|antiviral agents|mesh-ancestor
25699351|NCT02105701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24519102|NCT03432949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24519103|NCT03432949|Glucocorticoids|glucocorticoids|mesh-ancestor
24519104|NCT03432949|Hormones|hormones|mesh-ancestor
24519105|NCT03432949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24519106|NCT03432949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24901763|NCT04381104|Antipyretics|antipyretics|mesh-ancestor
24901764|NCT04380597|Betamethasone|betamethasone|mesh-list
24901815|NCT04380857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24901816|NCT04380857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24901817|NCT04380402|Atorvastatin|atorvastatin|mesh-list
24901818|NCT04380402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24901819|NCT04380402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24901820|NCT04380402|Antimetabolites|antimetabolites|mesh-ancestor
24901821|NCT04380402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901822|NCT04380402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24901823|NCT04380402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24901824|NCT04380402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901825|NCT04380467|Vitamin D|vitamin d|mesh-list
24901928|NCT04380012|Trastuzumab|trastuzumab|mesh-list
24901929|NCT04380012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24901930|NCT04380012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24901931|NCT04380025|Pycnogenols|pycnogenols|mesh-list
24901932|NCT04380025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24901933|NCT04380025|Immunologic Factors|immunologic factors|mesh-ancestor
24901995|NCT04378972|Vitamins|vitamins|mesh-ancestor
24519213|NCT02977052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519214|NCT02977052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24519215|NCT02977052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901957|NCT04379180|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24901958|NCT04379180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901959|NCT04379180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901960|NCT04379180|Urological Agents|urological agents|mesh-ancestor
24901961|NCT04379180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24901962|NCT04379180|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24818180|NCT02087332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24818181|NCT02087332|Diuretics|diuretics|mesh-ancestor
24818182|NCT02087332|Natriuretic Agents|natriuretic agents|mesh-ancestor
24818183|NCT02087332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818184|NCT02087332|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24818185|NCT02087332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24818186|NCT02087332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818187|NCT02087384|Vaccines|vaccines|mesh-list
24818188|NCT02087384|Immunologic Factors|immunologic factors|mesh-ancestor
24901973|NCT04379219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901974|NCT04379219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24901975|NCT04379219|Dermatologic Agents|dermatologic agents|mesh-ancestor
24901976|NCT04379219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901977|NCT04379219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25064078|NCT03463317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25064079|NCT03463317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25064080|NCT03463317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25064081|NCT03463317|Analgesics|analgesics|mesh-ancestor
25064082|NCT03463317|Sensory System Agents|sensory system agents|mesh-ancestor
25064083|NCT03463317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25064084|NCT03463317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25064085|NCT03463317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24901978|NCT04379219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24901979|NCT04379219|Immunologic Factors|immunologic factors|mesh-ancestor
24901980|NCT04379219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24901981|NCT04379219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24901982|NCT04379310|Calcium Channel Blockers|calcium channel blockers|mesh-list
25699352|NCT02105974|Fluticasone|fluticasone|mesh-list
25699354|NCT02105974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24902009|NCT04378972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902011|NCT04378972|GABA Agonists|gaba agonists|mesh-ancestor
24902012|NCT04378972|GABA Agents|gaba agents|mesh-ancestor
24902025|NCT04378868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902026|NCT04378868|Antitubercular Agents|antitubercular agents|mesh-ancestor
24902027|NCT04378868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24902028|NCT04378868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24902029|NCT04378608|Ribavirin|ribavirin|mesh-list
24902030|NCT04378608|Antimetabolites|antimetabolites|mesh-ancestor
24902057|NCT04378283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24902058|NCT04378283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24902059|NCT04378283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24902060|NCT04378283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24902061|NCT04378283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24902062|NCT04378283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902063|NCT04378283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24902068|NCT04378283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24902069|NCT04378283|Autonomic Agents|autonomic agents|mesh-ancestor
24902070|NCT04378283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24902071|NCT04378283|Respiratory System Agents|respiratory system agents|mesh-ancestor
24902072|NCT04378283|Mydriatics|mydriatics|mesh-ancestor
24902073|NCT04378283|Sympathomimetics|sympathomimetics|mesh-ancestor
24902074|NCT04378283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24902076|NCT04377867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24902077|NCT04377867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902078|NCT04377867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25064086|NCT03463317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24826549|NCT02135055|Analgesics|analgesics|mesh-ancestor
24519221|NCT02973386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24519222|NCT02973386|Antimetabolites|antimetabolites|mesh-ancestor
24519223|NCT02973386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519239|NCT02702180|Sargramostim|sargramostim|mesh-list
24519240|NCT02702180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519241|NCT02702180|Immunologic Factors|immunologic factors|mesh-ancestor
24519242|NCT02702180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519243|NCT02668653|Cytarabine|cytarabine|mesh-list
24519244|NCT02668653|Daunorubicin|daunorubicin|mesh-list
24902104|NCT04377386|Micronutrients|micronutrients|mesh-ancestor
25699355|NCT02105974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25699356|NCT02105974|Autonomic Agents|autonomic agents|mesh-ancestor
25699357|NCT02105974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699358|NCT02105974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699359|NCT02105974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25699360|NCT02105974|Respiratory System Agents|respiratory system agents|mesh-ancestor
25699361|NCT02105974|Dermatologic Agents|dermatologic agents|mesh-ancestor
25699362|NCT02105974|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25064096|NCT03463252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064097|NCT03463252|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25064098|NCT03463252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25064099|NCT03463252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25064100|NCT03463252|Contraceptive Agents|contraceptive agents|mesh-ancestor
25064101|NCT03463252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25064102|NCT03463252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25064103|NCT03463252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25064104|NCT03463252|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25064105|NCT03463252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25064106|NCT03463252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25064107|NCT03463083|Fentanyl|fentanyl|mesh-list
25064108|NCT03463083|Dexmedetomidine|dexmedetomidine|mesh-list
25064109|NCT03463083|Bupivacaine|bupivacaine|mesh-list
25064110|NCT03463083|Anesthetics, Local|anesthetics, local|mesh-ancestor
25064111|NCT03463083|Anesthetics|anesthetics|mesh-ancestor
25064112|NCT03463083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25064113|NCT03463083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826564|NCT02135120|Morphine|morphine|mesh-list
24902176|NCT04376788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902177|NCT04376788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902178|NCT04376528|Cyclosporine|cyclosporine|mesh-list
24902179|NCT04376528|Mycophenolic Acid|mycophenolic acid|mesh-list
24902180|NCT04376528|Cyclosporins|cyclosporins|mesh-list
24902181|NCT04376528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902193|NCT04376528|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24902194|NCT04376528|Antitubercular Agents|antitubercular agents|mesh-ancestor
24902195|NCT04376528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24902196|NCT04376814|Ritonavir|ritonavir|mesh-list
24902198|NCT04376814|Hydroxychloroquine|hydroxychloroquine|mesh-list
24902199|NCT04376814|Favipiravir|favipiravir|mesh-list
24902200|NCT04376814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24902201|NCT04376814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24902202|NCT04376814|Protease Inhibitors|protease inhibitors|mesh-ancestor
24902203|NCT04376814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902204|NCT04376814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902205|NCT04376814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24902233|NCT04376541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25064114|NCT03463083|Sensory System Agents|sensory system agents|mesh-ancestor
25064115|NCT03463083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25064116|NCT03463083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25064118|NCT03463083|Analgesics|analgesics|mesh-ancestor
25064119|NCT03463083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24902234|NCT04376541|Anesthetics, General|anesthetics, general|mesh-ancestor
24902235|NCT04376541|Anesthetics|anesthetics|mesh-ancestor
24902236|NCT04376307|Anesthetics|anesthetics|mesh-list
24902237|NCT04376307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24902238|NCT04376307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902240|NCT04376073|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24902241|NCT04376073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902242|NCT04376073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902243|NCT04376073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25699363|NCT02106156|Interferons|interferons|mesh-list
25699364|NCT02106156|Ribavirin|ribavirin|mesh-list
25699365|NCT02106156|Interferon-alpha|interferon-alpha|mesh-list
25699366|NCT02106156|Interferon alpha-2|interferon alpha-2|mesh-list
25699367|NCT02106156|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25699368|NCT02106156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25699369|NCT02106156|Antiviral Agents|antiviral agents|mesh-ancestor
24902244|NCT04376086|Anesthetics|anesthetics|mesh-list
24902299|NCT04375267|Olaparib|olaparib|mesh-list
24902342|NCT04374318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24519279|NCT02543255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24519280|NCT02543255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519281|NCT02543255|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24519282|NCT02543255|Fertility Agents|fertility agents|mesh-ancestor
24519283|NCT02543255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24902437|NCT04374006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24902438|NCT04374006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24902460|NCT04373967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24902461|NCT04373967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902463|NCT04373967|Hormones|hormones|mesh-ancestor
24725475|NCT01597895|Maraviroc|maraviroc|mesh-list
24902464|NCT04373967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24902465|NCT04373941|Lenograstim|lenograstim|mesh-list
24902466|NCT04373941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24902467|NCT04373941|Immunologic Factors|immunologic factors|mesh-ancestor
24902468|NCT04373941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902472|NCT04373356|Listerine|listerine|mesh-list
24902473|NCT04373356|Fluorides|fluorides|mesh-list
24902474|NCT04373356|Sodium Fluoride|sodium fluoride|mesh-list
24902618|NCT04371978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902619|NCT04371978|Incretins|incretins|mesh-ancestor
24902620|NCT04371978|Hormones|hormones|mesh-ancestor
24725670|NCT01598883|Heparin|heparin|mesh-list
24902621|NCT04371978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24902622|NCT04371978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24902623|NCT04371978|Protease Inhibitors|protease inhibitors|mesh-ancestor
24902624|NCT04371978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902625|NCT04371978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902626|NCT04371926|Hydroxychloroquine|hydroxychloroquine|mesh-list
24902627|NCT04371926|Antimalarials|antimalarials|mesh-ancestor
24902628|NCT04371926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24902629|NCT04371926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24902630|NCT04371926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902631|NCT04371926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902632|NCT04371926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902633|NCT04371926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24902634|NCT04371757|Doxazosin|doxazosin|mesh-list
24902635|NCT04371757|Adrenergic Agents|adrenergic agents|mesh-list
24902636|NCT04371757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24902637|NCT04371757|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24902638|NCT04371757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24902639|NCT04371757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24863608|NCT04194554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24863609|NCT04194554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543419|NCT00683670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24543420|NCT00683670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24543421|NCT00683670|Alkylating Agents|alkylating agents|mesh-ancestor
24902640|NCT04371757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24902641|NCT04371757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902642|NCT04371757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902658|NCT04371523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24902659|NCT04371822|Protoporphyrin IX|protoporphyrin ix|mesh-list
24902660|NCT04371822|Tin protoporphyrin IX|tin protoporphyrin ix|mesh-list
24902661|NCT04371822|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24902662|NCT04371822|Dermatologic Agents|dermatologic agents|mesh-ancestor
24902663|NCT04371822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902673|NCT04371224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24902674|NCT04371224|Immunologic Factors|immunologic factors|mesh-ancestor
24902724|NCT04371185|Dermatologic Agents|dermatologic agents|mesh-ancestor
24818336|NCT02088060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24902731|NCT04371146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24902732|NCT04371146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902734|NCT04371146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24902735|NCT04371146|Antidepressive Agents|antidepressive agents|mesh-ancestor
24902736|NCT04371146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24902737|NCT04371146|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24902738|NCT04371146|Adrenergic Agents|adrenergic agents|mesh-ancestor
24902740|NCT04370977|Lumefantrine|lumefantrine|mesh-list
24902741|NCT04370977|Artemether|artemether|mesh-list
25064120|NCT03463083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25699370|NCT02106156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25064122|NCT03463083|Adrenergic Agents|adrenergic agents|mesh-ancestor
25064123|NCT03463083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25064124|NCT03463083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064125|NCT03463083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25064126|NCT03463083|Narcotics|narcotics|mesh-ancestor
25064127|NCT03463083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25064128|NCT03463083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25064129|NCT03463083|Anesthetics, General|anesthetics, general|mesh-ancestor
24449877|NCT00317408|Cyclosporine|cyclosporine|mesh-list
24902778|NCT04370431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24902780|NCT04370431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543425|NCT00683735|Metformin|metformin|mesh-list
24543464|NCT00683891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24543465|NCT00683891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24543466|NCT00683891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24543467|NCT00683891|GABA Antagonists|gaba antagonists|mesh-ancestor
24543468|NCT00683891|GABA Agents|gaba agents|mesh-ancestor
24543469|NCT00683943|Lithium Carbonate|lithium carbonate|mesh-list
24543485|NCT00683969|Mycophenolic Acid|mycophenolic acid|mesh-list
24902781|NCT04370431|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24902782|NCT04370431|Protective Agents|protective agents|mesh-ancestor
24725778|NCT01599702|Hematinics|hematinics|mesh-ancestor
24902784|NCT04370587|Pembrolizumab|pembrolizumab|mesh-list
24902819|NCT04370288|Antidotes|antidotes|mesh-ancestor
24902820|NCT04370288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902821|NCT04369794|BCG Vaccine|bcg vaccine|mesh-list
24902822|NCT04369794|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24902823|NCT04369794|Immunologic Factors|immunologic factors|mesh-ancestor
24902824|NCT04369794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902828|NCT04369534|Clopidogrel|clopidogrel|mesh-list
24902829|NCT04369534|Ticagrelor|ticagrelor|mesh-list
24902830|NCT04369534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24902831|NCT04369534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24902832|NCT04369534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24902833|NCT04369534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24902834|NCT04369534|Purinergic Agents|purinergic agents|mesh-ancestor
24902835|NCT04369534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24902836|NCT04369534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902837|NCT04369534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902838|NCT04369586|Meplazumab|meplazumab|mesh-list
24902839|NCT04369586|Antiviral Agents|antiviral agents|mesh-ancestor
24902840|NCT04369586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902841|NCT04370080|Fluorides|fluorides|mesh-list
24902842|NCT04370080|Cariostatic Agents|cariostatic agents|mesh-ancestor
24902871|NCT04369222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902872|NCT04369222|Antifungal Agents|antifungal agents|mesh-ancestor
24902873|NCT04369222|Keratolytic Agents|keratolytic agents|mesh-ancestor
24902874|NCT04369222|Dermatologic Agents|dermatologic agents|mesh-ancestor
24902944|NCT04368598|Expectorants|expectorants|mesh-ancestor
24902945|NCT04368598|Respiratory System Agents|respiratory system agents|mesh-ancestor
24902963|NCT04368377|Fondaparinux|fondaparinux|mesh-list
24902964|NCT04368377|Clopidogrel|clopidogrel|mesh-list
24902965|NCT04368377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24902966|NCT04368377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25064130|NCT03463070|Misoprostol|misoprostol|mesh-list
25064131|NCT03463070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25064132|NCT03463070|Abortifacient Agents|abortifacient agents|mesh-ancestor
24902967|NCT04368377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24902968|NCT04368377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24902969|NCT04368377|Purinergic Agents|purinergic agents|mesh-ancestor
24902970|NCT04368377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24902971|NCT04368377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902972|NCT04368377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902973|NCT04368377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24902974|NCT04368377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24902975|NCT04368377|Analgesics|analgesics|mesh-ancestor
24902976|NCT04368377|Sensory System Agents|sensory system agents|mesh-ancestor
24818280|NCT02087579|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24818281|NCT02087631|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24818282|NCT02087631|Antidepressive Agents|antidepressive agents|mesh-ancestor
24818283|NCT02087631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24818284|NCT02087631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24818285|NCT02087631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24818286|NCT02087631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24818287|NCT02087631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818288|NCT02087683|Vitamin D|vitamin d|mesh-list
24818289|NCT02087683|Vitamins|vitamins|mesh-ancestor
24818290|NCT02087683|Micronutrients|micronutrients|mesh-ancestor
24818314|NCT02087813|Protective Agents|protective agents|mesh-ancestor
24818322|NCT02088008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24818323|NCT02088008|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24818324|NCT02088008|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24818325|NCT02088008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818326|NCT02088060|Cannabidiol|cannabidiol|mesh-list
24818327|NCT02088060|Olanzapine|olanzapine|mesh-list
24818328|NCT02088060|Antiemetics|antiemetics|mesh-ancestor
24818329|NCT02088060|Autonomic Agents|autonomic agents|mesh-ancestor
24818330|NCT02088060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24818331|NCT02088060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818332|NCT02088060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24818333|NCT02088060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24818334|NCT02088060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24902984|NCT04368377|Antipyretics|antipyretics|mesh-ancestor
24903004|NCT04368351|Hydroxychloroquine|hydroxychloroquine|mesh-list
24903005|NCT04368351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24903006|NCT04368351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903007|NCT04368351|Antimalarials|antimalarials|mesh-ancestor
24903008|NCT04368351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24903009|NCT04368351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24903010|NCT04368351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903011|NCT04368351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903012|NCT04368351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24903026|NCT04367831|Enoxaparin|enoxaparin|mesh-list
24479492|NCT00427089|Protective Agents|protective agents|mesh-ancestor
24903040|NCT04367155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24903041|NCT04367155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903042|NCT04367155|Hemostatics|hemostatics|mesh-ancestor
24903043|NCT04367155|Coagulants|coagulants|mesh-ancestor
24903044|NCT04367103|Phenylephrine|phenylephrine|mesh-list
24903045|NCT04367103|Oxymetazoline|oxymetazoline|mesh-list
24903046|NCT04367103|Norepinephrine|norepinephrine|mesh-list
24903047|NCT04367103|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24903048|NCT04367103|Mydriatics|mydriatics|mesh-ancestor
24903049|NCT04367103|Autonomic Agents|autonomic agents|mesh-ancestor
24903051|NCT04367103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903052|NCT04367103|Sympathomimetics|sympathomimetics|mesh-ancestor
24903053|NCT04367103|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24903054|NCT04367103|Nasal Decongestants|nasal decongestants|mesh-ancestor
24903055|NCT04367103|Respiratory System Agents|respiratory system agents|mesh-ancestor
24903056|NCT04367103|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24903057|NCT04367103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24903058|NCT04367103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24903059|NCT04367103|Adrenergic Agents|adrenergic agents|mesh-ancestor
24903060|NCT04367103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24903061|NCT04367103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903062|NCT04367103|Protective Agents|protective agents|mesh-ancestor
24903063|NCT04367051|Spironolactone|spironolactone|mesh-list
24903064|NCT04367051|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24903065|NCT04367051|Hormone Antagonists|hormone antagonists|mesh-ancestor
24479493|NCT00427089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479494|NCT00427089|Vitamins|vitamins|mesh-ancestor
24479495|NCT00427089|Micronutrients|micronutrients|mesh-ancestor
24479496|NCT00427089|Laxatives|laxatives|mesh-ancestor
24479497|NCT00427089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24479498|NCT00427102|Cisplatin|cisplatin|mesh-list
24903091|NCT04366622|Enzyme Activators|enzyme activators|mesh-ancestor
24903112|NCT04366739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24903113|NCT04366739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903114|NCT04366869|Salicylic Acid|salicylic acid|mesh-list
24903132|NCT04366089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903133|NCT04366089|Antimalarials|antimalarials|mesh-ancestor
24903134|NCT04366089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24903139|NCT04366050|Ramipril|ramipril|mesh-list
24903156|NCT04365686|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24903157|NCT04365686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24903158|NCT04365686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699371|NCT02106156|Antimetabolites|antimetabolites|mesh-ancestor
24903159|NCT04365686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24903162|NCT04365517|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24903163|NCT04365517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24903164|NCT04365517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903165|NCT04365517|Incretins|incretins|mesh-ancestor
24903166|NCT04365517|Hormones|hormones|mesh-ancestor
24903167|NCT04365517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24903168|NCT04365517|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25064139|NCT03463044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25064140|NCT03463005|Propolis|propolis|mesh-list
25064141|NCT03463005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903169|NCT04365517|Protease Inhibitors|protease inhibitors|mesh-ancestor
24903170|NCT04365517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903171|NCT04365517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903172|NCT04365582|Ritonavir|ritonavir|mesh-list
24903173|NCT04365582|Lopinavir|lopinavir|mesh-list
24903174|NCT04365582|Azithromycin|azithromycin|mesh-list
24903175|NCT04365582|Hydroxychloroquine|hydroxychloroquine|mesh-list
24903176|NCT04365582|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24903177|NCT04365582|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24903178|NCT04365582|Protease Inhibitors|protease inhibitors|mesh-ancestor
24903214|NCT04365127|Progesterone|progesterone|mesh-list
24903215|NCT04365127|Progestins|progestins|mesh-ancestor
24903216|NCT04365127|Hormones|hormones|mesh-ancestor
24903217|NCT04365127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24903218|NCT04365127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479600|NCT00427414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24903219|NCT04365309|Aspirin|aspirin|mesh-list
24903256|NCT04364906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24903257|NCT04364906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903258|NCT04364815|Hydroxychloroquine|hydroxychloroquine|mesh-list
24903259|NCT04364815|Antimalarials|antimalarials|mesh-ancestor
24903260|NCT04364815|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24903261|NCT04364815|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24903262|NCT04364815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903263|NCT04364815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903264|NCT04364815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903265|NCT04364815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24903266|NCT04365049|Gemcitabine|gemcitabine|mesh-list
24903267|NCT04365049|Apatinib|apatinib|mesh-list
24903268|NCT04365049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24903273|NCT04365049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903274|NCT04365049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903275|NCT04365049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24903276|NCT04365049|Immunologic Factors|immunologic factors|mesh-ancestor
24903277|NCT04365049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903279|NCT04364945|Dexmedetomidine|dexmedetomidine|mesh-list
24903286|NCT04364945|Analgesics|analgesics|mesh-ancestor
24903287|NCT04364945|Sensory System Agents|sensory system agents|mesh-ancestor
24903288|NCT04364945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24903289|NCT04364945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24903290|NCT04364945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24903291|NCT04364945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24903340|NCT04364516|Coagulants|coagulants|mesh-ancestor
24903341|NCT04364607|Neostigmine|neostigmine|mesh-list
24903342|NCT04364607|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24903343|NCT04364607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903344|NCT04364607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903345|NCT04364607|Cholinergic Agents|cholinergic agents|mesh-ancestor
24903346|NCT04364607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24903347|NCT04364607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903348|NCT04364607|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24903349|NCT04364607|Autonomic Agents|autonomic agents|mesh-ancestor
24903350|NCT04364607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25064142|NCT03462940|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
25064143|NCT03462940|Antiviral Agents|antiviral agents|mesh-ancestor
25064144|NCT03462940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25064145|NCT03462940|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25064146|NCT03462940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25064147|NCT03462836|Lidocaine|lidocaine|mesh-list
25064148|NCT03462836|Ketamine|ketamine|mesh-list
25064149|NCT03462836|Anesthetics, Local|anesthetics, local|mesh-ancestor
25064150|NCT03462836|Anesthetics|anesthetics|mesh-ancestor
25064151|NCT03462836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25064152|NCT03462836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903351|NCT04364399|Vaccines|vaccines|mesh-list
25699372|NCT02106156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699373|NCT02106156|Immunologic Factors|immunologic factors|mesh-ancestor
24903352|NCT04364399|Immunologic Factors|immunologic factors|mesh-ancestor
24818361|NCT02088411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818362|NCT02088411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24818363|NCT02088411|Immunologic Factors|immunologic factors|mesh-ancestor
24818365|NCT02088424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24818366|NCT02088424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903364|NCT04364425|Anesthetics, Local|anesthetics, local|mesh-ancestor
24903365|NCT04364425|Anesthetics|anesthetics|mesh-ancestor
24903366|NCT04364425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24903367|NCT04364425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903368|NCT04364425|Sensory System Agents|sensory system agents|mesh-ancestor
24643943|NCT01188031|Alprazolam|alprazolam|mesh-list
24903369|NCT04364425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24903370|NCT04364425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24903371|NCT04364425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24903372|NCT04364425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24903373|NCT04364425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24903374|NCT04364425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903375|NCT04364425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24903376|NCT04364425|Glucocorticoids|glucocorticoids|mesh-ancestor
24903377|NCT04364425|Hormones|hormones|mesh-ancestor
24903378|NCT04364425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24519303|NCT02437279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519304|NCT02437279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24519323|NCT02030990|Fluorometholone|fluorometholone|mesh-list
24519325|NCT02030990|Mitomycin|mitomycin|mesh-list
24903379|NCT04364425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24903380|NCT04364425|Immunologic Factors|immunologic factors|mesh-ancestor
24903382|NCT04364321|Diazepam|diazepam|mesh-list
24903383|NCT04364321|Clonazepam|clonazepam|mesh-list
24903394|NCT04364321|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24903395|NCT04364321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24903396|NCT04364321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24903397|NCT04364321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24903398|NCT04364321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24903399|NCT04364321|Anesthetics, General|anesthetics, general|mesh-ancestor
24903400|NCT04364321|Anesthetics|anesthetics|mesh-ancestor
24903401|NCT04364321|GABA Modulators|gaba modulators|mesh-ancestor
24903402|NCT04364321|GABA Agents|gaba agents|mesh-ancestor
24903403|NCT04364321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24903404|NCT04364321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903405|NCT04364139|Metoprolol|metoprolol|mesh-list
24903406|NCT04364139|Amlodipine|amlodipine|mesh-list
24903407|NCT04364139|Ramipril|ramipril|mesh-list
24903427|NCT04364581|Letrozole|letrozole|mesh-list
24903428|NCT04364581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24903429|NCT04364581|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24863782|NCT03350984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863783|NCT03328845|Insulin|insulin|mesh-list
24863784|NCT03328845|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24863785|NCT03328845|Insulin Lispro|insulin lispro|mesh-list
24903430|NCT04364581|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24903431|NCT04364581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903432|NCT04364581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064153|NCT03462836|Sensory System Agents|sensory system agents|mesh-ancestor
25064154|NCT03462836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25064155|NCT03462836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25064156|NCT03462836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25064157|NCT03462836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24948629|NCT03918187|Anesthetics, General|anesthetics, general|mesh-ancestor
25064158|NCT03462836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25064159|NCT03462836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064160|NCT03462836|Analgesics|analgesics|mesh-ancestor
24903433|NCT04364581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24903434|NCT04364581|Hormone Antagonists|hormone antagonists|mesh-ancestor
25407302|NCT03508921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24903435|NCT04364581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24903436|NCT04364581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726490|NCT01603498|Hormones|hormones|mesh-ancestor
24903437|NCT04364009|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24903438|NCT04364009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24903439|NCT04363827|Hydroxychloroquine|hydroxychloroquine|mesh-list
24903440|NCT04363827|Antimalarials|antimalarials|mesh-ancestor
24903441|NCT04363827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24903442|NCT04363827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24903443|NCT04363827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903444|NCT04363827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903445|NCT04363827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903446|NCT04363827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24903448|NCT04364113|Anesthetics, Local|anesthetics, local|mesh-ancestor
24903449|NCT04364113|Anesthetics|anesthetics|mesh-ancestor
24903478|NCT04363762|Salicylic Acid|salicylic acid|mesh-list
24903479|NCT04363762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903481|NCT04363762|Keratolytic Agents|keratolytic agents|mesh-ancestor
24903482|NCT04363762|Dermatologic Agents|dermatologic agents|mesh-ancestor
24903483|NCT04363450|Hydroxychloroquine|hydroxychloroquine|mesh-list
24903484|NCT04363450|Antimalarials|antimalarials|mesh-ancestor
24903485|NCT04363450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24903486|NCT04363450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24903487|NCT04363450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903488|NCT04363450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903489|NCT04363450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903490|NCT04363450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24903491|NCT04363203|Azithromycin|azithromycin|mesh-list
24903492|NCT04363203|Hydroxychloroquine|hydroxychloroquine|mesh-list
24903493|NCT04363203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24903494|NCT04363203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903495|NCT04363203|Antimalarials|antimalarials|mesh-ancestor
24903496|NCT04363203|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24903573|NCT04362241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24903574|NCT04362241|Antiemetics|antiemetics|mesh-ancestor
24903575|NCT04362241|Autonomic Agents|autonomic agents|mesh-ancestor
24863786|NCT03328845|Insulin Aspart|insulin aspart|mesh-list
24863789|NCT03305341|Molgramostim|molgramostim|mesh-list
24863808|NCT03284047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24863809|NCT03284047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863815|NCT03277261|Teriflunomide|teriflunomide|mesh-list
24863832|NCT03277248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903576|NCT04362241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24903577|NCT04362241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24903578|NCT04362241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24903579|NCT04362241|Protective Agents|protective agents|mesh-ancestor
24903581|NCT04362293|Plerixafor|plerixafor|mesh-list
24903582|NCT04362293|Cyclophosphamide|cyclophosphamide|mesh-list
24903583|NCT04362293|Thiotepa|thiotepa|mesh-list
24903584|NCT04362293|Alemtuzumab|alemtuzumab|mesh-list
24903585|NCT04362293|Hydroxyurea|hydroxyurea|mesh-list
24903586|NCT04362293|Azathioprine|azathioprine|mesh-list
24903587|NCT04362293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24903588|NCT04362293|Immunologic Factors|immunologic factors|mesh-ancestor
24903589|NCT04362293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903590|NCT04362293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24903591|NCT04362293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24903592|NCT04362293|Alkylating Agents|alkylating agents|mesh-ancestor
24903593|NCT04362293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903594|NCT04362293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24903595|NCT04362293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24903596|NCT04362293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24903597|NCT04362293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903598|NCT04362293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24903599|NCT04362293|Antifungal Agents|antifungal agents|mesh-ancestor
24903618|NCT04362332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24903638|NCT04361825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24903639|NCT04361825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24903640|NCT04361734|Nitroglycerin|nitroglycerin|mesh-list
24903641|NCT04361734|Vasodilator Agents|vasodilator agents|mesh-ancestor
24903642|NCT04361708|Leucovorin|leucovorin|mesh-list
24903643|NCT04361708|Docetaxel|docetaxel|mesh-list
24903644|NCT04361708|Fluorouracil|fluorouracil|mesh-list
24903645|NCT04361708|Oxaliplatin|oxaliplatin|mesh-list
24903646|NCT04361708|Irinotecan|irinotecan|mesh-list
24903647|NCT04361708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24903660|NCT04361708|Antidotes|antidotes|mesh-ancestor
24903661|NCT04361708|Protective Agents|protective agents|mesh-ancestor
24903662|NCT04361708|Vitamin B Complex|vitamin b complex|mesh-ancestor
24903664|NCT04361708|Micronutrients|micronutrients|mesh-ancestor
24903665|NCT04361552|Immunoglobulins|immunoglobulins|mesh-list
24903666|NCT04361552|Immunoglobulin G|immunoglobulin g|mesh-list
24903667|NCT04361552|Immunologic Factors|immunologic factors|mesh-ancestor
24903668|NCT04361552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903669|NCT04361721|Erenumab|erenumab|mesh-list
24903670|NCT04361721|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
24903671|NCT04361721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903672|NCT04361721|Analgesics|analgesics|mesh-ancestor
24903673|NCT04361721|Sensory System Agents|sensory system agents|mesh-ancestor
24903674|NCT04361721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24903675|NCT04361721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903676|NCT04361812|Omalizumab|omalizumab|mesh-list
24903677|NCT04361812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24903678|NCT04361812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24903679|NCT04361812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24903680|NCT04361812|Respiratory System Agents|respiratory system agents|mesh-ancestor
24903681|NCT04361812|Immunologic Factors|immunologic factors|mesh-ancestor
24903682|NCT04361812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903683|NCT04361643|Lenalidomide|lenalidomide|mesh-list
24903684|NCT04361643|Immunologic Factors|immunologic factors|mesh-ancestor
24449069|NCT00314171|Timolol|timolol|mesh-list
24903708|NCT04361175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903709|NCT04361175|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24903710|NCT04361175|Hormone Antagonists|hormone antagonists|mesh-ancestor
24903711|NCT04361175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24903712|NCT04361175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903714|NCT04361461|Hydroxychloroquine|hydroxychloroquine|mesh-list
24903715|NCT04361461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24903716|NCT04361461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903717|NCT04361461|Antimalarials|antimalarials|mesh-ancestor
24903718|NCT04361461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24903719|NCT04361461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24953247|NCT03887169|Hematinics|hematinics|mesh-ancestor
24953248|NCT03887130|Gemcitabine|gemcitabine|mesh-list
24903758|NCT04361370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24903760|NCT04361370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903761|NCT04361370|Growth Inhibitors|growth inhibitors|mesh-ancestor
24903762|NCT04361370|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24903763|NCT04361370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903804|NCT04361409|Antimetabolites|antimetabolites|mesh-ancestor
24903805|NCT04361409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903806|NCT04361409|Antiviral Agents|antiviral agents|mesh-ancestor
24903807|NCT04361409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903808|NCT04361409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903809|NCT04361409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24903854|NCT04360785|Methotrexate|methotrexate|mesh-list
24903855|NCT04360785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24903856|NCT04360785|Abortifacient Agents|abortifacient agents|mesh-ancestor
24903869|NCT04360785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24903871|NCT04360655|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24953271|NCT03886896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953272|NCT03886896|Sensory System Agents|sensory system agents|mesh-ancestor
24953273|NCT03886896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953274|NCT03886896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24903906|NCT04359966|Antacids|antacids|mesh-ancestor
24903907|NCT04359862|Propofol|propofol|mesh-list
24903908|NCT04359862|Sevoflurane|sevoflurane|mesh-list
24903909|NCT04359862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24903910|NCT04359862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24903911|NCT04359862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903912|NCT04359862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24903913|NCT04359862|Anesthetics, General|anesthetics, general|mesh-ancestor
24903914|NCT04359862|Anesthetics|anesthetics|mesh-ancestor
24903915|NCT04359862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24903916|NCT04359862|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24903917|NCT04360031|Mycophenolic Acid|mycophenolic acid|mesh-list
24903918|NCT04360031|Tacrolimus|tacrolimus|mesh-list
24903919|NCT04360031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24903920|NCT04360031|Immunologic Factors|immunologic factors|mesh-ancestor
24903921|NCT04360031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903922|NCT04360031|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24903954|NCT04360876|Dexamethasone acetate|dexamethasone acetate|mesh-list
24903955|NCT04360876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24903956|NCT04360876|Antiemetics|antiemetics|mesh-ancestor
24903957|NCT04360876|Autonomic Agents|autonomic agents|mesh-ancestor
24903958|NCT04360876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24903959|NCT04360876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903960|NCT04360876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24953275|NCT03886896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24953276|NCT03886896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24953277|NCT03886896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24953290|NCT03886948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24953291|NCT03886948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24953292|NCT03886948|Analgesics|analgesics|mesh-ancestor
24953293|NCT03886948|Sensory System Agents|sensory system agents|mesh-ancestor
24953294|NCT03886948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953295|NCT03886948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953296|NCT03886948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24903961|NCT04360876|Glucocorticoids|glucocorticoids|mesh-ancestor
24903962|NCT04360876|Hormones|hormones|mesh-ancestor
24903963|NCT04360876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24903964|NCT04360876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24903965|NCT04360876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24903966|NCT04359680|Nitazoxanide|nitazoxanide|mesh-list
24903967|NCT04359680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24903968|NCT04359680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903969|NCT04359615|Hydroxychloroquine|hydroxychloroquine|mesh-list
24903970|NCT04359615|Favipiravir|favipiravir|mesh-list
24903983|NCT04359823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24903985|NCT04359823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904000|NCT04359485|Keratolytic Agents|keratolytic agents|mesh-ancestor
24904001|NCT04359485|Dermatologic Agents|dermatologic agents|mesh-ancestor
24904002|NCT04359511|Prednisone|prednisone|mesh-list
24904003|NCT04359511|Hydrocortisone|hydrocortisone|mesh-list
24904004|NCT04359511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24904006|NCT04359511|Hormones|hormones|mesh-ancestor
24904007|NCT04359511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24904008|NCT04359511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904009|NCT04359511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24904010|NCT04359511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904011|NCT04359550|Antibodies|antibodies|mesh-list
24904012|NCT04359550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24904013|NCT04359550|Immunologic Factors|immunologic factors|mesh-ancestor
24904014|NCT04359550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904015|NCT04359524|Vitamin D|vitamin d|mesh-list
24953299|NCT03886948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24953300|NCT03887013|Trimetazidine|trimetazidine|mesh-list
24953301|NCT03887013|Vasodilator Agents|vasodilator agents|mesh-ancestor
24953302|NCT03886766|Efavirenz|efavirenz|mesh-list
24953303|NCT03886766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24953304|NCT03886766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24953305|NCT03886766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24953306|NCT03886766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064176|NCT03462446|Vitamin K|vitamin k|mesh-list
25064177|NCT03462446|Rivaroxaban|rivaroxaban|mesh-list
24904016|NCT04359524|Cholecalciferol|cholecalciferol|mesh-list
24904017|NCT04359524|Vitamins|vitamins|mesh-ancestor
24904018|NCT04359524|Micronutrients|micronutrients|mesh-ancestor
24904019|NCT04359524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904020|NCT04359524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24904021|NCT04359524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24904022|NCT04359199|Cisplatin|cisplatin|mesh-list
24904023|NCT04359199|Pembrolizumab|pembrolizumab|mesh-list
24904024|NCT04359199|Nivolumab|nivolumab|mesh-list
24904025|NCT04359199|Cetuximab|cetuximab|mesh-list
24904050|NCT04359095|Tubulin Modulators|tubulin modulators|mesh-ancestor
24904051|NCT04359095|Antimitotic Agents|antimitotic agents|mesh-ancestor
24904052|NCT04359095|Mitosis Modulators|mitosis modulators|mesh-ancestor
24904053|NCT04359095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904054|NCT04359212|Heparin|heparin|mesh-list
24904055|NCT04359212|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24904056|NCT04359212|Tinzaparin|tinzaparin|mesh-list
24904057|NCT04359212|Dalteparin|dalteparin|mesh-list
24904058|NCT04359212|PENTA|penta|mesh-list
24904059|NCT04359212|Fondaparinux|fondaparinux|mesh-list
24904060|NCT04359212|Anticoagulants|anticoagulants|mesh-ancestor
24904061|NCT04359212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24904062|NCT04359212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24904063|NCT04359212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904064|NCT04359212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24904065|NCT04359212|Antithrombins|antithrombins|mesh-ancestor
24904074|NCT04359316|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24904079|NCT04358965|Misoprostol|misoprostol|mesh-list
24904104|NCT04358614|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24904121|NCT04358627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904122|NCT04358718|Anesthetics|anesthetics|mesh-list
24904123|NCT04358718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24904124|NCT04358718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904125|NCT04358770|Clocortolone|clocortolone|mesh-list
24818375|NCT02088502|Acetylcysteine|acetylcysteine|mesh-list
24818376|NCT02088502|Theophylline|theophylline|mesh-list
24818377|NCT02088502|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24818378|NCT02088502|Antiviral Agents|antiviral agents|mesh-ancestor
24818379|NCT02088502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24818380|NCT02088502|Expectorants|expectorants|mesh-ancestor
24818381|NCT02088502|Respiratory System Agents|respiratory system agents|mesh-ancestor
24818382|NCT02088502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24818383|NCT02088502|Antioxidants|antioxidants|mesh-ancestor
24818397|NCT02088502|Purinergic Agents|purinergic agents|mesh-ancestor
24818401|NCT02088515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25064178|NCT03462446|Vitamins|vitamins|mesh-ancestor
25064179|NCT03462446|Micronutrients|micronutrients|mesh-ancestor
25064180|NCT03462446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818425|NCT02088671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24818426|NCT02088684|Fulvestrant|fulvestrant|mesh-list
24904148|NCT04358367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24904149|NCT04358367|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24904150|NCT04358367|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24904151|NCT04358367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24904152|NCT04358367|Adrenergic Agents|adrenergic agents|mesh-ancestor
24904153|NCT04358367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24904154|NCT04358367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904177|NCT04358354|Fluorouracil|fluorouracil|mesh-list
24904178|NCT04358354|Oxaliplatin|oxaliplatin|mesh-list
24904179|NCT04358354|Irinotecan|irinotecan|mesh-list
24904180|NCT04358354|Antimetabolites|antimetabolites|mesh-ancestor
24904181|NCT04358354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904182|NCT04358354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24863989|NCT02494258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24863991|NCT02494258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904183|NCT04358354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904224|NCT04357860|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24904251|NCT04357392|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24904253|NCT04357392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904254|NCT04357392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24480246|NCT00430118|Tubulin Modulators|tubulin modulators|mesh-ancestor
24519326|NCT02030990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24519327|NCT02030990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519328|NCT02030990|Alkylating Agents|alkylating agents|mesh-ancestor
24519329|NCT02030990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519330|NCT02030990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24519331|NCT02030990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24519332|NCT02030990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24519333|NCT02030990|Glucocorticoids|glucocorticoids|mesh-ancestor
24519334|NCT02030990|Hormones|hormones|mesh-ancestor
24904255|NCT04357392|Glucocorticoids|glucocorticoids|mesh-ancestor
24904257|NCT04357392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24904258|NCT04357392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24904259|NCT04357392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904260|NCT04357093|Listerine|listerine|mesh-list
24904261|NCT04357093|Grape Seed Extract|grape seed extract|mesh-list
24904262|NCT04357093|Fluorides|fluorides|mesh-list
24904263|NCT04357093|Sodium Fluoride|sodium fluoride|mesh-list
24904264|NCT04357093|Cariostatic Agents|cariostatic agents|mesh-ancestor
24904265|NCT04357093|Protective Agents|protective agents|mesh-ancestor
24451540|NCT00324077|Dasatinib|dasatinib|mesh-list
24904269|NCT04357093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24904270|NCT04357093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904271|NCT04357093|Antioxidants|antioxidants|mesh-ancestor
24904272|NCT04357093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904273|NCT04357002|Tranexamic Acid|tranexamic acid|mesh-list
24904274|NCT04357002|Dinoprostone|dinoprostone|mesh-list
24904275|NCT04357002|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25699374|NCT02106156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904276|NCT04357002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25699375|NCT02106325|Diphenhydramine|diphenhydramine|mesh-list
24904281|NCT04357002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25064204|NCT03462212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25064205|NCT03462212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826699|NCT02135822|Tubulin Modulators|tubulin modulators|mesh-ancestor
24826700|NCT02135822|Antimitotic Agents|antimitotic agents|mesh-ancestor
24904317|NCT04356508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24904318|NCT04356508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904409|NCT04355962|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24818440|NCT02088866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24818445|NCT02088866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24818446|NCT02088866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24818447|NCT02088866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24818448|NCT02088866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818449|NCT02088892|BCG Vaccine|bcg vaccine|mesh-list
24818450|NCT02088892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24818451|NCT02088892|Immunologic Factors|immunologic factors|mesh-ancestor
24818452|NCT02088892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818454|NCT02088918|Nateglinide|nateglinide|mesh-list
24818455|NCT02088918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24904446|NCT04355598|Anesthetics, Local|anesthetics, local|mesh-ancestor
24904447|NCT04355598|Anesthetics|anesthetics|mesh-ancestor
24904448|NCT04355598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24904449|NCT04355598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904450|NCT04355598|Sensory System Agents|sensory system agents|mesh-ancestor
24904451|NCT04355598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24904452|NCT04355598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24904453|NCT04355598|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25064206|NCT03462212|Tubulin Modulators|tubulin modulators|mesh-ancestor
25064207|NCT03462212|Antimitotic Agents|antimitotic agents|mesh-ancestor
24645784|NCT01199835|Calcium|calcium|mesh-list
24864052|NCT01525316|Lactoferrin|lactoferrin|mesh-list
24864053|NCT01525316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24864054|NCT01388491|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24452476|NCT05458674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25064209|NCT03462212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064210|NCT03462212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25064211|NCT03462212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25064212|NCT03462212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25064213|NCT03462212|Growth Substances|growth substances|mesh-ancestor
25064214|NCT03462212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826704|NCT02135822|Antimetabolites|antimetabolites|mesh-ancestor
24904454|NCT04355598|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24904455|NCT04355598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24904456|NCT04355598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904457|NCT04355598|Vasodilator Agents|vasodilator agents|mesh-ancestor
24904458|NCT04355598|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24904460|NCT04355637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24904461|NCT04355637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24904462|NCT04355637|Autonomic Agents|autonomic agents|mesh-ancestor
24904463|NCT04355637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24904464|NCT04355637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904465|NCT04355637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24904466|NCT04355637|Respiratory System Agents|respiratory system agents|mesh-ancestor
24904467|NCT04355637|Glucocorticoids|glucocorticoids|mesh-ancestor
24904469|NCT04355637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24904470|NCT04355468|Analgesics, Opioid|analgesics, opioid|mesh-list
24904471|NCT04355468|Anesthetics|anesthetics|mesh-list
24904472|NCT04355468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24904473|NCT04355468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904474|NCT04355468|Narcotics|narcotics|mesh-ancestor
24904475|NCT04355468|Analgesics|analgesics|mesh-ancestor
24904488|NCT04355416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904489|NCT04355416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904491|NCT04355494|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24904492|NCT04355494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24904493|NCT04355494|Immunologic Factors|immunologic factors|mesh-ancestor
24904494|NCT04355494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904495|NCT04355520|Fulvestrant|fulvestrant|mesh-list
24904496|NCT04355520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24904497|NCT04355520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904498|NCT04355520|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24904499|NCT04355520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24904500|NCT04355520|Hormone Antagonists|hormone antagonists|mesh-ancestor
24904501|NCT04355520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24904502|NCT04355520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904536|NCT04355455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24904537|NCT04355455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24904538|NCT04355455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24904539|NCT04355455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904540|NCT04355455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24904541|NCT04355455|Serotonin Agents|serotonin agents|mesh-ancestor
24904542|NCT04355455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904543|NCT04355455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24904544|NCT04355455|Antidepressive Agents|antidepressive agents|mesh-ancestor
24904545|NCT04355455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24904578|NCT04354961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904579|NCT04355039|Dexamethasone|dexamethasone|mesh-list
24904580|NCT04355039|Pomalidomide|pomalidomide|mesh-list
24904581|NCT04355039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24904582|NCT04355039|Antiemetics|antiemetics|mesh-ancestor
24904583|NCT04355039|Autonomic Agents|autonomic agents|mesh-ancestor
24904584|NCT04355039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24904585|NCT04355039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904586|NCT04355039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24904587|NCT04355039|Glucocorticoids|glucocorticoids|mesh-ancestor
24904589|NCT04355039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24904590|NCT04355039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24904591|NCT04355039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904592|NCT04355039|Immunologic Factors|immunologic factors|mesh-ancestor
24904593|NCT04355039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24904594|NCT04355039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24904595|NCT04355039|Growth Substances|growth substances|mesh-ancestor
24904631|NCT04354662|Protective Agents|protective agents|mesh-ancestor
24904633|NCT04354662|Vitamins|vitamins|mesh-ancestor
24519335|NCT02030990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24519336|NCT02030990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519337|NCT02030990|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24519338|NCT01898793|Vidarabine|vidarabine|mesh-list
24519339|NCT01898793|Aldesleukin|aldesleukin|mesh-list
24519340|NCT01898793|Cyclophosphamide|cyclophosphamide|mesh-list
24519341|NCT01898793|Fludarabine|fludarabine|mesh-list
24519342|NCT01898793|Fludarabine phosphate|fludarabine phosphate|mesh-list
24519343|NCT01898793|Interleukin-2|interleukin-2|mesh-list
24519344|NCT01898793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24519345|NCT01898793|Immunologic Factors|immunologic factors|mesh-ancestor
24519346|NCT01898793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818469|NCT02088970|Dermatologic Agents|dermatologic agents|mesh-ancestor
24818470|NCT02088983|Choline|choline|mesh-list
25064221|NCT03461783|Charcoal|charcoal|mesh-list
25064222|NCT03461783|Antidotes|antidotes|mesh-ancestor
25064223|NCT03461783|Protective Agents|protective agents|mesh-ancestor
25064224|NCT03461783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064225|NCT03461718|Fentanyl|fentanyl|mesh-list
25064226|NCT03461718|Midazolam|midazolam|mesh-list
25064227|NCT03461718|Ketamine|ketamine|mesh-list
25064228|NCT03461718|Analgesics|analgesics|mesh-ancestor
24710561|NCT01511159|Insulin|insulin|mesh-list
24818489|NCT02089061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904644|NCT04354545|Lifitegrast|lifitegrast|mesh-list
24818491|NCT02089126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24818492|NCT02089126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24727625|NCT01611480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904645|NCT04354545|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24904647|NCT04354350|Ramipril|ramipril|mesh-list
24904648|NCT04354350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24904649|NCT04354350|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24904650|NCT04354350|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24904651|NCT04354350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904652|NCT04354350|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25064234|NCT03461718|Anesthetics, General|anesthetics, general|mesh-ancestor
24710624|NCT01511263|Amiodarone|amiodarone|mesh-list
24904720|NCT04353505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904721|NCT04353505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24904722|NCT04353505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24904723|NCT04353505|Analgesics|analgesics|mesh-ancestor
24904724|NCT04353505|Sensory System Agents|sensory system agents|mesh-ancestor
24904725|NCT04353505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24904726|NCT04353505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24904727|NCT04353505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904728|NCT04353505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904729|NCT04353479|Decitabine|decitabine|mesh-list
24904730|NCT04353479|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24904731|NCT04353479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24904732|NCT04353479|Antimetabolites|antimetabolites|mesh-ancestor
24904733|NCT04353479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904734|NCT04353479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904735|NCT04353479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904741|NCT04353362|Amoxicillin|amoxicillin|mesh-list
24519347|NCT01898793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24813865|NCT02060656|Hormones|hormones|mesh-ancestor
24904742|NCT04353362|Metronidazole|metronidazole|mesh-list
24904743|NCT04353362|Ofloxacin|ofloxacin|mesh-list
24904744|NCT04353362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24904745|NCT04353362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24904746|NCT04353362|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24904747|NCT04353362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24904748|NCT04353362|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24904749|NCT04353362|Renal Agents|renal agents|mesh-ancestor
24904750|NCT04353362|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24904751|NCT04353362|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24904752|NCT04353362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904753|NCT04353362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904754|NCT04353362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904826|NCT04352855|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24904827|NCT04352855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904828|NCT04352855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904829|NCT04352855|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24904830|NCT04352855|Renal Agents|renal agents|mesh-ancestor
24904831|NCT04352686|Buspirone|buspirone|mesh-list
24904832|NCT04352686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24904833|NCT04352686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24904836|NCT04352686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24480724|NCT00431795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25699376|NCT02106325|Promethazine|promethazine|mesh-list
24904840|NCT04352686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904841|NCT04352621|Ketamine|ketamine|mesh-list
24904842|NCT04352621|Analgesics|analgesics|mesh-ancestor
25699377|NCT02106325|Ketamine|ketamine|mesh-list
25699378|NCT02106325|Analgesics|analgesics|mesh-ancestor
24659688|NCT01279291|Paclitaxel|paclitaxel|mesh-list
25699379|NCT02106325|Sensory System Agents|sensory system agents|mesh-ancestor
24904863|NCT04352400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24904865|NCT04352400|Protease Inhibitors|protease inhibitors|mesh-ancestor
25064244|NCT03461718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25064245|NCT03461718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25064246|NCT03461718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25064247|NCT03461718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25064248|NCT03461718|GABA Modulators|gaba modulators|mesh-ancestor
25064249|NCT03461718|GABA Agents|gaba agents|mesh-ancestor
25064250|NCT03461627|Fluticasone|fluticasone|mesh-list
25064251|NCT03461627|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25064252|NCT03461627|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25064253|NCT03461627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25064254|NCT03461627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25064255|NCT03461627|Autonomic Agents|autonomic agents|mesh-ancestor
25064256|NCT03461627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24710754|NCT01511731|Famotidine|famotidine|mesh-list
24904873|NCT04352153|Febuxostat|febuxostat|mesh-list
24904877|NCT04352153|Chelating Agents|chelating agents|mesh-ancestor
24904878|NCT04352153|Sequestering Agents|sequestering agents|mesh-ancestor
24904879|NCT04352153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904880|NCT04352153|Gout Suppressants|gout suppressants|mesh-ancestor
24904881|NCT04352153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24904882|NCT04352465|Methotrexate|methotrexate|mesh-list
24904883|NCT04352465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24904884|NCT04352465|Abortifacient Agents|abortifacient agents|mesh-ancestor
24904885|NCT04352465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24904886|NCT04352465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904887|NCT04352465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24904888|NCT04352465|Antimetabolites|antimetabolites|mesh-ancestor
24904889|NCT04352465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904890|NCT04352465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904891|NCT04352465|Dermatologic Agents|dermatologic agents|mesh-ancestor
24904892|NCT04352465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904893|NCT04352465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24904894|NCT04352465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24904895|NCT04352465|Immunologic Factors|immunologic factors|mesh-ancestor
24904896|NCT04352465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24446672|NCT00305630|Triamcinolone|triamcinolone|mesh-list
24904897|NCT04352465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24904898|NCT04351724|Ritonavir|ritonavir|mesh-list
24904899|NCT04351724|Lopinavir|lopinavir|mesh-list
24904900|NCT04351724|Hydroxychloroquine|hydroxychloroquine|mesh-list
24904901|NCT04351724|Chloroquine|chloroquine|mesh-list
24904902|NCT04351724|Remdesivir|remdesivir|mesh-list
24904903|NCT04351724|Candesartan|candesartan|mesh-list
24904904|NCT04351724|Antihypertensive Agents|antihypertensive agents|mesh-list
24904905|NCT04351724|Rivaroxaban|rivaroxaban|mesh-list
24904906|NCT04351724|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24904907|NCT04351724|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24904908|NCT04351724|Protease Inhibitors|protease inhibitors|mesh-ancestor
24480789|NCT00432120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064257|NCT03461627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064258|NCT03461627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25064259|NCT03461627|Respiratory System Agents|respiratory system agents|mesh-ancestor
25064260|NCT03461627|Dermatologic Agents|dermatologic agents|mesh-ancestor
25064261|NCT03461627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25407303|NCT03508921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25064262|NCT03461627|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25064264|NCT03461627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25064265|NCT03461627|Adrenergic Agents|adrenergic agents|mesh-ancestor
25064266|NCT03461627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24864318|NCT04948463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864319|NCT04948463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864320|NCT04948463|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24864321|NCT04948463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24864322|NCT04948463|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24864324|NCT04939363|Obinutuzumab|obinutuzumab|mesh-list
24864327|NCT04894721|Ivermectin|ivermectin|mesh-list
25064270|NCT03461627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25064271|NCT03461627|Sympathomimetics|sympathomimetics|mesh-ancestor
25064272|NCT03461575|Cyclosporine|cyclosporine|mesh-list
25064273|NCT03461575|Cyclosporins|cyclosporins|mesh-list
25064274|NCT03461575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826753|NCT02135887|Leucovorin|leucovorin|mesh-list
24519356|NCT01898793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24519357|NCT01898793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24519358|NCT01898793|Analgesics|analgesics|mesh-ancestor
24519359|NCT01898793|Sensory System Agents|sensory system agents|mesh-ancestor
24519360|NCT01898793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24519361|NCT01898793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24519362|NCT01898793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24519363|NCT01791920|Botulinum Toxins|botulinum toxins|mesh-list
24519364|NCT01791920|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24519365|NCT01791920|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24519379|NCT01773707|Immunologic Factors|immunologic factors|mesh-ancestor
24519380|NCT01773707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519381|NCT01773707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24519382|NCT01724866|Cyclophosphamide|cyclophosphamide|mesh-list
24519384|NCT01724866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24519385|NCT01724866|Immunologic Factors|immunologic factors|mesh-ancestor
24519386|NCT01724866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519387|NCT01724866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24904936|NCT04351763|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24904937|NCT04351763|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24904938|NCT04351763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24904939|NCT04351763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904940|NCT04351763|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24904941|NCT04351763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24904942|NCT04351763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24904943|NCT04351763|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24904944|NCT04351763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24904945|NCT04351763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818493|NCT02089126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818495|NCT02089126|Immunologic Factors|immunologic factors|mesh-ancestor
24818496|NCT02089178|Remifentanil|remifentanil|mesh-list
24818497|NCT02089178|Anesthetics|anesthetics|mesh-list
24818498|NCT02089178|Propofol|propofol|mesh-list
24818499|NCT02089178|Sevoflurane|sevoflurane|mesh-list
24818500|NCT02089178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24519394|NCT01724866|Antimitotic Agents|antimitotic agents|mesh-ancestor
24519398|NCT01711021|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24519399|NCT01711021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519400|NCT01711021|Sympathomimetics|sympathomimetics|mesh-ancestor
24519401|NCT01711021|Autonomic Agents|autonomic agents|mesh-ancestor
24519402|NCT01711021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24519403|NCT01711021|Dopamine Agents|dopamine agents|mesh-ancestor
24519404|NCT01711021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24519405|NCT01711021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519406|NCT01711021|Adrenergic Agents|adrenergic agents|mesh-ancestor
24519407|NCT01711021|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24818506|NCT02089178|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24818507|NCT02089178|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24614699|NCT01025934|Bevacizumab|bevacizumab|mesh-list
24818508|NCT02089178|Narcotics|narcotics|mesh-ancestor
24818509|NCT02089178|Analgesics|analgesics|mesh-ancestor
24614847|NCT01026428|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25699380|NCT02106325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24614848|NCT01026428|Dopamine Agents|dopamine agents|mesh-ancestor
24614849|NCT01026428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24614850|NCT01026428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623620|NCT01072812|Cholinergic Agents|cholinergic agents|mesh-ancestor
24904950|NCT04352062|Pantoprazole|pantoprazole|mesh-list
24904951|NCT04352062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24904952|NCT04352062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24904953|NCT04352062|Antioxidants|antioxidants|mesh-ancestor
24904954|NCT04352062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049767|NCT00566202|Serotonin Agents|serotonin agents|mesh-ancestor
24904955|NCT04352062|Protective Agents|protective agents|mesh-ancestor
24904956|NCT04352062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904960|NCT04352062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24904961|NCT04352062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24904962|NCT04352062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904963|NCT04352062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904964|NCT04352062|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24904965|NCT04352062|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24904966|NCT04352062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24904967|NCT04352062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24905010|NCT04351620|Hydroxychloroquine|hydroxychloroquine|mesh-list
24905011|NCT04351620|Antimalarials|antimalarials|mesh-ancestor
24905012|NCT04351620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24905013|NCT04351620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24905014|NCT04351620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905015|NCT04351620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905016|NCT04351620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905017|NCT04351620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24646302|NCT01203111|Insulin|insulin|mesh-list
24905019|NCT04351412|Fluorides, Topical|fluorides, topical|mesh-list
24905020|NCT04351412|Cariostatic Agents|cariostatic agents|mesh-ancestor
24905021|NCT04351412|Protective Agents|protective agents|mesh-ancestor
24905022|NCT04351412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905023|NCT04351594|Menthol|menthol|mesh-list
24905024|NCT04351594|Antipruritics|antipruritics|mesh-ancestor
24905025|NCT04351594|Dermatologic Agents|dermatologic agents|mesh-ancestor
24905026|NCT04351347|Ivermectin|ivermectin|mesh-list
24905027|NCT04351347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24905058|NCT04351191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905059|NCT04351191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905060|NCT04351191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24905061|NCT04351191|Amebicides|amebicides|mesh-ancestor
24905062|NCT04351581|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25064281|NCT03461575|Dermatologic Agents|dermatologic agents|mesh-ancestor
25064282|NCT03461575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24905141|NCT04350684|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24905142|NCT04350684|Protease Inhibitors|protease inhibitors|mesh-ancestor
24905143|NCT04350684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905144|NCT04350684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905145|NCT04350684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24905146|NCT04350684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24905186|NCT04350671|Immunologic Factors|immunologic factors|mesh-ancestor
24905187|NCT04350671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905188|NCT04350671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24905189|NCT04350086|Dexmedetomidine|dexmedetomidine|mesh-list
24905190|NCT04350086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24905191|NCT04350086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24905192|NCT04350086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905207|NCT04350190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905209|NCT04350281|Interferon-beta|interferon-beta|mesh-list
24905210|NCT04350281|Hydroxychloroquine|hydroxychloroquine|mesh-list
24905211|NCT04350281|Interferon beta-1b|interferon beta-1b|mesh-list
24905213|NCT04350281|Antiviral Agents|antiviral agents|mesh-ancestor
24905234|NCT04349592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905235|NCT04349592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24905236|NCT04349696|Mitiglinide|mitiglinide|mesh-list
24905237|NCT04349696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24905238|NCT04349696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905239|NCT04349228|Hydroxychloroquine|hydroxychloroquine|mesh-list
24905240|NCT04349228|Antimalarials|antimalarials|mesh-ancestor
24905241|NCT04349228|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24905242|NCT04349228|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24544595|NCT00689624|Cetuximab|cetuximab|mesh-list
24864715|NCT02755844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864725|NCT02741388|Gemcitabine|gemcitabine|mesh-list
24905243|NCT04349228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24623636|NCT01072942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24623637|NCT01072942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623638|NCT01072942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818540|NCT02089308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24818541|NCT02089308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24818542|NCT02089308|Cholinergic Agents|cholinergic agents|mesh-ancestor
24818543|NCT02089308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24449179|NCT00314639|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24818544|NCT02089308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818545|NCT02089386|Tamoxifen|tamoxifen|mesh-list
24818550|NCT02089386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24818551|NCT02089386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24818552|NCT02089386|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24818553|NCT02089386|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24818554|NCT02089386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24818556|NCT02089399|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24818557|NCT02089399|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24818558|NCT02089399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24818559|NCT02089399|Antimetabolites|antimetabolites|mesh-ancestor
24818560|NCT02089399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728302|NCT01615393|Ribavirin|ribavirin|mesh-list
24905255|NCT04349410|Clindamycin palmitate|clindamycin palmitate|mesh-list
24905256|NCT04349410|Clindamycin phosphate|clindamycin phosphate|mesh-list
24905257|NCT04349410|Primaquine|primaquine|mesh-list
24905258|NCT04349410|Methylprednisolone|methylprednisolone|mesh-list
24905289|NCT04349241|Antiviral Agents|antiviral agents|mesh-ancestor
25064296|NCT03461328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25064298|NCT03461328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25064303|NCT03461185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25064304|NCT03461185|Growth Substances|growth substances|mesh-ancestor
24864753|NCT02686346|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24864754|NCT02686346|Carboplatin|carboplatin|mesh-list
24864755|NCT02686346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25064305|NCT03461185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064306|NCT03461185|Growth Inhibitors|growth inhibitors|mesh-ancestor
24905290|NCT04349241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905291|NCT04349826|Azithromycin|azithromycin|mesh-list
24905292|NCT04349826|Cefixime|cefixime|mesh-list
24905293|NCT04349826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24905294|NCT04349826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905295|NCT04348786|Amoxicillin|amoxicillin|mesh-list
24905296|NCT04348786|Doxycycline|doxycycline|mesh-list
24905297|NCT04348786|Levofloxacin|levofloxacin|mesh-list
24905298|NCT04348786|Ofloxacin|ofloxacin|mesh-list
24905299|NCT04348786|Esomeprazole|esomeprazole|mesh-list
24905300|NCT04348786|Bismuth|bismuth|mesh-list
24905301|NCT04348786|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
24905302|NCT04348786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24905303|NCT04348786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905304|NCT04348786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24519413|NCT01670877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24519414|NCT01670877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519415|NCT01670877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24905312|NCT04348786|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24905313|NCT04348786|Renal Agents|renal agents|mesh-ancestor
24905314|NCT04348786|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24905315|NCT04348786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24856308|NCT02283710|Pentoxifylline|pentoxifylline|mesh-list
24905318|NCT04348786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24905323|NCT04348877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905327|NCT04348305|Hydrocortisone|hydrocortisone|mesh-list
24864756|NCT02686346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864757|NCT02686346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24864758|NCT02686346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24864759|NCT02686346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864762|NCT02686346|Alkylating Agents|alkylating agents|mesh-ancestor
24905328|NCT04348305|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24905329|NCT04348305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24905330|NCT04348370|Vaccines|vaccines|mesh-list
24905331|NCT04348370|BCG Vaccine|bcg vaccine|mesh-list
24905332|NCT04348370|Immunologic Factors|immunologic factors|mesh-ancestor
24905333|NCT04348370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905334|NCT04348370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24905335|NCT04348474|Azithromycin|azithromycin|mesh-list
24905336|NCT04348474|Hydroxychloroquine|hydroxychloroquine|mesh-list
24905337|NCT04348474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24905338|NCT04348474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905339|NCT04348474|Antimalarials|antimalarials|mesh-ancestor
25064314|NCT03461081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25064315|NCT03461081|Antimetabolites|antimetabolites|mesh-ancestor
24826785|NCT02135965|Purinergic Agents|purinergic agents|mesh-ancestor
24826786|NCT02135965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24826787|NCT02135965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24826788|NCT02135965|Autonomic Agents|autonomic agents|mesh-ancestor
24826789|NCT02135965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24826790|NCT02135965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24443924|NCT00296205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24443925|NCT00296205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24443926|NCT00296205|Alkylating Agents|alkylating agents|mesh-ancestor
24443930|NCT00296218|Irbesartan|irbesartan|mesh-list
24443935|NCT00296257|Rimacalib|rimacalib|mesh-list
24905344|NCT04348474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24905345|NCT04348409|Nitazoxanide|nitazoxanide|mesh-list
24519417|NCT01670877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24905420|NCT04347980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905424|NCT04347980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24905426|NCT04347980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905427|NCT04347980|Antimalarials|antimalarials|mesh-ancestor
25064321|NCT03461081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25064322|NCT03461081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24826791|NCT02135965|Respiratory System Agents|respiratory system agents|mesh-ancestor
24905428|NCT04347980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24905429|NCT04347980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24905430|NCT04347980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905431|NCT04347980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905432|NCT04347980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905433|NCT04347980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24905447|NCT04347720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24905448|NCT04347720|Analgesics|analgesics|mesh-ancestor
24905449|NCT04347720|Sensory System Agents|sensory system agents|mesh-ancestor
24905450|NCT04347720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24905451|NCT04347720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905452|NCT04347720|Antipyretics|antipyretics|mesh-ancestor
24905453|NCT04347720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24905454|NCT04347720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24905455|NCT04347720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24905456|NCT04347720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24905457|NCT04347720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905458|NCT04347720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905459|NCT04347720|Gout Suppressants|gout suppressants|mesh-ancestor
24905468|NCT04347577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407916|NCT00175890|Levetiracetam|levetiracetam|mesh-list
24459646|NCT00345696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24459647|NCT00345696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24459648|NCT00345696|Growth Substances|growth substances|mesh-ancestor
24856376|NCT02284035|Lamivudine|lamivudine|mesh-list
24905470|NCT04347577|Sensory System Agents|sensory system agents|mesh-ancestor
24905471|NCT04347577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24905472|NCT04347577|Antidepressive Agents|antidepressive agents|mesh-ancestor
24905473|NCT04347577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24905474|NCT04347577|Dopamine Agents|dopamine agents|mesh-ancestor
24905504|NCT04347031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905506|NCT04347005|Allopurinol|allopurinol|mesh-list
24905507|NCT04347005|Febuxostat|febuxostat|mesh-list
24905508|NCT04347005|Antimetabolites|antimetabolites|mesh-ancestor
24905509|NCT04347005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905510|NCT04347005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905511|NCT04347005|Gout Suppressants|gout suppressants|mesh-ancestor
25064323|NCT03461081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25064324|NCT03461081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064325|NCT03461081|Vasodilator Agents|vasodilator agents|mesh-ancestor
25064326|NCT03461081|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25064327|NCT03461081|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24826797|NCT02135965|Adrenergic Agents|adrenergic agents|mesh-ancestor
24905512|NCT04347005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24905513|NCT04347005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24905514|NCT04347005|Antioxidants|antioxidants|mesh-ancestor
24905515|NCT04347005|Protective Agents|protective agents|mesh-ancestor
24905516|NCT04347005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905517|NCT04347200|Anticoagulants|anticoagulants|mesh-list
24905518|NCT04347200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
24905529|NCT04346823|Anesthetics|anesthetics|mesh-ancestor
24905530|NCT04346823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24905531|NCT04346823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905532|NCT04347187|Anticoagulants|anticoagulants|mesh-list
24905533|NCT04346797|Eculizumab|eculizumab|mesh-list
24646546|NCT01204216|Biotin|biotin|mesh-list
24905670|NCT04345692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24481405|NCT00434382|Alfentanil|alfentanil|mesh-list
24481406|NCT00434382|Propofol|propofol|mesh-list
24905593|NCT04346277|Immunologic Factors|immunologic factors|mesh-ancestor
24905594|NCT04346277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064350|NCT03460964|Pilocarpine|pilocarpine|mesh-list
25064351|NCT03460964|Miotics|miotics|mesh-ancestor
25064352|NCT03460964|Autonomic Agents|autonomic agents|mesh-ancestor
25064353|NCT03460964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25064354|NCT03460964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064355|NCT03460964|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25064356|NCT03460964|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25064357|NCT03460964|Cholinergic Agents|cholinergic agents|mesh-ancestor
25064358|NCT03460964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24826821|NCT02136147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24826822|NCT02136147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24826823|NCT02136147|Adrenergic Agents|adrenergic agents|mesh-ancestor
25699381|NCT02106325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699382|NCT02106325|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25699383|NCT02106325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25699384|NCT02106325|Anesthetics, General|anesthetics, general|mesh-ancestor
25699385|NCT02106325|Anesthetics|anesthetics|mesh-ancestor
25699386|NCT02106325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25699387|NCT02106325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25699388|NCT02106325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24905634|NCT04346017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905635|NCT04346147|Imatinib Mesylate|imatinib mesylate|mesh-list
24905639|NCT04346147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905655|NCT04345432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24865031|NCT04931511|Hormones|hormones|mesh-ancestor
24544951|NCT00691145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24544952|NCT00691145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24865074|NCT04682288|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24905682|NCT04345445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24905713|NCT04345744|Dermatologic Agents|dermatologic agents|mesh-ancestor
25699389|NCT02106325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25699390|NCT02106325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699391|NCT02106325|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25699392|NCT02106325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25699393|NCT02106325|Anesthetics, Local|anesthetics, local|mesh-ancestor
25699394|NCT02106325|Antiemetics|antiemetics|mesh-ancestor
25699395|NCT02106325|Autonomic Agents|autonomic agents|mesh-ancestor
24905715|NCT04345458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24905716|NCT04345458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24905717|NCT04345458|Analgesics|analgesics|mesh-ancestor
24905718|NCT04345458|Sensory System Agents|sensory system agents|mesh-ancestor
24905719|NCT04345458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24905720|NCT04345458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905721|NCT04345458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24905722|NCT04345458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24905723|NCT04345458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24905724|NCT04345458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24905725|NCT04345458|Immunologic Factors|immunologic factors|mesh-ancestor
24905726|NCT04345419|Remdesivir|remdesivir|mesh-list
24905727|NCT04345419|Antimetabolites|antimetabolites|mesh-ancestor
24905731|NCT04345406|Chloroquine|chloroquine|mesh-list
24905740|NCT04345406|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24905741|NCT04345406|Protease Inhibitors|protease inhibitors|mesh-ancestor
24905742|NCT04345406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905743|NCT04345406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905744|NCT04345406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24905746|NCT04344951|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24905747|NCT04344951|Amebicides|amebicides|mesh-ancestor
24905748|NCT04344951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24905749|NCT04344951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24905750|NCT04344951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905751|NCT04344951|Antimalarials|antimalarials|mesh-ancestor
24905752|NCT04344951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24905753|NCT04344951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24905755|NCT04344951|Analgesics|analgesics|mesh-ancestor
25064367|NCT03460860|Protective Agents|protective agents|mesh-ancestor
24865172|NCT04298034|Labetalol|labetalol|mesh-list
25064368|NCT03460860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064369|NCT03460860|Vitamins|vitamins|mesh-ancestor
25064370|NCT03460860|Micronutrients|micronutrients|mesh-ancestor
25064371|NCT03460860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25064372|NCT03460860|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25064373|NCT03460860|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25064374|NCT03460860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25064375|NCT03460808|Acetylcysteine|acetylcysteine|mesh-list
25064376|NCT03460808|Atorvastatin|atorvastatin|mesh-list
25064377|NCT03460808|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24826835|NCT02136329|Urological Agents|urological agents|mesh-ancestor
24826836|NCT02136511|Rituximab|rituximab|mesh-list
24826837|NCT02136511|Idelalisib|idelalisib|mesh-list
24826838|NCT02136511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24826839|NCT02136511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905757|NCT04344951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24905758|NCT04344951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905759|NCT04344951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24905760|NCT04344951|Filaricides|filaricides|mesh-ancestor
24905761|NCT04344951|Antinematodal Agents|antinematodal agents|mesh-ancestor
24905762|NCT04344951|Anthelmintics|anthelmintics|mesh-ancestor
24905763|NCT04345094|Hydroquinone|hydroquinone|mesh-list
24905764|NCT04345094|Antioxidants|antioxidants|mesh-ancestor
24905782|NCT04345276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905784|NCT04345276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24905785|NCT04345276|Antiviral Agents|antiviral agents|mesh-ancestor
24905786|NCT04345276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905787|NCT04345276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24905788|NCT04345276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24905789|NCT04345198|Epinephrine|epinephrine|mesh-list
24905790|NCT04345198|Racepinephrine|racepinephrine|mesh-list
24905791|NCT04345198|Epinephryl borate|epinephryl borate|mesh-list
24905794|NCT04345198|Adrenergic Agents|adrenergic agents|mesh-ancestor
24905795|NCT04345198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24905796|NCT04345198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905797|NCT04345198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905798|NCT04345198|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24905799|NCT04345198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24905800|NCT04345198|Autonomic Agents|autonomic agents|mesh-ancestor
24905801|NCT04345198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24905802|NCT04345198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24905803|NCT04345198|Respiratory System Agents|respiratory system agents|mesh-ancestor
24905804|NCT04345198|Mydriatics|mydriatics|mesh-ancestor
24905805|NCT04345198|Sympathomimetics|sympathomimetics|mesh-ancestor
24905806|NCT04345198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24905807|NCT04344821|Calcium|calcium|mesh-list
24905808|NCT04344821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24905809|NCT04344821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905810|NCT04344483|Lidocaine|lidocaine|mesh-list
24905811|NCT04344483|Epinephrine|epinephrine|mesh-list
24905812|NCT04344483|Racepinephrine|racepinephrine|mesh-list
24905819|NCT04344483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24905820|NCT04344483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24905821|NCT04344483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24905822|NCT04344483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25064378|NCT03460808|Danazol|danazol|mesh-list
25064379|NCT03460808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25064380|NCT03460808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25064381|NCT03460808|Antimetabolites|antimetabolites|mesh-ancestor
25064382|NCT03460808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064383|NCT03460808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25064384|NCT03460808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25064385|NCT03460808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905823|NCT04344483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24920686|NCT04199143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24905824|NCT04344483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905825|NCT04344483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24905826|NCT04344483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24905827|NCT04344483|Adrenergic Agents|adrenergic agents|mesh-ancestor
24905828|NCT04344483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24905829|NCT04344483|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24905830|NCT04344483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24905831|NCT04344483|Autonomic Agents|autonomic agents|mesh-ancestor
24905845|NCT04344457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905847|NCT04344457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24905848|NCT04344457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24481538|NCT00435331|Verapamil|verapamil|mesh-list
24519435|NCT01518556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24519436|NCT01518556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519437|NCT01518556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24519438|NCT01518556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24519439|NCT01518556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24519440|NCT01518556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519442|NCT01208662|Lenalidomide|lenalidomide|mesh-list
24519443|NCT01208662|Bortezomib|bortezomib|mesh-list
24519444|NCT01208662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24519445|NCT01208662|Antiemetics|antiemetics|mesh-ancestor
24519446|NCT01208662|Autonomic Agents|autonomic agents|mesh-ancestor
24519447|NCT01208662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24905849|NCT04344457|Analgesics|analgesics|mesh-ancestor
24905850|NCT04344457|Sensory System Agents|sensory system agents|mesh-ancestor
24905851|NCT04344457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24905852|NCT04344457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905853|NCT04344457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24905854|NCT04344457|Gout Suppressants|gout suppressants|mesh-ancestor
24905855|NCT04344457|Tocolytic Agents|tocolytic agents|mesh-ancestor
24905856|NCT04344457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24905857|NCT04344457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24905858|NCT04344457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24905860|NCT04344756|Calcium heparin|calcium heparin|mesh-list
24905861|NCT04344756|Tinzaparin|tinzaparin|mesh-list
24905862|NCT04344756|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24905863|NCT04344756|Dalteparin|dalteparin|mesh-list
24905864|NCT04344756|Anticoagulants|anticoagulants|mesh-ancestor
24905865|NCT04344756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24905866|NCT04344756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24818577|NCT02089438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25064389|NCT03460808|Respiratory System Agents|respiratory system agents|mesh-ancestor
25064390|NCT03460808|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25064391|NCT03460808|Antioxidants|antioxidants|mesh-ancestor
25064392|NCT03460808|Protective Agents|protective agents|mesh-ancestor
24826852|NCT02136589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24600326|NCT01026220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24818594|NCT02089529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24818595|NCT02089529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818596|NCT02089529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24481593|NCT00435760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24454116|NCT04432012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24454125|NCT04392531|Cyclosporins|cyclosporins|mesh-list
24454126|NCT04392531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24454127|NCT04392531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519448|NCT01208662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519449|NCT01208662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24519450|NCT01208662|Glucocorticoids|glucocorticoids|mesh-ancestor
24519452|NCT01208662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24519453|NCT01208662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24818599|NCT02089529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24818600|NCT02089529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818601|NCT02089542|Methylene Blue|methylene blue|mesh-list
24818602|NCT02089542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24818603|NCT02089542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818604|NCT02089568|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25064395|NCT03460808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25064396|NCT03460808|Hormone Antagonists|hormone antagonists|mesh-ancestor
25699396|NCT02106325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25699397|NCT02106325|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25699398|NCT02106325|Histamine Antagonists|histamine antagonists|mesh-ancestor
25699399|NCT02106325|Histamine Agents|histamine agents|mesh-ancestor
25699400|NCT02106325|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25699401|NCT02106325|Antipruritics|antipruritics|mesh-ancestor
24826854|NCT02136589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24826855|NCT02136589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24826856|NCT02136589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24446042|NCT00303745|Capecitabine|capecitabine|mesh-list
24826857|NCT02136589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826858|NCT02136589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826859|NCT02136641|Fentanyl|fentanyl|mesh-list
24826860|NCT02136641|Midazolam|midazolam|mesh-list
24826861|NCT02136641|Ketamine|ketamine|mesh-list
24443958|NCT00296348|Antitubercular Agents|antitubercular agents|mesh-ancestor
24818605|NCT02089568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24818606|NCT02089568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24818607|NCT02089568|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24818608|NCT02089568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24818609|NCT02089568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818611|NCT02089633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24818612|NCT02089763|BCT-100|bct-100|mesh-list
24906053|NCT04343235|Natriuretic Agents|natriuretic agents|mesh-ancestor
24818619|NCT02089841|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24818620|NCT02089841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24818621|NCT02089854|Toremifene|toremifene|mesh-list
24818622|NCT02089854|Anastrozole|anastrozole|mesh-list
24818623|NCT02089854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24444310|NCT00297388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444311|NCT00297388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444312|NCT00297388|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24444630|NCT00298662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444631|NCT00298662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24444632|NCT00298662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444633|NCT00298662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444634|NCT00298662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25064411|NCT03460678|Pemetrexed|pemetrexed|mesh-list
25064412|NCT03460678|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24826864|NCT02136641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24583616|NCT00875771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24443964|NCT00296361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443965|NCT00296361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25699402|NCT02106325|Dermatologic Agents|dermatologic agents|mesh-ancestor
25699403|NCT02106390|Vaccines|vaccines|mesh-list
25699404|NCT02106390|Immunologic Factors|immunologic factors|mesh-ancestor
25699405|NCT02106390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699406|NCT02106403|Disinfectants|disinfectants|mesh-list
25699407|NCT02106403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25699408|NCT02106442|Risedronic Acid|risedronic acid|mesh-list
25699409|NCT02106442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25699410|NCT02106442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25699411|NCT02106442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538274|NCT00658255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24443966|NCT00296361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443967|NCT00296361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443968|NCT00296387|Atorvastatin|atorvastatin|mesh-list
24905918|NCT04344379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905919|NCT04344379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24905920|NCT04344041|Cholecalciferol|cholecalciferol|mesh-list
24905922|NCT04344041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24905923|NCT04344041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905924|NCT04344041|Vitamins|vitamins|mesh-ancestor
24905925|NCT04344041|Micronutrients|micronutrients|mesh-ancestor
24905926|NCT04344041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24905931|NCT04343885|Docetaxel|docetaxel|mesh-list
24905932|NCT04343885|177Lu-PSMA-617|177lu-psma-617|mesh-list
24905939|NCT04344158|Sorafenib|sorafenib|mesh-list
24905951|NCT04343768|Interferon-beta|interferon-beta|mesh-list
24905952|NCT04343768|Interferon beta-1a|interferon beta-1a|mesh-list
24905953|NCT04343768|Hydroxychloroquine|hydroxychloroquine|mesh-list
24905954|NCT04343768|Interferon beta-1b|interferon beta-1b|mesh-list
24826866|NCT02136641|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24711704|NCT01516580|Antimetabolites|antimetabolites|mesh-ancestor
24905956|NCT04343768|Antiviral Agents|antiviral agents|mesh-ancestor
24905957|NCT04343768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905958|NCT04343768|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24905959|NCT04343768|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24905960|NCT04343768|Protease Inhibitors|protease inhibitors|mesh-ancestor
24905961|NCT04343768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920687|NCT04199143|Anesthetics, General|anesthetics, general|mesh-ancestor
24905962|NCT04343768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905963|NCT04343768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24905964|NCT04343768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24905965|NCT04343768|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24905966|NCT04343768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24905967|NCT04343768|Antimalarials|antimalarials|mesh-ancestor
24905968|NCT04343768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24905969|NCT04343768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24905970|NCT04343768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24905971|NCT04343768|Immunologic Factors|immunologic factors|mesh-ancestor
24905972|NCT04343768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905973|NCT04343768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24905974|NCT04343729|Methylprednisolone|methylprednisolone|mesh-list
24905975|NCT04343729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24905976|NCT04343729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24905977|NCT04343729|Prednisolone|prednisolone|mesh-list
24905978|NCT04343729|Prednisolone acetate|prednisolone acetate|mesh-list
24906009|NCT04343651|Antiviral Agents|antiviral agents|mesh-ancestor
24906010|NCT04343651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24906011|NCT04343326|Menthol|menthol|mesh-list
24906012|NCT04343326|Antipruritics|antipruritics|mesh-ancestor
24906045|NCT04343001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24906046|NCT04343001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24906047|NCT04343001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24906048|NCT04343001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24906049|NCT04343001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24906050|NCT04343235|Labetalol|labetalol|mesh-list
25699412|NCT02106442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25699413|NCT02106442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699414|NCT02106442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25699415|NCT02106455|Risedronic Acid|risedronic acid|mesh-list
25699416|NCT02106455|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25699417|NCT02106455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25699418|NCT02106455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906051|NCT04343235|Furosemide|furosemide|mesh-list
24906052|NCT04343235|Diuretics|diuretics|mesh-ancestor
25064428|NCT03460470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064429|NCT03460470|Urological Agents|urological agents|mesh-ancestor
24906060|NCT04343235|Adrenergic Agents|adrenergic agents|mesh-ancestor
24906061|NCT04343235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24906085|NCT04342910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24906087|NCT04342676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24906088|NCT04342676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24906089|NCT04342598|Vitamin D|vitamin d|mesh-list
24906090|NCT04342598|Vitamins|vitamins|mesh-ancestor
24444900|NCT00299611|Anticonvulsants|anticonvulsants|mesh-ancestor
24906139|NCT04342065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24906140|NCT04342065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906142|NCT04342065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24906143|NCT04342065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24906144|NCT04342065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906145|NCT04342065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24906146|NCT04342065|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24906147|NCT04342065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24906148|NCT04342065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24906149|NCT04342065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24906150|NCT04342065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24856612|NCT02285751|Aspirin|aspirin|mesh-list
24444901|NCT00299611|Nootropic Agents|nootropic agents|mesh-ancestor
24444904|NCT00299650|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24444905|NCT00299650|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24444906|NCT00299650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24444907|NCT00299650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444908|NCT00299650|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24444909|NCT00299650|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24444910|NCT00299650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24444911|NCT00299650|Cholinergic Agents|cholinergic agents|mesh-ancestor
24444912|NCT00299650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24444913|NCT00299650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444914|NCT00299676|Galantamine|galantamine|mesh-list
24445051|NCT00300131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24445052|NCT00300131|Immunologic Factors|immunologic factors|mesh-ancestor
24445053|NCT00300131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445054|NCT00300196|Ancrod|ancrod|mesh-list
24445055|NCT00300196|Anticoagulants|anticoagulants|mesh-ancestor
24445056|NCT00300196|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24445057|NCT00300196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24906223|NCT04341935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481851|NCT00436943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24519454|NCT01208662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519455|NCT01208662|Immunologic Factors|immunologic factors|mesh-ancestor
24519456|NCT01208662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24519457|NCT01208662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24519458|NCT01208662|Growth Substances|growth substances|mesh-ancestor
24906243|NCT04341402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24906244|NCT04341402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906245|NCT04341402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24906246|NCT04341402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24906247|NCT04341402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24906249|NCT04341402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818628|NCT02089854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445086|NCT00300339|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24445218|NCT00300846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24445219|NCT00300846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445220|NCT00300846|Dopamine Agonists|dopamine agonists|mesh-ancestor
24445221|NCT00300846|Dopamine Agents|dopamine agents|mesh-ancestor
24445222|NCT00300846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24445223|NCT00300846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445226|NCT00300846|Serotonin Agents|serotonin agents|mesh-ancestor
24818632|NCT02089854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818635|NCT02089854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24818637|NCT02089867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24818638|NCT02089867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24818639|NCT02089867|Antimetabolites|antimetabolites|mesh-ancestor
24818640|NCT02089867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818641|NCT02089867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24818642|NCT02089932|Dexmedetomidine|dexmedetomidine|mesh-list
24818643|NCT02089932|Bupivacaine|bupivacaine|mesh-list
24818644|NCT02089932|Anesthetics, Local|anesthetics, local|mesh-ancestor
24818645|NCT02089932|Anesthetics|anesthetics|mesh-ancestor
24818646|NCT02089932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24818647|NCT02089932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818648|NCT02089932|Sensory System Agents|sensory system agents|mesh-ancestor
24818649|NCT02089932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24818650|NCT02089932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24445239|NCT00300924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24445779|NCT00302536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445781|NCT00302549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24445782|NCT00302549|Immunologic Factors|immunologic factors|mesh-ancestor
24445783|NCT00302549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445784|NCT00302549|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24445785|NCT00302549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445786|NCT00302549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906283|NCT04341675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25699419|NCT02106455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25699420|NCT02106455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699421|NCT02106455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25699422|NCT02106494|Dexamethasone|dexamethasone|mesh-list
25699423|NCT02106494|Ondansetron|ondansetron|mesh-list
25699424|NCT02106494|Fosaprepitant|fosaprepitant|mesh-list
25699425|NCT02106494|Aprepitant|aprepitant|mesh-list
25699426|NCT02106494|Granisetron|granisetron|mesh-list
24906284|NCT04341675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24906285|NCT04341675|Antifungal Agents|antifungal agents|mesh-ancestor
24906286|NCT04341675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24906287|NCT04341675|Immunologic Factors|immunologic factors|mesh-ancestor
24906288|NCT04341675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906289|NCT04341818|Vitamin D|vitamin d|mesh-list
24906290|NCT04341818|Ergocalciferols|ergocalciferols|mesh-list
24906291|NCT04341818|Cholecalciferol|cholecalciferol|mesh-list
24906292|NCT04341818|Vitamins|vitamins|mesh-list
24906293|NCT04341818|Micronutrients|micronutrients|mesh-ancestor
24906294|NCT04341818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906295|NCT04341818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24906296|NCT04341818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24906337|NCT04341207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906338|NCT04341207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906386|NCT04341155|Dexamethasone acetate|dexamethasone acetate|mesh-list
24906387|NCT04341155|BB 1101|bb 1101|mesh-list
24906388|NCT04341155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25064437|NCT03460275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25064438|NCT03460275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920689|NCT04199143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24451306|NCT00323011|Vitamin B Complex|vitamin b complex|mesh-ancestor
24657218|NCT01266213|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24906396|NCT04341155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24906538|NCT04339361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906539|NCT04339361|Oxytocics|oxytocics|mesh-ancestor
24906540|NCT04339361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24856668|NCT02286206|Clozapine|clozapine|mesh-list
24906749|NCT04337632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24906574|NCT04339348|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24906576|NCT04339348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24906577|NCT04339348|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24906578|NCT04339348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24906624|NCT04338919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24906625|NCT04338919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906626|NCT04338919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24906627|NCT04338919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24906628|NCT04338919|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24906629|NCT04338919|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24906630|NCT04338919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906631|NCT04338919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24906632|NCT04338919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24657219|NCT01266213|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24866398|NCT05152901|Sympathomimetics|sympathomimetics|mesh-ancestor
24866399|NCT05152901|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24866400|NCT05152667|Dienogest|dienogest|mesh-list
24906647|NCT04338620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906648|NCT04338373|Atropine|atropine|mesh-list
24906649|NCT04338373|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24906718|NCT04337918|Vasodilator Agents|vasodilator agents|mesh-ancestor
24906720|NCT04337918|Protective Agents|protective agents|mesh-ancestor
24906721|NCT04337814|Ibuprofen|ibuprofen|mesh-list
24906722|NCT04337814|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24446037|NCT00303732|Immunologic Factors|immunologic factors|mesh-ancestor
24446038|NCT00303732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446039|NCT00303732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24482262|NCT00438269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24482263|NCT00438269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482264|NCT00438269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24906750|NCT04337632|Tubulin Modulators|tubulin modulators|mesh-ancestor
24906751|NCT04337632|Antimitotic Agents|antimitotic agents|mesh-ancestor
24906752|NCT04337632|Mitosis Modulators|mitosis modulators|mesh-ancestor
24906753|NCT04337632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906754|NCT04337632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24906755|NCT04337632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24906756|NCT04337632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24906757|NCT04337632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906758|NCT04337658|Capecitabine|capecitabine|mesh-list
24906759|NCT04337658|Trastuzumab|trastuzumab|mesh-list
24906760|NCT04337658|Fulvestrant|fulvestrant|mesh-list
24906761|NCT04337658|Pertuzumab|pertuzumab|mesh-list
24866401|NCT05152667|Levonorgestrel|levonorgestrel|mesh-list
24906776|NCT04337450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24906777|NCT04337450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906778|NCT04337450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519459|NCT01208662|Growth Inhibitors|growth inhibitors|mesh-ancestor
24519460|NCT01198522|Gemcitabine|gemcitabine|mesh-list
24519461|NCT01198522|Antibodies|antibodies|mesh-list
24519462|NCT01198522|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24482277|NCT00438321|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24906779|NCT04337450|Antiviral Agents|antiviral agents|mesh-ancestor
24906780|NCT04337450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24906781|NCT04337450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24906782|NCT04337450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24906783|NCT04337450|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24906784|NCT04337450|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24906785|NCT04337606|Decitabine|decitabine|mesh-list
24647292|NCT01207739|Hydroxychloroquine|hydroxychloroquine|mesh-list
24906789|NCT04337606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24906790|NCT04337606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906791|NCT04337268|Glucagon|glucagon|mesh-list
24906796|NCT04337268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906797|NCT04337268|Incretins|incretins|mesh-ancestor
24906798|NCT04336891|Methyltestosterone|methyltestosterone|mesh-list
24906799|NCT04336891|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24519463|NCT01198522|Immunologic Factors|immunologic factors|mesh-ancestor
24519464|NCT01198522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519465|NCT01198522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24519466|NCT01198522|Antimetabolites|antimetabolites|mesh-ancestor
24519467|NCT01198522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519468|NCT01198522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519469|NCT01198522|Antiviral Agents|antiviral agents|mesh-ancestor
24519470|NCT01198522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25064445|NCT03460145|Anesthetics, General|anesthetics, general|mesh-ancestor
25064446|NCT03460145|Anesthetics|anesthetics|mesh-ancestor
25064447|NCT03460041|Magnesium Sulfate|magnesium sulfate|mesh-list
25064448|NCT03460041|Bupivacaine|bupivacaine|mesh-list
25064449|NCT03460041|Anesthetics, Local|anesthetics, local|mesh-ancestor
25064450|NCT03460041|Anesthetics|anesthetics|mesh-ancestor
24695004|NCT04765371|Antiemetics|antiemetics|mesh-ancestor
24446319|NCT00304434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24446320|NCT00304434|Renal Agents|renal agents|mesh-ancestor
24446322|NCT00304447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24446323|NCT00304447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24906984|NCT04334928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24519472|NCT01198522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24446489|NCT00304850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24519500|NCT05333250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519502|NCT05333159|Dapagliflozin|dapagliflozin|mesh-list
24906804|NCT04336891|Testosterone undecanoate|testosterone undecanoate|mesh-list
24906805|NCT04336891|Testosterone enanthate|testosterone enanthate|mesh-list
24906806|NCT04336891|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24818716|NCT02090439|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24818717|NCT02090439|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24818718|NCT02090439|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24818719|NCT02090439|Adrenergic Agents|adrenergic agents|mesh-ancestor
24818720|NCT02090439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24818721|NCT02090439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818722|NCT02090439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818723|NCT02090439|Urological Agents|urological agents|mesh-ancestor
24818724|NCT02090504|Sodium Oxybate|sodium oxybate|mesh-list
24818726|NCT02090504|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24818727|NCT02090504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24818728|NCT02090504|Anesthetics, General|anesthetics, general|mesh-ancestor
24818729|NCT02090504|Anesthetics|anesthetics|mesh-ancestor
24818730|NCT02090504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24818731|NCT02090504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818732|NCT02090504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24818733|NCT02090504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24818734|NCT02090504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24818735|NCT02090504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24906807|NCT04336891|Estrogens|estrogens|mesh-ancestor
24906808|NCT04336891|Hormones|hormones|mesh-ancestor
24906810|NCT04336891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906816|NCT04336891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24906821|NCT04336904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24906822|NCT04336917|Lidocaine|lidocaine|mesh-list
24906823|NCT04336917|Bupivacaine|bupivacaine|mesh-list
24906824|NCT04336917|Anesthetics, Local|anesthetics, local|mesh-list
24906825|NCT04336917|Anesthetics|anesthetics|mesh-list
24906826|NCT04336917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25064459|NCT03460041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25064460|NCT03460041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064461|NCT03460041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24906827|NCT04336917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906828|NCT04336917|Sensory System Agents|sensory system agents|mesh-ancestor
24906829|NCT04336917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24906830|NCT04336917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24906867|NCT04336488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24906868|NCT04336488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906869|NCT04336488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24866710|NCT05084599|Metaraminol|metaraminol|mesh-list
24906870|NCT04336488|Immunologic Factors|immunologic factors|mesh-ancestor
24906871|NCT04336488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906872|NCT04336488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906873|NCT04336488|Protease Inhibitors|protease inhibitors|mesh-ancestor
25699427|NCT02106494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25699428|NCT02106494|Antiemetics|antiemetics|mesh-ancestor
25699429|NCT02106494|Autonomic Agents|autonomic agents|mesh-ancestor
25699430|NCT02106494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699431|NCT02106494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699432|NCT02106494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25699433|NCT02106494|Glucocorticoids|glucocorticoids|mesh-ancestor
25699434|NCT02106494|Hormones|hormones|mesh-ancestor
24906884|NCT04336228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906886|NCT04336228|Serotonin Agents|serotonin agents|mesh-ancestor
24906887|NCT04336228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24906888|NCT04336228|Antidepressive Agents|antidepressive agents|mesh-ancestor
24906889|NCT04336228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24906946|NCT04334824|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24906947|NCT04334824|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24906948|NCT04334824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24906952|NCT04334824|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24906953|NCT04334824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24906954|NCT04334824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064463|NCT03460041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25064464|NCT03460002|Vaccines|vaccines|mesh-list
25064465|NCT03460002|Immunologic Factors|immunologic factors|mesh-ancestor
25064466|NCT03460002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064467|NCT03459911|Losartan|losartan|mesh-list
24906955|NCT04334824|Protease Inhibitors|protease inhibitors|mesh-ancestor
24906956|NCT04334824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906957|NCT04334967|Ascorbic Acid|ascorbic acid|mesh-list
24906958|NCT04334967|Hydroxychloroquine|hydroxychloroquine|mesh-list
24906959|NCT04334967|Vitamins|vitamins|mesh-ancestor
24906960|NCT04334967|Micronutrients|micronutrients|mesh-ancestor
24906961|NCT04334967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906962|NCT04334967|Antimalarials|antimalarials|mesh-ancestor
24906963|NCT04334967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24906964|NCT04334967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24906965|NCT04334967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24906966|NCT04334967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906967|NCT04334967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906968|NCT04334967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24906969|NCT04334967|Antioxidants|antioxidants|mesh-ancestor
24647467|NCT01209026|Autonomic Agents|autonomic agents|mesh-ancestor
24906970|NCT04334967|Protective Agents|protective agents|mesh-ancestor
24906971|NCT04334928|Tenofovir|tenofovir|mesh-list
24906972|NCT04334928|Emtricitabine|emtricitabine|mesh-list
24906973|NCT04334928|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24906974|NCT04334928|Hydroxychloroquine|hydroxychloroquine|mesh-list
24906975|NCT04334928|Antiviral Agents|antiviral agents|mesh-ancestor
24906976|NCT04334928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24906977|NCT04334928|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24482383|NCT00438841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482385|NCT00438841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24482386|NCT00438841|Alkylating Agents|alkylating agents|mesh-ancestor
24482391|NCT00438841|Antiemetics|antiemetics|mesh-ancestor
24906978|NCT04334928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24906980|NCT04334928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906981|NCT04334928|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24906982|NCT04334928|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24906983|NCT04334928|Antimalarials|antimalarials|mesh-ancestor
24482393|NCT00438841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24657220|NCT01266213|Hormone Antagonists|hormone antagonists|mesh-ancestor
24906994|NCT04334629|Analgesics|analgesics|mesh-ancestor
24907035|NCT04334005|Micronutrients|micronutrients|mesh-ancestor
24907036|NCT04334005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907037|NCT04334005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24907038|NCT04333823|Dapagliflozin|dapagliflozin|mesh-list
24907039|NCT04333823|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24907040|NCT04333823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907041|NCT04333823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24907042|NCT04333823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907043|NCT04333992|Remifentanil|remifentanil|mesh-list
24907044|NCT04333992|Propofol|propofol|mesh-list
24907045|NCT04333992|Sevoflurane|sevoflurane|mesh-list
24907046|NCT04333992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24818736|NCT02090504|GABA Modulators|gaba modulators|mesh-ancestor
24818737|NCT02090504|GABA Agents|gaba agents|mesh-ancestor
24818749|NCT02090673|Exenatide|exenatide|mesh-list
24818760|NCT02090738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24505133|NCT00540098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24505134|NCT00540098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24505135|NCT00540098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505136|NCT00540098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24505150|NCT00540137|Protease Inhibitors|protease inhibitors|mesh-ancestor
24505151|NCT00540137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505152|NCT00540137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505153|NCT00540137|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24505154|NCT00540137|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24505155|NCT00540137|Antiviral Agents|antiviral agents|mesh-ancestor
24505156|NCT00540137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24505391|NCT00541073|Vitamin B Complex|vitamin b complex|mesh-ancestor
24505392|NCT00541073|Hematinics|hematinics|mesh-ancestor
24505394|NCT00541086|Letrozole|letrozole|mesh-list
24505395|NCT00541086|Anastrozole|anastrozole|mesh-list
24505396|NCT00541086|Exemestane|exemestane|mesh-list
24505397|NCT00541086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867280|NCT02478788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24505398|NCT00541086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505431|NCT00541125|Leucovorin|leucovorin|mesh-list
24507532|NCT00550992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507533|NCT00550992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24507538|NCT00550992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24818761|NCT02090738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25064468|NCT03459911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25064469|NCT03459911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24949115|NCT05255666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24949116|NCT05255666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826904|NCT02136784|Sensory System Agents|sensory system agents|mesh-ancestor
24818762|NCT02090738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24818763|NCT02090738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24818764|NCT02090738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24818765|NCT02090738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615009|NCT01027481|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24818767|NCT02090738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24818804|NCT02090920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24615084|NCT01027832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24818805|NCT02090933|Celecoxib|celecoxib|mesh-list
24818806|NCT02090933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24818807|NCT02090933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24818808|NCT02090933|Analgesics|analgesics|mesh-ancestor
24818809|NCT02090933|Sensory System Agents|sensory system agents|mesh-ancestor
24818810|NCT02090933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24818811|NCT02090933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907084|NCT04332978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24907085|NCT04332978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507539|NCT00550992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24507540|NCT00550992|Abortifacient Agents|abortifacient agents|mesh-ancestor
24507541|NCT00550992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24507542|NCT00550992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24507543|NCT00550992|Antimetabolites|antimetabolites|mesh-ancestor
24507544|NCT00550992|Dermatologic Agents|dermatologic agents|mesh-ancestor
24507545|NCT00550992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507546|NCT00550992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24907086|NCT04332978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24867281|NCT02478788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907087|NCT04332978|Respiratory System Agents|respiratory system agents|mesh-ancestor
24907088|NCT04332978|Dermatologic Agents|dermatologic agents|mesh-ancestor
24907089|NCT04332978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24907121|NCT04332627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907122|NCT04332627|Cholinergic Agents|cholinergic agents|mesh-ancestor
24907123|NCT04332627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24907124|NCT04332627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907125|NCT04332627|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24907126|NCT04332627|Autonomic Agents|autonomic agents|mesh-ancestor
24907127|NCT04332627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24907128|NCT04332666|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
24907129|NCT04332666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24907130|NCT04332666|Vasodilator Agents|vasodilator agents|mesh-ancestor
24507547|NCT00550992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24507548|NCT00550992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24507549|NCT00550992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24507550|NCT00550992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24507552|NCT00550992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24507553|NCT00550992|Antidotes|antidotes|mesh-ancestor
24507554|NCT00550992|Protective Agents|protective agents|mesh-ancestor
24507555|NCT00550992|Vitamin B Complex|vitamin b complex|mesh-ancestor
24511008|NCT00566904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24511009|NCT00566904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24511011|NCT00566904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24511012|NCT00566904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24511013|NCT00566904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24511014|NCT00566904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24511611|NCT00569816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24511612|NCT00569816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511614|NCT00569881|Gatifloxacin|gatifloxacin|mesh-list
24512246|NCT00573690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24907133|NCT04332536|Narcotics|narcotics|mesh-ancestor
24907134|NCT04332536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24907135|NCT04332536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907136|NCT04332536|Analgesics|analgesics|mesh-ancestor
24907137|NCT04332536|Sensory System Agents|sensory system agents|mesh-ancestor
24907138|NCT04332536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24907139|NCT04332536|Antitussive Agents|antitussive agents|mesh-ancestor
24949119|NCT05255666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24949120|NCT05255666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949121|NCT05255484|Antibodies|antibodies|mesh-list
24949122|NCT05255484|Immunologic Factors|immunologic factors|mesh-ancestor
24949123|NCT05255484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565777|NCT00782405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24565778|NCT00782405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24513178|NCT00579592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867464|NCT04372017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24867465|NCT04372017|Antimalarials|antimalarials|mesh-ancestor
24867466|NCT04372017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24513293|NCT00580437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513294|NCT00580437|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24513295|NCT00580437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24953307|NCT03886766|Antiviral Agents|antiviral agents|mesh-ancestor
24907140|NCT04332536|Respiratory System Agents|respiratory system agents|mesh-ancestor
24907141|NCT04332809|Gentamicins|gentamicins|mesh-list
24907142|NCT04332809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24907143|NCT04332809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24907144|NCT04332809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24907145|NCT04332809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907146|NCT04332809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907148|NCT04332276|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24907149|NCT04332276|Sympathomimetics|sympathomimetics|mesh-ancestor
24907150|NCT04332276|Autonomic Agents|autonomic agents|mesh-ancestor
24907151|NCT04332276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24482500|NCT00439283|Antimetabolites|antimetabolites|mesh-ancestor
24907170|NCT04332094|Hydroxychloroquine|hydroxychloroquine|mesh-list
24907171|NCT04332094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24907172|NCT04332094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24513296|NCT00580437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24513319|NCT00580619|Trimethaphan|trimethaphan|mesh-list
24513320|NCT00580619|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
24513321|NCT00580619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513322|NCT00580619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24513323|NCT00580619|Sympatholytics|sympatholytics|mesh-ancestor
24513324|NCT00580619|Autonomic Agents|autonomic agents|mesh-ancestor
24513325|NCT00580619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24513326|NCT00580619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513327|NCT00580619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24513328|NCT00580619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24513329|NCT00580619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24513332|NCT00580619|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24513355|NCT00580905|Sensory System Agents|sensory system agents|mesh-ancestor
24513356|NCT00580905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24513357|NCT00580905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513358|NCT00580905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24513406|NCT00581139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24513407|NCT00581139|Anesthetics, General|anesthetics, general|mesh-ancestor
24513408|NCT00581139|GABA Modulators|gaba modulators|mesh-ancestor
24446385|NCT00304616|Dopamine Agonists|dopamine agonists|mesh-ancestor
24446386|NCT00304616|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24860439|NCT02309970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24860440|NCT02309970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24860441|NCT02309970|Analgesics|analgesics|mesh-ancestor
25699435|NCT02106494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24907173|NCT04332094|Antimalarials|antimalarials|mesh-ancestor
24907174|NCT04332094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24907175|NCT04332094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24907176|NCT04332094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907177|NCT04332094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907178|NCT04332094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24907179|NCT04331834|Hydroxychloroquine|hydroxychloroquine|mesh-list
24907180|NCT04331834|Antimalarials|antimalarials|mesh-ancestor
24907196|NCT04331743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24907197|NCT04331743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24907198|NCT04331743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24953308|NCT03886766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24953309|NCT03886766|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24953310|NCT03886766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24953311|NCT03886766|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24953312|NCT03886766|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24953313|NCT03886766|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24953314|NCT03886766|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24953315|NCT03886441|Beclomethasone|beclomethasone|mesh-list
24953317|NCT03886441|Glucocorticoids|glucocorticoids|mesh-ancestor
24953318|NCT03886441|Hormones|hormones|mesh-ancestor
24953319|NCT03886441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24953320|NCT03886441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953321|NCT03886441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24907203|NCT04331730|Growth Substances|growth substances|mesh-ancestor
24907204|NCT04331730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856841|NCT02287181|Anesthetics|anesthetics|mesh-ancestor
24907208|NCT04331626|Nivolumab|nivolumab|mesh-list
24907209|NCT04331626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24907210|NCT04331626|Antimetabolites|antimetabolites|mesh-ancestor
24907211|NCT04331626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907212|NCT04331626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24907213|NCT04331626|Antiviral Agents|antiviral agents|mesh-ancestor
24907214|NCT04331626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24907215|NCT04331626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907216|NCT04331626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24907217|NCT04331626|Immunologic Factors|immunologic factors|mesh-ancestor
24907218|NCT04331626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907219|NCT04331626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24907220|NCT04331626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24907243|NCT04331600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24907244|NCT04331600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24907246|NCT04331600|Sensory System Agents|sensory system agents|mesh-ancestor
24907247|NCT04331600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24907248|NCT04331600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907249|NCT04331600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24907250|NCT04331600|Filaricides|filaricides|mesh-ancestor
24907251|NCT04331600|Antinematodal Agents|antinematodal agents|mesh-ancestor
24907252|NCT04331600|Anthelmintics|anthelmintics|mesh-ancestor
24513919|NCT00586365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24513920|NCT00586365|Analgesics|analgesics|mesh-ancestor
24513921|NCT00586365|Sensory System Agents|sensory system agents|mesh-ancestor
25699436|NCT02106494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25699437|NCT02106494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25699438|NCT02106494|Antipruritics|antipruritics|mesh-ancestor
25699439|NCT02106494|Dermatologic Agents|dermatologic agents|mesh-ancestor
25699440|NCT02106494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24514389|NCT00590174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514390|NCT00590174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25699441|NCT02106494|Serotonin Agents|serotonin agents|mesh-ancestor
24907260|NCT04331418|Dexmedetomidine|dexmedetomidine|mesh-list
24953324|NCT03886662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24953325|NCT03886662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24953326|NCT03886662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953327|NCT03886311|Nivolumab|nivolumab|mesh-list
24953328|NCT03886311|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
24953329|NCT03886311|Trabectedin|trabectedin|mesh-list
24953330|NCT03886311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25064476|NCT03459833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064477|NCT03459833|Viscosupplements|viscosupplements|mesh-ancestor
25064478|NCT03459833|Protective Agents|protective agents|mesh-ancestor
24826954|NCT02136888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826955|NCT02136888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826956|NCT02136888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24826957|NCT02136888|Contraceptive Agents|contraceptive agents|mesh-ancestor
24712358|NCT01520103|Antimitotic Agents|antimitotic agents|mesh-ancestor
24867563|NCT03990077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867565|NCT03842696|Mycophenolic Acid|mycophenolic acid|mesh-list
24867566|NCT03842696|Cyclophosphamide|cyclophosphamide|mesh-list
24867567|NCT03842696|Methotrexate|methotrexate|mesh-list
24907274|NCT04331470|Ritonavir|ritonavir|mesh-list
24907291|NCT04331470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24907292|NCT04331470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24907293|NCT04331470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24907294|NCT04331470|Autonomic Agents|autonomic agents|mesh-ancestor
24514393|NCT00590174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24514949|NCT00593580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515224|NCT00595985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515714|NCT00598858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24515715|NCT00598897|Clarithromycin|clarithromycin|mesh-list
24515716|NCT00598897|Rifabutin|rifabutin|mesh-list
24515717|NCT00598897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24515718|NCT00598897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24515719|NCT00598897|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24515720|NCT00598897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515721|NCT00598897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515869|NCT00599807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24515871|NCT00599820|Bevacizumab|bevacizumab|mesh-list
24515892|NCT00599898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515893|NCT00599898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24515894|NCT00599898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515895|NCT00599898|Vasodilator Agents|vasodilator agents|mesh-ancestor
24515896|NCT00599898|Tocolytic Agents|tocolytic agents|mesh-ancestor
24515898|NCT00599898|Hormone Antagonists|hormone antagonists|mesh-ancestor
24515990|NCT00600210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24515991|NCT00600210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24907295|NCT04331470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24907296|NCT04331470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907297|NCT04331470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24907298|NCT04331470|Respiratory System Agents|respiratory system agents|mesh-ancestor
24907299|NCT04331470|Glucocorticoids|glucocorticoids|mesh-ancestor
24907300|NCT04331470|Hormones|hormones|mesh-ancestor
24907301|NCT04331470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24907302|NCT04331470|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24907303|NCT04331470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24907304|NCT04331470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24907305|NCT04331470|Adrenergic Agents|adrenergic agents|mesh-ancestor
24907306|NCT04331470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24907307|NCT04331470|Amebicides|amebicides|mesh-ancestor
24907308|NCT04331470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24907309|NCT04331470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24907310|NCT04331470|Antimalarials|antimalarials|mesh-ancestor
24907311|NCT04331470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24907312|NCT04331470|Antinematodal Agents|antinematodal agents|mesh-ancestor
24907313|NCT04331470|Anthelmintics|anthelmintics|mesh-ancestor
24540940|NCT00670215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24540941|NCT00670215|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24907314|NCT04331470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24907315|NCT04331470|Immunologic Factors|immunologic factors|mesh-ancestor
24907316|NCT04331327|Mitogens|mitogens|mesh-list
24907317|NCT04331327|Mitosis Modulators|mitosis modulators|mesh-ancestor
24907318|NCT04331327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799811|NCT01971424|Antacids|antacids|mesh-ancestor
24515992|NCT00600210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24516238|NCT00601198|Vitamins|vitamins|mesh-ancestor
24516239|NCT00601198|Micronutrients|micronutrients|mesh-ancestor
24516240|NCT00601198|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24516467|NCT00602082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24516469|NCT00602082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516470|NCT00602082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24907320|NCT04331197|Clomiphene|clomiphene|mesh-list
24907321|NCT04331197|Enclomiphene|enclomiphene|mesh-list
24907322|NCT04331197|Zuclomiphene|zuclomiphene|mesh-list
24907323|NCT04331197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907324|NCT04331197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24907325|NCT04331197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24482619|NCT00440102|Analgesics|analgesics|mesh-ancestor
24519518|NCT05332821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519519|NCT05332730|Golimumab|golimumab|mesh-list
24907349|NCT04331054|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25064479|NCT03459807|Antihypertensive Agents|antihypertensive agents|mesh-list
25064480|NCT03459599|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25064481|NCT03459599|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25064482|NCT03459599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25064483|NCT03459599|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25064484|NCT03459599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25064485|NCT03459599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064487|NCT03459417|Sulpiride|sulpiride|mesh-list
25064488|NCT03459417|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25064489|NCT03459417|Narcotics|narcotics|mesh-ancestor
25064490|NCT03459417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25064491|NCT03459417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826958|NCT02136888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24826959|NCT02136888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826960|NCT02136888|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24826961|NCT02136888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24826962|NCT02136888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24826963|NCT02136888|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24826965|NCT02136888|Immunologic Factors|immunologic factors|mesh-ancestor
24482675|NCT00440167|Antiviral Agents|antiviral agents|mesh-ancestor
24482676|NCT00440167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24482677|NCT00440167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24482678|NCT00440167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24482679|NCT00440167|Immunologic Factors|immunologic factors|mesh-ancestor
24818831|NCT02091219|Vitamins|vitamins|mesh-ancestor
24818832|NCT02091219|Micronutrients|micronutrients|mesh-ancestor
24818833|NCT02091219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818870|NCT02091388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24907361|NCT04330872|Sensory System Agents|sensory system agents|mesh-ancestor
25699442|NCT02106494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25699443|NCT02106494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699444|NCT02106494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25699445|NCT02106494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25699446|NCT02106494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25699447|NCT02106494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25699448|NCT02106494|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25699449|NCT02106494|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24907362|NCT04330872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24818871|NCT02091388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24818872|NCT02091388|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24907363|NCT04330872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812970|NCT02055586|Antiviral Agents|antiviral agents|mesh-ancestor
24517446|NCT00607971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24907364|NCT04330872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24907365|NCT04330872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24907366|NCT04330872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24907367|NCT04330872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24907368|NCT04330872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907369|NCT04330872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24907370|NCT04330872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24907371|NCT04330872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907372|NCT04330872|Antipyretics|antipyretics|mesh-ancestor
24907374|NCT04330820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24907375|NCT04331093|Apatinib|apatinib|mesh-list
24907376|NCT04331093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24907377|NCT04331093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24907378|NCT04331093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907379|NCT04331093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907396|NCT04330755|Magnesium Sulfate|magnesium sulfate|mesh-list
24907397|NCT04330755|Simendan|simendan|mesh-list
24907398|NCT04330755|Analgesics|analgesics|mesh-ancestor
24907399|NCT04330755|Sensory System Agents|sensory system agents|mesh-ancestor
24519550|NCT05332496|Growth Substances|growth substances|mesh-ancestor
24519551|NCT05332496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519552|NCT05332496|Growth Inhibitors|growth inhibitors|mesh-ancestor
24517597|NCT00608790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24517598|NCT00608790|Respiratory System Agents|respiratory system agents|mesh-ancestor
24517599|NCT00608790|Tocolytic Agents|tocolytic agents|mesh-ancestor
24517600|NCT00608790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24517601|NCT00608790|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24517619|NCT00608816|Adrenergic Agents|adrenergic agents|mesh-ancestor
24907422|NCT04330300|Valsartan|valsartan|mesh-list
24907423|NCT04330300|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24907424|NCT04330300|Telmisartan|telmisartan|mesh-list
24907425|NCT04330300|Candesartan|candesartan|mesh-list
24907426|NCT04330300|Ramipril|ramipril|mesh-list
24907427|NCT04330300|Olmesartan|olmesartan|mesh-list
24907428|NCT04330300|Enalapril|enalapril|mesh-list
24907429|NCT04330300|Lisinopril|lisinopril|mesh-list
24907430|NCT04330300|Irbesartan|irbesartan|mesh-list
24907431|NCT04330300|Chlorthalidone|chlorthalidone|mesh-list
24907432|NCT04330300|Diltiazem|diltiazem|mesh-list
24907482|NCT04330495|Antimalarials|antimalarials|mesh-ancestor
24907484|NCT04330495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24907485|NCT04330495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24907486|NCT04330495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907487|NCT04330495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907488|NCT04330495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24907489|NCT04330677|Oxytocin|oxytocin|mesh-list
24907490|NCT04330677|Estrogens|estrogens|mesh-list
24907491|NCT04330677|Oxytocics|oxytocics|mesh-ancestor
24907492|NCT04330677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24907499|NCT04330638|Siltuximab|siltuximab|mesh-list
24907500|NCT04330638|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24907501|NCT04330638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24907502|NCT04330638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24907503|NCT04330326|Sorbitol|sorbitol|mesh-list
24907504|NCT04330326|Cathartics|cathartics|mesh-ancestor
24907505|NCT04330326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25064497|NCT03459417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25064498|NCT03459417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25064499|NCT03459417|Dopamine Agents|dopamine agents|mesh-ancestor
24647949|NCT01211509|Montelukast|montelukast|mesh-list
25064500|NCT03459417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25064501|NCT03459417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064502|NCT03459417|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25064504|NCT03459404|Sufentanil|sufentanil|mesh-list
25064505|NCT03459404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25064506|NCT03459404|Narcotics|narcotics|mesh-ancestor
25064507|NCT03459404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25064508|NCT03459404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064509|NCT03459404|Analgesics|analgesics|mesh-ancestor
25064510|NCT03459404|Sensory System Agents|sensory system agents|mesh-ancestor
25064511|NCT03459404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24826973|NCT02136979|Anesthetics|anesthetics|mesh-ancestor
24907521|NCT04329611|Antimalarials|antimalarials|mesh-ancestor
24517658|NCT00609115|Methylamphotericin B|methylamphotericin b|mesh-list
24517684|NCT00609284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517685|NCT00609284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24517686|NCT00609375|Cefepime|cefepime|mesh-list
24517687|NCT00609375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24517755|NCT00609817|Hormones|hormones|mesh-ancestor
24907544|NCT04329650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24907546|NCT04329650|Protective Agents|protective agents|mesh-ancestor
24907572|NCT04330144|Hydroxychloroquine|hydroxychloroquine|mesh-list
24907573|NCT04330144|Antimalarials|antimalarials|mesh-ancestor
24907574|NCT04330144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24517861|NCT00610454|Levetiracetam|levetiracetam|mesh-list
24517870|NCT00610493|Growth Substances|growth substances|mesh-ancestor
24517871|NCT00610493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517872|NCT00610493|Growth Inhibitors|growth inhibitors|mesh-ancestor
24517873|NCT00610493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24517874|NCT00610493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24517875|NCT00610493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24517876|NCT00610493|Antifungal Agents|antifungal agents|mesh-ancestor
24517877|NCT00610493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24517878|NCT00610493|Immunologic Factors|immunologic factors|mesh-ancestor
24517880|NCT00610506|Citalopram|citalopram|mesh-list
24517881|NCT00610506|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24518299|NCT05321199|Hemostatics|hemostatics|mesh-ancestor
24518300|NCT05321199|Coagulants|coagulants|mesh-ancestor
24541119|NCT00671008|Insulin|insulin|mesh-list
24518301|NCT05320731|Lidocaine|lidocaine|mesh-list
24518302|NCT05320731|Anesthetics, Local|anesthetics, local|mesh-ancestor
24518303|NCT05320731|Anesthetics|anesthetics|mesh-ancestor
24518304|NCT05320731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24518305|NCT05320731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520641|NCT05335837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24520642|NCT05335837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521026|NCT05199662|Tenecteplase|tenecteplase|mesh-list
24521027|NCT05199662|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24521028|NCT05199662|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24522903|NCT03049735|Norethindrone Acetate|norethindrone acetate|mesh-list
24522904|NCT03049735|Estradiol|estradiol|mesh-list
24522905|NCT03049735|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24522906|NCT03049735|Relugolix|relugolix|mesh-list
24522907|NCT03049735|Estrogens|estrogens|mesh-ancestor
24522908|NCT03049735|Hormones|hormones|mesh-ancestor
24522909|NCT03049735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24907575|NCT04330144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24907576|NCT04330144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24907577|NCT04330144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907578|NCT04330144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907579|NCT04330144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24907581|NCT04329585|Antidotes|antidotes|mesh-ancestor
24907582|NCT04329585|Protective Agents|protective agents|mesh-ancestor
24907583|NCT04329585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907584|NCT04329585|GABA Modulators|gaba modulators|mesh-ancestor
24907585|NCT04329585|GABA Agents|gaba agents|mesh-ancestor
24907586|NCT04329585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24907588|NCT04329572|Azithromycin|azithromycin|mesh-list
24482858|NCT00440804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24482859|NCT00440804|Analgesics|analgesics|mesh-ancestor
24482860|NCT00440804|Sensory System Agents|sensory system agents|mesh-ancestor
24482863|NCT00440804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25064512|NCT03459404|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25064513|NCT03459404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24522910|NCT03049735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522911|NCT03049735|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24522912|NCT03049735|Contraceptive Agents|contraceptive agents|mesh-ancestor
24522913|NCT03049735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24522914|NCT03049735|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24522915|NCT03049735|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24523054|NCT02897050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523060|NCT02897050|Antimetabolites|antimetabolites|mesh-ancestor
24523102|NCT02588248|Antipruritics|antipruritics|mesh-ancestor
24523103|NCT02588248|Dermatologic Agents|dermatologic agents|mesh-ancestor
24523105|NCT02588248|Autonomic Agents|autonomic agents|mesh-ancestor
24523106|NCT02588248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24523301|NCT02178709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523303|NCT02178709|Vitamins|vitamins|mesh-ancestor
24523304|NCT02178709|Micronutrients|micronutrients|mesh-ancestor
24523305|NCT02066220|Cyclophosphamide|cyclophosphamide|mesh-list
24523306|NCT02066220|Lomustine|lomustine|mesh-list
24523307|NCT02066220|Cisplatin|cisplatin|mesh-list
24523308|NCT02066220|Carboplatin|carboplatin|mesh-list
24523309|NCT02066220|Vincristine|vincristine|mesh-list
24523310|NCT02066220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24523311|NCT02066220|Immunologic Factors|immunologic factors|mesh-ancestor
24523313|NCT02066220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24523329|NCT01855867|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24523330|NCT01855867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24523331|NCT01855867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24523417|NCT00887536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24523418|NCT00887536|Alkylating Agents|alkylating agents|mesh-ancestor
24523419|NCT00887536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523420|NCT00887536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25064516|NCT03459248|Anesthetics|anesthetics|mesh-list
25064517|NCT03459248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25064518|NCT03459248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064519|NCT03459144|Ranibizumab|ranibizumab|mesh-list
25064520|NCT03459144|Verteporfin|verteporfin|mesh-list
24548074|NCT00707473|Antimitotic Agents|antimitotic agents|mesh-ancestor
24548075|NCT00707473|Mitosis Modulators|mitosis modulators|mesh-ancestor
24548077|NCT00707473|Antimetabolites|antimetabolites|mesh-ancestor
25699450|NCT02106832|Ciprofloxacin|ciprofloxacin|mesh-list
24868084|NCT03829462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24860906|NCT02313805|Insulin|insulin|mesh-list
24868085|NCT03829462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24868097|NCT03774641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868098|NCT03774641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24868099|NCT03774641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25064521|NCT03459144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25064522|NCT03459144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25064523|NCT03459144|Growth Substances|growth substances|mesh-ancestor
25064524|NCT03459144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064525|NCT03459144|Growth Inhibitors|growth inhibitors|mesh-ancestor
25064526|NCT03459144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24907606|NCT04329403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24907607|NCT04329403|Dermatologic Agents|dermatologic agents|mesh-ancestor
24907608|NCT04329390|Anticoagulants|anticoagulants|mesh-list
24907609|NCT04329130|Lenalidomide|lenalidomide|mesh-list
24907610|NCT04329130|Immunologic Factors|immunologic factors|mesh-ancestor
24907611|NCT04329130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907612|NCT04329130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24907658|NCT04328883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24907659|NCT04328883|Analgesics|analgesics|mesh-ancestor
24907660|NCT04328883|Sensory System Agents|sensory system agents|mesh-ancestor
24907661|NCT04328883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24482964|NCT00441181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24482966|NCT00441207|Antioxidants|antioxidants|mesh-ancestor
24482967|NCT00441207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482968|NCT00441207|Protective Agents|protective agents|mesh-ancestor
24530933|NCT00633347|Luteolytic Agents|luteolytic agents|mesh-ancestor
24482969|NCT00441207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482970|NCT00441207|Vitamins|vitamins|mesh-ancestor
24907746|NCT04328194|Hemostatics|hemostatics|mesh-ancestor
24907747|NCT04328194|Coagulants|coagulants|mesh-ancestor
24907748|NCT04327791|Baloxavir|baloxavir|mesh-list
24907749|NCT04327791|Antiviral Agents|antiviral agents|mesh-ancestor
24907750|NCT04327791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24523421|NCT00887536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24523422|NCT00887536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24523423|NCT00887536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24907751|NCT04327791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907752|NCT04327791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907753|NCT04327947|Hyaluronic Acid|hyaluronic acid|mesh-list
24907754|NCT04327947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24907755|NCT04327947|Immunologic Factors|immunologic factors|mesh-ancestor
24907756|NCT04327947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907757|NCT04327947|Viscosupplements|viscosupplements|mesh-ancestor
24907758|NCT04327947|Protective Agents|protective agents|mesh-ancestor
24615230|NCT01028482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615233|NCT01028482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615234|NCT01028495|Gemcitabine|gemcitabine|mesh-list
24615235|NCT01028495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24615236|NCT01028495|Antimetabolites|antimetabolites|mesh-ancestor
24907851|NCT04326985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24907852|NCT04326985|Immunologic Factors|immunologic factors|mesh-ancestor
24907853|NCT04326985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907854|NCT04326985|Viscosupplements|viscosupplements|mesh-ancestor
24907855|NCT04326985|Protective Agents|protective agents|mesh-ancestor
24907856|NCT04326894|Methotrexate|methotrexate|mesh-list
24868100|NCT03774641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24907857|NCT04326894|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24907858|NCT04326894|Abortifacient Agents|abortifacient agents|mesh-ancestor
24907859|NCT04326894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24661864|NCT01291433|Clodronic Acid|clodronic acid|mesh-list
25064527|NCT03459144|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25064528|NCT03459144|Dermatologic Agents|dermatologic agents|mesh-ancestor
25699451|NCT02106832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25699452|NCT02106832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25699453|NCT02106832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25064529|NCT03459105|Bupivacaine|bupivacaine|mesh-list
25064530|NCT03459105|Anesthetics|anesthetics|mesh-list
25064531|NCT03459105|Anesthetics, Local|anesthetics, local|mesh-ancestor
25699454|NCT02106832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25699455|NCT02106832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25699456|NCT02106832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064532|NCT03459105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25064533|NCT03459105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523457|NCT00467142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523459|NCT00467142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24523460|NCT00467142|Antimetabolites|antimetabolites|mesh-ancestor
24523461|NCT00467142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523462|NCT00467142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24523463|NCT00467142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24523464|NCT00467142|Immunologic Factors|immunologic factors|mesh-ancestor
24523465|NCT00467142|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24523466|NCT00467142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24523467|NCT00467142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24523469|NCT00467142|Protective Agents|protective agents|mesh-ancestor
24523471|NCT00467142|Vitamins|vitamins|mesh-ancestor
25064534|NCT03459105|Sensory System Agents|sensory system agents|mesh-ancestor
25064535|NCT03459105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25064536|NCT03458923|Diclofenac|diclofenac|mesh-list
25064537|NCT03458923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25064538|NCT03458923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25064539|NCT03458923|Ranibizumab|ranibizumab|mesh-list
25064540|NCT03458923|Endothelial Growth Factors|endothelial growth factors|mesh-list
25064541|NCT03458923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25064542|NCT03458923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25064543|NCT03458923|Growth Substances|growth substances|mesh-ancestor
25064544|NCT03458923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064545|NCT03458923|Growth Inhibitors|growth inhibitors|mesh-ancestor
25064546|NCT03458923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25064547|NCT03458923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064548|NCT03458923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25064549|NCT03458923|Analgesics|analgesics|mesh-ancestor
25064550|NCT03458923|Sensory System Agents|sensory system agents|mesh-ancestor
25064551|NCT03458923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25064552|NCT03458923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24907860|NCT04326894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907861|NCT04326894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24907862|NCT04326894|Antimetabolites|antimetabolites|mesh-ancestor
24907863|NCT04326894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907864|NCT04326894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24907865|NCT04326894|Dermatologic Agents|dermatologic agents|mesh-ancestor
24907866|NCT04326894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907867|NCT04326894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24907895|NCT04326764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24907896|NCT04326764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907953|NCT04325984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24907955|NCT04325932|Coagulants|coagulants|mesh-ancestor
24907956|NCT04325932|Fertility Agents, Male|fertility agents, male|mesh-ancestor
24907957|NCT04325932|Fertility Agents|fertility agents|mesh-ancestor
24907958|NCT04325932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24907959|NCT04325932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523488|NCT05342558|Respiratory System Agents|respiratory system agents|mesh-ancestor
24907960|NCT04325893|Hydroxychloroquine|hydroxychloroquine|mesh-list
24907961|NCT04325893|Antimalarials|antimalarials|mesh-ancestor
24907962|NCT04325893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24907963|NCT04325893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24907964|NCT04325893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24907965|NCT04325893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25064553|NCT03458923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25064554|NCT03458923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25064555|NCT03458715|Empagliflozin|empagliflozin|mesh-list
25064556|NCT03458715|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25064557|NCT03458715|Linagliptin|linagliptin|mesh-list
24530965|NCT00633412|Ranitidine|ranitidine|mesh-list
24524995|NCT04115644|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24524996|NCT04115644|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24524997|NCT04115644|Ketorolac|ketorolac|mesh-list
24524998|NCT04115644|Bupivacaine|bupivacaine|mesh-list
24524999|NCT04115644|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24525000|NCT04115644|Anesthetics, Local|anesthetics, local|mesh-ancestor
24527482|NCT00616850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24527483|NCT00616850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24527502|NCT00616889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24527503|NCT00616889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24527562|NCT00617370|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24527563|NCT00617370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24527564|NCT00617370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24527565|NCT00617370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24528643|NCT00622011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24528644|NCT00622011|Dopamine Agents|dopamine agents|mesh-ancestor
24528645|NCT00622037|Lubricant Eye Drops|lubricant eye drops|mesh-list
24528648|NCT00622115|Enoxaparin|enoxaparin|mesh-list
24528695|NCT00622349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528696|NCT00622349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24528697|NCT00622349|Antimetabolites|antimetabolites|mesh-ancestor
24530930|NCT00633347|Fertility Agents|fertility agents|mesh-ancestor
24530931|NCT00633347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24530932|NCT00633347|Hormone Antagonists|hormone antagonists|mesh-ancestor
24907972|NCT04325633|Sensory System Agents|sensory system agents|mesh-ancestor
24907973|NCT04325633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24907974|NCT04325633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907975|NCT04325633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24907976|NCT04325633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24907977|NCT04325633|Gout Suppressants|gout suppressants|mesh-ancestor
24907978|NCT04325633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24907979|NCT04325633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907980|NCT04325633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907981|NCT04325724|Dermatologic Agents|dermatologic agents|mesh-list
24907982|NCT04325490|Hydrocortisone|hydrocortisone|mesh-list
24907983|NCT04325490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24868218|NCT02318329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24907984|NCT04325698|Paclitaxel|paclitaxel|mesh-list
24907985|NCT04325698|Bevacizumab|bevacizumab|mesh-list
24907989|NCT04325698|Tubulin Modulators|tubulin modulators|mesh-ancestor
24907990|NCT04325698|Antimitotic Agents|antimitotic agents|mesh-ancestor
24907991|NCT04325698|Mitosis Modulators|mitosis modulators|mesh-ancestor
24907992|NCT04325698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908010|NCT04325425|Folfirinox|folfirinox|mesh-list
24908011|NCT04325425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908012|NCT04325425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24908013|NCT04325425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24908014|NCT04325425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24908019|NCT04325113|Anesthetics|anesthetics|mesh-ancestor
24908037|NCT04325061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908038|NCT04325061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24908040|NCT04325061|Hormones|hormones|mesh-ancestor
24908041|NCT04325061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24530934|NCT00633347|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24530935|NCT00633347|Contraceptive Agents|contraceptive agents|mesh-ancestor
24530967|NCT00633412|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24530970|NCT00633412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530971|NCT00633412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530972|NCT00633412|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24530983|NCT00633438|Celecoxib|celecoxib|mesh-list
24531048|NCT00633685|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24531049|NCT00633685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24531050|NCT00633685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24531817|NCT00637286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531818|NCT00637325|Trastuzumab|trastuzumab|mesh-list
24908043|NCT04325061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908044|NCT04325061|Protease Inhibitors|protease inhibitors|mesh-ancestor
24908045|NCT04325061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908046|NCT04325061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908047|NCT04325009|Atorvastatin|atorvastatin|mesh-list
24908048|NCT04325009|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24908049|NCT04325009|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24908050|NCT04325009|Antimetabolites|antimetabolites|mesh-ancestor
24908051|NCT04325009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908052|NCT04325009|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24908053|NCT04325009|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24908054|NCT04325009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908055|NCT04324411|Sirolimus|sirolimus|mesh-list
24532274|NCT00638859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24532275|NCT00638859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24532276|NCT00638976|Eptifibatide|eptifibatide|mesh-list
24532278|NCT00639015|Phenylephrine|phenylephrine|mesh-list
24532363|NCT00639574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24532364|NCT00639574|Analgesics|analgesics|mesh-ancestor
24532365|NCT00639574|Sensory System Agents|sensory system agents|mesh-ancestor
24532366|NCT00639574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24908134|NCT04323657|Cyclophosphamide|cyclophosphamide|mesh-list
24532367|NCT00639574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532370|NCT00639587|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24532371|NCT00639587|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24532372|NCT00639587|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24908056|NCT04324411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24908057|NCT04324411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24908058|NCT04324411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24908059|NCT04324411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908086|NCT04324307|Antiviral Agents|antiviral agents|mesh-ancestor
24908087|NCT04324307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24908088|NCT04324307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908089|NCT04324307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24908091|NCT04324307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064559|NCT03458715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064560|NCT03458715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24868327|NCT05156892|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25064561|NCT03458715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064562|NCT03458715|Incretins|incretins|mesh-ancestor
25064563|NCT03458715|Hormones|hormones|mesh-ancestor
24827034|NCT02137239|Everolimus|everolimus|mesh-list
24908093|NCT04324307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24908094|NCT04324476|Bevacizumab|bevacizumab|mesh-list
24908095|NCT04324476|Capecitabine|capecitabine|mesh-list
24908096|NCT04324476|Oxaliplatin|oxaliplatin|mesh-list
24908097|NCT04324476|Irinotecan|irinotecan|mesh-list
24908098|NCT04324476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24908122|NCT04324294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24908123|NCT04323748|Rituximab|rituximab|mesh-list
25699457|NCT02106832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25699458|NCT02106832|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25699459|NCT02106832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25699460|NCT02106884|Gemcitabine|gemcitabine|mesh-list
25699461|NCT02106884|Paclitaxel|paclitaxel|mesh-list
25699462|NCT02106884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25699463|NCT02106884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25699464|NCT02106884|Tubulin Modulators|tubulin modulators|mesh-ancestor
25699465|NCT02106884|Antimitotic Agents|antimitotic agents|mesh-ancestor
24908124|NCT04323748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24908125|NCT04323748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908126|NCT04323748|Immunologic Factors|immunologic factors|mesh-ancestor
24908127|NCT04323748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908128|NCT04323748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24908130|NCT04323761|Antimetabolites|antimetabolites|mesh-ancestor
24908131|NCT04323761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908132|NCT04323761|Antiviral Agents|antiviral agents|mesh-ancestor
24908133|NCT04323761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24908135|NCT04323657|Fludarabine|fludarabine|mesh-list
24908136|NCT04323657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24908137|NCT04323657|Immunologic Factors|immunologic factors|mesh-ancestor
24908138|NCT04323657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908139|NCT04323657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24908140|NCT04323657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24908141|NCT04323657|Alkylating Agents|alkylating agents|mesh-ancestor
24908142|NCT04323657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908143|NCT04323657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908144|NCT04323657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24908145|NCT04323527|Chloroquine|chloroquine|mesh-list
24908146|NCT04323527|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24908147|NCT04323527|Amebicides|amebicides|mesh-ancestor
24908148|NCT04323527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24908149|NCT04323527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24908150|NCT04323527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24908151|NCT04323527|Antimalarials|antimalarials|mesh-ancestor
24908152|NCT04323527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24908171|NCT04323631|Antimalarials|antimalarials|mesh-ancestor
24548329|NCT00709137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868355|NCT05156541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24868356|NCT05156541|Antiviral Agents|antiviral agents|mesh-ancestor
24446600|NCT00305422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24446601|NCT00305422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24868357|NCT05156541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24548352|NCT00709189|Hematinics|hematinics|mesh-ancestor
24908172|NCT04323631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24908173|NCT04323631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24908174|NCT04323631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24908175|NCT04323631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908176|NCT04323631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908177|NCT04323631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24908210|NCT04322760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24908211|NCT04322760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24908212|NCT04322760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908213|NCT04322760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24908214|NCT04322760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24908215|NCT04322760|Analgesics|analgesics|mesh-ancestor
24908216|NCT04322760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24908217|NCT04322760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24908218|NCT04322760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24908219|NCT04322760|Adrenergic Agents|adrenergic agents|mesh-ancestor
24908220|NCT04322760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24908229|NCT04322552|Apatinib|apatinib|mesh-list
24908230|NCT04322552|Digoxin|digoxin|mesh-list
24908231|NCT04322552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908232|NCT04322552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24908233|NCT04322552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908234|NCT04322552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908235|NCT04322552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24908236|NCT04322552|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25064564|NCT03458715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25064565|NCT03458715|Protease Inhibitors|protease inhibitors|mesh-ancestor
25064566|NCT03458715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25064567|NCT03458689|Analgesics|analgesics|mesh-list
25064568|NCT03458689|Sensory System Agents|sensory system agents|mesh-ancestor
25064569|NCT03458689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25064570|NCT03458689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908309|NCT04321642|Nitrous Oxide|nitrous oxide|mesh-list
24908310|NCT04321642|Entonox|entonox|mesh-list
24908311|NCT04321642|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24908312|NCT04321642|Anesthetics|anesthetics|mesh-ancestor
24908313|NCT04321642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24908314|NCT04321642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908315|NCT04321642|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24908316|NCT04321642|Anesthetics, General|anesthetics, general|mesh-ancestor
24908317|NCT04321642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24908318|NCT04321642|Analgesics|analgesics|mesh-ancestor
24908319|NCT04321642|Sensory System Agents|sensory system agents|mesh-ancestor
24908320|NCT04321642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24908322|NCT04321850|Zinc Sulfate|zinc sulfate|mesh-list
24908323|NCT04321850|Trace Elements|trace elements|mesh-ancestor
24908324|NCT04321850|Micronutrients|micronutrients|mesh-ancestor
24908325|NCT04321850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908326|NCT04321850|Astringents|astringents|mesh-ancestor
24908327|NCT04321850|Dermatologic Agents|dermatologic agents|mesh-ancestor
24908328|NCT04321616|Hydroxychloroquine|hydroxychloroquine|mesh-list
24908329|NCT04321616|Remdesivir|remdesivir|mesh-list
24908330|NCT04321616|Antimalarials|antimalarials|mesh-ancestor
24908331|NCT04321616|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24908337|NCT04321616|Antimetabolites|antimetabolites|mesh-ancestor
24548421|NCT00709436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24548422|NCT00709436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24548423|NCT00709436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24623691|NCT01073189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24856991|NCT02288338|Antimetabolites|antimetabolites|mesh-ancestor
24623694|NCT01073189|Dopamine Agents|dopamine agents|mesh-ancestor
24623695|NCT01073189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24623696|NCT01073202|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25699466|NCT02106884|Mitosis Modulators|mitosis modulators|mesh-ancestor
24712864|NCT01523041|Insulin Aspart|insulin aspart|mesh-list
25699467|NCT02106884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699468|NCT02106884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25699469|NCT02106884|Antimetabolites|antimetabolites|mesh-ancestor
25699470|NCT02106884|Antiviral Agents|antiviral agents|mesh-ancestor
25699471|NCT02106884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25699472|NCT02106884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25699474|NCT02106884|Immunologic Factors|immunologic factors|mesh-ancestor
25699475|NCT02106884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623697|NCT01073202|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24623698|NCT01073202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25699476|NCT02106923|Metformin|metformin|mesh-list
24908403|NCT04320706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908410|NCT04320589|Dexmedetomidine|dexmedetomidine|mesh-list
24908411|NCT04320589|Anesthetics|anesthetics|mesh-list
24908412|NCT04320589|Anesthetics, General|anesthetics, general|mesh-list
24868519|NCT04455464|Autonomic Agents|autonomic agents|mesh-ancestor
24908420|NCT04320589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24908421|NCT04320589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24908422|NCT04320589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24908423|NCT04320589|Adrenergic Agents|adrenergic agents|mesh-ancestor
24908424|NCT04320589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24908425|NCT04320589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908426|NCT04320238|Interferons|interferons|mesh-list
24908427|NCT04320238|Interferon-alpha|interferon-alpha|mesh-list
24908428|NCT04320238|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
24908429|NCT04320238|Thymalfasin|thymalfasin|mesh-list
24908430|NCT04320238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908431|NCT04320238|Antiviral Agents|antiviral agents|mesh-ancestor
24908432|NCT04320238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24908433|NCT04320238|Immunologic Factors|immunologic factors|mesh-ancestor
24908434|NCT04320238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908435|NCT04320238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24908444|NCT04320277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908445|NCT04320277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24908446|NCT04320277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24908447|NCT04320277|Antiviral Agents|antiviral agents|mesh-ancestor
24908448|NCT04320277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24908449|NCT04320277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24908466|NCT04319978|Antiemetics|antiemetics|mesh-ancestor
24908467|NCT04319978|Autonomic Agents|autonomic agents|mesh-ancestor
24908468|NCT04319978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857028|NCT02288923|Ibuprofen|ibuprofen|mesh-list
24908469|NCT04319978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908470|NCT04319978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24908471|NCT04319978|Glucocorticoids|glucocorticoids|mesh-ancestor
24908472|NCT04319978|Hormones|hormones|mesh-ancestor
24908473|NCT04319978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24908474|NCT04319978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24908476|NCT04320173|Lidocaine|lidocaine|mesh-list
24908485|NCT04320173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24908486|NCT04320173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24908487|NCT04320173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908489|NCT04319926|Anesthetics, Local|anesthetics, local|mesh-ancestor
24908490|NCT04319926|Anesthetics|anesthetics|mesh-ancestor
24908491|NCT04319926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24908492|NCT04319926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908493|NCT04319926|Sensory System Agents|sensory system agents|mesh-ancestor
24908494|NCT04319926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24908497|NCT04319926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25064578|NCT03458559|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25064579|NCT03458559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908498|NCT04319926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24662626|NCT01295775|Antimetabolites|antimetabolites|mesh-ancestor
24908499|NCT04319926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908500|NCT04319900|Chloroquine|chloroquine|mesh-list
24908502|NCT04319900|Amebicides|amebicides|mesh-ancestor
25699477|NCT02106923|Empagliflozin|empagliflozin|mesh-list
25699478|NCT02106923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25699479|NCT02106923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699480|NCT02106923|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25699481|NCT02106923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699482|NCT02106962|Bacitracin|bacitracin|mesh-list
24908504|NCT04319900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24908505|NCT04319900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24908507|NCT04319900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24908508|NCT04319900|Antiviral Agents|antiviral agents|mesh-ancestor
24908509|NCT04319471|Capecitabine|capecitabine|mesh-list
24908510|NCT04319471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24908511|NCT04319471|Antimetabolites|antimetabolites|mesh-ancestor
24908513|NCT04319471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908531|NCT04319601|Rituximab|rituximab|mesh-list
24908532|NCT04319601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24908533|NCT04319601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908534|NCT04319601|Immunologic Factors|immunologic factors|mesh-ancestor
24908535|NCT04319601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908549|NCT04319549|Sodium Hypochlorite|sodium hypochlorite|mesh-list
24868725|NCT03379389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908551|NCT04319549|Ketorolac|ketorolac|mesh-list
24908552|NCT04319549|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24908553|NCT04319549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24908554|NCT04319549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24908584|NCT04318847|Antiemetics|antiemetics|mesh-ancestor
24908585|NCT04318847|Autonomic Agents|autonomic agents|mesh-ancestor
24908586|NCT04318847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24908587|NCT04318847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908588|NCT04318847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24908589|NCT04318847|Antipruritics|antipruritics|mesh-ancestor
24908590|NCT04318847|Dermatologic Agents|dermatologic agents|mesh-ancestor
24857058|NCT02289027|Vaccines|vaccines|mesh-list
24908601|NCT04318444|Antimalarials|antimalarials|mesh-ancestor
24908602|NCT04318444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24908603|NCT04318444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24908604|NCT04318444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24908605|NCT04318444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908638|NCT04318158|Anesthetics, Local|anesthetics, local|mesh-ancestor
24908639|NCT04318158|Anesthetics|anesthetics|mesh-ancestor
24908640|NCT04318158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24908641|NCT04318158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908642|NCT04318158|Sensory System Agents|sensory system agents|mesh-ancestor
25699483|NCT02106962|Tranexamic Acid|tranexamic acid|mesh-list
25699484|NCT02106962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25699485|NCT02106962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25699486|NCT02106962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699487|NCT02106962|Hemostatics|hemostatics|mesh-ancestor
25699488|NCT02106962|Coagulants|coagulants|mesh-ancestor
25699489|NCT02106962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25699490|NCT02106962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24908643|NCT04318158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24908644|NCT04318158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24908645|NCT04318158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24908646|NCT04318158|Analgesics|analgesics|mesh-ancestor
24908647|NCT04318158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24908648|NCT04318158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24908651|NCT04318158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24908652|NCT04318158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818886|NCT02091401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24818887|NCT02091401|Tocolytic Agents|tocolytic agents|mesh-ancestor
24818888|NCT02091401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24818889|NCT02091492|Teriparatide|teriparatide|mesh-list
24818890|NCT02091492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24818891|NCT02091492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908700|NCT04317235|Anesthetics|anesthetics|mesh-ancestor
24908701|NCT04317235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24908702|NCT04317235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908703|NCT04317235|Sensory System Agents|sensory system agents|mesh-ancestor
24908704|NCT04317235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24908705|NCT04317248|Cyclophosphamide|cyclophosphamide|mesh-list
24908706|NCT04317248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24908707|NCT04317248|Immunologic Factors|immunologic factors|mesh-ancestor
24908708|NCT04317248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908709|NCT04317248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24908710|NCT04317248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24908711|NCT04317248|Alkylating Agents|alkylating agents|mesh-ancestor
24908712|NCT04317248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483649|NCT00444379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24483657|NCT00444418|Naltrexone|naltrexone|mesh-list
24519556|NCT05332483|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24519557|NCT05332483|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24908713|NCT04317248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908714|NCT04317248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24908716|NCT04316936|Prednisolone|prednisolone|mesh-list
24908724|NCT04316936|Antiemetics|antiemetics|mesh-ancestor
24908725|NCT04316936|Autonomic Agents|autonomic agents|mesh-ancestor
24908730|NCT04316936|Hormones|hormones|mesh-ancestor
24600327|NCT01026220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24908742|NCT04317157|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24908744|NCT04317157|Purinergic Agents|purinergic agents|mesh-ancestor
24908745|NCT04317157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24908746|NCT04317079|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
24908747|NCT04317079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24908748|NCT04317079|Antioxidants|antioxidants|mesh-ancestor
24908749|NCT04317079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699491|NCT02106962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25699492|NCT02106975|Ascorbic Acid|ascorbic acid|mesh-list
25699493|NCT02106975|Vitamins|vitamins|mesh-ancestor
25699494|NCT02106975|Micronutrients|micronutrients|mesh-ancestor
25699495|NCT02106975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699496|NCT02106975|Antioxidants|antioxidants|mesh-ancestor
25699497|NCT02106975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699498|NCT02106975|Protective Agents|protective agents|mesh-ancestor
25699499|NCT02107014|Naltrexone|naltrexone|mesh-list
25699500|NCT02107014|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24908750|NCT04317079|Protective Agents|protective agents|mesh-ancestor
24908751|NCT04317079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868925|NCT05158647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868927|NCT05158647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24868928|NCT05158647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24868929|NCT05158647|Anticonvulsants|anticonvulsants|mesh-ancestor
24908752|NCT04317079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24908753|NCT04317183|Miconazole|miconazole|mesh-list
24908754|NCT04317183|Antifungal Agents|antifungal agents|mesh-ancestor
24908755|NCT04317183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24908756|NCT04317183|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24908757|NCT04317183|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24908758|NCT04317183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908759|NCT04317183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908760|NCT04317183|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24908761|NCT04317183|Hormone Antagonists|hormone antagonists|mesh-ancestor
24908762|NCT04317183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24908763|NCT04317183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908764|NCT04317183|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24908765|NCT04317183|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24908766|NCT04317001|Modafinil|modafinil|mesh-list
24908774|NCT04316845|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24908775|NCT04316845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908783|NCT04316377|Hydroxychloroquine|hydroxychloroquine|mesh-list
24908784|NCT04316377|Antimalarials|antimalarials|mesh-ancestor
24908785|NCT04316377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24908787|NCT04316377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24908788|NCT04316377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908789|NCT04316377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908790|NCT04316377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24908791|NCT04316351|Pemetrexed|pemetrexed|mesh-list
24908792|NCT04316351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908793|NCT04316351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908794|NCT04316351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908795|NCT04316351|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24908796|NCT04316351|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24908838|NCT04315935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24908839|NCT04315935|Anesthetics, General|anesthetics, general|mesh-ancestor
24908841|NCT04315935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24908842|NCT04315935|Narcotics|narcotics|mesh-ancestor
24908843|NCT04315935|Analgesics|analgesics|mesh-ancestor
24908844|NCT04315935|Sensory System Agents|sensory system agents|mesh-ancestor
24908845|NCT04315935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24908846|NCT04315935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24908847|NCT04315935|Antitussive Agents|antitussive agents|mesh-ancestor
24908852|NCT04315909|Vitamins|vitamins|mesh-ancestor
24908853|NCT04315909|Micronutrients|micronutrients|mesh-ancestor
24908854|NCT04315909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908855|NCT04315909|Antioxidants|antioxidants|mesh-ancestor
24908856|NCT04315909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908893|NCT04315688|Insulin|insulin|mesh-list
24908894|NCT04315688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24869227|NCT04278404|Dexmedetomidine|dexmedetomidine|mesh-list
24908897|NCT04315454|Anesthetics, Local|anesthetics, local|mesh-ancestor
24908898|NCT04315454|Anesthetics|anesthetics|mesh-ancestor
24908899|NCT04315454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24908900|NCT04315454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908901|NCT04315454|Sensory System Agents|sensory system agents|mesh-ancestor
24908902|NCT04315454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24908903|NCT04315493|Maleic acid|maleic acid|mesh-list
24908904|NCT04315493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908905|NCT04315493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908906|NCT04315194|Clarithromycin|clarithromycin|mesh-list
24908907|NCT04315194|Oseltamivir|oseltamivir|mesh-list
24908908|NCT04315194|Naproxen|naproxen|mesh-list
24908909|NCT04315194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24908910|NCT04315194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24908911|NCT04315194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24908912|NCT04315194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908913|NCT04315194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857121|NCT02289378|Antimitotic Agents|antimitotic agents|mesh-ancestor
25699501|NCT02107014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24827059|NCT02137239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25064598|NCT03458416|Anticonvulsants|anticonvulsants|mesh-ancestor
25064599|NCT03458260|Rituximab|rituximab|mesh-list
25064600|NCT03458260|Etoposide|etoposide|mesh-list
25064601|NCT03458260|Ifosfamide|ifosfamide|mesh-list
25064602|NCT03458260|Pixantrone|pixantrone|mesh-list
25064603|NCT03458260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24827060|NCT02137239|Protective Agents|protective agents|mesh-ancestor
24827061|NCT02137239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24857207|NCT02289768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857208|NCT02289768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24857209|NCT02289768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519559|NCT05332483|Contraceptive Agents|contraceptive agents|mesh-ancestor
24519560|NCT05332483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24519561|NCT05332483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519562|NCT05332483|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24519563|NCT05332483|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24519564|NCT05332483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24519565|NCT05332483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519566|NCT05332483|Appetite Stimulants|appetite stimulants|mesh-ancestor
24908921|NCT04315194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908922|NCT04315194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24908923|NCT04315194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24394581|NCT00133692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24394582|NCT00133692|Diuretics|diuretics|mesh-ancestor
24394583|NCT00133692|Natriuretic Agents|natriuretic agents|mesh-ancestor
24394584|NCT00133692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394649|NCT00133822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394650|NCT00133822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394651|NCT00133822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24394652|NCT00133822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24394653|NCT00133822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24394654|NCT00133822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24394655|NCT00133822|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24394656|NCT00133822|Dopamine Agents|dopamine agents|mesh-ancestor
24394657|NCT00133822|Antidepressive Agents|antidepressive agents|mesh-ancestor
24394658|NCT00133822|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24394659|NCT00133822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25064608|NCT03458260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25064609|NCT03458260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25064610|NCT03458260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25064611|NCT03458260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25064612|NCT03458260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064613|NCT03458260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25064614|NCT03458260|Alkylating Agents|alkylating agents|mesh-ancestor
24827071|NCT02137265|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24827072|NCT02137265|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24827073|NCT02137278|Antihypertensive Agents|antihypertensive agents|mesh-list
24827074|NCT02137278|Levodopa|levodopa|mesh-list
24827075|NCT02137278|Antipsychotic Agents|antipsychotic agents|mesh-list
24827076|NCT02137278|Antidepressive Agents|antidepressive agents|mesh-list
24827077|NCT02137278|Diuretics|diuretics|mesh-list
24827078|NCT02137278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24394660|NCT00133822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24394661|NCT00133848|Retapamulin|retapamulin|mesh-list
24394662|NCT00133848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24394663|NCT00133848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24394664|NCT00133861|Botulinum Toxins|botulinum toxins|mesh-list
24908935|NCT04315155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908937|NCT04315116|Antidiarrheals|antidiarrheals|mesh-list
24908938|NCT04315116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24908939|NCT04314739|Resveratrol|resveratrol|mesh-list
24908940|NCT04314739|Antioxidants|antioxidants|mesh-ancestor
24908944|NCT04314739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908945|NCT04314739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24827088|NCT02137356|Capecitabine|capecitabine|mesh-list
24827089|NCT02137356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24827090|NCT02137356|Antimetabolites|antimetabolites|mesh-ancestor
24908947|NCT04314310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24908948|NCT04314310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24908949|NCT04314310|Analgesics|analgesics|mesh-ancestor
24908950|NCT04314310|Sensory System Agents|sensory system agents|mesh-ancestor
24908958|NCT04314297|Durvalumab|durvalumab|mesh-list
24908961|NCT04314674|Mannitol|mannitol|mesh-list
24908962|NCT04314674|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24908963|NCT04314674|Diuretics|diuretics|mesh-ancestor
24908964|NCT04314674|Natriuretic Agents|natriuretic agents|mesh-ancestor
24908965|NCT04314674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908966|NCT04314505|Analgesics, Opioid|analgesics, opioid|mesh-list
24908967|NCT04314505|Narcotics|narcotics|mesh-ancestor
24908968|NCT04314505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24908969|NCT04314505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908970|NCT04314505|Analgesics|analgesics|mesh-ancestor
24908971|NCT04314505|Sensory System Agents|sensory system agents|mesh-ancestor
24908973|NCT04314193|Prednisolone|prednisolone|mesh-list
24908979|NCT04314193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24908980|NCT04314193|Antimetabolites|antimetabolites|mesh-ancestor
24908981|NCT04314193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869126|NCT04748588|Bamlanivimab|bamlanivimab|mesh-list
24908982|NCT04314193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24909008|NCT04313699|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24909009|NCT04313699|Antiviral Agents|antiviral agents|mesh-ancestor
24909010|NCT04313699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24909011|NCT04313764|Bupivacaine|bupivacaine|mesh-list
24909012|NCT04313764|Anesthetics, Local|anesthetics, local|mesh-ancestor
24909013|NCT04313764|Anesthetics|anesthetics|mesh-ancestor
24909014|NCT04313764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24909015|NCT04313764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909016|NCT04313764|Sensory System Agents|sensory system agents|mesh-ancestor
24909017|NCT04313764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24909018|NCT04313504|Niraparib|niraparib|mesh-list
24909019|NCT04313504|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24909020|NCT04313504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24909021|NCT04313504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909022|NCT04313504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24909023|NCT04313452|Insulin|insulin|mesh-list
24909024|NCT04313452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25064640|NCT03458143|Sensory System Agents|sensory system agents|mesh-ancestor
24827100|NCT02137395|Glucocorticoids|glucocorticoids|mesh-ancestor
24827101|NCT02137395|Hormones|hormones|mesh-ancestor
24649516|NCT01220232|Abacavir|abacavir|mesh-list
24663072|NCT01298271|Propranolol|propranolol|mesh-list
24827103|NCT02137395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24909025|NCT04313452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909057|NCT04313374|Sensory System Agents|sensory system agents|mesh-ancestor
24909058|NCT04313374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24909059|NCT04313374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24909060|NCT04313374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24909061|NCT04313374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24909062|NCT04313374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24909063|NCT04313335|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24909064|NCT04313335|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24909065|NCT04313335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24909066|NCT04313335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24909067|NCT04313335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909068|NCT04313335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24909069|NCT04313335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909070|NCT04313335|Analgesics|analgesics|mesh-ancestor
24909071|NCT04313335|Sensory System Agents|sensory system agents|mesh-ancestor
24909072|NCT04313335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24909073|NCT04313335|Antidepressive Agents|antidepressive agents|mesh-ancestor
24909074|NCT04313335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24909075|NCT04313335|Dopamine Agents|dopamine agents|mesh-ancestor
24909076|NCT04312997|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
24909077|NCT04312997|Respiratory System Agents|respiratory system agents|mesh-ancestor
24909078|NCT04313023|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
24909079|NCT04313023|Respiratory System Agents|respiratory system agents|mesh-ancestor
24909102|NCT04312750|Anesthetics|anesthetics|mesh-ancestor
24909103|NCT04312750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24909104|NCT04312750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909105|NCT04312750|Sensory System Agents|sensory system agents|mesh-ancestor
24909107|NCT04312750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24909108|NCT04312750|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24909109|NCT04312750|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24909110|NCT04312750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24909111|NCT04312750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909112|NCT04312698|Antihypertensive Agents|antihypertensive agents|mesh-list
24909121|NCT04312347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909122|NCT04312347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24909123|NCT04312347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24909124|NCT04312347|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24909125|NCT04312347|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25064641|NCT03458143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25064642|NCT03458143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064643|NCT03458143|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25064644|NCT03458143|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25064645|NCT03458143|Anesthetics, General|anesthetics, general|mesh-ancestor
25064646|NCT03458143|Anesthetics|anesthetics|mesh-ancestor
25064647|NCT03458143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25064648|NCT03458143|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25064649|NCT03458143|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24827105|NCT02137421|Resveratrol|resveratrol|mesh-list
24827106|NCT02137421|Antioxidants|antioxidants|mesh-ancestor
24713398|NCT01526005|Nicotine|nicotine|mesh-list
24909135|NCT04312243|Antioxidants|antioxidants|mesh-ancestor
24909145|NCT04312438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909146|NCT04312360|Metronidazole|metronidazole|mesh-list
24909147|NCT04312360|Fosfomycin|fosfomycin|mesh-list
24909151|NCT04312360|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24909152|NCT04312204|Gemcitabine|gemcitabine|mesh-list
24909153|NCT04312204|Carboplatin|carboplatin|mesh-list
24909154|NCT04312204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24909155|NCT04312204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24909156|NCT04312204|Antimetabolites|antimetabolites|mesh-ancestor
24909157|NCT04312204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909158|NCT04312204|Antiviral Agents|antiviral agents|mesh-ancestor
24909159|NCT04312204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24909160|NCT04312204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24909161|NCT04312204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24909162|NCT04312204|Immunologic Factors|immunologic factors|mesh-ancestor
24909163|NCT04312204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909164|NCT04312282|Itraconazole|itraconazole|mesh-list
24909165|NCT04312282|Rifampin|rifampin|mesh-list
24909166|NCT04312282|Antifungal Agents|antifungal agents|mesh-ancestor
24909167|NCT04312282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24909168|NCT04312282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24909169|NCT04312282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24909170|NCT04312282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24909172|NCT04312282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24909190|NCT04312152|Tocopherols|tocopherols|mesh-list
24909191|NCT04312152|Folic Acid|folic acid|mesh-list
24909192|NCT04312152|Vitamin B Complex|vitamin b complex|mesh-list
24909193|NCT04312152|Micronutrients|micronutrients|mesh-ancestor
24909194|NCT04312152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909195|NCT04312152|Antioxidants|antioxidants|mesh-ancestor
24909196|NCT04312152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909197|NCT04312152|Protective Agents|protective agents|mesh-ancestor
24909198|NCT04312152|Hematinics|hematinics|mesh-ancestor
24909199|NCT04312048|Isosorbide|isosorbide|mesh-list
24909200|NCT04312048|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24909201|NCT04312048|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25064650|NCT03458143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25064651|NCT03458143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649729|NCT01221740|Analgesics|analgesics|mesh-ancestor
25064652|NCT03458143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25064653|NCT03458143|Narcotics|narcotics|mesh-ancestor
25064654|NCT03458078|Magnesium Sulfate|magnesium sulfate|mesh-list
25064655|NCT03458078|Midazolam|midazolam|mesh-list
24909202|NCT04312048|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24869223|NCT04278404|Nifedipine|nifedipine|mesh-list
24869224|NCT04278404|Milrinone|milrinone|mesh-list
24869225|NCT04278404|Furosemide|furosemide|mesh-list
24869226|NCT04278404|Spironolactone|spironolactone|mesh-list
24909204|NCT04312048|Natriuretic Agents|natriuretic agents|mesh-ancestor
24909205|NCT04312048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909206|NCT04312048|Vasodilator Agents|vasodilator agents|mesh-ancestor
24909207|NCT04312048|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24909208|NCT04312048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909209|NCT04312061|Tramadol|tramadol|mesh-list
24909210|NCT04312061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24909211|NCT04312061|Narcotics|narcotics|mesh-ancestor
24909212|NCT04312061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24909223|NCT04311697|Phentolamine|phentolamine|mesh-list
24909224|NCT04311697|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
24909225|NCT04311697|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24909228|NCT04311697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24909229|NCT04311697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909230|NCT04311697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649786|NCT01221883|Anesthetics|anesthetics|mesh-ancestor
24909231|NCT04311697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24909232|NCT04311697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24909233|NCT04311697|Vasodilator Agents|vasodilator agents|mesh-ancestor
24909234|NCT04311697|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24909235|NCT04311697|Protective Agents|protective agents|mesh-ancestor
24909237|NCT04311580|Mitomycin|mitomycin|mesh-list
24909238|NCT04311580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24909239|NCT04311580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24909240|NCT04311580|Alkylating Agents|alkylating agents|mesh-ancestor
24869277|NCT04278404|Antimetabolites|antimetabolites|mesh-ancestor
24909241|NCT04311580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909242|NCT04311580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24909243|NCT04311580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24909244|NCT04311424|Tirzepatide|tirzepatide|mesh-list
24909245|NCT04311424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24909246|NCT04311424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909247|NCT04311424|Incretins|incretins|mesh-ancestor
24909248|NCT04311424|Hormones|hormones|mesh-ancestor
24909249|NCT04311424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24909250|NCT04311658|Isosorbide|isosorbide|mesh-list
24909251|NCT04311658|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24909252|NCT04311658|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
24909253|NCT04311658|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24909254|NCT04311658|Diuretics|diuretics|mesh-ancestor
24909255|NCT04311658|Natriuretic Agents|natriuretic agents|mesh-ancestor
24909256|NCT04311658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909257|NCT04311658|Vasodilator Agents|vasodilator agents|mesh-ancestor
24909258|NCT04311658|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24909259|NCT04311658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909260|NCT04311645|Charcoal|charcoal|mesh-list
24909261|NCT04311645|Antidotes|antidotes|mesh-ancestor
24909262|NCT04311645|Protective Agents|protective agents|mesh-ancestor
24909263|NCT04311645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909264|NCT04311255|Anesthetics|anesthetics|mesh-list
24909265|NCT04311255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24909266|NCT04311255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909267|NCT04310943|Paclitaxel|paclitaxel|mesh-list
24649864|NCT01222221|Temozolomide|temozolomide|mesh-list
25064656|NCT03458078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25064657|NCT03458078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25064658|NCT03458078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25064659|NCT03458078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064660|NCT03458078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25064661|NCT03458078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25064662|NCT03458078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24909270|NCT04310943|Tubulin Modulators|tubulin modulators|mesh-ancestor
24909271|NCT04310943|Antimitotic Agents|antimitotic agents|mesh-ancestor
24909272|NCT04310943|Mitosis Modulators|mitosis modulators|mesh-ancestor
24909273|NCT04310943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909274|NCT04310683|Hormones|hormones|mesh-list
24909275|NCT04310683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24909276|NCT04310683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909277|NCT04310579|Midazolam|midazolam|mesh-list
24909278|NCT04310579|Oxycodone|oxycodone|mesh-list
24909279|NCT04310579|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24909280|NCT04310579|Paroxetine|paroxetine|mesh-list
24909281|NCT04310579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24909293|NCT04310579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24909294|NCT04310579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909295|NCT04310579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24909297|NCT04310579|Analgesics|analgesics|mesh-ancestor
24909298|NCT04310579|Sensory System Agents|sensory system agents|mesh-ancestor
24909299|NCT04310579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24909300|NCT04310579|Antidepressive Agents|antidepressive agents|mesh-ancestor
24909301|NCT04310579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24909302|NCT04310579|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24909303|NCT04310579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24909304|NCT04310579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24909305|NCT04310579|Serotonin Agents|serotonin agents|mesh-ancestor
24909306|NCT04310579|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24909307|NCT04310579|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24909308|NCT04310579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24909309|NCT04310579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24909310|NCT04310709|Nivolumab|nivolumab|mesh-list
24909311|NCT04310709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24909312|NCT04310709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24909313|NCT04310709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24909314|NCT04310709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909315|NCT04310774|Tegafur|tegafur|mesh-list
24909316|NCT04310774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24909317|NCT04310774|Antimetabolites|antimetabolites|mesh-ancestor
24909318|NCT04310774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909319|NCT04310774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24909320|NCT04310254|Edetic Acid|edetic acid|mesh-list
24909321|NCT04310254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24909322|NCT04310254|Pentetic Acid|pentetic acid|mesh-list
24909323|NCT04310254|Anticoagulants|anticoagulants|mesh-ancestor
24909324|NCT04310254|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24909325|NCT04310254|Chelating Agents|chelating agents|mesh-ancestor
24909326|NCT04310254|Sequestering Agents|sequestering agents|mesh-ancestor
24909327|NCT04310254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909328|NCT04310254|Antidotes|antidotes|mesh-ancestor
24909329|NCT04310254|Protective Agents|protective agents|mesh-ancestor
24909330|NCT04310254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909331|NCT04310254|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24909332|NCT04310280|Insulin Glargine|insulin glargine|mesh-list
24909333|NCT04310280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24909335|NCT04310228|Favipiravir|favipiravir|mesh-list
24663418|NCT01301040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24909342|NCT04310176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25064664|NCT03458078|Anesthetics, General|anesthetics, general|mesh-ancestor
25064666|NCT03458078|GABA Modulators|gaba modulators|mesh-ancestor
24909347|NCT04310176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909348|NCT04310176|Growth Inhibitors|growth inhibitors|mesh-ancestor
24909349|NCT04310176|Antimetabolites|antimetabolites|mesh-ancestor
24909350|NCT04310176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909351|NCT04310176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24909387|NCT04309643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24909388|NCT04309643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909389|NCT04309643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24909391|NCT04309643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24909392|NCT04309643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24909393|NCT04309643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24732432|NCT01639456|Aldesleukin|aldesleukin|mesh-list
24909395|NCT04309708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24909396|NCT04309708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24909397|NCT04309708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24909398|NCT04309708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909429|NCT04308954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909431|NCT04309058|Vitamins|vitamins|mesh-ancestor
24909432|NCT04309058|Micronutrients|micronutrients|mesh-ancestor
24909433|NCT04309058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909434|NCT04309058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24909435|NCT04308551|Aspirin|aspirin|mesh-list
24909436|NCT04308551|Indobufen|indobufen|mesh-list
24650084|NCT01223755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24909479|NCT04308343|Methotrexate|methotrexate|mesh-list
24909480|NCT04308343|Letrozole|letrozole|mesh-list
24909481|NCT04308343|Cetrorelix|cetrorelix|mesh-list
24909482|NCT04308343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24909483|NCT04308343|Abortifacient Agents|abortifacient agents|mesh-ancestor
24909484|NCT04308343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24909485|NCT04308343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909486|NCT04308343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24909487|NCT04308343|Antimetabolites|antimetabolites|mesh-ancestor
25407304|NCT03508921|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24909488|NCT04308343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909490|NCT04308343|Dermatologic Agents|dermatologic agents|mesh-ancestor
24909491|NCT04308343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24909492|NCT04308343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24909520|NCT04308161|Hormone Antagonists|hormone antagonists|mesh-ancestor
24909521|NCT04308161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24909522|NCT04308161|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24909523|NCT04308161|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24909525|NCT04308031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24909526|NCT04308031|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24650257|NCT01224847|Lidocaine|lidocaine|mesh-list
24484292|NCT00447473|Hormone Antagonists|hormone antagonists|mesh-ancestor
24814676|NCT02065947|Respiratory System Agents|respiratory system agents|mesh-ancestor
24814677|NCT02065947|Mydriatics|mydriatics|mesh-ancestor
24814678|NCT02065947|Sympathomimetics|sympathomimetics|mesh-ancestor
25064667|NCT03458078|GABA Agents|gaba agents|mesh-ancestor
25064668|NCT03458078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25064669|NCT03458078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064670|NCT03458078|Analgesics|analgesics|mesh-ancestor
25064671|NCT03458078|Sensory System Agents|sensory system agents|mesh-ancestor
25064672|NCT03458078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24909566|NCT04307290|Dexmedetomidine|dexmedetomidine|mesh-list
24909567|NCT04307290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24909568|NCT04307290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24909569|NCT04307290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909570|NCT04307290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24909571|NCT04307290|Analgesics|analgesics|mesh-ancestor
24909572|NCT04307290|Sensory System Agents|sensory system agents|mesh-ancestor
24909573|NCT04307290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24909574|NCT04307290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24909575|NCT04307290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24909576|NCT04307290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24909577|NCT04307290|Adrenergic Agents|adrenergic agents|mesh-ancestor
24909578|NCT04307290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24869517|NCT03193931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24519567|NCT05332483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24519583|NCT05332314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24519584|NCT05332314|Analgesics|analgesics|mesh-ancestor
24519585|NCT05332314|Sensory System Agents|sensory system agents|mesh-ancestor
24519586|NCT05332314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24519587|NCT05332314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519599|NCT05332106|Estrogens|estrogens|mesh-ancestor
24519600|NCT05332106|Hormones|hormones|mesh-ancestor
24519601|NCT05332106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24519602|NCT05332106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909583|NCT04307147|Antimetabolites|antimetabolites|mesh-ancestor
24909584|NCT04307147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909585|NCT04307147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24909586|NCT04307147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24909587|NCT04307147|Tubulin Modulators|tubulin modulators|mesh-ancestor
24909588|NCT04307147|Antimitotic Agents|antimitotic agents|mesh-ancestor
24909589|NCT04307147|Mitosis Modulators|mitosis modulators|mesh-ancestor
24909590|NCT04307082|Ibrexafungerp|ibrexafungerp|mesh-list
24909591|NCT04307082|Antifungal Agents|antifungal agents|mesh-ancestor
24909592|NCT04307082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24909593|NCT04307069|Oxytocin|oxytocin|mesh-list
24909594|NCT04307069|Oxytocics|oxytocics|mesh-ancestor
24909595|NCT04307069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24909596|NCT04307069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909597|NCT04306913|Cardioplegic Solutions|cardioplegic solutions|mesh-list
24909598|NCT04306913|Esmolol|esmolol|mesh-list
24909599|NCT04306913|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24909600|NCT04306913|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24909601|NCT04306913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24909602|NCT04306913|Adrenergic Agents|adrenergic agents|mesh-ancestor
24909603|NCT04306913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24909604|NCT04306913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909607|NCT04306666|Anesthetics|anesthetics|mesh-list
24909609|NCT04306666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909611|NCT04306653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24909612|NCT04306653|Glucocorticoids|glucocorticoids|mesh-ancestor
24909613|NCT04306653|Hormones|hormones|mesh-ancestor
25064673|NCT03458078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25064674|NCT03458078|Anticonvulsants|anticonvulsants|mesh-ancestor
25064675|NCT03458078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24484300|NCT00447577|Autonomic Agents|autonomic agents|mesh-ancestor
24484301|NCT00447577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24519603|NCT05332106|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24519604|NCT05332106|Contraceptive Agents|contraceptive agents|mesh-ancestor
24519605|NCT05332106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24519606|NCT05332106|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24519607|NCT05332106|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24519608|NCT05332106|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24519609|NCT05332106|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24519610|NCT05332106|Hormone Antagonists|hormone antagonists|mesh-ancestor
24909614|NCT04306653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24909615|NCT04306653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909616|NCT04306653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24909617|NCT04306653|Respiratory System Agents|respiratory system agents|mesh-ancestor
24909619|NCT04306731|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24909620|NCT04306731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24909631|NCT04306692|Inositol|inositol|mesh-list
24909640|NCT04306692|Fertility Agents|fertility agents|mesh-ancestor
24909641|NCT04306692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24909642|NCT04306692|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24909643|NCT04306692|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24909644|NCT04306692|Vitamin B Complex|vitamin b complex|mesh-ancestor
24909645|NCT04306692|Vitamins|vitamins|mesh-ancestor
24869587|NCT02804932|Dopamine Agents|dopamine agents|mesh-ancestor
24909649|NCT04306627|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
24909650|NCT04306627|Atorvastatin|atorvastatin|mesh-list
24909651|NCT04306627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24909652|NCT04306627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24909653|NCT04306627|Antimetabolites|antimetabolites|mesh-ancestor
24909654|NCT04306627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909655|NCT04306627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24909656|NCT04306627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24909657|NCT04306627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24909658|NCT04306627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24909659|NCT04306627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24909660|NCT04306627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24909661|NCT04306627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24909662|NCT04306627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909663|NCT04306627|Vasodilator Agents|vasodilator agents|mesh-ancestor
24909664|NCT04306627|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24909665|NCT04306627|Protease Inhibitors|protease inhibitors|mesh-ancestor
24818909|NCT02091817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064676|NCT03458078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25064677|NCT03458078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25064678|NCT03458078|Tocolytic Agents|tocolytic agents|mesh-ancestor
25064679|NCT03458078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25064680|NCT03457753|Riluzole|riluzole|mesh-list
25064681|NCT03457753|Anticonvulsants|anticonvulsants|mesh-ancestor
25064682|NCT03457753|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24812985|NCT02055703|Donepezil|donepezil|mesh-list
25064683|NCT03457753|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25064684|NCT03457753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25064685|NCT03457753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699502|NCT02107014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541827|NCT00675493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064686|NCT03457753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818910|NCT02091830|Acetaminophen|acetaminophen|mesh-list
24818911|NCT02091830|Cortisone|cortisone|mesh-list
24818912|NCT02091830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24484340|NCT00447863|Contraceptive Agents|contraceptive agents|mesh-ancestor
24484341|NCT00447863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24484342|NCT00447863|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24818916|NCT02091830|Sensory System Agents|sensory system agents|mesh-ancestor
24818917|NCT02091830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24818918|NCT02091830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818919|NCT02091830|Antipyretics|antipyretics|mesh-ancestor
24818920|NCT02091830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24818921|NCT02091908|Lactitol|lactitol|mesh-list
24818922|NCT02091908|Vaccines|vaccines|mesh-list
24818923|NCT02091908|Immunologic Factors|immunologic factors|mesh-ancestor
24818924|NCT02091908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818925|NCT02091908|Cathartics|cathartics|mesh-ancestor
24818926|NCT02091908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24818927|NCT02091973|Everolimus|everolimus|mesh-list
24818928|NCT02091973|Tacrolimus|tacrolimus|mesh-list
24818929|NCT02091973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24818930|NCT02091973|Immunologic Factors|immunologic factors|mesh-ancestor
24818931|NCT02091973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818932|NCT02091973|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24818933|NCT02091973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24818934|NCT02091973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818935|NCT02091973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24818936|NCT02092012|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
24818963|NCT02092363|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24818964|NCT02092363|Carboplatin|carboplatin|mesh-list
24818965|NCT02092363|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
24818966|NCT02092363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24818967|NCT02092363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24818968|NCT02092363|Tubulin Modulators|tubulin modulators|mesh-ancestor
25064687|NCT03457753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25064688|NCT03457753|Protective Agents|protective agents|mesh-ancestor
25064689|NCT03457597|Pioglitazone|pioglitazone|mesh-list
25064690|NCT03457597|Tolbutamide|tolbutamide|mesh-list
25064691|NCT03457597|Metoprolol|metoprolol|mesh-list
25064693|NCT03457597|Omeprazole|omeprazole|mesh-list
25064694|NCT03457597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25064695|NCT03457597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24827140|NCT02137616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24827141|NCT02137616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24827142|NCT02137616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24827143|NCT02137616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24818969|NCT02092363|Antimitotic Agents|antimitotic agents|mesh-ancestor
24818970|NCT02092363|Mitosis Modulators|mitosis modulators|mesh-ancestor
24651342|NCT01231126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24818981|NCT02092428|Adenosine|adenosine|mesh-list
24818982|NCT02092428|Regadenoson|regadenoson|mesh-list
24909666|NCT04306354|Oxytocin|oxytocin|mesh-list
24909667|NCT04306354|Oxytocics|oxytocics|mesh-ancestor
24909668|NCT04306354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24519646|NCT05331768|Terlipressin|terlipressin|mesh-list
24519647|NCT05331768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24623253|NCT01070706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623254|NCT01070706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24623255|NCT01070706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25699503|NCT02107014|Sensory System Agents|sensory system agents|mesh-ancestor
24623256|NCT01070706|Growth Substances|growth substances|mesh-ancestor
25699504|NCT02107014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24519648|NCT05331768|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24909673|NCT04306276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24909674|NCT04306276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909675|NCT04306276|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24909676|NCT04306276|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24909677|NCT04306276|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24909678|NCT04306276|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24909680|NCT04306276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24909681|NCT04306276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24909682|NCT04306276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24909684|NCT04306471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24909685|NCT04306471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24909686|NCT04306471|Antimetabolites|antimetabolites|mesh-ancestor
24909687|NCT04306471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909688|NCT04306471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24909689|NCT04306367|Pembrolizumab|pembrolizumab|mesh-list
24909690|NCT04306367|Olaparib|olaparib|mesh-list
24909691|NCT04306367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24909692|NCT04306367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24909693|NCT04306367|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25064696|NCT03457597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25064697|NCT03457597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064698|NCT03457597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25064699|NCT03457597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25064700|NCT03457597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25064701|NCT03457597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25064702|NCT03457597|Anesthetics, General|anesthetics, general|mesh-ancestor
24909694|NCT04306367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24909695|NCT04306367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909696|NCT04306159|Anesthetics|anesthetics|mesh-list
24909697|NCT04306159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24909698|NCT04306159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909699|NCT04305743|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24909700|NCT04305743|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24869681|NCT00741988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24869682|NCT00741988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24869683|NCT00741988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24869684|NCT00741988|Growth Substances|growth substances|mesh-ancestor
24909710|NCT04305964|Trace Elements|trace elements|mesh-ancestor
24909711|NCT04305964|Micronutrients|micronutrients|mesh-ancestor
24909712|NCT04305964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909713|NCT04306042|Pembrolizumab|pembrolizumab|mesh-list
24909714|NCT04306042|Nivolumab|nivolumab|mesh-list
24909715|NCT04306042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24909716|NCT04306042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24909717|NCT04306042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24909718|NCT04306042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909719|NCT04306081|Evolocumab|evolocumab|mesh-list
24909720|NCT04306081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24909721|NCT04306081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24909722|NCT04306081|Antimetabolites|antimetabolites|mesh-ancestor
24909723|NCT04306081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909724|NCT04306081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24909725|NCT04305587|Clopidogrel|clopidogrel|mesh-list
24909726|NCT04305587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24909727|NCT04305587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24909728|NCT04305587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24909729|NCT04305587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24909745|NCT04305457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24909746|NCT04305457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909747|NCT04305457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24909748|NCT04305457|Respiratory System Agents|respiratory system agents|mesh-ancestor
24909749|NCT04305457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24909750|NCT04305457|Antioxidants|antioxidants|mesh-ancestor
24909751|NCT04305457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909752|NCT04305457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24909753|NCT04305457|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24909754|NCT04305457|Vasodilator Agents|vasodilator agents|mesh-ancestor
24909755|NCT04305457|Gasotransmitters|gasotransmitters|mesh-ancestor
24909772|NCT04305028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24909773|NCT04305028|Antipyretics|antipyretics|mesh-ancestor
24909774|NCT04305028|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24909775|NCT04305028|Antithrombins|antithrombins|mesh-ancestor
24909776|NCT04305028|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24484496|NCT00448825|Topiramate|topiramate|mesh-list
24484497|NCT00448825|Anticonvulsants|anticonvulsants|mesh-ancestor
24484498|NCT00448825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24909778|NCT04305028|Anticoagulants|anticoagulants|mesh-ancestor
24909795|NCT04305106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24909796|NCT04305106|Growth Substances|growth substances|mesh-ancestor
24909797|NCT04305106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909798|NCT04305106|Growth Inhibitors|growth inhibitors|mesh-ancestor
24909799|NCT04305015|Analgesics, Opioid|analgesics, opioid|mesh-list
24909800|NCT04305015|Narcotics|narcotics|mesh-ancestor
24909801|NCT04305015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24909802|NCT04305015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909804|NCT04305015|Sensory System Agents|sensory system agents|mesh-ancestor
24909805|NCT04305015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24909806|NCT04304716|Anesthetics|anesthetics|mesh-list
24909807|NCT04304716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24909808|NCT04304716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909816|NCT04304573|Calcium|calcium|mesh-list
24909817|NCT04304573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24909818|NCT04304573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909819|NCT04304560|Dapagliflozin|dapagliflozin|mesh-list
24909820|NCT04304560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24909821|NCT04304560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909822|NCT04304560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24651837|NCT01234142|Varenicline|varenicline|mesh-list
24909823|NCT04304560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909824|NCT04304430|Dapagliflozin|dapagliflozin|mesh-list
24909825|NCT04304430|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24909826|NCT04304430|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24909827|NCT04304430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909828|NCT04304430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24909829|NCT04304430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909830|NCT04304430|Protease Inhibitors|protease inhibitors|mesh-ancestor
24909831|NCT04304430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24909832|NCT04304209|Capecitabine|capecitabine|mesh-list
24909833|NCT04304209|Oxaliplatin|oxaliplatin|mesh-list
24909834|NCT04304209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24909835|NCT04304209|Antimetabolites|antimetabolites|mesh-ancestor
24910031|NCT04302532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25064710|NCT03457597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24827153|NCT02137616|Dopamine Agonists|dopamine agonists|mesh-ancestor
24909837|NCT04304209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24909839|NCT04304157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24909840|NCT04304157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24909863|NCT04304352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24909864|NCT04304352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24909865|NCT04304352|Antimetabolites|antimetabolites|mesh-ancestor
24909866|NCT04304352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24909867|NCT04304352|Tubulin Modulators|tubulin modulators|mesh-ancestor
24909868|NCT04304352|Antimitotic Agents|antimitotic agents|mesh-ancestor
24909869|NCT04304352|Mitosis Modulators|mitosis modulators|mesh-ancestor
24732854|NCT01641666|Ribavirin|ribavirin|mesh-list
24909871|NCT04304261|Dapagliflozin|dapagliflozin|mesh-list
24909888|NCT04304313|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24909889|NCT04304313|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24909890|NCT04304313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24909891|NCT04304313|Urological Agents|urological agents|mesh-ancestor
24909892|NCT04304196|TEMPO|tempo|mesh-list
24909893|NCT04304196|Antioxidants|antioxidants|mesh-ancestor
24909894|NCT04304196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909895|NCT04304196|Protective Agents|protective agents|mesh-ancestor
24909896|NCT04304196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909897|NCT04303741|Apatinib|apatinib|mesh-list
24909898|NCT04303741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519665|NCT05331690|Sensory System Agents|sensory system agents|mesh-ancestor
24909913|NCT04304040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909914|NCT04303884|Pembrolizumab|pembrolizumab|mesh-list
24909915|NCT04303884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24909916|NCT04303884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24909924|NCT04303988|Bevacizumab|bevacizumab|mesh-list
24909973|NCT04303377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909974|NCT04303377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24909976|NCT04303312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24909977|NCT04303429|Capecitabine|capecitabine|mesh-list
24909978|NCT04303429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24909979|NCT04303429|Antimetabolites|antimetabolites|mesh-ancestor
24869959|NCT05070650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24869960|NCT05070650|Adrenergic Agents|adrenergic agents|mesh-ancestor
24869961|NCT05070650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24869962|NCT05025293|Zoledronic Acid|zoledronic acid|mesh-list
24909980|NCT04303429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909981|NCT04303429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24909982|NCT04303598|Tenofovir|tenofovir|mesh-list
24909983|NCT04303598|Lamivudine|lamivudine|mesh-list
24909984|NCT04303598|Efavirenz|efavirenz|mesh-list
24909985|NCT04303598|Antiviral Agents|antiviral agents|mesh-ancestor
24909986|NCT04303598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24909987|NCT04303598|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24909988|NCT04303598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24909989|NCT04303598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484651|NCT00449501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24519666|NCT05331690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24519667|NCT05324215|Fentanyl|fentanyl|mesh-list
24519668|NCT05324215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24519669|NCT05324215|Narcotics|narcotics|mesh-ancestor
24519670|NCT05324215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24519671|NCT05324215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910032|NCT04302532|Hormone Antagonists|hormone antagonists|mesh-ancestor
24909992|NCT04303598|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24909993|NCT04303598|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24909994|NCT04303598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24909995|NCT04303598|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24909996|NCT04303598|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24909997|NCT04303598|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24519677|NCT05324215|Anesthetics, General|anesthetics, general|mesh-ancestor
24519678|NCT05324215|Anesthetics|anesthetics|mesh-ancestor
24519680|NCT05320991|Analgesics|analgesics|mesh-ancestor
24519681|NCT05320991|Sensory System Agents|sensory system agents|mesh-ancestor
24519682|NCT05320991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24910020|NCT04303065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910022|NCT04302805|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24910023|NCT04302805|Immunologic Factors|immunologic factors|mesh-ancestor
24910024|NCT04302805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910025|NCT04302805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24818983|NCT02092428|Analgesics|analgesics|mesh-ancestor
24818984|NCT02092428|Sensory System Agents|sensory system agents|mesh-ancestor
24818985|NCT02092428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24818986|NCT02092428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818987|NCT02092428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24818988|NCT02092428|Vasodilator Agents|vasodilator agents|mesh-ancestor
24818989|NCT02092428|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24818990|NCT02092428|Purinergic Agonists|purinergic agonists|mesh-ancestor
24818991|NCT02092428|Purinergic Agents|purinergic agents|mesh-ancestor
24484700|NCT00449618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24484701|NCT00449618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24484702|NCT00449618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519683|NCT05320991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519684|NCT05320991|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24519685|NCT05320991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24519686|NCT05320991|Anesthetics, General|anesthetics, general|mesh-ancestor
24519687|NCT05320991|Anesthetics|anesthetics|mesh-ancestor
24519688|NCT05320991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25064727|NCT03457389|Cabergoline|cabergoline|mesh-list
24869987|NCT04622553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25064728|NCT03457389|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24870209|NCT03188354|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24870210|NCT03188354|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24870216|NCT03122431|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24870218|NCT03122431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24870270|NCT02621151|Gemcitabine|gemcitabine|mesh-list
25064729|NCT03457389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25064730|NCT03457389|Dopamine Agonists|dopamine agonists|mesh-ancestor
25064731|NCT03457389|Dopamine Agents|dopamine agents|mesh-ancestor
24827158|NCT02137629|Azacitidine|azacitidine|mesh-list
24519691|NCT05320991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24818995|NCT02092506|Amoxicillin|amoxicillin|mesh-list
24818996|NCT02092506|Metronidazole|metronidazole|mesh-list
24818997|NCT02092506|Clarithromycin|clarithromycin|mesh-list
24818998|NCT02092506|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24818999|NCT02092506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24819000|NCT02092506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24819001|NCT02092506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24819002|NCT02092506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24910026|NCT04302532|Ubiquinone|ubiquinone|mesh-list
24910027|NCT04302532|Coenzyme Q10|coenzyme q10|mesh-list
24910028|NCT04302532|Clomiphene|clomiphene|mesh-list
24910029|NCT04302532|Enclomiphene|enclomiphene|mesh-list
24910030|NCT04302532|Zuclomiphene|zuclomiphene|mesh-list
24910033|NCT04302532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24910034|NCT04302532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910035|NCT04302532|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24910037|NCT04302532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24910038|NCT04302532|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24910039|NCT04302532|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24910040|NCT04302532|Micronutrients|micronutrients|mesh-ancestor
24910041|NCT04302532|Vitamins|vitamins|mesh-ancestor
24910042|NCT04302649|Dialysis Solutions|dialysis solutions|mesh-list
24910043|NCT04302649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24910044|NCT04302402|Rifaximin|rifaximin|mesh-list
24910045|NCT04302402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24910046|NCT04302402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24910047|NCT04302402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24910048|NCT04302441|Capecitabine|capecitabine|mesh-list
24870271|NCT02621151|Pembrolizumab|pembrolizumab|mesh-list
24910049|NCT04302441|Vinorelbine|vinorelbine|mesh-list
24484704|NCT00449618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25699505|NCT02107131|Ranibizumab|ranibizumab|mesh-list
25699506|NCT02107131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25699507|NCT02107131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25699508|NCT02107131|Growth Substances|growth substances|mesh-ancestor
25699509|NCT02107131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699510|NCT02107131|Growth Inhibitors|growth inhibitors|mesh-ancestor
25699511|NCT02107131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25699512|NCT02107274|Azithromycin|azithromycin|mesh-list
25699513|NCT02107274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25699514|NCT02107274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24484705|NCT00449618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484706|NCT00449618|Antipyretics|antipyretics|mesh-ancestor
24484707|NCT00449657|Gemcitabine|gemcitabine|mesh-list
24519692|NCT05320991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910074|NCT04302584|Natriuretic Agents|natriuretic agents|mesh-ancestor
24910075|NCT04302350|Nitrous Oxide|nitrous oxide|mesh-list
24910076|NCT04302350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24910077|NCT04302350|Anesthetics, General|anesthetics, general|mesh-ancestor
24910078|NCT04302350|Anesthetics|anesthetics|mesh-ancestor
25064732|NCT03457389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25064733|NCT03457389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064734|NCT03457389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064736|NCT03457337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25064737|NCT03457337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25064738|NCT03457337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24910088|NCT04302116|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24910098|NCT04302116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24910099|NCT04302116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910100|NCT04302116|Antiemetics|antiemetics|mesh-ancestor
24910101|NCT04302116|Autonomic Agents|autonomic agents|mesh-ancestor
24910102|NCT04302116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24910103|NCT04302116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24910104|NCT04302116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24910105|NCT04302116|Protective Agents|protective agents|mesh-ancestor
24910106|NCT04302116|Anticonvulsants|anticonvulsants|mesh-ancestor
24910107|NCT04302116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24910108|NCT04302116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910109|NCT04302116|GABA Agents|gaba agents|mesh-ancestor
24910110|NCT04302116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24910111|NCT04301908|Interferons|interferons|mesh-list
24910112|NCT04301908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652494|NCT01238705|Metoprolol|metoprolol|mesh-list
24910122|NCT04301895|Remifentanil|remifentanil|mesh-list
24910123|NCT04301895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24910124|NCT04301895|Narcotics|narcotics|mesh-ancestor
24910126|NCT04301895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910127|NCT04301895|Analgesics|analgesics|mesh-ancestor
24910128|NCT04301895|Sensory System Agents|sensory system agents|mesh-ancestor
24910129|NCT04301895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24870422|NCT05162001|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24870423|NCT05162001|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
24910132|NCT04301882|Antiviral Agents|antiviral agents|mesh-list
24910133|NCT04301882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910134|NCT04301882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24910135|NCT04301882|Antimetabolites|antimetabolites|mesh-ancestor
24910136|NCT04301882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910137|NCT04301869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24910138|NCT04301869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24910139|NCT04301479|Hydrocortisone|hydrocortisone|mesh-list
24910140|NCT04301479|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24910141|NCT04301479|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25699515|NCT02107339|Methadone|methadone|mesh-list
25699516|NCT02107339|Hydromorphone|hydromorphone|mesh-list
25699517|NCT02107339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25699518|NCT02107339|Narcotics|narcotics|mesh-ancestor
25699519|NCT02107339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25699520|NCT02107339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699521|NCT02107339|Analgesics|analgesics|mesh-ancestor
25699522|NCT02107339|Sensory System Agents|sensory system agents|mesh-ancestor
24910143|NCT04301479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25064743|NCT03457233|Progesterone|progesterone|mesh-list
25064744|NCT03457233|Progestins|progestins|mesh-ancestor
25064745|NCT03457233|Hormones|hormones|mesh-ancestor
25064746|NCT03457233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25064747|NCT03457233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910144|NCT04301492|Vortioxetine|vortioxetine|mesh-list
24910145|NCT04301492|Antidepressive Agents|antidepressive agents|mesh-ancestor
24910146|NCT04301492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24910147|NCT04301492|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24910148|NCT04301492|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24910149|NCT04301492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24910150|NCT04301492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910151|NCT04301492|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24910152|NCT04301492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24910153|NCT04301492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24910154|NCT04301492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910155|NCT04301492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24910156|NCT04301492|Serotonin Agents|serotonin agents|mesh-ancestor
24870424|NCT05162001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24910167|NCT04301661|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24910168|NCT04301661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24910169|NCT04301661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24910170|NCT04301661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910171|NCT04301661|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24910172|NCT04301661|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24910173|NCT04301739|Paclitaxel|paclitaxel|mesh-list
24910174|NCT04301739|Cyclophosphamide|cyclophosphamide|mesh-list
24910175|NCT04301739|Carboplatin|carboplatin|mesh-list
24910176|NCT04301739|Doxorubicin|doxorubicin|mesh-list
24910177|NCT04301739|Epirubicin|epirubicin|mesh-list
24910188|NCT04301739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24910189|NCT04301739|Alkylating Agents|alkylating agents|mesh-ancestor
24910194|NCT04301739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24910195|NCT04301583|Proanthocyanidin|proanthocyanidin|mesh-list
24910197|NCT04301583|Antioxidants|antioxidants|mesh-ancestor
24484797|NCT00450086|Hormones|hormones|mesh-ancestor
24910198|NCT04301583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910199|NCT04301583|Protective Agents|protective agents|mesh-ancestor
24910200|NCT04301583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910201|NCT04301583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24910202|NCT04301583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24910203|NCT04301583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24910204|NCT04301557|Capecitabine|capecitabine|mesh-list
24910205|NCT04301557|Oxaliplatin|oxaliplatin|mesh-list
24910206|NCT04301557|Antibodies|antibodies|mesh-list
24910207|NCT04301557|Immunologic Factors|immunologic factors|mesh-ancestor
24910208|NCT04301557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910209|NCT04301557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24910210|NCT04301557|Antimetabolites|antimetabolites|mesh-ancestor
24910211|NCT04301557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910212|NCT04301557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25064748|NCT03457233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25064749|NCT03457233|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25064750|NCT03457233|Fertility Agents|fertility agents|mesh-ancestor
24910220|NCT04301726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910222|NCT04301349|Dinoprostone|dinoprostone|mesh-list
24910223|NCT04301349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24910242|NCT04301336|Sensory System Agents|sensory system agents|mesh-ancestor
24910243|NCT04301336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24910244|NCT04301336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24910245|NCT04301336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24910246|NCT04301336|Antimetabolites|antimetabolites|mesh-ancestor
24484858|NCT00450229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484859|NCT00450229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484860|NCT00450281|Antibodies|antibodies|mesh-list
24484861|NCT00450281|Immunologic Factors|immunologic factors|mesh-ancestor
24484862|NCT00450281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484863|NCT00450307|Antibodies|antibodies|mesh-list
24484864|NCT00450307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24484866|NCT00450307|Immunologic Factors|immunologic factors|mesh-ancestor
24484867|NCT00450307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519741|NCT05242874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24652924|NCT01240941|Goserelin|goserelin|mesh-list
24519754|NCT05195034|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24519755|NCT05195034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24519756|NCT05195034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519757|NCT05195034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24519765|NCT05195034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24910264|NCT04301024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24910265|NCT04301024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910266|NCT04301024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24910267|NCT04301024|Analgesics|analgesics|mesh-ancestor
24910268|NCT04301024|Sensory System Agents|sensory system agents|mesh-ancestor
24910269|NCT04301024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24910270|NCT04301323|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24910271|NCT04301323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24910272|NCT04300959|Gemcitabine|gemcitabine|mesh-list
24910273|NCT04300959|Cisplatin|cisplatin|mesh-list
24910274|NCT04300959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910275|NCT04300959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24910276|NCT04300959|Antimetabolites|antimetabolites|mesh-ancestor
24910277|NCT04300959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910278|NCT04300959|Antiviral Agents|antiviral agents|mesh-ancestor
24910279|NCT04300959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25064753|NCT03457194|Immunologic Factors|immunologic factors|mesh-ancestor
25064754|NCT03457194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827187|NCT02137733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24827188|NCT02137733|Antioxidants|antioxidants|mesh-ancestor
24827189|NCT02137733|Protective Agents|protective agents|mesh-ancestor
24827190|NCT02137733|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24827191|NCT02137733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24910299|NCT04300686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24910300|NCT04300686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24910301|NCT04300881|Eplerenone|eplerenone|mesh-list
24910302|NCT04300881|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24653154|NCT01242228|Vildagliptin|vildagliptin|mesh-list
24910321|NCT04300751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910323|NCT04300751|Sensory System Agents|sensory system agents|mesh-ancestor
24910324|NCT04300751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24910325|NCT04300322|Progesterone|progesterone|mesh-list
24910326|NCT04300322|Progestins|progestins|mesh-ancestor
24910327|NCT04300322|Hormones|hormones|mesh-ancestor
24910328|NCT04300322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24910329|NCT04300322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910340|NCT04299971|Methotrexate|methotrexate|mesh-list
24910341|NCT04299971|Tofacitinib|tofacitinib|mesh-list
24910342|NCT04299971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24910343|NCT04299971|Abortifacient Agents|abortifacient agents|mesh-ancestor
24910344|NCT04299971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24910345|NCT04299971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910346|NCT04299971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24910347|NCT04299971|Antimetabolites|antimetabolites|mesh-ancestor
24870878|NCT03155061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407305|NCT03508921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24910348|NCT04299971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910349|NCT04299971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910350|NCT04299971|Dermatologic Agents|dermatologic agents|mesh-ancestor
24910351|NCT04299971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24519772|NCT05159934|Autonomic Agents|autonomic agents|mesh-ancestor
24519773|NCT05159934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25064763|NCT03456947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25064764|NCT03456947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25064765|NCT03456947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064769|NCT03456947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25064770|NCT03456947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25064771|NCT03456791|Protease Inhibitors|protease inhibitors|mesh-list
24827192|NCT02137733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24827193|NCT02137733|Vasodilator Agents|vasodilator agents|mesh-ancestor
24827200|NCT02137759|Temozolomide|temozolomide|mesh-list
24827194|NCT02137733|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24827195|NCT02137733|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24827196|NCT02137733|Sympatholytics|sympatholytics|mesh-ancestor
24827197|NCT02137733|Autonomic Agents|autonomic agents|mesh-ancestor
24714443|NCT01530607|Immunologic Factors|immunologic factors|mesh-ancestor
24519774|NCT05159934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519775|NCT05159934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24519776|NCT05159934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24519777|NCT05159934|Cholinergic Agents|cholinergic agents|mesh-ancestor
24519778|NCT05159934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24519779|NCT05159934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519785|NCT05151471|Protective Agents|protective agents|mesh-ancestor
24910353|NCT04299971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24910354|NCT04299971|Immunologic Factors|immunologic factors|mesh-ancestor
24910355|NCT04299971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24910356|NCT04299971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24910357|NCT04299971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24910358|NCT04299633|Calcium|calcium|mesh-list
24910359|NCT04299633|Sevelamer|sevelamer|mesh-list
24910360|NCT04299633|Calcium acetate|calcium acetate|mesh-list
24910361|NCT04299633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24910392|NCT04298528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24910394|NCT04298684|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24910395|NCT04298684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24485022|NCT00451139|Artemether|artemether|mesh-list
24910406|NCT04298372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910407|NCT04298372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24910408|NCT04298372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24910409|NCT04298372|Growth Substances|growth substances|mesh-ancestor
24910410|NCT04298372|Growth Inhibitors|growth inhibitors|mesh-ancestor
25064772|NCT03456791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25064773|NCT03456791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064774|NCT03456752|Dexamethasone|dexamethasone|mesh-list
25064775|NCT03456752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25064776|NCT03456752|Antiemetics|antiemetics|mesh-ancestor
25064777|NCT03456752|Autonomic Agents|autonomic agents|mesh-ancestor
25064778|NCT03456752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25064779|NCT03456752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827198|NCT02137733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24714508|NCT01531049|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24871163|NCT04658173|Sensory System Agents|sensory system agents|mesh-ancestor
24871164|NCT04658173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24871201|NCT04565392|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25699523|NCT02107339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699524|NCT02107339|Antitussive Agents|antitussive agents|mesh-ancestor
25699525|NCT02107339|Respiratory System Agents|respiratory system agents|mesh-ancestor
24446963|NCT00306748|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25699526|NCT02107703|Fulvestrant|fulvestrant|mesh-list
25699527|NCT02107703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24446964|NCT00306748|Enzyme Activators|enzyme activators|mesh-ancestor
25064780|NCT03456752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25064781|NCT03456752|Glucocorticoids|glucocorticoids|mesh-ancestor
25064782|NCT03456752|Hormones|hormones|mesh-ancestor
25064783|NCT03456752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25064784|NCT03456752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25064785|NCT03456752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25064786|NCT03456713|Mirikizumab|mirikizumab|mesh-list
25064787|NCT03456713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25064788|NCT03456713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25064789|NCT03456713|Analgesics|analgesics|mesh-ancestor
25064790|NCT03456713|Sensory System Agents|sensory system agents|mesh-ancestor
24827199|NCT02137733|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24733383|NCT01645475|Natriuretic Agents|natriuretic agents|mesh-ancestor
24871339|NCT03558152|Vedolizumab|vedolizumab|mesh-list
24871340|NCT03558152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24871341|NCT03548246|Hydrocortisone|hydrocortisone|mesh-list
24910421|NCT04298021|Durvalumab|durvalumab|mesh-list
24910422|NCT04298021|Olaparib|olaparib|mesh-list
24910423|NCT04298021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24910424|NCT04298021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910425|NCT04298021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24910426|NCT04298021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24910427|NCT04298021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910428|NCT04298008|Durvalumab|durvalumab|mesh-list
24910429|NCT04298008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24910430|NCT04298008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910431|NCT04297839|Heparin|heparin|mesh-list
25064791|NCT03456713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25064792|NCT03456713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064793|NCT03456713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25064794|NCT03456713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25064795|NCT03456713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25064796|NCT03456713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24827204|NCT02137759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910432|NCT04297839|Calcium heparin|calcium heparin|mesh-list
24910433|NCT04297839|Citric Acid|citric acid|mesh-list
24910434|NCT04297839|Sodium Citrate|sodium citrate|mesh-list
24910435|NCT04297839|Anticoagulants|anticoagulants|mesh-ancestor
24910436|NCT04297839|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24910437|NCT04297839|Chelating Agents|chelating agents|mesh-ancestor
24485043|NCT00451230|Cocaine|cocaine|mesh-list
24485044|NCT00451230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24485045|NCT00451230|Anesthetics, Local|anesthetics, local|mesh-ancestor
24485046|NCT00451230|Anesthetics|anesthetics|mesh-ancestor
24485058|NCT00451360|Diacetylrhein|diacetylrhein|mesh-list
24519786|NCT05151471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910438|NCT04297839|Sequestering Agents|sequestering agents|mesh-ancestor
24910439|NCT04297839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910440|NCT04297839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24871342|NCT03548246|Fludrocortisone|fludrocortisone|mesh-list
24871537|NCT00424099|Dopamine Agents|dopamine agents|mesh-ancestor
25064808|NCT03456661|Levobupivacaine|levobupivacaine|mesh-list
24949393|NCT04865835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949395|NCT04814940|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24949397|NCT04814940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24827206|NCT02137759|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24827207|NCT02137759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24827208|NCT02137863|Dexmedetomidine|dexmedetomidine|mesh-list
24827209|NCT02137863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24827210|NCT02137863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24827211|NCT02137863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827212|NCT02137863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24827213|NCT02137863|Analgesics|analgesics|mesh-ancestor
24910442|NCT04297215|Anti-Infective Agents|anti-infective agents|mesh-list
24910443|NCT04297215|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24949470|NCT04669457|Dexmedetomidine|dexmedetomidine|mesh-list
24949471|NCT04669457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24949472|NCT04669457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24949473|NCT04669457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949474|NCT04669457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24949475|NCT04669457|Analgesics|analgesics|mesh-ancestor
24827214|NCT02137863|Sensory System Agents|sensory system agents|mesh-ancestor
24827215|NCT02137863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24827216|NCT02137863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24827217|NCT02137863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24827218|NCT02137863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24827219|NCT02137863|Adrenergic Agents|adrenergic agents|mesh-ancestor
24827220|NCT02137863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24871739|NCT04923295|Dapagliflozin|dapagliflozin|mesh-list
24654259|NCT01248338|Vasodilator Agents|vasodilator agents|mesh-ancestor
24654478|NCT01249690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24949484|NCT04669457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24949485|NCT04669457|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24827221|NCT02137863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827223|NCT02137928|Etoposide|etoposide|mesh-list
24827224|NCT02137928|Etoposide phosphate|etoposide phosphate|mesh-list
24827225|NCT02137928|Vincristine|vincristine|mesh-list
24827226|NCT02137928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827227|NCT02137928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24910481|NCT04297072|Rivaroxaban|rivaroxaban|mesh-list
24910482|NCT04297072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24910483|NCT04297072|Antithrombins|antithrombins|mesh-ancestor
24910484|NCT04297072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24910485|NCT04297072|Protease Inhibitors|protease inhibitors|mesh-ancestor
24871911|NCT03651518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24871912|NCT03651518|Dermatologic Agents|dermatologic agents|mesh-ancestor
24871913|NCT03624517|Octreotide|octreotide|mesh-list
24910486|NCT04297072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24949486|NCT04669457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24949487|NCT04669457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24949488|NCT04669457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24953331|NCT03886311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910487|NCT04297072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910493|NCT04297033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24910494|NCT04297033|Antimetabolites|antimetabolites|mesh-ancestor
24910495|NCT04297033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910496|NCT04297033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24910497|NCT04297033|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24910498|NCT04297033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24910499|NCT04296851|Niclosamide|niclosamide|mesh-list
24910510|NCT04296422|Piroxicam|piroxicam|mesh-list
24910511|NCT04296422|Contraceptive Agents|contraceptive agents|mesh-list
24910512|NCT04296422|Contraceptives, Oral|contraceptives, oral|mesh-list
24910513|NCT04296422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24910514|NCT04296422|Analgesics|analgesics|mesh-ancestor
24485118|NCT00451711|Amphotericin B|amphotericin b|mesh-list
24872145|NCT05398679|Linezolid|linezolid|mesh-list
24872146|NCT05398679|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24872147|NCT05398679|Tedizolid|tedizolid|mesh-list
24872148|NCT05398679|Fusidic Acid|fusidic acid|mesh-list
24872149|NCT05398679|Dicloxacillin|dicloxacillin|mesh-list
24872150|NCT05398679|Cefaclor|cefaclor|mesh-list
24485119|NCT00451711|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24485120|NCT00451711|Amebicides|amebicides|mesh-ancestor
24485121|NCT00451711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24485122|NCT00451711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24485123|NCT00451711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24485124|NCT00451711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24953337|NCT03885947|Cyclophosphamide|cyclophosphamide|mesh-list
24953339|NCT03885947|Valproic Acid|valproic acid|mesh-list
24953340|NCT03885947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24953341|NCT03885947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953342|NCT03885947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24953343|NCT03885947|Immunologic Factors|immunologic factors|mesh-ancestor
24827231|NCT02137928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827232|NCT02137928|Tubulin Modulators|tubulin modulators|mesh-ancestor
24694608|NCT05385861|Irinotecan|irinotecan|mesh-list
24872229|NCT05398367|Galactogogues|galactogogues|mesh-list
24872313|NCT05397236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24872314|NCT05397236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446965|NCT00306748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819024|NCT02092597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24819025|NCT02092597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819026|NCT02092597|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24819027|NCT02092597|Incretins|incretins|mesh-ancestor
24819028|NCT02092597|Hormones|hormones|mesh-ancestor
24819029|NCT02092597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24819030|NCT02092597|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24819031|NCT02092597|Protease Inhibitors|protease inhibitors|mesh-ancestor
24953345|NCT03885947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24953346|NCT03885947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24953347|NCT03885947|Alkylating Agents|alkylating agents|mesh-ancestor
24953348|NCT03885947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24953349|NCT03885947|Anticonvulsants|anticonvulsants|mesh-ancestor
24953350|NCT03885947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24953351|NCT03885947|GABA Agents|gaba agents|mesh-ancestor
24953352|NCT03885947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24827233|NCT02137928|Antimitotic Agents|antimitotic agents|mesh-ancestor
24827234|NCT02137928|Mitosis Modulators|mitosis modulators|mesh-ancestor
24827236|NCT02137954|Anesthetics, Local|anesthetics, local|mesh-ancestor
24827237|NCT02137954|Anesthetics|anesthetics|mesh-ancestor
24827238|NCT02137954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24827239|NCT02137954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827240|NCT02137954|Sensory System Agents|sensory system agents|mesh-ancestor
24614822|NCT01026415|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24953353|NCT03885947|Antimanic Agents|antimanic agents|mesh-ancestor
24953354|NCT03885947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24953358|NCT03885895|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24953359|NCT03885895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24953360|NCT03885895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953361|NCT03885895|Hemostatics|hemostatics|mesh-ancestor
24953362|NCT03885895|Coagulants|coagulants|mesh-ancestor
25064809|NCT03456661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24827241|NCT02137954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24827242|NCT02137954|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24827243|NCT02137954|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24910529|NCT04296578|Abiraterone Acetate|abiraterone acetate|mesh-list
24910530|NCT04296578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24910531|NCT04296578|Glucocorticoids|glucocorticoids|mesh-ancestor
24910532|NCT04296578|Hormones|hormones|mesh-ancestor
24910533|NCT04296578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24872655|NCT05293249|Antiemetics|antiemetics|mesh-ancestor
24872708|NCT05244109|Antibodies|antibodies|mesh-list
24872709|NCT05244109|Immunoglobulins|immunoglobulins|mesh-list
25064815|NCT03456661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25064816|NCT03456661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24827244|NCT02137954|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24827245|NCT02137954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24827246|NCT02137954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872710|NCT05244109|Immunologic Factors|immunologic factors|mesh-ancestor
24910535|NCT04296578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24910536|NCT04296578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910537|NCT04296578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25064817|NCT03456661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25064818|NCT03456661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25064819|NCT03456661|Adrenergic Agents|adrenergic agents|mesh-ancestor
25064820|NCT03456661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25064821|NCT03456661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064822|NCT03456661|Anesthetics, Local|anesthetics, local|mesh-ancestor
24862558|NCT05142709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862559|NCT05142709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813504|NCT02058706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25064823|NCT03456661|Anesthetics|anesthetics|mesh-ancestor
25064824|NCT03456648|Apixaban|apixaban|mesh-list
25064825|NCT03456648|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24827252|NCT02137993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24827253|NCT02137993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24827254|NCT02137993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24827255|NCT02137993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24827256|NCT02137993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24584093|NCT00878514|GABA Agents|gaba agents|mesh-ancestor
24827257|NCT02137993|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24827258|NCT02137993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24827259|NCT02137993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24910538|NCT04296578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24910547|NCT04296695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24910548|NCT04296695|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24910549|NCT04296695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25699528|NCT02107703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25699529|NCT02107703|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25699530|NCT02107703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25699531|NCT02107703|Hormone Antagonists|hormone antagonists|mesh-ancestor
25699532|NCT02107703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25699533|NCT02107703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699534|NCT02107898|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25699535|NCT02107898|Immunologic Factors|immunologic factors|mesh-ancestor
24910550|NCT04296695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24910551|NCT04296695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910552|NCT04296695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24862584|NCT05042466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862586|NCT05037552|Hemostatics|hemostatics|mesh-list
24862587|NCT05037552|Coagulants|coagulants|mesh-ancestor
24862588|NCT05021926|Lidocaine|lidocaine|mesh-list
24542370|NCT00678457|Ondansetron|ondansetron|mesh-list
24519832|NCT04907370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519833|NCT04907370|Antiviral Agents|antiviral agents|mesh-ancestor
24519834|NCT04907370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24519835|NCT04907370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24519836|NCT04907370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24910587|NCT04296175|Carboplatin|carboplatin|mesh-list
24910588|NCT04296175|Epirubicin|epirubicin|mesh-list
25064848|NCT03456531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25064849|NCT03456531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25064850|NCT03456531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25064851|NCT03456531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064852|NCT03456531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25064853|NCT03456531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25064854|NCT03456531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25064855|NCT03456531|Antipyretics|antipyretics|mesh-ancestor
25064856|NCT03456466|Rituximab|rituximab|mesh-list
25064857|NCT03456466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25064858|NCT03456466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25064859|NCT03456466|Immunologic Factors|immunologic factors|mesh-ancestor
24827273|NCT02138058|Anticonvulsants|anticonvulsants|mesh-ancestor
24827274|NCT02138058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24827275|NCT02138058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827276|NCT02138084|Ritonavir|ritonavir|mesh-list
24827277|NCT02138084|Fostemsavir|fostemsavir|mesh-list
24827278|NCT02138084|Rifabutin|rifabutin|mesh-list
24827279|NCT02138084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24827280|NCT02138084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24827281|NCT02138084|Protease Inhibitors|protease inhibitors|mesh-ancestor
24827282|NCT02138084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24827283|NCT02138084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910589|NCT04296175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24910590|NCT04296175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910610|NCT04296162|Mitosis Modulators|mitosis modulators|mesh-ancestor
24485275|NCT00452322|Methyltestosterone|methyltestosterone|mesh-list
24485276|NCT00452322|Testosterone|testosterone|mesh-list
24485277|NCT00452322|Testosterone undecanoate|testosterone undecanoate|mesh-list
25064861|NCT03456466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25064862|NCT03456401|Sorafenib|sorafenib|mesh-list
25064863|NCT03456401|Sunitinib|sunitinib|mesh-list
25064874|NCT03456154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25064875|NCT03456154|Antifungal Agents|antifungal agents|mesh-ancestor
25064876|NCT03456154|Keratolytic Agents|keratolytic agents|mesh-ancestor
24935296|NCT04052178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24935298|NCT04051723|Dexamethasone|dexamethasone|mesh-list
25064877|NCT03456154|Dermatologic Agents|dermatologic agents|mesh-ancestor
24827289|NCT02138084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24827290|NCT02138084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24827291|NCT02138084|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24827292|NCT02138084|Antitubercular Agents|antitubercular agents|mesh-ancestor
25699536|NCT02107898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699537|NCT02108171|Dexmedetomidine|dexmedetomidine|mesh-list
25699538|NCT02108171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25699539|NCT02108171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25699540|NCT02108171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699541|NCT02108171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25699542|NCT02108171|Analgesics|analgesics|mesh-ancestor
24862673|NCT04722952|Azacitidine|azacitidine|mesh-list
24862674|NCT04722952|Homoharringtonine|homoharringtonine|mesh-list
24862675|NCT04722952|Visilizumab|visilizumab|mesh-list
24542448|NCT00678756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542449|NCT00678756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542450|NCT00678756|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24542451|NCT00678756|Hormone Antagonists|hormone antagonists|mesh-ancestor
24862699|NCT04715191|Cyclophosphamide|cyclophosphamide|mesh-list
24862700|NCT04715191|Fludarabine|fludarabine|mesh-list
24542455|NCT00678769|Sirolimus|sirolimus|mesh-list
24485281|NCT00452322|Hormones|hormones|mesh-ancestor
24485282|NCT00452322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24485283|NCT00452322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485284|NCT00452322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24485285|NCT00452322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485286|NCT00452322|Anabolic Agents|anabolic agents|mesh-ancestor
24910640|NCT04295967|Formaldehyde|formaldehyde|mesh-list
24910662|NCT04295317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24827295|NCT02138292|Trametinib|trametinib|mesh-list
24827296|NCT02138292|Digoxin|digoxin|mesh-list
24827297|NCT02138292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910663|NCT04295317|Antimetabolites|antimetabolites|mesh-ancestor
24910664|NCT04295317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485287|NCT00452556|Docetaxel|docetaxel|mesh-list
24485288|NCT00452556|Leuprolide|leuprolide|mesh-list
24485289|NCT00452556|Androgens|androgens|mesh-list
25699543|NCT02108171|Sensory System Agents|sensory system agents|mesh-ancestor
25699544|NCT02108171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699545|NCT02108171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25699546|NCT02108171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25699547|NCT02108171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25699548|NCT02108171|Adrenergic Agents|adrenergic agents|mesh-ancestor
25699549|NCT02108171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25699550|NCT02108171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699551|NCT02108288|Carteolol|carteolol|mesh-list
24542532|NCT00679146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542534|NCT00679146|Tubulin Modulators|tubulin modulators|mesh-ancestor
24542535|NCT00679146|Antimitotic Agents|antimitotic agents|mesh-ancestor
24874239|NCT04860141|Gabapentin|gabapentin|mesh-list
24485290|NCT00452556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485291|NCT00452556|Tubulin Modulators|tubulin modulators|mesh-ancestor
24485292|NCT00452556|Antimitotic Agents|antimitotic agents|mesh-ancestor
24485293|NCT00452556|Mitosis Modulators|mitosis modulators|mesh-ancestor
24910665|NCT04295317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910667|NCT04295551|Lopinavir|lopinavir|mesh-list
24910668|NCT04295551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24910669|NCT04295551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24910670|NCT04295551|Protease Inhibitors|protease inhibitors|mesh-ancestor
24910671|NCT04295551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24910672|NCT04295551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910673|NCT04295551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24910674|NCT04295551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24910675|NCT04295551|Antiviral Agents|antiviral agents|mesh-ancestor
24910676|NCT04295551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24910677|NCT04295551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24910678|NCT04295551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25064893|NCT03455426|Hormone Antagonists|hormone antagonists|mesh-ancestor
25064894|NCT03455426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25064895|NCT03455426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064896|NCT03455322|Octreotide|octreotide|mesh-list
25064897|NCT03455322|Norepinephrine|norepinephrine|mesh-list
25064898|NCT03455322|Midodrine|midodrine|mesh-list
24657547|NCT01268176|Vitamins|vitamins|mesh-ancestor
24874637|NCT04616547|Edetic Acid|edetic acid|mesh-list
25064901|NCT03455322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25064902|NCT03455322|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25064903|NCT03455322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25064904|NCT03455322|Adrenergic Agents|adrenergic agents|mesh-ancestor
24775031|NCT01849835|Antipruritics|antipruritics|mesh-ancestor
25064905|NCT03455322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25064906|NCT03455322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064907|NCT03455322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064908|NCT03455322|Sympathomimetics|sympathomimetics|mesh-ancestor
25064909|NCT03455322|Autonomic Agents|autonomic agents|mesh-ancestor
24827298|NCT02138292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24827299|NCT02138292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24827300|NCT02138292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827301|NCT02138292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24827302|NCT02138292|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25699552|NCT02108288|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25699553|NCT02108288|Latanoprost|latanoprost|mesh-list
25699554|NCT02108288|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25699555|NCT02108288|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25699556|NCT02108288|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25699557|NCT02108288|Adrenergic Agents|adrenergic agents|mesh-ancestor
25699558|NCT02108288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25699559|NCT02108288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064910|NCT03455322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25064911|NCT03455322|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25064912|NCT03455322|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25064913|NCT03455179|Methamphetamine|methamphetamine|mesh-list
25064914|NCT03455179|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25064915|NCT03455179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064916|NCT03455179|Sympathomimetics|sympathomimetics|mesh-ancestor
25064917|NCT03455179|Autonomic Agents|autonomic agents|mesh-ancestor
24827306|NCT02138357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24827307|NCT02138357|Narcotics|narcotics|mesh-ancestor
25064924|NCT03455179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25064925|NCT03455179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25064926|NCT03455179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25064929|NCT03455088|Fluoxetine|fluoxetine|mesh-list
25064930|NCT03455088|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25064931|NCT03455088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25064932|NCT03455088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24827308|NCT02138357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24827309|NCT02138357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827310|NCT02138357|Analgesics|analgesics|mesh-ancestor
24827311|NCT02138357|Sensory System Agents|sensory system agents|mesh-ancestor
24827312|NCT02138357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24827313|NCT02138357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24827314|NCT02138383|Gemcitabine|gemcitabine|mesh-list
24827315|NCT02138383|Paclitaxel|paclitaxel|mesh-list
24827316|NCT02138383|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24827317|NCT02138383|Androgens|androgens|mesh-list
25407306|NCT03508921|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24910700|NCT04295161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24910701|NCT04295161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064933|NCT03455088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064935|NCT03455088|Serotonin Agents|serotonin agents|mesh-ancestor
25064936|NCT03455088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064937|NCT03455088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25064938|NCT03455088|Antidepressive Agents|antidepressive agents|mesh-ancestor
25064939|NCT03455088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25064940|NCT03455088|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25064941|NCT03455088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25064942|NCT03455088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24827318|NCT02138383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24827319|NCT02138383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827320|NCT02138383|Tubulin Modulators|tubulin modulators|mesh-ancestor
24827321|NCT02138383|Antimitotic Agents|antimitotic agents|mesh-ancestor
24827322|NCT02138383|Mitosis Modulators|mitosis modulators|mesh-ancestor
24715853|NCT01538693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24910709|NCT04294784|Antimitotic Agents|antimitotic agents|mesh-ancestor
25064945|NCT03455075|Contraceptive Agents|contraceptive agents|mesh-ancestor
25064946|NCT03455075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25064947|NCT03455075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064948|NCT03455075|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25064949|NCT03455075|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25064950|NCT03455075|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24827323|NCT02138383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827324|NCT02138383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24827325|NCT02138383|Antimetabolites|antimetabolites|mesh-ancestor
24485346|NCT00452608|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24485347|NCT00452608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485348|NCT00452634|Irinotecan|irinotecan|mesh-list
24485349|NCT00452634|Simvastatin|simvastatin|mesh-list
24485350|NCT00452634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485351|NCT00452634|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24485352|NCT00452634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24485353|NCT00452634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24436100|NCT00268957|Sevelamer|sevelamer|mesh-list
24658246|NCT01271023|Insulin|insulin|mesh-list
24910711|NCT04294784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910715|NCT04294823|Esomeprazole|esomeprazole|mesh-list
24910716|NCT04294823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24910717|NCT04294823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24910718|NCT04294823|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24910719|NCT04294823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24910720|NCT04294823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910721|NCT04294836|Curcumin|curcumin|mesh-list
24910735|NCT04294966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910736|NCT04294966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24910737|NCT04294966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24863026|NCT03696784|Immunologic Factors|immunologic factors|mesh-ancestor
24863027|NCT03696784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910738|NCT04294966|Analgesics|analgesics|mesh-ancestor
24910739|NCT04294966|Sensory System Agents|sensory system agents|mesh-ancestor
24910740|NCT04294966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24910741|NCT04294966|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24910742|NCT04294966|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24875847|NCT03819465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910744|NCT04294966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910745|NCT04294966|Hormones|hormones|mesh-ancestor
24910746|NCT04294966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24910747|NCT04294732|Bupivacaine|bupivacaine|mesh-list
24910748|NCT04294732|Anesthetics, Local|anesthetics, local|mesh-ancestor
24910749|NCT04294732|Anesthetics|anesthetics|mesh-ancestor
25064951|NCT03455049|Andrographolide|andrographolide|mesh-list
24671119|NCT01323608|Vitamin D|vitamin d|mesh-list
24827327|NCT02138383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24827328|NCT02138383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24827329|NCT02138383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24827330|NCT02138383|Immunologic Factors|immunologic factors|mesh-ancestor
24827331|NCT02138383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827333|NCT02138383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24827334|NCT02138396|Fentanyl|fentanyl|mesh-list
24827335|NCT02138396|Naltrexone|naltrexone|mesh-list
24827336|NCT02138396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24827337|NCT02138396|Narcotics|narcotics|mesh-ancestor
24827338|NCT02138396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24827339|NCT02138396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827340|NCT02138396|Analgesics|analgesics|mesh-ancestor
25064970|NCT03454945|Antimalarials|antimalarials|mesh-ancestor
25064971|NCT03454945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25064972|NCT03454945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25064973|NCT03454919|Palbociclib|palbociclib|mesh-list
25064974|NCT03454919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25064975|NCT03454919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25064976|NCT03454919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25064977|NCT03454919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064978|NCT03454841|Ticagrelor|ticagrelor|mesh-list
24827341|NCT02138396|Sensory System Agents|sensory system agents|mesh-ancestor
24664936|NCT01309438|Erythromycin stearate|erythromycin stearate|mesh-list
24827342|NCT02138396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24827343|NCT02138396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24827344|NCT02138396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24827345|NCT02138396|Anesthetics, General|anesthetics, general|mesh-ancestor
24827346|NCT02138396|Anesthetics|anesthetics|mesh-ancestor
24910750|NCT04294732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24910751|NCT04294732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910752|NCT04294732|Sensory System Agents|sensory system agents|mesh-ancestor
24910753|NCT04294732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24910754|NCT04294953|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24910755|NCT04294953|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25699560|NCT02108288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699561|NCT02108288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24910756|NCT04294953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25699562|NCT02108288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24475228|NCT00409591|Ritonavir|ritonavir|mesh-list
24910757|NCT04294953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24910758|NCT04294953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910759|NCT04294953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24910760|NCT04294953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910762|NCT04294953|Sensory System Agents|sensory system agents|mesh-ancestor
24910764|NCT04294953|Antidepressive Agents|antidepressive agents|mesh-ancestor
24910765|NCT04294953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24910766|NCT04294953|Dopamine Agents|dopamine agents|mesh-ancestor
24910767|NCT04294992|Ondansetron|ondansetron|mesh-list
24910768|NCT04294992|Antiemetics|antiemetics|mesh-ancestor
24485396|NCT00452881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485397|NCT00452881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24485398|NCT00452881|Immunologic Factors|immunologic factors|mesh-ancestor
24485399|NCT00452881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485400|NCT00452894|Varenicline|varenicline|mesh-list
24910769|NCT04294992|Autonomic Agents|autonomic agents|mesh-ancestor
24910770|NCT04294992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24876096|NCT03730649|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24910771|NCT04294992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910772|NCT04294992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24910773|NCT04294992|Antipruritics|antipruritics|mesh-ancestor
25064979|NCT03454841|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25064980|NCT03454841|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25064981|NCT03454841|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25064982|NCT03454841|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25064983|NCT03454841|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25064984|NCT03454841|Purinergic Agents|purinergic agents|mesh-ancestor
25064985|NCT03454841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24827347|NCT02138396|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24827348|NCT02138396|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24827350|NCT02138409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24827351|NCT02138409|Narcotics|narcotics|mesh-ancestor
24910774|NCT04294992|Dermatologic Agents|dermatologic agents|mesh-ancestor
25064986|NCT03454841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25064987|NCT03454841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064988|NCT03454789|Lidocaine|lidocaine|mesh-list
25064989|NCT03454789|Anesthetics, Local|anesthetics, local|mesh-ancestor
25064990|NCT03454789|Anesthetics|anesthetics|mesh-ancestor
25064991|NCT03454789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25064992|NCT03454789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25064993|NCT03454789|Sensory System Agents|sensory system agents|mesh-ancestor
24827352|NCT02138409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24827353|NCT02138409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827354|NCT02138409|Analgesics|analgesics|mesh-ancestor
24827355|NCT02138409|Sensory System Agents|sensory system agents|mesh-ancestor
24827356|NCT02138409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24827357|NCT02138409|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24827358|NCT02138409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24827359|NCT02138409|Anesthetics, General|anesthetics, general|mesh-ancestor
24827360|NCT02138409|Anesthetics|anesthetics|mesh-ancestor
25699563|NCT02108288|Sympatholytics|sympatholytics|mesh-ancestor
25699564|NCT02108288|Autonomic Agents|autonomic agents|mesh-ancestor
25699565|NCT02108288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699566|NCT02109029|Insulin|insulin|mesh-list
25699567|NCT02109029|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24759919|NCT01755494|Saxagliptin|saxagliptin|mesh-list
25699568|NCT02109029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25699569|NCT02109029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699570|NCT02109133|Rocuronium|rocuronium|mesh-list
24485424|NCT00452907|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24436173|NCT00269217|Vasodilator Agents|vasodilator agents|mesh-ancestor
24485425|NCT00452907|Renal Agents|renal agents|mesh-ancestor
24485426|NCT00452920|Docetaxel|docetaxel|mesh-list
24485427|NCT00452920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485428|NCT00452920|Tubulin Modulators|tubulin modulators|mesh-ancestor
24485430|NCT00452920|Mitosis Modulators|mitosis modulators|mesh-ancestor
24485431|NCT00452920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485432|NCT00452972|Anesthetics|anesthetics|mesh-list
24485433|NCT00452972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24485434|NCT00452972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485435|NCT00452985|Carboplatin|carboplatin|mesh-list
24485437|NCT00452985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25064999|NCT03454789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065001|NCT03454724|Everolimus|everolimus|mesh-list
24827361|NCT02138500|PF-06372865|pf-06372865|mesh-list
24827362|NCT02138500|GABA Modulators|gaba modulators|mesh-ancestor
24827363|NCT02138500|GABA Agents|gaba agents|mesh-ancestor
24827364|NCT02138500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24910802|NCT04294056|Anesthetics, General|anesthetics, general|mesh-ancestor
24910804|NCT04294134|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
24910805|NCT04294134|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24910806|NCT04294134|Serotonin Agents|serotonin agents|mesh-ancestor
24876747|NCT03249792|Pembrolizumab|pembrolizumab|mesh-list
24910807|NCT04294134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24910808|NCT04294134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910809|NCT04294134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910810|NCT04293809|Bupivacaine|bupivacaine|mesh-list
24910811|NCT04293809|Anesthetics, Local|anesthetics, local|mesh-ancestor
24910812|NCT04293809|Anesthetics|anesthetics|mesh-ancestor
24910813|NCT04293809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24910814|NCT04293809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910815|NCT04293809|Sensory System Agents|sensory system agents|mesh-ancestor
24910816|NCT04293809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24910817|NCT04293822|Cetirizine|cetirizine|mesh-list
24910818|NCT04293822|Minoxidil|minoxidil|mesh-list
24485446|NCT00453050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485447|NCT00453050|Interferon Inducers|interferon inducers|mesh-ancestor
24910826|NCT04293822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910827|NCT04293822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24910828|NCT04293822|Vasodilator Agents|vasodilator agents|mesh-ancestor
24910829|NCT04293887|Interferons|interferons|mesh-list
24910830|NCT04293887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910831|NCT04293887|Antiviral Agents|antiviral agents|mesh-ancestor
24910832|NCT04293887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25699571|NCT02109133|Atracurium|atracurium|mesh-list
25699572|NCT02109133|Neostigmine|neostigmine|mesh-list
25699573|NCT02109133|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25699574|NCT02109133|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25699575|NCT02109133|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25699576|NCT02109133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699577|NCT02109133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699578|NCT02109133|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25699579|NCT02109133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25699580|NCT02109133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819092|NCT02093143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24819093|NCT02093143|Narcotics|narcotics|mesh-ancestor
25065002|NCT03454724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065003|NCT03454724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25065004|NCT03454724|Immunologic Factors|immunologic factors|mesh-ancestor
25065005|NCT03454724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065006|NCT03454724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25065007|NCT03454724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25065008|NCT03454724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25065009|NCT03454724|Antifungal Agents|antifungal agents|mesh-ancestor
25065010|NCT03454646|Rivastigmine|rivastigmine|mesh-list
25065011|NCT03454646|Donepezil|donepezil|mesh-list
24716210|NCT01540708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24819095|NCT02093143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819096|NCT02093143|Analgesics|analgesics|mesh-ancestor
24935503|NCT04049747|Hormone Antagonists|hormone antagonists|mesh-ancestor
24819097|NCT02093143|Sensory System Agents|sensory system agents|mesh-ancestor
24819098|NCT02093143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24819099|NCT02093195|Bosentan|bosentan|mesh-list
24819100|NCT02093195|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24819101|NCT02093195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24819102|NCT02093195|Respiratory System Agents|respiratory system agents|mesh-ancestor
24819103|NCT02093195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24819104|NCT02093195|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24819105|NCT02093195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819106|NCT02093299|Clopidogrel|clopidogrel|mesh-list
24819107|NCT02093299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25065012|NCT03454646|Galantamine|galantamine|mesh-list
25065013|NCT03454646|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
25065014|NCT03454646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25065015|NCT03454646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065016|NCT03454646|Cholinergic Agents|cholinergic agents|mesh-ancestor
25065017|NCT03454646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25065018|NCT03454646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065019|NCT03454646|Nootropic Agents|nootropic agents|mesh-ancestor
25065020|NCT03454646|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25065021|NCT03454646|Autonomic Agents|autonomic agents|mesh-ancestor
25065022|NCT03454646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25065023|NCT03454646|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25065024|NCT03454646|Protective Agents|protective agents|mesh-ancestor
25065025|NCT03454620|Irinotecan|irinotecan|mesh-list
24949597|NCT04375033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827365|NCT02138500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827366|NCT02138500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827367|NCT02138539|Hydroquinone|hydroquinone|mesh-list
24827368|NCT02138539|Antioxidants|antioxidants|mesh-ancestor
24827369|NCT02138539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827370|NCT02138539|Protective Agents|protective agents|mesh-ancestor
25065026|NCT03454620|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25065027|NCT03454620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25065028|NCT03454620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25065029|NCT03454620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699581|NCT02109133|Cholinergic Agents|cholinergic agents|mesh-ancestor
25065031|NCT03454503|Imatinib Mesylate|imatinib mesylate|mesh-list
25065032|NCT03454503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065033|NCT03454503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24827379|NCT02138708|Sensory System Agents|sensory system agents|mesh-ancestor
24827380|NCT02138708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24716346|NCT01541137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24451383|NCT00323505|Immunologic Factors|immunologic factors|mesh-ancestor
24819108|NCT02093299|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24819113|NCT02093299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819114|NCT02093299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819116|NCT02093403|Azacitidine|azacitidine|mesh-list
24819117|NCT02093403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24819118|NCT02093403|Antimetabolites|antimetabolites|mesh-ancestor
24819119|NCT02093403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819120|NCT02093403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24819121|NCT02093403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819122|NCT02093533|Eculizumab|eculizumab|mesh-list
24819146|NCT02093728|Itraconazole|itraconazole|mesh-list
24819147|NCT02093728|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
24819148|NCT02093728|Fluconazole|fluconazole|mesh-list
24819152|NCT02093728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24615542|NCT01030120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24615543|NCT01030120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615544|NCT01030120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24615545|NCT01030120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24615546|NCT01030120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24878155|NCT02097225|Trametinib|trametinib|mesh-list
24615547|NCT01030120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24615548|NCT01030120|Immunologic Factors|immunologic factors|mesh-ancestor
24623704|NCT01073319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25065044|NCT03454217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25065045|NCT03453931|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25065046|NCT03453931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25065047|NCT03453931|Glucocorticoids|glucocorticoids|mesh-ancestor
25699582|NCT02109133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25699583|NCT02109133|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25699584|NCT02109133|Autonomic Agents|autonomic agents|mesh-ancestor
25699585|NCT02109133|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25699586|NCT02109133|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25699587|NCT02109445|Gemcitabine|gemcitabine|mesh-list
25699588|NCT02109445|Paclitaxel|paclitaxel|mesh-list
25699589|NCT02109445|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25699590|NCT02109445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25699591|NCT02109445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25699592|NCT02109445|Tubulin Modulators|tubulin modulators|mesh-ancestor
25699593|NCT02109445|Antimitotic Agents|antimitotic agents|mesh-ancestor
24623705|NCT01073319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910835|NCT04293549|Mitosis Modulators|mitosis modulators|mesh-ancestor
24827394|NCT02138773|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24827396|NCT02138773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24716526|NCT01542190|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24733844|NCT01648998|Fludrocortisone|fludrocortisone|mesh-list
24949790|NCT03657160|Vedolizumab|vedolizumab|mesh-list
24949791|NCT03657160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24949792|NCT03625141|Atezolizumab|atezolizumab|mesh-list
24949793|NCT03625141|Vemurafenib|vemurafenib|mesh-list
24949794|NCT03625141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24949795|NCT03625141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24949796|NCT03625141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24949797|NCT03625141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949798|NCT03585465|Cyclophosphamide|cyclophosphamide|mesh-list
24716594|NCT01542697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910915|NCT04292418|Mycophenolic Acid|mycophenolic acid|mesh-list
24910916|NCT04292418|Tacrolimus|tacrolimus|mesh-list
24910917|NCT04292418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24910918|NCT04292418|Immunologic Factors|immunologic factors|mesh-ancestor
24910919|NCT04292418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910952|NCT04292704|Clotrimazole|clotrimazole|mesh-list
24910953|NCT04292704|Miconazole|miconazole|mesh-list
24910966|NCT04292704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24910968|NCT04292119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910969|NCT04292119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24910970|NCT04292119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24910971|NCT04292119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910972|NCT04292184|Sodium thiosulfate|sodium thiosulfate|mesh-list
24910973|NCT04292184|Antidotes|antidotes|mesh-ancestor
24910974|NCT04292184|Protective Agents|protective agents|mesh-ancestor
24910975|NCT04292184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910976|NCT04292184|Antioxidants|antioxidants|mesh-ancestor
24910996|NCT04292314|Hydroxyurea|hydroxyurea|mesh-list
24910997|NCT04292314|Deferoxamine|deferoxamine|mesh-list
24910998|NCT04292314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910999|NCT04292314|Antisickling Agents|antisickling agents|mesh-ancestor
24911000|NCT04292314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24911007|NCT04291794|Propofol|propofol|mesh-list
24911009|NCT04291794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24911010|NCT04291794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911011|NCT04291794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24911012|NCT04291794|Anesthetics, General|anesthetics, general|mesh-ancestor
24911013|NCT04291794|Anesthetics|anesthetics|mesh-ancestor
24911014|NCT04291729|Interferons|interferons|mesh-list
24911015|NCT04291729|Ritonavir|ritonavir|mesh-list
24911016|NCT04291729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24911017|NCT04291729|Antiviral Agents|antiviral agents|mesh-ancestor
24911018|NCT04291729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24911019|NCT04291729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24911020|NCT04291729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24911021|NCT04291729|Protease Inhibitors|protease inhibitors|mesh-ancestor
24911022|NCT04291729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24911023|NCT04291729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911024|NCT04291729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25699594|NCT02109445|Mitosis Modulators|mitosis modulators|mesh-ancestor
24806342|NCT02015299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849232|NCT01767129|Quinidine|quinidine|mesh-list
24911025|NCT04291729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24911026|NCT04291729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24911027|NCT04291729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24911028|NCT04291768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24911029|NCT04291768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24911030|NCT04291768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24911031|NCT04291768|Antitubercular Agents|antitubercular agents|mesh-ancestor
24911032|NCT04291755|Pembrolizumab|pembrolizumab|mesh-list
24911033|NCT04291755|Nivolumab|nivolumab|mesh-list
24911034|NCT04291755|Ipilimumab|ipilimumab|mesh-list
24949799|NCT03585465|Capecitabine|capecitabine|mesh-list
24953363|NCT03886233|Immunosuppressive Agents|immunosuppressive agents|mesh-list
24953364|NCT03886233|Immunologic Factors|immunologic factors|mesh-ancestor
24953365|NCT03886233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953366|NCT03885804|Dexmedetomidine|dexmedetomidine|mesh-list
24953367|NCT03885804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24953368|NCT03885804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24953369|NCT03885804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911064|NCT04291209|Antidotes|antidotes|mesh-ancestor
24911066|NCT04290819|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24911067|NCT04290819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911068|NCT04290819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24911069|NCT04290819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24911070|NCT04290819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911071|NCT04290819|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24911072|NCT04290819|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24911073|NCT04290819|Purinergic Agents|purinergic agents|mesh-ancestor
24911074|NCT04290819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24911075|NCT04290936|Tenofovir|tenofovir|mesh-list
24911076|NCT04290936|Antiviral Agents|antiviral agents|mesh-ancestor
24911077|NCT04290936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24911078|NCT04290936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24911079|NCT04290936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24911080|NCT04290936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24911081|NCT04290936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911087|NCT04290871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24911088|NCT04290871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911089|NCT04290871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24911090|NCT04290871|Respiratory System Agents|respiratory system agents|mesh-ancestor
24911091|NCT04290871|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24911092|NCT04290871|Antioxidants|antioxidants|mesh-ancestor
24911093|NCT04290871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911094|NCT04290871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24911095|NCT04290871|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24911097|NCT04290871|Gasotransmitters|gasotransmitters|mesh-ancestor
24623706|NCT01073319|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24623707|NCT01073319|Protective Agents|protective agents|mesh-ancestor
24623708|NCT01073332|Antioxidants|antioxidants|mesh-list
24623709|NCT01073332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623710|NCT01073332|Protective Agents|protective agents|mesh-ancestor
25699595|NCT02109445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699596|NCT02109445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25699597|NCT02109445|Antimetabolites|antimetabolites|mesh-ancestor
25699598|NCT02109445|Antiviral Agents|antiviral agents|mesh-ancestor
24623711|NCT01073332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623712|NCT01073371|Prilocaine|prilocaine|mesh-list
25699599|NCT02109445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25699600|NCT02109445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25699601|NCT02109445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24911098|NCT04290871|Protective Agents|protective agents|mesh-ancestor
24911110|NCT04291066|Antidotes|antidotes|mesh-ancestor
24911111|NCT04290884|Tranexamic Acid|tranexamic acid|mesh-list
24911112|NCT04290884|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24911113|NCT04290884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24911114|NCT04290884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911115|NCT04290884|Hemostatics|hemostatics|mesh-ancestor
24953374|NCT03885804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24953375|NCT03885804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24953376|NCT03885804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24953377|NCT03885804|Adrenergic Agents|adrenergic agents|mesh-ancestor
24953378|NCT03885804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24953379|NCT03885804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953380|NCT03885258|Melatonin|melatonin|mesh-list
24953381|NCT03885258|Antioxidants|antioxidants|mesh-ancestor
24953382|NCT03885258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953383|NCT03885258|Protective Agents|protective agents|mesh-ancestor
24953384|NCT03885258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953385|NCT03885258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24953386|NCT03885427|Ketamine|ketamine|mesh-list
24953387|NCT03885427|Analgesics|analgesics|mesh-ancestor
24911124|NCT04290793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24911125|NCT04290793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24911126|NCT04290793|Alkylating Agents|alkylating agents|mesh-ancestor
24911127|NCT04290793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911128|NCT04290793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24911129|NCT04290793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24911130|NCT04290793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24911131|NCT04290793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24911132|NCT04290793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24911133|NCT04290793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24911134|NCT04290793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24911135|NCT04290858|Nitric Oxide|nitric oxide|mesh-list
24911136|NCT04290858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24911137|NCT04290858|Autonomic Agents|autonomic agents|mesh-ancestor
24911138|NCT04290858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24911139|NCT04290858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911140|NCT04290858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24911141|NCT04290858|Respiratory System Agents|respiratory system agents|mesh-ancestor
24911142|NCT04290858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24911143|NCT04290858|Antioxidants|antioxidants|mesh-ancestor
24911144|NCT04290858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911145|NCT04290858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24911146|NCT04290858|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24911147|NCT04290858|Vasodilator Agents|vasodilator agents|mesh-ancestor
24911148|NCT04290858|Gasotransmitters|gasotransmitters|mesh-ancestor
24911157|NCT04291118|Respiratory System Agents|respiratory system agents|mesh-ancestor
24911158|NCT04291118|Glucocorticoids|glucocorticoids|mesh-ancestor
24911160|NCT04291118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24911161|NCT04290442|Ropivacaine|ropivacaine|mesh-list
24911162|NCT04290442|Anesthetics, Local|anesthetics, local|mesh-ancestor
24911163|NCT04290442|Anesthetics|anesthetics|mesh-ancestor
24911164|NCT04290442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24911165|NCT04290442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911166|NCT04290442|Sensory System Agents|sensory system agents|mesh-ancestor
24779185|NCT01874561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24779186|NCT01874561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24779187|NCT01874561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24779188|NCT01874561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779189|NCT01874561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779191|NCT01874574|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24779192|NCT01874574|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24779193|NCT01874574|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24911167|NCT04290442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24911168|NCT04290455|Castor Oil|castor oil|mesh-list
24911169|NCT04290455|Cathartics|cathartics|mesh-ancestor
24911170|NCT04290455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24911171|NCT04290429|Teduglutide|teduglutide|mesh-list
24911198|NCT04290390|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24911199|NCT04290390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24911200|NCT04290390|Antitubercular Agents|antitubercular agents|mesh-ancestor
24911254|NCT04290104|Sulbactam|sulbactam|mesh-list
24911255|NCT04290104|Sultamicillin|sultamicillin|mesh-list
24911256|NCT04290104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24911257|NCT04290104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24911258|NCT04290104|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24911259|NCT04290104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24911260|NCT04290104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734236|NCT01651364|Cabergoline|cabergoline|mesh-list
24452747|NCT05455944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24665579|NCT01313585|Albuterol|albuterol|mesh-list
24911261|NCT04290026|Metoclopramide|metoclopramide|mesh-list
24911262|NCT04290026|Granisetron|granisetron|mesh-list
24911263|NCT04290026|Antiemetics|antiemetics|mesh-ancestor
24911264|NCT04290026|Autonomic Agents|autonomic agents|mesh-ancestor
24446867|NCT00306397|Sirolimus|sirolimus|mesh-list
24446868|NCT00306397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24446869|NCT00306397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446870|NCT00306397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24446871|NCT00306397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446872|NCT00306397|Antifungal Agents|antifungal agents|mesh-ancestor
24911289|NCT04289675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24911290|NCT04289675|Antiviral Agents|antiviral agents|mesh-ancestor
24911291|NCT04289675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24911292|NCT04289675|Immunologic Factors|immunologic factors|mesh-ancestor
24446875|NCT00306397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446876|NCT00306410|Cholecalciferol|cholecalciferol|mesh-list
24779195|NCT01874574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24911301|NCT04289675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24911303|NCT04289974|Fulvestrant|fulvestrant|mesh-list
24911304|NCT04289974|Palbociclib|palbociclib|mesh-list
24911305|NCT04289974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24911306|NCT04289974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24911307|NCT04289974|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24911308|NCT04289974|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24911309|NCT04289974|Hormone Antagonists|hormone antagonists|mesh-ancestor
24911310|NCT04289974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24911311|NCT04289974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911332|NCT04289792|Immunologic Factors|immunologic factors|mesh-ancestor
24911333|NCT04289792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911334|NCT04289103|Inolimomab|inolimomab|mesh-list
24911335|NCT04289103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24911336|NCT04289103|Immunologic Factors|immunologic factors|mesh-ancestor
24911339|NCT04289467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24911342|NCT04289467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911343|NCT04289467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24911344|NCT04289467|Serotonin Agents|serotonin agents|mesh-ancestor
24911345|NCT04289467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911346|NCT04289090|Propofol|propofol|mesh-list
24911347|NCT04289090|Sevoflurane|sevoflurane|mesh-list
24911348|NCT04289090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24911349|NCT04289090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24911350|NCT04289090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911351|NCT04289090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24911352|NCT04289090|Anesthetics, General|anesthetics, general|mesh-ancestor
24911353|NCT04289090|Anesthetics|anesthetics|mesh-ancestor
24911362|NCT04289207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24911363|NCT04289207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911364|NCT04288999|Capecitabine|capecitabine|mesh-list
25699602|NCT02109445|Immunologic Factors|immunologic factors|mesh-ancestor
25699603|NCT02109445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699604|NCT02109484|Vaccines|vaccines|mesh-list
25699605|NCT02109484|Immunologic Factors|immunologic factors|mesh-ancestor
24911365|NCT04288999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24911366|NCT04288999|Antimetabolites|antimetabolites|mesh-ancestor
24911367|NCT04288999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911368|NCT04288999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24911369|NCT04288765|Dexamethasone|dexamethasone|mesh-list
24911370|NCT04288765|Lenalidomide|lenalidomide|mesh-list
24911371|NCT04288765|Daratumumab|daratumumab|mesh-list
24911372|NCT04288765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24911373|NCT04288765|Antiemetics|antiemetics|mesh-ancestor
24911374|NCT04288765|Autonomic Agents|autonomic agents|mesh-ancestor
24453996|NCT04575233|Sensory System Agents|sensory system agents|mesh-ancestor
25050071|NCT00544115|Dermatologic Agents|dermatologic agents|mesh-ancestor
25050072|NCT00544115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050073|NCT00544115|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25050074|NCT00544115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25050075|NCT00544115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24665640|NCT01313819|Dopamine Agents|dopamine agents|mesh-ancestor
24911375|NCT04288765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24911376|NCT04288765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911377|NCT04288765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24911378|NCT04288765|Glucocorticoids|glucocorticoids|mesh-ancestor
24911379|NCT04288765|Hormones|hormones|mesh-ancestor
24911409|NCT04288349|Anesthetics, Local|anesthetics, local|mesh-ancestor
24734396|NCT01652118|Clarithromycin|clarithromycin|mesh-list
24911410|NCT04288349|Anesthetics|anesthetics|mesh-ancestor
24911411|NCT04288349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24911412|NCT04288349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911413|NCT04288349|Sensory System Agents|sensory system agents|mesh-ancestor
24779196|NCT01874574|Glucocorticoids|glucocorticoids|mesh-ancestor
24779197|NCT01874574|Hormones|hormones|mesh-ancestor
24779198|NCT01874574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24779199|NCT01874574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779200|NCT01874574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24779201|NCT01874574|Immunologic Factors|immunologic factors|mesh-ancestor
24779202|NCT01874574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24779203|NCT01874574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779204|NCT01874574|Viscosupplements|viscosupplements|mesh-ancestor
24779205|NCT01874574|Protective Agents|protective agents|mesh-ancestor
25065062|NCT03453840|Lumefantrine|lumefantrine|mesh-list
25065063|NCT03453840|Artemether|artemether|mesh-list
25065064|NCT03453840|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24911428|NCT04288232|Aflibercept|aflibercept|mesh-list
24911429|NCT04288232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24911430|NCT04288232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24911431|NCT04288232|Growth Substances|growth substances|mesh-ancestor
24911432|NCT04288232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911433|NCT04288232|Growth Inhibitors|growth inhibitors|mesh-ancestor
24911434|NCT04288232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24911435|NCT04288219|Nifedipine|nifedipine|mesh-list
24911436|NCT04288219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24486006|NCT00455806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24486009|NCT00455832|Ribavirin|ribavirin|mesh-list
24911439|NCT04288219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25065068|NCT03453840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25065069|NCT03453723|Lidocaine|lidocaine|mesh-list
25065070|NCT03453723|Anesthetics, Local|anesthetics, local|mesh-ancestor
25065071|NCT03453723|Anesthetics|anesthetics|mesh-ancestor
25065072|NCT03453723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25065073|NCT03453723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065074|NCT03453723|Sensory System Agents|sensory system agents|mesh-ancestor
25065075|NCT03453723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25065076|NCT03453723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25065078|NCT03453723|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24827433|NCT02139098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25699606|NCT02109484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699607|NCT02109562|Risperidone|risperidone|mesh-list
25699608|NCT02109562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25699609|NCT02109562|Serotonin Agents|serotonin agents|mesh-ancestor
24827434|NCT02139098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25699610|NCT02109562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25699611|NCT02109562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827435|NCT02139098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24827436|NCT02139098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827437|NCT02139098|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24827440|NCT02139098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24827441|NCT02139098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827442|NCT02139098|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24827443|NCT02139098|Antidepressive Agents|antidepressive agents|mesh-ancestor
24827444|NCT02139098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24827445|NCT02139098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24911440|NCT04288219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911441|NCT04288219|Vasodilator Agents|vasodilator agents|mesh-ancestor
24911442|NCT04288219|Tocolytic Agents|tocolytic agents|mesh-ancestor
24911443|NCT04288219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24911444|NCT04287894|Pemetrexed|pemetrexed|mesh-list
24911445|NCT04287894|Durvalumab|durvalumab|mesh-list
24911446|NCT04287894|Tremelimumab|tremelimumab|mesh-list
24911463|NCT04287777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24911464|NCT04287777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486037|NCT00455897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24486038|NCT00455910|Thalidomide|thalidomide|mesh-list
24486039|NCT00455910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25065080|NCT03453723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065081|NCT03453632|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25065082|NCT03453632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25065086|NCT03453632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25065087|NCT03453632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827447|NCT02139098|Sensory System Agents|sensory system agents|mesh-ancestor
24827448|NCT02139098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24827449|NCT02139098|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24827450|NCT02139098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24827451|NCT02139098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24827452|NCT02139098|Adrenergic Agents|adrenergic agents|mesh-ancestor
24827453|NCT02139241|Ramosetron|ramosetron|mesh-list
24486040|NCT00455910|Immunologic Factors|immunologic factors|mesh-ancestor
24486041|NCT00455910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519878|NCT04542278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24486069|NCT00456235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24911474|NCT04287842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24911475|NCT04287842|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24911476|NCT04287842|Anesthetics, General|anesthetics, general|mesh-ancestor
24911477|NCT04287842|Anesthetics|anesthetics|mesh-ancestor
24911478|NCT04287842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24911479|NCT04287842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911480|NCT04287426|Remifentanil|remifentanil|mesh-list
24911481|NCT04287426|Rocuronium|rocuronium|mesh-list
24911482|NCT04287426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24911483|NCT04287426|Narcotics|narcotics|mesh-ancestor
24911484|NCT04287426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24911485|NCT04287426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911486|NCT04287426|Analgesics|analgesics|mesh-ancestor
24660983|NCT01287494|Sertraline|sertraline|mesh-list
24911487|NCT04287426|Sensory System Agents|sensory system agents|mesh-ancestor
24911488|NCT04287426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24911489|NCT04287426|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24911490|NCT04287426|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24911491|NCT04287426|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24911492|NCT04287543|Melatonin|melatonin|mesh-list
24911493|NCT04287543|Antioxidants|antioxidants|mesh-ancestor
24911494|NCT04287543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911495|NCT04287543|Protective Agents|protective agents|mesh-ancestor
24486070|NCT00456235|Immunologic Factors|immunologic factors|mesh-ancestor
24486071|NCT00456235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519886|NCT04500665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24911496|NCT04287543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880509|NCT03608358|Metformin|metformin|mesh-list
25699612|NCT02109562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699613|NCT02109562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24911497|NCT04287543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24911498|NCT04287361|Clonazepam|clonazepam|mesh-list
25699614|NCT02109562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25065088|NCT03453541|Ketorolac|ketorolac|mesh-list
25065089|NCT03453541|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25065090|NCT03453541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25065091|NCT03453541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25065092|NCT03453541|Analgesics|analgesics|mesh-ancestor
25065093|NCT03453541|Sensory System Agents|sensory system agents|mesh-ancestor
25065094|NCT03453541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25065095|NCT03453541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827455|NCT02139241|Autonomic Agents|autonomic agents|mesh-ancestor
24827456|NCT02139241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24827457|NCT02139241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623723|NCT01073384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24623724|NCT01073384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623725|NCT01073384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24623726|NCT01073384|Respiratory System Agents|respiratory system agents|mesh-ancestor
24623728|NCT01073501|Analgesics|analgesics|mesh-ancestor
24623733|NCT01073501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24623734|NCT01073501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24623735|NCT01073501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623736|NCT01073501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24623737|NCT01073501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24623738|NCT01073501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24623739|NCT01073501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24623740|NCT01073501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24623748|NCT01073527|Respiratory System Agents|respiratory system agents|mesh-ancestor
24623749|NCT01073527|Tocolytic Agents|tocolytic agents|mesh-ancestor
24623750|NCT01073527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24623751|NCT01073527|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24623752|NCT01073527|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24623753|NCT01073527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24623754|NCT01073527|Adrenergic Agents|adrenergic agents|mesh-ancestor
24623755|NCT01073527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24623756|NCT01073527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880972|NCT03174275|Mitosis Modulators|mitosis modulators|mesh-ancestor
24880973|NCT03174275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623757|NCT01073527|Analgesics|analgesics|mesh-ancestor
25065096|NCT03453541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25065097|NCT03453541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25065109|NCT03453346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25065110|NCT03453281|Aflibercept|aflibercept|mesh-list
25065111|NCT03453281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25065112|NCT03453281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25065113|NCT03453281|Growth Substances|growth substances|mesh-ancestor
25065114|NCT03453281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065115|NCT03453281|Growth Inhibitors|growth inhibitors|mesh-ancestor
25065116|NCT03453281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065117|NCT03453190|Apremilast|apremilast|mesh-list
25065118|NCT03453190|Clobetasol|clobetasol|mesh-list
24827458|NCT02139241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24827459|NCT02139241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24827460|NCT02139241|Serotonin Agents|serotonin agents|mesh-ancestor
24827461|NCT02139241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24827462|NCT02139241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827463|NCT02139267|Vaccines|vaccines|mesh-list
24827464|NCT02139267|Immunologic Factors|immunologic factors|mesh-ancestor
24827465|NCT02139267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623758|NCT01073527|Sensory System Agents|sensory system agents|mesh-ancestor
24911502|NCT04287361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24911503|NCT04287361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911504|NCT04287361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911505|NCT04287387|Pioglitazone|pioglitazone|mesh-list
24911506|NCT04287387|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24911508|NCT04287387|Dapagliflozin|dapagliflozin|mesh-list
24911509|NCT04287387|Glimepiride|glimepiride|mesh-list
24911510|NCT04287387|Acarbose|acarbose|mesh-list
24911511|NCT04287387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24911512|NCT04287387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911513|NCT04287387|Incretins|incretins|mesh-ancestor
24911514|NCT04287387|Hormones|hormones|mesh-ancestor
25065119|NCT03453190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25065120|NCT03453190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25065121|NCT03453190|Analgesics|analgesics|mesh-ancestor
24661250|NCT01288716|Baclofen|baclofen|mesh-list
24827479|NCT02139579|Growth Substances|growth substances|mesh-ancestor
24827480|NCT02139579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827481|NCT02139579|Growth Inhibitors|growth inhibitors|mesh-ancestor
24827485|NCT02139618|Dermatologic Agents|dermatologic agents|mesh-ancestor
24519888|NCT04500665|Antimitotic Agents|antimitotic agents|mesh-ancestor
24519889|NCT04500665|Mitosis Modulators|mitosis modulators|mesh-ancestor
24519890|NCT04500665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911525|NCT04287205|Dydrogesterone|dydrogesterone|mesh-list
24911526|NCT04287205|Progestins|progestins|mesh-ancestor
24911527|NCT04287205|Hormones|hormones|mesh-ancestor
24911528|NCT04287205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24911532|NCT04286711|Apatinib|apatinib|mesh-list
24911533|NCT04286711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24911534|NCT04286711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24911535|NCT04286711|Tubulin Modulators|tubulin modulators|mesh-ancestor
24911536|NCT04286711|Antimitotic Agents|antimitotic agents|mesh-ancestor
24911537|NCT04286711|Mitosis Modulators|mitosis modulators|mesh-ancestor
24911538|NCT04286711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911539|NCT04286711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24911540|NCT04286711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24911541|NCT04286399|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
24911542|NCT04286399|Angiotensin II|angiotensin ii|mesh-list
24911543|NCT04286399|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24911544|NCT04286399|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
25065128|NCT03453190|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25065129|NCT03453190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25065130|NCT03453190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065131|NCT03453190|Glucocorticoids|glucocorticoids|mesh-ancestor
25065132|NCT03453190|Hormones|hormones|mesh-ancestor
25065133|NCT03453190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25065134|NCT03453177|Fosfomycin|fosfomycin|mesh-list
25065135|NCT03453177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25065136|NCT03453177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25065137|NCT03453164|Nivolumab|nivolumab|mesh-list
25065138|NCT03453164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25065139|NCT03453164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065140|NCT03453164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24911545|NCT04286399|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24911546|NCT04286399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24911547|NCT04286399|Adrenergic Agents|adrenergic agents|mesh-ancestor
24911548|NCT04286399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24911549|NCT04286399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911588|NCT04286035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24911589|NCT04286035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911590|NCT04286035|Sensory System Agents|sensory system agents|mesh-ancestor
24911591|NCT04286035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24911593|NCT04286087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24911594|NCT04286087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911595|NCT04285775|Chrysarobin|chrysarobin|mesh-list
24911596|NCT04285775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24911597|NCT04285775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24519891|NCT04500665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24911599|NCT04285775|Sensory System Agents|sensory system agents|mesh-ancestor
24911600|NCT04285775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24911601|NCT04285775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065141|NCT03453164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065142|NCT03452891|Simvastatin|simvastatin|mesh-list
25065143|NCT03452891|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25065144|NCT03452891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24476580|NCT00415831|Levodopa|levodopa|mesh-list
25065145|NCT03452891|Antimetabolites|antimetabolites|mesh-ancestor
25065146|NCT03452891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065147|NCT03452891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25065148|NCT03452891|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25065149|NCT03452891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25065150|NCT03452722|Plasminogen|plasminogen|mesh-list
24661590|NCT01290120|Rituximab|rituximab|mesh-list
24911611|NCT04286152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911612|NCT04286152|Urological Agents|urological agents|mesh-ancestor
24911613|NCT04285528|Lidocaine|lidocaine|mesh-list
24911614|NCT04285528|Fentanyl|fentanyl|mesh-list
24911615|NCT04285528|Ketamine|ketamine|mesh-list
24911616|NCT04285528|Propofol|propofol|mesh-list
24911617|NCT04285528|Anesthetics, Local|anesthetics, local|mesh-ancestor
24911618|NCT04285528|Anesthetics|anesthetics|mesh-ancestor
24911619|NCT04285528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24911620|NCT04285528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911621|NCT04285528|Sensory System Agents|sensory system agents|mesh-ancestor
24911622|NCT04285528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24519925|NCT04413279|Dexamethasone|dexamethasone|mesh-list
24519926|NCT04413279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24519927|NCT04413279|Antiemetics|antiemetics|mesh-ancestor
24519928|NCT04413279|Autonomic Agents|autonomic agents|mesh-ancestor
24486258|NCT00456937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24486259|NCT00456963|Losartan|losartan|mesh-list
24486260|NCT00456963|Enalapril|enalapril|mesh-list
24911623|NCT04285528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24911624|NCT04285528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24911625|NCT04285528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25065151|NCT03452722|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25065152|NCT03452722|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25065153|NCT03452722|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25065154|NCT03452722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065155|NCT03452696|Calcium|calcium|mesh-list
25065167|NCT03452579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25065168|NCT03452579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065169|NCT03452579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25065170|NCT03452579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24827490|NCT02139761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24827491|NCT02139761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24827492|NCT02139761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24827493|NCT02139761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24827496|NCT02139761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911638|NCT04285528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24486269|NCT00456976|Selegiline|selegiline|mesh-list
24519929|NCT04413279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24519930|NCT04413279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519931|NCT04413279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24519932|NCT04413279|Glucocorticoids|glucocorticoids|mesh-ancestor
24519934|NCT04413279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24519935|NCT04413279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24519936|NCT04413279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065172|NCT03452579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065174|NCT03452579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25065175|NCT03452579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065176|NCT03452553|Doxorubicin|doxorubicin|mesh-list
25699615|NCT02109562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25699616|NCT02109562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25699617|NCT02109562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25699618|NCT02109562|Dopamine Agents|dopamine agents|mesh-ancestor
25699619|NCT02109640|Oxycodone|oxycodone|mesh-list
25699620|NCT02109640|Naloxone|naloxone|mesh-list
24477195|NCT00417768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477196|NCT00417794|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24477197|NCT00417794|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25065177|NCT03452553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25065178|NCT03452553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827501|NCT02139761|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24827502|NCT02139761|Dopamine Agents|dopamine agents|mesh-ancestor
24827503|NCT02139761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24717526|NCT01548326|Atorvastatin|atorvastatin|mesh-list
24911692|NCT04284839|Warfarin|warfarin|mesh-list
24911699|NCT04284839|Antithrombins|antithrombins|mesh-ancestor
24911700|NCT04284839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24911701|NCT04284839|Protease Inhibitors|protease inhibitors|mesh-ancestor
24911702|NCT04284839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24911703|NCT04284839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911704|NCT04284826|Mitomycins|mitomycins|mesh-list
24911705|NCT04284826|Mitomycin|mitomycin|mesh-list
24911706|NCT04284826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24911707|NCT04284826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24911708|NCT04284826|Alkylating Agents|alkylating agents|mesh-ancestor
24911709|NCT04284826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911710|NCT04284826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25065179|NCT03452553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25065180|NCT03452553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25065181|NCT03452553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25065182|NCT03452553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065183|NCT03452501|Infliximab|infliximab|mesh-list
25065184|NCT03452501|Dermatologic Agents|dermatologic agents|mesh-ancestor
25065185|NCT03452501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24827504|NCT02139761|Adrenergic Agents|adrenergic agents|mesh-ancestor
25699621|NCT02109640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25699622|NCT02109640|Narcotics|narcotics|mesh-ancestor
25699623|NCT02109640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24935684|NCT04048200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24935686|NCT04048200|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24911711|NCT04284826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24911712|NCT04284644|Propofol|propofol|mesh-list
24911713|NCT04284644|Sevoflurane|sevoflurane|mesh-list
25699624|NCT02109640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699625|NCT02109640|Analgesics|analgesics|mesh-ancestor
25699626|NCT02109640|Sensory System Agents|sensory system agents|mesh-ancestor
25699627|NCT02109640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699628|NCT02109640|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25699629|NCT02109939|Psychotropic Drugs|psychotropic drugs|mesh-list
24477484|NCT00418782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24911714|NCT04284644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24911715|NCT04284644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24911716|NCT04284644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911717|NCT04284644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24437237|NCT00273039|Paroxetine|paroxetine|mesh-list
24486278|NCT00456976|Protective Agents|protective agents|mesh-ancestor
24486285|NCT00457054|Antimanic Agents|antimanic agents|mesh-ancestor
24519956|NCT04333407|Atorvastatin|atorvastatin|mesh-list
24519957|NCT04333407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24519958|NCT04333407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24519959|NCT04333407|Analgesics|analgesics|mesh-ancestor
24519960|NCT04333407|Sensory System Agents|sensory system agents|mesh-ancestor
25065195|NCT03452475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24584396|NCT00880243|Immunologic Factors|immunologic factors|mesh-ancestor
24911730|NCT04284761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24911731|NCT04284852|Niraparib|niraparib|mesh-list
24911732|NCT04284852|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24911733|NCT04284852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24911734|NCT04284852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911735|NCT04284852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24911736|NCT04284514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24911737|NCT04284514|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24911738|NCT04284215|Paclitaxel|paclitaxel|mesh-list
25065204|NCT03452345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25065206|NCT03452332|Ipilimumab|ipilimumab|mesh-list
24827506|NCT02139761|Analgesics|analgesics|mesh-ancestor
24911743|NCT04284215|Antimitotic Agents|antimitotic agents|mesh-ancestor
24911744|NCT04284215|Mitosis Modulators|mitosis modulators|mesh-ancestor
24911745|NCT04284215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911746|NCT04284202|Dasatinib|dasatinib|mesh-list
24911747|NCT04284202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24911748|NCT04284202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24911749|NCT04284202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24519972|NCT04333407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24519973|NCT04333407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24519974|NCT04333407|Antimetabolites|antimetabolites|mesh-ancestor
24519975|NCT04333407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25699630|NCT02110225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25699631|NCT02110225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24519976|NCT04333407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24584473|NCT00880477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24827507|NCT02139761|Sensory System Agents|sensory system agents|mesh-ancestor
25699632|NCT02110225|Mitogens|mitogens|mesh-list
25699633|NCT02110225|Mitosis Modulators|mitosis modulators|mesh-ancestor
25699634|NCT02110225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699635|NCT02110238|Hyaluronic Acid|hyaluronic acid|mesh-list
25699636|NCT02110238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25699637|NCT02110238|Immunologic Factors|immunologic factors|mesh-ancestor
25699638|NCT02110238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699639|NCT02110238|Viscosupplements|viscosupplements|mesh-ancestor
24477660|NCT00419601|Anesthetics|anesthetics|mesh-ancestor
25065286|NCT03451500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24519977|NCT04333407|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24519978|NCT04333407|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24519979|NCT04333407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25065218|NCT03452306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24935724|NCT04047706|Alkylating Agents|alkylating agents|mesh-ancestor
25065219|NCT03452306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065220|NCT03452267|Metformin|metformin|mesh-list
25065221|NCT03452267|Pioglitazone|pioglitazone|mesh-list
25065222|NCT03452267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25065223|NCT03452267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949986|NCT03113123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24949987|NCT03106324|Lenalidomide|lenalidomide|mesh-list
24949988|NCT03106324|Immunologic Factors|immunologic factors|mesh-ancestor
24949989|NCT03106324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949990|NCT03106324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24949991|NCT03106324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24949992|NCT03106324|Growth Substances|growth substances|mesh-ancestor
24949993|NCT03106324|Growth Inhibitors|growth inhibitors|mesh-ancestor
24827508|NCT02139761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24827509|NCT02139904|Vinorelbine|vinorelbine|mesh-list
24827510|NCT02139904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24827511|NCT02139904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827512|NCT02139904|Tubulin Modulators|tubulin modulators|mesh-ancestor
24827513|NCT02139904|Antimitotic Agents|antimitotic agents|mesh-ancestor
24827514|NCT02139904|Mitosis Modulators|mitosis modulators|mesh-ancestor
24827515|NCT02139904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827516|NCT02139930|Nicotine|nicotine|mesh-list
24827517|NCT02139930|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24827518|NCT02139930|Autonomic Agents|autonomic agents|mesh-ancestor
24827519|NCT02139930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24827520|NCT02139930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827521|NCT02139930|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24827522|NCT02139930|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24949994|NCT03106324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24949995|NCT03095612|Docetaxel|docetaxel|mesh-list
24949996|NCT03095612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950002|NCT03063203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24950004|NCT03063203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950005|NCT03063203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827523|NCT02139930|Cholinergic Agents|cholinergic agents|mesh-ancestor
24827524|NCT02139930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24827525|NCT02139930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953414|NCT03885388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953415|NCT03885388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24953417|NCT03885388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953418|NCT03885388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24953419|NCT03885388|Dermatologic Agents|dermatologic agents|mesh-ancestor
24953420|NCT03885388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24911756|NCT04284098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623761|NCT01073527|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24623762|NCT01073527|Purinergic Agonists|purinergic agonists|mesh-ancestor
24819153|NCT02093728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819154|NCT02093728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819155|NCT02093728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24819156|NCT02093728|Hormone Antagonists|hormone antagonists|mesh-ancestor
24819157|NCT02093728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24819158|NCT02093728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911789|NCT04284150|Anesthetics|anesthetics|mesh-ancestor
25699640|NCT02110238|Protective Agents|protective agents|mesh-ancestor
25699641|NCT02110264|Naltrexone|naltrexone|mesh-list
25699642|NCT02110264|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25699643|NCT02110264|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25699644|NCT02110264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699645|NCT02110264|Sensory System Agents|sensory system agents|mesh-ancestor
25699646|NCT02110264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699647|NCT02110706|Rituximab|rituximab|mesh-list
25699648|NCT02110706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24807178|NCT02020161|Dermatologic Agents|dermatologic agents|mesh-ancestor
24477781|NCT00420030|Anticoagulants|anticoagulants|mesh-ancestor
24477782|NCT00420030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24477783|NCT00420043|Imatinib Mesylate|imatinib mesylate|mesh-list
24477784|NCT00420043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477785|NCT00420043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24911790|NCT04284150|GABA Modulators|gaba modulators|mesh-ancestor
24911791|NCT04284150|GABA Agents|gaba agents|mesh-ancestor
24911793|NCT04284059|Vitamins|vitamins|mesh-list
24911794|NCT04284059|Micronutrients|micronutrients|mesh-ancestor
24911795|NCT04284059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911796|NCT04284059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24911797|NCT04283916|Botulinum Toxins|botulinum toxins|mesh-list
24911808|NCT04283747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911811|NCT04284007|Levobupivacaine|levobupivacaine|mesh-list
24911812|NCT04284007|BB 1101|bb 1101|mesh-list
24911813|NCT04284007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24911814|NCT04284007|Antiemetics|antiemetics|mesh-ancestor
24911815|NCT04284007|Autonomic Agents|autonomic agents|mesh-ancestor
24913229|NCT04267913|Mitosis Modulators|mitosis modulators|mesh-ancestor
24911816|NCT04284007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24911817|NCT04284007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911818|NCT04284007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24911819|NCT04284007|Glucocorticoids|glucocorticoids|mesh-ancestor
24911820|NCT04284007|Hormones|hormones|mesh-ancestor
24911821|NCT04284007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24911822|NCT04284007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24911823|NCT04284007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24911831|NCT04283877|Methylphenidate|methylphenidate|mesh-list
24911832|NCT04283877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24911833|NCT04283877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911834|NCT04283877|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24911835|NCT04283877|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24911836|NCT04283877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24911837|NCT04283877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911838|NCT04283877|Dopamine Agents|dopamine agents|mesh-ancestor
24911839|NCT04283877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24911840|NCT04283630|Ascorbic Acid|ascorbic acid|mesh-list
24911841|NCT04283630|Vitamins|vitamins|mesh-ancestor
24911842|NCT04283630|Micronutrients|micronutrients|mesh-ancestor
24911844|NCT04283630|Antioxidants|antioxidants|mesh-ancestor
24911853|NCT04283331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24911854|NCT04283331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911857|NCT04283435|Sildenafil Citrate|sildenafil citrate|mesh-list
24911858|NCT04283435|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24911859|NCT04283435|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24911861|NCT04283435|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24911862|NCT04283435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911863|NCT04283435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911905|NCT04282902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24911906|NCT04282902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911907|NCT04282902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24953426|NCT03885388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24953427|NCT03885388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24953428|NCT03885388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24953429|NCT03885388|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25065224|NCT03451981|Chlorhexidine|chlorhexidine|mesh-list
25065225|NCT03451981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25065226|NCT03451981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25065227|NCT03451981|Disinfectants|disinfectants|mesh-ancestor
25065228|NCT03451903|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25065229|NCT03451903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25065230|NCT03451903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24827538|NCT02140073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24911908|NCT04282902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24911909|NCT04282902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24911910|NCT04282902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24911911|NCT04282902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24911912|NCT04283162|Calcium, Dietary|calcium, dietary|mesh-list
25699649|NCT02110706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25699650|NCT02110706|Immunologic Factors|immunologic factors|mesh-ancestor
25699651|NCT02110706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699652|NCT02110706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25699653|NCT02111083|Insulin Lispro|insulin lispro|mesh-list
25699654|NCT02111083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24911914|NCT04283162|Calcium|calcium|mesh-list
24911915|NCT04283162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24911916|NCT04283162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911917|NCT04283162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24911918|NCT04283162|Hemostatics|hemostatics|mesh-ancestor
24911919|NCT04283162|Coagulants|coagulants|mesh-ancestor
24911920|NCT04282824|Edetic Acid|edetic acid|mesh-list
24911921|NCT04282824|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
24911922|NCT04282824|Chelating Agents|chelating agents|mesh-ancestor
24911944|NCT04282941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24911945|NCT04282941|Analgesics|analgesics|mesh-ancestor
24911946|NCT04282941|Sensory System Agents|sensory system agents|mesh-ancestor
24911947|NCT04282941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24911948|NCT04282941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911984|NCT04282746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911986|NCT04282291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24911987|NCT04282291|Narcotics|narcotics|mesh-ancestor
24911988|NCT04282291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24911989|NCT04282291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911990|NCT04282291|Analgesics|analgesics|mesh-ancestor
24911991|NCT04282291|Sensory System Agents|sensory system agents|mesh-ancestor
24911992|NCT04282291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24911993|NCT04282200|Ketorolac|ketorolac|mesh-list
25065231|NCT03451903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065233|NCT03451734|Antipsychotic Agents|antipsychotic agents|mesh-list
24881640|NCT01912651|Cephalexin|cephalexin|mesh-list
24816107|NCT02074189|Immunologic Factors|immunologic factors|mesh-ancestor
24816108|NCT02074189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816109|NCT02074202|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24816110|NCT02074202|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24816111|NCT02074202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912001|NCT04282200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24912008|NCT04282096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912015|NCT04281862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24912016|NCT04281862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912017|NCT04282031|Letrozole|letrozole|mesh-list
24912018|NCT04282031|Fulvestrant|fulvestrant|mesh-list
24912019|NCT04282031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912020|NCT04282031|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24912021|NCT04282031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24912022|NCT04282031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24912023|NCT04282031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912024|NCT04282031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24912025|NCT04282031|Hormone Antagonists|hormone antagonists|mesh-ancestor
24912026|NCT04282031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24912042|NCT04281576|Oxaliplatin|oxaliplatin|mesh-list
24912043|NCT04281576|Trastuzumab|trastuzumab|mesh-list
24912044|NCT04281576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24912045|NCT04281576|Antimetabolites|antimetabolites|mesh-ancestor
24912057|NCT04281628|Ketamine|ketamine|mesh-list
24912058|NCT04281628|Analgesics|analgesics|mesh-ancestor
24912059|NCT04281628|Sensory System Agents|sensory system agents|mesh-ancestor
24912060|NCT04281628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24912061|NCT04281628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912062|NCT04281628|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24912085|NCT04281342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24912086|NCT04281342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24912087|NCT04281342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24912088|NCT04281342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24912095|NCT04281095|Botulinum Toxins|botulinum toxins|mesh-list
24912096|NCT04281095|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24912097|NCT04281095|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24912098|NCT04281095|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24912099|NCT04281095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24912100|NCT04281095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912125|NCT04280263|Caffeine|caffeine|mesh-list
24912126|NCT04280263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24881780|NCT01358877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24881781|NCT01358877|Immunologic Factors|immunologic factors|mesh-ancestor
24881782|NCT01358877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699655|NCT02111083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699656|NCT02111096|Metformin|metformin|mesh-list
24478178|NCT00421785|Antidotes|antidotes|mesh-ancestor
24912127|NCT04280263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912128|NCT04280263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24912130|NCT04280263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912131|NCT04280263|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24912132|NCT04280263|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24912133|NCT04280263|Purinergic Agents|purinergic agents|mesh-ancestor
24912134|NCT04280263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24912186|NCT04278703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24912189|NCT04278703|Sensory System Agents|sensory system agents|mesh-ancestor
24912190|NCT04278703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24912191|NCT04278807|Anesthetics|anesthetics|mesh-list
24912255|NCT04278040|Alkylating Agents|alkylating agents|mesh-ancestor
24912256|NCT04278040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912257|NCT04278040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912258|NCT04278040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24912259|NCT04278040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24912260|NCT04278040|Immunologic Factors|immunologic factors|mesh-ancestor
24912261|NCT04278040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912263|NCT04277884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24912277|NCT04277702|Montelukast|montelukast|mesh-list
24486889|NCT00460473|Sensory System Agents|sensory system agents|mesh-ancestor
24486890|NCT00460473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24912300|NCT04277533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819174|NCT02093910|Autonomic Agents|autonomic agents|mesh-ancestor
24912327|NCT04276688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24912328|NCT04276688|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24912329|NCT04276688|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24912330|NCT04276688|Protease Inhibitors|protease inhibitors|mesh-ancestor
24912331|NCT04276688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24912332|NCT04276688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912333|NCT04276688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24912334|NCT04276688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24912335|NCT04276688|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24912336|NCT04276688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24912337|NCT04276688|Antimetabolites|antimetabolites|mesh-ancestor
24912338|NCT04276688|Immunologic Factors|immunologic factors|mesh-ancestor
24912339|NCT04276688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912340|NCT04276688|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24520000|NCT04286529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520001|NCT04286529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24520002|NCT04286529|Vitamins|vitamins|mesh-ancestor
24912447|NCT04275388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24912448|NCT04275388|Protease Inhibitors|protease inhibitors|mesh-ancestor
24912449|NCT04275388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24912463|NCT04275258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912464|NCT04275258|Analgesics|analgesics|mesh-ancestor
24912465|NCT04275258|Sensory System Agents|sensory system agents|mesh-ancestor
24912466|NCT04275258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24912467|NCT04275492|Pramipexole|pramipexole|mesh-list
24912468|NCT04275492|Antioxidants|antioxidants|mesh-ancestor
24912469|NCT04275492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912470|NCT04275492|Protective Agents|protective agents|mesh-ancestor
24912471|NCT04275492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912472|NCT04275492|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24912473|NCT04275492|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24912474|NCT04275492|Dopamine Agonists|dopamine agonists|mesh-ancestor
24912475|NCT04275492|Dopamine Agents|dopamine agents|mesh-ancestor
24912476|NCT04275492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24912477|NCT04275115|Midazolam|midazolam|mesh-list
24912478|NCT04275115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24912479|NCT04275115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24912480|NCT04275115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24912481|NCT04275115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912519|NCT04274608|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24912520|NCT04274608|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24912521|NCT04274608|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24912522|NCT04274608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25699657|NCT02111096|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24912523|NCT04274608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912526|NCT04274608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912527|NCT04274608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24912528|NCT04274608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24819175|NCT02093910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24819176|NCT02093910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819177|NCT02093910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24819178|NCT02093910|Glucocorticoids|glucocorticoids|mesh-ancestor
24819179|NCT02093910|Hormones|hormones|mesh-ancestor
24819181|NCT02093910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24819182|NCT02093910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24819183|NCT02094001|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24819184|NCT02094001|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24819185|NCT02094001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819186|NCT02094053|Donepezil|donepezil|mesh-list
24912532|NCT04274816|Tremelimumab|tremelimumab|mesh-list
24912533|NCT04274816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912534|NCT04274803|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24912537|NCT04274803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24912553|NCT04274257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24912554|NCT04274257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912555|NCT04274257|Immunologic Factors|immunologic factors|mesh-ancestor
24912636|NCT04273529|Growth Substances|growth substances|mesh-ancestor
24912637|NCT04273529|Growth Inhibitors|growth inhibitors|mesh-ancestor
24912663|NCT04273282|Methylprednisolone|methylprednisolone|mesh-list
24912664|NCT04273282|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24912665|NCT04273282|Prednisolone acetate|prednisolone acetate|mesh-list
24912666|NCT04273282|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24912667|NCT04273282|Prednisolone phosphate|prednisolone phosphate|mesh-list
24912668|NCT04273282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24912669|NCT04273282|Antiemetics|antiemetics|mesh-ancestor
24912670|NCT04273282|Autonomic Agents|autonomic agents|mesh-ancestor
24912671|NCT04273282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24912672|NCT04273282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912673|NCT04273282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24912674|NCT04273282|Glucocorticoids|glucocorticoids|mesh-ancestor
24912711|NCT04273035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24912712|NCT04273035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24912713|NCT04273035|Anesthetics, General|anesthetics, general|mesh-ancestor
24912714|NCT04273035|Anesthetics|anesthetics|mesh-ancestor
24912715|NCT04273035|GABA Modulators|gaba modulators|mesh-ancestor
24912716|NCT04273035|GABA Agents|gaba agents|mesh-ancestor
24912717|NCT04273035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24912718|NCT04273035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912719|NCT04272788|Infliximab|infliximab|mesh-list
24912720|NCT04272788|Dermatologic Agents|dermatologic agents|mesh-ancestor
24912721|NCT04272788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24912722|NCT04272788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24912723|NCT04272645|Atezolizumab|atezolizumab|mesh-list
24912724|NCT04272645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912725|NCT04272567|Norepinephrine|norepinephrine|mesh-list
24912726|NCT04272567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24912728|NCT04272567|Adrenergic Agents|adrenergic agents|mesh-ancestor
24912743|NCT04272476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912744|NCT04272476|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24912745|NCT04272476|Antidepressive Agents|antidepressive agents|mesh-ancestor
24912746|NCT04272476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24912747|NCT04272476|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24912748|NCT04272476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24520043|NCT04019964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24520045|NCT04019964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24912764|NCT04272255|Scopolamine|scopolamine|mesh-list
24912765|NCT04272255|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24912766|NCT04272255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24912767|NCT04272255|Antiemetics|antiemetics|mesh-ancestor
24912768|NCT04272255|Autonomic Agents|autonomic agents|mesh-ancestor
24912769|NCT04272255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24882360|NCT01111565|Dopamine Agonists|dopamine agonists|mesh-ancestor
24882529|NCT05169593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24882530|NCT05169554|Amoxicillin|amoxicillin|mesh-list
25699658|NCT02111096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24882531|NCT05169554|Clarithromycin|clarithromycin|mesh-list
24882532|NCT05169554|Rifampin|rifampin|mesh-list
24882533|NCT05169554|Clavulanic Acid|clavulanic acid|mesh-list
24882534|NCT05169554|Clavulanic Acids|clavulanic acids|mesh-list
24882535|NCT05169554|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24912770|NCT04272255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912771|NCT04272255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24912772|NCT04272255|Mydriatics|mydriatics|mesh-ancestor
24912773|NCT04272255|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24912774|NCT04272255|Cholinergic Agents|cholinergic agents|mesh-ancestor
24912840|NCT04270994|Oxytocics|oxytocics|mesh-ancestor
24912843|NCT04271189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24912844|NCT04271189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24912845|NCT04271189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912848|NCT04271189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24912849|NCT04271189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24912850|NCT04271189|Protease Inhibitors|protease inhibitors|mesh-ancestor
24912851|NCT04271189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24912852|NCT04271189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912853|NCT04271384|Nivolumab|nivolumab|mesh-list
24912854|NCT04271384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24912855|NCT04271384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912856|NCT04271384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24912866|NCT04270929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912867|NCT04270656|Insulin|insulin|mesh-list
24912868|NCT04270656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24912869|NCT04270656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912870|NCT04270708|Dexmedetomidine|dexmedetomidine|mesh-list
25065278|NCT03451500|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25065279|NCT03451500|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25065280|NCT03451500|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24912871|NCT04270708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24704816|NCT01480687|Ciprofibrate|ciprofibrate|mesh-list
24912872|NCT04270708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24912873|NCT04270708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912874|NCT04270708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24912875|NCT04270708|Analgesics|analgesics|mesh-ancestor
24912876|NCT04270708|Sensory System Agents|sensory system agents|mesh-ancestor
24912885|NCT04270552|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24912886|NCT04270552|Immunologic Factors|immunologic factors|mesh-ancestor
24912887|NCT04270552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912888|NCT04270487|Octylonium|octylonium|mesh-list
24912889|NCT04270487|Bromides|bromides|mesh-list
24912890|NCT04270487|Anticonvulsants|anticonvulsants|mesh-ancestor
24912891|NCT04270487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24912892|NCT04270487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24912894|NCT04270487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24912895|NCT04270487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912896|NCT04270487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24912897|NCT04270487|Parasympatholytics|parasympatholytics|mesh-ancestor
24912898|NCT04270487|Autonomic Agents|autonomic agents|mesh-ancestor
24912899|NCT04270487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24912900|NCT04270487|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24912901|NCT04270487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24912902|NCT04270487|Cholinergic Agents|cholinergic agents|mesh-ancestor
24912903|NCT04270487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24912904|NCT04270370|Atorvastatin|atorvastatin|mesh-list
24819187|NCT02094053|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24819188|NCT02094053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819205|NCT02094157|Warfarin|warfarin|mesh-list
24827587|NCT02140268|Anesthetics, General|anesthetics, general|mesh-ancestor
24819224|NCT02094274|Autonomic Agents|autonomic agents|mesh-ancestor
24819225|NCT02094274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24438597|NCT00276315|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24487451|NCT00463086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24487452|NCT00463112|Sibutramine|sibutramine|mesh-list
24819236|NCT02094274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819238|NCT02094287|Antipruritics|antipruritics|mesh-ancestor
24819239|NCT02094287|Dermatologic Agents|dermatologic agents|mesh-ancestor
24819240|NCT02094287|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24819241|NCT02094287|Histamine Antagonists|histamine antagonists|mesh-ancestor
24912934|NCT04269954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912935|NCT04269954|Hemostatics|hemostatics|mesh-ancestor
24478890|NCT00424853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478892|NCT00424853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24478893|NCT00424853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478894|NCT00424853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24478895|NCT00424853|Immunologic Factors|immunologic factors|mesh-ancestor
24912936|NCT04269954|Coagulants|coagulants|mesh-ancestor
24912937|NCT04270318|Pemetrexed|pemetrexed|mesh-list
24912938|NCT04270318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912939|NCT04270318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24912940|NCT04270318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912941|NCT04270318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24912942|NCT04270318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24912943|NCT04270071|Nitroglycerin|nitroglycerin|mesh-list
24912944|NCT04270071|Vasodilator Agents|vasodilator agents|mesh-ancestor
24912945|NCT04270019|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24912946|NCT04270019|Laxatives|laxatives|mesh-ancestor
24912947|NCT04270019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24912948|NCT04269863|Aspirin|aspirin|mesh-list
24912949|NCT04269863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24912950|NCT04269863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24912951|NCT04269863|Analgesics|analgesics|mesh-ancestor
24912952|NCT04269863|Sensory System Agents|sensory system agents|mesh-ancestor
24912953|NCT04269863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24912954|NCT04269863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912963|NCT04269863|Antipyretics|antipyretics|mesh-ancestor
24912966|NCT04269928|Epinephryl borate|epinephryl borate|mesh-list
24912967|NCT04269928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24912968|NCT04269928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24912969|NCT04269928|Adrenergic Agents|adrenergic agents|mesh-ancestor
24912970|NCT04269928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24912985|NCT04269369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24912986|NCT04269369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912987|NCT04269369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24912988|NCT04269369|Immunologic Factors|immunologic factors|mesh-ancestor
24912989|NCT04269369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912990|NCT04269460|Bupivacaine|bupivacaine|mesh-list
24912991|NCT04269460|Anesthetics, Local|anesthetics, local|mesh-ancestor
24912992|NCT04269460|Anesthetics|anesthetics|mesh-ancestor
24912993|NCT04269460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24913010|NCT04269187|Purinergic Agents|purinergic agents|mesh-ancestor
24913012|NCT04268966|Brincidofovir|brincidofovir|mesh-list
24505723|NCT00542139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913013|NCT04268966|Antiviral Agents|antiviral agents|mesh-ancestor
24913014|NCT04268966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24913015|NCT04269278|Dexmedetomidine|dexmedetomidine|mesh-list
24913016|NCT04269278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24913017|NCT04269278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24913018|NCT04269278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913019|NCT04269278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24913020|NCT04269278|Analgesics|analgesics|mesh-ancestor
24913021|NCT04269278|Sensory System Agents|sensory system agents|mesh-ancestor
24913022|NCT04269278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24913026|NCT04269278|Adrenergic Agents|adrenergic agents|mesh-ancestor
24913027|NCT04269278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24913028|NCT04269278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913029|NCT04269109|Analgesics, Opioid|analgesics, opioid|mesh-list
24913030|NCT04269109|Narcotics|narcotics|mesh-ancestor
24913031|NCT04269109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24913032|NCT04269109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913033|NCT04269109|Analgesics|analgesics|mesh-ancestor
25699659|NCT02111096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699660|NCT02111096|Incretins|incretins|mesh-ancestor
25699661|NCT02111096|Hormones|hormones|mesh-ancestor
25699662|NCT02111096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25699663|NCT02111096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25699664|NCT02111096|Protease Inhibitors|protease inhibitors|mesh-ancestor
24913034|NCT04269109|Sensory System Agents|sensory system agents|mesh-ancestor
24913035|NCT04269109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699665|NCT02111096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25699666|NCT02111096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913037|NCT04268888|Chlorotrianisene|chlorotrianisene|mesh-list
24913038|NCT04268888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24913039|NCT04268888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913040|NCT04268888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24913041|NCT04268888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913042|NCT04268888|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24913043|NCT04268888|Estrogens|estrogens|mesh-ancestor
24913044|NCT04268888|Hormones|hormones|mesh-ancestor
24913059|NCT04268927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913060|NCT04268927|Hormones|hormones|mesh-ancestor
24913061|NCT04268602|Anesthetics|anesthetics|mesh-list
24913062|NCT04268602|Anesthetics, Local|anesthetics, local|mesh-list
24819278|NCT02094469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24913066|NCT04268602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24913086|NCT04268303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24913087|NCT04268303|Adrenergic Agents|adrenergic agents|mesh-ancestor
24913088|NCT04268303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24913089|NCT04268303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913090|NCT04268524|Miltefosine|miltefosine|mesh-list
24913091|NCT04268524|Antifungal Agents|antifungal agents|mesh-ancestor
24913092|NCT04268524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24913093|NCT04268524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913094|NCT04268524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24913095|NCT04268524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24913097|NCT04268563|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24913098|NCT04268563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24913099|NCT04268563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913100|NCT04268563|Incretins|incretins|mesh-ancestor
24913101|NCT04268563|Hormones|hormones|mesh-ancestor
24913102|NCT04268563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24913103|NCT04268563|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24913104|NCT04268563|Protease Inhibitors|protease inhibitors|mesh-ancestor
24913105|NCT04268563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24913106|NCT04268563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913107|NCT04268472|Darunavir|darunavir|mesh-list
24913108|NCT04268472|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24913109|NCT04268472|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24913110|NCT04268472|Protease Inhibitors|protease inhibitors|mesh-ancestor
24913111|NCT04268472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24913135|NCT04268394|Antimetabolites|antimetabolites|mesh-ancestor
24913136|NCT04268394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913137|NCT04268394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913138|NCT04268394|Dermatologic Agents|dermatologic agents|mesh-ancestor
24913139|NCT04268394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24913142|NCT04268394|Immunologic Factors|immunologic factors|mesh-ancestor
24913143|NCT04268394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24913144|NCT04268394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24913145|NCT04268394|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24913146|NCT04268394|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24913147|NCT04268394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24913148|NCT04268394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24913149|NCT04268394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24913150|NCT04268394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24913151|NCT04268394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24913152|NCT04268394|Anesthetics, General|anesthetics, general|mesh-ancestor
24913153|NCT04268394|Anesthetics|anesthetics|mesh-ancestor
24913154|NCT04268394|GABA Modulators|gaba modulators|mesh-ancestor
24913155|NCT04268394|GABA Agents|gaba agents|mesh-ancestor
24913156|NCT04268394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24913157|NCT04268394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24913158|NCT04268394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24913159|NCT04268394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24913160|NCT04268394|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24913161|NCT04268394|Antifungal Agents|antifungal agents|mesh-ancestor
24913162|NCT04268394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24913163|NCT04268394|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24913164|NCT04268394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24913167|NCT04268394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24913168|NCT04268394|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24913169|NCT04268394|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24913170|NCT04268394|Antitubercular Agents|antitubercular agents|mesh-ancestor
24913171|NCT04268394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24913172|NCT04268394|Leprostatic Agents|leprostatic agents|mesh-ancestor
24913173|NCT04268394|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24913174|NCT04268394|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24913175|NCT04268394|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24913176|NCT04268394|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24913177|NCT04268394|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24913178|NCT04268394|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24913179|NCT04268394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24913180|NCT04268394|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24913181|NCT04268394|Protective Agents|protective agents|mesh-ancestor
24913182|NCT04268394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24913183|NCT04268394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24913184|NCT04268394|Analgesics|analgesics|mesh-ancestor
24913185|NCT04268394|Sensory System Agents|sensory system agents|mesh-ancestor
24913186|NCT04268394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24913187|NCT04268394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24913188|NCT04268394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24913199|NCT04267653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24913200|NCT04267679|Cannabidiol|cannabidiol|mesh-list
24913206|NCT04267913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24913207|NCT04267913|Antibodies|antibodies|mesh-list
24913208|NCT04267913|Immunoglobulins|immunoglobulins|mesh-list
24913209|NCT04267913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24913210|NCT04267913|Lexatumumab|lexatumumab|mesh-list
24913211|NCT04267913|BB 1101|bb 1101|mesh-list
24913220|NCT04267913|Hormones|hormones|mesh-ancestor
24913221|NCT04267913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24913222|NCT04267913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24913223|NCT04267913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065289|NCT03451500|Dopamine Agonists|dopamine agonists|mesh-ancestor
25065290|NCT03451487|Acetaminophen|acetaminophen|mesh-list
25065291|NCT03451487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24913224|NCT04267913|Protease Inhibitors|protease inhibitors|mesh-ancestor
24913225|NCT04267913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24913226|NCT04267913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913227|NCT04267913|Tubulin Modulators|tubulin modulators|mesh-ancestor
24913228|NCT04267913|Antimitotic Agents|antimitotic agents|mesh-ancestor
24819253|NCT02094313|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24819254|NCT02094313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819255|NCT02094339|Analgesics|analgesics|mesh-list
24819256|NCT02094339|Ropivacaine|ropivacaine|mesh-list
24819257|NCT02094339|Anesthetics, Local|anesthetics, local|mesh-ancestor
24819258|NCT02094339|Anesthetics|anesthetics|mesh-ancestor
24819270|NCT02094391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819271|NCT02094469|Cilostazol|cilostazol|mesh-list
24819272|NCT02094469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24819273|NCT02094469|Autonomic Agents|autonomic agents|mesh-ancestor
24819274|NCT02094469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24819275|NCT02094469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819276|NCT02094469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24819279|NCT02094469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24819280|NCT02094469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819281|NCT02094469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24819282|NCT02094469|Vasodilator Agents|vasodilator agents|mesh-ancestor
24819283|NCT02094469|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24819284|NCT02094469|Protective Agents|protective agents|mesh-ancestor
24819285|NCT02094469|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24819286|NCT02094469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24819287|NCT02094469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819288|NCT02094599|Dronabinol|dronabinol|mesh-list
24819289|NCT02094599|Hallucinogens|hallucinogens|mesh-ancestor
24819290|NCT02094599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819291|NCT02094599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24819292|NCT02094599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24913259|NCT04267549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24736352|NCT01661530|Vitamin E|vitamin e|mesh-list
24913260|NCT04267237|Atezolizumab|atezolizumab|mesh-list
24913261|NCT04267237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913262|NCT04267224|Ticagrelor|ticagrelor|mesh-list
24913263|NCT04267224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24913264|NCT04267224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24913265|NCT04267224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24913266|NCT04267224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24913267|NCT04267224|Purinergic Agents|purinergic agents|mesh-ancestor
24913268|NCT04267224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24913269|NCT04267224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913270|NCT04267224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913271|NCT04267250|Levonorgestrel|levonorgestrel|mesh-list
24667111|NCT01322204|Analgesics|analgesics|mesh-ancestor
24667112|NCT01322204|Sensory System Agents|sensory system agents|mesh-ancestor
24913272|NCT04267250|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24913273|NCT04267250|Estradiol|estradiol|mesh-list
24913274|NCT04267250|PF-06700841|pf-06700841|mesh-list
24913275|NCT04267250|Estrogens|estrogens|mesh-ancestor
24913276|NCT04267250|Hormones|hormones|mesh-ancestor
24913277|NCT04267250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24849726|NCT02249910|Metformin|metformin|mesh-list
24913278|NCT04267250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913279|NCT04267250|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24666890|NCT01321268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24913288|NCT04267250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913290|NCT04267042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24913291|NCT04267042|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24913292|NCT04267042|Autonomic Agents|autonomic agents|mesh-ancestor
24913293|NCT04267042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24913294|NCT04267042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913295|NCT04267042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24913296|NCT04267042|Respiratory System Agents|respiratory system agents|mesh-ancestor
25065292|NCT03451487|Analgesics|analgesics|mesh-ancestor
25065293|NCT03451487|Sensory System Agents|sensory system agents|mesh-ancestor
25065294|NCT03451487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24913297|NCT04267042|Glucocorticoids|glucocorticoids|mesh-ancestor
24913298|NCT04267042|Hormones|hormones|mesh-ancestor
24913299|NCT04267042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24913300|NCT04267081|Venetoclax|venetoclax|mesh-list
24913301|NCT04267081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913302|NCT04267146|Nivolumab|nivolumab|mesh-list
24913303|NCT04267146|Temozolomide|temozolomide|mesh-list
24913304|NCT04267146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24913305|NCT04267146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913306|NCT04267146|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24913336|NCT04266288|Sensory System Agents|sensory system agents|mesh-ancestor
24913337|NCT04266288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24913338|NCT04266288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913339|NCT04266288|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24913340|NCT04266288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24913342|NCT04266288|Anesthetics|anesthetics|mesh-ancestor
24913343|NCT04266288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24913344|NCT04266288|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24913346|NCT04266288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24913347|NCT04266288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589479|NCT00907764|Purinergic Agonists|purinergic agonists|mesh-ancestor
24807574|NCT02022540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807576|NCT02022644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24807577|NCT02022644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24807578|NCT02022644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24913350|NCT04266132|Anesthetics|anesthetics|mesh-ancestor
24913351|NCT04266132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24913352|NCT04266132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913353|NCT04266132|Sensory System Agents|sensory system agents|mesh-ancestor
24913354|NCT04266132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24913355|NCT04265833|Calcium|calcium|mesh-list
24913356|NCT04265833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24913357|NCT04265833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913358|NCT04266002|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24913359|NCT04266002|Antiviral Agents|antiviral agents|mesh-ancestor
24913360|NCT04266002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24913361|NCT04265872|Pembrolizumab|pembrolizumab|mesh-list
24913362|NCT04265872|Bortezomib|bortezomib|mesh-list
24913363|NCT04265872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913364|NCT04265872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24913365|NCT04265456|Acetaminophen|acetaminophen|mesh-list
24913366|NCT04265456|Pregabalin|pregabalin|mesh-list
24913367|NCT04265456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24913368|NCT04265456|Analgesics|analgesics|mesh-ancestor
24913369|NCT04265456|Sensory System Agents|sensory system agents|mesh-ancestor
24913370|NCT04265456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24913371|NCT04265456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913375|NCT04265456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24913376|NCT04265456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913377|NCT04265456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24520071|NCT03936192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24520074|NCT03936192|Sensory System Agents|sensory system agents|mesh-ancestor
24520075|NCT03936192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24520076|NCT03936192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520077|NCT03936192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24913380|NCT04265456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24913381|NCT04265456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25065295|NCT03451487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913387|NCT04265274|Copper|copper|mesh-list
24913451|NCT04264026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520079|NCT03936192|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24520080|NCT03936192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24520081|NCT03936192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819301|NCT02094599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24819302|NCT02094651|Valproic Acid|valproic acid|mesh-list
24819303|NCT02094651|Anticonvulsants|anticonvulsants|mesh-ancestor
24819304|NCT02094651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819305|NCT02094651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819306|NCT02094651|GABA Agents|gaba agents|mesh-ancestor
24819333|NCT02094807|Acetaminophen|acetaminophen|mesh-list
24819334|NCT02094807|Diclofenac|diclofenac|mesh-list
24819335|NCT02094807|Oxycodone|oxycodone|mesh-list
24819336|NCT02094807|Tramadol|tramadol|mesh-list
24913455|NCT04264026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913456|NCT04264026|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25699667|NCT02111200|Sodium Benzoate|sodium benzoate|mesh-list
25699668|NCT02111200|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25699669|NCT02111200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25699670|NCT02111200|Antifungal Agents|antifungal agents|mesh-ancestor
25699671|NCT02111200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25699672|NCT02111369|Propranolol|propranolol|mesh-list
25699673|NCT02111369|Botulinum Toxins|botulinum toxins|mesh-list
25699674|NCT02111369|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25699675|NCT02111369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25699676|NCT02111369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699677|NCT02111369|Cholinergic Agents|cholinergic agents|mesh-ancestor
24807729|NCT02023450|Saquinavir|saquinavir|mesh-list
24913457|NCT04264026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25065307|NCT03451435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065308|NCT03451435|Antidotes|antidotes|mesh-ancestor
25065309|NCT03451396|Lifitegrast|lifitegrast|mesh-list
25065310|NCT03451396|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25065311|NCT03451396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24913464|NCT04264039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913466|NCT04264039|Immunologic Factors|immunologic factors|mesh-ancestor
24913467|NCT04264039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913468|NCT04264039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24520093|NCT03897335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24913469|NCT04264039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24913471|NCT04264039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24913472|NCT04264260|Colchicine|colchicine|mesh-list
24913473|NCT04264260|Gout Suppressants|gout suppressants|mesh-ancestor
24913474|NCT04264260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24913475|NCT04264260|Tubulin Modulators|tubulin modulators|mesh-ancestor
24913476|NCT04264260|Antimitotic Agents|antimitotic agents|mesh-ancestor
24913477|NCT04264260|Mitosis Modulators|mitosis modulators|mesh-ancestor
24913501|NCT04264286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24488051|NCT00466388|Cholinergic Agents|cholinergic agents|mesh-ancestor
24488052|NCT00466388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24488053|NCT00466388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488054|NCT00466401|Simvastatin|simvastatin|mesh-list
24488055|NCT00466401|Ezetimibe|ezetimibe|mesh-list
24520094|NCT03897335|Autonomic Agents|autonomic agents|mesh-ancestor
24520095|NCT03897335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24913502|NCT04264286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913503|NCT04264286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913504|NCT04263870|Capecitabine|capecitabine|mesh-list
24913505|NCT04263870|Oxaliplatin|oxaliplatin|mesh-list
24913506|NCT04263870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24913507|NCT04263870|Antimetabolites|antimetabolites|mesh-ancestor
24913508|NCT04263870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913509|NCT04263870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913510|NCT04263844|Midazolam|midazolam|mesh-list
24913511|NCT04263844|Dexmedetomidine|dexmedetomidine|mesh-list
24913512|NCT04263844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24913513|NCT04263844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24913537|NCT04263519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913539|NCT04263519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24913540|NCT04263519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913541|NCT04263402|Methylprednisolone|methylprednisolone|mesh-list
24913542|NCT04263402|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24913543|NCT04263402|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24913544|NCT04263402|Prednisolone|prednisolone|mesh-list
25699678|NCT02111369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25699679|NCT02111369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913552|NCT04263402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913554|NCT04263402|Glucocorticoids|glucocorticoids|mesh-ancestor
24913555|NCT04263402|Hormones|hormones|mesh-ancestor
24913556|NCT04263402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24857369|NCT02291367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857370|NCT02291367|Antidepressive Agents|antidepressive agents|mesh-ancestor
24668266|NCT05010590|Denosumab|denosumab|mesh-list
24913573|NCT04262999|Levetiracetam|levetiracetam|mesh-list
24913574|NCT04262999|Valproic Acid|valproic acid|mesh-list
24819397|NCT02095314|Immunologic Factors|immunologic factors|mesh-ancestor
24913664|NCT04262804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24520142|NCT03879577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24520148|NCT03822871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24520149|NCT03822871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520151|NCT03736863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520152|NCT03736863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24520153|NCT03736863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24913665|NCT04262804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24913666|NCT04262804|Tubulin Modulators|tubulin modulators|mesh-ancestor
24913667|NCT04262804|Antimitotic Agents|antimitotic agents|mesh-ancestor
24913668|NCT04262804|Mitosis Modulators|mitosis modulators|mesh-ancestor
24913693|NCT04262193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913695|NCT04262089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24913696|NCT04262089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913697|NCT04261907|Ritonavir|ritonavir|mesh-list
24913698|NCT04261907|Lopinavir|lopinavir|mesh-list
24913699|NCT04261907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24913709|NCT04261907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24913716|NCT04261634|Mitogens|mitogens|mesh-list
24913717|NCT04261634|Mitosis Modulators|mitosis modulators|mesh-ancestor
24913718|NCT04261634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913719|NCT04261426|Immunoglobulins|immunoglobulins|mesh-list
25065333|NCT03451266|Vitamins|vitamins|mesh-ancestor
25065334|NCT03451266|Micronutrients|micronutrients|mesh-ancestor
25065335|NCT03451266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065336|NCT03451266|Antioxidants|antioxidants|mesh-ancestor
24913720|NCT04261426|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24913721|NCT04261426|Antibodies|antibodies|mesh-list
24913722|NCT04261426|gamma-Globulins|gamma-globulins|mesh-list
24736786|NCT01665222|Analgesics|analgesics|mesh-ancestor
24913723|NCT04261426|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24913724|NCT04261426|Immunologic Factors|immunologic factors|mesh-ancestor
24913725|NCT04261426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913726|NCT04261478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
24913728|NCT04261465|Carboplatin|carboplatin|mesh-list
24913729|NCT04261465|Olaparib|olaparib|mesh-list
24913730|NCT04261465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24913731|NCT04261465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913732|NCT04261465|Tubulin Modulators|tubulin modulators|mesh-ancestor
24913733|NCT04261465|Antimitotic Agents|antimitotic agents|mesh-ancestor
24913734|NCT04261465|Mitosis Modulators|mitosis modulators|mesh-ancestor
24913735|NCT04261465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913741|NCT04261517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24913742|NCT04261517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24913759|NCT04261023|Abatacept|abatacept|mesh-list
24819337|NCT02094807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24819343|NCT02094807|Antipyretics|antipyretics|mesh-ancestor
24819344|NCT02094807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24819345|NCT02094807|Narcotics|narcotics|mesh-ancestor
24819346|NCT02094807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24488313|NCT00467766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488314|NCT00467766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520154|NCT03736863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520155|NCT03711305|Carboplatin|carboplatin|mesh-list
24520156|NCT03711305|Etoposide|etoposide|mesh-list
24520157|NCT03711305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520158|NCT03711305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24520159|NCT03711305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24520160|NCT03711305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24520161|NCT03711305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24520162|NCT03711305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520163|NCT03672695|Venetoclax|venetoclax|mesh-list
24520164|NCT03672695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24819347|NCT02094807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24819348|NCT02094807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24819349|NCT02094807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24819350|NCT02094807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819351|NCT02094807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819352|NCT02094833|Vaccines|vaccines|mesh-list
24819353|NCT02094833|Immunologic Factors|immunologic factors|mesh-ancestor
24819354|NCT02094833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819355|NCT02094924|Candesartan|candesartan|mesh-list
24819356|NCT02094924|Candesartan cilexetil|candesartan cilexetil|mesh-list
24819357|NCT02094924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24819358|NCT02094924|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24819359|NCT02094924|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24819360|NCT02094924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819361|NCT02094963|Clopidogrel|clopidogrel|mesh-list
24819362|NCT02094963|Ticagrelor|ticagrelor|mesh-list
24819363|NCT02094963|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24913779|NCT04260828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24913780|NCT04260828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913781|NCT04260828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24913782|NCT04260828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24913783|NCT04260828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24913784|NCT04260828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24913785|NCT04260828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913786|NCT04260828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24913787|NCT04260828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24913788|NCT04260828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24913805|NCT04260711|Analgesics|analgesics|mesh-ancestor
24520227|NCT03486314|Paclitaxel|paclitaxel|mesh-list
24520228|NCT03486314|Docetaxel|docetaxel|mesh-list
24520229|NCT03486314|Carboplatin|carboplatin|mesh-list
24520230|NCT03486314|Pevonedistat|pevonedistat|mesh-list
24913825|NCT04260516|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24913826|NCT04260516|Antiviral Agents|antiviral agents|mesh-ancestor
24913827|NCT04260516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24913829|NCT04260516|Respiratory System Agents|respiratory system agents|mesh-ancestor
24913830|NCT04260516|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24913831|NCT04260516|Antioxidants|antioxidants|mesh-ancestor
24913902|NCT04259684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24913832|NCT04260516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913833|NCT04260516|Protective Agents|protective agents|mesh-ancestor
24913834|NCT04260516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913836|NCT04260581|Amantadine|amantadine|mesh-list
24393651|NCT00130572|Analgesics|analgesics|mesh-ancestor
24913837|NCT04260581|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24913838|NCT04260581|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24913839|NCT04260581|Antiviral Agents|antiviral agents|mesh-ancestor
24913840|NCT04260581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24913841|NCT04260581|Dopamine Agents|dopamine agents|mesh-ancestor
24913842|NCT04260581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24913843|NCT04260581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913844|NCT04260581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913845|NCT04260581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24913846|NCT04260581|Analgesics|analgesics|mesh-ancestor
24913847|NCT04260581|Sensory System Agents|sensory system agents|mesh-ancestor
24913848|NCT04260581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24913849|NCT04260685|Lidocaine|lidocaine|mesh-list
24913850|NCT04260685|Esmolol|esmolol|mesh-list
24913851|NCT04260685|Anesthetics, Local|anesthetics, local|mesh-ancestor
24520231|NCT03486314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24520232|NCT03486314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520233|NCT03486314|Tubulin Modulators|tubulin modulators|mesh-ancestor
24913852|NCT04260685|Anesthetics|anesthetics|mesh-ancestor
24913853|NCT04260685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24913854|NCT04260685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936018|NCT04046185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24936019|NCT04046159|Tamoxifen|tamoxifen|mesh-list
24913855|NCT04260685|Sensory System Agents|sensory system agents|mesh-ancestor
24913856|NCT04260685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24913857|NCT04260685|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24913858|NCT04260685|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24913859|NCT04260685|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24913860|NCT04260685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24913861|NCT04260685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913862|NCT04260685|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24913863|NCT04260685|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24913864|NCT04260685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24913865|NCT04260685|Adrenergic Agents|adrenergic agents|mesh-ancestor
24913866|NCT04260685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24913867|NCT04260360|Docetaxel|docetaxel|mesh-list
24913868|NCT04260360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913869|NCT04260360|Tubulin Modulators|tubulin modulators|mesh-ancestor
24913870|NCT04260360|Antimitotic Agents|antimitotic agents|mesh-ancestor
24913871|NCT04260360|Mitosis Modulators|mitosis modulators|mesh-ancestor
24913872|NCT04260360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913873|NCT04260035|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
24913874|NCT04260035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24913875|NCT04260035|Vasodilator Agents|vasodilator agents|mesh-ancestor
24913876|NCT04260035|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24913893|NCT04260113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913894|NCT04260113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24913895|NCT04260113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24913896|NCT04260113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913897|NCT04259684|Nitric Oxide|nitric oxide|mesh-list
24913898|NCT04259684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24913899|NCT04259684|Autonomic Agents|autonomic agents|mesh-ancestor
24913900|NCT04259684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25065337|NCT03451266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065338|NCT03451266|Protective Agents|protective agents|mesh-ancestor
25065339|NCT03451227|Dexmedetomidine|dexmedetomidine|mesh-list
25065340|NCT03451227|Remifentanil|remifentanil|mesh-list
24913901|NCT04259684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913903|NCT04259684|Respiratory System Agents|respiratory system agents|mesh-ancestor
24913904|NCT04259684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24913905|NCT04259684|Antioxidants|antioxidants|mesh-ancestor
24913906|NCT04259684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913907|NCT04259684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24913908|NCT04259684|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24913909|NCT04259684|Vasodilator Agents|vasodilator agents|mesh-ancestor
24913913|NCT04259606|Antacids|antacids|mesh-ancestor
24819382|NCT02095119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819383|NCT02095119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24819384|NCT02095119|Immunologic Factors|immunologic factors|mesh-ancestor
24819385|NCT02095119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819386|NCT02095119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24819387|NCT02095132|Irinotecan|irinotecan|mesh-list
24615775|NCT01031732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615776|NCT01031732|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24615777|NCT01031732|Autonomic Agents|autonomic agents|mesh-ancestor
24615778|NCT01031732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24615779|NCT01031732|Nootropic Agents|nootropic agents|mesh-ancestor
24819398|NCT02095314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819400|NCT02095366|Morphine|morphine|mesh-list
24819401|NCT02095366|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24819402|NCT02095366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24819403|NCT02095366|Narcotics|narcotics|mesh-ancestor
24488547|NCT00469326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24520258|NCT03377387|Capecitabine|capecitabine|mesh-list
24520259|NCT03377387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24520260|NCT03377387|Antimetabolites|antimetabolites|mesh-ancestor
24520261|NCT03377387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520262|NCT03377387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520312|NCT02993198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24520314|NCT02993198|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24520315|NCT02993198|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24520317|NCT02795858|Ramucirumab|ramucirumab|mesh-list
24520319|NCT02795858|Somatostatin|somatostatin|mesh-list
24520320|NCT02795858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24520321|NCT02795858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24520322|NCT02795858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520323|NCT02795858|Hormones|hormones|mesh-ancestor
24520324|NCT02795858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24520325|NCT02795858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520326|NCT02794883|Durvalumab|durvalumab|mesh-list
24520327|NCT02794883|Ipilimumab|ipilimumab|mesh-list
24520328|NCT02794883|Tremelimumab|tremelimumab|mesh-list
24520329|NCT02794883|Immunoglobulins|immunoglobulins|mesh-list
24520330|NCT02794883|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24520331|NCT02794883|Immunoglobulin G|immunoglobulin g|mesh-list
24819410|NCT02095366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24913939|NCT04259333|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24913940|NCT04259333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24913941|NCT04259333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24913947|NCT04259333|Narcotics|narcotics|mesh-ancestor
24913948|NCT04259333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24913949|NCT04259333|Antitussive Agents|antitussive agents|mesh-ancestor
24913950|NCT04259333|Respiratory System Agents|respiratory system agents|mesh-ancestor
24913952|NCT04259073|Analgesics|analgesics|mesh-ancestor
24913953|NCT04259073|Sensory System Agents|sensory system agents|mesh-ancestor
24913954|NCT04259073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24913955|NCT04259073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913956|NCT04259073|Anticonvulsants|anticonvulsants|mesh-ancestor
24913957|NCT04259073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24913958|NCT04259073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24913959|NCT04259073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488575|NCT00469430|Cefotaxime|cefotaxime|mesh-list
24520345|NCT02771249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24520346|NCT02771249|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24520347|NCT02771249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24520348|NCT02771249|Antimetabolites|antimetabolites|mesh-ancestor
24520349|NCT02771249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520350|NCT02771249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24520351|NCT02771249|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24520352|NCT02771249|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24520353|NCT02771249|Protease Inhibitors|protease inhibitors|mesh-ancestor
24520354|NCT02771249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24520355|NCT02771249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24520356|NCT02771249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24520357|NCT02771249|Antiviral Agents|antiviral agents|mesh-ancestor
24520358|NCT02771249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24913971|NCT04258956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913973|NCT04259008|Trace Elements|trace elements|mesh-ancestor
24913974|NCT04259008|Micronutrients|micronutrients|mesh-ancestor
24913975|NCT04259008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913976|NCT04258930|Calcium|calcium|mesh-list
24913977|NCT04258930|Calcium acetate|calcium acetate|mesh-list
24913978|NCT04258930|Aluminum sulfate|aluminum sulfate|mesh-list
24913979|NCT04258930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24913980|NCT04258930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913981|NCT04258930|Chelating Agents|chelating agents|mesh-ancestor
24913982|NCT04258930|Sequestering Agents|sequestering agents|mesh-ancestor
24913983|NCT04258930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488587|NCT00469443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24520359|NCT02771249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24520396|NCT02339922|Immunoglobulins|immunoglobulins|mesh-list
24520397|NCT02339922|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24520399|NCT02339922|Immunologic Factors|immunologic factors|mesh-ancestor
24520400|NCT02339922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520401|NCT02339922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25065344|NCT03451227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25065345|NCT03451227|Analgesics|analgesics|mesh-ancestor
25065346|NCT03451227|Sensory System Agents|sensory system agents|mesh-ancestor
25065347|NCT03451227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24520402|NCT02339922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24520403|NCT02339922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050171|NCT00535366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520404|NCT02339922|Protease Inhibitors|protease inhibitors|mesh-ancestor
24520405|NCT02339922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24913989|NCT04258657|Tubulin Modulators|tubulin modulators|mesh-ancestor
24913990|NCT04258657|Antimitotic Agents|antimitotic agents|mesh-ancestor
24913991|NCT04258657|Mitosis Modulators|mitosis modulators|mesh-ancestor
24913992|NCT04258657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913994|NCT04258553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913995|NCT04258553|Protective Agents|protective agents|mesh-ancestor
24913996|NCT04258553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913997|NCT04258839|Brexpiprazole|brexpiprazole|mesh-list
24913998|NCT04258839|Serotonin Agents|serotonin agents|mesh-ancestor
24913999|NCT04258839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24914000|NCT04258839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914001|NCT04258839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914002|NCT04258839|Dopamine Agonists|dopamine agonists|mesh-ancestor
24914003|NCT04258839|Dopamine Agents|dopamine agents|mesh-ancestor
24914004|NCT04258475|Raltegravir Potassium|raltegravir potassium|mesh-list
24914006|NCT04258475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24914007|NCT04258475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914008|NCT04258475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24914009|NCT04258475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24914049|NCT04258163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914050|NCT04258163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914052|NCT04258163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24914053|NCT04258163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24914054|NCT04258163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24914055|NCT04258163|Immunologic Factors|immunologic factors|mesh-ancestor
24914056|NCT04258163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914057|NCT04258163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24914058|NCT04258163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24914082|NCT04258423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914083|NCT04258423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914084|NCT04258306|Resveratrol|resveratrol|mesh-list
24914086|NCT04258306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914087|NCT04258306|Protective Agents|protective agents|mesh-ancestor
24914088|NCT04258306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914089|NCT04258306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24914099|NCT04258098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24914100|NCT04258098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24914101|NCT04258098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24914102|NCT04258098|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24914123|NCT04257838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24914124|NCT04257838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24914125|NCT04257838|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24914126|NCT04257838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24914127|NCT04257838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914128|NCT04257851|Sumatriptan|sumatriptan|mesh-list
24914129|NCT04257851|Theophylline|theophylline|mesh-list
24914130|NCT04257851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24488736|NCT00469846|Protective Agents|protective agents|mesh-ancestor
24914159|NCT04257396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24914160|NCT04257396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24914161|NCT04257461|Capecitabine|capecitabine|mesh-list
24883501|NCT05239078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883502|NCT05239078|Sensory System Agents|sensory system agents|mesh-ancestor
25699680|NCT02111369|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24883503|NCT05239078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24883519|NCT05238727|Mepivacaine|mepivacaine|mesh-list
24481561|NCT00435448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24481562|NCT00435448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25699681|NCT02111369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24914163|NCT04257461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24914164|NCT04257461|Antimetabolites|antimetabolites|mesh-ancestor
24520431|NCT02020707|Mitosis Modulators|mitosis modulators|mesh-ancestor
24520432|NCT02020707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520433|NCT02020707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24520434|NCT02020707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24520435|NCT02020707|Growth Substances|growth substances|mesh-ancestor
24520436|NCT02020707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520437|NCT02020707|Growth Inhibitors|growth inhibitors|mesh-ancestor
24520438|NCT02020707|Immunologic Factors|immunologic factors|mesh-ancestor
24520441|NCT01928394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24520442|NCT01928394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520443|NCT01928394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24520444|NCT01928394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520445|NCT01657500|Gentamicins|gentamicins|mesh-list
24520446|NCT01657500|Dextrans|dextrans|mesh-list
24914205|NCT04256993|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
24914206|NCT04256993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914207|NCT04256798|Chlorhexidine|chlorhexidine|mesh-list
24914208|NCT04256798|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24914209|NCT04256798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24914210|NCT04256798|Disinfectants|disinfectants|mesh-ancestor
24914211|NCT04257032|Dabigatran|dabigatran|mesh-list
24914212|NCT04257032|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24914213|NCT04257032|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24914214|NCT04257032|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24819437|NCT02095522|Colchicine|colchicine|mesh-list
24819438|NCT02095522|Gout Suppressants|gout suppressants|mesh-ancestor
24819439|NCT02095522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24819440|NCT02095522|Tubulin Modulators|tubulin modulators|mesh-ancestor
24819441|NCT02095522|Antimitotic Agents|antimitotic agents|mesh-ancestor
24819442|NCT02095522|Mitosis Modulators|mitosis modulators|mesh-ancestor
24914242|NCT04256473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914244|NCT04256343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914245|NCT04256343|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24914246|NCT04256343|Protective Agents|protective agents|mesh-ancestor
24914248|NCT04256252|Rituximab|rituximab|mesh-list
25065352|NCT03451227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25065353|NCT03451227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914261|NCT04256525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24914262|NCT04256525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914263|NCT04256525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24914264|NCT04256525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24914265|NCT04256525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24914266|NCT04256525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24914267|NCT04256525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914268|NCT04256525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24914269|NCT04256525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24914270|NCT04256525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24914271|NCT04256525|Antipyretics|antipyretics|mesh-ancestor
24914272|NCT04256525|Anticoagulants|anticoagulants|mesh-ancestor
24914273|NCT04256525|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24914274|NCT04256525|Antithrombins|antithrombins|mesh-ancestor
24914275|NCT04256525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24914443|NCT04255121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24914294|NCT04256057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24914295|NCT04256057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914296|NCT04256057|Anesthetics|anesthetics|mesh-ancestor
24914297|NCT04256057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24914298|NCT04256057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24914299|NCT04256057|Anticonvulsants|anticonvulsants|mesh-ancestor
24914300|NCT04256057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24914301|NCT04256057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24914302|NCT04256057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914303|NCT04256057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25699682|NCT02111369|Adrenergic Agents|adrenergic agents|mesh-ancestor
25699683|NCT02111369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25699684|NCT02111369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25699685|NCT02111369|Vasodilator Agents|vasodilator agents|mesh-ancestor
24914305|NCT04256057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24914312|NCT04255992|Calcium, Dietary|calcium, dietary|mesh-list
24914313|NCT04255992|Vitamin D|vitamin d|mesh-list
24914314|NCT04255992|Calcium|calcium|mesh-list
24914315|NCT04255992|Vitamins|vitamins|mesh-ancestor
24914316|NCT04255992|Micronutrients|micronutrients|mesh-ancestor
24914317|NCT04255992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914318|NCT04255992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24914319|NCT04255992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24914320|NCT04255836|Durvalumab|durvalumab|mesh-list
24914321|NCT04255836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24914322|NCT04255836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439993|NCT00281255|Dobutamine|dobutamine|mesh-list
24488995|NCT00470977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24488996|NCT00470977|Growth Substances|growth substances|mesh-ancestor
24488997|NCT00470977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488998|NCT00470977|Growth Inhibitors|growth inhibitors|mesh-ancestor
24914345|NCT04255576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24914346|NCT04255576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24914347|NCT04255498|Etanercept|etanercept|mesh-list
24914348|NCT04255498|Mifepristone|mifepristone|mesh-list
24914388|NCT04255251|Fluorides, Topical|fluorides, topical|mesh-list
24914389|NCT04255251|Cariostatic Agents|cariostatic agents|mesh-ancestor
24914390|NCT04255251|Protective Agents|protective agents|mesh-ancestor
24914391|NCT04255251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914392|NCT04255160|Estradiol|estradiol|mesh-list
25065354|NCT03451227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25065355|NCT03451227|Narcotics|narcotics|mesh-ancestor
25065356|NCT03451110|Fluconazole|fluconazole|mesh-list
25065357|NCT03451110|Lemborexant|lemborexant|mesh-list
25065358|NCT03451110|Famotidine|famotidine|mesh-list
24827649|NCT02140632|Methylprednisolone|methylprednisolone|mesh-list
24914393|NCT04255160|Estrogens|estrogens|mesh-ancestor
24914394|NCT04255160|Hormones|hormones|mesh-ancestor
24914395|NCT04255160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24914396|NCT04255160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914397|NCT04255134|Adalimumab|adalimumab|mesh-list
24914398|NCT04255134|Abatacept|abatacept|mesh-list
24914399|NCT04255134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24914400|NCT04255134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24914401|NCT04255134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24914402|NCT04255134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914403|NCT04255134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914404|NCT04255134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24914405|NCT04255134|Immunologic Factors|immunologic factors|mesh-ancestor
24914407|NCT04255017|Ritonavir|ritonavir|mesh-list
24914435|NCT04255121|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24914437|NCT04255121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24914438|NCT04255121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914439|NCT04255121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24914440|NCT04255121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24914441|NCT04255121|Adrenergic Agents|adrenergic agents|mesh-ancestor
24914442|NCT04255121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24914444|NCT04255121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24914445|NCT04255121|Autonomic Agents|autonomic agents|mesh-ancestor
24914446|NCT04255121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24914447|NCT04255121|Respiratory System Agents|respiratory system agents|mesh-ancestor
24914472|NCT04255056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24914473|NCT04255056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24914474|NCT04255056|Alkylating Agents|alkylating agents|mesh-ancestor
24914475|NCT04255056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914476|NCT04255056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914477|NCT04255056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24914478|NCT04255056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24914479|NCT04255056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24914480|NCT04255056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24914481|NCT04255056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24914483|NCT04254913|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24914484|NCT04254913|Antioxidants|antioxidants|mesh-ancestor
24914485|NCT04254913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25065361|NCT03451110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25065362|NCT03451110|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25065363|NCT03451110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24914488|NCT04254913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914489|NCT04254874|Interferons|interferons|mesh-list
24914490|NCT04254874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914491|NCT04254874|Antiviral Agents|antiviral agents|mesh-ancestor
24914492|NCT04254874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24914493|NCT04254744|Sevoflurane|sevoflurane|mesh-list
24914494|NCT04254744|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24883779|NCT04817410|Naltrexone|naltrexone|mesh-list
24914495|NCT04254744|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24914497|NCT04254744|Anesthetics|anesthetics|mesh-ancestor
24914501|NCT04254523|Bupivacaine|bupivacaine|mesh-list
24914502|NCT04254523|Anesthetics, Local|anesthetics, local|mesh-ancestor
24914503|NCT04254523|Anesthetics|anesthetics|mesh-ancestor
24914504|NCT04254523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24914505|NCT04254523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914506|NCT04254523|Sensory System Agents|sensory system agents|mesh-ancestor
24668357|NCT04936763|Immunologic Factors|immunologic factors|mesh-ancestor
24849880|NCT02251041|Melatonin|melatonin|mesh-list
24914507|NCT04254523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24914508|NCT04254523|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24914509|NCT04254523|Narcotics|narcotics|mesh-ancestor
24914510|NCT04254523|Analgesics|analgesics|mesh-ancestor
24914511|NCT04254601|Erythromycin|erythromycin|mesh-list
24914512|NCT04254601|Erythromycin Estolate|erythromycin estolate|mesh-list
24914513|NCT04254601|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24914514|NCT04254601|Erythromycin stearate|erythromycin stearate|mesh-list
24914515|NCT04254601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24914534|NCT04254679|Sensory System Agents|sensory system agents|mesh-ancestor
24914535|NCT04254679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24914541|NCT04254471|Rabeprazole|rabeprazole|mesh-list
24914542|NCT04254471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914543|NCT04254471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24914544|NCT04254471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24914545|NCT04254471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24914546|NCT04254471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450987|NCT00321230|Laxatives|laxatives|mesh-ancestor
24450988|NCT00321230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24450989|NCT00321347|Lidocaine|lidocaine|mesh-list
24450990|NCT00321347|Anesthetics, Local|anesthetics, local|mesh-ancestor
24914560|NCT04254640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24914561|NCT04254640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24914562|NCT04254640|Immunologic Factors|immunologic factors|mesh-ancestor
24914563|NCT04254640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914567|NCT04254640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24914568|NCT04254640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24914569|NCT04254042|Perindopril|perindopril|mesh-list
24914570|NCT04254042|Zofenopril|zofenopril|mesh-list
24914586|NCT04254081|Sensory System Agents|sensory system agents|mesh-ancestor
24914587|NCT04254081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24827660|NCT02140632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914588|NCT04254081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24914589|NCT04254081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24819472|NCT02095704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24819473|NCT02095704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819474|NCT02095704|Antipyretics|antipyretics|mesh-ancestor
24819475|NCT02095717|Curcumin|curcumin|mesh-list
24819476|NCT02095717|Docetaxel|docetaxel|mesh-list
24819477|NCT02095717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24819478|NCT02095717|Tubulin Modulators|tubulin modulators|mesh-ancestor
24819479|NCT02095717|Antimitotic Agents|antimitotic agents|mesh-ancestor
24819480|NCT02095717|Mitosis Modulators|mitosis modulators|mesh-ancestor
24819481|NCT02095717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819482|NCT02095717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24819483|NCT02095717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24819484|NCT02095717|Analgesics|analgesics|mesh-ancestor
24819485|NCT02095717|Sensory System Agents|sensory system agents|mesh-ancestor
24819486|NCT02095717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24819487|NCT02095717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819488|NCT02095717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24509738|NCT00561964|Irbesartan|irbesartan|mesh-list
24482841|NCT00440739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482842|NCT00440739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24482843|NCT00440739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24808215|NCT02025855|Analgesics|analgesics|mesh-ancestor
24819497|NCT02095730|Dermatologic Agents|dermatologic agents|mesh-ancestor
24819499|NCT02095782|Carboplatin|carboplatin|mesh-list
24819500|NCT02095782|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24819501|NCT02095782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24819502|NCT02095782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24819503|NCT02095782|Tubulin Modulators|tubulin modulators|mesh-ancestor
24819504|NCT02095782|Antimitotic Agents|antimitotic agents|mesh-ancestor
24819505|NCT02095782|Mitosis Modulators|mitosis modulators|mesh-ancestor
24819506|NCT02095782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819507|NCT02095782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24819508|NCT02095782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819509|NCT02095834|Dexamethasone|dexamethasone|mesh-list
24819510|NCT02095834|Dexamethasone acetate|dexamethasone acetate|mesh-list
24819511|NCT02095834|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24819513|NCT02095834|BB 1101|bb 1101|mesh-list
24819514|NCT02095834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24819515|NCT02095834|Antiemetics|antiemetics|mesh-ancestor
24819516|NCT02095834|Autonomic Agents|autonomic agents|mesh-ancestor
24819517|NCT02095834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24819518|NCT02095834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533518|NCT00644306|Hormones|hormones|mesh-ancestor
24819519|NCT02095834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24819520|NCT02095834|Glucocorticoids|glucocorticoids|mesh-ancestor
24819521|NCT02095834|Hormones|hormones|mesh-ancestor
24819522|NCT02095834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24737816|NCT01670773|Analgesics|analgesics|mesh-ancestor
24914597|NCT04253912|Povidone-Iodine|povidone-iodine|mesh-list
24914598|NCT04253912|Povidone|povidone|mesh-list
24839862|NCT02206425|Growth Substances|growth substances|mesh-ancestor
24914599|NCT04253912|Plasma Substitutes|plasma substitutes|mesh-ancestor
24914600|NCT04253912|Blood Substitutes|blood substitutes|mesh-ancestor
24914603|NCT04253574|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24914604|NCT04253574|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24914605|NCT04253574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914606|NCT04253678|Vortioxetine|vortioxetine|mesh-list
24914617|NCT04253678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24914618|NCT04253678|Serotonin Agents|serotonin agents|mesh-ancestor
24914619|NCT04253678|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24914620|NCT04253678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24914621|NCT04253678|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24914622|NCT04253678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24914623|NCT04253561|Trastuzumab|trastuzumab|mesh-list
24914625|NCT04253561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24914626|NCT04253561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914627|NCT04253873|Temozolomide|temozolomide|mesh-list
24914628|NCT04253873|Apatinib|apatinib|mesh-list
24914629|NCT04253873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24914630|NCT04253873|Alkylating Agents|alkylating agents|mesh-ancestor
25065365|NCT03451110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914631|NCT04253873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914632|NCT04253873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914653|NCT04253132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24914654|NCT04253145|Atezolizumab|atezolizumab|mesh-list
24914655|NCT04253145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24920692|NCT04199143|Analgesics|analgesics|mesh-ancestor
24914666|NCT04253353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914667|NCT04253353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24914668|NCT04253353|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24914669|NCT04253353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24914670|NCT04253223|Volagidemab|volagidemab|mesh-list
25699686|NCT02111447|Propofol|propofol|mesh-list
25699687|NCT02111447|Sevoflurane|sevoflurane|mesh-list
25699688|NCT02111447|Isoflurane|isoflurane|mesh-list
25699689|NCT02111447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25699690|NCT02111447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25699691|NCT02111447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699692|NCT02111447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24483627|NCT00444340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483629|NCT00444340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24914671|NCT04253223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24914672|NCT04253223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914674|NCT04252963|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24816270|NCT02075619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24914675|NCT04252963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24914676|NCT04252963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914677|NCT04252664|Remdesivir|remdesivir|mesh-list
24914678|NCT04252664|Antimetabolites|antimetabolites|mesh-ancestor
24914679|NCT04252664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914680|NCT04252664|Antiviral Agents|antiviral agents|mesh-ancestor
24914681|NCT04252664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24914704|NCT04252365|Pembrolizumab|pembrolizumab|mesh-list
24914705|NCT04252365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24914707|NCT04252456|Leucovorin|leucovorin|mesh-list
24914708|NCT04252456|Folic Acid|folic acid|mesh-list
24914709|NCT04252456|Fluorouracil|fluorouracil|mesh-list
24914710|NCT04252456|Aflibercept|aflibercept|mesh-list
24914711|NCT04252456|Levoleucovorin|levoleucovorin|mesh-list
24914712|NCT04252456|Antimetabolites|antimetabolites|mesh-ancestor
24914713|NCT04252456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914714|NCT04252456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24914715|NCT04252456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914716|NCT04252456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24914717|NCT04252456|Immunologic Factors|immunologic factors|mesh-ancestor
24914718|NCT04252456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914733|NCT04252443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914735|NCT04252443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24914736|NCT04252248|Decitabine|decitabine|mesh-list
24914737|NCT04252248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24914738|NCT04252248|Antimetabolites|antimetabolites|mesh-ancestor
24914739|NCT04252248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914740|NCT04252248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914741|NCT04252248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737921|NCT01671787|Tenofovir|tenofovir|mesh-list
24914742|NCT04252274|Darunavir|darunavir|mesh-list
24914751|NCT04252274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24914752|NCT04252274|Antiviral Agents|antiviral agents|mesh-ancestor
24914753|NCT04252274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24914754|NCT04252274|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24914755|NCT04252274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24914756|NCT04252300|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24914757|NCT04252300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24914758|NCT04252300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24914759|NCT04252300|Antimetabolites|antimetabolites|mesh-ancestor
25065366|NCT03451110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25065367|NCT03451110|Hormone Antagonists|hormone antagonists|mesh-ancestor
25065368|NCT03451110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25065369|NCT03451110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065370|NCT03451110|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25065371|NCT03451110|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25065372|NCT03451110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25065373|NCT03451110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25065374|NCT03451110|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25065375|NCT03451110|Histamine Antagonists|histamine antagonists|mesh-ancestor
25065376|NCT03451110|Histamine Agents|histamine agents|mesh-ancestor
25699693|NCT02111447|Anesthetics, General|anesthetics, general|mesh-ancestor
25699694|NCT02111447|Anesthetics|anesthetics|mesh-ancestor
25699695|NCT02111447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25699696|NCT02111447|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25699697|NCT02111564|Rivaroxaban|rivaroxaban|mesh-list
25699698|NCT02111564|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25699699|NCT02111564|Antithrombins|antithrombins|mesh-ancestor
25699700|NCT02111564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25699701|NCT02111564|Protease Inhibitors|protease inhibitors|mesh-ancestor
25699702|NCT02111564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25699703|NCT02111564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699704|NCT02111564|Anticoagulants|anticoagulants|mesh-ancestor
25699705|NCT02111603|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
25699706|NCT02111603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24484124|NCT00446680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25065378|NCT03451110|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25065379|NCT03451110|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24914761|NCT04252300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24914777|NCT04252521|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24914778|NCT04252521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24914779|NCT04252521|Dopamine Agents|dopamine agents|mesh-ancestor
24914780|NCT04252521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24914781|NCT04252521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914782|NCT04252521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24914783|NCT04252521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24914784|NCT04252521|Analgesics|analgesics|mesh-ancestor
24914785|NCT04252521|Sensory System Agents|sensory system agents|mesh-ancestor
24914786|NCT04252521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24914787|NCT04252521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24914788|NCT04252521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24914789|NCT04252521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24839863|NCT02206425|Growth Inhibitors|growth inhibitors|mesh-ancestor
24819525|NCT02095834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24819526|NCT02095834|Alkylating Agents|alkylating agents|mesh-ancestor
24819527|NCT02095834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819528|NCT02095834|Protease Inhibitors|protease inhibitors|mesh-ancestor
24819529|NCT02095834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819530|NCT02095834|Dermatologic Agents|dermatologic agents|mesh-ancestor
24819532|NCT02095847|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25108287|NCT03133195|Teriparatide|teriparatide|mesh-list
24829720|NCT02154074|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24829721|NCT02154074|Anesthetics, General|anesthetics, general|mesh-ancestor
24829722|NCT02154217|Timolol|timolol|mesh-list
24829723|NCT02154217|Bimatoprost|bimatoprost|mesh-list
24829724|NCT02154217|Latanoprost|latanoprost|mesh-list
24829725|NCT02154217|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24829726|NCT02154217|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24829727|NCT02154217|Adrenergic Agents|adrenergic agents|mesh-ancestor
24829728|NCT02154217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24872443|NCT05385705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829838|NCT02154776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24829840|NCT02154789|Polidocanol|polidocanol|mesh-list
24829841|NCT02154789|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
24829842|NCT02154789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24831381|NCT02165033|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24831382|NCT02165033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24831383|NCT02165033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24831384|NCT02165033|Adrenergic Agents|adrenergic agents|mesh-ancestor
24831385|NCT02165033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24831386|NCT02165033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831387|NCT02165046|Budesonide|budesonide|mesh-list
25699707|NCT02111603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25699708|NCT02111603|Antimetabolites|antimetabolites|mesh-ancestor
25699709|NCT02111603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831389|NCT02165046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24831390|NCT02165046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24832246|NCT02170987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24832247|NCT02170987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24832248|NCT02170987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24832249|NCT02170987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24832250|NCT02170987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832251|NCT02170987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832252|NCT02170987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24832253|NCT02170987|Antithrombins|antithrombins|mesh-ancestor
24832254|NCT02170987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832255|NCT02170987|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832256|NCT02170987|Anticoagulants|anticoagulants|mesh-ancestor
24832257|NCT02171000|Dabigatran|dabigatran|mesh-list
24832258|NCT02171000|Antithrombins|antithrombins|mesh-ancestor
24834829|NCT02181309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24833784|NCT02175589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24833890|NCT02176122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833891|NCT02176135|Auranofin|auranofin|mesh-list
24833892|NCT02176135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24833893|NCT02176161|Metformin|metformin|mesh-list
24833894|NCT02176161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24833895|NCT02176161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833896|NCT02176187|Fenoterol|fenoterol|mesh-list
24505266|NCT00540787|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24833897|NCT02176187|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
24833898|NCT02176187|Ipratropium|ipratropium|mesh-list
24833899|NCT02176187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24833900|NCT02176187|Autonomic Agents|autonomic agents|mesh-ancestor
24833901|NCT02176187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24743612|NCT04722679|Anticoagulants|anticoagulants|mesh-list
24833933|NCT02176200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833935|NCT02176200|Cholinergic Agents|cholinergic agents|mesh-ancestor
24833936|NCT02176213|Dexamethasone|dexamethasone|mesh-list
24833937|NCT02176213|Cyclophosphamide|cyclophosphamide|mesh-list
24833938|NCT02176213|Pomalidomide|pomalidomide|mesh-list
24833939|NCT02176213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24833940|NCT02176213|Immunologic Factors|immunologic factors|mesh-ancestor
24834229|NCT02177448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743926|NCT04564885|Meloxicam|meloxicam|mesh-list
24834264|NCT02177487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24834300|NCT02177539|Cholinergic Agents|cholinergic agents|mesh-ancestor
24834301|NCT02177539|Parasympatholytics|parasympatholytics|mesh-ancestor
24834333|NCT02177760|Antifungal Agents|antifungal agents|mesh-ancestor
24834344|NCT02177851|Micronutrients|micronutrients|mesh-ancestor
24834345|NCT02177851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834346|NCT02177955|Midazolam|midazolam|mesh-list
24872663|NCT05293249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24872664|NCT05293249|Protective Agents|protective agents|mesh-ancestor
24872665|NCT05293249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24834347|NCT02177955|Diazepam|diazepam|mesh-list
24834384|NCT02178137|Dermatologic Agents|dermatologic agents|mesh-ancestor
24834386|NCT02178150|Antacids|antacids|mesh-ancestor
24744056|NCT04523428|Venetoclax|venetoclax|mesh-list
24834457|NCT02178683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834494|NCT02179099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24834495|NCT02179099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834496|NCT02179099|Cholinergic Agents|cholinergic agents|mesh-ancestor
24834497|NCT02179099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24834754|NCT02180880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834755|NCT02180880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24834792|NCT02181205|Anesthetics|anesthetics|mesh-ancestor
25699710|NCT02111603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25699711|NCT02111746|Bupivacaine|bupivacaine|mesh-list
25699712|NCT02111746|Anesthetics, Local|anesthetics, local|mesh-ancestor
25699713|NCT02111746|Anesthetics|anesthetics|mesh-ancestor
25699714|NCT02111746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25699715|NCT02111746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484396|NCT00448110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622877|NCT01068977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24622878|NCT01068977|Growth Substances|growth substances|mesh-ancestor
24622879|NCT01068977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622880|NCT01068977|Growth Inhibitors|growth inhibitors|mesh-ancestor
24622881|NCT01068977|Immunologic Factors|immunologic factors|mesh-ancestor
24834825|NCT02181309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24834826|NCT02181309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24834827|NCT02181309|Analgesics|analgesics|mesh-ancestor
24834828|NCT02181309|Sensory System Agents|sensory system agents|mesh-ancestor
24835711|NCT02183272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835913|NCT02183584|Incretins|incretins|mesh-ancestor
24835914|NCT02183584|Hormones|hormones|mesh-ancestor
24836258|NCT02184819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836259|NCT02184819|Protective Agents|protective agents|mesh-ancestor
24836534|NCT02186145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24836536|NCT02186145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24505561|NCT00541411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25108275|NCT03133065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25108276|NCT03133312|Chlorhexidine|chlorhexidine|mesh-list
25108277|NCT03133312|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25108278|NCT03133312|Povidone-Iodine|povidone-iodine|mesh-list
25108279|NCT03133312|Povidone|povidone|mesh-list
25108280|NCT03133312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25108281|NCT03133312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25108282|NCT03133312|Disinfectants|disinfectants|mesh-ancestor
25108283|NCT03133312|Dermatologic Agents|dermatologic agents|mesh-ancestor
25108284|NCT03133312|Plasma Substitutes|plasma substitutes|mesh-ancestor
25108285|NCT03133312|Blood Substitutes|blood substitutes|mesh-ancestor
25108286|NCT03133195|Vitamin D|vitamin d|mesh-list
25108302|NCT03133299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25108304|NCT03132688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24836544|NCT02186158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836545|NCT02186158|Antioxidants|antioxidants|mesh-ancestor
24836546|NCT02186158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836547|NCT02186158|Protective Agents|protective agents|mesh-ancestor
24837264|NCT02190708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24837265|NCT02190708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837266|NCT02190708|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24837267|NCT02190708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24837268|NCT02190708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24837269|NCT02190708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24837270|NCT02190708|Anesthetics, General|anesthetics, general|mesh-ancestor
24837271|NCT02190708|Anesthetics|anesthetics|mesh-ancestor
24837272|NCT02190708|GABA Modulators|gaba modulators|mesh-ancestor
24837273|NCT02190708|GABA Agents|gaba agents|mesh-ancestor
24837274|NCT02190708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24750302|NCT01697618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24837327|NCT02191007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24837328|NCT02191007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837329|NCT02191007|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24837330|NCT02191007|Respiratory System Agents|respiratory system agents|mesh-ancestor
24837331|NCT02191007|Dermatologic Agents|dermatologic agents|mesh-ancestor
24837332|NCT02191007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24837558|NCT02191943|Fluorides|fluorides|mesh-list
24837559|NCT02191943|Fluorides, Topical|fluorides, topical|mesh-list
24750600|NCT01699594|Miotics|miotics|mesh-ancestor
24837657|NCT02192632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837658|NCT02192632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24837659|NCT02192632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24837660|NCT02192632|Dermatologic Agents|dermatologic agents|mesh-ancestor
25699716|NCT02111746|Sensory System Agents|sensory system agents|mesh-ancestor
25699717|NCT02111746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699718|NCT02111785|Dexamethasone|dexamethasone|mesh-list
25699719|NCT02111785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25699720|NCT02111785|Antiemetics|antiemetics|mesh-ancestor
25699721|NCT02111785|Autonomic Agents|autonomic agents|mesh-ancestor
25699722|NCT02111785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699723|NCT02111785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699724|NCT02111785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25699725|NCT02111785|Glucocorticoids|glucocorticoids|mesh-ancestor
25699726|NCT02111785|Hormones|hormones|mesh-ancestor
25699727|NCT02111785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24837661|NCT02192697|Naquotinib|naquotinib|mesh-list
24837662|NCT02192697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24837663|NCT02192697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24450261|NCT00318422|Rosiglitazone|rosiglitazone|mesh-list
24837665|NCT02192697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837667|NCT02192710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24837669|NCT02192710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24837703|NCT02192723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24837705|NCT02192723|Dopamine Agonists|dopamine agonists|mesh-ancestor
24837706|NCT02192723|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24837707|NCT02192723|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24837708|NCT02192723|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24837709|NCT02192723|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24837710|NCT02192827|Dexamethasone|dexamethasone|mesh-list
24750735|NCT01700413|Idarubicin|idarubicin|mesh-list
24837771|NCT02193256|Adrenergic Agents|adrenergic agents|mesh-ancestor
24837772|NCT02193269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24838060|NCT02195089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838061|NCT02195115|Amitriptyline|amitriptyline|mesh-list
24838205|NCT02196142|Mannitol|mannitol|mesh-list
24838208|NCT02196142|Natriuretic Agents|natriuretic agents|mesh-ancestor
24838209|NCT02196142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838210|NCT02196142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24838212|NCT02196155|Botulinum Toxins|botulinum toxins|mesh-list
24838213|NCT02196155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24838214|NCT02196155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24838246|NCT02196441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24838247|NCT02196441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838248|NCT02196441|Sensory System Agents|sensory system agents|mesh-ancestor
24838249|NCT02196441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838250|NCT02196493|Azithromycin|azithromycin|mesh-list
24838251|NCT02196493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24838252|NCT02196493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24838254|NCT02196662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24838255|NCT02196662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24838256|NCT02196662|Analgesics|analgesics|mesh-ancestor
24838257|NCT02196662|Sensory System Agents|sensory system agents|mesh-ancestor
24838289|NCT02196805|Protective Agents|protective agents|mesh-ancestor
24838290|NCT02196805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838291|NCT02197000|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
24838292|NCT02197000|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24838293|NCT02197000|Protective Agents|protective agents|mesh-ancestor
24838294|NCT02197000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838475|NCT02198170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24838476|NCT02198170|Hormone Antagonists|hormone antagonists|mesh-ancestor
24838477|NCT02198170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24838478|NCT02198170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838479|NCT02198170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24838480|NCT02198170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24838481|NCT02198170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24838482|NCT02198209|Liraglutide|liraglutide|mesh-list
24838483|NCT02198209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24838484|NCT02198209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838485|NCT02198209|Incretins|incretins|mesh-ancestor
24838486|NCT02198209|Hormones|hormones|mesh-ancestor
24838487|NCT02198209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24838488|NCT02198248|Prednisolone|prednisolone|mesh-list
24838489|NCT02198248|Rituximab|rituximab|mesh-list
25699728|NCT02111785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25699729|NCT02111785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25699730|NCT02111798|Bupropion|bupropion|mesh-list
25699731|NCT02111798|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25699732|NCT02111798|Antidepressive Agents|antidepressive agents|mesh-ancestor
25699733|NCT02111798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25699734|NCT02111798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25699735|NCT02111798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25699736|NCT02111798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25699737|NCT02111798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786302|NCT01918995|Regadenoson|regadenoson|mesh-list
24786303|NCT01918995|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
24786305|NCT01918995|Purinergic Agonists|purinergic agonists|mesh-ancestor
24786306|NCT01918995|Purinergic Agents|purinergic agents|mesh-ancestor
24786307|NCT01918995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24754084|NCT01718964|Mannitol|mannitol|mesh-list
24838762|NCT02200159|Analgesics|analgesics|mesh-ancestor
24838763|NCT02200159|Sensory System Agents|sensory system agents|mesh-ancestor
24751648|NCT01705314|Vitamin D|vitamin d|mesh-list
24838796|NCT02200354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24838797|NCT02200354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24838798|NCT02200354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24838799|NCT02200354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24838800|NCT02200354|Growth Substances|growth substances|mesh-ancestor
24838801|NCT02200354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838802|NCT02200354|Growth Inhibitors|growth inhibitors|mesh-ancestor
24838803|NCT02200354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24838804|NCT02200354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838834|NCT02200640|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24838835|NCT02200640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838837|NCT02200653|Telmisartan|telmisartan|mesh-list
24838838|NCT02200653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24838839|NCT02200653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24838840|NCT02200653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24838841|NCT02200653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24838842|NCT02200653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838843|NCT02200718|Freund's Adjuvant|freund's adjuvant|mesh-list
24838871|NCT02200848|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24838872|NCT02200848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24838873|NCT02200848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839462|NCT02204501|GABA Agents|gaba agents|mesh-ancestor
24839463|NCT02204501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24839464|NCT02204501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598612|NCT00957060|Glimepiride|glimepiride|mesh-list
24839465|NCT02204527|Vitamin D|vitamin d|mesh-list
24839466|NCT02204527|Ergocalciferols|ergocalciferols|mesh-list
24839470|NCT02204527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839471|NCT02204527|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24839472|NCT02204527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24839473|NCT02204553|Panobinostat|panobinostat|mesh-list
24839474|NCT02204553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24839475|NCT02204553|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24839476|NCT02204553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24839477|NCT02204553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839478|NCT02204644|Imatinib Mesylate|imatinib mesylate|mesh-list
24839479|NCT02204644|HH-GV-678|hh-gv-678|mesh-list
24839480|NCT02204644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24839481|NCT02204644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24839482|NCT02204644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24839549|NCT02205164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24752329|NCT01709942|Cetrorelix|cetrorelix|mesh-list
24839859|NCT02206425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24839860|NCT02206425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25699739|NCT02111798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25699740|NCT02111798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699741|NCT02111798|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25699742|NCT02111798|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24839861|NCT02206425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24839865|NCT02206425|Protective Agents|protective agents|mesh-ancestor
24839953|NCT02206763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24839954|NCT02206763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24839955|NCT02206763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24873175|NCT05339334|Ritonavir|ritonavir|mesh-list
24873176|NCT05339334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24839960|NCT02206789|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24839961|NCT02206789|Prednisolone acetate|prednisolone acetate|mesh-list
24839962|NCT02206789|Cyclosporins|cyclosporins|mesh-list
24839963|NCT02206789|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24839964|NCT02206789|Prednisolone phosphate|prednisolone phosphate|mesh-list
24839965|NCT02206789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840025|NCT02206854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840026|NCT02206854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840028|NCT02206867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24840029|NCT02206867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24840030|NCT02206932|Sofosbuvir|sofosbuvir|mesh-list
24840067|NCT02207361|Mitosis Modulators|mitosis modulators|mesh-ancestor
24840068|NCT02207361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840069|NCT02207361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24752807|NCT01712139|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24840106|NCT02207452|Adrenergic Agents|adrenergic agents|mesh-ancestor
24840107|NCT02207452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24752840|NCT01712321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25108310|NCT03132779|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25108311|NCT03132779|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25108312|NCT03132779|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25108313|NCT03132779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25108314|NCT03132623|Andrographolide|andrographolide|mesh-list
25108315|NCT03132623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25108316|NCT03132623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25108317|NCT03132623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25108318|NCT03132623|Analgesics|analgesics|mesh-ancestor
25108319|NCT03132623|Sensory System Agents|sensory system agents|mesh-ancestor
25108320|NCT03132623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108321|NCT03132623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108322|NCT03132623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25108323|NCT03132623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25108324|NCT03132623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25108345|NCT03132610|Sensory System Agents|sensory system agents|mesh-ancestor
25108346|NCT03132610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108347|NCT03132610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108348|NCT03132610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25108349|NCT03132610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25108350|NCT03132610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25108351|NCT03132610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25108352|NCT03132610|Antiviral Agents|antiviral agents|mesh-ancestor
25108353|NCT03132610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25108354|NCT03132701|Magnesium Sulfate|magnesium sulfate|mesh-list
25108355|NCT03132701|Analgesics|analgesics|mesh-ancestor
25108356|NCT03132701|Sensory System Agents|sensory system agents|mesh-ancestor
25108357|NCT03132701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108358|NCT03132701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108359|NCT03132701|Anesthetics|anesthetics|mesh-ancestor
24840415|NCT02210104|Alkylating Agents|alkylating agents|mesh-ancestor
24840416|NCT02210104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840417|NCT02210104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24840418|NCT02210104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24840419|NCT02210104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24840429|NCT02210117|Immunoglobulin G|immunoglobulin g|mesh-list
24840430|NCT02210117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24840431|NCT02210117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24840432|NCT02210117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24840433|NCT02210117|Growth Substances|growth substances|mesh-ancestor
24840438|NCT02210117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840439|NCT02210156|Micronutrients|micronutrients|mesh-list
24840473|NCT02210598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24840474|NCT02210598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840476|NCT02210663|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24840477|NCT02210663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840478|NCT02210663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840479|NCT02210663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24840480|NCT02210702|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24840481|NCT02210702|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24840482|NCT02210702|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24840483|NCT02210702|Norethindrone|norethindrone|mesh-list
24840512|NCT02210728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840513|NCT02210728|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24507154|NCT00548964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840514|NCT02210728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24840515|NCT02210728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24840516|NCT02210728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840610|NCT02211222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24859034|NCT02301286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24840647|NCT02211625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24840648|NCT02211625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840649|NCT02211625|Analgesics|analgesics|mesh-ancestor
24840650|NCT02211625|Sensory System Agents|sensory system agents|mesh-ancestor
24840651|NCT02211625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24840652|NCT02211690|Tenofovir|tenofovir|mesh-list
24840653|NCT02211690|Emtricitabine|emtricitabine|mesh-list
24840654|NCT02211690|Dolutegravir|dolutegravir|mesh-list
24840677|NCT02211729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840679|NCT02211729|Renal Agents|renal agents|mesh-ancestor
24840680|NCT02211742|Dapagliflozin|dapagliflozin|mesh-list
24840681|NCT02211742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24840682|NCT02211742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840683|NCT02211742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24840684|NCT02211742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840685|NCT02211833|Pemetrexed|pemetrexed|mesh-list
24840686|NCT02211833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24840687|NCT02211833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840688|NCT02211833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840689|NCT02211833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24840690|NCT02211833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24840691|NCT02211846|Mirabegron|mirabegron|mesh-list
24840692|NCT02211846|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24840693|NCT02211846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24840694|NCT02211846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24840695|NCT02211846|Adrenergic Agents|adrenergic agents|mesh-ancestor
24840696|NCT02211846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24840791|NCT02212561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24840792|NCT02212561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24840793|NCT02212561|Immunologic Factors|immunologic factors|mesh-ancestor
24840794|NCT02212561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24840795|NCT02212561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24840796|NCT02212561|Antiviral Agents|antiviral agents|mesh-ancestor
24840797|NCT02212561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24840798|NCT02212561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24840799|NCT02212613|Brexpiprazole|brexpiprazole|mesh-list
24840800|NCT02212613|Serotonin Agents|serotonin agents|mesh-ancestor
24840801|NCT02212613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24859035|NCT02301286|Analgesics|analgesics|mesh-ancestor
24840960|NCT02213315|Mavrilimumab|mavrilimumab|mesh-list
24840961|NCT02213315|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24840962|NCT02213315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24840963|NCT02213315|Immunologic Factors|immunologic factors|mesh-ancestor
24753504|NCT01715636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24840981|NCT02213497|Paclitaxel|paclitaxel|mesh-list
24840982|NCT02213497|Carboplatin|carboplatin|mesh-list
24840984|NCT02213497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24840985|NCT02213497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24840986|NCT02213497|Tubulin Modulators|tubulin modulators|mesh-ancestor
24840987|NCT02213497|Antimitotic Agents|antimitotic agents|mesh-ancestor
24840988|NCT02213497|Mitosis Modulators|mitosis modulators|mesh-ancestor
24840989|NCT02213497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840990|NCT02213497|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24840993|NCT02213588|Protective Agents|protective agents|mesh-ancestor
24840994|NCT02213588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840996|NCT02213614|Antidepressive Agents|antidepressive agents|mesh-ancestor
24840997|NCT02213614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24840998|NCT02213614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840999|NCT02213614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841060|NCT02213848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24841061|NCT02213848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841062|NCT02213887|Pantoprazole|pantoprazole|mesh-list
24841063|NCT02213887|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24841064|NCT02213887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24841265|NCT02215057|Sensory System Agents|sensory system agents|mesh-ancestor
24841266|NCT02215057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24841267|NCT02215057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24841268|NCT02215057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24841269|NCT02215057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24841270|NCT02215057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24841271|NCT02215057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841272|NCT02215096|GSK2636771|gsk2636771|mesh-list
24841273|NCT02215096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24619326|NCT01052025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24841295|NCT02215213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841296|NCT02215213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24841297|NCT02215213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24841299|NCT02215330|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24841300|NCT02215330|Hormone Antagonists|hormone antagonists|mesh-ancestor
24841301|NCT02215330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24841302|NCT02215330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841303|NCT02215330|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24841304|NCT02215330|Diuretics|diuretics|mesh-ancestor
24841305|NCT02215330|Natriuretic Agents|natriuretic agents|mesh-ancestor
24841306|NCT02215330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24841307|NCT02215382|Atropine|atropine|mesh-list
24841308|NCT02215382|Neostigmine|neostigmine|mesh-list
24841309|NCT02215382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24841310|NCT02215382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24841311|NCT02215382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24841312|NCT02215382|Autonomic Agents|autonomic agents|mesh-ancestor
24841313|NCT02215382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24841314|NCT02215382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841315|NCT02215382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24841316|NCT02215382|Respiratory System Agents|respiratory system agents|mesh-ancestor
24841317|NCT02215382|Mydriatics|mydriatics|mesh-ancestor
24841318|NCT02215382|Parasympatholytics|parasympatholytics|mesh-ancestor
24841319|NCT02215382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24841320|NCT02215382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24841321|NCT02215382|Cholinergic Agents|cholinergic agents|mesh-ancestor
24841322|NCT02215382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24619349|NCT01052129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24841349|NCT02215434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841350|NCT02215434|Anabolic Agents|anabolic agents|mesh-ancestor
24841351|NCT02215447|Paclitaxel|paclitaxel|mesh-list
24841453|NCT02216045|Ribavirin|ribavirin|mesh-list
24841454|NCT02216045|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24841455|NCT02216045|Interferon-alpha|interferon-alpha|mesh-list
24841529|NCT02216383|Syntometrine|syntometrine|mesh-list
24841530|NCT02216383|Ergonovine|ergonovine|mesh-list
24841531|NCT02216383|Oxytocics|oxytocics|mesh-ancestor
24841532|NCT02216383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24544185|NCT00687661|Diphosphonates|diphosphonates|mesh-list
24841649|NCT02217202|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24841650|NCT02217202|Laxatives|laxatives|mesh-ancestor
24841651|NCT02217202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24841652|NCT02217267|Lidocaine|lidocaine|mesh-list
24841653|NCT02217267|Anesthetics, Local|anesthetics, local|mesh-ancestor
24841654|NCT02217267|Anesthetics|anesthetics|mesh-ancestor
24841655|NCT02217267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24841656|NCT02217267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841694|NCT02217631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24841924|NCT02219100|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24754332|NCT01720056|Verapamil|verapamil|mesh-list
24485638|NCT00454272|Vancomycin|vancomycin|mesh-list
24485639|NCT00454272|Teicoplanin|teicoplanin|mesh-list
24485643|NCT00454350|Vitamins|vitamins|mesh-ancestor
24842227|NCT02220114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842228|NCT02220153|Rozanolixizumab|rozanolixizumab|mesh-list
24842229|NCT02220153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24842230|NCT02220153|Immunologic Factors|immunologic factors|mesh-ancestor
24842231|NCT02220153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842232|NCT02220218|Metformin|metformin|mesh-list
24842233|NCT02220218|Canagliflozin|canagliflozin|mesh-list
24842234|NCT02220218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24842235|NCT02220218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859038|NCT02301286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786385|NCT01919593|Plasma Substitutes|plasma substitutes|mesh-ancestor
24786386|NCT01919593|Blood Substitutes|blood substitutes|mesh-ancestor
24936338|NCT04041492|Vitamin D|vitamin d|mesh-list
24578677|NCT00850746|Z 338|z 338|mesh-list
24578690|NCT00850850|Physostigmine|physostigmine|mesh-list
24578691|NCT00850850|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24578692|NCT00850850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24578693|NCT00850850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578694|NCT00850850|Cholinergic Agents|cholinergic agents|mesh-ancestor
24578695|NCT00850850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25108383|NCT03132272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108384|NCT03132493|Nivolumab|nivolumab|mesh-list
25108385|NCT03132493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25108386|NCT03132493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108387|NCT03132493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25108388|NCT03132493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108389|NCT03132519|Remifentanil|remifentanil|mesh-list
25108390|NCT03132519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25108391|NCT03132519|Narcotics|narcotics|mesh-ancestor
25108392|NCT03132519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25108393|NCT03132519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108394|NCT03132519|Analgesics|analgesics|mesh-ancestor
25108395|NCT03132519|Sensory System Agents|sensory system agents|mesh-ancestor
25108396|NCT03132519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108397|NCT03132233|Calcium|calcium|mesh-list
25108405|NCT03132142|Sensory System Agents|sensory system agents|mesh-ancestor
25108406|NCT03132142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108407|NCT03132142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108408|NCT03132142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25108409|NCT03132142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24842303|NCT02220530|Sensory System Agents|sensory system agents|mesh-ancestor
24842304|NCT02220530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24842375|NCT02220803|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24842376|NCT02220803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842377|NCT02220803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842378|NCT02220803|Diuretics|diuretics|mesh-ancestor
24842461|NCT02221401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842462|NCT02221401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842463|NCT02221414|Metformin|metformin|mesh-list
24842464|NCT02221414|Linagliptin|linagliptin|mesh-list
24842465|NCT02221414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24842466|NCT02221414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842467|NCT02221414|Incretins|incretins|mesh-ancestor
24842468|NCT02221414|Hormones|hormones|mesh-ancestor
24842469|NCT02221414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24842470|NCT02221414|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24842471|NCT02221414|Protease Inhibitors|protease inhibitors|mesh-ancestor
24842472|NCT02221414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842473|NCT02221414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842474|NCT02221453|Triamcinolone|triamcinolone|mesh-list
24842475|NCT02221453|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24842476|NCT02221453|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24842477|NCT02221453|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24842478|NCT02221453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24842479|NCT02221453|Glucocorticoids|glucocorticoids|mesh-ancestor
24842480|NCT02221453|Hormones|hormones|mesh-ancestor
25699743|NCT02111798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709511|NCT02268396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25709512|NCT02268396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25709513|NCT02268396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24842519|NCT02221583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842520|NCT02221583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24842521|NCT02221583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24842522|NCT02221583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24842523|NCT02221583|Antitubercular Agents|antitubercular agents|mesh-ancestor
24842524|NCT02221583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24842525|NCT02221583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24842526|NCT02221596|Vitamin D|vitamin d|mesh-list
24842634|NCT02222441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24842635|NCT02222441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842636|NCT02222441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24842637|NCT02222441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24842638|NCT02222441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842639|NCT02222441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842640|NCT02222441|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24842898|NCT02224170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24842899|NCT02224170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24842900|NCT02224170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24842901|NCT02224170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842913|NCT02224443|Midazolam|midazolam|mesh-list
24508128|NCT00554242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842914|NCT02224443|Dexmedetomidine|dexmedetomidine|mesh-list
24842915|NCT02224443|Remifentanil|remifentanil|mesh-list
24842916|NCT02224443|Propofol|propofol|mesh-list
24842917|NCT02224443|Etomidate|etomidate|mesh-list
24842918|NCT02224443|Sevoflurane|sevoflurane|mesh-list
24842919|NCT02224443|Atracurium|atracurium|mesh-list
24842920|NCT02224443|Cisatracurium|cisatracurium|mesh-list
24842921|NCT02224443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24842922|NCT02224443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24842957|NCT02224456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24842958|NCT02224456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842959|NCT02224456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842960|NCT02224456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24842961|NCT02224456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24842962|NCT02224534|Clopidogrel|clopidogrel|mesh-list
24842963|NCT02224534|Ticagrelor|ticagrelor|mesh-list
24842964|NCT02224534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24843298|NCT02226913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24843299|NCT02226913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24843300|NCT02226913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24843301|NCT02226913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843302|NCT02226913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24843303|NCT02226913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24843304|NCT02226913|Adrenergic Agents|adrenergic agents|mesh-ancestor
24843305|NCT02226913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24843306|NCT02226913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24843307|NCT02226913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25407307|NCT03508921|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24843377|NCT02227056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843379|NCT02227056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24843380|NCT02227082|Olaparib|olaparib|mesh-list
24843463|NCT02227797|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24843464|NCT02227797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24873908|NCT04975347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24873909|NCT04975347|Sensory System Agents|sensory system agents|mesh-ancestor
24873910|NCT04975347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24873911|NCT04975334|Naloxone|naloxone|mesh-list
24873912|NCT04975334|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24873914|NCT04975334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24873915|NCT04975334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24873916|NCT04975334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24873917|NCT04975334|Sensory System Agents|sensory system agents|mesh-ancestor
24873918|NCT04975334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24873919|NCT04971837|Cannabidiol|cannabidiol|mesh-list
24873920|NCT04971837|Sorbitol|sorbitol|mesh-list
24843785|NCT02229617|Testosterone undecanoate|testosterone undecanoate|mesh-list
24843786|NCT02229617|Testosterone enanthate|testosterone enanthate|mesh-list
24843788|NCT02229617|Androgens|androgens|mesh-ancestor
24844031|NCT02230930|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24844032|NCT02230930|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24844033|NCT02230930|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24844034|NCT02230930|Apomorphine|apomorphine|mesh-list
24844035|NCT02230930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24844036|NCT02230930|Emetics|emetics|mesh-ancestor
24844037|NCT02230930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844038|NCT02230930|Autonomic Agents|autonomic agents|mesh-ancestor
24844039|NCT02230930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24844101|NCT02231281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24844102|NCT02231281|Antimetabolites|antimetabolites|mesh-ancestor
24844103|NCT02231294|Pramipexole|pramipexole|mesh-list
24844104|NCT02231294|Antioxidants|antioxidants|mesh-ancestor
24844182|NCT02231606|Dopamine Agents|dopamine agents|mesh-ancestor
24844183|NCT02231606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24844378|NCT02232542|Analgesics|analgesics|mesh-ancestor
24844566|NCT02233231|Varenicline|varenicline|mesh-list
24844567|NCT02233231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24844568|NCT02233231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24844569|NCT02233231|Cholinergic Agents|cholinergic agents|mesh-ancestor
24844570|NCT02233231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24844571|NCT02233231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844572|NCT02233231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844573|NCT02233244|Midazolam|midazolam|mesh-list
24844574|NCT02233244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24844575|NCT02233244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24844576|NCT02233244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24844577|NCT02233244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809010|NCT02030678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809011|NCT02030678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844578|NCT02233244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24844579|NCT02233244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24844580|NCT02233244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24844581|NCT02233244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24844582|NCT02233244|Anesthetics, General|anesthetics, general|mesh-ancestor
24844583|NCT02233244|Anesthetics|anesthetics|mesh-ancestor
24844584|NCT02233244|GABA Modulators|gaba modulators|mesh-ancestor
24844585|NCT02233244|GABA Agents|gaba agents|mesh-ancestor
24844586|NCT02233244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24757592|NCT01741285|Fluticasone|fluticasone|mesh-list
24844609|NCT02233452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24844624|NCT02233504|Sequestering Agents|sequestering agents|mesh-ancestor
24844625|NCT02233504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844627|NCT02233556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24844628|NCT02233556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24844629|NCT02233556|Dopamine Agents|dopamine agents|mesh-ancestor
24844630|NCT02233556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24844631|NCT02233556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844632|NCT02233556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844681|NCT02233790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844715|NCT02233920|Autonomic Agents|autonomic agents|mesh-ancestor
24844716|NCT02233920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24844717|NCT02233920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844718|NCT02233972|Midazolam|midazolam|mesh-list
24844719|NCT02233972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24844720|NCT02233972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24844721|NCT02233972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24844722|NCT02233972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844723|NCT02233972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24844724|NCT02233972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24844725|NCT02233972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24844726|NCT02233972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24844727|NCT02233972|Anesthetics, General|anesthetics, general|mesh-ancestor
24844728|NCT02233972|Anesthetics|anesthetics|mesh-ancestor
24844729|NCT02233972|GABA Modulators|gaba modulators|mesh-ancestor
24844730|NCT02233972|GABA Agents|gaba agents|mesh-ancestor
24513240|NCT00580112|Hormones|hormones|mesh-ancestor
25108459|NCT03132168|Anesthetics|anesthetics|mesh-list
25108460|NCT03132168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25108461|NCT03132168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623349|NCT01071005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108494|NCT03131700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24844821|NCT02234739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24936407|NCT04040491|Antiviral Agents|antiviral agents|mesh-ancestor
24844822|NCT02234739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25699744|NCT02111863|Aldesleukin|aldesleukin|mesh-list
25699745|NCT02111863|Cyclophosphamide|cyclophosphamide|mesh-list
24844863|NCT02234882|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24844866|NCT02234921|Vaccines|vaccines|mesh-list
25699746|NCT02111863|Fludarabine|fludarabine|mesh-list
25699747|NCT02111863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25699748|NCT02111863|Immunologic Factors|immunologic factors|mesh-ancestor
25699749|NCT02111863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699750|NCT02111863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25699751|NCT02111863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25699752|NCT02111863|Alkylating Agents|alkylating agents|mesh-ancestor
25699753|NCT02111863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844867|NCT02234921|Immunologic Factors|immunologic factors|mesh-ancestor
24844868|NCT02234921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844869|NCT02234921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24844870|NCT02234921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24844871|NCT02234921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24844872|NCT02234921|Alkylating Agents|alkylating agents|mesh-ancestor
24844873|NCT02234921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844874|NCT02234921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24844875|NCT02234921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24844876|NCT02234921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24844877|NCT02234921|Interferon Inducers|interferon inducers|mesh-ancestor
24844878|NCT02235012|Ketamine|ketamine|mesh-list
24844879|NCT02235012|Analgesics|analgesics|mesh-ancestor
24623356|NCT01071057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24623357|NCT01071057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623358|NCT01071057|Analgesics|analgesics|mesh-ancestor
24844882|NCT02235012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844883|NCT02235012|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24844884|NCT02235012|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24844885|NCT02235012|Anesthetics, General|anesthetics, general|mesh-ancestor
24844886|NCT02235012|Anesthetics|anesthetics|mesh-ancestor
24844887|NCT02235012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24844888|NCT02235012|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24844889|NCT02235012|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24844890|NCT02235012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24844891|NCT02235012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844892|NCT02235194|Chromium|chromium|mesh-list
24844893|NCT02235194|Picolinic acid|picolinic acid|mesh-list
24844894|NCT02235194|Trace Elements|trace elements|mesh-ancestor
24844895|NCT02235194|Micronutrients|micronutrients|mesh-ancestor
24757803|NCT01742624|Tacrolimus|tacrolimus|mesh-list
24845032|NCT02235662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24845033|NCT02235662|Contraceptive Agents|contraceptive agents|mesh-ancestor
24845034|NCT02235662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24845035|NCT02235662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845036|NCT02235662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24845037|NCT02235662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24845038|NCT02235662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24845039|NCT02235805|Magnesium citrate|magnesium citrate|mesh-list
24845040|NCT02235805|Cathartics|cathartics|mesh-ancestor
24845041|NCT02235805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24845042|NCT02235909|Losartan|losartan|mesh-list
24845043|NCT02235909|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
24845044|NCT02235909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24845045|NCT02235909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24845046|NCT02235909|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24845047|NCT02235909|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24845095|NCT02236065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24845096|NCT02236065|Immunologic Factors|immunologic factors|mesh-ancestor
24845097|NCT02236065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845098|NCT02236078|Isoniazid|isoniazid|mesh-list
24845099|NCT02236078|Antitubercular Agents|antitubercular agents|mesh-ancestor
24845100|NCT02236078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24845101|NCT02236078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24845102|NCT02236078|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24845103|NCT02236078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24845104|NCT02236078|Antimetabolites|antimetabolites|mesh-ancestor
24845226|NCT02237053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24845227|NCT02237053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24845228|NCT02237079|Bazedoxifene|bazedoxifene|mesh-list
24845371|NCT02237755|Clomiphene|clomiphene|mesh-list
24845372|NCT02237755|Enclomiphene|enclomiphene|mesh-list
24845373|NCT02237755|Zuclomiphene|zuclomiphene|mesh-list
24845374|NCT02237755|Anticoagulants|anticoagulants|mesh-ancestor
24845375|NCT02237755|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24845376|NCT02237755|Chelating Agents|chelating agents|mesh-ancestor
24845377|NCT02237755|Sequestering Agents|sequestering agents|mesh-ancestor
24845378|NCT02237755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845379|NCT02237755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24845380|NCT02237755|Hormone Antagonists|hormone antagonists|mesh-ancestor
24845381|NCT02237755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24845382|NCT02237755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845403|NCT02237820|Hormones|hormones|mesh-ancestor
24845722|NCT02238470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24845723|NCT02238470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845724|NCT02238509|Trastuzumab|trastuzumab|mesh-list
24845725|NCT02238509|Lapatinib|lapatinib|mesh-list
24845726|NCT02238509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24845727|NCT02238509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24845728|NCT02238509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24845729|NCT02238509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24845730|NCT02238509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845731|NCT02238535|Iloprost|iloprost|mesh-list
24845732|NCT02238535|Warfarin|warfarin|mesh-list
24845733|NCT02238535|Anticoagulants|anticoagulants|mesh-ancestor
24845734|NCT02238535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24845735|NCT02238535|Vasodilator Agents|vasodilator agents|mesh-ancestor
24845736|NCT02238639|Fibrin fragment D|fibrin fragment d|mesh-list
24845737|NCT02238639|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24845738|NCT02238639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24845831|NCT02239484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845832|NCT02239484|Urological Agents|urological agents|mesh-ancestor
24845833|NCT02239484|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24845873|NCT02239900|Ipilimumab|ipilimumab|mesh-list
24846130|NCT02241356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24846131|NCT02241356|Dopamine Agents|dopamine agents|mesh-ancestor
24846132|NCT02241356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24846169|NCT02241564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24846170|NCT02241564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24846171|NCT02241564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24846172|NCT02241564|Antifungal Agents|antifungal agents|mesh-ancestor
24846173|NCT02241564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24846206|NCT02242032|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24846207|NCT02242084|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24846208|NCT02242084|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24846209|NCT02242084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24874435|NCT04751500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24874436|NCT04751500|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24874437|NCT04751500|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24874438|NCT04751500|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24874439|NCT04751500|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24874440|NCT04751500|Contraceptive Agents|contraceptive agents|mesh-ancestor
24874441|NCT04751500|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24874443|NCT04751500|Hormone Antagonists|hormone antagonists|mesh-ancestor
24874458|NCT04750616|Vitamin B Complex|vitamin b complex|mesh-ancestor
24874459|NCT04750616|Vitamins|vitamins|mesh-ancestor
24874468|NCT04740307|Lenvatinib|lenvatinib|mesh-list
24874469|NCT04740307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24874470|NCT04740307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24874471|NCT04740307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24874472|NCT04740307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24874502|NCT04722822|Vaccines|vaccines|mesh-list
24874504|NCT04722822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24874508|NCT04704661|Camptothecin|camptothecin|mesh-list
24874509|NCT04704661|Immunoconjugates|immunoconjugates|mesh-list
24874510|NCT04704661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24874511|NCT04704661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24874512|NCT04704661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24874513|NCT04704661|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24874514|NCT04704661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24874515|NCT04704661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24874516|NCT04704661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24874517|NCT04704661|Immunologic Factors|immunologic factors|mesh-ancestor
24874518|NCT04704661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459007|NCT00343369|Autonomic Agents|autonomic agents|mesh-ancestor
24459008|NCT00343369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24459009|NCT00343369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24874563|NCT04657666|Nabiximols|nabiximols|mesh-list
24874564|NCT04657666|Analgesics|analgesics|mesh-ancestor
24874565|NCT04657666|Sensory System Agents|sensory system agents|mesh-ancestor
24874566|NCT04657666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24874567|NCT04657666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24874568|NCT04645966|Acetaminophen|acetaminophen|mesh-list
24874569|NCT04645966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24874570|NCT04645966|Analgesics|analgesics|mesh-ancestor
24809164|NCT02031601|Antimitotic Agents|antimitotic agents|mesh-ancestor
24809165|NCT02031601|Mitosis Modulators|mitosis modulators|mesh-ancestor
24809166|NCT02031601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809167|NCT02031601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809208|NCT02031965|Antiemetics|antiemetics|mesh-ancestor
24874571|NCT04645966|Sensory System Agents|sensory system agents|mesh-ancestor
24874572|NCT04645966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24874573|NCT04645966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24874574|NCT04645966|Antipyretics|antipyretics|mesh-ancestor
24459350|NCT00344422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459351|NCT00344422|Protease Inhibitors|protease inhibitors|mesh-ancestor
24459352|NCT00344422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459494|NCT00344825|Antimetabolites|antimetabolites|mesh-ancestor
24459704|NCT00345982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408238|NCT00177008|Aripiprazole|aripiprazole|mesh-list
24537325|NCT00654290|Propranolol|propranolol|mesh-list
24537406|NCT00654537|Atorvastatin|atorvastatin|mesh-list
25699754|NCT02111863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25699755|NCT02111863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25699756|NCT02111863|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25699757|NCT02111863|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25699758|NCT02111863|Antiviral Agents|antiviral agents|mesh-ancestor
25699759|NCT02111863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25699760|NCT02112045|Melphalan|melphalan|mesh-list
25699761|NCT02112045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25699762|NCT02112045|Alkylating Agents|alkylating agents|mesh-ancestor
25709514|NCT02268396|Adrenergic Agents|adrenergic agents|mesh-ancestor
24408805|NCT00179699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24459737|NCT00346255|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
24459738|NCT00346255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24459739|NCT00346255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450575|NCT00319670|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24450577|NCT00319670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24450578|NCT00319683|Eniluracil|eniluracil|mesh-list
24885106|NCT02593123|Mycophenolic Acid|mycophenolic acid|mesh-list
24885107|NCT02593123|Molgramostim|molgramostim|mesh-list
24885108|NCT02593123|Lenograstim|lenograstim|mesh-list
24509750|NCT00562055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24509751|NCT00562055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509752|NCT00562055|Adrenergic Agents|adrenergic agents|mesh-ancestor
24509753|NCT00562055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24450579|NCT00319683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538564|NCT00659958|Zonisamide|zonisamide|mesh-list
24859204|NCT02302495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24859205|NCT02302495|Alkylating Agents|alkylating agents|mesh-ancestor
24859206|NCT02302495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859207|NCT02302495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24859208|NCT02302495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24859209|NCT02302495|Immunologic Factors|immunologic factors|mesh-ancestor
24859210|NCT02302508|Clopidogrel|clopidogrel|mesh-list
24859212|NCT02302508|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24539661|NCT00664846|Antipyretics|antipyretics|mesh-ancestor
24813237|NCT02057107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859551|NCT02304094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24859552|NCT02304094|Glucocorticoids|glucocorticoids|mesh-ancestor
24859554|NCT02304094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24859555|NCT02304094|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24859556|NCT02304094|Protective Agents|protective agents|mesh-ancestor
24859557|NCT02304094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24859558|NCT02304094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859559|NCT02304107|Letrozole|letrozole|mesh-list
24859560|NCT02304107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859561|NCT02304107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24859562|NCT02304107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24859563|NCT02304107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24859564|NCT02304107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859565|NCT02304107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24859721|NCT02305394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24859722|NCT02305394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859723|NCT02305485|Everolimus|everolimus|mesh-list
24488508|NCT00469131|Mycophenolic Acid|mycophenolic acid|mesh-list
24488509|NCT00469131|Tacrolimus|tacrolimus|mesh-list
24859724|NCT02305485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24860356|NCT02309385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24860358|NCT02309385|Hormones|hormones|mesh-ancestor
24540749|NCT00669487|Antiviral Agents|antiviral agents|mesh-ancestor
24540750|NCT00669487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24540751|NCT00669487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24540752|NCT00669487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25108511|NCT03131843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24540984|NCT00670410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24540985|NCT00670423|Sirolimus|sirolimus|mesh-list
24540986|NCT00670423|Bortezomib|bortezomib|mesh-list
24540987|NCT00670423|Tacrolimus|tacrolimus|mesh-list
24540988|NCT00670423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24540989|NCT00670423|Immunologic Factors|immunologic factors|mesh-ancestor
25108521|NCT03131973|Pravastatin|pravastatin|mesh-list
25108522|NCT03131973|Montelukast|montelukast|mesh-list
25108523|NCT03131973|Branebrutinib|branebrutinib|mesh-list
25108524|NCT03131973|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25108525|NCT03131973|Abortifacient Agents|abortifacient agents|mesh-ancestor
25108526|NCT03131973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25108527|NCT03131973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108528|NCT03131973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25108529|NCT03131973|Antimetabolites|antimetabolites|mesh-ancestor
25108530|NCT03131973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108531|NCT03131973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108532|NCT03131973|Dermatologic Agents|dermatologic agents|mesh-ancestor
25108533|NCT03131973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25108534|NCT03131973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25108535|NCT03131973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25108536|NCT03131973|Immunologic Factors|immunologic factors|mesh-ancestor
25108537|NCT03131973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25108538|NCT03131973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25108539|NCT03131973|Antidotes|antidotes|mesh-ancestor
25108540|NCT03131973|Protective Agents|protective agents|mesh-ancestor
25108542|NCT03131973|Vitamins|vitamins|mesh-ancestor
24861381|NCT02317341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24861382|NCT02317341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24861383|NCT02317341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24861384|NCT02317341|GABA Modulators|gaba modulators|mesh-ancestor
24861385|NCT02317341|GABA Agents|gaba agents|mesh-ancestor
24861386|NCT02317419|Gemcitabine|gemcitabine|mesh-list
24861470|NCT02318043|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24861471|NCT02318043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24861472|NCT02318043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24861473|NCT02318043|Autonomic Agents|autonomic agents|mesh-ancestor
24861474|NCT02318043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24861475|NCT02318043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861476|NCT02318043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24861477|NCT02318043|Respiratory System Agents|respiratory system agents|mesh-ancestor
24861499|NCT02318082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861500|NCT02318082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24861501|NCT02318082|Analgesics|analgesics|mesh-ancestor
24861502|NCT02318082|Sensory System Agents|sensory system agents|mesh-ancestor
24861503|NCT02318082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24861504|NCT02318082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861505|NCT02318082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24861506|NCT02318082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24861507|NCT02318082|Antiviral Agents|antiviral agents|mesh-ancestor
24861508|NCT02318082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24861510|NCT02318121|Oxytocics|oxytocics|mesh-ancestor
24861514|NCT02318199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24861515|NCT02318199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861516|NCT02318225|Misoprostol|misoprostol|mesh-list
24861517|NCT02318225|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24861662|NCT02319343|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24861663|NCT02319343|Prednisolone phosphate|prednisolone phosphate|mesh-list
24861664|NCT02319343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24861665|NCT02319343|Antiemetics|antiemetics|mesh-ancestor
24861666|NCT02319343|Autonomic Agents|autonomic agents|mesh-ancestor
24861667|NCT02319343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24861668|NCT02319343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861669|NCT02319343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25699763|NCT02112045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699764|NCT02112045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861671|NCT02319343|Hormones|hormones|mesh-ancestor
24861672|NCT02319343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24861673|NCT02319343|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24861674|NCT02319343|Protective Agents|protective agents|mesh-ancestor
24861675|NCT02319343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24861676|NCT02319343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861677|NCT02319460|Thrombin|thrombin|mesh-list
24861678|NCT02319460|Hemostatics|hemostatics|mesh-ancestor
24861679|NCT02319460|Coagulants|coagulants|mesh-ancestor
24861680|NCT02319499|Vitamin A|vitamin a|mesh-list
24861681|NCT02319499|Iron|iron|mesh-list
24861682|NCT02319499|Zinc|zinc|mesh-list
24861683|NCT02319499|Vitamins|vitamins|mesh-ancestor
24861684|NCT02319499|Micronutrients|micronutrients|mesh-ancestor
24861685|NCT02319499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861686|NCT02319499|Trace Elements|trace elements|mesh-ancestor
24861687|NCT02319564|Beclomethasone|beclomethasone|mesh-list
24861688|NCT02319564|Albuterol|albuterol|mesh-list
24861729|NCT02319707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861731|NCT02319772|Antiviral Agents|antiviral agents|mesh-ancestor
24861732|NCT02319772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24861733|NCT02319889|Paclitaxel|paclitaxel|mesh-list
24861734|NCT02319889|Carboplatin|carboplatin|mesh-list
24861735|NCT02319889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24861736|NCT02319889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24861737|NCT02319889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861738|NCT02319889|Tubulin Modulators|tubulin modulators|mesh-ancestor
24861739|NCT02319889|Antimitotic Agents|antimitotic agents|mesh-ancestor
24861740|NCT02319889|Mitosis Modulators|mitosis modulators|mesh-ancestor
24875179|NCT04346654|Glucocorticoids|glucocorticoids|mesh-ancestor
24875180|NCT04346654|Hormones|hormones|mesh-ancestor
24875181|NCT04346654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24875182|NCT04346654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24875183|NCT04346654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24875185|NCT04345913|Tubulin Modulators|tubulin modulators|mesh-ancestor
24861821|NCT02320357|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24861823|NCT02320357|Purinergic Agents|purinergic agents|mesh-ancestor
24861826|NCT02320357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861827|NCT02320383|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24861828|NCT02320383|Obinutuzumab|obinutuzumab|mesh-list
24861829|NCT02320383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24861830|NCT02320383|Alkylating Agents|alkylating agents|mesh-ancestor
24861831|NCT02320383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861832|NCT02320383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861833|NCT02320383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24861835|NCT02320448|Doxorubicin|doxorubicin|mesh-list
24861836|NCT02320448|Oxaliplatin|oxaliplatin|mesh-list
24861876|NCT02321176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861877|NCT02321176|Protective Agents|protective agents|mesh-ancestor
24861878|NCT02321176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861879|NCT02321176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24861880|NCT02321176|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24861881|NCT02321241|Aflibercept|aflibercept|mesh-list
24861882|NCT02321241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24861883|NCT02321241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24861884|NCT02321241|Growth Substances|growth substances|mesh-ancestor
24861885|NCT02321241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861886|NCT02321241|Growth Inhibitors|growth inhibitors|mesh-ancestor
24861943|NCT02321384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24861980|NCT02321761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24861981|NCT02321761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861982|NCT02321761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861983|NCT02321761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24861984|NCT02321761|Analgesics|analgesics|mesh-ancestor
24861985|NCT02321761|Sensory System Agents|sensory system agents|mesh-ancestor
24861986|NCT02321761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24861987|NCT02321839|Ranibizumab|ranibizumab|mesh-list
24861988|NCT02321839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24510314|NCT00564200|Autonomic Agents|autonomic agents|mesh-ancestor
24862030|NCT02322346|Sensory System Agents|sensory system agents|mesh-ancestor
24862034|NCT02322372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24862035|NCT02322372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862036|NCT02322372|Anesthetics, Local|anesthetics, local|mesh-ancestor
24862037|NCT02322372|Sensory System Agents|sensory system agents|mesh-ancestor
24862038|NCT02322372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108576|NCT03131973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25108578|NCT03131973|Sensory System Agents|sensory system agents|mesh-ancestor
24489365|NCT00472823|Vitamin D|vitamin d|mesh-list
24809349|NCT02033239|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24809350|NCT02033239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24489437|NCT00473239|Cholecalciferol|cholecalciferol|mesh-list
24489482|NCT00473551|Alkylating Agents|alkylating agents|mesh-ancestor
24489483|NCT00473551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489521|NCT00473915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24489522|NCT00473915|Autonomic Agents|autonomic agents|mesh-ancestor
24489523|NCT00473915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489524|NCT00473915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108579|NCT03131973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108580|NCT03131973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25108581|NCT03131973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25108582|NCT03131973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25108583|NCT03131973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25108584|NCT03131973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25108585|NCT03131882|Triamcinolone|triamcinolone|mesh-list
25108586|NCT03131882|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25108587|NCT03131882|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25108588|NCT03131882|Hyaluronic Acid|hyaluronic acid|mesh-list
25108589|NCT03131882|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25108590|NCT03131882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24862091|NCT02322853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24862093|NCT02322853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24862094|NCT02322853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24862095|NCT02322853|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24862096|NCT02322853|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24862097|NCT02322853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24813421|NCT02058446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875338|NCT04220008|Cyclophosphamide|cyclophosphamide|mesh-list
24875339|NCT04220008|Busulfan|busulfan|mesh-list
24875340|NCT04220008|Rituximab|rituximab|mesh-list
24875341|NCT04220008|Vorinostat|vorinostat|mesh-list
24875342|NCT04220008|Clofarabine|clofarabine|mesh-list
24875343|NCT04220008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24875344|NCT04220008|Tacrolimus|tacrolimus|mesh-list
24875345|NCT04220008|Antibodies|antibodies|mesh-list
24875366|NCT04220008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24875367|NCT04220008|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24864491|NCT03881020|Fluorides|fluorides|mesh-list
24864492|NCT03881020|Cariostatic Agents|cariostatic agents|mesh-ancestor
24864493|NCT03881020|Protective Agents|protective agents|mesh-ancestor
24864494|NCT03881020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864495|NCT03872401|Evolocumab|evolocumab|mesh-list
24864496|NCT03872401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24864497|NCT03872401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24864498|NCT03872401|Antimetabolites|antimetabolites|mesh-ancestor
24864499|NCT03872401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813935|NCT02061267|Vitamins|vitamins|mesh-ancestor
24813936|NCT02061267|Micronutrients|micronutrients|mesh-ancestor
24813937|NCT02061267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24875429|NCT04176848|Durvalumab|durvalumab|mesh-list
24875430|NCT04176848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24875496|NCT04156334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866204|NCT03042819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24866205|NCT03042819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866499|NCT04778267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25699765|NCT02112045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25699766|NCT02112045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25699767|NCT02112045|Immunologic Factors|immunologic factors|mesh-ancestor
25699768|NCT02112045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699769|NCT02112370|Epinephrine|epinephrine|mesh-list
25699770|NCT02112370|Racepinephrine|racepinephrine|mesh-list
25699771|NCT02112370|Ropivacaine|ropivacaine|mesh-list
25699772|NCT02112370|Epinephryl borate|epinephryl borate|mesh-list
25699773|NCT02112370|Anesthetics, Local|anesthetics, local|mesh-ancestor
25699774|NCT02112370|Anesthetics|anesthetics|mesh-ancestor
25699775|NCT02112370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25699776|NCT02112370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699777|NCT02112370|Sensory System Agents|sensory system agents|mesh-ancestor
24490059|NCT00476216|Fondaparinux|fondaparinux|mesh-list
24490060|NCT00476216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24490158|NCT00476853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24490159|NCT00476853|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24490160|NCT00476853|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24490162|NCT00476918|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24490163|NCT00476918|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24490164|NCT00476918|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24866500|NCT04778267|Sensory System Agents|sensory system agents|mesh-ancestor
24866502|NCT04760717|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24866503|NCT04760717|Hormone Antagonists|hormone antagonists|mesh-ancestor
24866504|NCT04760717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24866505|NCT04760717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866508|NCT04760717|Natriuretic Agents|natriuretic agents|mesh-ancestor
24866509|NCT04702256|Mycophenolic Acid|mycophenolic acid|mesh-list
24866511|NCT04702256|Methylprednisolone|methylprednisolone|mesh-list
24866547|NCT04638634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866689|NCT05195450|Tenofovir|tenofovir|mesh-list
24866690|NCT05195450|Antiviral Agents|antiviral agents|mesh-ancestor
24866754|NCT04990804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866755|NCT04990804|Sensory System Agents|sensory system agents|mesh-ancestor
24866756|NCT04990804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24875562|NCT04043806|Ivacaftor|ivacaftor|mesh-list
24546815|NCT00700544|Hormones|hormones|mesh-ancestor
24866874|NCT04294550|Naloxegol|naloxegol|mesh-list
24866875|NCT04294550|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24866876|NCT04294550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866877|NCT04294550|Sensory System Agents|sensory system agents|mesh-ancestor
24866878|NCT04294550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24866934|NCT03908307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24866935|NCT03908307|Glucocorticoids|glucocorticoids|mesh-ancestor
24866943|NCT03878979|Nivolumab|nivolumab|mesh-list
24814367|NCT02064153|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24814368|NCT02064218|Antihypertensive Agents|antihypertensive agents|mesh-list
24875642|NCT03982030|Dalbavancin|dalbavancin|mesh-list
24875643|NCT03982030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25108606|NCT03131765|Immunologic Factors|immunologic factors|mesh-ancestor
24814402|NCT02064491|Docetaxel|docetaxel|mesh-list
24814403|NCT02064491|Cisplatin|cisplatin|mesh-list
24814404|NCT02064491|Carboplatin|carboplatin|mesh-list
24814405|NCT02064491|Pemetrexed|pemetrexed|mesh-list
24814406|NCT02064491|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24814407|NCT02064491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24814408|NCT02064491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610138|NCT00999973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610139|NCT00999973|Alkylating Agents|alkylating agents|mesh-ancestor
24547172|NCT00702819|Bevacizumab|bevacizumab|mesh-list
24877593|NCT02529852|Tubulin Modulators|tubulin modulators|mesh-ancestor
24867334|NCT01126749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24867335|NCT01126749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24867336|NCT01126749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24936550|NCT04038970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936551|NCT04038970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24867337|NCT01126749|Immunologic Factors|immunologic factors|mesh-ancestor
24867338|NCT01126749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867849|NCT05154682|Analgesics|analgesics|mesh-ancestor
24867850|NCT05154682|Sensory System Agents|sensory system agents|mesh-ancestor
24867851|NCT05154682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24867852|NCT05154682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867853|NCT05154682|Antipyretics|antipyretics|mesh-ancestor
24867854|NCT05154682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24867855|NCT05154682|Narcotics|narcotics|mesh-ancestor
24867856|NCT05154682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24867917|NCT05005897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868007|NCT04285684|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24868035|NCT04013555|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24868036|NCT04013555|Antioxidants|antioxidants|mesh-ancestor
24868037|NCT04013555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868038|NCT04013555|Protective Agents|protective agents|mesh-ancestor
25699778|NCT02112370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699779|NCT02112370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25699780|NCT02112370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25699781|NCT02112370|Adrenergic Agents|adrenergic agents|mesh-ancestor
25699782|NCT02112370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25699783|NCT02112370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699784|NCT02112370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25699785|NCT02112370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24868040|NCT04013555|Antidotes|antidotes|mesh-ancestor
24868041|NCT04013555|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24868079|NCT03831711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24548477|NCT00709644|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24868820|NCT02209545|Vitamins|vitamins|mesh-ancestor
24868856|NCT00521846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868857|NCT00521846|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24868858|NCT00521846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24868969|NCT05157893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815363|NCT02069977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25108608|NCT03131622|Coal Tar|coal tar|mesh-list
25108621|NCT03131336|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
25108622|NCT03131336|Hemostatics|hemostatics|mesh-ancestor
25108623|NCT03131336|Coagulants|coagulants|mesh-ancestor
25108624|NCT03131375|Dexmedetomidine|dexmedetomidine|mesh-list
25108625|NCT03131375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25108626|NCT03131375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25108627|NCT03131375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108628|NCT03131375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25108629|NCT03131375|Analgesics|analgesics|mesh-ancestor
25108630|NCT03131375|Sensory System Agents|sensory system agents|mesh-ancestor
25108637|NCT03131375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108638|NCT03130933|Amoxicillin|amoxicillin|mesh-list
24875895|NCT03813147|Cytarabine|cytarabine|mesh-list
24868979|NCT05157542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24548900|NCT00712517|Sevoflurane|sevoflurane|mesh-list
24869259|NCT04278404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24869261|NCT04278404|Analgesics|analgesics|mesh-ancestor
24869262|NCT04278404|Sensory System Agents|sensory system agents|mesh-ancestor
24870079|NCT04031846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870080|NCT04028362|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
24870132|NCT03761784|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24870133|NCT03761784|Dermatologic Agents|dermatologic agents|mesh-ancestor
24870134|NCT03761784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870135|NCT03761784|Keratolytic Agents|keratolytic agents|mesh-ancestor
24870136|NCT03739099|Pancrelipase|pancrelipase|mesh-list
24870137|NCT03739099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24870138|NCT03703778|Ascorbic Acid|ascorbic acid|mesh-list
24870139|NCT03703778|Methyltestosterone|methyltestosterone|mesh-list
24870140|NCT03703778|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24870141|NCT03703778|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24870142|NCT03703778|Androgens|androgens|mesh-list
24870143|NCT03703778|Hormones|hormones|mesh-ancestor
24870144|NCT03703778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24870211|NCT03188354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870212|NCT03122431|Hydroxychloroquine|hydroxychloroquine|mesh-list
24870213|NCT03122431|Thalidomide|thalidomide|mesh-list
24870214|NCT03122431|Antimalarials|antimalarials|mesh-ancestor
24870508|NCT05067270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870509|NCT05067270|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24870511|NCT05063851|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24870512|NCT05063851|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24870513|NCT05063851|Dopamine Agents|dopamine agents|mesh-ancestor
24870514|NCT05063851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24870515|NCT05063851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870516|NCT05063851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887304|NCT04518163|Coagulants|coagulants|mesh-ancestor
24870666|NCT04577690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24870667|NCT04577690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24870668|NCT04577690|Adrenergic Agents|adrenergic agents|mesh-ancestor
24870669|NCT04577690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24814827|NCT02066844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24814828|NCT02066844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870689|NCT04510311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870690|NCT04510311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24870691|NCT04510311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870692|NCT04510311|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24870693|NCT04496596|Suramin|suramin|mesh-list
24870694|NCT04496596|Antinematodal Agents|antinematodal agents|mesh-ancestor
24870695|NCT04496596|Anthelmintics|anthelmintics|mesh-ancestor
24870696|NCT04496596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24870697|NCT04496596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24870698|NCT04496596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870699|NCT04496596|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24870772|NCT03942224|Bortezomib|bortezomib|mesh-list
24870773|NCT03942224|Daratumumab|daratumumab|mesh-list
24870774|NCT03942224|Ixazomib|ixazomib|mesh-list
24870775|NCT03942224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24870776|NCT03942224|Antiemetics|antiemetics|mesh-ancestor
24870799|NCT03837015|Hormones|hormones|mesh-ancestor
24870800|NCT03837015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24870807|NCT03654729|Edetic Acid|edetic acid|mesh-list
24870902|NCT03106688|Sensory System Agents|sensory system agents|mesh-ancestor
24870903|NCT03106688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24870905|NCT02966873|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24870906|NCT02966873|Antiviral Agents|antiviral agents|mesh-ancestor
24870907|NCT02966873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24870908|NCT02966873|Expectorants|expectorants|mesh-ancestor
24870911|NCT02966873|Antioxidants|antioxidants|mesh-ancestor
24870925|NCT02513329|Anesthetics|anesthetics|mesh-ancestor
24850455|NCT02253095|Micronutrients|micronutrients|mesh-list
24870926|NCT02513329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24870927|NCT02513329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871029|NCT05163704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871030|NCT05163704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24871031|NCT05163704|Analgesics|analgesics|mesh-ancestor
24871060|NCT05163366|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24871062|NCT05163366|Anesthetics, General|anesthetics, general|mesh-ancestor
24871063|NCT05163366|Anesthetics|anesthetics|mesh-ancestor
24871064|NCT05163366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24871065|NCT05163366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24871066|NCT05163366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24871067|NCT05163366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24871160|NCT04658173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24871161|NCT04658173|Narcotics|narcotics|mesh-ancestor
24871162|NCT04658173|Analgesics|analgesics|mesh-ancestor
24871221|NCT04375956|Pembrolizumab|pembrolizumab|mesh-list
24871222|NCT04375956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24871223|NCT04375956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871224|NCT04373707|Enoxaparin|enoxaparin|mesh-list
24871225|NCT04373707|Dalteparin|dalteparin|mesh-list
24871226|NCT04373707|Tinzaparin|tinzaparin|mesh-list
24871284|NCT04050085|Nivolumab|nivolumab|mesh-list
24871285|NCT04050085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24871683|NCT05110209|Ranibizumab|ranibizumab|mesh-list
24871684|NCT05110209|Aflibercept|aflibercept|mesh-list
24871685|NCT05110209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24871787|NCT04527289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24871788|NCT04527289|Analgesics|analgesics|mesh-ancestor
24871789|NCT04527289|Sensory System Agents|sensory system agents|mesh-ancestor
24871792|NCT04525898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24871795|NCT04525898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871796|NCT04525898|Analgesics|analgesics|mesh-ancestor
24871797|NCT04525898|Sensory System Agents|sensory system agents|mesh-ancestor
24871798|NCT04525898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24809466|NCT02033798|Urological Agents|urological agents|mesh-ancestor
24597743|NCT00951444|Antimetabolites|antimetabolites|mesh-ancestor
24871799|NCT04525898|Antitussive Agents|antitussive agents|mesh-ancestor
24871800|NCT04525898|Respiratory System Agents|respiratory system agents|mesh-ancestor
24871801|NCT04518124|Propranolol|propranolol|mesh-list
24871837|NCT04282070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814858|NCT02067078|Bupivacaine|bupivacaine|mesh-list
24814859|NCT02067078|Epinephryl borate|epinephryl borate|mesh-list
24814860|NCT02067078|BB 1101|bb 1101|mesh-list
24814861|NCT02067078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24814862|NCT02067078|Antiemetics|antiemetics|mesh-ancestor
24814863|NCT02067078|Autonomic Agents|autonomic agents|mesh-ancestor
24814864|NCT02067078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24814865|NCT02067078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814866|NCT02067078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24814867|NCT02067078|Glucocorticoids|glucocorticoids|mesh-ancestor
24850602|NCT02253784|Sensory System Agents|sensory system agents|mesh-ancestor
24871878|NCT04078906|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
24871879|NCT04078906|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24871880|NCT04078906|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24871958|NCT03436199|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24871959|NCT03436199|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24871960|NCT03436199|Antiviral Agents|antiviral agents|mesh-ancestor
24871998|NCT03217136|Metronidazole|metronidazole|mesh-list
24871999|NCT03217136|Meropenem|meropenem|mesh-list
24872000|NCT03217136|Tazobactam|tazobactam|mesh-list
24872001|NCT03217136|Ceftolozane|ceftolozane|mesh-list
24872039|NCT05400070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24814947|NCT02067442|Analgesics|analgesics|mesh-ancestor
24814979|NCT02067780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24814980|NCT02067780|Renal Agents|renal agents|mesh-ancestor
24814981|NCT02067780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24814982|NCT02067780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24814983|NCT02067780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24814984|NCT02067780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24814985|NCT02067780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814986|NCT02067780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24814987|NCT02067780|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24814988|NCT02067780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24814989|NCT02067910|Abatacept|abatacept|mesh-list
24814990|NCT02067910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24814991|NCT02067910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814992|NCT02067910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24814993|NCT02067910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24814994|NCT02067910|Immunologic Factors|immunologic factors|mesh-ancestor
24814995|NCT02067910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814996|NCT02067910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24814997|NCT02067936|Remifentanil|remifentanil|mesh-list
24814998|NCT02067936|Propofol|propofol|mesh-list
24814999|NCT02067936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25108667|NCT03131037|Antiviral Agents|antiviral agents|mesh-ancestor
24850682|NCT02253875|Ritonavir|ritonavir|mesh-list
24872176|NCT05398679|Leprostatic Agents|leprostatic agents|mesh-ancestor
24872177|NCT05398679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24872208|NCT05398393|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
24872209|NCT05398393|Atorvastatin|atorvastatin|mesh-list
24872210|NCT05398393|Hypolipidemic Agents|hypolipidemic agents|mesh-list
24872211|NCT05398393|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24872212|NCT05398393|Antimetabolites|antimetabolites|mesh-ancestor
24872213|NCT05398393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872546|NCT05315479|Analgesics|analgesics|mesh-ancestor
24872547|NCT05315479|Sensory System Agents|sensory system agents|mesh-ancestor
24872548|NCT05315479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24872549|NCT05315479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872550|NCT05315479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24872583|NCT05309460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24872584|NCT05309460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872585|NCT05309460|Vasodilator Agents|vasodilator agents|mesh-ancestor
25699786|NCT02112370|Autonomic Agents|autonomic agents|mesh-ancestor
24872586|NCT05309460|Tocolytic Agents|tocolytic agents|mesh-ancestor
24872587|NCT05309460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25407308|NCT03508921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24876323|NCT03597568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24876324|NCT03597568|Protective Agents|protective agents|mesh-ancestor
24876325|NCT03597568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24876326|NCT03597568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24873206|NCT05320380|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24873207|NCT05320380|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24873208|NCT05320380|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24873209|NCT05320380|Methotrexate|methotrexate|mesh-list
24873210|NCT05320380|Fludarabine phosphate|fludarabine phosphate|mesh-list
24873211|NCT05320380|Fludarabine|fludarabine|mesh-list
24873212|NCT05320380|Daunorubicin|daunorubicin|mesh-list
24873213|NCT05320380|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24873214|NCT05320380|Abortifacient Agents|abortifacient agents|mesh-ancestor
24873215|NCT05320380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24873216|NCT05320380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24873244|NCT05319015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24873345|NCT05263895|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24876399|NCT03579446|Narcotics|narcotics|mesh-ancestor
24876400|NCT03579446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24876402|NCT03579446|Analgesics|analgesics|mesh-ancestor
24876431|NCT03548584|Dopamine Agonists|dopamine agonists|mesh-ancestor
24876432|NCT03548584|Dopamine Agents|dopamine agents|mesh-ancestor
24876433|NCT03528642|Temozolomide|temozolomide|mesh-list
24876434|NCT03528642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24876435|NCT03528642|Alkylating Agents|alkylating agents|mesh-ancestor
24876436|NCT03528642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24876437|NCT03528642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24873667|NCT05086107|Rifabutin|rifabutin|mesh-list
24873668|NCT05086107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24873669|NCT05086107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24873670|NCT05086107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24873671|NCT05086107|Antitubercular Agents|antitubercular agents|mesh-ancestor
24873727|NCT05049213|Povidone|povidone|mesh-list
24873728|NCT05049213|Plasma Substitutes|plasma substitutes|mesh-ancestor
24873729|NCT05049213|Blood Substitutes|blood substitutes|mesh-ancestor
24874312|NCT04830215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24874313|NCT04830215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24874709|NCT04592809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24874710|NCT04592809|GABA Modulators|gaba modulators|mesh-ancestor
24874711|NCT04592809|GABA Agents|gaba agents|mesh-ancestor
25108670|NCT03131141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24511444|NCT00568750|Dasatinib|dasatinib|mesh-list
25108671|NCT03131141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25108672|NCT03130855|Carticaine|carticaine|mesh-list
25108673|NCT03130855|Anesthetics, Local|anesthetics, local|mesh-ancestor
25108674|NCT03130855|Anesthetics|anesthetics|mesh-ancestor
25108675|NCT03130855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25108676|NCT03130855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108677|NCT03130855|Sensory System Agents|sensory system agents|mesh-ancestor
25108678|NCT03130855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24786627|NCT01921010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24874751|NCT04576104|Metformin|metformin|mesh-list
24874752|NCT04576104|Megestrol|megestrol|mesh-list
24874753|NCT04576104|Megestrol Acetate|megestrol acetate|mesh-list
24874994|NCT04481204|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24874995|NCT04481204|Cisplatin|cisplatin|mesh-list
24874996|NCT04481204|Fluorouracil|fluorouracil|mesh-list
24874997|NCT04481204|Oxaliplatin|oxaliplatin|mesh-list
24874998|NCT04481204|Irinotecan|irinotecan|mesh-list
24874999|NCT04481204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24875000|NCT04481204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24875001|NCT04481204|Tubulin Modulators|tubulin modulators|mesh-ancestor
24875002|NCT04481204|Antimitotic Agents|antimitotic agents|mesh-ancestor
24875003|NCT04481204|Mitosis Modulators|mitosis modulators|mesh-ancestor
24875004|NCT04481204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875005|NCT04481204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24875006|NCT04481204|Antimetabolites|antimetabolites|mesh-ancestor
24876524|NCT03463876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407309|NCT03508726|Ascorbic Acid|ascorbic acid|mesh-list
24875738|NCT03896269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24875739|NCT03896269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24875740|NCT03896269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24875741|NCT03896269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24875750|NCT03878095|Olaparib|olaparib|mesh-list
24887305|NCT04517526|Bevacizumab|bevacizumab|mesh-list
24578936|NCT00852436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24578937|NCT00852436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24578938|NCT00852436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851227|NCT02256124|Lamotrigine|lamotrigine|mesh-list
24815430|NCT02070198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815431|NCT02070289|PF-06372865|pf-06372865|mesh-list
24815432|NCT02070289|GABA Modulators|gaba modulators|mesh-ancestor
24815433|NCT02070289|GABA Agents|gaba agents|mesh-ancestor
24815434|NCT02070289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24815435|NCT02070289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815436|NCT02070289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815437|NCT02070406|Aldesleukin|aldesleukin|mesh-list
24815438|NCT02070406|Cyclophosphamide|cyclophosphamide|mesh-list
24815439|NCT02070406|Fludarabine|fludarabine|mesh-list
24815440|NCT02070406|Fludarabine phosphate|fludarabine phosphate|mesh-list
24623393|NCT01071187|Cholinergic Agents|cholinergic agents|mesh-ancestor
24623394|NCT01071187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24623395|NCT01071187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623396|NCT01071187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623398|NCT01071291|Nicotinic Acids|nicotinic acids|mesh-list
24623399|NCT01071291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24623400|NCT01071291|Antimetabolites|antimetabolites|mesh-ancestor
25108681|NCT03130842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25108682|NCT03130842|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25108683|NCT03130842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25108684|NCT03130842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24876837|NCT03199053|Dapagliflozin|dapagliflozin|mesh-list
24876867|NCT03141684|Immunoglobulins|immunoglobulins|mesh-list
24876868|NCT03141684|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24876869|NCT03141684|Immunoglobulin G|immunoglobulin g|mesh-list
24876870|NCT03141684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24876871|NCT03141684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24876872|NCT03141684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24876873|NCT03141684|Growth Substances|growth substances|mesh-ancestor
24876874|NCT03141684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24876875|NCT03141684|Growth Inhibitors|growth inhibitors|mesh-ancestor
24876876|NCT03141684|Immunologic Factors|immunologic factors|mesh-ancestor
24815445|NCT02070406|Immunologic Factors|immunologic factors|mesh-ancestor
24815457|NCT02070406|Sensory System Agents|sensory system agents|mesh-ancestor
24877333|NCT02819635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24877335|NCT02812420|Durvalumab|durvalumab|mesh-list
24877336|NCT02812420|Ipilimumab|ipilimumab|mesh-list
24877337|NCT02812420|Tremelimumab|tremelimumab|mesh-list
24877338|NCT02812420|Immunoglobulins|immunoglobulins|mesh-list
24877339|NCT02812420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24877340|NCT02812420|Immunoglobulin G|immunoglobulin g|mesh-list
24877341|NCT02812420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24877342|NCT02812420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24877343|NCT02812420|Immunologic Factors|immunologic factors|mesh-ancestor
24877344|NCT02812420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24877345|NCT02812420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24877346|NCT02812420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878373|NCT01861314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24878374|NCT01861314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878375|NCT01861314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24878376|NCT01861314|Antimetabolites|antimetabolites|mesh-ancestor
24878377|NCT01854775|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24878378|NCT01854775|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24878379|NCT01854775|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24878380|NCT01854775|Antiviral Agents|antiviral agents|mesh-ancestor
24880025|NCT04219735|Minocycline|minocycline|mesh-list
24880026|NCT04219735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24880275|NCT03902418|Emtricitabine|emtricitabine|mesh-list
24880276|NCT03902418|Antiviral Agents|antiviral agents|mesh-ancestor
24880392|NCT03802071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880393|NCT03802071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24815914|NCT02072720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24815915|NCT02072720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815916|NCT02072720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24815917|NCT02072720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24815918|NCT02072720|Growth Substances|growth substances|mesh-ancestor
24880471|NCT03654274|Estradiol|estradiol|mesh-list
24881008|NCT03173053|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24881086|NCT03082521|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24881087|NCT03082521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24881088|NCT03069638|Dexmedetomidine|dexmedetomidine|mesh-list
24815970|NCT02072967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815972|NCT02073084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24815973|NCT02073084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24815974|NCT02073084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25108709|NCT03130504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25108710|NCT03130504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108711|NCT03130504|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25108712|NCT03130504|Hormone Antagonists|hormone antagonists|mesh-ancestor
25108714|NCT03130634|Antioxidants|antioxidants|mesh-ancestor
25108715|NCT03130634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108716|NCT03130634|Protective Agents|protective agents|mesh-ancestor
25108717|NCT03130634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108718|NCT03130556|Rabeprazole|rabeprazole|mesh-list
25108719|NCT03130556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25108720|NCT03130556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25108721|NCT03130556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25108722|NCT03130556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25108723|NCT03130556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108724|NCT03130452|Amoxicillin|amoxicillin|mesh-list
25108725|NCT03130452|Metronidazole|metronidazole|mesh-list
25108726|NCT03130452|Clarithromycin|clarithromycin|mesh-list
25108727|NCT03130452|Lansoprazole|lansoprazole|mesh-list
25108728|NCT03130452|Dexlansoprazole|dexlansoprazole|mesh-list
25108729|NCT03130452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25108730|NCT03130452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25108731|NCT03130452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25108732|NCT03130452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25108734|NCT03130452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881931|NCT00389870|Cyclosporine|cyclosporine|mesh-list
24881933|NCT00389870|Panitumumab|panitumumab|mesh-list
24881934|NCT00389870|Cyclosporins|cyclosporins|mesh-list
24881935|NCT00389870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24881936|NCT00389870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24881937|NCT00389870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881938|NCT00389870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881974|NCT00006455|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24612077|NCT01011751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24623421|NCT01071304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24623422|NCT01071304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623423|NCT01071369|Betamethasone|betamethasone|mesh-list
24623424|NCT01071369|Betamethasone Valerate|betamethasone valerate|mesh-list
24623425|NCT01071369|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24623426|NCT01071369|Betamethasone benzoate|betamethasone benzoate|mesh-list
24623427|NCT01071369|Lidocaine|lidocaine|mesh-list
24886143|NCT02963610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886144|NCT02963610|Immunologic Factors|immunologic factors|mesh-ancestor
24886145|NCT02963610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886146|NCT02963610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24886147|NCT02963610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24886148|NCT02963610|Growth Substances|growth substances|mesh-ancestor
24886149|NCT02963610|Growth Inhibitors|growth inhibitors|mesh-ancestor
24886150|NCT02945800|Gemcitabine|gemcitabine|mesh-list
24886151|NCT02945800|Paclitaxel|paclitaxel|mesh-list
24886152|NCT02945800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24886153|NCT02945800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886154|NCT02945800|Tubulin Modulators|tubulin modulators|mesh-ancestor
24886155|NCT02945800|Antimitotic Agents|antimitotic agents|mesh-ancestor
24886156|NCT02945800|Mitosis Modulators|mitosis modulators|mesh-ancestor
24708811|NCT01503008|Metformin|metformin|mesh-list
24886715|NCT04523675|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24886734|NCT04523506|Botulinum Toxins|botulinum toxins|mesh-list
24886747|NCT04523272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24886748|NCT04523272|Growth Substances|growth substances|mesh-ancestor
24886750|NCT04523272|Growth Inhibitors|growth inhibitors|mesh-ancestor
24877427|NCT02692339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24877428|NCT02692339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24887147|NCT04519463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24887148|NCT04519463|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24887149|NCT04519463|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24887150|NCT04519463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24887151|NCT04519463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887153|NCT04519762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24887155|NCT04519710|Ocrelizumab|ocrelizumab|mesh-list
24465522|NCT00369993|Fluticasone|fluticasone|mesh-list
24887187|NCT04519385|Antiemetics|antiemetics|mesh-ancestor
24887188|NCT04519385|Autonomic Agents|autonomic agents|mesh-ancestor
24887189|NCT04519385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24887190|NCT04519385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887191|NCT04519385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24887192|NCT04519385|Glucocorticoids|glucocorticoids|mesh-ancestor
24887097|NCT04520178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24887194|NCT04519385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24887195|NCT04519385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24887196|NCT04519385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887197|NCT04518852|Sorafenib|sorafenib|mesh-list
24887198|NCT04518852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465542|NCT00370019|Estradiol|estradiol|mesh-list
24887265|NCT04518202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24887267|NCT04518202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24887290|NCT04517890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24887291|NCT04517890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24887292|NCT04517890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887294|NCT04518176|Oxytocics|oxytocics|mesh-ancestor
24887295|NCT04518176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24887296|NCT04518176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887297|NCT04517851|Elotuzumab|elotuzumab|mesh-list
24887298|NCT04517851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887299|NCT04518163|Tranexamic Acid|tranexamic acid|mesh-list
24887300|NCT04518163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24887301|NCT04518163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24887302|NCT04518163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887303|NCT04518163|Hemostatics|hemostatics|mesh-ancestor
24887432|NCT04516655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24887433|NCT04516603|4-Aminopyridine|4-aminopyridine|mesh-list
24887434|NCT04516603|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24877563|NCT02535078|Durvalumab|durvalumab|mesh-list
24877564|NCT02535078|Tremelimumab|tremelimumab|mesh-list
24887474|NCT04516226|Chlorhexidine|chlorhexidine|mesh-list
24887475|NCT04516226|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24887476|NCT04516226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24851983|NCT02259946|Anticonvulsants|anticonvulsants|mesh-ancestor
24887477|NCT04516226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24887478|NCT04516226|Disinfectants|disinfectants|mesh-ancestor
24887479|NCT04516226|Dermatologic Agents|dermatologic agents|mesh-ancestor
24887480|NCT04515966|Methylprednisolone|methylprednisolone|mesh-list
24887481|NCT04515966|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24887511|NCT04515979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24887514|NCT04515836|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24887515|NCT04515836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887516|NCT04515836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887517|NCT04515836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887518|NCT04515732|Apremilast|apremilast|mesh-list
24887519|NCT04515732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24887520|NCT04515732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24887521|NCT04515732|Analgesics|analgesics|mesh-ancestor
24887522|NCT04515732|Sensory System Agents|sensory system agents|mesh-ancestor
24887523|NCT04515732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24887524|NCT04515732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24877591|NCT02529852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24495930|NCT00502567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495931|NCT00502567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24495932|NCT00502567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24877592|NCT02529852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24887759|NCT04513184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887760|NCT04513184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24887761|NCT04513184|Glucocorticoids|glucocorticoids|mesh-ancestor
24887763|NCT04513184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24512527|NCT00575549|Dobutamine|dobutamine|mesh-list
24816644|NCT02078089|Sensory System Agents|sensory system agents|mesh-ancestor
24816645|NCT02078089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816646|NCT02078089|Anticonvulsants|anticonvulsants|mesh-ancestor
24816647|NCT02078089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24816648|NCT02078089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24816649|NCT02078089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24816650|NCT02078089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24877706|NCT02496208|Nivolumab|nivolumab|mesh-list
24877707|NCT02496208|Ipilimumab|ipilimumab|mesh-list
24877708|NCT02496208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24877709|NCT02496208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24877710|NCT02496208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24877711|NCT02496208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710488|NCT01510847|Hormones|hormones|mesh-ancestor
24888017|NCT04509635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24888018|NCT04509635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24888020|NCT04509440|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24888021|NCT04509440|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24888022|NCT04509440|Anesthetics|anesthetics|mesh-list
24888023|NCT04509440|Mepivacaine|mepivacaine|mesh-list
24888024|NCT04509440|Anesthetics, Local|anesthetics, local|mesh-list
24888025|NCT04509440|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24887877|NCT04511299|SMOFlipid|smoflipid|mesh-list
24888026|NCT04509440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24888027|NCT04509440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888028|NCT04509440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24888030|NCT04509440|Hormones|hormones|mesh-ancestor
24888160|NCT04508439|Anticoagulants|anticoagulants|mesh-ancestor
24888161|NCT04508439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24888162|NCT04508439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24888163|NCT04508439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888164|NCT04508400|Dexamethasone|dexamethasone|mesh-list
24888165|NCT04508400|Dexamethasone acetate|dexamethasone acetate|mesh-list
24888166|NCT04508400|Ondansetron|ondansetron|mesh-list
24888167|NCT04508400|Fosaprepitant|fosaprepitant|mesh-list
24888168|NCT04508400|Aprepitant|aprepitant|mesh-list
24888169|NCT04508400|BB 1101|bb 1101|mesh-list
24888170|NCT04508400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24888171|NCT04508400|Antiemetics|antiemetics|mesh-ancestor
24888172|NCT04508400|Autonomic Agents|autonomic agents|mesh-ancestor
24888173|NCT04508400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24888174|NCT04508400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888175|NCT04508400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24888210|NCT04508452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24888211|NCT04508452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24888212|NCT04508166|Sodium Oxybate|sodium oxybate|mesh-list
24888233|NCT04508140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24877738|NCT02473042|Serotonin Agents|serotonin agents|mesh-ancestor
24877777|NCT02435212|Deferasirox|deferasirox|mesh-list
24888244|NCT04508036|Fibrin fragment D|fibrin fragment d|mesh-list
24888245|NCT04508036|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24888246|NCT04508036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24888247|NCT04508036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888248|NCT04508036|Hemostatics|hemostatics|mesh-ancestor
24888249|NCT04508036|Coagulants|coagulants|mesh-ancestor
24887898|NCT04511195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891153|NCT04475614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888259|NCT04507607|Antiviral Agents|antiviral agents|mesh-ancestor
24888260|NCT04507607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24888261|NCT04507607|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24888262|NCT04507607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25699787|NCT02112370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25699788|NCT02112370|Respiratory System Agents|respiratory system agents|mesh-ancestor
25699789|NCT02112370|Mydriatics|mydriatics|mesh-ancestor
24888263|NCT04507607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25699790|NCT02112370|Sympathomimetics|sympathomimetics|mesh-ancestor
24786656|NCT01921218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24786657|NCT01921218|Immunologic Factors|immunologic factors|mesh-ancestor
24786658|NCT01921218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24786667|NCT01921218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24786668|NCT01921218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24786669|NCT01921231|Bupivacaine|bupivacaine|mesh-list
24786671|NCT01921231|Anesthetics, Local|anesthetics, local|mesh-ancestor
24786672|NCT01921231|Anesthetics|anesthetics|mesh-ancestor
24786682|NCT01921361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24786683|NCT01921361|Analgesics|analgesics|mesh-ancestor
24852202|NCT02261090|Antioxidants|antioxidants|mesh-ancestor
24466253|NCT00372736|Mitosis Modulators|mitosis modulators|mesh-ancestor
24888324|NCT04506034|Sensory System Agents|sensory system agents|mesh-ancestor
24888325|NCT04506034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24815584|NCT02071212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24815587|NCT02071303|Celecoxib|celecoxib|mesh-list
24888362|NCT04505943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24888385|NCT04505644|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24816708|NCT02078336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24815615|NCT02071342|Everolimus|everolimus|mesh-list
24815628|NCT02071368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24815629|NCT02071368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815630|NCT02071368|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24700156|NCT01450995|Serotonin Agents|serotonin agents|mesh-ancestor
24877782|NCT02419807|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24877783|NCT02419807|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
24877784|NCT02419807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24877785|NCT02419807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24877787|NCT02417103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24877788|NCT02417103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816722|NCT02078440|Bromocriptine|bromocriptine|mesh-list
24816723|NCT02078440|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24816724|NCT02078440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24888944|NCT04499313|Methylprednisolone|methylprednisolone|mesh-list
24888945|NCT04499313|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24888111|NCT04509258|Antioxidants|antioxidants|mesh-ancestor
24888946|NCT04499313|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24889063|NCT04498520|Fulvestrant|fulvestrant|mesh-list
24889097|NCT04497831|Morphine|morphine|mesh-list
24877955|NCT02208375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24889153|NCT04496882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24889161|NCT04496492|Tocotrienols|tocotrienols|mesh-list
24889162|NCT04496492|Vitamin E|vitamin e|mesh-list
24889163|NCT04496492|Tocopherols|tocopherols|mesh-list
24889269|NCT04494659|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24889270|NCT04494659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24889271|NCT04494763|Propranolol|propranolol|mesh-list
24711853|NCT01517399|Vitamin K|vitamin k|mesh-list
24889331|NCT04494321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24889332|NCT04494321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889368|NCT04494243|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24889369|NCT04494243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889370|NCT04494243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889371|NCT04494399|Interferons|interferons|mesh-list
24889372|NCT04494399|Ribavirin|ribavirin|mesh-list
24889473|NCT04493099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889476|NCT04493099|Growth Inhibitors|growth inhibitors|mesh-ancestor
24889477|NCT04493099|Growth Substances|growth substances|mesh-ancestor
24889478|NCT04493099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889494|NCT04492774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24889496|NCT04492774|Hormones|hormones|mesh-ancestor
24889533|NCT04492319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889534|NCT04492319|Cholinergic Agents|cholinergic agents|mesh-ancestor
24889535|NCT04492319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24623507|NCT01072045|Prednisone|prednisone|mesh-list
24812156|NCT02050009|Metformin|metformin|mesh-list
24889826|NCT04489446|Sildenafil Citrate|sildenafil citrate|mesh-list
24889827|NCT04489446|Vasodilator Agents|vasodilator agents|mesh-ancestor
24889828|NCT04489446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24889829|NCT04489446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24889830|NCT04489446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889831|NCT04489446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889832|NCT04489446|Urological Agents|urological agents|mesh-ancestor
24889834|NCT04489147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24889835|NCT04489147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889836|NCT04489121|Omalizumab|omalizumab|mesh-list
24889838|NCT04489121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24889839|NCT04489121|Respiratory System Agents|respiratory system agents|mesh-ancestor
24889866|NCT04488744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24889867|NCT04488744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889868|NCT04488744|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24889869|NCT04488744|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24889870|NCT04488744|Cholinergic Agents|cholinergic agents|mesh-ancestor
24816832|NCT02079194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24878122|NCT02142803|Bevacizumab|bevacizumab|mesh-list
24878123|NCT02142803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24878124|NCT02142803|Endothelial Growth Factors|endothelial growth factors|mesh-list
24878125|NCT02142803|Antibodies|antibodies|mesh-list
24878126|NCT02142803|Immunoglobulins|immunoglobulins|mesh-list
24878127|NCT02142803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24878128|NCT02142803|Immunoglobulin G|immunoglobulin g|mesh-list
24878129|NCT02142803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24878130|NCT02142803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24878131|NCT02142803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24878132|NCT02142803|Growth Substances|growth substances|mesh-ancestor
24878133|NCT02142803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24878134|NCT02142803|Growth Inhibitors|growth inhibitors|mesh-ancestor
24816833|NCT02079194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816834|NCT02079194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24816835|NCT02079194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24816836|NCT02079194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24890513|NCT04482712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24890514|NCT04482712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108763|NCT03130348|Dexamethasone acetate|dexamethasone acetate|mesh-list
24890515|NCT04482712|Antifungal Agents|antifungal agents|mesh-ancestor
24786684|NCT01921361|Sensory System Agents|sensory system agents|mesh-ancestor
24786685|NCT01921361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812364|NCT02051842|Metadoxine|metadoxine|mesh-list
24890516|NCT04482712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24890982|NCT04477642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891007|NCT04477525|Sensory System Agents|sensory system agents|mesh-ancestor
24891008|NCT04477525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891010|NCT04477317|Racepinephrine|racepinephrine|mesh-list
24891011|NCT04477317|Nordefrin|nordefrin|mesh-list
24891012|NCT04477317|Mepivacaine|mepivacaine|mesh-list
24891013|NCT04477317|Carticaine|carticaine|mesh-list
24891014|NCT04477317|Epinephryl borate|epinephryl borate|mesh-list
24891015|NCT04477317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24891016|NCT04477317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24816875|NCT02079337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24816876|NCT02079337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816877|NCT02079337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816878|NCT02079350|Polygeline|polygeline|mesh-list
24816879|NCT02079350|Plasma Substitutes|plasma substitutes|mesh-ancestor
24816880|NCT02079350|Blood Substitutes|blood substitutes|mesh-ancestor
24816881|NCT02079480|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
24816882|NCT02079480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24816884|NCT02079480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891152|NCT04475614|Micronutrients|micronutrients|mesh-ancestor
24891339|NCT04473144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24891341|NCT04473144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815660|NCT02071459|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24815661|NCT02071459|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24936767|NCT04036526|Vaccines|vaccines|mesh-list
24891385|NCT04471922|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24891386|NCT04471922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24891387|NCT04471922|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24891388|NCT04471922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24891389|NCT04471922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891397|NCT04471480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24891398|NCT04471480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891399|NCT04471480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24891401|NCT04471441|Everolimus|everolimus|mesh-list
24891402|NCT04471441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815669|NCT02071537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815671|NCT02071537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24815672|NCT02071537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815673|NCT02071537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24815674|NCT02071537|Immunologic Factors|immunologic factors|mesh-ancestor
24815675|NCT02071537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815676|NCT02071537|Amebicides|amebicides|mesh-ancestor
24815677|NCT02071537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24815678|NCT02071537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24815679|NCT02071537|Antimalarials|antimalarials|mesh-ancestor
24815680|NCT02071537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24700706|NCT01454518|Anesthetics|anesthetics|mesh-list
24891403|NCT04471441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24889210|NCT04496024|Ofloxacin|ofloxacin|mesh-list
24891629|NCT04468685|Ondansetron|ondansetron|mesh-list
24891630|NCT04468685|Antiemetics|antiemetics|mesh-ancestor
24891656|NCT04468139|Antioxidants|antioxidants|mesh-ancestor
24891657|NCT04468139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891658|NCT04468139|Protective Agents|protective agents|mesh-ancestor
24891659|NCT04468542|Triamcinolone|triamcinolone|mesh-list
24891660|NCT04468542|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24891661|NCT04468542|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24891662|NCT04468542|Bupivacaine|bupivacaine|mesh-list
24891663|NCT04468542|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24891664|NCT04468542|Anesthetics, Local|anesthetics, local|mesh-ancestor
24891665|NCT04468542|Anesthetics|anesthetics|mesh-ancestor
24891666|NCT04468542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24891667|NCT04468542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891668|NCT04468542|Sensory System Agents|sensory system agents|mesh-ancestor
24891670|NCT04468542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24891879|NCT04467125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24891880|NCT04467125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891881|NCT04467125|Sensory System Agents|sensory system agents|mesh-ancestor
24891882|NCT04467125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891883|NCT04467125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24891884|NCT04467125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24891912|NCT04466917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24891913|NCT04466917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24891914|NCT04466917|Growth Substances|growth substances|mesh-ancestor
24891915|NCT04466917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891916|NCT04466917|Growth Inhibitors|growth inhibitors|mesh-ancestor
24891918|NCT04466943|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24891919|NCT04466943|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24891920|NCT04466943|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24891921|NCT04466943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891922|NCT04466943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891923|NCT04466670|Aspirin|aspirin|mesh-list
24891924|NCT04466670|Heparin|heparin|mesh-list
24891925|NCT04466670|Calcium heparin|calcium heparin|mesh-list
24891926|NCT04466670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24891927|NCT04466670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24891928|NCT04466670|Analgesics|analgesics|mesh-ancestor
24891963|NCT04466046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24891964|NCT04466046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891965|NCT04466046|Antiemetics|antiemetics|mesh-ancestor
24891966|NCT04466046|Autonomic Agents|autonomic agents|mesh-ancestor
24891967|NCT04466046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891968|NCT04466046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24891969|NCT04466046|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24891970|NCT04466046|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24786686|NCT01921361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24786687|NCT01921361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24786688|NCT01921361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24786689|NCT01921361|Adrenergic Agents|adrenergic agents|mesh-ancestor
24786690|NCT01921361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24786691|NCT01921361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891971|NCT04466046|Serotonin Agents|serotonin agents|mesh-ancestor
24892010|NCT04466241|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24892047|NCT04465916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24892049|NCT04465942|Pembrolizumab|pembrolizumab|mesh-list
24892076|NCT04465773|Remifentanil|remifentanil|mesh-list
24497448|NCT00510159|Artesunate|artesunate|mesh-list
24892077|NCT04465773|Propofol|propofol|mesh-list
24892078|NCT04465773|Anesthetics|anesthetics|mesh-ancestor
24878509|NCT01587352|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24878510|NCT01587352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24878511|NCT01587352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892079|NCT04465773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24892080|NCT04465773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892081|NCT04465773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24892082|NCT04465773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24892083|NCT04465773|Anesthetics, General|anesthetics, general|mesh-ancestor
24892084|NCT04465773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24892086|NCT04465773|Analgesics|analgesics|mesh-ancestor
24892087|NCT04465773|Sensory System Agents|sensory system agents|mesh-ancestor
24892088|NCT04465773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24892089|NCT04465500|Androgens|androgens|mesh-list
24892090|NCT04465500|Hormones|hormones|mesh-ancestor
24892091|NCT04465500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24892092|NCT04465500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892093|NCT04465695|Interferons|interferons|mesh-list
24892094|NCT04465695|Interferon-beta|interferon-beta|mesh-list
24892095|NCT04465695|Clofazimine|clofazimine|mesh-list
24892096|NCT04465695|Interferon beta-1b|interferon beta-1b|mesh-list
24892097|NCT04465695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24892098|NCT04465695|Antiviral Agents|antiviral agents|mesh-ancestor
24892099|NCT04465695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24892100|NCT04465695|Immunologic Factors|immunologic factors|mesh-ancestor
24892135|NCT04465123|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24892204|NCT04464694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24892205|NCT04464694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24623563|NCT01072240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623564|NCT01072240|Immunologic Factors|immunologic factors|mesh-ancestor
24623565|NCT01072240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892206|NCT04464694|Growth Substances|growth substances|mesh-ancestor
24892208|NCT04464694|Growth Inhibitors|growth inhibitors|mesh-ancestor
24892209|NCT04464694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24892210|NCT04464811|Furosemide|furosemide|mesh-list
24878530|NCT01582191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892211|NCT04464811|Diuretics|diuretics|mesh-ancestor
24892212|NCT04464811|Natriuretic Agents|natriuretic agents|mesh-ancestor
24892213|NCT04464811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469343|NCT00385463|Montelukast|montelukast|mesh-list
24892238|NCT04464850|Micronutrients|micronutrients|mesh-ancestor
24892239|NCT04464850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892241|NCT04464850|Vitamin B Complex|vitamin b complex|mesh-ancestor
24892242|NCT04464850|Vitamins|vitamins|mesh-ancestor
24892243|NCT04464863|Metronidazole|metronidazole|mesh-list
24892244|NCT04464863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24892245|NCT04464863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24892246|NCT04464863|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24892327|NCT04464005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24892330|NCT04464122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24892331|NCT04464122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892332|NCT04463875|Coenzyme Q10|coenzyme q10|mesh-list
24816945|NCT02080026|Analgesics|analgesics|mesh-ancestor
24816946|NCT02080026|Sensory System Agents|sensory system agents|mesh-ancestor
24816947|NCT02080026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816948|NCT02080026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816949|NCT02080026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24816950|NCT02080026|Filaricides|filaricides|mesh-ancestor
24816951|NCT02080026|Antinematodal Agents|antinematodal agents|mesh-ancestor
24816952|NCT02080026|Anthelmintics|anthelmintics|mesh-ancestor
24816953|NCT02080026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850610|NCT02253797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24850611|NCT02253797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24936956|NCT04034173|Leucovorin|leucovorin|mesh-list
24816954|NCT02080026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816955|NCT02080026|Antimetabolites|antimetabolites|mesh-ancestor
24816956|NCT02080078|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24816957|NCT02080078|Theophylline|theophylline|mesh-list
24816958|NCT02080078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24892368|NCT04463966|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24892369|NCT04463966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25407310|NCT03508726|Vitamins|vitamins|mesh-ancestor
24469477|NCT00385970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24892450|NCT04462588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24892453|NCT04462614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24892454|NCT04462614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24892490|NCT04462666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892493|NCT04462666|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24892494|NCT04462666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24892495|NCT04462666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24892496|NCT04462666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892502|NCT04462250|Sensory System Agents|sensory system agents|mesh-ancestor
24469583|NCT00386503|Antimalarials|antimalarials|mesh-ancestor
24892542|NCT04462003|Anticoagulants|anticoagulants|mesh-ancestor
24878682|NCT01160211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24878683|NCT01160211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24878684|NCT01160211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24878685|NCT01160211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24878686|NCT01160211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892579|NCT04461665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24892580|NCT04461535|Hormones|hormones|mesh-list
24892581|NCT04461535|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24892582|NCT04461535|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
24892583|NCT04461535|beta-Endorphin|beta-endorphin|mesh-list
24892584|NCT04461535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24892585|NCT04461535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892586|NCT04461535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24892587|NCT04461535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892588|NCT04461249|Travoprost|travoprost|mesh-list
24892589|NCT04461249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24892590|NCT04461249|Latanoprost|latanoprost|mesh-list
24892591|NCT04461249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24892592|NCT04461249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24892593|NCT04461353|Hydroxychloroquine|hydroxychloroquine|mesh-list
24892594|NCT04461353|Antimalarials|antimalarials|mesh-ancestor
24892756|NCT04459676|Mitosis Modulators|mitosis modulators|mesh-ancestor
24892757|NCT04459676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892765|NCT04459078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24878720|NCT01093573|Azacitidine|azacitidine|mesh-list
24892766|NCT04459078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24892767|NCT04459078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24892768|NCT04459078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24892829|NCT04458636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24892830|NCT04458636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892831|NCT04458636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24892877|NCT04457765|Blood Substitutes|blood substitutes|mesh-ancestor
24892999|NCT04455711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24893000|NCT04455711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24893001|NCT04455711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24893002|NCT04455711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24893003|NCT04455711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893004|NCT04455711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24893006|NCT04455711|Analgesics|analgesics|mesh-ancestor
24893007|NCT04455555|Rotigotine|rotigotine|mesh-list
24611486|NCT01009801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24893010|NCT04455555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24893011|NCT04455555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893012|NCT04455555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893013|NCT04455477|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24893014|NCT04455477|Natriuretic Agents|natriuretic agents|mesh-ancestor
24779179|NCT01874470|Diuretics|diuretics|mesh-list
24893015|NCT04455477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817001|NCT02080169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24817002|NCT02080169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24817003|NCT02080169|GABA Modulators|gaba modulators|mesh-ancestor
24817005|NCT02080182|Acetylcysteine|acetylcysteine|mesh-list
24817006|NCT02080182|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24817007|NCT02080182|Antiviral Agents|antiviral agents|mesh-ancestor
24817008|NCT02080182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24817009|NCT02080182|Expectorants|expectorants|mesh-ancestor
24817013|NCT02080182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817014|NCT02080182|Protective Agents|protective agents|mesh-ancestor
24893058|NCT04454775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893059|NCT04454775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893060|NCT04454775|Anticoagulants|anticoagulants|mesh-ancestor
24810211|NCT02038634|Respiratory System Agents|respiratory system agents|mesh-ancestor
24498317|NCT00513968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24498318|NCT00513968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25699791|NCT02112370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24893180|NCT04453436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24893181|NCT04453436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893182|NCT04453436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893183|NCT04453436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24893184|NCT04453436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24893185|NCT04453436|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24893350|NCT04451174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893351|NCT04451174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24893352|NCT04451174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24893353|NCT04451122|Tea Tree Oil|tea tree oil|mesh-list
24893354|NCT04451122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24893386|NCT04450446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24878817|NCT00740805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24878818|NCT00740805|Immunologic Factors|immunologic factors|mesh-ancestor
24878819|NCT00740805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24878820|NCT00740805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24878821|NCT00740805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24878822|NCT00740805|Alkylating Agents|alkylating agents|mesh-ancestor
24878823|NCT00740805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878824|NCT00740805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24893393|NCT04450134|Fexofenadine|fexofenadine|mesh-list
25108783|NCT03130179|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24878837|NCT00669734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24878838|NCT00669734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24878839|NCT00669734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25108784|NCT03130179|Autonomic Agents|autonomic agents|mesh-ancestor
25108785|NCT03130179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108786|NCT03130179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108787|NCT03130179|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25108794|NCT03130010|Analgesics|analgesics|mesh-ancestor
25108795|NCT03130010|Sensory System Agents|sensory system agents|mesh-ancestor
25108796|NCT03130010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108797|NCT03130010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108798|NCT03130205|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25108799|NCT03130205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25108800|NCT03130205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108801|NCT03130218|Peppermint oil|peppermint oil|mesh-list
25108813|NCT03130153|Analgesics|analgesics|mesh-ancestor
25108814|NCT03130153|Sensory System Agents|sensory system agents|mesh-ancestor
25699792|NCT02112448|Acetaminophen|acetaminophen|mesh-list
25699793|NCT02112448|Ketorolac|ketorolac|mesh-list
25699794|NCT02112448|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25699795|NCT02112448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25699796|NCT02112448|Analgesics|analgesics|mesh-ancestor
25699797|NCT02112448|Sensory System Agents|sensory system agents|mesh-ancestor
25699798|NCT02112448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699799|NCT02112448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699800|NCT02112448|Antipyretics|antipyretics|mesh-ancestor
25699801|NCT02112448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25108815|NCT03130153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108816|NCT03130153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108817|NCT03130153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25108818|NCT03130153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25108819|NCT03130153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25108820|NCT03130153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25108821|NCT03130153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108822|NCT03130153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25108823|NCT03130153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25108824|NCT03130153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25108826|NCT03130153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25108827|NCT03130153|Antifungal Agents|antifungal agents|mesh-ancestor
25108828|NCT03130153|Keratolytic Agents|keratolytic agents|mesh-ancestor
25108829|NCT03130153|Dermatologic Agents|dermatologic agents|mesh-ancestor
25108830|NCT03130114|Azithromycin|azithromycin|mesh-list
25108831|NCT03130114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25108832|NCT03130114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25108833|NCT03130270|Apatinib|apatinib|mesh-list
25108834|NCT03130270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108837|NCT03130270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893549|NCT04448379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716108|NCT01539902|Cyclophosphamide|cyclophosphamide|mesh-list
24893661|NCT04447092|Mitosis Modulators|mitosis modulators|mesh-ancestor
24893662|NCT04447092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893722|NCT04446663|Mitosis Modulators|mitosis modulators|mesh-ancestor
24893824|NCT04446234|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24893825|NCT04446234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24893826|NCT04446234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24893827|NCT04446065|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24893828|NCT04446065|Antioxidants|antioxidants|mesh-ancestor
24893829|NCT04446065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893830|NCT04446065|Protective Agents|protective agents|mesh-ancestor
24893831|NCT04446065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817042|NCT02080416|Antiviral Agents|antiviral agents|mesh-ancestor
24817043|NCT02080416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24817044|NCT02080494|Tranexamic Acid|tranexamic acid|mesh-list
24817048|NCT02080494|Hemostatics|hemostatics|mesh-ancestor
24893838|NCT04445948|Clarithromycin|clarithromycin|mesh-list
24893839|NCT04445948|Lactoferrin|lactoferrin|mesh-list
24893840|NCT04445948|Esomeprazole|esomeprazole|mesh-list
24893841|NCT04445948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24893842|NCT04445948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24893843|NCT04445948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24893844|NCT04445948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24893845|NCT04445948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24893846|NCT04445948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24470924|NCT00392470|Cetuximab|cetuximab|mesh-list
24893914|NCT04446104|Ivermectin|ivermectin|mesh-list
24893915|NCT04446104|Povidone-Iodine|povidone-iodine|mesh-list
24893916|NCT04446104|Povidone|povidone|mesh-list
24893917|NCT04446104|Vitamins|vitamins|mesh-ancestor
24893918|NCT04446104|Micronutrients|micronutrients|mesh-ancestor
24893919|NCT04446104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893920|NCT04446104|Antimalarials|antimalarials|mesh-ancestor
24893921|NCT04446104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24893922|NCT04446104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24893923|NCT04446104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24893924|NCT04446104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24470987|NCT00392886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25699802|NCT02112448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24893955|NCT04445727|Micronutrients|micronutrients|mesh-ancestor
24893956|NCT04445727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893957|NCT04445727|Antioxidants|antioxidants|mesh-ancestor
25699803|NCT02112448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25699804|NCT02112448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25699805|NCT02112448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25699806|NCT02112448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699807|NCT02113007|Rituximab|rituximab|mesh-list
25699808|NCT02113007|Temozolomide|temozolomide|mesh-list
25699809|NCT02113007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25699810|NCT02113007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25699811|NCT02113007|Immunologic Factors|immunologic factors|mesh-ancestor
24499394|NCT00519246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24499395|NCT00519246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499396|NCT00519246|Analgesics|analgesics|mesh-ancestor
24893958|NCT04445727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893959|NCT04445727|Protective Agents|protective agents|mesh-ancestor
24893960|NCT04445779|Ubiquinone|ubiquinone|mesh-list
24893961|NCT04445779|Coenzyme Q10|coenzyme q10|mesh-list
24815721|NCT02071641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24815722|NCT02071641|Growth Substances|growth substances|mesh-ancestor
24815723|NCT02071641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815724|NCT02071641|Growth Inhibitors|growth inhibitors|mesh-ancestor
24815725|NCT02071641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24890673|NCT04481282|Sympathomimetics|sympathomimetics|mesh-ancestor
24817106|NCT02081027|Anticonvulsants|anticonvulsants|mesh-ancestor
24817107|NCT02081027|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24817108|NCT02081027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24817109|NCT02081027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24817110|NCT02081027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817116|NCT02081144|Autonomic Agents|autonomic agents|mesh-ancestor
24817117|NCT02081144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24817118|NCT02081144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817119|NCT02081144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24817120|NCT02081144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24817121|NCT02081144|Cholinergic Agents|cholinergic agents|mesh-ancestor
24817122|NCT02081144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24471219|NCT00394056|Paroxetine|paroxetine|mesh-list
24894150|NCT04443556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24894151|NCT04443634|Bupivacaine|bupivacaine|mesh-list
24894153|NCT04443634|Anesthetics|anesthetics|mesh-ancestor
24894253|NCT04443049|Anthelmintics|anthelmintics|mesh-ancestor
24894282|NCT04442919|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24894283|NCT04442919|Anesthetics, General|anesthetics, general|mesh-ancestor
24894284|NCT04442919|Anesthetics|anesthetics|mesh-ancestor
24894285|NCT04442750|Bupivacaine|bupivacaine|mesh-list
24894286|NCT04442750|Anesthetics, Local|anesthetics, local|mesh-ancestor
24894287|NCT04442750|Anesthetics|anesthetics|mesh-ancestor
24894288|NCT04442750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24894289|NCT04442750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894290|NCT04442750|Sensory System Agents|sensory system agents|mesh-ancestor
24894291|NCT04442750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24894293|NCT04442984|Oxaliplatin|oxaliplatin|mesh-list
24894294|NCT04442984|Irinotecan|irinotecan|mesh-list
24894364|NCT04441385|Antiviral Agents|antiviral agents|mesh-ancestor
24894365|NCT04441385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24894366|NCT04441385|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24894367|NCT04441424|Azithromycin|azithromycin|mesh-list
24894368|NCT04441424|Hydroxychloroquine|hydroxychloroquine|mesh-list
24894369|NCT04441424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24894370|NCT04441424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24894371|NCT04441424|Antimalarials|antimalarials|mesh-ancestor
24894372|NCT04441424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24894373|NCT04441424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24894374|NCT04441424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24894375|NCT04441424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894376|NCT04441424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25108849|NCT03129646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626451|NCT01087437|Calcium|calcium|mesh-list
24786767|NCT01921673|Mitosis Modulators|mitosis modulators|mesh-ancestor
24786768|NCT01921673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786769|NCT01921738|Azithromycin|azithromycin|mesh-list
24786770|NCT01921738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24786771|NCT01921738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24879136|NCT05016518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24879137|NCT05016518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24879138|NCT05016518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879139|NCT05016518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24879140|NCT05016518|Anesthetics, General|anesthetics, general|mesh-ancestor
25699812|NCT02113007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699813|NCT02113007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25699814|NCT02113007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25699815|NCT02113007|Alkylating Agents|alkylating agents|mesh-ancestor
25699816|NCT02113007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699817|NCT02113241|Dapagliflozin|dapagliflozin|mesh-list
24894591|NCT04438980|Prednisolone phosphate|prednisolone phosphate|mesh-list
24894592|NCT04438980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24894593|NCT04438980|Antiemetics|antiemetics|mesh-ancestor
24894594|NCT04438980|Autonomic Agents|autonomic agents|mesh-ancestor
24894595|NCT04438980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24850813|NCT02254018|Maytansine|maytansine|mesh-list
24894596|NCT04438980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894597|NCT04438980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24894598|NCT04438980|Glucocorticoids|glucocorticoids|mesh-ancestor
24894599|NCT04438980|Hormones|hormones|mesh-ancestor
24894600|NCT04438980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24471831|NCT00396929|Antimitotic Agents|antimitotic agents|mesh-ancestor
24894827|NCT05387031|Ustekinumab|ustekinumab|mesh-list
24894828|NCT05387031|Dermatologic Agents|dermatologic agents|mesh-ancestor
24894829|NCT05386979|Analgesics, Opioid|analgesics, opioid|mesh-list
24894830|NCT05386979|Anesthetics|anesthetics|mesh-list
24894831|NCT05386979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24894832|NCT05386979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894833|NCT05386979|Narcotics|narcotics|mesh-ancestor
24894834|NCT05386979|Analgesics|analgesics|mesh-ancestor
24894835|NCT05386979|Sensory System Agents|sensory system agents|mesh-ancestor
24894836|NCT05386979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24894837|NCT05380154|Botulinum Toxins|botulinum toxins|mesh-list
24894838|NCT05380154|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24894839|NCT05380154|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24894840|NCT05380154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24894841|NCT05380154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24894842|NCT05380154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894843|NCT05380154|Cholinergic Agents|cholinergic agents|mesh-ancestor
24894844|NCT05380154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25108874|NCT03129347|Nalmefene|nalmefene|mesh-list
25108875|NCT03129347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24894845|NCT05380154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879249|NCT04923737|Sensory System Agents|sensory system agents|mesh-ancestor
24879250|NCT04923737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24879251|NCT04923737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24641755|NCT01175161|Copper|copper|mesh-list
24894846|NCT05380154|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24894847|NCT05380154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24894848|NCT05379855|Atropine|atropine|mesh-list
24894849|NCT05379855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24894850|NCT05379855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24894851|NCT05379855|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24894852|NCT05379855|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24894853|NCT05379855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24894854|NCT05379855|Autonomic Agents|autonomic agents|mesh-ancestor
24894856|NCT05379855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894857|NCT05379855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24894858|NCT05379855|Respiratory System Agents|respiratory system agents|mesh-ancestor
24894859|NCT05379855|Mydriatics|mydriatics|mesh-ancestor
24894860|NCT05379855|Parasympatholytics|parasympatholytics|mesh-ancestor
24895559|NCT03895099|Contraceptive Agents|contraceptive agents|mesh-ancestor
24895560|NCT03895099|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24895561|NCT03895099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895562|NCT03895099|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24895563|NCT03895099|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24896222|NCT01117441|Daunorubicin|daunorubicin|mesh-list
24896223|NCT01117441|Asparaginase|asparaginase|mesh-list
24896224|NCT01117441|Mercaptopurine|mercaptopurine|mesh-list
24896225|NCT01117441|Thioguanine|thioguanine|mesh-list
24896226|NCT01117441|Pegaspargase|pegaspargase|mesh-list
24896228|NCT01117441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24896229|NCT01117441|Immunologic Factors|immunologic factors|mesh-ancestor
24613270|NCT01017939|Prednisone|prednisone|mesh-list
24879344|NCT04807673|Paclitaxel|paclitaxel|mesh-list
24879345|NCT04807673|Pembrolizumab|pembrolizumab|mesh-list
24879346|NCT04807673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24879347|NCT04807673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24879348|NCT04807673|Tubulin Modulators|tubulin modulators|mesh-ancestor
24879349|NCT04807673|Antimitotic Agents|antimitotic agents|mesh-ancestor
24896330|NCT04437836|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24500208|NCT00523185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24500210|NCT00523185|Anesthetics|anesthetics|mesh-ancestor
24896332|NCT04437836|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24896333|NCT04437758|Ascorbic Acid|ascorbic acid|mesh-list
24475089|NCT00408798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24815765|NCT02071888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24815766|NCT02071888|Growth Substances|growth substances|mesh-ancestor
24815767|NCT02071888|Growth Inhibitors|growth inhibitors|mesh-ancestor
24815768|NCT02071927|Azacitidine|azacitidine|mesh-list
24815769|NCT02071927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24815770|NCT02071927|Antimetabolites|antimetabolites|mesh-ancestor
24815771|NCT02071927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815772|NCT02071927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24475155|NCT00409227|Urological Agents|urological agents|mesh-ancestor
24475157|NCT00409253|Urapidil|urapidil|mesh-list
24475158|NCT00409253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24475159|NCT00409253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24475160|NCT00409253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24475161|NCT00409253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890948|NCT04478513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24475162|NCT00409253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24879417|NCT04788420|Sorafenib|sorafenib|mesh-list
24475219|NCT00409461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475220|NCT00409461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24475221|NCT00409461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24898224|NCT04416334|Mitosis Modulators|mitosis modulators|mesh-ancestor
24898589|NCT04412148|Glucocorticoids|glucocorticoids|mesh-ancestor
24898676|NCT04411433|Hydroxychloroquine|hydroxychloroquine|mesh-list
24898677|NCT04411433|Favipiravir|favipiravir|mesh-list
24898760|NCT04411069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475784|NCT00411372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24898859|NCT04410211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24898860|NCT04410211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24898861|NCT04410211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898862|NCT04410211|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24898863|NCT04410211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24898864|NCT04410211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24898865|NCT04410211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24898866|NCT04410211|Anesthetics, General|anesthetics, general|mesh-ancestor
24898920|NCT04409223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24898921|NCT04409223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898923|NCT04409483|Lopinavir|lopinavir|mesh-list
24898924|NCT04409483|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24898925|NCT04409483|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24898926|NCT04409483|Protease Inhibitors|protease inhibitors|mesh-ancestor
24898927|NCT04409483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24475915|NCT00412022|Tamoxifen|tamoxifen|mesh-list
24475916|NCT00412022|Zoledronic Acid|zoledronic acid|mesh-list
24879418|NCT04788420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24879419|NCT04788420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24898984|NCT04408144|Hormones|hormones|mesh-ancestor
24898985|NCT04408144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24898986|NCT04408144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898987|NCT04408443|Vitamin D|vitamin d|mesh-list
24898988|NCT04408443|Cholecalciferol|cholecalciferol|mesh-list
24898989|NCT04408443|Vitamins|vitamins|mesh-ancestor
24898990|NCT04408443|Micronutrients|micronutrients|mesh-ancestor
24898991|NCT04408443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898992|NCT04408443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25108894|NCT03129555|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25108895|NCT03129555|Antithrombins|antithrombins|mesh-ancestor
24891048|NCT04477096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25699818|NCT02113241|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25699819|NCT02113241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699820|NCT02113241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25699821|NCT02113241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699822|NCT02113579|Fluorides|fluorides|mesh-list
25699823|NCT02113579|Cariostatic Agents|cariostatic agents|mesh-ancestor
25699824|NCT02113579|Protective Agents|protective agents|mesh-ancestor
24500646|NCT00525278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108896|NCT03129555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25108897|NCT03129555|Protease Inhibitors|protease inhibitors|mesh-ancestor
25108898|NCT03129555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25108899|NCT03129555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108900|NCT03129555|Anticoagulants|anticoagulants|mesh-ancestor
25108901|NCT03129542|Midodrine|midodrine|mesh-list
25108902|NCT03129542|Sympathomimetics|sympathomimetics|mesh-ancestor
25108903|NCT03129542|Autonomic Agents|autonomic agents|mesh-ancestor
25108904|NCT03129542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108905|NCT03129542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108906|NCT03129542|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25108907|NCT03129542|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25108914|NCT03129256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108915|NCT03129256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25108916|NCT03129256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25108917|NCT03129256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108918|NCT03129074|Capecitabine|capecitabine|mesh-list
25108919|NCT03129074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24879489|NCT04727229|Anesthetics|anesthetics|mesh-ancestor
24879490|NCT04727229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24879491|NCT04727229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879492|NCT04727229|Sensory System Agents|sensory system agents|mesh-ancestor
25108920|NCT03129074|Antimetabolites|antimetabolites|mesh-ancestor
25108921|NCT03129074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108922|NCT03129074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108923|NCT03129022|Anesthetics|anesthetics|mesh-list
25108924|NCT03129022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25108925|NCT03129022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108926|NCT03129009|Anesthetics|anesthetics|mesh-list
25108927|NCT03129009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25108928|NCT03129009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108929|NCT03128866|Tranexamic Acid|tranexamic acid|mesh-list
25108930|NCT03128866|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25108931|NCT03128866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24817792|NCT02085603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817793|NCT02085603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899056|NCT04407234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24899057|NCT04407234|Incretins|incretins|mesh-ancestor
24899058|NCT04407234|Hormones|hormones|mesh-ancestor
24899059|NCT04407234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24899060|NCT04407130|Doxycycline|doxycycline|mesh-list
24899061|NCT04407130|Ivermectin|ivermectin|mesh-list
24899062|NCT04407130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24899153|NCT04406506|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24899154|NCT04406506|Erythromycin stearate|erythromycin stearate|mesh-list
24899164|NCT04406259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24899165|NCT04406259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899166|NCT04406259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24899167|NCT04406259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899168|NCT04406259|Vasodilator Agents|vasodilator agents|mesh-ancestor
24899200|NCT04405921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899201|NCT04405921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24476225|NCT00413608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24476226|NCT00413608|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24476227|NCT00413608|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24476228|NCT00413608|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24476287|NCT00413829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24853822|NCT02270437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24476321|NCT00414128|Antitubercular Agents|antitubercular agents|mesh-ancestor
24476426|NCT00414947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476566|NCT00415766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24476567|NCT00415766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476568|NCT00415779|Zoledronic Acid|zoledronic acid|mesh-list
24476570|NCT00415779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25699825|NCT02113579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699826|NCT02114151|Sofosbuvir|sofosbuvir|mesh-list
25699827|NCT02114151|Simeprevir|simeprevir|mesh-list
25699828|NCT02114151|Antiviral Agents|antiviral agents|mesh-ancestor
24476571|NCT00415779|Tubulin Modulators|tubulin modulators|mesh-ancestor
24899775|NCT04400019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24899776|NCT04400019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24899777|NCT04400019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899778|NCT04400019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899779|NCT04400019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24899780|NCT04400136|Lansoprazole|lansoprazole|mesh-list
24899781|NCT04400136|Dexlansoprazole|dexlansoprazole|mesh-list
24879698|NCT04528680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24879699|NCT04528680|Tubulin Modulators|tubulin modulators|mesh-ancestor
24879700|NCT04528680|Antimitotic Agents|antimitotic agents|mesh-ancestor
24879701|NCT04528680|Mitosis Modulators|mitosis modulators|mesh-ancestor
24879702|NCT04528680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108932|NCT03128866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900015|NCT04397770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900016|NCT04397770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24900017|NCT04397770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24900018|NCT04397770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900019|NCT04397601|Bevacizumab|bevacizumab|mesh-list
24900020|NCT04397601|Aflibercept|aflibercept|mesh-list
24900022|NCT04397601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24817933|NCT02086019|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24476782|NCT00416507|Gemcitabine|gemcitabine|mesh-list
24476825|NCT00416650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24476826|NCT00416650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476827|NCT00416650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476828|NCT00416676|Cyclophosphamide|cyclophosphamide|mesh-list
24476829|NCT00416676|Carboplatin|carboplatin|mesh-list
24476830|NCT00416676|Etoposide|etoposide|mesh-list
24476831|NCT00416676|Vincristine|vincristine|mesh-list
24476832|NCT00416676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24476848|NCT00416728|Valsartan|valsartan|mesh-list
24815850|NCT02072291|Nifedipine|nifedipine|mesh-list
24815851|NCT02072291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24815852|NCT02072291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24815853|NCT02072291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815854|NCT02072291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24815855|NCT02072291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815856|NCT02072291|Vasodilator Agents|vasodilator agents|mesh-ancestor
24815857|NCT02072291|Tocolytic Agents|tocolytic agents|mesh-ancestor
24900125|NCT04397393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24900126|NCT04397393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24900127|NCT04397393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24900128|NCT04397393|Anesthetics, General|anesthetics, general|mesh-ancestor
24900129|NCT04397393|Anesthetics|anesthetics|mesh-ancestor
24900130|NCT04397393|GABA Modulators|gaba modulators|mesh-ancestor
24900131|NCT04397393|GABA Agents|gaba agents|mesh-ancestor
24900132|NCT04397393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24786870|NCT01922154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24786871|NCT01922154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24786872|NCT01922193|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24786889|NCT01922427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24786890|NCT01922427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24786892|NCT01922427|Sensory System Agents|sensory system agents|mesh-ancestor
24786893|NCT01922427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108970|NCT03128398|Autonomic Agents|autonomic agents|mesh-ancestor
24900133|NCT04397393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900134|NCT04397289|Heparin|heparin|mesh-list
24900135|NCT04397289|Rivaroxaban|rivaroxaban|mesh-list
24900136|NCT04397289|Anticoagulants|anticoagulants|mesh-ancestor
24900137|NCT04397289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24900145|NCT04397549|Morphine|morphine|mesh-list
24900153|NCT04397328|Hydroxychloroquine|hydroxychloroquine|mesh-list
24900154|NCT04397328|Antimalarials|antimalarials|mesh-ancestor
24900155|NCT04397328|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25699829|NCT02114151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25699830|NCT02114151|Protease Inhibitors|protease inhibitors|mesh-ancestor
25699831|NCT02114151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25699832|NCT02114151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900157|NCT04397328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24900309|NCT04395638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24854114|NCT02271971|Vitamin D|vitamin d|mesh-list
24900311|NCT04395417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24723211|NCT01586013|Propofol|propofol|mesh-list
24900312|NCT04395417|Immunologic Factors|immunologic factors|mesh-ancestor
24880046|NCT04155632|Expectorants|expectorants|mesh-ancestor
24900313|NCT04395417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900314|NCT04395417|Viscosupplements|viscosupplements|mesh-ancestor
24900315|NCT04395417|Protective Agents|protective agents|mesh-ancestor
24900316|NCT04395365|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24900317|NCT04395365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24900318|NCT04395365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24900320|NCT04395365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24900329|NCT04395105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24477220|NCT00417872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24477221|NCT00417872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24477222|NCT00417872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24477224|NCT00417898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24477239|NCT00417911|Bortezomib|bortezomib|mesh-list
24900467|NCT04393610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24900468|NCT04393610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900469|NCT04393610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24900470|NCT04393610|Narcotics|narcotics|mesh-ancestor
24900471|NCT04393610|Analgesics|analgesics|mesh-ancestor
24900472|NCT04393610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24900473|NCT04393610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24900665|NCT04392037|Cyclophosphamide|cyclophosphamide|mesh-list
24900666|NCT04392037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24900667|NCT04392037|Immunologic Factors|immunologic factors|mesh-ancestor
24900668|NCT04392037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900702|NCT04391868|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24900703|NCT04391868|Chelating Agents|chelating agents|mesh-ancestor
24900704|NCT04391868|Sequestering Agents|sequestering agents|mesh-ancestor
24900705|NCT04391868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900706|NCT04391868|Vasodilator Agents|vasodilator agents|mesh-ancestor
24900707|NCT04391868|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24900708|NCT04391868|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24900709|NCT04391868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24880030|NCT04178460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24880031|NCT04178460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880032|NCT04178460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880034|NCT04175925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24880035|NCT04175925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24880036|NCT04175925|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24880037|NCT04175925|Histamine Antagonists|histamine antagonists|mesh-ancestor
24880038|NCT04175925|Histamine Agents|histamine agents|mesh-ancestor
24880039|NCT04175925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24880040|NCT04175925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880041|NCT04175925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880042|NCT04155632|Acetylcysteine|acetylcysteine|mesh-list
24880043|NCT04155632|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24818053|NCT02086838|Iron-Dextran Complex|iron-dextran complex|mesh-list
24818055|NCT02086838|Anticoagulants|anticoagulants|mesh-ancestor
24818056|NCT02086838|Plasma Substitutes|plasma substitutes|mesh-ancestor
24900777|NCT04391361|Sensory System Agents|sensory system agents|mesh-ancestor
24891251|NCT04474093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24891252|NCT04474093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24891253|NCT04474093|Antimanic Agents|antimanic agents|mesh-ancestor
24891258|NCT04473989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900778|NCT04391361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24900779|NCT04391361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24900780|NCT04391361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24900781|NCT04391361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24900782|NCT04391361|Adrenergic Agents|adrenergic agents|mesh-ancestor
24900783|NCT04391361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24900784|NCT04391361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900785|NCT04391361|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24900786|NCT04391361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24900787|NCT04391361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25699833|NCT02114177|Sofosbuvir|sofosbuvir|mesh-list
25699834|NCT02114177|Simeprevir|simeprevir|mesh-list
24501982|NCT00531895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501984|NCT00531895|Sensory System Agents|sensory system agents|mesh-ancestor
24501985|NCT00531895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24501987|NCT00531895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24900788|NCT04391361|Autonomic Agents|autonomic agents|mesh-ancestor
24900789|NCT04391361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24900790|NCT04391361|Respiratory System Agents|respiratory system agents|mesh-ancestor
24900792|NCT04391361|Parasympatholytics|parasympatholytics|mesh-ancestor
24901224|NCT04387500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24901226|NCT04387500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901228|NCT04387630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24901229|NCT04387630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901231|NCT04387201|Hydroxocobalamin|hydroxocobalamin|mesh-list
24901270|NCT04386850|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
24818120|NCT02087007|Respiratory System Agents|respiratory system agents|mesh-ancestor
24818121|NCT02087007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24818122|NCT02087007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24478082|NCT00421447|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25108972|NCT03128398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786905|NCT01922466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24786906|NCT01922466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24786907|NCT01922492|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24786908|NCT01922492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786909|NCT01922596|Ropivacaine|ropivacaine|mesh-list
25109002|NCT03128346|Anesthetics, General|anesthetics, general|mesh-ancestor
25109003|NCT03128346|Anesthetics|anesthetics|mesh-ancestor
24901506|NCT04383977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24901507|NCT04383977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24901508|NCT04383977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24901509|NCT04383977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24901510|NCT04383977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901511|NCT04383977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901512|NCT04383977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24880158|NCT04016753|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
24880159|NCT04016753|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24880160|NCT04016753|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24880161|NCT04016753|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24880162|NCT04016753|Contraceptive Agents|contraceptive agents|mesh-ancestor
24901564|NCT04383418|Adrenergic Agents|adrenergic agents|mesh-ancestor
24901565|NCT04383418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24901592|NCT04382768|Analgesics|analgesics|mesh-ancestor
24446805|NCT00306033|gamma-Globulins|gamma-globulins|mesh-list
24901593|NCT04382768|Sensory System Agents|sensory system agents|mesh-ancestor
24901594|NCT04382768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24901595|NCT04382768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901596|NCT04382768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24901597|NCT04382768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24901598|NCT04382768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24901599|NCT04382768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901600|NCT04382768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901607|NCT04383275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24901608|NCT04382846|Nitazoxanide|nitazoxanide|mesh-list
24901609|NCT04382846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24901610|NCT04382846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24478312|NCT00422318|Uricosuric Agents|uricosuric agents|mesh-ancestor
24901634|NCT04382625|Hydroxychloroquine|hydroxychloroquine|mesh-list
24901635|NCT04382625|Antimalarials|antimalarials|mesh-ancestor
24901636|NCT04382625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24901637|NCT04382625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24901638|NCT04382625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446806|NCT00306033|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24446807|NCT00306033|Immunoglobulins|immunoglobulins|mesh-list
24891367|NCT04472689|Anesthetics|anesthetics|mesh-ancestor
24891368|NCT04472689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25699835|NCT02114177|Antiviral Agents|antiviral agents|mesh-ancestor
25699836|NCT02114177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25699837|NCT02114177|Protease Inhibitors|protease inhibitors|mesh-ancestor
25699838|NCT02114177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25699839|NCT02114177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699840|NCT02114385|Vaccines|vaccines|mesh-list
25699841|NCT02114385|Immunologic Factors|immunologic factors|mesh-ancestor
25699842|NCT02114385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502856|NCT04151667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24891369|NCT04472689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891370|NCT04472689|Sensory System Agents|sensory system agents|mesh-ancestor
24891371|NCT04472689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891372|NCT04472689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24891373|NCT04472689|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24891374|NCT04472689|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24468656|NCT00382538|Luteolytic Agents|luteolytic agents|mesh-ancestor
24891407|NCT04471441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24901639|NCT04382625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24891421|NCT04470908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24880179|NCT03988933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24880180|NCT03988933|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24880181|NCT03988933|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24880182|NCT03988933|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24880183|NCT03988933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24901640|NCT04382625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901641|NCT04382625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24901643|NCT04382443|Gout Suppressants|gout suppressants|mesh-ancestor
24901644|NCT04382443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24901645|NCT04382443|Tubulin Modulators|tubulin modulators|mesh-ancestor
24901646|NCT04382443|Antimitotic Agents|antimitotic agents|mesh-ancestor
24901647|NCT04382443|Mitosis Modulators|mitosis modulators|mesh-ancestor
24818148|NCT02087111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24901690|NCT04382300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24901691|NCT04382300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24901692|NCT04382300|Growth Substances|growth substances|mesh-ancestor
24901693|NCT04382300|Growth Inhibitors|growth inhibitors|mesh-ancestor
24901694|NCT04382300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24901695|NCT04382027|Vitamins|vitamins|mesh-list
24901696|NCT04382027|Vitamin K|vitamin k|mesh-list
24901697|NCT04382027|Vitamin K 2|vitamin k 2|mesh-list
24901698|NCT04382027|Micronutrients|micronutrients|mesh-ancestor
24901699|NCT04382027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901700|NCT04382027|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24901701|NCT04382027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24901703|NCT04382027|Hemostatics|hemostatics|mesh-ancestor
24901714|NCT04381910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901715|NCT04381910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901716|NCT04381910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24901717|NCT04381741|Antibodies|antibodies|mesh-list
24901718|NCT04381741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24901719|NCT04381741|Immunologic Factors|immunologic factors|mesh-ancestor
24901720|NCT04381741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901721|NCT04381520|Antihypertensive Agents|antihypertensive agents|mesh-list
24901722|NCT04382144|Bupivacaine|bupivacaine|mesh-list
24901723|NCT04382144|Anesthetics, Local|anesthetics, local|mesh-ancestor
24901724|NCT04382144|Anesthetics|anesthetics|mesh-ancestor
24901725|NCT04382144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24901726|NCT04382144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901884|NCT04380298|Anesthetics|anesthetics|mesh-ancestor
24901885|NCT04380298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24901886|NCT04380298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902042|NCT04378231|Clavulanic Acids|clavulanic acids|mesh-list
24902043|NCT04378231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24902044|NCT04378231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24902045|NCT04378231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902046|NCT04378231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24902047|NCT04378231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902048|NCT04378231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902049|NCT04378283|Lidocaine|lidocaine|mesh-list
24902192|NCT04376528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24902254|NCT04376216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24902255|NCT04376216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24902256|NCT04375995|Nitric Oxide|nitric oxide|mesh-list
24902257|NCT04375995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24902258|NCT04375995|Autonomic Agents|autonomic agents|mesh-ancestor
24902259|NCT04375995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24902260|NCT04375995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902261|NCT04375995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25699843|NCT02114684|Moxifloxacin|moxifloxacin|mesh-list
25699844|NCT02114684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25699845|NCT02114684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25699846|NCT02114684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25699847|NCT02114684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25699848|NCT02114684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25699849|NCT02114684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810496|NCT02040597|Beclomethasone|beclomethasone|mesh-list
24902262|NCT04375995|Respiratory System Agents|respiratory system agents|mesh-ancestor
24902263|NCT04375995|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24902264|NCT04375995|Antioxidants|antioxidants|mesh-ancestor
24902265|NCT04375995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902266|NCT04375995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24902267|NCT04375995|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24902268|NCT04375995|Vasodilator Agents|vasodilator agents|mesh-ancestor
24902269|NCT04375995|Gasotransmitters|gasotransmitters|mesh-ancestor
24902270|NCT04375995|Protective Agents|protective agents|mesh-ancestor
24902271|NCT04375943|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
24902272|NCT04375943|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24902273|NCT04375943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902274|NCT04375943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902385|NCT04374799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902387|NCT04374279|Androgen Antagonists|androgen antagonists|mesh-ancestor
24902388|NCT04374279|Hormone Antagonists|hormone antagonists|mesh-ancestor
24902389|NCT04374279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24818227|NCT02087527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818228|NCT02087527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24818229|NCT02087527|Glucocorticoids|glucocorticoids|mesh-ancestor
24818230|NCT02087527|Hormones|hormones|mesh-ancestor
24818231|NCT02087527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24818232|NCT02087527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24818233|NCT02087527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24818234|NCT02087540|Telmisartan|telmisartan|mesh-list
24818235|NCT02087540|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24818236|NCT02087540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24818237|NCT02087540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24818238|NCT02087540|Antimetabolites|antimetabolites|mesh-ancestor
24818239|NCT02087540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818240|NCT02087540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24818241|NCT02087540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24818242|NCT02087540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725443|NCT01597765|Vitamins|vitamins|mesh-list
24902390|NCT04374279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902391|NCT04374279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24902392|NCT04374552|Azithromycin|azithromycin|mesh-list
24902393|NCT04374552|Hydroxychloroquine|hydroxychloroquine|mesh-list
24902394|NCT04374552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24902395|NCT04374552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902396|NCT04374552|Antimalarials|antimalarials|mesh-ancestor
24902397|NCT04374552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24902398|NCT04374552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24902401|NCT04374552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24902402|NCT04374071|Methylprednisolone|methylprednisolone|mesh-list
24902404|NCT04374071|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24902405|NCT04374071|Prednisolone|prednisolone|mesh-list
24902406|NCT04374071|Prednisolone acetate|prednisolone acetate|mesh-list
24902407|NCT04374071|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24902408|NCT04374071|Prednisolone phosphate|prednisolone phosphate|mesh-list
24902413|NCT04374071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902414|NCT04374071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24902439|NCT04374006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24902440|NCT04374188|Ciprofloxacin|ciprofloxacin|mesh-list
24902441|NCT04374188|Levofloxacin|levofloxacin|mesh-list
24902443|NCT04374188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24902444|NCT04374188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902445|NCT04374188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24902446|NCT04374188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24902447|NCT04374188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902448|NCT04374188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902449|NCT04374188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24902450|NCT04374188|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25407311|NCT03508726|Micronutrients|micronutrients|mesh-ancestor
24503463|NCT01220583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24902451|NCT04374188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24902452|NCT04374188|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24902453|NCT04374188|Renal Agents|renal agents|mesh-ancestor
25699850|NCT02114684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25699851|NCT02114892|Resveratrol|resveratrol|mesh-list
25699852|NCT02114892|Antioxidants|antioxidants|mesh-ancestor
25699853|NCT02114892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699854|NCT02114892|Protective Agents|protective agents|mesh-ancestor
25699855|NCT02114892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699856|NCT02114892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25699857|NCT02114892|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24902454|NCT04374032|Enkephalin, Methionine|enkephalin, methionine|mesh-list
24902455|NCT04374032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24902456|NCT04374032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902457|NCT04374032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902484|NCT04372849|Insulin|insulin|mesh-list
24902485|NCT04372849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24902486|NCT04372849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902487|NCT04372836|Vasopressins|vasopressins|mesh-list
24902488|NCT04372836|Arginine Vasopressin|arginine vasopressin|mesh-list
24902489|NCT04372836|Hemostatics|hemostatics|mesh-ancestor
24902493|NCT04372836|Natriuretic Agents|natriuretic agents|mesh-ancestor
24902541|NCT04372264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902542|NCT04372264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902543|NCT04372264|Antipyretics|antipyretics|mesh-ancestor
24902544|NCT04372316|Vitamin B 12|vitamin b 12|mesh-list
24902545|NCT04372316|Vitamin B Complex|vitamin b complex|mesh-ancestor
24902546|NCT04372316|Vitamins|vitamins|mesh-ancestor
24902547|NCT04372316|Micronutrients|micronutrients|mesh-ancestor
24902548|NCT04372316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902549|NCT04372407|Itraconazole|itraconazole|mesh-list
24902550|NCT04372407|Antifungal Agents|antifungal agents|mesh-ancestor
24902551|NCT04372407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902552|NCT04372407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24902553|NCT04372407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24902554|NCT04372407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902555|NCT04372407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902556|NCT04372407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24891641|NCT04468685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24902558|NCT04372407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24902559|NCT04372407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902579|NCT04371874|Antipyretics|antipyretics|mesh-ancestor
24902580|NCT04371874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24902581|NCT04371874|Diuretics|diuretics|mesh-ancestor
24902582|NCT04371874|Natriuretic Agents|natriuretic agents|mesh-ancestor
24902583|NCT04371874|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24902584|NCT04371874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24902585|NCT04371874|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24902586|NCT04371874|Protease Inhibitors|protease inhibitors|mesh-ancestor
24902587|NCT04371874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24902588|NCT04371874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24902589|NCT04371874|Vasodilator Agents|vasodilator agents|mesh-ancestor
24786936|NCT01922713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786938|NCT01922713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786939|NCT01922713|Protective Agents|protective agents|mesh-ancestor
24786940|NCT01922713|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24786941|NCT01922713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24786942|NCT01922713|Provitamins|provitamins|mesh-ancestor
24786943|NCT01922765|Amoxicillin|amoxicillin|mesh-list
24891747|NCT04467931|Nebivolol|nebivolol|mesh-list
24891748|NCT04467931|Chlorthalidone|chlorthalidone|mesh-list
24786944|NCT01922765|Metronidazole|metronidazole|mesh-list
24786945|NCT01922765|Clarithromycin|clarithromycin|mesh-list
24786946|NCT01922765|Rabeprazole|rabeprazole|mesh-list
24902613|NCT04372082|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24902614|NCT04372082|Anthelmintics|anthelmintics|mesh-ancestor
24902643|NCT04371601|Oseltamivir|oseltamivir|mesh-list
24902644|NCT04371601|Hormones|hormones|mesh-list
24902645|NCT04371601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25699858|NCT02114931|Adalimumab|adalimumab|mesh-list
25699859|NCT02114931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25699860|NCT02114931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25699861|NCT02115048|Letrozole|letrozole|mesh-list
25699862|NCT02115048|Afatinib|afatinib|mesh-list
24902646|NCT04371601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902648|NCT04371601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902649|NCT04371601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902650|NCT04371601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902651|NCT04371523|Hydroxychloroquine|hydroxychloroquine|mesh-list
24902652|NCT04371523|Antimalarials|antimalarials|mesh-ancestor
24902653|NCT04371523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24902654|NCT04371523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24902655|NCT04371523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902656|NCT04371523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902657|NCT04371523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902677|NCT04371224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24902678|NCT04371224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902679|NCT04371224|Antidotes|antidotes|mesh-ancestor
24902680|NCT04371224|Protective Agents|protective agents|mesh-ancestor
24902681|NCT04371224|Vitamin B Complex|vitamin b complex|mesh-ancestor
24902682|NCT04371224|Vitamins|vitamins|mesh-ancestor
24902683|NCT04371224|Micronutrients|micronutrients|mesh-ancestor
24725734|NCT01599312|Micronutrients|micronutrients|mesh-ancestor
24902684|NCT04371575|Carbamazepine|carbamazepine|mesh-list
24902685|NCT04371575|Oxcarbazepine|oxcarbazepine|mesh-list
24891776|NCT04467931|Guanabenz|guanabenz|mesh-list
24902686|NCT04371575|Anticonvulsants|anticonvulsants|mesh-ancestor
24902687|NCT04371575|Antimanic Agents|antimanic agents|mesh-ancestor
24902688|NCT04371575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24902689|NCT04371575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24902690|NCT04371575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902691|NCT04371575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24902692|NCT04371575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24902694|NCT04371575|Sensory System Agents|sensory system agents|mesh-ancestor
24902695|NCT04371575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24902696|NCT04371575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24902697|NCT04371575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24902698|NCT04371575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902699|NCT04371575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24902700|NCT04371575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24902701|NCT04371575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24902702|NCT04371341|Bupivacaine|bupivacaine|mesh-list
24902703|NCT04371341|Anesthetics, Local|anesthetics, local|mesh-ancestor
24902704|NCT04371341|Anesthetics|anesthetics|mesh-ancestor
24902705|NCT04371341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24902706|NCT04371341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891832|NCT04467931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24891833|NCT04467931|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24891834|NCT04467931|Sympathomimetics|sympathomimetics|mesh-ancestor
24891835|NCT04467931|Urological Agents|urological agents|mesh-ancestor
24891836|NCT04467931|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
24891837|NCT04467931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24891838|NCT04467931|Serotonin Agents|serotonin agents|mesh-ancestor
24891845|NCT04467983|Denosumab|denosumab|mesh-list
24902707|NCT04371341|Sensory System Agents|sensory system agents|mesh-ancestor
24818243|NCT02087540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24818244|NCT02087540|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24818246|NCT02087566|Linezolid|linezolid|mesh-list
24818247|NCT02087566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24818269|NCT02087579|Autonomic Agents|autonomic agents|mesh-ancestor
24818270|NCT02087579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24818271|NCT02087579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24880624|NCT03557840|Temocillin|temocillin|mesh-list
24614488|NCT01024491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24614489|NCT01024491|Serotonin Agents|serotonin agents|mesh-ancestor
24614490|NCT01024491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614491|NCT01024491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24614492|NCT01024491|Antidepressive Agents|antidepressive agents|mesh-ancestor
24614493|NCT01024491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24818275|NCT02087579|Antidepressive Agents|antidepressive agents|mesh-ancestor
24818276|NCT02087579|Dopamine Agonists|dopamine agonists|mesh-ancestor
24818277|NCT02087579|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24818278|NCT02087579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24818279|NCT02087579|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24902708|NCT04371341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24902709|NCT04371367|Avdoralimab|avdoralimab|mesh-list
24902710|NCT04371367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24902711|NCT04371367|Antiviral Agents|antiviral agents|mesh-ancestor
24902712|NCT04371367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902713|NCT04371406|Azithromycin|azithromycin|mesh-list
24902714|NCT04371406|Hydroxychloroquine|hydroxychloroquine|mesh-list
24902715|NCT04371406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24902716|NCT04371406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902717|NCT04371406|Antimalarials|antimalarials|mesh-ancestor
24902748|NCT04370977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24902749|NCT04370977|Antiviral Agents|antiviral agents|mesh-ancestor
24902750|NCT04370977|Schistosomicides|schistosomicides|mesh-ancestor
24902751|NCT04370977|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24902752|NCT04370977|Anthelmintics|anthelmintics|mesh-ancestor
24902753|NCT04370782|Azithromycin|azithromycin|mesh-list
24902754|NCT04370782|Doxycycline|doxycycline|mesh-list
24902756|NCT04370782|Zinc Sulfate|zinc sulfate|mesh-list
24902757|NCT04370782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24902758|NCT04370782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902759|NCT04370782|Antimalarials|antimalarials|mesh-ancestor
24902787|NCT04370262|Famotidine|famotidine|mesh-list
24902788|NCT04370262|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24902789|NCT04370262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24902790|NCT04370262|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24891866|NCT04467450|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24902791|NCT04370262|Histamine Antagonists|histamine antagonists|mesh-ancestor
24902792|NCT04370262|Histamine Agents|histamine agents|mesh-ancestor
24902793|NCT04370262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24902794|NCT04370262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902795|NCT04370262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902796|NCT04370015|Hydroxychloroquine|hydroxychloroquine|mesh-list
24902797|NCT04370015|Antimalarials|antimalarials|mesh-ancestor
24902798|NCT04370015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24902799|NCT04370015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24902800|NCT04370015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902801|NCT04370015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902802|NCT04370015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902803|NCT04370015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24902804|NCT04370288|Ascorbic Acid|ascorbic acid|mesh-list
24902805|NCT04370288|Acetylcysteine|acetylcysteine|mesh-list
24902806|NCT04370288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24902807|NCT04370288|Methylene Blue|methylene blue|mesh-list
24902808|NCT04370288|Vitamins|vitamins|mesh-ancestor
24902809|NCT04370288|Micronutrients|micronutrients|mesh-ancestor
24902810|NCT04370288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902811|NCT04370288|Antioxidants|antioxidants|mesh-ancestor
24902812|NCT04370288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902813|NCT04370288|Protective Agents|protective agents|mesh-ancestor
24902814|NCT04370288|Antiviral Agents|antiviral agents|mesh-ancestor
24902815|NCT04370288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902816|NCT04370288|Expectorants|expectorants|mesh-ancestor
24902817|NCT04370288|Respiratory System Agents|respiratory system agents|mesh-ancestor
24479310|NCT00426348|Antioxidants|antioxidants|mesh-ancestor
24880685|NCT03463993|Hemostatics|hemostatics|mesh-ancestor
24880686|NCT03463993|Coagulants|coagulants|mesh-ancestor
24880687|NCT03418038|Vitamins|vitamins|mesh-list
24880688|NCT03418038|Ascorbic Acid|ascorbic acid|mesh-list
24880689|NCT03418038|Gemcitabine|gemcitabine|mesh-list
24902843|NCT04370080|Protective Agents|protective agents|mesh-ancestor
24902844|NCT04370080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902845|NCT04370392|Anesthetics|anesthetics|mesh-list
24902846|NCT04370392|Anesthetics, Local|anesthetics, local|mesh-list
24902847|NCT04370392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24902848|NCT04370392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902849|NCT04370392|Sensory System Agents|sensory system agents|mesh-ancestor
24902850|NCT04370392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24902851|NCT04369391|Moxifloxacin|moxifloxacin|mesh-list
24902852|NCT04369391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24902853|NCT04369391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902854|NCT04369391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24504378|NCT00535808|Nitroglycerin|nitroglycerin|mesh-list
24902855|NCT04369391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24902856|NCT04369391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902857|NCT04369391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902858|NCT04369391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24902859|NCT04369222|Acetaminophen|acetaminophen|mesh-list
24902860|NCT04369222|Aspirin|aspirin|mesh-list
24902861|NCT04369222|Salicylic Acid|salicylic acid|mesh-list
24902862|NCT04369222|Salicylates|salicylates|mesh-list
24902863|NCT04369222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
24902864|NCT04369222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24880719|NCT03418038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24880720|NCT03418038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24880721|NCT03418038|Protease Inhibitors|protease inhibitors|mesh-ancestor
24880722|NCT03418038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24880723|NCT03418038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880724|NCT03418038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24880725|NCT03418038|Antimetabolites|antimetabolites|mesh-ancestor
24880727|NCT03418038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902865|NCT04369222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24902866|NCT04369222|Analgesics|analgesics|mesh-ancestor
24902867|NCT04369222|Sensory System Agents|sensory system agents|mesh-ancestor
24902868|NCT04369222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24902869|NCT04369222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902870|NCT04369222|Antipyretics|antipyretics|mesh-ancestor
24479358|NCT00426543|Rituximab|rituximab|mesh-list
24902900|NCT04368585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24902901|NCT04368585|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24902902|NCT04368585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902903|NCT04368585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902904|NCT04368585|Antifoaming Agents|antifoaming agents|mesh-ancestor
24902906|NCT04368585|Dermatologic Agents|dermatologic agents|mesh-ancestor
24902907|NCT04368585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24902908|NCT04368585|Immunologic Factors|immunologic factors|mesh-ancestor
24902909|NCT04368585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902910|NCT04368585|Antacids|antacids|mesh-ancestor
24902911|NCT04368585|Antioxidants|antioxidants|mesh-ancestor
24902912|NCT04368585|Protective Agents|protective agents|mesh-ancestor
24902913|NCT04368546|Sunitinib|sunitinib|mesh-list
24902914|NCT04368546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24902915|NCT04368546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24902946|NCT04368598|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24902947|NCT04368598|Antioxidants|antioxidants|mesh-ancestor
24902948|NCT04368598|Protective Agents|protective agents|mesh-ancestor
24902949|NCT04368598|Antidotes|antidotes|mesh-ancestor
24902950|NCT04368520|Vitamin D|vitamin d|mesh-list
24902951|NCT04368520|Ergocalciferols|ergocalciferols|mesh-list
24902952|NCT04368520|Cholecalciferol|cholecalciferol|mesh-list
24902953|NCT04368520|Vitamins|vitamins|mesh-list
24902954|NCT04368520|Micronutrients|micronutrients|mesh-ancestor
24902955|NCT04368520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902956|NCT04368520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24579325|NCT00854477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579326|NCT00854477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24818297|NCT02087722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818298|NCT02087722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24818299|NCT02087813|Methylprednisolone|methylprednisolone|mesh-list
24818300|NCT02087813|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24818301|NCT02087813|Protease Inhibitors|protease inhibitors|mesh-list
24818302|NCT02087813|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
24818303|NCT02087813|Protein C Inhibitor|protein c inhibitor|mesh-list
24818304|NCT02087813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24903000|NCT04367948|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25109009|NCT03127800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25109011|NCT03127800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25109012|NCT03127800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109013|NCT03127800|Analgesics|analgesics|mesh-ancestor
25109014|NCT03127800|Sensory System Agents|sensory system agents|mesh-ancestor
25109015|NCT03127800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25109016|NCT03127605|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25109017|NCT03127605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25699863|NCT02115048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109018|NCT03127605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109019|NCT03127605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25109020|NCT03127371|Nitrous Oxide|nitrous oxide|mesh-list
25109021|NCT03127371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25109023|NCT03127371|Anesthetics|anesthetics|mesh-ancestor
25109024|NCT03127371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24903001|NCT04367948|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24903002|NCT04367948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815925|NCT02072746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880856|NCT03270176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880857|NCT03242382|Palbociclib|palbociclib|mesh-list
24880858|NCT03242382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880859|NCT03242382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24880860|NCT03242382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24880861|NCT03242382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892162|NCT04465175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24892163|NCT04465175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24892164|NCT04465175|Anticonvulsants|anticonvulsants|mesh-ancestor
24892217|NCT04465097|Exemestane|exemestane|mesh-list
24903105|NCT04366739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24903106|NCT04366739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24903107|NCT04366739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24903135|NCT04366089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24903136|NCT04366089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903204|NCT04365270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24903205|NCT04365270|Chelating Agents|chelating agents|mesh-ancestor
24903231|NCT04365309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24903232|NCT04365309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24903233|NCT04365309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903234|NCT04365309|Antipyretics|antipyretics|mesh-ancestor
24903235|NCT04365231|Azithromycin|azithromycin|mesh-list
24903236|NCT04365231|Hydroxychloroquine|hydroxychloroquine|mesh-list
24903237|NCT04365231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24903238|NCT04365231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903239|NCT04365231|Antimalarials|antimalarials|mesh-ancestor
24429831|NCT00245154|Paclitaxel|paclitaxel|mesh-list
24815927|NCT02072746|Dermatologic Agents|dermatologic agents|mesh-ancestor
24815928|NCT02072785|Vincristine|vincristine|mesh-list
24892304|NCT04464135|Retinol acetate|retinol acetate|mesh-list
24815929|NCT02072785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24815930|NCT02072785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479626|NCT00427570|Antimetabolites|antimetabolites|mesh-ancestor
24903362|NCT04364425|Lidocaine|lidocaine|mesh-list
24903363|NCT04364425|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24818337|NCT02088060|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24818338|NCT02088060|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24818339|NCT02088060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24818340|NCT02088060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818341|NCT02088060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24504994|NCT00538889|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24504995|NCT00538889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24504999|NCT00538889|Serotonin Agents|serotonin agents|mesh-ancestor
24818342|NCT02088060|Serotonin Agents|serotonin agents|mesh-ancestor
24818343|NCT02088060|Anticonvulsants|anticonvulsants|mesh-ancestor
24818344|NCT02088398|Ricolinostat|ricolinostat|mesh-list
24818345|NCT02088398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815934|NCT02072785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815937|NCT02072798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24815938|NCT02072798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24815940|NCT02072811|Daunorubicin|daunorubicin|mesh-list
24815941|NCT02072811|Mitoxantrone|mitoxantrone|mesh-list
24815942|NCT02072811|Cladribine|cladribine|mesh-list
24815943|NCT02072811|Lenograstim|lenograstim|mesh-list
24815944|NCT02072811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24815945|NCT02072811|Antimetabolites|antimetabolites|mesh-ancestor
24903410|NCT04364139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24903411|NCT04364139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903412|NCT04364139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24903413|NCT04364139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903414|NCT04364139|Vasodilator Agents|vasodilator agents|mesh-ancestor
24903415|NCT04364139|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24903416|NCT04364139|Sympatholytics|sympatholytics|mesh-ancestor
24903417|NCT04364139|Autonomic Agents|autonomic agents|mesh-ancestor
24903418|NCT04364139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24903419|NCT04364139|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24903420|NCT04364139|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24815946|NCT02072811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815947|NCT02072811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815948|NCT02072811|Antiviral Agents|antiviral agents|mesh-ancestor
24815949|NCT02072811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24815950|NCT02072811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24815951|NCT02072811|Immunologic Factors|immunologic factors|mesh-ancestor
24903424|NCT04364139|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24903425|NCT04364139|Protease Inhibitors|protease inhibitors|mesh-ancestor
24903426|NCT04364139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903450|NCT04364113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24903451|NCT04364113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903452|NCT04364113|Sensory System Agents|sensory system agents|mesh-ancestor
24903455|NCT04364022|Lopinavir|lopinavir|mesh-list
24903456|NCT04364022|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24903457|NCT04364022|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24903458|NCT04364022|Protease Inhibitors|protease inhibitors|mesh-ancestor
24903459|NCT04364022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903460|NCT04364022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903461|NCT04364022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24903462|NCT04364022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24903463|NCT04364022|Antiviral Agents|antiviral agents|mesh-ancestor
24903464|NCT04364022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903465|NCT04364022|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24815964|NCT02072967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815965|NCT02072967|Immunologic Factors|immunologic factors|mesh-ancestor
24892349|NCT04463875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24815966|NCT02072967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815967|NCT02072967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24703299|NCT01470937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24880942|NCT03179605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24880943|NCT03179605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880944|NCT03177291|Pirfenidone|pirfenidone|mesh-list
24880945|NCT03177291|Paclitaxel|paclitaxel|mesh-list
24880946|NCT03177291|Carboplatin|carboplatin|mesh-list
24880947|NCT03177291|Pemetrexed|pemetrexed|mesh-list
25699864|NCT02115048|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25699865|NCT02115048|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25699866|NCT02115048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24880950|NCT03177291|Tubulin Modulators|tubulin modulators|mesh-ancestor
25699867|NCT02115048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699868|NCT02115048|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25699869|NCT02115048|Hormone Antagonists|hormone antagonists|mesh-ancestor
25699870|NCT02115048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24759365|NCT01750866|Lenograstim|lenograstim|mesh-list
24759367|NCT01750866|Glucocorticoids|glucocorticoids|mesh-ancestor
24903466|NCT04364022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24903467|NCT04364035|Vesatolimod|vesatolimod|mesh-list
24903468|NCT04364035|Antiviral Agents|antiviral agents|mesh-ancestor
24903469|NCT04364035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903470|NCT04363866|Hydroxychloroquine|hydroxychloroquine|mesh-list
24903510|NCT04363255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903512|NCT04363359|Immunologic Factors|immunologic factors|mesh-ancestor
24903513|NCT04363359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903514|NCT04363216|Ascorbic Acid|ascorbic acid|mesh-list
24903515|NCT04363216|Vitamins|vitamins|mesh-ancestor
24903516|NCT04363216|Micronutrients|micronutrients|mesh-ancestor
24903517|NCT04363216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903518|NCT04363216|Antioxidants|antioxidants|mesh-ancestor
24903519|NCT04363216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903520|NCT04363216|Protective Agents|protective agents|mesh-ancestor
24903521|NCT04363060|Amoxicillin|amoxicillin|mesh-list
24903522|NCT04363060|Azithromycin|azithromycin|mesh-list
24903523|NCT04363060|Clavulanic Acid|clavulanic acid|mesh-list
24903524|NCT04363060|Clavulanic Acids|clavulanic acids|mesh-list
24903525|NCT04363060|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24903526|NCT04363060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24903527|NCT04363060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903559|NCT04362384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818368|NCT02088450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24818369|NCT02088450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24818370|NCT02088450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24726616|NCT01604811|Tamsulosin|tamsulosin|mesh-list
24903560|NCT04362241|Prednisolone|prednisolone|mesh-list
24903561|NCT04362241|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24903562|NCT04362241|Methylprednisolone|methylprednisolone|mesh-list
24903563|NCT04362241|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24903564|NCT04362241|Prednisolone acetate|prednisolone acetate|mesh-list
24903567|NCT04362241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24903568|NCT04362241|Glucocorticoids|glucocorticoids|mesh-ancestor
24903570|NCT04362241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24479802|NCT00428454|Sirolimus|sirolimus|mesh-list
24903601|NCT04362293|Antisickling Agents|antisickling agents|mesh-ancestor
24903602|NCT04362293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903603|NCT04362293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24903604|NCT04362293|Antimetabolites|antimetabolites|mesh-ancestor
24903605|NCT04362293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24903606|NCT04362293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24903607|NCT04362293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24903608|NCT04362293|Antiviral Agents|antiviral agents|mesh-ancestor
24903609|NCT04362332|Hydroxychloroquine|hydroxychloroquine|mesh-list
24903610|NCT04362332|Chloroquine|chloroquine|mesh-list
24903611|NCT04362332|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24903612|NCT04362332|Antimalarials|antimalarials|mesh-ancestor
24881014|NCT03173053|Renal Agents|renal agents|mesh-ancestor
24903747|NCT04361305|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25699871|NCT02115048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903748|NCT04361305|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25407312|NCT03508726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699872|NCT02115048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25699873|NCT02115113|Everolimus|everolimus|mesh-list
25699874|NCT02115113|Tacrolimus|tacrolimus|mesh-list
24903750|NCT04361305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903751|NCT04361305|Urological Agents|urological agents|mesh-ancestor
24903752|NCT04361370|Bevacizumab|bevacizumab|mesh-list
24903753|NCT04361370|Pembrolizumab|pembrolizumab|mesh-list
24903782|NCT04361474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24903783|NCT04361474|Autonomic Agents|autonomic agents|mesh-ancestor
24903784|NCT04361474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24903793|NCT04361058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24903794|NCT04361058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24903795|NCT04361058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903796|NCT04361409|Gemcitabine|gemcitabine|mesh-list
24903797|NCT04361409|Rituximab|rituximab|mesh-list
24903798|NCT04361409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24903799|NCT04361409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24903816|NCT04360759|Hydroxychloroquine|hydroxychloroquine|mesh-list
24903817|NCT04360759|Chloroquine|chloroquine|mesh-list
24579328|NCT00854503|Simvastatin|simvastatin|mesh-list
24579329|NCT00854503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24579330|NCT00854503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24579331|NCT00854503|Antimetabolites|antimetabolites|mesh-ancestor
24579332|NCT00854503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579333|NCT00854503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24579334|NCT00854503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24579335|NCT00854503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579336|NCT00854529|Bevacizumab|bevacizumab|mesh-list
24579337|NCT00854529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24579338|NCT00854529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24903820|NCT04360759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24903821|NCT04360759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903822|NCT04360759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903823|NCT04360759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903824|NCT04360759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24903825|NCT04360759|Amebicides|amebicides|mesh-ancestor
24903826|NCT04361032|Deferoxamine|deferoxamine|mesh-list
24903827|NCT04361032|Siderophores|siderophores|mesh-ancestor
24903828|NCT04361032|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24903829|NCT04361032|Chelating Agents|chelating agents|mesh-ancestor
24903830|NCT04361032|Sequestering Agents|sequestering agents|mesh-ancestor
24903831|NCT04361032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818371|NCT02088450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881112|NCT03015610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903832|NCT04360941|Palbociclib|palbociclib|mesh-list
24903833|NCT04360941|Avelumab|avelumab|mesh-list
24903834|NCT04360941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24903835|NCT04360941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24903836|NCT04360941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903837|NCT04360941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903838|NCT04360941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24903839|NCT04360824|Enoxaparin|enoxaparin|mesh-list
24903840|NCT04360824|Anticoagulants|anticoagulants|mesh-ancestor
24903841|NCT04360824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25407313|NCT03508726|Antioxidants|antioxidants|mesh-ancestor
25699875|NCT02115113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25699876|NCT02115113|Immunologic Factors|immunologic factors|mesh-ancestor
25699877|NCT02115113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810888|NCT02043223|Protective Agents|protective agents|mesh-ancestor
24810896|NCT02043288|Antiviral Agents|antiviral agents|mesh-ancestor
24810897|NCT02043288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24810898|NCT02043288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24810899|NCT02043288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24903842|NCT04360824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24903843|NCT04360824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109025|NCT03127371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109026|NCT03127371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25109033|NCT03127449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109035|NCT03127631|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25109036|NCT03127631|Atorvastatin|atorvastatin|mesh-list
25109037|NCT03127631|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25109038|NCT03127631|Simvastatin|simvastatin|mesh-list
25109039|NCT03127631|Pravastatin|pravastatin|mesh-list
25109040|NCT03127631|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25109041|NCT03127631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25109042|NCT03127631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25109043|NCT03127631|Analgesics|analgesics|mesh-ancestor
25109044|NCT03127631|Sensory System Agents|sensory system agents|mesh-ancestor
24881158|NCT02977494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109045|NCT03127631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24903949|NCT04360356|Ivermectin|ivermectin|mesh-list
24903950|NCT04360356|Nitazoxanide|nitazoxanide|mesh-list
24903951|NCT04360356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24903952|NCT04360356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903953|NCT04360876|Dexamethasone|dexamethasone|mesh-list
24903986|NCT04359823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24903987|NCT04359823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24903988|NCT04359823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903989|NCT04359576|Hemostatics|hemostatics|mesh-list
24903990|NCT04359576|Coagulants|coagulants|mesh-ancestor
24903991|NCT04359537|Hydroxychloroquine|hydroxychloroquine|mesh-list
24903992|NCT04359537|Antimalarials|antimalarials|mesh-ancestor
24903993|NCT04359537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24903994|NCT04359537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24903995|NCT04359537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903996|NCT04359537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903997|NCT04359537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903998|NCT04359537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24904027|NCT04359199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24893256|NCT04452929|Analgesics|analgesics|mesh-ancestor
24893577|NCT04448028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904028|NCT04359199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24904029|NCT04359199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24904030|NCT04359199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904031|NCT04359095|Tenofovir|tenofovir|mesh-list
24904032|NCT04359095|Emtricitabine|emtricitabine|mesh-list
24904033|NCT04359095|Colchicine|colchicine|mesh-list
24904034|NCT04359095|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24904036|NCT04359095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24904037|NCT04359095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24904038|NCT04359095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24904039|NCT04359095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904040|NCT04359095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904041|NCT04359095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24904042|NCT04359095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25699878|NCT02115113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25699879|NCT02115113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25699880|NCT02115113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699881|NCT02115113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904043|NCT04359095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24904044|NCT04359095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24904045|NCT04359095|Antimetabolites|antimetabolites|mesh-ancestor
24904046|NCT04359095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24904086|NCT04358965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24904087|NCT04358965|Abortifacient Agents|abortifacient agents|mesh-ancestor
24904088|NCT04358965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24904089|NCT04358965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904090|NCT04358965|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24904091|NCT04358965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24904092|NCT04358965|Oxytocics|oxytocics|mesh-ancestor
24904093|NCT04358614|Ritonavir|ritonavir|mesh-list
24904094|NCT04358614|Lopinavir|lopinavir|mesh-list
24904095|NCT04358614|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24536799|NCT00652483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24904097|NCT04358614|Protease Inhibitors|protease inhibitors|mesh-ancestor
24815985|NCT02073149|Chelating Agents|chelating agents|mesh-ancestor
24893942|NCT04446130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893945|NCT04445857|Calcitonin|calcitonin|mesh-list
24894026|NCT04444635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24894027|NCT04444635|Anesthetics, General|anesthetics, general|mesh-ancestor
24894028|NCT04444635|Anesthetics|anesthetics|mesh-ancestor
24894029|NCT04444726|Betamethasone|betamethasone|mesh-list
24818385|NCT02088502|Protective Agents|protective agents|mesh-ancestor
24818386|NCT02088502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818387|NCT02088502|Antidotes|antidotes|mesh-ancestor
24818388|NCT02088502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24818389|NCT02088502|Autonomic Agents|autonomic agents|mesh-ancestor
24818390|NCT02088502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24818391|NCT02088502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24818392|NCT02088502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24818393|NCT02088502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24818394|NCT02088502|Vasodilator Agents|vasodilator agents|mesh-ancestor
24818395|NCT02088502|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24818427|NCT02088684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24818428|NCT02088684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24818429|NCT02088684|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24818430|NCT02088684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24818431|NCT02088684|Hormone Antagonists|hormone antagonists|mesh-ancestor
24818432|NCT02088684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24818433|NCT02088684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818434|NCT02088801|Pyrithione zinc|pyrithione zinc|mesh-list
24818435|NCT02088801|Keratolytic Agents|keratolytic agents|mesh-ancestor
24894189|NCT04443387|Vitamins|vitamins|mesh-ancestor
24818436|NCT02088801|Dermatologic Agents|dermatologic agents|mesh-ancestor
24818437|NCT02088866|Lidocaine|lidocaine|mesh-list
24818438|NCT02088866|Anesthetics, Local|anesthetics, local|mesh-ancestor
24904126|NCT04358770|Fluocortolone|fluocortolone|mesh-list
24904127|NCT04358770|Clocortolone pivalate|clocortolone pivalate|mesh-list
24480178|NCT00430066|Imatinib Mesylate|imatinib mesylate|mesh-list
24904157|NCT04358341|Fluorouracil|fluorouracil|mesh-list
24904158|NCT04358341|Irinotecan|irinotecan|mesh-list
24904159|NCT04358341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24904160|NCT04358341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904161|NCT04358341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24904162|NCT04358341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24904163|NCT04358341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904164|NCT04358341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904166|NCT04358341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24904167|NCT04358341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24904168|NCT04358341|Immunologic Factors|immunologic factors|mesh-ancestor
24904169|NCT04358341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904170|NCT04358341|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24904171|NCT04358432|Ezetimibe|ezetimibe|mesh-list
24904195|NCT04358497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24904196|NCT04358497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25407393|NCT03504410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24894563|NCT04439474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24894613|NCT04438837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894614|NCT04438837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24894615|NCT04438902|Osimertinib|osimertinib|mesh-list
24894616|NCT04438902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894617|NCT04438902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24894618|NCT04438902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24513939|NCT00586430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24904197|NCT04358497|Analgesics|analgesics|mesh-ancestor
24513940|NCT00586430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24513941|NCT00586430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24514058|NCT00587496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514059|NCT00587496|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24894735|NCT05388188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24894736|NCT05388188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24894737|NCT05388188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24894738|NCT05388188|Anesthetics, General|anesthetics, general|mesh-ancestor
24894739|NCT05388188|Anesthetics|anesthetics|mesh-ancestor
24894740|NCT05388123|Rituximab|rituximab|mesh-list
24894817|NCT05387187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24894818|NCT05387187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24894931|NCT05373446|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24851335|NCT02256683|Dabigatran|dabigatran|mesh-list
24514134|NCT00588016|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24904204|NCT04358497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904205|NCT04358497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904206|NCT04358497|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
24904207|NCT04358497|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24904208|NCT04358120|Hyaluronic Acid|hyaluronic acid|mesh-list
24904209|NCT04358120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24904210|NCT04358120|Immunologic Factors|immunologic factors|mesh-ancestor
24904211|NCT04358120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904212|NCT04358120|Viscosupplements|viscosupplements|mesh-ancestor
24904213|NCT04358120|Protective Agents|protective agents|mesh-ancestor
24904214|NCT04358055|Hyaluronic Acid|hyaluronic acid|mesh-list
25699882|NCT02115139|Ipilimumab|ipilimumab|mesh-list
24904215|NCT04358055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24904216|NCT04358055|Immunologic Factors|immunologic factors|mesh-ancestor
24904217|NCT04358055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817234|NCT02082054|Nasal Decongestants|nasal decongestants|mesh-ancestor
24817235|NCT02082054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24817236|NCT02082054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24817237|NCT02082054|Sympathomimetics|sympathomimetics|mesh-ancestor
24817238|NCT02082054|Adrenergic Agents|adrenergic agents|mesh-ancestor
24817239|NCT02082054|Antipruritics|antipruritics|mesh-ancestor
24817240|NCT02082054|Dermatologic Agents|dermatologic agents|mesh-ancestor
24817243|NCT02082054|Histamine Agents|histamine agents|mesh-ancestor
24904219|NCT04358055|Protective Agents|protective agents|mesh-ancestor
24904282|NCT04357002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904283|NCT04357301|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
24904284|NCT04357015|Tranexamic Acid|tranexamic acid|mesh-list
24904285|NCT04357015|Carbetocin|carbetocin|mesh-list
24904286|NCT04357015|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24904287|NCT04357015|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24904288|NCT04357015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904289|NCT04357015|Hemostatics|hemostatics|mesh-ancestor
24904290|NCT04357015|Coagulants|coagulants|mesh-ancestor
24904291|NCT04357015|Oxytocics|oxytocics|mesh-ancestor
24904292|NCT04357015|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24904293|NCT04357015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459572|NCT00345098|Amibegron|amibegron|mesh-list
24904294|NCT04356872|Doxorubicin|doxorubicin|mesh-list
24904341|NCT04356417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904345|NCT04356222|Methotrexate|methotrexate|mesh-list
24904347|NCT04356222|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24904348|NCT04356222|Abortifacient Agents|abortifacient agents|mesh-ancestor
24904349|NCT04356222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24904350|NCT04356222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904351|NCT04356222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24904352|NCT04356222|Antimetabolites|antimetabolites|mesh-ancestor
24904353|NCT04356222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904354|NCT04356222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904355|NCT04356222|Dermatologic Agents|dermatologic agents|mesh-ancestor
24904356|NCT04356222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904357|NCT04356222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24480312|NCT00430443|Annamycin|annamycin|mesh-list
24904381|NCT04356118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24904382|NCT04356118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24904383|NCT04356118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24904384|NCT04356118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24904385|NCT04356118|Growth Substances|growth substances|mesh-ancestor
24904386|NCT04356118|Growth Inhibitors|growth inhibitors|mesh-ancestor
24904387|NCT04356170|Docetaxel|docetaxel|mesh-list
24817284|NCT02082405|Bortezomib|bortezomib|mesh-list
24904388|NCT04356170|Fluorouracil|fluorouracil|mesh-list
24904389|NCT04356170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904390|NCT04356170|Tubulin Modulators|tubulin modulators|mesh-ancestor
24904391|NCT04356170|Antimitotic Agents|antimitotic agents|mesh-ancestor
24904392|NCT04356170|Mitosis Modulators|mitosis modulators|mesh-ancestor
24904393|NCT04356170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699883|NCT02115139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24904394|NCT04356170|Antimetabolites|antimetabolites|mesh-ancestor
25699884|NCT02115139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25699885|NCT02115139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24762631|NCT01768897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25699886|NCT02115139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699887|NCT02115256|Nitroglycerin|nitroglycerin|mesh-list
25699888|NCT02115256|Terbutaline|terbutaline|mesh-list
25699889|NCT02115256|Vasodilator Agents|vasodilator agents|mesh-ancestor
25699890|NCT02115256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24904395|NCT04356170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24904396|NCT04356170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24904397|NCT04356170|Immunologic Factors|immunologic factors|mesh-ancestor
24904398|NCT04356170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904400|NCT04355845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24904401|NCT04355845|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24904402|NCT04355845|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24904403|NCT04355845|Serotonin Agents|serotonin agents|mesh-ancestor
24904404|NCT04355845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24904406|NCT04355845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514559|NCT00591604|Vitamin D|vitamin d|mesh-list
24514560|NCT00591604|Vitamins|vitamins|mesh-ancestor
24514561|NCT00591604|Micronutrients|micronutrients|mesh-ancestor
24514562|NCT00591604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514566|NCT00591617|Narcotics|narcotics|mesh-ancestor
24514587|NCT00591643|Respiratory System Agents|respiratory system agents|mesh-ancestor
24514588|NCT00591643|Mydriatics|mydriatics|mesh-ancestor
24514589|NCT00591643|Sympathomimetics|sympathomimetics|mesh-ancestor
24514590|NCT00591643|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24514591|NCT00591708|Calcium, Dietary|calcium, dietary|mesh-list
24514592|NCT00591708|Citric Acid|citric acid|mesh-list
24904408|NCT04355962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24818456|NCT02088918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818457|NCT02088944|Infliximab|infliximab|mesh-list
24904412|NCT04355962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24904413|NCT04355962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904414|NCT04355949|Vitamin D|vitamin d|mesh-list
24904415|NCT04355949|Ergocalciferols|ergocalciferols|mesh-list
24904416|NCT04355949|Cholecalciferol|cholecalciferol|mesh-list
24904417|NCT04355949|Vitamins|vitamins|mesh-list
24904418|NCT04355949|Folic Acid|folic acid|mesh-list
24904419|NCT04355949|Vitamin B 12|vitamin b 12|mesh-list
24904420|NCT04355949|Hydroxocobalamin|hydroxocobalamin|mesh-list
24904421|NCT04355949|Vitamin B Complex|vitamin b complex|mesh-list
24904422|NCT04355949|Micronutrients|micronutrients|mesh-ancestor
24904423|NCT04355949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904424|NCT04355949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24881398|NCT02546232|Paclitaxel|paclitaxel|mesh-list
24904425|NCT04355949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24904426|NCT04355949|Hematinics|hematinics|mesh-ancestor
24904427|NCT04355936|Telmisartan|telmisartan|mesh-list
24904428|NCT04355936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24904429|NCT04355936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24904430|NCT04355936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24904431|NCT04355936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904432|NCT04355806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24904434|NCT04355806|Vaccines|vaccines|mesh-list
24895189|NCT04879550|Antithrombin III|antithrombin iii|mesh-list
24895190|NCT04879550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24895191|NCT04879550|Protease Inhibitors|protease inhibitors|mesh-ancestor
24514595|NCT00591708|Calcium citrate malate|calcium citrate malate|mesh-list
24514596|NCT00591708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24514597|NCT00591708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514598|NCT00591708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24514599|NCT00591708|Anticoagulants|anticoagulants|mesh-ancestor
24514600|NCT00591708|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24904518|NCT04355247|Prednisolone|prednisolone|mesh-list
24904519|NCT04355247|Prednisolone acetate|prednisolone acetate|mesh-list
24904520|NCT04355247|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24904521|NCT04355247|Prednisolone phosphate|prednisolone phosphate|mesh-list
24904522|NCT04355247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24904523|NCT04355247|Antiemetics|antiemetics|mesh-ancestor
24904524|NCT04355247|Autonomic Agents|autonomic agents|mesh-ancestor
24904525|NCT04355247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24904526|NCT04355247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904527|NCT04355247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24904528|NCT04355247|Glucocorticoids|glucocorticoids|mesh-ancestor
24904529|NCT04355247|Hormones|hormones|mesh-ancestor
24904530|NCT04355247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24904531|NCT04355247|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24904532|NCT04355247|Protective Agents|protective agents|mesh-ancestor
24904564|NCT04355052|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24904565|NCT04355052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904566|NCT04355052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904567|NCT04355052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25699891|NCT02115256|Autonomic Agents|autonomic agents|mesh-ancestor
24904568|NCT04355052|Protease Inhibitors|protease inhibitors|mesh-ancestor
24904569|NCT04355052|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24904576|NCT04354961|Antimitotic Agents|antimitotic agents|mesh-ancestor
24904605|NCT04354805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24904607|NCT04354805|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24904608|NCT04354805|Dopamine Agents|dopamine agents|mesh-ancestor
24904609|NCT04354805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24904610|NCT04354805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904611|NCT04355156|Axitinib|axitinib|mesh-list
24904612|NCT04355156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904613|NCT04355156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24904614|NCT04355156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25109068|NCT03127137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24904615|NCT04355156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904616|NCT04354662|Leucovorin|leucovorin|mesh-list
24904617|NCT04354662|Docetaxel|docetaxel|mesh-list
24904618|NCT04354662|Fluorouracil|fluorouracil|mesh-list
24904619|NCT04354662|Oxaliplatin|oxaliplatin|mesh-list
24904620|NCT04354662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904621|NCT04354662|Tubulin Modulators|tubulin modulators|mesh-ancestor
24904653|NCT04354350|Protease Inhibitors|protease inhibitors|mesh-ancestor
24621398|NCT01062139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24621399|NCT01062139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621400|NCT01062139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621401|NCT01062139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24621402|NCT01062152|Lenalidomide|lenalidomide|mesh-list
24787010|NCT01923077|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24787011|NCT01923077|Simvastatin|simvastatin|mesh-list
24787012|NCT01923077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24787013|NCT01923077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24787014|NCT01923077|Antimetabolites|antimetabolites|mesh-ancestor
24787015|NCT01923077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787020|NCT01923090|Dutasteride|dutasteride|mesh-list
24787021|NCT01923090|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24787022|NCT01923090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25109046|NCT03127631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109047|NCT03127631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25109048|NCT03127631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25109049|NCT03127631|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25109050|NCT03127631|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25109051|NCT03127631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816013|NCT02073552|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24816014|NCT02073552|Antioxidants|antioxidants|mesh-ancestor
24816015|NCT02073552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816016|NCT02073552|Protective Agents|protective agents|mesh-ancestor
24816017|NCT02073552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816046|NCT02073838|Ribavirin|ribavirin|mesh-list
24816047|NCT02073838|Decitabine|decitabine|mesh-list
24611840|NCT01011010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24816048|NCT02073838|Antimetabolites|antimetabolites|mesh-ancestor
24816049|NCT02073838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816057|NCT02073916|Trastuzumab|trastuzumab|mesh-list
24514756|NCT00592670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24514757|NCT00592670|Serotonin Agents|serotonin agents|mesh-ancestor
24514758|NCT00592670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514759|NCT00592670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24514760|NCT00592670|Antidepressive Agents|antidepressive agents|mesh-ancestor
24514761|NCT00592670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24514816|NCT00593060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109063|NCT03127137|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25109064|NCT03127137|Lidocaine|lidocaine|mesh-list
25699892|NCT02115256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699893|NCT02115256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699894|NCT02115256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25699895|NCT02115256|Respiratory System Agents|respiratory system agents|mesh-ancestor
25699896|NCT02115256|Sympathomimetics|sympathomimetics|mesh-ancestor
25699897|NCT02115256|Tocolytic Agents|tocolytic agents|mesh-ancestor
24937867|NCT04024865|Domperidone|domperidone|mesh-list
25109065|NCT03127137|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25109066|NCT03127137|Anesthetics, Local|anesthetics, local|mesh-ancestor
25109069|NCT03127137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109070|NCT03127137|Sensory System Agents|sensory system agents|mesh-ancestor
25109071|NCT03127137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25109072|NCT03127137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25109073|NCT03127137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25109074|NCT03127137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25109075|NCT03127137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25109076|NCT03127137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109077|NCT03127137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25109078|NCT03127137|Glucocorticoids|glucocorticoids|mesh-ancestor
25109079|NCT03127137|Hormones|hormones|mesh-ancestor
25109080|NCT03127137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25109081|NCT03127137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25109082|NCT03127137|Immunologic Factors|immunologic factors|mesh-ancestor
25109083|NCT03127137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25109084|NCT03127319|Docetaxel|docetaxel|mesh-list
24817316|NCT02082652|Etonogestrel|etonogestrel|mesh-list
24817317|NCT02082652|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24895395|NCT04369469|Ravulizumab|ravulizumab|mesh-list
24895396|NCT04369469|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24895397|NCT04369469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24895403|NCT04278053|Inositol|inositol|mesh-list
24895424|NCT04125927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895425|NCT04119180|Midazolam|midazolam|mesh-list
24895426|NCT04119180|Ketamine|ketamine|mesh-list
24895427|NCT04119180|Analgesics|analgesics|mesh-ancestor
24895428|NCT04119180|Sensory System Agents|sensory system agents|mesh-ancestor
24816061|NCT02073916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109090|NCT03127319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109092|NCT03127319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25109093|NCT03127345|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25109094|NCT03127345|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24881513|NCT02101853|Asparaginase|asparaginase|mesh-list
24881514|NCT02101853|Mitoxantrone|mitoxantrone|mesh-list
24881515|NCT02101853|Mercaptopurine|mercaptopurine|mesh-list
24881516|NCT02101853|Pegaspargase|pegaspargase|mesh-list
24904762|NCT04353336|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24904763|NCT04353336|Antimalarials|antimalarials|mesh-ancestor
24895552|NCT03900949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24895553|NCT03900949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24817319|NCT02082652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24817320|NCT02082652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817321|NCT02082652|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24817323|NCT02082665|Midazolam|midazolam|mesh-list
24817324|NCT02082665|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24817325|NCT02082665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24817326|NCT02082665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24817327|NCT02082665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24895580|NCT03878199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24895581|NCT03878199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24895582|NCT03878199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24895583|NCT03878199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24895584|NCT03851159|Mannitol|mannitol|mesh-list
24895585|NCT03851159|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24895586|NCT03851159|Diuretics|diuretics|mesh-ancestor
24895587|NCT03851159|Natriuretic Agents|natriuretic agents|mesh-ancestor
24895588|NCT03851159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895589|NCT03840967|Niraparib|niraparib|mesh-list
24895590|NCT03840967|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24895591|NCT03840967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904764|NCT04353336|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24904765|NCT04353336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24904766|NCT04353336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24904767|NCT04353336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904768|NCT04353336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904769|NCT04353336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24904770|NCT04353336|Amebicides|amebicides|mesh-ancestor
24904771|NCT04353336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24904772|NCT04353336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24904773|NCT04353336|Analgesics|analgesics|mesh-ancestor
24904774|NCT04353336|Sensory System Agents|sensory system agents|mesh-ancestor
24904783|NCT04352959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904796|NCT04353024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904798|NCT04353193|Octreotide|octreotide|mesh-list
24904799|NCT04353193|Terlipressin|terlipressin|mesh-list
24904800|NCT04353193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24904801|NCT04353193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24904802|NCT04353193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904868|NCT04352400|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24904869|NCT04352400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24904870|NCT04352400|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24904871|NCT04352400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24904872|NCT04352400|Immunologic Factors|immunologic factors|mesh-ancestor
24904874|NCT04352153|Citric Acid|citric acid|mesh-list
24904875|NCT04352153|Anticoagulants|anticoagulants|mesh-ancestor
24904876|NCT04352153|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24855702|NCT02280616|Hormones|hormones|mesh-ancestor
24480763|NCT00432068|Octreotide|octreotide|mesh-list
24480794|NCT00432198|Zolpidem|zolpidem|mesh-list
24480795|NCT00432198|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24623621|NCT01072812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24623622|NCT01072812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623623|NCT01072890|Sirolimus|sirolimus|mesh-list
24515100|NCT00594542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24895698|NCT03474276|Antiparasitic Agents|antiparasitic agents|mesh-list
24895699|NCT03474276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24895700|NCT03474276|Anthelmintics|anthelmintics|mesh-ancestor
24895701|NCT03474276|Anticestodal Agents|anticestodal agents|mesh-ancestor
24895702|NCT03474276|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24904981|NCT04351867|Oxaliplatin|oxaliplatin|mesh-list
24904982|NCT04351867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904983|NCT04351867|Tubulin Modulators|tubulin modulators|mesh-ancestor
24904984|NCT04351867|Antimitotic Agents|antimitotic agents|mesh-ancestor
24904985|NCT04351867|Mitosis Modulators|mitosis modulators|mesh-ancestor
24905030|NCT04351308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905031|NCT04351308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24905032|NCT04351308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905033|NCT04351308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905034|NCT04351516|Hydroxychloroquine|hydroxychloroquine|mesh-list
24905035|NCT04351516|Antimalarials|antimalarials|mesh-ancestor
24905036|NCT04351516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24905037|NCT04351516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24905038|NCT04351516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905039|NCT04351516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905040|NCT04351516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905044|NCT04351256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905045|NCT04351490|Cholecalciferol|cholecalciferol|mesh-list
24905046|NCT04351490|Vitamin D|vitamin d|mesh-list
24905047|NCT04351490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24905048|NCT04351490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905049|NCT04351490|Vitamins|vitamins|mesh-ancestor
24905050|NCT04351490|Micronutrients|micronutrients|mesh-ancestor
24905051|NCT04351490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24905052|NCT04351191|Hydroxychloroquine|hydroxychloroquine|mesh-list
24905053|NCT04351191|Chloroquine|chloroquine|mesh-list
24905054|NCT04351191|Antimalarials|antimalarials|mesh-ancestor
24905055|NCT04351191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24905056|NCT04351191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24905057|NCT04351191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24480936|NCT00432757|Histamine Agents|histamine agents|mesh-ancestor
24905093|NCT04350320|Tubulin Modulators|tubulin modulators|mesh-ancestor
24905094|NCT04350320|Antimitotic Agents|antimitotic agents|mesh-ancestor
24905095|NCT04350320|Mitosis Modulators|mitosis modulators|mesh-ancestor
24480989|NCT00433069|Ribavirin|ribavirin|mesh-list
24905129|NCT04350502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905130|NCT04350502|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24905132|NCT04350684|Ritonavir|ritonavir|mesh-list
24905133|NCT04350684|Lopinavir|lopinavir|mesh-list
24905134|NCT04350684|Interferon-beta|interferon-beta|mesh-list
24905136|NCT04350684|Hydroxychloroquine|hydroxychloroquine|mesh-list
24905137|NCT04350684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905138|NCT04350684|Antiviral Agents|antiviral agents|mesh-ancestor
24905171|NCT04350671|Antiviral Agents|antiviral agents|mesh-ancestor
24905172|NCT04350671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905173|NCT04350671|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24905223|NCT04350281|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24905225|NCT04349930|Anticonvulsants|anticonvulsants|mesh-ancestor
24905226|NCT04349592|Azithromycin|azithromycin|mesh-list
24905227|NCT04349592|Hydroxychloroquine|hydroxychloroquine|mesh-list
24905228|NCT04349592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24905229|NCT04349592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905230|NCT04349592|Antimalarials|antimalarials|mesh-ancestor
24905231|NCT04349592|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24905232|NCT04349592|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24905233|NCT04349592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623639|NCT01072942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623640|NCT01072942|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24623641|NCT01072942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24623643|NCT01072955|Calcium heparin|calcium heparin|mesh-list
24623644|NCT01072955|Anticoagulants|anticoagulants|mesh-ancestor
24623645|NCT01072955|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24623646|NCT01072955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24623647|NCT01072955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816077|NCT02074137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905376|NCT04348006|Growth Inhibitors|growth inhibitors|mesh-ancestor
24905377|NCT04347733|Triamcinolone|triamcinolone|mesh-list
24905378|NCT04347733|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24905379|NCT04347733|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24905380|NCT04347733|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24515398|NCT00596609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515399|NCT00596609|Analgesics|analgesics|mesh-ancestor
24515400|NCT00596609|Sensory System Agents|sensory system agents|mesh-ancestor
24515401|NCT00596609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24515402|NCT00596648|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24515403|NCT00596648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24515404|NCT00596648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24905389|NCT04347733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905390|NCT04347902|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
24905391|NCT04347902|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24905392|NCT04347902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24905393|NCT04348045|Durvalumab|durvalumab|mesh-list
24905394|NCT04348045|Olaparib|olaparib|mesh-list
24905395|NCT04348045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24905396|NCT04348045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905397|NCT04348045|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24905398|NCT04348045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855932|NCT02281929|Hormones|hormones|mesh-ancestor
24905404|NCT04347889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905565|NCT04346589|Immunologic Factors|immunologic factors|mesh-ancestor
24905566|NCT04346589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905641|NCT04345848|Enoxaparin|enoxaparin|mesh-list
24905642|NCT04345848|Calcium heparin|calcium heparin|mesh-list
24905643|NCT04345848|Anticoagulants|anticoagulants|mesh-ancestor
24905644|NCT04345848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24905645|NCT04345848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24905646|NCT04345848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905647|NCT04345783|Apatinib|apatinib|mesh-list
24905648|NCT04345783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905649|NCT04345783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24905650|NCT04345783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25109097|NCT03127189|Rilpivirine|rilpivirine|mesh-list
24905651|NCT04345783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905652|NCT04345432|Gabapentin|gabapentin|mesh-list
24905653|NCT04345432|Analgesics|analgesics|mesh-ancestor
24905654|NCT04345432|Sensory System Agents|sensory system agents|mesh-ancestor
24905685|NCT04345445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24905686|NCT04345445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905687|NCT04345445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24905689|NCT04345445|Hormones|hormones|mesh-ancestor
25075972|NCT03376932|Tocolytic Agents|tocolytic agents|mesh-ancestor
25075974|NCT03376932|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25075975|NCT03376932|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25075976|NCT03376932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25075977|NCT03376932|Adrenergic Agents|adrenergic agents|mesh-ancestor
25075978|NCT03376854|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
25075979|NCT03376854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25075980|NCT03376854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24626481|NCT01087567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24881894|NCT00593567|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24881896|NCT00593567|Renal Agents|renal agents|mesh-ancestor
25076051|NCT03376178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076052|NCT03376178|Sensory System Agents|sensory system agents|mesh-ancestor
25076053|NCT03376178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076054|NCT03376178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24626482|NCT01087567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24626483|NCT01087567|Immunologic Factors|immunologic factors|mesh-ancestor
24626485|NCT01087580|Docetaxel|docetaxel|mesh-list
24626486|NCT01087580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626487|NCT01087580|Tubulin Modulators|tubulin modulators|mesh-ancestor
24626488|NCT01087580|Antimitotic Agents|antimitotic agents|mesh-ancestor
24626490|NCT01087580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626492|NCT01087580|Glucocorticoids|glucocorticoids|mesh-ancestor
24626493|NCT01087580|Hormones|hormones|mesh-ancestor
24817362|NCT02083055|Vasodilator Agents|vasodilator agents|mesh-ancestor
25076066|NCT03376048|Ropivacaine|ropivacaine|mesh-list
25076067|NCT03376048|Anesthetics, Local|anesthetics, local|mesh-ancestor
25076068|NCT03376048|Anesthetics|anesthetics|mesh-ancestor
25076069|NCT03376048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25076070|NCT03376048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076071|NCT03376048|Sensory System Agents|sensory system agents|mesh-ancestor
25076072|NCT03376048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076073|NCT03375996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25076074|NCT03375996|Cyclopentolate|cyclopentolate|mesh-list
25076075|NCT03375996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25076112|NCT03375671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25076113|NCT03375671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25076114|NCT03375671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25076115|NCT03375671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25076116|NCT03375671|GABA Modulators|gaba modulators|mesh-ancestor
25076117|NCT03375671|GABA Agents|gaba agents|mesh-ancestor
25076118|NCT03375671|Antiemetics|antiemetics|mesh-ancestor
25076119|NCT03375671|Autonomic Agents|autonomic agents|mesh-ancestor
25076120|NCT03375671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25076121|NCT03375671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25076245|NCT03374540|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24896360|NCT04437004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896361|NCT04437004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24896405|NCT04437160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25076246|NCT03374540|Protease Inhibitors|protease inhibitors|mesh-ancestor
25076247|NCT03374540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25076248|NCT03374540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076249|NCT03374540|Anticoagulants|anticoagulants|mesh-ancestor
25076250|NCT03374540|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25076251|NCT03374540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25699898|NCT02115256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25699899|NCT02115256|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25699900|NCT02115256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25699901|NCT02115256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25076252|NCT03374540|Hemostatics|hemostatics|mesh-ancestor
25699902|NCT02115256|Adrenergic Agents|adrenergic agents|mesh-ancestor
25076275|NCT03374306|Lubricant Eye Drops|lubricant eye drops|mesh-list
25076276|NCT03374306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24962209|NCT03801629|Analgesics|analgesics|mesh-ancestor
25076277|NCT03374306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25076278|NCT03374306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25076279|NCT03374306|Autonomic Agents|autonomic agents|mesh-ancestor
25076280|NCT03374306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076281|NCT03374306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076282|NCT03374306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25076283|NCT03374306|Respiratory System Agents|respiratory system agents|mesh-ancestor
25076284|NCT03374306|Mydriatics|mydriatics|mesh-ancestor
25076285|NCT03374306|Parasympatholytics|parasympatholytics|mesh-ancestor
25076286|NCT03374306|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25076287|NCT03374306|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25076288|NCT03374306|Cholinergic Agents|cholinergic agents|mesh-ancestor
24454367|NCT03978624|Pembrolizumab|pembrolizumab|mesh-list
24454368|NCT03978624|Entinostat|entinostat|mesh-list
24454369|NCT03978624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24454370|NCT03978624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24454371|NCT03978624|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24454372|NCT03978624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24454373|NCT03978624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24454374|NCT03975439|Chrysarobin|chrysarobin|mesh-list
24954417|NCT03876899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954418|NCT03876899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24954419|NCT03876899|Dermatologic Agents|dermatologic agents|mesh-ancestor
24882268|NCT01962792|Autonomic Agents|autonomic agents|mesh-ancestor
24882269|NCT01962792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24882270|NCT01962792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882271|NCT01962792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24882272|NCT01962792|Glucocorticoids|glucocorticoids|mesh-ancestor
24954420|NCT03876704|Vitamins|vitamins|mesh-list
24954421|NCT03876704|Micronutrients|micronutrients|mesh-ancestor
24954455|NCT03876886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24882296|NCT01850108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24954456|NCT03876886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25699911|NCT02115282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25699912|NCT02115282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25699913|NCT02115282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699914|NCT02115282|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25699915|NCT02115282|Hormone Antagonists|hormone antagonists|mesh-ancestor
25699916|NCT02115282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25699917|NCT02115282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699918|NCT02115282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25699919|NCT02115308|Regadenoson|regadenoson|mesh-list
25699920|NCT02115308|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25699921|NCT02115308|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25699922|NCT02115308|Purinergic Agonists|purinergic agonists|mesh-ancestor
24954458|NCT03876886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24954459|NCT03876886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24954460|NCT03876886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24954461|NCT03876886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24780111|NCT01881763|Ketamine|ketamine|mesh-list
24954462|NCT03876886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24954484|NCT03876548|Cadexomer iodine|cadexomer iodine|mesh-list
24954485|NCT03876548|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24954486|NCT03876548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24954487|NCT03876548|Trace Elements|trace elements|mesh-ancestor
24954488|NCT03876548|Micronutrients|micronutrients|mesh-ancestor
24954489|NCT03876548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954490|NCT03876587|Docetaxel|docetaxel|mesh-list
25076362|NCT03373708|Cyclophosphamide|cyclophosphamide|mesh-list
25076364|NCT03373708|Letrozole|letrozole|mesh-list
25076365|NCT03373708|Epirubicin|epirubicin|mesh-list
25076368|NCT03373708|Immunologic Factors|immunologic factors|mesh-ancestor
25076369|NCT03373708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076370|NCT03373708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25076371|NCT03373708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25076372|NCT03373708|Alkylating Agents|alkylating agents|mesh-ancestor
25076373|NCT03373708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076374|NCT03373708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25076405|NCT03373409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25076406|NCT03373409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25076407|NCT03373409|Adrenergic Agents|adrenergic agents|mesh-ancestor
25076408|NCT03373409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25076409|NCT03373409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076410|NCT03373318|Plasma-lyte 148|plasma-lyte 148|mesh-list
25076411|NCT03373318|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25076412|NCT03373318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24896781|NCT04432714|Etoposide|etoposide|mesh-list
24896782|NCT04432714|Vincristine|vincristine|mesh-list
24896783|NCT04432714|Lenalidomide|lenalidomide|mesh-list
24896784|NCT04432714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24896785|NCT04432714|Immunologic Factors|immunologic factors|mesh-ancestor
24896786|NCT04432714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076413|NCT03373305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24882387|NCT00950989|Vitamin B Complex|vitamin b complex|mesh-ancestor
24882388|NCT00950989|Vitamins|vitamins|mesh-ancestor
24454375|NCT03975439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24454376|NCT03975439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24454377|NCT03975439|Analgesics|analgesics|mesh-ancestor
24454378|NCT03975439|Sensory System Agents|sensory system agents|mesh-ancestor
24454379|NCT03975439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076424|NCT03373305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25076425|NCT03373305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25076426|NCT03373305|Growth Substances|growth substances|mesh-ancestor
25076428|NCT03373305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25076429|NCT03373305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25076430|NCT03373305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076431|NCT03373305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25076433|NCT03373266|Sevoflurane|sevoflurane|mesh-list
25076435|NCT03373266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24516181|NCT00600847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24516182|NCT00600873|Pramipexole|pramipexole|mesh-list
25076436|NCT03373266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076437|NCT03373266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25076438|NCT03373266|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25076439|NCT03373266|Anesthetics, General|anesthetics, general|mesh-ancestor
25076440|NCT03373227|Tacrolimus|tacrolimus|mesh-list
25076441|NCT03373227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25076442|NCT03373227|Immunologic Factors|immunologic factors|mesh-ancestor
25699923|NCT02115308|Purinergic Agents|purinergic agents|mesh-ancestor
25076478|NCT03372785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25076481|NCT03372785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25076482|NCT03372785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25076483|NCT03372785|Antipyretics|antipyretics|mesh-ancestor
25076484|NCT03372785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25076485|NCT03372785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25076486|NCT03372785|Antimetabolites|antimetabolites|mesh-ancestor
25076487|NCT03372785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25076488|NCT03372785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25076489|NCT03372785|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25076490|NCT03372785|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25076491|NCT03372785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25076492|NCT03372785|Purinergic Agents|purinergic agents|mesh-ancestor
25076493|NCT03372785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25076494|NCT03372785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25076495|NCT03372785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25076496|NCT03372785|Sympatholytics|sympatholytics|mesh-ancestor
25076497|NCT03372785|Autonomic Agents|autonomic agents|mesh-ancestor
25076498|NCT03372785|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25076499|NCT03372785|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25076500|NCT03372785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25076501|NCT03372785|Adrenergic Agents|adrenergic agents|mesh-ancestor
25076502|NCT03372681|Antidiarrheals|antidiarrheals|mesh-list
25699924|NCT02115308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25699925|NCT02115308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699926|NCT02115308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076522|NCT03372473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25076523|NCT03372473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076524|NCT03372473|Antipruritics|antipruritics|mesh-ancestor
25076525|NCT03372473|Dermatologic Agents|dermatologic agents|mesh-ancestor
25076526|NCT03372473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25076527|NCT03372473|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25076528|NCT03372473|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25076529|NCT03372473|Histamine Antagonists|histamine antagonists|mesh-ancestor
25076530|NCT03372473|Histamine Agents|histamine agents|mesh-ancestor
25076534|NCT03372447|Hydroxocobalamin|hydroxocobalamin|mesh-list
25076535|NCT03372447|Vitamin B 12|vitamin b 12|mesh-list
25076536|NCT03372447|Vitamin B Complex|vitamin b complex|mesh-ancestor
25076538|NCT03372447|Micronutrients|micronutrients|mesh-ancestor
24516276|NCT00601302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516277|NCT00601302|Vasodilator Agents|vasodilator agents|mesh-ancestor
24516278|NCT00601315|Clarithromycin|clarithromycin|mesh-list
24516279|NCT00601315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25076539|NCT03372447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076540|NCT03372447|Hematinics|hematinics|mesh-ancestor
25076541|NCT03372304|Ropivacaine|ropivacaine|mesh-list
25076542|NCT03372304|Anesthetics, Local|anesthetics, local|mesh-ancestor
25076543|NCT03372304|Anesthetics|anesthetics|mesh-ancestor
25076544|NCT03372304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25076545|NCT03372304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076546|NCT03372304|Sensory System Agents|sensory system agents|mesh-ancestor
25076547|NCT03372304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076548|NCT03372265|Ropivacaine|ropivacaine|mesh-list
25076549|NCT03372265|Anesthetics, Local|anesthetics, local|mesh-ancestor
25076550|NCT03372265|Anesthetics|anesthetics|mesh-ancestor
25076551|NCT03372265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25076552|NCT03372265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076553|NCT03372265|Sensory System Agents|sensory system agents|mesh-ancestor
25076554|NCT03372265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076555|NCT03372239|Tryptophan|tryptophan|mesh-list
25076556|NCT03372239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25076557|NCT03372239|Antidepressive Agents|antidepressive agents|mesh-ancestor
25076558|NCT03372239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25076559|NCT03372200|Febuxostat|febuxostat|mesh-list
25076560|NCT03372200|Dotinurad|dotinurad|mesh-list
25076561|NCT03372200|Gout Suppressants|gout suppressants|mesh-ancestor
25076562|NCT03372200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25076563|NCT03372200|Uricosuric Agents|uricosuric agents|mesh-ancestor
25076565|NCT03372122|Chlorhexidine|chlorhexidine|mesh-list
25076566|NCT03372122|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24882506|NCT05169801|Paclitaxel|paclitaxel|mesh-list
24516309|NCT00601510|Capecitabine|capecitabine|mesh-list
25076567|NCT03372122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25076576|NCT03372109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076578|NCT03371992|Pembrolizumab|pembrolizumab|mesh-list
25076579|NCT03371992|Nivolumab|nivolumab|mesh-list
25076580|NCT03371992|Atezolizumab|atezolizumab|mesh-list
25076581|NCT03371992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25076582|NCT03371992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25076583|NCT03371992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25076584|NCT03371992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076585|NCT03371953|Atracurium|atracurium|mesh-list
25076592|NCT03371953|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25076593|NCT03371953|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25076594|NCT03371953|Cholinergic Agents|cholinergic agents|mesh-ancestor
24954494|NCT03876587|Mitosis Modulators|mitosis modulators|mesh-ancestor
25076595|NCT03371953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25076596|NCT03371953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954495|NCT03876587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954496|NCT03876574|Gemcitabine|gemcitabine|mesh-list
24954497|NCT03876574|Dexamethasone|dexamethasone|mesh-list
24954498|NCT03876574|Floxuridine|floxuridine|mesh-list
24954503|NCT03876574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954542|NCT03876067|Cardioplegic Solutions|cardioplegic solutions|mesh-list
24954504|NCT03876574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24954505|NCT03876574|Glucocorticoids|glucocorticoids|mesh-ancestor
24954506|NCT03876574|Hormones|hormones|mesh-ancestor
24954507|NCT03876574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24954508|NCT03876574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24954509|NCT03876574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24954510|NCT03876574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24954511|NCT03876574|Antimetabolites|antimetabolites|mesh-ancestor
24954512|NCT03876574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954514|NCT03876574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24954515|NCT03876574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25699927|NCT02115321|Grazoprevir|grazoprevir|mesh-list
25699928|NCT02115321|Antiviral Agents|antiviral agents|mesh-ancestor
25699929|NCT02115321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25699930|NCT02115347|Ertugliflozin|ertugliflozin|mesh-list
25699931|NCT02115347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25699932|NCT02115347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699933|NCT02115347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25699934|NCT02115347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699935|NCT02115581|Ubiquinone|ubiquinone|mesh-list
25699936|NCT02115581|Coenzyme Q10|coenzyme q10|mesh-list
25699937|NCT02115581|Micronutrients|micronutrients|mesh-ancestor
25699938|NCT02115581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699939|NCT02115581|Vitamins|vitamins|mesh-ancestor
25699940|NCT02115750|Etanercept|etanercept|mesh-list
25699941|NCT02115750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24954532|NCT03876041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24954533|NCT03876041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24954534|NCT03876041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24954535|NCT03876041|Protease Inhibitors|protease inhibitors|mesh-ancestor
24954536|NCT03876041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24954537|NCT03876041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954538|NCT03876041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24954539|NCT03876041|Protective Agents|protective agents|mesh-ancestor
24954540|NCT03875963|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24954541|NCT03875963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24954543|NCT03876067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24954544|NCT03875911|Mitomycins|mitomycins|mesh-list
25076597|NCT03371862|Liraglutide|liraglutide|mesh-list
25076598|NCT03371862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25076599|NCT03371862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076600|NCT03371862|Incretins|incretins|mesh-ancestor
25076601|NCT03371862|Hormones|hormones|mesh-ancestor
25076602|NCT03371862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25076603|NCT03371849|Montelukast|montelukast|mesh-list
25076604|NCT03371849|Levocetirizine|levocetirizine|mesh-list
25076605|NCT03371849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25076606|NCT03371849|Respiratory System Agents|respiratory system agents|mesh-ancestor
25076607|NCT03371849|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25076608|NCT03371849|Hormone Antagonists|hormone antagonists|mesh-ancestor
25076609|NCT03371849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25076622|NCT03371797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25076623|NCT03371797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25076624|NCT03371797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076625|NCT03371797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25076626|NCT03371797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076627|NCT03371797|Vasodilator Agents|vasodilator agents|mesh-ancestor
25076628|NCT03371797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24882618|NCT05168059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24882619|NCT05168059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882620|NCT05168007|Cariprazine|cariprazine|mesh-list
24882621|NCT05168007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24882636|NCT05167175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24882637|NCT05167175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882638|NCT05167175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24882639|NCT05167175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516551|NCT00602394|Antimanic Agents|antimanic agents|mesh-ancestor
24447922|NCT00309881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24447923|NCT00309881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24447924|NCT00309881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24447926|NCT00309881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24447927|NCT00309881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24447928|NCT00309881|Glucocorticoids|glucocorticoids|mesh-ancestor
24447929|NCT00309881|Hormones|hormones|mesh-ancestor
24447930|NCT00309881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24447931|NCT00309881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24447932|NCT00309881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24447933|NCT00309881|Tubulin Modulators|tubulin modulators|mesh-ancestor
24447934|NCT00309881|Antimitotic Agents|antimitotic agents|mesh-ancestor
24447935|NCT00309881|Mitosis Modulators|mitosis modulators|mesh-ancestor
24447936|NCT00309894|Ketoconazole|ketoconazole|mesh-list
24447937|NCT00309894|Hydrocortisone|hydrocortisone|mesh-list
24447939|NCT00309894|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24447946|NCT00309894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24447947|NCT00309894|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25076645|NCT03371563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25076646|NCT03371550|Docetaxel|docetaxel|mesh-list
24817651|NCT02084875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076654|NCT03371498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25076655|NCT03371498|Prednisolone|prednisolone|mesh-list
24882660|NCT05166538|Ticagrelor|ticagrelor|mesh-list
25076677|NCT03371342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25076678|NCT03371342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076679|NCT03371342|Cholinergic Agents|cholinergic agents|mesh-ancestor
25699942|NCT02115750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25699943|NCT02115750|Analgesics|analgesics|mesh-ancestor
25699944|NCT02115750|Sensory System Agents|sensory system agents|mesh-ancestor
25699945|NCT02115750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076686|NCT03371095|Cyclophosphamide|cyclophosphamide|mesh-list
24882666|NCT05166538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24882667|NCT05166538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882668|NCT05166538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882669|NCT05161429|Insulin|insulin|mesh-list
24882670|NCT05161429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24882671|NCT05161429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882672|NCT05148975|Dimercaprol|dimercaprol|mesh-list
24882673|NCT05148975|Chelating Agents|chelating agents|mesh-ancestor
25076695|NCT03371095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25076696|NCT03371095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25076697|NCT03371095|Dermatologic Agents|dermatologic agents|mesh-ancestor
25076698|NCT03371095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25076699|NCT03371069|Methylphenidate|methylphenidate|mesh-list
25076700|NCT03371069|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25076701|NCT03371069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076702|NCT03371069|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25076703|NCT03371069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25076704|NCT03371069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25076705|NCT03371069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699946|NCT02115750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699947|NCT02115750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25699948|NCT02115750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25699949|NCT02115750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25699950|NCT02115750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25699951|NCT02115750|Immunologic Factors|immunologic factors|mesh-ancestor
25076728|NCT03370848|Antipyretics|antipyretics|mesh-ancestor
25076729|NCT03370848|Cathartics|cathartics|mesh-ancestor
25076730|NCT03370848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25076732|NCT03370835|Carvedilol|carvedilol|mesh-list
25076733|NCT03370835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25076734|NCT03370835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25076735|NCT03370835|Sympatholytics|sympatholytics|mesh-ancestor
25076736|NCT03370835|Autonomic Agents|autonomic agents|mesh-ancestor
25076737|NCT03370835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076738|NCT03370835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076739|NCT03370835|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24516713|NCT00602862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516715|NCT00602901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24516716|NCT00602901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25699952|NCT02116205|Vaccines|vaccines|mesh-list
25699953|NCT02116205|Immunologic Factors|immunologic factors|mesh-ancestor
25699954|NCT02116205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699955|NCT02116309|Indomethacin|indomethacin|mesh-list
25699956|NCT02116309|Epinephrine|epinephrine|mesh-list
25699957|NCT02116309|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25699958|NCT02116309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25699959|NCT02116309|Adrenergic Agents|adrenergic agents|mesh-ancestor
25076758|NCT03370705|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
24474443|NCT00406042|Prednisolone phosphate|prednisolone phosphate|mesh-list
24474445|NCT00406042|Glucocorticoids|glucocorticoids|mesh-ancestor
25076765|NCT03370705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25076766|NCT03370705|Antimetabolites|antimetabolites|mesh-ancestor
25076767|NCT03370705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076768|NCT03370705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25076769|NCT03370705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25076770|NCT03370705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25076771|NCT03370705|Protease Inhibitors|protease inhibitors|mesh-ancestor
25076772|NCT03370705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25076773|NCT03370705|Anticoagulants|anticoagulants|mesh-ancestor
25076774|NCT03370705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25076816|NCT03370588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25076822|NCT03370562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24897426|NCT04425642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25076823|NCT03370562|Analgesics|analgesics|mesh-ancestor
25076824|NCT03370562|Sensory System Agents|sensory system agents|mesh-ancestor
25076825|NCT03370562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076826|NCT03370562|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25076827|NCT03370562|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25076828|NCT03370562|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25076829|NCT03370562|Adrenergic Agents|adrenergic agents|mesh-ancestor
25076830|NCT03370562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25076831|NCT03370562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076832|NCT03370406|Fluorouracil|fluorouracil|mesh-list
25076872|NCT03370159|Antimitotic Agents|antimitotic agents|mesh-ancestor
25076873|NCT03370159|Mitosis Modulators|mitosis modulators|mesh-ancestor
25076874|NCT03370159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076875|NCT03370159|Antioxidants|antioxidants|mesh-ancestor
25076876|NCT03370159|Protective Agents|protective agents|mesh-ancestor
25076877|NCT03370159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076878|NCT03370159|Vitamin B Complex|vitamin b complex|mesh-ancestor
24954547|NCT03875911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24954548|NCT03875911|Alkylating Agents|alkylating agents|mesh-ancestor
24954549|NCT03875911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954550|NCT03875911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24954551|NCT03875911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816140|NCT02074293|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24816141|NCT02074293|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24816142|NCT02074293|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24816143|NCT02074293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816144|NCT02074293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816145|NCT02074293|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24816146|NCT02074293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25076894|NCT03369964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25076895|NCT03369964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25076896|NCT03369925|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
25076897|NCT03369925|Nootropic Agents|nootropic agents|mesh-ancestor
25076898|NCT03369847|Budesonide|budesonide|mesh-list
25076899|NCT03369847|Beclomethasone|beclomethasone|mesh-list
25076900|NCT03369847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25076901|NCT03369847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24817700|NCT02085239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817701|NCT02085291|Norepinephrine|norepinephrine|mesh-list
24474826|NCT00407589|Besifloxacin|besifloxacin|mesh-list
24474827|NCT00407589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24474828|NCT00407589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24882873|NCT04847206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24882874|NCT04847206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24882875|NCT04847206|Adrenergic Agents|adrenergic agents|mesh-ancestor
25076918|NCT03369795|Methotrexate|methotrexate|mesh-list
25076919|NCT03369795|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25076922|NCT03369795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076923|NCT03369795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25076927|NCT03369795|Dermatologic Agents|dermatologic agents|mesh-ancestor
25076928|NCT03369795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25076929|NCT03369795|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25076930|NCT03369795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25076933|NCT03369795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25076935|NCT03369782|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25076936|NCT03369782|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25076937|NCT03369782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25076938|NCT03369782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076939|NCT03369782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076940|NCT03369574|Reslizumab|reslizumab|mesh-list
25076941|NCT03369574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25076942|NCT03369574|Respiratory System Agents|respiratory system agents|mesh-ancestor
25076943|NCT03369379|Cholecalciferol|cholecalciferol|mesh-list
25076944|NCT03369379|Vitamins|vitamins|mesh-ancestor
25076945|NCT03369379|Micronutrients|micronutrients|mesh-ancestor
25076946|NCT03369379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882918|NCT04769206|Autonomic Agents|autonomic agents|mesh-ancestor
24882919|NCT04769206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24882920|NCT04769206|Nootropic Agents|nootropic agents|mesh-ancestor
25076947|NCT03369379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25076948|NCT03369379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25076949|NCT03369327|Sofosbuvir|sofosbuvir|mesh-list
25076950|NCT03369327|Antiviral Agents|antiviral agents|mesh-ancestor
25076951|NCT03369327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25076952|NCT03369262|Atosiban|atosiban|mesh-list
25076953|NCT03369262|Hormone Antagonists|hormone antagonists|mesh-ancestor
25076954|NCT03369262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25076955|NCT03369262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076956|NCT03369262|Tocolytic Agents|tocolytic agents|mesh-ancestor
25076957|NCT03369262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25076958|NCT03369119|Montelukast|montelukast|mesh-list
25076959|NCT03369119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25076960|NCT03369119|Respiratory System Agents|respiratory system agents|mesh-ancestor
25076961|NCT03369119|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25076962|NCT03369119|Hormone Antagonists|hormone antagonists|mesh-ancestor
25076963|NCT03369119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25076964|NCT03369119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076965|NCT03369119|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25076966|NCT03369119|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25076967|NCT03369119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076968|NCT03369093|Amoxicillin|amoxicillin|mesh-list
25076969|NCT03369093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25076973|NCT03369067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25076974|NCT03369067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25076975|NCT03369015|Amphetamine|amphetamine|mesh-list
25076976|NCT03369015|Dextroamphetamine|dextroamphetamine|mesh-list
25076977|NCT03369015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25076980|NCT03369015|Autonomic Agents|autonomic agents|mesh-ancestor
25076981|NCT03369015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25076982|NCT03369015|Dopamine Agents|dopamine agents|mesh-ancestor
25076983|NCT03369015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25076984|NCT03369015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25076985|NCT03369015|Adrenergic Agents|adrenergic agents|mesh-ancestor
25076986|NCT03369015|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25076987|NCT03369015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25076988|NCT03369015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24626525|NCT01087632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25076989|NCT03369015|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25076990|NCT03369002|Seladelpar|seladelpar|mesh-list
25076991|NCT03369002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25076992|NCT03369002|Antimetabolites|antimetabolites|mesh-ancestor
25076994|NCT03369002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25077046|NCT03368391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25077047|NCT03368391|Respiratory System Agents|respiratory system agents|mesh-ancestor
25077048|NCT03368391|Mydriatics|mydriatics|mesh-ancestor
25077058|NCT03368352|Protective Agents|protective agents|mesh-ancestor
25077059|NCT03368352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077060|NCT03368352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24626526|NCT01087658|Calcium|calcium|mesh-list
25077061|NCT03368274|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
25077062|NCT03368274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25077064|NCT03368274|Hormones|hormones|mesh-ancestor
25077065|NCT03368274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25077066|NCT03368274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077068|NCT03368131|Oxaliplatin|oxaliplatin|mesh-list
25699960|NCT02116309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25699961|NCT02116309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699962|NCT02116309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699963|NCT02116309|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25699964|NCT02116309|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25699965|NCT02116309|Autonomic Agents|autonomic agents|mesh-ancestor
25699966|NCT02116309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25077075|NCT03367728|Ropivacaine|ropivacaine|mesh-list
25077076|NCT03367728|Anesthetics, Local|anesthetics, local|mesh-ancestor
25077077|NCT03367728|Anesthetics|anesthetics|mesh-ancestor
25077078|NCT03367728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25077079|NCT03367728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077080|NCT03367728|Sensory System Agents|sensory system agents|mesh-ancestor
25077081|NCT03367728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25077082|NCT03367676|Docetaxel|docetaxel|mesh-list
25077083|NCT03367676|Trastuzumab|trastuzumab|mesh-list
25077084|NCT03367676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25077085|NCT03367676|Tubulin Modulators|tubulin modulators|mesh-ancestor
25077086|NCT03367676|Antimitotic Agents|antimitotic agents|mesh-ancestor
25077087|NCT03367676|Mitosis Modulators|mitosis modulators|mesh-ancestor
25077088|NCT03367676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077089|NCT03367676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25077090|NCT03367663|Prednisone|prednisone|mesh-list
25077091|NCT03367663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25077092|NCT03367663|Glucocorticoids|glucocorticoids|mesh-ancestor
25077093|NCT03367663|Hormones|hormones|mesh-ancestor
25077094|NCT03367663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25077095|NCT03367663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077116|NCT03367195|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25077117|NCT03367195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25077118|NCT03367195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077119|NCT03367182|Paclitaxel|paclitaxel|mesh-list
25077120|NCT03367182|Bevacizumab|bevacizumab|mesh-list
25077121|NCT03367182|Doxorubicin|doxorubicin|mesh-list
25077122|NCT03367182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25077123|NCT03367182|Topotecan|topotecan|mesh-list
25077124|NCT03367182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25077125|NCT03367182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25077126|NCT03367182|Tubulin Modulators|tubulin modulators|mesh-ancestor
25077127|NCT03367182|Antimitotic Agents|antimitotic agents|mesh-ancestor
25077128|NCT03367182|Mitosis Modulators|mitosis modulators|mesh-ancestor
25077129|NCT03367182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077130|NCT03367182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25077131|NCT03367182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24475014|NCT00408525|Nootropic Agents|nootropic agents|mesh-ancestor
24516985|NCT00605111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24516986|NCT00605111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516987|NCT00605137|Insulin|insulin|mesh-list
25077132|NCT03367182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24883081|NCT04579510|Vaccines|vaccines|mesh-list
25699967|NCT02116309|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25699968|NCT02116309|Respiratory System Agents|respiratory system agents|mesh-ancestor
25699969|NCT02116309|Mydriatics|mydriatics|mesh-ancestor
25699970|NCT02116309|Sympathomimetics|sympathomimetics|mesh-ancestor
25699971|NCT02116309|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25077187|NCT03366883|Tubulin Modulators|tubulin modulators|mesh-ancestor
25077188|NCT03366883|Antimitotic Agents|antimitotic agents|mesh-ancestor
25077189|NCT03366883|Mitosis Modulators|mitosis modulators|mesh-ancestor
25077190|NCT03366883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077212|NCT03366597|Anesthetics, General|anesthetics, general|mesh-ancestor
24626532|NCT01087710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626533|NCT01087710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626534|NCT01087710|Protective Agents|protective agents|mesh-ancestor
24626536|NCT01087749|Propranolol|propranolol|mesh-list
24626537|NCT01087749|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24626538|NCT01087749|Eprosartan|eprosartan|mesh-list
24626539|NCT01087749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24626540|NCT01087749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24626541|NCT01087749|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24626549|NCT01087749|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24626550|NCT01087749|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24626551|NCT01087749|Adrenergic Agents|adrenergic agents|mesh-ancestor
24626552|NCT01087749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24626553|NCT01087749|Vasodilator Agents|vasodilator agents|mesh-ancestor
24811029|NCT02044250|Analgesics|analgesics|mesh-ancestor
24626554|NCT01087749|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
24954558|NCT03875872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24898400|NCT04414800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24898401|NCT04414800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24448064|NCT00310128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24448065|NCT00310128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24448066|NCT00310128|Glucocorticoids|glucocorticoids|mesh-ancestor
24448067|NCT00310128|Hormones|hormones|mesh-ancestor
25077230|NCT03366584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25077231|NCT03366584|Glucocorticoids|glucocorticoids|mesh-ancestor
25077232|NCT03366584|Hormones|hormones|mesh-ancestor
25077233|NCT03366584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25077235|NCT03366584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25077238|NCT03366584|Trace Elements|trace elements|mesh-ancestor
25077239|NCT03366584|Antioxidants|antioxidants|mesh-ancestor
25077240|NCT03366584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077241|NCT03366584|Protective Agents|protective agents|mesh-ancestor
25077242|NCT03366584|Provitamins|provitamins|mesh-ancestor
25077243|NCT03366584|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25077244|NCT03366584|Chelating Agents|chelating agents|mesh-ancestor
25077245|NCT03366584|Sequestering Agents|sequestering agents|mesh-ancestor
25077246|NCT03366571|Entecavir|entecavir|mesh-list
25077247|NCT03366571|Antiviral Agents|antiviral agents|mesh-ancestor
24404443|NCT00163449|Hormones|hormones|mesh-ancestor
24517190|NCT00606450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24517191|NCT00606450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24517192|NCT00606450|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24454544|NCT03897868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25077248|NCT03366571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25077249|NCT03366480|Paclitaxel|paclitaxel|mesh-list
25077250|NCT03366480|Carboplatin|carboplatin|mesh-list
25077251|NCT03366480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25077252|NCT03366480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25077253|NCT03366480|Tubulin Modulators|tubulin modulators|mesh-ancestor
25077254|NCT03366480|Antimitotic Agents|antimitotic agents|mesh-ancestor
25077255|NCT03366480|Mitosis Modulators|mitosis modulators|mesh-ancestor
25077256|NCT03366480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963307|NCT03791827|Cyclosporine|cyclosporine|mesh-list
25077257|NCT03366259|Misoprostol|misoprostol|mesh-list
25077258|NCT03366259|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25077259|NCT03366259|Abortifacient Agents|abortifacient agents|mesh-ancestor
25077260|NCT03366259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25077261|NCT03366259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077262|NCT03366259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25077263|NCT03366259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24454551|NCT03897868|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24454553|NCT03878524|Leucovorin|leucovorin|mesh-list
24454554|NCT03878524|Vitamin A|vitamin a|mesh-list
24454555|NCT03878524|Sirolimus|sirolimus|mesh-list
24454556|NCT03878524|Celecoxib|celecoxib|mesh-list
24454557|NCT03878524|Paclitaxel|paclitaxel|mesh-list
24454558|NCT03878524|Maytansine|maytansine|mesh-list
24454559|NCT03878524|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24454560|NCT03878524|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24454561|NCT03878524|Bevacizumab|bevacizumab|mesh-list
25699979|NCT02116309|Tocolytic Agents|tocolytic agents|mesh-ancestor
25699980|NCT02116309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24454562|NCT03878524|Carboplatin|carboplatin|mesh-list
24454563|NCT03878524|Doxorubicin|doxorubicin|mesh-list
24454564|NCT03878524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25699981|NCT02116309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25699982|NCT02116309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25699983|NCT02116361|Botulinum Toxins|botulinum toxins|mesh-list
25699984|NCT02116361|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25699985|NCT02116361|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25699986|NCT02116361|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25077320|NCT03365817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25077321|NCT03365817|Anesthetics, General|anesthetics, general|mesh-ancestor
25077323|NCT03365817|Antitussive Agents|antitussive agents|mesh-ancestor
25077324|NCT03365817|Respiratory System Agents|respiratory system agents|mesh-ancestor
25077325|NCT03365765|Fluorouracil|fluorouracil|mesh-list
25077348|NCT03365726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077349|NCT03365726|Protective Agents|protective agents|mesh-ancestor
25077351|NCT03365479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25077352|NCT03365479|Vasodilator Agents|vasodilator agents|mesh-ancestor
25077353|NCT03365466|Aspirin|aspirin|mesh-list
25077354|NCT03365466|Heparin|heparin|mesh-list
25699987|NCT02116361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25077377|NCT03365388|Immunologic Factors|immunologic factors|mesh-ancestor
25077378|NCT03365388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077379|NCT03365388|Viscosupplements|viscosupplements|mesh-ancestor
25077380|NCT03365388|Protective Agents|protective agents|mesh-ancestor
24454600|NCT03878524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24454601|NCT03878524|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24454602|NCT03878524|Immunoglobulin G|immunoglobulin g|mesh-list
24454603|NCT03878524|Immunoconjugates|immunoconjugates|mesh-list
24454604|NCT03878524|Entrectinib|entrectinib|mesh-list
24454605|NCT03878524|Benzenesulfonamide|benzenesulfonamide|mesh-list
24454609|NCT03878524|Antimitotic Agents|antimitotic agents|mesh-ancestor
24899230|NCT04405375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476191|NCT00413426|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24476192|NCT00413426|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24454610|NCT03878524|Mitosis Modulators|mitosis modulators|mesh-ancestor
24454611|NCT03878524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24454612|NCT03878524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24454615|NCT03878524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24454616|NCT03878524|Growth Inhibitors|growth inhibitors|mesh-ancestor
25077381|NCT03365336|Oseltamivir|oseltamivir|mesh-list
25077382|NCT03365336|Antiviral Agents|antiviral agents|mesh-ancestor
25077383|NCT03365336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25077384|NCT03365336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25077385|NCT03365336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077386|NCT03365141|Triamcinolone|triamcinolone|mesh-list
25077387|NCT03365141|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25077388|NCT03365141|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25077389|NCT03365141|Tacrolimus|tacrolimus|mesh-list
25077390|NCT03365141|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25077391|NCT03365141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25077392|NCT03365141|Immunologic Factors|immunologic factors|mesh-ancestor
25077393|NCT03365141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24454634|NCT03878524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25077406|NCT03365115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077407|NCT03365115|Analgesics|analgesics|mesh-ancestor
25077408|NCT03365115|Sensory System Agents|sensory system agents|mesh-ancestor
25077409|NCT03365115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25077410|NCT03365115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25077411|NCT03365115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25077412|NCT03365115|Anesthetics, General|anesthetics, general|mesh-ancestor
25077413|NCT03365115|Anesthetics|anesthetics|mesh-ancestor
25077414|NCT03364998|Factor VIII|factor viii|mesh-list
25077415|NCT03364998|Coagulants|coagulants|mesh-ancestor
25077416|NCT03364985|Dapagliflozin|dapagliflozin|mesh-list
25077417|NCT03364985|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25077418|NCT03364985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077419|NCT03364985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25077420|NCT03364985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077422|NCT03364842|Diuretics|diuretics|mesh-ancestor
25077423|NCT03364842|Natriuretic Agents|natriuretic agents|mesh-ancestor
25077424|NCT03364842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077426|NCT03364842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25077427|NCT03364842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077428|NCT03364829|Glycopyrrolate|glycopyrrolate|mesh-list
25077429|NCT03364829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25077430|NCT03364829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25077431|NCT03364829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25077432|NCT03364829|Cholinergic Agents|cholinergic agents|mesh-ancestor
25077433|NCT03364829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25077434|NCT03364829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077435|NCT03364829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077437|NCT03364764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24954596|NCT03874884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24954597|NCT03874806|Ropivacaine|ropivacaine|mesh-list
24954598|NCT03874806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24954599|NCT03874806|Anesthetics, Local|anesthetics, local|mesh-ancestor
24954600|NCT03874806|Anesthetics|anesthetics|mesh-ancestor
24954601|NCT03874806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24954602|NCT03874806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954603|NCT03874806|Sensory System Agents|sensory system agents|mesh-ancestor
24954604|NCT03874806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24954605|NCT03874585|Nicotine|nicotine|mesh-list
24954606|NCT03874585|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24954607|NCT03874585|Autonomic Agents|autonomic agents|mesh-ancestor
24954608|NCT03874585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24954609|NCT03874585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954610|NCT03874585|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24954611|NCT03874585|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24954612|NCT03874585|Cholinergic Agents|cholinergic agents|mesh-ancestor
25699988|NCT02116361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25699989|NCT02116361|Cholinergic Agents|cholinergic agents|mesh-ancestor
25699990|NCT02116361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25699991|NCT02116361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25699992|NCT02116361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25699993|NCT02116361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25699994|NCT02116530|Dexamethasone|dexamethasone|mesh-list
25077475|NCT03364348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25077476|NCT03364348|Tubulin Modulators|tubulin modulators|mesh-ancestor
25077477|NCT03364348|Antimitotic Agents|antimitotic agents|mesh-ancestor
25077478|NCT03364348|Mitosis Modulators|mitosis modulators|mesh-ancestor
25077479|NCT03364348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077480|NCT03364218|Acetylcysteine|acetylcysteine|mesh-list
25077481|NCT03364218|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25077482|NCT03364218|Antiviral Agents|antiviral agents|mesh-ancestor
25077483|NCT03364218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25077484|NCT03364218|Expectorants|expectorants|mesh-ancestor
25077485|NCT03364218|Respiratory System Agents|respiratory system agents|mesh-ancestor
25077486|NCT03364218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25077487|NCT03364218|Antioxidants|antioxidants|mesh-ancestor
24883447|NCT03850366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24883449|NCT03840148|Meropenem|meropenem|mesh-list
25077488|NCT03364218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077489|NCT03364218|Protective Agents|protective agents|mesh-ancestor
25077490|NCT03364218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077492|NCT03364088|Oxycodone|oxycodone|mesh-list
25077493|NCT03364088|Anesthetics|anesthetics|mesh-list
25077494|NCT03364088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25077495|NCT03364088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077496|NCT03364088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25077497|NCT03364088|Narcotics|narcotics|mesh-ancestor
25077498|NCT03364088|Analgesics|analgesics|mesh-ancestor
25077499|NCT03364088|Sensory System Agents|sensory system agents|mesh-ancestor
25077500|NCT03364088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25077501|NCT03364075|Propranolol|propranolol|mesh-list
25077502|NCT03364075|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25077503|NCT03364075|Serotonin|serotonin|mesh-list
25077504|NCT03364075|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25077505|NCT03364075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25699995|NCT02116530|Cyclophosphamide|cyclophosphamide|mesh-list
25699996|NCT02116530|Doxorubicin|doxorubicin|mesh-list
25699997|NCT02116530|Ondansetron|ondansetron|mesh-list
25700004|NCT02116530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25700005|NCT02116530|Immunologic Factors|immunologic factors|mesh-ancestor
25700006|NCT02116530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700007|NCT02116530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25700008|NCT02116530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25700009|NCT02116530|Alkylating Agents|alkylating agents|mesh-ancestor
25700010|NCT02116530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700011|NCT02116530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700012|NCT02116530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25077556|NCT03363815|Omeprazole|omeprazole|mesh-list
25077557|NCT03363815|Warfarin|warfarin|mesh-list
25077558|NCT03363815|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25077559|NCT03363815|Vitamins|vitamins|mesh-ancestor
25077560|NCT03363815|Micronutrients|micronutrients|mesh-ancestor
25077561|NCT03363815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077562|NCT03363815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25077567|NCT03363815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25077568|NCT03363815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25077569|NCT03363815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25077571|NCT03363815|Anesthetics|anesthetics|mesh-ancestor
24901447|NCT04384744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901449|NCT04384783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24901450|NCT04384783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901451|NCT04384991|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24901452|NCT04384991|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24901453|NCT04384666|Rotigotine|rotigotine|mesh-list
24901454|NCT04384666|Dopamine Agonists|dopamine agonists|mesh-ancestor
24901455|NCT04384666|Dopamine Agents|dopamine agents|mesh-ancestor
24901467|NCT04384653|Furosemide|furosemide|mesh-list
24901468|NCT04384653|Diuretics|diuretics|mesh-ancestor
24901469|NCT04384653|Natriuretic Agents|natriuretic agents|mesh-ancestor
24901470|NCT04384653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901471|NCT04384653|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24901472|NCT04384653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24519089|NCT03441893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901474|NCT04384731|Poractant alfa|poractant alfa|mesh-list
24901475|NCT04384731|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
25407394|NCT03504410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24883583|NCT05237843|Antipyretics|antipyretics|mesh-ancestor
25700013|NCT02116530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25700014|NCT02116530|Autonomic Agents|autonomic agents|mesh-ancestor
25700015|NCT02116530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25700016|NCT02116530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25700017|NCT02116530|Glucocorticoids|glucocorticoids|mesh-ancestor
25700018|NCT02116530|Hormones|hormones|mesh-ancestor
25700019|NCT02116530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25077659|NCT03363191|Respiratory System Agents|respiratory system agents|mesh-ancestor
25077660|NCT03363191|Dermatologic Agents|dermatologic agents|mesh-ancestor
25077661|NCT03363191|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25077662|NCT03363191|Tocolytic Agents|tocolytic agents|mesh-ancestor
25077663|NCT03363191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25077664|NCT03363191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25077665|NCT03363191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25077666|NCT03363191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25077667|NCT03363191|Adrenergic Agents|adrenergic agents|mesh-ancestor
25077668|NCT03363191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24883618|NCT05237323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24883619|NCT05237323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24883620|NCT05237323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700020|NCT02116530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25700021|NCT02116530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25700022|NCT02116530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25700023|NCT02116530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25700024|NCT02116530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25077719|NCT03362788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25077720|NCT03362788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077722|NCT03362788|Coagulants|coagulants|mesh-ancestor
25077723|NCT03362775|Propofol|propofol|mesh-list
25077724|NCT03362775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25077725|NCT03362775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25077726|NCT03362775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077727|NCT03362775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25077728|NCT03362775|Anesthetics, General|anesthetics, general|mesh-ancestor
25077729|NCT03362775|Anesthetics|anesthetics|mesh-ancestor
25077730|NCT03362736|Ustekinumab|ustekinumab|mesh-list
25077731|NCT03362736|Dermatologic Agents|dermatologic agents|mesh-ancestor
25077732|NCT03362697|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25077733|NCT03362697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25077734|NCT03362684|Cetuximab|cetuximab|mesh-list
25077735|NCT03362684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25077736|NCT03362684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25077737|NCT03362632|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25077738|NCT03362632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25077739|NCT03362515|Furosemide|furosemide|mesh-list
25077753|NCT03362281|Clarithromycin|clarithromycin|mesh-list
25077755|NCT03362281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25077756|NCT03362281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25077757|NCT03362281|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25077758|NCT03362281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25077759|NCT03362281|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25077760|NCT03362281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25077761|NCT03362281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077762|NCT03362281|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25077763|NCT03362281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25077764|NCT03362281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25077765|NCT03362268|Omeprazole|omeprazole|mesh-list
25077766|NCT03362268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25077767|NCT03362268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25077768|NCT03362268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24902284|NCT04374981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25077769|NCT03362268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25077788|NCT03362073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25077789|NCT03362073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077790|NCT03362073|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25077791|NCT03362073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25700025|NCT02116530|Antipruritics|antipruritics|mesh-ancestor
25700026|NCT02116530|Dermatologic Agents|dermatologic agents|mesh-ancestor
25700027|NCT02116530|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25700028|NCT02116530|Serotonin Agents|serotonin agents|mesh-ancestor
25700029|NCT02116530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25700030|NCT02116530|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25700031|NCT02116530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25700032|NCT02116530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25700033|NCT02116530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25700034|NCT02116530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24902416|NCT04374071|Hormones|hormones|mesh-ancestor
24902417|NCT04374071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24902418|NCT04374071|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24448339|NCT00311389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24448340|NCT00311389|Adrenergic Agents|adrenergic agents|mesh-ancestor
24448341|NCT00311389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24448342|NCT00311389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448343|NCT00311389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077825|NCT03361774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883783|NCT04817410|Sensory System Agents|sensory system agents|mesh-ancestor
24448344|NCT00311389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24448345|NCT00311389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24448364|NCT00311558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448375|NCT00311636|Fluorouracil|fluorouracil|mesh-list
24448376|NCT00311636|Methotrexate|methotrexate|mesh-list
24448377|NCT00311636|Epirubicin|epirubicin|mesh-list
24448394|NCT00311636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24448395|NCT00311636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448396|NCT00311636|Antimetabolites|antimetabolites|mesh-ancestor
24883792|NCT04770012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24454942|NCT03161353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24454943|NCT03161353|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24454944|NCT03161353|Hormone Antagonists|hormone antagonists|mesh-ancestor
25077869|NCT03361319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700035|NCT02116530|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25700036|NCT02116530|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25700037|NCT02116530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25700038|NCT02116530|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25700039|NCT02116530|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25700040|NCT02116608|Povidone-Iodine|povidone-iodine|mesh-list
25700041|NCT02116608|Silver Nitrate|silver nitrate|mesh-list
25700042|NCT02116608|Hydrocortisone|hydrocortisone|mesh-list
25077881|NCT03361280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077882|NCT03361163|Bromoacetylalprenololmenthane|bromoacetylalprenololmenthane|mesh-list
25077883|NCT03361163|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25077884|NCT03361163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25077885|NCT03361163|Adrenergic Agents|adrenergic agents|mesh-ancestor
25077886|NCT03361163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25077887|NCT03361163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25077888|NCT03361163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25077889|NCT03361163|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25077891|NCT03361124|Oxytocin|oxytocin|mesh-list
25700043|NCT02116608|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
25700044|NCT02116608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24904112|NCT04358627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24904113|NCT04358627|Analgesics|analgesics|mesh-ancestor
25700049|NCT02116660|Lopinavir|lopinavir|mesh-list
24954641|NCT03874130|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24954642|NCT03874130|Cholinergic Agents|cholinergic agents|mesh-ancestor
24954643|NCT03874130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24954644|NCT03874130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954645|NCT03874130|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24954646|NCT03874130|Parasympatholytics|parasympatholytics|mesh-ancestor
24954648|NCT03874260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24954649|NCT03874260|Antimetabolites|antimetabolites|mesh-ancestor
24954650|NCT03874260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954651|NCT03874260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24884008|NCT03683355|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24818627|NCT02089854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078099|NCT03359161|Natriuretic Agents|natriuretic agents|mesh-ancestor
25078100|NCT03359161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078107|NCT03359070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25078108|NCT03359070|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25078109|NCT03359070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25078110|NCT03359070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078111|NCT03359070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078112|NCT03359070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24884007|NCT03683355|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25078114|NCT03359070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25078115|NCT03359070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078116|NCT03359070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25078117|NCT03359070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25078118|NCT03359070|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25078120|NCT03359057|Vitamin B Complex|vitamin b complex|mesh-list
25078121|NCT03359057|Levonorgestrel|levonorgestrel|mesh-list
25078122|NCT03359057|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25078123|NCT03359057|Estradiol|estradiol|mesh-list
25078124|NCT03359057|Estrogens|estrogens|mesh-ancestor
25078125|NCT03359057|Hormones|hormones|mesh-ancestor
25078126|NCT03359057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24954662|NCT03874156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884020|NCT03571633|Tubulin Modulators|tubulin modulators|mesh-ancestor
24954696|NCT03872661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24954697|NCT03872661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24954698|NCT03872661|Growth Substances|growth substances|mesh-ancestor
24954699|NCT03872661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884057|NCT03433183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24884058|NCT03433183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24884060|NCT03433183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519509|NCT05332821|Bevacizumab|bevacizumab|mesh-list
24954702|NCT03872661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954703|NCT03872661|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24954704|NCT03872661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24954705|NCT03872830|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
24954706|NCT03872830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24954707|NCT03872830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24954709|NCT03872830|Sensory System Agents|sensory system agents|mesh-ancestor
24954710|NCT03872830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24954711|NCT03872830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954712|NCT03872830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24954713|NCT03872830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24954714|NCT03872596|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24954717|NCT03872596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24954718|NCT03872596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24954720|NCT03872596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954722|NCT03872570|Oxymetazoline|oxymetazoline|mesh-list
24954723|NCT03872570|Norepinephrine|norepinephrine|mesh-list
25700077|NCT02116777|Alkylating Agents|alkylating agents|mesh-ancestor
25700078|NCT02116777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700079|NCT02116777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700080|NCT02116777|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25700081|NCT02116777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700082|NCT02116803|Fulvestrant|fulvestrant|mesh-list
25700083|NCT02116803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25700084|NCT02116803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24818843|NCT02091297|Analgesics|analgesics|mesh-ancestor
24818844|NCT02091297|Sensory System Agents|sensory system agents|mesh-ancestor
24818845|NCT02091297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24818846|NCT02091297|Anesthetics, Local|anesthetics, local|mesh-ancestor
24818847|NCT02091297|Anesthetics|anesthetics|mesh-ancestor
24818848|NCT02091297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24954728|NCT03872570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954729|NCT03872570|Sympathomimetics|sympathomimetics|mesh-ancestor
24954730|NCT03872570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24954731|NCT03872570|Nasal Decongestants|nasal decongestants|mesh-ancestor
24954732|NCT03872570|Respiratory System Agents|respiratory system agents|mesh-ancestor
24954733|NCT03872570|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24954734|NCT03872570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24954735|NCT03872570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25078127|NCT03359057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078128|NCT03359057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25078129|NCT03359057|Contraceptive Agents|contraceptive agents|mesh-ancestor
25078130|NCT03359057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25078131|NCT03359057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25078132|NCT03359057|Hematinics|hematinics|mesh-ancestor
25078133|NCT03359057|Vitamins|vitamins|mesh-ancestor
25078134|NCT03359057|Micronutrients|micronutrients|mesh-ancestor
25078135|NCT03359057|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25078136|NCT03359057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25078137|NCT03359057|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25078139|NCT03359018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24954736|NCT03872570|Adrenergic Agents|adrenergic agents|mesh-ancestor
24954737|NCT03872570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24954738|NCT03872570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954739|NCT03872570|Protective Agents|protective agents|mesh-ancestor
24954740|NCT03872505|Paclitaxel|paclitaxel|mesh-list
24954741|NCT03872505|Carboplatin|carboplatin|mesh-list
24954742|NCT03872505|Durvalumab|durvalumab|mesh-list
24448671|NCT00312546|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24448672|NCT00312546|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24448673|NCT00312546|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24954750|NCT03872336|Labetalol|labetalol|mesh-list
24505118|NCT00539968|Antimitotic Agents|antimitotic agents|mesh-ancestor
24954756|NCT03872336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954757|NCT03872336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24954758|NCT03872336|Sympathomimetics|sympathomimetics|mesh-ancestor
24954759|NCT03872336|Autonomic Agents|autonomic agents|mesh-ancestor
24954760|NCT03872336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24954761|NCT03872336|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24954762|NCT03872336|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24954764|NCT03873415|Dermatologic Agents|dermatologic agents|mesh-ancestor
24954765|NCT03873415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24954766|NCT03873415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24954767|NCT03873415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907810|NCT04327427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24954782|NCT03872232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24954783|NCT03872232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24954784|NCT03872232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24954785|NCT03872232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24954787|NCT03871972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24954788|NCT03871972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24954789|NCT03871972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24954790|NCT03871972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24954794|NCT03871972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954796|NCT03872011|Ascorbic Acid|ascorbic acid|mesh-list
24954797|NCT03872011|Thiamine|thiamine|mesh-list
24780464|NCT01884441|Tubulin Modulators|tubulin modulators|mesh-ancestor
24954806|NCT03871777|Chlorhexidine|chlorhexidine|mesh-list
24884175|NCT02813200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24884176|NCT02813200|Respiratory System Agents|respiratory system agents|mesh-ancestor
24884177|NCT02813200|Parasympatholytics|parasympatholytics|mesh-ancestor
24954815|NCT03871621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954816|NCT03871621|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24954817|NCT03871621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954818|NCT03871803|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24954819|NCT03871803|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24954820|NCT03871803|Adrenergic Agents|adrenergic agents|mesh-ancestor
24954821|NCT03871803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24954822|NCT03871803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884186|NCT02744742|Cyclophosphamide|cyclophosphamide|mesh-list
24884188|NCT02744742|Decitabine|decitabine|mesh-list
24954833|NCT03871517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24954834|NCT03871517|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24954835|NCT03871517|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24954836|NCT03871517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954837|NCT03871517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24954838|NCT03871517|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24954839|NCT03871517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24954841|NCT03871361|Abatacept|abatacept|mesh-list
24448736|NCT00312988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24448737|NCT00312988|Antimetabolites|antimetabolites|mesh-ancestor
24448738|NCT00312988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954843|NCT03871361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954844|NCT03871361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24954845|NCT03871361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24954846|NCT03871361|Immunologic Factors|immunologic factors|mesh-ancestor
24954847|NCT03871361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954848|NCT03871361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24954849|NCT03871218|Hyaluronic Acid|hyaluronic acid|mesh-list
24954850|NCT03871218|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24954851|NCT03871218|Immunologic Factors|immunologic factors|mesh-ancestor
24954852|NCT03871218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954853|NCT03871218|Viscosupplements|viscosupplements|mesh-ancestor
24954854|NCT03871218|Protective Agents|protective agents|mesh-ancestor
24954855|NCT03871322|Vitamin D|vitamin d|mesh-list
24954857|NCT03871322|Cholecalciferol|cholecalciferol|mesh-list
24954858|NCT03871322|Vitamins|vitamins|mesh-list
24954859|NCT03871322|Micronutrients|micronutrients|mesh-ancestor
24954860|NCT03871322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954861|NCT03871322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24954862|NCT03871322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24954863|NCT03871478|Lidocaine|lidocaine|mesh-list
24954864|NCT03871478|Bupivacaine|bupivacaine|mesh-list
24954865|NCT03871478|Anesthetics, Local|anesthetics, local|mesh-ancestor
24954866|NCT03871478|Anesthetics|anesthetics|mesh-ancestor
24954867|NCT03871478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24954868|NCT03871478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700090|NCT02116972|FX006|fx006|mesh-list
25700091|NCT02116972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25700092|NCT02116972|Glucocorticoids|glucocorticoids|mesh-ancestor
25700093|NCT02116972|Hormones|hormones|mesh-ancestor
25700094|NCT02116972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25700095|NCT02116972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700096|NCT02116972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24954906|NCT03870594|Chrysarobin|chrysarobin|mesh-list
24954907|NCT03870594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24954908|NCT03870594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24954909|NCT03870594|Analgesics|analgesics|mesh-ancestor
24954910|NCT03870594|Sensory System Agents|sensory system agents|mesh-ancestor
24954911|NCT03870594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25700100|NCT02117024|Vinorelbine|vinorelbine|mesh-list
25700101|NCT02117024|Docetaxel|docetaxel|mesh-list
25700102|NCT02117024|Cyclophosphamide|cyclophosphamide|mesh-list
24954943|NCT03870503|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24954951|NCT03870256|Abortifacient Agents|abortifacient agents|mesh-ancestor
24910164|NCT04301661|Abacavir|abacavir|mesh-list
24910165|NCT04301661|Antiviral Agents|antiviral agents|mesh-ancestor
24910166|NCT04301661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24910224|NCT04301349|Abortifacient Agents|abortifacient agents|mesh-ancestor
24910225|NCT04301349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24910226|NCT04301349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484831|NCT00450164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24484832|NCT00450164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24484833|NCT00450164|Sympatholytics|sympatholytics|mesh-ancestor
24484834|NCT00450164|Autonomic Agents|autonomic agents|mesh-ancestor
24519766|NCT05195034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519768|NCT05177614|Trace Elements|trace elements|mesh-list
24780693|NCT01885988|Nebivolol|nebivolol|mesh-list
25700103|NCT02117024|Pemetrexed|pemetrexed|mesh-list
25700104|NCT02117024|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25700105|NCT02117024|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25700106|NCT02117024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24955012|NCT03869528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24780826|NCT01886443|Vasodilator Agents|vasodilator agents|mesh-ancestor
24780827|NCT01886443|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24780828|NCT01886443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24780829|NCT01886443|Immunologic Factors|immunologic factors|mesh-ancestor
24780830|NCT01886534|Diuretics|diuretics|mesh-list
24780831|NCT01886534|Natriuretic Agents|natriuretic agents|mesh-ancestor
24910609|NCT04296162|Antimitotic Agents|antimitotic agents|mesh-ancestor
24910641|NCT04295967|Disinfectants|disinfectants|mesh-ancestor
24910642|NCT04295967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24910643|NCT04296149|Octreotide|octreotide|mesh-list
24910644|NCT04296149|Edotreotide|edotreotide|mesh-list
24910645|NCT04296149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25700116|NCT02117024|Alkylating Agents|alkylating agents|mesh-ancestor
25700117|NCT02117024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25700118|NCT02117024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25700119|NCT02117024|Antimetabolites|antimetabolites|mesh-ancestor
25700120|NCT02117024|Antiviral Agents|antiviral agents|mesh-ancestor
25700121|NCT02117024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25700122|NCT02117024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24910694|NCT04295161|Abiraterone Acetate|abiraterone acetate|mesh-list
24910695|NCT04295161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24780844|NCT01886573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780845|NCT01886573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24780847|NCT01886599|Asunaprevir|asunaprevir|mesh-list
24780848|NCT01886599|Protease Inhibitors|protease inhibitors|mesh-ancestor
24780849|NCT01886599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780850|NCT01886599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780851|NCT01886638|Abacavir|abacavir|mesh-list
24780852|NCT01886638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24780853|NCT01886638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24780854|NCT01886638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780855|NCT01886638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780856|NCT01886638|Antiviral Agents|antiviral agents|mesh-ancestor
24780857|NCT01886638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24780858|NCT01886638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24955013|NCT03869528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24884367|NCT00862251|Antimetabolites|antimetabolites|mesh-ancestor
25700123|NCT02117024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24819139|NCT02093598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24819141|NCT02093598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24819142|NCT02093598|Antifungal Agents|antifungal agents|mesh-ancestor
24819143|NCT02093598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24955032|NCT03869047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24955033|NCT03869047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955034|NCT03869047|Sensory System Agents|sensory system agents|mesh-ancestor
24884382|NCT00782184|Simvastatin|simvastatin|mesh-list
24955035|NCT03869047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955036|NCT03869047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24955037|NCT03869047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24955038|NCT03869047|Analgesics|analgesics|mesh-ancestor
24955039|NCT03869047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24955040|NCT03869047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24955041|NCT03869047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25700124|NCT02117024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25700125|NCT02117024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25700126|NCT02117349|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25700127|NCT02117349|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
25700128|NCT02117349|Hemostatics|hemostatics|mesh-ancestor
25700129|NCT02117349|Coagulants|coagulants|mesh-ancestor
25700130|NCT02117479|Capecitabine|capecitabine|mesh-list
25700131|NCT02117479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24955053|NCT03869073|Antimetabolites|antimetabolites|mesh-ancestor
24955054|NCT03869073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955055|NCT03869073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24955057|NCT03868969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24955058|NCT03868969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24955059|NCT03868436|Methoxyflurane|methoxyflurane|mesh-list
24955060|NCT03868436|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24955061|NCT03868436|Anesthetics, General|anesthetics, general|mesh-ancestor
24955082|NCT03868124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24911218|NCT04290195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24911219|NCT04290013|Tranexamic Acid|tranexamic acid|mesh-list
24911220|NCT04290013|Norethindrone|norethindrone|mesh-list
24911221|NCT04290013|Norethindrone Acetate|norethindrone acetate|mesh-list
24911232|NCT04290013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911235|NCT04290208|Acetaminophen|acetaminophen|mesh-list
25700132|NCT02117479|Antimetabolites|antimetabolites|mesh-ancestor
25078155|NCT03358953|Autonomic Agents|autonomic agents|mesh-ancestor
25078156|NCT03358953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078157|NCT03358953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078158|NCT03358953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25078159|NCT03358953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25078160|NCT03358953|Cholinergic Agents|cholinergic agents|mesh-ancestor
25078161|NCT03358953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25078162|NCT03358953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078164|NCT03358888|Narcotics|narcotics|mesh-ancestor
24448940|NCT00313599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448941|NCT00313625|Methotrexate|methotrexate|mesh-list
24448942|NCT00313625|Melphalan|melphalan|mesh-list
24448943|NCT00313625|Busulfan|busulfan|mesh-list
24448944|NCT00313625|Tacrolimus|tacrolimus|mesh-list
24448945|NCT00313625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24448946|NCT00313625|Abortifacient Agents|abortifacient agents|mesh-ancestor
24448947|NCT00313625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24519952|NCT04333407|Aspirin|aspirin|mesh-list
24519953|NCT04333407|Omeprazole|omeprazole|mesh-list
25078172|NCT03358719|Decitabine|decitabine|mesh-list
25078173|NCT03358719|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25078174|NCT03358719|Poly ICLC|poly iclc|mesh-list
25078175|NCT03358719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25078176|NCT03358719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25078177|NCT03358719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25078178|NCT03358719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078179|NCT03358719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25078180|NCT03358719|Antimetabolites|antimetabolites|mesh-ancestor
25078181|NCT03358719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078182|NCT03358719|Interferon Inducers|interferon inducers|mesh-ancestor
24519954|NCT04333407|Rivaroxaban|rivaroxaban|mesh-list
24519955|NCT04333407|Clopidogrel|clopidogrel|mesh-list
24455153|NCT02628067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24455154|NCT02628067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24955117|NCT03868033|Zoledronic Acid|zoledronic acid|mesh-list
24964293|NCT03783949|Gemcitabine|gemcitabine|mesh-list
25078189|NCT03358524|Vitamins|vitamins|mesh-list
24535664|NCT00649532|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24955119|NCT03868033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24955145|NCT03867994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24955146|NCT03867994|Antioxidants|antioxidants|mesh-ancestor
24955147|NCT03867994|Protective Agents|protective agents|mesh-ancestor
24955148|NCT03867994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24884515|NCT00418834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884516|NCT00418834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24455155|NCT02567409|Gemcitabine|gemcitabine|mesh-list
24912252|NCT04278547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24455156|NCT02567409|Cisplatin|cisplatin|mesh-list
24455157|NCT02567409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912385|NCT04276545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24912386|NCT04276545|Anesthetics, General|anesthetics, general|mesh-ancestor
24912387|NCT04276545|Anesthetics|anesthetics|mesh-ancestor
24912388|NCT04276545|GABA Modulators|gaba modulators|mesh-ancestor
24912421|NCT04275414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912422|NCT04275414|Growth Inhibitors|growth inhibitors|mesh-ancestor
24486935|NCT00460681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486936|NCT00460707|Ketoconazole|ketoconazole|mesh-list
25700135|NCT02117570|Vaccines|vaccines|mesh-list
25700136|NCT02117570|Immunologic Factors|immunologic factors|mesh-ancestor
25700137|NCT02117570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700138|NCT02117648|Clarithromycin|clarithromycin|mesh-list
25700139|NCT02117648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24486937|NCT00460707|Casopitant|casopitant|mesh-list
24486938|NCT00460707|Antifungal Agents|antifungal agents|mesh-ancestor
25700140|NCT02117648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24955160|NCT03867695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24955161|NCT03867695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955162|NCT03867695|Sensory System Agents|sensory system agents|mesh-ancestor
24955163|NCT03867695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24822096|NCT02109783|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24955164|NCT03867851|Heparin|heparin|mesh-list
24955165|NCT03867851|Anticoagulants|anticoagulants|mesh-ancestor
24955170|NCT03867097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24955172|NCT03867071|Epoetin Alfa|epoetin alfa|mesh-list
24955173|NCT03867071|Hematinics|hematinics|mesh-ancestor
24955174|NCT03867370|Lenvatinib|lenvatinib|mesh-list
24884532|NCT00398151|Montelukast|montelukast|mesh-list
24884533|NCT00398151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24912702|NCT04273100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24912857|NCT04271384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912858|NCT04270864|Nivolumab|nivolumab|mesh-list
24912859|NCT04270864|Ipilimumab|ipilimumab|mesh-list
24955175|NCT03867370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24955176|NCT03867370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24955177|NCT03867370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24955178|NCT03867370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955179|NCT03867214|Tranexamic Acid|tranexamic acid|mesh-list
24955180|NCT03867214|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24955181|NCT03867214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24955182|NCT03867214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955187|NCT03867123|Alkylating Agents|alkylating agents|mesh-ancestor
24955188|NCT03867123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912860|NCT04270864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24912861|NCT04270864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912862|NCT04270864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24912863|NCT04270864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912864|NCT04270968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24912865|NCT04270929|Folfirinox|folfirinox|mesh-list
24520047|NCT04019015|Thrombin|thrombin|mesh-list
24955189|NCT03867123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24955190|NCT03867240|Gabapentin|gabapentin|mesh-list
24955191|NCT03867240|Analgesics|analgesics|mesh-ancestor
24955192|NCT03867240|Sensory System Agents|sensory system agents|mesh-ancestor
24955193|NCT03867240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955194|NCT03867240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884546|NCT00394160|Hormone Antagonists|hormone antagonists|mesh-ancestor
25700141|NCT02117648|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25700142|NCT02117648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700143|NCT02117648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700144|NCT02117648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25700145|NCT02117648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25700146|NCT02117687|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25700147|NCT02117687|Hyaluronic Acid|hyaluronic acid|mesh-list
24955210|NCT03866980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24955211|NCT03866980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24913051|NCT04268927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913052|NCT04268927|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24736107|NCT01660295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24913053|NCT04268927|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24913054|NCT04268927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24955214|NCT03866993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25700148|NCT02117687|Glycerol|glycerol|mesh-list
24955246|NCT03866733|Analgesics|analgesics|mesh-ancestor
24955247|NCT03866733|Sensory System Agents|sensory system agents|mesh-ancestor
24955248|NCT03866733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25700157|NCT02117934|Vaccines|vaccines|mesh-list
25700158|NCT02117934|Immunologic Factors|immunologic factors|mesh-ancestor
25700159|NCT02117934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700160|NCT02118012|Ribavirin|ribavirin|mesh-list
25700161|NCT02118012|Antimetabolites|antimetabolites|mesh-ancestor
25700162|NCT02118012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700163|NCT02118012|Antiviral Agents|antiviral agents|mesh-ancestor
25700164|NCT02118012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24455176|NCT02448771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24455177|NCT02448771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24955257|NCT03866369|Moxifloxacin|moxifloxacin|mesh-list
24955258|NCT03866369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24955259|NCT03866369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24955260|NCT03866369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24816357|NCT02076659|Methotrexate|methotrexate|mesh-list
24455178|NCT02448771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24455182|NCT02448771|Hormone Antagonists|hormone antagonists|mesh-ancestor
24455192|NCT02337829|Acalabrutinib|acalabrutinib|mesh-list
24455193|NCT02337829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24455194|NCT02329080|Cytarabine|cytarabine|mesh-list
24455202|NCT02329080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24955261|NCT03866369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24955262|NCT03866369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24955263|NCT03866369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955264|NCT03866369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24955265|NCT03866408|Pioglitazone|pioglitazone|mesh-list
24955266|NCT03866408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24955267|NCT03866408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955269|NCT03866447|Adapalene|adapalene|mesh-list
24955270|NCT03866447|Vitamins|vitamins|mesh-ancestor
24955271|NCT03866447|Micronutrients|micronutrients|mesh-ancestor
24955272|NCT03866447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816363|NCT02076659|Antimetabolites|antimetabolites|mesh-ancestor
24455203|NCT02329080|Immunologic Factors|immunologic factors|mesh-ancestor
24455209|NCT02329080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24455210|NCT02329080|Antimetabolites|antimetabolites|mesh-ancestor
24822761|NCT02113150|Narcotics|narcotics|mesh-ancestor
24455211|NCT02329080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955273|NCT03866447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24955274|NCT03866447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24955275|NCT03866447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24955276|NCT03866447|Analgesics|analgesics|mesh-ancestor
24955277|NCT03866447|Sensory System Agents|sensory system agents|mesh-ancestor
24955278|NCT03866447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24760231|NCT01756781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078190|NCT03358524|Vitamin E|vitamin e|mesh-list
24955294|NCT03865888|Cyclosporine|cyclosporine|mesh-list
24955302|NCT03865888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955303|NCT03865888|Antifungal Agents|antifungal agents|mesh-ancestor
24955304|NCT03865888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24955305|NCT03865888|Dermatologic Agents|dermatologic agents|mesh-ancestor
24884610|NCT00157937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24884611|NCT00157937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24520291|NCT03085004|Antimetabolites|antimetabolites|mesh-ancestor
24955306|NCT03865888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24955307|NCT03865706|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24955308|NCT03865706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24955309|NCT03865706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24955310|NCT03865706|Antitubercular Agents|antitubercular agents|mesh-ancestor
24955312|NCT03865550|Analgesics|analgesics|mesh-ancestor
24955313|NCT03865550|Sensory System Agents|sensory system agents|mesh-ancestor
24955314|NCT03865550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955315|NCT03865550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955316|NCT03865550|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24955317|NCT03865550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24781137|NCT01888250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781138|NCT01888250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24781139|NCT01888250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781140|NCT01888250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24781141|NCT01888250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24781142|NCT01888250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24884655|NCT03754153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24884656|NCT03754153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884657|NCT03754153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24884658|NCT03754153|Respiratory System Agents|respiratory system agents|mesh-ancestor
24884659|NCT03754153|Mydriatics|mydriatics|mesh-ancestor
24816367|NCT02076659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24884666|NCT03753074|Tenofovir|tenofovir|mesh-list
25700166|NCT02118337|Durvalumab|durvalumab|mesh-list
25700167|NCT02118337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25700168|NCT02118337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700169|NCT02118337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25709515|NCT02268396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25709516|NCT02268396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709517|NCT02268396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25709518|NCT02268396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25709519|NCT02268396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25709520|NCT02268396|Cholinergic Agents|cholinergic agents|mesh-ancestor
25700173|NCT02118597|Simeprevir|simeprevir|mesh-list
24393179|NCT00129038|Sensory System Agents|sensory system agents|mesh-ancestor
25078206|NCT03358277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25078207|NCT03358277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25078208|NCT03358277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24955365|NCT03865160|Autonomic Agents|autonomic agents|mesh-ancestor
25700174|NCT02118597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700175|NCT02118597|Antiviral Agents|antiviral agents|mesh-ancestor
25700176|NCT02118597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24955373|NCT03865160|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24955374|NCT03865160|Cholinergic Agents|cholinergic agents|mesh-ancestor
24955375|NCT03865160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24955376|NCT03865160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955377|NCT03865004|Acetaminophen|acetaminophen|mesh-list
24955378|NCT03865004|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
24955380|NCT03865004|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24955381|NCT03865004|Narcotics|narcotics|mesh-ancestor
24955382|NCT03865004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24955383|NCT03865004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955384|NCT03865004|Analgesics|analgesics|mesh-ancestor
24884706|NCT03699540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24884707|NCT03699540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884708|NCT03697876|Hyaluronic Acid|hyaluronic acid|mesh-list
24393235|NCT00129181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24393236|NCT00129181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451890|NCT00325117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451891|NCT00325117|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24451892|NCT00325117|Protease Inhibitors|protease inhibitors|mesh-ancestor
24451893|NCT00325117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451914|NCT00325182|Nootropic Agents|nootropic agents|mesh-ancestor
24451915|NCT00325286|Carbamazepine|carbamazepine|mesh-list
24451942|NCT00325351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451943|NCT00325390|Clopidogrel|clopidogrel|mesh-list
24451944|NCT00325390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24393238|NCT00129181|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24955385|NCT03865004|Sensory System Agents|sensory system agents|mesh-ancestor
25700177|NCT02118597|Antimetabolites|antimetabolites|mesh-ancestor
25700178|NCT02118597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700179|NCT02118597|Protease Inhibitors|protease inhibitors|mesh-ancestor
25700180|NCT02118597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700181|NCT02118714|Atrasentan|atrasentan|mesh-list
25700182|NCT02118714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700183|NCT02118714|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
24955406|NCT03865147|Anesthetics, Local|anesthetics, local|mesh-ancestor
24955407|NCT03865147|Anesthetics|anesthetics|mesh-ancestor
24955408|NCT03865147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24955409|NCT03865147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955410|NCT03865147|Sensory System Agents|sensory system agents|mesh-ancestor
24393262|NCT00129298|GABA Agents|gaba agents|mesh-ancestor
24393287|NCT00129506|Abortifacient Agents|abortifacient agents|mesh-ancestor
24955420|NCT03865147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24964342|NCT03783728|Pyridoxine|pyridoxine|mesh-list
24955421|NCT03865147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24955422|NCT03865147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24955423|NCT03865147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24955424|NCT03865147|Antipyretics|antipyretics|mesh-ancestor
24393290|NCT00129506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24393291|NCT00129506|Antimetabolites|antimetabolites|mesh-ancestor
24955442|NCT03865121|Autonomic Agents|autonomic agents|mesh-ancestor
24955443|NCT03865121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955444|NCT03865121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955445|NCT03865121|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24955446|NCT03865121|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24955447|NCT03865121|Cholinergic Agents|cholinergic agents|mesh-ancestor
24955448|NCT03865121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24955449|NCT03865121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955451|NCT03864978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24955452|NCT03864978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24955453|NCT03864978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24884773|NCT03603509|Vaccines|vaccines|mesh-list
24393309|NCT00129519|Interferon Inducers|interferon inducers|mesh-ancestor
24393310|NCT00129597|Ketamine|ketamine|mesh-list
24393311|NCT00129597|Analgesics|analgesics|mesh-ancestor
24393312|NCT00129597|Sensory System Agents|sensory system agents|mesh-ancestor
24393313|NCT00129597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24393314|NCT00129597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393315|NCT00129597|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24393329|NCT00129753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24819670|NCT02096601|Dopamine Agents|dopamine agents|mesh-ancestor
24393330|NCT00129753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700184|NCT02118714|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25700185|NCT02118714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700186|NCT02118831|Bevacizumab|bevacizumab|mesh-list
25700187|NCT02118831|Ranibizumab|ranibizumab|mesh-list
25700188|NCT02118831|Aflibercept|aflibercept|mesh-list
25700189|NCT02118831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24393331|NCT00129805|Aspirin|aspirin|mesh-list
24393332|NCT00129805|Sarpogrelate|sarpogrelate|mesh-list
25700190|NCT02118831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700191|NCT02118831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24955456|NCT03864783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24955457|NCT03864783|Analgesics|analgesics|mesh-ancestor
24955458|NCT03864783|Sensory System Agents|sensory system agents|mesh-ancestor
24955459|NCT03864783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955460|NCT03864783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955461|NCT03864783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24955466|NCT03864666|Cilostazol|cilostazol|mesh-list
24955467|NCT03864666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24955468|NCT03864666|Autonomic Agents|autonomic agents|mesh-ancestor
24955469|NCT03864666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24393341|NCT00129805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24393342|NCT00129805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24393343|NCT00129805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393345|NCT00129805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24393354|NCT00129818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24393355|NCT00129818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24393356|NCT00129818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393357|NCT00129844|Motexafin gadolinium|motexafin gadolinium|mesh-list
24393368|NCT00129857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24393369|NCT00129857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24393370|NCT00129857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24393371|NCT00129857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955470|NCT03864666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955472|NCT03864666|Respiratory System Agents|respiratory system agents|mesh-ancestor
24955473|NCT03864666|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24955474|NCT03864666|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24955475|NCT03864666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955476|NCT03864666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24955477|NCT03864666|Vasodilator Agents|vasodilator agents|mesh-ancestor
24955478|NCT03864666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24955479|NCT03864666|Protective Agents|protective agents|mesh-ancestor
24955480|NCT03864666|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24393372|NCT00129857|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24393373|NCT00129857|Protective Agents|protective agents|mesh-ancestor
24393375|NCT00129870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393394|NCT00129922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393395|NCT00129922|Tubulin Modulators|tubulin modulators|mesh-ancestor
24393396|NCT00129922|Antimitotic Agents|antimitotic agents|mesh-ancestor
24393397|NCT00129922|Mitosis Modulators|mitosis modulators|mesh-ancestor
24393398|NCT00129922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393399|NCT00129922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24393400|NCT00129922|Immunologic Factors|immunologic factors|mesh-ancestor
24393401|NCT00129922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393402|NCT00129922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24393403|NCT00129922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24393406|NCT00129922|Antimetabolites|antimetabolites|mesh-ancestor
24955488|NCT03864250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24955489|NCT03864250|Glucocorticoids|glucocorticoids|mesh-ancestor
24955491|NCT03864250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24955499|NCT03864250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955500|NCT03864601|JNJ-56136379|jnj-56136379|mesh-list
24955501|NCT03864601|Antiviral Agents|antiviral agents|mesh-ancestor
24955502|NCT03864601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24884814|NCT03459859|Cytarabine|cytarabine|mesh-list
24393417|NCT00129948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24393419|NCT00130000|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24393420|NCT00130000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24393421|NCT00130000|Immunologic Factors|immunologic factors|mesh-ancestor
24393422|NCT00130000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393424|NCT00130013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24393425|NCT00130013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24393427|NCT00130026|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24393428|NCT00130026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393429|NCT00130026|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24393430|NCT00130026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24393431|NCT00130026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393432|NCT00130026|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25700193|NCT02118831|Growth Substances|growth substances|mesh-ancestor
25700194|NCT02118831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700195|NCT02118831|Growth Inhibitors|growth inhibitors|mesh-ancestor
25700196|NCT02118896|Tacrolimus|tacrolimus|mesh-list
25700197|NCT02118896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25700198|NCT02118896|Immunologic Factors|immunologic factors|mesh-ancestor
25700199|NCT02118896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700200|NCT02118896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25700201|NCT02118896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700202|NCT02118896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393457|NCT00130091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24393458|NCT00130091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393459|NCT00130091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24393460|NCT00130091|Sympatholytics|sympatholytics|mesh-ancestor
24393461|NCT00130091|Autonomic Agents|autonomic agents|mesh-ancestor
24393462|NCT00130091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24393463|NCT00130091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24393470|NCT00130143|Protective Agents|protective agents|mesh-ancestor
24393471|NCT00130143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393472|NCT00130156|Doxazosin|doxazosin|mesh-list
24393473|NCT00130156|Bunazosin|bunazosin|mesh-list
24393474|NCT00130156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24393475|NCT00130156|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24393476|NCT00130156|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24393477|NCT00130156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24393478|NCT00130156|Adrenergic Agents|adrenergic agents|mesh-ancestor
24393479|NCT00130156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24393480|NCT00130156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393481|NCT00130156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955537|NCT03864172|Calcium|calcium|mesh-list
24955538|NCT03864172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24955539|NCT03864172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955540|NCT03864172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24884862|NCT03339284|BB 1101|bb 1101|mesh-list
24421706|NCT00219921|Sensory System Agents|sensory system agents|mesh-ancestor
24421707|NCT00219921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24421708|NCT00219934|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24421709|NCT00219934|Antiviral Agents|antiviral agents|mesh-ancestor
24421710|NCT00219934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24421711|NCT00219973|Bemiparin|bemiparin|mesh-list
24393483|NCT00130195|Dexamethasone|dexamethasone|mesh-list
24393506|NCT00130195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24393507|NCT00130195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24393508|NCT00130195|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24393510|NCT00130195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24393511|NCT00130195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24393512|NCT00130195|Antimetabolites|antimetabolites|mesh-ancestor
24955547|NCT03863925|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24955548|NCT03863925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24955549|NCT03863925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955550|NCT03863925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24955551|NCT03863925|Anesthetics, General|anesthetics, general|mesh-ancestor
24955552|NCT03863925|Anesthetics|anesthetics|mesh-ancestor
24955553|NCT03863977|Dexamethasone|dexamethasone|mesh-list
24955554|NCT03863977|Dexamethasone acetate|dexamethasone acetate|mesh-list
24955555|NCT03863977|Bupivacaine|bupivacaine|mesh-list
24955556|NCT03863977|BB 1101|bb 1101|mesh-list
24955557|NCT03863977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24955558|NCT03863977|Antiemetics|antiemetics|mesh-ancestor
24955559|NCT03863977|Autonomic Agents|autonomic agents|mesh-ancestor
24955560|NCT03863977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955561|NCT03863977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955562|NCT03863977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24884870|NCT03339284|Hormones|hormones|mesh-ancestor
24955564|NCT03863977|Hormones|hormones|mesh-ancestor
24955565|NCT03863977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24955566|NCT03863977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24955567|NCT03863977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24955568|NCT03863977|Protease Inhibitors|protease inhibitors|mesh-ancestor
24955569|NCT03863977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24955570|NCT03863977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955572|NCT03863977|Anesthetics|anesthetics|mesh-ancestor
24955573|NCT03863977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24955574|NCT03863977|Sensory System Agents|sensory system agents|mesh-ancestor
25700203|NCT02118961|Vaccines|vaccines|mesh-list
25700204|NCT02118961|Immunologic Factors|immunologic factors|mesh-ancestor
25700205|NCT02118961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700206|NCT02119026|Bevacizumab|bevacizumab|mesh-list
25700207|NCT02119026|Capecitabine|capecitabine|mesh-list
25700208|NCT02119026|Oxaliplatin|oxaliplatin|mesh-list
25700209|NCT02119026|Irinotecan|irinotecan|mesh-list
25700210|NCT02119026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25700211|NCT02119026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24422035|NCT00221039|Dermatologic Agents|dermatologic agents|mesh-ancestor
24955575|NCT03864016|Sufentanil|sufentanil|mesh-list
24393530|NCT00130221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24393531|NCT00130221|Disinfectants|disinfectants|mesh-ancestor
24393532|NCT00130221|Dermatologic Agents|dermatologic agents|mesh-ancestor
24393533|NCT00130234|Omalizumab|omalizumab|mesh-list
24393534|NCT00130234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24393535|NCT00130234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24393536|NCT00130234|Respiratory System Agents|respiratory system agents|mesh-ancestor
24393537|NCT00130325|Isoniazid|isoniazid|mesh-list
24393538|NCT00130325|Antitubercular Agents|antitubercular agents|mesh-ancestor
24393539|NCT00130325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24393540|NCT00130325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24955576|NCT03864016|Dsuvia|dsuvia|mesh-list
24955577|NCT03864016|Anesthetics|anesthetics|mesh-ancestor
24955578|NCT03864016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24955579|NCT03864016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955580|NCT03864016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24955581|NCT03864016|Narcotics|narcotics|mesh-ancestor
24955582|NCT03864016|Analgesics|analgesics|mesh-ancestor
24451962|NCT00325455|Antimetabolites|antimetabolites|mesh-ancestor
24393550|NCT00130338|Cholinergic Agents|cholinergic agents|mesh-ancestor
24393551|NCT00130338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24393564|NCT00130351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24393565|NCT00130351|Adrenergic Agents|adrenergic agents|mesh-ancestor
24393566|NCT00130351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24393567|NCT00130351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393569|NCT00130364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24393570|NCT00130364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24393571|NCT00130364|Analgesics|analgesics|mesh-ancestor
24917144|NCT04232800|Riboflavin|riboflavin|mesh-list
24393572|NCT00130364|Sensory System Agents|sensory system agents|mesh-ancestor
24393573|NCT00130364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24393574|NCT00130364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393575|NCT00130364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24393576|NCT00130364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24393577|NCT00130364|Dermatologic Agents|dermatologic agents|mesh-ancestor
24393578|NCT00130364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24393579|NCT00130364|Immunologic Factors|immunologic factors|mesh-ancestor
24451963|NCT00325455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451964|NCT00325455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24451966|NCT00325546|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24451967|NCT00325546|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24451969|NCT00325546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24451974|NCT00325637|Losartan|losartan|mesh-list
24451975|NCT00325637|Cilnidipine|cilnidipine|mesh-list
24451976|NCT00325637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24955607|NCT03863392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955597|NCT03863691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621046|NCT01060501|Levoleucovorin|levoleucovorin|mesh-list
24621047|NCT01060501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24955598|NCT03863691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24621048|NCT01060501|Antiviral Agents|antiviral agents|mesh-ancestor
24621049|NCT01060501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24955599|NCT03863691|Antidepressive Agents|antidepressive agents|mesh-ancestor
24955600|NCT03863405|Metformin|metformin|mesh-list
24955601|NCT03863405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24955603|NCT03863392|Misoprostol|misoprostol|mesh-list
25700212|NCT02119026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25700213|NCT02119026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24955604|NCT03863392|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24955605|NCT03863392|Abortifacient Agents|abortifacient agents|mesh-ancestor
25700214|NCT02119026|Growth Substances|growth substances|mesh-ancestor
25700215|NCT02119026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700216|NCT02119026|Growth Inhibitors|growth inhibitors|mesh-ancestor
25700217|NCT02119026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25700218|NCT02119026|Antimetabolites|antimetabolites|mesh-ancestor
24463978|NCT00362895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24455228|NCT02244125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24455229|NCT02244125|Immunologic Factors|immunologic factors|mesh-ancestor
24455230|NCT02244125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455231|NCT02244125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24393635|NCT00130546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24393638|NCT00130546|Antimitotic Agents|antimitotic agents|mesh-ancestor
24393639|NCT00130546|Mitosis Modulators|mitosis modulators|mesh-ancestor
24393640|NCT00130546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700219|NCT02119026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700220|NCT02119026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25700221|NCT02119026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25700222|NCT02119026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700223|NCT02119104|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25700224|NCT02119104|Immunologic Factors|immunologic factors|mesh-ancestor
25700225|NCT02119104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700226|NCT02119156|Belimumab|belimumab|mesh-list
25700227|NCT02119156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25700228|NCT02119156|Immunologic Factors|immunologic factors|mesh-ancestor
25700229|NCT02119156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955637|NCT03863223|Tubulin Modulators|tubulin modulators|mesh-ancestor
24955638|NCT03863223|Antimitotic Agents|antimitotic agents|mesh-ancestor
24955639|NCT03863223|Mitosis Modulators|mitosis modulators|mesh-ancestor
24955640|NCT03863223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955641|NCT03863223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24955645|NCT03862690|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24955646|NCT03862690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24955648|NCT03862768|Sunitinib|sunitinib|mesh-list
24393694|NCT00130767|Finasteride|finasteride|mesh-list
24393695|NCT00130767|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24393696|NCT00130767|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24393697|NCT00130767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078224|NCT03358082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25078225|NCT03358017|Zoledronic Acid|zoledronic acid|mesh-list
25078226|NCT03358017|Atorvastatin|atorvastatin|mesh-list
25078227|NCT03358017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24955650|NCT03862768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24955651|NCT03862768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24955652|NCT03862768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24955653|NCT03862768|Growth Substances|growth substances|mesh-ancestor
24955654|NCT03862768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955655|NCT03862768|Growth Inhibitors|growth inhibitors|mesh-ancestor
24955656|NCT03862768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24955657|NCT03862768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24955658|NCT03862768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955659|NCT03862456|Azithromycin|azithromycin|mesh-list
24955660|NCT03862456|Metronidazole|metronidazole|mesh-list
24955661|NCT03862456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24955662|NCT03862456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25700230|NCT02119260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25700231|NCT02119650|Cisplatin|cisplatin|mesh-list
25700232|NCT02119650|Pemetrexed|pemetrexed|mesh-list
25700233|NCT02119650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700234|NCT02119650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24955696|NCT03862404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955697|NCT03862404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24955698|NCT03862404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24955699|NCT03862404|Adrenergic Agents|adrenergic agents|mesh-ancestor
24955700|NCT03862404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24955701|NCT03862404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955702|NCT03862404|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24955703|NCT03862404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24955704|NCT03862404|Autonomic Agents|autonomic agents|mesh-ancestor
24955705|NCT03862404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24955706|NCT03862404|Respiratory System Agents|respiratory system agents|mesh-ancestor
24781422|NCT01889498|Acetazolamide|acetazolamide|mesh-list
24781498|NCT01889979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781499|NCT01889979|Analgesics|analgesics|mesh-ancestor
24781500|NCT01889979|Sensory System Agents|sensory system agents|mesh-ancestor
24781501|NCT01889979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24781502|NCT01889992|Sirolimus|sirolimus|mesh-list
24781503|NCT01889992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24781504|NCT01889992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24393797|NCT00131027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393798|NCT00131027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24393799|NCT00131027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24393801|NCT00131027|Autonomic Agents|autonomic agents|mesh-ancestor
24393802|NCT00131027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24393803|NCT00131027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24393804|NCT00131027|Glucocorticoids|glucocorticoids|mesh-ancestor
24393806|NCT00131027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24393807|NCT00131027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24393808|NCT00131027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24393809|NCT00131027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24393810|NCT00131027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24393811|NCT00131027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24393812|NCT00131027|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24393813|NCT00131027|Abortifacient Agents|abortifacient agents|mesh-ancestor
24393814|NCT00131027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24781505|NCT01889992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24781506|NCT01889992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393815|NCT00131027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24393819|NCT00131027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24393820|NCT00131027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24393821|NCT00131027|Antiviral Agents|antiviral agents|mesh-ancestor
24393822|NCT00131027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24393823|NCT00131027|Tubulin Modulators|tubulin modulators|mesh-ancestor
24393824|NCT00131027|Antimitotic Agents|antimitotic agents|mesh-ancestor
24393825|NCT00131027|Mitosis Modulators|mitosis modulators|mesh-ancestor
24393826|NCT00131040|Aprotinin|aprotinin|mesh-list
24393827|NCT00131040|Hemostatics|hemostatics|mesh-ancestor
24393828|NCT00131040|Coagulants|coagulants|mesh-ancestor
25709521|NCT02268864|Simeprevir|simeprevir|mesh-list
25709522|NCT02268864|Antiviral Agents|antiviral agents|mesh-ancestor
25709523|NCT02268864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25709524|NCT02268864|Protease Inhibitors|protease inhibitors|mesh-ancestor
24955725|NCT03862287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24955726|NCT03862287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24955727|NCT03862287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24541795|NCT00675246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24955788|NCT03861364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24955789|NCT03861364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24955790|NCT03861364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955791|NCT03861364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24955792|NCT03861364|Anesthetics, General|anesthetics, general|mesh-ancestor
24955793|NCT03861364|Anesthetics|anesthetics|mesh-ancestor
24955795|NCT03860870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24955796|NCT03860870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24955797|NCT03860870|Adrenergic Agents|adrenergic agents|mesh-ancestor
24955798|NCT03860870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24955799|NCT03860870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955800|NCT03860870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955801|NCT03860870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24861933|NCT02321384|Anesthetics|anesthetics|mesh-ancestor
24393961|NCT00131404|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
24955836|NCT03860662|GABA Agents|gaba agents|mesh-ancestor
24955837|NCT03860662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25709525|NCT02268864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709526|NCT02268864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709527|NCT02268955|Ibuprofen|ibuprofen|mesh-list
25709528|NCT02268955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25709529|NCT02268955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25709530|NCT02268955|Analgesics|analgesics|mesh-ancestor
24955849|NCT03860636|Contraceptive Agents|contraceptive agents|mesh-ancestor
24955853|NCT03860480|Bupivacaine|bupivacaine|mesh-list
24955854|NCT03860480|Anesthetics, Local|anesthetics, local|mesh-ancestor
24955855|NCT03860480|Anesthetics|anesthetics|mesh-ancestor
24955856|NCT03860480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24494923|NCT00497523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24955857|NCT03860480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955858|NCT03860480|Sensory System Agents|sensory system agents|mesh-ancestor
24955859|NCT03860480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955861|NCT03860012|Hematinics|hematinics|mesh-ancestor
24955862|NCT03860012|Vitamin B Complex|vitamin b complex|mesh-ancestor
24393971|NCT00131430|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24393981|NCT00131482|Thrombin|thrombin|mesh-list
24393982|NCT00131482|Hemostatics|hemostatics|mesh-ancestor
24393983|NCT00131482|Coagulants|coagulants|mesh-ancestor
24393985|NCT00131495|Androgens|androgens|mesh-ancestor
24393986|NCT00131495|Hormones|hormones|mesh-ancestor
24955863|NCT03860012|Vitamins|vitamins|mesh-ancestor
24955864|NCT03860012|Micronutrients|micronutrients|mesh-ancestor
24955865|NCT03860012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955866|NCT03860129|Sevoflurane|sevoflurane|mesh-list
24955867|NCT03860129|Desflurane|desflurane|mesh-list
24955868|NCT03860129|Isoflurane|isoflurane|mesh-list
24955869|NCT03860129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24955870|NCT03860129|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24955871|NCT03860129|Anesthetics, General|anesthetics, general|mesh-ancestor
24955873|NCT03860129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24955874|NCT03860129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955875|NCT03860220|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
24955887|NCT03860220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24955888|NCT03859934|Melatonin|melatonin|mesh-list
24955889|NCT03859934|Antioxidants|antioxidants|mesh-ancestor
24955890|NCT03859934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955891|NCT03859934|Protective Agents|protective agents|mesh-ancestor
24919950|NCT04206865|Valsartan|valsartan|mesh-list
24955896|NCT03859908|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24955897|NCT03859908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24955898|NCT03859908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24938566|NCT04017741|Anesthetics|anesthetics|mesh-ancestor
24955899|NCT03859908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25078228|NCT03358017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25078229|NCT03358017|Antimetabolites|antimetabolites|mesh-ancestor
25078230|NCT03358017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078231|NCT03358017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24394059|NCT00131963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24394060|NCT00131963|Immunologic Factors|immunologic factors|mesh-ancestor
24394061|NCT00131963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394062|NCT00131963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24394063|NCT00131963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24394064|NCT00131963|Alkylating Agents|alkylating agents|mesh-ancestor
24394065|NCT00131963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24394074|NCT00131989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394076|NCT00132054|Amrubicin|amrubicin|mesh-list
24394077|NCT00132054|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24394078|NCT00132054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24394082|NCT00132067|Vorinostat|vorinostat|mesh-list
24394087|NCT00132093|Eplerenone|eplerenone|mesh-list
24394088|NCT00132093|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24394089|NCT00132093|Hormone Antagonists|hormone antagonists|mesh-ancestor
24394090|NCT00132093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24394091|NCT00132093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394092|NCT00132093|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24394093|NCT00132093|Diuretics|diuretics|mesh-ancestor
24394094|NCT00132093|Natriuretic Agents|natriuretic agents|mesh-ancestor
24394095|NCT00132093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24394096|NCT00132106|Phentolamine|phentolamine|mesh-list
24394097|NCT00132106|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24394098|NCT00132106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24394099|NCT00132106|Adrenergic Agents|adrenergic agents|mesh-ancestor
25078249|NCT03357900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25078250|NCT03357900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078251|NCT03357900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24394100|NCT00132106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24394101|NCT00132106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452090|NCT00325962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24452091|NCT00325962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452092|NCT00325962|Vasodilator Agents|vasodilator agents|mesh-ancestor
24452093|NCT00326027|Pantoprazole|pantoprazole|mesh-list
24452094|NCT00326027|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24452095|NCT00326027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24452096|NCT00326027|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24452097|NCT00326027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24452098|NCT00326027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452099|NCT00326053|Budesonide|budesonide|mesh-list
24452100|NCT00326053|Formoterol Fumarate|formoterol fumarate|mesh-list
24452101|NCT00326053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24452102|NCT00326053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24452103|NCT00326053|Autonomic Agents|autonomic agents|mesh-ancestor
24452104|NCT00326053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24452105|NCT00326053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452106|NCT00326053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25078252|NCT03357900|Anesthetics, General|anesthetics, general|mesh-ancestor
25078253|NCT03357900|Anesthetics|anesthetics|mesh-ancestor
25078254|NCT03357900|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25078255|NCT03357900|Narcotics|narcotics|mesh-ancestor
25078256|NCT03357900|Analgesics|analgesics|mesh-ancestor
25078257|NCT03357900|Sensory System Agents|sensory system agents|mesh-ancestor
25078258|NCT03357900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078259|NCT03357874|Clopidogrel|clopidogrel|mesh-list
25078260|NCT03357874|Ticagrelor|ticagrelor|mesh-list
25078261|NCT03357874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25078262|NCT03357874|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25078263|NCT03357874|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25078264|NCT03357874|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24394129|NCT00132236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24394130|NCT00132236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394131|NCT00132236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24394132|NCT00132236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24394139|NCT00132275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24394140|NCT00132275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24394141|NCT00132275|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24394142|NCT00132275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394143|NCT00132275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394144|NCT00132379|Docetaxel|docetaxel|mesh-list
24394145|NCT00132379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24394146|NCT00132379|Tubulin Modulators|tubulin modulators|mesh-ancestor
24394147|NCT00132379|Antimitotic Agents|antimitotic agents|mesh-ancestor
24394148|NCT00132379|Mitosis Modulators|mitosis modulators|mesh-ancestor
25078266|NCT03357874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25078267|NCT03357874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078268|NCT03357874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394164|NCT00132431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394165|NCT00132431|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24394166|NCT00132431|Hormone Antagonists|hormone antagonists|mesh-ancestor
24955919|NCT03859856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24955920|NCT03859856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955921|NCT03859583|Capsaicin|capsaicin|mesh-list
24955925|NCT03859583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955926|NCT03859583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812209|NCT02050529|Labetalol|labetalol|mesh-list
24955928|NCT03859570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24955929|NCT03859570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24955962|NCT03859102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24955980|NCT03859102|Dermatologic Agents|dermatologic agents|mesh-ancestor
24955981|NCT03859102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24955982|NCT03859102|Serotonin Agents|serotonin agents|mesh-ancestor
24955983|NCT03859102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24955984|NCT03859102|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24955985|NCT03859102|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24955986|NCT03859102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700242|NCT02119663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25709531|NCT02268955|Sensory System Agents|sensory system agents|mesh-ancestor
25709532|NCT02268955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25709533|NCT02268955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709534|NCT02268955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25709535|NCT02268955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25709536|NCT02268955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25709537|NCT02268955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709538|NCT02268955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709539|NCT02269163|Immunoglobulins|immunoglobulins|mesh-list
25709540|NCT02269163|Antibodies|antibodies|mesh-list
25709541|NCT02269163|gamma-Globulins|gamma-globulins|mesh-list
25709542|NCT02269163|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25709543|NCT02269163|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24781781|NCT01891812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24781782|NCT01891812|Analgesics|analgesics|mesh-ancestor
24452120|NCT00326092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24452121|NCT00326092|Adrenergic Agents|adrenergic agents|mesh-ancestor
24452122|NCT00326092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24452123|NCT00326092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452124|NCT00326092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452125|NCT00326092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24452126|NCT00326092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24626578|NCT01087879|Contraceptive Agents|contraceptive agents|mesh-list
24626580|NCT01087879|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24626581|NCT01087879|Estrogens|estrogens|mesh-ancestor
24626582|NCT01087879|Hormones|hormones|mesh-ancestor
24626583|NCT01087879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24626584|NCT01087879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626585|NCT01087879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24626586|NCT01087879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24626587|NCT01087879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24462865|NCT00357708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24462866|NCT00357708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462867|NCT00357708|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24462868|NCT00357721|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24462869|NCT00357721|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24462870|NCT00357721|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24462871|NCT00357721|Protease Inhibitors|protease inhibitors|mesh-ancestor
24462872|NCT00357721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394200|NCT00132548|Anthelmintics|anthelmintics|mesh-ancestor
25700243|NCT02119819|Metformin|metformin|mesh-list
25700244|NCT02119819|Exenatide|exenatide|mesh-list
25700245|NCT02119819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25700246|NCT02119819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700247|NCT02119819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25700248|NCT02119819|Incretins|incretins|mesh-ancestor
25700249|NCT02119819|Hormones|hormones|mesh-ancestor
25700250|NCT02119819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25700251|NCT02120157|Mycophenolic Acid|mycophenolic acid|mesh-list
25700252|NCT02120157|Cyclophosphamide|cyclophosphamide|mesh-list
24956055|NCT03857854|Sensory System Agents|sensory system agents|mesh-ancestor
24956089|NCT03857763|Antimitotic Agents|antimitotic agents|mesh-ancestor
24956090|NCT03857763|Mitosis Modulators|mitosis modulators|mesh-ancestor
24956091|NCT03857763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956092|NCT03857763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24956093|NCT03857763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24956094|NCT03857386|Anesthetics|anesthetics|mesh-list
24956095|NCT03857386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24956096|NCT03857386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956097|NCT03857815|Antibodies|antibodies|mesh-list
24956098|NCT03857815|Immunologic Factors|immunologic factors|mesh-ancestor
24956099|NCT03857815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956100|NCT03857581|Olanzapine|olanzapine|mesh-list
24462952|NCT00358124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462953|NCT00358176|Risedronic Acid|risedronic acid|mesh-list
25700253|NCT02120157|Busulfan|busulfan|mesh-list
25700254|NCT02120157|Tacrolimus|tacrolimus|mesh-list
25700255|NCT02120157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25700256|NCT02120157|Immunologic Factors|immunologic factors|mesh-ancestor
24956145|NCT03856970|Estrogens|estrogens|mesh-ancestor
24956147|NCT03856970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24956148|NCT03856970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956149|NCT03856970|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24956150|NCT03856970|Contraceptive Agents|contraceptive agents|mesh-ancestor
24956151|NCT03856970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24781863|NCT01892644|Deferasirox|deferasirox|mesh-list
24956168|NCT03856671|Neomycin|neomycin|mesh-list
24956169|NCT03856671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24956170|NCT03856671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24956171|NCT03856671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24956172|NCT03856671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24956173|NCT03856671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24956174|NCT03856671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24956175|NCT03856671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956212|NCT03856242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816400|NCT02076828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24816401|NCT02076828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956213|NCT03856242|Urological Agents|urological agents|mesh-ancestor
25700257|NCT02120157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956235|NCT03856112|Glycine Agents|glycine agents|mesh-ancestor
25700258|NCT02120157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25700259|NCT02120157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25700260|NCT02120157|Alkylating Agents|alkylating agents|mesh-ancestor
25700261|NCT02120157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700262|NCT02120157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700263|NCT02120157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25700264|NCT02120157|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24956237|NCT03856112|Dermatologic Agents|dermatologic agents|mesh-ancestor
24956238|NCT03855865|Vortioxetine|vortioxetine|mesh-list
24956239|NCT03855865|Antidepressive Agents|antidepressive agents|mesh-ancestor
24956240|NCT03855865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24956241|NCT03855865|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24782038|NCT01893450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24782039|NCT01893450|Dopamine Agonists|dopamine agonists|mesh-ancestor
24782040|NCT01893450|Dopamine Agents|dopamine agents|mesh-ancestor
24782041|NCT01893450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24782042|NCT01893450|Antithyroid Agents|antithyroid agents|mesh-ancestor
24782043|NCT01893541|Propranolol|propranolol|mesh-list
24782044|NCT01893541|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24782045|NCT01893541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24782046|NCT01893541|Adrenergic Agents|adrenergic agents|mesh-ancestor
24782047|NCT01893541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24782048|NCT01893541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782049|NCT01893541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782050|NCT01893541|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24782051|NCT01893541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24782052|NCT01893541|Vasodilator Agents|vasodilator agents|mesh-ancestor
24626632|NCT01088022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626633|NCT01088022|Protease Inhibitors|protease inhibitors|mesh-ancestor
24626634|NCT01088022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626635|NCT01088022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626636|NCT01088022|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24626637|NCT01088022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24626638|NCT01088022|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24626639|NCT01088022|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25078277|NCT03357822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078278|NCT03357822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078279|NCT03357822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25078280|NCT03357822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25078281|NCT03357796|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
25078282|NCT03357796|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25078283|NCT03357796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25078284|NCT03357796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25078285|NCT03357796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078286|NCT03357796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25078287|NCT03357796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078288|NCT03357796|Antidepressive Agents|antidepressive agents|mesh-ancestor
25078289|NCT03357796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25078291|NCT03357757|Valproic Acid|valproic acid|mesh-list
25078292|NCT03357757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25078293|NCT03357757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25078294|NCT03357757|Anticonvulsants|anticonvulsants|mesh-ancestor
25078295|NCT03357757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078296|NCT03357757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078297|NCT03357757|GABA Agents|gaba agents|mesh-ancestor
25078298|NCT03357757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25078308|NCT03357718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078309|NCT03357718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25078310|NCT03357718|Analgesics|analgesics|mesh-ancestor
25078311|NCT03357718|Sensory System Agents|sensory system agents|mesh-ancestor
25078312|NCT03357718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078313|NCT03357718|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25078314|NCT03357718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25078315|NCT03357718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25078316|NCT03357718|Adrenergic Agents|adrenergic agents|mesh-ancestor
25078317|NCT03357718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25078318|NCT03357718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078319|NCT03357718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25078320|NCT03357718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24626641|NCT01088035|Carboplatin|carboplatin|mesh-list
24626642|NCT01088035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626643|NCT01088165|Adalimumab|adalimumab|mesh-list
24626644|NCT01088165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24626645|NCT01088165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24626646|NCT01088178|Levonorgestrel|levonorgestrel|mesh-list
24626647|NCT01088178|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24645933|NCT01200745|Capsaicin|capsaicin|mesh-list
24626652|NCT01088178|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24626653|NCT01088178|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24626654|NCT01088191|Hyaluronic Acid|hyaluronic acid|mesh-list
24626655|NCT01088191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24626656|NCT01088191|Immunologic Factors|immunologic factors|mesh-ancestor
24626657|NCT01088191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626658|NCT01088191|Viscosupplements|viscosupplements|mesh-ancestor
24522872|NCT03103087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956243|NCT03855865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24626659|NCT01088191|Protective Agents|protective agents|mesh-ancestor
24956244|NCT03855865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956245|NCT03855865|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24956246|NCT03855865|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24964438|NCT03783182|Betamethasone|betamethasone|mesh-list
24956247|NCT03855865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24956249|NCT03855865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24956255|NCT03855826|Amiodarone|amiodarone|mesh-list
24956256|NCT03855826|Nifekalant|nifekalant|mesh-list
24956257|NCT03855826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24956258|NCT03855826|Vasodilator Agents|vasodilator agents|mesh-ancestor
24956259|NCT03855826|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24956260|NCT03855826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24956261|NCT03855826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956262|NCT03855826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24956263|NCT03855826|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24956264|NCT03855826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24956266|NCT03855826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24956267|NCT03855826|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24956268|NCT03855826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24956269|NCT03855501|Calcium|calcium|mesh-list
24956282|NCT03855579|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24956283|NCT03855423|Tocotrienols|tocotrienols|mesh-list
24956284|NCT03855423|Vitamin E|vitamin e|mesh-list
24956285|NCT03855423|Tocopherols|tocopherols|mesh-list
24956286|NCT03855423|Tocovid|tocovid|mesh-list
24956287|NCT03855423|Antioxidants|antioxidants|mesh-ancestor
24956288|NCT03855423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956289|NCT03855423|Protective Agents|protective agents|mesh-ancestor
24885618|NCT05027425|Durvalumab|durvalumab|mesh-list
24956290|NCT03855423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956291|NCT03855423|Vitamins|vitamins|mesh-ancestor
24956292|NCT03855423|Micronutrients|micronutrients|mesh-ancestor
24956293|NCT03855527|Chlorhexidine|chlorhexidine|mesh-list
24956294|NCT03855527|Fluorides|fluorides|mesh-list
24956295|NCT03855527|Cariostatic Agents|cariostatic agents|mesh-ancestor
24956296|NCT03855527|Protective Agents|protective agents|mesh-ancestor
24956297|NCT03855527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956298|NCT03855527|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24956299|NCT03855527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24956300|NCT03855527|Disinfectants|disinfectants|mesh-ancestor
24956301|NCT03855306|Glyburide|glyburide|mesh-list
24956302|NCT03855306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24956303|NCT03855306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956304|NCT03855384|Cisplatin|cisplatin|mesh-list
24956305|NCT03855384|Carboplatin|carboplatin|mesh-list
24956306|NCT03855384|Fluorouracil|fluorouracil|mesh-list
24956307|NCT03855384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24956308|NCT03855384|Antimetabolites|antimetabolites|mesh-ancestor
24956309|NCT03855384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497866|NCT00512291|Olanzapine|olanzapine|mesh-list
24956392|NCT03854812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24956393|NCT03854812|Narcotics|narcotics|mesh-ancestor
24956394|NCT03854812|Analgesics|analgesics|mesh-ancestor
24956395|NCT03854812|Sensory System Agents|sensory system agents|mesh-ancestor
24956396|NCT03854812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24956397|NCT03854812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24462998|NCT00358319|Anticonvulsants|anticonvulsants|mesh-ancestor
24462999|NCT00358319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24956398|NCT03854812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24956399|NCT03854812|Anticonvulsants|anticonvulsants|mesh-ancestor
24956400|NCT03854812|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24956401|NCT03854812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24956402|NCT03854812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956403|NCT03854812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24956404|NCT03854812|Tocolytic Agents|tocolytic agents|mesh-ancestor
24956405|NCT03854812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24956406|NCT03854942|Naltrexone|naltrexone|mesh-list
24956407|NCT03854942|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24956408|NCT03854942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24956409|NCT03854942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956410|NCT03854942|Sensory System Agents|sensory system agents|mesh-ancestor
24956411|NCT03854942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24956412|NCT03854708|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
24956417|NCT03854383|Isosorbide|isosorbide|mesh-list
24956418|NCT03854383|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24956435|NCT03854617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24956436|NCT03854617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24956437|NCT03854617|Tubulin Modulators|tubulin modulators|mesh-ancestor
24956438|NCT03854617|Antimitotic Agents|antimitotic agents|mesh-ancestor
24956439|NCT03854617|Mitosis Modulators|mitosis modulators|mesh-ancestor
24956440|NCT03854617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956441|NCT03854409|Aripiprazole|aripiprazole|mesh-list
24956442|NCT03854409|Antidepressive Agents|antidepressive agents|mesh-ancestor
24956443|NCT03854409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24956444|NCT03854409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24956445|NCT03854409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24956446|NCT03854409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24956447|NCT03854409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956448|NCT03854409|Dopamine Agonists|dopamine agonists|mesh-ancestor
24956449|NCT03854409|Dopamine Agents|dopamine agents|mesh-ancestor
24956450|NCT03854409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24956451|NCT03854409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956473|NCT03854396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24956474|NCT03854396|Immunologic Factors|immunologic factors|mesh-ancestor
24956475|NCT03854396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956477|NCT03854266|Calcium heparin|calcium heparin|mesh-list
24956478|NCT03854266|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24956479|NCT03854266|Anticoagulants|anticoagulants|mesh-ancestor
24956480|NCT03854266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24956481|NCT03854266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24956482|NCT03854266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956483|NCT03854175|Sildenafil Citrate|sildenafil citrate|mesh-list
24956484|NCT03854175|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24956485|NCT03854175|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24956486|NCT03854175|Estradiol|estradiol|mesh-list
24956487|NCT03854175|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24956491|NCT03854175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24956492|NCT03854175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956493|NCT03854175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24956494|NCT03854175|Contraceptive Agents|contraceptive agents|mesh-ancestor
24956495|NCT03854175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24956496|NCT03854175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24956497|NCT03854175|Vasodilator Agents|vasodilator agents|mesh-ancestor
24956498|NCT03854175|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24956499|NCT03854175|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24956500|NCT03854175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24956501|NCT03854175|Urological Agents|urological agents|mesh-ancestor
24956506|NCT03853954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24956507|NCT03853954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956508|NCT03853993|Vaccines|vaccines|mesh-list
24463009|NCT00358358|Xhance|xhance|mesh-list
24463010|NCT00358358|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24463011|NCT00358358|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24463012|NCT00358358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24463013|NCT00358358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24782293|NCT01895218|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
24782294|NCT01895218|Hematinics|hematinics|mesh-ancestor
24782295|NCT01895231|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
24782296|NCT01895231|Hematinics|hematinics|mesh-ancestor
24782297|NCT01895257|Leucovorin|leucovorin|mesh-list
24782298|NCT01895257|Fluorouracil|fluorouracil|mesh-list
24782299|NCT01895257|Levoleucovorin|levoleucovorin|mesh-list
24782300|NCT01895257|Antidotes|antidotes|mesh-ancestor
24782301|NCT01895257|Protective Agents|protective agents|mesh-ancestor
24782302|NCT01895257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782303|NCT01895257|Vitamin B Complex|vitamin b complex|mesh-ancestor
24782304|NCT01895257|Vitamins|vitamins|mesh-ancestor
25078322|NCT03357718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24782305|NCT01895257|Micronutrients|micronutrients|mesh-ancestor
24782306|NCT01895257|Antimetabolites|antimetabolites|mesh-ancestor
24956552|NCT03853538|Dermatologic Agents|dermatologic agents|mesh-ancestor
24956561|NCT03853304|Folic Acid|folic acid|mesh-list
24956562|NCT03853304|Vitamin B 12|vitamin b 12|mesh-list
24956563|NCT03853304|Hydroxocobalamin|hydroxocobalamin|mesh-list
24956564|NCT03853304|Vitamins|vitamins|mesh-ancestor
24956580|NCT03853200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24956581|NCT03853200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24956583|NCT03853200|Dermatologic Agents|dermatologic agents|mesh-ancestor
24956584|NCT03853200|Anticoagulants|anticoagulants|mesh-ancestor
24956585|NCT03853200|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24956586|NCT03853200|Chelating Agents|chelating agents|mesh-ancestor
24956587|NCT03853200|Sequestering Agents|sequestering agents|mesh-ancestor
24956588|NCT03853200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956589|NCT03853200|Antidotes|antidotes|mesh-ancestor
24956590|NCT03853200|Protective Agents|protective agents|mesh-ancestor
24600658|NCT00959777|Lenograstim|lenograstim|mesh-list
24956591|NCT03853200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956592|NCT03853200|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24956593|NCT03853200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24956598|NCT03852979|Paclitaxel|paclitaxel|mesh-list
24956599|NCT03852979|Carboplatin|carboplatin|mesh-list
24956600|NCT03852979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24956601|NCT03852979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24956602|NCT03852979|Tubulin Modulators|tubulin modulators|mesh-ancestor
24816453|NCT02077010|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24816454|NCT02077010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24816455|NCT02077010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816456|NCT02077010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816496|NCT02077478|Remifentanil|remifentanil|mesh-list
24956612|NCT03852797|Ketamine|ketamine|mesh-list
24956613|NCT03852797|Propofol|propofol|mesh-list
24956614|NCT03852797|Etomidate|etomidate|mesh-list
24956615|NCT03852797|Oxytocin|oxytocin|mesh-list
24956616|NCT03852797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24956617|NCT03852797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24956618|NCT03852797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956619|NCT03852797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24956620|NCT03852797|Anesthetics, General|anesthetics, general|mesh-ancestor
24956621|NCT03852797|Anesthetics|anesthetics|mesh-ancestor
24956622|NCT03852797|Analgesics|analgesics|mesh-ancestor
24956623|NCT03852797|Sensory System Agents|sensory system agents|mesh-ancestor
24956624|NCT03852797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24956631|NCT03852797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24956634|NCT03852628|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24463016|NCT00358358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463017|NCT00358358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24463018|NCT00358358|Respiratory System Agents|respiratory system agents|mesh-ancestor
24956635|NCT03852628|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24956636|NCT03852628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956637|NCT03852628|Sensory System Agents|sensory system agents|mesh-ancestor
24956638|NCT03852628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24956639|NCT03852628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24956640|NCT03852628|Narcotics|narcotics|mesh-ancestor
24956647|NCT03852602|Analgesics|analgesics|mesh-list
24956648|NCT03852602|Sensory System Agents|sensory system agents|mesh-ancestor
24956649|NCT03852602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24956650|NCT03852602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956651|NCT03852446|Tryptophan|tryptophan|mesh-list
24813015|NCT02055716|Sulforaphane|sulforaphane|mesh-list
24956652|NCT03852446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24956654|NCT03852446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24956655|NCT03852407|Cyclophosphamide|cyclophosphamide|mesh-list
24463019|NCT00358358|Dermatologic Agents|dermatologic agents|mesh-ancestor
24463020|NCT00358358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25700271|NCT02120261|Triamcinolone|triamcinolone|mesh-list
25700272|NCT02120261|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25700273|NCT02120261|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25700274|NCT02120261|Lidocaine|lidocaine|mesh-list
25700275|NCT02120261|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25700276|NCT02120261|Anesthetics, Local|anesthetics, local|mesh-ancestor
25700277|NCT02120261|Anesthetics|anesthetics|mesh-ancestor
24956656|NCT03852407|Melphalan|melphalan|mesh-list
24956657|NCT03852407|Fludarabine|fludarabine|mesh-list
24956658|NCT03852407|Thymoglobulin|thymoglobulin|mesh-list
24956659|NCT03852407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24956660|NCT03852407|Immunologic Factors|immunologic factors|mesh-ancestor
24956661|NCT03852407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956663|NCT03852407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24956664|NCT03852407|Alkylating Agents|alkylating agents|mesh-ancestor
24956665|NCT03852407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956673|NCT03852251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24956675|NCT03852251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956676|NCT03852251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24956677|NCT03852160|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24956678|NCT03852160|Mirtazapine|mirtazapine|mesh-list
24956679|NCT03852160|Trazodone|trazodone|mesh-list
24956680|NCT03852160|S 20098|s 20098|mesh-list
24956681|NCT03852160|Citalopram|citalopram|mesh-list
24956682|NCT03852160|Bupropion|bupropion|mesh-list
24956683|NCT03852160|Sertraline|sertraline|mesh-list
24956684|NCT03852160|Esketamine|esketamine|mesh-list
24956685|NCT03852160|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24956686|NCT03852160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24956687|NCT03852160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24956688|NCT03852160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956689|NCT03852160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24956690|NCT03852160|Serotonin Agents|serotonin agents|mesh-ancestor
24956691|NCT03852160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885921|NCT04132427|Vancomycin|vancomycin|mesh-list
24956692|NCT03852160|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24956693|NCT03852160|Antidepressive Agents|antidepressive agents|mesh-ancestor
24956694|NCT03852160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24956695|NCT03852160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24956696|NCT03852160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24956697|NCT03852160|Dopamine Agents|dopamine agents|mesh-ancestor
24956698|NCT03852160|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24956699|NCT03852160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24956700|NCT03852160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24956701|NCT03852160|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24956702|NCT03852160|Analgesics|analgesics|mesh-ancestor
24956703|NCT03852160|Sensory System Agents|sensory system agents|mesh-ancestor
24956704|NCT03852160|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24956705|NCT03852160|Histamine Antagonists|histamine antagonists|mesh-ancestor
24956706|NCT03852160|Histamine Agents|histamine agents|mesh-ancestor
24956707|NCT03852160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24956708|NCT03852160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24956709|NCT03852160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24956710|NCT03852160|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24956711|NCT03852160|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24956712|NCT03852160|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24956713|NCT03852160|Adrenergic Agents|adrenergic agents|mesh-ancestor
24956714|NCT03852160|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24956715|NCT03852160|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24956716|NCT03852160|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24956717|NCT03852160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24956718|NCT03852056|Fluorides|fluorides|mesh-list
24956719|NCT03852056|Tin Fluorides|tin fluorides|mesh-list
24956720|NCT03852056|Cariostatic Agents|cariostatic agents|mesh-ancestor
24956721|NCT03852056|Protective Agents|protective agents|mesh-ancestor
24956722|NCT03852056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956723|NCT03851835|Ondansetron|ondansetron|mesh-list
24956724|NCT03851835|Antiemetics|antiemetics|mesh-ancestor
24956730|NCT03851835|Dermatologic Agents|dermatologic agents|mesh-ancestor
24956752|NCT03851432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956753|NCT03851562|Alprostadil|alprostadil|mesh-list
24956754|NCT03851562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24956755|NCT03851562|Vasodilator Agents|vasodilator agents|mesh-ancestor
24428862|NCT00241371|Clofarabine|clofarabine|mesh-list
24956756|NCT03851562|Urological Agents|urological agents|mesh-ancestor
24956757|NCT03851289|Calcium|calcium|mesh-list
24782653|NCT01897116|Antimalarials|antimalarials|mesh-ancestor
24956762|NCT03851341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24956763|NCT03851341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956764|NCT03851341|Incretins|incretins|mesh-ancestor
24956765|NCT03851341|Hormones|hormones|mesh-ancestor
24956769|NCT03851341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24956770|NCT03851341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956772|NCT03851172|Nepafenac|nepafenac|mesh-list
24956773|NCT03851172|Cyclopentolate|cyclopentolate|mesh-list
24956774|NCT03851172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24956775|NCT03851172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24956776|NCT03851172|Analgesics|analgesics|mesh-ancestor
24956777|NCT03851172|Sensory System Agents|sensory system agents|mesh-ancestor
24956778|NCT03851172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24956779|NCT03851172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956780|NCT03851172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24956781|NCT03851172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24782505|NCT01896349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24956782|NCT03851172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24956814|NCT03850886|Antimetabolites|antimetabolites|mesh-ancestor
24956815|NCT03850886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956816|NCT03850886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24956817|NCT03850886|Vasodilator Agents|vasodilator agents|mesh-ancestor
24956818|NCT03850769|Paclitaxel|paclitaxel|mesh-list
24956819|NCT03850769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24956820|NCT03850769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24956821|NCT03850769|Tubulin Modulators|tubulin modulators|mesh-ancestor
24956822|NCT03850769|Antimitotic Agents|antimitotic agents|mesh-ancestor
24886032|NCT03688802|Varenicline|varenicline|mesh-list
24956829|NCT03850561|Vitamins|vitamins|mesh-ancestor
24938818|NCT04015596|Naproxen|naproxen|mesh-list
24782579|NCT01896622|Ritonavir|ritonavir|mesh-list
24782635|NCT01897038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24782636|NCT01897038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782637|NCT01897051|Rifaximin|rifaximin|mesh-list
24782638|NCT01897051|Propranolol|propranolol|mesh-list
24782639|NCT01897051|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24782640|NCT01897051|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24782641|NCT01897051|Adrenergic Agents|adrenergic agents|mesh-ancestor
24782642|NCT01897051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24782643|NCT01897051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782644|NCT01897051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782645|NCT01897051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24782646|NCT01897051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24782647|NCT01897051|Vasodilator Agents|vasodilator agents|mesh-ancestor
24782648|NCT01897051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24782649|NCT01897051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24782650|NCT01897051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24782651|NCT01897116|Hydroxychloroquine|hydroxychloroquine|mesh-list
24782652|NCT01897116|Vemurafenib|vemurafenib|mesh-list
24782654|NCT01897116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24782655|NCT01897116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24782656|NCT01897116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24862557|NCT05142709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24782658|NCT01897116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782659|NCT01897116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24782660|NCT01897116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24782661|NCT01897116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24782663|NCT01897324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24782664|NCT01897324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626660|NCT01088230|Botulinum Toxins|botulinum toxins|mesh-list
24626661|NCT01088230|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24626662|NCT01088230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24626663|NCT01088230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626664|NCT01088230|Cholinergic Agents|cholinergic agents|mesh-ancestor
24626665|NCT01088230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25700278|NCT02120261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25700279|NCT02120261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700280|NCT02120261|Sensory System Agents|sensory system agents|mesh-ancestor
24428953|NCT00241618|Immunologic Factors|immunologic factors|mesh-ancestor
24601723|NCT00965796|Lidocaine|lidocaine|mesh-list
24601811|NCT00966056|Mitomycin|mitomycin|mesh-list
24601812|NCT00966056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24601813|NCT00966056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24601814|NCT00966056|Alkylating Agents|alkylating agents|mesh-ancestor
24626666|NCT01088230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626667|NCT01088256|Etoricoxib|etoricoxib|mesh-list
24626668|NCT01088256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24626669|NCT01088256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24626670|NCT01088256|Analgesics|analgesics|mesh-ancestor
24626671|NCT01088256|Sensory System Agents|sensory system agents|mesh-ancestor
24626672|NCT01088256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24956830|NCT03850652|Iron|iron|mesh-list
24956831|NCT03850652|Trace Elements|trace elements|mesh-ancestor
24956832|NCT03850652|Micronutrients|micronutrients|mesh-ancestor
24956833|NCT03850652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956834|NCT03850587|Celecoxib|celecoxib|mesh-list
24956835|NCT03850587|Tramadol|tramadol|mesh-list
24956836|NCT03850587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24956837|NCT03850587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24956838|NCT03850587|Analgesics|analgesics|mesh-ancestor
24956839|NCT03850587|Sensory System Agents|sensory system agents|mesh-ancestor
24956840|NCT03850587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24956841|NCT03850587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956847|NCT03850587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956866|NCT03849833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24956867|NCT03849508|Phenylephrine|phenylephrine|mesh-list
24956868|NCT03849508|Oxymetazoline|oxymetazoline|mesh-list
24956869|NCT03849508|Norepinephrine|norepinephrine|mesh-list
24956870|NCT03849508|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24956871|NCT03849508|Mydriatics|mydriatics|mesh-ancestor
24956872|NCT03849508|Autonomic Agents|autonomic agents|mesh-ancestor
24956873|NCT03849508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24956874|NCT03849508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956875|NCT03849508|Sympathomimetics|sympathomimetics|mesh-ancestor
24956876|NCT03849508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24956877|NCT03849508|Nasal Decongestants|nasal decongestants|mesh-ancestor
24956878|NCT03849508|Respiratory System Agents|respiratory system agents|mesh-ancestor
24956879|NCT03849508|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24956880|NCT03849508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24956881|NCT03849508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24956882|NCT03849508|Adrenergic Agents|adrenergic agents|mesh-ancestor
24956883|NCT03849508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24956884|NCT03849508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956885|NCT03849508|Protective Agents|protective agents|mesh-ancestor
24956886|NCT03849612|Insulin Lispro|insulin lispro|mesh-list
24956887|NCT03849612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24956888|NCT03849612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956889|NCT03849664|Riboflavin|riboflavin|mesh-list
24956893|NCT03849664|Flavin Mononucleotide|flavin mononucleotide|mesh-list
24956894|NCT03849664|Povidone|povidone|mesh-list
24956895|NCT03849664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24956896|NCT03849664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956897|NCT03849664|Plasma Substitutes|plasma substitutes|mesh-ancestor
24956898|NCT03849664|Blood Substitutes|blood substitutes|mesh-ancestor
24956899|NCT03849664|Vitamin B Complex|vitamin b complex|mesh-ancestor
24956903|NCT03849664|Dermatologic Agents|dermatologic agents|mesh-ancestor
24956904|NCT03849664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24956905|NCT03849664|Antimetabolites|antimetabolites|mesh-ancestor
24956906|NCT03849664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956907|NCT03849664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24956908|NCT03849664|Vasodilator Agents|vasodilator agents|mesh-ancestor
24956909|NCT03849729|Phentermine|phentermine|mesh-list
24956910|NCT03849729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24956911|NCT03849729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956912|NCT03849729|Appetite Depressants|appetite depressants|mesh-ancestor
24956913|NCT03849729|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24956914|NCT03849729|Sympathomimetics|sympathomimetics|mesh-ancestor
24956915|NCT03849729|Autonomic Agents|autonomic agents|mesh-ancestor
25700281|NCT02120261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24956916|NCT03849729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24956917|NCT03849729|Adrenergic Agents|adrenergic agents|mesh-ancestor
24956918|NCT03849729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24957015|NCT03847792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24957018|NCT03847792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24957019|NCT03847792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957020|NCT03847792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24957021|NCT03847792|Glucocorticoids|glucocorticoids|mesh-ancestor
24957022|NCT03847792|Hormones|hormones|mesh-ancestor
24957023|NCT03847792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24957024|NCT03847792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24957025|NCT03847792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24957026|NCT03847792|Anesthetics, Local|anesthetics, local|mesh-ancestor
24957027|NCT03847792|Anesthetics|anesthetics|mesh-ancestor
24957028|NCT03847792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24957029|NCT03847792|Sensory System Agents|sensory system agents|mesh-ancestor
24957030|NCT03847792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24957031|NCT03847792|Narcotics|narcotics|mesh-ancestor
24957032|NCT03847792|Analgesics|analgesics|mesh-ancestor
24452227|NCT00326456|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24463043|NCT00358384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25407395|NCT03504410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24957087|NCT03847623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957088|NCT03847623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24957089|NCT03847623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24957090|NCT03847623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24957091|NCT03847623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24957100|NCT03847363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24463075|NCT00358553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463076|NCT00358566|Gemcitabine|gemcitabine|mesh-list
24463077|NCT00358566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25700282|NCT02120261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25700283|NCT02120261|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25700284|NCT02120261|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25700285|NCT02120261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25700286|NCT02120261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700287|NCT02120261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25700288|NCT02120261|Glucocorticoids|glucocorticoids|mesh-ancestor
24957104|NCT03847207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24957105|NCT03847207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957108|NCT03847246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24957109|NCT03847155|Nicotine|nicotine|mesh-list
24957110|NCT03847155|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25078328|NCT03357653|Losartan|losartan|mesh-list
24886249|NCT02432378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886250|NCT02285192|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24886251|NCT02285192|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24886252|NCT02285192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708615|NCT01501786|Ketamine|ketamine|mesh-list
24886253|NCT02090998|Lidocaine|lidocaine|mesh-list
24463109|NCT00358748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24463110|NCT00358813|Casopitant|casopitant|mesh-list
24463111|NCT00358813|Antiemetics|antiemetics|mesh-ancestor
24463112|NCT00358813|Autonomic Agents|autonomic agents|mesh-ancestor
24463113|NCT00358813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24463114|NCT00358813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463115|NCT00358813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24463116|NCT00358813|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24452294|NCT00327080|Cholinergic Agents|cholinergic agents|mesh-ancestor
24957111|NCT03847155|Autonomic Agents|autonomic agents|mesh-ancestor
25078329|NCT03357653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25078330|NCT03357653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25078331|NCT03357653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25078332|NCT03357653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25078382|NCT03356899|Anesthetics, Local|anesthetics, local|mesh-ancestor
25078333|NCT03357653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463145|NCT00359125|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24463147|NCT00359125|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24463148|NCT00359125|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24463150|NCT00359125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24775462|NCT01852409|Growth Inhibitors|growth inhibitors|mesh-ancestor
24465104|NCT00367913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24465108|NCT00367913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24512007|NCT00572065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512008|NCT00572065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24957145|NCT03847376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24957146|NCT03847376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24957220|NCT03846284|Bupivacaine|bupivacaine|mesh-list
24957221|NCT03846284|Anesthetics, Local|anesthetics, local|mesh-list
24957222|NCT03846284|Anesthetics|anesthetics|mesh-list
24957223|NCT03846284|N-Methylaspartate|n-methylaspartate|mesh-list
24957224|NCT03846284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24957225|NCT03846284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957226|NCT03846284|Sensory System Agents|sensory system agents|mesh-ancestor
24957227|NCT03846284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24957228|NCT03846284|Analgesics|analgesics|mesh-ancestor
24762175|NCT01766583|Lenalidomide|lenalidomide|mesh-list
24957229|NCT03846284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24957230|NCT03846284|Anticonvulsants|anticonvulsants|mesh-ancestor
24957231|NCT03846284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24957232|NCT03846284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24957233|NCT03846284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957234|NCT03846284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24957235|NCT03846284|Tocolytic Agents|tocolytic agents|mesh-ancestor
24957236|NCT03846284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24957240|NCT03846102|Acetaminophen|acetaminophen|mesh-list
24957241|NCT03846102|Morphine|morphine|mesh-list
24957242|NCT03846102|Levobupivacaine|levobupivacaine|mesh-list
24957243|NCT03846102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24957244|NCT03846102|Narcotics|narcotics|mesh-ancestor
24957245|NCT03846102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24957246|NCT03846102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862990|NCT03812991|Calcitonin|calcitonin|mesh-list
24957255|NCT03845699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24957256|NCT03845699|Narcotics|narcotics|mesh-ancestor
24957257|NCT03845699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24957258|NCT03845699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957259|NCT03845699|Analgesics|analgesics|mesh-ancestor
24957260|NCT03845699|Sensory System Agents|sensory system agents|mesh-ancestor
24957261|NCT03845699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24957262|NCT03845699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24957263|NCT03845699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24957264|NCT03845699|Anesthetics, General|anesthetics, general|mesh-ancestor
24957265|NCT03845699|Anesthetics|anesthetics|mesh-ancestor
24957266|NCT03845777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
24957269|NCT03845881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24957270|NCT03845881|Narcotics|narcotics|mesh-ancestor
24957271|NCT03845881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24957272|NCT03845881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957273|NCT03845881|Analgesics|analgesics|mesh-ancestor
24957274|NCT03845881|Sensory System Agents|sensory system agents|mesh-ancestor
24957275|NCT03845881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24957276|NCT03845673|Psyllium|psyllium|mesh-list
24957277|NCT03845673|Cathartics|cathartics|mesh-ancestor
24957278|NCT03845673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24957279|NCT03845387|Pramipexole|pramipexole|mesh-list
24957280|NCT03845387|Antioxidants|antioxidants|mesh-ancestor
24957281|NCT03845387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957282|NCT03845387|Protective Agents|protective agents|mesh-ancestor
25700289|NCT02120261|Hormones|hormones|mesh-ancestor
24957283|NCT03845387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957284|NCT03845387|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24957285|NCT03845387|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24957286|NCT03845387|Dopamine Agonists|dopamine agonists|mesh-ancestor
24957287|NCT03845387|Dopamine Agents|dopamine agents|mesh-ancestor
24957288|NCT03845387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24957289|NCT03845348|Ketoconazole|ketoconazole|mesh-list
24957290|NCT03845348|Antifungal Agents|antifungal agents|mesh-ancestor
24957294|NCT03845348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24957295|NCT03845348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957296|NCT03845348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24957297|NCT03845348|Hormone Antagonists|hormone antagonists|mesh-ancestor
24957298|NCT03845348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24957299|NCT03845348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957313|NCT03845179|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24957314|NCT03845179|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24957315|NCT03845179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24957316|NCT03845179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957350|NCT03844841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957352|NCT03844984|Midazolam|midazolam|mesh-list
24957353|NCT03844984|Ketamine|ketamine|mesh-list
24957354|NCT03844984|Anesthetics, Local|anesthetics, local|mesh-ancestor
24957355|NCT03844984|Anesthetics|anesthetics|mesh-ancestor
24957356|NCT03844984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24957357|NCT03844984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957358|NCT03844984|Sensory System Agents|sensory system agents|mesh-ancestor
24957359|NCT03844984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24957360|NCT03844984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24957361|NCT03844984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24957362|NCT03844984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24957363|NCT03844984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24957364|NCT03844984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957365|NCT03844984|Analgesics|analgesics|mesh-ancestor
24957366|NCT03844984|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24957367|NCT03844984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24783232|NCT01900717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24783233|NCT01900717|Immunologic Factors|immunologic factors|mesh-ancestor
24783234|NCT01900717|Antidotes|antidotes|mesh-ancestor
24783235|NCT01900717|Protective Agents|protective agents|mesh-ancestor
24783236|NCT01900717|Vitamin B Complex|vitamin b complex|mesh-ancestor
24783237|NCT01900717|Vitamins|vitamins|mesh-ancestor
24783238|NCT01900717|Micronutrients|micronutrients|mesh-ancestor
24575278|NCT00830492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24575279|NCT00830492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575280|NCT00830492|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24575282|NCT00830492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24575283|NCT00830492|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24575284|NCT00830492|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24575293|NCT00830505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575305|NCT00830505|Hormones|hormones|mesh-ancestor
24625608|NCT01082705|Piperaquine|piperaquine|mesh-list
24626673|NCT01088256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626674|NCT01088256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24626675|NCT01088256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24626676|NCT01088256|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24626677|NCT01088256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24626680|NCT01088282|Dipivefrin|dipivefrin|mesh-list
24626691|NCT01088373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626692|NCT01088373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24626693|NCT01088373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24626694|NCT01088373|Growth Substances|growth substances|mesh-ancestor
24626695|NCT01088373|Growth Inhibitors|growth inhibitors|mesh-ancestor
24626696|NCT01088373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626697|NCT01088373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24957384|NCT03844932|Immunologic Factors|immunologic factors|mesh-ancestor
24957385|NCT03844932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957386|NCT03844932|Antifungal Agents|antifungal agents|mesh-ancestor
24957387|NCT03844932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24957388|NCT03844932|Dermatologic Agents|dermatologic agents|mesh-ancestor
24957389|NCT03844932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24957390|NCT03844932|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24957391|NCT03844854|Salicylic Acid|salicylic acid|mesh-list
24957402|NCT03844581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24957403|NCT03844581|Cholinergic Agents|cholinergic agents|mesh-ancestor
24957404|NCT03844581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24957405|NCT03844581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957406|NCT03844581|Urological Agents|urological agents|mesh-ancestor
24957407|NCT03844633|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24957408|NCT03844633|Medroxyprogesterone|medroxyprogesterone|mesh-list
24957409|NCT03844633|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24957410|NCT03844633|Contraceptive Agents|contraceptive agents|mesh-ancestor
24957411|NCT03844633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24957412|NCT03844633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957413|NCT03844633|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24957414|NCT03844633|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24957415|NCT03844633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24957416|NCT03844633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24957417|NCT03844633|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24957418|NCT03844633|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24957419|NCT03844633|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24957422|NCT03844451|Anesthetics, Local|anesthetics, local|mesh-ancestor
24957423|NCT03844451|Anesthetics|anesthetics|mesh-ancestor
24957424|NCT03844451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24957425|NCT03844451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957426|NCT03844451|Sensory System Agents|sensory system agents|mesh-ancestor
24957427|NCT03844451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24957428|NCT03844451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24957429|NCT03844451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24886589|NCT04525326|Growth Substances|growth substances|mesh-ancestor
24957430|NCT03844451|Adrenergic Agents|adrenergic agents|mesh-ancestor
24957431|NCT03844451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24957432|NCT03844451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957433|NCT03844451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24957434|NCT03844451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24957435|NCT03844451|Autonomic Agents|autonomic agents|mesh-ancestor
24957436|NCT03844451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24806134|NCT02013960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24806135|NCT02013960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24452342|NCT00327145|Natriuretic Agents|natriuretic agents|mesh-ancestor
24452343|NCT00327145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24452345|NCT00327184|Anticoagulants|anticoagulants|mesh-ancestor
24957449|NCT03844776|Analgesics|analgesics|mesh-ancestor
24957450|NCT03844776|Sensory System Agents|sensory system agents|mesh-ancestor
24957451|NCT03844776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24957452|NCT03844776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957453|NCT03844776|Antipyretics|antipyretics|mesh-ancestor
24957454|NCT03844776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24957455|NCT03844776|Disinfectants|disinfectants|mesh-ancestor
24957456|NCT03844776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24957457|NCT03844776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24957458|NCT03844776|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24957459|NCT03844776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407396|NCT03504410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24957525|NCT03844360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24957526|NCT03844360|Immunologic Factors|immunologic factors|mesh-ancestor
24463243|NCT00359658|Immunologic Factors|immunologic factors|mesh-ancestor
24463263|NCT00359697|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24463264|NCT00359697|Diuretics|diuretics|mesh-ancestor
24463266|NCT00359697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463267|NCT00359723|Methylphenidate|methylphenidate|mesh-list
24463268|NCT00359723|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24463269|NCT00359723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463270|NCT00359723|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24463271|NCT00359723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24783469|NCT01902160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24783471|NCT01902160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24957650|NCT03843047|Autonomic Agents|autonomic agents|mesh-ancestor
24783473|NCT01902186|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24957651|NCT03843047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24783492|NCT01902225|Doxorubicin|doxorubicin|mesh-list
24957652|NCT03843047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957653|NCT03843047|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24957654|NCT03843047|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24957655|NCT03843047|Cholinergic Agents|cholinergic agents|mesh-ancestor
24957656|NCT03843047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24957657|NCT03843047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957659|NCT03842800|Analgesics|analgesics|mesh-ancestor
24957660|NCT03842800|Sensory System Agents|sensory system agents|mesh-ancestor
24465315|NCT00368901|Hematinics|hematinics|mesh-ancestor
24584313|NCT00879827|PENTA|penta|mesh-list
24957720|NCT03842046|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24957721|NCT03842046|Mydriatics|mydriatics|mesh-ancestor
24957722|NCT03842046|Autonomic Agents|autonomic agents|mesh-ancestor
24957723|NCT03842046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24957724|NCT03842046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957725|NCT03842046|Sympathomimetics|sympathomimetics|mesh-ancestor
24957726|NCT03842046|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24957727|NCT03842046|Nasal Decongestants|nasal decongestants|mesh-ancestor
24957728|NCT03842046|Respiratory System Agents|respiratory system agents|mesh-ancestor
24957729|NCT03842046|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24957730|NCT03842046|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24957731|NCT03842046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24957732|NCT03842046|Adrenergic Agents|adrenergic agents|mesh-ancestor
24957733|NCT03842046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24957750|NCT03841773|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24957751|NCT03841773|Antidepressive Agents|antidepressive agents|mesh-ancestor
24957752|NCT03841773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24957759|NCT03841890|Tolnaftate|tolnaftate|mesh-list
24452356|NCT00327197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24452357|NCT00327262|Imatinib Mesylate|imatinib mesylate|mesh-list
24957763|NCT03841721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24957764|NCT03841721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24957765|NCT03841721|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24957766|NCT03841721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24957767|NCT03841721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957769|NCT03841747|Pembrolizumab|pembrolizumab|mesh-list
25078413|NCT03356769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24957770|NCT03841747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24957771|NCT03841747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24957772|NCT03841747|Tubulin Modulators|tubulin modulators|mesh-ancestor
24957773|NCT03841747|Antimitotic Agents|antimitotic agents|mesh-ancestor
24957774|NCT03841747|Mitosis Modulators|mitosis modulators|mesh-ancestor
24957775|NCT03841747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957776|NCT03841747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24957777|NCT03841526|Glucagon|glucagon|mesh-list
24957778|NCT03841526|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24957820|NCT03841474|Serotonin Agents|serotonin agents|mesh-ancestor
24957821|NCT03841474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783665|NCT01903083|Urological Agents|urological agents|mesh-ancestor
24957843|NCT03839888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24957844|NCT03839888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957845|NCT03839888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24957846|NCT03839888|Respiratory System Agents|respiratory system agents|mesh-ancestor
24957847|NCT03839888|Mydriatics|mydriatics|mesh-ancestor
24957848|NCT03839888|Parasympatholytics|parasympatholytics|mesh-ancestor
24957849|NCT03839888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24957850|NCT03839888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24957851|NCT03839888|Cholinergic Agents|cholinergic agents|mesh-ancestor
24957852|NCT03839888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24957853|NCT03839888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957854|NCT03840057|Azithromycin|azithromycin|mesh-list
24671178|NCT01324180|Doxorubicin|doxorubicin|mesh-list
24604822|NCT00981851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24957855|NCT03840057|Metoclopramide|metoclopramide|mesh-list
24957856|NCT03840057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24957857|NCT03840057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24957858|NCT03840057|Antiemetics|antiemetics|mesh-ancestor
24957859|NCT03840057|Autonomic Agents|autonomic agents|mesh-ancestor
24957860|NCT03840057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24957861|NCT03840057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957862|NCT03840057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24957863|NCT03840057|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24957864|NCT03840057|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24957865|NCT03840057|Dopamine Agents|dopamine agents|mesh-ancestor
24957869|NCT03840070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24957870|NCT03840070|Immunologic Factors|immunologic factors|mesh-ancestor
24957871|NCT03840070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957872|NCT03840070|Viscosupplements|viscosupplements|mesh-ancestor
24957873|NCT03840070|Protective Agents|protective agents|mesh-ancestor
24783742|NCT01903694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24957880|NCT03839771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24957881|NCT03839771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452358|NCT00327262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24452359|NCT00327262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24452360|NCT00327262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24452361|NCT00327262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452362|NCT00327288|Docetaxel|docetaxel|mesh-list
24452363|NCT00327288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24452364|NCT00327288|Tubulin Modulators|tubulin modulators|mesh-ancestor
24452365|NCT00327288|Antimitotic Agents|antimitotic agents|mesh-ancestor
24452366|NCT00327288|Mitosis Modulators|mitosis modulators|mesh-ancestor
24452367|NCT00327288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452368|NCT00327327|Gemcitabine|gemcitabine|mesh-list
24452369|NCT00327327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24452370|NCT00327327|Antimetabolites|antimetabolites|mesh-ancestor
24452371|NCT00327327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452372|NCT00327327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24452373|NCT00327327|Antiviral Agents|antiviral agents|mesh-ancestor
24957903|NCT03839537|Carbon Monoxide|carbon monoxide|mesh-list
24957904|NCT03839537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24957905|NCT03839537|Autonomic Agents|autonomic agents|mesh-ancestor
24957906|NCT03839537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24957907|NCT03839537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24957908|NCT03839537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24957909|NCT03839537|Respiratory System Agents|respiratory system agents|mesh-ancestor
24957910|NCT03839537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24957911|NCT03839537|Antioxidants|antioxidants|mesh-ancestor
24957912|NCT03839537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957913|NCT03839537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24957914|NCT03839537|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24957915|NCT03839537|Vasodilator Agents|vasodilator agents|mesh-ancestor
24957916|NCT03839537|Gasotransmitters|gasotransmitters|mesh-ancestor
24886971|NCT04521491|Vitamins|vitamins|mesh-ancestor
24463309|NCT00359892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463310|NCT00359905|Tamsulosin|tamsulosin|mesh-list
24463311|NCT00359905|Silodosin|silodosin|mesh-list
24475449|NCT00410540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078419|NCT03356769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078421|NCT03356600|Apatinib|apatinib|mesh-list
25078422|NCT03356600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25078423|NCT03356600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25078424|NCT03356600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407397|NCT03504410|Antiviral Agents|antiviral agents|mesh-ancestor
25078426|NCT03356730|Vitamin D|vitamin d|mesh-list
24957939|NCT03839251|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24957940|NCT03839251|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24957942|NCT03839251|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24957944|NCT03839251|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24938975|NCT04014283|Selenium|selenium|mesh-list
24957945|NCT03839251|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24575871|NCT00834925|Diltiazem|diltiazem|mesh-list
24783821|NCT01904214|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24783822|NCT01904214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783823|NCT01904214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24783824|NCT01904214|Immunologic Factors|immunologic factors|mesh-ancestor
24783825|NCT01904214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783829|NCT01904253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24783830|NCT01904253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783831|NCT01904253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783832|NCT01904253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24575879|NCT00835029|Clotrimazole|clotrimazole|mesh-list
24575880|NCT00835029|Miconazole|miconazole|mesh-list
24626699|NCT01088373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646349|NCT01203306|Octreotide|octreotide|mesh-list
24646477|NCT01204112|Rifampin|rifampin|mesh-list
24626721|NCT01088516|Protease Inhibitors|protease inhibitors|mesh-ancestor
24814210|NCT02063334|Vitamin D|vitamin d|mesh-list
24626722|NCT01088516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626723|NCT01088516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626725|NCT01088516|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24626726|NCT01088516|Antiviral Agents|antiviral agents|mesh-ancestor
24626727|NCT01088516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24626728|NCT01088516|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24626729|NCT01088516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24626730|NCT01088516|Antimetabolites|antimetabolites|mesh-ancestor
24626731|NCT01088516|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24626732|NCT01088516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24626733|NCT01088555|Sodium thiosulfate|sodium thiosulfate|mesh-list
24626735|NCT01088555|Protective Agents|protective agents|mesh-ancestor
24626736|NCT01088555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626737|NCT01088555|Antioxidants|antioxidants|mesh-ancestor
24605075|NCT00983151|Tramadol|tramadol|mesh-list
24626738|NCT01088555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626739|NCT01088555|Antitubercular Agents|antitubercular agents|mesh-ancestor
24626740|NCT01088555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24626741|NCT01088555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24626742|NCT01088555|Chelating Agents|chelating agents|mesh-ancestor
24626743|NCT01088555|Sequestering Agents|sequestering agents|mesh-ancestor
24957949|NCT03839160|Morphine|morphine|mesh-list
24957950|NCT03839160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24957967|NCT03839134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24957968|NCT03839134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24957969|NCT03839134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24957970|NCT03839134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24957971|NCT03839134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957972|NCT03839134|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24957973|NCT03839134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24957974|NCT03839134|Adrenergic Agents|adrenergic agents|mesh-ancestor
24957975|NCT03839134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24475508|NCT00410631|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24475510|NCT00410631|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24957977|NCT03839134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24957978|NCT03839134|Autonomic Agents|autonomic agents|mesh-ancestor
24957979|NCT03839134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24957980|NCT03839134|Respiratory System Agents|respiratory system agents|mesh-ancestor
24957981|NCT03839134|Mydriatics|mydriatics|mesh-ancestor
24957982|NCT03839134|Sympathomimetics|sympathomimetics|mesh-ancestor
24957983|NCT03839134|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24957984|NCT03839433|Ciclesonide|ciclesonide|mesh-list
24957985|NCT03839433|Glucocorticoids|glucocorticoids|mesh-ancestor
24957986|NCT03839433|Hormones|hormones|mesh-ancestor
24957987|NCT03839433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24957988|NCT03839433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709544|NCT02269163|Immunoglobulin G|immunoglobulin g|mesh-list
24957995|NCT03838926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24957996|NCT03838926|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24957997|NCT03838783|Insulin|insulin|mesh-list
24957998|NCT03838783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25078449|NCT03356353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24957999|NCT03838783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958005|NCT03838497|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24958008|NCT03838328|Tranexamic Acid|tranexamic acid|mesh-list
24958084|NCT03836807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24958085|NCT03836807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24958086|NCT03836807|Analgesics|analgesics|mesh-ancestor
24958087|NCT03836807|Sensory System Agents|sensory system agents|mesh-ancestor
24958088|NCT03836807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24958089|NCT03836807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958090|NCT03836807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24958091|NCT03836807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24958092|NCT03836807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24958093|NCT03836807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24958108|NCT03836885|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24958109|NCT03836885|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24958110|NCT03836885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24958111|NCT03836885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958113|NCT03836833|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24958114|NCT03836833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24958115|NCT03836833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24958116|NCT03836833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958117|NCT03836833|Antiviral Agents|antiviral agents|mesh-ancestor
24958118|NCT03836833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24958119|NCT03836833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25078429|NCT03356730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958120|NCT03836833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24958121|NCT03836781|Chlorhexidine|chlorhexidine|mesh-list
24958122|NCT03836781|Ketorolac|ketorolac|mesh-list
24958123|NCT03836781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24958124|NCT03836781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24958125|NCT03836781|Disinfectants|disinfectants|mesh-ancestor
24958133|NCT03836781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24958134|NCT03836781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24958135|NCT03836781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24958136|NCT03836781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958137|NCT03836638|Botulinum Toxins|botulinum toxins|mesh-list
25709545|NCT02269163|Immunologic Factors|immunologic factors|mesh-ancestor
25709546|NCT02269163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709547|NCT02269241|Drospirenone|drospirenone|mesh-list
24958138|NCT03836638|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24958139|NCT03836638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24958368|NCT03833895|Mydriatics|mydriatics|mesh-ancestor
24958195|NCT03835715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24958196|NCT03835715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24958197|NCT03835715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24958204|NCT03835715|Serotonin Agents|serotonin agents|mesh-ancestor
24958261|NCT03834935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24958262|NCT03834935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24958263|NCT03834935|Analgesics|analgesics|mesh-ancestor
24958264|NCT03834935|Sensory System Agents|sensory system agents|mesh-ancestor
24958265|NCT03834935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24958266|NCT03834935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958267|NCT03834935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24958268|NCT03834935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24958269|NCT03834935|Dermatologic Agents|dermatologic agents|mesh-ancestor
24605880|NCT00987779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24605881|NCT00987779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24958270|NCT03834935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24958271|NCT03834935|Immunologic Factors|immunologic factors|mesh-ancestor
24958272|NCT03834935|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24958273|NCT03834935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24958274|NCT03834935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958275|NCT03835065|Calpastatin|calpastatin|mesh-list
24958277|NCT03835065|Protease Inhibitors|protease inhibitors|mesh-ancestor
24958278|NCT03835065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24958280|NCT03834610|Tadalafil|tadalafil|mesh-list
24958282|NCT03834610|Androgens|androgens|mesh-ancestor
24958283|NCT03834610|Hormones|hormones|mesh-ancestor
24958284|NCT03834610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24958285|NCT03834610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958286|NCT03834610|Vasodilator Agents|vasodilator agents|mesh-ancestor
24958287|NCT03834610|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24958288|NCT03834610|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24958289|NCT03834610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24958290|NCT03834610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958291|NCT03834610|Urological Agents|urological agents|mesh-ancestor
24958292|NCT03834454|Bupivacaine|bupivacaine|mesh-list
24958293|NCT03834454|Anesthetics, Local|anesthetics, local|mesh-ancestor
24958294|NCT03834454|Anesthetics|anesthetics|mesh-ancestor
24958295|NCT03834454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24958296|NCT03834454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958297|NCT03834454|Sensory System Agents|sensory system agents|mesh-ancestor
24958298|NCT03834454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24784344|NCT01907529|Mitosis Modulators|mitosis modulators|mesh-ancestor
24784345|NCT01907529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24784346|NCT01907529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24784347|NCT01907529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24784348|NCT01907529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24784349|NCT01907529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24784350|NCT01907529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24784351|NCT01907529|Growth Substances|growth substances|mesh-ancestor
24784352|NCT01907529|Growth Inhibitors|growth inhibitors|mesh-ancestor
24576405|NCT00838305|Serotonin Agents|serotonin agents|mesh-ancestor
24626744|NCT01088594|Pioglitazone|pioglitazone|mesh-list
24626745|NCT01088594|Rosiglitazone|rosiglitazone|mesh-list
24626746|NCT01088594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24626747|NCT01088594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626748|NCT01088607|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24626749|NCT01088607|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24626750|NCT01088607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24626751|NCT01088620|Pemetrexed|pemetrexed|mesh-list
24626752|NCT01088620|Panitumumab|panitumumab|mesh-list
24626753|NCT01088620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626754|NCT01088620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700290|NCT02120261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25700291|NCT02120261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25081601|NCT03328494|Paclitaxel|paclitaxel|mesh-list
24626755|NCT01088620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626756|NCT01088620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24626757|NCT01088620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25078440|NCT03356444|Hormone Antagonists|hormone antagonists|mesh-ancestor
25078441|NCT03356444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25078442|NCT03356444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078443|NCT03356444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25078444|NCT03356353|Sildenafil Citrate|sildenafil citrate|mesh-list
25078445|NCT03356353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078446|NCT03356353|Vasodilator Agents|vasodilator agents|mesh-ancestor
25078447|NCT03356353|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25078448|NCT03356353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25078450|NCT03356353|Urological Agents|urological agents|mesh-ancestor
25078451|NCT03356158|Cetuximab|cetuximab|mesh-list
25078452|NCT03356158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25078453|NCT03356158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25078454|NCT03356080|Cytarabine|cytarabine|mesh-list
25078455|NCT03356080|Decitabine|decitabine|mesh-list
25078456|NCT03356080|Tretinoin|tretinoin|mesh-list
25078457|NCT03356080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25078458|NCT03356080|Antimetabolites|antimetabolites|mesh-ancestor
25078459|NCT03356080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078460|NCT03356080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25078461|NCT03356080|Antiviral Agents|antiviral agents|mesh-ancestor
25078462|NCT03356080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25078463|NCT03356080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25078464|NCT03356080|Immunologic Factors|immunologic factors|mesh-ancestor
25078465|NCT03356080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958358|NCT03834129|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24958359|NCT03834129|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24958360|NCT03834129|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24958362|NCT03834129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24958363|NCT03834129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958365|NCT03833895|Oxymetazoline|oxymetazoline|mesh-list
24958366|NCT03833895|Norepinephrine|norepinephrine|mesh-list
24958367|NCT03833895|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24958369|NCT03833895|Autonomic Agents|autonomic agents|mesh-ancestor
24958370|NCT03833895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24958371|NCT03833895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958372|NCT03833895|Sympathomimetics|sympathomimetics|mesh-ancestor
24958373|NCT03833895|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24958374|NCT03833895|Nasal Decongestants|nasal decongestants|mesh-ancestor
24958375|NCT03833895|Respiratory System Agents|respiratory system agents|mesh-ancestor
24958376|NCT03833895|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24958391|NCT03833947|Glucocorticoids|glucocorticoids|mesh-ancestor
24958392|NCT03833947|Hormones|hormones|mesh-ancestor
24958393|NCT03833947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24958394|NCT03833947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24958395|NCT03833947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24958396|NCT03833947|Anesthetics, Local|anesthetics, local|mesh-ancestor
24958397|NCT03833947|Anesthetics|anesthetics|mesh-ancestor
24958398|NCT03833947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24958399|NCT03833947|Sensory System Agents|sensory system agents|mesh-ancestor
24958400|NCT03833947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24958401|NCT03833947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24958402|NCT03833947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24958403|NCT03833947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24958404|NCT03833947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958405|NCT03833596|Prednisone|prednisone|mesh-list
24958406|NCT03833596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25700292|NCT02120261|Immunologic Factors|immunologic factors|mesh-ancestor
25700293|NCT02120261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700294|NCT02120287|Bevacizumab|bevacizumab|mesh-list
25700295|NCT02120287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25700296|NCT02120287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700297|NCT02120287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25700298|NCT02120287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24777537|NCT01864824|Vitamin B 12|vitamin b 12|mesh-list
24958407|NCT03833596|Glucocorticoids|glucocorticoids|mesh-ancestor
24958410|NCT03833596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958411|NCT03833596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24958412|NCT03833596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24958413|NCT03833466|Metformin|metformin|mesh-list
24958414|NCT03833466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24958415|NCT03833466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958416|NCT03833570|Melatonin|melatonin|mesh-list
24958417|NCT03833570|Antioxidants|antioxidants|mesh-ancestor
24958418|NCT03833570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958419|NCT03833570|Protective Agents|protective agents|mesh-ancestor
24958420|NCT03833570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958421|NCT03833570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24958433|NCT03833362|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24958434|NCT03833362|Protease Inhibitors|protease inhibitors|mesh-ancestor
24958435|NCT03833362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24958455|NCT03833063|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24958456|NCT03833063|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24958457|NCT03833063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24958458|NCT03833063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24958459|NCT03833063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958460|NCT03833063|Cholinergic Agents|cholinergic agents|mesh-ancestor
24958461|NCT03833063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24958506|NCT03832621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24958508|NCT03832673|Pembrolizumab|pembrolizumab|mesh-list
24958509|NCT03832673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24958510|NCT03832673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24958511|NCT03832699|Dydrogesterone|dydrogesterone|mesh-list
24958512|NCT03832699|Progesterone|progesterone|mesh-list
24958513|NCT03832699|Progestins|progestins|mesh-ancestor
24958514|NCT03832699|Hormones|hormones|mesh-ancestor
24958515|NCT03832699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24958516|NCT03832699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958517|NCT03832465|Levofloxacin|levofloxacin|mesh-list
24958571|NCT03831984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24958572|NCT03831984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24958573|NCT03831984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24958574|NCT03831815|Rocuronium|rocuronium|mesh-list
24958575|NCT03831815|Cisatracurium|cisatracurium|mesh-list
24958576|NCT03831815|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24958577|NCT03831815|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24958578|NCT03831815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24958579|NCT03831815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24958580|NCT03831815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958581|NCT03831321|Diclofenac|diclofenac|mesh-list
24958582|NCT03831321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24958583|NCT03831321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24958584|NCT03831321|Analgesics|analgesics|mesh-ancestor
24958585|NCT03831321|Sensory System Agents|sensory system agents|mesh-ancestor
24958586|NCT03831321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24958587|NCT03831321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958588|NCT03831321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24958589|NCT03831321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24958590|NCT03831321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24958591|NCT03831321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24958592|NCT03831321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958593|NCT03831464|Metformin|metformin|mesh-list
24958595|NCT03831464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958596|NCT03831269|Azithromycin|azithromycin|mesh-list
24958597|NCT03831269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24958598|NCT03831269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24784604|NCT01909089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24784605|NCT01909089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784606|NCT01909089|Sensory System Agents|sensory system agents|mesh-ancestor
24784608|NCT01909115|Vitamin D|vitamin d|mesh-list
24626762|NCT01088659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24626763|NCT01088659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24626764|NCT01088659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24626765|NCT01088659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626777|NCT01088724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24626778|NCT01088724|Alkylating Agents|alkylating agents|mesh-ancestor
24626779|NCT01088724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700299|NCT02120287|Growth Substances|growth substances|mesh-ancestor
24626780|NCT01088724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626781|NCT01088724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24626782|NCT01088724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24626783|NCT01088724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24626784|NCT01088724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24626785|NCT01088724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24626786|NCT01088724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626787|NCT01088737|Imiquimod|imiquimod|mesh-list
24626788|NCT01088737|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24626789|NCT01088737|Immunologic Factors|immunologic factors|mesh-ancestor
24626790|NCT01088737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958600|NCT03831126|Betamethasone Valerate|betamethasone valerate|mesh-list
24958601|NCT03831126|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24958602|NCT03831126|Betamethasone benzoate|betamethasone benzoate|mesh-list
24958603|NCT03831126|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24958604|NCT03831126|Glucocorticoids|glucocorticoids|mesh-ancestor
24958606|NCT03831126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24958607|NCT03831126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958608|NCT03831126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25078473|NCT03355963|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25078474|NCT03355963|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25078475|NCT03355963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25078477|NCT03355963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078478|NCT03355963|Cholinergic Agents|cholinergic agents|mesh-ancestor
25078479|NCT03355963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25078480|NCT03355963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078481|NCT03355963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25078482|NCT03355963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078483|NCT03355794|Everolimus|everolimus|mesh-list
25078484|NCT03355794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25078485|NCT03355794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25078486|NCT03355794|Immunologic Factors|immunologic factors|mesh-ancestor
25078487|NCT03355794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078488|NCT03355768|Romidepsin|romidepsin|mesh-list
25078489|NCT03355768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25078490|NCT03355768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25078491|NCT03355716|Fentanyl|fentanyl|mesh-list
25078492|NCT03355716|Ketamine|ketamine|mesh-list
25078493|NCT03355716|Morphine|morphine|mesh-list
24958617|NCT03830827|Antidepressive Agents|antidepressive agents|mesh-ancestor
24958618|NCT03830827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24958619|NCT03830827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24958620|NCT03830827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24958621|NCT03830827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24958622|NCT03830827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958623|NCT03830827|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24606728|NCT05409027|Cortisone|cortisone|mesh-list
24958624|NCT03830827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24958625|NCT03830827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24958626|NCT03830827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958627|NCT03830827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24958633|NCT03830957|Metoprolol|metoprolol|mesh-list
25078498|NCT03355716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958659|NCT03830684|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
24958660|NCT03830684|Hormone Antagonists|hormone antagonists|mesh-ancestor
24958661|NCT03830684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24958662|NCT03830606|Paclitaxel|paclitaxel|mesh-list
24958663|NCT03830606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24958664|NCT03830606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24958665|NCT03830606|Tubulin Modulators|tubulin modulators|mesh-ancestor
24958666|NCT03830606|Antimitotic Agents|antimitotic agents|mesh-ancestor
24958667|NCT03830606|Mitosis Modulators|mitosis modulators|mesh-ancestor
24958668|NCT03830606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958696|NCT03830164|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24958697|NCT03830164|Vasodilator Agents|vasodilator agents|mesh-ancestor
24958698|NCT03830164|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24958700|NCT03830385|Bleomycin|bleomycin|mesh-list
24958713|NCT03830086|Sensory System Agents|sensory system agents|mesh-ancestor
24958714|NCT03830086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24958715|NCT03830086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24958716|NCT03830086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24958717|NCT03830086|Anesthetics, General|anesthetics, general|mesh-ancestor
24463352|NCT00360191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24463353|NCT00360191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24463354|NCT00360191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463355|NCT00360191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24463356|NCT00360191|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24806508|NCT02016287|Paclitaxel|paclitaxel|mesh-list
24463359|NCT00360191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958718|NCT03830086|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24958719|NCT03830086|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24958720|NCT03830086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24958721|NCT03830086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24958722|NCT03830086|GABA Modulators|gaba modulators|mesh-ancestor
24958723|NCT03830086|GABA Agents|gaba agents|mesh-ancestor
24958724|NCT03830086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24958725|NCT03830086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958726|NCT03830086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24958727|NCT03830086|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24958728|NCT03830086|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24958729|NCT03830086|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24958730|NCT03830086|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24958731|NCT03830086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24958732|NCT03830086|Narcotics|narcotics|mesh-ancestor
24958746|NCT03830034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958747|NCT03829696|Misoprostol|misoprostol|mesh-list
24958748|NCT03829696|Mifepristone|mifepristone|mesh-list
24958749|NCT03829696|Ulipristal acetate|ulipristal acetate|mesh-list
24958750|NCT03829696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25700300|NCT02120287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700301|NCT02120287|Growth Inhibitors|growth inhibitors|mesh-ancestor
24958761|NCT03829696|Contraceptive Agents|contraceptive agents|mesh-ancestor
24958762|NCT03829696|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24958763|NCT03829696|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24958764|NCT03829696|Hormone Antagonists|hormone antagonists|mesh-ancestor
24784773|NCT01910259|Diuretics|diuretics|mesh-ancestor
24958765|NCT03829696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24958769|NCT03829839|Lorazepam|lorazepam|mesh-list
24958773|NCT03829839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958774|NCT03829839|Anticonvulsants|anticonvulsants|mesh-ancestor
24958775|NCT03829839|Antiemetics|antiemetics|mesh-ancestor
24958776|NCT03829839|Autonomic Agents|autonomic agents|mesh-ancestor
24958777|NCT03829839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24958778|NCT03829839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24958779|NCT03829839|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24958795|NCT03829774|Analgesics|analgesics|mesh-ancestor
24958796|NCT03829774|Sensory System Agents|sensory system agents|mesh-ancestor
24958797|NCT03829774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24958798|NCT03829774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958799|NCT03829774|Antipyretics|antipyretics|mesh-ancestor
24958800|NCT03830060|Hydrocortisone|hydrocortisone|mesh-list
24958801|NCT03830060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24958802|NCT03829917|Paromomycin|paromomycin|mesh-list
24958803|NCT03829917|Miltefosine|miltefosine|mesh-list
24958804|NCT03829917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24958805|NCT03829917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24958806|NCT03829917|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24958807|NCT03829917|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24958809|NCT03829917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24958810|NCT03829930|Entinostat|entinostat|mesh-list
24958811|NCT03829930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24958812|NCT03829930|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25078499|NCT03355716|Sensory System Agents|sensory system agents|mesh-ancestor
24958813|NCT03829930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24958814|NCT03829930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958815|NCT03829566|Methylprednisolone|methylprednisolone|mesh-list
24958816|NCT03829566|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24958821|NCT03829566|Rituximab|rituximab|mesh-list
24958822|NCT03829566|Thymoglobulin|thymoglobulin|mesh-list
24958823|NCT03829566|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24958824|NCT03829566|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24958825|NCT03829566|Prednisolone phosphate|prednisolone phosphate|mesh-list
24958827|NCT03829566|Immunologic Factors|immunologic factors|mesh-ancestor
24958828|NCT03829566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958829|NCT03829566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24958830|NCT03829566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24958838|NCT03829566|Autonomic Agents|autonomic agents|mesh-ancestor
24958839|NCT03829566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24958840|NCT03829566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24958841|NCT03829566|Glucocorticoids|glucocorticoids|mesh-ancestor
24463361|NCT00360295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24463362|NCT00360295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24463363|NCT00360386|Clopidogrel|clopidogrel|mesh-list
24463364|NCT00360386|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24958858|NCT03829345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958860|NCT03829605|Hydrogen Sulfide|hydrogen sulfide|mesh-list
24784887|NCT01910844|Alkylating Agents|alkylating agents|mesh-ancestor
24784888|NCT01910844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784889|NCT01910844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784890|NCT01910844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24784891|NCT01910870|Cyclophosphamide|cyclophosphamide|mesh-list
24784892|NCT01910870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24784893|NCT01910870|Immunologic Factors|immunologic factors|mesh-ancestor
24784894|NCT01910870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784895|NCT01910870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24784896|NCT01910870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24958861|NCT03829605|Gasotransmitters|gasotransmitters|mesh-ancestor
24958862|NCT03829605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24958863|NCT03829605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958864|NCT03829605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958876|NCT03829124|Ketamine|ketamine|mesh-list
24958877|NCT03829124|Propofol|propofol|mesh-list
24958878|NCT03829124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24958882|NCT03829124|Anesthetics, General|anesthetics, general|mesh-ancestor
24958883|NCT03829124|Anesthetics|anesthetics|mesh-ancestor
24958884|NCT03829124|Analgesics|analgesics|mesh-ancestor
24958885|NCT03829124|Sensory System Agents|sensory system agents|mesh-ancestor
24958886|NCT03829124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24958974|NCT03828474|Anticonvulsants|anticonvulsants|mesh-ancestor
24958975|NCT03828474|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24958976|NCT03828474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24958977|NCT03828474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24958978|NCT03828474|Diuretics|diuretics|mesh-ancestor
24958979|NCT03828474|Natriuretic Agents|natriuretic agents|mesh-ancestor
24958980|NCT03828474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958981|NCT03828279|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
24958982|NCT03828279|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24779370|NCT01875757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24958983|NCT03828279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24958984|NCT03828279|Immunologic Factors|immunologic factors|mesh-ancestor
24958985|NCT03828279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958986|NCT03828175|Anesthetics|anesthetics|mesh-list
24958987|NCT03828175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24958988|NCT03828175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958989|NCT03828227|Bevacizumab|bevacizumab|mesh-list
24958990|NCT03828227|Capecitabine|capecitabine|mesh-list
24958991|NCT03828227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24958992|NCT03828227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24958993|NCT03828227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24958994|NCT03828227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24958995|NCT03828227|Growth Substances|growth substances|mesh-ancestor
24958996|NCT03828227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24958997|NCT03828227|Growth Inhibitors|growth inhibitors|mesh-ancestor
24958998|NCT03828227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24958999|NCT03828227|Antimetabolites|antimetabolites|mesh-ancestor
24959000|NCT03828227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959019|NCT03827876|Glucocorticoids|glucocorticoids|mesh-ancestor
24959021|NCT03827876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24959022|NCT03827876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959023|NCT03827876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24959024|NCT03827876|Respiratory System Agents|respiratory system agents|mesh-ancestor
24959025|NCT03827876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24959028|NCT03827876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959030|NCT03827876|Vitamins|vitamins|mesh-ancestor
24763953|NCT01778413|Tenofovir|tenofovir|mesh-list
24959031|NCT03827876|Micronutrients|micronutrients|mesh-ancestor
24959032|NCT03827876|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24959033|NCT03827876|Dermatologic Agents|dermatologic agents|mesh-ancestor
24959035|NCT03828084|Tetrahydrouridine|tetrahydrouridine|mesh-list
24959036|NCT03828084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24959037|NCT03828084|Antimetabolites|antimetabolites|mesh-ancestor
24959038|NCT03828084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959039|NCT03828084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24959040|NCT03828084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24959041|NCT03828058|Tacrolimus|tacrolimus|mesh-list
24959042|NCT03828058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24959043|NCT03828058|Immunologic Factors|immunologic factors|mesh-ancestor
24959044|NCT03828058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959045|NCT03828058|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24959046|NCT03828058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24959047|NCT03828058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959048|NCT03827642|Naloxone|naloxone|mesh-list
24959049|NCT03827642|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24959050|NCT03827642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959051|NCT03827642|Sensory System Agents|sensory system agents|mesh-ancestor
24959052|NCT03827642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24959053|NCT03827629|Naloxone|naloxone|mesh-list
24959114|NCT03827278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959115|NCT03827278|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24959116|NCT03827278|Amebicides|amebicides|mesh-ancestor
24959117|NCT03827278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24959118|NCT03827278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24959119|NCT03827278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24959120|NCT03826940|Lovastatin|lovastatin|mesh-list
24959121|NCT03826940|L 647318|l 647318|mesh-list
24959122|NCT03826940|Dihydromevinolin|dihydromevinolin|mesh-list
24959123|NCT03826940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24959124|NCT03826940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24959125|NCT03826940|Antimetabolites|antimetabolites|mesh-ancestor
24959126|NCT03826940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959127|NCT03826940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24959128|NCT03826940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24959129|NCT03826940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24785152|NCT01912391|Protective Agents|protective agents|mesh-ancestor
24785224|NCT01912755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24785225|NCT01912755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785226|NCT01912755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24785227|NCT01912755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24785228|NCT01912755|Adrenergic Agents|adrenergic agents|mesh-ancestor
25700302|NCT02120300|Sofosbuvir|sofosbuvir|mesh-list
25700303|NCT02120300|Antiviral Agents|antiviral agents|mesh-ancestor
25700304|NCT02120300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25700305|NCT02120417|Capecitabine|capecitabine|mesh-list
24785229|NCT01912755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24785230|NCT01912755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24785231|NCT01912755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24785235|NCT01912755|Mydriatics|mydriatics|mesh-ancestor
24785236|NCT01912755|Sympathomimetics|sympathomimetics|mesh-ancestor
24785237|NCT01912755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24785238|NCT01912820|Quercetin|quercetin|mesh-list
24785239|NCT01912820|Antioxidants|antioxidants|mesh-ancestor
24774734|NCT01847599|Antimetabolites|antimetabolites|mesh-ancestor
24785240|NCT01912820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785241|NCT01912820|Protective Agents|protective agents|mesh-ancestor
24785242|NCT01912820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785243|NCT01912898|Vitamin D|vitamin d|mesh-list
24785244|NCT01912898|Ergocalciferols|ergocalciferols|mesh-list
24785245|NCT01912898|Cholecalciferol|cholecalciferol|mesh-list
24785246|NCT01912898|Vitamins|vitamins|mesh-list
24785247|NCT01912898|Micronutrients|micronutrients|mesh-ancestor
24785248|NCT01912898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785249|NCT01912898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24785250|NCT01912898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24785251|NCT01912976|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
24785252|NCT01912976|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24626806|NCT01088750|Glucocorticoids|glucocorticoids|mesh-ancestor
24959148|NCT03826589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24959149|NCT03826589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24959150|NCT03826589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959151|NCT03826706|Pyrithione zinc|pyrithione zinc|mesh-list
24959152|NCT03826706|Keratolytic Agents|keratolytic agents|mesh-ancestor
24959153|NCT03826706|Dermatologic Agents|dermatologic agents|mesh-ancestor
24959155|NCT03826615|Analgesics|analgesics|mesh-ancestor
24959156|NCT03826615|Sensory System Agents|sensory system agents|mesh-ancestor
24959157|NCT03826615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24959158|NCT03826615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959159|NCT03826615|Anticonvulsants|anticonvulsants|mesh-ancestor
24959160|NCT03826615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24959161|NCT03826615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24959162|NCT03826615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24959163|NCT03826615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24959164|NCT03826615|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24959168|NCT03826615|Antimanic Agents|antimanic agents|mesh-ancestor
24959174|NCT03826602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24463409|NCT00360750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24463410|NCT00360750|Antimetabolites|antimetabolites|mesh-ancestor
24463411|NCT00360750|Antiviral Agents|antiviral agents|mesh-ancestor
24463412|NCT00360750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24463413|NCT00360750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24463414|NCT00360750|Immunologic Factors|immunologic factors|mesh-ancestor
24463415|NCT00360750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463416|NCT00360750|Tubulin Modulators|tubulin modulators|mesh-ancestor
24463417|NCT00360750|Antimitotic Agents|antimitotic agents|mesh-ancestor
24463418|NCT00360750|Mitosis Modulators|mitosis modulators|mesh-ancestor
24959175|NCT03826602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24959176|NCT03826602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959177|NCT03826550|Diclofenac|diclofenac|mesh-list
25700306|NCT02120417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25700307|NCT02120417|Antimetabolites|antimetabolites|mesh-ancestor
25700308|NCT02120417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959178|NCT03826550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25700309|NCT02120417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700310|NCT02120664|Corticosterone|corticosterone|mesh-list
25700311|NCT02120664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25700312|NCT02120794|Insulin|insulin|mesh-list
24959179|NCT03826550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24959180|NCT03826550|Analgesics|analgesics|mesh-ancestor
24959181|NCT03826550|Sensory System Agents|sensory system agents|mesh-ancestor
24671347|NCT01325051|Antiviral Agents|antiviral agents|mesh-ancestor
24959182|NCT03826550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24959183|NCT03826550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959184|NCT03826550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24959185|NCT03826550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24959186|NCT03826550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24959187|NCT03826550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24959188|NCT03826550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959189|NCT03826485|Pranlukast|pranlukast|mesh-list
24959190|NCT03826485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24959191|NCT03826485|Respiratory System Agents|respiratory system agents|mesh-ancestor
24959192|NCT03826485|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24959193|NCT03826485|Hormone Antagonists|hormone antagonists|mesh-ancestor
24959194|NCT03826485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24959195|NCT03826485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959196|NCT03826524|Epinephrine|epinephrine|mesh-list
24959197|NCT03826524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24959198|NCT03826524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24959199|NCT03826524|Adrenergic Agents|adrenergic agents|mesh-ancestor
24959200|NCT03826524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24959201|NCT03826524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959202|NCT03826524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959203|NCT03826524|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24959212|NCT03826368|Cannabidiol|cannabidiol|mesh-list
24959233|NCT03826004|Dermatologic Agents|dermatologic agents|mesh-ancestor
24959234|NCT03826004|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24959235|NCT03826004|Histamine Antagonists|histamine antagonists|mesh-ancestor
24959236|NCT03826004|Histamine Agents|histamine agents|mesh-ancestor
24959237|NCT03826004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24959238|NCT03826004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959239|NCT03826004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959240|NCT03826004|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24959242|NCT03825861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24959243|NCT03825809|Acetaminophen|acetaminophen|mesh-list
24959244|NCT03825809|Celecoxib|celecoxib|mesh-list
24959245|NCT03825809|Ketorolac|ketorolac|mesh-list
24959246|NCT03825809|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
24959247|NCT03825809|Diazepam|diazepam|mesh-list
24959248|NCT03825809|Gabapentin|gabapentin|mesh-list
24959249|NCT03825809|Hydrocodone|hydrocodone|mesh-list
24959250|NCT03825809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24959251|NCT03825809|Analgesics|analgesics|mesh-ancestor
24959252|NCT03825809|Sensory System Agents|sensory system agents|mesh-ancestor
24959253|NCT03825809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24959254|NCT03825809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959255|NCT03825809|Antipyretics|antipyretics|mesh-ancestor
24959256|NCT03825809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24959257|NCT03825809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24959258|NCT03825809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24959259|NCT03825809|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24959260|NCT03825809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24959261|NCT03825809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24959262|NCT03825809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959263|NCT03825809|Anticonvulsants|anticonvulsants|mesh-ancestor
24609087|NCT00994968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609088|NCT00994968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24609089|NCT00994968|Antimetabolites|antimetabolites|mesh-ancestor
24609090|NCT00994981|Magnesium Sulfate|magnesium sulfate|mesh-list
24959264|NCT03825809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24959265|NCT03825809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24959266|NCT03825809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24609094|NCT00994981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609096|NCT00994981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24609097|NCT00994981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24609098|NCT00994981|Anticonvulsants|anticonvulsants|mesh-ancestor
24959335|NCT03825250|Antimanic Agents|antimanic agents|mesh-ancestor
24959336|NCT03825250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24959337|NCT03825250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24959338|NCT03825250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24959339|NCT03825445|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24671364|NCT01325194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24671365|NCT01325194|Immunologic Factors|immunologic factors|mesh-ancestor
24671366|NCT01325194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671367|NCT01325220|Baclofen|baclofen|mesh-list
24671368|NCT01325220|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24671369|NCT01325220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637209|NCT01149304|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24637210|NCT01149304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637211|NCT01149304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24502927|NCT04020172|Dobutamine|dobutamine|mesh-list
24785466|NCT01914627|Antifungal Agents|antifungal agents|mesh-ancestor
24785467|NCT01914627|Keratolytic Agents|keratolytic agents|mesh-ancestor
24785468|NCT01914627|Dermatologic Agents|dermatologic agents|mesh-ancestor
24785469|NCT01914627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24785470|NCT01914627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24785471|NCT01914627|Analgesics|analgesics|mesh-ancestor
24463419|NCT00360763|Candesartan|candesartan|mesh-list
24463420|NCT00360763|Candesartan cilexetil|candesartan cilexetil|mesh-list
24463421|NCT00360763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24463422|NCT00360763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24463423|NCT00360763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24463424|NCT00360763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463425|NCT00360776|Tipifarnib|tipifarnib|mesh-list
24463426|NCT00360776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463427|NCT00360815|Insulin|insulin|mesh-list
24463428|NCT00360815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24463433|NCT00360854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24463439|NCT00360945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609166|NCT00995241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609167|NCT00995241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609168|NCT00995293|Docetaxel|docetaxel|mesh-list
24609169|NCT00995293|Fluorouracil|fluorouracil|mesh-list
24609170|NCT00995293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609171|NCT00995293|Tubulin Modulators|tubulin modulators|mesh-ancestor
24609172|NCT00995293|Antimitotic Agents|antimitotic agents|mesh-ancestor
24637222|NCT01149330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24609177|NCT00995293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24609178|NCT00995293|Immunologic Factors|immunologic factors|mesh-ancestor
24609179|NCT00995293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609180|NCT00995306|Capsaicin|capsaicin|mesh-list
24609181|NCT00995306|Antipruritics|antipruritics|mesh-ancestor
24463441|NCT00360984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24463442|NCT00360984|Insulin Glargine|insulin glargine|mesh-list
24785472|NCT01914627|Sensory System Agents|sensory system agents|mesh-ancestor
24785473|NCT01914627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24785474|NCT01914627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785475|NCT01914627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24785477|NCT01914627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24785478|NCT01914627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626821|NCT01088763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24626824|NCT01088763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24626825|NCT01088763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24626826|NCT01088763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626828|NCT01088763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626829|NCT01088802|Carboplatin|carboplatin|mesh-list
24626830|NCT01088802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626831|NCT01088815|Gemcitabine|gemcitabine|mesh-list
24626832|NCT01088815|Paclitaxel|paclitaxel|mesh-list
24626833|NCT01088815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24626834|NCT01088815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626835|NCT01088815|Tubulin Modulators|tubulin modulators|mesh-ancestor
24626836|NCT01088815|Antimitotic Agents|antimitotic agents|mesh-ancestor
24626837|NCT01088815|Mitosis Modulators|mitosis modulators|mesh-ancestor
24626838|NCT01088815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626839|NCT01088815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24626840|NCT01088815|Antimetabolites|antimetabolites|mesh-ancestor
24626841|NCT01088815|Antiviral Agents|antiviral agents|mesh-ancestor
24959386|NCT03825367|Azacitidine|azacitidine|mesh-list
24959387|NCT03825367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24959388|NCT03825367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24959389|NCT03825367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24959390|NCT03825367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959391|NCT03825367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24959392|NCT03825367|Antimetabolites|antimetabolites|mesh-ancestor
24959393|NCT03825367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24959394|NCT03825328|Gemcitabine|gemcitabine|mesh-list
24959395|NCT03825328|Paclitaxel|paclitaxel|mesh-list
24959396|NCT03825328|Oxaliplatin|oxaliplatin|mesh-list
24959400|NCT03825328|Tubulin Modulators|tubulin modulators|mesh-ancestor
24959443|NCT03825081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24959444|NCT03825081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959445|NCT03825081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959446|NCT03825081|Miotics|miotics|mesh-ancestor
24959447|NCT03825081|Autonomic Agents|autonomic agents|mesh-ancestor
24959448|NCT03825081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24959449|NCT03825081|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24959450|NCT03825081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24959451|NCT03825081|Cholinergic Agents|cholinergic agents|mesh-ancestor
24959452|NCT03825068|Anesthetics|anesthetics|mesh-list
24959453|NCT03825068|Anesthetics, General|anesthetics, general|mesh-list
24959454|NCT03825068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24959455|NCT03825068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785480|NCT01914692|Somatostatin|somatostatin|mesh-list
24488420|NCT00468429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488422|NCT00468520|Oxytocin|oxytocin|mesh-list
24488423|NCT00468520|Oxytocics|oxytocics|mesh-ancestor
24488424|NCT00468520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24780369|NCT01884116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24780370|NCT01884272|Naproxen|naproxen|mesh-list
24780371|NCT01884272|Indomethacin|indomethacin|mesh-list
24780372|NCT01884272|Lesinurad|lesinurad|mesh-list
24637565|NCT01151397|Antimetabolites|antimetabolites|mesh-ancestor
24780373|NCT01884272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24780375|NCT01884272|Analgesics|analgesics|mesh-ancestor
24959457|NCT03824665|Nalbuphine|nalbuphine|mesh-list
24959459|NCT03824665|Narcotics|narcotics|mesh-ancestor
24959460|NCT03824665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24959461|NCT03824665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959462|NCT03824665|Analgesics|analgesics|mesh-ancestor
24959463|NCT03824665|Sensory System Agents|sensory system agents|mesh-ancestor
24959464|NCT03824665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24959469|NCT03825016|Diclofenac|diclofenac|mesh-list
24807061|NCT02019485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24807062|NCT02019485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807063|NCT02019485|Analgesics|analgesics|mesh-ancestor
24807064|NCT02019485|Sensory System Agents|sensory system agents|mesh-ancestor
24463446|NCT00361010|Anticonvulsants|anticonvulsants|mesh-ancestor
24463447|NCT00361010|Nootropic Agents|nootropic agents|mesh-ancestor
24959494|NCT03824717|Sensory System Agents|sensory system agents|mesh-ancestor
24959495|NCT03824717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24959496|NCT03824834|Morphine|morphine|mesh-list
24959497|NCT03824834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24959498|NCT03824834|Narcotics|narcotics|mesh-ancestor
24959499|NCT03824834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24959503|NCT03824834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24959505|NCT03824691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24959506|NCT03824691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24959507|NCT03824379|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24959508|NCT03824379|Magnesium citrate|magnesium citrate|mesh-list
24609607|NCT00997477|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24609608|NCT00997477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24609609|NCT00997477|Adrenergic Agents|adrenergic agents|mesh-ancestor
24609610|NCT00997477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24959509|NCT03824379|Cathartics|cathartics|mesh-ancestor
24959510|NCT03824379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24959511|NCT03824379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959512|NCT03824171|Cholecalciferol|cholecalciferol|mesh-list
24959513|NCT03824171|Vitamin D|vitamin d|mesh-list
24959514|NCT03824171|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
24959515|NCT03824171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24959516|NCT03824171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959517|NCT03824171|Vitamins|vitamins|mesh-ancestor
24959518|NCT03824171|Micronutrients|micronutrients|mesh-ancestor
24959519|NCT03824171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24959520|NCT03824171|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24959521|NCT03824171|Hormone Antagonists|hormone antagonists|mesh-ancestor
24959522|NCT03824171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24959523|NCT03824171|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24959536|NCT03824314|Anesthetics, General|anesthetics, general|mesh-ancestor
24959538|NCT03824314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24959539|NCT03824314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24959540|NCT03824314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24959541|NCT03824314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24959542|NCT03824314|GABA Modulators|gaba modulators|mesh-ancestor
24959544|NCT03824314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24959545|NCT03824314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700313|NCT02120794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25700314|NCT02120794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700315|NCT02120833|Decanoic acid|decanoic acid|mesh-list
25700316|NCT02120833|Antifungal Agents|antifungal agents|mesh-ancestor
25700317|NCT02120833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25700318|NCT02120898|Imiquimod|imiquimod|mesh-list
25700319|NCT02120898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25700320|NCT02120898|Immunologic Factors|immunologic factors|mesh-ancestor
25700321|NCT02120898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700322|NCT02120898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700323|NCT02120898|Interferon Inducers|interferon inducers|mesh-ancestor
25700324|NCT02120924|Azelaic acid|azelaic acid|mesh-list
24959546|NCT03824119|Ibuprofen|ibuprofen|mesh-list
24780612|NCT01885338|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24780613|NCT01885338|Antiviral Agents|antiviral agents|mesh-ancestor
24959547|NCT03824119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24959548|NCT03824119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24959549|NCT03824119|Analgesics|analgesics|mesh-ancestor
24959550|NCT03824119|Sensory System Agents|sensory system agents|mesh-ancestor
24959551|NCT03824119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24959552|NCT03824119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959553|NCT03824119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24959554|NCT03824119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24959555|NCT03824119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24959556|NCT03824119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24959557|NCT03824119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609612|NCT00997542|Allopurinol|allopurinol|mesh-list
24959558|NCT03824340|Doxycycline|doxycycline|mesh-list
24959559|NCT03824340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24959560|NCT03824340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24959561|NCT03824340|Antimalarials|antimalarials|mesh-ancestor
24959562|NCT03824340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24959563|NCT03824340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24959564|NCT03824002|Insulin|insulin|mesh-list
24959565|NCT03824002|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24959566|NCT03824002|Metformin|metformin|mesh-list
24959567|NCT03824002|Insulin Glargine|insulin glargine|mesh-list
24959568|NCT03824002|Insulin Aspart|insulin aspart|mesh-list
24959569|NCT03824002|Dulaglutide|dulaglutide|mesh-list
24959570|NCT03824002|Repaglinide|repaglinide|mesh-list
24959571|NCT03824002|Insulin, Long-Acting|insulin, long-acting|mesh-list
24959572|NCT03824002|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24959573|NCT03824002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24959574|NCT03824002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959579|NCT03823911|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
24959580|NCT03823911|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
24959581|NCT03823911|Antiviral Agents|antiviral agents|mesh-ancestor
24959582|NCT03823911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24959583|NCT03823846|Flurbiprofen|flurbiprofen|mesh-list
24959584|NCT03823846|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
24959590|NCT03823846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959591|NCT03823846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24959592|NCT03823846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24609669|NCT00997750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24609671|NCT00997750|Sensory System Agents|sensory system agents|mesh-ancestor
24671376|NCT01325220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959593|NCT03823846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24959594|NCT03823846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24959595|NCT03823846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24959596|NCT03823846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24959597|NCT03823846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959598|NCT03823846|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24959599|NCT03823846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24959600|NCT03823846|Narcotics|narcotics|mesh-ancestor
24959601|NCT03823846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24959620|NCT03823625|Ipilimumab|ipilimumab|mesh-list
24959621|NCT03823625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24959622|NCT03823625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24959623|NCT03823625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24959624|NCT03823625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959625|NCT03823781|Milrinone|milrinone|mesh-list
24959626|NCT03823781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24959627|NCT03823781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24959628|NCT03823781|Vasodilator Agents|vasodilator agents|mesh-ancestor
24959629|NCT03823781|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24959630|NCT03823781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24959631|NCT03823781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24959632|NCT03823781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959633|NCT03823781|Protective Agents|protective agents|mesh-ancestor
24959634|NCT03823781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959635|NCT03823339|Liraglutide|liraglutide|mesh-list
24959636|NCT03823339|Xultophy|xultophy|mesh-list
24959637|NCT03823339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25700325|NCT02120924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700326|NCT02120924|Dermatologic Agents|dermatologic agents|mesh-ancestor
25700327|NCT02120950|Aflibercept|aflibercept|mesh-list
25700328|NCT02120950|Verteporfin|verteporfin|mesh-list
24780778|NCT01886352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24959638|NCT03823339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959699|NCT03823248|Micronutrients|micronutrients|mesh-ancestor
24959700|NCT03823248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959701|NCT03822936|Fluorouracil|fluorouracil|mesh-list
24959702|NCT03822936|Oxaliplatin|oxaliplatin|mesh-list
24959703|NCT03822936|Irinotecan|irinotecan|mesh-list
24959704|NCT03822936|Antimetabolites|antimetabolites|mesh-ancestor
24959705|NCT03822936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959706|NCT03822936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24959707|NCT03822936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24959708|NCT03822936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24959709|NCT03822936|Immunologic Factors|immunologic factors|mesh-ancestor
24959710|NCT03822936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959711|NCT03822936|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24959712|NCT03822936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24959713|NCT03822936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24959714|NCT03822962|Acetaminophen|acetaminophen|mesh-list
24959715|NCT03822962|Ibuprofen|ibuprofen|mesh-list
24959716|NCT03822962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24959717|NCT03822962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24959718|NCT03822962|Analgesics|analgesics|mesh-ancestor
24959719|NCT03822962|Sensory System Agents|sensory system agents|mesh-ancestor
24959746|NCT03822559|Timolol|timolol|mesh-list
24959747|NCT03822559|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24959748|NCT03822559|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24959749|NCT03822559|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24959750|NCT03822559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24959751|NCT03822559|Adrenergic Agents|adrenergic agents|mesh-ancestor
24959752|NCT03822559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24959956|NCT03820245|Protective Agents|protective agents|mesh-ancestor
24959753|NCT03822559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959754|NCT03822559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959755|NCT03822559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24959756|NCT03822559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24959757|NCT03822845|Edetic Acid|edetic acid|mesh-list
24959762|NCT03822845|Anticoagulants|anticoagulants|mesh-ancestor
24959763|NCT03822845|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24959764|NCT03822845|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24959765|NCT03822546|Nicotine|nicotine|mesh-list
24959766|NCT03822546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24959767|NCT03822546|Autonomic Agents|autonomic agents|mesh-ancestor
24959768|NCT03822546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24959769|NCT03822546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959770|NCT03822546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24959771|NCT03822546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24959772|NCT03822546|Cholinergic Agents|cholinergic agents|mesh-ancestor
24959773|NCT03822546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24959774|NCT03822546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959775|NCT03822520|Moxifloxacin|moxifloxacin|mesh-list
24959776|NCT03822520|Celecoxib|celecoxib|mesh-list
24959777|NCT03822520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24959778|NCT03822520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24959779|NCT03822520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24959780|NCT03822520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24959781|NCT03822520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24959785|NCT03822520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24959786|NCT03822520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24959787|NCT03822520|Analgesics|analgesics|mesh-ancestor
24959788|NCT03822520|Sensory System Agents|sensory system agents|mesh-ancestor
24959789|NCT03822520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24959790|NCT03822520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24959791|NCT03822520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24959792|NCT03822520|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24959793|NCT03822520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24959794|NCT03822091|Terlipressin|terlipressin|mesh-list
24959795|NCT03822091|Norepinephrine|norepinephrine|mesh-list
24959796|NCT03822091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24959797|NCT03822091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24959808|NCT03822065|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24959810|NCT03822065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24959811|NCT03822065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700329|NCT02120950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24959814|NCT03822065|Antidepressive Agents|antidepressive agents|mesh-ancestor
24959817|NCT03822312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24959819|NCT03822169|Choline|choline|mesh-list
24959820|NCT03822169|Lipotropic Agents|lipotropic agents|mesh-ancestor
24959821|NCT03822169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24959822|NCT03822169|Antimetabolites|antimetabolites|mesh-ancestor
24610173|NCT01000441|Adalimumab|adalimumab|mesh-list
24959823|NCT03822169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959824|NCT03822169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24959825|NCT03822169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24959826|NCT03822169|Nootropic Agents|nootropic agents|mesh-ancestor
24959827|NCT03821987|Cyclophosphamide|cyclophosphamide|mesh-list
24959828|NCT03821987|Busulfan|busulfan|mesh-list
24959829|NCT03821987|Fludarabine|fludarabine|mesh-list
24959830|NCT03821987|Thymoglobulin|thymoglobulin|mesh-list
24959831|NCT03821987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24959832|NCT03821987|Immunologic Factors|immunologic factors|mesh-ancestor
24959833|NCT03821987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959834|NCT03821987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24959835|NCT03821987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24959836|NCT03821987|Alkylating Agents|alkylating agents|mesh-ancestor
24807098|NCT02019810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24959837|NCT03821987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959838|NCT03821987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24959839|NCT03821987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24610310|NCT01001247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24959857|NCT03821701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959858|NCT03821623|Niacinamide|niacinamide|mesh-list
24959860|NCT03821623|Nicotinic Acids|nicotinic acids|mesh-list
24959861|NCT03821623|Vitamin B Complex|vitamin b complex|mesh-ancestor
24959862|NCT03821623|Vitamins|vitamins|mesh-ancestor
24959863|NCT03821623|Micronutrients|micronutrients|mesh-ancestor
24959864|NCT03821623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610316|NCT01001260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24610317|NCT01001260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24610318|NCT01001260|Analgesics|analgesics|mesh-ancestor
24610319|NCT01001260|Sensory System Agents|sensory system agents|mesh-ancestor
24610320|NCT01001260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24610321|NCT01001260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610322|NCT01001260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24610323|NCT01001260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24610324|NCT01001260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24610325|NCT01001260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24610326|NCT01001260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610327|NCT01001260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24610328|NCT01001260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24610329|NCT01001260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610359|NCT01001624|Protective Agents|protective agents|mesh-ancestor
24671455|NCT01325987|Vitamin D|vitamin d|mesh-list
24959865|NCT03821623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24959866|NCT03821623|Antimetabolites|antimetabolites|mesh-ancestor
24959867|NCT03821623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959868|NCT03821623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24959869|NCT03821623|Vasodilator Agents|vasodilator agents|mesh-ancestor
24959870|NCT03821714|Vitamins|vitamins|mesh-list
25700330|NCT02120950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25700331|NCT02120950|Growth Substances|growth substances|mesh-ancestor
25700332|NCT02120950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700333|NCT02120950|Growth Inhibitors|growth inhibitors|mesh-ancestor
24959871|NCT03821714|Hydrocortisone|hydrocortisone|mesh-list
24959872|NCT03821714|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24959873|NCT03821714|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24959895|NCT03821415|Estrogens|estrogens|mesh-ancestor
24959896|NCT03821415|Hormones|hormones|mesh-ancestor
24959897|NCT03821415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24786050|NCT01917799|Aspirin|aspirin|mesh-list
24959898|NCT03821415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959899|NCT03821454|Capecitabine|capecitabine|mesh-list
25078569|NCT03355352|Narcotics|narcotics|mesh-ancestor
24959900|NCT03821454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24959902|NCT03821454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959903|NCT03821454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24959904|NCT03821493|Itraconazole|itraconazole|mesh-list
24959905|NCT03821493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24959906|NCT03821493|Antifungal Agents|antifungal agents|mesh-ancestor
24959907|NCT03821493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24959908|NCT03821493|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24959909|NCT03821493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24959910|NCT03821493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24959911|NCT03821493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959912|NCT03821493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24959913|NCT03821493|Hormone Antagonists|hormone antagonists|mesh-ancestor
24959914|NCT03821493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24959919|NCT03821168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24959920|NCT03821168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24959921|NCT03821168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24959922|NCT03821168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24959923|NCT03821168|Growth Substances|growth substances|mesh-ancestor
24959925|NCT03821168|Growth Inhibitors|growth inhibitors|mesh-ancestor
24959926|NCT03821168|Hematinics|hematinics|mesh-ancestor
24959927|NCT03820830|Palbociclib|palbociclib|mesh-list
24959928|NCT03820830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24959929|NCT03820830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24671817|NCT01328015|Autonomic Agents|autonomic agents|mesh-ancestor
24959930|NCT03820830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24959931|NCT03820830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959933|NCT03820622|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24959934|NCT03820622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24959935|NCT03820622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24959936|NCT03820622|Tubulin Modulators|tubulin modulators|mesh-ancestor
24959937|NCT03820622|Antimitotic Agents|antimitotic agents|mesh-ancestor
24959938|NCT03820622|Mitosis Modulators|mitosis modulators|mesh-ancestor
24959939|NCT03820622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959940|NCT03820531|Pancrelipase|pancrelipase|mesh-list
24959941|NCT03820531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24959942|NCT03820518|Calcitriol|calcitriol|mesh-list
24959943|NCT03820518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24959944|NCT03820518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959945|NCT03820518|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24959946|NCT03820518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24959947|NCT03820518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959948|NCT03820518|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24959949|NCT03820518|Vitamins|vitamins|mesh-ancestor
24889015|NCT04498897|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24711489|NCT01515774|Antioxidants|antioxidants|mesh-ancestor
24889016|NCT04498689|Gemcitabine|gemcitabine|mesh-list
24889018|NCT04498689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24889019|NCT04498689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24889020|NCT04498689|Tubulin Modulators|tubulin modulators|mesh-ancestor
24889021|NCT04498689|Antimitotic Agents|antimitotic agents|mesh-ancestor
24889022|NCT04498689|Mitosis Modulators|mitosis modulators|mesh-ancestor
24959950|NCT03820518|Micronutrients|micronutrients|mesh-ancestor
24816054|NCT02073838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24959953|NCT03820245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24959955|NCT03820245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959957|NCT03820245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24959958|NCT03820245|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24959959|NCT03820245|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24959960|NCT03820245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24959961|NCT03820206|Tranexamic Acid|tranexamic acid|mesh-list
24959962|NCT03820206|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24959963|NCT03820206|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24959964|NCT03820206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24959965|NCT03820206|Hemostatics|hemostatics|mesh-ancestor
24959966|NCT03820206|Coagulants|coagulants|mesh-ancestor
24959967|NCT03820193|Acetaminophen|acetaminophen|mesh-list
24463465|NCT00361114|Sulfadoxine|sulfadoxine|mesh-list
24463466|NCT00361114|Dapsone|dapsone|mesh-list
24959969|NCT03820193|Ketorolac|ketorolac|mesh-list
24959970|NCT03820193|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
24959971|NCT03820193|Diazepam|diazepam|mesh-list
24959972|NCT03820193|Gabapentin|gabapentin|mesh-list
25078570|NCT03355352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25078571|NCT03355352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078572|NCT03355352|Analgesics|analgesics|mesh-ancestor
25078573|NCT03355352|Sensory System Agents|sensory system agents|mesh-ancestor
25078574|NCT03355352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078575|NCT03355352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25078576|NCT03355352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25078577|NCT03355352|Anesthetics, General|anesthetics, general|mesh-ancestor
25078578|NCT03355352|Anesthetics|anesthetics|mesh-ancestor
25078579|NCT03355300|Cannabidiol|cannabidiol|mesh-list
25078583|NCT03355248|Oxycodone|oxycodone|mesh-list
25078584|NCT03355248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25078585|NCT03355248|Analgesics|analgesics|mesh-ancestor
25078586|NCT03355248|Sensory System Agents|sensory system agents|mesh-ancestor
25078587|NCT03355248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078588|NCT03355248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078589|NCT03355248|Antipyretics|antipyretics|mesh-ancestor
25078590|NCT03355248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25078591|NCT03355248|Narcotics|narcotics|mesh-ancestor
25078592|NCT03355248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25078593|NCT03355248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25078594|NCT03355248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25078595|NCT03355248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25078596|NCT03355170|Domperidone|domperidone|mesh-list
25700334|NCT02120950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700335|NCT02120950|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25700336|NCT02120950|Dermatologic Agents|dermatologic agents|mesh-ancestor
25078597|NCT03355170|Lansoprazole|lansoprazole|mesh-list
25078598|NCT03355170|Dexlansoprazole|dexlansoprazole|mesh-list
25700337|NCT02121002|Diclofenac|diclofenac|mesh-list
24959981|NCT03820193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24959982|NCT03820193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24959983|NCT03820193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24959984|NCT03820193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24786046|NCT01917721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24786047|NCT01917721|Antimalarials|antimalarials|mesh-ancestor
24786048|NCT01917721|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24786049|NCT01917721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25078599|NCT03355170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25078600|NCT03355170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24786056|NCT01917799|Sensory System Agents|sensory system agents|mesh-ancestor
24786057|NCT01917799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24786058|NCT01917799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786059|NCT01917799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24786060|NCT01917799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24786061|NCT01917799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24786062|NCT01917799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24786063|NCT01917799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786064|NCT01917799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24786065|NCT01917799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24786066|NCT01917799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24960005|NCT03820193|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24960006|NCT03820193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24960007|NCT03820193|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24960008|NCT03820193|Anesthetics, General|anesthetics, general|mesh-ancestor
24960009|NCT03820193|Anesthetics|anesthetics|mesh-ancestor
24960010|NCT03820193|GABA Modulators|gaba modulators|mesh-ancestor
24960011|NCT03820193|GABA Agents|gaba agents|mesh-ancestor
24960038|NCT03820180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24960039|NCT03820180|Sympathomimetics|sympathomimetics|mesh-ancestor
24960040|NCT03820037|Opicapone|opicapone|mesh-list
24960041|NCT03820037|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24960042|NCT03820037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24960043|NCT03820037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960044|NCT03820037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24960045|NCT03820037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24960046|NCT03819790|Insulin|insulin|mesh-list
24960047|NCT03819790|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24960048|NCT03819790|Metformin|metformin|mesh-list
24960049|NCT03819790|Insulin Glargine|insulin glargine|mesh-list
24960052|NCT03819790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24960053|NCT03819790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960055|NCT03819647|Anticonvulsants|anticonvulsants|mesh-ancestor
24960056|NCT03819556|Caseins|caseins|mesh-list
24960057|NCT03819556|Chelating Agents|chelating agents|mesh-ancestor
24960058|NCT03819556|Sequestering Agents|sequestering agents|mesh-ancestor
24960059|NCT03819556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672393|NCT01331928|Oxaliplatin|oxaliplatin|mesh-list
24960080|NCT03819348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24476999|NCT00416923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24960083|NCT03819348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24960091|NCT03819231|Oxytocin|oxytocin|mesh-list
24960092|NCT03819231|Oxytocics|oxytocics|mesh-ancestor
24960093|NCT03819231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24960094|NCT03819231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960095|NCT03819322|Sofosbuvir|sofosbuvir|mesh-list
24960096|NCT03819322|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
24960097|NCT03819322|Velpatasvir|velpatasvir|mesh-list
24960098|NCT03819322|Antiviral Agents|antiviral agents|mesh-ancestor
24960099|NCT03819322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24960100|NCT03820908|Bisantrene|bisantrene|mesh-list
24960101|NCT03820908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24960102|NCT03820908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24960103|NCT03819101|Aspirin|aspirin|mesh-list
25700338|NCT02121002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25700339|NCT02121002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25700340|NCT02121002|Analgesics|analgesics|mesh-ancestor
24960110|NCT03819101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24960112|NCT03819101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24960113|NCT03819101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24960114|NCT03819101|Analgesics|analgesics|mesh-ancestor
24960115|NCT03819101|Sensory System Agents|sensory system agents|mesh-ancestor
24960116|NCT03819101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24960117|NCT03819101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960118|NCT03819101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24960119|NCT03819101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24960120|NCT03819101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24960121|NCT03819101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24960122|NCT03819101|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24960123|NCT03819101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24960124|NCT03819101|Antipyretics|antipyretics|mesh-ancestor
24960125|NCT03819127|Metformin|metformin|mesh-list
24960126|NCT03819127|Vildagliptin|vildagliptin|mesh-list
24960127|NCT03819127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24960128|NCT03819127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960129|NCT03819127|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24960130|NCT03819127|Protease Inhibitors|protease inhibitors|mesh-ancestor
24960131|NCT03819127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24960132|NCT03819127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960133|NCT03819010|Letrozole|letrozole|mesh-list
24960134|NCT03819010|Palbociclib|palbociclib|mesh-list
24960135|NCT03819010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24960136|NCT03819010|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24960137|NCT03819010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24463484|NCT00361153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463486|NCT00361166|Pimavanserin|pimavanserin|mesh-list
24463487|NCT00361166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24463488|NCT00361166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24960138|NCT03819010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24960139|NCT03819010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960140|NCT03819010|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24960141|NCT03819010|Hormone Antagonists|hormone antagonists|mesh-ancestor
24960142|NCT03819010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25700341|NCT02121002|Sensory System Agents|sensory system agents|mesh-ancestor
25700342|NCT02121002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25700343|NCT02121002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960164|NCT03818932|Ketorolac|ketorolac|mesh-list
24960165|NCT03818932|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
24960166|NCT03818932|Diazepam|diazepam|mesh-list
24960167|NCT03818932|Gabapentin|gabapentin|mesh-list
24960168|NCT03818932|Hydrocodone|hydrocodone|mesh-list
24672943|NCT01334502|Hormones|hormones|mesh-ancestor
24960169|NCT03818932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24960170|NCT03818932|Analgesics|analgesics|mesh-ancestor
24960171|NCT03818932|Sensory System Agents|sensory system agents|mesh-ancestor
24477280|NCT00418119|Hematinics|hematinics|mesh-ancestor
24960172|NCT03818932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24960174|NCT03818932|Antipyretics|antipyretics|mesh-ancestor
24960175|NCT03818932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24960176|NCT03818932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24960177|NCT03818932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24960178|NCT03818932|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24960179|NCT03818932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24960180|NCT03818932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24960181|NCT03818932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960182|NCT03818932|Anticonvulsants|anticonvulsants|mesh-ancestor
24960183|NCT03818932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24960184|NCT03818932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24960185|NCT03818932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24960213|NCT03818919|Hydrocodone|hydrocodone|mesh-list
24960214|NCT03818919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24960215|NCT03818919|Analgesics|analgesics|mesh-ancestor
24960216|NCT03818919|Sensory System Agents|sensory system agents|mesh-ancestor
24960217|NCT03818919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24960218|NCT03818919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960219|NCT03818919|Antipyretics|antipyretics|mesh-ancestor
24960220|NCT03818919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24960221|NCT03818919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24960222|NCT03818919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24765278|NCT01787396|Metformin|metformin|mesh-list
24960223|NCT03818919|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24960224|NCT03818919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24490548|NCT00478907|Anesthetics, General|anesthetics, general|mesh-ancestor
24490550|NCT00478907|Analgesics|analgesics|mesh-ancestor
24490551|NCT00478907|Sensory System Agents|sensory system agents|mesh-ancestor
24490556|NCT00478907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24490592|NCT00479076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24782234|NCT01895023|Dexmedetomidine|dexmedetomidine|mesh-list
24782249|NCT01895023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24782250|NCT01895023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24782251|NCT01895023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24782252|NCT01895023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24782253|NCT01895023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24960226|NCT03818919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960227|NCT03818919|Anticonvulsants|anticonvulsants|mesh-ancestor
24960228|NCT03818919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24960229|NCT03818919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24960230|NCT03818919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24960232|NCT03818919|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24457094|NCT00333112|Tamsulosin|tamsulosin|mesh-list
24960233|NCT03818919|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24960273|NCT03818282|Paclitaxel|paclitaxel|mesh-list
24960274|NCT03818282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24960275|NCT03818282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24960276|NCT03818282|Tubulin Modulators|tubulin modulators|mesh-ancestor
24960296|NCT03817970|Dermatologic Agents|dermatologic agents|mesh-ancestor
24960297|NCT03817970|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24960298|NCT03817970|Serotonin Agents|serotonin agents|mesh-ancestor
24960299|NCT03817970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24960300|NCT03817970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960301|NCT03817970|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24960302|NCT03817970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24960303|NCT03817970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24960304|NCT03817970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24960305|NCT03817970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24960306|NCT03817970|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24960307|NCT03818295|Praliciguat|praliciguat|mesh-list
24960308|NCT03818295|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
24960309|NCT03818295|Enzyme Activators|enzyme activators|mesh-ancestor
24960311|NCT03818295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24960329|NCT03818048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24960330|NCT03818048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24960331|NCT03818048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960332|NCT03818048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24960333|NCT03818048|Anesthetics, General|anesthetics, general|mesh-ancestor
24960334|NCT03818048|Anesthetics|anesthetics|mesh-ancestor
24960335|NCT03818048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24960336|NCT03818048|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24960337|NCT03818334|Cyclophosphamide|cyclophosphamide|mesh-list
24960342|NCT03818334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24960343|NCT03818334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24960344|NCT03818334|Alkylating Agents|alkylating agents|mesh-ancestor
24960345|NCT03818334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960346|NCT03818334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24960347|NCT03818334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24960348|NCT03818321|Methenamine|methenamine|mesh-list
24960349|NCT03818321|Methenamine hippurate|methenamine hippurate|mesh-list
24960350|NCT03818321|Methenamine mandelate|methenamine mandelate|mesh-list
24960351|NCT03818321|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24889373|NCT04494399|Interferon-beta|interferon-beta|mesh-list
24889374|NCT04494399|Interferon beta-1b|interferon beta-1b|mesh-list
24889375|NCT04494399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700344|NCT02121002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25700345|NCT02121002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25700346|NCT02121002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25700347|NCT02121002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700348|NCT02121002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700349|NCT02121041|Losartan|losartan|mesh-list
25700350|NCT02121041|Amlodipine|amlodipine|mesh-list
25700351|NCT02121041|Chlorthalidone|chlorthalidone|mesh-list
25700352|NCT02121041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25700353|NCT02121041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25700354|NCT02121041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24960361|NCT03817541|Anesthetics|anesthetics|mesh-ancestor
24960362|NCT03817619|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
24960363|NCT03817619|Antiviral Agents|antiviral agents|mesh-ancestor
24960364|NCT03817619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24960366|NCT03817567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24960367|NCT03817567|Immunologic Factors|immunologic factors|mesh-ancestor
24960368|NCT03817567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960369|NCT03817411|Capecitabine|capecitabine|mesh-list
24960370|NCT03817411|Oxaliplatin|oxaliplatin|mesh-list
24960371|NCT03817411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24960372|NCT03817411|Antimetabolites|antimetabolites|mesh-ancestor
24960373|NCT03817411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960374|NCT03817411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24960375|NCT03817476|BI 425809|bi 425809|mesh-list
24960376|NCT03817476|Nootropic Agents|nootropic agents|mesh-ancestor
24960380|NCT03817359|Remifentanil|remifentanil|mesh-list
24960381|NCT03817359|Propofol|propofol|mesh-list
24960382|NCT03817359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24623500|NCT01071928|Docetaxel|docetaxel|mesh-list
24452388|NCT00327353|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24452389|NCT00327353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24452390|NCT00327353|Adrenergic Agents|adrenergic agents|mesh-ancestor
24452391|NCT00327353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24452392|NCT00327353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673378|NCT01337440|Incretins|incretins|mesh-ancestor
24463548|NCT00361348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24463549|NCT00361348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24463550|NCT00361348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463551|NCT00361387|Methylphenidate|methylphenidate|mesh-list
24939254|NCT04011878|Mitomycins|mitomycins|mesh-list
24463552|NCT00361387|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24960383|NCT03817359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24960384|NCT03817359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960385|NCT03817359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24960386|NCT03817359|Anesthetics, General|anesthetics, general|mesh-ancestor
24960387|NCT03817359|Anesthetics|anesthetics|mesh-ancestor
24960388|NCT03817359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24960389|NCT03817359|Narcotics|narcotics|mesh-ancestor
24960390|NCT03817359|Analgesics|analgesics|mesh-ancestor
24960391|NCT03817359|Sensory System Agents|sensory system agents|mesh-ancestor
24960392|NCT03817359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078615|NCT03355053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25078617|NCT03355053|Sensory System Agents|sensory system agents|mesh-ancestor
25078618|NCT03355053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078619|NCT03355053|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25078621|NCT03355053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25078622|NCT03355053|Adrenergic Agents|adrenergic agents|mesh-ancestor
25078623|NCT03355053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25078624|NCT03355053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078626|NCT03355027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25078627|NCT03355027|Simvastatin|simvastatin|mesh-list
25078628|NCT03355027|Ezetimibe|ezetimibe|mesh-list
25078629|NCT03355027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25078630|NCT03355027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25078631|NCT03355027|Antimetabolites|antimetabolites|mesh-ancestor
25078632|NCT03355027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078633|NCT03355027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25078634|NCT03355027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25078635|NCT03355027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078636|NCT03355014|Metformin|metformin|mesh-list
25078637|NCT03355014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25078638|NCT03355014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078639|NCT03354962|Nivolumab|nivolumab|mesh-list
25078640|NCT03354962|Ipilimumab|ipilimumab|mesh-list
24960439|NCT03817112|Adrenergic Agents|adrenergic agents|mesh-ancestor
24960440|NCT03817112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24960441|NCT03817112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960442|NCT03816774|Simethicone|simethicone|mesh-list
24960443|NCT03816774|Antifoaming Agents|antifoaming agents|mesh-ancestor
24960444|NCT03816774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960445|NCT03816774|Emollients|emollients|mesh-ancestor
24960446|NCT03816774|Dermatologic Agents|dermatologic agents|mesh-ancestor
24960448|NCT03816592|Anesthetics|anesthetics|mesh-list
24960453|NCT03816592|Sensory System Agents|sensory system agents|mesh-ancestor
24960454|NCT03816592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24960455|NCT03816488|Metformin|metformin|mesh-list
24960456|NCT03816488|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
24960457|NCT03816488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24960458|NCT03816488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960459|NCT03816488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24960460|NCT03816488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24960461|NCT03816488|Analgesics|analgesics|mesh-ancestor
24960462|NCT03816488|Sensory System Agents|sensory system agents|mesh-ancestor
24960463|NCT03816488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24960464|NCT03816488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24960465|NCT03816488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24960466|NCT03816553|Apatinib|apatinib|mesh-list
24960467|NCT03816553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24960468|NCT03816553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24960469|NCT03816553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24960470|NCT03816553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960471|NCT03816618|Fusidic Acid|fusidic acid|mesh-list
24960472|NCT03816618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24960473|NCT03816618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24960474|NCT03816618|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24960479|NCT03816267|Autonomic Agents|autonomic agents|mesh-ancestor
24960480|NCT03816267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24960481|NCT03816267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960482|NCT03816267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24960483|NCT03816267|Respiratory System Agents|respiratory system agents|mesh-ancestor
24960484|NCT03816267|Tocolytic Agents|tocolytic agents|mesh-ancestor
24960485|NCT03816267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24960486|NCT03816267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24960487|NCT03816267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24960488|NCT03816267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24960489|NCT03816267|Adrenergic Agents|adrenergic agents|mesh-ancestor
24960490|NCT03816267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24477627|NCT00419484|Pioglitazone|pioglitazone|mesh-list
24960494|NCT03816306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960495|NCT03816020|Niacinamide|niacinamide|mesh-list
24960497|NCT03816020|Nicotinic Acids|nicotinic acids|mesh-list
24960498|NCT03816020|Vitamin B Complex|vitamin b complex|mesh-ancestor
24960499|NCT03816020|Vitamins|vitamins|mesh-ancestor
24960500|NCT03816020|Micronutrients|micronutrients|mesh-ancestor
24960501|NCT03816020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960502|NCT03816020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24960503|NCT03816020|Antimetabolites|antimetabolites|mesh-ancestor
24960504|NCT03816020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960505|NCT03816020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24960506|NCT03816020|Vasodilator Agents|vasodilator agents|mesh-ancestor
24960507|NCT03816072|Phenylephrine|phenylephrine|mesh-list
24960508|NCT03816072|Oxymetazoline|oxymetazoline|mesh-list
24889581|NCT04491786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24889582|NCT04491786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24889583|NCT04491786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24960523|NCT03816072|Sympathomimetics|sympathomimetics|mesh-ancestor
24960524|NCT03816072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24960525|NCT03816072|Nasal Decongestants|nasal decongestants|mesh-ancestor
24960526|NCT03816072|Respiratory System Agents|respiratory system agents|mesh-ancestor
24960527|NCT03816072|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24960528|NCT03816072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24960529|NCT03816072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24960530|NCT03816072|Adrenergic Agents|adrenergic agents|mesh-ancestor
24960559|NCT03815838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960561|NCT03815539|Hyaluronic Acid|hyaluronic acid|mesh-list
24960562|NCT03815539|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24960563|NCT03815539|Immunologic Factors|immunologic factors|mesh-ancestor
24960564|NCT03815539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960565|NCT03815539|Viscosupplements|viscosupplements|mesh-ancestor
24960566|NCT03815539|Protective Agents|protective agents|mesh-ancestor
24960567|NCT03815487|Insulin|insulin|mesh-list
24960568|NCT03815487|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24960569|NCT03815487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24960570|NCT03815487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960571|NCT03815474|Epirubicin|epirubicin|mesh-list
24960572|NCT03815474|Ifosfamide|ifosfamide|mesh-list
24960573|NCT03815474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24960574|NCT03815474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24960575|NCT03815474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24960576|NCT03815474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24960577|NCT03815474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24960578|NCT03815474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960579|NCT03815474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24960580|NCT03815474|Alkylating Agents|alkylating agents|mesh-ancestor
24960581|NCT03815461|Paclitaxel|paclitaxel|mesh-list
24960582|NCT03815461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24960583|NCT03815461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24960584|NCT03815461|Tubulin Modulators|tubulin modulators|mesh-ancestor
24960585|NCT03815461|Antimitotic Agents|antimitotic agents|mesh-ancestor
24960586|NCT03815461|Mitosis Modulators|mitosis modulators|mesh-ancestor
24960587|NCT03815461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960588|NCT03815448|Methotrexate|methotrexate|mesh-list
24960589|NCT03815448|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24960590|NCT03815448|Abortifacient Agents|abortifacient agents|mesh-ancestor
24960591|NCT03815448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24960592|NCT03815448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960593|NCT03815448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24960594|NCT03815448|Antimetabolites|antimetabolites|mesh-ancestor
24960595|NCT03815448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960596|NCT03815448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24960597|NCT03815448|Dermatologic Agents|dermatologic agents|mesh-ancestor
24960598|NCT03815448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24960599|NCT03815448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24960600|NCT03815448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24960602|NCT03815448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25700356|NCT02121041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25700357|NCT02121041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700358|NCT02121041|Vasodilator Agents|vasodilator agents|mesh-ancestor
25700359|NCT02121041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24960616|NCT03815435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24960617|NCT03815435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463609|NCT00361621|Bortezomib|bortezomib|mesh-list
24889663|NCT04490967|Salicylates|salicylates|mesh-list
24889665|NCT04490967|Silymarin|silymarin|mesh-list
24889666|NCT04490967|Antioxidants|antioxidants|mesh-ancestor
24889667|NCT04490967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889668|NCT04490967|Protective Agents|protective agents|mesh-ancestor
24889669|NCT04490967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889676|NCT04490967|Analgesics|analgesics|mesh-ancestor
24463645|NCT00361751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463646|NCT00361751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24463647|NCT00361790|Aripiprazole|aripiprazole|mesh-list
24463649|NCT00361790|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24463650|NCT00361790|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24463651|NCT00361790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24960973|NCT03813186|Antimetabolites|antimetabolites|mesh-ancestor
24463652|NCT00361790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463653|NCT00361790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25700362|NCT02121041|Diuretics|diuretics|mesh-ancestor
25700363|NCT02121041|Natriuretic Agents|natriuretic agents|mesh-ancestor
24960700|NCT03814447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24960706|NCT03814616|Artesunate|artesunate|mesh-list
24960715|NCT03814616|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24960716|NCT03814616|Anthelmintics|anthelmintics|mesh-ancestor
24960717|NCT03814642|Esomeprazole|esomeprazole|mesh-list
24960718|NCT03814642|Clopidogrel|clopidogrel|mesh-list
24960719|NCT03814642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24960720|NCT03814642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24960721|NCT03814642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24960722|NCT03814642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24960723|NCT03814642|Purinergic Agents|purinergic agents|mesh-ancestor
24960724|NCT03814642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24960725|NCT03814642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960726|NCT03814642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960727|NCT03814642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24960746|NCT03814343|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24960747|NCT03814343|Antioxidants|antioxidants|mesh-ancestor
24960748|NCT03814343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960749|NCT03814226|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
24960750|NCT03814226|Growth Substances|growth substances|mesh-ancestor
24960751|NCT03814226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960752|NCT03814226|Vasodilator Agents|vasodilator agents|mesh-ancestor
24960753|NCT03814226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24786673|NCT01921231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24765749|NCT01790308|Hormones|hormones|mesh-ancestor
24786674|NCT01921231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786675|NCT01921231|Sensory System Agents|sensory system agents|mesh-ancestor
24786676|NCT01921231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24786678|NCT01921361|Levobupivacaine|levobupivacaine|mesh-list
24786679|NCT01921361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24786680|NCT01921361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25078657|NCT03354624|Mitogens|mitogens|mesh-list
25078658|NCT03354624|Mitosis Modulators|mitosis modulators|mesh-ancestor
25078659|NCT03354624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078660|NCT03354572|Acetylcysteine|acetylcysteine|mesh-list
25078661|NCT03354572|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25078662|NCT03354572|Antiviral Agents|antiviral agents|mesh-ancestor
25078663|NCT03354572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25078664|NCT03354572|Expectorants|expectorants|mesh-ancestor
25078665|NCT03354572|Respiratory System Agents|respiratory system agents|mesh-ancestor
25078666|NCT03354572|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25078667|NCT03354572|Antioxidants|antioxidants|mesh-ancestor
25700364|NCT02121041|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25700365|NCT02121067|Levonorgestrel|levonorgestrel|mesh-list
25700366|NCT02121067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25078668|NCT03354572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078669|NCT03354572|Protective Agents|protective agents|mesh-ancestor
25078670|NCT03354572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078671|NCT03354572|Antidotes|antidotes|mesh-ancestor
25078672|NCT03354494|Desogestrel|desogestrel|mesh-list
25078673|NCT03354494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25078674|NCT03354494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25078675|NCT03354494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25078676|NCT03354494|Contraceptive Agents|contraceptive agents|mesh-ancestor
25078677|NCT03354494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25078678|NCT03354494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078679|NCT03354494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25078680|NCT03354494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25078681|NCT03354494|Progestins|progestins|mesh-ancestor
25078682|NCT03354494|Hormones|hormones|mesh-ancestor
24960823|NCT03813927|Vitamin D|vitamin d|mesh-list
24960824|NCT03813927|Vitamins|vitamins|mesh-ancestor
24960848|NCT03813771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24960849|NCT03813771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24960850|NCT03813771|Antimalarials|antimalarials|mesh-ancestor
24960851|NCT03813771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24960852|NCT03813771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24960853|NCT03813771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24960854|NCT03813771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24960855|NCT03813771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24960857|NCT03813771|Sensory System Agents|sensory system agents|mesh-ancestor
24960858|NCT03813771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24960859|NCT03813771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24960860|NCT03813771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24960861|NCT03813641|Capecitabine|capecitabine|mesh-list
24960862|NCT03813641|Raltitrexed|raltitrexed|mesh-list
24960863|NCT03813641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24960864|NCT03813641|Antimetabolites|antimetabolites|mesh-ancestor
24960865|NCT03813641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960866|NCT03813641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24960867|NCT03813641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24960868|NCT03813641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24960869|NCT03813693|Chlorhexidine|chlorhexidine|mesh-list
24960870|NCT03813693|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24960871|NCT03813693|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24960872|NCT03813693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24960873|NCT03813693|Disinfectants|disinfectants|mesh-ancestor
24960874|NCT03813693|Dermatologic Agents|dermatologic agents|mesh-ancestor
24960875|NCT03813394|Bevacizumab|bevacizumab|mesh-list
24960876|NCT03813394|Pembrolizumab|pembrolizumab|mesh-list
24467459|NCT00377793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24467460|NCT00377793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24960884|NCT03813329|Calcium Carbonate|calcium carbonate|mesh-list
24960885|NCT03813329|Calcium|calcium|mesh-list
24960886|NCT03813329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24960887|NCT03813329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960888|NCT03813329|Antacids|antacids|mesh-ancestor
24960889|NCT03813329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960890|NCT03813329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24960891|NCT03813277|Dexmedetomidine|dexmedetomidine|mesh-list
24960892|NCT03813277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24960893|NCT03813277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24960894|NCT03813277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960895|NCT03813277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24960896|NCT03813277|Analgesics|analgesics|mesh-ancestor
24960897|NCT03813277|Sensory System Agents|sensory system agents|mesh-ancestor
24960898|NCT03813277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24960899|NCT03813277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24960900|NCT03813277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24960901|NCT03813277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24960902|NCT03813277|Adrenergic Agents|adrenergic agents|mesh-ancestor
24960903|NCT03813277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24960904|NCT03813277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960905|NCT03813316|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24960906|NCT03813316|Ertugliflozin|ertugliflozin|mesh-list
24960907|NCT03813316|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24960908|NCT03813316|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
24960909|NCT03813316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25700367|NCT02121067|Contraceptive Agents|contraceptive agents|mesh-ancestor
24960920|NCT03813303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24960921|NCT03813303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24960922|NCT03813303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960923|NCT03813303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24960924|NCT03813303|Anesthetics, General|anesthetics, general|mesh-ancestor
24960926|NCT03813303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24960927|NCT03813303|Narcotics|narcotics|mesh-ancestor
24960928|NCT03813303|Analgesics|analgesics|mesh-ancestor
24960929|NCT03813303|Sensory System Agents|sensory system agents|mesh-ancestor
24960930|NCT03813303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24960931|NCT03813303|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24960932|NCT03813303|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24960933|NCT03813303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24960934|NCT03813303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24960935|NCT03813303|GABA Modulators|gaba modulators|mesh-ancestor
24960936|NCT03813303|GABA Agents|gaba agents|mesh-ancestor
24960937|NCT03813303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24960938|NCT03813303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960939|NCT03813043|Midazolam|midazolam|mesh-list
24960940|NCT03813043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24960941|NCT03813043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24960942|NCT03813043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24960943|NCT03813043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960961|NCT03812965|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24960962|NCT03812965|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24960963|NCT03812965|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24960964|NCT03812965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24960965|NCT03812965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960966|NCT03812965|Cholinergic Agents|cholinergic agents|mesh-ancestor
24960967|NCT03812965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24960968|NCT03812965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960969|NCT03812965|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24960970|NCT03812965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24960971|NCT03813186|Decitabine|decitabine|mesh-list
24960972|NCT03813186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24960974|NCT03813186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24960975|NCT03813186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24960976|NCT03813186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24960977|NCT03812939|Octreotide|octreotide|mesh-list
24889987|NCT04487444|Thymalfasin|thymalfasin|mesh-list
24463674|NCT00361803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463675|NCT00361803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463676|NCT00361868|Metformin|metformin|mesh-list
24960978|NCT03812939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24960979|NCT03812939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24960980|NCT03812939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24960982|NCT03813030|Prilocaine|prilocaine|mesh-list
24816809|NCT02079064|Propofol|propofol|mesh-list
24960984|NCT03813030|Anesthetics|anesthetics|mesh-ancestor
24960985|NCT03813030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24960986|NCT03813030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24960987|NCT03813030|Sensory System Agents|sensory system agents|mesh-ancestor
24960988|NCT03813030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24960989|NCT03813030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24960999|NCT03812783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961001|NCT03812796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24961002|NCT03812796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463677|NCT00361868|Rosiglitazone|rosiglitazone|mesh-list
24463678|NCT00361868|Fenofibrate|fenofibrate|mesh-list
24463679|NCT00361868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24463680|NCT00361868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463681|NCT00361868|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24463682|NCT00361868|Antimetabolites|antimetabolites|mesh-ancestor
24961004|NCT03812731|Ropivacaine|ropivacaine|mesh-list
24961005|NCT03812731|Anesthetics, Local|anesthetics, local|mesh-ancestor
24786963|NCT01922817|Incretins|incretins|mesh-ancestor
24786965|NCT01922817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24786966|NCT01922817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786967|NCT01922817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24786968|NCT01922817|Protease Inhibitors|protease inhibitors|mesh-ancestor
24786969|NCT01922817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24786970|NCT01922817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786971|NCT01922817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24786972|NCT01922921|polysaccharide-K|polysaccharide-k|mesh-list
24786973|NCT01922921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24786976|NCT01922921|Antibodies|antibodies|mesh-list
24786977|NCT01922921|Immunoglobulins|immunoglobulins|mesh-list
24786978|NCT01922921|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24786979|NCT01922921|Immunologic Factors|immunologic factors|mesh-ancestor
24786980|NCT01922921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786981|NCT01922921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24786982|NCT01922921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24786983|NCT01922921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24786984|NCT01922921|Antiviral Agents|antiviral agents|mesh-ancestor
24786985|NCT01922921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24786986|NCT01922921|Interferon Inducers|interferon inducers|mesh-ancestor
24786987|NCT01922921|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24786988|NCT01922921|Protective Agents|protective agents|mesh-ancestor
24786989|NCT01922999|Melatonin|melatonin|mesh-list
24786990|NCT01922999|Antioxidants|antioxidants|mesh-ancestor
24786991|NCT01922999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961006|NCT03812731|Anesthetics|anesthetics|mesh-ancestor
24961007|NCT03812731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961008|NCT03812731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816796|NCT02078895|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25700368|NCT02121067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25700369|NCT02121067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700370|NCT02121067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24961048|NCT03812770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24961050|NCT03812770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24463683|NCT00361868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961051|NCT03812770|Immunologic Factors|immunologic factors|mesh-ancestor
24675161|NCT02903823|Baclofen|baclofen|mesh-list
24961052|NCT03812770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961053|NCT03812770|Antidotes|antidotes|mesh-ancestor
24961054|NCT03812770|Protective Agents|protective agents|mesh-ancestor
24961055|NCT03812770|Vitamin B Complex|vitamin b complex|mesh-ancestor
24961056|NCT03812770|Vitamins|vitamins|mesh-ancestor
24961057|NCT03812770|Micronutrients|micronutrients|mesh-ancestor
24463704|NCT00361907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463705|NCT00361920|Prednisone|prednisone|mesh-list
24961083|NCT03811860|Lithium Carbonate|lithium carbonate|mesh-list
24961084|NCT03811860|Antidepressive Agents|antidepressive agents|mesh-ancestor
24961085|NCT03811860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24961086|NCT03811860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24961087|NCT03811860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961088|NCT03811860|Antimanic Agents|antimanic agents|mesh-ancestor
24961089|NCT03811860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24961090|NCT03811860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961091|NCT03811860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961093|NCT03811418|Trastuzumab|trastuzumab|mesh-list
24961094|NCT03811418|Vinorelbine|vinorelbine|mesh-list
24961095|NCT03811418|Pertuzumab|pertuzumab|mesh-list
24961096|NCT03811418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24961097|NCT03811418|Tubulin Modulators|tubulin modulators|mesh-ancestor
24961098|NCT03811418|Antimitotic Agents|antimitotic agents|mesh-ancestor
24961099|NCT03811418|Mitosis Modulators|mitosis modulators|mesh-ancestor
24961100|NCT03811418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961101|NCT03811418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24961102|NCT03811418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24961103|NCT03811509|Denosumab|denosumab|mesh-list
24961104|NCT03811509|Diphosphonates|diphosphonates|mesh-list
24890103|NCT04485702|Midazolam|midazolam|mesh-list
24463706|NCT00361920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24463707|NCT00361920|Glucocorticoids|glucocorticoids|mesh-ancestor
25700371|NCT02121067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25700372|NCT02121067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25700373|NCT02121262|Dexamethasone|dexamethasone|mesh-list
24675359|NCT00496834|Natriuretic Agents|natriuretic agents|mesh-ancestor
25700374|NCT02121262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24961115|NCT03810872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24961116|NCT03810872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787041|NCT01923337|Irinotecan|irinotecan|mesh-list
24961117|NCT03811223|Evolocumab|evolocumab|mesh-list
24961118|NCT03811223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24961141|NCT03810703|Adrenergic Agents|adrenergic agents|mesh-ancestor
24961142|NCT03810703|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24961143|NCT03810703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24890117|NCT04485702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463725|NCT00361959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463726|NCT00361959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24463727|NCT00361959|Respiratory System Agents|respiratory system agents|mesh-ancestor
24463728|NCT00361959|Dermatologic Agents|dermatologic agents|mesh-ancestor
24463729|NCT00361959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24463730|NCT00361959|Parasympatholytics|parasympatholytics|mesh-ancestor
24961144|NCT03810703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24961145|NCT03810703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24961147|NCT03810742|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24961148|NCT03810742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24961149|NCT03810742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24961150|NCT03810742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961151|NCT03810742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24961153|NCT03810547|Propofol|propofol|mesh-list
24961154|NCT03810547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24961155|NCT03810547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961156|NCT03810547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078683|NCT03354494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24961157|NCT03810547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24961158|NCT03810547|Anesthetics, General|anesthetics, general|mesh-ancestor
24961159|NCT03810547|Anesthetics|anesthetics|mesh-ancestor
24961160|NCT03810547|Analgesics|analgesics|mesh-ancestor
24961161|NCT03810547|Sensory System Agents|sensory system agents|mesh-ancestor
24961162|NCT03810547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961163|NCT03810547|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24961164|NCT03810547|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24961165|NCT03810547|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24961166|NCT03810547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24787123|NCT01923831|Hormones|hormones|mesh-ancestor
25700375|NCT02121262|Antiemetics|antiemetics|mesh-ancestor
25700376|NCT02121262|Autonomic Agents|autonomic agents|mesh-ancestor
25700377|NCT02121262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25700378|NCT02121262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961220|NCT03809702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961221|NCT03809702|Anticonvulsants|anticonvulsants|mesh-ancestor
24961222|NCT03809702|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24961223|NCT03809702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24961224|NCT03809702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961225|NCT03809702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24961226|NCT03809702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24961227|NCT03809702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24961245|NCT03809897|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24961246|NCT03809897|Cholinergic Agents|cholinergic agents|mesh-ancestor
24961247|NCT03809897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24961248|NCT03809897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961250|NCT03809650|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
24961251|NCT03809650|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24961252|NCT03809650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675785|NCT01345279|Tubulin Modulators|tubulin modulators|mesh-ancestor
24961253|NCT03809650|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
24961254|NCT03809546|Dronabinol|dronabinol|mesh-list
24961255|NCT03809546|Hallucinogens|hallucinogens|mesh-ancestor
24961256|NCT03809546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961257|NCT03809546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24961258|NCT03809546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24961259|NCT03809546|Analgesics|analgesics|mesh-ancestor
24961260|NCT03809546|Sensory System Agents|sensory system agents|mesh-ancestor
24961261|NCT03809546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961262|NCT03809546|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25700379|NCT02121262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25700380|NCT02121262|Glucocorticoids|glucocorticoids|mesh-ancestor
25700381|NCT02121262|Hormones|hormones|mesh-ancestor
25700382|NCT02121262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25700383|NCT02121262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25700384|NCT02121262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700385|NCT02121301|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25700386|NCT02121301|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25700387|NCT02121392|Bupivacaine|bupivacaine|mesh-list
25700388|NCT02121392|Anesthetics, Local|anesthetics, local|mesh-ancestor
24463795|NCT00362258|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24463796|NCT00362258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463798|NCT00362271|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24961319|NCT03809455|Fentanyl|fentanyl|mesh-list
24961320|NCT03809455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24961321|NCT03809455|Narcotics|narcotics|mesh-ancestor
24961322|NCT03809455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961323|NCT03809455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961324|NCT03809455|Analgesics|analgesics|mesh-ancestor
24961325|NCT03809455|Sensory System Agents|sensory system agents|mesh-ancestor
24961326|NCT03809455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961327|NCT03809455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24961328|NCT03809455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24961329|NCT03809455|Anesthetics, General|anesthetics, general|mesh-ancestor
24961330|NCT03809455|Anesthetics|anesthetics|mesh-ancestor
24961331|NCT03809325|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24961332|NCT03809325|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24961333|NCT03809325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25700389|NCT02121392|Anesthetics|anesthetics|mesh-ancestor
25700390|NCT02121392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25700391|NCT02121392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463799|NCT00362271|Antidepressive Agents|antidepressive agents|mesh-ancestor
25700392|NCT02121392|Sensory System Agents|sensory system agents|mesh-ancestor
25700393|NCT02121392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961381|NCT03809221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961382|NCT03809221|Luteolytic Agents|luteolytic agents|mesh-ancestor
24787320|NCT01924468|Methylphenidate|methylphenidate|mesh-list
24787321|NCT01924468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24787322|NCT01924468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787340|NCT01924481|Caffeine|caffeine|mesh-list
24961383|NCT03809221|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24961384|NCT03809221|Contraceptive Agents|contraceptive agents|mesh-ancestor
24961386|NCT03809221|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24961387|NCT03809221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24961388|NCT03809221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24961391|NCT03809156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24961392|NCT03809156|Enzyme Activators|enzyme activators|mesh-ancestor
24610764|NCT01004900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24961393|NCT03809156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961394|NCT03808844|Propofol|propofol|mesh-list
24961395|NCT03808844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24961396|NCT03808844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961400|NCT03808844|Anesthetics|anesthetics|mesh-ancestor
24961427|NCT03808805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961430|NCT03808805|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24712909|NCT01523119|Ondansetron|ondansetron|mesh-list
24463836|NCT00362323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463837|NCT00362323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24463838|NCT00362505|Clevudine|clevudine|mesh-list
24463839|NCT00362505|Antiviral Agents|antiviral agents|mesh-ancestor
24463840|NCT00362505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24463841|NCT00362531|Prednisone|prednisone|mesh-list
24463842|NCT00362531|Tacrolimus|tacrolimus|mesh-list
24463843|NCT00362531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24463844|NCT00362531|Glucocorticoids|glucocorticoids|mesh-ancestor
24961454|NCT03808259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24961455|NCT03808259|Anesthetics, General|anesthetics, general|mesh-ancestor
24961456|NCT03808259|Anesthetics|anesthetics|mesh-ancestor
24961457|NCT03808259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961458|NCT03808259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24961502|NCT03807596|Hyaluronic Acid|hyaluronic acid|mesh-list
24961503|NCT03807596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24961504|NCT03807596|Immunologic Factors|immunologic factors|mesh-ancestor
24961505|NCT03807596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961506|NCT03807596|Viscosupplements|viscosupplements|mesh-ancestor
24961507|NCT03807596|Protective Agents|protective agents|mesh-ancestor
24961508|NCT03807882|Clozapine|clozapine|mesh-list
24961509|NCT03807882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24961510|NCT03807882|Serotonin Agents|serotonin agents|mesh-ancestor
24961511|NCT03807882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25700394|NCT02121418|Cytarabine|cytarabine|mesh-list
24961535|NCT03807297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24961536|NCT03807297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24890457|NCT04483284|Hormones|hormones|mesh-ancestor
24463907|NCT00362726|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24463908|NCT00362726|Maleic acid|maleic acid|mesh-list
24463909|NCT00362726|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24961537|NCT03807297|Adrenergic Agents|adrenergic agents|mesh-ancestor
24610817|NCT01005381|Calcium, Dietary|calcium, dietary|mesh-list
24961538|NCT03807297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24961539|NCT03807297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961540|NCT03807297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24961541|NCT03807297|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24961543|NCT03807362|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24961544|NCT03807362|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24961545|NCT03807362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24961546|NCT03807362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961547|NCT03807271|Anesthetics|anesthetics|mesh-list
24961548|NCT03807271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961549|NCT03807271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961555|NCT03806816|Melatonin|melatonin|mesh-list
24961592|NCT03806595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24961593|NCT03806595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961594|NCT03806777|Dexmedetomidine|dexmedetomidine|mesh-list
24961595|NCT03806777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24961596|NCT03806777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961597|NCT03806777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961598|NCT03806777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24961599|NCT03806777|Analgesics|analgesics|mesh-ancestor
24961600|NCT03806777|Sensory System Agents|sensory system agents|mesh-ancestor
25078685|NCT03354338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25078686|NCT03354338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24961649|NCT03806387|Alemtuzumab|alemtuzumab|mesh-list
24961650|NCT03806387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24961651|NCT03806387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24961652|NCT03806062|Domperidone|domperidone|mesh-list
24961653|NCT03806062|Antiemetics|antiemetics|mesh-ancestor
24961654|NCT03806062|Autonomic Agents|autonomic agents|mesh-ancestor
24961655|NCT03806062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961665|NCT03806036|Zuclomiphene|zuclomiphene|mesh-list
24961666|NCT03806036|Vitamins|vitamins|mesh-ancestor
24961667|NCT03806036|Micronutrients|micronutrients|mesh-ancestor
24961668|NCT03806036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961669|NCT03806036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24961670|NCT03806036|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24961671|NCT03806036|Hormone Antagonists|hormone antagonists|mesh-ancestor
24961672|NCT03806036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24961673|NCT03806036|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24961674|NCT03806036|Fertility Agents|fertility agents|mesh-ancestor
24961675|NCT03806036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24961676|NCT03806036|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24961678|NCT03805945|Dexmedetomidine|dexmedetomidine|mesh-list
24961679|NCT03805945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24961680|NCT03805945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24787628|NCT01926132|Micronutrients|micronutrients|mesh-ancestor
24787629|NCT01926158|Denosumab|denosumab|mesh-list
24787636|NCT01926210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787639|NCT01926210|Hormone Antagonists|hormone antagonists|mesh-ancestor
24787640|NCT01926210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24787641|NCT01926210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787642|NCT01926236|Leucovorin|leucovorin|mesh-list
24961681|NCT03805945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961682|NCT03805945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24961683|NCT03805945|Analgesics|analgesics|mesh-ancestor
24890666|NCT04481282|Danazol|danazol|mesh-list
24463926|NCT00362752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24463927|NCT00362752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24463928|NCT00362752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463929|NCT00362752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24961690|NCT03805945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24961691|NCT03805945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961692|NCT03806374|Lidocaine|lidocaine|mesh-list
24961693|NCT03806374|Fentanyl|fentanyl|mesh-list
24961694|NCT03806374|Ketamine|ketamine|mesh-list
24961695|NCT03806374|Propofol|propofol|mesh-list
24961696|NCT03806374|Cisatracurium|cisatracurium|mesh-list
24961697|NCT03806374|Anesthetics, Local|anesthetics, local|mesh-ancestor
24961698|NCT03806374|Anesthetics|anesthetics|mesh-ancestor
24961699|NCT03806374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961700|NCT03806374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961701|NCT03806374|Sensory System Agents|sensory system agents|mesh-ancestor
24961702|NCT03806374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25700395|NCT02121418|Decitabine|decitabine|mesh-list
25700396|NCT02121418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25700397|NCT02121418|Antimetabolites|antimetabolites|mesh-ancestor
25700398|NCT02121418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700399|NCT02121418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700400|NCT02121418|Antiviral Agents|antiviral agents|mesh-ancestor
24789298|NCT01936233|Aspirin|aspirin|mesh-list
24961703|NCT03806374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24961704|NCT03806374|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24961705|NCT03806374|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24961706|NCT03806374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24961707|NCT03806374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961708|NCT03806374|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24961709|NCT03806374|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24961710|NCT03806374|Anesthetics, General|anesthetics, general|mesh-ancestor
24961712|NCT03806374|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24961713|NCT03806374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24961714|NCT03806374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24961715|NCT03806374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24961716|NCT03806374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24961717|NCT03806374|Narcotics|narcotics|mesh-ancestor
24961718|NCT03806374|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24961724|NCT03806101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24961725|NCT03806101|Antimetabolites|antimetabolites|mesh-ancestor
24961726|NCT03806101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961727|NCT03806101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24961728|NCT03806101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24961729|NCT03806101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24961730|NCT03806101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24961731|NCT03806049|Paclitaxel|paclitaxel|mesh-list
24677078|NCT01354301|Everolimus|everolimus|mesh-list
24961736|NCT03806049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24961737|NCT03806049|Tubulin Modulators|tubulin modulators|mesh-ancestor
24961738|NCT03806049|Antimitotic Agents|antimitotic agents|mesh-ancestor
24961739|NCT03806049|Mitosis Modulators|mitosis modulators|mesh-ancestor
24961740|NCT03806049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961816|NCT03804931|Aminosalicylic Acid|aminosalicylic acid|mesh-list
24961986|NCT03803449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24961780|NCT03805633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24961782|NCT03805282|Anesthetics, Local|anesthetics, local|mesh-ancestor
24961783|NCT03805282|Anesthetics|anesthetics|mesh-ancestor
24961784|NCT03805282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961793|NCT03805360|Ropivacaine|ropivacaine|mesh-list
24677445|NCT01356368|Antimitotic Agents|antimitotic agents|mesh-ancestor
24961804|NCT03805503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961805|NCT03805503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961806|NCT03805503|Sensory System Agents|sensory system agents|mesh-ancestor
24961807|NCT03805503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961809|NCT03805178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24961810|NCT03805178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961811|NCT03805178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24961812|NCT03805178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24961813|NCT03805178|Immunologic Factors|immunologic factors|mesh-ancestor
24961814|NCT03805178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961815|NCT03805178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24961818|NCT03804931|Mesalamine|mesalamine|mesh-list
24961819|NCT03804931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24961820|NCT03804931|Glucocorticoids|glucocorticoids|mesh-ancestor
24961821|NCT03804931|Hormones|hormones|mesh-ancestor
24961822|NCT03804931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24961823|NCT03804931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961824|NCT03804931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24961825|NCT03804931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24961826|NCT03804931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24961827|NCT03804931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24961828|NCT03804931|Analgesics|analgesics|mesh-ancestor
24961829|NCT03804931|Sensory System Agents|sensory system agents|mesh-ancestor
24961830|NCT03804931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24479545|NCT00427271|Aspirin|aspirin|mesh-list
25700401|NCT02121418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25700402|NCT02121418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25700403|NCT02121418|Immunologic Factors|immunologic factors|mesh-ancestor
25700404|NCT02121418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700405|NCT02121418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700406|NCT02121483|Empagliflozin|empagliflozin|mesh-list
25700407|NCT02121483|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25700408|NCT02121483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961865|NCT03804866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961866|NCT03804840|Dronabinol|dronabinol|mesh-list
24961867|NCT03804840|Hallucinogens|hallucinogens|mesh-ancestor
24961868|NCT03804840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961869|NCT03804840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24961870|NCT03804840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24463964|NCT00362895|Tobramycin|tobramycin|mesh-list
24961879|NCT03804840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24961880|NCT03804749|Suramin|suramin|mesh-list
24961881|NCT03804749|Antinematodal Agents|antinematodal agents|mesh-ancestor
24961882|NCT03804749|Anthelmintics|anthelmintics|mesh-ancestor
24961883|NCT03804749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24961884|NCT03804749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24961885|NCT03804749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24961886|NCT03804749|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24961887|NCT03804749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24961888|NCT03804372|Tenofovir|tenofovir|mesh-list
24961889|NCT03804372|Rituximab|rituximab|mesh-list
24961890|NCT03804372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24961891|NCT03804372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24961892|NCT03804372|Immunologic Factors|immunologic factors|mesh-ancestor
24961893|NCT03804372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961894|NCT03804372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24961895|NCT03804372|Antiviral Agents|antiviral agents|mesh-ancestor
24961896|NCT03804372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24961897|NCT03804372|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24961898|NCT03804372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24961899|NCT03804372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24961900|NCT03804372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961901|NCT03804372|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24961902|NCT03804372|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24961903|NCT03804541|Ensartinib|ensartinib|mesh-list
24961904|NCT03804541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24961905|NCT03804541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24961906|NCT03804541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24961907|NCT03804541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961909|NCT03804723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24961910|NCT03804723|Glucocorticoids|glucocorticoids|mesh-ancestor
24580144|NCT00860639|Gemtuzumab|gemtuzumab|mesh-list
24961941|NCT03804229|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24961942|NCT03804229|Protective Agents|protective agents|mesh-ancestor
24787852|NCT01927913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787853|NCT01927965|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
24787854|NCT01927965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24787855|NCT01927965|Alkylating Agents|alkylating agents|mesh-ancestor
24787856|NCT01927965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787857|NCT01927965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787859|NCT01928043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24787860|NCT01928043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24787861|NCT01928043|Analgesics|analgesics|mesh-ancestor
24787862|NCT01928043|Sensory System Agents|sensory system agents|mesh-ancestor
24961975|NCT03803449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24961976|NCT03803449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24961977|NCT03803449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24961978|NCT03803449|Anesthetics, General|anesthetics, general|mesh-ancestor
24961979|NCT03803449|Anesthetics|anesthetics|mesh-ancestor
24790827|NCT01945528|Lidocaine|lidocaine|mesh-list
24790927|NCT05410275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961980|NCT03803449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24509334|NCT00559741|Irinotecan|irinotecan|mesh-list
24961981|NCT03803449|Narcotics|narcotics|mesh-ancestor
24961982|NCT03803449|Analgesics|analgesics|mesh-ancestor
24961983|NCT03803449|Sensory System Agents|sensory system agents|mesh-ancestor
24961984|NCT03803449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24961985|NCT03803449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24961987|NCT03803449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24961988|NCT03803449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24961989|NCT03803449|GABA Modulators|gaba modulators|mesh-ancestor
24961990|NCT03803449|GABA Agents|gaba agents|mesh-ancestor
24961991|NCT03803449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24961992|NCT03803449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24961993|NCT03803839|Clodronic Acid|clodronic acid|mesh-list
25078738|NCT03353948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078739|NCT03353909|Hyaluronic Acid|hyaluronic acid|mesh-list
25078740|NCT03353909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25078741|NCT03353909|Immunologic Factors|immunologic factors|mesh-ancestor
25078742|NCT03353909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078743|NCT03353909|Viscosupplements|viscosupplements|mesh-ancestor
25078744|NCT03353909|Protective Agents|protective agents|mesh-ancestor
25078745|NCT03353883|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25078746|NCT03353883|Luteolytic Agents|luteolytic agents|mesh-ancestor
24962020|NCT03803267|Fentanyl|fentanyl|mesh-list
24962044|NCT03803007|Anticoagulants|anticoagulants|mesh-ancestor
24962045|NCT03803215|Theophylline|theophylline|mesh-list
24962046|NCT03803215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24962047|NCT03803215|Autonomic Agents|autonomic agents|mesh-ancestor
24962048|NCT03803215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962049|NCT03803215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962050|NCT03803215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24962051|NCT03803215|Respiratory System Agents|respiratory system agents|mesh-ancestor
24962052|NCT03803215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24962053|NCT03803215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24962054|NCT03803215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962055|NCT03803215|Vasodilator Agents|vasodilator agents|mesh-ancestor
24817835|NCT02085824|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24962056|NCT03803215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24962057|NCT03803215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24962058|NCT03803215|Purinergic Agents|purinergic agents|mesh-ancestor
25078751|NCT03353883|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24962060|NCT03803163|Treprostinil|treprostinil|mesh-list
24962061|NCT03803163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24962062|NCT03802747|Durvalumab|durvalumab|mesh-list
24962063|NCT03802747|Tremelimumab|tremelimumab|mesh-list
24962064|NCT03802747|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24962069|NCT03802838|Amisulpride|amisulpride|mesh-list
24962074|NCT03802838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25700409|NCT02121483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25700410|NCT02121483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700411|NCT02121509|Metformin|metformin|mesh-list
25700412|NCT02121509|Linagliptin|linagliptin|mesh-list
25700413|NCT02121509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25700414|NCT02121509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700415|NCT02121509|Incretins|incretins|mesh-ancestor
25700416|NCT02121509|Hormones|hormones|mesh-ancestor
25700417|NCT02121509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25700418|NCT02121509|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24962075|NCT03802838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24962076|NCT03802838|Dopamine Agents|dopamine agents|mesh-ancestor
24962077|NCT03802838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24962087|NCT03802773|Alkylating Agents|alkylating agents|mesh-ancestor
24962088|NCT03802773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962089|NCT03802773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962090|NCT03802773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24962091|NCT03802552|Cephalexin|cephalexin|mesh-list
24678235|NCT01360437|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24678236|NCT01360437|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24962092|NCT03802552|Cefadroxil|cefadroxil|mesh-list
24962093|NCT03802552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24962094|NCT03802552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24962095|NCT03802318|Amoxicillin|amoxicillin|mesh-list
24962096|NCT03802318|Rabeprazole|rabeprazole|mesh-list
24962100|NCT03802318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24962101|NCT03802318|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24962102|NCT03802318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24962103|NCT03802318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962105|NCT03802422|Hydroxocobalamin|hydroxocobalamin|mesh-list
24962106|NCT03802422|Vitamins|vitamins|mesh-ancestor
24962107|NCT03802422|Micronutrients|micronutrients|mesh-ancestor
24962108|NCT03802422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807542|NCT02022527|Aspirin|aspirin|mesh-list
24962111|NCT03802149|Ulipristal acetate|ulipristal acetate|mesh-list
24962112|NCT03802149|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24962113|NCT03802149|Contraceptive Agents|contraceptive agents|mesh-ancestor
24962114|NCT03802149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24962115|NCT03802149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962116|NCT03802149|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24962117|NCT03802032|Lidocaine|lidocaine|mesh-list
24962118|NCT03802032|Anesthetics, Local|anesthetics, local|mesh-ancestor
24962119|NCT03802032|Anesthetics|anesthetics|mesh-ancestor
25700419|NCT02121509|Protease Inhibitors|protease inhibitors|mesh-ancestor
25700420|NCT02121509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700421|NCT02121509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700422|NCT02121756|Dipyridamole|dipyridamole|mesh-list
25700423|NCT02121756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25700424|NCT02121756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700425|NCT02121756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700426|NCT02121756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25700427|NCT02121756|Vasodilator Agents|vasodilator agents|mesh-ancestor
24962120|NCT03802032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24962121|NCT03802032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962122|NCT03802032|Sensory System Agents|sensory system agents|mesh-ancestor
24962123|NCT03802032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962124|NCT03802032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24962125|NCT03802032|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24962126|NCT03802032|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24962127|NCT03802032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24962128|NCT03802032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962137|NCT03802162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962138|NCT03802162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24962139|NCT03802162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24962141|NCT03801746|Rifampin|rifampin|mesh-list
24962142|NCT03801746|Probenecid|probenecid|mesh-list
24962143|NCT03801746|Cyclosporins|cyclosporins|mesh-list
24962179|NCT03801733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24962180|NCT03801733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24962181|NCT03801733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24962182|NCT03801733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24962184|NCT03801733|Sensory System Agents|sensory system agents|mesh-ancestor
24962185|NCT03801733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962186|NCT03801733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962187|NCT03801733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24962188|NCT03801733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24962189|NCT03801733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24962190|NCT03801707|Sofosbuvir|sofosbuvir|mesh-list
24962191|NCT03801707|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
24962192|NCT03801707|Velpatasvir|velpatasvir|mesh-list
24962193|NCT03801707|Antiviral Agents|antiviral agents|mesh-ancestor
24962194|NCT03801707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24962195|NCT03801668|Paclitaxel|paclitaxel|mesh-list
24962196|NCT03801668|Oxaliplatin|oxaliplatin|mesh-list
24962197|NCT03801668|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24962259|NCT03801031|Anesthetics, Local|anesthetics, local|mesh-ancestor
24962198|NCT03801668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24962199|NCT03801668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962200|NCT03801668|Tubulin Modulators|tubulin modulators|mesh-ancestor
24962201|NCT03801668|Antimitotic Agents|antimitotic agents|mesh-ancestor
24962202|NCT03801668|Mitosis Modulators|mitosis modulators|mesh-ancestor
24962203|NCT03801668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962204|NCT03801629|Morphine|morphine|mesh-list
24962205|NCT03801629|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24962206|NCT03801629|Narcotics|narcotics|mesh-ancestor
24962207|NCT03801629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24962233|NCT03801759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962234|NCT03801759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24962235|NCT03801759|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24962236|NCT03801759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24962237|NCT03801759|Protective Agents|protective agents|mesh-ancestor
24962238|NCT03801759|Antiviral Agents|antiviral agents|mesh-ancestor
24962239|NCT03801759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24962240|NCT03801759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24962241|NCT03801759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24962242|NCT03801499|Lenvatinib|lenvatinib|mesh-list
24962243|NCT03801499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24788202|NCT01930292|Paclitaxel|paclitaxel|mesh-list
24788203|NCT01930292|Carboplatin|carboplatin|mesh-list
24788204|NCT01930292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24788205|NCT01930292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24788206|NCT01930292|Tubulin Modulators|tubulin modulators|mesh-ancestor
24788207|NCT01930292|Antimitotic Agents|antimitotic agents|mesh-ancestor
24788208|NCT01930292|Mitosis Modulators|mitosis modulators|mesh-ancestor
24788209|NCT01930292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788210|NCT01930318|Parecoxib|parecoxib|mesh-list
24626842|NCT01088815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24626843|NCT01088815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626844|NCT01088815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24626845|NCT01088815|Immunologic Factors|immunologic factors|mesh-ancestor
24626846|NCT01088815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700428|NCT02121795|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25700429|NCT02121795|Antiviral Agents|antiviral agents|mesh-ancestor
24626847|NCT01088893|Everolimus|everolimus|mesh-list
24626858|NCT01088919|Pioglitazone|pioglitazone|mesh-list
24626859|NCT01088919|Ipragliflozin|ipragliflozin|mesh-list
24626860|NCT01088919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24962244|NCT03801499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24962245|NCT03801499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24962246|NCT03801499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962247|NCT03801252|Azithromycin|azithromycin|mesh-list
24962248|NCT03801252|Cefazolin|cefazolin|mesh-list
24962251|NCT03801187|Chlorhexidine|chlorhexidine|mesh-list
24962252|NCT03801187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24962253|NCT03801187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24962254|NCT03801187|Disinfectants|disinfectants|mesh-ancestor
24962255|NCT03801226|Calcium|calcium|mesh-list
24962256|NCT03801226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24962257|NCT03801226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962258|NCT03801031|Lidocaine|lidocaine|mesh-list
24962262|NCT03801031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962263|NCT03801031|Sensory System Agents|sensory system agents|mesh-ancestor
24962264|NCT03801031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962265|NCT03801031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24962266|NCT03801031|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24962267|NCT03801031|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24962268|NCT03801031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24891217|NCT04474262|Midodrine|midodrine|mesh-list
24962269|NCT03801031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962270|NCT03801317|Micronutrients|micronutrients|mesh-list
24962271|NCT03801317|Trace Elements|trace elements|mesh-list
24962272|NCT03801317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962273|NCT03800953|Avelumab|avelumab|mesh-list
24962274|NCT03800953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25700430|NCT02121795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25700431|NCT02121847|Cyclosporine|cyclosporine|mesh-list
25700432|NCT02121847|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25700433|NCT02121847|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25700434|NCT02121847|Lubricant Eye Drops|lubricant eye drops|mesh-list
25700435|NCT02121847|Cyclosporins|cyclosporins|mesh-list
25700436|NCT02121847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24962284|NCT03800667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585944|NCT00888303|Hormones|hormones|mesh-ancestor
24464039|NCT00363090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24464045|NCT00363090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464046|NCT00363090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24464047|NCT00363090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24464048|NCT00363090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24464049|NCT00363090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24464050|NCT00363090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24464051|NCT00363090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464052|NCT00363090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24464053|NCT00363090|Glucocorticoids|glucocorticoids|mesh-ancestor
24464054|NCT00363090|Hormones|hormones|mesh-ancestor
24464055|NCT00363090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24962286|NCT03800667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962287|NCT03800667|Vitamins|vitamins|mesh-ancestor
24962288|NCT03800667|Micronutrients|micronutrients|mesh-ancestor
24962289|NCT03800745|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24962290|NCT03800745|Laxatives|laxatives|mesh-ancestor
24962291|NCT03800745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24962292|NCT03800550|Clarithromycin|clarithromycin|mesh-list
24962293|NCT03800550|Bedaquiline|bedaquiline|mesh-list
24962294|NCT03800550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24962295|NCT03800550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24962303|NCT03800264|Bisoprolol|bisoprolol|mesh-list
24962304|NCT03800264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24962305|NCT03800264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24962306|NCT03800264|Sympatholytics|sympatholytics|mesh-ancestor
24962307|NCT03800264|Autonomic Agents|autonomic agents|mesh-ancestor
24962308|NCT03800264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962309|NCT03800264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700437|NCT02121847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700438|NCT02121847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25700439|NCT02121847|Immunologic Factors|immunologic factors|mesh-ancestor
25700440|NCT02121847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700441|NCT02121847|Antifungal Agents|antifungal agents|mesh-ancestor
25700442|NCT02121847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25700443|NCT02121847|Dermatologic Agents|dermatologic agents|mesh-ancestor
25700444|NCT02121847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24962310|NCT03800264|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24962311|NCT03800264|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24494435|NCT00495183|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24494436|NCT00495183|Cholinergic Agents|cholinergic agents|mesh-ancestor
24793084|NCT04232683|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24962312|NCT03800264|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24962313|NCT03800264|Adrenergic Agents|adrenergic agents|mesh-ancestor
24891261|NCT04473911|Sirolimus|sirolimus|mesh-list
24464056|NCT00363090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24464061|NCT00363090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24464068|NCT00363155|Immunologic Factors|immunologic factors|mesh-ancestor
24464069|NCT00363155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962314|NCT03800264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25078752|NCT03353883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24962315|NCT03800264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962316|NCT03800797|Loxoprofen|loxoprofen|mesh-list
24962317|NCT03800797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24962318|NCT03800797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24962319|NCT03800797|Analgesics|analgesics|mesh-ancestor
24962320|NCT03800797|Sensory System Agents|sensory system agents|mesh-ancestor
24962321|NCT03800797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962322|NCT03800797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962323|NCT03800797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24962324|NCT03800797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24962325|NCT03800290|Clenbuterol|clenbuterol|mesh-list
24962326|NCT03800290|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24962327|NCT03800290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24962328|NCT03800290|Adrenergic Agents|adrenergic agents|mesh-ancestor
24962329|NCT03800290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24962330|NCT03800290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962331|NCT03800290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962333|NCT03800290|Autonomic Agents|autonomic agents|mesh-ancestor
24962334|NCT03800290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962335|NCT03800290|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24962336|NCT03800290|Respiratory System Agents|respiratory system agents|mesh-ancestor
24962337|NCT03800290|Sympathomimetics|sympathomimetics|mesh-ancestor
24962338|NCT03800524|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
24962339|NCT03800524|Antiviral Agents|antiviral agents|mesh-ancestor
24962340|NCT03800524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24962341|NCT03800524|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24962342|NCT03800524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24962343|NCT03800433|Pentoxifylline|pentoxifylline|mesh-list
24962344|NCT03800433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24580588|NCT00862420|Ticlopidine|ticlopidine|mesh-list
24962349|NCT03800433|Protective Agents|protective agents|mesh-ancestor
24962350|NCT03800433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962351|NCT03800433|Vasodilator Agents|vasodilator agents|mesh-ancestor
24962354|NCT03799809|Voriconazole|voriconazole|mesh-list
24962355|NCT03799809|Antifungal Agents|antifungal agents|mesh-ancestor
24962356|NCT03799809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24962357|NCT03799809|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24962358|NCT03799809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24962359|NCT03799809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24962360|NCT03799809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962361|NCT03799809|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24962362|NCT03799809|Hormone Antagonists|hormone antagonists|mesh-ancestor
24962363|NCT03799809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24962364|NCT03799809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700445|NCT02121847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25700446|NCT02121847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25700447|NCT02121847|Laxatives|laxatives|mesh-ancestor
25700448|NCT02121847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25700449|NCT02122380|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25700450|NCT02122380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25700451|NCT02122380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700452|NCT02122380|Incretins|incretins|mesh-ancestor
24967315|NCT03760770|Vitamins|vitamins|mesh-ancestor
24967316|NCT03760770|Micronutrients|micronutrients|mesh-ancestor
24967317|NCT03760770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962365|NCT03799809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24962366|NCT03799679|Antineoplastic Agents|antineoplastic agents|mesh-list
24962368|NCT03799536|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24962369|NCT03799536|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24962370|NCT03799536|Adrenergic Agents|adrenergic agents|mesh-ancestor
24962371|NCT03799536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24480286|NCT00430196|Adrenergic Agents|adrenergic agents|mesh-ancestor
24962372|NCT03799536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962373|NCT03799536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962374|NCT03799536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24962375|NCT03799536|Sympatholytics|sympatholytics|mesh-ancestor
24962376|NCT03799536|Autonomic Agents|autonomic agents|mesh-ancestor
24962403|NCT03799172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24962405|NCT03799120|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24962406|NCT03799120|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24962407|NCT03799120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24962408|NCT03799120|Adrenergic Agents|adrenergic agents|mesh-ancestor
24962409|NCT03799120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24962410|NCT03799120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962411|NCT03799120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962412|NCT03799120|Urological Agents|urological agents|mesh-ancestor
24962413|NCT03799094|Ascorbic Acid|ascorbic acid|mesh-list
24962414|NCT03799094|Vitamins|vitamins|mesh-ancestor
24962415|NCT03799094|Micronutrients|micronutrients|mesh-ancestor
24962416|NCT03799094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962417|NCT03799094|Antioxidants|antioxidants|mesh-ancestor
24962418|NCT03799094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962419|NCT03799094|Protective Agents|protective agents|mesh-ancestor
24962420|NCT03798912|Octreotide|octreotide|mesh-list
24962438|NCT03798821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24962439|NCT03798821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24962440|NCT03798600|Caspofungin|caspofungin|mesh-list
24962441|NCT03798600|Antifungal Agents|antifungal agents|mesh-ancestor
24962442|NCT03798600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24962443|NCT03798600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24962444|NCT03798600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962445|NCT03798522|Nalbuphine|nalbuphine|mesh-list
24962446|NCT03798522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24962447|NCT03798522|Narcotics|narcotics|mesh-ancestor
24962448|NCT03798522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24962468|NCT03798314|Immunologic Factors|immunologic factors|mesh-ancestor
24962469|NCT03798314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962470|NCT03798314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24962471|NCT03798314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24962472|NCT03798314|Growth Substances|growth substances|mesh-ancestor
24962473|NCT03798314|Growth Inhibitors|growth inhibitors|mesh-ancestor
24962474|NCT03798106|Durvalumab|durvalumab|mesh-list
24962475|NCT03798106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24962476|NCT03798106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962477|NCT03798119|Tenofovir|tenofovir|mesh-list
24962478|NCT03798119|Antiviral Agents|antiviral agents|mesh-ancestor
24962479|NCT03798119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24962480|NCT03798119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24962481|NCT03798119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24962482|NCT03798119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24962483|NCT03798119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962484|NCT03798119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24962493|NCT03799822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24962495|NCT03799822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700453|NCT02122380|Hormones|hormones|mesh-ancestor
25700454|NCT02122380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25700455|NCT02122380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25700456|NCT02122380|Protease Inhibitors|protease inhibitors|mesh-ancestor
25700457|NCT02122380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24962496|NCT03799822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082723|NCT03320603|Hemostatics|hemostatics|mesh-ancestor
25082724|NCT03320603|Coagulants|coagulants|mesh-ancestor
25082725|NCT03320538|Rabeprazole|rabeprazole|mesh-list
25082726|NCT03320538|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25082727|NCT03320538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25082728|NCT03320538|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25082729|NCT03320538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25082731|NCT03320486|Ketoconazole|ketoconazole|mesh-list
24962497|NCT03799822|Anticoagulants|anticoagulants|mesh-ancestor
24962498|NCT03799822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24962499|NCT03799822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24962500|NCT03799822|Hemostatics|hemostatics|mesh-ancestor
24464075|NCT00363259|Antiviral Agents|antiviral agents|mesh-ancestor
24464076|NCT00363259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24464077|NCT00363285|Cyproterone Acetate|cyproterone acetate|mesh-list
24464079|NCT00363285|Cyproterone|cyproterone|mesh-list
24962501|NCT03799822|Coagulants|coagulants|mesh-ancestor
24962528|NCT03799913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24962529|NCT03799913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24962530|NCT03799913|Alkylating Agents|alkylating agents|mesh-ancestor
24962531|NCT03799913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891478|NCT04470804|Sirolimus|sirolimus|mesh-list
24962532|NCT03799913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962533|NCT03799913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24962534|NCT03797833|Anesthetics|anesthetics|mesh-list
24962535|NCT03797833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24962536|NCT03797833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962537|NCT03799601|Carboplatin|carboplatin|mesh-list
24962538|NCT03799601|Docetaxel|docetaxel|mesh-list
24962539|NCT03799601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962540|NCT03799601|Tubulin Modulators|tubulin modulators|mesh-ancestor
24962541|NCT03799601|Antimitotic Agents|antimitotic agents|mesh-ancestor
24962542|NCT03799601|Mitosis Modulators|mitosis modulators|mesh-ancestor
24962543|NCT03799601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962544|NCT03797703|Lidocaine|lidocaine|mesh-list
24962545|NCT03797703|Anesthetics, Local|anesthetics, local|mesh-ancestor
24962546|NCT03797703|Anesthetics|anesthetics|mesh-ancestor
24962547|NCT03797703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24962548|NCT03797703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962549|NCT03797703|Sensory System Agents|sensory system agents|mesh-ancestor
25700458|NCT02122380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700459|NCT02122471|Plecanatide|plecanatide|mesh-list
25700460|NCT02122471|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25700461|NCT02122471|Enzyme Activators|enzyme activators|mesh-ancestor
25700462|NCT02122471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700463|NCT02122471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25700464|NCT02122770|Itraconazole|itraconazole|mesh-list
25700465|NCT02122770|Fluconazole|fluconazole|mesh-list
25700466|NCT02122770|Paclitaxel|paclitaxel|mesh-list
25700467|NCT02122770|Docetaxel|docetaxel|mesh-list
24962550|NCT03797703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962551|NCT03797703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24962552|NCT03797703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24962553|NCT03797703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24962554|NCT03797703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24962555|NCT03797703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962557|NCT03797729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24962558|NCT03797729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24962559|NCT03797729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962560|NCT03797729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24788398|NCT01931215|Anesthetics|anesthetics|mesh-ancestor
24788437|NCT01931332|Heroin|heroin|mesh-list
24788474|NCT01931514|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24788475|NCT01931514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788477|NCT01931592|Colistin|colistin|mesh-list
24788483|NCT01931592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788484|NCT01931657|Mifepristone|mifepristone|mesh-list
24788485|NCT01931657|Levonorgestrel|levonorgestrel|mesh-list
24788486|NCT01931657|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24788487|NCT01931657|Abortifacient Agents|abortifacient agents|mesh-ancestor
24788488|NCT01931657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24788489|NCT01931657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788490|NCT01931657|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24788501|NCT01931683|Remifentanil|remifentanil|mesh-list
24962585|NCT03797079|Bupivacaine|bupivacaine|mesh-list
24962586|NCT03797079|Anesthetics, Local|anesthetics, local|mesh-ancestor
24962587|NCT03797079|Anesthetics|anesthetics|mesh-ancestor
24962590|NCT03797079|Sensory System Agents|sensory system agents|mesh-ancestor
24962597|NCT03797443|Paclitaxel|paclitaxel|mesh-list
24962598|NCT03797443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24962599|NCT03797443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962600|NCT03797443|Tubulin Modulators|tubulin modulators|mesh-ancestor
24962601|NCT03797443|Antimitotic Agents|antimitotic agents|mesh-ancestor
24962602|NCT03797443|Mitosis Modulators|mitosis modulators|mesh-ancestor
24962603|NCT03797443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962604|NCT03797443|Vitamins|vitamins|mesh-ancestor
24962605|NCT03797443|Micronutrients|micronutrients|mesh-ancestor
24962606|NCT03797443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962607|NCT03797443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24962608|NCT03797443|Antimetabolites|antimetabolites|mesh-ancestor
24962609|NCT03797443|Antiviral Agents|antiviral agents|mesh-ancestor
24962610|NCT03797443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24962615|NCT03797443|Protective Agents|protective agents|mesh-ancestor
24962616|NCT03796884|Linaclotide|linaclotide|mesh-list
24962619|NCT03796884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962620|NCT03796884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24962622|NCT03797222|Tocopherols|tocopherols|mesh-list
24962623|NCT03797222|alpha-Tocopherol|alpha-tocopherol|mesh-list
24962624|NCT03797222|Vitamins|vitamins|mesh-ancestor
24962625|NCT03797222|Micronutrients|micronutrients|mesh-ancestor
24962626|NCT03797222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962627|NCT03797222|Antioxidants|antioxidants|mesh-ancestor
24818364|NCT02088424|Insulin|insulin|mesh-list
24962628|NCT03797222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962629|NCT03797222|Protective Agents|protective agents|mesh-ancestor
24962630|NCT03796975|Metformin|metformin|mesh-list
24962631|NCT03796975|Pioglitazone|pioglitazone|mesh-list
24962632|NCT03796975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24962633|NCT03796975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962636|NCT03796572|Ropivacaine|ropivacaine|mesh-list
24962637|NCT03796572|Anesthetics, Local|anesthetics, local|mesh-ancestor
24962638|NCT03796572|Anesthetics|anesthetics|mesh-ancestor
24962639|NCT03796572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24962640|NCT03796572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962641|NCT03796572|Sensory System Agents|sensory system agents|mesh-ancestor
24962660|NCT03796403|Analgesics|analgesics|mesh-ancestor
24962661|NCT03796403|Sensory System Agents|sensory system agents|mesh-ancestor
24962662|NCT03796403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962663|NCT03796403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962664|NCT03796403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24962665|NCT03796403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25078782|NCT03353857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24444015|NCT00296530|Dermatologic Agents|dermatologic agents|mesh-ancestor
24962666|NCT03796403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24962667|NCT03796403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24962669|NCT03796507|Temozolomide|temozolomide|mesh-list
24962670|NCT03796507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24962671|NCT03796507|Alkylating Agents|alkylating agents|mesh-ancestor
24962672|NCT03796507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495748|NCT00501839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24495749|NCT00501839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495750|NCT00501839|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24967856|NCT03756116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24967857|NCT03756090|Paclitaxel|paclitaxel|mesh-list
24967858|NCT03756090|Cyclophosphamide|cyclophosphamide|mesh-list
24967859|NCT03756090|Epirubicin|epirubicin|mesh-list
24967860|NCT03756090|Palbociclib|palbociclib|mesh-list
24967861|NCT03756090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24967862|NCT03756090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967863|NCT03756090|Tubulin Modulators|tubulin modulators|mesh-ancestor
24962673|NCT03796507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962674|NCT03796377|Rivaroxaban|rivaroxaban|mesh-list
24962675|NCT03796377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24962676|NCT03796377|Antithrombins|antithrombins|mesh-ancestor
24962677|NCT03796377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24962678|NCT03796377|Protease Inhibitors|protease inhibitors|mesh-ancestor
24962679|NCT03796377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24962681|NCT03796377|Anticoagulants|anticoagulants|mesh-ancestor
24962725|NCT03795571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962726|NCT03795571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24962727|NCT03795571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24962729|NCT03795571|Autonomic Agents|autonomic agents|mesh-ancestor
24962730|NCT03795571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962731|NCT03795571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24962732|NCT03795571|Glucocorticoids|glucocorticoids|mesh-ancestor
24962733|NCT03795571|Hormones|hormones|mesh-ancestor
24788595|NCT01932372|Tofacitinib|tofacitinib|mesh-list
24962742|NCT03795571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24962743|NCT03795571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24962744|NCT03795571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24962745|NCT03795571|Growth Substances|growth substances|mesh-ancestor
24962746|NCT03795571|Growth Inhibitors|growth inhibitors|mesh-ancestor
24962747|NCT03795649|Tranexamic Acid|tranexamic acid|mesh-list
24962748|NCT03795649|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24962760|NCT03795597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24962761|NCT03795597|Immunologic Factors|immunologic factors|mesh-ancestor
24962762|NCT03795597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962764|NCT03795805|Anesthetics, Local|anesthetics, local|mesh-ancestor
24962765|NCT03795805|Anesthetics|anesthetics|mesh-ancestor
24962766|NCT03795805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24962767|NCT03795805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962768|NCT03795805|Sensory System Agents|sensory system agents|mesh-ancestor
24962769|NCT03795805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962770|NCT03795805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24962771|NCT03795805|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24962772|NCT03795805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24962773|NCT03795805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24962774|NCT03795805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962775|NCT03795090|Anti-Infective Agents|anti-infective agents|mesh-list
24962776|NCT03795090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24962785|NCT03795272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24891726|NCT04467931|Atenolol|atenolol|mesh-list
25700468|NCT02122770|Carboplatin|carboplatin|mesh-list
25700469|NCT02122770|Pevonedistat|pevonedistat|mesh-list
25700470|NCT02122770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25700471|NCT02122770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700472|NCT02122770|Tubulin Modulators|tubulin modulators|mesh-ancestor
25700473|NCT02122770|Antimitotic Agents|antimitotic agents|mesh-ancestor
25700474|NCT02122770|Mitosis Modulators|mitosis modulators|mesh-ancestor
25700475|NCT02122770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700476|NCT02122770|Antifungal Agents|antifungal agents|mesh-ancestor
25700477|NCT02122770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25700478|NCT02122770|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25700479|NCT02122770|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24793754|NCT02542696|Autonomic Agents|autonomic agents|mesh-ancestor
24962786|NCT03795272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962787|NCT03795272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962789|NCT03795311|Folfirinox|folfirinox|mesh-list
24962790|NCT03795311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24962791|NCT03795311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962792|NCT03795311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25078784|NCT03353857|Antitubercular Agents|antitubercular agents|mesh-ancestor
25078785|NCT03353857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25078786|NCT03353857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25078787|NCT03353857|Leprostatic Agents|leprostatic agents|mesh-ancestor
24964038|NCT03785873|Antimetabolites|antimetabolites|mesh-ancestor
24962827|NCT03794505|Sensory System Agents|sensory system agents|mesh-ancestor
24962828|NCT03794505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962829|NCT03794505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24962830|NCT03794505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24962831|NCT03794505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24962832|NCT03794505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24962833|NCT03794505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962834|NCT03794505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24962835|NCT03794505|Antiemetics|antiemetics|mesh-ancestor
24962836|NCT03794505|Autonomic Agents|autonomic agents|mesh-ancestor
24962837|NCT03794505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24962838|NCT03794505|Glucocorticoids|glucocorticoids|mesh-ancestor
24962839|NCT03794505|Hormones|hormones|mesh-ancestor
24962840|NCT03794505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24962841|NCT03794505|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24962842|NCT03794505|Protective Agents|protective agents|mesh-ancestor
24962843|NCT03794505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24962844|NCT03794505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962845|NCT03794544|Durvalumab|durvalumab|mesh-list
24962846|NCT03794544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24962847|NCT03794544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962862|NCT03794518|Pioglitazone|pioglitazone|mesh-list
24962863|NCT03794518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24962864|NCT03794518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962865|NCT03794557|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
24962866|NCT03794557|Respiratory System Agents|respiratory system agents|mesh-ancestor
24962867|NCT03794492|Mycophenolic Acid|mycophenolic acid|mesh-list
24962868|NCT03794492|Methylprednisolone|methylprednisolone|mesh-list
24962869|NCT03794492|Prednisolone|prednisolone|mesh-list
24962870|NCT03794492|Tacrolimus|tacrolimus|mesh-list
24788691|NCT01932918|Morphine|morphine|mesh-list
24788766|NCT01933542|Narcotics|narcotics|mesh-ancestor
24788767|NCT01933542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24788768|NCT01933542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788769|NCT01933542|Analgesics|analgesics|mesh-ancestor
24788770|NCT01933542|Sensory System Agents|sensory system agents|mesh-ancestor
24788771|NCT01933542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24788772|NCT01933542|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24788773|NCT01933542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24788774|NCT01933568|Cisplatin|cisplatin|mesh-list
24788775|NCT01933568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626861|NCT01088919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626862|NCT01088919|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24626863|NCT01088919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648256|NCT01213355|Nootropic Agents|nootropic agents|mesh-ancestor
24626865|NCT01088932|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24626866|NCT01088932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700480|NCT02122770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700481|NCT02122770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25700482|NCT02122770|Hormone Antagonists|hormone antagonists|mesh-ancestor
25700483|NCT02122770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25700484|NCT02122770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626868|NCT01088932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626869|NCT01088958|Micronutrients|micronutrients|mesh-list
24626870|NCT01088958|Trace Elements|trace elements|mesh-list
24626871|NCT01088958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626872|NCT01089075|Hydrocortisone|hydrocortisone|mesh-list
24648327|NCT01213667|Ranibizumab|ranibizumab|mesh-list
24648395|NCT01214122|Warfarin|warfarin|mesh-list
24648470|NCT01214941|Itraconazole|itraconazole|mesh-list
24626873|NCT01089075|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24626874|NCT01089075|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24626875|NCT01089075|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24626876|NCT01089075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24626877|NCT01089088|Gemcitabine|gemcitabine|mesh-list
24626879|NCT01089088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25078958|NCT03352076|Hormone Antagonists|hormone antagonists|mesh-ancestor
24626880|NCT01089088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24626881|NCT01089088|Antimetabolites|antimetabolites|mesh-ancestor
24626882|NCT01089088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626883|NCT01089088|Antiviral Agents|antiviral agents|mesh-ancestor
24626884|NCT01089088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24648887|NCT01217177|Everolimus|everolimus|mesh-list
24626900|NCT01089166|Metformin|metformin|mesh-list
24626901|NCT01089166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24626902|NCT01089166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626903|NCT01089179|Metformin|metformin|mesh-list
24626904|NCT01089179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24626905|NCT01089179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626906|NCT01089192|Metformin|metformin|mesh-list
24626907|NCT01089192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24626908|NCT01089192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626909|NCT01089205|Metformin|metformin|mesh-list
24626910|NCT01089205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24626911|NCT01089205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626912|NCT01089218|Amoxicillin|amoxicillin|mesh-list
24626913|NCT01089218|Clavulanic Acid|clavulanic acid|mesh-list
24626914|NCT01089218|Clavulanic Acids|clavulanic acids|mesh-list
24962871|NCT03794492|Basiliximab|basiliximab|mesh-list
24962872|NCT03794492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24962873|NCT03794492|Immunologic Factors|immunologic factors|mesh-ancestor
24962874|NCT03794492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962875|NCT03794492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24962876|NCT03794492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24962877|NCT03794492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962878|NCT03794492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24962879|NCT03794492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962906|NCT03794596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24962907|NCT03794596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24962908|NCT03794596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24962909|NCT03794596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24962910|NCT03794596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962911|NCT03794596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24962912|NCT03794596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24962913|NCT03794596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24962914|NCT03794596|Antipyretics|antipyretics|mesh-ancestor
24962915|NCT03794596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24962916|NCT03794596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962917|NCT03794596|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24962918|NCT03794596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24962919|NCT03794219|Naproxen|naproxen|mesh-list
24962920|NCT03794219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24962921|NCT03794219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24962922|NCT03794219|Analgesics|analgesics|mesh-ancestor
24962923|NCT03794219|Sensory System Agents|sensory system agents|mesh-ancestor
24962924|NCT03794219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24962925|NCT03794219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962926|NCT03794219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24962927|NCT03794219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24682583|NCT01386996|Budesonide|budesonide|mesh-list
24962928|NCT03794219|Gout Suppressants|gout suppressants|mesh-ancestor
24962929|NCT03794219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24962974|NCT03794167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24962975|NCT03794167|Alkylating Agents|alkylating agents|mesh-ancestor
24962976|NCT03794167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962977|NCT03794167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962978|NCT03794167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24962979|NCT03794167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24962984|NCT03794180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24962985|NCT03794180|Antiviral Agents|antiviral agents|mesh-ancestor
24962986|NCT03794180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24962987|NCT03794297|Trametinib|trametinib|mesh-list
24962988|NCT03794297|Dabrafenib|dabrafenib|mesh-list
24962989|NCT03794297|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
24962990|NCT03794297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24962991|NCT03794297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24962992|NCT03794297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24962993|NCT03794297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24962994|NCT03794297|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24962995|NCT03794297|Protective Agents|protective agents|mesh-ancestor
24962996|NCT03794297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24962997|NCT03794297|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24962998|NCT03794297|Antioxidants|antioxidants|mesh-ancestor
24962999|NCT03793725|Apatinib|apatinib|mesh-list
24963000|NCT03793725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24963001|NCT03793725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24963002|NCT03793725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24768011|NCT01805232|Antiviral Agents|antiviral agents|mesh-ancestor
25078794|NCT03353857|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24963017|NCT03793309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24963018|NCT03793283|Insulin|insulin|mesh-list
24963019|NCT03793283|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24464114|NCT00363376|Antiemetics|antiemetics|mesh-ancestor
24464115|NCT00363376|Autonomic Agents|autonomic agents|mesh-ancestor
24464116|NCT00363376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24963020|NCT03793283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24963021|NCT03793283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963023|NCT03793075|Propofol|propofol|mesh-list
24963024|NCT03793075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24963025|NCT03793075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24963026|NCT03793075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963027|NCT03793075|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24963028|NCT03793075|Anesthetics, General|anesthetics, general|mesh-ancestor
24963029|NCT03793075|Anesthetics|anesthetics|mesh-ancestor
24963030|NCT03793075|Analgesics|analgesics|mesh-ancestor
24963031|NCT03793075|Sensory System Agents|sensory system agents|mesh-ancestor
24963032|NCT03793075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24963033|NCT03793075|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24963034|NCT03793075|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24963035|NCT03793075|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24963036|NCT03793075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24963037|NCT03793075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963038|NCT03793205|Lenograstim|lenograstim|mesh-list
24963039|NCT03793205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24963040|NCT03793205|Immunologic Factors|immunologic factors|mesh-ancestor
24963041|NCT03793205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963042|NCT03793114|Cosyntropin|cosyntropin|mesh-list
24963048|NCT03792776|Anesthetics, Local|anesthetics, local|mesh-ancestor
24963049|NCT03792776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24963050|NCT03792776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963051|NCT03792776|Sensory System Agents|sensory system agents|mesh-ancestor
24963052|NCT03792776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24963053|NCT03792776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24963054|NCT03792776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24963057|NCT03792776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963058|NCT03792828|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24963059|NCT03792828|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25078795|NCT03353857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25078796|NCT03353857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25078798|NCT03353857|Hormones|hormones|mesh-ancestor
25078799|NCT03353857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25078800|NCT03353857|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25700485|NCT02122770|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25078802|NCT03353857|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25078803|NCT03353857|Diuretics|diuretics|mesh-ancestor
25078804|NCT03353857|Natriuretic Agents|natriuretic agents|mesh-ancestor
25078805|NCT03353857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24789018|NCT01935193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24789019|NCT01935193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24789020|NCT01935193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24789021|NCT01935193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24789022|NCT01935193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24789023|NCT01935193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24789024|NCT01935193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24789025|NCT01935193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789026|NCT01935206|Naloxone|naloxone|mesh-list
24789027|NCT01935206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24789028|NCT01935206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789029|NCT01935206|Sensory System Agents|sensory system agents|mesh-ancestor
24789030|NCT01935206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24789031|NCT01935310|Imiquimod|imiquimod|mesh-list
24789032|NCT01935310|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24789033|NCT01935310|Immunologic Factors|immunologic factors|mesh-ancestor
24789034|NCT01935310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789035|NCT01935310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789036|NCT01935310|Interferon Inducers|interferon inducers|mesh-ancestor
24626915|NCT01089218|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24626916|NCT01089218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24963120|NCT03792906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24963122|NCT03792906|Sensory System Agents|sensory system agents|mesh-ancestor
24963123|NCT03792906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24963124|NCT03792906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24963126|NCT03792906|Adrenergic Agents|adrenergic agents|mesh-ancestor
24963127|NCT03792906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24963128|NCT03792906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963129|NCT03792906|Sympathomimetics|sympathomimetics|mesh-ancestor
24963130|NCT03792906|Autonomic Agents|autonomic agents|mesh-ancestor
24963131|NCT03792906|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24963136|NCT03792620|Daratumumab|daratumumab|mesh-list
24963137|NCT03792620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24963138|NCT03792503|Pemetrexed|pemetrexed|mesh-list
24963139|NCT03792503|Apatinib|apatinib|mesh-list
24963140|NCT03792503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24963141|NCT03792503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24963142|NCT03792503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963143|NCT03792503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24963144|NCT03792503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24963145|NCT03792503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24963146|NCT03792217|Sodium Hypochlorite|sodium hypochlorite|mesh-list
24963147|NCT03792217|Eusol|eusol|mesh-list
24963148|NCT03792217|Disinfectants|disinfectants|mesh-ancestor
24963149|NCT03792217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24963150|NCT03792139|Itraconazole|itraconazole|mesh-list
24963151|NCT03792139|Antifungal Agents|antifungal agents|mesh-ancestor
24963152|NCT03792139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24963175|NCT03792295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24963176|NCT03792295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24963177|NCT03792295|Analgesics|analgesics|mesh-ancestor
24963178|NCT03792295|Sensory System Agents|sensory system agents|mesh-ancestor
24963179|NCT03792295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24963180|NCT03792295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963181|NCT03792295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24963182|NCT03792295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24963183|NCT03792295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24963184|NCT03792295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24963185|NCT03792295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963186|NCT03792295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24963187|NCT03792295|Narcotics|narcotics|mesh-ancestor
24963188|NCT03792295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24963189|NCT03792295|Antipyretics|antipyretics|mesh-ancestor
24963190|NCT03792152|Warfarin|warfarin|mesh-list
24963191|NCT03792152|Rivaroxaban|rivaroxaban|mesh-list
24963192|NCT03792152|Anticoagulants|anticoagulants|mesh-ancestor
24963208|NCT03792321|Hormones|hormones|mesh-ancestor
24963216|NCT03792009|Anesthetics|anesthetics|mesh-ancestor
24963217|NCT03792009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24963218|NCT03792009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082855|NCT03319550|Caseins|caseins|mesh-list
24963219|NCT03792009|Sensory System Agents|sensory system agents|mesh-ancestor
24963220|NCT03792009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24963221|NCT03791957|Chrysarobin|chrysarobin|mesh-list
24963222|NCT03791957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24963223|NCT03791957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24963224|NCT03791957|Analgesics|analgesics|mesh-ancestor
24963225|NCT03791957|Sensory System Agents|sensory system agents|mesh-ancestor
24963226|NCT03791957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24963227|NCT03791957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963228|NCT03791957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24963229|NCT03791957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24963230|NCT03792074|Paclitaxel|paclitaxel|mesh-list
24963231|NCT03792074|Bevacizumab|bevacizumab|mesh-list
24963232|NCT03792074|Carboplatin|carboplatin|mesh-list
24963233|NCT03792074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24963234|NCT03792074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24963235|NCT03792074|Tubulin Modulators|tubulin modulators|mesh-ancestor
24963236|NCT03792074|Antimitotic Agents|antimitotic agents|mesh-ancestor
24963237|NCT03792074|Mitosis Modulators|mitosis modulators|mesh-ancestor
24683190|NCT01390519|Immunologic Factors|immunologic factors|mesh-ancestor
24963238|NCT03792074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963239|NCT03792074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24963240|NCT03792074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24963241|NCT03792074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24963242|NCT03792074|Growth Substances|growth substances|mesh-ancestor
24963243|NCT03792074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963244|NCT03792074|Growth Inhibitors|growth inhibitors|mesh-ancestor
24963245|NCT03792113|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24963247|NCT03792113|Coagulants|coagulants|mesh-ancestor
24963248|NCT03791905|Leucovorin|leucovorin|mesh-list
24464117|NCT00363376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464118|NCT00363376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24963295|NCT03791801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24963296|NCT03791801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963297|NCT03791801|Cholinergic Agents|cholinergic agents|mesh-ancestor
24963298|NCT03791801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24963299|NCT03791801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24963300|NCT03791801|Autonomic Agents|autonomic agents|mesh-ancestor
24963301|NCT03791801|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24963302|NCT03791801|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24963303|NCT03791801|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24963304|NCT03791775|Polidocanol|polidocanol|mesh-list
24963305|NCT03791775|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
24963306|NCT03791775|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24963308|NCT03791827|Mycophenolic Acid|mycophenolic acid|mesh-list
24963309|NCT03791827|Hydroxychloroquine|hydroxychloroquine|mesh-list
24963310|NCT03791827|Prednisone|prednisone|mesh-list
24963311|NCT03791827|Prednisolone|prednisolone|mesh-list
24963312|NCT03791827|Cyclophosphamide|cyclophosphamide|mesh-list
24963343|NCT03791827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24963345|NCT03791827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24683554|NCT01392833|Prednisolone phosphate|prednisolone phosphate|mesh-list
24963350|NCT03791762|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
24963351|NCT03791762|Vasodilator Agents|vasodilator agents|mesh-ancestor
24963352|NCT03791762|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24963353|NCT03791762|Protective Agents|protective agents|mesh-ancestor
25700486|NCT02122770|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24963369|NCT03791463|Salvianolic acid A|salvianolic acid a|mesh-list
24963370|NCT03791463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24963371|NCT03791463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24963372|NCT03791463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963373|NCT03791463|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24963375|NCT03791424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24963376|NCT03791424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24963377|NCT03791424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24963378|NCT03791424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963379|NCT03791424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24963380|NCT03791424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24963381|NCT03791424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24963382|NCT03791424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24963383|NCT03791424|Anesthetics, General|anesthetics, general|mesh-ancestor
24963384|NCT03791424|Anesthetics|anesthetics|mesh-ancestor
24963385|NCT03791424|GABA Modulators|gaba modulators|mesh-ancestor
24963386|NCT03791424|GABA Agents|gaba agents|mesh-ancestor
24963387|NCT03791424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24963389|NCT03791294|Titanium dioxide|titanium dioxide|mesh-list
24963413|NCT03790839|Incretins|incretins|mesh-ancestor
24963414|NCT03790839|Hormones|hormones|mesh-ancestor
24963415|NCT03790839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24963416|NCT03790839|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24963417|NCT03790839|Protease Inhibitors|protease inhibitors|mesh-ancestor
24963418|NCT03790839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24963419|NCT03790839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963420|NCT03791125|Salvianolic acid A|salvianolic acid a|mesh-list
24963421|NCT03791125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768406|NCT01807832|Capsaicin|capsaicin|mesh-list
24963423|NCT03791125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963424|NCT03791125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24789359|NCT01936545|Desflurane|desflurane|mesh-list
24789360|NCT01936545|Liver Extracts|liver extracts|mesh-list
24789361|NCT01936545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24789362|NCT01936545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24789363|NCT01936545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789364|NCT01936545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24789365|NCT01936545|Anesthetics, General|anesthetics, general|mesh-ancestor
24789366|NCT01936545|Anesthetics|anesthetics|mesh-ancestor
24789387|NCT01936805|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24789388|NCT01936805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24789390|NCT01936961|Immunologic Factors|immunologic factors|mesh-ancestor
24789391|NCT01936961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626917|NCT01089218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24626918|NCT01089218|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24626919|NCT01089218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626920|NCT01089218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626922|NCT01089309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24626923|NCT01089309|Hormone Antagonists|hormone antagonists|mesh-ancestor
24626924|NCT01089309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24626925|NCT01089309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626926|NCT01089309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24963443|NCT03790670|Immunologic Factors|immunologic factors|mesh-ancestor
24963444|NCT03790670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963446|NCT03790540|Anesthetics, Local|anesthetics, local|mesh-ancestor
24963515|NCT03790371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24963517|NCT03790163|Levobupivacaine|levobupivacaine|mesh-list
24963518|NCT03790163|Anesthetics, Local|anesthetics, local|mesh-ancestor
24963519|NCT03790163|Anesthetics|anesthetics|mesh-ancestor
24452630|NCT05457959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24452631|NCT05457959|Antiviral Agents|antiviral agents|mesh-ancestor
24452632|NCT05457959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24452633|NCT05457946|Vaccines|vaccines|mesh-list
25700487|NCT02122770|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25700488|NCT02123017|Lactulose|lactulose|mesh-list
25700489|NCT02123017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25700490|NCT02123134|Deoxycholic Acid|deoxycholic acid|mesh-list
25700491|NCT02123134|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25700492|NCT02123134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25700493|NCT02123446|Cephalexin|cephalexin|mesh-list
25700494|NCT02123446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25700495|NCT02123446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25700496|NCT02123459|Cephalexin|cephalexin|mesh-list
25700497|NCT02123459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25700498|NCT02123459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25700499|NCT02123472|Cephalexin|cephalexin|mesh-list
24464130|NCT00363376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24464131|NCT00363376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24464132|NCT00363389|Misoprostol|misoprostol|mesh-list
24464133|NCT00363389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24963520|NCT03790163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24963521|NCT03790163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963522|NCT03790163|Sensory System Agents|sensory system agents|mesh-ancestor
24963523|NCT03790163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24963524|NCT03790358|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
24963525|NCT03790358|Hallucinogens|hallucinogens|mesh-ancestor
24963526|NCT03790358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963527|NCT03790358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24963528|NCT03790358|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24963542|NCT03790384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963543|NCT03790384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24963545|NCT03790384|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24963546|NCT03790384|Immunologic Factors|immunologic factors|mesh-ancestor
24963547|NCT03790384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963548|NCT03790293|Rituximab|rituximab|mesh-list
24541565|NCT00673829|Interleukin-2|interleukin-2|mesh-list
24963549|NCT03790293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24963550|NCT03790293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24963560|NCT03790020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24963561|NCT03790072|Cyclophosphamide|cyclophosphamide|mesh-list
24963563|NCT03790072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24963564|NCT03790072|Immunologic Factors|immunologic factors|mesh-ancestor
24963565|NCT03790072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963566|NCT03790072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24963567|NCT03790072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24963568|NCT03790072|Alkylating Agents|alkylating agents|mesh-ancestor
24963572|NCT03789890|Itraconazole|itraconazole|mesh-list
25078876|NCT03353012|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24963600|NCT03790085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24963601|NCT03790085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24963602|NCT03790085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24963603|NCT03790085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24963604|NCT03790085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24963605|NCT03790085|Antidepressive Agents|antidepressive agents|mesh-ancestor
24963606|NCT03790085|Dopamine Agonists|dopamine agonists|mesh-ancestor
24963607|NCT03790085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24963608|NCT03790085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24963609|NCT03790085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24963610|NCT03790085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24963664|NCT03789370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24963665|NCT03789370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24963666|NCT03789370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963667|NCT03789370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24963668|NCT03789370|Anesthetics, General|anesthetics, general|mesh-ancestor
24963669|NCT03789370|Anesthetics|anesthetics|mesh-ancestor
24963670|NCT03789370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24963671|NCT03789370|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24963672|NCT03789539|Vaccines|vaccines|mesh-list
24963673|NCT03789539|Immunologic Factors|immunologic factors|mesh-ancestor
24963675|NCT03789422|Cetirizine|cetirizine|mesh-list
24963731|NCT03789058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963732|NCT03788889|Ketamine|ketamine|mesh-list
24963733|NCT03788889|Lorazepam|lorazepam|mesh-list
24963734|NCT03788889|Phenobarbital|phenobarbital|mesh-list
24963735|NCT03788889|Analgesics|analgesics|mesh-ancestor
24963736|NCT03788889|Sensory System Agents|sensory system agents|mesh-ancestor
25700500|NCT02123472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25700501|NCT02123472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25700502|NCT02123511|Acetylcysteine|acetylcysteine|mesh-list
24963743|NCT03788889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24963744|NCT03788889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24963745|NCT03788889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24963746|NCT03788889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24963747|NCT03788889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963764|NCT03788902|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24963765|NCT03788902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24963766|NCT03788902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24963767|NCT03788902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963768|NCT03788902|Dopamine Agents|dopamine agents|mesh-ancestor
24963769|NCT03788902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24963770|NCT03788863|Diflucortolone|diflucortolone|mesh-list
24963771|NCT03788863|Diflucortolone valerate|diflucortolone valerate|mesh-list
24963772|NCT03788863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24963773|NCT03788863|Glucocorticoids|glucocorticoids|mesh-ancestor
24963774|NCT03788863|Hormones|hormones|mesh-ancestor
24963775|NCT03788863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24963776|NCT03788863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963777|NCT03789032|Rabeprazole|rabeprazole|mesh-list
24963791|NCT03788694|Sensory System Agents|sensory system agents|mesh-ancestor
24963792|NCT03788694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24963793|NCT03788694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963794|NCT03788694|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24963795|NCT03788694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24541603|NCT00674089|Vitamin A|vitamin a|mesh-list
24963796|NCT03788694|Anesthetics, General|anesthetics, general|mesh-ancestor
24963798|NCT03788694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24963799|NCT03788694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24963800|NCT03788694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24963826|NCT03788681|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25078878|NCT03353012|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24963828|NCT03788681|Estradiol|estradiol|mesh-list
25078879|NCT03352947|Trametinib|trametinib|mesh-list
25078880|NCT03352947|Dabrafenib|dabrafenib|mesh-list
25078881|NCT03352947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24964200|NCT03784599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078882|NCT03352947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25078883|NCT03352947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078884|NCT03352947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078885|NCT03352895|Grape Seed Extract|grape seed extract|mesh-list
25078886|NCT03352895|Resveratrol|resveratrol|mesh-list
25078887|NCT03352895|Antioxidants|antioxidants|mesh-ancestor
25078888|NCT03352895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078889|NCT03352895|Protective Agents|protective agents|mesh-ancestor
25078890|NCT03352895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789711|NCT01938729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789712|NCT01938729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24789713|NCT01938729|Antimetabolites|antimetabolites|mesh-ancestor
24789714|NCT01938729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789715|NCT01938729|Antiviral Agents|antiviral agents|mesh-ancestor
24789716|NCT01938729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24789717|NCT01938729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700503|NCT02123511|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25700504|NCT02123511|Antiviral Agents|antiviral agents|mesh-ancestor
25700505|NCT02123511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24963867|NCT03787992|Aflutinib|aflutinib|mesh-list
24963868|NCT03787992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24963869|NCT03787992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24963870|NCT03787992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24963871|NCT03787992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963872|NCT03787940|Isoniazid|isoniazid|mesh-list
24963873|NCT03787940|Antitubercular Agents|antitubercular agents|mesh-ancestor
24963874|NCT03787940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24963875|NCT03787940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24963876|NCT03787940|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24963877|NCT03787940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24963878|NCT03787940|Antimetabolites|antimetabolites|mesh-ancestor
24963879|NCT03787940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963880|NCT03787940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24963881|NCT03787953|Antibodies|antibodies|mesh-list
24963882|NCT03787953|Immunologic Factors|immunologic factors|mesh-ancestor
24963883|NCT03787953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963884|NCT03788018|Lidocaine|lidocaine|mesh-list
24963885|NCT03788018|Dexmedetomidine|dexmedetomidine|mesh-list
24963886|NCT03788018|Anesthetics, Local|anesthetics, local|mesh-ancestor
24963887|NCT03788018|Anesthetics|anesthetics|mesh-ancestor
24963888|NCT03788018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24963889|NCT03788018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963890|NCT03788018|Sensory System Agents|sensory system agents|mesh-ancestor
24963891|NCT03788018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24963892|NCT03788018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24963893|NCT03788018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24963894|NCT03788018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24963895|NCT03788018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24482643|NCT00440128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482644|NCT00440128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24482645|NCT00440128|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24482666|NCT00440154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963896|NCT03788018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963897|NCT03788018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24963898|NCT03788018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24963899|NCT03788018|Analgesics|analgesics|mesh-ancestor
24963901|NCT03788018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24963963|NCT03787147|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24963964|NCT03787147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24939606|NCT04008186|Metformin|metformin|mesh-list
24963965|NCT03787147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24963967|NCT03786887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24963968|NCT03786887|Narcotics|narcotics|mesh-ancestor
24963969|NCT03786887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24963970|NCT03786887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963971|NCT03786887|Analgesics|analgesics|mesh-ancestor
24963972|NCT03786887|Sensory System Agents|sensory system agents|mesh-ancestor
24963973|NCT03786887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24963974|NCT03787043|Metformin|metformin|mesh-list
24963975|NCT03787043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24963976|NCT03787043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24963977|NCT03787017|Metformin|metformin|mesh-list
24963978|NCT03787017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25700506|NCT02123511|Expectorants|expectorants|mesh-ancestor
25700507|NCT02123511|Respiratory System Agents|respiratory system agents|mesh-ancestor
24963981|NCT03786757|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24963982|NCT03786757|Antithrombins|antithrombins|mesh-ancestor
24963983|NCT03786757|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24963987|NCT03786757|Anticoagulants|anticoagulants|mesh-ancestor
24963998|NCT03787030|Vasodilator Agents|vasodilator agents|mesh-ancestor
24963999|NCT03787069|Lidocaine|lidocaine|mesh-list
24964000|NCT03787069|Anesthetics, Local|anesthetics, local|mesh-ancestor
24964001|NCT03787069|Anesthetics|anesthetics|mesh-ancestor
24964002|NCT03787069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24964003|NCT03787069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964004|NCT03787069|Sensory System Agents|sensory system agents|mesh-ancestor
24964005|NCT03787069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24964006|NCT03787069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24964007|NCT03787069|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24964008|NCT03787069|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24964009|NCT03787069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24964010|NCT03787069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964011|NCT03786562|Morphine|morphine|mesh-list
24964013|NCT03786562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24964014|NCT03786562|Narcotics|narcotics|mesh-ancestor
24964015|NCT03786562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24964016|NCT03786562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964017|NCT03786562|Analgesics|analgesics|mesh-ancestor
24964018|NCT03786562|Sensory System Agents|sensory system agents|mesh-ancestor
24964019|NCT03786562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24964020|NCT03786289|Epoetin Alfa|epoetin alfa|mesh-list
24964021|NCT03786289|Hematinics|hematinics|mesh-ancestor
24964022|NCT03786419|Atezolizumab|atezolizumab|mesh-list
24964023|NCT03786419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24964024|NCT03786120|Zolpidem|zolpidem|mesh-list
24964025|NCT03786120|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24964026|NCT03786120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24964027|NCT03786120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24964028|NCT03786120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964029|NCT03786120|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24964030|NCT03786120|GABA Agonists|gaba agonists|mesh-ancestor
24964031|NCT03786120|GABA Agents|gaba agents|mesh-ancestor
24964032|NCT03786120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24769095|NCT01812538|Diclofenac|diclofenac|mesh-list
24964037|NCT03785873|Irinotecan|irinotecan|mesh-list
24964039|NCT03785873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964041|NCT03785873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24964042|NCT03785873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24964043|NCT03785873|Immunologic Factors|immunologic factors|mesh-ancestor
24964044|NCT03785873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964045|NCT03785873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24964046|NCT03785873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24964047|NCT03785873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24964048|NCT03785873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24964053|NCT03785873|Vitamins|vitamins|mesh-ancestor
24964059|NCT03786237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964060|NCT03786029|Acetaminophen|acetaminophen|mesh-list
24964061|NCT03786029|Ibuprofen|ibuprofen|mesh-list
24964062|NCT03786029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24964063|NCT03786029|Analgesics|analgesics|mesh-ancestor
24964064|NCT03786029|Sensory System Agents|sensory system agents|mesh-ancestor
24964065|NCT03786029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24893063|NCT04454840|Riluzole|riluzole|mesh-list
25700508|NCT02123511|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25700509|NCT02123511|Antioxidants|antioxidants|mesh-ancestor
25700510|NCT02123511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700511|NCT02123511|Protective Agents|protective agents|mesh-ancestor
24501717|NCT00530582|Hormones|hormones|mesh-ancestor
24501718|NCT00530582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24464205|NCT00363753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24790049|NCT01940393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893091|NCT04454307|Analgesics|analgesics|mesh-ancestor
24464208|NCT00363753|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24464213|NCT00363792|Vasodilator Agents|vasodilator agents|mesh-ancestor
24464215|NCT00363831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24464216|NCT00363844|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24464217|NCT00363844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24464218|NCT00363844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464219|NCT00363844|Incretins|incretins|mesh-ancestor
24464220|NCT00363844|Hormones|hormones|mesh-ancestor
24464221|NCT00363844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24464222|NCT00363844|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24464223|NCT00363844|Protease Inhibitors|protease inhibitors|mesh-ancestor
24464224|NCT00363844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464225|NCT00363844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464226|NCT00363857|Ropinirole|ropinirole|mesh-list
24790050|NCT01940393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790051|NCT01940393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25078906|NCT03352843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25078907|NCT03352843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24790052|NCT01940393|Cholinergic Agents|cholinergic agents|mesh-ancestor
24790053|NCT01940419|Tranexamic Acid|tranexamic acid|mesh-list
24790054|NCT01940419|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24790055|NCT01940419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24790056|NCT01940419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790057|NCT01940419|Hemostatics|hemostatics|mesh-ancestor
24790058|NCT01940419|Coagulants|coagulants|mesh-ancestor
24790059|NCT01940536|Tranexamic Acid|tranexamic acid|mesh-list
24790060|NCT01940536|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24790061|NCT01940536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24790062|NCT01940536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790063|NCT01940536|Hemostatics|hemostatics|mesh-ancestor
24790064|NCT01940536|Coagulants|coagulants|mesh-ancestor
24790065|NCT01940601|Lenograstim|lenograstim|mesh-list
24790066|NCT01940601|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24790068|NCT01940601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582556|NCT00870337|Everolimus|everolimus|mesh-list
24626927|NCT01089309|Diuretics|diuretics|mesh-ancestor
24626928|NCT01089309|Natriuretic Agents|natriuretic agents|mesh-ancestor
24626929|NCT01089348|Metronidazole|metronidazole|mesh-list
24626930|NCT01089348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24626935|NCT01089439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24626936|NCT01089439|Autonomic Agents|autonomic agents|mesh-ancestor
24626937|NCT01089439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24626938|NCT01089439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626939|NCT01089439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24626940|NCT01089439|Respiratory System Agents|respiratory system agents|mesh-ancestor
24626941|NCT01089439|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24626942|NCT01089439|Antioxidants|antioxidants|mesh-ancestor
24626943|NCT01089439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626944|NCT01089439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24626945|NCT01089439|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24626946|NCT01089439|Vasodilator Agents|vasodilator agents|mesh-ancestor
24626947|NCT01089439|Gasotransmitters|gasotransmitters|mesh-ancestor
24626948|NCT01089439|Protective Agents|protective agents|mesh-ancestor
24626949|NCT01089452|Amlodipine|amlodipine|mesh-list
24626950|NCT01089452|Olmesartan|olmesartan|mesh-list
24626951|NCT01089452|Perindopril|perindopril|mesh-list
24649054|NCT01218425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24626952|NCT01089452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25700512|NCT02123511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700513|NCT02123511|Antidotes|antidotes|mesh-ancestor
24626953|NCT01089452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25700514|NCT02123576|Pentoxifylline|pentoxifylline|mesh-list
25700515|NCT02123576|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25083070|NCT03318211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25083071|NCT03318211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24626954|NCT01089452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24626955|NCT01089452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626957|NCT01089452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626958|NCT01089452|Vasodilator Agents|vasodilator agents|mesh-ancestor
24964104|NCT03785158|Melatonin|melatonin|mesh-list
24964105|NCT03785158|Antioxidants|antioxidants|mesh-ancestor
24964106|NCT03785158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964107|NCT03785158|Protective Agents|protective agents|mesh-ancestor
24964108|NCT03785158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964109|NCT03785158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24964119|NCT03785015|Aspirin|aspirin|mesh-list
24964131|NCT03785015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24964132|NCT03785015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24964133|NCT03785015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24964134|NCT03785015|Antipyretics|antipyretics|mesh-ancestor
24964135|NCT03785184|Dexamethasone|dexamethasone|mesh-list
24964136|NCT03785184|Lenalidomide|lenalidomide|mesh-list
24964137|NCT03785184|Venetoclax|venetoclax|mesh-list
24964138|NCT03785184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24964139|NCT03785184|Antiemetics|antiemetics|mesh-ancestor
24964140|NCT03785184|Autonomic Agents|autonomic agents|mesh-ancestor
24964141|NCT03785184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24964142|NCT03785184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964143|NCT03785184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24964144|NCT03785184|Glucocorticoids|glucocorticoids|mesh-ancestor
24964145|NCT03785184|Hormones|hormones|mesh-ancestor
24964146|NCT03785184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24964147|NCT03785184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24964148|NCT03785184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24964149|NCT03785184|Immunologic Factors|immunologic factors|mesh-ancestor
24964150|NCT03785184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24964151|NCT03785184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24964152|NCT03785184|Growth Substances|growth substances|mesh-ancestor
24964153|NCT03785184|Growth Inhibitors|growth inhibitors|mesh-ancestor
24964154|NCT03785041|Tramadol|tramadol|mesh-list
24964155|NCT03785041|Levobupivacaine|levobupivacaine|mesh-list
24464232|NCT00363857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464235|NCT00363909|Citalopram|citalopram|mesh-list
24464236|NCT00363909|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24964157|NCT03785041|Narcotics|narcotics|mesh-ancestor
24964158|NCT03785041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24964159|NCT03785041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964160|NCT03785041|Analgesics|analgesics|mesh-ancestor
24964194|NCT03784599|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24964195|NCT03784599|Osimertinib|osimertinib|mesh-list
24964196|NCT03784599|Maytansine|maytansine|mesh-list
24964197|NCT03784599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24964198|NCT03784599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24964199|NCT03784599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24964201|NCT03784599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964202|NCT03784599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24964203|NCT03784599|Tubulin Modulators|tubulin modulators|mesh-ancestor
24964204|NCT03784599|Antimitotic Agents|antimitotic agents|mesh-ancestor
24964205|NCT03784599|Mitosis Modulators|mitosis modulators|mesh-ancestor
24964206|NCT03784703|Atorvastatin|atorvastatin|mesh-list
25700516|NCT02123576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700517|NCT02123576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700518|NCT02123576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24970026|NCT03737708|Immunologic Factors|immunologic factors|mesh-ancestor
24970027|NCT03737708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24970034|NCT03737656|Hormones|hormones|mesh-ancestor
24964207|NCT03784703|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24964208|NCT03784703|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24964209|NCT03784703|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24964210|NCT03784703|Antimetabolites|antimetabolites|mesh-ancestor
24964211|NCT03784703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964212|NCT03784703|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24964213|NCT03784703|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24964214|NCT03784703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24964215|NCT03784677|SOR-C13|sor-c13|mesh-list
24964216|NCT03784677|Calcium|calcium|mesh-list
24964217|NCT03784677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24964219|NCT03784677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24964253|NCT03784105|Sensory System Agents|sensory system agents|mesh-ancestor
24964254|NCT03784105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24964255|NCT03784105|Antitussive Agents|antitussive agents|mesh-ancestor
24964256|NCT03784105|Respiratory System Agents|respiratory system agents|mesh-ancestor
24964257|NCT03784014|Durvalumab|durvalumab|mesh-list
24964258|NCT03784014|Olaparib|olaparib|mesh-list
24964259|NCT03784014|Lapatinib|lapatinib|mesh-list
24964260|NCT03784014|Palbociclib|palbociclib|mesh-list
24964261|NCT03784014|Trametinib|trametinib|mesh-list
24964262|NCT03784014|Dabrafenib|dabrafenib|mesh-list
24964263|NCT03784014|Ceritinib|ceritinib|mesh-list
24964271|NCT03784261|Abatacept|abatacept|mesh-list
24964286|NCT03783897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24964287|NCT03783897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686464|NCT04786093|Durvalumab|durvalumab|mesh-list
24964288|NCT03783897|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24964289|NCT03783897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24759742|NCT01754324|Narcotics|narcotics|mesh-ancestor
24964290|NCT03783897|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24964291|NCT03783897|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24964292|NCT03783897|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24964294|NCT03783949|Paclitaxel|paclitaxel|mesh-list
24964295|NCT03783949|Carboplatin|carboplatin|mesh-list
24964296|NCT03783949|Niraparib|niraparib|mesh-list
24964297|NCT03783949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24964298|NCT03783949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24964299|NCT03783949|Tubulin Modulators|tubulin modulators|mesh-ancestor
24964300|NCT03783949|Antimitotic Agents|antimitotic agents|mesh-ancestor
24964301|NCT03783949|Mitosis Modulators|mitosis modulators|mesh-ancestor
24964302|NCT03783949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964303|NCT03783949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24964304|NCT03783949|Antimetabolites|antimetabolites|mesh-ancestor
24964305|NCT03783949|Antiviral Agents|antiviral agents|mesh-ancestor
24964306|NCT03783949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24964307|NCT03783949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24964334|NCT03784040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24964335|NCT03784040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964336|NCT03783845|Amoxicillin|amoxicillin|mesh-list
24964337|NCT03783845|Metronidazole|metronidazole|mesh-list
24760141|NCT01756443|Mydriatics|mydriatics|mesh-ancestor
24760158|NCT01756495|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24964338|NCT03783845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24964339|NCT03783845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24964340|NCT03783845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24964341|NCT03783845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24964345|NCT03783728|Rifapentine|rifapentine|mesh-list
24964346|NCT03783728|Vitamins|vitamins|mesh-ancestor
24964347|NCT03783728|Micronutrients|micronutrients|mesh-ancestor
24964348|NCT03783728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964349|NCT03783728|Vitamin B Complex|vitamin b complex|mesh-ancestor
24964350|NCT03783728|Antitubercular Agents|antitubercular agents|mesh-ancestor
24964401|NCT03783676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24964402|NCT03783455|Hyaluronic Acid|hyaluronic acid|mesh-list
24964403|NCT03783455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24964404|NCT03783455|Immunologic Factors|immunologic factors|mesh-ancestor
24964405|NCT03783455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964406|NCT03783455|Viscosupplements|viscosupplements|mesh-ancestor
25700519|NCT02123576|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25700520|NCT02123576|Protective Agents|protective agents|mesh-ancestor
24790972|NCT05409339|Diuretics|diuretics|mesh-ancestor
25078912|NCT03352700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078913|NCT03352700|Sensory System Agents|sensory system agents|mesh-ancestor
25078914|NCT03352700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970162|NCT03735446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24970163|NCT03735446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970164|NCT03735446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24970165|NCT03735446|Antimetabolites|antimetabolites|mesh-ancestor
24970166|NCT03735446|Antiviral Agents|antiviral agents|mesh-ancestor
24970167|NCT03735446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24970168|NCT03735446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24970169|NCT03735446|Immunologic Factors|immunologic factors|mesh-ancestor
24970170|NCT03735446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970171|NCT03735446|Analgesics|analgesics|mesh-ancestor
24970172|NCT03735446|Sensory System Agents|sensory system agents|mesh-ancestor
24970173|NCT03735446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970174|NCT03735433|Aspirin|aspirin|mesh-list
25078915|NCT03352674|Insulin|insulin|mesh-list
25078916|NCT03352674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25078917|NCT03352674|Insulin Glargine|insulin glargine|mesh-list
25078921|NCT03352479|Narcotics|narcotics|mesh-ancestor
25078922|NCT03352479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25078923|NCT03352479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078924|NCT03352479|Analgesics|analgesics|mesh-ancestor
25078925|NCT03352479|Sensory System Agents|sensory system agents|mesh-ancestor
25078926|NCT03352479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078927|NCT03352362|Acetaminophen|acetaminophen|mesh-list
25078928|NCT03352362|Ibuprofen|ibuprofen|mesh-list
25078929|NCT03352362|Propacetamol|propacetamol|mesh-list
25078930|NCT03352362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25078931|NCT03352362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25078932|NCT03352362|Analgesics|analgesics|mesh-ancestor
25078933|NCT03352362|Sensory System Agents|sensory system agents|mesh-ancestor
25078934|NCT03352362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25078935|NCT03352362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964445|NCT03783182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24686696|NCT04640636|GABA Agents|gaba agents|mesh-ancestor
24964446|NCT03783182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964447|NCT03783182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24964448|NCT03783182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24964449|NCT03783182|Respiratory System Agents|respiratory system agents|mesh-ancestor
24964450|NCT03783299|Lumefantrine|lumefantrine|mesh-list
24964451|NCT03783299|Artemether|artemether|mesh-list
24964452|NCT03783299|Primaquine|primaquine|mesh-list
24964453|NCT03783299|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24964454|NCT03783299|Antimalarials|antimalarials|mesh-ancestor
24964455|NCT03783299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24964456|NCT03783299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24790337|NCT01942109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24790338|NCT01942174|Methotrexate|methotrexate|mesh-list
24790339|NCT01942174|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24790340|NCT01942174|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24790341|NCT01942174|Abortifacient Agents|abortifacient agents|mesh-ancestor
24790342|NCT01942174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24790343|NCT01942174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790344|NCT01942174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24790345|NCT01942174|Antimetabolites|antimetabolites|mesh-ancestor
24964459|NCT03783273|Cholecalciferol|cholecalciferol|mesh-list
24964460|NCT03783273|Vitamins|vitamins|mesh-ancestor
24964461|NCT03783273|Micronutrients|micronutrients|mesh-ancestor
24964462|NCT03783273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964463|NCT03783273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24964464|NCT03783273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24964465|NCT03782987|Itraconazole|itraconazole|mesh-list
24964466|NCT03782987|Antifungal Agents|antifungal agents|mesh-ancestor
24964467|NCT03782987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24964478|NCT03783065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25700521|NCT02123576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700522|NCT02123576|Vasodilator Agents|vasodilator agents|mesh-ancestor
25700523|NCT02123576|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25700524|NCT02123576|Antioxidants|antioxidants|mesh-ancestor
25700525|NCT02123849|Aspirin|aspirin|mesh-list
25700526|NCT02123849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25700527|NCT02123849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25700528|NCT02123849|Analgesics|analgesics|mesh-ancestor
25700529|NCT02123849|Sensory System Agents|sensory system agents|mesh-ancestor
25700530|NCT02123849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25700531|NCT02123849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700532|NCT02123849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25700533|NCT02123849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24964480|NCT03783065|Adrenergic Agents|adrenergic agents|mesh-ancestor
24964481|NCT03783065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24964482|NCT03783065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964483|NCT03783065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964484|NCT03783065|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24964485|NCT03783065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24964486|NCT03783065|Vasodilator Agents|vasodilator agents|mesh-ancestor
24964487|NCT03782935|Choline|choline|mesh-list
24964488|NCT03782935|Lipotropic Agents|lipotropic agents|mesh-ancestor
24964496|NCT03782831|Immunologic Factors|immunologic factors|mesh-ancestor
24964497|NCT03782831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964498|NCT03783000|BI 425809|bi 425809|mesh-list
24964499|NCT03783000|Nootropic Agents|nootropic agents|mesh-ancestor
24964500|NCT03782805|Cholecalciferol|cholecalciferol|mesh-list
24964501|NCT03782805|Vitamin D|vitamin d|mesh-list
24964502|NCT03782805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24964529|NCT03782662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24964530|NCT03782662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24964531|NCT03782662|Hormone Antagonists|hormone antagonists|mesh-ancestor
24964532|NCT03782662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24762094|NCT01766089|Analgesics|analgesics|mesh-ancestor
24964533|NCT03782662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24964534|NCT03782662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24964540|NCT03782662|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24964541|NCT03782662|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24964542|NCT03782662|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24964543|NCT03782662|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24686961|NCT04481412|Histamine Agents|histamine agents|mesh-ancestor
24964544|NCT03782662|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24790395|NCT01942343|Droperidol|droperidol|mesh-list
24964545|NCT03782662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24964546|NCT03782662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24964547|NCT03782662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24964548|NCT03782662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24964549|NCT03782662|Vasodilator Agents|vasodilator agents|mesh-ancestor
24964550|NCT03782480|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24964551|NCT03782480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24964552|NCT03782480|Immunologic Factors|immunologic factors|mesh-ancestor
24964553|NCT03782480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964554|NCT03782025|Vitamin K 1|vitamin k 1|mesh-list
24964555|NCT03782025|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24964556|NCT03782025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24964557|NCT03782025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964572|NCT03781908|Silver Nitrate|silver nitrate|mesh-list
24964573|NCT03781908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24964574|NCT03781908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24964575|NCT03781895|Cholecalciferol|cholecalciferol|mesh-list
24964576|NCT03781895|Vitamin D|vitamin d|mesh-list
24964577|NCT03781895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24964578|NCT03781895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964579|NCT03781895|Vitamins|vitamins|mesh-ancestor
24964580|NCT03781895|Micronutrients|micronutrients|mesh-ancestor
24964581|NCT03781895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24964582|NCT03781843|Lidocaine|lidocaine|mesh-list
24964583|NCT03781843|Anesthetics, Local|anesthetics, local|mesh-ancestor
24964584|NCT03781843|Anesthetics|anesthetics|mesh-ancestor
24964585|NCT03781843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24964586|NCT03781843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964587|NCT03781843|Sensory System Agents|sensory system agents|mesh-ancestor
24964588|NCT03781843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24964589|NCT03781843|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24964590|NCT03781843|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24964591|NCT03781843|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24964592|NCT03781843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24964593|NCT03781843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964595|NCT03781869|Etoposide|etoposide|mesh-list
24964605|NCT03781687|Narcotics|narcotics|mesh-ancestor
24964606|NCT03781687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25078947|NCT03352128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964607|NCT03781687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964608|NCT03781687|Analgesics|analgesics|mesh-ancestor
24964609|NCT03781687|Sensory System Agents|sensory system agents|mesh-ancestor
24807182|NCT02020161|Immunologic Factors|immunologic factors|mesh-ancestor
24970389|NCT03733587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970390|NCT03733587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24970391|NCT03733574|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24964610|NCT03781687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24964611|NCT03781596|Fluticasone|fluticasone|mesh-list
24964612|NCT03781596|Omeprazole|omeprazole|mesh-list
24964613|NCT03781596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24964614|NCT03781596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24964615|NCT03781596|Autonomic Agents|autonomic agents|mesh-ancestor
24964644|NCT03781635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24964645|NCT03781635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964646|NCT03781544|Acetaminophen|acetaminophen|mesh-list
24964647|NCT03781544|Diclofenac|diclofenac|mesh-list
24964648|NCT03781544|Tramadol|tramadol|mesh-list
24964683|NCT03781700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24964685|NCT03781466|Progesterone|progesterone|mesh-list
24964686|NCT03781466|Progestins|progestins|mesh-ancestor
24763537|NCT01774487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24964687|NCT03781466|Hormones|hormones|mesh-ancestor
24964688|NCT03781466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24964689|NCT03781466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764481|NCT01782001|Vitamins|vitamins|mesh-list
24555404|NCT00741429|Insulin|insulin|mesh-list
24964716|NCT03781115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24964717|NCT03781115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24964718|NCT03781115|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24964719|NCT03781115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24964720|NCT03781115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24964721|NCT03781115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964722|NCT03781115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24964724|NCT03781115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24964725|NCT03781115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24764970|NCT01785446|Dsuvia|dsuvia|mesh-list
24964726|NCT03781115|Dopamine Agents|dopamine agents|mesh-ancestor
24964727|NCT03781050|Sirolimus|sirolimus|mesh-list
24964728|NCT03781050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24964729|NCT03781050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24964730|NCT03781050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24964731|NCT03781050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24964732|NCT03781050|Antifungal Agents|antifungal agents|mesh-ancestor
24964733|NCT03781050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24964734|NCT03781050|Immunologic Factors|immunologic factors|mesh-ancestor
24964735|NCT03781050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964780|NCT03780556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24964781|NCT03780556|Analgesics|analgesics|mesh-ancestor
24964782|NCT03780556|Sensory System Agents|sensory system agents|mesh-ancestor
24964789|NCT03780621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24964790|NCT03780621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24964791|NCT03780621|Analgesics|analgesics|mesh-ancestor
24964792|NCT03780621|Sensory System Agents|sensory system agents|mesh-ancestor
24964793|NCT03780621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24964794|NCT03780621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964795|NCT03780621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24765668|NCT01789879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24964796|NCT03780621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24964797|NCT03780621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24964798|NCT03780621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24964799|NCT03780621|Antiviral Agents|antiviral agents|mesh-ancestor
24964800|NCT03780621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24964801|NCT03780634|Sorafenib|sorafenib|mesh-list
24964802|NCT03780634|Antibodies|antibodies|mesh-list
24964803|NCT03780634|Immunoglobulins|immunoglobulins|mesh-list
24964804|NCT03780634|Immunologic Factors|immunologic factors|mesh-ancestor
24627089|NCT01090648|Antiviral Agents|antiviral agents|mesh-ancestor
24808458|NCT02027324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25700534|NCT02123849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25700535|NCT02123849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25700536|NCT02123849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700537|NCT02123849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25700538|NCT02123849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25700539|NCT02123849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700540|NCT02123849|Antipyretics|antipyretics|mesh-ancestor
25700541|NCT02123966|Sirolimus|sirolimus|mesh-list
25700542|NCT02123966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24970516|NCT03732547|Antiviral Agents|antiviral agents|mesh-ancestor
25078952|NCT03352115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25078954|NCT03352115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25078955|NCT03352115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25078957|NCT03352076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25078959|NCT03352076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25078960|NCT03352076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078962|NCT03351842|Carboplatin|carboplatin|mesh-list
25078964|NCT03351842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25078965|NCT03351842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25078967|NCT03351842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25078976|NCT03351686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25078977|NCT03351686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25078978|NCT03351686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25078979|NCT03351686|Hemostatics|hemostatics|mesh-ancestor
25078980|NCT03351686|Coagulants|coagulants|mesh-ancestor
25078983|NCT03351569|Immunoglobulins|immunoglobulins|mesh-list
25078984|NCT03351569|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25078985|NCT03351569|Antibodies|antibodies|mesh-list
25078986|NCT03351569|gamma-Globulins|gamma-globulins|mesh-list
25078987|NCT03351569|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24964805|NCT03780634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964806|NCT03780634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24687923|NCT03584516|Prednisone|prednisone|mesh-list
24964807|NCT03780634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24964808|NCT03780634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24964809|NCT03780634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964810|NCT03780192|Sirolimus|sirolimus|mesh-list
24964811|NCT03780192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24964812|NCT03780192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24964813|NCT03780192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24964814|NCT03780192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24964815|NCT03780192|Antifungal Agents|antifungal agents|mesh-ancestor
24964816|NCT03780192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24964817|NCT03780192|Immunologic Factors|immunologic factors|mesh-ancestor
24964818|NCT03780192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964819|NCT03780569|Temozolomide|temozolomide|mesh-list
24964820|NCT03780569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24964821|NCT03780569|Alkylating Agents|alkylating agents|mesh-ancestor
24964823|NCT03780569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24964837|NCT03780205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24964838|NCT03780361|Aflibercept|aflibercept|mesh-list
24766097|NCT01792570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24964839|NCT03780361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24964840|NCT03780361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24964841|NCT03780361|Growth Substances|growth substances|mesh-ancestor
24964842|NCT03780361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964843|NCT03780361|Growth Inhibitors|growth inhibitors|mesh-ancestor
24964844|NCT03780361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24964845|NCT03780270|Fluorides|fluorides|mesh-list
24964846|NCT03780270|Fluorides, Topical|fluorides, topical|mesh-list
24964847|NCT03780270|Cariostatic Agents|cariostatic agents|mesh-ancestor
24964848|NCT03780270|Protective Agents|protective agents|mesh-ancestor
24964849|NCT03780270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964850|NCT03780127|Fenfluramine|fenfluramine|mesh-list
24964851|NCT03780127|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24964852|NCT03780127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24964853|NCT03780127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24964854|NCT03780127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964855|NCT03780127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24964856|NCT03780127|Serotonin Agents|serotonin agents|mesh-ancestor
24964857|NCT03780127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964858|NCT03779776|Vitamins|vitamins|mesh-list
24964859|NCT03779776|Micronutrients|micronutrients|mesh-ancestor
24964867|NCT03780049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24964878|NCT03779789|Citalopram|citalopram|mesh-list
24964879|NCT03779789|Fluoxetine|fluoxetine|mesh-list
24964880|NCT03779789|Paroxetine|paroxetine|mesh-list
25700543|NCT02123966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25700544|NCT02123966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25700545|NCT02123966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700546|NCT02123966|Antifungal Agents|antifungal agents|mesh-ancestor
25700547|NCT02123966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25700548|NCT02123966|Immunologic Factors|immunologic factors|mesh-ancestor
24970713|NCT03731286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24970714|NCT03731286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964881|NCT03779789|Sertraline|sertraline|mesh-list
24964883|NCT03779789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24964884|NCT03779789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24964885|NCT03779789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964886|NCT03779789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24964888|NCT03779789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964889|NCT03779789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24964890|NCT03779789|Antidepressive Agents|antidepressive agents|mesh-ancestor
24964891|NCT03779789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24964892|NCT03779789|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24766728|NCT01796418|Beraprost|beraprost|mesh-list
24766749|NCT01796522|Progesterone|progesterone|mesh-list
24766838|NCT01796951|Antipyretics|antipyretics|mesh-ancestor
24766978|NCT01798017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24964893|NCT03779789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24964894|NCT03779789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24964895|NCT03779789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24964896|NCT03779789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24964897|NCT03779789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24964898|NCT03779789|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24964926|NCT03779451|Hormones|hormones|mesh-ancestor
24964927|NCT03779451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24964928|NCT03779451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964929|NCT03779594|Acetazolamide|acetazolamide|mesh-list
24964930|NCT03779594|Anticonvulsants|anticonvulsants|mesh-ancestor
24964931|NCT03779594|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24964932|NCT03779594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24964933|NCT03779594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964934|NCT03779594|Diuretics|diuretics|mesh-ancestor
24964935|NCT03779594|Natriuretic Agents|natriuretic agents|mesh-ancestor
24964936|NCT03779594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078988|NCT03351569|Immunologic Factors|immunologic factors|mesh-ancestor
25078989|NCT03351569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25078990|NCT03351517|Tapentadol|tapentadol|mesh-list
25078991|NCT03351517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24627028|NCT01090128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627029|NCT01090128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24627030|NCT01090128|Immunologic Factors|immunologic factors|mesh-ancestor
24627031|NCT01090128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627032|NCT01090128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24627033|NCT01090128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24627034|NCT01090128|Alkylating Agents|alkylating agents|mesh-ancestor
24627035|NCT01090128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24627036|NCT01090128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24627037|NCT01090128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24627038|NCT01090128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24627039|NCT01090128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627041|NCT01090167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24627042|NCT01090167|Antimetabolites|antimetabolites|mesh-ancestor
24627043|NCT01090167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627044|NCT01090167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24627045|NCT01090206|Vitamin D|vitamin d|mesh-list
24627046|NCT01090206|Calcium|calcium|mesh-list
24627047|NCT01090206|Vitamins|vitamins|mesh-ancestor
25700551|NCT02124044|Protease Inhibitors|protease inhibitors|mesh-ancestor
25700552|NCT02124044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700553|NCT02124044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700554|NCT02124083|Vorinostat|vorinostat|mesh-list
25700555|NCT02124083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700556|NCT02124083|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24627057|NCT01090466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964961|NCT03779659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24964981|NCT03779672|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24964982|NCT03779672|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24964984|NCT03779282|Ketamine|ketamine|mesh-list
24964985|NCT03779282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24964986|NCT03779282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24964987|NCT03779282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24964988|NCT03779282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24964989|NCT03779282|Analgesics|analgesics|mesh-ancestor
24964990|NCT03779282|Sensory System Agents|sensory system agents|mesh-ancestor
24964991|NCT03779282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24964994|NCT03779282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24964997|NCT03779282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24964998|NCT03779282|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25078996|NCT03351517|Sensory System Agents|sensory system agents|mesh-ancestor
25078997|NCT03351517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24688503|NCT03012672|Antimetabolites|antimetabolites|mesh-ancestor
25078998|NCT03351517|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25078999|NCT03351517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25079000|NCT03351517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25079001|NCT03351517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079002|NCT03351517|Adrenergic Agents|adrenergic agents|mesh-ancestor
25079003|NCT03351517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25079004|NCT03351361|Nivolumab|nivolumab|mesh-list
25079005|NCT03351361|Ipilimumab|ipilimumab|mesh-list
25079006|NCT03351361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25079007|NCT03351361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079008|NCT03351361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24965006|NCT03779360|Clindamycin phosphate|clindamycin phosphate|mesh-list
24965007|NCT03779360|Erythromycin|erythromycin|mesh-list
24965008|NCT03779360|Erythromycin Estolate|erythromycin estolate|mesh-list
24965009|NCT03779360|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24965010|NCT03779360|Erythromycin stearate|erythromycin stearate|mesh-list
24965011|NCT03779360|Prednisolone|prednisolone|mesh-list
24965013|NCT03779360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24464249|NCT00363909|Autonomic Agents|autonomic agents|mesh-ancestor
24965014|NCT03779360|Glucocorticoids|glucocorticoids|mesh-ancestor
24965015|NCT03779360|Hormones|hormones|mesh-ancestor
25700557|NCT02124083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700558|NCT02124083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700559|NCT02124161|Vaccines|vaccines|mesh-list
25700560|NCT02124161|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25700561|NCT02124161|Immunologic Factors|immunologic factors|mesh-ancestor
25700562|NCT02124161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700563|NCT02124512|Rifaximin|rifaximin|mesh-list
25700564|NCT02124512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25700565|NCT02124512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25700566|NCT02124512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25700568|NCT02124564|Anticonvulsants|anticonvulsants|mesh-ancestor
25700569|NCT02124564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25700570|NCT02124564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24965016|NCT03779360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24965017|NCT03779360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965020|NCT03779360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24965021|NCT03779360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24965022|NCT03779360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24965023|NCT03779360|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24965024|NCT03779360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700571|NCT02124564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25700572|NCT02124564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700573|NCT02124707|Paclitaxel|paclitaxel|mesh-list
25700574|NCT02124707|Carboplatin|carboplatin|mesh-list
25700575|NCT02124707|Cetuximab|cetuximab|mesh-list
24790970|NCT05409339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24790971|NCT05409339|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24790973|NCT05409339|Natriuretic Agents|natriuretic agents|mesh-ancestor
24627063|NCT01090466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627064|NCT01090466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24627065|NCT01090466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24627066|NCT01090466|Antifungal Agents|antifungal agents|mesh-ancestor
24627067|NCT01090505|Oxaliplatin|oxaliplatin|mesh-list
24627068|NCT01090505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24627069|NCT01090518|Hydrocortisone|hydrocortisone|mesh-list
24627070|NCT01090518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24627071|NCT01090596|Naproxen|naproxen|mesh-list
24627091|NCT01090661|Moxifloxacin|moxifloxacin|mesh-list
24627092|NCT01090661|Mipomersen|mipomersen|mesh-list
24627094|NCT01090661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24965103|NCT03778723|Narcotics|narcotics|mesh-ancestor
24965104|NCT03778723|Analgesics|analgesics|mesh-ancestor
24770469|NCT01820767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24965116|NCT03779061|Anesthetics|anesthetics|mesh-ancestor
24965118|NCT03778619|Rituximab|rituximab|mesh-list
24965137|NCT03778645|Epinephryl borate|epinephryl borate|mesh-list
24965138|NCT03778645|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24965139|NCT03778645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24965140|NCT03778645|Adrenergic Agents|adrenergic agents|mesh-ancestor
24965141|NCT03778645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24965142|NCT03778645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965143|NCT03778645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965144|NCT03778645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24965145|NCT03778645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24688654|NCT02810457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688655|NCT02810457|Tubulin Modulators|tubulin modulators|mesh-ancestor
24965146|NCT03778645|Autonomic Agents|autonomic agents|mesh-ancestor
24965147|NCT03778645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24965148|NCT03778645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24965151|NCT03778645|Sympathomimetics|sympathomimetics|mesh-ancestor
24965152|NCT03778645|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24965153|NCT03778450|Analgesics, Opioid|analgesics, opioid|mesh-list
24965154|NCT03778450|Analgesics|analgesics|mesh-list
24965155|NCT03778450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
24965156|NCT03778450|Narcotics|narcotics|mesh-ancestor
24965157|NCT03778450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24965158|NCT03778450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965159|NCT03778450|Sensory System Agents|sensory system agents|mesh-ancestor
24965160|NCT03778450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24965161|NCT03778359|Leuprolide|leuprolide|mesh-list
24965162|NCT03778359|Dienogest|dienogest|mesh-list
24965164|NCT03778359|Progestins|progestins|mesh-list
24627134|NCT01090700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24627135|NCT01090700|Protease Inhibitors|protease inhibitors|mesh-ancestor
24627136|NCT01090700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700576|NCT02124707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25700577|NCT02124707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700578|NCT02124707|Tubulin Modulators|tubulin modulators|mesh-ancestor
25700579|NCT02124707|Antimitotic Agents|antimitotic agents|mesh-ancestor
24965053|NCT03779191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24965054|NCT03779191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24971087|NCT03728829|Antimitotic Agents|antimitotic agents|mesh-ancestor
24971088|NCT03728829|Mitosis Modulators|mitosis modulators|mesh-ancestor
24971089|NCT03728829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971090|NCT03728829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24965055|NCT03779191|Growth Substances|growth substances|mesh-ancestor
24965056|NCT03779191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965057|NCT03779191|Growth Inhibitors|growth inhibitors|mesh-ancestor
24965059|NCT03779087|Levofloxacin|levofloxacin|mesh-list
24965060|NCT03779087|Ofloxacin|ofloxacin|mesh-list
24965061|NCT03779087|Tetracycline|tetracycline|mesh-list
24965062|NCT03779087|Esomeprazole|esomeprazole|mesh-list
24965063|NCT03779087|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24965064|NCT03779087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24965065|NCT03779087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24965066|NCT03779087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24965067|NCT03779087|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24965068|NCT03779087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24965069|NCT03779087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965070|NCT03779087|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24965071|NCT03779087|Renal Agents|renal agents|mesh-ancestor
24965072|NCT03779087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24965073|NCT03779087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25079011|NCT03351322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25079012|NCT03351322|Vasodilator Agents|vasodilator agents|mesh-ancestor
25079013|NCT03351296|Bevacizumab|bevacizumab|mesh-list
25079014|NCT03351296|Capecitabine|capecitabine|mesh-list
25079015|NCT03351296|Temozolomide|temozolomide|mesh-list
25079016|NCT03351296|Streptozocin|streptozocin|mesh-list
25079017|NCT03351296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24464251|NCT00363909|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24464252|NCT00363909|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24688656|NCT02810457|Antimitotic Agents|antimitotic agents|mesh-ancestor
24452695|NCT05457751|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24452696|NCT05457751|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24452720|NCT05457530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24452721|NCT05457530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452722|NCT05457530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25700585|NCT02124746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700586|NCT02124746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700587|NCT02124759|Sevelamer|sevelamer|mesh-list
25700588|NCT02124759|Chelating Agents|chelating agents|mesh-ancestor
25700589|NCT02124759|Sequestering Agents|sequestering agents|mesh-ancestor
25700590|NCT02124759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700591|NCT02124772|Trametinib|trametinib|mesh-list
25700592|NCT02124772|Dabrafenib|dabrafenib|mesh-list
25700593|NCT02124772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24452731|NCT05457361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24452732|NCT05457361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24452733|NCT05457361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24452734|NCT05457361|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24452735|NCT05456113|Cannabidiol|cannabidiol|mesh-list
24452736|NCT05456113|Anticonvulsants|anticonvulsants|mesh-ancestor
24464281|NCT00364000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24464282|NCT00364000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464283|NCT00364000|Chelating Agents|chelating agents|mesh-ancestor
24464284|NCT00364000|Sequestering Agents|sequestering agents|mesh-ancestor
24464285|NCT00364000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464286|NCT00364026|Darusentan|darusentan|mesh-list
24627140|NCT01090713|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24627141|NCT01090713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24650928|NCT01228422|Interferons|interferons|mesh-list
24627142|NCT01090713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24627143|NCT01090713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627144|NCT01090713|Dopamine Agents|dopamine agents|mesh-ancestor
24627145|NCT01090713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24627146|NCT01090778|Hormones|hormones|mesh-list
24627147|NCT01090778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24627148|NCT01090778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627149|NCT01090830|Paclitaxel|paclitaxel|mesh-list
24627150|NCT01090830|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24627151|NCT01090830|Bevacizumab|bevacizumab|mesh-list
24627152|NCT01090830|Carboplatin|carboplatin|mesh-list
24627153|NCT01090830|Belinostat|belinostat|mesh-list
24627154|NCT01090830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24627155|NCT01090830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24627156|NCT01090830|Tubulin Modulators|tubulin modulators|mesh-ancestor
24627157|NCT01090830|Antimitotic Agents|antimitotic agents|mesh-ancestor
24627158|NCT01090830|Mitosis Modulators|mitosis modulators|mesh-ancestor
24627159|NCT01090830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627160|NCT01090830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24965215|NCT03778541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965216|NCT03778541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965222|NCT03778593|Leucovorin|leucovorin|mesh-list
24965223|NCT03778593|Fluorouracil|fluorouracil|mesh-list
24965224|NCT03778593|Oxaliplatin|oxaliplatin|mesh-list
24965225|NCT03778593|Irinotecan|irinotecan|mesh-list
24965226|NCT03778593|Antimetabolites|antimetabolites|mesh-ancestor
24965227|NCT03778593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771583|NCT01828294|Antibodies|antibodies|mesh-list
24965274|NCT03778242|Oxytocin|oxytocin|mesh-list
24965275|NCT03778242|Oxytocics|oxytocics|mesh-ancestor
24965276|NCT03778242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24965277|NCT03778242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965278|NCT03778138|Pemetrexed|pemetrexed|mesh-list
24965279|NCT03778138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965280|NCT03778138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24965281|NCT03778138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965282|NCT03778138|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24965283|NCT03778138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24965285|NCT03777956|Anticonvulsants|anticonvulsants|mesh-ancestor
25083263|NCT03317093|Ceftobiprole|ceftobiprole|mesh-list
25083264|NCT03317093|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
25083265|NCT03317093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25083266|NCT03317093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25083267|NCT03317067|Dexmedetomidine|dexmedetomidine|mesh-list
25083268|NCT03317067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25083269|NCT03317067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25083270|NCT03317067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083271|NCT03317067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24965346|NCT03777696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24965358|NCT03777787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965360|NCT03777787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965361|NCT03777787|Sensory System Agents|sensory system agents|mesh-ancestor
24965362|NCT03777787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24965363|NCT03777644|Morphine|morphine|mesh-list
24791277|NCT04812028|Magnesium Sulfate|magnesium sulfate|mesh-list
24791278|NCT04812028|Analgesics|analgesics|mesh-ancestor
24791279|NCT04812028|Sensory System Agents|sensory system agents|mesh-ancestor
24791280|NCT04812028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24791281|NCT04812028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965364|NCT03777644|Ropivacaine|ropivacaine|mesh-list
24965365|NCT03777644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24965366|NCT03777644|Narcotics|narcotics|mesh-ancestor
24965367|NCT03777644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24965380|NCT03777605|Nitroglycerin|nitroglycerin|mesh-list
24965381|NCT03777605|Vasodilator Agents|vasodilator agents|mesh-ancestor
24965518|NCT03776279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965519|NCT03776279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24965520|NCT03776279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24965521|NCT03776279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24965522|NCT03776279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965530|NCT03776305|Imipenem|imipenem|mesh-list
24965531|NCT03776305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24965532|NCT03776305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24965533|NCT03776240|Trastuzumab|trastuzumab|mesh-list
24965534|NCT03776240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24965535|NCT03776240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894535|NCT04439786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24894536|NCT04439786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24894538|NCT04439825|Botulinum Toxins|botulinum toxins|mesh-list
24965536|NCT03776058|Cinacalcet|cinacalcet|mesh-list
24965537|NCT03776058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24965591|NCT03775902|Vasodilator Agents|vasodilator agents|mesh-ancestor
24965592|NCT03775902|Vitamin B Complex|vitamin b complex|mesh-ancestor
24965593|NCT03775902|Vitamins|vitamins|mesh-ancestor
24965594|NCT03775902|Micronutrients|micronutrients|mesh-ancestor
24791476|NCT04411940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24791477|NCT04294160|Trametinib|trametinib|mesh-list
24791478|NCT04294160|Dabrafenib|dabrafenib|mesh-list
24791479|NCT04294160|Spartalizumab|spartalizumab|mesh-list
24791480|NCT04294160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965613|NCT03775590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24965614|NCT03775590|Immunologic Factors|immunologic factors|mesh-ancestor
24965615|NCT03775590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965616|NCT03775590|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24965617|NCT03775590|Protective Agents|protective agents|mesh-ancestor
24965618|NCT03775590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965619|NCT03775746|Rivaroxaban|rivaroxaban|mesh-list
24965622|NCT03775746|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24689237|NCT01982448|Tubulin Modulators|tubulin modulators|mesh-ancestor
24965623|NCT03775746|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25700602|NCT02124811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25700603|NCT02124811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25700604|NCT02125279|Calcitriol|calcitriol|mesh-list
25700605|NCT02125279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25700606|NCT02125279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700607|NCT02125279|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25700608|NCT02125279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25700609|NCT02125279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965652|NCT03775538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965653|NCT03775538|Protective Agents|protective agents|mesh-ancestor
24464367|NCT00364442|Adrenergic Agents|adrenergic agents|mesh-ancestor
24965703|NCT03775395|Lenvatinib|lenvatinib|mesh-list
24965704|NCT03775395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965705|NCT03775395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24965706|NCT03775395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24965707|NCT03775395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965708|NCT03775356|Anesthetics|anesthetics|mesh-list
24965709|NCT03775356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24965710|NCT03775356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464368|NCT00364442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24464369|NCT00364442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464371|NCT00364455|Hematinics|hematinics|mesh-ancestor
24464372|NCT00364481|Omeprazole|omeprazole|mesh-list
24965740|NCT03774953|Vitamins|vitamins|mesh-list
24965741|NCT03774953|Micronutrients|micronutrients|mesh-ancestor
24965829|NCT03774446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24965830|NCT03774446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24965831|NCT03774446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965832|NCT03774095|Pycnogenols|pycnogenols|mesh-list
24965833|NCT03774095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24965834|NCT03774095|Immunologic Factors|immunologic factors|mesh-ancestor
24965835|NCT03774095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965836|NCT03774095|Antioxidants|antioxidants|mesh-ancestor
24965837|NCT03774095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965838|NCT03774095|Protective Agents|protective agents|mesh-ancestor
24965839|NCT03774095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24965840|NCT03773744|Cyclophosphamide|cyclophosphamide|mesh-list
24965841|NCT03773744|Pembrolizumab|pembrolizumab|mesh-list
24965842|NCT03773744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24965843|NCT03773744|Immunologic Factors|immunologic factors|mesh-ancestor
24965845|NCT03773744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24791714|NCT03496662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24791715|NCT03496662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24791716|NCT03496662|Immunologic Factors|immunologic factors|mesh-ancestor
24791717|NCT03496662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791718|NCT03496662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24791719|NCT03496662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24791721|NCT03416335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24791722|NCT03416335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791724|NCT03333005|Clotrimazole|clotrimazole|mesh-list
24966020|NCT03772054|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24966021|NCT03771820|Pembrolizumab|pembrolizumab|mesh-list
24966022|NCT03771820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25700610|NCT02125279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24503770|NCT00532818|Vasodilator Agents|vasodilator agents|mesh-ancestor
24503771|NCT00532857|Gemcitabine|gemcitabine|mesh-list
24503772|NCT00532857|Paclitaxel|paclitaxel|mesh-list
24971520|NCT03725423|Apatinib|apatinib|mesh-list
24971521|NCT03725423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24971522|NCT03725423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24971523|NCT03725423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24971524|NCT03725423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971525|NCT03725267|Melatonin|melatonin|mesh-list
24971526|NCT03725267|Antioxidants|antioxidants|mesh-ancestor
24971527|NCT03725267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966023|NCT03771820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24966024|NCT03771846|Leucovorin|leucovorin|mesh-list
24966025|NCT03771846|Gemcitabine|gemcitabine|mesh-list
24966026|NCT03771846|Fluorouracil|fluorouracil|mesh-list
24966027|NCT03771846|Oxaliplatin|oxaliplatin|mesh-list
24966031|NCT03771846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966032|NCT03771846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24966053|NCT03771755|Antipyretics|antipyretics|mesh-ancestor
24966054|NCT03771755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24966055|NCT03771755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24966056|NCT03771755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24966057|NCT03771755|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24584942|NCT00882375|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24584943|NCT00882375|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24584944|NCT00882375|Cholinergic Agents|cholinergic agents|mesh-ancestor
24584945|NCT00882375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24584946|NCT00882375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966165|NCT03770806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24966167|NCT03771053|Ezetimibe|ezetimibe|mesh-list
24966168|NCT03771053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24966169|NCT03771053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24966170|NCT03771053|Antimetabolites|antimetabolites|mesh-ancestor
24779017|NCT01873339|Midazolam|midazolam|mesh-list
24966190|NCT03770663|Alkylating Agents|alkylating agents|mesh-ancestor
24966191|NCT03770663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966192|NCT03770663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24966193|NCT03770663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24966194|NCT03770663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24965107|NCT03778723|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24965108|NCT03778723|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24965109|NCT03778723|Anesthetics, General|anesthetics, general|mesh-ancestor
24817218|NCT02082054|Ephedrine|ephedrine|mesh-list
24817219|NCT02082054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24817220|NCT02082054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24689469|NCT01464268|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24464422|NCT00364806|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24464423|NCT00364806|Dopamine Agents|dopamine agents|mesh-ancestor
24464424|NCT00364806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24464425|NCT00364806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464426|NCT00364806|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24464427|NCT00364806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24464428|NCT00364806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24464429|NCT00364806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24464430|NCT00364871|Naltrexone|naltrexone|mesh-list
24464431|NCT00364871|Bupropion|bupropion|mesh-list
25700611|NCT02125279|Vitamins|vitamins|mesh-ancestor
25700612|NCT02125279|Micronutrients|micronutrients|mesh-ancestor
25700613|NCT02125279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25700614|NCT02125292|Mesalamine|mesalamine|mesh-list
25700615|NCT02125292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25700616|NCT02125292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25700617|NCT02125292|Analgesics|analgesics|mesh-ancestor
25700618|NCT02125292|Sensory System Agents|sensory system agents|mesh-ancestor
25700619|NCT02125292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25700620|NCT02125292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700621|NCT02125292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25083298|NCT03316963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083302|NCT03316963|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25083306|NCT03316898|Donepezil|donepezil|mesh-list
25083307|NCT03316898|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25083308|NCT03316898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25083309|NCT03316898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083310|NCT03316898|Cholinergic Agents|cholinergic agents|mesh-ancestor
25083311|NCT03316898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25083312|NCT03316898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083313|NCT03316898|Nootropic Agents|nootropic agents|mesh-ancestor
25083314|NCT03316898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25083315|NCT03316898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25083316|NCT03316898|Dopamine Agents|dopamine agents|mesh-ancestor
25083317|NCT03316898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24622882|NCT01069042|Enalapril|enalapril|mesh-list
24464432|NCT00364871|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24464433|NCT00364871|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24965111|NCT03779061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24965112|NCT03779061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24965113|NCT03779061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965114|NCT03779061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24965115|NCT03779061|Anesthetics, General|anesthetics, general|mesh-ancestor
24464439|NCT00364871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24464440|NCT00364871|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24464441|NCT00364871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25079077|NCT03350633|Antimetabolites|antimetabolites|mesh-ancestor
25079104|NCT03350373|Dotinurad|dotinurad|mesh-list
25079105|NCT03350373|Uricosuric Agents|uricosuric agents|mesh-ancestor
25079106|NCT03350373|Gout Suppressants|gout suppressants|mesh-ancestor
25079107|NCT03350373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25079108|NCT03350373|Renal Agents|renal agents|mesh-ancestor
25079109|NCT03350347|Darbepoetin alfa|darbepoetin alfa|mesh-list
25079110|NCT03350347|Hematinics|hematinics|mesh-ancestor
24966273|NCT03769935|Etoposide|etoposide|mesh-list
24464467|NCT00365001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24792223|NCT05411276|Maleic acid|maleic acid|mesh-list
24792224|NCT05411276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24792225|NCT05411276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808924|NCT02029924|Insulin Lispro|insulin lispro|mesh-list
24780159|NCT01882127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24627232|NCT01091337|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24627233|NCT01091337|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24627234|NCT01091337|Adrenergic Agents|adrenergic agents|mesh-ancestor
24627235|NCT01091337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24895030|NCT05214599|Hormones|hormones|mesh-ancestor
24464468|NCT00365001|Dermatologic Agents|dermatologic agents|mesh-ancestor
24464469|NCT00365001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700622|NCT02125292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25700623|NCT02125604|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25700624|NCT02125604|Dermatologic Agents|dermatologic agents|mesh-ancestor
25700625|NCT02125604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25700626|NCT02125604|Immunologic Factors|immunologic factors|mesh-ancestor
25700627|NCT02125604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700628|NCT02125721|Penicillamine|penicillamine|mesh-list
25700629|NCT02125721|Antidotes|antidotes|mesh-ancestor
25700630|NCT02125721|Protective Agents|protective agents|mesh-ancestor
25700631|NCT02125721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700632|NCT02125721|Chelating Agents|chelating agents|mesh-ancestor
25700633|NCT02125721|Sequestering Agents|sequestering agents|mesh-ancestor
25700634|NCT02125721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700635|NCT02125721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25700636|NCT02125734|Bromides|bromides|mesh-list
25700637|NCT02125734|Tiotropium Bromide|tiotropium bromide|mesh-list
24464470|NCT00365001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25700638|NCT02125734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24971674|NCT03723395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24971675|NCT03723395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24971677|NCT03723395|Antimetabolites|antimetabolites|mesh-ancestor
24464471|NCT00365001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24464472|NCT00365001|Immunologic Factors|immunologic factors|mesh-ancestor
24464484|NCT00365040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464486|NCT00365040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464487|NCT00365170|Insulin|insulin|mesh-list
24464488|NCT00365170|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24464499|NCT00365183|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24464500|NCT00365183|Dermatologic Agents|dermatologic agents|mesh-ancestor
24464501|NCT00365222|Temozolomide|temozolomide|mesh-list
24464502|NCT00365222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24464522|NCT00365287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24464523|NCT00365287|Antimetabolites|antimetabolites|mesh-ancestor
24464524|NCT00365287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464525|NCT00365287|Antifungal Agents|antifungal agents|mesh-ancestor
24464527|NCT00365287|Dermatologic Agents|dermatologic agents|mesh-ancestor
24464528|NCT00365287|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24464529|NCT00365287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24464530|NCT00365287|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24464531|NCT00365287|Antitubercular Agents|antitubercular agents|mesh-ancestor
24464532|NCT00365287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24464540|NCT00365313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464541|NCT00365313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24464542|NCT00365313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24464543|NCT00365313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24464544|NCT00365313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24464545|NCT00365313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627236|NCT01091337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627237|NCT01091337|Sympathomimetics|sympathomimetics|mesh-ancestor
24627238|NCT01091376|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24627239|NCT01091376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24627240|NCT01091376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24966282|NCT03769870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24966283|NCT03769870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24966284|NCT03769870|Antimetabolites|antimetabolites|mesh-ancestor
24966285|NCT03769870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966286|NCT03769870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24966287|NCT03769870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24966288|NCT03769870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25079122|NCT03350334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24966290|NCT03769818|Dexamethasone acetate|dexamethasone acetate|mesh-list
24966291|NCT03769818|Bupivacaine|bupivacaine|mesh-list
24966293|NCT03769818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24966294|NCT03769818|Antiemetics|antiemetics|mesh-ancestor
24966295|NCT03769818|Autonomic Agents|autonomic agents|mesh-ancestor
24966296|NCT03769818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24690038|NCT01398618|Isoniazid|isoniazid|mesh-list
24464577|NCT00365339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24464578|NCT00365339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24464579|NCT00365339|Serotonin Agents|serotonin agents|mesh-ancestor
24464580|NCT00365339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24464581|NCT00365339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24464582|NCT00365339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24464583|NCT00365339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24464584|NCT00365339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24464585|NCT00365339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24966401|NCT03768531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966402|NCT03768518|Exenatide|exenatide|mesh-list
24966403|NCT03768518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24966404|NCT03768518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966405|NCT03768518|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24966406|NCT03768518|Incretins|incretins|mesh-ancestor
24464680|NCT00365898|Sensory System Agents|sensory system agents|mesh-ancestor
24464681|NCT00365898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24464682|NCT00365924|Teriparatide|teriparatide|mesh-list
25700639|NCT02125734|Autonomic Agents|autonomic agents|mesh-ancestor
25700640|NCT02125734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25700641|NCT02125734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971864|NCT03721874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24971866|NCT03721757|Nivolumab|nivolumab|mesh-list
24971928|NCT03721627|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
24971929|NCT03721627|Antiviral Agents|antiviral agents|mesh-ancestor
24971930|NCT03721627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24971933|NCT03721614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24971934|NCT03721614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24464684|NCT00365924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464685|NCT00365924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24464686|NCT00365937|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
24464687|NCT00365937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
24464688|NCT00365937|Immunologic Factors|immunologic factors|mesh-ancestor
24464689|NCT00365937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464690|NCT00365950|Warfarin|warfarin|mesh-list
24966409|NCT03768427|Atorvastatin|atorvastatin|mesh-list
24966410|NCT03768427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24966411|NCT03768427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24966412|NCT03768427|Antimetabolites|antimetabolites|mesh-ancestor
24966413|NCT03768427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966414|NCT03768427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24966415|NCT03768427|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24966416|NCT03768427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24895115|NCT05014919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24464691|NCT00365950|Anticoagulants|anticoagulants|mesh-ancestor
24464692|NCT00366002|Darifenacin|darifenacin|mesh-list
24464693|NCT00366002|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24464694|NCT00366002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24464695|NCT00366002|Cholinergic Agents|cholinergic agents|mesh-ancestor
24464696|NCT00366002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24464697|NCT00366002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464698|NCT00366002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464699|NCT00366002|Urological Agents|urological agents|mesh-ancestor
24464700|NCT00366067|Phenytoin|phenytoin|mesh-list
24464701|NCT00366067|Anticonvulsants|anticonvulsants|mesh-ancestor
24464723|NCT00366262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24464724|NCT00366262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24464727|NCT00366262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24464728|NCT00366262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464729|NCT00366262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24464753|NCT00366652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25700642|NCT02125734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25700643|NCT02125734|Respiratory System Agents|respiratory system agents|mesh-ancestor
25700644|NCT02125734|Parasympatholytics|parasympatholytics|mesh-ancestor
25700645|NCT02125734|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25700646|NCT02125734|Cholinergic Agents|cholinergic agents|mesh-ancestor
25700647|NCT02125734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25700648|NCT02125734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700649|NCT02125734|Anticonvulsants|anticonvulsants|mesh-ancestor
25700650|NCT02125877|Deferasirox|deferasirox|mesh-list
25700651|NCT02125877|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25700652|NCT02125877|Chelating Agents|chelating agents|mesh-ancestor
25700653|NCT02125877|Sequestering Agents|sequestering agents|mesh-ancestor
25700654|NCT02125877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700655|NCT02126839|Albuterol|albuterol|mesh-list
24971991|NCT03720899|Autonomic Agents|autonomic agents|mesh-ancestor
24971992|NCT03720899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24971993|NCT03720899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464758|NCT00366652|Sensory System Agents|sensory system agents|mesh-ancestor
24464759|NCT00366652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24966460|NCT03767920|Glucocorticoids|glucocorticoids|mesh-ancestor
24966461|NCT03767920|Hormones|hormones|mesh-ancestor
24464783|NCT00366834|Glucocorticoids|glucocorticoids|mesh-ancestor
24464784|NCT00366834|Hormones|hormones|mesh-ancestor
24966499|NCT03767335|Fulvestrant|fulvestrant|mesh-list
24464785|NCT00366834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24464786|NCT00366834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24464787|NCT00366834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24464788|NCT00366834|Protease Inhibitors|protease inhibitors|mesh-ancestor
24464789|NCT00366834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464790|NCT00366834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464791|NCT00366834|Antipruritics|antipruritics|mesh-ancestor
24464792|NCT00366834|Dermatologic Agents|dermatologic agents|mesh-ancestor
24464793|NCT00366834|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24966462|NCT03767920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24966463|NCT03767920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24966464|NCT03767920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24966465|NCT03767920|Protease Inhibitors|protease inhibitors|mesh-ancestor
24966466|NCT03767920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966467|NCT03767920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966468|NCT03767920|Anesthetics, Local|anesthetics, local|mesh-ancestor
24966469|NCT03767920|Anesthetics|anesthetics|mesh-ancestor
24966470|NCT03767920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24966496|NCT03767439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24792415|NCT05223075|Sensory System Agents|sensory system agents|mesh-ancestor
24792416|NCT05223075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24792417|NCT05223075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24792418|NCT05223075|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24627243|NCT01091415|Calcium|calcium|mesh-list
24651351|NCT01231139|Antipyretics|antipyretics|mesh-ancestor
24627244|NCT01091415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24627245|NCT01091415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627246|NCT01091493|Moxifloxacin|moxifloxacin|mesh-list
24627247|NCT01091493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24627248|NCT01091493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25700656|NCT02126839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25700657|NCT02126839|Autonomic Agents|autonomic agents|mesh-ancestor
25700658|NCT02126839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25700659|NCT02126839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700660|NCT02126839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25700661|NCT02126839|Respiratory System Agents|respiratory system agents|mesh-ancestor
25700662|NCT02126839|Tocolytic Agents|tocolytic agents|mesh-ancestor
25700663|NCT02126839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25700664|NCT02126839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24627256|NCT01091571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627257|NCT01091571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627258|NCT01091571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24627259|NCT01091571|Vasodilator Agents|vasodilator agents|mesh-ancestor
24627260|NCT01091649|Ritonavir|ritonavir|mesh-list
24966497|NCT03767439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966498|NCT03767335|Trastuzumab|trastuzumab|mesh-list
24966500|NCT03767335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25079123|NCT03350334|Dopamine Agents|dopamine agents|mesh-ancestor
24966501|NCT03767335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24966502|NCT03767335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24966510|NCT03767322|Antimetabolites|antimetabolites|mesh-ancestor
24966511|NCT03767322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464921|NCT00367302|Sensory System Agents|sensory system agents|mesh-ancestor
24464923|NCT00367302|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24966512|NCT03767322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966513|NCT03767322|Gout Suppressants|gout suppressants|mesh-ancestor
24966514|NCT03767322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24966515|NCT03767322|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24966516|NCT03767322|Antioxidants|antioxidants|mesh-ancestor
24966517|NCT03767322|Protective Agents|protective agents|mesh-ancestor
24966518|NCT03767322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966519|NCT03767296|Phenylephrine|phenylephrine|mesh-list
24966520|NCT03767296|Oxymetazoline|oxymetazoline|mesh-list
24966521|NCT03767296|Ephedrine|ephedrine|mesh-list
24966522|NCT03767296|Pseudoephedrine|pseudoephedrine|mesh-list
24966523|NCT03767296|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24966528|NCT03767296|Sympathomimetics|sympathomimetics|mesh-ancestor
24966529|NCT03767296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24966530|NCT03767296|Nasal Decongestants|nasal decongestants|mesh-ancestor
24966531|NCT03767296|Respiratory System Agents|respiratory system agents|mesh-ancestor
24966532|NCT03767296|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24966533|NCT03767296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24966534|NCT03767296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24966535|NCT03767296|Adrenergic Agents|adrenergic agents|mesh-ancestor
24966536|NCT03767296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24966537|NCT03767296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966538|NCT03767296|Protective Agents|protective agents|mesh-ancestor
24966539|NCT03767296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24966540|NCT03767296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24453178|NCT05238831|Vemurafenib|vemurafenib|mesh-list
24966549|NCT03767036|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25700665|NCT02126839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24972223|NCT03719391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24972224|NCT03719391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972225|NCT03719391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24972226|NCT03719391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24972227|NCT03719391|Cholinergic Agents|cholinergic agents|mesh-ancestor
24972228|NCT03719391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24972229|NCT03719391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700666|NCT02126839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25700667|NCT02126839|Adrenergic Agents|adrenergic agents|mesh-ancestor
25700668|NCT02126839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25700669|NCT02126839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700670|NCT02127125|Sevelamer|sevelamer|mesh-list
24972230|NCT03719313|Interferons|interferons|mesh-list
24972231|NCT03719313|Ritonavir|ritonavir|mesh-list
24504053|NCT00533923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24504054|NCT00533923|Dermatologic Agents|dermatologic agents|mesh-ancestor
24504055|NCT00533923|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24504056|NCT00533923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24504078|NCT00533936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24504079|NCT00533936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504080|NCT00533936|Antimetabolites|antimetabolites|mesh-ancestor
24504081|NCT00533936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24504082|NCT00533936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24504084|NCT00533962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24504085|NCT00533962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24504086|NCT00533962|Growth Substances|growth substances|mesh-ancestor
24966550|NCT03767036|Tramadol|tramadol|mesh-list
24966551|NCT03767036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24966552|NCT03767036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24966553|NCT03767036|Analgesics|analgesics|mesh-ancestor
24966554|NCT03767036|Sensory System Agents|sensory system agents|mesh-ancestor
24966559|NCT03767036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24966560|NCT03767036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966561|NCT03767036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966562|NCT03767036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24966564|NCT03767036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24966565|NCT03766997|Hydrocortisone|hydrocortisone|mesh-list
24966593|NCT03766893|Buprenorphine|buprenorphine|mesh-list
24966594|NCT03766893|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
24965172|NCT03778359|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24965173|NCT03778359|Fertility Agents|fertility agents|mesh-ancestor
25700671|NCT02127125|Chelating Agents|chelating agents|mesh-ancestor
25700672|NCT02127125|Sequestering Agents|sequestering agents|mesh-ancestor
25700673|NCT02127125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709548|NCT02269241|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25709549|NCT02269241|Hormone Antagonists|hormone antagonists|mesh-ancestor
25709550|NCT02269241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25709551|NCT02269241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709552|NCT02269241|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25709553|NCT02269241|Diuretics|diuretics|mesh-ancestor
25709554|NCT02269241|Natriuretic Agents|natriuretic agents|mesh-ancestor
25709555|NCT02269943|Azacitidine|azacitidine|mesh-list
25709556|NCT02269943|Cc-486|cc-486|mesh-list
25709557|NCT02269943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25709558|NCT02269943|Antimetabolites|antimetabolites|mesh-ancestor
25709559|NCT02269943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709560|NCT02269943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25709561|NCT02269943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709562|NCT02270242|Aspirin|aspirin|mesh-list
25709563|NCT02270242|Ticagrelor|ticagrelor|mesh-list
25709564|NCT02270242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25709565|NCT02270242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25709566|NCT02270242|Analgesics|analgesics|mesh-ancestor
24965174|NCT03778359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24965175|NCT03778359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965176|NCT03778359|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24965178|NCT03778359|Hormone Antagonists|hormone antagonists|mesh-ancestor
25079124|NCT03350321|Darbepoetin alfa|darbepoetin alfa|mesh-list
25079125|NCT03350321|Hematinics|hematinics|mesh-ancestor
25079126|NCT03350295|Nifurtimox|nifurtimox|mesh-list
24464971|NCT00367471|Trastuzumab|trastuzumab|mesh-list
24464972|NCT00367471|Lapatinib|lapatinib|mesh-list
24464974|NCT00367471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24453201|NCT05238831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24453202|NCT05238831|Antimetabolites|antimetabolites|mesh-ancestor
24464992|NCT00367497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24453220|NCT05226299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079128|NCT03350295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25079129|NCT03350295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25079130|NCT03350295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25079131|NCT03350191|Exenatide|exenatide|mesh-list
25079132|NCT03350191|Glucagon|glucagon|mesh-list
25079133|NCT03350191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25079135|NCT03350191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25079136|NCT03350191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079137|NCT03350191|Incretins|incretins|mesh-ancestor
25079138|NCT03350191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25079139|NCT03350191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25079140|NCT03350126|Nivolumab|nivolumab|mesh-list
25079141|NCT03350126|Ipilimumab|ipilimumab|mesh-list
25079142|NCT03350126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25079143|NCT03350126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079144|NCT03350126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25079145|NCT03350126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079154|NCT03349866|Oxaliplatin|oxaliplatin|mesh-list
25079155|NCT03349866|Apatinib|apatinib|mesh-list
25079156|NCT03349866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25079157|NCT03349866|Antimetabolites|antimetabolites|mesh-ancestor
25079191|NCT03349606|FLB 457|flb 457|mesh-list
25079192|NCT03349606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25079193|NCT03349606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079194|NCT03349606|Sympathomimetics|sympathomimetics|mesh-ancestor
24966595|NCT03766893|Naloxone|naloxone|mesh-list
24966596|NCT03766893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25700677|NCT02127372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700678|NCT02127372|Tubulin Modulators|tubulin modulators|mesh-ancestor
25700679|NCT02127372|Antimitotic Agents|antimitotic agents|mesh-ancestor
25700680|NCT02127372|Mitosis Modulators|mitosis modulators|mesh-ancestor
25700681|NCT02127372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700682|NCT02127372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25700683|NCT02127372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700684|NCT02127970|Dalbavancin|dalbavancin|mesh-list
24966597|NCT03766893|Narcotics|narcotics|mesh-ancestor
24966669|NCT03766594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966671|NCT03766490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24966672|NCT03766490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24966673|NCT03766490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966674|NCT03766490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966675|NCT03766425|Aflibercept|aflibercept|mesh-list
24966676|NCT03766425|Mitomycins|mitomycins|mesh-list
24966677|NCT03766425|Mitomycin|mitomycin|mesh-list
24627169|NCT01090882|Anesthetics, Local|anesthetics, local|mesh-ancestor
24966678|NCT03766425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24966679|NCT03766425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24966680|NCT03766425|Growth Substances|growth substances|mesh-ancestor
24966681|NCT03766425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966682|NCT03766425|Growth Inhibitors|growth inhibitors|mesh-ancestor
24966683|NCT03766425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24966684|NCT03766425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24966685|NCT03766425|Alkylating Agents|alkylating agents|mesh-ancestor
24966686|NCT03766425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966687|NCT03766425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24966712|NCT03765944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24966713|NCT03765944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24966714|NCT03765944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24966715|NCT03765944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612118|NCT01012011|Sorafenib|sorafenib|mesh-list
24966816|NCT03764683|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
24966817|NCT03764683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24966818|NCT03764683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966819|NCT03764605|Metformin|metformin|mesh-list
24966820|NCT03764605|Tolvaptan|tolvaptan|mesh-list
24966821|NCT03764605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24966822|NCT03764605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966823|NCT03764605|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25700685|NCT02127970|Teicoplanin|teicoplanin|mesh-list
24465102|NCT00367913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24465113|NCT00367913|Antitubercular Agents|antitubercular agents|mesh-ancestor
24465172|NCT00368121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24465222|NCT00368303|Serotonin Agents|serotonin agents|mesh-ancestor
24465223|NCT00368303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465224|NCT00368303|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24465225|NCT00368303|Antidepressive Agents|antidepressive agents|mesh-ancestor
24465226|NCT00368303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24465229|NCT00368303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966900|NCT03764280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24966901|NCT03764280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966903|NCT03764267|Remifentanil|remifentanil|mesh-list
24966904|NCT03764267|Anesthetics|anesthetics|mesh-list
24966905|NCT03764267|Anesthetics, General|anesthetics, general|mesh-list
24966906|NCT03764267|Anesthetics, Local|anesthetics, local|mesh-ancestor
24966907|NCT03764267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24465234|NCT00368329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700686|NCT02127970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25700687|NCT02127970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25700688|NCT02128217|Ribavirin|ribavirin|mesh-list
25700689|NCT02128217|Sofosbuvir|sofosbuvir|mesh-list
25700690|NCT02128217|Ledipasvir|ledipasvir|mesh-list
25700691|NCT02128217|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25700692|NCT02128217|Antimetabolites|antimetabolites|mesh-ancestor
25700693|NCT02128217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700694|NCT02128217|Antiviral Agents|antiviral agents|mesh-ancestor
25700695|NCT02128217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25700696|NCT02128230|Thalidomide|thalidomide|mesh-list
25700697|NCT02128230|Dexamethasone|dexamethasone|mesh-list
24966976|NCT03763760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25700698|NCT02128230|Dexamethasone acetate|dexamethasone acetate|mesh-list
24966977|NCT03763760|Glucocorticoids|glucocorticoids|mesh-ancestor
24966979|NCT03763760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24966980|NCT03763760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24966981|NCT03763760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24966982|NCT03763734|Dexamethasone|dexamethasone|mesh-list
24966983|NCT03763734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24627170|NCT01090882|Anesthetics|anesthetics|mesh-ancestor
24627171|NCT01090882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24627172|NCT01090882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627180|NCT01090895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627181|NCT01090895|Protective Agents|protective agents|mesh-ancestor
24627182|NCT01090908|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24627183|NCT01090908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24627184|NCT01091012|Sildenafil Citrate|sildenafil citrate|mesh-list
24627185|NCT01091012|Vasodilator Agents|vasodilator agents|mesh-ancestor
24627186|NCT01091012|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24627187|NCT01091012|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24965193|NCT03778281|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24965194|NCT03778281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965195|NCT03778281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25079196|NCT03349606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24895520|NCT03970356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24895529|NCT03905265|Moxidectin|moxidectin|mesh-list
24895530|NCT03905265|Anthelmintics|anthelmintics|mesh-ancestor
24895531|NCT03905265|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24895532|NCT03905265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24895533|NCT03905265|Antinematodal Agents|antinematodal agents|mesh-ancestor
24895534|NCT03900949|Cytarabine|cytarabine|mesh-list
24966991|NCT03763734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24966992|NCT03763734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24966993|NCT03763734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24966994|NCT03763669|Folic Acid|folic acid|mesh-list
24966995|NCT03763669|Vitamin B Complex|vitamin b complex|mesh-list
24967024|NCT03763279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24967025|NCT03763279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24967026|NCT03763279|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24792891|NCT04475016|Alkylating Agents|alkylating agents|mesh-ancestor
24967053|NCT03763110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24967054|NCT03763110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24967055|NCT03763110|Antitubercular Agents|antitubercular agents|mesh-ancestor
24967057|NCT03763084|Sufentanil|sufentanil|mesh-list
24967058|NCT03763084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24967059|NCT03763084|Analgesics|analgesics|mesh-ancestor
24967060|NCT03763084|Sensory System Agents|sensory system agents|mesh-ancestor
24967061|NCT03763084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25700699|NCT02128230|Cyclophosphamide|cyclophosphamide|mesh-list
25700700|NCT02128230|Melphalan|melphalan|mesh-list
25700701|NCT02128230|Cisplatin|cisplatin|mesh-list
25700702|NCT02128230|Doxorubicin|doxorubicin|mesh-list
25700703|NCT02128230|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25700704|NCT02128230|Etoposide|etoposide|mesh-list
25700705|NCT02128230|Etoposide phosphate|etoposide phosphate|mesh-list
25700706|NCT02128230|Lenalidomide|lenalidomide|mesh-list
25700707|NCT02128230|Lenograstim|lenograstim|mesh-list
25700708|NCT02128230|BB 1101|bb 1101|mesh-list
25700709|NCT02128230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25700710|NCT02128230|Immunologic Factors|immunologic factors|mesh-ancestor
24967062|NCT03763084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692851|NCT01416948|Methylphenidate|methylphenidate|mesh-list
24967064|NCT03763084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24967065|NCT03763084|Narcotics|narcotics|mesh-ancestor
24786162|NCT01918254|Pertuzumab|pertuzumab|mesh-list
24627261|NCT01091649|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24627262|NCT01091649|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24627263|NCT01091649|Protease Inhibitors|protease inhibitors|mesh-ancestor
24627264|NCT01091649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627265|NCT01091649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627266|NCT01091649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24627267|NCT01091649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24627268|NCT01091649|Antiviral Agents|antiviral agents|mesh-ancestor
24627269|NCT01091649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24627270|NCT01091649|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24627271|NCT01091649|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24627272|NCT01091701|Plasma-lyte 148|plasma-lyte 148|mesh-list
24627273|NCT01091701|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24627274|NCT01091701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24627275|NCT01091727|Botulinum Toxins|botulinum toxins|mesh-list
24627276|NCT01091727|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24627277|NCT01091727|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24627278|NCT01091727|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24895568|NCT03878199|Daunorubicin|daunorubicin|mesh-list
24465370|NCT00369252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24465371|NCT00369252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465372|NCT00369291|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
24465373|NCT00369291|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24465374|NCT00369291|Immunologic Factors|immunologic factors|mesh-ancestor
24465375|NCT00369291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465377|NCT00369356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24465378|NCT00369356|Glucocorticoids|glucocorticoids|mesh-ancestor
24465379|NCT00369356|Hormones|hormones|mesh-ancestor
24465406|NCT00369447|Nimotuzumab|nimotuzumab|mesh-list
24465408|NCT00369447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967094|NCT03762928|GABA Agents|gaba agents|mesh-ancestor
24967095|NCT03762928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24967096|NCT03762928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967097|NCT03762928|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24967098|NCT03762928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24967099|NCT03762928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24967152|NCT03762382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24967153|NCT03762382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24967154|NCT03762382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967155|NCT03762382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24967156|NCT03762382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24967157|NCT03762382|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24967158|NCT03762382|Contraceptive Agents|contraceptive agents|mesh-ancestor
24967159|NCT03762382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24967160|NCT03762382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967161|NCT03762382|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24967210|NCT03761485|Fluorides|fluorides|mesh-list
24967211|NCT03761485|Cariostatic Agents|cariostatic agents|mesh-ancestor
24967212|NCT03761485|Protective Agents|protective agents|mesh-ancestor
24967215|NCT03761472|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24967216|NCT03761472|Immunologic Factors|immunologic factors|mesh-ancestor
24967217|NCT03761472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967218|NCT03761472|Viscosupplements|viscosupplements|mesh-ancestor
24967219|NCT03761472|Protective Agents|protective agents|mesh-ancestor
24967220|NCT03761329|Lidocaine|lidocaine|mesh-list
24967221|NCT03761329|Anesthetics|anesthetics|mesh-list
24967222|NCT03761329|Anesthetics, Local|anesthetics, local|mesh-ancestor
24693090|NCT01418157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967223|NCT03761329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24967224|NCT03761329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967225|NCT03761329|Sensory System Agents|sensory system agents|mesh-ancestor
24967226|NCT03761329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24967227|NCT03761329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24967228|NCT03761329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24967229|NCT03761329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24967230|NCT03761329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24967233|NCT03761264|Zinc Oxide|zinc oxide|mesh-list
24472694|NCT00400231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24895644|NCT03675893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587819|NCT00897221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587821|NCT00897312|Ribavirin|ribavirin|mesh-list
24587822|NCT00897312|Interferon-alpha|interferon-alpha|mesh-list
24587823|NCT00897312|Tremelimumab|tremelimumab|mesh-list
24587824|NCT00897312|Infliximab|infliximab|mesh-list
24587825|NCT00897312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587826|NCT00897312|Antiviral Agents|antiviral agents|mesh-ancestor
24587827|NCT00897312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24973253|NCT03710434|Lansoprazole|lansoprazole|mesh-list
24895645|NCT03675893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895646|NCT03675893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24895647|NCT03675893|Hormone Antagonists|hormone antagonists|mesh-ancestor
24895648|NCT03675893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24895650|NCT03643367|Propofol|propofol|mesh-list
24465477|NCT00369811|Anesthetics, General|anesthetics, general|mesh-ancestor
24465478|NCT00369811|Anesthetics|anesthetics|mesh-ancestor
24465479|NCT00369837|Clevidipine|clevidipine|mesh-list
24465480|NCT00369837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24465481|NCT00369837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24465482|NCT00369837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465523|NCT00369993|Xhance|xhance|mesh-list
24465524|NCT00369993|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24793810|NCT02205047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24793811|NCT02205047|Immunologic Factors|immunologic factors|mesh-ancestor
24793812|NCT02205047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793813|NCT02205047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24793814|NCT02192359|Irinotecan|irinotecan|mesh-list
24793815|NCT02192359|Camptothecin|camptothecin|mesh-list
24793816|NCT02192359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24793817|NCT02192359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24793818|NCT02192359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24793819|NCT02192359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793820|NCT02192359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793821|NCT02192359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24793822|NCT02167477|Pyrithione zinc|pyrithione zinc|mesh-list
24793823|NCT02167477|Keratolytic Agents|keratolytic agents|mesh-ancestor
24465525|NCT00369993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24465526|NCT00369993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24465527|NCT00369993|Autonomic Agents|autonomic agents|mesh-ancestor
24465528|NCT00369993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24465529|NCT00369993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465530|NCT00369993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24465531|NCT00369993|Respiratory System Agents|respiratory system agents|mesh-ancestor
24465533|NCT00369993|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24465535|NCT00369993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24465536|NCT00369993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24465537|NCT00369993|Adrenergic Agents|adrenergic agents|mesh-ancestor
24465538|NCT00369993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24465539|NCT00369993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465540|NCT00370019|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24465541|NCT00370019|Medroxyprogesterone|medroxyprogesterone|mesh-list
24465543|NCT00370019|Estrogens|estrogens|mesh-ancestor
24465545|NCT00370019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24465546|NCT00370019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465547|NCT00370019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24627312|NCT01091818|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24627313|NCT01091818|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24627314|NCT01091818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24627384|NCT01092520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627385|NCT01092520|Anticonvulsants|anticonvulsants|mesh-ancestor
24790300|NCT01941966|Capecitabine|capecitabine|mesh-list
24627424|NCT01092624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24465592|NCT00370240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25700711|NCT02128230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700712|NCT02128230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25700713|NCT02128230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25700714|NCT02128230|Alkylating Agents|alkylating agents|mesh-ancestor
25700715|NCT02128230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700716|NCT02128230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700717|NCT02128230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25700718|NCT02128230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24465681|NCT00370539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24465682|NCT00370539|Glucocorticoids|glucocorticoids|mesh-ancestor
24795325|NCT03052933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465688|NCT00370539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465690|NCT00370539|Dermatologic Agents|dermatologic agents|mesh-ancestor
24465692|NCT00370565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24465693|NCT00370565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24465694|NCT00370565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465695|NCT00370591|Fluticasone|fluticasone|mesh-list
24465696|NCT00370591|Xhance|xhance|mesh-list
24465723|NCT00370630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465726|NCT00370630|Glucocorticoids|glucocorticoids|mesh-ancestor
24465728|NCT00370630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24465729|NCT00370643|Insulin|insulin|mesh-list
24465730|NCT00370643|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24465731|NCT00370643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24465732|NCT00370643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465733|NCT00370656|Pregabalin|pregabalin|mesh-list
24465734|NCT00370656|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24465735|NCT00370656|Amitriptyline|amitriptyline|mesh-list
24465736|NCT00370656|Analgesics|analgesics|mesh-ancestor
24465737|NCT00370656|Sensory System Agents|sensory system agents|mesh-ancestor
24465738|NCT00370656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24465741|NCT00370656|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24465743|NCT00370656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465744|NCT00370656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24465745|NCT00370656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24465746|NCT00370656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24465747|NCT00370656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24465754|NCT00370656|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24465755|NCT00370656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24465756|NCT00370656|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24465757|NCT00370656|Adrenergic Agents|adrenergic agents|mesh-ancestor
24465758|NCT00370669|Triamcinolone|triamcinolone|mesh-list
24465759|NCT00370669|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24465837|NCT00370786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24465838|NCT00370786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24627477|NCT01092975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24627478|NCT01092975|Nasal Decongestants|nasal decongestants|mesh-ancestor
24627479|NCT01092975|Respiratory System Agents|respiratory system agents|mesh-ancestor
24627480|NCT01092975|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24627481|NCT01092975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24627482|NCT01092975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24627483|NCT01092975|Adrenergic Agents|adrenergic agents|mesh-ancestor
24627484|NCT01092975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24627485|NCT01092975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627486|NCT01092975|Protective Agents|protective agents|mesh-ancestor
24627540|NCT01093261|Fludrocortisone|fludrocortisone|mesh-list
24627541|NCT01093261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24627542|NCT01093274|Picosulfate sodium|picosulfate sodium|mesh-list
24627544|NCT01093274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24654706|NCT01251107|Prednisone|prednisone|mesh-list
24627547|NCT01093300|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24895774|NCT03060434|Ibuprofen|ibuprofen|mesh-list
24465839|NCT00370786|Growth Substances|growth substances|mesh-ancestor
24465840|NCT00370786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465841|NCT00370786|Growth Inhibitors|growth inhibitors|mesh-ancestor
24465842|NCT00370799|Betamethasone|betamethasone|mesh-list
24465843|NCT00370799|Betamethasone Valerate|betamethasone valerate|mesh-list
24465844|NCT00370799|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24465845|NCT00370799|Betamethasone benzoate|betamethasone benzoate|mesh-list
24465846|NCT00370799|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24465847|NCT00370799|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24465848|NCT00370799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24465849|NCT00370799|Glucocorticoids|glucocorticoids|mesh-ancestor
24465850|NCT00370799|Hormones|hormones|mesh-ancestor
24465851|NCT00370799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24465852|NCT00370799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465859|NCT00370825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24465860|NCT00370825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24465861|NCT00370825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465862|NCT00370851|Bevacizumab|bevacizumab|mesh-list
24465863|NCT00370851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24465872|NCT00370968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465874|NCT00371007|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24465875|NCT00371007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24627548|NCT01093300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654888|NCT01251926|Bevacizumab|bevacizumab|mesh-list
24627549|NCT01093300|Tubulin Modulators|tubulin modulators|mesh-ancestor
24627550|NCT01093300|Antimitotic Agents|antimitotic agents|mesh-ancestor
24627551|NCT01093300|Mitosis Modulators|mitosis modulators|mesh-ancestor
24627552|NCT01093300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627553|NCT01093300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24627556|NCT01093365|Varenicline|varenicline|mesh-list
24627572|NCT01093768|Hemostatics|hemostatics|mesh-ancestor
24627573|NCT01093768|Coagulants|coagulants|mesh-ancestor
24627574|NCT01093768|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24627575|NCT01093768|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24655159|NCT00660673|Levodopa|levodopa|mesh-list
24965232|NCT03778593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965233|NCT03778593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24965234|NCT03778593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24965235|NCT03778593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24965237|NCT03778593|Protective Agents|protective agents|mesh-ancestor
24965238|NCT03778593|Vitamin B Complex|vitamin b complex|mesh-ancestor
24965239|NCT03778593|Vitamins|vitamins|mesh-ancestor
24465903|NCT00371033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24465937|NCT00371124|Respiratory System Agents|respiratory system agents|mesh-ancestor
24465939|NCT00371124|Parasympatholytics|parasympatholytics|mesh-ancestor
24465940|NCT00371124|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24465941|NCT00371124|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24465942|NCT00371124|Cholinergic Agents|cholinergic agents|mesh-ancestor
24465943|NCT00371124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24465944|NCT00371124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465945|NCT00371306|Metformin|metformin|mesh-list
24465946|NCT00371306|Glyburide|glyburide|mesh-list
24465971|NCT00371410|Glucocorticoids|glucocorticoids|mesh-ancestor
24465972|NCT00371410|Hormones|hormones|mesh-ancestor
24465973|NCT00371410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24465974|NCT00371410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465975|NCT00371410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24965240|NCT03778593|Micronutrients|micronutrients|mesh-ancestor
24965241|NCT03778008|Vitamin B 12|vitamin b 12|mesh-list
24965242|NCT03778008|Gentamicins|gentamicins|mesh-list
24965243|NCT03778008|Dexamethasone|dexamethasone|mesh-list
24965244|NCT03778008|Lidocaine|lidocaine|mesh-list
24965245|NCT03778008|Mitogens|mitogens|mesh-list
24965246|NCT03778008|Vitamins|vitamins|mesh-ancestor
24965247|NCT03778008|Micronutrients|micronutrients|mesh-ancestor
24965248|NCT03778008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466015|NCT00371527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24965257|NCT03778008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24627580|NCT01093807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24627581|NCT01093807|Protease Inhibitors|protease inhibitors|mesh-ancestor
24627582|NCT01093807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627583|NCT01093807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627584|NCT01093807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24627585|NCT01093807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24627586|NCT01093807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24627587|NCT01093807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24627588|NCT01093807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627589|NCT01093820|Epoetin Alfa|epoetin alfa|mesh-list
24627590|NCT01093820|Hematinics|hematinics|mesh-ancestor
24627591|NCT01093937|Varenicline|varenicline|mesh-list
24796921|NCT01953172|Antioxidants|antioxidants|mesh-ancestor
24466016|NCT00371527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466018|NCT00371553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466019|NCT00371553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24466020|NCT00371553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24466021|NCT00371553|Growth Substances|growth substances|mesh-ancestor
24466022|NCT00371553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466023|NCT00371553|Growth Inhibitors|growth inhibitors|mesh-ancestor
24466024|NCT00371553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24932212|NCT04081909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24932214|NCT04081909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794614|NCT04875715|Hydroquinone|hydroquinone|mesh-list
24794615|NCT04875715|Antioxidants|antioxidants|mesh-ancestor
24466025|NCT00371553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466026|NCT00371553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466027|NCT00371579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24466028|NCT00371579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24466029|NCT00371579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24466030|NCT00371579|Antimetabolites|antimetabolites|mesh-ancestor
24466033|NCT00371579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24466034|NCT00371579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466036|NCT00371592|Antiviral Agents|antiviral agents|mesh-ancestor
24466038|NCT00371696|Acetaminophen|acetaminophen|mesh-list
24466054|NCT00371735|Chlorproguanil|chlorproguanil|mesh-list
24466055|NCT00371735|Proguanil|proguanil|mesh-list
24466056|NCT00371735|Antimalarials|antimalarials|mesh-ancestor
24466057|NCT00371735|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25079250|NCT03349177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25079251|NCT03349177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25079252|NCT03349177|Alkylating Agents|alkylating agents|mesh-ancestor
25079253|NCT03349177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079254|NCT03349177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079255|NCT03349177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25079256|NCT03349177|Tubulin Modulators|tubulin modulators|mesh-ancestor
24466062|NCT00371735|Schistosomicides|schistosomicides|mesh-ancestor
24466087|NCT00371956|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
24466088|NCT00371956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24466092|NCT00371956|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24466093|NCT00371956|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24466094|NCT00371956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24466095|NCT00371995|Amphotericin B|amphotericin b|mesh-list
24466096|NCT00371995|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24466097|NCT00371995|Miltefosine|miltefosine|mesh-list
24466098|NCT00371995|Amebicides|amebicides|mesh-ancestor
24466099|NCT00371995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24796928|NCT01953367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24796929|NCT01953367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24796930|NCT01953406|Fluorouracil|fluorouracil|mesh-list
24796931|NCT01953406|Mitomycins|mitomycins|mesh-list
24796932|NCT01953406|Mitomycin|mitomycin|mesh-list
24796933|NCT01953406|Antimetabolites|antimetabolites|mesh-ancestor
24796934|NCT01953406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796935|NCT01953406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24796936|NCT01953406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796937|NCT01953406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24797066|NCT01953796|Clomiphene|clomiphene|mesh-list
24797269|NCT01954992|Antimetabolites|antimetabolites|mesh-ancestor
24797341|NCT01955187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24466112|NCT00372086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466113|NCT00372099|Calcitonin|calcitonin|mesh-list
24466114|NCT00372099|Salmon calcitonin|salmon calcitonin|mesh-list
24466115|NCT00372099|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
24466116|NCT00372099|Katacalcin|katacalcin|mesh-list
24466172|NCT00372307|Pimecrolimus|pimecrolimus|mesh-list
25700719|NCT02128230|Antiemetics|antiemetics|mesh-ancestor
25700720|NCT02128230|Autonomic Agents|autonomic agents|mesh-ancestor
25700721|NCT02128230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25700722|NCT02128230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25700723|NCT02128230|Glucocorticoids|glucocorticoids|mesh-ancestor
25700724|NCT02128230|Hormones|hormones|mesh-ancestor
25709567|NCT02270242|Sensory System Agents|sensory system agents|mesh-ancestor
24466173|NCT00372307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24466174|NCT00372307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24466175|NCT00372307|Analgesics|analgesics|mesh-ancestor
24466176|NCT00372307|Sensory System Agents|sensory system agents|mesh-ancestor
24466177|NCT00372307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24466178|NCT00372307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466179|NCT00372307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24466180|NCT00372307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24466181|NCT00372307|Dermatologic Agents|dermatologic agents|mesh-ancestor
24466182|NCT00372307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24466183|NCT00372307|Immunologic Factors|immunologic factors|mesh-ancestor
24466184|NCT00372307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24466185|NCT00372307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466186|NCT00372307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415466|NCT00199576|Hormones|hormones|mesh-ancestor
24466187|NCT00372372|Risedronic Acid|risedronic acid|mesh-list
24466190|NCT00372372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466191|NCT00372372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24466192|NCT00372372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466193|NCT00372372|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24466194|NCT00372476|Imatinib Mesylate|imatinib mesylate|mesh-list
24797634|NCT01956981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24797868|NCT01958905|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24797869|NCT01958905|Antimalarials|antimalarials|mesh-ancestor
24797870|NCT01958905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24797871|NCT01958905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24797872|NCT01958905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24797873|NCT01958944|Nitric Oxide|nitric oxide|mesh-list
24797874|NCT01958944|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24797875|NCT01958944|Autonomic Agents|autonomic agents|mesh-ancestor
24797876|NCT01958944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24466196|NCT00372476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466197|NCT00372476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24466231|NCT00372658|Anesthetics, Local|anesthetics, local|mesh-ancestor
24466233|NCT00372658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24797880|NCT01958944|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24797881|NCT01958944|Antioxidants|antioxidants|mesh-ancestor
24797882|NCT01958944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797883|NCT01958944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24797884|NCT01958944|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24798130|NCT01960647|Tubulin Modulators|tubulin modulators|mesh-ancestor
24798131|NCT01960647|Antimitotic Agents|antimitotic agents|mesh-ancestor
24798132|NCT01960647|Mitosis Modulators|mitosis modulators|mesh-ancestor
24798133|NCT01960647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798134|NCT01960764|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24798137|NCT01960829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24798138|NCT01960829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24798139|NCT01960829|Immunologic Factors|immunologic factors|mesh-ancestor
24895925|NCT02819479|Bevacizumab|bevacizumab|mesh-list
24466427|NCT00373503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24466428|NCT00373503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24466429|NCT00373503|Adrenergic Agents|adrenergic agents|mesh-ancestor
24466430|NCT00373542|Ropinirole|ropinirole|mesh-list
24627655|NCT01094275|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24627656|NCT01094275|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24627657|NCT01094275|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24627658|NCT01094275|Purinergic Agents|purinergic agents|mesh-ancestor
24627659|NCT01094275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25079265|NCT03349112|Lidocaine|lidocaine|mesh-list
24895950|NCT02794896|Anesthetics|anesthetics|mesh-ancestor
24466431|NCT00373542|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24466452|NCT00373581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24466453|NCT00373581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24466454|NCT00373581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24466455|NCT00373581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24466486|NCT00373620|Mitosis Modulators|mitosis modulators|mesh-ancestor
24694953|NCT05020782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466563|NCT00373893|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24466564|NCT00373893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24466565|NCT00373893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466566|NCT00373906|Bortezomib|bortezomib|mesh-list
24466676|NCT00374478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24466677|NCT00374478|Mydriatics|mydriatics|mesh-ancestor
24466678|NCT00374478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24466679|NCT00374478|Cholinergic Agents|cholinergic agents|mesh-ancestor
24466680|NCT00374478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24466681|NCT00374478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466682|NCT00374478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24466683|NCT00374478|Parasympatholytics|parasympatholytics|mesh-ancestor
24627706|NCT01094457|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24627707|NCT01094457|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24627709|NCT01094457|Purinergic Agents|purinergic agents|mesh-ancestor
24627710|NCT01094457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24973980|NCT05177276|Irinotecan|irinotecan|mesh-list
24627711|NCT01094457|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25700725|NCT02128230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25700726|NCT02128230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24798713|NCT01964586|Sympathomimetics|sympathomimetics|mesh-ancestor
24798714|NCT01964586|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24627788|NCT01094964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24627789|NCT01094964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627790|NCT01094964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798977|NCT01966289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798978|NCT01966289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24799322|NCT01968460|Protective Agents|protective agents|mesh-ancestor
24799323|NCT01968460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799324|NCT01968460|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24799325|NCT01968460|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24627913|NCT01095640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24627914|NCT01095640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627915|NCT01095640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24627916|NCT01095640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24627917|NCT01095640|Dermatologic Agents|dermatologic agents|mesh-ancestor
24627919|NCT01095679|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24627920|NCT01095679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627921|NCT01095679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24694954|NCT05007652|Plerixafor|plerixafor|mesh-list
24466791|NCT00374959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24466792|NCT00374959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24466793|NCT00374985|Docetaxel|docetaxel|mesh-list
24466794|NCT00374985|Oxaliplatin|oxaliplatin|mesh-list
24466795|NCT00374985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466796|NCT00374985|Tubulin Modulators|tubulin modulators|mesh-ancestor
24466797|NCT00374985|Antimitotic Agents|antimitotic agents|mesh-ancestor
24466798|NCT00374985|Mitosis Modulators|mitosis modulators|mesh-ancestor
24466799|NCT00374985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466800|NCT00375050|Riluzole|riluzole|mesh-list
24466802|NCT00375050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24466853|NCT00375297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466854|NCT00375297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627922|NCT01095679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24627923|NCT01095679|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24466875|NCT00375388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466876|NCT00375440|Tranexamic Acid|tranexamic acid|mesh-list
24466877|NCT00375440|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24466878|NCT00375440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24466879|NCT00375440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466881|NCT00375440|Coagulants|coagulants|mesh-ancestor
25700727|NCT02128230|Protease Inhibitors|protease inhibitors|mesh-ancestor
25700728|NCT02128230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700729|NCT02128230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25700730|NCT02128230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25700731|NCT02128230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25700732|NCT02128230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24466882|NCT00375466|Tranexamic Acid|tranexamic acid|mesh-list
25700733|NCT02128230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24759604|NCT01752959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24759620|NCT01753102|Estradiol|estradiol|mesh-list
24457500|NCT00334594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458468|NCT00338052|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24458469|NCT00338091|Losartan|losartan|mesh-list
24458470|NCT00338091|Benazepril|benazepril|mesh-list
24458471|NCT00338091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24458472|NCT00338091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24458473|NCT00338091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24458545|NCT00338338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24974087|NCT05175131|Antifoaming Agents|antifoaming agents|mesh-ancestor
24974151|NCT05156684|Zinc|zinc|mesh-list
24742718|NCT05189444|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24742719|NCT05189444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24742720|NCT05189444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24742723|NCT05189444|Antacids|antacids|mesh-ancestor
24466883|NCT00375466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24466885|NCT00375466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466887|NCT00375466|Coagulants|coagulants|mesh-ancestor
24466888|NCT00375557|Valproic Acid|valproic acid|mesh-list
24466889|NCT00375557|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24466890|NCT00375557|Antidepressive Agents|antidepressive agents|mesh-ancestor
24466891|NCT00375557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24466892|NCT00375557|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24466893|NCT00375557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24466894|NCT00375557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24466895|NCT00375557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466896|NCT00375557|Anticonvulsants|anticonvulsants|mesh-ancestor
24466912|NCT00375583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800430|NCT01975662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24800431|NCT01975688|Nabiximols|nabiximols|mesh-list
24800432|NCT01975688|Analgesics|analgesics|mesh-ancestor
24800433|NCT01975688|Sensory System Agents|sensory system agents|mesh-ancestor
24800437|NCT01975714|Latanoprost|latanoprost|mesh-list
24800442|NCT01975727|Dexamethasone acetate|dexamethasone acetate|mesh-list
24800443|NCT01975727|BB 1101|bb 1101|mesh-list
24800444|NCT01975727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24800445|NCT01975727|Antiemetics|antiemetics|mesh-ancestor
24800446|NCT01975727|Autonomic Agents|autonomic agents|mesh-ancestor
24800447|NCT01975727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24695107|NCT04510051|Alkylating Agents|alkylating agents|mesh-ancestor
24800674|NCT01977339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24800675|NCT01977378|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24772099|NCT01831505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24772100|NCT01831505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24772101|NCT01831505|Alkylating Agents|alkylating agents|mesh-ancestor
24563285|NCT00770835|Metformin|metformin|mesh-list
24800676|NCT01977378|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24800677|NCT01977378|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25700734|NCT02128230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25700735|NCT02128230|Growth Substances|growth substances|mesh-ancestor
25700736|NCT02128230|Growth Inhibitors|growth inhibitors|mesh-ancestor
25700737|NCT02128230|Leprostatic Agents|leprostatic agents|mesh-ancestor
25700738|NCT02128230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25700739|NCT02128230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25700740|NCT02128230|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25700741|NCT02128490|Naproxen|naproxen|mesh-list
25700742|NCT02128490|Colchicine|colchicine|mesh-list
25700743|NCT02128490|Febuxostat|febuxostat|mesh-list
25700744|NCT02128490|Lansoprazole|lansoprazole|mesh-list
25700745|NCT02128490|Dexlansoprazole|dexlansoprazole|mesh-list
25700746|NCT02128490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25700747|NCT02128490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25700748|NCT02128490|Analgesics|analgesics|mesh-ancestor
25700749|NCT02128490|Sensory System Agents|sensory system agents|mesh-ancestor
25700750|NCT02128490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25700751|NCT02128490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700752|NCT02128490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24794696|NCT04776850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25700753|NCT02128490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25700754|NCT02128490|Gout Suppressants|gout suppressants|mesh-ancestor
24794697|NCT04776850|Antitubercular Agents|antitubercular agents|mesh-ancestor
24794698|NCT04776850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24794699|NCT04776850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24461332|NCT00351910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24461333|NCT00351910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24461334|NCT00351910|Adrenergic Agents|adrenergic agents|mesh-ancestor
24794718|NCT04757662|Tadalafil|tadalafil|mesh-list
24794719|NCT04757662|Vasodilator Agents|vasodilator agents|mesh-ancestor
24794720|NCT04757662|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24794721|NCT04757662|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24794722|NCT04757662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24794723|NCT04757662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794724|NCT04757662|Urological Agents|urological agents|mesh-ancestor
24467017|NCT00376012|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24467018|NCT00376012|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24467019|NCT00376012|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24467020|NCT00376012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24467021|NCT00376012|Antimetabolites|antimetabolites|mesh-ancestor
24467022|NCT00376012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24467023|NCT00376025|Antioxidants|antioxidants|mesh-list
24467024|NCT00376025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467025|NCT00376025|Protective Agents|protective agents|mesh-ancestor
24467026|NCT00376025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467028|NCT00376038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24628012|NCT01096121|Enalapril|enalapril|mesh-list
24628013|NCT01096121|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24628014|NCT01096121|Protease Inhibitors|protease inhibitors|mesh-ancestor
24628015|NCT01096121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628016|NCT01096121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628017|NCT01096121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24628018|NCT01096199|Cisplatin|cisplatin|mesh-list
24628019|NCT01096199|Everolimus|everolimus|mesh-list
24801596|NCT01984177|Hormones|hormones|mesh-list
24801597|NCT01984177|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24801598|NCT01984177|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
24801599|NCT01984177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24801600|NCT01984177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801601|NCT01984255|Ipilimumab|ipilimumab|mesh-list
24801602|NCT01984255|Bavituximab|bavituximab|mesh-list
24467029|NCT00376038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467030|NCT00376051|Citalopram|citalopram|mesh-list
24467031|NCT00376051|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24467032|NCT00376051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24467033|NCT00376051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25700755|NCT02128490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25700756|NCT02128490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700757|NCT02128490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700758|NCT02128490|Tubulin Modulators|tubulin modulators|mesh-ancestor
25700759|NCT02128490|Antimitotic Agents|antimitotic agents|mesh-ancestor
25700760|NCT02128490|Mitosis Modulators|mitosis modulators|mesh-ancestor
25700761|NCT02128490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700762|NCT02128490|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25700763|NCT02128490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25700764|NCT02128490|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25700765|NCT02128542|Sofosbuvir|sofosbuvir|mesh-list
25700766|NCT02128542|Antiviral Agents|antiviral agents|mesh-ancestor
25700767|NCT02128542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25700768|NCT02128828|Cenicriviroc|cenicriviroc|mesh-list
25700769|NCT02128828|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24974346|NCT04911361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24974347|NCT04911361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24974348|NCT04911361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24974349|NCT04893343|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24974350|NCT04893343|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24974351|NCT04893343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24974352|NCT04893343|Antitubercular Agents|antitubercular agents|mesh-ancestor
24974429|NCT04682860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974431|NCT04682860|Mydriatics|mydriatics|mesh-ancestor
24467034|NCT00376051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467092|NCT00376155|Renal Agents|renal agents|mesh-ancestor
24467097|NCT00376181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24695170|NCT04425902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24695171|NCT04425902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24449098|NCT00314314|Insulin|insulin|mesh-list
24628053|NCT01096329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24628054|NCT01096329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24628055|NCT01096329|Anabolic Agents|anabolic agents|mesh-ancestor
24628056|NCT01096355|R04929097|r04929097|mesh-list
24802680|NCT01991574|Calcium acetate|calcium acetate|mesh-list
24802681|NCT01991574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24802682|NCT01991574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802683|NCT01991574|Chelating Agents|chelating agents|mesh-ancestor
24802684|NCT01991574|Sequestering Agents|sequestering agents|mesh-ancestor
24802685|NCT01991574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802687|NCT01991587|Immunologic Factors|immunologic factors|mesh-ancestor
24802688|NCT01991587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802689|NCT01991626|Iron|iron|mesh-list
24802690|NCT01991626|Trace Elements|trace elements|mesh-list
24802691|NCT01991626|Micronutrients|micronutrients|mesh-list
24802692|NCT01991626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802693|NCT01991678|Etirinotecan pegol|etirinotecan pegol|mesh-list
24802694|NCT01991678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24802695|NCT01991678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24802696|NCT01991678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24467157|NCT00376428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467158|NCT00376428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467160|NCT00376467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467161|NCT00376467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24467162|NCT00376467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467163|NCT00376467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467164|NCT00376480|Methylprednisolone|methylprednisolone|mesh-list
24467228|NCT00376584|Vitamin B Complex|vitamin b complex|mesh-ancestor
24467229|NCT00376584|Vitamins|vitamins|mesh-ancestor
24467230|NCT00376584|Micronutrients|micronutrients|mesh-ancestor
24467231|NCT00376584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467232|NCT00376662|Etidronic Acid|etidronic acid|mesh-list
24467233|NCT00376662|Hormones|hormones|mesh-list
24467234|NCT00376662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24467235|NCT00376662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467236|NCT00376662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24467237|NCT00376701|Bevacizumab|bevacizumab|mesh-list
24467238|NCT00376701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24467239|NCT00376701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24695248|NCT04072146|Varenicline|varenicline|mesh-list
25700770|NCT02128828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700771|NCT02128828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25700772|NCT02128828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25700773|NCT02128828|Antiviral Agents|antiviral agents|mesh-ancestor
25700774|NCT02128828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25700775|NCT02128932|Insulin Glargine|insulin glargine|mesh-list
25700776|NCT02128932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25700777|NCT02128932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700778|NCT02129075|Poly I-C|poly i-c|mesh-list
25700779|NCT02129075|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24974482|NCT04610528|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
24974483|NCT04610528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24974484|NCT04610528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24933066|NCT04074317|Insulin|insulin|mesh-list
24461747|NCT00353561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24461748|NCT00353561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461749|NCT00353561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461751|NCT00353561|Hormone Antagonists|hormone antagonists|mesh-ancestor
24461859|NCT00354185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461860|NCT00354185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461861|NCT00354198|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24461862|NCT00354198|Pentoxifylline|pentoxifylline|mesh-list
24461863|NCT00354198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24461864|NCT00354198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700780|NCT02129075|Poly ICLC|poly iclc|mesh-list
24802698|NCT01991678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597076|NCT00947063|Anesthetics, Local|anesthetics, local|mesh-ancestor
24628093|NCT01096511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24628094|NCT01096511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628095|NCT01096511|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24628096|NCT01096511|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24628098|NCT01096654|Epinephrine|epinephrine|mesh-list
24628099|NCT01096654|Racepinephrine|racepinephrine|mesh-list
24628100|NCT01096654|Epinephryl borate|epinephryl borate|mesh-list
24628101|NCT01096654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24628102|NCT01096654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24628103|NCT01096654|Adrenergic Agents|adrenergic agents|mesh-ancestor
24817411|NCT02083536|Tubulin Modulators|tubulin modulators|mesh-ancestor
24896075|NCT02438722|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24817412|NCT02083536|Antimitotic Agents|antimitotic agents|mesh-ancestor
24896076|NCT02438722|Immunologic Factors|immunologic factors|mesh-ancestor
24896077|NCT02438722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896078|NCT02438722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24896079|NCT02438722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24896080|NCT02438722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896081|NCT02438722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896082|NCT02419560|Venetoclax|venetoclax|mesh-list
24896083|NCT02419560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24896084|NCT02405520|Vaccines|vaccines|mesh-list
24896085|NCT02405520|Immunologic Factors|immunologic factors|mesh-ancestor
24896086|NCT02405520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473164|NCT00402207|Hormones|hormones|mesh-ancestor
24467297|NCT00376987|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24467298|NCT00376987|Protective Agents|protective agents|mesh-ancestor
24628106|NCT01096654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628107|NCT01096654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24628108|NCT01096654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24628136|NCT01096706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25700781|NCT02129075|Flt3 ligand protein|flt3 ligand protein|mesh-list
25700782|NCT02129075|Interferon Inducers|interferon inducers|mesh-ancestor
25700783|NCT02129075|Immunologic Factors|immunologic factors|mesh-ancestor
25700784|NCT02129075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700785|NCT02129075|Laxatives|laxatives|mesh-ancestor
25700786|NCT02129075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25700787|NCT02129075|Antiviral Agents|antiviral agents|mesh-ancestor
25700788|NCT02129075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25700789|NCT02129075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25700790|NCT02129075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25700791|NCT02129075|Protective Agents|protective agents|mesh-ancestor
25700792|NCT02129192|Amlodipine|amlodipine|mesh-list
25700793|NCT02129192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25700794|NCT02129192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25700795|NCT02129192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25700796|NCT02129192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700797|NCT02129192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25700798|NCT02129192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700799|NCT02129192|Vasodilator Agents|vasodilator agents|mesh-ancestor
24974563|NCT04469491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24974567|NCT04394481|Dexamethasone|dexamethasone|mesh-list
24628137|NCT01096706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24628139|NCT01096706|Antipyretics|antipyretics|mesh-ancestor
24628140|NCT01096706|Antifungal Agents|antifungal agents|mesh-ancestor
24628141|NCT01096706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24628142|NCT01096706|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24661007|NCT01287598|Warfarin|warfarin|mesh-list
24628143|NCT01096706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24628144|NCT01096706|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24628145|NCT01096706|Hormone Antagonists|hormone antagonists|mesh-ancestor
24467347|NCT00377104|Growth Substances|growth substances|mesh-ancestor
24467348|NCT00377104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467349|NCT00377104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24628146|NCT01096706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24628147|NCT01096706|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24628148|NCT01096706|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25079270|NCT03349112|Sensory System Agents|sensory system agents|mesh-ancestor
24965258|NCT03778008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965259|NCT03778008|Anesthetics, Local|anesthetics, local|mesh-ancestor
24965260|NCT03778008|Anesthetics|anesthetics|mesh-ancestor
24965261|NCT03778008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24965262|NCT03778008|Sensory System Agents|sensory system agents|mesh-ancestor
24965263|NCT03778008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24965264|NCT03778008|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24965265|NCT03778008|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24965266|NCT03778008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24965267|NCT03778008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965268|NCT03778008|Mitosis Modulators|mitosis modulators|mesh-ancestor
25079276|NCT03349112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079278|NCT03349008|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
25079279|NCT03349008|Antiviral Agents|antiviral agents|mesh-ancestor
25079280|NCT03349008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25079281|NCT03349008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25079290|NCT03348917|Chlorhexidine|chlorhexidine|mesh-list
25079291|NCT03348917|Povidone-Iodine|povidone-iodine|mesh-list
25079292|NCT03348917|Povidone|povidone|mesh-list
25079293|NCT03348917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24467437|NCT00377728|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
24467442|NCT00377780|Docetaxel|docetaxel|mesh-list
25079299|NCT03348826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25079300|NCT03348826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25079301|NCT03348826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25079302|NCT03348826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079303|NCT03348800|Anesthetics|anesthetics|mesh-list
25079304|NCT03348800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25079305|NCT03348800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079306|NCT03348735|Lidocaine|lidocaine|mesh-list
25079307|NCT03348735|Pregabalin|pregabalin|mesh-list
25079308|NCT03348735|Capsaicin|capsaicin|mesh-list
25079309|NCT03348735|Anesthetics, Local|anesthetics, local|mesh-ancestor
25079310|NCT03348735|Anesthetics|anesthetics|mesh-ancestor
24467555|NCT00378066|Growth Substances|growth substances|mesh-ancestor
24467556|NCT00378066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079315|NCT03348735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25079316|NCT03348735|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25079317|NCT03348735|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25079318|NCT03348735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25079319|NCT03348735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079320|NCT03348735|Analgesics|analgesics|mesh-ancestor
25079321|NCT03348735|Anticonvulsants|anticonvulsants|mesh-ancestor
25079322|NCT03348735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25079323|NCT03348735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25079324|NCT03348735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25079325|NCT03348735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25700800|NCT02129426|Midazolam|midazolam|mesh-list
25700801|NCT02129426|Dexmedetomidine|dexmedetomidine|mesh-list
25700802|NCT02129426|Ketamine|ketamine|mesh-list
25700803|NCT02129426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24462153|NCT00355277|Amitriptyline|amitriptyline|mesh-list
24664891|NCT01309139|Cholinergic Agents|cholinergic agents|mesh-ancestor
24802454|NCT01990144|Rituximab|rituximab|mesh-list
24804049|NCT02000700|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24628181|NCT01096940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628182|NCT01096940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24628183|NCT01096940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24628184|NCT01096940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628186|NCT01097148|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24628187|NCT01097148|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24628188|NCT01097148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24628189|NCT01097148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24628190|NCT01097148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628191|NCT01097148|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24628192|NCT01097148|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24628193|NCT01097148|Cholinergic Agents|cholinergic agents|mesh-ancestor
24628194|NCT01097148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24628195|NCT01097148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661775|NCT01290939|Bevacizumab|bevacizumab|mesh-list
24628197|NCT01097213|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24628198|NCT01097213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24804553|NCT02003209|Carboplatin|carboplatin|mesh-list
24467577|NCT00378118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467578|NCT00378144|Acetaminophen|acetaminophen|mesh-list
24467579|NCT00378144|Pseudoephedrine|pseudoephedrine|mesh-list
24467580|NCT00378144|Ephedrine|ephedrine|mesh-list
24467581|NCT00378144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24467582|NCT00378144|Analgesics|analgesics|mesh-ancestor
24467583|NCT00378144|Sensory System Agents|sensory system agents|mesh-ancestor
24467584|NCT00378144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24467585|NCT00378144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805898|NCT02012595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805899|NCT02012595|Cholinergic Agents|cholinergic agents|mesh-ancestor
24805900|NCT02012595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24805901|NCT02012595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805902|NCT02012595|Nootropic Agents|nootropic agents|mesh-ancestor
24805903|NCT02012738|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
24805904|NCT02012738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467606|NCT00378183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24467607|NCT00378183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24467608|NCT00378183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24467611|NCT00378196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24467612|NCT00378196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24467613|NCT00378196|Growth Substances|growth substances|mesh-ancestor
24467614|NCT00378196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467615|NCT00378196|Growth Inhibitors|growth inhibitors|mesh-ancestor
24467616|NCT00378196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467617|NCT00378287|Rabeprazole|rabeprazole|mesh-list
24467621|NCT00378287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467622|NCT00378287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467623|NCT00378313|Gemcitabine|gemcitabine|mesh-list
25700804|NCT02129426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25700805|NCT02129426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700806|NCT02129426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25700807|NCT02129426|Analgesics|analgesics|mesh-ancestor
25700808|NCT02129426|Sensory System Agents|sensory system agents|mesh-ancestor
25700809|NCT02129426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25700810|NCT02129426|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24695420|NCT03596424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24695421|NCT03596424|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24695422|NCT03596424|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24695423|NCT03596424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24806584|NCT02016547|Anticoagulants|anticoagulants|mesh-ancestor
24817415|NCT02083575|Vitamins|vitamins|mesh-list
24467643|NCT00378365|Arsenic Trioxide|arsenic trioxide|mesh-list
24467644|NCT00378365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806585|NCT02016547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24601448|NCT00964184|Metformin|metformin|mesh-list
24628332|NCT01098201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628333|NCT01098201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24628334|NCT01098344|Gemcitabine|gemcitabine|mesh-list
24628335|NCT01098344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24628336|NCT01098344|Antimetabolites|antimetabolites|mesh-ancestor
24628337|NCT01098344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628338|NCT01098344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24628339|NCT01098344|Antiviral Agents|antiviral agents|mesh-ancestor
24628340|NCT01098344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24628341|NCT01098344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628363|NCT01098383|Antimetabolites|antimetabolites|mesh-ancestor
24628364|NCT01098383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24628365|NCT01098383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24628366|NCT01098383|Vasodilator Agents|vasodilator agents|mesh-ancestor
24663595|NCT01302340|Hormones|hormones|mesh-ancestor
24806805|NCT02018263|Autonomic Agents|autonomic agents|mesh-ancestor
24806806|NCT02018263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24467658|NCT00378443|Glucocorticoids|glucocorticoids|mesh-ancestor
24467659|NCT00378443|Hormones|hormones|mesh-ancestor
24467660|NCT00378443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24467661|NCT00378443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700817|NCT02129426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25700818|NCT02129426|Anesthetics, General|anesthetics, general|mesh-ancestor
25700819|NCT02129426|Anesthetics|anesthetics|mesh-ancestor
25700820|NCT02129426|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25700821|NCT02129426|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25700822|NCT02129426|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25700823|NCT02129426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24794884|NCT04233866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24467710|NCT00378547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24467712|NCT00378547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467713|NCT00378547|Protease Inhibitors|protease inhibitors|mesh-ancestor
24467714|NCT00378547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24806813|NCT02018263|Anesthetics, Local|anesthetics, local|mesh-ancestor
24806815|NCT02018263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24628386|NCT01098513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24628387|NCT01098526|Efavirenz|efavirenz|mesh-list
24628388|NCT01098526|Dolutegravir|dolutegravir|mesh-list
24628389|NCT01098526|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24628390|NCT01098526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24628391|NCT01098526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628392|NCT01098526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628393|NCT01098526|Antiviral Agents|antiviral agents|mesh-ancestor
24628394|NCT01098526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24628399|NCT01098526|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24807124|NCT02019875|Antitubercular Agents|antitubercular agents|mesh-ancestor
24807125|NCT02019875|Leprostatic Agents|leprostatic agents|mesh-ancestor
24807126|NCT02019875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24807127|NCT02019875|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24807128|NCT02019875|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24807129|NCT02019875|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24965317|NCT03777930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24965318|NCT03777930|Growth Substances|growth substances|mesh-ancestor
24965319|NCT03777930|Growth Inhibitors|growth inhibitors|mesh-ancestor
24965320|NCT03777930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965321|NCT03777930|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24965322|NCT03777930|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24467726|NCT00378547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24467727|NCT00378547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24467729|NCT00378612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24467730|NCT00378612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24467731|NCT00378612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24467732|NCT00378612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467733|NCT00378612|Antifungal Agents|antifungal agents|mesh-ancestor
24467734|NCT00378612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24467735|NCT00378612|Immunologic Factors|immunologic factors|mesh-ancestor
24467765|NCT00378677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25079337|NCT03348696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079338|NCT03348696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25079339|NCT03348696|Glucocorticoids|glucocorticoids|mesh-ancestor
25079340|NCT03348696|Hormones|hormones|mesh-ancestor
25079341|NCT03348696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25079342|NCT03348696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25079343|NCT03348696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079344|NCT03348696|Protease Inhibitors|protease inhibitors|mesh-ancestor
24467870|NCT00379015|Alkylating Agents|alkylating agents|mesh-ancestor
24467871|NCT00379015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467872|NCT00379015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467873|NCT00379015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24467874|NCT00379015|Tubulin Modulators|tubulin modulators|mesh-ancestor
24467875|NCT00379015|Antimitotic Agents|antimitotic agents|mesh-ancestor
24467876|NCT00379015|Mitosis Modulators|mitosis modulators|mesh-ancestor
24467877|NCT00379015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24467878|NCT00379015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25079357|NCT03348423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25079358|NCT03348423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079359|NCT03348423|Analgesics|analgesics|mesh-ancestor
25079360|NCT03348423|Sensory System Agents|sensory system agents|mesh-ancestor
25079361|NCT03348423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25079362|NCT03348423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25079363|NCT03348423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25700824|NCT02129426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25700825|NCT02129426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25700826|NCT02129426|GABA Modulators|gaba modulators|mesh-ancestor
25700827|NCT02129426|GABA Agents|gaba agents|mesh-ancestor
25700828|NCT02129478|Olanzapine|olanzapine|mesh-list
25700829|NCT02129478|Antiemetics|antiemetics|mesh-ancestor
25700830|NCT02129478|Autonomic Agents|autonomic agents|mesh-ancestor
25700831|NCT02129478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25700832|NCT02129478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467907|NCT00379041|Bleomycin|bleomycin|mesh-list
24467908|NCT00379041|Vincristine|vincristine|mesh-list
24467909|NCT00379041|Vinblastine|vinblastine|mesh-list
24467910|NCT00379041|Procarbazine|procarbazine|mesh-list
24467911|NCT00379041|Mechlorethamine|mechlorethamine|mesh-list
24467912|NCT00379041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24467913|NCT00379041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467914|NCT00379041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24467932|NCT00379067|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24467933|NCT00379067|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24467934|NCT00379067|Adrenergic Agents|adrenergic agents|mesh-ancestor
24467935|NCT00379067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24467936|NCT00379067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807132|NCT02019875|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24807133|NCT02020005|Nicotine|nicotine|mesh-list
24807134|NCT02020005|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24515692|NCT00598793|Insulin|insulin|mesh-list
24467937|NCT00379067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469175|NCT00384800|Growth Substances|growth substances|mesh-ancestor
24468173|NCT00380289|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24468174|NCT00380289|Adrenergic Agents|adrenergic agents|mesh-ancestor
24468175|NCT00380289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24468176|NCT00380289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468177|NCT00380289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468382|NCT00381251|Estrogens|estrogens|mesh-ancestor
24468559|NCT00382213|Olmesartan|olmesartan|mesh-list
24446808|NCT00306033|Immunologic Factors|immunologic factors|mesh-ancestor
24446809|NCT00306033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628400|NCT01098526|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24628432|NCT01099059|Amantadine|amantadine|mesh-list
24628433|NCT01099059|Methylphenidate|methylphenidate|mesh-list
24628434|NCT01099059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24628435|NCT01099059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896434|NCT04436172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896435|NCT04436328|Anti-Infective Agents|anti-infective agents|mesh-list
24468749|NCT00383045|Analgesics|analgesics|mesh-ancestor
24628437|NCT01099059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24628438|NCT01099059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24628439|NCT01099059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628440|NCT01099059|Dopamine Agents|dopamine agents|mesh-ancestor
24469181|NCT00384826|Paclitaxel|paclitaxel|mesh-list
24468914|NCT00383890|Sensory System Agents|sensory system agents|mesh-ancestor
24468915|NCT00383890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24468916|NCT00383890|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24468917|NCT00383890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24468918|NCT00383890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24468919|NCT00383890|Adrenergic Agents|adrenergic agents|mesh-ancestor
24468920|NCT00383890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24468921|NCT00383890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468990|NCT00384202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468991|NCT00384202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24468992|NCT00384202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24468993|NCT00384202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468994|NCT00384215|Insulin Glargine|insulin glargine|mesh-list
24468995|NCT00384215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24468996|NCT00384215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468998|NCT00384280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24468999|NCT00384280|Antitubercular Agents|antitubercular agents|mesh-ancestor
24469000|NCT00384280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24469001|NCT00384280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24628441|NCT01099059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24628442|NCT01099059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24807515|NCT02022475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24807668|NCT02023047|Nifedipine|nifedipine|mesh-list
24807738|NCT02023450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24807739|NCT02023450|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24807740|NCT02023450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24807794|NCT02023684|Lidocaine|lidocaine|mesh-list
24807942|NCT02024425|Protective Agents|protective agents|mesh-ancestor
24808098|NCT02025166|Lornoxicam|lornoxicam|mesh-list
24469040|NCT00384410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24469041|NCT00384410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24469042|NCT00384410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24469043|NCT00384436|Citalopram|citalopram|mesh-list
24469044|NCT00384436|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24469045|NCT00384436|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24695622|NCT02547662|Glucocorticoids|glucocorticoids|mesh-ancestor
24469048|NCT00384436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24628446|NCT01099059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24628448|NCT01099059|Sensory System Agents|sensory system agents|mesh-ancestor
24628449|NCT01099059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24628450|NCT01099072|Methylphenidate|methylphenidate|mesh-list
24628451|NCT01099072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24628452|NCT01099072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808915|NCT02029794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808916|NCT02029898|Remifentanil|remifentanil|mesh-list
24808918|NCT02029898|Narcotics|narcotics|mesh-ancestor
24809635|NCT02035397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24809636|NCT02035397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809637|NCT02035397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24809638|NCT02035397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24809639|NCT02035410|Hydrogen Peroxide|hydrogen peroxide|mesh-list
24809640|NCT02035410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24809641|NCT02035410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24809642|NCT02035488|Tobramycin|tobramycin|mesh-list
24809643|NCT02035488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24809644|NCT02035488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24809645|NCT02035527|Docetaxel|docetaxel|mesh-list
24809646|NCT02035527|Sorafenib|sorafenib|mesh-list
24809647|NCT02035527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809648|NCT02035527|Tubulin Modulators|tubulin modulators|mesh-ancestor
24809649|NCT02035527|Antimitotic Agents|antimitotic agents|mesh-ancestor
24809650|NCT02035527|Mitosis Modulators|mitosis modulators|mesh-ancestor
24809651|NCT02035527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809652|NCT02035527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24462596|NCT00357084|Prednisone|prednisone|mesh-list
24462598|NCT00357084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24462599|NCT00357084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24462601|NCT00357084|Prednisolone acetate|prednisolone acetate|mesh-list
24809653|NCT02035527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628459|NCT01099085|Simvastatin|simvastatin|mesh-list
24469173|NCT00384800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24469174|NCT00384800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24469213|NCT00384917|Antifungal Agents|antifungal agents|mesh-ancestor
24469751|NCT00386997|Amphotericin B|amphotericin b|mesh-list
24469214|NCT00384917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24628461|NCT01099085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24628462|NCT01099085|Antimetabolites|antimetabolites|mesh-ancestor
24628464|NCT01099085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24628472|NCT01099137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628473|NCT01099137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628474|NCT01099150|Proanthocyanidin|proanthocyanidin|mesh-list
24628475|NCT01099150|Procyanidin|procyanidin|mesh-list
24628476|NCT01099150|Antioxidants|antioxidants|mesh-ancestor
24628477|NCT01099150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628478|NCT01099150|Protective Agents|protective agents|mesh-ancestor
24772614|NCT01834820|Dexamethasone|dexamethasone|mesh-list
24628479|NCT01099150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628480|NCT01099150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24628481|NCT01099150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24628482|NCT01099150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24628483|NCT01099228|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24628484|NCT01099228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469361|NCT00385502|Antifungal Agents|antifungal agents|mesh-ancestor
24469362|NCT00385502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24469363|NCT00385502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24469426|NCT00385710|Anticonvulsants|anticonvulsants|mesh-ancestor
24469427|NCT00385710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469428|NCT00385710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628485|NCT01099228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628486|NCT01099228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628487|NCT01099228|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24628488|NCT01099436|Zoledronic Acid|zoledronic acid|mesh-list
24628489|NCT01099436|Cyclophosphamide|cyclophosphamide|mesh-list
24809731|NCT02036060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809732|NCT02036060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24809735|NCT02036060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24809945|NCT02036879|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
24809946|NCT02036879|Estradiol|estradiol|mesh-list
24809947|NCT02036879|Estrogens|estrogens|mesh-ancestor
24809948|NCT02036879|Hormones|hormones|mesh-ancestor
24809949|NCT02036879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24809950|NCT02036879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809951|NCT02036879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24809952|NCT02036879|Contraceptive Agents|contraceptive agents|mesh-ancestor
24809969|NCT02037035|Ketamine|ketamine|mesh-list
24810065|NCT02037672|Metformin|metformin|mesh-list
24810225|NCT02038842|Immunologic Factors|immunologic factors|mesh-ancestor
24810226|NCT02038842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810227|NCT02039011|Tiotropium Bromide|tiotropium bromide|mesh-list
24469535|NCT00386269|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24469536|NCT00386269|Narcotics|narcotics|mesh-ancestor
24469605|NCT00386529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24469606|NCT00386529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700833|NCT02129478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25700834|NCT02129478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25700835|NCT02129478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25700836|NCT02129478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25083892|NCT03311906|Immunologic Factors|immunologic factors|mesh-ancestor
25083893|NCT03311906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469608|NCT00386529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24469609|NCT00386529|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24469610|NCT00386529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24469612|NCT00386529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24469623|NCT00386555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469624|NCT00386555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24469625|NCT00386555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469626|NCT00386581|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24469627|NCT00386581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24469631|NCT00386581|Adrenergic Agents|adrenergic agents|mesh-ancestor
24469753|NCT00386997|Amebicides|amebicides|mesh-ancestor
24469754|NCT00386997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24469755|NCT00386997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24469794|NCT00387374|Tubulin Modulators|tubulin modulators|mesh-ancestor
24469795|NCT00387374|Antimitotic Agents|antimitotic agents|mesh-ancestor
24469796|NCT00387374|Mitosis Modulators|mitosis modulators|mesh-ancestor
24469797|NCT00387374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469799|NCT00387374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24469800|NCT00387374|Growth Substances|growth substances|mesh-ancestor
24469801|NCT00387374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469802|NCT00387374|Growth Inhibitors|growth inhibitors|mesh-ancestor
24469803|NCT00387374|Immunologic Factors|immunologic factors|mesh-ancestor
24469804|NCT00387400|Everolimus|everolimus|mesh-list
25079388|NCT03348098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25079389|NCT03348059|Antiviral Agents|antiviral agents|mesh-list
25079390|NCT03348059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25079391|NCT03348046|Infliximab|infliximab|mesh-list
25079392|NCT03348046|Dermatologic Agents|dermatologic agents|mesh-ancestor
25079393|NCT03348046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25079394|NCT03348046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25079395|NCT03347994|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
25079396|NCT03347994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25079397|NCT03347994|Alkylating Agents|alkylating agents|mesh-ancestor
25079398|NCT03347994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079399|NCT03347994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079400|NCT03347968|Warfarin|warfarin|mesh-list
25079404|NCT03347968|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25079405|NCT03347968|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24470134|NCT00388895|Imatinib Mesylate|imatinib mesylate|mesh-list
24470135|NCT00388895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470136|NCT00388895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24470137|NCT00388895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24470138|NCT00388895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470140|NCT00388986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24470141|NCT00388986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470142|NCT00388999|Lectins|lectins|mesh-list
24470143|NCT00388999|Agglutinins|agglutinins|mesh-ancestor
24470144|NCT00388999|Immunologic Factors|immunologic factors|mesh-ancestor
24470145|NCT00388999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470146|NCT00388999|Coagulants|coagulants|mesh-ancestor
24470147|NCT00389025|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25700837|NCT02129478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25700838|NCT02129478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25700839|NCT02129478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25700840|NCT02129478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25700841|NCT02129478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700842|NCT02129478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25700843|NCT02129478|Serotonin Agents|serotonin agents|mesh-ancestor
25700844|NCT02129556|Pembrolizumab|pembrolizumab|mesh-list
24470375|NCT00389987|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24470377|NCT00390000|Pemetrexed|pemetrexed|mesh-list
24470378|NCT00390000|Vatalanib|vatalanib|mesh-list
24470379|NCT00390000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470380|NCT00390000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24470381|NCT00390000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470382|NCT00390000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24470383|NCT00390000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24470384|NCT00390000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24470385|NCT00390026|Bevacizumab|bevacizumab|mesh-list
24470386|NCT00390026|Verteporfin|verteporfin|mesh-list
24470387|NCT00390026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24470586|NCT00390793|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24470587|NCT00390793|Methotrexate|methotrexate|mesh-list
24470588|NCT00390793|Vincristine|vincristine|mesh-list
24470589|NCT00390793|Daunorubicin|daunorubicin|mesh-list
24470590|NCT00390793|Dasatinib|dasatinib|mesh-list
24470591|NCT00390793|BB 1101|bb 1101|mesh-list
24470592|NCT00390793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24470593|NCT00390793|Immunologic Factors|immunologic factors|mesh-ancestor
24470594|NCT00390793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470595|NCT00390793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24470596|NCT00390793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24470602|NCT00390793|Antiemetics|antiemetics|mesh-ancestor
25079417|NCT03347916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25079418|NCT03347916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25079419|NCT03347916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25079420|NCT03347916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24470745|NCT00391417|Hormones|hormones|mesh-ancestor
24470746|NCT00391417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24470747|NCT00391417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470748|NCT00391534|Oxcarbazepine|oxcarbazepine|mesh-list
24470749|NCT00391534|Anticonvulsants|anticonvulsants|mesh-ancestor
24470750|NCT00391534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24470751|NCT00391534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24470752|NCT00391534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24470817|NCT00392080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470818|NCT00392080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24470819|NCT00392080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24470820|NCT00392080|Gout Suppressants|gout suppressants|mesh-ancestor
24470821|NCT00392080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24470822|NCT00392080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628491|NCT01099436|Doxorubicin|doxorubicin|mesh-list
24628492|NCT01099436|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24628493|NCT01099436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24628494|NCT01099436|Immunologic Factors|immunologic factors|mesh-ancestor
24628495|NCT01099436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628497|NCT01099436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24550542|NCT00721201|Mifepristone|mifepristone|mesh-list
24628498|NCT01099436|Alkylating Agents|alkylating agents|mesh-ancestor
24628499|NCT01099436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628500|NCT01099436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24628501|NCT01099436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24628502|NCT01099436|Tubulin Modulators|tubulin modulators|mesh-ancestor
24628503|NCT01099436|Antimitotic Agents|antimitotic agents|mesh-ancestor
24628504|NCT01099436|Mitosis Modulators|mitosis modulators|mesh-ancestor
24664590|NCT01307865|Natriuretic Agents|natriuretic agents|mesh-ancestor
24628506|NCT01099436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24810506|NCT02040597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24810507|NCT02040597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24810508|NCT02040597|Adrenergic Agents|adrenergic agents|mesh-ancestor
24810509|NCT02040597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24810510|NCT02040597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810511|NCT02040597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24810512|NCT02040597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24810513|NCT02040597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24810514|NCT02040597|Cholinergic Agents|cholinergic agents|mesh-ancestor
24810515|NCT02040597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24810516|NCT02040597|Glucocorticoids|glucocorticoids|mesh-ancestor
24810518|NCT02040597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24810519|NCT02040636|Vaccines|vaccines|mesh-list
24810520|NCT02040636|Immunologic Factors|immunologic factors|mesh-ancestor
24810521|NCT02040636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084379|NCT03307603|Nivolumab|nivolumab|mesh-list
24810522|NCT02040649|Midazolam|midazolam|mesh-list
24810523|NCT02040649|Propofol|propofol|mesh-list
24810524|NCT02040649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24471079|NCT00393263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24471080|NCT00393263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24471081|NCT00393263|Dermatologic Agents|dermatologic agents|mesh-ancestor
24471118|NCT00393328|Dopamine Agents|dopamine agents|mesh-ancestor
24471119|NCT00393328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24471120|NCT00393328|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24471121|NCT00393328|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24471122|NCT00393328|Serotonin Agents|serotonin agents|mesh-ancestor
24471123|NCT00393328|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24471124|NCT00393328|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24471125|NCT00393328|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24471126|NCT00393328|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24471128|NCT00393393|Viscosupplements|viscosupplements|mesh-ancestor
24471129|NCT00393393|Protective Agents|protective agents|mesh-ancestor
24471131|NCT00393445|Glucagon|glucagon|mesh-list
24811003|NCT02044146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24811004|NCT02044146|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24811005|NCT02044146|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24811006|NCT02044146|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24811007|NCT02044146|Purinergic Agents|purinergic agents|mesh-ancestor
24811008|NCT02044146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24811009|NCT02044146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811010|NCT02044146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628513|NCT01099462|Analgesics|analgesics|mesh-ancestor
24628514|NCT01099462|Sensory System Agents|sensory system agents|mesh-ancestor
24628515|NCT01099462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24628516|NCT01099462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628517|NCT01099462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24628518|NCT01099462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24628519|NCT01099462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24628520|NCT01099462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817547|NCT02084446|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24817548|NCT02084446|Protective Agents|protective agents|mesh-ancestor
24817549|NCT02084472|Petrolatum|petrolatum|mesh-list
24471221|NCT00394056|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24628526|NCT01099527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628527|NCT01099527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24628528|NCT01099527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24628529|NCT01099527|Immunologic Factors|immunologic factors|mesh-ancestor
24628530|NCT01099527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628531|NCT01099566|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24628532|NCT01099566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24628533|NCT01099592|Citalopram|citalopram|mesh-list
24628534|NCT01099592|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24628535|NCT01099592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24628536|NCT01099592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24628537|NCT01099592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628538|NCT01099592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24628539|NCT01099592|Serotonin Agents|serotonin agents|mesh-ancestor
24628540|NCT01099592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628541|NCT01099592|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24628542|NCT01099592|Antidepressive Agents|antidepressive agents|mesh-ancestor
24628543|NCT01099592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24628544|NCT01099605|Bupivacaine|bupivacaine|mesh-list
24628545|NCT01099605|Anesthetics, Local|anesthetics, local|mesh-ancestor
24628546|NCT01099605|Anesthetics|anesthetics|mesh-ancestor
24628547|NCT01099605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24628548|NCT01099605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664773|NCT01308632|Irinotecan|irinotecan|mesh-list
24664920|NCT01309425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24628549|NCT01099605|Sensory System Agents|sensory system agents|mesh-ancestor
24628550|NCT01099605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24628551|NCT01099722|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24628552|NCT01099722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25079424|NCT03347916|Antimanic Agents|antimanic agents|mesh-ancestor
24471583|NCT00396045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24471584|NCT00396045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24811675|NCT02047578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811676|NCT02047578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24811677|NCT02047578|Immunologic Factors|immunologic factors|mesh-ancestor
24811678|NCT02047578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811679|NCT02047578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24811680|NCT02047578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24811797|NCT02048384|Metformin|metformin|mesh-list
24811868|NCT02048683|Anesthetics|anesthetics|mesh-ancestor
24811991|NCT02049190|Fertility Agents|fertility agents|mesh-ancestor
24811992|NCT02049190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24811993|NCT02049190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811994|NCT02049190|Hormone Antagonists|hormone antagonists|mesh-ancestor
24811997|NCT02049203|Enzyme Activators|enzyme activators|mesh-ancestor
24471618|NCT00396227|Protease Inhibitors|protease inhibitors|mesh-ancestor
24471619|NCT00396227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812260|NCT02050893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24812261|NCT02050893|GABA Modulators|gaba modulators|mesh-ancestor
24812262|NCT02050893|GABA Agents|gaba agents|mesh-ancestor
24812263|NCT02050893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24471620|NCT00396227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471621|NCT00396240|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24471622|NCT00396240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24548365|NCT00709215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24548367|NCT00709254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24548368|NCT00709254|Narcotics|narcotics|mesh-ancestor
24548369|NCT00709254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24471623|NCT00396240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24471624|NCT00396240|Antimetabolites|antimetabolites|mesh-ancestor
24471625|NCT00396240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471626|NCT00396240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24471759|NCT00396747|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24471760|NCT00396747|Prednisolone|prednisolone|mesh-list
24471761|NCT00396747|Prednisolone acetate|prednisolone acetate|mesh-list
24471762|NCT00396747|Methotrexate|methotrexate|mesh-list
24471763|NCT00396747|Infliximab|infliximab|mesh-list
24471764|NCT00396747|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24471780|NCT00396747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24471849|NCT00397059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24471851|NCT00397072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24471852|NCT00397098|Amibegron|amibegron|mesh-list
24446828|NCT00306150|Aprotinin|aprotinin|mesh-list
24446829|NCT00306150|Hemostatics|hemostatics|mesh-ancestor
24472051|NCT00397800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24472052|NCT00397800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24472053|NCT00397800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24965388|NCT03777761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24965389|NCT03777761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965390|NCT03777761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965391|NCT03777761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24965392|NCT03777488|Tranexamic Acid|tranexamic acid|mesh-list
24965393|NCT03777488|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24628632|NCT01100203|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24628635|NCT01100203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472341|NCT00398905|Protease Inhibitors|protease inhibitors|mesh-ancestor
24472342|NCT00398905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24472343|NCT00398905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700845|NCT02129556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25700846|NCT02129556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629262|NCT01103830|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24629263|NCT01103830|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24629264|NCT01103830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24629265|NCT01103830|Antimalarials|antimalarials|mesh-ancestor
24629267|NCT01103830|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25079452|NCT03347721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25079453|NCT03347721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079454|NCT03347721|Sensory System Agents|sensory system agents|mesh-ancestor
24965441|NCT03777033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628638|NCT01100203|Natriuretic Agents|natriuretic agents|mesh-ancestor
24628639|NCT01100203|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24628640|NCT01100216|Nicotine|nicotine|mesh-list
24813007|NCT02055703|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24813008|NCT02055703|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24813009|NCT02055703|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24472353|NCT00398957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24472354|NCT00398957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24472355|NCT00398957|Narcotics|narcotics|mesh-ancestor
24472356|NCT00398957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24813028|NCT02056041|Hematinics|hematinics|mesh-ancestor
24813029|NCT02056106|Antidepressive Agents|antidepressive agents|mesh-list
24813030|NCT02056106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24813031|NCT02056184|Adalimumab|adalimumab|mesh-list
24813032|NCT02056184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24813033|NCT02056184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24628641|NCT01100216|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24628642|NCT01100216|Autonomic Agents|autonomic agents|mesh-ancestor
24628643|NCT01100216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24472444|NCT00399165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24472448|NCT00399165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24472450|NCT00399165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472451|NCT00399165|Hormone Antagonists|hormone antagonists|mesh-ancestor
24472452|NCT00399204|Metformin|metformin|mesh-list
24472453|NCT00399204|Pioglitazone|pioglitazone|mesh-list
24472454|NCT00399204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24472455|NCT00399204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472456|NCT00399243|Sumatriptan|sumatriptan|mesh-list
24472457|NCT00399243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24472458|NCT00399243|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24472459|NCT00399243|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24472480|NCT00399282|Micronutrients|micronutrients|mesh-ancestor
24472481|NCT00399282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472482|NCT00399282|Antioxidants|antioxidants|mesh-ancestor
24472483|NCT00399282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472484|NCT00399282|Protective Agents|protective agents|mesh-ancestor
24608971|NCT00994695|Immunologic Factors|immunologic factors|mesh-ancestor
25700847|NCT02129660|Glycopyrrolate|glycopyrrolate|mesh-list
25700848|NCT02129660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25700849|NCT02129660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25700850|NCT02129660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25700851|NCT02129660|Cholinergic Agents|cholinergic agents|mesh-ancestor
25700852|NCT02129660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25700853|NCT02129660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608972|NCT00994695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608973|NCT00994708|Esomeprazole|esomeprazole|mesh-list
25700854|NCT02129660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700855|NCT02129725|Sildenafil Citrate|sildenafil citrate|mesh-list
25700856|NCT02129725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700857|NCT02129725|Vasodilator Agents|vasodilator agents|mesh-ancestor
24608974|NCT00994708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24608975|NCT00994708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24608976|NCT00994708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24608977|NCT00994708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608979|NCT00994734|Mifepristone|mifepristone|mesh-list
24472497|NCT00399334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24472498|NCT00399334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24472499|NCT00399334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472500|NCT00399334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24472501|NCT00399399|Cyclophosphamide|cyclophosphamide|mesh-list
24472549|NCT00399477|Dopamine Agonists|dopamine agonists|mesh-ancestor
24472550|NCT00399633|Sumatriptan|sumatriptan|mesh-list
24472551|NCT00399633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24472552|NCT00399633|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24472553|NCT00399633|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24472554|NCT00399633|Serotonin Agents|serotonin agents|mesh-ancestor
24813659|NCT02059772|Growth Substances|growth substances|mesh-ancestor
24813660|NCT02059772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696358|NCT01429025|Rituximab|rituximab|mesh-list
24813661|NCT02059772|Growth Inhibitors|growth inhibitors|mesh-ancestor
24813662|NCT02059772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813663|NCT02059850|Cyclophosphamide|cyclophosphamide|mesh-list
24813664|NCT02059850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24813665|NCT02059850|Immunologic Factors|immunologic factors|mesh-ancestor
24813666|NCT02059850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813667|NCT02059850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24813668|NCT02059850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24813669|NCT02059850|Alkylating Agents|alkylating agents|mesh-ancestor
24813972|NCT02061631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813973|NCT02061631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24813993|NCT02061657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24609643|NCT00997659|Chromium|chromium|mesh-list
24628661|NCT01100359|Carboplatin|carboplatin|mesh-list
24472607|NCT00399698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24472608|NCT00399698|Dopamine Agents|dopamine agents|mesh-ancestor
24472609|NCT00399711|Metformin|metformin|mesh-list
24472610|NCT00399711|Rosiglitazone|rosiglitazone|mesh-list
24472611|NCT00399711|Repaglinide|repaglinide|mesh-list
24472612|NCT00399711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24472613|NCT00399711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472614|NCT00399724|Insulin Glargine|insulin glargine|mesh-list
24472615|NCT00399724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24472616|NCT00399724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472617|NCT00399737|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24472618|NCT00399737|Protease Inhibitors|protease inhibitors|mesh-ancestor
24472619|NCT00399737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24472620|NCT00399737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472621|NCT00399750|Bevacizumab|bevacizumab|mesh-list
24472622|NCT00399750|Oxaliplatin|oxaliplatin|mesh-list
24472634|NCT00399867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472635|NCT00399867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24472636|NCT00399867|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24472637|NCT00399867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24472639|NCT00399945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24472640|NCT00399945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24472641|NCT00399971|Immunologic Factors|immunologic factors|mesh-list
24548445|NCT00709553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24472642|NCT00399971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472643|NCT00400075|Cyclophosphamide|cyclophosphamide|mesh-list
24472644|NCT00400075|Azathioprine|azathioprine|mesh-list
24814227|NCT02063360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24814229|NCT02063360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24814230|NCT02063360|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25700858|NCT02129725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24629577|NCT01106235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24629578|NCT01106235|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24472702|NCT00400335|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24472703|NCT00400335|Dutasteride|dutasteride|mesh-list
24472704|NCT00400335|Androgens|androgens|mesh-ancestor
24472706|NCT00400335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24472707|NCT00400335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472708|NCT00400335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24897005|NCT04430933|Mitosis Modulators|mitosis modulators|mesh-ancestor
24897006|NCT04430933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814231|NCT02063360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24814510|NCT02064842|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24814512|NCT02064842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24814513|NCT02064842|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24814514|NCT02064842|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24814515|NCT02064881|Metformin|metformin|mesh-list
24814527|NCT02065063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24472788|NCT00400582|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24472789|NCT00400582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472792|NCT00400595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24472793|NCT00400595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24814884|NCT02067078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24814885|NCT02067078|Adrenergic Agents|adrenergic agents|mesh-ancestor
24814886|NCT02067078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24814887|NCT02067078|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24814892|NCT02067078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24814893|NCT02067078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24814894|NCT02067078|Respiratory System Agents|respiratory system agents|mesh-ancestor
24814895|NCT02067078|Mydriatics|mydriatics|mesh-ancestor
25079455|NCT03347721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24965444|NCT03776916|Simethicone|simethicone|mesh-list
24965445|NCT03776916|Antifoaming Agents|antifoaming agents|mesh-ancestor
24965446|NCT03776916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965447|NCT03776916|Emollients|emollients|mesh-ancestor
24965448|NCT03776916|Dermatologic Agents|dermatologic agents|mesh-ancestor
24965449|NCT03776838|Fentanyl|fentanyl|mesh-list
24965450|NCT03776838|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24965451|NCT03776838|Narcotics|narcotics|mesh-ancestor
24965452|NCT03776838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24965453|NCT03776838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965454|NCT03776838|Analgesics|analgesics|mesh-ancestor
24965455|NCT03776838|Sensory System Agents|sensory system agents|mesh-ancestor
24965456|NCT03776838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24472800|NCT00400608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472801|NCT00400608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24472802|NCT00400608|Respiratory System Agents|respiratory system agents|mesh-ancestor
24472803|NCT00400608|Glucocorticoids|glucocorticoids|mesh-ancestor
25700859|NCT02129725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25700860|NCT02129725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700861|NCT02129725|Urological Agents|urological agents|mesh-ancestor
25700862|NCT02130024|Ranibizumab|ranibizumab|mesh-list
25700863|NCT02130024|Aflibercept|aflibercept|mesh-list
25700864|NCT02130024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25700865|NCT02130024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24472805|NCT00400608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24815475|NCT02070458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815476|NCT02070458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079456|NCT03347721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25079457|NCT03347721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25079458|NCT03347721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25079459|NCT03347721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25079462|NCT03347708|Hyaluronic Acid|hyaluronic acid|mesh-list
24472919|NCT00401128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472949|NCT00401206|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24472950|NCT00401206|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24472951|NCT00401206|Adrenergic Agents|adrenergic agents|mesh-ancestor
24472952|NCT00401206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24472953|NCT00401206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472955|NCT00401219|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24472958|NCT00401219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24472959|NCT00401219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472960|NCT00401323|Docetaxel|docetaxel|mesh-list
24472961|NCT00401323|Fluorouracil|fluorouracil|mesh-list
24444370|NCT00297661|Immunologic Factors|immunologic factors|mesh-ancestor
24444371|NCT00297661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444372|NCT00297674|Clarithromycin|clarithromycin|mesh-list
24444373|NCT00297674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24444374|NCT00297674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24444400|NCT00297765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444401|NCT00297765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444403|NCT00297804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24444404|NCT00297804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24444405|NCT00297804|Tubulin Modulators|tubulin modulators|mesh-ancestor
24444406|NCT00297804|Antimitotic Agents|antimitotic agents|mesh-ancestor
24816294|NCT02075749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628753|NCT01101269|Protective Agents|protective agents|mesh-ancestor
24666660|NCT01320345|Antimetabolites|antimetabolites|mesh-ancestor
24628757|NCT01101386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24628758|NCT01101386|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24628759|NCT01101386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24628760|NCT01101386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628761|NCT01101386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628762|NCT01101386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24628763|NCT01101386|Hormone Antagonists|hormone antagonists|mesh-ancestor
24628764|NCT01101386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24628765|NCT01101386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444476|NCT00298168|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24444477|NCT00298168|Protective Agents|protective agents|mesh-ancestor
24444537|NCT00298415|Carboplatin|carboplatin|mesh-list
24444538|NCT00298415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24444539|NCT00298415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24444540|NCT00298415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700866|NCT02130024|Growth Substances|growth substances|mesh-ancestor
25700867|NCT02130024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700868|NCT02130024|Growth Inhibitors|growth inhibitors|mesh-ancestor
25700869|NCT02130024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700870|NCT02130063|Iron|iron|mesh-list
25086058|NCT03292965|Cholinergic Agents|cholinergic agents|mesh-ancestor
24444541|NCT00298415|Tubulin Modulators|tubulin modulators|mesh-ancestor
24444542|NCT00298415|Antimitotic Agents|antimitotic agents|mesh-ancestor
24444543|NCT00298415|Mitosis Modulators|mitosis modulators|mesh-ancestor
24444544|NCT00298415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444545|NCT00298415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24444546|NCT00298415|Antimetabolites|antimetabolites|mesh-ancestor
24444547|NCT00298415|Antiviral Agents|antiviral agents|mesh-ancestor
24473026|NCT00401609|Etoposide|etoposide|mesh-list
24473027|NCT00401609|Vinorelbine|vinorelbine|mesh-list
24473028|NCT00401609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473029|NCT00401609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24473030|NCT00401609|Antimetabolites|antimetabolites|mesh-ancestor
24473031|NCT00401609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473032|NCT00401609|Antiviral Agents|antiviral agents|mesh-ancestor
24473033|NCT00401609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24473118|NCT00402038|Sensory System Agents|sensory system agents|mesh-ancestor
24473119|NCT00402038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24473120|NCT00402077|Pramlintide|pramlintide|mesh-list
24473121|NCT00402077|Phentermine|phentermine|mesh-list
24473122|NCT00402077|Sibutramine|sibutramine|mesh-list
24473123|NCT00402077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24473124|NCT00402077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473125|NCT00402077|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24473126|NCT00402077|Appetite Depressants|appetite depressants|mesh-ancestor
24473127|NCT00402077|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24473128|NCT00402077|Sympathomimetics|sympathomimetics|mesh-ancestor
24473129|NCT00402077|Autonomic Agents|autonomic agents|mesh-ancestor
24473130|NCT00402077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24473131|NCT00402077|Adrenergic Agents|adrenergic agents|mesh-ancestor
24473253|NCT00402454|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24473254|NCT00402454|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24473255|NCT00402454|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24473256|NCT00402454|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24473257|NCT00402454|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24473258|NCT00402454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24473259|NCT00402454|Antimetabolites|antimetabolites|mesh-ancestor
24473260|NCT00402454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24473262|NCT00402467|Rivaroxaban|rivaroxaban|mesh-list
24473263|NCT00402467|Enoxaparin sodium|enoxaparin sodium|mesh-list
24473264|NCT00402467|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24473265|NCT00402467|Antithrombins|antithrombins|mesh-ancestor
24473266|NCT00402467|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24473267|NCT00402467|Protease Inhibitors|protease inhibitors|mesh-ancestor
24473268|NCT00402467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473269|NCT00402467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473270|NCT00402467|Anticoagulants|anticoagulants|mesh-ancestor
24628795|NCT01101412|Chelating Agents|chelating agents|mesh-ancestor
24473401|NCT00402636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24473402|NCT00402636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24628806|NCT01101529|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24628807|NCT01101529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24612708|NCT01015209|Chitosan|chitosan|mesh-list
24628808|NCT01101529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628809|NCT01101568|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24816461|NCT02077231|Retinol palmitate|retinol palmitate|mesh-list
24816462|NCT02077231|Micronutrients|micronutrients|mesh-ancestor
24816463|NCT02077231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816464|NCT02077231|Antioxidants|antioxidants|mesh-ancestor
24816465|NCT02077231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816466|NCT02077231|Protective Agents|protective agents|mesh-ancestor
24816467|NCT02077231|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25700871|NCT02130063|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25700872|NCT02130063|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
24816468|NCT02077231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700873|NCT02130063|Trace Elements|trace elements|mesh-ancestor
25700874|NCT02130063|Micronutrients|micronutrients|mesh-ancestor
25700875|NCT02130063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700876|NCT02130063|Hematinics|hematinics|mesh-ancestor
25700877|NCT02130284|Insulin|insulin|mesh-list
24444812|NCT00299208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444813|NCT00299208|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24444814|NCT00299208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24444815|NCT00299208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24444816|NCT00299208|Analgesics|analgesics|mesh-ancestor
24444817|NCT00299208|Sensory System Agents|sensory system agents|mesh-ancestor
24444818|NCT00299234|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24444819|NCT00299234|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24473548|NCT00403286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24473549|NCT00403286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473551|NCT00403286|Respiratory System Agents|respiratory system agents|mesh-ancestor
24473552|NCT00403286|Dermatologic Agents|dermatologic agents|mesh-ancestor
24473553|NCT00403286|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24473554|NCT00403286|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24473555|NCT00403286|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24473556|NCT00403286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24473557|NCT00403286|Adrenergic Agents|adrenergic agents|mesh-ancestor
24816484|NCT02077309|Protease Inhibitors|protease inhibitors|mesh-ancestor
24816485|NCT02077309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816486|NCT02077309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816487|NCT02077322|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
24816488|NCT02077322|Hemostatics|hemostatics|mesh-ancestor
24816489|NCT02077322|Coagulants|coagulants|mesh-ancestor
24816492|NCT02077348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24816493|NCT02077400|Cefazolin|cefazolin|mesh-list
24816494|NCT02077400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24816495|NCT02077400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24816571|NCT02077777|Aminosalicylic Acid|aminosalicylic acid|mesh-list
24965458|NCT03776838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24965459|NCT03776838|Anesthetics, General|anesthetics, general|mesh-ancestor
24965460|NCT03776838|Anesthetics|anesthetics|mesh-ancestor
24965461|NCT03777345|Cobalt|cobalt|mesh-list
24965462|NCT03777345|Chromium|chromium|mesh-list
24965463|NCT03777345|Trace Elements|trace elements|mesh-ancestor
24965464|NCT03777345|Micronutrients|micronutrients|mesh-ancestor
24965465|NCT03777345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965466|NCT03776955|Carvedilol|carvedilol|mesh-list
24816801|NCT02078895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816802|NCT02078895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24816803|NCT02078895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816804|NCT02078973|Tolvaptan|tolvaptan|mesh-list
24816805|NCT02078973|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24816806|NCT02078973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816807|NCT02078973|Natriuretic Agents|natriuretic agents|mesh-ancestor
24816808|NCT02078973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817645|NCT02084784|Methylene Blue|methylene blue|mesh-list
24473677|NCT00403780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473678|NCT00403780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24473680|NCT00403780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24628821|NCT01101581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24628825|NCT01101581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628827|NCT01101620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24628828|NCT01101620|Vasodilator Agents|vasodilator agents|mesh-ancestor
24628829|NCT01101620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24667185|NCT05461092|Morphine|morphine|mesh-list
24668589|NCT04764630|Naloxone|naloxone|mesh-list
24669728|NCT03691376|Aldesleukin|aldesleukin|mesh-list
24669795|NCT03613181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24550452|NCT00720590|Ritonavir|ritonavir|mesh-list
24473682|NCT00403780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25700878|NCT02130284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25700879|NCT02130284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25700880|NCT02130284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700881|NCT02130557|Imatinib Mesylate|imatinib mesylate|mesh-list
25700882|NCT02130557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25086549|NCT03288610|Natriuretic Agents|natriuretic agents|mesh-ancestor
25086550|NCT03288610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473683|NCT00403806|Dexamethasone|dexamethasone|mesh-list
24473684|NCT00403806|Dexamethasone acetate|dexamethasone acetate|mesh-list
24473687|NCT00403806|Antiemetics|antiemetics|mesh-ancestor
24444849|NCT00299364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473737|NCT00403975|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24473738|NCT00403975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24473739|NCT00403988|Oxaliplatin|oxaliplatin|mesh-list
24473740|NCT00403988|Vinorelbine|vinorelbine|mesh-list
24473741|NCT00403988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697051|NCT01432496|Anesthetics|anesthetics|mesh-ancestor
24473742|NCT00403988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24445547|NCT00301847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445548|NCT00301860|Cyclosporine|cyclosporine|mesh-list
24445604|NCT00301912|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24445605|NCT00301912|Alkylating Agents|alkylating agents|mesh-ancestor
24445606|NCT00301912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24473761|NCT00404131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24473763|NCT00404157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24817033|NCT02080377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817035|NCT02080416|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24817036|NCT02080416|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24613143|NCT01017380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24613144|NCT01017380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24613145|NCT01017380|Analgesics|analgesics|mesh-ancestor
24817290|NCT02082405|Alkylating Agents|alkylating agents|mesh-ancestor
24817291|NCT02082405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817292|NCT02082405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550496|NCT00720811|Sensory System Agents|sensory system agents|mesh-ancestor
24445962|NCT00303290|Antimetabolites|antimetabolites|mesh-ancestor
24445963|NCT00303290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445964|NCT00303290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24445965|NCT00303290|Immunologic Factors|immunologic factors|mesh-ancestor
24550499|NCT00720811|Antipyretics|antipyretics|mesh-ancestor
24550510|NCT00720850|Lenalidomide|lenalidomide|mesh-list
24550511|NCT00720850|Immunologic Factors|immunologic factors|mesh-ancestor
24550512|NCT00720850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550513|NCT00720850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24550514|NCT00720850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24613434|NCT01019083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24817419|NCT02083575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817420|NCT02083575|Antioxidants|antioxidants|mesh-ancestor
24817421|NCT02083575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817422|NCT02083575|Protective Agents|protective agents|mesh-ancestor
24817423|NCT02083575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24817424|NCT02083575|Chelating Agents|chelating agents|mesh-ancestor
24817425|NCT02083575|Sequestering Agents|sequestering agents|mesh-ancestor
24817426|NCT02083627|Fidaxomicin|fidaxomicin|mesh-list
24817427|NCT02083627|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24817428|NCT02083627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25700883|NCT02130557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25700884|NCT02130557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700885|NCT02130557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700886|NCT02130635|Nemiralisib|nemiralisib|mesh-list
25700887|NCT02130635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25700888|NCT02130635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700889|NCT02130635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086800|NCT03285906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774738|NCT01847599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445995|NCT00303433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24817429|NCT02083627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24817430|NCT02083627|Antimetabolites|antimetabolites|mesh-ancestor
24817431|NCT02083627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817432|NCT02083627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25079479|NCT03347591|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24446216|NCT00304018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24550517|NCT00720850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550518|NCT00720902|Hormones|hormones|mesh-list
24550519|NCT00720902|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
24550520|NCT00720902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24550521|NCT00720902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550522|NCT00720915|Anticoagulants|anticoagulants|mesh-list
24550523|NCT00720915|Fibrin fragment D|fibrin fragment d|mesh-list
24550539|NCT00721032|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24550540|NCT00721032|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24550541|NCT00721032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24550543|NCT00721201|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24550544|NCT00721201|Abortifacient Agents|abortifacient agents|mesh-ancestor
24550545|NCT00721201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24550546|NCT00721201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474451|NCT00406042|Antiemetics|antiemetics|mesh-ancestor
24473998|NCT00404716|Autonomic Agents|autonomic agents|mesh-ancestor
24473999|NCT00404716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24474000|NCT00404716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474001|NCT00404716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24474002|NCT00404716|Respiratory System Agents|respiratory system agents|mesh-ancestor
24474003|NCT00404716|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24474004|NCT00404716|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24474005|NCT00404716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474006|NCT00404716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24474007|NCT00404716|Vasodilator Agents|vasodilator agents|mesh-ancestor
24550559|NCT00721240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24550560|NCT00721240|Respiratory System Agents|respiratory system agents|mesh-ancestor
24550561|NCT00721240|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24550563|NCT00721240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24550564|NCT00721240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550565|NCT00721240|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24550566|NCT00721240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24474460|NCT00406094|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24897361|NCT04426955|Paclitaxel|paclitaxel|mesh-list
25700890|NCT02131064|Carboplatin|carboplatin|mesh-list
25700891|NCT02131064|Docetaxel|docetaxel|mesh-list
25700892|NCT02131064|Trastuzumab|trastuzumab|mesh-list
25700893|NCT02131064|Pertuzumab|pertuzumab|mesh-list
25700894|NCT02131064|Maytansine|maytansine|mesh-list
25700895|NCT02131064|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25700896|NCT02131064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24631067|NCT01115985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24631068|NCT01115985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24631069|NCT01115985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631072|NCT01116050|Abortifacient Agents|abortifacient agents|mesh-ancestor
24631089|NCT01116128|Hormones|hormones|mesh-ancestor
24462835|NCT00357643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25087109|NCT03282643|Tinzaparin|tinzaparin|mesh-list
24818217|NCT02087475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24818218|NCT02087488|Eszopiclone|eszopiclone|mesh-list
24965467|NCT03776955|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24818219|NCT02087488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24818220|NCT02087488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24818221|NCT02087488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550567|NCT00721240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550568|NCT00721305|Lovastatin|lovastatin|mesh-list
24550569|NCT00721305|L 647318|l 647318|mesh-list
24550570|NCT00721305|Dihydromevinolin|dihydromevinolin|mesh-list
24550571|NCT00721305|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24550572|NCT00721305|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24550573|NCT00721305|Antimetabolites|antimetabolites|mesh-ancestor
24550574|NCT00721305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550575|NCT00721305|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24550576|NCT00721305|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24550577|NCT00721305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550578|NCT00721331|Mometasone Furoate|mometasone furoate|mesh-list
24550579|NCT00721331|Loratadine|loratadine|mesh-list
24550580|NCT00721331|Nortriptyline|nortriptyline|mesh-list
24550581|NCT00721331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24550582|NCT00721331|Dermatologic Agents|dermatologic agents|mesh-ancestor
24550583|NCT00721331|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24550584|NCT00721331|Antipruritics|antipruritics|mesh-ancestor
24550585|NCT00721331|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24550586|NCT00721331|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24550587|NCT00721331|Histamine Antagonists|histamine antagonists|mesh-ancestor
24697804|NCT01437371|Captopril|captopril|mesh-list
24697805|NCT01437371|Trandolapril|trandolapril|mesh-list
24697806|NCT01437371|Enzyme Inhibitors|enzyme inhibitors|mesh-list
24697807|NCT01437371|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24697808|NCT01437371|Protease Inhibitors|protease inhibitors|mesh-ancestor
24550589|NCT00721331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24550608|NCT00721448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24550609|NCT00721448|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24550610|NCT00721448|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24550611|NCT00721448|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24550612|NCT00721448|Purinergic Agents|purinergic agents|mesh-ancestor
24550613|NCT00721448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24550614|NCT00721448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446294|NCT00304317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446296|NCT00304369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446297|NCT00304369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24446298|NCT00304369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24446299|NCT00304369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24446300|NCT00304382|Vaccines|vaccines|mesh-list
24446301|NCT00304382|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24446302|NCT00304382|Immunologic Factors|immunologic factors|mesh-ancestor
24446303|NCT00304382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446304|NCT00304421|Rabeprazole|rabeprazole|mesh-list
24446305|NCT00304421|Pantoprazole|pantoprazole|mesh-list
24446306|NCT00304421|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24535354|NCT00649012|Pioglitazone|pioglitazone|mesh-list
25700897|NCT02131064|Tubulin Modulators|tubulin modulators|mesh-ancestor
25700898|NCT02131064|Antimitotic Agents|antimitotic agents|mesh-ancestor
25700899|NCT02131064|Mitosis Modulators|mitosis modulators|mesh-ancestor
25700900|NCT02131064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700901|NCT02131064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25700902|NCT02131064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25700903|NCT02131233|Raltegravir Potassium|raltegravir potassium|mesh-list
25700904|NCT02131233|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24631513|NCT01118598|Niacinamide|niacinamide|mesh-list
24631514|NCT01118598|Vitamin B Complex|vitamin b complex|mesh-ancestor
25087293|NCT03280095|Codeine|codeine|mesh-list
25087303|NCT03280095|Antitussive Agents|antitussive agents|mesh-ancestor
24550619|NCT00721487|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24818511|NCT02089178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24818512|NCT02089204|Deoxyglucose|deoxyglucose|mesh-list
24818513|NCT02089204|Fluorides|fluorides|mesh-list
24818514|NCT02089204|Cariostatic Agents|cariostatic agents|mesh-ancestor
24818515|NCT02089204|Protective Agents|protective agents|mesh-ancestor
24818516|NCT02089204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818517|NCT02089204|Antimetabolites|antimetabolites|mesh-ancestor
24818518|NCT02089204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818519|NCT02089204|Antiviral Agents|antiviral agents|mesh-ancestor
24818520|NCT02089204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24818521|NCT02089256|Liraglutide|liraglutide|mesh-list
24818522|NCT02089256|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25079480|NCT03347591|Protective Agents|protective agents|mesh-ancestor
24965468|NCT03776955|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24965469|NCT03776955|Adrenergic Agents|adrenergic agents|mesh-ancestor
24697904|NCT01437813|Glimepiride|glimepiride|mesh-list
24697905|NCT01437813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24965470|NCT03776955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24965471|NCT03776955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965472|NCT03776955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965473|NCT03776955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24965474|NCT03776955|Antioxidants|antioxidants|mesh-ancestor
24965475|NCT03776955|Protective Agents|protective agents|mesh-ancestor
24965476|NCT03776955|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24965477|NCT03776955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24965478|NCT03776955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24965479|NCT03776955|Vasodilator Agents|vasodilator agents|mesh-ancestor
24965480|NCT03776955|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24965481|NCT03776955|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24965482|NCT03776656|Allopurinol|allopurinol|mesh-list
24965483|NCT03776656|Antimetabolites|antimetabolites|mesh-ancestor
24965484|NCT03776656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965485|NCT03776656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24965486|NCT03776656|Gout Suppressants|gout suppressants|mesh-ancestor
24965487|NCT03776656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24773964|NCT01843153|Anesthetics, Local|anesthetics, local|mesh-ancestor
24965488|NCT03776656|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24965489|NCT03776656|Antioxidants|antioxidants|mesh-ancestor
24965490|NCT03776656|Protective Agents|protective agents|mesh-ancestor
24965491|NCT03776656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965492|NCT03776409|Vancomycin|vancomycin|mesh-list
24965493|NCT03776409|Tazobactam|tazobactam|mesh-list
24965494|NCT03776409|Piperacillin|piperacillin|mesh-list
24965495|NCT03776409|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24818523|NCT02089256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818524|NCT02089256|Incretins|incretins|mesh-ancestor
24818525|NCT02089256|Hormones|hormones|mesh-ancestor
24818526|NCT02089256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24818527|NCT02089295|Oxycodone|oxycodone|mesh-list
24818528|NCT02089295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24818529|NCT02089295|Narcotics|narcotics|mesh-ancestor
24698028|NCT01438515|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24698029|NCT01438554|Trametinib|trametinib|mesh-list
24698030|NCT01438554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698095|NCT01438749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24698096|NCT01438749|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25700905|NCT02131233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25700906|NCT02131233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25700907|NCT02131233|Antiviral Agents|antiviral agents|mesh-ancestor
25700908|NCT02131233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24698097|NCT01438749|Anesthetics, General|anesthetics, general|mesh-ancestor
24698098|NCT01438749|Anesthetics|anesthetics|mesh-ancestor
25700909|NCT02131233|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24698099|NCT01438749|GABA Modulators|gaba modulators|mesh-ancestor
24698100|NCT01438749|GABA Agents|gaba agents|mesh-ancestor
24818530|NCT02089295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24818531|NCT02089295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818532|NCT02089295|Analgesics|analgesics|mesh-ancestor
24818533|NCT02089295|Sensory System Agents|sensory system agents|mesh-ancestor
25079488|NCT03347526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079489|NCT03347526|Hormones|hormones|mesh-ancestor
25079490|NCT03347526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25079491|NCT03347513|Glycine|glycine|mesh-list
25079492|NCT03347513|Glycine Agents|glycine agents|mesh-ancestor
25079493|NCT03347513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25079494|NCT03347513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079495|NCT03347513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079496|NCT03347461|Ciprofloxacin|ciprofloxacin|mesh-list
25079497|NCT03347461|Dexamethasone|dexamethasone|mesh-list
25079498|NCT03347461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25079499|NCT03347461|Antiemetics|antiemetics|mesh-ancestor
25079500|NCT03347461|Autonomic Agents|autonomic agents|mesh-ancestor
25079501|NCT03347461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25079502|NCT03347461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079503|NCT03347461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25079504|NCT03347461|Glucocorticoids|glucocorticoids|mesh-ancestor
25079505|NCT03347461|Hormones|hormones|mesh-ancestor
25079506|NCT03347461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25079507|NCT03347461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25079508|NCT03347461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550627|NCT00721487|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24550628|NCT00721487|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24550630|NCT00721526|Lorazepam|lorazepam|mesh-list
24550631|NCT00721526|Anticonvulsants|anticonvulsants|mesh-ancestor
24550632|NCT00721526|Antiemetics|antiemetics|mesh-ancestor
24550634|NCT00721526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24550635|NCT00721526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698161|NCT01439230|Cholinergic Agents|cholinergic agents|mesh-ancestor
24550638|NCT00721526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24550640|NCT00721526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24550641|NCT00721526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24474195|NCT00405236|Tiotropium Bromide|tiotropium bromide|mesh-list
24474196|NCT00405236|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24474197|NCT00405236|Autonomic Agents|autonomic agents|mesh-ancestor
24474198|NCT00405236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24474199|NCT00405236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818776|NCT02090790|Dexamethasone acetate|dexamethasone acetate|mesh-list
24818778|NCT02090790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24818779|NCT02090790|Antiemetics|antiemetics|mesh-ancestor
24818780|NCT02090790|Autonomic Agents|autonomic agents|mesh-ancestor
24818781|NCT02090790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24818782|NCT02090790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818783|NCT02090790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24818784|NCT02090790|Glucocorticoids|glucocorticoids|mesh-ancestor
24818785|NCT02090790|Hormones|hormones|mesh-ancestor
24818786|NCT02090790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24818787|NCT02090790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24818788|NCT02090790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24818789|NCT02090790|Protease Inhibitors|protease inhibitors|mesh-ancestor
24818790|NCT02090790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24818791|NCT02090790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818792|NCT02090829|Oxytocin|oxytocin|mesh-list
24818793|NCT02090829|Oxytocics|oxytocics|mesh-ancestor
24818794|NCT02090829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25088321|NCT04962022|Antiviral Agents|antiviral agents|mesh-ancestor
25088322|NCT04962022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25088325|NCT04962022|Antifungal Agents|antifungal agents|mesh-ancestor
25088444|NCT04427904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25088445|NCT04427904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25088446|NCT04427904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25088447|NCT04427904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25088448|NCT04427904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818795|NCT02090829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818796|NCT02090920|Nifedipine|nifedipine|mesh-list
24818797|NCT02090920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24818798|NCT02090920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24818799|NCT02090920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818800|NCT02090920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24818801|NCT02090920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819047|NCT02092766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24819048|NCT02092766|Antiviral Agents|antiviral agents|mesh-ancestor
24698250|NCT01440114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24698251|NCT01440114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698252|NCT01440114|Analgesics|analgesics|mesh-ancestor
24819049|NCT02092766|Schistosomicides|schistosomicides|mesh-ancestor
24819050|NCT02092766|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24819051|NCT02092766|Anthelmintics|anthelmintics|mesh-ancestor
24819052|NCT02092766|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24819053|NCT02092766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819054|NCT02092766|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24819055|NCT02092766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24819056|NCT02092766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24819057|NCT02092766|Analgesics|analgesics|mesh-ancestor
24819058|NCT02092766|Sensory System Agents|sensory system agents|mesh-ancestor
24819059|NCT02092818|Riociguat|riociguat|mesh-list
24819060|NCT02092818|Enzyme Activators|enzyme activators|mesh-ancestor
24819061|NCT02092818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819062|NCT02092896|Liraglutide|liraglutide|mesh-list
24819063|NCT02092896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24965497|NCT03776409|beta-Lactams|beta-lactams|mesh-list
24819064|NCT02092896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819065|NCT02092896|Incretins|incretins|mesh-ancestor
24819066|NCT02092896|Hormones|hormones|mesh-ancestor
24819067|NCT02092896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24819068|NCT02092974|Citalopram|citalopram|mesh-list
24819069|NCT02092974|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24759719|NCT01754116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24819074|NCT02092974|Serotonin Agents|serotonin agents|mesh-ancestor
24819077|NCT02092974|Antidepressive Agents|antidepressive agents|mesh-ancestor
24819078|NCT02092974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24550644|NCT00721526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24446413|NCT00304655|Dopamine Agonists|dopamine agonists|mesh-ancestor
24446418|NCT00304655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24550645|NCT00721526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550646|NCT00721526|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24550647|NCT00721526|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
24819307|NCT02094651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24819308|NCT02094651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819309|NCT02094651|Antimanic Agents|antimanic agents|mesh-ancestor
24819310|NCT02094651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24819311|NCT02094651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24819312|NCT02094651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24819313|NCT02094703|Levofloxacin|levofloxacin|mesh-list
24819314|NCT02094703|Ofloxacin|ofloxacin|mesh-list
24819315|NCT02094703|Solifenacin Succinate|solifenacin succinate|mesh-list
24819316|NCT02094703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24698258|NCT01440114|Anesthetics|anesthetics|mesh-ancestor
24698287|NCT01440361|Belimumab|belimumab|mesh-list
24698288|NCT01440361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25700910|NCT02131233|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25700911|NCT02131233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700912|NCT02131233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700913|NCT02131233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25700914|NCT02131233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25700915|NCT02131259|Afatinib|afatinib|mesh-list
25700916|NCT02131259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25700917|NCT02131259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24698289|NCT01440361|Immunologic Factors|immunologic factors|mesh-ancestor
24698290|NCT01440361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698343|NCT01440621|Vitamin B Complex|vitamin b complex|mesh-ancestor
24698345|NCT01440621|Micronutrients|micronutrients|mesh-ancestor
24819317|NCT02094703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24819318|NCT02094703|Renal Agents|renal agents|mesh-ancestor
24819319|NCT02094703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24819320|NCT02094703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24819321|NCT02094703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24819322|NCT02094703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819323|NCT02094703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819324|NCT02094703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24819325|NCT02094703|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24819326|NCT02094703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24819327|NCT02094703|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24819328|NCT02094703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24819329|NCT02094703|Cholinergic Agents|cholinergic agents|mesh-ancestor
24819330|NCT02094703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24819331|NCT02094703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819332|NCT02094703|Urological Agents|urological agents|mesh-ancestor
24550648|NCT00721526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550649|NCT00721552|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24810378|NCT02039869|Omeprazole|omeprazole|mesh-list
24550651|NCT00721552|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24550652|NCT00721552|Methylprednisolone|methylprednisolone|mesh-list
24550653|NCT00721552|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24550654|NCT00721552|Prednisolone acetate|prednisolone acetate|mesh-list
24550656|NCT00721552|Prednisolone phosphate|prednisolone phosphate|mesh-list
24550657|NCT00721552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24550658|NCT00721552|Glucocorticoids|glucocorticoids|mesh-ancestor
24550659|NCT00721552|Hormones|hormones|mesh-ancestor
24550660|NCT00721552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24550661|NCT00721552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550662|NCT00721552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24550663|NCT00721552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550664|NCT00721552|Antiemetics|antiemetics|mesh-ancestor
24550665|NCT00721552|Autonomic Agents|autonomic agents|mesh-ancestor
24550666|NCT00721552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24550667|NCT00721552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24550668|NCT00721552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24550669|NCT00721552|Protective Agents|protective agents|mesh-ancestor
24819627|NCT02096289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24819628|NCT02096289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24819629|NCT02096289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25079509|NCT03347461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819658|NCT02096510|Hydrocortisone|hydrocortisone|mesh-list
24819941|NCT02097966|Ribavirin|ribavirin|mesh-list
24759670|NCT01753752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24759671|NCT01753752|Antiviral Agents|antiviral agents|mesh-ancestor
24759672|NCT01753752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24759673|NCT01753752|Expectorants|expectorants|mesh-ancestor
24759674|NCT01753752|Respiratory System Agents|respiratory system agents|mesh-ancestor
24759675|NCT01753752|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24759676|NCT01753752|Antioxidants|antioxidants|mesh-ancestor
24759677|NCT01753752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759678|NCT01753752|Protective Agents|protective agents|mesh-ancestor
24759679|NCT01753752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759680|NCT01753752|Antidotes|antidotes|mesh-ancestor
24759681|NCT01753752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24759682|NCT01753752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24759683|NCT01753752|Antimetabolites|antimetabolites|mesh-ancestor
24759684|NCT01753752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24759685|NCT01753752|Chelating Agents|chelating agents|mesh-ancestor
24759686|NCT01753752|Sequestering Agents|sequestering agents|mesh-ancestor
24759687|NCT01753752|Hemostatics|hemostatics|mesh-ancestor
24759688|NCT01753752|Coagulants|coagulants|mesh-ancestor
24759689|NCT01753882|Citalopram|citalopram|mesh-list
24759690|NCT01753882|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25089043|NCT03269591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25089044|NCT03269591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795361|NCT02953509|Magrolimab|magrolimab|mesh-list
25089045|NCT03269591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089046|NCT03269383|Bupivacaine|bupivacaine|mesh-list
25089047|NCT03269383|Anesthetics, Local|anesthetics, local|mesh-ancestor
24632190|NCT01122563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632191|NCT01122563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632192|NCT01122563|Urological Agents|urological agents|mesh-ancestor
24632252|NCT01122940|Phenytoin|phenytoin|mesh-list
24759691|NCT01753882|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24759692|NCT01753882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24759693|NCT01753882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759694|NCT01753882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24759695|NCT01753882|Serotonin Agents|serotonin agents|mesh-ancestor
24759696|NCT01753882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759700|NCT01754116|Cabotegravir|cabotegravir|mesh-list
24759708|NCT01754116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24759709|NCT01754116|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24759710|NCT01754116|Anesthetics, General|anesthetics, general|mesh-ancestor
24759711|NCT01754116|Anesthetics|anesthetics|mesh-ancestor
24759712|NCT01754116|GABA Modulators|gaba modulators|mesh-ancestor
24759713|NCT01754116|GABA Agents|gaba agents|mesh-ancestor
24759714|NCT01754116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24759715|NCT01754116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759716|NCT01754116|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24759717|NCT01754116|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24759718|NCT01754116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759724|NCT01754181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24759725|NCT01754181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759727|NCT01754220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24759728|NCT01754220|Respiratory System Agents|respiratory system agents|mesh-ancestor
24759729|NCT01754220|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24759730|NCT01754220|Hormone Antagonists|hormone antagonists|mesh-ancestor
24550527|NCT00720915|Hemostatics|hemostatics|mesh-ancestor
24897633|NCT04423627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24897634|NCT04423627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24759775|NCT01754805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759776|NCT01754805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612848|NCT01015547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24612849|NCT01015547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612850|NCT01015547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24446423|NCT00304655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24446424|NCT00304668|Dapivirine|dapivirine|mesh-list
24446425|NCT00304668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24965499|NCT03776409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24965500|NCT03776409|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24965501|NCT03776409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24965502|NCT03776409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965504|NCT03776448|Antidotes|antidotes|mesh-ancestor
24965505|NCT03776448|Protective Agents|protective agents|mesh-ancestor
24965506|NCT03776448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965507|NCT03776383|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24965508|NCT03776383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24965509|NCT03776500|Macozinone|macozinone|mesh-list
24965510|NCT03776500|Antitubercular Agents|antitubercular agents|mesh-ancestor
24965511|NCT03776500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24965512|NCT03776500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24965513|NCT03776279|Mitoxantrone|mitoxantrone|mesh-list
25079513|NCT03347461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25700918|NCT02131259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700919|NCT02131259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700920|NCT02131272|Insulin|insulin|mesh-list
25700921|NCT02131272|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25700922|NCT02131272|Insulin Detemir|insulin detemir|mesh-list
25700923|NCT02131272|Isophane Insulin, Human|isophane insulin, human|mesh-list
25700924|NCT02131272|Insulin, Isophane|insulin, isophane|mesh-list
25700925|NCT02131272|Isophane insulin, beef|isophane insulin, beef|mesh-list
25700926|NCT02131272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25700927|NCT02131272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700928|NCT02131324|Clobetasol|clobetasol|mesh-list
24632750|NCT01125527|Immunologic Factors|immunologic factors|mesh-ancestor
25089295|NCT03267316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25089296|NCT03267316|Immunologic Factors|immunologic factors|mesh-ancestor
25079514|NCT03347461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25079515|NCT03347461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25079516|NCT03347461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25079517|NCT03347370|Interferons|interferons|mesh-list
25079518|NCT03347370|Interferon-beta|interferon-beta|mesh-list
25079519|NCT03347370|Interferon beta-1a|interferon beta-1a|mesh-list
25079520|NCT03347370|Interferon beta-1b|interferon beta-1b|mesh-list
25079521|NCT03347370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079522|NCT03347370|Antiviral Agents|antiviral agents|mesh-ancestor
25079523|NCT03347370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25079524|NCT03347370|Immunologic Factors|immunologic factors|mesh-ancestor
25079525|NCT03347370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079526|NCT03347370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25079527|NCT03347357|Tacrolimus|tacrolimus|mesh-list
25079528|NCT03347357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24474433|NCT00406003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25079540|NCT03347344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079541|NCT03347344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25079542|NCT03347344|Protective Agents|protective agents|mesh-ancestor
25079543|NCT03347240|Baclofen|baclofen|mesh-list
25079558|NCT03346993|Sensory System Agents|sensory system agents|mesh-ancestor
25079559|NCT03346993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25079561|NCT03346837|Rifampin|rifampin|mesh-list
25079562|NCT03346837|Linrodostat|linrodostat|mesh-list
25079563|NCT03346837|Antifungal Agents|antifungal agents|mesh-ancestor
25079564|NCT03346837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25079565|NCT03346837|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25079566|NCT03346837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24774131|NCT01843868|Glucocorticoids|glucocorticoids|mesh-ancestor
24759778|NCT01754805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759779|NCT01754805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24759782|NCT01754805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24759783|NCT01754805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24759785|NCT01754831|Fluorides, Topical|fluorides, topical|mesh-list
24759786|NCT01754831|Cariostatic Agents|cariostatic agents|mesh-ancestor
24759787|NCT01754831|Protective Agents|protective agents|mesh-ancestor
24759788|NCT01754831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759789|NCT01754844|AZD7624|azd7624|mesh-list
24759790|NCT01754844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24759791|NCT01754844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759792|NCT01754844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759793|NCT01754870|Rituximab|rituximab|mesh-list
24759794|NCT01754870|Lenalidomide|lenalidomide|mesh-list
24759822|NCT01754961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759823|NCT01754961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24897747|NCT04422392|Paclitaxel|paclitaxel|mesh-list
24759824|NCT01754961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24759826|NCT01754974|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24759827|NCT01754974|Antimetabolites|antimetabolites|mesh-ancestor
24759828|NCT01754974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759829|NCT01754974|Antiviral Agents|antiviral agents|mesh-ancestor
24759833|NCT01755078|Calcium|calcium|mesh-list
24759834|NCT01755078|Sevelamer|sevelamer|mesh-list
24759835|NCT01755078|Calcium acetate|calcium acetate|mesh-list
24759836|NCT01755078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24759837|NCT01755078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759839|NCT01755078|Antacids|antacids|mesh-ancestor
24759848|NCT01755117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759849|NCT01755117|Sensory System Agents|sensory system agents|mesh-ancestor
24759850|NCT01755117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24759851|NCT01755182|Somatostatin|somatostatin|mesh-list
24759852|NCT01755182|Hormones|hormones|mesh-ancestor
24759882|NCT01755338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24759883|NCT01755338|Antiemetics|antiemetics|mesh-ancestor
25700929|NCT02131324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25700930|NCT02131324|Glucocorticoids|glucocorticoids|mesh-ancestor
25700931|NCT02131324|Hormones|hormones|mesh-ancestor
25700932|NCT02131324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25700933|NCT02131324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700934|NCT02132117|Phenylephrine|phenylephrine|mesh-list
25700935|NCT02132117|Oxymetazoline|oxymetazoline|mesh-list
24633324|NCT01128322|Vitamins|vitamins|mesh-ancestor
24759927|NCT01755494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795402|NCT02807454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759928|NCT01755494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550740|NCT00722098|Vaccines|vaccines|mesh-list
24550741|NCT00722098|Immunologic Factors|immunologic factors|mesh-ancestor
24550742|NCT00722098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550750|NCT00722150|Artesunate|artesunate|mesh-list
24759929|NCT01755520|Aspirin|aspirin|mesh-list
24759930|NCT01755520|Ticagrelor|ticagrelor|mesh-list
24759931|NCT01755520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24759932|NCT01755520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24759933|NCT01755520|Analgesics|analgesics|mesh-ancestor
24759934|NCT01755520|Sensory System Agents|sensory system agents|mesh-ancestor
24759935|NCT01755520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24759936|NCT01755520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759937|NCT01755520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24759938|NCT01755520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24759939|NCT01755520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24446531|NCT00305201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24446532|NCT00305201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446533|NCT00305266|gamma-Globulins|gamma-globulins|mesh-list
24446534|NCT00305266|Immunologic Factors|immunologic factors|mesh-ancestor
24759960|NCT01755559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24759961|NCT01755559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446569|NCT00305370|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24446570|NCT00305370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24446571|NCT00305383|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24446572|NCT00305383|Taribavirin|taribavirin|mesh-list
24759984|NCT01755663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24759985|NCT01755663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24759986|NCT01755663|Adrenergic Agents|adrenergic agents|mesh-ancestor
24759987|NCT01755663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24759988|NCT01755663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759989|NCT01755676|Orlistat|orlistat|mesh-list
24759990|NCT01755676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759991|NCT01755676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759992|NCT01755676|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24759993|NCT01755676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24759994|NCT01755728|Acetaminophen|acetaminophen|mesh-list
24759995|NCT01755728|Ibuprofen|ibuprofen|mesh-list
24759996|NCT01755728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24759997|NCT01755728|Analgesics|analgesics|mesh-ancestor
24759998|NCT01755728|Sensory System Agents|sensory system agents|mesh-ancestor
24759999|NCT01755728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24760000|NCT01755728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760001|NCT01755728|Antipyretics|antipyretics|mesh-ancestor
24760002|NCT01755728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24760003|NCT01755728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24760004|NCT01755728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24699138|NCT01445210|Anesthetics|anesthetics|mesh-ancestor
24760021|NCT01755871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760022|NCT01755897|Paclitaxel|paclitaxel|mesh-list
24965556|NCT03775876|Anesthetics|anesthetics|mesh-ancestor
24965557|NCT03775876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24965558|NCT03775876|Analgesics|analgesics|mesh-ancestor
24965559|NCT03775876|Sensory System Agents|sensory system agents|mesh-ancestor
24965560|NCT03775876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24965561|NCT03775876|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24965562|NCT03775876|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24965563|NCT03775876|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24965564|NCT03775876|Adrenergic Agents|adrenergic agents|mesh-ancestor
24965565|NCT03775876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24965566|NCT03775876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965567|NCT03775668|Enmetazobactam|enmetazobactam|mesh-list
24965568|NCT03775668|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24965569|NCT03775668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24965570|NCT03775668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699669|NCT01448330|Antipyretics|antipyretics|mesh-ancestor
25700936|NCT02132117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25700937|NCT02132117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25700938|NCT02132117|Adrenergic Agents|adrenergic agents|mesh-ancestor
24699670|NCT01448330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24699672|NCT01448330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24965571|NCT03775668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24965572|NCT03775668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24965573|NCT03775863|Liver Extracts|liver extracts|mesh-list
24965574|NCT03775863|Hematinics|hematinics|mesh-ancestor
24897843|NCT04421300|Hyaluronic Acid|hyaluronic acid|mesh-list
24474462|NCT00406094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24474464|NCT00406094|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24474465|NCT00406094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24474466|NCT00406094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474467|NCT00406146|Artesunate|artesunate|mesh-list
24474468|NCT00406146|Lumefantrine|lumefantrine|mesh-list
24474469|NCT00406146|Artemether|artemether|mesh-list
24474470|NCT00406146|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24474471|NCT00406146|Amodiaquine|amodiaquine|mesh-list
24474472|NCT00406146|Antimalarials|antimalarials|mesh-ancestor
24474473|NCT00406146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24474474|NCT00406146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24474475|NCT00406146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446605|NCT00305461|Ciclesonide|ciclesonide|mesh-list
24965577|NCT03775707|Immunologic Factors|immunologic factors|mesh-ancestor
24965578|NCT03775707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965579|NCT03775707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965580|NCT03775707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24965581|NCT03775707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474574|NCT00406731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474576|NCT00406744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24474577|NCT00406744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474578|NCT00406744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24474579|NCT00406744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24474580|NCT00406744|Growth Substances|growth substances|mesh-ancestor
24474581|NCT00406744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474588|NCT00406796|Growth Inhibitors|growth inhibitors|mesh-ancestor
24474589|NCT00406796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474590|NCT00406861|Montelukast|montelukast|mesh-list
24474591|NCT00406861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24760048|NCT01756105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760050|NCT01756118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079569|NCT03346837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25079570|NCT03346837|Hormone Antagonists|hormone antagonists|mesh-ancestor
24474705|NCT00407056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474706|NCT00407082|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
24474707|NCT00407082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24474719|NCT00407121|Growth Inhibitors|growth inhibitors|mesh-ancestor
24474720|NCT00407186|Cisplatin|cisplatin|mesh-list
24474721|NCT00407186|Capecitabine|capecitabine|mesh-list
24474722|NCT00407186|Epirubicin|epirubicin|mesh-list
25079593|NCT03346681|Respiratory System Agents|respiratory system agents|mesh-ancestor
25079594|NCT03346681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24774367|NCT01845194|Antitussive Agents|antitussive agents|mesh-ancestor
24760051|NCT01756131|Cabotegravir|cabotegravir|mesh-list
24760052|NCT01756131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24760053|NCT01756131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24760054|NCT01756131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760055|NCT01756131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760056|NCT01756131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24760057|NCT01756131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24760058|NCT01756131|Antiviral Agents|antiviral agents|mesh-ancestor
24760059|NCT01756131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24760060|NCT01756170|Paclitaxel|paclitaxel|mesh-list
24760061|NCT01756170|Cisplatin|cisplatin|mesh-list
24760062|NCT01756170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24760063|NCT01756170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760064|NCT01756170|Tubulin Modulators|tubulin modulators|mesh-ancestor
24760065|NCT01756170|Antimitotic Agents|antimitotic agents|mesh-ancestor
24760068|NCT01756183|Paclitaxel|paclitaxel|mesh-list
24760109|NCT01756430|Protective Agents|protective agents|mesh-ancestor
24760110|NCT01756430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24760111|NCT01756430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24760112|NCT01756430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24760113|NCT01756430|Vasodilator Agents|vasodilator agents|mesh-ancestor
24760114|NCT01756430|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24760115|NCT01756430|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24760116|NCT01756443|Lidocaine|lidocaine|mesh-list
24760117|NCT01756443|Epinephrine|epinephrine|mesh-list
24760118|NCT01756443|Racepinephrine|racepinephrine|mesh-list
24760127|NCT01756443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24420123|NCT00215241|Risperidone|risperidone|mesh-list
24760128|NCT01756443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24760129|NCT01756443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24760130|NCT01756443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24760131|NCT01756443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760132|NCT01756443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24760133|NCT01756443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24760134|NCT01756443|Adrenergic Agents|adrenergic agents|mesh-ancestor
24760135|NCT01756443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24760136|NCT01756443|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24760137|NCT01756443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24760138|NCT01756443|Autonomic Agents|autonomic agents|mesh-ancestor
24760149|NCT01756495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24760150|NCT01756495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760151|NCT01756495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760152|NCT01756495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760153|NCT01756495|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24760154|NCT01756495|Contraceptive Agents|contraceptive agents|mesh-ancestor
24760155|NCT01756495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24760156|NCT01756495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760157|NCT01756495|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24760159|NCT01756495|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24760161|NCT01756508|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24760162|NCT01756508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24760163|NCT01756508|Immunologic Factors|immunologic factors|mesh-ancestor
24760164|NCT01756508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760166|NCT01756521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25700939|NCT02132117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25700940|NCT02132117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700941|NCT02132117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700942|NCT02132117|Sympathomimetics|sympathomimetics|mesh-ancestor
25700943|NCT02132117|Autonomic Agents|autonomic agents|mesh-ancestor
25700944|NCT02132117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25700945|NCT02132117|Nasal Decongestants|nasal decongestants|mesh-ancestor
25700946|NCT02132117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25700947|NCT02132117|Respiratory System Agents|respiratory system agents|mesh-ancestor
24760167|NCT01756521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24760168|NCT01756521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24760169|NCT01756521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24760170|NCT01756521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760171|NCT01756521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760172|NCT01756521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760173|NCT01756547|Potassium Citrate|potassium citrate|mesh-list
24760174|NCT01756547|Diuretics|diuretics|mesh-ancestor
24760175|NCT01756547|Natriuretic Agents|natriuretic agents|mesh-ancestor
24760176|NCT01756547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760177|NCT01756547|Expectorants|expectorants|mesh-ancestor
24760178|NCT01756547|Respiratory System Agents|respiratory system agents|mesh-ancestor
24760179|NCT01756612|Epoetin Alfa|epoetin alfa|mesh-list
24760180|NCT01756612|Hematinics|hematinics|mesh-ancestor
24760181|NCT01756638|Prednisolone|prednisolone|mesh-list
24760182|NCT01756638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24760184|NCT01756638|Hormones|hormones|mesh-ancestor
24760188|NCT01756638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760190|NCT01756651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24760191|NCT01756651|Narcotics|narcotics|mesh-ancestor
24760192|NCT01756651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24760193|NCT01756651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760194|NCT01756651|Analgesics|analgesics|mesh-ancestor
24760195|NCT01756651|Sensory System Agents|sensory system agents|mesh-ancestor
24760196|NCT01756651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24760197|NCT01756651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24760217|NCT01756781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24760218|NCT01756781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760220|NCT01756781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24760230|NCT01756781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24760233|NCT01756989|Celecoxib|celecoxib|mesh-list
24760234|NCT01756989|Etoposide|etoposide|mesh-list
24760235|NCT01756989|Etoposide phosphate|etoposide phosphate|mesh-list
24760236|NCT01756989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24760237|NCT01756989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760238|NCT01756989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24760239|NCT01756989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24760240|NCT01756989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760241|NCT01756989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760242|NCT01756989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24760243|NCT01756989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24760244|NCT01756989|Analgesics|analgesics|mesh-ancestor
24760245|NCT01756989|Sensory System Agents|sensory system agents|mesh-ancestor
24760246|NCT01756989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24760247|NCT01756989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760248|NCT01756989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24760249|NCT01756989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24760250|NCT01756989|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24760251|NCT01756989|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24760252|NCT01756989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24760253|NCT01756989|Immunologic Factors|immunologic factors|mesh-ancestor
24760255|NCT01756989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24760256|NCT01756989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24760257|NCT01756989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24760261|NCT01757015|Glycopyrrolate|glycopyrrolate|mesh-list
24760266|NCT01757015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24760267|NCT01757015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760268|NCT01757015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760269|NCT01757106|Sevoflurane|sevoflurane|mesh-list
24760270|NCT01757106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24760271|NCT01757106|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24760272|NCT01757106|Anesthetics, General|anesthetics, general|mesh-ancestor
24760273|NCT01757106|Anesthetics|anesthetics|mesh-ancestor
24774559|NCT01846364|Protective Agents|protective agents|mesh-ancestor
24760274|NCT01757106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24760275|NCT01757106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760276|NCT01757236|Vancomycin|vancomycin|mesh-list
24760277|NCT01757236|Rifampin|rifampin|mesh-list
24760278|NCT01757236|Clindamycin|clindamycin|mesh-list
24760279|NCT01757236|Ceftriaxone|ceftriaxone|mesh-list
24760280|NCT01757236|Linezolid|linezolid|mesh-list
24760281|NCT01757236|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24760282|NCT01757236|Fluoroquinolones|fluoroquinolones|mesh-list
24760283|NCT01757236|Trimethoprim|trimethoprim|mesh-list
24760284|NCT01757236|Sulfamethoxazole|sulfamethoxazole|mesh-list
24760285|NCT01757236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25700948|NCT02132117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25089967|NCT03261635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760286|NCT01757236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24760287|NCT01757236|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25700949|NCT02132117|Mydriatics|mydriatics|mesh-ancestor
24760288|NCT01757236|Antitubercular Agents|antitubercular agents|mesh-ancestor
24760289|NCT01757236|Leprostatic Agents|leprostatic agents|mesh-ancestor
24760334|NCT01757366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24760335|NCT01757366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760336|NCT01757431|Eculizumab|eculizumab|mesh-list
24760337|NCT01757431|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24760338|NCT01757431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24760339|NCT01757431|Immunologic Factors|immunologic factors|mesh-ancestor
24760340|NCT01757431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700460|NCT01452607|Antioxidants|antioxidants|mesh-ancestor
24613105|NCT01017107|Protein C|protein c|mesh-list
24760341|NCT01757457|Abciximab|abciximab|mesh-list
24760342|NCT01757457|Anticoagulants|anticoagulants|mesh-ancestor
24760343|NCT01757457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24760344|NCT01757574|Alemtuzumab|alemtuzumab|mesh-list
24760345|NCT01757574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24760346|NCT01757574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760347|NCT01757587|Insulin|insulin|mesh-list
24760348|NCT01757587|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24551198|NCT00724386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551199|NCT00724529|Infliximab|infliximab|mesh-list
24978789|NCT02903381|Hormones|hormones|mesh-ancestor
24551200|NCT00724529|Dermatologic Agents|dermatologic agents|mesh-ancestor
24551201|NCT00724529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24551202|NCT00724529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24551203|NCT00724542|Voglibose|voglibose|mesh-list
24551204|NCT00724542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24551205|NCT00724542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551206|NCT00724542|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24551207|NCT00724542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24551209|NCT00724581|Amiodarone|amiodarone|mesh-list
24551214|NCT00724581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551215|NCT00724581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25079596|NCT03346681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774630|NCT01846962|Glucocorticoids|glucocorticoids|mesh-ancestor
24551216|NCT00724581|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24551217|NCT00724581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24551218|NCT00724581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24551219|NCT00724581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24551220|NCT00724581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24501795|NCT00531115|Cetuximab|cetuximab|mesh-list
24551223|NCT00724620|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24551224|NCT00724620|Antimetabolites|antimetabolites|mesh-ancestor
24551225|NCT00724620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760352|NCT01757587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760353|NCT01757587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24760354|NCT01757587|Protease Inhibitors|protease inhibitors|mesh-ancestor
24760355|NCT01757587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760356|NCT01757587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760357|NCT01757639|Ipilimumab|ipilimumab|mesh-list
24760358|NCT01757639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24760359|NCT01757639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760360|NCT01757639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24760361|NCT01757639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760362|NCT01757756|Midazolam|midazolam|mesh-list
24760363|NCT01757756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24760364|NCT01757756|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24760375|NCT01757756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24760376|NCT01757756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760377|NCT01757769|Silodosin|silodosin|mesh-list
24760378|NCT01757769|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24760380|NCT01757769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24760381|NCT01757769|Adrenergic Agents|adrenergic agents|mesh-ancestor
24760382|NCT01757769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24760383|NCT01757769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760384|NCT01757769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700950|NCT02132117|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25700951|NCT02132117|Protective Agents|protective agents|mesh-ancestor
25700952|NCT02132169|Cetirizine|cetirizine|mesh-list
24965582|NCT03775707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965584|NCT03775902|Glimepiride|glimepiride|mesh-list
24965585|NCT03775902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25079598|NCT03346681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079599|NCT03346681|Antidotes|antidotes|mesh-ancestor
25079600|NCT03346642|Decitabine|decitabine|mesh-list
25079601|NCT03346642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25079602|NCT03346642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25079603|NCT03346642|Antimetabolites|antimetabolites|mesh-ancestor
25079604|NCT03346642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079605|NCT03346642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079606|NCT03346642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25079607|NCT03346629|Misoprostol|misoprostol|mesh-list
25079608|NCT03346629|Mifepristone|mifepristone|mesh-list
25079611|NCT03346629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25079624|NCT03346629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25079625|NCT03346629|Luteolytic Agents|luteolytic agents|mesh-ancestor
25079626|NCT03346629|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25079627|NCT03346629|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25079630|NCT03346538|Antioxidants|antioxidants|mesh-ancestor
25079631|NCT03346538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079632|NCT03346538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25079633|NCT03346538|Protective Agents|protective agents|mesh-ancestor
25079634|NCT03346538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079635|NCT03346525|Penicillins|penicillins|mesh-list
25079636|NCT03346525|Penicillin G|penicillin g|mesh-list
25079637|NCT03346525|Penicillin G Benzathine|penicillin g benzathine|mesh-list
25079642|NCT03346317|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25079643|NCT03346317|Estradiol|estradiol|mesh-list
25079644|NCT03346317|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25079645|NCT03346317|Dydrogesterone|dydrogesterone|mesh-list
25079646|NCT03346317|Estrogens|estrogens|mesh-ancestor
25079647|NCT03346317|Hormones|hormones|mesh-ancestor
25079648|NCT03346317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25079649|NCT03346317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079650|NCT03346317|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25079651|NCT03346317|Contraceptive Agents|contraceptive agents|mesh-ancestor
25079652|NCT03346317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25079653|NCT03346317|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25079654|NCT03346317|Progestins|progestins|mesh-ancestor
25079655|NCT03346252|Botulinum Toxins|botulinum toxins|mesh-list
25079656|NCT03346252|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25079657|NCT03346252|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25079658|NCT03346252|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25079659|NCT03346252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25079660|NCT03346252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760416|NCT01757899|Protective Agents|protective agents|mesh-ancestor
24760417|NCT01757899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24760418|NCT01757899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760420|NCT01758029|Testosterone|testosterone|mesh-list
24502129|NCT05319639|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24810453|NCT02040350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760434|NCT01758094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25700953|NCT02132169|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25700954|NCT02132169|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24760444|NCT01758107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24760445|NCT01758107|Dermatologic Agents|dermatologic agents|mesh-ancestor
24760446|NCT01758107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24760447|NCT01758107|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24760479|NCT01758172|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24760480|NCT01758172|Plasma Substitutes|plasma substitutes|mesh-ancestor
24760481|NCT01758172|Blood Substitutes|blood substitutes|mesh-ancestor
24760482|NCT01758185|Vaccines|vaccines|mesh-list
24760483|NCT01758185|Immunologic Factors|immunologic factors|mesh-ancestor
24760484|NCT01758185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760485|NCT01758198|Methotrexate|methotrexate|mesh-list
24760486|NCT01758198|Abatacept|abatacept|mesh-list
24760487|NCT01758198|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24760488|NCT01758198|Abortifacient Agents|abortifacient agents|mesh-ancestor
24760489|NCT01758198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24760490|NCT01758198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760491|NCT01758198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24760492|NCT01758198|Antimetabolites|antimetabolites|mesh-ancestor
24760493|NCT01758198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760494|NCT01758198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760495|NCT01758198|Dermatologic Agents|dermatologic agents|mesh-ancestor
24760496|NCT01758198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760497|NCT01758198|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24760498|NCT01758198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24760499|NCT01758198|Immunologic Factors|immunologic factors|mesh-ancestor
24760504|NCT01758263|Nebivolol|nebivolol|mesh-list
24760510|NCT01758263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760511|NCT01758263|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24760512|NCT01758263|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24760513|NCT01758263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24760514|NCT01758263|Adrenergic Agents|adrenergic agents|mesh-ancestor
24760515|NCT01758263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24760516|NCT01758263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760517|NCT01758263|Vasodilator Agents|vasodilator agents|mesh-ancestor
24760518|NCT01758263|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24760519|NCT01758263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24760520|NCT01758263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24760522|NCT01758367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24760523|NCT01758367|Antimetabolites|antimetabolites|mesh-ancestor
24760524|NCT01758367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474886|NCT00407862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24474887|NCT00407862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24474888|NCT00407862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402615|NCT00158028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24402616|NCT00158028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402617|NCT00158028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402816|NCT00158522|Antiviral Agents|antiviral agents|mesh-ancestor
24402826|NCT00158548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24474889|NCT00407927|Epinastine|epinastine|mesh-list
24474890|NCT00407927|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24760526|NCT01758367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760528|NCT01758380|Vildagliptin|vildagliptin|mesh-list
24760529|NCT01758380|Gliclazide|gliclazide|mesh-list
24760549|NCT01758471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24760550|NCT01758471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760552|NCT01758627|Dialysis Solutions|dialysis solutions|mesh-ancestor
24760553|NCT01758627|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24760554|NCT01758640|Warfarin|warfarin|mesh-list
24760555|NCT01758640|Phenindione|phenindione|mesh-list
24760556|NCT01758640|Anticoagulants|anticoagulants|mesh-ancestor
24760557|NCT01758666|Leucovorin|leucovorin|mesh-list
24760558|NCT01758666|Methotrexate|methotrexate|mesh-list
24760559|NCT01758666|Calcium|calcium|mesh-list
24760560|NCT01758666|Levoleucovorin|levoleucovorin|mesh-list
24701143|NCT01457261|Albuterol|albuterol|mesh-list
24760561|NCT01758666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24701269|NCT01458015|Tapentadol|tapentadol|mesh-list
24701270|NCT01458015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24701271|NCT01458015|Narcotics|narcotics|mesh-ancestor
24760562|NCT01758666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760565|NCT01758666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24760566|NCT01758666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24475318|NCT00409890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24475319|NCT00409890|Mydriatics|mydriatics|mesh-ancestor
24475320|NCT00409890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24898227|NCT04416399|Budesonide|budesonide|mesh-list
24760568|NCT01758666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760569|NCT01758666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760570|NCT01758666|Dermatologic Agents|dermatologic agents|mesh-ancestor
24760571|NCT01758666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760572|NCT01758666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24760573|NCT01758666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24760574|NCT01758666|Immunologic Factors|immunologic factors|mesh-ancestor
24760576|NCT01758666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24760577|NCT01758666|Antidotes|antidotes|mesh-ancestor
24760578|NCT01758666|Protective Agents|protective agents|mesh-ancestor
24760579|NCT01758666|Vitamin B Complex|vitamin b complex|mesh-ancestor
24760580|NCT01758666|Vitamins|vitamins|mesh-ancestor
24760581|NCT01758666|Micronutrients|micronutrients|mesh-ancestor
24760582|NCT01758744|Treprostinil|treprostinil|mesh-list
24760583|NCT01758744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24760584|NCT01758809|Bupivacaine|bupivacaine|mesh-list
24760585|NCT01758809|Anesthetics, Local|anesthetics, local|mesh-ancestor
24760592|NCT01758835|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
24760594|NCT01758835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760595|NCT01758835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760596|NCT01758913|Ibuprofen|ibuprofen|mesh-list
24760597|NCT01758913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24760598|NCT01758913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24898259|NCT04416035|Paclitaxel|paclitaxel|mesh-list
24898260|NCT04416035|Bevacizumab|bevacizumab|mesh-list
24898261|NCT04416035|Carboplatin|carboplatin|mesh-list
24898262|NCT04416035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24898263|NCT04416035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898264|NCT04416035|Tubulin Modulators|tubulin modulators|mesh-ancestor
24898265|NCT04416035|Antimitotic Agents|antimitotic agents|mesh-ancestor
24898266|NCT04416035|Mitosis Modulators|mitosis modulators|mesh-ancestor
24898267|NCT04416035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760599|NCT01758913|Analgesics|analgesics|mesh-ancestor
24760608|NCT01758978|Hydrocodone|hydrocodone|mesh-list
24760609|NCT01758978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25700955|NCT02132169|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25700956|NCT02132169|Histamine Antagonists|histamine antagonists|mesh-ancestor
25700957|NCT02132169|Histamine Agents|histamine agents|mesh-ancestor
25700958|NCT02132169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25700959|NCT02132169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760630|NCT01759108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760631|NCT01759108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760633|NCT01759394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760634|NCT01759394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760635|NCT01759485|Vitamin D|vitamin d|mesh-list
24760636|NCT01759485|Cholecalciferol|cholecalciferol|mesh-list
24403077|NCT00159159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24760637|NCT01759485|Vitamins|vitamins|mesh-ancestor
24760638|NCT01759485|Micronutrients|micronutrients|mesh-ancestor
24760639|NCT01759485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701328|NCT01458431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24701329|NCT01458431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760645|NCT01759524|Anesthetics, Local|anesthetics, local|mesh-ancestor
24760647|NCT01759524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24760648|NCT01759524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760649|NCT01759524|Sensory System Agents|sensory system agents|mesh-ancestor
24760650|NCT01759524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24774961|NCT01848925|Hydroxyurea|hydroxyurea|mesh-list
24760651|NCT01759524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24898352|NCT04415008|Cytarabine|cytarabine|mesh-list
24760652|NCT01759524|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24760653|NCT01759524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24760654|NCT01759524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24760655|NCT01759524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760656|NCT01759524|Analgesics|analgesics|mesh-ancestor
24760673|NCT01759589|Anesthetics|anesthetics|mesh-list
24760674|NCT01759589|Sevoflurane|sevoflurane|mesh-list
24760675|NCT01759589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24760676|NCT01759589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24760677|NCT01759589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760678|NCT01759589|Anesthetics, General|anesthetics, general|mesh-ancestor
24760679|NCT01759589|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24760680|NCT01759589|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24760681|NCT01759589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24760682|NCT01759589|Narcotics|narcotics|mesh-ancestor
24760683|NCT01759589|Analgesics|analgesics|mesh-ancestor
24760690|NCT01759706|Anesthetics|anesthetics|mesh-list
24760691|NCT01759706|Ropivacaine|ropivacaine|mesh-list
24760692|NCT01759706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24760693|NCT01759706|Antiemetics|antiemetics|mesh-ancestor
24760694|NCT01759706|Autonomic Agents|autonomic agents|mesh-ancestor
24760695|NCT01759706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24760696|NCT01759706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760698|NCT01759706|Glucocorticoids|glucocorticoids|mesh-ancestor
24760699|NCT01759706|Hormones|hormones|mesh-ancestor
24760700|NCT01759706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24760701|NCT01759706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24760702|NCT01759706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978940|NCT02318654|Anesthetics|anesthetics|mesh-ancestor
24760703|NCT01759706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24760704|NCT01759706|Antipruritics|antipruritics|mesh-ancestor
24760705|NCT01759706|Dermatologic Agents|dermatologic agents|mesh-ancestor
24760706|NCT01759706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24760707|NCT01759706|Serotonin Agents|serotonin agents|mesh-ancestor
24760708|NCT01759706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24760709|NCT01759706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760710|NCT01759706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24760711|NCT01759706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24760712|NCT01759706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25079679|NCT03346226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25079680|NCT03346226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25079681|NCT03346226|Adrenergic Agents|adrenergic agents|mesh-ancestor
25079682|NCT03346226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25079683|NCT03346226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079684|NCT03346200|Tamoxifen|tamoxifen|mesh-list
25700960|NCT02132169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079685|NCT03346200|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25079686|NCT03346200|Hormone Antagonists|hormone antagonists|mesh-ancestor
25700961|NCT02132195|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25700962|NCT02132195|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
25700963|NCT02132195|beta-Endorphin|beta-endorphin|mesh-list
25700964|NCT02132195|Hormones|hormones|mesh-ancestor
25700965|NCT02132195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25700966|NCT02132195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079687|NCT03346200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25079688|NCT03346200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079689|NCT03346200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24446627|NCT00305487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446628|NCT00305487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24446629|NCT00305500|Citalopram|citalopram|mesh-list
24475187|NCT00409318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25079690|NCT03346200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079691|NCT03346200|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24475189|NCT00409318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24475190|NCT00409318|Immunologic Factors|immunologic factors|mesh-ancestor
24475192|NCT00409357|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24475193|NCT00409357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24475194|NCT00409357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24475195|NCT00409357|Adrenergic Agents|adrenergic agents|mesh-ancestor
24475196|NCT00409357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25079721|NCT03346083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079722|NCT03346083|Anticoagulants|anticoagulants|mesh-ancestor
25079724|NCT03345992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25079725|NCT03345992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25079726|NCT03345992|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25079727|NCT03345992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25079728|NCT03345992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079729|NCT03345992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25079730|NCT03345992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25079731|NCT03345966|Antibodies|antibodies|mesh-list
25079732|NCT03345966|Immunologic Factors|immunologic factors|mesh-ancestor
25079733|NCT03345966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079734|NCT03345940|Dimethyl Fumarate|dimethyl fumarate|mesh-list
24965644|NCT03775538|Dopamine|dopamine|mesh-list
25079735|NCT03345940|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25079736|NCT03345940|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24551583|NCT05372887|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24551584|NCT05372887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551585|NCT05372887|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24551587|NCT05372887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24760718|NCT01759706|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24760719|NCT01759706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24760720|NCT01759706|Anesthetics, General|anesthetics, general|mesh-ancestor
24760721|NCT01759706|Anesthetics, Local|anesthetics, local|mesh-ancestor
24760722|NCT01759706|Anticonvulsants|anticonvulsants|mesh-ancestor
24760723|NCT01759706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24760724|NCT01759706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24760725|NCT01759706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24760726|NCT01759706|GABA Modulators|gaba modulators|mesh-ancestor
24760727|NCT01759706|GABA Agents|gaba agents|mesh-ancestor
24760728|NCT01759719|Chromium|chromium|mesh-list
24760729|NCT01759719|Trace Elements|trace elements|mesh-ancestor
24760730|NCT01759719|Micronutrients|micronutrients|mesh-ancestor
24760731|NCT01759719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760732|NCT01759732|Cyclophosphamide|cyclophosphamide|mesh-list
24760733|NCT01759732|Fludarabine|fludarabine|mesh-list
24760734|NCT01759732|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24760735|NCT01759732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24760768|NCT01759875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24760769|NCT01759875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24760770|NCT01759875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24760771|NCT01759875|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24760772|NCT01759875|Lipotropic Agents|lipotropic agents|mesh-ancestor
24760773|NCT01759875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24760775|NCT01759875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24760785|NCT01760005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760787|NCT01760018|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24760788|NCT01760018|Anesthetics, General|anesthetics, general|mesh-ancestor
24760789|NCT01760018|Anesthetics|anesthetics|mesh-ancestor
24760790|NCT01760018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24760791|NCT01760018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475292|NCT00409760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090907|NCT03252665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25090908|NCT03252665|Vitamin B Complex|vitamin b complex|mesh-ancestor
25090909|NCT03252665|Vitamins|vitamins|mesh-ancestor
25090910|NCT03252665|Micronutrients|micronutrients|mesh-ancestor
25090911|NCT03252665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090912|NCT03252457|Dexamethasone|dexamethasone|mesh-list
25090913|NCT03252457|Hydrocortisone|hydrocortisone|mesh-list
25090914|NCT03252457|Decitabine|decitabine|mesh-list
25090915|NCT03252457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25090922|NCT03252457|Hormones|hormones|mesh-ancestor
24760792|NCT01760096|Cyclosporine|cyclosporine|mesh-list
24760793|NCT01760096|Levamisole|levamisole|mesh-list
24760794|NCT01760096|Cyclosporins|cyclosporins|mesh-list
24760795|NCT01760096|Glucocorticoids|glucocorticoids|mesh-list
24760796|NCT01760096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760797|NCT01760096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760798|NCT01760096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24760799|NCT01760096|Immunologic Factors|immunologic factors|mesh-ancestor
24760800|NCT01760096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760801|NCT01760096|Antifungal Agents|antifungal agents|mesh-ancestor
24760802|NCT01760096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24760803|NCT01760096|Dermatologic Agents|dermatologic agents|mesh-ancestor
24760804|NCT01760096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24760805|NCT01760096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24760806|NCT01760096|Hormones|hormones|mesh-ancestor
24760807|NCT01760096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24760808|NCT01760096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24760809|NCT01760096|Antinematodal Agents|antinematodal agents|mesh-ancestor
24760810|NCT01760096|Anthelmintics|anthelmintics|mesh-ancestor
24760811|NCT01760096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24760812|NCT01760109|Piperacillin|piperacillin|mesh-list
24760813|NCT01760109|Sulbactam|sulbactam|mesh-list
24760814|NCT01760109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24760815|NCT01760109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24760816|NCT01760109|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24760817|NCT01760109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760818|NCT01760109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760819|NCT01760122|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24760820|NCT01760122|Antiviral Agents|antiviral agents|mesh-ancestor
24760821|NCT01760122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24760822|NCT01760148|Interferons|interferons|mesh-list
24760823|NCT01760148|Ribavirin|ribavirin|mesh-list
24760824|NCT01760148|Interferon-alpha|interferon-alpha|mesh-list
24760826|NCT01760148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760833|NCT01760161|Ropivacaine|ropivacaine|mesh-list
24760834|NCT01760161|Anesthetics, Local|anesthetics, local|mesh-ancestor
24760835|NCT01760161|Anesthetics|anesthetics|mesh-ancestor
24423615|NCT00226434|Antiviral Agents|antiviral agents|mesh-ancestor
24760836|NCT01760161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25079781|NCT03345095|Temozolomide|temozolomide|mesh-list
24760859|NCT01760226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24760860|NCT01760226|Alkylating Agents|alkylating agents|mesh-ancestor
24760861|NCT01760226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760862|NCT01760226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760863|NCT01760226|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24760864|NCT01760226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24760865|NCT01760226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24760866|NCT01760226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24760867|NCT01760226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25700967|NCT02132195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25700968|NCT02132195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700969|NCT02132247|Diclofenac|diclofenac|mesh-list
25700970|NCT02132247|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
25700971|NCT02132247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25700972|NCT02132247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25700973|NCT02132247|Analgesics|analgesics|mesh-ancestor
25700974|NCT02132247|Sensory System Agents|sensory system agents|mesh-ancestor
25091112|NCT03251222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24760868|NCT01760226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760869|NCT01760226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24760870|NCT01760226|Glucocorticoids|glucocorticoids|mesh-ancestor
24760872|NCT01760226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24760873|NCT01760226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24760874|NCT01760226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24760875|NCT01760226|Abortifacient Agents|abortifacient agents|mesh-ancestor
24760876|NCT01760226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24760877|NCT01760226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24760929|NCT01760460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24760930|NCT01760460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24760931|NCT01760460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760933|NCT01760564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760934|NCT01760564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760935|NCT01760564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24760936|NCT01760564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24760937|NCT01760564|Antiviral Agents|antiviral agents|mesh-ancestor
24760938|NCT01760564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24760939|NCT01760564|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24760940|NCT01760564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24760941|NCT01760564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760942|NCT01760577|Botulinum Toxins|botulinum toxins|mesh-list
24760943|NCT01760577|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24760944|NCT01760577|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24760945|NCT01760577|Hyaluronic Acid|hyaluronic acid|mesh-list
24760946|NCT01760577|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24550671|NCT00721552|Incretins|incretins|mesh-ancestor
24634014|NCT01131806|Xhance|xhance|mesh-list
24634266|NCT01132638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634268|NCT01132677|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24634269|NCT01132677|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24634270|NCT01132677|Prednisolone|prednisolone|mesh-list
24761348|NCT01762319|Abortifacient Agents|abortifacient agents|mesh-ancestor
24551857|NCT04892277|Fludarabine|fludarabine|mesh-list
24551858|NCT04892277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24551859|NCT04892277|Immunologic Factors|immunologic factors|mesh-ancestor
24551860|NCT04892277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551861|NCT04892277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24551862|NCT04892277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24551863|NCT04892277|Alkylating Agents|alkylating agents|mesh-ancestor
24551864|NCT04892277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551865|NCT04892277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24551866|NCT04892277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24760947|NCT01760577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24475872|NCT00411879|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24475881|NCT00411879|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24475882|NCT00411879|Respiratory System Agents|respiratory system agents|mesh-ancestor
24475883|NCT00411879|Mydriatics|mydriatics|mesh-ancestor
24475884|NCT00411879|Sympathomimetics|sympathomimetics|mesh-ancestor
24475886|NCT00411879|Hemostatics|hemostatics|mesh-ancestor
24760948|NCT01760577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24760949|NCT01760577|Cholinergic Agents|cholinergic agents|mesh-ancestor
24760950|NCT01760577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24760951|NCT01760577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760952|NCT01760577|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24760953|NCT01760577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24760954|NCT01760577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24760955|NCT01760577|Immunologic Factors|immunologic factors|mesh-ancestor
24760956|NCT01760577|Viscosupplements|viscosupplements|mesh-ancestor
24760957|NCT01760577|Protective Agents|protective agents|mesh-ancestor
24760959|NCT01760642|Ketoconazole|ketoconazole|mesh-list
24760960|NCT01760642|Midazolam|midazolam|mesh-list
24760961|NCT01760642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24760962|NCT01760642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24760963|NCT01760642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24634271|NCT01132677|Prednisolone acetate|prednisolone acetate|mesh-list
24760964|NCT01760642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503572|NCT00532285|Gemcitabine|gemcitabine|mesh-list
24760965|NCT01760642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24760966|NCT01760642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24760967|NCT01760642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24760968|NCT01760642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24760969|NCT01760642|Anesthetics, General|anesthetics, general|mesh-ancestor
24760971|NCT01760642|GABA Modulators|gaba modulators|mesh-ancestor
24760972|NCT01760642|GABA Agents|gaba agents|mesh-ancestor
24760979|NCT01760642|Leprostatic Agents|leprostatic agents|mesh-ancestor
24760981|NCT01760642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760982|NCT01760642|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24760983|NCT01760642|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24760984|NCT01760642|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24760987|NCT01760642|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24760988|NCT01760642|Antifungal Agents|antifungal agents|mesh-ancestor
24760989|NCT01760642|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24760990|NCT01760642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24760991|NCT01760642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24760992|NCT01760642|Hormone Antagonists|hormone antagonists|mesh-ancestor
24760993|NCT01760642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24760994|NCT01760642|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24760995|NCT01760655|Vidarabine|vidarabine|mesh-list
24760996|NCT01760655|Mycophenolic Acid|mycophenolic acid|mesh-list
24760997|NCT01760655|Cyclophosphamide|cyclophosphamide|mesh-list
24760998|NCT01760655|Thiotepa|thiotepa|mesh-list
24965712|NCT03774901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24965713|NCT03774901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079737|NCT03345940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079738|NCT03345940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25079739|NCT03345940|Immunologic Factors|immunologic factors|mesh-ancestor
25079740|NCT03345940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079741|NCT03345940|Dermatologic Agents|dermatologic agents|mesh-ancestor
24761000|NCT01760655|Fludarabine phosphate|fludarabine phosphate|mesh-list
24761001|NCT01760655|Tacrolimus|tacrolimus|mesh-list
24761002|NCT01760655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24634756|NCT01134926|Misoprostol|misoprostol|mesh-list
24634757|NCT01134926|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24634758|NCT01134926|Abortifacient Agents|abortifacient agents|mesh-ancestor
24634772|NCT01134991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24634773|NCT01134991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24761006|NCT01760655|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24761007|NCT01760655|Alkylating Agents|alkylating agents|mesh-ancestor
24761008|NCT01760655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761009|NCT01760655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761010|NCT01760655|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24761011|NCT01760655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24761012|NCT01760655|Antimetabolites|antimetabolites|mesh-ancestor
24761013|NCT01760655|Antiviral Agents|antiviral agents|mesh-ancestor
24761014|NCT01760655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24761015|NCT01760655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24761016|NCT01760655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761017|NCT01760655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24761018|NCT01760655|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24761019|NCT01760655|Antitubercular Agents|antitubercular agents|mesh-ancestor
24761027|NCT01760694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24761028|NCT01760694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761029|NCT01760694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761030|NCT01760694|Antidotes|antidotes|mesh-ancestor
24761031|NCT01760694|Protective Agents|protective agents|mesh-ancestor
25091574|NCT03248401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25091575|NCT03248401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091576|NCT03248401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24761032|NCT01760694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761033|NCT01760694|Vitamin B Complex|vitamin b complex|mesh-ancestor
24761034|NCT01760694|Vitamins|vitamins|mesh-ancestor
24761035|NCT01760694|Micronutrients|micronutrients|mesh-ancestor
24761036|NCT01760746|Bevacizumab|bevacizumab|mesh-list
24761037|NCT01760746|Ranibizumab|ranibizumab|mesh-list
24898714|NCT04411329|Analgesics|analgesics|mesh-ancestor
24761042|NCT01760746|Growth Substances|growth substances|mesh-ancestor
24761046|NCT01760798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24761047|NCT01760798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761048|NCT01760798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24761049|NCT01760811|Cetuximab|cetuximab|mesh-list
24634860|NCT01135628|Nitazoxanide|nitazoxanide|mesh-list
24665759|NCT01314586|Estrogens|estrogens|mesh-ancestor
24634861|NCT01135628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24634862|NCT01135628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24761050|NCT01760811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24761051|NCT01760811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761052|NCT01760824|Amoxicillin|amoxicillin|mesh-list
24761053|NCT01760824|Metronidazole|metronidazole|mesh-list
24761054|NCT01760824|Clarithromycin|clarithromycin|mesh-list
24761055|NCT01760824|Tetracycline|tetracycline|mesh-list
24551869|NCT04800224|Propolis|propolis|mesh-list
24761056|NCT01760824|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
24761057|NCT01760824|Esomeprazole|esomeprazole|mesh-list
24761058|NCT01760824|Bismuth|bismuth|mesh-list
24761059|NCT01760824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24761060|NCT01760824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24761061|NCT01760824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24761062|NCT01760824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24761067|NCT01760824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761068|NCT01760824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24761069|NCT01760824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24761070|NCT01760824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24761096|NCT01760980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24761097|NCT01760980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761098|NCT01761071|Diclofenac|diclofenac|mesh-list
24761099|NCT01761071|Ketorolac|ketorolac|mesh-list
24761100|NCT01761071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24761101|NCT01761071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24761102|NCT01761071|Analgesics|analgesics|mesh-ancestor
24476140|NCT00413179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24476141|NCT00413179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24762067|NCT01765881|Misoprostol|misoprostol|mesh-list
24476142|NCT00413179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24476144|NCT00413257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24476145|NCT00413257|Analgesics|analgesics|mesh-ancestor
24476146|NCT00413257|Sensory System Agents|sensory system agents|mesh-ancestor
24476147|NCT00413257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24476148|NCT00413257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761103|NCT01761071|Sensory System Agents|sensory system agents|mesh-ancestor
24761104|NCT01761071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24761105|NCT01761071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761106|NCT01761071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24761107|NCT01761071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24761108|NCT01761071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24761109|NCT01761071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761110|NCT01761071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761111|NCT01761110|Buprenorphine|buprenorphine|mesh-list
25700975|NCT02132247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25700976|NCT02132247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700977|NCT02132247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25700978|NCT02132247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25700979|NCT02132247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25700980|NCT02132247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25700981|NCT02132247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700982|NCT02132312|Phenylephrine|phenylephrine|mesh-list
25700983|NCT02132312|Oxymetazoline|oxymetazoline|mesh-list
24634863|NCT01135641|Cyclosporine|cyclosporine|mesh-list
24634864|NCT01135641|Rituximab|rituximab|mesh-list
24761112|NCT01761110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24761113|NCT01761110|Narcotics|narcotics|mesh-ancestor
24761114|NCT01761110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24761115|NCT01761110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761116|NCT01761110|Analgesics|analgesics|mesh-ancestor
24761117|NCT01761110|Sensory System Agents|sensory system agents|mesh-ancestor
24761118|NCT01761110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24761119|NCT01761110|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24761120|NCT01761149|Remifentanil|remifentanil|mesh-list
24761121|NCT01761149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24761122|NCT01761149|Narcotics|narcotics|mesh-ancestor
24761123|NCT01761149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24761124|NCT01761149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761125|NCT01761149|Analgesics|analgesics|mesh-ancestor
24761126|NCT01761149|Sensory System Agents|sensory system agents|mesh-ancestor
24761127|NCT01761149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24761131|NCT01761201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24761132|NCT01761201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24761133|NCT01761201|Renal Agents|renal agents|mesh-ancestor
24761134|NCT01761201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24761135|NCT01761201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24761136|NCT01761201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24761137|NCT01761201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761138|NCT01761201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761139|NCT01761201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761140|NCT01761201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24761143|NCT01761201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24761145|NCT01761201|Antimetabolites|antimetabolites|mesh-ancestor
24761146|NCT01761201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24761147|NCT01761214|Amoxicillin|amoxicillin|mesh-list
24761153|NCT01761214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24761154|NCT01761214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24761155|NCT01761214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24761156|NCT01761214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24761157|NCT01761214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761158|NCT01761214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761159|NCT01761214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761160|NCT01761214|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24761161|NCT01761214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24761162|NCT01761318|Liraglutide|liraglutide|mesh-list
24761163|NCT01761318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24761164|NCT01761318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761165|NCT01761318|Incretins|incretins|mesh-ancestor
24761167|NCT01761318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24761168|NCT01761344|Hydrocortisone|hydrocortisone|mesh-list
24761169|NCT01761344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24761170|NCT01761461|Oxaliplatin|oxaliplatin|mesh-list
24761171|NCT01761461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898867|NCT04410211|Anesthetics|anesthetics|mesh-ancestor
24761183|NCT01761513|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24761184|NCT01761513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761185|NCT01761513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761186|NCT01761526|Rotigotine|rotigotine|mesh-list
24761187|NCT01761526|Dopamine Agonists|dopamine agonists|mesh-ancestor
24761188|NCT01761526|Dopamine Agents|dopamine agents|mesh-ancestor
24761189|NCT01761526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24761190|NCT01761526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761191|NCT01761526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761192|NCT01761552|Atropine|atropine|mesh-list
24761193|NCT01761552|Neostigmine|neostigmine|mesh-list
24761194|NCT01761552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24761195|NCT01761552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24761196|NCT01761552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24761203|NCT01761552|Parasympatholytics|parasympatholytics|mesh-ancestor
25700984|NCT02132312|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24761204|NCT01761552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24761205|NCT01761552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24761206|NCT01761552|Cholinergic Agents|cholinergic agents|mesh-ancestor
24761207|NCT01761552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24761208|NCT01761552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761221|NCT01761669|Vitamins|vitamins|mesh-ancestor
24761222|NCT01761669|Micronutrients|micronutrients|mesh-ancestor
24761223|NCT01761669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761224|NCT01761669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24761225|NCT01761877|Sulindac|sulindac|mesh-list
24761226|NCT01761877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24761227|NCT01761877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24761228|NCT01761877|Analgesics|analgesics|mesh-ancestor
24761229|NCT01761877|Sensory System Agents|sensory system agents|mesh-ancestor
24761230|NCT01761877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24761231|NCT01761877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761232|NCT01761877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24761233|NCT01761877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24761234|NCT01761877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761247|NCT01761916|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24761248|NCT01761916|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24761249|NCT01761916|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24620117|NCT01055470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24620118|NCT01055470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620120|NCT01055470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24620121|NCT01055470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24620122|NCT01055470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620123|NCT01055470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620124|NCT01055483|Panobinostat|panobinostat|mesh-list
24620132|NCT01055522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24620134|NCT01055522|Sensory System Agents|sensory system agents|mesh-ancestor
24620135|NCT01055522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24620136|NCT01055522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620137|NCT01055522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24620138|NCT01055522|Alkylating Agents|alkylating agents|mesh-ancestor
24620139|NCT01055522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620152|NCT01055691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620153|NCT01055691|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24620154|NCT01055691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620155|NCT01055743|Fluorouracil|fluorouracil|mesh-list
24620156|NCT01055743|Antimetabolites|antimetabolites|mesh-ancestor
24761295|NCT01762163|Aspirin|aspirin|mesh-list
24761296|NCT01762163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24476546|NCT00415701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24476547|NCT00415740|Levodopa|levodopa|mesh-list
24476548|NCT00415740|Carbidopa|carbidopa|mesh-list
24476549|NCT00415740|Entacapone|entacapone|mesh-list
24476550|NCT00415740|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24476551|NCT00415740|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24476552|NCT00415740|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24476553|NCT00415740|Dopamine Agents|dopamine agents|mesh-ancestor
24476554|NCT00415740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24476692|NCT00416169|Autonomic Agents|autonomic agents|mesh-ancestor
24476698|NCT00416221|Citalopram|citalopram|mesh-list
24476699|NCT00416221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24476700|NCT00416221|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24476701|NCT00416221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24476702|NCT00416221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24761340|NCT01762319|Vitamin B 6|vitamin b 6|mesh-list
24761341|NCT01762319|Pyridoxal|pyridoxal|mesh-list
24761342|NCT01762319|Pyridoxine|pyridoxine|mesh-list
24761343|NCT01762319|Misoprostol|misoprostol|mesh-list
24761344|NCT01762319|Vitamins|vitamins|mesh-ancestor
24761345|NCT01762319|Micronutrients|micronutrients|mesh-ancestor
24476706|NCT00416221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476707|NCT00416221|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24412391|NCT00191347|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24476709|NCT00416273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476710|NCT00416325|Lycopene|lycopene|mesh-list
24476711|NCT00416325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24476712|NCT00416325|Antioxidants|antioxidants|mesh-ancestor
24476713|NCT00416325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476714|NCT00416325|Protective Agents|protective agents|mesh-ancestor
24476715|NCT00416325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476716|NCT00416325|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24476717|NCT00416325|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25079748|NCT03345797|Testosterone|testosterone|mesh-list
25079749|NCT03345797|Androgens|androgens|mesh-ancestor
25079750|NCT03345797|Hormones|hormones|mesh-ancestor
25079752|NCT03345797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476765|NCT00416429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476767|NCT00416429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24476768|NCT00416429|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24476770|NCT00416429|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24476771|NCT00416429|Contraceptive Agents|contraceptive agents|mesh-ancestor
24476772|NCT00416429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24476773|NCT00416429|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24476774|NCT00416429|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24476775|NCT00416429|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24476776|NCT00416429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25079776|NCT03345147|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25079777|NCT03345147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079778|NCT03345134|Pembrolizumab|pembrolizumab|mesh-list
25079779|NCT03345134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25079780|NCT03345134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761351|NCT01762319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24761353|NCT01762319|Vitamin B Complex|vitamin b complex|mesh-ancestor
24761354|NCT01762332|Remifentanil|remifentanil|mesh-list
24761395|NCT01762540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24761396|NCT01762540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761397|NCT01762540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24761399|NCT01762540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24761400|NCT01762540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24761401|NCT01762540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761402|NCT01762644|Cyclosporine|cyclosporine|mesh-list
24761403|NCT01762644|Omeprazole|omeprazole|mesh-list
24761404|NCT01762644|Cyclosporins|cyclosporins|mesh-list
24761405|NCT01762644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477862|NCT00420563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477863|NCT00420563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24477864|NCT00420563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24477865|NCT00420563|Alkylating Agents|alkylating agents|mesh-ancestor
24477866|NCT00420563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477867|NCT00420563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477868|NCT00420563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24477869|NCT00420563|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24477870|NCT00420563|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24477871|NCT00420563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24477872|NCT00420563|Contraceptive Agents|contraceptive agents|mesh-ancestor
24477873|NCT00420563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24477874|NCT00420563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24761407|NCT01762644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24761408|NCT01762644|Immunologic Factors|immunologic factors|mesh-ancestor
24761409|NCT01762644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761410|NCT01762644|Antifungal Agents|antifungal agents|mesh-ancestor
24761411|NCT01762644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24761412|NCT01762644|Dermatologic Agents|dermatologic agents|mesh-ancestor
24761413|NCT01762644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24761414|NCT01762644|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24761415|NCT01762644|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24761416|NCT01762644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24761417|NCT01762644|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24761418|NCT01762657|Cyclosporine|cyclosporine|mesh-list
24761419|NCT01762657|Lansoprazole|lansoprazole|mesh-list
24761420|NCT01762657|Dexlansoprazole|dexlansoprazole|mesh-list
24761421|NCT01762657|Cyclosporins|cyclosporins|mesh-list
25700985|NCT02132312|Mydriatics|mydriatics|mesh-ancestor
25700986|NCT02132312|Autonomic Agents|autonomic agents|mesh-ancestor
25700987|NCT02132312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25092220|NCT03243552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092221|NCT03243552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092223|NCT03243500|Bupivacaine|bupivacaine|mesh-list
24761422|NCT01762657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477875|NCT00420563|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24477876|NCT00420563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24477997|NCT00421122|Formoterol Fumarate|formoterol fumarate|mesh-list
24477998|NCT00421122|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24636188|NCT01143831|Vitamins|vitamins|mesh-list
24477999|NCT00421122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24478000|NCT00421122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24478001|NCT00421122|Autonomic Agents|autonomic agents|mesh-ancestor
24478002|NCT00421122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24478011|NCT00421122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24478012|NCT00421122|Adrenergic Agents|adrenergic agents|mesh-ancestor
24478013|NCT00421122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24761423|NCT01762657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761424|NCT01762657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24965814|NCT03773991|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24965815|NCT03773991|Antioxidants|antioxidants|mesh-ancestor
24761431|NCT01762657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24478014|NCT00421122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478015|NCT00421122|Sympathomimetics|sympathomimetics|mesh-ancestor
24478016|NCT00421122|Tocolytic Agents|tocolytic agents|mesh-ancestor
24478017|NCT00421122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24478018|NCT00421187|Amphotericin B|amphotericin b|mesh-list
24478019|NCT00421187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24478020|NCT00421187|Amebicides|amebicides|mesh-ancestor
24478021|NCT00421187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24478022|NCT00421187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24478077|NCT00421434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478078|NCT00421434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24478079|NCT00421447|Anastrozole|anastrozole|mesh-list
24478080|NCT00421447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24478081|NCT00421447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478087|NCT00421447|Hormone Antagonists|hormone antagonists|mesh-ancestor
25700988|NCT02132312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25700989|NCT02132312|Sympathomimetics|sympathomimetics|mesh-ancestor
25700990|NCT02132312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25700991|NCT02132312|Nasal Decongestants|nasal decongestants|mesh-ancestor
25700992|NCT02132312|Respiratory System Agents|respiratory system agents|mesh-ancestor
25700993|NCT02132312|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25092525|NCT03241641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24413668|NCT00194818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413669|NCT00194818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24413670|NCT00194818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24413671|NCT00194857|Epoetin Alfa|epoetin alfa|mesh-list
24413672|NCT00194857|Hematinics|hematinics|mesh-ancestor
24413673|NCT00194883|Hormones|hormones|mesh-list
24478088|NCT00421447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24478089|NCT00421447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478093|NCT00421460|Testosterone enanthate|testosterone enanthate|mesh-list
24478094|NCT00421460|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24478095|NCT00421460|Androgens|androgens|mesh-ancestor
24478096|NCT00421460|Hormones|hormones|mesh-ancestor
24478100|NCT00421460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478141|NCT00421551|Antiviral Agents|antiviral agents|mesh-ancestor
24761433|NCT01762657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24761434|NCT01762657|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24761435|NCT01762670|Metronidazole|metronidazole|mesh-list
24761436|NCT01762670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24761437|NCT01762670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24761438|NCT01762670|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24761439|NCT01762670|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24761440|NCT01762787|Aspirin|aspirin|mesh-list
24761441|NCT01762787|Prednisolone|prednisolone|mesh-list
24761442|NCT01762787|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24761443|NCT01762787|Methylprednisolone|methylprednisolone|mesh-list
24761444|NCT01762787|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24761445|NCT01762787|Prednisolone acetate|prednisolone acetate|mesh-list
24761446|NCT01762787|Cantharidin|cantharidin|mesh-list
24761447|NCT01762787|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24761448|NCT01762787|Prednisolone phosphate|prednisolone phosphate|mesh-list
24478202|NCT00421863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24478203|NCT00421863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478204|NCT00421863|Vasodilator Agents|vasodilator agents|mesh-ancestor
24478205|NCT00421863|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24761468|NCT01762787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761469|NCT01762787|Antiemetics|antiemetics|mesh-ancestor
24761470|NCT01762787|Autonomic Agents|autonomic agents|mesh-ancestor
24761471|NCT01762787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24761472|NCT01762787|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24761473|NCT01762787|Protective Agents|protective agents|mesh-ancestor
24761474|NCT01762826|Inositol|inositol|mesh-list
24761475|NCT01762826|Vitamin B Complex|vitamin b complex|mesh-ancestor
24761476|NCT01762826|Vitamins|vitamins|mesh-ancestor
24761477|NCT01762826|Micronutrients|micronutrients|mesh-ancestor
24761478|NCT01762826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761479|NCT01762839|Moxifloxacin|moxifloxacin|mesh-list
24478246|NCT00421967|Analgesics|analgesics|mesh-ancestor
24478258|NCT00421967|Autonomic Agents|autonomic agents|mesh-ancestor
24478291|NCT00422188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24478292|NCT00422214|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24478293|NCT00422214|Antidepressive Agents|antidepressive agents|mesh-ancestor
24478294|NCT00422214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24478295|NCT00422214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24478296|NCT00422214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24478297|NCT00422214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24478298|NCT00422214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478300|NCT00422240|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
25700994|NCT02132312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25700995|NCT02132312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25700996|NCT02132312|Adrenergic Agents|adrenergic agents|mesh-ancestor
25700997|NCT02132312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25700998|NCT02132312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25700999|NCT02132312|Protective Agents|protective agents|mesh-ancestor
25701000|NCT02132468|Fosbretabulin|fosbretabulin|mesh-list
25701001|NCT02132468|Combretastatin|combretastatin|mesh-list
24478301|NCT00422240|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24478302|NCT00422240|Dermatologic Agents|dermatologic agents|mesh-ancestor
25701002|NCT02132468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25701003|NCT02132468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25701004|NCT02132468|Tubulin Modulators|tubulin modulators|mesh-ancestor
24478303|NCT00422240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24478304|NCT00422240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24478305|NCT00422240|Analgesics|analgesics|mesh-ancestor
24478306|NCT00422240|Sensory System Agents|sensory system agents|mesh-ancestor
24478307|NCT00422240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24478308|NCT00422240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478309|NCT00422240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24478313|NCT00422318|Gout Suppressants|gout suppressants|mesh-ancestor
24478314|NCT00422318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24478315|NCT00422318|Renal Agents|renal agents|mesh-ancestor
24478349|NCT00422435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761490|NCT01762852|Immunologic Factors|immunologic factors|mesh-ancestor
24761491|NCT01762852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761492|NCT01762878|Nemiralisib|nemiralisib|mesh-list
24761493|NCT01762878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24761494|NCT01762878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761495|NCT01762878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761496|NCT01762891|Acetaminophen|acetaminophen|mesh-list
24761497|NCT01762891|Celecoxib|celecoxib|mesh-list
24761498|NCT01762891|Rofecoxib|rofecoxib|mesh-list
25079782|NCT03345095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25079783|NCT03345095|Alkylating Agents|alkylating agents|mesh-ancestor
24775917|NCT01855581|Ketamine|ketamine|mesh-list
24761499|NCT01762891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24761500|NCT01762891|Analgesics|analgesics|mesh-ancestor
24761501|NCT01762891|Sensory System Agents|sensory system agents|mesh-ancestor
24761502|NCT01762891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24761503|NCT01762891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761504|NCT01762891|Antipyretics|antipyretics|mesh-ancestor
24761505|NCT01762891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24761506|NCT01762891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24761527|NCT01762995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24761528|NCT01762995|Trace Elements|trace elements|mesh-ancestor
24761529|NCT01762995|Micronutrients|micronutrients|mesh-ancestor
24552341|NCT03504241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761530|NCT01763021|Rifampin|rifampin|mesh-list
24761531|NCT01763021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24761532|NCT01763021|Antitubercular Agents|antitubercular agents|mesh-ancestor
24761547|NCT01763281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24761548|NCT01763281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761549|NCT01763385|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24761550|NCT01763385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761551|NCT01763385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24761552|NCT01763385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761553|NCT01763385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761571|NCT01763424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24761572|NCT01763424|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24899215|NCT04405622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761573|NCT01763424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24761574|NCT01763437|Tetracycline|tetracycline|mesh-list
24761575|NCT01763437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24761576|NCT01763437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24761577|NCT01763437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24761578|NCT01763437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761579|NCT01763437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761580|NCT01763450|Bevacizumab|bevacizumab|mesh-list
24761581|NCT01763450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24761582|NCT01763450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761583|NCT01763450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24761584|NCT01763450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24761585|NCT01763450|Growth Substances|growth substances|mesh-ancestor
24761586|NCT01763450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761587|NCT01763450|Growth Inhibitors|growth inhibitors|mesh-ancestor
24761588|NCT01763463|Fluticasone|fluticasone|mesh-list
24761590|NCT01763463|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24618356|NCT01047995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24478650|NCT00423826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24761598|NCT01763463|Respiratory System Agents|respiratory system agents|mesh-ancestor
24761599|NCT01763463|Dermatologic Agents|dermatologic agents|mesh-ancestor
24638239|NCT01155505|Growth Substances|growth substances|mesh-ancestor
24761600|NCT01763463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24761601|NCT01763463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24761602|NCT01763463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24761604|NCT01763463|Adrenergic Agents|adrenergic agents|mesh-ancestor
24761605|NCT01763463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24761606|NCT01763463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761607|NCT01763463|Glucocorticoids|glucocorticoids|mesh-ancestor
24761609|NCT01763463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24761610|NCT01763463|Sympathomimetics|sympathomimetics|mesh-ancestor
24761612|NCT01763476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24761613|NCT01763476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761614|NCT01763476|Tubulin Modulators|tubulin modulators|mesh-ancestor
24761615|NCT01763476|Antimitotic Agents|antimitotic agents|mesh-ancestor
24761616|NCT01763476|Mitosis Modulators|mitosis modulators|mesh-ancestor
24761617|NCT01763476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761618|NCT01763541|Anastrozole|anastrozole|mesh-list
24761619|NCT01763541|Leuprolide|leuprolide|mesh-list
24761620|NCT01763541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24761621|NCT01763541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761622|NCT01763541|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24761623|NCT01763541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24761624|NCT01763541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761625|NCT01763541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761626|NCT01763541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24761627|NCT01763541|Hormone Antagonists|hormone antagonists|mesh-ancestor
24761650|NCT01763658|Immunoglobulins|immunoglobulins|mesh-list
24761651|NCT01763658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24761656|NCT01763658|Antiemetics|antiemetics|mesh-ancestor
24761657|NCT01763658|Autonomic Agents|autonomic agents|mesh-ancestor
24761658|NCT01763658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24761659|NCT01763658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761660|NCT01763658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24761661|NCT01763658|Glucocorticoids|glucocorticoids|mesh-ancestor
24761662|NCT01763658|Hormones|hormones|mesh-ancestor
24761663|NCT01763658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24761664|NCT01763658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24761666|NCT01763658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761667|NCT01763658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24761668|NCT01763658|Protective Agents|protective agents|mesh-ancestor
24761693|NCT01763749|Clopidogrel|clopidogrel|mesh-list
24761694|NCT01763749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24761695|NCT01763749|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24761698|NCT01763749|Purinergic Agents|purinergic agents|mesh-ancestor
24761719|NCT01764087|Tubulin Modulators|tubulin modulators|mesh-ancestor
24761720|NCT01764087|Antimitotic Agents|antimitotic agents|mesh-ancestor
24761721|NCT01764087|Mitosis Modulators|mitosis modulators|mesh-ancestor
24761722|NCT01764087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761723|NCT01764087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761724|NCT01764126|Vaccines|vaccines|mesh-list
24761725|NCT01764126|Immunologic Factors|immunologic factors|mesh-ancestor
24761726|NCT01764126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761727|NCT01764139|Vitamin D|vitamin d|mesh-list
24761728|NCT01764139|Vitamins|vitamins|mesh-ancestor
24761729|NCT01764139|Micronutrients|micronutrients|mesh-ancestor
24761730|NCT01764139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761731|NCT01764139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24761732|NCT01764178|Valsartan|valsartan|mesh-list
24761733|NCT01764178|Pitavastatin|pitavastatin|mesh-list
24761734|NCT01764178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24476207|NCT00413452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761735|NCT01764178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25079784|NCT03345095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965816|NCT03773991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079789|NCT03345004|Vitamins|vitamins|mesh-list
24478791|NCT00424580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478792|NCT00424580|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24478793|NCT00424580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24478794|NCT00424580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478795|NCT00424580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24478796|NCT00424580|Cholinergic Agents|cholinergic agents|mesh-ancestor
24478797|NCT00424580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24478798|NCT00424580|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24478799|NCT00424580|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24478801|NCT00424580|Histamine Agents|histamine agents|mesh-ancestor
24478802|NCT00424606|Docetaxel|docetaxel|mesh-list
24478803|NCT00424606|Epirubicin|epirubicin|mesh-list
24478804|NCT00424606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478805|NCT00424606|Tubulin Modulators|tubulin modulators|mesh-ancestor
24478808|NCT00424606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478811|NCT00424606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24478812|NCT00424606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478813|NCT00424710|Ranibizumab|ranibizumab|mesh-list
24478814|NCT00424710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24478815|NCT00424710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24478816|NCT00424710|Growth Substances|growth substances|mesh-ancestor
24762068|NCT01765881|Dinoprostone|dinoprostone|mesh-list
24478817|NCT00424710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079798|NCT03344952|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25079799|NCT03344952|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25079800|NCT03344952|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25079801|NCT03344952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25079802|NCT03344952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079803|NCT03344952|Cholinergic Agents|cholinergic agents|mesh-ancestor
25079805|NCT03344952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079806|NCT03344952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25079807|NCT03344952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25079808|NCT03344822|Choline|choline|mesh-list
25079809|NCT03344822|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25079810|NCT03344822|Lipotropic Agents|lipotropic agents|mesh-ancestor
25079811|NCT03344822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25079812|NCT03344822|Antimetabolites|antimetabolites|mesh-ancestor
25079813|NCT03344822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079814|NCT03344822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25079815|NCT03344822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25079816|NCT03344822|Nootropic Agents|nootropic agents|mesh-ancestor
25079817|NCT03344822|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25079818|NCT03344705|Cyclophosphamide|cyclophosphamide|mesh-list
25079819|NCT03344705|Fludarabine|fludarabine|mesh-list
25079820|NCT03344705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25079821|NCT03344705|Immunologic Factors|immunologic factors|mesh-ancestor
25079822|NCT03344705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079823|NCT03344705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25079824|NCT03344705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25079825|NCT03344705|Alkylating Agents|alkylating agents|mesh-ancestor
25079826|NCT03344705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079827|NCT03344705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079828|NCT03344705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25079829|NCT03344679|Magnesium Sulfate|magnesium sulfate|mesh-list
25079830|NCT03344679|Adenosine|adenosine|mesh-list
25079831|NCT03344679|Bupivacaine|bupivacaine|mesh-list
24478818|NCT00424710|Growth Inhibitors|growth inhibitors|mesh-ancestor
24478819|NCT00424710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478820|NCT00424723|Pemetrexed|pemetrexed|mesh-list
24478821|NCT00424723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478822|NCT00424723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478823|NCT00424723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079841|NCT03344679|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25079842|NCT03344679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25079843|NCT03344679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079844|NCT03344679|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25079845|NCT03344679|Tocolytic Agents|tocolytic agents|mesh-ancestor
25079846|NCT03344679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25079847|NCT03344679|Vasodilator Agents|vasodilator agents|mesh-ancestor
25079848|NCT03344679|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25079849|NCT03344679|Purinergic Agonists|purinergic agonists|mesh-ancestor
25079850|NCT03344679|Purinergic Agents|purinergic agents|mesh-ancestor
25079851|NCT03344679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25079852|NCT03344627|Meropenem|meropenem|mesh-list
25079853|NCT03344627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25079854|NCT03344627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25079855|NCT03344614|Apatinib|apatinib|mesh-list
25079856|NCT03344614|Raltitrexed|raltitrexed|mesh-list
25079857|NCT03344614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761736|NCT01764178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24761737|NCT01764178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761738|NCT01764178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25094076|NCT03229278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25094142|NCT03228771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25094143|NCT03228771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25094144|NCT03228771|Antimetabolites|antimetabolites|mesh-ancestor
24761739|NCT01764178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24761740|NCT01764178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24761741|NCT01764178|Antimetabolites|antimetabolites|mesh-ancestor
24761750|NCT01764230|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24761751|NCT01764230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24761752|NCT01764230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761753|NCT01764295|Olmesartan|olmesartan|mesh-list
24761754|NCT01764295|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24761755|NCT01764295|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24761756|NCT01764295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24761757|NCT01764295|Antimetabolites|antimetabolites|mesh-ancestor
24761758|NCT01764295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761759|NCT01764295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24761762|NCT01764295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24761763|NCT01764295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24761768|NCT01764451|Antimetabolites|antimetabolites|mesh-ancestor
24761769|NCT01764451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761770|NCT01764451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24899352|NCT04404517|Adalimumab|adalimumab|mesh-list
24478824|NCT00424723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24478826|NCT00424788|Natalizumab|natalizumab|mesh-list
24478827|NCT00424788|Immunologic Factors|immunologic factors|mesh-ancestor
24478828|NCT00424788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478829|NCT00424801|Nicorandil|nicorandil|mesh-list
24478830|NCT00424801|Valsartan|valsartan|mesh-list
24478831|NCT00424801|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24478832|NCT00424801|Doxazosin|doxazosin|mesh-list
24478833|NCT00424801|Lercanidipine|lercanidipine|mesh-list
24478834|NCT00424801|Pindolol|pindolol|mesh-list
24478857|NCT00424801|Vitamin B Complex|vitamin b complex|mesh-ancestor
24478858|NCT00424801|Vitamins|vitamins|mesh-ancestor
24478859|NCT00424801|Micronutrients|micronutrients|mesh-ancestor
24478860|NCT00424801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24478884|NCT00424853|Gemcitabine|gemcitabine|mesh-list
24638729|NCT01157754|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24478911|NCT00424931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478912|NCT00424931|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24478913|NCT00424931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24478914|NCT00424931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24478915|NCT00424931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478917|NCT00424944|Immunologic Factors|immunologic factors|mesh-ancestor
24478918|NCT00424944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761771|NCT01764451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24761772|NCT01764451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761774|NCT01764555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24761775|NCT01764555|Analgesics|analgesics|mesh-ancestor
24761776|NCT01764555|Sensory System Agents|sensory system agents|mesh-ancestor
24761777|NCT01764555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24761778|NCT01764555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761779|NCT01764555|Antipyretics|antipyretics|mesh-ancestor
24761781|NCT01764581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24761782|NCT01764581|Immunologic Factors|immunologic factors|mesh-ancestor
24761783|NCT01764581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761784|NCT01764581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24761785|NCT01764581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761786|NCT01764581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761787|NCT01764672|Methylphenidate|methylphenidate|mesh-list
24761788|NCT01764672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24761789|NCT01764672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761790|NCT01764672|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24761791|NCT01764672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25701005|NCT02132468|Antimitotic Agents|antimitotic agents|mesh-ancestor
25701006|NCT02132468|Mitosis Modulators|mitosis modulators|mesh-ancestor
25701007|NCT02132468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701008|NCT02132533|Nifedipine|nifedipine|mesh-list
25701009|NCT02132533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25701010|NCT02132533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25701011|NCT02132533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701012|NCT02132533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25094484|NCT03225924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25094485|NCT03225924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25094486|NCT03225924|Alkylating Agents|alkylating agents|mesh-ancestor
24761792|NCT01764672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24761793|NCT01764672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761794|NCT01764672|Dopamine Agents|dopamine agents|mesh-ancestor
24761795|NCT01764672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24761796|NCT01764750|Vancomycin|vancomycin|mesh-list
24479169|NCT00425841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479171|NCT00425841|Antiviral Agents|antiviral agents|mesh-ancestor
24479172|NCT00425841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24479174|NCT00425841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24479175|NCT00425841|Immunologic Factors|immunologic factors|mesh-ancestor
24479176|NCT00425841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479177|NCT00425906|Nicotine|nicotine|mesh-list
24479178|NCT00425906|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24479179|NCT00425906|Autonomic Agents|autonomic agents|mesh-ancestor
24479180|NCT00425906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24479405|NCT00426647|Narcotics|narcotics|mesh-ancestor
24479406|NCT00426647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24479407|NCT00426647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479408|NCT00426647|Analgesics|analgesics|mesh-ancestor
24761802|NCT01764828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761803|NCT01764828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761804|NCT01764828|Antiviral Agents|antiviral agents|mesh-ancestor
24761805|NCT01764828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24761806|NCT01764828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761807|NCT01764828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24479440|NCT00426933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24479442|NCT00426946|Antidepressive Agents|antidepressive agents|mesh-ancestor
24761824|NCT01764867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761825|NCT01764867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24761826|NCT01764867|Serotonin Agents|serotonin agents|mesh-ancestor
24761827|NCT01764867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761828|NCT01764867|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24761829|NCT01764867|Antidepressive Agents|antidepressive agents|mesh-ancestor
24761830|NCT01764867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24761831|NCT01764867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24761832|NCT01764867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24761833|NCT01764867|Parasympatholytics|parasympatholytics|mesh-ancestor
24761834|NCT01764867|Autonomic Agents|autonomic agents|mesh-ancestor
24761835|NCT01764867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24761836|NCT01764867|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24761837|NCT01764867|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24761838|NCT01764867|Cholinergic Agents|cholinergic agents|mesh-ancestor
24761839|NCT01764867|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24761840|NCT01764867|Dopamine Agents|dopamine agents|mesh-ancestor
24761841|NCT01764867|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24810740|NCT02042326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701013|NCT02132533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701014|NCT02132533|Vasodilator Agents|vasodilator agents|mesh-ancestor
25701015|NCT02132533|Tocolytic Agents|tocolytic agents|mesh-ancestor
25701016|NCT02132533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25701017|NCT02132637|Insulin|insulin|mesh-list
25701018|NCT02132637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25701019|NCT02132637|Insulin Glargine|insulin glargine|mesh-list
25701020|NCT02132637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25701021|NCT02132637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701022|NCT02132754|Pembrolizumab|pembrolizumab|mesh-list
25701023|NCT02132754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25701024|NCT02132754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25094742|NCT03223220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25094743|NCT03223220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25094744|NCT03223220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24761842|NCT01764867|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24761843|NCT01764867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761844|NCT01764867|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24761845|NCT01764867|Analgesics|analgesics|mesh-ancestor
24761846|NCT01764867|Sensory System Agents|sensory system agents|mesh-ancestor
24761847|NCT01764867|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24761848|NCT01764867|Histamine Antagonists|histamine antagonists|mesh-ancestor
24639777|NCT01164176|Everolimus|everolimus|mesh-list
24761849|NCT01764867|Histamine Agents|histamine agents|mesh-ancestor
24761850|NCT01764867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24761851|NCT01764867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24761854|NCT01764867|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24761899|NCT01765088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24761900|NCT01765231|Entecavir|entecavir|mesh-list
24761901|NCT01765231|Antiviral Agents|antiviral agents|mesh-ancestor
24761933|NCT01765374|Immunologic Factors|immunologic factors|mesh-ancestor
24761934|NCT01765374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761935|NCT01765374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24761936|NCT01765400|Clopidogrel|clopidogrel|mesh-list
24761937|NCT01765400|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24761938|NCT01765400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24761939|NCT01765400|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24965859|NCT03773536|Artesunate|artesunate|mesh-list
24965860|NCT03773536|Primaquine|primaquine|mesh-list
24965861|NCT03773536|Amodiaquine|amodiaquine|mesh-list
24965862|NCT03773536|Antimalarials|antimalarials|mesh-ancestor
24965863|NCT03773536|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24965864|NCT03773536|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24965865|NCT03773536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24965866|NCT03773536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965867|NCT03773536|Antiviral Agents|antiviral agents|mesh-ancestor
24965868|NCT03773536|Schistosomicides|schistosomicides|mesh-ancestor
24965869|NCT03773536|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24965870|NCT03773536|Anthelmintics|anthelmintics|mesh-ancestor
24965871|NCT03773809|Vitamin D|vitamin d|mesh-list
24965872|NCT03773809|Ergocalciferols|ergocalciferols|mesh-list
24965873|NCT03773809|Cholecalciferol|cholecalciferol|mesh-list
24965874|NCT03773809|Vitamins|vitamins|mesh-list
24965875|NCT03773809|Micronutrients|micronutrients|mesh-ancestor
24965876|NCT03773809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639808|NCT01164215|Vitamins|vitamins|mesh-ancestor
24965877|NCT03773809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24640327|NCT01167725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24640328|NCT01167725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965878|NCT03773809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24965911|NCT03773094|Chlorhexidine|chlorhexidine|mesh-list
24965912|NCT03773094|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24965913|NCT03773094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24965914|NCT03773094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24965915|NCT03773094|Disinfectants|disinfectants|mesh-ancestor
24761974|NCT01765608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761975|NCT01765608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24761990|NCT01765738|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24761991|NCT01765738|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24761992|NCT01765738|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24761994|NCT01765790|Immunoglobulins|immunoglobulins|mesh-list
25079858|NCT03344614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25079859|NCT03344614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25079860|NCT03344614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079861|NCT03344614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25079862|NCT03344614|Antimetabolites|antimetabolites|mesh-ancestor
25079863|NCT03344614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25079864|NCT03344536|Fulvestrant|fulvestrant|mesh-list
25079865|NCT03344536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25701025|NCT02132767|Digoxin|digoxin|mesh-list
25701026|NCT02132767|Amiodarone|amiodarone|mesh-list
25701027|NCT02132767|Calcium Channel Blockers|calcium channel blockers|mesh-list
25095063|NCT03220815|Adrenergic Agents|adrenergic agents|mesh-ancestor
25095064|NCT03220815|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25095065|NCT03220815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25095066|NCT03220815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25095067|NCT03220815|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25095068|NCT03220841|Adalimumab|adalimumab|mesh-list
25095069|NCT03220841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25095070|NCT03220841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25095071|NCT03220880|Dexmedetomidine|dexmedetomidine|mesh-list
25095072|NCT03220880|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25095073|NCT03220880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25095074|NCT03220880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095075|NCT03220880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25095076|NCT03220880|Analgesics|analgesics|mesh-ancestor
25095077|NCT03220880|Sensory System Agents|sensory system agents|mesh-ancestor
25095121|NCT03220555|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25095125|NCT03220256|Anticonvulsants|anticonvulsants|mesh-ancestor
25079866|NCT03344536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079867|NCT03344536|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25079868|NCT03344536|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25079869|NCT03344536|Hormone Antagonists|hormone antagonists|mesh-ancestor
24620185|NCT01055756|Adrenergic Agents|adrenergic agents|mesh-ancestor
25079870|NCT03344536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24479506|NCT00427128|Serotonin Agents|serotonin agents|mesh-ancestor
24479507|NCT00427128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479508|NCT00427128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24479509|NCT00427128|Antidepressive Agents|antidepressive agents|mesh-ancestor
25079871|NCT03344536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079872|NCT03344523|Iron protein succinylate|iron protein succinylate|mesh-list
25079873|NCT03344523|Hematinics|hematinics|mesh-ancestor
25079874|NCT03344445|Anesthetics|anesthetics|mesh-list
25079875|NCT03344445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24762006|NCT01765829|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24762008|NCT01765829|Antipsychotic Agents|antipsychotic agents|mesh-list
24762009|NCT01765829|Clozapine|clozapine|mesh-list
24762010|NCT01765829|Asenapine|asenapine|mesh-list
24762011|NCT01765829|Amisulpride|amisulpride|mesh-list
24762012|NCT01765829|Perphenazine|perphenazine|mesh-list
24762013|NCT01765829|Sertindole|sertindole|mesh-list
24762014|NCT01765829|Sulpiride|sulpiride|mesh-list
24762015|NCT01765829|Clopenthixol|clopenthixol|mesh-list
24762016|NCT01765829|Clothiapine|clothiapine|mesh-list
24762017|NCT01765829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24762018|NCT01765829|Serotonin Agents|serotonin agents|mesh-ancestor
24762019|NCT01765829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24762020|NCT01765829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762021|NCT01765829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762022|NCT01765829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24762023|NCT01765829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24762024|NCT01765829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24479510|NCT00427128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24479511|NCT00427128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24479512|NCT00427128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24762025|NCT01765829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24762026|NCT01765829|Dopamine Agents|dopamine agents|mesh-ancestor
24762027|NCT01765829|Antiemetics|antiemetics|mesh-ancestor
24762028|NCT01765829|Autonomic Agents|autonomic agents|mesh-ancestor
24762029|NCT01765829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24762030|NCT01765829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25701028|NCT02132767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25701029|NCT02132767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701030|NCT02132767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25701031|NCT02132767|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25701032|NCT02132767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25701033|NCT02132767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701034|NCT02132767|Protective Agents|protective agents|mesh-ancestor
25701035|NCT02132767|Vasodilator Agents|vasodilator agents|mesh-ancestor
25701036|NCT02132767|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25701037|NCT02132767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25701038|NCT02132767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25701039|NCT02132767|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25701040|NCT02132767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25701041|NCT02132767|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25701042|NCT02132767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25095411|NCT03218969|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25095412|NCT03218969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24413674|NCT00194883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24413675|NCT00194883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413677|NCT00194909|Vasodilator Agents|vasodilator agents|mesh-ancestor
25095470|NCT03218631|Androgens|androgens|mesh-ancestor
25095471|NCT03218631|Hormones|hormones|mesh-ancestor
25095472|NCT03218631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24762034|NCT01765829|Antidepressive Agents|antidepressive agents|mesh-ancestor
24762042|NCT01765829|GABA Agents|gaba agents|mesh-ancestor
24762043|NCT01765829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24762044|NCT01765829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24762045|NCT01765842|Rituximab|rituximab|mesh-list
24762046|NCT01765842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24762047|NCT01765842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24762048|NCT01765842|Immunologic Factors|immunologic factors|mesh-ancestor
24762049|NCT01765842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762050|NCT01765842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24762051|NCT01765855|Betrixaban|betrixaban|mesh-list
24762052|NCT01765855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24762053|NCT01765855|Antithrombins|antithrombins|mesh-ancestor
24762054|NCT01765855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24762055|NCT01765855|Protease Inhibitors|protease inhibitors|mesh-ancestor
24762056|NCT01765855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762057|NCT01765855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762058|NCT01765855|Anticoagulants|anticoagulants|mesh-ancestor
24762060|NCT01765868|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24762061|NCT01765868|Antithrombins|antithrombins|mesh-ancestor
24762062|NCT01765868|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24762063|NCT01765868|Protease Inhibitors|protease inhibitors|mesh-ancestor
24762064|NCT01765868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762065|NCT01765868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762066|NCT01765868|Anticoagulants|anticoagulants|mesh-ancestor
24762074|NCT01765881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24762075|NCT01765881|Oxytocics|oxytocics|mesh-ancestor
24762077|NCT01765946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24762078|NCT01765946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762079|NCT01766063|Interferons|interferons|mesh-list
24762080|NCT01766063|Interferon-beta|interferon-beta|mesh-list
24762081|NCT01766063|Interferon beta-1b|interferon beta-1b|mesh-list
24762082|NCT01766063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776500|NCT01858168|Irinotecan|irinotecan|mesh-list
24762083|NCT01766063|Antiviral Agents|antiviral agents|mesh-ancestor
24762084|NCT01766063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24762085|NCT01766063|Immunologic Factors|immunologic factors|mesh-ancestor
24762086|NCT01766063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762087|NCT01766063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24762088|NCT01766089|Dexmedetomidine|dexmedetomidine|mesh-list
24762089|NCT01766089|Remifentanil|remifentanil|mesh-list
24762090|NCT01766089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24762104|NCT01766089|Narcotics|narcotics|mesh-ancestor
24762109|NCT01766154|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24762110|NCT01766180|Resveratrol|resveratrol|mesh-list
24762111|NCT01766180|Antioxidants|antioxidants|mesh-ancestor
24762112|NCT01766180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762113|NCT01766180|Protective Agents|protective agents|mesh-ancestor
24762114|NCT01766180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762115|NCT01766180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762116|NCT01766180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24762117|NCT01766258|Carbidopa|carbidopa|mesh-list
24762118|NCT01766258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24640657|NCT01169506|Silicon|silicon|mesh-list
24762119|NCT01766258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24762120|NCT01766258|Dopamine Agents|dopamine agents|mesh-ancestor
25701043|NCT02132767|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25701044|NCT02132832|Buspirone|buspirone|mesh-list
25701045|NCT02132832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25701046|NCT02132832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25701047|NCT02132832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25701048|NCT02132832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701049|NCT02132832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25701050|NCT02132832|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25701051|NCT02132832|Serotonin Agents|serotonin agents|mesh-ancestor
25701052|NCT02132832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24762123|NCT01766258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762124|NCT01766258|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24762125|NCT01766258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762126|NCT01766323|Modafinil|modafinil|mesh-list
24762127|NCT01766323|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24762128|NCT01766323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762129|NCT01766323|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24762130|NCT01766323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24762131|NCT01766323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24762132|NCT01766323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762133|NCT01766375|Cyclosporine|cyclosporine|mesh-list
24762134|NCT01766375|Mycophenolic Acid|mycophenolic acid|mesh-list
24762135|NCT01766375|Methotrexate|methotrexate|mesh-list
24762136|NCT01766375|Cyclosporins|cyclosporins|mesh-list
24762137|NCT01766375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24762138|NCT01766375|Abortifacient Agents|abortifacient agents|mesh-ancestor
24762139|NCT01766375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24762140|NCT01766375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762141|NCT01766375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24762142|NCT01766375|Antimetabolites|antimetabolites|mesh-ancestor
24762144|NCT01766375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24762146|NCT01766375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762147|NCT01766375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24762174|NCT01766518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762176|NCT01766583|Immunologic Factors|immunologic factors|mesh-ancestor
24762177|NCT01766583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762178|NCT01766583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24762179|NCT01766583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24762180|NCT01766583|Growth Substances|growth substances|mesh-ancestor
24762181|NCT01766583|Growth Inhibitors|growth inhibitors|mesh-ancestor
24762182|NCT01766583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24762183|NCT01766609|Triamcinolone|triamcinolone|mesh-list
24783895|NCT01904695|Diuretics|diuretics|mesh-list
24762184|NCT01766609|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24762185|NCT01766609|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24762186|NCT01766609|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24762187|NCT01766609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24762188|NCT01766609|Glucocorticoids|glucocorticoids|mesh-ancestor
24762189|NCT01766609|Hormones|hormones|mesh-ancestor
24762190|NCT01766609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24553526|NCT00731627|Simvastatin|simvastatin|mesh-list
24762192|NCT01766609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24762201|NCT01766843|Charcoal|charcoal|mesh-list
24762202|NCT01766843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24762203|NCT01766843|Autonomic Agents|autonomic agents|mesh-ancestor
24762204|NCT01766843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24899577|NCT04402723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24899578|NCT04402723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899579|NCT04402320|Midazolam|midazolam|mesh-list
24899580|NCT04402320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24899581|NCT04402320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24899582|NCT04402320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24618976|NCT01050387|Vitamin D|vitamin d|mesh-list
24762242|NCT01767259|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24620157|NCT01055743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762243|NCT01767259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24762244|NCT01767272|Fexofenadine|fexofenadine|mesh-list
24762245|NCT01767272|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25096147|NCT03213886|Vitamin D|vitamin d|mesh-list
24762246|NCT01767272|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24762247|NCT01767272|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24762248|NCT01767272|Histamine Antagonists|histamine antagonists|mesh-ancestor
24762249|NCT01767272|Histamine Agents|histamine agents|mesh-ancestor
24762250|NCT01767272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24762251|NCT01767272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762252|NCT01767272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762253|NCT01767298|Valsartan|valsartan|mesh-list
24762285|NCT01767428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24762287|NCT01767428|Sensory System Agents|sensory system agents|mesh-ancestor
24762288|NCT01767428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24762289|NCT01767428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762290|NCT01767428|Antipyretics|antipyretics|mesh-ancestor
24762292|NCT01767454|Trametinib|trametinib|mesh-list
24762293|NCT01767454|Dabrafenib|dabrafenib|mesh-list
24762294|NCT01767454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24762295|NCT01767454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24762296|NCT01767454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24762297|NCT01767454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762298|NCT01767454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24762299|NCT01767454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762300|NCT01767532|Cephalexin|cephalexin|mesh-list
24762301|NCT01767532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24762302|NCT01767532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24762303|NCT01767545|Dexamethasone|dexamethasone|mesh-list
24762304|NCT01767545|Bevacizumab|bevacizumab|mesh-list
24762347|NCT01767714|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24762348|NCT01767714|Immunologic Factors|immunologic factors|mesh-ancestor
24762349|NCT01767714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762350|NCT01767714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24762351|NCT01767714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24762352|NCT01767714|Antiviral Agents|antiviral agents|mesh-ancestor
24762353|NCT01767714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24762354|NCT01767896|Vaccines|vaccines|mesh-list
24762355|NCT01767896|Immunologic Factors|immunologic factors|mesh-ancestor
24620186|NCT01055795|Bevacizumab|bevacizumab|mesh-list
24762357|NCT01768039|Vitamin D|vitamin d|mesh-list
24762358|NCT01768039|Vitamins|vitamins|mesh-ancestor
24762359|NCT01768039|Micronutrients|micronutrients|mesh-ancestor
24762360|NCT01768039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762361|NCT01768039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24762362|NCT01768078|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24762363|NCT01768078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24899635|NCT04401878|Lidocaine|lidocaine|mesh-list
24479677|NCT00427947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24479681|NCT00428025|Analgesics|analgesics|mesh-ancestor
24479703|NCT00428064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24479704|NCT00428064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24479705|NCT00428064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479706|NCT00428129|Plasminogen|plasminogen|mesh-list
24479707|NCT00428129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24479708|NCT00428129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24762369|NCT01768078|Hormones|hormones|mesh-ancestor
24553527|NCT00731627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24762371|NCT01768078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762372|NCT01768078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24762373|NCT01768078|Respiratory System Agents|respiratory system agents|mesh-ancestor
24762374|NCT01768182|Leucovorin|leucovorin|mesh-list
24762375|NCT01768182|Folic Acid|folic acid|mesh-list
24762376|NCT01768182|Levoleucovorin|levoleucovorin|mesh-list
24762377|NCT01768182|Antidotes|antidotes|mesh-ancestor
24762378|NCT01768182|Protective Agents|protective agents|mesh-ancestor
24762379|NCT01768182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762380|NCT01768182|Vitamin B Complex|vitamin b complex|mesh-ancestor
24762381|NCT01768182|Vitamins|vitamins|mesh-ancestor
24762382|NCT01768182|Micronutrients|micronutrients|mesh-ancestor
24762383|NCT01768182|Hematinics|hematinics|mesh-ancestor
24762384|NCT01768195|Entecavir|entecavir|mesh-list
24762385|NCT01768195|Antiviral Agents|antiviral agents|mesh-ancestor
24762386|NCT01768195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24762387|NCT01768208|Saxagliptin|saxagliptin|mesh-list
25709568|NCT02270242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24762388|NCT01768208|Incretins|incretins|mesh-ancestor
24762389|NCT01768208|Hormones|hormones|mesh-ancestor
24762390|NCT01768208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24762391|NCT01768208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899647|NCT04401852|Magnesium Sulfate|magnesium sulfate|mesh-list
24479709|NCT00428129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479710|NCT00428142|Prednisone|prednisone|mesh-list
24479711|NCT00428142|Cyclophosphamide|cyclophosphamide|mesh-list
24479712|NCT00428142|Rituximab|rituximab|mesh-list
24479713|NCT00428142|Vincristine|vincristine|mesh-list
24479714|NCT00428142|Bortezomib|bortezomib|mesh-list
24479715|NCT00428142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24479716|NCT00428142|Immunologic Factors|immunologic factors|mesh-ancestor
24479717|NCT00428142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479718|NCT00428142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24479719|NCT00428142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24479720|NCT00428142|Alkylating Agents|alkylating agents|mesh-ancestor
24479721|NCT00428142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479722|NCT00428142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479846|NCT00428558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24479847|NCT00428558|Antimetabolites|antimetabolites|mesh-ancestor
24479848|NCT00428558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762392|NCT01768208|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24762393|NCT01768208|Protease Inhibitors|protease inhibitors|mesh-ancestor
24762394|NCT01768208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762395|NCT01768208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762396|NCT01768208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24762397|NCT01768247|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24762398|NCT01768247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24641977|NCT01176903|Cholinergic Agents|cholinergic agents|mesh-ancestor
24762405|NCT01768260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24965918|NCT03773042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24965919|NCT03773042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24965920|NCT03773042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965921|NCT03773042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24965922|NCT03773042|Anesthetics, General|anesthetics, general|mesh-ancestor
24965923|NCT03773042|Anesthetics|anesthetics|mesh-ancestor
24762407|NCT01768260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24762408|NCT01768260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24762410|NCT01768260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24762412|NCT01768260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24762437|NCT01768299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24762438|NCT01768299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24762440|NCT01768299|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24762441|NCT01768299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24762442|NCT01768299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24762443|NCT01768299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24762444|NCT01768299|Contraceptive Agents|contraceptive agents|mesh-ancestor
24762445|NCT01768299|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24762446|NCT01768299|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24762447|NCT01768299|Hormone Antagonists|hormone antagonists|mesh-ancestor
24762448|NCT01768299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24762449|NCT01768299|Luteolytic Agents|luteolytic agents|mesh-ancestor
24762450|NCT01768299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24762451|NCT01768299|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24762452|NCT01768312|Cyclosporine|cyclosporine|mesh-list
24762453|NCT01768312|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24762454|NCT01768312|Cyclosporins|cyclosporins|mesh-list
24762455|NCT01768312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762456|NCT01768312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762457|NCT01768312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24762525|NCT01768481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24762526|NCT01768481|Antimetabolites|antimetabolites|mesh-ancestor
24762527|NCT01768481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762528|NCT01768481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24762529|NCT01768481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24762530|NCT01768481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762531|NCT01768507|Resveratrol|resveratrol|mesh-list
24762532|NCT01768507|Antioxidants|antioxidants|mesh-ancestor
24642091|NCT01177514|Antimanic Agents|antimanic agents|mesh-ancestor
24762533|NCT01768507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762534|NCT01768507|Protective Agents|protective agents|mesh-ancestor
24762535|NCT01768507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762536|NCT01768507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762537|NCT01768507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24762538|NCT01768663|Itraconazole|itraconazole|mesh-list
24762540|NCT01768663|Rifampin|rifampin|mesh-list
24762541|NCT01768663|Ivacaftor|ivacaftor|mesh-list
24762542|NCT01768663|Antifungal Agents|antifungal agents|mesh-ancestor
24762543|NCT01768663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24762544|NCT01768663|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24762545|NCT01768663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24762546|NCT01768663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762547|NCT01768663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762548|NCT01768663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24762549|NCT01768663|Hormone Antagonists|hormone antagonists|mesh-ancestor
24762564|NCT01768663|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24762565|NCT01768663|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24762566|NCT01768663|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24762567|NCT01768663|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24762569|NCT01768663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24762570|NCT01768741|Liver Extracts|liver extracts|mesh-list
24762571|NCT01768741|Hematinics|hematinics|mesh-ancestor
24762572|NCT01768767|Ketamine|ketamine|mesh-list
24762573|NCT01768767|Analgesics|analgesics|mesh-ancestor
24762574|NCT01768767|Sensory System Agents|sensory system agents|mesh-ancestor
24762575|NCT01768767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24762576|NCT01768767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762577|NCT01768767|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24762578|NCT01768767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24762579|NCT01768767|Anesthetics, General|anesthetics, general|mesh-ancestor
24762580|NCT01768767|Anesthetics|anesthetics|mesh-ancestor
24762581|NCT01768767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24762582|NCT01768767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24762583|NCT01768767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24762584|NCT01768767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24762585|NCT01768767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762586|NCT01768780|Glycopyrrolate|glycopyrrolate|mesh-list
24762587|NCT01768780|Bupivacaine|bupivacaine|mesh-list
24762588|NCT01768780|Cholinergic Antagonists|cholinergic antagonists|mesh-list
24762589|NCT01768780|Anesthetics, Local|anesthetics, local|mesh-ancestor
24762590|NCT01768780|Anesthetics|anesthetics|mesh-ancestor
24619355|NCT01052129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24762593|NCT01768780|Sensory System Agents|sensory system agents|mesh-ancestor
24762607|NCT01768884|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24762609|NCT01768884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762610|NCT01768884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24762611|NCT01768884|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24553406|NCT00731016|Pravastatin|pravastatin|mesh-list
24553525|NCT00731601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479878|NCT00428727|Respiratory System Agents|respiratory system agents|mesh-ancestor
24479881|NCT00428727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479882|NCT00428727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25701053|NCT02132832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701054|NCT02132936|Calcipotriene|calcipotriene|mesh-list
24620179|NCT01055756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24620180|NCT01055756|Respiratory System Agents|respiratory system agents|mesh-ancestor
24620181|NCT01055756|Nasal Decongestants|nasal decongestants|mesh-ancestor
24620182|NCT01055756|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24620183|NCT01055756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24620187|NCT01055795|Everolimus|everolimus|mesh-list
24620188|NCT01055795|Panobinostat|panobinostat|mesh-list
24643078|NCT01183624|Analgesics|analgesics|mesh-list
24620189|NCT01055795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24620190|NCT01055795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24762638|NCT01768988|Pregabalin|pregabalin|mesh-list
24762639|NCT01768988|Analgesics|analgesics|mesh-ancestor
24762640|NCT01768988|Sensory System Agents|sensory system agents|mesh-ancestor
24762641|NCT01768988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24762642|NCT01768988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762643|NCT01768988|Anticonvulsants|anticonvulsants|mesh-ancestor
24762644|NCT01768988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24762645|NCT01768988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24810842|NCT02042690|Antimetabolites|antimetabolites|mesh-ancestor
24762646|NCT01768988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762647|NCT01768988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24762657|NCT01769027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24762658|NCT01769027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24762659|NCT01769027|Antidepressive Agents|antidepressive agents|mesh-ancestor
24762660|NCT01769027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24762661|NCT01769027|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24762662|NCT01769027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24762663|NCT01769027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24762664|NCT01769027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762665|NCT01769027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24762667|NCT01769027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762668|NCT01769027|Immunologic Factors|immunologic factors|mesh-ancestor
24762670|NCT01769040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24762671|NCT01769040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24762672|NCT01769040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24643083|NCT01183663|Sirolimus|sirolimus|mesh-list
24762673|NCT01769066|Pemetrexed|pemetrexed|mesh-list
24762674|NCT01769066|Gefitinib|gefitinib|mesh-list
24762675|NCT01769066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24762676|NCT01769066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762677|NCT01769066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762678|NCT01769066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24762679|NCT01769066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24762680|NCT01769066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24762681|NCT01769079|Isosorbide|isosorbide|mesh-list
24762682|NCT01769079|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24762684|NCT01769079|Natriuretic Agents|natriuretic agents|mesh-ancestor
24762685|NCT01769079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762686|NCT01769118|Caffeine|caffeine|mesh-list
24762687|NCT01769118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24762688|NCT01769118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460620|NCT00349089|Pemetrexed|pemetrexed|mesh-list
24762692|NCT01769118|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24762695|NCT01769118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24476780|NCT00416468|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24762697|NCT01769183|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24762698|NCT01769183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24437183|NCT00272870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762699|NCT01769183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24762700|NCT01769183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24762701|NCT01769183|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24762702|NCT01769183|Protective Agents|protective agents|mesh-ancestor
24762703|NCT01769183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762704|NCT01769183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24762705|NCT01769183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24762783|NCT01769768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24762706|NCT01769183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24762707|NCT01769183|Growth Substances|growth substances|mesh-ancestor
24762708|NCT01769183|Growth Inhibitors|growth inhibitors|mesh-ancestor
24762709|NCT01769235|Clindamycin|clindamycin|mesh-list
24762710|NCT01769235|Clindamycin palmitate|clindamycin palmitate|mesh-list
24762711|NCT01769235|Clindamycin phosphate|clindamycin phosphate|mesh-list
24762712|NCT01769235|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24762713|NCT01769235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24762714|NCT01769235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24762715|NCT01769235|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24762716|NCT01769235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762717|NCT01769235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762718|NCT01769235|Dermatologic Agents|dermatologic agents|mesh-ancestor
24762719|NCT01769482|Udenafil|udenafil|mesh-list
24762720|NCT01769482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24762721|NCT01769482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24762722|NCT01769482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762723|NCT01769482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762724|NCT01769625|Vitamin D|vitamin d|mesh-list
24762725|NCT01769625|Cholecalciferol|cholecalciferol|mesh-list
24762726|NCT01769625|Celecoxib|celecoxib|mesh-list
24762727|NCT01769625|Vitamins|vitamins|mesh-ancestor
24762728|NCT01769625|Micronutrients|micronutrients|mesh-ancestor
24553534|NCT00731861|Paclitaxel|paclitaxel|mesh-list
24553536|NCT00731861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24553537|NCT00731861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24553544|NCT00731926|Vitamins|vitamins|mesh-list
24762729|NCT01769625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762730|NCT01769625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24762731|NCT01769625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24762732|NCT01769625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24762733|NCT01769625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24762734|NCT01769625|Analgesics|analgesics|mesh-ancestor
24762735|NCT01769625|Sensory System Agents|sensory system agents|mesh-ancestor
24762736|NCT01769625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24762737|NCT01769625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24762738|NCT01769625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24762739|NCT01769625|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24762740|NCT01769625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24762741|NCT01769625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25701055|NCT02132936|Dermatologic Agents|dermatologic agents|mesh-ancestor
25701056|NCT02132949|Paclitaxel|paclitaxel|mesh-list
25701057|NCT02132949|Docetaxel|docetaxel|mesh-list
25701058|NCT02132949|Cyclophosphamide|cyclophosphamide|mesh-list
25701059|NCT02132949|Doxorubicin|doxorubicin|mesh-list
25701060|NCT02132949|Fluorouracil|fluorouracil|mesh-list
25701061|NCT02132949|Trastuzumab|trastuzumab|mesh-list
25701062|NCT02132949|Epirubicin|epirubicin|mesh-list
25701063|NCT02132949|Pertuzumab|pertuzumab|mesh-list
24762742|NCT01769625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762744|NCT01769651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24762745|NCT01769651|Narcotics|narcotics|mesh-ancestor
24762746|NCT01769651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24762747|NCT01769651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762748|NCT01769651|Analgesics|analgesics|mesh-ancestor
24762749|NCT01769651|Sensory System Agents|sensory system agents|mesh-ancestor
24762750|NCT01769651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24762751|NCT01769651|Antitussive Agents|antitussive agents|mesh-ancestor
24762770|NCT01769677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24762771|NCT01769677|Antitussive Agents|antitussive agents|mesh-ancestor
24762772|NCT01769677|Respiratory System Agents|respiratory system agents|mesh-ancestor
24762774|NCT01769703|Antithrombins|antithrombins|mesh-ancestor
24762775|NCT01769703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24762776|NCT01769703|Protease Inhibitors|protease inhibitors|mesh-ancestor
24762777|NCT01769703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762778|NCT01769703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762779|NCT01769703|Anticoagulants|anticoagulants|mesh-ancestor
24762780|NCT01769768|Bupropion|bupropion|mesh-list
24762781|NCT01769768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24762782|NCT01769768|Antidepressive Agents|antidepressive agents|mesh-ancestor
24762784|NCT01769768|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24762785|NCT01769768|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24762786|NCT01769768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24762787|NCT01769768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762788|NCT01769768|Dopamine Agents|dopamine agents|mesh-ancestor
24762789|NCT01769768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24762790|NCT01769768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762791|NCT01769768|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24762792|NCT01769768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24762793|NCT01769768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762794|NCT01769781|Anastrozole|anastrozole|mesh-list
24762795|NCT01769781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24762826|NCT01769898|Budesonide|budesonide|mesh-list
24762838|NCT01769898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24762839|NCT01769898|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24762840|NCT01769898|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24762841|NCT01769898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24762842|NCT01769898|Adrenergic Agents|adrenergic agents|mesh-ancestor
25079908|NCT03344042|Sufentanil|sufentanil|mesh-list
24643512|NCT01185873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24965943|NCT03772483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24965944|NCT03772483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965945|NCT03772561|Durvalumab|durvalumab|mesh-list
24965946|NCT03772561|Olaparib|olaparib|mesh-list
24965947|NCT03772561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24965948|NCT03772561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24965949|NCT03772561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24965950|NCT03772561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24965951|NCT03772561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24965952|NCT03772262|Metformin|metformin|mesh-list
24965955|NCT03772262|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24965956|NCT03772262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24965957|NCT03772262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965958|NCT03772262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24965964|NCT03772262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24965965|NCT03772262|Anesthetics, General|anesthetics, general|mesh-ancestor
24965966|NCT03772262|Anesthetics|anesthetics|mesh-ancestor
24965967|NCT03772262|GABA Modulators|gaba modulators|mesh-ancestor
24965968|NCT03772262|GABA Agents|gaba agents|mesh-ancestor
24965969|NCT03772262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25079909|NCT03344042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25079910|NCT03344042|Narcotics|narcotics|mesh-ancestor
25079911|NCT03344042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25079912|NCT03344042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079913|NCT03344042|Analgesics|analgesics|mesh-ancestor
25079922|NCT03344029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079924|NCT03344003|Coagulants|coagulants|mesh-ancestor
25079925|NCT03343977|Docetaxel|docetaxel|mesh-list
25079926|NCT03343977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079927|NCT03343977|Tubulin Modulators|tubulin modulators|mesh-ancestor
25079928|NCT03343977|Antimitotic Agents|antimitotic agents|mesh-ancestor
25079936|NCT03343873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079940|NCT03343873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25079941|NCT03343873|Analgesics|analgesics|mesh-ancestor
25079942|NCT03343873|Sensory System Agents|sensory system agents|mesh-ancestor
25079943|NCT03343873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25079944|NCT03343873|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25079945|NCT03343873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25079946|NCT03343873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25079947|NCT03343873|Adrenergic Agents|adrenergic agents|mesh-ancestor
24762882|NCT01770041|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24762883|NCT01770041|Analgesics|analgesics|mesh-ancestor
24762884|NCT01770041|Sensory System Agents|sensory system agents|mesh-ancestor
24643562|NCT01186094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24762885|NCT01770041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24762886|NCT01770041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762887|NCT01770041|Antipyretics|antipyretics|mesh-ancestor
24762888|NCT01770080|Peppermint oil|peppermint oil|mesh-list
24810902|NCT02043314|Isoniazid|isoniazid|mesh-list
24554788|NCT00738192|Citric Acid|citric acid|mesh-list
24762894|NCT01770080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24762895|NCT01770080|Parasympatholytics|parasympatholytics|mesh-ancestor
24762896|NCT01770106|Denosumab|denosumab|mesh-list
24762897|NCT01770106|Alendronate|alendronate|mesh-list
24762898|NCT01770106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24762899|NCT01770106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24762900|NCT01770132|Gemcitabine|gemcitabine|mesh-list
24762901|NCT01770132|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
24762935|NCT01770210|Atorvastatin|atorvastatin|mesh-list
24762936|NCT01770210|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24762937|NCT01770210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24762938|NCT01770210|Antimetabolites|antimetabolites|mesh-ancestor
24762939|NCT01770210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762940|NCT01770210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24762941|NCT01770210|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24762942|NCT01770210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762943|NCT01770223|Ribavirin|ribavirin|mesh-list
24762944|NCT01770223|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24762945|NCT01770223|Antimetabolites|antimetabolites|mesh-ancestor
24762946|NCT01770223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762947|NCT01770223|Antiviral Agents|antiviral agents|mesh-ancestor
24762948|NCT01770223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24762961|NCT01770301|Antimitotic Agents|antimitotic agents|mesh-ancestor
24762962|NCT01770301|Mitosis Modulators|mitosis modulators|mesh-ancestor
24537131|NCT00653562|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24762964|NCT01770301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24762965|NCT01770301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24762966|NCT01770301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24762967|NCT01770301|Growth Substances|growth substances|mesh-ancestor
24762968|NCT01770301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643848|NCT01187719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643910|NCT01187888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762969|NCT01770301|Growth Inhibitors|growth inhibitors|mesh-ancestor
24762971|NCT01770444|Thioguanine|thioguanine|mesh-list
24762972|NCT01770444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24762973|NCT01770444|Antimetabolites|antimetabolites|mesh-ancestor
24762974|NCT01770444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24762975|NCT01770444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24762976|NCT01770444|Antiviral Agents|antiviral agents|mesh-ancestor
24762977|NCT01770444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24762978|NCT01770444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24762979|NCT01770444|Immunologic Factors|immunologic factors|mesh-ancestor
24762986|NCT01770470|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25097963|NCT03200236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097965|NCT03200015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25097966|NCT03200015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097967|NCT03200184|Sofosbuvir|sofosbuvir|mesh-list
24414231|NCT00196625|Ritonavir|ritonavir|mesh-list
24762987|NCT01770470|Chelating Agents|chelating agents|mesh-ancestor
24762988|NCT01770470|Sequestering Agents|sequestering agents|mesh-ancestor
24762989|NCT01770470|Hemostatics|hemostatics|mesh-ancestor
24762990|NCT01770470|Coagulants|coagulants|mesh-ancestor
24762991|NCT01770600|Risperidone|risperidone|mesh-list
24762992|NCT01770600|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24762993|NCT01770600|Serotonin Agents|serotonin agents|mesh-ancestor
24762994|NCT01770600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24762995|NCT01770600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620236|NCT01056042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24762998|NCT01770600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24461640|NCT00353015|Cisplatin|cisplatin|mesh-list
24762999|NCT01770600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24763000|NCT01770600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24763001|NCT01770600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24763002|NCT01770600|Dopamine Agents|dopamine agents|mesh-ancestor
24763003|NCT01770769|Cloxacillin|cloxacillin|mesh-list
24763004|NCT01770769|Cephalothin|cephalothin|mesh-list
24763005|NCT01770769|Dalteparin|dalteparin|mesh-list
24763007|NCT01770769|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24763008|NCT01770769|Anticoagulants|anticoagulants|mesh-ancestor
24763009|NCT01770769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24763010|NCT01770769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24763011|NCT01770769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763012|NCT01770769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24763013|NCT01770769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24763015|NCT01770795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24763016|NCT01770795|Antimetabolites|antimetabolites|mesh-ancestor
24763017|NCT01770795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763018|NCT01770795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24763019|NCT01770795|Antiviral Agents|antiviral agents|mesh-ancestor
24763020|NCT01770795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24763021|NCT01770795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763022|NCT01770795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24763023|NCT01770795|Immunologic Factors|immunologic factors|mesh-ancestor
24763024|NCT01770795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763312|NCT01772940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763027|NCT01770899|Respiratory System Agents|respiratory system agents|mesh-ancestor
24763028|NCT01770899|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24763050|NCT01771081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24763051|NCT01771081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24763052|NCT01771081|Growth Substances|growth substances|mesh-ancestor
24763053|NCT01771081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763054|NCT01771081|Growth Inhibitors|growth inhibitors|mesh-ancestor
24763055|NCT01771081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24763058|NCT01771146|Folfirinox|folfirinox|mesh-list
24763059|NCT01771146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24763060|NCT01771146|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24763061|NCT01771146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24763062|NCT01771146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763066|NCT01771185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24763067|NCT01771185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763068|NCT01771198|Simvastatin|simvastatin|mesh-list
24763069|NCT01771198|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24763070|NCT01771198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24763071|NCT01771198|Antimetabolites|antimetabolites|mesh-ancestor
25701064|NCT02132949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25701065|NCT02132949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25701066|NCT02132949|Tubulin Modulators|tubulin modulators|mesh-ancestor
25701067|NCT02132949|Antimitotic Agents|antimitotic agents|mesh-ancestor
25701068|NCT02132949|Mitosis Modulators|mitosis modulators|mesh-ancestor
25701069|NCT02132949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701070|NCT02132949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25701071|NCT02132949|Immunologic Factors|immunologic factors|mesh-ancestor
25701072|NCT02132949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701073|NCT02132949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25701074|NCT02132949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25701075|NCT02132949|Alkylating Agents|alkylating agents|mesh-ancestor
25098192|NCT03198819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24763072|NCT01771198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763073|NCT01771198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24763074|NCT01771198|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24763076|NCT01771289|Docetaxel|docetaxel|mesh-list
24763077|NCT01771289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24763078|NCT01771289|Tubulin Modulators|tubulin modulators|mesh-ancestor
24763079|NCT01771289|Antimitotic Agents|antimitotic agents|mesh-ancestor
24763080|NCT01771289|Mitosis Modulators|mitosis modulators|mesh-ancestor
24763081|NCT01771289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763083|NCT01771302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24763084|NCT01771302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763085|NCT01771328|Hydrocortisone|hydrocortisone|mesh-list
24763086|NCT01771328|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24763088|NCT01771328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24763120|NCT01771458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24763121|NCT01771458|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24763122|NCT01771458|Hormone Antagonists|hormone antagonists|mesh-ancestor
24763123|NCT01771458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24763124|NCT01771458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24763125|NCT01771458|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24763126|NCT01771458|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24763127|NCT01771458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24763128|NCT05318443|Paclitaxel|paclitaxel|mesh-list
24763129|NCT05318443|Carboplatin|carboplatin|mesh-list
24763130|NCT05318443|Bevacizumab|bevacizumab|mesh-list
24763131|NCT05318443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24763133|NCT05318443|Tubulin Modulators|tubulin modulators|mesh-ancestor
24763134|NCT05318443|Antimitotic Agents|antimitotic agents|mesh-ancestor
24763135|NCT05318443|Mitosis Modulators|mitosis modulators|mesh-ancestor
24763136|NCT05318443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763137|NCT05318443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24763138|NCT05318443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24763139|NCT05318443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24763140|NCT05318443|Growth Substances|growth substances|mesh-ancestor
24763141|NCT05318443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763142|NCT05318443|Growth Inhibitors|growth inhibitors|mesh-ancestor
24763143|NCT05318365|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24763144|NCT05318365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24763145|NCT05318365|Laxatives|laxatives|mesh-ancestor
24763146|NCT05318339|Trastuzumab|trastuzumab|mesh-list
24763147|NCT05318339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24763148|NCT05318339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24763149|NCT01771783|Enzyme Inhibitors|enzyme inhibitors|mesh-list
24763150|NCT01771783|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24763157|NCT01771822|Analgesics|analgesics|mesh-ancestor
24763182|NCT01771874|Serotonin Agents|serotonin agents|mesh-ancestor
24763183|NCT01771874|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24763184|NCT01771874|Adrenergic Agents|adrenergic agents|mesh-ancestor
24763186|NCT01771978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24763187|NCT01771978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24763188|NCT01771978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24763189|NCT01771978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763190|NCT01771978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24763191|NCT01771978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763192|NCT01771978|Vasodilator Agents|vasodilator agents|mesh-ancestor
24763193|NCT01772056|Fluticasone|fluticasone|mesh-list
24763194|NCT01772056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24763195|NCT01772056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24763196|NCT01772056|Autonomic Agents|autonomic agents|mesh-ancestor
24763197|NCT01772056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24763198|NCT01772056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763199|NCT01772056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24763200|NCT01772056|Respiratory System Agents|respiratory system agents|mesh-ancestor
24763201|NCT01772056|Dermatologic Agents|dermatologic agents|mesh-ancestor
24763202|NCT01772056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24763203|NCT01772212|Terbinafine|terbinafine|mesh-list
24763204|NCT01772212|Antifungal Agents|antifungal agents|mesh-ancestor
25701076|NCT02132949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25701077|NCT02132949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25098360|NCT03197571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098361|NCT03197571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25098363|NCT03197571|Alkylating Agents|alkylating agents|mesh-ancestor
25098417|NCT03197584|Vitamins|vitamins|mesh-ancestor
25098418|NCT03197584|Micronutrients|micronutrients|mesh-ancestor
25098419|NCT03197584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25098420|NCT03197584|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24763205|NCT01772212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24620200|NCT01055795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620202|NCT01055808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24620203|NCT01055808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620204|NCT01055821|Interferons|interferons|mesh-list
24620205|NCT01055821|Ribavirin|ribavirin|mesh-list
24620206|NCT01055821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24620207|NCT01055821|Antiviral Agents|antiviral agents|mesh-ancestor
24620208|NCT01055821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24620209|NCT01055821|Antimetabolites|antimetabolites|mesh-ancestor
24620210|NCT01055821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620211|NCT01055847|Aztreonam|aztreonam|mesh-list
24620212|NCT01055847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24620237|NCT01056042|Medroxyprogesterone|medroxyprogesterone|mesh-list
24620239|NCT01056042|Estradiol|estradiol|mesh-list
24620240|NCT01056042|Estrogens|estrogens|mesh-ancestor
24620241|NCT01056042|Hormones|hormones|mesh-ancestor
24620242|NCT01056042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24620243|NCT01056042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24965992|NCT03772223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24965993|NCT03772223|Tocolytic Agents|tocolytic agents|mesh-ancestor
25079959|NCT03343795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25079960|NCT03343795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079961|NCT03343678|Venetoclax|venetoclax|mesh-list
25079962|NCT03343678|BI 836826|bi 836826|mesh-list
25079963|NCT03343678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079964|NCT03343678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25079975|NCT03343652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25079976|NCT03343652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25079977|NCT03343652|Alkylating Agents|alkylating agents|mesh-ancestor
25079978|NCT03343600|Imatinib Mesylate|imatinib mesylate|mesh-list
25079979|NCT03343600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25079980|NCT03343600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25079981|NCT03343600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25079982|NCT03343600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644636|NCT01192165|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25079983|NCT03343548|Magnesium Sulfate|magnesium sulfate|mesh-list
25079984|NCT03343548|Analgesics|analgesics|mesh-ancestor
25079985|NCT03343548|Sensory System Agents|sensory system agents|mesh-ancestor
25079986|NCT03343548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25079987|NCT03343548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25079988|NCT03343548|Anesthetics|anesthetics|mesh-ancestor
25079989|NCT03343548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25079990|NCT03343548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25079998|NCT03343509|Metronidazole|metronidazole|mesh-list
25079999|NCT03343509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25080000|NCT03343509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25080001|NCT03343509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25080002|NCT03343509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25080003|NCT03343444|Sofosbuvir|sofosbuvir|mesh-list
25080004|NCT03343444|Ledipasvir|ledipasvir|mesh-list
25080005|NCT03343444|Antiviral Agents|antiviral agents|mesh-ancestor
25080006|NCT03343444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25080007|NCT03343418|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25080008|NCT03343418|Hemostatics|hemostatics|mesh-ancestor
25080015|NCT03343366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25080016|NCT03343366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25080017|NCT03343366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25080018|NCT03343002|Fentanyl|fentanyl|mesh-list
25080019|NCT03343002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25080020|NCT03343002|Narcotics|narcotics|mesh-ancestor
25701078|NCT02132949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25701079|NCT02132949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25701080|NCT02132949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25701081|NCT02132949|Antimetabolites|antimetabolites|mesh-ancestor
25701082|NCT02132949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25701083|NCT02132949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25701084|NCT02133001|Esketamine|esketamine|mesh-list
25080021|NCT03343002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24620254|NCT01056042|Progestins|progestins|mesh-ancestor
24763218|NCT01772251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24763219|NCT01772251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763221|NCT01772290|Fluconazole|fluconazole|mesh-list
24763222|NCT01772290|Rabeprazole|rabeprazole|mesh-list
24763223|NCT01772290|Antifungal Agents|antifungal agents|mesh-ancestor
24763224|NCT01772290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24763225|NCT01772290|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24763226|NCT01772290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24763227|NCT01772290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763228|NCT01772290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763229|NCT01772290|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24763230|NCT01772290|Hormone Antagonists|hormone antagonists|mesh-ancestor
24763231|NCT01772290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24763232|NCT01772290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763233|NCT01772290|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24763234|NCT01772290|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24763235|NCT01772290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24763236|NCT01772290|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24763237|NCT01772290|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24763238|NCT01772290|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24763239|NCT01772381|Dexamethasone|dexamethasone|mesh-list
24763240|NCT01772381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24763241|NCT01772381|Antiemetics|antiemetics|mesh-ancestor
24763242|NCT01772381|Autonomic Agents|autonomic agents|mesh-ancestor
24763243|NCT01772381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24763259|NCT01772563|Itraconazole|itraconazole|mesh-list
24763260|NCT01772563|Antifungal Agents|antifungal agents|mesh-ancestor
24763261|NCT01772563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24763262|NCT01772563|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24763263|NCT01772563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24763264|NCT01772563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763265|NCT01772563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763266|NCT01772563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24763267|NCT01772563|Hormone Antagonists|hormone antagonists|mesh-ancestor
24763278|NCT01772615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25701085|NCT02133001|Antidepressive Agents|antidepressive agents|mesh-ancestor
25701086|NCT02133001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24763279|NCT01772615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763280|NCT01772615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763281|NCT01772615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24763282|NCT01772615|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24763283|NCT01772615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24763284|NCT01772641|Varenicline|varenicline|mesh-list
24763285|NCT01772641|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24763286|NCT01772641|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24763287|NCT01772641|Cholinergic Agents|cholinergic agents|mesh-ancestor
24900529|NCT04393025|Aspirin|aspirin|mesh-list
24763288|NCT01772641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24763289|NCT01772641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763290|NCT01772641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763292|NCT01772797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24763293|NCT01772797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24763294|NCT01772797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763295|NCT01772797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763296|NCT01772836|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
24763297|NCT01772836|Biapenem|biapenem|mesh-list
24763298|NCT01772836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763299|NCT01772836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763300|NCT01772836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24763301|NCT01772836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24763302|NCT01772940|Ritonavir|ritonavir|mesh-list
24763303|NCT01772940|Lopinavir|lopinavir|mesh-list
24763304|NCT01772940|Tenofovir|tenofovir|mesh-list
24763305|NCT01772940|Lamivudine|lamivudine|mesh-list
24763306|NCT01772940|Zidovudine|zidovudine|mesh-list
24480162|NCT00429975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24480163|NCT00429975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480164|NCT00429975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480165|NCT00429975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480166|NCT00429975|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24480167|NCT00429975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24480168|NCT00430001|Docetaxel|docetaxel|mesh-list
24480169|NCT00430001|Trastuzumab|trastuzumab|mesh-list
24480170|NCT00430001|Vinorelbine|vinorelbine|mesh-list
24480171|NCT00430001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480172|NCT00430001|Tubulin Modulators|tubulin modulators|mesh-ancestor
24480173|NCT00430001|Antimitotic Agents|antimitotic agents|mesh-ancestor
24480174|NCT00430001|Mitosis Modulators|mitosis modulators|mesh-ancestor
24480175|NCT00430001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763313|NCT01772940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763314|NCT01772940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24763315|NCT01772940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24763317|NCT01772940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24763318|NCT01772940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24763319|NCT01772940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24763320|NCT01772940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24763321|NCT01772940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24763322|NCT01772940|Antimetabolites|antimetabolites|mesh-ancestor
24763323|NCT01772940|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24763324|NCT01772940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24763325|NCT01772953|Treosulfan|treosulfan|mesh-list
24763326|NCT01772953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24763327|NCT01772953|Alkylating Agents|alkylating agents|mesh-ancestor
24763328|NCT01772953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645096|NCT01195727|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24645097|NCT01195727|Antithrombins|antithrombins|mesh-ancestor
24777782|NCT01866605|Midazolam|midazolam|mesh-list
25701087|NCT02133131|Sofosbuvir|sofosbuvir|mesh-list
25701088|NCT02133131|Grazoprevir|grazoprevir|mesh-list
25701089|NCT02133131|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25099223|NCT03193112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763359|NCT01773044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24763360|NCT01773044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763361|NCT01773096|Methylnaltrexone|methylnaltrexone|mesh-list
24554060|NCT00734123|Diuretics|diuretics|mesh-list
24763362|NCT01773096|Bisacodyl|bisacodyl|mesh-list
24763363|NCT01773096|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24763364|NCT01773096|Magnesium Hydroxide|magnesium hydroxide|mesh-list
24763365|NCT01773096|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
24763368|NCT01773096|Laxatives|laxatives|mesh-ancestor
24763369|NCT01773096|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24763370|NCT01773096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763371|NCT01773096|Sensory System Agents|sensory system agents|mesh-ancestor
24763372|NCT01773096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24763373|NCT01773096|Antacids|antacids|mesh-ancestor
24763374|NCT01773096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763375|NCT01773096|Antidiarrheals|antidiarrheals|mesh-ancestor
24763376|NCT01773174|Dabigatran|dabigatran|mesh-list
24763377|NCT01773174|Antithrombins|antithrombins|mesh-ancestor
24763378|NCT01773174|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24763379|NCT01773174|Protease Inhibitors|protease inhibitors|mesh-ancestor
24763380|NCT01773174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763381|NCT01773174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645098|NCT01195727|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24763382|NCT01773174|Anticoagulants|anticoagulants|mesh-ancestor
24763383|NCT01773408|Cytarabine|cytarabine|mesh-list
24763384|NCT01773408|Daunorubicin|daunorubicin|mesh-list
24763385|NCT01773408|Idarubicin|idarubicin|mesh-list
24763386|NCT01773408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24763387|NCT01773408|Antimetabolites|antimetabolites|mesh-ancestor
24763388|NCT01773408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763405|NCT01773512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24763406|NCT01773512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24763407|NCT01773512|Antimetabolites|antimetabolites|mesh-ancestor
24777847|NCT01867281|Antipyretics|antipyretics|mesh-ancestor
24763408|NCT01773512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763409|NCT01773512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24763410|NCT01773512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24763411|NCT01773512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763412|NCT01773538|Rifaximin|rifaximin|mesh-list
24763413|NCT01773538|Lactulose|lactulose|mesh-list
24763414|NCT01773538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24763415|NCT01773538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24763416|NCT01773538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24763417|NCT01773616|Mycophenolic Acid|mycophenolic acid|mesh-list
24763418|NCT01773616|Prednisolone|prednisolone|mesh-list
24763419|NCT01773616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24763420|NCT01773616|Methylprednisolone|methylprednisolone|mesh-list
24763421|NCT01773616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24763422|NCT01773616|Prednisolone acetate|prednisolone acetate|mesh-list
24763423|NCT01773616|Rituximab|rituximab|mesh-list
24763424|NCT01773616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24763425|NCT01773616|Prednisolone phosphate|prednisolone phosphate|mesh-list
24763426|NCT01773616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24763427|NCT01773616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24763428|NCT01773616|Immunologic Factors|immunologic factors|mesh-ancestor
24763429|NCT01773616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645260|NCT01197014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24763431|NCT01773616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24763432|NCT01773616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24763433|NCT01773616|Antitubercular Agents|antitubercular agents|mesh-ancestor
24763434|NCT01773616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24763435|NCT01773616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24763478|NCT01773876|Antifungal Agents|antifungal agents|mesh-ancestor
24763479|NCT01773876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24763481|NCT01774370|Antithrombins|antithrombins|mesh-ancestor
24763482|NCT01774370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24763483|NCT01774370|Protease Inhibitors|protease inhibitors|mesh-ancestor
24763484|NCT01774370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763485|NCT01774370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900712|NCT04391582|Silver Sulfadiazine|silver sulfadiazine|mesh-list
24480176|NCT00430001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25701090|NCT02133131|Antiviral Agents|antiviral agents|mesh-ancestor
25701091|NCT02133131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25099622|NCT03188445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099623|NCT03188445|Protective Agents|protective agents|mesh-ancestor
25099624|NCT03188445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099625|NCT03188445|Vitamins|vitamins|mesh-ancestor
25099626|NCT03188445|Micronutrients|micronutrients|mesh-ancestor
25099627|NCT03188445|Trace Elements|trace elements|mesh-ancestor
25099628|NCT03188445|Hematinics|hematinics|mesh-ancestor
25099629|NCT03188471|Aspirin|aspirin|mesh-list
25099630|NCT03188471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099631|NCT03188471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25099632|NCT03188471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24480177|NCT00430001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24480179|NCT00430066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480180|NCT00430066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24480181|NCT00430066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480182|NCT00430066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480183|NCT00430079|Etanidazole|etanidazole|mesh-list
24480392|NCT00430924|Diuretics|diuretics|mesh-ancestor
24480404|NCT00431028|Ciprofloxacin|ciprofloxacin|mesh-list
24763499|NCT01774474|Dexamethasone|dexamethasone|mesh-list
24763500|NCT01774474|Dexamethasone acetate|dexamethasone acetate|mesh-list
24763502|NCT01774474|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24763503|NCT01774474|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24763505|NCT01774474|Bevacizumab|bevacizumab|mesh-list
24763506|NCT01774474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24763507|NCT01774474|BB 1101|bb 1101|mesh-list
24763508|NCT01774474|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24763509|NCT01774474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24763510|NCT01774474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24763511|NCT01774474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24763512|NCT01774474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24763513|NCT01774474|Growth Substances|growth substances|mesh-ancestor
24763514|NCT01774474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966084|NCT03771781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966085|NCT03771781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24966086|NCT03771781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966087|NCT03771768|Triamcinolone|triamcinolone|mesh-list
24966088|NCT03771768|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24966089|NCT03771768|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24966090|NCT03771768|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24966091|NCT03771768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24966092|NCT03771768|Glucocorticoids|glucocorticoids|mesh-ancestor
24966094|NCT03771768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24966095|NCT03771768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966096|NCT03771768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25080041|NCT03342859|Ulipristal acetate|ulipristal acetate|mesh-list
25080042|NCT03342859|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25080043|NCT03342859|Contraceptive Agents|contraceptive agents|mesh-ancestor
25080044|NCT03342859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25080045|NCT03342859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080046|NCT03342859|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25080048|NCT03342807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25080049|NCT03342807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080050|NCT03342651|Vitamin D|vitamin d|mesh-list
25080051|NCT03342651|Vitamins|vitamins|mesh-ancestor
25080052|NCT03342651|Micronutrients|micronutrients|mesh-ancestor
25701092|NCT02133352|Ranolazine|ranolazine|mesh-list
25701093|NCT02133352|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25701094|NCT02133352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25701095|NCT02133352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701096|NCT02133664|Thioctic Acid|thioctic acid|mesh-list
25701097|NCT02133664|Antioxidants|antioxidants|mesh-ancestor
25701098|NCT02133664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701099|NCT02133664|Protective Agents|protective agents|mesh-ancestor
25701100|NCT02133664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701101|NCT02133664|Vitamin B Complex|vitamin b complex|mesh-ancestor
25701102|NCT02133664|Vitamins|vitamins|mesh-ancestor
25100113|NCT03185351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100127|NCT03185104|Fluorides|fluorides|mesh-list
25080053|NCT03342651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080054|NCT03342651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25080055|NCT03342599|Thioctic Acid|thioctic acid|mesh-list
25080056|NCT03342599|Antioxidants|antioxidants|mesh-ancestor
25080057|NCT03342599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080058|NCT03342599|Protective Agents|protective agents|mesh-ancestor
25080059|NCT03342599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080060|NCT03342599|Vitamin B Complex|vitamin b complex|mesh-ancestor
25080061|NCT03342599|Vitamins|vitamins|mesh-ancestor
25080062|NCT03342599|Micronutrients|micronutrients|mesh-ancestor
25080063|NCT03342443|Memantine|memantine|mesh-list
25080064|NCT03342443|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25080065|NCT03342443|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25080066|NCT03342443|Dopamine Agents|dopamine agents|mesh-ancestor
25080067|NCT03342443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25080068|NCT03342443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763515|NCT01774474|Growth Inhibitors|growth inhibitors|mesh-ancestor
24763516|NCT01774474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24763517|NCT01774474|Antiemetics|antiemetics|mesh-ancestor
24763518|NCT01774474|Autonomic Agents|autonomic agents|mesh-ancestor
24763519|NCT01774474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24763520|NCT01774474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24763521|NCT01774474|Glucocorticoids|glucocorticoids|mesh-ancestor
24763522|NCT01774474|Hormones|hormones|mesh-ancestor
24763523|NCT01774474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24645576|NCT01198665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24763524|NCT01774474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24763525|NCT01774474|Protease Inhibitors|protease inhibitors|mesh-ancestor
24620271|NCT01056224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24620272|NCT01056237|Mycophenolic Acid|mycophenolic acid|mesh-list
24620273|NCT01056237|Azathioprine|azathioprine|mesh-list
24620274|NCT01056237|Tacrolimus|tacrolimus|mesh-list
24620275|NCT01056237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24620276|NCT01056237|Immunologic Factors|immunologic factors|mesh-ancestor
24620277|NCT01056237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620278|NCT01056237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24620279|NCT01056237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620280|NCT01056237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620287|NCT01056237|Antimetabolites|antimetabolites|mesh-ancestor
24620295|NCT01056419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24620296|NCT01056419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620297|NCT01056497|Thioctic Acid|thioctic acid|mesh-list
24620298|NCT01056497|Antioxidants|antioxidants|mesh-ancestor
24620299|NCT01056497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620300|NCT01056497|Protective Agents|protective agents|mesh-ancestor
24620301|NCT01056497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620302|NCT01056497|Vitamin B Complex|vitamin b complex|mesh-ancestor
24620303|NCT01056497|Vitamins|vitamins|mesh-ancestor
24620304|NCT01056497|Micronutrients|micronutrients|mesh-ancestor
24620305|NCT01056549|Exenatide|exenatide|mesh-list
24620306|NCT01056549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24620307|NCT01056549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620308|NCT01056549|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24620309|NCT01056549|Incretins|incretins|mesh-ancestor
24763554|NCT01774812|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
24763555|NCT01774812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24763556|NCT01774812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763557|NCT01774812|Vitamins|vitamins|mesh-ancestor
24763558|NCT01774812|Micronutrients|micronutrients|mesh-ancestor
24763559|NCT01774812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24763560|NCT01774838|Clopidogrel|clopidogrel|mesh-list
24763561|NCT01774838|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24763562|NCT01774838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24763563|NCT01774838|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24763564|NCT01774838|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24763565|NCT01774838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24763566|NCT01774838|Purinergic Agents|purinergic agents|mesh-ancestor
24763567|NCT01774838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24763568|NCT01774838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645596|NCT01198860|Tenofovir|tenofovir|mesh-list
25701103|NCT02133664|Micronutrients|micronutrients|mesh-ancestor
25701104|NCT02133742|Pembrolizumab|pembrolizumab|mesh-list
25701105|NCT02133742|Axitinib|axitinib|mesh-list
25106057|NCT04594746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24645673|NCT01199328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645677|NCT01199328|Antipyretics|antipyretics|mesh-ancestor
24763579|NCT01774877|Immunologic Factors|immunologic factors|mesh-ancestor
24763580|NCT01774877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763581|NCT01775098|Allopurinol|allopurinol|mesh-list
24763588|NCT01775098|Antioxidants|antioxidants|mesh-ancestor
24763589|NCT01775098|Protective Agents|protective agents|mesh-ancestor
24763590|NCT01775098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763591|NCT01775215|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24763592|NCT01775215|Natriuretic Agents|natriuretic agents|mesh-ancestor
24763593|NCT01775215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763594|NCT01775397|Vancomycin|vancomycin|mesh-list
24763595|NCT01775397|Fidaxomicin|fidaxomicin|mesh-list
24763596|NCT01775397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24763597|NCT01775397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24763598|NCT01775475|Prednisone|prednisone|mesh-list
24763599|NCT01775475|Cyclophosphamide|cyclophosphamide|mesh-list
24763600|NCT01775475|Lomustine|lomustine|mesh-list
24763601|NCT01775475|Doxorubicin|doxorubicin|mesh-list
24763602|NCT01775475|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24763603|NCT01775475|Etoposide|etoposide|mesh-list
24763604|NCT01775475|Vincristine|vincristine|mesh-list
24763605|NCT01775475|Etoposide phosphate|etoposide phosphate|mesh-list
24763606|NCT01775475|Procarbazine|procarbazine|mesh-list
24763607|NCT01775475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24763608|NCT01775475|Immunologic Factors|immunologic factors|mesh-ancestor
24763609|NCT01775475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763610|NCT01775475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24763611|NCT01775475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24763612|NCT01775475|Alkylating Agents|alkylating agents|mesh-ancestor
24763613|NCT01775475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763620|NCT01775475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24763621|NCT01775475|Glucocorticoids|glucocorticoids|mesh-ancestor
24763623|NCT01775475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24763624|NCT01775475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24763625|NCT01775475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24763626|NCT01775475|Tubulin Modulators|tubulin modulators|mesh-ancestor
24763627|NCT01775475|Antimitotic Agents|antimitotic agents|mesh-ancestor
24763628|NCT01775475|Mitosis Modulators|mitosis modulators|mesh-ancestor
24763630|NCT01775540|Lubricant Eye Drops|lubricant eye drops|mesh-list
24451677|NCT00324480|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24645750|NCT01199523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24645751|NCT01199523|Adrenergic Agents|adrenergic agents|mesh-ancestor
24763631|NCT01775540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24763632|NCT01775540|Antiemetics|antiemetics|mesh-ancestor
24763633|NCT01775540|Autonomic Agents|autonomic agents|mesh-ancestor
24763634|NCT01775540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24763635|NCT01775540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763636|NCT01775540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24763637|NCT01775540|Glucocorticoids|glucocorticoids|mesh-ancestor
24763639|NCT01775540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24763640|NCT01775540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24554334|NCT00735813|Heparin|heparin|mesh-list
24763641|NCT01775540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24763663|NCT01775761|Moxifloxacin|moxifloxacin|mesh-list
24763664|NCT01775761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24763665|NCT01775761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25701106|NCT02133742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25701107|NCT02133742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25701108|NCT02133742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25701109|NCT02133742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763666|NCT01775761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24763667|NCT01775761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24763668|NCT01775761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25101126|NCT03177252|Lidocaine|lidocaine|mesh-list
24763669|NCT01775761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763670|NCT01775761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24763671|NCT01775839|Aspirin|aspirin|mesh-list
24763672|NCT01775839|Digoxin|digoxin|mesh-list
24763673|NCT01775839|Clopidogrel|clopidogrel|mesh-list
24763674|NCT01775839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24763675|NCT01775839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24763676|NCT01775839|Analgesics|analgesics|mesh-ancestor
24763677|NCT01775839|Sensory System Agents|sensory system agents|mesh-ancestor
24818063|NCT02086903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24763678|NCT01775839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24763679|NCT01775839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763680|NCT01775839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24763682|NCT01775839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24763683|NCT01775839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24763685|NCT01775839|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24763691|NCT01775839|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24763692|NCT01775839|Purinergic Agents|purinergic agents|mesh-ancestor
24763693|NCT01775839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24763694|NCT01775839|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24763696|NCT01775839|Protective Agents|protective agents|mesh-ancestor
24763697|NCT01775891|Flecainide|flecainide|mesh-list
24763698|NCT01775891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
24763699|NCT01775891|Propafenone|propafenone|mesh-list
24763700|NCT01775891|Pilsicainide|pilsicainide|mesh-list
24763701|NCT01775891|Lidocaine|lidocaine|mesh-list
24763702|NCT01775891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24763703|NCT01775891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24584947|NCT00882388|Aspirin|aspirin|mesh-list
24584948|NCT00882388|Celecoxib|celecoxib|mesh-list
24627188|NCT01091012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627189|NCT01091012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627190|NCT01091012|Urological Agents|urological agents|mesh-ancestor
24627191|NCT01091051|Ustekinumab|ustekinumab|mesh-list
24627192|NCT01091051|Dermatologic Agents|dermatologic agents|mesh-ancestor
24627193|NCT01091077|Naringenin|naringenin|mesh-list
24627194|NCT01091077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24627195|NCT01091077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24480500|NCT00431171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480501|NCT00431171|Antimanic Agents|antimanic agents|mesh-ancestor
24480502|NCT00431171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24645752|NCT01199523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24480503|NCT00431171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24480504|NCT00431171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480506|NCT00431197|Testosterone|testosterone|mesh-list
24480507|NCT00431197|Antifungal Agents|antifungal agents|mesh-ancestor
24627196|NCT01091077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24627197|NCT01091077|Hormone Antagonists|hormone antagonists|mesh-ancestor
24627198|NCT01091077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24627199|NCT01091077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627200|NCT01091207|Sorafenib|sorafenib|mesh-list
24627201|NCT01091207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24627202|NCT01091207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24627203|NCT01091207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627204|NCT01091207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627205|NCT01091220|Certolizumab Pegol|certolizumab pegol|mesh-list
24627206|NCT01091220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24627207|NCT01091220|Immunologic Factors|immunologic factors|mesh-ancestor
24627208|NCT01091220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627209|NCT01091220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24763704|NCT01775891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24763705|NCT01775891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763706|NCT01775891|Anesthetics, Local|anesthetics, local|mesh-ancestor
24763707|NCT01775891|Anesthetics|anesthetics|mesh-ancestor
24763708|NCT01775891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24763709|NCT01775891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763710|NCT01775891|Sensory System Agents|sensory system agents|mesh-ancestor
24763711|NCT01775891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24763712|NCT01776047|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
24763713|NCT01776047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24763714|NCT01776203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24763715|NCT01776203|Medroxyprogesterone|medroxyprogesterone|mesh-list
24763716|NCT01776203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24763717|NCT01776203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24480508|NCT00431197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24480509|NCT00431197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24480510|NCT00431197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24646094|NCT01202058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646224|NCT01202487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24646225|NCT01202487|Adrenergic Agents|adrenergic agents|mesh-ancestor
24462735|NCT00357422|Ethanol|ethanol|mesh-list
24480526|NCT00431236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24480527|NCT00431236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480528|NCT00431236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24763718|NCT01776203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24763720|NCT01776203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24763721|NCT01776203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763722|NCT01776203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24646226|NCT01202487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24763723|NCT01776203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24763724|NCT01776203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24763725|NCT01776203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24763726|NCT01776203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24763727|NCT01776320|Alprostadil|alprostadil|mesh-list
24763728|NCT01776320|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24554464|NCT00736697|Moxidectin|moxidectin|mesh-list
25080083|NCT03342352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25080084|NCT03342352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24554465|NCT00736697|Anthelmintics|anthelmintics|mesh-ancestor
24554466|NCT00736697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24554467|NCT00736697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24554468|NCT00736697|Antinematodal Agents|antinematodal agents|mesh-ancestor
24554469|NCT00736801|Fluticasone|fluticasone|mesh-list
24554470|NCT00736801|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24554471|NCT00736801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24763729|NCT01776320|Vasodilator Agents|vasodilator agents|mesh-ancestor
24763730|NCT01776320|Urological Agents|urological agents|mesh-ancestor
24763732|NCT01776437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24763733|NCT01776437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763734|NCT01776437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763735|NCT01776437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480535|NCT00431236|Dermatologic Agents|dermatologic agents|mesh-ancestor
24480536|NCT00431236|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24763741|NCT01776515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24763742|NCT01776515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763743|NCT01776515|Antipyretics|antipyretics|mesh-ancestor
24763744|NCT01776515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24763745|NCT01776515|Narcotics|narcotics|mesh-ancestor
24555657|NCT00742638|Valproic Acid|valproic acid|mesh-list
24763747|NCT01776567|Everolimus|everolimus|mesh-list
24763748|NCT01776567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24763749|NCT01776567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24763750|NCT01776567|Immunologic Factors|immunologic factors|mesh-ancestor
24763751|NCT01776567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763752|NCT01776671|Gabapentin|gabapentin|mesh-list
24763753|NCT01776671|Analgesics|analgesics|mesh-ancestor
24763754|NCT01776671|Sensory System Agents|sensory system agents|mesh-ancestor
24763755|NCT01776671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24763756|NCT01776671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763757|NCT01776671|Anticonvulsants|anticonvulsants|mesh-ancestor
24763758|NCT01776671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24763759|NCT01776671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24763760|NCT01776671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24763761|NCT01776671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24763762|NCT01776671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25102440|NCT03169127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25102441|NCT03169127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25102442|NCT03169127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25102443|NCT03169127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102444|NCT03169127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102445|NCT03168958|Methadone|methadone|mesh-list
25102446|NCT03168958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24763763|NCT01776671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24763764|NCT01776671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24763765|NCT01776671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763766|NCT01776671|Antimanic Agents|antimanic agents|mesh-ancestor
24763767|NCT01776684|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24763768|NCT01776684|Gefitinib|gefitinib|mesh-list
24763769|NCT01776684|Afatinib|afatinib|mesh-list
24763770|NCT01776684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24763771|NCT01776684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24763772|NCT01776684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901026|NCT04389424|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24480538|NCT00431236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24480539|NCT00431236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763773|NCT01776684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763774|NCT01776788|Insulin|insulin|mesh-list
24763775|NCT01776788|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24763776|NCT01776788|Exenatide|exenatide|mesh-list
24763777|NCT01776788|Insulin Lispro|insulin lispro|mesh-list
24763778|NCT01776788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24763779|NCT01776788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763780|NCT01776788|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24763782|NCT01776788|Hormones|hormones|mesh-ancestor
24763783|NCT01776788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24763785|NCT01776853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24763786|NCT01776970|Nabiximols|nabiximols|mesh-list
24763787|NCT01776970|Analgesics|analgesics|mesh-ancestor
24763788|NCT01776970|Sensory System Agents|sensory system agents|mesh-ancestor
24763789|NCT01776970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24763790|NCT01776970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763791|NCT01777087|Capsaicin|capsaicin|mesh-list
24763792|NCT01777087|Antipruritics|antipruritics|mesh-ancestor
24763793|NCT01777087|Dermatologic Agents|dermatologic agents|mesh-ancestor
24763794|NCT01777087|Sensory System Agents|sensory system agents|mesh-ancestor
24763795|NCT01777087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24763796|NCT01777087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080085|NCT03342300|Doxorubicin|doxorubicin|mesh-list
24763798|NCT01777100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24480577|NCT00431340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480578|NCT00431340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480579|NCT00431353|Valganciclovir|valganciclovir|mesh-list
24480580|NCT00431353|Ganciclovir|ganciclovir|mesh-list
24763799|NCT01777100|Narcotics|narcotics|mesh-ancestor
24763800|NCT01777100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24763801|NCT01777100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763802|NCT01777100|Analgesics|analgesics|mesh-ancestor
24763803|NCT01777100|Sensory System Agents|sensory system agents|mesh-ancestor
24763804|NCT01777100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24763805|NCT01777100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24763832|NCT01777477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24763833|NCT01777503|Clopidogrel|clopidogrel|mesh-list
24763834|NCT01777503|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24763835|NCT01777503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24763836|NCT01777503|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24763837|NCT01777503|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24763838|NCT01777503|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24763839|NCT01777503|Purinergic Agents|purinergic agents|mesh-ancestor
25701110|NCT02133742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701111|NCT02133781|Vaccines|vaccines|mesh-list
25701112|NCT02133781|Immunologic Factors|immunologic factors|mesh-ancestor
25701113|NCT02133781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701114|NCT02134015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25701115|NCT02134015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25701116|NCT02134015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25103146|NCT03163914|Sympathomimetics|sympathomimetics|mesh-ancestor
24763841|NCT01777503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763842|NCT01777503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763843|NCT01777685|Sulpiride|sulpiride|mesh-list
24763844|NCT01777685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24763845|NCT01777685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24763846|NCT01777685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24763847|NCT01777685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763848|NCT01777685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24763849|NCT01777685|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24763850|NCT01777685|Dopamine Agents|dopamine agents|mesh-ancestor
24763851|NCT01777685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24763852|NCT01777685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763853|NCT01777685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24763854|NCT01777685|Antidepressive Agents|antidepressive agents|mesh-ancestor
24763855|NCT01777737|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24763856|NCT01777737|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24763857|NCT01777737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24763858|NCT01777737|Renal Agents|renal agents|mesh-ancestor
24763859|NCT01777737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24763860|NCT01777737|Antimalarials|antimalarials|mesh-ancestor
24763861|NCT01777737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24980323|NCT05375097|Erenumab|erenumab|mesh-list
24451709|NCT00324571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451710|NCT00324597|Gemcitabine|gemcitabine|mesh-list
24451711|NCT00324597|Motesanib diphosphate|motesanib diphosphate|mesh-list
24451713|NCT00324597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24451714|NCT00324597|Antimetabolites|antimetabolites|mesh-ancestor
24451715|NCT00324597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451716|NCT00324597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451717|NCT00324597|Antiviral Agents|antiviral agents|mesh-ancestor
24451718|NCT00324597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24451719|NCT00324597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451720|NCT00324597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24451721|NCT00324597|Immunologic Factors|immunologic factors|mesh-ancestor
24451722|NCT00324597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451723|NCT00324597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24763862|NCT01777737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24763863|NCT01777867|Methacholine Chloride|methacholine chloride|mesh-list
24763866|NCT01777867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24763867|NCT01777867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763868|NCT01777867|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24763869|NCT01777867|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
24763870|NCT01777867|Respiratory System Agents|respiratory system agents|mesh-ancestor
24763871|NCT01777867|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24763872|NCT01777867|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24763873|NCT01777867|Cholinergic Agents|cholinergic agents|mesh-ancestor
24763874|NCT01777867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24763875|NCT01777867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763877|NCT01777919|Temozolomide|temozolomide|mesh-list
24763878|NCT01777919|Disulfiram|disulfiram|mesh-list
24763879|NCT01777919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24763880|NCT01777919|Alkylating Agents|alkylating agents|mesh-ancestor
24763881|NCT01777919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763882|NCT01777919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24763883|NCT01777919|Trace Elements|trace elements|mesh-ancestor
24763884|NCT01777919|Micronutrients|micronutrients|mesh-ancestor
24763885|NCT01777919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763886|NCT01777919|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24647307|NCT01207921|Immunologic Factors|immunologic factors|mesh-ancestor
24763887|NCT01777919|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25701117|NCT02134015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25701118|NCT02134015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701119|NCT02134184|Vaccines|vaccines|mesh-list
25701120|NCT02134184|Immunologic Factors|immunologic factors|mesh-ancestor
24763888|NCT01777919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763889|NCT01778075|Acetaminophen|acetaminophen|mesh-list
24763891|NCT01778075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24763892|NCT01778075|Analgesics|analgesics|mesh-ancestor
24763893|NCT01778075|Sensory System Agents|sensory system agents|mesh-ancestor
24763894|NCT01778075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24763895|NCT01778075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763896|NCT01778075|Antipyretics|antipyretics|mesh-ancestor
24763897|NCT01778075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24763898|NCT01778075|Narcotics|narcotics|mesh-ancestor
24763899|NCT01778075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24763902|NCT01778101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24763903|NCT01778101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24763906|NCT01778101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763908|NCT01778114|Ergocalciferols|ergocalciferols|mesh-list
24763909|NCT01778114|Cholecalciferol|cholecalciferol|mesh-list
24763910|NCT01778114|Vitamins|vitamins|mesh-list
24763911|NCT01778114|Micronutrients|micronutrients|mesh-ancestor
24763912|NCT01778114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763913|NCT01778114|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24763914|NCT01778114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24763915|NCT01778192|Picosulfate sodium|picosulfate sodium|mesh-list
24763916|NCT01778192|Magnesium citrate|magnesium citrate|mesh-list
24763917|NCT01778192|Citric Acid|citric acid|mesh-list
24763918|NCT01778192|Sodium Citrate|sodium citrate|mesh-list
24763919|NCT01778192|Anticoagulants|anticoagulants|mesh-ancestor
24763920|NCT01778192|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24763921|NCT01778192|Chelating Agents|chelating agents|mesh-ancestor
24763922|NCT01778192|Sequestering Agents|sequestering agents|mesh-ancestor
24763923|NCT01778192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763925|NCT01778192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24480581|NCT00431353|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
24480582|NCT00431353|Antiviral Agents|antiviral agents|mesh-ancestor
24480583|NCT00431353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24480584|NCT00431353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24480585|NCT00431353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480587|NCT00431379|Tenecteplase|tenecteplase|mesh-list
24480621|NCT00431392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24480726|NCT00431795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480727|NCT00431990|Dexamethasone|dexamethasone|mesh-list
24480728|NCT00431990|Bortezomib|bortezomib|mesh-list
24480729|NCT00431990|Romidepsin|romidepsin|mesh-list
24451725|NCT00324610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24451726|NCT00324610|Antimetabolites|antimetabolites|mesh-ancestor
24480730|NCT00431990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24480731|NCT00431990|Antiemetics|antiemetics|mesh-ancestor
24480732|NCT00431990|Autonomic Agents|autonomic agents|mesh-ancestor
24480733|NCT00431990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24480734|NCT00431990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480735|NCT00431990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24480736|NCT00431990|Glucocorticoids|glucocorticoids|mesh-ancestor
24480738|NCT00431990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24480739|NCT00431990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24480740|NCT00431990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480741|NCT00431990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24480742|NCT00432016|Zidovudine|zidovudine|mesh-list
24480743|NCT00432016|Antimetabolites|antimetabolites|mesh-ancestor
24763927|NCT01778218|Antimetabolites|antimetabolites|mesh-ancestor
24763928|NCT01778218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763929|NCT01778218|Antiviral Agents|antiviral agents|mesh-ancestor
24763930|NCT01778218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24763931|NCT01778244|Metformin|metformin|mesh-list
24554723|NCT00737789|Sensory System Agents|sensory system agents|mesh-ancestor
24554724|NCT00737789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24554725|NCT00737789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554726|NCT00737789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24554727|NCT00737789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24620310|NCT01056549|Hormones|hormones|mesh-ancestor
24620311|NCT01056549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24620312|NCT01056614|Methotrexate|methotrexate|mesh-list
24620313|NCT01056614|Fludarabine phosphate|fludarabine phosphate|mesh-list
24620314|NCT01056614|Fludarabine|fludarabine|mesh-list
24480744|NCT00432016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480745|NCT00432016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25104801|NCT03151005|Contraceptive Agents|contraceptive agents|mesh-list
24480759|NCT00432055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24480760|NCT00432055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480762|NCT00432055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24480764|NCT00432068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24480765|NCT00432068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24480766|NCT00432068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480773|NCT00432081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480774|NCT00432081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24480775|NCT00432081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24480776|NCT00432081|Gout Suppressants|gout suppressants|mesh-ancestor
24480777|NCT00432081|Tocolytic Agents|tocolytic agents|mesh-ancestor
24480778|NCT00432081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24480779|NCT00432081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24480780|NCT00432081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480781|NCT00432081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480782|NCT00432120|Clopidogrel|clopidogrel|mesh-list
24480828|NCT00432367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24480829|NCT00432367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24480830|NCT00432367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480831|NCT00432367|Antiviral Agents|antiviral agents|mesh-ancestor
24480832|NCT00432367|Schistosomicides|schistosomicides|mesh-ancestor
24620315|NCT01056614|Busulfan|busulfan|mesh-list
24620316|NCT01056614|Tacrolimus|tacrolimus|mesh-list
24620317|NCT01056614|Thymoglobulin|thymoglobulin|mesh-list
24620318|NCT01056614|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24620319|NCT01056614|Immunoglobulins|immunoglobulins|mesh-list
24620320|NCT01056614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24620321|NCT01056614|Abortifacient Agents|abortifacient agents|mesh-ancestor
24620322|NCT01056614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24629430|NCT01105286|Vitamin D|vitamin d|mesh-list
24451728|NCT00324610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647845|NCT01211158|Ketamine|ketamine|mesh-list
24620323|NCT01056614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620324|NCT01056614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24620325|NCT01056614|Antimetabolites|antimetabolites|mesh-ancestor
24620326|NCT01056614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620327|NCT01056614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24620328|NCT01056614|Dermatologic Agents|dermatologic agents|mesh-ancestor
24620329|NCT01056614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620330|NCT01056614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24620331|NCT01056614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24620332|NCT01056614|Immunologic Factors|immunologic factors|mesh-ancestor
24620333|NCT01056614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24620334|NCT01056614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24620335|NCT01056614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24620336|NCT01056614|Alkylating Agents|alkylating agents|mesh-ancestor
24620337|NCT01056614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25701121|NCT02134184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701122|NCT02134210|Etanercept|etanercept|mesh-list
25701123|NCT02134210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25701124|NCT02134210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25701125|NCT02134210|Analgesics|analgesics|mesh-ancestor
25701126|NCT02134210|Sensory System Agents|sensory system agents|mesh-ancestor
25701127|NCT02134210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25701128|NCT02134210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701129|NCT02134210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25701130|NCT02134210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24620338|NCT01056614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24620339|NCT01056627|Valproic Acid|valproic acid|mesh-list
24975159|NCT04689347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24975160|NCT04689347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24975161|NCT04689347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24975162|NCT04689347|Growth Substances|growth substances|mesh-ancestor
24975163|NCT04689347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975164|NCT04689347|Growth Inhibitors|growth inhibitors|mesh-ancestor
24975165|NCT04689347|Antimetabolites|antimetabolites|mesh-ancestor
24975166|NCT04689347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620340|NCT01056627|Anticonvulsants|anticonvulsants|mesh-ancestor
24620341|NCT01056627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620342|NCT01056627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620343|NCT01056627|GABA Agents|gaba agents|mesh-ancestor
24620344|NCT01056627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24620345|NCT01056627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901176|NCT04387929|Antibodies|antibodies|mesh-list
24480833|NCT00432367|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24480834|NCT00432367|Anthelmintics|anthelmintics|mesh-ancestor
24480835|NCT00432367|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24480836|NCT00432367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480837|NCT00432367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480838|NCT00432367|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24620346|NCT01056627|Antimanic Agents|antimanic agents|mesh-ancestor
24620348|NCT01056627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24620349|NCT01056627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24620350|NCT01056679|Doxorubicin|doxorubicin|mesh-list
24627210|NCT01091324|Dextromethorphan|dextromethorphan|mesh-list
24627211|NCT01091324|Silymarin|silymarin|mesh-list
24620351|NCT01056679|Lenalidomide|lenalidomide|mesh-list
24620352|NCT01056679|Vinblastine|vinblastine|mesh-list
24763932|NCT01778244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24763933|NCT01778244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763934|NCT01778283|Dialysis Solutions|dialysis solutions|mesh-list
24763935|NCT01778283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24763936|NCT01778309|Acetylcysteine|acetylcysteine|mesh-list
24763937|NCT01778309|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24763938|NCT01778309|Antiviral Agents|antiviral agents|mesh-ancestor
24763939|NCT01778309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24763940|NCT01778309|Expectorants|expectorants|mesh-ancestor
24620353|NCT01056679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24620354|NCT01056679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24620355|NCT01056679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24620356|NCT01056679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24620357|NCT01056679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763941|NCT01778309|Respiratory System Agents|respiratory system agents|mesh-ancestor
24763942|NCT01778309|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24763943|NCT01778309|Antioxidants|antioxidants|mesh-ancestor
24763944|NCT01778309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763945|NCT01778309|Protective Agents|protective agents|mesh-ancestor
24763946|NCT01778309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763947|NCT01778309|Antidotes|antidotes|mesh-ancestor
24763948|NCT01778400|Ethanol|ethanol|mesh-list
24763949|NCT01778400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24763950|NCT01778400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24763951|NCT01778400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24763952|NCT01778400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763954|NCT01778413|Emtricitabine|emtricitabine|mesh-list
24763960|NCT01778413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24763962|NCT01778413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763963|NCT01778413|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24763969|NCT01778413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24763970|NCT01778413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25701131|NCT02134210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25701132|NCT02134210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25701133|NCT02134210|Immunologic Factors|immunologic factors|mesh-ancestor
25701134|NCT02134314|Complement C1s|complement c1s|mesh-list
25701135|NCT02134314|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25701136|NCT02134314|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
25701137|NCT02134314|Immunologic Factors|immunologic factors|mesh-ancestor
25701138|NCT02134314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701139|NCT02134314|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25105410|NCT03146000|Sensory System Agents|sensory system agents|mesh-ancestor
25105411|NCT03146000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25105412|NCT03146000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25105413|NCT03146000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25105414|NCT03146000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25105415|NCT03146000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25105428|NCT03146325|Omeprazole|omeprazole|mesh-list
25105435|NCT03146325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25105436|NCT03146325|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24975609|NCT03440112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975610|NCT03440112|GABA Modulators|gaba modulators|mesh-ancestor
24975612|NCT03440112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24975613|NCT03434262|Gemcitabine|gemcitabine|mesh-list
24763971|NCT01778647|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
24763972|NCT01778647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763973|NCT01778686|Pindolol|pindolol|mesh-list
24763974|NCT01778686|Citalopram|citalopram|mesh-list
24763975|NCT01778686|Tryptophan|tryptophan|mesh-list
24763976|NCT01778686|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24763977|NCT01778686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24763978|NCT01778686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24763979|NCT01778686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763980|NCT01778686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24763981|NCT01778686|Serotonin Agents|serotonin agents|mesh-ancestor
24763982|NCT01778686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763983|NCT01778686|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24763984|NCT01778686|Antidepressive Agents|antidepressive agents|mesh-ancestor
24763985|NCT01778686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24763986|NCT01778686|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24763987|NCT01778686|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24763988|NCT01778686|Adrenergic Agents|adrenergic agents|mesh-ancestor
24763989|NCT01778686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24763990|NCT01778686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24763991|NCT01778686|Vasodilator Agents|vasodilator agents|mesh-ancestor
24763992|NCT01778803|Paclitaxel|paclitaxel|mesh-list
24763993|NCT01778803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24764008|NCT01778842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764010|NCT01779089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24480876|NCT00432510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480877|NCT00432510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24480878|NCT00432510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24480909|NCT00432614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24480910|NCT00432614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480911|NCT00432614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24480913|NCT00432614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480914|NCT00432614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24480915|NCT00432614|Antidepressive Agents|antidepressive agents|mesh-ancestor
24480916|NCT00432614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24480917|NCT00432614|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24480918|NCT00432614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24480919|NCT00432614|Adrenergic Agents|adrenergic agents|mesh-ancestor
24480920|NCT00432627|Deferasirox|deferasirox|mesh-list
24480921|NCT00432627|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24480922|NCT00432627|Chelating Agents|chelating agents|mesh-ancestor
24480923|NCT00432627|Sequestering Agents|sequestering agents|mesh-ancestor
25701140|NCT02134314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25701141|NCT02134353|Mannitol|mannitol|mesh-list
25701142|NCT02134353|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25701143|NCT02134353|Diuretics|diuretics|mesh-ancestor
25701144|NCT02134353|Natriuretic Agents|natriuretic agents|mesh-ancestor
25701145|NCT02134353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701146|NCT02134951|Ketamine|ketamine|mesh-list
25701147|NCT02134951|Analgesics|analgesics|mesh-ancestor
25701148|NCT02134951|Sensory System Agents|sensory system agents|mesh-ancestor
25701149|NCT02134951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25701150|NCT02134951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701151|NCT02134951|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25701152|NCT02134951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25701153|NCT02134951|Anesthetics, General|anesthetics, general|mesh-ancestor
24481007|NCT00433095|Mitosis Modulators|mitosis modulators|mesh-ancestor
24481008|NCT00433095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481011|NCT00433121|Citalopram|citalopram|mesh-list
24481012|NCT00433121|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24481013|NCT00433121|Serotonin Agents|serotonin agents|mesh-ancestor
24481014|NCT00433121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24764011|NCT01779089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24764012|NCT01779206|Paclitaxel|paclitaxel|mesh-list
24764013|NCT01779206|Docetaxel|docetaxel|mesh-list
24764020|NCT01779206|Mitosis Modulators|mitosis modulators|mesh-ancestor
24764021|NCT01779206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764022|NCT01779206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24764023|NCT01779206|Immunologic Factors|immunologic factors|mesh-ancestor
24764024|NCT01779206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620874|NCT01059552|Vorinostat|vorinostat|mesh-list
24764025|NCT01779206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24764026|NCT01779206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24764027|NCT01779206|Alkylating Agents|alkylating agents|mesh-ancestor
24764028|NCT01779206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24764029|NCT01779206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24764030|NCT01779206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24764031|NCT01779206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24764032|NCT01779206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764033|NCT01779232|Danazol|danazol|mesh-list
24481148|NCT00433459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24481201|NCT00433719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24481202|NCT00433719|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24481203|NCT00433719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24481204|NCT00433719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24481205|NCT00433719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24481207|NCT00433719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24481208|NCT00433732|Naproxen|naproxen|mesh-list
24764035|NCT01779232|Hormone Antagonists|hormone antagonists|mesh-ancestor
24764036|NCT01779232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24764037|NCT01779232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764038|NCT01779245|Calcium|calcium|mesh-list
24764039|NCT01779245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24764040|NCT01779245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764041|NCT01779258|Desonide|desonide|mesh-list
24764042|NCT01779258|Glycerol|glycerol|mesh-list
24764043|NCT01779258|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24764044|NCT01779258|Protective Agents|protective agents|mesh-ancestor
24629990|NCT01108939|Antimalarials|antimalarials|mesh-list
24764057|NCT01779284|Travoprost|travoprost|mesh-list
24764058|NCT01779284|Latanoprost|latanoprost|mesh-list
24764059|NCT01779284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24764060|NCT01779284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24764061|NCT01779284|Adrenergic Agents|adrenergic agents|mesh-ancestor
24764062|NCT01779284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24764063|NCT01779284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764064|NCT01779284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764065|NCT01779284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24764066|NCT01779284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24764067|NCT01779284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24764068|NCT01779284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24764069|NCT01779362|Metformin|metformin|mesh-list
24481209|NCT00433732|Sumatriptan|sumatriptan|mesh-list
24481210|NCT00433732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25701154|NCT02134951|Anesthetics|anesthetics|mesh-ancestor
24976195|NCT00360425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764072|NCT01779362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24764073|NCT01779362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764074|NCT01779362|Incretins|incretins|mesh-ancestor
24764075|NCT01779362|Hormones|hormones|mesh-ancestor
24764076|NCT01779362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24764077|NCT01779401|Aspirin|aspirin|mesh-list
24764078|NCT01779401|Cilostazol|cilostazol|mesh-list
24764079|NCT01779401|Clopidogrel|clopidogrel|mesh-list
24764082|NCT01779401|Analgesics|analgesics|mesh-ancestor
24764083|NCT01779401|Sensory System Agents|sensory system agents|mesh-ancestor
24764084|NCT01779401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24764085|NCT01779401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764086|NCT01779401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24764087|NCT01779401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24764088|NCT01779401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24764089|NCT01779401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24764090|NCT01779401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764091|NCT01779401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24764218|NCT01780181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764129|NCT01779492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24764130|NCT01779518|Interferons|interferons|mesh-list
24764131|NCT01779518|Ribavirin|ribavirin|mesh-list
24764132|NCT01779518|Sofosbuvir|sofosbuvir|mesh-list
24764133|NCT01779518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24764134|NCT01779518|Antiviral Agents|antiviral agents|mesh-ancestor
24764135|NCT01779518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24764136|NCT01779518|Antimetabolites|antimetabolites|mesh-ancestor
24550673|NCT00721552|Protease Inhibitors|protease inhibitors|mesh-ancestor
24764137|NCT01779518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630128|NCT01109654|Hormones|hormones|mesh-ancestor
24481229|NCT00433784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24764138|NCT01779596|Bosentan|bosentan|mesh-list
24764139|NCT01779596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24764140|NCT01779596|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24764141|NCT01779596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764142|NCT01779609|Bosentan|bosentan|mesh-list
24764143|NCT01779609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25701155|NCT02134951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25701156|NCT02134951|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25701157|NCT02134951|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25701158|NCT02134951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25701159|NCT02134951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701160|NCT02134977|Leuprolide|leuprolide|mesh-list
25701161|NCT02134977|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25701162|NCT02134977|Fertility Agents|fertility agents|mesh-ancestor
25701163|NCT02134977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24976569|NCT03164655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976570|NCT03164655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24976575|NCT03164655|Antimetabolites|antimetabolites|mesh-ancestor
24976646|NCT05276492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24976647|NCT05276492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976648|NCT05276323|Hydrocortisone|hydrocortisone|mesh-list
24976649|NCT05276323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24976650|NCT05276258|Bupivacaine|bupivacaine|mesh-list
24976651|NCT05276258|Anesthetics, Local|anesthetics, local|mesh-ancestor
24976652|NCT05276258|Anesthetics|anesthetics|mesh-ancestor
24764144|NCT01779609|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24764145|NCT01779609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764146|NCT01779687|Raltegravir Potassium|raltegravir potassium|mesh-list
24764147|NCT01779687|Atorvastatin|atorvastatin|mesh-list
24764148|NCT01779687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24764149|NCT01779687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24764150|NCT01779687|Antimetabolites|antimetabolites|mesh-ancestor
24764151|NCT01779687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764152|NCT01779687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24764153|NCT01779687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24764154|NCT01779687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764155|NCT01779687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24764156|NCT01779687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24764169|NCT01779830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24764170|NCT01779830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764172|NCT01779843|Idarubicin|idarubicin|mesh-list
24764176|NCT01779843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24764178|NCT01779843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24764179|NCT01779843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24764180|NCT01779843|Immunologic Factors|immunologic factors|mesh-ancestor
24764181|NCT01779843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764182|NCT01779843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24778613|NCT01871701|Autonomic Agents|autonomic agents|mesh-ancestor
24764183|NCT01779843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24764184|NCT01779843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24764185|NCT01779843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764186|NCT01779882|Cyclophosphamide|cyclophosphamide|mesh-list
24764188|NCT01779882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24764189|NCT01779882|Immunologic Factors|immunologic factors|mesh-ancestor
24764190|NCT01779882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764191|NCT01779882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24764192|NCT01779882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24764193|NCT01779882|Alkylating Agents|alkylating agents|mesh-ancestor
24764194|NCT01779882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764195|NCT01779882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24764196|NCT01779882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24764198|NCT01779908|Vitamins|vitamins|mesh-ancestor
24764199|NCT01779908|Micronutrients|micronutrients|mesh-ancestor
24764200|NCT01779908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764219|NCT01780181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24764220|NCT01780181|Immunologic Factors|immunologic factors|mesh-ancestor
24764221|NCT01780181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764222|NCT01780181|Tubulin Modulators|tubulin modulators|mesh-ancestor
24764223|NCT01780181|Antimitotic Agents|antimitotic agents|mesh-ancestor
24764224|NCT01780181|Mitosis Modulators|mitosis modulators|mesh-ancestor
24764225|NCT01780181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24764227|NCT01780233|Naltrexone|naltrexone|mesh-list
24764228|NCT01780233|Citric Acid|citric acid|mesh-list
24764229|NCT01780233|Sodium Citrate|sodium citrate|mesh-list
24764230|NCT01780233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24764231|NCT01780233|Narcotics|narcotics|mesh-ancestor
24764232|NCT01780233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24764233|NCT01780233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764234|NCT01780233|Analgesics|analgesics|mesh-ancestor
24764235|NCT01780233|Sensory System Agents|sensory system agents|mesh-ancestor
24764236|NCT01780233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25701164|NCT02134977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701165|NCT02134977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25701166|NCT02134977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25701167|NCT02135016|Lidocaine|lidocaine|mesh-list
25701168|NCT02135016|Anesthetics, Local|anesthetics, local|mesh-ancestor
25701169|NCT02135016|Anesthetics|anesthetics|mesh-ancestor
25701170|NCT02135016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25701171|NCT02135016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701172|NCT02135016|Sensory System Agents|sensory system agents|mesh-ancestor
24977028|NCT04666688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24977029|NCT04666688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24977030|NCT04666688|Immunologic Factors|immunologic factors|mesh-ancestor
24977031|NCT04666688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764237|NCT01780233|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24764238|NCT01780233|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24481292|NCT00434005|Expectorants|expectorants|mesh-ancestor
24481293|NCT00434005|Respiratory System Agents|respiratory system agents|mesh-ancestor
24481294|NCT00434005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24481295|NCT00434005|Antioxidants|antioxidants|mesh-ancestor
24481296|NCT00434005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481297|NCT00434005|Protective Agents|protective agents|mesh-ancestor
24481298|NCT00434005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481299|NCT00434005|Antidotes|antidotes|mesh-ancestor
24481300|NCT00434031|Cyclophosphamide|cyclophosphamide|mesh-list
24481301|NCT00434031|Docetaxel|docetaxel|mesh-list
24481302|NCT00434031|Doxorubicin|doxorubicin|mesh-list
24481303|NCT00434031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24481304|NCT00434031|Trastuzumab|trastuzumab|mesh-list
24481321|NCT00434031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24481322|NCT00434044|Etanercept|etanercept|mesh-list
24481323|NCT00434044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24481324|NCT00434044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24481325|NCT00434044|Analgesics|analgesics|mesh-ancestor
24481326|NCT00434044|Sensory System Agents|sensory system agents|mesh-ancestor
24481327|NCT00434044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24764239|NCT01780233|Anesthetics, General|anesthetics, general|mesh-ancestor
24764240|NCT01780233|Anesthetics|anesthetics|mesh-ancestor
24764241|NCT01780233|Anticoagulants|anticoagulants|mesh-ancestor
24764242|NCT01780233|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24764243|NCT01780233|Chelating Agents|chelating agents|mesh-ancestor
24554995|NCT00739141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554996|NCT00739141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24554997|NCT00739141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24554998|NCT00739193|Amiodarone|amiodarone|mesh-list
24554999|NCT00739193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24555000|NCT00739193|Vasodilator Agents|vasodilator agents|mesh-ancestor
24555001|NCT00739193|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24555002|NCT00739193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24555003|NCT00739193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555004|NCT00739193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24555005|NCT00739193|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24555006|NCT00739193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24555007|NCT00739193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24555008|NCT00739193|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24555009|NCT00739193|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24764244|NCT01780233|Sequestering Agents|sequestering agents|mesh-ancestor
25080088|NCT03342300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24764245|NCT01780233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764257|NCT01780259|GABA Modulators|gaba modulators|mesh-ancestor
24764258|NCT01780259|GABA Agents|gaba agents|mesh-ancestor
24481328|NCT00434044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764259|NCT01780259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24764260|NCT01780259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764261|NCT01780311|Sotalol|sotalol|mesh-list
24764262|NCT01780311|Flecainide|flecainide|mesh-list
24764263|NCT01780311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
24764264|NCT01780311|Propafenone|propafenone|mesh-list
24764266|NCT01780311|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24764267|NCT01780311|Adrenergic Agents|adrenergic agents|mesh-ancestor
24764268|NCT01780311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24764269|NCT01780311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764270|NCT01780311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764271|NCT01780311|Sympatholytics|sympatholytics|mesh-ancestor
24764272|NCT01780311|Autonomic Agents|autonomic agents|mesh-ancestor
24764273|NCT01780311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24764274|NCT01780311|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24764275|NCT01780311|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24764276|NCT01780311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24764277|NCT01780467|Dopamine|dopamine|mesh-list
24764278|NCT01780467|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25701173|NCT02135016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25701174|NCT02135016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25701175|NCT02135016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24977626|NCT02648997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977627|NCT02564380|Pembrolizumab|pembrolizumab|mesh-list
24977628|NCT02564380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24977629|NCT02564380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977631|NCT02560298|Cisplatin|cisplatin|mesh-list
24764279|NCT01780467|Sympathomimetics|sympathomimetics|mesh-ancestor
24764280|NCT01780467|Autonomic Agents|autonomic agents|mesh-ancestor
24764281|NCT01780467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24764282|NCT01780467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764283|NCT01780467|Dopamine Agents|dopamine agents|mesh-ancestor
24764284|NCT01780467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24764285|NCT01780467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764302|NCT01780519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764303|NCT01780558|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24764304|NCT01780558|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24764305|NCT01780558|Hormones|hormones|mesh-list
24764306|NCT01780558|Estradiol|estradiol|mesh-list
24764307|NCT01780558|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24764308|NCT01780558|Progesterone|progesterone|mesh-list
24764309|NCT01780558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24764310|NCT01780558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764311|NCT01780558|Estrogens|estrogens|mesh-ancestor
24764312|NCT01780558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24764313|NCT01780558|Contraceptive Agents|contraceptive agents|mesh-ancestor
24764314|NCT01780558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24764315|NCT01780558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24764325|NCT01780610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24764326|NCT01780610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764327|NCT01780610|Estrogens|estrogens|mesh-ancestor
24764328|NCT01780610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24764329|NCT01780610|Contraceptive Agents|contraceptive agents|mesh-ancestor
24764330|NCT01780610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24764331|NCT01780610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24764332|NCT01780610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24764333|NCT01780610|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24764334|NCT01780610|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24764335|NCT01780610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764336|NCT01780610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764337|NCT01780610|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24764338|NCT01780610|Hormone Antagonists|hormone antagonists|mesh-ancestor
24764339|NCT01780610|Progestins|progestins|mesh-ancestor
25080089|NCT03342300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25080102|NCT03342079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25080103|NCT03342079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080104|NCT03342079|Sensory System Agents|sensory system agents|mesh-ancestor
25080105|NCT03342079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25080106|NCT03342079|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25080107|NCT03342079|Anesthetics, General|anesthetics, general|mesh-ancestor
25080108|NCT03342079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25080113|NCT03342040|Anesthetics|anesthetics|mesh-ancestor
25080114|NCT03342040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25080115|NCT03342040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080116|NCT03342040|Sensory System Agents|sensory system agents|mesh-ancestor
25080117|NCT03342040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24764340|NCT01780740|Atorvastatin|atorvastatin|mesh-list
24764341|NCT01780740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24764369|NCT01780909|Dopamine Agents|dopamine agents|mesh-ancestor
24764370|NCT01780909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24764371|NCT01780909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764372|NCT01780909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25701176|NCT02135016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25701177|NCT02135016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25701178|NCT02135016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701179|NCT02135094|Oxymetazoline|oxymetazoline|mesh-list
25701180|NCT02135094|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25701181|NCT02135094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25701182|NCT02135094|Adrenergic Agents|adrenergic agents|mesh-ancestor
25701183|NCT02135094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24415351|NCT00199277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415354|NCT00199316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24415355|NCT00199316|Narcotics|narcotics|mesh-ancestor
24415356|NCT00199316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24415384|NCT00199355|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24764373|NCT01780909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24764374|NCT01780909|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24764375|NCT01780909|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24764377|NCT01780948|Atorvastatin|atorvastatin|mesh-list
24764378|NCT01780948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24764379|NCT01780948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24764380|NCT01780948|Antimetabolites|antimetabolites|mesh-ancestor
24764381|NCT01780948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764410|NCT01781377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24764411|NCT01781377|Dopamine Agents|dopamine agents|mesh-ancestor
24764415|NCT01781442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24764416|NCT01781442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24764417|NCT01781442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24764418|NCT01781442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24764419|NCT01781442|Antifungal Agents|antifungal agents|mesh-ancestor
24764420|NCT01781442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24764421|NCT01781442|Immunologic Factors|immunologic factors|mesh-ancestor
24764422|NCT01781442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764423|NCT01781507|Cetirizine|cetirizine|mesh-list
24764424|NCT01781507|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24764425|NCT01781507|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24764426|NCT01781507|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24764427|NCT01781507|Histamine Antagonists|histamine antagonists|mesh-ancestor
24764428|NCT01781507|Histamine Agents|histamine agents|mesh-ancestor
24764429|NCT01781507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24764432|NCT01781663|Petrolatum|petrolatum|mesh-list
24764464|NCT01781936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24764465|NCT01781936|Glucocorticoids|glucocorticoids|mesh-ancestor
24764466|NCT01781936|Hormones|hormones|mesh-ancestor
24764467|NCT01781936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24764468|NCT01781936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764469|NCT01781988|Gemcitabine|gemcitabine|mesh-list
24764470|NCT01781988|Carboplatin|carboplatin|mesh-list
24764471|NCT01781988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550674|NCT00721552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764472|NCT01781988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24764473|NCT01781988|Antimetabolites|antimetabolites|mesh-ancestor
24764474|NCT01781988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764475|NCT01781988|Antiviral Agents|antiviral agents|mesh-ancestor
24764476|NCT01781988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24764482|NCT01782001|Vitamin A|vitamin a|mesh-list
24764493|NCT01782261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24764494|NCT01782261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764495|NCT01782261|Incretins|incretins|mesh-ancestor
24764496|NCT01782261|Hormones|hormones|mesh-ancestor
24764497|NCT01782261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24764498|NCT01782261|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24764502|NCT01782274|Vaccines|vaccines|mesh-list
24764503|NCT01782274|Immunologic Factors|immunologic factors|mesh-ancestor
24764504|NCT01782274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764505|NCT01782287|Vaccines|vaccines|mesh-list
24764506|NCT01782287|Immunologic Factors|immunologic factors|mesh-ancestor
24764507|NCT01782287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764508|NCT01782300|Vaccines|vaccines|mesh-list
24764509|NCT01782300|Immunologic Factors|immunologic factors|mesh-ancestor
24556382|NCT00747409|Insulin|insulin|mesh-list
24764510|NCT01782300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080118|NCT03341988|Ritonavir|ritonavir|mesh-list
24764562|NCT01782612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24764563|NCT01782612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764564|NCT01782651|Capecitabine|capecitabine|mesh-list
24764565|NCT01782651|Lapatinib|lapatinib|mesh-list
24764566|NCT01782651|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24764567|NCT01782651|Antimetabolites|antimetabolites|mesh-ancestor
25701184|NCT02135094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701185|NCT02135094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701186|NCT02135094|Sympathomimetics|sympathomimetics|mesh-ancestor
25701187|NCT02135094|Autonomic Agents|autonomic agents|mesh-ancestor
25701188|NCT02135094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24764568|NCT01782651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415936|NCT00201539|Analgesics|analgesics|mesh-ancestor
24764583|NCT01782781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24556454|NCT00747799|Fluorouracil|fluorouracil|mesh-list
24764585|NCT01782781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24764586|NCT01782781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24764587|NCT01782781|Autonomic Agents|autonomic agents|mesh-ancestor
24764588|NCT01782781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24764589|NCT01782781|Respiratory System Agents|respiratory system agents|mesh-ancestor
24764591|NCT01782781|Sympathomimetics|sympathomimetics|mesh-ancestor
24481329|NCT00434044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24481330|NCT00434044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24481331|NCT00434044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24481332|NCT00434044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24481333|NCT00434044|Immunologic Factors|immunologic factors|mesh-ancestor
24481334|NCT00434083|Naproxen|naproxen|mesh-list
24481335|NCT00434083|Sumatriptan|sumatriptan|mesh-list
24649638|NCT01221025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481336|NCT00434083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24481337|NCT00434083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24481488|NCT00435058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481489|NCT00435058|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24481490|NCT00435058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24481491|NCT00435058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24481492|NCT00435058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24481493|NCT00435058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24481494|NCT00435175|Estradiol|estradiol|mesh-list
24764592|NCT01782781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24764593|NCT01782846|Codeine|codeine|mesh-list
24764594|NCT01782846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24966133|NCT03770923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24966134|NCT03770923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966135|NCT03770923|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24966136|NCT03770923|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24966137|NCT03770923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966138|NCT03770936|Candesartan|candesartan|mesh-list
24966140|NCT03770936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24966143|NCT03770936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966144|NCT03770936|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24966145|NCT03770936|Protease Inhibitors|protease inhibitors|mesh-ancestor
24966146|NCT03770936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966147|NCT03770806|Acetaminophen|acetaminophen|mesh-list
24966148|NCT03770806|Celecoxib|celecoxib|mesh-list
24966149|NCT03770806|Oxycodone|oxycodone|mesh-list
24901761|NCT04381104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24901762|NCT04381104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481495|NCT00435175|Estrogens|estrogens|mesh-ancestor
24481496|NCT00435175|Hormones|hormones|mesh-ancestor
24481500|NCT00435279|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24481501|NCT00435279|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24481502|NCT00435279|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24481552|NCT00435448|Lonidamine|lonidamine|mesh-list
24481553|NCT00435448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481582|NCT00435760|Tiotropium Bromide|tiotropium bromide|mesh-list
24481583|NCT00435760|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24481584|NCT00435760|Autonomic Agents|autonomic agents|mesh-ancestor
24481585|NCT00435760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24649750|NCT01221831|Dienogest|dienogest|mesh-list
24450667|NCT00320021|Pyridoxamine|pyridoxamine|mesh-list
24481586|NCT00435760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481587|NCT00435760|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24481596|NCT00435799|Dextrans|dextrans|mesh-list
24481597|NCT00435799|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24481598|NCT00435799|Vitamin B Complex|vitamin b complex|mesh-ancestor
24481599|NCT00435799|Vitamins|vitamins|mesh-ancestor
24481600|NCT00435799|Micronutrients|micronutrients|mesh-ancestor
24481601|NCT00435799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481602|NCT00435799|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24481603|NCT00435799|Dermatologic Agents|dermatologic agents|mesh-ancestor
24481604|NCT00435799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24481605|NCT00435799|Anticoagulants|anticoagulants|mesh-ancestor
24481606|NCT00435799|Plasma Substitutes|plasma substitutes|mesh-ancestor
24481607|NCT00435799|Blood Substitutes|blood substitutes|mesh-ancestor
24966152|NCT03770806|Sensory System Agents|sensory system agents|mesh-ancestor
24966153|NCT03770806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24966154|NCT03770806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966155|NCT03770806|Antipyretics|antipyretics|mesh-ancestor
25701189|NCT02135094|Nasal Decongestants|nasal decongestants|mesh-ancestor
24966156|NCT03770806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24966157|NCT03770806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24966158|NCT03770806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24966159|NCT03770806|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24966160|NCT03770806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24966161|NCT03770806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764673|NCT01783106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24966162|NCT03770806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966163|NCT03770806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24966164|NCT03770806|Narcotics|narcotics|mesh-ancestor
24966166|NCT03771053|Simvastatin|simvastatin|mesh-list
25080119|NCT03341988|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25080120|NCT03341988|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25080121|NCT03341988|Protease Inhibitors|protease inhibitors|mesh-ancestor
25080122|NCT03341988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25080123|NCT03341988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080124|NCT03341988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25080125|NCT03341988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25080126|NCT03341988|Antiviral Agents|antiviral agents|mesh-ancestor
25080127|NCT03341988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25080128|NCT03341988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25080129|NCT03341988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25080130|NCT03341845|Avelumab|avelumab|mesh-list
25080131|NCT03341845|Axitinib|axitinib|mesh-list
25080132|NCT03341845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24481679|NCT00436371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24481680|NCT00436371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481681|NCT00436371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24481682|NCT00436371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24481683|NCT00436371|Dopamine Agents|dopamine agents|mesh-ancestor
24481684|NCT00436371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24481685|NCT00436371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481687|NCT00436371|Antidepressive Agents|antidepressive agents|mesh-ancestor
24481688|NCT00436423|Gemcitabine|gemcitabine|mesh-list
24481689|NCT00436423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24481690|NCT00436423|Antimetabolites|antimetabolites|mesh-ancestor
25080133|NCT03341845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25080134|NCT03341845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25080135|NCT03341845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25080136|NCT03341845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080137|NCT03341767|Clofazimine|clofazimine|mesh-list
25080138|NCT03341767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25080139|NCT03341767|Leprostatic Agents|leprostatic agents|mesh-ancestor
25080140|NCT03341767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25080141|NCT03341767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25080142|NCT03341741|Tobramycin|tobramycin|mesh-list
25080143|NCT03341741|Colistin|colistin|mesh-list
25080144|NCT03341741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25080145|NCT03341741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25080146|NCT03341494|Thalidomide|thalidomide|mesh-list
25080147|NCT03341494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25080148|NCT03341494|Immunologic Factors|immunologic factors|mesh-ancestor
25080149|NCT03341494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080150|NCT03341494|Leprostatic Agents|leprostatic agents|mesh-ancestor
25080151|NCT03341494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25080152|NCT03341494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25080153|NCT03341494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25080154|NCT03341494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25080155|NCT03341494|Growth Substances|growth substances|mesh-ancestor
25080156|NCT03341494|Growth Inhibitors|growth inhibitors|mesh-ancestor
25080157|NCT03341494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24764601|NCT01782846|Antitussive Agents|antitussive agents|mesh-ancestor
24764602|NCT01782846|Respiratory System Agents|respiratory system agents|mesh-ancestor
24764603|NCT01782911|Resveratrol|resveratrol|mesh-list
24764604|NCT01782911|Antioxidants|antioxidants|mesh-ancestor
24764605|NCT01782911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764606|NCT01782911|Protective Agents|protective agents|mesh-ancestor
24764607|NCT01782911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764608|NCT01782911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764609|NCT01782911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24764610|NCT01782924|Brodalumab|brodalumab|mesh-list
24764611|NCT01782924|Dermatologic Agents|dermatologic agents|mesh-ancestor
24764612|NCT01782937|Brodalumab|brodalumab|mesh-list
24764613|NCT01782937|Dermatologic Agents|dermatologic agents|mesh-ancestor
24764615|NCT01782950|Isoniazid|isoniazid|mesh-list
24764616|NCT01782950|Pyrazinamide|pyrazinamide|mesh-list
24764617|NCT01782950|Ethambutol|ethambutol|mesh-list
24555395|NCT00741364|Cholecalciferol|cholecalciferol|mesh-list
24555396|NCT00741364|Vitamins|vitamins|mesh-ancestor
24555397|NCT00741364|Micronutrients|micronutrients|mesh-ancestor
24555398|NCT00741364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555399|NCT00741364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24764674|NCT01783106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24555400|NCT00741364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24555401|NCT00741377|Zoledronic Acid|zoledronic acid|mesh-list
24555402|NCT00741377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24555403|NCT00741377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555405|NCT00741429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24555406|NCT00741429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650011|NCT01223326|Acetylcysteine|acetylcysteine|mesh-list
24650224|NCT01224652|Irinotecan|irinotecan|mesh-list
24650225|NCT01224652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24620368|NCT01056679|Mitosis Modulators|mitosis modulators|mesh-ancestor
24620380|NCT01056835|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24620381|NCT01056835|Vasodilator Agents|vasodilator agents|mesh-ancestor
24620382|NCT01056861|Botulinum Toxins|botulinum toxins|mesh-list
24620383|NCT01056861|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24620384|NCT01056861|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24620385|NCT01056861|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24620386|NCT01056861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24620387|NCT01056861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620388|NCT01056861|Cholinergic Agents|cholinergic agents|mesh-ancestor
24620389|NCT01056861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24620390|NCT01056861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620391|NCT01056861|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24620392|NCT01056861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25080159|NCT03341429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24620393|NCT01056874|Maraviroc|maraviroc|mesh-list
24620394|NCT01056874|Digoxin|digoxin|mesh-list
24620395|NCT01056874|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24764618|NCT01782950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24764619|NCT01782950|Antitubercular Agents|antitubercular agents|mesh-ancestor
24764620|NCT01782950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24764621|NCT01782950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24764622|NCT01782950|Leprostatic Agents|leprostatic agents|mesh-ancestor
24764623|NCT01782950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24764624|NCT01782950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764626|NCT01782950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24764627|NCT01782950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24764628|NCT01782950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24764629|NCT01782950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24764630|NCT01782950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24764631|NCT01782950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24764632|NCT01782950|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24764633|NCT01782950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24764634|NCT01782950|Antimetabolites|antimetabolites|mesh-ancestor
24764653|NCT01783106|Hydroxychloroquine|hydroxychloroquine|mesh-list
24764654|NCT01783106|Doxycycline|doxycycline|mesh-list
24764655|NCT01783106|Ciprofloxacin|ciprofloxacin|mesh-list
24764658|NCT01783106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24764659|NCT01783106|Autonomic Agents|autonomic agents|mesh-ancestor
24764660|NCT01783106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24764661|NCT01783106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764662|NCT01783106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24764663|NCT01783106|Respiratory System Agents|respiratory system agents|mesh-ancestor
24764664|NCT01783106|Glucocorticoids|glucocorticoids|mesh-ancestor
24764665|NCT01783106|Hormones|hormones|mesh-ancestor
24764666|NCT01783106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24764667|NCT01783106|Antimalarials|antimalarials|mesh-ancestor
24650234|NCT01224717|Teriparatide|teriparatide|mesh-list
24650336|NCT01225237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24650357|NCT01225341|Cholinergic Agents|cholinergic agents|mesh-ancestor
24650358|NCT01225341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24977987|NCT01127256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24416919|NCT00204503|Valproic Acid|valproic acid|mesh-list
24650360|NCT01225406|Antiviral Agents|antiviral agents|mesh-ancestor
24650361|NCT01225406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24650362|NCT01225406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24764668|NCT01783106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24764669|NCT01783106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24764670|NCT01783106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24764671|NCT01783106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24576176|NCT00837317|Phenol|phenol|mesh-list
24764672|NCT01783106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481818|NCT00436839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481819|NCT00436839|Tubulin Modulators|tubulin modulators|mesh-ancestor
24764678|NCT01783106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24764679|NCT01783106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24764680|NCT01783197|Paclitaxel|paclitaxel|mesh-list
24764681|NCT01783197|Carboplatin|carboplatin|mesh-list
24764692|NCT01783340|Azithromycin|azithromycin|mesh-list
24764693|NCT01783340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24764694|NCT01783340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24764696|NCT01783379|Antifungal Agents|antifungal agents|mesh-ancestor
24764697|NCT01783379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24764698|NCT01783431|Poly ICLC|poly iclc|mesh-list
24764699|NCT01783431|Interferon Inducers|interferon inducers|mesh-ancestor
24764700|NCT01783431|Immunologic Factors|immunologic factors|mesh-ancestor
24764701|NCT01783431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764702|NCT01783587|Docetaxel|docetaxel|mesh-list
24764703|NCT01783587|Afatinib|afatinib|mesh-list
24764704|NCT01783587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24764705|NCT01783587|Tubulin Modulators|tubulin modulators|mesh-ancestor
24764706|NCT01783587|Antimitotic Agents|antimitotic agents|mesh-ancestor
24764707|NCT01783587|Mitosis Modulators|mitosis modulators|mesh-ancestor
24764708|NCT01783587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764709|NCT01783587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24764710|NCT01783587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764711|NCT01783717|Exenatide|exenatide|mesh-list
24764712|NCT01783717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24764713|NCT01783717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764714|NCT01783717|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24764715|NCT01783717|Incretins|incretins|mesh-ancestor
24764716|NCT01783717|Hormones|hormones|mesh-ancestor
24764725|NCT01783756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24650467|NCT01225874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24650468|NCT01225874|Tubulin Modulators|tubulin modulators|mesh-ancestor
24764726|NCT01783756|Immunologic Factors|immunologic factors|mesh-ancestor
24764727|NCT01783756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764728|NCT01783756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24764730|NCT01783834|Pemetrexed|pemetrexed|mesh-list
24764731|NCT01783834|Gefitinib|gefitinib|mesh-list
24764732|NCT01783834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24764733|NCT01783834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764734|NCT01783834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764735|NCT01783834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24764736|NCT01783834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24764737|NCT01783834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24764738|NCT01783925|Aflibercept|aflibercept|mesh-list
24764739|NCT01783925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24764740|NCT01783925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24764741|NCT01783925|Growth Substances|growth substances|mesh-ancestor
24764742|NCT01783925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764743|NCT01783925|Growth Inhibitors|growth inhibitors|mesh-ancestor
24764744|NCT01783925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24764745|NCT01783951|Cisplatin|cisplatin|mesh-list
24764746|NCT01783951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24764747|NCT01783964|Cytarabine|cytarabine|mesh-list
24764754|NCT01783964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24764755|NCT01783964|Immunologic Factors|immunologic factors|mesh-ancestor
24764756|NCT01783964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764757|NCT01783977|Vaccines|vaccines|mesh-list
24764758|NCT01783977|Immunologic Factors|immunologic factors|mesh-ancestor
24764759|NCT01783977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764760|NCT01784107|Ifosfamide|ifosfamide|mesh-list
24764778|NCT01784250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25701190|NCT02135094|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25701191|NCT02135094|Respiratory System Agents|respiratory system agents|mesh-ancestor
25701192|NCT02135107|Rabeprazole|rabeprazole|mesh-list
25701193|NCT02135107|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24764779|NCT01784250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24981719|NCT01952782|Naloxone|naloxone|mesh-list
24981720|NCT01952782|Hormones|hormones|mesh-list
24981723|NCT01952782|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24764807|NCT01784315|Artemisinins|artemisinins|mesh-list
24764808|NCT01784315|Artemisinin|artemisinin|mesh-list
24764809|NCT01784315|Amebicides|amebicides|mesh-ancestor
24764810|NCT01784315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24764811|NCT01784315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24764812|NCT01784315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24764813|NCT01784315|Antimalarials|antimalarials|mesh-ancestor
24764814|NCT01784315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24764815|NCT01784315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24764816|NCT01784315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24764817|NCT01784315|Analgesics|analgesics|mesh-ancestor
24764818|NCT01784315|Sensory System Agents|sensory system agents|mesh-ancestor
24764819|NCT01784315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24764820|NCT01784315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764821|NCT01784315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24764822|NCT01784315|Filaricides|filaricides|mesh-ancestor
24764823|NCT01784315|Antinematodal Agents|antinematodal agents|mesh-ancestor
24764824|NCT01784315|Anthelmintics|anthelmintics|mesh-ancestor
24764826|NCT01784380|Clomiphene|clomiphene|mesh-list
24764827|NCT01784380|Enclomiphene|enclomiphene|mesh-list
24764828|NCT01784380|Zuclomiphene|zuclomiphene|mesh-list
24764829|NCT01784380|Menotropins|menotropins|mesh-list
24764830|NCT01784380|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
24482121|NCT00437996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24482235|NCT00438217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24764835|NCT01784380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24764836|NCT01784380|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24764837|NCT01784380|Fertility Agents|fertility agents|mesh-ancestor
24764838|NCT01784380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24764839|NCT01784380|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24764840|NCT01784380|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24764841|NCT01784380|Androgen Antagonists|androgen antagonists|mesh-ancestor
24764843|NCT01784445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24764844|NCT01784445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24764845|NCT01784536|Oritavancin|oritavancin|mesh-list
24764846|NCT01784536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24764847|NCT01784536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24764848|NCT01784549|Gemcitabine|gemcitabine|mesh-list
24764849|NCT01784549|Docetaxel|docetaxel|mesh-list
24764850|NCT01784549|Pemetrexed|pemetrexed|mesh-list
24764851|NCT01784549|Vinorelbine|vinorelbine|mesh-list
24764852|NCT01784549|Gefitinib|gefitinib|mesh-list
24764853|NCT01784549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24764854|NCT01784549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24764855|NCT01784549|Antimetabolites|antimetabolites|mesh-ancestor
24764856|NCT01784549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764857|NCT01784549|Antiviral Agents|antiviral agents|mesh-ancestor
24764858|NCT01784549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24764859|NCT01784549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966175|NCT03770416|Nivolumab|nivolumab|mesh-list
24966189|NCT03770663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24966196|NCT03770663|Antimetabolites|antimetabolites|mesh-ancestor
25080160|NCT03341429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080161|NCT03341429|Incretins|incretins|mesh-ancestor
25080162|NCT03341429|Hormones|hormones|mesh-ancestor
25080163|NCT03341429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25080164|NCT03341390|Aspirin|aspirin|mesh-list
25080165|NCT03341390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25080166|NCT03341390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25080169|NCT03341390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25080170|NCT03341390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080171|NCT03341390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25080172|NCT03341390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25080173|NCT03341390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25080174|NCT03341390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25080175|NCT03341390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080176|NCT03341390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25080177|NCT03341390|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25080178|NCT03341390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25080180|NCT03341260|Diclofenac|diclofenac|mesh-list
25080181|NCT03341260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25080182|NCT03341260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25080183|NCT03341260|Analgesics|analgesics|mesh-ancestor
25080184|NCT03341260|Sensory System Agents|sensory system agents|mesh-ancestor
25701194|NCT02135107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24418008|NCT00208299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418009|NCT00208299|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
24418010|NCT00208312|Adenosine|adenosine|mesh-list
24418011|NCT00208312|Regadenoson|regadenoson|mesh-list
24418012|NCT00208312|Analgesics|analgesics|mesh-ancestor
24418035|NCT00208442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418036|NCT00208520|Lamotrigine|lamotrigine|mesh-list
25080185|NCT03341260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25080186|NCT03341260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482236|NCT00438217|Contraceptive Agents|contraceptive agents|mesh-ancestor
24482237|NCT00438217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24482265|NCT00438269|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24482266|NCT00438269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24482267|NCT00438269|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24482268|NCT00438321|Anastrozole|anastrozole|mesh-list
24482270|NCT00438321|Testosterone|testosterone|mesh-list
24482271|NCT00438321|Androgens|androgens|mesh-ancestor
24482272|NCT00438321|Hormones|hormones|mesh-ancestor
24482273|NCT00438321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24482274|NCT00438321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080187|NCT03341260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25080188|NCT03341260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25080189|NCT03341260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25080190|NCT03341260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25080191|NCT03341260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080192|NCT03341234|Bupivacaine|bupivacaine|mesh-list
25080193|NCT03341234|Anesthetics, Local|anesthetics, local|mesh-ancestor
25080194|NCT03341234|Anesthetics|anesthetics|mesh-ancestor
25080195|NCT03341234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25080196|NCT03341234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080197|NCT03341234|Sensory System Agents|sensory system agents|mesh-ancestor
25080198|NCT03341234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25080199|NCT03341117|Aspirin|aspirin|mesh-list
25080200|NCT03341117|Magnesium Oxide|magnesium oxide|mesh-list
25080201|NCT03341117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25080202|NCT03341117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25080203|NCT03341117|Analgesics|analgesics|mesh-ancestor
25080204|NCT03341117|Sensory System Agents|sensory system agents|mesh-ancestor
25080205|NCT03341117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25080206|NCT03341117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080207|NCT03341117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25080208|NCT03341117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25080209|NCT03341117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25080210|NCT03341117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25080211|NCT03341117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764865|NCT01784549|Mitosis Modulators|mitosis modulators|mesh-ancestor
24764866|NCT01784549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24764867|NCT01784549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24764868|NCT01784549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24764869|NCT01784549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24764892|NCT01784978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24764893|NCT01784978|Immunologic Factors|immunologic factors|mesh-ancestor
24764894|NCT01784978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764895|NCT01784978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24764903|NCT01785004|Cholecalciferol|cholecalciferol|mesh-list
24764904|NCT01785004|Vitamins|vitamins|mesh-ancestor
24764905|NCT01785004|Micronutrients|micronutrients|mesh-ancestor
24764906|NCT01785004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764907|NCT01785004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24764908|NCT01785004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25701195|NCT02135107|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25701196|NCT02135107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25701197|NCT02135107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709569|NCT02270242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709570|NCT02270242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25709571|NCT02270242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25709572|NCT02270242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24764910|NCT01785030|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24764911|NCT01785030|Anesthetics, General|anesthetics, general|mesh-ancestor
24650714|NCT01227590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24764912|NCT01785030|Anesthetics|anesthetics|mesh-ancestor
24764913|NCT01785030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24764914|NCT01785030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764915|NCT01785030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24764916|NCT01785030|Analgesics|analgesics|mesh-ancestor
24764917|NCT01785030|Sensory System Agents|sensory system agents|mesh-ancestor
24764918|NCT01785030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24764919|NCT01785043|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24764920|NCT01785043|Liraglutide|liraglutide|mesh-list
24764921|NCT01785043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24764922|NCT01785043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764923|NCT01785043|Incretins|incretins|mesh-ancestor
24764924|NCT01785043|Hormones|hormones|mesh-ancestor
24764925|NCT01785043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24764926|NCT01785043|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24764927|NCT01785043|Protease Inhibitors|protease inhibitors|mesh-ancestor
24764928|NCT01785043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764929|NCT01785043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764930|NCT01785056|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24764931|NCT01785056|Immunologic Factors|immunologic factors|mesh-ancestor
24764936|NCT01785108|Vitamins|vitamins|mesh-ancestor
24764937|NCT01785108|Micronutrients|micronutrients|mesh-ancestor
24764938|NCT01785108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764940|NCT01785108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24764941|NCT01785108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24764942|NCT01785108|Analgesics|analgesics|mesh-ancestor
24764943|NCT01785108|Sensory System Agents|sensory system agents|mesh-ancestor
24764944|NCT01785108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24764945|NCT01785108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24764946|NCT01785108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24764947|NCT01785108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24764948|NCT01785108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764949|NCT01785108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764950|NCT01785108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24764951|NCT01785108|Immunologic Factors|immunologic factors|mesh-ancestor
24764952|NCT01785290|Haloperidol|haloperidol|mesh-list
24764953|NCT01785290|Haloperidol decanoate|haloperidol decanoate|mesh-list
24764954|NCT01785290|Antiemetics|antiemetics|mesh-ancestor
24764979|NCT01785446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24764980|NCT01785446|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24764981|NCT01785446|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24764982|NCT01785446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24650800|NCT01228045|Trastuzumab|trastuzumab|mesh-list
24764983|NCT01785446|Adrenergic Agents|adrenergic agents|mesh-ancestor
24764984|NCT01785446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24764985|NCT01785446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764986|NCT01785446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24764987|NCT01785446|Narcotics|narcotics|mesh-ancestor
24764988|NCT01785446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24764989|NCT01785446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24764990|NCT01785446|Anesthetics, General|anesthetics, general|mesh-ancestor
24764991|NCT01785446|Anesthetics|anesthetics|mesh-ancestor
24764992|NCT01785446|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24764993|NCT01785446|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24764994|NCT01785446|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24764995|NCT01785446|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24764996|NCT01785446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24764997|NCT01785446|Cholinergic Agents|cholinergic agents|mesh-ancestor
24764998|NCT01785589|Adenosine|adenosine|mesh-list
24764999|NCT01785589|Analgesics|analgesics|mesh-ancestor
24632685|NCT01125150|Metformin|metformin|mesh-list
24765002|NCT01785589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765003|NCT01785589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24765004|NCT01785589|Vasodilator Agents|vasodilator agents|mesh-ancestor
24765005|NCT01785589|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24765006|NCT01785589|Purinergic Agonists|purinergic agonists|mesh-ancestor
24765007|NCT01785589|Purinergic Agents|purinergic agents|mesh-ancestor
24765008|NCT01785589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24765013|NCT01785641|Cefazolin|cefazolin|mesh-list
24765014|NCT01785641|Ceftazidime|ceftazidime|mesh-list
24765015|NCT01785641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24765016|NCT01785641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24765017|NCT01785641|Antitubercular Agents|antitubercular agents|mesh-ancestor
24765018|NCT01785641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24765019|NCT01785641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24765020|NCT01785641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24650910|NCT01228357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24650911|NCT01228357|Analgesics|analgesics|mesh-ancestor
24650912|NCT01228357|Sensory System Agents|sensory system agents|mesh-ancestor
24765021|NCT01785641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765022|NCT01785641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24765023|NCT01785641|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24765024|NCT01785641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24765026|NCT01785693|Clonidine|clonidine|mesh-list
24765027|NCT01785693|Levobupivacaine|levobupivacaine|mesh-list
24765031|NCT01785693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765032|NCT01785693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24765033|NCT01785693|Sympatholytics|sympatholytics|mesh-ancestor
24765034|NCT01785693|Autonomic Agents|autonomic agents|mesh-ancestor
24765035|NCT01785693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24765036|NCT01785693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24765037|NCT01785693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24765038|NCT01785693|Adrenergic Agents|adrenergic agents|mesh-ancestor
24765039|NCT01785693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24765040|NCT01785693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765041|NCT01785693|Anesthetics, Local|anesthetics, local|mesh-ancestor
24765042|NCT01785693|Anesthetics|anesthetics|mesh-ancestor
24765043|NCT01785693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24765044|NCT01785797|Silicon|silicon|mesh-list
24765045|NCT01785797|Trace Elements|trace elements|mesh-ancestor
24765046|NCT01785797|Micronutrients|micronutrients|mesh-ancestor
24765047|NCT01785797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765049|NCT01785836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24765050|NCT01785836|Antimalarials|antimalarials|mesh-ancestor
24765051|NCT01785836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24765052|NCT01785836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24765053|NCT01785836|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24765054|NCT01785836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24765055|NCT01785836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765056|NCT01785836|Leprostatic Agents|leprostatic agents|mesh-ancestor
24765057|NCT01785836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24765059|NCT01785862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24765060|NCT01785862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24765061|NCT01785862|Analgesics|analgesics|mesh-ancestor
24765062|NCT01785862|Sensory System Agents|sensory system agents|mesh-ancestor
24765063|NCT01785862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24765064|NCT01785862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765065|NCT01785862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24765066|NCT01785862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24765067|NCT01785862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24765068|NCT01785862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24765069|NCT01785862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765071|NCT01785979|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24765072|NCT01785979|Prednisone|prednisone|mesh-list
24765074|NCT01785979|Glucocorticoids|glucocorticoids|mesh-ancestor
24765099|NCT01786018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24765100|NCT01786018|Abortifacient Agents|abortifacient agents|mesh-ancestor
24765101|NCT01786018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25080212|NCT03341117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24779598|NCT01877122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24765102|NCT01786018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765103|NCT01786018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24765104|NCT01786018|Antimetabolites|antimetabolites|mesh-ancestor
24765105|NCT01786018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765106|NCT01786018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24765107|NCT01786018|Dermatologic Agents|dermatologic agents|mesh-ancestor
24765108|NCT01786018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24765307|NCT01787669|Dexamethasone|dexamethasone|mesh-list
24765110|NCT01786018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24765111|NCT01786018|Immunologic Factors|immunologic factors|mesh-ancestor
24765154|NCT01786226|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24765155|NCT01786226|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24765156|NCT01786226|Contraceptive Agents|contraceptive agents|mesh-ancestor
24765157|NCT01786226|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24765158|NCT01786226|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24981980|NCT04499950|Naltrexone|naltrexone|mesh-list
24765159|NCT01786226|Hormone Antagonists|hormone antagonists|mesh-ancestor
24765160|NCT01786226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24765161|NCT01786226|Luteolytic Agents|luteolytic agents|mesh-ancestor
24765162|NCT01786226|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24765163|NCT01786226|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24765165|NCT01786382|Omeprazole|omeprazole|mesh-list
24765166|NCT01786382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24765167|NCT01786382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24765168|NCT01786382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24765169|NCT01786382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765170|NCT01786382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24765171|NCT01786382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24765172|NCT01786382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25080213|NCT03341117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24966224|NCT03770000|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24966225|NCT03770000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24966226|NCT03770000|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
24966227|NCT03770000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966228|NCT03770000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966229|NCT03770312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
24765173|NCT01786382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24765174|NCT01786382|Anesthetics, General|anesthetics, general|mesh-ancestor
24765175|NCT01786382|Anesthetics|anesthetics|mesh-ancestor
24765176|NCT01786382|GABA Modulators|gaba modulators|mesh-ancestor
24765177|NCT01786382|GABA Agents|gaba agents|mesh-ancestor
24765178|NCT01786382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24765179|NCT01786382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765180|NCT01786382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24765181|NCT01786382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24765186|NCT01786538|Leucovorin|leucovorin|mesh-list
24765189|NCT01786538|Antimetabolites|antimetabolites|mesh-ancestor
24555986|NCT00744549|Vitamin D|vitamin d|mesh-list
24765211|NCT01786616|Adrenergic Agents|adrenergic agents|mesh-ancestor
24765212|NCT01786616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25701198|NCT02135146|Plasma-lyte 148|plasma-lyte 148|mesh-list
25701199|NCT02135146|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25701200|NCT02135146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25701201|NCT02135432|Ivacaftor|ivacaftor|mesh-list
24765213|NCT01786616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765215|NCT01786655|Bupivacaine|bupivacaine|mesh-list
25080214|NCT03341117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25080215|NCT03341117|Antipyretics|antipyretics|mesh-ancestor
25080216|NCT03341117|Antacids|antacids|mesh-ancestor
25080217|NCT03341117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25080218|NCT03341104|Bupivacaine|bupivacaine|mesh-list
24765218|NCT01786655|Anesthetics|anesthetics|mesh-ancestor
24765219|NCT01786655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24765220|NCT01786655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765221|NCT01786655|Sensory System Agents|sensory system agents|mesh-ancestor
24765222|NCT01786655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24765223|NCT01786655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24765224|NCT01786655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24765225|NCT01786655|Adrenergic Agents|adrenergic agents|mesh-ancestor
24765226|NCT01786655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24765227|NCT01786655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765228|NCT01786655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24765229|NCT01786655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24765230|NCT01786655|Autonomic Agents|autonomic agents|mesh-ancestor
24765231|NCT01786655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24765233|NCT01786655|Mydriatics|mydriatics|mesh-ancestor
24765282|NCT01787474|Fludarabine|fludarabine|mesh-list
24765283|NCT01787474|Fludarabine phosphate|fludarabine phosphate|mesh-list
24556099|NCT00745004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556100|NCT00745004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24765306|NCT01787630|Protective Agents|protective agents|mesh-ancestor
24765308|NCT01787669|Bevacizumab|bevacizumab|mesh-list
24765309|NCT01787669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24765310|NCT01787669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24765311|NCT01787669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24765312|NCT01787669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24765313|NCT01787669|Growth Substances|growth substances|mesh-ancestor
24765314|NCT01787669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765315|NCT01787669|Growth Inhibitors|growth inhibitors|mesh-ancestor
24765316|NCT01787669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24765318|NCT01787669|Autonomic Agents|autonomic agents|mesh-ancestor
24765319|NCT01787669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24765320|NCT01787669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24765321|NCT01787669|Glucocorticoids|glucocorticoids|mesh-ancestor
24765322|NCT01787669|Hormones|hormones|mesh-ancestor
24765323|NCT01787669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24765324|NCT01787669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24765325|NCT01788007|Imiquimod|imiquimod|mesh-list
24765326|NCT01788007|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24765327|NCT01788007|Immunologic Factors|immunologic factors|mesh-ancestor
24765328|NCT01788007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765329|NCT01788007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24765330|NCT01788007|Interferon Inducers|interferon inducers|mesh-ancestor
24765331|NCT01788072|Oxytocin|oxytocin|mesh-list
24765332|NCT01788072|Oxytocics|oxytocics|mesh-ancestor
24765333|NCT01788072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24765334|NCT01788072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765335|NCT01788176|Zoledronic Acid|zoledronic acid|mesh-list
24765353|NCT01788254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24765354|NCT01788254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765360|NCT01788254|Anesthetics|anesthetics|mesh-ancestor
24765361|NCT01788254|GABA Modulators|gaba modulators|mesh-ancestor
24765362|NCT01788254|GABA Agents|gaba agents|mesh-ancestor
24765363|NCT01788254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24765364|NCT01788254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765365|NCT01788254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24765366|NCT01788254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24765367|NCT01788254|Antimetabolites|antimetabolites|mesh-ancestor
24765368|NCT01788254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24765369|NCT01788254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24765370|NCT01788254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24765408|NCT01788371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24765409|NCT01788371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24765410|NCT01788384|Clindamycin|clindamycin|mesh-list
24765411|NCT01788384|Clindamycin palmitate|clindamycin palmitate|mesh-list
24765412|NCT01788384|Clindamycin phosphate|clindamycin phosphate|mesh-list
24765413|NCT01788384|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24765414|NCT01788384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24765415|NCT01788384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25701202|NCT02135432|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24765416|NCT01788384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24765417|NCT01788384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24765418|NCT01788384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765419|NCT01788384|Dermatologic Agents|dermatologic agents|mesh-ancestor
24765420|NCT01788462|Tesamorelin|tesamorelin|mesh-list
24765421|NCT01788462|Growth Substances|growth substances|mesh-ancestor
24765422|NCT01788462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765423|NCT01788501|Cyclosporine|cyclosporine|mesh-list
24765424|NCT01788501|Methotrexate|methotrexate|mesh-list
24765425|NCT01788501|Tacrolimus|tacrolimus|mesh-list
24765426|NCT01788501|Cyclosporins|cyclosporins|mesh-list
24765427|NCT01788501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24765428|NCT01788501|Abortifacient Agents|abortifacient agents|mesh-ancestor
24765429|NCT01788501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24765474|NCT01788722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24765476|NCT01788722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24765477|NCT01788774|Risperidone|risperidone|mesh-list
24765478|NCT01788774|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24765481|NCT01788774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765484|NCT01788774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24765485|NCT01788774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24765486|NCT01788774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24765487|NCT01788774|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24765488|NCT01788774|Dopamine Agents|dopamine agents|mesh-ancestor
24765489|NCT01788969|Citalopram|citalopram|mesh-list
24765490|NCT01788969|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24765491|NCT01788969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25080282|NCT03340662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24765492|NCT01788969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24766213|NCT01793350|Immunologic Factors|immunologic factors|mesh-ancestor
24765493|NCT01788969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765494|NCT01788969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24765495|NCT01788969|Serotonin Agents|serotonin agents|mesh-ancestor
24765496|NCT01788969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765497|NCT01788969|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24765498|NCT01788969|Antidepressive Agents|antidepressive agents|mesh-ancestor
24765499|NCT01788969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24765500|NCT01788982|Nintedanib|nintedanib|mesh-list
24765501|NCT01788982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24765502|NCT01788982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24765584|NCT01789385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24765585|NCT01789385|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24765586|NCT01789385|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24765587|NCT01789385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24765588|NCT01789385|Adrenergic Agents|adrenergic agents|mesh-ancestor
24652103|NCT01236495|Morphine|morphine|mesh-list
24765589|NCT01789385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24765590|NCT01789385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765591|NCT01789437|Dexamethasone|dexamethasone|mesh-list
24780074|NCT01881074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24765592|NCT01789437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24765593|NCT01789437|Antiemetics|antiemetics|mesh-ancestor
24765594|NCT01789437|Autonomic Agents|autonomic agents|mesh-ancestor
24765625|NCT01789710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24765626|NCT01789710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24765628|NCT01789710|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24765629|NCT01789710|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24765631|NCT01789723|Leucovorin|leucovorin|mesh-list
24765632|NCT01789723|Levoleucovorin|levoleucovorin|mesh-list
24765633|NCT01789723|Antidotes|antidotes|mesh-ancestor
24765634|NCT01789723|Protective Agents|protective agents|mesh-ancestor
24765635|NCT01789723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765636|NCT01789723|Vitamin B Complex|vitamin b complex|mesh-ancestor
24765637|NCT01789723|Vitamins|vitamins|mesh-ancestor
24765638|NCT01789723|Micronutrients|micronutrients|mesh-ancestor
24765639|NCT01789827|Interleukin-2|interleukin-2|mesh-list
24765640|NCT01789827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24765641|NCT01789827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24765642|NCT01789827|Analgesics|analgesics|mesh-ancestor
24765643|NCT01789827|Sensory System Agents|sensory system agents|mesh-ancestor
24765644|NCT01789827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24765645|NCT01789827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966257|NCT03770013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24966258|NCT03770013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966259|NCT03770013|Sensory System Agents|sensory system agents|mesh-ancestor
24966262|NCT03770013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25080243|NCT03340779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080244|NCT03340779|Sympathomimetics|sympathomimetics|mesh-ancestor
25080245|NCT03340779|Autonomic Agents|autonomic agents|mesh-ancestor
25080246|NCT03340779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25080247|NCT03340779|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25080248|NCT03340779|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25080249|NCT03340779|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25080250|NCT03340779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25080251|NCT03340779|Protective Agents|protective agents|mesh-ancestor
25080252|NCT03340753|Mineralocorticoids|mineralocorticoids|mesh-list
25080253|NCT03340753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
25080254|NCT03340753|Hormones|hormones|mesh-ancestor
25080255|NCT03340753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25080256|NCT03340753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080257|NCT03340753|Hormone Antagonists|hormone antagonists|mesh-ancestor
25080258|NCT03340753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25080259|NCT03340753|Diuretics|diuretics|mesh-ancestor
25080260|NCT03340753|Natriuretic Agents|natriuretic agents|mesh-ancestor
25080261|NCT03340740|Cetirizine|cetirizine|mesh-list
25080262|NCT03340740|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25080263|NCT03340740|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25080278|NCT03340662|Antifungal Agents|antifungal agents|mesh-ancestor
25080279|NCT03340662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25080280|NCT03340662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25080281|NCT03340662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25080283|NCT03340662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080284|NCT03340662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25080285|NCT03340662|Hormone Antagonists|hormone antagonists|mesh-ancestor
25080286|NCT03340662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25080287|NCT03340662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080288|NCT03340662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25080289|NCT03340662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25080290|NCT03340662|Antitubercular Agents|antitubercular agents|mesh-ancestor
25080291|NCT03340662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25080292|NCT03340662|Leprostatic Agents|leprostatic agents|mesh-ancestor
25080293|NCT03340662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25080294|NCT03340662|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25080295|NCT03340662|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25080296|NCT03340662|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25080297|NCT03340662|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25080298|NCT03340662|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25080299|NCT03340662|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24780173|NCT01882179|Hormone Antagonists|hormone antagonists|mesh-ancestor
24765693|NCT01789957|Exenatide|exenatide|mesh-list
24765694|NCT01789957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24765695|NCT01789957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765696|NCT01789957|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24765697|NCT01789957|Incretins|incretins|mesh-ancestor
24765698|NCT01789957|Hormones|hormones|mesh-ancestor
24765699|NCT01789957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24765700|NCT01790009|Acetaminophen|acetaminophen|mesh-list
24765701|NCT01790009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24765702|NCT01790009|Analgesics|analgesics|mesh-ancestor
24765703|NCT01790009|Sensory System Agents|sensory system agents|mesh-ancestor
24765704|NCT01790009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24765705|NCT01790009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765706|NCT01790009|Antipyretics|antipyretics|mesh-ancestor
24765707|NCT01790022|Methylprednisolone|methylprednisolone|mesh-list
24765708|NCT01790022|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24765709|NCT01790022|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24765711|NCT01790022|Prednisolone acetate|prednisolone acetate|mesh-list
24765712|NCT01790022|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24765716|NCT01790022|Autonomic Agents|autonomic agents|mesh-ancestor
24765717|NCT01790022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24765719|NCT01790022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24765744|NCT01790165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080300|NCT03340662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25701203|NCT02135432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25701204|NCT02135432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701205|NCT02135445|Relugolix|relugolix|mesh-list
24534875|NCT00648193|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24534876|NCT00648193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24780245|NCT01882660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24765745|NCT01790308|Liraglutide|liraglutide|mesh-list
24765746|NCT01790308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24765747|NCT01790308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765748|NCT01790308|Incretins|incretins|mesh-ancestor
24765750|NCT01790308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24765752|NCT01790464|Anesthetics, Local|anesthetics, local|mesh-ancestor
24765753|NCT01790464|Anesthetics|anesthetics|mesh-ancestor
24765754|NCT01790464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24765755|NCT01790464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765756|NCT01790464|Sensory System Agents|sensory system agents|mesh-ancestor
24765757|NCT01790464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24765758|NCT01790464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24765759|NCT01790464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24765760|NCT01790464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24765761|NCT01790464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24765762|NCT01790464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765763|NCT01790529|Metronidazole|metronidazole|mesh-list
24765764|NCT01790529|Cefuroxime|cefuroxime|mesh-list
24765766|NCT01790529|Anesthetics|anesthetics|mesh-list
24765787|NCT01790555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24765788|NCT01790555|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24765789|NCT01790555|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24765790|NCT01790555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24765791|NCT01790555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24765792|NCT01790555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24765793|NCT01790555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24765794|NCT01790555|Anesthetics, General|anesthetics, general|mesh-ancestor
24765795|NCT01790555|Anesthetics|anesthetics|mesh-ancestor
24765796|NCT01790555|GABA Modulators|gaba modulators|mesh-ancestor
24765797|NCT01790555|GABA Agents|gaba agents|mesh-ancestor
24765804|NCT01790555|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24765805|NCT01790555|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24765806|NCT01790555|Hormones|hormones|mesh-ancestor
24765807|NCT01790555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24765808|NCT01790672|Ethanol|ethanol|mesh-list
24765809|NCT01790672|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24765810|NCT01790672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24765811|NCT01790672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24765812|NCT01790672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765813|NCT01790737|Cyclophosphamide|cyclophosphamide|mesh-list
24765814|NCT01790737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24556613|NCT00748371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25080301|NCT03340662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24780278|NCT01883232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24556614|NCT00748371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556615|NCT00748371|Antipyretics|antipyretics|mesh-ancestor
24765819|NCT01790737|Alkylating Agents|alkylating agents|mesh-ancestor
24765820|NCT01790737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765821|NCT01790737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24765822|NCT01790737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24765823|NCT01790854|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24765824|NCT01790854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24765826|NCT01790893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24765827|NCT01790893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24765828|NCT01790893|Growth Substances|growth substances|mesh-ancestor
24765829|NCT01790893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765830|NCT01790893|Growth Inhibitors|growth inhibitors|mesh-ancestor
24765831|NCT01790893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24765832|NCT01790971|Morphine|morphine|mesh-list
24765833|NCT01790971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24765834|NCT01790971|Narcotics|narcotics|mesh-ancestor
24765835|NCT01790971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24765836|NCT01790971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765837|NCT01790971|Analgesics|analgesics|mesh-ancestor
24765838|NCT01790971|Sensory System Agents|sensory system agents|mesh-ancestor
25701206|NCT02135445|Androgen Antagonists|androgen antagonists|mesh-ancestor
25701207|NCT02135445|Hormone Antagonists|hormone antagonists|mesh-ancestor
25709573|NCT02270242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24765875|NCT01791114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24765876|NCT01791114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765877|NCT01791114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627230|NCT01091337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24627231|NCT01091337|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24966281|NCT03769870|Atorvastatin|atorvastatin|mesh-list
25080303|NCT03340662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25080304|NCT03340662|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25080305|NCT03340662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25080306|NCT03340662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25080307|NCT03340662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25080308|NCT03340662|Serotonin Agents|serotonin agents|mesh-ancestor
25080309|NCT03340662|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25080310|NCT03340662|Antidepressive Agents|antidepressive agents|mesh-ancestor
25080311|NCT03340662|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25080312|NCT03340662|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25080313|NCT03340597|Olorofim|olorofim|mesh-list
25080314|NCT03340597|Antifungal Agents|antifungal agents|mesh-ancestor
25080315|NCT03340597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25080316|NCT03340558|Atezolizumab|atezolizumab|mesh-list
25080317|NCT03340558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25080318|NCT03340493|Tenecteplase|tenecteplase|mesh-list
25080319|NCT03340493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25080320|NCT03340493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24766019|NCT01792037|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24765927|NCT01791400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765930|NCT01791400|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24765932|NCT01791400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24765933|NCT01791400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765934|NCT01791400|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24765935|NCT01791400|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24765936|NCT01791400|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24780475|NCT01884506|Iron|iron|mesh-list
24765961|NCT01791647|Vitamin B Complex|vitamin b complex|mesh-ancestor
24765962|NCT01791647|Vitamins|vitamins|mesh-ancestor
24765963|NCT01791647|Micronutrients|micronutrients|mesh-ancestor
24765964|NCT01791699|Moxonidine|moxonidine|mesh-list
24765965|NCT01791699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24765966|NCT01791751|Clomiphene|clomiphene|mesh-list
24765967|NCT01791751|Enclomiphene|enclomiphene|mesh-list
24765968|NCT01791751|Zuclomiphene|zuclomiphene|mesh-list
24556755|NCT00749502|Niraparib|niraparib|mesh-list
24765970|NCT01791751|Hormone Antagonists|hormone antagonists|mesh-ancestor
24652984|NCT01241162|Decitabine|decitabine|mesh-list
24765971|NCT01791751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24765972|NCT01791751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765973|NCT01791751|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24765974|NCT01791751|Fertility Agents|fertility agents|mesh-ancestor
24765975|NCT01791751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24765976|NCT01791751|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24765977|NCT01791751|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24765978|NCT01791868|Valproic Acid|valproic acid|mesh-list
24765979|NCT01791868|Anticonvulsants|anticonvulsants|mesh-ancestor
24765980|NCT01791868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24765981|NCT01791868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24765983|NCT01791868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24765984|NCT01791868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765985|NCT01791868|Antimanic Agents|antimanic agents|mesh-ancestor
24765986|NCT01791868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24765987|NCT01791868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24765988|NCT01791868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24765989|NCT01791881|Botulinum Toxins|botulinum toxins|mesh-list
24765990|NCT01791881|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24765991|NCT01791881|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24765992|NCT01791881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24765993|NCT01791881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24766012|NCT01792037|Methylprednisolone|methylprednisolone|mesh-list
25701208|NCT02135445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24766014|NCT01792037|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24766015|NCT01792037|Prednisolone|prednisolone|mesh-list
24766016|NCT01792037|Prednisolone acetate|prednisolone acetate|mesh-list
24766018|NCT01792037|Etomidate|etomidate|mesh-list
24766020|NCT01792037|Prednisolone phosphate|prednisolone phosphate|mesh-list
24766021|NCT01792037|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24766022|NCT01792037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24766023|NCT01792037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24766024|NCT01792037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766071|NCT01792375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24766072|NCT01792375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766073|NCT01792388|Vitamin D|vitamin d|mesh-list
24766074|NCT01792388|Vitamins|vitamins|mesh-ancestor
24766075|NCT01792388|Micronutrients|micronutrients|mesh-ancestor
24766076|NCT01792388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766077|NCT01792388|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24766078|NCT01792505|Imiquimod|imiquimod|mesh-list
24766079|NCT01792505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24766080|NCT01792505|Immunologic Factors|immunologic factors|mesh-ancestor
24766081|NCT01792505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766082|NCT01792505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24766083|NCT01792505|Interferon Inducers|interferon inducers|mesh-ancestor
24766085|NCT01792557|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24766086|NCT01792557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24766087|NCT01792557|Disinfectants|disinfectants|mesh-ancestor
24766088|NCT01792557|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
24766092|NCT01792570|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24766093|NCT01792570|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24766094|NCT01792570|Protease Inhibitors|protease inhibitors|mesh-ancestor
24766095|NCT01792570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24766096|NCT01792570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766098|NCT01792570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24766099|NCT01792570|Antiviral Agents|antiviral agents|mesh-ancestor
24766100|NCT01792570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24766101|NCT01792570|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24766118|NCT01792700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24766119|NCT01792700|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24766120|NCT01792700|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24766121|NCT01792713|Sertaconazole|sertaconazole|mesh-list
24766122|NCT01792713|Antifungal Agents|antifungal agents|mesh-ancestor
24766129|NCT01792804|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24766130|NCT01792804|Floxacillin|floxacillin|mesh-list
24766131|NCT01792804|Cloxacillin|cloxacillin|mesh-list
24766132|NCT01792804|Trimethoprim|trimethoprim|mesh-list
24766133|NCT01792804|Sulfamethoxazole|sulfamethoxazole|mesh-list
24766134|NCT01792804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24766135|NCT01792804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24556957|NCT00750529|Cholinergic Agents|cholinergic agents|mesh-ancestor
24556958|NCT00750529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24556960|NCT00750529|Nootropic Agents|nootropic agents|mesh-ancestor
24766136|NCT01792804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25080324|NCT03340376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24966365|NCT03768882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766137|NCT01792804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24766138|NCT01792804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766139|NCT01792804|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24766140|NCT01792804|Renal Agents|renal agents|mesh-ancestor
24766141|NCT01792804|Antimalarials|antimalarials|mesh-ancestor
24766143|NCT01792804|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24766144|NCT01792804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24766145|NCT01792804|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24766146|NCT01792804|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24766147|NCT01792804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24766148|NCT01792934|Bevacizumab|bevacizumab|mesh-list
24766149|NCT01792934|Irinotecan|irinotecan|mesh-list
24766150|NCT01792934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24766166|NCT01793038|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24766167|NCT01793038|Hormone Antagonists|hormone antagonists|mesh-ancestor
24766168|NCT01793038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24622968|NCT01069328|Paclitaxel|paclitaxel|mesh-list
24766169|NCT01793038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766170|NCT01793038|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24766171|NCT01793038|Fertility Agents|fertility agents|mesh-ancestor
24766172|NCT01793038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24766173|NCT01793038|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24766174|NCT01793038|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24766175|NCT01793038|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24766196|NCT01793259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24766197|NCT01793259|Immunologic Factors|immunologic factors|mesh-ancestor
24766198|NCT01793259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24766199|NCT01793259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24766200|NCT01793272|Pentoxifylline|pentoxifylline|mesh-list
24766201|NCT01793272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24766202|NCT01793272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24766203|NCT01793272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766204|NCT01793272|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24766205|NCT01793272|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24766206|NCT01793272|Protective Agents|protective agents|mesh-ancestor
24780675|NCT01885598|Apixaban|apixaban|mesh-list
24766207|NCT01793272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766208|NCT01793272|Vasodilator Agents|vasodilator agents|mesh-ancestor
24766209|NCT01793272|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24766210|NCT01793272|Antioxidants|antioxidants|mesh-ancestor
24766211|NCT01793350|Benphothiamine|benphothiamine|mesh-list
24766212|NCT01793350|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24557029|NCT00751062|Timolol|timolol|mesh-list
24766248|NCT01793753|Propofol|propofol|mesh-list
24766249|NCT01793753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24766286|NCT01794078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766287|NCT01794078|Vasodilator Agents|vasodilator agents|mesh-ancestor
24766288|NCT01794078|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24766289|NCT01794078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24766290|NCT01794078|Purinergic Agents|purinergic agents|mesh-ancestor
24766291|NCT01794078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24766292|NCT01794078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24766293|NCT01794078|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24766294|NCT01794078|Protective Agents|protective agents|mesh-ancestor
24766295|NCT01794078|Plant Growth Regulators|plant growth regulators|mesh-ancestor
24766296|NCT01794078|Growth Substances|growth substances|mesh-ancestor
24766298|NCT01794091|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24766299|NCT01794091|Hormone Antagonists|hormone antagonists|mesh-ancestor
24766300|NCT01794091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24766301|NCT01794091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766302|NCT01794091|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24653942|NCT01246323|Sensory System Agents|sensory system agents|mesh-ancestor
24766303|NCT01794091|Diuretics|diuretics|mesh-ancestor
24766328|NCT01794208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766329|NCT01794247|Lidocaine|lidocaine|mesh-list
24766330|NCT01794247|Magnesium Sulfate|magnesium sulfate|mesh-list
24766331|NCT01794247|Fentanyl|fentanyl|mesh-list
24766332|NCT01794247|Anesthetics, Local|anesthetics, local|mesh-ancestor
24766333|NCT01794247|Anesthetics|anesthetics|mesh-ancestor
24766334|NCT01794247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24766335|NCT01794247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766336|NCT01794247|Sensory System Agents|sensory system agents|mesh-ancestor
24766337|NCT01794247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24766338|NCT01794247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24766339|NCT01794247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24766340|NCT01794247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24396132|NCT00137852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24766341|NCT01794247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24766342|NCT01794247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766344|NCT01794247|Narcotics|narcotics|mesh-ancestor
24766345|NCT01794247|Analgesics|analgesics|mesh-ancestor
24766346|NCT01794247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24766347|NCT01794247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24766348|NCT01794247|Anesthetics, General|anesthetics, general|mesh-ancestor
24766349|NCT01794247|Anticonvulsants|anticonvulsants|mesh-ancestor
24766350|NCT01794247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24766377|NCT01794351|Protective Agents|protective agents|mesh-ancestor
24766378|NCT01794351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766379|NCT01794351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24766380|NCT01794351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24766381|NCT01794429|Exenatide|exenatide|mesh-list
24766382|NCT01794429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24766383|NCT01794429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766384|NCT01794429|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24766385|NCT01794429|Incretins|incretins|mesh-ancestor
24766386|NCT01794429|Hormones|hormones|mesh-ancestor
24766387|NCT01794429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24766388|NCT01794507|Dexamethasone|dexamethasone|mesh-list
24780821|NCT01886443|Protease Inhibitors|protease inhibitors|mesh-ancestor
24766389|NCT01794507|Bortezomib|bortezomib|mesh-list
24766390|NCT01794507|Venetoclax|venetoclax|mesh-list
24766391|NCT01794507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24766392|NCT01794507|Antiemetics|antiemetics|mesh-ancestor
24766393|NCT01794507|Autonomic Agents|autonomic agents|mesh-ancestor
24766401|NCT01794507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24766402|NCT01794533|Lidocaine|lidocaine|mesh-list
24766403|NCT01794533|Epinephrine|epinephrine|mesh-list
24766404|NCT01794533|Racepinephrine|racepinephrine|mesh-list
24766405|NCT01794533|Fentanyl|fentanyl|mesh-list
24766420|NCT01794533|Analgesics|analgesics|mesh-ancestor
24766421|NCT01794533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24766422|NCT01794533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24766423|NCT01794533|Anesthetics, General|anesthetics, general|mesh-ancestor
24766424|NCT01794533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24766425|NCT01794533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24766426|NCT01794533|Adrenergic Agents|adrenergic agents|mesh-ancestor
24766427|NCT01794533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24766428|NCT01794533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24766429|NCT01794533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24766430|NCT01794533|Autonomic Agents|autonomic agents|mesh-ancestor
24766431|NCT01794533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24766433|NCT01794533|Mydriatics|mydriatics|mesh-ancestor
24766434|NCT01794533|Sympathomimetics|sympathomimetics|mesh-ancestor
24766435|NCT01794533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24766436|NCT01794572|Melphalan|melphalan|mesh-list
24766437|NCT01794572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24766438|NCT01794572|Alkylating Agents|alkylating agents|mesh-ancestor
24766439|NCT01794572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766440|NCT01794572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24766441|NCT01794572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24766442|NCT01794572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24766443|NCT01794572|Immunologic Factors|immunologic factors|mesh-ancestor
24766444|NCT01794572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766445|NCT01794767|Heparin|heparin|mesh-list
24766446|NCT01794767|Calcium heparin|calcium heparin|mesh-list
24766447|NCT01794767|Anticoagulants|anticoagulants|mesh-ancestor
24766448|NCT01794767|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24766449|NCT01794767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24766450|NCT01794767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766451|NCT01794897|Valacyclovir|valacyclovir|mesh-list
24766452|NCT01794897|Antiviral Agents|antiviral agents|mesh-ancestor
24766464|NCT01794975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24766465|NCT01794975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24766466|NCT01794975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24766467|NCT01794975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24766468|NCT01794975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766469|NCT01794975|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24766470|NCT01794975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24766471|NCT01794975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24766472|NCT01794975|Adrenergic Agents|adrenergic agents|mesh-ancestor
24766474|NCT01795027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24766478|NCT01795131|Micronutrients|micronutrients|mesh-ancestor
24766479|NCT01795131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766481|NCT01795131|Hematinics|hematinics|mesh-ancestor
24766482|NCT01795144|Glucagon|glucagon|mesh-list
24766483|NCT01795144|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24766484|NCT01795144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24766485|NCT01795144|Hormones|hormones|mesh-ancestor
24766486|NCT01795144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24766487|NCT01795144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766488|NCT01795144|Incretins|incretins|mesh-ancestor
24766489|NCT01795170|Pyridoxine|pyridoxine|mesh-list
24766490|NCT01795170|Vitamin B Complex|vitamin b complex|mesh-ancestor
24766491|NCT01795170|Vitamins|vitamins|mesh-ancestor
24766492|NCT01795170|Micronutrients|micronutrients|mesh-ancestor
24766493|NCT01795170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766512|NCT01795209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24766513|NCT01795222|Midazolam|midazolam|mesh-list
24766514|NCT01795222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24766515|NCT01795222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24766516|NCT01795222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24766669|NCT01796028|Mitosis Modulators|mitosis modulators|mesh-ancestor
24766517|NCT01795222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766518|NCT01795222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24766519|NCT01795222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24766522|NCT01795222|Anesthetics, General|anesthetics, general|mesh-ancestor
24766523|NCT01795222|Anesthetics|anesthetics|mesh-ancestor
24766524|NCT01795222|GABA Modulators|gaba modulators|mesh-ancestor
24766525|NCT01795222|GABA Agents|gaba agents|mesh-ancestor
24766526|NCT01795222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24766527|NCT01795222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766528|NCT01795235|Atenolol|atenolol|mesh-list
24766529|NCT01795235|Glucagon|glucagon|mesh-list
24766530|NCT01795235|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24766531|NCT01795235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24766532|NCT01795235|Hormones|hormones|mesh-ancestor
24766533|NCT01795235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24766534|NCT01795235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766535|NCT01795235|Incretins|incretins|mesh-ancestor
24766536|NCT01795235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24766537|NCT01795235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24766538|NCT01795235|Sympatholytics|sympatholytics|mesh-ancestor
24966387|NCT03768609|Immunologic Factors|immunologic factors|mesh-ancestor
24966388|NCT03768609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080327|NCT03340376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25080328|NCT03340376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25080329|NCT03340376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080330|NCT03340168|Bisphenol A|bisphenol a|mesh-list
25080331|NCT03340168|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25080332|NCT03340168|Estrogens|estrogens|mesh-ancestor
25080333|NCT03340168|Hormones|hormones|mesh-ancestor
25701209|NCT02135445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701210|NCT02136420|Promethazine|promethazine|mesh-list
25701211|NCT02136420|Diphenhydramine|diphenhydramine|mesh-list
25701212|NCT02136420|Antipruritics|antipruritics|mesh-ancestor
25701213|NCT02136420|Dermatologic Agents|dermatologic agents|mesh-ancestor
25701214|NCT02136420|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25701215|NCT02136420|Histamine Antagonists|histamine antagonists|mesh-ancestor
25701216|NCT02136420|Histamine Agents|histamine agents|mesh-ancestor
25701217|NCT02136420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25080334|NCT03340168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25080336|NCT03340168|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25080337|NCT03340168|Antioxidants|antioxidants|mesh-ancestor
25080338|NCT03340168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080339|NCT03340168|Protective Agents|protective agents|mesh-ancestor
25080340|NCT03339921|Botulinum Toxins|botulinum toxins|mesh-list
25080341|NCT03339921|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25080342|NCT03339921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25080343|NCT03339921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080344|NCT03339921|Cholinergic Agents|cholinergic agents|mesh-ancestor
25080345|NCT03339921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25080346|NCT03339921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080347|NCT03339804|Cyclophosphamide|cyclophosphamide|mesh-list
25080348|NCT03339804|Doxorubicin|doxorubicin|mesh-list
25080349|NCT03339804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25080350|NCT03339804|Immunologic Factors|immunologic factors|mesh-ancestor
25080367|NCT03339752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25080368|NCT03339752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25080369|NCT03339752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25080370|NCT03339700|Gemcitabine|gemcitabine|mesh-list
25080371|NCT03339700|Cyclophosphamide|cyclophosphamide|mesh-list
25080372|NCT03339700|Busulfan|busulfan|mesh-list
24766542|NCT01795235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24766543|NCT01795235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24766544|NCT01795235|Adrenergic Agents|adrenergic agents|mesh-ancestor
24766545|NCT01795235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24766546|NCT01795235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766599|NCT01795664|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24766600|NCT01795664|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24766601|NCT01795664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24766602|NCT01795664|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24766603|NCT01795664|Autonomic Agents|autonomic agents|mesh-ancestor
24766604|NCT01795664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24766605|NCT01795664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766606|NCT01795664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24766607|NCT01795664|Respiratory System Agents|respiratory system agents|mesh-ancestor
24766608|NCT01795664|Dermatologic Agents|dermatologic agents|mesh-ancestor
24766609|NCT01795664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24766610|NCT01795664|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24766611|NCT01795664|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24766612|NCT01795664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24766613|NCT01795664|Adrenergic Agents|adrenergic agents|mesh-ancestor
24766614|NCT01795664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24654652|NCT01250743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766615|NCT01795664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766616|NCT01795664|Glucocorticoids|glucocorticoids|mesh-ancestor
24766617|NCT01795664|Hormones|hormones|mesh-ancestor
24766618|NCT01795664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24766619|NCT01795664|Sympathomimetics|sympathomimetics|mesh-ancestor
24766620|NCT01795703|Prednisolone|prednisolone|mesh-list
24766621|NCT01795703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24766622|NCT01795703|Glucocorticoids|glucocorticoids|mesh-ancestor
24766623|NCT01795703|Hormones|hormones|mesh-ancestor
25080376|NCT03339700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24766645|NCT01795976|Interleukin-2|interleukin-2|mesh-list
24766646|NCT01795976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24766647|NCT01795976|Immunologic Factors|immunologic factors|mesh-ancestor
24766648|NCT01795976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766761|NCT01796613|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24766649|NCT01795976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24766650|NCT01795976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24766651|NCT01795976|Alkylating Agents|alkylating agents|mesh-ancestor
24766652|NCT01795976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766653|NCT01795976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24766654|NCT01795976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24766655|NCT01795976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24766656|NCT01795976|Analgesics|analgesics|mesh-ancestor
24766657|NCT01795976|Sensory System Agents|sensory system agents|mesh-ancestor
24766658|NCT01795976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24766663|NCT01796028|Docetaxel|docetaxel|mesh-list
24766664|NCT01796028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24766665|NCT01796028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766666|NCT01796028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24766667|NCT01796028|Tubulin Modulators|tubulin modulators|mesh-ancestor
24766668|NCT01796028|Antimitotic Agents|antimitotic agents|mesh-ancestor
24766700|NCT01796132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24766701|NCT01796132|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24766702|NCT01796132|Analgesics|analgesics|mesh-ancestor
24766703|NCT01796132|Sensory System Agents|sensory system agents|mesh-ancestor
24766704|NCT01796132|Dopamine Agents|dopamine agents|mesh-ancestor
24766705|NCT01796132|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24654886|NCT01251874|Antiviral Agents|antiviral agents|mesh-ancestor
24766706|NCT01796132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24557601|NCT00753064|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24766707|NCT01796132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24766708|NCT01796132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24766709|NCT01796132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24766710|NCT01796132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24766711|NCT01796132|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24766712|NCT01796132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24766713|NCT01796288|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24766714|NCT01796288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24766715|NCT01796288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24766716|NCT01796288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24766717|NCT01796288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766719|NCT01796366|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24766720|NCT01796366|Insulin Glargine|insulin glargine|mesh-list
24766721|NCT01796366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24766722|NCT01796366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766723|NCT01796405|Clofarabine|clofarabine|mesh-list
24766724|NCT01796405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24766725|NCT01796405|Antimetabolites|antimetabolites|mesh-ancestor
24766726|NCT01796405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766727|NCT01796405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24766729|NCT01796418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24766743|NCT01796483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24766744|NCT01796483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24766745|NCT01796483|Adrenergic Agents|adrenergic agents|mesh-ancestor
24766746|NCT01796483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24766747|NCT01796483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766748|NCT01796522|Nifedipine|nifedipine|mesh-list
24766750|NCT01796522|Progestins|progestins|mesh-ancestor
24766751|NCT01796522|Hormones|hormones|mesh-ancestor
24766752|NCT01796522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24766753|NCT01796522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766754|NCT01796522|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24766755|NCT01796522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24766756|NCT01796522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766757|NCT01796522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24766758|NCT01796522|Vasodilator Agents|vasodilator agents|mesh-ancestor
24766759|NCT01796522|Tocolytic Agents|tocolytic agents|mesh-ancestor
24766760|NCT01796522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24766763|NCT01796613|Etonogestrel|etonogestrel|mesh-list
24766764|NCT01796613|NuvaRing|nuvaring|mesh-list
24766765|NCT01796613|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24766766|NCT01796613|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24766767|NCT01796613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24766803|NCT01796808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24766804|NCT01796808|Adrenergic Agents|adrenergic agents|mesh-ancestor
24766805|NCT01796808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24766819|NCT01796938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24766820|NCT01796938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24766848|NCT01797198|Gemfibrozil|gemfibrozil|mesh-list
24766849|NCT01797198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24766850|NCT01797198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766851|NCT01797198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24766852|NCT01797198|Antimetabolites|antimetabolites|mesh-ancestor
24766853|NCT01797198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766854|NCT01797198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24966418|NCT03768258|Anastrozole|anastrozole|mesh-list
24966419|NCT03768258|Testosterone|testosterone|mesh-list
24766855|NCT01797198|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24766856|NCT01797198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24766857|NCT01797198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24766858|NCT01797289|Fibrin fragment D|fibrin fragment d|mesh-list
24766859|NCT01797289|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24766860|NCT01797289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24766861|NCT01797289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766862|NCT01797289|Hemostatics|hemostatics|mesh-ancestor
24766863|NCT01797289|Coagulants|coagulants|mesh-ancestor
24766865|NCT01797315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24766866|NCT01797315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24766867|NCT01797315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24766868|NCT01797315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24766869|NCT01797315|Antifungal Agents|antifungal agents|mesh-ancestor
24766870|NCT01797315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24766871|NCT01797315|Immunologic Factors|immunologic factors|mesh-ancestor
24766872|NCT01797315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766873|NCT01797341|Tacrolimus|tacrolimus|mesh-list
24766874|NCT01797341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24766875|NCT01797341|Immunologic Factors|immunologic factors|mesh-ancestor
24766876|NCT01797341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766891|NCT01797718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24766892|NCT01797718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24766893|NCT01797718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766894|NCT01797718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24766895|NCT01797718|Hormone Antagonists|hormone antagonists|mesh-ancestor
24766896|NCT01797718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24766897|NCT01797718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766899|NCT01797718|Hormones|hormones|mesh-ancestor
24766900|NCT01797757|Orlistat|orlistat|mesh-list
24766901|NCT01797757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767135|NCT01798914|Insulin|insulin|mesh-list
24766902|NCT01797757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766903|NCT01797757|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24766904|NCT01797757|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24766906|NCT01797796|Antipruritics|antipruritics|mesh-ancestor
24766907|NCT01797796|Dermatologic Agents|dermatologic agents|mesh-ancestor
24766908|NCT01797796|Sensory System Agents|sensory system agents|mesh-ancestor
24766909|NCT01797796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24766910|NCT01797796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766912|NCT01797848|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24766913|NCT01797848|Antimetabolites|antimetabolites|mesh-ancestor
24766914|NCT01797848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766915|NCT01797848|Antiviral Agents|antiviral agents|mesh-ancestor
24766916|NCT01797848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24766917|NCT01797900|Paclitaxel|paclitaxel|mesh-list
24766918|NCT01797900|Cisplatin|cisplatin|mesh-list
24766919|NCT01797900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24557822|NCT00754351|Growth Inhibitors|growth inhibitors|mesh-ancestor
24966427|NCT03768258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24966428|NCT03768258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24966429|NCT03768258|Anabolic Agents|anabolic agents|mesh-ancestor
24966430|NCT03768258|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24766938|NCT01797926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24766939|NCT01797926|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24766940|NCT01797926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24766941|NCT01797926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766942|NCT01797926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24766943|NCT01797926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766944|NCT01797926|Vasodilator Agents|vasodilator agents|mesh-ancestor
24766945|NCT01797926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24766946|NCT01797926|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24766947|NCT01797926|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24766948|NCT01797978|Methylene Blue|methylene blue|mesh-list
24766949|NCT01797978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24766964|NCT01797991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24766965|NCT01797991|Protease Inhibitors|protease inhibitors|mesh-ancestor
24766966|NCT01797991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24766967|NCT01797991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24766968|NCT01798017|Misoprostol|misoprostol|mesh-list
24766969|NCT01798017|Mifepristone|mifepristone|mesh-list
24766970|NCT01798017|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24766971|NCT01798017|Abortifacient Agents|abortifacient agents|mesh-ancestor
24766972|NCT01798017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24766973|NCT01798017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24766974|NCT01798017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25080380|NCT03339700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25080381|NCT03339700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25080382|NCT03339700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25080385|NCT03339700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25080386|NCT03339700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25080389|NCT03339544|Celecoxib|celecoxib|mesh-list
25080390|NCT03339544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25080391|NCT03339544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25080392|NCT03339544|Analgesics|analgesics|mesh-ancestor
24557975|NCT00755053|Clotrimazole|clotrimazole|mesh-list
24557977|NCT00755053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24557978|NCT00755053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24557979|NCT00755053|Antifungal Agents|antifungal agents|mesh-ancestor
24557980|NCT00755053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24557981|NCT00755053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24557982|NCT00755053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557983|NCT00755053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557984|NCT00755053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24557985|NCT00755053|Hormone Antagonists|hormone antagonists|mesh-ancestor
24557993|NCT00755066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25701218|NCT02136420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767005|NCT01798277|Vasodilator Agents|vasodilator agents|mesh-ancestor
24767006|NCT01798277|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24767007|NCT01798277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24767008|NCT01798277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767009|NCT01798277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24767010|NCT01798277|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24767011|NCT01798277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24767012|NCT01798277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767013|NCT01798277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24767014|NCT01798277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24767015|NCT01798277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24767016|NCT01798277|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24767017|NCT01798277|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24767018|NCT01798277|Adrenergic Agents|adrenergic agents|mesh-ancestor
24767019|NCT01798277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24767020|NCT01798277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767045|NCT01798472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767046|NCT01798472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767047|NCT01798472|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24767048|NCT01798472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24767049|NCT01798472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767050|NCT01798498|Hyaluronic Acid|hyaluronic acid|mesh-list
24767051|NCT01798498|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24767052|NCT01798498|Immunologic Factors|immunologic factors|mesh-ancestor
24767053|NCT01798498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767054|NCT01798498|Viscosupplements|viscosupplements|mesh-ancestor
24767055|NCT01798498|Protective Agents|protective agents|mesh-ancestor
24767057|NCT01798537|Colistin|colistin|mesh-list
24767058|NCT01798537|Nystatin|nystatin|mesh-list
24767059|NCT01798537|Neomycin|neomycin|mesh-list
24767060|NCT01798537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24767061|NCT01798537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24767062|NCT01798537|Antifungal Agents|antifungal agents|mesh-ancestor
24767098|NCT01798680|Cholecalciferol|cholecalciferol|mesh-list
24767099|NCT01798680|Vitamins|vitamins|mesh-ancestor
24767100|NCT01798680|Micronutrients|micronutrients|mesh-ancestor
24767101|NCT01798680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558001|NCT00755118|Leucovorin|leucovorin|mesh-list
24767123|NCT01798875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24767124|NCT01798875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767125|NCT01798875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24767126|NCT01798875|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24767127|NCT01798901|Decitabine|decitabine|mesh-list
24767128|NCT01798901|Azacitidine|azacitidine|mesh-list
24767129|NCT01798901|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
24767130|NCT01798901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24767131|NCT01798901|Antimetabolites|antimetabolites|mesh-ancestor
24767132|NCT01798901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767133|NCT01798901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767134|NCT01798901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767141|NCT01798979|Midazolam|midazolam|mesh-list
25080395|NCT03339544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080396|NCT03339544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25080397|NCT03339544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25080433|NCT03339258|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25080434|NCT03339258|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25080435|NCT03339258|Adrenergic Agents|adrenergic agents|mesh-ancestor
25080436|NCT03339258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25080437|NCT03339258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080438|NCT03339258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080439|NCT03339024|Oxytocin|oxytocin|mesh-list
25080440|NCT03339024|Oxytocics|oxytocics|mesh-ancestor
25080441|NCT03339024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25080442|NCT03339024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767180|NCT01799109|Adrenergic Agents|adrenergic agents|mesh-ancestor
24767181|NCT01799109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24767185|NCT01799109|Anesthetics|anesthetics|mesh-ancestor
24767186|NCT01799109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24767187|NCT01799109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24767188|NCT01799109|Anticonvulsants|anticonvulsants|mesh-ancestor
24767189|NCT01799109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24767190|NCT01799109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24767191|NCT01799109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24767192|NCT01799161|Theophylline|theophylline|mesh-list
24767193|NCT01799161|Vaccines|vaccines|mesh-list
24767194|NCT01799161|Immunologic Factors|immunologic factors|mesh-ancestor
24767195|NCT01799161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767196|NCT01799161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24767197|NCT01799161|Autonomic Agents|autonomic agents|mesh-ancestor
24767222|NCT01799356|Antitubercular Agents|antitubercular agents|mesh-ancestor
24767223|NCT01799356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24767224|NCT01799356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24767225|NCT01799356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767226|NCT01799356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767227|NCT01799356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767228|NCT01799356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24767229|NCT01799356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24767231|NCT01799356|Renal Agents|renal agents|mesh-ancestor
24767232|NCT01799356|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24767233|NCT01799356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24767234|NCT01799460|Cyclosporine|cyclosporine|mesh-list
24767235|NCT01799460|Cyclophosphamide|cyclophosphamide|mesh-list
24767237|NCT01799460|Cyclosporins|cyclosporins|mesh-list
24767238|NCT01799460|Immunosuppressive Agents|immunosuppressive agents|mesh-list
24767239|NCT01799460|Glucocorticoids|glucocorticoids|mesh-list
24767240|NCT01799460|Immunologic Factors|immunologic factors|mesh-ancestor
24767241|NCT01799460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767246|NCT01799460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767267|NCT01799603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767268|NCT01799603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767269|NCT01799616|Pamidronate|pamidronate|mesh-list
24767270|NCT01799616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24767271|NCT01799616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767272|NCT01799798|Denosumab|denosumab|mesh-list
24767273|NCT01799798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24767274|NCT01799798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767275|NCT01799850|Pioglitazone|pioglitazone|mesh-list
24767276|NCT01799850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24767277|NCT01799850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767278|NCT01799863|Ketorolac|ketorolac|mesh-list
24767279|NCT01799863|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24767280|NCT01799863|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24767281|NCT01799863|Lubricant Eye Drops|lubricant eye drops|mesh-list
24397576|NCT00141908|Castor Oil|castor oil|mesh-list
24767282|NCT01799863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24767284|NCT01799863|Analgesics|analgesics|mesh-ancestor
24767285|NCT01799863|Sensory System Agents|sensory system agents|mesh-ancestor
24767286|NCT01799863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24767287|NCT01799863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767288|NCT01799863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24767289|NCT01799863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24767290|NCT01799863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24767292|NCT01799863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767293|NCT01799863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24767294|NCT01799863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24767295|NCT01799863|Laxatives|laxatives|mesh-ancestor
24767297|NCT01799902|Solifenacin Succinate|solifenacin succinate|mesh-list
24767298|NCT01799902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24767309|NCT01800006|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24767310|NCT01800006|Antithrombins|antithrombins|mesh-ancestor
24767311|NCT01800006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24767312|NCT01800006|Protease Inhibitors|protease inhibitors|mesh-ancestor
24767313|NCT01800006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767314|NCT01800006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767315|NCT01800006|Anticoagulants|anticoagulants|mesh-ancestor
24767317|NCT01800019|Varenicline|varenicline|mesh-list
24767318|NCT01800019|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24781774|NCT01891708|Growth Inhibitors|growth inhibitors|mesh-ancestor
24767335|NCT01800227|Pioglitazone|pioglitazone|mesh-list
24767338|NCT01800240|Metformin|metformin|mesh-list
24767352|NCT01800357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24767354|NCT01800357|Sensory System Agents|sensory system agents|mesh-ancestor
24767355|NCT01800357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24767356|NCT01800357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767357|NCT01800357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24767358|NCT01800357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24767359|NCT01800357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24767360|NCT01800357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24767361|NCT01800357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767362|NCT01800357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24767363|NCT01800357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24767364|NCT01800357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767365|NCT01800357|Antipyretics|antipyretics|mesh-ancestor
24767366|NCT01800357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24767367|NCT01800357|Immunologic Factors|immunologic factors|mesh-ancestor
24767368|NCT01800396|Caseins|caseins|mesh-list
24767369|NCT01800396|Chelating Agents|chelating agents|mesh-ancestor
24767370|NCT01800396|Sequestering Agents|sequestering agents|mesh-ancestor
24767371|NCT01800396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767372|NCT01800422|Progesterone|progesterone|mesh-list
24767373|NCT01800422|Progestins|progestins|mesh-ancestor
24767374|NCT01800422|Hormones|hormones|mesh-ancestor
24397729|NCT00142467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24558375|NCT00756873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24558376|NCT00756873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24558377|NCT00756873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24558379|NCT00756990|Naltrexone|naltrexone|mesh-list
24482291|NCT00438386|Dopamine Agents|dopamine agents|mesh-ancestor
24482295|NCT00438386|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24482297|NCT00438386|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24482298|NCT00438386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25701219|NCT02136420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701220|NCT02136420|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25701221|NCT02136420|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24558380|NCT00756990|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24558381|NCT00756990|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24558382|NCT00756990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558383|NCT00756990|Sensory System Agents|sensory system agents|mesh-ancestor
24558384|NCT00756990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24558386|NCT00757016|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24558387|NCT00757016|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24558388|NCT00757016|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24558389|NCT00757016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24558390|NCT00757016|Glucocorticoids|glucocorticoids|mesh-ancestor
24558391|NCT00757016|Hormones|hormones|mesh-ancestor
24558392|NCT00757016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24558393|NCT00757016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558394|NCT00757016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24558398|NCT00757029|Norepinephrine|norepinephrine|mesh-list
24767396|NCT01800526|Antioxidants|antioxidants|mesh-ancestor
24767397|NCT01800526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656792|NCT01264237|Sensory System Agents|sensory system agents|mesh-ancestor
24767404|NCT01800630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767405|NCT01800630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767406|NCT01800630|Antiviral Agents|antiviral agents|mesh-ancestor
24767407|NCT01800630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24767408|NCT01800630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767409|NCT01800630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24397830|NCT00142844|Naltrexone|naltrexone|mesh-list
24767410|NCT01800630|Immunologic Factors|immunologic factors|mesh-ancestor
24767411|NCT01800630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767413|NCT01800643|Alkylating Agents|alkylating agents|mesh-ancestor
24767418|NCT01800643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24767419|NCT01800643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767420|NCT01800643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24767421|NCT01800695|Temozolomide|temozolomide|mesh-list
24767422|NCT01800695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24767423|NCT01800695|Alkylating Agents|alkylating agents|mesh-ancestor
24767424|NCT01800695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767425|NCT01800695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767426|NCT01800708|Prednisolone|prednisolone|mesh-list
24767427|NCT01800708|Triamcinolone|triamcinolone|mesh-list
24767428|NCT01800708|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24767429|NCT01800708|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24767430|NCT01800708|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24767431|NCT01800708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24767432|NCT01800708|Glucocorticoids|glucocorticoids|mesh-ancestor
24767433|NCT01800708|Hormones|hormones|mesh-ancestor
24767434|NCT01800708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24767435|NCT01800708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767436|NCT01800708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24767437|NCT01800708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767439|NCT01800708|Immunologic Factors|immunologic factors|mesh-ancestor
24767440|NCT01800708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767441|NCT01800708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767442|NCT01800747|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24767443|NCT01800747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25701222|NCT02136420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25701223|NCT02136420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25701224|NCT02136420|Anesthetics, Local|anesthetics, local|mesh-ancestor
25701225|NCT02136420|Anesthetics|anesthetics|mesh-ancestor
24444100|NCT00296712|Parasympatholytics|parasympatholytics|mesh-ancestor
24444101|NCT00296712|Autonomic Agents|autonomic agents|mesh-ancestor
24444102|NCT00296712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24444103|NCT00296712|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24767444|NCT01800799|Anti-Infective Agents|anti-infective agents|mesh-list
24767465|NCT01800825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767466|NCT01800942|Azithromycin|azithromycin|mesh-list
24558415|NCT00757081|Deoxycholic Acid|deoxycholic acid|mesh-list
24558416|NCT00757081|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24558417|NCT00757081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24767467|NCT01800942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24767468|NCT01800942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24767469|NCT01801046|Cytarabine|cytarabine|mesh-list
24767470|NCT01801046|Mitoxantrone|mitoxantrone|mesh-list
25080444|NCT03338426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24792419|NCT05223075|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24792420|NCT05223075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24792421|NCT05223075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767482|NCT01801046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24767483|NCT01801046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24767484|NCT01801046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24767485|NCT01801046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767486|NCT01801072|Levetiracetam|levetiracetam|mesh-list
24767487|NCT01801072|Anticonvulsants|anticonvulsants|mesh-ancestor
24767488|NCT01801072|Nootropic Agents|nootropic agents|mesh-ancestor
24767489|NCT01801137|Everolimus|everolimus|mesh-list
24767490|NCT01801137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767491|NCT01801137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24767492|NCT01801137|Immunologic Factors|immunologic factors|mesh-ancestor
24767493|NCT01801137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767494|NCT01801163|Sorafenib|sorafenib|mesh-list
24767495|NCT01801163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767496|NCT01801163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24767497|NCT01801163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767498|NCT01801163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767499|NCT01801228|Eplerenone|eplerenone|mesh-list
24767500|NCT01801228|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24767501|NCT01801228|Hormone Antagonists|hormone antagonists|mesh-ancestor
24767502|NCT01801228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24767503|NCT01801228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767504|NCT01801228|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24767506|NCT01801228|Natriuretic Agents|natriuretic agents|mesh-ancestor
24767507|NCT01801228|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24767508|NCT01801410|Misoprostol|misoprostol|mesh-list
24767509|NCT01801410|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24767510|NCT01801410|Abortifacient Agents|abortifacient agents|mesh-ancestor
24767511|NCT01801410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24767512|NCT01801410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767513|NCT01801410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24904821|NCT04352855|Tazobactam|tazobactam|mesh-list
24559356|NCT05008146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24767520|NCT01801423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767522|NCT01801644|Gemcitabine|gemcitabine|mesh-list
24767523|NCT01801644|Cisplatin|cisplatin|mesh-list
24767524|NCT01801644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657190|NCT01266174|Eltoprazine|eltoprazine|mesh-list
24767525|NCT01801644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24767526|NCT01801644|Antimetabolites|antimetabolites|mesh-ancestor
24767527|NCT01801644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767528|NCT01801644|Antiviral Agents|antiviral agents|mesh-ancestor
24767534|NCT01801774|Triamcinolone|triamcinolone|mesh-list
24767535|NCT01801774|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24767574|NCT01802268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767575|NCT01802268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767576|NCT01802268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24621121|NCT01060696|Analgesics|analgesics|mesh-ancestor
24767585|NCT01802450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767586|NCT01802476|Palbociclib|palbociclib|mesh-list
25701226|NCT02136420|Sensory System Agents|sensory system agents|mesh-ancestor
25701227|NCT02136420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25701228|NCT02136420|Antiemetics|antiemetics|mesh-ancestor
25701229|NCT02136420|Autonomic Agents|autonomic agents|mesh-ancestor
25701230|NCT02136420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24767587|NCT01802476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767588|NCT01802476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24767589|NCT01802476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767590|NCT01802476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767591|NCT01802489|Amiloride|amiloride|mesh-list
24767592|NCT01802489|Diuretics|diuretics|mesh-ancestor
24767595|NCT01802489|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24767596|NCT01802489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24767597|NCT01802489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24767598|NCT01802489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767599|NCT01802489|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24767600|NCT01802489|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24767602|NCT01802502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24767603|NCT01802502|Antitubercular Agents|antitubercular agents|mesh-ancestor
24767604|NCT01802502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24767605|NCT01802502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24767606|NCT01802502|Leprostatic Agents|leprostatic agents|mesh-ancestor
24767607|NCT01802502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24767608|NCT01802502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767609|NCT01802502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767610|NCT01802502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24767611|NCT01802502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24767612|NCT01802502|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24767613|NCT01802502|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24767614|NCT01802502|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24482345|NCT00438776|Antiemetics|antiemetics|mesh-ancestor
24482346|NCT00438776|Autonomic Agents|autonomic agents|mesh-ancestor
24482347|NCT00438776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24482348|NCT00438776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482350|NCT00438776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24482405|NCT00438841|Growth Inhibitors|growth inhibitors|mesh-ancestor
24482406|NCT00438906|Secretin|secretin|mesh-list
24482407|NCT00438906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24482408|NCT00438906|Hormones|hormones|mesh-ancestor
24482409|NCT00438906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24767647|NCT01802619|Gasotransmitters|gasotransmitters|mesh-ancestor
24767648|NCT01802619|Protective Agents|protective agents|mesh-ancestor
24982728|NCT00480805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25080494|NCT03337672|Dexmedetomidine|dexmedetomidine|mesh-list
24767649|NCT01802645|Leucovorin|leucovorin|mesh-list
24767650|NCT01802645|Folic Acid|folic acid|mesh-list
24767651|NCT01802645|Bevacizumab|bevacizumab|mesh-list
24767652|NCT01802645|Cetuximab|cetuximab|mesh-list
24767653|NCT01802645|Fluorouracil|fluorouracil|mesh-list
24767654|NCT01802645|Oxaliplatin|oxaliplatin|mesh-list
24558682|NCT05436002|Protective Agents|protective agents|mesh-ancestor
24904935|NCT04351763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482464|NCT00439062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24620416|NCT01056926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24620417|NCT01056926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620418|NCT01057069|Paclitaxel|paclitaxel|mesh-list
24620419|NCT01057069|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24620420|NCT01057069|Cyclophosphamide|cyclophosphamide|mesh-list
24620421|NCT01057069|Carboplatin|carboplatin|mesh-list
24620422|NCT01057069|Doxorubicin|doxorubicin|mesh-list
24620423|NCT01057069|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24620424|NCT01057069|Thiotepa|thiotepa|mesh-list
24620425|NCT01057069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24620426|NCT01057069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24620427|NCT01057069|Tubulin Modulators|tubulin modulators|mesh-ancestor
24620428|NCT01057069|Antimitotic Agents|antimitotic agents|mesh-ancestor
24620429|NCT01057069|Mitosis Modulators|mitosis modulators|mesh-ancestor
24620430|NCT01057069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620431|NCT01057069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24767668|NCT01802645|Immunologic Factors|immunologic factors|mesh-ancestor
24767669|NCT01802645|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25701231|NCT02136498|Varenicline|varenicline|mesh-list
25701232|NCT02136498|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25701233|NCT02136498|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25701234|NCT02136498|Cholinergic Agents|cholinergic agents|mesh-ancestor
25701235|NCT02136498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24767670|NCT01802645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24767671|NCT01802645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767672|NCT01802645|Antidotes|antidotes|mesh-ancestor
24767673|NCT01802645|Protective Agents|protective agents|mesh-ancestor
24767674|NCT01802645|Vitamin B Complex|vitamin b complex|mesh-ancestor
24767675|NCT01802645|Vitamins|vitamins|mesh-ancestor
24767676|NCT01802645|Micronutrients|micronutrients|mesh-ancestor
24767677|NCT01802645|Hematinics|hematinics|mesh-ancestor
24767678|NCT01802658|Zoledronic Acid|zoledronic acid|mesh-list
24767679|NCT01802658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24767680|NCT01802658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767681|NCT01802684|Aflibercept|aflibercept|mesh-list
24767682|NCT01802684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24767683|NCT01802684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24767684|NCT01802684|Growth Substances|growth substances|mesh-ancestor
24767685|NCT01802684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767686|NCT01802684|Growth Inhibitors|growth inhibitors|mesh-ancestor
24767723|NCT01802892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24767724|NCT01802918|Ritonavir|ritonavir|mesh-list
24767725|NCT01802918|GSK-2838232|gsk-2838232|mesh-list
24767726|NCT01802918|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24767727|NCT01802918|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24767728|NCT01802918|Protease Inhibitors|protease inhibitors|mesh-ancestor
24767729|NCT01802918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767730|NCT01802918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767731|NCT01802918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24767732|NCT01802918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24767733|NCT01802918|Antiviral Agents|antiviral agents|mesh-ancestor
24767734|NCT01802918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24767735|NCT01802918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24767736|NCT01802918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24767738|NCT01802931|Antifungal Agents|antifungal agents|mesh-ancestor
24767739|NCT01802931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24767740|NCT01802931|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24767741|NCT01802931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24767742|NCT01802931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767743|NCT01802931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558788|NCT05434689|Hormones|hormones|mesh-ancestor
24558789|NCT05434689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24558790|NCT05434689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24558791|NCT05434689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767766|NCT01803087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24767767|NCT01803087|Autonomic Agents|autonomic agents|mesh-ancestor
24767768|NCT01803087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24767769|NCT01803087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767770|NCT01803087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24767771|NCT01803087|Respiratory System Agents|respiratory system agents|mesh-ancestor
24767772|NCT01803087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24767773|NCT01803087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24767774|NCT01803087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24767775|NCT01803087|Adrenergic Agents|adrenergic agents|mesh-ancestor
24657754|NCT01269151|Ranibizumab|ranibizumab|mesh-list
24657929|NCT01269528|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24657930|NCT01269528|Cholinergic Agents|cholinergic agents|mesh-ancestor
24657931|NCT01269541|Rifampin|rifampin|mesh-list
24767776|NCT01803087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24767777|NCT01803087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767793|NCT01803191|Ciprofloxacin|ciprofloxacin|mesh-list
24767794|NCT01803191|Fosfomycin|fosfomycin|mesh-list
24767795|NCT01803191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24767796|NCT01803191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24767797|NCT01803191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24905090|NCT04350320|Colchicine|colchicine|mesh-list
24767826|NCT01803503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24767827|NCT01803503|Growth Substances|growth substances|mesh-ancestor
24767828|NCT01803503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767829|NCT01803503|Growth Inhibitors|growth inhibitors|mesh-ancestor
24767830|NCT01803503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24767831|NCT01803503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25701236|NCT02136498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767845|NCT01803659|Retinol palmitate|retinol palmitate|mesh-list
24543168|NCT00682149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543169|NCT00682149|Antioxidants|antioxidants|mesh-ancestor
24543170|NCT00682149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701237|NCT02136498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767846|NCT01803659|Carotenoids|carotenoids|mesh-list
24767847|NCT01803659|Antioxidants|antioxidants|mesh-ancestor
24767848|NCT01803659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767849|NCT01803659|Protective Agents|protective agents|mesh-ancestor
24767850|NCT01803659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767851|NCT01803659|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24767852|NCT01803659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767853|NCT01803659|Vitamins|vitamins|mesh-ancestor
24767854|NCT01803659|Micronutrients|micronutrients|mesh-ancestor
24767855|NCT01803763|Omalizumab|omalizumab|mesh-list
24767856|NCT01803763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24767857|NCT01803763|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24767858|NCT01803763|Respiratory System Agents|respiratory system agents|mesh-ancestor
24767859|NCT01803828|Tadalafil|tadalafil|mesh-list
24767860|NCT01803828|Vasodilator Agents|vasodilator agents|mesh-ancestor
24767861|NCT01803828|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24767862|NCT01803828|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24767863|NCT01803828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767865|NCT01803828|Urological Agents|urological agents|mesh-ancestor
24767903|NCT01804244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767904|NCT01804244|Antiviral Agents|antiviral agents|mesh-ancestor
24767905|NCT01804244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24767906|NCT01804244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24767913|NCT01804361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767914|NCT01804361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24767915|NCT01804361|Immunologic Factors|immunologic factors|mesh-ancestor
24767916|NCT01804361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767917|NCT01804361|Antifungal Agents|antifungal agents|mesh-ancestor
24767918|NCT01804361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24767939|NCT01804387|Antiviral Agents|antiviral agents|mesh-ancestor
24767940|NCT01804387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24767941|NCT01804387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24767942|NCT01804387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24767943|NCT01804400|Montelukast|montelukast|mesh-list
24767944|NCT01804400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24767945|NCT01804400|Respiratory System Agents|respiratory system agents|mesh-ancestor
24767960|NCT01804543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767961|NCT01804595|Sunscreening Agents|sunscreening agents|mesh-list
24767990|NCT01804985|Imatinib Mesylate|imatinib mesylate|mesh-list
24767991|NCT01804985|Dasatinib|dasatinib|mesh-list
24767992|NCT01804985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24767993|NCT01804985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24767994|NCT01804985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24767995|NCT01804985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767996|NCT01805115|Misoprostol|misoprostol|mesh-list
24811384|NCT02046538|Irinotecan|irinotecan|mesh-list
24767997|NCT01805115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24767998|NCT01805115|Abortifacient Agents|abortifacient agents|mesh-ancestor
24767999|NCT01805115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24768000|NCT01805115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768001|NCT01805115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24768002|NCT01805115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24768004|NCT01805232|Artesunate|artesunate|mesh-list
25701238|NCT02136576|Listerine|listerine|mesh-list
25701239|NCT02136576|Sodium Fluoride|sodium fluoride|mesh-list
25701240|NCT02136576|Cariostatic Agents|cariostatic agents|mesh-ancestor
25701241|NCT02136576|Protective Agents|protective agents|mesh-ancestor
25701242|NCT02136576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701243|NCT02136576|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25701244|NCT02136576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24768005|NCT01805232|Quinine|quinine|mesh-list
24768006|NCT01805232|Antimalarials|antimalarials|mesh-ancestor
24768007|NCT01805232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24768008|NCT01805232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24768009|NCT01805232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24768010|NCT01805232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768012|NCT01805232|Schistosomicides|schistosomicides|mesh-ancestor
24768013|NCT01805232|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24768014|NCT01805232|Anthelmintics|anthelmintics|mesh-ancestor
25080508|NCT03337672|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25080509|NCT03337672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25080510|NCT03337672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25080511|NCT03337672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25080512|NCT03337672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25080513|NCT03337672|Anesthetics, General|anesthetics, general|mesh-ancestor
25080515|NCT03337672|GABA Modulators|gaba modulators|mesh-ancestor
25080516|NCT03337672|GABA Agents|gaba agents|mesh-ancestor
25080517|NCT03337607|Celecoxib|celecoxib|mesh-list
25080518|NCT03337607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25080519|NCT03337607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25080520|NCT03337607|Eperisone|eperisone|mesh-list
25080521|NCT03337607|Parasympatholytics|parasympatholytics|mesh-list
25080522|NCT03337607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25080525|NCT03337607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25080526|NCT03337607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080535|NCT03337607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25080536|NCT03337607|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25080537|NCT03337607|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25080538|NCT03337607|Autonomic Agents|autonomic agents|mesh-ancestor
25080539|NCT03337607|Vasodilator Agents|vasodilator agents|mesh-ancestor
25080540|NCT03337581|Dexmedetomidine|dexmedetomidine|mesh-list
25080541|NCT03337581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24482588|NCT00439855|Calcium heparin|calcium heparin|mesh-list
24482589|NCT00439855|Anticoagulants|anticoagulants|mesh-ancestor
24482590|NCT00439855|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24482591|NCT00439855|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24482592|NCT00439855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080543|NCT03337581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080544|NCT03337581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25080546|NCT03337581|Sensory System Agents|sensory system agents|mesh-ancestor
25080547|NCT03337581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25080548|NCT03337581|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25080549|NCT03337581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25080550|NCT03337581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25080551|NCT03337581|Adrenergic Agents|adrenergic agents|mesh-ancestor
25080552|NCT03337581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25080553|NCT03337581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080554|NCT03337529|Ascorbic Acid|ascorbic acid|mesh-list
25080556|NCT03337529|Micronutrients|micronutrients|mesh-ancestor
24966508|NCT03767322|Allopurinol|allopurinol|mesh-list
25080557|NCT03337529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080558|NCT03337529|Antioxidants|antioxidants|mesh-ancestor
25080560|NCT03337529|Protective Agents|protective agents|mesh-ancestor
24768024|NCT01805258|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24768025|NCT01805258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24768026|NCT01805258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905311|NCT04348786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24658437|NCT01271582|Leucovorin|leucovorin|mesh-list
24768027|NCT01805258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768028|NCT01805258|Antiviral Agents|antiviral agents|mesh-ancestor
24768029|NCT01805258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24768030|NCT01805258|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24768031|NCT01805258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24768032|NCT01805258|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24768033|NCT01805258|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24768034|NCT01805258|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24768035|NCT01805258|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24768036|NCT01805258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24768037|NCT01805258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24768038|NCT01805310|Magnesium citrate|magnesium citrate|mesh-list
24768039|NCT01805310|Cathartics|cathartics|mesh-ancestor
24768040|NCT01805310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24768041|NCT01805388|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24543798|NCT00685529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24543799|NCT00685529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24768084|NCT01805596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768085|NCT01805700|Caffeine|caffeine|mesh-list
24768086|NCT01805700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24768087|NCT01805700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768088|NCT01805700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25080564|NCT03337503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24768089|NCT01805700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24768090|NCT01805700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768098|NCT01805726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24768099|NCT01805726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768100|NCT01805726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24768101|NCT01805726|Analgesics|analgesics|mesh-ancestor
24768102|NCT01805726|Sensory System Agents|sensory system agents|mesh-ancestor
24768103|NCT01805726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24768104|NCT01805726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24768105|NCT01805726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24768106|NCT01805726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24768107|NCT01805726|Adrenergic Agents|adrenergic agents|mesh-ancestor
24768108|NCT01805726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24768109|NCT01805726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768110|NCT01805726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24768111|NCT01805726|Narcotics|narcotics|mesh-ancestor
24768112|NCT01805726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24768113|NCT01805726|Anesthetics, General|anesthetics, general|mesh-ancestor
24768114|NCT01805726|Anesthetics|anesthetics|mesh-ancestor
24768116|NCT01805804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24768117|NCT01805804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24768118|NCT01805804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24768119|NCT01805804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768127|NCT01805817|Hormones|hormones|mesh-ancestor
24768128|NCT01805817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24559140|NCT05271071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24559141|NCT05271071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24559142|NCT05271071|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24559143|NCT05271071|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24559144|NCT05271071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24559145|NCT05271071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24559153|NCT05249569|Avelumab|avelumab|mesh-list
24559155|NCT05249569|Axitinib|axitinib|mesh-list
24559161|NCT05230901|Dihydralazine|dihydralazine|mesh-list
24768129|NCT01805817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768130|NCT01805817|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24768131|NCT01805817|Contraceptive Agents|contraceptive agents|mesh-ancestor
24768132|NCT01805817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24768133|NCT01805817|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24768134|NCT01805817|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24768135|NCT01805817|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24768136|NCT01805817|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24768137|NCT01805817|Trace Elements|trace elements|mesh-ancestor
24768138|NCT01805817|Micronutrients|micronutrients|mesh-ancestor
24768139|NCT01805817|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24768140|NCT01805817|Hormone Antagonists|hormone antagonists|mesh-ancestor
24768141|NCT01805817|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24768142|NCT01805817|Diuretics|diuretics|mesh-ancestor
24768145|NCT01805856|Piperacillin|piperacillin|mesh-list
24768157|NCT01806090|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24768158|NCT01806090|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24768159|NCT01806090|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24768160|NCT01806090|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24768161|NCT01806090|Purinergic Agents|purinergic agents|mesh-ancestor
24768162|NCT01806090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24768163|NCT01806090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768164|NCT01806090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768165|NCT01806103|Anti-Infective Agents|anti-infective agents|mesh-list
24768166|NCT01806103|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24768167|NCT01806116|Decitabine|decitabine|mesh-list
24768186|NCT01806311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24768200|NCT01806324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25701245|NCT02136914|Amantadine|amantadine|mesh-list
25701246|NCT02136914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24768203|NCT01806324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24768204|NCT01806337|Alemtuzumab|alemtuzumab|mesh-list
24768205|NCT01806337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24768206|NCT01806337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768207|NCT01806363|Telmisartan|telmisartan|mesh-list
24768208|NCT01806363|Chlorthalidone|chlorthalidone|mesh-list
24768209|NCT01806363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24768210|NCT01806363|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24768211|NCT01806363|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24768212|NCT01806363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768213|NCT01806363|Diuretics|diuretics|mesh-ancestor
24768214|NCT01806363|Natriuretic Agents|natriuretic agents|mesh-ancestor
24768215|NCT01806363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768216|NCT01806363|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24768217|NCT01806363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24768218|NCT01806376|Maleic acid|maleic acid|mesh-list
24768220|NCT01806376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768251|NCT01806792|Vitamins|vitamins|mesh-ancestor
24768252|NCT01806792|Micronutrients|micronutrients|mesh-ancestor
24768253|NCT01806792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24768254|NCT01806792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24768255|NCT01806792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24768256|NCT01806792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768257|NCT01806805|Zonisamide|zonisamide|mesh-list
24768258|NCT01806805|Anticonvulsants|anticonvulsants|mesh-ancestor
24768259|NCT01806805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24768260|NCT01806805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24768261|NCT01806805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768262|NCT01806805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24768263|NCT01806805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768264|NCT01806948|Ramosetron|ramosetron|mesh-list
24768265|NCT01806948|Antiemetics|antiemetics|mesh-ancestor
24768266|NCT01806948|Autonomic Agents|autonomic agents|mesh-ancestor
24768267|NCT01806948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24768268|NCT01806948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768270|NCT01806948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24768271|NCT01806948|Serotonin Agents|serotonin agents|mesh-ancestor
25701247|NCT02136914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25701248|NCT02136914|Antiviral Agents|antiviral agents|mesh-ancestor
25701249|NCT02136914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25701250|NCT02136914|Dopamine Agents|dopamine agents|mesh-ancestor
25701251|NCT02136914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25701252|NCT02136914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701253|NCT02136914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701254|NCT02136914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25701255|NCT02136914|Analgesics|analgesics|mesh-ancestor
25701256|NCT02136914|Sensory System Agents|sensory system agents|mesh-ancestor
24544552|NCT00689520|Acenocoumarol|acenocoumarol|mesh-list
24544553|NCT00689520|Vitamins|vitamins|mesh-ancestor
24544554|NCT00689520|Micronutrients|micronutrients|mesh-ancestor
24768273|NCT01806948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768275|NCT01807078|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24768276|NCT01807078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24768277|NCT01807078|Antimetabolites|antimetabolites|mesh-ancestor
24768278|NCT01807078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768279|NCT01807078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24768280|NCT01807117|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24768281|NCT01807117|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24768282|NCT01807117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768283|NCT01807286|Dexamethasone|dexamethasone|mesh-list
24768284|NCT01807286|Melphalan|melphalan|mesh-list
24768285|NCT01807286|Pomalidomide|pomalidomide|mesh-list
24768286|NCT01807286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24768287|NCT01807286|Antiemetics|antiemetics|mesh-ancestor
24768288|NCT01807286|Autonomic Agents|autonomic agents|mesh-ancestor
24768289|NCT01807286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24768290|NCT01807286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768291|NCT01807286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24768292|NCT01807286|Glucocorticoids|glucocorticoids|mesh-ancestor
24966578|NCT03766984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24966579|NCT03766984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24966580|NCT03766984|Analgesics|analgesics|mesh-ancestor
24966581|NCT03766984|Sensory System Agents|sensory system agents|mesh-ancestor
25080565|NCT03337503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25080566|NCT03337503|Analgesics|analgesics|mesh-ancestor
25080567|NCT03337503|Sensory System Agents|sensory system agents|mesh-ancestor
25080568|NCT03337503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24768294|NCT01807286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24768295|NCT01807286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24768296|NCT01807286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768297|NCT01807286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24768298|NCT01807286|Alkylating Agents|alkylating agents|mesh-ancestor
24768299|NCT01807286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768300|NCT01807286|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24768301|NCT01807286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24768302|NCT01807286|Immunologic Factors|immunologic factors|mesh-ancestor
24768308|NCT01807325|Pancreatin|pancreatin|mesh-list
24768309|NCT01807325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24768310|NCT01807377|Midazolam|midazolam|mesh-list
24768311|NCT01807377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24768312|NCT01807377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24768313|NCT01807377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24768314|NCT01807377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768315|NCT01807377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24768316|NCT01807377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24768317|NCT01807377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24768318|NCT01807377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24768319|NCT01807377|Anesthetics, General|anesthetics, general|mesh-ancestor
24768320|NCT01807377|Anesthetics|anesthetics|mesh-ancestor
24768321|NCT01807377|GABA Modulators|gaba modulators|mesh-ancestor
24768336|NCT01807429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24768337|NCT01807429|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24768338|NCT01807429|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24768339|NCT01807429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24768340|NCT01807429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768341|NCT01807429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25701257|NCT02136914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25701258|NCT02137226|Adalimumab|adalimumab|mesh-list
25701259|NCT02137226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25701260|NCT02137226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25701261|NCT02137369|Dexetimide|dexetimide|mesh-list
25701262|NCT02137369|Citalopram|citalopram|mesh-list
25701263|NCT02137369|Sertraline|sertraline|mesh-list
25701264|NCT02137369|Antidepressive Agents|antidepressive agents|mesh-list
25701265|NCT02137369|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
24768343|NCT01807429|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24768344|NCT01807429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24768367|NCT01807611|Fludarabine|fludarabine|mesh-list
24559383|NCT04984759|Antimalarials|antimalarials|mesh-ancestor
24559384|NCT04984759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24559385|NCT04984759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24782861|NCT01898585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24559386|NCT04984759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24559394|NCT04949191|Pembrolizumab|pembrolizumab|mesh-list
24559395|NCT04949191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24559396|NCT04949191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24559398|NCT04908579|Bupivacaine|bupivacaine|mesh-list
24559399|NCT04908579|Anesthetics, Local|anesthetics, local|mesh-ancestor
24559400|NCT04908579|Anesthetics|anesthetics|mesh-ancestor
24559401|NCT04908579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24559402|NCT04908579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24559403|NCT04908579|Sensory System Agents|sensory system agents|mesh-ancestor
24559404|NCT04908579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24559405|NCT04908579|Analgesics|analgesics|mesh-ancestor
24559406|NCT04908579|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24768368|NCT01807611|Lenograstim|lenograstim|mesh-list
24768369|NCT01807611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24768370|NCT01807611|Immunologic Factors|immunologic factors|mesh-ancestor
24768371|NCT01807611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768372|NCT01807611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24768373|NCT01807611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24768374|NCT01807611|Alkylating Agents|alkylating agents|mesh-ancestor
24768375|NCT01807611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768376|NCT01807611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768377|NCT01807611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24768378|NCT01807611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24451776|NCT00324766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451778|NCT00324779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24768492|NCT01808586|Lidocaine|lidocaine|mesh-list
24451779|NCT00324779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451780|NCT00324779|Immunologic Factors|immunologic factors|mesh-ancestor
24451781|NCT00324779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768379|NCT01807611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24768380|NCT01807611|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24768381|NCT01807611|Antitubercular Agents|antitubercular agents|mesh-ancestor
24768382|NCT01807611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24559407|NCT04908579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24559409|NCT04908579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24559410|NCT04908579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24768391|NCT01807767|Mycophenolic Acid|mycophenolic acid|mesh-list
24768392|NCT01807767|Everolimus|everolimus|mesh-list
24768393|NCT01807767|Tacrolimus|tacrolimus|mesh-list
24768394|NCT01807767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24768395|NCT01807767|Immunologic Factors|immunologic factors|mesh-ancestor
24768396|NCT01807767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768397|NCT01807767|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24768398|NCT01807767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24768399|NCT01807767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768400|NCT01807767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768401|NCT01807767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24768402|NCT01807767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24768403|NCT01807767|Antitubercular Agents|antitubercular agents|mesh-ancestor
24768404|NCT01807767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24768405|NCT01807767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24768407|NCT01807832|Antipruritics|antipruritics|mesh-ancestor
24768408|NCT01807832|Dermatologic Agents|dermatologic agents|mesh-ancestor
24768409|NCT01807832|Sensory System Agents|sensory system agents|mesh-ancestor
24768410|NCT01807832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24768411|NCT01807832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768412|NCT01807910|Choline|choline|mesh-list
24768423|NCT01807962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24768424|NCT01807962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768425|NCT01807962|Sensory System Agents|sensory system agents|mesh-ancestor
24768426|NCT01807962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24768427|NCT01807962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24768428|NCT01807962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24768429|NCT01807962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24768430|NCT01807962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24768431|NCT01807962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768432|NCT01808014|Nefopam|nefopam|mesh-list
24768433|NCT01808014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24768434|NCT01808014|Analgesics|analgesics|mesh-ancestor
24768435|NCT01808014|Sensory System Agents|sensory system agents|mesh-ancestor
24768436|NCT01808014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24768437|NCT01808014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768438|NCT01808131|Lesinurad|lesinurad|mesh-list
24768439|NCT01808131|Gout Suppressants|gout suppressants|mesh-ancestor
24768440|NCT01808131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24768441|NCT01808131|Uricosuric Agents|uricosuric agents|mesh-ancestor
24768442|NCT01808131|Renal Agents|renal agents|mesh-ancestor
24768443|NCT01808300|Thioctic Acid|thioctic acid|mesh-list
24768444|NCT01808300|Pregabalin|pregabalin|mesh-list
24768445|NCT01808300|Analgesics|analgesics|mesh-ancestor
24768468|NCT01808469|Immunologic Factors|immunologic factors|mesh-ancestor
24768475|NCT01808495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768476|NCT01808495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24768477|NCT01808495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24768479|NCT01808521|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24768480|NCT01808521|Antiviral Agents|antiviral agents|mesh-ancestor
24768481|NCT01808521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24768482|NCT01808521|Expectorants|expectorants|mesh-ancestor
24768483|NCT01808521|Respiratory System Agents|respiratory system agents|mesh-ancestor
24768484|NCT01808521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24768485|NCT01808521|Antioxidants|antioxidants|mesh-ancestor
24768486|NCT01808521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080636|NCT03336840|Anesthetics, Local|anesthetics, local|mesh-ancestor
24966646|NCT03766724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768487|NCT01808521|Protective Agents|protective agents|mesh-ancestor
24768488|NCT01808521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768489|NCT01808521|Antidotes|antidotes|mesh-ancestor
24768490|NCT01808586|Dexamethasone|dexamethasone|mesh-list
24768491|NCT01808586|Betamethasone|betamethasone|mesh-list
24768494|NCT01808586|Antiemetics|antiemetics|mesh-ancestor
24768495|NCT01808586|Autonomic Agents|autonomic agents|mesh-ancestor
24768496|NCT01808586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24768497|NCT01808586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768498|NCT01808586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24482740|NCT00440349|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24482743|NCT00440375|Rosiglitazone|rosiglitazone|mesh-list
24482753|NCT00440414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24482754|NCT00440427|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24482755|NCT00440427|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24768499|NCT01808586|Glucocorticoids|glucocorticoids|mesh-ancestor
24768500|NCT01808586|Hormones|hormones|mesh-ancestor
24768501|NCT01808586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24768507|NCT01808586|Sensory System Agents|sensory system agents|mesh-ancestor
24768508|NCT01808586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24768509|NCT01808586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24768510|NCT01808586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24768511|NCT01808586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24768512|NCT01808586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768513|NCT01808586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24768514|NCT01808586|Respiratory System Agents|respiratory system agents|mesh-ancestor
24768515|NCT01808638|Gemcitabine|gemcitabine|mesh-list
24768516|NCT01808638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24768517|NCT01808638|Antimetabolites|antimetabolites|mesh-ancestor
24768518|NCT01808638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768519|NCT01808638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768520|NCT01808638|Antiviral Agents|antiviral agents|mesh-ancestor
24768521|NCT01808638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25701266|NCT02137369|Serotonin|serotonin|mesh-list
24768522|NCT01808638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24768523|NCT01808638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24768524|NCT01808638|Immunologic Factors|immunologic factors|mesh-ancestor
24768525|NCT01808638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768526|NCT01808768|Alcaftadine|alcaftadine|mesh-list
24768527|NCT01808768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24768528|NCT01808768|Histamine Antagonists|histamine antagonists|mesh-ancestor
24768530|NCT01808768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24768531|NCT01808768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768532|NCT01808768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768533|NCT01808898|Bupivacaine|bupivacaine|mesh-list
24768534|NCT01808898|Anesthetics, Local|anesthetics, local|mesh-list
24768537|NCT01808898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24768538|NCT01808898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768539|NCT01808898|Sensory System Agents|sensory system agents|mesh-ancestor
24768541|NCT01808911|Cyclophosphamide|cyclophosphamide|mesh-list
24768549|NCT01808911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768550|NCT01808911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768551|NCT01808911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24768552|NCT01808911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24768554|NCT01809041|Propofol|propofol|mesh-list
24768555|NCT01809041|Sevoflurane|sevoflurane|mesh-list
24768556|NCT01809041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24768557|NCT01809041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24768558|NCT01809041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768559|NCT01809041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24768560|NCT01809041|Anesthetics, General|anesthetics, general|mesh-ancestor
25080637|NCT03336840|Anesthetics|anesthetics|mesh-ancestor
24966647|NCT03766607|Paclitaxel|paclitaxel|mesh-list
24966648|NCT03766607|Trastuzumab|trastuzumab|mesh-list
24966649|NCT03766607|Ramucirumab|ramucirumab|mesh-list
25080638|NCT03336840|Sensory System Agents|sensory system agents|mesh-ancestor
25080639|NCT03336840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24966651|NCT03766607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24966652|NCT03766607|Tubulin Modulators|tubulin modulators|mesh-ancestor
24966657|NCT03766594|Folic Acid|folic acid|mesh-list
24768561|NCT01809041|Anesthetics|anesthetics|mesh-ancestor
24768562|NCT01809041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24768563|NCT01809041|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24768564|NCT01809041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24768565|NCT01809041|Narcotics|narcotics|mesh-ancestor
24768566|NCT01809041|Analgesics|analgesics|mesh-ancestor
24768567|NCT01809041|Sensory System Agents|sensory system agents|mesh-ancestor
24768568|NCT01809041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24768569|NCT01809158|Minocycline|minocycline|mesh-list
24768573|NCT01809171|Cholecalciferol|cholecalciferol|mesh-list
24768574|NCT01809171|Vitamins|vitamins|mesh-ancestor
24768575|NCT01809171|Micronutrients|micronutrients|mesh-ancestor
24400330|NCT00150358|Vasodilator Agents|vasodilator agents|mesh-ancestor
24768577|NCT01809171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24768578|NCT01809171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24768580|NCT01809184|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24768581|NCT01809184|Insulin Glargine|insulin glargine|mesh-list
24768582|NCT01809184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24768583|NCT01809184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768584|NCT01809301|Niacin|niacin|mesh-list
24768585|NCT01809301|Nicotinic Acids|nicotinic acids|mesh-list
24768586|NCT01809301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24768587|NCT01809301|Antimetabolites|antimetabolites|mesh-ancestor
24768588|NCT01809301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768589|NCT01809301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24768590|NCT01809301|Vasodilator Agents|vasodilator agents|mesh-ancestor
24768591|NCT01809301|Vitamin B Complex|vitamin b complex|mesh-ancestor
24768592|NCT01809301|Vitamins|vitamins|mesh-ancestor
24768593|NCT01809301|Micronutrients|micronutrients|mesh-ancestor
24768594|NCT01809301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768595|NCT01809340|Minocycline|minocycline|mesh-list
24768600|NCT01809340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768601|NCT01809340|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24768603|NCT01809340|Anesthetics, General|anesthetics, general|mesh-ancestor
24660145|NCT01281813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24768633|NCT01809626|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24768634|NCT01809626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24768635|NCT01809626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24768636|NCT01809626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768637|NCT01809626|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24768638|NCT01809626|GABA Agonists|gaba agonists|mesh-ancestor
24768639|NCT01809626|GABA Agents|gaba agents|mesh-ancestor
24451793|NCT00324831|Cyclophosphamide|cyclophosphamide|mesh-list
24451794|NCT00324831|Rituximab|rituximab|mesh-list
24451795|NCT00324831|Doxorubicin|doxorubicin|mesh-list
24451796|NCT00324831|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24451797|NCT00324831|Vincristine|vincristine|mesh-list
24451798|NCT00324831|Vaccines|vaccines|mesh-list
24451799|NCT00324831|Antibodies|antibodies|mesh-list
24451800|NCT00324831|Immunoglobulins|immunoglobulins|mesh-list
24451801|NCT00324831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24451802|NCT00324831|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24451803|NCT00324831|Sargramostim|sargramostim|mesh-list
24451804|NCT00324831|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
24768640|NCT01809626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24983251|NCT01697527|Antimetabolites|antimetabolites|mesh-ancestor
24768641|NCT01809626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24559704|NCT04507906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768657|NCT01809743|Purinergic Agonists|purinergic agonists|mesh-ancestor
24768658|NCT01809743|Purinergic Agents|purinergic agents|mesh-ancestor
24768659|NCT01809743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24768660|NCT01809743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768661|NCT01809743|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
24768662|NCT01809808|Hormones|hormones|mesh-list
24768663|NCT01809808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24768664|NCT01809808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768665|NCT01809847|Ofatumumab|ofatumumab|mesh-list
24768666|NCT01809847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768667|NCT01809860|Sirolimus|sirolimus|mesh-list
24768668|NCT01809860|Isavuconazole|isavuconazole|mesh-list
24768669|NCT01809860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24768670|NCT01809860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24768671|NCT01809860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24768672|NCT01809860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768673|NCT01809860|Antifungal Agents|antifungal agents|mesh-ancestor
24768674|NCT01809860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24768675|NCT01809860|Immunologic Factors|immunologic factors|mesh-ancestor
24768676|NCT01809860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768677|NCT01809886|Neostigmine|neostigmine|mesh-list
24768678|NCT01809886|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24768679|NCT01809886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24768680|NCT01809886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768688|NCT01809925|Calcium polycarbophil|calcium polycarbophil|mesh-list
24768689|NCT01809925|Cathartics|cathartics|mesh-ancestor
24768690|NCT01809925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24768699|NCT01810237|Antithrombins|antithrombins|mesh-ancestor
24768700|NCT01810237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24768701|NCT01810237|Protease Inhibitors|protease inhibitors|mesh-ancestor
24768702|NCT01810237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24768703|NCT01810237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768704|NCT01810237|Anticoagulants|anticoagulants|mesh-ancestor
24768705|NCT01810315|Estradiol|estradiol|mesh-list
24768706|NCT01810315|Estrogens|estrogens|mesh-ancestor
24768707|NCT01810315|Hormones|hormones|mesh-ancestor
24768708|NCT01810315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24768709|NCT01810315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768710|NCT01810354|Cefazolin|cefazolin|mesh-list
24768711|NCT01810354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24768712|NCT01810354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24768713|NCT01810367|Gemcitabine|gemcitabine|mesh-list
24768714|NCT01810367|Cisplatin|cisplatin|mesh-list
24768715|NCT01810367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768716|NCT01810367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24768717|NCT01810367|Antimetabolites|antimetabolites|mesh-ancestor
24768718|NCT01810367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768719|NCT01810367|Antiviral Agents|antiviral agents|mesh-ancestor
24768720|NCT01810367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24768753|NCT01810458|Anesthetics, General|anesthetics, general|mesh-ancestor
24768755|NCT01810458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24768756|NCT01810458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24768757|NCT01810458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24451805|NCT00324831|Immunologic Factors|immunologic factors|mesh-ancestor
24451806|NCT00324831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451807|NCT00324831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24451808|NCT00324831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24451809|NCT00324831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25701267|NCT02137369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24451811|NCT00324831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451812|NCT00324831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451813|NCT00324831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24768759|NCT01810458|GABA Agents|gaba agents|mesh-ancestor
24768760|NCT01810458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24768761|NCT01810458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24768762|NCT01810458|Antipyretics|antipyretics|mesh-ancestor
24768763|NCT01810458|Hematinics|hematinics|mesh-ancestor
24768764|NCT01810458|Antiemetics|antiemetics|mesh-ancestor
24768765|NCT01810458|Autonomic Agents|autonomic agents|mesh-ancestor
24768766|NCT01810458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24768767|NCT01810458|Antipruritics|antipruritics|mesh-ancestor
24768768|NCT01810458|Dermatologic Agents|dermatologic agents|mesh-ancestor
24768769|NCT01810458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24768770|NCT01810458|Serotonin Agents|serotonin agents|mesh-ancestor
24768771|NCT01810458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24768772|NCT01810458|Anticonvulsants|anticonvulsants|mesh-ancestor
24768773|NCT01810458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24768774|NCT01810458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24768810|NCT01810601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24768811|NCT01810601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768812|NCT01810640|Liver Extracts|liver extracts|mesh-list
24768813|NCT01810640|Hematinics|hematinics|mesh-ancestor
24768814|NCT01810731|Vaccines|vaccines|mesh-list
24768815|NCT01810731|Immunologic Factors|immunologic factors|mesh-ancestor
24768818|NCT01810770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768820|NCT01810796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24768821|NCT01810796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24660293|NCT01282632|Olanzapine|olanzapine|mesh-list
24768822|NCT01810796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768823|NCT01810809|Hylan|hylan|mesh-list
24768824|NCT01810809|Hyaluronic Acid|hyaluronic acid|mesh-list
24768825|NCT01810809|Viscosupplements|viscosupplements|mesh-ancestor
24768826|NCT01810809|Protective Agents|protective agents|mesh-ancestor
24768827|NCT01810809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768828|NCT01810809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24768829|NCT01810809|Immunologic Factors|immunologic factors|mesh-ancestor
24768830|NCT01810848|Hyaluronic Acid|hyaluronic acid|mesh-list
24768831|NCT01810848|Hylan|hylan|mesh-list
24768832|NCT01810848|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24768833|NCT01810848|Immunologic Factors|immunologic factors|mesh-ancestor
24768834|NCT01810848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768835|NCT01810848|Viscosupplements|viscosupplements|mesh-ancestor
24768836|NCT01810848|Protective Agents|protective agents|mesh-ancestor
24768837|NCT01810887|Ritonavir|ritonavir|mesh-list
24768838|NCT01810887|Darunavir|darunavir|mesh-list
24768839|NCT01810887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24768840|NCT01810887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24768841|NCT01810887|Protease Inhibitors|protease inhibitors|mesh-ancestor
24768842|NCT01810887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24768843|NCT01810887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768844|NCT01810887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25701268|NCT02137369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25701269|NCT02137369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701270|NCT02137369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25701271|NCT02137369|Serotonin Agents|serotonin agents|mesh-ancestor
24768845|NCT01810887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24482815|NCT00440687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24482816|NCT00440713|Aripiprazole|aripiprazole|mesh-list
24482825|NCT00440713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24858394|NCT02296762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24482826|NCT00440713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768847|NCT01810887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24768848|NCT01810887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24768849|NCT01810887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24768851|NCT01810926|Rituximab|rituximab|mesh-list
24768852|NCT01810926|Methotrexate|methotrexate|mesh-list
24768853|NCT01810926|Fludarabine|fludarabine|mesh-list
24768854|NCT01810926|Thiotepa|thiotepa|mesh-list
24768855|NCT01810926|Treosulfan|treosulfan|mesh-list
24768856|NCT01810926|Antibodies|antibodies|mesh-list
24768857|NCT01810926|Cyclosporins|cyclosporins|mesh-list
24768859|NCT01810926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768860|NCT01810926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24768861|NCT01810926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768862|NCT01810926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24768863|NCT01810926|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24768864|NCT01810926|Abortifacient Agents|abortifacient agents|mesh-ancestor
24660473|NCT01283789|Everolimus|everolimus|mesh-list
24660542|NCT01284309|Adrenergic Agents|adrenergic agents|mesh-ancestor
24768865|NCT01810926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24768866|NCT01810926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25080657|NCT03336632|Cyclophosphamide|cyclophosphamide|mesh-list
25080658|NCT03336632|Cyclosporins|cyclosporins|mesh-list
24966716|NCT03765944|Antifungal Agents|antifungal agents|mesh-ancestor
24560035|NCT03734198|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24966717|NCT03765944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24966718|NCT03765944|Immunologic Factors|immunologic factors|mesh-ancestor
24966719|NCT03765944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966720|NCT03765931|Amoxicillin|amoxicillin|mesh-list
24966721|NCT03765931|Doxycycline|doxycycline|mesh-list
24966722|NCT03765931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24966723|NCT03765931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24966724|NCT03765931|Antimalarials|antimalarials|mesh-ancestor
24966725|NCT03765931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24966726|NCT03765931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24966727|NCT03765827|Vitamins|vitamins|mesh-list
24966728|NCT03765827|Vitamin E|vitamin e|mesh-list
24966729|NCT03765827|Tocopherols|tocopherols|mesh-list
24966730|NCT03765827|Tocotrienols|tocotrienols|mesh-list
24966731|NCT03765827|alpha-Tocopherol|alpha-tocopherol|mesh-list
24966735|NCT03765827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966736|NCT03765827|Protective Agents|protective agents|mesh-ancestor
24966737|NCT03765697|Lidocaine|lidocaine|mesh-list
24966738|NCT03765697|Anesthetics, Local|anesthetics, local|mesh-ancestor
24966739|NCT03765697|Anesthetics|anesthetics|mesh-ancestor
24966740|NCT03765697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24966741|NCT03765697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966742|NCT03765697|Sensory System Agents|sensory system agents|mesh-ancestor
24966743|NCT03765697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24966744|NCT03765697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25080660|NCT03336632|Immunologic Factors|immunologic factors|mesh-ancestor
25080663|NCT03336632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25080665|NCT03336632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080666|NCT03336632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25080667|NCT03336632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25080668|NCT03336632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25080669|NCT03336632|Antifungal Agents|antifungal agents|mesh-ancestor
25080673|NCT03336593|Vaccines|vaccines|mesh-list
25080696|NCT03336346|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25080697|NCT03336346|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25080698|NCT03336346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25080699|NCT03336346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25080700|NCT03336346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24768867|NCT01810926|Antimetabolites|antimetabolites|mesh-ancestor
24768868|NCT01810926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768869|NCT01810926|Dermatologic Agents|dermatologic agents|mesh-ancestor
25701272|NCT02137369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701273|NCT02137369|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25701274|NCT02137369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24768870|NCT01810926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24768871|NCT01810926|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24768872|NCT01810926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24768873|NCT01810926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24768874|NCT01810926|Antifungal Agents|antifungal agents|mesh-ancestor
24768875|NCT01810926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24768876|NCT01810926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24768877|NCT01810926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24768878|NCT01810926|Alkylating Agents|alkylating agents|mesh-ancestor
24768879|NCT01810926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24768880|NCT01811056|Mifepristone|mifepristone|mesh-list
24768881|NCT01811056|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24768882|NCT01811056|Abortifacient Agents|abortifacient agents|mesh-ancestor
24768883|NCT01811056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24768933|NCT01811381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24768934|NCT01811381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768935|NCT01811381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24768936|NCT01811381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24768937|NCT01811381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24768938|NCT01811381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24768939|NCT01811381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24768941|NCT01811459|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24768942|NCT01811459|Haloperidol decanoate|haloperidol decanoate|mesh-list
24983506|NCT05185518|Insulin|insulin|mesh-list
24768943|NCT01811459|Antidepressive Agents|antidepressive agents|mesh-ancestor
24768944|NCT01811459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24768945|NCT01811459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24768946|NCT01811459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24768947|NCT01811459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24768948|NCT01811459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768949|NCT01811459|Antiemetics|antiemetics|mesh-ancestor
24768950|NCT01811459|Autonomic Agents|autonomic agents|mesh-ancestor
24768951|NCT01811459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24768952|NCT01811459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24560033|NCT03739710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24560034|NCT03734198|Daratumumab|daratumumab|mesh-list
24560036|NCT03734198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24560037|NCT03734198|Immunologic Factors|immunologic factors|mesh-ancestor
24560038|NCT03734198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24768964|NCT01811667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24768965|NCT01811667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24560039|NCT03724149|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
24768966|NCT01811667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25080701|NCT03336346|Contraceptive Agents|contraceptive agents|mesh-ancestor
24769018|NCT01812122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769020|NCT01812135|Immunologic Factors|immunologic factors|mesh-ancestor
24769021|NCT01812135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769022|NCT01812200|Rivaroxaban|rivaroxaban|mesh-list
24769023|NCT01812200|Dabigatran|dabigatran|mesh-list
24769024|NCT01812200|Phenprocoumon|phenprocoumon|mesh-list
24769025|NCT01812200|Ticagrelor|ticagrelor|mesh-list
24769026|NCT01812200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24769027|NCT01812200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24769028|NCT01812200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24769029|NCT01812200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24769030|NCT01812200|Purinergic Agents|purinergic agents|mesh-ancestor
24769031|NCT01812200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24769032|NCT01812200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769033|NCT01812200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769034|NCT01812200|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24769035|NCT01812200|Antithrombins|antithrombins|mesh-ancestor
24769036|NCT01812200|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24769037|NCT01812200|Protease Inhibitors|protease inhibitors|mesh-ancestor
24769038|NCT01812200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24769039|NCT01812200|Anticoagulants|anticoagulants|mesh-ancestor
24769041|NCT01812239|Progestins|progestins|mesh-list
24769042|NCT01812239|Hormones|hormones|mesh-ancestor
24769043|NCT01812239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24769044|NCT01812239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769045|NCT01812330|Clopidogrel|clopidogrel|mesh-list
24769046|NCT01812330|Ticagrelor|ticagrelor|mesh-list
24769047|NCT01812330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24769048|NCT01812330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24660671|NCT01285141|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24769049|NCT01812330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25701275|NCT02137369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25701276|NCT02137369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24769050|NCT01812330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24769052|NCT01812330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24769054|NCT01812330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769055|NCT01812356|Nitrous Oxide|nitrous oxide|mesh-list
24769056|NCT01812356|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24769057|NCT01812356|Anesthetics, General|anesthetics, general|mesh-ancestor
24769058|NCT01812356|Anesthetics|anesthetics|mesh-ancestor
24769059|NCT01812356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24769060|NCT01812356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769061|NCT01812356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24769062|NCT01812356|Analgesics|analgesics|mesh-ancestor
24769063|NCT01812356|Sensory System Agents|sensory system agents|mesh-ancestor
24769064|NCT01812356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24769065|NCT01812369|Gemcitabine|gemcitabine|mesh-list
24769094|NCT01812434|Urological Agents|urological agents|mesh-ancestor
24769096|NCT01812538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24769097|NCT01812538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24769098|NCT01812538|Analgesics|analgesics|mesh-ancestor
24769099|NCT01812538|Sensory System Agents|sensory system agents|mesh-ancestor
24769100|NCT01812538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24769101|NCT01812538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769102|NCT01812538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24769103|NCT01812538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24769104|NCT01812538|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24769105|NCT01812538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24769106|NCT01812538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769107|NCT01812551|Alendronate|alendronate|mesh-list
24769108|NCT01812551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24769109|NCT01812551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769110|NCT01812603|Nabiximols|nabiximols|mesh-list
24769111|NCT01812603|Analgesics|analgesics|mesh-ancestor
24769112|NCT01812603|Sensory System Agents|sensory system agents|mesh-ancestor
24769113|NCT01812603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24769147|NCT01812928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24769148|NCT01812928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769149|NCT01812928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24769150|NCT01812928|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24769151|NCT01812928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24769152|NCT01812928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769153|NCT01812954|Cyclosporine|cyclosporine|mesh-list
24769155|NCT01812954|Etanercept|etanercept|mesh-list
24769156|NCT01812954|Methotrexate|methotrexate|mesh-list
24769157|NCT01812954|Infliximab|infliximab|mesh-list
24769158|NCT01812954|Ustekinumab|ustekinumab|mesh-list
24769159|NCT01812954|Acitretin|acitretin|mesh-list
24769160|NCT01812954|Cyclosporins|cyclosporins|mesh-list
24769161|NCT01812954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24769162|NCT01812954|Abortifacient Agents|abortifacient agents|mesh-ancestor
24769163|NCT01812954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24769406|NCT01814098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24769165|NCT01812954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24769166|NCT01812954|Antimetabolites|antimetabolites|mesh-ancestor
24769167|NCT01812954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769168|NCT01812954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24769169|NCT01812954|Dermatologic Agents|dermatologic agents|mesh-ancestor
24769170|NCT01812954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24769171|NCT01812954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24769172|NCT01812954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24769185|NCT01812954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24769186|NCT01812954|Keratolytic Agents|keratolytic agents|mesh-ancestor
24769187|NCT01812967|Caseins|caseins|mesh-list
24769188|NCT01812967|Chelating Agents|chelating agents|mesh-ancestor
24769189|NCT01812967|Sequestering Agents|sequestering agents|mesh-ancestor
24401049|NCT00152035|Adderall|adderall|mesh-list
24769190|NCT01812967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560207|NCT03205137|Amlodipine|amlodipine|mesh-list
24769191|NCT01813162|Tenofovir|tenofovir|mesh-list
24769192|NCT01813162|Metronidazole|metronidazole|mesh-list
24769193|NCT01813162|Terconazole|terconazole|mesh-list
24769194|NCT01813162|Contraceptive Agents|contraceptive agents|mesh-list
24769195|NCT01813162|Antiviral Agents|antiviral agents|mesh-ancestor
24769196|NCT01813162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24769197|NCT01813162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24769198|NCT01813162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24769199|NCT01813162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24769200|NCT01813162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769201|NCT01813162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24624178|NCT01074996|Vitamins|vitamins|mesh-ancestor
24769202|NCT01813162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24769203|NCT01813162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24769205|NCT01813162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24769215|NCT01813201|Hormones|hormones|mesh-ancestor
24769236|NCT01813448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24769237|NCT01813461|Isavuconazole|isavuconazole|mesh-list
24769238|NCT01813461|Antifungal Agents|antifungal agents|mesh-ancestor
24769239|NCT01813461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24769240|NCT01813487|Entecavir|entecavir|mesh-list
24769241|NCT01813487|Antiviral Agents|antiviral agents|mesh-ancestor
24769242|NCT01813487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24769243|NCT01813513|Simeprevir|simeprevir|mesh-list
24769244|NCT01813513|Antiviral Agents|antiviral agents|mesh-ancestor
24769245|NCT01813513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24769246|NCT01813513|Protease Inhibitors|protease inhibitors|mesh-ancestor
24769247|NCT01813513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661419|NCT01289327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661420|NCT01289327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24661422|NCT01289327|Analgesics|analgesics|mesh-ancestor
24661423|NCT01289327|Sensory System Agents|sensory system agents|mesh-ancestor
24769254|NCT01813552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24769260|NCT01813552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24769261|NCT01813552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24769263|NCT01813552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24769264|NCT01813552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24769265|NCT01813565|Hyaluronic Acid|hyaluronic acid|mesh-list
24769266|NCT01813565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24769267|NCT01813565|Immunologic Factors|immunologic factors|mesh-ancestor
24769268|NCT01813565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769269|NCT01813565|Viscosupplements|viscosupplements|mesh-ancestor
24769270|NCT01813565|Protective Agents|protective agents|mesh-ancestor
24769271|NCT01813591|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24769274|NCT01813591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769275|NCT01813604|Vaccines|vaccines|mesh-list
24769276|NCT01813604|Immunologic Factors|immunologic factors|mesh-ancestor
24769277|NCT01813604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769278|NCT01813617|Prednisone|prednisone|mesh-list
24769279|NCT01813617|Methotrexate|methotrexate|mesh-list
24769280|NCT01813617|Azathioprine|azathioprine|mesh-list
24769281|NCT01813617|Immunosuppressive Agents|immunosuppressive agents|mesh-list
24661425|NCT01289483|Fospropofol|fospropofol|mesh-list
24661496|NCT01289756|Enclomiphene|enclomiphene|mesh-list
24769285|NCT01813617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24769287|NCT01813617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24769332|NCT01813656|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24769333|NCT01813656|Serotonin Agents|serotonin agents|mesh-ancestor
24769334|NCT01813656|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24769335|NCT01813656|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24769336|NCT01813656|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24769337|NCT01813656|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24769338|NCT01813773|Aflibercept|aflibercept|mesh-list
24769341|NCT01813773|Growth Substances|growth substances|mesh-ancestor
24769342|NCT01813773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769343|NCT01813773|Growth Inhibitors|growth inhibitors|mesh-ancestor
24769344|NCT01813773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24769345|NCT01813812|Rebamipide|rebamipide|mesh-list
24769346|NCT01813812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24769347|NCT01813812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24769348|NCT01813812|Antioxidants|antioxidants|mesh-ancestor
24769349|NCT01813812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769350|NCT01813812|Protective Agents|protective agents|mesh-ancestor
24769351|NCT01813812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769353|NCT01813955|Papaverine|papaverine|mesh-list
24769354|NCT01813955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24769355|NCT01813955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24769357|NCT01813955|Vasodilator Agents|vasodilator agents|mesh-ancestor
24769382|NCT01814059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24769383|NCT01814059|Immunologic Factors|immunologic factors|mesh-ancestor
24769387|NCT01814085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24769388|NCT01814085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24769389|NCT01814085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769390|NCT01814085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24769391|NCT01814085|Serotonin Agents|serotonin agents|mesh-ancestor
24769392|NCT01814085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769393|NCT01814085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24769394|NCT01814085|Antidepressive Agents|antidepressive agents|mesh-ancestor
24769395|NCT01814085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24769396|NCT01814098|Citalopram|citalopram|mesh-list
24769397|NCT01814098|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24769398|NCT01814098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24769399|NCT01814098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24769400|NCT01814098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769401|NCT01814098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24769402|NCT01814098|Serotonin Agents|serotonin agents|mesh-ancestor
24769403|NCT01814098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769404|NCT01814098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24769405|NCT01814098|Antidepressive Agents|antidepressive agents|mesh-ancestor
24769409|NCT01814163|Carboplatin|carboplatin|mesh-list
24769410|NCT01814163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24769411|NCT01814163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24769412|NCT01814163|Tubulin Modulators|tubulin modulators|mesh-ancestor
24401194|NCT00152386|Immunologic Factors|immunologic factors|mesh-ancestor
24560496|NCT02476279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24729666|NCT01623102|Cisplatin|cisplatin|mesh-list
24482827|NCT00440713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24482828|NCT00440713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24560498|NCT02476279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620437|NCT01057069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24620438|NCT01057069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24620439|NCT01057069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24620440|NCT01057069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24620441|NCT01057069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620442|NCT01057160|Rizatriptan|rizatriptan|mesh-list
24620443|NCT01057160|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24620444|NCT01057160|Serotonin Agents|serotonin agents|mesh-ancestor
24620454|NCT01057186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24620455|NCT01057186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620456|NCT01057186|Vitamins|vitamins|mesh-ancestor
24483074|NCT00441662|Triamcinolone|triamcinolone|mesh-list
24483075|NCT00441662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24483076|NCT00441662|Glucocorticoids|glucocorticoids|mesh-ancestor
24483077|NCT00441662|Hormones|hormones|mesh-ancestor
24483081|NCT00441740|Docetaxel|docetaxel|mesh-list
24483090|NCT00441740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24483091|NCT00441740|Immunologic Factors|immunologic factors|mesh-ancestor
24483150|NCT00442026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483152|NCT00442026|Antimitotic Agents|antimitotic agents|mesh-ancestor
24483153|NCT00442026|Mitosis Modulators|mitosis modulators|mesh-ancestor
24483154|NCT00442052|Aspirin|aspirin|mesh-list
24483155|NCT00442052|Omeprazole|omeprazole|mesh-list
24483156|NCT00442052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24483157|NCT00442052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24483158|NCT00442052|Analgesics|analgesics|mesh-ancestor
24483159|NCT00442052|Sensory System Agents|sensory system agents|mesh-ancestor
24792683|NCT04792385|Drospirenone|drospirenone|mesh-list
24792684|NCT04792385|Contraceptive Agents|contraceptive agents|mesh-list
24792685|NCT04792385|Contraceptives, Oral|contraceptives, oral|mesh-list
24792686|NCT04792385|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
24966752|NCT03765645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24966753|NCT03765645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24966754|NCT03765645|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24966755|NCT03765645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24769445|NCT01814189|Antiemetics|antiemetics|mesh-ancestor
24769446|NCT01814189|Autonomic Agents|autonomic agents|mesh-ancestor
24769447|NCT01814189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24769460|NCT01814410|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24769461|NCT01814410|Cholinergic Agents|cholinergic agents|mesh-ancestor
24769462|NCT01814410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24769463|NCT01814410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769464|NCT01814410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24769465|NCT01814410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24769466|NCT01814410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24769468|NCT01814423|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24769469|NCT01814423|Amebicides|amebicides|mesh-ancestor
24769470|NCT01814423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24769471|NCT01814423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24401453|NCT00152958|Pramipexole|pramipexole|mesh-list
24769475|NCT01814423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24769476|NCT01814423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24769478|NCT01814423|Sensory System Agents|sensory system agents|mesh-ancestor
24769479|NCT01814423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24769480|NCT01814423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769481|NCT01814423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24769482|NCT01814423|Filaricides|filaricides|mesh-ancestor
24769483|NCT01814423|Antinematodal Agents|antinematodal agents|mesh-ancestor
24769484|NCT01814423|Anthelmintics|anthelmintics|mesh-ancestor
24769485|NCT01814449|Letrozole|letrozole|mesh-list
24769486|NCT01814449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24769487|NCT01814449|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24769488|NCT01814449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24769505|NCT01814475|Immunologic Factors|immunologic factors|mesh-ancestor
24770285|NCT01819441|Natriuretic Agents|natriuretic agents|mesh-ancestor
24769515|NCT01814501|Panitumumab|panitumumab|mesh-list
25701277|NCT02137369|Parasympatholytics|parasympatholytics|mesh-ancestor
24769516|NCT01814501|Calcium|calcium|mesh-list
24769517|NCT01814501|Levoleucovorin|levoleucovorin|mesh-list
24769531|NCT01814501|Vitamin B Complex|vitamin b complex|mesh-ancestor
24769532|NCT01814501|Vitamins|vitamins|mesh-ancestor
24769533|NCT01814501|Micronutrients|micronutrients|mesh-ancestor
24769534|NCT01814501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24769535|NCT01814514|Timolol|timolol|mesh-list
24769536|NCT01814514|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24769537|NCT01814514|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24769538|NCT01814514|Adrenergic Agents|adrenergic agents|mesh-ancestor
24769539|NCT01814514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24769540|NCT01814514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626417|NCT01087359|Melatonin|melatonin|mesh-list
24769541|NCT01814514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769542|NCT01814514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24769543|NCT01814514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24769545|NCT01814618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24769546|NCT01814618|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24769547|NCT01814618|Autonomic Agents|autonomic agents|mesh-ancestor
24769548|NCT01814618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24769549|NCT01814618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769550|NCT01814618|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24560572|NCT02312245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24769574|NCT01814709|Antifungal Agents|antifungal agents|mesh-ancestor
24769575|NCT01814709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24769576|NCT01814709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24769577|NCT01814709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24769578|NCT01814709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24769579|NCT01814709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769580|NCT01814709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24769581|NCT01814709|Hormone Antagonists|hormone antagonists|mesh-ancestor
24769582|NCT01814709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24769583|NCT01814709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769584|NCT01814709|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24769585|NCT01814709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24769586|NCT01814709|Antitubercular Agents|antitubercular agents|mesh-ancestor
24769587|NCT01814709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24769588|NCT01814709|Leprostatic Agents|leprostatic agents|mesh-ancestor
24769589|NCT01814709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24769590|NCT01814709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24769591|NCT01814709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24769592|NCT01814709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24769594|NCT01814709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24401609|NCT00153491|Artemether|artemether|mesh-list
24769595|NCT01814709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24769596|NCT01814826|Azacitidine|azacitidine|mesh-list
24769597|NCT01814826|Pevonedistat|pevonedistat|mesh-list
24769598|NCT01814826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24769599|NCT01814826|Antimetabolites|antimetabolites|mesh-ancestor
24769977|NCT01817322|Antiemetics|antiemetics|mesh-ancestor
24769621|NCT01814891|Vitamins|vitamins|mesh-ancestor
24769622|NCT01814891|Micronutrients|micronutrients|mesh-ancestor
24769623|NCT01814891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769624|NCT01814904|Bile Acids and Salts|bile acids and salts|mesh-list
24769625|NCT01814904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24769626|NCT01814930|Contraceptive Agents|contraceptive agents|mesh-list
24769627|NCT01814930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24769628|NCT01814930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769629|NCT01815021|Calcium, Dietary|calcium, dietary|mesh-list
24769630|NCT01815021|Calcium Carbonate|calcium carbonate|mesh-list
24769631|NCT01815021|Calcium|calcium|mesh-list
24769632|NCT01815021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24769633|NCT01815021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769634|NCT01815021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24769635|NCT01815021|Antacids|antacids|mesh-ancestor
24769636|NCT01815021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769637|NCT01815021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24769638|NCT01815047|Vitamin D|vitamin d|mesh-list
24769639|NCT01815047|Cholecalciferol|cholecalciferol|mesh-list
24769640|NCT01815047|Vitamins|vitamins|mesh-ancestor
24769641|NCT01815047|Micronutrients|micronutrients|mesh-ancestor
24769642|NCT01815047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769643|NCT01815047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24769664|NCT01815125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24769665|NCT01815203|Caffeine|caffeine|mesh-list
24769666|NCT01815203|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24769667|NCT01815203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401665|NCT00153660|Celecoxib|celecoxib|mesh-list
24769670|NCT01815203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769671|NCT01815203|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24769672|NCT01815203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24769673|NCT01815203|Purinergic Agents|purinergic agents|mesh-ancestor
24769674|NCT01815203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24769675|NCT01815242|Gemcitabine|gemcitabine|mesh-list
24769676|NCT01815242|Paclitaxel|paclitaxel|mesh-list
24769677|NCT01815242|Carboplatin|carboplatin|mesh-list
24769678|NCT01815242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24769679|NCT01815242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24769680|NCT01815242|Tubulin Modulators|tubulin modulators|mesh-ancestor
24769681|NCT01815242|Antimitotic Agents|antimitotic agents|mesh-ancestor
24769682|NCT01815242|Mitosis Modulators|mitosis modulators|mesh-ancestor
24769683|NCT01815242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769684|NCT01815242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24769685|NCT01815242|Antimetabolites|antimetabolites|mesh-ancestor
24769692|NCT01815255|Tenofovir|tenofovir|mesh-list
24769715|NCT01815307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769716|NCT01815307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24769717|NCT01815307|Antiviral Agents|antiviral agents|mesh-ancestor
24769718|NCT01815307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24769719|NCT01815307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24769720|NCT01815307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24769721|NCT01815307|Immunologic Factors|immunologic factors|mesh-ancestor
24769722|NCT01815307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769724|NCT01815437|Ergocalciferols|ergocalciferols|mesh-list
25080748|NCT03335904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24769725|NCT01815437|Cholecalciferol|cholecalciferol|mesh-list
24769726|NCT01815437|Vitamins|vitamins|mesh-list
24401763|NCT00153998|Leucovorin|leucovorin|mesh-list
24769727|NCT01815437|Micronutrients|micronutrients|mesh-ancestor
24769735|NCT01815541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24769761|NCT01815944|Ropivacaine|ropivacaine|mesh-list
24769762|NCT01815944|Anesthetics, Local|anesthetics, local|mesh-ancestor
24769763|NCT01815944|Anesthetics|anesthetics|mesh-ancestor
24769764|NCT01815944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24769765|NCT01815944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769766|NCT01815944|Sensory System Agents|sensory system agents|mesh-ancestor
24769767|NCT01815944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24769768|NCT01816009|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24769769|NCT01816009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24769771|NCT01816035|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24769772|NCT01816035|Maytansine|maytansine|mesh-list
25701278|NCT02137369|Autonomic Agents|autonomic agents|mesh-ancestor
25701279|NCT02137369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24769773|NCT01816035|Immunoconjugates|immunoconjugates|mesh-list
24769774|NCT01816035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24769775|NCT01816035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24769776|NCT01816035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24769777|NCT01816035|Tubulin Modulators|tubulin modulators|mesh-ancestor
24769778|NCT01816035|Antimitotic Agents|antimitotic agents|mesh-ancestor
24769779|NCT01816035|Mitosis Modulators|mitosis modulators|mesh-ancestor
24769780|NCT01816035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769781|NCT01816035|Immunologic Factors|immunologic factors|mesh-ancestor
24769782|NCT01816035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769784|NCT01816191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24769787|NCT01816191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769788|NCT01816191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24769816|NCT01816334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24769818|NCT01816334|Analgesics|analgesics|mesh-ancestor
24769819|NCT01816334|Sensory System Agents|sensory system agents|mesh-ancestor
24769820|NCT01816334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24966802|NCT03764722|Simendan|simendan|mesh-list
24966803|NCT03764722|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24966804|NCT03764722|Vasodilator Agents|vasodilator agents|mesh-ancestor
24966805|NCT03764722|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24966806|NCT03764722|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24966807|NCT03764722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966808|NCT03764722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966809|NCT03764722|Protective Agents|protective agents|mesh-ancestor
24966810|NCT03764722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24966811|NCT03764683|Suvorexant|suvorexant|mesh-list
24966812|NCT03764683|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24966813|NCT03764683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24966814|NCT03764683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24966815|NCT03764683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080750|NCT03335904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080773|NCT03335579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25080774|NCT03335579|Narcotics|narcotics|mesh-ancestor
25080775|NCT03335579|Analgesics|analgesics|mesh-ancestor
25080776|NCT03335579|Sensory System Agents|sensory system agents|mesh-ancestor
24401811|NCT00154050|Quinapril|quinapril|mesh-list
25080777|NCT03335579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25080778|NCT03335579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25080779|NCT03335527|Dexmedetomidine|dexmedetomidine|mesh-list
25080782|NCT03335527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080783|NCT03335527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25080785|NCT03335527|Sensory System Agents|sensory system agents|mesh-ancestor
25080786|NCT03335527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25080787|NCT03335527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25080788|NCT03335527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25080789|NCT03335527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25080790|NCT03335527|Adrenergic Agents|adrenergic agents|mesh-ancestor
25080791|NCT03335527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25080792|NCT03335527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080794|NCT03335501|Hormones|hormones|mesh-list
25080795|NCT03335501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080796|NCT03335501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25080797|NCT03335501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24784428|NCT01907984|GABA Agents|gaba agents|mesh-ancestor
24769823|NCT01816334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769824|NCT01816412|Paclitaxel|paclitaxel|mesh-list
24769825|NCT01816412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24769826|NCT01816412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24769839|NCT01816529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24769840|NCT01816529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769841|NCT01816529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24769849|NCT01816581|Morphine|morphine|mesh-list
24769850|NCT01816581|Naloxone|naloxone|mesh-list
24769851|NCT01816581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24769852|NCT01816581|Narcotics|narcotics|mesh-ancestor
24769853|NCT01816581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24769854|NCT01816581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769855|NCT01816581|Analgesics|analgesics|mesh-ancestor
24769856|NCT01816581|Sensory System Agents|sensory system agents|mesh-ancestor
24769857|NCT01816581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24769858|NCT01816581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24769859|NCT01816620|Dexamethasone|dexamethasone|mesh-list
24769860|NCT01816620|Lenalidomide|lenalidomide|mesh-list
24769861|NCT01816620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24769894|NCT01816789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769895|NCT01816958|Ketamine|ketamine|mesh-list
25080798|NCT03335436|Gabapentin|gabapentin|mesh-list
24769896|NCT01816958|Analgesics|analgesics|mesh-ancestor
24769897|NCT01816958|Sensory System Agents|sensory system agents|mesh-ancestor
24769898|NCT01816958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25080799|NCT03335436|Analgesics|analgesics|mesh-ancestor
24769899|NCT01816958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769900|NCT01816958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24769901|NCT01816958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24769902|NCT01816958|Anesthetics, General|anesthetics, general|mesh-ancestor
24769903|NCT01816958|Anesthetics|anesthetics|mesh-ancestor
24769904|NCT01816958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24769905|NCT01816958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24769906|NCT01816958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24769907|NCT01816958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24769908|NCT01816958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663302|NCT01300312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24769935|NCT01816997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24769936|NCT01817023|Cisplatin|cisplatin|mesh-list
24769937|NCT01817023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24769938|NCT01817036|Vitamin D|vitamin d|mesh-list
24769939|NCT01817036|Vitamins|vitamins|mesh-ancestor
24769940|NCT01817036|Micronutrients|micronutrients|mesh-ancestor
24769941|NCT01817036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769942|NCT01817036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24769943|NCT01817153|Hydrocortisone|hydrocortisone|mesh-list
24769944|NCT01817153|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24769945|NCT01817153|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24769950|NCT01817257|Heparin|heparin|mesh-list
24769952|NCT01817257|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24769953|NCT01817257|Tinzaparin|tinzaparin|mesh-list
24769954|NCT01817257|Dalteparin|dalteparin|mesh-list
24769955|NCT01817257|Anticoagulants|anticoagulants|mesh-ancestor
24769956|NCT01817257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24769957|NCT01817257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24769958|NCT01817257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24769959|NCT01817283|Triptolide|triptolide|mesh-list
24769960|NCT01817283|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
24769961|NCT01817283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769962|NCT01817283|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24769963|NCT01817283|Contraceptive Agents|contraceptive agents|mesh-ancestor
24769964|NCT01817283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24769965|NCT01817283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24769970|NCT01817283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24769971|NCT01817322|Mycophenolic Acid|mycophenolic acid|mesh-list
24769972|NCT01817322|Methylprednisolone|methylprednisolone|mesh-list
24769973|NCT01817322|Prednisolone|prednisolone|mesh-list
24769974|NCT01817322|Deflazacort|deflazacort|mesh-list
24769975|NCT01817322|Basiliximab|basiliximab|mesh-list
24769976|NCT01817322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24769978|NCT01817322|Autonomic Agents|autonomic agents|mesh-ancestor
24966840|NCT03764553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24966841|NCT03764553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24966842|NCT03764553|Antidotes|antidotes|mesh-ancestor
24966843|NCT03764553|Protective Agents|protective agents|mesh-ancestor
24966844|NCT03764553|Vitamin B Complex|vitamin b complex|mesh-ancestor
24966846|NCT03764553|Micronutrients|micronutrients|mesh-ancestor
24966847|NCT03764540|Prednisone|prednisone|mesh-list
24966848|NCT03764540|Docetaxel|docetaxel|mesh-list
24966849|NCT03764540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24966850|NCT03764540|Tubulin Modulators|tubulin modulators|mesh-ancestor
24966851|NCT03764540|Antimitotic Agents|antimitotic agents|mesh-ancestor
24966852|NCT03764540|Mitosis Modulators|mitosis modulators|mesh-ancestor
24966853|NCT03764540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966854|NCT03764540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24966856|NCT03764540|Hormones|hormones|mesh-ancestor
24966857|NCT03764540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24784531|NCT01908465|Histamine Agents|histamine agents|mesh-ancestor
24769979|NCT01817322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24769980|NCT01817322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769981|NCT01817322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24770003|NCT01817348|Sensory System Agents|sensory system agents|mesh-ancestor
24770004|NCT01817348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24770005|NCT01817348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24770006|NCT01817348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24770008|NCT01817348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24770009|NCT01817348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770011|NCT01817400|Pioglitazone|pioglitazone|mesh-list
24770012|NCT01817400|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
24770013|NCT01817400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24770014|NCT01817400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24770015|NCT01817400|Analgesics|analgesics|mesh-ancestor
24770016|NCT01817400|Sensory System Agents|sensory system agents|mesh-ancestor
24770017|NCT01817400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24770018|NCT01817400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080800|NCT03335436|Sensory System Agents|sensory system agents|mesh-ancestor
25080801|NCT03335436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25080802|NCT03335436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080803|NCT03335436|Anticonvulsants|anticonvulsants|mesh-ancestor
25080804|NCT03335436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25080805|NCT03335436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25080806|NCT03335436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25080807|NCT03335436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25080808|NCT03335436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25080809|NCT03335436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25080810|NCT03335436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25080811|NCT03335436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770029|NCT01817400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24770031|NCT01817439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24770032|NCT01817439|Vasodilator Agents|vasodilator agents|mesh-ancestor
24770033|NCT01817439|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24770034|NCT01817439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24770035|NCT01817439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770036|NCT01817439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24770037|NCT01817439|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24770038|NCT01817439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24770039|NCT01817439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770040|NCT01817439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24770041|NCT01817439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24770042|NCT01817439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24770043|NCT01817452|Paclitaxel|paclitaxel|mesh-list
24770044|NCT01817452|Trastuzumab|trastuzumab|mesh-list
24770045|NCT01817452|Pertuzumab|pertuzumab|mesh-list
24770046|NCT01817452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24770047|NCT01817452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24770048|NCT01817452|Tubulin Modulators|tubulin modulators|mesh-ancestor
24770049|NCT01817452|Antimitotic Agents|antimitotic agents|mesh-ancestor
24770050|NCT01817452|Mitosis Modulators|mitosis modulators|mesh-ancestor
24770051|NCT01817452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483186|NCT00442221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24483187|NCT00442221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24483188|NCT00442221|Gout Suppressants|gout suppressants|mesh-ancestor
24483189|NCT00442221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24483190|NCT00442221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770059|NCT01817699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24664531|NCT01307488|Antiviral Agents|antiviral agents|mesh-ancestor
24561189|NCT00758732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561192|NCT00758732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24561193|NCT00758732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620503|NCT01057329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24620504|NCT01057329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24620505|NCT01057329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620506|NCT01057329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24620507|NCT01057329|Serotonin Agents|serotonin agents|mesh-ancestor
24620508|NCT01057329|Antidepressive Agents|antidepressive agents|mesh-ancestor
24620509|NCT01057329|Dopamine Agonists|dopamine agonists|mesh-ancestor
24549475|NCT00715455|Calcium heparin|calcium heparin|mesh-list
24549476|NCT00715455|Anticoagulants|anticoagulants|mesh-ancestor
24620510|NCT01057329|Dopamine Agents|dopamine agents|mesh-ancestor
24620511|NCT01057329|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24620512|NCT01057329|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24983746|NCT05170139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620513|NCT01057329|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24620514|NCT01057329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24620515|NCT01057329|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24620516|NCT01057329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24620517|NCT01057329|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24620518|NCT01057329|Analgesics|analgesics|mesh-ancestor
24770061|NCT01817803|Furosemide|furosemide|mesh-list
24770062|NCT01817803|Spironolactone|spironolactone|mesh-list
24770063|NCT01817803|Diuretics|diuretics|mesh-ancestor
24770064|NCT01817803|Natriuretic Agents|natriuretic agents|mesh-ancestor
24770065|NCT01817803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770066|NCT01817803|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24770067|NCT01817803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24770068|NCT01817803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770069|NCT01817803|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24770070|NCT01817803|Hormone Antagonists|hormone antagonists|mesh-ancestor
24770071|NCT01817803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24770072|NCT01817803|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24770073|NCT01817803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24770096|NCT01817894|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24770097|NCT01817894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24770098|NCT01817894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24770099|NCT01817894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24770100|NCT01817894|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
24770101|NCT01817894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770102|NCT01817894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770105|NCT01817972|Antimetabolites|antimetabolites|mesh-ancestor
24770106|NCT01817972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770107|NCT01817972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24770108|NCT01817972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24770109|NCT01817972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24770110|NCT01817972|Immunologic Factors|immunologic factors|mesh-ancestor
24770111|NCT01817972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770112|NCT01817972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24770121|NCT01818232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770123|NCT01818232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770124|NCT01818648|Exenatide|exenatide|mesh-list
24770125|NCT01818648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24770126|NCT01818648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770127|NCT01818648|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24770128|NCT01818648|Incretins|incretins|mesh-ancestor
24770129|NCT01818648|Hormones|hormones|mesh-ancestor
24770130|NCT01818648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24770131|NCT01818713|Doxorubicin|doxorubicin|mesh-list
24770132|NCT01818713|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24770133|NCT01818713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25080818|NCT03335423|Narcotics|narcotics|mesh-ancestor
25701280|NCT02137369|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25701281|NCT02137369|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25701282|NCT02137369|Cholinergic Agents|cholinergic agents|mesh-ancestor
25701283|NCT02137369|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25701284|NCT02137382|Pancrelipase|pancrelipase|mesh-list
25701285|NCT02137382|Pancreatin|pancreatin|mesh-list
25701286|NCT02137382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25701287|NCT02137538|Letrozole|letrozole|mesh-list
25701288|NCT02137538|Anastrozole|anastrozole|mesh-list
25701289|NCT02137538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25701290|NCT02137538|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25701291|NCT02137538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25701292|NCT02137538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770140|NCT01818843|Antimetabolites|antimetabolites|mesh-ancestor
24770141|NCT01818843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770142|NCT01818843|Gasotransmitters|gasotransmitters|mesh-ancestor
24770143|NCT01818843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24770144|NCT01818843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770146|NCT01818856|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24770158|NCT01818869|Adenosine|adenosine|mesh-list
24770166|NCT01818869|Purinergic Agonists|purinergic agonists|mesh-ancestor
24770167|NCT01818869|Purinergic Agents|purinergic agents|mesh-ancestor
24770168|NCT01818869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24770173|NCT01818908|Etoposide|etoposide|mesh-list
24770174|NCT01818908|Vincristine|vincristine|mesh-list
24770175|NCT01818908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24770183|NCT01818908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24770184|NCT01818908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24770185|NCT01818908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24770186|NCT01818908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24770187|NCT01818908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770188|NCT01818908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24770189|NCT01818908|Glucocorticoids|glucocorticoids|mesh-ancestor
24770190|NCT01818908|Hormones|hormones|mesh-ancestor
24770191|NCT01818908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24770192|NCT01818908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24770193|NCT01818908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24770194|NCT01818908|Tubulin Modulators|tubulin modulators|mesh-ancestor
24770195|NCT01818908|Antimitotic Agents|antimitotic agents|mesh-ancestor
24770196|NCT01818908|Mitosis Modulators|mitosis modulators|mesh-ancestor
24770226|NCT01819064|Respiratory System Agents|respiratory system agents|mesh-ancestor
24770227|NCT01819064|Mydriatics|mydriatics|mesh-ancestor
24770228|NCT01819064|Parasympatholytics|parasympatholytics|mesh-ancestor
24770229|NCT01819064|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24770230|NCT01819064|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24770231|NCT01819064|Cholinergic Agents|cholinergic agents|mesh-ancestor
24770232|NCT01819064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24770233|NCT01819064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770234|NCT01819155|Vaccines|vaccines|mesh-list
24770235|NCT01819155|Immunologic Factors|immunologic factors|mesh-ancestor
24770236|NCT01819155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770237|NCT01819220|Amlodipine|amlodipine|mesh-list
24770238|NCT01819220|Valsartan|valsartan|mesh-list
24770239|NCT01819220|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24770268|NCT01819285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770269|NCT01819389|Imatinib Mesylate|imatinib mesylate|mesh-list
24770270|NCT01819389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24770271|NCT01819389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24770272|NCT01819389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770273|NCT01819389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770275|NCT01819402|Glimepiride|glimepiride|mesh-list
24770276|NCT01819402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24770277|NCT01819402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770278|NCT01819402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24770279|NCT01819402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24770280|NCT01819402|Immunologic Factors|immunologic factors|mesh-ancestor
24770281|NCT01819441|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24770282|NCT01819441|Perindopril|perindopril|mesh-list
24770283|NCT01819441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24770284|NCT01819441|Diuretics|diuretics|mesh-ancestor
24770286|NCT01819441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770287|NCT01819441|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24770288|NCT01819441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24770289|NCT01819441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24966861|NCT03764527|Lumefantrine|lumefantrine|mesh-list
24770307|NCT01819649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770308|NCT01819649|Protective Agents|protective agents|mesh-ancestor
24770309|NCT01819649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770310|NCT01819649|Trace Elements|trace elements|mesh-ancestor
24770311|NCT01819649|Micronutrients|micronutrients|mesh-ancestor
24770312|NCT01819701|Ubiquinone|ubiquinone|mesh-list
24770313|NCT01819701|Coenzyme Q10|coenzyme q10|mesh-list
24770314|NCT01819701|Micronutrients|micronutrients|mesh-ancestor
24770315|NCT01819701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770317|NCT01819779|Amlodipine|amlodipine|mesh-list
24770318|NCT01819779|Valsartan|valsartan|mesh-list
24770319|NCT01819779|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
24770320|NCT01819779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24770321|NCT01819779|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24770322|NCT01819779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24770323|NCT01819779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770324|NCT01819779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24770325|NCT01819779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770326|NCT01819779|Vasodilator Agents|vasodilator agents|mesh-ancestor
24770327|NCT01819779|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24770328|NCT01819779|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24770329|NCT01819857|Ondansetron|ondansetron|mesh-list
24770343|NCT01819857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24770366|NCT01820026|Amoxicillin|amoxicillin|mesh-list
24770367|NCT01820026|Azithromycin|azithromycin|mesh-list
24770368|NCT01820026|Vancomycin|vancomycin|mesh-list
24770369|NCT01820026|Imipenem|imipenem|mesh-list
24770370|NCT01820026|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24770371|NCT01820026|Cefotaxime|cefotaxime|mesh-list
24770372|NCT01820026|Cefoxitin|cefoxitin|mesh-list
24770373|NCT01820026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24770374|NCT01820026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24770375|NCT01820026|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24770376|NCT01820026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770378|NCT01820091|Levoleucovorin|levoleucovorin|mesh-list
24770381|NCT01820091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770382|NCT01820104|Lansoprazole|lansoprazole|mesh-list
24770383|NCT01820104|Dexlansoprazole|dexlansoprazole|mesh-list
24770384|NCT01820104|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24770385|NCT01820104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24770386|NCT01820104|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24770387|NCT01820104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770388|NCT01820104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770389|NCT01820143|Esomeprazole|esomeprazole|mesh-list
24770390|NCT01820143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24770416|NCT01820325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24770417|NCT01820325|Tubulin Modulators|tubulin modulators|mesh-ancestor
24770418|NCT01820325|Antimitotic Agents|antimitotic agents|mesh-ancestor
24770419|NCT01820325|Mitosis Modulators|mitosis modulators|mesh-ancestor
24770420|NCT01820325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770422|NCT01820442|Clonidine|clonidine|mesh-list
24770423|NCT01820442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24770424|NCT01820442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24770425|NCT01820442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770426|NCT01820442|Sensory System Agents|sensory system agents|mesh-ancestor
24770427|NCT01820442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24770428|NCT01820442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24770429|NCT01820442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24770430|NCT01820442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24770431|NCT01820442|Adrenergic Agents|adrenergic agents|mesh-ancestor
24770432|NCT01820442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24770433|NCT01820442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770434|NCT01820442|Analgesics|analgesics|mesh-ancestor
24770435|NCT01820442|Sympatholytics|sympatholytics|mesh-ancestor
24770436|NCT01820442|Autonomic Agents|autonomic agents|mesh-ancestor
24770438|NCT01820455|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24770439|NCT01820455|Mupirocin|mupirocin|mesh-list
24770440|NCT01820455|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24770441|NCT01820455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24770442|NCT01820455|Disinfectants|disinfectants|mesh-ancestor
24770468|NCT01820767|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24770478|NCT01820832|Cholecalciferol|cholecalciferol|mesh-list
25701293|NCT02137538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770479|NCT01820832|Calcitriol|calcitriol|mesh-list
24549857|NCT00717782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549930|NCT00718146|Immunologic Factors|immunologic factors|mesh-ancestor
24770480|NCT01820832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24770481|NCT01820832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770482|NCT01820832|Vitamins|vitamins|mesh-ancestor
24770483|NCT01820832|Micronutrients|micronutrients|mesh-ancestor
24770484|NCT01820832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24770485|NCT01820832|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24770486|NCT01820832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24562421|NCT00766350|Adrenergic Agents|adrenergic agents|mesh-ancestor
24770487|NCT01820832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770488|NCT01820832|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24770490|NCT01820858|Carboplatin|carboplatin|mesh-list
24770491|NCT01820858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24770492|NCT01820858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24770493|NCT01820858|Tubulin Modulators|tubulin modulators|mesh-ancestor
24770494|NCT01820858|Antimitotic Agents|antimitotic agents|mesh-ancestor
24770495|NCT01820858|Mitosis Modulators|mitosis modulators|mesh-ancestor
24770496|NCT01820858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770497|NCT01820897|Trimethoprim|trimethoprim|mesh-list
24770498|NCT01820897|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24770500|NCT01820897|Fosfomycin|fosfomycin|mesh-list
24770511|NCT01820897|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24770512|NCT01820897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24770519|NCT01821001|Bromocriptine|bromocriptine|mesh-list
24770520|NCT01821001|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24770521|NCT01821001|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24770522|NCT01821001|Hormone Antagonists|hormone antagonists|mesh-ancestor
24770523|NCT01821001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24770524|NCT01821001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770525|NCT01821001|Dopamine Agonists|dopamine agonists|mesh-ancestor
24770526|NCT01821001|Dopamine Agents|dopamine agents|mesh-ancestor
24770527|NCT01821001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24770528|NCT01821001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770529|NCT01821027|Canagliflozin|canagliflozin|mesh-list
24770530|NCT01821027|Simvastatin|simvastatin|mesh-list
24770531|NCT01821027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24770532|NCT01821027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24770533|NCT01821027|Antimetabolites|antimetabolites|mesh-ancestor
24770535|NCT01821027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24770559|NCT01821066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24770568|NCT01821170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24770569|NCT01821170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770571|NCT01821170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24770573|NCT01821235|Analgesics|analgesics|mesh-ancestor
24770574|NCT01821235|Sensory System Agents|sensory system agents|mesh-ancestor
24770575|NCT01821235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24770632|NCT01821430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24770633|NCT01821430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24770634|NCT01821430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24770635|NCT01821430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24770636|NCT01821430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24770637|NCT01821456|Antiviral Agents|antiviral agents|mesh-list
24770638|NCT01821456|Anti-Infective Agents|anti-infective agents|mesh-list
24770639|NCT01821573|Botulinum Toxins|botulinum toxins|mesh-list
24402266|NCT00156299|Hormones|hormones|mesh-ancestor
24770650|NCT01821612|Leucovorin|leucovorin|mesh-list
24770659|NCT01821612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24770660|NCT01821612|Antiviral Agents|antiviral agents|mesh-ancestor
24770661|NCT01821612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24770662|NCT01821612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770663|NCT01821612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24770664|NCT01821612|Immunologic Factors|immunologic factors|mesh-ancestor
25701294|NCT02137538|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25701295|NCT02137538|Hormone Antagonists|hormone antagonists|mesh-ancestor
25701296|NCT02137538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25701297|NCT02137538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701298|NCT02137538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25701299|NCT02137772|Letermovir|letermovir|mesh-list
24770679|NCT01821677|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24770680|NCT01821677|Hormone Antagonists|hormone antagonists|mesh-ancestor
24770681|NCT01821677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24770682|NCT01821677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770683|NCT01821703|Spironolactone|spironolactone|mesh-list
25080835|NCT03335293|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25080836|NCT03335293|Autonomic Agents|autonomic agents|mesh-ancestor
25080837|NCT03335293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25080838|NCT03335293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25080839|NCT03335293|Respiratory System Agents|respiratory system agents|mesh-ancestor
25080840|NCT03335293|Mydriatics|mydriatics|mesh-ancestor
25080869|NCT03335098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25080870|NCT03335098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080871|NCT03335098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25080875|NCT03335098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25080876|NCT03335098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25080877|NCT03335098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25080878|NCT03335098|Immunologic Factors|immunologic factors|mesh-ancestor
25080879|NCT03335098|Leprostatic Agents|leprostatic agents|mesh-ancestor
25080880|NCT03335098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25080881|NCT03335098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25080882|NCT03335098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25080890|NCT03335072|Azithromycin|azithromycin|mesh-list
25080891|NCT03335072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25080892|NCT03335072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25080893|NCT03335059|Mitomycins|mitomycins|mesh-list
24770700|NCT01821872|Sensory System Agents|sensory system agents|mesh-ancestor
24770701|NCT01821872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25701300|NCT02137772|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25701301|NCT02137772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25701302|NCT02137772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701303|NCT02137772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25701304|NCT02137772|Antiviral Agents|antiviral agents|mesh-ancestor
25701305|NCT02137772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25701306|NCT02137785|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25701307|NCT02137785|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24770702|NCT01821872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770703|NCT01821872|Antipyretics|antipyretics|mesh-ancestor
24770704|NCT01821989|Lactoferrin|lactoferrin|mesh-list
24770705|NCT01821989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24770706|NCT01822015|Cytarabine|cytarabine|mesh-list
24770707|NCT01822015|Sirolimus|sirolimus|mesh-list
24770708|NCT01822015|Idarubicin|idarubicin|mesh-list
24770709|NCT01822015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24770710|NCT01822015|Antimetabolites|antimetabolites|mesh-ancestor
24561797|NCT00762918|Vitamin D|vitamin d|mesh-list
24770711|NCT01822015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770712|NCT01822015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24770713|NCT01822015|Antiviral Agents|antiviral agents|mesh-ancestor
24770714|NCT01822015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24561866|NCT00763347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561868|NCT00763347|Hormones|hormones|mesh-ancestor
24561869|NCT00763347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24562641|NCT00767546|Cholinergic Agents|cholinergic agents|mesh-ancestor
24561873|NCT00763347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561874|NCT00763373|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24561879|NCT00763438|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24561880|NCT00763438|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24561881|NCT00763438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24561882|NCT00763438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561883|NCT00763438|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24620571|NCT01057628|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24620580|NCT01057654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24770794|NCT01822483|Mycophenolic Acid|mycophenolic acid|mesh-list
24620581|NCT01057654|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24620582|NCT01057654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620584|NCT01057758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24620585|NCT01057758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24620587|NCT01057758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620588|NCT01057758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24620589|NCT01057758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24620590|NCT01057758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620592|NCT01057849|Risperidone|risperidone|mesh-list
24620593|NCT01057849|Aripiprazole|aripiprazole|mesh-list
24620594|NCT01057849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24620595|NCT01057849|Serotonin Agents|serotonin agents|mesh-ancestor
25080902|NCT03335007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24577556|NCT00844688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24620596|NCT01057849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24620597|NCT01057849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620598|NCT01057849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620599|NCT01057849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24620600|NCT01057849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24620602|NCT01057849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24620605|NCT01057849|Antiemetics|antiemetics|mesh-ancestor
24620606|NCT01057849|Autonomic Agents|autonomic agents|mesh-ancestor
24770715|NCT01822015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24770716|NCT01822015|Immunologic Factors|immunologic factors|mesh-ancestor
24770717|NCT01822015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770718|NCT01822015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24770719|NCT01822015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24770720|NCT01822015|Antifungal Agents|antifungal agents|mesh-ancestor
24770721|NCT01822015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24483191|NCT00442221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483192|NCT00442221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24770722|NCT01822015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24770723|NCT01822015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770724|NCT01822028|Miglustat|miglustat|mesh-list
24770725|NCT01822028|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
24770726|NCT01822028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770727|NCT01822028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770728|NCT01822028|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24770729|NCT01822028|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24770730|NCT01822028|Antiviral Agents|antiviral agents|mesh-ancestor
24770731|NCT01822028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24770732|NCT01822028|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24770789|NCT01822431|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24770790|NCT01822431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24770791|NCT01822431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770792|NCT01822431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770793|NCT01822431|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24770798|NCT01822483|Antitubercular Agents|antitubercular agents|mesh-ancestor
24770799|NCT01822483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24770800|NCT01822483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24770801|NCT01822483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770820|NCT01822613|Tubulin Modulators|tubulin modulators|mesh-ancestor
24770821|NCT01822613|Antimitotic Agents|antimitotic agents|mesh-ancestor
24770822|NCT01822613|Mitosis Modulators|mitosis modulators|mesh-ancestor
24770823|NCT01822613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770824|NCT01822613|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24770825|NCT01822613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24770826|NCT01822613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770829|NCT01822639|Enalaprilat|enalaprilat|mesh-list
24770830|NCT01822639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24770831|NCT01822639|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24770832|NCT01822639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24770833|NCT01822639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770834|NCT01822639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24770835|NCT01822639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770836|NCT01822639|Vasodilator Agents|vasodilator agents|mesh-ancestor
24770837|NCT01822639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770838|NCT01822639|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24770868|NCT01822860|Chlorthalidone|chlorthalidone|mesh-list
24770869|NCT01822860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24770870|NCT01822860|Diuretics|diuretics|mesh-ancestor
24770871|NCT01822860|Natriuretic Agents|natriuretic agents|mesh-ancestor
24770875|NCT01822860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770876|NCT01822951|Cerebrolysin|cerebrolysin|mesh-list
24770877|NCT01822951|Donepezil|donepezil|mesh-list
24770878|NCT01822951|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24770879|NCT01822951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770890|NCT01822977|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24770891|NCT01822977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770892|NCT01822977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770893|NCT01823029|Epoetin Alfa|epoetin alfa|mesh-list
24770894|NCT01823029|Hematinics|hematinics|mesh-ancestor
24770895|NCT01823042|Azathioprine|azathioprine|mesh-list
24770896|NCT01823042|Antimetabolites|antimetabolites|mesh-ancestor
24770897|NCT01823042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770898|NCT01823042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24770899|NCT01823042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24770900|NCT01823042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24770901|NCT01823042|Immunologic Factors|immunologic factors|mesh-ancestor
24770902|NCT01823042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770903|NCT01823042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24770908|NCT01823081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24770920|NCT01823133|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24770921|NCT01823133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24770922|NCT01823133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24770923|NCT01823133|Antimetabolites|antimetabolites|mesh-ancestor
25080904|NCT03335007|Analgesics|analgesics|mesh-ancestor
25080905|NCT03335007|Sensory System Agents|sensory system agents|mesh-ancestor
25080906|NCT03335007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24770941|NCT01823185|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24770942|NCT01823185|Purinergic Agents|purinergic agents|mesh-ancestor
24770943|NCT01823185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24770944|NCT01823185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795977|NCT01947062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770945|NCT01823185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770946|NCT01823393|Heparin|heparin|mesh-list
24770947|NCT01823393|Calcium heparin|calcium heparin|mesh-list
24770948|NCT01823393|Anticoagulants|anticoagulants|mesh-ancestor
24770949|NCT01823393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24770950|NCT01823393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24770951|NCT01823393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770952|NCT01823523|Clindamycin|clindamycin|mesh-list
24770953|NCT01823523|Clindamycin palmitate|clindamycin palmitate|mesh-list
24770954|NCT01823523|Clindamycin phosphate|clindamycin phosphate|mesh-list
24770956|NCT01823523|Cephalexin|cephalexin|mesh-list
24770957|NCT01823523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24770958|NCT01823523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24770959|NCT01823523|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24770960|NCT01823523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24770961|NCT01823523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24770962|NCT01823744|Micronutrients|micronutrients|mesh-list
25701310|NCT02137837|Fulvestrant|fulvestrant|mesh-list
25701311|NCT02137837|Anastrozole|anastrozole|mesh-list
25701312|NCT02137837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25701313|NCT02137837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25701314|NCT02137837|Immunologic Factors|immunologic factors|mesh-ancestor
25701315|NCT02137837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770995|NCT01824043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24770997|NCT01824043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24770998|NCT01824043|Growth Inhibitors|growth inhibitors|mesh-ancestor
24770999|NCT01824043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771000|NCT01824056|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24771001|NCT01824056|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24771002|NCT01824056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771004|NCT01824199|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24771005|NCT01824199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24771006|NCT01824199|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24771008|NCT01824199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771010|NCT01824225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24771011|NCT01824225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24771012|NCT01824225|Growth Substances|growth substances|mesh-ancestor
24771013|NCT01824225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771014|NCT01824225|Growth Inhibitors|growth inhibitors|mesh-ancestor
24771015|NCT01824225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771016|NCT01824238|Oxazolidinones|oxazolidinones|mesh-list
24771017|NCT01824238|Anacetrapib|anacetrapib|mesh-list
24771018|NCT01824238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24771019|NCT01824238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24771020|NCT01824238|Antimetabolites|antimetabolites|mesh-ancestor
24771021|NCT01824238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771022|NCT01824238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24771024|NCT01824238|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24771025|NCT01824238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771026|NCT01824251|Immunoglobulins|immunoglobulins|mesh-list
24771027|NCT01824251|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24771028|NCT01824251|gamma-Globulins|gamma-globulins|mesh-list
24771029|NCT01824251|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24771038|NCT01824264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24771039|NCT01824264|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24771040|NCT01824264|Protease Inhibitors|protease inhibitors|mesh-ancestor
24771041|NCT01824264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771042|NCT01824264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771043|NCT01824264|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25701316|NCT02137837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25701317|NCT02137837|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24771058|NCT01824420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24771059|NCT01824420|Renal Agents|renal agents|mesh-ancestor
24771061|NCT01824433|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24771062|NCT01824433|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24771063|NCT01824433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24771064|NCT01824433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24771065|NCT01824433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771066|NCT01824433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24771079|NCT01824524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24771080|NCT01824524|Narcotics|narcotics|mesh-ancestor
24771081|NCT01824524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24403290|NCT00159731|Anticonvulsants|anticonvulsants|mesh-ancestor
24771084|NCT01824524|Sensory System Agents|sensory system agents|mesh-ancestor
24771085|NCT01824524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24771086|NCT01824615|Sunitinib|sunitinib|mesh-list
24771087|NCT01824615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771088|NCT01824615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24771089|NCT01824615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24771090|NCT01824615|Growth Substances|growth substances|mesh-ancestor
24771091|NCT01824615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771092|NCT01824615|Growth Inhibitors|growth inhibitors|mesh-ancestor
24771093|NCT01824615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24771094|NCT01824615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771095|NCT01824615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771096|NCT01824758|Lidocaine|lidocaine|mesh-list
24771098|NCT01824758|Esmolol|esmolol|mesh-list
24771099|NCT01824758|Anesthetics, Local|anesthetics, local|mesh-ancestor
24562174|NCT00764907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771100|NCT01824758|Anesthetics|anesthetics|mesh-ancestor
24771101|NCT01824758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24771102|NCT01824758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771103|NCT01824758|Sensory System Agents|sensory system agents|mesh-ancestor
24771104|NCT01824758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24562248|NCT00765167|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24562249|NCT00765167|Triclosan|triclosan|mesh-list
24562250|NCT00765167|Fluorides|fluorides|mesh-list
24562251|NCT00765167|Cariostatic Agents|cariostatic agents|mesh-ancestor
24562252|NCT00765167|Protective Agents|protective agents|mesh-ancestor
24562253|NCT00765167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562254|NCT00765167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24562255|NCT00765167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24562256|NCT00765167|Disinfectants|disinfectants|mesh-ancestor
24562257|NCT00765167|Dermatologic Agents|dermatologic agents|mesh-ancestor
24562258|NCT00765167|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24562259|NCT00765167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24562260|NCT00765167|Antimetabolites|antimetabolites|mesh-ancestor
24403334|NCT00159809|Sildenafil Citrate|sildenafil citrate|mesh-list
24562263|NCT00765271|Ritonavir|ritonavir|mesh-list
24562264|NCT00765271|Darunavir|darunavir|mesh-list
24562265|NCT00765271|Raltegravir Potassium|raltegravir potassium|mesh-list
24562266|NCT00765271|Abacavir|abacavir|mesh-list
24562267|NCT00765271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25701318|NCT02137837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25701319|NCT02137837|Hormone Antagonists|hormone antagonists|mesh-ancestor
25701320|NCT02137837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24562268|NCT00765271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25701321|NCT02137837|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25701322|NCT02137837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24801540|NCT01984073|Niacin|niacin|mesh-list
24771114|NCT01824758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24771115|NCT01824758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24771116|NCT01824758|Adrenergic Agents|adrenergic agents|mesh-ancestor
25080913|NCT03334981|Narcotics|narcotics|mesh-ancestor
25080914|NCT03334981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25080915|NCT03334981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080916|NCT03334981|Analgesics|analgesics|mesh-ancestor
25080917|NCT03334981|Sensory System Agents|sensory system agents|mesh-ancestor
25080918|NCT03334981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25080919|NCT03334981|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25080920|NCT03334981|Antitussive Agents|antitussive agents|mesh-ancestor
25080921|NCT03334981|Respiratory System Agents|respiratory system agents|mesh-ancestor
24966973|NCT03763760|Autonomic Agents|autonomic agents|mesh-ancestor
24966974|NCT03763760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24562270|NCT00765271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562271|NCT00765271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771179|NCT01825044|Immunologic Factors|immunologic factors|mesh-ancestor
24771180|NCT01825044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771182|NCT01825044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24771183|NCT01825044|Dermatologic Agents|dermatologic agents|mesh-ancestor
24771184|NCT01825044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24771185|NCT01825044|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24771188|NCT01825083|Sensory System Agents|sensory system agents|mesh-ancestor
24771189|NCT01825083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24771190|NCT01825083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771191|NCT01825083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24771192|NCT01825083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24771193|NCT01825083|Anesthetics, General|anesthetics, general|mesh-ancestor
24771194|NCT01825083|Anesthetics|anesthetics|mesh-ancestor
24771200|NCT01825109|Vaccines|vaccines|mesh-list
24771223|NCT01825473|Erythromycin|erythromycin|mesh-list
24771224|NCT01825473|Erythromycin Estolate|erythromycin estolate|mesh-list
24771225|NCT01825473|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24771226|NCT01825473|Erythromycin stearate|erythromycin stearate|mesh-list
24771227|NCT01825473|Phenobarbital|phenobarbital|mesh-list
24771230|NCT01825473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24771231|NCT01825473|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24771232|NCT01825473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771233|NCT01825473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771234|NCT01825473|Anticonvulsants|anticonvulsants|mesh-ancestor
24771235|NCT01825473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24771236|NCT01825473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24771237|NCT01825473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771238|NCT01825473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24771239|NCT01825473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24771240|NCT01825473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24771241|NCT01825473|GABA Modulators|gaba modulators|mesh-ancestor
24771242|NCT01825473|GABA Agents|gaba agents|mesh-ancestor
24771243|NCT01825473|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24771244|NCT01825473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24771245|NCT01825473|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24771246|NCT01825551|Lenograstim|lenograstim|mesh-list
24771247|NCT01825551|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24771248|NCT01825551|Immunologic Factors|immunologic factors|mesh-ancestor
24771249|NCT01825551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771250|NCT01825590|Dialysis Solutions|dialysis solutions|mesh-list
24771251|NCT01825590|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24771252|NCT01825603|Gemcitabine|gemcitabine|mesh-list
24771253|NCT01825603|Cisplatin|cisplatin|mesh-list
24771254|NCT01825603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771255|NCT01825603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24771256|NCT01825603|Antimetabolites|antimetabolites|mesh-ancestor
25407398|NCT03504410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25701323|NCT02137837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771258|NCT01825603|Antiviral Agents|antiviral agents|mesh-ancestor
24771259|NCT01825603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24771260|NCT01825603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483264|NCT00442546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24771276|NCT01825733|Antiemetics|antiemetics|mesh-ancestor
24771277|NCT01825733|Autonomic Agents|autonomic agents|mesh-ancestor
24771278|NCT01825733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24771279|NCT01825733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771280|NCT01825733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24771281|NCT01825733|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25080922|NCT03334877|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24771282|NCT01825733|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24771283|NCT01825733|Serotonin Agents|serotonin agents|mesh-ancestor
24771284|NCT01825733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24771285|NCT01825733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771286|NCT01825850|Irbesartan|irbesartan|mesh-list
24771287|NCT01825850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24771288|NCT01825850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24771289|NCT01825850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24771290|NCT01825850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771291|NCT01825863|Ropivacaine|ropivacaine|mesh-list
24771292|NCT01825863|Anesthetics, Local|anesthetics, local|mesh-ancestor
24771293|NCT01825863|Anesthetics|anesthetics|mesh-ancestor
24771294|NCT01825863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24483266|NCT00442585|Ibuprofen|ibuprofen|mesh-list
24771298|NCT01825902|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24771299|NCT01825902|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24533821|NCT00645242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771300|NCT01825902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771302|NCT01825928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24771303|NCT01825928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24771304|NCT01825928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24771305|NCT01825928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771306|NCT01825928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24771308|NCT01825928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24771309|NCT01825928|Serotonin Agents|serotonin agents|mesh-ancestor
24771310|NCT01825928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24771311|NCT01825928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771317|NCT01825993|Anesthetics, Local|anesthetics, local|mesh-ancestor
24771319|NCT01825993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24771320|NCT01825993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771321|NCT01825993|Sensory System Agents|sensory system agents|mesh-ancestor
24771322|NCT01825993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24771323|NCT01825993|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24771324|NCT01825993|Narcotics|narcotics|mesh-ancestor
24771325|NCT01825993|Analgesics|analgesics|mesh-ancestor
24771326|NCT01826149|Propofol|propofol|mesh-list
24771327|NCT01826149|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24771328|NCT01826149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24771329|NCT01826149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771330|NCT01826149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24771331|NCT01826149|Anesthetics, General|anesthetics, general|mesh-ancestor
24771339|NCT01826175|Purinergic Agents|purinergic agents|mesh-ancestor
24771340|NCT01826175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24771341|NCT01826175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771342|NCT01826175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771343|NCT01826253|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24771344|NCT01826253|Plasma Substitutes|plasma substitutes|mesh-ancestor
24771345|NCT01826253|Blood Substitutes|blood substitutes|mesh-ancestor
24771346|NCT01826279|Resveratrol|resveratrol|mesh-list
24771347|NCT01826279|Antioxidants|antioxidants|mesh-ancestor
24771348|NCT01826279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771349|NCT01826279|Protective Agents|protective agents|mesh-ancestor
24771377|NCT01826916|Ecallantide|ecallantide|mesh-list
24771388|NCT01827007|Blood Substitutes|blood substitutes|mesh-ancestor
24771418|NCT01827124|Oxytocics|oxytocics|mesh-ancestor
24771419|NCT01827124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24771420|NCT01827124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771421|NCT01827137|Lenalidomide|lenalidomide|mesh-list
24771422|NCT01827137|Molgramostim|molgramostim|mesh-list
24771423|NCT01827137|Sargramostim|sargramostim|mesh-list
24771424|NCT01827137|Immunologic Factors|immunologic factors|mesh-ancestor
24447890|NCT00309816|Urological Agents|urological agents|mesh-ancestor
24447895|NCT00309855|Hormones|hormones|mesh-ancestor
24533954|NCT00645515|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24533955|NCT00645515|Dopamine Agents|dopamine agents|mesh-ancestor
24771425|NCT01827137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771426|NCT01827137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24771427|NCT01827137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24771428|NCT01827137|Growth Substances|growth substances|mesh-ancestor
24771429|NCT01827137|Growth Inhibitors|growth inhibitors|mesh-ancestor
24562556|NCT00766909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24562557|NCT00766909|Immunologic Factors|immunologic factors|mesh-ancestor
24562558|NCT00766909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562559|NCT00766909|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24562560|NCT00766909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562561|NCT00766909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771466|NCT01827293|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24771467|NCT01827293|Histamine Antagonists|histamine antagonists|mesh-ancestor
24771468|NCT01827293|Histamine Agents|histamine agents|mesh-ancestor
24771469|NCT01827293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24771470|NCT01827293|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24771471|NCT01827293|Anesthetics, Local|anesthetics, local|mesh-ancestor
24771472|NCT01827293|Anesthetics|anesthetics|mesh-ancestor
24771473|NCT01827293|Sensory System Agents|sensory system agents|mesh-ancestor
24771474|NCT01827345|Vitamin D|vitamin d|mesh-list
24771475|NCT01827345|Vitamins|vitamins|mesh-ancestor
24771476|NCT01827345|Micronutrients|micronutrients|mesh-ancestor
24771477|NCT01827345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771478|NCT01827345|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24771479|NCT01827397|Vaccines|vaccines|mesh-list
24771480|NCT01827397|Immunologic Factors|immunologic factors|mesh-ancestor
24771481|NCT01827397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771482|NCT01827540|Dolutegravir|dolutegravir|mesh-list
24771487|NCT01827540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24771488|NCT01827540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771489|NCT01827540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24771490|NCT01827540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24771491|NCT01827540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24771492|NCT01827540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24771493|NCT01827540|Anesthetics, General|anesthetics, general|mesh-ancestor
24771494|NCT01827540|Anesthetics|anesthetics|mesh-ancestor
24771495|NCT01827540|GABA Modulators|gaba modulators|mesh-ancestor
24771496|NCT01827540|GABA Agents|gaba agents|mesh-ancestor
24483267|NCT00442585|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24483268|NCT00442585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24483269|NCT00442585|Analgesics|analgesics|mesh-ancestor
24483270|NCT00442585|Sensory System Agents|sensory system agents|mesh-ancestor
24483271|NCT00442585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24483272|NCT00442585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483273|NCT00442585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24483278|NCT00442637|Bevacizumab|bevacizumab|mesh-list
24771497|NCT01827540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24771498|NCT01827540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771499|NCT01827540|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24771500|NCT01827540|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24771501|NCT01827540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25701324|NCT02137837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701325|NCT02138006|Insulin|insulin|mesh-list
25701326|NCT02138006|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25701327|NCT02138006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25701328|NCT02138006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701329|NCT02138136|Lubiprostone|lubiprostone|mesh-list
25701330|NCT02138136|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24771503|NCT01827540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24771504|NCT01827540|Antiviral Agents|antiviral agents|mesh-ancestor
24771505|NCT01827540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24771506|NCT01827540|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24771507|NCT01827618|Sirolimus|sirolimus|mesh-list
24771508|NCT01827618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24771509|NCT01827618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24771510|NCT01827618|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24771511|NCT01827618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771512|NCT01827618|Antifungal Agents|antifungal agents|mesh-ancestor
24771513|NCT01827618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24771514|NCT01827618|Immunologic Factors|immunologic factors|mesh-ancestor
24967015|NCT03763396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24967016|NCT03763396|Hormone Antagonists|hormone antagonists|mesh-ancestor
24967017|NCT03763396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24967018|NCT03763396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967019|NCT03763396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24967020|NCT03763396|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24967021|NCT03763396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24967022|NCT03763396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25080924|NCT03334877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080925|NCT03334838|Nifurtimox|nifurtimox|mesh-list
25080926|NCT03334838|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25080927|NCT03334838|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25080928|NCT03334838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25080929|NCT03334838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25080961|NCT03334487|Autonomic Agents|autonomic agents|mesh-ancestor
25080962|NCT03334487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25080963|NCT03334487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080965|NCT03334487|Glucocorticoids|glucocorticoids|mesh-ancestor
25080966|NCT03334487|Hormones|hormones|mesh-ancestor
25080967|NCT03334487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25080968|NCT03334487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25080969|NCT03334487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771524|NCT01827722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771528|NCT01827722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24771529|NCT01827722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24771530|NCT01827722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771531|NCT01827722|Protease Inhibitors|protease inhibitors|mesh-ancestor
24771532|NCT01827722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984800|NCT04040959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24771533|NCT01827722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771534|NCT01827722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24771535|NCT01827722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24771536|NCT01827722|Growth Substances|growth substances|mesh-ancestor
24771537|NCT01827722|Growth Inhibitors|growth inhibitors|mesh-ancestor
24771538|NCT01827735|Aldesleukin|aldesleukin|mesh-list
24771563|NCT01827878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771564|NCT01827878|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24771565|NCT01827878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24771566|NCT01827878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771567|NCT01827878|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24771568|NCT01827878|Protease Inhibitors|protease inhibitors|mesh-ancestor
24771569|NCT01827878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771570|NCT01827878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24771614|NCT01828385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24403964|NCT00162227|Antiviral Agents|antiviral agents|mesh-ancestor
24771615|NCT01828385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701331|NCT02138136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25701332|NCT02138136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701333|NCT02138747|Mirabegron|mirabegron|mesh-list
25701334|NCT02138747|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25701335|NCT02138747|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25701336|NCT02138747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25701337|NCT02138747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25701338|NCT02138747|Adrenergic Agents|adrenergic agents|mesh-ancestor
24771616|NCT01828385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24771617|NCT01828385|Tocolytic Agents|tocolytic agents|mesh-ancestor
24771618|NCT01828385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24771619|NCT01828437|Pyridoxine|pyridoxine|mesh-list
24771620|NCT01828437|Prednisolone|prednisolone|mesh-list
24771621|NCT01828437|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24771622|NCT01828437|Methylprednisolone|methylprednisolone|mesh-list
24771623|NCT01828437|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24771624|NCT01828437|Prednisolone acetate|prednisolone acetate|mesh-list
24771625|NCT01828437|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24771626|NCT01828437|Prednisolone phosphate|prednisolone phosphate|mesh-list
24771627|NCT01828437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24771628|NCT01828437|Glucocorticoids|glucocorticoids|mesh-ancestor
24771629|NCT01828437|Hormones|hormones|mesh-ancestor
24771630|NCT01828437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24771631|NCT01828437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771632|NCT01828437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24771633|NCT01828437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771634|NCT01828437|Antiemetics|antiemetics|mesh-ancestor
24771635|NCT01828437|Autonomic Agents|autonomic agents|mesh-ancestor
24771636|NCT01828437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24771637|NCT01828437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24771639|NCT01828437|Protective Agents|protective agents|mesh-ancestor
24771655|NCT01828489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771656|NCT01828606|Monensin|monensin|mesh-list
24771657|NCT01828606|Antifungal Agents|antifungal agents|mesh-ancestor
24771658|NCT01828606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24771659|NCT01828606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24771660|NCT01828606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24771661|NCT01828606|Coccidiostats|coccidiostats|mesh-ancestor
24771662|NCT01828606|Proton Ionophores|proton ionophores|mesh-ancestor
24771745|NCT01829451|Protective Agents|protective agents|mesh-ancestor
24771746|NCT01829529|Amoxicillin|amoxicillin|mesh-list
24771760|NCT01829685|Antiviral Agents|antiviral agents|mesh-ancestor
24771761|NCT01829685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24771762|NCT01829685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24771763|NCT01829685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24771764|NCT01829685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771765|NCT01829685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771766|NCT01829698|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24771768|NCT01829698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24771770|NCT01829711|Protective Agents|protective agents|mesh-list
24771771|NCT01829711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771772|NCT01829711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771773|NCT01829802|Ritonavir|ritonavir|mesh-list
24771774|NCT01829802|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24771775|NCT01829802|Raltegravir Potassium|raltegravir potassium|mesh-list
25080970|NCT03334136|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
24621348|NCT01061814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24771776|NCT01829802|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24771777|NCT01829802|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24771778|NCT01829802|Protease Inhibitors|protease inhibitors|mesh-ancestor
24771779|NCT01829802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771780|NCT01829802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771781|NCT01829802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24771782|NCT01829802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24771783|NCT01829802|Antiviral Agents|antiviral agents|mesh-ancestor
24771784|NCT01829802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24771785|NCT01829802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24771786|NCT01829802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24562951|NCT00769145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562952|NCT00769145|Growth Inhibitors|growth inhibitors|mesh-ancestor
24562953|NCT00769145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562954|NCT00769158|Topiramate|topiramate|mesh-list
24562955|NCT00769158|Naltrexone|naltrexone|mesh-list
24562956|NCT00769158|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24562957|NCT00769158|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24562958|NCT00769158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562960|NCT00769158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24562961|NCT00769158|Anticonvulsants|anticonvulsants|mesh-ancestor
24562962|NCT00769158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24562963|NCT00769171|Moxifloxacin|moxifloxacin|mesh-list
24562964|NCT00769171|Metronidazole|metronidazole|mesh-list
24562965|NCT00769171|Ceftriaxone|ceftriaxone|mesh-list
24562966|NCT00769171|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24562974|NCT00769171|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24562975|NCT00769171|Contraceptive Agents|contraceptive agents|mesh-ancestor
24562976|NCT00769171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24562977|NCT00769171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771787|NCT01829802|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24771788|NCT01829802|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24771790|NCT01829841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771791|NCT01829841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24771792|NCT01829841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24562978|NCT00769171|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24562983|NCT00769210|Simvastatin|simvastatin|mesh-list
24771793|NCT01829841|Growth Substances|growth substances|mesh-ancestor
24771794|NCT01829841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771795|NCT01829841|Growth Inhibitors|growth inhibitors|mesh-ancestor
24771796|NCT01829841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24771797|NCT01829841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771798|NCT01829841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771799|NCT01829893|Tamsulosin|tamsulosin|mesh-list
24771800|NCT01829893|Finasteride|finasteride|mesh-list
24771801|NCT01829893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24771802|NCT01829893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24771803|NCT01829893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24771804|NCT01829893|Adrenergic Agents|adrenergic agents|mesh-ancestor
24793041|NCT04270175|Growth Inhibitors|growth inhibitors|mesh-ancestor
25080974|NCT03334136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080975|NCT03334136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25080976|NCT03333824|Midazolam|midazolam|mesh-list
25080977|NCT03333824|Granisetron|granisetron|mesh-list
25080978|NCT03333824|Caffeine|caffeine|mesh-list
25080979|NCT03333824|Omeprazole|omeprazole|mesh-list
25080980|NCT03333824|Adavosertib|adavosertib|mesh-list
25080981|NCT03333824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25080982|NCT03333824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25080983|NCT03333824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25080984|NCT03333824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25080985|NCT03333824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25080986|NCT03333824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25080987|NCT03333824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25080988|NCT03333824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25080989|NCT03333824|Anesthetics, General|anesthetics, general|mesh-ancestor
25080990|NCT03333824|Anesthetics|anesthetics|mesh-ancestor
25080991|NCT03333824|GABA Modulators|gaba modulators|mesh-ancestor
25080992|NCT03333824|GABA Agents|gaba agents|mesh-ancestor
25080993|NCT03333824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25080994|NCT03333824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25080995|NCT03333824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25080996|NCT03333824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25080997|NCT03333824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25080998|NCT03333824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25080999|NCT03333824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25081000|NCT03333824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25081001|NCT03333824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25081002|NCT03333824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25081003|NCT03333824|Purinergic Agents|purinergic agents|mesh-ancestor
25081004|NCT03333824|Antiemetics|antiemetics|mesh-ancestor
25081005|NCT03333824|Autonomic Agents|autonomic agents|mesh-ancestor
25081006|NCT03333824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25081007|NCT03333824|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24771818|NCT01830101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771842|NCT01830270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24771843|NCT01830270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24771844|NCT01830270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24771845|NCT01830270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771846|NCT01830296|Morphine|morphine|mesh-list
24771847|NCT01830296|Remifentanil|remifentanil|mesh-list
24771848|NCT01830296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24771849|NCT01830296|Narcotics|narcotics|mesh-ancestor
24771850|NCT01830296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24771851|NCT01830296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771852|NCT01830296|Analgesics|analgesics|mesh-ancestor
24771861|NCT01830322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24771862|NCT01830322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771863|NCT01830322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24771864|NCT01830322|Immunologic Factors|immunologic factors|mesh-ancestor
24771865|NCT01830322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771898|NCT01830465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24771899|NCT01830478|Rituximab|rituximab|mesh-list
24771900|NCT01830478|Lenalidomide|lenalidomide|mesh-list
24786534|NCT01920542|Analgesics|analgesics|mesh-ancestor
24771901|NCT01830478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24771902|NCT01830478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771904|NCT01830478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771905|NCT01830478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24771906|NCT01830478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24771907|NCT01830478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24771908|NCT01830478|Growth Substances|growth substances|mesh-ancestor
24771909|NCT01830478|Growth Inhibitors|growth inhibitors|mesh-ancestor
24771911|NCT01830491|Clopidogrel|clopidogrel|mesh-list
24771912|NCT01830491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24771913|NCT01830491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24771914|NCT01830491|Analgesics|analgesics|mesh-ancestor
24771915|NCT01830491|Sensory System Agents|sensory system agents|mesh-ancestor
24771916|NCT01830491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24771917|NCT01830491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771918|NCT01830491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24771924|NCT01830491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24771925|NCT01830491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24771926|NCT01830491|Antipyretics|antipyretics|mesh-ancestor
24771927|NCT01830491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24771928|NCT01830491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24444135|NCT00296777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444136|NCT00296777|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24444137|NCT00296777|Antidepressive Agents|antidepressive agents|mesh-ancestor
24444138|NCT00296777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24444139|NCT00296777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24534567|NCT00647634|Alprazolam|alprazolam|mesh-list
24444140|NCT00296777|Dopamine Agents|dopamine agents|mesh-ancestor
24444141|NCT00296777|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24444142|NCT00296777|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24444143|NCT00296777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444144|NCT00296777|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24444145|NCT00296777|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24444149|NCT00296790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24444150|NCT00296790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24444151|NCT00296790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444152|NCT00296790|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24444153|NCT00296790|GABA Agonists|gaba agonists|mesh-ancestor
24444154|NCT00296790|GABA Agents|gaba agents|mesh-ancestor
24771929|NCT01830491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24771930|NCT01830491|Purinergic Agents|purinergic agents|mesh-ancestor
24771931|NCT01830491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24771932|NCT01830517|Losartan|losartan|mesh-list
24771948|NCT01830530|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24771949|NCT01830530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771950|NCT01830530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24771951|NCT01830530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24771952|NCT01830530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24771953|NCT01830530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771956|NCT01830530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24771957|NCT01830556|Cetuximab|cetuximab|mesh-list
24771958|NCT01830556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24771959|NCT01830556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771960|NCT01830777|Cytarabine|cytarabine|mesh-list
24771961|NCT01830777|Etoposide|etoposide|mesh-list
24771962|NCT01830777|Mitoxantrone|mitoxantrone|mesh-list
24771963|NCT01830777|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24771964|NCT01830777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24771965|NCT01830777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24771966|NCT01830777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24771967|NCT01830777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24771969|NCT01830777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771970|NCT01830777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24771971|NCT01830777|Antimetabolites|antimetabolites|mesh-ancestor
24771972|NCT01830777|Antiviral Agents|antiviral agents|mesh-ancestor
24771973|NCT01830777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24771974|NCT01830777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24771975|NCT01830777|Immunologic Factors|immunologic factors|mesh-ancestor
24771976|NCT01830777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771977|NCT01830777|Analgesics|analgesics|mesh-ancestor
24772000|NCT01830868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772001|NCT01830868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24772002|NCT01830868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772004|NCT01830907|Micronutrients|micronutrients|mesh-ancestor
24772005|NCT01830907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772007|NCT01830946|Chelating Agents|chelating agents|mesh-ancestor
24772039|NCT01831193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24772040|NCT01831193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772041|NCT01831193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24772042|NCT01831193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24772043|NCT01831193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772044|NCT01831193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404341|NCT00163150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772051|NCT01831323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24772052|NCT01831323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24772053|NCT01831323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24772054|NCT01831323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24772056|NCT01831323|Sensory System Agents|sensory system agents|mesh-ancestor
24772057|NCT01831323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24772058|NCT01831323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772059|NCT01831323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24772060|NCT01831323|Cathartics|cathartics|mesh-ancestor
24772061|NCT01831440|Antidepressive Agents|antidepressive agents|mesh-list
24772062|NCT01831440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24772064|NCT01831479|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24772065|NCT01831479|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24772066|NCT01831479|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24772067|NCT01831479|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24483291|NCT00442676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24967088|NCT03762928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24483292|NCT00442676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24483293|NCT00442676|Analgesics|analgesics|mesh-ancestor
24483294|NCT00442676|Sensory System Agents|sensory system agents|mesh-ancestor
24483361|NCT00443170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24483362|NCT00443170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24483363|NCT00443170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24483364|NCT00443170|Anesthetics, General|anesthetics, general|mesh-ancestor
24483365|NCT00443170|Anesthetics|anesthetics|mesh-ancestor
24483366|NCT00443170|GABA Modulators|gaba modulators|mesh-ancestor
24483367|NCT00443170|GABA Agents|gaba agents|mesh-ancestor
24483368|NCT00443170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24483369|NCT00443170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772068|NCT01831479|Antimetabolites|antimetabolites|mesh-ancestor
24772069|NCT01831479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772070|NCT01831479|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24772071|NCT01831479|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24772072|NCT01831479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772073|NCT01831479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24772074|NCT01831479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24772075|NCT01831479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24772076|NCT01831505|Prednisolone|prednisolone|mesh-list
24772077|NCT01831505|Rituximab|rituximab|mesh-list
24772078|NCT01831505|Doxorubicin|doxorubicin|mesh-list
24772079|NCT01831505|Vincristine|vincristine|mesh-list
24772080|NCT01831505|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24404383|NCT00163319|Hormones|hormones|mesh-ancestor
24772084|NCT01831505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772085|NCT01831505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24772086|NCT01831505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24772087|NCT01831505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24772088|NCT01831505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24772089|NCT01831505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772090|NCT01831505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772091|NCT01831505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24772092|NCT01831505|Tubulin Modulators|tubulin modulators|mesh-ancestor
24772093|NCT01831505|Antimitotic Agents|antimitotic agents|mesh-ancestor
24772094|NCT01831505|Mitosis Modulators|mitosis modulators|mesh-ancestor
24772095|NCT01831505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24772096|NCT01831505|Glucocorticoids|glucocorticoids|mesh-ancestor
24772097|NCT01831505|Hormones|hormones|mesh-ancestor
24772098|NCT01831505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24772102|NCT01831622|Methylphenidate|methylphenidate|mesh-list
24483370|NCT00443170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24483371|NCT00443170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24483372|NCT00443170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24483373|NCT00443170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772106|NCT01831622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24772107|NCT01831622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24404406|NCT00163371|Glucocorticoids|glucocorticoids|mesh-ancestor
24620615|NCT01057849|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24620616|NCT01057849|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24967089|NCT03762928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24859029|NCT02301221|Vancomycin|vancomycin|mesh-list
24620622|NCT01057875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627280|NCT01091727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627281|NCT01091727|Cholinergic Agents|cholinergic agents|mesh-ancestor
24627282|NCT01091727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24627283|NCT01091727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627284|NCT01091727|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24627285|NCT01091727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24627286|NCT01091753|Amlodipine|amlodipine|mesh-list
24909618|NCT04306731|Trimethoprim|trimethoprim|mesh-list
24627287|NCT01091753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24627288|NCT01091753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24627289|NCT01091753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24627290|NCT01091753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627291|NCT01091753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24627292|NCT01091753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627294|NCT01091766|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24627295|NCT01091792|Bevacizumab|bevacizumab|mesh-list
24651865|NCT01234285|Anticoagulants|anticoagulants|mesh-ancestor
24483415|NCT00443235|Growth Inhibitors|growth inhibitors|mesh-ancestor
25081031|NCT03333525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25081032|NCT03333525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081033|NCT03333499|Trimetazidine|trimetazidine|mesh-list
25081034|NCT03333499|Vasodilator Agents|vasodilator agents|mesh-ancestor
25081035|NCT03333395|Heparin|heparin|mesh-list
25081036|NCT03333395|Albuterol|albuterol|mesh-list
25081037|NCT03333395|Anticoagulants|anticoagulants|mesh-ancestor
25081038|NCT03333395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25081039|NCT03333395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25081040|NCT03333395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081041|NCT03333395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25081042|NCT03333395|Autonomic Agents|autonomic agents|mesh-ancestor
25081043|NCT03333395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25407399|NCT03504410|Analgesics|analgesics|mesh-ancestor
24448001|NCT00310011|Mitosis Modulators|mitosis modulators|mesh-ancestor
25081044|NCT03333395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081045|NCT03333395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25081046|NCT03333395|Respiratory System Agents|respiratory system agents|mesh-ancestor
25081047|NCT03333395|Tocolytic Agents|tocolytic agents|mesh-ancestor
25081048|NCT03333395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25081049|NCT03333395|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25081050|NCT03333395|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25081051|NCT03333395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25081052|NCT03333395|Adrenergic Agents|adrenergic agents|mesh-ancestor
25081053|NCT03333395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25081054|NCT03333369|Levodopa|levodopa|mesh-list
25081055|NCT03333369|Benserazide|benserazide|mesh-list
25081056|NCT03333369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25081057|NCT03333369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25081058|NCT03333369|Dopamine Agents|dopamine agents|mesh-ancestor
25081059|NCT03333369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25081060|NCT03333369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081061|NCT03333369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081063|NCT03333278|Vitamins|vitamins|mesh-list
24620635|NCT01058057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620636|NCT01058057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24620642|NCT01058109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620654|NCT01058174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620656|NCT01058174|Hormone Antagonists|hormone antagonists|mesh-ancestor
24620657|NCT01058174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24620658|NCT01058174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620659|NCT01058174|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24620660|NCT01058174|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24620669|NCT01058252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24620670|NCT01058252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772109|NCT01831622|Dopamine Agents|dopamine agents|mesh-ancestor
24772110|NCT01831622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24772112|NCT01831661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24772113|NCT01831661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772121|NCT01831687|Sensory System Agents|sensory system agents|mesh-ancestor
24772122|NCT01831687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24772123|NCT01831687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772124|NCT01831687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24772125|NCT01831687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24772126|NCT01831687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24772127|NCT01831687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24772128|NCT01831687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772129|NCT01831687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772130|NCT01831700|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24772131|NCT01831700|Lisinopril|lisinopril|mesh-list
24772132|NCT01831700|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
24772133|NCT01831700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24772134|NCT01831700|Diuretics|diuretics|mesh-ancestor
24772135|NCT01831700|Natriuretic Agents|natriuretic agents|mesh-ancestor
24772136|NCT01831700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772137|NCT01831700|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24772146|NCT01831947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24772147|NCT01831947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24772155|NCT01832129|Vitamins|vitamins|mesh-list
24772157|NCT01832129|Vitamin B 12|vitamin b 12|mesh-list
24772158|NCT01832129|Vitamin B Complex|vitamin b complex|mesh-list
24772159|NCT01832129|Micronutrients|micronutrients|mesh-ancestor
24772160|NCT01832129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772161|NCT01832129|Hematinics|hematinics|mesh-ancestor
24772162|NCT01832285|Fluvoxamine|fluvoxamine|mesh-list
25701339|NCT02138747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25701340|NCT02138747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701341|NCT02138747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701342|NCT02138747|Urological Agents|urological agents|mesh-ancestor
25701343|NCT02138747|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25701344|NCT02138747|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24772163|NCT01832285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24772164|NCT01832285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24772165|NCT01832285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24772166|NCT01832285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772167|NCT01832285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24772168|NCT01832285|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24563359|NCT00771342|Nitric Oxide|nitric oxide|mesh-list
24772181|NCT01832311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24772182|NCT01832311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24772184|NCT01832311|Sensory System Agents|sensory system agents|mesh-ancestor
24772185|NCT01832311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24772186|NCT01832311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772187|NCT01832311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24772188|NCT01832311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24772189|NCT01832311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24772190|NCT01832311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772191|NCT01832311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772192|NCT01832350|Quinidine|quinidine|mesh-list
24772193|NCT01832350|Dextromethorphan|dextromethorphan|mesh-list
24772194|NCT01832350|Antitussive Agents|antitussive agents|mesh-ancestor
24772195|NCT01832350|Respiratory System Agents|respiratory system agents|mesh-ancestor
24624542|NCT01076621|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24772196|NCT01832350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24772197|NCT01832350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24772198|NCT01832350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24772199|NCT01832350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772200|NCT01832350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772201|NCT01832350|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24772202|NCT01832350|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24772203|NCT01832350|Adrenergic Agents|adrenergic agents|mesh-ancestor
24772220|NCT01832363|Anesthetics, General|anesthetics, general|mesh-ancestor
24772221|NCT01832363|Anesthetics|anesthetics|mesh-ancestor
24772222|NCT01832363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24772223|NCT01832363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772225|NCT01832415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24772226|NCT01832415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772228|NCT01832415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24772229|NCT01832415|Growth Substances|growth substances|mesh-ancestor
24772230|NCT01832415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772231|NCT01832415|Growth Inhibitors|growth inhibitors|mesh-ancestor
24772233|NCT01832467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24772234|NCT01832467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772235|NCT01832558|Eplerenone|eplerenone|mesh-list
24772236|NCT01832558|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24772237|NCT01832558|Hormone Antagonists|hormone antagonists|mesh-ancestor
24772238|NCT01832558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24772239|NCT01832558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772240|NCT01832558|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24772241|NCT01832558|Diuretics|diuretics|mesh-ancestor
24772242|NCT01832558|Natriuretic Agents|natriuretic agents|mesh-ancestor
24772243|NCT01832558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24772244|NCT01832571|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24772245|NCT01832571|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24772246|NCT01832571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24772247|NCT01832571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772248|NCT01832571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772249|NCT01832571|Antiviral Agents|antiviral agents|mesh-ancestor
24772250|NCT01832571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24563454|NCT00771641|Cobalt|cobalt|mesh-list
24772258|NCT01832662|Caffeine|caffeine|mesh-list
24772259|NCT01832662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24772260|NCT01832662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772261|NCT01832662|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24772263|NCT01832662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772264|NCT01832662|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24772265|NCT01832662|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24772267|NCT01832662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24772268|NCT01832675|Bupivacaine|bupivacaine|mesh-list
24772269|NCT01832675|Anesthetics, Local|anesthetics, local|mesh-ancestor
24772270|NCT01832675|Anesthetics|anesthetics|mesh-ancestor
24772271|NCT01832675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24772272|NCT01832675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772273|NCT01832675|Sensory System Agents|sensory system agents|mesh-ancestor
24772274|NCT01832675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24772275|NCT01832870|Ipilimumab|ipilimumab|mesh-list
24772276|NCT01832870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24772277|NCT01832870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772278|NCT01832870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24772279|NCT01832870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772280|NCT01832896|Ecallantide|ecallantide|mesh-list
24772281|NCT01832896|Analgesics|analgesics|mesh-ancestor
24772282|NCT01832896|Sensory System Agents|sensory system agents|mesh-ancestor
24772283|NCT01832896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24772284|NCT01832896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772285|NCT01832896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24772287|NCT01832896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24772288|NCT01832896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24772289|NCT01832922|Rituximab|rituximab|mesh-list
25081064|NCT03333278|Ascorbic Acid|ascorbic acid|mesh-list
25081065|NCT03333278|Thiamine|thiamine|mesh-list
24579327|NCT00854503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24772290|NCT01832922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24772291|NCT01832922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24772292|NCT01832922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772293|NCT01832922|Immunologic Factors|immunologic factors|mesh-ancestor
24772296|NCT01832922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24772297|NCT01832922|Alkylating Agents|alkylating agents|mesh-ancestor
24772391|NCT01833559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24772298|NCT01832922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772299|NCT01832935|Insulin|insulin|mesh-list
24772300|NCT01832935|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24772301|NCT01832935|Insulin Glargine|insulin glargine|mesh-list
24772302|NCT01832935|Isophane Insulin, Human|isophane insulin, human|mesh-list
24772303|NCT01832935|Insulin, Isophane|insulin, isophane|mesh-list
24772304|NCT01832935|Isophane insulin, beef|isophane insulin, beef|mesh-list
24772306|NCT01832935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772307|NCT01832948|Leucovorin|leucovorin|mesh-list
24772308|NCT01832948|Folic Acid|folic acid|mesh-list
24772309|NCT01832948|Oxaliplatin|oxaliplatin|mesh-list
24772310|NCT01832948|Endostar protein|endostar protein|mesh-list
24772311|NCT01832948|Levoleucovorin|levoleucovorin|mesh-list
24772312|NCT01832948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772313|NCT01832948|Antidotes|antidotes|mesh-ancestor
24772314|NCT01832948|Protective Agents|protective agents|mesh-ancestor
24772315|NCT01832948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772316|NCT01832948|Vitamin B Complex|vitamin b complex|mesh-ancestor
24772317|NCT01832948|Vitamins|vitamins|mesh-ancestor
24772328|NCT01832987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24772330|NCT01832987|Antimalarials|antimalarials|mesh-ancestor
24772337|NCT01832987|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24772338|NCT01832987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24772339|NCT01832987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24772340|NCT01833221|Lidocaine|lidocaine|mesh-list
24772341|NCT01833221|Anesthetics, Local|anesthetics, local|mesh-ancestor
24772342|NCT01833221|Anesthetics|anesthetics|mesh-ancestor
24772343|NCT01833221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24772344|NCT01833221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772345|NCT01833221|Sensory System Agents|sensory system agents|mesh-ancestor
24772346|NCT01833221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24772347|NCT01833221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24772348|NCT01833221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24772349|NCT01833221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24772350|NCT01833221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25701345|NCT02138747|Cholinergic Agents|cholinergic agents|mesh-ancestor
24772351|NCT01833221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772353|NCT01833299|Chlorotrianisene|chlorotrianisene|mesh-list
24772354|NCT01833299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772355|NCT01833299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24772356|NCT01833299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772357|NCT01833299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772358|NCT01833299|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24772361|NCT01833299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25081066|NCT03333278|Hydrocortisone|hydrocortisone|mesh-list
24967101|NCT03762928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24967102|NCT03762928|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24909885|NCT04304313|Sildenafil Citrate|sildenafil citrate|mesh-list
24483470|NCT00443690|Diuretics|diuretics|mesh-ancestor
24483471|NCT00443690|Natriuretic Agents|natriuretic agents|mesh-ancestor
24483472|NCT00443690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483473|NCT00443716|Estrogens|estrogens|mesh-list
24483474|NCT00443716|Hormones|hormones|mesh-ancestor
24967104|NCT03762928|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24967105|NCT03762928|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24967106|NCT03762928|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24967107|NCT03762928|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24967108|NCT03762889|Anesthetics|anesthetics|mesh-list
24967109|NCT03762889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24967110|NCT03762889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967111|NCT03762824|Vaccines|vaccines|mesh-list
24967112|NCT03762824|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24967113|NCT03762824|Immunologic Factors|immunologic factors|mesh-ancestor
24967114|NCT03762824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967115|NCT03762785|Dexmedetomidine|dexmedetomidine|mesh-list
24967116|NCT03762785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24967117|NCT03762785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24967118|NCT03762785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081088|NCT03333018|Formoterol Fumarate|formoterol fumarate|mesh-list
25081089|NCT03333018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25081090|NCT03333018|Autonomic Agents|autonomic agents|mesh-ancestor
25081091|NCT03333018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24772387|NCT01833351|Protective Agents|protective agents|mesh-ancestor
24772388|NCT01833559|Insulin|insulin|mesh-list
24772389|NCT01833559|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24772390|NCT01833559|Isophane Insulin, Human|isophane insulin, human|mesh-list
24772396|NCT01833572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772397|NCT01833572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563572|NCT00772499|Atenolol|atenolol|mesh-list
24772399|NCT01833611|Antiviral Agents|antiviral agents|mesh-ancestor
24772400|NCT01833611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24772401|NCT01833663|Solifenacin Succinate|solifenacin succinate|mesh-list
24772402|NCT01833663|Estrogens|estrogens|mesh-list
24772403|NCT01833663|Hormones|hormones|mesh-ancestor
24772404|NCT01833663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24772426|NCT01833715|Analgesics|analgesics|mesh-ancestor
24772427|NCT01833715|Sensory System Agents|sensory system agents|mesh-ancestor
24483807|NCT00445081|Cyclosporins|cyclosporins|mesh-list
24483808|NCT00445081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24483809|NCT00445081|Glucocorticoids|glucocorticoids|mesh-ancestor
24483810|NCT00445081|Hormones|hormones|mesh-ancestor
24483833|NCT00445094|Protease Inhibitors|protease inhibitors|mesh-ancestor
24483834|NCT00445094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483835|NCT00445094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24483836|NCT00445159|Treprostinil|treprostinil|mesh-list
24483837|NCT00445159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24483838|NCT00445185|Vaccines|vaccines|mesh-list
24483839|NCT00445185|Immunologic Factors|immunologic factors|mesh-ancestor
24772428|NCT01833715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24772430|NCT01833715|Respiratory System Agents|respiratory system agents|mesh-ancestor
24772431|NCT01833728|Acetaminophen|acetaminophen|mesh-list
24772432|NCT01833728|Propacetamol|propacetamol|mesh-list
24772433|NCT01833728|Nefopam|nefopam|mesh-list
24772434|NCT01833728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24772436|NCT01833728|Sensory System Agents|sensory system agents|mesh-ancestor
24772437|NCT01833728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24772438|NCT01833728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772439|NCT01833728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24772440|NCT01833728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24772441|NCT01833728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24772442|NCT01833728|Antipyretics|antipyretics|mesh-ancestor
24772443|NCT01833767|Cyclophosphamide|cyclophosphamide|mesh-list
24772445|NCT01833767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24772446|NCT01833767|Immunologic Factors|immunologic factors|mesh-ancestor
24772447|NCT01833767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772448|NCT01833767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24772449|NCT01833767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24772450|NCT01833767|Alkylating Agents|alkylating agents|mesh-ancestor
24772451|NCT01833767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772452|NCT01833767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772453|NCT01833767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24772454|NCT01833767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24772455|NCT01833767|Analgesics|analgesics|mesh-ancestor
24772456|NCT01833767|Sensory System Agents|sensory system agents|mesh-ancestor
24772457|NCT01833767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24772458|NCT01833793|Levonorgestrel|levonorgestrel|mesh-list
24772459|NCT01833793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24772460|NCT01833793|Contraceptive Agents|contraceptive agents|mesh-ancestor
24910021|NCT04302805|Thymoglobulin|thymoglobulin|mesh-list
24483840|NCT00445185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483949|NCT00446004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24483950|NCT00446004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24483951|NCT00446004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483952|NCT00446004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483953|NCT00446004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24483954|NCT00446004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24483955|NCT00446017|Milrinone|milrinone|mesh-list
24483956|NCT00446017|Epinephrine|epinephrine|mesh-list
24772461|NCT01833793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24772462|NCT01833793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772463|NCT01833793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24772464|NCT01833793|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24772506|NCT01834014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24772507|NCT01834014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24772508|NCT01834014|Immunologic Factors|immunologic factors|mesh-ancestor
24563707|NCT00773058|Hydrocortisone|hydrocortisone|mesh-list
24563708|NCT00773058|Glucocorticoids|glucocorticoids|mesh-list
24563709|NCT00773058|Hormones|hormones|mesh-ancestor
24563710|NCT00773058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24563711|NCT00773058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563712|NCT00773058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24563713|NCT00773084|Lisinopril|lisinopril|mesh-list
24563714|NCT00773084|Spironolactone|spironolactone|mesh-list
24563716|NCT00773084|Hormone Antagonists|hormone antagonists|mesh-ancestor
24772509|NCT01834170|Gemcitabine|gemcitabine|mesh-list
24772510|NCT01834170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24772511|NCT01834170|Antimetabolites|antimetabolites|mesh-ancestor
24772512|NCT01834170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772513|NCT01834170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772514|NCT01834170|Antiviral Agents|antiviral agents|mesh-ancestor
24483957|NCT00446017|Racepinephrine|racepinephrine|mesh-list
24483958|NCT00446017|Epinephryl borate|epinephryl borate|mesh-list
24483959|NCT00446017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24483960|NCT00446017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24772544|NCT01834209|Hormone Antagonists|hormone antagonists|mesh-ancestor
24772545|NCT01834209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24772546|NCT01834235|Gemcitabine|gemcitabine|mesh-list
24772548|NCT01834235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24772549|NCT01834235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772550|NCT01834235|Tubulin Modulators|tubulin modulators|mesh-ancestor
24772551|NCT01834235|Antimitotic Agents|antimitotic agents|mesh-ancestor
24772552|NCT01834235|Mitosis Modulators|mitosis modulators|mesh-ancestor
24772583|NCT01834508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24772585|NCT01834508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772586|NCT01834547|Methylphenidate|methylphenidate|mesh-list
24772587|NCT01834547|Caffeine|caffeine|mesh-list
24772588|NCT01834547|Modafinil|modafinil|mesh-list
24910090|NCT04302116|Vigabatrin|vigabatrin|mesh-list
24772591|NCT01834547|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25701346|NCT02138825|Riociguat|riociguat|mesh-list
25701347|NCT02138825|Enzyme Activators|enzyme activators|mesh-ancestor
25701348|NCT02138825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701349|NCT02138838|Cinacalcet|cinacalcet|mesh-list
25701350|NCT02138838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24772592|NCT01834547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24772593|NCT01834547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24772594|NCT01834547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772596|NCT01834547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24772597|NCT01834547|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24772598|NCT01834547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772599|NCT01834547|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24772600|NCT01834547|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24772602|NCT01834547|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24772603|NCT01834547|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24772604|NCT01834547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24772605|NCT01834768|Eplerenone|eplerenone|mesh-list
24772606|NCT01834768|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24772607|NCT01834768|Hormone Antagonists|hormone antagonists|mesh-ancestor
24772608|NCT01834768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24772609|NCT01834768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772610|NCT01834768|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24772611|NCT01834768|Diuretics|diuretics|mesh-ancestor
24772613|NCT01834768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24772615|NCT01834820|Epinephrine|epinephrine|mesh-list
24772616|NCT01834820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24772617|NCT01834820|Antiemetics|antiemetics|mesh-ancestor
24772618|NCT01834820|Autonomic Agents|autonomic agents|mesh-ancestor
24772619|NCT01834820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24772620|NCT01834820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484009|NCT00446173|Immunologic Factors|immunologic factors|mesh-ancestor
24772621|NCT01834820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24772622|NCT01834820|Glucocorticoids|glucocorticoids|mesh-ancestor
24772623|NCT01834820|Hormones|hormones|mesh-ancestor
24772624|NCT01834820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24772625|NCT01834820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24772626|NCT01834820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772627|NCT01834820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24772628|NCT01834820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24772629|NCT01834820|Adrenergic Agents|adrenergic agents|mesh-ancestor
24772630|NCT01834820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24772631|NCT01834820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772632|NCT01834820|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24772633|NCT01834820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24772634|NCT01834820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24772635|NCT01834820|Respiratory System Agents|respiratory system agents|mesh-ancestor
24772637|NCT01834820|Sympathomimetics|sympathomimetics|mesh-ancestor
24772638|NCT01834820|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24772639|NCT01834885|Fluticasone|fluticasone|mesh-list
24772640|NCT01834885|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24772641|NCT01834885|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24772642|NCT01834885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24772643|NCT01834885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24772644|NCT01834885|Autonomic Agents|autonomic agents|mesh-ancestor
24772645|NCT01834885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24772646|NCT01834885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772647|NCT01834885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24772648|NCT01834885|Respiratory System Agents|respiratory system agents|mesh-ancestor
24772649|NCT01834885|Dermatologic Agents|dermatologic agents|mesh-ancestor
24772650|NCT01834885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24772652|NCT01834885|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24772653|NCT01834885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24772654|NCT01834885|Adrenergic Agents|adrenergic agents|mesh-ancestor
24772655|NCT01834885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24563846|NCT00774007|Mesalamine|mesalamine|mesh-list
24772656|NCT01834885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772657|NCT01834885|Glucocorticoids|glucocorticoids|mesh-ancestor
24772658|NCT01834885|Hormones|hormones|mesh-ancestor
24772659|NCT01834885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24772660|NCT01834885|Sympathomimetics|sympathomimetics|mesh-ancestor
24772661|NCT01834898|Oxycodone|oxycodone|mesh-list
24772666|NCT01834898|Analgesics|analgesics|mesh-ancestor
24772667|NCT01834898|Sensory System Agents|sensory system agents|mesh-ancestor
24772668|NCT01834898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24772669|NCT01834911|Tetrabenazine|tetrabenazine|mesh-list
24772670|NCT01834911|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24772671|NCT01834911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24772672|NCT01834911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24535591|NCT00649415|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24772673|NCT01834911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772675|NCT01834911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24772676|NCT01834911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772677|NCT01834963|Interferons|interferons|mesh-list
24772678|NCT01834963|Interferon-alpha|interferon-alpha|mesh-list
24772679|NCT01834963|Cisplatin|cisplatin|mesh-list
24772680|NCT01834963|Fluorouracil|fluorouracil|mesh-list
24772681|NCT01834963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772682|NCT01834963|Antimetabolites|antimetabolites|mesh-ancestor
24772683|NCT01834963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772684|NCT01834963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24772685|NCT01834963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24772686|NCT01834963|Immunologic Factors|immunologic factors|mesh-ancestor
24772687|NCT01834963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772688|NCT01834963|Antiviral Agents|antiviral agents|mesh-ancestor
24772689|NCT01834963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24772690|NCT01834989|Mitogens|mitogens|mesh-list
24772693|NCT01835067|Ranibizumab|ranibizumab|mesh-list
24772697|NCT01835067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24772698|NCT01835067|Growth Substances|growth substances|mesh-ancestor
24772699|NCT01835067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772700|NCT01835067|Growth Inhibitors|growth inhibitors|mesh-ancestor
24772701|NCT01835067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772702|NCT01835067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24772703|NCT01835067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24483996|NCT00446069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25081093|NCT03333018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24967123|NCT03762785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24967124|NCT03762785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24967125|NCT03762785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24967126|NCT03762785|Adrenergic Agents|adrenergic agents|mesh-ancestor
24967142|NCT03762538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24967143|NCT03762538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967144|NCT03762538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24967145|NCT03762538|Anesthetics, General|anesthetics, general|mesh-ancestor
24967148|NCT03762382|Levonorgestrel|levonorgestrel|mesh-list
24967149|NCT03762382|Antiviral Agents|antiviral agents|mesh-ancestor
24967150|NCT03762382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25081094|NCT03333018|Respiratory System Agents|respiratory system agents|mesh-ancestor
25081095|NCT03333018|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24772768|NCT01835665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24772769|NCT01835665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24772794|NCT01835938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772795|NCT01835938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24772796|NCT01835938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772797|NCT01835938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772799|NCT01836016|Xhance|xhance|mesh-list
24772800|NCT01836016|Albuterol|albuterol|mesh-list
24772801|NCT01836016|Formoterol Fumarate|formoterol fumarate|mesh-list
24772802|NCT01836016|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24772803|NCT01836016|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24772804|NCT01836016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24772805|NCT01836016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24772806|NCT01836016|Autonomic Agents|autonomic agents|mesh-ancestor
24772807|NCT01836016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24772808|NCT01836016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772809|NCT01836016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24772810|NCT01836016|Respiratory System Agents|respiratory system agents|mesh-ancestor
24772811|NCT01836016|Dermatologic Agents|dermatologic agents|mesh-ancestor
24772812|NCT01836016|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24772813|NCT01836016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24772814|NCT01836016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24772815|NCT01836016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24772816|NCT01836016|Adrenergic Agents|adrenergic agents|mesh-ancestor
24772818|NCT01836016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772820|NCT01836016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24772821|NCT01836016|Glucocorticoids|glucocorticoids|mesh-ancestor
24772822|NCT01836016|Hormones|hormones|mesh-ancestor
24772823|NCT01836016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24772824|NCT01836016|Sympathomimetics|sympathomimetics|mesh-ancestor
24772825|NCT01836094|Methylene Blue|methylene blue|mesh-list
24483993|NCT00446069|Morphine|morphine|mesh-list
24483994|NCT00446069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24483995|NCT00446069|Narcotics|narcotics|mesh-ancestor
24484010|NCT00446173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484011|NCT00446173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24484012|NCT00446173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24772828|NCT01836120|Docetaxel|docetaxel|mesh-list
24967169|NCT03762317|Sensory System Agents|sensory system agents|mesh-ancestor
24967170|NCT03762317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24967171|NCT03762317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967172|NCT03762317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24967173|NCT03762317|Sympatholytics|sympatholytics|mesh-ancestor
24967174|NCT03762317|Autonomic Agents|autonomic agents|mesh-ancestor
24967175|NCT03762317|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24967176|NCT03762317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24967177|NCT03762317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24967178|NCT03762317|Adrenergic Agents|adrenergic agents|mesh-ancestor
24967179|NCT03762317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24967180|NCT03762317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967182|NCT03762148|Ascorbic Acid|ascorbic acid|mesh-list
24967183|NCT03762148|Ferrous fumarate|ferrous fumarate|mesh-list
24967184|NCT03762148|Iron|iron|mesh-list
24967185|NCT03762148|Micronutrients|micronutrients|mesh-ancestor
24787565|NCT01925898|Midazolam|midazolam|mesh-list
24564097|NCT00775086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24564100|NCT00775086|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24620671|NCT01058252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620672|NCT01058252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24620688|NCT01058291|Emetics|emetics|mesh-ancestor
24620691|NCT01058291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24620692|NCT01058291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24620693|NCT01058291|Dopamine Agonists|dopamine agonists|mesh-ancestor
24620694|NCT01058291|Dopamine Agents|dopamine agents|mesh-ancestor
24620695|NCT01058291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24620696|NCT01058291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620697|NCT01058317|Propranolol|propranolol|mesh-list
24620698|NCT01058317|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24620699|NCT01058317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25081104|NCT03332953|Autonomic Agents|autonomic agents|mesh-ancestor
25081105|NCT03332953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25081106|NCT03332953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081107|NCT03332953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25081108|NCT03332953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25081109|NCT03332953|Cholinergic Agents|cholinergic agents|mesh-ancestor
25081110|NCT03332953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25081111|NCT03332953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081112|NCT03332940|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
25081113|NCT03332940|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25081114|NCT03332940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081115|NCT03332888|Rituximab|rituximab|mesh-list
25081116|NCT03332888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25081117|NCT03332888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24620713|NCT01058408|Everolimus|everolimus|mesh-list
24620714|NCT01058408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24620715|NCT01058408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24620716|NCT01058408|Immunologic Factors|immunologic factors|mesh-ancestor
24484013|NCT00446173|Alkylating Agents|alkylating agents|mesh-ancestor
24620717|NCT01058408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620718|NCT01058577|Somatostatin|somatostatin|mesh-list
24772867|NCT01836328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772868|NCT01836328|Analgesics|analgesics|mesh-ancestor
24772869|NCT01836328|Sensory System Agents|sensory system agents|mesh-ancestor
24772870|NCT01836328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24772871|NCT01836328|Antitussive Agents|antitussive agents|mesh-ancestor
24772872|NCT01836328|Respiratory System Agents|respiratory system agents|mesh-ancestor
24772891|NCT01836406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24772892|NCT01836406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24772893|NCT01836406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772894|NCT01836406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772895|NCT01836484|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24772896|NCT01836484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24772897|NCT01836484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772898|NCT01836536|Bevacizumab|bevacizumab|mesh-list
24773758|NCT01841775|Antimetabolites|antimetabolites|mesh-ancestor
24772899|NCT01836536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24772900|NCT01836536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24564597|NCT00776828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24772902|NCT01836536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24772903|NCT01836536|Growth Substances|growth substances|mesh-ancestor
24772904|NCT01836536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772905|NCT01836536|Growth Inhibitors|growth inhibitors|mesh-ancestor
24772906|NCT01836575|Carboplatin|carboplatin|mesh-list
24772907|NCT01836575|Pemetrexed|pemetrexed|mesh-list
24772908|NCT01836575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772909|NCT01836575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24772910|NCT01836575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772911|NCT01836575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24772912|NCT01836575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24772913|NCT01836614|Lidocaine|lidocaine|mesh-list
24772914|NCT01836614|Anesthetics, Local|anesthetics, local|mesh-ancestor
24772915|NCT01836614|Anesthetics|anesthetics|mesh-ancestor
24772916|NCT01836614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24772917|NCT01836614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772918|NCT01836614|Sensory System Agents|sensory system agents|mesh-ancestor
24772923|NCT01836614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24772924|NCT01836614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772925|NCT01836653|Bevacizumab|bevacizumab|mesh-list
24772927|NCT01836653|Fluorouracil|fluorouracil|mesh-list
24772928|NCT01836653|Oxaliplatin|oxaliplatin|mesh-list
24484015|NCT00446173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484016|NCT00446173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24484017|NCT00446212|Propofol|propofol|mesh-list
24484018|NCT00446212|Desflurane|desflurane|mesh-list
24484019|NCT00446212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24484020|NCT00446212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24484021|NCT00446212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484022|NCT00446212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24484023|NCT00446212|Anesthetics, General|anesthetics, general|mesh-ancestor
24484024|NCT00446212|Anesthetics|anesthetics|mesh-ancestor
24484025|NCT00446212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24484064|NCT00446420|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24772936|NCT01836653|Antimetabolites|antimetabolites|mesh-ancestor
24772937|NCT01836653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24772938|NCT01836653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24787650|NCT01926236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772939|NCT01836653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24772940|NCT01836653|Immunologic Factors|immunologic factors|mesh-ancestor
24772941|NCT01836679|Paclitaxel|paclitaxel|mesh-list
24772942|NCT01836679|Carboplatin|carboplatin|mesh-list
24772943|NCT01836679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24772944|NCT01836679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772945|NCT01836679|Tubulin Modulators|tubulin modulators|mesh-ancestor
24772946|NCT01836679|Antimitotic Agents|antimitotic agents|mesh-ancestor
24772947|NCT01836679|Mitosis Modulators|mitosis modulators|mesh-ancestor
24772948|NCT01836679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701351|NCT02138838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772949|NCT01836757|Dimethyl sulfone|dimethyl sulfone|mesh-list
24772950|NCT01836757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24484066|NCT00446420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24484067|NCT00446420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24484068|NCT00446420|GABA Modulators|gaba modulators|mesh-ancestor
24484069|NCT00446420|GABA Agents|gaba agents|mesh-ancestor
24484070|NCT00446420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24772972|NCT01837043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772974|NCT01837108|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24772975|NCT01837108|Hormone Antagonists|hormone antagonists|mesh-ancestor
24772976|NCT01837108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24772977|NCT01837108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772978|NCT01837108|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24772979|NCT01837108|Diuretics|diuretics|mesh-ancestor
24772980|NCT01837108|Natriuretic Agents|natriuretic agents|mesh-ancestor
24772981|NCT01837108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24772982|NCT01837199|Amoxicillin|amoxicillin|mesh-list
24772983|NCT01837199|Metronidazole|metronidazole|mesh-list
24772984|NCT01837199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24772985|NCT01837199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24772986|NCT01837199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24772987|NCT01837199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24772988|NCT01837251|Bevacizumab|bevacizumab|mesh-list
24772989|NCT01837251|Carboplatin|carboplatin|mesh-list
24772990|NCT01837251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24772992|NCT01837251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24772993|NCT01837251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24772994|NCT01837251|Growth Substances|growth substances|mesh-ancestor
24772995|NCT01837251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24772996|NCT01837251|Growth Inhibitors|growth inhibitors|mesh-ancestor
24773045|NCT01837394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24773047|NCT01837394|Antiemetics|antiemetics|mesh-ancestor
24773048|NCT01837394|Autonomic Agents|autonomic agents|mesh-ancestor
24773049|NCT01837394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24773050|NCT01837394|Antipruritics|antipruritics|mesh-ancestor
24773051|NCT01837394|Dermatologic Agents|dermatologic agents|mesh-ancestor
24773052|NCT01837394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24773053|NCT01837394|Serotonin Agents|serotonin agents|mesh-ancestor
24773054|NCT01837394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24773055|NCT01837394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773056|NCT01837394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24773057|NCT01837394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24773058|NCT01837394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24773059|NCT01837394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24773060|NCT01837394|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24773076|NCT01837446|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
24773077|NCT01837446|Anesthetics, Local|anesthetics, local|mesh-ancestor
24484084|NCT00446472|Growth Substances|growth substances|mesh-ancestor
24484085|NCT00446472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484086|NCT00446524|Amlodipine|amlodipine|mesh-list
24484087|NCT00446524|Valsartan|valsartan|mesh-list
24484088|NCT00446524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24484089|NCT00446524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24484090|NCT00446524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24967186|NCT03762148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967187|NCT03762148|Antioxidants|antioxidants|mesh-ancestor
24967188|NCT03762148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967189|NCT03762148|Protective Agents|protective agents|mesh-ancestor
24967190|NCT03762148|Trace Elements|trace elements|mesh-ancestor
24967191|NCT03762096|Resveratrol|resveratrol|mesh-list
24967192|NCT03762096|Antioxidants|antioxidants|mesh-ancestor
24967193|NCT03762096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967194|NCT03762096|Protective Agents|protective agents|mesh-ancestor
24967198|NCT03761511|Niacinamide|niacinamide|mesh-list
25081119|NCT03332888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081120|NCT03332888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25081121|NCT03332732|Metronidazole|metronidazole|mesh-list
25081122|NCT03332732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25081123|NCT03332732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25081124|NCT03332732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25081125|NCT03332732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25081126|NCT03332719|Etanercept|etanercept|mesh-list
25081127|NCT03332719|Methotrexate|methotrexate|mesh-list
25081128|NCT03332719|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25081129|NCT03332719|Abortifacient Agents|abortifacient agents|mesh-ancestor
25081130|NCT03332719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25081131|NCT03332719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081132|NCT03332719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25081134|NCT03332719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081135|NCT03332719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081136|NCT03332719|Dermatologic Agents|dermatologic agents|mesh-ancestor
25081137|NCT03332719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25081138|NCT03332719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25081139|NCT03332719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25081153|NCT03332602|Retinol palmitate|retinol palmitate|mesh-list
25081155|NCT03332602|Hyaluronic Acid|hyaluronic acid|mesh-list
25081156|NCT03332602|Micronutrients|micronutrients|mesh-ancestor
25081157|NCT03332602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081158|NCT03332602|Hematinics|hematinics|mesh-ancestor
25081159|NCT03332602|Vitamin B Complex|vitamin b complex|mesh-ancestor
24910623|NCT04295993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25081160|NCT03332602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25081161|NCT03332602|Immunologic Factors|immunologic factors|mesh-ancestor
25081162|NCT03332602|Viscosupplements|viscosupplements|mesh-ancestor
25081163|NCT03332602|Protective Agents|protective agents|mesh-ancestor
25081164|NCT03332602|Antioxidants|antioxidants|mesh-ancestor
25081165|NCT03332602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081166|NCT03332602|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25081167|NCT03332602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081168|NCT03332602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25081169|NCT03332602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24773125|NCT01837628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773127|NCT01837628|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24773128|NCT01837628|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24773129|NCT01837628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24773130|NCT01837628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773131|NCT01837628|Emollients|emollients|mesh-ancestor
24773132|NCT01837628|Dermatologic Agents|dermatologic agents|mesh-ancestor
24773134|NCT01837667|LB100|lb100|mesh-list
24773135|NCT01837667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24773136|NCT01837667|Tubulin Modulators|tubulin modulators|mesh-ancestor
24773137|NCT01837667|Antimitotic Agents|antimitotic agents|mesh-ancestor
24773138|NCT01837667|Mitosis Modulators|mitosis modulators|mesh-ancestor
24773139|NCT01837667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773140|NCT01837667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773141|NCT01837810|Ibuprofen|ibuprofen|mesh-list
24565147|NCT00778973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773144|NCT01837810|Analgesics|analgesics|mesh-ancestor
24773145|NCT01837810|Sensory System Agents|sensory system agents|mesh-ancestor
24773146|NCT01837810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773147|NCT01837810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773148|NCT01837810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24773151|NCT01837810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773152|NCT01837810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773154|NCT01837927|Tiotropium Bromide|tiotropium bromide|mesh-list
24773155|NCT01837927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24773156|NCT01837927|Autonomic Agents|autonomic agents|mesh-ancestor
24773157|NCT01837927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773158|NCT01837927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773159|NCT01837927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24773171|NCT01837992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24773172|NCT01837992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24773173|NCT01838083|Insulin Glargine|insulin glargine|mesh-list
24773174|NCT01838083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24773175|NCT01838083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773176|NCT01838252|Hyaluronic Acid|hyaluronic acid|mesh-list
24773177|NCT01838252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24621491|NCT01062802|Atorvastatin|atorvastatin|mesh-list
24773178|NCT01838252|Immunologic Factors|immunologic factors|mesh-ancestor
24773179|NCT01838252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773180|NCT01838252|Viscosupplements|viscosupplements|mesh-ancestor
24773181|NCT01838252|Protective Agents|protective agents|mesh-ancestor
24773182|NCT01838330|Psyllium|psyllium|mesh-list
24773183|NCT01838330|Cathartics|cathartics|mesh-ancestor
24773184|NCT01838330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24773185|NCT01838395|Cytarabine|cytarabine|mesh-list
24773191|NCT01838395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24773192|NCT01838395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24773193|NCT01838395|Immunologic Factors|immunologic factors|mesh-ancestor
24773194|NCT01838395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773195|NCT01838434|Lenalidomide|lenalidomide|mesh-list
24773196|NCT01838434|Idelalisib|idelalisib|mesh-list
24773197|NCT01838434|Immunologic Factors|immunologic factors|mesh-ancestor
24773198|NCT01838434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773199|NCT01838434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24773200|NCT01838434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24773201|NCT01838434|Growth Substances|growth substances|mesh-ancestor
24773202|NCT01838434|Growth Inhibitors|growth inhibitors|mesh-ancestor
24773203|NCT01838434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24773204|NCT01838434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773205|NCT01838434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773206|NCT01838460|Lobeline|lobeline|mesh-list
24773207|NCT01838460|Nicotine|nicotine|mesh-list
24773208|NCT01838460|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24773209|NCT01838460|Autonomic Agents|autonomic agents|mesh-ancestor
24773210|NCT01838460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773211|NCT01838460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773215|NCT01838460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24773219|NCT01838473|Nicotine|nicotine|mesh-list
24773220|NCT01838473|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24773221|NCT01838473|Autonomic Agents|autonomic agents|mesh-ancestor
24773222|NCT01838473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773223|NCT01838473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773224|NCT01838473|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24773225|NCT01838473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24773226|NCT01838473|Cholinergic Agents|cholinergic agents|mesh-ancestor
24773227|NCT01838473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24773236|NCT01838538|Antimitotic Agents|antimitotic agents|mesh-ancestor
24773237|NCT01838538|Mitosis Modulators|mitosis modulators|mesh-ancestor
24536097|NCT00650351|Ciprofloxacin|ciprofloxacin|mesh-list
24773238|NCT01838538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773239|NCT01838538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24773240|NCT01838538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24773241|NCT01838538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24773242|NCT01838538|Growth Substances|growth substances|mesh-ancestor
24773243|NCT01838538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773244|NCT01838538|Growth Inhibitors|growth inhibitors|mesh-ancestor
24773246|NCT01838668|Dermatologic Agents|dermatologic agents|mesh-ancestor
24773247|NCT01838668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24773248|NCT01838668|Immunologic Factors|immunologic factors|mesh-ancestor
24773249|NCT01838668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773250|NCT01838707|Fentanyl|fentanyl|mesh-list
24773251|NCT01838707|Morphine|morphine|mesh-list
24773252|NCT01838707|Bupivacaine|bupivacaine|mesh-list
24773253|NCT01838707|Anesthetics, Local|anesthetics, local|mesh-ancestor
24773254|NCT01838707|Anesthetics|anesthetics|mesh-ancestor
25081185|NCT03332524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24773255|NCT01838707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24564442|NCT00776477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24564443|NCT00776477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24564444|NCT00776477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24564450|NCT00776477|Antipyretics|antipyretics|mesh-ancestor
24773256|NCT01838707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773262|NCT01838707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24773263|NCT01838707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24773264|NCT01838707|Anesthetics, General|anesthetics, general|mesh-ancestor
24773265|NCT01838772|Interferons|interferons|mesh-list
24773266|NCT01838772|Ribavirin|ribavirin|mesh-list
24773274|NCT01838850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24773275|NCT01838850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24773276|NCT01838850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773277|NCT01838902|Primaquine|primaquine|mesh-list
24773278|NCT01838902|Antimalarials|antimalarials|mesh-ancestor
24773279|NCT01838902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24773280|NCT01838902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24773281|NCT01838902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24773282|NCT01838928|Bupivacaine|bupivacaine|mesh-list
24773283|NCT01838928|Anesthetics, Local|anesthetics, local|mesh-ancestor
24773284|NCT01838928|Anesthetics|anesthetics|mesh-ancestor
24565296|NCT00779714|Antimitotic Agents|antimitotic agents|mesh-ancestor
24773287|NCT01838928|Sensory System Agents|sensory system agents|mesh-ancestor
24773288|NCT01838928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773289|NCT01838993|Lidocaine|lidocaine|mesh-list
24773290|NCT01838993|Anesthetics, Local|anesthetics, local|mesh-ancestor
24773291|NCT01838993|Anesthetics|anesthetics|mesh-ancestor
24773292|NCT01838993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24773293|NCT01838993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773294|NCT01838993|Sensory System Agents|sensory system agents|mesh-ancestor
24773295|NCT01838993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773296|NCT01838993|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24773297|NCT01838993|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24773298|NCT01838993|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24773299|NCT01838993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24773323|NCT01839097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24773324|NCT01839097|Alkylating Agents|alkylating agents|mesh-ancestor
24773325|NCT01839097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773326|NCT01839097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24773327|NCT01839097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24967255|NCT03760978|Dexmedetomidine|dexmedetomidine|mesh-list
24773328|NCT01839097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24773329|NCT01839097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24773330|NCT01839097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24773331|NCT01839097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773332|NCT01839097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24565038|NCT00778583|Nitrofurantoin|nitrofurantoin|mesh-list
24564594|NCT00776828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564596|NCT00776828|Respiratory System Agents|respiratory system agents|mesh-ancestor
24564598|NCT00776828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24564599|NCT00776828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564600|NCT00776828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24564601|NCT00776828|Vasodilator Agents|vasodilator agents|mesh-ancestor
24564602|NCT00776828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24564603|NCT00776828|Protective Agents|protective agents|mesh-ancestor
24564604|NCT00776828|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24564605|NCT00776828|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24564606|NCT00776828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564608|NCT00776841|Bile Acids and Salts|bile acids and salts|mesh-list
24564609|NCT00776841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24773344|NCT01839149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24773345|NCT01839149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773347|NCT01839175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24773348|NCT01839175|Immunologic Factors|immunologic factors|mesh-ancestor
24773349|NCT01839175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773350|NCT01839240|Cytarabine|cytarabine|mesh-list
24773351|NCT01839240|Azacitidine|azacitidine|mesh-list
24773352|NCT01839240|Mitoxantrone|mitoxantrone|mesh-list
24773353|NCT01839240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24773354|NCT01839240|Antimetabolites|antimetabolites|mesh-ancestor
24773355|NCT01839240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773356|NCT01839240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24773357|NCT01839240|Antiviral Agents|antiviral agents|mesh-ancestor
24773358|NCT01839240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24910792|NCT04294329|Anesthetics|anesthetics|mesh-ancestor
24484104|NCT00446537|Dopamine Agents|dopamine agents|mesh-ancestor
24484107|NCT00446576|Hematinics|hematinics|mesh-ancestor
24484129|NCT00446771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484130|NCT00446784|Methotrexate|methotrexate|mesh-list
24536202|NCT00650468|Tacrolimus|tacrolimus|mesh-list
24484131|NCT00446784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24484132|NCT00446784|Abortifacient Agents|abortifacient agents|mesh-ancestor
24773359|NCT01839240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24773360|NCT01839240|Immunologic Factors|immunologic factors|mesh-ancestor
24773361|NCT01839240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773362|NCT01839240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773363|NCT01839240|Analgesics|analgesics|mesh-ancestor
24773364|NCT01839240|Sensory System Agents|sensory system agents|mesh-ancestor
24773365|NCT01839240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773366|NCT01839240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24773367|NCT01839240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24773368|NCT01839253|Atenolol|atenolol|mesh-list
24773369|NCT01839253|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24773376|NCT01839253|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24773377|NCT01839253|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24773378|NCT01839253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24773379|NCT01839253|Adrenergic Agents|adrenergic agents|mesh-ancestor
24773380|NCT01839253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25701352|NCT02138838|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24773381|NCT01839253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773383|NCT01839253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773384|NCT01839344|Acarbose|acarbose|mesh-list
24773385|NCT01839344|Quercetin|quercetin|mesh-list
24773386|NCT01839344|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24773387|NCT01839344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773388|NCT01839344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773389|NCT01839344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24773390|NCT01839344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773391|NCT01839344|Antioxidants|antioxidants|mesh-ancestor
24773397|NCT01839357|Protease Inhibitors|protease inhibitors|mesh-ancestor
24773398|NCT01839357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773399|NCT01839357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773400|NCT01839357|Anticoagulants|anticoagulants|mesh-ancestor
24773401|NCT01839370|Pramlintide|pramlintide|mesh-list
24773402|NCT01839370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24773403|NCT01839370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773404|NCT01839383|Dialysis Solutions|dialysis solutions|mesh-list
24773405|NCT01839383|Calcium|calcium|mesh-list
24565448|NCT00780598|Tosedostat|tosedostat|mesh-list
24773406|NCT01839383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24565041|NCT00778583|Renal Agents|renal agents|mesh-ancestor
24773407|NCT01839383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773408|NCT01839383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24773566|NCT01840423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773410|NCT01839500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24773411|NCT01839500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24773412|NCT01839552|Fentanyl|fentanyl|mesh-list
24773413|NCT01839552|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24773423|NCT01839552|Anesthetics|anesthetics|mesh-ancestor
24773424|NCT01839578|Heparin|heparin|mesh-list
24773425|NCT01839578|Calcium heparin|calcium heparin|mesh-list
24773426|NCT01839578|Anticoagulants|anticoagulants|mesh-ancestor
24773427|NCT01839578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773428|NCT01839578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24773429|NCT01839578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24773430|NCT01839630|Sorafenib|sorafenib|mesh-list
24773431|NCT01839630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24773432|NCT01839630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24773435|NCT01839643|Meloxicam|meloxicam|mesh-list
24773436|NCT01839643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24773437|NCT01839643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24773438|NCT01839643|Analgesics|analgesics|mesh-ancestor
24773439|NCT01839643|Sensory System Agents|sensory system agents|mesh-ancestor
24773440|NCT01839643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773441|NCT01839643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773442|NCT01839643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24773443|NCT01839643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24773444|NCT01839643|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24773445|NCT01839643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24773446|NCT01839643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773447|NCT01839643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773448|NCT01839734|Lubiprostone|lubiprostone|mesh-list
24773449|NCT01839734|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24773450|NCT01839734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24967256|NCT03760978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24967257|NCT03760978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24967258|NCT03760978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967259|NCT03760978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24967260|NCT03760978|Analgesics|analgesics|mesh-ancestor
24967261|NCT03760978|Sensory System Agents|sensory system agents|mesh-ancestor
24967262|NCT03760978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24967263|NCT03760978|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24967264|NCT03760978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24967265|NCT03760978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24967266|NCT03760978|Adrenergic Agents|adrenergic agents|mesh-ancestor
24967267|NCT03760978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24967268|NCT03760978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967269|NCT03760848|Midazolam|midazolam|mesh-list
24967270|NCT03760848|Atorvastatin|atorvastatin|mesh-list
24967271|NCT03760848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24967272|NCT03760848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25701353|NCT02138838|Hormone Antagonists|hormone antagonists|mesh-ancestor
25701354|NCT02138838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25701355|NCT02138916|Benralizumab|benralizumab|mesh-list
25701356|NCT02138916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25701357|NCT02138916|Respiratory System Agents|respiratory system agents|mesh-ancestor
24967273|NCT03760848|Antimetabolites|antimetabolites|mesh-ancestor
24967274|NCT03760848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967275|NCT03760848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24967276|NCT03760848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24967277|NCT03760848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24967278|NCT03760848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24967279|NCT03760848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24788147|NCT01929668|Vitamins|vitamins|mesh-ancestor
24773451|NCT01839734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773452|NCT01839773|Paclitaxel|paclitaxel|mesh-list
24773453|NCT01839773|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24773454|NCT01839773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24773455|NCT01839773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24773456|NCT01839773|Tubulin Modulators|tubulin modulators|mesh-ancestor
24773457|NCT01839773|Antimitotic Agents|antimitotic agents|mesh-ancestor
24773458|NCT01839773|Mitosis Modulators|mitosis modulators|mesh-ancestor
24773459|NCT01839773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773460|NCT01839812|Cosyntropin|cosyntropin|mesh-list
24773461|NCT01839812|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24773462|NCT01839812|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
24773463|NCT01839812|beta-Endorphin|beta-endorphin|mesh-list
24773464|NCT01839812|Hormones|hormones|mesh-ancestor
24773465|NCT01839812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24773466|NCT01839812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773467|NCT01839812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24773684|NCT01841320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24773468|NCT01839812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773470|NCT01839851|Hormones|hormones|mesh-ancestor
24773471|NCT01839851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24773472|NCT01839851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081187|NCT03332524|Analgesics|analgesics|mesh-ancestor
25081188|NCT03332524|Sensory System Agents|sensory system agents|mesh-ancestor
25081189|NCT03332524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25081190|NCT03332524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081191|NCT03332524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25081192|NCT03332524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25081193|NCT03332524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24910859|NCT04292990|Analgesics|analgesics|mesh-ancestor
24484133|NCT00446784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25081194|NCT03332524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25081195|NCT03332524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081196|NCT03332524|Antipruritics|antipruritics|mesh-ancestor
25081197|NCT03332524|Dermatologic Agents|dermatologic agents|mesh-ancestor
25081198|NCT03332524|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25081199|NCT03332524|Histamine Antagonists|histamine antagonists|mesh-ancestor
25081200|NCT03332524|Histamine Agents|histamine agents|mesh-ancestor
25081201|NCT03332524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25081202|NCT03332524|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25081203|NCT03332329|Entecavir|entecavir|mesh-list
25081204|NCT03332329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25081205|NCT03332329|Molgramostim|molgramostim|mesh-list
25081206|NCT03332329|Vaccines|vaccines|mesh-list
25081207|NCT03332329|Sargramostim|sargramostim|mesh-list
25081208|NCT03332329|Immunologic Factors|immunologic factors|mesh-ancestor
25081209|NCT03332329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081210|NCT03332329|Antiviral Agents|antiviral agents|mesh-ancestor
25081211|NCT03332329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25081212|NCT03332329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24773482|NCT01839890|Paclitaxel|paclitaxel|mesh-list
24773488|NCT01839890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773495|NCT01839929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701358|NCT02139007|Alendronate|alendronate|mesh-list
25701359|NCT02139007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25701360|NCT02139007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701361|NCT02139046|Naproxen|naproxen|mesh-list
24564687|NCT00777517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24773497|NCT01839955|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24773498|NCT01839955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24773499|NCT01839955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24773500|NCT01839955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773501|NCT01839955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773502|NCT01839955|Anticestodal Agents|anticestodal agents|mesh-ancestor
24773503|NCT01839955|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24773504|NCT01839955|Anthelmintics|anthelmintics|mesh-ancestor
24773505|NCT01839955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24773506|NCT01839955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24773507|NCT01839955|Antimalarials|antimalarials|mesh-ancestor
24773508|NCT01839955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24773509|NCT01839955|Antinematodal Agents|antinematodal agents|mesh-ancestor
24773510|NCT01839968|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24773511|NCT01839968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24773512|NCT01839981|Thioctic Acid|thioctic acid|mesh-list
24773513|NCT01839981|Antioxidants|antioxidants|mesh-ancestor
24773514|NCT01839981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773515|NCT01839981|Protective Agents|protective agents|mesh-ancestor
24773516|NCT01839981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773517|NCT01839981|Vitamin B Complex|vitamin b complex|mesh-ancestor
24773518|NCT01839981|Vitamins|vitamins|mesh-ancestor
24773519|NCT01839981|Micronutrients|micronutrients|mesh-ancestor
24773520|NCT01839994|Androgens|androgens|mesh-list
24773521|NCT01839994|Hormones|hormones|mesh-ancestor
24773522|NCT01839994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24773523|NCT01839994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773538|NCT01840189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24773545|NCT01840254|Sensory System Agents|sensory system agents|mesh-ancestor
24773546|NCT01840254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773547|NCT01840254|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24773548|NCT01840254|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24773560|NCT01840423|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24773562|NCT01840423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24774094|NCT01843829|Antimitotic Agents|antimitotic agents|mesh-ancestor
24773567|NCT01840423|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24773568|NCT01840449|Lanreotide|lanreotide|mesh-list
24773569|NCT01840449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24773570|NCT01840683|Heparin|heparin|mesh-list
24564758|NCT00777738|Bortezomib|bortezomib|mesh-list
24773605|NCT01840813|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24773606|NCT01840813|Abortifacient Agents|abortifacient agents|mesh-ancestor
24773607|NCT01840813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24773608|NCT01840813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773609|NCT01840813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24773610|NCT01840813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24773611|NCT01840813|Oxytocics|oxytocics|mesh-ancestor
24773612|NCT01841008|Tacrolimus|tacrolimus|mesh-list
24773613|NCT01841008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24773614|NCT01841008|Immunologic Factors|immunologic factors|mesh-ancestor
24773615|NCT01841008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773620|NCT01841099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24773621|NCT01841099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24773622|NCT01841099|Analgesics|analgesics|mesh-ancestor
24773623|NCT01841099|Sensory System Agents|sensory system agents|mesh-ancestor
24773624|NCT01841099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773635|NCT01841125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24773636|NCT01841125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773637|NCT01841125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24773638|NCT01841125|Serotonin Agents|serotonin agents|mesh-ancestor
24773639|NCT01841125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773640|NCT01841125|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24773641|NCT01841125|Antidepressive Agents|antidepressive agents|mesh-ancestor
24773642|NCT01841125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24773643|NCT01841164|Montelukast|montelukast|mesh-list
24773644|NCT01841164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25701362|NCT02139046|Colchicine|colchicine|mesh-list
25701363|NCT02139046|Febuxostat|febuxostat|mesh-list
25701364|NCT02139046|Lansoprazole|lansoprazole|mesh-list
25701365|NCT02139046|Dexlansoprazole|dexlansoprazole|mesh-list
24773645|NCT01841164|Respiratory System Agents|respiratory system agents|mesh-ancestor
24773646|NCT01841164|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24773648|NCT01841164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24773650|NCT01841164|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24773651|NCT01841164|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24773660|NCT01841242|Blood Substitutes|blood substitutes|mesh-ancestor
24773662|NCT01841294|Anesthetics, Local|anesthetics, local|mesh-ancestor
24788294|NCT01930708|Dimethyl Fumarate|dimethyl fumarate|mesh-list
24773663|NCT01841294|Anesthetics|anesthetics|mesh-ancestor
24773664|NCT01841294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24773665|NCT01841294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773666|NCT01841294|Sensory System Agents|sensory system agents|mesh-ancestor
24773667|NCT01841294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773668|NCT01841294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24773669|NCT01841294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24405742|NCT00168181|Pilocarpine|pilocarpine|mesh-list
24773670|NCT01841294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24773671|NCT01841294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24773672|NCT01841294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773673|NCT01841307|Cromolyn Sodium|cromolyn sodium|mesh-list
24773674|NCT01841307|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
24773675|NCT01841307|Immunologic Factors|immunologic factors|mesh-ancestor
24773677|NCT01841307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24773678|NCT01841307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24773680|NCT01841320|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24773681|NCT01841320|Methadone|methadone|mesh-list
24773682|NCT01841320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24773683|NCT01841320|Narcotics|narcotics|mesh-ancestor
24773685|NCT01841320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773687|NCT01841320|Sensory System Agents|sensory system agents|mesh-ancestor
24773688|NCT01841320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773689|NCT01841320|Antitussive Agents|antitussive agents|mesh-ancestor
24773690|NCT01841320|Respiratory System Agents|respiratory system agents|mesh-ancestor
24773691|NCT01841320|Antiviral Agents|antiviral agents|mesh-ancestor
24773692|NCT01841320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24773693|NCT01841411|Metronidazole|metronidazole|mesh-list
24773694|NCT01841411|Acetylcysteine|acetylcysteine|mesh-list
24773700|NCT01841411|Antiviral Agents|antiviral agents|mesh-ancestor
24773701|NCT01841411|Expectorants|expectorants|mesh-ancestor
24773702|NCT01841411|Respiratory System Agents|respiratory system agents|mesh-ancestor
24773703|NCT01841411|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24773704|NCT01841411|Antioxidants|antioxidants|mesh-ancestor
24773705|NCT01841411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773706|NCT01841411|Protective Agents|protective agents|mesh-ancestor
24773707|NCT01841411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773708|NCT01841411|Antidotes|antidotes|mesh-ancestor
24773709|NCT01841424|Benzocaine|benzocaine|mesh-list
24773710|NCT01841424|Anesthetics, Local|anesthetics, local|mesh-ancestor
24773711|NCT01841424|Anesthetics|anesthetics|mesh-ancestor
24773712|NCT01841424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24773715|NCT01841424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773716|NCT01841463|Vemurafenib|vemurafenib|mesh-list
24773717|NCT01841463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24773718|NCT01841463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24773719|NCT01841463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773720|NCT01841463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773721|NCT01841502|Paroxetine|paroxetine|mesh-list
24773722|NCT01841502|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24773723|NCT01841502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24773724|NCT01841502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24773725|NCT01841502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773726|NCT01841502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24773727|NCT01841502|Serotonin Agents|serotonin agents|mesh-ancestor
24773728|NCT01841502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773729|NCT01841502|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24773730|NCT01841502|Antidepressive Agents|antidepressive agents|mesh-ancestor
24773731|NCT01841502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24773732|NCT01841502|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24773733|NCT01841502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24773734|NCT01841502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25081214|NCT03332316|Dexamethasone acetate|dexamethasone acetate|mesh-list
24773735|NCT01841515|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24967280|NCT03760848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24967281|NCT03760848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967282|NCT03760848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24967283|NCT03760848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24967284|NCT03760848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24967285|NCT03760848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24967286|NCT03760848|Anesthetics, General|anesthetics, general|mesh-ancestor
24967289|NCT03760848|GABA Agents|gaba agents|mesh-ancestor
24967298|NCT03760822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967300|NCT03760809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24967301|NCT03760809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24967302|NCT03760809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967303|NCT03760809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24967304|NCT03760809|Analgesics|analgesics|mesh-ancestor
24967305|NCT03760809|Sensory System Agents|sensory system agents|mesh-ancestor
24773736|NCT01841515|Hemostatics|hemostatics|mesh-ancestor
24773737|NCT01841515|Coagulants|coagulants|mesh-ancestor
24773738|NCT01841515|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24773739|NCT01841515|Natriuretic Agents|natriuretic agents|mesh-ancestor
24773740|NCT01841515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773742|NCT01841658|Hematinics|hematinics|mesh-ancestor
24773743|NCT01841658|Vitamin B Complex|vitamin b complex|mesh-ancestor
24773744|NCT01841658|Vitamins|vitamins|mesh-ancestor
24773755|NCT01841775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24773756|NCT01841775|Antiviral Agents|antiviral agents|mesh-ancestor
24773757|NCT01841775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25081216|NCT03332316|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25081217|NCT03332316|BB 1101|bb 1101|mesh-list
25081218|NCT03332316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25081219|NCT03332316|Antiemetics|antiemetics|mesh-ancestor
25081220|NCT03332316|Autonomic Agents|autonomic agents|mesh-ancestor
25081221|NCT03332316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25081222|NCT03332316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081224|NCT03332316|Glucocorticoids|glucocorticoids|mesh-ancestor
25081225|NCT03332316|Hormones|hormones|mesh-ancestor
25081226|NCT03332316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25081227|NCT03332316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25081228|NCT03332316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081229|NCT03332316|Anesthetics, Local|anesthetics, local|mesh-ancestor
25081230|NCT03332316|Anesthetics|anesthetics|mesh-ancestor
25081231|NCT03332316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25081232|NCT03332316|Sensory System Agents|sensory system agents|mesh-ancestor
25081233|NCT03332316|Protease Inhibitors|protease inhibitors|mesh-ancestor
25081234|NCT03332316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25081235|NCT03332316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081236|NCT03332225|Interferons|interferons|mesh-list
25081237|NCT03332225|Interferon-gamma|interferon-gamma|mesh-list
25081238|NCT03332225|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24788421|NCT01931293|Hematinics|hematinics|mesh-ancestor
24773764|NCT01841827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773765|NCT01841827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24773766|NCT01841827|Respiratory System Agents|respiratory system agents|mesh-ancestor
24773767|NCT01841827|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24773768|NCT01841827|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24773769|NCT01841827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773770|NCT01841827|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24773771|NCT01841827|Vasodilator Agents|vasodilator agents|mesh-ancestor
24773772|NCT01841827|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24773773|NCT01841827|Protective Agents|protective agents|mesh-ancestor
24773774|NCT01841827|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24773775|NCT01841827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24773779|NCT01842074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24773780|NCT01842087|Iproplatin|iproplatin|mesh-list
24773786|NCT01842113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24773787|NCT01842113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24773788|NCT01842113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24773789|NCT01842139|Poly I-C|poly i-c|mesh-list
24773790|NCT01842139|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24773791|NCT01842139|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
24773792|NCT01842139|Poly ICLC|poly iclc|mesh-list
24773793|NCT01842139|Basiliximab|basiliximab|mesh-list
24773794|NCT01842139|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24773795|NCT01842139|Immunologic Factors|immunologic factors|mesh-ancestor
24773796|NCT01842139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773797|NCT01842139|Interferon Inducers|interferon inducers|mesh-ancestor
24773798|NCT01842139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24773799|NCT01842139|Laxatives|laxatives|mesh-ancestor
24773801|NCT01842139|Antiviral Agents|antiviral agents|mesh-ancestor
24773813|NCT01842230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773814|NCT01842230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24773815|NCT01842230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24773816|NCT01842230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773817|NCT01842230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24773818|NCT01842230|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24565036|NCT00778557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24565037|NCT00778557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24773819|NCT01842230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24773820|NCT01842230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24773821|NCT01842230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773822|NCT01842230|Vasodilator Agents|vasodilator agents|mesh-ancestor
24565106|NCT00778739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24565108|NCT00778752|Immunologic Factors|immunologic factors|mesh-ancestor
24565109|NCT00778752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620734|NCT01058759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620736|NCT01058824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24620737|NCT01058824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24620738|NCT01058824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24620744|NCT01058876|Nicotine|nicotine|mesh-list
24620746|NCT01058876|Autonomic Agents|autonomic agents|mesh-ancestor
24620747|NCT01058876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24509689|NCT00561704|Losartan|losartan|mesh-list
24620748|NCT01058876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620749|NCT01058876|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24620750|NCT01058876|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24620751|NCT01058876|Cholinergic Agents|cholinergic agents|mesh-ancestor
24620752|NCT01058876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24620753|NCT01058876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620754|NCT01058902|Aspirin|aspirin|mesh-list
24620755|NCT01058902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24620756|NCT01058902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24620757|NCT01058902|Analgesics|analgesics|mesh-ancestor
24620758|NCT01058902|Sensory System Agents|sensory system agents|mesh-ancestor
24620759|NCT01058902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24620760|NCT01058902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620761|NCT01058902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24620762|NCT01058902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24620763|NCT01058902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24620764|NCT01058902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24620766|NCT01058902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24773856|NCT01842321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24773857|NCT01842321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24773858|NCT01842321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773859|NCT01842321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773860|NCT01842321|Hormone Antagonists|hormone antagonists|mesh-ancestor
24773861|NCT01842321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24773862|NCT01842321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701366|NCT02139046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25701367|NCT02139046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25701368|NCT02139046|Analgesics|analgesics|mesh-ancestor
25701369|NCT02139046|Sensory System Agents|sensory system agents|mesh-ancestor
24773863|NCT01842321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24773864|NCT01842373|Lidocaine|lidocaine|mesh-list
24773865|NCT01842373|Tetracaine|tetracaine|mesh-list
24773866|NCT01842373|Benzocaine|benzocaine|mesh-list
24773867|NCT01842373|Anesthetics, Local|anesthetics, local|mesh-ancestor
24773868|NCT01842373|Anesthetics|anesthetics|mesh-ancestor
24773869|NCT01842373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24773870|NCT01842373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773871|NCT01842373|Sensory System Agents|sensory system agents|mesh-ancestor
24773872|NCT01842373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773873|NCT01842373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24773874|NCT01842373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24773875|NCT01842373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24773876|NCT01842373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24773912|NCT01842893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773913|NCT01842893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24773914|NCT01842893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24773915|NCT01842893|Anesthetics, General|anesthetics, general|mesh-ancestor
24773917|NCT01842932|Bromides|bromides|mesh-list
24773927|NCT01842932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773928|NCT01843010|Parecoxib|parecoxib|mesh-list
24773929|NCT01843010|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24773930|NCT01843010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24773931|NCT01843010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773932|NCT01843010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773933|NCT01843010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24773934|NCT01843010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24773935|NCT01843010|Analgesics|analgesics|mesh-ancestor
24773936|NCT01843010|Sensory System Agents|sensory system agents|mesh-ancestor
24773937|NCT01843010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24581042|NCT00864318|Paclitaxel|paclitaxel|mesh-list
24773943|NCT01843075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773944|NCT01843075|Incretins|incretins|mesh-ancestor
24773945|NCT01843075|Hormones|hormones|mesh-ancestor
24773946|NCT01843075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24773948|NCT01843088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24773950|NCT01843088|Natriuretic Agents|natriuretic agents|mesh-ancestor
24773951|NCT01843088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773952|NCT01843127|Exenatide|exenatide|mesh-list
24773953|NCT01843127|Ranolazine|ranolazine|mesh-list
24773954|NCT01843127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24773967|NCT01843153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773977|NCT01843179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24773979|NCT01843179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24773980|NCT01843179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24773981|NCT01843179|Antiviral Agents|antiviral agents|mesh-ancestor
24773982|NCT01843179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24773983|NCT01843179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24773984|NCT01843179|Immunologic Factors|immunologic factors|mesh-ancestor
24773985|NCT01843179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24773986|NCT01843179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24773987|NCT01843179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24773988|NCT01843179|Analgesics|analgesics|mesh-ancestor
24773989|NCT01843179|Sensory System Agents|sensory system agents|mesh-ancestor
24773990|NCT01843179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24773991|NCT01843179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24773992|NCT01843179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24773993|NCT01843179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24773994|NCT01843179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24773995|NCT01843257|Ethanol|ethanol|mesh-list
24773996|NCT01843257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24773997|NCT01843257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24773998|NCT01843257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24484134|NCT00446784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484135|NCT00446784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24434758|NCT00263458|Buprenorphine|buprenorphine|mesh-list
24484136|NCT00446784|Antimetabolites|antimetabolites|mesh-ancestor
24484137|NCT00446784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484138|NCT00446784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24773999|NCT01843257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774001|NCT01843296|Fentanyl|fentanyl|mesh-list
24774002|NCT01843296|Bupivacaine|bupivacaine|mesh-list
24774005|NCT01843296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24774006|NCT01843296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774007|NCT01843296|Sensory System Agents|sensory system agents|mesh-ancestor
24774008|NCT01843296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24774009|NCT01843296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24774010|NCT01843296|Narcotics|narcotics|mesh-ancestor
24774011|NCT01843296|Analgesics|analgesics|mesh-ancestor
24774012|NCT01843296|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25081239|NCT03332225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967306|NCT03760809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24967307|NCT03760809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24967308|NCT03760809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24967309|NCT03760809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24967310|NCT03760809|Adrenergic Agents|adrenergic agents|mesh-ancestor
24967311|NCT03760809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24967312|NCT03760809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774017|NCT01843296|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24774018|NCT01843296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24774019|NCT01843296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774020|NCT01843296|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24774021|NCT01843296|Tocolytic Agents|tocolytic agents|mesh-ancestor
24774022|NCT01843296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24774023|NCT01843309|Spironolactone|spironolactone|mesh-list
24774024|NCT01843309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24774025|NCT01843309|Hormone Antagonists|hormone antagonists|mesh-ancestor
24774026|NCT01843309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24774027|NCT01843309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081241|NCT03332225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25081242|NCT03332225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25081243|NCT03332069|Cisplatin|cisplatin|mesh-list
25081254|NCT03331913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25081255|NCT03331913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25081256|NCT03331913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25081257|NCT03331913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081258|NCT03331913|Cholinergic Agents|cholinergic agents|mesh-ancestor
25081259|NCT03331913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25081260|NCT03331913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081261|NCT03331913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25081262|NCT03331913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25081263|NCT03331861|Metformin|metformin|mesh-list
25081264|NCT03331861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25081265|NCT03331861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081266|NCT03331770|Latanoprost|latanoprost|mesh-list
24774032|NCT01843439|Vitamin B Complex|vitamin b complex|mesh-ancestor
24774033|NCT01843439|Vitamins|vitamins|mesh-ancestor
24774034|NCT01843439|Micronutrients|micronutrients|mesh-ancestor
24774035|NCT01843439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774036|NCT01843452|Capecitabine|capecitabine|mesh-list
24774037|NCT01843452|Mitomycins|mitomycins|mesh-list
24774038|NCT01843452|Mitomycin|mitomycin|mesh-list
24774039|NCT01843452|Panitumumab|panitumumab|mesh-list
24774040|NCT01843452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24774041|NCT01843452|Antimetabolites|antimetabolites|mesh-ancestor
24774042|NCT01843452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774043|NCT01843452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774044|NCT01843452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24774045|NCT01843452|Alkylating Agents|alkylating agents|mesh-ancestor
24566193|NCT00784745|Dexamethasone|dexamethasone|mesh-list
24774046|NCT01843452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24774047|NCT01843452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774055|NCT01843556|Cholinergic Agents|cholinergic agents|mesh-ancestor
24774056|NCT01843556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24774057|NCT01843556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774058|NCT01843556|Nootropic Agents|nootropic agents|mesh-ancestor
24774059|NCT01843647|Cisplatin|cisplatin|mesh-list
24774060|NCT01843647|Vinorelbine|vinorelbine|mesh-list
24774061|NCT01843647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774065|NCT01843647|Mitosis Modulators|mitosis modulators|mesh-ancestor
24774066|NCT01843647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774067|NCT01843699|Topiramate|topiramate|mesh-list
24774068|NCT01843699|Anticonvulsants|anticonvulsants|mesh-ancestor
24774069|NCT01843699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24774070|NCT01843699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774071|NCT01843725|Capecitabine|capecitabine|mesh-list
24774072|NCT01843725|Aflibercept|aflibercept|mesh-list
24774073|NCT01843725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24774074|NCT01843725|Antimetabolites|antimetabolites|mesh-ancestor
24774075|NCT01843725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774076|NCT01843725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774077|NCT01843725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24774078|NCT01843725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24774079|NCT01843725|Growth Substances|growth substances|mesh-ancestor
24774080|NCT01843725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774081|NCT01843725|Growth Inhibitors|growth inhibitors|mesh-ancestor
24774082|NCT01843738|Vemurafenib|vemurafenib|mesh-list
24774083|NCT01843738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774084|NCT01843738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24774085|NCT01843738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774086|NCT01843738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774087|NCT01843829|Paclitaxel|paclitaxel|mesh-list
24774088|NCT01843829|Carboplatin|carboplatin|mesh-list
24774089|NCT01843829|Capecitabine|capecitabine|mesh-list
24774090|NCT01843829|Oxaliplatin|oxaliplatin|mesh-list
24536946|NCT00652925|Analgesics|analgesics|mesh-ancestor
24774091|NCT01843829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24774092|NCT01843829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774093|NCT01843829|Tubulin Modulators|tubulin modulators|mesh-ancestor
24774103|NCT01843868|Lorazepam|lorazepam|mesh-list
24774104|NCT01843868|Ondansetron|ondansetron|mesh-list
24774105|NCT01843868|Aprepitant|aprepitant|mesh-list
24774106|NCT01843868|Palonosetron|palonosetron|mesh-list
24774107|NCT01843868|Metoclopramide|metoclopramide|mesh-list
24774108|NCT01843868|Granisetron|granisetron|mesh-list
24565323|NCT00779792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788828|NCT01934088|Fentanyl|fentanyl|mesh-list
24565324|NCT00779792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774109|NCT01843868|Prochlorperazine|prochlorperazine|mesh-list
24774111|NCT01843868|Antiemetics|antiemetics|mesh-list
24774113|NCT01843868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24510479|NCT00564655|Anesthetics|anesthetics|mesh-ancestor
24774114|NCT01843868|Immunologic Factors|immunologic factors|mesh-ancestor
24774115|NCT01843868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774116|NCT01843868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24774117|NCT01843868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24774118|NCT01843868|Alkylating Agents|alkylating agents|mesh-ancestor
24774119|NCT01843868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774120|NCT01843868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774121|NCT01843868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24774122|NCT01843868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24774123|NCT01843868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24774145|NCT01843868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24774146|NCT01843868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24774147|NCT01843868|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24774148|NCT01843868|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24774149|NCT01843868|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24774150|NCT01843868|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24774151|NCT01843868|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24774152|NCT01843868|Dopamine Agents|dopamine agents|mesh-ancestor
24774153|NCT01843868|Anticonvulsants|anticonvulsants|mesh-ancestor
24774154|NCT01843868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24774155|NCT01843868|GABA Modulators|gaba modulators|mesh-ancestor
24774156|NCT01843868|GABA Agents|gaba agents|mesh-ancestor
24774157|NCT01843998|Sirolimus|sirolimus|mesh-list
24774158|NCT01843998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24774159|NCT01843998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24774160|NCT01843998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25701370|NCT02139046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25701371|NCT02139046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701372|NCT02139046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25701373|NCT02139046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25701374|NCT02139046|Gout Suppressants|gout suppressants|mesh-ancestor
24774161|NCT01843998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774162|NCT01843998|Antifungal Agents|antifungal agents|mesh-ancestor
24774163|NCT01843998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24774164|NCT01843998|Immunologic Factors|immunologic factors|mesh-ancestor
24774165|NCT01843998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774169|NCT01844024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24484310|NCT00447577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24484311|NCT00447577|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24484312|NCT00447681|Fezakinumab|fezakinumab|mesh-list
24484313|NCT00447681|Dermatologic Agents|dermatologic agents|mesh-ancestor
24484314|NCT00447759|Ibuprofen|ibuprofen|mesh-list
24484315|NCT00447759|Celecoxib|celecoxib|mesh-list
24565483|NCT00780780|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24565484|NCT00780780|Nepafenac|nepafenac|mesh-list
24565485|NCT00780780|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24565486|NCT00780780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24565488|NCT00780780|Hormones|hormones|mesh-ancestor
24565489|NCT00780780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24565490|NCT00780780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565491|NCT00780780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24565492|NCT00780780|Immunologic Factors|immunologic factors|mesh-ancestor
24565493|NCT00780780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565494|NCT00780780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565495|NCT00780780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24565496|NCT00780780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24565497|NCT00780780|Analgesics|analgesics|mesh-ancestor
24484463|NCT00448461|Protease Inhibitors|protease inhibitors|mesh-ancestor
24484464|NCT00448461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484465|NCT00448552|Capecitabine|capecitabine|mesh-list
24484466|NCT00448552|Oxaliplatin|oxaliplatin|mesh-list
24484472|NCT00448578|Antidepressive Agents|antidepressive agents|mesh-ancestor
24484473|NCT00448578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24774186|NCT01844323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774187|NCT01844323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24774188|NCT01844323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774189|NCT01844323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774190|NCT01844401|Albuterol|albuterol|mesh-list
24774191|NCT01844401|Procaterol|procaterol|mesh-list
24774192|NCT01844401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24774193|NCT01844401|Autonomic Agents|autonomic agents|mesh-ancestor
24784943|NCT01911247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24774194|NCT01844401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24774197|NCT01844401|Respiratory System Agents|respiratory system agents|mesh-ancestor
24774198|NCT01844401|Tocolytic Agents|tocolytic agents|mesh-ancestor
24774199|NCT01844401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24774200|NCT01844401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24774201|NCT01844401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24774202|NCT01844401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24774203|NCT01844401|Adrenergic Agents|adrenergic agents|mesh-ancestor
24774204|NCT01844401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24774205|NCT01844401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774206|NCT01844401|Sympathomimetics|sympathomimetics|mesh-ancestor
24774207|NCT01844427|Memantine|memantine|mesh-list
24774208|NCT01844427|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24774210|NCT01844427|Dopamine Agents|dopamine agents|mesh-ancestor
24774211|NCT01844427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24774212|NCT01844427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774213|NCT01844427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774214|NCT01844427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24774215|NCT01844427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24774216|NCT01844622|Domperidone|domperidone|mesh-list
24774217|NCT01844622|Antiemetics|antiemetics|mesh-ancestor
24774218|NCT01844622|Autonomic Agents|autonomic agents|mesh-ancestor
24774219|NCT01844622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24484492|NCT00448786|Vitamin B Complex|vitamin b complex|mesh-ancestor
24484493|NCT00448786|Vitamins|vitamins|mesh-ancestor
24774220|NCT01844622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774221|NCT01844622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24774223|NCT01844622|Dopamine Agents|dopamine agents|mesh-ancestor
24774224|NCT01844622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24774225|NCT01844622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774226|NCT01844635|Thymoglobulin|thymoglobulin|mesh-list
24774227|NCT01844635|Immunologic Factors|immunologic factors|mesh-ancestor
24522466|NCT03760185|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24774260|NCT01844791|Gemcitabine|gemcitabine|mesh-list
24774261|NCT01844791|Pentamidine|pentamidine|mesh-list
24774262|NCT01844791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24774263|NCT01844791|Antimetabolites|antimetabolites|mesh-ancestor
24774264|NCT01844791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774265|NCT01844791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774266|NCT01844791|Antiviral Agents|antiviral agents|mesh-ancestor
24774267|NCT01844791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24774268|NCT01844791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774269|NCT01844791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24774270|NCT01844791|Immunologic Factors|immunologic factors|mesh-ancestor
24774271|NCT01844791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774272|NCT01844791|Antifungal Agents|antifungal agents|mesh-ancestor
24774273|NCT01844791|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24774274|NCT01844791|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24774275|NCT01844791|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24774276|NCT01844804|Infliximab|infliximab|mesh-list
24774277|NCT01844804|Dermatologic Agents|dermatologic agents|mesh-ancestor
24774278|NCT01844804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24774279|NCT01844804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24774280|NCT01844869|Homoharringtonine|homoharringtonine|mesh-list
24774281|NCT01844869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24774282|NCT01844869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774283|NCT01844869|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24774284|NCT01844869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774285|NCT01844869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774286|NCT01844947|Sorafenib|sorafenib|mesh-list
24774287|NCT01844947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774289|NCT01844947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484494|NCT00448786|Micronutrients|micronutrients|mesh-ancestor
24484495|NCT00448786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565501|NCT00780793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
24774290|NCT01844947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774291|NCT01845012|Dialysis Solutions|dialysis solutions|mesh-list
24774292|NCT01845012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24774293|NCT01845038|Timolol|timolol|mesh-list
24774294|NCT01845038|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24774295|NCT01845038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25081268|NCT03331770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24789083|NCT01935518|Fasudil|fasudil|mesh-list
24774296|NCT01845038|Adrenergic Agents|adrenergic agents|mesh-ancestor
24774297|NCT01845038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24774298|NCT01845038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774299|NCT01845038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774300|NCT01845038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24774301|NCT01845038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24774302|NCT01845064|Kallikreins|kallikreins|mesh-list
24774303|NCT01845064|Coagulants|coagulants|mesh-ancestor
24774304|NCT01845064|Fertility Agents, Male|fertility agents, male|mesh-ancestor
24774305|NCT01845064|Fertility Agents|fertility agents|mesh-ancestor
24774307|NCT01845064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774308|NCT01845090|Calcium Carbonate|calcium carbonate|mesh-list
24774310|NCT01845090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24774311|NCT01845090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774313|NCT01845090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774314|NCT01845090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24774315|NCT01845142|Vitamin D|vitamin d|mesh-list
24774316|NCT01845142|Cholecalciferol|cholecalciferol|mesh-list
24774317|NCT01845142|Vitamins|vitamins|mesh-ancestor
24774318|NCT01845142|Micronutrients|micronutrients|mesh-ancestor
24774319|NCT01845142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484894|NCT00450567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24484895|NCT00450567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484897|NCT00450645|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24484898|NCT00450645|Tinzaparin|tinzaparin|mesh-list
24484899|NCT00450645|Dalteparin|dalteparin|mesh-list
24484900|NCT00450645|Anticoagulants|anticoagulants|mesh-ancestor
25701375|NCT02139046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24484901|NCT00450645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24484902|NCT00450645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24774320|NCT01845142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24774321|NCT01845142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24774323|NCT01845194|Talinolol|talinolol|mesh-list
24774324|NCT01845194|Torsemide|torsemide|mesh-list
24774325|NCT01845194|Midazolam|midazolam|mesh-list
24774326|NCT01845194|Codeine|codeine|mesh-list
24774327|NCT01845194|Caffeine|caffeine|mesh-list
24774328|NCT01845194|Pravastatin|pravastatin|mesh-list
24774329|NCT01845194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24774330|NCT01845194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24774331|NCT01845194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24774332|NCT01845194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774333|NCT01845194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24774334|NCT01845194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24774335|NCT01845194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24774336|NCT01845194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24774337|NCT01845194|Anesthetics, General|anesthetics, general|mesh-ancestor
24774338|NCT01845194|Anesthetics|anesthetics|mesh-ancestor
24774339|NCT01845194|GABA Modulators|gaba modulators|mesh-ancestor
24774340|NCT01845194|GABA Agents|gaba agents|mesh-ancestor
24774341|NCT01845194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24774342|NCT01845194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774343|NCT01845194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24774344|NCT01845194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24774345|NCT01845194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774346|NCT01845194|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24774347|NCT01845194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24774348|NCT01845194|Purinergic Agents|purinergic agents|mesh-ancestor
24774349|NCT01845194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24774350|NCT01845194|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24774351|NCT01845194|Sympatholytics|sympatholytics|mesh-ancestor
24774352|NCT01845194|Autonomic Agents|autonomic agents|mesh-ancestor
24774353|NCT01845194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24774354|NCT01845194|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24774355|NCT01845194|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24774356|NCT01845194|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24774357|NCT01845194|Adrenergic Agents|adrenergic agents|mesh-ancestor
24774358|NCT01845194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24774375|NCT01845246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24774376|NCT01845259|Liraglutide|liraglutide|mesh-list
24774377|NCT01845259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24774378|NCT01845259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774379|NCT01845259|Incretins|incretins|mesh-ancestor
24774380|NCT01845259|Hormones|hormones|mesh-ancestor
24774381|NCT01845259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24774382|NCT01845272|Amlodipine|amlodipine|mesh-list
24774383|NCT01845272|Candesartan|candesartan|mesh-list
24774384|NCT01845272|Candesartan cilexetil|candesartan cilexetil|mesh-list
24774385|NCT01845272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24774386|NCT01845272|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24774387|NCT01845272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24774388|NCT01845272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774389|NCT01845272|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25067540|NCT03443141|Protective Agents|protective agents|mesh-ancestor
24774390|NCT01845272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774392|NCT01845272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24774393|NCT01845272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24774395|NCT01845298|Rifamycins|rifamycins|mesh-list
24774396|NCT01845298|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24774397|NCT01845298|Antitubercular Agents|antitubercular agents|mesh-ancestor
24774398|NCT01845298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24774399|NCT01845298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24774400|NCT01845298|Leprostatic Agents|leprostatic agents|mesh-ancestor
24774401|NCT01845298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25701376|NCT02139046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25701377|NCT02139046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774402|NCT01845298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774403|NCT01845298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774404|NCT01845298|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24774405|NCT01845298|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24774406|NCT01845298|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24774407|NCT01845298|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24774416|NCT01845363|Anti-Infective Agents|anti-infective agents|mesh-list
24774417|NCT01845363|Cefazolin|cefazolin|mesh-list
24774418|NCT01845363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24774419|NCT01845376|Anesthetics|anesthetics|mesh-list
24774420|NCT01845376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24774421|NCT01845376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774422|NCT01845428|Pravastatin|pravastatin|mesh-list
24774423|NCT01845428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24774425|NCT01845428|Antimetabolites|antimetabolites|mesh-ancestor
24774431|NCT01845493|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24774432|NCT01845493|Protective Agents|protective agents|mesh-ancestor
24774433|NCT01845493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774434|NCT01845493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24565642|NCT00781521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565643|NCT00781521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774435|NCT01845532|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24774436|NCT01845532|Anesthetics, Local|anesthetics, local|mesh-ancestor
24774437|NCT01845532|Anesthetics|anesthetics|mesh-ancestor
25081283|NCT03331523|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25081284|NCT03331523|Betamethasone benzoate|betamethasone benzoate|mesh-list
25081285|NCT03331523|Calcipotriene|calcipotriene|mesh-list
25081286|NCT03331523|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25081287|NCT03331523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25081288|NCT03331523|Glucocorticoids|glucocorticoids|mesh-ancestor
25081289|NCT03331523|Hormones|hormones|mesh-ancestor
25081290|NCT03331523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25081291|NCT03331523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081292|NCT03331523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25081293|NCT03331523|Respiratory System Agents|respiratory system agents|mesh-ancestor
25081294|NCT03331523|Dermatologic Agents|dermatologic agents|mesh-ancestor
25081295|NCT03331445|Nitric Oxide|nitric oxide|mesh-list
25081296|NCT03331445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25081297|NCT03331445|Autonomic Agents|autonomic agents|mesh-ancestor
25081298|NCT03331445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25081299|NCT03331445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081300|NCT03331445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25081301|NCT03331445|Respiratory System Agents|respiratory system agents|mesh-ancestor
25081302|NCT03331445|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25081303|NCT03331445|Antioxidants|antioxidants|mesh-ancestor
25081304|NCT03331445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081305|NCT03331445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25081306|NCT03331445|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25081307|NCT03331445|Vasodilator Agents|vasodilator agents|mesh-ancestor
25081308|NCT03331445|Gasotransmitters|gasotransmitters|mesh-ancestor
25081309|NCT03331445|Protective Agents|protective agents|mesh-ancestor
25081310|NCT03331432|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
25081311|NCT03331432|Antiviral Agents|antiviral agents|mesh-ancestor
25081312|NCT03331432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25081313|NCT03331432|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25081320|NCT03331302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081322|NCT03331263|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25081325|NCT03331263|Disinfectants|disinfectants|mesh-ancestor
24774443|NCT01845558|Wobenzym|wobenzym|mesh-list
24774444|NCT01845558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24774445|NCT01845558|Immunologic Factors|immunologic factors|mesh-ancestor
24774446|NCT01845558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774447|NCT01845584|Immunoglobulins|immunoglobulins|mesh-list
24774450|NCT01845584|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24774451|NCT01845584|Immunologic Factors|immunologic factors|mesh-ancestor
24774452|NCT01845584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774454|NCT01845610|Trace Elements|trace elements|mesh-ancestor
24774455|NCT01845610|Micronutrients|micronutrients|mesh-ancestor
24774456|NCT01845610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774457|NCT01845675|Temozolomide|temozolomide|mesh-list
24774458|NCT01845675|Dacarbazine|dacarbazine|mesh-list
24774459|NCT01845675|Endostatins|endostatins|mesh-list
24774461|NCT01845675|Alkylating Agents|alkylating agents|mesh-ancestor
24774489|NCT01845701|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24774490|NCT01845701|Anthelmintics|anthelmintics|mesh-ancestor
24774491|NCT01845727|Amphotericin B|amphotericin b|mesh-list
24774492|NCT01845727|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24774493|NCT01845727|Amebicides|amebicides|mesh-ancestor
24774494|NCT01845727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24774495|NCT01845727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24774496|NCT01845727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24774497|NCT01845727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24774498|NCT01845727|Antifungal Agents|antifungal agents|mesh-ancestor
24565708|NCT00782041|Levoleucovorin|levoleucovorin|mesh-list
24565709|NCT00782041|Antimetabolites|antimetabolites|mesh-ancestor
24565710|NCT00782041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522355|NCT03940196|Antimitotic Agents|antimitotic agents|mesh-ancestor
24565711|NCT00782041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24565779|NCT00782405|Adrenergic Agents|adrenergic agents|mesh-ancestor
24565780|NCT00782405|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24565784|NCT00782470|Factor VIII|factor viii|mesh-list
24565790|NCT00782548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565791|NCT00782548|Analgesics|analgesics|mesh-ancestor
24565792|NCT00782548|Sensory System Agents|sensory system agents|mesh-ancestor
24565793|NCT00782548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24565794|NCT00782652|Nitric Oxide|nitric oxide|mesh-list
24565795|NCT00782652|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24565796|NCT00782652|Autonomic Agents|autonomic agents|mesh-ancestor
24565797|NCT00782652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24565798|NCT00782652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565799|NCT00782652|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24565800|NCT00782652|Respiratory System Agents|respiratory system agents|mesh-ancestor
24565801|NCT00782652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24565802|NCT00782652|Antioxidants|antioxidants|mesh-ancestor
24565803|NCT00782652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565804|NCT00782652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24565805|NCT00782652|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24565806|NCT00782652|Vasodilator Agents|vasodilator agents|mesh-ancestor
24565807|NCT00782652|Gasotransmitters|gasotransmitters|mesh-ancestor
24774511|NCT01845844|Ranibizumab|ranibizumab|mesh-list
24774512|NCT01845844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24774513|NCT01845844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24774514|NCT01845844|Growth Substances|growth substances|mesh-ancestor
24774515|NCT01845844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774516|NCT01845844|Growth Inhibitors|growth inhibitors|mesh-ancestor
24774517|NCT01845844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774519|NCT01846026|Cholecalciferol|cholecalciferol|mesh-list
24774521|NCT01846026|Micronutrients|micronutrients|mesh-ancestor
24774522|NCT01846026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774543|NCT01846273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24774544|NCT01846273|Growth Substances|growth substances|mesh-ancestor
24774545|NCT01846273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774546|NCT01846273|Growth Inhibitors|growth inhibitors|mesh-ancestor
24774547|NCT01846273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774548|NCT01846273|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24774549|NCT01846273|Dermatologic Agents|dermatologic agents|mesh-ancestor
24774550|NCT01846325|Vitamin E|vitamin e|mesh-list
24774551|NCT01846325|Vitamins|vitamins|mesh-ancestor
24774552|NCT01846325|Micronutrients|micronutrients|mesh-ancestor
24774553|NCT01846325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774554|NCT01846325|Antioxidants|antioxidants|mesh-ancestor
24774555|NCT01846325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774556|NCT01846325|Protective Agents|protective agents|mesh-ancestor
24774557|NCT01846364|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
24774558|NCT01846364|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24774566|NCT01846390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24774567|NCT01846390|Antiemetics|antiemetics|mesh-ancestor
24774568|NCT01846390|Autonomic Agents|autonomic agents|mesh-ancestor
24774571|NCT01846390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24774575|NCT01846390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24774576|NCT01846390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24774577|NCT01846390|Antimetabolites|antimetabolites|mesh-ancestor
24774578|NCT01846390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774579|NCT01846390|Antiviral Agents|antiviral agents|mesh-ancestor
24774580|NCT01846390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24774581|NCT01846390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774582|NCT01846390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24774583|NCT01846390|Immunologic Factors|immunologic factors|mesh-ancestor
24774584|NCT01846390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24774585|NCT01846559|Clopidogrel|clopidogrel|mesh-list
24774595|NCT01846650|Capecitabine|capecitabine|mesh-list
24774596|NCT01846650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24774597|NCT01846650|Antimetabolites|antimetabolites|mesh-ancestor
24774598|NCT01846650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774599|NCT01846650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774601|NCT01846806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24774602|NCT01846806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24774603|NCT01846806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24774604|NCT01846832|Interferons|interferons|mesh-list
24774605|NCT01846832|Ribavirin|ribavirin|mesh-list
24565809|NCT00782847|Cyproterone Acetate|cyproterone acetate|mesh-list
24565810|NCT00782847|Cyproterone|cyproterone|mesh-list
24565811|NCT00782847|Androgen Antagonists|androgen antagonists|mesh-ancestor
24565812|NCT00782847|Hormone Antagonists|hormone antagonists|mesh-ancestor
24774606|NCT01846832|Interferon-alpha|interferon-alpha|mesh-list
24774609|NCT01846832|Simeprevir|simeprevir|mesh-list
24774610|NCT01846832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774611|NCT01846832|Antiviral Agents|antiviral agents|mesh-ancestor
24774612|NCT01846832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24774613|NCT01846832|Antimetabolites|antimetabolites|mesh-ancestor
24774614|NCT01846832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774615|NCT01846832|Immunologic Factors|immunologic factors|mesh-ancestor
24774616|NCT01846832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774617|NCT01846832|Protease Inhibitors|protease inhibitors|mesh-ancestor
24774618|NCT01846832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774620|NCT01846962|Budesonide|budesonide|mesh-list
24774621|NCT01846962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24774622|NCT01846962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24774623|NCT01846962|Autonomic Agents|autonomic agents|mesh-ancestor
24774624|NCT01846962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24774625|NCT01846962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774626|NCT01846962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24774627|NCT01846962|Respiratory System Agents|respiratory system agents|mesh-ancestor
24774628|NCT01846962|Dermatologic Agents|dermatologic agents|mesh-ancestor
24774629|NCT01846962|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24774631|NCT01846962|Hormones|hormones|mesh-ancestor
24774632|NCT01846962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24774633|NCT01846975|Abatacept|abatacept|mesh-list
24774634|NCT01846975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24774635|NCT01846975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774636|NCT01846975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774637|NCT01846975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24774638|NCT01846975|Immunologic Factors|immunologic factors|mesh-ancestor
24774654|NCT01847157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24774655|NCT01847157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774656|NCT01847157|Anesthetics, Local|anesthetics, local|mesh-ancestor
24774657|NCT01847157|Sensory System Agents|sensory system agents|mesh-ancestor
24774658|NCT01847157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24774659|NCT01847235|Temozolomide|temozolomide|mesh-list
25067548|NCT03443037|Amantadine|amantadine|mesh-list
24774661|NCT01847235|Alkylating Agents|alkylating agents|mesh-ancestor
24774662|NCT01847235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774663|NCT01847235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774665|NCT01847326|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24774666|NCT01847326|Carboplatin|carboplatin|mesh-list
24774667|NCT01847326|Fluorouracil|fluorouracil|mesh-list
24774668|NCT01847326|Hydroxyurea|hydroxyurea|mesh-list
24774669|NCT01847326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24522308|NCT04001621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522324|NCT03964688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522326|NCT03961165|Scopolamine|scopolamine|mesh-list
24522327|NCT03961165|Bromides|bromides|mesh-list
24522328|NCT03961165|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24522329|NCT03961165|Anticonvulsants|anticonvulsants|mesh-ancestor
24522330|NCT03961165|Parasympatholytics|parasympatholytics|mesh-ancestor
24522331|NCT03961165|Autonomic Agents|autonomic agents|mesh-ancestor
24522351|NCT03940196|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24522352|NCT03940196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24522353|NCT03940196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522354|NCT03940196|Tubulin Modulators|tubulin modulators|mesh-ancestor
24522370|NCT03927378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24522371|NCT03927378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24522372|NCT03927378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24522373|NCT03927378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920709|NCT04199169|Vaccines|vaccines|mesh-list
24920710|NCT04199169|Immunologic Factors|immunologic factors|mesh-ancestor
24920711|NCT04199169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920712|NCT04198844|Warfarin|warfarin|mesh-list
24920713|NCT04198844|Apixaban|apixaban|mesh-list
24920714|NCT04198844|Anticoagulants|anticoagulants|mesh-ancestor
24920715|NCT04198844|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24920716|NCT04198844|Antithrombins|antithrombins|mesh-ancestor
24920717|NCT04198844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24920718|NCT04198844|Protease Inhibitors|protease inhibitors|mesh-ancestor
24920719|NCT04198844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920720|NCT04198844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920721|NCT04198727|Capecitabine|capecitabine|mesh-list
24620536|NCT01057407|Sevelamer|sevelamer|mesh-list
24620537|NCT01057407|Chelating Agents|chelating agents|mesh-ancestor
25067440|NCT03443778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25067441|NCT03443778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067442|NCT03443778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24829895|NCT02155166|Analgesics|analgesics|mesh-ancestor
24620541|NCT01057498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24620542|NCT01057498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24620543|NCT01057498|Analgesics|analgesics|mesh-ancestor
24620544|NCT01057498|Sensory System Agents|sensory system agents|mesh-ancestor
24620545|NCT01057498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24620546|NCT01057498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620547|NCT01057498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24620548|NCT01057498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24620549|NCT01057498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24620550|NCT01057511|Progesterone|progesterone|mesh-list
24620551|NCT01057511|Progestins|progestins|mesh-ancestor
24522374|NCT03927378|Antidepressive Agents|antidepressive agents|mesh-ancestor
24522375|NCT03927378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24522376|NCT03925402|Ertapenem|ertapenem|mesh-list
24522377|NCT03925402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24522378|NCT03925402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24522379|NCT03896477|Vaccines|vaccines|mesh-list
24522380|NCT03896477|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24522384|NCT03893175|Ibuprofen|ibuprofen|mesh-list
24522385|NCT03893175|Oxycodone|oxycodone|mesh-list
24522386|NCT03893175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24522387|NCT03893175|Analgesics|analgesics|mesh-ancestor
24522388|NCT03893175|Sensory System Agents|sensory system agents|mesh-ancestor
24522389|NCT03893175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24522390|NCT03893175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522391|NCT03893175|Antipyretics|antipyretics|mesh-ancestor
24522403|NCT03862157|Enzyme Inhibitors|enzyme inhibitors|mesh-list
24522404|NCT03862157|Pevonedistat|pevonedistat|mesh-list
24522405|NCT03862157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24522467|NCT03760185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24522468|NCT03760185|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24522469|NCT03760185|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24522470|NCT03760185|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24986842|NCT05076409|Fluconazole|fluconazole|mesh-list
24522471|NCT03760185|Adrenergic Agents|adrenergic agents|mesh-ancestor
24522472|NCT03760185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24522473|NCT03760185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067443|NCT03443778|Glucocorticoids|glucocorticoids|mesh-ancestor
25067445|NCT03443778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25067446|NCT03443778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25067447|NCT03443778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25067448|NCT03443778|Anesthetics, Local|anesthetics, local|mesh-ancestor
25067449|NCT03443778|Anesthetics|anesthetics|mesh-ancestor
25067450|NCT03443778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25067451|NCT03443778|Sensory System Agents|sensory system agents|mesh-ancestor
25067452|NCT03443765|Vitamin D|vitamin d|mesh-list
25067453|NCT03443765|Immunoglobulins|immunoglobulins|mesh-list
25067454|NCT03443765|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25067455|NCT03443765|Antibodies|antibodies|mesh-list
25067456|NCT03443765|Vitamins|vitamins|mesh-ancestor
25067457|NCT03443765|Micronutrients|micronutrients|mesh-ancestor
25067458|NCT03443765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920870|NCT04197115|Antioxidants|antioxidants|mesh-ancestor
25067463|NCT03443726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25067464|NCT03443726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24920787|NCT04197570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
24920788|NCT04197570|Anesthetics|anesthetics|mesh-list
24920789|NCT04197570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24920790|NCT04197570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920791|NCT04197570|Narcotics|narcotics|mesh-ancestor
24920792|NCT04197570|Sensory System Agents|sensory system agents|mesh-ancestor
24393929|NCT00131313|Rituximab|rituximab|mesh-list
24920793|NCT04197570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24920794|NCT04197882|Molgramostim|molgramostim|mesh-list
24920795|NCT04197882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24920796|NCT04197622|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24920797|NCT04197622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24920798|NCT04197622|Diuretics|diuretics|mesh-ancestor
24920799|NCT04197622|Natriuretic Agents|natriuretic agents|mesh-ancestor
24920800|NCT04197622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920801|NCT04197622|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24920802|NCT04197622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24920803|NCT04197622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920804|NCT04197739|Amikacin|amikacin|mesh-list
24920805|NCT04197739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25067469|NCT03443726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25067470|NCT03443726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24920832|NCT04197219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920833|NCT04196855|Teriparatide|teriparatide|mesh-list
24920834|NCT04196855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24920835|NCT04196855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920836|NCT04196855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24920837|NCT04196829|Fluorides|fluorides|mesh-list
24920838|NCT04196829|Cariostatic Agents|cariostatic agents|mesh-ancestor
24920839|NCT04196829|Protective Agents|protective agents|mesh-ancestor
24920840|NCT04196829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920841|NCT04196946|Fentanyl|fentanyl|mesh-list
24920842|NCT04196946|Alfentanil|alfentanil|mesh-list
24920843|NCT04196946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24920844|NCT04196946|Narcotics|narcotics|mesh-ancestor
24920845|NCT04196946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24920846|NCT04196946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920847|NCT04196946|Analgesics|analgesics|mesh-ancestor
24522485|NCT03747419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24920852|NCT04196946|Anesthetics, General|anesthetics, general|mesh-ancestor
24920854|NCT04197050|Valsartan|valsartan|mesh-list
25067489|NCT03443570|Immunologic Factors|immunologic factors|mesh-ancestor
25067490|NCT03443570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067491|NCT03443570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25067492|NCT03443518|Remifentanil|remifentanil|mesh-list
25067493|NCT03443518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25067494|NCT03443518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067495|NCT03443518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25067496|NCT03443518|Narcotics|narcotics|mesh-ancestor
25067497|NCT03443518|Analgesics|analgesics|mesh-ancestor
25067498|NCT03443518|Sensory System Agents|sensory system agents|mesh-ancestor
24920859|NCT04197050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920861|NCT04197115|Ascorbic Acid|ascorbic acid|mesh-list
24920862|NCT04197115|Vitamin B Complex|vitamin b complex|mesh-list
24920863|NCT04197115|Hydrocortisone|hydrocortisone|mesh-list
24920864|NCT04197115|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24920865|NCT04197115|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24920866|NCT04197115|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24920867|NCT04197115|Micronutrients|micronutrients|mesh-ancestor
24920868|NCT04197115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920869|NCT04197115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24952617|NCT03892928|Anesthetics|anesthetics|mesh-ancestor
24952618|NCT03892928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24952619|NCT03892928|Analgesics|analgesics|mesh-ancestor
24952620|NCT03892928|Sensory System Agents|sensory system agents|mesh-ancestor
25067510|NCT03443492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25067511|NCT03443492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920895|NCT04196400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24920896|NCT04196400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920897|NCT04196400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24920898|NCT04196400|Respiratory System Agents|respiratory system agents|mesh-ancestor
24920899|NCT04196426|Calcium|calcium|mesh-list
24920900|NCT04196426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24920901|NCT04196426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920902|NCT04196309|Heparin|heparin|mesh-list
24620804|NCT01059110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24522514|NCT03673956|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24522515|NCT03673956|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24920907|NCT04196309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25067512|NCT03443492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25067513|NCT03443492|Immunologic Factors|immunologic factors|mesh-ancestor
25701378|NCT02139046|Tubulin Modulators|tubulin modulators|mesh-ancestor
25067514|NCT03443492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067515|NCT03443492|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25067516|NCT03443492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25067517|NCT03443492|Antidotes|antidotes|mesh-ancestor
25067518|NCT03443492|Protective Agents|protective agents|mesh-ancestor
25067519|NCT03443492|Vitamin B Complex|vitamin b complex|mesh-ancestor
24920924|NCT04196270|Anesthetics|anesthetics|mesh-ancestor
24920925|NCT04196270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24920926|NCT04196270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920927|NCT04196270|Sensory System Agents|sensory system agents|mesh-ancestor
24920928|NCT04196270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24920929|NCT04196231|Insulin|insulin|mesh-list
24920930|NCT04196231|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24920931|NCT04196231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24920932|NCT04196231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920933|NCT04195997|Heparin|heparin|mesh-list
24920934|NCT04195997|Bivalirudin|bivalirudin|mesh-list
24920935|NCT04195997|Anticoagulants|anticoagulants|mesh-ancestor
24920936|NCT04195997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24920937|NCT04195997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24920938|NCT04195997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920950|NCT04195828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920951|NCT04195828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24920952|NCT04195828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25067539|NCT03443141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067549|NCT03443037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25067550|NCT03443037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25067551|NCT03443037|Antiviral Agents|antiviral agents|mesh-ancestor
25067552|NCT03443037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25067553|NCT03443037|Dopamine Agents|dopamine agents|mesh-ancestor
25067554|NCT03443037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25067555|NCT03443037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067556|NCT03443037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067557|NCT03443037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25067558|NCT03443037|Analgesics|analgesics|mesh-ancestor
25067559|NCT03443037|Sensory System Agents|sensory system agents|mesh-ancestor
24920959|NCT04195867|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24920960|NCT04195867|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24920961|NCT04195867|Autonomic Agents|autonomic agents|mesh-ancestor
24920962|NCT04195867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24920963|NCT04195867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920964|NCT04195867|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24920965|NCT04195867|Respiratory System Agents|respiratory system agents|mesh-ancestor
24920966|NCT04195867|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24920967|NCT04195867|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24920968|NCT04195867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24920971|NCT04195867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920998|NCT04195100|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24920999|NCT04195100|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24921000|NCT04195100|Cholinergic Agents|cholinergic agents|mesh-ancestor
24921001|NCT04195100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24921002|NCT04195100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921003|NCT04195321|Phenylephrine|phenylephrine|mesh-list
24921004|NCT04195321|Oxymetazoline|oxymetazoline|mesh-list
24921005|NCT04195321|Norepinephrine|norepinephrine|mesh-list
24921006|NCT04195321|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25067560|NCT03443037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25067561|NCT03442907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25067573|NCT03442673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067574|NCT03442673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25067588|NCT03442283|Micronutrients|micronutrients|mesh-ancestor
25067589|NCT03442283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067595|NCT03442023|Chlorhexidine|chlorhexidine|mesh-list
25067596|NCT03442023|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25067597|NCT03442023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25067598|NCT03442023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25067599|NCT03442023|Disinfectants|disinfectants|mesh-ancestor
25067600|NCT03442023|Dermatologic Agents|dermatologic agents|mesh-ancestor
25067601|NCT03441841|Lidocaine|lidocaine|mesh-list
25067602|NCT03441841|Prilocaine|prilocaine|mesh-list
25067603|NCT03441841|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25067604|NCT03441841|Anesthetics, Local|anesthetics, local|mesh-ancestor
25067605|NCT03441841|Anesthetics|anesthetics|mesh-ancestor
25067606|NCT03441841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25067607|NCT03441841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067609|NCT03441841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25067610|NCT03441841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25067611|NCT03441841|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25067612|NCT03441841|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25067613|NCT03441841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25067614|NCT03441841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067615|NCT03441841|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25067616|NCT03441815|Histamine|histamine|mesh-list
25067617|NCT03441815|Glutarimide|glutarimide|mesh-list
24522562|NCT03651011|Aflibercept|aflibercept|mesh-list
24921052|NCT04194905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24921077|NCT04194684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921078|NCT04194515|Metformin|metformin|mesh-list
24921079|NCT04194515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24921080|NCT04194515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921081|NCT04194359|Capecitabine|capecitabine|mesh-list
24921082|NCT04194359|Oxaliplatin|oxaliplatin|mesh-list
24921083|NCT04194359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921084|NCT04194359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24921085|NCT04194359|Antimetabolites|antimetabolites|mesh-ancestor
25067704|NCT03440788|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25067643|NCT03441412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25067644|NCT03441412|Autonomic Agents|autonomic agents|mesh-ancestor
25067645|NCT03441412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25067646|NCT03441412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25067647|NCT03441412|Respiratory System Agents|respiratory system agents|mesh-ancestor
25067648|NCT03441412|Mydriatics|mydriatics|mesh-ancestor
25067649|NCT03441412|Sympathomimetics|sympathomimetics|mesh-ancestor
25067650|NCT03441412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25067651|NCT03441412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25067652|NCT03441412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25067653|NCT03441412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25067654|NCT03441412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24496426|NCT00504816|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
24496427|NCT00504816|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24496429|NCT00504816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24496430|NCT00504816|Contraceptive Agents|contraceptive agents|mesh-ancestor
24496431|NCT00504816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24496432|NCT00504816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496433|NCT00504816|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24522594|NCT03628066|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24522595|NCT03628066|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24921112|NCT04194086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24921113|NCT04194086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921114|NCT04194086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921115|NCT04194086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24921116|NCT04194086|Hormone Antagonists|hormone antagonists|mesh-ancestor
24921117|NCT04194086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24921118|NCT04194086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921119|NCT04194216|Clindamycin|clindamycin|mesh-list
24921120|NCT04194216|Clindamycin palmitate|clindamycin palmitate|mesh-list
24921121|NCT04194216|Clindamycin phosphate|clindamycin phosphate|mesh-list
24921122|NCT04194216|Cephalexin|cephalexin|mesh-list
24921123|NCT04194216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24921124|NCT04194216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25067656|NCT03441412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25067657|NCT03441412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25067658|NCT03441412|Sympatholytics|sympatholytics|mesh-ancestor
25067659|NCT03441412|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25067660|NCT03441412|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25067661|NCT03441412|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25067662|NCT03441373|Histamine|histamine|mesh-list
25067663|NCT03441373|Histamine phosphate|histamine phosphate|mesh-list
25067664|NCT03441373|Glutarimide|glutarimide|mesh-list
24406899|NCT00171535|Amlodipine|amlodipine|mesh-list
25067666|NCT03441373|Histamine Agents|histamine agents|mesh-ancestor
25067667|NCT03441373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24952718|NCT03892330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25067668|NCT03441373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952792|NCT03892148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830113|NCT02157337|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24921125|NCT04194216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24921126|NCT04194216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921127|NCT04194216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921128|NCT04194034|Flucytosine|flucytosine|mesh-list
24921129|NCT04194034|Antifungal Agents|antifungal agents|mesh-ancestor
24921130|NCT04194034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24921131|NCT04194034|Antimetabolites|antimetabolites|mesh-ancestor
24921132|NCT04194034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921133|NCT04194255|Ferrous fumarate|ferrous fumarate|mesh-list
24921134|NCT04194255|Trace Elements|trace elements|mesh-ancestor
24921135|NCT04194255|Micronutrients|micronutrients|mesh-ancestor
24921136|NCT04194255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921137|NCT04193930|Letrozole|letrozole|mesh-list
24921138|NCT04193930|Menotropins|menotropins|mesh-list
24921139|NCT04193930|Hormones|hormones|mesh-list
24921170|NCT04193852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621570|NCT01063101|Fucoidan|fucoidan|mesh-list
24621571|NCT01063101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24522596|NCT03628066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24522597|NCT03628066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522598|NCT03628066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24522626|NCT03567720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24522627|NCT03557788|Rifaximin|rifaximin|mesh-list
24522628|NCT03557788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24522629|NCT03557788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24522630|NCT03557788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25067669|NCT03441373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067670|NCT03441373|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25067671|NCT03441373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25067672|NCT03441217|Scopolamine|scopolamine|mesh-list
25067673|NCT03441217|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25067674|NCT03441217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25067675|NCT03441217|Antiemetics|antiemetics|mesh-ancestor
25067676|NCT03441217|Autonomic Agents|autonomic agents|mesh-ancestor
25067677|NCT03441217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25067678|NCT03441217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067679|NCT03441217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25067680|NCT03441217|Mydriatics|mydriatics|mesh-ancestor
25067681|NCT03441217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25067682|NCT03441217|Cholinergic Agents|cholinergic agents|mesh-ancestor
24830129|NCT02157428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24830131|NCT02157467|Moxifloxacin|moxifloxacin|mesh-list
24621578|NCT01063140|Vaccines|vaccines|mesh-list
24621940|NCT01064973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621942|NCT01064986|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24621943|NCT01064986|Epinephrine|epinephrine|mesh-list
24621944|NCT01064986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24621945|NCT01064986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24621946|NCT01064986|Adrenergic Agents|adrenergic agents|mesh-ancestor
24450793|NCT00320619|Aminocaproic Acid|aminocaproic acid|mesh-list
24522653|NCT03491059|Nicotine|nicotine|mesh-list
24522654|NCT03491059|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24621963|NCT01064999|Antimetabolites|antimetabolites|mesh-ancestor
24921177|NCT04193852|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24921178|NCT04193852|Hormone Antagonists|hormone antagonists|mesh-ancestor
24921179|NCT04193852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24921210|NCT04193319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24496575|NCT00505531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24496576|NCT00505531|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24496577|NCT00505531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24522655|NCT03491059|Autonomic Agents|autonomic agents|mesh-ancestor
24921235|NCT04193137|Captopril|captopril|mesh-list
24921236|NCT04193137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24921237|NCT04193137|Protease Inhibitors|protease inhibitors|mesh-ancestor
24921238|NCT04193137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921239|NCT04193137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921240|NCT04193137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24802452|NCT01990118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24802453|NCT01990118|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24802455|NCT01990144|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24802456|NCT01990144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24921242|NCT04193059|Docetaxel|docetaxel|mesh-list
24921243|NCT04193059|Cyclophosphamide|cyclophosphamide|mesh-list
24921244|NCT04193059|Carboplatin|carboplatin|mesh-list
24921245|NCT04193059|Trastuzumab|trastuzumab|mesh-list
24921246|NCT04193059|Epirubicin|epirubicin|mesh-list
24921256|NCT04193059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921258|NCT04193059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25067693|NCT03440996|Protective Agents|protective agents|mesh-ancestor
25067694|NCT03440996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067695|NCT03440996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25067696|NCT03440996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24921281|NCT04192812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921282|NCT04192812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24921283|NCT04192812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407124|NCT00171938|Imatinib Mesylate|imatinib mesylate|mesh-list
24921285|NCT04192617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24921287|NCT04192617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24921288|NCT04192617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921289|NCT04192617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24921290|NCT04192617|Antimetabolites|antimetabolites|mesh-ancestor
24921291|NCT04192617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921292|NCT04192617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921293|NCT04192617|Dermatologic Agents|dermatologic agents|mesh-ancestor
24921294|NCT04192617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921295|NCT04192617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24921296|NCT04192617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24921297|NCT04192617|Immunologic Factors|immunologic factors|mesh-ancestor
24921298|NCT04192617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24921299|NCT04192617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24921315|NCT04192643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407171|NCT00172302|Vitamins|vitamins|mesh-ancestor
24921327|NCT04192292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24921328|NCT04192292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921329|NCT04192292|Incretins|incretins|mesh-ancestor
24921331|NCT04192292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25067705|NCT03440788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25067706|NCT03440788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25067707|NCT03440515|Prednisone|prednisone|mesh-list
25067708|NCT03440515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25067709|NCT03440515|Glucocorticoids|glucocorticoids|mesh-ancestor
25067710|NCT03440515|Hormones|hormones|mesh-ancestor
25067711|NCT03440515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25067712|NCT03440515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067713|NCT03440515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24921332|NCT04192292|Protease Inhibitors|protease inhibitors|mesh-ancestor
24921333|NCT04192292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921334|NCT04192292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921335|NCT04192253|Paclitaxel|paclitaxel|mesh-list
24921336|NCT04192253|Carboplatin|carboplatin|mesh-list
24921337|NCT04192253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25701379|NCT02139046|Antimitotic Agents|antimitotic agents|mesh-ancestor
25701380|NCT02139046|Mitosis Modulators|mitosis modulators|mesh-ancestor
25701381|NCT02139046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25701382|NCT02139046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25701383|NCT02139046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25701384|NCT02139046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25701385|NCT02139280|Cyclophosphamide|cyclophosphamide|mesh-list
25701386|NCT02139280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25701387|NCT02139280|Immunologic Factors|immunologic factors|mesh-ancestor
25701388|NCT02139280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701389|NCT02139280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24921339|NCT04192253|Tubulin Modulators|tubulin modulators|mesh-ancestor
24921340|NCT04192253|Antimitotic Agents|antimitotic agents|mesh-ancestor
24921341|NCT04192253|Mitosis Modulators|mitosis modulators|mesh-ancestor
24921342|NCT04192253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921343|NCT04192656|Methylprednisolone|methylprednisolone|mesh-list
24921354|NCT04192656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921355|NCT04192656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24921356|NCT04192656|Glucocorticoids|glucocorticoids|mesh-ancestor
24921358|NCT04192656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24921359|NCT04192656|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24921360|NCT04192656|Protective Agents|protective agents|mesh-ancestor
24921361|NCT04192656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24921362|NCT04192656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921363|NCT04191954|Fasudil|fasudil|mesh-list
24921364|NCT04191954|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24921365|NCT04191954|Lubricant Eye Drops|lubricant eye drops|mesh-list
24921366|NCT04191954|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24921367|NCT04191954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24921368|NCT04191954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24921369|NCT04191954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921370|NCT04191954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24921371|NCT04191954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921372|NCT04191954|Vasodilator Agents|vasodilator agents|mesh-ancestor
24921373|NCT04191954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24921374|NCT04191954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921375|NCT04192032|Nicotine|nicotine|mesh-list
24921376|NCT04192032|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24921377|NCT04192032|Autonomic Agents|autonomic agents|mesh-ancestor
24921378|NCT04192032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24921379|NCT04192032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921380|NCT04192032|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24921381|NCT04192032|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24921382|NCT04192032|Cholinergic Agents|cholinergic agents|mesh-ancestor
24921383|NCT04192032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24921384|NCT04192032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921385|NCT04192331|Paclitaxel|paclitaxel|mesh-list
24921386|NCT04192331|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24496758|NCT00506571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496759|NCT00506571|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25067727|NCT03440359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25067728|NCT03440359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067729|NCT03440359|Progestins|progestins|mesh-ancestor
25067730|NCT03440359|Hormones|hormones|mesh-ancestor
25067731|NCT03440333|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25067732|NCT03440333|Respiratory System Agents|respiratory system agents|mesh-ancestor
25067733|NCT03440268|Acetylcysteine|acetylcysteine|mesh-list
25067734|NCT03440268|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25067735|NCT03440268|Antiviral Agents|antiviral agents|mesh-ancestor
25067736|NCT03440268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25067737|NCT03440268|Expectorants|expectorants|mesh-ancestor
25067738|NCT03440268|Respiratory System Agents|respiratory system agents|mesh-ancestor
25067739|NCT03440268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25067740|NCT03440268|Antioxidants|antioxidants|mesh-ancestor
25067741|NCT03440268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067743|NCT03440268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067744|NCT03440268|Antidotes|antidotes|mesh-ancestor
25067745|NCT03440177|Ramipril|ramipril|mesh-list
24830172|NCT02157571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522685|NCT03412266|Fludarabine|fludarabine|mesh-list
24522686|NCT03412266|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24522708|NCT03411031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522709|NCT03411031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24522710|NCT03411031|Glucocorticoids|glucocorticoids|mesh-ancestor
24522711|NCT03411031|Hormones|hormones|mesh-ancestor
24522712|NCT03411031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24522713|NCT03411031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24522714|NCT03411031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522715|NCT03411031|Immunologic Factors|immunologic factors|mesh-ancestor
24522716|NCT03411031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25067746|NCT03440177|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25701390|NCT02139280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25701391|NCT02139280|Alkylating Agents|alkylating agents|mesh-ancestor
25067747|NCT03440177|Protease Inhibitors|protease inhibitors|mesh-ancestor
25067748|NCT03440177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25067749|NCT03440177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067750|NCT03440177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25067752|NCT03440034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25067753|NCT03440034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952888|NCT03891095|Oxytocin|oxytocin|mesh-list
25067754|NCT03439943|Lixisenatide|lixisenatide|mesh-list
25067755|NCT03439943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25067756|NCT03439943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067757|NCT03439787|Epinephrine|epinephrine|mesh-list
25067758|NCT03439787|Bupivacaine|bupivacaine|mesh-list
25067759|NCT03439787|Anesthetics, Local|anesthetics, local|mesh-ancestor
25067760|NCT03439787|Anesthetics|anesthetics|mesh-ancestor
24522717|NCT03411031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24522718|NCT03411031|Growth Substances|growth substances|mesh-ancestor
24522719|NCT03411031|Growth Inhibitors|growth inhibitors|mesh-ancestor
24522720|NCT03411031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24522721|NCT03411031|Leprostatic Agents|leprostatic agents|mesh-ancestor
24522722|NCT03411031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24921425|NCT04191863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24921426|NCT04191863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24622364|NCT01066728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622365|NCT01066728|Vasodilator Agents|vasodilator agents|mesh-ancestor
24622366|NCT01066728|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24622367|NCT01066728|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24622368|NCT01066728|Purinergic Agents|purinergic agents|mesh-ancestor
24622372|NCT01066754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24622373|NCT01066754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25067761|NCT03439787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25067762|NCT03439787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067763|NCT03439787|Sensory System Agents|sensory system agents|mesh-ancestor
25067764|NCT03439787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25067765|NCT03439787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25067767|NCT03439787|Adrenergic Agents|adrenergic agents|mesh-ancestor
24921466|NCT04190927|Progesterone|progesterone|mesh-list
24921467|NCT04190927|Estrogens|estrogens|mesh-ancestor
24921469|NCT04190927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24921470|NCT04190927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921471|NCT04190927|Progestins|progestins|mesh-ancestor
24921472|NCT04191278|Varenicline|varenicline|mesh-list
24921473|NCT04191278|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24921474|NCT04191278|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24921475|NCT04191278|Cholinergic Agents|cholinergic agents|mesh-ancestor
24921476|NCT04191278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25067782|NCT03439501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25067783|NCT03439358|Magnesium Sulfate|magnesium sulfate|mesh-list
25067784|NCT03439358|Analgesics|analgesics|mesh-ancestor
25067785|NCT03439358|Sensory System Agents|sensory system agents|mesh-ancestor
25067786|NCT03439358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25067787|NCT03439358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067788|NCT03439358|Anesthetics|anesthetics|mesh-ancestor
25067789|NCT03439358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25067790|NCT03439358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25067791|NCT03439358|Anticonvulsants|anticonvulsants|mesh-ancestor
25067792|NCT03439358|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25067793|NCT03439358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25067794|NCT03439358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067795|NCT03439358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25067796|NCT03439358|Tocolytic Agents|tocolytic agents|mesh-ancestor
25701392|NCT02139280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701393|NCT02139280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25701394|NCT02139280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25701395|NCT02139358|Gemcitabine|gemcitabine|mesh-list
25701396|NCT02139358|Trastuzumab|trastuzumab|mesh-list
25701397|NCT02139358|Pertuzumab|pertuzumab|mesh-list
24522738|NCT03365752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24522739|NCT03365752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522741|NCT03365752|Sensory System Agents|sensory system agents|mesh-ancestor
24522742|NCT03365752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24522784|NCT03127592|Sensory System Agents|sensory system agents|mesh-ancestor
24522785|NCT03127592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24522786|NCT03127592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24522787|NCT03127592|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24522788|NCT03127592|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24522789|NCT03127592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921507|NCT04189900|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24921508|NCT04189900|Contraceptive Agents|contraceptive agents|mesh-ancestor
24921509|NCT04189900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24538455|NCT00659412|Methotrexate|methotrexate|mesh-list
24921510|NCT04189900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921512|NCT04189900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24921513|NCT04189900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921515|NCT04190160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24921516|NCT04190160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921517|NCT04190160|Incretins|incretins|mesh-ancestor
24921523|NCT04190004|Coagulants|coagulants|mesh-ancestor
25067802|NCT03438955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25067803|NCT03438955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25067804|NCT03438955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25067805|NCT03438955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067806|NCT03438942|Folic Acid|folic acid|mesh-list
25067807|NCT03438942|Hematinics|hematinics|mesh-ancestor
25067808|NCT03438942|Vitamin B Complex|vitamin b complex|mesh-ancestor
25067809|NCT03438942|Vitamins|vitamins|mesh-ancestor
25067810|NCT03438942|Micronutrients|micronutrients|mesh-ancestor
25067811|NCT03438942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067812|NCT03438890|Chlorhexidine|chlorhexidine|mesh-list
24921526|NCT04190004|Natriuretic Agents|natriuretic agents|mesh-ancestor
24921527|NCT04190004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921528|NCT04189744|Metronidazole|metronidazole|mesh-list
24921529|NCT04189744|Pyrimethamine|pyrimethamine|mesh-list
24921530|NCT04189744|Piperaquine|piperaquine|mesh-list
24921531|NCT04189744|Sulfadoxine|sulfadoxine|mesh-list
24921532|NCT04189744|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24921534|NCT04189744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24921535|NCT04189744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24921536|NCT04189744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24921537|NCT04189744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24921538|NCT04189744|Antimalarials|antimalarials|mesh-ancestor
24921539|NCT04189744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24921540|NCT04189744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24522794|NCT03116425|Micronutrients|micronutrients|mesh-ancestor
24522795|NCT03116425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522796|NCT03110822|Methylprednisolone|methylprednisolone|mesh-list
24921558|NCT04189484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921559|NCT04189484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24921560|NCT04189484|Immunologic Factors|immunologic factors|mesh-ancestor
24921561|NCT04189484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921562|NCT04189302|Pyrithione zinc|pyrithione zinc|mesh-list
24921563|NCT04189302|Keratolytic Agents|keratolytic agents|mesh-ancestor
24921564|NCT04189302|Dermatologic Agents|dermatologic agents|mesh-ancestor
24921565|NCT04189211|Trastuzumab|trastuzumab|mesh-list
24921566|NCT04189211|Maytansine|maytansine|mesh-list
24921567|NCT04189211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24921568|NCT04189211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921569|NCT04189211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24921570|NCT04189211|Tubulin Modulators|tubulin modulators|mesh-ancestor
24921571|NCT04189211|Antimitotic Agents|antimitotic agents|mesh-ancestor
24921572|NCT04189211|Mitosis Modulators|mitosis modulators|mesh-ancestor
25701398|NCT02139358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25701399|NCT02139358|Antimetabolites|antimetabolites|mesh-ancestor
25067823|NCT03438773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067824|NCT03438773|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25701400|NCT02139358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701401|NCT02139358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25067825|NCT03438773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25067826|NCT03438773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952965|NCT03890341|Diuretics|diuretics|mesh-ancestor
24830272|NCT02158143|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24921587|NCT04189055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24921610|NCT04189666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921611|NCT04189666|Cholinergic Agents|cholinergic agents|mesh-ancestor
24921612|NCT04189666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24921613|NCT04189666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24921614|NCT04189198|Bupivacaine|bupivacaine|mesh-list
24921616|NCT04189198|Anesthetics, Local|anesthetics, local|mesh-ancestor
24538530|NCT00659685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24538531|NCT00659685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24538532|NCT00659698|Pancrelipase|pancrelipase|mesh-list
24921617|NCT04189198|Anesthetics|anesthetics|mesh-ancestor
24921618|NCT04189198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24921619|NCT04189198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921620|NCT04189198|Sensory System Agents|sensory system agents|mesh-ancestor
24921621|NCT04189198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24921622|NCT04188691|Vaccines|vaccines|mesh-list
24921623|NCT04188691|Immunologic Factors|immunologic factors|mesh-ancestor
24921624|NCT04188691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921625|NCT04188483|Selenium|selenium|mesh-list
24921626|NCT04188483|Antioxidants|antioxidants|mesh-ancestor
24921628|NCT04188483|Protective Agents|protective agents|mesh-ancestor
24921629|NCT04188483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921630|NCT04188483|Trace Elements|trace elements|mesh-ancestor
24921631|NCT04188483|Micronutrients|micronutrients|mesh-ancestor
24921633|NCT04188431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24921648|NCT04188561|Viscosupplements|viscosupplements|mesh-ancestor
24921649|NCT04188561|Protective Agents|protective agents|mesh-ancestor
24921650|NCT04188353|Mannitol|mannitol|mesh-list
24921651|NCT04188353|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24921652|NCT04188353|Diuretics|diuretics|mesh-ancestor
24953060|NCT03889366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25067828|NCT03438708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25067829|NCT03438708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25067830|NCT03438708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25067831|NCT03438708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067832|NCT03438604|Donepezil|donepezil|mesh-list
25067833|NCT03438604|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25067834|NCT03438604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25067835|NCT03438604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067836|NCT03438604|Cholinergic Agents|cholinergic agents|mesh-ancestor
25067837|NCT03438604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25067838|NCT03438604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067839|NCT03438604|Nootropic Agents|nootropic agents|mesh-ancestor
25067840|NCT03438487|Vaccines|vaccines|mesh-list
25067841|NCT03438487|Immunologic Factors|immunologic factors|mesh-ancestor
25067842|NCT03438487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067843|NCT03438344|Vaccines|vaccines|mesh-list
25067844|NCT03438344|Immunologic Factors|immunologic factors|mesh-ancestor
25067845|NCT03438344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067846|NCT03438253|Anesthetics|anesthetics|mesh-list
25067847|NCT03438253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25067848|NCT03438253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067849|NCT03438240|Fentanyl|fentanyl|mesh-list
25067850|NCT03438240|Dexmedetomidine|dexmedetomidine|mesh-list
24622390|NCT01066806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624012|NCT01074346|Interferon-beta|interferon-beta|mesh-list
24624013|NCT01074346|Interferon beta-1a|interferon beta-1a|mesh-list
24624014|NCT01074346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622391|NCT01066832|Paclitaxel|paclitaxel|mesh-list
24622560|NCT01067534|Albuterol|albuterol|mesh-list
25067855|NCT03438240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25067856|NCT03438240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067857|NCT03438240|Sensory System Agents|sensory system agents|mesh-ancestor
25067858|NCT03438240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25067859|NCT03438240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25067860|NCT03438240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25067861|NCT03438240|Analgesics|analgesics|mesh-ancestor
25067862|NCT03438240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25067863|NCT03438240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25067864|NCT03438240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25067865|NCT03438240|Adrenergic Agents|adrenergic agents|mesh-ancestor
25067866|NCT03438240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25067867|NCT03438240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067868|NCT03438240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25067869|NCT03438240|Narcotics|narcotics|mesh-ancestor
24538533|NCT00659698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25067870|NCT03438240|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25067871|NCT03438240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25067872|NCT03438240|Anesthetics, General|anesthetics, general|mesh-ancestor
25067873|NCT03438240|Autonomic Agents|autonomic agents|mesh-ancestor
25067874|NCT03438227|Dextrans|dextrans|mesh-list
25067875|NCT03438227|Iron-Dextran Complex|iron-dextran complex|mesh-list
25067876|NCT03438227|Anticoagulants|anticoagulants|mesh-ancestor
25067877|NCT03438227|Plasma Substitutes|plasma substitutes|mesh-ancestor
25067878|NCT03438227|Blood Substitutes|blood substitutes|mesh-ancestor
25067879|NCT03438227|Hematinics|hematinics|mesh-ancestor
24622770|NCT01068353|Immunologic Factors|immunologic factors|mesh-ancestor
24622771|NCT01068392|Prednisolone|prednisolone|mesh-list
24622772|NCT01068392|Oxaliplatin|oxaliplatin|mesh-list
24622773|NCT01068392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622774|NCT01068392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24622775|NCT01068392|Glucocorticoids|glucocorticoids|mesh-ancestor
24622776|NCT01068392|Hormones|hormones|mesh-ancestor
24622777|NCT01068392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24622784|NCT01068405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622785|NCT01068405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24622786|NCT01068405|Antimetabolites|antimetabolites|mesh-ancestor
24624016|NCT01074346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24624017|NCT01074346|Immunologic Factors|immunologic factors|mesh-ancestor
24624018|NCT01074346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624019|NCT01074346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24624020|NCT01074359|Tocopherylquinone|tocopherylquinone|mesh-list
24624021|NCT01074359|Anticoagulants|anticoagulants|mesh-ancestor
25067880|NCT03438214|Vancomycin|vancomycin|mesh-list
25067881|NCT03438214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25067882|NCT03438214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24953104|NCT03888677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953105|NCT03888677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24953106|NCT03888677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24953107|NCT03888677|Alkylating Agents|alkylating agents|mesh-ancestor
24953108|NCT03888677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953109|NCT03888677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24953110|NCT03888677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24953111|NCT03888677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24953112|NCT03888677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24830338|NCT02158702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830339|NCT02158702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24830340|NCT02158702|Glucocorticoids|glucocorticoids|mesh-ancestor
24830341|NCT02158702|Hormones|hormones|mesh-ancestor
24624022|NCT01074359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24624023|NCT01074359|Antioxidants|antioxidants|mesh-ancestor
24624024|NCT01074359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624025|NCT01074359|Protective Agents|protective agents|mesh-ancestor
24624026|NCT01074359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623096|NCT01070186|Growth Substances|growth substances|mesh-ancestor
24921669|NCT04188249|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24921670|NCT04188249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24921671|NCT04188249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24921673|NCT04188249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921674|NCT04188158|Capecitabine|capecitabine|mesh-list
24921675|NCT04188158|Oxaliplatin|oxaliplatin|mesh-list
24921708|NCT04188314|Isoflurane|isoflurane|mesh-list
24921709|NCT04188314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24921710|NCT04188314|Anesthetics, General|anesthetics, general|mesh-ancestor
24921711|NCT04188314|Anesthetics|anesthetics|mesh-ancestor
24921712|NCT04188314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24921713|NCT04188314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921714|NCT04187755|Ceftazidime|ceftazidime|mesh-list
24921715|NCT04187755|Cefepime|cefepime|mesh-list
24921716|NCT04187755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24921717|NCT04187755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24921718|NCT04187807|Melatonin|melatonin|mesh-list
24921719|NCT04187807|Antioxidants|antioxidants|mesh-ancestor
24921720|NCT04187807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921721|NCT04187807|Protective Agents|protective agents|mesh-ancestor
24921722|NCT04187807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921723|NCT04187807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24921724|NCT04187898|Cyclophosphamide|cyclophosphamide|mesh-list
24921725|NCT04187898|Docetaxel|docetaxel|mesh-list
24953124|NCT03888534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24953487|NCT03884465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24953489|NCT03884530|Ticagrelor|ticagrelor|mesh-list
24953490|NCT03884530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24953491|NCT03884530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24953492|NCT03884530|Analgesics|analgesics|mesh-ancestor
24953493|NCT03884530|Sensory System Agents|sensory system agents|mesh-ancestor
24953494|NCT03884530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953495|NCT03884530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953501|NCT03884530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24953502|NCT03884530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24953503|NCT03884530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830350|NCT02158845|Leuprolide|leuprolide|mesh-list
24522802|NCT03110822|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24522803|NCT03110822|Prednisolone phosphate|prednisolone phosphate|mesh-list
24921736|NCT04187898|Antimitotic Agents|antimitotic agents|mesh-ancestor
24921737|NCT04187898|Mitosis Modulators|mitosis modulators|mesh-ancestor
24921738|NCT04187469|Moxifloxacin|moxifloxacin|mesh-list
24921750|NCT04187469|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24921751|NCT04187469|Antitubercular Agents|antitubercular agents|mesh-ancestor
24921752|NCT04187469|Leprostatic Agents|leprostatic agents|mesh-ancestor
24921753|NCT04187469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24921754|NCT04187469|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24538796|NCT00660855|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24921755|NCT04187469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24921756|NCT04187469|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24921757|NCT04187469|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24921758|NCT04187469|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24497175|NCT00508664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24497176|NCT00508664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24953505|NCT03884530|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24953506|NCT03884530|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24953507|NCT03884530|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24953508|NCT03884530|Purinergic Agents|purinergic agents|mesh-ancestor
24953509|NCT03884530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24953511|NCT03884127|Ezetimibe|ezetimibe|mesh-list
24809983|NCT02037191|Methotrexate|methotrexate|mesh-list
24953513|NCT03884127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24953514|NCT03884127|Antimetabolites|antimetabolites|mesh-ancestor
24497177|NCT00508664|Immunologic Factors|immunologic factors|mesh-ancestor
24497178|NCT00508664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497179|NCT00508664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24497180|NCT00508690|Metronidazole|metronidazole|mesh-list
24497181|NCT00508690|Kanamycin|kanamycin|mesh-list
24497182|NCT00508690|Cefmetazole|cefmetazole|mesh-list
24497183|NCT00508690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24497184|NCT00508690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24921780|NCT04187456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24921781|NCT04187456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24921782|NCT04187456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921783|NCT04187456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24921784|NCT04187456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24921785|NCT04187456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24921786|NCT04187456|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24921787|NCT04187456|Anesthetics, General|anesthetics, general|mesh-ancestor
24921788|NCT04187456|Anesthetics|anesthetics|mesh-ancestor
24921841|NCT04186299|Epinephrine|epinephrine|mesh-list
24921843|NCT04186299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25701402|NCT02139358|Antiviral Agents|antiviral agents|mesh-ancestor
25701403|NCT02139358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25701404|NCT02139358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25701405|NCT02139358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25701406|NCT02139358|Immunologic Factors|immunologic factors|mesh-ancestor
25701407|NCT02139358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921845|NCT04186299|Adrenergic Agents|adrenergic agents|mesh-ancestor
24921846|NCT04186299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24921847|NCT04186299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921848|NCT04186299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921849|NCT04186299|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24921850|NCT04186299|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24921851|NCT04186299|Autonomic Agents|autonomic agents|mesh-ancestor
24953519|NCT03883841|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24921899|NCT04185649|Lapatinib|lapatinib|mesh-list
24497329|NCT00509470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497330|NCT00509470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24522809|NCT03110822|Growth Inhibitors|growth inhibitors|mesh-ancestor
25067899|NCT03437824|Vitamins|vitamins|mesh-ancestor
25067900|NCT03437824|Micronutrients|micronutrients|mesh-ancestor
24623099|NCT01070186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24623100|NCT01070186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623101|NCT01070186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623104|NCT01070225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24623105|NCT01070225|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24623106|NCT01070225|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24623107|NCT01070225|Adrenergic Agents|adrenergic agents|mesh-ancestor
24623108|NCT01070225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24497357|NCT00509613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921941|NCT04185077|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24921942|NCT04185077|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24921948|NCT04185077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921949|NCT04185194|Lidocaine|lidocaine|mesh-list
24921950|NCT04185194|Anesthetics, Local|anesthetics, local|mesh-ancestor
24921951|NCT04185194|Anesthetics|anesthetics|mesh-ancestor
24921952|NCT04185194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24921953|NCT04185194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921954|NCT04185194|Sensory System Agents|sensory system agents|mesh-ancestor
24921955|NCT04185194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24921956|NCT04185194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24921957|NCT04185194|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24921958|NCT04185194|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24921959|NCT04185194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24921975|NCT04185103|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24921976|NCT04185103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24921977|NCT04185103|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25067938|NCT03437707|Acetaminophen|acetaminophen|mesh-list
25067939|NCT03437707|Ibuprofen|ibuprofen|mesh-list
25067940|NCT03437707|Morphine|morphine|mesh-list
25067941|NCT03437707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25067942|NCT03437707|Narcotics|narcotics|mesh-ancestor
24921980|NCT04184921|Aspirin|aspirin|mesh-list
24921988|NCT04184921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24921989|NCT04184921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24921990|NCT04184921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24921991|NCT04184921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24921992|NCT04184921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921993|NCT04184921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24921994|NCT04184921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24921995|NCT04184921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921997|NCT04184921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921998|NCT04184921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24921999|NCT04184518|Durvalumab|durvalumab|mesh-list
24922000|NCT04184518|Cediranib|cediranib|mesh-list
24922001|NCT04184518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24922002|NCT04184518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922003|NCT04184518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24922004|NCT04184518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922005|NCT04184518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24922006|NCT04184466|Insulin|insulin|mesh-list
24922007|NCT04184466|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24922008|NCT04184466|Insulin Aspart|insulin aspart|mesh-list
24922009|NCT04184466|Insulin, Long-Acting|insulin, long-acting|mesh-list
24922010|NCT04184466|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24922011|NCT04184466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24922012|NCT04184466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922013|NCT04184492|Insulin|insulin|mesh-list
25067964|NCT03437629|Calcium|calcium|mesh-list
25701408|NCT02139358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24922028|NCT04184505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922031|NCT04183881|Dermatologic Agents|dermatologic agents|mesh-ancestor
24922032|NCT04184141|Alprazolam|alprazolam|mesh-list
24922033|NCT04184141|Hydroxyzine|hydroxyzine|mesh-list
24922034|NCT04184141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24922035|NCT04184141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24922036|NCT04184141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922037|NCT04184141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24922038|NCT04184141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24922039|NCT04184141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24922048|NCT04184141|Histamine Agents|histamine agents|mesh-ancestor
24922049|NCT04184115|Scopolamine|scopolamine|mesh-list
24922050|NCT04184115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24922051|NCT04184115|Antiemetics|antiemetics|mesh-ancestor
24922052|NCT04184115|Autonomic Agents|autonomic agents|mesh-ancestor
24922053|NCT04184115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24922054|NCT04184115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522813|NCT03110822|Autonomic Agents|autonomic agents|mesh-ancestor
24522814|NCT03110822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24522815|NCT03110822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24522816|NCT03110822|Glucocorticoids|glucocorticoids|mesh-ancestor
24522817|NCT03110822|Hormones|hormones|mesh-ancestor
24522819|NCT03110822|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25067974|NCT03437590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067975|NCT03437473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25067977|NCT03437473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25067978|NCT03437473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953202|NCT03887754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24953203|NCT03887754|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24953204|NCT03887754|Dopamine Agents|dopamine agents|mesh-ancestor
24953206|NCT03887871|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24953207|NCT03887871|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24953208|NCT03887871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24953209|NCT03887871|Adrenergic Agents|adrenergic agents|mesh-ancestor
24953210|NCT03887871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24953211|NCT03887871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953212|NCT03887871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953213|NCT03887871|Urological Agents|urological agents|mesh-ancestor
24953214|NCT03887858|Tamsulosin|tamsulosin|mesh-list
24922060|NCT04184115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922061|NCT04184115|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24922062|NCT04183634|Rotigotine|rotigotine|mesh-list
24922063|NCT04183634|Dopamine Agonists|dopamine agonists|mesh-ancestor
24922064|NCT04183634|Dopamine Agents|dopamine agents|mesh-ancestor
24922065|NCT04183634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24953216|NCT03887858|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25067979|NCT03437473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067980|NCT03437460|Ibuprofen|ibuprofen|mesh-list
25067981|NCT03437460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25067982|NCT03437460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25067983|NCT03437460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25067984|NCT03437460|Analgesics|analgesics|mesh-ancestor
25067985|NCT03437460|Sensory System Agents|sensory system agents|mesh-ancestor
25067986|NCT03437460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25067987|NCT03437460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25067988|NCT03437460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25067989|NCT03437460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25067990|NCT03437460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25067991|NCT03437460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067992|NCT03437226|Simendan|simendan|mesh-list
25067993|NCT03437226|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25067994|NCT03437226|Vasodilator Agents|vasodilator agents|mesh-ancestor
25067995|NCT03437226|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25067996|NCT03437226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25067997|NCT03437226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25701409|NCT02139592|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25701410|NCT02139592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24802539|NCT01990781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24570870|NCT00806962|Vaccines|vaccines|mesh-list
24522855|NCT03103750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24522856|NCT03103750|Dopamine Agents|dopamine agents|mesh-ancestor
24522857|NCT03103750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24922086|NCT04183608|Adalimumab|adalimumab|mesh-list
24922101|NCT04183738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24922102|NCT04183738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24922103|NCT04183738|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24922104|NCT04183738|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24922105|NCT04183491|Interferons|interferons|mesh-list
24922106|NCT04183491|Interferon-beta|interferon-beta|mesh-list
24922107|NCT04183491|Interferon beta-1a|interferon beta-1a|mesh-list
25067998|NCT03437226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25067999|NCT03437226|Protective Agents|protective agents|mesh-ancestor
25068000|NCT03437226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068001|NCT03437213|Anesthetics|anesthetics|mesh-list
25068002|NCT03437213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24830520|NCT02159690|Prednisone|prednisone|mesh-list
24922127|NCT04183387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24922128|NCT04183387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24922129|NCT04183387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24922130|NCT04183114|Vaccines|vaccines|mesh-list
24922131|NCT04183114|Immunologic Factors|immunologic factors|mesh-ancestor
24623544|NCT01072071|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24623545|NCT01072071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24623546|NCT01072071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623547|NCT01072097|Atorvastatin|atorvastatin|mesh-list
24623548|NCT01072097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24623549|NCT01072097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24497601|NCT00510640|Growth Substances|growth substances|mesh-ancestor
24497602|NCT00510640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497603|NCT00510640|Growth Inhibitors|growth inhibitors|mesh-ancestor
24497604|NCT00510640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24497605|NCT00510640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497606|NCT00510640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497608|NCT00510666|Butorphanol|butorphanol|mesh-list
24522874|NCT03103087|Contraceptive Agents|contraceptive agents|mesh-ancestor
25068003|NCT03437213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068005|NCT03437200|Ipilimumab|ipilimumab|mesh-list
25068006|NCT03437200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25068007|NCT03437200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623935|NCT01074021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623937|NCT01074060|Cyclophosphamide|cyclophosphamide|mesh-list
24623938|NCT01074060|Lenograstim|lenograstim|mesh-list
24623939|NCT01074060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24623940|NCT01074060|Immunologic Factors|immunologic factors|mesh-ancestor
24623941|NCT01074060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623942|NCT01074060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24623943|NCT01074060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24623944|NCT01074060|Alkylating Agents|alkylating agents|mesh-ancestor
24623945|NCT01074060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623946|NCT01074060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623947|NCT01074060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24623948|NCT01074060|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24623949|NCT01074060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24623950|NCT01074060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24623951|NCT01074060|Antiviral Agents|antiviral agents|mesh-ancestor
24623952|NCT01074060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25068028|NCT03437057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25068029|NCT03437057|Analgesics|analgesics|mesh-ancestor
25068030|NCT03437057|Sensory System Agents|sensory system agents|mesh-ancestor
25068031|NCT03437057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25068032|NCT03437057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068033|NCT03437057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25068034|NCT03437057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25068035|NCT03437057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25068036|NCT03437057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25701411|NCT02139592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25701412|NCT02139644|Fluticasone|fluticasone|mesh-list
24623964|NCT01074073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623965|NCT01074073|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24623966|NCT01074073|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24624027|NCT01074411|Carboplatin|carboplatin|mesh-list
24624029|NCT01074411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624030|NCT01074567|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
24624031|NCT01074567|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24624032|NCT01074567|Protective Agents|protective agents|mesh-ancestor
24624033|NCT01074567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624034|NCT01074567|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24624035|NCT01074567|Antioxidants|antioxidants|mesh-ancestor
24624036|NCT01074567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624037|NCT01074593|Interferons|interferons|mesh-list
24624038|NCT01074593|Interferon-beta|interferon-beta|mesh-list
24624039|NCT01074593|Interferon beta-1a|interferon beta-1a|mesh-list
24745797|NCT03590652|Immunologic Factors|immunologic factors|mesh-ancestor
24922195|NCT04182737|Immunoglobulin A|immunoglobulin a|mesh-list
24922197|NCT04182737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922199|NCT04182568|Docetaxel|docetaxel|mesh-list
24922200|NCT04182568|Cyclophosphamide|cyclophosphamide|mesh-list
24922201|NCT04182568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25068050|NCT03436836|Nalbuphine|nalbuphine|mesh-list
24922211|NCT04182568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24922213|NCT04182568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24922214|NCT04182854|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24497699|NCT00511446|Tubulin Modulators|tubulin modulators|mesh-ancestor
24497700|NCT00511446|Antimitotic Agents|antimitotic agents|mesh-ancestor
24497701|NCT00511446|Mitosis Modulators|mitosis modulators|mesh-ancestor
24497702|NCT00511446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497703|NCT00511446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24497704|NCT00511446|Antimetabolites|antimetabolites|mesh-ancestor
24497705|NCT00511498|Sildenafil Citrate|sildenafil citrate|mesh-list
24497706|NCT00511498|Vasodilator Agents|vasodilator agents|mesh-ancestor
24497707|NCT00511498|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24497708|NCT00511498|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24497709|NCT00511498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497710|NCT00511498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497711|NCT00511498|Urological Agents|urological agents|mesh-ancestor
24497713|NCT00511576|Mocetinostat|mocetinostat|mesh-list
24922215|NCT04182854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24922216|NCT04182854|Diuretics|diuretics|mesh-ancestor
24922217|NCT04182854|Natriuretic Agents|natriuretic agents|mesh-ancestor
24922218|NCT04182854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922219|NCT04182854|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24922220|NCT04182854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24922221|NCT04182854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922222|NCT04182724|Paclitaxel|paclitaxel|mesh-list
24922223|NCT04182724|Apatinib|apatinib|mesh-list
24922224|NCT04182724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24922225|NCT04182724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922263|NCT04182399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24922264|NCT04182399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24922265|NCT04182399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922266|NCT04182399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24922267|NCT04182399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922268|NCT04181957|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
24922269|NCT04181957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24922270|NCT04181957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922271|NCT04181957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24922272|NCT04181957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24922273|NCT04181957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24922274|NCT04181957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701413|NCT02139644|Xhance|xhance|mesh-list
25701414|NCT02139644|Beclomethasone|beclomethasone|mesh-list
25701415|NCT02139644|Albuterol|albuterol|mesh-list
25701416|NCT02139644|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25068054|NCT03436836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25068055|NCT03436836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516230|NCT00601198|Oxaliplatin|oxaliplatin|mesh-list
25068057|NCT03436836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25068058|NCT03436836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25068059|NCT03436836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24922303|NCT04181736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24922304|NCT04181736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922305|NCT04181736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922307|NCT04181749|Atorvastatin|atorvastatin|mesh-list
24922347|NCT04181385|Hormone Antagonists|hormone antagonists|mesh-ancestor
24922348|NCT04181385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24922349|NCT04181385|Dopamine Agonists|dopamine agonists|mesh-ancestor
24922350|NCT04181385|Dopamine Agents|dopamine agents|mesh-ancestor
24922351|NCT04181489|Prednisolone|prednisolone|mesh-list
24922352|NCT04181489|Cyclophosphamide|cyclophosphamide|mesh-list
24922353|NCT04181489|Rituximab|rituximab|mesh-list
24922354|NCT04181489|Doxorubicin|doxorubicin|mesh-list
24922355|NCT04181489|Vincristine|vincristine|mesh-list
24922356|NCT04181489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24922357|NCT04181489|Immunologic Factors|immunologic factors|mesh-ancestor
24922358|NCT04181489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922359|NCT04181489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25068069|NCT03436719|Cefoperazone|cefoperazone|mesh-list
25068070|NCT03436719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25068071|NCT03436719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25068072|NCT03436719|Antitubercular Agents|antitubercular agents|mesh-ancestor
25068073|NCT03436719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24922378|NCT04181489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24922379|NCT04181346|Pregabalin|pregabalin|mesh-list
24922380|NCT04181346|Analgesics|analgesics|mesh-ancestor
24922381|NCT04181346|Sensory System Agents|sensory system agents|mesh-ancestor
24922382|NCT04181346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24922383|NCT04181346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922384|NCT04181346|Anticonvulsants|anticonvulsants|mesh-ancestor
24922385|NCT04181346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24922386|NCT04181346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24497875|NCT00512291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24497876|NCT00512291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24497877|NCT00512291|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24497878|NCT00512291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24497879|NCT00512291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24922387|NCT04181346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922388|NCT04181346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24922389|NCT04181346|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24922390|NCT04181346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24922391|NCT04181346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24922392|NCT04181346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24922393|NCT04181203|Leuprolide|leuprolide|mesh-list
24922394|NCT04181203|Goserelin|goserelin|mesh-list
24922395|NCT04181203|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24922396|NCT04181203|Hormones|hormones|mesh-list
24922397|NCT04181203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24922398|NCT04181203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922399|NCT04181203|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24922400|NCT04181203|Fertility Agents|fertility agents|mesh-ancestor
24922401|NCT04181203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24922402|NCT04181203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24922403|NCT04181203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922404|NCT04181203|Luteolytic Agents|luteolytic agents|mesh-ancestor
24922405|NCT04181203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24922406|NCT04181203|Contraceptive Agents|contraceptive agents|mesh-ancestor
24922407|NCT04181203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24922408|NCT04180982|Febuxostat|febuxostat|mesh-list
24922409|NCT04180982|Gout Suppressants|gout suppressants|mesh-ancestor
24922410|NCT04180982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24497895|NCT00512395|Sensory System Agents|sensory system agents|mesh-ancestor
24497896|NCT00512395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24497897|NCT00512395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24497898|NCT00512395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24497899|NCT00512395|Anesthetics, General|anesthetics, general|mesh-ancestor
24497900|NCT00512395|Anesthetics|anesthetics|mesh-ancestor
24497901|NCT00512395|Anesthetics, Local|anesthetics, local|mesh-ancestor
24497902|NCT00512408|Testosterone|testosterone|mesh-list
24922411|NCT04180657|Protein C|protein c|mesh-list
24922412|NCT04180657|Anticoagulants|anticoagulants|mesh-ancestor
24922413|NCT04180657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24624040|NCT01074593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922433|NCT04180150|Entecavir|entecavir|mesh-list
25068113|NCT03436225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24830629|NCT02160275|Insulin|insulin|mesh-list
24922436|NCT04180007|Apatinib|apatinib|mesh-list
24497920|NCT00512668|Sirolimus|sirolimus|mesh-list
24922438|NCT04180007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24922439|NCT04180007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24922440|NCT04180007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922441|NCT04179747|Sildenafil Citrate|sildenafil citrate|mesh-list
24922442|NCT04179747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922443|NCT04179747|Vasodilator Agents|vasodilator agents|mesh-ancestor
24922444|NCT04179747|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24922445|NCT04179747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24922446|NCT04179747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24922447|NCT04179747|Urological Agents|urological agents|mesh-ancestor
24922448|NCT04179942|Nitric Oxide|nitric oxide|mesh-list
24922449|NCT04179942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24922450|NCT04179942|Autonomic Agents|autonomic agents|mesh-ancestor
24922451|NCT04179942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24922452|NCT04179942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922453|NCT04179942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24922454|NCT04179942|Respiratory System Agents|respiratory system agents|mesh-ancestor
24922455|NCT04179942|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24922456|NCT04179942|Antioxidants|antioxidants|mesh-ancestor
24922457|NCT04179942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068116|NCT03436225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25068117|NCT03436225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25068118|NCT03436225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25068119|NCT03436225|Protease Inhibitors|protease inhibitors|mesh-ancestor
25068120|NCT03436225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25068121|NCT03436225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068122|NCT03436225|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24922504|NCT04179617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24922505|NCT04179617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24922506|NCT04179617|Cholinergic Agents|cholinergic agents|mesh-ancestor
24922507|NCT04179617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24922562|NCT04178876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24922563|NCT04178876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922565|NCT04178655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24922566|NCT04178655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25068123|NCT03436225|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25068124|NCT03436225|Respiratory System Agents|respiratory system agents|mesh-ancestor
25068125|NCT03436225|Tocolytic Agents|tocolytic agents|mesh-ancestor
25068126|NCT03436225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25068127|NCT03436225|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25068128|NCT03436225|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25068129|NCT03436225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25068130|NCT03436225|Adrenergic Agents|adrenergic agents|mesh-ancestor
25068131|NCT03436225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25068132|NCT03436173|Fluoxetine|fluoxetine|mesh-list
25068133|NCT03436173|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25068134|NCT03436173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25068135|NCT03436173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25068136|NCT03436173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068137|NCT03436173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25068138|NCT03436173|Serotonin Agents|serotonin agents|mesh-ancestor
25068139|NCT03436173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068140|NCT03436173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25068141|NCT03436173|Antidepressive Agents|antidepressive agents|mesh-ancestor
25068142|NCT03436173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25068143|NCT03436173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25068144|NCT03436173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25068145|NCT03436173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25068146|NCT03436121|Midazolam|midazolam|mesh-list
25068147|NCT03436121|Ketamine|ketamine|mesh-list
25068148|NCT03436121|Analgesics|analgesics|mesh-ancestor
24922568|NCT04178655|Hemostatics|hemostatics|mesh-ancestor
24922569|NCT04178655|Coagulants|coagulants|mesh-ancestor
24922570|NCT04178785|Remifentanil|remifentanil|mesh-list
24922571|NCT04178785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24922572|NCT04178785|Narcotics|narcotics|mesh-ancestor
24922573|NCT04178785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24922574|NCT04178785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922575|NCT04178785|Analgesics|analgesics|mesh-ancestor
24922576|NCT04178785|Sensory System Agents|sensory system agents|mesh-ancestor
24922577|NCT04178785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25068152|NCT03436121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25068153|NCT03436121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25068154|NCT03436121|Anesthetics, General|anesthetics, general|mesh-ancestor
25068155|NCT03436121|Anesthetics|anesthetics|mesh-ancestor
25068156|NCT03436121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25068157|NCT03436121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25068158|NCT03436121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25068159|NCT03436121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25068160|NCT03436121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068161|NCT03436121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24746200|NCT03237702|Carotenoids|carotenoids|mesh-list
24922586|NCT04178291|Erythritol|erythritol|mesh-list
24922587|NCT04178291|Vasodilator Agents|vasodilator agents|mesh-ancestor
24922588|NCT04178512|Dexamethasone|dexamethasone|mesh-list
24922589|NCT04178512|Dexamethasone acetate|dexamethasone acetate|mesh-list
24922590|NCT04178512|Fentanyl|fentanyl|mesh-list
24922591|NCT04178512|BB 1101|bb 1101|mesh-list
24922592|NCT04178512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24922593|NCT04178512|Antiemetics|antiemetics|mesh-ancestor
24922594|NCT04178512|Autonomic Agents|autonomic agents|mesh-ancestor
24922595|NCT04178512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24922596|NCT04178512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922597|NCT04178512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24922598|NCT04178512|Glucocorticoids|glucocorticoids|mesh-ancestor
24922599|NCT04178512|Hormones|hormones|mesh-ancestor
24922626|NCT04178200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24922627|NCT04178200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24922628|NCT04178200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24922629|NCT04178200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24922630|NCT04178200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24922631|NCT04178200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922632|NCT04178057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24922634|NCT04178057|Immunoglobulins|immunoglobulins|mesh-list
24922635|NCT04178057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24922636|NCT04178057|Mitogens|mitogens|mesh-list
24922637|NCT04178057|Endothelial Growth Factors|endothelial growth factors|mesh-list
24922638|NCT04178057|Immunologic Factors|immunologic factors|mesh-ancestor
24922639|NCT04178057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922640|NCT04178057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922641|NCT04178057|Mitosis Modulators|mitosis modulators|mesh-ancestor
24922642|NCT04178057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922643|NCT04178057|Growth Substances|growth substances|mesh-ancestor
24922644|NCT04177875|Paclitaxel|paclitaxel|mesh-list
24922645|NCT04177875|Docetaxel|docetaxel|mesh-list
24922646|NCT04177875|Cisplatin|cisplatin|mesh-list
24922647|NCT04177875|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24498141|NCT00513266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24498142|NCT00513266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498143|NCT00513266|Antidotes|antidotes|mesh-ancestor
24498144|NCT00513266|Protective Agents|protective agents|mesh-ancestor
24498145|NCT00513266|Vitamin B Complex|vitamin b complex|mesh-ancestor
24498146|NCT00513266|Vitamins|vitamins|mesh-ancestor
24498147|NCT00513266|Micronutrients|micronutrients|mesh-ancestor
24498148|NCT00513383|Paclitaxel|paclitaxel|mesh-list
24498149|NCT00513383|Docetaxel|docetaxel|mesh-list
24498150|NCT00513383|Carboplatin|carboplatin|mesh-list
25068167|NCT03436121|GABA Agents|gaba agents|mesh-ancestor
24626396|NCT01087190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24953389|NCT03885427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953390|NCT03885427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953391|NCT03885427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24953392|NCT03885427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24953393|NCT03885427|Anesthetics, General|anesthetics, general|mesh-ancestor
24953394|NCT03885427|Anesthetics|anesthetics|mesh-ancestor
24953395|NCT03885427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24953396|NCT03885427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24953397|NCT03885427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24953398|NCT03885427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24830683|NCT02160353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830686|NCT02160548|Atropine|atropine|mesh-list
24624055|NCT01074632|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
24624056|NCT01074632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24465019|NCT00367536|Hormone Antagonists|hormone antagonists|mesh-ancestor
24624057|NCT01074632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24624058|NCT01074632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24624059|NCT01074632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624060|NCT01074632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24624061|NCT01074632|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24498166|NCT00513396|Antitubercular Agents|antitubercular agents|mesh-ancestor
24498167|NCT00513396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24498168|NCT00513396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24498170|NCT00513396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24624062|NCT01074632|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24624063|NCT01074632|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24624064|NCT01074632|Adrenergic Agents|adrenergic agents|mesh-ancestor
24624065|NCT01074632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24624066|NCT01074632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624067|NCT01074632|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24408766|NCT00179465|Tiagabine|tiagabine|mesh-list
24624068|NCT01074632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24624069|NCT01074632|Serotonin Agents|serotonin agents|mesh-ancestor
24624070|NCT01074632|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24624071|NCT01074632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24624074|NCT01074645|Antiviral Agents|antiviral agents|mesh-ancestor
24624075|NCT01074645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24498242|NCT00513656|Narcotics|narcotics|mesh-ancestor
24624081|NCT01074645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24624082|NCT01074697|Dexamethasone|dexamethasone|mesh-list
24624083|NCT01074697|Palonosetron|palonosetron|mesh-list
24624084|NCT01074697|Fosaprepitant|fosaprepitant|mesh-list
24953399|NCT03885427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953400|NCT03885219|Paclitaxel|paclitaxel|mesh-list
24953401|NCT03885219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24953402|NCT03885219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24953403|NCT03885219|Tubulin Modulators|tubulin modulators|mesh-ancestor
24624085|NCT01074697|Aprepitant|aprepitant|mesh-list
24624086|NCT01074697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24624087|NCT01074697|Antiemetics|antiemetics|mesh-ancestor
24624088|NCT01074697|Autonomic Agents|autonomic agents|mesh-ancestor
24624089|NCT01074697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24624090|NCT01074697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820354|NCT02099240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24624094|NCT01074697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24624095|NCT01074697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24624096|NCT01074697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624097|NCT01074697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624098|NCT01074697|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24624099|NCT01074697|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24624100|NCT01074697|Serotonin Agents|serotonin agents|mesh-ancestor
24624101|NCT01074697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24498216|NCT00513552|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24498217|NCT00513552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498218|NCT00513552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498219|NCT00513552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24498220|NCT00513552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24498221|NCT00513552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24498222|NCT00513552|Antitubercular Agents|antitubercular agents|mesh-ancestor
24498223|NCT00513552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24498224|NCT00513552|Leprostatic Agents|leprostatic agents|mesh-ancestor
24498225|NCT00513578|Sargramostim|sargramostim|mesh-list
24498226|NCT00513578|Freund's Adjuvant|freund's adjuvant|mesh-list
24498227|NCT00513578|Immunologic Factors|immunologic factors|mesh-ancestor
24498228|NCT00513578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624103|NCT01074723|Carotenoids|carotenoids|mesh-list
24624104|NCT01074723|Antioxidants|antioxidants|mesh-ancestor
24624105|NCT01074723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624106|NCT01074723|Protective Agents|protective agents|mesh-ancestor
24624107|NCT01074723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624108|NCT01074801|Insulin|insulin|mesh-list
24498238|NCT00513643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701417|NCT02139644|Adrenergic Agonists|adrenergic agonists|mesh-list
25701418|NCT02139644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24498239|NCT00513656|Oxycodone|oxycodone|mesh-list
24498240|NCT00513656|Naloxone|naloxone|mesh-list
24498241|NCT00513656|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24522880|NCT03103087|Androgen Antagonists|androgen antagonists|mesh-ancestor
24522881|NCT03103087|Hormone Antagonists|hormone antagonists|mesh-ancestor
24522882|NCT03102047|Durvalumab|durvalumab|mesh-list
24522883|NCT03102047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24522896|NCT03071926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24522897|NCT03071926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24522898|NCT03071926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24922674|NCT04178109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24922675|NCT04178109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24922694|NCT04177342|Fentanyl|fentanyl|mesh-list
24922695|NCT04177342|Oxycodone|oxycodone|mesh-list
24922696|NCT04177342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24922697|NCT04177342|Narcotics|narcotics|mesh-ancestor
24922698|NCT04177342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24922699|NCT04177342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922700|NCT04177342|Analgesics|analgesics|mesh-ancestor
24922701|NCT04177342|Sensory System Agents|sensory system agents|mesh-ancestor
24922702|NCT04177342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24922703|NCT04177342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24922704|NCT04177342|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24922705|NCT04177342|Anesthetics, General|anesthetics, general|mesh-ancestor
24922706|NCT04177342|Anesthetics|anesthetics|mesh-ancestor
24498264|NCT00513864|Morphine|morphine|mesh-list
24394395|NCT00133224|Glucocorticoids|glucocorticoids|mesh-ancestor
24922783|NCT04177095|Sirolimus|sirolimus|mesh-list
24922784|NCT04177095|Prednisone|prednisone|mesh-list
24922785|NCT04177095|Everolimus|everolimus|mesh-list
24922786|NCT04177095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24922787|NCT04177095|Glucocorticoids|glucocorticoids|mesh-ancestor
24922788|NCT04177095|Hormones|hormones|mesh-ancestor
24922855|NCT04176328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24522943|NCT03012971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24522945|NCT03012971|Sensory System Agents|sensory system agents|mesh-ancestor
24522946|NCT03012971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24922873|NCT04176068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24922874|NCT04176068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068171|NCT03435900|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25068172|NCT03435900|Metronidazole|metronidazole|mesh-list
25068173|NCT03435900|Fosfomycin|fosfomycin|mesh-list
25068174|NCT03435900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25068175|NCT03435900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25068176|NCT03435900|Antitubercular Agents|antitubercular agents|mesh-ancestor
25068177|NCT03435900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25068178|NCT03435900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25068179|NCT03435744|Simvastatin|simvastatin|mesh-list
25068180|NCT03435744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25068181|NCT03435744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25068182|NCT03435744|Antimetabolites|antimetabolites|mesh-ancestor
25068183|NCT03435744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068184|NCT03435744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24922900|NCT04175158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922901|NCT04175158|Growth Inhibitors|growth inhibitors|mesh-ancestor
24922902|NCT04174937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24922904|NCT04175067|Antioxidants|antioxidants|mesh-list
24624134|NCT01074892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24624135|NCT01074892|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24624136|NCT01074892|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24624137|NCT01074892|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24624138|NCT01074892|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24455321|NCT01795586|Carboplatin|carboplatin|mesh-list
24922920|NCT04174872|Sensory System Agents|sensory system agents|mesh-ancestor
24922921|NCT04174872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24922922|NCT04174872|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24922923|NCT04174872|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24922924|NCT04174872|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24600466|NCT00958854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24600467|NCT00958854|Alkylating Agents|alkylating agents|mesh-ancestor
24600469|NCT00958854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600470|NCT00958854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24600471|NCT00958854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24600473|NCT00958854|Leprostatic Agents|leprostatic agents|mesh-ancestor
24600474|NCT00958854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24600475|NCT00958854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24600686|NCT00959972|Cholinergic Agents|cholinergic agents|mesh-ancestor
24600693|NCT00960037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600694|NCT00960037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24600695|NCT00960037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24636392|NCT01145079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24600696|NCT00960232|Cholecalciferol|cholecalciferol|mesh-list
24600697|NCT00960232|Vitamin D|vitamin d|mesh-list
24600698|NCT00960232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24600699|NCT00960232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600700|NCT00960232|Vitamins|vitamins|mesh-ancestor
24600701|NCT00960232|Micronutrients|micronutrients|mesh-ancestor
24600702|NCT00960232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24600703|NCT00960245|Nadolol|nadolol|mesh-list
24600704|NCT00960245|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24600705|NCT00960245|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24600706|NCT00960245|Adrenergic Agents|adrenergic agents|mesh-ancestor
24600707|NCT00960245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25068213|NCT03435289|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25068214|NCT03435289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25068215|NCT03435289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600798|NCT00960635|Vitamins|vitamins|mesh-ancestor
24600842|NCT00960830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24600843|NCT00960830|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24636471|NCT01145677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24601019|NCT00962156|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24601020|NCT00962156|Plasma Substitutes|plasma substitutes|mesh-ancestor
24601021|NCT00962156|Blood Substitutes|blood substitutes|mesh-ancestor
24601022|NCT00962234|Deuterium Oxide|deuterium oxide|mesh-list
24601023|NCT00962234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24601024|NCT00962234|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24601025|NCT00962234|Protective Agents|protective agents|mesh-ancestor
24601026|NCT00962234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601027|NCT00962286|Furosemide|furosemide|mesh-list
24601028|NCT00962286|Diuretics|diuretics|mesh-ancestor
24601029|NCT00962286|Natriuretic Agents|natriuretic agents|mesh-ancestor
24601122|NCT00962715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601123|NCT00962767|Gemtuzumab|gemtuzumab|mesh-list
24601124|NCT00962767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24601125|NCT00962767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24601165|NCT00963209|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24601167|NCT00963209|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24601169|NCT00963222|Vitamins|vitamins|mesh-ancestor
24601186|NCT00963443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24601187|NCT00963443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601189|NCT00963443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24601190|NCT00963443|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24601191|NCT00963443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24601192|NCT00963443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601193|NCT00963443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24601194|NCT00963443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24601195|NCT00963443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601196|NCT00963443|Antipyretics|antipyretics|mesh-ancestor
24601197|NCT00963443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25701419|NCT02139644|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25701420|NCT02139644|Autonomic Agents|autonomic agents|mesh-ancestor
25701421|NCT02139644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25701422|NCT02139644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701423|NCT02139644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25701424|NCT02139644|Respiratory System Agents|respiratory system agents|mesh-ancestor
25701425|NCT02139644|Dermatologic Agents|dermatologic agents|mesh-ancestor
24601303|NCT00963833|Antiviral Agents|antiviral agents|mesh-ancestor
24601304|NCT00963833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25701426|NCT02139644|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25068223|NCT03435289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24601305|NCT00963833|Immunologic Factors|immunologic factors|mesh-ancestor
24601306|NCT00963833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601307|NCT00963833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24601308|NCT00963846|Huperzine A|huperzine a|mesh-list
24601309|NCT00963846|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24601310|NCT00963846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601343|NCT00964041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24636532|NCT01145976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601344|NCT00964041|Antitubercular Agents|antitubercular agents|mesh-ancestor
24601345|NCT00964041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24601346|NCT00964041|Antimetabolites|antimetabolites|mesh-ancestor
24517228|NCT00606775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24601731|NCT00965796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24601733|NCT00965796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24601734|NCT00965796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601735|NCT00965809|Dronabinol|dronabinol|mesh-list
24601736|NCT00965809|Hallucinogens|hallucinogens|mesh-ancestor
24601775|NCT00965913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24601776|NCT00965913|Autonomic Agents|autonomic agents|mesh-ancestor
24601777|NCT00965913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24601778|NCT00965913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601818|NCT00966082|Propranolol|propranolol|mesh-list
24601819|NCT00966082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24601820|NCT00966082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24601821|NCT00966082|Adrenergic Agents|adrenergic agents|mesh-ancestor
24601822|NCT00966082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24601892|NCT00966329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24601893|NCT00966329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24601894|NCT00966329|Antiviral Agents|antiviral agents|mesh-ancestor
24601895|NCT00966329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24601896|NCT00966329|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24601898|NCT00966368|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24601977|NCT00966836|Everolimus|everolimus|mesh-list
24601978|NCT00966836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24601979|NCT00966836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24601980|NCT00966836|Immunologic Factors|immunologic factors|mesh-ancestor
24601981|NCT00966836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601982|NCT00966836|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24601983|NCT00966836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24601984|NCT00966836|Antitubercular Agents|antitubercular agents|mesh-ancestor
24601994|NCT00966901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601995|NCT00966901|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24601996|NCT00966901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24602105|NCT00967174|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24602106|NCT00967174|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24602107|NCT00967174|Cholinergic Agents|cholinergic agents|mesh-ancestor
24602108|NCT00967174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24602109|NCT00967174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602202|NCT00967603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602354|NCT00968435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24602355|NCT00968435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24602356|NCT00968435|Growth Substances|growth substances|mesh-ancestor
24602357|NCT00968435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602358|NCT00968435|Growth Inhibitors|growth inhibitors|mesh-ancestor
24602359|NCT00968461|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
24602360|NCT00968461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25068228|NCT03435133|Ticagrelor|ticagrelor|mesh-list
24830765|NCT02161159|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24602389|NCT00968578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24602390|NCT00968578|Protective Agents|protective agents|mesh-ancestor
24602391|NCT00968578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24602392|NCT00968578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602393|NCT00968591|Everolimus|everolimus|mesh-list
24602394|NCT00968591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602395|NCT00968591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24602396|NCT00968591|Immunologic Factors|immunologic factors|mesh-ancestor
24602397|NCT00968591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602398|NCT00968682|Trastuzumab|trastuzumab|mesh-list
24539426|NCT00663832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24602399|NCT00968682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25701427|NCT02139644|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24602400|NCT00968682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602401|NCT00968734|Cholecalciferol|cholecalciferol|mesh-list
24602402|NCT00968734|Vitamin D|vitamin d|mesh-list
24602403|NCT00968734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24602404|NCT00968734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602405|NCT00968734|Vitamins|vitamins|mesh-ancestor
24602406|NCT00968734|Micronutrients|micronutrients|mesh-ancestor
24604327|NCT00978588|Plasma Substitutes|plasma substitutes|mesh-ancestor
24602408|NCT00968760|Cytarabine|cytarabine|mesh-list
24602409|NCT00968760|Etoposide|etoposide|mesh-list
24602410|NCT00968760|Melphalan|melphalan|mesh-list
24602411|NCT00968760|Interleukin-2|interleukin-2|mesh-list
24602412|NCT00968760|Carmustine|carmustine|mesh-list
24517396|NCT00607685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24602413|NCT00968760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24602414|NCT00968760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602415|NCT00968760|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24602416|NCT00968760|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24602417|NCT00968760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24602539|NCT00969293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24602540|NCT00969306|Chloroquine|chloroquine|mesh-list
24602541|NCT00969306|Amebicides|amebicides|mesh-ancestor
24602587|NCT00969592|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24602588|NCT00969592|Insulin Aspart|insulin aspart|mesh-list
24602589|NCT00969592|Insulin, Long-Acting|insulin, long-acting|mesh-list
24602590|NCT00969592|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24602591|NCT00969592|Insulin glulisine|insulin glulisine|mesh-list
24602592|NCT00969592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24602641|NCT00969982|Abortifacient Agents|abortifacient agents|mesh-ancestor
24602963|NCT00971763|Antimitotic Agents|antimitotic agents|mesh-ancestor
24602964|NCT00971763|Mitosis Modulators|mitosis modulators|mesh-ancestor
24602965|NCT00971763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24602966|NCT00971763|Glucocorticoids|glucocorticoids|mesh-ancestor
24602967|NCT00971763|Hormones|hormones|mesh-ancestor
24603000|NCT00971893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24603001|NCT00971893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603003|NCT00971893|Glucocorticoids|glucocorticoids|mesh-ancestor
24603004|NCT00971893|Hormones|hormones|mesh-ancestor
24603035|NCT00972101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24603036|NCT00972101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24603037|NCT00972101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24603307|NCT00973219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603309|NCT00973219|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24603310|NCT00973219|Immunologic Factors|immunologic factors|mesh-ancestor
24603311|NCT00973219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603312|NCT00973232|Acetaminophen|acetaminophen|mesh-list
24603313|NCT00973232|Tramadol|tramadol|mesh-list
24603314|NCT00973232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24603323|NCT00973245|Warfarin|warfarin|mesh-list
24603344|NCT00973310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24603346|NCT00973310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603347|NCT00973323|Warfarin|warfarin|mesh-list
24603348|NCT00973323|Rivaroxaban|rivaroxaban|mesh-list
24603349|NCT00973323|Anticoagulants|anticoagulants|mesh-ancestor
24603350|NCT00973323|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24603351|NCT00973323|Antithrombins|antithrombins|mesh-ancestor
24603352|NCT00973323|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24539446|NCT00663897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24603353|NCT00973323|Protease Inhibitors|protease inhibitors|mesh-ancestor
24603354|NCT00973323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603384|NCT00973505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24603385|NCT00973505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603386|NCT00973505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24603389|NCT00973583|Micronutrients|micronutrients|mesh-ancestor
24603433|NCT00973778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25701428|NCT02139644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25701429|NCT02139644|Adrenergic Agents|adrenergic agents|mesh-ancestor
24603435|NCT00973804|Tacrolimus|tacrolimus|mesh-list
25701430|NCT02139644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25701431|NCT02139644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701432|NCT02139644|Tocolytic Agents|tocolytic agents|mesh-ancestor
25701433|NCT02139644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25701434|NCT02139644|Glucocorticoids|glucocorticoids|mesh-ancestor
25701435|NCT02139644|Hormones|hormones|mesh-ancestor
25701436|NCT02139644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25701437|NCT02139943|Canagliflozin|canagliflozin|mesh-list
24603436|NCT00973804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24603437|NCT00973804|Immunologic Factors|immunologic factors|mesh-ancestor
25068240|NCT03435107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603543|NCT00974324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603544|NCT00974389|Bevacizumab|bevacizumab|mesh-list
24603545|NCT00974389|Tegafur|tegafur|mesh-list
24603546|NCT00974389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24603547|NCT00974389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603548|NCT00974389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24603549|NCT00974389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24603550|NCT00974389|Growth Substances|growth substances|mesh-ancestor
24603551|NCT00974389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603552|NCT00974389|Growth Inhibitors|growth inhibitors|mesh-ancestor
24603553|NCT00974389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24603554|NCT00974389|Antimetabolites|antimetabolites|mesh-ancestor
24603555|NCT00974389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603643|NCT00974792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24603644|NCT00974792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24603645|NCT00974792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603646|NCT00974792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24603647|NCT00974792|Abortifacient Agents|abortifacient agents|mesh-ancestor
24603648|NCT00974792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24603649|NCT00974792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24603650|NCT00974792|Antimetabolites|antimetabolites|mesh-ancestor
24603651|NCT00974792|Dermatologic Agents|dermatologic agents|mesh-ancestor
24671159|NCT01324076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24671160|NCT01324076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24671161|NCT01324076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671162|NCT01324076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603884|NCT00975988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603898|NCT00976092|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24603899|NCT00976092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24603900|NCT00976092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24603901|NCT00976092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24603902|NCT00976092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24603903|NCT00976092|Purinergic Agents|purinergic agents|mesh-ancestor
24603904|NCT00976092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24603905|NCT00976092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603906|NCT00976092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603908|NCT00976092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25068242|NCT03435094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25068243|NCT03435094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068244|NCT03434951|Morphine|morphine|mesh-list
25068245|NCT03434951|Bupivacaine|bupivacaine|mesh-list
25068246|NCT03434951|Anesthetics, Local|anesthetics, local|mesh-ancestor
25068247|NCT03434951|Anesthetics|anesthetics|mesh-ancestor
25068248|NCT03434951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24603909|NCT00976092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24603910|NCT00976092|Antithrombins|antithrombins|mesh-ancestor
24603911|NCT00976092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24603912|NCT00976092|Protease Inhibitors|protease inhibitors|mesh-ancestor
24603913|NCT00976092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603914|NCT00976105|Zolpidem|zolpidem|mesh-list
24603915|NCT00976105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
24603960|NCT00976300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603961|NCT00976300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603962|NCT00976300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24603980|NCT00976690|Azathioprine|azathioprine|mesh-list
24603992|NCT00976690|Sensory System Agents|sensory system agents|mesh-ancestor
24604135|NCT00977301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604136|NCT00977301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24604137|NCT00977301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24604138|NCT00977301|Antiviral Agents|antiviral agents|mesh-ancestor
24604139|NCT00977301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24604140|NCT00977301|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24604141|NCT00977301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24604178|NCT00977444|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24604179|NCT00977444|Prednisolone phosphate|prednisolone phosphate|mesh-list
24604180|NCT00977444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24604181|NCT00977444|Glucocorticoids|glucocorticoids|mesh-ancestor
24604182|NCT00977444|Hormones|hormones|mesh-ancestor
24604183|NCT00977444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24604184|NCT00977444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604185|NCT00977444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24604186|NCT00977444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604187|NCT00977444|Antiemetics|antiemetics|mesh-ancestor
24604188|NCT00977444|Autonomic Agents|autonomic agents|mesh-ancestor
24604189|NCT00977444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24604190|NCT00977444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24604328|NCT00978588|Blood Substitutes|blood substitutes|mesh-ancestor
25068249|NCT03434951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068250|NCT03434951|Sensory System Agents|sensory system agents|mesh-ancestor
25068251|NCT03434951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25068252|NCT03434951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25068253|NCT03434951|Narcotics|narcotics|mesh-ancestor
25068254|NCT03434951|Analgesics|analgesics|mesh-ancestor
25068255|NCT03434782|Listerine|listerine|mesh-list
25068256|NCT03434782|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25068257|NCT03434782|Fluorides|fluorides|mesh-list
24830787|NCT02161367|Emollients|emollients|mesh-ancestor
24604329|NCT00978601|Analgesics|analgesics|mesh-list
24604330|NCT00978601|Sensory System Agents|sensory system agents|mesh-ancestor
24604331|NCT00978601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24604332|NCT00978601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604361|NCT00978822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24604362|NCT00978822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24604363|NCT00978822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604364|NCT00978822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24604365|NCT00978822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604454|NCT00979589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24604455|NCT00979589|Analgesics|analgesics|mesh-ancestor
24604456|NCT00979589|Sensory System Agents|sensory system agents|mesh-ancestor
24604457|NCT00979589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24604458|NCT00979589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24604459|NCT00979589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24604460|NCT00979589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24604461|NCT00979589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24604462|NCT00979589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24604463|NCT00979589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604464|NCT00979589|Antipyretics|antipyretics|mesh-ancestor
24604465|NCT00979641|Docetaxel|docetaxel|mesh-list
24604466|NCT00979641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604467|NCT00979641|Tubulin Modulators|tubulin modulators|mesh-ancestor
24604468|NCT00979641|Antimitotic Agents|antimitotic agents|mesh-ancestor
25068258|NCT03434782|Sodium Fluoride|sodium fluoride|mesh-list
25068259|NCT03434782|Cariostatic Agents|cariostatic agents|mesh-ancestor
24604469|NCT00979641|Mitosis Modulators|mitosis modulators|mesh-ancestor
24604470|NCT00979641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604471|NCT00979667|Oseltamivir|oseltamivir|mesh-list
24604472|NCT00979667|Zanamivir|zanamivir|mesh-list
24604511|NCT00979862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604512|NCT00979862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604513|NCT00979862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605027|NCT00983021|Insulin, Long-Acting|insulin, long-acting|mesh-list
24605028|NCT00983021|Xultophy|xultophy|mesh-list
24605029|NCT00983021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24605030|NCT00983021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605031|NCT00983021|Incretins|incretins|mesh-ancestor
24605032|NCT00983021|Hormones|hormones|mesh-ancestor
24605033|NCT00983021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24605195|NCT00983736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605196|NCT00983736|Analgesics|analgesics|mesh-ancestor
24605197|NCT00983736|Sensory System Agents|sensory system agents|mesh-ancestor
24605198|NCT00983736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24605265|NCT00984347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605300|NCT00984425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605301|NCT00984425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605302|NCT00984438|Bevacizumab|bevacizumab|mesh-list
24605303|NCT00984438|Irinotecan|irinotecan|mesh-list
24605304|NCT00984438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24605305|NCT00984438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605452|NCT00985270|Leprostatic Agents|leprostatic agents|mesh-ancestor
24605511|NCT00985647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605512|NCT00985647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465551|NCT00370019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24802762|NCT01992211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802763|NCT01992211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24605514|NCT00985647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24605515|NCT00985647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24671198|NCT01324180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671203|NCT01324245|Fenoldopam|fenoldopam|mesh-list
24671231|NCT01324284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671232|NCT01324336|Mercaptopurine|mercaptopurine|mesh-list
24605516|NCT00985647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24605517|NCT00985660|Nisoldipine|nisoldipine|mesh-list
24606009|NCT00988520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24605518|NCT00985660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24605519|NCT00985660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24605520|NCT00985660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24605521|NCT00985660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605522|NCT00985660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24605523|NCT00985660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605524|NCT00985660|Vasodilator Agents|vasodilator agents|mesh-ancestor
24605525|NCT00985777|Vitamin E|vitamin e|mesh-list
24605596|NCT00986284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605598|NCT00986336|Risperidone|risperidone|mesh-list
24605599|NCT00986336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24605600|NCT00986336|Serotonin Agents|serotonin agents|mesh-ancestor
24605601|NCT00986336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24605602|NCT00986336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605603|NCT00986336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605604|NCT00986336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24605621|NCT00986505|Anesthetics, Local|anesthetics, local|mesh-ancestor
24605622|NCT00986505|Anesthetics|anesthetics|mesh-ancestor
24605650|NCT00986596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24605651|NCT00986596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24605653|NCT00986609|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24605654|NCT00986609|Vaccines|vaccines|mesh-list
24605655|NCT00986609|Poly ICLC|poly iclc|mesh-list
24605656|NCT00986609|Immunologic Factors|immunologic factors|mesh-ancestor
25068265|NCT03434704|Clotrimazole|clotrimazole|mesh-list
25068266|NCT03434704|Miconazole|miconazole|mesh-list
25068267|NCT03434704|Fludarabine|fludarabine|mesh-list
25068281|NCT03434704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25068282|NCT03434704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605751|NCT00987116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605752|NCT00987116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24605754|NCT00987116|Immunologic Factors|immunologic factors|mesh-ancestor
25068295|NCT03434691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24830831|NCT02161679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24830832|NCT02161679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830833|NCT02161679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605765|NCT00987207|Immunologic Factors|immunologic factors|mesh-ancestor
24605766|NCT00987207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605767|NCT00987207|Antifungal Agents|antifungal agents|mesh-ancestor
24605768|NCT00987207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24605769|NCT00987207|Dermatologic Agents|dermatologic agents|mesh-ancestor
24605770|NCT00987207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24605771|NCT00987207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24605772|NCT00987220|Donepezil|donepezil|mesh-list
24605818|NCT00987493|Rituximab|rituximab|mesh-list
24605819|NCT00987493|Lenalidomide|lenalidomide|mesh-list
24605820|NCT00987493|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24605821|NCT00987493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24605822|NCT00987493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605839|NCT00987636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24605840|NCT00987636|Immunologic Factors|immunologic factors|mesh-ancestor
24605841|NCT00987636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605842|NCT00987636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24605843|NCT00987636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605846|NCT00987662|Amlodipine|amlodipine|mesh-list
25407400|NCT03504410|Sensory System Agents|sensory system agents|mesh-ancestor
25701438|NCT02139943|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25701439|NCT02139943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701440|NCT02139943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24802839|NCT01992653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605855|NCT00987662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24605910|NCT00987844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605911|NCT00987870|Betamethasone|betamethasone|mesh-list
24605912|NCT00987870|Calcipotriene|calcipotriene|mesh-list
24605913|NCT00987870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24605950|NCT00988039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24605951|NCT00988078|Metformin|metformin|mesh-list
24605952|NCT00988078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24605953|NCT00988078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605954|NCT00988195|Doxorubicin|doxorubicin|mesh-list
24605955|NCT00988195|BCT-100|bct-100|mesh-list
24605956|NCT00988195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24605957|NCT00988195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605958|NCT00988195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24605959|NCT00988195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24606007|NCT00988520|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24606008|NCT00988520|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24606013|NCT00988663|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24606043|NCT00988728|Antiemetics|antiemetics|mesh-ancestor
24606044|NCT00988728|Autonomic Agents|autonomic agents|mesh-ancestor
24606045|NCT00988728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24606046|NCT00988728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606047|NCT00988728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24606104|NCT00988897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606105|NCT00988897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24606106|NCT00988897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24606235|NCT00989625|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24606236|NCT00989625|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24606275|NCT00989690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24606276|NCT00989690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24606277|NCT00989703|Methotrexate|methotrexate|mesh-list
24606278|NCT00989703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24606279|NCT00989703|Abortifacient Agents|abortifacient agents|mesh-ancestor
24606474|NCT00990600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24606527|NCT00990808|Anacetrapib|anacetrapib|mesh-list
24606528|NCT00990808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24606529|NCT00990808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24606530|NCT00990808|Antimetabolites|antimetabolites|mesh-ancestor
24606531|NCT00990808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606532|NCT00990808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24606533|NCT00990808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24606534|NCT00990808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606535|NCT00990834|Simvastatin|simvastatin|mesh-list
24606536|NCT00990834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24606537|NCT00990834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24606538|NCT00990834|Antimetabolites|antimetabolites|mesh-ancestor
24606539|NCT00990834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606540|NCT00990834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24606557|NCT00990860|Doxorubicin|doxorubicin|mesh-list
24606569|NCT00990886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24606570|NCT00990886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24606571|NCT00990886|Cholinergic Agents|cholinergic agents|mesh-ancestor
24606572|NCT00990886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24606573|NCT00990886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606574|NCT00990886|Urological Agents|urological agents|mesh-ancestor
24606576|NCT00990990|Oxazolidinones|oxazolidinones|mesh-list
24606577|NCT00990990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24606578|NCT00990990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24606580|NCT00990990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606727|NCT00991822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606729|NCT05409027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24606730|NCT05409027|Glucocorticoids|glucocorticoids|mesh-list
24606731|NCT05409027|Hormones|hormones|mesh-ancestor
24606732|NCT05409027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24606733|NCT05409027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606734|NCT05408988|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24606735|NCT05408988|Natriuretic Agents|natriuretic agents|mesh-ancestor
24606738|NCT05408936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606739|NCT05408936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25701441|NCT02139943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606740|NCT05408936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068320|NCT03434613|Antimetabolites|antimetabolites|mesh-ancestor
25068321|NCT03434613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068322|NCT03434613|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25068323|NCT03434613|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25068324|NCT03434613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25068325|NCT03434405|Psychotropic Drugs|psychotropic drugs|mesh-list
24606882|NCT05407467|Analgesics|analgesics|mesh-ancestor
24606883|NCT05407467|Sensory System Agents|sensory system agents|mesh-ancestor
24607177|NCT05072093|Antiviral Agents|antiviral agents|mesh-ancestor
24607181|NCT05072093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24607962|NCT03077698|Progestins|progestins|mesh-list
24607963|NCT03077698|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
24607994|NCT02874742|Bortezomib|bortezomib|mesh-list
24608008|NCT02874742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24608009|NCT02874742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24608116|NCT02315326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24608118|NCT02275286|Trabectedin|trabectedin|mesh-list
24608119|NCT02275286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24608120|NCT02275286|Alkylating Agents|alkylating agents|mesh-ancestor
24608121|NCT02275286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608122|NCT02275286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608177|NCT02007655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608178|NCT02007655|Anticoagulants|anticoagulants|mesh-ancestor
24608786|NCT00993694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24608787|NCT00993694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24608788|NCT00993694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608789|NCT00993694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608790|NCT00993694|Leprostatic Agents|leprostatic agents|mesh-ancestor
24608791|NCT00993694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24608792|NCT00993707|Hyaluronic Acid|hyaluronic acid|mesh-list
24608793|NCT00993707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24608794|NCT00993707|Immunologic Factors|immunologic factors|mesh-ancestor
24608795|NCT00993707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608796|NCT00993707|Viscosupplements|viscosupplements|mesh-ancestor
24608797|NCT00993707|Protective Agents|protective agents|mesh-ancestor
24608798|NCT00993720|Liraglutide|liraglutide|mesh-list
24608799|NCT00993720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24608800|NCT00993720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608801|NCT00993720|Incretins|incretins|mesh-ancestor
24608802|NCT00993720|Hormones|hormones|mesh-ancestor
24608827|NCT00993863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24608828|NCT00993863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24608829|NCT00993863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608830|NCT00993863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608831|NCT00993876|Citalopram|citalopram|mesh-list
24608832|NCT00993876|Reboxetine|reboxetine|mesh-list
24609246|NCT00995618|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24609247|NCT00995657|Fluticasone|fluticasone|mesh-list
24609249|NCT00995657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24609250|NCT00995657|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24609280|NCT00995839|Vasopressins|vasopressins|mesh-list
24609281|NCT00995839|Arginine Vasopressin|arginine vasopressin|mesh-list
24609282|NCT00995839|Hemostatics|hemostatics|mesh-ancestor
24609283|NCT00995839|Coagulants|coagulants|mesh-ancestor
24609284|NCT00995839|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24609285|NCT00995839|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24609286|NCT00995839|Natriuretic Agents|natriuretic agents|mesh-ancestor
24609287|NCT00995839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701442|NCT02139982|Ropivacaine|ropivacaine|mesh-list
24609288|NCT00995839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24609526|NCT00997074|Sensory System Agents|sensory system agents|mesh-ancestor
24609527|NCT00997074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25701443|NCT02139982|Anesthetics, Local|anesthetics, local|mesh-ancestor
25701444|NCT02139982|Anesthetics|anesthetics|mesh-ancestor
25701445|NCT02139982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24465808|NCT00370760|Dexamethasone|dexamethasone|mesh-list
24609528|NCT00997074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609529|NCT00997074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24609530|NCT00997074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24609531|NCT00997074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25068347|NCT03434275|Sensory System Agents|sensory system agents|mesh-ancestor
25068348|NCT03434275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24609532|NCT00997074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609534|NCT00997087|Antidotes|antidotes|mesh-ancestor
24609535|NCT00997087|Protective Agents|protective agents|mesh-ancestor
24609536|NCT00997087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609537|NCT00997087|GABA Modulators|gaba modulators|mesh-ancestor
24609538|NCT00997087|GABA Agents|gaba agents|mesh-ancestor
24609539|NCT00997087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24609540|NCT00997087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609541|NCT00997191|Triamcinolone|triamcinolone|mesh-list
24609542|NCT00997191|Bevacizumab|bevacizumab|mesh-list
24609552|NCT00997191|Hormones|hormones|mesh-ancestor
24609553|NCT00997191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24609554|NCT00997269|Ubiquinone|ubiquinone|mesh-list
24609555|NCT00997269|Coenzyme Q10|coenzyme q10|mesh-list
24609556|NCT00997269|Micronutrients|micronutrients|mesh-ancestor
24609557|NCT00997269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609559|NCT00997347|Misoprostol|misoprostol|mesh-list
24609560|NCT00997347|Mifepristone|mifepristone|mesh-list
24610088|NCT00999791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610090|NCT00999791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24610091|NCT00999791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24610092|NCT00999791|Analgesics|analgesics|mesh-ancestor
24610093|NCT00999791|Sensory System Agents|sensory system agents|mesh-ancestor
24610094|NCT00999791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24610095|NCT00999791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24671405|NCT01325558|Antiviral Agents|antiviral agents|mesh-ancestor
24671406|NCT01325558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24671407|NCT01325558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671408|NCT01325558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24671409|NCT01325558|Immunologic Factors|immunologic factors|mesh-ancestor
24671410|NCT01325558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671411|NCT01325571|Tacrolimus|tacrolimus|mesh-list
24671412|NCT01325571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24671413|NCT01325571|Immunologic Factors|immunologic factors|mesh-ancestor
24671414|NCT01325571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671415|NCT01325571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24671416|NCT01325571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671417|NCT01325571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610221|NCT01000623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610222|NCT01000623|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24610259|NCT01000857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24610260|NCT01000857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24610261|NCT01000857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539607|NCT00664690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539608|NCT00664690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24610262|NCT01000857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24610263|NCT01000857|Serotonin Agents|serotonin agents|mesh-ancestor
24610266|NCT01000857|Antidepressive Agents|antidepressive agents|mesh-ancestor
24610267|NCT01000857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24610268|NCT01000857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24610269|NCT01000857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24610270|NCT01000857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610271|NCT01000896|Paclitaxel|paclitaxel|mesh-list
24610272|NCT01000896|Carboplatin|carboplatin|mesh-list
24610273|NCT01000896|Saracatinib|saracatinib|mesh-list
24610274|NCT01000896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24610275|NCT01000896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610358|NCT01001624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610360|NCT01001624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610361|NCT01001624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24610362|NCT01001637|Curcumin|curcumin|mesh-list
24610363|NCT01001637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24610364|NCT01001637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24610365|NCT01001637|Analgesics|analgesics|mesh-ancestor
24610366|NCT01001637|Sensory System Agents|sensory system agents|mesh-ancestor
24671487|NCT01326221|Tenofovir|tenofovir|mesh-list
25701447|NCT02139982|Sensory System Agents|sensory system agents|mesh-ancestor
24671543|NCT01326468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671544|NCT01326494|Prednisone|prednisone|mesh-list
24671545|NCT01326494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24671546|NCT01326494|Glucocorticoids|glucocorticoids|mesh-ancestor
24671547|NCT01326494|Hormones|hormones|mesh-ancestor
24671548|NCT01326494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24671549|NCT01326494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671550|NCT01326494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24671551|NCT01326494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637379|NCT01149980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671579|NCT01326611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24671580|NCT01326611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24671581|NCT01326611|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24671582|NCT01326611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671652|NCT01326988|Anesthetics|anesthetics|mesh-list
24671653|NCT01326988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24671654|NCT01326988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671706|NCT01327235|Cisplatin|cisplatin|mesh-list
25068366|NCT03434197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25068367|NCT03434197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447343|NCT00308269|Micronutrients|micronutrients|mesh-ancestor
24671746|NCT01327469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24671747|NCT01327469|Antinematodal Agents|antinematodal agents|mesh-ancestor
24671748|NCT01327469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610389|NCT01001780|Pentostatin|pentostatin|mesh-list
24610402|NCT01001845|Vitamin E|vitamin e|mesh-list
24671808|NCT01327859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671809|NCT01327859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671810|NCT01327859|Cholinergic Agents|cholinergic agents|mesh-ancestor
24671811|NCT01327859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24671812|NCT01327859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671858|NCT01328171|Vitamins|vitamins|mesh-ancestor
24456050|NCT00329693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456051|NCT00329693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456052|NCT00329758|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24456053|NCT00329758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24456054|NCT00329758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24672016|NCT01329276|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24672017|NCT01329276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24672018|NCT01329276|Respiratory System Agents|respiratory system agents|mesh-ancestor
24672019|NCT01329289|Dexamethasone|dexamethasone|mesh-list
24672020|NCT01329289|Dexamethasone acetate|dexamethasone acetate|mesh-list
24672049|NCT01329406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24672050|NCT01329406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672051|NCT01329406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24672052|NCT01329406|Analgesics|analgesics|mesh-ancestor
25068369|NCT03434106|Anticoagulants|anticoagulants|mesh-ancestor
24672202|NCT01330563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24672203|NCT01330563|Hormone Antagonists|hormone antagonists|mesh-ancestor
24672204|NCT01330563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24672244|NCT01330706|Disinfectants|disinfectants|mesh-ancestor
24672245|NCT01330706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24672246|NCT01330810|Curcumin|curcumin|mesh-list
24637501|NCT01150786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672329|NCT01331590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672330|NCT01331590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24672331|NCT01331590|Glucocorticoids|glucocorticoids|mesh-ancestor
24672332|NCT01331590|Hormones|hormones|mesh-ancestor
25701448|NCT02139982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25701449|NCT02140060|Travoprost|travoprost|mesh-list
25701450|NCT02140060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25701451|NCT02140060|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25701452|NCT02140060|Brinzolamide|brinzolamide|mesh-list
25701453|NCT02140060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25701454|NCT02140060|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24803164|NCT01994967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803165|NCT01994967|Sensory System Agents|sensory system agents|mesh-ancestor
24803166|NCT01994967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803168|NCT01994980|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24803169|NCT01994980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24803170|NCT01994980|Antitubercular Agents|antitubercular agents|mesh-ancestor
24672333|NCT01331590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24672334|NCT01331590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24672335|NCT01331590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24675812|NCT01345448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24672336|NCT01331590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24672337|NCT01331590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24672338|NCT01331590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25068382|NCT03433859|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25068383|NCT03433859|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25068384|NCT03433859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25068385|NCT03433859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068386|NCT03433859|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25068387|NCT03433859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25068388|NCT03433859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672494|NCT01332383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672532|NCT01332422|Respiratory System Agents|respiratory system agents|mesh-ancestor
24672533|NCT01332422|Dermatologic Agents|dermatologic agents|mesh-ancestor
24672534|NCT01332422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24672535|NCT01332422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24672536|NCT01332422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24672537|NCT01332422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24672538|NCT01332422|Adrenergic Agents|adrenergic agents|mesh-ancestor
24517857|NCT00610350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672539|NCT01332422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24672852|NCT01333982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24672853|NCT01333982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24672870|NCT01334073|Immunologic Factors|immunologic factors|mesh-ancestor
24672871|NCT01334073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672872|NCT01334073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24672878|NCT01334112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672879|NCT01334112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24672880|NCT01334112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672881|NCT01334112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672883|NCT01334151|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24672884|NCT01334151|Insulin Lispro|insulin lispro|mesh-list
24672885|NCT01334151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24672886|NCT01334151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672887|NCT01334177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24672888|NCT01334177|Cetuximab|cetuximab|mesh-list
24672889|NCT01334177|Antibodies|antibodies|mesh-list
24672890|NCT01334177|Immunoglobulins|immunoglobulins|mesh-list
24672891|NCT01334177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24672892|NCT01334177|Immunologic Factors|immunologic factors|mesh-ancestor
24672893|NCT01334177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672894|NCT01334177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672895|NCT01334203|Ranolazine|ranolazine|mesh-list
24672896|NCT01334203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24672897|NCT01334203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24672898|NCT01334203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672899|NCT01334268|Paclitaxel|paclitaxel|mesh-list
24672982|NCT01334632|Sensory System Agents|sensory system agents|mesh-ancestor
24672983|NCT01334632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24672984|NCT01334645|Arginine Vasopressin|arginine vasopressin|mesh-list
25701455|NCT02140060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25701456|NCT02140060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701457|NCT02140164|Minocycline|minocycline|mesh-list
25701458|NCT02140164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25701459|NCT02140164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25701460|NCT02140372|Colchicine|colchicine|mesh-list
25701461|NCT02140372|Gout Suppressants|gout suppressants|mesh-ancestor
24803363|NCT01996085|Adrenergic Agents|adrenergic agents|mesh-ancestor
24803364|NCT01996085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24803365|NCT01996150|Sodium Hypochlorite|sodium hypochlorite|mesh-list
24803367|NCT01996150|Disinfectants|disinfectants|mesh-ancestor
24803368|NCT01996150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24803369|NCT01996189|Insulin|insulin|mesh-list
24803370|NCT01996189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24673079|NCT01335321|Triamcinolone|triamcinolone|mesh-list
25068395|NCT03433807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068396|NCT03433586|Aspirin|aspirin|mesh-list
25068397|NCT03433586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25068398|NCT03433586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25068399|NCT03433586|Analgesics|analgesics|mesh-ancestor
25068400|NCT03433586|Sensory System Agents|sensory system agents|mesh-ancestor
25068401|NCT03433586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25068402|NCT03433586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830902|NCT02162121|Anesthetics|anesthetics|mesh-list
24830903|NCT02162121|Ropivacaine|ropivacaine|mesh-list
24673080|NCT01335321|Hyaluronic Acid|hyaluronic acid|mesh-list
24673082|NCT01335321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24673083|NCT01335321|Glucocorticoids|glucocorticoids|mesh-ancestor
24673084|NCT01335321|Hormones|hormones|mesh-ancestor
24673085|NCT01335321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24673091|NCT01335334|Metronidazole|metronidazole|mesh-list
24673092|NCT01335334|Tetracycline|tetracycline|mesh-list
24673093|NCT01335334|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
24673094|NCT01335334|Omeprazole|omeprazole|mesh-list
24673095|NCT01335334|Bismuth|bismuth|mesh-list
24673096|NCT01335334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673097|NCT01335334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24673098|NCT01335334|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24673099|NCT01335334|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24673215|NCT01336218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673216|NCT01336218|Leprostatic Agents|leprostatic agents|mesh-ancestor
24673217|NCT01336218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24673218|NCT01336218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673219|NCT01336218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673220|NCT01336218|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25068408|NCT03433586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25068409|NCT03433586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25068410|NCT03433586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830911|NCT02162121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24673306|NCT01336829|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24673307|NCT01336829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24673308|NCT01336829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673310|NCT01336829|Antiviral Agents|antiviral agents|mesh-ancestor
24673348|NCT01337323|Dermatologic Agents|dermatologic agents|mesh-ancestor
24673349|NCT01337323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24673350|NCT01337362|Insulin|insulin|mesh-list
24673351|NCT01337362|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24673352|NCT01337362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24673353|NCT01337362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673354|NCT01337375|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24673355|NCT01337375|Interferon-alpha|interferon-alpha|mesh-list
24610482|NCT01002690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24610483|NCT01002690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24610484|NCT01002690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24610485|NCT01002690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24610486|NCT01002690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673588|NCT01339039|Bevacizumab|bevacizumab|mesh-list
24673589|NCT01339039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24673590|NCT01339039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673591|NCT01339039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25701462|NCT02140372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25701463|NCT02140372|Tubulin Modulators|tubulin modulators|mesh-ancestor
25701464|NCT02140372|Antimitotic Agents|antimitotic agents|mesh-ancestor
25701465|NCT02140372|Mitosis Modulators|mitosis modulators|mesh-ancestor
25701466|NCT02140372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701467|NCT02140372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25701468|NCT02140411|Ranibizumab|ranibizumab|mesh-list
25701469|NCT02140411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24673628|NCT01339286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24673629|NCT01339286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068412|NCT03433534|Nivolumab|nivolumab|mesh-list
25068415|NCT03433534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24803601|NCT01997294|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24803602|NCT01997294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24803603|NCT01997294|Antimetabolites|antimetabolites|mesh-ancestor
24803604|NCT01997294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068416|NCT03433534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068417|NCT03433469|Osimertinib|osimertinib|mesh-list
25068418|NCT03433469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673631|NCT01339312|Immunologic Factors|immunologic factors|mesh-ancestor
24673632|NCT01339312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673633|NCT01339442|Fulvestrant|fulvestrant|mesh-list
24673634|NCT01339442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24673635|NCT01339442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673636|NCT01339442|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24673637|NCT01339442|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24673638|NCT01339442|Hormone Antagonists|hormone antagonists|mesh-ancestor
24673639|NCT01339442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24673640|NCT01339442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673642|NCT01339468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24673643|NCT01339468|Immunologic Factors|immunologic factors|mesh-ancestor
24673644|NCT01339468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673645|NCT01339468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24673646|NCT01339468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673647|NCT01339468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673648|NCT01339481|Abatacept|abatacept|mesh-list
24673722|NCT01339754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610547|NCT01003002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610550|NCT01003054|Imatinib Mesylate|imatinib mesylate|mesh-list
24610551|NCT01003054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24610552|NCT01003054|Immunologic Factors|immunologic factors|mesh-ancestor
24610553|NCT01003054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674440|NCT05220319|Prednisolone acetate|prednisolone acetate|mesh-list
24674441|NCT05220319|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24674442|NCT05220319|Prednisolone phosphate|prednisolone phosphate|mesh-list
24674520|NCT05148312|Glucocorticoids|glucocorticoids|mesh-ancestor
24674522|NCT05148312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24674523|NCT05124691|Ivermectin|ivermectin|mesh-list
24674524|NCT05124691|Albendazole|albendazole|mesh-list
24674525|NCT05124691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24610561|NCT01003054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610562|NCT01003158|Paclitaxel|paclitaxel|mesh-list
24610563|NCT01003158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24610564|NCT01003158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610565|NCT01003158|Tubulin Modulators|tubulin modulators|mesh-ancestor
24674648|NCT04983407|Tubulin Modulators|tubulin modulators|mesh-ancestor
24674649|NCT04983407|Antimitotic Agents|antimitotic agents|mesh-ancestor
24674704|NCT04757571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24674705|NCT04757571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24674706|NCT04757571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24674707|NCT04757571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674708|NCT04757571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24610642|NCT01004237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24610643|NCT01004237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24610644|NCT01004237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610645|NCT01004315|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24610646|NCT01004315|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24675011|NCT03635749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24675012|NCT03635749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675013|NCT03635749|Antipyretics|antipyretics|mesh-ancestor
25068428|NCT03433352|Antithyroid Agents|antithyroid agents|mesh-ancestor
25068429|NCT03433352|Hormone Antagonists|hormone antagonists|mesh-ancestor
25068430|NCT03433352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25068431|NCT03433352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675014|NCT03635749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24675015|NCT03635749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24675016|NCT03635749|Antimetabolites|antimetabolites|mesh-ancestor
24675017|NCT03635749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25701470|NCT02140411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25701471|NCT02140411|Growth Substances|growth substances|mesh-ancestor
25701472|NCT02140411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701473|NCT02140411|Growth Inhibitors|growth inhibitors|mesh-ancestor
24675050|NCT03526432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675051|NCT03526432|Growth Inhibitors|growth inhibitors|mesh-ancestor
24675264|NCT02225405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610704|NCT01004497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24610705|NCT01004497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24610706|NCT01004497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24610707|NCT01004497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24610709|NCT01004497|Sensory System Agents|sensory system agents|mesh-ancestor
24610711|NCT01004575|Chromium|chromium|mesh-list
24610712|NCT01004575|Trace Elements|trace elements|mesh-ancestor
24610714|NCT01004575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675302|NCT00812006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24675303|NCT00812006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675304|NCT00812006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675306|NCT00739050|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24675307|NCT00739050|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24675308|NCT00739050|Antimetabolites|antimetabolites|mesh-ancestor
24675309|NCT00739050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675310|NCT00739050|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25068432|NCT03433352|Antimetabolites|antimetabolites|mesh-ancestor
25068433|NCT03433352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068434|NCT03433326|Grazoprevir|grazoprevir|mesh-list
25068435|NCT03433326|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
24675318|NCT00654628|Ezetimibe|ezetimibe|mesh-list
24675422|NCT00189280|Interferon Inducers|interferon inducers|mesh-ancestor
24675423|NCT00166504|Atorvastatin|atorvastatin|mesh-list
24675424|NCT00166504|Simvastatin|simvastatin|mesh-list
24675425|NCT00166504|Ezetimibe|ezetimibe|mesh-list
24675426|NCT00166504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24675427|NCT00166504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24675428|NCT00166504|Antimetabolites|antimetabolites|mesh-ancestor
24675430|NCT00166504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24675456|NCT01343225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675509|NCT01343628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675510|NCT01343628|Adrenergic Agents|adrenergic agents|mesh-ancestor
24675511|NCT01343628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24675512|NCT01343628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675513|NCT01343680|Heparin|heparin|mesh-list
24675741|NCT01344720|Etoricoxib|etoricoxib|mesh-list
24675806|NCT01345370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675807|NCT01345370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24675808|NCT01345448|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24675809|NCT01345448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24675810|NCT01345448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24675811|NCT01345448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24675813|NCT01345448|Adrenergic Agents|adrenergic agents|mesh-ancestor
24675821|NCT01345604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675822|NCT01345604|Sensory System Agents|sensory system agents|mesh-ancestor
24675823|NCT01345604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24675824|NCT01345643|Chrysarobin|chrysarobin|mesh-list
24675825|NCT01345643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24675894|NCT01346137|Meloxicam|meloxicam|mesh-list
24610765|NCT01004900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24610767|NCT01005095|Ergocalciferols|ergocalciferols|mesh-list
24676180|NCT01348984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24676181|NCT01348984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460516|NCT00348530|Verapamil|verapamil|mesh-list
24676241|NCT01349205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24676242|NCT01349257|Formoterol Fumarate|formoterol fumarate|mesh-list
24676243|NCT01349257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24676244|NCT01349257|Autonomic Agents|autonomic agents|mesh-ancestor
24676245|NCT01349257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24676246|NCT01349257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676247|NCT01349257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24803896|NCT01999413|Daunorubicin|daunorubicin|mesh-list
24803898|NCT01999413|Antimetabolites|antimetabolites|mesh-ancestor
24803927|NCT01999673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803928|NCT01999686|Metformin|metformin|mesh-list
24803929|NCT01999686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24676248|NCT01349257|Respiratory System Agents|respiratory system agents|mesh-ancestor
24676249|NCT01349257|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24676250|NCT01349257|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24676251|NCT01349257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24676252|NCT01349257|Adrenergic Agents|adrenergic agents|mesh-ancestor
24676253|NCT01349257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24676254|NCT01349257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676255|NCT01349270|Prednisone|prednisone|mesh-list
25068461|NCT03433144|Hemostatics|hemostatics|mesh-ancestor
25068462|NCT03433144|Coagulants|coagulants|mesh-ancestor
25068463|NCT03433092|Carotenoids|carotenoids|mesh-list
25068464|NCT03433092|Antioxidants|antioxidants|mesh-ancestor
24676400|NCT01350024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676401|NCT01350024|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24676402|NCT01350024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24676404|NCT01350024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24676405|NCT01350024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25068468|NCT03433014|Levobupivacaine|levobupivacaine|mesh-list
25068469|NCT03433014|Anesthetics, Local|anesthetics, local|mesh-ancestor
25068470|NCT03433014|Anesthetics|anesthetics|mesh-ancestor
25068471|NCT03433014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25068472|NCT03433014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068473|NCT03433014|Sensory System Agents|sensory system agents|mesh-ancestor
25068474|NCT03433014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25068475|NCT03433001|Dexamethasone|dexamethasone|mesh-list
25068476|NCT03433001|Lenalidomide|lenalidomide|mesh-list
25068477|NCT03433001|Ixazomib|ixazomib|mesh-list
25068478|NCT03433001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25068479|NCT03433001|Antiemetics|antiemetics|mesh-ancestor
25068480|NCT03433001|Autonomic Agents|autonomic agents|mesh-ancestor
24677252|NCT01355263|Vitamins|vitamins|mesh-ancestor
24677253|NCT01355263|Micronutrients|micronutrients|mesh-ancestor
24677254|NCT01355263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677255|NCT01355276|Domperidone|domperidone|mesh-list
24677256|NCT01355276|Cinitapride|cinitapride|mesh-list
24677257|NCT01355276|Antiemetics|antiemetics|mesh-ancestor
24677258|NCT01355276|Autonomic Agents|autonomic agents|mesh-ancestor
24677304|NCT01355562|Sensory System Agents|sensory system agents|mesh-ancestor
24677393|NCT01356121|GABA Agents|gaba agents|mesh-ancestor
24677394|NCT01356121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24677395|NCT01356121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677396|NCT01356212|Ketorolac|ketorolac|mesh-list
24677397|NCT01356212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24677398|NCT01356212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24677399|NCT01356212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24677400|NCT01356212|Analgesics|analgesics|mesh-ancestor
24677401|NCT01356212|Sensory System Agents|sensory system agents|mesh-ancestor
24677402|NCT01356212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24677403|NCT01356212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677404|NCT01356212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25068491|NCT03433001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25068492|NCT03433001|Growth Substances|growth substances|mesh-ancestor
25068493|NCT03433001|Growth Inhibitors|growth inhibitors|mesh-ancestor
25068494|NCT03433001|Protease Inhibitors|protease inhibitors|mesh-ancestor
25068495|NCT03433001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25068496|NCT03433001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068498|NCT03432975|Povidone|povidone|mesh-list
25068499|NCT03432975|Plasma Substitutes|plasma substitutes|mesh-ancestor
25068500|NCT03432975|Blood Substitutes|blood substitutes|mesh-ancestor
24830987|NCT02162381|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24830988|NCT02162381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677970|NCT01359397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677971|NCT01359397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24677972|NCT01359397|Antimetabolites|antimetabolites|mesh-ancestor
24677973|NCT01359423|Cilostazol|cilostazol|mesh-list
24677974|NCT01359423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24677975|NCT01359423|Autonomic Agents|autonomic agents|mesh-ancestor
25701474|NCT02140411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25701475|NCT02140593|Rocuronium|rocuronium|mesh-list
25701476|NCT02140593|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25701477|NCT02140593|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25701478|NCT02140593|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24678127|NCT01359930|Bupropion|bupropion|mesh-list
24678301|NCT01360788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24678302|NCT01360788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24539816|NCT00665717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678303|NCT01360788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24678304|NCT01360788|Adrenergic Agents|adrenergic agents|mesh-ancestor
25068501|NCT03432975|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25068502|NCT03432975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25068503|NCT03432923|Benzocaine|benzocaine|mesh-list
24953521|NCT03883880|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24953522|NCT03883880|Capsaicin|capsaicin|mesh-list
24831001|NCT02162485|Xhance|xhance|mesh-list
24678305|NCT01360788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24678306|NCT01360788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678307|NCT01360788|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24678353|NCT01361399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24678354|NCT01361399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24678450|NCT01361997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24678451|NCT01361997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24681354|NCT01379976|Nootropic Agents|nootropic agents|mesh-ancestor
24678452|NCT01361997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678454|NCT01362010|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24678490|NCT01362218|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24678492|NCT01362218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24678493|NCT01362309|Cycloserine|cycloserine|mesh-list
24678545|NCT01363037|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24678547|NCT01363063|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24678548|NCT01363063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24678549|NCT01363063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24678550|NCT01363063|Analgesics|analgesics|mesh-ancestor
24678551|NCT01363063|Sensory System Agents|sensory system agents|mesh-ancestor
24678648|NCT01363310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24678649|NCT01363310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24678650|NCT01363310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24678651|NCT01363323|Moxifloxacin|moxifloxacin|mesh-list
24678653|NCT01363323|Methylnaltrexone|methylnaltrexone|mesh-list
24678654|NCT01363323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24678655|NCT01363323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24678656|NCT01363323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24678700|NCT01363570|Ranibizumab|ranibizumab|mesh-list
24611032|NCT01006525|Zolpidem|zolpidem|mesh-list
24611033|NCT01006525|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24611034|NCT01006525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24611035|NCT01006525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24611036|NCT01006525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611037|NCT01006525|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24463440|NCT00360984|Insulin|insulin|mesh-list
24678973|NCT01365676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24678974|NCT01365676|Antiviral Agents|antiviral agents|mesh-ancestor
24678975|NCT01365676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24678976|NCT01365676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678977|NCT01365676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678978|NCT01365676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24678983|NCT01365871|Anesthetics|anesthetics|mesh-list
24679141|NCT01367028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679143|NCT01367028|Tubulin Modulators|tubulin modulators|mesh-ancestor
24679144|NCT01367028|Antimitotic Agents|antimitotic agents|mesh-ancestor
24679145|NCT01367028|Mitosis Modulators|mitosis modulators|mesh-ancestor
24679216|NCT01367509|Sensory System Agents|sensory system agents|mesh-ancestor
24680556|NCT01375348|Remifentanil|remifentanil|mesh-list
24679217|NCT01367509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679438|NCT01368445|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24679439|NCT01368445|Histamine Antagonists|histamine antagonists|mesh-ancestor
24679440|NCT01368445|Histamine Agents|histamine agents|mesh-ancestor
24679441|NCT01368445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24679442|NCT01368458|Antipsychotic Agents|antipsychotic agents|mesh-list
24679443|NCT01368458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24679444|NCT01368458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24679445|NCT01368458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679446|NCT01368458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24679447|NCT01368627|Sirolimus|sirolimus|mesh-list
24679448|NCT01368627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24804407|NCT02002312|Sequestering Agents|sequestering agents|mesh-ancestor
24804408|NCT02002312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804410|NCT02002325|Plasminogen|plasminogen|mesh-list
24679449|NCT01368627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24611038|NCT01006525|GABA Agonists|gaba agonists|mesh-ancestor
24611039|NCT01006525|GABA Agents|gaba agents|mesh-ancestor
24611076|NCT01006720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24679564|NCT01369238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679565|NCT01369238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679610|NCT01369368|Valproic Acid|valproic acid|mesh-list
24679611|NCT01369368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24679612|NCT01369368|Antimetabolites|antimetabolites|mesh-ancestor
24679613|NCT01369368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679614|NCT01369368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24679615|NCT01369368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24679616|NCT01369368|Anticonvulsants|anticonvulsants|mesh-ancestor
24679617|NCT01369368|GABA Agents|gaba agents|mesh-ancestor
24679826|NCT01370915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679827|NCT01370915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24679828|NCT01370915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24679829|NCT01370915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24679887|NCT01371448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24679888|NCT01371448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679889|NCT01371448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24953572|NCT03883763|Anesthetics|anesthetics|mesh-ancestor
24680052|NCT01372839|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24680053|NCT01372839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680054|NCT01372865|Mometasone Furoate|mometasone furoate|mesh-list
24680073|NCT01372904|Protease Inhibitors|protease inhibitors|mesh-ancestor
24539907|NCT00665990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680074|NCT01372904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680075|NCT01372904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680076|NCT01372930|Etanercept|etanercept|mesh-list
24680077|NCT01372930|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24680078|NCT01372930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24680079|NCT01372930|Analgesics|analgesics|mesh-ancestor
24680080|NCT01372930|Sensory System Agents|sensory system agents|mesh-ancestor
24680081|NCT01372930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24680082|NCT01372930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680083|NCT01372930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24680084|NCT01372930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24680085|NCT01372930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24989485|NCT05148546|Nivolumab|nivolumab|mesh-list
24953573|NCT03883763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24953574|NCT03883763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068504|NCT03432923|Anesthetics, Local|anesthetics, local|mesh-ancestor
25068505|NCT03432923|Anesthetics|anesthetics|mesh-ancestor
25068506|NCT03432923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24680346|NCT01374308|Antiviral Agents|antiviral agents|mesh-ancestor
24680347|NCT01374308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24680348|NCT01374308|Immunologic Factors|immunologic factors|mesh-ancestor
24680349|NCT01374308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680350|NCT01374373|Epoetin Alfa|epoetin alfa|mesh-list
24680351|NCT01374373|Hematinics|hematinics|mesh-ancestor
24680352|NCT01374464|Levobupivacaine|levobupivacaine|mesh-list
24680353|NCT01374464|Anesthetics, Local|anesthetics, local|mesh-ancestor
24680354|NCT01374464|Anesthetics|anesthetics|mesh-ancestor
24680355|NCT01374464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24680356|NCT01374464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680357|NCT01374464|Sensory System Agents|sensory system agents|mesh-ancestor
24680359|NCT01374581|Artesunate|artesunate|mesh-list
24680502|NCT01375023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680553|NCT01375335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24680554|NCT01375335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680555|NCT01375335|Protective Agents|protective agents|mesh-ancestor
24680563|NCT01375348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24680662|NCT01375816|Growth Inhibitors|growth inhibitors|mesh-ancestor
24680663|NCT01375816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24680664|NCT01375816|Antimetabolites|antimetabolites|mesh-ancestor
25701479|NCT02140593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25701480|NCT02140593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701481|NCT02140645|Linagliptin|linagliptin|mesh-list
25701482|NCT02140645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24680665|NCT01375816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680667|NCT01375816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24680668|NCT01375816|Immunologic Factors|immunologic factors|mesh-ancestor
24680669|NCT01375816|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24680672|NCT01375816|Antidotes|antidotes|mesh-ancestor
24680836|NCT01376271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680837|NCT01376271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24680838|NCT01376271|Antidepressive Agents|antidepressive agents|mesh-ancestor
24680840|NCT01376271|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24680906|NCT01376765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680944|NCT01377168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680945|NCT01377168|Sensory System Agents|sensory system agents|mesh-ancestor
24680946|NCT01377168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24680948|NCT01377220|Lipotropic Agents|lipotropic agents|mesh-ancestor
24680949|NCT01377220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24680950|NCT01377220|Antimetabolites|antimetabolites|mesh-ancestor
24680951|NCT01377220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680952|NCT01377220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24680953|NCT01377220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24680954|NCT01377220|Nootropic Agents|nootropic agents|mesh-ancestor
24681028|NCT01377597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681029|NCT01377610|Naltrexone|naltrexone|mesh-list
24681030|NCT01377610|Buprenorphine|buprenorphine|mesh-list
24681031|NCT01377610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24681351|NCT01379976|Vitamins|vitamins|mesh-ancestor
24681352|NCT01379976|Micronutrients|micronutrients|mesh-ancestor
24681353|NCT01379976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681355|NCT01380015|Rosmarinic acid|rosmarinic acid|mesh-list
24681356|NCT01380015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24681357|NCT01380015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25068557|NCT03432793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25068558|NCT03432793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25068559|NCT03432793|Serotonin Agents|serotonin agents|mesh-ancestor
25068560|NCT03432793|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25068561|NCT03432793|Antidepressive Agents|antidepressive agents|mesh-ancestor
25068562|NCT03432793|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25068563|NCT03432793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25068564|NCT03432780|Docetaxel|docetaxel|mesh-list
25068565|NCT03432780|Hormones|hormones|mesh-list
25068566|NCT03432780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681471|NCT01380548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681796|NCT01382017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24681797|NCT01382134|Aspirin|aspirin|mesh-list
24681798|NCT01382134|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24681856|NCT01382342|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24681857|NCT01382342|Protective Agents|protective agents|mesh-ancestor
24681858|NCT01382342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681859|NCT01382368|Sildenafil Citrate|sildenafil citrate|mesh-list
24681860|NCT01382368|Vasodilator Agents|vasodilator agents|mesh-ancestor
24681861|NCT01382368|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24681862|NCT01382368|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24681863|NCT01382368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681864|NCT01382368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681865|NCT01382368|Urological Agents|urological agents|mesh-ancestor
24682168|NCT01384578|Tocopherols|tocopherols|mesh-list
24682169|NCT01384578|Tocotrienols|tocotrienols|mesh-list
24682359|NCT01386086|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24682360|NCT01386086|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24682361|NCT01386086|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24682362|NCT01386086|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24682364|NCT01386151|Mitosis Modulators|mitosis modulators|mesh-ancestor
24611327|NCT01008631|Antidotes|antidotes|mesh-ancestor
24611328|NCT01008631|Protective Agents|protective agents|mesh-ancestor
24611329|NCT01008631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611330|NCT01008631|Antioxidants|antioxidants|mesh-ancestor
24611331|NCT01008631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611332|NCT01008631|Antitubercular Agents|antitubercular agents|mesh-ancestor
24682467|NCT01386567|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24682468|NCT01386567|Chelating Agents|chelating agents|mesh-ancestor
24682574|NCT01386853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25701483|NCT02140645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599297|NCT04913805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24599298|NCT04913805|Antimetabolites|antimetabolites|mesh-ancestor
24599299|NCT04913805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599300|NCT04913805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25068590|NCT03432689|Antitubercular Agents|antitubercular agents|mesh-ancestor
25068591|NCT03432689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25068592|NCT03432689|Antimetabolites|antimetabolites|mesh-ancestor
25068594|NCT03432676|Pembrolizumab|pembrolizumab|mesh-list
24611388|NCT01009073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24611389|NCT01009177|Bosentan|bosentan|mesh-list
24611390|NCT01009177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24611391|NCT01009177|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24682873|NCT01388842|Gasotransmitters|gasotransmitters|mesh-ancestor
24682874|NCT01388842|Protective Agents|protective agents|mesh-ancestor
24682875|NCT01388855|Vitamin D|vitamin d|mesh-list
24682876|NCT01388855|Cholecalciferol|cholecalciferol|mesh-list
24682877|NCT01388855|Vitamins|vitamins|mesh-ancestor
24682878|NCT01388855|Micronutrients|micronutrients|mesh-ancestor
24682879|NCT01388855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682880|NCT01388855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24682909|NCT01389193|Ibudilast|ibudilast|mesh-list
24682910|NCT01389193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24682911|NCT01389193|Autonomic Agents|autonomic agents|mesh-ancestor
24682912|NCT01389193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24682913|NCT01389193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682914|NCT01389193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24683272|NCT01390961|Adrenergic Agents|adrenergic agents|mesh-ancestor
24683273|NCT01390961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24683274|NCT01390961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683275|NCT01390961|Nasal Decongestants|nasal decongestants|mesh-ancestor
24683276|NCT01390961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24683277|NCT01390961|Respiratory System Agents|respiratory system agents|mesh-ancestor
24683278|NCT01390961|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24683279|NCT01390961|Histamine Antagonists|histamine antagonists|mesh-ancestor
24683280|NCT01390961|Histamine Agents|histamine agents|mesh-ancestor
24683324|NCT01391221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24683325|NCT01391221|Dopamine Agents|dopamine agents|mesh-ancestor
24683560|NCT01392833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24683561|NCT01392833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24683563|NCT01392833|Autonomic Agents|autonomic agents|mesh-ancestor
24683568|NCT01392833|Antimetabolites|antimetabolites|mesh-ancestor
24683601|NCT01393080|Tubulin Modulators|tubulin modulators|mesh-ancestor
24683602|NCT01393080|Antimitotic Agents|antimitotic agents|mesh-ancestor
24683603|NCT01393080|Mitosis Modulators|mitosis modulators|mesh-ancestor
24683604|NCT01393080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683606|NCT01393145|Xhance|xhance|mesh-list
24683607|NCT01393145|Formoterol Fumarate|formoterol fumarate|mesh-list
24683608|NCT01393145|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24683609|NCT01393145|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24683610|NCT01393145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24683611|NCT01393145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24683612|NCT01393145|Autonomic Agents|autonomic agents|mesh-ancestor
24683613|NCT01393145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24683682|NCT01393548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24683683|NCT01393548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683684|NCT01393548|Sympathomimetics|sympathomimetics|mesh-ancestor
24683685|NCT01393548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24683686|NCT01393548|Nasal Decongestants|nasal decongestants|mesh-ancestor
24683687|NCT01393548|Respiratory System Agents|respiratory system agents|mesh-ancestor
24683688|NCT01393548|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24683690|NCT01393548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24683691|NCT01393548|Adrenergic Agents|adrenergic agents|mesh-ancestor
24683692|NCT01393548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24683693|NCT01393548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683694|NCT01393548|Protective Agents|protective agents|mesh-ancestor
25701484|NCT02140645|Incretins|incretins|mesh-ancestor
25701485|NCT02140645|Hormones|hormones|mesh-ancestor
25701486|NCT02140645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25701487|NCT02140645|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24683695|NCT01393548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24683696|NCT01393548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24683773|NCT01394029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683774|NCT01394094|Calcium|calcium|mesh-list
24539965|NCT00666055|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24683775|NCT01394094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24683776|NCT01394094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683777|NCT01394133|Ritonavir|ritonavir|mesh-list
24683778|NCT01394133|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24683779|NCT01394133|Tenofovir|tenofovir|mesh-list
24683780|NCT01394133|Emtricitabine|emtricitabine|mesh-list
24683781|NCT01394133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24683782|NCT01394133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24683783|NCT01394133|Protease Inhibitors|protease inhibitors|mesh-ancestor
24683784|NCT01394133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683786|NCT01394133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25068631|NCT03432598|Paclitaxel|paclitaxel|mesh-list
25068641|NCT03432598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25068642|NCT03432598|Antimetabolites|antimetabolites|mesh-ancestor
25068643|NCT03432598|Antiviral Agents|antiviral agents|mesh-ancestor
25068644|NCT03432598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25068645|NCT03432598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25068646|NCT03432598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25068647|NCT03432598|Immunologic Factors|immunologic factors|mesh-ancestor
25068648|NCT03432598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068649|NCT03432598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25068650|NCT03432598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25068651|NCT03432598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25068652|NCT03432598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25068653|NCT03432572|Riboflavin|riboflavin|mesh-list
25068654|NCT03432572|Thiamine|thiamine|mesh-list
25068655|NCT03432572|Vitamin B Complex|vitamin b complex|mesh-ancestor
24831165|NCT02163954|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24684137|NCT01395667|Antidotes|antidotes|mesh-ancestor
24684138|NCT01395667|Protective Agents|protective agents|mesh-ancestor
24684139|NCT01395667|Vitamin B Complex|vitamin b complex|mesh-ancestor
24684140|NCT01395667|Vitamins|vitamins|mesh-ancestor
24684141|NCT01395667|Micronutrients|micronutrients|mesh-ancestor
24684153|NCT01395849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468754|NCT00383136|Tirofiban|tirofiban|mesh-list
24684154|NCT01395849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25068665|NCT03432468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684236|NCT01395953|Serotonin Agents|serotonin agents|mesh-ancestor
24684237|NCT01395953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24684238|NCT01395953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684239|NCT01395992|Asenapine|asenapine|mesh-list
24684240|NCT01395992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24684241|NCT01395992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24684242|NCT01395992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24684243|NCT01395992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684244|NCT01395992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24684245|NCT01396200|Hydroxychloroquine|hydroxychloroquine|mesh-list
24684246|NCT01396200|Sirolimus|sirolimus|mesh-list
24684247|NCT01396200|Antimalarials|antimalarials|mesh-ancestor
24684248|NCT01396200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24684249|NCT01396200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24684250|NCT01396200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24684251|NCT01396200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24684253|NCT01396200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25068668|NCT03432442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25068669|NCT03432312|Nicotine|nicotine|mesh-list
25068670|NCT03432312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25068671|NCT03432312|Autonomic Agents|autonomic agents|mesh-ancestor
25068672|NCT03432312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24831196|NCT02164032|Insulin|insulin|mesh-list
24684436|NCT05268718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684437|NCT05268718|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24684438|NCT05268627|Liraglutide|liraglutide|mesh-list
24684439|NCT05268627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24684440|NCT05268627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684441|NCT05268627|Incretins|incretins|mesh-ancestor
24684443|NCT05268627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24684444|NCT05268601|Bamlanivimab|bamlanivimab|mesh-list
24684445|NCT05268601|Antiviral Agents|antiviral agents|mesh-ancestor
24684446|NCT05268601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24684447|NCT05268562|Ketamine|ketamine|mesh-list
24684448|NCT05268562|Propofol|propofol|mesh-list
24684449|NCT05268562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24684450|NCT05268562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24684451|NCT05268562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611521|NCT01009892|Sensory System Agents|sensory system agents|mesh-ancestor
24611522|NCT01009892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24611523|NCT01009892|Antitussive Agents|antitussive agents|mesh-ancestor
24611524|NCT01009892|Respiratory System Agents|respiratory system agents|mesh-ancestor
24611525|NCT01009944|Atenolol|atenolol|mesh-list
24611526|NCT01009944|Lisinopril|lisinopril|mesh-list
24611527|NCT01009944|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24611528|NCT01009944|Protease Inhibitors|protease inhibitors|mesh-ancestor
24611529|NCT01009944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611530|NCT01009944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611531|NCT01009944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24611532|NCT01009944|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24611533|NCT01009944|Protective Agents|protective agents|mesh-ancestor
24611537|NCT01009944|Autonomic Agents|autonomic agents|mesh-ancestor
25068676|NCT03432312|Cholinergic Agents|cholinergic agents|mesh-ancestor
25068677|NCT03432312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25068678|NCT03432312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068680|NCT03432273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25068681|NCT03432273|Autonomic Agents|autonomic agents|mesh-ancestor
25068682|NCT03432273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25068683|NCT03432273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068684|NCT03432273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25068685|NCT03432273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24684605|NCT04975269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684607|NCT04975269|Natriuretic Agents|natriuretic agents|mesh-ancestor
24684608|NCT04975269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684609|NCT04971720|Valsartan|valsartan|mesh-list
24684610|NCT04971720|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24684611|NCT04971720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24684612|NCT04971720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24684615|NCT04965870|Trifluridine|trifluridine|mesh-list
24685026|NCT03040726|Serotonin Agents|serotonin agents|mesh-ancestor
24684671|NCT04782180|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
24684673|NCT04782180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24684674|NCT04782180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24684675|NCT04782180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24684676|NCT04782180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24684677|NCT04782180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684678|NCT04782180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24684679|NCT04782180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24684812|NCT03982693|Edetic Acid|edetic acid|mesh-list
24684813|NCT03982693|Pentetic Acid|pentetic acid|mesh-list
24684858|NCT03580473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684859|NCT03580473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24684860|NCT03580473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684861|NCT03580473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24684862|NCT03580473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24684863|NCT03580473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24684864|NCT03580473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24684865|NCT03580473|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24684866|NCT03580473|Contraceptive Agents|contraceptive agents|mesh-ancestor
24611545|NCT01009957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611546|NCT01009957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24611547|NCT01009957|Immunologic Factors|immunologic factors|mesh-ancestor
24611548|NCT01009957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611550|NCT01009970|Cyclophosphamide|cyclophosphamide|mesh-list
24611551|NCT01009970|Rituximab|rituximab|mesh-list
24611552|NCT01009970|Doxorubicin|doxorubicin|mesh-list
24611553|NCT01009970|Vincristine|vincristine|mesh-list
24685002|NCT03107611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685004|NCT03089866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24685005|NCT03089866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24685006|NCT03089866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24685007|NCT03089866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685008|NCT03089866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24685009|NCT03089866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24640428|NCT01167946|Hormones|hormones|mesh-ancestor
24685011|NCT03089866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25701488|NCT02140645|Protease Inhibitors|protease inhibitors|mesh-ancestor
25701489|NCT02140645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24685012|NCT03089866|Anesthetics, General|anesthetics, general|mesh-ancestor
24685014|NCT03089866|GABA Modulators|gaba modulators|mesh-ancestor
24685016|NCT03089866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24822014|NCT02109510|Ketamine|ketamine|mesh-list
24540121|NCT00666692|Carboplatin|carboplatin|mesh-list
24540122|NCT00666692|Volociximab|volociximab|mesh-list
24685017|NCT03089866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685019|NCT03040726|Antiemetics|antiemetics|mesh-ancestor
24685020|NCT03040726|Autonomic Agents|autonomic agents|mesh-ancestor
24685021|NCT03040726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24685022|NCT03040726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685023|NCT03040726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25068696|NCT03432221|Antidepressive Agents|antidepressive agents|mesh-ancestor
25068697|NCT03432221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25068699|NCT03432195|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25068700|NCT03432195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25068701|NCT03432195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068702|NCT03432195|Cholinergic Agents|cholinergic agents|mesh-ancestor
25068703|NCT03432195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24685024|NCT03040726|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24685025|NCT03040726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24685027|NCT03040726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24685028|NCT03040726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469729|NCT00386867|Misoprostol|misoprostol|mesh-list
24469731|NCT00386867|Abortifacient Agents|abortifacient agents|mesh-ancestor
24685044|NCT02607956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685045|NCT02607956|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24685046|NCT02607956|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24685047|NCT02607956|Antiviral Agents|antiviral agents|mesh-ancestor
24685048|NCT02607956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24685051|NCT02499666|Clopidogrel|clopidogrel|mesh-list
24685158|NCT01798004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24685159|NCT01798004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24685160|NCT01798004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24685161|NCT01798004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24685162|NCT01798004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24685163|NCT01798004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24685164|NCT01798004|Tubulin Modulators|tubulin modulators|mesh-ancestor
24685296|NCT05274113|Antiemetics|antiemetics|mesh-ancestor
24685297|NCT05274113|Autonomic Agents|autonomic agents|mesh-ancestor
24685298|NCT05274113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24685303|NCT05274113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24685304|NCT05274113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24685305|NCT05274113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24685306|NCT05274113|Anesthetics, Local|anesthetics, local|mesh-ancestor
24685307|NCT05274113|Anesthetics|anesthetics|mesh-ancestor
24685332|NCT05273775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24685333|NCT05273775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24685334|NCT05273775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24685335|NCT05273775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24685336|NCT05273775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24685337|NCT05273775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24685338|NCT05273775|Anesthetics, General|anesthetics, general|mesh-ancestor
24685339|NCT05273775|Anesthetics|anesthetics|mesh-ancestor
24685340|NCT05273775|GABA Modulators|gaba modulators|mesh-ancestor
24685400|NCT05273346|Sensory System Agents|sensory system agents|mesh-ancestor
24685401|NCT05273346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24685402|NCT05273346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685503|NCT05271370|HIV Antibodies|hiv antibodies|mesh-list
24685504|NCT05271370|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24685505|NCT05271370|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24685506|NCT05271370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685507|NCT05271370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24685508|NCT05271370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24685509|NCT05271370|Antiviral Agents|antiviral agents|mesh-ancestor
24685510|NCT05271370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24685511|NCT05271370|Immunologic Factors|immunologic factors|mesh-ancestor
24685569|NCT05271045|Vitamin D|vitamin d|mesh-list
24685833|NCT05168735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685834|NCT05166746|Clindamycin|clindamycin|mesh-list
24685835|NCT05166746|Clindamycin palmitate|clindamycin palmitate|mesh-list
24685836|NCT05166746|Clindamycin phosphate|clindamycin phosphate|mesh-list
24685837|NCT05166746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24685838|NCT05166746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24685840|NCT05166746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24685947|NCT05137119|Vancomycin|vancomycin|mesh-list
25068735|NCT03431909|Kallikreins|kallikreins|mesh-list
25068736|NCT03431909|Clopidogrel|clopidogrel|mesh-list
25068737|NCT03431909|Atorvastatin|atorvastatin|mesh-list
25068738|NCT03431909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25068739|NCT03431909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24611622|NCT01010139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24611629|NCT01010152|Codeine|codeine|mesh-list
24686050|NCT05067439|Caffeine|caffeine|mesh-list
24686051|NCT05067439|Omeprazole|omeprazole|mesh-list
24686052|NCT05067439|Abrocitinib|abrocitinib|mesh-list
24686053|NCT05067439|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24686054|NCT05067439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24686055|NCT05067439|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24686056|NCT05067439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24686058|NCT05067439|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24686280|NCT04919564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24686281|NCT04919564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686282|NCT04918823|Cyclosporine|cyclosporine|mesh-list
24686349|NCT04888858|Anesthetics, Local|anesthetics, local|mesh-ancestor
24686350|NCT04888858|Anesthetics|anesthetics|mesh-ancestor
24686351|NCT04888858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24686354|NCT04888858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25068740|NCT03431909|Analgesics|analgesics|mesh-ancestor
25068741|NCT03431909|Sensory System Agents|sensory system agents|mesh-ancestor
24449150|NCT00314613|Serotonin Agents|serotonin agents|mesh-ancestor
24686355|NCT04888858|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24686356|NCT04888858|Narcotics|narcotics|mesh-ancestor
24686357|NCT04888858|Analgesics|analgesics|mesh-ancestor
24686358|NCT04888858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24686359|NCT04888858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24686360|NCT04888858|Anesthetics, General|anesthetics, general|mesh-ancestor
24686361|NCT04886284|Ertapenem|ertapenem|mesh-list
24686427|NCT04818957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24686428|NCT04801641|Nabilone|nabilone|mesh-list
24686429|NCT04801641|Antiemetics|antiemetics|mesh-ancestor
24686430|NCT04801641|Autonomic Agents|autonomic agents|mesh-ancestor
24640867|NCT01170429|Sympathomimetics|sympathomimetics|mesh-ancestor
24686431|NCT04801641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24686432|NCT04801641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686433|NCT04801641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24686463|NCT04791761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24686465|NCT04786093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24686466|NCT04786093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24686467|NCT04783376|Insulin|insulin|mesh-list
24686468|NCT04783376|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24686469|NCT04783376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24686470|NCT04783376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686517|NCT04760691|Hormones|hormones|mesh-ancestor
24686546|NCT04706767|Dexmedetomidine|dexmedetomidine|mesh-list
24686547|NCT04706767|Anesthetics, Local|anesthetics, local|mesh-ancestor
24686548|NCT04706767|Anesthetics|anesthetics|mesh-ancestor
24686549|NCT04706767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24686550|NCT04706767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686551|NCT04706767|Sensory System Agents|sensory system agents|mesh-ancestor
24686604|NCT04690686|Antimitotic Agents|antimitotic agents|mesh-ancestor
24686605|NCT04690686|Mitosis Modulators|mitosis modulators|mesh-ancestor
24686606|NCT04690686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686608|NCT04682626|Vitamin D|vitamin d|mesh-list
24686609|NCT04682626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24686610|NCT04682626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686611|NCT04682626|Vitamins|vitamins|mesh-ancestor
24686612|NCT04682626|Micronutrients|micronutrients|mesh-ancestor
24686613|NCT04682626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24686614|NCT04679818|Fentanyl|fentanyl|mesh-list
24686615|NCT04679818|Analgesics, Opioid|analgesics, opioid|mesh-list
24686616|NCT04679818|Narcotics|narcotics|mesh-ancestor
24686617|NCT04679818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25068770|NCT03431831|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25068771|NCT03431831|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25068772|NCT03431831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25068773|NCT03431831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687027|NCT04418466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24467817|NCT00378833|Antimetabolites|antimetabolites|mesh-ancestor
24467819|NCT00378833|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24467868|NCT00379015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24687028|NCT04418466|Dopamine Agents|dopamine agents|mesh-ancestor
24687104|NCT04380831|Immunologic Factors|immunologic factors|mesh-ancestor
24687145|NCT04302168|Lipotropic Agents|lipotropic agents|mesh-ancestor
24687146|NCT04302168|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24687147|NCT04302168|Antimetabolites|antimetabolites|mesh-ancestor
24687148|NCT04302168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687149|NCT04302168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24687151|NCT04302168|Nootropic Agents|nootropic agents|mesh-ancestor
24687203|NCT04245644|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24687204|NCT04245644|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24687205|NCT04245644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687206|NCT04245644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25068774|NCT03431831|Sensory System Agents|sensory system agents|mesh-ancestor
25068775|NCT03431831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24687209|NCT04245644|Antipyretics|antipyretics|mesh-ancestor
24687233|NCT04212013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24687234|NCT04195776|Tenofovir|tenofovir|mesh-list
24687235|NCT04195776|Antiviral Agents|antiviral agents|mesh-ancestor
24687236|NCT04195776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24687237|NCT04195776|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24687238|NCT04195776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24687284|NCT04095104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687285|NCT04095104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24687286|NCT04095104|Appetite Depressants|appetite depressants|mesh-ancestor
24687287|NCT04095104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24687288|NCT04095104|Sympathomimetics|sympathomimetics|mesh-ancestor
24687289|NCT04095104|Autonomic Agents|autonomic agents|mesh-ancestor
24687290|NCT04095104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24687291|NCT04095104|Adrenergic Agents|adrenergic agents|mesh-ancestor
24687295|NCT04074512|Trace Elements|trace elements|mesh-ancestor
24611750|NCT01010581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611751|NCT01010581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611752|NCT01010581|Dermatologic Agents|dermatologic agents|mesh-ancestor
24611753|NCT01010581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611754|NCT01010581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24611760|NCT01010581|Vitamin B Complex|vitamin b complex|mesh-ancestor
24611761|NCT01010581|Vitamins|vitamins|mesh-ancestor
24611762|NCT01010581|Micronutrients|micronutrients|mesh-ancestor
24611763|NCT01010646|Ribavirin|ribavirin|mesh-list
24611764|NCT01010646|Interferon-alpha|interferon-alpha|mesh-list
24687324|NCT04057131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24687325|NCT04057131|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
24687326|NCT04057131|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
24687327|NCT04057131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687365|NCT04020718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24687366|NCT04020718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687367|NCT04020718|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24687368|NCT04020718|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24687369|NCT04020718|Cholinergic Agents|cholinergic agents|mesh-ancestor
24687370|NCT04020718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24990358|NCT03176498|Aspirin|aspirin|mesh-list
25068776|NCT03431831|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25068777|NCT03431831|Antidepressive Agents|antidepressive agents|mesh-ancestor
25068778|NCT03431831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25068779|NCT03431831|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24687371|NCT04020718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687373|NCT04014530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24687374|NCT04014530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24687388|NCT04011150|Anesthetics, General|anesthetics, general|mesh-ancestor
24687390|NCT04009967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24687391|NCT04009967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24687392|NCT04008082|Lenvatinib|lenvatinib|mesh-list
24687393|NCT04008082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24687394|NCT04008082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25701490|NCT02140645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701491|NCT02140970|Ibuprofen|ibuprofen|mesh-list
25701492|NCT02140970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24687395|NCT04008082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24687396|NCT04008082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687397|NCT04002180|Vedolizumab|vedolizumab|mesh-list
24687398|NCT04002180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25068785|NCT03431831|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25068786|NCT03431831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25068787|NCT03431831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25068789|NCT03431805|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25068790|NCT03431805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25068791|NCT03431805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25068792|NCT03431805|Hemostatics|hemostatics|mesh-ancestor
25068793|NCT03431805|Coagulants|coagulants|mesh-ancestor
25068794|NCT03431766|Chlorhexidine|chlorhexidine|mesh-list
25068795|NCT03431766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25068796|NCT03431766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24831316|NCT02164812|Moxifloxacin|moxifloxacin|mesh-list
24687560|NCT03897439|Cholinergic Agents|cholinergic agents|mesh-ancestor
25068808|NCT03431714|Schistosomicides|schistosomicides|mesh-ancestor
25068809|NCT03431714|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25068810|NCT03431714|Anthelmintics|anthelmintics|mesh-ancestor
25068811|NCT03431701|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25068812|NCT03431701|Chlorhexidine|chlorhexidine|mesh-list
25068813|NCT03431701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24954016|NCT03879837|Xhance|xhance|mesh-list
24953575|NCT03883763|Sensory System Agents|sensory system agents|mesh-ancestor
24953577|NCT03883347|Dexmedetomidine|dexmedetomidine|mesh-list
24953578|NCT03883347|Remifentanil|remifentanil|mesh-list
24953579|NCT03883347|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24953580|NCT03883347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24953581|NCT03883347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953582|NCT03883347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24953583|NCT03883347|Analgesics|analgesics|mesh-ancestor
24953584|NCT03883347|Sensory System Agents|sensory system agents|mesh-ancestor
24831334|NCT02164825|Morphine|morphine|mesh-list
24687834|NCT03659799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24687835|NCT03659799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687836|NCT03638999|Ketorolac|ketorolac|mesh-list
24687837|NCT03638999|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24687838|NCT03638999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24687839|NCT03638999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24953592|NCT03883347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24953593|NCT03883347|Narcotics|narcotics|mesh-ancestor
24953594|NCT03883360|Cannabidiol|cannabidiol|mesh-list
24953595|NCT03883360|Anticonvulsants|anticonvulsants|mesh-ancestor
24953597|NCT03883698|Antiviral Agents|antiviral agents|mesh-ancestor
24953598|NCT03883698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24953599|NCT03883269|Ethanol|ethanol|mesh-list
24953600|NCT03883269|Clindamycin|clindamycin|mesh-list
24953601|NCT03883269|Clindamycin palmitate|clindamycin palmitate|mesh-list
24953602|NCT03883269|Clindamycin phosphate|clindamycin phosphate|mesh-list
24953603|NCT03883269|Erythromycin|erythromycin|mesh-list
25068814|NCT03431701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25068815|NCT03431701|Disinfectants|disinfectants|mesh-ancestor
25068816|NCT03431675|Ciprofloxacin|ciprofloxacin|mesh-list
25068817|NCT03431675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25068818|NCT03431675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25068819|NCT03431675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25068820|NCT03431675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24687982|NCT03555877|Anastrozole|anastrozole|mesh-list
24687983|NCT03555877|Exemestane|exemestane|mesh-list
24687984|NCT03555877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24687985|NCT03555877|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24687986|NCT03555877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24688101|NCT03386162|Fulvestrant|fulvestrant|mesh-list
24688102|NCT03386162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24688103|NCT03386162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688104|NCT03386162|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25701493|NCT02140970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25701494|NCT02140970|Analgesics|analgesics|mesh-ancestor
24688105|NCT03386162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24688106|NCT03386162|Hormone Antagonists|hormone antagonists|mesh-ancestor
25701495|NCT02140970|Sensory System Agents|sensory system agents|mesh-ancestor
25701496|NCT02140970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25701497|NCT02140970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468586|NCT00382343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468588|NCT00382343|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24688107|NCT03386162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24688108|NCT03386162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688109|NCT03360214|Bupivacaine|bupivacaine|mesh-list
25068943|NCT03430544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25068944|NCT03430544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25068945|NCT03430544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068946|NCT03430544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25068947|NCT03430518|Durvalumab|durvalumab|mesh-list
25068948|NCT03430518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25068949|NCT03430518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25068950|NCT03430505|Albuterol|albuterol|mesh-list
25068951|NCT03430505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25068952|NCT03430505|Autonomic Agents|autonomic agents|mesh-ancestor
25068953|NCT03430505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25068954|NCT03430505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25068955|NCT03430505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25068956|NCT03430505|Respiratory System Agents|respiratory system agents|mesh-ancestor
24953627|NCT03883204|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24953628|NCT03883204|Serotonin Agents|serotonin agents|mesh-ancestor
24953629|NCT03883204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24953630|NCT03883204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953631|NCT03883204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953632|NCT03883204|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24953633|NCT03883204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24953634|NCT03883204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24953635|NCT03883204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24953636|NCT03883204|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24953637|NCT03883204|Dopamine Agents|dopamine agents|mesh-ancestor
24953638|NCT03883204|Antidepressive Agents|antidepressive agents|mesh-ancestor
24953640|NCT03883204|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24953641|NCT03883204|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24953642|NCT03883204|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24953643|NCT03883204|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24953644|NCT03882710|Metoprolol|metoprolol|mesh-list
24953645|NCT03882710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24953646|NCT03882710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24688185|NCT03279289|Immunologic Factors|immunologic factors|mesh-ancestor
24688186|NCT03279289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688187|NCT03279289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24688188|NCT03279289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24611793|NCT01010698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611794|NCT01010698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611795|NCT01010698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24611796|NCT01010698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24611797|NCT01010698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611798|NCT01010789|Modafinil|modafinil|mesh-list
24611799|NCT01010789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24611800|NCT01010789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069041|NCT03429738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069042|NCT03429738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25069043|NCT03429738|Autonomic Agents|autonomic agents|mesh-ancestor
25069044|NCT03429738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24688304|NCT03151408|Azacitidine|azacitidine|mesh-list
24688305|NCT03151408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24688306|NCT03151408|Antimetabolites|antimetabolites|mesh-ancestor
24688307|NCT03151408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688308|NCT03151408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688309|NCT03151408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24688310|NCT03141671|Prednisone|prednisone|mesh-list
24688311|NCT03141671|Bicalutamide|bicalutamide|mesh-list
24688312|NCT03141671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25701498|NCT02140970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25701499|NCT02140970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25701500|NCT02140970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25701501|NCT02140970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25701502|NCT02140970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805278|NCT02008461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805279|NCT02008461|Cholinergic Agents|cholinergic agents|mesh-ancestor
24805280|NCT02008461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24469299|NCT00385398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469300|NCT00385398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24469333|NCT00385450|Nelfinavir|nelfinavir|mesh-list
24688313|NCT03141671|Glucocorticoids|glucocorticoids|mesh-ancestor
25069062|NCT03429400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25069063|NCT03429400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069064|NCT03429400|Analgesics|analgesics|mesh-ancestor
25069065|NCT03429400|Sensory System Agents|sensory system agents|mesh-ancestor
25069066|NCT03429400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25069067|NCT03429309|Propofol|propofol|mesh-list
25069068|NCT03429309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24688424|NCT03070327|Immunologic Factors|immunologic factors|mesh-ancestor
24688425|NCT03070327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688426|NCT03070327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24688427|NCT03070327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24688428|NCT03070327|Alkylating Agents|alkylating agents|mesh-ancestor
25069081|NCT03429179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25069082|NCT03429179|Antitussive Agents|antitussive agents|mesh-ancestor
25069083|NCT03429179|Respiratory System Agents|respiratory system agents|mesh-ancestor
25069131|NCT03428685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069132|NCT03428633|Morphine|morphine|mesh-list
25069133|NCT03428633|Ropivacaine|ropivacaine|mesh-list
25069134|NCT03428633|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24688450|NCT03061903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24688452|NCT03061643|Androgens|androgens|mesh-list
24688453|NCT03061643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688530|NCT03011775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24688531|NCT03011775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24688532|NCT03011775|Antimetabolites|antimetabolites|mesh-ancestor
24688533|NCT03011775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688534|NCT03011775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24688539|NCT03011775|Analgesics|analgesics|mesh-ancestor
24688540|NCT03011775|Sensory System Agents|sensory system agents|mesh-ancestor
24688541|NCT03011775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24688542|NCT03011775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24445196|NCT00300794|Sensory System Agents|sensory system agents|mesh-ancestor
24445201|NCT00300794|Anesthetics, General|anesthetics, general|mesh-ancestor
24688858|NCT02636322|Growth Inhibitors|growth inhibitors|mesh-ancestor
24688859|NCT02636322|Keratolytic Agents|keratolytic agents|mesh-ancestor
24688860|NCT02636322|Dermatologic Agents|dermatologic agents|mesh-ancestor
24688862|NCT02619552|Budesonide|budesonide|mesh-list
24688863|NCT02619552|Adalimumab|adalimumab|mesh-list
24688864|NCT02619552|Infliximab|infliximab|mesh-list
24688865|NCT02619552|Certolizumab Pegol|certolizumab pegol|mesh-list
24688866|NCT02619552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24688867|NCT02619552|Glucocorticoids|glucocorticoids|mesh-ancestor
24688868|NCT02619552|Hormones|hormones|mesh-ancestor
24688869|NCT02619552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24688870|NCT02619552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688983|NCT02500849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688984|NCT02500849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24688985|NCT02500849|Immunologic Factors|immunologic factors|mesh-ancestor
24688986|NCT02500849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688987|NCT02500849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24688988|NCT02500849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688989|NCT02500849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24688998|NCT02482233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24688999|NCT02482233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069170|NCT03428503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25069172|NCT03428503|Antipyretics|antipyretics|mesh-ancestor
25069190|NCT03428373|Rivaroxaban|rivaroxaban|mesh-list
25701503|NCT02141217|Amoxicillin|amoxicillin|mesh-list
25701504|NCT02141217|Clindamycin|clindamycin|mesh-list
25701505|NCT02141217|Clindamycin palmitate|clindamycin palmitate|mesh-list
25701506|NCT02141217|Clindamycin phosphate|clindamycin phosphate|mesh-list
25701507|NCT02141217|Clavulanic Acid|clavulanic acid|mesh-list
25701508|NCT02141217|Clavulanic Acids|clavulanic acids|mesh-list
25701509|NCT02141217|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25701510|NCT02141217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25069191|NCT03428373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25069192|NCT03428373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25069193|NCT03428373|Analgesics|analgesics|mesh-ancestor
25069194|NCT03428373|Sensory System Agents|sensory system agents|mesh-ancestor
24831774|NCT02168881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24831776|NCT02168881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24689071|NCT02369653|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24689072|NCT02369653|Protease Inhibitors|protease inhibitors|mesh-ancestor
24689130|NCT02299999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24689131|NCT02299999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689132|NCT02299999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24953671|NCT03882775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953672|NCT03882775|Antithrombins|antithrombins|mesh-ancestor
24953673|NCT03882775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24953674|NCT03882775|Protease Inhibitors|protease inhibitors|mesh-ancestor
24953675|NCT03882775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24953677|NCT03882788|Isoflurane|isoflurane|mesh-list
24953678|NCT03882788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24953679|NCT03882788|Narcotics|narcotics|mesh-ancestor
24953680|NCT03882788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24953681|NCT03882788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953682|NCT03882788|Analgesics|analgesics|mesh-ancestor
24953683|NCT03882788|Sensory System Agents|sensory system agents|mesh-ancestor
24953684|NCT03882788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953685|NCT03882788|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24953686|NCT03882788|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24953687|NCT03882788|Anesthetics, General|anesthetics, general|mesh-ancestor
24953688|NCT03882788|Anesthetics|anesthetics|mesh-ancestor
24953689|NCT03882788|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24953690|NCT03882489|Chloroprocaine|chloroprocaine|mesh-list
24540310|NCT00667303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540311|NCT00667407|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24540312|NCT00667407|Albuterol|albuterol|mesh-list
24540313|NCT00667407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24540314|NCT00667407|Autonomic Agents|autonomic agents|mesh-ancestor
24540315|NCT00667407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24540316|NCT00667407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540317|NCT00667407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24540318|NCT00667407|Respiratory System Agents|respiratory system agents|mesh-ancestor
24540319|NCT00667407|Tocolytic Agents|tocolytic agents|mesh-ancestor
24540320|NCT00667407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24540322|NCT00667407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24953691|NCT03882489|Anesthetics, Local|anesthetics, local|mesh-ancestor
24953692|NCT03882489|Anesthetics|anesthetics|mesh-ancestor
24953693|NCT03882489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24689285|NCT01879228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689288|NCT01829958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24641564|NCT01174290|Autonomic Agents|autonomic agents|mesh-ancestor
24689320|NCT01729754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24689321|NCT01729754|Analgesics|analgesics|mesh-ancestor
24451286|NCT00323011|Irinotecan|irinotecan|mesh-list
24689681|NCT00678730|Sensory System Agents|sensory system agents|mesh-ancestor
24689705|NCT00447122|Oxaliplatin|oxaliplatin|mesh-list
24689707|NCT00447122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24689708|NCT00447122|Antimetabolites|antimetabolites|mesh-ancestor
24689709|NCT00447122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689710|NCT00447122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689711|NCT00447122|Antiviral Agents|antiviral agents|mesh-ancestor
24689712|NCT00447122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24689713|NCT00447122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689714|NCT00447122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24689715|NCT00447122|Immunologic Factors|immunologic factors|mesh-ancestor
24953695|NCT03882489|Sensory System Agents|sensory system agents|mesh-ancestor
24953696|NCT03882489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24470116|NCT00388882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24470117|NCT00388882|Autonomic Agents|autonomic agents|mesh-ancestor
24805324|NCT02008968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805325|NCT02008968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24953697|NCT03882541|Midazolam|midazolam|mesh-list
24953698|NCT03882541|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24779383|NCT01875926|Gontivimab|gontivimab|mesh-list
24953699|NCT03882541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24779449|NCT01876290|Autonomic Agents|autonomic agents|mesh-ancestor
24779450|NCT01876290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24779451|NCT01876290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779452|NCT01876290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24779453|NCT01876290|Glucocorticoids|glucocorticoids|mesh-ancestor
24779454|NCT01876290|Hormones|hormones|mesh-ancestor
24779455|NCT01876290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24779456|NCT01876290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25069216|NCT03428256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069217|NCT03428191|Dexmedetomidine|dexmedetomidine|mesh-list
25069218|NCT03428191|Remifentanil|remifentanil|mesh-list
25069219|NCT03428191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24689716|NCT00447122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689796|NCT00309985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24689797|NCT00309985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069220|NCT03428191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25069221|NCT03428191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069222|NCT03428191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25069224|NCT03428191|Sensory System Agents|sensory system agents|mesh-ancestor
25069225|NCT03428191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24689956|NCT01398202|Cholecalciferol|cholecalciferol|mesh-list
24689957|NCT01398202|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
24689958|NCT01398202|Calcifediol|calcifediol|mesh-list
25069237|NCT03428139|Protective Agents|protective agents|mesh-ancestor
25069238|NCT03428139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069239|NCT03428139|Vitamin B Complex|vitamin b complex|mesh-ancestor
25069241|NCT03428139|Micronutrients|micronutrients|mesh-ancestor
25069242|NCT03428022|Apatinib|apatinib|mesh-list
25069243|NCT03428022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069244|NCT03428022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25069245|NCT03428022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25069246|NCT03428022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069247|NCT03427944|Calcium Dobesilate|calcium dobesilate|mesh-list
25069248|NCT03427944|Calcium|calcium|mesh-list
25069249|NCT03427944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25069250|NCT03427944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069251|NCT03427944|Hemostatics|hemostatics|mesh-ancestor
25069252|NCT03427944|Coagulants|coagulants|mesh-ancestor
25069253|NCT03427801|Hematinics|hematinics|mesh-list
25069254|NCT03427632|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
25069255|NCT03427632|Vasodilator Agents|vasodilator agents|mesh-ancestor
24689959|NCT01398202|Vitamins|vitamins|mesh-ancestor
24689960|NCT01398202|Micronutrients|micronutrients|mesh-ancestor
24689961|NCT01398202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690044|NCT01398618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24690045|NCT01398618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25701511|NCT02141217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25701512|NCT02141217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25701513|NCT02141217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25701514|NCT02141217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701515|NCT02141217|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25701516|NCT02141295|Leucovorin|leucovorin|mesh-list
25701517|NCT02141295|Folic Acid|folic acid|mesh-list
25701518|NCT02141295|Bevacizumab|bevacizumab|mesh-list
25701519|NCT02141295|Oxaliplatin|oxaliplatin|mesh-list
25701520|NCT02141295|Levoleucovorin|levoleucovorin|mesh-list
25701521|NCT02141295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25701522|NCT02141295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24690046|NCT01398618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690047|NCT01398618|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24690257|NCT01400646|Antithrombins|antithrombins|mesh-ancestor
24690048|NCT01398618|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24690049|NCT01398618|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24690050|NCT01398618|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25069256|NCT03427632|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25069257|NCT03427632|Protective Agents|protective agents|mesh-ancestor
25069258|NCT03427632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069260|NCT03427554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069261|NCT03427554|Keratolytic Agents|keratolytic agents|mesh-ancestor
25069262|NCT03427554|Dermatologic Agents|dermatologic agents|mesh-ancestor
25069264|NCT03427502|Bupivacaine|bupivacaine|mesh-list
25069265|NCT03427502|Anesthetics, Local|anesthetics, local|mesh-ancestor
25069266|NCT03427502|Anesthetics|anesthetics|mesh-ancestor
25069267|NCT03427502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25069268|NCT03427502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069269|NCT03427502|Sensory System Agents|sensory system agents|mesh-ancestor
25069270|NCT03427502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24690079|NCT01399086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24690080|NCT01399086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069286|NCT03427437|Bupivacaine|bupivacaine|mesh-list
25069287|NCT03427437|Epinephryl borate|epinephryl borate|mesh-list
25069288|NCT03427437|Anesthetics, Local|anesthetics, local|mesh-ancestor
25069289|NCT03427437|Anesthetics|anesthetics|mesh-ancestor
25069290|NCT03427437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25069291|NCT03427437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069292|NCT03427437|Sensory System Agents|sensory system agents|mesh-ancestor
25069293|NCT03427437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25069294|NCT03427437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25069296|NCT03427437|Adrenergic Agents|adrenergic agents|mesh-ancestor
25069297|NCT03427437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25069298|NCT03427437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069299|NCT03427437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25069300|NCT03427437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24690082|NCT01399151|Ergocalciferols|ergocalciferols|mesh-list
24611925|NCT01011257|Clopidogrel|clopidogrel|mesh-list
24611926|NCT01011257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24611927|NCT01011257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24611928|NCT01011257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24611929|NCT01011257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24611930|NCT01011257|Purinergic Agents|purinergic agents|mesh-ancestor
24611931|NCT01011257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24611967|NCT01011478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611968|NCT01011530|Pevonedistat|pevonedistat|mesh-list
24611969|NCT01011530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611970|NCT01011530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611971|NCT01011543|Dimercaprol|dimercaprol|mesh-list
24611972|NCT01011543|Chelating Agents|chelating agents|mesh-ancestor
24611973|NCT01011543|Sequestering Agents|sequestering agents|mesh-ancestor
24611974|NCT01011543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611975|NCT01011621|Prednisolone|prednisolone|mesh-list
24611976|NCT01011621|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24611977|NCT01011621|Methylprednisolone|methylprednisolone|mesh-list
24611978|NCT01011621|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24611979|NCT01011621|Prednisolone acetate|prednisolone acetate|mesh-list
24690083|NCT01399151|Cholecalciferol|cholecalciferol|mesh-list
25069301|NCT03427437|Autonomic Agents|autonomic agents|mesh-ancestor
25069302|NCT03427437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25069303|NCT03427437|Respiratory System Agents|respiratory system agents|mesh-ancestor
25069304|NCT03427437|Mydriatics|mydriatics|mesh-ancestor
25069305|NCT03427437|Sympathomimetics|sympathomimetics|mesh-ancestor
25069306|NCT03427437|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25069307|NCT03427385|Ropivacaine|ropivacaine|mesh-list
25069308|NCT03427385|Anesthetics, Local|anesthetics, local|mesh-ancestor
25069309|NCT03427385|Anesthetics|anesthetics|mesh-ancestor
25069310|NCT03427385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25069311|NCT03427385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069312|NCT03427385|Sensory System Agents|sensory system agents|mesh-ancestor
24690114|NCT01399450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24690115|NCT01399450|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24690116|NCT01399450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24690117|NCT01399450|Serotonin Agents|serotonin agents|mesh-ancestor
24690119|NCT01399450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690371|NCT01401179|Erythromycin Estolate|erythromycin estolate|mesh-list
24690123|NCT01399463|Paclitaxel|paclitaxel|mesh-list
24690124|NCT01399463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25069330|NCT03427216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069332|NCT03427216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25069333|NCT03427216|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25069334|NCT03427216|GABA Agonists|gaba agonists|mesh-ancestor
25069335|NCT03427216|GABA Agents|gaba agents|mesh-ancestor
25069336|NCT03427216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25069337|NCT03427216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069338|NCT03427216|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25069339|NCT03427216|Anticonvulsants|anticonvulsants|mesh-ancestor
25069340|NCT03427216|Antiemetics|antiemetics|mesh-ancestor
25069341|NCT03427216|Autonomic Agents|autonomic agents|mesh-ancestor
25069342|NCT03427216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25069343|NCT03427216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25069344|NCT03427216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25069345|NCT03427216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25069346|NCT03427216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25069350|NCT03427216|Anesthetics|anesthetics|mesh-ancestor
24641690|NCT01174914|Tenofovir|tenofovir|mesh-list
24690155|NCT01399840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24690157|NCT01399853|Immunologic Factors|immunologic factors|mesh-ancestor
24690158|NCT01399853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690159|NCT01400009|Vitamin D|vitamin d|mesh-list
24690160|NCT01400009|Cholecalciferol|cholecalciferol|mesh-list
25069364|NCT03426982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069365|NCT03426969|Mycophenolic Acid|mycophenolic acid|mesh-list
25069366|NCT03426969|Cyclophosphamide|cyclophosphamide|mesh-list
25069367|NCT03426969|Melphalan|melphalan|mesh-list
25069368|NCT03426969|Mechlorethamine|mechlorethamine|mesh-list
25069369|NCT03426969|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25069370|NCT03426969|Fludarabine|fludarabine|mesh-list
25069371|NCT03426969|Fludarabine phosphate|fludarabine phosphate|mesh-list
25069372|NCT03426969|Tacrolimus|tacrolimus|mesh-list
25069393|NCT03426956|Canagliflozin|canagliflozin|mesh-list
25069394|NCT03426956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25069395|NCT03426956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069396|NCT03426956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25069397|NCT03426956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832047|NCT02170571|Protease Inhibitors|protease inhibitors|mesh-ancestor
24690187|NCT01400165|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24690188|NCT01400165|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24690189|NCT01400165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24690193|NCT01400165|Serotonin Agents|serotonin agents|mesh-ancestor
24690194|NCT01400165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24690195|NCT01400165|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24690196|NCT01400165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24690197|NCT01400165|Adrenergic Agents|adrenergic agents|mesh-ancestor
24690198|NCT01400165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24690199|NCT01400165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24690204|NCT01400217|Beclomethasone|beclomethasone|mesh-list
24690239|NCT01400568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24690240|NCT01400568|Respiratory System Agents|respiratory system agents|mesh-ancestor
24690241|NCT01400568|Dermatologic Agents|dermatologic agents|mesh-ancestor
24690242|NCT01400568|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24690243|NCT01400633|Decitabine|decitabine|mesh-list
24690244|NCT01400633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24690245|NCT01400633|Antimetabolites|antimetabolites|mesh-ancestor
24690246|NCT01400633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690247|NCT01400633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069456|NCT03426462|Anesthetics, General|anesthetics, general|mesh-ancestor
25069457|NCT03426462|Anesthetics|anesthetics|mesh-ancestor
25069458|NCT03426202|Modafinil|modafinil|mesh-list
24690248|NCT01400633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690249|NCT01400646|Vitamins|vitamins|mesh-list
24690250|NCT01400646|Vitamin K|vitamin k|mesh-list
24690251|NCT01400646|Warfarin|warfarin|mesh-list
24690252|NCT01400646|Rivaroxaban|rivaroxaban|mesh-list
24690253|NCT01400646|Micronutrients|micronutrients|mesh-ancestor
24690254|NCT01400646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690255|NCT01400646|Anticoagulants|anticoagulants|mesh-ancestor
25701523|NCT02141295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24690256|NCT01400646|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24690376|NCT01401179|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24805511|NCT02009748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24805513|NCT02009787|Cholecalciferol|cholecalciferol|mesh-list
24805514|NCT02009787|Vitamins|vitamins|mesh-ancestor
24690377|NCT01401179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690378|NCT01401179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690379|NCT01401179|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24690380|NCT01401179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24690381|NCT01401179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24690476|NCT01402089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24690477|NCT01402089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24445341|NCT00301301|Rituximab|rituximab|mesh-list
24690478|NCT01402089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690479|NCT01402089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24690480|NCT01402089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24690481|NCT01402089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24690540|NCT01402336|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24690575|NCT01402596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24690576|NCT01402596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24690577|NCT01402596|Anesthetics, General|anesthetics, general|mesh-ancestor
24690578|NCT01402596|Anesthetics|anesthetics|mesh-ancestor
24690579|NCT01402596|GABA Modulators|gaba modulators|mesh-ancestor
24690580|NCT01402596|GABA Agents|gaba agents|mesh-ancestor
24690584|NCT01402622|Anesthetics|anesthetics|mesh-ancestor
25069471|NCT03426124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069472|NCT03426085|Liraglutide|liraglutide|mesh-list
25069473|NCT03426085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25069474|NCT03426085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069475|NCT03426085|Incretins|incretins|mesh-ancestor
25069476|NCT03426085|Hormones|hormones|mesh-ancestor
25069477|NCT03426085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25069478|NCT03426033|Warfarin|warfarin|mesh-list
25069479|NCT03426033|Anticoagulants|anticoagulants|mesh-ancestor
25069480|NCT03426020|Midazolam|midazolam|mesh-list
25069481|NCT03426020|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25069482|NCT03426020|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25069483|NCT03426020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25069484|NCT03426020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069485|NCT03426020|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25069486|NCT03426020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25069487|NCT03426020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25069488|NCT03426020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25069489|NCT03426020|Anesthetics, General|anesthetics, general|mesh-ancestor
25069490|NCT03426020|Anesthetics|anesthetics|mesh-ancestor
25069491|NCT03426020|GABA Modulators|gaba modulators|mesh-ancestor
25069492|NCT03426020|GABA Agents|gaba agents|mesh-ancestor
25069493|NCT03426020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25069494|NCT03426020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069495|NCT03425994|Emtricitabine|emtricitabine|mesh-list
25069496|NCT03425994|Cobicistat|cobicistat|mesh-list
25069497|NCT03425994|Elvitegravir|elvitegravir|mesh-list
25069498|NCT03425994|Antiviral Agents|antiviral agents|mesh-ancestor
25069499|NCT03425994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25069500|NCT03425994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25069501|NCT03425994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25069502|NCT03425994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25701524|NCT02141295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25701525|NCT02141295|Growth Substances|growth substances|mesh-ancestor
25701526|NCT02141295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701527|NCT02141295|Growth Inhibitors|growth inhibitors|mesh-ancestor
25701528|NCT02141295|Antidotes|antidotes|mesh-ancestor
25701529|NCT02141295|Protective Agents|protective agents|mesh-ancestor
25701530|NCT02141295|Vitamin B Complex|vitamin b complex|mesh-ancestor
25701531|NCT02141295|Vitamins|vitamins|mesh-ancestor
25701532|NCT02141295|Micronutrients|micronutrients|mesh-ancestor
25701533|NCT02141295|Hematinics|hematinics|mesh-ancestor
25069503|NCT03425994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069504|NCT03425994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25069507|NCT03425994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25069508|NCT03425994|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25069512|NCT03425929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069513|NCT03425747|Calcium, Dietary|calcium, dietary|mesh-list
25069514|NCT03425747|Calcium Carbonate|calcium carbonate|mesh-list
25069515|NCT03425747|Calcium|calcium|mesh-list
25069516|NCT03425747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25069517|NCT03425747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069518|NCT03425747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25069519|NCT03425747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069521|NCT03425747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25069522|NCT03425734|Dexmedetomidine|dexmedetomidine|mesh-list
25069523|NCT03425734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24690643|NCT01403259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24690645|NCT01403285|Molgramostim|molgramostim|mesh-list
24690666|NCT01403363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24449706|NCT00316745|Oxaliplatin|oxaliplatin|mesh-list
24690667|NCT01403363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24690668|NCT01403363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24690670|NCT01403363|Anesthetics|anesthetics|mesh-ancestor
24690671|NCT01403389|Eculizumab|eculizumab|mesh-list
24690672|NCT01403389|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24690673|NCT01403389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24690674|NCT01403389|Immunologic Factors|immunologic factors|mesh-ancestor
24690675|NCT01403389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690676|NCT01403415|Sirolimus|sirolimus|mesh-list
24690677|NCT01403415|Dexamethasone|dexamethasone|mesh-list
24690678|NCT01403415|Dexamethasone acetate|dexamethasone acetate|mesh-list
24690679|NCT01403415|Methotrexate|methotrexate|mesh-list
24690680|NCT01403415|Vincristine|vincristine|mesh-list
24690681|NCT01403415|Asparaginase|asparaginase|mesh-list
24690682|NCT01403415|Mitoxantrone|mitoxantrone|mesh-list
24690683|NCT01403415|Pegaspargase|pegaspargase|mesh-list
24690684|NCT01403415|BB 1101|bb 1101|mesh-list
24690685|NCT01403415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24690686|NCT01403415|Antiemetics|antiemetics|mesh-ancestor
24690687|NCT01403415|Autonomic Agents|autonomic agents|mesh-ancestor
24690688|NCT01403415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24690689|NCT01403415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690692|NCT01403415|Hormones|hormones|mesh-ancestor
25069565|NCT03425656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25069566|NCT03425656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25069567|NCT03425656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25069568|NCT03425656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25069569|NCT03425617|Tiotropium Bromide|tiotropium bromide|mesh-list
25069571|NCT03425617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25069572|NCT03425617|Autonomic Agents|autonomic agents|mesh-ancestor
25069573|NCT03425617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25069574|NCT03425617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443775|NCT00295971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25069575|NCT03425617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25069576|NCT03425617|Respiratory System Agents|respiratory system agents|mesh-ancestor
25069577|NCT03425617|Parasympatholytics|parasympatholytics|mesh-ancestor
24779461|NCT01876290|Serotonin Agents|serotonin agents|mesh-ancestor
25069596|NCT03425474|Propofol|propofol|mesh-list
25069597|NCT03425474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25069598|NCT03425474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25069599|NCT03425474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069600|NCT03425474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25069601|NCT03425474|Anesthetics, General|anesthetics, general|mesh-ancestor
25069602|NCT03425474|Anesthetics|anesthetics|mesh-ancestor
25069603|NCT03425461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25069604|NCT03425461|Nivolumab|nivolumab|mesh-list
24690733|NCT01403506|Antidotes|antidotes|mesh-ancestor
24690734|NCT01403545|Curcumin|curcumin|mesh-list
24690735|NCT01403545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24690736|NCT01403545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24690737|NCT01403545|Analgesics|analgesics|mesh-ancestor
25701534|NCT02141451|Rituximab|rituximab|mesh-list
24690738|NCT01403545|Sensory System Agents|sensory system agents|mesh-ancestor
24690739|NCT01403545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24690740|NCT01403545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690741|NCT01403545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24690757|NCT01403740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24690758|NCT01403740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690759|NCT01403740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690760|NCT01403740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24690761|NCT01403740|Antifungal Agents|antifungal agents|mesh-ancestor
24690799|NCT01404013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690800|NCT01404013|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24690801|NCT01404013|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24690802|NCT01404013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690804|NCT01404104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24690805|NCT01404104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24540372|NCT00667641|Tubulin Modulators|tubulin modulators|mesh-ancestor
24540373|NCT00667641|Antimitotic Agents|antimitotic agents|mesh-ancestor
24540374|NCT00667641|Mitosis Modulators|mitosis modulators|mesh-ancestor
24540375|NCT00667641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540377|NCT00667758|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24690806|NCT01404104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24690807|NCT01404104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24690808|NCT01404104|Antifungal Agents|antifungal agents|mesh-ancestor
24690809|NCT01404104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25107468|NCT03140033|Ranitidine|ranitidine|mesh-list
24690810|NCT01404104|Immunologic Factors|immunologic factors|mesh-ancestor
24690811|NCT01404104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690812|NCT01404117|Interferons|interferons|mesh-list
24690813|NCT01404117|Interferon-beta|interferon-beta|mesh-list
24690814|NCT01404117|Glatiramer Acetate|glatiramer acetate|mesh-list
24690816|NCT01404117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24690826|NCT01404156|Leucovorin|leucovorin|mesh-list
24690833|NCT01404156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24690834|NCT01404156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24690854|NCT01404169|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24690855|NCT01404169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690856|NCT01404169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690857|NCT01404169|Cholinergic Agents|cholinergic agents|mesh-ancestor
24690858|NCT01404169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24690859|NCT01404169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690860|NCT01404169|Nootropic Agents|nootropic agents|mesh-ancestor
24690861|NCT01404182|Vaccines|vaccines|mesh-list
24690862|NCT01404182|Immunologic Factors|immunologic factors|mesh-ancestor
25069621|NCT03425162|Anesthetics, Local|anesthetics, local|mesh-ancestor
25069622|NCT03425162|Anesthetics|anesthetics|mesh-ancestor
25069623|NCT03425162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25069624|NCT03425162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069625|NCT03425162|Sensory System Agents|sensory system agents|mesh-ancestor
25069626|NCT03425162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25069627|NCT03425162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25069628|NCT03425162|Narcotics|narcotics|mesh-ancestor
25069629|NCT03425162|Analgesics|analgesics|mesh-ancestor
25069630|NCT03425084|Morphine|morphine|mesh-list
25069631|NCT03425084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25069632|NCT03425084|Narcotics|narcotics|mesh-ancestor
24832290|NCT02171039|Atorvastatin|atorvastatin|mesh-list
24690863|NCT01404182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690864|NCT01404312|Pyridoxine|pyridoxine|mesh-list
24690865|NCT01404312|Pyridoxal|pyridoxal|mesh-list
24690919|NCT01404442|Anesthetics, General|anesthetics, general|mesh-ancestor
24690920|NCT01404442|Anesthetics|anesthetics|mesh-ancestor
24690921|NCT01404442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24690922|NCT01404442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24612042|NCT01011699|Sequestering Agents|sequestering agents|mesh-ancestor
24612044|NCT01011699|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24612045|NCT01011699|Hormone Antagonists|hormone antagonists|mesh-ancestor
24612046|NCT01011699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24612047|NCT01011751|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24690954|NCT01404598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24690955|NCT01404598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690956|NCT01404598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24690957|NCT01404598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24690958|NCT01404598|Gout Suppressants|gout suppressants|mesh-ancestor
24690969|NCT01404637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701535|NCT02141451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24690970|NCT01404637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690971|NCT01404637|Urological Agents|urological agents|mesh-ancestor
24690973|NCT01404676|Vildagliptin|vildagliptin|mesh-list
24690974|NCT01404676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24690975|NCT01404676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24690976|NCT01404676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690977|NCT01404676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24690978|NCT01404676|Immunologic Factors|immunologic factors|mesh-ancestor
24690979|NCT01404676|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24690980|NCT01404676|Protease Inhibitors|protease inhibitors|mesh-ancestor
24690981|NCT01404676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690982|NCT01404676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690983|NCT01404689|Dexmedetomidine|dexmedetomidine|mesh-list
24690984|NCT01404689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25069633|NCT03425084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25069634|NCT03425084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069635|NCT03425084|Analgesics|analgesics|mesh-ancestor
24832301|NCT02171039|Anticoagulants|anticoagulants|mesh-ancestor
24832302|NCT02171052|Digoxin|digoxin|mesh-list
24832303|NCT02171052|Dabigatran|dabigatran|mesh-list
24832304|NCT02171052|Antithrombins|antithrombins|mesh-ancestor
24832305|NCT02171052|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24690985|NCT01404689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24690986|NCT01404689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690987|NCT01404689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24690988|NCT01404689|Analgesics|analgesics|mesh-ancestor
24690989|NCT01404689|Sensory System Agents|sensory system agents|mesh-ancestor
24690990|NCT01404689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24691018|NCT01404715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691019|NCT01404741|Azacitidine|azacitidine|mesh-list
24691020|NCT01404741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24691021|NCT01404741|Antimetabolites|antimetabolites|mesh-ancestor
24691023|NCT01404741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691084|NCT01405079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24691085|NCT01405079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691112|NCT01405131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691130|NCT01405157|Autonomic Agents|autonomic agents|mesh-ancestor
24691131|NCT01405157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24691132|NCT01405157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691133|NCT01405157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24691134|NCT01405157|Glucocorticoids|glucocorticoids|mesh-ancestor
24691135|NCT01405157|Hormones|hormones|mesh-ancestor
24691136|NCT01405157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24691137|NCT01405157|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25069654|NCT03424889|Respiratory System Agents|respiratory system agents|mesh-ancestor
25069655|NCT03424876|Sunitinib|sunitinib|mesh-list
25069656|NCT03424876|Imatinib Mesylate|imatinib mesylate|mesh-list
25069657|NCT03424876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069658|NCT03424876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25069659|NCT03424876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25069660|NCT03424876|Growth Substances|growth substances|mesh-ancestor
24691936|NCT01409616|Protease Inhibitors|protease inhibitors|mesh-ancestor
25069661|NCT03424876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069662|NCT03424876|Growth Inhibitors|growth inhibitors|mesh-ancestor
25069663|NCT03424876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25069664|NCT03424876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25069665|NCT03424876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832344|NCT02171325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25701536|NCT02141451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25701537|NCT02141451|Immunologic Factors|immunologic factors|mesh-ancestor
25701538|NCT02141451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701539|NCT02141451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25701540|NCT02141490|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25701541|NCT02141490|Hematinics|hematinics|mesh-ancestor
25701542|NCT02141490|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25701543|NCT02141490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25701544|NCT02141555|Misoprostol|misoprostol|mesh-list
25701545|NCT02141555|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25701546|NCT02141555|Abortifacient Agents|abortifacient agents|mesh-ancestor
24832345|NCT02171325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691167|NCT01405235|Mitosis Modulators|mitosis modulators|mesh-ancestor
24691168|NCT01405235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691169|NCT01405248|3-n-butylphthalide|3-n-butylphthalide|mesh-list
24691170|NCT01405248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24691171|NCT01405248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24691172|NCT01405248|Protective Agents|protective agents|mesh-ancestor
24691173|NCT01405248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691175|NCT01405326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24691176|NCT01405326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24691177|NCT01405339|Budesonide|budesonide|mesh-list
24691178|NCT01405339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24691179|NCT01405339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24691180|NCT01405339|Autonomic Agents|autonomic agents|mesh-ancestor
24691181|NCT01405339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24691182|NCT01405339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691183|NCT01405339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24691184|NCT01405339|Respiratory System Agents|respiratory system agents|mesh-ancestor
24691185|NCT01405339|Glucocorticoids|glucocorticoids|mesh-ancestor
24691186|NCT01405339|Hormones|hormones|mesh-ancestor
24691207|NCT01405482|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24691242|NCT01405612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24691243|NCT01405612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24691244|NCT01405612|Anesthetics, General|anesthetics, general|mesh-ancestor
24691245|NCT01405612|Anesthetics|anesthetics|mesh-ancestor
24691246|NCT01405612|GABA Modulators|gaba modulators|mesh-ancestor
24691247|NCT01405612|GABA Agents|gaba agents|mesh-ancestor
24691248|NCT01405612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24476521|NCT00415402|Vitamin D|vitamin d|mesh-list
24991575|NCT05123170|Lidocaine|lidocaine|mesh-list
24691249|NCT01405612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691250|NCT01405807|Alemtuzumab|alemtuzumab|mesh-list
24691251|NCT01405807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24691252|NCT01405807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612048|NCT01011751|Leuprolide|leuprolide|mesh-list
24612049|NCT01011751|Flutamide|flutamide|mesh-list
24612050|NCT01011751|Cyproterone Acetate|cyproterone acetate|mesh-list
24612051|NCT01011751|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24612103|NCT01011920|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24612104|NCT01011998|Imatinib Mesylate|imatinib mesylate|mesh-list
24612105|NCT01011998|Valproic Acid|valproic acid|mesh-list
24612106|NCT01011998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612107|NCT01011998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24612108|NCT01011998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25069698|NCT03424733|Sensory System Agents|sensory system agents|mesh-ancestor
25069699|NCT03424733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25069700|NCT03424733|Antipyretics|antipyretics|mesh-ancestor
25069701|NCT03424733|Immunologic Factors|immunologic factors|mesh-ancestor
24691271|NCT01405989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691272|NCT01405989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691273|NCT01405989|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24691274|NCT01405989|Hormone Antagonists|hormone antagonists|mesh-ancestor
24691275|NCT01405989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24691276|NCT01405989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691277|NCT01405989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24691278|NCT01405989|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24691279|NCT01405989|Antithrombins|antithrombins|mesh-ancestor
24691280|NCT01405989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24691281|NCT01405989|Protease Inhibitors|protease inhibitors|mesh-ancestor
24691282|NCT01405989|Anticoagulants|anticoagulants|mesh-ancestor
24691283|NCT01406002|Rifampin|rifampin|mesh-list
24691284|NCT01406002|Darexaban|darexaban|mesh-list
24691285|NCT01406002|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24691286|NCT01406002|Antitubercular Agents|antitubercular agents|mesh-ancestor
24691287|NCT01406002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24691288|NCT01406002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24691289|NCT01406002|Leprostatic Agents|leprostatic agents|mesh-ancestor
24691290|NCT01406002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24691291|NCT01406002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691937|NCT01409616|Anticoagulants|anticoagulants|mesh-ancestor
25701547|NCT02141555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24691405|NCT01406431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24691407|NCT01406431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691408|NCT01406431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24473984|NCT00404599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24473985|NCT00404599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473986|NCT00404625|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24691409|NCT01406470|Immunoglobulins|immunoglobulins|mesh-list
24691410|NCT01406470|Antibodies|antibodies|mesh-list
24691411|NCT01406470|gamma-Globulins|gamma-globulins|mesh-list
24691412|NCT01406470|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24691414|NCT01406470|Immunoglobulin G|immunoglobulin g|mesh-list
24691415|NCT01406470|Immunologic Factors|immunologic factors|mesh-ancestor
24691416|NCT01406470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069702|NCT03424733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24691492|NCT01407237|Angiotensin II|angiotensin ii|mesh-list
24540534|NCT00668330|Alfacalcidol|alfacalcidol|mesh-list
24691493|NCT01407237|Giapreza|giapreza|mesh-list
24691494|NCT01407237|Angiotensinogen|angiotensinogen|mesh-list
24691495|NCT01407237|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24691496|NCT01407237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24691497|NCT01407237|Protease Inhibitors|protease inhibitors|mesh-ancestor
24691498|NCT01407237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691499|NCT01407237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691500|NCT01407289|Insulin|insulin|mesh-list
24691569|NCT01407887|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24691570|NCT01407887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25069738|NCT03424408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25069739|NCT03424408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25069740|NCT03424408|Analgesics|analgesics|mesh-ancestor
25069741|NCT03424408|Sensory System Agents|sensory system agents|mesh-ancestor
24691595|NCT01408056|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24691596|NCT01408056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691597|NCT01408095|Glimepiride|glimepiride|mesh-list
24691598|NCT01408095|Globalagliatin|globalagliatin|mesh-list
24691599|NCT01408095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24691609|NCT01408160|Antimetabolites|antimetabolites|mesh-ancestor
24691610|NCT01408160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691611|NCT01408160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691612|NCT01408160|Antiviral Agents|antiviral agents|mesh-ancestor
24691613|NCT01408160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24691672|NCT01408498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691674|NCT01408524|Labetalol|labetalol|mesh-list
24691675|NCT01408524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24691676|NCT01408524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24691677|NCT01408524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24691678|NCT01408524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691679|NCT01408524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24691680|NCT01408524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691681|NCT01408524|Vasodilator Agents|vasodilator agents|mesh-ancestor
24451465|NCT00323830|Capecitabine|capecitabine|mesh-list
24691821|NCT01409174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069742|NCT03424408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24691822|NCT01409174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24691925|NCT01409616|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24691926|NCT01409616|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24691927|NCT01409616|Purinergic Agents|purinergic agents|mesh-ancestor
24691928|NCT01409616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24691929|NCT01409616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24691930|NCT01409616|Antifungal Agents|antifungal agents|mesh-ancestor
24691931|NCT01409616|Keratolytic Agents|keratolytic agents|mesh-ancestor
24691932|NCT01409616|Dermatologic Agents|dermatologic agents|mesh-ancestor
24691933|NCT01409616|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24691934|NCT01409616|Antithrombins|antithrombins|mesh-ancestor
24691935|NCT01409616|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24691939|NCT01409694|Ergocalciferols|ergocalciferols|mesh-list
24691940|NCT01409694|Cholecalciferol|cholecalciferol|mesh-list
24691941|NCT01409694|Vitamins|vitamins|mesh-list
24691995|NCT01410214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691996|NCT01410214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701548|NCT02141555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701549|NCT02141555|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25701550|NCT02141555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24691997|NCT01410214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25701551|NCT02141555|Oxytocics|oxytocics|mesh-ancestor
25701552|NCT02141581|Vaccines|vaccines|mesh-list
25701553|NCT02141581|Immunologic Factors|immunologic factors|mesh-ancestor
25701554|NCT02141581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474340|NCT00405730|Ketorolac|ketorolac|mesh-list
24691998|NCT01410214|Tubulin Modulators|tubulin modulators|mesh-ancestor
24691999|NCT01410214|Antimitotic Agents|antimitotic agents|mesh-ancestor
24692020|NCT01410708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24692163|NCT01411735|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24692164|NCT01411735|Protease Inhibitors|protease inhibitors|mesh-ancestor
24692165|NCT01411735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24692166|NCT01411735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692167|NCT01411735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24692168|NCT01411930|Olanzapine|olanzapine|mesh-list
24692169|NCT01411930|Aripiprazole|aripiprazole|mesh-list
24692170|NCT01411930|Antiemetics|antiemetics|mesh-ancestor
24692171|NCT01411930|Autonomic Agents|autonomic agents|mesh-ancestor
24692172|NCT01411930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24692173|NCT01411930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692174|NCT01411930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24692175|NCT01411930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24692176|NCT01411930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24692177|NCT01411930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24692178|NCT01411930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24692179|NCT01411930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24692211|NCT01411969|Protective Agents|protective agents|mesh-ancestor
24612119|NCT01012011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612120|NCT01012011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24612121|NCT01012011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612148|NCT01012193|Autonomic Agents|autonomic agents|mesh-ancestor
24692247|NCT01412307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692248|NCT01412307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24692249|NCT01412307|Alkylating Agents|alkylating agents|mesh-ancestor
24692250|NCT01412307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692251|NCT01412385|Immunoglobulins|immunoglobulins|mesh-list
24692252|NCT01412385|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24692253|NCT01412385|Antibodies|antibodies|mesh-list
24692254|NCT01412385|gamma-Globulins|gamma-globulins|mesh-list
24692255|NCT01412385|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24692256|NCT01412385|Immunoglobulin G|immunoglobulin g|mesh-list
24692257|NCT01412385|Immunologic Factors|immunologic factors|mesh-ancestor
24692258|NCT01412385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692259|NCT01412411|Micronutrients|micronutrients|mesh-list
24692260|NCT01412411|Trace Elements|trace elements|mesh-list
24692290|NCT01412632|Sensory System Agents|sensory system agents|mesh-ancestor
24692291|NCT01412632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24692322|NCT01412840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24692323|NCT01412840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24692324|NCT01412840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692325|NCT01412892|Everolimus|everolimus|mesh-list
24692326|NCT01412892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692327|NCT01412892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24692328|NCT01412892|Immunologic Factors|immunologic factors|mesh-ancestor
24692342|NCT01413022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24692343|NCT01413022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24692344|NCT01413022|Antidotes|antidotes|mesh-ancestor
24692345|NCT01413022|Protective Agents|protective agents|mesh-ancestor
24692346|NCT01413022|Vitamin B Complex|vitamin b complex|mesh-ancestor
24692347|NCT01413022|Vitamins|vitamins|mesh-ancestor
24692348|NCT01413022|Micronutrients|micronutrients|mesh-ancestor
24692427|NCT01413854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24692428|NCT01413854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24692429|NCT01413854|Analgesics|analgesics|mesh-ancestor
24692430|NCT01413854|Sensory System Agents|sensory system agents|mesh-ancestor
24692431|NCT01413854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24692432|NCT01413854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692433|NCT01413854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24692434|NCT01413854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24692435|NCT01413854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24692436|NCT01413854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24692489|NCT01414608|Cisplatin|cisplatin|mesh-list
24692490|NCT01414608|Carboplatin|carboplatin|mesh-list
25069761|NCT03424356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069762|NCT03424356|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25069763|NCT03424356|Anesthetics, General|anesthetics, general|mesh-ancestor
25069764|NCT03424356|Anesthetics|anesthetics|mesh-ancestor
24692551|NCT01415128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692553|NCT01415128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692554|NCT01415128|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24692555|NCT01415128|Antidepressive Agents|antidepressive agents|mesh-ancestor
25701555|NCT02141620|Acetylcysteine|acetylcysteine|mesh-list
25701557|NCT02141620|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24692556|NCT01415128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25069773|NCT03424291|Apatinib|apatinib|mesh-list
24692567|NCT01415141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24692568|NCT01415284|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24692569|NCT01415284|Plasma Substitutes|plasma substitutes|mesh-ancestor
24692570|NCT01415284|Blood Substitutes|blood substitutes|mesh-ancestor
24692571|NCT01415336|Cyclophosphamide|cyclophosphamide|mesh-list
24692636|NCT01415687|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24692637|NCT01415687|Chelating Agents|chelating agents|mesh-ancestor
24692638|NCT01415687|Sequestering Agents|sequestering agents|mesh-ancestor
24692639|NCT01415687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692640|NCT01415687|Cathartics|cathartics|mesh-ancestor
24692662|NCT01415765|Cyclophosphamide|cyclophosphamide|mesh-list
24692663|NCT01415765|Rituximab|rituximab|mesh-list
24692664|NCT01415765|Doxorubicin|doxorubicin|mesh-list
24692665|NCT01415765|Etoposide|etoposide|mesh-list
24692666|NCT01415765|Vincristine|vincristine|mesh-list
24692667|NCT01415765|Pevonedistat|pevonedistat|mesh-list
24692668|NCT01415765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24692669|NCT01415765|Immunologic Factors|immunologic factors|mesh-ancestor
24692670|NCT01415765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692671|NCT01415765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24692672|NCT01415765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24692673|NCT01415765|Alkylating Agents|alkylating agents|mesh-ancestor
24692674|NCT01415765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692675|NCT01415765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692676|NCT01415765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24692677|NCT01415765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24692678|NCT01415765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24692679|NCT01415765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24692706|NCT01415895|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24692707|NCT01415895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692708|NCT01415895|Sensory System Agents|sensory system agents|mesh-ancestor
24692709|NCT01415895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24692710|NCT01415895|Analgesics|analgesics|mesh-ancestor
24692711|NCT01415895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24692712|NCT01415895|Sympatholytics|sympatholytics|mesh-ancestor
24692713|NCT01415895|Autonomic Agents|autonomic agents|mesh-ancestor
24692714|NCT01415895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24692715|NCT01415895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24692716|NCT01415895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24692717|NCT01415895|Adrenergic Agents|adrenergic agents|mesh-ancestor
24692718|NCT01415895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24692719|NCT01415895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692720|NCT01416038|Cyclophosphamide|cyclophosphamide|mesh-list
24692721|NCT01416038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24692722|NCT01416038|Immunologic Factors|immunologic factors|mesh-ancestor
24692723|NCT01416038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692741|NCT01416116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25069791|NCT03424135|Analgesics|analgesics|mesh-ancestor
25069792|NCT03424135|Sensory System Agents|sensory system agents|mesh-ancestor
25069793|NCT03424135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25069794|NCT03424135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069795|NCT03424135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25069796|NCT03424135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24692799|NCT01416558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24692800|NCT01416558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692801|NCT01416558|Tubulin Modulators|tubulin modulators|mesh-ancestor
24692802|NCT01416558|Antimitotic Agents|antimitotic agents|mesh-ancestor
24692803|NCT01416558|Mitosis Modulators|mitosis modulators|mesh-ancestor
24692804|NCT01416558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692861|NCT01416948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24692862|NCT01416948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24692863|NCT01416948|Cholinergic Agents|cholinergic agents|mesh-ancestor
24692864|NCT01416948|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24612185|NCT01012349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24612186|NCT01012349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24612187|NCT01012349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612188|NCT01012349|Antipyretics|antipyretics|mesh-ancestor
24612189|NCT01012349|Anticoagulants|anticoagulants|mesh-ancestor
25701558|NCT02141620|Antiviral Agents|antiviral agents|mesh-ancestor
25069808|NCT03424135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25069809|NCT03424135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25069810|NCT03424135|Histamine Antagonists|histamine antagonists|mesh-ancestor
25069811|NCT03424135|Histamine Agents|histamine agents|mesh-ancestor
25069812|NCT03424135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25069813|NCT03424135|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25069814|NCT03424135|Antipruritics|antipruritics|mesh-ancestor
25069815|NCT03424135|Dermatologic Agents|dermatologic agents|mesh-ancestor
25069816|NCT03423979|Paclitaxel|paclitaxel|mesh-list
25069817|NCT03423979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25069818|NCT03423979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25069819|NCT03423979|Tubulin Modulators|tubulin modulators|mesh-ancestor
25069820|NCT03423979|Antimitotic Agents|antimitotic agents|mesh-ancestor
24612190|NCT01012349|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24612191|NCT01012349|Chelating Agents|chelating agents|mesh-ancestor
24692987|NCT01417572|Sensory System Agents|sensory system agents|mesh-ancestor
24692988|NCT01417572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24692989|NCT01417572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24692990|NCT01417572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24692991|NCT01417572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24692992|NCT01417572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24692993|NCT01417572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692994|NCT01417689|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24692995|NCT01417689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24692996|NCT01417754|Toremifene|toremifene|mesh-list
24692997|NCT01417754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25069821|NCT03423979|Mitosis Modulators|mitosis modulators|mesh-ancestor
25069822|NCT03423979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069823|NCT03423849|Gemcitabine|gemcitabine|mesh-list
25069824|NCT03423849|Capecitabine|capecitabine|mesh-list
25069825|NCT03423849|Vinorelbine|vinorelbine|mesh-list
24832483|NCT02171559|Dabigatran|dabigatran|mesh-list
24692998|NCT01417754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692999|NCT01417754|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24693000|NCT01417754|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24693005|NCT01417767|Decitabine|decitabine|mesh-list
24693010|NCT01417767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693012|NCT01417806|Pasireotide|pasireotide|mesh-list
24693036|NCT01417923|Vitamin D|vitamin d|mesh-list
24693053|NCT01418118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693054|NCT01418118|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24642556|NCT01180075|Protease Inhibitors|protease inhibitors|mesh-ancestor
24693055|NCT01418118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24693056|NCT01418118|Autonomic Agents|autonomic agents|mesh-ancestor
24693057|NCT01418118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24693058|NCT01418118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24693059|NCT01418118|Respiratory System Agents|respiratory system agents|mesh-ancestor
24693060|NCT01418118|Mydriatics|mydriatics|mesh-ancestor
24693061|NCT01418118|Sympathomimetics|sympathomimetics|mesh-ancestor
24693062|NCT01418118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24693063|NCT01418118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24693064|NCT01418118|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24693065|NCT01418118|Protective Agents|protective agents|mesh-ancestor
24693072|NCT01418131|Immunologic Factors|immunologic factors|mesh-ancestor
24693073|NCT01418131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540776|NCT00669643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24540777|NCT00669643|Antimalarials|antimalarials|mesh-ancestor
24693074|NCT01418131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693076|NCT01418144|Ropivacaine|ropivacaine|mesh-list
24693107|NCT01418274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693108|NCT01418274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693109|NCT01418274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24693110|NCT01418274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24693111|NCT01418274|Antiviral Agents|antiviral agents|mesh-ancestor
24693112|NCT01418274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24693113|NCT01418274|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24693114|NCT01418274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24693115|NCT01418274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24693212|NCT01418729|Pravastatin|pravastatin|mesh-list
24693213|NCT01418729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24693214|NCT01418729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24693215|NCT01418729|Antimetabolites|antimetabolites|mesh-ancestor
24693216|NCT01418729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693217|NCT01418729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24693218|NCT01418729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24693219|NCT01418729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693221|NCT01418742|Panitumumab|panitumumab|mesh-list
24693222|NCT01418742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24693223|NCT01418742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24693224|NCT01418742|Antimalarials|antimalarials|mesh-ancestor
24693225|NCT01418742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24693226|NCT01418742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24693227|NCT01418742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24693228|NCT01418742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24693229|NCT01418794|Sirolimus|sirolimus|mesh-list
25069845|NCT03423823|Growth Substances|growth substances|mesh-ancestor
25069846|NCT03423823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693304|NCT01419405|Sensory System Agents|sensory system agents|mesh-ancestor
24693305|NCT01419405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24693306|NCT01419405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693308|NCT01419405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24693309|NCT01419405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24693310|NCT01419405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693311|NCT01419405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24693312|NCT01419405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24693313|NCT01419405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24540778|NCT00669643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24693314|NCT01419405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24693315|NCT01419405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24693316|NCT01419405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24693317|NCT01419405|Narcotics|narcotics|mesh-ancestor
24693318|NCT01419457|Favipiravir|favipiravir|mesh-list
24693342|NCT01419730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24693344|NCT01419821|Ergocalciferols|ergocalciferols|mesh-list
24693359|NCT01419873|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24693360|NCT01419873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24693361|NCT01419873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693362|NCT01420055|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24693396|NCT01420250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24693397|NCT01420250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693398|NCT01420250|Hormone Antagonists|hormone antagonists|mesh-ancestor
24693418|NCT01420341|Antimalarials|antimalarials|mesh-ancestor
24693419|NCT01420341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24693420|NCT01420341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24693421|NCT01420367|Metronidazole|metronidazole|mesh-list
24693422|NCT01420367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24693423|NCT01420367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25069847|NCT03423823|Growth Inhibitors|growth inhibitors|mesh-ancestor
25069849|NCT03423810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25069850|NCT03423810|Vasodilator Agents|vasodilator agents|mesh-ancestor
25069851|NCT03423797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25069852|NCT03423667|Acetylcysteine|acetylcysteine|mesh-list
24612244|NCT01012843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612245|NCT01012869|Everolimus|everolimus|mesh-list
24612246|NCT01012869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612247|NCT01012869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24612248|NCT01012869|Immunologic Factors|immunologic factors|mesh-ancestor
24612249|NCT01012869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612250|NCT01012882|Immunologic Factors|immunologic factors|mesh-list
24612251|NCT01012882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612252|NCT01012934|Alendronate|alendronate|mesh-list
24612253|NCT01012934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24540805|NCT00669656|Estrogens|estrogens|mesh-ancestor
24540806|NCT00669656|Hormones|hormones|mesh-ancestor
24540807|NCT00669656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24612254|NCT01012934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612255|NCT01012960|Methylnaltrexone|methylnaltrexone|mesh-list
24612260|NCT01013012|Dexamethasone|dexamethasone|mesh-list
24693512|NCT01420913|Analgesics|analgesics|mesh-ancestor
24693513|NCT01420913|Sensory System Agents|sensory system agents|mesh-ancestor
24693514|NCT01420913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24693515|NCT01420913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693516|NCT01420913|Anticonvulsants|anticonvulsants|mesh-ancestor
24693517|NCT01420913|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24693518|NCT01420913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24693519|NCT01420913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693586|NCT01421173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25701559|NCT02141620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25701560|NCT02141620|Expectorants|expectorants|mesh-ancestor
24693587|NCT01421173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24693588|NCT01421173|Alkylating Agents|alkylating agents|mesh-ancestor
24693592|NCT01421212|Immunoglobulins|immunoglobulins|mesh-list
24693594|NCT01421212|gamma-Globulins|gamma-globulins|mesh-list
24693595|NCT01421212|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24693596|NCT01421212|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24693597|NCT01421212|Immunoglobulin G|immunoglobulin g|mesh-list
24693598|NCT01421212|Immunologic Factors|immunologic factors|mesh-ancestor
24693599|NCT01421212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693601|NCT01421264|Analgesics|analgesics|mesh-ancestor
24693602|NCT01421264|Sensory System Agents|sensory system agents|mesh-ancestor
24693603|NCT01421264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24693604|NCT01421264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693605|NCT01421264|Anticonvulsants|anticonvulsants|mesh-ancestor
24693606|NCT01421264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24693607|NCT01421264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24693644|NCT01421693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24540819|NCT00669721|Anticoagulants|anticoagulants|mesh-ancestor
24540821|NCT00669721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24540823|NCT00669747|Carboplatin|carboplatin|mesh-list
24693750|NCT01422096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24693751|NCT01422096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24693842|NCT01422616|Nicardipine|nicardipine|mesh-list
24693843|NCT01422616|Phentolamine|phentolamine|mesh-list
24693845|NCT01422616|Enalaprilat|enalaprilat|mesh-list
25069880|NCT03423342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069881|NCT03423342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25069882|NCT03423342|Vasodilator Agents|vasodilator agents|mesh-ancestor
25069883|NCT03423329|Ibuprofen|ibuprofen|mesh-list
25069884|NCT03423329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25069885|NCT03423329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25069886|NCT03423329|Analgesics|analgesics|mesh-ancestor
25069887|NCT03423329|Sensory System Agents|sensory system agents|mesh-ancestor
25069888|NCT03423329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25069914|NCT03422978|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25069915|NCT03422978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25069916|NCT03422978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25069917|NCT03422978|Adrenergic Agents|adrenergic agents|mesh-ancestor
25069918|NCT03422978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25069919|NCT03422978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069920|NCT03422887|Flurbiprofen|flurbiprofen|mesh-list
25069921|NCT03422887|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
25069922|NCT03422887|Nalbuphine|nalbuphine|mesh-list
25069923|NCT03422887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25069924|NCT03422887|Narcotics|narcotics|mesh-ancestor
25069925|NCT03422887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25069926|NCT03422887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069927|NCT03422887|Analgesics|analgesics|mesh-ancestor
25069928|NCT03422887|Sensory System Agents|sensory system agents|mesh-ancestor
25069929|NCT03422887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25069930|NCT03422887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25069931|NCT03422887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25069932|NCT03422887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25069933|NCT03422887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25069934|NCT03422887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25069935|NCT03422887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693922|NCT01422785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24693923|NCT01422785|Keratolytic Agents|keratolytic agents|mesh-ancestor
24693924|NCT01422954|Chloroquine|chloroquine|mesh-list
24693926|NCT01422954|Proguanil|proguanil|mesh-list
24693927|NCT01422954|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
24693928|NCT01422954|Amebicides|amebicides|mesh-ancestor
24693929|NCT01422954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24693930|NCT01422954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24693931|NCT01422954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24693932|NCT01422954|Antimalarials|antimalarials|mesh-ancestor
24693933|NCT01422954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24693934|NCT01422954|Antimetabolites|antimetabolites|mesh-ancestor
24693935|NCT01422954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701561|NCT02141620|Respiratory System Agents|respiratory system agents|mesh-ancestor
24693936|NCT01423019|Synephrine|synephrine|mesh-list
24693937|NCT01423019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24693938|NCT01423019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24693939|NCT01423019|Adrenergic Agents|adrenergic agents|mesh-ancestor
24693940|NCT01423019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24693941|NCT01423019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693942|NCT01423019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693943|NCT01423019|Sympathomimetics|sympathomimetics|mesh-ancestor
24693944|NCT01423019|Autonomic Agents|autonomic agents|mesh-ancestor
24693945|NCT01423019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24779464|NCT01876290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24693953|NCT01423032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24693954|NCT01423032|Alkylating Agents|alkylating agents|mesh-ancestor
24693955|NCT01423123|Paclitaxel|paclitaxel|mesh-list
24693956|NCT01423123|Trastuzumab|trastuzumab|mesh-list
24693957|NCT01423123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24693958|NCT01423123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24693959|NCT01423123|Tubulin Modulators|tubulin modulators|mesh-ancestor
24693960|NCT01423123|Antimitotic Agents|antimitotic agents|mesh-ancestor
24693961|NCT01423123|Mitosis Modulators|mitosis modulators|mesh-ancestor
24612331|NCT01013506|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24612332|NCT01013506|Hormone Antagonists|hormone antagonists|mesh-ancestor
24612333|NCT01013506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24612342|NCT01013532|Sensory System Agents|sensory system agents|mesh-ancestor
24626405|NCT01087203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24626406|NCT01087203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694028|NCT01423500|Etoposide phosphate|etoposide phosphate|mesh-list
24694029|NCT01423500|Thiotepa|thiotepa|mesh-list
24694030|NCT01423500|Treosulfan|treosulfan|mesh-list
24694031|NCT01423500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694032|NCT01423500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694033|NCT01423500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24694034|NCT01423500|Immunologic Factors|immunologic factors|mesh-ancestor
24694035|NCT01423500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694036|NCT01423500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24694037|NCT01423500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24694038|NCT01423500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25069951|NCT03422796|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25069952|NCT03422796|Autonomic Agents|autonomic agents|mesh-ancestor
25069953|NCT03422796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25069975|NCT03422705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25069976|NCT03422705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25069977|NCT03422705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25069978|NCT03422705|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24694227|NCT01424449|Dopamine Agonists|dopamine agonists|mesh-ancestor
24694228|NCT01424449|Dopamine Agents|dopamine agents|mesh-ancestor
24694229|NCT01424449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24694230|NCT01424449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694231|NCT01424449|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24694232|NCT01424449|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24694233|NCT01424449|Serotonin Agents|serotonin agents|mesh-ancestor
24694234|NCT01424449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25069979|NCT03422705|Protective Agents|protective agents|mesh-ancestor
25069980|NCT03422705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25069981|NCT03422640|Apremilast|apremilast|mesh-list
24694356|NCT01425164|Antioxidants|antioxidants|mesh-ancestor
24694357|NCT01425164|Protective Agents|protective agents|mesh-ancestor
24694358|NCT01425164|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24694359|NCT01425164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24694360|NCT01425164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24694361|NCT01425164|Vasodilator Agents|vasodilator agents|mesh-ancestor
24694362|NCT01425164|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24694363|NCT01425164|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24694365|NCT01425216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694366|NCT01425216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24694367|NCT01425216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25069995|NCT03422575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25069996|NCT03422575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25069997|NCT03422575|Analgesics|analgesics|mesh-ancestor
25069998|NCT03422575|Sensory System Agents|sensory system agents|mesh-ancestor
25069999|NCT03422575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25070000|NCT03422575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070001|NCT03422575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24694368|NCT01425216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694369|NCT01425242|Amlodipine|amlodipine|mesh-list
24694377|NCT01425320|Dapsone|dapsone|mesh-list
24612400|NCT01013779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24612401|NCT01013779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612402|NCT01013779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612403|NCT01013805|Leucovorin|leucovorin|mesh-list
24612404|NCT01013805|Fluorouracil|fluorouracil|mesh-list
24612405|NCT01013805|Oxaliplatin|oxaliplatin|mesh-list
24612406|NCT01013805|Antimetabolites|antimetabolites|mesh-ancestor
24612409|NCT01013805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694436|NCT01425476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694437|NCT01425567|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
24694438|NCT01425567|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24694439|NCT01425567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24694441|NCT01425580|Liraglutide|liraglutide|mesh-list
24694442|NCT01425580|Glimepiride|glimepiride|mesh-list
24694443|NCT01425580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24694444|NCT01425580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694445|NCT01425580|Incretins|incretins|mesh-ancestor
24694446|NCT01425580|Hormones|hormones|mesh-ancestor
24694457|NCT01425619|Sensory System Agents|sensory system agents|mesh-ancestor
24694458|NCT01425619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24694459|NCT01425619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24694460|NCT01425619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24694461|NCT01425619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24541095|NCT00670787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541096|NCT00670787|Diuretics|diuretics|mesh-ancestor
24694462|NCT01425619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24785514|NCT01914900|Fluorouracil|fluorouracil|mesh-list
24612431|NCT01013987|Raltegravir Potassium|raltegravir potassium|mesh-list
24694509|NCT01425775|Micronutrients|micronutrients|mesh-ancestor
24694510|NCT01425775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694511|NCT01425775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24694512|NCT05386914|Sirolimus|sirolimus|mesh-list
24694513|NCT05386914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24694514|NCT05386914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24694515|NCT05386914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24694516|NCT05386914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694517|NCT05386914|Antifungal Agents|antifungal agents|mesh-ancestor
24694519|NCT05386914|Immunologic Factors|immunologic factors|mesh-ancestor
24694520|NCT05386914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694521|NCT05386706|Metformin|metformin|mesh-list
24694522|NCT05386706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24694523|NCT05386706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694524|NCT05386446|Interferons|interferons|mesh-list
24694525|NCT05386446|Interferon-gamma|interferon-gamma|mesh-list
24694526|NCT05386446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694527|NCT05386446|Antiviral Agents|antiviral agents|mesh-ancestor
24694528|NCT05386446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24694529|NCT05386290|Mesalamine|mesalamine|mesh-list
24694530|NCT05386290|Infliximab|infliximab|mesh-list
24694531|NCT05386290|Ustekinumab|ustekinumab|mesh-list
24694668|NCT05385068|Niraparib|niraparib|mesh-list
24694669|NCT05385068|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24694670|NCT05385068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24694671|NCT05385068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701562|NCT02141620|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25109163|NCT03126864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25109164|NCT03126864|Alkylating Agents|alkylating agents|mesh-ancestor
25109165|NCT03126864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109166|NCT03126864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109167|NCT03126864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25109168|NCT03126864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25109169|NCT03126864|Antimetabolites|antimetabolites|mesh-ancestor
25109170|NCT03126864|Antiviral Agents|antiviral agents|mesh-ancestor
25109171|NCT03126864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25109172|NCT03126578|Midazolam|midazolam|mesh-list
24694672|NCT05385068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694673|NCT05385042|Vitamin B 12|vitamin b 12|mesh-list
24694674|NCT05385042|Thiamine|thiamine|mesh-list
24694675|NCT05385042|Vitamins|vitamins|mesh-ancestor
24694676|NCT05385042|Micronutrients|micronutrients|mesh-ancestor
24694677|NCT05385042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694678|NCT05385042|Vitamin B Complex|vitamin b complex|mesh-ancestor
24694679|NCT05385029|Carbimazole|carbimazole|mesh-list
24694680|NCT05385029|Antithyroid Agents|antithyroid agents|mesh-ancestor
24694681|NCT05385029|Hormone Antagonists|hormone antagonists|mesh-ancestor
24694682|NCT05385029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24694683|NCT05385029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480184|NCT00430079|Imidazole|imidazole|mesh-list
24694781|NCT05308979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25070051|NCT03422315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070052|NCT03422315|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25070053|NCT03422315|Anesthetics, General|anesthetics, general|mesh-ancestor
25070054|NCT03422315|Anesthetics|anesthetics|mesh-ancestor
25070055|NCT03422289|Folic Acid|folic acid|mesh-list
25070056|NCT03422289|Vitamin B Complex|vitamin b complex|mesh-list
25070057|NCT03422289|Inositol|inositol|mesh-list
25070058|NCT03422289|Hematinics|hematinics|mesh-ancestor
25070059|NCT03422289|Vitamins|vitamins|mesh-ancestor
25070060|NCT03422289|Micronutrients|micronutrients|mesh-ancestor
24541149|NCT00671203|Erythromycin Estolate|erythromycin estolate|mesh-list
24541151|NCT00671203|Erythromycin stearate|erythromycin stearate|mesh-list
24541170|NCT00671320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24541171|NCT00671320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541172|NCT00671320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24541173|NCT00671320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25070061|NCT03422289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070062|NCT03422146|Tea Tree Oil|tea tree oil|mesh-list
24694811|NCT05244525|Adrenergic Agents|adrenergic agents|mesh-ancestor
24694812|NCT05244525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24694813|NCT05244525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694814|NCT05244525|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25070069|NCT03422055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25070070|NCT03422042|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25070071|NCT03422042|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25070072|NCT03422042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24832735|NCT02172144|Autonomic Agents|autonomic agents|mesh-ancestor
24694815|NCT05244525|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24694816|NCT05244525|Autonomic Agents|autonomic agents|mesh-ancestor
24694817|NCT05244525|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24694820|NCT05244525|Sympathomimetics|sympathomimetics|mesh-ancestor
24694821|NCT05244525|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24694822|NCT05210439|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25701563|NCT02141620|Antioxidants|antioxidants|mesh-ancestor
25701564|NCT02141620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701565|NCT02141620|Protective Agents|protective agents|mesh-ancestor
25701566|NCT02141620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701567|NCT02141620|Antidotes|antidotes|mesh-ancestor
25701568|NCT02141620|Anesthetics, Local|anesthetics, local|mesh-ancestor
25701569|NCT02141620|Anesthetics|anesthetics|mesh-ancestor
25701570|NCT02141620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25701571|NCT02141620|Sensory System Agents|sensory system agents|mesh-ancestor
25701572|NCT02141620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24694823|NCT05210439|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24694835|NCT05176379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24612422|NCT01013831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612426|NCT01013909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24612427|NCT01013909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612428|NCT01013909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612429|NCT01013987|Ritonavir|ritonavir|mesh-list
24612430|NCT01013987|Darunavir|darunavir|mesh-list
24694871|NCT05113615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541192|NCT00671372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24541193|NCT00671372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541194|NCT00671372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541195|NCT00671424|Remogliflozin etabonate|remogliflozin etabonate|mesh-list
24541196|NCT00671424|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24541198|NCT00671424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24541200|NCT00671424|Natriuretic Agents|natriuretic agents|mesh-ancestor
24541201|NCT00671424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541202|NCT00671424|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24541203|NCT00671424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24541204|NCT00671424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541205|NCT00671424|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25070077|NCT03421990|Anesthetics|anesthetics|mesh-list
25070079|NCT03421990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694926|NCT05089916|Osimertinib|osimertinib|mesh-list
24694927|NCT05089916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694969|NCT04850378|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24694971|NCT04850378|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24694975|NCT04850378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24694976|NCT04850378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694977|NCT04850378|Anticoagulants|anticoagulants|mesh-ancestor
24694978|NCT04850378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24694979|NCT04850378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24694980|NCT04838808|Rivaroxaban|rivaroxaban|mesh-list
24694981|NCT04838808|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24694982|NCT04838808|Antithrombins|antithrombins|mesh-ancestor
24694983|NCT04838808|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24695007|NCT04765371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695009|NCT04765371|Glucocorticoids|glucocorticoids|mesh-ancestor
24695011|NCT04765371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24695012|NCT04765371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24695013|NCT04765371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24695014|NCT04765371|Protease Inhibitors|protease inhibitors|mesh-ancestor
24695015|NCT04765371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24695016|NCT04765371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070090|NCT03421860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070091|NCT03421860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070092|NCT03421860|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25070093|NCT03421860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25070094|NCT03421860|Autonomic Agents|autonomic agents|mesh-ancestor
24695017|NCT04765371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24695018|NCT04765371|Protective Agents|protective agents|mesh-ancestor
24695019|NCT04744363|Ustekinumab|ustekinumab|mesh-list
24695020|NCT04744363|Dermatologic Agents|dermatologic agents|mesh-ancestor
24695022|NCT04729517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24695023|NCT04729517|Autonomic Agents|autonomic agents|mesh-ancestor
24695024|NCT04729517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24695055|NCT04673162|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24695056|NCT04673162|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24695057|NCT04673162|Prednisolone|prednisolone|mesh-list
24695058|NCT04673162|Prednisolone acetate|prednisolone acetate|mesh-list
24695121|NCT04425902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24695122|NCT04425902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695123|NCT04425902|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24541262|NCT00671697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541268|NCT00671801|Lenalidomide|lenalidomide|mesh-list
24541269|NCT00671801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24695138|NCT04425902|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24695139|NCT04425902|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24695140|NCT04425902|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24695163|NCT04425902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24612456|NCT01014104|Methylprednisolone|methylprednisolone|mesh-list
24695177|NCT04311762|Cisplatin|cisplatin|mesh-list
24695178|NCT04311762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24695192|NCT04246762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24695194|NCT04246762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24695195|NCT04246762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25070107|NCT03421860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25070108|NCT03421860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25070109|NCT03421860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25070110|NCT03421860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25070111|NCT03421860|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25070112|NCT03421860|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25070113|NCT03421860|Nasal Decongestants|nasal decongestants|mesh-ancestor
25070114|NCT03421860|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24541335|NCT00672347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24541336|NCT00672347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24541337|NCT00672347|Narcotics|narcotics|mesh-ancestor
24541338|NCT00672347|Analgesics|analgesics|mesh-ancestor
24541339|NCT00672347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24541340|NCT00672347|Sympatholytics|sympatholytics|mesh-ancestor
24541341|NCT00672347|Autonomic Agents|autonomic agents|mesh-ancestor
24446955|NCT00306735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446956|NCT00306735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24446957|NCT00306735|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25070115|NCT03421860|Protective Agents|protective agents|mesh-ancestor
25070116|NCT03421860|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25070117|NCT03421821|Ropivacaine|ropivacaine|mesh-list
24695301|NCT03837626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695302|NCT03837626|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24695303|NCT03837626|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24695304|NCT03837626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24695305|NCT03837626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070120|NCT03421821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25070121|NCT03421821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070122|NCT03421821|Sensory System Agents|sensory system agents|mesh-ancestor
25070123|NCT03421821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25070124|NCT03421743|Molgramostim|molgramostim|mesh-list
25070125|NCT03421743|Sargramostim|sargramostim|mesh-list
25070126|NCT03421743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24832780|NCT02172235|Pioglitazone|pioglitazone|mesh-list
24695306|NCT03837626|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24612461|NCT01014104|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24612462|NCT01014104|Prednisolone phosphate|prednisolone phosphate|mesh-list
24612463|NCT01014104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24695582|NCT02860000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24695583|NCT02860000|Hormone Antagonists|hormone antagonists|mesh-ancestor
24695584|NCT02860000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24695585|NCT02860000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695646|NCT02449161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24695658|NCT02348216|Cyclophosphamide|cyclophosphamide|mesh-list
24695659|NCT02348216|Fludarabine|fludarabine|mesh-list
24695729|NCT01949714|Epinephryl borate|epinephryl borate|mesh-list
24695730|NCT01949714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24695731|NCT01949714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24695732|NCT01949714|Adrenergic Agents|adrenergic agents|mesh-ancestor
24695733|NCT01949714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24695734|NCT01949714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695735|NCT01949714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695736|NCT01949714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24695737|NCT01949714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24695738|NCT01949714|Autonomic Agents|autonomic agents|mesh-ancestor
24695739|NCT01949714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24695740|NCT01949714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24695741|NCT01949714|Respiratory System Agents|respiratory system agents|mesh-ancestor
24695782|NCT01231906|Isophosphamide mustard|isophosphamide mustard|mesh-list
24695783|NCT01231906|Doxorubicin|doxorubicin|mesh-list
25070149|NCT03421483|Vitamin B Complex|vitamin b complex|mesh-ancestor
25070150|NCT03421483|Vitamins|vitamins|mesh-ancestor
25070151|NCT03421483|Micronutrients|micronutrients|mesh-ancestor
25070152|NCT03421483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070153|NCT03421366|Posaconazole|posaconazole|mesh-list
25070154|NCT03421366|Antifungal Agents|antifungal agents|mesh-ancestor
25070155|NCT03421366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25070156|NCT03421366|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24612582|NCT01014520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612584|NCT01014520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24612585|NCT01014520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24612586|NCT01014520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24612587|NCT01014520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24612588|NCT01014520|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24612589|NCT01014520|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24612590|NCT01014520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24695836|NCT01425827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24695837|NCT01425827|Dopamine Agents|dopamine agents|mesh-ancestor
24695838|NCT01425840|Lidocaine|lidocaine|mesh-list
24695839|NCT01425840|Anesthetics, Local|anesthetics, local|mesh-ancestor
24695887|NCT01426165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24695888|NCT01426165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24695889|NCT01426165|Anticonvulsants|anticonvulsants|mesh-ancestor
24695890|NCT01426165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24695891|NCT01426165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24695892|NCT01426165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695893|NCT01426165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24695894|NCT01426165|Tocolytic Agents|tocolytic agents|mesh-ancestor
24695895|NCT01426165|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24695897|NCT01426256|Cholecalciferol|cholecalciferol|mesh-list
24695898|NCT01426256|Vitamins|vitamins|mesh-ancestor
24695899|NCT01426256|Micronutrients|micronutrients|mesh-ancestor
24695900|NCT01426256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695902|NCT01426256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24695903|NCT01426334|Cyclosporine|cyclosporine|mesh-list
24695904|NCT01426334|Dasatinib|dasatinib|mesh-list
24695905|NCT01426334|Cyclosporins|cyclosporins|mesh-list
24695906|NCT01426334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24695907|NCT01426334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695908|NCT01426334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24695909|NCT01426334|Immunologic Factors|immunologic factors|mesh-ancestor
24695910|NCT01426334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695911|NCT01426334|Antifungal Agents|antifungal agents|mesh-ancestor
24695912|NCT01426334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24695913|NCT01426334|Dermatologic Agents|dermatologic agents|mesh-ancestor
24695914|NCT01426334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24695941|NCT01426633|Gemcitabine|gemcitabine|mesh-list
25070166|NCT03421366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070167|NCT03421314|Selenium|selenium|mesh-list
25070168|NCT03421314|Antioxidants|antioxidants|mesh-ancestor
25070169|NCT03421314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070170|NCT03421314|Protective Agents|protective agents|mesh-ancestor
25070171|NCT03421314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070172|NCT03421314|Trace Elements|trace elements|mesh-ancestor
25070173|NCT03421314|Micronutrients|micronutrients|mesh-ancestor
25070174|NCT03421275|Fentanyl|fentanyl|mesh-list
25070175|NCT03421275|Esketamine|esketamine|mesh-list
25070176|NCT03421275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25070191|NCT03421119|Metformin|metformin|mesh-list
24696024|NCT01426971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696025|NCT01426971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24696026|NCT01426971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24696098|NCT01427283|Naloxone|naloxone|mesh-list
24696099|NCT01427283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24696100|NCT01427283|Narcotics|narcotics|mesh-ancestor
25070193|NCT03421119|Secretagogues|secretagogues|mesh-list
24696101|NCT01427283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24696102|NCT01427283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696103|NCT01427283|Analgesics|analgesics|mesh-ancestor
24908623|NCT04318652|Autonomic Agents|autonomic agents|mesh-ancestor
24908624|NCT04318652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24908625|NCT04318652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908626|NCT04318652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24908627|NCT04318652|Glucocorticoids|glucocorticoids|mesh-ancestor
24696104|NCT01427283|Sensory System Agents|sensory system agents|mesh-ancestor
24696114|NCT01427335|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24696115|NCT01427335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696116|NCT01427335|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24696117|NCT01427387|Linaclotide|linaclotide|mesh-list
24696118|NCT01427387|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
24696119|NCT01427387|Enzyme Activators|enzyme activators|mesh-ancestor
24696120|NCT01427387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696121|NCT01427387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24696122|NCT01427400|Botulinum Toxins|botulinum toxins|mesh-list
24696123|NCT01427400|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24696134|NCT01427478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24696135|NCT01427478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24696136|NCT01427478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24696137|NCT01427478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696138|NCT01427491|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24696139|NCT01427491|Laxatives|laxatives|mesh-ancestor
24696140|NCT01427491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24696141|NCT01427582|Trabectedin|trabectedin|mesh-list
24696142|NCT01427582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24696158|NCT01427686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696170|NCT01427946|Everolimus|everolimus|mesh-list
24696171|NCT01427946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24696172|NCT01427946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24696225|NCT01428180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24696226|NCT01428180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24696227|NCT01428180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696236|NCT01428284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696240|NCT01428284|Renal Agents|renal agents|mesh-ancestor
25070195|NCT03421119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070196|NCT03421119|Incretins|incretins|mesh-ancestor
25070197|NCT03421119|Hormones|hormones|mesh-ancestor
25070198|NCT03421119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25070199|NCT03421002|Micafungin|micafungin|mesh-list
25070200|NCT03421002|Antifungal Agents|antifungal agents|mesh-ancestor
25070201|NCT03421002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24832840|NCT02172326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24696426|NCT01429415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24696427|NCT01429415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24696428|NCT01429415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696429|NCT01429415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24696532|NCT01429844|Immunologic Factors|immunologic factors|mesh-ancestor
24696533|NCT01429844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696534|NCT01429844|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24955521|NCT03864575|Analgesics|analgesics|mesh-ancestor
24696535|NCT01429844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24696536|NCT01429844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696537|NCT01429844|Antifungal Agents|antifungal agents|mesh-ancestor
24696538|NCT01429844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24696539|NCT01429844|Dermatologic Agents|dermatologic agents|mesh-ancestor
24696540|NCT01429844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24696541|NCT01429870|Triamcinolone|triamcinolone|mesh-list
24696542|NCT01429870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24696543|NCT01429870|Glucocorticoids|glucocorticoids|mesh-ancestor
24696544|NCT01429870|Hormones|hormones|mesh-ancestor
24696589|NCT01430078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696590|NCT01430078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25701573|NCT02141620|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25701574|NCT02141620|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25701575|NCT02141620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25701576|NCT02141620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25701577|NCT02141620|Dopamine Agents|dopamine agents|mesh-ancestor
24908951|NCT04314310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24908952|NCT04314310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908953|NCT04314310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24908954|NCT04314310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24908955|NCT04314310|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24908956|NCT04314310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908957|NCT04314310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908959|NCT04314297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24908960|NCT04314297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24909039|NCT04313270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909040|NCT04313270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24909041|NCT04313218|Misoprostol|misoprostol|mesh-list
24696591|NCT01430078|Immunologic Factors|immunologic factors|mesh-ancestor
24696605|NCT01430260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24696606|NCT01430260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696607|NCT01430260|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24696608|NCT01430260|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24696609|NCT01430260|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24696610|NCT01430260|Histamine Antagonists|histamine antagonists|mesh-ancestor
24696611|NCT01430260|Histamine Agents|histamine agents|mesh-ancestor
24696612|NCT01430260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24696613|NCT01430260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696614|NCT01430312|Azelaic acid|azelaic acid|mesh-list
24696615|NCT01430312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24696616|NCT01430312|Dermatologic Agents|dermatologic agents|mesh-ancestor
24696618|NCT01430351|Mefloquine|mefloquine|mesh-list
24696619|NCT01430351|Temozolomide|temozolomide|mesh-list
24696620|NCT01430351|Memantine|memantine|mesh-list
24696621|NCT01430351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24696622|NCT01430351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070234|NCT03420937|Mydriatics|mydriatics|mesh-ancestor
24696624|NCT01430351|Alkylating Agents|alkylating agents|mesh-ancestor
24696625|NCT01430351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696626|NCT01430351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24696627|NCT01430351|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24696628|NCT01430351|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24696629|NCT01430351|Dopamine Agents|dopamine agents|mesh-ancestor
24696630|NCT01430351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24696631|NCT01430351|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24696632|NCT01430351|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24696633|NCT01430351|Antimalarials|antimalarials|mesh-ancestor
24696639|NCT01430520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24696640|NCT01430520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24541599|NCT00674063|Alefacept|alefacept|mesh-list
24696641|NCT01430520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696642|NCT01430520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24696643|NCT01430520|Serotonin Agents|serotonin agents|mesh-ancestor
24696644|NCT01430520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696645|NCT01430520|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24696646|NCT01430520|Antidepressive Agents|antidepressive agents|mesh-ancestor
24696647|NCT01430520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24696653|NCT01430689|Vaccines|vaccines|mesh-list
24696694|NCT01431053|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24696695|NCT01431053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24696696|NCT01431053|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24696697|NCT01431053|Hormone Antagonists|hormone antagonists|mesh-ancestor
24696698|NCT01431053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25701578|NCT02141620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25701579|NCT02141633|Fluticasone|fluticasone|mesh-list
25701580|NCT02141633|Xhance|xhance|mesh-list
25701581|NCT02141633|Albuterol|albuterol|mesh-list
25701582|NCT02141633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25701583|NCT02141633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25701584|NCT02141633|Autonomic Agents|autonomic agents|mesh-ancestor
25701585|NCT02141633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25701586|NCT02141633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701587|NCT02141633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25701588|NCT02141633|Respiratory System Agents|respiratory system agents|mesh-ancestor
25701589|NCT02141633|Dermatologic Agents|dermatologic agents|mesh-ancestor
25701590|NCT02141633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25701591|NCT02141633|Tocolytic Agents|tocolytic agents|mesh-ancestor
25701592|NCT02141633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25109221|NCT03126708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109224|NCT03126695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25109227|NCT03126695|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24696699|NCT01431092|Melatonin|melatonin|mesh-list
24696717|NCT01431118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24696718|NCT01431118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696761|NCT01431326|Hormones|hormones|mesh-ancestor
24444129|NCT00296777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24444130|NCT00296777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24696808|NCT01431326|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24696809|NCT01431326|GABA Agonists|gaba agonists|mesh-ancestor
24696810|NCT01431326|GABA Agents|gaba agents|mesh-ancestor
24643389|NCT01185418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25070237|NCT03420937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25070238|NCT03420937|Cholinergic Agents|cholinergic agents|mesh-ancestor
25070239|NCT03420937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25070240|NCT03420937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070241|NCT03420937|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25070242|NCT03420937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832867|NCT02172352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24696811|NCT01431326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24444131|NCT00296777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24696812|NCT01431326|Serotonin Agents|serotonin agents|mesh-ancestor
24696813|NCT01431326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24696814|NCT01431326|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24696815|NCT01431326|Chelating Agents|chelating agents|mesh-ancestor
24696816|NCT01431326|Sequestering Agents|sequestering agents|mesh-ancestor
24696817|NCT01431326|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24696818|NCT01431326|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24696845|NCT01431404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24696846|NCT01431404|Analgesics|analgesics|mesh-ancestor
24696847|NCT01431404|Sensory System Agents|sensory system agents|mesh-ancestor
24696848|NCT01431404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24696849|NCT01431404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696850|NCT01431404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24696851|NCT01431404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24696852|NCT01431404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24696853|NCT01431404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24696862|NCT01431443|Theobromine|theobromine|mesh-list
24696863|NCT01431443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24696864|NCT01431443|Autonomic Agents|autonomic agents|mesh-ancestor
24696865|NCT01431443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24696866|NCT01431443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696867|NCT01431443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24696868|NCT01431443|Respiratory System Agents|respiratory system agents|mesh-ancestor
24696869|NCT01431443|Vasodilator Agents|vasodilator agents|mesh-ancestor
24696871|NCT01431456|Rivaroxaban|rivaroxaban|mesh-list
24696872|NCT01431456|Dabigatran|dabigatran|mesh-list
24696873|NCT01431456|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25070245|NCT03420911|Midazolam|midazolam|mesh-list
24696890|NCT01431495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696892|NCT01431547|Immunologic Factors|immunologic factors|mesh-ancestor
24696893|NCT01431547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696894|NCT01431612|Phenylephrine|phenylephrine|mesh-list
24696895|NCT01431612|Oxymetazoline|oxymetazoline|mesh-list
24696896|NCT01431612|Esmolol|esmolol|mesh-list
24696897|NCT01431612|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24696898|NCT01431612|Mydriatics|mydriatics|mesh-ancestor
24696899|NCT01431612|Autonomic Agents|autonomic agents|mesh-ancestor
24696900|NCT01431612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24696901|NCT01431612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696902|NCT01431612|Sympathomimetics|sympathomimetics|mesh-ancestor
25701593|NCT02141633|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25701594|NCT02141633|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25701595|NCT02141633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25701596|NCT02141633|Adrenergic Agents|adrenergic agents|mesh-ancestor
25701597|NCT02141633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25701598|NCT02141633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109247|NCT03126422|Adrenergic Agents|adrenergic agents|mesh-ancestor
24696903|NCT01431612|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24696904|NCT01431612|Nasal Decongestants|nasal decongestants|mesh-ancestor
24696905|NCT01431612|Respiratory System Agents|respiratory system agents|mesh-ancestor
24696906|NCT01431612|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24696907|NCT01431612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24696908|NCT01431612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24696909|NCT01431612|Adrenergic Agents|adrenergic agents|mesh-ancestor
24696923|NCT01431742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24696924|NCT01431742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696925|NCT01431742|Analgesics|analgesics|mesh-ancestor
24696926|NCT01431742|Sensory System Agents|sensory system agents|mesh-ancestor
24696927|NCT01431742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24696928|NCT01431742|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24696929|NCT01431781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24696930|NCT01431781|Somatostatin|somatostatin|mesh-list
24696931|NCT01431781|Hormones|hormones|mesh-ancestor
24696963|NCT01432028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24696964|NCT01432028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696965|NCT01432028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24696966|NCT01432028|Contraceptive Agents|contraceptive agents|mesh-ancestor
24696967|NCT01432028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24696968|NCT01432028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24696969|NCT01432028|Progestins|progestins|mesh-ancestor
24696970|NCT01432028|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24696971|NCT01432028|Hormone Antagonists|hormone antagonists|mesh-ancestor
24696972|NCT01432028|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24696985|NCT01432080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696986|NCT01432080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24696987|NCT01432080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24696988|NCT01432080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24696989|NCT01432080|Autonomic Agents|autonomic agents|mesh-ancestor
24612709|NCT01015209|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24612710|NCT01015209|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24612711|NCT01015209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24612712|NCT01015209|Antiviral Agents|antiviral agents|mesh-ancestor
24612713|NCT01015209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24612714|NCT01015209|Expectorants|expectorants|mesh-ancestor
24612715|NCT01015209|Respiratory System Agents|respiratory system agents|mesh-ancestor
24612716|NCT01015209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24612717|NCT01015209|Antioxidants|antioxidants|mesh-ancestor
24612762|NCT01015339|Capecitabine|capecitabine|mesh-list
24612763|NCT01015339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24612764|NCT01015339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697000|NCT01432080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697001|NCT01432080|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24697002|NCT01432080|Hormone Antagonists|hormone antagonists|mesh-ancestor
24697007|NCT01432106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24697008|NCT01432106|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24697009|NCT01432106|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24697010|NCT01432106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697014|NCT01432119|Cetuximab|cetuximab|mesh-list
24697081|NCT01432587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24697082|NCT01432587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24697083|NCT01432587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697084|NCT01432665|Sildenafil Citrate|sildenafil citrate|mesh-list
24697085|NCT01432665|Testosterone|testosterone|mesh-list
24697086|NCT01432665|Androgens|androgens|mesh-ancestor
24697087|NCT01432665|Hormones|hormones|mesh-ancestor
24697088|NCT01432665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24697098|NCT01432704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24697099|NCT01432704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697100|NCT01432704|Vitamins|vitamins|mesh-ancestor
24697101|NCT01432704|Micronutrients|micronutrients|mesh-ancestor
24697102|NCT01432704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24697103|NCT01432717|Luspatercept|luspatercept|mesh-list
24697104|NCT01432717|Hematinics|hematinics|mesh-ancestor
24697105|NCT01432782|Botulinum Toxins|botulinum toxins|mesh-list
24697106|NCT01432782|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24697107|NCT01432782|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24697108|NCT01432782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24697109|NCT01432782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24697110|NCT01432782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701599|NCT02141659|Relugolix|relugolix|mesh-list
24697111|NCT01432782|Cholinergic Agents|cholinergic agents|mesh-ancestor
24697112|NCT01432782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24697113|NCT01432782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697114|NCT01432782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24697115|NCT01432782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24697117|NCT01432821|Emetics|emetics|mesh-ancestor
24697118|NCT01432821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697119|NCT01432821|Autonomic Agents|autonomic agents|mesh-ancestor
24697120|NCT01432821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24697121|NCT01432821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24697125|NCT01432821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697126|NCT01432873|Selenium|selenium|mesh-list
24697127|NCT01432873|Antioxidants|antioxidants|mesh-ancestor
25070265|NCT03420911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25070266|NCT03420911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25070267|NCT03420794|Analgesics|analgesics|mesh-list
25070268|NCT03420794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
25070269|NCT03420794|Sensory System Agents|sensory system agents|mesh-ancestor
24697128|NCT01432873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697129|NCT01432873|Protective Agents|protective agents|mesh-ancestor
24697212|NCT01433666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24697213|NCT01433666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24697214|NCT01433666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697215|NCT01433705|Regadenoson|regadenoson|mesh-list
24697216|NCT01433705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697217|NCT01433705|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
24697218|NCT01433705|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24697219|NCT01433705|Purinergic Agonists|purinergic agonists|mesh-ancestor
24697220|NCT01433705|Purinergic Agents|purinergic agents|mesh-ancestor
25070270|NCT03420794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25070271|NCT03420794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070272|NCT03420742|Midazolam|midazolam|mesh-list
25070273|NCT03420742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25070274|NCT03420742|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24832892|NCT02172391|Cholinergic Agents|cholinergic agents|mesh-ancestor
24697286|NCT01434069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697287|NCT01434069|Antidotes|antidotes|mesh-ancestor
24697288|NCT01434069|Protective Agents|protective agents|mesh-ancestor
24697289|NCT01434069|Vitamin B Complex|vitamin b complex|mesh-ancestor
24697291|NCT01434069|Micronutrients|micronutrients|mesh-ancestor
24697292|NCT01434069|Hormones|hormones|mesh-ancestor
24697293|NCT01434069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24697294|NCT01434108|Phenylacetic acid|phenylacetic acid|mesh-list
24697295|NCT01434108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24697296|NCT01434108|Antimetabolites|antimetabolites|mesh-ancestor
24697297|NCT01434108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697300|NCT01434134|Candesartan|candesartan|mesh-list
24697348|NCT01434173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24697349|NCT01434173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24697350|NCT01434173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24697351|NCT01434173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697352|NCT01434173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697353|NCT01434173|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24697354|NCT01434173|Contraceptive Agents|contraceptive agents|mesh-ancestor
24697355|NCT01434173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24697356|NCT01434173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697357|NCT01434173|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25070286|NCT03420742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070287|NCT03420703|Morphine|morphine|mesh-list
24955530|NCT03864185|Rituximab|rituximab|mesh-list
25070288|NCT03420703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25070289|NCT03420703|Narcotics|narcotics|mesh-ancestor
25070290|NCT03420703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25070292|NCT03420703|Analgesics|analgesics|mesh-ancestor
24697422|NCT01434459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24697423|NCT01434459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24697424|NCT01434459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24697425|NCT01434459|Immunologic Factors|immunologic factors|mesh-ancestor
24697426|NCT01434459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697428|NCT01434849|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24697429|NCT01434849|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24697430|NCT01434849|Adrenergic Agents|adrenergic agents|mesh-ancestor
24912800|NCT04271839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24912801|NCT04271839|Respiratory System Agents|respiratory system agents|mesh-ancestor
24912802|NCT04271839|Dermatologic Agents|dermatologic agents|mesh-ancestor
24487317|NCT00462631|Paclitaxel|paclitaxel|mesh-list
24912836|NCT04270994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24912838|NCT04270994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24697431|NCT01434849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24697432|NCT01434849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697433|NCT01434849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697434|NCT01434849|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24697437|NCT01434862|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
25070297|NCT03420638|Anesthetics, Local|anesthetics, local|mesh-ancestor
25070298|NCT03420638|Anesthetics|anesthetics|mesh-ancestor
25070299|NCT03420638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25070300|NCT03420638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070301|NCT03420638|Sensory System Agents|sensory system agents|mesh-ancestor
25070302|NCT03420638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24697438|NCT01434862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24697439|NCT01434862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697440|NCT01434862|Appetite Depressants|appetite depressants|mesh-ancestor
24697444|NCT01434888|Timolol|timolol|mesh-list
24697458|NCT01434901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24697459|NCT01434901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697460|NCT01434901|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24697461|NCT01434901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24697462|NCT01434901|Cholinergic Agents|cholinergic agents|mesh-ancestor
24697463|NCT01434901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24697464|NCT01434901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697466|NCT01434914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24697467|NCT01434914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24697468|NCT01435083|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24612795|NCT01015417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24697470|NCT01435083|Coagulants|coagulants|mesh-ancestor
24697471|NCT01435083|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24697472|NCT01435083|Natriuretic Agents|natriuretic agents|mesh-ancestor
24697473|NCT01435083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697474|NCT01435161|Telmisartan|telmisartan|mesh-list
24697475|NCT01435161|Antihypertensive Agents|antihypertensive agents|mesh-list
24697476|NCT01435161|Nifedipine|nifedipine|mesh-list
24697477|NCT01435161|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24697478|NCT01435161|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24697479|NCT01435161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697480|NCT01435161|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24697481|NCT01435161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24697495|NCT01435213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697496|NCT01435213|Analgesics|analgesics|mesh-ancestor
24697497|NCT01435213|Sensory System Agents|sensory system agents|mesh-ancestor
24697498|NCT01435213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24697499|NCT01435213|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24697500|NCT01435213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24697501|NCT01435213|Anesthetics, General|anesthetics, general|mesh-ancestor
24697502|NCT01435213|Anesthetics|anesthetics|mesh-ancestor
24697503|NCT01435213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24543018|NCT00681603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24543019|NCT00681603|Growth Substances|growth substances|mesh-ancestor
24543021|NCT00681603|Growth Inhibitors|growth inhibitors|mesh-ancestor
24697505|NCT01435213|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24697506|NCT01435213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24697507|NCT01435213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697508|NCT01435213|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24697509|NCT01435213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24697510|NCT01435213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24697511|NCT01435213|Adrenergic Agents|adrenergic agents|mesh-ancestor
24697522|NCT01435291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24697523|NCT01435291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25701600|NCT02141659|Androgen Antagonists|androgen antagonists|mesh-ancestor
25701601|NCT02141659|Hormone Antagonists|hormone antagonists|mesh-ancestor
25701602|NCT02141659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25701603|NCT02141659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701604|NCT02141672|Cyclosporine|cyclosporine|mesh-list
25701605|NCT02141672|Antifungal Agents|antifungal agents|mesh-ancestor
25701606|NCT02141672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25701607|NCT02141672|Dermatologic Agents|dermatologic agents|mesh-ancestor
25701608|NCT02141672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25701609|NCT02141672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697524|NCT01435291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697525|NCT01435343|Cytarabine|cytarabine|mesh-list
24697526|NCT01435343|Plerixafor|plerixafor|mesh-list
24697527|NCT01435343|Fludarabine|fludarabine|mesh-list
24697554|NCT01435395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24697556|NCT01435395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697557|NCT01435486|Caffeine|caffeine|mesh-list
25070310|NCT03420638|Autonomic Agents|autonomic agents|mesh-ancestor
25070311|NCT03420638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25070312|NCT03420638|Respiratory System Agents|respiratory system agents|mesh-ancestor
25070314|NCT03420638|Sympathomimetics|sympathomimetics|mesh-ancestor
25070315|NCT03420638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25070316|NCT03420586|Nitrous Oxide|nitrous oxide|mesh-list
25070330|NCT03420534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070332|NCT03420469|Bupropion|bupropion|mesh-list
25070333|NCT03420469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24697691|NCT01436539|Antiviral Agents|antiviral agents|mesh-ancestor
24697692|NCT01436539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24697693|NCT01436539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24697694|NCT01436539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25070334|NCT03420469|Antidepressive Agents|antidepressive agents|mesh-ancestor
25070335|NCT03420469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25070336|NCT03420469|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25070337|NCT03420469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25070338|NCT03420469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25070339|NCT03420469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070340|NCT03420469|Dopamine Agents|dopamine agents|mesh-ancestor
25070341|NCT03420469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25070342|NCT03420469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697733|NCT01436929|Antioxidants|antioxidants|mesh-ancestor
24697734|NCT01436929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697735|NCT01436929|Protective Agents|protective agents|mesh-ancestor
24697736|NCT01436929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697768|NCT01437189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697769|NCT01437189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24697770|NCT01437189|Serotonin Agents|serotonin agents|mesh-ancestor
24697771|NCT01437189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697772|NCT01437228|Povidone-Iodine|povidone-iodine|mesh-list
24697774|NCT01437228|Plasma Substitutes|plasma substitutes|mesh-ancestor
24697775|NCT01437228|Blood Substitutes|blood substitutes|mesh-ancestor
24697776|NCT01437228|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24697777|NCT01437228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24697778|NCT01437293|Carbidopa|carbidopa|mesh-list
24697779|NCT01437293|Entacapone|entacapone|mesh-list
24697780|NCT01437293|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24697781|NCT01437293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24697782|NCT01437293|Dopamine Agents|dopamine agents|mesh-ancestor
24697783|NCT01437293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24697822|NCT01437462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24697824|NCT01437566|Fulvestrant|fulvestrant|mesh-list
24697825|NCT01437566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24697826|NCT01437566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697827|NCT01437566|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24697828|NCT01437566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24697829|NCT01437566|Hormone Antagonists|hormone antagonists|mesh-ancestor
24697830|NCT01437566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24697831|NCT01437566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697832|NCT01437579|Botulinum Toxins|botulinum toxins|mesh-list
24697833|NCT01437579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24697834|NCT01437579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24697835|NCT01437579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697836|NCT01437579|Cholinergic Agents|cholinergic agents|mesh-ancestor
24697837|NCT01437579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24697838|NCT01437579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697839|NCT01437592|Insulin|insulin|mesh-list
24697856|NCT01437644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701610|NCT02141672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24697857|NCT01437670|Solifenacin Succinate|solifenacin succinate|mesh-list
24697858|NCT01437670|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24697859|NCT01437670|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24697860|NCT01437670|Cholinergic Agents|cholinergic agents|mesh-ancestor
24697861|NCT01437670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24697862|NCT01437670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697863|NCT01437670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697864|NCT01437670|Urological Agents|urological agents|mesh-ancestor
24955602|NCT03863405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070363|NCT03420313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24626419|NCT01087359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626421|NCT01087359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626422|NCT01087359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24626425|NCT01087398|Busulfan|busulfan|mesh-list
25070364|NCT03420313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25070365|NCT03420144|Hormones|hormones|mesh-list
25070366|NCT03420144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24832966|NCT02172469|Bromides|bromides|mesh-list
24697936|NCT01437982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24697937|NCT01437982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697938|NCT01437982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24697939|NCT01437982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697940|NCT01437982|Antiemetics|antiemetics|mesh-ancestor
24697941|NCT01437982|Autonomic Agents|autonomic agents|mesh-ancestor
24697942|NCT01437982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25070367|NCT03420144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070368|NCT03420040|Insulin Glargine|insulin glargine|mesh-list
25070369|NCT03420040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25070370|NCT03420040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070371|NCT03419975|Latanoprost|latanoprost|mesh-list
25070372|NCT03419975|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25070373|NCT03419975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25070374|NCT03419949|Pregabalin|pregabalin|mesh-list
24832978|NCT02172469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24832979|NCT02172469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832980|NCT02172469|Anticonvulsants|anticonvulsants|mesh-ancestor
24832981|NCT02172482|Bromides|bromides|mesh-list
24697943|NCT01437982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24697944|NCT01437982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24697945|NCT01437982|Protective Agents|protective agents|mesh-ancestor
24697946|NCT01437982|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24697947|NCT01438021|Methotrexate|methotrexate|mesh-list
24697948|NCT01438021|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24697949|NCT01438021|Abortifacient Agents|abortifacient agents|mesh-ancestor
24697950|NCT01438021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24697951|NCT01438021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697952|NCT01438021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24697953|NCT01438021|Antimetabolites|antimetabolites|mesh-ancestor
24697954|NCT01438021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697955|NCT01438021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697956|NCT01438021|Dermatologic Agents|dermatologic agents|mesh-ancestor
24697957|NCT01438021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24697981|NCT01438112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24697982|NCT01438112|Alkylating Agents|alkylating agents|mesh-ancestor
24697983|NCT01438112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24697984|NCT01438112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24697985|NCT01438112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24697987|NCT01438190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24697988|NCT01438190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697989|NCT01438320|Quercetin|quercetin|mesh-list
24697990|NCT01438320|Antioxidants|antioxidants|mesh-ancestor
24698009|NCT01438515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24698010|NCT01438515|Disinfectants|disinfectants|mesh-ancestor
24698011|NCT01438515|Dermatologic Agents|dermatologic agents|mesh-ancestor
24698012|NCT01438515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25701611|NCT02141672|Immunologic Factors|immunologic factors|mesh-ancestor
25701612|NCT02141672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701613|NCT02141672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25701614|NCT02141672|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25701615|NCT02141854|Fluticasone|fluticasone|mesh-list
24915129|NCT04669132|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24698013|NCT01438515|Antimalarials|antimalarials|mesh-ancestor
24698014|NCT01438515|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24698015|NCT01438515|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24698016|NCT01438515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24698017|NCT01438515|Antitubercular Agents|antitubercular agents|mesh-ancestor
24698018|NCT01438515|Leprostatic Agents|leprostatic agents|mesh-ancestor
24698019|NCT01438515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24832983|NCT02172482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24832984|NCT02172482|Autonomic Agents|autonomic agents|mesh-ancestor
24698021|NCT01438515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698022|NCT01438515|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24698023|NCT01438515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24698024|NCT01438515|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24698025|NCT01438515|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24698026|NCT01438515|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24698027|NCT01438515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24698031|NCT01438554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24698032|NCT01438554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698033|NCT01438554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698034|NCT01438567|Oxycodone|oxycodone|mesh-list
24698035|NCT01438567|Naloxone|naloxone|mesh-list
24698036|NCT01438567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24698037|NCT01438567|Narcotics|narcotics|mesh-ancestor
24698588|NCT01441986|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24698038|NCT01438567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24698039|NCT01438567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698040|NCT01438567|Analgesics|analgesics|mesh-ancestor
24698041|NCT01438567|Sensory System Agents|sensory system agents|mesh-ancestor
24698059|NCT01438580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698060|NCT01438580|Antipyretics|antipyretics|mesh-ancestor
24698061|NCT01438580|Anticoagulants|anticoagulants|mesh-ancestor
24698062|NCT01438632|Insulin|insulin|mesh-list
24698063|NCT01438632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24543583|NCT00684372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698064|NCT01438632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698065|NCT01438723|Metformin|metformin|mesh-list
24698066|NCT01438723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24698067|NCT01438723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698068|NCT01438736|Etonogestrel|etonogestrel|mesh-list
24698069|NCT01438736|Desogestrel|desogestrel|mesh-list
24698070|NCT01438736|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24698071|NCT01438736|Contraceptive Agents|contraceptive agents|mesh-ancestor
24698072|NCT01438736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24698073|NCT01438736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698074|NCT01438736|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24698075|NCT01438736|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24698076|NCT01438736|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24698077|NCT01438736|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24698078|NCT01438736|Progestins|progestins|mesh-ancestor
24698079|NCT01438736|Hormones|hormones|mesh-ancestor
24698080|NCT01438736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24698081|NCT01438749|Diazepam|diazepam|mesh-list
24698082|NCT01438749|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24698083|NCT01438749|Anticonvulsants|anticonvulsants|mesh-ancestor
24698084|NCT01438749|Antiemetics|antiemetics|mesh-ancestor
24698085|NCT01438749|Autonomic Agents|autonomic agents|mesh-ancestor
24698086|NCT01438749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24698087|NCT01438749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698117|NCT01438944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24698118|NCT01438944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698121|NCT01439100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24698122|NCT01439100|Narcotics|narcotics|mesh-ancestor
24543584|NCT00684372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698123|NCT01439100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24698124|NCT01439100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698125|NCT01439100|Analgesics|analgesics|mesh-ancestor
24698126|NCT01439100|Sensory System Agents|sensory system agents|mesh-ancestor
24698127|NCT01439100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24698128|NCT01439100|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24698129|NCT01439152|Maytansine|maytansine|mesh-list
24698130|NCT01439152|Immunoconjugates|immunoconjugates|mesh-list
24698131|NCT01439152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25701617|NCT02141854|Albuterol|albuterol|mesh-list
24616067|NCT01033760|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24489973|NCT00476073|Adrenergic Agents|adrenergic agents|mesh-ancestor
24915296|NCT03568994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24915297|NCT03568994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24915298|NCT03568994|Antimalarials|antimalarials|mesh-ancestor
24915299|NCT03568994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24915300|NCT03568994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24915301|NCT03538899|Busulfan|busulfan|mesh-list
24915302|NCT03538899|Alkylating Agents|alkylating agents|mesh-ancestor
24698132|NCT01439152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698133|NCT01439152|Tubulin Modulators|tubulin modulators|mesh-ancestor
24698134|NCT01439152|Antimitotic Agents|antimitotic agents|mesh-ancestor
24698135|NCT01439152|Mitosis Modulators|mitosis modulators|mesh-ancestor
24698136|NCT01439152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698137|NCT01439152|Immunologic Factors|immunologic factors|mesh-ancestor
24698138|NCT01439152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698139|NCT01439178|Bevacizumab|bevacizumab|mesh-list
25070388|NCT03419949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25070389|NCT03419949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24698171|NCT01439243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698172|NCT01439243|Nootropic Agents|nootropic agents|mesh-ancestor
24698173|NCT01439399|Lidocaine|lidocaine|mesh-list
24698192|NCT01439399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24698194|NCT01439438|Anticonvulsants|anticonvulsants|mesh-ancestor
24698195|NCT01439438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24698196|NCT01439438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698224|NCT01439984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698225|NCT01439997|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24612809|NCT01015456|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24612810|NCT01015456|Antitubercular Agents|antitubercular agents|mesh-ancestor
24612811|NCT01015456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24612812|NCT01015456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24612813|NCT01015456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612815|NCT01015482|Remifentanil|remifentanil|mesh-list
24612816|NCT01015482|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24698269|NCT01440309|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24698270|NCT01440309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24698271|NCT01440335|Fenoterol|fenoterol|mesh-list
24698272|NCT01440335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24698273|NCT01440335|Autonomic Agents|autonomic agents|mesh-ancestor
25070405|NCT03419910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070406|NCT03419910|Antifungal Agents|antifungal agents|mesh-ancestor
25070407|NCT03419910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24698302|NCT01440582|Bortezomib|bortezomib|mesh-list
24698303|NCT01440582|Panobinostat|panobinostat|mesh-list
24698304|NCT01440582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24698305|NCT01440582|Antiemetics|antiemetics|mesh-ancestor
24698306|NCT01440582|Autonomic Agents|autonomic agents|mesh-ancestor
24698307|NCT01440582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24698308|NCT01440582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698309|NCT01440582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24698310|NCT01440582|Glucocorticoids|glucocorticoids|mesh-ancestor
24698311|NCT01440582|Hormones|hormones|mesh-ancestor
24698312|NCT01440582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24698313|NCT01440582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25701618|NCT02141854|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25701619|NCT02141854|Adrenergic Agonists|adrenergic agonists|mesh-list
25701620|NCT02141854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25701621|NCT02141854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25701622|NCT02141854|Autonomic Agents|autonomic agents|mesh-ancestor
25701623|NCT02141854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25701624|NCT02141854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701625|NCT02141854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25701626|NCT02141854|Respiratory System Agents|respiratory system agents|mesh-ancestor
25701627|NCT02141854|Dermatologic Agents|dermatologic agents|mesh-ancestor
25701628|NCT02141854|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25701629|NCT02141854|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25701630|NCT02141854|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24698314|NCT01440582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698315|NCT01440582|Immunologic Factors|immunologic factors|mesh-ancestor
24698316|NCT01440582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25701631|NCT02141854|Adrenergic Agents|adrenergic agents|mesh-ancestor
25701632|NCT02141854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25701633|NCT02141854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698335|NCT01440621|Pyridoxine|pyridoxine|mesh-list
24698336|NCT01440621|Modafinil|modafinil|mesh-list
24698337|NCT01440621|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24698338|NCT01440621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698339|NCT01440621|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24698340|NCT01440621|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24698356|NCT01440725|Mitosis Modulators|mitosis modulators|mesh-ancestor
24698357|NCT01440725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698359|NCT01440751|Mitomycin|mitomycin|mesh-list
24698360|NCT01440751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24698361|NCT01440751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698362|NCT01440751|Alkylating Agents|alkylating agents|mesh-ancestor
24698363|NCT01440751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698364|NCT01440751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24698365|NCT01440751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698376|NCT01440829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24698377|NCT01440829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698378|NCT01440829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698379|NCT01440842|Insulin|insulin|mesh-list
24698380|NCT01440842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24698442|NCT01441206|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24698443|NCT01441232|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24698444|NCT01441232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
24698445|NCT01441232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25070453|NCT03419494|Doxorubicin|doxorubicin|mesh-list
25070454|NCT03419494|Daunorubicin|daunorubicin|mesh-list
25070455|NCT03419494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25070456|NCT03419494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24833053|NCT02172547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698450|NCT01441232|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24698451|NCT01441232|Protease Inhibitors|protease inhibitors|mesh-ancestor
24698452|NCT01441232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698453|NCT01441232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698454|NCT01441232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24698474|NCT01441388|Crizotinib|crizotinib|mesh-list
24698488|NCT01441427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698490|NCT01441505|Ketamine|ketamine|mesh-list
24698491|NCT01441505|Analgesics|analgesics|mesh-ancestor
24698492|NCT01441505|Sensory System Agents|sensory system agents|mesh-ancestor
24698493|NCT01441505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24698494|NCT01441505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698495|NCT01441505|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24698496|NCT01441505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24698497|NCT01441505|Anesthetics, General|anesthetics, general|mesh-ancestor
24698498|NCT01441505|Anesthetics|anesthetics|mesh-ancestor
24698499|NCT01441505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24698500|NCT01441505|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24543996|NCT00686361|Choline|choline|mesh-list
24543997|NCT00686361|Lipotropic Agents|lipotropic agents|mesh-ancestor
24698501|NCT01441505|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24698502|NCT01441505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24698503|NCT01441505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701634|NCT02141854|Tocolytic Agents|tocolytic agents|mesh-ancestor
25701635|NCT02141854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25701636|NCT02141997|Adalimumab|adalimumab|mesh-list
25701637|NCT02141997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25701638|NCT02141997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25701639|NCT02142049|Lenalidomide|lenalidomide|mesh-list
25701640|NCT02142049|Immunologic Factors|immunologic factors|mesh-ancestor
25701641|NCT02142049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698504|NCT01441505|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24543999|NCT00686361|Antimetabolites|antimetabolites|mesh-ancestor
24698505|NCT01441505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24698506|NCT01441505|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24698507|NCT01441505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24698508|NCT01441505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24698509|NCT01441505|GABA Modulators|gaba modulators|mesh-ancestor
24698510|NCT01441505|GABA Agents|gaba agents|mesh-ancestor
24698512|NCT01441531|Analgesics|analgesics|mesh-ancestor
24698513|NCT01441531|Sensory System Agents|sensory system agents|mesh-ancestor
24698514|NCT01441531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24698515|NCT01441531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698540|NCT01441804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698541|NCT01441804|Antiviral Agents|antiviral agents|mesh-ancestor
24698542|NCT01441804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24698543|NCT01441804|Immunologic Factors|immunologic factors|mesh-ancestor
24698544|NCT01441804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698545|NCT01441869|Metformin|metformin|mesh-list
24698546|NCT01441869|Saxagliptin|saxagliptin|mesh-list
24698547|NCT01441869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25070458|NCT03419494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25070459|NCT03419494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25070460|NCT03419494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25070461|NCT03419494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070462|NCT03419442|Docetaxel|docetaxel|mesh-list
25070463|NCT03419442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25070464|NCT03419442|Tubulin Modulators|tubulin modulators|mesh-ancestor
24643596|NCT01186159|Parecoxib|parecoxib|mesh-list
24698845|NCT01443117|Vaccines|vaccines|mesh-list
24698591|NCT01441986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24698592|NCT01441986|Dopamine Agents|dopamine agents|mesh-ancestor
24698593|NCT01441986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24698630|NCT01442428|Autonomic Agents|autonomic agents|mesh-ancestor
24698631|NCT01442428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24698632|NCT01442428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698633|NCT01442428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24698634|NCT01442428|Glucocorticoids|glucocorticoids|mesh-ancestor
24698667|NCT01442532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24698668|NCT01442532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24698669|NCT01442532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698670|NCT01442532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24698671|NCT01442532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24698672|NCT01442532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24643610|NCT01186172|Ethanol|ethanol|mesh-list
24698673|NCT01442532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24698674|NCT01442532|Anesthetics, General|anesthetics, general|mesh-ancestor
24698675|NCT01442532|Anesthetics|anesthetics|mesh-ancestor
24698676|NCT01442532|GABA Modulators|gaba modulators|mesh-ancestor
24698677|NCT01442532|GABA Agents|gaba agents|mesh-ancestor
24698687|NCT01442571|Hyaluronic Acid|hyaluronic acid|mesh-list
24698688|NCT01442571|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24698689|NCT01442571|Immunologic Factors|immunologic factors|mesh-ancestor
24698690|NCT01442571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698691|NCT01442571|Viscosupplements|viscosupplements|mesh-ancestor
25070516|NCT03418831|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25070517|NCT03418831|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25070518|NCT03418831|Hormone Antagonists|hormone antagonists|mesh-ancestor
25070519|NCT03418831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25070520|NCT03418831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070521|NCT03418831|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25070522|NCT03418831|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25070523|NCT03418831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24698692|NCT01442571|Protective Agents|protective agents|mesh-ancestor
24698693|NCT01442610|Rasagiline|rasagiline|mesh-list
24698695|NCT01442610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544405|NCT00688922|Pravastatin|pravastatin|mesh-list
24698696|NCT01442610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698697|NCT01442610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24612833|NCT01015482|Sensory System Agents|sensory system agents|mesh-ancestor
24612834|NCT01015482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24612835|NCT01015495|Ranibizumab|ranibizumab|mesh-list
24612842|NCT01015547|Sulfasalazine|sulfasalazine|mesh-list
24612843|NCT01015547|Methotrexate|methotrexate|mesh-list
24612844|NCT01015547|Infliximab|infliximab|mesh-list
24612845|NCT01015547|Naltrexone|naltrexone|mesh-list
24612856|NCT01015547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24819751|NCT02097147|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
24819752|NCT02097147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24819756|NCT02097147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24612857|NCT01015547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24698701|NCT01442662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24698702|NCT01442662|Antimetabolites|antimetabolites|mesh-ancestor
24698703|NCT01442662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698704|NCT01442662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698705|NCT01442662|Antiviral Agents|antiviral agents|mesh-ancestor
24698706|NCT01442662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24612891|NCT01015729|Esomeprazole|esomeprazole|mesh-list
24612892|NCT01015729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24612893|NCT01015729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24698707|NCT01442662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698782|NCT01442935|Antimetabolites|antimetabolites|mesh-ancestor
24698783|NCT01442935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24698784|NCT01442935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24698785|NCT01442935|Immunologic Factors|immunologic factors|mesh-ancestor
24698786|NCT01442974|Gemcitabine|gemcitabine|mesh-list
24698787|NCT01442974|Paclitaxel|paclitaxel|mesh-list
24698793|NCT01442974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698794|NCT01442974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24698796|NCT01442974|Antiviral Agents|antiviral agents|mesh-ancestor
24698797|NCT01442974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24698798|NCT01442974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698799|NCT01442974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24698800|NCT01442974|Immunologic Factors|immunologic factors|mesh-ancestor
24824290|NCT02122679|Hemostatics|hemostatics|mesh-ancestor
24698802|NCT01442987|Irbesartan|irbesartan|mesh-list
24698803|NCT01442987|Atorvastatin|atorvastatin|mesh-list
24698804|NCT01442987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24698805|NCT01442987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24698806|NCT01442987|Antimetabolites|antimetabolites|mesh-ancestor
24698807|NCT01442987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698808|NCT01442987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24698809|NCT01442987|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24698810|NCT01442987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698811|NCT01442987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24698812|NCT01442987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24698815|NCT01443065|Folic Acid|folic acid|mesh-list
24698816|NCT01443065|Oxaliplatin|oxaliplatin|mesh-list
24698817|NCT01443065|Panitumumab|panitumumab|mesh-list
24698818|NCT01443065|Fluorouracil|fluorouracil|mesh-list
24698819|NCT01443065|Rilotumumab|rilotumumab|mesh-list
24698820|NCT01443065|Levoleucovorin|levoleucovorin|mesh-list
24698821|NCT01443065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698822|NCT01443065|Antidotes|antidotes|mesh-ancestor
24698823|NCT01443065|Protective Agents|protective agents|mesh-ancestor
24698824|NCT01443065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698825|NCT01443065|Vitamin B Complex|vitamin b complex|mesh-ancestor
24698826|NCT01443065|Vitamins|vitamins|mesh-ancestor
24698827|NCT01443065|Micronutrients|micronutrients|mesh-ancestor
24698828|NCT01443065|Hematinics|hematinics|mesh-ancestor
24698829|NCT01443065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24698830|NCT01443065|Antimetabolites|antimetabolites|mesh-ancestor
24698831|NCT01443065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698832|NCT01443065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25070527|NCT03418597|Anesthetics|anesthetics|mesh-list
25070528|NCT03418597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25070529|NCT03418597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070538|NCT03418558|Mitosis Modulators|mitosis modulators|mesh-ancestor
25070539|NCT03418558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070540|NCT03418532|Osimertinib|osimertinib|mesh-list
25070541|NCT03418532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25070542|NCT03418532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25070543|NCT03418532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25701642|NCT02142049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25701643|NCT02142049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25701644|NCT02142049|Growth Substances|growth substances|mesh-ancestor
25070544|NCT03418532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070545|NCT03418506|Lobeline|lobeline|mesh-list
25070546|NCT03418506|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24833124|NCT02172781|Cholinergic Agents|cholinergic agents|mesh-ancestor
25701645|NCT02142049|Growth Inhibitors|growth inhibitors|mesh-ancestor
25701646|NCT02142049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917706|NCT04226963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24917707|NCT04226963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24917708|NCT04226963|Anesthetics, General|anesthetics, general|mesh-ancestor
24917775|NCT04226443|GABA Modulators|gaba modulators|mesh-ancestor
24917803|NCT04225780|Ganciclovir|ganciclovir|mesh-list
24833125|NCT02172781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25701647|NCT02142153|Olorofim|olorofim|mesh-list
25701648|NCT02142153|Antifungal Agents|antifungal agents|mesh-ancestor
25701649|NCT02142153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24833126|NCT02172781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833127|NCT02172794|Tiotropium Bromide|tiotropium bromide|mesh-list
24698839|NCT01443104|Immunologic Factors|immunologic factors|mesh-ancestor
24698840|NCT01443104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698841|NCT01443104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24698842|NCT01443104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24698843|NCT01443104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24698844|NCT01443104|Antifungal Agents|antifungal agents|mesh-ancestor
24698846|NCT01443117|Immunologic Factors|immunologic factors|mesh-ancestor
24698847|NCT01443117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698849|NCT01443169|Analgesics|analgesics|mesh-ancestor
24698850|NCT01443169|Sensory System Agents|sensory system agents|mesh-ancestor
24698851|NCT01443169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24698852|NCT01443169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070554|NCT03418506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070555|NCT03418506|Respiratory System Agents|respiratory system agents|mesh-ancestor
25070556|NCT03418337|Lansoprazole|lansoprazole|mesh-list
25070557|NCT03418337|Dexlansoprazole|dexlansoprazole|mesh-list
25070558|NCT03418337|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25070559|NCT03418337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25070560|NCT03418337|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25070561|NCT03418337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25070562|NCT03418337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070563|NCT03418246|Calcium|calcium|mesh-list
24626429|NCT01087398|Thymoglobulin|thymoglobulin|mesh-list
24955787|NCT03861364|Propofol|propofol|mesh-list
25070564|NCT03418246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25070566|NCT03418090|Xenon|xenon|mesh-list
25070585|NCT03417921|Mitosis Modulators|mitosis modulators|mesh-ancestor
25070586|NCT03417921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070587|NCT03417921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25070588|NCT03417921|Antimetabolites|antimetabolites|mesh-ancestor
25070589|NCT03417921|Antiviral Agents|antiviral agents|mesh-ancestor
25070590|NCT03417921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25070591|NCT03417921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25070592|NCT03417921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25070593|NCT03417921|Immunologic Factors|immunologic factors|mesh-ancestor
25070594|NCT03417921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955860|NCT03860012|Folic Acid|folic acid|mesh-list
24626430|NCT01087398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24626431|NCT01087398|Immunologic Factors|immunologic factors|mesh-ancestor
24626432|NCT01087398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953700|NCT03882541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24698954|NCT01443806|Antiviral Agents|antiviral agents|mesh-ancestor
24698955|NCT01443806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24698957|NCT01443806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698958|NCT01443897|Vitamin D|vitamin d|mesh-list
24698959|NCT01443897|Ergocalciferols|ergocalciferols|mesh-list
24698960|NCT01443897|Cholecalciferol|cholecalciferol|mesh-list
24698961|NCT01443897|Vitamins|vitamins|mesh-list
24698962|NCT01443897|Micronutrients|micronutrients|mesh-ancestor
24698963|NCT01443897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698964|NCT01443897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25701650|NCT02142712|Diphenhydramine|diphenhydramine|mesh-list
25701651|NCT02142712|Promethazine|promethazine|mesh-list
25701652|NCT02142712|Dextromethorphan|dextromethorphan|mesh-list
25701653|NCT02142712|Pantoprazole|pantoprazole|mesh-list
25701654|NCT02142712|Famotidine|famotidine|mesh-list
25701655|NCT02142712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24698965|NCT01443897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24698966|NCT01443988|Travoprost|travoprost|mesh-list
24698967|NCT01443988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24698968|NCT01444001|Vaccines|vaccines|mesh-list
24698969|NCT01444001|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24698970|NCT01444001|Immunologic Factors|immunologic factors|mesh-ancestor
24698971|NCT01444001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698994|NCT01444131|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24698995|NCT01444131|Cholinergic Agents|cholinergic agents|mesh-ancestor
24698996|NCT01444131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24698997|NCT01444131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698998|NCT01444196|Desloratadine|desloratadine|mesh-list
24698999|NCT01444196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24699000|NCT01444196|Cholinergic Agents|cholinergic agents|mesh-ancestor
24699001|NCT01444196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24699002|NCT01444196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699003|NCT01444196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699004|NCT01444196|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24699005|NCT01444196|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24699006|NCT01444196|Histamine Antagonists|histamine antagonists|mesh-ancestor
24699007|NCT01444196|Histamine Agents|histamine agents|mesh-ancestor
24699011|NCT01444248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699012|NCT01444248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24699013|NCT01444248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24699014|NCT01444248|Immunologic Factors|immunologic factors|mesh-ancestor
24699015|NCT01444339|Vaccines|vaccines|mesh-list
24699016|NCT01444339|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24699017|NCT01444339|Immunologic Factors|immunologic factors|mesh-ancestor
24699018|NCT01444339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699019|NCT01444352|Vaccines|vaccines|mesh-list
24643672|NCT01186549|Adrenergic Agents|adrenergic agents|mesh-ancestor
24699036|NCT01444547|Tubulin Modulators|tubulin modulators|mesh-ancestor
24699037|NCT01444547|Antimitotic Agents|antimitotic agents|mesh-ancestor
24699038|NCT01444547|Mitosis Modulators|mitosis modulators|mesh-ancestor
24699039|NCT01444547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699041|NCT01444586|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24699042|NCT01444586|Antithrombins|antithrombins|mesh-ancestor
24699043|NCT01444586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24699059|NCT01444612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699060|NCT01444612|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24699061|NCT01444612|Antithrombins|antithrombins|mesh-ancestor
24699062|NCT01444612|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24699063|NCT01444612|Protease Inhibitors|protease inhibitors|mesh-ancestor
24699064|NCT01444612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699065|NCT01444677|Beta-lapachone|beta-lapachone|mesh-list
24699066|NCT01444677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24699067|NCT01444677|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24425071|NCT00231959|Antioxidants|antioxidants|mesh-ancestor
24699181|NCT01445262|Histamine Antagonists|histamine antagonists|mesh-ancestor
24699182|NCT01445262|Histamine Agents|histamine agents|mesh-ancestor
24699183|NCT01445262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24699184|NCT01445262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699185|NCT01445262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699186|NCT01445340|Romidepsin|romidepsin|mesh-list
24699187|NCT01445340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24699188|NCT01445340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24699189|NCT01445379|Ipilimumab|ipilimumab|mesh-list
24699190|NCT01445379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24699191|NCT01445379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24699192|NCT01445379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24953717|NCT03882099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24810224|NCT02038842|Vaccines|vaccines|mesh-list
24953720|NCT03882164|Immunologic Factors|immunologic factors|mesh-ancestor
24953721|NCT03882164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953722|NCT03882164|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24953723|NCT03882164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24953724|NCT03882164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953728|NCT03882255|Propranolol|propranolol|mesh-list
24953729|NCT03882255|Ponesimod|ponesimod|mesh-list
24953730|NCT03882255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24953731|NCT03882255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24953732|NCT03882255|Adrenergic Agents|adrenergic agents|mesh-ancestor
24953739|NCT03882255|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24953741|NCT03882255|Immunologic Factors|immunologic factors|mesh-ancestor
24953742|NCT03882008|Abatacept|abatacept|mesh-list
24699232|NCT01445587|Bortezomib|bortezomib|mesh-list
24699233|NCT01445587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24699234|NCT01445600|Retapamulin|retapamulin|mesh-list
25701657|NCT02142712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24699235|NCT01445600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24699236|NCT01445600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24699237|NCT01445639|Dexmedetomidine|dexmedetomidine|mesh-list
24699238|NCT01445639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24699333|NCT01446211|Antimetabolites|antimetabolites|mesh-ancestor
24699341|NCT01446211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24699342|NCT01446211|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24699343|NCT01446211|Protective Agents|protective agents|mesh-ancestor
24699345|NCT01446276|Antioxidants|antioxidants|mesh-ancestor
24699346|NCT01446276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699347|NCT01446276|Protective Agents|protective agents|mesh-ancestor
24699348|NCT01446276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699349|NCT01446276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699350|NCT01446276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24699351|NCT01446328|Olanzapine|olanzapine|mesh-list
24699352|NCT01446328|Aripiprazole|aripiprazole|mesh-list
24699353|NCT01446328|Amisulpride|amisulpride|mesh-list
24699355|NCT01446328|Autonomic Agents|autonomic agents|mesh-ancestor
24699356|NCT01446328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24699357|NCT01446328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699358|NCT01446328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24699359|NCT01446328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24699360|NCT01446328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24699361|NCT01446328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25070623|NCT03417427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24699384|NCT01446445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24699385|NCT01446445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699387|NCT01446458|Folfirinox|folfirinox|mesh-list
24699396|NCT01446484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24699397|NCT01446484|Immunologic Factors|immunologic factors|mesh-ancestor
24699398|NCT01446484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699399|NCT01446484|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24699400|NCT01446484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699401|NCT01446484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699402|NCT01446484|Antifungal Agents|antifungal agents|mesh-ancestor
24699403|NCT01446484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24699404|NCT01446484|Dermatologic Agents|dermatologic agents|mesh-ancestor
24699405|NCT01446484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24699406|NCT01446484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612962|NCT01016054|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24612963|NCT01016054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612964|NCT01016054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24699411|NCT01446484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24699414|NCT01446497|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24699415|NCT01446497|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25070634|NCT03417388|Aspirin|aspirin|mesh-list
24425683|NCT00234026|Gemcitabine|gemcitabine|mesh-list
25070657|NCT03417388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25070658|NCT03417388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25070659|NCT03417388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25070660|NCT03417388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25070661|NCT03417388|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25070662|NCT03417388|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24545345|NCT00693108|Hormones|hormones|mesh-ancestor
25070663|NCT03417388|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24833265|NCT02173457|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24833266|NCT02173457|Protease Inhibitors|protease inhibitors|mesh-ancestor
24833267|NCT02173457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24833268|NCT02173457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833269|NCT02173639|Metformin|metformin|mesh-list
25070664|NCT03417388|Protease Inhibitors|protease inhibitors|mesh-ancestor
25070665|NCT03417388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25070666|NCT03417388|Protective Agents|protective agents|mesh-ancestor
25070667|NCT03417284|Melphalan|melphalan|mesh-list
25070668|NCT03417284|Lenograstim|lenograstim|mesh-list
25070669|NCT03417284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25070670|NCT03417284|Immunologic Factors|immunologic factors|mesh-ancestor
25070671|NCT03417284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070672|NCT03417284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25070673|NCT03417284|Alkylating Agents|alkylating agents|mesh-ancestor
25070674|NCT03417284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701658|NCT02142712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25070675|NCT03417284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25070676|NCT03417284|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25070677|NCT03417284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25070678|NCT03417206|Remifentanil|remifentanil|mesh-list
24833296|NCT02173665|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24699463|NCT01446952|Micronutrients|micronutrients|mesh-ancestor
24699464|NCT01446952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699478|NCT01447069|Albuterol|albuterol|mesh-list
24699479|NCT01447069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24699480|NCT01447069|Autonomic Agents|autonomic agents|mesh-ancestor
24699481|NCT01447069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24485071|NCT00451412|Heparin|heparin|mesh-list
24699482|NCT01447069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699510|NCT01447212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699511|NCT01447212|Analgesics|analgesics|mesh-ancestor
24699512|NCT01447212|Sensory System Agents|sensory system agents|mesh-ancestor
24699513|NCT01447212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24699514|NCT01447355|Vitamin D|vitamin d|mesh-list
24699515|NCT01447355|Cholecalciferol|cholecalciferol|mesh-list
24699516|NCT01447355|Vitamins|vitamins|mesh-ancestor
24699517|NCT01447355|Micronutrients|micronutrients|mesh-ancestor
24699518|NCT01447355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699519|NCT01447355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24699520|NCT01447355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24699521|NCT01447368|Cinacalcet|cinacalcet|mesh-list
24699522|NCT01447368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24699523|NCT01447368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699525|NCT01447368|Hormone Antagonists|hormone antagonists|mesh-ancestor
24699526|NCT01447368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24699527|NCT01447394|Interferons|interferons|mesh-list
24699528|NCT01447394|Ribavirin|ribavirin|mesh-list
24699529|NCT01447394|Interferon-alpha|interferon-alpha|mesh-list
24699530|NCT01447394|Interferon alpha-2|interferon alpha-2|mesh-list
25070679|NCT03417206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25070680|NCT03417206|Narcotics|narcotics|mesh-ancestor
25070681|NCT03417206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25070694|NCT03417037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070695|NCT03417037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25070696|NCT03416777|Tocopherols|tocopherols|mesh-list
25070697|NCT03416777|Vitamin E|vitamin e|mesh-list
25070698|NCT03416777|Tocotrienols|tocotrienols|mesh-list
24833308|NCT02173691|Parasympatholytics|parasympatholytics|mesh-ancestor
24833309|NCT02173691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24833310|NCT02173691|Cholinergic Agents|cholinergic agents|mesh-ancestor
24833311|NCT02173691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24833312|NCT02173691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833313|NCT02173691|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24833314|NCT02173691|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24833315|NCT02173691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24833316|NCT02173691|Adrenergic Agents|adrenergic agents|mesh-ancestor
24833317|NCT02173717|Rifampin|rifampin|mesh-list
24699531|NCT01447394|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24699532|NCT01447394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24699533|NCT01447394|Antiviral Agents|antiviral agents|mesh-ancestor
24699534|NCT01447394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24699535|NCT01447394|Antimetabolites|antimetabolites|mesh-ancestor
24699536|NCT01447394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699605|NCT01448031|Esomeprazole|esomeprazole|mesh-list
24699606|NCT01448031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24699607|NCT01448031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24699608|NCT01448031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24699609|NCT01448031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699610|NCT01448031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699611|NCT01448070|Insulin|insulin|mesh-list
24699612|NCT01448070|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24699613|NCT01448070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24699614|NCT01448070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699615|NCT01448096|Rituximab|rituximab|mesh-list
24699616|NCT01448096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24699617|NCT01448096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24699618|NCT01448096|Immunologic Factors|immunologic factors|mesh-ancestor
24699619|NCT01448096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699620|NCT01448096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24699621|NCT01448109|Hydrocortisone|hydrocortisone|mesh-list
25070723|NCT03416517|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24699677|NCT01448395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699685|NCT01448499|Amisulpride|amisulpride|mesh-list
24699686|NCT01448499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24699687|NCT01448499|Serotonin Agents|serotonin agents|mesh-ancestor
24699688|NCT01448499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24699689|NCT01448499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699690|NCT01448499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699691|NCT01448499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24699692|NCT01448499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24699693|NCT01448499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24699694|NCT01448499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24699695|NCT01448499|GABA Antagonists|gaba antagonists|mesh-ancestor
24699696|NCT01448499|GABA Agents|gaba agents|mesh-ancestor
24699697|NCT01448499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24699698|NCT01448499|Dopamine Agents|dopamine agents|mesh-ancestor
24699699|NCT01448499|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24699700|NCT01448499|Antidepressive Agents|antidepressive agents|mesh-ancestor
24613014|NCT01016249|Mydriatics|mydriatics|mesh-ancestor
24613015|NCT01016249|Sympathomimetics|sympathomimetics|mesh-ancestor
24613022|NCT01016626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24613023|NCT01016626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613024|NCT01016626|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24613025|NCT01016626|Antitubercular Agents|antitubercular agents|mesh-ancestor
24613026|NCT01016626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24613027|NCT01016626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24613028|NCT01016626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699769|NCT01448837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699770|NCT01448837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699771|NCT01448837|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24699772|NCT01448837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24699831|NCT01449253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24699832|NCT01449253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24699833|NCT01449253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699834|NCT01449253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699871|NCT01449435|Autonomic Agents|autonomic agents|mesh-ancestor
24699872|NCT01449435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24699873|NCT01449435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699874|NCT01449435|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24699875|NCT01449435|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
24699876|NCT01449435|Respiratory System Agents|respiratory system agents|mesh-ancestor
24699877|NCT01449435|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24699878|NCT01449435|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24699879|NCT01449435|Cholinergic Agents|cholinergic agents|mesh-ancestor
24699880|NCT01449435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24699918|NCT01449578|Dopamine Agents|dopamine agents|mesh-ancestor
24699919|NCT01449578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24699922|NCT01449617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24699923|NCT01449617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25070726|NCT03416517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070727|NCT03416517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25070728|NCT03416491|Sofosbuvir|sofosbuvir|mesh-list
25070729|NCT03416491|Antiviral Agents|antiviral agents|mesh-ancestor
25070730|NCT03416491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24699924|NCT01449617|Analgesics|analgesics|mesh-ancestor
24699925|NCT01449617|Sensory System Agents|sensory system agents|mesh-ancestor
24699926|NCT01449617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24699927|NCT01449617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699928|NCT01449617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24699929|NCT01449617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24699930|NCT01449617|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24699931|NCT01449617|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24699932|NCT01449617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699933|NCT01449617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24699934|NCT01449617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24699935|NCT01449617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699936|NCT01449617|Antipyretics|antipyretics|mesh-ancestor
24700046|NCT01450215|Growth Substances|growth substances|mesh-ancestor
24700047|NCT01450215|Growth Inhibitors|growth inhibitors|mesh-ancestor
24700048|NCT01450215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24700061|NCT01450345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24700062|NCT01450345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24613075|NCT01016886|Perindopril|perindopril|mesh-list
24700084|NCT01450410|Antimetabolites|antimetabolites|mesh-ancestor
24700085|NCT01450410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700086|NCT01450410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24700087|NCT01450410|Vasodilator Agents|vasodilator agents|mesh-ancestor
24700090|NCT01450462|Vitamins|vitamins|mesh-ancestor
24700091|NCT01450462|Micronutrients|micronutrients|mesh-ancestor
24700092|NCT01450462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700093|NCT01450462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24700108|NCT01450566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24700109|NCT01450566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700110|NCT01450566|Sensory System Agents|sensory system agents|mesh-ancestor
25070754|NCT03416361|Vitamin D|vitamin d|mesh-list
25070755|NCT03416361|Cholecalciferol|cholecalciferol|mesh-list
25070756|NCT03416361|Vitamins|vitamins|mesh-ancestor
25070757|NCT03416361|Micronutrients|micronutrients|mesh-ancestor
25070758|NCT03416361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070759|NCT03416361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25070760|NCT03416361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24700118|NCT01450774|Formoterol Fumarate|formoterol fumarate|mesh-list
24700119|NCT01450774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25070784|NCT03416062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956066|NCT03857399|Caspofungin|caspofungin|mesh-list
25070786|NCT03415906|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25070787|NCT03415906|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
25070788|NCT03415906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25070789|NCT03415906|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25070790|NCT03415906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070838|NCT03415750|Mycophenolic Acid|mycophenolic acid|mesh-list
25070839|NCT03415750|Everolimus|everolimus|mesh-list
25070840|NCT03415750|Tacrolimus|tacrolimus|mesh-list
25070841|NCT03415750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25070842|NCT03415750|Immunologic Factors|immunologic factors|mesh-ancestor
25070843|NCT03415750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070844|NCT03415750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25070845|NCT03415750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25070846|NCT03415750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070847|NCT03415750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25070853|NCT03415711|Mesalamine|mesalamine|mesh-list
25070869|NCT03415646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25070873|NCT03415594|Hormones|hormones|mesh-ancestor
25070912|NCT03415087|Anesthetics, Local|anesthetics, local|mesh-ancestor
25070913|NCT03415087|Anesthetics|anesthetics|mesh-ancestor
25070914|NCT03415087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25070915|NCT03415087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070916|NCT03415087|Sensory System Agents|sensory system agents|mesh-ancestor
25070917|NCT03415087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25070918|NCT03415087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25070919|NCT03415087|Narcotics|narcotics|mesh-ancestor
25070920|NCT03415087|Analgesics|analgesics|mesh-ancestor
25070921|NCT03415087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25070922|NCT03415087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25070923|NCT03415087|Anesthetics, General|anesthetics, general|mesh-ancestor
25070924|NCT03414931|Sertraline|sertraline|mesh-list
25070925|NCT03414931|Antidepressive Agents|antidepressive agents|mesh-ancestor
25070926|NCT03414931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25070927|NCT03414931|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25070928|NCT03414931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25070929|NCT03414931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25070930|NCT03414931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070931|NCT03414931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25070932|NCT03414931|Serotonin Agents|serotonin agents|mesh-ancestor
25070933|NCT03414931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25070934|NCT03414918|Clarithromycin|clarithromycin|mesh-list
25070935|NCT03414918|Roxithromycin|roxithromycin|mesh-list
25070962|NCT03414879|Anesthetics, General|anesthetics, general|mesh-ancestor
25070963|NCT03414879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25070964|NCT03414879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25070965|NCT03414879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25070966|NCT03414840|Atorvastatin|atorvastatin|mesh-list
25070967|NCT03414840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25070968|NCT03414840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25070969|NCT03414840|Antimetabolites|antimetabolites|mesh-ancestor
25070970|NCT03414840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070971|NCT03414840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25701659|NCT02142712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701660|NCT02142712|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25701661|NCT02142712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25701662|NCT02142712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24498213|NCT00513552|Clofazimine|clofazimine|mesh-list
24498214|NCT00513552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25070972|NCT03414840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25070973|NCT03414840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25070974|NCT03414814|Osimertinib|osimertinib|mesh-list
25070975|NCT03414814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25070976|NCT03414814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25070977|NCT03414814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25070978|NCT03414814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25070979|NCT03414450|Dasatinib|dasatinib|mesh-list
24833571|NCT02174575|Sevoflurane|sevoflurane|mesh-list
24700121|NCT01450774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24700122|NCT01450774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700123|NCT01450774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25071034|NCT03413410|Autonomic Agents|autonomic agents|mesh-ancestor
25071035|NCT03413410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25071036|NCT03413410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071037|NCT03413410|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25071038|NCT03413410|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25071039|NCT03413410|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25071040|NCT03413410|Adrenergic Agents|adrenergic agents|mesh-ancestor
25071041|NCT03413410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25071042|NCT03413410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071043|NCT03413371|Acetaminophen|acetaminophen|mesh-list
25071052|NCT03413371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25071053|NCT03413371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25071054|NCT03413371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25071055|NCT03413371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25071056|NCT03413371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25071057|NCT03413371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071058|NCT03413371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25071059|NCT03413371|Analgesics|analgesics|mesh-ancestor
25071060|NCT03413371|Antipyretics|antipyretics|mesh-ancestor
25071061|NCT03413358|Carboplatin|carboplatin|mesh-list
24956334|NCT03855267|Propofol|propofol|mesh-list
24953745|NCT03882008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24953766|NCT03881943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24953767|NCT03881943|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24833679|NCT02175069|Ropivacaine|ropivacaine|mesh-list
24700162|NCT01451060|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24700163|NCT01451060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700164|NCT01451060|Sympathomimetics|sympathomimetics|mesh-ancestor
24953768|NCT03881943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24953769|NCT03881943|Antipyretics|antipyretics|mesh-ancestor
24953770|NCT03881943|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24953771|NCT03881943|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24953772|NCT03881943|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24953773|NCT03881943|Purinergic Agents|purinergic agents|mesh-ancestor
24953774|NCT03881943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24953775|NCT03881904|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24953776|NCT03881904|Gestodene|gestodene|mesh-list
24953785|NCT03881904|Hormones|hormones|mesh-ancestor
24953815|NCT03881423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953816|NCT03881423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953817|NCT03881293|Lidocaine|lidocaine|mesh-list
24953818|NCT03881293|Anesthetics, Local|anesthetics, local|mesh-ancestor
24953819|NCT03881293|Anesthetics|anesthetics|mesh-ancestor
24953820|NCT03881293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24953821|NCT03881293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953822|NCT03881293|Sensory System Agents|sensory system agents|mesh-ancestor
24953823|NCT03881293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953824|NCT03881293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25071062|NCT03413358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071063|NCT03413319|Tilavonemab|tilavonemab|mesh-list
25071064|NCT03413319|Nootropic Agents|nootropic agents|mesh-ancestor
25071065|NCT03413150|Amiodarone|amiodarone|mesh-list
25071066|NCT03413150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25071067|NCT03413150|Vasodilator Agents|vasodilator agents|mesh-ancestor
25071069|NCT03413150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24498752|NCT00516152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24498757|NCT00516191|Doxorubicin|doxorubicin|mesh-list
24923212|NCT04171817|Chlorhexidine|chlorhexidine|mesh-list
25071070|NCT03413150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833734|NCT02175394|Contraceptive Agents|contraceptive agents|mesh-ancestor
24700216|NCT01451294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24700217|NCT01451294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700218|NCT01451294|Protective Agents|protective agents|mesh-ancestor
24700220|NCT01451320|Plasminogen|plasminogen|mesh-list
25071189|NCT03412513|Urological Agents|urological agents|mesh-ancestor
24447446|NCT00308503|SR 46349B|sr 46349b|mesh-list
24447447|NCT00308503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25071071|NCT03413150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25071072|NCT03413150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25071073|NCT03413150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25071074|NCT03413150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25071075|NCT03413150|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25071076|NCT03413150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25071077|NCT03413150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25071078|NCT03413059|Triamcinolone|triamcinolone|mesh-list
25071079|NCT03413059|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25071080|NCT03413059|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25071082|NCT03413059|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25071144|NCT03412721|Sensory System Agents|sensory system agents|mesh-ancestor
25071145|NCT03412721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25071146|NCT03412721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700272|NCT01451658|Vasodilator Agents|vasodilator agents|mesh-ancestor
24700273|NCT01451710|Prednisone|prednisone|mesh-list
24700274|NCT01451710|Prednisolone|prednisolone|mesh-list
24700275|NCT01451710|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24700276|NCT01451710|Methylprednisolone|methylprednisolone|mesh-list
24700277|NCT01451710|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24700278|NCT01451710|Prednisolone acetate|prednisolone acetate|mesh-list
24700279|NCT01451710|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25071147|NCT03412682|Budesonide|budesonide|mesh-list
25071148|NCT03412682|Mesalamine|mesalamine|mesh-list
25071149|NCT03412682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25071162|NCT03412682|Sensory System Agents|sensory system agents|mesh-ancestor
25071163|NCT03412682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25071164|NCT03412552|Magnesium Sulfate|magnesium sulfate|mesh-list
24833834|NCT02175901|Antacids|antacids|mesh-ancestor
24700296|NCT01451788|Coagulants|coagulants|mesh-ancestor
24700297|NCT01451840|Lidocaine|lidocaine|mesh-list
24700298|NCT01451840|Remifentanil|remifentanil|mesh-list
24700299|NCT01451840|Anesthetics, Local|anesthetics, local|mesh-ancestor
24700300|NCT01451840|Anesthetics|anesthetics|mesh-ancestor
24700301|NCT01451840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24700302|NCT01451840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700303|NCT01451840|Sensory System Agents|sensory system agents|mesh-ancestor
24700304|NCT01451840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24643754|NCT01187108|Antidotes|antidotes|mesh-ancestor
24700305|NCT01451840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24700306|NCT01451840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24700307|NCT01451840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24700309|NCT01451840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700310|NCT01451840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24700312|NCT01451840|Analgesics|analgesics|mesh-ancestor
24700313|NCT01451853|Ebselen|ebselen|mesh-list
24700314|NCT01451853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24700315|NCT01451853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24700316|NCT01451853|Analgesics|analgesics|mesh-ancestor
25071171|NCT03412552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25071172|NCT03412552|Anticonvulsants|anticonvulsants|mesh-ancestor
25071173|NCT03412552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25071174|NCT03412552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25071175|NCT03412552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071176|NCT03412552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25071177|NCT03412552|Tocolytic Agents|tocolytic agents|mesh-ancestor
25071178|NCT03412552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25071179|NCT03412526|Fludarabine|fludarabine|mesh-list
25071180|NCT03412526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25701663|NCT02142712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701664|NCT02142712|Anesthetics, Local|anesthetics, local|mesh-ancestor
25071181|NCT03412513|Mirabegron|mirabegron|mesh-list
25071182|NCT03412513|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25701665|NCT02142712|Anesthetics|anesthetics|mesh-ancestor
25071184|NCT03412513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25071185|NCT03412513|Adrenergic Agents|adrenergic agents|mesh-ancestor
25071186|NCT03412513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25071187|NCT03412513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071188|NCT03412513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953828|NCT03881293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953830|NCT03881111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24953841|NCT03881449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24953842|NCT03881449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953843|NCT03881449|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24953844|NCT03881449|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24953846|NCT03881449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24953847|NCT03881449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24953848|NCT03881449|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24953849|NCT03881449|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24953851|NCT03881319|Contraceptive Agents|contraceptive agents|mesh-list
24953852|NCT03881319|Contraceptives, Oral|contraceptives, oral|mesh-list
24953853|NCT03881319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24953854|NCT03881319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953855|NCT03881319|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24779543|NCT01876771|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
24953856|NCT03880981|Acetaminophen|acetaminophen|mesh-list
24953857|NCT03880981|Ibuprofen|ibuprofen|mesh-list
24953858|NCT03880981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24953859|NCT03880981|Analgesics|analgesics|mesh-ancestor
24547032|NCT00701961|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24953860|NCT03880981|Sensory System Agents|sensory system agents|mesh-ancestor
24953861|NCT03880981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953862|NCT03880981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953863|NCT03880981|Antipyretics|antipyretics|mesh-ancestor
25071242|NCT03412071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25071243|NCT03412071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25071244|NCT03412071|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25071245|NCT03412071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25071246|NCT03412071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071247|NCT03412071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25071248|NCT03412071|Alkylating Agents|alkylating agents|mesh-ancestor
25071249|NCT03412071|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25071250|NCT03412006|Fulacimstat|fulacimstat|mesh-list
25071251|NCT03412006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25071252|NCT03412006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071253|NCT03411967|Docetaxel|docetaxel|mesh-list
25071254|NCT03411967|Apatinib|apatinib|mesh-list
25071255|NCT03411967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071256|NCT03411967|Tubulin Modulators|tubulin modulators|mesh-ancestor
25071257|NCT03411967|Antimitotic Agents|antimitotic agents|mesh-ancestor
25071258|NCT03411967|Mitosis Modulators|mitosis modulators|mesh-ancestor
25071259|NCT03411967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071260|NCT03411967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25071261|NCT03411967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25071262|NCT03411941|Aflibercept|aflibercept|mesh-list
25071263|NCT03411941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25071264|NCT03411941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25071265|NCT03411941|Growth Substances|growth substances|mesh-ancestor
25071266|NCT03411941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071267|NCT03411941|Growth Inhibitors|growth inhibitors|mesh-ancestor
25071268|NCT03411941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24700335|NCT01451879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700336|NCT01451879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24700351|NCT01451918|Resveratrol|resveratrol|mesh-list
24700352|NCT01451918|Antioxidants|antioxidants|mesh-ancestor
24547033|NCT00701961|Anthelmintics|anthelmintics|mesh-ancestor
24547034|NCT00702091|Ramipril|ramipril|mesh-list
24547149|NCT00702676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24547150|NCT00702676|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24547151|NCT00702676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24547152|NCT00702676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24547153|NCT00702676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547155|NCT00702728|Diuretics|diuretics|mesh-ancestor
24547156|NCT00702728|Natriuretic Agents|natriuretic agents|mesh-ancestor
24547157|NCT00702728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547165|NCT00702793|Varenicline|varenicline|mesh-list
24700353|NCT01451918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071269|NCT03411850|Abatacept|abatacept|mesh-list
25071273|NCT03411850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25071274|NCT03411850|Immunologic Factors|immunologic factors|mesh-ancestor
25071275|NCT03411850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071276|NCT03411850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25071277|NCT03411798|Hydroxychloroquine|hydroxychloroquine|mesh-list
25071278|NCT03411798|Sulfasalazine|sulfasalazine|mesh-list
25071279|NCT03411798|Methotrexate|methotrexate|mesh-list
25071280|NCT03411798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25071281|NCT03411798|Abortifacient Agents|abortifacient agents|mesh-ancestor
25071286|NCT03411798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071287|NCT03411798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071288|NCT03411798|Dermatologic Agents|dermatologic agents|mesh-ancestor
25071289|NCT03411798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25071290|NCT03411798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25071291|NCT03411798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25071292|NCT03411798|Immunologic Factors|immunologic factors|mesh-ancestor
25071293|NCT03411798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25071294|NCT03411798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25071295|NCT03411798|Antimalarials|antimalarials|mesh-ancestor
25071296|NCT03411798|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25071297|NCT03411798|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25071298|NCT03411798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25071299|NCT03411798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25071300|NCT03411798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25071301|NCT03411798|Analgesics|analgesics|mesh-ancestor
25071302|NCT03411798|Sensory System Agents|sensory system agents|mesh-ancestor
25071306|NCT03411551|Anesthetics|anesthetics|mesh-list
24547217|NCT00702975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547218|NCT00703066|Vaccines|vaccines|mesh-list
24547219|NCT00703066|Immunologic Factors|immunologic factors|mesh-ancestor
24547221|NCT00703079|Octreotide|octreotide|mesh-list
24547242|NCT00703170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071307|NCT03411551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25071308|NCT03411551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071316|NCT03411434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25071317|NCT03411434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25071318|NCT03411434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071319|NCT03411434|Dopamine Agents|dopamine agents|mesh-ancestor
25071320|NCT03411434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25071321|NCT03411369|Vitamins|vitamins|mesh-list
25071322|NCT03411369|Micronutrients|micronutrients|mesh-ancestor
25071323|NCT03411369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071324|NCT03411330|Lidocaine|lidocaine|mesh-list
25071325|NCT03411330|Bupivacaine|bupivacaine|mesh-list
25071326|NCT03411330|Anesthetics, Local|anesthetics, local|mesh-ancestor
25071327|NCT03411330|Anesthetics|anesthetics|mesh-ancestor
25071328|NCT03411330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25071329|NCT03411330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071330|NCT03411330|Sensory System Agents|sensory system agents|mesh-ancestor
24956653|NCT03852446|Antidepressive Agents|antidepressive agents|mesh-ancestor
25071331|NCT03411330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25071332|NCT03411330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25071333|NCT03411330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25071334|NCT03411330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25071335|NCT03411330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25071336|NCT03411330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071367|NCT03411096|Sensory System Agents|sensory system agents|mesh-ancestor
25071368|NCT03411096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25071370|NCT03410836|Anesthetics, Local|anesthetics, local|mesh-ancestor
25071371|NCT03410836|Anesthetics|anesthetics|mesh-ancestor
24547243|NCT00703170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24547244|NCT00703170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24547245|NCT00703170|Antifungal Agents|antifungal agents|mesh-ancestor
24547257|NCT00703235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547258|NCT00703235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25071372|NCT03410836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25071373|NCT03410836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071375|NCT03410836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25071376|NCT03410836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24700356|NCT01451918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25071377|NCT03410836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25071378|NCT03410836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25071546|NCT03407976|Apatinib|apatinib|mesh-list
25071380|NCT03410836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071383|NCT03410784|Pembrolizumab|pembrolizumab|mesh-list
25071384|NCT03410784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25071385|NCT03410784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071386|NCT03410784|Tubulin Modulators|tubulin modulators|mesh-ancestor
25071393|NCT03410524|Simethicone|simethicone|mesh-list
25071420|NCT03410212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071426|NCT03409874|Diclofenac|diclofenac|mesh-list
25071427|NCT03409874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25071428|NCT03409874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25071429|NCT03409874|Analgesics|analgesics|mesh-ancestor
25071430|NCT03409874|Sensory System Agents|sensory system agents|mesh-ancestor
25071431|NCT03409874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25071432|NCT03409874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071433|NCT03409874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25071434|NCT03409874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25071435|NCT03409874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25071436|NCT03409874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547361|NCT00703625|Antimitotic Agents|antimitotic agents|mesh-ancestor
24547362|NCT00703625|Mitosis Modulators|mitosis modulators|mesh-ancestor
25071437|NCT03409874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071438|NCT03409835|Ramosetron|ramosetron|mesh-list
25071439|NCT03409835|Antiemetics|antiemetics|mesh-ancestor
25071440|NCT03409835|Autonomic Agents|autonomic agents|mesh-ancestor
25071441|NCT03409835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25071442|NCT03409835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071443|NCT03409835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25071444|NCT03409835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25071445|NCT03409835|Serotonin Agents|serotonin agents|mesh-ancestor
25071446|NCT03409835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25071447|NCT03409835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071448|NCT03409679|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25071454|NCT03409432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25071455|NCT03409432|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25071457|NCT03409432|Antibodies|antibodies|mesh-list
25071458|NCT03409432|Immunoglobulins|immunoglobulins|mesh-list
25071461|NCT03409432|Immunologic Factors|immunologic factors|mesh-ancestor
25071462|NCT03409432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071463|NCT03409432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071464|NCT03409432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25071465|NCT03409432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25071466|NCT03409432|Growth Substances|growth substances|mesh-ancestor
25071467|NCT03409432|Growth Inhibitors|growth inhibitors|mesh-ancestor
25071468|NCT03409367|Emollients|emollients|mesh-list
24547363|NCT00703625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547364|NCT00703625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24547365|NCT00703625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24547366|NCT00703625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24547367|NCT00703625|Antifungal Agents|antifungal agents|mesh-ancestor
24547368|NCT00703625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24547369|NCT00703625|Immunologic Factors|immunologic factors|mesh-ancestor
24547370|NCT00703625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547405|NCT00703742|Antidepressive Agents|antidepressive agents|mesh-ancestor
24547406|NCT00703742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24547408|NCT00703755|Fenofibrate|fenofibrate|mesh-list
24547409|NCT00703755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24447543|NCT00308841|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24447544|NCT00308841|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24547465|NCT00704145|Antimitotic Agents|antimitotic agents|mesh-ancestor
24547466|NCT00704145|Mitosis Modulators|mitosis modulators|mesh-ancestor
24547467|NCT00704145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547468|NCT00704223|Insulin Aspart|insulin aspart|mesh-list
25701666|NCT02142712|Sensory System Agents|sensory system agents|mesh-ancestor
25701667|NCT02142712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25701668|NCT02142712|Antiemetics|antiemetics|mesh-ancestor
25701669|NCT02142712|Autonomic Agents|autonomic agents|mesh-ancestor
24547490|NCT00704275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547491|NCT00704275|Antifungal Agents|antifungal agents|mesh-ancestor
25071470|NCT03409367|Dermatologic Agents|dermatologic agents|mesh-ancestor
25071471|NCT03409250|Ranibizumab|ranibizumab|mesh-list
25071472|NCT03409250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25071473|NCT03409250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25071474|NCT03409250|Growth Substances|growth substances|mesh-ancestor
25071475|NCT03409250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071476|NCT03409250|Growth Inhibitors|growth inhibitors|mesh-ancestor
25071477|NCT03409250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071478|NCT03409237|Mannitol|mannitol|mesh-list
25071479|NCT03409237|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25071480|NCT03409237|Diuretics|diuretics|mesh-ancestor
25071481|NCT03409237|Natriuretic Agents|natriuretic agents|mesh-ancestor
25071482|NCT03409237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24956864|NCT03849833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953871|NCT03880903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24953872|NCT03880903|Autonomic Agents|autonomic agents|mesh-ancestor
24953873|NCT03880903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953874|NCT03880903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953881|NCT03880903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24953882|NCT03880903|Adrenergic Agents|adrenergic agents|mesh-ancestor
24953883|NCT03880903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24953884|NCT03880903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953886|NCT03880968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24956981|NCT03848780|Desflurane|desflurane|mesh-list
25071483|NCT03409068|Anesthetics|anesthetics|mesh-list
25071484|NCT03409068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25071485|NCT03409068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071489|NCT03408847|Hormones|hormones|mesh-ancestor
25071490|NCT03408847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25071491|NCT03408847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071492|NCT03408847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25071493|NCT03408847|Respiratory System Agents|respiratory system agents|mesh-ancestor
25071494|NCT03408756|Methotrexate|methotrexate|mesh-list
25071495|NCT03408756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25071496|NCT03408756|Abortifacient Agents|abortifacient agents|mesh-ancestor
25071497|NCT03408756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25071498|NCT03408756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071499|NCT03408756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25071500|NCT03408756|Antimetabolites|antimetabolites|mesh-ancestor
25071501|NCT03408756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071502|NCT03408756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071503|NCT03408756|Dermatologic Agents|dermatologic agents|mesh-ancestor
25071504|NCT03408756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25071505|NCT03408756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25071506|NCT03408756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25071507|NCT03408756|Immunologic Factors|immunologic factors|mesh-ancestor
25071508|NCT03408756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25071509|NCT03408756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25071511|NCT03408587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25071513|NCT03408587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25071514|NCT03408587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071516|NCT03408457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25071517|NCT03408405|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25071518|NCT03408405|Hormones|hormones|mesh-ancestor
25071519|NCT03408405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25071520|NCT03408405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071521|NCT03408145|Hyaluronic Acid|hyaluronic acid|mesh-list
25071522|NCT03408145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25071523|NCT03408145|Immunologic Factors|immunologic factors|mesh-ancestor
25071524|NCT03408145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071538|NCT03408054|Oxytocics|oxytocics|mesh-ancestor
25071539|NCT03408054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25071540|NCT03408054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071541|NCT03408054|Vasodilator Agents|vasodilator agents|mesh-ancestor
25071542|NCT03408015|Lifitegrast|lifitegrast|mesh-list
25071543|NCT03408015|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25071544|NCT03408015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25071545|NCT03407976|Pembrolizumab|pembrolizumab|mesh-list
25071555|NCT03407872|Esketamine|esketamine|mesh-list
25071556|NCT03407872|Antidepressive Agents|antidepressive agents|mesh-ancestor
24547494|NCT00704275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24926903|NCT04137588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926908|NCT04137653|Paclitaxel|paclitaxel|mesh-list
24547570|NCT00704691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547571|NCT00704691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25071557|NCT03407872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25071558|NCT03407703|Grazoprevir|grazoprevir|mesh-list
25071559|NCT03407703|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25071560|NCT03407703|Antiviral Agents|antiviral agents|mesh-ancestor
25071561|NCT03407703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25071562|NCT03407599|Insulin Aspart|insulin aspart|mesh-list
25071563|NCT03407599|Insulin, Long-Acting|insulin, long-acting|mesh-list
25071564|NCT03407599|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25071565|NCT03407599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25071566|NCT03407599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071567|NCT03407521|Isosorbide|isosorbide|mesh-list
25071568|NCT03407521|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25071569|NCT03407521|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25071570|NCT03407521|Misoprostol|misoprostol|mesh-list
25071571|NCT03407521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25071572|NCT03407521|Abortifacient Agents|abortifacient agents|mesh-ancestor
25071573|NCT03407521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25071574|NCT03407521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071575|NCT03407521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25071576|NCT03407521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25071577|NCT03407521|Oxytocics|oxytocics|mesh-ancestor
25071627|NCT03407105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25071628|NCT03407105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071629|NCT03407105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25071630|NCT03407105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071634|NCT03407027|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25071635|NCT03407027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25071636|NCT03407027|Glucocorticoids|glucocorticoids|mesh-ancestor
25071637|NCT03407027|Hormones|hormones|mesh-ancestor
25071638|NCT03407027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25071639|NCT03407027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071640|NCT03407027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25071641|NCT03407027|Immunologic Factors|immunologic factors|mesh-ancestor
25071642|NCT03407027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547655|NCT00704990|Trace Elements|trace elements|mesh-ancestor
24547656|NCT00704990|Antioxidants|antioxidants|mesh-ancestor
24547657|NCT00704990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547658|NCT00704990|Protective Agents|protective agents|mesh-ancestor
24547659|NCT00705042|Etanercept|etanercept|mesh-list
24547660|NCT00705042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24547692|NCT00705198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071643|NCT03407027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071644|NCT03406988|Nifedipine|nifedipine|mesh-list
25071645|NCT03406988|Iloprost|iloprost|mesh-list
25071646|NCT03406988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25071647|NCT03406988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25071648|NCT03406988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071649|NCT03406988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25071650|NCT03406988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071651|NCT03406988|Vasodilator Agents|vasodilator agents|mesh-ancestor
25071658|NCT03406936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25071659|NCT03406936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071660|NCT03406936|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25071661|NCT03406936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25071662|NCT03406936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25071663|NCT03406936|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25071664|NCT03406936|Anesthetics, General|anesthetics, general|mesh-ancestor
25071665|NCT03406936|Anesthetics|anesthetics|mesh-ancestor
25071666|NCT03406936|GABA Modulators|gaba modulators|mesh-ancestor
24547693|NCT00705198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547694|NCT00705315|Bevacizumab|bevacizumab|mesh-list
24547695|NCT00705315|Docetaxel|docetaxel|mesh-list
24547696|NCT00705315|Epirubicin|epirubicin|mesh-list
24547697|NCT00705315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25071667|NCT03406936|GABA Agents|gaba agents|mesh-ancestor
24834389|NCT02178254|Fosfomycin|fosfomycin|mesh-list
25701670|NCT02142712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25701671|NCT02142712|Histamine Antagonists|histamine antagonists|mesh-ancestor
24700358|NCT01452009|Travoprost|travoprost|mesh-list
25071668|NCT03406936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25071669|NCT03406936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071670|NCT03406871|Nivolumab|nivolumab|mesh-list
25071671|NCT03406871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25071672|NCT03406871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071673|NCT03406871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25071674|NCT03406871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071675|NCT03406858|Pembrolizumab|pembrolizumab|mesh-list
25071676|NCT03406858|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25071677|NCT03406858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25071678|NCT03406858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071680|NCT03406858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071681|NCT03406832|Nitroprusside|nitroprusside|mesh-list
25071682|NCT03406832|Tirofiban|tirofiban|mesh-list
25071683|NCT03406832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25071684|NCT03406832|Vasodilator Agents|vasodilator agents|mesh-ancestor
25071685|NCT03406832|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25071686|NCT03406832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782874|NCT01898676|Anticonvulsants|anticonvulsants|mesh-ancestor
25071687|NCT03406832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25071693|NCT03406819|Vasodilator Agents|vasodilator agents|mesh-ancestor
25071694|NCT03406819|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25071695|NCT03406819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071696|NCT03406819|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25071697|NCT03406819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25071698|NCT03406819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25071699|NCT03406793|Iron|iron|mesh-list
25071700|NCT03406793|Zinc|zinc|mesh-list
25071701|NCT03406793|Trace Elements|trace elements|mesh-ancestor
25071702|NCT03406793|Micronutrients|micronutrients|mesh-ancestor
25071703|NCT03406793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071706|NCT03406689|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25071707|NCT03406689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25071708|NCT03406689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25071709|NCT03406689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25071710|NCT03406689|Analgesics|analgesics|mesh-ancestor
25071711|NCT03406689|Sensory System Agents|sensory system agents|mesh-ancestor
25071712|NCT03406689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25071757|NCT03406533|Adrenergic Agents|adrenergic agents|mesh-ancestor
25071758|NCT03406533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25071759|NCT03406533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071760|NCT03406533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25071761|NCT03406533|Narcotics|narcotics|mesh-ancestor
24957173|NCT03846765|Sympathomimetics|sympathomimetics|mesh-ancestor
24547869|NCT00706225|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24547870|NCT00706225|Hormones|hormones|mesh-ancestor
24547871|NCT00706225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24547877|NCT00706277|Fentanyl|fentanyl|mesh-list
25071762|NCT03406533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25071763|NCT03406533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25071764|NCT03406533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25071765|NCT03406533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25071766|NCT03406533|GABA Modulators|gaba modulators|mesh-ancestor
25071767|NCT03406533|GABA Agents|gaba agents|mesh-ancestor
25071768|NCT03406520|Chlorhexidine|chlorhexidine|mesh-list
25071769|NCT03406520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25071770|NCT03406520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25071771|NCT03406520|Disinfectants|disinfectants|mesh-ancestor
25071772|NCT03406403|Anesthetics|anesthetics|mesh-list
25701672|NCT02142712|Histamine Agents|histamine agents|mesh-ancestor
25701673|NCT02142712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25701674|NCT02142712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25701675|NCT02142712|Antipruritics|antipruritics|mesh-ancestor
25701676|NCT02142712|Dermatologic Agents|dermatologic agents|mesh-ancestor
25701677|NCT02142712|Antitussive Agents|antitussive agents|mesh-ancestor
25701678|NCT02142712|Respiratory System Agents|respiratory system agents|mesh-ancestor
25701679|NCT02142712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24929483|NCT04111822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071773|NCT03406403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25071774|NCT03406403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071776|NCT03406299|Gemcitabine|gemcitabine|mesh-list
25071777|NCT03406299|Oxaliplatin|oxaliplatin|mesh-list
25071778|NCT03406299|Tegafur|tegafur|mesh-list
25071779|NCT03406299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071780|NCT03406299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25071781|NCT03406299|Antimetabolites|antimetabolites|mesh-ancestor
25071782|NCT03406299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071783|NCT03406299|Antiviral Agents|antiviral agents|mesh-ancestor
25071805|NCT03406169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071806|NCT03406169|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25071808|NCT03406091|Plerixafor|plerixafor|mesh-list
25071809|NCT03406091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25071810|NCT03406091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25071811|NCT03406091|Antiviral Agents|antiviral agents|mesh-ancestor
25071812|NCT03406091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25071813|NCT03405974|Aspirin|aspirin|mesh-list
24834534|NCT02179528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24700359|NCT01452009|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24700360|NCT01452009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24700361|NCT01452009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24700362|NCT01452100|Prednisone|prednisone|mesh-list
24700363|NCT01452100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24700364|NCT01452100|Glucocorticoids|glucocorticoids|mesh-ancestor
24700365|NCT01452100|Hormones|hormones|mesh-ancestor
24700366|NCT01452100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24700367|NCT01452100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700368|NCT01452100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24700369|NCT01452100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24700370|NCT01452113|Vildagliptin|vildagliptin|mesh-list
24700371|NCT01452113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24700372|NCT01452113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071814|NCT03405974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25071815|NCT03405974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25071816|NCT03405974|Analgesics|analgesics|mesh-ancestor
25071817|NCT03405974|Sensory System Agents|sensory system agents|mesh-ancestor
25071818|NCT03405974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25071819|NCT03405974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071820|NCT03405974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25071821|NCT03405974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25071822|NCT03405974|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25071823|NCT03405974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25071824|NCT03405974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071825|NCT03405974|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25071826|NCT03405974|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25071827|NCT03405974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25071828|NCT03405974|Antipyretics|antipyretics|mesh-ancestor
25071829|NCT03405948|Botulinum Toxins|botulinum toxins|mesh-list
25071830|NCT03405948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25071831|NCT03405948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25071832|NCT03405948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071833|NCT03405948|Cholinergic Agents|cholinergic agents|mesh-ancestor
25071834|NCT03405948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25071835|NCT03405948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071836|NCT03405805|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25071837|NCT03405805|Immunologic Factors|immunologic factors|mesh-ancestor
24953887|NCT03880968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24953890|NCT03880968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953891|NCT03880968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953892|NCT03880968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24953893|NCT03880968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24953894|NCT03880968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24953895|NCT03880968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24953896|NCT03880968|Immunologic Factors|immunologic factors|mesh-ancestor
24953897|NCT03880916|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24643763|NCT01187186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24700373|NCT01452113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24953898|NCT03880916|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25701680|NCT02142712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25701681|NCT02142712|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24929777|NCT04109339|Oxytocin|oxytocin|mesh-list
25071852|NCT03405584|Natriuretic Agents|natriuretic agents|mesh-ancestor
25071853|NCT03405584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071854|NCT03405584|Expectorants|expectorants|mesh-ancestor
25071855|NCT03405584|Respiratory System Agents|respiratory system agents|mesh-ancestor
25071856|NCT03405454|Durvalumab|durvalumab|mesh-list
25071857|NCT03405454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25071858|NCT03405454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071859|NCT03405376|Aflibercept|aflibercept|mesh-list
24700374|NCT01452113|Protease Inhibitors|protease inhibitors|mesh-ancestor
24700375|NCT01452113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700376|NCT01452113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700377|NCT01452139|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24700378|NCT01452139|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25071860|NCT03405376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25071861|NCT03405376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25071862|NCT03405376|Growth Substances|growth substances|mesh-ancestor
25071863|NCT03405376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071864|NCT03405376|Growth Inhibitors|growth inhibitors|mesh-ancestor
25071865|NCT03405376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071866|NCT03405337|Factor VIII|factor viii|mesh-list
25071867|NCT03405337|Coagulants|coagulants|mesh-ancestor
25071869|NCT03405272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25071870|NCT03405272|Immunologic Factors|immunologic factors|mesh-ancestor
25071871|NCT03405272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071872|NCT03405207|Vitamin D|vitamin d|mesh-list
24700388|NCT01452243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700389|NCT01452243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24700390|NCT01452243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24700391|NCT01452256|Propofol|propofol|mesh-list
24700392|NCT01452256|Desflurane|desflurane|mesh-list
24700412|NCT01452477|Sensory System Agents|sensory system agents|mesh-ancestor
24700413|NCT01452477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24700414|NCT01452477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700415|NCT01452477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24700416|NCT01452477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24700417|NCT01452477|Anticoagulants|anticoagulants|mesh-ancestor
24953910|NCT03880734|Cholecalciferol|cholecalciferol|mesh-list
25071887|NCT03405194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25071888|NCT03405194|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25071889|NCT03405194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25071890|NCT03405194|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25071891|NCT03405194|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25071892|NCT03405194|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25071893|NCT03405194|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25071921|NCT03405142|Dextrans|dextrans|mesh-list
25071922|NCT03405142|Edetic Acid|edetic acid|mesh-list
25071923|NCT03405142|Pentetic Acid|pentetic acid|mesh-list
25071924|NCT03405142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25071925|NCT03405142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25071926|NCT03405142|Anticoagulants|anticoagulants|mesh-ancestor
25071927|NCT03405142|Plasma Substitutes|plasma substitutes|mesh-ancestor
25071928|NCT03405142|Blood Substitutes|blood substitutes|mesh-ancestor
25071929|NCT03405142|Antidotes|antidotes|mesh-ancestor
25071930|NCT03405142|Protective Agents|protective agents|mesh-ancestor
25071931|NCT03405142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071933|NCT03405142|Sequestering Agents|sequestering agents|mesh-ancestor
25071934|NCT03405142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071935|NCT03405142|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25071936|NCT03405142|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25071937|NCT03405142|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25071938|NCT03405064|Linezolid|linezolid|mesh-list
25071940|NCT03405064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25071941|NCT03405064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25071942|NCT03405064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25071943|NCT03405064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25071944|NCT03405064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071945|NCT03404947|Ethanol|ethanol|mesh-list
25071946|NCT03404947|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25071947|NCT03404947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25071948|NCT03404947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25701682|NCT02143141|Morphine|morphine|mesh-list
25701683|NCT02143141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25701684|NCT02143141|Narcotics|narcotics|mesh-ancestor
25071949|NCT03404947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071950|NCT03404908|Acetaminophen|acetaminophen|mesh-list
25071951|NCT03404908|Dipyrone|dipyrone|mesh-list
25071952|NCT03404908|Ketoprofen|ketoprofen|mesh-list
24834697|NCT02180516|Meloxicam|meloxicam|mesh-list
24700418|NCT01452477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24700419|NCT01452477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24700420|NCT01452477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24700421|NCT01452477|Immunologic Factors|immunologic factors|mesh-ancestor
24700422|NCT01452542|Eliglustat|eliglustat|mesh-list
24700423|NCT01452542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700424|NCT01452542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700425|NCT01452568|Aspirin|aspirin|mesh-list
24700426|NCT01452568|Salicylic Acid|salicylic acid|mesh-list
24700427|NCT01452568|Salicylates|salicylates|mesh-list
24700428|NCT01452568|Warfarin|warfarin|mesh-list
24700429|NCT01452568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25071954|NCT03404908|Ropivacaine|ropivacaine|mesh-list
25071955|NCT03404908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25071956|NCT03404908|Narcotics|narcotics|mesh-ancestor
25071957|NCT03404908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25071958|NCT03404908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071959|NCT03404908|Analgesics|analgesics|mesh-ancestor
25071960|NCT03404908|Sensory System Agents|sensory system agents|mesh-ancestor
25071961|NCT03404908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25071962|NCT03404908|Anesthetics, Local|anesthetics, local|mesh-ancestor
25071963|NCT03404908|Anesthetics|anesthetics|mesh-ancestor
25071964|NCT03404908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25071965|NCT03404908|Antipyretics|antipyretics|mesh-ancestor
24548397|NCT00709332|Contraceptive Agents|contraceptive agents|mesh-ancestor
25071966|NCT03404908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25071967|NCT03404908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25071968|NCT03404908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25071969|NCT03404908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25071970|NCT03404908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25072109|NCT03403140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25071971|NCT03404908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071972|NCT03404804|Amoxicillin|amoxicillin|mesh-list
25071973|NCT03404804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25071974|NCT03404804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25071975|NCT03404752|Lenograstim|lenograstim|mesh-list
25071976|NCT03404752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25071977|NCT03404752|Immunologic Factors|immunologic factors|mesh-ancestor
25071978|NCT03404752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071979|NCT03404739|Ceftazidime|ceftazidime|mesh-list
25071980|NCT03404739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25071981|NCT03404739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25071982|NCT03404635|Rivaroxaban|rivaroxaban|mesh-list
25071983|NCT03404635|Apixaban|apixaban|mesh-list
25071984|NCT03404635|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25071985|NCT03404635|Antithrombins|antithrombins|mesh-ancestor
25071986|NCT03404635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25071987|NCT03404635|Protease Inhibitors|protease inhibitors|mesh-ancestor
25071988|NCT03404635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25071989|NCT03404635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25071994|NCT03404544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25071995|NCT03404544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25071996|NCT03404479|Celecoxib|celecoxib|mesh-list
25071997|NCT03404479|Diacetylrhein|diacetylrhein|mesh-list
25071998|NCT03404479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25071999|NCT03404479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25072000|NCT03404479|Analgesics|analgesics|mesh-ancestor
25072001|NCT03404479|Sensory System Agents|sensory system agents|mesh-ancestor
25072002|NCT03404479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25072080|NCT03403777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25072081|NCT03403777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24953911|NCT03880734|Vitamin D|vitamin d|mesh-list
25072083|NCT03403647|Vitamins|vitamins|mesh-ancestor
25072084|NCT03403647|Micronutrients|micronutrients|mesh-ancestor
25072085|NCT03403647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072086|NCT03403647|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24548659|NCT00711204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548699|NCT00711789|Angiotensinogen|angiotensinogen|mesh-list
25072087|NCT03403595|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
25072088|NCT03403595|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24474169|NCT00405158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24930681|NCT04098653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25072089|NCT03403595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072090|NCT03403452|Apatinib|apatinib|mesh-list
25072091|NCT03403452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25072092|NCT03403452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25072093|NCT03403452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25072094|NCT03403452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072095|NCT03403439|Itraconazole|itraconazole|mesh-list
24700431|NCT01452568|Analgesics|analgesics|mesh-ancestor
24700432|NCT01452568|Sensory System Agents|sensory system agents|mesh-ancestor
24700433|NCT01452568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24700434|NCT01452568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700435|NCT01452568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24700468|NCT01452633|Anesthetics|anesthetics|mesh-ancestor
24700469|NCT01452633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24700470|NCT01452633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700471|NCT01452633|Sensory System Agents|sensory system agents|mesh-ancestor
24700472|NCT01452633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24700473|NCT01452659|Relugolix|relugolix|mesh-list
24700474|NCT01452659|Androgen Antagonists|androgen antagonists|mesh-ancestor
24700475|NCT01452659|Hormone Antagonists|hormone antagonists|mesh-ancestor
24700476|NCT01452659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24700477|NCT01452659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700478|NCT01452685|Leuprolide|leuprolide|mesh-list
25072101|NCT03403439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072102|NCT03403439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25072103|NCT03403439|Hormone Antagonists|hormone antagonists|mesh-ancestor
25072104|NCT03403439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25072105|NCT03403439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072106|NCT03403439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25072108|NCT03403140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25072110|NCT03403140|Analgesics|analgesics|mesh-ancestor
25072111|NCT03403140|Sensory System Agents|sensory system agents|mesh-ancestor
25072112|NCT03403140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25072113|NCT03403140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072114|NCT03403140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25072115|NCT03403140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25072116|NCT03403140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25072117|NCT03403140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25072118|NCT03403140|Immunologic Factors|immunologic factors|mesh-ancestor
24447665|NCT00309361|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25072119|NCT03403101|Oxaliplatin|oxaliplatin|mesh-list
25072121|NCT03403101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25072153|NCT03402984|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25072154|NCT03402984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24953912|NCT03880734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24953913|NCT03880734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953914|NCT03880734|Vitamins|vitamins|mesh-ancestor
24953915|NCT03880734|Micronutrients|micronutrients|mesh-ancestor
24953916|NCT03880734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24953917|NCT03880877|Leucovorin|leucovorin|mesh-list
24953918|NCT03880877|Antidotes|antidotes|mesh-ancestor
24953919|NCT03880877|Protective Agents|protective agents|mesh-ancestor
24953920|NCT03880877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953921|NCT03880877|Vitamin B Complex|vitamin b complex|mesh-ancestor
24779615|NCT01877356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24779616|NCT01877356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779617|NCT01877512|Hormones|hormones|mesh-list
24779618|NCT01877512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24953922|NCT03880877|Vitamins|vitamins|mesh-ancestor
24953923|NCT03880877|Micronutrients|micronutrients|mesh-ancestor
24953924|NCT03880695|Doxorubicin|doxorubicin|mesh-list
24953934|NCT03880448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24953935|NCT03880448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24953936|NCT03880448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24613115|NCT01017133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613116|NCT01017133|Cariostatic Agents|cariostatic agents|mesh-ancestor
24613117|NCT01017133|Protective Agents|protective agents|mesh-ancestor
24613118|NCT01017133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613120|NCT01017133|Antiviral Agents|antiviral agents|mesh-ancestor
24613121|NCT01017133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24613122|NCT01017159|Immunoglobulins|immunoglobulins|mesh-list
25701685|NCT02143141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24931013|NCT04094909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931014|NCT04094909|Growth Inhibitors|growth inhibitors|mesh-ancestor
24931016|NCT04094727|Artemether|artemether|mesh-list
24613123|NCT01017159|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24613124|NCT01017159|Antibodies|antibodies|mesh-list
24953944|NCT03880487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24953945|NCT03880825|Metformin|metformin|mesh-list
24953946|NCT03880825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24953947|NCT03880825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953948|NCT03880357|Betamethasone|betamethasone|mesh-list
24953949|NCT03880357|Betamethasone Valerate|betamethasone valerate|mesh-list
24953950|NCT03880357|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24953951|NCT03880357|Betamethasone benzoate|betamethasone benzoate|mesh-list
24953952|NCT03880357|Calcipotriene|calcipotriene|mesh-list
25072162|NCT03402880|Immunoglobulin G|immunoglobulin g|mesh-list
25072163|NCT03402880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25072164|NCT03402880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25072165|NCT03402880|Immunologic Factors|immunologic factors|mesh-ancestor
25072166|NCT03402880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072167|NCT03402815|Maraviroc|maraviroc|mesh-list
25072168|NCT03402815|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25072169|NCT03402815|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25072170|NCT03402815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072171|NCT03402815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25072173|NCT03402815|Antiviral Agents|antiviral agents|mesh-ancestor
25072193|NCT03402438|Fulacimstat|fulacimstat|mesh-list
25072194|NCT03402438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25072195|NCT03402438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072196|NCT03402321|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
24834982|NCT02181985|Heparin|heparin|mesh-list
24700506|NCT01452724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24700507|NCT01452724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24700508|NCT01452724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700509|NCT01452724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700510|NCT01452737|Bisacodyl|bisacodyl|mesh-list
24700511|NCT01452737|Cathartics|cathartics|mesh-ancestor
24700512|NCT01452737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24700528|NCT01452828|Tedizolid phosphate|tedizolid phosphate|mesh-list
24700530|NCT01452828|Oxazolidinones|oxazolidinones|mesh-list
24700531|NCT01452828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24700532|NCT01452828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24700534|NCT01452828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25072207|NCT03402295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25072208|NCT03402295|Alkylating Agents|alkylating agents|mesh-ancestor
24700717|NCT01454609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835005|NCT02182024|Dabigatran|dabigatran|mesh-list
24700597|NCT01453530|Glycopyrrolate|glycopyrrolate|mesh-list
24700598|NCT01453530|Neostigmine|neostigmine|mesh-list
24700599|NCT01453530|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24700600|NCT01453530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700601|NCT01453530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700602|NCT01453530|Cholinergic Agents|cholinergic agents|mesh-ancestor
24700603|NCT01453530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24700604|NCT01453530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700605|NCT01453530|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24700623|NCT01453738|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24700631|NCT01453881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24700632|NCT01453881|Respiratory System Agents|respiratory system agents|mesh-ancestor
24700633|NCT01453881|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24700634|NCT01453881|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24700635|NCT01453881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24549625|NCT00716391|Cetuximab|cetuximab|mesh-list
25072217|NCT03402295|Glucocorticoids|glucocorticoids|mesh-ancestor
25701686|NCT02143141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701687|NCT02143141|Analgesics|analgesics|mesh-ancestor
25701688|NCT02143141|Sensory System Agents|sensory system agents|mesh-ancestor
25072218|NCT03402295|Hormones|hormones|mesh-ancestor
25072219|NCT03402295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25072220|NCT03402295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25072221|NCT03402295|Leprostatic Agents|leprostatic agents|mesh-ancestor
25701689|NCT02143141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24931557|NCT04088110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25072222|NCT03402295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25072223|NCT03402295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25072224|NCT03402295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25072225|NCT03402295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25072226|NCT03402295|Growth Substances|growth substances|mesh-ancestor
24700642|NCT01453881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24700643|NCT01453920|Ranibizumab|ranibizumab|mesh-list
24700644|NCT01453920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24700645|NCT01453920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24700695|NCT01454180|Protective Agents|protective agents|mesh-ancestor
25072244|NCT03402204|Protease Inhibitors|protease inhibitors|mesh-ancestor
25072245|NCT03402204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25072246|NCT03402204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25072247|NCT03402204|Antiviral Agents|antiviral agents|mesh-ancestor
25072248|NCT03402191|Sildenafil Citrate|sildenafil citrate|mesh-list
25072249|NCT03402191|Vasodilator Agents|vasodilator agents|mesh-ancestor
25072250|NCT03402191|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25072251|NCT03402191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25072252|NCT03402191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25072253|NCT03402191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072254|NCT03402191|Urological Agents|urological agents|mesh-ancestor
25072256|NCT03402165|Ledipasvir|ledipasvir|mesh-list
25072257|NCT03402165|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25072258|NCT03402165|Antiviral Agents|antiviral agents|mesh-ancestor
25072259|NCT03402165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24700708|NCT01454518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24700709|NCT01454518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700710|NCT01454518|Sensory System Agents|sensory system agents|mesh-ancestor
24700711|NCT01454518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24700712|NCT01454609|Clonidine|clonidine|mesh-list
24700713|NCT01454609|Bupivacaine|bupivacaine|mesh-list
24700714|NCT01454609|Anesthetics, Local|anesthetics, local|mesh-ancestor
24700715|NCT01454609|Anesthetics|anesthetics|mesh-ancestor
24700716|NCT01454609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24700735|NCT01454622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700737|NCT01454635|Antidepressive Agents|antidepressive agents|mesh-ancestor
24700738|NCT01454635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24643854|NCT01187862|Efavirenz|efavirenz|mesh-list
24700744|NCT01454635|Serotonin Agents|serotonin agents|mesh-ancestor
25072283|NCT03402113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25072284|NCT03402113|Analgesics|analgesics|mesh-ancestor
25072285|NCT03402113|Sensory System Agents|sensory system agents|mesh-ancestor
25072286|NCT03402113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25072287|NCT03402113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25072288|NCT03402113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25072289|NCT03402113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25072290|NCT03402113|Adrenergic Agents|adrenergic agents|mesh-ancestor
25072291|NCT03402113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25072292|NCT03402113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072293|NCT03402113|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25072294|NCT03402113|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24700883|NCT01455532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24700884|NCT01455532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24701464|NCT01459198|Immunologic Factors|immunologic factors|mesh-ancestor
24700885|NCT01455532|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24700886|NCT01455636|Micronutrients|micronutrients|mesh-list
24700887|NCT01455636|Trace Elements|trace elements|mesh-list
24700888|NCT01455636|Hand Sanitizers|hand sanitizers|mesh-list
24700889|NCT01455636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700890|NCT01455636|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24700891|NCT01455636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24700892|NCT01455636|Disinfectants|disinfectants|mesh-ancestor
24700893|NCT01455649|Cyclosporine|cyclosporine|mesh-list
24700894|NCT01455649|Everolimus|everolimus|mesh-list
24700895|NCT01455649|Tacrolimus|tacrolimus|mesh-list
24700896|NCT01455649|Cyclosporins|cyclosporins|mesh-list
24700897|NCT01455649|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
25701690|NCT02143648|Nalbuphine|nalbuphine|mesh-list
25701691|NCT02143648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25701692|NCT02143648|Narcotics|narcotics|mesh-ancestor
25701693|NCT02143648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25701694|NCT02143648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932759|NCT04076865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24932760|NCT04076865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24932761|NCT04076865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24932762|NCT04076865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932763|NCT04076865|Histamine Agonists|histamine agonists|mesh-ancestor
24700898|NCT01455649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24700899|NCT01455649|Immunologic Factors|immunologic factors|mesh-ancestor
24700900|NCT01455649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072295|NCT03402113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25072296|NCT03402113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25072297|NCT03402113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25072298|NCT03402113|Anesthetics, General|anesthetics, general|mesh-ancestor
25072299|NCT03402113|Anesthetics|anesthetics|mesh-ancestor
25072300|NCT03402113|GABA Modulators|gaba modulators|mesh-ancestor
25072301|NCT03402113|GABA Agents|gaba agents|mesh-ancestor
25072302|NCT03402100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25072303|NCT03402100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25072304|NCT03402087|Leucovorin|leucovorin|mesh-list
25072305|NCT03402087|Methotrexate|methotrexate|mesh-list
25072306|NCT03402087|BMS-986165|bms-986165|mesh-list
25072307|NCT03402087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25072308|NCT03402087|Abortifacient Agents|abortifacient agents|mesh-ancestor
25072309|NCT03402087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24613214|NCT01017770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24613215|NCT01017770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24700925|NCT01455883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24613216|NCT01017770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613217|NCT01017770|Antiviral Agents|antiviral agents|mesh-ancestor
24700926|NCT01455909|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24700928|NCT01455909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24700929|NCT01455909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700930|NCT01455909|Incretins|incretins|mesh-ancestor
24700931|NCT01455909|Hormones|hormones|mesh-ancestor
24700932|NCT01455909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24700933|NCT01455909|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24700934|NCT01455909|Protease Inhibitors|protease inhibitors|mesh-ancestor
24700935|NCT01455909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700936|NCT01455909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700937|NCT01455909|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24700938|NCT01455922|Glimepiride|glimepiride|mesh-list
24700939|NCT01455922|Exenatide|exenatide|mesh-list
24700940|NCT01455922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24700941|NCT01455922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24700942|NCT01455922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700943|NCT01455922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24700944|NCT01455922|Immunologic Factors|immunologic factors|mesh-ancestor
24700945|NCT01455922|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24700946|NCT01455922|Incretins|incretins|mesh-ancestor
24700947|NCT01455922|Hormones|hormones|mesh-ancestor
24700948|NCT01455922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24700949|NCT01455935|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24700950|NCT01455935|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24700951|NCT01455935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24700985|NCT01456247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24700986|NCT01456247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24700991|NCT01456260|Dexlansoprazole|dexlansoprazole|mesh-list
25072324|NCT03402087|Vitamin B Complex|vitamin b complex|mesh-ancestor
25072325|NCT03402087|Vitamins|vitamins|mesh-ancestor
24701028|NCT01456468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701029|NCT01456468|Keratolytic Agents|keratolytic agents|mesh-ancestor
24701030|NCT01456468|Dermatologic Agents|dermatologic agents|mesh-ancestor
24701031|NCT01456481|Midodrine|midodrine|mesh-list
24701049|NCT01456507|Analgesics|analgesics|mesh-ancestor
25701695|NCT02143648|Analgesics|analgesics|mesh-ancestor
25701696|NCT02143648|Sensory System Agents|sensory system agents|mesh-ancestor
25701697|NCT02143648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25701698|NCT02143843|Bimatoprost|bimatoprost|mesh-list
25701699|NCT02143843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24701051|NCT01456507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24701052|NCT01456507|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24701053|NCT01456507|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25701700|NCT02143973|Nalbuphine|nalbuphine|mesh-list
25701701|NCT02143973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25701702|NCT02143973|Narcotics|narcotics|mesh-ancestor
24933633|NCT04068870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933634|NCT04068948|Midazolam|midazolam|mesh-list
24933635|NCT04068948|Meperidine|meperidine|mesh-list
24933636|NCT04068948|Hydroxyzine|hydroxyzine|mesh-list
24933637|NCT04068948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24933723|NCT04067817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24933724|NCT04067817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24933726|NCT04067817|Adrenergic Agents|adrenergic agents|mesh-ancestor
24933727|NCT04067817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24701054|NCT01456546|Proguanil|proguanil|mesh-list
24701055|NCT01456546|Clopidogrel|clopidogrel|mesh-list
24701056|NCT01456546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24701057|NCT01456546|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24701058|NCT01456546|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24701059|NCT01456546|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24701060|NCT01456546|Purinergic Agents|purinergic agents|mesh-ancestor
24701125|NCT01457040|Etoposide phosphate|etoposide phosphate|mesh-list
25072338|NCT03402048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25072339|NCT03402048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25072340|NCT03402048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25072341|NCT03402048|Immunologic Factors|immunologic factors|mesh-ancestor
25072342|NCT03402048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072343|NCT03402048|Tubulin Modulators|tubulin modulators|mesh-ancestor
24701159|NCT01457469|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24701160|NCT01457469|Autonomic Agents|autonomic agents|mesh-ancestor
24701161|NCT01457469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24701162|NCT01457469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701163|NCT01457469|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24701164|NCT01457469|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24701165|NCT01457469|Cholinergic Agents|cholinergic agents|mesh-ancestor
24701166|NCT01457469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24701167|NCT01457469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701168|NCT01457495|Edetic Acid|edetic acid|mesh-list
24701169|NCT01457495|Pentetic Acid|pentetic acid|mesh-list
24701170|NCT01457495|Antidotes|antidotes|mesh-ancestor
24701171|NCT01457495|Protective Agents|protective agents|mesh-ancestor
24701172|NCT01457495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701173|NCT01457495|Chelating Agents|chelating agents|mesh-ancestor
24701174|NCT01457495|Sequestering Agents|sequestering agents|mesh-ancestor
24701175|NCT01457495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701205|NCT01457690|Tocotrienols|tocotrienols|mesh-list
24701206|NCT01457690|alpha-Tocopherol|alpha-tocopherol|mesh-list
24701207|NCT01457690|Antioxidants|antioxidants|mesh-ancestor
24701208|NCT01457690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701209|NCT01457690|Protective Agents|protective agents|mesh-ancestor
24701210|NCT01457690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701211|NCT01457690|Vitamins|vitamins|mesh-ancestor
24701212|NCT01457690|Micronutrients|micronutrients|mesh-ancestor
24701213|NCT01457716|Budesonide|budesonide|mesh-list
24701257|NCT01457937|Ribavirin|ribavirin|mesh-list
24701296|NCT01458054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24701297|NCT01458054|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24613245|NCT01017822|Gemcitabine|gemcitabine|mesh-list
25072344|NCT03402048|Antimitotic Agents|antimitotic agents|mesh-ancestor
25072345|NCT03402048|Mitosis Modulators|mitosis modulators|mesh-ancestor
25072346|NCT03402048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25072432|NCT03401593|Anesthetics, General|anesthetics, general|mesh-ancestor
25072351|NCT03401957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24957875|NCT03839771|Glycine|glycine|mesh-list
24953957|NCT03880357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24953958|NCT03880357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953959|NCT03880357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24953960|NCT03880357|Respiratory System Agents|respiratory system agents|mesh-ancestor
24953961|NCT03880357|Dermatologic Agents|dermatologic agents|mesh-ancestor
25701703|NCT02143973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25701704|NCT02143973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701705|NCT02143973|Analgesics|analgesics|mesh-ancestor
25701706|NCT02143973|Sensory System Agents|sensory system agents|mesh-ancestor
25701707|NCT02143973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25701708|NCT02144012|Docetaxel|docetaxel|mesh-list
25701709|NCT02144012|Trastuzumab|trastuzumab|mesh-list
25701710|NCT02144012|Maytansine|maytansine|mesh-list
25701711|NCT02144012|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24953964|NCT03880409|Lidocaine|lidocaine|mesh-list
24953965|NCT03880409|Epinephrine|epinephrine|mesh-list
24953966|NCT03880409|Racepinephrine|racepinephrine|mesh-list
24934597|NCT04060381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953967|NCT03880409|Carticaine|carticaine|mesh-list
24953968|NCT03880409|Epinephryl borate|epinephryl borate|mesh-list
24550417|NCT00720512|Micronutrients|micronutrients|mesh-ancestor
24550418|NCT00720538|Thalidomide|thalidomide|mesh-list
24550419|NCT00720538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24550420|NCT00720538|Immunologic Factors|immunologic factors|mesh-ancestor
24953976|NCT03880409|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24953977|NCT03880409|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24953978|NCT03880409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24953979|NCT03880409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072352|NCT03401827|Gemcitabine|gemcitabine|mesh-list
25072353|NCT03401827|Paclitaxel|paclitaxel|mesh-list
25072354|NCT03401827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25072355|NCT03401827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25072356|NCT03401827|Tubulin Modulators|tubulin modulators|mesh-ancestor
25072357|NCT03401827|Antimitotic Agents|antimitotic agents|mesh-ancestor
25072358|NCT03401827|Mitosis Modulators|mitosis modulators|mesh-ancestor
25072359|NCT03401827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072360|NCT03401827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25072389|NCT03401736|Anesthetics|anesthetics|mesh-ancestor
25072390|NCT03401736|GABA Modulators|gaba modulators|mesh-ancestor
25072391|NCT03401736|GABA Agents|gaba agents|mesh-ancestor
25072394|NCT03401619|Salmon calcitonin|salmon calcitonin|mesh-list
25072395|NCT03401619|Diphosphonates|diphosphonates|mesh-list
25072396|NCT03401619|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
25072397|NCT03401619|Katacalcin|katacalcin|mesh-list
25072398|NCT03401619|Vitamins|vitamins|mesh-ancestor
25072399|NCT03401619|Micronutrients|micronutrients|mesh-ancestor
25072400|NCT03401619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072401|NCT03401619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25072402|NCT03401619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25072403|NCT03401619|Vasodilator Agents|vasodilator agents|mesh-ancestor
24701412|NCT01458769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701414|NCT01458769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24701415|NCT01458769|Antiviral Agents|antiviral agents|mesh-ancestor
24701416|NCT01458769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24701417|NCT01458808|Dialysis Solutions|dialysis solutions|mesh-list
24701418|NCT01458808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25072414|NCT03401606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25072415|NCT03401606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25072416|NCT03401606|Adrenergic Agents|adrenergic agents|mesh-ancestor
25072417|NCT03401606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25072418|NCT03401606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072419|NCT03401606|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25072421|NCT03401593|Fentanyl|fentanyl|mesh-list
25072422|NCT03401593|Midazolam|midazolam|mesh-list
24550421|NCT00720538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072423|NCT03401593|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25072424|NCT03401593|Narcotics|narcotics|mesh-ancestor
25072425|NCT03401593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25072426|NCT03401593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072427|NCT03401593|Analgesics|analgesics|mesh-ancestor
25072428|NCT03401593|Sensory System Agents|sensory system agents|mesh-ancestor
25072429|NCT03401593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25072430|NCT03401593|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25072431|NCT03401593|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25072471|NCT03401476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25072472|NCT03401372|Doxycycline|doxycycline|mesh-list
25072473|NCT03401372|Dexamethasone|dexamethasone|mesh-list
25072474|NCT03401372|Cyclophosphamide|cyclophosphamide|mesh-list
25072475|NCT03401372|Bortezomib|bortezomib|mesh-list
25072476|NCT03401372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24626724|NCT01088516|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25072477|NCT03401372|Immunologic Factors|immunologic factors|mesh-ancestor
25072478|NCT03401372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072479|NCT03401372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25072480|NCT03401372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25072481|NCT03401372|Alkylating Agents|alkylating agents|mesh-ancestor
25072482|NCT03401372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072483|NCT03401372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25072484|NCT03401372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25701712|NCT02144012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25004667|NCT02600923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25004668|NCT02600923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004669|NCT02600923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25004670|NCT02484664|Celecoxib|celecoxib|mesh-list
25004671|NCT02484664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25004672|NCT02484664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25004673|NCT02484664|Analgesics|analgesics|mesh-ancestor
25004674|NCT02484664|Sensory System Agents|sensory system agents|mesh-ancestor
25004675|NCT02484664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25004676|NCT02484664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004677|NCT02484664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25004690|NCT02428647|Zinc|zinc|mesh-list
25072485|NCT03401372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25072486|NCT03401372|Antiemetics|antiemetics|mesh-ancestor
25072487|NCT03401372|Autonomic Agents|autonomic agents|mesh-ancestor
25072488|NCT03401372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25072495|NCT03401372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25072496|NCT03401372|Antimalarials|antimalarials|mesh-ancestor
25072497|NCT03401372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25072498|NCT03401372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25072499|NCT03401346|Dihydroergotamine|dihydroergotamine|mesh-list
25072500|NCT03401346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25072501|NCT03401346|Dopamine Agonists|dopamine agonists|mesh-ancestor
25072502|NCT03401346|Dopamine Agents|dopamine agents|mesh-ancestor
25072503|NCT03401346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25072504|NCT03401346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072505|NCT03401346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072506|NCT03401346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25072507|NCT03401346|Analgesics|analgesics|mesh-ancestor
25072508|NCT03401346|Sensory System Agents|sensory system agents|mesh-ancestor
25072509|NCT03401346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25072510|NCT03401268|Immunoglobulins|immunoglobulins|mesh-list
25072511|NCT03401268|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25072512|NCT03401268|Antibodies|antibodies|mesh-list
25072513|NCT03401268|Immunologic Factors|immunologic factors|mesh-ancestor
25072514|NCT03401268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072515|NCT03401177|Naproxen|naproxen|mesh-list
25072516|NCT03401177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25072517|NCT03401177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25072518|NCT03401177|Analgesics|analgesics|mesh-ancestor
25072519|NCT03401177|Sensory System Agents|sensory system agents|mesh-ancestor
25072520|NCT03401177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25072521|NCT03401177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072522|NCT03401177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24835328|NCT02182648|Anesthetics|anesthetics|mesh-ancestor
24701421|NCT01458964|Antidepressive Agents|antidepressive agents|mesh-ancestor
24701422|NCT01458964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24701423|NCT01458964|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24701424|NCT01458964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25072533|NCT03401073|Immunologic Factors|immunologic factors|mesh-ancestor
25072534|NCT03401073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072538|NCT03400995|Ziresovir|ziresovir|mesh-list
25072539|NCT03400995|Antiviral Agents|antiviral agents|mesh-ancestor
25072540|NCT03400995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25072541|NCT03400969|Glycerol|glycerol|mesh-list
25072542|NCT03400969|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25072543|NCT03400969|Protective Agents|protective agents|mesh-ancestor
25072544|NCT03400969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072571|NCT03400709|Expectorants|expectorants|mesh-ancestor
25072572|NCT03400709|Respiratory System Agents|respiratory system agents|mesh-ancestor
25072573|NCT03400709|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25072574|NCT03400709|Antioxidants|antioxidants|mesh-ancestor
25072575|NCT03400709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701713|NCT02144012|Tubulin Modulators|tubulin modulators|mesh-ancestor
25701714|NCT02144012|Antimitotic Agents|antimitotic agents|mesh-ancestor
25701715|NCT02144012|Mitosis Modulators|mitosis modulators|mesh-ancestor
25701716|NCT02144012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701717|NCT02144012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25701718|NCT02144012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25701719|NCT02144077|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25701720|NCT02144077|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
25701721|NCT02144077|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25701722|NCT02144077|Dermatologic Agents|dermatologic agents|mesh-ancestor
25701723|NCT02144233|Salicylic Acid|salicylic acid|mesh-list
25701724|NCT02144233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25701725|NCT02144233|Antifungal Agents|antifungal agents|mesh-ancestor
24670748|NCT01998971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072576|NCT03400709|Protective Agents|protective agents|mesh-ancestor
25072577|NCT03400709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701454|NCT01459146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24701456|NCT01459146|Anticestodal Agents|anticestodal agents|mesh-ancestor
24701457|NCT01459146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24701458|NCT01459146|Tubulin Modulators|tubulin modulators|mesh-ancestor
24701459|NCT01459146|Antimitotic Agents|antimitotic agents|mesh-ancestor
24701460|NCT01459146|Mitosis Modulators|mitosis modulators|mesh-ancestor
24701461|NCT01459146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701462|NCT01459146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701463|NCT01459198|Vaccines|vaccines|mesh-list
24701468|NCT01459211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24701469|NCT01459211|Antiemetics|antiemetics|mesh-ancestor
24701470|NCT01459211|Autonomic Agents|autonomic agents|mesh-ancestor
24701471|NCT01459211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25072602|NCT03400592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25072603|NCT03400592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25072604|NCT03400423|Caffeine|caffeine|mesh-list
25072605|NCT03400423|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25072606|NCT03400423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072607|NCT03400423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24701472|NCT01459211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701496|NCT01459315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24701497|NCT01459367|Lansoprazole|lansoprazole|mesh-list
24701498|NCT01459367|Dexlansoprazole|dexlansoprazole|mesh-list
24701499|NCT01459367|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24701500|NCT01459367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24701501|NCT01459367|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24701502|NCT01459367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701503|NCT01459367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701524|NCT01459380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24701525|NCT01459380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701526|NCT01459380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701527|NCT01459380|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24701529|NCT01459406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701530|NCT01459419|Antibodies|antibodies|mesh-list
24701531|NCT01459419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24701533|NCT01459419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072634|NCT03400254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25072635|NCT03400254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25072636|NCT03400254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072637|NCT03400254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25072638|NCT03400254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25072639|NCT03400241|Bromides|bromides|mesh-list
25072640|NCT03400241|Tiotropium Bromide|tiotropium bromide|mesh-list
25072641|NCT03400241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25072642|NCT03400241|Autonomic Agents|autonomic agents|mesh-ancestor
25072643|NCT03400241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25072644|NCT03400241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072645|NCT03400241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25072653|NCT03400189|Sulthiame|sulthiame|mesh-list
24953980|NCT03880409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24953981|NCT03880409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24953982|NCT03880409|Adrenergic Agents|adrenergic agents|mesh-ancestor
24953983|NCT03880409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24953984|NCT03880409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24953985|NCT03880409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24953986|NCT03880409|Autonomic Agents|autonomic agents|mesh-ancestor
24953987|NCT03880409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24953988|NCT03880409|Respiratory System Agents|respiratory system agents|mesh-ancestor
24953989|NCT03880409|Mydriatics|mydriatics|mesh-ancestor
24953990|NCT03880409|Sympathomimetics|sympathomimetics|mesh-ancestor
24953991|NCT03880409|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24953992|NCT03880045|Vasopressins|vasopressins|mesh-list
24953993|NCT03880045|Arginine Vasopressin|arginine vasopressin|mesh-list
24953994|NCT03880045|Hemostatics|hemostatics|mesh-ancestor
24953995|NCT03880045|Coagulants|coagulants|mesh-ancestor
24953996|NCT03880045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24953997|NCT03880045|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24954010|NCT03880123|Ixazomib|ixazomib|mesh-list
24954011|NCT03880123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24954012|NCT03880123|Protease Inhibitors|protease inhibitors|mesh-ancestor
25701726|NCT02144233|Keratolytic Agents|keratolytic agents|mesh-ancestor
25701727|NCT02144233|Dermatologic Agents|dermatologic agents|mesh-ancestor
24954013|NCT03880123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24954014|NCT03880123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954015|NCT03879837|Fluticasone|fluticasone|mesh-list
24954017|NCT03879837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24954018|NCT03879837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24954019|NCT03879837|Autonomic Agents|autonomic agents|mesh-ancestor
24835523|NCT02183051|Sensory System Agents|sensory system agents|mesh-ancestor
24644061|NCT01188824|Cilostazol|cilostazol|mesh-list
24633731|NCT01130922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24633732|NCT01130922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633733|NCT01130922|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24633735|NCT01130922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24633736|NCT01131000|Ibuprofen|ibuprofen|mesh-list
24633864|NCT01131468|Antiviral Agents|antiviral agents|mesh-ancestor
25072713|NCT03399708|Apremilast|apremilast|mesh-list
25072714|NCT03399708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25072715|NCT03399708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25072716|NCT03399708|Analgesics|analgesics|mesh-ancestor
25072717|NCT03399708|Sensory System Agents|sensory system agents|mesh-ancestor
25072718|NCT03399708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25072726|NCT03399669|Gefitinib|gefitinib|mesh-list
24633986|NCT01131767|Sympathomimetics|sympathomimetics|mesh-ancestor
24633987|NCT01131767|Adrenergic Agents|adrenergic agents|mesh-ancestor
24633988|NCT01131767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24633990|NCT01131780|Pseudoephedrine|pseudoephedrine|mesh-list
24633992|NCT01131780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24633993|NCT01131780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24633994|NCT01131780|Analgesics|analgesics|mesh-ancestor
24633995|NCT01131780|Sensory System Agents|sensory system agents|mesh-ancestor
24633996|NCT01131780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24633997|NCT01131780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633999|NCT01131780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24634000|NCT01131780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24634001|NCT01131780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634002|NCT01131780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634003|NCT01131780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24634004|NCT01131780|Autonomic Agents|autonomic agents|mesh-ancestor
24634005|NCT01131780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24634007|NCT01131780|Nasal Decongestants|nasal decongestants|mesh-ancestor
24634008|NCT01131780|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24634009|NCT01131780|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24634010|NCT01131780|Sympathomimetics|sympathomimetics|mesh-ancestor
24634011|NCT01131780|Adrenergic Agents|adrenergic agents|mesh-ancestor
24634012|NCT01131780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24634013|NCT01131806|Fluticasone|fluticasone|mesh-list
24634015|NCT01131806|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24634016|NCT01131806|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24634039|NCT01131897|Anticonvulsants|anticonvulsants|mesh-ancestor
25072758|NCT03399526|Micronutrients|micronutrients|mesh-ancestor
25072759|NCT03399526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25072760|NCT03399487|Ceritinib|ceritinib|mesh-list
25072761|NCT03399487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25072762|NCT03399487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25072763|NCT03399487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25072764|NCT03399487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072765|NCT03399474|Lidocaine|lidocaine|mesh-list
25004930|NCT05201560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25004931|NCT05201560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004932|NCT05201560|Analgesics|analgesics|mesh-ancestor
25004933|NCT05201560|Sensory System Agents|sensory system agents|mesh-ancestor
25004934|NCT05201560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25004937|NCT05201560|Anesthetics, General|anesthetics, general|mesh-ancestor
25072766|NCT03399474|Dexmedetomidine|dexmedetomidine|mesh-list
25072767|NCT03399474|Anesthetics, Local|anesthetics, local|mesh-ancestor
25072768|NCT03399474|Anesthetics|anesthetics|mesh-ancestor
25072769|NCT03399474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25072770|NCT03399474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072771|NCT03399474|Sensory System Agents|sensory system agents|mesh-ancestor
24634418|NCT01133444|Urological Agents|urological agents|mesh-ancestor
25072772|NCT03399474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25072773|NCT03399474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25072774|NCT03399474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25072776|NCT03399474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25072777|NCT03399474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072778|NCT03399474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25072779|NCT03399474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25072780|NCT03399474|Analgesics|analgesics|mesh-ancestor
25072781|NCT03399474|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25072782|NCT03399474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25072783|NCT03399474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25072807|NCT03399435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25072808|NCT03399435|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25072809|NCT03399435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25072816|NCT03399435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25072817|NCT03399435|Respiratory System Agents|respiratory system agents|mesh-ancestor
25072818|NCT03399435|Mydriatics|mydriatics|mesh-ancestor
25072819|NCT03399435|Sympathomimetics|sympathomimetics|mesh-ancestor
25072820|NCT03399435|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25072821|NCT03399435|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25072822|NCT03399435|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25072823|NCT03399409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25072824|NCT03399201|Anesthetics|anesthetics|mesh-list
25072825|NCT03399201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25072826|NCT03399201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072827|NCT03399110|Capecitabine|capecitabine|mesh-list
25072828|NCT03399110|Oxaliplatin|oxaliplatin|mesh-list
25072829|NCT03399110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25072830|NCT03399110|Antimetabolites|antimetabolites|mesh-ancestor
25072831|NCT03399110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072832|NCT03399110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25072833|NCT03399032|Caspofungin|caspofungin|mesh-list
25072834|NCT03399032|Antifungal Agents|antifungal agents|mesh-ancestor
25072835|NCT03399032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25072836|NCT03399032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25072838|NCT03399019|Midazolam|midazolam|mesh-list
25072878|NCT03398941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25072879|NCT03398941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25072880|NCT03398876|Nicotine|nicotine|mesh-list
25072881|NCT03398876|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25072882|NCT03398876|Autonomic Agents|autonomic agents|mesh-ancestor
25072883|NCT03398876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24634042|NCT01131910|Immunologic Factors|immunologic factors|mesh-ancestor
24634043|NCT01131910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634044|NCT01131923|Amlodipine|amlodipine|mesh-list
24634045|NCT01131923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24634113|NCT01132157|Anesthetics, General|anesthetics, general|mesh-ancestor
24634116|NCT01132170|Valproic Acid|valproic acid|mesh-list
24634117|NCT01132170|Anticonvulsants|anticonvulsants|mesh-ancestor
24634118|NCT01132170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634119|NCT01132170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634120|NCT01132170|GABA Agents|gaba agents|mesh-ancestor
24634121|NCT01132170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24634122|NCT01132170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634131|NCT01132183|GABA Agents|gaba agents|mesh-ancestor
24634132|NCT01132183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25108101|NCT03134612|Sensory System Agents|sensory system agents|mesh-ancestor
25701728|NCT02144259|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25701729|NCT02144259|Medroxyprogesterone|medroxyprogesterone|mesh-list
25701730|NCT02144259|Etonogestrel|etonogestrel|mesh-list
25701731|NCT02144259|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25701732|NCT02144259|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25701733|NCT02144259|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24457414|NCT00334360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24457415|NCT00334360|Analgesics|analgesics|mesh-ancestor
24457416|NCT00334360|Sensory System Agents|sensory system agents|mesh-ancestor
24634133|NCT01132183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634134|NCT01132183|Antimanic Agents|antimanic agents|mesh-ancestor
24634135|NCT01132183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24634136|NCT01132183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24634137|NCT01132183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24634172|NCT01132222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24634173|NCT01132235|Etanercept|etanercept|mesh-list
24634240|NCT01132586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25072895|NCT03398837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072897|NCT03398837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25072898|NCT03398837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072899|NCT03398837|Hallucinogens|hallucinogens|mesh-ancestor
25072900|NCT03398837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25072901|NCT03398837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25072902|NCT03398837|Analgesics|analgesics|mesh-ancestor
25072906|NCT03398824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25072907|NCT03398824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072908|NCT03398811|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25072910|NCT03398811|Desogestrel|desogestrel|mesh-list
25072911|NCT03398811|Medroxyprogesterone|medroxyprogesterone|mesh-list
25072912|NCT03398811|Progesterone|progesterone|mesh-list
25072913|NCT03398811|Progestins|progestins|mesh-ancestor
25072914|NCT03398811|Hormones|hormones|mesh-ancestor
25072915|NCT03398811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25072916|NCT03398811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634275|NCT01132677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24634276|NCT01132677|Antiemetics|antiemetics|mesh-ancestor
24634277|NCT01132677|Autonomic Agents|autonomic agents|mesh-ancestor
24634278|NCT01132677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24634279|NCT01132677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634280|NCT01132677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24634281|NCT01132677|Glucocorticoids|glucocorticoids|mesh-ancestor
24634282|NCT01132677|Hormones|hormones|mesh-ancestor
24634283|NCT01132677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24634284|NCT01132677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24634285|NCT01132677|Protective Agents|protective agents|mesh-ancestor
24634286|NCT01132677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25072940|NCT03398785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25072941|NCT03398785|Respiratory System Agents|respiratory system agents|mesh-ancestor
25072943|NCT03398785|Sympathomimetics|sympathomimetics|mesh-ancestor
25072944|NCT03398785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25072945|NCT03398759|Butorphanol|butorphanol|mesh-list
25072946|NCT03398759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25072947|NCT03398759|Narcotics|narcotics|mesh-ancestor
25072948|NCT03398759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25072949|NCT03398759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25072950|NCT03398759|Analgesics|analgesics|mesh-ancestor
25072951|NCT03398759|Sensory System Agents|sensory system agents|mesh-ancestor
25072952|NCT03398759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25072953|NCT03398759|Antitussive Agents|antitussive agents|mesh-ancestor
25072954|NCT03398759|Respiratory System Agents|respiratory system agents|mesh-ancestor
25072955|NCT03398759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24835783|NCT02183389|Linagliptin|linagliptin|mesh-list
24634305|NCT01132768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24634306|NCT01132768|Sympatholytics|sympatholytics|mesh-ancestor
24634307|NCT01132768|Autonomic Agents|autonomic agents|mesh-ancestor
24634388|NCT01133353|Tetrabenazine|tetrabenazine|mesh-list
24634389|NCT01133353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24634390|NCT01133353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24634391|NCT01133353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24634392|NCT01133353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634394|NCT01133353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25701734|NCT02144259|Contraceptive Agents|contraceptive agents|mesh-ancestor
25701735|NCT02144259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25073131|NCT03397069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25072967|NCT03398434|Protease Inhibitors|protease inhibitors|mesh-ancestor
25072968|NCT03398434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25072969|NCT03398434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072970|NCT03398434|Anticoagulants|anticoagulants|mesh-ancestor
24958525|NCT03832465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24835806|NCT02183402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24835807|NCT02183402|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24634416|NCT01133444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24634417|NCT01133444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634420|NCT01133457|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24634421|NCT01133457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24634422|NCT01133457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634423|NCT01133457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634424|NCT01133457|Hormone Antagonists|hormone antagonists|mesh-ancestor
24634425|NCT01133457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24634426|NCT01133457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634427|NCT01133457|Urological Agents|urological agents|mesh-ancestor
24634551|NCT01133912|Mitosis Modulators|mitosis modulators|mesh-ancestor
24634552|NCT01133912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072980|NCT03398122|Apatinib|apatinib|mesh-list
25072981|NCT03398122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25072982|NCT03398122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25072983|NCT03398122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25072984|NCT03398122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072985|NCT03398083|Alprazolam|alprazolam|mesh-list
25072986|NCT03398083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25072987|NCT03398083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25072988|NCT03398083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634553|NCT01133912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24634554|NCT01133912|Antimetabolites|antimetabolites|mesh-ancestor
24634555|NCT01133912|Antiviral Agents|antiviral agents|mesh-ancestor
24634556|NCT01133912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24634557|NCT01133912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634562|NCT01133925|Sirolimus|sirolimus|mesh-list
24634580|NCT01134185|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24634581|NCT01134185|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24634582|NCT01134185|Serotonin Agents|serotonin agents|mesh-ancestor
24634583|NCT01134185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24634584|NCT01134185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634658|NCT01134484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24634659|NCT01134484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24634660|NCT01134484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24634661|NCT01134484|Immunologic Factors|immunologic factors|mesh-ancestor
24634662|NCT01134484|Leprostatic Agents|leprostatic agents|mesh-ancestor
24634663|NCT01134484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24634664|NCT01134484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24634665|NCT01134484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25073132|NCT03397069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25072989|NCT03398083|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25072990|NCT03398083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25072991|NCT03398083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25072992|NCT03398083|GABA Modulators|gaba modulators|mesh-ancestor
25072993|NCT03398083|GABA Agents|gaba agents|mesh-ancestor
25072994|NCT03398083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25072995|NCT03398083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25072996|NCT03398044|Dexamethasone|dexamethasone|mesh-list
25072997|NCT03398044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25072998|NCT03398044|Antiemetics|antiemetics|mesh-ancestor
25072999|NCT03398044|Autonomic Agents|autonomic agents|mesh-ancestor
25073000|NCT03398044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25073001|NCT03398044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073002|NCT03398044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25073003|NCT03398044|Glucocorticoids|glucocorticoids|mesh-ancestor
25073005|NCT03398044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25073006|NCT03398044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25073007|NCT03398044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073008|NCT03398031|Magnesium Oxide|magnesium oxide|mesh-list
25073009|NCT03398031|Antacids|antacids|mesh-ancestor
25073012|NCT03398018|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25073013|NCT03398018|Hormones|hormones|mesh-ancestor
25073014|NCT03398018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25073015|NCT03398018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073016|NCT03397992|Dialysis Solutions|dialysis solutions|mesh-list
25073017|NCT03397992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24835846|NCT02183441|Hormones|hormones|mesh-ancestor
24634695|NCT01134536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24634696|NCT01134666|Cetuximab|cetuximab|mesh-list
24634697|NCT01134666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24634698|NCT01134666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24634699|NCT01134692|Norfloxacin|norfloxacin|mesh-list
24634700|NCT01134692|Propranolol|propranolol|mesh-list
24634701|NCT01134692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25073027|NCT03397914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25073028|NCT03397914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25073029|NCT03397888|Betrixaban|betrixaban|mesh-list
25073030|NCT03397888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25073031|NCT03397888|Antithrombins|antithrombins|mesh-ancestor
25073032|NCT03397888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25073033|NCT03397888|Protease Inhibitors|protease inhibitors|mesh-ancestor
25073034|NCT03397888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073035|NCT03397888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073049|NCT03397862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073050|NCT03397862|Nootropic Agents|nootropic agents|mesh-ancestor
25073052|NCT03397797|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25073053|NCT03397797|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25073054|NCT03397797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25073055|NCT03397797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25073064|NCT03397615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25073065|NCT03397615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25073067|NCT03397537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073068|NCT03397537|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25073069|NCT03397537|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25073070|NCT03397537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073071|NCT03397537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073072|NCT03397537|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25073073|NCT03397537|Hormone Antagonists|hormone antagonists|mesh-ancestor
25073074|NCT03397537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25073075|NCT03397537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073076|NCT03397446|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25073077|NCT03397446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25073078|NCT03397446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073079|NCT03397446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25073080|NCT03397446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25073081|NCT03397446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25073082|NCT03397446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073083|NCT03397446|Dopamine Agents|dopamine agents|mesh-ancestor
25073089|NCT03397264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073090|NCT03397264|Growth Inhibitors|growth inhibitors|mesh-ancestor
25073091|NCT03397264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073092|NCT03397199|Apatinib|apatinib|mesh-list
25073093|NCT03397199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073094|NCT03397199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25073095|NCT03397199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073096|NCT03397199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073097|NCT03397186|Trabectedin|trabectedin|mesh-list
25073098|NCT03397186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25073099|NCT03397186|Alkylating Agents|alkylating agents|mesh-ancestor
25073100|NCT03397186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073101|NCT03397186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24954023|NCT03879837|Respiratory System Agents|respiratory system agents|mesh-ancestor
24954024|NCT03879837|Dermatologic Agents|dermatologic agents|mesh-ancestor
24954025|NCT03879837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24954026|NCT03879811|Nivolumab|nivolumab|mesh-list
24954027|NCT03879811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24954028|NCT03879811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24954029|NCT03879811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24954030|NCT03879811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954031|NCT03879707|Melatonin|melatonin|mesh-list
24954032|NCT03879707|Antioxidants|antioxidants|mesh-ancestor
24954033|NCT03879707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954034|NCT03879707|Protective Agents|protective agents|mesh-ancestor
24954035|NCT03879707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954036|NCT03879707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24954038|NCT03879746|Tamsulosin|tamsulosin|mesh-list
24954039|NCT03879746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24954040|NCT03879746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24954041|NCT03879746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24954042|NCT03879746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954043|NCT03879746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24954044|NCT03879746|Serotonin Agents|serotonin agents|mesh-ancestor
24954045|NCT03879746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954046|NCT03879746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24954047|NCT03879746|Antidepressive Agents|antidepressive agents|mesh-ancestor
24954048|NCT03879746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24954049|NCT03879746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24784714|NCT01910142|Vitamin K|vitamin k|mesh-list
25073118|NCT03397082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073119|NCT03397082|Sensory System Agents|sensory system agents|mesh-ancestor
25073120|NCT03397082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24634736|NCT01134848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634737|NCT01134848|Cholinergic Agents|cholinergic agents|mesh-ancestor
25073121|NCT03397082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25073124|NCT03397082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25073125|NCT03397082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073127|NCT03397069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25073128|NCT03397069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25073129|NCT03397069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25073130|NCT03397069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634741|NCT01134848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24634742|NCT01134848|Hormones|hormones|mesh-ancestor
25073150|NCT03396601|Sensory System Agents|sensory system agents|mesh-ancestor
25073151|NCT03396601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25073152|NCT03396601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073153|NCT03396601|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25073154|NCT03396601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25073155|NCT03396601|Anesthetics, General|anesthetics, general|mesh-ancestor
25073156|NCT03396601|Anesthetics|anesthetics|mesh-ancestor
25073157|NCT03396601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25073158|NCT03396601|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25073159|NCT03396601|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25073160|NCT03396601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25073161|NCT03396601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634923|NCT01135953|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24634924|NCT01135953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24634925|NCT01135953|Renal Agents|renal agents|mesh-ancestor
24634926|NCT01135953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24634927|NCT01135953|Antitubercular Agents|antitubercular agents|mesh-ancestor
24634928|NCT01135953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24634929|NCT01135953|Antimetabolites|antimetabolites|mesh-ancestor
24634930|NCT01135953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073181|NCT03396523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25073182|NCT03396523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25073183|NCT03396523|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25073184|NCT03396523|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25073185|NCT03396523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073186|NCT03396497|Pembrolizumab|pembrolizumab|mesh-list
25073187|NCT03396497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25073188|NCT03396497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073189|NCT03396484|Methyldopa|methyldopa|mesh-list
25073190|NCT03396484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25073191|NCT03396484|Sympatholytics|sympatholytics|mesh-ancestor
25073192|NCT03396484|Autonomic Agents|autonomic agents|mesh-ancestor
25073194|NCT03396484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073195|NCT03396484|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25073198|NCT03396484|Adrenergic Agents|adrenergic agents|mesh-ancestor
25073199|NCT03396484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24634944|NCT01136031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24634945|NCT01136031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634947|NCT01136213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24634948|NCT01136213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24634949|NCT01136213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24634950|NCT01136213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634951|NCT01136213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24634952|NCT01136213|Serotonin Agents|serotonin agents|mesh-ancestor
24634953|NCT01136213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073200|NCT03396484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073201|NCT03396393|Artenimol|artenimol|mesh-list
25073202|NCT03396393|Antimalarials|antimalarials|mesh-ancestor
25073203|NCT03396393|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25073207|NCT03396380|Vitamin D|vitamin d|mesh-list
24635028|NCT01136525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24635029|NCT01136538|Valacyclovir|valacyclovir|mesh-list
24635030|NCT01136538|Antiviral Agents|antiviral agents|mesh-ancestor
24635031|NCT01136538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24635032|NCT01136551|Huperzine A|huperzine a|mesh-list
24635033|NCT01136551|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24635034|NCT01136551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635035|NCT01136551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635036|NCT01136551|Cholinergic Agents|cholinergic agents|mesh-ancestor
24635037|NCT01136551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24635038|NCT01136551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635039|NCT01136551|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24635040|NCT01136551|Protective Agents|protective agents|mesh-ancestor
24635058|NCT01136759|Antiviral Agents|antiviral agents|mesh-ancestor
24635059|NCT01136759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24635060|NCT01136759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24635061|NCT01136759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25073222|NCT03396380|Sequestering Agents|sequestering agents|mesh-ancestor
25073223|NCT03396380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073224|NCT03396380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25073225|NCT03396380|Hormone Antagonists|hormone antagonists|mesh-ancestor
25073226|NCT03396380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25073227|NCT03396380|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25073228|NCT03396380|Fertility Agents|fertility agents|mesh-ancestor
25073229|NCT03396380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25073230|NCT03396380|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24635076|NCT01136850|Antimalarials|antimalarials|mesh-ancestor
24635077|NCT01136850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24635078|NCT01136850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24635079|NCT01136850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635080|NCT01136850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635081|NCT01136850|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24635082|NCT01136850|Renal Agents|renal agents|mesh-ancestor
24635084|NCT01136863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24635085|NCT01136863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24635092|NCT01136941|Zileuton|zileuton|mesh-list
24635101|NCT01136941|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24635102|NCT01136941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635103|NCT01136941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635104|NCT01136941|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24635105|NCT01136941|Hormone Antagonists|hormone antagonists|mesh-ancestor
24635186|NCT01137695|Pramlintide|pramlintide|mesh-list
24635189|NCT01137695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635190|NCT01137695|Appetite Depressants|appetite depressants|mesh-ancestor
24635191|NCT01137695|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24635192|NCT01137695|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
24635193|NCT01137695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635194|NCT01137708|Levonorgestrel|levonorgestrel|mesh-list
24635195|NCT01137708|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24635196|NCT01137708|Tofacitinib|tofacitinib|mesh-list
24635197|NCT01137708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24635198|NCT01137708|Contraceptive Agents|contraceptive agents|mesh-ancestor
24635199|NCT01137708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24635200|NCT01137708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635201|NCT01137708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24635202|NCT01137708|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24635203|NCT01137708|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24635204|NCT01137708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24635205|NCT01137708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635252|NCT01137942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24635253|NCT01137942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25073257|NCT03396250|Autonomic Agents|autonomic agents|mesh-ancestor
25073258|NCT03396250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25073259|NCT03396250|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25073260|NCT03396250|Histamine Antagonists|histamine antagonists|mesh-ancestor
25073261|NCT03396250|Histamine Agents|histamine agents|mesh-ancestor
25073262|NCT03396250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25073263|NCT03396250|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25073264|NCT03396250|Antipruritics|antipruritics|mesh-ancestor
25073265|NCT03396250|Dermatologic Agents|dermatologic agents|mesh-ancestor
24836123|NCT02184247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635270|NCT01137994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24635280|NCT01138072|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24635281|NCT01138072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635283|NCT01138085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24635284|NCT01138085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24635411|NCT01139138|Irinotecan|irinotecan|mesh-list
24635412|NCT01139138|Everolimus|everolimus|mesh-list
24635431|NCT01139151|Immunologic Factors|immunologic factors|mesh-ancestor
24635432|NCT01139151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635433|NCT01139203|Lamivudine|lamivudine|mesh-list
24635434|NCT01139203|Adefovir|adefovir|mesh-list
24635435|NCT01139203|Entecavir|entecavir|mesh-list
24635436|NCT01139203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24635438|NCT01139203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073303|NCT03395912|Anesthetics|anesthetics|mesh-list
25073304|NCT03395912|Anesthetics, Local|anesthetics, local|mesh-list
25073305|NCT03395912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25073306|NCT03395912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073307|NCT03395912|Sensory System Agents|sensory system agents|mesh-ancestor
25073308|NCT03395912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24635515|NCT01139840|Cholecalciferol|cholecalciferol|mesh-list
24635516|NCT01139840|Vitamins|vitamins|mesh-list
24635517|NCT01139840|Micronutrients|micronutrients|mesh-ancestor
24635530|NCT01139905|Antiviral Agents|antiviral agents|mesh-ancestor
24635531|NCT01139905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24635532|NCT01139905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24635533|NCT01139905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24635534|NCT01140009|Vaccines|vaccines|mesh-list
24635535|NCT01140009|Immunologic Factors|immunologic factors|mesh-ancestor
24635536|NCT01140009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635537|NCT01140035|Insulin|insulin|mesh-list
24635538|NCT01140035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24635539|NCT01140035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635540|NCT01140074|Zinc Sulfate|zinc sulfate|mesh-list
24635541|NCT01140074|Astringents|astringents|mesh-ancestor
24635542|NCT01140074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635543|NCT01140074|Dermatologic Agents|dermatologic agents|mesh-ancestor
24635566|NCT01140308|Micronutrients|micronutrients|mesh-ancestor
24635567|NCT01140308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635568|NCT01140308|Vitamins|vitamins|mesh-ancestor
24635600|NCT01140412|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25005110|NCT04856176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25005111|NCT04856176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25005112|NCT04856176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25073373|NCT03395262|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25073374|NCT03395262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073375|NCT03395262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25073376|NCT03395262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073377|NCT03395262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073378|NCT03395262|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25073380|NCT03395262|Purinergic Agents|purinergic agents|mesh-ancestor
25073382|NCT03395223|Methylene Blue|methylene blue|mesh-list
25073384|NCT03395223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073386|NCT03395171|Cholecalciferol|cholecalciferol|mesh-list
25073387|NCT03395171|Vitamins|vitamins|mesh-ancestor
25073388|NCT03395171|Micronutrients|micronutrients|mesh-ancestor
25073389|NCT03395171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073390|NCT03395171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25073391|NCT03395171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25073392|NCT03395132|Fusidic Acid|fusidic acid|mesh-list
25073393|NCT03395132|Betamethasone|betamethasone|mesh-list
25073394|NCT03395132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25073395|NCT03395132|Glucocorticoids|glucocorticoids|mesh-ancestor
25073396|NCT03395132|Hormones|hormones|mesh-ancestor
25073397|NCT03395132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25073398|NCT03395132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073399|NCT03395132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24635664|NCT01140620|Anesthetics, General|anesthetics, general|mesh-ancestor
24635679|NCT01140737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24635680|NCT01140737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24635681|NCT01140737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635682|NCT01140737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635683|NCT01140828|Rabeprazole|rabeprazole|mesh-list
24635684|NCT01140828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24635685|NCT01140828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24635686|NCT01140828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24635687|NCT01140828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073400|NCT03395132|Respiratory System Agents|respiratory system agents|mesh-ancestor
24959009|NCT03828032|Mannitol|mannitol|mesh-list
24954051|NCT03879746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24954052|NCT03879746|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24954053|NCT03879746|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24954054|NCT03879746|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24635738|NCT01140984|Hormones|hormones|mesh-ancestor
24635759|NCT01141036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24635761|NCT01141036|GABA Agents|gaba agents|mesh-ancestor
24635762|NCT01141036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24635796|NCT01141192|Vitamins|vitamins|mesh-ancestor
24635797|NCT01141192|Micronutrients|micronutrients|mesh-ancestor
24635798|NCT01141192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635799|NCT01141192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24635800|NCT01141192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24635801|NCT01141244|Sirolimus|sirolimus|mesh-list
24635802|NCT01141244|Irinotecan|irinotecan|mesh-list
24635803|NCT01141244|Temozolomide|temozolomide|mesh-list
24635804|NCT01141244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24635807|NCT01141244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701736|NCT02144259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701737|NCT02144259|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25701738|NCT02144259|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25701739|NCT02144259|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25701740|NCT02144259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24635844|NCT01141452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24635845|NCT01141452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24635846|NCT01141452|Autonomic Agents|autonomic agents|mesh-ancestor
24635847|NCT01141452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24635848|NCT01141452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635863|NCT01141465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24635881|NCT01141465|Sympathomimetics|sympathomimetics|mesh-ancestor
24954068|NCT03879590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24954069|NCT03879590|Antitussive Agents|antitussive agents|mesh-ancestor
25073401|NCT03395132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25073402|NCT03395132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25073403|NCT03395132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25073404|NCT03395132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073405|NCT03395132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073407|NCT03395093|Midazolam|midazolam|mesh-list
25073408|NCT03395093|Propofol|propofol|mesh-list
25073409|NCT03395093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25073410|NCT03395093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25073411|NCT03395093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073412|NCT03395093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25073413|NCT03395093|Anesthetics, General|anesthetics, general|mesh-ancestor
25073414|NCT03395093|Anesthetics|anesthetics|mesh-ancestor
24836297|NCT02185118|Sevoflurane|sevoflurane|mesh-list
24635882|NCT01141543|Plerixafor|plerixafor|mesh-list
24635883|NCT01141543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24635884|NCT01141543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24635885|NCT01141543|Antiviral Agents|antiviral agents|mesh-ancestor
24635886|NCT01141543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24635999|NCT01142401|Bortezomib|bortezomib|mesh-list
24636000|NCT01142401|Fulvestrant|fulvestrant|mesh-list
24636001|NCT01142401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24636004|NCT01142401|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24636005|NCT01142401|Hormone Antagonists|hormone antagonists|mesh-ancestor
24636006|NCT01142401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24636007|NCT01142401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636008|NCT01142414|Fluorouracil|fluorouracil|mesh-list
24636009|NCT01142414|Panitumumab|panitumumab|mesh-list
24636010|NCT01142414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24636011|NCT01142414|Antimetabolites|antimetabolites|mesh-ancestor
24636107|NCT01142778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24636108|NCT01142778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24636111|NCT01142778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636112|NCT01142778|Growth Inhibitors|growth inhibitors|mesh-ancestor
24636113|NCT01142778|Tubulin Modulators|tubulin modulators|mesh-ancestor
24636114|NCT01142778|Antimitotic Agents|antimitotic agents|mesh-ancestor
24636115|NCT01142778|Mitosis Modulators|mitosis modulators|mesh-ancestor
24636116|NCT01142778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636118|NCT01142843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24636162|NCT01143545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24636174|NCT01143584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636176|NCT01143584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24518712|NCT04472637|Atorvastatin|atorvastatin|mesh-list
24518713|NCT04472637|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24518714|NCT04472637|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24518715|NCT04472637|Antimetabolites|antimetabolites|mesh-ancestor
24518746|NCT04417049|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24518872|NCT04094961|BB 1101|bb 1101|mesh-list
24519312|NCT02224144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24519313|NCT02224144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24519314|NCT02224144|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24519315|NCT02224144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24519316|NCT02224144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519317|NCT02224144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24519497|NCT05333250|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24636177|NCT01143584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636178|NCT01143584|Protective Agents|protective agents|mesh-ancestor
24636250|NCT01144169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24636251|NCT01144169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24636252|NCT01144169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24636253|NCT01144169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636254|NCT01144169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636255|NCT01144169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24636257|NCT01144195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24636258|NCT01144195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24636259|NCT01144260|Bafetinib|bafetinib|mesh-list
24636260|NCT01144260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24636261|NCT01144260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666254|NCT01318161|Anesthetics|anesthetics|mesh-ancestor
24636264|NCT01144312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24636265|NCT01144312|Narcotics|narcotics|mesh-ancestor
24636266|NCT01144312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24636267|NCT01144312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636269|NCT01144312|Sensory System Agents|sensory system agents|mesh-ancestor
25073426|NCT03395093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25073436|NCT03395002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25073437|NCT03395002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25073438|NCT03395002|Autonomic Agents|autonomic agents|mesh-ancestor
25073439|NCT03395002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25073440|NCT03395002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073441|NCT03395002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25073442|NCT03395002|Respiratory System Agents|respiratory system agents|mesh-ancestor
25073443|NCT03395002|Dermatologic Agents|dermatologic agents|mesh-ancestor
25073444|NCT03395002|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25073445|NCT03395002|Parasympatholytics|parasympatholytics|mesh-ancestor
24636270|NCT01144312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24636271|NCT01144312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24636272|NCT01144312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24636273|NCT01144312|Anesthetics, General|anesthetics, general|mesh-ancestor
24636274|NCT01144312|Anesthetics|anesthetics|mesh-ancestor
24636276|NCT01144390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24636277|NCT01144390|Narcotics|narcotics|mesh-ancestor
24636278|NCT01144390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24636279|NCT01144390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636280|NCT01144390|Analgesics|analgesics|mesh-ancestor
24636281|NCT01144390|Sensory System Agents|sensory system agents|mesh-ancestor
24636283|NCT01144390|Antitussive Agents|antitussive agents|mesh-ancestor
25073449|NCT03395002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701741|NCT02144259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25701742|NCT02139540|Nitrous Oxide|nitrous oxide|mesh-list
25701743|NCT02139540|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25701744|NCT02139540|Anesthetics, General|anesthetics, general|mesh-ancestor
25701745|NCT02139540|Anesthetics|anesthetics|mesh-ancestor
25701746|NCT02139540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25701747|NCT02139540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701748|NCT02139540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25701749|NCT02139540|Analgesics|analgesics|mesh-ancestor
25701750|NCT02139540|Sensory System Agents|sensory system agents|mesh-ancestor
25701751|NCT02139540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25701752|NCT02144675|Cytarabine|cytarabine|mesh-list
25701753|NCT02144675|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
25701754|NCT02144675|Salicylates|salicylates|mesh-list
25073450|NCT03395002|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25073451|NCT03395002|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25073452|NCT03395002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25073453|NCT03395002|Adrenergic Agents|adrenergic agents|mesh-ancestor
25073454|NCT03394989|Fluticasone|fluticasone|mesh-list
24836337|NCT02185326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24836338|NCT02185326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836339|NCT02185352|Cisplatin|cisplatin|mesh-list
24836340|NCT02185352|Etoposide|etoposide|mesh-list
24836341|NCT02185352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24636353|NCT01144923|Sensory System Agents|sensory system agents|mesh-ancestor
24636354|NCT01144923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24636460|NCT01145612|Sympatholytics|sympatholytics|mesh-ancestor
24636461|NCT01145612|Autonomic Agents|autonomic agents|mesh-ancestor
24636462|NCT01145612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24636463|NCT01145612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636533|NCT01145976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073456|NCT03394989|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25073457|NCT03394989|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24959034|NCT03828084|Decitabine|decitabine|mesh-list
25073458|NCT03394989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25073459|NCT03394989|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25073460|NCT03394989|Autonomic Agents|autonomic agents|mesh-ancestor
25073461|NCT03394989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25073462|NCT03394989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073463|NCT03394989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25073464|NCT03394989|Respiratory System Agents|respiratory system agents|mesh-ancestor
25073465|NCT03394989|Dermatologic Agents|dermatologic agents|mesh-ancestor
25073466|NCT03394989|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25073467|NCT03394989|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25073468|NCT03394989|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25073469|NCT03394989|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25073470|NCT03394989|Adrenergic Agents|adrenergic agents|mesh-ancestor
25073480|NCT03394950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073481|NCT03394833|Polygeline|polygeline|mesh-list
25073482|NCT03394833|Plasma Substitutes|plasma substitutes|mesh-ancestor
25073483|NCT03394833|Blood Substitutes|blood substitutes|mesh-ancestor
25073484|NCT03394820|Dexamethasone|dexamethasone|mesh-list
25073485|NCT03394820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25073486|NCT03394820|Antiemetics|antiemetics|mesh-ancestor
25073488|NCT03394820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25073489|NCT03394820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073490|NCT03394820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25073491|NCT03394820|Glucocorticoids|glucocorticoids|mesh-ancestor
25073492|NCT03394820|Hormones|hormones|mesh-ancestor
25073493|NCT03394820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25073494|NCT03394820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25073495|NCT03394820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073496|NCT03394807|Levobupivacaine|levobupivacaine|mesh-list
25073497|NCT03394807|Anesthetics, Local|anesthetics, local|mesh-ancestor
25073498|NCT03394807|Anesthetics|anesthetics|mesh-ancestor
25073499|NCT03394807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25073500|NCT03394807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836390|NCT02185651|Miglustat|miglustat|mesh-list
24636759|NCT01147146|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24636760|NCT01147146|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24636761|NCT01147146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24636762|NCT01147146|Cholinergic Agents|cholinergic agents|mesh-ancestor
24636801|NCT01147432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24636802|NCT01147432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636803|NCT01147510|Montelukast|montelukast|mesh-list
24636804|NCT01147510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24636805|NCT01147510|Respiratory System Agents|respiratory system agents|mesh-ancestor
24636806|NCT01147510|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24636807|NCT01147510|Hormone Antagonists|hormone antagonists|mesh-ancestor
24636808|NCT01147510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24636809|NCT01147510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636900|NCT01148004|Fenofibrate|fenofibrate|mesh-list
24636902|NCT01148004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25701755|NCT02144675|Idarubicin|idarubicin|mesh-list
25701756|NCT02144675|Choline|choline|mesh-list
25701757|NCT02144675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25701758|NCT02144675|Antimetabolites|antimetabolites|mesh-ancestor
25701759|NCT02144675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701760|NCT02144675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25701761|NCT02144675|Antiviral Agents|antiviral agents|mesh-ancestor
24636903|NCT01148004|Protease Inhibitors|protease inhibitors|mesh-ancestor
24636904|NCT01148004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073507|NCT03394586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25073508|NCT03394586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25073509|NCT03394586|Immunologic Factors|immunologic factors|mesh-ancestor
25073510|NCT03394586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073512|NCT03394573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25073513|NCT03394573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25073514|NCT03394573|Growth Substances|growth substances|mesh-ancestor
25073515|NCT03394573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073516|NCT03394573|Growth Inhibitors|growth inhibitors|mesh-ancestor
25073517|NCT03394573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073519|NCT03394430|Dexmedetomidine|dexmedetomidine|mesh-list
25073520|NCT03394430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25073521|NCT03394430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25073522|NCT03394430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073523|NCT03394430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25073524|NCT03394430|Analgesics|analgesics|mesh-ancestor
25073525|NCT03394430|Sensory System Agents|sensory system agents|mesh-ancestor
25073526|NCT03394430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25073527|NCT03394430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25073528|NCT03394430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25073529|NCT03394430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25073530|NCT03394430|Adrenergic Agents|adrenergic agents|mesh-ancestor
25073531|NCT03394430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25073532|NCT03394430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073533|NCT03394430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24836395|NCT02185651|Antiviral Agents|antiviral agents|mesh-ancestor
24836396|NCT02185651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24836397|NCT02185651|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24836398|NCT02185651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24636926|NCT01148147|Analgesics|analgesics|mesh-ancestor
24636927|NCT01148147|Sensory System Agents|sensory system agents|mesh-ancestor
24636928|NCT01148147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24636929|NCT01148147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073534|NCT03394430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25073535|NCT03394430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25073536|NCT03394430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25073537|NCT03394430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25073538|NCT03394430|Anesthetics, General|anesthetics, general|mesh-ancestor
25073540|NCT03394430|GABA Modulators|gaba modulators|mesh-ancestor
25073541|NCT03394430|GABA Agents|gaba agents|mesh-ancestor
25073542|NCT03394287|Apatinib|apatinib|mesh-list
25073543|NCT03394287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073544|NCT03394287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25073545|NCT03394287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836422|NCT02185833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24836423|NCT02185833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24836424|NCT02185846|Dirithromycin|dirithromycin|mesh-list
24836425|NCT02185846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24836426|NCT02185846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24836427|NCT02185859|Lidocaine|lidocaine|mesh-list
24636930|NCT01148147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24636931|NCT01148147|Vasodilator Agents|vasodilator agents|mesh-ancestor
24636932|NCT01148147|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24636933|NCT01148147|Purinergic Agonists|purinergic agonists|mesh-ancestor
24636934|NCT01148147|Purinergic Agents|purinergic agents|mesh-ancestor
24636935|NCT01148147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24636937|NCT01148160|Voriconazole|voriconazole|mesh-list
24636971|NCT01148264|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24636972|NCT01148264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24636973|NCT01148264|Dopamine Agents|dopamine agents|mesh-ancestor
24637032|NCT01148342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24637033|NCT01148342|Adrenergic Agents|adrenergic agents|mesh-ancestor
24637035|NCT01148446|Cyclophosphamide|cyclophosphamide|mesh-list
24637037|NCT01148446|Doxorubicin|doxorubicin|mesh-list
24637038|NCT01148446|Vincristine|vincristine|mesh-list
25701762|NCT02144675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24637040|NCT01148446|Vinblastine|vinblastine|mesh-list
24637041|NCT01148446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24528661|NCT00622141|Antiviral Agents|antiviral agents|mesh-ancestor
24528662|NCT00622141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24528663|NCT00622141|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24637091|NCT01148576|Protective Agents|protective agents|mesh-ancestor
24637094|NCT01148576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24637095|NCT01148576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24637096|NCT01148576|Antimetabolites|antimetabolites|mesh-ancestor
24637097|NCT01148576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24637098|NCT01148576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24637099|NCT01148576|Antitubercular Agents|antitubercular agents|mesh-ancestor
24637100|NCT01148576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24637101|NCT01148576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24637103|NCT01148615|Aflibercept|aflibercept|mesh-list
24637104|NCT01148615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637105|NCT01148615|Tubulin Modulators|tubulin modulators|mesh-ancestor
25073546|NCT03394287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073547|NCT03394222|Budesonide|budesonide|mesh-list
25073548|NCT03394222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24637158|NCT01149018|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24637159|NCT01149018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24637161|NCT01149018|Hormones|hormones|mesh-ancestor
24637196|NCT01149278|Anesthetics, Local|anesthetics, local|mesh-ancestor
24637197|NCT01149278|Anesthetics|anesthetics|mesh-ancestor
24637198|NCT01149278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24637199|NCT01149278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637200|NCT01149278|Sensory System Agents|sensory system agents|mesh-ancestor
24637203|NCT01149304|Pentoxifylline|pentoxifylline|mesh-list
24637386|NCT01149980|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24637389|NCT01149980|Autonomic Agents|autonomic agents|mesh-ancestor
24637398|NCT01149993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637399|NCT01149993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24637400|NCT01149993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24637401|NCT01149993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637402|NCT01149993|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24637403|NCT01149993|Antitubercular Agents|antitubercular agents|mesh-ancestor
24637404|NCT01149993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24637405|NCT01149993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24637406|NCT01149993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637407|NCT01149993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637408|NCT01150110|Salicylic Acid|salicylic acid|mesh-list
24637460|NCT01150448|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24637461|NCT01150448|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24637462|NCT01150448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24637463|NCT01150448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637464|NCT01150448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24637465|NCT01150448|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24637466|NCT01150448|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24637467|NCT01150448|Serotonin Agents|serotonin agents|mesh-ancestor
24637468|NCT01150448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24637548|NCT01151306|Antimetabolites|antimetabolites|mesh-ancestor
24637549|NCT01151306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637550|NCT01151306|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24637552|NCT01151306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073576|NCT03394196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073577|NCT03394196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25073578|NCT03394196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25073579|NCT03394196|Antiviral Agents|antiviral agents|mesh-ancestor
25073580|NCT03394196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25073581|NCT03394196|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25073582|NCT03394196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25073583|NCT03394196|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24474283|NCT00405431|Lubricant Eye Drops|lubricant eye drops|mesh-list
25701763|NCT02144675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25701764|NCT02144675|Immunologic Factors|immunologic factors|mesh-ancestor
25701765|NCT02144675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701766|NCT02144675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25701767|NCT02144675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25701768|NCT02144675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25701769|NCT02144675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25701770|NCT02144675|Lipotropic Agents|lipotropic agents|mesh-ancestor
25701771|NCT02144675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25701772|NCT02144675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25701773|NCT02144675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25701774|NCT02144675|Nootropic Agents|nootropic agents|mesh-ancestor
24530027|NCT00628732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530028|NCT00628810|Leucovorin|leucovorin|mesh-list
25073584|NCT03394196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25073585|NCT03394196|Antimetabolites|antimetabolites|mesh-ancestor
25073586|NCT03394196|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25073587|NCT03394196|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25073588|NCT03394144|Durvalumab|durvalumab|mesh-list
25073589|NCT03394144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25073590|NCT03394144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073591|NCT03394131|Insulin|insulin|mesh-list
24637639|NCT01151878|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
24637641|NCT01151878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24637642|NCT01151943|Anesthetics|anesthetics|mesh-list
24637643|NCT01151943|Anesthetics, Local|anesthetics, local|mesh-list
24637644|NCT01151943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24637645|NCT01151943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637646|NCT01151943|Sensory System Agents|sensory system agents|mesh-ancestor
24637649|NCT01152047|Oxytocics|oxytocics|mesh-ancestor
24637679|NCT01152476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24637680|NCT01152476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637681|NCT01152476|Analgesics|analgesics|mesh-ancestor
24637682|NCT01152476|Sensory System Agents|sensory system agents|mesh-ancestor
24637683|NCT01152476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24637684|NCT01152593|Mupirocin|mupirocin|mesh-list
24637686|NCT01152593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24637687|NCT01152593|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24637688|NCT01152593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637689|NCT01152593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637690|NCT01152606|Trastuzumab|trastuzumab|mesh-list
24637691|NCT01152606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24637692|NCT01152606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637693|NCT01152710|Capecitabine|capecitabine|mesh-list
24637694|NCT01152710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24637695|NCT01152710|Antimetabolites|antimetabolites|mesh-ancestor
24637696|NCT01152710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073603|NCT03394105|Antimitotic Agents|antimitotic agents|mesh-ancestor
25073604|NCT03394105|Mitosis Modulators|mitosis modulators|mesh-ancestor
25073605|NCT03394105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073606|NCT03394001|Ketorolac|ketorolac|mesh-list
25073607|NCT03394001|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25073608|NCT03394001|Lidocaine|lidocaine|mesh-list
25073609|NCT03394001|Anesthetics, Local|anesthetics, local|mesh-ancestor
24637854|NCT01153386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24637855|NCT01153542|Ivacaftor|ivacaftor|mesh-list
24637856|NCT01153542|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24637857|NCT01153542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24637858|NCT01153542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637859|NCT01153568|Vitamin D|vitamin d|mesh-list
24637860|NCT01153568|Cholecalciferol|cholecalciferol|mesh-list
24637861|NCT01153568|Vitamins|vitamins|mesh-ancestor
24637862|NCT01153568|Micronutrients|micronutrients|mesh-ancestor
24637863|NCT01153568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637864|NCT01153568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24637866|NCT01153659|Esomeprazole|esomeprazole|mesh-list
24637867|NCT01153659|Rabeprazole|rabeprazole|mesh-list
24637868|NCT01153659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24637958|NCT01154387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637959|NCT01154387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24637960|NCT01154387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637961|NCT01154387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637962|NCT01154387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24637964|NCT01154387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24637965|NCT01154387|Antitubercular Agents|antitubercular agents|mesh-ancestor
24637966|NCT01154387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25073610|NCT03394001|Anesthetics|anesthetics|mesh-ancestor
25073611|NCT03394001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25073612|NCT03394001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073613|NCT03394001|Sensory System Agents|sensory system agents|mesh-ancestor
24474284|NCT00405431|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25701775|NCT02144675|Analgesics|analgesics|mesh-ancestor
25701776|NCT02144675|Sensory System Agents|sensory system agents|mesh-ancestor
25701777|NCT02144675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25073615|NCT03394001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25073616|NCT03394001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25073617|NCT03394001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25073618|NCT03394001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25073619|NCT03394001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073620|NCT03394001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25073621|NCT03394001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24638041|NCT01154647|Serotonin Agents|serotonin agents|mesh-ancestor
24638042|NCT01154647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638043|NCT01154647|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24638044|NCT01154647|Antidepressive Agents|antidepressive agents|mesh-ancestor
24638045|NCT01154647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24638046|NCT01154738|Lidocaine|lidocaine|mesh-list
24638047|NCT01154738|Anesthetics, Local|anesthetics, local|mesh-ancestor
24638085|NCT01154803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638087|NCT01154829|Amisulpride|amisulpride|mesh-list
24638088|NCT01154829|Antidepressive Agents|antidepressive agents|mesh-ancestor
24638150|NCT01155089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24638186|NCT01155206|Glucagon|glucagon|mesh-list
24638187|NCT01155206|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24638188|NCT01155206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24638189|NCT01155206|Hormones|hormones|mesh-ancestor
24638190|NCT01155206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24638191|NCT01155206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638192|NCT01155206|Incretins|incretins|mesh-ancestor
24638193|NCT01155232|Teriparatide|teriparatide|mesh-list
24638194|NCT01155232|Parathyroid Hormone|parathyroid hormone|mesh-list
24638195|NCT01155232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638196|NCT01155232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24638233|NCT01155453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638245|NCT01155635|Adrenergic Agents|adrenergic agents|mesh-ancestor
24638246|NCT01155635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24638247|NCT01155635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638248|NCT01155635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638249|NCT01155635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24638251|NCT01155635|Protective Agents|protective agents|mesh-ancestor
24638252|NCT01155635|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24638253|NCT01155635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24638254|NCT01155635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24638255|NCT01155635|Vasodilator Agents|vasodilator agents|mesh-ancestor
24638256|NCT01155635|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24432917|NCT00257023|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24638257|NCT01155635|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24638279|NCT01155791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24638282|NCT01155791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24638283|NCT01155791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638284|NCT01155791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24638286|NCT01155895|Benazepril|benazepril|mesh-list
24638287|NCT01155895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25073687|NCT03393767|Growth Substances|growth substances|mesh-ancestor
25073688|NCT03393767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073689|NCT03393767|Growth Inhibitors|growth inhibitors|mesh-ancestor
24638338|NCT01155947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24638339|NCT01155947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638340|NCT01155947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24638341|NCT01155947|Hormone Antagonists|hormone antagonists|mesh-ancestor
24638342|NCT01155947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24638343|NCT01155947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638344|NCT01155960|Anastrozole|anastrozole|mesh-list
24638345|NCT01155960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24638346|NCT01155960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638347|NCT01155960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24638348|NCT01155960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24638349|NCT01155960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073693|NCT03393728|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25073694|NCT03393728|Adrenergic Agents|adrenergic agents|mesh-ancestor
25073695|NCT03393728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25073696|NCT03393728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073697|NCT03393728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073698|NCT03393728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25073699|NCT03393728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25073700|NCT03393728|Vasodilator Agents|vasodilator agents|mesh-ancestor
24638366|NCT01155986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638367|NCT01156077|Tedizolid phosphate|tedizolid phosphate|mesh-list
24638368|NCT01156077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24954070|NCT03879590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24954072|NCT03879590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954073|NCT03879460|Naltrexone|naltrexone|mesh-list
24779762|NCT01878643|Vancomycin|vancomycin|mesh-list
24954075|NCT03879460|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24954076|NCT03879460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954077|NCT03879460|Sensory System Agents|sensory system agents|mesh-ancestor
24954078|NCT03879460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24954079|NCT03879564|Ketamine|ketamine|mesh-list
24954080|NCT03879564|Analgesics|analgesics|mesh-ancestor
24954081|NCT03879564|Sensory System Agents|sensory system agents|mesh-ancestor
24954082|NCT03879564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24954083|NCT03879564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954084|NCT03879564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24954085|NCT03879564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24954086|NCT03879564|Anesthetics, General|anesthetics, general|mesh-ancestor
24638369|NCT01156077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24638370|NCT01156129|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
24638371|NCT01156129|Antidiarrheals|antidiarrheals|mesh-ancestor
24638372|NCT01156129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24638373|NCT01156233|Anesthetics|anesthetics|mesh-list
24638374|NCT01156233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24638375|NCT01156233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638377|NCT01156246|Dapagliflozin|dapagliflozin|mesh-list
24638378|NCT01156246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24638379|NCT01156246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638391|NCT01156350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24638408|NCT01156389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24638409|NCT01156389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638411|NCT01156389|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24638412|NCT01156389|Anthelmintics|anthelmintics|mesh-ancestor
24638413|NCT01156519|Hydrocortisone|hydrocortisone|mesh-list
24638414|NCT01156519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24638415|NCT01156584|Flucytosine|flucytosine|mesh-list
24638416|NCT01156584|Antifungal Agents|antifungal agents|mesh-ancestor
24638417|NCT01156584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24638418|NCT01156584|Antimetabolites|antimetabolites|mesh-ancestor
24638438|NCT01156688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638454|NCT01156779|Incretins|incretins|mesh-ancestor
24666871|NCT01321255|Antipyretics|antipyretics|mesh-ancestor
24638505|NCT01156883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24638506|NCT01156883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24638507|NCT01156883|Antimetabolites|antimetabolites|mesh-ancestor
24638508|NCT01156883|Dermatologic Agents|dermatologic agents|mesh-ancestor
24638528|NCT01156922|Immunologic Factors|immunologic factors|mesh-ancestor
24638529|NCT01156922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638530|NCT01156922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24638532|NCT01156948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24954113|NCT03879382|Cyclophosphamide|cyclophosphamide|mesh-list
24954114|NCT03879382|Fludarabine|fludarabine|mesh-list
25073720|NCT03393702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638593|NCT01157247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24638595|NCT01157247|Analgesics|analgesics|mesh-ancestor
24638596|NCT01157247|Sensory System Agents|sensory system agents|mesh-ancestor
24638597|NCT01157247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24638598|NCT01157247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24638599|NCT01157247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24638600|NCT01157247|Anesthetics, General|anesthetics, general|mesh-ancestor
24638601|NCT01157312|Citric Acid|citric acid|mesh-list
24638602|NCT01157312|Sodium Citrate|sodium citrate|mesh-list
24638603|NCT01157312|Clomiphene|clomiphene|mesh-list
24638615|NCT01157312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24638616|NCT01157312|Fertility Agents|fertility agents|mesh-ancestor
24638617|NCT01157312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25073728|NCT03393572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073729|NCT03393572|Sensory System Agents|sensory system agents|mesh-ancestor
25073730|NCT03393572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25073731|NCT03393572|Analgesics|analgesics|mesh-ancestor
25073733|NCT03393572|Anticonvulsants|anticonvulsants|mesh-ancestor
24638694|NCT01157559|Dopamine Agents|dopamine agents|mesh-ancestor
24638696|NCT01157572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24638697|NCT01157572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24638698|NCT01157572|Sympatholytics|sympatholytics|mesh-ancestor
25073748|NCT03393481|Anticoagulants|anticoagulants|mesh-ancestor
25073749|NCT03393481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25073750|NCT03393481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25073751|NCT03393481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073752|NCT03393416|Antibodies|antibodies|mesh-list
25073753|NCT03393416|Immunologic Factors|immunologic factors|mesh-ancestor
24638787|NCT01158144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24638788|NCT01158144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24638789|NCT01158144|Growth Substances|growth substances|mesh-ancestor
24638790|NCT01158144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638791|NCT01158144|Growth Inhibitors|growth inhibitors|mesh-ancestor
24638792|NCT01158170|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24638793|NCT01158170|Gefitinib|gefitinib|mesh-list
24638794|NCT01158170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638795|NCT01158170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24638796|NCT01158170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24638797|NCT01158170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638798|NCT01158183|Interferons|interferons|mesh-list
24638799|NCT01158183|Interferon-beta|interferon-beta|mesh-list
24638821|NCT01158287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638822|NCT01158365|Glycerol|glycerol|mesh-list
24638823|NCT01158365|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24638824|NCT01158365|Protective Agents|protective agents|mesh-ancestor
24638825|NCT01158365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638826|NCT01158560|Vitamin D|vitamin d|mesh-list
24638827|NCT01158560|Cholecalciferol|cholecalciferol|mesh-list
25073756|NCT03393403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25073757|NCT03393403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25073758|NCT03393403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073759|NCT03393403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25073761|NCT03393403|Sensory System Agents|sensory system agents|mesh-ancestor
25073762|NCT03393403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24638942|NCT01159236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24638998|NCT01159418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638999|NCT01159418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24639000|NCT01159418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639001|NCT01159548|Promethazine|promethazine|mesh-list
24639002|NCT01159548|Diphenhydramine|diphenhydramine|mesh-list
24639003|NCT01159548|Antipruritics|antipruritics|mesh-ancestor
24639004|NCT01159548|Dermatologic Agents|dermatologic agents|mesh-ancestor
24639005|NCT01159548|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24639006|NCT01159548|Histamine Antagonists|histamine antagonists|mesh-ancestor
24639007|NCT01159548|Histamine Agents|histamine agents|mesh-ancestor
24639008|NCT01159548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24639009|NCT01159548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639010|NCT01159548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639011|NCT01159548|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24639012|NCT01159548|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24639013|NCT01159548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24639014|NCT01159548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24639015|NCT01159548|Anesthetics, Local|anesthetics, local|mesh-ancestor
24639016|NCT01159548|Anesthetics|anesthetics|mesh-ancestor
24639017|NCT01159548|Sensory System Agents|sensory system agents|mesh-ancestor
24639018|NCT01159548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25701778|NCT02144675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24707731|NCT01497483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24707733|NCT01497483|Antimetabolites|antimetabolites|mesh-ancestor
24707734|NCT01497483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24707735|NCT01497483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24707736|NCT01497522|Vildagliptin|vildagliptin|mesh-list
24639061|NCT01159847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24836699|NCT02187068|Analgesics|analgesics|mesh-ancestor
24639090|NCT01160185|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24639091|NCT01160185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24639092|NCT01160185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639093|NCT01160276|Cyclosporine|cyclosporine|mesh-list
24639094|NCT01160276|Colchicine|colchicine|mesh-list
24639095|NCT01160276|Tacrolimus|tacrolimus|mesh-list
24639096|NCT01160276|Cyclosporins|cyclosporins|mesh-list
24639097|NCT01160276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24639098|NCT01160276|Immunologic Factors|immunologic factors|mesh-ancestor
24639099|NCT01160276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639100|NCT01160276|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24639101|NCT01160276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639102|NCT01160276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639103|NCT01160276|Antifungal Agents|antifungal agents|mesh-ancestor
24639104|NCT01160276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24639142|NCT01160328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24639143|NCT01160328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639144|NCT01160328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24639145|NCT01160328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639150|NCT01160341|Testosterone|testosterone|mesh-list
24639597|NCT01162967|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24639190|NCT01160588|Sertraline|sertraline|mesh-list
24639191|NCT01160588|Antidepressive Agents|antidepressive agents|mesh-ancestor
24639192|NCT01160588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24639193|NCT01160588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24639194|NCT01160588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24639195|NCT01160588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25073814|NCT03393117|Anesthetics|anesthetics|mesh-ancestor
24836728|NCT02187120|Coagulants|coagulants|mesh-ancestor
24836729|NCT02187133|Rituximab|rituximab|mesh-list
24836730|NCT02187133|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24836732|NCT02187133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639287|NCT01160991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639288|NCT01160991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24639289|NCT01160991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24639290|NCT01160991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24639291|NCT01160991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24639292|NCT01160991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24639293|NCT01160991|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24639294|NCT01160991|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24639295|NCT01160991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25073829|NCT03393026|Adrenergic Agents|adrenergic agents|mesh-ancestor
25073830|NCT03393026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24836742|NCT02187250|Metformin|metformin|mesh-list
24639427|NCT01161459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639428|NCT01161550|Cytarabine|cytarabine|mesh-list
24639429|NCT01161550|Tretinoin|tretinoin|mesh-list
24639430|NCT01161550|Cladribine|cladribine|mesh-list
24639431|NCT01161550|Midostaurin|midostaurin|mesh-list
24639432|NCT01161550|Lenograstim|lenograstim|mesh-list
24639433|NCT01161550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25701779|NCT02144675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25701780|NCT02144675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25701781|NCT02144675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25701782|NCT02144675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25701783|NCT02144714|Adalimumab|adalimumab|mesh-list
24639434|NCT01161550|Antimetabolites|antimetabolites|mesh-ancestor
24639435|NCT01161550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639436|NCT01161550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639437|NCT01161550|Antiviral Agents|antiviral agents|mesh-ancestor
24639438|NCT01161550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24639471|NCT01161888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073847|NCT03392792|Plasminogen|plasminogen|mesh-list
25073848|NCT03392792|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25073849|NCT03392792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24836759|NCT02187367|Cyclophosphamide|cyclophosphamide|mesh-list
24639502|NCT01161979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24639503|NCT01161979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639504|NCT01161979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24639505|NCT01161979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639507|NCT01162031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639508|NCT01162460|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
24639509|NCT01162460|Anticonvulsants|anticonvulsants|mesh-ancestor
24639510|NCT01162460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24639511|NCT01162460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24639512|NCT01162460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25073862|NCT03392623|Niacin|niacin|mesh-list
25073870|NCT03392623|Protective Agents|protective agents|mesh-ancestor
24639555|NCT01162824|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24639556|NCT01162824|Purinergic Agonists|purinergic agonists|mesh-ancestor
24639557|NCT01162824|Purinergic Agents|purinergic agents|mesh-ancestor
24639558|NCT01162824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24639559|NCT01162824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639560|NCT01162824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24639561|NCT01162824|Cholinergic Agents|cholinergic agents|mesh-ancestor
24639562|NCT01162889|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24639563|NCT01162889|Immunologic Factors|immunologic factors|mesh-ancestor
24639586|NCT01162941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24639587|NCT01162941|Glucocorticoids|glucocorticoids|mesh-ancestor
24639589|NCT01162941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24639590|NCT01162941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639591|NCT01162941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24639592|NCT01162941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639593|NCT01162967|Posaconazole|posaconazole|mesh-list
24639594|NCT01162967|Benzonidazole|benzonidazole|mesh-list
24639595|NCT01162967|Antifungal Agents|antifungal agents|mesh-ancestor
24639596|NCT01162967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24639598|NCT01162967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24639599|NCT01162967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24639600|NCT01162967|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24639601|NCT01162967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25073885|NCT03392571|Tubulin Modulators|tubulin modulators|mesh-ancestor
25073886|NCT03392571|Antimitotic Agents|antimitotic agents|mesh-ancestor
25073887|NCT03392571|Mitosis Modulators|mitosis modulators|mesh-ancestor
25073888|NCT03392571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073889|NCT03392571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25073890|NCT03392571|Antimetabolites|antimetabolites|mesh-ancestor
25073891|NCT03392571|Antiviral Agents|antiviral agents|mesh-ancestor
24639642|NCT01163396|Protective Agents|protective agents|mesh-ancestor
24639643|NCT01163396|Vitamin B Complex|vitamin b complex|mesh-ancestor
24639644|NCT01163396|Vitamins|vitamins|mesh-ancestor
24639750|NCT01164059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24639751|NCT01164059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24639752|NCT01164059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639753|NCT01164059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24639754|NCT01164059|Serotonin Agents|serotonin agents|mesh-ancestor
24639755|NCT01164059|Antidepressive Agents|antidepressive agents|mesh-ancestor
24639756|NCT01164059|Dopamine Agonists|dopamine agonists|mesh-ancestor
24639757|NCT01164059|Dopamine Agents|dopamine agents|mesh-ancestor
24639758|NCT01164059|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24639759|NCT01164059|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24639760|NCT01164059|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24639763|NCT01164059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24639764|NCT01164059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24639766|NCT01164085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24639767|NCT01164085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24639768|NCT01164085|Analgesics|analgesics|mesh-ancestor
24639769|NCT01164085|Sensory System Agents|sensory system agents|mesh-ancestor
24639770|NCT01164085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24639771|NCT01164085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639772|NCT01164085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25073920|NCT03392051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073921|NCT03391934|Leucovorin|leucovorin|mesh-list
25073922|NCT03391934|Fluorouracil|fluorouracil|mesh-list
25073923|NCT03391934|Irinotecan|irinotecan|mesh-list
25073924|NCT03391934|Cetuximab|cetuximab|mesh-list
25073925|NCT03391934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073926|NCT03391934|Antimetabolites|antimetabolites|mesh-ancestor
25073927|NCT03391934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073928|NCT03391934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25073929|NCT03391934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073930|NCT03391934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25073931|NCT03391934|Immunologic Factors|immunologic factors|mesh-ancestor
25073932|NCT03391934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24639811|NCT01164267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639812|NCT01164267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24639813|NCT01164267|Immunologic Factors|immunologic factors|mesh-ancestor
24639814|NCT01164267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639815|NCT01164306|Nicotine|nicotine|mesh-list
24639816|NCT01164306|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24639817|NCT01164306|Autonomic Agents|autonomic agents|mesh-ancestor
24639818|NCT01164306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24639819|NCT01164306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639820|NCT01164306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24639862|NCT01164605|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24639863|NCT01164605|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24639864|NCT01164605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639865|NCT01164605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639868|NCT01164709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639869|NCT01164709|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24639870|NCT01164709|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25073933|NCT03391934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25073934|NCT03391934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073935|NCT03391934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25073936|NCT03391934|Antidotes|antidotes|mesh-ancestor
25073937|NCT03391934|Protective Agents|protective agents|mesh-ancestor
25073939|NCT03391934|Vitamins|vitamins|mesh-ancestor
25073940|NCT03391934|Micronutrients|micronutrients|mesh-ancestor
25073941|NCT03391856|Acetylcysteine|acetylcysteine|mesh-list
25073942|NCT03391856|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25073943|NCT03391856|Antiviral Agents|antiviral agents|mesh-ancestor
25073944|NCT03391856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25073945|NCT03391856|Expectorants|expectorants|mesh-ancestor
25073946|NCT03391856|Respiratory System Agents|respiratory system agents|mesh-ancestor
24639871|NCT01164709|Protease Inhibitors|protease inhibitors|mesh-ancestor
24639872|NCT01164709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639873|NCT01164709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639874|NCT01164709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24639875|NCT01164709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24639876|NCT01164709|Antiviral Agents|antiviral agents|mesh-ancestor
24639877|NCT01164709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24639878|NCT01164761|Ramipril|ramipril|mesh-list
24639880|NCT01164761|Protease Inhibitors|protease inhibitors|mesh-ancestor
24639916|NCT01164826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24639917|NCT01164826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25073949|NCT03391856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073950|NCT03391856|Protective Agents|protective agents|mesh-ancestor
24454934|NCT03161353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073951|NCT03391856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073953|NCT03391843|Cetuximab|cetuximab|mesh-list
25073954|NCT03391843|Oxaliplatin|oxaliplatin|mesh-list
25073955|NCT03391843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25073956|NCT03391843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25073957|NCT03391830|Ascorbic Acid|ascorbic acid|mesh-list
25073958|NCT03391830|Atorvastatin|atorvastatin|mesh-list
25073959|NCT03391830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25073960|NCT03391830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24640031|NCT01165645|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24640032|NCT01165645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24640033|NCT01165814|Naproxen|naproxen|mesh-list
24640034|NCT01165814|Tramadol|tramadol|mesh-list
24640035|NCT01165814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24640036|NCT01165814|Narcotics|narcotics|mesh-ancestor
24640037|NCT01165814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24640038|NCT01165814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640040|NCT01165814|Sensory System Agents|sensory system agents|mesh-ancestor
24640120|NCT01166087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640121|NCT01166087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24640123|NCT01166087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640124|NCT01166087|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24640125|NCT01166087|Antidepressive Agents|antidepressive agents|mesh-ancestor
24640126|NCT01166087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25073962|NCT03391830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25073963|NCT03391830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25073964|NCT03391830|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25073965|NCT03391830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25073966|NCT03391830|Antioxidants|antioxidants|mesh-ancestor
25073967|NCT03391830|Protective Agents|protective agents|mesh-ancestor
25073968|NCT03391830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073969|NCT03391830|Vitamins|vitamins|mesh-ancestor
25073970|NCT03391830|Micronutrients|micronutrients|mesh-ancestor
25073971|NCT03391700|Rocuronium|rocuronium|mesh-list
25073972|NCT03391700|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25073973|NCT03391700|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24640236|NCT01167010|Respiratory System Agents|respiratory system agents|mesh-ancestor
24640237|NCT01167010|Glucocorticoids|glucocorticoids|mesh-ancestor
24640239|NCT01167010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24640268|NCT01167101|Protective Agents|protective agents|mesh-ancestor
24640269|NCT01167101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640272|NCT01167127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24640273|NCT01167127|Narcotics|narcotics|mesh-ancestor
24640274|NCT01167127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24640275|NCT01167127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640276|NCT01167127|Analgesics|analgesics|mesh-ancestor
24640277|NCT01167127|Sensory System Agents|sensory system agents|mesh-ancestor
24640278|NCT01167127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24640279|NCT01167127|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24640281|NCT01167231|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25073977|NCT03391609|Dexmedetomidine|dexmedetomidine|mesh-list
25073978|NCT03391609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25073979|NCT03391609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25073980|NCT03391609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25073981|NCT03391609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25073982|NCT03391609|Analgesics|analgesics|mesh-ancestor
25073983|NCT03391609|Sensory System Agents|sensory system agents|mesh-ancestor
25073984|NCT03391609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25073985|NCT03391609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25073986|NCT03391609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25073987|NCT03391609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25073988|NCT03391609|Adrenergic Agents|adrenergic agents|mesh-ancestor
25073989|NCT03391609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25073990|NCT03391609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640283|NCT01167231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640284|NCT01167231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24640285|NCT01167231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640325|NCT01167725|Mitomycin|mitomycin|mesh-list
24640326|NCT01167725|Levoleucovorin|levoleucovorin|mesh-list
24640337|NCT01167725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24640338|NCT01167725|Immunologic Factors|immunologic factors|mesh-ancestor
24640339|NCT01167725|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24640340|NCT01167725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24640341|NCT01167725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640342|NCT01167725|Antidotes|antidotes|mesh-ancestor
24640343|NCT01167725|Protective Agents|protective agents|mesh-ancestor
24640344|NCT01167725|Vitamin B Complex|vitamin b complex|mesh-ancestor
24640345|NCT01167725|Vitamins|vitamins|mesh-ancestor
24640346|NCT01167725|Micronutrients|micronutrients|mesh-ancestor
24640347|NCT01167725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24640348|NCT01167725|Alkylating Agents|alkylating agents|mesh-ancestor
24856101|NCT02282787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24640349|NCT01167725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24640375|NCT01167803|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24640376|NCT01167803|Anesthetics, General|anesthetics, general|mesh-ancestor
24954122|NCT03879382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24954123|NCT03879382|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24954124|NCT03879174|Tamoxifen|tamoxifen|mesh-list
25074002|NCT03391570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25074003|NCT03391427|Lidocaine|lidocaine|mesh-list
24640378|NCT01167803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24640380|NCT01167816|Azacitidine|azacitidine|mesh-list
24640381|NCT01167816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24640382|NCT01167816|Antimetabolites|antimetabolites|mesh-ancestor
24640383|NCT01167816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640384|NCT01167816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640385|NCT01167816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640386|NCT01167894|Simvastatin|simvastatin|mesh-list
24640387|NCT01167894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24640388|NCT01167894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24640389|NCT01167894|Antimetabolites|antimetabolites|mesh-ancestor
24640390|NCT01167894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640391|NCT01167894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24640392|NCT01167894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24640393|NCT01167894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640394|NCT01167920|Calcium Channel Blockers|calcium channel blockers|mesh-list
24640427|NCT01167946|Glucocorticoids|glucocorticoids|mesh-ancestor
24640429|NCT01167946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24640430|NCT01167946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24640431|NCT01167946|Protective Agents|protective agents|mesh-ancestor
24640432|NCT01167946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24640433|NCT01167946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640435|NCT01168011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640436|NCT01168011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24640437|NCT01168011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640438|NCT01168011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074005|NCT03391427|Anesthetics, Local|anesthetics, local|mesh-ancestor
25074021|NCT03391427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25074022|NCT03391427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24959735|NCT03822715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074024|NCT03391245|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
25074025|NCT03391245|Calcifediol|calcifediol|mesh-list
24640439|NCT01168063|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24640484|NCT01168492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24640485|NCT01168492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640486|NCT01168505|Teferrol|teferrol|mesh-list
24640487|NCT01168505|Hematinics|hematinics|mesh-ancestor
24640488|NCT01168531|Dexamethasone|dexamethasone|mesh-list
24640489|NCT01168531|Pregabalin|pregabalin|mesh-list
24640490|NCT01168531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24640491|NCT01168531|Antiemetics|antiemetics|mesh-ancestor
24640492|NCT01168531|Autonomic Agents|autonomic agents|mesh-ancestor
24640501|NCT01168531|Analgesics|analgesics|mesh-ancestor
24640502|NCT01168531|Sensory System Agents|sensory system agents|mesh-ancestor
24640503|NCT01168531|Anticonvulsants|anticonvulsants|mesh-ancestor
24640504|NCT01168531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24640505|NCT01168531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24640506|NCT01168531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24454973|NCT03122262|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24454974|NCT03122262|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25074030|NCT03391219|Bevacizumab|bevacizumab|mesh-list
25701784|NCT02144714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25701785|NCT02144714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24714735|NCT01532466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24714736|NCT01532466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24714737|NCT01532466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24714739|NCT01532518|MEN 11420|men 11420|mesh-list
25074031|NCT03391219|Fasudil|fasudil|mesh-list
25074032|NCT03391219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25074033|NCT03391219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812983|NCT02055703|Rifampin|rifampin|mesh-list
25074034|NCT03391219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25074061|NCT03390972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25074062|NCT03390972|Adrenergic Agents|adrenergic agents|mesh-ancestor
24640590|NCT01169025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640591|NCT01169025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24640612|NCT01169298|Lenalidomide|lenalidomide|mesh-list
24640613|NCT01169298|Immunologic Factors|immunologic factors|mesh-ancestor
24640614|NCT01169298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640615|NCT01169298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24640616|NCT01169298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24640617|NCT01169298|Growth Substances|growth substances|mesh-ancestor
24640618|NCT01169298|Growth Inhibitors|growth inhibitors|mesh-ancestor
24640619|NCT01169298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640620|NCT01169389|Bupivacaine|bupivacaine|mesh-list
24640621|NCT01169389|Anesthetics, Local|anesthetics, local|mesh-ancestor
24640622|NCT01169389|Anesthetics|anesthetics|mesh-ancestor
24640706|NCT01169688|Protective Agents|protective agents|mesh-ancestor
24640707|NCT01169688|Parasympatholytics|parasympatholytics|mesh-ancestor
24640708|NCT01169688|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24640709|NCT01169688|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24640710|NCT01169688|Cholinergic Agents|cholinergic agents|mesh-ancestor
24640711|NCT01169740|Bilirubin|bilirubin|mesh-list
24640712|NCT01169740|Antioxidants|antioxidants|mesh-ancestor
24640713|NCT01169740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640714|NCT01169740|Protective Agents|protective agents|mesh-ancestor
24640715|NCT01169740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640716|NCT01169792|Tamoxifen|tamoxifen|mesh-list
24640807|NCT01170130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24640808|NCT01170130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24640809|NCT01170130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640810|NCT01170143|Trastuzumab|trastuzumab|mesh-list
24640811|NCT01170143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24640812|NCT01170143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640814|NCT01170169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24640815|NCT01170169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24640816|NCT01170169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24640864|NCT01170429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640865|NCT01170429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24640866|NCT01170429|Respiratory System Agents|respiratory system agents|mesh-ancestor
24640868|NCT01170429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24640869|NCT01170429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24640870|NCT01170429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24640871|NCT01170429|Adrenergic Agents|adrenergic agents|mesh-ancestor
24640872|NCT01170429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24640887|NCT01170468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24640888|NCT01170468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24640890|NCT01170494|Vitamin D|vitamin d|mesh-list
24640891|NCT01170494|Ergocalciferols|ergocalciferols|mesh-list
24640892|NCT01170494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24640899|NCT01170507|Cholecalciferol|cholecalciferol|mesh-list
24640900|NCT01170507|Vitamins|vitamins|mesh-list
24640901|NCT01170507|Micronutrients|micronutrients|mesh-ancestor
24640902|NCT01170507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701787|NCT02145026|Hematinics|hematinics|mesh-ancestor
25701788|NCT02145039|Cyclophosphamide|cyclophosphamide|mesh-list
25701789|NCT02145039|Fludarabine|fludarabine|mesh-list
25701790|NCT02145039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25701791|NCT02145039|Immunologic Factors|immunologic factors|mesh-ancestor
25701792|NCT02145039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701793|NCT02145039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24640904|NCT01170507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24640912|NCT01170585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640913|NCT01170637|Ibuprofen|ibuprofen|mesh-list
24640914|NCT01170637|Pseudoephedrine|pseudoephedrine|mesh-list
25074090|NCT03390790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074092|NCT03390738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25074093|NCT03390738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25074094|NCT03390738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25074095|NCT03390738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074096|NCT03390712|Risperidone|risperidone|mesh-list
25074097|NCT03390712|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25074098|NCT03390712|Antipsychotic Agents|antipsychotic agents|mesh-list
25074099|NCT03390712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25074100|NCT03390712|Serotonin Agents|serotonin agents|mesh-ancestor
25074101|NCT03390712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25074102|NCT03390712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074103|NCT03390712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640915|NCT01170637|Ephedrine|ephedrine|mesh-list
24667696|NCT05323214|Anesthetics, Local|anesthetics, local|mesh-ancestor
24435305|NCT00265928|Rituximab|rituximab|mesh-list
24640916|NCT01170637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24640917|NCT01170637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24640918|NCT01170637|Analgesics|analgesics|mesh-ancestor
24640919|NCT01170637|Sensory System Agents|sensory system agents|mesh-ancestor
24640920|NCT01170637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24640921|NCT01170637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640922|NCT01170637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24640923|NCT01170637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24640924|NCT01170637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24640925|NCT01170637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640926|NCT01170637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640927|NCT01170637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24640928|NCT01170637|Autonomic Agents|autonomic agents|mesh-ancestor
24640929|NCT01170637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24640930|NCT01170637|Respiratory System Agents|respiratory system agents|mesh-ancestor
24641055|NCT01171651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24641057|NCT01171651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641058|NCT01171755|Gemcitabine|gemcitabine|mesh-list
24641059|NCT01171755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24641060|NCT01171755|Antimetabolites|antimetabolites|mesh-ancestor
24641062|NCT01171755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641093|NCT01171859|Doxycycline|doxycycline|mesh-list
24641094|NCT01171859|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
25074121|NCT03390608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25074122|NCT03390608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25074124|NCT03390608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25074125|NCT03390608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074127|NCT03390595|Carboplatin|carboplatin|mesh-list
25074128|NCT03390595|Avelumab|avelumab|mesh-list
25074129|NCT03390595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25074130|NCT03390595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25074131|NCT03390595|Antimetabolites|antimetabolites|mesh-ancestor
25074132|NCT03390595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074133|NCT03390595|Antiviral Agents|antiviral agents|mesh-ancestor
25074134|NCT03390595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25074135|NCT03390595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25074136|NCT03390595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25074137|NCT03390595|Immunologic Factors|immunologic factors|mesh-ancestor
25074138|NCT03390595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641112|NCT01171911|Esmolol|esmolol|mesh-list
24641113|NCT01171911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24641114|NCT01171911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641115|NCT01171911|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24641135|NCT01172028|Docetaxel|docetaxel|mesh-list
24641136|NCT01172028|Pemetrexed|pemetrexed|mesh-list
24641137|NCT01172028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641138|NCT01172028|Tubulin Modulators|tubulin modulators|mesh-ancestor
24641139|NCT01172028|Antimitotic Agents|antimitotic agents|mesh-ancestor
24641140|NCT01172028|Mitosis Modulators|mitosis modulators|mesh-ancestor
24954193|NCT03878693|Fomepizole|fomepizole|mesh-list
24641141|NCT01172028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641142|NCT01172028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641143|NCT01172028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24641144|NCT01172028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24641150|NCT01172171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641151|NCT01172171|Protective Agents|protective agents|mesh-ancestor
24641152|NCT01172171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641205|NCT01172431|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24641206|NCT01172431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24641207|NCT01172431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641208|NCT01172444|Mesalamine|mesalamine|mesh-list
24641209|NCT01172444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24641210|NCT01172444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25074139|NCT03390595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25074140|NCT03390582|Methimazole|methimazole|mesh-list
25074141|NCT03390582|Antithyroid Agents|antithyroid agents|mesh-ancestor
25074142|NCT03390582|Hormone Antagonists|hormone antagonists|mesh-ancestor
25074143|NCT03390582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25074144|NCT03390582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074146|NCT03390465|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25074147|NCT03390465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25074148|NCT03390465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25074149|NCT03390465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24837081|NCT02188615|Antimitotic Agents|antimitotic agents|mesh-ancestor
24641211|NCT01172444|Analgesics|analgesics|mesh-ancestor
24641306|NCT01172782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24641319|NCT01172912|Antiemetics|antiemetics|mesh-ancestor
24641320|NCT01172912|Autonomic Agents|autonomic agents|mesh-ancestor
24641321|NCT01172912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24641336|NCT01172925|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24641337|NCT01172925|Autonomic Agents|autonomic agents|mesh-ancestor
24641338|NCT01172925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24641339|NCT01172925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641346|NCT01172925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641347|NCT01172964|Flucytosine|flucytosine|mesh-list
24641348|NCT01172964|Antifungal Agents|antifungal agents|mesh-ancestor
24641349|NCT01172964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24641350|NCT01172964|Antimetabolites|antimetabolites|mesh-ancestor
24641578|NCT01174303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24641579|NCT01174303|Insulin Aspart|insulin aspart|mesh-list
24641580|NCT01174303|Insulin, Long-Acting|insulin, long-acting|mesh-list
24641581|NCT01174303|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24641582|NCT01174303|Biphasic Insulins|biphasic insulins|mesh-list
24474285|NCT00405431|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25701794|NCT02145039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25701795|NCT02145039|Alkylating Agents|alkylating agents|mesh-ancestor
24717504|NCT01548209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24641583|NCT01174303|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24641584|NCT01174303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24641585|NCT01174303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641586|NCT01174394|Fluoxetine|fluoxetine|mesh-list
24641587|NCT01174394|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24641588|NCT01174394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24641706|NCT01174914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24641707|NCT01174914|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24641708|NCT01174914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24641709|NCT01174914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641736|NCT01174953|Hormone Antagonists|hormone antagonists|mesh-ancestor
24641737|NCT01174953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24641738|NCT01174953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641739|NCT01174953|Urological Agents|urological agents|mesh-ancestor
24641740|NCT01175044|Povidone-Iodine|povidone-iodine|mesh-list
24641741|NCT01175044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24641742|NCT01175044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24641743|NCT01175096|Everolimus|everolimus|mesh-list
24641744|NCT01175096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641745|NCT01175096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24641746|NCT01175096|Immunologic Factors|immunologic factors|mesh-ancestor
24641747|NCT01175096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074183|NCT03390374|Nystatin|nystatin|mesh-list
24447891|NCT00309855|Anastrozole|anastrozole|mesh-list
24641832|NCT01175733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641833|NCT01175746|Nicardipine|nicardipine|mesh-list
24641834|NCT01175746|Remifentanil|remifentanil|mesh-list
24641835|NCT01175746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24641892|NCT01176344|Vitamins|vitamins|mesh-ancestor
24641893|NCT01176344|Micronutrients|micronutrients|mesh-ancestor
24641894|NCT01176344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641895|NCT01176344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24642081|NCT01177514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642082|NCT01177514|Anticonvulsants|anticonvulsants|mesh-ancestor
24642083|NCT01177514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24642084|NCT01177514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24642085|NCT01177514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24642086|NCT01177514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24642087|NCT01177514|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24642088|NCT01177514|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24642089|NCT01177514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24642133|NCT01177852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24803209|NCT01995058|Prednisone|prednisone|mesh-list
24642134|NCT01177852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642136|NCT01177852|Anesthetics|anesthetics|mesh-ancestor
24642137|NCT01177852|Sensory System Agents|sensory system agents|mesh-ancestor
24642138|NCT01177852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24642139|NCT01177852|Antiemetics|antiemetics|mesh-ancestor
24642140|NCT01177852|Autonomic Agents|autonomic agents|mesh-ancestor
24642141|NCT01177852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24642142|NCT01177852|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24642144|NCT01177852|Histamine Agents|histamine agents|mesh-ancestor
24642177|NCT01178021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642197|NCT01178151|Everolimus|everolimus|mesh-list
24642248|NCT01178645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642249|NCT01178645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24642250|NCT01178645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24642251|NCT01178645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642252|NCT01178645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642253|NCT01178645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24642263|NCT01178658|Cytarabine|cytarabine|mesh-list
24642282|NCT01178658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24642283|NCT01178697|Triamcinolone|triamcinolone|mesh-list
24642284|NCT01178697|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24642285|NCT01178697|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24642286|NCT01178697|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24642288|NCT01178697|Glucocorticoids|glucocorticoids|mesh-ancestor
24642289|NCT01178697|Hormones|hormones|mesh-ancestor
24642291|NCT01178697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642347|NCT01179009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25074218|NCT03389958|Copper|copper|mesh-list
25074219|NCT03389958|Trace Elements|trace elements|mesh-ancestor
25074220|NCT03389958|Micronutrients|micronutrients|mesh-ancestor
25701796|NCT02145039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074221|NCT03389958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074222|NCT03389789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25074224|NCT03389776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25074225|NCT03389776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642468|NCT01179529|Omalizumab|omalizumab|mesh-list
24642527|NCT01179828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24642528|NCT01179828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24642529|NCT01179828|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24642530|NCT01179828|GABA Agonists|gaba agonists|mesh-ancestor
24642637|NCT01180348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642638|NCT01180348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24642639|NCT01180348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24642641|NCT01180413|Amlodipine|amlodipine|mesh-list
24642642|NCT01180413|Ramipril|ramipril|mesh-list
25074535|NCT03387631|Antimalarials|antimalarials|mesh-ancestor
24642692|NCT01180946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642693|NCT01180946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24642696|NCT01180959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24642930|NCT01182168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24642931|NCT01182168|Antimetabolites|antimetabolites|mesh-ancestor
24642932|NCT01182168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642933|NCT01182168|Antiviral Agents|antiviral agents|mesh-ancestor
24642934|NCT01182168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24642935|NCT01182168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642936|NCT01182168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24642937|NCT01182168|Immunologic Factors|immunologic factors|mesh-ancestor
24642938|NCT01182168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642958|NCT01182597|Lansoprazole|lansoprazole|mesh-list
24642959|NCT01182597|Dexlansoprazole|dexlansoprazole|mesh-list
24642960|NCT01182597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24642961|NCT01182597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24642962|NCT01182597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24642963|NCT01182597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642964|NCT01182597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642966|NCT01182636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24642967|NCT01182636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24642968|NCT01182636|Analgesics|analgesics|mesh-ancestor
24642969|NCT01182636|Sensory System Agents|sensory system agents|mesh-ancestor
24642970|NCT01182636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24642971|NCT01182636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642972|NCT01182636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24642973|NCT01182636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24642974|NCT01182636|Dermatologic Agents|dermatologic agents|mesh-ancestor
24622660|NCT01067989|Capecitabine|capecitabine|mesh-list
24643018|NCT01183247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24779926|NCT01879917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24779927|NCT01879930|Doxycycline|doxycycline|mesh-list
24779928|NCT01879930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24779929|NCT01879930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24779930|NCT01879930|Antimalarials|antimalarials|mesh-ancestor
24779931|NCT01879930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24779932|NCT01879930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24626433|NCT01087398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24626434|NCT01087398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24626436|NCT01087398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24626437|NCT01087398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24626438|NCT01087398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24626439|NCT01087398|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25074249|NCT03389659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25074250|NCT03389607|Anesthetics|anesthetics|mesh-list
25074253|NCT03389490|Insulin|insulin|mesh-list
25074267|NCT03389451|Chelating Agents|chelating agents|mesh-ancestor
25074268|NCT03389451|Sequestering Agents|sequestering agents|mesh-ancestor
25074269|NCT03389451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074270|NCT03389451|Anticoagulants|anticoagulants|mesh-ancestor
25074271|NCT03389451|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25074272|NCT03389451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25074273|NCT03389412|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25074274|NCT03389412|Hemostatics|hemostatics|mesh-ancestor
25074277|NCT03389412|Natriuretic Agents|natriuretic agents|mesh-ancestor
25074278|NCT03389412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074279|NCT03389321|Macitentan|macitentan|mesh-list
25074280|NCT03389321|Riociguat|riociguat|mesh-list
25074281|NCT03389321|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25074294|NCT03389295|Antimetabolites|antimetabolites|mesh-ancestor
25074295|NCT03389295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25074296|NCT03389295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25074297|NCT03389295|Immunologic Factors|immunologic factors|mesh-ancestor
25074298|NCT03389295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074300|NCT03389256|Gefitinib|gefitinib|mesh-list
25074301|NCT03389256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25074302|NCT03389256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25074303|NCT03389256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25074304|NCT03389256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074305|NCT03389191|Acyclovir|acyclovir|mesh-list
25074306|NCT03389191|Antiviral Agents|antiviral agents|mesh-ancestor
25074307|NCT03389191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25074308|NCT03389139|Anesthetics|anesthetics|mesh-list
25074309|NCT03389139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25074310|NCT03389139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074311|NCT03389126|Avelumab|avelumab|mesh-list
25074312|NCT03389126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25074313|NCT03389126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25074314|NCT03389087|Etoposide|etoposide|mesh-list
25074315|NCT03389087|Apatinib|apatinib|mesh-list
25074316|NCT03389087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25074327|NCT03389061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25074328|NCT03388970|Vitamin K|vitamin k|mesh-list
25074329|NCT03388970|Vitamin K 1|vitamin k 1|mesh-list
25074330|NCT03388970|Vitamins|vitamins|mesh-ancestor
25074331|NCT03388970|Micronutrients|micronutrients|mesh-ancestor
25074332|NCT03388970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074336|NCT03388970|Hemostatics|hemostatics|mesh-ancestor
25074352|NCT03388957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25074353|NCT03388957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074354|NCT03388957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25074355|NCT03388957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25074356|NCT03388957|Adrenergic Agents|adrenergic agents|mesh-ancestor
25074357|NCT03388957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25074358|NCT03388957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25074359|NCT03388957|Vasodilator Agents|vasodilator agents|mesh-ancestor
25074360|NCT03388892|Paclitaxel|paclitaxel|mesh-list
25074361|NCT03388892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25074362|NCT03388892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25074368|NCT03388866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074369|NCT03388853|Acetylcysteine|acetylcysteine|mesh-list
25074370|NCT03388853|Doxofylline|doxofylline|mesh-list
25074371|NCT03388853|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25074372|NCT03388853|Antiviral Agents|antiviral agents|mesh-ancestor
25074373|NCT03388853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25074374|NCT03388853|Expectorants|expectorants|mesh-ancestor
25074375|NCT03388853|Respiratory System Agents|respiratory system agents|mesh-ancestor
25074376|NCT03388853|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25074377|NCT03388853|Antioxidants|antioxidants|mesh-ancestor
25074378|NCT03388853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074408|NCT03388671|Anesthetics, Local|anesthetics, local|mesh-ancestor
25074410|NCT03388671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25074411|NCT03388671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074412|NCT03388671|Sensory System Agents|sensory system agents|mesh-ancestor
25074413|NCT03388671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25074414|NCT03388580|Dimercaprol|dimercaprol|mesh-list
25074415|NCT03388580|Chelating Agents|chelating agents|mesh-ancestor
25074417|NCT03388580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074419|NCT03388541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25074420|NCT03388541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25074421|NCT03388541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074422|NCT03388541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25074423|NCT03388541|Analgesics|analgesics|mesh-ancestor
25074424|NCT03388541|Sensory System Agents|sensory system agents|mesh-ancestor
25074425|NCT03388541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25074426|NCT03388541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25074427|NCT03388541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25006208|NCT05204056|Epinephrine|epinephrine|mesh-list
25074428|NCT03388541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25074429|NCT03388541|Adrenergic Agents|adrenergic agents|mesh-ancestor
25074430|NCT03388541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25074431|NCT03388541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074432|NCT03388463|Omeprazole|omeprazole|mesh-list
25074433|NCT03388463|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25074434|NCT03388463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25074435|NCT03388463|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25074436|NCT03388463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25074445|NCT03388346|Edetic Acid|edetic acid|mesh-list
25074446|NCT03388346|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25074447|NCT03388346|Chelating Agents|chelating agents|mesh-ancestor
25074457|NCT03388151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074458|NCT03388151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25074459|NCT03388151|Anesthetics, General|anesthetics, general|mesh-ancestor
25074460|NCT03388151|Anesthetics|anesthetics|mesh-ancestor
25074461|NCT03388151|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25074462|NCT03388151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25074463|NCT03388151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24954162|NCT03878888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074464|NCT03388151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25074465|NCT03388151|GABA Modulators|gaba modulators|mesh-ancestor
25074466|NCT03388151|GABA Agents|gaba agents|mesh-ancestor
25074467|NCT03388151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25074468|NCT03388151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074469|NCT03388125|Ethanolamine oleate|ethanolamine oleate|mesh-list
25074470|NCT03388125|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25074471|NCT03388125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24954163|NCT03878888|Sensory System Agents|sensory system agents|mesh-ancestor
24954164|NCT03878888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24837448|NCT02191319|Antiviral Agents|antiviral agents|mesh-ancestor
24643062|NCT01183572|Trace Elements|trace elements|mesh-ancestor
24643063|NCT01183572|Micronutrients|micronutrients|mesh-ancestor
24643064|NCT01183572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643065|NCT01183572|Hematinics|hematinics|mesh-ancestor
24643066|NCT01183572|Vitamins|vitamins|mesh-ancestor
24643067|NCT01183585|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24643068|NCT01183585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24643070|NCT01183585|Antimetabolites|antimetabolites|mesh-ancestor
24643071|NCT01183585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643072|NCT01183585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24643091|NCT01183663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24643092|NCT01183663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24643093|NCT01183663|Growth Substances|growth substances|mesh-ancestor
24954165|NCT03879005|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
24954166|NCT03879005|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24954167|NCT03879005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954172|NCT03878771|Hormones|hormones|mesh-ancestor
24954173|NCT03878771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24954176|NCT03878771|Anesthetics|anesthetics|mesh-ancestor
24954177|NCT03878771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24954178|NCT03878771|Sensory System Agents|sensory system agents|mesh-ancestor
24954179|NCT03878771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24954180|NCT03878784|Sumatriptan|sumatriptan|mesh-list
24954181|NCT03878784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24954182|NCT03878784|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24954183|NCT03878784|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24954184|NCT03878784|Serotonin Agents|serotonin agents|mesh-ancestor
24954185|NCT03878784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24954186|NCT03878784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954187|NCT03878784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720393|NCT01568268|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24720394|NCT01568268|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24720395|NCT01568268|Serotonin Agents|serotonin agents|mesh-ancestor
24720396|NCT01568268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24954188|NCT03878654|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
24954189|NCT03878654|Antiviral Agents|antiviral agents|mesh-ancestor
24954190|NCT03878654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24954191|NCT03878654|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24954192|NCT03878654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24954219|NCT03878082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954220|NCT03878082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24954221|NCT03878082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24954222|NCT03878082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24954226|NCT03877705|Sodium Fluoride|sodium fluoride|mesh-list
24954227|NCT03877705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24954228|NCT03877705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24954229|NCT03877705|Cariostatic Agents|cariostatic agents|mesh-ancestor
24954230|NCT03877705|Protective Agents|protective agents|mesh-ancestor
24954231|NCT03877705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954232|NCT03877718|Promethazine|promethazine|mesh-list
25074472|NCT03387956|Dexamethasone|dexamethasone|mesh-list
25074473|NCT03387956|Atropine|atropine|mesh-list
25074474|NCT03387956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25074475|NCT03387956|Antiemetics|antiemetics|mesh-ancestor
25074476|NCT03387956|Autonomic Agents|autonomic agents|mesh-ancestor
24954233|NCT03877718|Diphenhydramine|diphenhydramine|mesh-list
25074477|NCT03387956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25074478|NCT03387956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074479|NCT03387956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25074480|NCT03387956|Glucocorticoids|glucocorticoids|mesh-ancestor
25074490|NCT03387956|Mydriatics|mydriatics|mesh-ancestor
25074491|NCT03387956|Parasympatholytics|parasympatholytics|mesh-ancestor
25074492|NCT03387956|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25074493|NCT03387956|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25074494|NCT03387956|Cholinergic Agents|cholinergic agents|mesh-ancestor
25074495|NCT03387956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25074496|NCT03387956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074497|NCT03387943|Cisplatin|cisplatin|mesh-list
25074498|NCT03387943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25074499|NCT03387904|Irinotecan|irinotecan|mesh-list
25074500|NCT03387904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25074501|NCT03387904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25074502|NCT03387904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25074503|NCT03387904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074517|NCT03387787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074518|NCT03387644|Pregabalin|pregabalin|mesh-list
25074519|NCT03387644|Analgesics|analgesics|mesh-ancestor
25074520|NCT03387644|Sensory System Agents|sensory system agents|mesh-ancestor
25074521|NCT03387644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25074522|NCT03387644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074523|NCT03387644|Anticonvulsants|anticonvulsants|mesh-ancestor
24643094|NCT01183663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643095|NCT01183663|Growth Inhibitors|growth inhibitors|mesh-ancestor
24643096|NCT01183663|Antimetabolites|antimetabolites|mesh-ancestor
24643097|NCT01183663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643098|NCT01183663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25074524|NCT03387644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25074525|NCT03387644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24804672|NCT02004301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25074526|NCT03387644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074532|NCT03387631|Lumefantrine|lumefantrine|mesh-list
25074533|NCT03387631|Artemether|artemether|mesh-list
25074534|NCT03387631|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25074537|NCT03387631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25074538|NCT03387631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25074540|NCT03387592|Fluorouracil|fluorouracil|mesh-list
25074541|NCT03387592|Capecitabine|capecitabine|mesh-list
25074542|NCT03387592|Temozolomide|temozolomide|mesh-list
25074543|NCT03387592|Levoleucovorin|levoleucovorin|mesh-list
25074544|NCT03387592|Antimetabolites|antimetabolites|mesh-ancestor
25701797|NCT02145039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25701798|NCT02145039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25701799|NCT02145078|Gemcitabine|gemcitabine|mesh-list
25701800|NCT02145078|Docetaxel|docetaxel|mesh-list
25074546|NCT03387592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25074550|NCT03387592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074551|NCT03387592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25074552|NCT03387592|Alkylating Agents|alkylating agents|mesh-ancestor
25074553|NCT03387592|Antidotes|antidotes|mesh-ancestor
25074554|NCT03387592|Protective Agents|protective agents|mesh-ancestor
25074555|NCT03387592|Vitamin B Complex|vitamin b complex|mesh-ancestor
25074557|NCT03387592|Micronutrients|micronutrients|mesh-ancestor
25074558|NCT03387566|Immunoglobulins|immunoglobulins|mesh-list
25074628|NCT03387111|Vitamins|vitamins|mesh-ancestor
25074629|NCT03387111|Micronutrients|micronutrients|mesh-ancestor
25074630|NCT03387098|Leucovorin|leucovorin|mesh-list
25074631|NCT03387098|Paclitaxel|paclitaxel|mesh-list
25074632|NCT03387098|Cyclophosphamide|cyclophosphamide|mesh-list
25074633|NCT03387098|Bevacizumab|bevacizumab|mesh-list
25074634|NCT03387098|Fluorouracil|fluorouracil|mesh-list
25074643|NCT03387098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074644|NCT03387098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25074645|NCT03387098|Immunologic Factors|immunologic factors|mesh-ancestor
25074646|NCT03387098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074647|NCT03387098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25074648|NCT03387098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25074649|NCT03387098|Alkylating Agents|alkylating agents|mesh-ancestor
25074650|NCT03387098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25074651|NCT03387098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25074652|NCT03387098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25074653|NCT03387098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25074654|NCT03387098|Growth Substances|growth substances|mesh-ancestor
25074655|NCT03387098|Growth Inhibitors|growth inhibitors|mesh-ancestor
25074656|NCT03387098|Antimetabolites|antimetabolites|mesh-ancestor
25074657|NCT03387098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25074658|NCT03387098|Antidotes|antidotes|mesh-ancestor
25074659|NCT03387098|Protective Agents|protective agents|mesh-ancestor
25074660|NCT03387098|Vitamin B Complex|vitamin b complex|mesh-ancestor
25074661|NCT03387098|Vitamins|vitamins|mesh-ancestor
25074662|NCT03387098|Micronutrients|micronutrients|mesh-ancestor
24643102|NCT01183663|Protective Agents|protective agents|mesh-ancestor
24643103|NCT01183663|Vitamin B Complex|vitamin b complex|mesh-ancestor
24643105|NCT01183663|Micronutrients|micronutrients|mesh-ancestor
24643106|NCT01183663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24643107|NCT01183663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643108|NCT01183663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24643109|NCT01183663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24643110|NCT01183663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24643111|NCT01183663|Antifungal Agents|antifungal agents|mesh-ancestor
24643112|NCT01183676|Valproic Acid|valproic acid|mesh-list
24643145|NCT01183910|Antacids|antacids|mesh-ancestor
24643146|NCT01183910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643147|NCT01183910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24643148|NCT01183962|Vitamin D|vitamin d|mesh-list
24643149|NCT01183962|Vitamins|vitamins|mesh-ancestor
24643150|NCT01183962|Micronutrients|micronutrients|mesh-ancestor
24643151|NCT01183962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643152|NCT01183962|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24643153|NCT01184144|Pioglitazone|pioglitazone|mesh-list
25074809|NCT03385863|Poractant alfa|poractant alfa|mesh-list
25074673|NCT03386838|Nivolumab|nivolumab|mesh-list
25074674|NCT03386838|Cetuximab|cetuximab|mesh-list
25074675|NCT03386838|Linrodostat|linrodostat|mesh-list
25074676|NCT03386838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25074677|NCT03386838|Antimetabolites|antimetabolites|mesh-ancestor
25074678|NCT03386838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074679|NCT03386838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25701801|NCT02145078|Pemetrexed|pemetrexed|mesh-list
25074680|NCT03386838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25074681|NCT03386838|Immunologic Factors|immunologic factors|mesh-ancestor
25701802|NCT02145078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25109745|NCT03122002|Aspirin|aspirin|mesh-list
25074682|NCT03386838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643171|NCT01184287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643172|NCT01184287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643173|NCT01184300|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24643174|NCT01184300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24643175|NCT01184378|Caseins|caseins|mesh-list
24643176|NCT01184378|Chelating Agents|chelating agents|mesh-ancestor
24643177|NCT01184378|Sequestering Agents|sequestering agents|mesh-ancestor
24643178|NCT01184378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074705|NCT03386630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074706|NCT03386630|Sensory System Agents|sensory system agents|mesh-ancestor
25074707|NCT03386630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25074708|NCT03386630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25074709|NCT03386630|Narcotics|narcotics|mesh-ancestor
25074710|NCT03386630|Analgesics|analgesics|mesh-ancestor
25074711|NCT03386630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25074712|NCT03386630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25074713|NCT03386630|Anesthetics, General|anesthetics, general|mesh-ancestor
25074714|NCT03386591|Naloxone|naloxone|mesh-list
25074715|NCT03386591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25074717|NCT03386591|Sensory System Agents|sensory system agents|mesh-ancestor
25074755|NCT03386305|Tacrolimus|tacrolimus|mesh-list
25074756|NCT03386305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25074757|NCT03386305|Immunologic Factors|immunologic factors|mesh-ancestor
25074758|NCT03386305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074759|NCT03386305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25074760|NCT03386305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25074761|NCT03386305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074762|NCT03386279|Moxifloxacin|moxifloxacin|mesh-list
25074763|NCT03386279|Abrocitinib|abrocitinib|mesh-list
25074764|NCT03386279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25074765|NCT03386279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25074766|NCT03386279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25074767|NCT03386279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25074768|NCT03386279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25074769|NCT03386279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074770|NCT03386279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25074771|NCT03386279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25074772|NCT03386227|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25074773|NCT03386227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25074774|NCT03386201|Methylene Blue|methylene blue|mesh-list
25074775|NCT03386201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25074787|NCT03386071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25074788|NCT03386071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25074789|NCT03386071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25074790|NCT03386071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074791|NCT03385967|Dexmedetomidine|dexmedetomidine|mesh-list
25074792|NCT03385967|Ropivacaine|ropivacaine|mesh-list
25074793|NCT03385967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25074794|NCT03385967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25074795|NCT03385967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074796|NCT03385967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25074807|NCT03385967|Anesthetics|anesthetics|mesh-ancestor
25074808|NCT03385863|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25074810|NCT03385863|Respiratory System Agents|respiratory system agents|mesh-ancestor
25074811|NCT03385668|Pirfenidone|pirfenidone|mesh-list
25074812|NCT03385668|Analgesics|analgesics|mesh-ancestor
25074813|NCT03385668|Sensory System Agents|sensory system agents|mesh-ancestor
24691903|NCT01409603|Anticoagulants|anticoagulants|mesh-ancestor
25074814|NCT03385668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25074815|NCT03385668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074816|NCT03385668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25074817|NCT03385668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25074818|NCT03385668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25074819|NCT03385668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24643179|NCT01184391|Valproic Acid|valproic acid|mesh-list
24643180|NCT01184391|Anticonvulsants|anticonvulsants|mesh-ancestor
24643181|NCT01184391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643182|NCT01184391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643183|NCT01184391|GABA Agents|gaba agents|mesh-ancestor
24643184|NCT01184391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24643185|NCT01184391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074820|NCT03385668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25074821|NCT03385551|Estradiol|estradiol|mesh-list
25701803|NCT02145078|Antimetabolites|antimetabolites|mesh-ancestor
25074822|NCT03385551|Estrogens|estrogens|mesh-ancestor
25074823|NCT03385551|Hormones|hormones|mesh-ancestor
25074824|NCT03385551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25074825|NCT03385551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074826|NCT03385538|Clopidogrel|clopidogrel|mesh-list
25074827|NCT03385538|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25074828|NCT03385538|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25074829|NCT03385538|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25074830|NCT03385538|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25074831|NCT03385538|Purinergic Agents|purinergic agents|mesh-ancestor
25074842|NCT03385525|Antimanic Agents|antimanic agents|mesh-ancestor
25074843|NCT03385525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25074844|NCT03385525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25074845|NCT03385525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25074846|NCT03385395|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25074847|NCT03385395|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25074848|NCT03385395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25074849|NCT03385395|Protease Inhibitors|protease inhibitors|mesh-ancestor
25074850|NCT03385395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25074851|NCT03385395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074853|NCT03385382|Ranibizumab|ranibizumab|mesh-list
24837932|NCT02194257|Ambroxol|ambroxol|mesh-list
25074858|NCT03385382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074859|NCT03385382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25074860|NCT03385382|Glucocorticoids|glucocorticoids|mesh-ancestor
25074861|NCT03385382|Hormones|hormones|mesh-ancestor
25074863|NCT03385382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25074903|NCT03385161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074904|NCT03385161|Cholinergic Agents|cholinergic agents|mesh-ancestor
25074905|NCT03385161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25074906|NCT03385161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074907|NCT03385161|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25074908|NCT03385161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25074909|NCT03385161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25074910|NCT03385161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25074911|NCT03385161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25074912|NCT03385135|Allopurinol|allopurinol|mesh-list
25074913|NCT03385135|Antimetabolites|antimetabolites|mesh-ancestor
25074914|NCT03385135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25074915|NCT03385135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25074916|NCT03385135|Gout Suppressants|gout suppressants|mesh-ancestor
25074917|NCT03385135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25074918|NCT03385135|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25074919|NCT03385135|Antioxidants|antioxidants|mesh-ancestor
25074920|NCT03385135|Protective Agents|protective agents|mesh-ancestor
25074921|NCT03385135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074922|NCT03385096|Cyclophosphamide|cyclophosphamide|mesh-list
25074923|NCT03385096|Melphalan|melphalan|mesh-list
25074924|NCT03385096|Busulfan|busulfan|mesh-list
25074925|NCT03385096|Etoposide|etoposide|mesh-list
24643187|NCT01184391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24643188|NCT01184391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24643189|NCT01184391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24643190|NCT01184404|Bosentan|bosentan|mesh-list
24643191|NCT01184404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25075271|NCT03382431|Antiviral Agents|antiviral agents|mesh-ancestor
25074935|NCT03385096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25074936|NCT03385096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25074937|NCT03385096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25074938|NCT03385096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25074939|NCT03385057|Acetaminophen|acetaminophen|mesh-list
25074941|NCT03385057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25074942|NCT03385057|Analgesics|analgesics|mesh-ancestor
25074943|NCT03385057|Sensory System Agents|sensory system agents|mesh-ancestor
25074944|NCT03385057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25074945|NCT03385057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25074946|NCT03385057|Antipyretics|antipyretics|mesh-ancestor
25074947|NCT03385057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25074948|NCT03385057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25074949|NCT03385057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25074950|NCT03385057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25074951|NCT03385057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25074953|NCT03384862|Folic Acid|folic acid|mesh-list
25701804|NCT02145078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643301|NCT01185067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24643302|NCT01185067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24643304|NCT01185119|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24643305|NCT01185119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24643306|NCT01185119|Hormones|hormones|mesh-ancestor
25074999|NCT03384277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075001|NCT03384277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25075002|NCT03384277|Alkylating Agents|alkylating agents|mesh-ancestor
25075055|NCT03383406|Abortifacient Agents|abortifacient agents|mesh-ancestor
25075056|NCT03383406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25075057|NCT03383406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075058|NCT03383406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25075059|NCT03383406|Antimetabolites|antimetabolites|mesh-ancestor
25075060|NCT03383406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075061|NCT03383406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075062|NCT03383406|Dermatologic Agents|dermatologic agents|mesh-ancestor
25075063|NCT03383406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075064|NCT03383406|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25075065|NCT03383406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25075066|NCT03383406|Immunologic Factors|immunologic factors|mesh-ancestor
25075067|NCT03383406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24954272|NCT03877549|Antiemetics|antiemetics|mesh-ancestor
24954275|NCT03877549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954276|NCT03877549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24954277|NCT03877549|Glucocorticoids|glucocorticoids|mesh-ancestor
24954278|NCT03877549|Hormones|hormones|mesh-ancestor
24954279|NCT03877549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24954280|NCT03877549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24954281|NCT03877549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24954283|NCT03877874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24954322|NCT03877679|Analgesics|analgesics|mesh-ancestor
24954323|NCT03877679|Sensory System Agents|sensory system agents|mesh-ancestor
24954324|NCT03877679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24954325|NCT03877679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24954326|NCT03877679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24954327|NCT03877562|Olanzapine|olanzapine|mesh-list
24954328|NCT03877562|Antiemetics|antiemetics|mesh-ancestor
24954329|NCT03877562|Autonomic Agents|autonomic agents|mesh-ancestor
24954330|NCT03877562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24954331|NCT03877562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954332|NCT03877562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24954333|NCT03877562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24954334|NCT03877562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24954335|NCT03877562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24954336|NCT03877562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25075070|NCT03383406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25075071|NCT03383406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25075072|NCT03383406|Antiviral Agents|antiviral agents|mesh-ancestor
25075073|NCT03383406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25075074|NCT03383406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25075075|NCT03383406|Alkylating Agents|alkylating agents|mesh-ancestor
25075076|NCT03383393|Adenosine|adenosine|mesh-list
25075077|NCT03383393|Eptifibatide|eptifibatide|mesh-list
25075078|NCT03383393|Analgesics|analgesics|mesh-ancestor
25075094|NCT03383367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075112|NCT03383328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25075113|NCT03383328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25075114|NCT03383328|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25075115|NCT03383328|Protective Agents|protective agents|mesh-ancestor
25075116|NCT03383328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25075117|NCT03383328|Analgesics|analgesics|mesh-ancestor
25075118|NCT03383328|Sensory System Agents|sensory system agents|mesh-ancestor
25075119|NCT03383328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25075120|NCT03383315|Tramadol|tramadol|mesh-list
25075121|NCT03383315|Metoclopramide|metoclopramide|mesh-list
25075123|NCT03383315|Narcotics|narcotics|mesh-ancestor
25075136|NCT03383315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075137|NCT03383302|Nivolumab|nivolumab|mesh-list
25075138|NCT03383302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25075139|NCT03383302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075140|NCT03383302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25075141|NCT03383302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075142|NCT03383276|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24724533|NCT01593410|Antiemetics|antiemetics|mesh-ancestor
24724534|NCT01593410|Autonomic Agents|autonomic agents|mesh-ancestor
25075143|NCT03383276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25075144|NCT03383237|Apatinib|apatinib|mesh-list
25075145|NCT03383237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075181|NCT03383068|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25075183|NCT03383068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075184|NCT03383068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25075185|NCT03383003|Amoxicillin|amoxicillin|mesh-list
25075186|NCT03383003|Metronidazole|metronidazole|mesh-list
25075187|NCT03383003|Clarithromycin|clarithromycin|mesh-list
25075188|NCT03383003|Esomeprazole|esomeprazole|mesh-list
25075189|NCT03383003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25075190|NCT03383003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25075191|NCT03383003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25075192|NCT03383003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25075193|NCT03383003|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25075194|NCT03383003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25075195|NCT03383003|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25075196|NCT03383003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075197|NCT03383003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075198|NCT03383003|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25075199|NCT03383003|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25075200|NCT03383003|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25075226|NCT03382886|Growth Inhibitors|growth inhibitors|mesh-ancestor
25075227|NCT03382886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25075228|NCT03382886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075229|NCT03382756|Choline|choline|mesh-list
25075230|NCT03382756|Atorvastatin|atorvastatin|mesh-list
25075231|NCT03382756|Fenofibrate|fenofibrate|mesh-list
25075232|NCT03382756|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25075233|NCT03382756|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25075234|NCT03382756|Antimetabolites|antimetabolites|mesh-ancestor
25075235|NCT03382756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075236|NCT03382756|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25075237|NCT03382756|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25075238|NCT03382756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075239|NCT03382756|Lipotropic Agents|lipotropic agents|mesh-ancestor
25075240|NCT03382756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25075241|NCT03382756|Nootropic Agents|nootropic agents|mesh-ancestor
25075242|NCT03382743|Lidocaine|lidocaine|mesh-list
24643314|NCT01185158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643315|NCT01185184|Tofacitinib|tofacitinib|mesh-list
24643316|NCT01185184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24643317|NCT01185184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643334|NCT01185197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25075272|NCT03382431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25075273|NCT03382431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075274|NCT03382431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954337|NCT03877562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24954338|NCT03877562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24954339|NCT03877562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24643338|NCT01185223|Antiviral Agents|antiviral agents|mesh-ancestor
24643339|NCT01185223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24954340|NCT03877562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075275|NCT03382314|Cholecalciferol|cholecalciferol|mesh-list
25075276|NCT03382314|Vitamin D|vitamin d|mesh-list
25075277|NCT03382314|Bazedoxifene|bazedoxifene|mesh-list
25075278|NCT03382314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25075279|NCT03382314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075280|NCT03382314|Vitamins|vitamins|mesh-ancestor
25075281|NCT03382314|Micronutrients|micronutrients|mesh-ancestor
25075350|NCT03381664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25075351|NCT03381664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25075352|NCT03381664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075353|NCT03381664|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25075354|NCT03381664|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25701805|NCT02145078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25701806|NCT02145078|Antiviral Agents|antiviral agents|mesh-ancestor
25701807|NCT02145078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25075355|NCT03381664|Cholinergic Agents|cholinergic agents|mesh-ancestor
25701808|NCT02145078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075357|NCT03381664|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25075358|NCT03381664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25075361|NCT03381599|Lenograstim|lenograstim|mesh-list
25075362|NCT03381599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25075363|NCT03381599|Immunologic Factors|immunologic factors|mesh-ancestor
25075364|NCT03381599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075365|NCT03381495|Sufentanil|sufentanil|mesh-list
25075366|NCT03381495|Ropivacaine|ropivacaine|mesh-list
25075367|NCT03381495|Anesthetics, Local|anesthetics, local|mesh-ancestor
25075368|NCT03381495|Anesthetics|anesthetics|mesh-ancestor
25075369|NCT03381495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25075370|NCT03381495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075371|NCT03381495|Sensory System Agents|sensory system agents|mesh-ancestor
25075372|NCT03381495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25075373|NCT03381495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25075374|NCT03381495|Narcotics|narcotics|mesh-ancestor
25075375|NCT03381495|Analgesics|analgesics|mesh-ancestor
25075418|NCT03381118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25075419|NCT03381118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25075420|NCT03381118|Immunologic Factors|immunologic factors|mesh-ancestor
25075421|NCT03381118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075422|NCT03381066|Cisplatin|cisplatin|mesh-list
25075423|NCT03381066|Pemetrexed|pemetrexed|mesh-list
25075424|NCT03381066|Vinorelbine|vinorelbine|mesh-list
25075425|NCT03381066|Gefitinib|gefitinib|mesh-list
25075426|NCT03381066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075427|NCT03381066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075428|NCT03381066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075429|NCT03381066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25075430|NCT03381066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25075431|NCT03381066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25075432|NCT03381066|Tubulin Modulators|tubulin modulators|mesh-ancestor
25075433|NCT03381066|Antimitotic Agents|antimitotic agents|mesh-ancestor
25075434|NCT03381066|Mitosis Modulators|mitosis modulators|mesh-ancestor
25075435|NCT03381066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25075436|NCT03381053|Imatinib Mesylate|imatinib mesylate|mesh-list
25075437|NCT03381053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075438|NCT03381053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25075472|NCT03380936|Immunologic Factors|immunologic factors|mesh-ancestor
25075473|NCT03380936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075474|NCT03380936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24838626|NCT02198924|Celecoxib|celecoxib|mesh-list
24643340|NCT01185223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25075478|NCT03380871|Pembrolizumab|pembrolizumab|mesh-list
25075479|NCT03380871|Pemetrexed|pemetrexed|mesh-list
25075480|NCT03380871|Poly ICLC|poly iclc|mesh-list
25075481|NCT03380871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075482|NCT03380871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25075483|NCT03380871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24810776|NCT02042482|Ubiquinone|ubiquinone|mesh-list
24954376|NCT03877120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24954377|NCT03877120|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24954378|NCT03877120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24954379|NCT03877120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24954380|NCT03877120|Adrenergic Agents|adrenergic agents|mesh-ancestor
24954381|NCT03877120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24780105|NCT01881568|Tranexamic Acid|tranexamic acid|mesh-list
24780106|NCT01881568|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24780107|NCT01881568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24780108|NCT01881568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780109|NCT01881568|Hemostatics|hemostatics|mesh-ancestor
24780110|NCT01881568|Coagulants|coagulants|mesh-ancestor
24626456|NCT01087476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24626457|NCT01087476|Antimalarials|antimalarials|mesh-ancestor
25075531|NCT03380468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075532|NCT03380468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075533|NCT03380468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727716|NCT01612273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727717|NCT01612273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25075534|NCT03380468|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25075535|NCT03380468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25075540|NCT03380442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25075541|NCT03380442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075542|NCT03380442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25075543|NCT03380442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25075544|NCT03380442|Anesthetics, General|anesthetics, general|mesh-ancestor
25075546|NCT03380442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25075547|NCT03380442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25075548|NCT03380442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25075549|NCT03380442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25075550|NCT03380442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075551|NCT03380442|Hallucinogens|hallucinogens|mesh-ancestor
25075552|NCT03380442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25075553|NCT03380403|Ciprofloxacin|ciprofloxacin|mesh-list
25075563|NCT03380325|Iloprost|iloprost|mesh-list
25075596|NCT03379974|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25075597|NCT03379974|Natriuretic Agents|natriuretic agents|mesh-ancestor
25075598|NCT03379974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075600|NCT03379909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25075601|NCT03379909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075602|NCT03379779|Dimercaprol|dimercaprol|mesh-list
25075603|NCT03379779|Chelating Agents|chelating agents|mesh-ancestor
25075604|NCT03379779|Sequestering Agents|sequestering agents|mesh-ancestor
25075605|NCT03379779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075606|NCT03379441|Pembrolizumab|pembrolizumab|mesh-list
25075607|NCT03379441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25075608|NCT03379441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075609|NCT03379194|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25075610|NCT03379194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25075611|NCT03379181|Propranolol|propranolol|mesh-list
25075612|NCT03379181|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25075623|NCT03379103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25075624|NCT03379103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25075625|NCT03379103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075626|NCT03379103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25075627|NCT03379103|Anesthetics, General|anesthetics, general|mesh-ancestor
25075628|NCT03379103|Anesthetics|anesthetics|mesh-ancestor
25075629|NCT03379103|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25075630|NCT03379103|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24626460|NCT01087554|Sirolimus|sirolimus|mesh-list
24626461|NCT01087554|Everolimus|everolimus|mesh-list
25075656|NCT03378960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075658|NCT03378934|Clopidogrel|clopidogrel|mesh-list
25075659|NCT03378934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25075660|NCT03378934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25075661|NCT03378934|Analgesics|analgesics|mesh-ancestor
25075662|NCT03378934|Sensory System Agents|sensory system agents|mesh-ancestor
25075663|NCT03378934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25075664|NCT03378934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075665|NCT03378934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25075666|NCT03378934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25075667|NCT03378934|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24626478|NCT01087567|Glimepiride|glimepiride|mesh-list
24626479|NCT01087567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25075668|NCT03378934|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25075670|NCT03378934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25075717|NCT03378427|Ciprofloxacin|ciprofloxacin|mesh-list
24838940|NCT02201199|Insulin|insulin|mesh-list
24643344|NCT01185236|Simvastatin|simvastatin|mesh-list
24643346|NCT01185236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24643347|NCT01185236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24643348|NCT01185236|Antimetabolites|antimetabolites|mesh-ancestor
24643349|NCT01185236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643350|NCT01185236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24643351|NCT01185236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24643352|NCT01185236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643353|NCT01185262|Rituximab|rituximab|mesh-list
24643354|NCT01185262|Lenalidomide|lenalidomide|mesh-list
25701809|NCT02145078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25701810|NCT02145078|Immunologic Factors|immunologic factors|mesh-ancestor
24728835|NCT01618591|Azithromycin|azithromycin|mesh-list
24728837|NCT01618591|Ofloxacin|ofloxacin|mesh-list
24643355|NCT01185262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24643356|NCT01185262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24643357|NCT01185262|Immunologic Factors|immunologic factors|mesh-ancestor
24643358|NCT01185262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643359|NCT01185262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24643362|NCT01185262|Growth Substances|growth substances|mesh-ancestor
24643387|NCT01185418|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25075719|NCT03378427|Ofloxacin|ofloxacin|mesh-list
25075720|NCT03378427|Minocycline|minocycline|mesh-list
25075721|NCT03378427|Rifampin|rifampin|mesh-list
25075722|NCT03378427|Clindamycin|clindamycin|mesh-list
25075723|NCT03378427|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25075724|NCT03378427|Tedizolid|tedizolid|mesh-list
25075725|NCT03378427|Teicoplanin|teicoplanin|mesh-list
25075726|NCT03378427|Fusidic Acid|fusidic acid|mesh-list
25075727|NCT03378427|Tedizolid phosphate|tedizolid phosphate|mesh-list
25075728|NCT03378427|Trimethoprim|trimethoprim|mesh-list
25075729|NCT03378427|Sulfamethoxazole|sulfamethoxazole|mesh-list
25075744|NCT03378427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25075745|NCT03378427|Antitubercular Agents|antitubercular agents|mesh-ancestor
25075746|NCT03378427|Leprostatic Agents|leprostatic agents|mesh-ancestor
25075747|NCT03378427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25075748|NCT03378427|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25075749|NCT03378427|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25075750|NCT03378427|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25075751|NCT03378427|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25075752|NCT03378427|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25075757|NCT03378427|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25075759|NCT03378401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24961677|NCT03806036|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25075760|NCT03378401|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25075761|NCT03378323|Anesthetics|anesthetics|mesh-list
25075762|NCT03378323|Anesthetics, Local|anesthetics, local|mesh-list
25075763|NCT03378323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25075764|NCT03378323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075765|NCT03378323|Sensory System Agents|sensory system agents|mesh-ancestor
25075766|NCT03378323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25075767|NCT03378310|Linrodostat|linrodostat|mesh-list
25075768|NCT03378310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075769|NCT03378310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075770|NCT03378297|Aspirin|aspirin|mesh-list
25075771|NCT03378297|Metformin|metformin|mesh-list
25075772|NCT03378297|Letrozole|letrozole|mesh-list
25075773|NCT03378297|Olaparib|olaparib|mesh-list
25075774|NCT03378297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25075775|NCT03378297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075776|NCT03378297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075788|NCT03378297|Sensory System Agents|sensory system agents|mesh-ancestor
25075795|NCT03378297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25075797|NCT03377907|Lidocaine|lidocaine|mesh-list
25075798|NCT03377907|Ketamine|ketamine|mesh-list
25075799|NCT03377907|Anesthetics, Local|anesthetics, local|mesh-ancestor
25075800|NCT03377907|Anesthetics|anesthetics|mesh-ancestor
25075801|NCT03377907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25075802|NCT03377907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075803|NCT03377907|Sensory System Agents|sensory system agents|mesh-ancestor
25075804|NCT03377907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25075805|NCT03377907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25075806|NCT03377907|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25075807|NCT03377907|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25075808|NCT03377907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25075809|NCT03377907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075810|NCT03377907|Analgesics|analgesics|mesh-ancestor
25075839|NCT03377725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075840|NCT03377725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25075841|NCT03377725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075842|NCT03377608|Tenofovir|tenofovir|mesh-list
25075843|NCT03377608|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25075844|NCT03377608|Medroxyprogesterone|medroxyprogesterone|mesh-list
25075845|NCT03377608|Antiviral Agents|antiviral agents|mesh-ancestor
25075846|NCT03377608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25701811|NCT02145078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701812|NCT02145078|Tubulin Modulators|tubulin modulators|mesh-ancestor
25075847|NCT03377608|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25075848|NCT03377608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25075849|NCT03377608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075850|NCT03377608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075852|NCT03377608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25075853|NCT03377608|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25075854|NCT03377608|Contraceptive Agents|contraceptive agents|mesh-ancestor
25075855|NCT03377608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25075856|NCT03377608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839065|NCT02201914|Contraceptive Agents|contraceptive agents|mesh-ancestor
24643403|NCT01185418|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24643404|NCT01185444|Hyaluronic Acid|hyaluronic acid|mesh-list
24643405|NCT01185444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24643406|NCT01185444|Immunologic Factors|immunologic factors|mesh-ancestor
24643407|NCT01185444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643488|NCT01185847|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25075904|NCT03377348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075905|NCT03377348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25075907|NCT03377348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075908|NCT03377348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075910|NCT03377335|Dapagliflozin|dapagliflozin|mesh-list
25075911|NCT03377335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25075912|NCT03377335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25075913|NCT03377335|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25075914|NCT03377335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25075915|NCT03377283|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25075916|NCT03377283|Thymoglobulin|thymoglobulin|mesh-list
25075917|NCT03377283|Immunologic Factors|immunologic factors|mesh-ancestor
25075918|NCT03377283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643493|NCT01185860|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24998421|NCT02881957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24998444|NCT02761694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24998445|NCT02761694|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24998461|NCT02691793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24998462|NCT02691793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24998463|NCT02691793|Growth Substances|growth substances|mesh-ancestor
24998511|NCT02574455|Vinorelbine|vinorelbine|mesh-list
24998512|NCT02574455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24998513|NCT02574455|Antimetabolites|antimetabolites|mesh-ancestor
24998514|NCT02574455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998515|NCT02574455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998516|NCT02574455|Antiviral Agents|antiviral agents|mesh-ancestor
24998517|NCT02574455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24998519|NCT02574455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24998520|NCT02574455|Immunologic Factors|immunologic factors|mesh-ancestor
24998521|NCT02574455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998522|NCT02574455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24998523|NCT02574455|Tubulin Modulators|tubulin modulators|mesh-ancestor
24998524|NCT02574455|Antimitotic Agents|antimitotic agents|mesh-ancestor
24998525|NCT02574455|Mitosis Modulators|mitosis modulators|mesh-ancestor
24998527|NCT02566304|Mycophenolic Acid|mycophenolic acid|mesh-list
24998528|NCT02566304|Cyclophosphamide|cyclophosphamide|mesh-list
24998529|NCT02566304|Fludarabine|fludarabine|mesh-list
24998530|NCT02566304|Fludarabine phosphate|fludarabine phosphate|mesh-list
24998574|NCT02518594|Progesterone|progesterone|mesh-list
24998575|NCT02518594|Progestins|progestins|mesh-ancestor
24936431|NCT04040465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24936432|NCT04040465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24936433|NCT04040465|Antipyretics|antipyretics|mesh-ancestor
24936434|NCT04040452|Ketorolac|ketorolac|mesh-list
24936435|NCT04040452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24936436|NCT04040452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24936437|NCT04040452|Analgesics|analgesics|mesh-ancestor
24936438|NCT04040452|Sensory System Agents|sensory system agents|mesh-ancestor
24998629|NCT02426281|Mitosis Modulators|mitosis modulators|mesh-ancestor
24998630|NCT02426281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24998631|NCT02426281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24998632|NCT02426281|Antimetabolites|antimetabolites|mesh-ancestor
24998633|NCT02426281|Antiviral Agents|antiviral agents|mesh-ancestor
24998634|NCT02426281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24998635|NCT02426281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998636|NCT02426281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24998637|NCT02426281|Immunologic Factors|immunologic factors|mesh-ancestor
24998638|NCT02426281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998639|NCT02397083|Everolimus|everolimus|mesh-list
24998640|NCT02397083|Levonorgestrel|levonorgestrel|mesh-list
24998641|NCT02397083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998642|NCT02397083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24998643|NCT02397083|Immunologic Factors|immunologic factors|mesh-ancestor
24998644|NCT02397083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998645|NCT02397083|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24998646|NCT02397083|Contraceptive Agents|contraceptive agents|mesh-ancestor
25048631|NCT00680342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048632|NCT00680342|Protective Agents|protective agents|mesh-ancestor
25048633|NCT00680342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048634|NCT00679731|Methotrexate|methotrexate|mesh-list
25048635|NCT00679731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25048636|NCT00679731|Abortifacient Agents|abortifacient agents|mesh-ancestor
25048637|NCT00679731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25048638|NCT00679731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998735|NCT01376427|Dermatologic Agents|dermatologic agents|mesh-ancestor
24998736|NCT01376427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24998737|NCT01376427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24998738|NCT01376427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24998739|NCT01376427|Immunologic Factors|immunologic factors|mesh-ancestor
24998740|NCT01376427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24998741|NCT01376427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24998742|NCT01376427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24998743|NCT01376427|Tubulin Modulators|tubulin modulators|mesh-ancestor
24998744|NCT01376427|Antimitotic Agents|antimitotic agents|mesh-ancestor
24998745|NCT01376427|Mitosis Modulators|mitosis modulators|mesh-ancestor
24998746|NCT01096966|Bupivacaine|bupivacaine|mesh-list
24998787|NCT00145795|Antiviral Agents|antiviral agents|mesh-ancestor
24998788|NCT00145795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24998789|NCT00145795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24998790|NCT00145795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24998791|NCT00005044|Bicalutamide|bicalutamide|mesh-list
24998793|NCT00005044|Hormones|hormones|mesh-list
24998794|NCT00005044|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24998795|NCT00005044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24998796|NCT00005044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998797|NCT00005044|Androgen Antagonists|androgen antagonists|mesh-ancestor
24998798|NCT00005044|Hormone Antagonists|hormone antagonists|mesh-ancestor
24998799|NCT00005044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24998800|NCT00005044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24998801|NCT00002874|Bicalutamide|bicalutamide|mesh-list
24643500|NCT01185860|Antiviral Agents|antiviral agents|mesh-ancestor
24643501|NCT01185860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24643502|NCT01185860|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24448713|NCT00312754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24448730|NCT00312819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643537|NCT01185977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24643538|NCT01185977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24998838|NCT05422131|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24998839|NCT05422131|Serotonin Agents|serotonin agents|mesh-ancestor
24998840|NCT05422131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24998841|NCT05422131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701813|NCT02145078|Antimitotic Agents|antimitotic agents|mesh-ancestor
25701814|NCT02145078|Mitosis Modulators|mitosis modulators|mesh-ancestor
25701815|NCT02145078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25701816|NCT02145078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25701817|NCT02145182|Eculizumab|eculizumab|mesh-list
24998842|NCT05422131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24998843|NCT05422131|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24730443|NCT01627938|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24730444|NCT01627938|Protective Agents|protective agents|mesh-ancestor
24730445|NCT01627938|Antimitotic Agents|antimitotic agents|mesh-ancestor
24730446|NCT01627938|Mitosis Modulators|mitosis modulators|mesh-ancestor
24730447|NCT01628055|Immunoglobulins|immunoglobulins|mesh-list
24998844|NCT05422131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24998845|NCT05422131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24998846|NCT05422131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24998847|NCT05422131|GABA Antagonists|gaba antagonists|mesh-ancestor
24998848|NCT05422131|GABA Agents|gaba agents|mesh-ancestor
24999001|NCT05393713|Immunologic Factors|immunologic factors|mesh-ancestor
24999002|NCT05393713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999003|NCT05388006|Durvalumab|durvalumab|mesh-list
24936978|NCT04034199|Denosumab|denosumab|mesh-list
24936979|NCT04034199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24936980|NCT04034199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936981|NCT04033939|Propofol|propofol|mesh-list
24936982|NCT04033939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24936983|NCT04033939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24936984|NCT04033939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936985|NCT04033939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24936986|NCT04033939|Anesthetics, General|anesthetics, general|mesh-ancestor
24936987|NCT04033939|Anesthetics|anesthetics|mesh-ancestor
24761535|NCT01763021|Leprostatic Agents|leprostatic agents|mesh-ancestor
24798282|NCT01962181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24798283|NCT01962181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24798284|NCT01962181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798285|NCT01962181|Dopamine Agents|dopamine agents|mesh-ancestor
25048704|NCT00675844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048706|NCT00675844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25048707|NCT00675844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25048708|NCT00675844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25048709|NCT00674440|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
25048710|NCT00674440|Dopamine Agents|dopamine agents|mesh-ancestor
25048711|NCT00674440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25048723|NCT00673478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25048724|NCT00673478|Cholinergic Agents|cholinergic agents|mesh-ancestor
25048725|NCT00673478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25048726|NCT00673478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048727|NCT00673478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25048728|NCT00673478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25048729|NCT00673478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25048730|NCT00673478|Adrenergic Agents|adrenergic agents|mesh-ancestor
25048731|NCT00673062|Pseudoephedrine|pseudoephedrine|mesh-list
25048733|NCT00673062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25048734|NCT00673062|Autonomic Agents|autonomic agents|mesh-ancestor
24798296|NCT01962363|Antioxidants|antioxidants|mesh-ancestor
24798297|NCT01962363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798298|NCT01962363|Protective Agents|protective agents|mesh-ancestor
24798299|NCT01962363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643641|NCT01186471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24643646|NCT01186471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24643647|NCT01186471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643649|NCT01186497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24643650|NCT01186497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24643651|NCT01186497|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24643652|NCT01186497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643653|NCT01186497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643654|NCT01186549|Lidocaine|lidocaine|mesh-list
24643663|NCT01186549|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24643664|NCT01186549|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25701818|NCT02145182|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25701819|NCT02145182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25701820|NCT02145182|Immunologic Factors|immunologic factors|mesh-ancestor
25701821|NCT02145182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701822|NCT02145247|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24730767|NCT01630278|Analgesics|analgesics|mesh-ancestor
24730798|NCT01630538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730799|NCT01630538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24643665|NCT01186549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24643666|NCT01186549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24643667|NCT01186549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798301|NCT01962363|Micronutrients|micronutrients|mesh-ancestor
24798302|NCT01962376|Bevacizumab|bevacizumab|mesh-list
24798303|NCT01962376|Capecitabine|capecitabine|mesh-list
24798304|NCT01962376|Oxaliplatin|oxaliplatin|mesh-list
24798305|NCT01962376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24798306|NCT01962376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24798307|NCT01962376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24943693|NCT03967665|Acetylcysteine|acetylcysteine|mesh-list
24798308|NCT01962376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24798309|NCT01962376|Growth Substances|growth substances|mesh-ancestor
24798310|NCT01962376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798311|NCT01962376|Growth Inhibitors|growth inhibitors|mesh-ancestor
24798312|NCT01962376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24798313|NCT01962376|Antimetabolites|antimetabolites|mesh-ancestor
24798314|NCT01962376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798315|NCT01962454|Methyltestosterone|methyltestosterone|mesh-list
24798316|NCT01962454|Testosterone|testosterone|mesh-list
24798325|NCT01962454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24798326|NCT01962454|Anabolic Agents|anabolic agents|mesh-ancestor
24798327|NCT01962571|Epoetin Alfa|epoetin alfa|mesh-list
24798328|NCT01962571|Hematinics|hematinics|mesh-ancestor
24798347|NCT01962831|Dinoprostone|dinoprostone|mesh-list
24798348|NCT01962831|Oxytocics|oxytocics|mesh-ancestor
24798349|NCT01962831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24999057|NCT05312762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24999058|NCT05312762|Antimetabolites|antimetabolites|mesh-ancestor
24999059|NCT05312762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999066|NCT05312762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24999098|NCT05202964|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24999099|NCT05202964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24999161|NCT05095116|Dermatologic Agents|dermatologic agents|mesh-ancestor
24999162|NCT05095116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24999163|NCT05083312|Fluticasone|fluticasone|mesh-list
24999164|NCT05083312|Xhance|xhance|mesh-list
24999165|NCT05083312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24999166|NCT05083312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24999167|NCT05083312|Autonomic Agents|autonomic agents|mesh-ancestor
24840137|NCT02207920|Vaccines|vaccines|mesh-list
24643695|NCT01186653|Dermatologic Agents|dermatologic agents|mesh-ancestor
24643696|NCT01186653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24643697|NCT01186653|Glucocorticoids|glucocorticoids|mesh-ancestor
24643698|NCT01186653|Hormones|hormones|mesh-ancestor
24643699|NCT01186653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24999236|NCT04884399|Ranibizumab|ranibizumab|mesh-list
24999237|NCT04884399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24999238|NCT04884399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24999239|NCT04884399|Growth Substances|growth substances|mesh-ancestor
24999240|NCT04884399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999241|NCT04884399|Growth Inhibitors|growth inhibitors|mesh-ancestor
24999242|NCT04884399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999243|NCT04850599|Pomalidomide|pomalidomide|mesh-list
24999244|NCT04850599|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24999245|NCT04850599|Immunologic Factors|immunologic factors|mesh-ancestor
24999246|NCT04850599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999259|NCT04839328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24937259|NCT04031703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24937260|NCT04031703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24937261|NCT04031703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24937262|NCT04031703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24761871|NCT01765010|Vitamin D|vitamin d|mesh-list
24798350|NCT01962831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701823|NCT02145247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25701824|NCT02145247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701825|NCT02145676|Botulinum Toxins|botulinum toxins|mesh-list
24798351|NCT01963039|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
24798352|NCT01963039|Vasodilator Agents|vasodilator agents|mesh-ancestor
24798360|NCT01963182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798362|NCT01963221|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24643740|NCT01186887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643741|NCT01186887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643742|NCT01187108|Acetylcysteine|acetylcysteine|mesh-list
24643743|NCT01187108|Acetazolamide|acetazolamide|mesh-list
24643744|NCT01187108|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25048788|NCT00668772|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25048789|NCT00668772|Cholinergic Agents|cholinergic agents|mesh-ancestor
25048790|NCT00668772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24999323|NCT04565847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24999324|NCT04565847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24999325|NCT04565847|Respiratory System Agents|respiratory system agents|mesh-ancestor
24999326|NCT04565847|Tocolytic Agents|tocolytic agents|mesh-ancestor
24999327|NCT04565847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24999328|NCT04565847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24999334|NCT04554732|Mitogens|mitogens|mesh-list
24999380|NCT04504045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24999381|NCT04504045|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24999382|NCT04504045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24999383|NCT04504045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24999384|NCT04504045|Adrenergic Agents|adrenergic agents|mesh-ancestor
24798397|NCT01963416|Trace Elements|trace elements|mesh-list
24798398|NCT01963416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798399|NCT01963442|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24798401|NCT01963442|beta-Lactams|beta-lactams|mesh-list
24937544|NCT04027829|Analgesics|analgesics|mesh-ancestor
24937545|NCT04027829|Sensory System Agents|sensory system agents|mesh-ancestor
24937546|NCT04027829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937547|NCT04027829|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24937548|NCT04027829|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24937549|NCT04027829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24937550|NCT04027829|Adrenergic Agents|adrenergic agents|mesh-ancestor
24937553|NCT04027764|Paclitaxel|paclitaxel|mesh-list
24937583|NCT04027959|Hematinics|hematinics|mesh-ancestor
24999720|NCT03492671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24999721|NCT03492671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999722|NCT03492671|Tubulin Modulators|tubulin modulators|mesh-ancestor
24999723|NCT03492671|Antimitotic Agents|antimitotic agents|mesh-ancestor
24999724|NCT03492671|Mitosis Modulators|mitosis modulators|mesh-ancestor
24999725|NCT03492671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24999726|NCT03492671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24999727|NCT03492671|Antimetabolites|antimetabolites|mesh-ancestor
24643766|NCT01187212|Capecitabine|capecitabine|mesh-list
24643768|NCT01187212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24643769|NCT01187212|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24643827|NCT01187589|Respiratory System Agents|respiratory system agents|mesh-ancestor
24999738|NCT03477630|Viscosupplements|viscosupplements|mesh-ancestor
24999739|NCT03477630|Protective Agents|protective agents|mesh-ancestor
24999741|NCT03426657|Tremelimumab|tremelimumab|mesh-list
24999742|NCT03426657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24999743|NCT03426657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24643841|NCT01187615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24643842|NCT01187615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24643844|NCT01187719|Anticonvulsants|anticonvulsants|mesh-ancestor
24643849|NCT01187719|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24999797|NCT03188796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24643861|NCT01187862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24999798|NCT03188796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24999800|NCT03174353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24937826|NCT04025203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24937827|NCT04025203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24937828|NCT04025203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24937829|NCT04025203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24937830|NCT04025203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24937831|NCT04025203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24937832|NCT04025203|Antimanic Agents|antimanic agents|mesh-ancestor
24937833|NCT04025177|Indomethacin|indomethacin|mesh-list
24937834|NCT04025177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24937835|NCT04025177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24937836|NCT04025177|Analgesics|analgesics|mesh-ancestor
24937837|NCT04025177|Sensory System Agents|sensory system agents|mesh-ancestor
24937838|NCT04025177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937839|NCT04025177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937840|NCT04025177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24937841|NCT04025177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24937842|NCT04025177|Gout Suppressants|gout suppressants|mesh-ancestor
24937843|NCT04025177|Tocolytic Agents|tocolytic agents|mesh-ancestor
24937846|NCT04025177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24999905|NCT02884219|Gout Suppressants|gout suppressants|mesh-ancestor
24999906|NCT02884219|Tocolytic Agents|tocolytic agents|mesh-ancestor
24999907|NCT02884219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24999910|NCT02880371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999911|NCT02727803|Cyclophosphamide|cyclophosphamide|mesh-list
24999912|NCT02727803|Melphalan|melphalan|mesh-list
24999913|NCT02727803|Busulfan|busulfan|mesh-list
24999914|NCT02727803|Mechlorethamine|mechlorethamine|mesh-list
24999915|NCT02727803|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25048830|NCT00662740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048831|NCT00662740|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25048832|NCT00662740|Respiratory System Agents|respiratory system agents|mesh-ancestor
24999916|NCT02727803|Rituximab|rituximab|mesh-list
24999917|NCT02727803|Fludarabine|fludarabine|mesh-list
24999918|NCT02727803|Fludarabine phosphate|fludarabine phosphate|mesh-list
24999919|NCT02727803|Clofarabine|clofarabine|mesh-list
24999920|NCT02727803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24999921|NCT02727803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24999957|NCT02532660|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24999958|NCT02532660|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24841144|NCT02214433|Pantoprazole|pantoprazole|mesh-list
24841145|NCT02214433|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24841146|NCT02214433|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24841147|NCT02214433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24841148|NCT02214433|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24643863|NCT01187862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24643905|NCT01187862|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24643906|NCT01187862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24643908|NCT01187888|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24643930|NCT01188005|Antioxidants|antioxidants|mesh-ancestor
24643931|NCT01188005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643932|NCT01188005|Protective Agents|protective agents|mesh-ancestor
24643933|NCT01188005|Antiviral Agents|antiviral agents|mesh-ancestor
24643934|NCT01188005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24643935|NCT01188005|Expectorants|expectorants|mesh-ancestor
24643936|NCT01188005|Respiratory System Agents|respiratory system agents|mesh-ancestor
24643937|NCT01188005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24643938|NCT01188005|Antidotes|antidotes|mesh-ancestor
24643939|NCT01188005|Antimetabolites|antimetabolites|mesh-ancestor
24999979|NCT02434354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999981|NCT02419417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24999982|NCT02419417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24999983|NCT02419417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24999984|NCT02419417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448961|NCT00313625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24448963|NCT00313625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24448965|NCT00313690|Bortezomib|bortezomib|mesh-list
24999985|NCT02342275|Propranolol|propranolol|mesh-list
24999986|NCT02342275|Atenolol|atenolol|mesh-list
24999987|NCT02342275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24999988|NCT02342275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25000039|NCT01970722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25000040|NCT01970722|Tubulin Modulators|tubulin modulators|mesh-ancestor
25000041|NCT01970722|Antimitotic Agents|antimitotic agents|mesh-ancestor
25000042|NCT01970722|Mitosis Modulators|mitosis modulators|mesh-ancestor
25000043|NCT01970722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000044|NCT01970722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25000045|NCT01970722|Antimetabolites|antimetabolites|mesh-ancestor
25000046|NCT01970722|Antiviral Agents|antiviral agents|mesh-ancestor
25000047|NCT01970722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25000048|NCT01970722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25000049|NCT01970722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25000050|NCT01970722|Immunologic Factors|immunologic factors|mesh-ancestor
25000051|NCT01970722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000052|NCT01970722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25000053|NCT01970722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25000054|NCT01970722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24938050|NCT04022811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24938051|NCT04022811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24938052|NCT04022811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24938053|NCT04022811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24938054|NCT04022811|Immunologic Factors|immunologic factors|mesh-ancestor
24938055|NCT04022811|Viscosupplements|viscosupplements|mesh-ancestor
24938061|NCT04022811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24798490|NCT01963832|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24798491|NCT01963832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25000135|NCT00726596|Hydroxychloroquine|hydroxychloroquine|mesh-list
25000136|NCT00726596|Antimalarials|antimalarials|mesh-ancestor
25000137|NCT00726596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25000138|NCT00726596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25000139|NCT00726596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24455116|NCT02846545|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24455117|NCT02846545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25000140|NCT00726596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25000141|NCT00726596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000142|NCT00726596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25048834|NCT00662740|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25048835|NCT00662740|Cholinergic Agents|cholinergic agents|mesh-ancestor
25048836|NCT00662740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25048837|NCT00662740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048873|NCT00659191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048874|NCT00659191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25048875|NCT00659191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24636723|NCT01147133|Clopidogrel|clopidogrel|mesh-list
25048876|NCT00659191|Antiviral Agents|antiviral agents|mesh-ancestor
25048877|NCT00659191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25048879|NCT00659061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000175|NCT03639948|Tubulin Modulators|tubulin modulators|mesh-ancestor
25000176|NCT03639948|Antimitotic Agents|antimitotic agents|mesh-ancestor
25000177|NCT03639948|Mitosis Modulators|mitosis modulators|mesh-ancestor
25000178|NCT03639948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000179|NCT03639948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25000227|NCT04294576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841567|NCT02216617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24643966|NCT01188148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24643967|NCT01188148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24643968|NCT01188148|Dopamine Agents|dopamine agents|mesh-ancestor
24643969|NCT01188148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24643970|NCT01188148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643988|NCT01188265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048896|NCT00658372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25048897|NCT00658372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24643992|NCT01188265|GABA Agents|gaba agents|mesh-ancestor
24644027|NCT01188317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24644028|NCT01188317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24938239|NCT04020653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24938240|NCT04020653|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24938241|NCT04020653|Dermatologic Agents|dermatologic agents|mesh-ancestor
25000331|NCT05135650|Myeloma Proteins|myeloma proteins|mesh-list
25000332|NCT05135650|Paraproteins|paraproteins|mesh-list
25000333|NCT05135650|Immunologic Factors|immunologic factors|mesh-ancestor
24617444|NCT01043211|Autonomic Agents|autonomic agents|mesh-ancestor
25000334|NCT05135650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000342|NCT05183048|Panitumumab|panitumumab|mesh-list
25000343|NCT05183048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25000344|NCT05183048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25000489|NCT04374019|Camostat|camostat|mesh-list
25000490|NCT04374019|Antimalarials|antimalarials|mesh-ancestor
25000491|NCT04374019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25000492|NCT04374019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25000493|NCT04374019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24644089|NCT01188889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24644090|NCT01188889|Immunologic Factors|immunologic factors|mesh-ancestor
25000553|NCT04225988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25000554|NCT04225988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000555|NCT04212364|Naloxone|naloxone|mesh-list
25000556|NCT04212364|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25000557|NCT04212364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000558|NCT04212364|Sensory System Agents|sensory system agents|mesh-ancestor
25000559|NCT04212364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25000644|NCT03990363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000645|NCT03930186|Apremilast|apremilast|mesh-list
25000646|NCT03930186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25000647|NCT03930186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25000648|NCT03930186|Analgesics|analgesics|mesh-ancestor
25000649|NCT03930186|Sensory System Agents|sensory system agents|mesh-ancestor
25000650|NCT03930186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25000651|NCT03930186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000652|NCT03930186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25000653|NCT03930186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25000654|NCT03930186|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25000655|NCT03930186|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25000656|NCT03930186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25000676|NCT03835819|Pembrolizumab|pembrolizumab|mesh-list
25000677|NCT03835819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25000678|NCT03835819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25701826|NCT02145676|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25701827|NCT02145676|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25701828|NCT02145676|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25701829|NCT02145676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25701830|NCT02145676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701831|NCT02145676|Cholinergic Agents|cholinergic agents|mesh-ancestor
25701832|NCT02145676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24734141|NCT01650727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24734142|NCT01650740|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24734217|NCT01651312|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25000679|NCT03817463|Empagliflozin|empagliflozin|mesh-list
25000680|NCT03817463|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25000681|NCT03817463|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25000682|NCT03817463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000683|NCT03817463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25000684|NCT03817463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000685|NCT03817463|Protease Inhibitors|protease inhibitors|mesh-ancestor
25000690|NCT03787849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25000691|NCT03787849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000692|NCT03787849|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25000693|NCT03787849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25000694|NCT03787849|Anesthetics, General|anesthetics, general|mesh-ancestor
25000697|NCT03781440|Lidocaine|lidocaine|mesh-list
25000718|NCT03777319|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25000719|NCT03777319|Hormone Antagonists|hormone antagonists|mesh-ancestor
25000720|NCT03777319|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25000722|NCT03777319|Natriuretic Agents|natriuretic agents|mesh-ancestor
25000723|NCT03740100|Sirolimus|sirolimus|mesh-list
25000724|NCT03740100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25000725|NCT03740100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25000726|NCT03740100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25000727|NCT03740100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25000728|NCT03740100|Antifungal Agents|antifungal agents|mesh-ancestor
25000729|NCT03740100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25000730|NCT03740100|Immunologic Factors|immunologic factors|mesh-ancestor
25000731|NCT03740100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000732|NCT03687814|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25000733|NCT03687814|Laxatives|laxatives|mesh-ancestor
25000734|NCT03687814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25048935|NCT00658008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25000774|NCT03490513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25000775|NCT03490513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938651|NCT04017624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24938652|NCT04017624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938654|NCT04017377|Cisplatin|cisplatin|mesh-list
24938655|NCT04017377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24938656|NCT04017377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24938660|NCT04017377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938662|NCT04017598|Trace Elements|trace elements|mesh-ancestor
24938663|NCT04017598|Micronutrients|micronutrients|mesh-ancestor
24938664|NCT04017598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938665|NCT04017455|Bevacizumab|bevacizumab|mesh-list
24938666|NCT04017455|Atezolizumab|atezolizumab|mesh-list
25701833|NCT02145676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701834|NCT02145676|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25701835|NCT02145676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25701836|NCT02146248|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25701837|NCT02146248|Contraceptive Agents|contraceptive agents|mesh-list
25701838|NCT02146248|Medroxyprogesterone|medroxyprogesterone|mesh-list
25701839|NCT02146248|Contraceptives, Oral|contraceptives, oral|mesh-list
25701840|NCT02146248|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
24842181|NCT02219984|Anticoagulants|anticoagulants|mesh-list
24644198|NCT01189695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24644199|NCT01189721|Propofol|propofol|mesh-list
24644200|NCT01189721|Sevoflurane|sevoflurane|mesh-list
24644201|NCT01189721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24644202|NCT01189721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24644273|NCT01190137|Vitamins|vitamins|mesh-ancestor
24393188|NCT00129038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24393189|NCT00129038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24393190|NCT00129038|Antipyretics|antipyretics|mesh-ancestor
24393191|NCT00129038|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24393192|NCT00129038|Vasodilator Agents|vasodilator agents|mesh-ancestor
24393193|NCT00129090|Rituximab|rituximab|mesh-list
24393202|NCT00129142|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24393203|NCT00129142|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24393208|NCT00129155|Treosulfan|treosulfan|mesh-list
24644274|NCT01190137|Micronutrients|micronutrients|mesh-ancestor
24644275|NCT01190137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24644276|NCT01190163|Oxytocin|oxytocin|mesh-list
24644277|NCT01190163|Dinoprostone|dinoprostone|mesh-list
24644280|NCT01190163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644281|NCT01190241|Everolimus|everolimus|mesh-list
24644282|NCT01190241|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24644283|NCT01190241|Sorafenib|sorafenib|mesh-list
24644284|NCT01190241|Sunitinib|sunitinib|mesh-list
24644285|NCT01190241|Lapatinib|lapatinib|mesh-list
24644287|NCT01190241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24644289|NCT01190241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644290|NCT01190241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24644291|NCT01190241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644292|NCT01190241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644293|NCT01190241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24644294|NCT01190241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24644295|NCT01190241|Growth Substances|growth substances|mesh-ancestor
24644296|NCT01190241|Growth Inhibitors|growth inhibitors|mesh-ancestor
24644297|NCT01190293|Efavirenz|efavirenz|mesh-list
24644298|NCT01190293|Maraviroc|maraviroc|mesh-list
24644328|NCT01190358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644329|NCT01190358|Protective Agents|protective agents|mesh-ancestor
24644330|NCT01190358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644332|NCT01190371|Antimalarials|antimalarials|mesh-ancestor
24644336|NCT01190371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644337|NCT01190371|Antiviral Agents|antiviral agents|mesh-ancestor
24644338|NCT01190371|Schistosomicides|schistosomicides|mesh-ancestor
24644339|NCT01190371|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24644340|NCT01190371|Anthelmintics|anthelmintics|mesh-ancestor
24644341|NCT01190384|Grape Seed Extract|grape seed extract|mesh-list
24644342|NCT01190384|Antioxidants|antioxidants|mesh-list
24644343|NCT01190384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644344|NCT01190384|Protective Agents|protective agents|mesh-ancestor
24644345|NCT01190384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048955|NCT00656357|Sensory System Agents|sensory system agents|mesh-ancestor
25048956|NCT00656357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25048957|NCT00656357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25701841|NCT02146248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25701842|NCT02146248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701843|NCT02146248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25048958|NCT00656357|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24735583|NCT01657812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735584|NCT01657812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24735585|NCT01657812|Analgesics|analgesics|mesh-ancestor
24735586|NCT01657812|Sensory System Agents|sensory system agents|mesh-ancestor
24735587|NCT01657812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24735588|NCT01657812|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24735589|NCT01657812|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24735590|NCT01657812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25048959|NCT00656357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25048960|NCT00656357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25048961|NCT00656357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25048962|NCT00656357|Dopamine Agents|dopamine agents|mesh-ancestor
25000832|NCT03053362|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25000833|NCT03053362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25000834|NCT02906332|Dexamethasone|dexamethasone|mesh-list
25000835|NCT02906332|Pembrolizumab|pembrolizumab|mesh-list
25000836|NCT02906332|Lenalidomide|lenalidomide|mesh-list
24451894|NCT00325117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451895|NCT00325169|Tiotropium Bromide|tiotropium bromide|mesh-list
24451896|NCT00325169|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24451897|NCT00325169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25000837|NCT02906332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25000838|NCT02906332|Antiemetics|antiemetics|mesh-ancestor
25000839|NCT02906332|Autonomic Agents|autonomic agents|mesh-ancestor
24945477|NCT03950141|Apatinib|apatinib|mesh-list
25000857|NCT05463224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000879|NCT05462938|Dexmedetomidine|dexmedetomidine|mesh-list
25000881|NCT05462938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25000882|NCT05462938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25000883|NCT05462938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25000884|NCT05462938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25000923|NCT05462613|Aspirin|aspirin|mesh-list
25000939|NCT05462613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25000940|NCT05462613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25000941|NCT05462613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25000942|NCT05462613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25000943|NCT05462613|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25000944|NCT05462613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25000945|NCT05462613|Antipyretics|antipyretics|mesh-ancestor
25000946|NCT05462548|Luspatercept|luspatercept|mesh-list
25000947|NCT05462548|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
24644376|NCT01190670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644377|NCT01190670|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24938885|NCT04015778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938886|NCT04015778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24938887|NCT04015778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24644379|NCT01190670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644381|NCT01190683|Vitamin D|vitamin d|mesh-list
24644501|NCT01191424|Respiratory System Agents|respiratory system agents|mesh-ancestor
24644502|NCT01191424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24644504|NCT01191424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24644505|NCT01191424|Adrenergic Agents|adrenergic agents|mesh-ancestor
24644506|NCT01191424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24393390|NCT00129922|Cyclophosphamide|cyclophosphamide|mesh-list
24393391|NCT00129922|Fluorouracil|fluorouracil|mesh-list
24393392|NCT00129922|Epirubicin|epirubicin|mesh-list
24393393|NCT00129922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25701844|NCT02146248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25701845|NCT02146248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25701846|NCT02146248|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25701847|NCT02146248|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25701848|NCT02146248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25701849|NCT02146248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25701850|NCT02146430|Pregabalin|pregabalin|mesh-list
25701851|NCT02146430|Analgesics|analgesics|mesh-ancestor
24617787|NCT01045681|Protease Inhibitors|protease inhibitors|mesh-ancestor
24644609|NCT01191957|Alkylating Agents|alkylating agents|mesh-ancestor
24644610|NCT01191957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938888|NCT04015661|Paclitaxel|paclitaxel|mesh-list
24938889|NCT04015661|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24938890|NCT04015661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24938891|NCT04015661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24938892|NCT04015661|Tubulin Modulators|tubulin modulators|mesh-ancestor
24938893|NCT04015661|Antimitotic Agents|antimitotic agents|mesh-ancestor
24938894|NCT04015661|Mitosis Modulators|mitosis modulators|mesh-ancestor
25001035|NCT05461755|Tretinoin|tretinoin|mesh-list
25001036|NCT05461755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25001037|NCT05461755|Keratolytic Agents|keratolytic agents|mesh-ancestor
24842408|NCT02221063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842409|NCT02221102|Aspirin|aspirin|mesh-list
24842410|NCT02221102|Edoxaban|edoxaban|mesh-list
24842411|NCT02221102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24842412|NCT02221102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24842413|NCT02221102|Analgesics|analgesics|mesh-ancestor
24842414|NCT02221102|Sensory System Agents|sensory system agents|mesh-ancestor
24644611|NCT01191957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25048987|NCT00650702|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24393423|NCT00130013|Amoxicillin|amoxicillin|mesh-list
25048992|NCT00649025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25048993|NCT00649025|Autonomic Agents|autonomic agents|mesh-ancestor
25048994|NCT00649025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25048995|NCT00649025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25048996|NCT00649025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25048997|NCT00649025|Respiratory System Agents|respiratory system agents|mesh-ancestor
25048998|NCT00649025|Dermatologic Agents|dermatologic agents|mesh-ancestor
25048999|NCT00649025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25049000|NCT00647231|Ketoprofen|ketoprofen|mesh-list
25049001|NCT00647231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25049002|NCT00647231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25049003|NCT00647231|Analgesics|analgesics|mesh-ancestor
25001253|NCT05391230|Permethrin|permethrin|mesh-list
25001254|NCT05391230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25001255|NCT05391230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049028|NCT00643383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25049030|NCT00643383|Sensory System Agents|sensory system agents|mesh-ancestor
25049031|NCT00643383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25049032|NCT00643383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049033|NCT00643383|Antipyretics|antipyretics|mesh-ancestor
25049034|NCT00643383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25049035|NCT00643383|Narcotics|narcotics|mesh-ancestor
25049036|NCT00643383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25049037|NCT00642148|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25049038|NCT00642148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25049039|NCT00642148|Autonomic Agents|autonomic agents|mesh-ancestor
25049040|NCT00642148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25001297|NCT05383482|Antimitotic Agents|antimitotic agents|mesh-ancestor
25001298|NCT05383482|Mitosis Modulators|mitosis modulators|mesh-ancestor
25001299|NCT05383482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393630|NCT00130507|Tubulin Modulators|tubulin modulators|mesh-ancestor
24393631|NCT00130507|Antimitotic Agents|antimitotic agents|mesh-ancestor
24393632|NCT00130507|Mitosis Modulators|mitosis modulators|mesh-ancestor
25701853|NCT02146430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25701854|NCT02146430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701855|NCT02146430|Anticonvulsants|anticonvulsants|mesh-ancestor
25701856|NCT02146430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25701857|NCT02146430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25701858|NCT02146430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644667|NCT01192308|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24644668|NCT01192308|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24644669|NCT01192308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24644670|NCT01192490|Lidocaine|lidocaine|mesh-list
24644696|NCT01192529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24644697|NCT01192529|Adrenergic Agents|adrenergic agents|mesh-ancestor
24644698|NCT01192529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24644699|NCT01192529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644700|NCT01192581|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24644701|NCT01192581|Plasma Substitutes|plasma substitutes|mesh-ancestor
24644702|NCT01192581|Blood Substitutes|blood substitutes|mesh-ancestor
24798524|NCT01964027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24798525|NCT01964027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24798526|NCT01964027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24627653|NCT01094275|Clopidogrel|clopidogrel|mesh-list
24798527|NCT01964040|Dexmedetomidine|dexmedetomidine|mesh-list
24798528|NCT01964040|Bupivacaine|bupivacaine|mesh-list
24798529|NCT01964040|Anesthetics, Local|anesthetics, local|mesh-ancestor
24798530|NCT01964040|Anesthetics|anesthetics|mesh-ancestor
24798531|NCT01964040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24798532|NCT01964040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798533|NCT01964040|Sensory System Agents|sensory system agents|mesh-ancestor
25701859|NCT02146430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25701860|NCT02146430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25701861|NCT02146430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25701862|NCT02146430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25701863|NCT02146430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25701864|NCT02147067|Ranolazine|ranolazine|mesh-list
25701865|NCT02147067|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25701866|NCT02147067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25701867|NCT02147067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701868|NCT02147132|Nicotine|nicotine|mesh-list
25701869|NCT02147132|Varenicline|varenicline|mesh-list
25701870|NCT02147132|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25701871|NCT02147132|Autonomic Agents|autonomic agents|mesh-ancestor
24740540|NCT01688947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24740541|NCT01688947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798534|NCT01964040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24798535|NCT01964040|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25049073|NCT00637130|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25049074|NCT00637130|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25049075|NCT00637130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25049085|NCT00636480|Disinfectants|disinfectants|mesh-ancestor
25049086|NCT00636480|Dermatologic Agents|dermatologic agents|mesh-ancestor
25049088|NCT00635505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25049089|NCT00635505|Autonomic Agents|autonomic agents|mesh-ancestor
25049090|NCT00635505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25049091|NCT00635505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049092|NCT00635505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25049093|NCT00635505|Respiratory System Agents|respiratory system agents|mesh-ancestor
25049094|NCT00635505|Tocolytic Agents|tocolytic agents|mesh-ancestor
25049095|NCT00635505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25049096|NCT00635505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24798550|NCT01964079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24798551|NCT01964079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798552|NCT01964079|Vasodilator Agents|vasodilator agents|mesh-ancestor
24798553|NCT01964079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24798554|NCT01964079|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24798555|NCT01964079|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24798556|NCT01964157|Ceritinib|ceritinib|mesh-list
24798557|NCT01964157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393786|NCT00131027|Vincristine|vincristine|mesh-list
25001588|NCT05278338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25001589|NCT05278338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842996|NCT02225054|Ropivacaine|ropivacaine|mesh-list
24842997|NCT02225054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24644717|NCT01192724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24644821|NCT01193387|Insulin, Long-Acting|insulin, long-acting|mesh-list
24644822|NCT01193387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24644823|NCT01193387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644824|NCT01193400|Cytarabine|cytarabine|mesh-list
24644825|NCT01193400|Clofarabine|clofarabine|mesh-list
24644826|NCT01193400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24644827|NCT01193400|Antimetabolites|antimetabolites|mesh-ancestor
24393913|NCT00131261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25049161|NCT00631111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25049162|NCT00631111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25049163|NCT00631111|Analgesics|analgesics|mesh-ancestor
25049164|NCT00631111|Sensory System Agents|sensory system agents|mesh-ancestor
25701872|NCT02147132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25701873|NCT02147132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701874|NCT02147132|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25701875|NCT02147132|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25701876|NCT02147132|Cholinergic Agents|cholinergic agents|mesh-ancestor
25701877|NCT02147132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25701878|NCT02147132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701879|NCT02147158|Ulipristal acetate|ulipristal acetate|mesh-list
25049165|NCT00631111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25049166|NCT00631111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25049167|NCT00631111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25049168|NCT00631111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24939568|NCT04008888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939569|NCT04008888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939570|NCT04008888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24939581|NCT04008290|Liraglutide|liraglutide|mesh-list
24939582|NCT04008290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24939583|NCT04008290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939584|NCT04008290|Incretins|incretins|mesh-ancestor
24939585|NCT04008290|Hormones|hormones|mesh-ancestor
24939586|NCT04008290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24939602|NCT04008225|Dimercaprol|dimercaprol|mesh-list
25049170|NCT00631111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049171|NCT00631111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24644877|NCT01193504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644878|NCT01193504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24644879|NCT01193504|Glucocorticoids|glucocorticoids|mesh-ancestor
24644880|NCT01193504|Hormones|hormones|mesh-ancestor
24644905|NCT01193621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24644906|NCT01193621|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24644907|NCT01193621|Dopamine Agents|dopamine agents|mesh-ancestor
24644908|NCT01193621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24843616|NCT02228512|Prednisone|prednisone|mesh-list
25002079|NCT04929080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25002080|NCT04929080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843426|NCT02227420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25049211|NCT00629551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049212|NCT00629551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25049213|NCT00629551|Serotonin Agents|serotonin agents|mesh-ancestor
24644923|NCT01193855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24644924|NCT01193855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644925|NCT01193855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644926|NCT01193855|Hormone Antagonists|hormone antagonists|mesh-ancestor
24644927|NCT01193855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24644928|NCT01193855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644929|NCT01193881|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24644931|NCT01193881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644932|NCT01193881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24644933|NCT01193881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644934|NCT01193881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644936|NCT01194037|Interferon-alpha|interferon-alpha|mesh-list
24644937|NCT01194037|Interferon alpha-2|interferon alpha-2|mesh-list
25049225|NCT00626704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25701882|NCT02147158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25701883|NCT02147158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701884|NCT02147158|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25701885|NCT02147197|Ulipristal acetate|ulipristal acetate|mesh-list
25701886|NCT02147197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25701887|NCT02147197|Contraceptive Agents|contraceptive agents|mesh-ancestor
25701888|NCT02147197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24745266|NCT03846570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24745267|NCT03846570|Respiratory System Agents|respiratory system agents|mesh-ancestor
24745268|NCT03846570|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24745269|NCT03846570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24745332|NCT03825536|Adrenergic Agents|adrenergic agents|mesh-ancestor
24745333|NCT03825536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24745334|NCT03825536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24745335|NCT03825536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24745336|NCT03825536|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24745338|NCT03816397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24645009|NCT01194791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24645010|NCT01194791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24645011|NCT01194791|Antiemetics|antiemetics|mesh-ancestor
24452051|NCT00325858|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24645012|NCT01194791|Autonomic Agents|autonomic agents|mesh-ancestor
24645013|NCT01194791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24645014|NCT01194791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24645015|NCT01194791|Glucocorticoids|glucocorticoids|mesh-ancestor
24645016|NCT01194791|Hormones|hormones|mesh-ancestor
24798596|NCT01964287|Irinotecan|irinotecan|mesh-list
24798597|NCT01964287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24798598|NCT01964287|Folfirinox|folfirinox|mesh-list
24798599|NCT01964287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24798600|NCT01964287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24798601|NCT01964287|Tubulin Modulators|tubulin modulators|mesh-ancestor
24798602|NCT01964287|Antimitotic Agents|antimitotic agents|mesh-ancestor
24798603|NCT01964287|Mitosis Modulators|mitosis modulators|mesh-ancestor
24798604|NCT01964287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798605|NCT01964287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24798606|NCT01964287|Antimetabolites|antimetabolites|mesh-ancestor
24798607|NCT01964287|Antiviral Agents|antiviral agents|mesh-ancestor
24798608|NCT01964287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24798609|NCT01964287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25002169|NCT04852224|Leuprolide|leuprolide|mesh-list
25002187|NCT04822597|Lidocaine|lidocaine|mesh-list
25002188|NCT04822597|Anesthetics, Local|anesthetics, local|mesh-ancestor
25002189|NCT04822597|Anesthetics|anesthetics|mesh-ancestor
25002190|NCT04822597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25002191|NCT04822597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25002192|NCT04822597|Sensory System Agents|sensory system agents|mesh-ancestor
25002193|NCT04822597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25002194|NCT04822597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25002195|NCT04822597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25002196|NCT04822597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25002197|NCT04822597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25002198|NCT04822597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25002199|NCT04808778|Hydroxyurea|hydroxyurea|mesh-list
25002200|NCT04808778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25002201|NCT04808778|Antisickling Agents|antisickling agents|mesh-ancestor
25002202|NCT04808778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25002203|NCT04808778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25002204|NCT04808778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24645147|NCT01196234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24645148|NCT01196234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25002274|NCT04752384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25701889|NCT02147197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701890|NCT02147197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25701891|NCT02147561|Botulinum Toxins|botulinum toxins|mesh-list
25701892|NCT02147561|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25701893|NCT02147561|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25701894|NCT02147561|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25701895|NCT02147561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25701896|NCT02147561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701897|NCT02147561|Cholinergic Agents|cholinergic agents|mesh-ancestor
25701898|NCT02147561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25002275|NCT04752384|Narcotics|narcotics|mesh-ancestor
25002276|NCT04752384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24746822|NCT03435640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24746823|NCT03435640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25002277|NCT04752384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25002279|NCT04752384|Sensory System Agents|sensory system agents|mesh-ancestor
24393995|NCT00131521|Antioxidants|antioxidants|mesh-ancestor
24393996|NCT00131521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25002280|NCT04752384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25002281|NCT04752384|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25002282|NCT04747314|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25002283|NCT04747314|Aripiprazole|aripiprazole|mesh-list
25002284|NCT04747314|Mirtazapine|mirtazapine|mesh-list
25002285|NCT04747314|Citalopram|citalopram|mesh-list
25002286|NCT04747314|Bupropion|bupropion|mesh-list
25002287|NCT04747314|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25002288|NCT04747314|Sertraline|sertraline|mesh-list
25002289|NCT04747314|Antidepressive Agents|antidepressive agents|mesh-list
25002290|NCT04747314|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25002291|NCT04747314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25002292|NCT04747314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25002294|NCT04747314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24645197|NCT01196507|Protective Agents|protective agents|mesh-ancestor
24645198|NCT01196507|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25002300|NCT04747314|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25002301|NCT04747314|Dopamine Agents|dopamine agents|mesh-ancestor
25002302|NCT04747314|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25002303|NCT04747314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25002304|NCT04747314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25002305|NCT04747314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25002306|NCT04747314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25002307|NCT04747314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25002308|NCT04747314|Dopamine Agonists|dopamine agonists|mesh-ancestor
25002309|NCT04747314|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25002310|NCT04747314|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25002311|NCT04747314|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25002312|NCT04747314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25002313|NCT04747314|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25002314|NCT04747314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25002315|NCT04747314|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25002316|NCT04747314|Analgesics|analgesics|mesh-ancestor
25002317|NCT04747314|Sensory System Agents|sensory system agents|mesh-ancestor
24843733|NCT02229058|Tubulin Modulators|tubulin modulators|mesh-ancestor
24645199|NCT01196507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24645200|NCT01196507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24645201|NCT01196507|Vasodilator Agents|vasodilator agents|mesh-ancestor
24394071|NCT00131989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24394072|NCT00131989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24645202|NCT01196507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24645204|NCT01196546|Metformin|metformin|mesh-list
25701903|NCT02147587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25701904|NCT02147587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25701905|NCT02147587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701906|NCT02147691|Azelaic acid|azelaic acid|mesh-list
25701907|NCT02147691|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25701908|NCT02147691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25701909|NCT02147691|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24645276|NCT01197040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25002318|NCT04747314|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25002319|NCT04747314|Histamine Antagonists|histamine antagonists|mesh-ancestor
25002320|NCT04747314|Histamine Agents|histamine agents|mesh-ancestor
24645278|NCT01197040|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24645279|NCT01197040|Antitubercular Agents|antitubercular agents|mesh-ancestor
24645280|NCT01197040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24645281|NCT01197040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24645282|NCT01197040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24645283|NCT01197040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645285|NCT01197144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24645286|NCT01197144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24645287|NCT01197157|Nitazoxanide|nitazoxanide|mesh-list
24645312|NCT01197170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24645315|NCT01197261|Oxycodone|oxycodone|mesh-list
24645346|NCT01197781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645347|NCT01197781|Vasodilator Agents|vasodilator agents|mesh-ancestor
24645348|NCT01197846|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24645349|NCT01197846|Antidepressive Agents|antidepressive agents|mesh-ancestor
24645350|NCT01197846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24645351|NCT01197846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24645392|NCT01198184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24645393|NCT01198184|Immunologic Factors|immunologic factors|mesh-ancestor
24645394|NCT01198184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645395|NCT01198184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24645396|NCT01198184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645436|NCT01198236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24645476|NCT01198353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24645477|NCT01198353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24645478|NCT01198353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24645479|NCT01198353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24645480|NCT01198353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24645481|NCT01198353|Dopamine Agents|dopamine agents|mesh-ancestor
24645483|NCT01198379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24645484|NCT01198379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24645485|NCT01198379|Analgesics|analgesics|mesh-ancestor
24645527|NCT01198496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24645528|NCT01198496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24645529|NCT01198496|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25701911|NCT02147691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25701912|NCT02147691|Adrenergic Agents|adrenergic agents|mesh-ancestor
25701913|NCT02147691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25701914|NCT02147691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701915|NCT02147691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701916|NCT02147691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24940071|NCT04003844|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24940073|NCT04003844|Immunoglobulin G|immunoglobulin g|mesh-list
24940074|NCT04003844|Immunologic Factors|immunologic factors|mesh-ancestor
24940075|NCT04003844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940076|NCT04003844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24940077|NCT04003844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24940078|NCT04003844|Analgesics|analgesics|mesh-ancestor
25002589|NCT04490057|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25002590|NCT04490057|Autonomic Agents|autonomic agents|mesh-ancestor
25002591|NCT04490057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25002599|NCT04490057|Antidepressive Agents|antidepressive agents|mesh-ancestor
25002600|NCT04490057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25002604|NCT04490057|Dopamine Agents|dopamine agents|mesh-ancestor
24449853|NCT00317330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24645646|NCT01199159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24645647|NCT01199159|Oxytocics|oxytocics|mesh-ancestor
24645648|NCT01199159|Vitamin B Complex|vitamin b complex|mesh-ancestor
24645649|NCT01199224|Veliparib|veliparib|mesh-list
24645650|NCT01199224|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24645651|NCT01199224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24645652|NCT01199224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645653|NCT01199224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24645654|NCT01199276|Sevoflurane|sevoflurane|mesh-list
24645655|NCT01199276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24645656|NCT01199276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24645683|NCT01199367|Letrozole|letrozole|mesh-list
24645684|NCT01199367|Lapatinib|lapatinib|mesh-list
24645685|NCT01199367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24645686|NCT01199367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24394192|NCT00132548|Antimalarials|antimalarials|mesh-ancestor
24394193|NCT00132548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24645687|NCT01199367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24645744|NCT01199523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24645757|NCT01199562|Antiviral Agents|antiviral agents|mesh-list
24645758|NCT01199562|Foscarnet|foscarnet|mesh-list
24645759|NCT01199562|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
24645760|NCT01199562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24645761|NCT01199562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24645800|NCT01200004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24645806|NCT01200004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645808|NCT01200056|Atorvastatin|atorvastatin|mesh-list
24645809|NCT01200056|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24645810|NCT01200056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24645811|NCT01200056|Antimetabolites|antimetabolites|mesh-ancestor
24645812|NCT01200056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645859|NCT01200264|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24645860|NCT01200264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25701917|NCT02147691|Dermatologic Agents|dermatologic agents|mesh-ancestor
25701918|NCT02147899|Secnidazole|secnidazole|mesh-list
25701919|NCT02147899|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25701920|NCT02147899|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25701921|NCT02147899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25701922|NCT02148250|Insulin|insulin|mesh-list
25701923|NCT02148250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25701924|NCT02148250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25701925|NCT02148250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701926|NCT02148445|Nicotine|nicotine|mesh-list
25701927|NCT02148445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24645867|NCT01200472|Sensory System Agents|sensory system agents|mesh-ancestor
24645868|NCT01200472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24645869|NCT01200472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645870|NCT01200472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24645871|NCT01200472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24645872|NCT01200472|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24645873|NCT01200472|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24645874|NCT01200472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24645875|NCT01200472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452130|NCT00326105|Antidepressive Agents|antidepressive agents|mesh-ancestor
24452131|NCT00326105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24452132|NCT00326105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24452133|NCT00326105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24452134|NCT00326105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24452135|NCT00326105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452137|NCT00326131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24452138|NCT00326144|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24452139|NCT00326144|Antidepressive Agents|antidepressive agents|mesh-ancestor
24452140|NCT00326144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24452141|NCT00326144|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24452142|NCT00326144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24452143|NCT00326144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24452144|NCT00326144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452145|NCT00326157|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24452146|NCT00326157|Antifungal Agents|antifungal agents|mesh-ancestor
25002678|NCT04412096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25002679|NCT04412096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25002680|NCT04412096|Adrenergic Agents|adrenergic agents|mesh-ancestor
25002681|NCT04412096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25002682|NCT04412096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25002683|NCT04412096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25002684|NCT04412096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25002685|NCT04412096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24452152|NCT00326235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25049283|NCT00624858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25049284|NCT00624858|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25049285|NCT00624858|Antidepressive Agents|antidepressive agents|mesh-ancestor
25049286|NCT00624858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25049287|NCT00624858|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25049289|NCT00624858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25049292|NCT00624858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25049293|NCT00624858|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25049294|NCT00624858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24940264|NCT04002700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25701928|NCT02148445|Autonomic Agents|autonomic agents|mesh-ancestor
25701929|NCT02148445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25701930|NCT02148445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701931|NCT02148445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25701932|NCT02148445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24754205|NCT01719627|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24646005|NCT01201213|Anesthetics|anesthetics|mesh-list
24646006|NCT01201213|Anesthetics, Local|anesthetics, local|mesh-list
24646007|NCT01201213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24646008|NCT01201213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646010|NCT01201213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24646011|NCT01201239|Raltegravir Potassium|raltegravir potassium|mesh-list
24646012|NCT01201239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24646013|NCT01201239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24646014|NCT01201239|Antiviral Agents|antiviral agents|mesh-ancestor
24646015|NCT01201239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24646016|NCT01201239|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24646017|NCT01201239|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24646018|NCT01201239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646019|NCT01201239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646020|NCT01201278|Insulin|insulin|mesh-list
24646021|NCT01201278|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25002754|NCT04369937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25002755|NCT04369937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25002783|NCT04313959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25002785|NCT04313959|Autonomic Agents|autonomic agents|mesh-ancestor
25002786|NCT04313959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25002787|NCT04313959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25002788|NCT04313959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25002789|NCT04313959|Glucocorticoids|glucocorticoids|mesh-ancestor
25002790|NCT04313959|Hormones|hormones|mesh-ancestor
25002792|NCT04313959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24646048|NCT01201577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24646049|NCT01201577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24646050|NCT01201577|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24646051|NCT01201577|Renal Agents|renal agents|mesh-ancestor
24646052|NCT01201577|Antimalarials|antimalarials|mesh-ancestor
24646053|NCT01201577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24646054|NCT01201577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24646056|NCT01201642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25701933|NCT02148445|Cholinergic Agents|cholinergic agents|mesh-ancestor
25701934|NCT02148445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25701935|NCT02148445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701936|NCT02148588|Lidocaine|lidocaine|mesh-list
25701937|NCT02148588|Anesthetics, Local|anesthetics, local|mesh-ancestor
25701938|NCT02148588|Anesthetics|anesthetics|mesh-ancestor
25701939|NCT02148588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25701940|NCT02148588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701941|NCT02148588|Sensory System Agents|sensory system agents|mesh-ancestor
25701942|NCT02148588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24462890|NCT00357825|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24646141|NCT01202149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24646142|NCT01202149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24646144|NCT01202149|Sensory System Agents|sensory system agents|mesh-ancestor
24646145|NCT01202149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24646146|NCT01202149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646147|NCT01202149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24646192|NCT01202435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25002855|NCT04257500|Contraceptive Agents|contraceptive agents|mesh-ancestor
25002856|NCT04257500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25002857|NCT04257500|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25002858|NCT04257500|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25002859|NCT04257500|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24844253|NCT02231957|Immunologic Factors|immunologic factors|mesh-ancestor
24844254|NCT02231957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844255|NCT02232035|Diazepam|diazepam|mesh-list
24646339|NCT01203267|Paclitaxel|paclitaxel|mesh-list
24646340|NCT01203267|Carboplatin|carboplatin|mesh-list
24646341|NCT01203267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24646342|NCT01203267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24646343|NCT01203267|Tubulin Modulators|tubulin modulators|mesh-ancestor
24646344|NCT01203267|Antimitotic Agents|antimitotic agents|mesh-ancestor
24646345|NCT01203267|Mitosis Modulators|mitosis modulators|mesh-ancestor
24646346|NCT01203267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462891|NCT00357825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24462892|NCT00357825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24462893|NCT00357825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462894|NCT00357825|Adrenergic Agents|adrenergic agents|mesh-ancestor
24646347|NCT01203306|Bevacizumab|bevacizumab|mesh-list
24646348|NCT01203306|Capecitabine|capecitabine|mesh-list
24646350|NCT01203306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24646351|NCT01203306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24646352|NCT01203306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24646353|NCT01203306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24646354|NCT01203306|Growth Substances|growth substances|mesh-ancestor
24646355|NCT01203306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646356|NCT01203306|Growth Inhibitors|growth inhibitors|mesh-ancestor
24646357|NCT01203306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24646358|NCT01203306|Antimetabolites|antimetabolites|mesh-ancestor
24646359|NCT01203306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646360|NCT01203306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24646361|NCT01203306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24646362|NCT01203345|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24646363|NCT01203345|Immunologic Factors|immunologic factors|mesh-ancestor
24646364|NCT01203345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646380|NCT01203371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24646381|NCT01203371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24646382|NCT01203371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24646384|NCT01203384|Analgesics|analgesics|mesh-ancestor
24646389|NCT01203384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24462898|NCT00357851|Hemostatics|hemostatics|mesh-ancestor
24462899|NCT00357851|Coagulants|coagulants|mesh-ancestor
24462900|NCT00357851|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24646392|NCT01203384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24646421|NCT01203696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24646422|NCT01203696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24646423|NCT01203696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24646424|NCT01203696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646425|NCT01203696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24646426|NCT01203696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646427|NCT01203696|Vasodilator Agents|vasodilator agents|mesh-ancestor
24646428|NCT01203709|Mycophenolic Acid|mycophenolic acid|mesh-list
24646430|NCT01203709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24646431|NCT01203709|Immunologic Factors|immunologic factors|mesh-ancestor
24646432|NCT01203709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646467|NCT01204086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24646469|NCT01204086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646470|NCT01204086|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24646471|NCT01204086|Antidepressive Agents|antidepressive agents|mesh-ancestor
24646472|NCT01204086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24646473|NCT01204086|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24646474|NCT01204086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24646475|NCT01204086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646476|NCT01204086|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25002930|NCT04191616|Dexamethasone|dexamethasone|mesh-list
24940442|NCT04001231|Exenatide|exenatide|mesh-list
25002931|NCT04191616|Pomalidomide|pomalidomide|mesh-list
24646569|NCT01204320|Paclitaxel|paclitaxel|mesh-list
25002935|NCT04191616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25002936|NCT04191616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25002937|NCT04191616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25002938|NCT04191616|Glucocorticoids|glucocorticoids|mesh-ancestor
25002940|NCT04191616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25002941|NCT04191616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25002942|NCT04191616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25002943|NCT04191616|Immunologic Factors|immunologic factors|mesh-ancestor
25002944|NCT04191616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25002945|NCT04191616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25002946|NCT04191616|Growth Substances|growth substances|mesh-ancestor
25002947|NCT04191616|Growth Inhibitors|growth inhibitors|mesh-ancestor
25002948|NCT04166942|Belumosudil|belumosudil|mesh-list
25002949|NCT04166942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24844334|NCT02232347|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24844335|NCT02232360|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24940599|NCT03999775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940600|NCT03999775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24940601|NCT03999775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24940602|NCT03999723|Ascorbic Acid|ascorbic acid|mesh-list
24940603|NCT03999723|Vitamins|vitamins|mesh-ancestor
24940604|NCT03999723|Micronutrients|micronutrients|mesh-ancestor
24940605|NCT03999723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940606|NCT03999723|Antioxidants|antioxidants|mesh-ancestor
24940607|NCT03999723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940608|NCT03999723|Protective Agents|protective agents|mesh-ancestor
24940609|NCT03999372|Hyaluronic Acid|hyaluronic acid|mesh-list
24940610|NCT03999372|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24940611|NCT03999372|Immunologic Factors|immunologic factors|mesh-ancestor
24940612|NCT03999372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940613|NCT03999372|Viscosupplements|viscosupplements|mesh-ancestor
24940614|NCT03999372|Protective Agents|protective agents|mesh-ancestor
24798610|NCT01964287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24844477|NCT02232932|Capecitabine|capecitabine|mesh-list
24462954|NCT00358176|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24462966|NCT00358228|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24462967|NCT00358228|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24646674|NCT01204593|Insulin|insulin|mesh-list
24646675|NCT01204593|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24646767|NCT01205074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395326|NCT00135746|Cholinergic Agents|cholinergic agents|mesh-ancestor
24646768|NCT01205074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646822|NCT01205204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646823|NCT01205217|Paclitaxel|paclitaxel|mesh-list
24646824|NCT01205217|Cyclophosphamide|cyclophosphamide|mesh-list
24646825|NCT01205217|Trastuzumab|trastuzumab|mesh-list
24646826|NCT01205217|Epirubicin|epirubicin|mesh-list
24646827|NCT01205217|Lapatinib|lapatinib|mesh-list
24646828|NCT01205217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24646829|NCT01205217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24646830|NCT01205217|Tubulin Modulators|tubulin modulators|mesh-ancestor
24646831|NCT01205217|Antimitotic Agents|antimitotic agents|mesh-ancestor
24646832|NCT01205217|Mitosis Modulators|mitosis modulators|mesh-ancestor
24646833|NCT01205217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646834|NCT01205217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24646835|NCT01205217|Immunologic Factors|immunologic factors|mesh-ancestor
24462968|NCT00358228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24646847|NCT01205243|Abacavir|abacavir|mesh-list
24646865|NCT01205256|Respiratory System Agents|respiratory system agents|mesh-ancestor
24646866|NCT01205282|Pioglitazone|pioglitazone|mesh-list
24646867|NCT01205282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25003091|NCT04032665|Rivaroxaban|rivaroxaban|mesh-list
24844512|NCT02233049|Everolimus|everolimus|mesh-list
24844514|NCT02233049|Dasatinib|dasatinib|mesh-list
24646874|NCT01205321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24646875|NCT01205347|Simvastatin|simvastatin|mesh-list
24646876|NCT01205347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24646877|NCT01205347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24646878|NCT01205347|Antimetabolites|antimetabolites|mesh-ancestor
24646927|NCT01205711|Levoleucovorin|levoleucovorin|mesh-list
24646928|NCT01205711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24646929|NCT01205711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646930|NCT01205711|Antimetabolites|antimetabolites|mesh-ancestor
24646931|NCT01205711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646932|NCT01205711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24646990|NCT01205958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24646991|NCT01205958|Gout Suppressants|gout suppressants|mesh-ancestor
24646992|NCT01205984|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24646993|NCT01205984|Methylprednisolone|methylprednisolone|mesh-list
24646994|NCT01205984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24462990|NCT00358293|Autonomic Agents|autonomic agents|mesh-ancestor
24462991|NCT00358293|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24462992|NCT00358293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24462993|NCT00358293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24462994|NCT00358293|Adrenergic Agents|adrenergic agents|mesh-ancestor
24452200|NCT00326391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25003171|NCT03959085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25003172|NCT03959085|Antimetabolites|antimetabolites|mesh-ancestor
25003173|NCT03959085|Dermatologic Agents|dermatologic agents|mesh-ancestor
25003174|NCT03959085|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25003175|NCT03959085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24647106|NCT01206270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647107|NCT01206270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24647109|NCT01206270|Anabolic Agents|anabolic agents|mesh-ancestor
24647110|NCT01206270|Cathartics|cathartics|mesh-ancestor
24647111|NCT01206270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24647113|NCT01206348|Clindamycin|clindamycin|mesh-list
24647114|NCT01206348|Clindamycin palmitate|clindamycin palmitate|mesh-list
24647115|NCT01206348|Clindamycin phosphate|clindamycin phosphate|mesh-list
24647116|NCT01206348|Tretinoin|tretinoin|mesh-list
24647117|NCT01206348|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25701943|NCT02148588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24647118|NCT01206348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24396851|NCT00140153|Hormones|hormones|mesh-ancestor
24647119|NCT01206348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24647120|NCT01206348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24647121|NCT01206348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24647122|NCT01206348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25003239|NCT03911505|Miglustat|miglustat|mesh-list
25003240|NCT03911505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25003241|NCT03911505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25003242|NCT03911505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25003243|NCT03911505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24452201|NCT00326391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25003244|NCT03911505|Antiviral Agents|antiviral agents|mesh-ancestor
25003245|NCT03911505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25003246|NCT03911505|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25003247|NCT03911505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25003248|NCT03911505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049334|NCT00616798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25049335|NCT00616798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049336|NCT00616798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25049337|NCT00616330|Clindamycin|clindamycin|mesh-list
25049338|NCT00616330|Clindamycin palmitate|clindamycin palmitate|mesh-list
25049339|NCT00616330|Clindamycin phosphate|clindamycin phosphate|mesh-list
25049340|NCT00616330|Butoconazole|butoconazole|mesh-list
25049341|NCT00616330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24940794|NCT03997539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24940795|NCT03997539|Tubulin Modulators|tubulin modulators|mesh-ancestor
24940796|NCT03997539|Antimitotic Agents|antimitotic agents|mesh-ancestor
24940797|NCT03997539|Mitosis Modulators|mitosis modulators|mesh-ancestor
24940798|NCT03997539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798627|NCT01964391|Paclitaxel|paclitaxel|mesh-list
24798628|NCT01964391|Docetaxel|docetaxel|mesh-list
24798629|NCT01964391|Cyclophosphamide|cyclophosphamide|mesh-list
25049342|NCT00616330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24798630|NCT01964391|Carboplatin|carboplatin|mesh-list
24798631|NCT01964391|Doxorubicin|doxorubicin|mesh-list
24798632|NCT01964391|Trastuzumab|trastuzumab|mesh-list
24798633|NCT01964391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24798634|NCT01964391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24798635|NCT01964391|Tubulin Modulators|tubulin modulators|mesh-ancestor
24448290|NCT00311051|Montelukast|montelukast|mesh-list
24798636|NCT01964391|Antimitotic Agents|antimitotic agents|mesh-ancestor
24448297|NCT00311051|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24798637|NCT01964391|Mitosis Modulators|mitosis modulators|mesh-ancestor
24798638|NCT01964391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798639|NCT01964391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24647184|NCT01206881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24647185|NCT01206881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24647186|NCT01206881|Alkylating Agents|alkylating agents|mesh-ancestor
24647187|NCT01206881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647188|NCT01206881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647202|NCT01206907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647204|NCT01206907|Sensory System Agents|sensory system agents|mesh-ancestor
24647205|NCT01206907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24647206|NCT01206907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24647207|NCT01206946|Betamethasone|betamethasone|mesh-list
24647209|NCT01206946|Glucocorticoids|glucocorticoids|mesh-ancestor
24647222|NCT01206972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647223|NCT01206972|Anticoagulants|anticoagulants|mesh-ancestor
24647224|NCT01206972|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24647225|NCT01206972|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24647226|NCT01206998|Progesterone|progesterone|mesh-list
24647227|NCT01206998|Progestins|progestins|mesh-ancestor
24647228|NCT01206998|Hormones|hormones|mesh-ancestor
24647229|NCT01206998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24647230|NCT01206998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463024|NCT00358358|Adrenergic Agents|adrenergic agents|mesh-ancestor
24463025|NCT00358358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24463026|NCT00358358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463027|NCT00358358|Glucocorticoids|glucocorticoids|mesh-ancestor
24463029|NCT00358358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24647321|NCT01208012|Liraglutide|liraglutide|mesh-list
24647322|NCT01208012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24647323|NCT01208012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647324|NCT01208012|Incretins|incretins|mesh-ancestor
24798666|NCT01964534|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24798667|NCT01964534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24798668|NCT01964534|Antimetabolites|antimetabolites|mesh-ancestor
24798669|NCT01964534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798670|NCT01964534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24798671|NCT01964534|Antiviral Agents|antiviral agents|mesh-ancestor
24798672|NCT01964534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24798677|NCT01964573|Rotigotine|rotigotine|mesh-list
25075923|NCT03377257|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24941157|NCT03994211|Itraconazole|itraconazole|mesh-list
25003601|NCT03284866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25003613|NCT03248297|Amoxicillin|amoxicillin|mesh-list
25003614|NCT03248297|Azithromycin|azithromycin|mesh-list
25003615|NCT03248297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25003616|NCT03248297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25003632|NCT03197064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25003633|NCT03197064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25003634|NCT03197064|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25003635|NCT03197064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25049356|NCT00614601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049358|NCT00613002|Androgens|androgens|mesh-ancestor
25049359|NCT00613002|Hormones|hormones|mesh-ancestor
25049361|NCT00613002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049375|NCT00612820|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25049376|NCT00612820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049377|NCT00612820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25003650|NCT03173560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647729|NCT01210391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647730|NCT01210430|Vitamins|vitamins|mesh-list
24647731|NCT01210430|Ascorbic Acid|ascorbic acid|mesh-list
24647732|NCT01210430|Losartan|losartan|mesh-list
24647733|NCT01210430|Micronutrients|micronutrients|mesh-ancestor
24647734|NCT01210430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647735|NCT01210430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24647784|NCT01210677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24647785|NCT01210677|Glucocorticoids|glucocorticoids|mesh-ancestor
24647787|NCT01210677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24647788|NCT01210677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941247|NCT03992937|Levonorgestrel|levonorgestrel|mesh-list
24941248|NCT03992937|Progesterone|progesterone|mesh-list
24941249|NCT03992937|Progestins|progestins|mesh-ancestor
24941250|NCT03992937|Hormones|hormones|mesh-ancestor
24647789|NCT01210677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24647790|NCT01210677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647792|NCT01210742|Viscosupplements|viscosupplements|mesh-ancestor
24647793|NCT01210742|Protective Agents|protective agents|mesh-ancestor
24647794|NCT01210742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463139|NCT00359125|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24463140|NCT00359125|Abortifacient Agents|abortifacient agents|mesh-ancestor
24463141|NCT00359125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24463144|NCT00359125|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25003817|NCT03003546|Paclitaxel|paclitaxel|mesh-list
25003818|NCT03003546|Rituximab|rituximab|mesh-list
25003819|NCT03003546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25003820|NCT03003546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25003821|NCT03003546|Tubulin Modulators|tubulin modulators|mesh-ancestor
25003822|NCT03003546|Antimitotic Agents|antimitotic agents|mesh-ancestor
25003823|NCT03003546|Mitosis Modulators|mitosis modulators|mesh-ancestor
25003824|NCT03003546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25003825|NCT03003546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25003826|NCT03003546|Immunologic Factors|immunologic factors|mesh-ancestor
24647831|NCT01211002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24647832|NCT01211002|Growth Substances|growth substances|mesh-ancestor
24647833|NCT01211002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647868|NCT01211210|Antimetabolites|antimetabolites|mesh-ancestor
24647869|NCT01211210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647870|NCT01211210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25049428|NCT00607256|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25049429|NCT00607256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25049430|NCT00607256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25049431|NCT00607256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049432|NCT00607256|Adrenergic Agents|adrenergic agents|mesh-ancestor
25049433|NCT00607256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25049434|NCT00607256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049435|NCT00606697|Vofopitant|vofopitant|mesh-list
25049436|NCT00606697|Vestipitant|vestipitant|mesh-list
25049437|NCT00606697|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25049438|NCT00606697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25049439|NCT00606697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049440|NCT00606697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049441|NCT00606697|Antiemetics|antiemetics|mesh-ancestor
25049442|NCT00606697|Autonomic Agents|autonomic agents|mesh-ancestor
25049443|NCT00606697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24647878|NCT01211223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24647879|NCT01211223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24647880|NCT01211223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25049458|NCT00602745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049459|NCT00602745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25049460|NCT00602745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25049461|NCT00602745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25049462|NCT00602745|Immunologic Factors|immunologic factors|mesh-ancestor
25049463|NCT00602745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049464|NCT00602602|Gemcitabine|gemcitabine|mesh-list
25049465|NCT00602602|Bevacizumab|bevacizumab|mesh-list
25049466|NCT00602602|Fluorouracil|fluorouracil|mesh-list
25049467|NCT00602602|Oxaliplatin|oxaliplatin|mesh-list
25049468|NCT00602602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25049469|NCT00602602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25049470|NCT00602602|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25049471|NCT00602602|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25049472|NCT00602602|Growth Substances|growth substances|mesh-ancestor
25049473|NCT00602602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049474|NCT00602602|Growth Inhibitors|growth inhibitors|mesh-ancestor
25049475|NCT00602602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25049476|NCT00602602|Antimetabolites|antimetabolites|mesh-ancestor
25049477|NCT00602602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049478|NCT00602602|Antiviral Agents|antiviral agents|mesh-ancestor
25003914|NCT02923128|Sufentanil|sufentanil|mesh-list
24798694|NCT01964586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24798695|NCT01964586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24798696|NCT01964586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24798697|NCT01964586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24798698|NCT01964586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798699|NCT01964586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24798719|NCT01964781|Racepinephrine|racepinephrine|mesh-list
24798720|NCT01964781|Bupivacaine|bupivacaine|mesh-list
24798721|NCT01964781|Tranexamic Acid|tranexamic acid|mesh-list
24798722|NCT01964781|Epinephryl borate|epinephryl borate|mesh-list
24798723|NCT01964781|Anesthetics, Local|anesthetics, local|mesh-ancestor
24798724|NCT01964781|Anesthetics|anesthetics|mesh-ancestor
24798725|NCT01964781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24798726|NCT01964781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798728|NCT01964781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24798729|NCT01964781|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24647883|NCT01211275|Axitinib|axitinib|mesh-list
24647884|NCT01211275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647885|NCT01211275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24647886|NCT01211275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647887|NCT01211275|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24647889|NCT01211275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24647908|NCT01211327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647919|NCT01211327|Antifungal Agents|antifungal agents|mesh-ancestor
24647920|NCT01211327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24647921|NCT01211327|Dermatologic Agents|dermatologic agents|mesh-ancestor
24647922|NCT01211327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24647923|NCT01211327|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24647924|NCT01211457|Decitabine|decitabine|mesh-list
24647925|NCT01211457|Venetoclax|venetoclax|mesh-list
24647926|NCT01211457|Sapacitabine|sapacitabine|mesh-list
24647927|NCT01211457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24647928|NCT01211457|Antimetabolites|antimetabolites|mesh-ancestor
24647929|NCT01211457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647931|NCT01211457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24647956|NCT01211509|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24647989|NCT01211795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24648016|NCT01211821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648017|NCT01211834|Antirheumatic Agents|antirheumatic agents|mesh-list
25049495|NCT00602329|Growth Inhibitors|growth inhibitors|mesh-ancestor
25049496|NCT00602329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25049498|NCT00602329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049499|NCT00602329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25049500|NCT00602329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25049501|NCT00602329|Immunologic Factors|immunologic factors|mesh-ancestor
25049502|NCT00602329|Antidotes|antidotes|mesh-ancestor
25049510|NCT00598312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25049511|NCT00598312|Fertility Agents|fertility agents|mesh-ancestor
25049512|NCT00598312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24845611|NCT02238340|Ketoprofen|ketoprofen|mesh-list
24648018|NCT01211847|Diazoxide|diazoxide|mesh-list
24648019|NCT01211847|Choline|choline|mesh-list
24648020|NCT01211847|Lipotropic Agents|lipotropic agents|mesh-ancestor
24648034|NCT01211860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648035|NCT01211860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24648036|NCT01211860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24798758|NCT01964846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648092|NCT01212315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24648093|NCT01212315|Antimetabolites|antimetabolites|mesh-ancestor
24648094|NCT01212315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648095|NCT01212315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24648096|NCT01212367|Interferons|interferons|mesh-list
24648097|NCT01212367|Interferon-alpha|interferon-alpha|mesh-list
24648098|NCT01212367|Interferon alpha-2|interferon alpha-2|mesh-list
24648099|NCT01212367|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
24648100|NCT01212367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450387|NCT00318955|Anesthetics|anesthetics|mesh-ancestor
24648115|NCT01212523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24648116|NCT01212523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24648117|NCT01212523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648118|NCT01212523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24648119|NCT01212523|Anesthetics, General|anesthetics, general|mesh-ancestor
24648120|NCT01212523|Anesthetics|anesthetics|mesh-ancestor
24648141|NCT01212809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648143|NCT01212809|Protective Agents|protective agents|mesh-ancestor
24798760|NCT01964846|Protective Agents|protective agents|mesh-ancestor
24798761|NCT01964846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24798762|NCT01964911|Ropivacaine|ropivacaine|mesh-list
24798763|NCT01964911|Anesthetics, Local|anesthetics, local|mesh-ancestor
24798768|NCT01964911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24798770|NCT01965041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24798771|NCT01965041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25004041|NCT02807636|Antiviral Agents|antiviral agents|mesh-ancestor
25004042|NCT02807636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25004043|NCT02807636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004044|NCT02807636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25004045|NCT02807636|Immunologic Factors|immunologic factors|mesh-ancestor
25004046|NCT02807636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004048|NCT02764541|Letrozole|letrozole|mesh-list
24648169|NCT01212887|Aldesleukin|aldesleukin|mesh-list
24648170|NCT01212887|Cyclophosphamide|cyclophosphamide|mesh-list
24648171|NCT01212887|Fludarabine|fludarabine|mesh-list
24648172|NCT01212887|Fludarabine phosphate|fludarabine phosphate|mesh-list
24648173|NCT01212887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24648174|NCT01212887|Immunologic Factors|immunologic factors|mesh-ancestor
24648175|NCT01212887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648176|NCT01212887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24648177|NCT01212887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24648178|NCT01212887|Alkylating Agents|alkylating agents|mesh-ancestor
24648179|NCT01212887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648180|NCT01212887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648181|NCT01212887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24648182|NCT01212887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24648183|NCT01212887|Antimetabolites|antimetabolites|mesh-ancestor
24648184|NCT01212887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24648185|NCT01212887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24648186|NCT01212887|Antiviral Agents|antiviral agents|mesh-ancestor
24648187|NCT01212887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24648189|NCT01212913|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24648223|NCT01213147|Zuclomiphene|zuclomiphene|mesh-list
24648224|NCT01213147|Buserelin|buserelin|mesh-list
24648225|NCT01213147|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24648226|NCT01213147|Hormone Antagonists|hormone antagonists|mesh-ancestor
24648227|NCT01213147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24648228|NCT01213147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648229|NCT01213147|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24648230|NCT01213147|Fertility Agents|fertility agents|mesh-ancestor
24648231|NCT01213147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24648244|NCT01213238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24648245|NCT01213238|Antimetabolites|antimetabolites|mesh-ancestor
25004050|NCT02764541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25004051|NCT02764541|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25004052|NCT02764541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25004053|NCT02764541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004054|NCT02764541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004055|NCT02764541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25004056|NCT02764541|Hormone Antagonists|hormone antagonists|mesh-ancestor
25004057|NCT02764541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24648949|NCT01217632|Antiviral Agents|antiviral agents|mesh-ancestor
25004058|NCT02764541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004059|NCT02764541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24845659|NCT02238392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24648246|NCT01213238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648248|NCT01213355|Donepezil|donepezil|mesh-list
24648249|NCT01213355|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24648284|NCT01213394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648285|NCT01213394|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25004076|NCT02763579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648320|NCT01213550|Dermatologic Agents|dermatologic agents|mesh-ancestor
24648322|NCT01213563|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24648323|NCT01213563|Insulin, neutral|insulin, neutral|mesh-list
24648324|NCT01213563|Insulin, Regular, Pork|insulin, regular, pork|mesh-list
24648325|NCT01213563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24648326|NCT01213563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648328|NCT01213667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24648329|NCT01213667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24648330|NCT01213667|Growth Substances|growth substances|mesh-ancestor
24648331|NCT01213667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648332|NCT01213667|Growth Inhibitors|growth inhibitors|mesh-ancestor
24648333|NCT01213667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648334|NCT01213680|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
24648335|NCT01213680|Ferric Compounds|ferric compounds|mesh-list
24648336|NCT01213680|Hematinics|hematinics|mesh-ancestor
24648337|NCT01213693|Fluticasone|fluticasone|mesh-list
24648338|NCT01213693|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24648339|NCT01213693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24648340|NCT01213693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24648341|NCT01213693|Autonomic Agents|autonomic agents|mesh-ancestor
24648342|NCT01213693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24648343|NCT01213693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648344|NCT01213693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24648345|NCT01213693|Respiratory System Agents|respiratory system agents|mesh-ancestor
24648475|NCT01214941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24648476|NCT01214941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648477|NCT01214941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648478|NCT01214941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24648479|NCT01214941|Hormone Antagonists|hormone antagonists|mesh-ancestor
25004165|NCT02591953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25004166|NCT02591953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25004167|NCT02591953|Protective Agents|protective agents|mesh-ancestor
25004231|NCT02201381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25004232|NCT02201381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004233|NCT02201381|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25004234|NCT02201381|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25004235|NCT02201381|Antimetabolites|antimetabolites|mesh-ancestor
25004236|NCT02201381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004237|NCT02201381|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25004238|NCT02201381|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25004239|NCT02201381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004241|NCT02201381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25004242|NCT02201381|Antimalarials|antimalarials|mesh-ancestor
24941612|NCT03989700|Vitamin B Complex|vitamin b complex|mesh-ancestor
24941614|NCT03989557|Clopidogrel|clopidogrel|mesh-list
24941621|NCT03989557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24941623|NCT03989557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24941624|NCT03989557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24941625|NCT03989557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24941626|NCT03989557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24941627|NCT03989557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24941628|NCT03989557|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24941629|NCT03989557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24941630|NCT03989557|Antipyretics|antipyretics|mesh-ancestor
24941631|NCT03989557|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24941632|NCT03989557|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24941633|NCT03989557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24941634|NCT03989557|Purinergic Agents|purinergic agents|mesh-ancestor
24941635|NCT03989557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24941636|NCT03989271|Quercetin|quercetin|mesh-list
24941637|NCT03989271|Antioxidants|antioxidants|mesh-ancestor
24622152|NCT01065857|Chelating Agents|chelating agents|mesh-ancestor
24648554|NCT01215409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648555|NCT01215409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004358|NCT01941875|Progestins|progestins|mesh-ancestor
25004360|NCT01941875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25004361|NCT01941875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648556|NCT01215409|Urological Agents|urological agents|mesh-ancestor
24648557|NCT01215539|Panitumumab|panitumumab|mesh-list
24648558|NCT01215539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24648559|NCT01215539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648561|NCT01215565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648562|NCT01215565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24648563|NCT01215565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24648564|NCT01215565|Growth Substances|growth substances|mesh-ancestor
24648565|NCT01215565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648566|NCT01215565|Growth Inhibitors|growth inhibitors|mesh-ancestor
24648567|NCT01215565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24429416|NCT00243880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24429775|NCT00245024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429776|NCT00245089|Dactinomycin|dactinomycin|mesh-list
24430481|NCT00247988|Antimitotic Agents|antimitotic agents|mesh-ancestor
24430482|NCT00247988|Mitosis Modulators|mitosis modulators|mesh-ancestor
24430483|NCT00247988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648568|NCT01215565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648569|NCT01215565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648571|NCT01215578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648572|NCT01215578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24648573|NCT01215578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25004375|NCT01874353|Olaparib|olaparib|mesh-list
25004376|NCT01874353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25004377|NCT01874353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004378|NCT01874353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004379|NCT01874353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25004389|NCT01814657|Lidocaine|lidocaine|mesh-list
25004390|NCT01814657|Anesthetics, Local|anesthetics, local|mesh-ancestor
25004391|NCT01814657|Anesthetics|anesthetics|mesh-ancestor
25004392|NCT01814657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25004393|NCT01814657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648627|NCT01216085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648628|NCT01216085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24648629|NCT01216085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648674|NCT01216293|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24648675|NCT01216293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648676|NCT01216293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648678|NCT01216345|Oxaliplatin|oxaliplatin|mesh-list
24648680|NCT01216345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24648681|NCT01216345|Antimetabolites|antimetabolites|mesh-ancestor
25004395|NCT01814657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25004396|NCT01814657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25004397|NCT01814657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25004398|NCT01814657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25004399|NCT01814657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25004400|NCT01814657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004401|NCT01773395|Methotrexate|methotrexate|mesh-list
25004402|NCT01773395|Fludarabine|fludarabine|mesh-list
25004403|NCT01773395|Busulfan|busulfan|mesh-list
25004404|NCT01773395|Tacrolimus|tacrolimus|mesh-list
25004405|NCT01773395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25004406|NCT01773395|Abortifacient Agents|abortifacient agents|mesh-ancestor
25004407|NCT01773395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25004408|NCT01773395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004409|NCT01773395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25004410|NCT01773395|Antimetabolites|antimetabolites|mesh-ancestor
25004411|NCT01773395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004412|NCT01773395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25004413|NCT01773395|Dermatologic Agents|dermatologic agents|mesh-ancestor
25004414|NCT01773395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648682|NCT01216345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648684|NCT01216345|Antiviral Agents|antiviral agents|mesh-ancestor
24648685|NCT01216345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24648686|NCT01216345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648687|NCT01216345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25701944|NCT02148588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25701945|NCT02148588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25701946|NCT02148588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25701947|NCT02148588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701948|NCT02148718|Adalimumab|adalimumab|mesh-list
25701949|NCT02148718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25701950|NCT02148718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25701951|NCT02148874|Vaccines|vaccines|mesh-list
24434222|NCT00261729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434223|NCT00261729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24434660|NCT00263094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24648688|NCT01216345|Immunologic Factors|immunologic factors|mesh-ancestor
24648689|NCT01216345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648690|NCT01216345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24592659|NCT00923637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24846073|NCT02241083|Autonomic Agents|autonomic agents|mesh-ancestor
24846074|NCT02241083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24648691|NCT01216371|Sunitinib|sunitinib|mesh-list
24648692|NCT01216371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648693|NCT01216371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24648694|NCT01216371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24648695|NCT01216371|Growth Substances|growth substances|mesh-ancestor
24648696|NCT01216371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648715|NCT01216488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24648716|NCT01216488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648717|NCT01216488|Sensory System Agents|sensory system agents|mesh-ancestor
24648718|NCT01216488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24648719|NCT01216488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24648720|NCT01216488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24648721|NCT01216488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24648722|NCT01216488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24648723|NCT01216488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648724|NCT01216579|Mannitol|mannitol|mesh-list
24648725|NCT01216579|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24648726|NCT01216579|Diuretics|diuretics|mesh-ancestor
24648727|NCT01216579|Natriuretic Agents|natriuretic agents|mesh-ancestor
24648728|NCT01216579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648730|NCT01216605|Oxytocics|oxytocics|mesh-ancestor
24622148|NCT01065857|Citric Acid|citric acid|mesh-list
24622149|NCT01065857|Sodium Citrate|sodium citrate|mesh-list
24622150|NCT01065857|Anticoagulants|anticoagulants|mesh-ancestor
24622151|NCT01065857|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24622163|NCT01065870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622164|NCT01065870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622166|NCT01065870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24622167|NCT01065870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622169|NCT01065870|Immunologic Factors|immunologic factors|mesh-ancestor
24826754|NCT02135887|Folic Acid|folic acid|mesh-list
25049547|NCT00589823|Sensory System Agents|sensory system agents|mesh-ancestor
25049548|NCT00589823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25049558|NCT00584974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25049559|NCT00584974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049560|NCT00584974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25049561|NCT00584974|Antidepressive Agents|antidepressive agents|mesh-ancestor
25049562|NCT00584974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25049563|NCT00583830|Paclitaxel|paclitaxel|mesh-list
25049564|NCT00583830|Carboplatin|carboplatin|mesh-list
25049565|NCT00583830|Mapatumumab|mapatumumab|mesh-list
25049566|NCT00583830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25049567|NCT00583830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25049568|NCT00583830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25049569|NCT00583830|Tubulin Modulators|tubulin modulators|mesh-ancestor
25049570|NCT00583830|Antimitotic Agents|antimitotic agents|mesh-ancestor
25049571|NCT00583830|Mitosis Modulators|mitosis modulators|mesh-ancestor
25049572|NCT00583830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049573|NCT00583830|Immunologic Factors|immunologic factors|mesh-ancestor
25049574|NCT00583830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049575|NCT00583674|Cisplatin|cisplatin|mesh-list
25049576|NCT00583674|Capecitabine|capecitabine|mesh-list
25049577|NCT00583674|Trebananib|trebananib|mesh-list
25049578|NCT00583674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25049579|NCT00583674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25049580|NCT00583674|Antimetabolites|antimetabolites|mesh-ancestor
25701952|NCT02148874|Immunologic Factors|immunologic factors|mesh-ancestor
25701953|NCT02148874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701954|NCT02149108|Nintedanib|nintedanib|mesh-list
25701955|NCT02149108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24790438|NCT01942460|Hematinics|hematinics|mesh-ancestor
25049581|NCT00583674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049603|NCT00580216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049604|NCT00580216|Vitamin B Complex|vitamin b complex|mesh-ancestor
25049605|NCT00580216|Vitamins|vitamins|mesh-ancestor
25049606|NCT00580216|Micronutrients|micronutrients|mesh-ancestor
25049607|NCT00580216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049608|NCT00580125|Aripiprazole|aripiprazole|mesh-list
25049609|NCT00580125|Antidepressive Agents|antidepressive agents|mesh-ancestor
25049610|NCT00580125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25049611|NCT00580125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25049612|NCT00580125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25049613|NCT00580125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25049614|NCT00580125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049615|NCT00580125|Dopamine Agonists|dopamine agonists|mesh-ancestor
25049616|NCT00580125|Dopamine Agents|dopamine agents|mesh-ancestor
24942032|NCT03984656|Lidocaine|lidocaine|mesh-list
24942033|NCT03984656|Anesthetics, Local|anesthetics, local|mesh-ancestor
24942034|NCT03984656|Anesthetics|anesthetics|mesh-ancestor
24942035|NCT03984656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24648752|NCT01216644|Micronutrients|micronutrients|mesh-ancestor
24648753|NCT01216644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24648754|NCT01216644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24648755|NCT01216644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24648756|NCT01216644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648757|NCT01216657|Sunitinib|sunitinib|mesh-list
24648758|NCT01216657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648759|NCT01216657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24648760|NCT01216657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24648761|NCT01216657|Growth Substances|growth substances|mesh-ancestor
24648762|NCT01216657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648763|NCT01216657|Growth Inhibitors|growth inhibitors|mesh-ancestor
24648767|NCT01216696|Ipilimumab|ipilimumab|mesh-list
24648806|NCT01216904|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24648819|NCT01216956|Antimetabolites|antimetabolites|mesh-ancestor
24648876|NCT01217138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648877|NCT01217138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648878|NCT01217138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24648879|NCT01217138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24648880|NCT01217138|Autonomic Agents|autonomic agents|mesh-ancestor
24648881|NCT01217138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24648882|NCT01217138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24648893|NCT01217203|Immunologic Factors|immunologic factors|mesh-ancestor
24648894|NCT01217203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648895|NCT01217203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24648896|NCT01217203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24648897|NCT01217203|Growth Substances|growth substances|mesh-ancestor
24942036|NCT03984656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24942037|NCT03984656|Sensory System Agents|sensory system agents|mesh-ancestor
24942038|NCT03984656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24942039|NCT03984656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24942040|NCT03984656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24942041|NCT03984656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24942042|NCT03984656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24846235|NCT02242240|Tiotropium Bromide|tiotropium bromide|mesh-list
24846236|NCT02242240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24846237|NCT02242240|Autonomic Agents|autonomic agents|mesh-ancestor
24846238|NCT02242240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24846239|NCT02242240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846241|NCT02242240|Respiratory System Agents|respiratory system agents|mesh-ancestor
24648898|NCT01217203|Growth Inhibitors|growth inhibitors|mesh-ancestor
24648899|NCT01217203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648901|NCT01217294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24648902|NCT01217294|Narcotics|narcotics|mesh-ancestor
24648939|NCT01217580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24648940|NCT01217580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648941|NCT01217580|Sensory System Agents|sensory system agents|mesh-ancestor
24648942|NCT01217580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24648943|NCT01217619|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24648944|NCT01217619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648945|NCT01217619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24648946|NCT01217619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648947|NCT01217619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701956|NCT02149108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24440590|NCT00283790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24440591|NCT00283790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440592|NCT00283829|Docetaxel|docetaxel|mesh-list
24648981|NCT01217879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648983|NCT01217970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24648984|NCT01217970|Autonomic Agents|autonomic agents|mesh-ancestor
24648985|NCT01217970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24648986|NCT01217970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648987|NCT01217970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24648988|NCT01217970|Respiratory System Agents|respiratory system agents|mesh-ancestor
24648989|NCT01217970|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24649072|NCT01218568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24942285|NCT03982784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24942287|NCT03982784|Analgesics|analgesics|mesh-ancestor
24767539|NCT01801774|Glucocorticoids|glucocorticoids|mesh-ancestor
24767540|NCT01801774|Hormones|hormones|mesh-ancestor
24767541|NCT01801774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24767542|NCT01801774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24767547|NCT01801904|Panitumumab|panitumumab|mesh-list
24942763|NCT03978364|Azacitidine|azacitidine|mesh-list
24942764|NCT03978364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24942765|NCT03978364|Antimetabolites|antimetabolites|mesh-ancestor
24942766|NCT03978364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24942767|NCT03978364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24942768|NCT03978364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24942769|NCT03978286|Vortioxetine|vortioxetine|mesh-list
24942770|NCT03978286|Sertraline|sertraline|mesh-list
24942771|NCT03978286|Antidepressive Agents|antidepressive agents|mesh-ancestor
24942772|NCT03978286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24942773|NCT03978286|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24622176|NCT01065961|BB 1101|bb 1101|mesh-list
24622181|NCT01065961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622182|NCT01065961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24622183|NCT01065961|Glucocorticoids|glucocorticoids|mesh-ancestor
24622184|NCT01065961|Hormones|hormones|mesh-ancestor
24622185|NCT01065961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24622186|NCT01065961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24622187|NCT01065961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622188|NCT01065961|Protease Inhibitors|protease inhibitors|mesh-ancestor
24622189|NCT01065961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622190|NCT01065961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622191|NCT01065987|Tizanidine|tizanidine|mesh-list
24649120|NCT01218620|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24649121|NCT01218620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24649122|NCT01218620|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24649123|NCT01218620|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24649124|NCT01218620|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24649125|NCT01218620|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24649126|NCT01218620|Antifungal Agents|antifungal agents|mesh-ancestor
24649174|NCT01218737|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24649175|NCT01218737|Prednisolone phosphate|prednisolone phosphate|mesh-list
24649176|NCT01218737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24649177|NCT01218737|Glucocorticoids|glucocorticoids|mesh-ancestor
24649178|NCT01218737|Hormones|hormones|mesh-ancestor
24649179|NCT01218737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24649181|NCT01218737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24649182|NCT01218737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649183|NCT01218737|Antiemetics|antiemetics|mesh-ancestor
24649184|NCT01218737|Autonomic Agents|autonomic agents|mesh-ancestor
24649185|NCT01218737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24649186|NCT01218737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24649187|NCT01218737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24649188|NCT01218737|Protective Agents|protective agents|mesh-ancestor
24649189|NCT01218737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24649190|NCT01218737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24649191|NCT01218737|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25701957|NCT02149108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25701958|NCT02149108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701959|NCT02149173|Deoxyglucose|deoxyglucose|mesh-list
25701960|NCT02149173|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25701961|NCT02149173|Fluorides|fluorides|mesh-list
25701962|NCT02149173|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25701963|NCT02149173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701965|NCT02149173|Protective Agents|protective agents|mesh-ancestor
25701966|NCT02149173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442597|NCT00291759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24442598|NCT00291759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460447|NCT00348413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24649262|NCT01219101|Zuclomiphene|zuclomiphene|mesh-list
24649263|NCT01219101|Anticoagulants|anticoagulants|mesh-ancestor
24649264|NCT01219101|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24942940|NCT03976271|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24942941|NCT03976271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798789|NCT01965275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24798793|NCT01965301|Promethazine|promethazine|mesh-list
24798794|NCT01965301|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24798795|NCT01965301|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24798796|NCT01965301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24798797|NCT01965301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846347|NCT02242396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24649265|NCT01219101|Chelating Agents|chelating agents|mesh-ancestor
24649266|NCT01219101|Sequestering Agents|sequestering agents|mesh-ancestor
24649269|NCT01219101|Hormone Antagonists|hormone antagonists|mesh-ancestor
24649270|NCT01219101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24649271|NCT01219101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649272|NCT01219101|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24649273|NCT01219101|Fertility Agents|fertility agents|mesh-ancestor
24649274|NCT01219101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24649275|NCT01219101|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24649276|NCT01219101|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24649277|NCT01219153|Letrozole|letrozole|mesh-list
24649278|NCT01219153|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
24649721|NCT01221740|Levomilnacipran|levomilnacipran|mesh-list
24649279|NCT01219153|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24649280|NCT01219153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649282|NCT01219153|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24649283|NCT01219153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24649284|NCT01219153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649286|NCT01219153|Hormone Antagonists|hormone antagonists|mesh-ancestor
24649287|NCT01219153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24649288|NCT01219153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649290|NCT01219205|Bevacizumab|bevacizumab|mesh-list
24649291|NCT01219205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24649292|NCT01219205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649293|NCT01219205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24649294|NCT01219205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24649295|NCT01219205|Growth Substances|growth substances|mesh-ancestor
24649296|NCT01219205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649297|NCT01219205|Growth Inhibitors|growth inhibitors|mesh-ancestor
24649298|NCT01219244|Resveratrol|resveratrol|mesh-list
24649299|NCT01219244|Antioxidants|antioxidants|mesh-ancestor
24649300|NCT01219244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649301|NCT01219244|Protective Agents|protective agents|mesh-ancestor
24649302|NCT01219244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649303|NCT01219244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24649304|NCT01219244|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24649323|NCT01219400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24649324|NCT01219400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649325|NCT01219400|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24798799|NCT01965301|Anesthetics|anesthetics|mesh-ancestor
24798800|NCT01965301|Sensory System Agents|sensory system agents|mesh-ancestor
25701967|NCT02149173|Antimetabolites|antimetabolites|mesh-ancestor
25701968|NCT02149173|Antiviral Agents|antiviral agents|mesh-ancestor
25701969|NCT02149173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25701970|NCT02149199|Budesonide|budesonide|mesh-list
24649328|NCT01219400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649329|NCT01219413|Perindopril|perindopril|mesh-list
24649330|NCT01219413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24649331|NCT01219413|Protease Inhibitors|protease inhibitors|mesh-ancestor
24649332|NCT01219413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24649333|NCT01219413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649334|NCT01219413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24649335|NCT01219556|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24649337|NCT01219556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24649338|NCT01219556|Diuretics|diuretics|mesh-ancestor
24649340|NCT01219556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649341|NCT01219556|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24649342|NCT01219556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24649343|NCT01219556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798819|NCT01965353|Autonomic Agents|autonomic agents|mesh-ancestor
24949462|NCT04718792|Psilocybin|psilocybin|mesh-list
24649381|NCT01219686|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24649382|NCT01219686|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24649383|NCT01219686|Cholinergic Agents|cholinergic agents|mesh-ancestor
24649384|NCT01219686|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24649385|NCT01219686|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24649386|NCT01219686|Adrenergic Agents|adrenergic agents|mesh-ancestor
24649387|NCT01219686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24649756|NCT01221831|Hormones|hormones|mesh-ancestor
24649388|NCT01219686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24649389|NCT01219686|Vasodilator Agents|vasodilator agents|mesh-ancestor
24649390|NCT01219699|Fulvestrant|fulvestrant|mesh-list
24649455|NCT01219920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649456|NCT01219920|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24649457|NCT01219920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24649458|NCT01219920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24649460|NCT01220063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24649461|NCT01220063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24649462|NCT01220063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24649464|NCT01220063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649466|NCT01220076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24649467|NCT01220076|Hormone Antagonists|hormone antagonists|mesh-ancestor
24649468|NCT01220076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24649469|NCT01220076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701972|NCT02149199|Formoterol Fumarate|formoterol fumarate|mesh-list
25701973|NCT02149199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25701974|NCT02149199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25701975|NCT02149199|Autonomic Agents|autonomic agents|mesh-ancestor
25701976|NCT02149199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25701977|NCT02149199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701978|NCT02149199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25701979|NCT02149199|Respiratory System Agents|respiratory system agents|mesh-ancestor
25701980|NCT02149199|Glucocorticoids|glucocorticoids|mesh-ancestor
25701981|NCT02149199|Hormones|hormones|mesh-ancestor
24649470|NCT01220076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24649471|NCT01220076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649472|NCT01220076|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24649473|NCT01220076|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24649474|NCT01220076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24649476|NCT01220102|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24649477|NCT01220102|Dermatologic Agents|dermatologic agents|mesh-ancestor
24649478|NCT01220102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24649479|NCT01220102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24649481|NCT01220102|Sensory System Agents|sensory system agents|mesh-ancestor
24649482|NCT01220102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24649483|NCT01220102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649484|NCT01220102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24649485|NCT01220102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24649557|NCT01220362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24649558|NCT01220362|Anesthetics, General|anesthetics, general|mesh-ancestor
24649560|NCT01220375|Vinorelbine|vinorelbine|mesh-list
24649561|NCT01220375|Lenograstim|lenograstim|mesh-list
24649562|NCT01220375|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24649563|NCT01220375|Immunologic Factors|immunologic factors|mesh-ancestor
24649564|NCT01220375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649565|NCT01220375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24649566|NCT01220375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649567|NCT01220375|Tubulin Modulators|tubulin modulators|mesh-ancestor
24649568|NCT01220375|Antimitotic Agents|antimitotic agents|mesh-ancestor
24649569|NCT01220375|Mitosis Modulators|mitosis modulators|mesh-ancestor
24649610|NCT01220622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24649701|NCT01221558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24649702|NCT01221558|Antioxidants|antioxidants|mesh-ancestor
24649703|NCT01221558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649704|NCT01221558|Protective Agents|protective agents|mesh-ancestor
24450611|NCT00319852|Vaccines|vaccines|mesh-list
24649705|NCT01221558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649706|NCT01221558|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24649707|NCT01221558|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24649708|NCT01221558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649709|NCT01221636|Abatacept|abatacept|mesh-list
24649710|NCT01221636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24649711|NCT01221636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649712|NCT01221636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649713|NCT01221636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24649714|NCT01221636|Immunologic Factors|immunologic factors|mesh-ancestor
24649715|NCT01221636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798828|NCT01965353|Immunologic Factors|immunologic factors|mesh-ancestor
24798829|NCT01965353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24798830|NCT01965353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24649716|NCT01221636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24649717|NCT01221675|Antibodies|antibodies|mesh-list
24649718|NCT01221675|Immunologic Factors|immunologic factors|mesh-ancestor
24649719|NCT01221675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649720|NCT01221740|Milnacipran|milnacipran|mesh-list
24649757|NCT01221831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24649758|NCT01221831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649759|NCT01221831|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24649760|NCT01221831|Contraceptive Agents|contraceptive agents|mesh-ancestor
24649761|NCT01221831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24649762|NCT01221831|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24649763|NCT01221831|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24649764|NCT01221831|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24649765|NCT01221831|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24649769|NCT01221883|Diazepam|diazepam|mesh-list
24649788|NCT01221883|GABA Agents|gaba agents|mesh-ancestor
24649789|NCT01221883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24649790|NCT01221883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649791|NCT01221896|Choline|choline|mesh-list
24649792|NCT01221896|Lipotropic Agents|lipotropic agents|mesh-ancestor
24649793|NCT01221896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24649794|NCT01221896|Antimetabolites|antimetabolites|mesh-ancestor
24649795|NCT01221896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649796|NCT01221896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24649904|NCT01222611|Fosamprenavir|fosamprenavir|mesh-list
24649921|NCT01222650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649922|NCT01222650|Urological Agents|urological agents|mesh-ancestor
24649923|NCT01222676|Gemcitabine|gemcitabine|mesh-list
24649925|NCT01222676|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24649926|NCT01222676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649927|NCT01222676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24649928|NCT01222676|Antimetabolites|antimetabolites|mesh-ancestor
24649929|NCT01222676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649930|NCT01222676|Antiviral Agents|antiviral agents|mesh-ancestor
24649931|NCT01222676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24649932|NCT01222676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24649933|NCT01222676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24649934|NCT01222676|Immunologic Factors|immunologic factors|mesh-ancestor
24649966|NCT01222923|Dopamine Agents|dopamine agents|mesh-ancestor
24649967|NCT01222936|Panobinostat|panobinostat|mesh-list
24649968|NCT01222936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649969|NCT01222936|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24649970|NCT01222936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24649999|NCT01223079|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24650001|NCT01223079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24650002|NCT01223079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650003|NCT01223131|Insulin|insulin|mesh-list
24650004|NCT01223131|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24650005|NCT01223131|Insulin Glargine|insulin glargine|mesh-list
24650051|NCT01223612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650052|NCT01223612|Growth Inhibitors|growth inhibitors|mesh-ancestor
24650053|NCT01223612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650054|NCT01223625|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24650055|NCT01223625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24650056|NCT01223625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24798847|NCT01965405|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24798848|NCT01965405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24943013|NCT03975166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24943087|NCT03974932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24943088|NCT03974932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24943089|NCT03974932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24463865|NCT00362583|Fentanyl|fentanyl|mesh-list
24650057|NCT01223625|Antimetabolites|antimetabolites|mesh-ancestor
24650058|NCT01223625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650059|NCT01223625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24650061|NCT01223625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24650095|NCT01223768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650096|NCT01223768|Nootropic Agents|nootropic agents|mesh-ancestor
24650098|NCT01223820|Antipruritics|antipruritics|mesh-ancestor
24650099|NCT01223820|Dermatologic Agents|dermatologic agents|mesh-ancestor
24650111|NCT01224041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24650113|NCT01224041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650114|NCT01224041|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24650115|NCT01224041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24943377|NCT03972046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24650116|NCT01224041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650117|NCT01224067|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24650118|NCT01224067|Antidepressive Agents|antidepressive agents|mesh-ancestor
24650119|NCT01224067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24650120|NCT01224067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24650121|NCT01224067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24650122|NCT01224067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24650123|NCT01224067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650125|NCT01224093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24650126|NCT01224093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650127|NCT01224093|Immunologic Factors|immunologic factors|mesh-ancestor
24650128|NCT01224093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650132|NCT01224197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24650133|NCT01224197|Protease Inhibitors|protease inhibitors|mesh-ancestor
24650134|NCT01224197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24650135|NCT01224197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650137|NCT01224301|Immunologic Factors|immunologic factors|mesh-ancestor
24650138|NCT01224301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650139|NCT01224314|Dialysis Solutions|dialysis solutions|mesh-list
24650140|NCT01224314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24650141|NCT01224353|Thioctic Acid|thioctic acid|mesh-list
24650142|NCT01224353|Antioxidants|antioxidants|mesh-ancestor
24943090|NCT03974932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24943091|NCT03974932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24943092|NCT03974932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943093|NCT03974932|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24943094|NCT03974685|Niacinamide|niacinamide|mesh-list
24943096|NCT03974685|Nicotinic Acids|nicotinic acids|mesh-list
24943097|NCT03974685|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
24943098|NCT03974685|Vitamin B Complex|vitamin b complex|mesh-ancestor
24943099|NCT03974685|Vitamins|vitamins|mesh-ancestor
24943100|NCT03974685|Micronutrients|micronutrients|mesh-ancestor
24943101|NCT03974685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943102|NCT03974685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24943103|NCT03974685|Antimetabolites|antimetabolites|mesh-ancestor
24943356|NCT03972358|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24650283|NCT01224951|Beclomethasone|beclomethasone|mesh-list
24650284|NCT01224951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24650285|NCT01224951|Glucocorticoids|glucocorticoids|mesh-ancestor
24650287|NCT01224951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24650288|NCT01224951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650289|NCT01224951|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24650323|NCT01225198|Micronutrients|micronutrients|mesh-ancestor
24650324|NCT01225198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650326|NCT01225224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24650327|NCT01225224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650328|NCT01225224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24650329|NCT01225224|Immunologic Factors|immunologic factors|mesh-ancestor
24650330|NCT01225224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650331|NCT01225237|Ramosetron|ramosetron|mesh-list
24650332|NCT01225237|Antiemetics|antiemetics|mesh-ancestor
24650333|NCT01225237|Autonomic Agents|autonomic agents|mesh-ancestor
24650334|NCT01225237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24650368|NCT01225419|Plerixafor|plerixafor|mesh-list
24650401|NCT01225523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650403|NCT01225653|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24650404|NCT01225653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24650405|NCT01225705|Ritonavir|ritonavir|mesh-list
24650435|NCT01225874|Prednisone|prednisone|mesh-list
24650436|NCT01225874|Methotrexate|methotrexate|mesh-list
24650437|NCT01225874|Vincristine|vincristine|mesh-list
24650438|NCT01225874|Daunorubicin|daunorubicin|mesh-list
24650439|NCT01225874|Asparaginase|asparaginase|mesh-list
24650440|NCT01225874|Pegaspargase|pegaspargase|mesh-list
24650441|NCT01225874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24650442|NCT01225874|Antiemetics|antiemetics|mesh-ancestor
24650443|NCT01225874|Autonomic Agents|autonomic agents|mesh-ancestor
24650444|NCT01225874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24650445|NCT01225874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650446|NCT01225874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24650447|NCT01225874|Glucocorticoids|glucocorticoids|mesh-ancestor
24650448|NCT01225874|Hormones|hormones|mesh-ancestor
24650449|NCT01225874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24650450|NCT01225874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24650451|NCT01225874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943376|NCT03972046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24943378|NCT03972046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846441|NCT02242734|Analgesics|analgesics|mesh-ancestor
24650452|NCT01225874|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24650453|NCT01225874|Abortifacient Agents|abortifacient agents|mesh-ancestor
24650454|NCT01225874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24650455|NCT01225874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24650456|NCT01225874|Antimetabolites|antimetabolites|mesh-ancestor
24650457|NCT01225874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650458|NCT01225874|Dermatologic Agents|dermatologic agents|mesh-ancestor
24650459|NCT01225874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24650460|NCT01225874|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24650486|NCT01225913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24650487|NCT01225913|Respiratory System Agents|respiratory system agents|mesh-ancestor
24650489|NCT01225913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24650490|NCT01225913|Glucocorticoids|glucocorticoids|mesh-ancestor
24650491|NCT01225913|Hormones|hormones|mesh-ancestor
24650492|NCT01225913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24650493|NCT01225913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24650494|NCT01225913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24650503|NCT01226017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650504|NCT01226056|Everolimus|everolimus|mesh-list
24650505|NCT01226056|Sorafenib|sorafenib|mesh-list
24650506|NCT01226056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650509|NCT01226056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650510|NCT01226056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24650512|NCT01226056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650577|NCT01226667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943379|NCT03972046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24943380|NCT03972228|Antineoplastic Agents|antineoplastic agents|mesh-list
24798849|NCT01965405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24798850|NCT01965522|Vitamin D|vitamin d|mesh-list
24798851|NCT01965522|Ergocalciferols|ergocalciferols|mesh-list
24798852|NCT01965522|Cholecalciferol|cholecalciferol|mesh-list
24798853|NCT01965522|Vitamins|vitamins|mesh-list
24798854|NCT01965522|Melatonin|melatonin|mesh-list
24798855|NCT01965522|Micronutrients|micronutrients|mesh-ancestor
24846444|NCT02242734|Antitussive Agents|antitussive agents|mesh-ancestor
24650579|NCT01226667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24650580|NCT01226667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24650581|NCT01226667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650582|NCT01226667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24650583|NCT01226667|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24650584|NCT01226667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24650585|NCT01226667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24650586|NCT01226667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24650588|NCT01226680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24650589|NCT01226680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24650590|NCT01226680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650591|NCT01226771|Ribavirin|ribavirin|mesh-list
24650592|NCT01226771|Antimetabolites|antimetabolites|mesh-ancestor
24650593|NCT01226771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650594|NCT01226771|Antiviral Agents|antiviral agents|mesh-ancestor
24650595|NCT01226771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24650596|NCT01226823|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24650597|NCT01226823|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24650598|NCT01226823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24650599|NCT01226849|Rituximab|rituximab|mesh-list
24650600|NCT01226849|Carboplatin|carboplatin|mesh-list
24650601|NCT01226849|Etoposide|etoposide|mesh-list
24650602|NCT01226849|Bortezomib|bortezomib|mesh-list
24650603|NCT01226849|Ifosfamide|ifosfamide|mesh-list
24650604|NCT01226849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24650605|NCT01226849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650606|NCT01226849|Immunologic Factors|immunologic factors|mesh-ancestor
24650662|NCT01227239|Oxaliplatin|oxaliplatin|mesh-list
24650663|NCT01227239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650664|NCT01227356|Interferons|interferons|mesh-list
24650693|NCT01227408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24650694|NCT01227408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24650695|NCT01227408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24650698|NCT01227408|Abortifacient Agents|abortifacient agents|mesh-ancestor
24450815|NCT00320658|Antacids|antacids|mesh-ancestor
24463976|NCT00362895|Hormones|hormones|mesh-ancestor
24551411|NCT00726258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24551412|NCT00726258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650699|NCT01227408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24650700|NCT01227408|Dermatologic Agents|dermatologic agents|mesh-ancestor
24650701|NCT01227408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24650702|NCT01227408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24650703|NCT01227590|Ritonavir|ritonavir|mesh-list
24650704|NCT01227590|Lopinavir|lopinavir|mesh-list
24650705|NCT01227590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24650706|NCT01227590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24650707|NCT01227590|Protease Inhibitors|protease inhibitors|mesh-ancestor
24650708|NCT01227590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24650709|NCT01227590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650710|NCT01227590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24650736|NCT01227720|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24650737|NCT01227720|Cholinergic Agents|cholinergic agents|mesh-ancestor
24650738|NCT01227720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24650739|NCT01227720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650740|NCT01227759|Tyrothricin|tyrothricin|mesh-list
24650760|NCT01227876|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24650761|NCT01227876|Methylprednisolone|methylprednisolone|mesh-list
24650762|NCT01227876|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24650763|NCT01227876|Prednisolone|prednisolone|mesh-list
24650768|NCT01227876|Antiemetics|antiemetics|mesh-ancestor
24650769|NCT01227876|Autonomic Agents|autonomic agents|mesh-ancestor
24650770|NCT01227876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24650771|NCT01227876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650772|NCT01227876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24650774|NCT01227876|Hormones|hormones|mesh-ancestor
24650775|NCT01227876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24650776|NCT01227876|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24650777|NCT01227876|Protective Agents|protective agents|mesh-ancestor
24650778|NCT01227876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24650779|NCT01227876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650781|NCT01227915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24798864|NCT01965587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24798865|NCT01965587|Contraceptive Agents|contraceptive agents|mesh-ancestor
24798866|NCT01965587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24798867|NCT01965587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798868|NCT01965587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24798869|NCT01965587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24798870|NCT01965587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24650820|NCT01228214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24650821|NCT01228214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24650822|NCT01228214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24650823|NCT01228214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24650826|NCT01228214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24650827|NCT01228214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24452588|NCT05458076|Ritonavir|ritonavir|mesh-list
24650860|NCT01228292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24650861|NCT01228292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650863|NCT01228305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24650864|NCT01228305|Analgesics|analgesics|mesh-ancestor
24650865|NCT01228305|Sensory System Agents|sensory system agents|mesh-ancestor
24650866|NCT01228305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24650867|NCT01228305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25701982|NCT02149199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24408425|NCT00177619|Alendronate|alendronate|mesh-list
25701983|NCT02149199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24650868|NCT01228305|Antipyretics|antipyretics|mesh-ancestor
24650869|NCT01228344|Lumefantrine|lumefantrine|mesh-list
24650870|NCT01228344|Artemether|artemether|mesh-list
25701984|NCT02149199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25701985|NCT02149199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25701986|NCT02149199|Adrenergic Agents|adrenergic agents|mesh-ancestor
25701987|NCT02149199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24552580|NCT02227927|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24552581|NCT02227927|Dopamine Agents|dopamine agents|mesh-ancestor
24552582|NCT02227927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24552583|NCT02227927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552607|NCT02060487|Sildenafil Citrate|sildenafil citrate|mesh-list
24552608|NCT02060487|Citric Acid|citric acid|mesh-list
24798871|NCT01965626|Oseltamivir|oseltamivir|mesh-list
24943381|NCT03971604|Vitamins|vitamins|mesh-list
24768612|NCT01809392|Decitabine|decitabine|mesh-list
24943484|NCT03970577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24943485|NCT03970577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24943486|NCT03970577|Immunologic Factors|immunologic factors|mesh-ancestor
24943487|NCT03970577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943488|NCT03970577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24943489|NCT03970577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24943490|NCT03970577|Glucocorticoids|glucocorticoids|mesh-ancestor
24943491|NCT03970577|Hormones|hormones|mesh-ancestor
24943492|NCT03970577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24650876|NCT01228357|Milnacipran|milnacipran|mesh-list
24650890|NCT01228357|Serotonin Agents|serotonin agents|mesh-ancestor
24650891|NCT01228357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650913|NCT01228357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24650914|NCT01228357|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24650915|NCT01228357|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24650916|NCT01228370|Silodosin|silodosin|mesh-list
24650917|NCT01228370|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24650918|NCT01228370|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24650919|NCT01228370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24650920|NCT01228370|Adrenergic Agents|adrenergic agents|mesh-ancestor
24650921|NCT01228370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24650922|NCT01228370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650923|NCT01228370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650924|NCT01228370|Urological Agents|urological agents|mesh-ancestor
24650926|NCT01228409|Keratolytic Agents|keratolytic agents|mesh-ancestor
24650927|NCT01228409|Dermatologic Agents|dermatologic agents|mesh-ancestor
24650929|NCT01228422|Interferon-alpha|interferon-alpha|mesh-list
24650930|NCT01228422|Interferon alpha-2|interferon alpha-2|mesh-list
24650931|NCT01228422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650932|NCT01228422|Antiviral Agents|antiviral agents|mesh-ancestor
24650933|NCT01228422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24943494|NCT03970668|Insulin|insulin|mesh-list
24650947|NCT01228552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650948|NCT01228565|Cetuximab|cetuximab|mesh-list
24650994|NCT01228630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24650995|NCT01228630|Sympathomimetics|sympathomimetics|mesh-ancestor
24650996|NCT01228630|Adrenergic Agents|adrenergic agents|mesh-ancestor
24650997|NCT01228656|Mometasone Furoate|mometasone furoate|mesh-list
24650999|NCT01228656|Salicylates|salicylates|mesh-list
24651000|NCT01228656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24651001|NCT01228656|Dermatologic Agents|dermatologic agents|mesh-ancestor
24651002|NCT01228656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24846486|NCT02242825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24651023|NCT01228994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651040|NCT01229072|Heparin|heparin|mesh-list
24651041|NCT01229072|Calcium heparin|calcium heparin|mesh-list
24651043|NCT01229072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24651044|NCT01229072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24651045|NCT01229072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651046|NCT01229085|Salicylic Acid|salicylic acid|mesh-list
25701988|NCT02149199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25701989|NCT02149199|Sympathomimetics|sympathomimetics|mesh-ancestor
25701990|NCT02149199|Tocolytic Agents|tocolytic agents|mesh-ancestor
25701991|NCT02149199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25701992|NCT02149264|Testosterone|testosterone|mesh-list
25701993|NCT02149264|Androgens|androgens|mesh-ancestor
24651047|NCT01229085|Salicylates|salicylates|mesh-list
24651048|NCT01229085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25701994|NCT02149264|Hormones|hormones|mesh-ancestor
25701995|NCT02149264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24651049|NCT01229085|Antifungal Agents|antifungal agents|mesh-ancestor
24651050|NCT01229085|Keratolytic Agents|keratolytic agents|mesh-ancestor
24651051|NCT01229085|Dermatologic Agents|dermatologic agents|mesh-ancestor
24651052|NCT01229085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24651053|NCT01229085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24651054|NCT01229085|Analgesics|analgesics|mesh-ancestor
24943700|NCT03967665|Antioxidants|antioxidants|mesh-ancestor
24943701|NCT03967665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24943702|NCT03967665|Protective Agents|protective agents|mesh-ancestor
24943703|NCT03967665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24943704|NCT03967665|Antidotes|antidotes|mesh-ancestor
24798872|NCT01965626|Dexamethasone|dexamethasone|mesh-list
24798873|NCT01965626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24798874|NCT01965626|Antiemetics|antiemetics|mesh-ancestor
24798875|NCT01965626|Autonomic Agents|autonomic agents|mesh-ancestor
24798876|NCT01965626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24798877|NCT01965626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798878|NCT01965626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24798879|NCT01965626|Glucocorticoids|glucocorticoids|mesh-ancestor
24798880|NCT01965626|Hormones|hormones|mesh-ancestor
24846487|NCT02242825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24846491|NCT02242825|Diuretics|diuretics|mesh-ancestor
24651089|NCT01229280|Urological Agents|urological agents|mesh-ancestor
24651090|NCT01229319|Imiquimod|imiquimod|mesh-list
24651091|NCT01229319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24651092|NCT01229319|Immunologic Factors|immunologic factors|mesh-ancestor
24651093|NCT01229319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651094|NCT01229319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651095|NCT01229319|Interferon Inducers|interferon inducers|mesh-ancestor
24651117|NCT01229605|Immunologic Factors|immunologic factors|mesh-ancestor
24651118|NCT01229605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651119|NCT01229605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24651120|NCT01229605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24651122|NCT01229605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651123|NCT01229605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651124|NCT01229605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24651137|NCT01229761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24651138|NCT01229761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651139|NCT01229761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798881|NCT01965626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24798882|NCT01965626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24798884|NCT01965626|Antiviral Agents|antiviral agents|mesh-ancestor
24798885|NCT01965626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24798886|NCT01965626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24798888|NCT01965730|Aminocaproic Acid|aminocaproic acid|mesh-list
24651175|NCT01229930|Paclitaxel|paclitaxel|mesh-list
24651176|NCT01229930|Carboplatin|carboplatin|mesh-list
24651177|NCT01229930|Cediranib|cediranib|mesh-list
24651178|NCT01229930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24651179|NCT01229930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651181|NCT01229930|Antimitotic Agents|antimitotic agents|mesh-ancestor
24651182|NCT01229930|Mitosis Modulators|mitosis modulators|mesh-ancestor
24651183|NCT01229930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651184|NCT01229930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651185|NCT01229930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24651186|NCT01230034|Ramipril|ramipril|mesh-list
24651187|NCT01230034|Imidapril|imidapril|mesh-list
24651188|NCT01230034|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24651189|NCT01230034|Protease Inhibitors|protease inhibitors|mesh-ancestor
24651190|NCT01230034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651191|NCT01230034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651192|NCT01230034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24651193|NCT01230359|Pyridoxine|pyridoxine|mesh-list
24651194|NCT01230359|Vitamin B 6|vitamin b 6|mesh-list
24651195|NCT01230359|Vitamins|vitamins|mesh-ancestor
24651196|NCT01230359|Micronutrients|micronutrients|mesh-ancestor
25701996|NCT02149264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008147|NCT01745588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25008148|NCT01745588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651198|NCT01230359|Vitamin B Complex|vitamin b complex|mesh-ancestor
24651230|NCT01230541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651232|NCT01230580|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24651246|NCT01230723|Everolimus|everolimus|mesh-list
24651247|NCT01230723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651248|NCT01230723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24651249|NCT01230723|Immunologic Factors|immunologic factors|mesh-ancestor
24651250|NCT01230723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651251|NCT01230736|Timolol|timolol|mesh-list
24651252|NCT01230736|Travoprost|travoprost|mesh-list
24651253|NCT01230736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24651254|NCT01230736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24651255|NCT01230736|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24651256|NCT01230736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24651257|NCT01230736|Adrenergic Agents|adrenergic agents|mesh-ancestor
24651258|NCT01230736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24651259|NCT01230736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651260|NCT01230736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651261|NCT01230736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24651262|NCT01230736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24651264|NCT01230775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24651265|NCT01230775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24651266|NCT01230775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049632|NCT00579189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24846505|NCT02242864|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
24846506|NCT02242864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24846507|NCT02242864|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24846508|NCT02242864|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24651374|NCT01231165|Purinergic Agents|purinergic agents|mesh-ancestor
24651375|NCT01231165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24651420|NCT01231529|Antiviral Agents|antiviral agents|mesh-ancestor
24651435|NCT01231542|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24651436|NCT01231542|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24651437|NCT01231542|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24651438|NCT01231542|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24651439|NCT01231542|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24651474|NCT01231698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651475|NCT01231698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651477|NCT01231737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24651478|NCT01231737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24464152|NCT00363532|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
24464153|NCT00363532|Katacalcin|katacalcin|mesh-list
24651479|NCT01231737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24651480|NCT01231737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24651481|NCT01231737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651482|NCT01231737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651483|NCT01231737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651485|NCT01231802|Fluorouracil|fluorouracil|mesh-list
24651486|NCT01231802|Capecitabine|capecitabine|mesh-list
24651488|NCT01231802|Antimetabolites|antimetabolites|mesh-ancestor
24651489|NCT01231802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651490|NCT01231802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24944113|NCT03963336|Natriuretic Agents|natriuretic agents|mesh-ancestor
24651522|NCT01231880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24651523|NCT01231997|Udenafil|udenafil|mesh-list
24651524|NCT01231997|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25701998|NCT02149303|Antithrombins|antithrombins|mesh-ancestor
25701999|NCT02149303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25702000|NCT02149303|Protease Inhibitors|protease inhibitors|mesh-ancestor
25702001|NCT02149303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25702002|NCT02149303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555790|NCT00743587|Gout Suppressants|gout suppressants|mesh-ancestor
24555791|NCT00743587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25702003|NCT02149303|Anticoagulants|anticoagulants|mesh-ancestor
25702004|NCT02149342|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
24555792|NCT00743587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25008239|NCT00826462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25008240|NCT00826462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25008241|NCT00826462|Immunologic Factors|immunologic factors|mesh-ancestor
25008242|NCT00826462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25008243|NCT00826462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24555846|NCT00743912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24555847|NCT00743912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24555848|NCT00743964|Capecitabine|capecitabine|mesh-list
24555849|NCT00743964|Epirubicin|epirubicin|mesh-list
24555850|NCT00743964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24555858|NCT00743990|Camphor|camphor|mesh-list
24651525|NCT01231997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24651526|NCT01231997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651561|NCT01232075|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24651562|NCT01232075|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24651579|NCT01232244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24651580|NCT01232244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651582|NCT01232257|Acetylcysteine|acetylcysteine|mesh-list
24651583|NCT01232257|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24651584|NCT01232257|Antiviral Agents|antiviral agents|mesh-ancestor
24651585|NCT01232257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24651586|NCT01232257|Expectorants|expectorants|mesh-ancestor
24651587|NCT01232257|Respiratory System Agents|respiratory system agents|mesh-ancestor
24651588|NCT01232257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24798916|NCT01966172|Ibuprofen|ibuprofen|mesh-list
24651608|NCT01232400|Adrenergic Agents|adrenergic agents|mesh-ancestor
24651609|NCT01232400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24651610|NCT01232400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651650|NCT01232777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24651651|NCT01232777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651652|NCT01232777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24651653|NCT01232777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24651654|NCT01232777|Growth Substances|growth substances|mesh-ancestor
24651697|NCT01233362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651699|NCT01233453|Everolimus|everolimus|mesh-list
24651700|NCT01233453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651701|NCT01233453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24651702|NCT01233453|Immunologic Factors|immunologic factors|mesh-ancestor
24651703|NCT01233453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651704|NCT01233453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24651706|NCT01233492|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24651707|NCT01233492|Diuretics|diuretics|mesh-ancestor
24651708|NCT01233492|Natriuretic Agents|natriuretic agents|mesh-ancestor
24943951|NCT03965442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24651709|NCT01233492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651711|NCT01233505|Oxaliplatin|oxaliplatin|mesh-list
24651712|NCT01233505|Veliparib|veliparib|mesh-list
24651713|NCT01233505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24651714|NCT01233505|Antimetabolites|antimetabolites|mesh-ancestor
24651715|NCT01233505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651716|NCT01233505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651719|NCT01233570|Tacrolimus|tacrolimus|mesh-list
24651754|NCT01233635|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25702005|NCT02149342|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25702006|NCT02149342|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25702007|NCT02149342|Dermatologic Agents|dermatologic agents|mesh-ancestor
25702008|NCT02149524|Trastuzumab|trastuzumab|mesh-list
25702009|NCT02149524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25702010|NCT02149524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25702011|NCT02149836|Ezogabine|ezogabine|mesh-list
25702012|NCT02149836|Anticonvulsants|anticonvulsants|mesh-ancestor
25702013|NCT02149836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25702014|NCT02149836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702015|NCT02149875|Cerebrolysin|cerebrolysin|mesh-list
25702016|NCT02149875|3-n-butylphthalide|3-n-butylphthalide|mesh-list
25702017|NCT02149875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25702018|NCT02149875|Protective Agents|protective agents|mesh-ancestor
25702019|NCT02149875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651762|NCT01233752|Sensory System Agents|sensory system agents|mesh-ancestor
24651763|NCT01233752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24651764|NCT01233791|Diazepam|diazepam|mesh-list
24452641|NCT05457894|Vaccines|vaccines|mesh-list
24464188|NCT00363727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651765|NCT01233791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24651766|NCT01233791|Anticonvulsants|anticonvulsants|mesh-ancestor
24651767|NCT01233791|Antiemetics|antiemetics|mesh-ancestor
24651768|NCT01233791|Autonomic Agents|autonomic agents|mesh-ancestor
24651769|NCT01233791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24651770|NCT01233791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651771|NCT01233791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24651772|NCT01233791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24769133|NCT01812720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24769134|NCT01812720|Glucocorticoids|glucocorticoids|mesh-ancestor
24769135|NCT01812720|Hormones|hormones|mesh-ancestor
24769136|NCT01812720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24769137|NCT01812720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24769138|NCT01812720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24769139|NCT01812889|TOL-463|tol-463|mesh-list
24769140|NCT01812889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24769141|NCT01812928|Diclofenac|diclofenac|mesh-list
24769142|NCT01812928|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
24769143|NCT01812928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24769144|NCT01812928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24651822|NCT01234051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651823|NCT01234116|Tenofovir|tenofovir|mesh-list
24651824|NCT01234116|Emtricitabine|emtricitabine|mesh-list
24651826|NCT01234116|Antiviral Agents|antiviral agents|mesh-ancestor
24651867|NCT01234285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24651868|NCT01234285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651869|NCT01234298|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
24651870|NCT01234298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24464211|NCT00363753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24464212|NCT00363792|Nitroglycerin|nitroglycerin|mesh-list
24464214|NCT00363831|Oxaliplatin|oxaliplatin|mesh-list
24651871|NCT01234298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651872|NCT01234298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24651873|NCT01234298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24651874|NCT01234298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24651875|NCT01234298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651876|NCT01234298|Dopamine Agents|dopamine agents|mesh-ancestor
24798926|NCT01966172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24798927|NCT01966172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24798928|NCT01966172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24798929|NCT01966172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24798930|NCT01966172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24798931|NCT01966172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24798932|NCT01966172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651919|NCT01234506|Estrogens|estrogens|mesh-ancestor
24651920|NCT01234506|Hormones|hormones|mesh-ancestor
25702020|NCT02149875|Nootropic Agents|nootropic agents|mesh-ancestor
25702021|NCT02149875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25702022|NCT02150213|Dexamethasone|dexamethasone|mesh-list
25702023|NCT02150213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24651926|NCT01234597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24651975|NCT01234896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24651976|NCT01234896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651977|NCT01234896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24651998|NCT01234974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651999|NCT01234974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24798933|NCT01966172|Antipyretics|antipyretics|mesh-ancestor
24798934|NCT01966172|Anticonvulsants|anticonvulsants|mesh-ancestor
24798935|NCT01966172|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24798936|NCT01966172|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24798937|NCT01966172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24798938|NCT01966172|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24464231|NCT00363857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24448762|NCT00313053|Mitosis Modulators|mitosis modulators|mesh-ancestor
24798939|NCT01966172|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24798940|NCT01966172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24846594|NCT02243137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24846595|NCT02243137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652111|NCT01236508|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24652112|NCT01236508|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24798941|NCT01966172|Antimanic Agents|antimanic agents|mesh-ancestor
24798942|NCT01966263|Epinephrine|epinephrine|mesh-list
24798943|NCT01966263|Racepinephrine|racepinephrine|mesh-list
24798944|NCT01966263|Ropivacaine|ropivacaine|mesh-list
24798945|NCT01966263|Epinephryl borate|epinephryl borate|mesh-list
24798946|NCT01966263|Anesthetics, Local|anesthetics, local|mesh-ancestor
24798947|NCT01966263|Anesthetics|anesthetics|mesh-ancestor
24944112|NCT03963336|Diuretics|diuretics|mesh-ancestor
24944116|NCT03963193|Irinotecan|irinotecan|mesh-list
24944117|NCT03963193|Etoposide|etoposide|mesh-list
24944118|NCT03963193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24944119|NCT03963193|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24944120|NCT03963193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24944121|NCT03963193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24944125|NCT03963115|Epinephrine|epinephrine|mesh-list
24944130|NCT03963115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944131|NCT03963115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24944132|NCT03963115|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24944133|NCT03963115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24944134|NCT03963115|Autonomic Agents|autonomic agents|mesh-ancestor
24944135|NCT03963115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24944136|NCT03963115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24944137|NCT03963115|Respiratory System Agents|respiratory system agents|mesh-ancestor
24944138|NCT03963115|Mydriatics|mydriatics|mesh-ancestor
24944139|NCT03963115|Sympathomimetics|sympathomimetics|mesh-ancestor
24464241|NCT00363909|Serotonin Agents|serotonin agents|mesh-ancestor
24464242|NCT00363909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464243|NCT00363909|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24944140|NCT03963115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24944141|NCT03963024|Treosulfan|treosulfan|mesh-list
24944142|NCT03963024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24944143|NCT03963024|Alkylating Agents|alkylating agents|mesh-ancestor
24846623|NCT02243254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24944307|NCT03961698|Mitosis Modulators|mitosis modulators|mesh-ancestor
24944308|NCT03961698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24944309|NCT03961698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24944310|NCT03961698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24944311|NCT03961698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24944312|NCT03961698|Growth Substances|growth substances|mesh-ancestor
24944313|NCT03961698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846637|NCT02243358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25702024|NCT02150213|Antiemetics|antiemetics|mesh-ancestor
24846638|NCT02243358|Immunologic Factors|immunologic factors|mesh-ancestor
24846639|NCT02243358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584141|NCT00878670|Antimetabolites|antimetabolites|mesh-ancestor
25008378|NCT05209295|Azacitidine|azacitidine|mesh-list
24443239|NCT00294164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24846641|NCT02243436|Methylprednisolone|methylprednisolone|mesh-list
24944317|NCT03961360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24944319|NCT03961360|Sensory System Agents|sensory system agents|mesh-ancestor
24944320|NCT03961360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24652266|NCT01237275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24652267|NCT01237275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24652273|NCT01237275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24652293|NCT01237483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24652294|NCT01237483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652295|NCT01237496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24652296|NCT01237496|Antiviral Agents|antiviral agents|mesh-ancestor
24652297|NCT01237496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24652298|NCT01237522|Metformin|metformin|mesh-list
24652299|NCT01237522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24652320|NCT01237782|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24652321|NCT01237782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24652323|NCT01237808|Etoposide|etoposide|mesh-list
24652324|NCT01237808|Tretinoin|tretinoin|mesh-list
24652325|NCT01237808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24652326|NCT01237808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652327|NCT01237808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24652328|NCT01237808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24652372|NCT01238029|Mitosis Modulators|mitosis modulators|mesh-ancestor
24652373|NCT01238029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24652374|NCT01238029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652375|NCT01238055|Docetaxel|docetaxel|mesh-list
24652376|NCT01238055|Sunitinib|sunitinib|mesh-list
24652377|NCT01238055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652378|NCT01238055|Tubulin Modulators|tubulin modulators|mesh-ancestor
24652379|NCT01238055|Antimitotic Agents|antimitotic agents|mesh-ancestor
24652380|NCT01238055|Mitosis Modulators|mitosis modulators|mesh-ancestor
24652381|NCT01238055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652382|NCT01238055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24652383|NCT01238055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24652384|NCT01238055|Growth Substances|growth substances|mesh-ancestor
24652404|NCT01238133|Antimitotic Agents|antimitotic agents|mesh-ancestor
24944321|NCT03961360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24769567|NCT01814683|Primaquine|primaquine|mesh-list
24944445|NCT03960671|Anticonvulsants|anticonvulsants|mesh-ancestor
24944593|NCT03959176|Sympathomimetics|sympathomimetics|mesh-ancestor
24944594|NCT03959176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24944595|NCT03959176|Nasal Decongestants|nasal decongestants|mesh-ancestor
24944596|NCT03959176|Respiratory System Agents|respiratory system agents|mesh-ancestor
24944863|NCT03956823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24652405|NCT01238133|Mitosis Modulators|mitosis modulators|mesh-ancestor
24652525|NCT01238718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24652526|NCT01238718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652527|NCT01238770|Cyclophosphamide|cyclophosphamide|mesh-list
24652528|NCT01238770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24652529|NCT01238770|Immunologic Factors|immunologic factors|mesh-ancestor
24652530|NCT01238770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652531|NCT01238770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24652532|NCT01238770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24652533|NCT01238770|Alkylating Agents|alkylating agents|mesh-ancestor
24652534|NCT01238770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652535|NCT01238770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652608|NCT01239173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702025|NCT02150213|Autonomic Agents|autonomic agents|mesh-ancestor
25702026|NCT02150213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25702027|NCT02150213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702028|NCT02150213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25702029|NCT02150213|Glucocorticoids|glucocorticoids|mesh-ancestor
25702030|NCT02150213|Hormones|hormones|mesh-ancestor
25702031|NCT02150213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25702032|NCT02150213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24652611|NCT01239173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24652612|NCT01239173|Vasodilator Agents|vasodilator agents|mesh-ancestor
24652613|NCT01239368|Sirolimus|sirolimus|mesh-list
24652614|NCT01239368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24652615|NCT01239368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24652616|NCT01239368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24652617|NCT01239368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652618|NCT01239368|Antifungal Agents|antifungal agents|mesh-ancestor
24652619|NCT01239368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24652620|NCT01239368|Immunologic Factors|immunologic factors|mesh-ancestor
24652621|NCT01239368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652622|NCT01239459|Teriflunomide|teriflunomide|mesh-list
24652623|NCT01239459|Cholestyramine Resin|cholestyramine resin|mesh-list
24652624|NCT01239459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24652625|NCT01239459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24652626|NCT01239459|Analgesics|analgesics|mesh-ancestor
24652627|NCT01239459|Sensory System Agents|sensory system agents|mesh-ancestor
24652628|NCT01239459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24846669|NCT02243553|Ritonavir|ritonavir|mesh-list
24652670|NCT01239498|Sympathomimetics|sympathomimetics|mesh-ancestor
24652671|NCT01239498|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24652672|NCT01239550|Insulin Detemir|insulin detemir|mesh-list
24652673|NCT01239550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24652674|NCT01239550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652676|NCT01239563|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24652677|NCT01239563|Basiliximab|basiliximab|mesh-list
24652678|NCT01239563|Immunologic Factors|immunologic factors|mesh-ancestor
24652679|NCT01239563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652680|NCT01239563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24652682|NCT01239719|Dexamethasone|dexamethasone|mesh-list
24652683|NCT01239719|Dexamethasone acetate|dexamethasone acetate|mesh-list
24652698|NCT01239719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652700|NCT01239719|Dermatologic Agents|dermatologic agents|mesh-ancestor
24652701|NCT01239719|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24652702|NCT01239719|Histamine Antagonists|histamine antagonists|mesh-ancestor
24652703|NCT01239719|Histamine Agents|histamine agents|mesh-ancestor
24652704|NCT01239719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24652705|NCT01239719|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24652706|NCT01239810|Hyaluronic Acid|hyaluronic acid|mesh-list
24652707|NCT01239810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24652708|NCT01239810|Immunologic Factors|immunologic factors|mesh-ancestor
24652709|NCT01239810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652710|NCT01239810|Viscosupplements|viscosupplements|mesh-ancestor
24652711|NCT01239810|Protective Agents|protective agents|mesh-ancestor
24652712|NCT01239849|Atorvastatin|atorvastatin|mesh-list
24652713|NCT01239849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24652714|NCT01239849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24652715|NCT01239849|Antimetabolites|antimetabolites|mesh-ancestor
24652716|NCT01239849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652717|NCT01239849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24592833|NCT00925730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592834|NCT00925730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24652725|NCT01239888|Oxytocin|oxytocin|mesh-list
24652726|NCT01239888|Oxytocics|oxytocics|mesh-ancestor
24652727|NCT01239888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24652728|NCT01239888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652729|NCT01239888|Androgen Antagonists|androgen antagonists|mesh-ancestor
24652730|NCT01239888|Hormone Antagonists|hormone antagonists|mesh-ancestor
24647081|NCT01206075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24652731|NCT01239888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24652732|NCT01239888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24652733|NCT01239888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24652734|NCT01239888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652735|NCT01239888|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24652736|NCT01239888|Anabolic Agents|anabolic agents|mesh-ancestor
24652737|NCT01239888|Hormones|hormones|mesh-ancestor
24652738|NCT01239940|Paclitaxel|paclitaxel|mesh-list
25702033|NCT02150213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652739|NCT01239940|Everolimus|everolimus|mesh-list
24652740|NCT01239940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25702034|NCT02150499|Albuterol|albuterol|mesh-list
25702035|NCT02150499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25702036|NCT02150499|Autonomic Agents|autonomic agents|mesh-ancestor
24652741|NCT01239940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652742|NCT01239940|Tubulin Modulators|tubulin modulators|mesh-ancestor
24652743|NCT01239940|Antimitotic Agents|antimitotic agents|mesh-ancestor
24652744|NCT01239940|Mitosis Modulators|mitosis modulators|mesh-ancestor
24652761|NCT01240096|Antidepressive Agents|antidepressive agents|mesh-ancestor
24652762|NCT01240096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24652763|NCT01240096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24652764|NCT01240096|Histamine Antagonists|histamine antagonists|mesh-ancestor
24652766|NCT01240096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24652767|NCT01240096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652768|NCT01240096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652769|NCT01240096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24652782|NCT01240109|Narcotics|narcotics|mesh-ancestor
24652793|NCT01240148|Sensory System Agents|sensory system agents|mesh-ancestor
24652794|NCT01240148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24652795|NCT01240148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24652796|NCT01240148|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24652797|NCT01240148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24652798|NCT01240148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24652799|NCT01240148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652800|NCT01240174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24652801|NCT01240174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24652803|NCT01240213|Vitamins|vitamins|mesh-ancestor
24652804|NCT01240213|Micronutrients|micronutrients|mesh-ancestor
24652811|NCT01240226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24652812|NCT01240226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652813|NCT01240226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652833|NCT01240408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24652834|NCT01240408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652835|NCT01240408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652836|NCT01240538|Cyclophosphamide|cyclophosphamide|mesh-list
24652837|NCT01240538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24652838|NCT01240538|Immunologic Factors|immunologic factors|mesh-ancestor
24652839|NCT01240538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652840|NCT01240538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24652842|NCT01240538|Alkylating Agents|alkylating agents|mesh-ancestor
24652843|NCT01240538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652873|NCT01240824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652880|NCT01240850|Methotrexate|methotrexate|mesh-list
24652881|NCT01240850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24652953|NCT01241032|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24652954|NCT01241032|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24652955|NCT01241032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652956|NCT01241032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652957|NCT01241084|Leukotriene Antagonists|leukotriene antagonists|mesh-list
24652958|NCT01241084|Hormone Antagonists|hormone antagonists|mesh-ancestor
24652959|NCT01241084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24652960|NCT01241084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652961|NCT01241084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24652962|NCT01241084|Respiratory System Agents|respiratory system agents|mesh-ancestor
24652963|NCT01241097|Simvastatin|simvastatin|mesh-list
24452685|NCT05457829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652980|NCT01241110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653000|NCT01241175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24653001|NCT01241175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702037|NCT02150499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25702038|NCT02150499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702039|NCT02150499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25702040|NCT02150499|Respiratory System Agents|respiratory system agents|mesh-ancestor
25702041|NCT02150499|Tocolytic Agents|tocolytic agents|mesh-ancestor
25702042|NCT02150499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25702043|NCT02150499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25702044|NCT02150499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24653002|NCT01241175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24653004|NCT01241175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24653005|NCT01241383|Bosentan|bosentan|mesh-list
24653006|NCT01241383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24653007|NCT01241383|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24653008|NCT01241383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653009|NCT01241409|Rabeprazole|rabeprazole|mesh-list
24622198|NCT01065987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24622199|NCT01065987|Parasympatholytics|parasympatholytics|mesh-ancestor
24622200|NCT01065987|Autonomic Agents|autonomic agents|mesh-ancestor
24622201|NCT01065987|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24622202|NCT01065987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24622203|NCT01065987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24622205|NCT01065987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24622207|NCT01066013|Anti-Infective Agents|anti-infective agents|mesh-list
24653103|NCT01242046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24653104|NCT01242072|Isophosphamide mustard|isophosphamide mustard|mesh-list
24653105|NCT01242072|Ifosfamide|ifosfamide|mesh-list
24653106|NCT01242072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24653107|NCT01242072|Alkylating Agents|alkylating agents|mesh-ancestor
24653108|NCT01242072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653109|NCT01242072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653110|NCT01242098|Fluticasone|fluticasone|mesh-list
24653111|NCT01242098|Beclomethasone|beclomethasone|mesh-list
24653112|NCT01242098|Formoterol Fumarate|formoterol fumarate|mesh-list
24653113|NCT01242098|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24653114|NCT01242098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24653115|NCT01242098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24653168|NCT01242267|Thalidomide|thalidomide|mesh-list
24653170|NCT01242267|Melphalan|melphalan|mesh-list
24653171|NCT01242267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653172|NCT01242267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24653220|NCT01242449|Tubulin Modulators|tubulin modulators|mesh-ancestor
24945006|NCT03955497|Immunologic Factors|immunologic factors|mesh-ancestor
24945007|NCT03955497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945008|NCT03955497|Viscosupplements|viscosupplements|mesh-ancestor
24653266|NCT01242826|Insulin Aspart|insulin aspart|mesh-list
24653267|NCT01242826|Biphasic Insulins|biphasic insulins|mesh-list
24653268|NCT01242826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24653269|NCT01242826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653270|NCT01242904|Icodextrin|icodextrin|mesh-list
24653271|NCT01242904|Dialysis Solutions|dialysis solutions|mesh-ancestor
24653272|NCT01242904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24653273|NCT01243060|Zolpidem|zolpidem|mesh-list
24653274|NCT01243060|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24653275|NCT01243060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24653276|NCT01243060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24653277|NCT01243060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464459|NCT00365001|Simvastatin|simvastatin|mesh-list
24653290|NCT01243086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24653291|NCT01243086|Glucocorticoids|glucocorticoids|mesh-ancestor
24653293|NCT01243086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24653294|NCT01243086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24653295|NCT01243086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653296|NCT01243086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24653297|NCT01243086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24653298|NCT01243086|Growth Substances|growth substances|mesh-ancestor
24653299|NCT01243086|Growth Inhibitors|growth inhibitors|mesh-ancestor
24653301|NCT01243203|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24653304|NCT01243203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24653305|NCT01243203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653306|NCT01243203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653307|NCT01243281|Entecavir|entecavir|mesh-list
24653309|NCT01243281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24653310|NCT01243359|Bevacizumab|bevacizumab|mesh-list
24653311|NCT01243359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24653337|NCT01243437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24653338|NCT01243437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24653339|NCT01243476|Lenalidomide|lenalidomide|mesh-list
24653340|NCT01243476|Immunologic Factors|immunologic factors|mesh-ancestor
24653341|NCT01243476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653342|NCT01243476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24653343|NCT01243476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24945223|NCT03952832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653388|NCT01243736|Metoclopramide|metoclopramide|mesh-list
24653389|NCT01243736|Simethicone|simethicone|mesh-list
24653390|NCT01243736|Antiemetics|antiemetics|mesh-ancestor
24653391|NCT01243736|Autonomic Agents|autonomic agents|mesh-ancestor
24653392|NCT01243736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24653393|NCT01243736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464600|NCT00365560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464601|NCT00365586|Ketoprofen|ketoprofen|mesh-list
24464602|NCT00365586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24464603|NCT00365586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24464604|NCT00365586|Analgesics|analgesics|mesh-ancestor
24464605|NCT00365586|Sensory System Agents|sensory system agents|mesh-ancestor
24464606|NCT00365586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24653394|NCT01243736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24653395|NCT01243736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24653396|NCT01243736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24653397|NCT01243736|Dopamine Agents|dopamine agents|mesh-ancestor
24653398|NCT01243736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24653403|NCT01243788|Fluticasone|fluticasone|mesh-list
24653405|NCT01243788|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24653406|NCT01243788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24653407|NCT01243788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24653408|NCT01243788|Autonomic Agents|autonomic agents|mesh-ancestor
24654345|NCT01248923|Proteasome Inhibitors|proteasome inhibitors|mesh-list
24653409|NCT01243788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24653410|NCT01243788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653411|NCT01243788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24653412|NCT01243788|Respiratory System Agents|respiratory system agents|mesh-ancestor
24653413|NCT01243788|Dermatologic Agents|dermatologic agents|mesh-ancestor
24653414|NCT01243788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24653415|NCT01243788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24653416|NCT01243788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24653433|NCT01243801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24653434|NCT01243801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653437|NCT01243827|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24653438|NCT01243827|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24464607|NCT00365586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464622|NCT00365612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24653439|NCT01243827|Adrenergic Agents|adrenergic agents|mesh-ancestor
24653440|NCT01243827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24653441|NCT01243827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653442|NCT01243827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653454|NCT01243827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24653466|NCT01243970|Nasal Decongestants|nasal decongestants|mesh-ancestor
24653467|NCT01243970|Respiratory System Agents|respiratory system agents|mesh-ancestor
25702049|NCT02150759|Fentanyl|fentanyl|mesh-list
25702050|NCT02150759|Dexmedetomidine|dexmedetomidine|mesh-list
25702051|NCT02150759|Ketamine|ketamine|mesh-list
25702052|NCT02150759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25702053|NCT02150759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25702054|NCT02150759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702055|NCT02150759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25702056|NCT02150759|Analgesics|analgesics|mesh-ancestor
25702057|NCT02150759|Sensory System Agents|sensory system agents|mesh-ancestor
25702058|NCT02150759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25702059|NCT02150759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25702060|NCT02150759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24653468|NCT01243970|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24653469|NCT01243970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24653470|NCT01243970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24653471|NCT01243970|Adrenergic Agents|adrenergic agents|mesh-ancestor
24653472|NCT01243970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24653473|NCT01243970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653474|NCT01243970|Protective Agents|protective agents|mesh-ancestor
24653475|NCT01243970|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24653477|NCT01243996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24653479|NCT01243996|Analgesics|analgesics|mesh-ancestor
24653540|NCT01244230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24653541|NCT01244230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653542|NCT01244230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653543|NCT01244256|Gentamicins|gentamicins|mesh-list
24653544|NCT01244256|Clotrimazole|clotrimazole|mesh-list
24653545|NCT01244256|Miconazole|miconazole|mesh-list
24653547|NCT01244256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24653548|NCT01244256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24653549|NCT01244256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24653550|NCT01244256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653551|NCT01244256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24670394|NCT02748018|Insulin|insulin|mesh-list
24653552|NCT01244256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24653553|NCT01244256|Glucocorticoids|glucocorticoids|mesh-ancestor
24653554|NCT01244256|Hormones|hormones|mesh-ancestor
24653644|NCT01244789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653645|NCT01244789|Tubulin Modulators|tubulin modulators|mesh-ancestor
24653646|NCT01244789|Antimitotic Agents|antimitotic agents|mesh-ancestor
24653647|NCT01244789|Mitosis Modulators|mitosis modulators|mesh-ancestor
24653648|NCT01244789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653650|NCT01244880|Analgesics|analgesics|mesh-ancestor
24945493|NCT03950154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945494|NCT03950154|Growth Inhibitors|growth inhibitors|mesh-ancestor
24945495|NCT03950154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24945496|NCT03950154|Antimetabolites|antimetabolites|mesh-ancestor
24945497|NCT03950154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653651|NCT01244880|Sensory System Agents|sensory system agents|mesh-ancestor
24653652|NCT01244880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24653653|NCT01244880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653746|NCT01245556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653747|NCT01245569|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24653748|NCT01245569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24653749|NCT01245569|Autonomic Agents|autonomic agents|mesh-ancestor
24653750|NCT01245569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24653751|NCT01245569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653752|NCT01245569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24653753|NCT01245569|Respiratory System Agents|respiratory system agents|mesh-ancestor
24653754|NCT01245569|Glucocorticoids|glucocorticoids|mesh-ancestor
24653756|NCT01245569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24653757|NCT01245569|Sympathomimetics|sympathomimetics|mesh-ancestor
24653758|NCT01245582|Capecitabine|capecitabine|mesh-list
24653759|NCT01245582|Oxaliplatin|oxaliplatin|mesh-list
25702064|NCT02150759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702065|NCT02150759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25702066|NCT02150759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25702067|NCT02150759|Anesthetics, General|anesthetics, general|mesh-ancestor
25702068|NCT02150759|Anesthetics|anesthetics|mesh-ancestor
24464889|NCT00367211|Sensory System Agents|sensory system agents|mesh-ancestor
24464890|NCT00367211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24464891|NCT00367211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464892|NCT00367211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24464893|NCT00367211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24464894|NCT00367211|Gout Suppressants|gout suppressants|mesh-ancestor
24464895|NCT00367211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24464909|NCT00367276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24464910|NCT00367276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945503|NCT03950271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945504|NCT03950271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653812|NCT01245868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24653813|NCT01245868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653867|NCT01245998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24653868|NCT01245998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24653869|NCT01245998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653891|NCT01246180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24653892|NCT01246180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24653893|NCT01246180|Analgesics|analgesics|mesh-ancestor
24653894|NCT01246180|Sensory System Agents|sensory system agents|mesh-ancestor
24464955|NCT00367419|Erythromycin Estolate|erythromycin estolate|mesh-list
24464956|NCT00367419|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24464957|NCT00367419|Erythromycin stearate|erythromycin stearate|mesh-list
24653895|NCT01246180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24653896|NCT01246180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653897|NCT01246180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24653898|NCT01246180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24653899|NCT01246180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24653902|NCT01246180|Diuretics|diuretics|mesh-ancestor
24798961|NCT01966263|Respiratory System Agents|respiratory system agents|mesh-ancestor
24945506|NCT03950050|Ambroxol|ambroxol|mesh-list
24945654|NCT03948737|Tocopherols|tocopherols|mesh-list
24945655|NCT03948737|Vitamin E|vitamin e|mesh-list
24945656|NCT03948737|Tocotrienols|tocotrienols|mesh-list
24945657|NCT03948737|alpha-Tocopherol|alpha-tocopherol|mesh-list
24945800|NCT03946826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24945801|NCT03946826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24945803|NCT03946514|Amlodipine|amlodipine|mesh-list
24945804|NCT03946514|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24945805|NCT03946514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24653984|NCT01246622|Cytarabine|cytarabine|mesh-list
24653985|NCT01246622|Lenalidomide|lenalidomide|mesh-list
24653986|NCT01246622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24653987|NCT01246622|Antimetabolites|antimetabolites|mesh-ancestor
24653988|NCT01246622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24945806|NCT03946514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24945807|NCT03946514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24945808|NCT03946514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846788|NCT02243852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653989|NCT01246622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653990|NCT01246622|Antiviral Agents|antiviral agents|mesh-ancestor
24653991|NCT01246622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24653992|NCT01246622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24653993|NCT01246622|Immunologic Factors|immunologic factors|mesh-ancestor
24453213|NCT05238831|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24453214|NCT05238831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24653994|NCT01246622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653995|NCT01246622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24653996|NCT01246622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24653997|NCT01246622|Growth Substances|growth substances|mesh-ancestor
24653998|NCT01246622|Growth Inhibitors|growth inhibitors|mesh-ancestor
24654000|NCT01246752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24654001|NCT01246752|Antimetabolites|antimetabolites|mesh-ancestor
24654029|NCT01246921|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24654030|NCT01246921|Autonomic Agents|autonomic agents|mesh-ancestor
24654031|NCT01246921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24654032|NCT01246921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654033|NCT01246921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24654034|NCT01246921|Respiratory System Agents|respiratory system agents|mesh-ancestor
24654035|NCT01246921|Dermatologic Agents|dermatologic agents|mesh-ancestor
24654036|NCT01246921|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24654038|NCT01247077|Antioxidants|antioxidants|mesh-ancestor
24654039|NCT01247077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654040|NCT01247077|Protective Agents|protective agents|mesh-ancestor
24654041|NCT01247077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654085|NCT01247558|Vitamins|vitamins|mesh-ancestor
24654148|NCT01247909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24654149|NCT01247909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24654150|NCT01247909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24654151|NCT01247909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654173|NCT01248078|Cephalexin|cephalexin|mesh-list
24654174|NCT01248078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24654175|NCT01248078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24654176|NCT01248091|Nitroprusside|nitroprusside|mesh-list
24654177|NCT01248091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24654178|NCT01248091|Vasodilator Agents|vasodilator agents|mesh-ancestor
24654181|NCT01248117|Ranibizumab|ranibizumab|mesh-list
24846805|NCT02244112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24630536|NCT01112215|Mycophenolic Acid|mycophenolic acid|mesh-list
24654203|NCT01248195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654205|NCT01248195|Serotonin Agents|serotonin agents|mesh-ancestor
24654206|NCT01248195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24654207|NCT01248195|GABA Antagonists|gaba antagonists|mesh-ancestor
24654208|NCT01248195|GABA Agents|gaba agents|mesh-ancestor
24654209|NCT01248195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24654210|NCT01248195|Dopamine Agents|dopamine agents|mesh-ancestor
24654211|NCT01248195|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24654212|NCT01248195|Antidepressive Agents|antidepressive agents|mesh-ancestor
24654213|NCT01248234|Propofol|propofol|mesh-list
24654214|NCT01248234|Etomidate|etomidate|mesh-list
24654215|NCT01248234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24654216|NCT01248234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24654217|NCT01248234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654228|NCT01248273|Immunologic Factors|immunologic factors|mesh-ancestor
24654229|NCT01248273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654230|NCT01248299|Cisplatin|cisplatin|mesh-list
24654231|NCT01248299|Docetaxel|docetaxel|mesh-list
24654232|NCT01248299|Oxaliplatin|oxaliplatin|mesh-list
24654233|NCT01248299|Fluorouracil|fluorouracil|mesh-list
24654234|NCT01248299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654235|NCT01248299|Tubulin Modulators|tubulin modulators|mesh-ancestor
24654236|NCT01248299|Antimitotic Agents|antimitotic agents|mesh-ancestor
24654237|NCT01248299|Mitosis Modulators|mitosis modulators|mesh-ancestor
24654238|NCT01248299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791727|NCT03333005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24791728|NCT03333005|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24791729|NCT03333005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24791730|NCT03333005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24791731|NCT03333005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791732|NCT03333005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24791733|NCT03333005|Hormone Antagonists|hormone antagonists|mesh-ancestor
24791735|NCT03333005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566125|NCT00784472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24566126|NCT00784485|Omalizumab|omalizumab|mesh-list
24566127|NCT00784485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24566128|NCT00784485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24566129|NCT00784485|Respiratory System Agents|respiratory system agents|mesh-ancestor
24566130|NCT00784498|Midazolam|midazolam|mesh-list
24654239|NCT01248299|Antimetabolites|antimetabolites|mesh-ancestor
24654323|NCT01248871|Remifentanil|remifentanil|mesh-list
24654324|NCT01248871|Dsuvia|dsuvia|mesh-list
24654336|NCT01248871|Narcotics|narcotics|mesh-ancestor
24654337|NCT01248871|Analgesics|analgesics|mesh-ancestor
24654338|NCT01248871|Sensory System Agents|sensory system agents|mesh-ancestor
24654339|NCT01248871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24654340|NCT01248871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24654341|NCT01248923|Dexamethasone|dexamethasone|mesh-list
24654342|NCT01248923|Bortezomib|bortezomib|mesh-list
24654343|NCT01248923|Filanesib|filanesib|mesh-list
24654350|NCT01248923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654407|NCT01249430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24654409|NCT01249430|Antiviral Agents|antiviral agents|mesh-ancestor
24654410|NCT01249430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24654412|NCT01249430|Immunologic Factors|immunologic factors|mesh-ancestor
24654413|NCT01249430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654414|NCT01249430|Analgesics|analgesics|mesh-ancestor
24654415|NCT01249430|Sensory System Agents|sensory system agents|mesh-ancestor
24654416|NCT01249430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24654418|NCT01249443|Carboplatin|carboplatin|mesh-list
24654419|NCT01249443|Vorinostat|vorinostat|mesh-list
24654420|NCT01249443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24654421|NCT01249443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654422|NCT01249443|Tubulin Modulators|tubulin modulators|mesh-ancestor
24654431|NCT01249521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654441|NCT01249547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654442|NCT01249638|Bevacizumab|bevacizumab|mesh-list
24654484|NCT01249690|Leprostatic Agents|leprostatic agents|mesh-ancestor
24654485|NCT01249690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24654486|NCT01249690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24654487|NCT01249690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24654488|NCT01249690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24654489|NCT01249690|Growth Substances|growth substances|mesh-ancestor
24654490|NCT01249690|Growth Inhibitors|growth inhibitors|mesh-ancestor
24654491|NCT01249690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24654492|NCT01249690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24654493|NCT01249690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25702069|NCT02150759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25702070|NCT02150759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25702071|NCT02150759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25702072|NCT02150759|Narcotics|narcotics|mesh-ancestor
25702073|NCT02150759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25702074|NCT02150954|Oxytocin|oxytocin|mesh-list
25702075|NCT02150954|Oxytocics|oxytocics|mesh-ancestor
25702076|NCT02150954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25702077|NCT02150954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702078|NCT02151058|Listerine|listerine|mesh-list
25702079|NCT02151058|Sodium Fluoride|sodium fluoride|mesh-list
25702080|NCT02151058|Cariostatic Agents|cariostatic agents|mesh-ancestor
25702081|NCT02151058|Protective Agents|protective agents|mesh-ancestor
25702082|NCT02151058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654494|NCT01249820|Anidulafungin|anidulafungin|mesh-list
25702083|NCT02151058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24654495|NCT01249820|Antifungal Agents|antifungal agents|mesh-ancestor
24946271|NCT03942458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24946272|NCT03942458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946273|NCT03942458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946275|NCT03941561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24946276|NCT03941561|Antimetabolites|antimetabolites|mesh-ancestor
24946277|NCT03941561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24946278|NCT03941561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654549|NCT01250340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24946280|NCT03941795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24946281|NCT03941795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24799028|NCT01966692|Fluticasone|fluticasone|mesh-list
24465190|NCT00368238|Clopidogrel|clopidogrel|mesh-list
24465191|NCT00368238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24465192|NCT00368238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24465193|NCT00368238|Analgesics|analgesics|mesh-ancestor
24465194|NCT00368238|Sensory System Agents|sensory system agents|mesh-ancestor
24465195|NCT00368238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24465196|NCT00368238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465197|NCT00368238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24465198|NCT00368238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24465199|NCT00368238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24465212|NCT00368264|Infliximab|infliximab|mesh-list
24799030|NCT01966692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24799031|NCT01966692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24799032|NCT01966692|Autonomic Agents|autonomic agents|mesh-ancestor
24799033|NCT01966692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24799034|NCT01966692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24771666|NCT01828606|Ionophores|ionophores|mesh-ancestor
24946459|NCT03939806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24946460|NCT03939806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799047|NCT01966783|Respiratory System Agents|respiratory system agents|mesh-ancestor
24799048|NCT01966783|Glucocorticoids|glucocorticoids|mesh-ancestor
24799049|NCT01966783|Hormones|hormones|mesh-ancestor
24799076|NCT01966913|Growth Substances|growth substances|mesh-ancestor
24799077|NCT01966913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846902|NCT02244268|Tamsulosin|tamsulosin|mesh-list
24654713|NCT01251107|Vincristine|vincristine|mesh-list
24654714|NCT01251107|Bleomycin|bleomycin|mesh-list
24654715|NCT01251107|Vinblastine|vinblastine|mesh-list
24654716|NCT01251107|Procarbazine|procarbazine|mesh-list
24654717|NCT01251107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24654718|NCT01251107|Immunologic Factors|immunologic factors|mesh-ancestor
24654719|NCT01251107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799079|NCT01967017|Lidocaine|lidocaine|mesh-list
24654777|NCT01251263|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24654778|NCT01251328|Anesthetics|anesthetics|mesh-list
24654779|NCT01251328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24654780|NCT01251328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654781|NCT01251458|Sirolimus|sirolimus|mesh-list
24654782|NCT01251458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24654783|NCT01251458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24654784|NCT01251458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24654785|NCT01251458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654786|NCT01251458|Antifungal Agents|antifungal agents|mesh-ancestor
24654787|NCT01251458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24654788|NCT01251458|Immunologic Factors|immunologic factors|mesh-ancestor
24654856|NCT01251835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654857|NCT01251835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859195|NCT02302495|Prednisone|prednisone|mesh-list
24654858|NCT01251835|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24654859|NCT01251835|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24654860|NCT01251835|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24654861|NCT01251835|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24654862|NCT01251835|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24654863|NCT01251835|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24654867|NCT01251848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24654920|NCT01252056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24654921|NCT01252056|Antimetabolites|antimetabolites|mesh-ancestor
24654922|NCT01252056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24654923|NCT01252056|Antioxidants|antioxidants|mesh-ancestor
24654924|NCT01252069|Ulipristal acetate|ulipristal acetate|mesh-list
24654925|NCT01252069|Progestins|progestins|mesh-list
24654926|NCT01252069|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24654927|NCT01252069|Contraceptive Agents|contraceptive agents|mesh-ancestor
24654928|NCT01252069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24654929|NCT01252069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654930|NCT01252069|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24654948|NCT01252225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24654949|NCT01252225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24654950|NCT01252225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24654951|NCT01252225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24654952|NCT01252225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24654953|NCT01252225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654955|NCT01252342|Oxytocics|oxytocics|mesh-ancestor
24654956|NCT01252342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24654964|NCT01252524|Psyllium|psyllium|mesh-list
24655014|NCT01253473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24655015|NCT01253473|Respiratory System Agents|respiratory system agents|mesh-ancestor
24655016|NCT01253473|Glucocorticoids|glucocorticoids|mesh-ancestor
24655017|NCT01253473|Hormones|hormones|mesh-ancestor
24655018|NCT01253473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24655019|NCT01253473|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24655020|NCT01253473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24655021|NCT01253473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24655022|NCT01253473|Adrenergic Agents|adrenergic agents|mesh-ancestor
24655023|NCT01253473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24655024|NCT01253473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655025|NCT01253473|Tocolytic Agents|tocolytic agents|mesh-ancestor
24655026|NCT01253473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24655027|NCT01253473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24655028|NCT01253473|Cholinergic Agents|cholinergic agents|mesh-ancestor
24655029|NCT01253681|Paclitaxel|paclitaxel|mesh-list
24655030|NCT01253681|Carboplatin|carboplatin|mesh-list
24655031|NCT01253681|Trebananib|trebananib|mesh-list
24655032|NCT01253681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24655033|NCT01253681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655034|NCT01253681|Tubulin Modulators|tubulin modulators|mesh-ancestor
24655053|NCT01254006|Thiamine|thiamine|mesh-list
24655062|NCT01254071|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24655063|NCT01254071|Adrenergic Agents|adrenergic agents|mesh-ancestor
24655064|NCT01254071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24655065|NCT01254071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655066|NCT01254071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655082|NCT01254175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655084|NCT01254383|Vasodilator Agents|vasodilator agents|mesh-ancestor
24655085|NCT01254383|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24655086|NCT01254383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25702084|NCT02151058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25709574|NCT02270242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655087|NCT01254383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24655088|NCT01254383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709575|NCT02270242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25709576|NCT02270242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24946545|NCT03937869|Secnidazole|secnidazole|mesh-list
24946546|NCT03937869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24946547|NCT03937869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24946548|NCT03937869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24655216|NCT01255046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655217|NCT01255046|Nootropic Agents|nootropic agents|mesh-ancestor
24655218|NCT01255215|Nitric Oxide|nitric oxide|mesh-list
24655219|NCT01255215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24655220|NCT01255215|Autonomic Agents|autonomic agents|mesh-ancestor
24655221|NCT01255215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24655222|NCT01255215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655223|NCT01255215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24655224|NCT01255215|Respiratory System Agents|respiratory system agents|mesh-ancestor
24655225|NCT01255215|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24655226|NCT01255215|Antioxidants|antioxidants|mesh-ancestor
24655227|NCT01255215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655228|NCT01255215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24655229|NCT01255215|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24655231|NCT01255215|Gasotransmitters|gasotransmitters|mesh-ancestor
24655293|NCT01255579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24655294|NCT01255579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24655343|NCT01255956|Paclitaxel|paclitaxel|mesh-list
24655344|NCT01255956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24655345|NCT01255956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655346|NCT01255956|Tubulin Modulators|tubulin modulators|mesh-ancestor
24655347|NCT01255956|Antimitotic Agents|antimitotic agents|mesh-ancestor
24655348|NCT01255956|Mitosis Modulators|mitosis modulators|mesh-ancestor
24655349|NCT01255956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655353|NCT01255956|Antifungal Agents|antifungal agents|mesh-ancestor
24655354|NCT01255956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24655355|NCT01255956|Immunologic Factors|immunologic factors|mesh-ancestor
24655356|NCT01255956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655357|NCT01256021|Botulinum Toxins|botulinum toxins|mesh-list
24655358|NCT01256021|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24655359|NCT01256021|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24655360|NCT01256021|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24655361|NCT01256021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24655362|NCT01256021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655363|NCT01256021|Cholinergic Agents|cholinergic agents|mesh-ancestor
24655364|NCT01256021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24655365|NCT01256021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655366|NCT01256021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24655367|NCT01256021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24465603|NCT00370253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24465604|NCT00370253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465605|NCT00370253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465671|NCT00370539|Bevacizumab|bevacizumab|mesh-list
24655369|NCT01256151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24655370|NCT01256151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24655371|NCT01256151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655372|NCT01256151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24655432|NCT01256632|Ranibizumab|ranibizumab|mesh-list
24655433|NCT01256632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24655434|NCT01256632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24655435|NCT01256632|Growth Substances|growth substances|mesh-ancestor
24655436|NCT01256632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655437|NCT01256632|Growth Inhibitors|growth inhibitors|mesh-ancestor
24846987|NCT02244515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846988|NCT02244528|Sildenafil Citrate|sildenafil citrate|mesh-list
24846989|NCT02244528|Vasodilator Agents|vasodilator agents|mesh-ancestor
24655493|NCT01256905|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24655494|NCT01256905|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24655495|NCT01256905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655497|NCT01257009|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24655498|NCT01257009|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24655499|NCT01257009|Antimetabolites|antimetabolites|mesh-ancestor
24655500|NCT01257009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655501|NCT01257009|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24655502|NCT01257009|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24655537|NCT01257126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24655539|NCT01257126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24655540|NCT01257126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24655541|NCT01257126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655542|NCT01257139|Docetaxel|docetaxel|mesh-list
24946758|NCT03935139|Protective Agents|protective agents|mesh-ancestor
24946759|NCT03935139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24946774|NCT03935074|Melphalan|melphalan|mesh-list
24465687|NCT00370539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24946993|NCT03933605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655582|NCT01257360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24655585|NCT01257373|Chromium|chromium|mesh-list
24655586|NCT01257373|Sirolimus|sirolimus|mesh-list
24655587|NCT01257373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24655588|NCT01257373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24655589|NCT01257373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24655590|NCT01257373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655591|NCT01257373|Antifungal Agents|antifungal agents|mesh-ancestor
24655592|NCT01257373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24655593|NCT01257373|Immunologic Factors|immunologic factors|mesh-ancestor
24655594|NCT01257373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655595|NCT01257373|Trace Elements|trace elements|mesh-ancestor
24655596|NCT01257373|Micronutrients|micronutrients|mesh-ancestor
24655597|NCT01257386|Mesalamine|mesalamine|mesh-list
24655598|NCT01257386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24655599|NCT01257386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24655600|NCT01257386|Analgesics|analgesics|mesh-ancestor
24655601|NCT01257386|Sensory System Agents|sensory system agents|mesh-ancestor
24655656|NCT01257516|Anticonvulsants|anticonvulsants|mesh-ancestor
24655660|NCT01257516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24655661|NCT01257516|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24655662|NCT01257516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24655663|NCT01257516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24655664|NCT01257516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24655666|NCT01257529|Analgesics|analgesics|mesh-ancestor
24655667|NCT01257529|Sensory System Agents|sensory system agents|mesh-ancestor
24655668|NCT01257529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24655669|NCT01257529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655780|NCT01257919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655781|NCT01257919|Dermatologic Agents|dermatologic agents|mesh-ancestor
24655782|NCT01257958|Vitamin D|vitamin d|mesh-list
24655783|NCT01257958|Vitamins|vitamins|mesh-ancestor
24655784|NCT01257958|Micronutrients|micronutrients|mesh-ancestor
24655785|NCT01257958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655786|NCT01257958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24655787|NCT01258010|Tranexamic Acid|tranexamic acid|mesh-list
24655788|NCT01258010|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24465781|NCT00370721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24465782|NCT00370721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24655789|NCT01258010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24655790|NCT01258010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655791|NCT01258010|Hemostatics|hemostatics|mesh-ancestor
24799105|NCT01967199|Immunologic Factors|immunologic factors|mesh-ancestor
24799106|NCT01967199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799107|NCT01967251|Udenafil|udenafil|mesh-list
25702085|NCT02151149|Paclitaxel|paclitaxel|mesh-list
25702086|NCT02151149|Carboplatin|carboplatin|mesh-list
25702087|NCT02151149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25702088|NCT02151149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799108|NCT01967251|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24799109|NCT01967251|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24799110|NCT01967251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24655835|NCT01258309|Histamine Antagonists|histamine antagonists|mesh-ancestor
24655836|NCT01258309|Histamine Agents|histamine agents|mesh-ancestor
24655837|NCT01258309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24655839|NCT01258322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24655840|NCT01258322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655842|NCT01258439|Darunavir|darunavir|mesh-list
24655843|NCT01258439|Tenofovir|tenofovir|mesh-list
24655844|NCT01258439|Emtricitabine|emtricitabine|mesh-list
24655845|NCT01258439|Raltegravir Potassium|raltegravir potassium|mesh-list
24655846|NCT01258439|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24655847|NCT01258439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24655848|NCT01258439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24655849|NCT01258439|Protease Inhibitors|protease inhibitors|mesh-ancestor
24655850|NCT01258439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24655851|NCT01258439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655852|NCT01258439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24655853|NCT01258439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24655854|NCT01258439|Antiviral Agents|antiviral agents|mesh-ancestor
24655855|NCT01258439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24655856|NCT01258439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24947363|NCT03929744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24847050|NCT02244866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655869|NCT01258491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24655870|NCT01258491|Antimetabolites|antimetabolites|mesh-ancestor
24655871|NCT01258491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655872|NCT01258491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24655873|NCT01258491|Vasodilator Agents|vasodilator agents|mesh-ancestor
24655874|NCT01258530|Oseltamivir|oseltamivir|mesh-list
24655875|NCT01258530|Antiviral Agents|antiviral agents|mesh-ancestor
24655876|NCT01258530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24655877|NCT01258530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24655879|NCT01258569|Alvimopan|alvimopan|mesh-list
24655880|NCT01258569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24655881|NCT01258634|Leucovorin|leucovorin|mesh-list
24655882|NCT01258634|Doxorubicin|doxorubicin|mesh-list
24655883|NCT01258634|Etoposide|etoposide|mesh-list
24655884|NCT01258634|Ifosfamide|ifosfamide|mesh-list
24655885|NCT01258634|Dexrazoxane|dexrazoxane|mesh-list
24655886|NCT01258634|Razoxane|razoxane|mesh-list
24655887|NCT01258634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655888|NCT01258634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24655889|NCT01258634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24655890|NCT01258634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24655892|NCT01258634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655893|NCT01258634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24655894|NCT01258634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655896|NCT01258634|Protective Agents|protective agents|mesh-ancestor
24655897|NCT01258634|Vitamin B Complex|vitamin b complex|mesh-ancestor
24655899|NCT01258634|Micronutrients|micronutrients|mesh-ancestor
24655900|NCT01258634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24655901|NCT01258634|Alkylating Agents|alkylating agents|mesh-ancestor
24655902|NCT01258634|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24655903|NCT01258634|Antimitotic Agents|antimitotic agents|mesh-ancestor
24655904|NCT01258634|Mitosis Modulators|mitosis modulators|mesh-ancestor
24655905|NCT01258686|Silymarin|silymarin|mesh-list
24655906|NCT01258686|Antioxidants|antioxidants|mesh-ancestor
24655907|NCT01258686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655908|NCT01258686|Protective Agents|protective agents|mesh-ancestor
24655909|NCT01258686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655910|NCT01258712|Methotrexate|methotrexate|mesh-list
24655911|NCT01258712|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24947364|NCT03929744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24947365|NCT03929744|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24947366|NCT03929744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24947367|NCT03929744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947368|NCT03929744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24947369|NCT03929744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24947370|NCT03929744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24947371|NCT03929744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24947372|NCT03929744|Anesthetics, General|anesthetics, general|mesh-ancestor
24568034|NCT00793923|Hormones|hormones|mesh-ancestor
24947374|NCT03929744|GABA Modulators|gaba modulators|mesh-ancestor
24947376|NCT03929744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24655912|NCT01258712|Abortifacient Agents|abortifacient agents|mesh-ancestor
24655966|NCT01258920|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24655967|NCT01258920|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24655968|NCT01258920|Serotonin Agents|serotonin agents|mesh-ancestor
24655969|NCT01258920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24655970|NCT01258920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655971|NCT01258920|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24655972|NCT01258920|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24655973|NCT01258920|Dopamine Agents|dopamine agents|mesh-ancestor
24655974|NCT01258959|Anesthetics|anesthetics|mesh-list
24655975|NCT01258959|Anesthetics, Local|anesthetics, local|mesh-list
24655976|NCT01258959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24655977|NCT01258959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655978|NCT01258959|Sensory System Agents|sensory system agents|mesh-ancestor
24655979|NCT01258959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24947378|NCT03929575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24947379|NCT03929575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24947623|NCT03927313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24947624|NCT03927313|Glucocorticoids|glucocorticoids|mesh-ancestor
24947625|NCT03927313|Hormones|hormones|mesh-ancestor
24947626|NCT03927313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24465988|NCT00371501|Analgesics|analgesics|mesh-ancestor
24466154|NCT00372294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24847075|NCT02245022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24655981|NCT01259050|Trace Elements|trace elements|mesh-ancestor
24655982|NCT01259050|Micronutrients|micronutrients|mesh-ancestor
24655983|NCT01259050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655984|NCT01259141|Azithromycin|azithromycin|mesh-list
24655985|NCT01259141|Moxifloxacin|moxifloxacin|mesh-list
24655986|NCT01259141|Cephalosporins|cephalosporins|mesh-list
24655987|NCT01259141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24655988|NCT01259141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24655989|NCT01259141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24655990|NCT01259141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24655991|NCT01259141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24655997|NCT01259193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24655998|NCT01259193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656002|NCT01259219|Rifabutin|rifabutin|mesh-list
24656008|NCT01259323|Immunologic Factors|immunologic factors|mesh-ancestor
24656009|NCT01259323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656011|NCT01259336|Antifungal Agents|antifungal agents|mesh-ancestor
24656017|NCT01259336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24656018|NCT01259336|Hormone Antagonists|hormone antagonists|mesh-ancestor
24656019|NCT01259336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24656020|NCT01259336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656021|NCT01259336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24656023|NCT01259362|Anesthetics, Local|anesthetics, local|mesh-ancestor
24656024|NCT01259362|Anesthetics|anesthetics|mesh-ancestor
24656025|NCT01259362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24656026|NCT01259362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656027|NCT01259362|Sensory System Agents|sensory system agents|mesh-ancestor
24656028|NCT01259362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24656029|NCT01259362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24656030|NCT01259362|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24656032|NCT01259362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24656053|NCT01259557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24656054|NCT01259557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656055|NCT01259557|Cholinergic Agents|cholinergic agents|mesh-ancestor
24656056|NCT01259557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24656057|NCT01259557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656058|NCT01259557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24656073|NCT01259817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656074|NCT01259817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24656075|NCT01259817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24656076|NCT01259817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24656077|NCT01259817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24466158|NCT00372294|Hormones|hormones|mesh-ancestor
24466349|NCT00373178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466350|NCT00373204|Motexafin gadolinium|motexafin gadolinium|mesh-list
25702089|NCT02151149|Tubulin Modulators|tubulin modulators|mesh-ancestor
24568545|NCT00796276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656078|NCT01259817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656079|NCT01259817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24656081|NCT01259817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656100|NCT01259934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656104|NCT01259934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656105|NCT01259973|Haloperidol|haloperidol|mesh-list
24656106|NCT01259973|Risperidone|risperidone|mesh-list
24656107|NCT01259973|Haloperidol decanoate|haloperidol decanoate|mesh-list
24656108|NCT01259973|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24656109|NCT01259973|Serotonin Agents|serotonin agents|mesh-ancestor
24656110|NCT01259973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24656111|NCT01259973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656112|NCT01259973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656113|NCT01259973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24656114|NCT01259973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24656115|NCT01259973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24656116|NCT01259973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24656117|NCT01259973|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24656145|NCT01260129|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24656146|NCT01260129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24656147|NCT01260129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24656148|NCT01260129|Adrenergic Agents|adrenergic agents|mesh-ancestor
24656149|NCT01260129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24656150|NCT01260129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656151|NCT01260129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656152|NCT01260129|Urological Agents|urological agents|mesh-ancestor
24656154|NCT01260233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24656156|NCT01260233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24656157|NCT01260233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656158|NCT01260233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24656159|NCT01260233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24656160|NCT01260233|Cholinergic Agents|cholinergic agents|mesh-ancestor
24656161|NCT01260233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24656162|NCT01260233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656163|NCT01260246|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24656164|NCT01260246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24656165|NCT01260246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656166|NCT01260246|Incretins|incretins|mesh-ancestor
24656168|NCT01260246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24656169|NCT01260246|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24656190|NCT01260506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24656191|NCT01260506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656192|NCT01260506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24656193|NCT01260506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24656205|NCT01260558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24656207|NCT01260558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656208|NCT01260558|Antifungal Agents|antifungal agents|mesh-ancestor
24656209|NCT01260558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24656210|NCT01260558|Immunologic Factors|immunologic factors|mesh-ancestor
24656211|NCT01260558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656212|NCT01260571|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24466489|NCT00373646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24656213|NCT01260571|Dermatologic Agents|dermatologic agents|mesh-ancestor
24656215|NCT01260610|Telbivudine|telbivudine|mesh-list
24656216|NCT01260610|Antiviral Agents|antiviral agents|mesh-ancestor
24656217|NCT01260610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24656218|NCT01260610|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24656219|NCT01260610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24656230|NCT01260623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656231|NCT01260623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24656232|NCT01260623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656234|NCT01260675|Naloxone|naloxone|mesh-list
24656235|NCT01260675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24656236|NCT01260675|Narcotics|narcotics|mesh-ancestor
25702090|NCT02151149|Antimitotic Agents|antimitotic agents|mesh-ancestor
25702091|NCT02151149|Mitosis Modulators|mitosis modulators|mesh-ancestor
25702092|NCT02151149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702093|NCT02151253|Modafinil|modafinil|mesh-list
25702094|NCT02151253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24791888|NCT02553460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656245|NCT01260714|Mitoxantrone|mitoxantrone|mesh-list
24656246|NCT01260714|Azacitidine|azacitidine|mesh-list
24656247|NCT01260714|Etoposide phosphate|etoposide phosphate|mesh-list
24656248|NCT01260714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24656249|NCT01260714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656250|NCT01260714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24656251|NCT01260714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24656252|NCT01260714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656253|NCT01260714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656254|NCT01260714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24656255|NCT01260714|Antimetabolites|antimetabolites|mesh-ancestor
24656256|NCT01260714|Analgesics|analgesics|mesh-ancestor
24656257|NCT01260714|Sensory System Agents|sensory system agents|mesh-ancestor
24656258|NCT01260714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24656284|NCT01260818|Coagulants|coagulants|mesh-ancestor
24656285|NCT01260844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24656286|NCT01260844|Immunologic Factors|immunologic factors|mesh-ancestor
24656287|NCT01260844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656288|NCT01260857|Hydroflumethiazide|hydroflumethiazide|mesh-list
24656289|NCT01260857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24656290|NCT01260857|Diuretics|diuretics|mesh-ancestor
24656313|NCT01261065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24656314|NCT01261065|Vasodilator Agents|vasodilator agents|mesh-ancestor
24656315|NCT01261065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24656316|NCT01261065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24656328|NCT01261078|Autonomic Agents|autonomic agents|mesh-ancestor
24656329|NCT01261078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24656330|NCT01261078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24656331|NCT01261078|Respiratory System Agents|respiratory system agents|mesh-ancestor
24656332|NCT01261078|Mydriatics|mydriatics|mesh-ancestor
24656333|NCT01261078|Sympathomimetics|sympathomimetics|mesh-ancestor
24656334|NCT01261078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24656335|NCT01261117|Ibuprofen|ibuprofen|mesh-list
24656336|NCT01261117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24466574|NCT00373919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24466575|NCT00373919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24466576|NCT00373919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656337|NCT01261117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24656338|NCT01261117|Analgesics|analgesics|mesh-ancestor
24656339|NCT01261117|Sensory System Agents|sensory system agents|mesh-ancestor
24656340|NCT01261117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24656341|NCT01261117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656366|NCT01261169|Antitubercular Agents|antitubercular agents|mesh-ancestor
24656367|NCT01261169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24656368|NCT01261169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24656369|NCT01261169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656370|NCT01261169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656372|NCT01261234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24656380|NCT01261234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656393|NCT01261286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24656394|NCT01261286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656395|NCT01261286|Vasodilator Agents|vasodilator agents|mesh-ancestor
24656396|NCT01261299|Carboplatin|carboplatin|mesh-list
24656397|NCT01261299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656398|NCT01261416|Levetiracetam|levetiracetam|mesh-list
24656399|NCT01261416|Anticonvulsants|anticonvulsants|mesh-ancestor
24656400|NCT01261416|Nootropic Agents|nootropic agents|mesh-ancestor
24656401|NCT01261481|Tolvaptan|tolvaptan|mesh-list
24466578|NCT00374023|Vitamin A|vitamin a|mesh-list
24466579|NCT00374023|Vitamins|vitamins|mesh-ancestor
25702095|NCT02151253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702096|NCT02151253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25702097|NCT02151253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25702098|NCT02151253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25702099|NCT02151253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656402|NCT01261481|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24656403|NCT01261481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656404|NCT01261481|Natriuretic Agents|natriuretic agents|mesh-ancestor
24656405|NCT01261481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656406|NCT01261546|Dexamethasone|dexamethasone|mesh-list
24656407|NCT01261546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24656455|NCT01261741|Memantine|memantine|mesh-list
24656456|NCT01261741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24656457|NCT01261741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24656458|NCT01261741|Dopamine Agents|dopamine agents|mesh-ancestor
24656459|NCT01261741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24656460|NCT01261741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656461|NCT01261741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656462|NCT01261741|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24656514|NCT01262274|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24656515|NCT01262274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656516|NCT01262274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656517|NCT01262274|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24656518|NCT01262274|Hormone Antagonists|hormone antagonists|mesh-ancestor
24656519|NCT01262274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24656530|NCT01262391|Urological Agents|urological agents|mesh-ancestor
24656531|NCT01262417|Hyaluronic Acid|hyaluronic acid|mesh-list
24656532|NCT01262417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24656533|NCT01262417|Immunologic Factors|immunologic factors|mesh-ancestor
24656534|NCT01262417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656535|NCT01262417|Viscosupplements|viscosupplements|mesh-ancestor
24656536|NCT01262417|Protective Agents|protective agents|mesh-ancestor
24656537|NCT01262469|Capecitabine|capecitabine|mesh-list
24656538|NCT01262469|Lapatinib|lapatinib|mesh-list
24656539|NCT01262469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24656540|NCT01262469|Antimetabolites|antimetabolites|mesh-ancestor
24847148|NCT02245295|Anesthetics|anesthetics|mesh-list
24656542|NCT01262469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656543|NCT01262469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24656544|NCT01262469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656545|NCT01262482|Oxaliplatin|oxaliplatin|mesh-list
24656546|NCT01262482|Sorafenib|sorafenib|mesh-list
24656547|NCT01262482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656559|NCT01262586|Protease Inhibitors|protease inhibitors|mesh-ancestor
24656560|NCT01262586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656561|NCT01262586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656563|NCT01262612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656564|NCT01262612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24656569|NCT01262729|Anesthetics, General|anesthetics, general|mesh-ancestor
24656570|NCT01262729|Anesthetics|anesthetics|mesh-ancestor
24656571|NCT01262729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24656572|NCT01262729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948323|NCT03920605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24948324|NCT03920605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24948325|NCT03920605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24948326|NCT03920605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24948327|NCT03920605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24656590|NCT01262963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656591|NCT01262963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24656643|NCT01263171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24656644|NCT01263171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656645|NCT01263171|Antimetabolites|antimetabolites|mesh-ancestor
24656646|NCT01263171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656647|NCT01263171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24656649|NCT01263171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24656650|NCT01263171|Immunologic Factors|immunologic factors|mesh-ancestor
24656652|NCT01263171|Protective Agents|protective agents|mesh-ancestor
24656653|NCT01263171|Vitamin B Complex|vitamin b complex|mesh-ancestor
24656654|NCT01263171|Vitamins|vitamins|mesh-ancestor
24656655|NCT01263171|Micronutrients|micronutrients|mesh-ancestor
24656656|NCT01263210|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24656657|NCT01263210|Immunologic Factors|immunologic factors|mesh-ancestor
24656696|NCT01263548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24656708|NCT01263652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24656710|NCT01263652|Sensory System Agents|sensory system agents|mesh-ancestor
24656711|NCT01263652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24656712|NCT01263652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656713|NCT01263652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24466696|NCT00374621|Diuretics|diuretics|mesh-ancestor
24656714|NCT01263652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24656715|NCT01263652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24656716|NCT01263652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656717|NCT01263652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656718|NCT01263652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24656719|NCT01263652|Narcotics|narcotics|mesh-ancestor
24656720|NCT01263652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24656721|NCT01263652|Antipyretics|antipyretics|mesh-ancestor
24656722|NCT01263652|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24656723|NCT01263652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24656724|NCT01263652|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24656725|NCT01263652|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24656726|NCT01263652|Parasympatholytics|parasympatholytics|mesh-ancestor
24656727|NCT01263652|Autonomic Agents|autonomic agents|mesh-ancestor
24656728|NCT01263652|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24656729|NCT01263652|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24656734|NCT01263808|Moxifloxacin|moxifloxacin|mesh-list
24799129|NCT01967381|Adrenergic Agents|adrenergic agents|mesh-ancestor
24799130|NCT01967381|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24799131|NCT01967381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24799132|NCT01967381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24799133|NCT01967381|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24799134|NCT01967459|Cholecalciferol|cholecalciferol|mesh-list
24799136|NCT01967459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24799137|NCT01967459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847141|NCT02245269|Protease Inhibitors|protease inhibitors|mesh-ancestor
24847142|NCT02245269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24847143|NCT02245269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24656742|NCT01263834|Bevacizumab|bevacizumab|mesh-list
24656743|NCT01263834|Mitomycins|mitomycins|mesh-list
24656744|NCT01263834|Mitomycin|mitomycin|mesh-list
24656745|NCT01263834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24656746|NCT01263834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656747|NCT01263834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24656748|NCT01263834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24656749|NCT01263834|Growth Substances|growth substances|mesh-ancestor
24656750|NCT01263834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656751|NCT01263834|Growth Inhibitors|growth inhibitors|mesh-ancestor
24656752|NCT01263834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24656753|NCT01263834|Alkylating Agents|alkylating agents|mesh-ancestor
24656754|NCT01263834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656755|NCT01263834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24656756|NCT01263834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656785|NCT01264133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656786|NCT01264211|Diacetylrhein|diacetylrhein|mesh-list
24656787|NCT01264211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24656789|NCT01264237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24453073|NCT05309629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24799139|NCT01967459|Micronutrients|micronutrients|mesh-ancestor
24799140|NCT01967459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24799141|NCT01967472|Artesunate|artesunate|mesh-list
24799142|NCT01967472|Lumefantrine|lumefantrine|mesh-list
24799143|NCT01967472|Artemether|artemether|mesh-list
24656790|NCT01264237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24571184|NCT00808366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24656791|NCT01264237|Analgesics|analgesics|mesh-ancestor
24656805|NCT01264289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466825|NCT00375245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24466826|NCT00375245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24656806|NCT01264289|Hormone Antagonists|hormone antagonists|mesh-ancestor
24656807|NCT01264289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24656808|NCT01264289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656809|NCT01264289|Urological Agents|urological agents|mesh-ancestor
24656811|NCT01264302|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24656812|NCT01264302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24656813|NCT01264302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656815|NCT01264302|Hormone Antagonists|hormone antagonists|mesh-ancestor
24656836|NCT01264341|Sirolimus|sirolimus|mesh-list
24656837|NCT01264341|Bevacizumab|bevacizumab|mesh-list
24656838|NCT01264341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24656839|NCT01264341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656840|NCT01264341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24656841|NCT01264341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24656842|NCT01264341|Growth Substances|growth substances|mesh-ancestor
24656843|NCT01264341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656844|NCT01264341|Growth Inhibitors|growth inhibitors|mesh-ancestor
24656845|NCT01264341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24656846|NCT01264341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24656847|NCT01264341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24656848|NCT01264341|Antifungal Agents|antifungal agents|mesh-ancestor
24656849|NCT01264341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24656850|NCT01264341|Immunologic Factors|immunologic factors|mesh-ancestor
24656907|NCT01264588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24656908|NCT01264588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656909|NCT01264640|Aspirin|aspirin|mesh-list
24656910|NCT01264640|Clopidogrel|clopidogrel|mesh-list
24656911|NCT01264640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24656912|NCT01264640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24656919|NCT01264640|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24656920|NCT01264640|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24656921|NCT01264640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466845|NCT00375284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24656922|NCT01264640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24656923|NCT01264640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24656924|NCT01264640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656925|NCT01264640|Antipyretics|antipyretics|mesh-ancestor
24656926|NCT01264640|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24656928|NCT01264640|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24656929|NCT01264640|Purinergic Agents|purinergic agents|mesh-ancestor
24656930|NCT01264640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24656932|NCT01264653|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24656933|NCT01264653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24656934|NCT01264653|Adrenergic Agents|adrenergic agents|mesh-ancestor
24656935|NCT01264653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24656936|NCT01264653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656937|NCT01264653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656938|NCT01264653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24656939|NCT01264653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24656940|NCT01264653|Autonomic Agents|autonomic agents|mesh-ancestor
24656976|NCT01264822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656978|NCT01264874|Cholecalciferol|cholecalciferol|mesh-list
24656979|NCT01264874|Vitamins|vitamins|mesh-ancestor
24656980|NCT01264874|Micronutrients|micronutrients|mesh-ancestor
24656981|NCT01264874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656982|NCT01264874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24466846|NCT00375284|Dopamine Agonists|dopamine agonists|mesh-ancestor
24466847|NCT00375284|Dopamine Agents|dopamine agents|mesh-ancestor
24466848|NCT00375284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24466849|NCT00375297|Sildenafil Citrate|sildenafil citrate|mesh-list
25702100|NCT02151448|Interferons|interferons|mesh-list
25702101|NCT02151448|Interferon-alpha|interferon-alpha|mesh-list
25702102|NCT02151448|Interferon alpha-2|interferon alpha-2|mesh-list
24466915|NCT00375596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25102847|NCT03166163|Disinfectants|disinfectants|mesh-ancestor
24656991|NCT01265017|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24656992|NCT01265017|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24656993|NCT01265017|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24656994|NCT01265017|Medroxyprogesterone|medroxyprogesterone|mesh-list
24656995|NCT01265017|Estradiol|estradiol|mesh-list
24799147|NCT01967472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24799148|NCT01967472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24799149|NCT01967472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24799150|NCT01967472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799151|NCT01967472|Antiviral Agents|antiviral agents|mesh-ancestor
24466916|NCT00375596|Antipruritics|antipruritics|mesh-ancestor
24466917|NCT00375596|Dermatologic Agents|dermatologic agents|mesh-ancestor
24466918|NCT00375596|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24466919|NCT00375596|Histamine Antagonists|histamine antagonists|mesh-ancestor
24466920|NCT00375596|Histamine Agents|histamine agents|mesh-ancestor
24847159|NCT02245373|Antidepressive Agents|antidepressive agents|mesh-list
24656996|NCT01265017|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24656997|NCT01265017|Hormones|hormones|mesh-ancestor
24656998|NCT01265017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24656999|NCT01265017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657000|NCT01265017|Estrogens|estrogens|mesh-ancestor
24657001|NCT01265017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24657002|NCT01265017|Contraceptive Agents|contraceptive agents|mesh-ancestor
24657003|NCT01265017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24657004|NCT01265017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24657005|NCT01265017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24657006|NCT01265017|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24657007|NCT01265017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24657008|NCT01265017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25702103|NCT02151448|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
25702104|NCT02151448|Celecoxib|celecoxib|mesh-list
25702105|NCT02151448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25702106|NCT02151448|Antiviral Agents|antiviral agents|mesh-ancestor
25702107|NCT02151448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25702108|NCT02151448|Immunologic Factors|immunologic factors|mesh-ancestor
25702109|NCT02151448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702110|NCT02151448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24571917|NCT00812266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571918|NCT00812266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24571919|NCT00812292|Rilpivirine|rilpivirine|mesh-list
24571922|NCT00812292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657009|NCT01265017|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24466978|NCT00375843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24657011|NCT01265017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657013|NCT01265108|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24657014|NCT01265108|Trace Elements|trace elements|mesh-ancestor
24657015|NCT01265108|Micronutrients|micronutrients|mesh-ancestor
24657016|NCT01265108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657017|NCT01265108|Hematinics|hematinics|mesh-ancestor
24657018|NCT01265147|Nedaplatin|nedaplatin|mesh-list
24657019|NCT01265147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657020|NCT01265173|Ciprofloxacin|ciprofloxacin|mesh-list
24657021|NCT01265173|Ceftriaxone|ceftriaxone|mesh-list
24657022|NCT01265173|Cefotaxime|cefotaxime|mesh-list
24657023|NCT01265173|Cefoxitin|cefoxitin|mesh-list
24657024|NCT01265173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24657025|NCT01265173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24657026|NCT01265173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24657027|NCT01265173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24657028|NCT01265173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657029|NCT01265173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657030|NCT01265173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657031|NCT01265173|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24657032|NCT01265173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24657033|NCT01265199|Cytarabine|cytarabine|mesh-list
24657034|NCT01265199|Daunorubicin|daunorubicin|mesh-list
24657035|NCT01265199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24657036|NCT01265199|Antimetabolites|antimetabolites|mesh-ancestor
24657037|NCT01265199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657038|NCT01265199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657039|NCT01265199|Antiviral Agents|antiviral agents|mesh-ancestor
24657040|NCT01265199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24657041|NCT01265199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24657042|NCT01265199|Immunologic Factors|immunologic factors|mesh-ancestor
24657043|NCT01265199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799158|NCT01967498|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24799159|NCT01967498|Hormone Antagonists|hormone antagonists|mesh-ancestor
24799160|NCT01967498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24799161|NCT01967498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799162|NCT01967498|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24799163|NCT01967498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24657045|NCT01265199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24657055|NCT01265342|Respiratory System Agents|respiratory system agents|mesh-ancestor
24657056|NCT01265433|Molgramostim|molgramostim|mesh-list
24657057|NCT01265433|Sargramostim|sargramostim|mesh-list
24467011|NCT00376012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657058|NCT01265433|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
24657059|NCT01265433|Immunologic Factors|immunologic factors|mesh-ancestor
24657060|NCT01265433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657061|NCT01265433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657062|NCT01265433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24657063|NCT01265576|Etodolac|etodolac|mesh-list
24657064|NCT01265576|Sorafenib|sorafenib|mesh-list
24657065|NCT01265576|Propranolol|propranolol|mesh-list
24657066|NCT01265576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657083|NCT01265576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24657084|NCT01265576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24657085|NCT01265576|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24657086|NCT01265576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24657088|NCT01265589|Pulmonary Surfactants|pulmonary surfactants|mesh-list
24657089|NCT01265589|Vitamins|vitamins|mesh-ancestor
24657090|NCT01265589|Micronutrients|micronutrients|mesh-ancestor
24657091|NCT01265589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702111|NCT02151448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25702112|NCT02151448|Analgesics|analgesics|mesh-ancestor
25702113|NCT02151448|Sensory System Agents|sensory system agents|mesh-ancestor
25702114|NCT02151448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25702115|NCT02151448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24657092|NCT01265589|Respiratory System Agents|respiratory system agents|mesh-ancestor
24657093|NCT01265641|Moxifloxacin|moxifloxacin|mesh-list
24657094|NCT01265641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24657095|NCT01265641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24799170|NCT01967524|Anesthetics|anesthetics|mesh-ancestor
24467012|NCT00376012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467013|NCT00376012|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24467014|NCT00376012|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24467015|NCT00376012|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24467016|NCT00376012|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24467035|NCT00376051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24467037|NCT00376051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467038|NCT00376051|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24467039|NCT00376051|Antidepressive Agents|antidepressive agents|mesh-ancestor
24467040|NCT00376051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24467042|NCT00376064|Cabergoline|cabergoline|mesh-list
24799171|NCT01967524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24657132|NCT01265888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657133|NCT01265888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24657134|NCT01265888|Respiratory System Agents|respiratory system agents|mesh-ancestor
24657135|NCT01265888|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24657136|NCT01265888|Antioxidants|antioxidants|mesh-ancestor
24657137|NCT01265888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657138|NCT01265888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24657139|NCT01265888|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24657140|NCT01265888|Vasodilator Agents|vasodilator agents|mesh-ancestor
24657141|NCT01265888|Gasotransmitters|gasotransmitters|mesh-ancestor
24657142|NCT01265888|Protective Agents|protective agents|mesh-ancestor
24657143|NCT01265927|Trastuzumab|trastuzumab|mesh-list
24467074|NCT00376103|Alkylating Agents|alkylating agents|mesh-ancestor
24467075|NCT00376103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467076|NCT00376103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467078|NCT00376129|Dermatologic Agents|dermatologic agents|mesh-ancestor
24467079|NCT00376129|Immunologic Factors|immunologic factors|mesh-ancestor
24467080|NCT00376129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467081|NCT00376155|Pyrimethamine|pyrimethamine|mesh-list
24467082|NCT00376155|Sulfadoxine|sulfadoxine|mesh-list
25102809|NCT03166397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102810|NCT03166397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102811|NCT03166397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25102812|NCT03166527|Immunoglobulins|immunoglobulins|mesh-list
25102813|NCT03166527|Antibodies|antibodies|mesh-list
25102814|NCT03166527|gamma-Globulins|gamma-globulins|mesh-list
25102815|NCT03166527|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25102816|NCT03166527|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24522264|NCT04047251|Topotecan|topotecan|mesh-list
25102844|NCT03166163|Chlorhexidine|chlorhexidine|mesh-list
25102845|NCT03166163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25102846|NCT03166163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25102848|NCT03165929|Flurbiprofen|flurbiprofen|mesh-list
25102849|NCT03165929|Analgesics|analgesics|mesh-ancestor
25102850|NCT03165929|Sensory System Agents|sensory system agents|mesh-ancestor
25102851|NCT03165929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25102852|NCT03165929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467091|NCT00376155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24467139|NCT00376337|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24467140|NCT00376376|Levofloxacin|levofloxacin|mesh-list
24467141|NCT00376376|Ofloxacin|ofloxacin|mesh-list
24467142|NCT00376376|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24467143|NCT00376376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24467144|NCT00376376|Renal Agents|renal agents|mesh-ancestor
24467145|NCT00376376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24467146|NCT00376376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24467147|NCT00376376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24467148|NCT00376376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25702116|NCT02151448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24572688|NCT00816283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25102858|NCT03165929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102859|NCT03165929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900900|NCT04390334|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24900911|NCT04390594|Analgesics|analgesics|mesh-ancestor
24818075|NCT02086929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818076|NCT02086929|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24818077|NCT02086929|Antidepressive Agents|antidepressive agents|mesh-ancestor
24818078|NCT02086929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24818079|NCT02086929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24901007|NCT04389580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901008|NCT04389580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24901010|NCT04389580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24901011|NCT04389580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25102860|NCT03165825|Dexamethasone|dexamethasone|mesh-list
25102861|NCT03165825|Betamethasone|betamethasone|mesh-list
25102862|NCT03165825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25102863|NCT03165825|Antiemetics|antiemetics|mesh-ancestor
25102899|NCT03165383|Morphine|morphine|mesh-list
25102900|NCT03165383|Bupivacaine|bupivacaine|mesh-list
25102901|NCT03165383|Anesthetics, Local|anesthetics, local|mesh-ancestor
25102902|NCT03165383|Anesthetics|anesthetics|mesh-ancestor
25102903|NCT03165383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25102932|NCT03165500|Analgesics|analgesics|mesh-ancestor
25102933|NCT03165500|Sensory System Agents|sensory system agents|mesh-ancestor
24467221|NCT00376519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25102934|NCT03165500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25102935|NCT03165500|Anticonvulsants|anticonvulsants|mesh-ancestor
25102936|NCT03165500|Antiemetics|antiemetics|mesh-ancestor
25102937|NCT03165500|Autonomic Agents|autonomic agents|mesh-ancestor
25102938|NCT03165500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24500629|NCT00525252|Baclofen|baclofen|mesh-list
24901012|NCT04389580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24901013|NCT04389580|Dermatologic Agents|dermatologic agents|mesh-ancestor
24901014|NCT04389424|Tamoxifen|tamoxifen|mesh-list
24901015|NCT04389424|Anastrozole|anastrozole|mesh-list
24724020|NCT01590732|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24901016|NCT04389424|Exemestane|exemestane|mesh-list
24901017|NCT04389424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24901018|NCT04389424|Hormone Antagonists|hormone antagonists|mesh-ancestor
24477780|NCT00420030|Abciximab|abciximab|mesh-list
24901079|NCT04388774|Ketamine|ketamine|mesh-list
24901080|NCT04388774|Analgesics|analgesics|mesh-ancestor
24901081|NCT04388774|Sensory System Agents|sensory system agents|mesh-ancestor
24467223|NCT00376584|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24467224|NCT00376584|Antimetabolites|antimetabolites|mesh-ancestor
24901082|NCT04388774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24901083|NCT04388774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901250|NCT04386876|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24901252|NCT04386876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24901253|NCT04386876|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24901254|NCT04386876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24467265|NCT00376831|Ketamine|ketamine|mesh-list
24467266|NCT00376831|Analgesics|analgesics|mesh-ancestor
24467267|NCT00376831|Sensory System Agents|sensory system agents|mesh-ancestor
24467268|NCT00376831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24467269|NCT00376831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518919|NCT03929601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24518920|NCT03929601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25102939|NCT03165500|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25102940|NCT03165500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25102942|NCT03165396|Sevoflurane|sevoflurane|mesh-list
25102943|NCT03165396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25102944|NCT03165396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25102945|NCT03165396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102946|NCT03165396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25102947|NCT03165396|Anesthetics, General|anesthetics, general|mesh-ancestor
25702117|NCT02151448|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25702118|NCT02151448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25102948|NCT03165396|Anesthetics|anesthetics|mesh-ancestor
25702119|NCT02151448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25702120|NCT02151448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102980|NCT03165240|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25102982|NCT03165240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25102983|NCT03165240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780573|NCT01884909|Adrenergic Agents|adrenergic agents|mesh-ancestor
25102985|NCT03165240|Diuretics|diuretics|mesh-ancestor
25102986|NCT03165240|Natriuretic Agents|natriuretic agents|mesh-ancestor
25102987|NCT03165240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25102988|NCT03165097|ACT-709478|act-709478|mesh-list
25102989|NCT03165097|Midazolam|midazolam|mesh-list
25102990|NCT03165097|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24518921|NCT03929601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518922|NCT03929601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24518923|NCT03910660|Pembrolizumab|pembrolizumab|mesh-list
24518924|NCT03910660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24518925|NCT03910660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24518926|NCT03899636|Folfirinox|folfirinox|mesh-list
24518927|NCT03899636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24818131|NCT02087020|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24818132|NCT02087020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25102992|NCT03165097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25102993|NCT03165097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102994|NCT03165097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25102995|NCT03165097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25102996|NCT03165097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25102997|NCT03165097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25102998|NCT03165097|Anesthetics, General|anesthetics, general|mesh-ancestor
25102999|NCT03165097|Anesthetics|anesthetics|mesh-ancestor
25103000|NCT03165097|GABA Modulators|gaba modulators|mesh-ancestor
25103001|NCT03165097|GABA Agents|gaba agents|mesh-ancestor
25103002|NCT03165097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25103003|NCT03165097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103004|NCT03165097|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25103005|NCT03165097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25103006|NCT03165097|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25103040|NCT03164694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25103041|NCT03164590|Dexmedetomidine|dexmedetomidine|mesh-list
25103042|NCT03164590|Ketamine|ketamine|mesh-list
25103043|NCT03164590|Bupivacaine|bupivacaine|mesh-list
25103044|NCT03164590|Anesthetics, Local|anesthetics, local|mesh-ancestor
25702121|NCT02151461|Metformin|metformin|mesh-list
24573058|NCT00817713|Albendazole|albendazole|mesh-list
24573059|NCT00817713|Praziquantel|praziquantel|mesh-list
24573060|NCT00817713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24792347|NCT05303038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24792348|NCT05303038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24792349|NCT05303038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24792351|NCT05303038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792352|NCT05303038|Growth Inhibitors|growth inhibitors|mesh-ancestor
25103045|NCT03164590|Anesthetics|anesthetics|mesh-ancestor
25103046|NCT03164590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25103047|NCT03164590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103048|NCT03164590|Sensory System Agents|sensory system agents|mesh-ancestor
25103049|NCT03164590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24523601|NCT05341401|Prednisolone|prednisolone|mesh-list
25103076|NCT03164421|Antioxidants|antioxidants|mesh-ancestor
24818133|NCT02087098|Solifenacin Succinate|solifenacin succinate|mesh-list
24818134|NCT02087098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24818135|NCT02087098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24818136|NCT02087098|Cholinergic Agents|cholinergic agents|mesh-ancestor
24519057|NCT03686332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901437|NCT04385407|Sofosbuvir|sofosbuvir|mesh-list
24901438|NCT04385407|Simeprevir|simeprevir|mesh-list
24901439|NCT04385407|Antimetabolites|antimetabolites|mesh-ancestor
24901440|NCT04385407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901441|NCT04385407|Antiviral Agents|antiviral agents|mesh-ancestor
24467279|NCT00376831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24901442|NCT04385407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24901443|NCT04385407|Protease Inhibitors|protease inhibitors|mesh-ancestor
24901844|NCT04380220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24901890|NCT04380298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24901891|NCT04380298|Adrenergic Agents|adrenergic agents|mesh-ancestor
24901892|NCT04380298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25103077|NCT03164421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103078|NCT03164421|Protective Agents|protective agents|mesh-ancestor
24901937|NCT04380025|Protective Agents|protective agents|mesh-ancestor
25103079|NCT03164421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103081|NCT03164304|Magnesium Sulfate|magnesium sulfate|mesh-list
25103082|NCT03164304|Analgesics|analgesics|mesh-ancestor
24731561|NCT01635608|Talinolol|talinolol|mesh-list
25103083|NCT03164304|Sensory System Agents|sensory system agents|mesh-ancestor
25103084|NCT03164304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25103085|NCT03164304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103086|NCT03164304|Anesthetics|anesthetics|mesh-ancestor
25103087|NCT03164304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25103088|NCT03164304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25103089|NCT03164304|Anticonvulsants|anticonvulsants|mesh-ancestor
25103090|NCT03164304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25103091|NCT03164304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25103092|NCT03164304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103093|NCT03164304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25103094|NCT03164304|Tocolytic Agents|tocolytic agents|mesh-ancestor
25103128|NCT03164018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103129|NCT03163914|Phenylephrine|phenylephrine|mesh-list
25103130|NCT03163914|Epinephrine|epinephrine|mesh-list
25103131|NCT03163914|Oxymetazoline|oxymetazoline|mesh-list
25103132|NCT03163914|Norepinephrine|norepinephrine|mesh-list
25103133|NCT03163914|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25103158|NCT03163693|Sensory System Agents|sensory system agents|mesh-ancestor
25702122|NCT02151461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25702123|NCT02151461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702124|NCT02151487|Dexamethasone|dexamethasone|mesh-list
25702125|NCT02151487|Dexamethasone acetate|dexamethasone acetate|mesh-list
25702126|NCT02151487|Clonidine|clonidine|mesh-list
25702127|NCT02151487|Ropivacaine|ropivacaine|mesh-list
25702128|NCT02151487|BB 1101|bb 1101|mesh-list
25702129|NCT02151487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25702130|NCT02151487|Antiemetics|antiemetics|mesh-ancestor
25702131|NCT02151487|Autonomic Agents|autonomic agents|mesh-ancestor
25702132|NCT02151487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25702133|NCT02151487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702134|NCT02151487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25103159|NCT03163693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25103160|NCT03163693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25103161|NCT03163693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25103162|NCT03163693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25103163|NCT03163693|Adrenergic Agents|adrenergic agents|mesh-ancestor
24901893|NCT04380298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901894|NCT04380298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24901895|NCT04380298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24901896|NCT04380298|Autonomic Agents|autonomic agents|mesh-ancestor
24901897|NCT04380298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24901898|NCT04380298|Respiratory System Agents|respiratory system agents|mesh-ancestor
24901899|NCT04380298|Mydriatics|mydriatics|mesh-ancestor
24901921|NCT04380103|Antimetabolites|antimetabolites|mesh-ancestor
24901934|NCT04380025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901935|NCT04380025|Antioxidants|antioxidants|mesh-ancestor
25103164|NCT03163693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25103165|NCT03163693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103166|NCT03163680|Omeprazole|omeprazole|mesh-list
25103167|NCT03163680|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25103168|NCT03163680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25103169|NCT03163680|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25103170|NCT03163680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25103171|NCT03163680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780780|NCT01886352|Sensory System Agents|sensory system agents|mesh-ancestor
25103172|NCT03163784|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25103173|NCT03163784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25103174|NCT03163784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25103175|NCT03163784|Antitubercular Agents|antitubercular agents|mesh-ancestor
25103176|NCT03163979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25103177|NCT03163979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25103178|NCT03163979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103179|NCT03164161|Endorphins|endorphins|mesh-list
25103205|NCT03163277|Maraviroc|maraviroc|mesh-list
25103206|NCT03163277|Darunavir|darunavir|mesh-list
25103207|NCT03163277|Cobicistat|cobicistat|mesh-list
25103208|NCT03163277|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
25103209|NCT03163277|Antiviral Agents|antiviral agents|mesh-ancestor
25103210|NCT03163277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25103211|NCT03163277|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25103212|NCT03163277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25103213|NCT03163277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25103214|NCT03163277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103215|NCT03163277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24969399|NCT03743259|Charcoal|charcoal|mesh-list
24901936|NCT04380025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901938|NCT04380025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24901940|NCT04379739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24901941|NCT04379739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24901942|NCT04379739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901943|NCT04379739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901944|NCT04379492|Hydroxychloroquine|hydroxychloroquine|mesh-list
24901945|NCT04379492|Antimalarials|antimalarials|mesh-ancestor
24901946|NCT04379492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24901947|NCT04379492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24901948|NCT04379492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24901949|NCT04379492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901950|NCT04379492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103216|NCT03163277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25103217|NCT03163277|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25103218|NCT03163277|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25103219|NCT03163277|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25103220|NCT03163277|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25103221|NCT03163277|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25103222|NCT03163277|Protease Inhibitors|protease inhibitors|mesh-ancestor
25103223|NCT03163277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25103224|NCT03163277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25103225|NCT03163238|Dexmedetomidine|dexmedetomidine|mesh-list
25103226|NCT03163238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25702135|NCT02151487|Glucocorticoids|glucocorticoids|mesh-ancestor
25103240|NCT03163420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25103242|NCT03163420|Analgesics|analgesics|mesh-ancestor
25103243|NCT03163420|Sensory System Agents|sensory system agents|mesh-ancestor
25103244|NCT03163420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24780962|NCT01887405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25103245|NCT03163420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103246|NCT03163420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25103247|NCT03163420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25103248|NCT03163420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25103249|NCT03163420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24969428|NCT03742908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24901951|NCT04379492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24901952|NCT04379180|Bosentan|bosentan|mesh-list
24901953|NCT04379180|Sildenafil Citrate|sildenafil citrate|mesh-list
24901954|NCT04379180|Tadalafil|tadalafil|mesh-list
24901955|NCT04379180|Vasodilator Agents|vasodilator agents|mesh-ancestor
24818195|NCT02087462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818196|NCT02087462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24818197|NCT02087462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24818198|NCT02087462|Analgesics|analgesics|mesh-ancestor
24818199|NCT02087462|Sensory System Agents|sensory system agents|mesh-ancestor
24818200|NCT02087462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24901964|NCT04379271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24901965|NCT04379271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901966|NCT04379219|Methotrexate|methotrexate|mesh-list
24478662|NCT00423865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24478663|NCT00423865|Immunologic Factors|immunologic factors|mesh-ancestor
24902089|NCT04377646|Hydroxychloroquine|hydroxychloroquine|mesh-list
24902090|NCT04377646|Antimalarials|antimalarials|mesh-ancestor
24902091|NCT04377646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24902092|NCT04377646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24902093|NCT04377646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902094|NCT04377646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902095|NCT04377646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902096|NCT04377646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24902097|NCT04377646|Trace Elements|trace elements|mesh-ancestor
24519268|NCT02591654|Pembrolizumab|pembrolizumab|mesh-list
24902149|NCT04376970|Antifungal Agents|antifungal agents|mesh-ancestor
24902150|NCT04376970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902151|NCT04376970|Dermatologic Agents|dermatologic agents|mesh-ancestor
25103250|NCT03163420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103251|NCT03163407|Norepinephrine|norepinephrine|mesh-list
25103252|NCT03163407|Ephedrine|ephedrine|mesh-list
25103253|NCT03163407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25103254|NCT03163407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25103255|NCT03163407|Adrenergic Agents|adrenergic agents|mesh-ancestor
25103256|NCT03163407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25103257|NCT03163407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103258|NCT03163407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103259|NCT03163407|Sympathomimetics|sympathomimetics|mesh-ancestor
25103260|NCT03163407|Autonomic Agents|autonomic agents|mesh-ancestor
25103261|NCT03163407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25103262|NCT03163407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25103263|NCT03163407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25103264|NCT03163381|Apatinib|apatinib|mesh-list
25103265|NCT03163381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25103266|NCT03163381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25103267|NCT03163381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25103268|NCT03163381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902152|NCT04376970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24902153|NCT04376970|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24902154|NCT04376970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24902155|NCT04376970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24902157|NCT04376970|Hormones|hormones|mesh-ancestor
24902158|NCT04376970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24902159|NCT04376970|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24902161|NCT04377048|Tegafur|tegafur|mesh-list
24902162|NCT04377048|Nivolumab|nivolumab|mesh-list
24902163|NCT04377048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24902164|NCT04377048|Antimetabolites|antimetabolites|mesh-ancestor
24902165|NCT04377048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702136|NCT02151487|Hormones|hormones|mesh-ancestor
24483195|NCT00442221|Serotonin Agents|serotonin agents|mesh-ancestor
25709577|NCT02270242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902225|NCT04376541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24902226|NCT04376541|Narcotics|narcotics|mesh-ancestor
24902227|NCT04376541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24902228|NCT04376541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478809|NCT00424606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24519269|NCT02591654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24902229|NCT04376541|Analgesics|analgesics|mesh-ancestor
24902230|NCT04376541|Sensory System Agents|sensory system agents|mesh-ancestor
24725265|NCT01596907|Pseudoephedrine|pseudoephedrine|mesh-list
24902231|NCT04376541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24902232|NCT04376541|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24902248|NCT04376216|Prednisolone|prednisolone|mesh-list
24902249|NCT04376216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24902250|NCT04376216|Glucocorticoids|glucocorticoids|mesh-ancestor
24902251|NCT04376216|Hormones|hormones|mesh-ancestor
24902252|NCT04376216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24902253|NCT04376216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902275|NCT04375852|Autoantibodies|autoantibodies|mesh-list
24902276|NCT04375852|Immunologic Factors|immunologic factors|mesh-ancestor
24902277|NCT04375852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902279|NCT04374981|Montelukast|montelukast|mesh-list
25103270|NCT03163576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25103271|NCT03163576|Antimetabolites|antimetabolites|mesh-ancestor
25103272|NCT03163576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103273|NCT03163576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25103274|NCT03163576|Vasodilator Agents|vasodilator agents|mesh-ancestor
25103275|NCT03163576|Vitamin B Complex|vitamin b complex|mesh-ancestor
25103277|NCT03163576|Micronutrients|micronutrients|mesh-ancestor
25103278|NCT03163576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103279|NCT03163173|Avasopasem manganese|avasopasem manganese|mesh-list
25103280|NCT03163173|Antioxidants|antioxidants|mesh-ancestor
25103281|NCT03163173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103282|NCT03163173|Protective Agents|protective agents|mesh-ancestor
25103283|NCT03163173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103302|NCT03162653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103304|NCT03162653|Gout Suppressants|gout suppressants|mesh-ancestor
25103305|NCT03162653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25103306|NCT03162653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25103307|NCT03162653|Antioxidants|antioxidants|mesh-ancestor
24467671|NCT00378443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467672|NCT00378456|Vitamins|vitamins|mesh-list
24467673|NCT00378456|Leucovorin|leucovorin|mesh-list
24467674|NCT00378456|Folic Acid|folic acid|mesh-list
24467675|NCT00378456|Vitamin A|vitamin a|mesh-list
24467676|NCT00378456|Zinc|zinc|mesh-list
24467677|NCT00378456|Selenium|selenium|mesh-list
24467678|NCT00378456|Retinol palmitate|retinol palmitate|mesh-list
24467679|NCT00378456|Levoleucovorin|levoleucovorin|mesh-list
24467680|NCT00378456|Antioxidants|antioxidants|mesh-list
24467681|NCT00378456|Micronutrients|micronutrients|mesh-ancestor
24467682|NCT00378456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902283|NCT04374981|Sensory System Agents|sensory system agents|mesh-ancestor
25103323|NCT03162406|Vitamins|vitamins|mesh-ancestor
25103324|NCT03162406|Micronutrients|micronutrients|mesh-ancestor
25103325|NCT03162406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103326|NCT03162406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25103327|NCT03162406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25103328|NCT03162900|Moxifloxacin|moxifloxacin|mesh-list
25103329|NCT03162900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25103330|NCT03162900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25103331|NCT03162900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25103332|NCT03162900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25103333|NCT03162900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25103334|NCT03162900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103335|NCT03162900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25103396|NCT03161977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103397|NCT03161652|Ranibizumab|ranibizumab|mesh-list
24818201|NCT02087462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24818202|NCT02087462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24818203|NCT02087462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25709578|NCT02270242|Antipyretics|antipyretics|mesh-ancestor
24818204|NCT02087462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573523|NCT00820547|Immunologic Factors|immunologic factors|mesh-ancestor
24573524|NCT00820547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573525|NCT00820547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24573526|NCT00820547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24573527|NCT00820547|Alkylating Agents|alkylating agents|mesh-ancestor
24573528|NCT00820547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818205|NCT02087462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818206|NCT02087475|Fluorouracil|fluorouracil|mesh-list
24818208|NCT02087475|Antimetabolites|antimetabolites|mesh-ancestor
24818209|NCT02087475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818210|NCT02087475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24818211|NCT02087475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24902889|NCT04368819|Antioxidants|antioxidants|mesh-ancestor
24902890|NCT04368819|Protective Agents|protective agents|mesh-ancestor
24902891|NCT04368819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902892|NCT04368585|Simethicone|simethicone|mesh-list
24902893|NCT04368585|Omeprazole|omeprazole|mesh-list
24902894|NCT04368585|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24902895|NCT04368585|Magnesium Hydroxide|magnesium hydroxide|mesh-list
24902896|NCT04368585|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
25103406|NCT03161652|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25103407|NCT03161652|Sympathomimetics|sympathomimetics|mesh-ancestor
25103408|NCT03161652|Autonomic Agents|autonomic agents|mesh-ancestor
25103409|NCT03161652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25103410|NCT03161652|Dopamine Agents|dopamine agents|mesh-ancestor
25103411|NCT03161652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25103412|NCT03161652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103413|NCT03161652|Protective Agents|protective agents|mesh-ancestor
25103414|NCT03161652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25103415|NCT03161652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25103416|NCT03161652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25103417|NCT03161652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25103418|NCT03161652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25103419|NCT03161652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25103420|NCT03161652|Antidepressive Agents|antidepressive agents|mesh-ancestor
24902897|NCT04368585|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
24902899|NCT04368585|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24902905|NCT04368585|Emollients|emollients|mesh-ancestor
24902916|NCT04368546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24902917|NCT04368546|Growth Substances|growth substances|mesh-ancestor
24902918|NCT04368546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903066|NCT04367051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24903068|NCT04367051|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24903070|NCT04367051|Natriuretic Agents|natriuretic agents|mesh-ancestor
24903071|NCT04367025|Oxaliplatin|oxaliplatin|mesh-list
24903072|NCT04367025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24903122|NCT04366960|Enoxaparin|enoxaparin|mesh-list
24903123|NCT04366960|Anticoagulants|anticoagulants|mesh-ancestor
24903124|NCT04366960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24903125|NCT04366960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24903126|NCT04366960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903127|NCT04366232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24903128|NCT04366232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24903129|NCT04366089|Azithromycin|azithromycin|mesh-list
24903130|NCT04366089|Hydroxychloroquine|hydroxychloroquine|mesh-list
24903131|NCT04366089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24903220|NCT04365309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25103422|NCT03161509|Lamotrigine|lamotrigine|mesh-list
25103423|NCT03161509|Carbamazepine|carbamazepine|mesh-list
25103424|NCT03161509|Phenytoin|phenytoin|mesh-list
25103425|NCT03161509|Valproic Acid|valproic acid|mesh-list
25103426|NCT03161509|Anticonvulsants|anticonvulsants|mesh-list
25103427|NCT03161509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25103428|NCT03161509|Analgesics|analgesics|mesh-ancestor
25702137|NCT02151487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25702138|NCT02151487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25702139|NCT02151487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25702140|NCT02151487|Protease Inhibitors|protease inhibitors|mesh-ancestor
25702141|NCT02151487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25702142|NCT02151487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702143|NCT02151487|Anesthetics, Local|anesthetics, local|mesh-ancestor
24573570|NCT00820794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573571|NCT00820794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573572|NCT00820794|Antimanic Agents|antimanic agents|mesh-ancestor
24573573|NCT00820794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25103429|NCT03161509|Sensory System Agents|sensory system agents|mesh-ancestor
25103445|NCT03161509|Antimanic Agents|antimanic agents|mesh-ancestor
25103446|NCT03161509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24781078|NCT01887847|Nicotine|nicotine|mesh-list
25103447|NCT03161509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25103448|NCT03161509|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25103449|NCT03161509|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25103450|NCT03161457|Rituximab|rituximab|mesh-list
25103451|NCT03161457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25103452|NCT03161457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25103453|NCT03161457|Immunologic Factors|immunologic factors|mesh-ancestor
24781170|NCT01888302|Immunologic Factors|immunologic factors|mesh-ancestor
25103454|NCT03161457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103455|NCT03161457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24818355|NCT02088411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24903227|NCT04365309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24903228|NCT04365309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25103468|NCT03161340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25103469|NCT03161340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25103470|NCT03161340|Antifungal Agents|antifungal agents|mesh-ancestor
25103471|NCT03161340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25103472|NCT03161340|Immunologic Factors|immunologic factors|mesh-ancestor
24781171|NCT01888302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781172|NCT01888302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25103473|NCT03161340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103475|NCT03161210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25103476|NCT03161210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903229|NCT04365309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24903230|NCT04365309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903246|NCT04365426|Contraceptives, Oral|contraceptives, oral|mesh-list
24903247|NCT04365426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24903248|NCT04365426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903249|NCT04365426|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24903251|NCT04364893|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24903252|NCT04364893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24903253|NCT04364893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903254|NCT04364893|Protease Inhibitors|protease inhibitors|mesh-ancestor
24903255|NCT04364906|Anesthetics|anesthetics|mesh-list
24903293|NCT04364945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24483961|NCT00446017|Adrenergic Agents|adrenergic agents|mesh-ancestor
24903306|NCT04364802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903307|NCT04364802|Trace Elements|trace elements|mesh-ancestor
24903308|NCT04364802|Micronutrients|micronutrients|mesh-ancestor
24903309|NCT04364802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903310|NCT04364802|Plasma Substitutes|plasma substitutes|mesh-ancestor
24903311|NCT04364802|Blood Substitutes|blood substitutes|mesh-ancestor
24903318|NCT04365036|Gemcitabine|gemcitabine|mesh-list
24903331|NCT04364516|Vitamin K|vitamin k|mesh-list
24903332|NCT04364516|Anticoagulants|anticoagulants|mesh-list
24903333|NCT04364516|Vitamins|vitamins|mesh-ancestor
24903334|NCT04364516|Micronutrients|micronutrients|mesh-ancestor
24903335|NCT04364516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903336|NCT04364516|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24903337|NCT04364516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24813380|NCT02058199|Anticoagulants|anticoagulants|mesh-ancestor
24903353|NCT04364399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903354|NCT04364451|Asparaginase|asparaginase|mesh-list
24903355|NCT04364451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24903356|NCT04364464|Riociguat|riociguat|mesh-list
24903357|NCT04364464|Enzyme Activators|enzyme activators|mesh-ancestor
24903358|NCT04364464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903359|NCT04364425|Triamcinolone|triamcinolone|mesh-list
24903360|NCT04364425|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24903361|NCT04364425|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24818349|NCT02088411|Diclofenac|diclofenac|mesh-list
24818350|NCT02088411|Wobenzym|wobenzym|mesh-list
24818351|NCT02088411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25702144|NCT02151487|Anesthetics|anesthetics|mesh-ancestor
25702145|NCT02151487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25702146|NCT02151487|Sensory System Agents|sensory system agents|mesh-ancestor
25702147|NCT02151487|Analgesics|analgesics|mesh-ancestor
25702148|NCT02151487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24818352|NCT02088411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24818353|NCT02088411|Analgesics|analgesics|mesh-ancestor
24818354|NCT02088411|Sensory System Agents|sensory system agents|mesh-ancestor
24479680|NCT00428025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24818356|NCT02088411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818357|NCT02088411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24818358|NCT02088411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25103477|NCT03161574|Fluorouracil|fluorouracil|mesh-list
25103478|NCT03161574|Oxaliplatin|oxaliplatin|mesh-list
25103480|NCT03161574|Antimetabolites|antimetabolites|mesh-ancestor
25103481|NCT03161574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103482|NCT03161574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25103513|NCT03161041|Growth Inhibitors|growth inhibitors|mesh-ancestor
25103514|NCT03161184|Sulfamethazine|sulfamethazine|mesh-list
25103515|NCT03161184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25103516|NCT03161106|Lactulose|lactulose|mesh-list
25103517|NCT03161106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25103518|NCT03160807|Levofloxacin|levofloxacin|mesh-list
25103519|NCT03160807|Ofloxacin|ofloxacin|mesh-list
25103540|NCT03160729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25103542|NCT03160729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25103543|NCT03160404|Zolpidem|zolpidem|mesh-list
25103544|NCT03160404|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25103545|NCT03160404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25103546|NCT03160404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25103547|NCT03160404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103548|NCT03160404|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25103549|NCT03160404|GABA Agonists|gaba agonists|mesh-ancestor
25103550|NCT03160404|GABA Agents|gaba agents|mesh-ancestor
25103551|NCT03160404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25103552|NCT03160404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103553|NCT03160651|Methylprednisolone|methylprednisolone|mesh-list
25103554|NCT03160651|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25103555|NCT03160651|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25103556|NCT03160651|Prednisolone|prednisolone|mesh-list
25103557|NCT03160651|Prednisolone acetate|prednisolone acetate|mesh-list
25103558|NCT03160651|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25103599|NCT03160001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25103600|NCT03160001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25103601|NCT03160001|Immunologic Factors|immunologic factors|mesh-ancestor
25103602|NCT03160001|Anticestodal Agents|anticestodal agents|mesh-ancestor
25103603|NCT03160001|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25103604|NCT03160001|Anthelmintics|anthelmintics|mesh-ancestor
25103605|NCT03160001|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25103606|NCT03160001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25103607|NCT03160001|Antinematodal Agents|antinematodal agents|mesh-ancestor
25103608|NCT03160040|Minocycline|minocycline|mesh-list
25103609|NCT03160040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25103610|NCT03160040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25103611|NCT03160261|Exenatide|exenatide|mesh-list
25103612|NCT03160261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25103613|NCT03160261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103614|NCT03160261|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25103615|NCT03160261|Incretins|incretins|mesh-ancestor
25103616|NCT03160261|Hormones|hormones|mesh-ancestor
25103617|NCT03160261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25103618|NCT03159988|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
25103665|NCT03159754|Tazobactam|tazobactam|mesh-list
25103666|NCT03159754|Piperacillin|piperacillin|mesh-list
25103667|NCT03159754|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25103668|NCT03159754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25103669|NCT03159754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25103670|NCT03159754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25103671|NCT03159754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25103672|NCT03159754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25103673|NCT03159754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25103674|NCT03159754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103675|NCT03159754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24818359|NCT02088411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24818360|NCT02088411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24818367|NCT02088450|Nitrendipine|nitrendipine|mesh-list
24903384|NCT04364321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25702149|NCT02151487|Sympatholytics|sympatholytics|mesh-ancestor
24903385|NCT04364321|Anticonvulsants|anticonvulsants|mesh-ancestor
24903386|NCT04364321|Antiemetics|antiemetics|mesh-ancestor
24903387|NCT04364321|Autonomic Agents|autonomic agents|mesh-ancestor
25702150|NCT02151487|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25702151|NCT02151487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25702152|NCT02151487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25702153|NCT02151487|Adrenergic Agents|adrenergic agents|mesh-ancestor
25702154|NCT02151487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25702155|NCT02151591|Varenicline|varenicline|mesh-list
24573777|NCT00822055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573796|NCT00822081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573797|NCT00822081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24573798|NCT00822081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24573799|NCT00822081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903388|NCT04364321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24903389|NCT04364321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903390|NCT04364321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24903391|NCT04364321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24903500|NCT04363203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24903502|NCT04363255|Carboplatin|carboplatin|mesh-list
24903529|NCT04363060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25103676|NCT03159754|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25103677|NCT03159754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25103679|NCT03159559|Aspirin|aspirin|mesh-list
25103680|NCT03159559|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25103681|NCT03159559|Alprostadil|alprostadil|mesh-list
25103682|NCT03159559|Clopidogrel|clopidogrel|mesh-list
25103683|NCT03159559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25103684|NCT03159559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25103685|NCT03159559|Analgesics|analgesics|mesh-ancestor
25103686|NCT03159559|Sensory System Agents|sensory system agents|mesh-ancestor
25103687|NCT03159559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25103688|NCT03159559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103689|NCT03159559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25103690|NCT03159559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25103691|NCT03159559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25103692|NCT03159559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25103693|NCT03159559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103694|NCT03159559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25103695|NCT03159559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25103696|NCT03159559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25103697|NCT03159559|Antipyretics|antipyretics|mesh-ancestor
25103698|NCT03159559|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25103699|NCT03159559|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25103700|NCT03159559|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25103701|NCT03159559|Purinergic Agents|purinergic agents|mesh-ancestor
25103732|NCT03159234|Respiratory System Agents|respiratory system agents|mesh-ancestor
25103733|NCT03159234|Mydriatics|mydriatics|mesh-ancestor
25103734|NCT03159234|Sympathomimetics|sympathomimetics|mesh-ancestor
25103735|NCT03159234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25103736|NCT03158935|Aldesleukin|aldesleukin|mesh-list
25103737|NCT03158935|Cyclophosphamide|cyclophosphamide|mesh-list
25103738|NCT03158935|Pembrolizumab|pembrolizumab|mesh-list
25103739|NCT03158935|Fludarabine|fludarabine|mesh-list
25103758|NCT03158935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25103759|NCT03158532|Nitroglycerin|nitroglycerin|mesh-list
25103760|NCT03158532|Vasodilator Agents|vasodilator agents|mesh-ancestor
25103762|NCT03158584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25103763|NCT03158584|Narcotics|narcotics|mesh-ancestor
25103764|NCT03158584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25103766|NCT03158584|Analgesics|analgesics|mesh-ancestor
25103767|NCT03158584|Sensory System Agents|sensory system agents|mesh-ancestor
25103768|NCT03158584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24781423|NCT01889498|Anticonvulsants|anticonvulsants|mesh-ancestor
25103769|NCT03158610|Capecitabine|capecitabine|mesh-list
25103770|NCT03158610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25103771|NCT03158610|Antimetabolites|antimetabolites|mesh-ancestor
25103772|NCT03158610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103773|NCT03158610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25103774|NCT03158792|Enoxaparin|enoxaparin|mesh-list
25702156|NCT02151591|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25702157|NCT02151591|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25702158|NCT02151591|Cholinergic Agents|cholinergic agents|mesh-ancestor
25702159|NCT02151591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25702160|NCT02151591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103775|NCT03158792|Enoxaparin sodium|enoxaparin sodium|mesh-list
25103776|NCT03158792|Anticoagulants|anticoagulants|mesh-ancestor
24468419|NCT00381511|Tinzaparin|tinzaparin|mesh-list
25702161|NCT02151591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009509|NCT05214157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009510|NCT05214157|Sensory System Agents|sensory system agents|mesh-ancestor
25103777|NCT03158792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25103778|NCT03158792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25103779|NCT03158792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103780|NCT03158376|Gabapentin|gabapentin|mesh-list
25103781|NCT03158376|Analgesics|analgesics|mesh-ancestor
25103782|NCT03158376|Sensory System Agents|sensory system agents|mesh-ancestor
25103783|NCT03158376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25103784|NCT03158376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103785|NCT03158376|Anticonvulsants|anticonvulsants|mesh-ancestor
25103786|NCT03158376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24903530|NCT04363060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903730|NCT04361188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24903755|NCT04361370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24903759|NCT04361370|Growth Substances|growth substances|mesh-ancestor
24903857|NCT04360785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25103841|NCT03158025|Lemborexant|lemborexant|mesh-list
25103788|NCT03158376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25103789|NCT03158376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25103790|NCT03158376|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25103791|NCT03158376|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25103792|NCT03158376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25103793|NCT03158376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103794|NCT03158376|Antimanic Agents|antimanic agents|mesh-ancestor
25103795|NCT03158142|Atropine|atropine|mesh-list
25103796|NCT03158142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25103797|NCT03158142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25103798|NCT03158142|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25103799|NCT03158142|Autonomic Agents|autonomic agents|mesh-ancestor
25103800|NCT03158142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25103801|NCT03158142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103802|NCT03158142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25103803|NCT03158142|Respiratory System Agents|respiratory system agents|mesh-ancestor
25103804|NCT03158142|Mydriatics|mydriatics|mesh-ancestor
24903972|NCT04359615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24903973|NCT04359615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24903974|NCT04359615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903975|NCT04359615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903976|NCT04359615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903977|NCT04359615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24903978|NCT04359615|Antiviral Agents|antiviral agents|mesh-ancestor
24903979|NCT04359823|Lovastatin|lovastatin|mesh-list
24903980|NCT04359823|L 647318|l 647318|mesh-list
24903981|NCT04359823|Dihydromevinolin|dihydromevinolin|mesh-list
24903982|NCT04359823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24903984|NCT04359823|Antimetabolites|antimetabolites|mesh-ancestor
24904105|NCT04358614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24904107|NCT04358796|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24904108|NCT04358627|Dexmedetomidine|dexmedetomidine|mesh-list
24818474|NCT02088983|Antimetabolites|antimetabolites|mesh-ancestor
24818475|NCT02088983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818476|NCT02088983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24818477|NCT02088983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25103831|NCT03158246|Vitamin D|vitamin d|mesh-list
25103832|NCT03158246|Zoledronic Acid|zoledronic acid|mesh-list
25103833|NCT03158246|Calcium|calcium|mesh-list
25103836|NCT03158246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702163|NCT02151643|Trace Elements|trace elements|mesh-ancestor
25702164|NCT02151643|Micronutrients|micronutrients|mesh-ancestor
25702165|NCT02151643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702166|NCT02151682|Morphine|morphine|mesh-list
25702167|NCT02151682|Tapentadol|tapentadol|mesh-list
25103837|NCT03158246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25702168|NCT02151682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25702169|NCT02151682|Narcotics|narcotics|mesh-ancestor
24574282|NCT00824811|Lubricant Eye Drops|lubricant eye drops|mesh-list
25103838|NCT03158246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25103839|NCT03158025|Zolpidem|zolpidem|mesh-list
25103840|NCT03158025|Suvorexant|suvorexant|mesh-list
24818478|NCT02088983|Nootropic Agents|nootropic agents|mesh-ancestor
24818480|NCT02089048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24818481|NCT02089061|Atorvastatin|atorvastatin|mesh-list
24818482|NCT02089061|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24818483|NCT02089061|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24818484|NCT02089061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24818485|NCT02089061|Antimetabolites|antimetabolites|mesh-ancestor
24818486|NCT02089061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818487|NCT02089061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24818488|NCT02089061|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24818490|NCT02089126|Glimepiride|glimepiride|mesh-list
24904684|NCT04354376|Telmisartan|telmisartan|mesh-list
24904685|NCT04354376|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
24904686|NCT04354376|Diuretics|diuretics|mesh-list
24904687|NCT04354376|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
24904708|NCT04353505|Dexamethasone|dexamethasone|mesh-list
24904709|NCT04353505|Ketorolac|ketorolac|mesh-list
24904710|NCT04353505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24904711|NCT04353505|Antiemetics|antiemetics|mesh-ancestor
24904712|NCT04353505|Autonomic Agents|autonomic agents|mesh-ancestor
24904713|NCT04353505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24904714|NCT04353505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904715|NCT04353505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24904716|NCT04353505|Glucocorticoids|glucocorticoids|mesh-ancestor
24904717|NCT04353505|Hormones|hormones|mesh-ancestor
24904855|NCT04352400|Nafamostat|nafamostat|mesh-list
24904856|NCT04352400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24904857|NCT04352400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24904858|NCT04352400|Analgesics|analgesics|mesh-ancestor
24519391|NCT01724866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468561|NCT00382213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24468562|NCT00382213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24468563|NCT00382213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24468564|NCT00382213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468566|NCT00382239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24468567|NCT00382239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468568|NCT00382239|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24468569|NCT00382239|Incretins|incretins|mesh-ancestor
24468570|NCT00382239|Hormones|hormones|mesh-ancestor
24468572|NCT00382330|Ciclopirox|ciclopirox|mesh-list
24519392|NCT01724866|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24519393|NCT01724866|Tubulin Modulators|tubulin modulators|mesh-ancestor
24904957|NCT04352062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25103843|NCT03158025|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25103844|NCT03158025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25103845|NCT03158025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103846|NCT03158025|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25103847|NCT03158025|GABA Agonists|gaba agonists|mesh-ancestor
25103848|NCT03158025|GABA Agents|gaba agents|mesh-ancestor
25103849|NCT03158025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25103850|NCT03158025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861440|NCT02317770|Anesthetics, Local|anesthetics, local|mesh-ancestor
25103851|NCT03158025|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25103852|NCT03157843|Heparin|heparin|mesh-list
25103853|NCT03157843|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25103854|NCT03157843|Tinzaparin|tinzaparin|mesh-list
25103855|NCT03157843|Dalteparin|dalteparin|mesh-list
25103856|NCT03157843|Anticoagulants|anticoagulants|mesh-ancestor
25103857|NCT03157843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25103858|NCT03157843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25103859|NCT03157843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103860|NCT03157804|Plerixafor|plerixafor|mesh-list
25103861|NCT03157804|Lenograstim|lenograstim|mesh-list
25103862|NCT03157804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25702170|NCT02151682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25702171|NCT02151682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103863|NCT03157804|Immunologic Factors|immunologic factors|mesh-ancestor
25103865|NCT03157804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25702172|NCT02151682|Analgesics|analgesics|mesh-ancestor
25009535|NCT05213676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009536|NCT05213676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25103866|NCT03157804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25103867|NCT03157804|Antiviral Agents|antiviral agents|mesh-ancestor
25103868|NCT03157804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25103869|NCT03157791|Simethicone|simethicone|mesh-list
24528690|NCT00622349|Gemcitabine|gemcitabine|mesh-list
25103890|NCT03157310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25103891|NCT03157310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103892|NCT03157414|Empagliflozin|empagliflozin|mesh-list
25103893|NCT03157414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24969726|NCT03740399|Anesthetics|anesthetics|mesh-list
24904958|NCT04352062|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24904959|NCT04352062|Renal Agents|renal agents|mesh-ancestor
24905087|NCT04350645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905089|NCT04350645|Coagulants|coagulants|mesh-ancestor
24905091|NCT04350320|Gout Suppressants|gout suppressants|mesh-ancestor
24905092|NCT04350320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24468612|NCT00382421|Analgesics|analgesics|mesh-ancestor
24468613|NCT00382421|Sensory System Agents|sensory system agents|mesh-ancestor
24468614|NCT00382421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24468615|NCT00382421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24468616|NCT00382421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24468617|NCT00382421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24905096|NCT04350320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905097|NCT04350320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905098|NCT04350528|Pentobarbital|pentobarbital|mesh-list
25103894|NCT03157414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103895|NCT03157414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25103896|NCT03157414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103897|NCT03157193|Hyaluronic Acid|hyaluronic acid|mesh-list
25103898|NCT03157193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25103899|NCT03157193|Immunologic Factors|immunologic factors|mesh-ancestor
25103900|NCT03157193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732751|NCT01641289|Analgesics|analgesics|mesh-ancestor
25103901|NCT03157193|Viscosupplements|viscosupplements|mesh-ancestor
25103902|NCT03157193|Protective Agents|protective agents|mesh-ancestor
25103904|NCT03157388|Gentamicins|gentamicins|mesh-list
25103906|NCT03157388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25103907|NCT03157388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25103908|NCT03157388|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25103909|NCT03157388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25103910|NCT03157388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103911|NCT03156855|Bismuth|bismuth|mesh-list
25103912|NCT03156855|Antacids|antacids|mesh-ancestor
25103913|NCT03156855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103914|NCT03156855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25103915|NCT03156920|Sumatriptan|sumatriptan|mesh-list
25103916|NCT03156920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25103917|NCT03156920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25103918|NCT03156920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25103919|NCT03156920|Serotonin Agents|serotonin agents|mesh-ancestor
25103920|NCT03156920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25103921|NCT03156920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103936|NCT03156842|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25103938|NCT03156907|Buprenorphine|buprenorphine|mesh-list
25103939|NCT03156907|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25103940|NCT03156907|Narcotics|narcotics|mesh-ancestor
25103941|NCT03156907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25103942|NCT03156907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103948|NCT03156829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25103949|NCT03156829|Glucocorticoids|glucocorticoids|mesh-ancestor
25103950|NCT03156829|Hormones|hormones|mesh-ancestor
25103951|NCT03156829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25103952|NCT03156829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103953|NCT03156829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25103954|NCT03156829|Respiratory System Agents|respiratory system agents|mesh-ancestor
25103955|NCT03156439|Huperzine A|huperzine a|mesh-list
25103956|NCT03156439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25103957|NCT03156439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25702173|NCT02151682|Sensory System Agents|sensory system agents|mesh-ancestor
25702174|NCT02151682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25103958|NCT03156439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103959|NCT03156439|Cholinergic Agents|cholinergic agents|mesh-ancestor
25103968|NCT03156452|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25103969|NCT03156452|Antitubercular Agents|antitubercular agents|mesh-ancestor
25103970|NCT03156452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25103971|NCT03156452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25103972|NCT03156452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25103973|NCT03156452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905099|NCT04350528|Chlorpromazine|chlorpromazine|mesh-list
24905100|NCT04350528|Antiemetics|antiemetics|mesh-ancestor
24905101|NCT04350528|Autonomic Agents|autonomic agents|mesh-ancestor
24905102|NCT04350528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24905103|NCT04350528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905104|NCT04350528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24905105|NCT04350528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24905106|NCT04350528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24905107|NCT04350528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24905108|NCT04350528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24818593|NCT02089529|Sensory System Agents|sensory system agents|mesh-ancestor
24818625|NCT02089854|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24818626|NCT02089854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24906062|NCT04343235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25103974|NCT03156452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24468717|NCT00382954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25103975|NCT03156452|Glucocorticoids|glucocorticoids|mesh-ancestor
25103976|NCT03156452|Hormones|hormones|mesh-ancestor
25103977|NCT03156452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25103978|NCT03156452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104013|NCT03156322|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25104014|NCT03156322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25104015|NCT03156322|Anesthetics, General|anesthetics, general|mesh-ancestor
25104016|NCT03156088|Neurotransmitter Agents|neurotransmitter agents|mesh-list
25104017|NCT03156088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104018|NCT03156088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104021|NCT03156036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25104022|NCT03156036|Antimetabolites|antimetabolites|mesh-ancestor
24732958|NCT01642667|Saruplase|saruplase|mesh-list
25104023|NCT03156036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104024|NCT03156036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25104025|NCT03156036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25104026|NCT03156036|Alkylating Agents|alkylating agents|mesh-ancestor
25104028|NCT03156179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25104029|NCT03156179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104030|NCT03156153|Bumetanide|bumetanide|mesh-list
25104031|NCT03156153|Diuretics|diuretics|mesh-ancestor
25104032|NCT03156153|Natriuretic Agents|natriuretic agents|mesh-ancestor
25104033|NCT03156153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104034|NCT03156153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24906063|NCT04343235|Sympathomimetics|sympathomimetics|mesh-ancestor
24906064|NCT04343235|Autonomic Agents|autonomic agents|mesh-ancestor
24906065|NCT04343235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24906066|NCT04343235|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24906067|NCT04343235|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24906069|NCT04343144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24906071|NCT04343144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24906205|NCT04341870|Azithromycin|azithromycin|mesh-list
24906206|NCT04341870|Hydroxychloroquine|hydroxychloroquine|mesh-list
24906207|NCT04341870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24906208|NCT04341870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24906209|NCT04341870|Antimalarials|antimalarials|mesh-ancestor
24906210|NCT04341870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24906211|NCT04341870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24906212|NCT04341870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906213|NCT04341870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906214|NCT04341870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24906215|NCT04341935|Linagliptin|linagliptin|mesh-list
24468743|NCT00383045|Naltrexone|naltrexone|mesh-list
24906216|NCT04341935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25104035|NCT03156153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25104036|NCT03156153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104037|NCT03156062|Salicylic Acid|salicylic acid|mesh-list
25702175|NCT02151682|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25702176|NCT02151682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24574557|NCT00826163|Hormones|hormones|mesh-ancestor
25104038|NCT03156062|Salicylates|salicylates|mesh-list
25104039|NCT03156062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25104040|NCT03156062|Antifungal Agents|antifungal agents|mesh-ancestor
25104041|NCT03156062|Keratolytic Agents|keratolytic agents|mesh-ancestor
25104042|NCT03156062|Dermatologic Agents|dermatologic agents|mesh-ancestor
25104043|NCT03156062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25104044|NCT03156062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25104045|NCT03156062|Analgesics|analgesics|mesh-ancestor
25104046|NCT03156062|Sensory System Agents|sensory system agents|mesh-ancestor
25104047|NCT03156062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25104048|NCT03156062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104049|NCT03156062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25104050|NCT03156062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25104051|NCT03156062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25104052|NCT03156062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25104053|NCT03156062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104054|NCT03156231|Acetazolamide|acetazolamide|mesh-list
25104055|NCT03156231|Anticonvulsants|anticonvulsants|mesh-ancestor
24906217|NCT04341935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906218|NCT04341935|Incretins|incretins|mesh-ancestor
24906220|NCT04341935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24481880|NCT00437177|Dopamine Agonists|dopamine agonists|mesh-ancestor
24481881|NCT00437177|Dopamine Agents|dopamine agents|mesh-ancestor
24468776|NCT00383370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24468777|NCT00383370|Growth Substances|growth substances|mesh-ancestor
24468778|NCT00383370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906224|NCT04341935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906225|NCT04341831|Teicoplanin|teicoplanin|mesh-list
24906226|NCT04341831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24906227|NCT04341831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24906228|NCT04341844|Methylene Blue|methylene blue|mesh-list
24906250|NCT04341402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24906251|NCT04341402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24906252|NCT04341402|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24906253|NCT04341402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24906254|NCT04341402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24906255|NCT04341402|Hormone Antagonists|hormone antagonists|mesh-ancestor
24906256|NCT04341402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24906257|NCT04341402|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24906258|NCT04341402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24906298|NCT04341727|Hydroxychloroquine|hydroxychloroquine|mesh-list
24485060|NCT00451373|Vancomycin|vancomycin|mesh-list
24906332|NCT04341207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24906333|NCT04341207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24906335|NCT04341207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24906336|NCT04341207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24906397|NCT04341155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24906398|NCT04341155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25104056|NCT03156231|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25104057|NCT03156231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25104058|NCT03156231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781704|NCT01891487|Bimatoprost|bimatoprost|mesh-list
25104059|NCT03156231|Diuretics|diuretics|mesh-ancestor
25104060|NCT03156231|Natriuretic Agents|natriuretic agents|mesh-ancestor
25104061|NCT03156231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104062|NCT03155971|Paclitaxel|paclitaxel|mesh-list
25104063|NCT03155971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25104064|NCT03155971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25104065|NCT03155971|Tubulin Modulators|tubulin modulators|mesh-ancestor
25104066|NCT03155971|Antimitotic Agents|antimitotic agents|mesh-ancestor
25104067|NCT03155971|Mitosis Modulators|mitosis modulators|mesh-ancestor
25104068|NCT03155971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104069|NCT03155893|Moxifloxacin|moxifloxacin|mesh-list
25104070|NCT03155893|Adafosbuvir|adafosbuvir|mesh-list
25104071|NCT03155893|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25104072|NCT03155893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25104073|NCT03155893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25104074|NCT03155893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25104075|NCT03155893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25702177|NCT02151682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24574754|NCT00827307|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25104076|NCT03155893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25104077|NCT03155893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104102|NCT03155477|Micronutrients|micronutrients|mesh-ancestor
25104103|NCT03155477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25104104|NCT03155646|Clonidine|clonidine|mesh-list
25104105|NCT03155646|Dexmedetomidine|dexmedetomidine|mesh-list
25104106|NCT03155646|Levobupivacaine|levobupivacaine|mesh-list
25104107|NCT03155646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25104108|NCT03155646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25104109|NCT03155646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104110|NCT03155646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25104111|NCT03155646|Analgesics|analgesics|mesh-ancestor
25104112|NCT03155646|Sensory System Agents|sensory system agents|mesh-ancestor
25104113|NCT03155646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24906399|NCT04341155|Protease Inhibitors|protease inhibitors|mesh-ancestor
24906400|NCT04341155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25104114|NCT03155646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25104115|NCT03155646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25104116|NCT03155646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25104117|NCT03155646|Adrenergic Agents|adrenergic agents|mesh-ancestor
25104118|NCT03155646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25104119|NCT03155646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104120|NCT03155646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25104121|NCT03155646|Sympatholytics|sympatholytics|mesh-ancestor
25104122|NCT03155646|Autonomic Agents|autonomic agents|mesh-ancestor
25104123|NCT03155646|Anesthetics, Local|anesthetics, local|mesh-ancestor
25104124|NCT03155646|Anesthetics|anesthetics|mesh-ancestor
25104125|NCT03155087|Metformin|metformin|mesh-list
25104126|NCT03155087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24468950|NCT00384020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25104127|NCT03155087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104128|NCT03155204|Tiotropium Bromide|tiotropium bromide|mesh-list
25104161|NCT03155035|Tubulin Modulators|tubulin modulators|mesh-ancestor
25104162|NCT03155035|Antimitotic Agents|antimitotic agents|mesh-ancestor
25104163|NCT03155035|Mitosis Modulators|mitosis modulators|mesh-ancestor
25104164|NCT03155035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104165|NCT03155035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25104166|NCT03154814|Urinastatin|urinastatin|mesh-list
25104167|NCT03154814|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25104168|NCT03154814|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25104169|NCT03154814|Protease Inhibitors|protease inhibitors|mesh-ancestor
24526349|NCT00611286|Clopidogrel|clopidogrel|mesh-list
25104201|NCT03154918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25104202|NCT03154918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25104203|NCT03154918|Alkylating Agents|alkylating agents|mesh-ancestor
25104205|NCT03154983|Apatinib|apatinib|mesh-list
25104206|NCT03154983|Tegafur|tegafur|mesh-list
25104207|NCT03154983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25104208|NCT03154983|Tubulin Modulators|tubulin modulators|mesh-ancestor
25104209|NCT03154983|Antimitotic Agents|antimitotic agents|mesh-ancestor
25104210|NCT03154983|Mitosis Modulators|mitosis modulators|mesh-ancestor
25104211|NCT03154983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906401|NCT04341155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906402|NCT04340544|Hydroxychloroquine|hydroxychloroquine|mesh-list
24906403|NCT04340544|Antimalarials|antimalarials|mesh-ancestor
24906404|NCT04340544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24906405|NCT04340544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25104212|NCT03154983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24526485|NCT00611819|Ribavirin|ribavirin|mesh-list
25104249|NCT03154385|Immunologic Factors|immunologic factors|mesh-ancestor
25104250|NCT03154385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104286|NCT03154281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25104287|NCT03154281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25104288|NCT03154281|Immunologic Factors|immunologic factors|mesh-ancestor
24541823|NCT00675493|Insulin Aspart|insulin aspart|mesh-list
25104289|NCT03154281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104290|NCT03154281|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25104291|NCT03154281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25104322|NCT03153917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25104323|NCT03153657|Piroxicam|piroxicam|mesh-list
25104324|NCT03153657|Piroxicam-beta-cyclodextrin|piroxicam-beta-cyclodextrin|mesh-list
25104325|NCT03153657|Betadex|betadex|mesh-list
25104326|NCT03153657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25104327|NCT03153657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25702178|NCT02151682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469106|NCT00384579|Botulinum Toxins|botulinum toxins|mesh-list
24469107|NCT00384579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24469108|NCT00384579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24469122|NCT00384605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24469109|NCT00384579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469110|NCT00384579|Cholinergic Agents|cholinergic agents|mesh-ancestor
24469111|NCT00384579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24469112|NCT00384579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469114|NCT00384592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25104328|NCT03153657|Analgesics|analgesics|mesh-ancestor
25104329|NCT03153657|Sensory System Agents|sensory system agents|mesh-ancestor
25104330|NCT03153657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25104331|NCT03153657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104332|NCT03153657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25104333|NCT03153657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24526712|NCT00612859|Levetiracetam|levetiracetam|mesh-list
25104347|NCT03153436|Micronutrients|micronutrients|mesh-ancestor
25104348|NCT03153436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104349|NCT03152942|Aminophylline|aminophylline|mesh-list
25104350|NCT03152942|Progesterone|progesterone|mesh-list
25104351|NCT03152942|Progestins|progestins|mesh-ancestor
25104352|NCT03152942|Hormones|hormones|mesh-ancestor
25104353|NCT03152942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24906406|NCT04340544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24906407|NCT04340544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906408|NCT04340544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906409|NCT04340544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24906411|NCT04340869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24906412|NCT04340869|Autonomic Agents|autonomic agents|mesh-ancestor
24906413|NCT04340869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24906414|NCT04340869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906415|NCT04340869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24906416|NCT04340869|Respiratory System Agents|respiratory system agents|mesh-ancestor
24906417|NCT04340869|Vasodilator Agents|vasodilator agents|mesh-ancestor
24906418|NCT04340778|Lidocaine|lidocaine|mesh-list
24906419|NCT04340778|Prilocaine|prilocaine|mesh-list
24906420|NCT04340778|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24906421|NCT04340778|Dinoprostone|dinoprostone|mesh-list
25104354|NCT03152942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104355|NCT03152942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25104356|NCT03152942|Autonomic Agents|autonomic agents|mesh-ancestor
25104357|NCT03152942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24469115|NCT00384592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25104358|NCT03152942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25104359|NCT03152942|Respiratory System Agents|respiratory system agents|mesh-ancestor
25104360|NCT03152942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25104361|NCT03152942|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25104362|NCT03152942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25104363|NCT03152942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104364|NCT03152942|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25104365|NCT03152942|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25104366|NCT03152942|Purinergic Agents|purinergic agents|mesh-ancestor
25104367|NCT03152942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25104368|NCT03152942|Protective Agents|protective agents|mesh-ancestor
25104369|NCT03153072|Amiodarone|amiodarone|mesh-list
24861904|NCT02321293|Gefitinib|gefitinib|mesh-list
25104370|NCT03153072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25104371|NCT03153072|Vasodilator Agents|vasodilator agents|mesh-ancestor
25104372|NCT03153072|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25104373|NCT03153072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25104374|NCT03153072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104375|NCT03153072|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24969941|NCT03738176|Glucocorticoids|glucocorticoids|mesh-ancestor
24906422|NCT04340778|Anesthetics, Local|anesthetics, local|mesh-ancestor
24906423|NCT04340778|Anesthetics|anesthetics|mesh-ancestor
24906424|NCT04340778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24906425|NCT04340778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906426|NCT04340778|Sensory System Agents|sensory system agents|mesh-ancestor
24906427|NCT04340778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24906477|NCT04340388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24906479|NCT04340388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906480|NCT04340388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24906481|NCT04340388|Antimetabolites|antimetabolites|mesh-ancestor
24906537|NCT04339361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24906580|NCT04339348|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24906581|NCT04338633|Calcium, Dietary|calcium, dietary|mesh-list
25702180|NCT02151682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25702181|NCT02151773|Vaccines|vaccines|mesh-list
25009589|NCT05212337|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24906582|NCT04338633|Calcium|calcium|mesh-list
24469120|NCT00384605|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24469195|NCT00384878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469196|NCT00384878|Antimetabolites|antimetabolites|mesh-ancestor
24469308|NCT00385411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469309|NCT00385411|Antimanic Agents|antimanic agents|mesh-ancestor
24469310|NCT00385411|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24906583|NCT04338633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24906584|NCT04338633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906585|NCT04338633|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24906586|NCT04338711|Tofacitinib|tofacitinib|mesh-list
24906587|NCT04338711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24906588|NCT04338711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906589|NCT04338711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818698|NCT02090322|Growth Substances|growth substances|mesh-ancestor
24818699|NCT02090322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818700|NCT02090322|Growth Inhibitors|growth inhibitors|mesh-ancestor
24818701|NCT02090348|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25104376|NCT03153072|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25104377|NCT03153072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25104378|NCT03153072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25104379|NCT03153072|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25104380|NCT03153072|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25104381|NCT03153072|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25104383|NCT03152981|Propofol|propofol|mesh-list
25104384|NCT03152981|Desflurane|desflurane|mesh-list
25104385|NCT03152981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25104386|NCT03152981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25104387|NCT03152981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104388|NCT03152981|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25104389|NCT03152981|Anesthetics, General|anesthetics, general|mesh-ancestor
25104390|NCT03152981|Anesthetics|anesthetics|mesh-ancestor
25104391|NCT03152981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25104392|NCT03152981|Narcotics|narcotics|mesh-ancestor
25104393|NCT03152981|Analgesics|analgesics|mesh-ancestor
25104394|NCT03152981|Sensory System Agents|sensory system agents|mesh-ancestor
25104395|NCT03152981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25104425|NCT03152955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25104426|NCT03152955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104427|NCT03152955|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25104428|NCT03152955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25104429|NCT03152955|Anesthetics, General|anesthetics, general|mesh-ancestor
25104430|NCT03152955|Anesthetics|anesthetics|mesh-ancestor
24906606|NCT04338906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24906607|NCT04338906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906608|NCT04338906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906609|NCT04338906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24906610|NCT04338906|Protease Inhibitors|protease inhibitors|mesh-ancestor
24906611|NCT04338906|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24906612|NCT04338906|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24906613|NCT04338802|Nintedanib|nintedanib|mesh-list
24906614|NCT04338802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24906615|NCT04338802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24906616|NCT04338802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906617|NCT04338802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906618|NCT04338919|Aspirin|aspirin|mesh-list
24906619|NCT04338919|Ticagrelor|ticagrelor|mesh-list
24519508|NCT05333159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482502|NCT00439283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24907152|NCT04332276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907153|NCT04332276|Dopamine Agents|dopamine agents|mesh-ancestor
24907154|NCT04332276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24436468|NCT00270049|Epoetin Alfa|epoetin alfa|mesh-list
24907622|NCT04329091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25104431|NCT03152955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25702182|NCT02151773|Immunologic Factors|immunologic factors|mesh-ancestor
25702183|NCT02151773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702184|NCT02151786|Lansoprazole|lansoprazole|mesh-list
25702185|NCT02151786|Dexlansoprazole|dexlansoprazole|mesh-list
25104432|NCT03152955|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25104434|NCT03152955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25104435|NCT03152955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104436|NCT03152955|Antiemetics|antiemetics|mesh-ancestor
25104437|NCT03152955|Autonomic Agents|autonomic agents|mesh-ancestor
25104468|NCT03152877|Anesthetics|anesthetics|mesh-ancestor
25104469|NCT03152877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25104470|NCT03152877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104471|NCT03152877|Sensory System Agents|sensory system agents|mesh-ancestor
25104472|NCT03152877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25104474|NCT03152370|Folic Acid|folic acid|mesh-list
25104475|NCT03152370|Capecitabine|capecitabine|mesh-list
25104476|NCT03152370|Oxaliplatin|oxaliplatin|mesh-list
25104477|NCT03152370|Levoleucovorin|levoleucovorin|mesh-list
25104478|NCT03152370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25104479|NCT03152370|Antimetabolites|antimetabolites|mesh-ancestor
25104480|NCT03152370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782135|NCT01894334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25104481|NCT03152370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24782136|NCT01894334|Protective Agents|protective agents|mesh-ancestor
24782138|NCT01894334|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25104482|NCT03152370|Antidotes|antidotes|mesh-ancestor
25104483|NCT03152370|Protective Agents|protective agents|mesh-ancestor
25104506|NCT03152409|Antipyretics|antipyretics|mesh-ancestor
24907623|NCT04329091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907625|NCT04329091|Analgesics|analgesics|mesh-ancestor
24907626|NCT04329091|Sensory System Agents|sensory system agents|mesh-ancestor
24907627|NCT04329091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24907628|NCT04329091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24907629|NCT04329091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24907630|NCT04329091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24907643|NCT04328805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24907644|NCT04328805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907645|NCT04328805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24907646|NCT04328805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24907647|NCT04328805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24907648|NCT04328805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907649|NCT04328805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907650|NCT04329000|Esomeprazole|esomeprazole|mesh-list
24907651|NCT04329000|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24907652|NCT04329000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24907806|NCT04327427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24907807|NCT04327427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907808|NCT04327427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25104507|NCT03152409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25104508|NCT03152409|Antifungal Agents|antifungal agents|mesh-ancestor
25104509|NCT03152409|Keratolytic Agents|keratolytic agents|mesh-ancestor
25104510|NCT03152409|Dermatologic Agents|dermatologic agents|mesh-ancestor
25104511|NCT03152474|Vitamin A|vitamin a|mesh-list
25104512|NCT03152474|Methylprednisolone|methylprednisolone|mesh-list
25104513|NCT03152474|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25104514|NCT03152474|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25104515|NCT03152474|Prednisolone|prednisolone|mesh-list
25104516|NCT03152474|Prednisolone acetate|prednisolone acetate|mesh-list
25104517|NCT03152474|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25104518|NCT03152474|Prednisolone phosphate|prednisolone phosphate|mesh-list
25104519|NCT03152474|Vitamins|vitamins|mesh-ancestor
25104520|NCT03152474|Micronutrients|micronutrients|mesh-ancestor
25104521|NCT03152474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104522|NCT03152474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25104523|NCT03152474|Antiemetics|antiemetics|mesh-ancestor
25104524|NCT03152474|Autonomic Agents|autonomic agents|mesh-ancestor
25104525|NCT03152474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25104526|NCT03152474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25104527|NCT03152474|Glucocorticoids|glucocorticoids|mesh-ancestor
25104528|NCT03152474|Hormones|hormones|mesh-ancestor
25104529|NCT03152474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25104530|NCT03152474|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25104531|NCT03152474|Protective Agents|protective agents|mesh-ancestor
25104532|NCT03152474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24908258|NCT04322175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24908259|NCT04322175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908260|NCT04322175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24908261|NCT04322175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24908685|NCT04317872|Protease Inhibitors|protease inhibitors|mesh-ancestor
24908687|NCT04317872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908689|NCT04317703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24908690|NCT04317703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908691|NCT04317508|Benzocaine|benzocaine|mesh-list
24908692|NCT04317508|Anesthetics, Local|anesthetics, local|mesh-ancestor
24908693|NCT04317508|Anesthetics|anesthetics|mesh-ancestor
24908694|NCT04317508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24527093|NCT00614965|Irinotecan|irinotecan|mesh-list
25104571|NCT03152149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25104572|NCT03152149|Parasympatholytics|parasympatholytics|mesh-ancestor
25104573|NCT03152149|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25104574|NCT03152149|Cholinergic Agents|cholinergic agents|mesh-ancestor
25104575|NCT03152149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25104576|NCT03152149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527278|NCT00615797|Antiemetics|antiemetics|mesh-ancestor
25104642|NCT03151720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104643|NCT03151681|Propranolol|propranolol|mesh-list
25104644|NCT03151681|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25104645|NCT03151681|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25104646|NCT03151681|Adrenergic Agents|adrenergic agents|mesh-ancestor
25104647|NCT03151681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25104648|NCT03151681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908695|NCT04317508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908696|NCT04317508|Sensory System Agents|sensory system agents|mesh-ancestor
24908697|NCT04317508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24908698|NCT04317235|Ropivacaine|ropivacaine|mesh-list
24469854|NCT00387556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24908699|NCT04317235|Anesthetics, Local|anesthetics, local|mesh-ancestor
24908731|NCT04316936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24908732|NCT04316936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24908733|NCT04316936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908734|NCT04316936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24908735|NCT04316936|Protective Agents|protective agents|mesh-ancestor
24908737|NCT04317157|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24908738|NCT04317157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908739|NCT04317157|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24908740|NCT04317157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908741|NCT04317157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908743|NCT04317157|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24908800|NCT04315974|Rivaroxaban|rivaroxaban|mesh-list
24908801|NCT04315974|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24908802|NCT04315974|Antithrombins|antithrombins|mesh-ancestor
24908803|NCT04315974|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24908804|NCT04315974|Protease Inhibitors|protease inhibitors|mesh-ancestor
24908805|NCT04315974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908806|NCT04315974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908807|NCT04315974|Anticoagulants|anticoagulants|mesh-ancestor
24909115|NCT04312698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909116|NCT04312698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24909117|NCT04312347|Tamoxifen|tamoxifen|mesh-list
24909118|NCT04312347|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24909119|NCT04312347|Hormone Antagonists|hormone antagonists|mesh-ancestor
24909120|NCT04312347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25104650|NCT03151681|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25104651|NCT03151681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25104653|NCT03151668|Dexmedetomidine|dexmedetomidine|mesh-list
25104654|NCT03151668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25104679|NCT03151499|Rifampin|rifampin|mesh-list
25104680|NCT03151499|BI 409306|bi 409306|mesh-list
25104681|NCT03151499|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25104682|NCT03151499|Antitubercular Agents|antitubercular agents|mesh-ancestor
25104683|NCT03151499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25104684|NCT03151499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25104685|NCT03151499|Leprostatic Agents|leprostatic agents|mesh-ancestor
25104686|NCT03151499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25104687|NCT03151499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25104688|NCT03151499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104689|NCT03151499|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25104690|NCT03151499|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25104691|NCT03151499|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24469857|NCT00387569|Vaccines|vaccines|mesh-list
25104692|NCT03151499|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25104693|NCT03151499|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24969956|NCT03738137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24909282|NCT04310579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24909283|NCT04310579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24909284|NCT04310579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909285|NCT04310579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24909286|NCT04310579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24909287|NCT04310579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24909288|NCT04310579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24909289|NCT04310579|Anesthetics, General|anesthetics, general|mesh-ancestor
24909290|NCT04310579|Anesthetics|anesthetics|mesh-ancestor
24909291|NCT04310579|GABA Modulators|gaba modulators|mesh-ancestor
24909292|NCT04310579|GABA Agents|gaba agents|mesh-ancestor
24909296|NCT04310579|Narcotics|narcotics|mesh-ancestor
24909352|NCT04310176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24909353|NCT04310176|Immunologic Factors|immunologic factors|mesh-ancestor
24909354|NCT04310176|Anticonvulsants|anticonvulsants|mesh-ancestor
24909355|NCT04310176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24818896|NCT02091505|Growth Substances|growth substances|mesh-ancestor
24818897|NCT02091505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818898|NCT02091505|Growth Inhibitors|growth inhibitors|mesh-ancestor
24818899|NCT02091505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24818901|NCT02091674|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24519591|NCT05332314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24519592|NCT05332314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519594|NCT05332106|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24519595|NCT05332106|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24519596|NCT05332106|Estradiol|estradiol|mesh-list
24519597|NCT05332106|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24519598|NCT05332106|Nandrolone|nandrolone|mesh-list
24909621|NCT04306731|Renal Agents|renal agents|mesh-ancestor
25104694|NCT03151499|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25104695|NCT03151499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25104696|NCT03151616|Cholinergic Antagonists|cholinergic antagonists|mesh-list
25104697|NCT03151616|Cholinergic Agents|cholinergic agents|mesh-ancestor
25104698|NCT03151616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25104699|NCT03151616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104700|NCT03151616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104728|NCT03151369|Analgesics|analgesics|mesh-list
25104729|NCT03151369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25104730|NCT03151369|Narcotics|narcotics|mesh-ancestor
25104731|NCT03151369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25104732|NCT03151369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104733|NCT03151369|Sensory System Agents|sensory system agents|mesh-ancestor
25104737|NCT03151213|Sensory System Agents|sensory system agents|mesh-ancestor
25104738|NCT03151213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25104739|NCT03151213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104740|NCT03151213|Anticonvulsants|anticonvulsants|mesh-ancestor
25104741|NCT03151213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25104742|NCT03151213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25104743|NCT03151213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104744|NCT03151213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25104745|NCT03151213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25104746|NCT03151213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25104747|NCT03151213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25104815|NCT03151239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104816|NCT03150680|Clopidogrel|clopidogrel|mesh-list
25104817|NCT03150680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25104818|NCT03150680|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25104819|NCT03150680|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25104820|NCT03150680|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25104821|NCT03150680|Purinergic Agents|purinergic agents|mesh-ancestor
25104822|NCT03150680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25104823|NCT03150680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104824|NCT03150680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104826|NCT03150706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25104827|NCT03150706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25104828|NCT03150771|Aripiprazole|aripiprazole|mesh-list
25104860|NCT03150667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25104861|NCT03150667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25104862|NCT03150667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24575556|NCT00832364|Dermatologic Agents|dermatologic agents|mesh-ancestor
25104864|NCT03150667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25104865|NCT03150667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104866|NCT03150667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104867|NCT03150888|Antihypertensive Agents|antihypertensive agents|mesh-list
25104868|NCT03150836|Durvalumab|durvalumab|mesh-list
25104869|NCT03150836|Tremelimumab|tremelimumab|mesh-list
25104899|NCT03150459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25104900|NCT03150459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25104901|NCT03150459|Antimetabolites|antimetabolites|mesh-ancestor
25104902|NCT03150459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104903|NCT03150459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25104904|NCT03150459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25104905|NCT03150459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25104906|NCT03150459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25104907|NCT03150459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25104908|NCT03150459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25104910|NCT03150524|Nimodipine|nimodipine|mesh-list
24909622|NCT04306731|Antimalarials|antimalarials|mesh-ancestor
24970049|NCT03737201|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24970050|NCT03737201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24970051|NCT03737201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25083077|NCT03318211|Tocolytic Agents|tocolytic agents|mesh-ancestor
24970084|NCT03736369|Esomeprazole|esomeprazole|mesh-list
24970085|NCT03736369|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24970086|NCT03736369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24970087|NCT03736369|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24970088|NCT03736369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24970089|NCT03736369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970090|NCT03736330|Pembrolizumab|pembrolizumab|mesh-list
24970091|NCT03736330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24970092|NCT03736330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24862216|NCT02323607|Decitabine|decitabine|mesh-list
24862217|NCT02323607|Daunorubicin|daunorubicin|mesh-list
24862218|NCT02323607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24451587|NCT00324363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24970093|NCT03736187|Metronidazole|metronidazole|mesh-list
24970094|NCT03736187|Cephalexin|cephalexin|mesh-list
24970095|NCT03736187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24470203|NCT00389129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24928523|NCT04121091|Antioxidants|antioxidants|mesh-ancestor
25104911|NCT03150524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25104912|NCT03150524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25104913|NCT03150524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24527977|NCT00619021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25104942|NCT03149939|Febuxostat|febuxostat|mesh-list
24998384|NCT02960646|Cyclophosphamide|cyclophosphamide|mesh-list
24998385|NCT02960646|Melphalan|melphalan|mesh-list
24998386|NCT02960646|Mechlorethamine|mechlorethamine|mesh-list
25104972|NCT03149432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25104973|NCT03149432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25104974|NCT03149432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25104975|NCT03149432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25104976|NCT03149432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25104977|NCT03149432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25104978|NCT03149432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104979|NCT03149432|Antimanic Agents|antimanic agents|mesh-ancestor
25104980|NCT03149419|Paroxetine|paroxetine|mesh-list
25104981|NCT03149419|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25104982|NCT03149419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25104983|NCT03149419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25104984|NCT03149419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104985|NCT03149419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25104986|NCT03149419|Serotonin Agents|serotonin agents|mesh-ancestor
25104987|NCT03149419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104988|NCT03149419|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25104989|NCT03149419|Antidepressive Agents|antidepressive agents|mesh-ancestor
25104990|NCT03149419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25104991|NCT03149419|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24970096|NCT03736187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24909623|NCT04306731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24909624|NCT04306731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24909625|NCT04306731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24909626|NCT04306731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24909627|NCT04306731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909628|NCT04306731|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24909629|NCT04306731|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25702186|NCT02151786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24575690|NCT00833339|Hormone Antagonists|hormone antagonists|mesh-ancestor
24484346|NCT00447915|Vitamin D|vitamin d|mesh-list
24909843|NCT04304157|Analgesics|analgesics|mesh-ancestor
24909844|NCT04304157|Sensory System Agents|sensory system agents|mesh-ancestor
24909845|NCT04304157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24909847|NCT04304157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24909848|NCT04304157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24909849|NCT04304157|Adrenergic Agents|adrenergic agents|mesh-ancestor
24909850|NCT04304157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24909851|NCT04304157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909852|NCT04304352|Cyclophosphamide|cyclophosphamide|mesh-list
24909853|NCT04304352|Capecitabine|capecitabine|mesh-list
24909854|NCT04304352|Vinorelbine|vinorelbine|mesh-list
24909855|NCT04304352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24909856|NCT04304352|Immunologic Factors|immunologic factors|mesh-ancestor
24909857|NCT04304352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909858|NCT04304352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25104992|NCT03149419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25104993|NCT03149419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25104994|NCT03149588|Propofol|propofol|mesh-list
25104995|NCT03149588|Sevoflurane|sevoflurane|mesh-list
25104996|NCT03149588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25104997|NCT03149588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25104998|NCT03149588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104999|NCT03149588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25105000|NCT03149588|Anesthetics, General|anesthetics, general|mesh-ancestor
25105023|NCT03149575|Alkylating Agents|alkylating agents|mesh-ancestor
25105024|NCT03149575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105025|NCT03149445|Metoprolol|metoprolol|mesh-list
25105026|NCT03149445|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25105027|NCT03149445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25105028|NCT03149445|Sympatholytics|sympatholytics|mesh-ancestor
25105029|NCT03149445|Autonomic Agents|autonomic agents|mesh-ancestor
25105030|NCT03149445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25105031|NCT03149445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105032|NCT03149445|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25105033|NCT03149445|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25105034|NCT03149445|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25105035|NCT03149445|Adrenergic Agents|adrenergic agents|mesh-ancestor
25105036|NCT03149445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25105037|NCT03149445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105038|NCT03149393|Mosapride|mosapride|mesh-list
25105039|NCT03149393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105040|NCT03149393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25105041|NCT03149393|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24782775|NCT01898039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24782776|NCT01898039|Alkylating Agents|alkylating agents|mesh-ancestor
25105068|NCT03148717|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25105069|NCT03148717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25105070|NCT03148717|Oxytocics|oxytocics|mesh-ancestor
25105071|NCT03148704|Palonosetron|palonosetron|mesh-list
25105072|NCT03148704|Antiemetics|antiemetics|mesh-ancestor
24909859|NCT04304352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24909860|NCT04304352|Alkylating Agents|alkylating agents|mesh-ancestor
25105073|NCT03148704|Autonomic Agents|autonomic agents|mesh-ancestor
25105074|NCT03148704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25105075|NCT03148704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105076|NCT03148704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25105077|NCT03148704|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25105078|NCT03148704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25105079|NCT03148704|Serotonin Agents|serotonin agents|mesh-ancestor
25105080|NCT03148704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25105081|NCT03148704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105082|NCT03148561|Misoprostol|misoprostol|mesh-list
24806820|NCT02018263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24909861|NCT04304352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909862|NCT04304352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24909899|NCT04303741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24909900|NCT04303741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24909901|NCT04303741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909902|NCT04303806|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24909903|NCT04303806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24909904|NCT04303806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25702187|NCT02151786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24909905|NCT04303806|Antimetabolites|antimetabolites|mesh-ancestor
24909906|NCT04303806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909907|NCT04303806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24909908|NCT04303806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24909909|NCT04303806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24909911|NCT04304040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24419851|NCT00214318|Metoprolol|metoprolol|mesh-list
24484602|NCT00449410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24519654|NCT05331690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24519655|NCT05331690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519656|NCT05331690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24519657|NCT05331690|Glucocorticoids|glucocorticoids|mesh-ancestor
24519658|NCT05331690|Hormones|hormones|mesh-ancestor
24519659|NCT05331690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24519660|NCT05331690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24519661|NCT05331690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910004|NCT04303130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24910005|NCT04303130|Growth Substances|growth substances|mesh-ancestor
24910006|NCT04303130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910007|NCT04303130|Growth Inhibitors|growth inhibitors|mesh-ancestor
24910008|NCT04303130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910009|NCT04303065|Dexamethasone|dexamethasone|mesh-list
24910010|NCT04303065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24910011|NCT04303065|Antiemetics|antiemetics|mesh-ancestor
24910012|NCT04303065|Autonomic Agents|autonomic agents|mesh-ancestor
24910013|NCT04303065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24910014|NCT04303065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910015|NCT04303065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24910016|NCT04303065|Glucocorticoids|glucocorticoids|mesh-ancestor
24910017|NCT04303065|Hormones|hormones|mesh-ancestor
24910018|NCT04303065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24910019|NCT04303065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24519672|NCT05324215|Analgesics|analgesics|mesh-ancestor
24519673|NCT05324215|Sensory System Agents|sensory system agents|mesh-ancestor
24519674|NCT05324215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24519675|NCT05324215|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24519676|NCT05324215|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24519679|NCT05320991|Ketamine|ketamine|mesh-list
24818992|NCT02092428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24818993|NCT02092428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818994|NCT02092428|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
25105083|NCT03148561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25105084|NCT03148561|Abortifacient Agents|abortifacient agents|mesh-ancestor
25105085|NCT03148561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25105086|NCT03148561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105087|NCT03148561|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25105111|NCT03148509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25105112|NCT03148509|Serotonin Agents|serotonin agents|mesh-ancestor
25105113|NCT03148509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25105114|NCT03148509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105115|NCT03148509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105116|NCT03148509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25105117|NCT03148509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25105118|NCT03148509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25105119|NCT03148509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25105120|NCT03148509|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25105121|NCT03148509|Dopamine Agents|dopamine agents|mesh-ancestor
25105122|NCT03148509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25105123|NCT03148509|Antidepressive Agents|antidepressive agents|mesh-ancestor
25105124|NCT03148509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25105125|NCT03148509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25105126|NCT03148509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24484690|NCT00449553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910056|NCT04302441|Antimitotic Agents|antimitotic agents|mesh-ancestor
24910057|NCT04302441|Mitosis Modulators|mitosis modulators|mesh-ancestor
24910059|NCT04302584|Arginine Vasopressin|arginine vasopressin|mesh-list
24910061|NCT04302584|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24910062|NCT04302584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24910063|NCT04302584|Adrenergic Agents|adrenergic agents|mesh-ancestor
24910064|NCT04302584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24910065|NCT04302584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910066|NCT04302584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910067|NCT04302584|Sympathomimetics|sympathomimetics|mesh-ancestor
24910068|NCT04302584|Autonomic Agents|autonomic agents|mesh-ancestor
24910069|NCT04302584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24910070|NCT04302584|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24910071|NCT04302584|Hemostatics|hemostatics|mesh-ancestor
24910072|NCT04302584|Coagulants|coagulants|mesh-ancestor
24910073|NCT04302584|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24910091|NCT04302116|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24451638|NCT00324467|Glucocorticoids|glucocorticoids|mesh-ancestor
24451639|NCT00324467|Hormones|hormones|mesh-ancestor
24451641|NCT00324467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24910092|NCT04302116|Prednisolone phosphate|prednisolone phosphate|mesh-list
24910093|NCT04302116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24910094|NCT04302116|Glucocorticoids|glucocorticoids|mesh-ancestor
24910095|NCT04302116|Hormones|hormones|mesh-ancestor
24910096|NCT04302116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24910097|NCT04302116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910157|NCT04301492|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24910158|NCT04301492|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24910159|NCT04301492|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25105127|NCT03148509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25105128|NCT03148509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25105129|NCT03148509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25105130|NCT03148509|Dopamine Agonists|dopamine agonists|mesh-ancestor
25105131|NCT03148509|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25105132|NCT03148509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25105133|NCT03148509|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25105134|NCT03148509|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25105135|NCT03148522|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25105136|NCT03148522|Mirtazapine|mirtazapine|mesh-list
25105137|NCT03148522|Citalopram|citalopram|mesh-list
25105138|NCT03148522|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24529790|NCT00627835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25105159|NCT03148522|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25105160|NCT03148522|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25105161|NCT03148522|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25105162|NCT03148522|Adrenergic Agents|adrenergic agents|mesh-ancestor
25105163|NCT03148522|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25105164|NCT03148522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25105165|NCT03148522|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25105168|NCT03148444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25105169|NCT03148444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25105170|NCT03148132|Bevacizumab|bevacizumab|mesh-list
24910160|NCT04301492|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24910161|NCT04301661|Tenofovir|tenofovir|mesh-list
24910163|NCT04301661|Emtricitabine|emtricitabine|mesh-list
24910458|NCT04297202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485073|NCT00451412|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24485074|NCT00451412|Tinzaparin|tinzaparin|mesh-list
24485075|NCT00451412|Dalteparin|dalteparin|mesh-list
24485076|NCT00451412|Certoparin|certoparin|mesh-list
24485077|NCT00451412|Anticoagulants|anticoagulants|mesh-ancestor
24485078|NCT00451412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24485079|NCT00451412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24485080|NCT00451412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485081|NCT00451490|S 20098|s 20098|mesh-list
24485082|NCT00451490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24485083|NCT00451490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24485084|NCT00451490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910488|NCT04297072|Anticoagulants|anticoagulants|mesh-ancestor
24910489|NCT04297033|Lovastatin|lovastatin|mesh-list
25105171|NCT03148132|Ranibizumab|ranibizumab|mesh-list
25105172|NCT03148132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25105173|NCT03148132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105174|NCT03148132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25105175|NCT03148132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25105176|NCT03148132|Growth Substances|growth substances|mesh-ancestor
25105177|NCT03148132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105178|NCT03148132|Growth Inhibitors|growth inhibitors|mesh-ancestor
25105179|NCT03148314|Misoprostol|misoprostol|mesh-list
25105180|NCT03148314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25105181|NCT03148314|Abortifacient Agents|abortifacient agents|mesh-ancestor
25105182|NCT03148314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25105183|NCT03148314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470980|NCT00392886|Cyclophosphamide|cyclophosphamide|mesh-list
24470981|NCT00392886|Temozolomide|temozolomide|mesh-list
25105184|NCT03148314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24580131|NCT00860496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580132|NCT00860496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25105185|NCT03148314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25105186|NCT03148314|Oxytocics|oxytocics|mesh-ancestor
25105187|NCT03148288|Vitamin D|vitamin d|mesh-list
25105188|NCT03148288|Vitamins|vitamins|mesh-ancestor
25105213|NCT03147677|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25105214|NCT03147677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105215|NCT03147677|Vitamins|vitamins|mesh-ancestor
25105216|NCT03147677|Micronutrients|micronutrients|mesh-ancestor
25105217|NCT03147599|Mebeverine|mebeverine|mesh-list
25105218|NCT03147599|Anticonvulsants|anticonvulsants|mesh-ancestor
24485096|NCT00451594|Glucocorticoids|glucocorticoids|mesh-ancestor
24519790|NCT05091866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24519791|NCT05091866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519796|NCT05007691|Salicylic Acid|salicylic acid|mesh-list
24519797|NCT05007691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24519798|NCT05007691|Antifungal Agents|antifungal agents|mesh-ancestor
24519799|NCT05007691|Keratolytic Agents|keratolytic agents|mesh-ancestor
24519800|NCT05007691|Dermatologic Agents|dermatologic agents|mesh-ancestor
24519801|NCT04986605|Methoxsalen|methoxsalen|mesh-list
24519802|NCT04986605|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24519803|NCT04986605|Dermatologic Agents|dermatologic agents|mesh-ancestor
24910490|NCT04297033|L 647318|l 647318|mesh-list
24910491|NCT04297033|Dihydromevinolin|dihydromevinolin|mesh-list
24910492|NCT04297033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24910515|NCT04296422|Sensory System Agents|sensory system agents|mesh-ancestor
24910516|NCT04296422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24910517|NCT04296422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910518|NCT04296422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24470982|NCT00392886|Thiotepa|thiotepa|mesh-list
24470983|NCT00392886|Carboplatin|carboplatin|mesh-list
24470984|NCT00392886|Methotrexate|methotrexate|mesh-list
24470985|NCT00392886|Etoposide|etoposide|mesh-list
24470986|NCT00392886|Vincristine|vincristine|mesh-list
24910593|NCT04296175|Mitosis Modulators|mitosis modulators|mesh-ancestor
24910594|NCT04296175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910595|NCT04296175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24910596|NCT04296175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24910597|NCT04296175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25105219|NCT03147599|Parasympatholytics|parasympatholytics|mesh-ancestor
25105220|NCT03147599|Autonomic Agents|autonomic agents|mesh-ancestor
25105221|NCT03147599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25105222|NCT03147599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105223|NCT03147404|Avelumab|avelumab|mesh-list
25105224|NCT03147404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25105225|NCT03147404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105226|NCT03147183|Thymoglobulin|thymoglobulin|mesh-list
25105227|NCT03147183|Immunologic Factors|immunologic factors|mesh-ancestor
25105228|NCT03147183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105229|NCT03147183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25105230|NCT03146962|Ascorbic Acid|ascorbic acid|mesh-list
25105231|NCT03146962|Vitamins|vitamins|mesh-ancestor
25105232|NCT03146962|Micronutrients|micronutrients|mesh-ancestor
25105233|NCT03146962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105234|NCT03146962|Antioxidants|antioxidants|mesh-ancestor
25105235|NCT03146962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105236|NCT03146962|Protective Agents|protective agents|mesh-ancestor
25105237|NCT03147066|Flurbiprofen|flurbiprofen|mesh-list
25105238|NCT03147066|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
25105239|NCT03147066|Dezocine|dezocine|mesh-list
25105240|NCT03147066|Analgesics|analgesics|mesh-ancestor
25105241|NCT03147066|Sensory System Agents|sensory system agents|mesh-ancestor
25105273|NCT03147092|Autonomic Agents|autonomic agents|mesh-ancestor
25105274|NCT03147092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25105275|NCT03147092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25105276|NCT03147092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25105277|NCT03147092|Adrenergic Agents|adrenergic agents|mesh-ancestor
25105278|NCT03147092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25105279|NCT03147092|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25105280|NCT03147092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25105281|NCT03147092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24528678|NCT00622245|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25702188|NCT02151786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25702189|NCT02151786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25105304|NCT03146793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910598|NCT04296175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25010100|NCT04643405|Gemcitabine|gemcitabine|mesh-list
24580764|NCT00863460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24580765|NCT00863460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24580766|NCT00863460|Antiviral Agents|antiviral agents|mesh-ancestor
24580816|NCT00863785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580817|NCT00863785|Protective Agents|protective agents|mesh-ancestor
24580818|NCT00863785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580969|NCT00864136|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24580970|NCT00864136|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24910599|NCT04296162|Capecitabine|capecitabine|mesh-list
24910600|NCT04296162|Trastuzumab|trastuzumab|mesh-list
24910601|NCT04296162|Vinorelbine|vinorelbine|mesh-list
24910602|NCT04296162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24910603|NCT04296162|Antimetabolites|antimetabolites|mesh-ancestor
24910604|NCT04296162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910605|NCT04296162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105306|NCT03146793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105307|NCT03146793|Antitubercular Agents|antitubercular agents|mesh-ancestor
25105308|NCT03146793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25105309|NCT03146793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25105310|NCT03146793|Chelating Agents|chelating agents|mesh-ancestor
25105311|NCT03146793|Sequestering Agents|sequestering agents|mesh-ancestor
25105312|NCT03147157|Tacrolimus|tacrolimus|mesh-list
25105313|NCT03147157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25105314|NCT03147157|Immunologic Factors|immunologic factors|mesh-ancestor
25105315|NCT03147157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105316|NCT03147157|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24783058|NCT01900028|Itraconazole|itraconazole|mesh-list
24783128|NCT01900301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783129|NCT01900301|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24783131|NCT01900327|Gemcitabine|gemcitabine|mesh-list
25105317|NCT03147157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25105318|NCT03147157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105320|NCT03146871|Decitabine|decitabine|mesh-list
25105321|NCT03146871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25105322|NCT03146871|Antimetabolites|antimetabolites|mesh-ancestor
24910606|NCT04296162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24910607|NCT04296162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24910608|NCT04296162|Tubulin Modulators|tubulin modulators|mesh-ancestor
24819123|NCT02093533|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24819124|NCT02093533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24819125|NCT02093533|Immunologic Factors|immunologic factors|mesh-ancestor
24819126|NCT02093533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819127|NCT02093585|Tenofovir|tenofovir|mesh-list
24819128|NCT02093585|Abacavir|abacavir|mesh-list
25105323|NCT03146871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105324|NCT03146871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105325|NCT03146871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25105326|NCT03146650|Nivolumab|nivolumab|mesh-list
25105327|NCT03146650|Ipilimumab|ipilimumab|mesh-list
25105328|NCT03146650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25105329|NCT03146650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105354|NCT03146689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25105355|NCT03146689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910927|NCT04292418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24446858|NCT00306319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446859|NCT00306319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446860|NCT00306358|Vitamin B 12|vitamin b 12|mesh-list
24446861|NCT00306358|Hydroxocobalamin|hydroxocobalamin|mesh-list
24910928|NCT04292418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24910929|NCT04292444|Oxytocin|oxytocin|mesh-list
24910930|NCT04292444|Oxytocics|oxytocics|mesh-ancestor
24910931|NCT04292444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24471301|NCT00394407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702190|NCT02151786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702191|NCT02151851|Methotrexate|methotrexate|mesh-list
24542298|NCT00678184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24542299|NCT00678184|Antimetabolites|antimetabolites|mesh-ancestor
25702192|NCT02151851|Certolizumab Pegol|certolizumab pegol|mesh-list
25702193|NCT02151851|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25702194|NCT02151851|Abortifacient Agents|abortifacient agents|mesh-ancestor
25702195|NCT02151851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25702196|NCT02151851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702197|NCT02151851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25702198|NCT02151851|Antimetabolites|antimetabolites|mesh-ancestor
24471363|NCT00394966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24910932|NCT04292444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910934|NCT04292808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24910935|NCT04292808|Anesthetics, General|anesthetics, general|mesh-ancestor
24910936|NCT04292808|Anesthetics|anesthetics|mesh-ancestor
24910937|NCT04292808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24911040|NCT04291287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24911048|NCT04291313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24911049|NCT04291313|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24911050|NCT04291456|Minocycline|minocycline|mesh-list
24911051|NCT04291456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24911052|NCT04291456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24911053|NCT04291209|Acetylcysteine|acetylcysteine|mesh-list
24911054|NCT04291209|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24911055|NCT04291209|Antiviral Agents|antiviral agents|mesh-ancestor
24911056|NCT04291209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24911057|NCT04291209|Expectorants|expectorants|mesh-ancestor
24911058|NCT04291209|Respiratory System Agents|respiratory system agents|mesh-ancestor
24911059|NCT04291209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24911060|NCT04291209|Antioxidants|antioxidants|mesh-ancestor
24911185|NCT04290390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911186|NCT04290390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24911187|NCT04290390|Contraceptive Agents|contraceptive agents|mesh-ancestor
24911188|NCT04290390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24911189|NCT04290390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24911190|NCT04290390|Antifungal Agents|antifungal agents|mesh-ancestor
24911191|NCT04290390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24485822|NCT00455234|Diphenhydramine|diphenhydramine|mesh-list
24485823|NCT00455234|Haloperidol|haloperidol|mesh-list
24485824|NCT00455234|Haloperidol decanoate|haloperidol decanoate|mesh-list
24911193|NCT04290390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24911194|NCT04290390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24911195|NCT04290390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911196|NCT04290390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24911197|NCT04290390|Hormone Antagonists|hormone antagonists|mesh-ancestor
24911211|NCT04290390|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24911212|NCT04290195|Aflibercept|aflibercept|mesh-list
24911213|NCT04290195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24911214|NCT04290195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24911215|NCT04290195|Growth Substances|growth substances|mesh-ancestor
24911216|NCT04290195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911217|NCT04290195|Growth Inhibitors|growth inhibitors|mesh-ancestor
24487952|NCT00466063|Deferasirox|deferasirox|mesh-list
24911516|NCT04287387|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25105356|NCT03146689|Antipruritics|antipruritics|mesh-ancestor
25105357|NCT03146689|Dermatologic Agents|dermatologic agents|mesh-ancestor
25105359|NCT03146481|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25105360|NCT03146481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25105361|NCT03146481|Analgesics|analgesics|mesh-ancestor
25105362|NCT03146481|Sensory System Agents|sensory system agents|mesh-ancestor
25105363|NCT03146481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25105364|NCT03146481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783197|NCT01900587|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25105365|NCT03146481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25105366|NCT03146481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25105367|NCT03146468|Nivolumab|nivolumab|mesh-list
25105368|NCT03146468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25105369|NCT03146468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105370|NCT03146468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25105371|NCT03146468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105372|NCT03146377|Capecitabine|capecitabine|mesh-list
25105373|NCT03146377|Oxaliplatin|oxaliplatin|mesh-list
25105374|NCT03146377|Irinotecan|irinotecan|mesh-list
25105375|NCT03146377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25105376|NCT03146377|Antimetabolites|antimetabolites|mesh-ancestor
24528797|NCT00622830|Darapladib|darapladib|mesh-list
24975037|NCT04788667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975039|NCT04788667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24975040|NCT04788667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975041|NCT04788667|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
24975042|NCT04788667|Analgesics|analgesics|mesh-ancestor
24975043|NCT04788667|Sensory System Agents|sensory system agents|mesh-ancestor
25083140|NCT03317847|Hormones|hormones|mesh-ancestor
24911517|NCT04287387|Protease Inhibitors|protease inhibitors|mesh-ancestor
24582961|NCT00872716|Antidepressive Agents|antidepressive agents|mesh-ancestor
24911518|NCT04287387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24911519|NCT04287387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911520|NCT04287387|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24911521|NCT04287387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24911522|NCT04287387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24911523|NCT04287387|Immunologic Factors|immunologic factors|mesh-ancestor
24911524|NCT04287387|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24486135|NCT00456482|Glucocorticoids|glucocorticoids|mesh-ancestor
24519887|NCT04500665|Tubulin Modulators|tubulin modulators|mesh-ancestor
24911570|NCT04286503|Amebicides|amebicides|mesh-ancestor
24911571|NCT04286503|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24911572|NCT04286503|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24911573|NCT04286503|Antimalarials|antimalarials|mesh-ancestor
24975044|NCT04788667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24975045|NCT04787250|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24975046|NCT04787250|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24975047|NCT04787250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24975048|NCT04787250|Antitubercular Agents|antitubercular agents|mesh-ancestor
24975049|NCT04776499|Perphenazine|perphenazine|mesh-list
24975050|NCT04776499|Riociguat|riociguat|mesh-list
24975051|NCT04776499|Propylthiouracil|propylthiouracil|mesh-list
24975052|NCT04776499|Enzyme Activators|enzyme activators|mesh-ancestor
24975053|NCT04776499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975083|NCT04753749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24975085|NCT04753749|Sensory System Agents|sensory system agents|mesh-ancestor
24975086|NCT04753749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24975087|NCT04753749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975088|NCT04753749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24975096|NCT04753749|Antipyretics|antipyretics|mesh-ancestor
24783272|NCT01900860|Micronutrients|micronutrients|mesh-ancestor
24975124|NCT04703920|Talazoparib|talazoparib|mesh-list
24975125|NCT04703920|Belinostat|belinostat|mesh-list
24970244|NCT03735134|Colchicine|colchicine|mesh-list
24911574|NCT04286503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24911575|NCT04286503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24911577|NCT04286503|Analgesics|analgesics|mesh-ancestor
24488142|NCT00466791|Dopamine Agents|dopamine agents|mesh-ancestor
24911669|NCT04285073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911670|NCT04285268|Rituximab|rituximab|mesh-list
24911671|NCT04285268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24911718|NCT04284644|Anesthetics, General|anesthetics, general|mesh-ancestor
24911719|NCT04284644|Anesthetics|anesthetics|mesh-ancestor
24911720|NCT04284644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24911722|NCT04284722|Metformin|metformin|mesh-list
24911758|NCT04284098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24911759|NCT04284098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24911760|NCT04284098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24911761|NCT04284098|Analgesics|analgesics|mesh-ancestor
24911762|NCT04284098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24911763|NCT04284098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24911764|NCT04284098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24911765|NCT04284098|Adrenergic Agents|adrenergic agents|mesh-ancestor
24975126|NCT04703920|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24975127|NCT04703920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24975128|NCT04703920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975129|NCT04703920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24975130|NCT04703920|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24794901|NCT04222283|Emtricitabine|emtricitabine|mesh-list
24794902|NCT04222283|Antiviral Agents|antiviral agents|mesh-ancestor
24794903|NCT04222283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24794904|NCT04222283|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24794905|NCT04222283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24794906|NCT04222283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588143|NCT00901290|Contraceptive Agents|contraceptive agents|mesh-list
24794907|NCT04222283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913231|NCT04267614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24975143|NCT04698031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529248|NCT00625170|Serotonin Agents|serotonin agents|mesh-ancestor
25702199|NCT02151851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702200|NCT02151851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25702201|NCT02151851|Dermatologic Agents|dermatologic agents|mesh-ancestor
25702202|NCT02151851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25702203|NCT02151851|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25702204|NCT02151851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24975171|NCT04689347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24975172|NCT04689347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24975173|NCT04689347|Antidotes|antidotes|mesh-ancestor
24975174|NCT04689347|Protective Agents|protective agents|mesh-ancestor
24975175|NCT04689347|Vitamin B Complex|vitamin b complex|mesh-ancestor
24975176|NCT04689347|Vitamins|vitamins|mesh-ancestor
24911766|NCT04284098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24911767|NCT04284098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911876|NCT04283292|Capsaicin|capsaicin|mesh-list
24911877|NCT04283292|Antipruritics|antipruritics|mesh-ancestor
24911878|NCT04283292|Dermatologic Agents|dermatologic agents|mesh-ancestor
24911879|NCT04283292|Sensory System Agents|sensory system agents|mesh-ancestor
24911882|NCT04283526|Decitabine|decitabine|mesh-list
24911949|NCT04282941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24911950|NCT04282941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24911951|NCT04282941|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24911952|NCT04282941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24912036|NCT04281745|Cholinergic Agents|cholinergic agents|mesh-ancestor
24975181|NCT04678479|Neurosteroids|neurosteroids|mesh-ancestor
24975182|NCT04678479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24975183|NCT04678479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975184|NCT04678479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975185|NCT04678479|GABA Modulators|gaba modulators|mesh-ancestor
24975186|NCT04678479|GABA Agents|gaba agents|mesh-ancestor
24975187|NCT04672291|Poly I-C|poly i-c|mesh-list
24975188|NCT04672291|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24975189|NCT04672291|Poly ICLC|poly iclc|mesh-list
24975190|NCT04672291|Interferon Inducers|interferon inducers|mesh-ancestor
24975191|NCT04672291|Immunologic Factors|immunologic factors|mesh-ancestor
24529284|NCT00625274|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24975220|NCT04616196|Cetuximab|cetuximab|mesh-list
24975221|NCT04616196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24975222|NCT04616196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24975223|NCT04578652|Metformin|metformin|mesh-list
24975224|NCT04578652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24975225|NCT04578652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975226|NCT04570670|Dimethyl Fumarate|dimethyl fumarate|mesh-list
24975227|NCT04570670|Dermatologic Agents|dermatologic agents|mesh-ancestor
24975228|NCT04570670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24975229|NCT04570670|Immunologic Factors|immunologic factors|mesh-ancestor
24975230|NCT04570670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975231|NCT04546581|Remdesivir|remdesivir|mesh-list
24975232|NCT04546581|Immunoglobulins|immunoglobulins|mesh-list
24911955|NCT04283110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24911956|NCT04283110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24911957|NCT04283110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24911976|NCT04282746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24911978|NCT04282746|Anesthetics, General|anesthetics, general|mesh-ancestor
24911979|NCT04282746|Anesthetics|anesthetics|mesh-ancestor
24911980|NCT04282746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24911981|NCT04282746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24911982|NCT04282746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24911983|NCT04282746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24911985|NCT04282291|Morphine|morphine|mesh-list
24912027|NCT04282031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912028|NCT04282031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24912029|NCT04282031|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24912030|NCT04281745|Botulinum Toxins|botulinum toxins|mesh-list
24912031|NCT04281745|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24912032|NCT04281745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24912033|NCT04281745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24975233|NCT04546581|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24975235|NCT04546581|Immunologic Factors|immunologic factors|mesh-ancestor
24975236|NCT04546581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529440|NCT00625937|Docetaxel|docetaxel|mesh-list
25702205|NCT02151851|Immunologic Factors|immunologic factors|mesh-ancestor
25702206|NCT02151851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24975261|NCT04421378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24975270|NCT04421378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975272|NCT04410445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24975273|NCT04410445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24975274|NCT04410445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24975275|NCT04410445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975276|NCT04401384|Pyridoxine|pyridoxine|mesh-list
24529615|NCT00626990|Temozolomide|temozolomide|mesh-list
24975305|NCT04276493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24975306|NCT04276493|Antimetabolites|antimetabolites|mesh-ancestor
24975307|NCT04239222|Ibuprofen|ibuprofen|mesh-list
24975308|NCT04239222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24970327|NCT03734302|Brexpiprazole|brexpiprazole|mesh-list
24912034|NCT04281745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24912035|NCT04281745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912805|NCT04271839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24912806|NCT04271839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24912807|NCT04271839|Adrenergic Agents|adrenergic agents|mesh-ancestor
24912808|NCT04271839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24912809|NCT04271839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975309|NCT04239222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24975310|NCT04239222|Analgesics|analgesics|mesh-ancestor
24975311|NCT04239222|Sensory System Agents|sensory system agents|mesh-ancestor
24975312|NCT04239222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24975313|NCT04239222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975314|NCT04239222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24975315|NCT04239222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24975316|NCT04239222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24975317|NCT04239222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24975318|NCT04239222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975373|NCT03968822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975378|NCT03915626|Rivastigmine|rivastigmine|mesh-list
24975379|NCT03915626|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24975380|NCT03915626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24975381|NCT03915626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975382|NCT03915626|Cholinergic Agents|cholinergic agents|mesh-ancestor
24975383|NCT03915626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24975384|NCT03915626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975385|NCT03915626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24975386|NCT03915626|Protective Agents|protective agents|mesh-ancestor
24975425|NCT03729245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24975426|NCT03729245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24975427|NCT03729245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24975428|NCT03729245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975429|NCT03729245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24975430|NCT03729245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24975431|NCT03729245|Growth Substances|growth substances|mesh-ancestor
24975432|NCT03729245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975433|NCT03729245|Growth Inhibitors|growth inhibitors|mesh-ancestor
24975434|NCT03729245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24975435|NCT03729245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24975436|NCT03698279|Vaccines|vaccines|mesh-list
24975437|NCT03698279|Immunologic Factors|immunologic factors|mesh-ancestor
24975438|NCT03698279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975439|NCT03692403|Quinagolide|quinagolide|mesh-list
24794971|NCT04131504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24795010|NCT03926143|Maytansine|maytansine|mesh-list
24975450|NCT03680274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975480|NCT03593811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24975481|NCT03593811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24975507|NCT03559010|Contraceptive Agents|contraceptive agents|mesh-ancestor
24975508|NCT03559010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24975509|NCT03559010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975510|NCT03559010|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24975511|NCT03559010|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24975512|NCT03520686|Paclitaxel|paclitaxel|mesh-list
24975513|NCT03520686|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24975514|NCT03520686|Cisplatin|cisplatin|mesh-list
24975515|NCT03520686|Carboplatin|carboplatin|mesh-list
24975516|NCT03520686|Pembrolizumab|pembrolizumab|mesh-list
24975517|NCT03520686|Pemetrexed|pemetrexed|mesh-list
24975518|NCT03520686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24471728|NCT00396682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24975519|NCT03520686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783273|NCT01900860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783274|NCT01900860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24783275|NCT01900860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24783277|NCT01900886|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24783278|NCT01900886|Antimetabolites|antimetabolites|mesh-ancestor
24783279|NCT01900886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783280|NCT01900886|Antiviral Agents|antiviral agents|mesh-ancestor
24783281|NCT01900886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783282|NCT01900938|Midazolam|midazolam|mesh-list
24783283|NCT01900938|Propofol|propofol|mesh-list
24783284|NCT01900938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25083147|NCT03317847|Analgesics|analgesics|mesh-ancestor
24912976|NCT04269928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24912977|NCT04269928|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24912978|NCT04269928|Respiratory System Agents|respiratory system agents|mesh-ancestor
24912979|NCT04269928|Mydriatics|mydriatics|mesh-ancestor
24912980|NCT04269928|Sympathomimetics|sympathomimetics|mesh-ancestor
24783285|NCT01900938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25105416|NCT03146000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105417|NCT03146000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25105418|NCT03146000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25105419|NCT03146000|Analgesics|analgesics|mesh-ancestor
25105420|NCT03146000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25105421|NCT03146000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25105422|NCT03146000|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25105423|NCT03146000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25105424|NCT03146000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25105425|NCT03146000|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25105426|NCT03146325|Metronidazole|metronidazole|mesh-list
25105427|NCT03146325|Tetracycline|tetracycline|mesh-list
25105429|NCT03146325|Bismuth|bismuth|mesh-list
25105430|NCT03146325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25105431|NCT03146325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25105432|NCT03146325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25105433|NCT03146325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25105434|NCT03146325|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24783289|NCT01900938|Anesthetics|anesthetics|mesh-ancestor
24542558|NCT00679250|Cetirizine|cetirizine|mesh-list
24542559|NCT00679250|Levocetirizine|levocetirizine|mesh-list
24542560|NCT00679250|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24542561|NCT00679250|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24542562|NCT00679250|Histamine Antagonists|histamine antagonists|mesh-ancestor
24457881|NCT00335582|Clonidine|clonidine|mesh-list
24975548|NCT03476603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975549|NCT03476577|Ibuprofen|ibuprofen|mesh-list
24975550|NCT03476577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24975551|NCT03476577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24975552|NCT03476577|Analgesics|analgesics|mesh-ancestor
24975553|NCT03476577|Sensory System Agents|sensory system agents|mesh-ancestor
24975554|NCT03476577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24471729|NCT00396721|Sirolimus|sirolimus|mesh-list
24975555|NCT03476577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975556|NCT03476577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24975557|NCT03476577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24975558|NCT03476577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24975559|NCT03476577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24975561|NCT03476551|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24975567|NCT03476551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24975600|NCT03440112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24975601|NCT03440112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24975602|NCT03440112|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24975603|NCT03440112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24975604|NCT03440112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975605|NCT03440112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24975606|NCT03440112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24975608|NCT03440112|Protective Agents|protective agents|mesh-ancestor
24530293|NCT00629720|Adrenergic Agents|adrenergic agents|mesh-ancestor
24975641|NCT03425838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24975642|NCT03404960|Nivolumab|nivolumab|mesh-list
24975643|NCT03404960|Ipilimumab|ipilimumab|mesh-list
24975644|NCT03404960|Niraparib|niraparib|mesh-list
24975645|NCT03404960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24975646|NCT03404960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24975647|NCT03404960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24975648|NCT03404960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975649|NCT03404960|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24975650|NCT03404960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24912981|NCT04269928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24912982|NCT04269369|Fluorouracil|fluorouracil|mesh-list
24912983|NCT04269369|Antimetabolites|antimetabolites|mesh-ancestor
25702207|NCT02151851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25702208|NCT02151877|Nitric Oxide|nitric oxide|mesh-list
25702209|NCT02151877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25702210|NCT02151877|Autonomic Agents|autonomic agents|mesh-ancestor
24585561|NCT00886106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24912984|NCT04269369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520050|NCT03980769|Vidarabine|vidarabine|mesh-list
24913045|NCT04268888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24913046|NCT04268888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913047|NCT04268888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24913048|NCT04268927|Letrozole|letrozole|mesh-list
24913049|NCT04268927|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
24913050|NCT04268927|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24913313|NCT04266509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24913314|NCT04266509|Antitubercular Agents|antitubercular agents|mesh-ancestor
24913315|NCT04266509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24913316|NCT04266509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24913317|NCT04266509|Leprostatic Agents|leprostatic agents|mesh-ancestor
24913318|NCT04266509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24913319|NCT04266509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24913320|NCT04266509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487883|NCT00465439|Autonomic Agents|autonomic agents|mesh-ancestor
24520052|NCT03980769|Fludarabine phosphate|fludarabine phosphate|mesh-list
24520054|NCT03980769|Treosulfan|treosulfan|mesh-list
24520055|NCT03980769|Busulfan|busulfan|mesh-list
24862870|NCT04107168|Ipilimumab|ipilimumab|mesh-list
24862871|NCT04107168|Durvalumab|durvalumab|mesh-list
24862872|NCT04107168|Atezolizumab|atezolizumab|mesh-list
24862873|NCT04107168|Tremelimumab|tremelimumab|mesh-list
24542689|NCT00679705|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24520056|NCT03980769|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24913324|NCT04266509|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24975680|NCT03283670|Nitrous Oxide|nitrous oxide|mesh-list
24975681|NCT03283670|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24975682|NCT03283670|Anesthetics, General|anesthetics, general|mesh-ancestor
24975683|NCT03283670|Anesthetics|anesthetics|mesh-ancestor
24975684|NCT03283670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24975685|NCT03283670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975686|NCT03283670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24975687|NCT03283670|Analgesics|analgesics|mesh-ancestor
24975688|NCT03283670|Sensory System Agents|sensory system agents|mesh-ancestor
24913772|NCT04261036|Vitamins|vitamins|mesh-ancestor
24975689|NCT03283670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24795011|NCT03926143|Tubulin Modulators|tubulin modulators|mesh-list
24795012|NCT03926143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24795013|NCT03926143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795014|NCT03926143|Antimitotic Agents|antimitotic agents|mesh-ancestor
24795015|NCT03926143|Mitosis Modulators|mitosis modulators|mesh-ancestor
24795016|NCT03926143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795017|NCT03915405|Avelumab|avelumab|mesh-list
24795047|NCT03831113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913325|NCT04266509|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24913326|NCT04266509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24487915|NCT00465543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487916|NCT00465608|Propranolol|propranolol|mesh-list
24487917|NCT00465608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24487918|NCT00465608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24487919|NCT00465608|Adrenergic Agents|adrenergic agents|mesh-ancestor
24487920|NCT00465608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24520085|NCT03901729|Furosemide|furosemide|mesh-list
24520086|NCT03901729|Diuretics|diuretics|mesh-ancestor
24520087|NCT03901729|Natriuretic Agents|natriuretic agents|mesh-ancestor
24520088|NCT03901729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520089|NCT03901729|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24520090|NCT03901729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24520091|NCT03901729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520092|NCT03897335|Aminophylline|aminophylline|mesh-list
24913452|NCT04264026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24913453|NCT04264026|Serotonin Agents|serotonin agents|mesh-ancestor
24913454|NCT04264026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24913498|NCT04264286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24913499|NCT04264286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24913524|NCT04263844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913525|NCT04263844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24913526|NCT04263844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25702211|NCT02151877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25702212|NCT02151877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011062|NCT02184741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011100|NCT01942122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011101|NCT01942122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011102|NCT01940094|Prednisone|prednisone|mesh-list
25011103|NCT01940094|Glucocorticoids|glucocorticoids|mesh-list
25011104|NCT01940094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25011105|NCT01940094|Hormones|hormones|mesh-ancestor
24913527|NCT04263844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24913528|NCT04263844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24913529|NCT04263844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24520096|NCT03897335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795050|NCT03831113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24795051|NCT03831113|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24795052|NCT03824327|Papaverine|papaverine|mesh-list
24795053|NCT03824327|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24795054|NCT03824327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795055|NCT03824327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471957|NCT00397592|Hormones|hormones|mesh-list
24863017|NCT03729271|Rifaximin|rifaximin|mesh-list
24795056|NCT03824327|Vasodilator Agents|vasodilator agents|mesh-ancestor
24795057|NCT03824327|Urological Agents|urological agents|mesh-ancestor
24975692|NCT03239145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24975693|NCT03239145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24975694|NCT03239145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24975695|NCT03239145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24520097|NCT03897335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24520098|NCT03897335|Respiratory System Agents|respiratory system agents|mesh-ancestor
24520100|NCT03897335|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24520101|NCT03897335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24520104|NCT03897335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24520137|NCT03879577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24520138|NCT03879577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975745|NCT03063749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24975746|NCT03063749|Immunologic Factors|immunologic factors|mesh-ancestor
24975747|NCT03063749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975748|NCT03013998|Cytarabine|cytarabine|mesh-list
24975749|NCT03013998|Azacitidine|azacitidine|mesh-list
24975750|NCT03013998|Decitabine|decitabine|mesh-list
24975751|NCT03013998|Daunorubicin|daunorubicin|mesh-list
24975752|NCT03013998|Venetoclax|venetoclax|mesh-list
24975753|NCT03013998|AZD5991|azd5991|mesh-list
24975754|NCT03013998|Pevonedistat|pevonedistat|mesh-list
24975755|NCT03013998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24975756|NCT03013998|Antimetabolites|antimetabolites|mesh-ancestor
24975757|NCT03013998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783335|NCT01901172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24783336|NCT01901172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783337|NCT01901172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783338|NCT01901172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25105451|NCT03145649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25105452|NCT03145649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105453|NCT03145714|Dexmedetomidine|dexmedetomidine|mesh-list
25105476|NCT03145610|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25105477|NCT03145610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25105478|NCT03145610|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25105479|NCT03145610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25105480|NCT03145610|Antimetabolites|antimetabolites|mesh-ancestor
25702213|NCT02151877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25702214|NCT02151877|Respiratory System Agents|respiratory system agents|mesh-ancestor
25702215|NCT02151877|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25702216|NCT02151877|Antioxidants|antioxidants|mesh-ancestor
25702217|NCT02151877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702218|NCT02151877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25702219|NCT02151877|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25105481|NCT03145610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572796|NCT00816790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24572797|NCT00816790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24572798|NCT00816790|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25011470|NCT04964193|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25011471|NCT04964193|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25011472|NCT04964193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25011473|NCT04964193|Contraceptive Agents|contraceptive agents|mesh-ancestor
25011474|NCT04964193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24520140|NCT03879577|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24913557|NCT04263402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24913558|NCT04263402|Protective Agents|protective agents|mesh-ancestor
24489309|NCT00472225|Rituximab|rituximab|mesh-list
24913752|NCT04261270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913753|NCT04261270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25105487|NCT03146104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25105488|NCT03146104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25105489|NCT03146104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105490|NCT03146104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25105491|NCT03146104|Anesthetics, General|anesthetics, general|mesh-ancestor
25105492|NCT03146104|Anesthetics|anesthetics|mesh-ancestor
25105503|NCT03145896|Micronutrients|micronutrients|mesh-ancestor
25105504|NCT03145896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105505|NCT03145896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25105506|NCT03145675|Enoxaparin|enoxaparin|mesh-list
24975812|NCT02885753|Levoleucovorin|levoleucovorin|mesh-list
24975813|NCT02885753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24975814|NCT02885753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24975815|NCT02885753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24975816|NCT02885753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24975817|NCT02885753|Growth Substances|growth substances|mesh-ancestor
24975818|NCT02885753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975819|NCT02885753|Growth Inhibitors|growth inhibitors|mesh-ancestor
24975820|NCT02885753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24913754|NCT04261270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24913755|NCT04261270|Antiviral Agents|antiviral agents|mesh-ancestor
24913756|NCT04261270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24913757|NCT04261270|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24913758|NCT04261270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24819364|NCT02094963|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24819365|NCT02094963|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24819366|NCT02094963|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24819367|NCT02094963|Purinergic Agents|purinergic agents|mesh-ancestor
24819368|NCT02094963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24819369|NCT02094963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819370|NCT02094963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520174|NCT03608657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913766|NCT04261023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24472077|NCT00398008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913767|NCT04261036|Ascorbic Acid|ascorbic acid|mesh-list
24975821|NCT02885753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24975822|NCT02885753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24975823|NCT02885753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975824|NCT02885753|Antimetabolites|antimetabolites|mesh-ancestor
24975825|NCT02885753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24975899|NCT02637531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24975900|NCT02637531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975901|NCT02624102|Antidepressive Agents|antidepressive agents|mesh-list
24975902|NCT02624102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24975903|NCT02573233|Fluticasone|fluticasone|mesh-list
24975905|NCT02573233|Mometasone Furoate|mometasone furoate|mesh-list
24975906|NCT02573233|Budesonide|budesonide|mesh-list
24975907|NCT02573233|Formoterol Fumarate|formoterol fumarate|mesh-list
24975908|NCT02573233|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24975909|NCT02573233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24975910|NCT02573233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25702220|NCT02151877|Vasodilator Agents|vasodilator agents|mesh-ancestor
25702221|NCT02151877|Gasotransmitters|gasotransmitters|mesh-ancestor
25702222|NCT02151877|Protective Agents|protective agents|mesh-ancestor
25702223|NCT02151994|Zamicastat|zamicastat|mesh-list
25702224|NCT02151994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25702225|NCT02151994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702226|NCT02152007|Sirolimus|sirolimus|mesh-list
25702227|NCT02152007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25702228|NCT02152007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24968464|NCT03751059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24968465|NCT03751059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968466|NCT03751059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25011750|NCT04231084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25011751|NCT04186494|Liraglutide|liraglutide|mesh-list
25011752|NCT04186494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25011753|NCT04186494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011754|NCT04186494|Incretins|incretins|mesh-ancestor
25011755|NCT04186494|Hormones|hormones|mesh-ancestor
24975911|NCT02573233|Autonomic Agents|autonomic agents|mesh-ancestor
24975912|NCT02573233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24975913|NCT02573233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975946|NCT02420795|TIC10 compound|tic10 compound|mesh-list
24975947|NCT02420795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24975948|NCT02384759|Aflibercept|aflibercept|mesh-list
24975949|NCT02384759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24913768|NCT04261036|Antioxidants|antioxidants|mesh-ancestor
24913769|NCT04261036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913770|NCT04261036|Protective Agents|protective agents|mesh-ancestor
24475378|NCT00410254|Anesthetics|anesthetics|mesh-ancestor
24913771|NCT04261036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975950|NCT02384759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24975951|NCT02384759|Growth Substances|growth substances|mesh-ancestor
24975952|NCT02384759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975953|NCT02384759|Growth Inhibitors|growth inhibitors|mesh-ancestor
24975954|NCT02384759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24975955|NCT02367846|Contraceptive Agents|contraceptive agents|mesh-list
24795092|NCT03726229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24795093|NCT03712228|Antibodies|antibodies|mesh-list
24795094|NCT03712228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24783405|NCT01901640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795095|NCT03712228|Immunologic Factors|immunologic factors|mesh-ancestor
24795096|NCT03712228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795097|NCT03626922|Folic Acid|folic acid|mesh-list
24795098|NCT03626922|Vitamin B 12|vitamin b 12|mesh-list
24795099|NCT03626922|Dexamethasone|dexamethasone|mesh-list
24795100|NCT03626922|Pembrolizumab|pembrolizumab|mesh-list
24795101|NCT03626922|Oxaliplatin|oxaliplatin|mesh-list
24795102|NCT03626922|Pemetrexed|pemetrexed|mesh-list
24795103|NCT03626922|Vitamins|vitamins|mesh-ancestor
24795104|NCT03626922|Micronutrients|micronutrients|mesh-ancestor
24795105|NCT03626922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795106|NCT03626922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24975985|NCT02199691|Vaccines|vaccines|mesh-list
24975986|NCT02199691|Immunologic Factors|immunologic factors|mesh-ancestor
24975987|NCT02199691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975988|NCT02199665|Dexamethasone|dexamethasone|mesh-list
24975989|NCT02199665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24975990|NCT02199665|Antiemetics|antiemetics|mesh-ancestor
24975991|NCT02199665|Autonomic Agents|autonomic agents|mesh-ancestor
24975992|NCT02199665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24913773|NCT04261036|Micronutrients|micronutrients|mesh-ancestor
24913774|NCT04260828|Aspirin|aspirin|mesh-list
24913777|NCT04260828|Analgesics|analgesics|mesh-ancestor
24913789|NCT04260828|Antipyretics|antipyretics|mesh-ancestor
24913790|NCT04260711|Interferons|interferons|mesh-list
24913791|NCT04260711|Teriflunomide|teriflunomide|mesh-list
24488380|NCT00468260|Epothilone B|epothilone b|mesh-list
24520175|NCT03608657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24520176|NCT03608657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24520177|NCT03608657|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24520178|NCT03608657|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24520179|NCT03608657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24520180|NCT03608657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520181|NCT03576885|Nitric Oxide|nitric oxide|mesh-list
25702229|NCT02152007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25702230|NCT02152007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25702231|NCT02152007|Antifungal Agents|antifungal agents|mesh-ancestor
25702232|NCT02152007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25702233|NCT02152007|Immunologic Factors|immunologic factors|mesh-ancestor
25702234|NCT02152007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702235|NCT02152137|Paclitaxel|paclitaxel|mesh-list
25702236|NCT02152137|Efatutazone|efatutazone|mesh-list
25702237|NCT02152137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24520182|NCT03576885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24520183|NCT03576885|Autonomic Agents|autonomic agents|mesh-ancestor
24520184|NCT03576885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24975993|NCT02199665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012053|NCT02335060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975994|NCT02199665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24975995|NCT02199665|Glucocorticoids|glucocorticoids|mesh-ancestor
24975996|NCT02199665|Hormones|hormones|mesh-ancestor
24975997|NCT02199665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24976025|NCT02088112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976026|NCT02076620|Doxorubicin|doxorubicin|mesh-list
24976027|NCT02076620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24976028|NCT02076620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976029|NCT02076620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24976030|NCT02076620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24976031|NCT02076620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24976032|NCT02076620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976033|NCT02010593|Dapivirine|dapivirine|mesh-list
24976034|NCT02010593|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24976035|NCT02010593|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24976036|NCT02010593|Antiviral Agents|antiviral agents|mesh-ancestor
24976037|NCT02010593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24976038|NCT01946074|Paclitaxel|paclitaxel|mesh-list
24976039|NCT01946074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24976040|NCT01946074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976041|NCT01946074|Tubulin Modulators|tubulin modulators|mesh-ancestor
24976042|NCT01946074|Antimitotic Agents|antimitotic agents|mesh-ancestor
24976043|NCT01946074|Mitosis Modulators|mitosis modulators|mesh-ancestor
24457907|NCT00335647|Fluphenazine|fluphenazine|mesh-list
24976072|NCT01702571|Mitosis Modulators|mitosis modulators|mesh-ancestor
24520222|NCT03561376|Sunscreening Agents|sunscreening agents|mesh-ancestor
24520186|NCT03576885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24520187|NCT03576885|Respiratory System Agents|respiratory system agents|mesh-ancestor
24520188|NCT03576885|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24520189|NCT03576885|Antioxidants|antioxidants|mesh-ancestor
24914223|NCT04257032|Anticoagulants|anticoagulants|mesh-ancestor
24520202|NCT03573648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24913793|NCT04260711|Dimethyl Fumarate|dimethyl fumarate|mesh-list
24913794|NCT04260711|(T,G)-A-L|(t,g)-a-l|mesh-list
24976079|NCT01578239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24976080|NCT01578239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24976081|NCT01578239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976118|NCT01336634|Trametinib|trametinib|mesh-list
24976119|NCT01336634|Dabrafenib|dabrafenib|mesh-list
24976120|NCT01336634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976121|NCT01336634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24976122|NCT01336634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24976157|NCT01220531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24976158|NCT01220531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24976159|NCT01220531|Protective Agents|protective agents|mesh-ancestor
24976160|NCT01220531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24976161|NCT01155375|Ferrous fumarate|ferrous fumarate|mesh-list
24976196|NCT00360425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976198|NCT00360425|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24976199|NCT00360425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24976200|NCT00346125|Doxorubicin|doxorubicin|mesh-list
24976201|NCT00346125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24795108|NCT03626922|Autonomic Agents|autonomic agents|mesh-ancestor
24795109|NCT03626922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24795110|NCT03626922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24472218|NCT00398554|Immunologic Factors|immunologic factors|mesh-ancestor
24472219|NCT00398554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472220|NCT00398554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24472221|NCT00398554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24913795|NCT04260711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913796|NCT04260711|Antiviral Agents|antiviral agents|mesh-ancestor
24913797|NCT04260711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24913798|NCT04260711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24913799|NCT04260711|Immunologic Factors|immunologic factors|mesh-ancestor
24913800|NCT04260711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913801|NCT04260711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24913802|NCT04260711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24913803|NCT04260711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24913804|NCT04260711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25702238|NCT02152137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25702239|NCT02152137|Tubulin Modulators|tubulin modulators|mesh-ancestor
24913807|NCT04260711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24520219|NCT03561376|Zinc Oxide|zinc oxide|mesh-list
24520220|NCT03561376|Emollients|emollients|mesh-ancestor
24520221|NCT03561376|Dermatologic Agents|dermatologic agents|mesh-ancestor
24795114|NCT03626922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24795115|NCT03626922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795116|NCT03626922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24533164|NCT00642499|Hormones|hormones|mesh-ancestor
24821398|NCT02104843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24976285|NCT04235855|Liver Extracts|liver extracts|mesh-list
24976286|NCT04235855|Hematinics|hematinics|mesh-ancestor
24976287|NCT04234945|Doxycycline|doxycycline|mesh-list
24976288|NCT04234945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24976289|NCT04234945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24913816|NCT04260607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24913817|NCT04260607|Anesthetics, General|anesthetics, general|mesh-ancestor
24913818|NCT04260607|Anesthetics|anesthetics|mesh-ancestor
24913819|NCT04260607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24913820|NCT04260607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24913821|NCT04260607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24913822|NCT04260607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24913823|NCT04260607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913824|NCT04260516|Acetylcysteine|acetylcysteine|mesh-list
24913828|NCT04260516|Expectorants|expectorants|mesh-ancestor
24913877|NCT04260035|Protective Agents|protective agents|mesh-ancestor
24913878|NCT04260035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913879|NCT04260269|Trifluridine|trifluridine|mesh-list
24913880|NCT04260269|Fluorouracil|fluorouracil|mesh-list
24488462|NCT00468754|Insulin|insulin|mesh-list
24520234|NCT03486314|Antimitotic Agents|antimitotic agents|mesh-ancestor
24520235|NCT03486314|Mitosis Modulators|mitosis modulators|mesh-ancestor
24520240|NCT03486314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24520241|NCT03486314|Leprostatic Agents|leprostatic agents|mesh-ancestor
24520242|NCT03486314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24520243|NCT03486314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24913936|NCT04259333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24913937|NCT04259333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819374|NCT02095119|Gemcitabine|gemcitabine|mesh-list
24819375|NCT02095119|Nimotuzumab|nimotuzumab|mesh-list
24472265|NCT00398658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472266|NCT00398684|Nevirapine|nevirapine|mesh-list
24472267|NCT00398684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24472268|NCT00398684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24472269|NCT00398684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819376|NCT02095119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24819377|NCT02095119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24819378|NCT02095119|Antimetabolites|antimetabolites|mesh-ancestor
24819379|NCT02095119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819380|NCT02095119|Antiviral Agents|antiviral agents|mesh-ancestor
24819381|NCT02095119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24520263|NCT03335488|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
24976290|NCT04234945|Antimalarials|antimalarials|mesh-ancestor
24976291|NCT04234945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24976292|NCT04234945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24976353|NCT04051268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976355|NCT04031508|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24976356|NCT04031508|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24976357|NCT04031508|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24976390|NCT03942419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976392|NCT03877354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24976393|NCT03877354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976394|NCT03733925|Golimumab|golimumab|mesh-list
24976395|NCT03733925|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24976396|NCT03733925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24976397|NCT03733925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24976398|NCT03733925|Immunologic Factors|immunologic factors|mesh-ancestor
24976399|NCT03733925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976437|NCT03602235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976438|NCT03602235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976439|NCT03602235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24976440|NCT03602235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24976441|NCT03602235|Immunologic Factors|immunologic factors|mesh-ancestor
24976445|NCT03602235|Vitamins|vitamins|mesh-ancestor
24976446|NCT03602235|Micronutrients|micronutrients|mesh-ancestor
24976479|NCT03516279|Pembrolizumab|pembrolizumab|mesh-list
24976480|NCT03516279|Imatinib Mesylate|imatinib mesylate|mesh-list
24976481|NCT03516279|Dasatinib|dasatinib|mesh-list
24976482|NCT03516279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24976483|NCT03516279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976484|NCT03516279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24976485|NCT03516279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24976486|NCT03516279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976487|NCT03508739|Valsartan|valsartan|mesh-list
24976488|NCT03508739|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24976489|NCT03508739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24976523|NCT03419234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976524|NCT03419234|Hormone Antagonists|hormone antagonists|mesh-ancestor
24976525|NCT03419234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24976526|NCT03419234|Antioxidants|antioxidants|mesh-ancestor
24976527|NCT03419234|Protective Agents|protective agents|mesh-ancestor
24976528|NCT03419234|Vitamins|vitamins|mesh-ancestor
24783458|NCT01902160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24783459|NCT01902160|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24783460|NCT01902160|Antibodies|antibodies|mesh-list
24783461|NCT01902160|Immunoglobulins|immunoglobulins|mesh-list
24575475|NCT00832013|Propofol|propofol|mesh-list
24783476|NCT01902186|Raltegravir Potassium|raltegravir potassium|mesh-list
24783477|NCT01902186|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24783478|NCT01902186|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24783479|NCT01902186|Protease Inhibitors|protease inhibitors|mesh-ancestor
24976678|NCT05275699|Glycine Agents|glycine agents|mesh-ancestor
24976679|NCT05275699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24976680|NCT05275699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976681|NCT05275699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976682|NCT05275270|Oxytocin|oxytocin|mesh-list
24976683|NCT05275270|Oxytocics|oxytocics|mesh-ancestor
24976684|NCT05275270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24976685|NCT05275270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976686|NCT05275179|Posaconazole|posaconazole|mesh-list
24976687|NCT05275179|Antifungal Agents|antifungal agents|mesh-ancestor
24976688|NCT05275179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24976689|NCT05275179|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24976690|NCT05275179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24976691|NCT05275179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24976692|NCT05275179|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24976698|NCT05275179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25105600|NCT05254899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24976699|NCT05275179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976700|NCT05274984|Lidocaine|lidocaine|mesh-list
24976701|NCT05274984|Anesthetics, Local|anesthetics, local|mesh-ancestor
24976702|NCT05274984|Anesthetics|anesthetics|mesh-ancestor
24976703|NCT05274984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25702242|NCT02152137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013428|NCT02733042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520265|NCT03335488|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24520266|NCT03335488|Protective Agents|protective agents|mesh-ancestor
24520267|NCT03335488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520268|NCT03335488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489807|NCT00475514|Frovatriptan|frovatriptan|mesh-list
24520419|NCT02020707|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24520420|NCT02020707|Bevacizumab|bevacizumab|mesh-list
24913984|NCT04258930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24913986|NCT04258657|Paclitaxel|paclitaxel|mesh-list
24913987|NCT04258657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24913988|NCT04258657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913993|NCT04258553|Antioxidants|antioxidants|mesh-list
24914090|NCT04258306|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24489886|NCT00475813|Xhance|xhance|mesh-list
24914194|NCT04257656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24914222|NCT04257032|Protease Inhibitors|protease inhibitors|mesh-ancestor
24914225|NCT04256642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24914226|NCT04256642|Narcotics|narcotics|mesh-ancestor
24914227|NCT04256642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24914228|NCT04256642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914229|NCT04256642|Analgesics|analgesics|mesh-ancestor
24819411|NCT02095366|Anesthetics, General|anesthetics, general|mesh-ancestor
24819412|NCT02095366|Anesthetics|anesthetics|mesh-ancestor
24794179|NCT05413330|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24794180|NCT05413330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24794181|NCT05413330|Glucocorticoids|glucocorticoids|mesh-ancestor
24794182|NCT05413330|Hormones|hormones|mesh-ancestor
24794183|NCT05413330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24794184|NCT05413330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794185|NCT05413330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24794186|NCT05413330|Immunologic Factors|immunologic factors|mesh-ancestor
24794187|NCT05413330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24794188|NCT05413330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794202|NCT05409365|Antibodies|antibodies|mesh-list
25083161|NCT03317717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807409|NCT02021851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24976704|NCT05274984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976705|NCT05274984|Sensory System Agents|sensory system agents|mesh-ancestor
24976706|NCT05274984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24976707|NCT05274984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24914531|NCT04254679|Narcotics|narcotics|mesh-ancestor
24976709|NCT05274984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24976710|NCT05274984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24976711|NCT05274984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976712|NCT05274893|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24976713|NCT05274893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976715|NCT05274672|Cephalexin|cephalexin|mesh-list
24976716|NCT05274672|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24976717|NCT05274672|Nitrofurantoin|nitrofurantoin|mesh-list
24976718|NCT05274672|Trimethoprim|trimethoprim|mesh-list
24914764|NCT04252261|Sulforaphane|sulforaphane|mesh-list
24976719|NCT05274672|Sulfamethoxazole|sulfamethoxazole|mesh-list
24976732|NCT05274672|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24976733|NCT05274672|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25702243|NCT02152163|Ibuprofen|ibuprofen|mesh-list
25702244|NCT02152163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25702245|NCT02152163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25702246|NCT02152163|Analgesics|analgesics|mesh-ancestor
25702247|NCT02152163|Sensory System Agents|sensory system agents|mesh-ancestor
25702248|NCT02152163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24976735|NCT05274672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24976736|NCT05274672|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24976738|NCT05255471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24976739|NCT05255471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24976740|NCT05255471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976741|NCT05255471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976742|NCT05232396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24976743|NCT05232396|Antibodies|antibodies|mesh-list
24976744|NCT05232396|Immunoglobulins|immunoglobulins|mesh-list
24976745|NCT05232396|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24621989|NCT01065129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24621990|NCT01065129|Antiviral Agents|antiviral agents|mesh-ancestor
24621991|NCT01065129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24621992|NCT01065194|Simendan|simendan|mesh-list
24621993|NCT01065194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24621994|NCT01065194|Vasodilator Agents|vasodilator agents|mesh-ancestor
24621995|NCT01065194|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24621996|NCT01065194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24621997|NCT01065194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621998|NCT01065194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621999|NCT01065194|Protective Agents|protective agents|mesh-ancestor
24622000|NCT01065194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622001|NCT01065220|Cyproterone Acetate|cyproterone acetate|mesh-list
24622002|NCT01065220|Testolactone|testolactone|mesh-list
24622003|NCT01065220|Lynestrenol|lynestrenol|mesh-list
24976755|NCT05222724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976756|NCT05222724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24976757|NCT05222724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24976767|NCT05216614|Fluvoxamine|fluvoxamine|mesh-list
24976768|NCT05216614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24976769|NCT05216614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24976770|NCT05216614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24976771|NCT05216614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976772|NCT05216614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24976773|NCT05216614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24976774|NCT05216614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24976775|NCT05216614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24976776|NCT05216614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976777|NCT05216614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24976778|NCT05216614|Serotonin Agents|serotonin agents|mesh-ancestor
24976779|NCT05216614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24976780|NCT05216614|Antidepressive Agents|antidepressive agents|mesh-ancestor
24976781|NCT05216614|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24976782|NCT05216614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24976783|NCT05216614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24976784|NCT05216614|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24976785|NCT05200312|Prednisone|prednisone|mesh-list
24976786|NCT05200312|Cyclophosphamide|cyclophosphamide|mesh-list
24976787|NCT05200312|Rituximab|rituximab|mesh-list
24976788|NCT05200312|Doxorubicin|doxorubicin|mesh-list
24976891|NCT04893915|Interleukin-2|interleukin-2|mesh-list
24976892|NCT04893915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25083195|NCT03317548|Progesterone|progesterone|mesh-list
24819414|NCT02095405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24819415|NCT02095405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819416|NCT02095405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24819417|NCT02095405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819418|NCT02095405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819419|NCT02095405|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24819420|NCT02095405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24914235|NCT04256733|Sensory System Agents|sensory system agents|mesh-ancestor
24472486|NCT00399295|Hydromorphone|hydromorphone|mesh-list
25702249|NCT02152163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702250|NCT02152163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25702251|NCT02152163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25013792|NCT05222191|Natriuretic Agents|natriuretic agents|mesh-ancestor
25013793|NCT05222191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25013794|NCT05222191|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25013795|NCT05222191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25013796|NCT05222191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013800|NCT05222113|Favipiravir|favipiravir|mesh-list
25013801|NCT05222113|Antimetabolites|antimetabolites|mesh-ancestor
25013802|NCT05222113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013803|NCT05222113|Antiviral Agents|antiviral agents|mesh-ancestor
25013804|NCT05222113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25013805|NCT05221892|Thiamine|thiamine|mesh-list
24575640|NCT00833157|Sensory System Agents|sensory system agents|mesh-ancestor
25013833|NCT05221736|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25013834|NCT05221736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24914236|NCT04256733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24914237|NCT04256733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914238|NCT04256473|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24914240|NCT04256473|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24914383|NCT04255238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24914384|NCT04255238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914385|NCT04255238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24914386|NCT04255238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914387|NCT04255251|Fluorides|fluorides|mesh-list
24976893|NCT04893915|Immunologic Factors|immunologic factors|mesh-ancestor
24976894|NCT04893915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976895|NCT04893915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24976896|NCT04893915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24976897|NCT04893915|Alkylating Agents|alkylating agents|mesh-ancestor
24976944|NCT04782830|Autonomic Agents|autonomic agents|mesh-ancestor
24976945|NCT04782830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24976946|NCT04782830|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24976947|NCT04782830|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24976948|NCT04782830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24976949|NCT04782830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24976950|NCT04781426|Tenofovir|tenofovir|mesh-list
24976951|NCT04781426|Lamivudine|lamivudine|mesh-list
24976952|NCT04781426|Antiviral Agents|antiviral agents|mesh-ancestor
24976953|NCT04781426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24976954|NCT04781426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24976955|NCT04781426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24976956|NCT04781426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24976957|NCT04781426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783539|NCT01902511|Lenograstim|lenograstim|mesh-list
24783540|NCT01902511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24977001|NCT04691856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24977002|NCT04691856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24472487|NCT00399295|Narcotic Antagonists|narcotic antagonists|mesh-list
24977003|NCT04691856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24977004|NCT04691856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977005|NCT04691856|Antipyretics|antipyretics|mesh-ancestor
24977006|NCT04671966|Cetrorelix|cetrorelix|mesh-list
24977007|NCT04671966|Estradiol|estradiol|mesh-list
24914452|NCT04254822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24914453|NCT04254822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24914454|NCT04254822|Adrenergic Agents|adrenergic agents|mesh-ancestor
25702252|NCT02152163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25702253|NCT02152163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25702254|NCT02152163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702255|NCT02152345|Methylprednisolone|methylprednisolone|mesh-list
25702256|NCT02152345|Abatacept|abatacept|mesh-list
25702257|NCT02152345|Tacrolimus|tacrolimus|mesh-list
25702258|NCT02152345|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25702259|NCT02152345|Thymoglobulin|thymoglobulin|mesh-list
25702260|NCT02152345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25702261|NCT02152345|Immunologic Factors|immunologic factors|mesh-ancestor
25702262|NCT02152345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702263|NCT02152345|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25702264|NCT02152345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25702265|NCT02152345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914464|NCT04254822|Vasodilator Agents|vasodilator agents|mesh-ancestor
24914465|NCT04254822|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24914466|NCT04254822|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24914467|NCT04255056|Cyclophosphamide|cyclophosphamide|mesh-list
24914469|NCT04255056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24914470|NCT04255056|Immunologic Factors|immunologic factors|mesh-ancestor
24914482|NCT04254913|Edaravone|edaravone|mesh-list
24914530|NCT04254679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
24977064|NCT04196283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914997|NCT05251766|Paclitaxel|paclitaxel|mesh-list
24977074|NCT03783286|Ivacaftor|ivacaftor|mesh-list
24977075|NCT03783286|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24977076|NCT03783286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24977112|NCT03622073|Oxytocics|oxytocics|mesh-ancestor
24977289|NCT02807805|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24977290|NCT02807805|Anthelmintics|anthelmintics|mesh-ancestor
24977291|NCT02807805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24977292|NCT02807805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24977293|NCT02807805|Antinematodal Agents|antinematodal agents|mesh-ancestor
24977295|NCT02764268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977296|NCT02764268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24977297|NCT02764268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24977298|NCT02764268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977299|NCT02714322|Adalimumab|adalimumab|mesh-list
24977300|NCT02714322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24977301|NCT02714322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24977302|NCT02607813|Spartalizumab|spartalizumab|mesh-list
24977303|NCT02607813|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24977304|NCT02607813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977305|NCT02607813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458141|NCT00336791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24977489|NCT02988401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24977490|NCT02988401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977491|NCT02987530|Tenofovir|tenofovir|mesh-list
24977555|NCT02884648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25702267|NCT02152345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25702268|NCT02152345|Antiemetics|antiemetics|mesh-ancestor
25702269|NCT02152345|Autonomic Agents|autonomic agents|mesh-ancestor
25702270|NCT02152345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25702271|NCT02152345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25702272|NCT02152345|Glucocorticoids|glucocorticoids|mesh-ancestor
25702273|NCT02152345|Hormones|hormones|mesh-ancestor
25702274|NCT02152345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25702275|NCT02152345|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25702276|NCT02152345|Protective Agents|protective agents|mesh-ancestor
25702277|NCT02152345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25702278|NCT02152345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25014566|NCT04291521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25014567|NCT04291521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014568|NCT04291521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25014569|NCT04291521|Anesthetics, General|anesthetics, general|mesh-ancestor
25014571|NCT04291521|Analgesics|analgesics|mesh-ancestor
25014572|NCT04291521|Sensory System Agents|sensory system agents|mesh-ancestor
25014573|NCT04291521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25014574|NCT04291521|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24472572|NCT00399685|Moxifloxacin|moxifloxacin|mesh-list
24472573|NCT00399685|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24472575|NCT00399685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24472576|NCT00399685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24472578|NCT00399685|Antiviral Agents|antiviral agents|mesh-ancestor
24977556|NCT02884648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24977557|NCT02884648|Growth Substances|growth substances|mesh-ancestor
24977558|NCT02884648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977559|NCT02884648|Growth Inhibitors|growth inhibitors|mesh-ancestor
24915480|NCT02237508|Antidotes|antidotes|mesh-ancestor
24977561|NCT02818023|Vemurafenib|vemurafenib|mesh-list
24977562|NCT02818023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24977565|NCT02818023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25105679|NCT05253781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25105680|NCT05253781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25105681|NCT05253781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25105682|NCT05253781|Antipyretics|antipyretics|mesh-ancestor
25105683|NCT05253768|Glycerol|glycerol|mesh-list
25105684|NCT05253768|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24575608|NCT00832689|Antiviral Agents|antiviral agents|mesh-ancestor
24977633|NCT02560298|Fluorouracil|fluorouracil|mesh-list
24977634|NCT02560298|Capecitabine|capecitabine|mesh-list
24977635|NCT02560298|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24977636|NCT02560298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24977637|NCT02560298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977638|NCT02560298|Tubulin Modulators|tubulin modulators|mesh-ancestor
24977639|NCT02560298|Antimitotic Agents|antimitotic agents|mesh-ancestor
24977640|NCT02560298|Mitosis Modulators|mitosis modulators|mesh-ancestor
24977641|NCT02560298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977642|NCT02560298|Antimetabolites|antimetabolites|mesh-ancestor
24977643|NCT02560298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24977644|NCT02560298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24977645|NCT02560298|Immunologic Factors|immunologic factors|mesh-ancestor
24977646|NCT02560298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977647|NCT02547493|Abatacept|abatacept|mesh-list
24977648|NCT02547493|Vaccines|vaccines|mesh-list
24977649|NCT02547493|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24977650|NCT02547493|Immunologic Factors|immunologic factors|mesh-ancestor
24977651|NCT02547493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977652|NCT02547493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24977653|NCT02547493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977688|NCT02459392|Antiemetics|antiemetics|mesh-ancestor
24977689|NCT02459392|Autonomic Agents|autonomic agents|mesh-ancestor
24977690|NCT02459392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24977691|NCT02459392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24977692|NCT02459392|Glucocorticoids|glucocorticoids|mesh-ancestor
24977693|NCT02459392|Hormones|hormones|mesh-ancestor
25702279|NCT02152371|Metformin|metformin|mesh-list
25702280|NCT02152371|Insulin Glargine|insulin glargine|mesh-list
25702281|NCT02152371|Dulaglutide|dulaglutide|mesh-list
25702282|NCT02152371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25702283|NCT02152371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702284|NCT02152384|Insulin|insulin|mesh-list
25702285|NCT02152384|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25702286|NCT02152384|Insulin Glargine|insulin glargine|mesh-list
25702287|NCT02152384|Insulin Lispro|insulin lispro|mesh-list
25702288|NCT02152384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25014940|NCT03629951|Antipsychotic Agents|antipsychotic agents|mesh-list
25014941|NCT03629951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25014942|NCT03629951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25014943|NCT03629951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014944|NCT03629951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24977694|NCT02459392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24977769|NCT02177695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24977770|NCT02177695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24977772|NCT02177695|Antimitotic Agents|antimitotic agents|mesh-ancestor
24977773|NCT02177695|Mitosis Modulators|mitosis modulators|mesh-ancestor
24977774|NCT02145403|Tacrolimus|tacrolimus|mesh-list
24977775|NCT02145403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24977777|NCT02145403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977778|NCT02145403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24977779|NCT02145403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24977780|NCT02145403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977781|NCT02105636|Docetaxel|docetaxel|mesh-list
24977782|NCT02105636|Methotrexate|methotrexate|mesh-list
24977783|NCT02105636|Nivolumab|nivolumab|mesh-list
24977784|NCT02105636|Cetuximab|cetuximab|mesh-list
24977785|NCT02105636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977786|NCT02105636|Tubulin Modulators|tubulin modulators|mesh-ancestor
24977787|NCT02105636|Antimitotic Agents|antimitotic agents|mesh-ancestor
24977788|NCT02105636|Mitosis Modulators|mitosis modulators|mesh-ancestor
24977789|NCT02105636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458197|NCT00336960|Immunologic Factors|immunologic factors|mesh-ancestor
24977810|NCT01988571|Atorvastatin|atorvastatin|mesh-list
24977811|NCT01988571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24977812|NCT01988571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24977813|NCT01988571|Antimetabolites|antimetabolites|mesh-ancestor
24472586|NCT00399685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24472587|NCT00399685|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24472588|NCT00399685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24472602|NCT00399698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472604|NCT00399698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24472605|NCT00399698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24472606|NCT00399698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24977814|NCT01988571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977815|NCT01988571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24977816|NCT01988571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24977817|NCT01988571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24977818|NCT01979367|Analgesics|analgesics|mesh-list
24977819|NCT01979367|Sensory System Agents|sensory system agents|mesh-ancestor
24977820|NCT01979367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24977821|NCT01979367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977822|NCT01973452|Dexmedetomidine|dexmedetomidine|mesh-list
24977829|NCT01973452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24977830|NCT01973452|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24977831|NCT01973452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24977832|NCT01973452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24977833|NCT01973452|Adrenergic Agents|adrenergic agents|mesh-ancestor
24977834|NCT01973452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25702289|NCT02152384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702290|NCT02152696|Methotrexate|methotrexate|mesh-list
25702291|NCT02152696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25702292|NCT02152696|Abortifacient Agents|abortifacient agents|mesh-ancestor
25702293|NCT02152696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25702294|NCT02152696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702295|NCT02152696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25702296|NCT02152696|Antimetabolites|antimetabolites|mesh-ancestor
25702297|NCT02152696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702298|NCT02152696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25702299|NCT02152696|Dermatologic Agents|dermatologic agents|mesh-ancestor
24977836|NCT01863550|Dexamethasone|dexamethasone|mesh-list
24977837|NCT01863550|Dexamethasone acetate|dexamethasone acetate|mesh-list
24977838|NCT01863550|Lenalidomide|lenalidomide|mesh-list
24977839|NCT01863550|Bortezomib|bortezomib|mesh-list
25702300|NCT02152696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25702301|NCT02152696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25702302|NCT02152696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25702303|NCT02152696|Immunologic Factors|immunologic factors|mesh-ancestor
25702304|NCT02152696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25702305|NCT02152696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25702306|NCT02153489|Bromides|bromides|mesh-list
25702307|NCT02153489|Anticonvulsants|anticonvulsants|mesh-ancestor
25702308|NCT02153671|Vaccines|vaccines|mesh-list
24977840|NCT01863550|Ichthammol|ichthammol|mesh-list
24977841|NCT01863550|BB 1101|bb 1101|mesh-list
24977867|NCT01824875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977868|NCT01824875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24977870|NCT01792583|Modafinil|modafinil|mesh-list
24977871|NCT01792583|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24977872|NCT01792583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977873|NCT01792583|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24977874|NCT01792583|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24977875|NCT01792583|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24977876|NCT01792583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977877|NCT01755975|Lenalidomide|lenalidomide|mesh-list
24977878|NCT01755975|Romidepsin|romidepsin|mesh-list
24977879|NCT01755975|Immunologic Factors|immunologic factors|mesh-ancestor
24472645|NCT00400075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24472678|NCT00400114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24472679|NCT00400114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24472680|NCT00400114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472681|NCT00400114|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24472682|NCT00400114|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24472683|NCT00400114|Growth Substances|growth substances|mesh-ancestor
24472684|NCT00400114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472685|NCT00400114|Growth Inhibitors|growth inhibitors|mesh-ancestor
24977880|NCT01755975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977881|NCT01755975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24977882|NCT01755975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24977883|NCT01755975|Growth Substances|growth substances|mesh-ancestor
24977884|NCT01755975|Growth Inhibitors|growth inhibitors|mesh-ancestor
24977885|NCT01755975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977886|NCT01755975|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24977887|NCT01670409|Cisplatin|cisplatin|mesh-list
24977888|NCT01670409|Fluorouracil|fluorouracil|mesh-list
24977889|NCT01670409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914532|NCT04254679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24914533|NCT04254679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914536|NCT04254380|Insulin Lispro|insulin lispro|mesh-list
24914590|NCT04254081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25105694|NCT05178823|Protective Agents|protective agents|mesh-ancestor
25105695|NCT05178823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105696|NCT05178823|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25702309|NCT02153671|Immunologic Factors|immunologic factors|mesh-ancestor
25702310|NCT02153671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702311|NCT02153723|Glatiramer Acetate|glatiramer acetate|mesh-list
25702312|NCT02153723|(T,G)-A-L|(t,g)-a-l|mesh-list
25702313|NCT02153723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25702314|NCT02153723|Immunologic Factors|immunologic factors|mesh-ancestor
25702315|NCT02153723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702316|NCT02153723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25015199|NCT02962102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25015200|NCT02962102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015201|NCT02962102|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25015202|NCT02962102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25015239|NCT02947750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914591|NCT04254081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24914592|NCT04254081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914593|NCT04254081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24914596|NCT04254081|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24819468|NCT02095704|Acetaminophen|acetaminophen|mesh-list
24819469|NCT02095704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24701613|NCT01459887|Cyclophosphamide|cyclophosphamide|mesh-list
24520449|NCT01657500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24520450|NCT01657500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24914689|NCT04252885|Ritonavir|ritonavir|mesh-list
24914690|NCT04252885|Lopinavir|lopinavir|mesh-list
25702317|NCT02153723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25702318|NCT02153788|Temazepam|temazepam|mesh-list
25702319|NCT02153788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25702320|NCT02153788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25702321|NCT02153788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702322|NCT02153788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25702323|NCT02153788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25702324|NCT02153788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25702325|NCT02153788|GABA Modulators|gaba modulators|mesh-ancestor
24914695|NCT04252885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914696|NCT04252885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24914697|NCT04252885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24914698|NCT04252885|Antiviral Agents|antiviral agents|mesh-ancestor
24914699|NCT04252885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24914700|NCT04252885|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24914701|NCT04252885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24914744|NCT04252274|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
24914745|NCT04252274|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24914746|NCT04252274|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24914747|NCT04252274|Protease Inhibitors|protease inhibitors|mesh-ancestor
24914748|NCT04252274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24472713|NCT00400335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24472714|NCT00400335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472715|NCT00400335|Hormone Antagonists|hormone antagonists|mesh-ancestor
24472716|NCT00400348|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
24472717|NCT00400348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472718|NCT00400348|Tubulin Modulators|tubulin modulators|mesh-ancestor
24914749|NCT04252274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914750|NCT04252274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24819545|NCT02095938|Amisulpride|amisulpride|mesh-list
24615913|NCT01032668|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24819546|NCT02095938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24819547|NCT02095938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24914806|NCT04251962|Anesthetics, Local|anesthetics, local|mesh-ancestor
24914807|NCT04251962|Anesthetics|anesthetics|mesh-ancestor
24914808|NCT04251962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24914809|NCT04251962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914810|NCT04251962|Sensory System Agents|sensory system agents|mesh-ancestor
24914811|NCT04251962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24914812|NCT04251962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24914813|NCT04251962|Narcotics|narcotics|mesh-ancestor
24914814|NCT04251962|Analgesics|analgesics|mesh-ancestor
24914815|NCT04251962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24914832|NCT04251871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24914833|NCT04251871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24914834|NCT04251871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24914835|NCT04251871|Immunologic Factors|immunologic factors|mesh-ancestor
24914836|NCT04251871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914838|NCT04251741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24914839|NCT04251741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24914840|NCT04251845|Melatonin|melatonin|mesh-list
24914841|NCT04251845|Antioxidants|antioxidants|mesh-ancestor
24914842|NCT04251845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914843|NCT04251845|Protective Agents|protective agents|mesh-ancestor
25702326|NCT02153788|GABA Agents|gaba agents|mesh-ancestor
25702327|NCT02153788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24914844|NCT04251845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702328|NCT02153788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702329|NCT02153905|Aldesleukin|aldesleukin|mesh-list
25702330|NCT02153905|Cyclophosphamide|cyclophosphamide|mesh-list
24857425|NCT02291666|Chlorzoxazone|chlorzoxazone|mesh-list
24857426|NCT02291666|Bupropion|bupropion|mesh-list
24534156|NCT00646204|Memantine|memantine|mesh-list
25702331|NCT02153905|Fludarabine|fludarabine|mesh-list
25702332|NCT02153905|Interleukin-2|interleukin-2|mesh-list
25702333|NCT02153905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25702334|NCT02153905|Immunologic Factors|immunologic factors|mesh-ancestor
25702335|NCT02153905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702336|NCT02153905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25702337|NCT02153905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25702338|NCT02153905|Alkylating Agents|alkylating agents|mesh-ancestor
25709579|NCT02270242|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25016836|NCT04140162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25016843|NCT04104178|Clindamycin|clindamycin|mesh-list
24472854|NCT00400777|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24702341|NCT01465256|Aspirin|aspirin|mesh-list
24971204|NCT03727464|Sevoflurane|sevoflurane|mesh-list
24490517|NCT00478699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24819592|NCT02096068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819593|NCT02096094|Chlorhexidine|chlorhexidine|mesh-list
24819594|NCT02096094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24819595|NCT02096094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24819596|NCT02096094|Disinfectants|disinfectants|mesh-ancestor
24819597|NCT02096133|Cholecalciferol|cholecalciferol|mesh-list
24819598|NCT02096133|Vitamin D|vitamin d|mesh-list
24915028|NCT05251610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24915029|NCT05251610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915030|NCT05251610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24915031|NCT05251610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24915032|NCT05251610|Vasodilator Agents|vasodilator agents|mesh-ancestor
24915033|NCT05213507|Amikacin|amikacin|mesh-list
24915034|NCT05213507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24915035|NCT05213507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24472859|NCT00400790|Desflurane|desflurane|mesh-list
24472860|NCT00400790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24472871|NCT00400816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24534309|NCT00646620|Tocolytic Agents|tocolytic agents|mesh-ancestor
24534310|NCT00646620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24534311|NCT00646620|Sympathomimetics|sympathomimetics|mesh-ancestor
24534312|NCT00646659|Carboplatin|carboplatin|mesh-list
24534313|NCT00646659|Docetaxel|docetaxel|mesh-list
24534314|NCT00646659|Fluorouracil|fluorouracil|mesh-list
24534315|NCT00646659|Cetuximab|cetuximab|mesh-list
24813058|NCT02056249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813059|NCT02056249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813060|NCT02056249|Sympathomimetics|sympathomimetics|mesh-ancestor
24915099|NCT04674670|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24915100|NCT04674670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24534316|NCT00646659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24534317|NCT00646659|Tubulin Modulators|tubulin modulators|mesh-ancestor
24534318|NCT00646659|Antimitotic Agents|antimitotic agents|mesh-ancestor
24534319|NCT00646659|Mitosis Modulators|mitosis modulators|mesh-ancestor
24702591|NCT01466712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24613401|NCT01018849|Vitamin D|vitamin d|mesh-list
25702339|NCT02153905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702340|NCT02153905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25702341|NCT02153905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24472920|NCT00401128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24472921|NCT00401128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24915101|NCT04674670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915102|NCT04674670|Sensory System Agents|sensory system agents|mesh-ancestor
24915103|NCT04674670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24915104|NCT04674670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24915105|NCT04674670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24915106|NCT04674670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24915107|NCT04674670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24915108|NCT04674670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24915109|NCT04674670|Dopamine Agents|dopamine agents|mesh-ancestor
24915158|NCT04538092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24915159|NCT04538092|Sensory System Agents|sensory system agents|mesh-ancestor
24534342|NCT00646737|Antitubercular Agents|antitubercular agents|mesh-ancestor
24534343|NCT00646737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24451058|NCT00321633|Docetaxel|docetaxel|mesh-list
24534344|NCT00646737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24534345|NCT00646737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534346|NCT00646737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534348|NCT00646750|Melphalan|melphalan|mesh-list
24534349|NCT00646750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24534351|NCT00646750|Immunologic Factors|immunologic factors|mesh-ancestor
24534422|NCT00646945|Anesthetics|anesthetics|mesh-ancestor
24534423|NCT00646945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24534424|NCT00646945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534425|NCT00646945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24534426|NCT00646945|Analgesics|analgesics|mesh-ancestor
24534427|NCT00646945|Sensory System Agents|sensory system agents|mesh-ancestor
24534428|NCT00646945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24534447|NCT00647049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24534448|NCT00647049|Antimetabolites|antimetabolites|mesh-ancestor
24534449|NCT00647049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534450|NCT00647049|Dermatologic Agents|dermatologic agents|mesh-ancestor
24451009|NCT00321477|Antiemetics|antiemetics|mesh-ancestor
24451010|NCT00321477|Autonomic Agents|autonomic agents|mesh-ancestor
24451011|NCT00321477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24451012|NCT00321477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451013|NCT00321477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24451014|NCT00321477|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24451015|NCT00321477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24451016|NCT00321477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451017|NCT00321490|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24451018|NCT00321490|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25702342|NCT02153905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24534496|NCT00647192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24857458|NCT02291666|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24857459|NCT02291666|Antitussive Agents|antitussive agents|mesh-ancestor
24857460|NCT02291666|Respiratory System Agents|respiratory system agents|mesh-ancestor
24857461|NCT02291666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24534497|NCT00647192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534498|NCT00647192|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24534499|NCT00647192|Diuretics|diuretics|mesh-ancestor
24534500|NCT00647192|Natriuretic Agents|natriuretic agents|mesh-ancestor
24703012|NCT01469338|Octreotide|octreotide|mesh-list
24915160|NCT04538092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24490651|NCT00479479|Vitamins|vitamins|mesh-ancestor
24915225|NCT03854019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915226|NCT03854019|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24915227|NCT03854019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24703150|NCT01469988|Hormones|hormones|mesh-ancestor
24534554|NCT00647608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534555|NCT00647608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534556|NCT00647608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24534557|NCT00647608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24534558|NCT00647608|Vasodilator Agents|vasodilator agents|mesh-ancestor
24857471|NCT02291705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857473|NCT02291705|Sensory System Agents|sensory system agents|mesh-ancestor
24857474|NCT02291705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857475|NCT02291731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24857476|NCT02291731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24459988|NCT00347035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24703516|NCT01472016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24703561|NCT01472315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703617|NCT01472796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24451042|NCT00321516|Dopamine Agents|dopamine agents|mesh-ancestor
24451043|NCT00321516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24451044|NCT00321516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451045|NCT00321516|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24451046|NCT00321516|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24451047|NCT00321516|Serotonin Agents|serotonin agents|mesh-ancestor
24451048|NCT00321516|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24451049|NCT00321516|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24451050|NCT00321516|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24451051|NCT00321516|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24451053|NCT00321581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451054|NCT00321581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24451055|NCT00321581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451056|NCT00321581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451057|NCT00321633|Carboplatin|carboplatin|mesh-list
24915231|NCT03854019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24915252|NCT03737370|Docetaxel|docetaxel|mesh-list
24473012|NCT00401492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473063|NCT00401661|Urological Agents|urological agents|mesh-ancestor
24473064|NCT00401674|Paclitaxel|paclitaxel|mesh-list
24473073|NCT00401765|Siltuximab|siltuximab|mesh-list
24473102|NCT00401856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473103|NCT00401856|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24473104|NCT00401856|Diuretics|diuretics|mesh-ancestor
24473105|NCT00401856|Natriuretic Agents|natriuretic agents|mesh-ancestor
24473151|NCT00402181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473152|NCT00402207|Fluticasone|fluticasone|mesh-list
24473153|NCT00402207|Beclomethasone|beclomethasone|mesh-list
24915279|NCT03568994|Atovaquone|atovaquone|mesh-list
24915280|NCT03568994|Etoposide|etoposide|mesh-list
24915281|NCT03568994|Daunorubicin|daunorubicin|mesh-list
24915282|NCT03568994|Gemtuzumab|gemtuzumab|mesh-list
24915283|NCT03568994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24915284|NCT03568994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915285|NCT03568994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24915286|NCT03568994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24915287|NCT03568994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24915288|NCT03568994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857515|NCT02292121|Natriuretic Agents|natriuretic agents|mesh-ancestor
24857516|NCT02292121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857517|NCT02292121|Cathartics|cathartics|mesh-ancestor
24857518|NCT02292121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24915350|NCT03324035|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24915351|NCT03324035|Narcotics|narcotics|mesh-ancestor
24915352|NCT03324035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24915353|NCT03324035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915354|NCT03324035|Analgesics|analgesics|mesh-ancestor
24915355|NCT03324035|Sensory System Agents|sensory system agents|mesh-ancestor
24915356|NCT03324035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24915357|NCT03324035|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25702343|NCT02153905|Analgesics|analgesics|mesh-ancestor
25019574|NCT03690414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25019575|NCT03690414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019576|NCT03690323|Gemcitabine|gemcitabine|mesh-list
25019681|NCT03689075|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25019682|NCT03689075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25019683|NCT03689075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019684|NCT03689010|Azelaic acid|azelaic acid|mesh-list
25019685|NCT03689010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25020356|NCT03680638|Tempol|tempol|mesh-list
24915358|NCT03324035|Antidepressive Agents|antidepressive agents|mesh-ancestor
24915359|NCT03324035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24915360|NCT03324035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24473198|NCT00402376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473199|NCT00402376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24473200|NCT00402376|Antioxidants|antioxidants|mesh-ancestor
24473201|NCT00402376|Protective Agents|protective agents|mesh-ancestor
24473202|NCT00402376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24473203|NCT00402376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24473204|NCT00402376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24473205|NCT00402376|Vasodilator Agents|vasodilator agents|mesh-ancestor
24473206|NCT00402376|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24473207|NCT00402376|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24444673|NCT00298870|Isoniazid|isoniazid|mesh-list
24444674|NCT00298870|Antitubercular Agents|antitubercular agents|mesh-ancestor
24444675|NCT00298870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24473225|NCT00402415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473227|NCT00402415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24473228|NCT00402415|Growth Substances|growth substances|mesh-ancestor
24473229|NCT00402415|Growth Inhibitors|growth inhibitors|mesh-ancestor
24473230|NCT00402415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24915361|NCT03324035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24915362|NCT03324035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24915363|NCT03324035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24703995|NCT01476007|Hydroxocobalamin|hydroxocobalamin|mesh-list
24857551|NCT02292303|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24857552|NCT02292303|Protective Agents|protective agents|mesh-ancestor
24857553|NCT02292459|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24444383|NCT00297739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24473231|NCT00402415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473232|NCT00402415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702344|NCT02153905|Sensory System Agents|sensory system agents|mesh-ancestor
25702345|NCT02153905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25702346|NCT02153905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25702347|NCT02153905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25702348|NCT02153905|Antiviral Agents|antiviral agents|mesh-ancestor
25702349|NCT02153905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25702350|NCT02153918|Metronidazole|metronidazole|mesh-list
25702351|NCT02153918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25702352|NCT02153918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25702353|NCT02153918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24742454|NCT05264896|Leucovorin|leucovorin|mesh-list
24451088|NCT00321802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451090|NCT00321802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24451091|NCT00321802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451092|NCT00321945|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24704340|NCT01477801|Vitamin D|vitamin d|mesh-list
24857575|NCT02292667|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24857576|NCT02292667|Narcotics|narcotics|mesh-ancestor
24857577|NCT02292667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24857578|NCT02292667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857579|NCT02292667|Analgesics|analgesics|mesh-ancestor
24857580|NCT02292667|Sensory System Agents|sensory system agents|mesh-ancestor
24857581|NCT02292667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857582|NCT02292667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24742230|NCT05296005|Immunologic Factors|immunologic factors|mesh-ancestor
24742231|NCT05296005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742238|NCT05295836|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24742239|NCT05295836|Protective Agents|protective agents|mesh-ancestor
24742241|NCT05295537|Liver Extracts|liver extracts|mesh-list
24857583|NCT02292667|Antipyretics|antipyretics|mesh-ancestor
24857584|NCT02292732|Trametinib|trametinib|mesh-list
24857585|NCT02292732|Norinyl|norinyl|mesh-list
24857586|NCT02292732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460070|NCT00347256|Cisplatin|cisplatin|mesh-list
24451100|NCT00322036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24451101|NCT00322036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534926|NCT00648297|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24473233|NCT00402441|Risedronic Acid|risedronic acid|mesh-list
24473234|NCT00402441|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24473308|NCT00402532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473309|NCT00402532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24473452|NCT00402792|Respiratory System Agents|respiratory system agents|mesh-ancestor
24473453|NCT00402792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24473455|NCT00402792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24473456|NCT00402909|Nateglinide|nateglinide|mesh-list
24473457|NCT00402909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24473458|NCT00402909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473459|NCT00402974|Vitamin K 2|vitamin k 2|mesh-list
24534927|NCT00648297|Adrenergic Agents|adrenergic agents|mesh-ancestor
24534928|NCT00648297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24534929|NCT00648297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534930|NCT00648297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857587|NCT02292732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24857626|NCT02293148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24857627|NCT02293148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704477|NCT01478490|Adrenergic Agents|adrenergic agents|mesh-ancestor
24742449|NCT05266248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742450|NCT05266248|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25021891|NCT03667313|Antimitotic Agents|antimitotic agents|mesh-ancestor
25021892|NCT03667313|Mitosis Modulators|mitosis modulators|mesh-ancestor
24915364|NCT03324035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915365|NCT03324035|Adrenergic Agents|adrenergic agents|mesh-ancestor
24915366|NCT03324035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24915367|NCT03320018|Minocycline|minocycline|mesh-list
24819654|NCT02096419|Purinergic Agents|purinergic agents|mesh-ancestor
24819655|NCT02096419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24819656|NCT02096419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915478|NCT02237508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24915479|NCT02237508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915481|NCT02237508|Protective Agents|protective agents|mesh-ancestor
24473460|NCT00402974|Vitamin K|vitamin k|mesh-list
24473595|NCT00403364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24473652|NCT00403663|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24473653|NCT00403663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24473654|NCT00403663|Anesthetics, General|anesthetics, general|mesh-ancestor
25083293|NCT03317015|Hormones|hormones|mesh-ancestor
24915488|NCT01822288|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24915490|NCT01822288|Medroxyprogesterone|medroxyprogesterone|mesh-list
24915491|NCT01822288|Estradiol|estradiol|mesh-list
24915492|NCT01822288|Estrogens|estrogens|mesh-ancestor
24915493|NCT01822288|Hormones|hormones|mesh-ancestor
24477853|NCT00420537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915494|NCT01822288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24915495|NCT01822288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915496|NCT01822288|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24915497|NCT01822288|Contraceptive Agents|contraceptive agents|mesh-ancestor
24915498|NCT01822288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24915499|NCT01822288|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24915500|NCT01822288|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24915501|NCT01822288|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24915502|NCT01822288|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24535068|NCT00648505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535070|NCT00648518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24535071|NCT00648518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535072|NCT00648531|Balsalazide|balsalazide|mesh-list
24535073|NCT00648531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24535074|NCT00648531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24535075|NCT00648531|Analgesics|analgesics|mesh-ancestor
24535076|NCT00648531|Sensory System Agents|sensory system agents|mesh-ancestor
24535077|NCT00648531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857642|NCT02293187|Micronutrients|micronutrients|mesh-ancestor
24857643|NCT02293187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460147|NCT00347503|Analgesics|analgesics|mesh-ancestor
25702354|NCT02153918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25702355|NCT02153983|Colchicine|colchicine|mesh-list
24535157|NCT00648661|Serotonin Agents|serotonin agents|mesh-ancestor
25702356|NCT02153983|Gout Suppressants|gout suppressants|mesh-ancestor
25702357|NCT02153983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25702358|NCT02153983|Tubulin Modulators|tubulin modulators|mesh-ancestor
25111834|NCT04608474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25111854|NCT04569747|Tamoxifen|tamoxifen|mesh-list
25111855|NCT04569747|Trastuzumab|trastuzumab|mesh-list
25111856|NCT04569747|Pertuzumab|pertuzumab|mesh-list
25111857|NCT04569747|Letrozole|letrozole|mesh-list
25022513|NCT03662113|Autonomic Agents|autonomic agents|mesh-ancestor
25022514|NCT03662113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25022530|NCT03662100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022531|NCT03662100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24535158|NCT00648661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857644|NCT02293187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24460148|NCT00347503|Sensory System Agents|sensory system agents|mesh-ancestor
24535159|NCT00648661|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24535160|NCT00648661|Antidepressive Agents|antidepressive agents|mesh-ancestor
24915503|NCT01822288|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24538712|NCT00660582|Cetuximab|cetuximab|mesh-list
24915505|NCT01822288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915517|NCT01583283|Autonomic Agents|autonomic agents|mesh-ancestor
24915518|NCT01583283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24915519|NCT01583283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915520|NCT01583283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24915521|NCT01583283|Glucocorticoids|glucocorticoids|mesh-ancestor
24915522|NCT01583283|Hormones|hormones|mesh-ancestor
24444586|NCT00298571|Epinephrine|epinephrine|mesh-list
24705047|NCT01481844|Bismuth|bismuth|mesh-list
24705085|NCT01482052|Immunologic Factors|immunologic factors|mesh-ancestor
24535234|NCT00648817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705142|NCT01482338|Hormones|hormones|mesh-ancestor
24915523|NCT01583283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24915524|NCT01583283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24915525|NCT01583283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915599|NCT04250142|Sympathomimetics|sympathomimetics|mesh-ancestor
24915600|NCT04250142|Autonomic Agents|autonomic agents|mesh-ancestor
24535262|NCT00648856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24535263|NCT00648856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535264|NCT00648856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535266|NCT00648856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535268|NCT00648869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24535269|NCT00648869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535270|NCT00648921|Olanzapine|olanzapine|mesh-list
24535271|NCT00648921|Antiemetics|antiemetics|mesh-ancestor
25702359|NCT02153983|Antimitotic Agents|antimitotic agents|mesh-ancestor
25702360|NCT02153983|Mitosis Modulators|mitosis modulators|mesh-ancestor
25702361|NCT02153983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702362|NCT02153983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25702363|NCT02154048|Dexamethasone|dexamethasone|mesh-list
25702364|NCT02154048|Ropivacaine|ropivacaine|mesh-list
25702365|NCT02154048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25702366|NCT02154048|Antiemetics|antiemetics|mesh-ancestor
24535272|NCT00648921|Autonomic Agents|autonomic agents|mesh-ancestor
24535273|NCT00648921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25022864|NCT03658746|Tetracycline|tetracycline|mesh-list
25022865|NCT03658746|Tinidazole|tinidazole|mesh-list
25022866|NCT03658746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25022867|NCT03658746|Furazolidone|furazolidone|mesh-list
25022967|NCT03658421|Sensory System Agents|sensory system agents|mesh-ancestor
25022968|NCT03658421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25022969|NCT03658421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25022970|NCT03658421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25022971|NCT03658421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25022972|NCT03658421|Adrenergic Agents|adrenergic agents|mesh-ancestor
25022973|NCT03658421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24857652|NCT02293291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24857653|NCT02293291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24857654|NCT02293291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857655|NCT02293330|Levobupivacaine|levobupivacaine|mesh-list
24857656|NCT02293330|Anesthetics, Local|anesthetics, local|mesh-ancestor
24857657|NCT02293330|Anesthetics|anesthetics|mesh-ancestor
24535820|NCT00649779|Tocolytic Agents|tocolytic agents|mesh-ancestor
24857726|NCT02293694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24857727|NCT02293694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857728|NCT02293694|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24857729|NCT02293694|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24857730|NCT02293694|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24857731|NCT02293694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24857732|NCT02293694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24857733|NCT02293785|Oxycodone|oxycodone|mesh-list
24857734|NCT02293785|Naloxone|naloxone|mesh-list
24857735|NCT02293785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24857736|NCT02293785|Narcotics|narcotics|mesh-ancestor
24451186|NCT00322569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24451187|NCT00322569|Dermatologic Agents|dermatologic agents|mesh-ancestor
24536137|NCT00650403|Serotonin Agents|serotonin agents|mesh-ancestor
24536138|NCT00650403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536139|NCT00650403|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24536140|NCT00650403|Antidepressive Agents|antidepressive agents|mesh-ancestor
24536191|NCT00650455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24536192|NCT00650455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702367|NCT02154048|Autonomic Agents|autonomic agents|mesh-ancestor
25702368|NCT02154048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25702369|NCT02154048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702370|NCT02154048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25702371|NCT02154048|Glucocorticoids|glucocorticoids|mesh-ancestor
25702372|NCT02154048|Hormones|hormones|mesh-ancestor
25702373|NCT02154048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25702374|NCT02154048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25702375|NCT02154048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25702376|NCT02154048|Anesthetics, Local|anesthetics, local|mesh-ancestor
25702377|NCT02154048|Anesthetics|anesthetics|mesh-ancestor
25023428|NCT03654703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023429|NCT03654703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25023430|NCT03654703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25023460|NCT03654144|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25023461|NCT03654144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25023462|NCT03654144|Hormone Antagonists|hormone antagonists|mesh-ancestor
25023525|NCT03653520|Diazepam|diazepam|mesh-list
24980293|NCT05420454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536362|NCT00650910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536363|NCT00650923|Temozolomide|temozolomide|mesh-list
24536364|NCT00650923|Aflibercept|aflibercept|mesh-list
24536365|NCT00650923|Endothelial Growth Factors|endothelial growth factors|mesh-list
24536366|NCT00650923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24537265|NCT00654121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24537266|NCT00654121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24706726|NCT01491295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538275|NCT00658255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24538633|NCT00660140|Antiviral Agents|antiviral agents|mesh-ancestor
24538634|NCT00660140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24538635|NCT00660140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538710|NCT00660582|Fluorouracil|fluorouracil|mesh-list
24538711|NCT00660582|Oxaliplatin|oxaliplatin|mesh-list
24538713|NCT00660582|Levoleucovorin|levoleucovorin|mesh-list
24538714|NCT00660582|Antimetabolites|antimetabolites|mesh-ancestor
24473916|NCT00404456|Melatonin|melatonin|mesh-list
24473928|NCT00404482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538715|NCT00660582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538716|NCT00660582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24538717|NCT00660582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538718|NCT00660582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24538719|NCT00660582|Immunologic Factors|immunologic factors|mesh-ancestor
25702378|NCT02154048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25702379|NCT02154048|Sensory System Agents|sensory system agents|mesh-ancestor
25702380|NCT02154061|Metronidazole|metronidazole|mesh-list
25702381|NCT02154061|Vancomycin|vancomycin|mesh-list
25702382|NCT02154061|Neomycin|neomycin|mesh-list
25702383|NCT02154061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25702384|NCT02154061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25702385|NCT02154061|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25702386|NCT02154061|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24857806|NCT02294084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857807|NCT02294110|Anesthetics|anesthetics|mesh-list
24707067|NCT01493973|Epoetin Alfa|epoetin alfa|mesh-list
24743078|NCT05013502|Empagliflozin|empagliflozin|mesh-list
24446214|NCT00304018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24473937|NCT00404508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473957|NCT00404534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538989|NCT00661596|Urological Agents|urological agents|mesh-ancestor
24538991|NCT00661635|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24538992|NCT00661635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24538993|NCT00661635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538994|NCT00661635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542891|NCT00680732|Folic Acid|folic acid|mesh-list
24445072|NCT00300313|Citalopram|citalopram|mesh-list
24445073|NCT00300313|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24445074|NCT00300313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24445075|NCT00300313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24857821|NCT02294162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24857824|NCT02294240|Folic Acid|folic acid|mesh-list
24971890|NCT03721679|Atezolizumab|atezolizumab|mesh-list
24915601|NCT04250142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24505099|NCT00539799|Glucocorticoids|glucocorticoids|mesh-ancestor
24541947|NCT00676039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24541948|NCT00676039|Antidepressive Agents|antidepressive agents|mesh-ancestor
24541949|NCT00676039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24541950|NCT00676039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24541951|NCT00676039|Serotonin Agents|serotonin agents|mesh-ancestor
24541952|NCT00676117|Loxoprofen|loxoprofen|mesh-list
24541953|NCT00676117|Esomeprazole|esomeprazole|mesh-list
24541954|NCT00676117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24541955|NCT00676117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24541956|NCT00676117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24541957|NCT00676117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542281|NCT00678145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24542282|NCT00678145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24542285|NCT00678145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24542286|NCT00678145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542287|NCT00678145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24743471|NCT04774315|Omalizumab|omalizumab|mesh-list
24542878|NCT00680641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24542879|NCT00680641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542881|NCT00680654|Enzyme Activators|enzyme activators|mesh-ancestor
24542882|NCT00680654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542883|NCT00680680|Dutasteride|dutasteride|mesh-list
25702387|NCT02154061|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25702388|NCT02154061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25702389|NCT02154061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702390|NCT02154139|Leuprolide|leuprolide|mesh-list
25702391|NCT02154139|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25702392|NCT02154139|Fertility Agents|fertility agents|mesh-ancestor
25702393|NCT02154139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24542885|NCT00680680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24542886|NCT00680680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542887|NCT00680680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542888|NCT00680680|Hormone Antagonists|hormone antagonists|mesh-ancestor
24542889|NCT00680680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24542890|NCT00680680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915973|NCT04246697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24857923|NCT02294357|Protease Inhibitors|protease inhibitors|mesh-ancestor
24520477|NCT01497509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520478|NCT01497509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24915727|NCT04249063|Sensory System Agents|sensory system agents|mesh-ancestor
24915728|NCT04249063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24915729|NCT04249063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24915730|NCT04249063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24915731|NCT04249063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24915732|NCT04249063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24915733|NCT04249063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915734|NCT04249037|Tenofovir|tenofovir|mesh-list
24915735|NCT04249037|Emtricitabine|emtricitabine|mesh-list
24915736|NCT04249037|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
24915737|NCT04249037|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24915738|NCT04249037|Antiviral Agents|antiviral agents|mesh-ancestor
24474043|NCT00404781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24474044|NCT00404781|Protective Agents|protective agents|mesh-ancestor
24474053|NCT00404794|Tacrolimus|tacrolimus|mesh-list
24474054|NCT00404794|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24474055|NCT00404794|Prednisolone phosphate|prednisolone phosphate|mesh-list
24915746|NCT04248621|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24915747|NCT04248621|Leuprolide|leuprolide|mesh-list
24915748|NCT04248621|Flutamide|flutamide|mesh-list
24915749|NCT04248621|Bicalutamide|bicalutamide|mesh-list
24915750|NCT04248621|Androgen Antagonists|androgen antagonists|mesh-list
24915751|NCT04248621|Androgens|androgens|mesh-list
24915804|NCT04247984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24915805|NCT04247984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915806|NCT04247984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24915807|NCT04247984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24915808|NCT04247984|Growth Substances|growth substances|mesh-ancestor
24915809|NCT04247984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024776|NCT03642847|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25024777|NCT03642847|Immunologic Factors|immunologic factors|mesh-ancestor
25024778|NCT03642847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024779|NCT03642665|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25024780|NCT03642665|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24474072|NCT00404794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24474073|NCT00404794|Antiemetics|antiemetics|mesh-ancestor
24474074|NCT00404794|Autonomic Agents|autonomic agents|mesh-ancestor
24474075|NCT00404794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24474076|NCT00404794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24474077|NCT00404794|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24474078|NCT00404794|Protective Agents|protective agents|mesh-ancestor
24474079|NCT00404833|Mycophenolic Acid|mycophenolic acid|mesh-list
24543076|NCT00681876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543084|NCT00681902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24543085|NCT00681902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24543086|NCT00681902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24543087|NCT00681902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24543088|NCT00681902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24543138|NCT00681993|Antimitotic Agents|antimitotic agents|mesh-ancestor
24543139|NCT00681993|Mitosis Modulators|mitosis modulators|mesh-ancestor
24543140|NCT00681993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24543141|NCT00681993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24543172|NCT00682214|Vitamin D|vitamin d|mesh-list
24543196|NCT00682344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24644987|NCT01194778|Vitamins|vitamins|mesh-list
24543384|NCT00683319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446360|NCT00304551|Immunologic Factors|immunologic factors|mesh-ancestor
24915974|NCT04246697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24543595|NCT00684450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543597|NCT00684463|Palonosetron|palonosetron|mesh-list
24543598|NCT00684463|Antiemetics|antiemetics|mesh-ancestor
24744017|NCT04540133|Glucocorticoids|glucocorticoids|mesh-ancestor
24744018|NCT04540133|Hormones|hormones|mesh-ancestor
24744019|NCT04540133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24543618|NCT00684606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543619|NCT00684632|Fentanyl|fentanyl|mesh-list
24543620|NCT00684632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24543621|NCT00684632|Narcotics|narcotics|mesh-ancestor
24543622|NCT00684632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25702394|NCT02154139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702395|NCT02154139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25702396|NCT02154139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25702397|NCT02154243|Midodrine|midodrine|mesh-list
25702398|NCT02154243|Sympathomimetics|sympathomimetics|mesh-ancestor
25702399|NCT02154243|Autonomic Agents|autonomic agents|mesh-ancestor
25702400|NCT02154243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25025230|NCT03639155|Glycine|glycine|mesh-list
25025231|NCT03639155|Glycine Agents|glycine agents|mesh-ancestor
25025232|NCT03639155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25025233|NCT03639155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025234|NCT03639155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025235|NCT03638960|Bupivacaine|bupivacaine|mesh-list
25025236|NCT03638960|Anesthetics, Local|anesthetics, local|mesh-ancestor
25025242|NCT03638869|Methadone|methadone|mesh-list
24543623|NCT00684632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543624|NCT00684632|Analgesics|analgesics|mesh-ancestor
24543625|NCT00684632|Sensory System Agents|sensory system agents|mesh-ancestor
24543626|NCT00684632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24543627|NCT00684632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24543628|NCT00684632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24543647|NCT00684853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24708897|NCT01503398|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24543772|NCT00685425|Tocolytic Agents|tocolytic agents|mesh-ancestor
24543773|NCT00685425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24614040|NCT01022138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543783|NCT00685503|Ranibizumab|ranibizumab|mesh-list
24543784|NCT00685503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24543785|NCT00685503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24543786|NCT00685503|Growth Substances|growth substances|mesh-ancestor
24543787|NCT00685503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915815|NCT04247984|Immunologic Factors|immunologic factors|mesh-ancestor
24915816|NCT04247984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24915817|NCT04247984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24915818|NCT04247984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24915819|NCT04248101|Silver Nitrate|silver nitrate|mesh-list
24915967|NCT04246697|Sensory System Agents|sensory system agents|mesh-ancestor
24915968|NCT04246697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24915969|NCT04246697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24915970|NCT04246697|Narcotics|narcotics|mesh-ancestor
24915971|NCT04246697|Analgesics|analgesics|mesh-ancestor
24915972|NCT04246697|Anticonvulsants|anticonvulsants|mesh-ancestor
24915975|NCT04246697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24915976|NCT04246697|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24915977|NCT04246697|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24915978|NCT04246697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24915979|NCT04246697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915980|NCT04246697|Antimanic Agents|antimanic agents|mesh-ancestor
24915981|NCT04246697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24915982|NCT04246697|Antipyretics|antipyretics|mesh-ancestor
25702401|NCT02154243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702402|NCT02154243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25702403|NCT02154243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25702404|NCT02154243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25702405|NCT02154243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25702406|NCT02154243|Adrenergic Agents|adrenergic agents|mesh-ancestor
25702407|NCT02154243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24916028|NCT04245371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25112369|NCT04157751|Empagliflozin|empagliflozin|mesh-list
24590243|NCT00911287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24982101|NCT04245748|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25702408|NCT02154243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025372|NCT03638037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025373|NCT03638037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25025375|NCT03637790|Abrocitinib|abrocitinib|mesh-list
25025376|NCT03637790|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24916029|NCT04245371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916030|NCT04245371|Sensory System Agents|sensory system agents|mesh-ancestor
24916031|NCT04245371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24916032|NCT04245371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24916033|NCT04245371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24916034|NCT04245371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24543788|NCT00685503|Growth Inhibitors|growth inhibitors|mesh-ancestor
24543791|NCT00685529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24857981|NCT02294591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543811|NCT00685568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543813|NCT00685568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24543814|NCT00685568|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24543815|NCT00685568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24543816|NCT00685568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543841|NCT00685646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24543842|NCT00685646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543858|NCT00685672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24543859|NCT00685672|Respiratory System Agents|respiratory system agents|mesh-ancestor
24543862|NCT00685672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24543863|NCT00685776|Anacetrapib|anacetrapib|mesh-list
24543864|NCT00685776|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24543865|NCT00685776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24543866|NCT00685776|Antimetabolites|antimetabolites|mesh-ancestor
24505102|NCT00539799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447021|NCT00307203|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24857992|NCT02294617|Cholinergic Agents|cholinergic agents|mesh-ancestor
24857993|NCT02294617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24857994|NCT02294617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857996|NCT02294643|Sarpogrelate|sarpogrelate|mesh-list
24543953|NCT00686140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24916035|NCT04245371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24916036|NCT04245371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819700|NCT02096926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24819701|NCT02096926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24819702|NCT02096926|Analgesics|analgesics|mesh-ancestor
25702409|NCT02154347|Mitiglinide|mitiglinide|mesh-list
25702410|NCT02154347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25702411|NCT02154347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702412|NCT02154425|Certolizumab Pegol|certolizumab pegol|mesh-list
25702413|NCT02154425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25702414|NCT02154425|Immunologic Factors|immunologic factors|mesh-ancestor
25702415|NCT02154425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702416|NCT02154425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24819703|NCT02096926|Sensory System Agents|sensory system agents|mesh-ancestor
24819704|NCT02096926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24819705|NCT02096926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819706|NCT02096926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24819707|NCT02096926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24819708|NCT02096926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24819709|NCT02096926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491258|NCT00481819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916296|NCT04242758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446403|NCT00304642|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24446404|NCT00304642|Antiviral Agents|antiviral agents|mesh-ancestor
24446405|NCT00304642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446407|NCT00304655|Antidepressive Agents|antidepressive agents|mesh-ancestor
24446408|NCT00304655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24916298|NCT04242758|Diuretics|diuretics|mesh-ancestor
24916299|NCT04242758|Natriuretic Agents|natriuretic agents|mesh-ancestor
24916300|NCT04242758|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24916301|NCT04242758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24916302|NCT04242212|Misoprostol|misoprostol|mesh-list
24916303|NCT04242212|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24543954|NCT00686140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24543955|NCT00686140|Analgesics|analgesics|mesh-ancestor
24543960|NCT00686140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24543961|NCT00686140|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24543962|NCT00686140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24543963|NCT00686140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479471|NCT00426998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543964|NCT00686140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543965|NCT00686179|Moxifloxacin|moxifloxacin|mesh-list
24543966|NCT00686179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24543967|NCT00686179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446658|NCT00305552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24543969|NCT00686179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24543971|NCT00686179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544001|NCT00686361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24544002|NCT00686361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24544004|NCT00686374|Adalimumab|adalimumab|mesh-list
24544005|NCT00686374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24544006|NCT00686374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24544007|NCT00686439|Adalimumab|adalimumab|mesh-list
24544068|NCT00686985|Tubulin Modulators|tubulin modulators|mesh-ancestor
24544069|NCT00686985|Antimitotic Agents|antimitotic agents|mesh-ancestor
24544070|NCT00686985|Mitosis Modulators|mitosis modulators|mesh-ancestor
24544071|NCT00686985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544072|NCT00687011|Dexamethasone|dexamethasone|mesh-list
24544073|NCT00687011|Palonosetron|palonosetron|mesh-list
24544074|NCT00687011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24544075|NCT00687011|Antiemetics|antiemetics|mesh-ancestor
24544076|NCT00687011|Autonomic Agents|autonomic agents|mesh-ancestor
24544077|NCT00687011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24544078|NCT00687011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544079|NCT00687011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24544080|NCT00687011|Glucocorticoids|glucocorticoids|mesh-ancestor
24544081|NCT00687011|Hormones|hormones|mesh-ancestor
24544082|NCT00687011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24544083|NCT00687011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25026017|NCT03632369|Xenon|xenon|mesh-list
24544084|NCT00687011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474243|NCT00405301|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24972267|NCT03719261|Hemostatics|hemostatics|mesh-ancestor
24916304|NCT04242212|Abortifacient Agents|abortifacient agents|mesh-ancestor
24916305|NCT04242212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24916306|NCT04242212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916307|NCT04242212|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24916311|NCT04242368|Xhance|xhance|mesh-list
24916312|NCT04242368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24916313|NCT04242368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24916314|NCT04242368|Autonomic Agents|autonomic agents|mesh-ancestor
24916315|NCT04242368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24916316|NCT04242368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916345|NCT04241731|Cetuximab|cetuximab|mesh-list
24916353|NCT04241731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916451|NCT04240834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24916453|NCT04240834|Analgesics|analgesics|mesh-ancestor
24916454|NCT04240834|Sensory System Agents|sensory system agents|mesh-ancestor
24916455|NCT04240834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24916456|NCT04240834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916457|NCT04240834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24709319|NCT01505088|Hormones|hormones|mesh-ancestor
24474264|NCT00405405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24474265|NCT00405405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474266|NCT00405405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24474267|NCT00405405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24474268|NCT00405405|Growth Substances|growth substances|mesh-ancestor
24474269|NCT00405405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709410|NCT01505439|Solifenacin Succinate|solifenacin succinate|mesh-list
25702417|NCT02154477|Insulin|insulin|mesh-list
25702418|NCT02154477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25702419|NCT02154477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702420|NCT02154763|Ropivacaine|ropivacaine|mesh-list
25702421|NCT02154763|Anesthetics, Local|anesthetics, local|mesh-ancestor
25702422|NCT02154763|Anesthetics|anesthetics|mesh-ancestor
25702423|NCT02154763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25702424|NCT02154763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702425|NCT02154763|Sensory System Agents|sensory system agents|mesh-ancestor
25702426|NCT02154763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25702427|NCT02155010|Dexmedetomidine|dexmedetomidine|mesh-list
24544172|NCT00687648|Dermatologic Agents|dermatologic agents|mesh-ancestor
24544173|NCT00687648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544174|NCT00687648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24544175|NCT00687648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24544176|NCT00687648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24447096|NCT00307502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24447098|NCT00307502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24447099|NCT00307502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24447100|NCT00307502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24447101|NCT00307502|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24544195|NCT00687700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24916458|NCT04240834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24916459|NCT04240834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24916460|NCT04240834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24916461|NCT04240834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446455|NCT00304772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24446456|NCT00304772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916462|NCT04240834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24916463|NCT04240834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24916464|NCT04240834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916465|NCT04240834|Antipyretics|antipyretics|mesh-ancestor
24916468|NCT04240834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24819803|NCT02097329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24819804|NCT02097329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24819805|NCT02097329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819810|NCT02097329|Histamine Antagonists|histamine antagonists|mesh-ancestor
24819813|NCT02097329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819814|NCT02097329|Antioxidants|antioxidants|mesh-ancestor
24819815|NCT02097329|Protective Agents|protective agents|mesh-ancestor
24819816|NCT02097329|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24819817|NCT02097329|Immunologic Factors|immunologic factors|mesh-ancestor
24819818|NCT02097342|Linagliptin|linagliptin|mesh-list
24916522|NCT04239859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24544197|NCT00687700|Vasodilator Agents|vasodilator agents|mesh-ancestor
24709531|NCT01506050|Histamine Agents|histamine agents|mesh-ancestor
24474300|NCT00405457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474301|NCT00405457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474302|NCT00405457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24474303|NCT00405457|Immunologic Factors|immunologic factors|mesh-ancestor
25702428|NCT02155010|Bupivacaine|bupivacaine|mesh-list
25702429|NCT02155010|Anesthetics, Local|anesthetics, local|mesh-ancestor
25702430|NCT02155010|Anesthetics|anesthetics|mesh-ancestor
25702431|NCT02155010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25702432|NCT02155010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026236|NCT03630614|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25026237|NCT03630614|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25026238|NCT03630614|Cholinergic Agents|cholinergic agents|mesh-ancestor
25026239|NCT03630614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24446661|NCT00305552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24858011|NCT02294643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709618|NCT01506505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24916616|NCT04238767|Antiviral Agents|antiviral agents|mesh-ancestor
24916617|NCT04238767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24916618|NCT04238806|Desflurane|desflurane|mesh-list
24916619|NCT04238806|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24916620|NCT04238806|Anesthetics, General|anesthetics, general|mesh-ancestor
24916621|NCT04238806|Anesthetics|anesthetics|mesh-ancestor
24916622|NCT04238806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24447145|NCT00307606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24447146|NCT00307606|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24447147|NCT00307606|Protective Agents|protective agents|mesh-ancestor
24447148|NCT00307606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24447149|NCT00307606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447150|NCT00307619|Topiramate|topiramate|mesh-list
24447151|NCT00307619|Anticonvulsants|anticonvulsants|mesh-ancestor
24447152|NCT00307619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24447154|NCT00307632|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24544287|NCT00688363|Analgesics|analgesics|mesh-ancestor
24544288|NCT00688363|Sensory System Agents|sensory system agents|mesh-ancestor
24858017|NCT02294643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24858018|NCT02294643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24858019|NCT02294643|Serotonin Agents|serotonin agents|mesh-ancestor
24474354|NCT00405730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474355|NCT00405730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474356|NCT00405769|Red yeast rice|red yeast rice|mesh-list
24474357|NCT00405769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24807539|NCT02022488|GABA Agents|gaba agents|mesh-ancestor
24544443|NCT00689000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544445|NCT00689000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24544446|NCT00689000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544447|NCT00689143|Sargramostim|sargramostim|mesh-list
24544448|NCT00689143|Immunologic Factors|immunologic factors|mesh-ancestor
24544449|NCT00689143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544450|NCT00689156|Cyclophosphamide|cyclophosphamide|mesh-list
24544451|NCT00689156|Docetaxel|docetaxel|mesh-list
24544495|NCT00689195|Sensory System Agents|sensory system agents|mesh-ancestor
25702433|NCT02155010|Sensory System Agents|sensory system agents|mesh-ancestor
25702434|NCT02155010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25702435|NCT02155010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25702436|NCT02155010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25702437|NCT02155010|Analgesics|analgesics|mesh-ancestor
25702438|NCT02155010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25702439|NCT02155010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25702440|NCT02155010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25702441|NCT02155010|Adrenergic Agents|adrenergic agents|mesh-ancestor
25702442|NCT02155010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25026432|NCT03628521|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25026433|NCT03628521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25026434|NCT03628521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25026435|NCT03628521|Antimetabolites|antimetabolites|mesh-ancestor
25026436|NCT03628521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026437|NCT03628521|Antiviral Agents|antiviral agents|mesh-ancestor
24544496|NCT00689195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24544497|NCT00689195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544498|NCT00689195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24544499|NCT00689195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24544500|NCT00689195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544501|NCT00689195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544502|NCT00689195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544503|NCT00689208|Atropine|atropine|mesh-list
24916703|NCT04237987|Interleukin-2|interleukin-2|mesh-list
24916704|NCT04237987|Cyclosporins|cyclosporins|mesh-list
24916705|NCT04237987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916706|NCT04237987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916707|NCT04237987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24916708|NCT04237987|Immunologic Factors|immunologic factors|mesh-ancestor
24916709|NCT04237987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916710|NCT04237987|Antifungal Agents|antifungal agents|mesh-ancestor
24916711|NCT04237987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24916712|NCT04237987|Dermatologic Agents|dermatologic agents|mesh-ancestor
24916713|NCT04237987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24916718|NCT04237987|Sensory System Agents|sensory system agents|mesh-ancestor
24916740|NCT04237935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24916741|NCT04237935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916742|NCT04237935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916743|NCT04237597|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
24916744|NCT04237597|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24916745|NCT04237597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916746|NCT04237597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24916747|NCT04237597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916748|NCT04237532|Dexmedetomidine|dexmedetomidine|mesh-list
24916749|NCT04237532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24916750|NCT04237532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24544504|NCT00689208|Physostigmine|physostigmine|mesh-list
24544505|NCT00689208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24544506|NCT00689208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24544507|NCT00689208|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24544508|NCT00689208|Autonomic Agents|autonomic agents|mesh-ancestor
24544558|NCT00689520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544560|NCT00689520|Coagulants|coagulants|mesh-ancestor
24544561|NCT00689520|Anticoagulants|anticoagulants|mesh-ancestor
24544562|NCT00689520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24544563|NCT00689559|Aripiprazole|aripiprazole|mesh-list
24544564|NCT00689559|Antidepressive Agents|antidepressive agents|mesh-ancestor
24544565|NCT00689559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24544566|NCT00689559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24916751|NCT04237532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916752|NCT04237532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24916753|NCT04237532|Analgesics|analgesics|mesh-ancestor
24916754|NCT04237532|Sensory System Agents|sensory system agents|mesh-ancestor
25702443|NCT02155010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702444|NCT02155101|Ritonavir|ritonavir|mesh-list
25702445|NCT02155101|Lopinavir|lopinavir|mesh-list
25702446|NCT02155101|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25702447|NCT02155101|Darunavir|darunavir|mesh-list
25702448|NCT02155101|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24446580|NCT00305396|Antifungal Agents|antifungal agents|mesh-ancestor
24446581|NCT00305396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24446582|NCT00305396|Immunologic Factors|immunologic factors|mesh-ancestor
24446583|NCT00305396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916755|NCT04237532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24916756|NCT04237532|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24916757|NCT04237532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24916758|NCT04237532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24916759|NCT04237532|Adrenergic Agents|adrenergic agents|mesh-ancestor
24916760|NCT04237532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24491583|NCT00483067|Immunologic Factors|immunologic factors|mesh-ancestor
24520523|NCT05337969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24520524|NCT05337969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520525|NCT05337969|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24520526|NCT05337969|Protease Inhibitors|protease inhibitors|mesh-ancestor
24544629|NCT00689715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544631|NCT00689715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24544632|NCT00689715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24446593|NCT00305422|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24446594|NCT00305422|Serotonin Agents|serotonin agents|mesh-ancestor
24446595|NCT00305422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24446596|NCT00305422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446597|NCT00305422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446598|NCT00305422|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24544633|NCT00689715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544634|NCT00689780|Midazolam|midazolam|mesh-list
24544635|NCT00689780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24544636|NCT00689780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24544663|NCT00689832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544664|NCT00689832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24544665|NCT00689832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544666|NCT00689832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026872|NCT03624595|Analgesics|analgesics|mesh-ancestor
24544667|NCT00689832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24544673|NCT00689832|Dermatologic Agents|dermatologic agents|mesh-ancestor
24544674|NCT00689832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24544677|NCT00689845|Prednisolone|prednisolone|mesh-list
24544678|NCT00689845|Cyclophosphamide|cyclophosphamide|mesh-list
24544679|NCT00689845|Ifosfamide|ifosfamide|mesh-list
24544680|NCT00689845|Rituximab|rituximab|mesh-list
24544681|NCT00689845|Doxorubicin|doxorubicin|mesh-list
24544682|NCT00689845|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24544683|NCT00689845|Methotrexate|methotrexate|mesh-list
24544684|NCT00689845|Etoposide|etoposide|mesh-list
24447207|NCT00307671|Mycophenolic Acid|mycophenolic acid|mesh-list
24858038|NCT02294656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858039|NCT02294838|Citric Acid|citric acid|mesh-list
24443230|NCT00294099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520527|NCT05337969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24520528|NCT05337969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520530|NCT05337657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520531|NCT05337657|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24520532|NCT05337657|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24520533|NCT05337657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24858041|NCT02294838|Anticoagulants|anticoagulants|mesh-ancestor
24858042|NCT02294838|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24858043|NCT02294838|Chelating Agents|chelating agents|mesh-ancestor
24858044|NCT02294838|Sequestering Agents|sequestering agents|mesh-ancestor
24447186|NCT00307645|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24447187|NCT00307645|Antitubercular Agents|antitubercular agents|mesh-ancestor
24447188|NCT00307645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24447189|NCT00307645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24447190|NCT00307645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24447191|NCT00307645|Antiemetics|antiemetics|mesh-ancestor
24447192|NCT00307645|Autonomic Agents|autonomic agents|mesh-ancestor
24447193|NCT00307645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24447194|NCT00307645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24447195|NCT00307645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24447196|NCT00307645|Protective Agents|protective agents|mesh-ancestor
24447197|NCT00307645|Antimetabolites|antimetabolites|mesh-ancestor
24447198|NCT00307645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24447199|NCT00307658|Immunoglobulins|immunoglobulins|mesh-list
24447200|NCT00307658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24447201|NCT00307658|Antibodies|antibodies|mesh-list
24447202|NCT00307658|Immunoglobulin G|immunoglobulin g|mesh-list
24544753|NCT00690105|Immunologic Factors|immunologic factors|mesh-ancestor
24544754|NCT00690105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520534|NCT05337657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520539|NCT05337332|Triamcinolone|triamcinolone|mesh-list
24916857|NCT04236323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24916858|NCT04236323|Narcotics|narcotics|mesh-ancestor
24916859|NCT04236323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24916860|NCT04236323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916861|NCT04236323|Analgesics|analgesics|mesh-ancestor
24916862|NCT04236323|Sensory System Agents|sensory system agents|mesh-ancestor
24544756|NCT00690105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544757|NCT00690105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544758|NCT00690105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24544759|NCT00690105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25702449|NCT02155101|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25702450|NCT02155101|Protease Inhibitors|protease inhibitors|mesh-ancestor
25702451|NCT02155101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25027102|NCT03622541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25027103|NCT03622541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25027104|NCT03622541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027106|NCT03622502|Remifentanil|remifentanil|mesh-list
25027107|NCT03622502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25027108|NCT03622502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25027109|NCT03622502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027110|NCT03622502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25027111|NCT03622502|Analgesics|analgesics|mesh-ancestor
25027112|NCT03622502|Sensory System Agents|sensory system agents|mesh-ancestor
24614232|NCT01023100|Tofacitinib|tofacitinib|mesh-list
24710430|NCT01510561|Gemcitabine|gemcitabine|mesh-list
24916867|NCT04236310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24916868|NCT04236310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25702452|NCT02155101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702453|NCT02155101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25702454|NCT02155101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25702455|NCT02155101|Antiviral Agents|antiviral agents|mesh-ancestor
25702456|NCT02155101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25702457|NCT02155101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25702458|NCT02155101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25702459|NCT02155257|Gabapentin|gabapentin|mesh-list
25702460|NCT02155257|Modafinil|modafinil|mesh-list
25702461|NCT02155257|Analgesics|analgesics|mesh-ancestor
25702462|NCT02155257|Sensory System Agents|sensory system agents|mesh-ancestor
25702463|NCT02155257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027288|NCT03621046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24592563|NCT00922649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027331|NCT03620825|Gout Suppressants|gout suppressants|mesh-ancestor
25027332|NCT03620825|Tocolytic Agents|tocolytic agents|mesh-ancestor
25027333|NCT03620825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25027334|NCT03620825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25027335|NCT03620825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25027336|NCT03620825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027337|NCT03620760|Aspirin|aspirin|mesh-list
25027338|NCT03620760|Ticagrelor|ticagrelor|mesh-list
25027339|NCT03620760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25027340|NCT03620760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25027341|NCT03620760|Analgesics|analgesics|mesh-ancestor
25027400|NCT03620513|Mydriatics|mydriatics|mesh-ancestor
24544845|NCT00690560|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24544847|NCT00690560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24544848|NCT00690560|Immunologic Factors|immunologic factors|mesh-ancestor
24544849|NCT00690560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474497|NCT00406250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474498|NCT00406250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24474499|NCT00406250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24474500|NCT00406250|Growth Substances|growth substances|mesh-ancestor
24474501|NCT00406250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474502|NCT00406250|Growth Inhibitors|growth inhibitors|mesh-ancestor
24474506|NCT00406302|Docetaxel|docetaxel|mesh-list
24474524|NCT00406380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24474525|NCT00406380|Growth Substances|growth substances|mesh-ancestor
24544850|NCT00690560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24972682|NCT03715725|Apixaban|apixaban|mesh-list
24916869|NCT04236310|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24916870|NCT04236310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24916871|NCT04236310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916872|NCT04236310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520593|NCT05336825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24520594|NCT05336825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24520595|NCT05336825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24520596|NCT05336825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24520597|NCT05336825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24917012|NCT04234776|Antidepressive Agents|antidepressive agents|mesh-ancestor
24917013|NCT04234776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24917067|NCT04234191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24917068|NCT04234191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917069|NCT04234191|Analgesics|analgesics|mesh-ancestor
24917070|NCT04234191|Sensory System Agents|sensory system agents|mesh-ancestor
24491863|NCT00484237|Analgesics|analgesics|mesh-ancestor
24447211|NCT00307671|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24447212|NCT00307671|Prednisolone|prednisolone|mesh-list
24447213|NCT00307671|Prednisolone acetate|prednisolone acetate|mesh-list
24447214|NCT00307671|Cyclophosphamide|cyclophosphamide|mesh-list
24447215|NCT00307671|Methotrexate|methotrexate|mesh-list
24447216|NCT00307671|Azathioprine|azathioprine|mesh-list
24447217|NCT00307671|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24447218|NCT00307671|Prednisolone phosphate|prednisolone phosphate|mesh-list
25702464|NCT02155257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702465|NCT02155257|Anticonvulsants|anticonvulsants|mesh-ancestor
25702466|NCT02155257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25702467|NCT02155257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25702468|NCT02155257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25702469|NCT02155257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25702470|NCT02155257|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25702471|NCT02155257|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25702472|NCT02155257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25702473|NCT02155257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702474|NCT02155257|Antimanic Agents|antimanic agents|mesh-ancestor
25702475|NCT02155257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25702476|NCT02155257|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25702477|NCT02155257|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24447219|NCT00307671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24447220|NCT00307671|Immunologic Factors|immunologic factors|mesh-ancestor
24544859|NCT00690560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24544860|NCT00690560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544861|NCT00690560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24544862|NCT00690560|Glucocorticoids|glucocorticoids|mesh-ancestor
24447221|NCT00307671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447222|NCT00307671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24447223|NCT00307671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24447224|NCT00307671|Alkylating Agents|alkylating agents|mesh-ancestor
24447225|NCT00307671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447226|NCT00307671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447227|NCT00307671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24447228|NCT00307671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24447229|NCT00307671|Glucocorticoids|glucocorticoids|mesh-ancestor
24447230|NCT00307671|Hormones|hormones|mesh-ancestor
24858059|NCT02294955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24858068|NCT02294955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474547|NCT00406471|Growth Inhibitors|growth inhibitors|mesh-ancestor
24474564|NCT00406679|Acetaminophen|acetaminophen|mesh-list
25702478|NCT02155257|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25702479|NCT02155309|Scopolamine|scopolamine|mesh-list
25702480|NCT02155309|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25702481|NCT02155309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25702482|NCT02155309|Antiemetics|antiemetics|mesh-ancestor
25702483|NCT02155309|Autonomic Agents|autonomic agents|mesh-ancestor
25702484|NCT02155309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25702485|NCT02155309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027845|NCT03616405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25027846|NCT03616405|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25027847|NCT03616301|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25027848|NCT03616301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25027849|NCT03616301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24746988|NCT02426658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24491864|NCT00484237|Sensory System Agents|sensory system agents|mesh-ancestor
24491865|NCT00484237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24520604|NCT05336721|Capecitabine|capecitabine|mesh-list
24520605|NCT05336721|Chiauranib|chiauranib|mesh-list
24520606|NCT05336721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24520607|NCT05336721|Antimetabolites|antimetabolites|mesh-ancestor
24520609|NCT05336721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474571|NCT00406679|Antipyretics|antipyretics|mesh-ancestor
24474572|NCT00406731|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
24474573|NCT00406731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474575|NCT00406744|Bevacizumab|bevacizumab|mesh-list
24491800|NCT00484003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24917100|NCT04233294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24917101|NCT04233294|Antimetabolites|antimetabolites|mesh-ancestor
24544904|NCT00690885|Interferon alpha-2|interferon alpha-2|mesh-list
24544905|NCT00690885|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
24544906|NCT00690885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544907|NCT00690885|Antiviral Agents|antiviral agents|mesh-ancestor
24544908|NCT00690885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24544909|NCT00690885|Immunologic Factors|immunologic factors|mesh-ancestor
24544916|NCT00690937|Chelating Agents|chelating agents|mesh-ancestor
25702486|NCT02155309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25702487|NCT02155309|Mydriatics|mydriatics|mesh-ancestor
25702488|NCT02155309|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25702489|NCT02155309|Cholinergic Agents|cholinergic agents|mesh-ancestor
25702490|NCT02155309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25702491|NCT02155309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028266|NCT03612401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028267|NCT03612401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474665|NCT00406991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24474666|NCT00406991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474668|NCT00406991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24474726|NCT00407186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447260|NCT00307723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24710781|NCT01511770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24879524|NCT04705818|Durvalumab|durvalumab|mesh-list
24411848|NCT00190268|Amifampridine|amifampridine|mesh-list
24411892|NCT00190333|Citalopram|citalopram|mesh-list
24710964|NCT01512537|Vitamin D|vitamin d|mesh-list
24545064|NCT00691795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24447291|NCT00307996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447292|NCT00307996|Vitamins|vitamins|mesh-ancestor
24858082|NCT02295046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858083|NCT02295046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24545074|NCT00691886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24545075|NCT00691886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24545076|NCT00691886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545077|NCT00691886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25702492|NCT02155309|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25702493|NCT02155309|Parasympatholytics|parasympatholytics|mesh-ancestor
25702494|NCT02155322|Interferons|interferons|mesh-list
25702495|NCT02155322|Interferon-alpha|interferon-alpha|mesh-list
24917102|NCT04233294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917103|NCT04233294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917104|NCT04233294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917105|NCT04233463|Budesonide|budesonide|mesh-list
24917106|NCT04233463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24917107|NCT04233463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24917108|NCT04233463|Autonomic Agents|autonomic agents|mesh-ancestor
24917109|NCT04233463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24917110|NCT04233463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917111|NCT04233463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24520698|NCT05334251|Anesthetics|anesthetics|mesh-list
24520699|NCT05334251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24858107|NCT02295150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879650|NCT04580277|Tofacitinib|tofacitinib|mesh-list
24545174|NCT00692263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24545205|NCT00692510|Omeprazole|omeprazole|mesh-list
24545206|NCT00692510|Bilirubin|bilirubin|mesh-list
24545207|NCT00692510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24447303|NCT00308048|Immunologic Factors|immunologic factors|mesh-ancestor
24447304|NCT00308048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447305|NCT00308100|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24447306|NCT00308100|Plasma Substitutes|plasma substitutes|mesh-ancestor
24447307|NCT00308100|Blood Substitutes|blood substitutes|mesh-ancestor
24858133|NCT02295475|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24858134|NCT02295475|Antithrombins|antithrombins|mesh-ancestor
24858135|NCT02295475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25029121|NCT03605056|Immunologic Factors|immunologic factors|mesh-ancestor
25029122|NCT03605056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25029123|NCT03605056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25029124|NCT03605056|Growth Substances|growth substances|mesh-ancestor
25029125|NCT03605056|Growth Inhibitors|growth inhibitors|mesh-ancestor
25113073|NCT03587311|Antimitotic Agents|antimitotic agents|mesh-ancestor
25113074|NCT03587311|Mitosis Modulators|mitosis modulators|mesh-ancestor
25113081|NCT03587311|Immunologic Factors|immunologic factors|mesh-ancestor
25113082|NCT03573960|Lenvatinib|lenvatinib|mesh-list
25113083|NCT03573960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25113084|NCT03573960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25113085|NCT03573960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25113086|NCT03573960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113087|NCT03565900|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24858136|NCT02295475|Protease Inhibitors|protease inhibitors|mesh-ancestor
24858137|NCT02295475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24858138|NCT02295475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447313|NCT00308165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24447314|NCT00308165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24545211|NCT00692510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24545212|NCT00692510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24545213|NCT00692510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24545214|NCT00692510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24545215|NCT00692510|Anesthetics, General|anesthetics, general|mesh-ancestor
24545217|NCT00692510|GABA Modulators|gaba modulators|mesh-ancestor
24858147|NCT02295566|Antioxidants|antioxidants|mesh-ancestor
24858148|NCT02295566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858149|NCT02295566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24858150|NCT02295566|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24858151|NCT02295566|Vasodilator Agents|vasodilator agents|mesh-ancestor
24858152|NCT02295566|Gasotransmitters|gasotransmitters|mesh-ancestor
24474838|NCT00407641|Anticoagulants|anticoagulants|mesh-ancestor
24474839|NCT00407641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24474840|NCT00407641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24545302|NCT00693004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545305|NCT00693030|Paclitaxel|paclitaxel|mesh-list
24545306|NCT00693030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24545307|NCT00693030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24545308|NCT00693030|Tubulin Modulators|tubulin modulators|mesh-ancestor
24858304|NCT02296203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25702497|NCT02155322|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25702498|NCT02155322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25702499|NCT02155322|Antiviral Agents|antiviral agents|mesh-ancestor
25702500|NCT02155322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25702501|NCT02155322|Immunologic Factors|immunologic factors|mesh-ancestor
25702502|NCT02155322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702503|NCT02155335|Golimumab|golimumab|mesh-list
25702504|NCT02155335|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25702505|NCT02155335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25702506|NCT02155335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25702507|NCT02155335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25702508|NCT02155335|Immunologic Factors|immunologic factors|mesh-ancestor
25702509|NCT02155335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702510|NCT02155465|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25702511|NCT02155465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25030082|NCT03598634|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25030083|NCT03598634|Dermatologic Agents|dermatologic agents|mesh-ancestor
24596135|NCT00941967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596136|NCT00941967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24671140|NCT01324063|Amsacrine|amsacrine|mesh-list
24596137|NCT00941967|Antiviral Agents|antiviral agents|mesh-ancestor
24596138|NCT00941967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25702512|NCT02155465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25702513|NCT02155465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25702514|NCT02155465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702515|NCT02155660|Benralizumab|benralizumab|mesh-list
25702516|NCT02155660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24711530|NCT01515826|BB 1101|bb 1101|mesh-list
24858314|NCT02296281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24545361|NCT00693199|Amlodipine|amlodipine|mesh-list
24545362|NCT00693199|Prazosin|prazosin|mesh-list
24545363|NCT00693199|Terazosin|terazosin|mesh-list
24545364|NCT00693199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24545365|NCT00693199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24545366|NCT00693199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24474894|NCT00407927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474895|NCT00407927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545367|NCT00693199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545368|NCT00693199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24545369|NCT00693199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545370|NCT00693199|Vasodilator Agents|vasodilator agents|mesh-ancestor
24460764|NCT00349440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545494|NCT00693524|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24711832|NCT01517321|Incretins|incretins|mesh-ancestor
24545590|NCT00693927|Fludarabine|fludarabine|mesh-list
24711948|NCT01517828|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24858347|NCT02296411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858348|NCT02296463|Vaccines|vaccines|mesh-list
24858349|NCT02296463|Immunologic Factors|immunologic factors|mesh-ancestor
24474896|NCT00408031|Cycloserine|cycloserine|mesh-list
24474897|NCT00408031|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24474898|NCT00408031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24474899|NCT00408031|Renal Agents|renal agents|mesh-ancestor
25702517|NCT02155660|Respiratory System Agents|respiratory system agents|mesh-ancestor
25702518|NCT02155738|Acetaminophen|acetaminophen|mesh-list
25702519|NCT02155738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25702520|NCT02155738|Analgesics|analgesics|mesh-ancestor
25702521|NCT02155738|Sensory System Agents|sensory system agents|mesh-ancestor
25702522|NCT02155738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25702523|NCT02155738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702524|NCT02155738|Antipyretics|antipyretics|mesh-ancestor
25030644|NCT03594188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25030645|NCT03594188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030646|NCT03594149|Levofloxacin|levofloxacin|mesh-list
25030647|NCT03594149|Ofloxacin|ofloxacin|mesh-list
25030677|NCT03593473|Oxytocin|oxytocin|mesh-list
25030678|NCT03593473|Oxytocics|oxytocics|mesh-ancestor
25030679|NCT03593473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25030680|NCT03593473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030681|NCT03593447|Ribavirin|ribavirin|mesh-list
25030682|NCT03593447|Yimitasvir|yimitasvir|mesh-list
25030683|NCT03593447|Antimetabolites|antimetabolites|mesh-ancestor
25030684|NCT03593447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030685|NCT03593447|Antiviral Agents|antiviral agents|mesh-ancestor
25030686|NCT03593447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24474900|NCT00408031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24474901|NCT00408031|Antitubercular Agents|antitubercular agents|mesh-ancestor
24474905|NCT00408135|Telithromycin|telithromycin|mesh-list
24474906|NCT00408135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24474907|NCT00408135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24474909|NCT00408148|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24474910|NCT00408148|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24474911|NCT00408148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24474913|NCT00408148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474922|NCT00408174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24474923|NCT00408174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474924|NCT00408174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24474925|NCT00408174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24858350|NCT02296463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858351|NCT02296567|Bevacizumab|bevacizumab|mesh-list
24858352|NCT02296567|Ranibizumab|ranibizumab|mesh-list
24858353|NCT02296567|Aflibercept|aflibercept|mesh-list
24858354|NCT02296567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24858383|NCT02296749|Sirolimus|sirolimus|mesh-list
24858384|NCT02296749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24858385|NCT02296749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24858386|NCT02296749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24858387|NCT02296749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858388|NCT02296749|Antifungal Agents|antifungal agents|mesh-ancestor
24520700|NCT05334251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520701|NCT05334043|Curcumin|curcumin|mesh-list
24520702|NCT05334043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24520703|NCT05334043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24520704|NCT05334043|Analgesics|analgesics|mesh-ancestor
24520705|NCT05334043|Sensory System Agents|sensory system agents|mesh-ancestor
24520708|NCT05334043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24813163|NCT02056743|GABA Agents|gaba agents|mesh-ancestor
24858391|NCT02296749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858392|NCT02296762|Sirolimus|sirolimus|mesh-list
24712076|NCT01518465|Antiemetics|antiemetics|mesh-ancestor
24858402|NCT02296996|Dabrafenib|dabrafenib|mesh-list
24614510|NCT01024543|Phenylephrine|phenylephrine|mesh-list
24858442|NCT02297477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712212|NCT01519128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24858471|NCT02297854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25702525|NCT02155829|Riluzole|riluzole|mesh-list
25702526|NCT02155829|Anticonvulsants|anticonvulsants|mesh-ancestor
25702527|NCT02155829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25702528|NCT02155829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25702529|NCT02155829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25702530|NCT02155829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702531|NCT02155829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702532|NCT02155829|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25702533|NCT02155829|Protective Agents|protective agents|mesh-ancestor
25702534|NCT02155881|Ciclesonide|ciclesonide|mesh-list
25702535|NCT02155881|Glucocorticoids|glucocorticoids|mesh-ancestor
25702536|NCT02155881|Hormones|hormones|mesh-ancestor
25702537|NCT02155881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24474964|NCT00408252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474965|NCT00408252|Growth Inhibitors|growth inhibitors|mesh-ancestor
24474966|NCT00408252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24474967|NCT00408252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24858472|NCT02297906|Ketorolac|ketorolac|mesh-list
24858473|NCT02297906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24858474|NCT02297906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24858475|NCT02297906|Analgesics|analgesics|mesh-ancestor
24858476|NCT02297906|Sensory System Agents|sensory system agents|mesh-ancestor
24712302|NCT01519726|Midazolam|midazolam|mesh-list
24858496|NCT02298010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520712|NCT05334043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520714|NCT05334004|Lopinavir|lopinavir|mesh-list
24917120|NCT04233346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917121|NCT04233203|Insulin|insulin|mesh-list
24917122|NCT04233203|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24858497|NCT02298062|Infliximab|infliximab|mesh-list
24858498|NCT02298062|Dermatologic Agents|dermatologic agents|mesh-ancestor
24858499|NCT02298062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24858500|NCT02298062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24858501|NCT02298088|Clopidogrel|clopidogrel|mesh-list
24858502|NCT02298088|Ticagrelor|ticagrelor|mesh-list
24858503|NCT02298088|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24858504|NCT02298088|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24858505|NCT02298088|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24858510|NCT02298088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858511|NCT02298101|Edetic Acid|edetic acid|mesh-list
24460976|NCT00350415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24858518|NCT02298101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858519|NCT02298101|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24858533|NCT02298166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24858535|NCT02298166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858536|NCT02298166|Analgesics|analgesics|mesh-ancestor
24858537|NCT02298166|Sensory System Agents|sensory system agents|mesh-ancestor
24858538|NCT02298166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858539|NCT02298166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24858540|NCT02298166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24461010|NCT00350467|Serotonin Agents|serotonin agents|mesh-ancestor
24545803|NCT00695032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24545804|NCT00695032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24545805|NCT00695032|Alkylating Agents|alkylating agents|mesh-ancestor
25113617|NCT02474173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113620|NCT02453620|Nivolumab|nivolumab|mesh-list
25113621|NCT02453620|Ipilimumab|ipilimumab|mesh-list
25113622|NCT02453620|Entinostat|entinostat|mesh-list
25113623|NCT02453620|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25113624|NCT02453620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25113625|NCT02453620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917123|NCT04233203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24917124|NCT04233203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917143|NCT04233502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24917145|NCT04232800|Vitamins|vitamins|mesh-ancestor
24917146|NCT04232800|Micronutrients|micronutrients|mesh-ancestor
24917147|NCT04232800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917148|NCT04232800|Vitamin B Complex|vitamin b complex|mesh-ancestor
24475036|NCT00408551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24475037|NCT00408551|Antidotes|antidotes|mesh-ancestor
24475038|NCT00408551|Protective Agents|protective agents|mesh-ancestor
24475039|NCT00408551|Vitamin B Complex|vitamin b complex|mesh-ancestor
24475040|NCT00408551|Vitamins|vitamins|mesh-ancestor
24475042|NCT00408655|Sirolimus|sirolimus|mesh-list
24475043|NCT00408655|Paclitaxel|paclitaxel|mesh-list
24475044|NCT00408655|Carboplatin|carboplatin|mesh-list
24475045|NCT00408655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24475046|NCT00408655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917149|NCT04232800|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24858541|NCT02298166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24858542|NCT02298205|Beclomethasone|beclomethasone|mesh-list
24858543|NCT02298205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24858544|NCT02298205|Glucocorticoids|glucocorticoids|mesh-ancestor
24858545|NCT02298205|Hormones|hormones|mesh-ancestor
24858546|NCT02298205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24858547|NCT02298205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712559|NCT01521455|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24712560|NCT01521455|Autonomic Agents|autonomic agents|mesh-ancestor
24712561|NCT01521455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24712562|NCT01521455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545851|NCT00695331|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24712668|NCT01522092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712669|NCT01522092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24712671|NCT01522092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712672|NCT01522092|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24712675|NCT01522105|Daptomycin|daptomycin|mesh-list
24545993|NCT00696202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24546007|NCT00696475|Antimetabolites|antimetabolites|mesh-ancestor
24546008|NCT00696475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546009|NCT00696475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24546010|NCT00696475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24546011|NCT00696475|Nootropic Agents|nootropic agents|mesh-ancestor
24546012|NCT00696475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24546013|NCT00696475|Vasodilator Agents|vasodilator agents|mesh-ancestor
24546014|NCT00696514|Vitamin D|vitamin d|mesh-list
24546015|NCT00696514|Ergocalciferols|ergocalciferols|mesh-list
24546016|NCT00696514|Cholecalciferol|cholecalciferol|mesh-list
24546017|NCT00696514|Vitamins|vitamins|mesh-list
24546019|NCT00696514|Vitamin B 12|vitamin b 12|mesh-list
24546020|NCT00696514|Micronutrients|micronutrients|mesh-ancestor
24546021|NCT00696514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546022|NCT00696514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24475047|NCT00408655|Tubulin Modulators|tubulin modulators|mesh-ancestor
24475048|NCT00408655|Antimitotic Agents|antimitotic agents|mesh-ancestor
24475049|NCT00408655|Mitosis Modulators|mitosis modulators|mesh-ancestor
25702538|NCT02155881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702539|NCT02155881|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25702540|NCT02155985|Aspirin|aspirin|mesh-list
25702541|NCT02155985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25702542|NCT02155985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25702543|NCT02155985|Analgesics|analgesics|mesh-ancestor
25702544|NCT02155985|Sensory System Agents|sensory system agents|mesh-ancestor
25702545|NCT02155985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24546029|NCT00696540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24546030|NCT00696540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546031|NCT00696540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24546032|NCT00696540|Respiratory System Agents|respiratory system agents|mesh-ancestor
24546033|NCT00696540|Tocolytic Agents|tocolytic agents|mesh-ancestor
24712792|NCT01522872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24712793|NCT01522872|Antiemetics|antiemetics|mesh-ancestor
24973276|NCT03710356|Danazol|danazol|mesh-list
24917150|NCT04232800|Dermatologic Agents|dermatologic agents|mesh-ancestor
24492014|NCT00484926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492015|NCT00484926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24492016|NCT00484926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24492018|NCT00484926|Antipyretics|antipyretics|mesh-ancestor
24520715|NCT05334004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24520716|NCT05334004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24520717|NCT05334004|Protease Inhibitors|protease inhibitors|mesh-ancestor
24520718|NCT05334004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917185|NCT04232332|Mitosis Modulators|mitosis modulators|mesh-ancestor
24917187|NCT04232007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
24917188|NCT04232150|Midazolam|midazolam|mesh-list
24917189|NCT04232150|Anesthetics|anesthetics|mesh-list
24917190|NCT04232150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24917191|NCT04232150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917192|NCT04232150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24475106|NCT00408941|Propofol|propofol|mesh-list
24475107|NCT00408941|Prilocaine|prilocaine|mesh-list
24475108|NCT00408941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24475112|NCT00408941|Anesthetics, General|anesthetics, general|mesh-ancestor
24917193|NCT04232150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24917194|NCT04232150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24917248|NCT04231851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24917249|NCT04231851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24917250|NCT04231851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24917251|NCT04231851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917252|NCT04231526|Pembrolizumab|pembrolizumab|mesh-list
24917253|NCT04231526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24917254|NCT04231526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917255|NCT04231435|Metformin|metformin|mesh-list
24917256|NCT04231435|Digoxin|digoxin|mesh-list
24813186|NCT02056743|Histamine Antagonists|histamine antagonists|mesh-ancestor
24813187|NCT02056743|Histamine Agents|histamine agents|mesh-ancestor
24858619|NCT02298387|Antibodies, Bispecific|antibodies, bispecific|mesh-list
24858620|NCT02298387|Immunologic Factors|immunologic factors|mesh-ancestor
24917257|NCT04231435|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24917258|NCT04231435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24917283|NCT04231448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917284|NCT04231448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24858625|NCT02298530|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24858626|NCT02298530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24482719|NCT00440323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24858627|NCT02298530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033677|NCT03571490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25033678|NCT03571490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033679|NCT03571490|Sensory System Agents|sensory system agents|mesh-ancestor
25033680|NCT03571490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25033681|NCT03571438|Sirolimus|sirolimus|mesh-list
24858628|NCT02298530|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24858629|NCT02298530|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24858630|NCT02298530|Purinergic Agents|purinergic agents|mesh-ancestor
24858631|NCT02298530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24858633|NCT02298582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24858634|NCT02298582|Narcotics|narcotics|mesh-ancestor
24858635|NCT02298582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24858636|NCT02298582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858637|NCT02298582|Analgesics|analgesics|mesh-ancestor
24858638|NCT02298582|Sensory System Agents|sensory system agents|mesh-ancestor
24858639|NCT02298582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858654|NCT02298660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24858655|NCT02298660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858656|NCT02298660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24858657|NCT02298660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858658|NCT02298764|Psychotropic Drugs|psychotropic drugs|mesh-list
24858660|NCT02298985|Antipsychotic Agents|antipsychotic agents|mesh-list
24858661|NCT02298985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24858662|NCT02298985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24858663|NCT02298985|Analgesics|analgesics|mesh-ancestor
24858664|NCT02298985|Sensory System Agents|sensory system agents|mesh-ancestor
24858665|NCT02298985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858666|NCT02298985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614608|NCT01025349|Growth Inhibitors|growth inhibitors|mesh-ancestor
24858676|NCT02299024|Narcotics|narcotics|mesh-ancestor
24917285|NCT04231448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24917286|NCT04231448|Alkylating Agents|alkylating agents|mesh-ancestor
24917287|NCT04231448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858677|NCT02299024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24858678|NCT02299024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858679|NCT02299024|Analgesics|analgesics|mesh-ancestor
24858695|NCT02299063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858697|NCT02299115|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24858698|NCT02299115|Methylprednisolone|methylprednisolone|mesh-list
24461178|NCT00351169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24546160|NCT00696995|Insulin Aspart|insulin aspart|mesh-list
24546161|NCT00696995|Biphasic Insulins|biphasic insulins|mesh-list
24546162|NCT00696995|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24546163|NCT00696995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24546164|NCT00696995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546165|NCT00697021|Aspirin|aspirin|mesh-list
24546166|NCT00697021|Clopidogrel|clopidogrel|mesh-list
24546167|NCT00697021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24712989|NCT01523431|Antidotes|antidotes|mesh-ancestor
24858703|NCT02299115|Prednisolone phosphate|prednisolone phosphate|mesh-list
24858704|NCT02299115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24858705|NCT02299115|Glucocorticoids|glucocorticoids|mesh-ancestor
24858706|NCT02299115|Hormones|hormones|mesh-ancestor
24858707|NCT02299115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24858708|NCT02299115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858709|NCT02299115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24546307|NCT00697658|Serotonin Agents|serotonin agents|mesh-ancestor
24546308|NCT00697658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24713157|NCT01524432|Hormone Antagonists|hormone antagonists|mesh-ancestor
24475428|NCT00410449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475429|NCT00410449|Protective Agents|protective agents|mesh-ancestor
24858749|NCT02299271|Sensory System Agents|sensory system agents|mesh-ancestor
24614644|NCT01025570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24614645|NCT01025570|Immunologic Factors|immunologic factors|mesh-ancestor
24614647|NCT01025583|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24447434|NCT00308477|Antiemetics|antiemetics|mesh-ancestor
25702546|NCT02155985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702547|NCT02155985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25702548|NCT02155985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25702549|NCT02155985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25702550|NCT02155985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24713291|NCT01524939|Immunoglobulin G|immunoglobulin g|mesh-list
25702551|NCT02155985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702552|NCT02155985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25702553|NCT02155985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25702554|NCT02155985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25702555|NCT02155985|Antipyretics|antipyretics|mesh-ancestor
24713292|NCT01524939|Immunologic Factors|immunologic factors|mesh-ancestor
24713293|NCT01524939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713294|NCT01525004|Vaccines|vaccines|mesh-list
24713297|NCT01525043|Naproxen|naproxen|mesh-list
24917288|NCT04231448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917418|NCT04230083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917419|NCT04230083|Androgens|androgens|mesh-ancestor
24917420|NCT04230083|Hormones|hormones|mesh-ancestor
24917421|NCT04230083|Anabolic Agents|anabolic agents|mesh-ancestor
24917422|NCT04230070|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24475524|NCT00410657|Prednisolone acetate|prednisolone acetate|mesh-list
24858792|NCT02299518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24546373|NCT00697892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24858841|NCT02299765|Antiviral Agents|antiviral agents|mesh-ancestor
24917426|NCT04230070|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
24917427|NCT04230070|Estradiol|estradiol|mesh-list
24917428|NCT04230070|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24917429|NCT04230070|Estrogens|estrogens|mesh-ancestor
24917430|NCT04230070|Hormones|hormones|mesh-ancestor
24917431|NCT04230070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24917432|NCT04230070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917433|NCT04230070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24917434|NCT04230070|Contraceptive Agents|contraceptive agents|mesh-ancestor
24917435|NCT04230070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24917436|NCT04230070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24917437|NCT04230070|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24520770|NCT05326360|Ramosetron|ramosetron|mesh-list
24917440|NCT04230070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24917441|NCT04229979|Cytarabine|cytarabine|mesh-list
24917487|NCT04229264|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24917488|NCT04229264|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24917504|NCT04229355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24917552|NCT04228263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24917553|NCT04228263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24917554|NCT04228263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24917555|NCT04228263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917556|NCT04228263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24917557|NCT04228263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24917558|NCT04228263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917559|NCT04228263|Antipyretics|antipyretics|mesh-ancestor
24917560|NCT04228263|Antimalarials|antimalarials|mesh-ancestor
24917561|NCT04228263|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24917562|NCT04228263|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24917563|NCT04228263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24917564|NCT04228263|Hematinics|hematinics|mesh-ancestor
24917565|NCT04228263|Vitamin B Complex|vitamin b complex|mesh-ancestor
24917566|NCT04228263|Vitamins|vitamins|mesh-ancestor
24917567|NCT04228263|Micronutrients|micronutrients|mesh-ancestor
24917568|NCT04228393|Mercaptopurine|mercaptopurine|mesh-list
24917569|NCT04228393|Antimetabolites|antimetabolites|mesh-ancestor
24917570|NCT04228393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917571|NCT04228393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24461303|NCT00351910|Citalopram|citalopram|mesh-list
24546383|NCT00697892|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24546384|NCT00697905|Gemcitabine|gemcitabine|mesh-list
24546385|NCT00697905|Carboplatin|carboplatin|mesh-list
24446719|NCT00305786|Gemcitabine|gemcitabine|mesh-list
25702556|NCT02156154|Acetaminophen|acetaminophen|mesh-list
25702557|NCT02156154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25702558|NCT02156154|Analgesics|analgesics|mesh-ancestor
25702559|NCT02156154|Sensory System Agents|sensory system agents|mesh-ancestor
25034559|NCT03563794|Vildagliptin|vildagliptin|mesh-list
25034560|NCT03563794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25034561|NCT03563794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034562|NCT03563794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25034603|NCT03563365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25034604|NCT03563365|Dermatologic Agents|dermatologic agents|mesh-ancestor
25034607|NCT03563365|Analgesics|analgesics|mesh-ancestor
24713415|NCT01526083|Lacosamide|lacosamide|mesh-list
24546386|NCT00697905|Fluorouracil|fluorouracil|mesh-list
24546387|NCT00697905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24546388|NCT00697905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24546389|NCT00697905|Antimetabolites|antimetabolites|mesh-ancestor
24713460|NCT01526161|Fluticasone|fluticasone|mesh-list
24858846|NCT02299765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858848|NCT02299817|Denosumab|denosumab|mesh-list
24858849|NCT02299817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24858850|NCT02299817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917572|NCT04228393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917573|NCT04228393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24917574|NCT04228393|Immunologic Factors|immunologic factors|mesh-ancestor
24917575|NCT04228393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917576|NCT04228393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24917577|NCT04228393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917578|NCT04227990|Cyclophosphamide|cyclophosphamide|mesh-list
24917579|NCT04227990|Docetaxel|docetaxel|mesh-list
24917580|NCT04227990|Doxorubicin|doxorubicin|mesh-list
24475808|NCT00411437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24917581|NCT04227990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24858851|NCT02299882|Vancomycin|vancomycin|mesh-list
24858852|NCT02299882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24858853|NCT02299882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24858854|NCT02299908|Bupivacaine|bupivacaine|mesh-list
24858856|NCT02299908|Anesthetics|anesthetics|mesh-list
24858904|NCT02300363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24858905|NCT02300363|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24858906|NCT02300363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24858907|NCT02300363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546397|NCT00697944|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24858939|NCT02300623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858940|NCT02300623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24858942|NCT02300623|Sensory System Agents|sensory system agents|mesh-ancestor
24858943|NCT02300623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858983|NCT02300818|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24546497|NCT00698763|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24475809|NCT00411437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425737|NCT00234195|Bupropion|bupropion|mesh-list
24475856|NCT00411866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24475857|NCT00411866|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24475858|NCT00411866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24475859|NCT00411866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24475860|NCT00411866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475866|NCT00411879|Vasopressins|vasopressins|mesh-list
24546527|NCT00698945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546528|NCT00699023|Simvastatin|simvastatin|mesh-list
24973463|NCT03709082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24917582|NCT04227990|Immunologic Factors|immunologic factors|mesh-ancestor
24917583|NCT04227990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917584|NCT04227990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24917585|NCT04227990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25702560|NCT02156154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25702561|NCT02156154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702562|NCT02156154|Antipyretics|antipyretics|mesh-ancestor
25702563|NCT02156492|Atorvastatin|atorvastatin|mesh-list
25702564|NCT02156492|Simvastatin|simvastatin|mesh-list
25702565|NCT02156492|Evacetrapib|evacetrapib|mesh-list
25702566|NCT02156492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25702567|NCT02156492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25702568|NCT02156492|Antimetabolites|antimetabolites|mesh-ancestor
25034746|NCT03562754|Anticoagulants|anticoagulants|mesh-ancestor
25034748|NCT03562754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24917586|NCT04227990|Alkylating Agents|alkylating agents|mesh-ancestor
24917592|NCT04227990|Mitosis Modulators|mitosis modulators|mesh-ancestor
24917593|NCT04227990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24917594|NCT04227990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24917595|NCT04227990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24917601|NCT04227886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917602|NCT04227886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917603|NCT04227886|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24917604|NCT04227886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24917605|NCT04227886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917606|NCT04227808|Lenvatinib|lenvatinib|mesh-list
24917607|NCT04227808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917608|NCT04227808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24917620|NCT04227704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24917621|NCT04227704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24917622|NCT04227704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24475870|NCT00411879|Epinephryl borate|epinephryl borate|mesh-list
24546913|NCT00701246|Vitamin B Complex|vitamin b complex|mesh-list
24800406|NCT01975441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800407|NCT01975441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800408|NCT01975441|Filaricides|filaricides|mesh-ancestor
24800409|NCT01975441|Antinematodal Agents|antinematodal agents|mesh-ancestor
24800410|NCT01975441|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24800411|NCT01975441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800412|NCT01975454|Capecitabine|capecitabine|mesh-list
24800413|NCT01975454|Oxaliplatin|oxaliplatin|mesh-list
24800414|NCT01975454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24800415|NCT01975454|Antimetabolites|antimetabolites|mesh-ancestor
24546585|NCT00699114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24546586|NCT00699114|Antitussive Agents|antitussive agents|mesh-ancestor
24546587|NCT00699114|Respiratory System Agents|respiratory system agents|mesh-ancestor
24546588|NCT00699179|Insulin Aspart|insulin aspart|mesh-list
24546589|NCT00699179|Biphasic Insulins|biphasic insulins|mesh-list
24546590|NCT00699179|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24546591|NCT00699179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24546592|NCT00699179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546593|NCT00699244|Anesthetics|anesthetics|mesh-list
24546594|NCT00699244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24546595|NCT00699244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713685|NCT01527032|Melphalan|melphalan|mesh-list
24546637|NCT00699452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24546638|NCT00699452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24546639|NCT00699452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546641|NCT00699465|Enoxaparin sodium|enoxaparin sodium|mesh-list
24546642|NCT00699465|Anticoagulants|anticoagulants|mesh-ancestor
24546643|NCT00699465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24546644|NCT00699465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24546645|NCT00699465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546646|NCT00699478|Vitamin B 12|vitamin b 12|mesh-list
24546667|NCT00699530|Cabergoline|cabergoline|mesh-list
24546668|NCT00699530|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24546669|NCT00699530|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24475990|NCT00412204|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24546670|NCT00699530|Dopamine Agonists|dopamine agonists|mesh-ancestor
24546671|NCT00699530|Dopamine Agents|dopamine agents|mesh-ancestor
24750918|NCT01701089|Selegiline|selegiline|mesh-list
24546697|NCT00699777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24546698|NCT00699777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546699|NCT00699777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24546700|NCT00699881|Cetuximab|cetuximab|mesh-list
25702569|NCT02156492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702570|NCT02156492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25702571|NCT02156492|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25702572|NCT02156492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25702573|NCT02156804|Nivolumab|nivolumab|mesh-list
25702574|NCT02156804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24588690|NCT00903942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588691|NCT00903994|Ketoprofen|ketoprofen|mesh-list
24546701|NCT00699881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24546702|NCT00699881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24546703|NCT00699894|Ondansetron|ondansetron|mesh-list
24546704|NCT00699894|Aprepitant|aprepitant|mesh-list
24546705|NCT00699894|Antiemetics|antiemetics|mesh-ancestor
24546706|NCT00699894|Autonomic Agents|autonomic agents|mesh-ancestor
24546827|NCT00700583|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24546828|NCT00700583|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24546829|NCT00700583|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24546830|NCT00700583|Adrenergic Agents|adrenergic agents|mesh-ancestor
24546831|NCT00700583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24546832|NCT00700583|Urological Agents|urological agents|mesh-ancestor
24546833|NCT00700648|Insulin Aspart|insulin aspart|mesh-list
24546866|NCT00700921|L 647318|l 647318|mesh-list
24546867|NCT00700921|Dihydromevinolin|dihydromevinolin|mesh-list
24800467|NCT01975753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24800468|NCT01975753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24800469|NCT01975753|Anesthetics, General|anesthetics, general|mesh-ancestor
24800470|NCT01975753|Anesthetics|anesthetics|mesh-ancestor
24800472|NCT01975805|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24800473|NCT01975805|Povidone-Iodine|povidone-iodine|mesh-list
24800474|NCT01975805|Povidone|povidone|mesh-list
24800475|NCT01975805|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24546921|NCT00701259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24546922|NCT00701259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24546923|NCT00701259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24546924|NCT00701259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546925|NCT00701285|Pravastatin|pravastatin|mesh-list
24546926|NCT00701285|Pitavastatin|pitavastatin|mesh-list
24546927|NCT00701285|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24546928|NCT00701285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24546929|NCT00701285|Antimetabolites|antimetabolites|mesh-ancestor
24474692|NCT00407017|Sensory System Agents|sensory system agents|mesh-ancestor
24546948|NCT00701298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24546949|NCT00701337|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24546950|NCT00701337|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24546951|NCT00701337|Estradiol|estradiol|mesh-list
24546987|NCT00701623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546989|NCT00701740|Terephthalylidene dicamphor sulfonic acid|terephthalylidene dicamphor sulfonic acid|mesh-list
24546990|NCT00701740|Dermatologic Agents|dermatologic agents|mesh-ancestor
24546991|NCT00701740|Sunscreening Agents|sunscreening agents|mesh-ancestor
24546992|NCT00701740|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24546993|NCT00701740|Protective Agents|protective agents|mesh-ancestor
24546994|NCT00701740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546995|NCT00701792|Liver Extracts|liver extracts|mesh-list
24546996|NCT00701792|Hematinics|hematinics|mesh-ancestor
24546997|NCT00701831|Insulin Glargine|insulin glargine|mesh-list
24446728|NCT00305786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24446729|NCT00305786|Immunologic Factors|immunologic factors|mesh-ancestor
24446730|NCT00305786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547160|NCT00702728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547161|NCT00702767|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24547162|NCT00702767|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24800543|NCT01976182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24800545|NCT01976195|Dexamethasone|dexamethasone|mesh-list
24476072|NCT00412763|Antioxidants|antioxidants|mesh-ancestor
24800546|NCT01976195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24800547|NCT01976195|Antiemetics|antiemetics|mesh-ancestor
24800548|NCT01976195|Autonomic Agents|autonomic agents|mesh-ancestor
24800549|NCT01976195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24800550|NCT01976195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800551|NCT01976195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24800552|NCT01976195|Glucocorticoids|glucocorticoids|mesh-ancestor
24800553|NCT01976195|Hormones|hormones|mesh-ancestor
24800554|NCT01976195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24800577|NCT01976611|Botulinum Toxins|botulinum toxins|mesh-list
24800578|NCT01976611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24800579|NCT01976611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25702575|NCT02156804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25702576|NCT02156804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25702577|NCT02156804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702578|NCT02157103|Bevacizumab|bevacizumab|mesh-list
25035596|NCT03554447|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25035597|NCT03554447|Antioxidants|antioxidants|mesh-ancestor
25035598|NCT03554408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25035599|NCT03554408|Antibodies|antibodies|mesh-list
25035600|NCT03554408|Immunoglobulins|immunoglobulins|mesh-list
25035601|NCT03554408|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25035602|NCT03554408|Immunologic Factors|immunologic factors|mesh-ancestor
25035603|NCT03554408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035634|NCT03554200|Empagliflozin|empagliflozin|mesh-list
25035695|NCT03553537|Cyclophosphamide|cyclophosphamide|mesh-list
25035696|NCT03553537|Doxorubicin|doxorubicin|mesh-list
24800580|NCT01976611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24800581|NCT01976611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24800582|NCT01976611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800583|NCT01976611|Cholinergic Agents|cholinergic agents|mesh-ancestor
24547279|NCT00703313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24547300|NCT00703352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547329|NCT00703430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547330|NCT00703430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547344|NCT00703482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24547345|NCT00703482|Vitamins|vitamins|mesh-ancestor
24547346|NCT00703482|Micronutrients|micronutrients|mesh-ancestor
24547355|NCT00703586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24547356|NCT00703586|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24547357|NCT00703625|Sirolimus|sirolimus|mesh-list
24917693|NCT04227093|Diuretics|diuretics|mesh-ancestor
24547477|NCT00704249|Antiviral Agents|antiviral agents|mesh-ancestor
24547478|NCT00704249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24547479|NCT00704249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24547480|NCT00704249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24547481|NCT00704249|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24547482|NCT00704249|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24547483|NCT00704275|Cyclosporine|cyclosporine|mesh-list
24547484|NCT00704275|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24547485|NCT00704275|Cyclosporins|cyclosporins|mesh-list
24547486|NCT00704275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547487|NCT00704275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547488|NCT00704275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24547489|NCT00704275|Immunologic Factors|immunologic factors|mesh-ancestor
24800614|NCT01976923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547534|NCT00704548|Simvastatin|simvastatin|mesh-list
24547535|NCT00704548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24547538|NCT00704548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547539|NCT00704548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24547540|NCT00704548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25702579|NCT02157103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25702580|NCT02157103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25702581|NCT02157103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25702582|NCT02157103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25702583|NCT02157103|Growth Substances|growth substances|mesh-ancestor
25702584|NCT02157103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702585|NCT02157103|Growth Inhibitors|growth inhibitors|mesh-ancestor
25702586|NCT02157298|Dapagliflozin|dapagliflozin|mesh-list
25702587|NCT02157298|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25036010|NCT03551197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24547597|NCT00704756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917624|NCT04227704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917625|NCT04227769|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24917626|NCT04227769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24547600|NCT00704756|Immunologic Factors|immunologic factors|mesh-ancestor
24547601|NCT00704756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547603|NCT00704821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547604|NCT00704821|Tubulin Modulators|tubulin modulators|mesh-ancestor
24547605|NCT00704821|Antimitotic Agents|antimitotic agents|mesh-ancestor
24547606|NCT00704821|Mitosis Modulators|mitosis modulators|mesh-ancestor
24547607|NCT00704821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547608|NCT00704860|Antidepressive Agents|antidepressive agents|mesh-list
24973693|NCT03707678|Albuterol|albuterol|mesh-list
24917634|NCT04227912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24917635|NCT04227912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24917636|NCT04227912|Analgesics|analgesics|mesh-ancestor
24917637|NCT04227912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24917638|NCT04227912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24917639|NCT04227652|Ibuprofen|ibuprofen|mesh-list
24917640|NCT04227652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24917641|NCT04227652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24917642|NCT04227652|Analgesics|analgesics|mesh-ancestor
24917643|NCT04227652|Sensory System Agents|sensory system agents|mesh-ancestor
24917644|NCT04227652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24917645|NCT04227652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917646|NCT04227652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24917647|NCT04227652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24917648|NCT04227652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24917649|NCT04227652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917650|NCT04227652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917692|NCT04227093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917701|NCT04226963|Ketamine|ketamine|mesh-list
24917702|NCT04226963|Analgesics|analgesics|mesh-ancestor
24917703|NCT04226963|Sensory System Agents|sensory system agents|mesh-ancestor
24917709|NCT04226963|Anesthetics|anesthetics|mesh-ancestor
24917740|NCT04226885|GABA Modulators|gaba modulators|mesh-ancestor
24917741|NCT04226885|GABA Agents|gaba agents|mesh-ancestor
24917742|NCT04226625|Propofol|propofol|mesh-list
24917743|NCT04226625|Desflurane|desflurane|mesh-list
24917744|NCT04226625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24917745|NCT04226625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24917746|NCT04226625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917747|NCT04226625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24917748|NCT04226625|Anesthetics, General|anesthetics, general|mesh-ancestor
24917749|NCT04226625|Anesthetics|anesthetics|mesh-ancestor
24547639|NCT00704951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24547640|NCT00704951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547734|NCT00705471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24800642|NCT01977300|Olanzapine|olanzapine|mesh-list
24800643|NCT01977300|Risperidone|risperidone|mesh-list
24800644|NCT01977300|Lithium Carbonate|lithium carbonate|mesh-list
24800645|NCT01977300|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24547750|NCT00705549|Cisplatin|cisplatin|mesh-list
24547751|NCT00705549|Docetaxel|docetaxel|mesh-list
24547752|NCT00705549|Vinorelbine|vinorelbine|mesh-list
25702588|NCT02157298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547753|NCT00705549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25702589|NCT02157298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25702590|NCT02157298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702591|NCT02157376|Esomeprazole|esomeprazole|mesh-list
25702592|NCT02157376|Cimetidine|cimetidine|mesh-list
25702593|NCT02157376|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25702594|NCT02157376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25036210|NCT03549611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24485243|NCT00452218|Sorafenib|sorafenib|mesh-list
25036212|NCT03549611|Sensory System Agents|sensory system agents|mesh-ancestor
24603876|NCT00975962|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25036253|NCT03549312|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25036254|NCT03549221|Ketorolac|ketorolac|mesh-list
25036308|NCT03548714|Ethanol|ethanol|mesh-list
25036309|NCT03548714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25036310|NCT03548714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24547754|NCT00705549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24547755|NCT00705549|Antimetabolites|antimetabolites|mesh-ancestor
24547756|NCT00705549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547851|NCT00706069|Antimetabolites|antimetabolites|mesh-ancestor
24547904|NCT00706680|Mycophenolic Acid|mycophenolic acid|mesh-list
24547905|NCT00706680|Prednisone|prednisone|mesh-list
24547906|NCT00706680|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24547907|NCT00706680|Cyclosporins|cyclosporins|mesh-list
24547908|NCT00706680|Thymoglobulin|thymoglobulin|mesh-list
24547909|NCT00706680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24547999|NCT00707083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24548000|NCT00707083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24548001|NCT00707083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24548002|NCT00707083|Tubulin Modulators|tubulin modulators|mesh-ancestor
24548003|NCT00707083|Antimitotic Agents|antimitotic agents|mesh-ancestor
24548004|NCT00707083|Mitosis Modulators|mitosis modulators|mesh-ancestor
24548005|NCT00707135|Sirolimus|sirolimus|mesh-list
24548006|NCT00707135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24548050|NCT00707408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548052|NCT00707421|Ketorolac|ketorolac|mesh-list
24548053|NCT00707421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24548054|NCT00707421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24548055|NCT00707421|Analgesics|analgesics|mesh-ancestor
24548056|NCT00707421|Sensory System Agents|sensory system agents|mesh-ancestor
24548057|NCT00707421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24548058|NCT00707421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548059|NCT00707421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24548060|NCT00707421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24548061|NCT00707421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24548062|NCT00707421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548063|NCT00707421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548064|NCT00707421|Glucocorticoids|glucocorticoids|mesh-ancestor
24548065|NCT00707421|Hormones|hormones|mesh-ancestor
24548066|NCT00707421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25702595|NCT02157376|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25702596|NCT02157376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25702597|NCT02157376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702598|NCT02157376|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25702599|NCT02157376|Histamine Antagonists|histamine antagonists|mesh-ancestor
25702600|NCT02157376|Histamine Agents|histamine agents|mesh-ancestor
25702601|NCT02157376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25702602|NCT02157376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548067|NCT00707421|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24548076|NCT00707473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548078|NCT00707473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24548079|NCT00707473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24548080|NCT00707473|Immunologic Factors|immunologic factors|mesh-ancestor
24548081|NCT00707473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548082|NCT00707512|Natalizumab|natalizumab|mesh-list
24548083|NCT00707512|Immunologic Factors|immunologic factors|mesh-ancestor
24548084|NCT00707512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548085|NCT00707551|Ketoconazole|ketoconazole|mesh-list
24548086|NCT00707551|Verapamil|verapamil|mesh-list
24548087|NCT00707551|Antifungal Agents|antifungal agents|mesh-ancestor
24548088|NCT00707551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24800807|NCT01978457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24800808|NCT01978457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24800809|NCT01978457|Dopamine Agents|dopamine agents|mesh-ancestor
24800811|NCT01978483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24800812|NCT01978483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800813|NCT01978496|Eletriptan|eletriptan|mesh-list
24800814|NCT01978496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24800815|NCT01978496|Serotonin Agents|serotonin agents|mesh-ancestor
24800816|NCT01978496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24476170|NCT00413361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24800817|NCT01978496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800819|NCT01978665|Prednisone|prednisone|mesh-list
24714833|NCT01533129|Androgens|androgens|mesh-ancestor
24800833|NCT01978678|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24800834|NCT01978678|Respiratory System Agents|respiratory system agents|mesh-ancestor
24800835|NCT01978678|Glucocorticoids|glucocorticoids|mesh-ancestor
24800836|NCT01978678|Hormones|hormones|mesh-ancestor
24800837|NCT01978678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24800838|NCT01978704|Insulin|insulin|mesh-list
24800839|NCT01978704|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24800840|NCT01978704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24800841|NCT01978704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800842|NCT01978717|Anesthetics|anesthetics|mesh-list
24800843|NCT01978717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24800844|NCT01978717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800845|NCT01978782|Raltegravir Potassium|raltegravir potassium|mesh-list
24800846|NCT01978782|Citalopram|citalopram|mesh-list
24800847|NCT01978782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24800848|NCT01978782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24800849|NCT01978782|Antiviral Agents|antiviral agents|mesh-ancestor
24800850|NCT01978782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24800851|NCT01978782|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24548130|NCT00707798|Immunologic Factors|immunologic factors|mesh-ancestor
24548131|NCT00707798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714923|NCT01533389|Silodosin|silodosin|mesh-list
24800893|NCT01979354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24800894|NCT01979354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800896|NCT01979354|Sensory System Agents|sensory system agents|mesh-ancestor
24800897|NCT01979354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24800898|NCT01979406|Vaccines|vaccines|mesh-list
24800899|NCT01979406|Immunologic Factors|immunologic factors|mesh-ancestor
24800900|NCT01979406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800901|NCT01979510|Acetaminophen|acetaminophen|mesh-list
24548193|NCT00708240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24800909|NCT01979510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24800910|NCT01979510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24800911|NCT01979510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24800912|NCT01979510|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24800913|NCT01979510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24800914|NCT01979510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800915|NCT01979510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036868|NCT03542552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25036869|NCT03542552|Anticonvulsants|anticonvulsants|mesh-ancestor
24993627|NCT05415917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24993628|NCT05415917|Immunologic Factors|immunologic factors|mesh-ancestor
24993629|NCT05415917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037054|NCT03540979|Progesterone|progesterone|mesh-list
25037055|NCT03540979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25037056|NCT03540979|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25037064|NCT03540979|Progestins|progestins|mesh-ancestor
24800917|NCT01979653|Dexmedetomidine|dexmedetomidine|mesh-list
24715012|NCT01533740|Antidotes|antidotes|mesh-ancestor
24800955|NCT01979679|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24800957|NCT01979679|Dopamine Agents|dopamine agents|mesh-ancestor
24800958|NCT01979965|Ranolazine|ranolazine|mesh-list
24800959|NCT01979965|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24800960|NCT01979965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24973872|NCT03706222|Grazoprevir|grazoprevir|mesh-list
24800962|NCT01980004|Potassium Citrate|potassium citrate|mesh-list
24800963|NCT01980004|Diuretics|diuretics|mesh-ancestor
24800964|NCT01980004|Natriuretic Agents|natriuretic agents|mesh-ancestor
24800965|NCT01980004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800966|NCT01980004|Expectorants|expectorants|mesh-ancestor
24800967|NCT01980004|Respiratory System Agents|respiratory system agents|mesh-ancestor
24800968|NCT01980069|Neostigmine|neostigmine|mesh-list
24800969|NCT01980069|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24800970|NCT01980069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800971|NCT01980069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800972|NCT01980069|Cholinergic Agents|cholinergic agents|mesh-ancestor
24800973|NCT01980069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24800974|NCT01980069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800975|NCT01980069|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24800976|NCT01980069|Autonomic Agents|autonomic agents|mesh-ancestor
24800977|NCT01980069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24800978|NCT01980082|Cefazolin|cefazolin|mesh-list
24800979|NCT01980082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24800980|NCT01980082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24800981|NCT01980277|Paclitaxel|paclitaxel|mesh-list
24800982|NCT01980277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24595157|NCT00937079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24595158|NCT00937079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595159|NCT00937079|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24595160|NCT00937079|Incretins|incretins|mesh-ancestor
24595161|NCT00937079|Hormones|hormones|mesh-ancestor
24595162|NCT00937079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24595163|NCT00937092|Dopamine|dopamine|mesh-list
24595164|NCT00937092|Furosemide|furosemide|mesh-list
24595165|NCT00937092|Diuretics|diuretics|mesh-ancestor
24548223|NCT00708357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548225|NCT00708396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24595177|NCT00937092|Protective Agents|protective agents|mesh-ancestor
24595179|NCT00937131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24595180|NCT00937131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24548268|NCT00708591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25702603|NCT02157376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25702604|NCT02157376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25702605|NCT02157623|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25702606|NCT02157623|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25702607|NCT02157623|Dermatologic Agents|dermatologic agents|mesh-ancestor
25702608|NCT02157935|Formoterol Fumarate|formoterol fumarate|mesh-list
25702609|NCT02157935|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25702610|NCT02157935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25037678|NCT03535792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25037679|NCT03535792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25037680|NCT03535792|Narcotics|narcotics|mesh-ancestor
25037681|NCT03535792|Analgesics|analgesics|mesh-ancestor
25037682|NCT03535792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25037683|NCT03535792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25037684|NCT03535792|Anesthetics, General|anesthetics, general|mesh-ancestor
24917776|NCT04226443|GABA Agents|gaba agents|mesh-ancestor
24917777|NCT04226443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24819927|NCT02097953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24917778|NCT04226443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917779|NCT04226443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24917780|NCT04226443|Narcotics|narcotics|mesh-ancestor
24917781|NCT04226443|Analgesics|analgesics|mesh-ancestor
24917782|NCT04226443|Sensory System Agents|sensory system agents|mesh-ancestor
24917783|NCT04226443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24548289|NCT00708799|Azithromycin|azithromycin|mesh-list
24548290|NCT00708799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24819928|NCT02097953|Antitubercular Agents|antitubercular agents|mesh-ancestor
24741083|NCT01691677|Hormones|hormones|mesh-ancestor
24917784|NCT04226105|Insulin|insulin|mesh-list
24917785|NCT04226105|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24917786|NCT04226105|Insulin Aspart|insulin aspart|mesh-list
24917787|NCT04226105|Insulin, Long-Acting|insulin, long-acting|mesh-list
24917788|NCT04226105|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24917848|NCT04225364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917849|NCT04225364|Tubulin Modulators|tubulin modulators|mesh-ancestor
24917850|NCT04225364|Antimitotic Agents|antimitotic agents|mesh-ancestor
24917851|NCT04225364|Mitosis Modulators|mitosis modulators|mesh-ancestor
24917852|NCT04225364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917853|NCT04225325|Dolutegravir|dolutegravir|mesh-list
25702611|NCT02157935|Autonomic Agents|autonomic agents|mesh-ancestor
25702612|NCT02157935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25702613|NCT02157935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702614|NCT02157935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25702615|NCT02157935|Respiratory System Agents|respiratory system agents|mesh-ancestor
25702616|NCT02157935|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25702617|NCT02157935|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25702618|NCT02157935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25702619|NCT02157935|Adrenergic Agents|adrenergic agents|mesh-ancestor
25702620|NCT02157935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25702621|NCT02157935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038051|NCT03533179|Glucagon|glucagon|mesh-list
24589057|NCT00905528|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25038111|NCT03532854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038112|NCT03532854|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25038113|NCT03532854|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25038114|NCT03532854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038115|NCT03532854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25038116|NCT03532854|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25038281|NCT05261971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25038282|NCT05261971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038283|NCT05261971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25038284|NCT05261971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24917854|NCT04225325|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
24917855|NCT04225325|Emtricitabine|emtricitabine|mesh-list
24917856|NCT04225325|Darunavir|darunavir|mesh-list
24917857|NCT04225325|Cobicistat|cobicistat|mesh-list
24917858|NCT04225325|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24917859|NCT04225325|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24801023|NCT01980472|Bevacizumab|bevacizumab|mesh-list
24801024|NCT01980472|Carboplatin|carboplatin|mesh-list
24801025|NCT01980472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24801027|NCT01980472|Tubulin Modulators|tubulin modulators|mesh-ancestor
24801028|NCT01980472|Antimitotic Agents|antimitotic agents|mesh-ancestor
24548330|NCT00709137|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24548331|NCT00709137|Diuretics|diuretics|mesh-ancestor
24801055|NCT01980550|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24801088|NCT01980745|Anthelmintics|anthelmintics|mesh-ancestor
24801090|NCT01980810|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24801091|NCT01980810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24548332|NCT00709137|Natriuretic Agents|natriuretic agents|mesh-ancestor
24548333|NCT00709137|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24548335|NCT00709137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24548336|NCT00709137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548337|NCT00709137|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24548338|NCT00709163|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24447614|NCT00309218|Prednisolone phosphate|prednisolone phosphate|mesh-list
24447616|NCT00309218|Antiemetics|antiemetics|mesh-ancestor
25702622|NCT02157948|Denosumab|denosumab|mesh-list
25702623|NCT02157948|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25702624|NCT02157948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702625|NCT02158039|Ethanol|ethanol|mesh-list
25702626|NCT02158039|Lidocaine|lidocaine|mesh-list
25702627|NCT02158039|Anesthetics, Local|anesthetics, local|mesh-ancestor
25702628|NCT02158039|Anesthetics|anesthetics|mesh-ancestor
25702629|NCT02158039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25702630|NCT02158039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702631|NCT02158039|Sensory System Agents|sensory system agents|mesh-ancestor
25702632|NCT02158039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25702633|NCT02158039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25702634|NCT02158039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24974063|NCT05175508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917860|NCT04225325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917861|NCT04225325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917862|NCT04225325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24917904|NCT04225195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24917905|NCT04225195|Antifungal Agents|antifungal agents|mesh-ancestor
24917906|NCT04225195|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24917907|NCT04225195|Protease Inhibitors|protease inhibitors|mesh-ancestor
24917908|NCT04225195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917909|NCT04225195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917914|NCT04225052|Varenicline|varenicline|mesh-list
24917915|NCT04225052|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24917916|NCT04225052|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24917917|NCT04225052|Cholinergic Agents|cholinergic agents|mesh-ancestor
24917918|NCT04225052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24917919|NCT04225052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917920|NCT04225052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917921|NCT04225065|Chlorhexidine|chlorhexidine|mesh-list
24917922|NCT04225065|Povidone-Iodine|povidone-iodine|mesh-list
24917923|NCT04225065|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24917924|NCT04225065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24917934|NCT04224818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24917935|NCT04224818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548478|NCT00709657|Bevacizumab|bevacizumab|mesh-list
24548479|NCT00709657|Ranibizumab|ranibizumab|mesh-list
24548480|NCT00709657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24548481|NCT00709657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24548482|NCT00709657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24548483|NCT00709657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24548484|NCT00709657|Growth Substances|growth substances|mesh-ancestor
24715597|NCT01537471|Meclizine|meclizine|mesh-list
24801163|NCT01981369|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24801164|NCT01981369|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24801165|NCT01981369|Adrenergic Agents|adrenergic agents|mesh-ancestor
24801166|NCT01981369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24801167|NCT01981369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801169|NCT01981447|Anticonvulsants|anticonvulsants|mesh-ancestor
24801170|NCT01981447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24801171|NCT01981447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24801172|NCT01981447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24801173|NCT01981447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548612|NCT00710619|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
24917936|NCT04224818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25702635|NCT02158039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25702636|NCT02158039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25702637|NCT02158039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702638|NCT02158039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25702639|NCT02158039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25709580|NCT02270242|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25709581|NCT02270242|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25709582|NCT02270242|Purinergic Agents|purinergic agents|mesh-ancestor
25039582|NCT03775421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039583|NCT03775421|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25039584|NCT03772964|Metformin|metformin|mesh-list
24996390|NCT03568708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996391|NCT03568708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24996392|NCT03568708|Contraceptive Agents|contraceptive agents|mesh-ancestor
24917937|NCT04224818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24917938|NCT04224818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917940|NCT04224649|Hyaluronic Acid|hyaluronic acid|mesh-list
24917941|NCT04224649|Anesthetics, Local|anesthetics, local|mesh-ancestor
24917983|NCT04224675|Adrenergic Agents|adrenergic agents|mesh-ancestor
24917984|NCT04224675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24917985|NCT04224675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917986|NCT04224675|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24917987|NCT04224675|Protease Inhibitors|protease inhibitors|mesh-ancestor
24801179|NCT01981499|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24801180|NCT01981499|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24801181|NCT01981499|Histamine Antagonists|histamine antagonists|mesh-ancestor
24801183|NCT01981499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24801184|NCT01981499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548680|NCT00711308|Hemostatics|hemostatics|mesh-ancestor
24548681|NCT00711308|Coagulants|coagulants|mesh-ancestor
24548682|NCT00711308|Anticoagulants|anticoagulants|mesh-ancestor
24548683|NCT00711308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24548684|NCT00711503|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24447644|NCT00309309|Rosiglitazone|rosiglitazone|mesh-list
24447645|NCT00309309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24447646|NCT00309309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447647|NCT00309322|Phentolamine|phentolamine|mesh-list
24447648|NCT00309322|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24447649|NCT00309322|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24549316|NCT00714558|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24476386|NCT00414648|Sirolimus|sirolimus|mesh-list
24476462|NCT00415103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24476463|NCT00415103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476464|NCT00415103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24476465|NCT00415103|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24548728|NCT00711854|Antitubercular Agents|antitubercular agents|mesh-ancestor
24548729|NCT00711854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24548730|NCT00711854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24548731|NCT00711854|Leprostatic Agents|leprostatic agents|mesh-ancestor
24548732|NCT00711854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24548733|NCT00711854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548734|NCT00711854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548735|NCT00711854|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24715794|NCT01538563|ON 01910|on 01910|mesh-list
24548770|NCT00711919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548772|NCT00711919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24548773|NCT00712049|Nicotinic Acids|nicotinic acids|mesh-list
24801190|NCT01981707|Lipotropic Agents|lipotropic agents|mesh-ancestor
24801191|NCT01981707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24801192|NCT01981707|Antimetabolites|antimetabolites|mesh-ancestor
24801193|NCT01981707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801194|NCT01981707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24801195|NCT01981707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24801196|NCT01981707|Nootropic Agents|nootropic agents|mesh-ancestor
24801198|NCT01981746|Anesthetics, Local|anesthetics, local|mesh-ancestor
24801199|NCT01981746|Anesthetics|anesthetics|mesh-ancestor
24548775|NCT00712049|Niacinamide|niacinamide|mesh-list
24548776|NCT00712049|Simvastatin|simvastatin|mesh-list
25702640|NCT02158273|Fenofibrate|fenofibrate|mesh-list
25702641|NCT02158273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25702642|NCT02158273|Antimetabolites|antimetabolites|mesh-ancestor
25702643|NCT02158273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702644|NCT02158273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25702645|NCT02158364|Vaccines|vaccines|mesh-list
25702646|NCT02158364|Immunologic Factors|immunologic factors|mesh-ancestor
25702647|NCT02158364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702648|NCT02158442|Clavulanic Acid|clavulanic acid|mesh-list
25702649|NCT02158442|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
24634451|NCT01133483|Ephedrine|ephedrine|mesh-list
24634452|NCT01133483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24589187|NCT00906061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589191|NCT00906061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25040377|NCT03137407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25040381|NCT03137407|Cholinergic Agents|cholinergic agents|mesh-ancestor
25040400|NCT03118570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25040401|NCT03110575|Cyclobenzaprine|cyclobenzaprine|mesh-list
25040402|NCT03110575|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25040403|NCT03110575|Antidepressive Agents|antidepressive agents|mesh-ancestor
25040404|NCT03110575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25040405|NCT03110575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25040406|NCT03110575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040407|NCT03110575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24548777|NCT00712049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24548778|NCT00712049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24548779|NCT00712049|Antimetabolites|antimetabolites|mesh-ancestor
24548781|NCT00712049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24553305|NCT00730249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24553306|NCT00730249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24553307|NCT00730249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553309|NCT00730249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24476509|NCT00415311|Agglutinins|agglutinins|mesh-ancestor
24476510|NCT00415311|Immunologic Factors|immunologic factors|mesh-ancestor
24548890|NCT00712504|Mitosis Modulators|mitosis modulators|mesh-ancestor
24548901|NCT00712517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24548902|NCT00712517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24715976|NCT01539265|Silodosin|silodosin|mesh-list
24801220|NCT01981811|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24486588|NCT00458510|Anesthetics|anesthetics|mesh-ancestor
24801221|NCT01981811|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24553393|NCT00730938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24553394|NCT00730938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24553395|NCT00730977|Mannitol|mannitol|mesh-list
24548980|NCT00712764|Analgesics|analgesics|mesh-ancestor
24548981|NCT00712764|Sensory System Agents|sensory system agents|mesh-ancestor
24548982|NCT00712764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24614951|NCT01026961|Antipruritics|antipruritics|mesh-ancestor
24549031|NCT00712933|Immunologic Factors|immunologic factors|mesh-ancestor
25702650|NCT02158442|Ticarcillin|ticarcillin|mesh-list
25702651|NCT02158442|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25702652|NCT02158442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25702653|NCT02158442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702654|NCT02158442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25702655|NCT02158442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25702656|NCT02158520|Paclitaxel|paclitaxel|mesh-list
25702657|NCT02158520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25702658|NCT02158520|Bevacizumab|bevacizumab|mesh-list
25702659|NCT02158520|Ipilimumab|ipilimumab|mesh-list
25702660|NCT02158520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25702661|NCT02158520|Endothelial Growth Factors|endothelial growth factors|mesh-list
25702662|NCT02158520|Antibodies|antibodies|mesh-list
25702663|NCT02158520|Immunoglobulins|immunoglobulins|mesh-list
25702664|NCT02158520|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25702665|NCT02158520|Immunoglobulin G|immunoglobulin g|mesh-list
25702666|NCT02158520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25702667|NCT02158520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549032|NCT00712933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607331|NCT04764942|Dexamethasone acetate|dexamethasone acetate|mesh-list
24549044|NCT00713167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549045|NCT00713167|Antioxidants|antioxidants|mesh-ancestor
24549046|NCT00713167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549047|NCT00713167|Protective Agents|protective agents|mesh-ancestor
24549048|NCT00713167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549050|NCT00713193|Prednisone|prednisone|mesh-list
24974279|NCT05003037|Carboplatin|carboplatin|mesh-list
24974280|NCT05003037|Pemetrexed|pemetrexed|mesh-list
24974281|NCT05003037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24801247|NCT01982019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801249|NCT01982071|Antifungal Agents|antifungal agents|mesh-ancestor
24801250|NCT01982071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24801251|NCT01982097|Sorafenib|sorafenib|mesh-list
24801252|NCT01982097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24801253|NCT01982097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24801254|NCT01982097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716114|NCT01539902|Alkylating Agents|alkylating agents|mesh-ancestor
24974282|NCT05003037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917988|NCT04224675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917989|NCT04224337|Doxorubicin|doxorubicin|mesh-list
24917990|NCT04224337|Durvalumab|durvalumab|mesh-list
24917991|NCT04224337|Ifosfamide|ifosfamide|mesh-list
24917992|NCT04224337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24917993|NCT04224337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917994|NCT04224337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24917995|NCT04224337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24917996|NCT04224337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917997|NCT04224337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917998|NCT04224337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24917999|NCT04224337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24918000|NCT04224337|Alkylating Agents|alkylating agents|mesh-ancestor
24918001|NCT04224441|Temozolomide|temozolomide|mesh-list
24918002|NCT04224441|Chlorpromazine|chlorpromazine|mesh-list
24918053|NCT04224350|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24918054|NCT04224350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918055|NCT04224350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918056|NCT04224246|Sodium Oxybate|sodium oxybate|mesh-list
24918057|NCT04224246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24918058|NCT04224246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24918140|NCT04223076|Chlorhexidine|chlorhexidine|mesh-list
24487101|NCT00461643|Metformin|metformin|mesh-list
24918141|NCT04223076|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24918142|NCT04223076|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24918143|NCT04223076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24918144|NCT04223076|Disinfectants|disinfectants|mesh-ancestor
24918145|NCT04223076|Dermatologic Agents|dermatologic agents|mesh-ancestor
24918146|NCT04222842|Vorolanib|vorolanib|mesh-list
24974307|NCT04976790|Analgesics|analgesics|mesh-ancestor
24974308|NCT04976790|Sensory System Agents|sensory system agents|mesh-ancestor
24974309|NCT04976790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24974310|NCT04976790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974311|NCT04976790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24794685|NCT04776850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24549174|NCT00713739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801268|NCT01982396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24801269|NCT01982396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24801270|NCT01982461|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24595479|NCT00938821|Anesthetics|anesthetics|mesh-ancestor
24595480|NCT00938821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24595481|NCT00938821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702668|NCT02158520|Tubulin Modulators|tubulin modulators|mesh-ancestor
24595482|NCT00938821|Sensory System Agents|sensory system agents|mesh-ancestor
24615036|NCT01027520|Monensin|monensin|mesh-list
25702669|NCT02158520|Antimitotic Agents|antimitotic agents|mesh-ancestor
24476649|NCT00415961|Paclitaxel|paclitaxel|mesh-list
24549206|NCT00713947|Pantoprazole|pantoprazole|mesh-list
24549215|NCT00713947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24549216|NCT00713947|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24549217|NCT00713947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24622291|NCT01066494|Antiviral Agents|antiviral agents|mesh-ancestor
24622292|NCT01066494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24622301|NCT01066559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622302|NCT01066572|Lisinopril|lisinopril|mesh-list
24622303|NCT01066572|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24622304|NCT01066572|Protease Inhibitors|protease inhibitors|mesh-ancestor
24622305|NCT01066572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622306|NCT01066572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622307|NCT01066572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24755639|NCT01727869|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24622308|NCT01066572|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24549303|NCT00714558|Naloxone|naloxone|mesh-list
24549304|NCT00714558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24549305|NCT00714558|Narcotics|narcotics|mesh-ancestor
24549306|NCT00714558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24549307|NCT00714558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549308|NCT00714558|Analgesics|analgesics|mesh-ancestor
24549309|NCT00714558|Sensory System Agents|sensory system agents|mesh-ancestor
24549310|NCT00714558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24549311|NCT00714558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24549312|NCT00714558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24549313|NCT00714558|Anesthetics, General|anesthetics, general|mesh-ancestor
24918147|NCT04222842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24918148|NCT04222842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918149|NCT04222842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918150|NCT04222855|Diltiazem|diltiazem|mesh-list
24476746|NCT00416390|Lycopene|lycopene|mesh-list
24476747|NCT00416390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24476748|NCT00416390|Antioxidants|antioxidants|mesh-ancestor
24476756|NCT00416429|Interferon-alpha|interferon-alpha|mesh-list
24476757|NCT00416429|Interferon alpha-2|interferon alpha-2|mesh-list
24476758|NCT00416429|Aldesleukin|aldesleukin|mesh-list
24476759|NCT00416429|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24476760|NCT00416429|Medroxyprogesterone|medroxyprogesterone|mesh-list
24476764|NCT00416429|Immunologic Factors|immunologic factors|mesh-ancestor
24476766|NCT00416429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24493070|NCT00489385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24549315|NCT00714558|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24622324|NCT01066663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24549359|NCT00714857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24549360|NCT00714857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549361|NCT00714857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24549362|NCT00714857|Analgesics|analgesics|mesh-ancestor
24493071|NCT00489398|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
24493072|NCT00489398|Epinastine|epinastine|mesh-list
24493073|NCT00489398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24493074|NCT00489398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24493075|NCT00489398|Analgesics|analgesics|mesh-ancestor
24447716|NCT00309491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24447717|NCT00309491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549405|NCT00715039|Antidepressive Agents|antidepressive agents|mesh-ancestor
24549406|NCT00715039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24549407|NCT00715039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24549408|NCT00715039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24549409|NCT00715039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549410|NCT00715039|Anticonvulsants|anticonvulsants|mesh-ancestor
24549411|NCT00715039|Antiemetics|antiemetics|mesh-ancestor
24549412|NCT00715039|Autonomic Agents|autonomic agents|mesh-ancestor
24549413|NCT00715039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24549414|NCT00715039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24549415|NCT00715039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24549430|NCT00715091|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24549432|NCT00715091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549464|NCT00715377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549465|NCT00715377|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24549466|NCT00715377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24549467|NCT00715377|Cholinergic Agents|cholinergic agents|mesh-ancestor
24716627|NCT01542801|Norfloxacin|norfloxacin|mesh-list
24801274|NCT01982461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801275|NCT01982461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24801276|NCT01982461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24801277|NCT01982461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24801279|NCT01982578|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24801280|NCT01982578|Protective Agents|protective agents|mesh-ancestor
24801281|NCT01982578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801282|NCT01982578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24801283|NCT01982578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24801284|NCT01982578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716672|NCT01543139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24801296|NCT01982734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24801297|NCT01982734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476908|NCT00416819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24476909|NCT00416819|Alkylating Agents|alkylating agents|mesh-ancestor
24477026|NCT00417014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24616544|NCT01037959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616545|NCT01037959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853763|NCT02270281|Analgesics|analgesics|mesh-ancestor
24918225|NCT04221971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24918226|NCT04221971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24918227|NCT04222010|Anesthetics|anesthetics|mesh-list
24918228|NCT04222010|Ropivacaine|ropivacaine|mesh-list
24918229|NCT04222010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24918230|NCT04222010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918231|NCT04222010|Anesthetics, Local|anesthetics, local|mesh-ancestor
24918232|NCT04222010|Sensory System Agents|sensory system agents|mesh-ancestor
24918234|NCT04221555|Docetaxel|docetaxel|mesh-list
24918274|NCT04221256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24549528|NCT00715780|Isophane insulin, beef|isophane insulin, beef|mesh-list
24549529|NCT00715780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24801318|NCT01982799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801320|NCT01982799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24801321|NCT01982799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24477103|NCT00417222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24477104|NCT00417222|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24801332|NCT01982864|Gentamicins|gentamicins|mesh-list
24801333|NCT01982864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24801334|NCT01982864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24801335|NCT01982864|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24801336|NCT01982864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24801337|NCT01982864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801338|NCT01982929|Epinephrine|epinephrine|mesh-list
24477186|NCT00417729|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25702670|NCT02158520|Mitosis Modulators|mitosis modulators|mesh-ancestor
24477201|NCT00417794|Adrenergic Agents|adrenergic agents|mesh-ancestor
24477202|NCT00417794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24477203|NCT00417794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549645|NCT00716547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24801350|NCT01982929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801352|NCT01982929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24801354|NCT01982929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24801355|NCT01982929|Respiratory System Agents|respiratory system agents|mesh-ancestor
24505107|NCT00539877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24717060|NCT01545297|Anesthetics|anesthetics|mesh-ancestor
24918275|NCT04221165|Analgesics, Opioid|analgesics, opioid|mesh-list
24918276|NCT04221165|Narcotics|narcotics|mesh-ancestor
24918277|NCT04221165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24918278|NCT04221165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918279|NCT04221165|Analgesics|analgesics|mesh-ancestor
24918280|NCT04221165|Sensory System Agents|sensory system agents|mesh-ancestor
24918281|NCT04221165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24918282|NCT04221321|Atorvastatin|atorvastatin|mesh-list
24918288|NCT04221321|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24918289|NCT04221321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918290|NCT04221126|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24918291|NCT04221126|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24918292|NCT04221126|Dermatologic Agents|dermatologic agents|mesh-ancestor
24477204|NCT00417807|Imatinib Mesylate|imatinib mesylate|mesh-list
24477205|NCT00417807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477206|NCT00417807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24477207|NCT00417807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918294|NCT04221529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24918295|NCT04221152|Empagliflozin|empagliflozin|mesh-list
24918320|NCT04220996|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24918321|NCT04220996|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24918322|NCT04220996|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24918323|NCT04220996|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24918325|NCT04220892|Pemetrexed|pemetrexed|mesh-list
24918326|NCT04220892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24918327|NCT04220892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24918328|NCT04220892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24741675|NCT05290506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918329|NCT04220892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918330|NCT04220892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24918331|NCT04220892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24918364|NCT04220632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24918365|NCT04220632|Protective Agents|protective agents|mesh-ancestor
24918366|NCT04220476|Letrozole|letrozole|mesh-list
24918367|NCT04220476|Palbociclib|palbociclib|mesh-list
24918368|NCT04220476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24918379|NCT04220281|Propofol|propofol|mesh-list
24918380|NCT04220281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24918381|NCT04220281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24549677|NCT00716911|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
24549678|NCT00716911|Antiviral Agents|antiviral agents|mesh-ancestor
24477350|NCT00418353|Antiemetics|antiemetics|mesh-ancestor
24477351|NCT00418353|Autonomic Agents|autonomic agents|mesh-ancestor
24446771|NCT00305838|Tamoxifen|tamoxifen|mesh-list
24549693|NCT00716950|Valsartan|valsartan|mesh-list
24549694|NCT00716950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24549695|NCT00716950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24549696|NCT00716950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24717122|NCT01545791|Insulin Detemir|insulin detemir|mesh-list
25709583|NCT02270242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25709584|NCT02270255|Lidocaine|lidocaine|mesh-list
25709585|NCT02270255|Ropivacaine|ropivacaine|mesh-list
24549726|NCT00717379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24918382|NCT04220281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918469|NCT04219358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24918470|NCT04219358|Interferon Inducers|interferon inducers|mesh-ancestor
24616555|NCT01038024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616556|NCT01038024|Protective Agents|protective agents|mesh-ancestor
24616558|NCT01038037|Carboplatin|carboplatin|mesh-list
24616901|NCT01039740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809278|NCT02032394|Chlorhexidine|chlorhexidine|mesh-list
24616902|NCT01039740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616903|NCT01039740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24616904|NCT01039740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24616905|NCT01039740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24616906|NCT01039740|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24493382|NCT00490737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493384|NCT00490789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24493385|NCT00490789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493386|NCT00490789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24477511|NCT00418860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24477512|NCT00418860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477513|NCT00418860|Antipyretics|antipyretics|mesh-ancestor
24477568|NCT00419146|Tocopherols|tocopherols|mesh-list
24477572|NCT00419146|Micronutrients|micronutrients|mesh-ancestor
24477582|NCT00419172|Antitubercular Agents|antitubercular agents|mesh-ancestor
24493387|NCT00490789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520907|NCT05243940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24520909|NCT05243940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24520910|NCT05243940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24520911|NCT05243940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24549773|NCT00717470|Protective Agents|protective agents|mesh-ancestor
24447791|NCT00309569|Antimetabolites|antimetabolites|mesh-ancestor
24447792|NCT00309569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24505108|NCT00539877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24801362|NCT01983124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24801363|NCT01983124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24801364|NCT01983124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801365|NCT01983137|Oxycodone|oxycodone|mesh-list
24801366|NCT01983137|Naloxone|naloxone|mesh-list
24801367|NCT01983137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24801368|NCT01983137|Narcotics|narcotics|mesh-ancestor
24477583|NCT00419172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24477639|NCT00419549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477641|NCT00419549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24520912|NCT05243940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520913|NCT05243940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24520914|NCT05243940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24520915|NCT05243940|Analgesics|analgesics|mesh-ancestor
24756964|NCT01736813|Maraviroc|maraviroc|mesh-list
24549799|NCT00717561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24549800|NCT00717561|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24549801|NCT00717587|Sunitinib|sunitinib|mesh-list
24549802|NCT00717587|Motexafin gadolinium|motexafin gadolinium|mesh-list
24549869|NCT00717808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24477755|NCT00419835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477756|NCT00419848|Azithromycin|azithromycin|mesh-list
24477757|NCT00419848|Doxycycline|doxycycline|mesh-list
24477758|NCT00419848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24477759|NCT00419848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24474693|NCT00407017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24549893|NCT00717938|Enoxaparin|enoxaparin|mesh-list
24549894|NCT00717938|Enoxaparin sodium|enoxaparin sodium|mesh-list
24549895|NCT00717938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549896|NCT00717938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24549897|NCT00717938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24549898|NCT00717938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24549899|NCT00717938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549900|NCT00717938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549901|NCT00717938|Anticoagulants|anticoagulants|mesh-ancestor
24549902|NCT00717938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24549903|NCT00717938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24549904|NCT00717951|Capecitabine|capecitabine|mesh-list
24549905|NCT00717951|Docetaxel|docetaxel|mesh-list
25709586|NCT02270255|Anesthetics, Local|anesthetics, local|mesh-ancestor
25709587|NCT02270255|Anesthetics|anesthetics|mesh-ancestor
24549926|NCT00717990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24549953|NCT00718354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24974581|NCT04394481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24477836|NCT00420524|Antimitotic Agents|antimitotic agents|mesh-ancestor
24477837|NCT00420524|Mitosis Modulators|mitosis modulators|mesh-ancestor
24427996|NCT00239421|Xhance|xhance|mesh-list
24477898|NCT00420654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24520916|NCT05243940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24520917|NCT05243940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24520918|NCT05243940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24520919|NCT05243940|Adrenergic Agents|adrenergic agents|mesh-ancestor
24623774|NCT01073579|GABA Agents|gaba agents|mesh-ancestor
24623775|NCT01073579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24623776|NCT01073579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623777|NCT01073644|Sunitinib|sunitinib|mesh-list
24623778|NCT01073644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623779|NCT01073644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24521038|NCT05174832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24521039|NCT05174832|Tubulin Modulators|tubulin modulators|mesh-ancestor
24521040|NCT05174832|Antimitotic Agents|antimitotic agents|mesh-ancestor
24521041|NCT05174832|Mitosis Modulators|mitosis modulators|mesh-ancestor
24521042|NCT05174832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549955|NCT00718354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549956|NCT00718354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24549957|NCT00718354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24549973|NCT00718406|Analgesics|analgesics|mesh-ancestor
24549974|NCT00718406|Sensory System Agents|sensory system agents|mesh-ancestor
24549975|NCT00718406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24549976|NCT00718406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24549977|NCT00718406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24801390|NCT01983449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801391|NCT01983449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24801392|NCT01983449|Glucocorticoids|glucocorticoids|mesh-ancestor
24549978|NCT00718406|Sympatholytics|sympatholytics|mesh-ancestor
24549979|NCT00718406|Autonomic Agents|autonomic agents|mesh-ancestor
24477899|NCT00420654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477956|NCT00421018|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24549980|NCT00718406|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24549981|NCT00718406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24549982|NCT00718406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24550001|NCT00718484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24790102|NCT01940952|Donepezil|donepezil|mesh-list
24717550|NCT01548521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24801399|NCT01983449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801400|NCT01983462|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24801401|NCT01983462|Clonidine|clonidine|mesh-list
24521043|NCT05174832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24521044|NCT05174832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24521045|NCT05174832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24521046|NCT05174507|Empagliflozin|empagliflozin|mesh-list
24918543|NCT04218500|Nicotinic Acids|nicotinic acids|mesh-list
24918544|NCT04218500|Vitamin B Complex|vitamin b complex|mesh-ancestor
24918546|NCT04218500|Micronutrients|micronutrients|mesh-ancestor
24918547|NCT04218500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918548|NCT04218500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24918549|NCT04218500|Antimetabolites|antimetabolites|mesh-ancestor
24918550|NCT04218500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477957|NCT00421018|Hormone Antagonists|hormone antagonists|mesh-ancestor
24477963|NCT00421044|Epothilone B|epothilone b|mesh-list
24918551|NCT04218500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24918552|NCT04218500|Vasodilator Agents|vasodilator agents|mesh-ancestor
24918553|NCT04218435|Valsartan|valsartan|mesh-list
24918554|NCT04218435|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24918559|NCT04218760|Isosorbide|isosorbide|mesh-list
24918638|NCT04217265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550029|NCT00718757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550030|NCT00718757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24550031|NCT00718757|Glucocorticoids|glucocorticoids|mesh-ancestor
24550032|NCT00718757|Hormones|hormones|mesh-ancestor
24550033|NCT00718757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24550034|NCT00718757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24550035|NCT00718757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550036|NCT00718757|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24550037|NCT00718757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24550038|NCT00718757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550039|NCT00718757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550040|NCT00718757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24550041|NCT00718757|Tubulin Modulators|tubulin modulators|mesh-ancestor
24717589|NCT01548859|Midazolam|midazolam|mesh-list
24550061|NCT00718796|Micronutrients|micronutrients|mesh-ancestor
24550062|NCT00718796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801402|NCT01983462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24801403|NCT01983462|Diuretics|diuretics|mesh-ancestor
24550063|NCT00718913|Docetaxel|docetaxel|mesh-list
24550064|NCT00718913|Capecitabine|capecitabine|mesh-list
24550065|NCT00718913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550067|NCT00718913|Antimitotic Agents|antimitotic agents|mesh-ancestor
24550068|NCT00718913|Mitosis Modulators|mitosis modulators|mesh-ancestor
24550069|NCT00718913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550070|NCT00718913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24550071|NCT00718913|Antimetabolites|antimetabolites|mesh-ancestor
24550072|NCT00718952|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24717636|NCT01549093|Antimetabolites|antimetabolites|mesh-ancestor
24550116|NCT00719121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24550118|NCT00719121|Dermatologic Agents|dermatologic agents|mesh-ancestor
24550119|NCT00719121|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24717687|NCT01549418|Antipyretics|antipyretics|mesh-ancestor
24550161|NCT00719420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24550162|NCT00719420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24550163|NCT00719420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24550164|NCT00719420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550165|NCT00719420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550166|NCT00719420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24550167|NCT00719420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24550168|NCT00719420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24550169|NCT00719433|Armin|armin|mesh-list
24550170|NCT00719433|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24550171|NCT00719433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550172|NCT00719433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757130|NCT01738087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24550173|NCT00719433|Cholinergic Agents|cholinergic agents|mesh-ancestor
24588137|NCT00901147|Bortezomib|bortezomib|mesh-list
24918758|NCT04216888|Anesthetics|anesthetics|mesh-ancestor
24918759|NCT04216888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24918760|NCT04216888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24918761|NCT04216888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24918762|NCT04216888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24918822|NCT04216472|Mitosis Modulators|mitosis modulators|mesh-ancestor
24918823|NCT04216472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918824|NCT04216472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918825|NCT04216186|Ubiquinone|ubiquinone|mesh-list
24918826|NCT04216186|Coenzyme Q10|coenzyme q10|mesh-list
24918827|NCT04216186|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24478068|NCT00421434|Ribavirin|ribavirin|mesh-list
24428163|NCT00239785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24478070|NCT00421434|Interferon-alpha|interferon-alpha|mesh-list
24478071|NCT00421434|Nitazoxanide|nitazoxanide|mesh-list
24478072|NCT00421434|Antimetabolites|antimetabolites|mesh-ancestor
25709588|NCT02270255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24478073|NCT00421434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918895|NCT04215835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24918896|NCT04215835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918897|NCT04215835|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24918932|NCT04215159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918933|NCT04215159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24918934|NCT04215159|Immunologic Factors|immunologic factors|mesh-ancestor
24918935|NCT04215159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918962|NCT04214938|Lidocaine|lidocaine|mesh-list
24550174|NCT00719433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24550175|NCT00719433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550177|NCT00719459|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24550178|NCT00719459|Trace Elements|trace elements|mesh-ancestor
24550179|NCT00719459|Micronutrients|micronutrients|mesh-ancestor
24550180|NCT00719459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550181|NCT00719459|Hematinics|hematinics|mesh-ancestor
24550182|NCT00719602|Ritonavir|ritonavir|mesh-list
24550183|NCT00719602|Lopinavir|lopinavir|mesh-list
24550184|NCT00719602|Lamivudine|lamivudine|mesh-list
24550185|NCT00719602|Zidovudine|zidovudine|mesh-list
24550186|NCT00719602|Nevirapine|nevirapine|mesh-list
24794812|NCT04443309|Lenvatinib|lenvatinib|mesh-list
24918963|NCT04214938|Xylometazoline|xylometazoline|mesh-list
24918964|NCT04214938|Anesthetics, Local|anesthetics, local|mesh-ancestor
24918965|NCT04214938|Anesthetics|anesthetics|mesh-ancestor
24918979|NCT04214990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24918980|NCT04214990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24918981|NCT04214990|Analgesics|analgesics|mesh-ancestor
24918982|NCT04214990|Sensory System Agents|sensory system agents|mesh-ancestor
24918983|NCT04214990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24918984|NCT04214990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919063|NCT04214626|Abortifacient Agents|abortifacient agents|mesh-ancestor
24919064|NCT04214626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24919065|NCT04214626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24919066|NCT04214626|Antimetabolites|antimetabolites|mesh-ancestor
24919067|NCT04214626|Dermatologic Agents|dermatologic agents|mesh-ancestor
24919068|NCT04214626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24919069|NCT04214626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24919070|NCT04214626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24919072|NCT04214626|Tubulin Modulators|tubulin modulators|mesh-ancestor
24919150|NCT04213937|Mitosis Modulators|mitosis modulators|mesh-ancestor
24919151|NCT04213937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478145|NCT00421642|Adalimumab|adalimumab|mesh-list
24919152|NCT04213937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24919153|NCT04213937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24919154|NCT04213937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617705|NCT01045083|Antidepressive Agents|antidepressive agents|mesh-ancestor
24617706|NCT01045083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24617707|NCT01045083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24617708|NCT01045083|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24617709|NCT01045083|Dopamine Agents|dopamine agents|mesh-ancestor
24617710|NCT01045109|Vitamin D|vitamin d|mesh-list
24617711|NCT01045109|Ergocalciferols|ergocalciferols|mesh-list
24919191|NCT04213833|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24919206|NCT04213781|Sensory System Agents|sensory system agents|mesh-ancestor
24919207|NCT04213781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24919208|NCT04213781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24919210|NCT04213885|Vitamin B Complex|vitamin b complex|mesh-ancestor
24919211|NCT04213885|Vitamins|vitamins|mesh-ancestor
24919212|NCT04213885|Micronutrients|micronutrients|mesh-ancestor
24919213|NCT04213885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919214|NCT04213885|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24919215|NCT04213885|Dermatologic Agents|dermatologic agents|mesh-ancestor
24919216|NCT04213378|Paclitaxel|paclitaxel|mesh-list
24919217|NCT04213378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24919218|NCT04213378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24919236|NCT04213612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24521209|NCT04991493|Tramadol|tramadol|mesh-list
24521210|NCT04991493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24521211|NCT04991493|Narcotics|narcotics|mesh-ancestor
24521212|NCT04991493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24494443|NCT00495287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24494444|NCT00495287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25709589|NCT02270255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494445|NCT00495287|Immunologic Factors|immunologic factors|mesh-ancestor
24794818|NCT04435795|Glucocorticoids|glucocorticoids|mesh-ancestor
24550198|NCT00719602|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24550199|NCT00719602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24550235|NCT00719797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24550236|NCT00719797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24555254|NCT00740571|Anticonvulsants|anticonvulsants|mesh-ancestor
24550237|NCT00719797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24550238|NCT00719797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24550239|NCT00719797|Growth Substances|growth substances|mesh-ancestor
24550240|NCT00719797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550241|NCT00719797|Growth Inhibitors|growth inhibitors|mesh-ancestor
24474694|NCT00407017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24550290|NCT00720135|Sensory System Agents|sensory system agents|mesh-ancestor
24550291|NCT00720135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24550308|NCT00720174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24550309|NCT00720174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24550310|NCT00720174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550311|NCT00720174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24490897|NCT00480389|Sorafenib|sorafenib|mesh-list
24550312|NCT00720174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24550313|NCT00720174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478352|NCT00422526|Hormones|hormones|mesh-ancestor
24446772|NCT00305838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24550315|NCT00720174|Immunologic Factors|immunologic factors|mesh-ancestor
24550385|NCT00720447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550386|NCT00720447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24550387|NCT00720447|Alkylating Agents|alkylating agents|mesh-ancestor
24550388|NCT00720447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24550389|NCT00720447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24550391|NCT00720512|Bevacizumab|bevacizumab|mesh-list
24550392|NCT00720512|Fluorouracil|fluorouracil|mesh-list
24550393|NCT00720512|Oxaliplatin|oxaliplatin|mesh-list
24550394|NCT00720512|Irinotecan|irinotecan|mesh-list
24550395|NCT00720512|Calcium|calcium|mesh-list
24801410|NCT01983462|Sensory System Agents|sensory system agents|mesh-ancestor
24801411|NCT01983462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24550440|NCT00720577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24550441|NCT00720577|Antimetabolites|antimetabolites|mesh-ancestor
24550442|NCT00720577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550443|NCT00720577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24550444|NCT00720577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24717907|NCT01550770|Propofol|propofol|mesh-list
24447853|NCT00309699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447854|NCT00309699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24447855|NCT00309699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24447858|NCT00309712|Fenofibrate|fenofibrate|mesh-list
25702671|NCT02158520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702672|NCT02158520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25702673|NCT02158520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25702674|NCT02158520|Growth Substances|growth substances|mesh-ancestor
25702675|NCT02158520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702676|NCT02158520|Growth Inhibitors|growth inhibitors|mesh-ancestor
24919814|NCT04208516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24919818|NCT04208516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24521495|NCT04745975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24521496|NCT04745975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24446847|NCT00306254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24446848|NCT00306254|Protease Inhibitors|protease inhibitors|mesh-ancestor
24809738|NCT02036073|Epoetin Alfa|epoetin alfa|mesh-list
24521497|NCT04745975|Immunologic Factors|immunologic factors|mesh-ancestor
24521498|NCT04745975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521500|NCT04745728|Cyclophosphamide|cyclophosphamide|mesh-list
24521501|NCT04745728|Rituximab|rituximab|mesh-list
24521502|NCT04745728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24521503|NCT04745728|Immunologic Factors|immunologic factors|mesh-ancestor
24521504|NCT04745728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521505|NCT04745728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24521506|NCT04745728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24521507|NCT04745728|Alkylating Agents|alkylating agents|mesh-ancestor
24521508|NCT04745728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919914|NCT04207723|Serotonin Agents|serotonin agents|mesh-ancestor
24919915|NCT04207723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801654|NCT01984827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24801655|NCT01984931|Medazepam|medazepam|mesh-list
24801656|NCT01984931|Metoclopramide|metoclopramide|mesh-list
24801657|NCT01984931|Bromazepam|bromazepam|mesh-list
24801658|NCT01984931|Simethicone|simethicone|mesh-list
24801659|NCT01984931|Trimebutine|trimebutine|mesh-list
24801660|NCT01984931|Mosapride|mosapride|mesh-list
24882153|NCT02735707|Cysteamine|cysteamine|mesh-list
24801661|NCT01984931|Maleic acid|maleic acid|mesh-list
24801662|NCT01984931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039929|NCT03588884|Cholecalciferol|cholecalciferol|mesh-list
24801663|NCT01984931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801664|NCT01984931|Antiemetics|antiemetics|mesh-ancestor
24801665|NCT01984931|Autonomic Agents|autonomic agents|mesh-ancestor
24801666|NCT01984931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24801667|NCT01984931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480263|NCT00430170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480273|NCT00430196|Tizanidine|tizanidine|mesh-list
24480274|NCT00430196|Analgesics|analgesics|mesh-ancestor
24480275|NCT00430196|Sensory System Agents|sensory system agents|mesh-ancestor
25702705|NCT02158806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25702706|NCT02158806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25702707|NCT02158806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25702708|NCT02158806|Antipyretics|antipyretics|mesh-ancestor
24812686|NCT02054078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24521873|NCT04456439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521885|NCT04456439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521886|NCT04456439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24521887|NCT04456439|Antipruritics|antipruritics|mesh-ancestor
24521888|NCT04456439|Dermatologic Agents|dermatologic agents|mesh-ancestor
24521889|NCT04456439|Antiviral Agents|antiviral agents|mesh-ancestor
24521890|NCT04456439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24920226|NCT04204382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24920227|NCT04204382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24920228|NCT04204382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24920229|NCT04204382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920230|NCT04204382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801704|NCT01985152|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
24801705|NCT01985152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24801706|NCT01985152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24920231|NCT04204382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24920247|NCT04204096|Vaccines|vaccines|mesh-list
24920278|NCT04203771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24920279|NCT04203771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24920280|NCT04203771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920281|NCT04203771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920282|NCT04203914|Empagliflozin|empagliflozin|mesh-list
24920283|NCT04203914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24920284|NCT04203914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920285|NCT04203914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24920286|NCT04203914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920315|NCT04203342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24920316|NCT04203342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920317|NCT04203342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24920319|NCT04203368|Verapamil|verapamil|mesh-list
24920320|NCT04203368|Analgesics|analgesics|mesh-ancestor
24920321|NCT04203368|Sensory System Agents|sensory system agents|mesh-ancestor
24560260|NCT03078010|Tazobactam|tazobactam|mesh-list
25702715|NCT02158975|Ixazomib|ixazomib|mesh-list
25702716|NCT02158975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25702717|NCT02158975|Protease Inhibitors|protease inhibitors|mesh-ancestor
25702718|NCT02158975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25702719|NCT02158975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702720|NCT02159053|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25702721|NCT02159053|Immunologic Factors|immunologic factors|mesh-ancestor
25702722|NCT02159053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495655|NCT00501410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522112|NCT04275661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522113|NCT04275661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24522114|NCT04275661|Anticonvulsants|anticonvulsants|mesh-ancestor
24522115|NCT04275661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24522116|NCT04275661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24522117|NCT04275661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24522118|NCT04275661|Tocolytic Agents|tocolytic agents|mesh-ancestor
24522119|NCT04275661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24454537|NCT03901469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24454538|NCT03901469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24454539|NCT03901469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481120|NCT00433368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702723|NCT02159352|Ritonavir|ritonavir|mesh-list
25702724|NCT02159352|Lopinavir|lopinavir|mesh-list
25702725|NCT02159352|Darunavir|darunavir|mesh-list
25702726|NCT02159352|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25702727|NCT02159352|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25702728|NCT02159352|Protease Inhibitors|protease inhibitors|mesh-ancestor
25702729|NCT02159352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709590|NCT02270255|Sensory System Agents|sensory system agents|mesh-ancestor
24801716|NCT01985256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24454624|NCT03878524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24454625|NCT03878524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24801717|NCT01985256|Antimetabolites|antimetabolites|mesh-ancestor
24454675|NCT03818607|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24454676|NCT03818607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24454677|NCT03818607|Immunologic Factors|immunologic factors|mesh-ancestor
24454678|NCT03818607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24454679|NCT03797014|Tenofovir|tenofovir|mesh-list
24454680|NCT03797014|Emtricitabine|emtricitabine|mesh-list
24454681|NCT03797014|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
24454682|NCT03797014|Antiviral Agents|antiviral agents|mesh-ancestor
24454683|NCT03797014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24454684|NCT03797014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24454685|NCT03797014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24454686|NCT03797014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24454687|NCT03797014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24454689|NCT03797014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24404748|NCT00164749|Curcumin|curcumin|mesh-list
24481280|NCT00433953|Antitubercular Agents|antitubercular agents|mesh-ancestor
24522126|NCT04256317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920442|NCT04202536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24920445|NCT04202484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24620225|NCT01055938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24620226|NCT01055938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25702739|NCT02159365|Elotuzumab|elotuzumab|mesh-list
25702740|NCT02159365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25702741|NCT02159365|Antiemetics|antiemetics|mesh-ancestor
25702742|NCT02159365|Autonomic Agents|autonomic agents|mesh-ancestor
25702743|NCT02159365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25702744|NCT02159365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702745|NCT02159365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25702746|NCT02159365|Glucocorticoids|glucocorticoids|mesh-ancestor
25702747|NCT02159365|Hormones|hormones|mesh-ancestor
24801740|NCT01985477|Glucocorticoids|glucocorticoids|mesh-ancestor
24560808|NCT01451515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24722455|NCT01580683|Protective Agents|protective agents|mesh-ancestor
24620227|NCT01055938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24620229|NCT01055964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24620230|NCT01055964|Immunologic Factors|immunologic factors|mesh-ancestor
24620231|NCT01055964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620232|NCT01055964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24620233|NCT01055964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620234|NCT01055964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623921|NCT01073995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24623923|NCT01073995|Sensory System Agents|sensory system agents|mesh-ancestor
24920452|NCT04202380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24920453|NCT04202367|Bupivacaine|bupivacaine|mesh-list
24920454|NCT04202367|Anesthetics, Local|anesthetics, local|mesh-ancestor
24920551|NCT04201769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24920556|NCT04201769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24801746|NCT01985477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25702749|NCT02159365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25702750|NCT02159365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25702751|NCT02159365|Immunologic Factors|immunologic factors|mesh-ancestor
25702752|NCT02159365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25702753|NCT02159365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25702754|NCT02159365|Growth Substances|growth substances|mesh-ancestor
25702755|NCT02159365|Growth Inhibitors|growth inhibitors|mesh-ancestor
25702756|NCT02159469|Methyltestosterone|methyltestosterone|mesh-list
24522291|NCT04004078|Clotrimazole|clotrimazole|mesh-list
24522293|NCT04004078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24522294|NCT04004078|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24522295|NCT04004078|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24522296|NCT04004078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24522297|NCT04004078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24522298|NCT04004078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522299|NCT04004078|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24920645|NCT04200235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24920646|NCT04200235|Analgesics|analgesics|mesh-ancestor
24920647|NCT04200235|Sensory System Agents|sensory system agents|mesh-ancestor
24920694|NCT04199143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24920695|NCT04199013|Fentanyl|fentanyl|mesh-list
24920696|NCT04199013|Ropivacaine|ropivacaine|mesh-list
24920697|NCT04199013|Anesthetics, Local|anesthetics, local|mesh-ancestor
24406446|NCT00170404|Folic Acid|folic acid|mesh-list
24454728|NCT03768089|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24454729|NCT03768089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24454730|NCT03768089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24454735|NCT03754140|Polidocanol|polidocanol|mesh-list
24454736|NCT03754140|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
24454737|NCT03754140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24481770|NCT00436761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24722706|NCT01582230|Vildagliptin|vildagliptin|mesh-list
25702757|NCT02159469|Testosterone|testosterone|mesh-list
25702758|NCT02159469|Testosterone undecanoate|testosterone undecanoate|mesh-list
25702759|NCT02159469|Testosterone enanthate|testosterone enanthate|mesh-list
25702760|NCT02159469|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25702761|NCT02159469|Androgens|androgens|mesh-ancestor
25702762|NCT02159469|Hormones|hormones|mesh-ancestor
25702763|NCT02159469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25702764|NCT02159469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688359|NCT03091660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24688612|NCT02879942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
24688613|NCT02879942|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
24688614|NCT02879942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24688615|NCT02879942|Growth Substances|growth substances|mesh-ancestor
24688616|NCT02879942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688617|NCT02879942|Growth Inhibitors|growth inhibitors|mesh-ancestor
24688618|NCT02879942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688619|NCT02873819|Cyclophosphamide|cyclophosphamide|mesh-list
24688620|NCT02873819|Sargramostim|sargramostim|mesh-list
24688621|NCT02873819|Poly ICLC|poly iclc|mesh-list
24688622|NCT02873819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24688623|NCT02873819|Immunologic Factors|immunologic factors|mesh-ancestor
24688624|NCT02873819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688940|NCT02551991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24688941|NCT02551991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688942|NCT02551991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25702765|NCT02159469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25702766|NCT02159469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25702767|NCT02159469|Anabolic Agents|anabolic agents|mesh-ancestor
25702768|NCT02159482|Interferons|interferons|mesh-list
25702769|NCT02159482|Interferon-alpha|interferon-alpha|mesh-list
25702770|NCT02159482|Interferon alpha-2|interferon alpha-2|mesh-list
25702771|NCT02159482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25702772|NCT02159482|Antiviral Agents|antiviral agents|mesh-ancestor
25702773|NCT02159482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25702774|NCT02159482|Immunologic Factors|immunologic factors|mesh-ancestor
25702775|NCT02159482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702776|NCT02159521|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25702777|NCT02159521|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25702778|NCT02159521|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25702779|NCT02159521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702780|NCT02159547|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
25702781|NCT02159547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25702782|NCT02159547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25702783|NCT02159547|Analgesics|analgesics|mesh-ancestor
25702784|NCT02159547|Sensory System Agents|sensory system agents|mesh-ancestor
25702785|NCT02159547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25702786|NCT02159547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702787|NCT02159547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25702788|NCT02159547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25702789|NCT02159807|Fentanyl|fentanyl|mesh-list
24689102|NCT02299999|Durvalumab|durvalumab|mesh-list
24689103|NCT02299999|Epirubicin|epirubicin|mesh-list
24801770|NCT01985724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24801771|NCT01985724|Immunologic Factors|immunologic factors|mesh-ancestor
24801772|NCT01985724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801773|NCT01985724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24920698|NCT04199013|Anesthetics|anesthetics|mesh-ancestor
24920699|NCT04199013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24920700|NCT04199013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920701|NCT04199013|Sensory System Agents|sensory system agents|mesh-ancestor
24920702|NCT04199013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24920703|NCT04199013|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24920704|NCT04199013|Narcotics|narcotics|mesh-ancestor
24920705|NCT04199013|Analgesics|analgesics|mesh-ancestor
24920706|NCT04199013|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24920707|NCT04199013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24443181|NCT00293891|Tacrolimus|tacrolimus|mesh-list
24522313|NCT03994796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522314|NCT03974594|Trifluridine|trifluridine|mesh-list
24522315|NCT03974594|Antimetabolites|antimetabolites|mesh-ancestor
24522316|NCT03974594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522317|NCT03974594|Antiviral Agents|antiviral agents|mesh-ancestor
24522318|NCT03974594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24522319|NCT03964688|Ascorbic Acid|ascorbic acid|mesh-list
24522320|NCT03964688|Vitamins|vitamins|mesh-ancestor
24522321|NCT03964688|Micronutrients|micronutrients|mesh-ancestor
24522322|NCT03964688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522323|NCT03964688|Antioxidants|antioxidants|mesh-ancestor
24522325|NCT03964688|Protective Agents|protective agents|mesh-ancestor
24522356|NCT03940196|Mitosis Modulators|mitosis modulators|mesh-ancestor
24522357|NCT03940196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522360|NCT03927378|Esketamine|esketamine|mesh-list
24522361|NCT03927378|Analgesics|analgesics|mesh-ancestor
24522362|NCT03927378|Sensory System Agents|sensory system agents|mesh-ancestor
24522363|NCT03927378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24522364|NCT03927378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522365|NCT03927378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24920729|NCT04198636|Denosumab|denosumab|mesh-list
24920730|NCT04198636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24920731|NCT04198636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744185|NCT04464577|Itraconazole|itraconazole|mesh-list
24920732|NCT04198467|Hyaluronic Acid|hyaluronic acid|mesh-list
24407468|NCT00174577|Dopamine Agents|dopamine agents|mesh-ancestor
24407494|NCT00174629|Gemcitabine|gemcitabine|mesh-list
24407495|NCT00174629|Docetaxel|docetaxel|mesh-list
24407496|NCT00174629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24407497|NCT00174629|Antimetabolites|antimetabolites|mesh-ancestor
24481899|NCT00437229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481900|NCT00437229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24407498|NCT00174629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407499|NCT00174629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25702793|NCT02159807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25702794|NCT02159807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702795|NCT02159807|Sensory System Agents|sensory system agents|mesh-ancestor
25702796|NCT02159807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24522398|NCT03893175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24522511|NCT03673956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522512|NCT03673956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522513|NCT03673956|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24920848|NCT04196946|Sensory System Agents|sensory system agents|mesh-ancestor
24482416|NCT00438958|Lenograstim|lenograstim|mesh-list
24920849|NCT04196946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24920850|NCT04196946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24920851|NCT04196946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24621251|NCT01061190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24621252|NCT01061190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24621253|NCT01061190|Vasodilator Agents|vasodilator agents|mesh-ancestor
24417942|NCT00208208|Ziprasidone|ziprasidone|mesh-list
24417944|NCT00208208|Serotonin Agents|serotonin agents|mesh-ancestor
24448176|NCT00310583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24448177|NCT00310583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24448178|NCT00310583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24448189|NCT00310596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448190|NCT00310596|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24448191|NCT00310596|Contraceptive Agents|contraceptive agents|mesh-ancestor
24448192|NCT00310596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24448193|NCT00310596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448194|NCT00310596|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24448195|NCT00310596|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24448196|NCT00310596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24448197|NCT00310765|Pregabalin|pregabalin|mesh-list
24448198|NCT00310765|Gabapentin|gabapentin|mesh-list
24448199|NCT00310765|Analgesics|analgesics|mesh-ancestor
24723737|NCT01588925|Dexamethasone|dexamethasone|mesh-list
24448209|NCT00310765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24448210|NCT00310765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24448255|NCT00310908|Narcotics|narcotics|mesh-ancestor
24421313|NCT00218283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724105|NCT01591122|Hormones|hormones|mesh-ancestor
24801860|NCT01985893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24522573|NCT03641326|Growth Substances|growth substances|mesh-ancestor
24522574|NCT03641326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522575|NCT03641326|Growth Inhibitors|growth inhibitors|mesh-ancestor
24522576|NCT03641326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24522577|NCT03641326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25702803|NCT02159859|Ertapenem|ertapenem|mesh-list
25702804|NCT02159859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25702805|NCT02159859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25702806|NCT02159872|Homoharringtonine|homoharringtonine|mesh-list
25702807|NCT02159872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25702808|NCT02159872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25702809|NCT02159872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25702810|NCT02159872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921226|NCT04193293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24921227|NCT04193293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921228|NCT04193293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921247|NCT04193059|Pertuzumab|pertuzumab|mesh-list
24921248|NCT04193059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24921249|NCT04193059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921250|NCT04193059|Tubulin Modulators|tubulin modulators|mesh-ancestor
24921251|NCT04193059|Antimitotic Agents|antimitotic agents|mesh-ancestor
24921252|NCT04193059|Mitosis Modulators|mitosis modulators|mesh-ancestor
24921253|NCT04193059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921254|NCT04193059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24921257|NCT04193059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24921316|NCT04192643|Hemostatics|hemostatics|mesh-ancestor
24921317|NCT04192643|Coagulants|coagulants|mesh-ancestor
24921318|NCT04192435|Tranexamic Acid|tranexamic acid|mesh-list
24921319|NCT04192435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24921320|NCT04192435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24921321|NCT04192435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921322|NCT04192435|Hemostatics|hemostatics|mesh-ancestor
24921323|NCT04192435|Coagulants|coagulants|mesh-ancestor
24921324|NCT04192292|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24921325|NCT04192292|Gliclazide|gliclazide|mesh-list
24921330|NCT04192292|Hormones|hormones|mesh-ancestor
24921399|NCT04191694|Antipruritics|antipruritics|mesh-ancestor
24482893|NCT00440869|Protective Agents|protective agents|mesh-ancestor
24482894|NCT00440869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482924|NCT00440960|GABA Modulators|gaba modulators|mesh-ancestor
24921406|NCT04191694|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24921407|NCT04191694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24921408|NCT04191694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24921409|NCT04191694|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24921410|NCT04191681|Valsartan|valsartan|mesh-list
24921414|NCT04191681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24724314|NCT01592201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24921415|NCT04191681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921416|NCT04191863|Valproic Acid|valproic acid|mesh-list
24921417|NCT04191863|Anticonvulsants|anticonvulsants|mesh-ancestor
24921418|NCT04191863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921419|NCT04191863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921420|NCT04191863|GABA Agents|gaba agents|mesh-ancestor
24483048|NCT00441532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24483049|NCT00441532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483050|NCT00441532|Sensory System Agents|sensory system agents|mesh-ancestor
24483051|NCT00441532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24483052|NCT00441532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24921421|NCT04191863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24921422|NCT04191863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921423|NCT04191863|Antimanic Agents|antimanic agents|mesh-ancestor
24921424|NCT04191863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24522731|NCT03366844|Pembrolizumab|pembrolizumab|mesh-list
24921468|NCT04190927|Hormones|hormones|mesh-ancestor
24921606|NCT04189666|Protective Agents|protective agents|mesh-ancestor
24921607|NCT04189666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921608|NCT04189666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24921701|NCT04188171|Polidocanol|polidocanol|mesh-list
24921702|NCT04188171|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
24921703|NCT04188171|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24921707|NCT04188314|Desflurane|desflurane|mesh-list
24483136|NCT00441961|Immunologic Factors|immunologic factors|mesh-ancestor
24483137|NCT00441961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24483138|NCT00441961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24483139|NCT00442026|Gemcitabine|gemcitabine|mesh-list
24483140|NCT00442026|Docetaxel|docetaxel|mesh-list
24483141|NCT00442026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24483142|NCT00442026|Antimetabolites|antimetabolites|mesh-ancestor
24483193|NCT00442221|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24483194|NCT00442221|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24483196|NCT00442221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24801895|NCT01986192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801897|NCT01986270|Eletriptan|eletriptan|mesh-list
24724419|NCT01593033|Micronutrients|micronutrients|mesh-list
24724458|NCT01593150|Dabigatran|dabigatran|mesh-list
24724501|NCT01593319|Anesthetics|anesthetics|mesh-ancestor
24483251|NCT00442494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24483252|NCT00442546|Pregabalin|pregabalin|mesh-list
24483253|NCT00442546|Analgesics|analgesics|mesh-ancestor
24483261|NCT00442546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24483378|NCT00443170|Purinergic Agents|purinergic agents|mesh-ancestor
24483379|NCT00443170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24483380|NCT00443170|Analgesics|analgesics|mesh-ancestor
24921912|NCT04185350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24921917|NCT04185233|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24921918|NCT04185233|Anesthetics, General|anesthetics, general|mesh-ancestor
24921919|NCT04185233|Anesthetics|anesthetics|mesh-ancestor
24497328|NCT00509470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24497358|NCT00509639|Metronidazole|metronidazole|mesh-list
24623112|NCT01070225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24563461|NCT00771680|Insulin, Long-Acting|insulin, long-acting|mesh-list
24563462|NCT00771680|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24801933|NCT01986426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801935|NCT01986465|Methylprednisolone|methylprednisolone|mesh-list
24801936|NCT01986465|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24801937|NCT01986465|Prednisolone|prednisolone|mesh-list
24801938|NCT01986465|Prednisolone acetate|prednisolone acetate|mesh-list
24801939|NCT01986465|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24801940|NCT01986465|Prednisolone phosphate|prednisolone phosphate|mesh-list
24801941|NCT01986465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24801942|NCT01986465|Antiemetics|antiemetics|mesh-ancestor
24483668|NCT00444470|Hemostatics|hemostatics|mesh-ancestor
24921960|NCT04185194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922040|NCT04184141|GABA Modulators|gaba modulators|mesh-ancestor
24922041|NCT04184141|GABA Agents|gaba agents|mesh-ancestor
24922042|NCT04184141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24922043|NCT04184141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922044|NCT04184141|Antipruritics|antipruritics|mesh-ancestor
24922045|NCT04184141|Dermatologic Agents|dermatologic agents|mesh-ancestor
24922046|NCT04184141|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24922047|NCT04184141|Histamine Antagonists|histamine antagonists|mesh-ancestor
24522842|NCT03103750|Dextroamphetamine|dextroamphetamine|mesh-list
24522843|NCT03103750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24522844|NCT03103750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522845|NCT03103750|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24563570|NCT00772473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622447|NCT01067053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622448|NCT01067053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24622449|NCT01067053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24622450|NCT01067053|Growth Substances|growth substances|mesh-ancestor
24622451|NCT01067053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564077|NCT00775073|Bevacizumab|bevacizumab|mesh-list
24564078|NCT00775073|Everolimus|everolimus|mesh-list
24564079|NCT00775073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24522846|NCT03103750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24522862|NCT03103087|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24522863|NCT03103087|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24522864|NCT03103087|Norethindrone|norethindrone|mesh-list
24522865|NCT03103087|Norethindrone Acetate|norethindrone acetate|mesh-list
24522866|NCT03103087|Estradiol|estradiol|mesh-list
24522867|NCT03103087|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24522868|NCT03103087|Relugolix|relugolix|mesh-list
24522869|NCT03103087|Estrogens|estrogens|mesh-ancestor
24522870|NCT03103087|Hormones|hormones|mesh-ancestor
24495566|NCT00501111|Nootropic Agents|nootropic agents|mesh-ancestor
24922239|NCT04182828|Anesthetics|anesthetics|mesh-ancestor
24922240|NCT04182828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24922241|NCT04182828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922242|NCT04182828|Sensory System Agents|sensory system agents|mesh-ancestor
24922243|NCT04182828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24922244|NCT04182828|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24922246|NCT04182828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24922256|NCT04182191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24922257|NCT04182191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24922259|NCT04182191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24922308|NCT04181749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24922309|NCT04181749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24922310|NCT04181749|Analgesics|analgesics|mesh-ancestor
24922311|NCT04181749|Sensory System Agents|sensory system agents|mesh-ancestor
24922312|NCT04181749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24922313|NCT04181749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922314|NCT04181749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24922315|NCT04181749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24922316|NCT04181749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24922317|NCT04181749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24922318|NCT04181749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484257|NCT00447369|Pregabalin|pregabalin|mesh-list
24564580|NCT00776802|Glucocorticoids|glucocorticoids|mesh-ancestor
24805933|NCT02012946|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24454993|NCT03031483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24802015|NCT01986777|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
24802016|NCT01986777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24802017|NCT01986777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922319|NCT04181749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24922320|NCT04181749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24922337|NCT04181385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24922370|NCT04181489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24922372|NCT04181489|Antimitotic Agents|antimitotic agents|mesh-ancestor
24624045|NCT01074593|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24624046|NCT01074619|Memantine|memantine|mesh-list
24624047|NCT01074619|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24624048|NCT01074619|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24624049|NCT01074619|Dopamine Agents|dopamine agents|mesh-ancestor
24624050|NCT01074619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24484258|NCT00447369|Valproic Acid|valproic acid|mesh-list
24922414|NCT04180657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24922415|NCT04180657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922416|NCT04180384|Paclitaxel|paclitaxel|mesh-list
24922417|NCT04180384|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24922418|NCT04180384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24922419|NCT04180384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922420|NCT04180384|Tubulin Modulators|tubulin modulators|mesh-ancestor
24922421|NCT04180384|Antimitotic Agents|antimitotic agents|mesh-ancestor
24922466|NCT04179604|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24922467|NCT04179604|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24922476|NCT04179500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24922477|NCT04179500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24922478|NCT04179500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24922480|NCT04179500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922481|NCT04179500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922482|NCT04179500|Antitubercular Agents|antitubercular agents|mesh-ancestor
24922483|NCT04179513|Methotrexate|methotrexate|mesh-list
24922484|NCT04179513|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24922485|NCT04179513|Abortifacient Agents|abortifacient agents|mesh-ancestor
24922486|NCT04179513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24922487|NCT04179513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922488|NCT04179513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24922533|NCT04179045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24922534|NCT04179045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922535|NCT04179045|Antifungal Agents|antifungal agents|mesh-ancestor
24922536|NCT04179045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24922537|NCT04179045|Immunologic Factors|immunologic factors|mesh-ancestor
24922538|NCT04179045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922539|NCT04179006|Antidepressive Agents|antidepressive agents|mesh-list
24922600|NCT04178512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24922601|NCT04178512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24922614|NCT04178512|Anesthetics|anesthetics|mesh-ancestor
24922615|NCT04178148|Amikacin|amikacin|mesh-list
24922616|NCT04178148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24922651|NCT04177875|Antimitotic Agents|antimitotic agents|mesh-ancestor
24922652|NCT04177875|Mitosis Modulators|mitosis modulators|mesh-ancestor
24922653|NCT04177875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922655|NCT04177641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922656|NCT04177641|Protective Agents|protective agents|mesh-ancestor
24922657|NCT04177641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922658|NCT04178109|Acetaminophen|acetaminophen|mesh-list
24922659|NCT04178109|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
24922661|NCT04178109|Ropivacaine|ropivacaine|mesh-list
24922662|NCT04178109|Levobupivacaine|levobupivacaine|mesh-list
24922663|NCT04178109|Anesthetics, Local|anesthetics, local|mesh-ancestor
24922664|NCT04178109|Anesthetics|anesthetics|mesh-ancestor
24922665|NCT04178109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24922666|NCT04178109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624052|NCT01074619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624053|NCT01074619|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24790367|NCT01942187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24790368|NCT01942187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24790369|NCT01942187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24790370|NCT01942187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24624054|NCT01074619|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24624346|NCT01075802|Tamoxifen|tamoxifen|mesh-list
24624073|NCT01074645|Tenofovir|tenofovir|mesh-list
24624078|NCT01074645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24624079|NCT01074645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498196|NCT00513513|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24498197|NCT00513513|Protease Inhibitors|protease inhibitors|mesh-ancestor
24498198|NCT00513513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498199|NCT00513513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498200|NCT00513513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24498201|NCT00513513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24922667|NCT04178109|Sensory System Agents|sensory system agents|mesh-ancestor
24922769|NCT04177043|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
24922770|NCT04177043|Immunologic Factors|immunologic factors|mesh-ancestor
24922771|NCT04177043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922818|NCT04176224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24922819|NCT04176224|Antioxidants|antioxidants|mesh-ancestor
24922820|NCT04176224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922821|NCT04176224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24802020|NCT01986777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24564892|NCT00778115|Emollients|emollients|mesh-ancestor
24725902|NCT01600430|Vitamin D|vitamin d|mesh-list
24484668|NCT00449514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24922822|NCT04176224|Protective Agents|protective agents|mesh-ancestor
24922823|NCT04176224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922828|NCT04176367|Nicergoline|nicergoline|mesh-list
24922829|NCT04176367|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24922830|NCT04176367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24922831|NCT04176367|Adrenergic Agents|adrenergic agents|mesh-ancestor
24922832|NCT04176367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24922835|NCT04176367|Vasodilator Agents|vasodilator agents|mesh-ancestor
24922836|NCT04176367|Nootropic Agents|nootropic agents|mesh-ancestor
24624139|NCT01074892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24624140|NCT01074892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624142|NCT01074892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24624144|NCT01074905|Chloroquine|chloroquine|mesh-list
24624145|NCT01074905|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24625348|NCT01081847|Mannitol|mannitol|mesh-list
24624146|NCT01074905|Primaquine|primaquine|mesh-list
24624147|NCT01074905|Antimalarials|antimalarials|mesh-ancestor
24624149|NCT01074905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24600337|NCT01026220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24600338|NCT01026220|Tubulin Modulators|tubulin modulators|mesh-ancestor
24600339|NCT01026220|Antimitotic Agents|antimitotic agents|mesh-ancestor
24600340|NCT01026220|Mitosis Modulators|mitosis modulators|mesh-ancestor
24600665|NCT00959881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600666|NCT00959881|Cholinergic Agents|cholinergic agents|mesh-ancestor
24600667|NCT00959881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430110|NCT00246194|Risperidone|risperidone|mesh-list
24484903|NCT00450645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484904|NCT00450736|Celecoxib|celecoxib|mesh-list
24484975|NCT00450957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802033|NCT01986894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24802034|NCT01986894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802035|NCT01986894|Immunologic Factors|immunologic factors|mesh-ancestor
24802036|NCT01986894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24802037|NCT01986894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24448702|NCT00312650|Antiviral Agents|antiviral agents|mesh-ancestor
24448703|NCT00312650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24448704|NCT00312650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616233|NCT01035190|Hormones|hormones|mesh-ancestor
24802051|NCT01986998|Autonomic Agents|autonomic agents|mesh-ancestor
24802052|NCT01986998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24802053|NCT01986998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802054|NCT01986998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24802056|NCT01986998|Hormones|hormones|mesh-ancestor
24726186|NCT01602185|Dopamine Agents|dopamine agents|mesh-ancestor
25702811|NCT02159872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600781|NCT00960518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448734|NCT00312988|Gemcitabine|gemcitabine|mesh-list
24448735|NCT00312988|Topotecan|topotecan|mesh-list
24485136|NCT00451724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24485137|NCT00451724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24435886|NCT00268411|Gemcitabine|gemcitabine|mesh-list
24485138|NCT00451724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24485139|NCT00451724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485140|NCT00451750|Hydrocortisone|hydrocortisone|mesh-list
24485141|NCT00451750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24485142|NCT00451763|Bevacizumab|bevacizumab|mesh-list
24600783|NCT00960544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24600784|NCT00960544|Antimetabolites|antimetabolites|mesh-ancestor
24636410|NCT01145326|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24636411|NCT01145326|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24636414|NCT01145365|Anesthetics|anesthetics|mesh-list
24600792|NCT00960557|Mitosis Modulators|mitosis modulators|mesh-ancestor
24600793|NCT00960557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802082|NCT01987167|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24802096|NCT01987297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24802097|NCT01987297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24474696|NCT00407017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24790381|NCT01942291|Niacin|niacin|mesh-list
24485556|NCT00453648|Protective Agents|protective agents|mesh-ancestor
24485557|NCT00453648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446856|NCT00306319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24446866|NCT00306358|Hematinics|hematinics|mesh-ancestor
24485605|NCT00453908|Adrenergic Agents|adrenergic agents|mesh-ancestor
25702812|NCT02159950|Vaccines|vaccines|mesh-list
25702813|NCT02159950|Immunologic Factors|immunologic factors|mesh-ancestor
25702814|NCT02159950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702815|NCT02159976|Amoxicillin|amoxicillin|mesh-list
25702816|NCT02159976|Metronidazole|metronidazole|mesh-list
25702817|NCT02159976|Clarithromycin|clarithromycin|mesh-list
25702818|NCT02159976|Tetracycline|tetracycline|mesh-list
25702819|NCT02159976|Pantoprazole|pantoprazole|mesh-list
25702820|NCT02159976|Bismuth|bismuth|mesh-list
25702821|NCT02159976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25702822|NCT02159976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24449017|NCT00313924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24449018|NCT00313924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449019|NCT00313924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449020|NCT00313924|Urological Agents|urological agents|mesh-ancestor
24449021|NCT00313937|Insulin Glargine|insulin glargine|mesh-list
24449022|NCT00313937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24727081|NCT01607970|Oxytocin|oxytocin|mesh-list
25702823|NCT02159976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25702824|NCT02159976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25702825|NCT02159976|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25702826|NCT02159976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25702827|NCT02159976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702828|NCT02159976|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25702829|NCT02159976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25702830|NCT02159976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25702831|NCT02159976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25702832|NCT02159976|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24601158|NCT00963209|Tamoxifen|tamoxifen|mesh-list
24601159|NCT00963209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24601160|NCT00963209|Hormone Antagonists|hormone antagonists|mesh-ancestor
24601161|NCT00963209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24601162|NCT00963209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601326|NCT00963976|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24601327|NCT00963976|Adrenergic Agents|adrenergic agents|mesh-ancestor
24601328|NCT00963976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24601329|NCT00963976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497294|NCT00509353|Antimitotic Agents|antimitotic agents|mesh-ancestor
24455162|NCT02567409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24455163|NCT02567409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24455164|NCT02567409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24455165|NCT02567409|Immunologic Factors|immunologic factors|mesh-ancestor
24455166|NCT02567409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802164|NCT01988298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24802165|NCT01988298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802167|NCT01988298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24802168|NCT01988298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24449452|NCT00315679|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24449453|NCT00315679|Protective Agents|protective agents|mesh-ancestor
24601429|NCT00964106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24601430|NCT00964106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24601431|NCT00964106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24601432|NCT00964106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24486125|NCT00456430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24486126|NCT00456430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486127|NCT00456430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24486128|NCT00456430|Serotonin Agents|serotonin agents|mesh-ancestor
24486129|NCT00456430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486136|NCT00456482|Hormones|hormones|mesh-ancestor
24601435|NCT00964171|Efavirenz|efavirenz|mesh-list
24601436|NCT00964171|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24601437|NCT00964171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24601438|NCT00964171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601439|NCT00964171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727646|NCT01611727|Cisplatin|cisplatin|mesh-list
24802197|NCT01988610|Mifepristone|mifepristone|mesh-list
24802198|NCT01988610|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24802199|NCT01988610|Abortifacient Agents|abortifacient agents|mesh-ancestor
24802200|NCT01988610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24802201|NCT01988610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702833|NCT02159976|Antacids|antacids|mesh-ancestor
25702834|NCT02160041|Infigratinib|infigratinib|mesh-list
25702835|NCT02160041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25702836|NCT02160145|Tolvaptan|tolvaptan|mesh-list
25702837|NCT02160145|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25702838|NCT02160145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702839|NCT02160145|Natriuretic Agents|natriuretic agents|mesh-ancestor
25702840|NCT02160145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702841|NCT02160288|Botulinum Toxins|botulinum toxins|mesh-list
24601470|NCT00964288|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24601471|NCT00964288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24601472|NCT00964288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601473|NCT00964327|Darunavir|darunavir|mesh-list
24601474|NCT00964327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24601475|NCT00964327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24486273|NCT00456976|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24486274|NCT00456976|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24601476|NCT00964327|Protease Inhibitors|protease inhibitors|mesh-ancestor
24601477|NCT00964327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601478|NCT00964327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601479|NCT00964327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24601480|NCT00964327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24601481|NCT00964327|Antiviral Agents|antiviral agents|mesh-ancestor
24601482|NCT00964327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24601483|NCT00964418|Insulin|insulin|mesh-list
24601484|NCT00964418|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24601485|NCT00964418|Insulin Glargine|insulin glargine|mesh-list
24393215|NCT00129168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24393216|NCT00129168|Antimetabolites|antimetabolites|mesh-ancestor
24393217|NCT00129168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393218|NCT00129168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393219|NCT00129168|Antiviral Agents|antiviral agents|mesh-ancestor
24393220|NCT00129168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24601486|NCT00964418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24601487|NCT00964418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802221|NCT01988831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24802222|NCT01988831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802223|NCT01988831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802224|NCT01988831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24802225|NCT01988831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24802226|NCT01988831|Vasodilator Agents|vasodilator agents|mesh-ancestor
24802228|NCT01988896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393933|NCT00131313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24393934|NCT00131313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24393935|NCT00131313|Alkylating Agents|alkylating agents|mesh-ancestor
24393936|NCT00131313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601488|NCT00964457|Cetuximab|cetuximab|mesh-list
24601489|NCT00964457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24601490|NCT00964457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24601491|NCT00964535|Budesonide|budesonide|mesh-list
24601492|NCT00964535|Formoterol Fumarate|formoterol fumarate|mesh-list
24601493|NCT00964535|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24601508|NCT00964535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24601509|NCT00964535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601510|NCT00964561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24601511|NCT00964561|Ciprofloxacin|ciprofloxacin|mesh-list
24636560|NCT01146041|Rivastigmine|rivastigmine|mesh-list
24601515|NCT00964561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24601516|NCT00964561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24601517|NCT00964561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601518|NCT00964561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601519|NCT00964561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24601520|NCT00964561|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24601521|NCT00964561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24601522|NCT00964574|Insulin|insulin|mesh-list
24601523|NCT00964574|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24601524|NCT00964574|Insulin Glargine|insulin glargine|mesh-list
24601526|NCT00964574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24601527|NCT00964574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601528|NCT00964626|Paclitaxel|paclitaxel|mesh-list
24601529|NCT00964626|Cisplatin|cisplatin|mesh-list
24486724|NCT00459719|Tacrolimus|tacrolimus|mesh-list
24486775|NCT00460083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24601530|NCT00964626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24601629|NCT00965107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24601630|NCT00965107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601631|NCT00965107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24601647|NCT00965172|Calcium|calcium|mesh-list
24601648|NCT00965172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24601649|NCT00965172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601650|NCT00965289|Rituximab|rituximab|mesh-list
24601651|NCT00965289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24601652|NCT00965289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24601653|NCT00965289|Immunologic Factors|immunologic factors|mesh-ancestor
24601654|NCT00965289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393937|NCT00131313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393938|NCT00131313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24497780|NCT00511849|Carboplatin|carboplatin|mesh-list
24393939|NCT00131313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24802260|NCT01989078|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24393941|NCT00131326|Viscosupplements|viscosupplements|mesh-ancestor
24393948|NCT00131339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24393950|NCT00131339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24393951|NCT00131339|Antimetabolites|antimetabolites|mesh-ancestor
25702842|NCT02160288|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25702843|NCT02160288|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24601660|NCT00965315|Antimetabolites|antimetabolites|mesh-ancestor
24601751|NCT00965874|Sensory System Agents|sensory system agents|mesh-ancestor
24601758|NCT00965874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24601759|NCT00965874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24601760|NCT00965874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601761|NCT00965874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24601762|NCT00965874|Tocolytic Agents|tocolytic agents|mesh-ancestor
24601763|NCT00965874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24601765|NCT00965900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24601789|NCT00965926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24601799|NCT00966004|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24601800|NCT00966004|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24601801|NCT00966004|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24601802|NCT00966004|Adrenergic Agents|adrenergic agents|mesh-ancestor
24601803|NCT00966004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24601804|NCT00966004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601805|NCT00966004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601806|NCT00966004|Urological Agents|urological agents|mesh-ancestor
24601807|NCT00966004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24601808|NCT00966004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24601809|NCT00966004|Cholinergic Agents|cholinergic agents|mesh-ancestor
24596628|NCT00944502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24394114|NCT00132158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394115|NCT00132158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24462914|NCT00357864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452203|NCT00326391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452206|NCT00326404|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24452207|NCT00326404|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24452208|NCT00326404|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24452209|NCT00326404|Desogestrel|desogestrel|mesh-list
24452210|NCT00326404|Estradiol|estradiol|mesh-list
24452211|NCT00326404|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25702846|NCT02160288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702847|NCT02160288|Cholinergic Agents|cholinergic agents|mesh-ancestor
25702848|NCT02160288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25702849|NCT02160288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702850|NCT02160288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25702851|NCT02160288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24452213|NCT00326404|Hormones|hormones|mesh-ancestor
24452214|NCT00326404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24452215|NCT00326404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452216|NCT00326404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24452217|NCT00326404|Contraceptive Agents|contraceptive agents|mesh-ancestor
24596646|NCT00944606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596648|NCT00944619|Insulin|insulin|mesh-list
24802263|NCT01989091|Heparin|heparin|mesh-list
24802264|NCT01989091|Anticoagulants|anticoagulants|mesh-ancestor
24802265|NCT01989091|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24568520|NCT00796250|Autonomic Agents|autonomic agents|mesh-ancestor
24452218|NCT00326404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24463067|NCT00358488|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24463068|NCT00358488|Adrenergic Agents|adrenergic agents|mesh-ancestor
24463069|NCT00358488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24463070|NCT00358488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463071|NCT00358488|Tocolytic Agents|tocolytic agents|mesh-ancestor
24463072|NCT00358488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24728913|NCT01618890|Propranolol|propranolol|mesh-list
24452257|NCT00326768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24452258|NCT00326768|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24452259|NCT00326768|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24452260|NCT00326768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452261|NCT00326768|Diuretics|diuretics|mesh-ancestor
24802274|NCT01989312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24802275|NCT01989312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802276|NCT01989312|Sensory System Agents|sensory system agents|mesh-ancestor
25086633|NCT03287609|Antimetabolites|antimetabolites|mesh-ancestor
24601856|NCT00966160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24601857|NCT00966160|Antimetabolites|antimetabolites|mesh-ancestor
24601858|NCT00966160|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24601859|NCT00966160|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24601860|NCT00966160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24601861|NCT00966160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24802277|NCT01989312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24802278|NCT01989312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24487346|NCT00462787|Antiemetics|antiemetics|mesh-ancestor
24802279|NCT01989312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24487361|NCT00462787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24487362|NCT00462787|Tubulin Modulators|tubulin modulators|mesh-ancestor
24487363|NCT00462787|Antimitotic Agents|antimitotic agents|mesh-ancestor
25702852|NCT02160535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25702853|NCT02160535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25702854|NCT02160535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25702855|NCT02160535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25702856|NCT02160535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702857|NCT02160535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25702858|NCT02160535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25702859|NCT02160535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702860|NCT02160535|Cholinergic Agents|cholinergic agents|mesh-ancestor
25702861|NCT02160535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24601875|NCT00966316|Analgesics|analgesics|mesh-ancestor
24601876|NCT00966316|Sensory System Agents|sensory system agents|mesh-ancestor
24601877|NCT00966316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24601899|NCT00966368|Insulin, Long-Acting|insulin, long-acting|mesh-list
24601930|NCT00966615|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24601931|NCT00966680|Anesthetics|anesthetics|mesh-list
24601932|NCT00966680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24601933|NCT00966680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601934|NCT00966706|Gemcitabine|gemcitabine|mesh-list
24601935|NCT00966706|Docetaxel|docetaxel|mesh-list
24601936|NCT00966706|Capecitabine|capecitabine|mesh-list
24601937|NCT00966706|Epirubicin|epirubicin|mesh-list
24601938|NCT00966706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24601939|NCT00966706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24601940|NCT00966706|Antimetabolites|antimetabolites|mesh-ancestor
24601941|NCT00966706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487364|NCT00462787|Mitosis Modulators|mitosis modulators|mesh-ancestor
24601942|NCT00966706|Antiviral Agents|antiviral agents|mesh-ancestor
24802324|NCT01989611|Emtricitabine|emtricitabine|mesh-list
24802325|NCT01989611|Antiviral Agents|antiviral agents|mesh-ancestor
24802326|NCT01989611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24802327|NCT01989611|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24802328|NCT01989611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24802329|NCT01989611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24802341|NCT01989663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24601943|NCT00966706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24601944|NCT00966706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601945|NCT00966706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24601946|NCT00966706|Immunologic Factors|immunologic factors|mesh-ancestor
24601947|NCT00966706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601948|NCT00966706|Tubulin Modulators|tubulin modulators|mesh-ancestor
24601949|NCT00966706|Antimitotic Agents|antimitotic agents|mesh-ancestor
24601950|NCT00966706|Mitosis Modulators|mitosis modulators|mesh-ancestor
24601951|NCT00966706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24601952|NCT00966706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24601954|NCT00966745|Milrinone|milrinone|mesh-list
24498910|NCT00516802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487494|NCT00463515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487495|NCT00463515|Antiviral Agents|antiviral agents|mesh-ancestor
24601955|NCT00966745|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25702862|NCT02160626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25702863|NCT02160730|Roscovitine|roscovitine|mesh-list
25702864|NCT02160730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24601956|NCT00966745|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24601957|NCT00966745|Vasodilator Agents|vasodilator agents|mesh-ancestor
24601958|NCT00966745|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24601960|NCT00966745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601961|NCT00966745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601962|NCT00966745|Protective Agents|protective agents|mesh-ancestor
24601963|NCT00966745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601965|NCT00966771|Levonorgestrel|levonorgestrel|mesh-list
24601966|NCT00966771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24601967|NCT00966771|Contraceptive Agents|contraceptive agents|mesh-ancestor
24602003|NCT00966966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602004|NCT00966966|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24802343|NCT01989676|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24802389|NCT01989845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802390|NCT01989845|Anticoagulants|anticoagulants|mesh-ancestor
24802392|NCT01989884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24802393|NCT01989897|Phenol|phenol|mesh-list
24802394|NCT01989897|Histamine|histamine|mesh-list
24463273|NCT00359723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463274|NCT00359723|Dopamine Agents|dopamine agents|mesh-ancestor
24463275|NCT00359723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24602005|NCT00966966|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24602006|NCT00966966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24602007|NCT00966966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24602008|NCT00967031|Capecitabine|capecitabine|mesh-list
24602050|NCT00967057|Mitosis Modulators|mitosis modulators|mesh-ancestor
24602051|NCT00967057|Analgesics|analgesics|mesh-ancestor
24602052|NCT00967057|Sensory System Agents|sensory system agents|mesh-ancestor
24602053|NCT00967057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24602054|NCT00967057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24602055|NCT00967057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24729233|NCT01620684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24802398|NCT01989897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802400|NCT01989897|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24569024|NCT00798616|Prednisolone|prednisolone|mesh-list
24463293|NCT00359853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24463294|NCT00359853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24802401|NCT01989897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24802402|NCT01989897|Disinfectants|disinfectants|mesh-ancestor
24802403|NCT01989897|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
24802404|NCT01989897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24602057|NCT00967070|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24602058|NCT00967070|Autonomic Agents|autonomic agents|mesh-ancestor
24602059|NCT00967070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24602060|NCT00967070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602061|NCT00967070|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24602062|NCT00967070|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24602063|NCT00967070|Cholinergic Agents|cholinergic agents|mesh-ancestor
24602064|NCT00967070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24602065|NCT00967070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602066|NCT00967096|Rifaximin|rifaximin|mesh-list
24602067|NCT00967096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24602068|NCT00967096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24602069|NCT00967096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24602070|NCT00967109|Chrysarobin|chrysarobin|mesh-list
24602103|NCT00967174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24602104|NCT00967174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602204|NCT00967629|Calcium|calcium|mesh-list
24602205|NCT00967629|Sevelamer|sevelamer|mesh-list
24602206|NCT00967629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24499708|NCT00520650|Dopamine Agonists|dopamine agonists|mesh-ancestor
24602207|NCT00967629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602208|NCT00967629|Antacids|antacids|mesh-ancestor
24602209|NCT00967629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602210|NCT00967629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24602211|NCT00967629|Chelating Agents|chelating agents|mesh-ancestor
24602212|NCT00967629|Sequestering Agents|sequestering agents|mesh-ancestor
24802406|NCT01989923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24802408|NCT01989923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24802409|NCT01989923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802410|NCT01989923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24802411|NCT01989923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24463296|NCT00359853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602214|NCT00967642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24602215|NCT00967642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602216|NCT00967655|Capecitabine|capecitabine|mesh-list
24602262|NCT00967772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24499348|NCT00519051|Serotonin Agents|serotonin agents|mesh-ancestor
24602273|NCT00967928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602274|NCT00967928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24602275|NCT00967928|Immunologic Factors|immunologic factors|mesh-ancestor
24602276|NCT00967928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602277|NCT00967954|Hormones|hormones|mesh-list
24602278|NCT00967954|Androgen Antagonists|androgen antagonists|mesh-list
24602279|NCT00967954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24602281|NCT00967954|Hormone Antagonists|hormone antagonists|mesh-ancestor
24602304|NCT00968006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24602305|NCT00968006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602306|NCT00968110|Omalizumab|omalizumab|mesh-list
24602307|NCT00968110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24602308|NCT00968110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24602309|NCT00968110|Respiratory System Agents|respiratory system agents|mesh-ancestor
24602310|NCT00968162|Fludarabine|fludarabine|mesh-list
24602311|NCT00968162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602312|NCT00968240|Bevacizumab|bevacizumab|mesh-list
24602313|NCT00968240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24602314|NCT00968240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602315|NCT00968240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24602316|NCT00968240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24602317|NCT00968240|Growth Substances|growth substances|mesh-ancestor
24602318|NCT00968240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602319|NCT00968240|Growth Inhibitors|growth inhibitors|mesh-ancestor
24602320|NCT00968331|Rituximab|rituximab|mesh-list
24602321|NCT00968331|Lenalidomide|lenalidomide|mesh-list
24602322|NCT00968331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24602323|NCT00968331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602324|NCT00968331|Immunologic Factors|immunologic factors|mesh-ancestor
24602325|NCT00968331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602326|NCT00968331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24487855|NCT00465283|Cholinergic Agents|cholinergic agents|mesh-ancestor
24487856|NCT00465283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24487857|NCT00465283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487858|NCT00465283|Nootropic Agents|nootropic agents|mesh-ancestor
24602327|NCT00968331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24602328|NCT00968331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24602329|NCT00968331|Growth Substances|growth substances|mesh-ancestor
24602330|NCT00968331|Growth Inhibitors|growth inhibitors|mesh-ancestor
24602333|NCT00968383|Adrenergic Agents|adrenergic agents|mesh-list
24602349|NCT00968396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602350|NCT00968435|Bevacizumab|bevacizumab|mesh-list
24602352|NCT00968435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24602353|NCT00968435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602361|NCT00968461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602362|NCT00968461|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24602363|NCT00968461|Protective Agents|protective agents|mesh-ancestor
24602364|NCT00968461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602365|NCT00968461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602366|NCT00968565|Citric Acid|citric acid|mesh-list
24602367|NCT00968565|Sodium Citrate|sodium citrate|mesh-list
24463312|NCT00359905|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24463313|NCT00359905|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24499987|NCT00521963|Infliximab|infliximab|mesh-list
24463314|NCT00359905|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24463315|NCT00359905|Adrenergic Agents|adrenergic agents|mesh-ancestor
24602373|NCT00968578|Methylprednisolone|methylprednisolone|mesh-list
24602374|NCT00968578|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24499638|NCT00520338|Celecoxib|celecoxib|mesh-list
24602438|NCT00968877|Micronutrients|micronutrients|mesh-ancestor
24602439|NCT00968877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24602440|NCT00968903|Methylprednisolone|methylprednisolone|mesh-list
24602441|NCT00968903|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24602442|NCT00968903|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24602443|NCT00968903|Prednisolone|prednisolone|mesh-list
24602444|NCT00968903|Prednisolone acetate|prednisolone acetate|mesh-list
24602445|NCT00968903|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24602446|NCT00968903|Prednisolone phosphate|prednisolone phosphate|mesh-list
24602488|NCT00969072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24602489|NCT00969072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24602490|NCT00969072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602491|NCT00969072|Hormone Antagonists|hormone antagonists|mesh-ancestor
24602492|NCT00969072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24602493|NCT00969072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602495|NCT00969085|Turmeric extract|turmeric extract|mesh-list
24602496|NCT00969085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24602497|NCT00969085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24602498|NCT00969085|Analgesics|analgesics|mesh-ancestor
24636635|NCT01146509|Donepezil|donepezil|mesh-list
24602542|NCT00969306|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24602543|NCT00969306|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24602544|NCT00969306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24602545|NCT00969306|Antimalarials|antimalarials|mesh-ancestor
24602546|NCT00969306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24602547|NCT00969319|Factor VIII|factor viii|mesh-list
24602548|NCT00969319|Coagulants|coagulants|mesh-ancestor
24602549|NCT00969397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
24463323|NCT00359970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24463324|NCT00359970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24463325|NCT00359970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24463327|NCT00360048|Oxytocics|oxytocics|mesh-ancestor
24463328|NCT00360048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24463329|NCT00360048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463330|NCT00360087|Bosentan|bosentan|mesh-list
24463331|NCT00360087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24487959|NCT00466076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24602550|NCT00969397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24602551|NCT00969397|Growth Substances|growth substances|mesh-ancestor
24602552|NCT00969397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602553|NCT00969397|Growth Inhibitors|growth inhibitors|mesh-ancestor
24602554|NCT00969397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602555|NCT00969449|Naproxen|naproxen|mesh-list
24602556|NCT00969449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24602557|NCT00969449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24602558|NCT00969449|Analgesics|analgesics|mesh-ancestor
24602559|NCT00969449|Sensory System Agents|sensory system agents|mesh-ancestor
24602560|NCT00969449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24602561|NCT00969449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702865|NCT02160730|Antiviral Agents|antiviral agents|mesh-ancestor
24602562|NCT00969449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24602563|NCT00969449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25702866|NCT02160730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24602652|NCT00969982|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24602654|NCT00969982|Hormone Antagonists|hormone antagonists|mesh-ancestor
24602655|NCT00969982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24602656|NCT00969982|Luteolytic Agents|luteolytic agents|mesh-ancestor
24602657|NCT00969982|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24602658|NCT00969982|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24602659|NCT00970008|CD59 Antigens|cd59 antigens|mesh-list
24602660|NCT00970008|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24602661|NCT00970008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24602662|NCT00970008|Immunologic Factors|immunologic factors|mesh-ancestor
24602663|NCT00970008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602664|NCT00970086|Bupivacaine|bupivacaine|mesh-list
24602665|NCT00970086|Levobupivacaine|levobupivacaine|mesh-list
24602666|NCT00970086|Anesthetics, Local|anesthetics, local|mesh-ancestor
24602667|NCT00970086|Anesthetics|anesthetics|mesh-ancestor
24602668|NCT00970086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24602669|NCT00970086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602670|NCT00970086|Sensory System Agents|sensory system agents|mesh-ancestor
24602671|NCT00970086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24602672|NCT00970138|Apatinib|apatinib|mesh-list
24602680|NCT00970450|Analgesics|analgesics|mesh-ancestor
24602681|NCT00970450|Sensory System Agents|sensory system agents|mesh-ancestor
24602682|NCT00970450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24602683|NCT00970450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602684|NCT00970450|Antipyretics|antipyretics|mesh-ancestor
24602685|NCT00970450|Antiemetics|antiemetics|mesh-ancestor
24602686|NCT00970450|Autonomic Agents|autonomic agents|mesh-ancestor
24602687|NCT00970450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24602697|NCT00970528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602698|NCT00970528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24602700|NCT00970567|Insulin|insulin|mesh-list
24602701|NCT00970567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24463332|NCT00360087|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24463333|NCT00360087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463335|NCT00360178|Valsartan|valsartan|mesh-list
24463336|NCT00360178|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24463337|NCT00360178|Candesartan|candesartan|mesh-list
24463338|NCT00360178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24463341|NCT00360178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602702|NCT00970567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602704|NCT00970580|Carboplatin|carboplatin|mesh-list
24602705|NCT00970580|Alkylating Agents|alkylating agents|mesh-list
24602706|NCT00970580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24602707|NCT00970580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602708|NCT00970580|Tubulin Modulators|tubulin modulators|mesh-ancestor
24602709|NCT00970580|Antimitotic Agents|antimitotic agents|mesh-ancestor
24602710|NCT00970580|Mitosis Modulators|mitosis modulators|mesh-ancestor
24602724|NCT00970762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602725|NCT00970762|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24602726|NCT00970762|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24602727|NCT00970762|Cholinergic Agents|cholinergic agents|mesh-ancestor
24602728|NCT00970762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24602729|NCT00970762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602731|NCT00970879|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24602733|NCT00970879|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24602734|NCT00970879|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24602735|NCT00970879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24602736|NCT00970879|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24602737|NCT00970879|Renal Agents|renal agents|mesh-ancestor
24602738|NCT00970879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24602739|NCT00970892|Warfarin|warfarin|mesh-list
24602740|NCT00970892|Anticoagulants|anticoagulants|mesh-ancestor
24602741|NCT00970905|Ondansetron|ondansetron|mesh-list
24602742|NCT00970905|Aprepitant|aprepitant|mesh-list
24602743|NCT00970905|Antiemetics|antiemetics|mesh-ancestor
24488248|NCT00467376|Insulin|insulin|mesh-list
24602744|NCT00970905|Autonomic Agents|autonomic agents|mesh-ancestor
24463342|NCT00360178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24463343|NCT00360178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24463344|NCT00360178|Vasodilator Agents|vasodilator agents|mesh-ancestor
24802422|NCT01990079|Nicotine|nicotine|mesh-list
24802423|NCT01990079|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24802424|NCT01990079|Autonomic Agents|autonomic agents|mesh-ancestor
24884595|NCT00271817|Vitamins|vitamins|mesh-ancestor
24802425|NCT01990079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24802426|NCT01990079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802427|NCT01990079|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24569231|NCT00799539|Prednisone|prednisone|mesh-list
24463345|NCT00360178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24463346|NCT00360178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24463347|NCT00360178|Diuretics|diuretics|mesh-ancestor
24463368|NCT00360386|Purinergic Agents|purinergic agents|mesh-ancestor
24463369|NCT00360386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24463370|NCT00360386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602779|NCT00970957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602780|NCT00970957|Growth Inhibitors|growth inhibitors|mesh-ancestor
24602781|NCT00970970|Bevacizumab|bevacizumab|mesh-list
24602782|NCT00970970|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
24602783|NCT00970970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24602784|NCT00970970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602785|NCT00970970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24602786|NCT00970970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24602787|NCT00970970|Growth Substances|growth substances|mesh-ancestor
24602788|NCT00970970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602789|NCT00970970|Growth Inhibitors|growth inhibitors|mesh-ancestor
24602792|NCT00970996|Interferons|interferons|mesh-list
24602842|NCT00971165|Chlorthalidone|chlorthalidone|mesh-list
24602843|NCT00971165|Amiloride|amiloride|mesh-list
24602844|NCT00971165|Diuretics|diuretics|mesh-list
24602856|NCT00971165|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24602857|NCT00971165|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24602858|NCT00971399|Ondansetron|ondansetron|mesh-list
24602859|NCT00971399|Ramosetron|ramosetron|mesh-list
24602860|NCT00971399|Antiemetics|antiemetics|mesh-ancestor
24602861|NCT00971399|Autonomic Agents|autonomic agents|mesh-ancestor
24602876|NCT00971581|Ketoprofen|ketoprofen|mesh-list
24602887|NCT00971581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24602888|NCT00971581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602889|NCT00971581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24602890|NCT00971581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24602891|NCT00971581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24602892|NCT00971607|Sevoflurane|sevoflurane|mesh-list
24616683|NCT01038583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25702867|NCT02160730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24603041|NCT00972101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24603042|NCT00972101|Antitubercular Agents|antitubercular agents|mesh-ancestor
24603043|NCT00972101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24603044|NCT00972101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24603045|NCT00972101|Alkylating Agents|alkylating agents|mesh-ancestor
24603046|NCT00972101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24603048|NCT00972140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24603049|NCT00972140|Autonomic Agents|autonomic agents|mesh-ancestor
24603050|NCT00972140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24603051|NCT00972140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603052|NCT00972140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24603053|NCT00972140|Respiratory System Agents|respiratory system agents|mesh-ancestor
24463654|NCT00361790|Serotonin Agents|serotonin agents|mesh-ancestor
24603054|NCT00972140|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24603055|NCT00972140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24603056|NCT00972140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24603057|NCT00972140|Adrenergic Agents|adrenergic agents|mesh-ancestor
24603083|NCT00972387|Prednisolone|prednisolone|mesh-list
24603084|NCT00972387|Cyclophosphamide|cyclophosphamide|mesh-list
24603085|NCT00972387|Doxorubicin|doxorubicin|mesh-list
24603086|NCT00972387|Vincristine|vincristine|mesh-list
24603087|NCT00972387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24603137|NCT00972660|Glucocorticoids|glucocorticoids|mesh-ancestor
24603138|NCT00972660|Hormones|hormones|mesh-ancestor
24603139|NCT00972660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24603140|NCT00972660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603141|NCT00972660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24603142|NCT00972660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603143|NCT00972660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603174|NCT00972829|Antimetabolites|antimetabolites|mesh-ancestor
24603246|NCT00972985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24603247|NCT00972985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24603248|NCT00972985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24603249|NCT00972985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24603250|NCT00972985|GABA Modulators|gaba modulators|mesh-ancestor
24603251|NCT00972985|GABA Agents|gaba agents|mesh-ancestor
24603252|NCT00973037|Tamoxifen|tamoxifen|mesh-list
24603253|NCT00973037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24603254|NCT00973037|Hormone Antagonists|hormone antagonists|mesh-ancestor
24603255|NCT00973037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24603256|NCT00973037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603257|NCT00973037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24603258|NCT00973037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603259|NCT00973037|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24463702|NCT00361907|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24463731|NCT00361959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24463732|NCT00361959|Cholinergic Agents|cholinergic agents|mesh-ancestor
24463733|NCT00361959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24463734|NCT00361959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463735|NCT00361959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24603293|NCT00973193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603294|NCT00973219|Interferons|interferons|mesh-list
24603295|NCT00973219|Tenofovir|tenofovir|mesh-list
24603296|NCT00973219|Interferon-alpha|interferon-alpha|mesh-list
24603297|NCT00973219|Interferon alpha-2|interferon alpha-2|mesh-list
24603298|NCT00973219|Adefovir|adefovir|mesh-list
24603299|NCT00973219|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
24603300|NCT00973219|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24603301|NCT00973219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603302|NCT00973219|Antiviral Agents|antiviral agents|mesh-ancestor
24603303|NCT00973219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24603304|NCT00973219|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24603305|NCT00973219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24603306|NCT00973219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488757|NCT00469937|Lithium Carbonate|lithium carbonate|mesh-list
24603355|NCT00973323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603356|NCT00973336|Vitamin D|vitamin d|mesh-list
24603357|NCT00973336|Calcium|calcium|mesh-list
24603358|NCT00973336|Vitamins|vitamins|mesh-ancestor
24603359|NCT00973336|Micronutrients|micronutrients|mesh-ancestor
24603360|NCT00973336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500823|NCT00525772|Glucocorticoids|glucocorticoids|mesh-ancestor
24603374|NCT00973453|Immunologic Factors|immunologic factors|mesh-list
24603375|NCT00973453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603381|NCT00973505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603383|NCT00973505|Hormone Antagonists|hormone antagonists|mesh-ancestor
24603390|NCT00973583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603391|NCT00973583|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24603392|NCT00973609|Folic Acid|folic acid|mesh-list
24603393|NCT00973609|Vitamin B Complex|vitamin b complex|mesh-list
24603394|NCT00973609|Bevacizumab|bevacizumab|mesh-list
24603395|NCT00973609|Fluorouracil|fluorouracil|mesh-list
24603396|NCT00973609|Capecitabine|capecitabine|mesh-list
24603397|NCT00973609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24603398|NCT00973609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488893|NCT00470483|Antidepressive Agents|antidepressive agents|mesh-ancestor
24488894|NCT00470483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24603399|NCT00973609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24603400|NCT00973609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24603401|NCT00973609|Growth Substances|growth substances|mesh-ancestor
24603402|NCT00973609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603403|NCT00973609|Growth Inhibitors|growth inhibitors|mesh-ancestor
24603404|NCT00973609|Antimetabolites|antimetabolites|mesh-ancestor
24603405|NCT00973609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603406|NCT00973609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24603407|NCT00973609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24603408|NCT00973609|Immunologic Factors|immunologic factors|mesh-ancestor
24603409|NCT00973609|Hematinics|hematinics|mesh-ancestor
24603410|NCT00973609|Vitamins|vitamins|mesh-ancestor
24603425|NCT00973713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24802493|NCT01990586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24570132|NCT00803465|Xhance|xhance|mesh-list
24463780|NCT00362206|Pravastatin|pravastatin|mesh-list
24463781|NCT00362206|Fenofibrate|fenofibrate|mesh-list
24463782|NCT00362206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24463783|NCT00362206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24802500|NCT01990755|Olanzapine|olanzapine|mesh-list
24730296|NCT01627353|Dexamethasone|dexamethasone|mesh-list
24603434|NCT00973804|Sirolimus|sirolimus|mesh-list
24603483|NCT00974012|Anticonvulsants|anticonvulsants|mesh-ancestor
24603484|NCT00974012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603485|NCT00974012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603486|NCT00974012|GABA Agents|gaba agents|mesh-ancestor
24603487|NCT00974012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24603640|NCT00974792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24603641|NCT00974792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24603642|NCT00974792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24603692|NCT00974987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24603693|NCT00974987|Alkylating Agents|alkylating agents|mesh-ancestor
24603694|NCT00974987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603695|NCT00974987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603696|NCT00975052|Metformin|metformin|mesh-list
24603697|NCT00975052|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24603698|NCT00975052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24603699|NCT00975052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603700|NCT00975052|Incretins|incretins|mesh-ancestor
24603701|NCT00975052|Hormones|hormones|mesh-ancestor
24603702|NCT00975052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24603703|NCT00975052|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24603704|NCT00975052|Protease Inhibitors|protease inhibitors|mesh-ancestor
24603705|NCT00975052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603707|NCT00975065|Metformin|metformin|mesh-list
24603736|NCT00975312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603737|NCT00975312|Keratolytic Agents|keratolytic agents|mesh-ancestor
24603738|NCT00975312|Dermatologic Agents|dermatologic agents|mesh-ancestor
24802525|NCT01990781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802526|NCT01990781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25702869|NCT02160730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702870|NCT02160808|Secretin|secretin|mesh-list
25702871|NCT02160808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25702872|NCT02160808|Hormones|hormones|mesh-ancestor
25702873|NCT02160808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25702874|NCT02160808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702875|NCT02160990|Exenatide|exenatide|mesh-list
25702876|NCT02160990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24603796|NCT00975754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24603797|NCT00975754|Autonomic Agents|autonomic agents|mesh-ancestor
24603798|NCT00975754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24501271|NCT00527800|Lumefantrine|lumefantrine|mesh-list
24802532|NCT01990781|Protease Inhibitors|protease inhibitors|mesh-ancestor
24802533|NCT01990781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24802534|NCT01990781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518990|NCT03710772|Antibodies|antibodies|mesh-list
24464065|NCT00363116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464066|NCT00363155|KRN 7000|krn 7000|mesh-list
24464067|NCT00363155|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24464070|NCT00363155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24464071|NCT00363259|Ribavirin|ribavirin|mesh-list
24464072|NCT00363259|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24603827|NCT00975897|Oxaliplatin|oxaliplatin|mesh-list
24603828|NCT00975897|Irinotecan|irinotecan|mesh-list
24603829|NCT00975897|Calcium|calcium|mesh-list
24603830|NCT00975897|Levoleucovorin|levoleucovorin|mesh-list
24603831|NCT00975897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24603832|NCT00975897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603833|NCT00975897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24603834|NCT00975897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24603835|NCT00975897|Growth Substances|growth substances|mesh-ancestor
24603836|NCT00975897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603837|NCT00975897|Growth Inhibitors|growth inhibitors|mesh-ancestor
24603847|NCT00975897|Antidotes|antidotes|mesh-ancestor
24603877|NCT00975962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24603878|NCT00975962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24603879|NCT00975962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603881|NCT00975988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24464073|NCT00363259|Antimetabolites|antimetabolites|mesh-ancestor
24464074|NCT00363259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802540|NCT01990781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25702877|NCT02160990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702878|NCT02160990|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25702879|NCT02160990|Incretins|incretins|mesh-ancestor
25702880|NCT02160990|Hormones|hormones|mesh-ancestor
24802541|NCT01990781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24802542|NCT01990781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24671146|NCT01324063|Antiviral Agents|antiviral agents|mesh-ancestor
24671147|NCT01324063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24671148|NCT01324063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24671149|NCT01324063|Immunologic Factors|immunologic factors|mesh-ancestor
24603917|NCT00976105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24603918|NCT00976105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603919|NCT00976105|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24603920|NCT00976105|GABA Agonists|gaba agonists|mesh-ancestor
24603922|NCT00976105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24603923|NCT00976105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603925|NCT00976131|Coenzyme Q10|coenzyme q10|mesh-list
24603926|NCT00976131|Micronutrients|micronutrients|mesh-ancestor
24603927|NCT00976131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603928|NCT00976131|Vitamins|vitamins|mesh-ancestor
24603929|NCT00976170|Sorafenib|sorafenib|mesh-list
24489836|NCT00475553|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24603938|NCT00976222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603939|NCT00976222|Growth Inhibitors|growth inhibitors|mesh-ancestor
24603940|NCT00976222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603941|NCT00976261|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24603942|NCT00976261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24604003|NCT00976768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464169|NCT00363584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464170|NCT00363584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24464172|NCT00363610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24464173|NCT00363688|Penicillins|penicillins|mesh-list
24464174|NCT00363688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24464175|NCT00363688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24604004|NCT00976768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24604005|NCT00976768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604006|NCT00976768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24604041|NCT00976976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604042|NCT00976976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24604080|NCT00977054|Antimetabolites|antimetabolites|mesh-ancestor
24604081|NCT00977054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604082|NCT00977054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604083|NCT00977093|Pentetic Acid|pentetic acid|mesh-list
24604084|NCT00977093|Antidotes|antidotes|mesh-ancestor
24604085|NCT00977093|Protective Agents|protective agents|mesh-ancestor
24604086|NCT00977093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604087|NCT00977093|Chelating Agents|chelating agents|mesh-ancestor
24604088|NCT00977093|Sequestering Agents|sequestering agents|mesh-ancestor
24604089|NCT00977093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604090|NCT00977093|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24604091|NCT00977132|Lenalidomide|lenalidomide|mesh-list
24604092|NCT00977132|Immunologic Factors|immunologic factors|mesh-ancestor
24604093|NCT00977132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604094|NCT00977132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24604095|NCT00977132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24604096|NCT00977132|Growth Substances|growth substances|mesh-ancestor
24604097|NCT00977132|Growth Inhibitors|growth inhibitors|mesh-ancestor
24604098|NCT00977132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604100|NCT00977145|Antiviral Agents|antiviral agents|mesh-ancestor
24604101|NCT00977145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24464185|NCT00363727|Dopamine Agonists|dopamine agonists|mesh-ancestor
24464186|NCT00363727|Dopamine Agents|dopamine agents|mesh-ancestor
24464187|NCT00363727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24802560|NCT01990937|Midazolam|midazolam|mesh-list
24802561|NCT01990937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24802562|NCT01990937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24802563|NCT01990937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24802564|NCT01990937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802565|NCT01990937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24802566|NCT01990937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24802567|NCT01990937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24802568|NCT01990937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24596909|NCT00946465|Ramipril|ramipril|mesh-list
24596973|NCT00946621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604124|NCT00977288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604125|NCT00977288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24604126|NCT00977288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24604313|NCT00978471|Alkylating Agents|alkylating agents|mesh-ancestor
24604314|NCT00978471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604367|NCT00978861|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24604368|NCT00978861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24604369|NCT00978913|Cyclophosphamide|cyclophosphamide|mesh-list
24604371|NCT00978913|Immunologic Factors|immunologic factors|mesh-ancestor
24604372|NCT00978913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604373|NCT00978913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24604374|NCT00978913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24604375|NCT00978913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24604376|NCT00978913|Alkylating Agents|alkylating agents|mesh-ancestor
24604377|NCT00978913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452676|NCT05457829|Doxorubicin|doxorubicin|mesh-list
24604378|NCT00978913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604490|NCT00979706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604491|NCT00979706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24604493|NCT00979706|Sensory System Agents|sensory system agents|mesh-ancestor
24604494|NCT00979706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24604496|NCT00979758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24604497|NCT00979758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24604498|NCT00979758|Antimetabolites|antimetabolites|mesh-ancestor
24604499|NCT00979758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604500|NCT00979758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24604501|NCT00979758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24604502|NCT00979758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604503|NCT00979836|Calcium Dobesilate|calcium dobesilate|mesh-list
24604504|NCT00979836|Calcium|calcium|mesh-list
24604505|NCT00979836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24604506|NCT00979836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604507|NCT00979836|Hemostatics|hemostatics|mesh-ancestor
24604508|NCT00979836|Coagulants|coagulants|mesh-ancestor
24604509|NCT00979862|Cediranib|cediranib|mesh-list
24604510|NCT00979862|Maleic acid|maleic acid|mesh-list
24604538|NCT00980031|Diuretics|diuretics|mesh-ancestor
24604539|NCT00980031|Natriuretic Agents|natriuretic agents|mesh-ancestor
24604540|NCT00980031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24604541|NCT00980109|Oseltamivir|oseltamivir|mesh-list
24604542|NCT00980109|Zanamivir|zanamivir|mesh-list
24604543|NCT00980109|Antiviral Agents|antiviral agents|mesh-ancestor
24604544|NCT00980109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24490542|NCT00478907|Thiopental|thiopental|mesh-list
24604545|NCT00980109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604546|NCT00980109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604547|NCT00980135|Hydrocortisone|hydrocortisone|mesh-list
24604548|NCT00980135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24604549|NCT00980187|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24604550|NCT00980187|Indapamide|indapamide|mesh-list
24604551|NCT00980187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24604552|NCT00980187|Diuretics|diuretics|mesh-ancestor
24464295|NCT00364052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25087346|NCT03279978|GABA Modulators|gaba modulators|mesh-ancestor
24491411|NCT00482313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24464315|NCT00364260|Epoetin Alfa|epoetin alfa|mesh-list
24464316|NCT00364260|Hematinics|hematinics|mesh-ancestor
24464317|NCT00364273|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24464318|NCT00364273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24464319|NCT00364273|Autonomic Agents|autonomic agents|mesh-ancestor
24464375|NCT00364481|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24464376|NCT00364481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24464377|NCT00364481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464378|NCT00364559|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24464379|NCT00364559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24731305|NCT01633983|Antimetabolites|antimetabolites|mesh-ancestor
25087352|NCT03279861|Valsartan|valsartan|mesh-list
24604574|NCT00980239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24604575|NCT00980239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24604576|NCT00980239|Growth Substances|growth substances|mesh-ancestor
24604577|NCT00980239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604578|NCT00980239|Growth Inhibitors|growth inhibitors|mesh-ancestor
24604579|NCT00980239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24604580|NCT00980239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24604582|NCT00980239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604585|NCT00980304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24802638|NCT01991288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802639|NCT01991288|Sensory System Agents|sensory system agents|mesh-ancestor
24802640|NCT01991288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24465131|NCT00367939|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24465132|NCT00367939|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24465135|NCT00367965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24465136|NCT00367965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24465137|NCT00367965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465140|NCT00367978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24465141|NCT00367978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24465142|NCT00367978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24465149|NCT00367978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24465150|NCT00368017|Pioglitazone|pioglitazone|mesh-list
24465151|NCT00368017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24465152|NCT00368017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465183|NCT00368160|Eszopiclone|eszopiclone|mesh-list
24465184|NCT00368160|Zopiclone|zopiclone|mesh-list
24465185|NCT00368160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24802665|NCT01991327|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24573105|NCT00817895|Cisplatin|cisplatin|mesh-list
25709591|NCT02270255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25709592|NCT02270255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25709593|NCT02270255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25709594|NCT02270255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25709595|NCT02270255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25709596|NCT02270255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709597|NCT02270736|Botulinum Toxins|botulinum toxins|mesh-list
25709598|NCT02270736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25702881|NCT02160990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24667023|NCT01321931|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24667024|NCT01321931|Cholinergic Agents|cholinergic agents|mesh-ancestor
24667025|NCT01321931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24667026|NCT01321931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24667028|NCT01321944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24667029|NCT01321944|Autonomic Agents|autonomic agents|mesh-ancestor
24667030|NCT01321944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24667031|NCT01321944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667032|NCT01321944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24667033|NCT01321944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24667034|NCT01321944|Cholinergic Agents|cholinergic agents|mesh-ancestor
24604587|NCT00980304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604588|NCT00980304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24604589|NCT00980356|Vildagliptin|vildagliptin|mesh-list
24604590|NCT00980356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24604591|NCT00980356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604592|NCT00980356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24604593|NCT00980356|Protease Inhibitors|protease inhibitors|mesh-ancestor
24604594|NCT00980356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604595|NCT00980356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604596|NCT00980382|Docetaxel|docetaxel|mesh-list
24604597|NCT00980382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604598|NCT00980382|Tubulin Modulators|tubulin modulators|mesh-ancestor
24604599|NCT00980382|Antimitotic Agents|antimitotic agents|mesh-ancestor
24604600|NCT00980382|Mitosis Modulators|mitosis modulators|mesh-ancestor
24604601|NCT00980382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604609|NCT00980408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604610|NCT00980408|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24604611|NCT00980408|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24604612|NCT00980408|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24604693|NCT00981201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24604694|NCT00981201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24604695|NCT00981201|Analgesics|analgesics|mesh-ancestor
24604696|NCT00981201|Sensory System Agents|sensory system agents|mesh-ancestor
24604697|NCT00981201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24604698|NCT00981201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604699|NCT00981201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24604700|NCT00981201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24604701|NCT00981201|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24604702|NCT00981201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24604703|NCT00981201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604704|NCT00981201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604705|NCT00981318|Ritonavir|ritonavir|mesh-list
24604706|NCT00981318|Lopinavir|lopinavir|mesh-list
24604707|NCT00981318|Maraviroc|maraviroc|mesh-list
24604708|NCT00981318|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24465336|NCT00369031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24465337|NCT00369031|Interferon Inducers|interferon inducers|mesh-ancestor
24465338|NCT00369031|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24465339|NCT00369031|Protective Agents|protective agents|mesh-ancestor
24465340|NCT00369044|Prednisone|prednisone|mesh-list
25702882|NCT02161146|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25702883|NCT02161146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25702884|NCT02161146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25702885|NCT02161146|Analgesics|analgesics|mesh-ancestor
25702886|NCT02161146|Sensory System Agents|sensory system agents|mesh-ancestor
25702887|NCT02161146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25702888|NCT02161146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702889|NCT02161146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25702890|NCT02161146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25702891|NCT02161146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25709599|NCT02270736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24465343|NCT00369044|Hormones|hormones|mesh-ancestor
24465344|NCT00369044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24465438|NCT00369551|Growth Inhibitors|growth inhibitors|mesh-ancestor
24465439|NCT00369551|Immunologic Factors|immunologic factors|mesh-ancestor
24465440|NCT00369603|Donepezil|donepezil|mesh-list
24465441|NCT00369603|Galantamine|galantamine|mesh-list
24465442|NCT00369603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24465443|NCT00369603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24465444|NCT00369603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465445|NCT00369603|Cholinergic Agents|cholinergic agents|mesh-ancestor
24802776|NCT01992328|Antibodies|antibodies|mesh-list
24802777|NCT01992328|Immunoglobulin G|immunoglobulin g|mesh-list
24802778|NCT01992328|gamma-Globulins|gamma-globulins|mesh-list
24802779|NCT01992328|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24802780|NCT01992328|Immunologic Factors|immunologic factors|mesh-ancestor
24802781|NCT01992328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802782|NCT01992341|Paclitaxel|paclitaxel|mesh-list
24802783|NCT01992341|Trebananib|trebananib|mesh-list
24802784|NCT01992341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24802785|NCT01992341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24802786|NCT01992341|Tubulin Modulators|tubulin modulators|mesh-ancestor
24802825|NCT01992601|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24465552|NCT00370019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24465553|NCT00370019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24465554|NCT00370019|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24583173|NCT00873535|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24604709|NCT00981318|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24604710|NCT00981318|Protease Inhibitors|protease inhibitors|mesh-ancestor
24604711|NCT00981318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604712|NCT00981318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604713|NCT00981318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24604733|NCT00981487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604734|NCT00981487|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24604735|NCT00981487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24604736|NCT00981487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24604737|NCT00981487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24802850|NCT01992653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24597222|NCT00947843|Aspirin|aspirin|mesh-list
24597294|NCT00948272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597295|NCT00948402|Metformin|metformin|mesh-list
24597296|NCT00948402|Biguanides|biguanides|mesh-list
24597297|NCT00948402|Contraceptive Agents|contraceptive agents|mesh-list
24597298|NCT00948402|Contraceptives, Oral|contraceptives, oral|mesh-list
24597299|NCT00948402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24597300|NCT00948402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597301|NCT00948402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24622538|NCT01067430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24622539|NCT01067430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622540|NCT01067430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24622541|NCT01067430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25702892|NCT02161146|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25702893|NCT02161146|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25702894|NCT02161146|Histamine Antagonists|histamine antagonists|mesh-ancestor
25702895|NCT02161146|Histamine Agents|histamine agents|mesh-ancestor
25702896|NCT02161146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25702897|NCT02161146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702898|NCT02161185|Midazolam|midazolam|mesh-list
25702899|NCT02161185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25709600|NCT02270736|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24533618|NCT00644631|Vasodilator Agents|vasodilator agents|mesh-ancestor
24622544|NCT01067430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465565|NCT00370045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24465568|NCT00370097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24465569|NCT00370097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24465570|NCT00370097|Autonomic Agents|autonomic agents|mesh-ancestor
24465571|NCT00370097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24465572|NCT00370097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465573|NCT00370097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24465574|NCT00370097|Respiratory System Agents|respiratory system agents|mesh-ancestor
25088000|NCT03274765|Estradiol|estradiol|mesh-list
24604738|NCT00981487|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24604739|NCT00981513|Vaccines|vaccines|mesh-list
24604740|NCT00981513|Immunologic Factors|immunologic factors|mesh-ancestor
24501711|NCT00530556|GABA Agonists|gaba agonists|mesh-ancestor
24604750|NCT00981708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24604751|NCT00981708|Immunologic Factors|immunologic factors|mesh-ancestor
24604752|NCT00981708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493262|NCT00490243|Budesonide|budesonide|mesh-list
24604753|NCT00981708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24604754|NCT00981708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24604755|NCT00981708|Alkylating Agents|alkylating agents|mesh-ancestor
24604756|NCT00981708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604757|NCT00981708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465575|NCT00370097|Dermatologic Agents|dermatologic agents|mesh-ancestor
24465576|NCT00370097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24465577|NCT00370188|Topiramate|topiramate|mesh-list
24465578|NCT00370188|Anticonvulsants|anticonvulsants|mesh-ancestor
24465579|NCT00370188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24465580|NCT00370188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521623|NCT04635605|Methylene Blue|methylene blue|mesh-list
24573839|NCT00822263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573840|NCT00822263|Protective Agents|protective agents|mesh-ancestor
24573841|NCT00822263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573842|NCT00822263|Antidotes|antidotes|mesh-ancestor
24465642|NCT00370370|Hormones|hormones|mesh-ancestor
24465643|NCT00370370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24465644|NCT00370370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24465645|NCT00370370|Immunologic Factors|immunologic factors|mesh-ancestor
24465646|NCT00370370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24465647|NCT00370370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465648|NCT00370422|Triamcinolone|triamcinolone|mesh-list
24465649|NCT00370422|Bevacizumab|bevacizumab|mesh-list
24465650|NCT00370422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24465651|NCT00370422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465652|NCT00370422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24465653|NCT00370422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24465724|NCT00370630|Growth Inhibitors|growth inhibitors|mesh-ancestor
24465725|NCT00370630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24465792|NCT00370734|Cholinergic Agents|cholinergic agents|mesh-ancestor
24733284|NCT01644838|Mydriatics|mydriatics|mesh-ancestor
24803028|NCT01993979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25088014|NCT03274596|Vitamin E|vitamin e|mesh-list
24443450|NCT00294944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24803037|NCT01993979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803038|NCT01994031|Paclitaxel|paclitaxel|mesh-list
24803039|NCT01994031|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24803072|NCT01994356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24803073|NCT01994356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803075|NCT01994460|Ethambutol|ethambutol|mesh-list
24803076|NCT01994460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24803077|NCT01994460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24803078|NCT01994460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24803079|NCT01994460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24803080|NCT01994460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803081|NCT01994460|Antitubercular Agents|antitubercular agents|mesh-ancestor
24803082|NCT01994642|Ciprofloxacin|ciprofloxacin|mesh-list
24803083|NCT01994642|Dexamethasone|dexamethasone|mesh-list
24803084|NCT01994642|Dexamethasone acetate|dexamethasone acetate|mesh-list
24803086|NCT01994642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24803087|NCT01994642|Antiemetics|antiemetics|mesh-ancestor
24803088|NCT01994642|Autonomic Agents|autonomic agents|mesh-ancestor
24733447|NCT01646294|Urological Agents|urological agents|mesh-ancestor
24803090|NCT01994642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803091|NCT01994642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24803092|NCT01994642|Glucocorticoids|glucocorticoids|mesh-ancestor
24803093|NCT01994642|Hormones|hormones|mesh-ancestor
24803094|NCT01994642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24803095|NCT01994642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24803096|NCT01994642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24803097|NCT01994642|Protease Inhibitors|protease inhibitors|mesh-ancestor
24803098|NCT01994642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25088060|NCT03274024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604758|NCT00981708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24604759|NCT00981708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24460545|NCT00348712|Rosiglitazone|rosiglitazone|mesh-list
24803126|NCT01994733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803127|NCT01994733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24803129|NCT01994733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803130|NCT01994733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24803131|NCT01994759|Methylprednisolone|methylprednisolone|mesh-list
24803132|NCT01994759|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24803133|NCT01994759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24803134|NCT01994759|Antiemetics|antiemetics|mesh-ancestor
24803136|NCT01994759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803137|NCT01994759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803138|NCT01994759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24803139|NCT01994759|Glucocorticoids|glucocorticoids|mesh-ancestor
24803140|NCT01994759|Hormones|hormones|mesh-ancestor
24803141|NCT01994759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24622559|NCT01067443|Anthelmintics|anthelmintics|mesh-ancestor
24622561|NCT01067534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24622562|NCT01067534|Autonomic Agents|autonomic agents|mesh-ancestor
24622563|NCT01067534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24583175|NCT00873535|Cholinergic Agents|cholinergic agents|mesh-ancestor
24583176|NCT00873535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24493722|NCT00492141|Alkylating Agents|alkylating agents|mesh-ancestor
24493730|NCT00492219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24493731|NCT00492219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24583177|NCT00873535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583178|NCT00873535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621749|NCT01063816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604760|NCT00981708|Antiemetics|antiemetics|mesh-ancestor
24604761|NCT00981708|Autonomic Agents|autonomic agents|mesh-ancestor
24604764|NCT00981708|Glucocorticoids|glucocorticoids|mesh-ancestor
24604781|NCT00981773|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24604782|NCT00981773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604783|NCT00981773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24604784|NCT00981773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24604785|NCT00981773|Antiviral Agents|antiviral agents|mesh-ancestor
24604786|NCT00981773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24604787|NCT00981773|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24604788|NCT00981786|Timolol|timolol|mesh-list
24604789|NCT00981786|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24604790|NCT00981786|Travoprost|travoprost|mesh-list
24604791|NCT00981786|Brinzolamide|brinzolamide|mesh-list
24604792|NCT00981786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24604793|NCT00981786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24621750|NCT01063816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24621751|NCT01063816|Antimetabolites|antimetabolites|mesh-ancestor
24622564|NCT01067534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622565|NCT01067534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24622566|NCT01067534|Respiratory System Agents|respiratory system agents|mesh-ancestor
24622567|NCT01067534|Tocolytic Agents|tocolytic agents|mesh-ancestor
24622568|NCT01067534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24536840|NCT00652691|Carboplatin|carboplatin|mesh-list
24803182|NCT01995006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24803183|NCT01995006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24803184|NCT01995006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803185|NCT01995006|Antipyretics|antipyretics|mesh-ancestor
24803186|NCT01995019|Methylprednisolone|methylprednisolone|mesh-list
24803187|NCT01995019|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24803188|NCT01995019|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24803213|NCT01995058|Hormones|hormones|mesh-ancestor
24803258|NCT01995331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24803271|NCT01995344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24803272|NCT01995344|Immunologic Factors|immunologic factors|mesh-ancestor
24803273|NCT01995344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803274|NCT01995344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24803275|NCT01995344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24803276|NCT01995344|Alkylating Agents|alkylating agents|mesh-ancestor
24803277|NCT01995344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803278|NCT01995344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24803279|NCT01995344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24604794|NCT00981786|Adrenergic Agents|adrenergic agents|mesh-ancestor
24604795|NCT00981786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24604796|NCT00981786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604797|NCT00981786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604798|NCT00981786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24493732|NCT00492219|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24604799|NCT00981786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24604801|NCT00981786|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24501762|NCT00530972|Ribavirin|ribavirin|mesh-list
24803280|NCT01995344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24803282|NCT01995344|Sensory System Agents|sensory system agents|mesh-ancestor
24803283|NCT01995344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803284|NCT01995370|Aspirin|aspirin|mesh-list
24803285|NCT01995370|Cilostazol|cilostazol|mesh-list
24803306|NCT01995370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24803345|NCT01996085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24803346|NCT01996085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803347|NCT01996085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24803348|NCT01996085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803350|NCT01996085|Diuretics|diuretics|mesh-ancestor
24803351|NCT01996085|Natriuretic Agents|natriuretic agents|mesh-ancestor
24803352|NCT01996085|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24803353|NCT01996085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24803354|NCT01996085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24597798|NCT00952003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597799|NCT00952003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24597800|NCT00952003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24597801|NCT00952003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24803387|NCT01996306|Capecitabine|capecitabine|mesh-list
24803388|NCT01996306|Irinotecan|irinotecan|mesh-list
24803389|NCT01996306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24803390|NCT01996306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24803391|NCT01996306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25088151|NCT03273075|Ticagrelor|ticagrelor|mesh-list
24604869|NCT00981929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24604871|NCT00981929|Sensory System Agents|sensory system agents|mesh-ancestor
24604872|NCT00981929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24604873|NCT00981942|Imatinib Mesylate|imatinib mesylate|mesh-list
24604874|NCT00981942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604875|NCT00981942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24604876|NCT00981942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604877|NCT00981942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604878|NCT00981955|Caffeine|caffeine|mesh-list
24604879|NCT00981955|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24604880|NCT00981955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493931|NCT00493116|Antiemetics|antiemetics|mesh-ancestor
24604883|NCT00981955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604884|NCT00981955|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24604885|NCT00981955|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24604887|NCT00981955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24604910|NCT00982332|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
24604911|NCT00982332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24604912|NCT00982332|Glucocorticoids|glucocorticoids|mesh-ancestor
24803392|NCT01996306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24803393|NCT01996306|Growth Substances|growth substances|mesh-ancestor
24803394|NCT01996306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803395|NCT01996306|Growth Inhibitors|growth inhibitors|mesh-ancestor
24803396|NCT01996306|Antimetabolites|antimetabolites|mesh-ancestor
24885767|NCT04632264|Oxytocin|oxytocin|mesh-list
24460542|NCT00348634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460543|NCT00348712|Insulin|insulin|mesh-list
24460544|NCT00348712|Metformin|metformin|mesh-list
24460546|NCT00348712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24460547|NCT00348712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24460548|NCT00348712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460549|NCT00348725|Metformin|metformin|mesh-list
24460550|NCT00348725|Fenofibrate|fenofibrate|mesh-list
24460551|NCT00348725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24460552|NCT00348725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733760|NCT01648465|Immunologic Factors|immunologic factors|mesh-ancestor
24803422|NCT01996384|Sensory System Agents|sensory system agents|mesh-ancestor
24803423|NCT01996384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803424|NCT01996384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24803425|NCT01996384|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24803426|NCT01996384|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24604914|NCT00982332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24604915|NCT00982332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604916|NCT00982332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24604917|NCT00982332|Respiratory System Agents|respiratory system agents|mesh-ancestor
24604918|NCT00982358|Valsartan|valsartan|mesh-list
24604919|NCT00982358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24604920|NCT00982358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24604921|NCT00982358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24604951|NCT00982540|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24604952|NCT00982540|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24604953|NCT00982540|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24604954|NCT00982540|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24604955|NCT00982540|Hormone Antagonists|hormone antagonists|mesh-ancestor
24604956|NCT00982540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24604962|NCT00982618|Lidocaine|lidocaine|mesh-list
24605035|NCT00983034|Clarithromycin|clarithromycin|mesh-list
24605036|NCT00983034|Lansoprazole|lansoprazole|mesh-list
24605037|NCT00983034|Dexlansoprazole|dexlansoprazole|mesh-list
24605038|NCT00983034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24605071|NCT00983125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24605072|NCT00983125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605073|NCT00983138|Asparaginase|asparaginase|mesh-list
24605074|NCT00983138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605120|NCT00983320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605122|NCT00983398|Carboplatin|carboplatin|mesh-list
24605126|NCT00983398|Mannitol|mannitol|mesh-list
24605193|NCT00983736|Narcotics|narcotics|mesh-ancestor
24605194|NCT00983736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24803427|NCT01996384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24803428|NCT01996384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803430|NCT01996423|Cholecalciferol|cholecalciferol|mesh-list
24803471|NCT01996475|Autonomic Agents|autonomic agents|mesh-ancestor
24803472|NCT01996475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803473|NCT01996475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24803503|NCT01996501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24803504|NCT01996501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24803505|NCT01996501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803507|NCT01996501|Serotonin Agents|serotonin agents|mesh-ancestor
24803508|NCT01996579|Lactoferrin|lactoferrin|mesh-list
24803509|NCT01996579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24803510|NCT01996618|Ranolazine|ranolazine|mesh-list
24803511|NCT01996618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24803512|NCT01996618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24803513|NCT01996618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803514|NCT01996683|Deferiprone|deferiprone|mesh-list
24803515|NCT01996683|Deferoxamine|deferoxamine|mesh-list
24803516|NCT01996683|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24803527|NCT01996735|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24803528|NCT01996735|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24803530|NCT01996735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24803531|NCT01996735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088202|NCT03272711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24605201|NCT00983788|Antimetabolites|antimetabolites|mesh-ancestor
24605202|NCT00983788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605203|NCT00983788|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24605204|NCT00983944|Prednisone|prednisone|mesh-list
24605205|NCT00983944|Cyclophosphamide|cyclophosphamide|mesh-list
24605206|NCT00983944|Rituximab|rituximab|mesh-list
24605207|NCT00983944|Doxorubicin|doxorubicin|mesh-list
24605208|NCT00983944|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24605209|NCT00983944|Etoposide|etoposide|mesh-list
24605210|NCT00983944|Vincristine|vincristine|mesh-list
24605211|NCT00983944|Bleomycin|bleomycin|mesh-list
24605212|NCT00983944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24605213|NCT00983944|Immunologic Factors|immunologic factors|mesh-ancestor
24605214|NCT00983944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605215|NCT00983944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24605246|NCT00984152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24605247|NCT00984152|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24605248|NCT00984152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24605249|NCT00984152|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24605250|NCT00984152|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24605251|NCT00984152|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24803532|NCT01996735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803534|NCT01996761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24803535|NCT01996761|Protective Agents|protective agents|mesh-ancestor
24803536|NCT01996761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803537|NCT01996761|Nootropic Agents|nootropic agents|mesh-ancestor
24803538|NCT01996891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24803539|NCT01996930|Silver Nitrate|silver nitrate|mesh-list
24803571|NCT01997138|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24803572|NCT01997138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24803573|NCT01997164|Aflibercept|aflibercept|mesh-list
24803574|NCT01997164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24803575|NCT01997164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24803576|NCT01997164|Growth Substances|growth substances|mesh-ancestor
24628196|NCT01097213|Ethanol|ethanol|mesh-list
24803577|NCT01997164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803578|NCT01997164|Growth Inhibitors|growth inhibitors|mesh-ancestor
24803614|NCT01997580|Serotonin Agents|serotonin agents|mesh-ancestor
24803615|NCT01997580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574587|NCT00826371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24574588|NCT00826527|Solifenacin Succinate|solifenacin succinate|mesh-list
24574589|NCT00826527|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24803669|NCT01997801|Sensory System Agents|sensory system agents|mesh-ancestor
24803670|NCT01997801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803671|NCT01997801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803678|NCT01997801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24803680|NCT01997801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803714|NCT01998126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24803715|NCT01998126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803716|NCT01998126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24803717|NCT01998126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24803718|NCT01998165|Remifentanil|remifentanil|mesh-list
24803719|NCT01998165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24803720|NCT01998165|Narcotics|narcotics|mesh-ancestor
24803721|NCT01998165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24803722|NCT01998165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803723|NCT01998165|Analgesics|analgesics|mesh-ancestor
24803745|NCT01998295|Antimalarials|antimalarials|mesh-ancestor
24803746|NCT01998295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24803747|NCT01998295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24803748|NCT01998295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24803749|NCT01998308|Hyaluronic Acid|hyaluronic acid|mesh-list
24803750|NCT01998308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24803751|NCT01998308|Immunologic Factors|immunologic factors|mesh-ancestor
24803752|NCT01998308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803753|NCT01998308|Viscosupplements|viscosupplements|mesh-ancestor
24803754|NCT01998308|Protective Agents|protective agents|mesh-ancestor
24803757|NCT01998347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24803758|NCT01998347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24803759|NCT01998347|Tubulin Modulators|tubulin modulators|mesh-ancestor
24803760|NCT01998347|Antimitotic Agents|antimitotic agents|mesh-ancestor
24803761|NCT01998347|Mitosis Modulators|mitosis modulators|mesh-ancestor
24605252|NCT00984152|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24605254|NCT00984152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24605255|NCT00984152|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24605256|NCT00984152|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24605257|NCT00984217|Panitumumab|panitumumab|mesh-list
24494798|NCT00497107|Levoleucovorin|levoleucovorin|mesh-list
24605580|NCT00986115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24605581|NCT00986128|Topiramate|topiramate|mesh-list
24803762|NCT01998347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803763|NCT01998347|Antimetabolites|antimetabolites|mesh-ancestor
24803764|NCT01998347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24803765|NCT01998347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24803766|NCT01998347|Immunologic Factors|immunologic factors|mesh-ancestor
24803767|NCT01998347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803768|NCT01998386|Hydrogen Peroxide|hydrogen peroxide|mesh-list
24443478|NCT00295100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24443480|NCT00295100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24443481|NCT00295100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24443483|NCT00295100|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24803769|NCT01998386|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24803770|NCT01998386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24803771|NCT01998451|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
24803772|NCT01998451|Antiviral Agents|antiviral agents|mesh-ancestor
24803773|NCT01998451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24803774|NCT01998451|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24803775|NCT01998451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24803787|NCT01998503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24803788|NCT01998503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24803789|NCT01998503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24803790|NCT01998503|Immunologic Factors|immunologic factors|mesh-ancestor
24803791|NCT01998503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24803792|NCT01998503|Alkylating Agents|alkylating agents|mesh-ancestor
24803793|NCT01998503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803794|NCT01998503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24803795|NCT01998503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24803796|NCT01998685|Fentanyl|fentanyl|mesh-list
24803797|NCT01998685|Midazolam|midazolam|mesh-list
24803798|NCT01998685|Remifentanil|remifentanil|mesh-list
24803864|NCT01998789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24803865|NCT01998789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803866|NCT01998789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598417|NCT00956098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803899|NCT01999413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803901|NCT01999413|Antiviral Agents|antiviral agents|mesh-ancestor
24803902|NCT01999413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24734189|NCT01650961|Serotonin Agents|serotonin agents|mesh-ancestor
24453539|NCT04941144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466199|NCT00372476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466200|NCT00372476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24466202|NCT00372476|Antimitotic Agents|antimitotic agents|mesh-ancestor
24466203|NCT00372476|Mitosis Modulators|mitosis modulators|mesh-ancestor
24466204|NCT00372515|Gefitinib|gefitinib|mesh-list
24466205|NCT00372515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466206|NCT00372515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24803905|NCT01999413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803906|NCT01999413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24803907|NCT01999413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24466240|NCT00372658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24466243|NCT00372710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24803978|NCT02000193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24803979|NCT02000193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803980|NCT02000206|Ketamine|ketamine|mesh-list
24803981|NCT02000206|Alfentanil|alfentanil|mesh-list
24803982|NCT02000206|Propofol|propofol|mesh-list
24803983|NCT02000206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24466248|NCT00372723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24466297|NCT00372853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466298|NCT00372853|Growth Inhibitors|growth inhibitors|mesh-ancestor
24466299|NCT00372853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24466300|NCT00372853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466301|NCT00372879|Vitamin E|vitamin e|mesh-list
24466302|NCT00372879|Vitamins|vitamins|mesh-ancestor
24466303|NCT00372879|Micronutrients|micronutrients|mesh-ancestor
24466304|NCT00372879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466305|NCT00372879|Antioxidants|antioxidants|mesh-ancestor
24466306|NCT00372879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466307|NCT00372879|Protective Agents|protective agents|mesh-ancestor
24466308|NCT00372892|Rituximab|rituximab|mesh-list
24466314|NCT00373048|Mefloquine|mefloquine|mesh-list
24804130|NCT02001259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24885977|NCT03835013|Exenatide|exenatide|mesh-list
24460652|NCT00349180|Enoxaparin sodium|enoxaparin sodium|mesh-list
24460653|NCT00349180|Anticoagulants|anticoagulants|mesh-ancestor
24460654|NCT00349180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24460655|NCT00349180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24804131|NCT02001259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804132|NCT02001259|Sensory System Agents|sensory system agents|mesh-ancestor
24804133|NCT02001259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804134|NCT02001259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24598729|NCT00957554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24598730|NCT00957554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598738|NCT00957866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598739|NCT00957866|Antiviral Agents|antiviral agents|mesh-ancestor
24598740|NCT00957866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24598741|NCT00957866|Antimetabolites|antimetabolites|mesh-ancestor
24605582|NCT00986128|Anticonvulsants|anticonvulsants|mesh-ancestor
24605583|NCT00986128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24605584|NCT00986128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605585|NCT00986167|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24605586|NCT00986167|Antidepressive Agents|antidepressive agents|mesh-ancestor
24605587|NCT00986167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24605588|NCT00986167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24605589|NCT00986167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24605590|NCT00986167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24605591|NCT00986167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605593|NCT00986284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605594|NCT00986284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24605595|NCT00986284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605597|NCT00986336|Topiramate|topiramate|mesh-list
24605623|NCT00986505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24605624|NCT00986505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605625|NCT00986505|Sensory System Agents|sensory system agents|mesh-ancestor
24605726|NCT00987038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24605727|NCT00987038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24605728|NCT00987038|Anesthetics, General|anesthetics, general|mesh-ancestor
24605729|NCT00987038|Anesthetics|anesthetics|mesh-ancestor
24605730|NCT00987038|GABA Modulators|gaba modulators|mesh-ancestor
24605731|NCT00987038|GABA Agents|gaba agents|mesh-ancestor
24605732|NCT00987038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24605733|NCT00987038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605735|NCT00987103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24605748|NCT00987116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24605749|NCT00987116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605750|NCT00987116|Antimetabolites|antimetabolites|mesh-ancestor
24605753|NCT00987116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24605773|NCT00987220|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24598742|NCT00957866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430266|NCT00246701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734576|NCT01652599|Dexamethasone|dexamethasone|mesh-list
24804196|NCT02001506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24804197|NCT02001506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24804198|NCT02001571|Abiraterone Acetate|abiraterone acetate|mesh-list
24804199|NCT02001571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804200|NCT02001571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24804201|NCT02001571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24804207|NCT02001584|Memantine|memantine|mesh-list
24804220|NCT02001584|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24804227|NCT02001740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804228|NCT02001740|Sensory System Agents|sensory system agents|mesh-ancestor
24804229|NCT02001740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804230|NCT02001740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24804231|NCT02001740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24804232|NCT02001740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24804233|NCT02001740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24804276|NCT02001909|Neomycin|neomycin|mesh-list
24804288|NCT02001935|Respiratory System Agents|respiratory system agents|mesh-ancestor
24804289|NCT02001935|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24443503|NCT00295282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804321|NCT02002000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24804324|NCT02002065|Vaccines|vaccines|mesh-list
24804377|NCT02002247|Micronutrients|micronutrients|mesh-ancestor
24804378|NCT02002260|Levonorgestrel|levonorgestrel|mesh-list
24804379|NCT02002260|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24804380|NCT02002260|Contraceptive Agents|contraceptive agents|mesh-list
24466442|NCT00373568|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24466443|NCT00373568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24466444|NCT00373581|Cocaine|cocaine|mesh-list
24466445|NCT00373581|Vigabatrin|vigabatrin|mesh-list
24466446|NCT00373581|Anesthetics, Local|anesthetics, local|mesh-ancestor
24599005|NCT05351229|Morphine|morphine|mesh-list
24599006|NCT05351229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24734811|NCT01654081|Irinotecan|irinotecan|mesh-list
24804434|NCT02002442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24804435|NCT02002442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24804436|NCT02002442|Disinfectants|disinfectants|mesh-ancestor
24804437|NCT02002598|Dexamethasone|dexamethasone|mesh-list
24804438|NCT02002598|Dexamethasone acetate|dexamethasone acetate|mesh-list
24804439|NCT02002598|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24804440|NCT02002598|BB 1101|bb 1101|mesh-list
24804441|NCT02002598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24804442|NCT02002598|Antiemetics|antiemetics|mesh-ancestor
24804443|NCT02002598|Autonomic Agents|autonomic agents|mesh-ancestor
24804444|NCT02002598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804445|NCT02002598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804446|NCT02002598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24804447|NCT02002598|Glucocorticoids|glucocorticoids|mesh-ancestor
24804448|NCT02002598|Hormones|hormones|mesh-ancestor
24804449|NCT02002598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24804450|NCT02002598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24804451|NCT02002598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804452|NCT02002598|Protease Inhibitors|protease inhibitors|mesh-ancestor
24804453|NCT02002598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24804454|NCT02002598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804455|NCT02002598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24804464|NCT02002663|Morphine|morphine|mesh-list
24734966|NCT01655056|Darexaban|darexaban|mesh-list
24804582|NCT02003456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804584|NCT02003495|Immunologic Factors|immunologic factors|mesh-ancestor
24804585|NCT02003495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804586|NCT02003664|Baclofen|baclofen|mesh-list
24804587|NCT02003664|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24804588|NCT02003664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702900|NCT02161185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25702901|NCT02161185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25702902|NCT02161185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702903|NCT02161185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25702904|NCT02161185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25702905|NCT02161185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25702906|NCT02161185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25702907|NCT02161185|Anesthetics, General|anesthetics, general|mesh-ancestor
24804589|NCT02003664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24804590|NCT02003664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804615|NCT02003885|Anesthetics|anesthetics|mesh-ancestor
24804616|NCT02003885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24804617|NCT02003885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804618|NCT02004067|Cyclosporine|cyclosporine|mesh-list
24804619|NCT02004067|Castor Oil|castor oil|mesh-list
24804620|NCT02004067|Cyclosporins|cyclosporins|mesh-list
24804621|NCT02004067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24804654|NCT02004197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804655|NCT02004197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24804656|NCT02004197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24804658|NCT02004197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24804659|NCT02004197|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24804685|NCT02004418|Lipotropic Agents|lipotropic agents|mesh-ancestor
24804686|NCT02004418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24804689|NCT02004418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24804693|NCT02004574|Betamethasone|betamethasone|mesh-list
24804724|NCT02004769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24804725|NCT02004769|Antimetabolites|antimetabolites|mesh-ancestor
24804726|NCT02004769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24804728|NCT02004782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24804729|NCT02004782|Glucocorticoids|glucocorticoids|mesh-ancestor
24804730|NCT02004782|Hormones|hormones|mesh-ancestor
24804731|NCT02004782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24804732|NCT02004782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804733|NCT02004782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24804734|NCT02004782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804735|NCT02004860|Ciclopirox|ciclopirox|mesh-list
24804736|NCT02004860|Tacrolimus|tacrolimus|mesh-list
24804737|NCT02004860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24804738|NCT02004860|Immunologic Factors|immunologic factors|mesh-ancestor
24804752|NCT02004899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804753|NCT02004899|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24804754|NCT02004899|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24804755|NCT02004899|Anesthetics, General|anesthetics, general|mesh-ancestor
24804756|NCT02004899|Anesthetics|anesthetics|mesh-ancestor
24804757|NCT02005068|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
24804758|NCT02005068|Cephalosporins|cephalosporins|mesh-list
24605774|NCT00987220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605775|NCT00987220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605776|NCT00987220|Cholinergic Agents|cholinergic agents|mesh-ancestor
24605777|NCT00987220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24605778|NCT00987220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605779|NCT00987220|Nootropic Agents|nootropic agents|mesh-ancestor
24605781|NCT00987233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24605782|NCT00987233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24605783|NCT00987233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24605784|NCT00987233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24605785|NCT00987233|Glucocorticoids|glucocorticoids|mesh-ancestor
24605786|NCT00987233|Hormones|hormones|mesh-ancestor
24605787|NCT00987233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24605788|NCT00987233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605789|NCT00987233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24605790|NCT00987233|Immunologic Factors|immunologic factors|mesh-ancestor
24446975|NCT00306800|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
24605814|NCT00987441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24605815|NCT00987441|Anesthetics, General|anesthetics, general|mesh-ancestor
24605816|NCT00987454|Epoetin Alfa|epoetin alfa|mesh-list
24605856|NCT00987662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24605858|NCT00987766|Oxaliplatin|oxaliplatin|mesh-list
24605859|NCT00987766|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24605860|NCT00987766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24605861|NCT00987766|Antimetabolites|antimetabolites|mesh-ancestor
24605862|NCT00987766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605863|NCT00987766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605864|NCT00987766|Antiviral Agents|antiviral agents|mesh-ancestor
24605865|NCT00987766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24605866|NCT00987766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24804759|NCT02005068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24804760|NCT02005068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24804761|NCT02005107|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24804762|NCT02005107|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25702908|NCT02161185|Anesthetics|anesthetics|mesh-ancestor
25702909|NCT02161185|GABA Modulators|gaba modulators|mesh-ancestor
24804763|NCT02005107|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24804780|NCT02005289|Lenalidomide|lenalidomide|mesh-list
24804861|NCT02005653|Doxycycline|doxycycline|mesh-list
24804862|NCT02005653|Albendazole|albendazole|mesh-list
24804863|NCT02005653|Diethylcarbamazine|diethylcarbamazine|mesh-list
24804864|NCT02005653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24804865|NCT02005653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24804866|NCT02005653|Antimalarials|antimalarials|mesh-ancestor
24804867|NCT02005653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24804868|NCT02005653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24804869|NCT02005653|Anthelmintics|anthelmintics|mesh-ancestor
24804870|NCT02005653|Anticestodal Agents|anticestodal agents|mesh-ancestor
24804871|NCT02005653|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24804872|NCT02005653|Tubulin Modulators|tubulin modulators|mesh-ancestor
24804873|NCT02005653|Antimitotic Agents|antimitotic agents|mesh-ancestor
24804874|NCT02005653|Mitosis Modulators|mitosis modulators|mesh-ancestor
24804875|NCT02005653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804876|NCT02005653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629035|NCT01102686|Vitamins|vitamins|mesh-ancestor
24605867|NCT00987766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24605868|NCT00987766|Immunologic Factors|immunologic factors|mesh-ancestor
24605869|NCT00987766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605870|NCT00987766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24605871|NCT00987779|Gabapentin|gabapentin|mesh-list
24605872|NCT00987779|Analgesics|analgesics|mesh-ancestor
24605873|NCT00987779|Sensory System Agents|sensory system agents|mesh-ancestor
24605874|NCT00987779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24605875|NCT00987779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605876|NCT00987779|Anticonvulsants|anticonvulsants|mesh-ancestor
24605877|NCT00987779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24605878|NCT00987779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24605879|NCT00987779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24605897|NCT00987792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24605898|NCT00987792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605899|NCT00987792|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24636901|NCT01148004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24605900|NCT00987792|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24605901|NCT00987792|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24605902|NCT00987844|Prucalopride|prucalopride|mesh-list
24605903|NCT00987844|Laxatives|laxatives|mesh-ancestor
24605904|NCT00987844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24605905|NCT00987844|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24804878|NCT02005653|Antinematodal Agents|antinematodal agents|mesh-ancestor
24804879|NCT02005653|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24804880|NCT02005653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24804882|NCT02005718|Vitamin D|vitamin d|mesh-list
24576109|NCT00836849|Sertraline|sertraline|mesh-list
24466630|NCT00374348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24466638|NCT00374387|Contraceptive Agents|contraceptive agents|mesh-ancestor
24466675|NCT00374478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804922|NCT02005783|Immunologic Factors|immunologic factors|mesh-ancestor
24804923|NCT02005783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804924|NCT02005783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24804925|NCT02005783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24804926|NCT02005783|Alkylating Agents|alkylating agents|mesh-ancestor
24497546|NCT00510406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24804927|NCT02005783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804928|NCT02005783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804929|NCT02005783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24804930|NCT02005783|Tubulin Modulators|tubulin modulators|mesh-ancestor
24804947|NCT02006043|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24804948|NCT02006043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804949|NCT02006043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24804950|NCT02006043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25702910|NCT02161185|GABA Agents|gaba agents|mesh-ancestor
25702911|NCT02161185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25702912|NCT02161185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702913|NCT02161406|Abatacept|abatacept|mesh-list
25702914|NCT02161406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25702915|NCT02161406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702916|NCT02161406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25702917|NCT02161406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25702918|NCT02161406|Immunologic Factors|immunologic factors|mesh-ancestor
25702919|NCT02161406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805004|NCT02006602|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24805005|NCT02006602|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24805006|NCT02006602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805007|NCT02006745|Ribavirin|ribavirin|mesh-list
24805008|NCT02006745|Antimetabolites|antimetabolites|mesh-ancestor
24805009|NCT02006745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805010|NCT02006745|Antiviral Agents|antiviral agents|mesh-ancestor
24805011|NCT02006745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24576369|NCT00838227|Modafinil|modafinil|mesh-list
24466812|NCT00375076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24466909|NCT00375583|Tubulin Modulators|tubulin modulators|mesh-ancestor
24466910|NCT00375583|Antimitotic Agents|antimitotic agents|mesh-ancestor
24466911|NCT00375583|Mitosis Modulators|mitosis modulators|mesh-ancestor
24466931|NCT00375622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629664|NCT01107093|Ulipristal acetate|ulipristal acetate|mesh-list
24466932|NCT00375622|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24466933|NCT00375622|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24466934|NCT00375622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24466935|NCT00375648|Zoledronic Acid|zoledronic acid|mesh-list
24498719|NCT00516113|Paroxetine|paroxetine|mesh-list
24805036|NCT02006966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805039|NCT02007005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24805040|NCT02007005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24576592|NCT00839371|Propofol|propofol|mesh-list
24466997|NCT00375895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24466998|NCT00375895|Dermatologic Agents|dermatologic agents|mesh-ancestor
24735595|NCT01657825|Warfarin|warfarin|mesh-list
24467050|NCT00376064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24467051|NCT00376064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467052|NCT00376064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467053|NCT00376077|Methylprednisolone|methylprednisolone|mesh-list
24467054|NCT00376077|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24467055|NCT00376077|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24467101|NCT00376272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24467102|NCT00376272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24467103|NCT00376272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24467104|NCT00376272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467105|NCT00376285|Fenofibrate|fenofibrate|mesh-list
24467106|NCT00376285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24606068|NCT00988780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24606069|NCT00988780|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24606070|NCT00988780|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24606071|NCT00988780|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24606072|NCT00988780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24606073|NCT00988780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24606074|NCT00988780|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24606075|NCT00988780|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24606076|NCT00988780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24606077|NCT00988780|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24606119|NCT00988949|Spiradoline|spiradoline|mesh-list
24467111|NCT00376311|Salmon calcitonin|salmon calcitonin|mesh-list
24467112|NCT00376311|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
24467113|NCT00376311|Katacalcin|katacalcin|mesh-list
24805051|NCT02007148|Antimetabolites|antimetabolites|mesh-ancestor
24805052|NCT02007161|Diclofenac|diclofenac|mesh-list
24805053|NCT02007161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24805054|NCT02007161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24805055|NCT02007161|Analgesics|analgesics|mesh-ancestor
24805056|NCT02007161|Sensory System Agents|sensory system agents|mesh-ancestor
24805057|NCT02007161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24805058|NCT02007161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805059|NCT02007161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24805060|NCT02007161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24805061|NCT02007161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24805062|NCT02007161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24576698|NCT00839826|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24735749|NCT01658358|Lapatinib|lapatinib|mesh-list
24805082|NCT02007330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24805083|NCT02007330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805085|NCT02007408|Anesthetics, Local|anesthetics, local|mesh-ancestor
24805087|NCT02007408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24467302|NCT00377000|Clindamycin phosphate|clindamycin phosphate|mesh-list
24606164|NCT00989274|Immunologic Factors|immunologic factors|mesh-ancestor
24467303|NCT00377000|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24467304|NCT00377000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24467305|NCT00377000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24825153|NCT02127697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467326|NCT00377065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24467327|NCT00377065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24467328|NCT00377065|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24467329|NCT00377065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467330|NCT00377065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467335|NCT00377091|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24467337|NCT00377091|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24467338|NCT00377091|Protease Inhibitors|protease inhibitors|mesh-ancestor
24467339|NCT00377091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467340|NCT00377091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467341|NCT00377091|Anticoagulants|anticoagulants|mesh-ancestor
24467342|NCT00377091|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24606218|NCT00989508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606221|NCT00989625|Sumatriptan|sumatriptan|mesh-list
24606222|NCT00989625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24606223|NCT00989625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24606224|NCT00989625|Analgesics|analgesics|mesh-ancestor
24606225|NCT00989625|Sensory System Agents|sensory system agents|mesh-ancestor
24606226|NCT00989625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24606227|NCT00989625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606228|NCT00989625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24606229|NCT00989625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24606230|NCT00989625|Gout Suppressants|gout suppressants|mesh-ancestor
24606231|NCT00989625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24606232|NCT00989625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606233|NCT00989625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606234|NCT00989625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24606281|NCT00989703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606282|NCT00989703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24606283|NCT00989703|Antimetabolites|antimetabolites|mesh-ancestor
24501520|NCT00529022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24501521|NCT00529022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501522|NCT00529022|Antimanic Agents|antimanic agents|mesh-ancestor
24501523|NCT00529022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24501524|NCT00529022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24501525|NCT00529022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24606284|NCT00989703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606285|NCT00989703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24606286|NCT00989703|Dermatologic Agents|dermatologic agents|mesh-ancestor
24400227|NCT00150111|Rituximab|rituximab|mesh-list
24502092|NCT05319834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24805106|NCT02007603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24805107|NCT02007603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24805108|NCT02007603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24805109|NCT02007603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805110|NCT02007603|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24805111|NCT02007629|Riociguat|riociguat|mesh-list
24805112|NCT02007629|Enzyme Activators|enzyme activators|mesh-ancestor
24805113|NCT02007629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805114|NCT02007746|Liver Extracts|liver extracts|mesh-list
24805115|NCT02007746|Hematinics|hematinics|mesh-ancestor
24805116|NCT02007798|Dexmedetomidine|dexmedetomidine|mesh-list
24467399|NCT00377468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24467401|NCT00377481|Hematinics|hematinics|mesh-ancestor
24467402|NCT00377494|Vaccines|vaccines|mesh-list
24467403|NCT00377494|Immunologic Factors|immunologic factors|mesh-ancestor
24467404|NCT00377494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467405|NCT00377546|Ketorolac|ketorolac|mesh-list
24467406|NCT00377546|Nepafenac|nepafenac|mesh-list
24467407|NCT00377546|Bromfenac|bromfenac|mesh-list
24467408|NCT00377546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24467409|NCT00377546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25702920|NCT02161406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24432477|NCT00254865|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24432478|NCT00254865|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24432479|NCT00254865|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24432480|NCT00254878|Methylphenidate|methylphenidate|mesh-list
24432481|NCT00254878|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24432482|NCT00254878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805127|NCT02007798|Adrenergic Agents|adrenergic agents|mesh-ancestor
24467413|NCT00377546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467415|NCT00377546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24631449|NCT01118234|Rituximab|rituximab|mesh-list
24467416|NCT00377546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24467417|NCT00377546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467418|NCT00377546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467419|NCT00377559|Docetaxel|docetaxel|mesh-list
24467420|NCT00377559|Doxorubicin|doxorubicin|mesh-list
24467421|NCT00377559|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24467422|NCT00377559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467423|NCT00377559|Tubulin Modulators|tubulin modulators|mesh-ancestor
24467425|NCT00377559|Mitosis Modulators|mitosis modulators|mesh-ancestor
24467426|NCT00377559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467446|NCT00377780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467447|NCT00377780|Tubulin Modulators|tubulin modulators|mesh-ancestor
24467448|NCT00377780|Antimitotic Agents|antimitotic agents|mesh-ancestor
24467449|NCT00377780|Mitosis Modulators|mitosis modulators|mesh-ancestor
24467450|NCT00377780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467451|NCT00377780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24467452|NCT00377780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24467453|NCT00377780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24467454|NCT00377780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467455|NCT00377780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24467456|NCT00377793|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24467457|NCT00377793|Vasodilator Agents|vasodilator agents|mesh-ancestor
24467458|NCT00377793|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24467479|NCT00377910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24467480|NCT00377910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467481|NCT00377910|Sensory System Agents|sensory system agents|mesh-ancestor
24467507|NCT00377936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24467508|NCT00377936|Tubulin Modulators|tubulin modulators|mesh-ancestor
24467509|NCT00377936|Antimitotic Agents|antimitotic agents|mesh-ancestor
24467510|NCT00377936|Mitosis Modulators|mitosis modulators|mesh-ancestor
24467513|NCT00377975|Caffeine|caffeine|mesh-list
24467514|NCT00377975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24467515|NCT00377975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467518|NCT00377975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467519|NCT00377975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467520|NCT00377975|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24467521|NCT00377975|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24467604|NCT00378183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24606347|NCT00990067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24606348|NCT00990067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24606349|NCT00990067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606350|NCT00990067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25702921|NCT02161458|Dexetimide|dexetimide|mesh-list
25702922|NCT02161458|Citalopram|citalopram|mesh-list
25702923|NCT02161458|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25702924|NCT02161458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25702925|NCT02161458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25702926|NCT02161458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702927|NCT02161458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25702928|NCT02161458|Serotonin Agents|serotonin agents|mesh-ancestor
25702929|NCT02161458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432776|NCT00256100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24432806|NCT00256269|Irinotecan|irinotecan|mesh-list
24606351|NCT00990067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606352|NCT00990067|Analgesics|analgesics|mesh-ancestor
24606353|NCT00990067|Sensory System Agents|sensory system agents|mesh-ancestor
24606354|NCT00990067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24606355|NCT00990067|Antidepressive Agents|antidepressive agents|mesh-ancestor
24606475|NCT00990600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606476|NCT00990600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606477|NCT00990600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24606478|NCT00990600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24606479|NCT00990600|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24606480|NCT00990600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24606481|NCT00990600|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24606482|NCT00990600|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24606483|NCT00990600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24606484|NCT00990600|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24606485|NCT00990639|Candesartan|candesartan|mesh-list
24606486|NCT00990639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24606519|NCT00990795|Immunologic Factors|immunologic factors|mesh-ancestor
24606520|NCT00990795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606521|NCT00990795|Antifungal Agents|antifungal agents|mesh-ancestor
24606522|NCT00990795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24606523|NCT00990795|Dermatologic Agents|dermatologic agents|mesh-ancestor
24606524|NCT00990795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24606525|NCT00990795|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24606526|NCT00990808|Atorvastatin|atorvastatin|mesh-list
24636954|NCT01148264|Olanzapine|olanzapine|mesh-list
24606626|NCT00991562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24606627|NCT00991562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24606628|NCT00991562|Tubulin Modulators|tubulin modulators|mesh-ancestor
24606629|NCT00991562|Antimitotic Agents|antimitotic agents|mesh-ancestor
24606630|NCT00991562|Mitosis Modulators|mitosis modulators|mesh-ancestor
24606631|NCT00991562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606632|NCT00991627|Atropine|atropine|mesh-list
24606633|NCT00991627|Ephedrine|ephedrine|mesh-list
24606635|NCT00991627|Morphine|morphine|mesh-list
24606636|NCT00991627|Bupivacaine|bupivacaine|mesh-list
24606637|NCT00991627|Anesthetics, Local|anesthetics, local|mesh-list
24606638|NCT00991627|Anesthetics|anesthetics|mesh-list
24606639|NCT00991627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24606640|NCT00991627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606641|NCT00991627|Sensory System Agents|sensory system agents|mesh-ancestor
24606642|NCT00991627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24606643|NCT00991627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24606644|NCT00991627|Narcotics|narcotics|mesh-ancestor
24606645|NCT00991627|Analgesics|analgesics|mesh-ancestor
24606646|NCT00991627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24606647|NCT00991627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24606648|NCT00991627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24606649|NCT00991627|Autonomic Agents|autonomic agents|mesh-ancestor
24606783|NCT05408208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24606784|NCT05408208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606785|NCT05408208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24606786|NCT05408208|Antimetabolites|antimetabolites|mesh-ancestor
24606787|NCT05408208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467646|NCT00378404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467647|NCT00378404|Tubulin Modulators|tubulin modulators|mesh-ancestor
24467648|NCT00378404|Antimitotic Agents|antimitotic agents|mesh-ancestor
24467649|NCT00378404|Mitosis Modulators|mitosis modulators|mesh-ancestor
24467650|NCT00378404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467651|NCT00378417|Vaccines|vaccines|mesh-list
25702930|NCT02161458|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25702931|NCT02161458|Antidepressive Agents|antidepressive agents|mesh-ancestor
25702932|NCT02161458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25702933|NCT02161458|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25702934|NCT02161458|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24433060|NCT00257452|Tiotropium Bromide|tiotropium bromide|mesh-list
24606793|NCT05408208|Immunologic Factors|immunologic factors|mesh-ancestor
24606831|NCT05408000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24606884|NCT05407467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24606885|NCT05407467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606887|NCT05407467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24606888|NCT05407467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24606889|NCT05407467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606890|NCT05407467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606891|NCT05407441|Nivolumab|nivolumab|mesh-list
24606892|NCT05407441|Ipilimumab|ipilimumab|mesh-list
24606893|NCT05407441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24606894|NCT05407441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24606895|NCT05407441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24606896|NCT05407441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606897|NCT05407246|Hemay005|hemay005|mesh-list
24606898|NCT05407246|Dermatologic Agents|dermatologic agents|mesh-ancestor
24606899|NCT05407246|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24805173|NCT02007928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24805174|NCT02007928|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24805175|NCT02007928|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24805176|NCT02007928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24805177|NCT02007928|Antidepressive Agents|antidepressive agents|mesh-ancestor
24805178|NCT02007928|Dopamine Agonists|dopamine agonists|mesh-ancestor
24805179|NCT02007928|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24805180|NCT02007928|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24805181|NCT02007928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24599832|NCT03581240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24599833|NCT03581240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24606901|NCT05407246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606903|NCT05407233|Insulin|insulin|mesh-list
24606940|NCT05406466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606948|NCT05404490|Bupivacaine|bupivacaine|mesh-list
24606949|NCT05404490|Anesthetics, Local|anesthetics, local|mesh-ancestor
24606950|NCT05404490|Anesthetics|anesthetics|mesh-ancestor
24606951|NCT05404490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24606952|NCT05404490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606953|NCT05404490|Sensory System Agents|sensory system agents|mesh-ancestor
24606954|NCT05404490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24467779|NCT00378716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24467780|NCT00378716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467781|NCT00378716|Antimetabolites|antimetabolites|mesh-ancestor
24467782|NCT00378716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467783|NCT00378716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24467784|NCT00378716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607108|NCT05213481|Sensory System Agents|sensory system agents|mesh-ancestor
24607109|NCT05213481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24607110|NCT05213481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24607111|NCT05213481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24607112|NCT05213481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607113|NCT05213481|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24607114|NCT05213481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24607115|NCT05213481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607171|NCT05123092|Sensory System Agents|sensory system agents|mesh-ancestor
24607172|NCT05123092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24607229|NCT04965818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607231|NCT04951206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24607232|NCT04951206|Glucocorticoids|glucocorticoids|mesh-ancestor
25702935|NCT02161458|Parasympatholytics|parasympatholytics|mesh-ancestor
25702936|NCT02161458|Autonomic Agents|autonomic agents|mesh-ancestor
25702937|NCT02161458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25702938|NCT02161458|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25702939|NCT02161458|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24607288|NCT04849455|Anesthetics|anesthetics|mesh-list
24607289|NCT04849455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24607290|NCT04849455|Narcotics|narcotics|mesh-ancestor
24607291|NCT04849455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24607292|NCT04849455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607293|NCT04849455|Analgesics|analgesics|mesh-ancestor
24607294|NCT04849455|Sensory System Agents|sensory system agents|mesh-ancestor
24607295|NCT04849455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24607296|NCT04848480|Insulin|insulin|mesh-list
24607298|NCT04848480|Insulin Aspart|insulin aspart|mesh-list
24607299|NCT04848480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24607300|NCT04848480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607301|NCT04836832|Acalabrutinib|acalabrutinib|mesh-list
24607346|NCT04764942|Protease Inhibitors|protease inhibitors|mesh-ancestor
24607347|NCT04764942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24607348|NCT04764942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467992|NCT00379431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24468030|NCT00379457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24468031|NCT00379483|Deferasirox|deferasirox|mesh-list
24468032|NCT00379483|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24468033|NCT00379483|Chelating Agents|chelating agents|mesh-ancestor
24607349|NCT04764942|Immunologic Factors|immunologic factors|mesh-ancestor
24607350|NCT04764942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24607351|NCT04764942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24607352|NCT04764942|Growth Substances|growth substances|mesh-ancestor
24502919|NCT04033419|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24502920|NCT04033419|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24607353|NCT04764942|Growth Inhibitors|growth inhibitors|mesh-ancestor
24607354|NCT04764942|Dermatologic Agents|dermatologic agents|mesh-ancestor
24607356|NCT04761198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24607357|NCT04761198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607358|NCT04761198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24607429|NCT04649229|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24671260|NCT01324583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24671261|NCT01324583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671262|NCT01324583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24671264|NCT01324596|Prednisolone|prednisolone|mesh-list
24671265|NCT01324596|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24607441|NCT04626141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434172|NCT00261599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24607492|NCT04469842|Tacrolimus|tacrolimus|mesh-list
24607493|NCT04469842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24607494|NCT04469842|Glucocorticoids|glucocorticoids|mesh-ancestor
24607495|NCT04469842|Hormones|hormones|mesh-ancestor
24607496|NCT04469842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24607497|NCT04469842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607506|NCT04469842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24468075|NCT00379691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468076|NCT00379691|Protective Agents|protective agents|mesh-ancestor
24468077|NCT00379717|Docetaxel|docetaxel|mesh-list
24736347|NCT01661439|Dalteparin|dalteparin|mesh-list
24805191|NCT02008006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24805192|NCT02008006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805193|NCT02008006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24805195|NCT02008006|Antiviral Agents|antiviral agents|mesh-ancestor
24805196|NCT02008006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24805197|NCT02008006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24805198|NCT02008006|Immunologic Factors|immunologic factors|mesh-ancestor
24805199|NCT02008006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805200|NCT02008006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24805201|NCT02008006|Alkylating Agents|alkylating agents|mesh-ancestor
24805202|NCT02008006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24805203|NCT02008019|Everolimus|everolimus|mesh-list
24805205|NCT02008019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24805206|NCT02008019|Immunologic Factors|immunologic factors|mesh-ancestor
24805207|NCT02008019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805208|NCT02008123|Primidone|primidone|mesh-list
24805209|NCT02008123|Anticonvulsants|anticonvulsants|mesh-ancestor
24805210|NCT02008123|GABA Modulators|gaba modulators|mesh-ancestor
24805211|NCT02008123|GABA Agents|gaba agents|mesh-ancestor
24805212|NCT02008123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24805213|NCT02008123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468134|NCT00380133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24607508|NCT04469842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24607509|NCT04469842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24607510|NCT04469842|Antimetabolites|antimetabolites|mesh-ancestor
24607511|NCT04469842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24607512|NCT04469842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24607513|NCT04442581|Pembrolizumab|pembrolizumab|mesh-list
24607546|NCT04424264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24607547|NCT04424264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24607548|NCT04424264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607549|NCT04424264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24607550|NCT04424264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24607551|NCT04424264|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24607552|NCT04424264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24607553|NCT04424264|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24607554|NCT04424264|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24607555|NCT04424264|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24607556|NCT04424264|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24736387|NCT01661777|Histamine Agents|histamine agents|mesh-ancestor
24805223|NCT02008162|Albuterol|albuterol|mesh-list
24468199|NCT00380445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468200|NCT00380445|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24468201|NCT00380445|Protease Inhibitors|protease inhibitors|mesh-ancestor
24468202|NCT00380445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24468203|NCT00380445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468204|NCT00380484|Budesonide|budesonide|mesh-list
24468205|NCT00380484|Montelukast|montelukast|mesh-list
24468206|NCT00380484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24468312|NCT00381030|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24468314|NCT00381030|Adrenergic Agents|adrenergic agents|mesh-ancestor
24468315|NCT00381030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24468316|NCT00381030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805224|NCT02008162|Tiotropium Bromide|tiotropium bromide|mesh-list
24502967|NCT03950817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702940|NCT02161458|Cholinergic Agents|cholinergic agents|mesh-ancestor
25702941|NCT02161484|Bupivacaine|bupivacaine|mesh-list
25702942|NCT02161484|Anesthetics, Local|anesthetics, local|mesh-ancestor
25702943|NCT02161484|Anesthetics|anesthetics|mesh-ancestor
25702944|NCT02161484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24502968|NCT03950817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24502969|NCT03950817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24805225|NCT02008162|Bronchodilator Agents|bronchodilator agents|mesh-list
24805226|NCT02008162|Autonomic Agents|autonomic agents|mesh-ancestor
24805227|NCT02008162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24805228|NCT02008162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805229|NCT02008162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24805230|NCT02008162|Respiratory System Agents|respiratory system agents|mesh-ancestor
24805252|NCT02008214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24468364|NCT00381199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24468365|NCT00381199|Analgesics|analgesics|mesh-ancestor
24468366|NCT00381199|Sensory System Agents|sensory system agents|mesh-ancestor
24468367|NCT00381199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24468368|NCT00381199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468369|NCT00381199|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24468370|NCT00381199|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24607557|NCT04424264|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24607605|NCT04230954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607620|NCT04217694|Memantine|memantine|mesh-list
24607621|NCT04217694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24607622|NCT04217694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24607623|NCT04217694|Dopamine Agents|dopamine agents|mesh-ancestor
24607629|NCT04192266|Estradiol|estradiol|mesh-list
24608846|NCT00994006|Magnesium Oxide|magnesium oxide|mesh-list
24468371|NCT00381199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24468474|NCT00381758|Methylphenidate|methylphenidate|mesh-list
24468475|NCT00381758|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24468476|NCT00381758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468477|NCT00381758|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24468672|NCT00382642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24468673|NCT00382642|Serotonin Agents|serotonin agents|mesh-ancestor
24468674|NCT00382642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24468675|NCT00382642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468676|NCT00382642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24468677|NCT00382642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24468678|NCT00382642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24468896|NCT00383864|Antiviral Agents|antiviral agents|mesh-ancestor
24468897|NCT00383864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25089150|NCT03268525|Bupivacaine|bupivacaine|mesh-list
24607701|NCT03978091|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24607702|NCT03978091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24607703|NCT03978091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607705|NCT03971409|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24607707|NCT03971409|Camptothecin|camptothecin|mesh-list
24607708|NCT03971409|Antibodies|antibodies|mesh-list
24607709|NCT03971409|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24607725|NCT03903640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24607726|NCT03903640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607727|NCT03903640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24607728|NCT03903640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607730|NCT03859687|Vitamin A|vitamin a|mesh-list
24607731|NCT03859687|Retinol palmitate|retinol palmitate|mesh-list
24607732|NCT03859687|Micronutrients|micronutrients|mesh-ancestor
24607733|NCT03859687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607734|NCT03859687|Antioxidants|antioxidants|mesh-ancestor
24607735|NCT03859687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607736|NCT03859687|Protective Agents|protective agents|mesh-ancestor
24607737|NCT03859687|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24607738|NCT03859687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607783|NCT03675139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607784|NCT03675139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24607785|NCT03675139|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24607786|NCT03675139|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24607787|NCT03675139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24607788|NCT03675139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607789|NCT03675139|Progestins|progestins|mesh-ancestor
24607790|NCT03675139|Hormones|hormones|mesh-ancestor
24607791|NCT03675139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24607792|NCT03646474|Tranexamic Acid|tranexamic acid|mesh-list
24607845|NCT03331484|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24607846|NCT03331484|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25089163|NCT03268278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089165|NCT03268278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25089166|NCT03268278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25089167|NCT03268278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25089168|NCT03268278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24468898|NCT00383864|Antimetabolites|antimetabolites|mesh-ancestor
24468899|NCT00383864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805268|NCT02008422|Antimetabolites|antimetabolites|mesh-ancestor
24469079|NCT00384553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24469080|NCT00384553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469081|NCT00384553|Immunologic Factors|immunologic factors|mesh-ancestor
24469082|NCT00384553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469083|NCT00384553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24469084|NCT00384566|Metoprolol|metoprolol|mesh-list
24469085|NCT00384566|Carvedilol|carvedilol|mesh-list
24469128|NCT00384618|Pravastatin|pravastatin|mesh-list
24469129|NCT00384618|Vitamins|vitamins|mesh-ancestor
24805275|NCT02008461|Botulinum Toxins|botulinum toxins|mesh-list
24578005|NCT00846677|Micronutrients|micronutrients|mesh-ancestor
24469160|NCT00384696|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24469161|NCT00384696|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24469162|NCT00384696|Cholinergic Agents|cholinergic agents|mesh-ancestor
24469163|NCT00384696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24469165|NCT00384800|Thalidomide|thalidomide|mesh-list
24469166|NCT00384800|Tegafur|tegafur|mesh-list
24469167|NCT00384800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24469168|NCT00384800|Immunologic Factors|immunologic factors|mesh-ancestor
24469169|NCT00384800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469170|NCT00384800|Leprostatic Agents|leprostatic agents|mesh-ancestor
24469171|NCT00384800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24469172|NCT00384800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24469280|NCT00385359|Tocolytic Agents|tocolytic agents|mesh-ancestor
24469282|NCT00385359|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24469283|NCT00385359|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24469284|NCT00385359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24469285|NCT00385359|Adrenergic Agents|adrenergic agents|mesh-ancestor
24469286|NCT00385359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24469341|NCT00385450|Antiviral Agents|antiviral agents|mesh-ancestor
24469548|NCT00386282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24469586|NCT00386503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24805289|NCT02008721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805290|NCT02008734|Palbociclib|palbociclib|mesh-list
24805291|NCT02008734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24805292|NCT02008734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24805293|NCT02008734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24805294|NCT02008734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805295|NCT02008747|Magnesium Sulfate|magnesium sulfate|mesh-list
24805296|NCT02008747|Analgesics|analgesics|mesh-ancestor
24805297|NCT02008747|Sensory System Agents|sensory system agents|mesh-ancestor
25089196|NCT03268226|Glycopyrrolate|glycopyrrolate|mesh-list
24607847|NCT03331484|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24607848|NCT03331484|Purinergic Agents|purinergic agents|mesh-ancestor
24503060|NCT03481634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24607849|NCT03331484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24607850|NCT03331484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455455|NCT00945724|Hormones|hormones|mesh-ancestor
24607851|NCT03331484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607852|NCT03331484|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24607853|NCT03331484|Antithrombins|antithrombins|mesh-ancestor
24607854|NCT03331484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24607855|NCT03331484|Protease Inhibitors|protease inhibitors|mesh-ancestor
24671299|NCT01324596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24671300|NCT01324596|Antiemetics|antiemetics|mesh-ancestor
24671301|NCT01324596|Autonomic Agents|autonomic agents|mesh-ancestor
24671302|NCT01324596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24671303|NCT01324596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24671304|NCT01324596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24671305|NCT01324596|Protective Agents|protective agents|mesh-ancestor
24671306|NCT01324635|Panobinostat|panobinostat|mesh-list
24671307|NCT01324635|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
24671308|NCT01324635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469587|NCT00386503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469588|NCT00386503|Antiviral Agents|antiviral agents|mesh-ancestor
24469589|NCT00386503|Schistosomicides|schistosomicides|mesh-ancestor
24469590|NCT00386503|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24469591|NCT00386503|Anthelmintics|anthelmintics|mesh-ancestor
24469592|NCT00386516|Fluorouracil|fluorouracil|mesh-list
24446818|NCT00306124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469931|NCT00388011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469933|NCT00388011|Sensory System Agents|sensory system agents|mesh-ancestor
24469934|NCT00388011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24469936|NCT00388076|Carboplatin|carboplatin|mesh-list
24469937|NCT00388076|Lapatinib|lapatinib|mesh-list
24805308|NCT02008747|Tocolytic Agents|tocolytic agents|mesh-ancestor
24805309|NCT02008747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24671309|NCT01324635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608062|NCT02451553|Capecitabine|capecitabine|mesh-list
24608064|NCT02451553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24608065|NCT02451553|Antimetabolites|antimetabolites|mesh-ancestor
24608066|NCT02451553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608067|NCT02451553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608068|NCT02451553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24608069|NCT02451553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608070|NCT02379247|Paclitaxel|paclitaxel|mesh-list
24608071|NCT02379247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24608072|NCT02379247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608243|NCT01646814|Aspirin|aspirin|mesh-list
24608244|NCT01646814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24608245|NCT01646814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24608246|NCT01646814|Analgesics|analgesics|mesh-ancestor
24608247|NCT01646814|Sensory System Agents|sensory system agents|mesh-ancestor
24608248|NCT01646814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24608249|NCT01646814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608250|NCT01646814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24608251|NCT01646814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24608252|NCT01646814|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24608253|NCT01646814|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24608254|NCT01646814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608255|NCT01646814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24608256|NCT01646814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24608257|NCT01646814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608340|NCT00991926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24608341|NCT00991926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24608342|NCT00991978|Bevacizumab|bevacizumab|mesh-list
24608343|NCT00991978|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
24608344|NCT00991978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24608345|NCT00991978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608346|NCT00991978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24805312|NCT02008786|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24469991|NCT00388271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469992|NCT00388271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469994|NCT00388336|Epoetin Alfa|epoetin alfa|mesh-list
24469995|NCT00388336|Hematinics|hematinics|mesh-ancestor
24469997|NCT00388388|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24469998|NCT00388388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24469999|NCT00388388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24737137|NCT01667120|Ketorolac|ketorolac|mesh-list
24470107|NCT00388856|Micronutrients|micronutrients|mesh-ancestor
24470150|NCT00389025|Analgesics|analgesics|mesh-ancestor
24470185|NCT00389090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24608394|NCT00992082|Epinephrine|epinephrine|mesh-list
24608395|NCT00992082|Morphine|morphine|mesh-list
24608396|NCT00992082|Ropivacaine|ropivacaine|mesh-list
24608397|NCT00992082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24608398|NCT00992082|Narcotics|narcotics|mesh-ancestor
24671329|NCT01324960|Azacitidine|azacitidine|mesh-list
24671330|NCT01324960|Histamine|histamine|mesh-list
24671332|NCT01324960|Antimetabolites|antimetabolites|mesh-ancestor
24608451|NCT00992134|Antimetabolites|antimetabolites|mesh-ancestor
24608452|NCT00992134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608453|NCT00992134|Antiviral Agents|antiviral agents|mesh-ancestor
24608454|NCT00992134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24608455|NCT00992134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24608456|NCT00992134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24503212|NCT02670252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503213|NCT02670252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503214|NCT02670252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24503216|NCT02665143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608457|NCT00992134|Alkylating Agents|alkylating agents|mesh-ancestor
24608516|NCT00992355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24608517|NCT00992355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24608518|NCT00992355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24608519|NCT00992355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24608521|NCT00992381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24608522|NCT00992381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24608523|NCT00992381|Analgesics|analgesics|mesh-ancestor
24608524|NCT00992381|Sensory System Agents|sensory system agents|mesh-ancestor
24608525|NCT00992381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24608526|NCT00992381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608580|NCT00992654|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24671336|NCT01324960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671337|NCT01324960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24671338|NCT01324960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24671340|NCT01324960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24805334|NCT02008981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24805335|NCT02008981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24805336|NCT02008981|Analgesics|analgesics|mesh-ancestor
24805337|NCT02008981|Sensory System Agents|sensory system agents|mesh-ancestor
24805338|NCT02008981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24805339|NCT02008981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470461|NCT00390208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24470463|NCT00390208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470464|NCT00390208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24671341|NCT01324960|Histamine Agonists|histamine agonists|mesh-ancestor
24671342|NCT01324960|Histamine Agents|histamine agents|mesh-ancestor
24671343|NCT01324960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24671344|NCT01325051|Raltegravir Potassium|raltegravir potassium|mesh-list
24671345|NCT01325051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24671346|NCT01325051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24671362|NCT01325194|Antiviral Agents|antiviral agents|mesh-ancestor
24608595|NCT00992693|Antimetabolites|antimetabolites|mesh-ancestor
24608596|NCT00992693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608597|NCT00992693|Antiviral Agents|antiviral agents|mesh-ancestor
24608598|NCT00992693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24608599|NCT00992706|Doxorubicin|doxorubicin|mesh-list
24608600|NCT00992706|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24608601|NCT00992706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24608714|NCT00993135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24608717|NCT00993135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608718|NCT00993135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24608720|NCT00993135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608721|NCT00993135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608722|NCT00993135|Dermatologic Agents|dermatologic agents|mesh-ancestor
24608723|NCT00993135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608726|NCT00993135|Immunologic Factors|immunologic factors|mesh-ancestor
24608778|NCT00993642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608779|NCT00993681|Vaccines|vaccines|mesh-list
24608780|NCT00993681|Immunologic Factors|immunologic factors|mesh-ancestor
24608781|NCT00993681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608782|NCT00993694|Dapsone|dapsone|mesh-list
24608783|NCT00993694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24608784|NCT00993694|Antimalarials|antimalarials|mesh-ancestor
24608785|NCT00993694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24608839|NCT00993876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608840|NCT00993876|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24608841|NCT00993876|Antidepressive Agents|antidepressive agents|mesh-ancestor
24608842|NCT00993876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24608844|NCT00993876|Adrenergic Agents|adrenergic agents|mesh-ancestor
24608845|NCT00994006|Magnesium citrate|magnesium citrate|mesh-list
24608847|NCT00994006|Levulinic acid|levulinic acid|mesh-list
24608848|NCT00994006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805344|NCT02008981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470714|NCT00391157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24470715|NCT00391157|Antiemetics|antiemetics|mesh-ancestor
24470716|NCT00391157|Autonomic Agents|autonomic agents|mesh-ancestor
24737469|NCT01669044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24805375|NCT02009189|Taurolidine|taurolidine|mesh-list
24470835|NCT00392106|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24470836|NCT00392106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24470837|NCT00392106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470838|NCT00392106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24608872|NCT00994097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608873|NCT00994097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24608874|NCT00994097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24608876|NCT00994149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24608889|NCT00994305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24608890|NCT00994305|Expectorants|expectorants|mesh-ancestor
24608891|NCT00994305|Respiratory System Agents|respiratory system agents|mesh-ancestor
24608892|NCT00994305|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24608929|NCT00994500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503257|NCT02384850|Antidotes|antidotes|mesh-ancestor
24608930|NCT00994500|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24608931|NCT00994500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608932|NCT00994500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608933|NCT00994513|Thioctic Acid|thioctic acid|mesh-list
24608934|NCT00994513|Antioxidants|antioxidants|mesh-ancestor
24608935|NCT00994513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608936|NCT00994513|Protective Agents|protective agents|mesh-ancestor
24608937|NCT00994513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608938|NCT00994513|Vitamin B Complex|vitamin b complex|mesh-ancestor
24609023|NCT00994786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24609024|NCT00994786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24470840|NCT00392106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24470848|NCT00392158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470849|NCT00392262|Amlodipine|amlodipine|mesh-list
24470850|NCT00392262|Valsartan|valsartan|mesh-list
24470851|NCT00392262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24470852|NCT00392262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24471000|NCT00392886|Antimetabolites|antimetabolites|mesh-ancestor
24471001|NCT00392886|Dermatologic Agents|dermatologic agents|mesh-ancestor
24471002|NCT00392886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24471003|NCT00392886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24471004|NCT00392886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24471005|NCT00392886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24805399|NCT02009306|Midazolam|midazolam|mesh-list
24737633|NCT01670071|Dopamine Agents|dopamine agents|mesh-ancestor
24471206|NCT00393744|Amoxicillin|amoxicillin|mesh-list
24471207|NCT00393744|Pristinamycin|pristinamycin|mesh-list
24471208|NCT00393744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24471266|NCT00394368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24805421|NCT02009410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24805422|NCT02009436|Azacitidine|azacitidine|mesh-list
24609027|NCT00994799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24609028|NCT00994799|Growth Substances|growth substances|mesh-ancestor
24609029|NCT00994799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609030|NCT00994799|Growth Inhibitors|growth inhibitors|mesh-ancestor
24609031|NCT00994799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609032|NCT00994812|Metformin|metformin|mesh-list
24609033|NCT00994812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24609034|NCT00994812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609035|NCT00994825|Simendan|simendan|mesh-list
24609036|NCT00994825|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24609037|NCT00994825|Vasodilator Agents|vasodilator agents|mesh-ancestor
24609038|NCT00994825|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24805423|NCT02009436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24805424|NCT02009436|Antimetabolites|antimetabolites|mesh-ancestor
24471327|NCT00394537|Labetalol|labetalol|mesh-list
24471369|NCT00394992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24471370|NCT00394992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24471371|NCT00394992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24471415|NCT00395213|Serotonin Agents|serotonin agents|mesh-ancestor
24471416|NCT00395213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24471417|NCT00395213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24471418|NCT00395239|Budesonide|budesonide|mesh-list
24737708|NCT01670175|Sirolimus|sirolimus|mesh-list
24805425|NCT02009436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805427|NCT02009436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24805429|NCT02009449|Gemcitabine|gemcitabine|mesh-list
24471529|NCT00395759|Lubricant Eye Drops|lubricant eye drops|mesh-list
24471544|NCT00395772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24471545|NCT00395772|Protease Inhibitors|protease inhibitors|mesh-ancestor
24471546|NCT00395772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24471547|NCT00395772|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24471548|NCT00395772|Hemostatics|hemostatics|mesh-ancestor
24471549|NCT00395772|Coagulants|coagulants|mesh-ancestor
24471550|NCT00395902|Cinacalcet|cinacalcet|mesh-list
24471551|NCT00395902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24471552|NCT00395902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765164|NCT01786382|Midazolam|midazolam|mesh-list
24609039|NCT00994825|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25702945|NCT02161484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702946|NCT02161484|Sensory System Agents|sensory system agents|mesh-ancestor
25702947|NCT02161484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24609040|NCT00994825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461214|NCT00351364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461215|NCT00351364|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24737822|NCT01670799|Ketorolac|ketorolac|mesh-list
24805469|NCT02009488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24471725|NCT00396682|Alkylating Agents|alkylating agents|mesh-ancestor
24471726|NCT00396682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471765|NCT00396747|Prednisolone phosphate|prednisolone phosphate|mesh-list
24471766|NCT00396747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24471767|NCT00396747|Abortifacient Agents|abortifacient agents|mesh-ancestor
24471768|NCT00396747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24471769|NCT00396747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471770|NCT00396747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24471771|NCT00396747|Antimetabolites|antimetabolites|mesh-ancestor
24737902|NCT01671722|Montelukast|montelukast|mesh-list
24471800|NCT00396760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24471801|NCT00396760|Protease Inhibitors|protease inhibitors|mesh-ancestor
24471802|NCT00396760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535724|NCT00649623|Olmesartan|olmesartan|mesh-list
24471993|NCT00397722|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24609086|NCT00994968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24609150|NCT00995124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24609159|NCT00995241|Raltegravir Potassium|raltegravir potassium|mesh-list
24609160|NCT00995241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24609161|NCT00995241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24609162|NCT00995241|Antiviral Agents|antiviral agents|mesh-ancestor
24609163|NCT00995241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24609164|NCT00995241|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24609165|NCT00995241|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24471973|NCT00397709|Isoniazid|isoniazid|mesh-list
24471974|NCT00397709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25089371|NCT03266549|Botulinum Toxins|botulinum toxins|mesh-list
24609329|NCT00996060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24609330|NCT00996060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609331|NCT00996060|Antimanic Agents|antimanic agents|mesh-ancestor
24609332|NCT00996060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24609333|NCT00996060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24609334|NCT00996060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24609335|NCT00996060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24609336|NCT00996060|Vasodilator Agents|vasodilator agents|mesh-ancestor
24609338|NCT00996099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24609339|NCT00996099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24609340|NCT00996099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609567|NCT00997347|Oxytocics|oxytocics|mesh-ancestor
24609568|NCT00997347|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24609569|NCT00997347|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24609570|NCT00997347|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24609571|NCT00997347|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24609572|NCT00997347|Contraceptive Agents|contraceptive agents|mesh-ancestor
24609606|NCT00997477|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24671428|NCT01325779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24671429|NCT01325779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24610129|NCT00999869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24610130|NCT00999869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24610131|NCT00999869|Immunologic Factors|immunologic factors|mesh-ancestor
24610132|NCT00999869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610133|NCT00999869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24610134|NCT00999869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24610136|NCT00999973|Mitomycin|mitomycin|mesh-list
24610137|NCT00999973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24610167|NCT01000298|Amoxicillin|amoxicillin|mesh-list
24610168|NCT01000298|Cefdinir|cefdinir|mesh-list
24610169|NCT01000298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24610170|NCT01000298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24610171|NCT01000415|Cisplatin|cisplatin|mesh-list
24610172|NCT01000415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610212|NCT01000597|Respiratory System Agents|respiratory system agents|mesh-ancestor
24610213|NCT01000597|Dermatologic Agents|dermatologic agents|mesh-ancestor
24610214|NCT01000597|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24610215|NCT01000623|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24471975|NCT00397709|Antitubercular Agents|antitubercular agents|mesh-ancestor
24471976|NCT00397709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24471977|NCT00397709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24471978|NCT00397709|Leprostatic Agents|leprostatic agents|mesh-ancestor
24471990|NCT00397709|Antimetabolites|antimetabolites|mesh-ancestor
24471991|NCT00397709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24671916|NCT01328392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24671964|NCT01328821|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24671965|NCT01328821|Protective Agents|protective agents|mesh-ancestor
24671966|NCT01328821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671967|NCT01328821|Vasodilator Agents|vasodilator agents|mesh-ancestor
24671968|NCT01328821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24671969|NCT01328821|Antioxidants|antioxidants|mesh-ancestor
24671970|NCT01328834|Tacrolimus|tacrolimus|mesh-list
24671971|NCT01328834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24456047|NCT00329693|Dopamine Agonists|dopamine agonists|mesh-ancestor
24671972|NCT01328834|Immunologic Factors|immunologic factors|mesh-ancestor
24637445|NCT01150331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24637446|NCT01150331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637447|NCT01150331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637448|NCT01150344|Artemether|artemether|mesh-list
24637449|NCT01150344|Atovaquone|atovaquone|mesh-list
24672007|NCT01329042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672063|NCT01329614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672064|NCT01329614|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24672065|NCT01329614|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24503652|NCT00532519|Serotonin Agents|serotonin agents|mesh-ancestor
24672147|NCT01329796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24672149|NCT01329796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24600109|NCT02573324|Immunologic Factors|immunologic factors|mesh-ancestor
24805489|NCT02009618|Rifaximin|rifaximin|mesh-list
24805490|NCT02009618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24805491|NCT02009618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24805492|NCT02009618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24805493|NCT02009631|Veliparib|veliparib|mesh-list
24805494|NCT02009631|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24805495|NCT02009631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24805496|NCT02009631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805497|NCT02009631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24805498|NCT02009709|Riboflavin|riboflavin|mesh-list
24805499|NCT02009709|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24805500|NCT02009709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24672150|NCT01329796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24672151|NCT01329796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24637504|NCT01150786|Trace Elements|trace elements|mesh-ancestor
24672247|NCT01330810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24672249|NCT01330810|Analgesics|analgesics|mesh-ancestor
24610405|NCT01001845|Antioxidants|antioxidants|mesh-ancestor
24610406|NCT01001845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610407|NCT01001845|Protective Agents|protective agents|mesh-ancestor
24610408|NCT01001845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610409|NCT01001845|Vitamins|vitamins|mesh-ancestor
24610410|NCT01001845|Micronutrients|micronutrients|mesh-ancestor
24610411|NCT01001871|Vitamins|vitamins|mesh-list
24610412|NCT01001871|Micronutrients|micronutrients|mesh-ancestor
24610413|NCT01001871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610414|NCT01001897|Misoprostol|misoprostol|mesh-list
24610415|NCT01001897|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24503742|NCT00532714|Irinotecan|irinotecan|mesh-list
24503775|NCT00532857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24610417|NCT01001897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24610418|NCT01001897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610419|NCT01001897|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24610420|NCT01001897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24610421|NCT01001897|Oxytocics|oxytocics|mesh-ancestor
24610422|NCT01001962|Metformin|metformin|mesh-list
24610423|NCT01001962|Empagliflozin|empagliflozin|mesh-list
24610424|NCT01001962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24610441|NCT01002079|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24610442|NCT01002079|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24436727|NCT00271245|Selenium|selenium|mesh-list
24610444|NCT01002092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24610445|NCT01002092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24610446|NCT01002092|Growth Substances|growth substances|mesh-ancestor
24610447|NCT01002092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610448|NCT01002092|Growth Inhibitors|growth inhibitors|mesh-ancestor
24672300|NCT01331434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24805502|NCT02009709|Vitamins|vitamins|mesh-ancestor
24805503|NCT02009709|Micronutrients|micronutrients|mesh-ancestor
24579531|NCT00855881|Tegafur|tegafur|mesh-list
25089424|NCT03266445|Narcotics|narcotics|mesh-ancestor
24672301|NCT01331434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672306|NCT01331447|Exemestane|exemestane|mesh-list
24672324|NCT01331590|Lenograstim|lenograstim|mesh-list
24672326|NCT01331590|Antiemetics|antiemetics|mesh-ancestor
24672327|NCT01331590|Autonomic Agents|autonomic agents|mesh-ancestor
24672328|NCT01331590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24672340|NCT01331590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672341|NCT01331590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24672342|NCT01331590|Immunologic Factors|immunologic factors|mesh-ancestor
24672343|NCT01331590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24672380|NCT01331902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24672381|NCT01331902|Vasodilator Agents|vasodilator agents|mesh-ancestor
24672382|NCT01331902|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24672383|NCT01331902|Purinergic Agonists|purinergic agonists|mesh-ancestor
24672384|NCT01331902|Purinergic Agents|purinergic agents|mesh-ancestor
24672385|NCT01331902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24672386|NCT01331902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672387|NCT01331902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24672388|NCT01331902|Vitamin B Complex|vitamin b complex|mesh-ancestor
24672390|NCT01331902|Micronutrients|micronutrients|mesh-ancestor
24672391|NCT01331928|Docetaxel|docetaxel|mesh-list
24672392|NCT01331928|Capecitabine|capecitabine|mesh-list
24672492|NCT01332383|Serotonin Agents|serotonin agents|mesh-ancestor
24672493|NCT01332383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24672531|NCT01332422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24672657|NCT01332929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24672658|NCT01332929|Growth Substances|growth substances|mesh-ancestor
24456719|NCT00332059|Timolol|timolol|mesh-list
24672659|NCT01332929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672660|NCT01332929|Growth Inhibitors|growth inhibitors|mesh-ancestor
24672662|NCT01332955|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24672663|NCT01332955|Antimetabolites|antimetabolites|mesh-ancestor
24672664|NCT01332955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672665|NCT01332955|Antiviral Agents|antiviral agents|mesh-ancestor
24672666|NCT01332955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24672707|NCT01333150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672756|NCT01333449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672796|NCT01333800|Respiratory System Agents|respiratory system agents|mesh-ancestor
24672797|NCT01333800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24672799|NCT01333852|Paclitaxel|paclitaxel|mesh-list
24672800|NCT01333852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24672801|NCT01333852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672802|NCT01333852|Tubulin Modulators|tubulin modulators|mesh-ancestor
24672803|NCT01333852|Antimitotic Agents|antimitotic agents|mesh-ancestor
24672804|NCT01333852|Mitosis Modulators|mitosis modulators|mesh-ancestor
24672805|NCT01333852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672806|NCT01333852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24672807|NCT01333852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805504|NCT02009709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805505|NCT02009709|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24805507|NCT02009748|Vitamin D|vitamin d|mesh-list
25702948|NCT02161562|Omalizumab|omalizumab|mesh-list
25702949|NCT02161562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25702950|NCT02161562|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24456934|NCT00332761|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24672854|NCT01333982|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24672855|NCT01333982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672856|NCT01333982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456935|NCT00332761|Antimetabolites|antimetabolites|mesh-ancestor
24456938|NCT00332761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24456939|NCT00332761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24456940|NCT00332761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24456941|NCT00332761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24456942|NCT00332761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672857|NCT01334034|Insulin Glargine|insulin glargine|mesh-list
24672858|NCT01334034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24672859|NCT01334034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672860|NCT01334047|Vaccines|vaccines|mesh-list
24672861|NCT01334047|Immunologic Factors|immunologic factors|mesh-ancestor
24672862|NCT01334047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672863|NCT01334060|Vaccines|vaccines|mesh-list
24672864|NCT01334060|Immunologic Factors|immunologic factors|mesh-ancestor
24672865|NCT01334060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672866|NCT01334073|Everolimus|everolimus|mesh-list
24672867|NCT01334073|Axitinib|axitinib|mesh-list
24672868|NCT01334073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672869|NCT01334073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24672882|NCT01334151|Insulin|insulin|mesh-list
24672901|NCT01334268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672928|NCT01334502|Immunologic Factors|immunologic factors|mesh-ancestor
24672929|NCT01334502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579672|NCT00856882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579673|NCT00856960|Losartan|losartan|mesh-list
24579674|NCT00856960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24579675|NCT00856960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24472181|NCT00398489|Hormone Antagonists|hormone antagonists|mesh-ancestor
24805524|NCT02010164|Micronutrients|micronutrients|mesh-ancestor
24805525|NCT02010164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472393|NCT00399074|Sulfadoxine|sulfadoxine|mesh-list
24672930|NCT01334502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24672931|NCT01334502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24672932|NCT01334502|Alkylating Agents|alkylating agents|mesh-ancestor
24672933|NCT01334502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672934|NCT01334502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672935|NCT01334502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24672936|NCT01334502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24672937|NCT01334502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24672938|NCT01334502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24673032|NCT01334905|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24673034|NCT01334905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24673035|NCT01334905|Adrenergic Agents|adrenergic agents|mesh-ancestor
24673036|NCT01334905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24673037|NCT01334905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673038|NCT01334905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673144|NCT01335529|Interferon-alpha|interferon-alpha|mesh-list
24438325|NCT00275535|Tacrolimus|tacrolimus|mesh-list
24673145|NCT01335529|Interferon alpha-2|interferon alpha-2|mesh-list
24673146|NCT01335529|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24673147|NCT01335529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673148|NCT01335529|Antiviral Agents|antiviral agents|mesh-ancestor
24673169|NCT01335685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24673170|NCT01335685|Alkylating Agents|alkylating agents|mesh-ancestor
24673171|NCT01335685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673172|NCT01335685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24673173|NCT01335685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24673174|NCT01335685|Immunologic Factors|immunologic factors|mesh-ancestor
24673175|NCT01335685|Protease Inhibitors|protease inhibitors|mesh-ancestor
24673176|NCT01335685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673177|NCT01335763|Insulin Glargine|insulin glargine|mesh-list
24472394|NCT00399074|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24472395|NCT00399074|Antimalarials|antimalarials|mesh-ancestor
24472396|NCT00399074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24472397|NCT00399074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24472398|NCT00399074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24472399|NCT00399074|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24472400|NCT00399074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24472401|NCT00399074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673260|NCT01336543|Antimetabolites|antimetabolites|mesh-ancestor
24673261|NCT01336543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673262|NCT01336543|Antiviral Agents|antiviral agents|mesh-ancestor
24673263|NCT01336543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673264|NCT01336543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673265|NCT01336543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24673266|NCT01336543|Immunologic Factors|immunologic factors|mesh-ancestor
24673267|NCT01336543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673268|NCT01336543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24673269|NCT01336543|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24673270|NCT01336543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24673271|NCT01336543|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24673272|NCT01336543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24673273|NCT01336582|Docetaxel|docetaxel|mesh-list
24610492|NCT01002703|Glucocorticoids|glucocorticoids|mesh-ancestor
24610494|NCT01002703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24610495|NCT01002703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610496|NCT01002703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24610497|NCT01002703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610498|NCT01002703|Immunologic Factors|immunologic factors|mesh-ancestor
24610499|NCT01002703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24610500|NCT01002703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24610501|NCT01002703|Growth Substances|growth substances|mesh-ancestor
24610502|NCT01002703|Growth Inhibitors|growth inhibitors|mesh-ancestor
24610504|NCT01002703|Alkylating Agents|alkylating agents|mesh-ancestor
24673369|NCT01337427|Antiviral Agents|antiviral agents|mesh-ancestor
24673370|NCT01337427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673371|NCT01337427|Immunologic Factors|immunologic factors|mesh-ancestor
24673372|NCT01337427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673373|NCT01337427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24673374|NCT01337440|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24673375|NCT01337440|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24673376|NCT01337440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24673489|NCT01338337|Antimetabolites|antimetabolites|mesh-ancestor
24673490|NCT01338337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673521|NCT01338675|Alkylating Agents|alkylating agents|mesh-ancestor
24673522|NCT01338675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673523|NCT01338675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24673524|NCT01338675|Immunologic Factors|immunologic factors|mesh-ancestor
24673525|NCT01338675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702951|NCT02161562|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25702952|NCT02161562|Respiratory System Agents|respiratory system agents|mesh-ancestor
24472471|NCT00399256|Antioxidants|antioxidants|mesh-ancestor
24472472|NCT00399256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472473|NCT00399256|Protective Agents|protective agents|mesh-ancestor
24472665|NCT00400088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472666|NCT00400088|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24805560|NCT02010905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24472697|NCT00400322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24472699|NCT00400335|Testosterone|testosterone|mesh-list
24472700|NCT00400335|Testosterone undecanoate|testosterone undecanoate|mesh-list
24472701|NCT00400335|Testosterone enanthate|testosterone enanthate|mesh-list
24403137|NCT00159458|Antiviral Agents|antiviral agents|mesh-ancestor
24673529|NCT01338740|Adalimumab|adalimumab|mesh-list
24673530|NCT01338740|Infliximab|infliximab|mesh-list
24673531|NCT01338740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24673532|NCT01338740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24673533|NCT01338740|Dermatologic Agents|dermatologic agents|mesh-ancestor
24673534|NCT01338740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24673649|NCT01339481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24673650|NCT01339481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401157|NCT00152243|Tegafur|tegafur|mesh-list
24673651|NCT01339481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673652|NCT01339481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24673653|NCT01339481|Immunologic Factors|immunologic factors|mesh-ancestor
24673654|NCT01339481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673655|NCT01339481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24673656|NCT01339572|Plerixafor|plerixafor|mesh-list
24673657|NCT01339572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24673658|NCT01339572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24673659|NCT01339572|Antiviral Agents|antiviral agents|mesh-ancestor
24673670|NCT01339624|Sensory System Agents|sensory system agents|mesh-ancestor
24673671|NCT01339624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24673672|NCT01339624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24673673|NCT01339624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24673674|NCT01339624|Anesthetics, General|anesthetics, general|mesh-ancestor
24673719|NCT01339754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24673720|NCT01339754|Alkylating Agents|alkylating agents|mesh-ancestor
24673721|NCT01339754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673724|NCT01339819|Phenprocoumon|phenprocoumon|mesh-list
24673725|NCT01339819|Antithrombins|antithrombins|mesh-ancestor
24673726|NCT01339819|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24673727|NCT01339819|Protease Inhibitors|protease inhibitors|mesh-ancestor
24673728|NCT01339819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673729|NCT01339819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673730|NCT01339819|Anticoagulants|anticoagulants|mesh-ancestor
24673731|NCT01339871|Vorinostat|vorinostat|mesh-list
24673732|NCT01339871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673733|NCT01339871|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24472736|NCT00400374|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24472737|NCT00400374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24472739|NCT00400387|Thiamine|thiamine|mesh-list
24472740|NCT00400387|Pyridoxine|pyridoxine|mesh-list
24472741|NCT00400387|Vitamin B 12|vitamin b 12|mesh-list
24805561|NCT02010905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24805562|NCT02010905|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24805563|NCT02010905|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24805564|NCT02010905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805565|NCT02010944|Solifenacin Succinate|solifenacin succinate|mesh-list
25702953|NCT02161562|Immunologic Factors|immunologic factors|mesh-ancestor
25089507|NCT03265002|Antidiarrheals|antidiarrheals|mesh-ancestor
24673734|NCT01339871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673735|NCT01339871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673736|NCT01339884|Resveratrol|resveratrol|mesh-list
24673737|NCT01339884|Antioxidants|antioxidants|mesh-ancestor
24673738|NCT01339884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673739|NCT01339884|Protective Agents|protective agents|mesh-ancestor
24673740|NCT01339884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673741|NCT01339884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504471|NCT00536640|Bevacizumab|bevacizumab|mesh-list
24504629|NCT00537472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24504630|NCT00537472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673742|NCT01339884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24673745|NCT01339988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24673746|NCT01339988|Immunologic Factors|immunologic factors|mesh-ancestor
24673747|NCT01339988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673748|NCT01339988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24673750|NCT01339988|Alkylating Agents|alkylating agents|mesh-ancestor
24673760|NCT01340118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24673761|NCT01340118|Respiratory System Agents|respiratory system agents|mesh-ancestor
24673762|NCT01340118|Glucocorticoids|glucocorticoids|mesh-ancestor
24673763|NCT01340118|Hormones|hormones|mesh-ancestor
24805593|NCT02010970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24805595|NCT02010970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24805596|NCT02010970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24738838|NCT01677884|Capecitabine|capecitabine|mesh-list
24444410|NCT00297817|Immunologic Factors|immunologic factors|mesh-ancestor
24473117|NCT00402038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473215|NCT00402376|Protease Inhibitors|protease inhibitors|mesh-ancestor
24473216|NCT00402415|Sirolimus|sirolimus|mesh-list
24473217|NCT00402415|Sunitinib|sunitinib|mesh-list
24673764|NCT01340118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24673775|NCT01340248|Carvedilol|carvedilol|mesh-list
24673776|NCT01340248|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24673777|NCT01340248|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24673778|NCT01340248|Adrenergic Agents|adrenergic agents|mesh-ancestor
24673779|NCT01340248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24673780|NCT01340248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673823|NCT01340521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673824|NCT01340521|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24673825|NCT01340521|Fertility Agents|fertility agents|mesh-ancestor
24673826|NCT01340521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24673827|NCT01340521|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24673829|NCT01340547|Isophosphamide mustard|isophosphamide mustard|mesh-list
24673852|NCT01340820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673853|NCT01340833|Dabrafenib|dabrafenib|mesh-list
24673854|NCT01340833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673855|NCT01340833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24673856|NCT01340833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473219|NCT00402415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24473220|NCT00402415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25702956|NCT02161575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25702957|NCT02161575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25702958|NCT02161575|Growth Substances|growth substances|mesh-ancestor
24473221|NCT00402415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473242|NCT00402454|Pyrazinamide|pyrazinamide|mesh-list
24473243|NCT00402454|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24473367|NCT00402571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473584|NCT00403338|Immunologic Factors|immunologic factors|mesh-ancestor
24473585|NCT00403338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473586|NCT00403364|Amoxicillin|amoxicillin|mesh-list
24473589|NCT00403364|Pantoprazole|pantoprazole|mesh-list
24473590|NCT00403364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24473591|NCT00403364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24473592|NCT00403364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24473593|NCT00403364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473594|NCT00403364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673857|NCT01340833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673858|NCT01340846|Ketoconazole|ketoconazole|mesh-list
24673860|NCT01340846|Warfarin|warfarin|mesh-list
24673861|NCT01340846|Gemfibrozil|gemfibrozil|mesh-list
24673862|NCT01340846|Anticoagulants|anticoagulants|mesh-ancestor
24673863|NCT01340846|Antifungal Agents|antifungal agents|mesh-ancestor
24673864|NCT01340846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673865|NCT01340846|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24673866|NCT01340846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24673867|NCT01340846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673868|NCT01340846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673869|NCT01340846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24673899|NCT01340950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24673907|NCT01341080|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24673908|NCT01341080|Cholinergic Agents|cholinergic agents|mesh-ancestor
24673909|NCT01341080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24673910|NCT01341080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673962|NCT01341262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24673964|NCT01341262|Growth Inhibitors|growth inhibitors|mesh-ancestor
24673965|NCT01341262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24673966|NCT01341275|Vaccines|vaccines|mesh-list
24673967|NCT01341275|Immunologic Factors|immunologic factors|mesh-ancestor
24673968|NCT01341275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673970|NCT01341340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673971|NCT01341340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24673972|NCT01341340|Immunologic Factors|immunologic factors|mesh-ancestor
24673973|NCT01341340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674065|NCT01341886|Metformin|metformin|mesh-list
24674066|NCT01341886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24674067|NCT01341886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674068|NCT01341938|Nicotine|nicotine|mesh-list
24674069|NCT01341938|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24674070|NCT01341938|Autonomic Agents|autonomic agents|mesh-ancestor
24674071|NCT01341938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24674112|NCT01342016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24674114|NCT01342016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24674116|NCT01342016|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24674118|NCT01342016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674119|NCT01342146|Hormones|hormones|mesh-list
24674120|NCT01342146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24674121|NCT01342146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674174|NCT01342237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674175|NCT01342237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24674176|NCT01342237|Alkylating Agents|alkylating agents|mesh-ancestor
24674177|NCT01342237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24674178|NCT01342237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24674179|NCT01342237|Immunologic Factors|immunologic factors|mesh-ancestor
24674180|NCT01342237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674181|NCT01342237|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24674182|NCT01342289|Mycophenolic Acid|mycophenolic acid|mesh-list
24674183|NCT01342289|Cyclophosphamide|cyclophosphamide|mesh-list
24674184|NCT01342289|Fludarabine|fludarabine|mesh-list
24674185|NCT01342289|Tacrolimus|tacrolimus|mesh-list
24674186|NCT01342289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24674187|NCT01342289|Immunologic Factors|immunologic factors|mesh-ancestor
24674188|NCT01342289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674230|NCT01342614|Protease Inhibitors|protease inhibitors|mesh-ancestor
24674231|NCT01342614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674232|NCT01342614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674233|NCT01342614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24674235|NCT01342627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24674236|NCT01342627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24674237|NCT01342627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674238|NCT01342627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674239|NCT01342679|Dasatinib|dasatinib|mesh-list
24674274|NCT01342731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674275|NCT01342744|Metformin|metformin|mesh-list
24674276|NCT01342744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24674277|NCT01342744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674278|NCT01342835|Propofol|propofol|mesh-list
24674279|NCT01342835|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24674280|NCT01342835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24674390|NCT05249933|Anesthetics|anesthetics|mesh-ancestor
24674391|NCT05249933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24674392|NCT05249933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805751|NCT02012036|Dermatologic Agents|dermatologic agents|mesh-ancestor
24674454|NCT05220319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24674455|NCT05220319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24674456|NCT05214066|Thymoglobulin|thymoglobulin|mesh-list
24674499|NCT05157698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24674500|NCT05157698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24674502|NCT05157698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24674503|NCT05157698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24674504|NCT05157698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24674505|NCT05157698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24674506|NCT05157698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674507|NCT05157698|Dopamine Agents|dopamine agents|mesh-ancestor
24505018|NCT00539071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505019|NCT00539071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505020|NCT00539071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24505021|NCT00539071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24505041|NCT00539331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24674508|NCT05157698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24674509|NCT05157698|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24674510|NCT05157698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24674511|NCT05157698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674513|NCT05148312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24674514|NCT05148312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24674515|NCT05148312|Autonomic Agents|autonomic agents|mesh-ancestor
24674516|NCT05148312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24674517|NCT05148312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674518|NCT05148312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24674519|NCT05148312|Respiratory System Agents|respiratory system agents|mesh-ancestor
24674590|NCT05063149|Broncho-Vaxom|broncho-vaxom|mesh-list
24610566|NCT01003158|Antimitotic Agents|antimitotic agents|mesh-ancestor
24610567|NCT01003158|Mitosis Modulators|mitosis modulators|mesh-ancestor
24610568|NCT01003158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610569|NCT01003314|Vaccines|vaccines|mesh-list
24610570|NCT01003314|Immunologic Factors|immunologic factors|mesh-ancestor
24610571|NCT01003314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674712|NCT04757571|Antidepressive Agents|antidepressive agents|mesh-ancestor
24674713|NCT04757571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24674714|NCT04757571|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24674715|NCT04757571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24674716|NCT04757571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674718|NCT04736394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24674719|NCT04736394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24674720|NCT04736394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25702959|NCT02161575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674721|NCT04736394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25702960|NCT02161575|Growth Inhibitors|growth inhibitors|mesh-ancestor
25702961|NCT02161575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24674796|NCT04409964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24674797|NCT04409964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674798|NCT04409964|Sensory System Agents|sensory system agents|mesh-ancestor
24674799|NCT04409964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24674800|NCT04409964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24674801|NCT04409964|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24674802|NCT04409964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24674803|NCT04409964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24674804|NCT04409964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674805|NCT04409964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24674806|NCT04409964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24674830|NCT04346394|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24674832|NCT04346394|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24674833|NCT04346394|Adrenergic Agents|adrenergic agents|mesh-ancestor
24674834|NCT04346394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24674835|NCT04346394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674836|NCT04346394|Urological Agents|urological agents|mesh-ancestor
24674838|NCT04326933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24674888|NCT04091022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674950|NCT03749057|Rivaroxaban|rivaroxaban|mesh-list
24674951|NCT03749057|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24674952|NCT03749057|Antithrombins|antithrombins|mesh-ancestor
24674953|NCT03749057|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24674954|NCT03749057|Protease Inhibitors|protease inhibitors|mesh-ancestor
24674955|NCT03749057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674998|NCT03635749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
24674999|NCT03635749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24675000|NCT03635749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24675107|NCT03122847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24675108|NCT03122847|Prednisolone|prednisolone|mesh-list
24675109|NCT03122847|Prednisolone acetate|prednisolone acetate|mesh-list
24675110|NCT03122847|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24675111|NCT03122847|Prednisolone phosphate|prednisolone phosphate|mesh-list
24675112|NCT03122847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24675113|NCT03122847|Antiemetics|antiemetics|mesh-ancestor
24675114|NCT03122847|Autonomic Agents|autonomic agents|mesh-ancestor
24675115|NCT03122847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24675116|NCT03122847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675117|NCT03122847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24675118|NCT03122847|Glucocorticoids|glucocorticoids|mesh-ancestor
24675121|NCT03122847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24675122|NCT03122847|Protective Agents|protective agents|mesh-ancestor
24675157|NCT02959944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24675158|NCT02959944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675159|NCT02959944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24675160|NCT02959944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24675202|NCT02710097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24675265|NCT02225405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24675266|NCT02225405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610684|NCT01004497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24610685|NCT01004497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24610687|NCT01004497|Autonomic Agents|autonomic agents|mesh-ancestor
24610688|NCT01004497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24610689|NCT01004497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24610690|NCT01004497|Glucocorticoids|glucocorticoids|mesh-ancestor
24610692|NCT01004497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24610693|NCT01004497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24610694|NCT01004497|Protease Inhibitors|protease inhibitors|mesh-ancestor
24610695|NCT01004497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610696|NCT01004497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24610697|NCT01004497|Antimetabolites|antimetabolites|mesh-ancestor
24610698|NCT01004497|Antiviral Agents|antiviral agents|mesh-ancestor
24610699|NCT01004497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24610700|NCT01004497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24610701|NCT01004497|Tubulin Modulators|tubulin modulators|mesh-ancestor
24610702|NCT01004497|Antimitotic Agents|antimitotic agents|mesh-ancestor
24610708|NCT01004497|Analgesics|analgesics|mesh-ancestor
25702962|NCT02161705|Ropivacaine|ropivacaine|mesh-list
25702963|NCT02161705|Anesthetics, Local|anesthetics, local|mesh-ancestor
24441526|NCT00287781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24675324|NCT00654628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24445680|NCT00302224|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24445681|NCT00302224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445682|NCT00302224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445683|NCT00302224|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24445684|NCT00302224|Hormone Antagonists|hormone antagonists|mesh-ancestor
24445685|NCT00302224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24445686|NCT00302224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445687|NCT00302224|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24805775|NCT02012075|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24805776|NCT02012075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24805777|NCT02012075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24805778|NCT02012075|Adrenergic Agents|adrenergic agents|mesh-ancestor
24675353|NCT00496834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24675354|NCT00496834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24675355|NCT00496834|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24675356|NCT00496834|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24675463|NCT01343225|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24675464|NCT01343225|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24675465|NCT01343225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24675466|NCT01343225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24675467|NCT01343290|Canagliflozin|canagliflozin|mesh-list
24675468|NCT01343290|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24675469|NCT01343290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675470|NCT01343290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24675471|NCT01343290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675473|NCT01343303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24675474|NCT01343303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24675475|NCT01343303|Analgesics|analgesics|mesh-ancestor
24675476|NCT01343303|Sensory System Agents|sensory system agents|mesh-ancestor
24675477|NCT01343303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24675478|NCT01343303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675479|NCT01343303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24675480|NCT01343303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24675502|NCT01343381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675679|NCT01344395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675783|NCT01345279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24675875|NCT01345864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24675876|NCT01345864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24675877|NCT01345864|Parasympatholytics|parasympatholytics|mesh-ancestor
24445796|NCT00302627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445798|NCT00302627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24473769|NCT00404183|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
24805789|NCT02012088|Prednisone|prednisone|mesh-list
25089658|NCT03263962|Canrenone|canrenone|mesh-list
24675878|NCT01345981|Lidocaine|lidocaine|mesh-list
24504928|NCT00538564|Tadalafil|tadalafil|mesh-list
24676042|NCT01347957|Autonomic Agents|autonomic agents|mesh-ancestor
24676043|NCT01347957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24676044|NCT01347957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610761|NCT01004900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24610762|NCT01004900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24610763|NCT01004900|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24505075|NCT00539630|Docetaxel|docetaxel|mesh-list
24676325|NCT01349699|Chelating Agents|chelating agents|mesh-ancestor
24676326|NCT01349699|Sequestering Agents|sequestering agents|mesh-ancestor
24676327|NCT01349699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676328|NCT01349699|Hematinics|hematinics|mesh-ancestor
24676329|NCT01349738|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24676382|NCT01349777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676383|NCT01349855|Insulin Glargine|insulin glargine|mesh-list
24676384|NCT01349855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24676385|NCT01349855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676386|NCT01350024|Lidocaine|lidocaine|mesh-list
24676387|NCT01350024|Epinephrine|epinephrine|mesh-list
24460643|NCT00349128|Metformin|metformin|mesh-list
24676388|NCT01350024|Racepinephrine|racepinephrine|mesh-list
24676389|NCT01350024|Epinephryl borate|epinephryl borate|mesh-list
25702964|NCT02161705|Anesthetics|anesthetics|mesh-ancestor
24676390|NCT01350024|Anesthetics, Local|anesthetics, local|mesh-ancestor
24676391|NCT01350024|Anesthetics|anesthetics|mesh-ancestor
24676392|NCT01350024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24676393|NCT01350024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676394|NCT01350024|Sensory System Agents|sensory system agents|mesh-ancestor
24676395|NCT01350024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24676432|NCT01350063|Troclosene|troclosene|mesh-list
24676433|NCT01350063|Antifungal Agents|antifungal agents|mesh-ancestor
24505081|NCT00539669|Docetaxel|docetaxel|mesh-list
24473815|NCT00404261|Respiratory System Agents|respiratory system agents|mesh-ancestor
24473816|NCT00404261|Dermatologic Agents|dermatologic agents|mesh-ancestor
24805792|NCT02012088|Doxorubicin|doxorubicin|mesh-list
24805793|NCT02012088|Vincristine|vincristine|mesh-list
24445903|NCT00303017|Naproxen|naproxen|mesh-list
24446132|NCT00303810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24446133|NCT00303810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24446134|NCT00303810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24473910|NCT00404417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473911|NCT00404417|Cholinergic Agents|cholinergic agents|mesh-ancestor
24805832|NCT02012166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24805833|NCT02012166|Hormones|hormones|mesh-ancestor
24805834|NCT02012166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24473994|NCT00404703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473995|NCT00404703|Growth Inhibitors|growth inhibitors|mesh-ancestor
25089675|NCT03263689|Sensory System Agents|sensory system agents|mesh-ancestor
24676648|NCT01351597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676650|NCT01351636|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24676651|NCT01351636|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24676654|NCT01351636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676655|NCT01351636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676656|NCT01351636|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24676657|NCT01351792|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24676660|NCT01351818|Hormones|hormones|mesh-list
24676692|NCT01352130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24676693|NCT01352130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676694|NCT01352130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24676695|NCT01352130|Antipruritics|antipruritics|mesh-ancestor
24676696|NCT01352130|Dermatologic Agents|dermatologic agents|mesh-ancestor
24676697|NCT01352130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24676719|NCT01352234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24676733|NCT01352312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676734|NCT01352312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24676735|NCT01352312|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
24676736|NCT01352312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676738|NCT01352338|Cyclophosphamide|cyclophosphamide|mesh-list
24676739|NCT01352338|Lenalidomide|lenalidomide|mesh-list
24676740|NCT01352338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24676741|NCT01352338|Immunologic Factors|immunologic factors|mesh-ancestor
24676742|NCT01352338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676743|NCT01352338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24676744|NCT01352338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24676745|NCT01352338|Alkylating Agents|alkylating agents|mesh-ancestor
24676746|NCT01352338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676747|NCT01352338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24676748|NCT01352338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24676846|NCT01352572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24676847|NCT01352572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24676848|NCT01352572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24676850|NCT01352572|Sensory System Agents|sensory system agents|mesh-ancestor
24676851|NCT01352572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24676852|NCT01352572|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24676860|NCT01352611|GABA Agonists|gaba agonists|mesh-ancestor
24676862|NCT01352611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24759192|NCT01749579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25702965|NCT02161705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24676899|NCT01353170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24676900|NCT01353170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676943|NCT01353378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24676944|NCT01353378|Adrenergic Agents|adrenergic agents|mesh-ancestor
24676945|NCT01353378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24676946|NCT01353378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676947|NCT01353391|Metformin|metformin|mesh-list
24676948|NCT01353391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24676949|NCT01353391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676950|NCT01353456|Dexmedetomidine|dexmedetomidine|mesh-list
24676951|NCT01353456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24676952|NCT01353456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24676953|NCT01353456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676954|NCT01353456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24676955|NCT01353456|Analgesics|analgesics|mesh-ancestor
24676956|NCT01353456|Sensory System Agents|sensory system agents|mesh-ancestor
24676957|NCT01353456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24676958|NCT01353456|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24676959|NCT01353456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24676999|NCT01353729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24677000|NCT01353729|Contraceptive Agents|contraceptive agents|mesh-ancestor
24677001|NCT01353729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24677002|NCT01353729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677003|NCT01353729|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24677004|NCT01353729|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24677005|NCT01353729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24677006|NCT01353729|Antiviral Agents|antiviral agents|mesh-ancestor
24677007|NCT01353742|Lamivudine|lamivudine|mesh-list
24677066|NCT01354262|Ergocalciferols|ergocalciferols|mesh-list
24740025|NCT01685931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24740078|NCT01686321|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24474171|NCT00405158|Sensory System Agents|sensory system agents|mesh-ancestor
24474172|NCT00405158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24474173|NCT00405158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24474174|NCT00405158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24474176|NCT00405171|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25089737|NCT03263520|Antiemetics|antiemetics|mesh-ancestor
24677075|NCT01354275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24677076|NCT01354275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677077|NCT01354301|Mycophenolic Acid|mycophenolic acid|mesh-list
24677185|NCT01354613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24677186|NCT01354613|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24677187|NCT01354613|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24677188|NCT01354613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24677189|NCT01354613|Adrenergic Agents|adrenergic agents|mesh-ancestor
24677190|NCT01354613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24677191|NCT01354613|Protective Agents|protective agents|mesh-ancestor
24677305|NCT01355562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24677306|NCT01355562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677308|NCT01355614|Dermatologic Agents|dermatologic agents|mesh-ancestor
24677309|NCT01355614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24462363|NCT00355862|Hormones|hormones|mesh-ancestor
24462488|NCT00356460|Mitogens|mitogens|mesh-list
24462489|NCT00356460|Immunologic Factors|immunologic factors|mesh-ancestor
24462512|NCT00356616|Abacavir|abacavir|mesh-list
24462571|NCT00357019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677310|NCT01355614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24461648|NCT00353028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24677311|NCT01355718|Repaglinide|repaglinide|mesh-list
24677312|NCT01355718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24677313|NCT01355718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677314|NCT01355757|Anesthetics|anesthetics|mesh-list
24677315|NCT01355757|Anesthetics, Local|anesthetics, local|mesh-list
24677316|NCT01355757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24677317|NCT01355757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677318|NCT01355757|Sensory System Agents|sensory system agents|mesh-ancestor
24610870|NCT01005537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24610871|NCT01005550|Ropivacaine|ropivacaine|mesh-list
24610872|NCT01005550|Anesthetics, Local|anesthetics, local|mesh-ancestor
24610873|NCT01005550|Anesthetics|anesthetics|mesh-ancestor
25702966|NCT02161705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610874|NCT01005550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24610875|NCT01005550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610876|NCT01005550|Sensory System Agents|sensory system agents|mesh-ancestor
24610877|NCT01005550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24610878|NCT01005628|Bortezomib|bortezomib|mesh-list
24610879|NCT01005628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610880|NCT01005641|Lapatinib|lapatinib|mesh-list
24610882|NCT01005641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610883|NCT01005641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24610884|NCT01005641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610886|NCT01005641|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24677391|NCT01356121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24677392|NCT01356121|GABA Modulators|gaba modulators|mesh-ancestor
24677405|NCT01356212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24677406|NCT01356212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24677407|NCT01356212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24677408|NCT01356212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677409|NCT01356225|Ketorolac|ketorolac|mesh-list
24677443|NCT01356368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24677444|NCT01356368|Tubulin Modulators|tubulin modulators|mesh-ancestor
24677504|NCT01356680|Etoposide|etoposide|mesh-list
24677505|NCT01356680|Vincristine|vincristine|mesh-list
24677506|NCT01356680|Doxorubicin|doxorubicin|mesh-list
24677507|NCT01356680|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24677510|NCT01356680|Procarbazine|procarbazine|mesh-list
24474179|NCT00405171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474181|NCT00405171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24474182|NCT00405171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24474183|NCT00405171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24474184|NCT00405171|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24474185|NCT00405171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24474188|NCT00405210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474189|NCT00405210|Tubulin Modulators|tubulin modulators|mesh-ancestor
24474190|NCT00405210|Antimitotic Agents|antimitotic agents|mesh-ancestor
24474254|NCT00405340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24474255|NCT00405366|Sorafenib|sorafenib|mesh-list
24474256|NCT00405366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24677511|NCT01356680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24677512|NCT01356680|Immunologic Factors|immunologic factors|mesh-ancestor
24411513|NCT00189345|Catumaxomab|catumaxomab|mesh-list
24677513|NCT01356680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677514|NCT01356680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24438984|NCT00277017|Growth Inhibitors|growth inhibitors|mesh-ancestor
24439458|NCT00278824|Analgesics|analgesics|mesh-ancestor
24677515|NCT01356680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24677526|NCT01356680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24677559|NCT01356758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24677560|NCT01356758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24677561|NCT01356758|Dermatologic Agents|dermatologic agents|mesh-ancestor
24677562|NCT01356758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24677563|NCT01356758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24677564|NCT01356758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24677565|NCT01356758|Analgesics|analgesics|mesh-ancestor
24677566|NCT01356758|Sensory System Agents|sensory system agents|mesh-ancestor
24677567|NCT01356758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24677568|NCT01356758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677569|NCT01356758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24677570|NCT01356758|Immunologic Factors|immunologic factors|mesh-ancestor
24677571|NCT01356797|Fentanyl|fentanyl|mesh-list
24677572|NCT01356797|Bupivacaine|bupivacaine|mesh-list
24677573|NCT01356797|Levobupivacaine|levobupivacaine|mesh-list
24677574|NCT01356797|Anesthetics, Local|anesthetics, local|mesh-ancestor
24677575|NCT01356797|Anesthetics|anesthetics|mesh-ancestor
24677576|NCT01356797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24677577|NCT01356797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677578|NCT01356797|Sensory System Agents|sensory system agents|mesh-ancestor
24677579|NCT01356797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24677580|NCT01356797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24403416|NCT00160316|Estradiol|estradiol|mesh-list
24677581|NCT01356797|Narcotics|narcotics|mesh-ancestor
24677582|NCT01356797|Analgesics|analgesics|mesh-ancestor
24677610|NCT01357031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677611|NCT01357031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24677612|NCT01357031|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24677624|NCT01357109|Bosentan|bosentan|mesh-list
24677630|NCT01357252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637987|NCT01154439|Mitoxantrone|mitoxantrone|mesh-list
24677631|NCT01357252|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24442957|NCT00293358|Ifosfamide|ifosfamide|mesh-list
24442958|NCT00293358|Etoposide phosphate|etoposide phosphate|mesh-list
24677710|NCT01357967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24677711|NCT01357967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24677712|NCT01357967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461517|NCT00352521|Irinotecan|irinotecan|mesh-list
24677769|NCT01358253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474258|NCT00405366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474259|NCT00405366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474260|NCT00405405|Bevacizumab|bevacizumab|mesh-list
24474261|NCT00405405|Cisplatin|cisplatin|mesh-list
24474262|NCT00405405|Docetaxel|docetaxel|mesh-list
24474263|NCT00405405|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24805939|NCT02012946|Sympathomimetics|sympathomimetics|mesh-ancestor
24805940|NCT02012946|Autonomic Agents|autonomic agents|mesh-ancestor
24805941|NCT02012946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24805942|NCT02012946|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24805943|NCT02012946|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24677770|NCT01358253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24677771|NCT01358253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24677772|NCT01358253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24677773|NCT01358253|Antiemetics|antiemetics|mesh-ancestor
24677774|NCT01358253|Autonomic Agents|autonomic agents|mesh-ancestor
24677775|NCT01358253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24677776|NCT01358253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24677777|NCT01358253|Glucocorticoids|glucocorticoids|mesh-ancestor
24677778|NCT01358253|Hormones|hormones|mesh-ancestor
24677779|NCT01358253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24677780|NCT01358253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24677807|NCT01358383|Naproxen|naproxen|mesh-list
24677808|NCT01358383|Esomeprazole|esomeprazole|mesh-list
24677809|NCT01358383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24677810|NCT01358383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24677811|NCT01358383|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24677812|NCT01358383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24677813|NCT01358383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677814|NCT01358383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24677815|NCT01358383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24677816|NCT01358383|Analgesics|analgesics|mesh-ancestor
24677817|NCT01358383|Sensory System Agents|sensory system agents|mesh-ancestor
24677818|NCT01358383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24677819|NCT01358383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677820|NCT01358383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24677821|NCT01358383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24677822|NCT01358383|Gout Suppressants|gout suppressants|mesh-ancestor
24677823|NCT01358383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24677824|NCT01358396|Chrysarobin|chrysarobin|mesh-list
24677825|NCT01358396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24677826|NCT01358396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24677827|NCT01358396|Analgesics|analgesics|mesh-ancestor
24677828|NCT01358396|Sensory System Agents|sensory system agents|mesh-ancestor
24677829|NCT01358396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24677830|NCT01358396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677831|NCT01358396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24677857|NCT01358500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24677858|NCT01358500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24677859|NCT01358500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24677860|NCT01358500|Anesthetics, General|anesthetics, general|mesh-ancestor
24677861|NCT01358500|Anesthetics|anesthetics|mesh-ancestor
24677862|NCT01358591|Calcium Carbonate|calcium carbonate|mesh-list
24677864|NCT01358591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24628938|NCT01102101|Analgesics|analgesics|mesh-ancestor
24677865|NCT01358591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677866|NCT01358591|Antacids|antacids|mesh-ancestor
24805944|NCT02012946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24805945|NCT02012946|Adrenergic Agents|adrenergic agents|mesh-ancestor
25702967|NCT02161705|Sensory System Agents|sensory system agents|mesh-ancestor
25702968|NCT02161705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25702969|NCT02161718|Olanzapine|olanzapine|mesh-list
24805946|NCT02012946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24805947|NCT02012998|Vaccines|vaccines|mesh-list
24805948|NCT02012998|Immunologic Factors|immunologic factors|mesh-ancestor
24805949|NCT02012998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805950|NCT02013089|Everolimus|everolimus|mesh-list
24805951|NCT02013089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24805952|NCT02013089|Sorafenib|sorafenib|mesh-list
24677867|NCT01358591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677868|NCT01358591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24677869|NCT01358812|Panitumumab|panitumumab|mesh-list
24677870|NCT01358812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24677871|NCT01358812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24677872|NCT01358916|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24677873|NCT01358916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24677874|NCT01359020|Acetaminophen|acetaminophen|mesh-list
24677875|NCT01359020|Dipyrone|dipyrone|mesh-list
24677876|NCT01359020|Ibuprofen|ibuprofen|mesh-list
24677877|NCT01359020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24677878|NCT01359020|Analgesics|analgesics|mesh-ancestor
24677879|NCT01359020|Sensory System Agents|sensory system agents|mesh-ancestor
24677880|NCT01359020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24677906|NCT01359085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24677907|NCT01359085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677908|NCT01359085|Anticonvulsants|anticonvulsants|mesh-ancestor
24677909|NCT01359085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24677910|NCT01359085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24906039|NCT04343001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24677911|NCT01359085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678025|NCT01359579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678027|NCT01359605|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
24678028|NCT01359605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678030|NCT01359618|Moxifloxacin|moxifloxacin|mesh-list
24678075|NCT01359670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24678076|NCT01359670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678077|NCT01359670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678078|NCT01359670|Urological Agents|urological agents|mesh-ancestor
24678079|NCT01359696|Gemcitabine|gemcitabine|mesh-list
24678080|NCT01359696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24678081|NCT01359696|Antimetabolites|antimetabolites|mesh-ancestor
24678082|NCT01359696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678083|NCT01359696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24678084|NCT01359696|Antiviral Agents|antiviral agents|mesh-ancestor
24678085|NCT01359696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24678086|NCT01359696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678087|NCT01359696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24678088|NCT01359696|Immunologic Factors|immunologic factors|mesh-ancestor
24678089|NCT01359696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678091|NCT01359709|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24678092|NCT01359709|Autonomic Agents|autonomic agents|mesh-ancestor
24678093|NCT01359709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24678094|NCT01359709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678095|NCT01359709|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24678096|NCT01359709|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24678097|NCT01359709|Cholinergic Agents|cholinergic agents|mesh-ancestor
24678100|NCT01359722|Acetylcysteine|acetylcysteine|mesh-list
24678129|NCT01359930|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24678130|NCT01359930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678233|NCT01360437|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24678234|NCT01360437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24462719|NCT00357318|Antibodies|antibodies|mesh-list
24462162|NCT00355277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24678293|NCT01360788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24678294|NCT01360788|Autonomic Agents|autonomic agents|mesh-ancestor
24905987|NCT04343729|Glucocorticoids|glucocorticoids|mesh-ancestor
24825896|NCT02130830|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24825897|NCT02130830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24905989|NCT04343729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24905990|NCT04343729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24906013|NCT04343326|Dermatologic Agents|dermatologic agents|mesh-ancestor
24906015|NCT04343170|Vitamin B 12|vitamin b 12|mesh-list
24906016|NCT04343170|Hydroxocobalamin|hydroxocobalamin|mesh-list
24906017|NCT04343170|Epoetin Alfa|epoetin alfa|mesh-list
24906019|NCT04343170|Micronutrients|micronutrients|mesh-ancestor
24906020|NCT04343170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906021|NCT04343170|Hematinics|hematinics|mesh-ancestor
24906022|NCT04343170|Vitamin B Complex|vitamin b complex|mesh-ancestor
24906023|NCT04343001|Aspirin|aspirin|mesh-list
24906024|NCT04343001|Losartan|losartan|mesh-list
24906025|NCT04343001|Simvastatin|simvastatin|mesh-list
24906026|NCT04343001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24906027|NCT04343001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24906028|NCT04343001|Analgesics|analgesics|mesh-ancestor
24906029|NCT04343001|Sensory System Agents|sensory system agents|mesh-ancestor
24906030|NCT04343001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24906031|NCT04343001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906032|NCT04343001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24906033|NCT04343001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24906034|NCT04343001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24906035|NCT04343001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24906036|NCT04343001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906037|NCT04343001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24678295|NCT01360788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24678296|NCT01360788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906038|NCT04343001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24906042|NCT04343001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24906043|NCT04343001|Antimetabolites|antimetabolites|mesh-ancestor
24906044|NCT04343001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24906078|NCT04342910|Tubulin Modulators|tubulin modulators|mesh-ancestor
24906079|NCT04342910|Antimitotic Agents|antimitotic agents|mesh-ancestor
24906080|NCT04342910|Mitosis Modulators|mitosis modulators|mesh-ancestor
24906081|NCT04342910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481737|NCT00436709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24906105|NCT04342728|Zinc|zinc|mesh-list
24906106|NCT04342728|Micronutrients|micronutrients|mesh-ancestor
24906107|NCT04342728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906108|NCT04342728|Trace Elements|trace elements|mesh-ancestor
24906109|NCT04342728|Antioxidants|antioxidants|mesh-ancestor
24906110|NCT04342728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906111|NCT04342728|Protective Agents|protective agents|mesh-ancestor
24906112|NCT04342650|Chloroquine|chloroquine|mesh-list
24906113|NCT04342650|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24906114|NCT04342650|Amebicides|amebicides|mesh-ancestor
24906115|NCT04342650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24906278|NCT04341493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906309|NCT04341727|Amebicides|amebicides|mesh-ancestor
24741451|NCT05288738|Dexmedetomidine|dexmedetomidine|mesh-list
24678297|NCT01360788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24678308|NCT01360788|Cholinergic Agents|cholinergic agents|mesh-ancestor
24678310|NCT01360827|Fluorouracil|fluorouracil|mesh-list
24678345|NCT01361399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678346|NCT01361399|Sensory System Agents|sensory system agents|mesh-ancestor
24678347|NCT01361399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24678348|NCT01361399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25702970|NCT02161718|Antiemetics|antiemetics|mesh-ancestor
25702971|NCT02161718|Autonomic Agents|autonomic agents|mesh-ancestor
25702972|NCT02161718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25702973|NCT02161718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702974|NCT02161718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25702975|NCT02161718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25702976|NCT02161718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25702977|NCT02161718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24678349|NCT01361399|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24678350|NCT01361399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24678351|NCT01361399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24678352|NCT01361399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678355|NCT01361399|Analgesics|analgesics|mesh-ancestor
24678456|NCT01362010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24678457|NCT01362036|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
24678458|NCT01362036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24678459|NCT01362036|Vasodilator Agents|vasodilator agents|mesh-ancestor
24678460|NCT01362153|Golimumab|golimumab|mesh-list
24678461|NCT01362153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24678462|NCT01362153|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24678463|NCT01362153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24906445|NCT04340401|Oxaliplatin|oxaliplatin|mesh-list
24906446|NCT04340401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24906447|NCT04340401|Antimetabolites|antimetabolites|mesh-ancestor
24906448|NCT04340401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906449|NCT04340401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24906450|NCT04340349|Hydroxychloroquine|hydroxychloroquine|mesh-list
24906452|NCT04340349|Antimalarials|antimalarials|mesh-ancestor
24906453|NCT04340349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24741536|NCT05288192|Triamcinolone|triamcinolone|mesh-list
24906697|NCT04337879|Calcium|calcium|mesh-list
24906698|NCT04337879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24906699|NCT04337879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482170|NCT00438113|Atenolol|atenolol|mesh-list
24906723|NCT04337814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24906724|NCT04337814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24906725|NCT04337814|Analgesics|analgesics|mesh-ancestor
24906726|NCT04337814|Sensory System Agents|sensory system agents|mesh-ancestor
24906727|NCT04337814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24678464|NCT01362153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24678465|NCT01362153|Immunologic Factors|immunologic factors|mesh-ancestor
24678489|NCT01362218|Antipyretics|antipyretics|mesh-ancestor
24678491|NCT01362218|Protease Inhibitors|protease inhibitors|mesh-ancestor
24678558|NCT01363063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678560|NCT01363089|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24678561|NCT01363089|Phenylephrine|phenylephrine|mesh-list
24678562|NCT01363089|Oxymetazoline|oxymetazoline|mesh-list
24678563|NCT01363089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24678564|NCT01363089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24678565|NCT01363089|Analgesics|analgesics|mesh-ancestor
24678566|NCT01363089|Sensory System Agents|sensory system agents|mesh-ancestor
24678567|NCT01363089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24678568|NCT01363089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678569|NCT01363089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24678570|NCT01363089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24678571|NCT01363089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24678572|NCT01363089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678573|NCT01363089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678574|NCT01363089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24678575|NCT01363089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24678588|NCT01363115|Calcium|calcium|mesh-list
24678589|NCT01363115|Vitamins|vitamins|mesh-ancestor
24678590|NCT01363115|Micronutrients|micronutrients|mesh-ancestor
24678591|NCT01363115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678592|NCT01363115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24610963|NCT01005797|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24610965|NCT01005927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24610966|NCT01005927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678641|NCT01363310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678642|NCT01363310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24678643|NCT01363310|Serotonin Agents|serotonin agents|mesh-ancestor
24678644|NCT01363310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678645|NCT01363310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24678894|NCT01364974|Peficitinib|peficitinib|mesh-list
24678895|NCT01364974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678896|NCT01364974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906728|NCT04337814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906899|NCT04336046|Anesthetics, Local|anesthetics, local|mesh-ancestor
24906900|NCT04336046|Anesthetics|anesthetics|mesh-ancestor
24906901|NCT04336046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24482330|NCT00438737|Growth Substances|growth substances|mesh-ancestor
24906929|NCT04335123|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24805934|NCT02012946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24906930|NCT04335123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906932|NCT04335513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24906933|NCT04335513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906934|NCT04335006|Paclitaxel|paclitaxel|mesh-list
24906935|NCT04335006|Apatinib|apatinib|mesh-list
24906936|NCT04335006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24907067|NCT04333628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24907069|NCT04333628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24907070|NCT04333550|Deferoxamine|deferoxamine|mesh-list
24907071|NCT04333550|Siderophores|siderophores|mesh-ancestor
25089875|NCT03262727|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24678897|NCT01364974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24678898|NCT01364974|Immunologic Factors|immunologic factors|mesh-ancestor
24679024|NCT01366001|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24679025|NCT01366118|Oxaliplatin|oxaliplatin|mesh-list
24679072|NCT01366300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24679073|NCT01366300|Anesthetics, General|anesthetics, general|mesh-ancestor
24679074|NCT01366313|Acetaminophen|acetaminophen|mesh-list
24679076|NCT01366313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24679077|NCT01366313|Narcotics|narcotics|mesh-ancestor
24679078|NCT01366313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24679079|NCT01366313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679080|NCT01366313|Analgesics|analgesics|mesh-ancestor
24679146|NCT01367028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679188|NCT01367418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24679189|NCT01367418|Narcotics|narcotics|mesh-ancestor
24679190|NCT01367418|Analgesics|analgesics|mesh-ancestor
24679191|NCT01367418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24679192|NCT01367418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24679193|NCT01367418|Anesthetics, General|anesthetics, general|mesh-ancestor
24679194|NCT01367431|Xanthohumol|xanthohumol|mesh-list
24679195|NCT01367431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24679196|NCT01367431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24679197|NCT01367431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24462419|NCT00356083|Methadone|methadone|mesh-list
24679248|NCT01367561|Naloxone|naloxone|mesh-list
24679287|NCT01367652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24679288|NCT01367652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24679289|NCT01367652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679290|NCT01367652|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24679291|NCT01367652|Hormone Antagonists|hormone antagonists|mesh-ancestor
24679292|NCT01367652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24679293|NCT01367652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679294|NCT01367678|Chlorhexidine|chlorhexidine|mesh-list
24907601|NCT04329403|Analgesics|analgesics|mesh-ancestor
24679295|NCT01367678|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24679296|NCT01367678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24679302|NCT01367743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24679303|NCT01367743|Adrenergic Agents|adrenergic agents|mesh-ancestor
24907453|NCT04330300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907547|NCT04329650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24907548|NCT04329650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24907549|NCT04329858|Methamphetamine|methamphetamine|mesh-list
24907550|NCT04329858|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24907551|NCT04329858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907552|NCT04329858|Sympathomimetics|sympathomimetics|mesh-ancestor
24679304|NCT01367743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24679305|NCT01367743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679306|NCT01367743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679307|NCT01367743|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24679308|NCT01367743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24679336|NCT01367912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24679357|NCT01368003|Dutasteride|dutasteride|mesh-list
24679379|NCT01368068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24679380|NCT01368068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679381|NCT01368068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24679382|NCT01368068|Serotonin Agents|serotonin agents|mesh-ancestor
24679383|NCT01368068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679384|NCT01368068|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24679385|NCT01368068|Antidepressive Agents|antidepressive agents|mesh-ancestor
24679386|NCT01368068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24462470|NCT00356395|Candesartan|candesartan|mesh-list
24679688|NCT01370096|Vasopressins|vasopressins|mesh-list
24679689|NCT01370096|Arginine Vasopressin|arginine vasopressin|mesh-list
24679714|NCT01370161|Adrenergic Agents|adrenergic agents|mesh-ancestor
24679715|NCT01370161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25702978|NCT02161718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25702979|NCT02161718|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25702980|NCT02161718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25702981|NCT02161718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24679716|NCT01370161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679717|NCT01370161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679719|NCT01370187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24679720|NCT01370187|Respiratory System Agents|respiratory system agents|mesh-ancestor
24679721|NCT01370187|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24679722|NCT01370187|Hormone Antagonists|hormone antagonists|mesh-ancestor
24679723|NCT01370187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24638522|NCT01156909|Immunologic Factors|immunologic factors|mesh-ancestor
24679724|NCT01370187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679725|NCT01370187|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24679728|NCT01370291|Risperidone|risperidone|mesh-list
24679769|NCT01370434|Vincristine|vincristine|mesh-list
24679770|NCT01370434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24679771|NCT01370434|Antiemetics|antiemetics|mesh-ancestor
24679772|NCT01370434|Autonomic Agents|autonomic agents|mesh-ancestor
24679773|NCT01370434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679777|NCT01370434|Hormones|hormones|mesh-ancestor
24679830|NCT01370915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24679831|NCT01370915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24679873|NCT01371435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24679874|NCT01371435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679875|NCT01371435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24679876|NCT01371435|Serotonin Agents|serotonin agents|mesh-ancestor
24679877|NCT01371435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907553|NCT04329858|Autonomic Agents|autonomic agents|mesh-ancestor
24907554|NCT04329858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24907555|NCT04329858|Dopamine Agents|dopamine agents|mesh-ancestor
24907556|NCT04329858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24907557|NCT04329858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907558|NCT04329858|Adrenergic Agents|adrenergic agents|mesh-ancestor
24818876|NCT02091401|Sensory System Agents|sensory system agents|mesh-ancestor
24818877|NCT02091401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24818878|NCT02091401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615158|NCT01028248|Growth Substances|growth substances|mesh-ancestor
24818879|NCT02091401|Anesthetics|anesthetics|mesh-ancestor
25109176|NCT03126578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818880|NCT02091401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24730556|NCT01628952|Curare|curare|mesh-list
24907598|NCT04329403|Adapalene|adapalene|mesh-list
24907599|NCT04329403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24907600|NCT04329403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24907602|NCT04329403|Sensory System Agents|sensory system agents|mesh-ancestor
24907603|NCT04329403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24907604|NCT04329403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907605|NCT04329403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25089914|NCT03262116|Insulin|insulin|mesh-list
24679878|NCT01371435|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24679879|NCT01371435|Antidepressive Agents|antidepressive agents|mesh-ancestor
24679880|NCT01371435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24679881|NCT01371435|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24679882|NCT01371435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24679883|NCT01371435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24679884|NCT01371448|Paroxetine|paroxetine|mesh-list
24679885|NCT01371448|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25702982|NCT02161718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702983|NCT02161718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25702984|NCT02161718|Serotonin Agents|serotonin agents|mesh-ancestor
25702985|NCT02161731|Warfarin|warfarin|mesh-list
25702986|NCT02161731|Evacetrapib|evacetrapib|mesh-list
25702987|NCT02161731|Anticoagulants|anticoagulants|mesh-ancestor
25702988|NCT02161731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25702989|NCT02161731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24679886|NCT01371448|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24680002|NCT01372423|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24680003|NCT01372423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24638594|NCT01157247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680004|NCT01372423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680005|NCT01372449|Memantine|memantine|mesh-list
24680006|NCT01372449|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24680007|NCT01372449|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24680027|NCT01372670|Dermatologic Agents|dermatologic agents|mesh-ancestor
24680028|NCT01372670|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24680029|NCT01372670|Histamine Antagonists|histamine antagonists|mesh-ancestor
24680189|NCT01373411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24680190|NCT01373411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680191|NCT01373411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680192|NCT01373463|Carboplatin|carboplatin|mesh-list
24680193|NCT01373463|Pemetrexed|pemetrexed|mesh-list
24680194|NCT01373463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680195|NCT01373463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907631|NCT04329091|Adrenergic Agents|adrenergic agents|mesh-ancestor
24907632|NCT04329091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24907633|NCT04329091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907634|NCT04328870|Oxytocin|oxytocin|mesh-list
24907635|NCT04328870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907636|NCT04328870|Oxytocics|oxytocics|mesh-ancestor
24907637|NCT04328870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24907638|NCT04328805|Ibuprofen|ibuprofen|mesh-list
24907639|NCT04328805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24907640|NCT04328805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24907641|NCT04328805|Analgesics|analgesics|mesh-ancestor
24907642|NCT04328805|Sensory System Agents|sensory system agents|mesh-ancestor
24907665|NCT04328883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24907666|NCT04328883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24680196|NCT01373463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680197|NCT01373463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24680198|NCT01373463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24680233|NCT01373593|Sensory System Agents|sensory system agents|mesh-ancestor
24680234|NCT01373593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24680235|NCT01373593|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24680236|NCT01373593|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24680240|NCT01373606|Terlipressin|terlipressin|mesh-list
24680275|NCT01373697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680276|NCT01373697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680277|NCT01373710|Trastuzumab|trastuzumab|mesh-list
24680278|NCT01373710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24680279|NCT01373710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680280|NCT01373736|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24680281|NCT01373736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680285|NCT01373749|Sildenafil Citrate|sildenafil citrate|mesh-list
24680436|NCT01374737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25702990|NCT02161731|Antimetabolites|antimetabolites|mesh-ancestor
25702991|NCT02161731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25702992|NCT02161731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25702993|NCT02162433|Dexmedetomidine|dexmedetomidine|mesh-list
25702994|NCT02162433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25702995|NCT02162433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25702996|NCT02162433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25702997|NCT02162433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25702998|NCT02162433|Analgesics|analgesics|mesh-ancestor
25702999|NCT02162433|Sensory System Agents|sensory system agents|mesh-ancestor
25703000|NCT02162433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24680438|NCT01374737|Adrenergic Agents|adrenergic agents|mesh-ancestor
24680439|NCT01374737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24907925|NCT04326725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24680440|NCT01374737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680617|NCT01375556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24680618|NCT01375556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680619|NCT01375582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24680620|NCT01375582|Lubricant Eye Drops|lubricant eye drops|mesh-list
24680621|NCT01375582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24680623|NCT01375634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24680624|NCT01375634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24680625|NCT01375634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24404389|NCT00163332|Hormones|hormones|mesh-ancestor
24680626|NCT01375634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680627|NCT01375634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24680681|NCT01375881|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24680682|NCT01375881|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24680683|NCT01375881|Protease Inhibitors|protease inhibitors|mesh-ancestor
24680684|NCT01375881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680685|NCT01375881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680686|NCT01375881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24680687|NCT01375881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24680688|NCT01375881|Antiviral Agents|antiviral agents|mesh-ancestor
24680689|NCT01375881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24680690|NCT01375881|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24680691|NCT01375881|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24680692|NCT01375920|Metyrapone|metyrapone|mesh-list
24907667|NCT04328883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907668|NCT04328883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24742047|NCT05293808|Aspirin|aspirin|mesh-list
24907728|NCT04328480|Gout Suppressants|gout suppressants|mesh-ancestor
24907729|NCT04328480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24907730|NCT04328480|Tubulin Modulators|tubulin modulators|mesh-ancestor
24907731|NCT04328480|Antimitotic Agents|antimitotic agents|mesh-ancestor
24907732|NCT04328480|Mitosis Modulators|mitosis modulators|mesh-ancestor
24907733|NCT04328480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907734|NCT04328480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24482972|NCT00441246|Phenylpropanolamine|phenylpropanolamine|mesh-list
24907811|NCT04327427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24907812|NCT04327427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907813|NCT04327427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24907868|NCT04326894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24907869|NCT04326894|Immunologic Factors|immunologic factors|mesh-ancestor
24907870|NCT04326894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24907871|NCT04326894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24907872|NCT04326868|Albendazole|albendazole|mesh-list
24907873|NCT04326868|Mebendazole|mebendazole|mesh-list
24907874|NCT04326868|Benzimidazole|benzimidazole|mesh-list
24907875|NCT04326868|Pyrantel|pyrantel|mesh-list
24907876|NCT04326868|Anthelmintics|anthelmintics|mesh-list
24907877|NCT04326868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24907878|NCT04326868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24907879|NCT04326868|Anticestodal Agents|anticestodal agents|mesh-ancestor
24631211|NCT01116531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24907880|NCT04326868|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24907881|NCT04326868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24907882|NCT04326868|Tubulin Modulators|tubulin modulators|mesh-ancestor
24907886|NCT04326868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25703001|NCT02162433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25703002|NCT02162433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25703003|NCT02162433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25703004|NCT02162433|Adrenergic Agents|adrenergic agents|mesh-ancestor
25703005|NCT02162433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25703006|NCT02162433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703007|NCT02162680|Lidocaine|lidocaine|mesh-list
25703008|NCT02162680|Anesthetics, Local|anesthetics, local|mesh-ancestor
25703009|NCT02162680|Anesthetics|anesthetics|mesh-ancestor
25703010|NCT02162680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25703011|NCT02162680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703012|NCT02162680|Sensory System Agents|sensory system agents|mesh-ancestor
25703013|NCT02162680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25703014|NCT02162680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24907887|NCT04326868|Antinematodal Agents|antinematodal agents|mesh-ancestor
25109197|NCT03126656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109198|NCT03126656|Anabolic Agents|anabolic agents|mesh-ancestor
25109199|NCT03126721|Midazolam|midazolam|mesh-list
25109200|NCT03126721|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25109201|NCT03126721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25109202|NCT03126721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25089934|NCT03262376|Vitamins|vitamins|mesh-list
25109203|NCT03126721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109204|NCT03126721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25109205|NCT03126721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25109206|NCT03126721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25109207|NCT03126721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25109208|NCT03126721|Anesthetics, General|anesthetics, general|mesh-ancestor
25109209|NCT03126721|Anesthetics|anesthetics|mesh-ancestor
24907894|NCT04326764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24483057|NCT00441597|Atorvastatin|atorvastatin|mesh-list
24907921|NCT04326725|Hydroxychloroquine|hydroxychloroquine|mesh-list
24907922|NCT04326725|Antimalarials|antimalarials|mesh-ancestor
24907923|NCT04326725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24907924|NCT04326725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24907927|NCT04326725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907928|NCT04326725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24907929|NCT04326296|Lenalidomide|lenalidomide|mesh-list
24907930|NCT04326296|Antibodies|antibodies|mesh-list
24907931|NCT04326296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24731075|NCT01632007|Alogliptin|alogliptin|mesh-list
24908115|NCT04324086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24908242|NCT04322786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908244|NCT04322422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24908245|NCT04322422|Respiratory System Agents|respiratory system agents|mesh-ancestor
24908246|NCT04322422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24908247|NCT04322422|Hormone Antagonists|hormone antagonists|mesh-ancestor
24908248|NCT04322422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24908249|NCT04322422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908250|NCT04322422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24680693|NCT01375920|Antimetabolites|antimetabolites|mesh-ancestor
24447874|NCT00309725|Autonomic Agents|autonomic agents|mesh-ancestor
24680694|NCT01375920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680695|NCT01375920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680696|NCT01375972|Gemcitabine|gemcitabine|mesh-list
24680697|NCT01375972|Cisplatin|cisplatin|mesh-list
24680698|NCT01375972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680699|NCT01375972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24680700|NCT01375972|Antimetabolites|antimetabolites|mesh-ancestor
24680701|NCT01375972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680702|NCT01375972|Antiviral Agents|antiviral agents|mesh-ancestor
24680703|NCT01375972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24680704|NCT01375972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908251|NCT04322422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25109210|NCT03126721|GABA Modulators|gaba modulators|mesh-ancestor
24665307|NCT01311622|Anticoagulants|anticoagulants|mesh-ancestor
24787161|NCT01923870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24787162|NCT01923870|Fertility Agents|fertility agents|mesh-ancestor
24787163|NCT01923870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24787164|NCT01923870|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24787165|NCT01923870|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24857050|NCT02288962|Cabergoline|cabergoline|mesh-list
24908252|NCT04322422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908273|NCT04322214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908274|NCT04322214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908275|NCT04322240|Thioctic Acid|thioctic acid|mesh-list
24908276|NCT04322240|Antioxidants|antioxidants|mesh-ancestor
25703015|NCT02162680|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25703016|NCT02162680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24805953|NCT02013089|Sunitinib|sunitinib|mesh-list
25703017|NCT02162680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25703018|NCT02162680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703019|NCT02162719|Paclitaxel|paclitaxel|mesh-list
25703020|NCT02162719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24908277|NCT04322240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908278|NCT04322240|Protective Agents|protective agents|mesh-ancestor
24908279|NCT04322240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908280|NCT04322240|Vitamin B Complex|vitamin b complex|mesh-ancestor
24908281|NCT04322240|Vitamins|vitamins|mesh-ancestor
24680705|NCT01375972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24680706|NCT01375972|Immunologic Factors|immunologic factors|mesh-ancestor
24680707|NCT01375972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680708|NCT01375985|Radavirsen|radavirsen|mesh-list
24438371|NCT00275652|Lamivudine|lamivudine|mesh-list
24680798|NCT01376206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24680799|NCT01376206|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24680800|NCT01376206|Autonomic Agents|autonomic agents|mesh-ancestor
24680841|NCT01376271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24680892|NCT01376713|Dacarbazine|dacarbazine|mesh-list
24680893|NCT01376713|Ofatumumab|ofatumumab|mesh-list
24680894|NCT01376713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24680895|NCT01376713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24680896|NCT01376713|Alkylating Agents|alkylating agents|mesh-ancestor
24680897|NCT01376713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680898|NCT01376713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680899|NCT01376713|Immunologic Factors|immunologic factors|mesh-ancestor
24680900|NCT01376713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680901|NCT01376765|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24680902|NCT01376765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24680903|NCT01376765|Immunologic Factors|immunologic factors|mesh-ancestor
24680904|NCT01376765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680905|NCT01376765|Antacids|antacids|mesh-ancestor
24680956|NCT01377246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24680957|NCT01377246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24680958|NCT01377246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680979|NCT01377324|Hormones|hormones|mesh-ancestor
24680980|NCT01377324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24680981|NCT01377324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462790|NCT00357604|Estrogens|estrogens|mesh-ancestor
24681169|NCT01378741|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24681170|NCT01378741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24681171|NCT01378741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681227|NCT01379001|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24908282|NCT04322240|Micronutrients|micronutrients|mesh-ancestor
24908284|NCT04321967|Vasodilator Agents|vasodilator agents|mesh-ancestor
24908290|NCT04321785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908291|NCT04321785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24908293|NCT04321785|Purinergic Agents|purinergic agents|mesh-ancestor
24908294|NCT04321785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24908295|NCT04321694|Mogamulizumab|mogamulizumab|mesh-list
24908296|NCT04321694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908297|NCT04321655|Ibuprofen|ibuprofen|mesh-list
24908298|NCT04321655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24908299|NCT04321655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24908300|NCT04321655|Analgesics|analgesics|mesh-ancestor
24547889|NCT00706277|Narcotics|narcotics|mesh-ancestor
24681228|NCT01379001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681229|NCT01379001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681230|NCT01379001|Cholinergic Agents|cholinergic agents|mesh-ancestor
24681231|NCT01379001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24681232|NCT01379001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681233|NCT01379001|Nootropic Agents|nootropic agents|mesh-ancestor
24681234|NCT01379001|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24681358|NCT01380015|Analgesics|analgesics|mesh-ancestor
24681359|NCT01380015|Sensory System Agents|sensory system agents|mesh-ancestor
24681360|NCT01380015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24681361|NCT01380015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681414|NCT01380353|Sensory System Agents|sensory system agents|mesh-ancestor
24681415|NCT01380353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24681416|NCT01380353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681417|NCT01380353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25703021|NCT02162719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681418|NCT01380353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24826063|NCT02132234|Infliximab|infliximab|mesh-list
24826064|NCT02132234|Certolizumab Pegol|certolizumab pegol|mesh-list
24826065|NCT02132234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24826066|NCT02132234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24681419|NCT01380353|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24681420|NCT01380353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681421|NCT01380353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681422|NCT01380431|Lisinopril|lisinopril|mesh-list
24628861|NCT01101685|Serotonin Agents|serotonin agents|mesh-ancestor
24681539|NCT01381055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681589|NCT01381354|Thiamine|thiamine|mesh-list
24681590|NCT01381354|Niacinamide|niacinamide|mesh-list
24681592|NCT01381354|Nicotinic Acids|nicotinic acids|mesh-list
24681593|NCT01381354|Acetylcarnitine|acetylcarnitine|mesh-list
24681594|NCT01381354|Ubiquinone|ubiquinone|mesh-list
24681595|NCT01381354|Acetylcysteine|acetylcysteine|mesh-list
24611296|NCT01008358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681596|NCT01381354|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
24681597|NCT01381354|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24681654|NCT01381497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24681655|NCT01381497|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24681656|NCT01381497|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24681723|NCT01381627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24611450|NCT01009541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24908443|NCT04320277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908475|NCT04319978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908477|NCT04320173|Anesthetics, Local|anesthetics, local|mesh-ancestor
24908478|NCT04320173|Anesthetics|anesthetics|mesh-ancestor
24908479|NCT04320173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24908480|NCT04320173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908481|NCT04320173|Sensory System Agents|sensory system agents|mesh-ancestor
24908482|NCT04320173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24742421|NCT05267938|Mydriatics|mydriatics|mesh-ancestor
24908558|NCT04319549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908559|NCT04319549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24908560|NCT04319549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24908561|NCT04319549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24908566|NCT04319289|Vitamin D|vitamin d|mesh-list
24908571|NCT04319289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908572|NCT04319289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24908573|NCT04319289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24908581|NCT04319419|Trace Elements|trace elements|mesh-list
24908582|NCT04319419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908583|NCT04318847|Ondansetron|ondansetron|mesh-list
24681724|NCT01381627|Analgesics|analgesics|mesh-ancestor
24681725|NCT01381627|Sensory System Agents|sensory system agents|mesh-ancestor
24681726|NCT01381627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24681727|NCT01381627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24681728|NCT01381627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24681913|NCT01382888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24681914|NCT01382888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24681915|NCT01382888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681916|NCT01382914|Chlorhexidine|chlorhexidine|mesh-list
24681917|NCT01382914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24681962|NCT01383330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681964|NCT01383343|Leucovorin|leucovorin|mesh-list
24681965|NCT01383343|Folic Acid|folic acid|mesh-list
24681966|NCT01383343|Bevacizumab|bevacizumab|mesh-list
24681967|NCT01383343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24681968|NCT01383343|Fluorouracil|fluorouracil|mesh-list
24681969|NCT01383343|Irinotecan|irinotecan|mesh-list
24681970|NCT01383343|Sorafenib|sorafenib|mesh-list
24681971|NCT01383343|Camptothecin|camptothecin|mesh-list
24681972|NCT01383343|Endothelial Growth Factors|endothelial growth factors|mesh-list
24681973|NCT01383343|Antibodies|antibodies|mesh-list
24681977|NCT01383343|Calcium|calcium|mesh-list
24682030|NCT01383460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682031|NCT01383460|Hematinics|hematinics|mesh-ancestor
24682032|NCT01383538|Leucovorin|leucovorin|mesh-list
24682033|NCT01383538|Oxaliplatin|oxaliplatin|mesh-list
25703022|NCT02162719|Tubulin Modulators|tubulin modulators|mesh-ancestor
25703023|NCT02162719|Antimitotic Agents|antimitotic agents|mesh-ancestor
25703024|NCT02162719|Mitosis Modulators|mitosis modulators|mesh-ancestor
25703025|NCT02162719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703026|NCT02162758|Dexlansoprazole|dexlansoprazole|mesh-list
24682034|NCT01383538|Irinotecan|irinotecan|mesh-list
25703027|NCT02162758|Lansoprazole|lansoprazole|mesh-list
25703028|NCT02162758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24826109|NCT02132416|Acetaminophen|acetaminophen|mesh-list
24682035|NCT01383538|Folfirinox|folfirinox|mesh-list
24682036|NCT01383538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24682037|NCT01383538|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24682038|NCT01383538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24682039|NCT01383538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682040|NCT01383538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682041|NCT01383538|Antidotes|antidotes|mesh-ancestor
24682042|NCT01383538|Protective Agents|protective agents|mesh-ancestor
24682193|NCT01384682|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24682195|NCT01384682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24682241|NCT01384994|Immunologic Factors|immunologic factors|mesh-ancestor
24908606|NCT04318444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908607|NCT04318444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24682242|NCT01384994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682243|NCT01384994|Hematinics|hematinics|mesh-ancestor
24682244|NCT01384994|Vitamins|vitamins|mesh-ancestor
24682245|NCT01384994|Micronutrients|micronutrients|mesh-ancestor
24682246|NCT01384994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24682247|NCT01385020|Gemfibrozil|gemfibrozil|mesh-list
24682248|NCT01385020|Red yeast rice|red yeast rice|mesh-list
24682249|NCT01385020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24682250|NCT01385020|Antimetabolites|antimetabolites|mesh-ancestor
24682251|NCT01385020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682252|NCT01385020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24611333|NCT01008631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24611334|NCT01008631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24611335|NCT01008631|Chelating Agents|chelating agents|mesh-ancestor
24611336|NCT01008631|Sequestering Agents|sequestering agents|mesh-ancestor
24611337|NCT01008709|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24611338|NCT01008709|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
24611340|NCT01008709|Hormones|hormones|mesh-ancestor
24611341|NCT01008709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24611342|NCT01008709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611343|NCT01008709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24611344|NCT01008709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611345|NCT01008761|Azithromycin|azithromycin|mesh-list
24611346|NCT01008761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24682410|NCT01386255|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24682411|NCT01386255|GABA Agonists|gaba agonists|mesh-ancestor
24682412|NCT01386255|GABA Agents|gaba agents|mesh-ancestor
24682413|NCT01386255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24682414|NCT01386255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682415|NCT01386268|Factor VIII|factor viii|mesh-list
24682416|NCT01386268|Coagulants|coagulants|mesh-ancestor
24682417|NCT01386294|Tenofovir|tenofovir|mesh-list
24682418|NCT01386294|Antiviral Agents|antiviral agents|mesh-ancestor
24682419|NCT01386294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24682475|NCT01386567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24466989|NCT00375895|Cyclosporine|cyclosporine|mesh-list
24682476|NCT01386567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24682477|NCT01386567|Anabolic Agents|anabolic agents|mesh-ancestor
24682478|NCT01386567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24682479|NCT01386567|Hormone Antagonists|hormone antagonists|mesh-ancestor
25703029|NCT02162758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25703030|NCT02162758|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25703031|NCT02162758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703032|NCT02162758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703033|NCT02162771|Prednisone|prednisone|mesh-list
25703034|NCT02162771|Prednisolone|prednisolone|mesh-list
25703035|NCT02162771|Cyclophosphamide|cyclophosphamide|mesh-list
25703036|NCT02162771|Rituximab|rituximab|mesh-list
25703037|NCT02162771|Vincristine|vincristine|mesh-list
25703038|NCT02162771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25703039|NCT02162771|Immunologic Factors|immunologic factors|mesh-ancestor
25703040|NCT02162771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703041|NCT02162771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24826123|NCT02132416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24826124|NCT02132416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24826125|NCT02132416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24682521|NCT01386593|Hormone Antagonists|hormone antagonists|mesh-ancestor
24682522|NCT01386593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24682523|NCT01386593|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24682524|NCT01386593|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24742553|NCT05225402|Norepinephrine|norepinephrine|mesh-list
24682528|NCT01386593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24682529|NCT01386593|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24682530|NCT01386593|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24682531|NCT01386593|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24682532|NCT01386593|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24682533|NCT01386593|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24682534|NCT01386593|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24682536|NCT01386658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24682537|NCT01386658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24682539|NCT01386658|Sensory System Agents|sensory system agents|mesh-ancestor
24682572|NCT01386853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682573|NCT01386853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24682577|NCT01386866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24682578|NCT01386866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682579|NCT01386866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682580|NCT01386879|Methylene Blue|methylene blue|mesh-list
24682581|NCT01386879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24629140|NCT01103401|Tobramycin|tobramycin|mesh-list
24682641|NCT01387295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24682754|NCT01388322|Enoxaparin|enoxaparin|mesh-list
24682805|NCT01388582|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24682806|NCT01388582|Progestins|progestins|mesh-ancestor
24682807|NCT01388582|Hormones|hormones|mesh-ancestor
24682808|NCT01388582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24682809|NCT01388595|Fluticasone|fluticasone|mesh-list
24682810|NCT01388595|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24682811|NCT01388595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24682812|NCT01388595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24682813|NCT01388595|Autonomic Agents|autonomic agents|mesh-ancestor
24682814|NCT01388595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24682815|NCT01388595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682816|NCT01388595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24818894|NCT02091505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24818895|NCT02091505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24908995|NCT04313907|Clonazepam|clonazepam|mesh-list
24908996|NCT04313907|Anticonvulsants|anticonvulsants|mesh-ancestor
24682817|NCT01388595|Respiratory System Agents|respiratory system agents|mesh-ancestor
24682818|NCT01388595|Dermatologic Agents|dermatologic agents|mesh-ancestor
24682819|NCT01388595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24682820|NCT01388595|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24611376|NCT01009021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24611377|NCT01009021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24611378|NCT01009021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611379|NCT01009021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703042|NCT02162771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25703043|NCT02162771|Alkylating Agents|alkylating agents|mesh-ancestor
25703044|NCT02162771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703045|NCT02162771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25703046|NCT02162771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25703047|NCT02162771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25703048|NCT02162771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25703049|NCT02162771|Glucocorticoids|glucocorticoids|mesh-ancestor
25703050|NCT02162771|Hormones|hormones|mesh-ancestor
25703051|NCT02162771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24682854|NCT01388738|Cerebrolysin|cerebrolysin|mesh-list
24682855|NCT01388738|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
24682856|NCT01388738|Nootropic Agents|nootropic agents|mesh-ancestor
24611381|NCT01009073|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24611382|NCT01009073|Navitoclax|navitoclax|mesh-list
24611383|NCT01009073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24611384|NCT01009073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24611385|NCT01009073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611451|NCT01009567|Cabergoline|cabergoline|mesh-list
24611393|NCT01009190|Carboplatin|carboplatin|mesh-list
24611394|NCT01009190|Rucaparib|rucaparib|mesh-list
24611395|NCT01009190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611396|NCT01009190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24611397|NCT01009190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682858|NCT01388738|Protective Agents|protective agents|mesh-ancestor
24683657|NCT01393340|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24682859|NCT01388738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682860|NCT01388842|Nitric Oxide|nitric oxide|mesh-list
24682861|NCT01388842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24682862|NCT01388842|Autonomic Agents|autonomic agents|mesh-ancestor
24404598|NCT00164125|Laxatives|laxatives|mesh-ancestor
24682863|NCT01388842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24682864|NCT01388842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682865|NCT01388842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24682866|NCT01388842|Respiratory System Agents|respiratory system agents|mesh-ancestor
24682867|NCT01388842|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24682868|NCT01388842|Antioxidants|antioxidants|mesh-ancestor
24682869|NCT01388842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682870|NCT01388842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24682871|NCT01388842|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24682872|NCT01388842|Vasodilator Agents|vasodilator agents|mesh-ancestor
24682918|NCT01389193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682919|NCT01389193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24682920|NCT01389193|Vasodilator Agents|vasodilator agents|mesh-ancestor
24682921|NCT01389206|Bosentan|bosentan|mesh-list
24682922|NCT01389206|Selexipag|selexipag|mesh-list
24682923|NCT01389206|Iloprost|iloprost|mesh-list
24682924|NCT01389206|Macitentan|macitentan|mesh-list
24682925|NCT01389206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24682926|NCT01389206|Vasodilator Agents|vasodilator agents|mesh-ancestor
24682927|NCT01389206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24682928|NCT01389206|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24682929|NCT01389206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682930|NCT01389206|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
24682931|NCT01389206|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
24682933|NCT01389271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24682934|NCT01389271|Vasodilator Agents|vasodilator agents|mesh-ancestor
24682935|NCT01389388|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24682936|NCT01389388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24682937|NCT01389388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24682939|NCT01389388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682940|NCT01389388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24908997|NCT04313907|GABA Modulators|gaba modulators|mesh-ancestor
24908998|NCT04313907|GABA Agents|gaba agents|mesh-ancestor
24908999|NCT04313907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25703052|NCT02162771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25703053|NCT02162771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25703054|NCT02162771|Tubulin Modulators|tubulin modulators|mesh-ancestor
25703055|NCT02162771|Antimitotic Agents|antimitotic agents|mesh-ancestor
25703056|NCT02162771|Mitosis Modulators|mitosis modulators|mesh-ancestor
25703057|NCT02162862|Bupropion|bupropion|mesh-list
25703058|NCT02162862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25703059|NCT02162862|Antidepressive Agents|antidepressive agents|mesh-ancestor
24826251|NCT02133638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24826252|NCT02133638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25703060|NCT02162862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25703061|NCT02162862|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25703062|NCT02162862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25703063|NCT02162862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24826253|NCT02133638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826254|NCT02133638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24826255|NCT02133638|Anesthetics, General|anesthetics, general|mesh-ancestor
24909000|NCT04313907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909001|NCT04313907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909002|NCT04313790|Heparin|heparin|mesh-list
24909003|NCT04313790|Calcium heparin|calcium heparin|mesh-list
24909004|NCT04313790|Anticoagulants|anticoagulants|mesh-ancestor
24909005|NCT04313790|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24909035|NCT04313270|Evolocumab|evolocumab|mesh-list
24909036|NCT04313270|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24787166|NCT01923909|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24787167|NCT01923909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24787168|NCT01923935|Melphalan|melphalan|mesh-list
24787169|NCT01923935|Busulfan|busulfan|mesh-list
24787170|NCT01923935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24787171|NCT01923935|Alkylating Agents|alkylating agents|mesh-ancestor
24550676|NCT00721604|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24787172|NCT01923935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787173|NCT01923935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787174|NCT01923935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24909052|NCT04313374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24682941|NCT01389388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24682953|NCT01389414|Antimetabolites|antimetabolites|mesh-ancestor
24682954|NCT01389414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682955|NCT01389414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24682956|NCT01389414|Antiviral Agents|antiviral agents|mesh-ancestor
24682957|NCT01389414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24682963|NCT01389427|Sirolimus|sirolimus|mesh-list
24683015|NCT01389505|Growth Inhibitors|growth inhibitors|mesh-ancestor
24683017|NCT01389544|Methadone|methadone|mesh-list
24683018|NCT01389544|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24683019|NCT01389544|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24683020|NCT01389544|Protease Inhibitors|protease inhibitors|mesh-ancestor
24683021|NCT01389544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683022|NCT01389544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683023|NCT01389544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24683024|NCT01389544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24683025|NCT01389544|Antiviral Agents|antiviral agents|mesh-ancestor
24683026|NCT01389544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24683027|NCT01389544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24683030|NCT01389544|Narcotics|narcotics|mesh-ancestor
24683067|NCT01389713|Luteolytic Agents|luteolytic agents|mesh-ancestor
24683086|NCT01389791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24909054|NCT04313374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24909055|NCT04313374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909080|NCT04312880|Tranexamic Acid|tranexamic acid|mesh-list
24909081|NCT04312880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24909082|NCT04312880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24909083|NCT04312880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703064|NCT02162862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703065|NCT02162862|Dopamine Agents|dopamine agents|mesh-ancestor
25703066|NCT02162862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25703067|NCT02162862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703068|NCT02162862|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25703069|NCT02162862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25703070|NCT02162862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703071|NCT02163421|Vedolizumab|vedolizumab|mesh-list
25703072|NCT02163421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25703073|NCT02163434|Gabapentin|gabapentin|mesh-list
25703074|NCT02163434|Metoclopramide|metoclopramide|mesh-list
25703075|NCT02163434|Analgesics|analgesics|mesh-ancestor
25703076|NCT02163434|Sensory System Agents|sensory system agents|mesh-ancestor
25703077|NCT02163434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25109217|NCT03126708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109218|NCT03126708|Tubulin Modulators|tubulin modulators|mesh-ancestor
25109219|NCT03126708|Antimitotic Agents|antimitotic agents|mesh-ancestor
25109220|NCT03126708|Mitosis Modulators|mitosis modulators|mesh-ancestor
24618348|NCT01047995|Ritonavir|ritonavir|mesh-list
24909092|NCT04312841|Letermovir|letermovir|mesh-list
24909093|NCT04312841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24909094|NCT04312841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24909095|NCT04312841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24909096|NCT04312841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909097|NCT04312841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24909098|NCT04312841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24909099|NCT04312841|Antiviral Agents|antiviral agents|mesh-ancestor
24909100|NCT04312750|Lidocaine|lidocaine|mesh-list
24909101|NCT04312750|Anesthetics, Local|anesthetics, local|mesh-ancestor
24909128|NCT04312243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24909129|NCT04312243|Autonomic Agents|autonomic agents|mesh-ancestor
24909130|NCT04312243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24683087|NCT01389791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24683088|NCT01389791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683089|NCT01389791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24683090|NCT01389791|Tocolytic Agents|tocolytic agents|mesh-ancestor
24683116|NCT01390012|Autonomic Agents|autonomic agents|mesh-ancestor
24683117|NCT01390012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24683118|NCT01390012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683119|NCT01390012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24683120|NCT01390012|Glucocorticoids|glucocorticoids|mesh-ancestor
24683122|NCT01390012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24683123|NCT01390012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24683124|NCT01390012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24683125|NCT01390012|Protease Inhibitors|protease inhibitors|mesh-ancestor
24683126|NCT01390012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683127|NCT01390012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683128|NCT01390051|Tinzaparin|tinzaparin|mesh-list
24683129|NCT01390051|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24683130|NCT01390051|Dalteparin|dalteparin|mesh-list
24683131|NCT01390051|Anticoagulants|anticoagulants|mesh-ancestor
24683132|NCT01390051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24683171|NCT01390337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24629405|NCT01105013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683172|NCT01390337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24909131|NCT04312243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909132|NCT04312243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24909133|NCT04312243|Respiratory System Agents|respiratory system agents|mesh-ancestor
24909134|NCT04312243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24909136|NCT04312243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909137|NCT04312243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24909373|NCT04310293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24909375|NCT04309929|Analgesics|analgesics|mesh-list
24909376|NCT04309929|Sensory System Agents|sensory system agents|mesh-ancestor
24909377|NCT04309929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24909378|NCT04309929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909401|NCT04309708|Vasodilator Agents|vasodilator agents|mesh-ancestor
24909402|NCT04309578|Capecitabine|capecitabine|mesh-list
25090171|NCT03259919|Metformin|metformin|mesh-list
24683173|NCT01390337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24683174|NCT01390337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683175|NCT01390480|Cholecalciferol|cholecalciferol|mesh-list
24683176|NCT01390480|Vitamin D|vitamin d|mesh-list
24683177|NCT01390480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24683818|NCT01394354|Hormones|hormones|mesh-ancestor
24683178|NCT01390480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683179|NCT01390480|Vitamins|vitamins|mesh-ancestor
24683180|NCT01390480|Micronutrients|micronutrients|mesh-ancestor
24683181|NCT01390480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25703078|NCT02163434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703079|NCT02163434|Anticonvulsants|anticonvulsants|mesh-ancestor
25703080|NCT02163434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24683182|NCT01390506|Selenious Acid|selenious acid|mesh-list
24683183|NCT01390506|Sodium Selenite|sodium selenite|mesh-list
24683184|NCT01390506|Trace Elements|trace elements|mesh-ancestor
24683185|NCT01390506|Micronutrients|micronutrients|mesh-ancestor
24683186|NCT01390506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683187|NCT01390519|Everolimus|everolimus|mesh-list
24683188|NCT01390519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24683189|NCT01390519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24683202|NCT01390623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24683203|NCT01390662|Vitamin D|vitamin d|mesh-list
24683204|NCT01390662|Cholecalciferol|cholecalciferol|mesh-list
24683205|NCT01390662|Vitamins|vitamins|mesh-ancestor
24683206|NCT01390662|Micronutrients|micronutrients|mesh-ancestor
24683210|NCT01390766|Azathioprine|azathioprine|mesh-list
24683211|NCT01390766|Antimetabolites|antimetabolites|mesh-ancestor
24683212|NCT01390766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683213|NCT01390766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24683214|NCT01390766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633714|NCT01130909|Anesthetics|anesthetics|mesh-ancestor
24683215|NCT01390766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24683335|NCT01391377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24683387|NCT01391715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24683388|NCT01391715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24683389|NCT01391715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24683390|NCT01391715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683391|NCT01391715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683392|NCT01391845|Ulipristal acetate|ulipristal acetate|mesh-list
24683393|NCT01391845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24683394|NCT01391845|Contraceptive Agents|contraceptive agents|mesh-ancestor
24683395|NCT01391845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24683396|NCT01391845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683397|NCT01391845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24683398|NCT01392014|Piperaquine|piperaquine|mesh-list
24683399|NCT01392014|Primaquine|primaquine|mesh-list
24683400|NCT01392014|Artenimol|artenimol|mesh-list
24683401|NCT01392014|Artemisinins|artemisinins|mesh-list
24683448|NCT01392287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683449|NCT01392287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909403|NCT04309578|Trastuzumab|trastuzumab|mesh-list
24909404|NCT04309578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24909405|NCT04309578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24909406|NCT04309578|Antimetabolites|antimetabolites|mesh-ancestor
24909407|NCT04309578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909408|NCT04309578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24909409|NCT04309357|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24909410|NCT04309357|Plasminogen|plasminogen|mesh-list
24909411|NCT04309357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24909412|NCT04309357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24909413|NCT04309357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683450|NCT01392287|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24683451|NCT01392287|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24683454|NCT01392430|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24683498|NCT01392638|Urological Agents|urological agents|mesh-ancestor
24394880|NCT00134498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24683499|NCT01392716|Rituximab|rituximab|mesh-list
24683500|NCT01392716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24611455|NCT01009567|Dopamine Agents|dopamine agents|mesh-ancestor
24683508|NCT01392755|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
24683509|NCT01392755|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24683510|NCT01392755|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24683531|NCT01392794|Ramosetron|ramosetron|mesh-list
24683546|NCT01392833|Prednisone|prednisone|mesh-list
24683547|NCT01392833|Methylprednisolone|methylprednisolone|mesh-list
24683548|NCT01392833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24683549|NCT01392833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24683550|NCT01392833|Prednisolone|prednisolone|mesh-list
24683551|NCT01392833|Prednisolone acetate|prednisolone acetate|mesh-list
24683552|NCT01392833|Azathioprine|azathioprine|mesh-list
24683553|NCT01392833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24629464|NCT01105390|Rilotumumab|rilotumumab|mesh-list
24683653|NCT01393288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24683654|NCT01393288|GABA Modulators|gaba modulators|mesh-ancestor
24683655|NCT01393288|GABA Agents|gaba agents|mesh-ancestor
24683656|NCT01393340|Omalizumab|omalizumab|mesh-list
24683658|NCT01393340|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24683659|NCT01393340|Respiratory System Agents|respiratory system agents|mesh-ancestor
24611433|NCT01009502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24611435|NCT01009502|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24611436|NCT01009502|Anthelmintics|anthelmintics|mesh-ancestor
24611437|NCT01009541|Pregabalin|pregabalin|mesh-list
25703081|NCT02163434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24611438|NCT01009541|Analgesics|analgesics|mesh-ancestor
24611439|NCT01009541|Sensory System Agents|sensory system agents|mesh-ancestor
24611440|NCT01009541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24611441|NCT01009541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611442|NCT01009541|Anticonvulsants|anticonvulsants|mesh-ancestor
24611443|NCT01009541|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24611444|NCT01009541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24611445|NCT01009541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909415|NCT04309240|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24909416|NCT04309240|Antithrombins|antithrombins|mesh-ancestor
24909417|NCT04309240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24909499|NCT04308343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24909500|NCT04308343|Hormone Antagonists|hormone antagonists|mesh-ancestor
24909501|NCT04308343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24909502|NCT04308343|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24909503|NCT04308343|Fertility Agents|fertility agents|mesh-ancestor
24909505|NCT04308174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24909527|NCT04308031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24909528|NCT04308031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909529|NCT04308031|Protective Agents|protective agents|mesh-ancestor
24909530|NCT04308031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909531|NCT04308070|Hemostatics|hemostatics|mesh-list
24909532|NCT04308070|Coagulants|coagulants|mesh-ancestor
24909533|NCT04307693|Ritonavir|ritonavir|mesh-list
24909534|NCT04307693|Lopinavir|lopinavir|mesh-list
24909535|NCT04307693|Hydroxychloroquine|hydroxychloroquine|mesh-list
24909536|NCT04307693|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24909537|NCT04307693|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24909538|NCT04307693|Protease Inhibitors|protease inhibitors|mesh-ancestor
24909539|NCT04307693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24909540|NCT04307693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909541|NCT04307693|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24909542|NCT04307693|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24909543|NCT04307693|Antiviral Agents|antiviral agents|mesh-ancestor
24909544|NCT04307693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24909846|NCT04304157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24611446|NCT01009541|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24611447|NCT01009541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24611448|NCT01009541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24611449|NCT01009541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24683717|NCT01393756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683718|NCT01393756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24683719|NCT01393756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24683793|NCT01394133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24683802|NCT01394341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683804|NCT01394341|Hormones|hormones|mesh-ancestor
24683805|NCT01394341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24683806|NCT01394354|Dexamethasone|dexamethasone|mesh-list
24683807|NCT01394354|Dexamethasone acetate|dexamethasone acetate|mesh-list
24484522|NCT00448981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24909880|NCT04304248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24909881|NCT04304248|Tubulin Modulators|tubulin modulators|mesh-ancestor
24909882|NCT04304248|Antimitotic Agents|antimitotic agents|mesh-ancestor
24909883|NCT04304248|Mitosis Modulators|mitosis modulators|mesh-ancestor
25090224|NCT03259516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683808|NCT01394354|Doxorubicin|doxorubicin|mesh-list
24683809|NCT01394354|Bortezomib|bortezomib|mesh-list
24683810|NCT01394354|Vorinostat|vorinostat|mesh-list
24683811|NCT01394354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24683812|NCT01394354|Antiemetics|antiemetics|mesh-ancestor
24683813|NCT01394354|Autonomic Agents|autonomic agents|mesh-ancestor
24683814|NCT01394354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24395895|NCT00137098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396208|NCT00138138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396209|NCT00138138|Dopamine Agents|dopamine agents|mesh-ancestor
24396210|NCT00138138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24683815|NCT01394354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683816|NCT01394354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25703082|NCT02163434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24683817|NCT01394354|Glucocorticoids|glucocorticoids|mesh-ancestor
24683819|NCT01394354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25703083|NCT02163434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24683820|NCT01394354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24683924|NCT01394757|Esketamine|esketamine|mesh-list
24683925|NCT01394757|Analgesics|analgesics|mesh-ancestor
24683926|NCT01394757|Sensory System Agents|sensory system agents|mesh-ancestor
24683927|NCT01394757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24683930|NCT01394757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24468624|NCT00382421|Autonomic Agents|autonomic agents|mesh-ancestor
24468625|NCT00382421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24683962|NCT01394835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683963|NCT01394835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683964|NCT01394848|Everolimus|everolimus|mesh-list
24683965|NCT01394848|Clopidogrel|clopidogrel|mesh-list
24683966|NCT01394848|Atorvastatin|atorvastatin|mesh-list
24683967|NCT01394848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24683968|NCT01394848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24683969|NCT01394848|Antimetabolites|antimetabolites|mesh-ancestor
24683970|NCT01394848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683971|NCT01394848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24683972|NCT01394848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24683973|NCT01394848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683974|NCT01394848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24683984|NCT01394887|Metformin|metformin|mesh-list
24684017|NCT01395147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24684071|NCT01395433|Dexetimide|dexetimide|mesh-list
24684075|NCT01395433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24396211|NCT00138164|Denileukin diftitox|denileukin diftitox|mesh-list
24396212|NCT00138164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684076|NCT01395433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684077|NCT01395433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24684078|NCT01395433|Serotonin Agents|serotonin agents|mesh-ancestor
24684079|NCT01395433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611489|NCT01009801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684288|NCT01396655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24684289|NCT01396655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611516|NCT01009892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24684291|NCT01396668|Capecitabine|capecitabine|mesh-list
24684292|NCT01396668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684293|NCT01396668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24684294|NCT01396668|Antimetabolites|antimetabolites|mesh-ancestor
24684295|NCT01396668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684296|NCT01396668|Antiviral Agents|antiviral agents|mesh-ancestor
24684297|NCT01396668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24684298|NCT01396668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24551538|NCT05373264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551549|NCT05373134|Pentoxifylline|pentoxifylline|mesh-list
24551550|NCT05373134|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24909943|NCT04303819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24396378|NCT00138866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24909944|NCT04303767|Calcium|calcium|mesh-list
24909945|NCT04303767|Caseins|caseins|mesh-list
24909946|NCT04303767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25090230|NCT03259516|Dermatologic Agents|dermatologic agents|mesh-ancestor
24684307|NCT01396681|Antiviral Agents|antiviral agents|mesh-ancestor
24684308|NCT01396681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24684309|NCT01396681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24684310|NCT01396681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24629651|NCT01107054|Moxifloxacin|moxifloxacin|mesh-list
24684381|NCT01397175|Everolimus|everolimus|mesh-list
24684382|NCT01397175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684383|NCT01397175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24684384|NCT01397175|Immunologic Factors|immunologic factors|mesh-ancestor
24684385|NCT01397175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684386|NCT01397214|Megestrol Acetate|megestrol acetate|mesh-list
24684387|NCT01397214|Megestrol|megestrol|mesh-list
24684388|NCT01397214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24684389|NCT01397214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684390|NCT01397214|Appetite Stimulants|appetite stimulants|mesh-ancestor
24684391|NCT01397214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24684392|NCT01397214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684400|NCT01397305|Pemetrexed|pemetrexed|mesh-list
25703084|NCT02163434|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25703085|NCT02163434|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24684430|NCT05268718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24684431|NCT05268718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24684433|NCT05268718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24640164|NCT01166477|Ritonavir|ritonavir|mesh-list
24909947|NCT04303767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909948|NCT04303767|Chelating Agents|chelating agents|mesh-ancestor
24909949|NCT04303767|Sequestering Agents|sequestering agents|mesh-ancestor
24407518|NCT00174655|Docetaxel|docetaxel|mesh-list
24485018|NCT00451113|Protease Inhibitors|protease inhibitors|mesh-ancestor
24485019|NCT00451113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485020|NCT00451113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485021|NCT00451139|Lumefantrine|lumefantrine|mesh-list
24485023|NCT00451139|Quinine|quinine|mesh-list
24684602|NCT04975269|Anticonvulsants|anticonvulsants|mesh-ancestor
24684603|NCT04975269|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24684604|NCT04975269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24629720|NCT01107431|Chromium|chromium|mesh-list
24684738|NCT04500756|Metformin|metformin|mesh-list
24684739|NCT04500756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24684750|NCT04466540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24684751|NCT04466540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684752|NCT04466540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24684753|NCT04453449|Midazolam|midazolam|mesh-list
24684754|NCT04453449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24684755|NCT04453449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24684756|NCT04453449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24684757|NCT04453449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684758|NCT04453449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24684815|NCT03982693|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24684816|NCT03982693|Chelating Agents|chelating agents|mesh-ancestor
24684817|NCT03982693|Sequestering Agents|sequestering agents|mesh-ancestor
24684818|NCT03982693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684819|NCT03982693|Antidotes|antidotes|mesh-ancestor
24684820|NCT03982693|Protective Agents|protective agents|mesh-ancestor
24684821|NCT03982693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396728|NCT00139815|PENTA|penta|mesh-list
24684822|NCT03982693|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24684823|NCT03937713|Eszopiclone|eszopiclone|mesh-list
24684824|NCT03937713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24684825|NCT03937713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24684826|NCT03937713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684827|NCT03817502|Cariprazine|cariprazine|mesh-list
24684828|NCT03817502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24684829|NCT03817502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24684830|NCT03817502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24684831|NCT03817502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684832|NCT03817502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24485025|NCT00451139|Proguanil|proguanil|mesh-list
24485026|NCT00451139|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24485027|NCT00451139|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
24485028|NCT00451139|Antimalarials|antimalarials|mesh-ancestor
24485029|NCT00451139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24485030|NCT00451139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24485031|NCT00451139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24485032|NCT00451139|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24485033|NCT00451139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684848|NCT03580473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24684849|NCT03580473|Antiemetics|antiemetics|mesh-ancestor
24684850|NCT03580473|Autonomic Agents|autonomic agents|mesh-ancestor
24684851|NCT03580473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24684852|NCT03580473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684853|NCT03580473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24684854|NCT03580473|Glucocorticoids|glucocorticoids|mesh-ancestor
24684855|NCT03580473|Hormones|hormones|mesh-ancestor
24684856|NCT03580473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24684857|NCT03580473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24485034|NCT00451139|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24485035|NCT00451139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24910559|NCT04296695|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24910560|NCT04296214|Azacitidine|azacitidine|mesh-list
24910561|NCT04296214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25703086|NCT02163434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24485326|NCT00452582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24485327|NCT00452582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24485328|NCT00452582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485329|NCT00452582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485330|NCT00452582|Urological Agents|urological agents|mesh-ancestor
24685102|NCT02215122|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24685140|NCT01798004|Cyclophosphamide|cyclophosphamide|mesh-list
24629912|NCT01108601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24397691|NCT00142337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24685419|NCT05272930|Hormone Antagonists|hormone antagonists|mesh-ancestor
24685420|NCT05272930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24685421|NCT05272930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24685422|NCT05272930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24685444|NCT05272696|Paclitaxel|paclitaxel|mesh-list
24685445|NCT05272696|Pembrolizumab|pembrolizumab|mesh-list
24685446|NCT05272696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24685453|NCT05272462|Minoxidil|minoxidil|mesh-list
24685576|NCT05270967|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24685577|NCT05270967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685578|NCT05270434|Dipyrone|dipyrone|mesh-list
24685619|NCT05270018|Broncho-Vaxom|broncho-vaxom|mesh-list
24685620|NCT05270018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24685621|NCT05270018|Immunologic Factors|immunologic factors|mesh-ancestor
24685622|NCT05270018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685623|NCT05269654|Mannitol|mannitol|mesh-list
24685624|NCT05269654|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24685625|NCT05269654|Diuretics|diuretics|mesh-ancestor
24685626|NCT05269654|Natriuretic Agents|natriuretic agents|mesh-ancestor
24685627|NCT05269654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685628|NCT05269459|Cannabidiol|cannabidiol|mesh-list
24685629|NCT05269459|Anticonvulsants|anticonvulsants|mesh-ancestor
24470376|NCT00389987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24685630|NCT05253846|Fluorouracil|fluorouracil|mesh-list
24685631|NCT05253846|Oxaliplatin|oxaliplatin|mesh-list
24685632|NCT05253846|Irinotecan|irinotecan|mesh-list
24685633|NCT05253846|Antimetabolites|antimetabolites|mesh-ancestor
24485354|NCT00452634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485355|NCT00452634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24485356|NCT00452634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24485357|NCT00452634|Antimetabolites|antimetabolites|mesh-ancestor
24485358|NCT00452634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24485359|NCT00452634|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24485360|NCT00452660|Deferasirox|deferasirox|mesh-list
24485361|NCT00452660|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24485362|NCT00452660|Chelating Agents|chelating agents|mesh-ancestor
24485363|NCT00452660|Sequestering Agents|sequestering agents|mesh-ancestor
24485364|NCT00452660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485366|NCT00452725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24485401|NCT00452894|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24485402|NCT00452894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24910956|NCT04292704|Antifungal Agents|antifungal agents|mesh-ancestor
24910957|NCT04292704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24910958|NCT04292704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24910959|NCT04292704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24910960|NCT04292704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910961|NCT04292704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24910962|NCT04292704|Hormone Antagonists|hormone antagonists|mesh-ancestor
24910963|NCT04292704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24910964|NCT04292704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090274|NCT03259152|Denosumab|denosumab|mesh-list
24685634|NCT05253846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685635|NCT05253846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24685677|NCT05248724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24685678|NCT05248724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24685679|NCT05248724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24685680|NCT05248724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24685681|NCT05248724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24685730|NCT05233982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24685731|NCT05232006|Niraparib|niraparib|mesh-list
25407401|NCT03504410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24826593|NCT02135263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24685732|NCT05232006|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24685733|NCT05232006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24685734|NCT05232006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911041|NCT04291287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911045|NCT04291313|Vitamins|vitamins|mesh-list
24911046|NCT04291313|Micronutrients|micronutrients|mesh-ancestor
24911047|NCT04291313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911082|NCT04290936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24911083|NCT04290936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24911084|NCT04290871|Nitric Oxide|nitric oxide|mesh-list
24911085|NCT04290871|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24911322|NCT04289792|Tubulin Modulators|tubulin modulators|mesh-ancestor
25090301|NCT03259243|Sensory System Agents|sensory system agents|mesh-ancestor
25090302|NCT03259243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25090303|NCT03258684|Ascorbic Acid|ascorbic acid|mesh-list
25090304|NCT03258684|Thiamine|thiamine|mesh-list
24685773|NCT05209841|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24685774|NCT05209841|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24629952|NCT01108848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24685932|NCT05138029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685933|NCT05138029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24685934|NCT05138029|Glucocorticoids|glucocorticoids|mesh-ancestor
24685935|NCT05138029|Hormones|hormones|mesh-ancestor
24685938|NCT05138029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24685979|NCT05124977|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24686028|NCT05075122|Pembrolizumab|pembrolizumab|mesh-list
24686029|NCT05075122|Sargramostim|sargramostim|mesh-list
24686030|NCT05075122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24686031|NCT05075122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24686032|NCT05075122|Immunologic Factors|immunologic factors|mesh-ancestor
24611612|NCT01010087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611613|NCT01010100|Acarbose|acarbose|mesh-list
24611614|NCT01010100|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24611615|NCT01010100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611616|NCT01010100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611617|NCT01010100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24686099|NCT05052528|Immunoglobulins|immunoglobulins|mesh-list
24686100|NCT05052528|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24686101|NCT05052528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24686102|NCT05052528|Immunologic Factors|immunologic factors|mesh-ancestor
24686103|NCT05052528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686104|NCT05052528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24911357|NCT04289194|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24911360|NCT04289207|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24911361|NCT04289207|Hormone Antagonists|hormone antagonists|mesh-ancestor
24911390|NCT04288700|Captopril|captopril|mesh-list
24911391|NCT04288700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24911392|NCT04288700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24911561|NCT04286503|Protease Inhibitors|protease inhibitors|mesh-ancestor
24486170|NCT00456716|Sorafenib|sorafenib|mesh-list
24911809|NCT04284007|Dexamethasone|dexamethasone|mesh-list
24911810|NCT04284007|Dexamethasone acetate|dexamethasone acetate|mesh-list
24911843|NCT04283630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911845|NCT04283630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911846|NCT04283630|Protective Agents|protective agents|mesh-ancestor
24911848|NCT04283487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24911849|NCT04283331|Proxymetacaine|proxymetacaine|mesh-list
24911850|NCT04283331|Propoxycaine|propoxycaine|mesh-list
24911851|NCT04283331|Anesthetics, Local|anesthetics, local|mesh-ancestor
24911886|NCT04283526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911888|NCT04283526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24687734|NCT03758170|Autonomic Agents|autonomic agents|mesh-ancestor
24911889|NCT04283526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24911925|NCT04282824|Anticoagulants|anticoagulants|mesh-ancestor
24911926|NCT04282824|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24911927|NCT04282824|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24911928|NCT04283058|Ketamine|ketamine|mesh-list
24911929|NCT04283058|Anesthetics|anesthetics|mesh-list
25703087|NCT02163434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911930|NCT04283058|Analgesics|analgesics|mesh-ancestor
25109255|NCT03126461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109256|NCT03126188|Sertraline|sertraline|mesh-list
24912014|NCT04281862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407402|NCT03504397|Leucovorin|leucovorin|mesh-list
24826597|NCT02135263|Dopamine Agents|dopamine agents|mesh-ancestor
24826598|NCT02135263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24709831|NCT01507311|Liraglutide|liraglutide|mesh-list
24912046|NCT04281576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912047|NCT04281576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912048|NCT04281576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24912049|NCT04281706|Propofol|propofol|mesh-list
24912050|NCT04281706|Etomidate|etomidate|mesh-list
24912051|NCT04281706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24912052|NCT04281706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24912053|NCT04281706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912054|NCT04281706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24887725|NCT04513340|Levodopa|levodopa|mesh-list
24551957|NCT04426240|Cyclosporine|cyclosporine|mesh-list
24912055|NCT04281706|Anesthetics, General|anesthetics, general|mesh-ancestor
24912089|NCT04281342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24686105|NCT05052528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24686106|NCT05052528|Alkylating Agents|alkylating agents|mesh-ancestor
24399148|NCT00146718|Amodiaquine|amodiaquine|mesh-list
24399149|NCT00146718|Antimalarials|antimalarials|mesh-ancestor
24630046|NCT01109134|Tirofiban|tirofiban|mesh-list
24686286|NCT04918823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405597|NCT00167739|Pyrimethamine|pyrimethamine|mesh-list
24686327|NCT04896645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24686328|NCT04896645|Autonomic Agents|autonomic agents|mesh-ancestor
24686329|NCT04896645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24686330|NCT04896645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686331|NCT04896645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24686332|NCT04896645|Respiratory System Agents|respiratory system agents|mesh-ancestor
24686333|NCT04896645|Tocolytic Agents|tocolytic agents|mesh-ancestor
24686334|NCT04896645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24686335|NCT04896645|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24686336|NCT04896645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24686337|NCT04896645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24686338|NCT04896645|Adrenergic Agents|adrenergic agents|mesh-ancestor
24686339|NCT04896645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24686340|NCT04896645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686341|NCT04895579|Durvalumab|durvalumab|mesh-list
24686342|NCT04895579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24686343|NCT04895579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24686344|NCT04894435|Vaccines|vaccines|mesh-list
24686345|NCT04894435|Immunologic Factors|immunologic factors|mesh-ancestor
24686346|NCT04894435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686347|NCT04888858|Fentanyl|fentanyl|mesh-list
24686348|NCT04888858|Bupivacaine|bupivacaine|mesh-list
24611639|NCT01010178|Theophylline|theophylline|mesh-list
24686379|NCT04879823|Autonomic Agents|autonomic agents|mesh-ancestor
24686380|NCT04879823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24686381|NCT04879823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686382|NCT04879823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24686383|NCT04879823|Glucocorticoids|glucocorticoids|mesh-ancestor
24686384|NCT04879823|Hormones|hormones|mesh-ancestor
24686385|NCT04879823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24686386|NCT04879823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24686387|NCT04879823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25703088|NCT02163434|Antimanic Agents|antimanic agents|mesh-ancestor
25703089|NCT02163434|Antiemetics|antiemetics|mesh-ancestor
25703090|NCT02163434|Autonomic Agents|autonomic agents|mesh-ancestor
25703091|NCT02163434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25703092|NCT02163434|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25703093|NCT02163434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25703094|NCT02163434|Dopamine Agents|dopamine agents|mesh-ancestor
25703095|NCT02163447|Pyrimethamine|pyrimethamine|mesh-list
25703096|NCT02163447|Piperaquine|piperaquine|mesh-list
25703097|NCT02163447|Sulfadoxine|sulfadoxine|mesh-list
25703098|NCT02163447|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25703099|NCT02163447|Artenimol|artenimol|mesh-list
25703100|NCT02163447|Artemisinins|artemisinins|mesh-list
25703101|NCT02163447|Antimalarials|antimalarials|mesh-ancestor
24686388|NCT04879823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24611669|NCT01010243|Immunologic Factors|immunologic factors|mesh-ancestor
24611670|NCT01010243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24611671|NCT01010243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24611672|NCT01010243|Growth Substances|growth substances|mesh-ancestor
24912090|NCT04281342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912091|NCT04281342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912092|NCT04281082|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24912093|NCT04281082|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24912094|NCT04281082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24912129|NCT04280263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24743176|NCT04973930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24787203|NCT01924000|Vasodilator Agents|vasodilator agents|mesh-ancestor
24787204|NCT01924013|Vitamin D|vitamin d|mesh-list
25109261|NCT03126188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25109262|NCT03126188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25109263|NCT03126188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109264|NCT03126188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25109265|NCT03126188|Serotonin Agents|serotonin agents|mesh-ancestor
24399267|NCT00147303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24399303|NCT00147355|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24405700|NCT00167960|Tazobactam|tazobactam|mesh-list
24405701|NCT00167960|Piperacillin|piperacillin|mesh-list
25109266|NCT03126188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109267|NCT03126188|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25109268|NCT03126188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25109269|NCT03126123|Acetic Acid|acetic acid|mesh-list
25109270|NCT03126123|Retinol acetate|retinol acetate|mesh-list
25109271|NCT03126123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25109272|NCT03126123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25109273|NCT03126123|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25109274|NCT03126123|Immunologic Factors|immunologic factors|mesh-ancestor
24912401|NCT04276090|Hormones|hormones|mesh-ancestor
24486900|NCT00460499|Insulin|insulin|mesh-list
24912524|NCT04274608|Cholinergic Agents|cholinergic agents|mesh-ancestor
24487021|NCT00460954|Dopamine Agents|dopamine agents|mesh-ancestor
24487022|NCT00460954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24487024|NCT00460954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912613|NCT04273581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25090385|NCT03258385|Vitamins|vitamins|mesh-ancestor
24686520|NCT04760691|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24686521|NCT04760691|Contraceptive Agents|contraceptive agents|mesh-ancestor
24686522|NCT04760691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24686523|NCT04760691|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24686524|NCT04760691|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24686525|NCT04760691|Fertility Agents|fertility agents|mesh-ancestor
24686526|NCT04760691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24686541|NCT04710641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686542|NCT04707664|Sargramostim|sargramostim|mesh-list
24686543|NCT04707664|Immunologic Factors|immunologic factors|mesh-ancestor
24686544|NCT04707664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912614|NCT04273581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24912615|NCT04273581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24912616|NCT04273581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24912617|NCT04273581|Growth Substances|growth substances|mesh-ancestor
24912839|NCT04270994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24912841|NCT04271189|Metformin|metformin|mesh-list
24912842|NCT04271189|Pioglitazone|pioglitazone|mesh-list
24912878|NCT04270708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24912879|NCT04270708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24819226|NCT02094274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819227|NCT02094274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24819228|NCT02094274|Respiratory System Agents|respiratory system agents|mesh-ancestor
24819229|NCT02094274|Dermatologic Agents|dermatologic agents|mesh-ancestor
24819230|NCT02094274|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25090398|NCT03258476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686545|NCT04706767|Lidocaine|lidocaine|mesh-list
24686662|NCT04641702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24686663|NCT04641702|Autonomic Agents|autonomic agents|mesh-ancestor
24686664|NCT04641702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24686665|NCT04641702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686666|NCT04641702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24686667|NCT04641702|Respiratory System Agents|respiratory system agents|mesh-ancestor
24686668|NCT04641702|Mydriatics|mydriatics|mesh-ancestor
24686669|NCT04641702|Parasympatholytics|parasympatholytics|mesh-ancestor
24686670|NCT04641702|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24686671|NCT04641702|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24686672|NCT04641702|Cholinergic Agents|cholinergic agents|mesh-ancestor
24686673|NCT04641702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24686674|NCT04641702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686675|NCT04640636|Midazolam|midazolam|mesh-list
24686676|NCT04640636|Ketamine|ketamine|mesh-list
24686677|NCT04640636|Analgesics|analgesics|mesh-ancestor
24686678|NCT04640636|Sensory System Agents|sensory system agents|mesh-ancestor
24686679|NCT04640636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24686680|NCT04640636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471648|NCT00396487|Irinotecan|irinotecan|mesh-list
24686681|NCT04640636|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24686682|NCT04640636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24686692|NCT04640636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24686693|NCT04640636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24686694|NCT04640636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24686695|NCT04640636|GABA Modulators|gaba modulators|mesh-ancestor
24913000|NCT04269187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24913080|NCT04268303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24913081|NCT04268303|Analgesics|analgesics|mesh-ancestor
24913082|NCT04268303|Sensory System Agents|sensory system agents|mesh-ancestor
24913083|NCT04268303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24686812|NCT04564612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24686813|NCT04564612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686814|NCT04564612|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24686815|NCT04564612|Hormone Antagonists|hormone antagonists|mesh-ancestor
24686816|NCT04564612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24686834|NCT04561648|Heparin|heparin|mesh-list
24686886|NCT04530006|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24686887|NCT04530006|Antiviral Agents|antiviral agents|mesh-ancestor
24686888|NCT04530006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24686889|NCT04530006|Dopamine Agents|dopamine agents|mesh-ancestor
24686890|NCT04530006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24686891|NCT04530006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686892|NCT04530006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686893|NCT04530006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24686894|NCT04530006|Analgesics|analgesics|mesh-ancestor
24686895|NCT04530006|Sensory System Agents|sensory system agents|mesh-ancestor
24686896|NCT04530006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24686949|NCT04496245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686950|NCT04481412|Cetirizine|cetirizine|mesh-list
24686951|NCT04481412|Ethanol|ethanol|mesh-list
24686952|NCT04481412|Minoxidil|minoxidil|mesh-list
24686953|NCT04481412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24686954|NCT04481412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24686955|NCT04481412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24686956|NCT04481412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686957|NCT04481412|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24630188|NCT01109888|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24687107|NCT04380831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24687108|NCT04380831|Alkylating Agents|alkylating agents|mesh-ancestor
24687109|NCT04380831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687110|NCT04380831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24687111|NCT04380831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24687113|NCT04368091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24687114|NCT04368091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24687115|NCT04368091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24687116|NCT04368091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24687117|NCT04368091|Antifungal Agents|antifungal agents|mesh-ancestor
24913118|NCT04268537|Antibodies, Blocking|antibodies, blocking|mesh-list
24913119|NCT04268537|Immunologic Factors|immunologic factors|mesh-ancestor
24913120|NCT04268537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913121|NCT04268394|Metformin|metformin|mesh-list
24913122|NCT04268394|Itraconazole|itraconazole|mesh-list
24913123|NCT04268394|Rifampin|rifampin|mesh-list
24400549|NCT00150839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24913124|NCT04268394|Sulfasalazine|sulfasalazine|mesh-list
24913125|NCT04268394|Methotrexate|methotrexate|mesh-list
24913126|NCT04268394|Digoxin|digoxin|mesh-list
24913127|NCT04268394|Midazolam|midazolam|mesh-list
24913128|NCT04268394|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24913129|NCT04268394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25703102|NCT02163447|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25703103|NCT02163447|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25703104|NCT02163447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25703107|NCT02163447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913130|NCT04268394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487634|NCT00464256|Hormones|hormones|mesh-ancestor
24913166|NCT04268394|Hormone Antagonists|hormone antagonists|mesh-ancestor
24687124|NCT04367883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687125|NCT04356950|Thrombin|thrombin|mesh-list
24687126|NCT04356950|Hemostatics|hemostatics|mesh-ancestor
24687127|NCT04356950|Coagulants|coagulants|mesh-ancestor
24687161|NCT04301011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24687162|NCT04301011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24687163|NCT04300127|Pioglitazone|pioglitazone|mesh-list
24687164|NCT04300127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24687165|NCT04300127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687166|NCT04294043|Gallium nitrate|gallium nitrate|mesh-list
24687167|NCT04294043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24687168|NCT04294043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687169|NCT04294043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24687170|NCT04287049|Azithromycin|azithromycin|mesh-list
24687171|NCT04287049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24687172|NCT04287049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24687183|NCT04271956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687191|NCT04245644|Aspirin|aspirin|mesh-list
24687192|NCT04245644|Metformin|metformin|mesh-list
24687193|NCT04245644|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24687239|NCT04195776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24687240|NCT04195776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687241|NCT04195776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24687242|NCT04195776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24472231|NCT00398554|Glucocorticoids|glucocorticoids|mesh-ancestor
24687244|NCT04186663|Cariostatic Agents|cariostatic agents|mesh-ancestor
24687245|NCT04186663|Protective Agents|protective agents|mesh-ancestor
24687254|NCT04164849|Dermatologic Agents|dermatologic agents|mesh-ancestor
24687283|NCT04095104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24487675|NCT00464373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24913202|NCT04267913|Dexamethasone|dexamethasone|mesh-list
24913203|NCT04267913|Dexamethasone acetate|dexamethasone acetate|mesh-list
24913204|NCT04267913|Docetaxel|docetaxel|mesh-list
24913205|NCT04267913|Ramucirumab|ramucirumab|mesh-list
24819259|NCT02094339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24819260|NCT02094339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819261|NCT02094339|Sensory System Agents|sensory system agents|mesh-ancestor
24819262|NCT02094339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24819263|NCT02094378|Esketamine|esketamine|mesh-list
24401416|NCT00152893|Niacin|niacin|mesh-list
24611719|NCT01010451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24402829|NCT00158548|Antiviral Agents|antiviral agents|mesh-ancestor
24611734|NCT01010516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611735|NCT01010516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24611736|NCT01010516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611737|NCT01010516|Vasodilator Agents|vasodilator agents|mesh-ancestor
24611738|NCT01010516|Vitamin B Complex|vitamin b complex|mesh-ancestor
24611742|NCT01010581|Folic Acid|folic acid|mesh-list
24611744|NCT01010581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24611745|NCT01010581|Abortifacient Agents|abortifacient agents|mesh-ancestor
24611746|NCT01010581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24611747|NCT01010581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611748|NCT01010581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24687328|NCT04057131|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24687329|NCT04057131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24687330|NCT04057131|Immunologic Factors|immunologic factors|mesh-ancestor
24687331|NCT04055389|Antithrombins|antithrombins|mesh-list
24687332|NCT04055389|Antithrombin III|antithrombin iii|mesh-list
24687362|NCT04020718|Nicotine|nicotine|mesh-list
24687363|NCT04020718|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24687364|NCT04020718|Autonomic Agents|autonomic agents|mesh-ancestor
24687372|NCT04014530|Pembrolizumab|pembrolizumab|mesh-list
24819264|NCT02094378|Antidepressive Agents|antidepressive agents|mesh-ancestor
24819265|NCT02094378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24819266|NCT02094391|Ipilimumab|ipilimumab|mesh-list
24819267|NCT02094391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25703108|NCT02163447|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25703109|NCT02163447|Renal Agents|renal agents|mesh-ancestor
24913284|NCT04267250|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24826710|NCT02135822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913285|NCT04267250|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24913286|NCT04267250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24913287|NCT04267250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24913410|NCT04264988|Protective Agents|protective agents|mesh-ancestor
24913411|NCT04264988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090442|NCT03257852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630313|NCT01110824|Adrenergic Agents|adrenergic agents|mesh-ancestor
24687651|NCT03845270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24687652|NCT03845270|Tubulin Modulators|tubulin modulators|mesh-ancestor
24687653|NCT03845270|Antimitotic Agents|antimitotic agents|mesh-ancestor
24687663|NCT03807921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24687664|NCT03807921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24687666|NCT03807921|Sensory System Agents|sensory system agents|mesh-ancestor
24687667|NCT03807921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24687668|NCT03807921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687669|NCT03807921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24687670|NCT03807921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24630371|NCT01111383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24687806|NCT03661996|Anesthetics, Local|anesthetics, local|mesh-ancestor
24687807|NCT03661996|Anesthetics|anesthetics|mesh-ancestor
24687808|NCT03661996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24687809|NCT03661996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687810|NCT03661996|Sensory System Agents|sensory system agents|mesh-ancestor
24687818|NCT03661996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24687819|NCT03661996|Adrenergic Agents|adrenergic agents|mesh-ancestor
24687820|NCT03661996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24687821|NCT03661996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24687822|NCT03661996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24687823|NCT03661996|Autonomic Agents|autonomic agents|mesh-ancestor
24687824|NCT03661996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24687825|NCT03661996|Respiratory System Agents|respiratory system agents|mesh-ancestor
24687889|NCT03618550|Vinorelbine|vinorelbine|mesh-list
24687890|NCT03618550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24687891|NCT03618550|Antimetabolites|antimetabolites|mesh-ancestor
24687908|NCT03601507|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
24687910|NCT03601507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687915|NCT03593434|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24687917|NCT03593434|Anesthetics|anesthetics|mesh-ancestor
24687918|NCT03593434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24687919|NCT03593434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687920|NCT03592407|Pembrolizumab|pembrolizumab|mesh-list
24687921|NCT03592407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24687922|NCT03592407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24687924|NCT03584516|Methylprednisolone|methylprednisolone|mesh-list
24687927|NCT03584516|Prednisolone|prednisolone|mesh-list
24913413|NCT04265027|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24913414|NCT04265027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24913415|NCT04265027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913416|NCT04265027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24913417|NCT04265027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24913418|NCT04264676|Metronidazole|metronidazole|mesh-list
24913419|NCT04264676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24913420|NCT04264676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24913421|NCT04264676|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24913422|NCT04264676|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24913593|NCT04262635|Capecitabine|capecitabine|mesh-list
24913594|NCT04262635|Cetuximab|cetuximab|mesh-list
24913595|NCT04262635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24913736|NCT04261465|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24913737|NCT04261465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24913738|NCT04261517|Hydroxychloroquine|hydroxychloroquine|mesh-list
24913739|NCT04261517|Antimalarials|antimalarials|mesh-ancestor
24913740|NCT04261517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24913910|NCT04259684|Gasotransmitters|gasotransmitters|mesh-ancestor
24913911|NCT04259684|Protective Agents|protective agents|mesh-ancestor
24913912|NCT04259606|Magnesium Oxide|magnesium oxide|mesh-list
24687973|NCT03563690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687974|NCT03563690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24687975|NCT03563690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24687976|NCT03563690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24687977|NCT03563690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25703110|NCT02163759|Adalimumab|adalimumab|mesh-list
24687978|NCT03563690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24687979|NCT03563690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687981|NCT03555877|Fulvestrant|fulvestrant|mesh-list
24402484|NCT00157508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24402780|NCT00158470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402781|NCT00158470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402782|NCT00158470|Antiviral Agents|antiviral agents|mesh-ancestor
24402828|NCT00158548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688113|NCT03360214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24688117|NCT03359239|Atezolizumab|atezolizumab|mesh-list
24688149|NCT03317405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24688150|NCT03315039|Annamycin|annamycin|mesh-list
24688151|NCT03315039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24688152|NCT03315039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913914|NCT04259606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914018|NCT04258644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24914020|NCT04258644|Tubulin Modulators|tubulin modulators|mesh-ancestor
24914021|NCT04258644|Antimitotic Agents|antimitotic agents|mesh-ancestor
24914022|NCT04258644|Mitosis Modulators|mitosis modulators|mesh-ancestor
24914024|NCT04258644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24914026|NCT04258683|Pembrolizumab|pembrolizumab|mesh-list
24914027|NCT04258683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24914028|NCT04258683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914059|NCT04258163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24914060|NCT04258163|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24914061|NCT04258163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24914062|NCT04258163|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24914063|NCT04258163|Hormone Antagonists|hormone antagonists|mesh-ancestor
24914064|NCT04258163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24688161|NCT03289325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24688162|NCT03289325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24688163|NCT03289325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688164|NCT03289325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24688165|NCT03289325|Analgesics|analgesics|mesh-ancestor
24688166|NCT03289325|Sensory System Agents|sensory system agents|mesh-ancestor
24688167|NCT03289325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24688168|NCT03289325|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24688169|NCT03289325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24688189|NCT03279289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24688190|NCT03279289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24688191|NCT03279289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24688192|NCT03279289|Growth Substances|growth substances|mesh-ancestor
24688193|NCT03279289|Growth Inhibitors|growth inhibitors|mesh-ancestor
24688194|NCT03279289|Antidotes|antidotes|mesh-ancestor
24688195|NCT03279289|Protective Agents|protective agents|mesh-ancestor
24688196|NCT03279289|Vitamin B Complex|vitamin b complex|mesh-ancestor
24688197|NCT03279289|Vitamins|vitamins|mesh-ancestor
24688198|NCT03279289|Micronutrients|micronutrients|mesh-ancestor
24688199|NCT03279289|Hematinics|hematinics|mesh-ancestor
24688244|NCT03254394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24688245|NCT03254394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24688246|NCT03254394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24688247|NCT03254394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688248|NCT03215940|Dronabinol|dronabinol|mesh-list
24688249|NCT03215940|Cannabidiol|cannabidiol|mesh-list
24688250|NCT03215940|Anticonvulsants|anticonvulsants|mesh-ancestor
24688258|NCT03215940|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24688259|NCT03215940|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24688260|NCT03215940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24688263|NCT03215940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24688264|NCT03209687|Menotropins|menotropins|mesh-list
24688265|NCT03209687|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24688266|NCT03209687|Fertility Agents|fertility agents|mesh-ancestor
24688267|NCT03209687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25703112|NCT02163759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25703113|NCT02163759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25703114|NCT02163759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25703115|NCT02163759|Immunologic Factors|immunologic factors|mesh-ancestor
24914066|NCT04258163|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24914067|NCT04258241|Bupivacaine|bupivacaine|mesh-list
24914068|NCT04258241|Anesthetics, Local|anesthetics, local|mesh-list
24914069|NCT04258241|Anesthetics|anesthetics|mesh-list
24914070|NCT04258241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24914071|NCT04258241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24914072|NCT04258241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914073|NCT04258241|Sensory System Agents|sensory system agents|mesh-ancestor
24914117|NCT04258007|Autonomic Agents|autonomic agents|mesh-ancestor
24914118|NCT04258007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24914120|NCT04257838|Tazobactam|tazobactam|mesh-list
24914121|NCT04257838|Piperacillin|piperacillin|mesh-list
24914122|NCT04257838|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24488715|NCT00469781|Sensory System Agents|sensory system agents|mesh-ancestor
24914230|NCT04256642|Sensory System Agents|sensory system agents|mesh-ancestor
24914231|NCT04256642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24914232|NCT04256733|Capsaicin|capsaicin|mesh-list
24914233|NCT04256733|Antipruritics|antipruritics|mesh-ancestor
24914234|NCT04256733|Dermatologic Agents|dermatologic agents|mesh-ancestor
24766662|NCT01796028|Metformin|metformin|mesh-list
24688268|NCT03209687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688269|NCT03203876|Nivolumab|nivolumab|mesh-list
24688270|NCT03203876|Ipilimumab|ipilimumab|mesh-list
24688377|NCT03080935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24688378|NCT03080935|Antimetabolites|antimetabolites|mesh-ancestor
24688379|NCT03080935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688380|NCT03080935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24688381|NCT03078855|Vitamin D|vitamin d|mesh-list
24688382|NCT03078855|Cholecalciferol|cholecalciferol|mesh-list
24688383|NCT03078855|Rituximab|rituximab|mesh-list
24688384|NCT03078855|Vitamins|vitamins|mesh-ancestor
24688385|NCT03078855|Micronutrients|micronutrients|mesh-ancestor
24688386|NCT03078855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688387|NCT03078855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24688407|NCT03071601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688408|NCT03071601|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24688409|NCT03071601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24688410|NCT03071601|Adrenergic Agents|adrenergic agents|mesh-ancestor
24688411|NCT03071601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24688412|NCT03071601|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24688413|NCT03071601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24688414|NCT03071601|Autonomic Agents|autonomic agents|mesh-ancestor
24688415|NCT03071601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24688416|NCT03071601|Respiratory System Agents|respiratory system agents|mesh-ancestor
24688461|NCT03061630|Gemcitabine|gemcitabine|mesh-list
24688462|NCT03061630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688463|NCT03061630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24688464|NCT03061630|Antimetabolites|antimetabolites|mesh-ancestor
24688465|NCT03061630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688466|NCT03061630|Antiviral Agents|antiviral agents|mesh-ancestor
24688467|NCT03061630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24688468|NCT03061630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819445|NCT02095548|Lorecivivint|lorecivivint|mesh-list
24819446|NCT02095548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24819447|NCT02095574|Venetoclax|venetoclax|mesh-list
24819448|NCT02095574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24819449|NCT02095665|Acetaminophen|acetaminophen|mesh-list
24914247|NCT04256343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914249|NCT04256252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24914250|NCT04256252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914251|NCT04256252|Immunologic Factors|immunologic factors|mesh-ancestor
24914252|NCT04256252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914253|NCT04256252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24914254|NCT04256525|Aspirin|aspirin|mesh-list
24914255|NCT04256525|Heparin|heparin|mesh-list
24914256|NCT04256525|Rivaroxaban|rivaroxaban|mesh-list
24914257|NCT04256525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24914258|NCT04256525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24914259|NCT04256525|Analgesics|analgesics|mesh-ancestor
24914330|NCT04255771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24914331|NCT04255771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24914332|NCT04255771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24914333|NCT04255771|Immunologic Factors|immunologic factors|mesh-ancestor
25703116|NCT02163759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914334|NCT04255771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914335|NCT04255589|Ethanol|ethanol|mesh-list
25703117|NCT02163824|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25703118|NCT02163824|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24443947|NCT00296348|Tacrolimus|tacrolimus|mesh-list
24914336|NCT04255589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24914337|NCT04255589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24914338|NCT04255589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24914339|NCT04255589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914340|NCT04255576|Vitamin D|vitamin d|mesh-list
24914341|NCT04255576|Calcium|calcium|mesh-list
24688469|NCT03061630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24688470|NCT03061630|Immunologic Factors|immunologic factors|mesh-ancestor
24688471|NCT03061630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688472|NCT03055390|Scopolamine|scopolamine|mesh-list
24914354|NCT04255498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914355|NCT04255498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24914356|NCT04255498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24914357|NCT04255498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24914358|NCT04255498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24914359|NCT04255498|Immunologic Factors|immunologic factors|mesh-ancestor
24914360|NCT04255498|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24914361|NCT04255498|Abortifacient Agents|abortifacient agents|mesh-ancestor
24688473|NCT03055390|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24688474|NCT03055390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24688475|NCT03055390|Antiemetics|antiemetics|mesh-ancestor
24688500|NCT03012672|Cladribine|cladribine|mesh-list
24688583|NCT02924480|Anesthetics, Local|anesthetics, local|mesh-ancestor
24688584|NCT02924480|Anesthetics|anesthetics|mesh-ancestor
24688585|NCT02924480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24688586|NCT02924480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688587|NCT02924480|Sensory System Agents|sensory system agents|mesh-ancestor
24688588|NCT02924480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24688589|NCT02924480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24641469|NCT01173640|GABA Agents|gaba agents|mesh-ancestor
24688590|NCT02924480|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24688591|NCT02924480|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24688592|NCT02924480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24688593|NCT02924480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688595|NCT02924064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24688596|NCT02924064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688597|NCT02917993|Osimertinib|osimertinib|mesh-list
24688598|NCT02917993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688600|NCT02917993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24688601|NCT02917993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688602|NCT02889900|Olaparib|olaparib|mesh-list
24688603|NCT02889900|Cediranib|cediranib|mesh-list
24688630|NCT02873819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24688631|NCT02873819|Interferon Inducers|interferon inducers|mesh-ancestor
24688632|NCT02872467|Oxytocin|oxytocin|mesh-list
24688633|NCT02872467|Oxytocics|oxytocics|mesh-ancestor
24688634|NCT02872467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24688635|NCT02872467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688636|NCT02863445|Levonorgestrel|levonorgestrel|mesh-list
24688637|NCT02863445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24688638|NCT02863445|Contraceptive Agents|contraceptive agents|mesh-ancestor
24688639|NCT02863445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24688640|NCT02863445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688641|NCT02863445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24688642|NCT02863445|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24688643|NCT02863445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24404963|NCT00165204|Androgen Antagonists|androgen antagonists|mesh-ancestor
24611818|NCT01010945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611819|NCT01010945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24611820|NCT01010945|Antimetabolites|antimetabolites|mesh-ancestor
24611821|NCT01010945|Antiviral Agents|antiviral agents|mesh-ancestor
24611822|NCT01010945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24611823|NCT01010945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703119|NCT02163837|Rifaximin|rifaximin|mesh-list
25703120|NCT02163837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25703121|NCT02163837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25703122|NCT02163837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25703123|NCT02164240|Sunitinib|sunitinib|mesh-list
24611824|NCT01010945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25703124|NCT02164240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25703125|NCT02164240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24611825|NCT01010945|Immunologic Factors|immunologic factors|mesh-ancestor
24611826|NCT01010945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611827|NCT01010945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24611837|NCT01010958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24611838|NCT01010958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24611839|NCT01011010|Doxorubicin|doxorubicin|mesh-list
24611843|NCT01011010|Sorafenib|sorafenib|mesh-list
24611844|NCT01011010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24611845|NCT01011010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611846|NCT01011010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24611847|NCT01011010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24611848|NCT01011010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611849|NCT01011010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611875|NCT01011062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24611876|NCT01011062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24611877|NCT01011062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611879|NCT01011114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24611880|NCT01011114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611881|NCT01011114|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24557693|NCT00753467|Adefovir|adefovir|mesh-list
24611882|NCT01011114|Hormone Antagonists|hormone antagonists|mesh-ancestor
24688707|NCT02723331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24688709|NCT02723331|Tubulin Modulators|tubulin modulators|mesh-ancestor
24688710|NCT02723331|Antimitotic Agents|antimitotic agents|mesh-ancestor
24688711|NCT02723331|Mitosis Modulators|mitosis modulators|mesh-ancestor
24688712|NCT02723331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688713|NCT02723331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24688714|NCT02723331|Antimetabolites|antimetabolites|mesh-ancestor
24688715|NCT02723331|Antiviral Agents|antiviral agents|mesh-ancestor
24688716|NCT02723331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24688717|NCT02723331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24688718|NCT02723331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24688719|NCT02723331|Immunologic Factors|immunologic factors|mesh-ancestor
24688720|NCT02723331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688721|NCT02719314|Methylprednisolone|methylprednisolone|mesh-list
24688722|NCT02719314|Glucocorticoids|glucocorticoids|mesh-list
25109277|NCT03126123|Protective Agents|protective agents|mesh-ancestor
24743593|NCT04733547|Furosemide|furosemide|mesh-list
24914375|NCT04255368|Lipotropic Agents|lipotropic agents|mesh-ancestor
24914376|NCT04255368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24914377|NCT04255368|Antimetabolites|antimetabolites|mesh-ancestor
24914378|NCT04255368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914379|NCT04255368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24914380|NCT04255368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24914381|NCT04255368|Nootropic Agents|nootropic agents|mesh-ancestor
24914382|NCT04255238|Dapagliflozin|dapagliflozin|mesh-list
24914416|NCT04255017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25109296|NCT03125980|Oxaliplatin|oxaliplatin|mesh-list
24914417|NCT04255017|Antiviral Agents|antiviral agents|mesh-ancestor
24914418|NCT04255017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24688976|NCT02516657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24914419|NCT04255017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25090573|NCT03256487|Morphine|morphine|mesh-list
24688762|NCT02711826|Autonomic Agents|autonomic agents|mesh-ancestor
24688763|NCT02711826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24688764|NCT02711826|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24688765|NCT02711826|Histamine Antagonists|histamine antagonists|mesh-ancestor
24688766|NCT02711826|Histamine Agents|histamine agents|mesh-ancestor
24688767|NCT02711826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24688768|NCT02711826|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24688769|NCT02711826|Antipruritics|antipruritics|mesh-ancestor
24688770|NCT02711826|Dermatologic Agents|dermatologic agents|mesh-ancestor
24688771|NCT02684253|Nivolumab|nivolumab|mesh-list
24688772|NCT02684253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24688773|NCT02684253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688774|NCT02684253|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24688775|NCT02684253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688776|NCT02666794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
24688777|NCT02666794|Sufentanil|sufentanil|mesh-list
24688778|NCT02666794|Morphine|morphine|mesh-list
24688780|NCT02666794|Bupivacaine|bupivacaine|mesh-list
24688781|NCT02666794|Anesthetics, Local|anesthetics, local|mesh-ancestor
24688782|NCT02666794|Anesthetics|anesthetics|mesh-ancestor
24688783|NCT02666794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25703126|NCT02164240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25703127|NCT02164240|Growth Substances|growth substances|mesh-ancestor
25703128|NCT02164240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703129|NCT02164240|Growth Inhibitors|growth inhibitors|mesh-ancestor
24688784|NCT02666794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688785|NCT02666794|Sensory System Agents|sensory system agents|mesh-ancestor
24630922|NCT01115049|Disinfectants|disinfectants|mesh-ancestor
24688832|NCT02636322|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24688833|NCT02636322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24688834|NCT02636322|Immunologic Factors|immunologic factors|mesh-ancestor
24688835|NCT02636322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688836|NCT02636322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24688871|NCT02619552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24688872|NCT02619552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688873|NCT02619552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24688875|NCT02619552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24688876|NCT02619552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24688877|NCT02619552|Respiratory System Agents|respiratory system agents|mesh-ancestor
24688878|NCT02619552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24688879|NCT02619552|Dermatologic Agents|dermatologic agents|mesh-ancestor
24688920|NCT02575963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688921|NCT02575963|Antiviral Agents|antiviral agents|mesh-ancestor
24688922|NCT02575963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24688923|NCT02575963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24688928|NCT02575963|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24688929|NCT02575963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24688930|NCT02575963|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24688931|NCT02575963|Hormone Antagonists|hormone antagonists|mesh-ancestor
24406813|NCT00171366|Vasodilator Agents|vasodilator agents|mesh-ancestor
24688932|NCT02575963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24688933|NCT02575963|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24688934|NCT02575963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24688936|NCT02551991|Fluorouracil|fluorouracil|mesh-list
24688958|NCT02539225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688960|NCT02535650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688961|NCT02527681|Ceftobiprole|ceftobiprole|mesh-list
24688962|NCT02527681|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
24688963|NCT02527681|Cephalosporins|cephalosporins|mesh-list
24688964|NCT02527681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24688965|NCT02527681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24688966|NCT02526017|Nivolumab|nivolumab|mesh-list
24688967|NCT02526017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24631022|NCT01115712|Pioglitazone|pioglitazone|mesh-list
24688968|NCT02526017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688969|NCT02526017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24688970|NCT02526017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688972|NCT02520362|Diphosphonates|diphosphonates|mesh-list
24688973|NCT02520362|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24474094|NCT00404833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24688974|NCT02520362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688975|NCT02516657|Liraglutide|liraglutide|mesh-list
24688978|NCT02516657|Incretins|incretins|mesh-ancestor
24688979|NCT02516657|Hormones|hormones|mesh-ancestor
24688980|NCT02516657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24689068|NCT02369653|Anticoagulants|anticoagulants|mesh-list
24689069|NCT02369653|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24689070|NCT02369653|Antithrombins|antithrombins|mesh-ancestor
24689133|NCT02299999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24689134|NCT02299999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24689135|NCT02299999|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24689136|NCT02299999|Abortifacient Agents|abortifacient agents|mesh-ancestor
24689137|NCT02299999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24689138|NCT02299999|Dermatologic Agents|dermatologic agents|mesh-ancestor
24689139|NCT02299999|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24689140|NCT02299999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24689141|NCT02299999|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24689142|NCT02299999|Androgen Antagonists|androgen antagonists|mesh-ancestor
25703130|NCT02164240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25703131|NCT02164240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703132|NCT02164240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703133|NCT02164318|Nitroglycerin|nitroglycerin|mesh-list
25703134|NCT02164318|Vasodilator Agents|vasodilator agents|mesh-ancestor
24689143|NCT02299999|Hormone Antagonists|hormone antagonists|mesh-ancestor
24914639|NCT04253132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914947|NCT05252715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915131|NCT04669132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24489820|NCT00475527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24915232|NCT03854019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24915233|NCT03854019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24915234|NCT03854019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24915235|NCT03854019|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24915236|NCT03854019|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24787233|NCT01924091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24787234|NCT01924091|Antiviral Agents|antiviral agents|mesh-ancestor
25090590|NCT03256149|Glucocorticoids|glucocorticoids|mesh-ancestor
24689145|NCT02293109|Leucovorin|leucovorin|mesh-list
24689153|NCT02293109|Cyclophosphamide|cyclophosphamide|mesh-list
24689154|NCT02293109|Rituximab|rituximab|mesh-list
24689155|NCT02293109|Doxorubicin|doxorubicin|mesh-list
24689156|NCT02293109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24689157|NCT02293109|Methotrexate|methotrexate|mesh-list
24689158|NCT02293109|Vincristine|vincristine|mesh-list
24689159|NCT02293109|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24689160|NCT02293109|Prednisolone phosphate|prednisolone phosphate|mesh-list
24689161|NCT02293109|Levoleucovorin|levoleucovorin|mesh-list
24689162|NCT02293109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24689163|NCT02293109|Immunologic Factors|immunologic factors|mesh-ancestor
24689164|NCT02293109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689165|NCT02293109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24689166|NCT02293109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24689167|NCT02293109|Alkylating Agents|alkylating agents|mesh-ancestor
24689168|NCT02293109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689169|NCT02293109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689170|NCT02293109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24689171|NCT02293109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24689219|NCT02183883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689220|NCT02158507|Lapatinib|lapatinib|mesh-list
24689221|NCT02158507|Veliparib|veliparib|mesh-list
24689222|NCT02158507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689223|NCT02158507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24689224|NCT02158507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689225|NCT02158507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689226|NCT02158507|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24689227|NCT01982630|Liraglutide|liraglutide|mesh-list
24689228|NCT01982630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24689229|NCT01982630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689230|NCT01982630|Incretins|incretins|mesh-ancestor
24689231|NCT01982630|Hormones|hormones|mesh-ancestor
24689232|NCT01982630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24689233|NCT01982448|Paclitaxel|paclitaxel|mesh-list
24689234|NCT01982448|Cisplatin|cisplatin|mesh-list
24689235|NCT01982448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24915567|NCT04250831|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
24915568|NCT04250831|Trace Elements|trace elements|mesh-ancestor
24915573|NCT04250506|Moxifloxacin|moxifloxacin|mesh-list
24915574|NCT04250506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24915575|NCT04250506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24915576|NCT04250506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24915635|NCT04250051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915739|NCT04249037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24915740|NCT04249037|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24915741|NCT04249037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24915742|NCT04249037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090602|NCT03256292|Androgens|androgens|mesh-ancestor
24631137|NCT01116193|Lenalidomide|lenalidomide|mesh-list
24689248|NCT01951469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24827164|NCT02137668|Vancomycin|vancomycin|mesh-list
24689249|NCT01940809|Nivolumab|nivolumab|mesh-list
24689250|NCT01940809|Ipilimumab|ipilimumab|mesh-list
24689251|NCT01940809|Trametinib|trametinib|mesh-list
24408877|NCT00179816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689253|NCT01940809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24689254|NCT01940809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689255|NCT01940809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24689256|NCT01940809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689257|NCT01940809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24689258|NCT01940809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689268|NCT01891747|Growth Inhibitors|growth inhibitors|mesh-ancestor
24915778|NCT04248348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24915779|NCT04248348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24915780|NCT04248348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915781|NCT04248309|Progesterone|progesterone|mesh-list
24915782|NCT04248309|Progestins|progestins|mesh-ancestor
24915784|NCT04248309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24915785|NCT04248309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915787|NCT04248205|Analgesics|analgesics|mesh-ancestor
24915788|NCT04248205|Sensory System Agents|sensory system agents|mesh-ancestor
24916019|NCT04245774|Anesthetics, Local|anesthetics, local|mesh-ancestor
24689269|NCT01891747|Vitamins|vitamins|mesh-ancestor
24689270|NCT01891747|Micronutrients|micronutrients|mesh-ancestor
24689271|NCT01891747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24689272|NCT01891747|Alkylating Agents|alkylating agents|mesh-ancestor
24689273|NCT01891747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689274|NCT01891747|Antioxidants|antioxidants|mesh-ancestor
24611892|NCT01011127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689275|NCT01891747|Protective Agents|protective agents|mesh-ancestor
24689276|NCT01879228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24451322|NCT00323154|Sensory System Agents|sensory system agents|mesh-ancestor
24451323|NCT00323154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24451324|NCT00323206|Interleukin-12|interleukin-12|mesh-list
24631297|NCT01116713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24916022|NCT04245774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916023|NCT04245774|Sensory System Agents|sensory system agents|mesh-ancestor
24916024|NCT04245774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24916025|NCT04245371|Lidocaine|lidocaine|mesh-list
24916382|NCT04241380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916383|NCT04241211|Denosumab|denosumab|mesh-list
24916580|NCT04239118|Hemostatics|hemostatics|mesh-list
24916581|NCT04239118|Coagulants|coagulants|mesh-ancestor
24916582|NCT04239170|Gemcitabine|gemcitabine|mesh-list
24916583|NCT04239170|Oxaliplatin|oxaliplatin|mesh-list
24916584|NCT04239170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24916585|NCT04239170|Antimetabolites|antimetabolites|mesh-ancestor
24916586|NCT04239170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916587|NCT04239170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24916588|NCT04239170|Antiviral Agents|antiviral agents|mesh-ancestor
24916697|NCT04238195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491513|NCT00482846|Melphalan|melphalan|mesh-list
24491630|NCT00483301|Sorafenib|sorafenib|mesh-list
24916886|NCT04236115|Sensory System Agents|sensory system agents|mesh-ancestor
24916887|NCT04236115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24916888|NCT04236115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24491671|NCT00483470|Vaccines|vaccines|mesh-list
24917351|NCT04230564|Azacitidine|azacitidine|mesh-list
25703135|NCT02164383|Nicotine|nicotine|mesh-list
24917352|NCT04230564|Venetoclax|venetoclax|mesh-list
24917353|NCT04230564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24917354|NCT04230564|Antimetabolites|antimetabolites|mesh-ancestor
24917355|NCT04230564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917356|NCT04230564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25703136|NCT02164383|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25703137|NCT02164383|Autonomic Agents|autonomic agents|mesh-ancestor
25703138|NCT02164383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25703139|NCT02164383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703140|NCT02164383|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25703141|NCT02164383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25703142|NCT02164383|Cholinergic Agents|cholinergic agents|mesh-ancestor
25703143|NCT02164383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25709601|NCT02270736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25709602|NCT02270736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25709603|NCT02270736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703144|NCT02164383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703145|NCT02164422|Guanfacine|guanfacine|mesh-list
24917357|NCT04230564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917388|NCT04230330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24917389|NCT04230330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917391|NCT04230330|Glucocorticoids|glucocorticoids|mesh-ancestor
24917392|NCT04230330|Hormones|hormones|mesh-ancestor
24744373|NCT04305444|Everolimus|everolimus|mesh-list
24917809|NCT04225780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917947|NCT04224649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24917948|NCT04224649|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24917949|NCT04224649|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24579570|NCT00856271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579572|NCT00856310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24409818|NCT00183404|Olanzapine|olanzapine|mesh-list
24579573|NCT00856310|Analgesics|analgesics|mesh-ancestor
24579574|NCT00856310|Sensory System Agents|sensory system agents|mesh-ancestor
24787302|NCT01924325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24787303|NCT01924325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787304|NCT01924325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24787305|NCT01924325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24787306|NCT01924325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787307|NCT01924325|Antipyretics|antipyretics|mesh-ancestor
24787308|NCT01924325|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25109345|NCT03125772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25109346|NCT03125772|Immunologic Factors|immunologic factors|mesh-ancestor
25109347|NCT03125772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109348|NCT03125694|Pioglitazone|pioglitazone|mesh-list
25109349|NCT03125694|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25109350|NCT03125694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25109351|NCT03125694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109352|NCT03125694|Incretins|incretins|mesh-ancestor
24689361|NCT01622998|Cholinergic Agents|cholinergic agents|mesh-ancestor
24689362|NCT01622998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24689363|NCT01622998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689366|NCT01595620|Hallucinogens|hallucinogens|mesh-ancestor
24689367|NCT01595620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689368|NCT01595620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24689369|NCT01595620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24689370|NCT01595620|Analgesics|analgesics|mesh-ancestor
24689371|NCT01595620|Sensory System Agents|sensory system agents|mesh-ancestor
24689372|NCT01595620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24689373|NCT01595620|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24689374|NCT01595620|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24689375|NCT01595620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24689376|NCT01595620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689377|NCT01595620|Hormones|hormones|mesh-ancestor
24689378|NCT01595620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24689379|NCT01595620|Antipruritics|antipruritics|mesh-ancestor
24689380|NCT01595620|Dermatologic Agents|dermatologic agents|mesh-ancestor
24689381|NCT01591629|Dronabinol|dronabinol|mesh-list
24689382|NCT01591629|Naloxone|naloxone|mesh-list
24689383|NCT01591629|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24689405|NCT01564537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24410042|NCT00184041|Antiviral Agents|antiviral agents|mesh-ancestor
25109384|NCT03125187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109386|NCT03125213|Antiviral Agents|antiviral agents|mesh-ancestor
25109387|NCT03125213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25109388|NCT03124680|Analgesics, Opioid|analgesics, opioid|mesh-list
25109389|NCT03124680|Narcotics|narcotics|mesh-ancestor
25109390|NCT03124680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25090691|NCT03254849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24689406|NCT01564537|Glucocorticoids|glucocorticoids|mesh-ancestor
24689407|NCT01564537|Hormones|hormones|mesh-ancestor
24689408|NCT01564537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24689409|NCT01564537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24689410|NCT01564537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25703146|NCT02164422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24827551|NCT02140242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24827552|NCT02140242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689411|NCT01564537|Immunologic Factors|immunologic factors|mesh-ancestor
24689412|NCT01564537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24689413|NCT01564537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24689414|NCT01564537|Growth Substances|growth substances|mesh-ancestor
24689468|NCT01464268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631364|NCT01117129|Antimetabolites|antimetabolites|mesh-ancestor
24689487|NCT01360593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689488|NCT01360593|Antiviral Agents|antiviral agents|mesh-ancestor
24689489|NCT01360593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24689490|NCT01360593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689491|NCT01360593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24689492|NCT01360593|Immunologic Factors|immunologic factors|mesh-ancestor
24689493|NCT01360593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689494|NCT01354977|Resveratrol|resveratrol|mesh-list
24689495|NCT01354977|Antioxidants|antioxidants|mesh-ancestor
24451370|NCT00323375|Chloroquine|chloroquine|mesh-list
24689496|NCT01354977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689497|NCT01354977|Protective Agents|protective agents|mesh-ancestor
24689514|NCT01216683|Bortezomib|bortezomib|mesh-list
24689515|NCT01216683|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24689516|NCT01216683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24689517|NCT01216683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689518|NCT01216683|Immunologic Factors|immunologic factors|mesh-ancestor
24689519|NCT01216683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689520|NCT01216683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24689521|NCT01216683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24689522|NCT01216683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24689523|NCT01216683|Growth Substances|growth substances|mesh-ancestor
24689524|NCT01216683|Growth Inhibitors|growth inhibitors|mesh-ancestor
24689525|NCT01216683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24410276|NCT00184977|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24410277|NCT00184977|Antiviral Agents|antiviral agents|mesh-ancestor
24689526|NCT01216683|Alkylating Agents|alkylating agents|mesh-ancestor
24689527|NCT01216683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689528|NCT01162109|Zinc Sulfate|zinc sulfate|mesh-list
24689529|NCT01162109|Astringents|astringents|mesh-ancestor
24689530|NCT01162109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689531|NCT01162109|Dermatologic Agents|dermatologic agents|mesh-ancestor
24689532|NCT01152541|Riboflavin|riboflavin|mesh-list
24689533|NCT01152541|Dextrans|dextrans|mesh-list
24689534|NCT01152541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24689536|NCT01152541|Vitamins|vitamins|mesh-ancestor
24689568|NCT01104350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689569|NCT01104350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24689570|NCT01104350|Immunologic Factors|immunologic factors|mesh-ancestor
24689571|NCT01104350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689572|NCT01085097|Mycophenolic Acid|mycophenolic acid|mesh-list
24689573|NCT01085097|Prednisone|prednisone|mesh-list
24689574|NCT01085097|Methylprednisolone|methylprednisolone|mesh-list
24689575|NCT01085097|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24689582|NCT01085097|Glucocorticoids|glucocorticoids|mesh-ancestor
24689583|NCT01085097|Hormones|hormones|mesh-ancestor
24689584|NCT01085097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24689585|NCT01085097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689586|NCT01085097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25109391|NCT03124680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109392|NCT03124680|Analgesics|analgesics|mesh-ancestor
25109393|NCT03124680|Sensory System Agents|sensory system agents|mesh-ancestor
24787336|NCT01924468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24918091|NCT04223739|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24918092|NCT04223739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25703147|NCT02164422|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25703148|NCT02164422|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25703149|NCT02164422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25703150|NCT02164422|Adrenergic Agents|adrenergic agents|mesh-ancestor
25703151|NCT02164422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25703152|NCT02164422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703153|NCT02164422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447162|NCT00307632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24447163|NCT00307632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24447167|NCT00307645|Prednisone|prednisone|mesh-list
24918452|NCT04219579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24918453|NCT04219579|Protease Inhibitors|protease inhibitors|mesh-ancestor
24918582|NCT04218734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918610|NCT04217798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24918611|NCT04217798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24918612|NCT04217798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24918613|NCT04217798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918614|NCT04217798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918615|NCT04217798|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24918616|NCT04217668|Isosorbide|isosorbide|mesh-list
24918617|NCT04217668|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24918618|NCT04217668|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
24918619|NCT04217668|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24918620|NCT04217668|Diuretics|diuretics|mesh-ancestor
24918621|NCT04217668|Natriuretic Agents|natriuretic agents|mesh-ancestor
24689587|NCT01085097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24410332|NCT00185107|Simvastatin|simvastatin|mesh-list
24689588|NCT01085097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24689589|NCT01085097|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24689590|NCT01085097|Antitubercular Agents|antitubercular agents|mesh-ancestor
24641592|NCT01174394|Serotonin Agents|serotonin agents|mesh-ancestor
24689591|NCT01085097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24689592|NCT01085097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24689613|NCT00962988|Antidepressive Agents|antidepressive agents|mesh-ancestor
24689614|NCT00962988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24689615|NCT00962988|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24689616|NCT00962988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24689617|NCT00962988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24689618|NCT00962988|Dopamine Agents|dopamine agents|mesh-ancestor
24689619|NCT00962988|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24689620|NCT00962988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24689621|NCT00962988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689622|NCT00920621|Vitamin D|vitamin d|mesh-list
24689623|NCT00920621|Ergocalciferols|ergocalciferols|mesh-list
24689624|NCT00920621|Cholecalciferol|cholecalciferol|mesh-list
24689673|NCT00682318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24689674|NCT00682318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689676|NCT00678730|Hallucinogens|hallucinogens|mesh-ancestor
24689677|NCT00678730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689678|NCT00678730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24689679|NCT00678730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24689680|NCT00678730|Analgesics|analgesics|mesh-ancestor
24689682|NCT00678730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24689683|NCT00678730|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24689684|NCT00678730|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24689685|NCT00678730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24918624|NCT04217668|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24918977|NCT04214938|Respiratory System Agents|respiratory system agents|mesh-ancestor
24919015|NCT04214821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24919044|NCT04214626|Vincristine|vincristine|mesh-list
24919045|NCT04214626|Lenalidomide|lenalidomide|mesh-list
24919046|NCT04214626|Epirubicin|epirubicin|mesh-list
24919047|NCT04214626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24919050|NCT04214626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24919051|NCT04214626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25703154|NCT02164513|Fluticasone|fluticasone|mesh-list
25703155|NCT02164513|Xhance|xhance|mesh-list
25703156|NCT02164513|Bromides|bromides|mesh-list
25703157|NCT02164513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25703158|NCT02164513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25703159|NCT02164513|Autonomic Agents|autonomic agents|mesh-ancestor
25703160|NCT02164513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25703161|NCT02164513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919052|NCT04214626|Alkylating Agents|alkylating agents|mesh-ancestor
24919053|NCT04214626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703162|NCT02164513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24410356|NCT00185120|Protease Inhibitors|protease inhibitors|mesh-ancestor
24919054|NCT04214626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919055|NCT04214626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24919056|NCT04214626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24919057|NCT04214626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24919058|NCT04214626|Glucocorticoids|glucocorticoids|mesh-ancestor
24919059|NCT04214626|Hormones|hormones|mesh-ancestor
24689686|NCT00678730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689687|NCT00678730|Hormones|hormones|mesh-ancestor
24689688|NCT00678730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24689689|NCT00600015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24689690|NCT00600015|Sorafenib|sorafenib|mesh-list
24689691|NCT00600015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689692|NCT00600015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24611895|NCT01011166|Antimetabolites|antimetabolites|mesh-ancestor
24611897|NCT01011166|Antiviral Agents|antiviral agents|mesh-ancestor
24689695|NCT00500071|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
24689696|NCT00500071|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24689697|NCT00500071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689802|NCT00290251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689803|NCT00290251|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24689804|NCT00214916|Insulin|insulin|mesh-list
24689805|NCT00214916|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24689806|NCT00214916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24689807|NCT00214916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689808|NCT00066963|Fluorides|fluorides|mesh-list
24689809|NCT00066963|Fluorides, Topical|fluorides, topical|mesh-list
24689810|NCT00066963|Cariostatic Agents|cariostatic agents|mesh-ancestor
24689811|NCT00066963|Protective Agents|protective agents|mesh-ancestor
24689812|NCT00066963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689813|NCT00055731|Aspirin|aspirin|mesh-list
24689814|NCT00055731|Docetaxel|docetaxel|mesh-list
24689815|NCT00055731|Goserelin|goserelin|mesh-list
24689816|NCT00055731|Bicalutamide|bicalutamide|mesh-list
24689817|NCT00055731|Estramustine|estramustine|mesh-list
24919060|NCT04214626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24494025|NCT00493415|Nitroglycerin|nitroglycerin|mesh-list
24919093|NCT04214145|Phenylephrine|phenylephrine|mesh-list
24919094|NCT04214145|Vasopressins|vasopressins|mesh-list
24919095|NCT04214145|Arginine Vasopressin|arginine vasopressin|mesh-list
24919096|NCT04214145|Oxymetazoline|oxymetazoline|mesh-list
24744730|NCT04169438|Petrolatum|petrolatum|mesh-list
24494266|NCT00494611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24494267|NCT00494624|Prednisolone|prednisolone|mesh-list
24494268|NCT00494624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24689818|NCT00055731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689819|NCT00055731|Tubulin Modulators|tubulin modulators|mesh-ancestor
24689820|NCT00055731|Antimitotic Agents|antimitotic agents|mesh-ancestor
24689821|NCT00055731|Mitosis Modulators|mitosis modulators|mesh-ancestor
24689822|NCT00055731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689825|NCT00055731|Analgesics|analgesics|mesh-ancestor
24689841|NCT00055731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24689842|NCT00055731|Alkylating Agents|alkylating agents|mesh-ancestor
24689843|NCT01397500|Testosterone|testosterone|mesh-list
24689844|NCT01397500|Androgens|androgens|mesh-ancestor
24689845|NCT01397500|Hormones|hormones|mesh-ancestor
24689846|NCT01397500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24689847|NCT01397500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689911|NCT01398046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24689912|NCT01398072|Azithromycin|azithromycin|mesh-list
24689913|NCT01398072|Moxifloxacin|moxifloxacin|mesh-list
24689914|NCT01398072|Doxycycline|doxycycline|mesh-list
24689915|NCT01398072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24689916|NCT01398072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24689917|NCT01398072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24689918|NCT01398072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24690007|NCT01398384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24690008|NCT01398384|Autonomic Agents|autonomic agents|mesh-ancestor
24690009|NCT01398384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24690010|NCT01398384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690011|NCT01398384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24690012|NCT01398384|Respiratory System Agents|respiratory system agents|mesh-ancestor
24690013|NCT01398384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24690014|NCT01398384|Antioxidants|antioxidants|mesh-ancestor
24410490|NCT00185510|Glucocorticoids|glucocorticoids|mesh-ancestor
24690015|NCT01398384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690016|NCT01398384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24690017|NCT01398384|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24690139|NCT01399515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24690208|NCT01400217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24690209|NCT01400217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690210|NCT01400217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24690211|NCT01400217|Respiratory System Agents|respiratory system agents|mesh-ancestor
24690213|NCT01400256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24494269|NCT00494624|Glucocorticoids|glucocorticoids|mesh-ancestor
24494270|NCT00494624|Hormones|hormones|mesh-ancestor
24919306|NCT04212832|Sensory System Agents|sensory system agents|mesh-ancestor
24494328|NCT00494884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494329|NCT00494884|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24919556|NCT04210453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494774|NCT00497003|Antioxidants|antioxidants|mesh-ancestor
24920257|NCT04204044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109395|NCT03124524|Dienogest|dienogest|mesh-list
24787337|NCT01924468|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24787338|NCT01924468|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24787339|NCT01924481|Theobromine|theobromine|mesh-list
24787341|NCT01924481|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24410611|NCT00186706|Trace Elements|trace elements|mesh-ancestor
24787342|NCT01924481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787343|NCT01924481|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24787344|NCT01924481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787345|NCT01924481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787346|NCT01924481|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24787347|NCT01924481|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24787348|NCT01924481|Purinergic Agents|purinergic agents|mesh-ancestor
24787349|NCT01924481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24690214|NCT01400256|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24690215|NCT01400256|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24690216|NCT01400256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690217|NCT01400308|Mupirocin|mupirocin|mesh-list
24690218|NCT01400308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24690219|NCT01400308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24690220|NCT01400308|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24690297|NCT01400737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690298|NCT01400737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690299|NCT01400750|Ciprofloxacin|ciprofloxacin|mesh-list
24690300|NCT01400750|Tobramycin|tobramycin|mesh-list
24787350|NCT01924481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24787351|NCT01924481|Autonomic Agents|autonomic agents|mesh-ancestor
24787352|NCT01924481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24787353|NCT01924481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24787354|NCT01924481|Respiratory System Agents|respiratory system agents|mesh-ancestor
25109397|NCT03124524|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25109398|NCT03124524|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25109399|NCT03124524|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25109400|NCT03124524|Estradiol|estradiol|mesh-list
25109401|NCT03124524|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25109431|NCT03124420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25109432|NCT03124420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25109433|NCT03124420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25109435|NCT03124082|Clonidine|clonidine|mesh-list
25109436|NCT03124082|Ketamine|ketamine|mesh-list
24690301|NCT01400750|Colistin|colistin|mesh-list
24690302|NCT01400750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24690303|NCT01400750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24690304|NCT01400750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24690305|NCT01400750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24690306|NCT01400750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690307|NCT01400750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690328|NCT01400867|Vancomycin|vancomycin|mesh-list
24410642|NCT00186823|Antibodies|antibodies|mesh-list
24410864|NCT00187070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24410865|NCT00187070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24690391|NCT01401192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690392|NCT01401192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24690393|NCT01401192|Immunologic Factors|immunologic factors|mesh-ancestor
24690394|NCT01401192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690395|NCT01401192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24690397|NCT01401387|Pancreatin|pancreatin|mesh-list
24690417|NCT01401491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24690418|NCT01401491|Antidepressive Agents|antidepressive agents|mesh-ancestor
24690419|NCT01401491|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24690420|NCT01401491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24690421|NCT01401491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690422|NCT01401491|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24690423|NCT01401803|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24690424|NCT01401803|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24690619|NCT01403025|Liraglutide|liraglutide|mesh-list
24690425|NCT01401803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24690426|NCT01401803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690427|NCT01401803|Cholinergic Agents|cholinergic agents|mesh-ancestor
24690428|NCT01401803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24690429|NCT01401803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690431|NCT01401933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24690473|NCT01402089|Midazolam|midazolam|mesh-list
24690474|NCT01402089|Caffeine|caffeine|mesh-list
24690475|NCT01402089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24690482|NCT01402089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24690483|NCT01402089|Anesthetics, General|anesthetics, general|mesh-ancestor
24690484|NCT01402089|Anesthetics|anesthetics|mesh-ancestor
24690485|NCT01402089|GABA Modulators|gaba modulators|mesh-ancestor
24690486|NCT01402089|GABA Agents|gaba agents|mesh-ancestor
24690487|NCT01402089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24690488|NCT01402089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690489|NCT01402089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24410866|NCT00187070|Antiviral Agents|antiviral agents|mesh-ancestor
24690490|NCT01402089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24690491|NCT01402089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690492|NCT01402089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24690493|NCT01402089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25109437|NCT03124082|Remifentanil|remifentanil|mesh-list
24552771|NCT00727753|Bevacizumab|bevacizumab|mesh-list
25109438|NCT03124082|Anesthetics, Local|anesthetics, local|mesh-ancestor
25109439|NCT03124082|Anesthetics|anesthetics|mesh-ancestor
25109440|NCT03124082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25109441|NCT03124082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109442|NCT03124082|Sensory System Agents|sensory system agents|mesh-ancestor
25109443|NCT03124082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25109444|NCT03124082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24690494|NCT01402089|Growth Substances|growth substances|mesh-ancestor
24690495|NCT01402089|Growth Inhibitors|growth inhibitors|mesh-ancestor
24690496|NCT01402089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24690497|NCT01402089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24690520|NCT01402271|Carboplatin|carboplatin|mesh-list
24631785|NCT01120158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24690531|NCT01402297|Sensory System Agents|sensory system agents|mesh-ancestor
24690532|NCT01402297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24690533|NCT01402297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690534|NCT01402297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24690535|NCT01402297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24690537|NCT01402297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690538|NCT01402297|Protective Agents|protective agents|mesh-ancestor
24690539|NCT01402297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690541|NCT01402336|Cetrorelix|cetrorelix|mesh-list
24690542|NCT01402336|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24690543|NCT01402336|Hormones|hormones|mesh-ancestor
24690544|NCT01402336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24690545|NCT01402336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690546|NCT01402336|Luteolytic Agents|luteolytic agents|mesh-ancestor
24690547|NCT01402336|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24690548|NCT01402336|Contraceptive Agents|contraceptive agents|mesh-ancestor
24690563|NCT01402583|Antimetabolites|antimetabolites|mesh-ancestor
24690564|NCT01402583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690565|NCT01402583|Antiviral Agents|antiviral agents|mesh-ancestor
24690566|NCT01402583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24690567|NCT01402596|Midazolam|midazolam|mesh-list
24690568|NCT01402596|Chloral Hydrate|chloral hydrate|mesh-list
24690569|NCT01402596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24690570|NCT01402596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25407403|NCT03504397|Folic Acid|folic acid|mesh-list
25703163|NCT02164513|Respiratory System Agents|respiratory system agents|mesh-ancestor
24690571|NCT01402596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24690572|NCT01402596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690573|NCT01402596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24690574|NCT01402596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24690583|NCT01402622|Propofol|propofol|mesh-list
24612016|NCT01011660|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24612017|NCT01011660|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24612018|NCT01011660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612019|NCT01011660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24612020|NCT01011660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24612021|NCT01011660|Diuretics|diuretics|mesh-ancestor
24690617|NCT01402882|Hemostatics|hemostatics|mesh-ancestor
24690618|NCT01402882|Coagulants|coagulants|mesh-ancestor
24690620|NCT01403025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24690621|NCT01403025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690622|NCT01403025|Incretins|incretins|mesh-ancestor
24690623|NCT01403025|Hormones|hormones|mesh-ancestor
24690624|NCT01403025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24690625|NCT01403103|Vitamin D|vitamin d|mesh-list
24690626|NCT01403103|Cholecalciferol|cholecalciferol|mesh-list
24690627|NCT01403103|Vitamins|vitamins|mesh-ancestor
24690628|NCT01403103|Micronutrients|micronutrients|mesh-ancestor
24690693|NCT01403415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24690694|NCT01403415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24690695|NCT01403415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24744879|NCT04096066|Antiemetics|antiemetics|mesh-ancestor
24920536|NCT04201990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920615|NCT04200885|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24920616|NCT04200885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24407940|NCT00175903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24407947|NCT00175981|Fluvoxamine|fluvoxamine|mesh-list
24407974|NCT00176020|Micronutrients|micronutrients|mesh-ancestor
24407975|NCT00176020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920618|NCT04200885|Autonomic Agents|autonomic agents|mesh-ancestor
24920619|NCT04200885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24920620|NCT04200885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920621|NCT04200885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24920622|NCT04200885|Glucocorticoids|glucocorticoids|mesh-ancestor
24920623|NCT04200885|Hormones|hormones|mesh-ancestor
25090796|NCT03253913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24690696|NCT01403415|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24690697|NCT01403415|Abortifacient Agents|abortifacient agents|mesh-ancestor
24690711|NCT01403415|Antimitotic Agents|antimitotic agents|mesh-ancestor
24690766|NCT01403740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24690767|NCT01403818|Ipragliflozin|ipragliflozin|mesh-list
24690768|NCT01403818|Mitiglinide|mitiglinide|mesh-list
24690769|NCT01403818|Calcium|calcium|mesh-list
24690770|NCT01403818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24690771|NCT01403818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690772|NCT01403818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24690773|NCT01403818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690774|NCT01403818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24690775|NCT01403844|Carotenoids|carotenoids|mesh-list
24690776|NCT01403844|Antioxidants|antioxidants|mesh-ancestor
24690777|NCT01403844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690778|NCT01403844|Protective Agents|protective agents|mesh-ancestor
24690779|NCT01403844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690780|NCT01403896|Plerixafor|plerixafor|mesh-list
24690781|NCT01403896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24690783|NCT01403896|Antiviral Agents|antiviral agents|mesh-ancestor
24690791|NCT01404000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690792|NCT01404013|Montelukast|montelukast|mesh-list
24690793|NCT01404013|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24690794|NCT01404013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24690803|NCT01404104|Sirolimus|sirolimus|mesh-list
24690836|NCT01404156|Antimitotic Agents|antimitotic agents|mesh-ancestor
24690837|NCT01404156|Mitosis Modulators|mitosis modulators|mesh-ancestor
24690838|NCT01404156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690839|NCT01404156|Antimetabolites|antimetabolites|mesh-ancestor
24690840|NCT01404156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24690841|NCT01404156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24690842|NCT01404156|Immunologic Factors|immunologic factors|mesh-ancestor
24690843|NCT01404156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690844|NCT01404156|Antidotes|antidotes|mesh-ancestor
24690845|NCT01404156|Protective Agents|protective agents|mesh-ancestor
24690846|NCT01404156|Vitamin B Complex|vitamin b complex|mesh-ancestor
24690847|NCT01404156|Vitamins|vitamins|mesh-ancestor
24690848|NCT01404156|Micronutrients|micronutrients|mesh-ancestor
24690849|NCT01404156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24690850|NCT01404156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24690851|NCT01404156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24690852|NCT01404156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690853|NCT01404169|Donepezil|donepezil|mesh-list
24690866|NCT01404312|Vitamin B 6|vitamin b 6|mesh-list
24411293|NCT00188630|Antioxidants|antioxidants|mesh-ancestor
24690867|NCT01404312|Isoniazid|isoniazid|mesh-list
24690868|NCT01404312|Rifapentine|rifapentine|mesh-list
24690869|NCT01404312|Vitamins|vitamins|mesh-ancestor
24690870|NCT01404312|Micronutrients|micronutrients|mesh-ancestor
24690871|NCT01404312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690872|NCT01404312|Vitamin B Complex|vitamin b complex|mesh-ancestor
24690873|NCT01404312|Antitubercular Agents|antitubercular agents|mesh-ancestor
24690874|NCT01404312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24690875|NCT01404312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24690876|NCT01404312|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24920624|NCT04200885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24920625|NCT04200885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24495857|NCT00502229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495889|NCT00502437|Granisetron|granisetron|mesh-list
24920742|NCT04198129|Clindamycin phosphate|clindamycin phosphate|mesh-list
24920743|NCT04198129|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24920744|NCT04198129|Ampicillin|ampicillin|mesh-list
24920745|NCT04198129|Sultamicillin|sultamicillin|mesh-list
24920746|NCT04198129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24920747|NCT04198129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24921190|NCT04193592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24921191|NCT04193592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24921192|NCT04193592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24921194|NCT04193592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921195|NCT04193501|Melatonin|melatonin|mesh-list
24921196|NCT04193501|Antioxidants|antioxidants|mesh-ancestor
24921197|NCT04193501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921198|NCT04193501|Protective Agents|protective agents|mesh-ancestor
24921199|NCT04193501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690877|NCT01404312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24690878|NCT01404312|Antimetabolites|antimetabolites|mesh-ancestor
24690879|NCT01404312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690880|NCT01404312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24690881|NCT01404312|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24690905|NCT01404377|Anesthetics, Local|anesthetics, local|mesh-ancestor
24690906|NCT01404377|Anesthetics|anesthetics|mesh-ancestor
24411295|NCT00188630|Protective Agents|protective agents|mesh-ancestor
24612029|NCT01011699|Nicotinic Acids|nicotinic acids|mesh-list
24612030|NCT01011699|Sevelamer|sevelamer|mesh-list
24612031|NCT01011699|Cinacalcet|cinacalcet|mesh-list
24612032|NCT01011699|Vitamin B Complex|vitamin b complex|mesh-ancestor
24612033|NCT01011699|Vitamins|vitamins|mesh-ancestor
24612034|NCT01011699|Micronutrients|micronutrients|mesh-ancestor
24612035|NCT01011699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612037|NCT01011699|Antimetabolites|antimetabolites|mesh-ancestor
24612038|NCT01011699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612039|NCT01011699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24690963|NCT01404637|Tamsulosin|tamsulosin|mesh-list
24691086|NCT01405118|Metformin|metformin|mesh-list
24691087|NCT01405118|Tofacitinib|tofacitinib|mesh-list
24691088|NCT01405118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24691089|NCT01405118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691090|NCT01405118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24691091|NCT01405118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691092|NCT01405118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691093|NCT01405131|Methylprednisolone|methylprednisolone|mesh-list
24691094|NCT01405131|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24691095|NCT01405131|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24691096|NCT01405131|Prednisolone|prednisolone|mesh-list
24691097|NCT01405131|Prednisolone acetate|prednisolone acetate|mesh-list
24691098|NCT01405131|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24691099|NCT01405131|Prednisolone phosphate|prednisolone phosphate|mesh-list
24691100|NCT01405131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24691101|NCT01405131|Antiemetics|antiemetics|mesh-ancestor
24691102|NCT01405131|Autonomic Agents|autonomic agents|mesh-ancestor
25703164|NCT02164513|Dermatologic Agents|dermatologic agents|mesh-ancestor
25703165|NCT02164513|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24921201|NCT04193553|Lenvatinib|lenvatinib|mesh-list
24921202|NCT04193553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25703166|NCT02164513|Anticonvulsants|anticonvulsants|mesh-ancestor
24921203|NCT04193553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24921204|NCT04193553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921589|NCT04189055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921591|NCT04189055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24921699|NCT04188184|Hemostatics|hemostatics|mesh-ancestor
24921794|NCT04186702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24921795|NCT04186702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24691103|NCT01405131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24691104|NCT01405131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691105|NCT01405131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24691106|NCT01405131|Glucocorticoids|glucocorticoids|mesh-ancestor
24691107|NCT01405131|Hormones|hormones|mesh-ancestor
24691108|NCT01405131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24691109|NCT01405131|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24691110|NCT01405131|Protective Agents|protective agents|mesh-ancestor
24691111|NCT01405131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24691759|NCT01408953|Growth Inhibitors|growth inhibitors|mesh-ancestor
24691196|NCT01405365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24691197|NCT01405430|Bevacizumab|bevacizumab|mesh-list
24691198|NCT01405430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24691199|NCT01405430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691200|NCT01405430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24691201|NCT01405430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24691202|NCT01405430|Growth Substances|growth substances|mesh-ancestor
24691203|NCT01405430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691204|NCT01405430|Growth Inhibitors|growth inhibitors|mesh-ancestor
24691205|NCT01405482|Botulinum Toxins|botulinum toxins|mesh-list
24691206|NCT01405482|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24612052|NCT01011751|Medroxyprogesterone|medroxyprogesterone|mesh-list
24612054|NCT01011751|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24612100|NCT01011920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24612101|NCT01011920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24612102|NCT01011920|Alkylating Agents|alkylating agents|mesh-ancestor
24691295|NCT01406002|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24691296|NCT01406002|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24691297|NCT01406002|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24691298|NCT01406002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24691304|NCT01406080|Adapalene|adapalene|mesh-list
24691307|NCT01406080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24691308|NCT01406080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24691309|NCT01406080|Analgesics|analgesics|mesh-ancestor
24787415|NCT01925092|Mifepristone|mifepristone|mesh-list
24691310|NCT01406080|Sensory System Agents|sensory system agents|mesh-ancestor
24691311|NCT01406080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24691312|NCT01406080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691313|NCT01406080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24691314|NCT01406080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24497198|NCT00508859|Serotonin Agents|serotonin agents|mesh-ancestor
24921829|NCT04186559|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24921830|NCT04186559|Protective Agents|protective agents|mesh-ancestor
24921831|NCT04186559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921978|NCT04185103|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24921979|NCT04185103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745154|NCT03928847|Antioxidants|antioxidants|mesh-ancestor
24787408|NCT01925027|Antifungal Agents|antifungal agents|mesh-ancestor
24691315|NCT01406080|Dermatologic Agents|dermatologic agents|mesh-ancestor
24691316|NCT01406080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691317|NCT01406080|Keratolytic Agents|keratolytic agents|mesh-ancestor
24691318|NCT01406132|Peficitinib|peficitinib|mesh-list
24691319|NCT01406132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691320|NCT01406132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691321|NCT01406132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24691322|NCT01406132|Immunologic Factors|immunologic factors|mesh-ancestor
24691323|NCT01406132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703167|NCT02164864|Aspirin|aspirin|mesh-list
25703168|NCT02164864|Warfarin|warfarin|mesh-list
25703169|NCT02164864|Dabigatran|dabigatran|mesh-list
25703170|NCT02164864|Clopidogrel|clopidogrel|mesh-list
25703171|NCT02164864|Ticagrelor|ticagrelor|mesh-list
24691324|NCT01406158|Solifenacin Succinate|solifenacin succinate|mesh-list
24691325|NCT01406158|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24691326|NCT01406158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24691327|NCT01406158|Cholinergic Agents|cholinergic agents|mesh-ancestor
24691328|NCT01406158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24691367|NCT01406262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24691368|NCT01406275|Amoxicillin|amoxicillin|mesh-list
24691369|NCT01406275|Clavulanic Acid|clavulanic acid|mesh-list
24691370|NCT01406275|Clavulanic Acids|clavulanic acids|mesh-list
24691371|NCT01406275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24691372|NCT01406275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24691373|NCT01406275|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24691374|NCT01406275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691460|NCT01406678|Analgesics|analgesics|mesh-ancestor
24691461|NCT01406678|Sensory System Agents|sensory system agents|mesh-ancestor
24691462|NCT01406678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24691463|NCT01406678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24691464|NCT01406678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24691465|NCT01406678|Anesthetics, General|anesthetics, general|mesh-ancestor
24691466|NCT01406678|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24691467|NCT01406704|Thioctic Acid|thioctic acid|mesh-list
24691468|NCT01406704|Rosiglitazone|rosiglitazone|mesh-list
24691469|NCT01406704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24691470|NCT01406704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408600|NCT00178828|Sertraline|sertraline|mesh-list
24691600|NCT01408095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24691601|NCT01408095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691602|NCT01408095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24691603|NCT01408095|Immunologic Factors|immunologic factors|mesh-ancestor
24691604|NCT01408095|Enzyme Activators|enzyme activators|mesh-ancestor
24691605|NCT01408095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691607|NCT01408160|Immunotoxins|immunotoxins|mesh-list
24691608|NCT01408160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24691682|NCT01408524|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24691683|NCT01408524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24691684|NCT01408524|Adrenergic Agents|adrenergic agents|mesh-ancestor
24411764|NCT00189982|Coagulants|coagulants|mesh-ancestor
24691685|NCT01408524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24691686|NCT01408524|Sympathomimetics|sympathomimetics|mesh-ancestor
24691687|NCT01408524|Autonomic Agents|autonomic agents|mesh-ancestor
24691688|NCT01408524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24691689|NCT01408524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24691690|NCT01408524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24691691|NCT01408589|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24691692|NCT01408589|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24691693|NCT01408589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24691694|NCT01408589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24787409|NCT01925027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24787410|NCT01925027|Immunologic Factors|immunologic factors|mesh-ancestor
24787411|NCT01925027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787412|NCT01925066|Vancomycin|vancomycin|mesh-list
24787413|NCT01925066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24626501|NCT01087593|Estrogens|estrogens|mesh-ancestor
24787414|NCT01925066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24787416|NCT01925092|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24787417|NCT01925092|Abortifacient Agents|abortifacient agents|mesh-ancestor
24787418|NCT01925092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24787419|NCT01925092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109463|NCT03124082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25109464|NCT03124082|Adrenergic Agents|adrenergic agents|mesh-ancestor
25109466|NCT03123770|Docetaxel|docetaxel|mesh-list
25109467|NCT03123770|Doxorubicin|doxorubicin|mesh-list
24691695|NCT01408589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691696|NCT01408589|Adrenergic Agents|adrenergic agents|mesh-ancestor
24691697|NCT01408589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24691698|NCT01408589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691700|NCT01408680|Coenzyme Q10|coenzyme q10|mesh-list
24691701|NCT01408680|Micronutrients|micronutrients|mesh-ancestor
24691702|NCT01408680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691703|NCT01408680|Vitamins|vitamins|mesh-ancestor
24691704|NCT01408797|Bortezomib|bortezomib|mesh-list
24691706|NCT01408810|Infliximab|infliximab|mesh-list
24691721|NCT01408836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691722|NCT01408836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24691723|NCT01408836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691724|NCT01408836|Antiemetics|antiemetics|mesh-ancestor
24691725|NCT01408836|Autonomic Agents|autonomic agents|mesh-ancestor
25407404|NCT03504397|Fluorouracil|fluorouracil|mesh-list
25703172|NCT02164864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24691738|NCT01408927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24691739|NCT01408927|Analgesics|analgesics|mesh-ancestor
24691740|NCT01408927|Sensory System Agents|sensory system agents|mesh-ancestor
24691741|NCT01408927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24691742|NCT01408927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691743|NCT01408927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24691744|NCT01408927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24691745|NCT01408927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24691746|NCT01408927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24691747|NCT01408927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477021|NCT00417014|Hormones|hormones|mesh-ancestor
24691748|NCT01408927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24691749|NCT01408927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24691750|NCT01408927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691751|NCT01408927|Antipyretics|antipyretics|mesh-ancestor
24691752|NCT01408953|Bevacizumab|bevacizumab|mesh-list
24691753|NCT01408953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24691754|NCT01408953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691758|NCT01408953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691767|NCT01408979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24691768|NCT01408979|Anticonvulsants|anticonvulsants|mesh-ancestor
24691769|NCT01408979|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24691770|NCT01408979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25109468|NCT03123770|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25109469|NCT03123770|Epirubicin|epirubicin|mesh-list
25109470|NCT03123770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24497904|NCT00512408|Hormones|hormones|mesh-ancestor
24497905|NCT00512408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24497906|NCT00512408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497907|NCT00512473|Hormones|hormones|mesh-list
24497908|NCT00512473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24497909|NCT00512473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497910|NCT00512486|Benralizumab|benralizumab|mesh-list
24497911|NCT00512486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24691771|NCT01408979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691772|NCT01408979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24691773|NCT01408979|Tocolytic Agents|tocolytic agents|mesh-ancestor
24691774|NCT01408979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24691775|NCT01409005|Gemcitabine|gemcitabine|mesh-list
24691776|NCT01409005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24691777|NCT01409005|Antimetabolites|antimetabolites|mesh-ancestor
24691778|NCT01409005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691779|NCT01409005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691780|NCT01409005|Antiviral Agents|antiviral agents|mesh-ancestor
24691808|NCT01409174|Cisplatin|cisplatin|mesh-list
24691809|NCT01409174|Temozolomide|temozolomide|mesh-list
24691810|NCT01409174|Ipilimumab|ipilimumab|mesh-list
24691811|NCT01409174|Interleukin-2|interleukin-2|mesh-list
24691812|NCT01409174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691813|NCT01409174|Antiviral Agents|antiviral agents|mesh-ancestor
24691814|NCT01409174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24691815|NCT01409174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24691820|NCT01409174|Immunologic Factors|immunologic factors|mesh-ancestor
24691863|NCT01409395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24691864|NCT01409395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24691865|NCT01409395|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24691866|NCT01409395|Histamine Antagonists|histamine antagonists|mesh-ancestor
24691867|NCT01409395|Histamine Agents|histamine agents|mesh-ancestor
24691868|NCT01409395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24691869|NCT01409395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691870|NCT01409408|Amlodipine|amlodipine|mesh-list
24691871|NCT01409408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24691872|NCT01409408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24691873|NCT01409408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24691874|NCT01409408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703173|NCT02164864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25703174|NCT02164864|Analgesics|analgesics|mesh-ancestor
24691875|NCT01409408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24691876|NCT01409408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691877|NCT01409408|Vasodilator Agents|vasodilator agents|mesh-ancestor
24447404|NCT00308425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24447405|NCT00308425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447406|NCT00308425|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24447407|NCT00308425|Antitubercular Agents|antitubercular agents|mesh-ancestor
24447408|NCT00308425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24447409|NCT00308425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24691878|NCT01409421|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24691879|NCT01409421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24691898|NCT01409603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691899|NCT01409603|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24691900|NCT01409603|Antithrombins|antithrombins|mesh-ancestor
24691901|NCT01409603|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24642024|NCT01177371|Cyclosporine|cyclosporine|mesh-list
24691904|NCT01409616|Aspirin|aspirin|mesh-list
24922437|NCT04180007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745303|NCT03836144|Diuretics|diuretics|mesh-ancestor
24498861|NCT00516607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923303|NCT04171180|Hormones|hormones|mesh-ancestor
24692002|NCT01410370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24692003|NCT01410370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24692004|NCT01410370|Growth Substances|growth substances|mesh-ancestor
24692005|NCT01410370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692006|NCT01410370|Growth Inhibitors|growth inhibitors|mesh-ancestor
24692007|NCT01410370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692008|NCT01410630|Telbivudine|telbivudine|mesh-list
24692009|NCT01410630|Antiviral Agents|antiviral agents|mesh-ancestor
24692010|NCT01410630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24692016|NCT01410682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24692017|NCT01410682|Disinfectants|disinfectants|mesh-ancestor
24692018|NCT01410708|Dasatinib|dasatinib|mesh-list
24692019|NCT01410708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692023|NCT01410747|Tacrolimus|tacrolimus|mesh-list
24692088|NCT01411124|Antiemetics|antiemetics|mesh-ancestor
24692089|NCT01411124|Autonomic Agents|autonomic agents|mesh-ancestor
24692090|NCT01411124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24692091|NCT01411124|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24692509|NCT01414868|Montelukast|montelukast|mesh-list
24692092|NCT01411124|Histamine Antagonists|histamine antagonists|mesh-ancestor
24692093|NCT01411124|Histamine Agents|histamine agents|mesh-ancestor
24692094|NCT01411124|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24692105|NCT01411202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24692106|NCT01411202|Antimalarials|antimalarials|mesh-ancestor
24692107|NCT01411202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24692199|NCT01411969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24692200|NCT01411969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692201|NCT01411969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692202|NCT01411969|Sympathomimetics|sympathomimetics|mesh-ancestor
24692203|NCT01411969|Autonomic Agents|autonomic agents|mesh-ancestor
24612154|NCT01012193|Vasodilator Agents|vasodilator agents|mesh-ancestor
24612155|NCT01012193|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24612156|NCT01012193|Protective Agents|protective agents|mesh-ancestor
24612157|NCT01012193|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24612158|NCT01012193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24612159|NCT01012193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612161|NCT01012232|Anesthetics, Local|anesthetics, local|mesh-ancestor
24612162|NCT01012232|Anesthetics|anesthetics|mesh-ancestor
24612163|NCT01012232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24923304|NCT04171180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24412518|NCT00191555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412520|NCT00191555|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24412636|NCT00191685|Dopamine Agents|dopamine agents|mesh-ancestor
24923305|NCT04171180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24923306|NCT04171180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24923307|NCT04171180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24612164|NCT01012232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612165|NCT01012232|Sensory System Agents|sensory system agents|mesh-ancestor
24612166|NCT01012232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25703175|NCT02164864|Sensory System Agents|sensory system agents|mesh-ancestor
25703176|NCT02164864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25703177|NCT02164864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703178|NCT02164864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25703179|NCT02164864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25703180|NCT02164864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25703181|NCT02164864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25709604|NCT02270736|Cholinergic Agents|cholinergic agents|mesh-ancestor
25703182|NCT02164864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827675|NCT02140801|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24827676|NCT02140801|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24612167|NCT01012284|Bedaquiline|bedaquiline|mesh-list
24692261|NCT01412411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692262|NCT01412437|Verapamil|verapamil|mesh-list
24692263|NCT01412437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24692264|NCT01412437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24692265|NCT01412437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24692266|NCT01412437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692267|NCT01412437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24408787|NCT00179686|Lenalidomide|lenalidomide|mesh-list
24408788|NCT00179686|Immunologic Factors|immunologic factors|mesh-ancestor
24692268|NCT01412437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692272|NCT01412515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24692273|NCT01412515|Immunologic Factors|immunologic factors|mesh-ancestor
24692274|NCT01412515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692275|NCT01412567|Vaccines|vaccines|mesh-list
24692276|NCT01412567|Immunologic Factors|immunologic factors|mesh-ancestor
24692277|NCT01412567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692278|NCT01412632|Remifentanil|remifentanil|mesh-list
24692279|NCT01412632|Propofol|propofol|mesh-list
24692280|NCT01412632|Prilocaine|prilocaine|mesh-list
24692281|NCT01412632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24692282|NCT01412632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24692283|NCT01412632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692284|NCT01412632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24692285|NCT01412632|Anesthetics, General|anesthetics, general|mesh-ancestor
24692286|NCT01412632|Anesthetics|anesthetics|mesh-ancestor
24692287|NCT01412632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24692288|NCT01412632|Narcotics|narcotics|mesh-ancestor
24692289|NCT01412632|Analgesics|analgesics|mesh-ancestor
24692293|NCT01412645|Resveratrol|resveratrol|mesh-list
24692329|NCT01412892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692330|NCT01413022|Leucovorin|leucovorin|mesh-list
24692331|NCT01413022|Fluorouracil|fluorouracil|mesh-list
24692338|NCT01413022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24692339|NCT01413022|Immunologic Factors|immunologic factors|mesh-ancestor
24692340|NCT01413022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692341|NCT01413022|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24692505|NCT01414816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692506|NCT01414816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24692507|NCT01414842|Dialysis Solutions|dialysis solutions|mesh-list
24692508|NCT01414842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24692510|NCT01414868|Leukotriene Antagonists|leukotriene antagonists|mesh-list
24692511|NCT01414868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24692512|NCT01414868|Respiratory System Agents|respiratory system agents|mesh-ancestor
24692513|NCT01414868|Hormone Antagonists|hormone antagonists|mesh-ancestor
24692514|NCT01414868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24692515|NCT01414868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612172|NCT01012349|Citric Acid|citric acid|mesh-list
24612173|NCT01012349|Sodium Citrate|sodium citrate|mesh-list
24612174|NCT01012349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24612175|NCT01012349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24612176|NCT01012349|Analgesics|analgesics|mesh-ancestor
24612177|NCT01012349|Sensory System Agents|sensory system agents|mesh-ancestor
24923308|NCT04171180|Adrenergic Agents|adrenergic agents|mesh-ancestor
24923309|NCT04171180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24923310|NCT04171180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923311|NCT04171193|Isoflurane|isoflurane|mesh-list
24923312|NCT04171193|Sertraline|sertraline|mesh-list
24923313|NCT04171193|Antidepressive Agents|antidepressive agents|mesh-ancestor
24498956|NCT00516945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24498957|NCT00516945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25109481|NCT03123770|Mitosis Modulators|mitosis modulators|mesh-ancestor
24498958|NCT00516958|Levofloxacin|levofloxacin|mesh-list
24498959|NCT00516958|Ofloxacin|ofloxacin|mesh-list
24498960|NCT00516958|Sodium Hypochlorite|sodium hypochlorite|mesh-list
24498961|NCT00516958|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24923364|NCT04170751|Norepinephrine|norepinephrine|mesh-list
24923365|NCT04170751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24612178|NCT01012349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24612179|NCT01012349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612180|NCT01012349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25703183|NCT02164864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25703184|NCT02164864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24612181|NCT01012349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24612182|NCT01012349|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24477970|NCT00421083|Vasodilator Agents|vasodilator agents|mesh-ancestor
24409010|NCT00180310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24692557|NCT01415128|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24692558|NCT01415128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24692587|NCT01415336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24692588|NCT01415336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24692589|NCT01415336|Antimetabolites|antimetabolites|mesh-ancestor
24692590|NCT01415466|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24692591|NCT01415466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24692592|NCT01415466|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24692593|NCT01415466|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24692594|NCT01415466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692595|NCT01415505|Valsartan|valsartan|mesh-list
24692685|NCT01415765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24692686|NCT01415765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24692687|NCT01415765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24692689|NCT01415765|Antimitotic Agents|antimitotic agents|mesh-ancestor
24692690|NCT01415765|Mitosis Modulators|mitosis modulators|mesh-ancestor
24692691|NCT01415778|Bicalutamide|bicalutamide|mesh-list
24692763|NCT01416220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692764|NCT01416220|Antimanic Agents|antimanic agents|mesh-ancestor
24692765|NCT01416220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24692766|NCT01416220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24692767|NCT01416220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692768|NCT01416220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24692769|NCT01416220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24692770|NCT01416220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24692847|NCT01416883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632287|NCT01123031|Dexlansoprazole|dexlansoprazole|mesh-list
24692917|NCT01417364|Testosterone enanthate|testosterone enanthate|mesh-list
24692918|NCT01417364|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24692919|NCT01417364|Androgens|androgens|mesh-ancestor
24692920|NCT01417364|Hormones|hormones|mesh-ancestor
24692921|NCT01417364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24692922|NCT01417364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923366|NCT04170751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24923367|NCT04170751|Adrenergic Agents|adrenergic agents|mesh-ancestor
24923368|NCT04170751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24923369|NCT04170751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923372|NCT04170751|Autonomic Agents|autonomic agents|mesh-ancestor
24923373|NCT04170751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24923374|NCT04170751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24923375|NCT04170751|Hemostatics|hemostatics|mesh-ancestor
24923376|NCT04170751|Coagulants|coagulants|mesh-ancestor
24923377|NCT04170751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24923378|NCT04170751|Natriuretic Agents|natriuretic agents|mesh-ancestor
24923379|NCT04170959|Metformin|metformin|mesh-list
24923380|NCT04170959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24923381|NCT04170959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923382|NCT04170595|Trastuzumab|trastuzumab|mesh-list
24923383|NCT04170595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24923384|NCT04170595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923385|NCT04170530|Oxaliplatin|oxaliplatin|mesh-list
24923386|NCT04170530|Irinotecan|irinotecan|mesh-list
24923387|NCT04170530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692923|NCT01417364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24692924|NCT01417364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692950|NCT01417429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24692951|NCT01417429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692952|NCT01417429|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24692953|NCT01417429|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24692954|NCT01417429|Cholinergic Agents|cholinergic agents|mesh-ancestor
24692955|NCT01417429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24692956|NCT01417429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692957|NCT01417429|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24692958|NCT01417429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24692959|NCT01417429|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24692960|NCT01417429|Nootropic Agents|nootropic agents|mesh-ancestor
25703185|NCT02164864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703186|NCT02164864|Antipyretics|antipyretics|mesh-ancestor
24692961|NCT01417494|Leucovorin|leucovorin|mesh-list
24692962|NCT01417494|Bevacizumab|bevacizumab|mesh-list
24692963|NCT01417494|Fluorouracil|fluorouracil|mesh-list
24692970|NCT01417494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692971|NCT01417494|Growth Inhibitors|growth inhibitors|mesh-ancestor
24692972|NCT01417494|Antimetabolites|antimetabolites|mesh-ancestor
24692973|NCT01417494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692974|NCT01417494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24692975|NCT01417494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24692976|NCT01417494|Immunologic Factors|immunologic factors|mesh-ancestor
24692977|NCT01417494|Antidotes|antidotes|mesh-ancestor
24692978|NCT01417494|Protective Agents|protective agents|mesh-ancestor
24693017|NCT01417806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24693018|NCT01417806|Hormones|hormones|mesh-ancestor
24693019|NCT01417806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24923424|NCT04170439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923426|NCT04170439|Hormone Antagonists|hormone antagonists|mesh-ancestor
24499018|NCT00517309|Vaccines|vaccines|mesh-list
24499053|NCT00517504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499054|NCT00517504|Dopamine Agents|dopamine agents|mesh-ancestor
24499055|NCT00517504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24499056|NCT00517517|Hemagglutinins|hemagglutinins|mesh-list
24499087|NCT00517725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24499088|NCT00517725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24499089|NCT00517725|Adrenergic Agents|adrenergic agents|mesh-ancestor
24499090|NCT00517725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24413146|NCT00193193|Paclitaxel|paclitaxel|mesh-list
24413221|NCT00193323|Gemcitabine|gemcitabine|mesh-list
24499091|NCT00517725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499092|NCT00517725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499093|NCT00517725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24499095|NCT00517725|Protective Agents|protective agents|mesh-ancestor
24499096|NCT00517725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24499099|NCT00517725|Vasodilator Agents|vasodilator agents|mesh-ancestor
24923527|NCT04169919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25090927|NCT03252457|Antimetabolites|antimetabolites|mesh-ancestor
24478458|NCT00422994|Ropinirole|ropinirole|mesh-list
24693022|NCT01417858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24693023|NCT01417858|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24693024|NCT01417858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24693030|NCT01417897|Insulin|insulin|mesh-list
24693087|NCT01418157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693088|NCT01418157|Diuretics|diuretics|mesh-ancestor
24693089|NCT01418157|Natriuretic Agents|natriuretic agents|mesh-ancestor
24693148|NCT01418534|Natriuretic Agents|natriuretic agents|mesh-ancestor
24693149|NCT01418534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693150|NCT01418534|Vasodilator Agents|vasodilator agents|mesh-ancestor
24693151|NCT01418534|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24693152|NCT01418534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693153|NCT01418547|Isosorbide|isosorbide|mesh-list
24693154|NCT01418547|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24693155|NCT01418547|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
24693232|NCT01418794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24693254|NCT01419132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693255|NCT01419132|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24693256|NCT01419132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24693257|NCT01419132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693260|NCT01419262|Cholecalciferol|cholecalciferol|mesh-list
24693261|NCT01419262|Vitamins|vitamins|mesh-list
24693262|NCT01419262|Micronutrients|micronutrients|mesh-ancestor
24693263|NCT01419262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499116|NCT00517764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499117|NCT00517764|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24499150|NCT00517985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413402|NCT00193726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24413403|NCT00193726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413404|NCT00193726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24413406|NCT00193726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24499152|NCT00517985|Sensory System Agents|sensory system agents|mesh-ancestor
24499199|NCT00518245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24499200|NCT00518245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24499201|NCT00518245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499202|NCT00518271|Sirolimus|sirolimus|mesh-list
24499203|NCT00518271|Tacrolimus|tacrolimus|mesh-list
24499204|NCT00518271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24499205|NCT00518271|Immunologic Factors|immunologic factors|mesh-ancestor
24693264|NCT01419262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24693265|NCT01419262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24693345|NCT01419821|Cholecalciferol|cholecalciferol|mesh-list
24693346|NCT01419821|Vitamins|vitamins|mesh-list
24693347|NCT01419821|Micronutrients|micronutrients|mesh-ancestor
24693348|NCT01419821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693349|NCT01419821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24693350|NCT01419821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24693355|NCT01419847|Ciclopirox|ciclopirox|mesh-list
24693356|NCT01419847|Antifungal Agents|antifungal agents|mesh-ancestor
24693357|NCT01419847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24693358|NCT01419873|Insulin|insulin|mesh-list
24693400|NCT01420302|Insulin|insulin|mesh-list
24693452|NCT01420523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693454|NCT01420523|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24693455|NCT01420523|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24693456|NCT01420575|Olanzapine|olanzapine|mesh-list
24693457|NCT01420575|Antiemetics|antiemetics|mesh-ancestor
24693458|NCT01420575|Autonomic Agents|autonomic agents|mesh-ancestor
24693459|NCT01420575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24693460|NCT01420575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693461|NCT01420575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24693462|NCT01420575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24693463|NCT01420575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24693464|NCT01420575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24693465|NCT01420575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24632517|NCT01124383|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24612276|NCT01013012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612278|NCT01013103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24612280|NCT01013103|Antimetabolites|antimetabolites|mesh-ancestor
24612281|NCT01013103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612282|NCT01013103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24612283|NCT01013103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24612284|NCT01013103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612285|NCT01013155|Perindopril|perindopril|mesh-list
24612286|NCT01013155|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24693505|NCT01420900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24642701|NCT01180959|Growth Substances|growth substances|mesh-ancestor
24693506|NCT01420900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693508|NCT01420900|Autonomic Agents|autonomic agents|mesh-ancestor
24693509|NCT01420900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24693510|NCT01420900|Nootropic Agents|nootropic agents|mesh-ancestor
24693511|NCT01420913|Pregabalin|pregabalin|mesh-list
24499206|NCT00518271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923609|NCT04168723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24923610|NCT04168723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24923611|NCT04168723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923612|NCT04168723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923613|NCT04168723|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24923614|NCT04168723|Contraceptive Agents|contraceptive agents|mesh-ancestor
24923615|NCT04168723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24923616|NCT04168723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923617|NCT04168723|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24923618|NCT04168723|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24923619|NCT04168723|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24923622|NCT04168619|Methotrexate|methotrexate|mesh-list
24923851|NCT04166565|Daratumumab|daratumumab|mesh-list
24624207|NCT01075308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624208|NCT01075425|Bortezomib|bortezomib|mesh-list
24500221|NCT00523289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500222|NCT00523289|Sensory System Agents|sensory system agents|mesh-ancestor
24500223|NCT00523289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24500224|NCT00523354|Infliximab|infliximab|mesh-list
24624303|NCT01075659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24624304|NCT01075659|Autonomic Agents|autonomic agents|mesh-ancestor
24624305|NCT01075659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24624306|NCT01075659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500610|NCT00525239|Efavirenz|efavirenz|mesh-list
24500611|NCT00525239|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24500612|NCT00525239|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24500613|NCT00525239|Protease Inhibitors|protease inhibitors|mesh-ancestor
24500614|NCT00525239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24500615|NCT00525239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500616|NCT00525239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24500617|NCT00525239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24500618|NCT00525239|Antiviral Agents|antiviral agents|mesh-ancestor
24500619|NCT00525239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24924963|NCT04154852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24925773|NCT04147572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925774|NCT04147572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24926377|NCT04142749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24926378|NCT04142749|Schistosomicides|schistosomicides|mesh-ancestor
24926379|NCT04142749|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24926380|NCT04142749|Anthelmintics|anthelmintics|mesh-ancestor
24926381|NCT04142749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24926382|NCT04142749|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24926383|NCT04142749|Protective Agents|protective agents|mesh-ancestor
24926384|NCT04142749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926529|NCT04140448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926531|NCT04140513|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24787505|NCT01925638|Hormone Antagonists|hormone antagonists|mesh-ancestor
24787506|NCT01925638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24787507|NCT01925638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693526|NCT01421043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24693527|NCT01421043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24693528|NCT01421043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24693530|NCT01421043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693553|NCT01421160|Anticoagulants|anticoagulants|mesh-ancestor
24926916|NCT04137653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927051|NCT04136028|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24927052|NCT04136028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24927183|NCT04135014|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24927184|NCT04135014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24927256|NCT04134273|Clindamycin phosphate|clindamycin phosphate|mesh-list
24927257|NCT04134273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24927258|NCT04134273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24927259|NCT04134273|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25109503|NCT03123718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24929390|NCT04113551|Adrenergic Agents|adrenergic agents|mesh-ancestor
24929444|NCT04112550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24929445|NCT04112550|Narcotics|narcotics|mesh-ancestor
24929486|NCT04111614|Tofacitinib|tofacitinib|mesh-list
24929487|NCT04111614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24929488|NCT04111614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24929489|NCT04111614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929490|NCT04111484|Adrenomedullin|adrenomedullin|mesh-list
24929491|NCT04111484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24929492|NCT04111484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24929493|NCT04111484|Autonomic Agents|autonomic agents|mesh-ancestor
24929494|NCT04111484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25091030|NCT03251469|Coagulants|coagulants|mesh-ancestor
24693563|NCT01421173|Busulfan|busulfan|mesh-list
24693564|NCT01421173|Vorinostat|vorinostat|mesh-list
24693565|NCT01421173|BB 1101|bb 1101|mesh-list
24693566|NCT01421173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24693567|NCT01421173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479002|NCT00425217|Rituximab|rituximab|mesh-list
24693568|NCT01421173|Immunologic Factors|immunologic factors|mesh-ancestor
24693569|NCT01421173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693608|NCT01421264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24929495|NCT04111484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929496|NCT04111484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24929497|NCT04111484|Respiratory System Agents|respiratory system agents|mesh-ancestor
24929498|NCT04111484|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24929499|NCT04111484|Vasodilator Agents|vasodilator agents|mesh-ancestor
24929500|NCT04111484|Protective Agents|protective agents|mesh-ancestor
24929502|NCT04111432|Immunologic Factors|immunologic factors|mesh-ancestor
24929503|NCT04111432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827816|NCT02141737|Anesthetics|anesthetics|mesh-ancestor
24827817|NCT02141737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24827818|NCT02141737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827819|NCT02141737|Sensory System Agents|sensory system agents|mesh-ancestor
24929504|NCT04111328|Sufentanil|sufentanil|mesh-list
24929505|NCT04111328|Dexmedetomidine|dexmedetomidine|mesh-list
24929506|NCT04111328|Dsuvia|dsuvia|mesh-list
24746331|NCT05437575|Fentanyl|fentanyl|mesh-list
24929708|NCT04110288|Tubulin Modulators|tubulin modulators|mesh-ancestor
24929709|NCT04110288|Antimitotic Agents|antimitotic agents|mesh-ancestor
24929710|NCT04110288|Mitosis Modulators|mitosis modulators|mesh-ancestor
24929711|NCT04110288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929712|NCT04110340|Ciprofloxacin|ciprofloxacin|mesh-list
24929713|NCT04110340|Streptomycin|streptomycin|mesh-list
24929714|NCT04110340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24929715|NCT04110340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24929716|NCT04110340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24929717|NCT04110340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24930033|NCT04105985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24746514|NCT05357859|Vitamin D|vitamin d|mesh-list
24930429|NCT04101578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24930430|NCT04101578|Alkylating Agents|alkylating agents|mesh-ancestor
24930431|NCT04101578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746597|NCT04895046|Niraparib|niraparib|mesh-list
24930525|NCT04101019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24930526|NCT04101019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930692|NCT04098653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506824|NCT00547183|Tadalafil|tadalafil|mesh-list
24930726|NCT04097847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24746665|NCT04590586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507040|NCT00548379|Vitamin D|vitamin d|mesh-list
24693695|NCT01421901|Ertapenem|ertapenem|mesh-list
24693719|NCT01421979|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24693720|NCT01421979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693721|NCT01421979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24693722|NCT01421979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693723|NCT01421979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693724|NCT01421979|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24693728|NCT01421992|Methylphenidate|methylphenidate|mesh-list
24693738|NCT01422018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24693739|NCT01422018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24693818|NCT01422499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24693819|NCT01422499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24693820|NCT01422499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693822|NCT01422590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24414153|NCT00196391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693828|NCT01422590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25109557|NCT03123276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109558|NCT03123276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25109559|NCT03123016|Apremilast|apremilast|mesh-list
25109560|NCT03123016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25109561|NCT03123016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25109562|NCT03123016|Analgesics|analgesics|mesh-ancestor
25109563|NCT03123016|Sensory System Agents|sensory system agents|mesh-ancestor
25109564|NCT03123016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25109565|NCT03123016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109566|NCT03123016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25109567|NCT03123016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25109568|NCT03123016|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24931083|NCT04093648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24931084|NCT04093648|Alkylating Agents|alkylating agents|mesh-ancestor
24624972|NCT01079676|Lenograstim|lenograstim|mesh-list
24624973|NCT01079676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24693829|NCT01422590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24693913|NCT01422785|Clindamycin phosphate|clindamycin phosphate|mesh-list
24693914|NCT01422785|Tretinoin|tretinoin|mesh-list
24693915|NCT01422785|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24693916|NCT01422785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24693917|NCT01422785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24693918|NCT01422785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25703187|NCT02164864|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25703188|NCT02164864|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25703189|NCT02164864|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25703190|NCT02164864|Purinergic Agents|purinergic agents|mesh-ancestor
25703191|NCT02164864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25703192|NCT02164864|Anticoagulants|anticoagulants|mesh-ancestor
24693919|NCT01422785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693920|NCT01422785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693921|NCT01422785|Dermatologic Agents|dermatologic agents|mesh-ancestor
24693972|NCT01423240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24693973|NCT01423240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693975|NCT01423240|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24693976|NCT01423240|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24693977|NCT01423240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24693978|NCT01423240|Adrenergic Agents|adrenergic agents|mesh-ancestor
24693979|NCT01423240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24612340|NCT01013532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24612341|NCT01013532|Analgesics|analgesics|mesh-ancestor
24694013|NCT01423370|Tadalafil|tadalafil|mesh-list
24694074|NCT01423747|Etoposide phosphate|etoposide phosphate|mesh-list
24694075|NCT01423747|Thiotepa|thiotepa|mesh-list
24694166|NCT01424176|Dopamine Agonists|dopamine agonists|mesh-ancestor
24694167|NCT01424176|Dopamine Agents|dopamine agents|mesh-ancestor
24694168|NCT01424176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24694169|NCT01424241|Octreotide|octreotide|mesh-list
24694170|NCT01424241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24694171|NCT01424241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24694172|NCT01424241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694173|NCT01424319|Atrasentan|atrasentan|mesh-list
24694174|NCT01424319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642846|NCT01181882|Aspirin|aspirin|mesh-list
24694175|NCT01424319|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
24694176|NCT01424319|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24931222|NCT04091763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24931223|NCT04091503|Temozolomide|temozolomide|mesh-list
24931224|NCT04091503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24931225|NCT04091503|Alkylating Agents|alkylating agents|mesh-ancestor
24931226|NCT04091503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931227|NCT04091503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931228|NCT04091490|Nivolumab|nivolumab|mesh-list
24931229|NCT04091490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24931230|NCT04091490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931231|NCT04091490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24931232|NCT04091490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931233|NCT04091412|3-n-butylphthalide|3-n-butylphthalide|mesh-list
24507432|NCT00550485|Serotonin Agents|serotonin agents|mesh-ancestor
24625104|NCT01080547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24625105|NCT01080547|Antimetabolites|antimetabolites|mesh-ancestor
24625106|NCT01080547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931703|NCT04085913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24931704|NCT04085913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24694177|NCT01424319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694197|NCT01424332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25703193|NCT02164864|Antithrombins|antithrombins|mesh-ancestor
25703194|NCT02164864|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25703195|NCT02164864|Protease Inhibitors|protease inhibitors|mesh-ancestor
25703196|NCT02164916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25703197|NCT02164916|Cetuximab|cetuximab|mesh-list
25703198|NCT02164916|Irinotecan|irinotecan|mesh-list
25703199|NCT02164916|Camptothecin|camptothecin|mesh-list
25703200|NCT02164916|Vemurafenib|vemurafenib|mesh-list
25703201|NCT02164916|Antibodies|antibodies|mesh-list
25703202|NCT02164916|Immunoglobulins|immunoglobulins|mesh-list
25703203|NCT02164916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25703204|NCT02164916|Immunoglobulin G|immunoglobulin g|mesh-list
25703205|NCT02164916|Mitogens|mitogens|mesh-list
25703206|NCT02164916|Immunologic Factors|immunologic factors|mesh-ancestor
24827886|NCT02142140|Dextroamphetamine|dextroamphetamine|mesh-list
24694198|NCT01424332|Antifungal Agents|antifungal agents|mesh-ancestor
24694199|NCT01424332|Keratolytic Agents|keratolytic agents|mesh-ancestor
24694200|NCT01424332|Dermatologic Agents|dermatologic agents|mesh-ancestor
24694201|NCT01424332|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24694202|NCT01424332|Antithrombins|antithrombins|mesh-ancestor
24694203|NCT01424332|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24542631|NCT00679614|Narcotics|narcotics|mesh-ancestor
24694204|NCT01424332|Protease Inhibitors|protease inhibitors|mesh-ancestor
24694205|NCT01424332|Anticoagulants|anticoagulants|mesh-ancestor
24694206|NCT01424345|Immunosuppressive Agents|immunosuppressive agents|mesh-list
24694207|NCT01424345|Immunologic Factors|immunologic factors|mesh-ancestor
24694208|NCT01424345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694209|NCT01424384|Citalopram|citalopram|mesh-list
24787590|NCT01925911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24787591|NCT01925911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787592|NCT01925911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24787593|NCT01925911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24787594|NCT01925911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25109590|NCT03122561|Sensory System Agents|sensory system agents|mesh-ancestor
25109591|NCT03122561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25109592|NCT03122561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787609|NCT01925937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24787610|NCT01925937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24787612|NCT01925937|Micronutrients|micronutrients|mesh-ancestor
24932599|NCT04077827|Anesthetics, General|anesthetics, general|mesh-ancestor
24932600|NCT04077827|Anesthetics|anesthetics|mesh-ancestor
24932601|NCT04077827|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24932602|NCT04077957|Hydroxychloroquine|hydroxychloroquine|mesh-list
24932603|NCT04077957|Sulfasalazine|sulfasalazine|mesh-list
24932606|NCT04077957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24932607|NCT04077957|Abortifacient Agents|abortifacient agents|mesh-ancestor
24694242|NCT01424618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24694243|NCT01424618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694244|NCT01424618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24694245|NCT01424618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694246|NCT01424618|Hormone Antagonists|hormone antagonists|mesh-ancestor
24694247|NCT01424618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24694249|NCT01424709|Cisplatin|cisplatin|mesh-list
24694250|NCT01424709|Docetaxel|docetaxel|mesh-list
24694282|NCT01424826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24414835|NCT00198978|Alkylating Agents|alkylating agents|mesh-ancestor
24694305|NCT01424839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24694331|NCT01425099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24694332|NCT01425099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694333|NCT01425099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24694335|NCT01425099|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24694337|NCT01425099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24694338|NCT01425099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694339|NCT01425099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24694340|NCT01425099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24694341|NCT01425099|Antiviral Agents|antiviral agents|mesh-ancestor
24694342|NCT01425099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24694343|NCT01425125|Tolvaptan|tolvaptan|mesh-list
24694386|NCT01425320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24694387|NCT01425320|Dermatologic Agents|dermatologic agents|mesh-ancestor
24694388|NCT01425320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24694389|NCT01425320|Antimalarials|antimalarials|mesh-ancestor
24694390|NCT01425320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24694391|NCT01425320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24612374|NCT01013558|Sensory System Agents|sensory system agents|mesh-ancestor
24612389|NCT01013675|Vaccines|vaccines|mesh-list
24612390|NCT01013675|Immunologic Factors|immunologic factors|mesh-ancestor
24612391|NCT01013675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612396|NCT01013779|Etoposide|etoposide|mesh-list
24694402|NCT01425398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24694403|NCT01425398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24694404|NCT01425398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24694405|NCT01425411|Valsartan|valsartan|mesh-list
25703207|NCT02164916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703208|NCT02164916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25703209|NCT02164916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25703210|NCT02164916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24828025|NCT02142790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828027|NCT02142829|Anesthetics, Local|anesthetics, local|mesh-ancestor
24828028|NCT02142829|Anesthetics|anesthetics|mesh-ancestor
24694406|NCT01425411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24694407|NCT01425411|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24694408|NCT01425411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24642872|NCT01181960|Risperidone|risperidone|mesh-list
24694409|NCT01425411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694410|NCT01425424|Vitamin D|vitamin d|mesh-list
24694411|NCT01425424|Ergocalciferols|ergocalciferols|mesh-list
24694447|NCT01425580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24694448|NCT01425580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24694449|NCT01425580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24625173|NCT01080729|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25004598|NCT02731352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004599|NCT02731352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004600|NCT02726659|Celecoxib|celecoxib|mesh-list
25004601|NCT02726659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25004602|NCT02726659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24933802|NCT04067102|Tubulin Modulators|tubulin modulators|mesh-ancestor
24933803|NCT04067102|Antimitotic Agents|antimitotic agents|mesh-ancestor
24933804|NCT04067102|Mitosis Modulators|mitosis modulators|mesh-ancestor
24625298|NCT01081548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625299|NCT01081548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24625300|NCT01081548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24694450|NCT01425580|Immunologic Factors|immunologic factors|mesh-ancestor
24694452|NCT01425619|Prilocaine|prilocaine|mesh-list
24694453|NCT01425619|Anesthetics, Local|anesthetics, local|mesh-ancestor
24694454|NCT01425619|Anesthetics|anesthetics|mesh-ancestor
24694480|NCT01425658|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24694481|NCT01425658|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24694482|NCT01425658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24694483|NCT01425658|Adrenergic Agents|adrenergic agents|mesh-ancestor
24694484|NCT01425658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24694538|NCT05386290|Analgesics|analgesics|mesh-ancestor
24694539|NCT05386290|Sensory System Agents|sensory system agents|mesh-ancestor
24694540|NCT05386290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24694541|NCT05386290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694542|NCT05386290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24694543|NCT05386186|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24694544|NCT05386186|Glimepiride|glimepiride|mesh-list
24694545|NCT05386186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24694546|NCT05386186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24694547|NCT05386186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933897|NCT04066257|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24933898|NCT04066257|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24933899|NCT04066257|Antacids|antacids|mesh-ancestor
24933900|NCT04066257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933931|NCT04066088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24933932|NCT04066088|Adrenergic Agents|adrenergic agents|mesh-ancestor
24933933|NCT04066088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24933934|NCT04066088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933935|NCT04066088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934122|NCT04063527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934123|NCT04063527|Tubulin Modulators|tubulin modulators|mesh-ancestor
24934124|NCT04063527|Antimitotic Agents|antimitotic agents|mesh-ancestor
24934125|NCT04063527|Mitosis Modulators|mitosis modulators|mesh-ancestor
24934126|NCT04063527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934127|NCT04063540|Amiloride|amiloride|mesh-list
24934128|NCT04063540|Diuretics|diuretics|mesh-ancestor
24694548|NCT05386186|Incretins|incretins|mesh-ancestor
24694549|NCT05386186|Hormones|hormones|mesh-ancestor
25407405|NCT03504397|Oxaliplatin|oxaliplatin|mesh-list
25703211|NCT02164916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703212|NCT02164916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703213|NCT02164916|Mitosis Modulators|mitosis modulators|mesh-ancestor
24694551|NCT05386186|Protease Inhibitors|protease inhibitors|mesh-ancestor
24694593|NCT05385900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694595|NCT05385887|Ciprofloxacin|ciprofloxacin|mesh-list
24694596|NCT05385887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24694597|NCT05385887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24694598|NCT05385887|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24694599|NCT05385887|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24694600|NCT05385887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24694601|NCT05385887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24694602|NCT05385887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24694603|NCT05385887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694604|NCT05385887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694605|NCT05385887|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24694606|NCT05385887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24694607|NCT05385861|Carboplatin|carboplatin|mesh-list
24694609|NCT05385861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694610|NCT05385861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24694611|NCT05385861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24694612|NCT05385861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24694613|NCT05385861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934757|NCT04058899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24934762|NCT04058899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24934763|NCT04058899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24934895|NCT04056949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24935105|NCT04054531|Pemetrexed|pemetrexed|mesh-list
24935106|NCT04054531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24553618|NCT00732407|Losartan|losartan|mesh-list
24935107|NCT04054531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935108|NCT04054531|Tubulin Modulators|tubulin modulators|mesh-ancestor
25004615|NCT02654132|Pomalidomide|pomalidomide|mesh-list
25004616|NCT02654132|Elotuzumab|elotuzumab|mesh-list
25004617|NCT02654132|BB 1101|bb 1101|mesh-list
24787694|NCT01926587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787695|NCT01926587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24787696|NCT01926639|Rituximab|rituximab|mesh-list
24787697|NCT01926639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24787698|NCT01926639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787699|NCT01926639|Immunologic Factors|immunologic factors|mesh-ancestor
24787700|NCT01926639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004697|NCT02371889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004698|NCT02257424|Hydroxychloroquine|hydroxychloroquine|mesh-list
24694749|NCT05370040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694770|NCT05316220|Analgesics|analgesics|mesh-ancestor
24694771|NCT05316220|Sensory System Agents|sensory system agents|mesh-ancestor
24694772|NCT05316220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25004699|NCT02257424|Trametinib|trametinib|mesh-list
25004700|NCT02257424|Dabrafenib|dabrafenib|mesh-list
25004701|NCT02257424|Antimalarials|antimalarials|mesh-ancestor
25004702|NCT02257424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25004703|NCT02257424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25004704|NCT02257424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25004705|NCT02257424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004706|NCT02257424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004707|NCT02257424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25004708|NCT02257424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25004709|NCT02257424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25004710|NCT02034422|Antioxidants|antioxidants|mesh-list
24747784|NCT03089203|Alkylating Agents|alkylating agents|mesh-ancestor
24454356|NCT04034485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24747878|NCT03054363|Letrozole|letrozole|mesh-list
25703216|NCT02164929|Acetaminophen|acetaminophen|mesh-list
25703217|NCT02164929|Dexamethasone|dexamethasone|mesh-list
25703218|NCT02164929|Lidocaine|lidocaine|mesh-list
24670607|NCT02201108|Teriflunomide|teriflunomide|mesh-list
24670608|NCT02201108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24670609|NCT02201108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25703219|NCT02164929|Epinephrine|epinephrine|mesh-list
25703220|NCT02164929|Midazolam|midazolam|mesh-list
24670884|NCT01457781|Gasotransmitters|gasotransmitters|mesh-ancestor
24455496|NCT00327535|Darbepoetin alfa|darbepoetin alfa|mesh-list
24455497|NCT00327535|Hematinics|hematinics|mesh-ancestor
24455498|NCT00327587|Amlodipine|amlodipine|mesh-list
24455499|NCT00327587|Valsartan|valsartan|mesh-list
24455500|NCT00327587|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24455514|NCT00327665|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24455515|NCT00327665|Immunologic Factors|immunologic factors|mesh-ancestor
24455516|NCT00327665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455517|NCT00327678|Rituximab|rituximab|mesh-list
24455518|NCT00327678|Imatinib Mesylate|imatinib mesylate|mesh-list
24748157|NCT02865187|Vitamin D|vitamin d|mesh-list
24516322|NCT00601536|Antimanic Agents|antimanic agents|mesh-ancestor
24748304|NCT02735044|Insulin|insulin|mesh-list
25091389|NCT03249168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24694818|NCT05244525|Respiratory System Agents|respiratory system agents|mesh-ancestor
24694819|NCT05244525|Mydriatics|mydriatics|mesh-ancestor
24612443|NCT01013987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24612444|NCT01013987|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24516983|NCT00605111|Insulin Aspart|insulin aspart|mesh-list
24456843|NCT00332384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456844|NCT00332384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004898|NCT05202496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24612445|NCT01013987|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24612446|NCT01013987|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24612447|NCT01013987|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24612448|NCT01013987|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24612449|NCT01014052|Retinol acetate|retinol acetate|mesh-list
24612450|NCT01014052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24612451|NCT01014052|Immunologic Factors|immunologic factors|mesh-ancestor
24694929|NCT05089916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24694930|NCT05089916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694934|NCT05041647|Dronabinol|dronabinol|mesh-list
24694935|NCT05041647|Hallucinogens|hallucinogens|mesh-ancestor
24694936|NCT05041647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417466|NCT00206544|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24417467|NCT00206544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24417468|NCT00206557|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
24417469|NCT00206557|Estradiol|estradiol|mesh-list
24694937|NCT05041647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24694938|NCT05041647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24694939|NCT05041647|Analgesics|analgesics|mesh-ancestor
24694940|NCT05041647|Sensory System Agents|sensory system agents|mesh-ancestor
24694941|NCT05041647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24694942|NCT05041647|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24694943|NCT05041647|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25004900|NCT05202496|Micronutrients|micronutrients|mesh-ancestor
25004901|NCT05202496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25004902|NCT05202288|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
25004903|NCT05202288|Antiviral Agents|antiviral agents|mesh-ancestor
25004904|NCT05202288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25004905|NCT05202275|Olanzapine|olanzapine|mesh-list
25004906|NCT05202275|Aprepitant|aprepitant|mesh-list
25004907|NCT05202275|Palonosetron|palonosetron|mesh-list
25004908|NCT05202275|Antiemetics|antiemetics|mesh-ancestor
25004909|NCT05202275|Autonomic Agents|autonomic agents|mesh-ancestor
25004910|NCT05202275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25004911|NCT05202275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004912|NCT05202275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25004913|NCT05202275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25004914|NCT05202275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25004915|NCT05202275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25004916|NCT05202275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25004917|NCT05202275|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24621470|NCT01062529|Somatostatin|somatostatin|mesh-list
24621471|NCT01062529|Hormones|hormones|mesh-ancestor
24621472|NCT01062529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24469259|NCT00385125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469260|NCT00385125|Immunologic Factors|immunologic factors|mesh-ancestor
24469261|NCT00385125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787884|NCT01928069|Hormone Antagonists|hormone antagonists|mesh-ancestor
24469510|NCT00386178|Micronutrients|micronutrients|mesh-ancestor
24469511|NCT00386178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469512|NCT00386178|Antioxidants|antioxidants|mesh-ancestor
24469513|NCT00386178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469514|NCT00386178|Protective Agents|protective agents|mesh-ancestor
24748576|NCT02367794|Carboplatin|carboplatin|mesh-list
24518879|NCT04094961|Glucocorticoids|glucocorticoids|mesh-ancestor
24518880|NCT04094961|Hormones|hormones|mesh-ancestor
24417470|NCT00206557|Estrogens|estrogens|mesh-ancestor
24417471|NCT00206557|Hormones|hormones|mesh-ancestor
24470789|NCT00391911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694944|NCT05041647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24694945|NCT05041647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694946|NCT05041647|Hormones|hormones|mesh-ancestor
24694947|NCT05041647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24694948|NCT05030415|Ixekizumab|ixekizumab|mesh-list
24694949|NCT05030415|Dermatologic Agents|dermatologic agents|mesh-ancestor
24694951|NCT05020782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24694952|NCT05020782|Immunologic Factors|immunologic factors|mesh-ancestor
24470913|NCT00392457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470914|NCT00392457|Antifungal Agents|antifungal agents|mesh-ancestor
24418094|NCT00208559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418095|NCT00208559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418096|NCT00208559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24418097|NCT00208559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24418098|NCT00208559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24418099|NCT00208559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24418100|NCT00208559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24418101|NCT00208559|Dopamine Agents|dopamine agents|mesh-ancestor
24418152|NCT00208741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418153|NCT00208741|GABA Agents|gaba agents|mesh-ancestor
24418154|NCT00208741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24418156|NCT00208793|Calcium, Dietary|calcium, dietary|mesh-list
24470915|NCT00392457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24470916|NCT00392457|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25703221|NCT02164929|Hydromorphone|hydromorphone|mesh-list
25703222|NCT02164929|Ropivacaine|ropivacaine|mesh-list
25703223|NCT02164929|Propofol|propofol|mesh-list
25703224|NCT02164929|Sevoflurane|sevoflurane|mesh-list
25703225|NCT02164929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25703226|NCT02164929|Antiemetics|antiemetics|mesh-ancestor
25703227|NCT02164929|Autonomic Agents|autonomic agents|mesh-ancestor
25703228|NCT02164929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25703229|NCT02164929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703230|NCT02164929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25703231|NCT02164929|Glucocorticoids|glucocorticoids|mesh-ancestor
24470918|NCT00392457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24470919|NCT00392457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470920|NCT00392457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24470921|NCT00392457|Hormone Antagonists|hormone antagonists|mesh-ancestor
24694965|NCT04930042|Ustekinumab|ustekinumab|mesh-list
24694970|NCT04850378|Apixaban|apixaban|mesh-list
24694989|NCT04809103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694990|NCT04804371|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24694991|NCT04804371|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24694992|NCT04804371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694994|NCT04765371|Dexamethasone acetate|dexamethasone acetate|mesh-list
24694995|NCT04765371|Prednisolone|prednisolone|mesh-list
24694996|NCT04765371|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24694997|NCT04765371|Methylprednisolone|methylprednisolone|mesh-list
24694998|NCT04765371|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24694999|NCT04765371|Prednisolone acetate|prednisolone acetate|mesh-list
24695000|NCT04765371|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24695001|NCT04765371|Prednisolone phosphate|prednisolone phosphate|mesh-list
24695002|NCT04765371|BB 1101|bb 1101|mesh-list
24695003|NCT04765371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24695005|NCT04765371|Autonomic Agents|autonomic agents|mesh-ancestor
24695006|NCT04765371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24695008|NCT04765371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24787912|NCT01928316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787913|NCT01928316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787914|NCT01928407|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24862809|NCT04356196|Verapamil|verapamil|mesh-list
24748832|NCT02102243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24695040|NCT04698525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24695041|NCT04698525|Dopamine Agents|dopamine agents|mesh-ancestor
24695042|NCT04698525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24695043|NCT04698525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695044|NCT04698525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695045|NCT04698525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24695046|NCT04698525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24695047|NCT04698525|Anticonvulsants|anticonvulsants|mesh-ancestor
24695048|NCT04698525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24695072|NCT04673162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24695073|NCT04673162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477218|NCT00417872|Nitazoxanide|nitazoxanide|mesh-list
24477219|NCT00417872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24477285|NCT00418132|Leprostatic Agents|leprostatic agents|mesh-ancestor
24477286|NCT00418132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24477287|NCT00418132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24477288|NCT00418132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24477289|NCT00418132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24477290|NCT00418132|Growth Substances|growth substances|mesh-ancestor
24477291|NCT00418132|Growth Inhibitors|growth inhibitors|mesh-ancestor
24479795|NCT00428428|Autonomic Agents|autonomic agents|mesh-ancestor
24520585|NCT05337085|GABA Modulators|gaba modulators|mesh-ancestor
24457115|NCT00333125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24457116|NCT00333125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457117|NCT00333125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457118|NCT00333125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24457119|NCT00333125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24457120|NCT00333125|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25091543|NCT03248648|Ketamine|ketamine|mesh-list
24479905|NCT00428818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24479954|NCT00429208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24457121|NCT00333125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479978|NCT00429377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479979|NCT00429377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24479980|NCT00429377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24695092|NCT04638660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695093|NCT04638660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24695100|NCT04510051|Cyclophosphamide|cyclophosphamide|mesh-list
24695101|NCT04510051|Fludarabine|fludarabine|mesh-list
24695102|NCT04510051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24480640|NCT00431522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24480641|NCT00431522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24480642|NCT00431522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24480643|NCT00431561|Temozolomide|temozolomide|mesh-list
24480713|NCT00431704|Antimitotic Agents|antimitotic agents|mesh-ancestor
24481248|NCT00433927|Cetuximab|cetuximab|mesh-list
24481249|NCT00433927|Irinotecan|irinotecan|mesh-list
24521499|NCT04745728|Prednisone|prednisone|mesh-list
24482028|NCT00437671|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24482029|NCT00437671|Immunologic Factors|immunologic factors|mesh-ancestor
24482079|NCT00437853|Hormone Antagonists|hormone antagonists|mesh-ancestor
24482318|NCT00438607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091617|NCT03248271|Insulin Lispro|insulin lispro|mesh-list
24695103|NCT04510051|Immunologic Factors|immunologic factors|mesh-ancestor
24695104|NCT04510051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695105|NCT04510051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24695106|NCT04510051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24633293|NCT01128101|Spironolactone|spironolactone|mesh-list
24483020|NCT00441428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483022|NCT00441506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
24457409|NCT00334360|Dexmedetomidine|dexmedetomidine|mesh-list
24457410|NCT00334360|Buspirone|buspirone|mesh-list
24457411|NCT00334360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24474683|NCT00407017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24419283|NCT00211614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24457425|NCT00334360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24457426|NCT00334360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25091630|NCT03247998|Remifentanil|remifentanil|mesh-list
24449063|NCT00314158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004952|NCT05201326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25004953|NCT05201326|Growth Substances|growth substances|mesh-ancestor
25004954|NCT05201326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004955|NCT05201326|Growth Inhibitors|growth inhibitors|mesh-ancestor
25004956|NCT05201326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25004957|NCT05201326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24415088|NCT00199069|Dexamethasone|dexamethasone|mesh-list
25004958|NCT05201326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004959|NCT05201326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004960|NCT05200793|Metformin|metformin|mesh-list
25004961|NCT05200793|Empagliflozin|empagliflozin|mesh-list
25004962|NCT05200793|Linagliptin|linagliptin|mesh-list
25004963|NCT05200793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25004964|NCT05200793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004965|NCT05200793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24490710|NCT00479739|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24490711|NCT00479739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24490712|NCT00479739|Adrenergic Agents|adrenergic agents|mesh-ancestor
24490713|NCT00479739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24491018|NCT00480844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24491019|NCT00480844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24491192|NCT00481572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24491193|NCT00481572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24491194|NCT00481572|Adrenergic Agents|adrenergic agents|mesh-ancestor
24491195|NCT00481572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24491196|NCT00481572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491197|NCT00481572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491199|NCT00481572|Autonomic Agents|autonomic agents|mesh-ancestor
24491200|NCT00481572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24491201|NCT00481572|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24491235|NCT00481702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24491236|NCT00481702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24497235|NCT00508976|Bupivacaine|bupivacaine|mesh-list
24497236|NCT00508976|Anesthetics, Local|anesthetics, local|mesh-ancestor
24419284|NCT00211614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419595|NCT00212875|Hematinics|hematinics|mesh-ancestor
24419596|NCT00213070|Miglitol|miglitol|mesh-list
24419597|NCT00213070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419598|NCT00213070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419599|NCT00213070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24497268|NCT00509158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24497269|NCT00509158|Immunologic Factors|immunologic factors|mesh-ancestor
24497270|NCT00509158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443222|NCT00294086|Valsartan|valsartan|mesh-list
24497272|NCT00509158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497273|NCT00509158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24695154|NCT04425902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24695155|NCT04425902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24695156|NCT04425902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24695157|NCT04425902|Adrenergic Agents|adrenergic agents|mesh-ancestor
24695158|NCT04425902|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24695159|NCT04425902|Protective Agents|protective agents|mesh-ancestor
24695162|NCT04425902|Antimetabolites|antimetabolites|mesh-ancestor
24695164|NCT04425902|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24695165|NCT04425902|Analgesics|analgesics|mesh-ancestor
24695166|NCT04425902|Sensory System Agents|sensory system agents|mesh-ancestor
24695167|NCT04425902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24695168|NCT04425902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24695169|NCT04425902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24497274|NCT00509184|Rituximab|rituximab|mesh-list
24497275|NCT00509184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24497276|NCT00509184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497303|NCT00509379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24497304|NCT00509405|Potassium Citrate|potassium citrate|mesh-list
24497305|NCT00509405|Diuretics|diuretics|mesh-ancestor
24497306|NCT00509405|Natriuretic Agents|natriuretic agents|mesh-ancestor
24749923|NCT01694797|Autonomic Agents|autonomic agents|mesh-ancestor
24499583|NCT00520104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24499584|NCT00520104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499585|NCT00520104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24499586|NCT00520104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24499587|NCT00520104|Anesthetics, General|anesthetics, general|mesh-ancestor
24499588|NCT00520104|Anesthetics|anesthetics|mesh-ancestor
24499617|NCT00520247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499618|NCT00520247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499619|NCT00520247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24499620|NCT00520260|Ketorolac|ketorolac|mesh-list
24499621|NCT00520260|Bromfenac|bromfenac|mesh-list
24499628|NCT00520260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24499629|NCT00520260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24499630|NCT00520260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24618935|NCT01050322|Antiviral Agents|antiviral agents|mesh-ancestor
25005052|NCT05049343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25005053|NCT05049343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25005054|NCT05049343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005055|NCT05041322|Buspirone|buspirone|mesh-list
25005056|NCT05041322|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25005057|NCT05041322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25005087|NCT04941755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005088|NCT04931641|Ferrous fumarate|ferrous fumarate|mesh-list
25005089|NCT04931641|Trace Elements|trace elements|mesh-ancestor
25005090|NCT04931641|Micronutrients|micronutrients|mesh-ancestor
24503953|NCT00533533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503954|NCT00533533|Tubulin Modulators|tubulin modulators|mesh-ancestor
24420128|NCT00215241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503955|NCT00533533|Antimitotic Agents|antimitotic agents|mesh-ancestor
24503956|NCT00533533|Mitosis Modulators|mitosis modulators|mesh-ancestor
24503957|NCT00533533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503958|NCT00533559|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
24503959|NCT00533559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503960|NCT00533585|Paclitaxel|paclitaxel|mesh-list
24503961|NCT00533585|Bevacizumab|bevacizumab|mesh-list
24503962|NCT00533585|Carboplatin|carboplatin|mesh-list
24503963|NCT00533585|Sorafenib|sorafenib|mesh-list
24503964|NCT00533585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24503965|NCT00533585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503966|NCT00533585|Tubulin Modulators|tubulin modulators|mesh-ancestor
24503967|NCT00533585|Antimitotic Agents|antimitotic agents|mesh-ancestor
24503968|NCT00533585|Mitosis Modulators|mitosis modulators|mesh-ancestor
24695244|NCT04166071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695245|NCT04166071|Sensory System Agents|sensory system agents|mesh-ancestor
24695274|NCT03996265|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24695275|NCT03996265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24506061|NCT00543959|Pioglitazone|pioglitazone|mesh-list
24506062|NCT00543959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24457668|NCT00334867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24457669|NCT00334867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24506063|NCT00543959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506064|NCT00544011|Bevacizumab|bevacizumab|mesh-list
24506065|NCT00544011|Fluorouracil|fluorouracil|mesh-list
24506066|NCT00544011|Capecitabine|capecitabine|mesh-list
24506184|NCT00544232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506185|NCT00544232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24506186|NCT00544232|Immunologic Factors|immunologic factors|mesh-ancestor
24506187|NCT00544232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506188|NCT00544232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24506189|NCT00544232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24506190|NCT00544232|Alkylating Agents|alkylating agents|mesh-ancestor
24506191|NCT00544232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25091754|NCT03247257|Anesthetics, General|anesthetics, general|mesh-ancestor
24506330|NCT00544687|Antidepressive Agents|antidepressive agents|mesh-ancestor
24506332|NCT00544687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24457670|NCT00334867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24788075|NCT01929278|Dermatologic Agents|dermatologic agents|mesh-ancestor
24788077|NCT01929330|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24788078|NCT01929330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24788079|NCT01929330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788080|NCT01929330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788081|NCT01929330|Hormone Antagonists|hormone antagonists|mesh-ancestor
24788082|NCT01929330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25091778|NCT03246776|Dermatologic Agents|dermatologic agents|mesh-ancestor
24695276|NCT03996265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24695277|NCT03996265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695284|NCT03945084|Niraparib|niraparib|mesh-list
24612465|NCT01014104|Autonomic Agents|autonomic agents|mesh-ancestor
24612466|NCT01014104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24612467|NCT01014104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612468|NCT01014104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24612469|NCT01014104|Glucocorticoids|glucocorticoids|mesh-ancestor
24612470|NCT01014104|Hormones|hormones|mesh-ancestor
24612471|NCT01014104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24612472|NCT01014104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24612473|NCT01014104|Protective Agents|protective agents|mesh-ancestor
24612474|NCT01014104|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24612475|NCT01014104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612476|NCT01014156|Epoprostenol|epoprostenol|mesh-list
24612477|NCT01014156|Tezosentan|tezosentan|mesh-list
24612478|NCT01014156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24612479|NCT01014156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24612480|NCT01014156|Vasodilator Agents|vasodilator agents|mesh-ancestor
24612481|NCT01014221|Prednisolone|prednisolone|mesh-list
24612482|NCT01014221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24612484|NCT01014221|Hormones|hormones|mesh-ancestor
24788083|NCT01929330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788084|NCT01929382|Interferons|interferons|mesh-list
24788085|NCT01929382|Interferon-gamma|interferon-gamma|mesh-list
24788086|NCT01929382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24788087|NCT01929382|Antiviral Agents|antiviral agents|mesh-ancestor
24788088|NCT01929382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24788089|NCT01929421|Gemcitabine|gemcitabine|mesh-list
24788090|NCT01929421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24788091|NCT01929421|Antimetabolites|antimetabolites|mesh-ancestor
24788092|NCT01929421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788093|NCT01929421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24788094|NCT01929421|Antiviral Agents|antiviral agents|mesh-ancestor
24788095|NCT01929421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24788096|NCT01929421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788097|NCT01929421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24788098|NCT01929421|Immunologic Factors|immunologic factors|mesh-ancestor
24788099|NCT01929421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788100|NCT01929486|Mogamulizumab|mogamulizumab|mesh-list
24612485|NCT01014221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24421183|NCT00218075|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24421248|NCT00218166|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
24421249|NCT00218166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24421291|NCT00218231|Dopamine Agents|dopamine agents|mesh-ancestor
24421292|NCT00218231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24612486|NCT01014221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612487|NCT01014221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24612488|NCT01014221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612491|NCT01014234|Cyclosporins|cyclosporins|mesh-list
24612492|NCT01014234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612505|NCT01014247|Moxifloxacin|moxifloxacin|mesh-list
24695364|NCT03737292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24695365|NCT03734211|Evolocumab|evolocumab|mesh-list
24695366|NCT03734211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24695367|NCT03734211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24788101|NCT01929486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24788102|NCT01929512|Metformin|metformin|mesh-list
24788103|NCT01929512|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24788104|NCT01929512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25109660|NCT03122353|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24508732|NCT00556634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24394208|NCT00132561|Sulfadoxine|sulfadoxine|mesh-list
24508797|NCT00557102|Protective Agents|protective agents|mesh-ancestor
24508798|NCT00557102|Vitamin B Complex|vitamin b complex|mesh-ancestor
24508799|NCT00557102|Vitamins|vitamins|mesh-ancestor
24508800|NCT00557102|Micronutrients|micronutrients|mesh-ancestor
24508801|NCT00557102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24508802|NCT00557180|Beclomethasone|beclomethasone|mesh-list
24508803|NCT00557180|Bromides|bromides|mesh-list
24508804|NCT00557180|Tiotropium Bromide|tiotropium bromide|mesh-list
24508805|NCT00557180|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24417493|NCT00206622|Hormones|hormones|mesh-ancestor
24508806|NCT00557180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24508889|NCT00557544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24508890|NCT00557544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508891|NCT00557557|Oxaliplatin|oxaliplatin|mesh-list
24508892|NCT00557557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508953|NCT00557921|Sensory System Agents|sensory system agents|mesh-ancestor
24508954|NCT00557921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24508955|NCT00557921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005147|NCT04742673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25005148|NCT04742673|Adrenergic Agents|adrenergic agents|mesh-ancestor
24695368|NCT03734211|Antimetabolites|antimetabolites|mesh-ancestor
24695369|NCT03734211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695370|NCT03734211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24695371|NCT03730974|Snake venom protein C activator|snake venom protein c activator|mesh-list
24695372|NCT03730974|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24695373|NCT03730974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24510493|NCT00564655|Respiratory System Agents|respiratory system agents|mesh-ancestor
24510495|NCT00564655|Sympathomimetics|sympathomimetics|mesh-ancestor
24510496|NCT00564655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24510726|NCT00565422|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24510727|NCT00565422|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24510728|NCT00565422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24510729|NCT00565422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510730|NCT00565422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24695416|NCT03596424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695417|NCT03596424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24695418|NCT03596424|Analgesics|analgesics|mesh-ancestor
24695419|NCT03596424|Sensory System Agents|sensory system agents|mesh-ancestor
24633560|NCT01129934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24422232|NCT00221650|Antimetabolites|antimetabolites|mesh-ancestor
24510764|NCT00565539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24510766|NCT00565591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24510767|NCT00565591|Autonomic Agents|autonomic agents|mesh-ancestor
24510768|NCT00565591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24510769|NCT00565591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510770|NCT00565591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24510825|NCT00565708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24510826|NCT00565708|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24510827|NCT00565708|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24510828|NCT00565708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510829|NCT00565708|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24457721|NCT00335075|Alkylating Agents|alkylating agents|mesh-ancestor
24526316|NCT00005780|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
24526317|NCT00005780|Immunologic Factors|immunologic factors|mesh-ancestor
24511378|NCT00568477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511379|NCT00568477|Immunologic Factors|immunologic factors|mesh-ancestor
24511380|NCT00568477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091836|NCT03246620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24695441|NCT03563222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24695442|NCT03559426|Antipsychotic Agents|antipsychotic agents|mesh-list
24695443|NCT03559426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24695444|NCT03559426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24695445|NCT03559426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695446|NCT03559426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24695447|NCT03512405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24422952|NCT00224302|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24512206|NCT00573599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24512207|NCT00573599|Antiemetics|antiemetics|mesh-ancestor
24512208|NCT00573599|Autonomic Agents|autonomic agents|mesh-ancestor
24512209|NCT00573599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24512347|NCT00574366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24512348|NCT00574366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512438|NCT00574964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24512439|NCT00574964|Alkylating Agents|alkylating agents|mesh-ancestor
24512440|NCT00574964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512441|NCT00574964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512443|NCT00575068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24512444|NCT00575068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24750929|NCT01701180|Oxytocin|oxytocin|mesh-list
25703232|NCT02164929|Hormones|hormones|mesh-ancestor
25703233|NCT02164929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25703234|NCT02164929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25703235|NCT02164929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25703236|NCT02164929|Anesthetics, Local|anesthetics, local|mesh-ancestor
25703237|NCT02164929|Anesthetics|anesthetics|mesh-ancestor
25703238|NCT02164929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25703239|NCT02164929|Sensory System Agents|sensory system agents|mesh-ancestor
24828871|NCT02148016|Renal Agents|renal agents|mesh-ancestor
24512638|NCT00575952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24512922|NCT00577668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24512923|NCT00577668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091879|NCT03246451|Metformin|metformin|mesh-list
24512927|NCT00577668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24512928|NCT00577668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24512970|NCT00577850|Risedronic Acid|risedronic acid|mesh-list
24512971|NCT00577850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24512972|NCT00577850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457749|NCT00335114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24396256|NCT00138229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24396257|NCT00138229|Alkylating Agents|alkylating agents|mesh-ancestor
24788177|NCT01929941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788178|NCT01929941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24457754|NCT00335166|Antioxidants|antioxidants|mesh-ancestor
24751128|NCT01702207|Tacrolimus|tacrolimus|mesh-list
24514583|NCT00591643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24514584|NCT00591643|Autonomic Agents|autonomic agents|mesh-ancestor
24583802|NCT00877097|Trisequens|trisequens|mesh-list
24583803|NCT00877097|Norethindrone|norethindrone|mesh-list
24583804|NCT00877097|Estradiol|estradiol|mesh-list
24423379|NCT00225706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520303|NCT02993198|Adrenergic Agents|adrenergic agents|mesh-ancestor
24583805|NCT00877097|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24583806|NCT00877097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583807|NCT00877097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24583809|NCT00877097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24583810|NCT00877097|Contraceptive Agents|contraceptive agents|mesh-ancestor
24583811|NCT00877097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24583812|NCT00877097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24583813|NCT00877097|Estrogens|estrogens|mesh-ancestor
24751163|NCT01702623|Anticonvulsants|anticonvulsants|mesh-ancestor
24695461|NCT03507699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24695462|NCT03507699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24695463|NCT03507699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24515276|NCT00596154|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24515277|NCT00596154|Cyclophosphamide|cyclophosphamide|mesh-list
24515278|NCT00596154|Busulfan|busulfan|mesh-list
24515279|NCT00596154|Thiotepa|thiotepa|mesh-list
24515280|NCT00596154|Rituximab|rituximab|mesh-list
24515281|NCT00596154|Methotrexate|methotrexate|mesh-list
24515282|NCT00596154|Vincristine|vincristine|mesh-list
24751204|NCT01702714|Paclitaxel|paclitaxel|mesh-list
24788192|NCT01930019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24788193|NCT01930019|Anesthetics, General|anesthetics, general|mesh-ancestor
24788194|NCT01930019|Anticonvulsants|anticonvulsants|mesh-ancestor
24396746|NCT00139854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24396747|NCT00139854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396748|NCT00139854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24518243|NCT05329857|Protease Inhibitors|protease inhibitors|mesh-ancestor
24518244|NCT05329857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24518278|NCT05329454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24518279|NCT05329454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518280|NCT05329454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24518282|NCT05329454|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24518351|NCT05214807|Viscosupplements|viscosupplements|mesh-ancestor
24518352|NCT05214807|Protective Agents|protective agents|mesh-ancestor
24518353|NCT05214807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518389|NCT05132595|Sensory System Agents|sensory system agents|mesh-ancestor
24518390|NCT05132595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24518670|NCT04562090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642976|NCT01182662|Cyclosporins|cyclosporins|mesh-list
24695464|NCT03507699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695465|NCT03495713|Nivolumab|nivolumab|mesh-list
24695466|NCT03495713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24695467|NCT03495713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24695468|NCT03495713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24695469|NCT03495713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695472|NCT03444753|Nivolumab|nivolumab|mesh-list
24695473|NCT03444753|Ipilimumab|ipilimumab|mesh-list
25703240|NCT02164929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25703241|NCT02164929|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25703242|NCT02164929|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24828878|NCT02148016|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24828879|NCT02148016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24828882|NCT02148016|Hormones|hormones|mesh-ancestor
24695474|NCT03444753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24695475|NCT03444753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424329|NCT00228865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24424330|NCT00228865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518700|NCT04524130|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24519625|NCT05332028|Anesthetics, Local|anesthetics, local|mesh-ancestor
24519626|NCT05332028|Anesthetics|anesthetics|mesh-ancestor
24519627|NCT05332028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24519628|NCT05332028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520254|NCT03425812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24394219|NCT00132561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24520292|NCT03085004|Antiviral Agents|antiviral agents|mesh-ancestor
24520293|NCT03085004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24520294|NCT03085004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24520295|NCT03085004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24520296|NCT03085004|Immunologic Factors|immunologic factors|mesh-ancestor
24520297|NCT03085004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520298|NCT03085004|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24520299|NCT03085004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24520300|NCT02993198|Carvedilol|carvedilol|mesh-list
24520301|NCT02993198|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24520302|NCT02993198|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24457792|NCT00335231|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24522257|NCT04081831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24522258|NCT04081831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24522259|NCT04081831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522260|NCT04081831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24522261|NCT04081831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24522419|NCT03853044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522421|NCT03853044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24695493|NCT03375203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24424332|NCT00228878|Insulin Aspart|insulin aspart|mesh-list
24695500|NCT03375203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695501|NCT03283137|Pembrolizumab|pembrolizumab|mesh-list
24695502|NCT03283137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24695503|NCT03283137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522424|NCT03853044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24522425|NCT03853044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24522458|NCT03803761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24522460|NCT03787251|Apatinib|apatinib|mesh-list
24522461|NCT03787251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522462|NCT03787251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24522463|NCT03787251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24522464|NCT03787251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522465|NCT03761173|Anticoagulants|anticoagulants|mesh-list
24580601|NCT00862420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24522503|NCT03673956|Mupirocin|mupirocin|mesh-list
24425267|NCT00232531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24522504|NCT03673956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24522505|NCT03673956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24522506|NCT03673956|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24522507|NCT03673956|Renal Agents|renal agents|mesh-ancestor
24455454|NCT00945724|Glucocorticoids|glucocorticoids|mesh-ancestor
24522508|NCT03673956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24522509|NCT03673956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24522696|NCT03412266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24522697|NCT03412266|Antimetabolites|antimetabolites|mesh-ancestor
24522698|NCT03412266|Antiviral Agents|antiviral agents|mesh-ancestor
24522699|NCT03412266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24522701|NCT03411031|Dexamethasone|dexamethasone|mesh-list
24522702|NCT03411031|Lenalidomide|lenalidomide|mesh-list
25703243|NCT02164929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25703244|NCT02164929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695528|NCT03158389|Sirolimus|sirolimus|mesh-list
24695544|NCT03142035|Contraceptive Agents|contraceptive agents|mesh-ancestor
24695545|NCT03142035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24695546|NCT03142035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695548|NCT03142035|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24695550|NCT03142035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24695551|NCT03142035|Hormone Antagonists|hormone antagonists|mesh-ancestor
24514813|NCT00593060|Sirolimus|sirolimus|mesh-list
24522761|NCT03253263|Growth Substances|growth substances|mesh-ancestor
24522762|NCT03253263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522764|NCT03205163|Coagulants|coagulants|mesh-ancestor
24522765|NCT03145766|Immunoglobulins|immunoglobulins|mesh-list
24522766|NCT03145766|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24522767|NCT03145766|Antibodies|antibodies|mesh-list
24751605|NCT01705002|Antimetabolites|antimetabolites|mesh-ancestor
24523119|NCT02584309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523120|NCT02584309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24523121|NCT02584309|Protective Agents|protective agents|mesh-ancestor
24523122|NCT02584309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695557|NCT02926833|Atezolizumab|atezolizumab|mesh-list
24695558|NCT02926833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24695559|NCT02926833|Immunologic Factors|immunologic factors|mesh-ancestor
24695560|NCT02926833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695561|NCT02926833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24695562|NCT02926833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24695563|NCT02926833|Alkylating Agents|alkylating agents|mesh-ancestor
24695590|NCT02786875|Ergocalciferols|ergocalciferols|mesh-list
24695591|NCT02786875|Cholecalciferol|cholecalciferol|mesh-list
24695592|NCT02786875|Vitamins|vitamins|mesh-list
24695593|NCT02786875|Micronutrients|micronutrients|mesh-ancestor
24695594|NCT02786875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695595|NCT02786875|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24523190|NCT02389036|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24523191|NCT02389036|Ciprofloxacin|ciprofloxacin|mesh-list
24523192|NCT02389036|Ceftriaxone|ceftriaxone|mesh-list
24555547|NCT00742014|Sildenafil Citrate|sildenafil citrate|mesh-list
24555548|NCT00742014|Vasodilator Agents|vasodilator agents|mesh-ancestor
24555549|NCT00742014|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24555550|NCT00742014|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24555551|NCT00742014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24555552|NCT00742014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425813|NCT00234416|Gefitinib|gefitinib|mesh-list
24426500|NCT00236223|Glucocorticoids|glucocorticoids|mesh-ancestor
24695615|NCT02547662|Glycine|glycine|mesh-list
24695616|NCT02547662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24695617|NCT02547662|Antiemetics|antiemetics|mesh-ancestor
24695618|NCT02547662|Autonomic Agents|autonomic agents|mesh-ancestor
24695619|NCT02547662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24695620|NCT02547662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695621|NCT02547662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24695633|NCT02547662|Growth Substances|growth substances|mesh-ancestor
24695662|NCT02348216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695663|NCT02348216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24695664|NCT02348216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24695665|NCT02348216|Alkylating Agents|alkylating agents|mesh-ancestor
24420697|NCT00216606|Topiramate|topiramate|mesh-list
24695666|NCT02348216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695667|NCT02348216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24555554|NCT00742040|Captopril|captopril|mesh-list
24523193|NCT02389036|Tobramycin|tobramycin|mesh-list
25703245|NCT02164929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25703246|NCT02164929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25703247|NCT02164929|Anesthetics, General|anesthetics, general|mesh-ancestor
25703248|NCT02164929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25703249|NCT02164929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24523591|NCT05341817|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25703250|NCT02164929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25703251|NCT02164929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25703252|NCT02164929|GABA Modulators|gaba modulators|mesh-ancestor
25703253|NCT02164929|GABA Agents|gaba agents|mesh-ancestor
24523592|NCT05341817|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24523593|NCT05341817|Luteolytic Agents|luteolytic agents|mesh-ancestor
24523594|NCT05341817|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24751649|NCT01705314|Vitamins|vitamins|mesh-ancestor
24524162|NCT05227391|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24524163|NCT05227391|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24524164|NCT05227391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24524188|NCT05170685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24524190|NCT05170685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24524191|NCT05170685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695668|NCT02348216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24695669|NCT02246257|Metformin|metformin|mesh-list
24695670|NCT02246257|Losartan|losartan|mesh-list
24695671|NCT02246257|Simvastatin|simvastatin|mesh-list
24695672|NCT02246257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24695673|NCT02246257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695674|NCT02246257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24695675|NCT02246257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24695703|NCT02124941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524239|NCT05109416|Bupivacaine|bupivacaine|mesh-list
24524240|NCT05109416|Anesthetics, Local|anesthetics, local|mesh-ancestor
24524241|NCT05109416|Anesthetics|anesthetics|mesh-ancestor
24524242|NCT05109416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24524243|NCT05109416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695712|NCT02094794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695713|NCT02094794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24695714|NCT02094794|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24695715|NCT02094794|Alkylating Agents|alkylating agents|mesh-ancestor
24695716|NCT02094794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695717|NCT02094794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24695718|NCT02094794|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24695719|NCT02094794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24395181|NCT00135408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24524403|NCT04973891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524405|NCT04966546|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24524406|NCT04966546|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24524407|NCT04966546|Dopamine Agents|dopamine agents|mesh-ancestor
24524408|NCT04966546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24524409|NCT04966546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524410|NCT04966546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524411|NCT04966546|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24524412|NCT04966546|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24524414|NCT04954742|Enzyme Activators|enzyme activators|mesh-ancestor
24524415|NCT04954742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524416|NCT04952402|Vaccines|vaccines|mesh-list
24524417|NCT04952402|Immunologic Factors|immunologic factors|mesh-ancestor
24421155|NCT00217828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24524418|NCT04952402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524419|NCT04951362|Ivermectin|ivermectin|mesh-list
25005239|NCT04368559|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25005240|NCT04368559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25005242|NCT04364048|Carboplatin|carboplatin|mesh-list
25005243|NCT04364048|Etoposide|etoposide|mesh-list
25005244|NCT04364048|Pemetrexed|pemetrexed|mesh-list
25005245|NCT04364048|Durvalumab|durvalumab|mesh-list
25703255|NCT02164929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25703256|NCT02164929|Analgesics|analgesics|mesh-ancestor
25703257|NCT02164929|Antipyretics|antipyretics|mesh-ancestor
25703258|NCT02164929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24524938|NCT04188873|Varenicline|varenicline|mesh-list
25703259|NCT02164929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25703260|NCT02164929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25703261|NCT02164929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25703262|NCT02164929|Adrenergic Agents|adrenergic agents|mesh-ancestor
24525463|NCT03326791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24525464|NCT03326791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24525465|NCT03326791|Analgesics|analgesics|mesh-ancestor
24525466|NCT03326791|Sensory System Agents|sensory system agents|mesh-ancestor
24695742|NCT01949714|Mydriatics|mydriatics|mesh-ancestor
24695743|NCT01949714|Sympathomimetics|sympathomimetics|mesh-ancestor
24695744|NCT01949714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24695745|NCT01596621|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24695746|NCT01596621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24695747|NCT01596621|Alkylating Agents|alkylating agents|mesh-ancestor
24525941|NCT02329847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24525942|NCT02329847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525975|NCT02265367|Analgesics|analgesics|mesh-ancestor
24525976|NCT02265367|Sensory System Agents|sensory system agents|mesh-ancestor
24525977|NCT02265367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24525978|NCT02161783|Cyclophosphamide|cyclophosphamide|mesh-list
24525979|NCT02161783|Fludarabine|fludarabine|mesh-list
24525980|NCT02161783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24525997|NCT02129348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005302|NCT04232423|Antiemetics|antiemetics|mesh-ancestor
25005303|NCT04232423|Autonomic Agents|autonomic agents|mesh-ancestor
25005304|NCT04232423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25005305|NCT04232423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005306|NCT04232423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25005307|NCT04232423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25005308|NCT04232423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25005309|NCT04232423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25005310|NCT04232423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25005311|NCT04232423|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25005312|NCT04232423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24752149|NCT01708642|Mydriatics|mydriatics|mesh-ancestor
24428910|NCT00241501|Esomeprazole|esomeprazole|mesh-list
24526125|NCT01188096|Poly ICLC|poly iclc|mesh-list
24526126|NCT01188096|Interferon Inducers|interferon inducers|mesh-ancestor
24526210|NCT00764270|Thioctic Acid|thioctic acid|mesh-list
24526211|NCT00764270|Antioxidants|antioxidants|mesh-ancestor
24526212|NCT00764270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526213|NCT00764270|Protective Agents|protective agents|mesh-ancestor
24526214|NCT00764270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526215|NCT00764270|Vitamin B Complex|vitamin b complex|mesh-ancestor
24526216|NCT00764270|Vitamins|vitamins|mesh-ancestor
24526217|NCT00764270|Micronutrients|micronutrients|mesh-ancestor
24526218|NCT00621751|Carbamazepine|carbamazepine|mesh-list
24752265|NCT01709656|Analgesics|analgesics|mesh-ancestor
24526344|NCT00611195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24526470|NCT00611754|Immunologic Factors|immunologic factors|mesh-ancestor
24526471|NCT00611754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526472|NCT00611793|Bevacizumab|bevacizumab|mesh-list
24526823|NCT00613457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526824|NCT00613457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24526826|NCT00613457|Alkylating Agents|alkylating agents|mesh-ancestor
24421493|NCT00219375|Sivelestat|sivelestat|mesh-list
24526833|NCT00613457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24526834|NCT00613457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24526835|NCT00613457|Glucocorticoids|glucocorticoids|mesh-ancestor
24474684|NCT00407017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24526860|NCT00613470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24526861|NCT00613470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526862|NCT00613470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24527121|NCT00615147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527122|NCT00615147|Hemostatics|hemostatics|mesh-ancestor
24527123|NCT00615147|Coagulants|coagulants|mesh-ancestor
24527124|NCT00615160|Dacarbazine|dacarbazine|mesh-list
24527126|NCT00615160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24527127|NCT00615160|Alkylating Agents|alkylating agents|mesh-ancestor
24527128|NCT00615160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527129|NCT00615160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24430663|NCT00248963|Estradiol|estradiol|mesh-list
24430664|NCT00248963|Estrogens|estrogens|mesh-ancestor
24829077|NCT02149823|Oxytocin|oxytocin|mesh-list
24527130|NCT00615160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24527131|NCT00615160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527132|NCT00615173|Cyclophosphamide|cyclophosphamide|mesh-list
24527133|NCT00615173|Azathioprine|azathioprine|mesh-list
24527134|NCT00615173|Tacrolimus|tacrolimus|mesh-list
24527135|NCT00615173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24527136|NCT00615173|Immunologic Factors|immunologic factors|mesh-ancestor
24527137|NCT00615173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527138|NCT00615173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24527202|NCT00615446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527203|NCT00615446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24457844|NCT00335400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24474685|NCT00407017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527494|NCT00616863|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24527495|NCT00616863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24527497|NCT00616876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24527517|NCT00616915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24527518|NCT00616915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752504|NCT01710696|Estradiol|estradiol|mesh-list
24866510|NCT04702256|Prednisone|prednisone|mesh-list
25005499|NCT03939520|Pirfenidone|pirfenidone|mesh-list
25005500|NCT03939520|Nintedanib|nintedanib|mesh-list
25005501|NCT03939520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005502|NCT03939520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25005503|NCT03939520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25005504|NCT03939520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005505|NCT03939520|Analgesics|analgesics|mesh-ancestor
25005506|NCT03939520|Sensory System Agents|sensory system agents|mesh-ancestor
24457899|NCT00335621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457900|NCT00335621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24530994|NCT00633438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430665|NCT00248963|Hormones|hormones|mesh-ancestor
24695790|NCT01231906|Dexrazoxane|dexrazoxane|mesh-list
24695791|NCT01231906|Razoxane|razoxane|mesh-list
24695792|NCT01231906|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
24695793|NCT01231906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24695794|NCT01231906|Immunologic Factors|immunologic factors|mesh-ancestor
24695795|NCT01231906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695796|NCT01231906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24643014|NCT01183247|Glucocorticoids|glucocorticoids|mesh-ancestor
24530999|NCT00633490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24531000|NCT00633490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531001|NCT00633542|Interferons|interferons|mesh-list
24531002|NCT00633542|Interferon-alpha|interferon-alpha|mesh-list
24531003|NCT00633542|Thalidomide|thalidomide|mesh-list
24531004|NCT00633542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531005|NCT00633542|Antiviral Agents|antiviral agents|mesh-ancestor
24531006|NCT00633542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24531038|NCT00633672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24531039|NCT00633672|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24531041|NCT00633672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531042|NCT00633672|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24866633|NCT05258474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24531121|NCT00634140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24532785|NCT00641082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532786|NCT00641095|Cyclophosphamide|cyclophosphamide|mesh-list
24532787|NCT00641095|Rituximab|rituximab|mesh-list
24532788|NCT00641095|Fludarabine|fludarabine|mesh-list
24532789|NCT00641095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24532818|NCT00641173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24532819|NCT00641173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24695797|NCT01231906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24695798|NCT01231906|Alkylating Agents|alkylating agents|mesh-ancestor
24695799|NCT01231906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695800|NCT01231906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24695815|NCT00223145|Goserelin|goserelin|mesh-list
24695816|NCT00223145|Bicalutamide|bicalutamide|mesh-list
24695817|NCT00223145|Androgens|androgens|mesh-list
24695819|NCT00223145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109680|NCT03122197|Letrozole|letrozole|mesh-list
24788549|NCT01932203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24788550|NCT01932203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788551|NCT01932203|Antipyretics|antipyretics|mesh-ancestor
24788552|NCT01932203|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24788553|NCT01932203|Autonomic Agents|autonomic agents|mesh-ancestor
24788554|NCT01932203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24619387|NCT01052298|Ciprofloxacin|ciprofloxacin|mesh-list
24701871|NCT01462058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24701872|NCT01462149|Carboplatin|carboplatin|mesh-list
24701873|NCT01462149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701874|NCT01462214|Everolimus|everolimus|mesh-list
24753958|NCT01718496|Analgesics|analgesics|mesh-ancestor
24701962|NCT01463150|Purinergic Agents|purinergic agents|mesh-ancestor
24701963|NCT01463150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24613349|NCT01018446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702170|NCT01464450|Antithrombins|antithrombins|mesh-ancestor
25092328|NCT03242460|Dexamethasone|dexamethasone|mesh-list
24695820|NCT00223145|Androgen Antagonists|androgen antagonists|mesh-ancestor
24695821|NCT00223145|Hormone Antagonists|hormone antagonists|mesh-ancestor
24695822|NCT00223145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24695823|NCT00223145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695824|NCT00223145|Hormones|hormones|mesh-ancestor
24481379|NCT00434135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24481380|NCT00434135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24702171|NCT01464450|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24754034|NCT01718873|Bevacizumab|bevacizumab|mesh-list
25005582|NCT03349775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25005583|NCT03349775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005584|NCT03256344|Atezolizumab|atezolizumab|mesh-list
25005585|NCT03256344|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25005586|NCT03256344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005587|NCT03256344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25005589|NCT03216187|Analgesics|analgesics|mesh-ancestor
25005590|NCT03216187|Sensory System Agents|sensory system agents|mesh-ancestor
25005591|NCT03216187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25005592|NCT03216187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005593|NCT03216187|Anticonvulsants|anticonvulsants|mesh-ancestor
25005594|NCT03216187|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25005595|NCT03216187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25005596|NCT03216187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005597|NCT03216187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25005598|NCT03216187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25005599|NCT03216187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25005600|NCT03216187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25005601|NCT03216187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25005640|NCT03019640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702734|NCT01467401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702735|NCT01467414|Insulin|insulin|mesh-list
24702736|NCT01467414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24702738|NCT01467518|Dolutegravir|dolutegravir|mesh-list
24754322|NCT01720030|Simendan|simendan|mesh-list
24754461|NCT01720615|Anesthetics|anesthetics|mesh-ancestor
24704394|NCT01478035|Phenytoin|phenytoin|mesh-list
24704395|NCT01478035|Anticonvulsants|anticonvulsants|mesh-ancestor
24704396|NCT01478035|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24704397|NCT01478035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24422332|NCT00222144|Tubulin Modulators|tubulin modulators|mesh-ancestor
24704398|NCT01478035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24704399|NCT01478035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703263|NCT02164929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25703264|NCT02164929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24490124|NCT00476463|Emtricitabine|emtricitabine|mesh-list
24704400|NCT01478035|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24704401|NCT01478035|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24754591|NCT01721655|Diuretics|diuretics|mesh-ancestor
25005655|NCT03019640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25005656|NCT03019640|Growth Substances|growth substances|mesh-ancestor
25005657|NCT03019640|Growth Inhibitors|growth inhibitors|mesh-ancestor
24704915|NCT01481194|Alkylating Agents|alkylating agents|mesh-ancestor
24704916|NCT01481194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704917|NCT01481194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24704918|NCT01481194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24704919|NCT01481194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24704920|NCT01481194|Antiemetics|antiemetics|mesh-ancestor
24704921|NCT01481194|Autonomic Agents|autonomic agents|mesh-ancestor
24704922|NCT01481194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24704923|NCT01481194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24704924|NCT01481194|Glucocorticoids|glucocorticoids|mesh-ancestor
24704925|NCT01481194|Hormones|hormones|mesh-ancestor
24704926|NCT01481194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24704927|NCT01481194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24704928|NCT01481194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24704929|NCT01481194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24704930|NCT01481194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24704931|NCT01481194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705910|NCT01487421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24705911|NCT01487421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705912|NCT01487512|Hydromorphone|hydromorphone|mesh-list
24705913|NCT01487512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24705914|NCT01487512|Narcotics|narcotics|mesh-ancestor
24705915|NCT01487512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24705982|NCT01488045|GABA Agents|gaba agents|mesh-ancestor
24705983|NCT01488045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24705984|NCT01488045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705985|NCT01488136|Diazoxide|diazoxide|mesh-list
24705986|NCT01488136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24705987|NCT01488136|Vasodilator Agents|vasodilator agents|mesh-ancestor
24705988|NCT01488201|Brodalumab|brodalumab|mesh-list
24705989|NCT01488201|Dermatologic Agents|dermatologic agents|mesh-ancestor
24705990|NCT01488227|Vitamin D|vitamin d|mesh-list
24709242|NCT01504659|Anesthetics, General|anesthetics, general|mesh-ancestor
24706506|NCT01490268|Anesthetics, General|anesthetics, general|mesh-ancestor
24706507|NCT01490268|Anesthetics|anesthetics|mesh-ancestor
24706509|NCT01490333|Cholecalciferol|cholecalciferol|mesh-list
24706510|NCT01490333|Vitamins|vitamins|mesh-ancestor
24706511|NCT01490333|Micronutrients|micronutrients|mesh-ancestor
24706759|NCT01491503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24706760|NCT01491503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24706761|NCT01491711|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24706896|NCT01492959|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24706992|NCT01493388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24706993|NCT01493388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706995|NCT01493440|Hormone Antagonists|hormone antagonists|mesh-ancestor
24706996|NCT01493440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24706997|NCT01493440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706998|NCT01493440|Tocolytic Agents|tocolytic agents|mesh-ancestor
24707060|NCT01493843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092440|NCT03241784|Analgesics|analgesics|mesh-ancestor
24695825|NCT01425827|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24695826|NCT01425827|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24707090|NCT01494090|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24707091|NCT01494090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24707093|NCT01494090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707094|NCT01494090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24707095|NCT01494090|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24707096|NCT01494090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707097|NCT01494155|Hydroxychloroquine|hydroxychloroquine|mesh-list
24707098|NCT01494155|Capecitabine|capecitabine|mesh-list
25407406|NCT03504397|Levoleucovorin|levoleucovorin|mesh-list
25703265|NCT02164929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25703266|NCT02164929|Respiratory System Agents|respiratory system agents|mesh-ancestor
25703267|NCT02164929|Mydriatics|mydriatics|mesh-ancestor
25703268|NCT02164929|Sympathomimetics|sympathomimetics|mesh-ancestor
24707099|NCT01494155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24707100|NCT01494155|Antimetabolites|antimetabolites|mesh-ancestor
24707101|NCT01494155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005812|NCT02560805|Sympatholytics|sympatholytics|mesh-ancestor
24707294|NCT01495117|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24707295|NCT01495117|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24707296|NCT01495117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24707298|NCT01495117|Dermatologic Agents|dermatologic agents|mesh-ancestor
24707299|NCT01495117|Trace Elements|trace elements|mesh-ancestor
24707300|NCT01495117|Micronutrients|micronutrients|mesh-ancestor
24707301|NCT01495117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707365|NCT01495338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24707366|NCT01495338|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24707448|NCT01495910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707449|NCT01495910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707957|NCT01498939|Insulin Detemir|insulin detemir|mesh-list
24708121|NCT01500018|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24868401|NCT04952324|Folic Acid|folic acid|mesh-list
24708146|NCT01500161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435073|NCT00265018|Doxorubicin|doxorubicin|mesh-list
24708147|NCT01500161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24708148|NCT01500161|Immunologic Factors|immunologic factors|mesh-ancestor
24708149|NCT01500161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708380|NCT01501136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24708381|NCT01501136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24708411|NCT01501149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24708413|NCT01501214|Hormone Antagonists|hormone antagonists|mesh-ancestor
24708414|NCT01501214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24708415|NCT01501214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708416|NCT01501214|Tocolytic Agents|tocolytic agents|mesh-ancestor
24708650|NCT01501890|Hormones|hormones|mesh-ancestor
24708651|NCT01501890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24708652|NCT01501890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24614038|NCT01022138|Alkylating Agents|alkylating agents|mesh-ancestor
24614039|NCT01022138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709243|NCT01504659|Anesthetics|anesthetics|mesh-ancestor
24709244|NCT01504659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24614062|NCT01022164|Coagulants|coagulants|mesh-ancestor
24614063|NCT01022229|Vitamins|vitamins|mesh-list
24614064|NCT01022229|Vitamin B 6|vitamin b 6|mesh-list
24614065|NCT01022229|Micronutrients|micronutrients|mesh-ancestor
24614066|NCT01022229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614096|NCT01022528|Dexamethasone acetate|dexamethasone acetate|mesh-list
25005725|NCT02796261|Eflornithine|eflornithine|mesh-list
24614099|NCT01022528|Antiemetics|antiemetics|mesh-ancestor
24614100|NCT01022528|Autonomic Agents|autonomic agents|mesh-ancestor
24614101|NCT01022528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24614102|NCT01022528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614103|NCT01022528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24614104|NCT01022528|Glucocorticoids|glucocorticoids|mesh-ancestor
24614105|NCT01022528|Hormones|hormones|mesh-ancestor
24614106|NCT01022528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24614107|NCT01022528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24614108|NCT01022528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614109|NCT01022528|Protease Inhibitors|protease inhibitors|mesh-ancestor
24614110|NCT01022528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709265|NCT01504828|Ramipril|ramipril|mesh-list
24709266|NCT01504828|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24709267|NCT01504828|Protease Inhibitors|protease inhibitors|mesh-ancestor
24709269|NCT01504828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709270|NCT01504828|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24709271|NCT01504906|Cyclosporine|cyclosporine|mesh-list
24709272|NCT01504906|Ticagrelor|ticagrelor|mesh-list
24709300|NCT01505088|Prednisolone|prednisolone|mesh-list
24709301|NCT01505088|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24709302|NCT01505088|Methylprednisolone|methylprednisolone|mesh-list
24709303|NCT01505088|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24709393|NCT01505413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24709394|NCT01505413|Antimetabolites|antimetabolites|mesh-ancestor
25407407|NCT03504397|Antimetabolites|antimetabolites|mesh-ancestor
25703269|NCT02164929|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25703270|NCT02164929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24829348|NCT02151630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24709395|NCT01505413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709397|NCT01505413|Antiviral Agents|antiviral agents|mesh-ancestor
24709398|NCT01505413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24435721|NCT00267826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24709399|NCT01505413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709400|NCT01505413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24709401|NCT01505413|Immunologic Factors|immunologic factors|mesh-ancestor
24709402|NCT01505413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695827|NCT01425827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24695828|NCT01425827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24695829|NCT01425827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695830|NCT01425827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24695831|NCT01425827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695832|NCT01425827|Analgesics|analgesics|mesh-ancestor
24709403|NCT01505413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24709406|NCT01505426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25109683|NCT03122197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24709611|NCT01506505|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24709612|NCT01506505|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24709613|NCT01506505|Antimetabolites|antimetabolites|mesh-ancestor
24709614|NCT01506505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709615|NCT01506505|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24709643|NCT01506544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709644|NCT01506544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709645|NCT01506544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24709646|NCT01506557|Cholecalciferol|cholecalciferol|mesh-list
25005729|NCT02796261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709778|NCT01506921|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24709873|NCT01507428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24709874|NCT01507428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24709875|NCT01507428|Tubulin Modulators|tubulin modulators|mesh-ancestor
24709912|NCT01507558|Dexamethasone|dexamethasone|mesh-list
24709913|NCT01507558|Dexamethasone acetate|dexamethasone acetate|mesh-list
24709914|NCT01507558|BB 1101|bb 1101|mesh-list
24709915|NCT01507558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24709916|NCT01507558|Antiemetics|antiemetics|mesh-ancestor
24709917|NCT01507558|Autonomic Agents|autonomic agents|mesh-ancestor
24709941|NCT01507701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709942|NCT01507701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24709944|NCT01507701|Autonomic Agents|autonomic agents|mesh-ancestor
24709945|NCT01507701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24709946|NCT01507701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24709947|NCT01507701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24709948|NCT01507701|Adrenergic Agents|adrenergic agents|mesh-ancestor
24755748|NCT01728909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005794|NCT02560805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25005795|NCT02560805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25005796|NCT02560805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005798|NCT02560805|Mydriatics|mydriatics|mesh-ancestor
25005799|NCT02560805|Autonomic Agents|autonomic agents|mesh-ancestor
25005800|NCT02560805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25005801|NCT02560805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005802|NCT02560805|Sympathomimetics|sympathomimetics|mesh-ancestor
25703271|NCT02164929|Narcotics|narcotics|mesh-ancestor
25709605|NCT02270736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25709606|NCT02270736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709607|NCT02270736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25709608|NCT02270736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25709609|NCT02270944|Vaccines|vaccines|mesh-list
25709610|NCT02270944|Immunologic Factors|immunologic factors|mesh-ancestor
25709611|NCT02270944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709612|NCT02270983|Linaclotide|linaclotide|mesh-list
25703272|NCT02164981|Nitroprusside|nitroprusside|mesh-list
25703273|NCT02164981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25005803|NCT02560805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25005804|NCT02560805|Nasal Decongestants|nasal decongestants|mesh-ancestor
25005805|NCT02560805|Respiratory System Agents|respiratory system agents|mesh-ancestor
25005806|NCT02560805|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25005807|NCT02560805|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25005808|NCT02560805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25005809|NCT02560805|Adrenergic Agents|adrenergic agents|mesh-ancestor
25005810|NCT02560805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25005811|NCT02560805|Protective Agents|protective agents|mesh-ancestor
24755785|NCT01728987|Vitamins|vitamins|mesh-ancestor
24710216|NCT01508923|Incretins|incretins|mesh-ancestor
24710217|NCT01508923|Hormones|hormones|mesh-ancestor
24710218|NCT01508923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24710219|NCT01508949|Liraglutide|liraglutide|mesh-list
24710220|NCT01508949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24710244|NCT01509209|Histamine Antagonists|histamine antagonists|mesh-ancestor
24710246|NCT01509209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24710247|NCT01509209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710248|NCT01509209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710310|NCT01509521|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24710311|NCT01509521|Mydriatics|mydriatics|mesh-ancestor
24710312|NCT01509521|Autonomic Agents|autonomic agents|mesh-ancestor
24614227|NCT01023087|Colistin|colistin|mesh-list
24614228|NCT01023087|Polymyxins|polymyxins|mesh-list
24614229|NCT01023087|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24614230|NCT01023087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24710425|NCT01510522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24710426|NCT01510522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710428|NCT01510548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24710464|NCT01510613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24710465|NCT01510613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755918|NCT01730209|Everolimus|everolimus|mesh-list
24710751|NCT01511718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24710752|NCT01511718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24710755|NCT01511731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24710802|NCT01511822|Contraceptive Agents|contraceptive agents|mesh-ancestor
24710803|NCT01511822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24710804|NCT01511822|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24710805|NCT01511822|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24710806|NCT01511822|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24710807|NCT01511822|Vitamin B Complex|vitamin b complex|mesh-ancestor
24710808|NCT01511822|Vitamins|vitamins|mesh-ancestor
24710823|NCT01511848|Deferiprone|deferiprone|mesh-list
24710824|NCT01511848|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24710825|NCT01511848|Chelating Agents|chelating agents|mesh-ancestor
24710826|NCT01511848|Sequestering Agents|sequestering agents|mesh-ancestor
24710827|NCT01511848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710828|NCT01511874|Leuprolide|leuprolide|mesh-list
24710829|NCT01511874|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24710830|NCT01511874|Fertility Agents|fertility agents|mesh-ancestor
24710831|NCT01511874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24710832|NCT01511874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710833|NCT01511874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24710834|NCT01511874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24710835|NCT01511887|Ibuprofen|ibuprofen|mesh-list
24710836|NCT01511887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24710837|NCT01511887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25407485|NCT03499249|Expectorants|expectorants|mesh-ancestor
25703274|NCT02164981|Vasodilator Agents|vasodilator agents|mesh-ancestor
25703275|NCT02164981|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25703276|NCT02164981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703277|NCT02165111|Botulinum Toxins|botulinum toxins|mesh-list
25703278|NCT02165111|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25703279|NCT02165111|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25703280|NCT02165111|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24423451|NCT00226044|Omeprazole|omeprazole|mesh-list
25703281|NCT02165111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24710873|NCT01512147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24710874|NCT01512147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710937|NCT01512459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25092665|NCT03239860|Antibodies|antibodies|mesh-list
24710941|NCT01512459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710942|NCT01512459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24710977|NCT01512680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710979|NCT01512784|Immunologic Factors|immunologic factors|mesh-ancestor
24710980|NCT01512784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710981|NCT01512862|Calcitriol|calcitriol|mesh-list
24710982|NCT01512862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24711018|NCT01512966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24711019|NCT01512966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24450043|NCT00317681|Tacrolimus|tacrolimus|mesh-list
24711038|NCT01513057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24711039|NCT01513057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24711041|NCT01513057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711042|NCT01513070|Aspirin|aspirin|mesh-list
24711043|NCT01513070|Isosorbide|isosorbide|mesh-list
24711044|NCT01513070|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24711045|NCT01513070|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
24711046|NCT01513070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24711047|NCT01513070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24614267|NCT01023334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24614268|NCT01023334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614269|NCT01023334|Sensory System Agents|sensory system agents|mesh-ancestor
24614270|NCT01023334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24756084|NCT01731158|Sorafenib|sorafenib|mesh-list
25005846|NCT02162420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005847|NCT02162420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005848|NCT02162420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25005849|NCT02162420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24711350|NCT01514838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711352|NCT01514838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711354|NCT01514851|Calcium Carbonate|calcium carbonate|mesh-list
24711361|NCT01514903|Sildenafil Citrate|sildenafil citrate|mesh-list
24711362|NCT01514903|Vasodilator Agents|vasodilator agents|mesh-ancestor
24557067|NCT00751205|Prednisone|prednisone|mesh-list
24711363|NCT01514903|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24711364|NCT01514903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24711365|NCT01514903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711366|NCT01514903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711367|NCT01514903|Urological Agents|urological agents|mesh-ancestor
24711368|NCT01514929|Moxifloxacin|moxifloxacin|mesh-list
24711369|NCT01514929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24711406|NCT01514968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24711407|NCT01514968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24711408|NCT01514981|Mogamulizumab|mogamulizumab|mesh-list
24711409|NCT01514981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24711410|NCT01515020|Vancomycin|vancomycin|mesh-list
24711411|NCT01515020|Daptomycin|daptomycin|mesh-list
24614356|NCT01023867|Nootropic Agents|nootropic agents|mesh-ancestor
24614358|NCT01023919|Paclitaxel|paclitaxel|mesh-list
24614359|NCT01023919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24614360|NCT01023919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614361|NCT01023919|Tubulin Modulators|tubulin modulators|mesh-ancestor
24614362|NCT01023919|Antimitotic Agents|antimitotic agents|mesh-ancestor
24711426|NCT01515137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24711514|NCT01515813|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25703282|NCT02165111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703283|NCT02165111|Cholinergic Agents|cholinergic agents|mesh-ancestor
25703284|NCT02165111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25703285|NCT02165111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703286|NCT02165111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25703287|NCT02165111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25703288|NCT02165202|Rilpivirine|rilpivirine|mesh-list
25703289|NCT02165202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25703290|NCT02165202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24711515|NCT01515813|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24711516|NCT01515813|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24711517|NCT01515813|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24711518|NCT01515813|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24711519|NCT01515813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24711520|NCT01515813|Antimetabolites|antimetabolites|mesh-ancestor
24711521|NCT01515813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24711522|NCT01515813|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24711556|NCT01515839|Acetylcarnitine|acetylcarnitine|mesh-list
24711557|NCT01515839|Acetylcysteine|acetylcysteine|mesh-list
24711558|NCT01515839|Vinpocetine|vinpocetine|mesh-list
24711559|NCT01515839|Huperzine A|huperzine a|mesh-list
24711560|NCT01515839|Antioxidants|antioxidants|mesh-ancestor
24711562|NCT01515839|Protective Agents|protective agents|mesh-ancestor
24711590|NCT01516060|Efavirenz|efavirenz|mesh-list
24711591|NCT01516060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24788839|NCT01934088|Analgesics|analgesics|mesh-ancestor
24788840|NCT01934088|Sensory System Agents|sensory system agents|mesh-ancestor
24788841|NCT01934088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24788842|NCT01934088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24788845|NCT01934088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24788846|NCT01934088|GABA Modulators|gaba modulators|mesh-ancestor
24788847|NCT01934088|GABA Agents|gaba agents|mesh-ancestor
24788848|NCT01934088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24756427|NCT01733290|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24712772|NCT01522820|Sirolimus|sirolimus|mesh-list
24712773|NCT01522820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24712774|NCT01522820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24712775|NCT01522820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24712776|NCT01522820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24712777|NCT01522820|Antifungal Agents|antifungal agents|mesh-ancestor
24756577|NCT01734330|Nicotine|nicotine|mesh-list
24712911|NCT01523119|Autonomic Agents|autonomic agents|mesh-ancestor
24712912|NCT01523119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24712948|NCT01523314|Growth Inhibitors|growth inhibitors|mesh-ancestor
24712949|NCT01523314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24712950|NCT01523327|Uric Acid|uric acid|mesh-list
24712951|NCT01523327|Antioxidants|antioxidants|mesh-ancestor
24712987|NCT01523431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24713021|NCT01523574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24713022|NCT01523574|Anticonvulsants|anticonvulsants|mesh-ancestor
24713023|NCT01523574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24713024|NCT01523574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24714530|NCT01531166|Interferon-alpha|interferon-alpha|mesh-list
24713025|NCT01523574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713026|NCT01523574|Tocolytic Agents|tocolytic agents|mesh-ancestor
24713066|NCT01524068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24713067|NCT01524068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24713068|NCT01524068|Immunologic Factors|immunologic factors|mesh-ancestor
24713069|NCT01524068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713070|NCT01524068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24713071|NCT01524081|Amoxicillin|amoxicillin|mesh-list
24713360|NCT01525771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005902|NCT01502085|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25005903|NCT01502085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25005904|NCT01502085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713491|NCT01526278|Calcitriol|calcitriol|mesh-list
24713492|NCT01526278|Maxmarvil|maxmarvil|mesh-list
24713493|NCT01526278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24713494|NCT01526278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713495|NCT01526278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24713496|NCT01526278|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24713497|NCT01526278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24713498|NCT01526278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703291|NCT02165202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703292|NCT02165202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703293|NCT02165202|Antiviral Agents|antiviral agents|mesh-ancestor
25703294|NCT02165202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25703295|NCT02165202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24713499|NCT01526278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25703296|NCT02165202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24829566|NCT02153125|Hormone Antagonists|hormone antagonists|mesh-ancestor
24829567|NCT02153125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24829568|NCT02153125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829569|NCT02153125|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24713528|NCT01526395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713529|NCT01526395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24713530|NCT01526395|Anesthetics, General|anesthetics, general|mesh-ancestor
24713531|NCT01526395|Anesthetics|anesthetics|mesh-ancestor
24713532|NCT01526460|Atorvastatin|atorvastatin|mesh-list
24713708|NCT01527032|Growth Substances|growth substances|mesh-ancestor
24713709|NCT01527032|Growth Inhibitors|growth inhibitors|mesh-ancestor
24713710|NCT01527097|Atorvastatin|atorvastatin|mesh-list
24713711|NCT01527097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24713712|NCT01527097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24713713|NCT01527097|Antimetabolites|antimetabolites|mesh-ancestor
24713714|NCT01527097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713715|NCT01527097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24713716|NCT01527097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24713717|NCT01527097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24713718|NCT01527279|Antazoline|antazoline|mesh-list
24713719|NCT01527279|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24713748|NCT01527422|Doxorubicin|doxorubicin|mesh-list
24713749|NCT01527422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24713750|NCT01527422|Vincristine|vincristine|mesh-list
24713751|NCT01527422|Sargramostim|sargramostim|mesh-list
24645589|NCT01198821|Antiviral Agents|antiviral agents|mesh-ancestor
24713752|NCT01527422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24713753|NCT01527422|Immunologic Factors|immunologic factors|mesh-ancestor
24713754|NCT01527422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713755|NCT01527422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24713756|NCT01527422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24713757|NCT01527422|Alkylating Agents|alkylating agents|mesh-ancestor
24713758|NCT01527422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713759|NCT01527422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24713760|NCT01527422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24713876|NCT01527890|Narcotics|narcotics|mesh-ancestor
24614728|NCT01026116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24614729|NCT01026116|Alkylating Agents|alkylating agents|mesh-ancestor
24756921|NCT01736514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24756922|NCT01736514|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24756923|NCT01736514|Antioxidants|antioxidants|mesh-ancestor
24714128|NCT01529177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24714130|NCT01529177|Fertility Agents|fertility agents|mesh-ancestor
24714131|NCT01529177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24714132|NCT01529177|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24714133|NCT01529177|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24714134|NCT01529190|Pregabalin|pregabalin|mesh-list
24756957|NCT01736800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24756958|NCT01736800|Alkylating Agents|alkylating agents|mesh-ancestor
24714135|NCT01529190|Analgesics|analgesics|mesh-ancestor
24714136|NCT01529190|Sensory System Agents|sensory system agents|mesh-ancestor
24714137|NCT01529190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24714138|NCT01529190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756959|NCT01736800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788887|NCT01934569|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24788888|NCT01934569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24756960|NCT01736800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24756961|NCT01736800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24788889|NCT01934569|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24437350|NCT00273455|Dorzolamide|dorzolamide|mesh-list
24788890|NCT01934569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788891|NCT01934569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24788912|NCT01934634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24788913|NCT01934634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788914|NCT01934634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24788915|NCT01934634|Immunologic Factors|immunologic factors|mesh-ancestor
24788916|NCT01934634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703297|NCT02165397|Rituximab|rituximab|mesh-list
24424375|NCT00229125|Lorazepam|lorazepam|mesh-list
25703298|NCT02165397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25703299|NCT02165397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25703300|NCT02165397|Immunologic Factors|immunologic factors|mesh-ancestor
25703301|NCT02165397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788917|NCT01934712|Insulin|insulin|mesh-list
24788918|NCT01934712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24788919|NCT01934712|Insulin Aspart|insulin aspart|mesh-list
24788920|NCT01934712|Insulin, Long-Acting|insulin, long-acting|mesh-list
24788922|NCT01934712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25005930|NCT01178814|Lenalidomide|lenalidomide|mesh-list
25005951|NCT01125176|Leprostatic Agents|leprostatic agents|mesh-ancestor
25005952|NCT01125176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25005953|NCT01125176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25005954|NCT00882050|Exenatide|exenatide|mesh-list
25005955|NCT00882050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25005956|NCT00882050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005957|NCT00882050|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25005958|NCT00882050|Incretins|incretins|mesh-ancestor
25005959|NCT00882050|Hormones|hormones|mesh-ancestor
25005960|NCT00882050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25005961|NCT00790829|Nicotine|nicotine|mesh-list
25005962|NCT00790829|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25005963|NCT00790829|Autonomic Agents|autonomic agents|mesh-ancestor
25005964|NCT00790829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25005965|NCT00790829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005966|NCT00790829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24714139|NCT01529190|Anticonvulsants|anticonvulsants|mesh-ancestor
24714140|NCT01529190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24714141|NCT01529190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24714159|NCT01529229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24714326|NCT01530126|Growth Substances|growth substances|mesh-ancestor
24714327|NCT01530126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614767|NCT01026311|Coenzyme Q10|coenzyme q10|mesh-list
24714329|NCT01530152|Anesthetics, Local|anesthetics, local|mesh-ancestor
24714331|NCT01530152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24714362|NCT01530308|Dopamine|dopamine|mesh-list
24714363|NCT01530308|Haloperidol|haloperidol|mesh-list
24714364|NCT01530308|Haloperidol decanoate|haloperidol decanoate|mesh-list
24714365|NCT01530308|Antipsychotic Agents|antipsychotic agents|mesh-list
24714366|NCT01530308|Dopamine Antagonists|dopamine antagonists|mesh-list
24714367|NCT01530308|Antiemetics|antiemetics|mesh-ancestor
24714368|NCT01530308|Autonomic Agents|autonomic agents|mesh-ancestor
24714369|NCT01530308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24714370|NCT01530308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714371|NCT01530308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24614778|NCT01026337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24614779|NCT01026337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24500796|NCT00525707|Tezosentan|tezosentan|mesh-list
24714390|NCT01530438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714391|NCT01530451|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24714392|NCT01530451|Hemostatics|hemostatics|mesh-ancestor
24714393|NCT01530451|Coagulants|coagulants|mesh-ancestor
24714394|NCT01530451|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24437523|NCT00273962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24437524|NCT00273962|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24714395|NCT01530451|Natriuretic Agents|natriuretic agents|mesh-ancestor
24714396|NCT01530451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714526|NCT01531140|Cathartics|cathartics|mesh-ancestor
24714527|NCT01531140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24714528|NCT01531140|Laxatives|laxatives|mesh-ancestor
24714529|NCT01531166|Interferons|interferons|mesh-list
24714912|NCT01533376|Lubricant Eye Drops|lubricant eye drops|mesh-list
24714913|NCT01533376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24714914|NCT01533376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24715150|NCT01534806|Analgesics|analgesics|mesh-ancestor
24715151|NCT01534806|Sensory System Agents|sensory system agents|mesh-ancestor
24715152|NCT01534806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24715268|NCT01535495|Adrenergic Agents|adrenergic agents|mesh-ancestor
24715269|NCT01535495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24715270|NCT01535495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715271|NCT01535495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715297|NCT01535768|Travoprost|travoprost|mesh-list
24715298|NCT01535768|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24715299|NCT01535768|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24715300|NCT01535768|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24715301|NCT01535768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24715302|NCT01535768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24715303|NCT01535768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25703302|NCT02165397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24715304|NCT01535768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24715305|NCT01535768|Adrenergic Agents|adrenergic agents|mesh-ancestor
24715306|NCT01535768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24715307|NCT01535768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715308|NCT01535768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715309|NCT01535781|Tranexamic Acid|tranexamic acid|mesh-list
24715310|NCT01535781|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24715311|NCT01535781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24715312|NCT01535781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715314|NCT01535781|Coagulants|coagulants|mesh-ancestor
24715315|NCT01535820|Ortho Evra|ortho evra|mesh-list
24715316|NCT01535820|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24715317|NCT01535820|Contraceptive Agents|contraceptive agents|mesh-ancestor
24715318|NCT01535820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24715319|NCT01535820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715350|NCT01536028|Insulin|insulin|mesh-list
24715352|NCT01536028|Insulin Aspart|insulin aspart|mesh-list
24715353|NCT01536028|Insulin, Long-Acting|insulin, long-acting|mesh-list
24715629|NCT01537744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24715631|NCT01537770|Anesthetics, Local|anesthetics, local|mesh-ancestor
24715632|NCT01537770|Anesthetics|anesthetics|mesh-ancestor
24715776|NCT01538485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715778|NCT01538485|Micronutrients|micronutrients|mesh-ancestor
24715779|NCT01538485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24715780|NCT01538511|Insulin|insulin|mesh-list
24715781|NCT01538511|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24715782|NCT01538511|Insulin Aspart|insulin aspart|mesh-list
24715783|NCT01538511|Insulin, Long-Acting|insulin, long-acting|mesh-list
24715784|NCT01538511|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24715785|NCT01538511|Biphasic Insulins|biphasic insulins|mesh-list
24715786|NCT01538511|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24715787|NCT01538511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24715788|NCT01538511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615072|NCT01027689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615073|NCT01027689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24716415|NCT01541436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716416|NCT01541475|Dexetimide|dexetimide|mesh-list
24716417|NCT01541475|Citalopram|citalopram|mesh-list
24716418|NCT01541475|Bupropion|bupropion|mesh-list
24716419|NCT01541475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24716420|NCT01541475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24716421|NCT01541475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25093079|NCT03236818|Bosentan|bosentan|mesh-list
24789101|NCT01935531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24789102|NCT01935531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24789103|NCT01935531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24789104|NCT01935531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789105|NCT01935531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24789106|NCT01935531|Immunologic Factors|immunologic factors|mesh-ancestor
24789107|NCT01935531|Viscosupplements|viscosupplements|mesh-ancestor
24789108|NCT01935531|Protective Agents|protective agents|mesh-ancestor
24789109|NCT01935544|Botulinum Toxins|botulinum toxins|mesh-list
24789110|NCT01935544|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24789111|NCT01935544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24789112|NCT01935544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789113|NCT01935544|Cholinergic Agents|cholinergic agents|mesh-ancestor
24789119|NCT01935557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24789120|NCT01935557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24789121|NCT01935557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789122|NCT01935596|Ropivacaine|ropivacaine|mesh-list
24789123|NCT01935596|Levobupivacaine|levobupivacaine|mesh-list
25109708|NCT03121963|Analgesics|analgesics|mesh-ancestor
25109709|NCT03121963|Sensory System Agents|sensory system agents|mesh-ancestor
24757985|NCT01743157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24716828|NCT01544140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24716829|NCT01544140|Anesthetics, General|anesthetics, general|mesh-ancestor
24716830|NCT01544140|Anesthetics|anesthetics|mesh-ancestor
24503513|NCT00532142|Hormones|hormones|mesh-ancestor
24716831|NCT01544140|GABA Modulators|gaba modulators|mesh-ancestor
24716832|NCT01544140|GABA Agents|gaba agents|mesh-ancestor
24716833|NCT01544140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24716834|NCT01544140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716835|NCT01544192|Tocopherols|tocopherols|mesh-list
24717000|NCT01544959|Fentanyl|fentanyl|mesh-list
24717001|NCT01544959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24717002|NCT01544959|Esmolol|esmolol|mesh-list
24717003|NCT01544959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24717004|NCT01544959|Narcotics|narcotics|mesh-ancestor
25006106|NCT05205317|Metformin|metformin|mesh-list
24717005|NCT01544959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24619935|NCT01054547|Sensory System Agents|sensory system agents|mesh-ancestor
24717083|NCT01545479|Protease Inhibitors|protease inhibitors|mesh-ancestor
24717119|NCT01545778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717121|NCT01545778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24717157|NCT01546051|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24717158|NCT01546051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24717159|NCT01546051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558721|NCT05435560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24558722|NCT05435560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717160|NCT01546051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717188|NCT01546116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24717190|NCT01546116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24717191|NCT01546389|Chloroquine|chloroquine|mesh-list
24717192|NCT01546389|Amebicides|amebicides|mesh-ancestor
24717193|NCT01546389|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24789139|NCT01935674|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24789140|NCT01935674|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24789141|NCT01935674|Protease Inhibitors|protease inhibitors|mesh-ancestor
24789142|NCT01935674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717290|NCT01547143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24717291|NCT01547143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717292|NCT01547143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24717293|NCT01547143|Glucocorticoids|glucocorticoids|mesh-ancestor
24717295|NCT01547143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24717296|NCT01547143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25006109|NCT05205200|Paclitaxel|paclitaxel|mesh-list
25006112|NCT05205200|Tubulin Modulators|tubulin modulators|mesh-ancestor
25006113|NCT05205200|Antimitotic Agents|antimitotic agents|mesh-ancestor
25006114|NCT05205200|Mitosis Modulators|mitosis modulators|mesh-ancestor
25006115|NCT05205200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006116|NCT05205122|Mitomycins|mitomycins|mesh-list
25006117|NCT05205122|Mitomycin|mitomycin|mesh-list
25006118|NCT05205122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25006119|NCT05205122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006120|NCT05205122|Alkylating Agents|alkylating agents|mesh-ancestor
25006121|NCT05205122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006122|NCT05205122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25006123|NCT05205122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717744|NCT01549704|Anesthetics|anesthetics|mesh-ancestor
24717745|NCT01549704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24717746|NCT01549704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717747|NCT01549704|Sensory System Agents|sensory system agents|mesh-ancestor
24717748|NCT01549704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24717749|NCT01549730|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
24717750|NCT01549730|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24717751|NCT01549730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717752|NCT01549743|Celecoxib|celecoxib|mesh-list
24717753|NCT01549743|Rebamipide|rebamipide|mesh-list
24717836|NCT01550302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24717837|NCT01550354|Alfentanil|alfentanil|mesh-list
24717838|NCT01550354|Propofol|propofol|mesh-list
24717839|NCT01550354|Rocuronium|rocuronium|mesh-list
24717840|NCT01550354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24717841|NCT01550354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24717842|NCT01550354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717843|NCT01550354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24717844|NCT01550354|Anesthetics, General|anesthetics, general|mesh-ancestor
24717845|NCT01550354|Anesthetics|anesthetics|mesh-ancestor
24717846|NCT01550354|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25703303|NCT02166047|Vesatolimod|vesatolimod|mesh-list
25703304|NCT02166047|Antiviral Agents|antiviral agents|mesh-ancestor
25703305|NCT02166047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25703306|NCT02166333|Vitamin D|vitamin d|mesh-list
25703307|NCT02166333|Ergocalciferols|ergocalciferols|mesh-list
25703308|NCT02166333|Cholecalciferol|cholecalciferol|mesh-list
24718196|NCT01552798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24646009|NCT01201213|Sensory System Agents|sensory system agents|mesh-ancestor
24718197|NCT01552798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24718198|NCT01552798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718284|NCT01553500|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
24718286|NCT01553500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24718287|NCT01553617|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24718288|NCT01553617|Plasma Substitutes|plasma substitutes|mesh-ancestor
24718289|NCT01553617|Blood Substitutes|blood substitutes|mesh-ancestor
24438036|NCT00274911|Lomustine|lomustine|mesh-list
25006155|NCT05204641|Rifaximin|rifaximin|mesh-list
25006156|NCT05204641|Levodopa|levodopa|mesh-list
25006157|NCT05204641|Benserazide|benserazide|mesh-list
25006158|NCT05204641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24718605|NCT01555879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718606|NCT01555879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24718920|NCT01557907|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24718921|NCT01557907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24718922|NCT01557907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718923|NCT01557985|Bupivacaine|bupivacaine|mesh-list
24718951|NCT01558167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24718952|NCT01558167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24718954|NCT01558167|Growth Inhibitors|growth inhibitors|mesh-ancestor
24718955|NCT01558167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24718956|NCT01558167|Alkylating Agents|alkylating agents|mesh-ancestor
24718957|NCT01558167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718958|NCT01558193|Vitamins|vitamins|mesh-list
24718959|NCT01558193|Evening primrose oil|evening primrose oil|mesh-list
24718960|NCT01558193|Micronutrients|micronutrients|mesh-ancestor
24718961|NCT01558193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718962|NCT01558193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24718963|NCT01558193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24718964|NCT01558193|Analgesics|analgesics|mesh-ancestor
24718965|NCT01558193|Sensory System Agents|sensory system agents|mesh-ancestor
24718966|NCT01558193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24718967|NCT01558193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24718968|NCT01558193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24718969|NCT01558193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24718970|NCT01558193|Antimetabolites|antimetabolites|mesh-ancestor
24719001|NCT01558622|Tramadol|tramadol|mesh-list
24719002|NCT01558622|Vitamins|vitamins|mesh-ancestor
24719003|NCT01558622|Micronutrients|micronutrients|mesh-ancestor
24719004|NCT01558622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719005|NCT01558622|Antioxidants|antioxidants|mesh-ancestor
24719006|NCT01558622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719007|NCT01558622|Protective Agents|protective agents|mesh-ancestor
24719008|NCT01558622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24789202|NCT01935830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24789203|NCT01935830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24789204|NCT01935830|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24789205|NCT01935830|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24789208|NCT01935830|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24789209|NCT01935869|Petrolatum|petrolatum|mesh-list
24789210|NCT01935869|Emollients|emollients|mesh-ancestor
24789211|NCT01935869|Dermatologic Agents|dermatologic agents|mesh-ancestor
24789212|NCT01935882|Lumefantrine|lumefantrine|mesh-list
24789213|NCT01935882|Artemether|artemether|mesh-list
24789214|NCT01935882|Primaquine|primaquine|mesh-list
24719150|NCT01559480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758848|NCT01748279|Autonomic Agents|autonomic agents|mesh-ancestor
24719191|NCT01559753|Ceftriaxone|ceftriaxone|mesh-list
24719257|NCT01560117|Immunologic Factors|immunologic factors|mesh-ancestor
24615272|NCT01028547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615273|NCT01028547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24719597|NCT01562717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24789247|NCT01936025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789248|NCT01936025|Antitussive Agents|antitussive agents|mesh-ancestor
24789249|NCT01936025|Respiratory System Agents|respiratory system agents|mesh-ancestor
24789250|NCT01936025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25006199|NCT05204069|Autonomic Agents|autonomic agents|mesh-ancestor
25006200|NCT05204069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25006201|NCT05204069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006202|NCT05204069|Parasympatholytics|parasympatholytics|mesh-ancestor
25006203|NCT05204069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25703309|NCT02166333|Vitamins|vitamins|mesh-list
25006204|NCT05204069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24719757|NCT01563835|Sequestering Agents|sequestering agents|mesh-ancestor
24719758|NCT01563835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719759|NCT01563939|Remifentanil|remifentanil|mesh-list
24719760|NCT01563939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24719889|NCT01564680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24719890|NCT01564680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24719892|NCT01564810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24719893|NCT01564810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719894|NCT01564823|Metronidazole|metronidazole|mesh-list
24719895|NCT01564823|Adalimumab|adalimumab|mesh-list
24719932|NCT01565096|Metformin|metformin|mesh-list
24719933|NCT01565096|Glimepiride|glimepiride|mesh-list
24615318|NCT01028781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621587|NCT01063179|Hormones|hormones|mesh-ancestor
24621588|NCT01063179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24621589|NCT01063179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621590|NCT01063179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24621591|NCT01063179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24621592|NCT01063179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24621593|NCT01063179|Alkylating Agents|alkylating agents|mesh-ancestor
24872055|NCT05399732|Hematinics|hematinics|mesh-ancestor
24615358|NCT01029132|Galantamine|galantamine|mesh-list
24615359|NCT01029132|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24615360|NCT01029132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615361|NCT01029132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615362|NCT01029132|Cholinergic Agents|cholinergic agents|mesh-ancestor
24615363|NCT01029132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24615364|NCT01029132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615365|NCT01029132|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24719943|NCT01565096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719970|NCT01565265|Hormone Antagonists|hormone antagonists|mesh-ancestor
24438465|NCT00276029|Etanercept|etanercept|mesh-list
24438625|NCT00276536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438626|NCT00276575|Bevacizumab|bevacizumab|mesh-list
24720213|NCT01567072|Sensory System Agents|sensory system agents|mesh-ancestor
24720214|NCT01567072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24720215|NCT01567072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720216|NCT01567072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24720217|NCT01567072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24722210|NCT01579110|Glucocorticoids|glucocorticoids|mesh-ancestor
24615370|NCT01029223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24615371|NCT01029223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24615373|NCT01029223|Autonomic Agents|autonomic agents|mesh-ancestor
24615374|NCT01029223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24720276|NCT01567540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720279|NCT01567540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24720280|NCT01567540|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24720281|NCT01567540|Protease Inhibitors|protease inhibitors|mesh-ancestor
24720282|NCT01567540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720315|NCT01567657|Anesthetics, General|anesthetics, general|mesh-ancestor
24720317|NCT01567657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24720318|NCT01567657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24720319|NCT01567657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24720320|NCT01567657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25109716|NCT03121963|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24720321|NCT01567657|GABA Modulators|gaba modulators|mesh-ancestor
24720322|NCT01567657|GABA Agents|gaba agents|mesh-ancestor
24720323|NCT01567657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24720324|NCT01567657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720325|NCT01567657|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24720326|NCT01567657|Narcotics|narcotics|mesh-ancestor
24720327|NCT01567657|Analgesics|analgesics|mesh-ancestor
24720477|NCT01568645|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24720478|NCT01568645|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24720480|NCT01568684|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24720481|NCT01568684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24720482|NCT01568684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24720483|NCT01568684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720516|NCT01568996|Protective Agents|protective agents|mesh-ancestor
24720517|NCT01568996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720518|NCT01568996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720520|NCT01569035|Anticoagulants|anticoagulants|mesh-ancestor
24720521|NCT01569048|Dexmedetomidine|dexmedetomidine|mesh-list
24720522|NCT01569048|Remifentanil|remifentanil|mesh-list
24720523|NCT01569048|Propofol|propofol|mesh-list
24720524|NCT01569048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24450453|NCT00319163|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24721012|NCT01571882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721014|NCT01571882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24721015|NCT01571908|Rocuronium|rocuronium|mesh-list
24721068|NCT01572116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24721069|NCT01572116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24721070|NCT01572116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24721071|NCT01572116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24721072|NCT01572116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25109725|NCT03121963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24721278|NCT01572961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24721279|NCT01572961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721281|NCT01572961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24721310|NCT01573338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24721311|NCT01573338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24789334|NCT01936350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789335|NCT01936350|Urological Agents|urological agents|mesh-ancestor
24721991|NCT01578252|Dermatologic Agents|dermatologic agents|mesh-ancestor
24721992|NCT01578252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24721993|NCT01578252|Serotonin Agents|serotonin agents|mesh-ancestor
24721994|NCT01578252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24721995|NCT01578252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721996|NCT01578252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24721997|NCT01578252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24722030|NCT01578343|Fludarabine phosphate|fludarabine phosphate|mesh-list
24722031|NCT01578343|Mitoxantrone|mitoxantrone|mesh-list
24722032|NCT01578343|Vorinostat|vorinostat|mesh-list
24722033|NCT01578343|BB 1101|bb 1101|mesh-list
24722034|NCT01578343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24722035|NCT01578343|Antiemetics|antiemetics|mesh-ancestor
24722036|NCT01578343|Autonomic Agents|autonomic agents|mesh-ancestor
24722037|NCT01578343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24722038|NCT01578343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722039|NCT01578343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24722380|NCT01579903|Coagulants|coagulants|mesh-ancestor
24722382|NCT01579929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24722383|NCT01579929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24722433|NCT01580371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722434|NCT01580501|Sildenafil Citrate|sildenafil citrate|mesh-list
25093566|NCT03234296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25093567|NCT03234387|Acetylcholine|acetylcholine|mesh-list
25093568|NCT03234387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093569|NCT03234387|Vasodilator Agents|vasodilator agents|mesh-ancestor
25093570|NCT03234387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25093571|NCT03234387|Cholinergic Agents|cholinergic agents|mesh-ancestor
24722444|NCT01580514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722445|NCT01580514|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24722446|NCT01580514|Incretins|incretins|mesh-ancestor
24722447|NCT01580514|Hormones|hormones|mesh-ancestor
24722448|NCT01580514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24722449|NCT01580683|Ascorbic Acid|ascorbic acid|mesh-list
24722450|NCT01580683|Vitamins|vitamins|mesh-ancestor
24722451|NCT01580683|Micronutrients|micronutrients|mesh-ancestor
25006329|NCT05156879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24722452|NCT01580683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615659|NCT01031030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24615660|NCT01031030|Alkylating Agents|alkylating agents|mesh-ancestor
24615661|NCT01031030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615662|NCT01031030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24615712|NCT01031368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25006378|NCT05124678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25006379|NCT05124678|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25006380|NCT05124678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25006381|NCT05124678|Antimetabolites|antimetabolites|mesh-ancestor
25006382|NCT05124678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703310|NCT02166333|Micronutrients|micronutrients|mesh-ancestor
25006383|NCT05124678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25006385|NCT05123365|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25006386|NCT05123365|Antiviral Agents|antiviral agents|mesh-ancestor
24789358|NCT01936545|Propofol|propofol|mesh-list
25006387|NCT05123365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25006388|NCT05123365|Expectorants|expectorants|mesh-ancestor
25006393|NCT05123365|Protective Agents|protective agents|mesh-ancestor
24722517|NCT01581151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24722518|NCT01581151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24722519|NCT01581151|Growth Substances|growth substances|mesh-ancestor
24722520|NCT01581151|Growth Inhibitors|growth inhibitors|mesh-ancestor
24722522|NCT01581164|Immunologic Factors|immunologic factors|mesh-ancestor
24722523|NCT01581164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722524|NCT01581242|Adefovir|adefovir|mesh-list
24722625|NCT01581814|Contraceptive Agents|contraceptive agents|mesh-ancestor
24722626|NCT01581814|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24722627|NCT01581814|Estrogens|estrogens|mesh-ancestor
24722778|NCT01582607|Levobupivacaine|levobupivacaine|mesh-list
24722779|NCT01582607|Anesthetics, Local|anesthetics, local|mesh-ancestor
24722780|NCT01582607|Anesthetics|anesthetics|mesh-ancestor
24722781|NCT01582607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24722782|NCT01582607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722783|NCT01582607|Sensory System Agents|sensory system agents|mesh-ancestor
24722784|NCT01582607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24722785|NCT01582607|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24722786|NCT01582607|Narcotics|narcotics|mesh-ancestor
24722787|NCT01582607|Analgesics|analgesics|mesh-ancestor
24722788|NCT01582607|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24722789|NCT01582607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24722790|NCT01582607|Anesthetics, General|anesthetics, general|mesh-ancestor
24722791|NCT01582646|Terbutaline|terbutaline|mesh-list
24722792|NCT01582646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24722825|NCT01582711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722826|NCT01582711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24722827|NCT01582711|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24722828|NCT01582711|Leprostatic Agents|leprostatic agents|mesh-ancestor
24722829|NCT01582737|Rivaroxaban|rivaroxaban|mesh-list
24559905|NCT04128748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722830|NCT01582737|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24722831|NCT01582737|Antithrombins|antithrombins|mesh-ancestor
24722832|NCT01582737|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24722833|NCT01582737|Protease Inhibitors|protease inhibitors|mesh-ancestor
24722834|NCT01582737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615713|NCT01031368|Antimetabolites|antimetabolites|mesh-ancestor
24615740|NCT01031589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24615741|NCT01031589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24615742|NCT01031589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24615743|NCT01031667|Cilostazol|cilostazol|mesh-list
24722863|NCT01583036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722864|NCT01583036|Protective Agents|protective agents|mesh-ancestor
24722866|NCT01583036|Anticonvulsants|anticonvulsants|mesh-ancestor
24722912|NCT01583439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722914|NCT01583439|Antiviral Agents|antiviral agents|mesh-ancestor
24723185|NCT01585623|Adrenergic Agents|adrenergic agents|mesh-ancestor
24723218|NCT01586052|Epoetin Alfa|epoetin alfa|mesh-list
24723219|NCT01586052|Hematinics|hematinics|mesh-ancestor
24789469|NCT01937442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789470|NCT01937442|Leprostatic Agents|leprostatic agents|mesh-ancestor
24789471|NCT01937442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24789472|NCT01937442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24789473|NCT01937442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25006416|NCT05083910|Oxytocin|oxytocin|mesh-list
25006417|NCT05083910|Carbetocin|carbetocin|mesh-list
25006418|NCT05083910|Oxytocics|oxytocics|mesh-ancestor
25006419|NCT05083910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25006420|NCT05083910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703311|NCT02166333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703312|NCT02166333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25703313|NCT02166333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25006421|NCT05083910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25006422|NCT05083910|Abortifacient Agents|abortifacient agents|mesh-ancestor
25006423|NCT05083910|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24439546|NCT00279266|Vitamins|vitamins|mesh-ancestor
24439718|NCT00280033|Antacids|antacids|mesh-ancestor
25006424|NCT05083910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25006425|NCT05083780|Hydroxychloroquine|hydroxychloroquine|mesh-list
25006426|NCT05083780|Chlorphenesin|chlorphenesin|mesh-list
25006427|NCT05083780|Antimalarials|antimalarials|mesh-ancestor
25006428|NCT05083780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25006429|NCT05083780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25006430|NCT05083780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25006431|NCT05083780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25006432|NCT05083780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006433|NCT05083780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25006434|NCT05083780|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25006435|NCT05083780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006436|NCT05083780|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24723262|NCT01586208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24723392|NCT01587261|Micronutrients|micronutrients|mesh-ancestor
24723393|NCT01587261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723394|NCT01587261|Antioxidants|antioxidants|mesh-ancestor
24723395|NCT01587261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723396|NCT01587261|Protective Agents|protective agents|mesh-ancestor
24723397|NCT01587313|Hydralazine|hydralazine|mesh-list
24723398|NCT01587313|Isosorbide|isosorbide|mesh-list
24723399|NCT01587313|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24723430|NCT01587339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24723431|NCT01587339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24723432|NCT01587339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723433|NCT01587339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24723434|NCT01587339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24723435|NCT01587339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24439719|NCT00280033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439720|NCT00280033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24439725|NCT00280098|Docetaxel|docetaxel|mesh-list
24723436|NCT01587339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24723437|NCT01587339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24723438|NCT01587339|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24723439|NCT01587339|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24723441|NCT01587378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24723442|NCT01587378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723476|NCT01587508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24723511|NCT01587638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24723512|NCT01587638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24723514|NCT01587638|Autonomic Agents|autonomic agents|mesh-ancestor
24723515|NCT01587638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24723517|NCT01587638|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24723518|NCT01587638|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24723519|NCT01587638|Adrenergic Agents|adrenergic agents|mesh-ancestor
24723520|NCT01587638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24723549|NCT01587937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24723550|NCT01587937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24723581|NCT01588171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723583|NCT01588314|Analgesics|analgesics|mesh-ancestor
24723584|NCT01588314|Sensory System Agents|sensory system agents|mesh-ancestor
24723585|NCT01588314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24824537|NCT02123654|Asunaprevir|asunaprevir|mesh-list
24723586|NCT01588314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723587|NCT01588314|Anticonvulsants|anticonvulsants|mesh-ancestor
24723588|NCT01588314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24723589|NCT01588314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24723590|NCT01588314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24723591|NCT01588314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24723618|NCT01588587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723619|NCT01588626|Ticagrelor|ticagrelor|mesh-list
24723620|NCT01588626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24723621|NCT01588626|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25703314|NCT02166346|4-Aminopyridine|4-aminopyridine|mesh-list
25703315|NCT02166346|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25703316|NCT02166346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25703317|NCT02166346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703318|NCT02166476|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25703319|NCT02166476|Levofloxacin|levofloxacin|mesh-list
25703320|NCT02166476|Ofloxacin|ofloxacin|mesh-list
25703321|NCT02166476|Meropenem|meropenem|mesh-list
25703322|NCT02166476|Tazobactam|tazobactam|mesh-list
24723622|NCT01588626|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24723623|NCT01588626|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24723624|NCT01588626|Purinergic Agents|purinergic agents|mesh-ancestor
24723625|NCT01588626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24725671|NCT01598883|Calcium heparin|calcium heparin|mesh-list
25006437|NCT05083780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24789487|NCT01937494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24789488|NCT01937494|Sensory System Agents|sensory system agents|mesh-ancestor
24789489|NCT01937494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24789491|NCT01937611|Dexmedetomidine|dexmedetomidine|mesh-list
24789492|NCT01937611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24789493|NCT01937611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24789494|NCT01937611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789495|NCT01937611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24789496|NCT01937611|Analgesics|analgesics|mesh-ancestor
24615771|NCT01031732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615772|NCT01031732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615773|NCT01031732|Cholinergic Agents|cholinergic agents|mesh-ancestor
24615774|NCT01031732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24615784|NCT01031888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24615786|NCT01031901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24615787|NCT01031901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24723725|NCT01588873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24723728|NCT01588912|Telbivudine|telbivudine|mesh-list
24723729|NCT01588912|Antiviral Agents|antiviral agents|mesh-ancestor
24723730|NCT01588912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24723761|NCT01589055|Autonomic Agents|autonomic agents|mesh-ancestor
24723762|NCT01589055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24723763|NCT01589055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723764|NCT01589055|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24723765|NCT01589055|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24723766|NCT01589055|Cholinergic Agents|cholinergic agents|mesh-ancestor
24723767|NCT01589055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24723768|NCT01589055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723769|NCT01589068|Nicotine|nicotine|mesh-list
24723808|NCT01589159|Antimetabolites|antimetabolites|mesh-ancestor
24723809|NCT01589159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723810|NCT01589159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24723811|NCT01589159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24723812|NCT01589159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24723813|NCT01589159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24723814|NCT01589159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24723815|NCT01589354|Ropivacaine|ropivacaine|mesh-list
24723852|NCT01589432|Sensory System Agents|sensory system agents|mesh-ancestor
24723853|NCT01589432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24723854|NCT01589432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24427846|NCT00239109|Olanzapine|olanzapine|mesh-list
24723855|NCT01589432|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24723856|NCT01589432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24723857|NCT01589432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24723858|NCT01589432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723860|NCT01589471|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24723861|NCT01589471|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24723862|NCT01589471|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25703324|NCT02166476|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25703325|NCT02166476|Vaborbactam|vaborbactam|mesh-list
25703326|NCT02166476|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
25703327|NCT02166476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25703328|NCT02166476|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25703329|NCT02166476|Renal Agents|renal agents|mesh-ancestor
25703330|NCT02166476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25703331|NCT02166476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25703332|NCT02166476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24723863|NCT01589471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24723864|NCT01589471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723865|NCT01589471|Cholinergic Agents|cholinergic agents|mesh-ancestor
24723952|NCT01590199|Hormones|hormones|mesh-ancestor
24560339|NCT02912572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24560364|NCT02870920|Durvalumab|durvalumab|mesh-list
24723953|NCT01590199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24723980|NCT01590342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24723981|NCT01590342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723987|NCT01590537|Copper|copper|mesh-list
24615830|NCT01032083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24615831|NCT01032083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24615832|NCT01032083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615833|NCT01032083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24615834|NCT01032083|Serotonin Agents|serotonin agents|mesh-ancestor
24615835|NCT01032083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615836|NCT01032083|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24724084|NCT01591031|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24724085|NCT01591031|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24724086|NCT01591031|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24724087|NCT01591031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24724088|NCT01591070|Tacrolimus|tacrolimus|mesh-list
24724089|NCT01591070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24724090|NCT01591070|Immunologic Factors|immunologic factors|mesh-ancestor
24724091|NCT01591070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724092|NCT01591070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24724123|NCT01591135|Antimetabolites|antimetabolites|mesh-ancestor
24724124|NCT01591135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24724125|NCT01591135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24724126|NCT01591135|Immunologic Factors|immunologic factors|mesh-ancestor
24724127|NCT01591135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724128|NCT01591148|Propofol|propofol|mesh-list
24724129|NCT01591148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24724130|NCT01591148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24724132|NCT01591148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24724255|NCT01592019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724257|NCT01592032|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24724258|NCT01592032|Linezolid|linezolid|mesh-list
24724259|NCT01592032|Daptomycin|daptomycin|mesh-list
24724260|NCT01592032|Tigecycline|tigecycline|mesh-list
24724261|NCT01592032|Teicoplanin|teicoplanin|mesh-list
24724262|NCT01592032|Anti-Infective Agents|anti-infective agents|mesh-list
24724263|NCT01592032|Heparin|heparin|mesh-list
24724264|NCT01592032|Calcium heparin|calcium heparin|mesh-list
24724265|NCT01592032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24724293|NCT01592162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724295|NCT01592162|Anesthetics, General|anesthetics, general|mesh-ancestor
24724296|NCT01592162|Anesthetics|anesthetics|mesh-ancestor
24724297|NCT01592162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24724298|NCT01592162|Narcotics|narcotics|mesh-ancestor
24724299|NCT01592162|Analgesics|analgesics|mesh-ancestor
24440153|NCT00281905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24724300|NCT01592162|Sensory System Agents|sensory system agents|mesh-ancestor
24724301|NCT01592162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24724302|NCT01592201|Olanzapine|olanzapine|mesh-list
24724303|NCT01592201|Risperidone|risperidone|mesh-list
24724304|NCT01592201|Aripiprazole|aripiprazole|mesh-list
24724305|NCT01592201|Antipsychotic Agents|antipsychotic agents|mesh-list
24724306|NCT01592201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24724307|NCT01592201|Serotonin Agents|serotonin agents|mesh-ancestor
24724308|NCT01592201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24724309|NCT01592201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724310|NCT01592201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724311|NCT01592201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24724312|NCT01592201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24724313|NCT01592201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24724335|NCT01592214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24724336|NCT01592227|Acetaminophen|acetaminophen|mesh-list
24724337|NCT01592227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24724338|NCT01592227|Analgesics|analgesics|mesh-ancestor
25703333|NCT02166476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703334|NCT02166476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24830700|NCT02160548|Adrenergic Agents|adrenergic agents|mesh-ancestor
24830701|NCT02160548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24724339|NCT01592227|Sensory System Agents|sensory system agents|mesh-ancestor
24724347|NCT01592253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789501|NCT01937611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24789502|NCT01937611|Adrenergic Agents|adrenergic agents|mesh-ancestor
24789503|NCT01937611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24789504|NCT01937611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789505|NCT01937611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24789506|NCT01937611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24789507|NCT01937611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24789508|NCT01937611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24789509|NCT01937611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24789510|NCT01937611|Anesthetics, General|anesthetics, general|mesh-ancestor
24789512|NCT01937611|GABA Modulators|gaba modulators|mesh-ancestor
24789513|NCT01937611|GABA Agents|gaba agents|mesh-ancestor
24789514|NCT01937650|Metronidazole|metronidazole|mesh-list
24789515|NCT01937650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24789516|NCT01937650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25006492|NCT04984330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109763|NCT03122002|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25109764|NCT03122002|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24615848|NCT01032122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24615849|NCT01032122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24615850|NCT01032122|Immunologic Factors|immunologic factors|mesh-ancestor
24615851|NCT01032122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615852|NCT01032122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24615853|NCT01032148|Panobinostat|panobinostat|mesh-list
24615854|NCT01032148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24724404|NCT01592630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24724405|NCT01592981|Cyclophosphamide|cyclophosphamide|mesh-list
24724406|NCT01592981|Rituximab|rituximab|mesh-list
24724407|NCT01592981|Fludarabine|fludarabine|mesh-list
24724408|NCT01592981|Bortezomib|bortezomib|mesh-list
24724409|NCT01592981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24724410|NCT01592981|Immunologic Factors|immunologic factors|mesh-ancestor
24724411|NCT01592981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724412|NCT01592981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24724413|NCT01592981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24724446|NCT01593124|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24724574|NCT01593566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24724575|NCT01593566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724577|NCT01593566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24724772|NCT01594619|Sensory System Agents|sensory system agents|mesh-ancestor
24561068|NCT00485693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24561069|NCT00485693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724773|NCT01594619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25006506|NCT04949022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25006507|NCT04949022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724784|NCT01594775|Oxytocics|oxytocics|mesh-ancestor
24724785|NCT01594775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24724786|NCT01594775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724787|NCT01594866|Dexetimide|dexetimide|mesh-list
24724788|NCT01594866|Citalopram|citalopram|mesh-list
24724789|NCT01594866|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24724790|NCT01594866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24724791|NCT01594866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24724792|NCT01594866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724793|NCT01594866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24724794|NCT01594866|Serotonin Agents|serotonin agents|mesh-ancestor
24724795|NCT01594866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724796|NCT01594866|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24724797|NCT01594866|Antidepressive Agents|antidepressive agents|mesh-ancestor
24724798|NCT01594866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24724799|NCT01594866|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24724971|NCT01595867|Sensory System Agents|sensory system agents|mesh-ancestor
24724972|NCT01595867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24724973|NCT01595867|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24724974|NCT01595867|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24724976|NCT01595880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24724977|NCT01595880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703335|NCT02166476|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24729622|NCT01622790|Lamivudine|lamivudine|mesh-list
24724978|NCT01595893|Vitamin D|vitamin d|mesh-list
24725010|NCT01595984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24725055|NCT01596166|Analgesics|analgesics|mesh-ancestor
24725056|NCT01596166|Sensory System Agents|sensory system agents|mesh-ancestor
24725057|NCT01596166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24725058|NCT01596166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725059|NCT01596166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24725060|NCT01596166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24725061|NCT01596166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24725062|NCT01596166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725063|NCT01596166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425910|NCT00234819|Estrogens|estrogens|mesh-list
24725272|NCT01596907|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24725273|NCT01596907|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24725274|NCT01596907|Purinergic Agents|purinergic agents|mesh-ancestor
24725275|NCT01596907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24725276|NCT01596907|Sympathomimetics|sympathomimetics|mesh-ancestor
24725277|NCT01596907|Autonomic Agents|autonomic agents|mesh-ancestor
24725278|NCT01596907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24615954|NCT01033149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24615955|NCT01033149|Expectorants|expectorants|mesh-ancestor
24615956|NCT01033149|Respiratory System Agents|respiratory system agents|mesh-ancestor
24615957|NCT01033149|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24615958|NCT01033149|Antioxidants|antioxidants|mesh-ancestor
24399542|NCT00148031|Interferons|interferons|mesh-list
24616006|NCT01033500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24616007|NCT01033500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725310|NCT01597011|Coagulants|coagulants|mesh-ancestor
24725311|NCT01597167|Magnesium Sulfate|magnesium sulfate|mesh-list
24725312|NCT01597167|Analgesics|analgesics|mesh-ancestor
24725313|NCT01597167|Sensory System Agents|sensory system agents|mesh-ancestor
24725314|NCT01597167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24725315|NCT01597167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725316|NCT01597167|Anesthetics|anesthetics|mesh-ancestor
24725317|NCT01597167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24725318|NCT01597167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24725319|NCT01597167|Anticonvulsants|anticonvulsants|mesh-ancestor
24725422|NCT01597661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725494|NCT01597934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725495|NCT01597934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725496|NCT01597934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24725497|NCT01597934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24725498|NCT01597986|Isavuconazole|isavuconazole|mesh-list
24725499|NCT01597986|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24616026|NCT01033526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24725535|NCT01598051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725541|NCT01598168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24725542|NCT01598168|Protease Inhibitors|protease inhibitors|mesh-ancestor
24725543|NCT01598168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725544|NCT01598168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725545|NCT01598168|Anticoagulants|anticoagulants|mesh-ancestor
24725548|NCT01598259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725549|NCT01598259|Protective Agents|protective agents|mesh-ancestor
24725673|NCT01598883|Anticoagulants|anticoagulants|mesh-ancestor
24725674|NCT01598883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24725675|NCT01598883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24725676|NCT01598883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725677|NCT01598883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24725678|NCT01598883|Protease Inhibitors|protease inhibitors|mesh-ancestor
24725679|NCT01598883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725681|NCT01598948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24725682|NCT01598948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24725683|NCT01598948|Antimetabolites|antimetabolites|mesh-ancestor
24725712|NCT01599078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24725713|NCT01599078|Tubulin Modulators|tubulin modulators|mesh-ancestor
24725714|NCT01599078|Antimitotic Agents|antimitotic agents|mesh-ancestor
24725715|NCT01599078|Mitosis Modulators|mitosis modulators|mesh-ancestor
24725716|NCT01599078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616132|NCT01034124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616135|NCT01034124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24725752|NCT01599364|Antiviral Agents|antiviral agents|mesh-ancestor
24725753|NCT01599364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25703336|NCT02166476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24725754|NCT01599364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24725755|NCT01599364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24725826|NCT01599962|Cinacalcet|cinacalcet|mesh-list
24725828|NCT01599962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616145|NCT01034189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616146|NCT01034189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24616147|NCT01034345|Sirolimus|sirolimus|mesh-list
24441062|NCT00285883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24441063|NCT00285883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24441064|NCT00285883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24616148|NCT01034345|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
24616176|NCT01034683|Vitamin B Complex|vitamin b complex|mesh-ancestor
24616177|NCT01034683|Vitamins|vitamins|mesh-ancestor
24616178|NCT01034683|Micronutrients|micronutrients|mesh-ancestor
24616179|NCT01034787|Tremelimumab|tremelimumab|mesh-list
24616180|NCT01034787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616181|NCT01034878|Sunitinib|sunitinib|mesh-list
24616182|NCT01034878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616183|NCT01034878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24616184|NCT01034878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24725879|NCT01600274|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24725880|NCT01600274|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24725966|NCT01600963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24725967|NCT01601002|Mirtazapine|mirtazapine|mesh-list
24725968|NCT01601002|Antidepressive Agents|antidepressive agents|mesh-ancestor
24725969|NCT01601002|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24725970|NCT01601002|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24725971|NCT01601002|Histamine Antagonists|histamine antagonists|mesh-ancestor
24725972|NCT01601002|Histamine Agents|histamine agents|mesh-ancestor
24725973|NCT01601002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24725974|NCT01601002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725975|NCT01601002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725976|NCT01601002|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24726059|NCT01601561|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24726060|NCT01601561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24726090|NCT01601795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24726091|NCT01601795|Anesthetics, General|anesthetics, general|mesh-ancestor
24726099|NCT01601899|Antiviral Agents|antiviral agents|mesh-ancestor
24726100|NCT01601899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24428550|NCT00240708|Risperidone|risperidone|mesh-list
24726101|NCT01601899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24726102|NCT01601899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24726103|NCT01601899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24726104|NCT01601899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726133|NCT01601912|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24726134|NCT01601912|Cholinergic Agents|cholinergic agents|mesh-ancestor
24726135|NCT01601912|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25006547|NCT04892420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24726136|NCT01601912|Adrenergic Agents|adrenergic agents|mesh-ancestor
24726138|NCT01601938|Antioxidants|antioxidants|mesh-ancestor
24726139|NCT01601938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726140|NCT01601938|Protective Agents|protective agents|mesh-ancestor
24726141|NCT01601938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726142|NCT01601938|Trace Elements|trace elements|mesh-ancestor
24726143|NCT01601938|Micronutrients|micronutrients|mesh-ancestor
24616186|NCT01034878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616187|NCT01034878|Growth Inhibitors|growth inhibitors|mesh-ancestor
24616188|NCT01034878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24616189|NCT01034878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616190|NCT01034878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616222|NCT01035021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24616223|NCT01035021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616225|NCT01035190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24616226|NCT01035190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24616227|NCT01035190|Autonomic Agents|autonomic agents|mesh-ancestor
24616228|NCT01035190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24616229|NCT01035190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616230|NCT01035190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24441141|NCT00286208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24441142|NCT00286208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441143|NCT00286208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24726262|NCT01602640|Fentanyl|fentanyl|mesh-list
24726270|NCT01602640|Sensory System Agents|sensory system agents|mesh-ancestor
24726271|NCT01602640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24726299|NCT01602822|Tenofovir|tenofovir|mesh-list
24726300|NCT01602822|Emtricitabine|emtricitabine|mesh-list
24726301|NCT01602822|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24726302|NCT01602822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24726303|NCT01602822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24726372|NCT01602939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401353|NCT00152750|Analgesics|analgesics|mesh-ancestor
24616293|NCT01035593|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24616295|NCT01035593|Immunologic Factors|immunologic factors|mesh-ancestor
24616296|NCT01035593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616297|NCT01035619|Moxidectin|moxidectin|mesh-list
24616298|NCT01035619|Anthelmintics|anthelmintics|mesh-ancestor
24616299|NCT01035619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24616300|NCT01035619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24616301|NCT01035619|Antinematodal Agents|antinematodal agents|mesh-ancestor
24616302|NCT01035671|Vitamin E|vitamin e|mesh-list
24726751|NCT01605487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726752|NCT01605487|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24726753|NCT01605487|Serotonin Agents|serotonin agents|mesh-ancestor
24726788|NCT01605864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24726789|NCT01605864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24726791|NCT01605929|Anesthetics, Local|anesthetics, local|mesh-ancestor
24726932|NCT01606878|Tubulin Modulators|tubulin modulators|mesh-ancestor
24726933|NCT01606878|Antimitotic Agents|antimitotic agents|mesh-ancestor
24726934|NCT01606878|Mitosis Modulators|mitosis modulators|mesh-ancestor
24726935|NCT01606878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24402141|NCT00155064|Protease Inhibitors|protease inhibitors|mesh-ancestor
24727269|NCT01608841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727270|NCT01608841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24727338|NCT01609166|Allopurinol|allopurinol|mesh-list
24648455|NCT01214772|Heparin|heparin|mesh-list
24727339|NCT01609166|Antimetabolites|antimetabolites|mesh-ancestor
24727511|NCT01610921|Analgesics|analgesics|mesh-ancestor
24728070|NCT01614132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728071|NCT01614132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24728072|NCT01614132|Tubulin Modulators|tubulin modulators|mesh-ancestor
24728103|NCT01614197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24441145|NCT00286208|Oxytocics|oxytocics|mesh-ancestor
24728104|NCT01614197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24728105|NCT01614197|Antiviral Agents|antiviral agents|mesh-ancestor
24728106|NCT01614197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24728107|NCT01614197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24728108|NCT01614223|Betamethasone|betamethasone|mesh-list
24728109|NCT01614223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24728110|NCT01614223|Glucocorticoids|glucocorticoids|mesh-ancestor
24728111|NCT01614223|Hormones|hormones|mesh-ancestor
24728112|NCT01614223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24728113|NCT01614223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616492|NCT01037517|Plerixafor|plerixafor|mesh-list
24616493|NCT01037517|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24616494|NCT01037517|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24616495|NCT01037517|Antiviral Agents|antiviral agents|mesh-ancestor
24616496|NCT01037517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24616497|NCT01037530|Ramipril|ramipril|mesh-list
24728991|NCT01619176|Abortifacient Agents|abortifacient agents|mesh-ancestor
24616498|NCT01037530|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24728163|NCT01614366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728164|NCT01614366|Vasodilator Agents|vasodilator agents|mesh-ancestor
24728165|NCT01614405|Ritonavir|ritonavir|mesh-list
24728166|NCT01614405|Lopinavir|lopinavir|mesh-list
24728261|NCT01615185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24728262|NCT01615185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728263|NCT01615185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24728294|NCT01615354|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24728295|NCT01615354|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25109766|NCT03122002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24728296|NCT01615354|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24728297|NCT01615354|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24728474|NCT01616407|Dopamine Agents|dopamine agents|mesh-ancestor
24728475|NCT01616407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24728476|NCT01616407|Hallucinogens|hallucinogens|mesh-ancestor
24728477|NCT01616407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24728478|NCT01616407|Serotonin Agents|serotonin agents|mesh-ancestor
24728479|NCT01616407|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24728480|NCT01616407|Adrenergic Agents|adrenergic agents|mesh-ancestor
24728481|NCT01616485|Sildenafil Citrate|sildenafil citrate|mesh-list
24728483|NCT01616485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703337|NCT02166697|Candesartan|candesartan|mesh-list
25703338|NCT02166697|Candesartan cilexetil|candesartan cilexetil|mesh-list
25703339|NCT02166697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25703340|NCT02166697|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24830780|NCT02161354|Analgesics|analgesics|mesh-ancestor
24728484|NCT01616485|Vasodilator Agents|vasodilator agents|mesh-ancestor
24728513|NCT01616680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24728514|NCT01616732|Testosterone|testosterone|mesh-list
24728515|NCT01616732|Androgens|androgens|mesh-ancestor
24728516|NCT01616732|Hormones|hormones|mesh-ancestor
24728517|NCT01616732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24728518|NCT01616732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728519|NCT01616784|Insulin|insulin|mesh-list
24728520|NCT01616784|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24728521|NCT01616784|Insulin Detemir|insulin detemir|mesh-list
24728522|NCT01616784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24728523|NCT01616784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728524|NCT01616849|Nimotuzumab|nimotuzumab|mesh-list
24516521|NCT00602303|Torsemide|torsemide|mesh-list
24728525|NCT01616849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24728526|NCT01616849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24728527|NCT01616875|Cisplatin|cisplatin|mesh-list
24728528|NCT01616875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24728564|NCT01616992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24616504|NCT01037595|Antioxidants|antioxidants|mesh-ancestor
24616505|NCT01037595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616506|NCT01037595|Protective Agents|protective agents|mesh-ancestor
24728570|NCT01617135|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24728571|NCT01617135|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24728572|NCT01617135|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24728573|NCT01617135|Dopamine Agents|dopamine agents|mesh-ancestor
24728579|NCT01617135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24728650|NCT01617551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728652|NCT01617564|Anesthetics, Local|anesthetics, local|mesh-ancestor
24728653|NCT01617564|Anesthetics|anesthetics|mesh-ancestor
24728654|NCT01617564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24728655|NCT01617564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728656|NCT01617564|Sensory System Agents|sensory system agents|mesh-ancestor
24728657|NCT01617564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24728658|NCT01617590|Methotrexate|methotrexate|mesh-list
24728659|NCT01617590|Leflunomide|leflunomide|mesh-list
24728660|NCT01617590|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24728661|NCT01617590|Abortifacient Agents|abortifacient agents|mesh-ancestor
24728662|NCT01617590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24728663|NCT01617590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728721|NCT01617772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728723|NCT01617798|Furosemide|furosemide|mesh-list
24728724|NCT01617798|Diuretics|diuretics|mesh-ancestor
24728725|NCT01617798|Natriuretic Agents|natriuretic agents|mesh-ancestor
24728726|NCT01617798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728727|NCT01617798|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24728728|NCT01617798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24728729|NCT01617798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728730|NCT01617798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25006629|NCT04843579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728992|NCT01619176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24728993|NCT01619176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728994|NCT01619176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24728995|NCT01619176|Antimetabolites|antimetabolites|mesh-ancestor
24729026|NCT01619436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24729027|NCT01619436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729028|NCT01619462|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24729029|NCT01619462|Immunologic Factors|immunologic factors|mesh-ancestor
24729030|NCT01619462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729031|NCT01619527|Darunavir|darunavir|mesh-list
24729032|NCT01619527|Cobicistat|cobicistat|mesh-list
24729033|NCT01619527|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24729034|NCT01619527|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24729035|NCT01619527|Protease Inhibitors|protease inhibitors|mesh-ancestor
25703341|NCT02166697|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25703342|NCT02166697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729036|NCT01619527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729037|NCT01619527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729067|NCT01619644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24729068|NCT01619683|Enclomiphene|enclomiphene|mesh-list
24729181|NCT01620320|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24729182|NCT01620320|Sympathomimetics|sympathomimetics|mesh-ancestor
24729183|NCT01620320|Autonomic Agents|autonomic agents|mesh-ancestor
24729206|NCT01620424|Biphasic Insulins|biphasic insulins|mesh-list
24737292|NCT01668069|Antipruritics|antipruritics|mesh-ancestor
24729207|NCT01620424|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24729208|NCT01620424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24729209|NCT01620424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729210|NCT01620437|Insulin Aspart|insulin aspart|mesh-list
24729211|NCT01620437|Biphasic Insulins|biphasic insulins|mesh-list
24729212|NCT01620437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24441762|NCT00288262|Melatonin|melatonin|mesh-list
24729215|NCT01620450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24729225|NCT01620476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24729311|NCT01621100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24729313|NCT01621100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24729314|NCT01621100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729315|NCT01621100|Analgesics|analgesics|mesh-ancestor
24729316|NCT01621100|Sensory System Agents|sensory system agents|mesh-ancestor
24729352|NCT01621217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729354|NCT01621256|Anticoagulants|anticoagulants|mesh-ancestor
24729363|NCT01621269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729365|NCT01621308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24729366|NCT01621308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729367|NCT01621321|Voriconazole|voriconazole|mesh-list
24729368|NCT01621321|Prednisolone|prednisolone|mesh-list
24729369|NCT01621321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24729370|NCT01621321|Glucocorticoids|glucocorticoids|mesh-ancestor
24729371|NCT01621321|Hormones|hormones|mesh-ancestor
24729372|NCT01621321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24729373|NCT01621321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729374|NCT01621321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24729375|NCT01621321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24729407|NCT01621386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729408|NCT01621451|Aspirin|aspirin|mesh-list
24729409|NCT01621451|Clopidogrel|clopidogrel|mesh-list
24729410|NCT01621451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24729937|NCT01624714|Alemtuzumab|alemtuzumab|mesh-list
24729938|NCT01624714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24729939|NCT01624714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24729940|NCT01624766|Denosumab|denosumab|mesh-list
24729941|NCT01624766|Everolimus|everolimus|mesh-list
24408264|NCT00177060|Narcotics|narcotics|mesh-ancestor
24730055|NCT01625520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24730056|NCT01625520|Immunologic Factors|immunologic factors|mesh-ancestor
24730057|NCT01625520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730058|NCT01625520|Hormones|hormones|mesh-ancestor
24649237|NCT01219062|Bupivacaine|bupivacaine|mesh-list
24730059|NCT01625520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24730060|NCT01625572|Morphine|morphine|mesh-list
24730061|NCT01625572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24730092|NCT01625806|Antifungal Agents|antifungal agents|mesh-ancestor
24730093|NCT01625806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24730094|NCT01625806|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24730095|NCT01625806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24730096|NCT01625806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734351|NCT01651962|Anesthetics, General|anesthetics, general|mesh-ancestor
24730193|NCT01627041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730195|NCT01627041|Antiviral Agents|antiviral agents|mesh-ancestor
24730196|NCT01627041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24730197|NCT01627041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24730198|NCT01627041|Immunologic Factors|immunologic factors|mesh-ancestor
24730199|NCT01627041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730200|NCT01627041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24730201|NCT01627041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24730202|NCT01627041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24730203|NCT01627041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24730402|NCT01627834|Dopamine Agonists|dopamine agonists|mesh-ancestor
25709613|NCT02270983|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
24730535|NCT01628731|Ethacrynic Acid|ethacrynic acid|mesh-list
24730537|NCT01628731|Natriuretic Agents|natriuretic agents|mesh-ancestor
24730538|NCT01628731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730539|NCT01628731|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24730540|NCT01628731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24409243|NCT00181584|Zoledronic Acid|zoledronic acid|mesh-list
24730849|NCT01630902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24730850|NCT01630902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24730851|NCT01630902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730852|NCT01630902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24731021|NCT01631539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731022|NCT01631539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731023|NCT01631539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459937|NCT00346879|PENTA|penta|mesh-list
24731117|NCT01632514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24731119|NCT01632540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24731121|NCT01632540|Hormones|hormones|mesh-ancestor
24731122|NCT01632540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24731123|NCT01632540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731124|NCT01632540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24731125|NCT01632540|Respiratory System Agents|respiratory system agents|mesh-ancestor
24731126|NCT01632592|Tesamorelin|tesamorelin|mesh-list
24731127|NCT01632592|Growth Substances|growth substances|mesh-ancestor
24395049|NCT00134992|Methylprednisolone|methylprednisolone|mesh-list
24731163|NCT01632826|Immunologic Factors|immunologic factors|mesh-ancestor
24731164|NCT01632826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731165|NCT01632826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24731766|NCT01636505|Ganirelix|ganirelix|mesh-list
24731805|NCT01636557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24731807|NCT01636557|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24731808|NCT01636557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24731810|NCT01636557|Coagulants|coagulants|mesh-ancestor
24731811|NCT01636570|Vitamin D|vitamin d|mesh-list
24731812|NCT01636570|Cholecalciferol|cholecalciferol|mesh-list
24731813|NCT01636570|Vitamins|vitamins|mesh-ancestor
24731814|NCT01636570|Micronutrients|micronutrients|mesh-ancestor
24731815|NCT01636570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731816|NCT01636570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24731817|NCT01636570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24731818|NCT01636596|Insulin Lispro|insulin lispro|mesh-list
24731819|NCT01636596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24617041|NCT01040429|Autonomic Agents|autonomic agents|mesh-ancestor
24617042|NCT01040429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24732201|NCT01638273|Anticonvulsants|anticonvulsants|mesh-ancestor
24617043|NCT01040429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24617044|NCT01040429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24732202|NCT01638273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24732304|NCT01638767|Contraceptives, Oral|contraceptives, oral|mesh-list
24649475|NCT01220102|Adapalene|adapalene|mesh-list
24732305|NCT01638767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24732333|NCT01638962|Celecoxib|celecoxib|mesh-list
24459966|NCT00346970|Niacin|niacin|mesh-list
24733088|NCT01643252|Micronutrients|micronutrients|mesh-ancestor
24733089|NCT01643252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733090|NCT01643252|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24734009|NCT01650181|Antioxidants|antioxidants|mesh-ancestor
24789729|NCT01938781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25006721|NCT04688177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416026|NCT00201747|Mitomycins|mitomycins|mesh-list
24416206|NCT00202293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24734349|NCT01651962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24734350|NCT01651962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24734352|NCT01651962|Anesthetics|anesthetics|mesh-ancestor
24734353|NCT01651962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24734354|NCT01651962|Autonomic Agents|autonomic agents|mesh-ancestor
24734355|NCT01651962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24734383|NCT01652014|Alkylating Agents|alkylating agents|mesh-ancestor
24734384|NCT01652014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416488|NCT00203190|Topiramate|topiramate|mesh-list
24734449|NCT01652326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24734485|NCT01652378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24734643|NCT01652898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734645|NCT01652924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24734646|NCT01652924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734648|NCT01653015|Immunologic Factors|immunologic factors|mesh-ancestor
24734649|NCT01653015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734650|NCT01653041|Everolimus|everolimus|mesh-list
24734651|NCT01653041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24734652|NCT01653041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24734655|NCT01653067|Cytarabine|cytarabine|mesh-list
24734822|NCT01654120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24734823|NCT01654146|Paclitaxel|paclitaxel|mesh-list
24734824|NCT01654146|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24734825|NCT01654146|Carboplatin|carboplatin|mesh-list
24734826|NCT01654146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24734827|NCT01654146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617546|NCT01043679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24617547|NCT01043679|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24617548|NCT01043679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24617549|NCT01043679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24617550|NCT01043679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617551|NCT01043744|Lumefantrine|lumefantrine|mesh-list
24734960|NCT01655004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734992|NCT01655095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24734993|NCT01655095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734994|NCT01655095|Cathartics|cathartics|mesh-ancestor
24734995|NCT01655108|Minoxidil|minoxidil|mesh-list
24734996|NCT01655108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24734997|NCT01655108|Vasodilator Agents|vasodilator agents|mesh-ancestor
24734998|NCT01655147|Rifampin|rifampin|mesh-list
24734999|NCT01655147|Abiraterone Acetate|abiraterone acetate|mesh-list
24735000|NCT01655147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24735001|NCT01655147|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24399425|NCT00147719|Antimetabolites|antimetabolites|mesh-ancestor
24617595|NCT01044225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24617596|NCT01044225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617597|NCT01044238|Methylphenidate|methylphenidate|mesh-list
24617598|NCT01044238|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24617599|NCT01044238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735118|NCT01655706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24735119|NCT01655706|Dopamine Agonists|dopamine agonists|mesh-ancestor
24735120|NCT01655706|Dopamine Agents|dopamine agents|mesh-ancestor
24735121|NCT01655706|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24735122|NCT01655706|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24735285|NCT01656109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735286|NCT01656109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24735287|NCT01656109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24735288|NCT01656109|Antiviral Agents|antiviral agents|mesh-ancestor
24735289|NCT01656109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24735406|NCT01656811|Respiratory System Agents|respiratory system agents|mesh-ancestor
24735407|NCT01656811|Tocolytic Agents|tocolytic agents|mesh-ancestor
24735441|NCT01657071|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24735442|NCT01657071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24735503|NCT01657396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24735504|NCT01657396|Disinfectants|disinfectants|mesh-ancestor
24735505|NCT01657409|Botulinum Toxins|botulinum toxins|mesh-list
24735506|NCT01657409|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24399875|NCT00148837|Interferons|interferons|mesh-list
24735535|NCT01657487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735536|NCT01657487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24735537|NCT01657487|Respiratory System Agents|respiratory system agents|mesh-ancestor
24735538|NCT01657487|Dermatologic Agents|dermatologic agents|mesh-ancestor
24735539|NCT01657487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24650538|NCT01226186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24735540|NCT01657487|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24735541|NCT01657487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24735734|NCT01658215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24735735|NCT01658215|Cholinergic Agents|cholinergic agents|mesh-ancestor
24735736|NCT01658215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24419993|NCT00214864|Tubulin Modulators|tubulin modulators|mesh-ancestor
24735832|NCT01658891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735834|NCT01658891|Glucocorticoids|glucocorticoids|mesh-ancestor
24735865|NCT01659099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24735866|NCT01659099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24735867|NCT01659099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24735868|NCT01659099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24735869|NCT01659099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735870|NCT01659099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24735871|NCT01659099|Glucocorticoids|glucocorticoids|mesh-ancestor
24735872|NCT01659099|Hormones|hormones|mesh-ancestor
24735907|NCT01659242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24735908|NCT01659242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24735909|NCT01659281|Artesunate|artesunate|mesh-list
24735910|NCT01659281|Mefloquine|mefloquine|mesh-list
24735911|NCT01659281|Antimalarials|antimalarials|mesh-ancestor
24400348|NCT00150384|Antimetabolites|antimetabolites|mesh-ancestor
24735936|NCT01659346|Carvedilol|carvedilol|mesh-list
24735937|NCT01659346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24735938|NCT01659346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24735939|NCT01659346|Adrenergic Agents|adrenergic agents|mesh-ancestor
24735940|NCT01659346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24735941|NCT01659346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735942|NCT01659346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735943|NCT01659346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24735944|NCT01659346|Antioxidants|antioxidants|mesh-ancestor
24735945|NCT01659346|Protective Agents|protective agents|mesh-ancestor
25006753|NCT04668365|Vincristine|vincristine|mesh-list
24789785|NCT01939093|GABA Modulators|gaba modulators|mesh-ancestor
24789786|NCT01939093|GABA Agents|gaba agents|mesh-ancestor
24789787|NCT01939093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24789788|NCT01939093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789794|NCT01939093|Histamine Agents|histamine agents|mesh-ancestor
24789796|NCT01939171|Immunologic Factors|immunologic factors|mesh-ancestor
25006776|NCT04668365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25006777|NCT04668365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25006778|NCT04668365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25006779|NCT04668365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25006787|NCT04635735|Ipilimumab|ipilimumab|mesh-list
25006788|NCT04635735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25006789|NCT04635735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006790|NCT04635735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25006791|NCT04635735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736090|NCT01659944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24736091|NCT01659944|Sympatholytics|sympatholytics|mesh-ancestor
24736092|NCT01659944|Autonomic Agents|autonomic agents|mesh-ancestor
24736093|NCT01659944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24736094|NCT01659944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736095|NCT01659944|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24736096|NCT01659944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24736097|NCT01659944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24736098|NCT01659944|Adrenergic Agents|adrenergic agents|mesh-ancestor
24736099|NCT01659944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24736100|NCT01659944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736101|NCT01659944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24736737|NCT01664845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736738|NCT01664845|Antimetabolites|antimetabolites|mesh-ancestor
24401249|NCT00152581|Immunologic Factors|immunologic factors|mesh-ancestor
24736771|NCT01665196|Antiviral Agents|antiviral agents|mesh-ancestor
24736772|NCT01665196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24736774|NCT01665209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24736775|NCT01665209|Narcotics|narcotics|mesh-ancestor
24736776|NCT01665209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24736777|NCT01665209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736778|NCT01665209|Analgesics|analgesics|mesh-ancestor
24736779|NCT01665209|Sensory System Agents|sensory system agents|mesh-ancestor
24736780|NCT01665209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24563512|NCT00772161|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24563537|NCT00772265|Insulin|insulin|mesh-list
24617859|NCT01045902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24736816|NCT01665235|Purinergic Agents|purinergic agents|mesh-ancestor
24736817|NCT01665235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25109782|NCT03122314|Acetaminophen|acetaminophen|mesh-list
24736818|NCT01665235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24736819|NCT01665235|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24736820|NCT01665235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24736858|NCT01665404|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24736921|NCT01665677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24736922|NCT01665677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24736923|NCT01665677|Antimetabolites|antimetabolites|mesh-ancestor
24736924|NCT01665677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736925|NCT01665677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24736926|NCT01665677|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24736927|NCT01665677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24736928|NCT01665703|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24736929|NCT01665703|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24736970|NCT01666080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24736971|NCT01666080|Immunologic Factors|immunologic factors|mesh-ancestor
24736972|NCT01666080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736973|NCT01666080|Alkylating Agents|alkylating agents|mesh-ancestor
24736974|NCT01666080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24737012|NCT01666262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737013|NCT01666301|Darbepoetin alfa|darbepoetin alfa|mesh-list
24737014|NCT01666301|Hematinics|hematinics|mesh-ancestor
24737015|NCT01666353|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24737293|NCT01668069|Dermatologic Agents|dermatologic agents|mesh-ancestor
24737294|NCT01668069|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24737741|NCT01670370|Oxaliplatin|oxaliplatin|mesh-list
24737742|NCT01670370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737743|NCT01670370|Immunologic Factors|immunologic factors|mesh-ancestor
24737744|NCT01670370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737745|NCT01670370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24737746|NCT01670370|Antimetabolites|antimetabolites|mesh-ancestor
24737747|NCT01670370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737748|NCT01670370|Antiviral Agents|antiviral agents|mesh-ancestor
24737749|NCT01670370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24737750|NCT01670370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737751|NCT01670370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24737786|NCT01670565|Belimumab|belimumab|mesh-list
24737787|NCT01670565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24738797|NCT01677468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24738798|NCT01677468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24738799|NCT01677468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739158|NCT01679574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24739159|NCT01679574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403721|NCT00161330|Ceftriaxone|ceftriaxone|mesh-list
24403734|NCT00161421|Leuprolide|leuprolide|mesh-list
24739193|NCT01679652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739194|NCT01679691|Anesthetics|anesthetics|mesh-list
24403756|NCT00161447|Testosterone|testosterone|mesh-list
24739222|NCT01679899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24739273|NCT01680146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739274|NCT01680185|Insulin|insulin|mesh-list
24739275|NCT01680185|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24739276|NCT01680185|Insulin Lispro|insulin lispro|mesh-list
24739277|NCT01680185|Isophane Insulin, Human|isophane insulin, human|mesh-list
24739278|NCT01680185|Insulin, Isophane|insulin, isophane|mesh-list
24739279|NCT01680185|Isophane insulin, beef|isophane insulin, beef|mesh-list
24739280|NCT01680185|Insulin, Short-Acting|insulin, short-acting|mesh-list
24739281|NCT01680185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24739282|NCT01680185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739283|NCT01680198|Vitamin D|vitamin d|mesh-list
24739284|NCT01680198|Vitamins|vitamins|mesh-ancestor
25006812|NCT04629378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24789843|NCT01939444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789844|NCT01939444|Sensory System Agents|sensory system agents|mesh-ancestor
24789845|NCT01939444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24789846|NCT01939457|Misoprostol|misoprostol|mesh-list
24789847|NCT01939457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24789848|NCT01939457|Abortifacient Agents|abortifacient agents|mesh-ancestor
24789849|NCT01939457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24789850|NCT01939457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789851|NCT01939457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24789852|NCT01939457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24739350|NCT01680718|Coagulants|coagulants|mesh-ancestor
25006813|NCT04629378|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25006814|NCT04629378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25006815|NCT04629378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006816|NCT04629378|Antitubercular Agents|antitubercular agents|mesh-ancestor
25006817|NCT04616183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25006818|NCT04616183|Cetuximab|cetuximab|mesh-list
25006819|NCT04616183|Antibodies|antibodies|mesh-list
24739354|NCT01680796|Dexamethasone|dexamethasone|mesh-list
24739384|NCT01680939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24739385|NCT01680939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739388|NCT01680952|Tacrolimus|tacrolimus|mesh-list
24739389|NCT01680952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24739390|NCT01680952|Immunologic Factors|immunologic factors|mesh-ancestor
24739391|NCT01680952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739392|NCT01680952|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24739393|NCT01680952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709614|NCT02270983|Enzyme Activators|enzyme activators|mesh-ancestor
24739394|NCT01680952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739395|NCT01680952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24739396|NCT01680952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739397|NCT01680952|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24739398|NCT01680952|Antitubercular Agents|antitubercular agents|mesh-ancestor
24739497|NCT01681979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24739498|NCT01681979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24739499|NCT01681979|Autonomic Agents|autonomic agents|mesh-ancestor
24739500|NCT01681979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24739501|NCT01681979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739502|NCT01681979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24739503|NCT01681979|Respiratory System Agents|respiratory system agents|mesh-ancestor
24739976|NCT01685502|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24739977|NCT01685502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24739978|NCT01685502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740009|NCT01685827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24740010|NCT01685827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24740011|NCT01685827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24740012|NCT01685827|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
24740013|NCT01685827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24740014|NCT01685827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740016|NCT01685853|Cathartics|cathartics|mesh-ancestor
24740017|NCT01685853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24740018|NCT01685853|Laxatives|laxatives|mesh-ancestor
24740019|NCT01685892|Venetoclax|venetoclax|mesh-list
24740020|NCT01685892|Obinutuzumab|obinutuzumab|mesh-list
24740021|NCT01685892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24740022|NCT01685892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24740023|NCT01685931|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24740024|NCT01685931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24740044|NCT01686009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740045|NCT01686009|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24740046|NCT01686009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24740047|NCT01686009|Anesthetics, General|anesthetics, general|mesh-ancestor
24740048|NCT01686009|Anesthetics|anesthetics|mesh-ancestor
24740049|NCT01686009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24740050|NCT01686009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24740051|NCT01686009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24740052|NCT01686009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24740053|NCT01686009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740054|NCT01686126|Metformin|metformin|mesh-list
24740055|NCT01686126|Levonorgestrel|levonorgestrel|mesh-list
24740056|NCT01686126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24740057|NCT01686126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740058|NCT01686126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24740059|NCT01686126|Contraceptive Agents|contraceptive agents|mesh-ancestor
24740157|NCT01686607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24740158|NCT01686607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740159|NCT01686607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24740160|NCT01686607|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24740199|NCT01686802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24740200|NCT01686802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24740235|NCT01687205|Antiviral Agents|antiviral agents|mesh-ancestor
24740236|NCT01687205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24740237|NCT01687205|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24740238|NCT01687205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24740239|NCT01687205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24740240|NCT01687205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740241|NCT01687205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24740308|NCT01687751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24740309|NCT01687751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24404960|NCT00165191|Immunologic Factors|immunologic factors|mesh-ancestor
24740372|NCT01688089|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24740373|NCT01688089|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24740374|NCT01688089|Dopamine Agents|dopamine agents|mesh-ancestor
24740375|NCT01688089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24740499|NCT01688648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25709615|NCT02270983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740501|NCT01688648|Adrenergic Agents|adrenergic agents|mesh-ancestor
24740502|NCT01688648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24740503|NCT01688700|Paclitaxel|paclitaxel|mesh-list
24740504|NCT01688700|Nimotuzumab|nimotuzumab|mesh-list
24740530|NCT01688934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24740531|NCT01688934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24740532|NCT01688934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740773|NCT01690221|Vasodilator Agents|vasodilator agents|mesh-ancestor
24740774|NCT01690247|Immunosuppressive Agents|immunosuppressive agents|mesh-list
24405460|NCT00167154|Risperidone|risperidone|mesh-list
24741043|NCT01691456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24741044|NCT01691456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742737|NCT05180006|Growth Substances|growth substances|mesh-ancestor
24741553|NCT05288179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741554|NCT05288179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24741555|NCT05288179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24741556|NCT05288179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24741557|NCT05288179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24741722|NCT05290090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618270|NCT01047566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24618271|NCT01047566|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24742002|NCT05294406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24742036|NCT05294055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24742037|NCT05294055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24742038|NCT05294055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24742039|NCT05294055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24742040|NCT05294055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24742041|NCT05294055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24742042|NCT05293977|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24742043|NCT05293977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24742062|NCT05293808|Antipyretics|antipyretics|mesh-ancestor
24742064|NCT05293704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24742065|NCT05293704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24742066|NCT05293704|Analgesics|analgesics|mesh-ancestor
24742067|NCT05293704|Sensory System Agents|sensory system agents|mesh-ancestor
24695833|NCT01425827|Sensory System Agents|sensory system agents|mesh-ancestor
24695834|NCT01425827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24695835|NCT01425827|Antidepressive Agents|antidepressive agents|mesh-ancestor
24612531|NCT01014338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651557|NCT01232075|Chelating Agents|chelating agents|mesh-ancestor
24742068|NCT05293704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24742069|NCT05293704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742070|NCT05293704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24742071|NCT05293704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24742072|NCT05293704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24742073|NCT05293704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24742074|NCT05293704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24531501|NCT00636116|Antivenins|antivenins|mesh-list
24742075|NCT05293704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24742076|NCT05293704|Antimalarials|antimalarials|mesh-ancestor
24425503|NCT00233558|Adalimumab|adalimumab|mesh-list
24742247|NCT05295355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24742248|NCT05295355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742249|NCT05295355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24742250|NCT05295355|Respiratory System Agents|respiratory system agents|mesh-ancestor
24742251|NCT05295355|Parasympatholytics|parasympatholytics|mesh-ancestor
24742252|NCT05295355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24742253|NCT05295355|Cholinergic Agents|cholinergic agents|mesh-ancestor
24425626|NCT00233805|Sirolimus|sirolimus|mesh-list
24742495|NCT05262686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24742496|NCT05262686|Antiviral Agents|antiviral agents|mesh-ancestor
24742497|NCT05262686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24742684|NCT05192629|Midazolam|midazolam|mesh-list
24742685|NCT05192629|Dexmedetomidine|dexmedetomidine|mesh-list
24742686|NCT05192629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24426100|NCT00235053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24742729|NCT05180006|Bevacizumab|bevacizumab|mesh-list
24742730|NCT05180006|Trastuzumab|trastuzumab|mesh-list
24742731|NCT05180006|Pertuzumab|pertuzumab|mesh-list
24742732|NCT05180006|Atezolizumab|atezolizumab|mesh-list
24742733|NCT05180006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25709616|NCT02270983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24742734|NCT05180006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24742735|NCT05180006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24449173|NCT00314626|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24742736|NCT05180006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24742824|NCT05150795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24742825|NCT05150795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742872|NCT05146778|Anesthetics, General|anesthetics, general|mesh-ancestor
24742910|NCT05110898|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24742911|NCT05110898|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24742912|NCT05110898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742913|NCT05110898|Diuretics|diuretics|mesh-ancestor
24742914|NCT05110898|Natriuretic Agents|natriuretic agents|mesh-ancestor
24742915|NCT05110898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742916|NCT05110898|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24743461|NCT04781647|Interferon-alpha|interferon-alpha|mesh-list
24742917|NCT05110898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24742924|NCT05103696|Etomidate|etomidate|mesh-list
24742925|NCT05103696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24407519|NCT00174655|Doxorubicin|doxorubicin|mesh-list
24407565|NCT00174707|Abortifacient Agents|abortifacient agents|mesh-ancestor
24789870|NCT01939509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24789871|NCT01939509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24789872|NCT01939509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24789873|NCT01939509|Adrenergic Agents|adrenergic agents|mesh-ancestor
24789874|NCT01939509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24789875|NCT01939509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789876|NCT01939522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24789879|NCT01939561|Lamotrigine|lamotrigine|mesh-list
24789880|NCT01939561|Anticonvulsants|anticonvulsants|mesh-ancestor
24618397|NCT01048138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618422|NCT01048229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618423|NCT01048229|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24618424|NCT01048229|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24618425|NCT01048229|Dopamine Agonists|dopamine agonists|mesh-ancestor
24618426|NCT01048229|Dopamine Agents|dopamine agents|mesh-ancestor
24618427|NCT01048229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24618428|NCT01048229|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24618429|NCT01048229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618430|NCT01048229|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24651808|NCT01233947|Fulvestrant|fulvestrant|mesh-list
24618431|NCT01048268|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
24618432|NCT01048268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24618433|NCT01048268|Incretins|incretins|mesh-ancestor
24743027|NCT05030025|Dideoxynucleosides|dideoxynucleosides|mesh-list
24743028|NCT05030025|Dolutegravir|dolutegravir|mesh-list
24743029|NCT05030025|Triumeq|triumeq|mesh-list
24743030|NCT05030025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24743031|NCT05030025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24743032|NCT05030025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24743033|NCT05030025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743035|NCT05030025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24743036|NCT05030025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24743037|NCT05030025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24743038|NCT05030025|Antimetabolites|antimetabolites|mesh-ancestor
24743039|NCT05030025|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25006845|NCT04606069|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
24743079|NCT05013502|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24743080|NCT05013502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743113|NCT04989621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24743115|NCT04989621|Immunologic Factors|immunologic factors|mesh-ancestor
24743116|NCT04989621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743117|NCT04989621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24743118|NCT04989049|Folic Acid|folic acid|mesh-list
24743119|NCT04989049|Hematinics|hematinics|mesh-ancestor
24743120|NCT04989049|Vitamin B Complex|vitamin b complex|mesh-ancestor
24743121|NCT04989049|Vitamins|vitamins|mesh-ancestor
25703343|NCT02167035|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
25703344|NCT02167035|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25703345|NCT02167035|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25703346|NCT02167035|Adrenergic Agents|adrenergic agents|mesh-ancestor
24743122|NCT04989049|Micronutrients|micronutrients|mesh-ancestor
24743123|NCT04989049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427103|NCT00237419|Infliximab|infliximab|mesh-list
24743207|NCT04964700|Immunologic Factors|immunologic factors|mesh-ancestor
24427136|NCT00237510|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24743335|NCT04882202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24743336|NCT04882202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743337|NCT04882202|Antipyretics|antipyretics|mesh-ancestor
24743338|NCT04871425|Fentanyl|fentanyl|mesh-list
24743441|NCT04800107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24743442|NCT04800107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743443|NCT04800107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24743444|NCT04800107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24743445|NCT04800107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24743446|NCT04800107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24743447|NCT04800107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743449|NCT04793867|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24743450|NCT04793867|Anesthetics, General|anesthetics, general|mesh-ancestor
24618435|NCT01048268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24618436|NCT01048268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618437|NCT01048307|Polihexanide|polihexanide|mesh-list
24618438|NCT01048307|Betaine|betaine|mesh-list
24408035|NCT00176293|Dexamethasone|dexamethasone|mesh-list
24743462|NCT04781647|Entecavir|entecavir|mesh-list
24743463|NCT04781647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24743525|NCT04753216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24743527|NCT04753216|Endothelial Growth Factors|endothelial growth factors|mesh-list
24743528|NCT04753216|Antibodies|antibodies|mesh-list
24998390|NCT02960646|Fludarabine phosphate|fludarabine phosphate|mesh-list
24891917|NCT04466943|Rocuronium|rocuronium|mesh-list
24743644|NCT04696380|Nicotine|nicotine|mesh-list
24743645|NCT04696380|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24743646|NCT04696380|Autonomic Agents|autonomic agents|mesh-ancestor
24743647|NCT04696380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24408246|NCT00177008|Dopamine Agents|dopamine agents|mesh-ancestor
24743681|NCT04659941|Immunologic Factors|immunologic factors|mesh-ancestor
24743682|NCT04659941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743684|NCT04659382|Atezolizumab|atezolizumab|mesh-list
24618464|NCT01048385|Micronutrients|micronutrients|mesh-ancestor
24618465|NCT01048385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744059|NCT04521920|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
24744060|NCT04521920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24744409|NCT04291079|Immunologic Factors|immunologic factors|mesh-ancestor
24744528|NCT04238546|Antifungal Agents|antifungal agents|mesh-ancestor
24744529|NCT04238546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24534324|NCT00646659|Immunologic Factors|immunologic factors|mesh-ancestor
24744530|NCT04238546|Immunologic Factors|immunologic factors|mesh-ancestor
24744561|NCT04233112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744562|NCT04233112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24744563|NCT04233034|Verapamil|verapamil|mesh-list
24744564|NCT04233034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24744565|NCT04233034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24744566|NCT04233034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24744567|NCT04233034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744568|NCT04233034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24744569|NCT04233034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744608|NCT04224558|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24744610|NCT04224558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24612532|NCT01014338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24612542|NCT01014416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612544|NCT01014468|Ranibizumab|ranibizumab|mesh-list
24612545|NCT01014468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24612546|NCT01014468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24443122|NCT00293696|Androgen Antagonists|androgen antagonists|mesh-ancestor
24443123|NCT00293696|Hormone Antagonists|hormone antagonists|mesh-ancestor
24612547|NCT01014468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24618499|NCT01048554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653364|NCT01243658|Oxytocics|oxytocics|mesh-ancestor
24744692|NCT04198428|Sensory System Agents|sensory system agents|mesh-ancestor
24744693|NCT04198428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24744694|NCT04187833|Nivolumab|nivolumab|mesh-list
24744695|NCT04187833|Talazoparib|talazoparib|mesh-list
24744696|NCT04187833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24744697|NCT04187833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24744698|NCT04187833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24744699|NCT04187833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744700|NCT04187833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24744701|NCT04187833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25006855|NCT04603846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24744780|NCT04143711|Mitosis Modulators|mitosis modulators|mesh-ancestor
24744781|NCT04143711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744872|NCT04099667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744873|NCT04099667|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24744874|NCT04099667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24744875|NCT04099667|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24744877|NCT04096066|Lenalidomide|lenalidomide|mesh-list
24744907|NCT04084548|Analgesics|analgesics|mesh-ancestor
24744908|NCT04084548|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24744909|NCT04084548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24429948|NCT00245609|Pregabalin|pregabalin|mesh-list
24550680|NCT00721747|Docetaxel|docetaxel|mesh-list
25006857|NCT04603846|Tubulin Modulators|tubulin modulators|mesh-ancestor
25006858|NCT04603846|Antimitotic Agents|antimitotic agents|mesh-ancestor
25006859|NCT04603846|Mitosis Modulators|mitosis modulators|mesh-ancestor
25006860|NCT04603846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430112|NCT00246194|Serotonin Agents|serotonin agents|mesh-ancestor
25006880|NCT04568902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25006888|NCT04566692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006890|NCT04549376|Cadexomer iodine|cadexomer iodine|mesh-list
25006891|NCT04549376|Povidone-Iodine|povidone-iodine|mesh-list
25006898|NCT04549376|Plasma Substitutes|plasma substitutes|mesh-ancestor
25006899|NCT04549376|Blood Substitutes|blood substitutes|mesh-ancestor
25006908|NCT04528134|Listerine|listerine|mesh-list
25006909|NCT04528134|Fluorides|fluorides|mesh-list
24789893|NCT01939574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25006910|NCT04528134|Sodium Fluoride|sodium fluoride|mesh-list
25006911|NCT04528134|Fluorides, Topical|fluorides, topical|mesh-list
25006912|NCT04528134|Cariostatic Agents|cariostatic agents|mesh-ancestor
25006913|NCT04528134|Protective Agents|protective agents|mesh-ancestor
25006914|NCT04528134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006915|NCT04528134|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25006916|NCT04528134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24745428|NCT03782142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24745429|NCT03782142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24745430|NCT03782142|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24745431|NCT03782142|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24745432|NCT03782142|Protease Inhibitors|protease inhibitors|mesh-ancestor
24745433|NCT03782142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24745434|NCT03782142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24745448|NCT03770299|Gemcitabine|gemcitabine|mesh-list
24745449|NCT03770299|Paclitaxel|paclitaxel|mesh-list
24745450|NCT03770299|Vinorelbine|vinorelbine|mesh-list
24745451|NCT03770299|Docetaxel|docetaxel|mesh-list
24745452|NCT03770299|Carboplatin|carboplatin|mesh-list
24745453|NCT03770299|Nivolumab|nivolumab|mesh-list
24745454|NCT03770299|Pemetrexed|pemetrexed|mesh-list
24745455|NCT03770299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24745462|NCT03770299|Antimetabolites|antimetabolites|mesh-ancestor
24745463|NCT03770299|Antiviral Agents|antiviral agents|mesh-ancestor
24745464|NCT03770299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24653705|NCT01245244|Analgesics|analgesics|mesh-ancestor
24745465|NCT03770299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24745466|NCT03770299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24745467|NCT03770299|Immunologic Factors|immunologic factors|mesh-ancestor
24745468|NCT03770299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745469|NCT03770299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24745470|NCT03770299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24745471|NCT03770299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24745472|NCT03770299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24745473|NCT03760835|Dexamethasone|dexamethasone|mesh-list
24745474|NCT03760835|Prednisone|prednisone|mesh-list
24745475|NCT03760835|Prednisolone|prednisolone|mesh-list
24745530|NCT03727880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745531|NCT03727750|Gemtuzumab|gemtuzumab|mesh-list
24745532|NCT03727750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24745533|NCT03727750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745534|NCT03724409|Octreotide|octreotide|mesh-list
24745535|NCT03724409|Edotreotide|edotreotide|mesh-list
24745536|NCT03724409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24745537|NCT03724409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24745538|NCT03724409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24832029|NCT02170415|Anesthetics|anesthetics|mesh-list
24832030|NCT02170415|Anesthetics, Local|anesthetics, local|mesh-list
24832031|NCT02170415|Analgesics|analgesics|mesh-ancestor
24832032|NCT02170415|Sensory System Agents|sensory system agents|mesh-ancestor
24832033|NCT02170415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24832099|NCT02170675|Dabigatran|dabigatran|mesh-list
24745539|NCT03724409|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24745540|NCT03724409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745879|NCT03533712|Hematinics|hematinics|mesh-ancestor
24745917|NCT03521830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24745918|NCT03521830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745919|NCT03518242|Cyclophosphamide|cyclophosphamide|mesh-list
24745920|NCT03518242|Capecitabine|capecitabine|mesh-list
24745921|NCT03518242|Methotrexate|methotrexate|mesh-list
24745922|NCT03518242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24745923|NCT03518242|Immunologic Factors|immunologic factors|mesh-ancestor
24745924|NCT03518242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745925|NCT03518242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24745926|NCT03518242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24746383|NCT05437432|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24746384|NCT05437432|Antidepressive Agents|antidepressive agents|mesh-ancestor
24430971|NCT00249899|Atorvastatin|atorvastatin|mesh-list
24789952|NCT01939743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789953|NCT01939743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24789954|NCT01939743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24789956|NCT01939743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25006974|NCT04401865|Vitamins|vitamins|mesh-ancestor
25006975|NCT04401865|Micronutrients|micronutrients|mesh-ancestor
25006976|NCT04401865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006977|NCT04401865|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25006978|NCT04401865|Dermatologic Agents|dermatologic agents|mesh-ancestor
25006979|NCT04401150|Ascorbic Acid|ascorbic acid|mesh-list
25006980|NCT04401150|Vitamins|vitamins|mesh-ancestor
25006981|NCT04401150|Micronutrients|micronutrients|mesh-ancestor
25006982|NCT04401150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006983|NCT04401150|Antioxidants|antioxidants|mesh-ancestor
25006984|NCT04401150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006985|NCT04401150|Protective Agents|protective agents|mesh-ancestor
24746546|NCT05145764|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24746547|NCT05145764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24411750|NCT00189878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24431463|NCT00251797|Thalidomide|thalidomide|mesh-list
24747776|NCT03096834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24747777|NCT03089203|Cyclophosphamide|cyclophosphamide|mesh-list
24747779|NCT03089203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24747780|NCT03089203|Immunologic Factors|immunologic factors|mesh-ancestor
24747781|NCT03089203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24747782|NCT03089203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24747783|NCT03089203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24747812|NCT03085485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24747899|NCT03048578|Liraglutide|liraglutide|mesh-list
24747900|NCT03048578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24747901|NCT03048578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24747902|NCT03048578|Incretins|incretins|mesh-ancestor
24747942|NCT03012815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24747943|NCT03012815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621711|NCT01063556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621712|NCT01063556|Cholinergic Agents|cholinergic agents|mesh-ancestor
24753226|NCT01714206|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24747983|NCT03006432|Hematinics|hematinics|mesh-ancestor
24747985|NCT03003065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24747986|NCT03003065|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24747987|NCT03003065|Dermatologic Agents|dermatologic agents|mesh-ancestor
24747988|NCT03001011|Sevelamer|sevelamer|mesh-list
25703347|NCT02167035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25703348|NCT02167035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703349|NCT02167035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703350|NCT02167035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25703351|NCT02167035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24747989|NCT03001011|Chelating Agents|chelating agents|mesh-ancestor
24748098|NCT02943785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24748099|NCT02943785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748107|NCT02908334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748108|NCT02908334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24748109|NCT02908334|Serotonin Agents|serotonin agents|mesh-ancestor
24748110|NCT02908334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748111|NCT02901067|Aspirin|aspirin|mesh-list
24748112|NCT02901067|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24748113|NCT02901067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24748114|NCT02901067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24748115|NCT02901067|Analgesics|analgesics|mesh-ancestor
24748116|NCT02901067|Sensory System Agents|sensory system agents|mesh-ancestor
24748117|NCT02901067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24748118|NCT02901067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748119|NCT02901067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24748120|NCT02901067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24748121|NCT02901067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24748185|NCT02821754|Tremelimumab|tremelimumab|mesh-list
24618748|NCT01049633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24618749|NCT01049633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24618750|NCT01049633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618751|NCT01049633|Antipyretics|antipyretics|mesh-ancestor
24618752|NCT01049633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24618753|NCT01049633|Immunologic Factors|immunologic factors|mesh-ancestor
24618754|NCT01049633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24618755|NCT01049633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24618756|NCT01049633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24618757|NCT01049633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24618758|NCT01049633|Anticoagulants|anticoagulants|mesh-ancestor
24618759|NCT01049633|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24618760|NCT01049633|Renal Agents|renal agents|mesh-ancestor
24618761|NCT01049633|Antimalarials|antimalarials|mesh-ancestor
24412846|NCT00192595|Tenofovir|tenofovir|mesh-list
24748527|NCT02449031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24748528|NCT02449031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24748529|NCT02439307|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24748530|NCT02439307|Rifaximin|rifaximin|mesh-list
24748531|NCT02439307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24748532|NCT02439307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24748567|NCT02368301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24748568|NCT02368301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748569|NCT02368301|Immunologic Factors|immunologic factors|mesh-ancestor
24748623|NCT02325466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24748624|NCT02325466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748625|NCT02325466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24748626|NCT02325466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24748627|NCT02325466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24748628|NCT02325466|Antipyretics|antipyretics|mesh-ancestor
24748684|NCT02240498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24748685|NCT02240498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24748686|NCT02240498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748687|NCT02215980|Dexamethasone|dexamethasone|mesh-list
24621733|NCT01063647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24621734|NCT01063647|Alkylating Agents|alkylating agents|mesh-ancestor
24621735|NCT01063647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621736|NCT01063647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24621737|NCT01063647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24621738|NCT01063647|Immunologic Factors|immunologic factors|mesh-ancestor
24621739|NCT01063647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621740|NCT01063647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24621741|NCT01063660|Treosulfan|treosulfan|mesh-list
24789975|NCT01939886|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24789976|NCT01939886|Anthelmintics|anthelmintics|mesh-ancestor
24789977|NCT01939912|Adenosine|adenosine|mesh-list
24789978|NCT01939912|Analgesics|analgesics|mesh-ancestor
24789979|NCT01939912|Sensory System Agents|sensory system agents|mesh-ancestor
25703352|NCT02167035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25703353|NCT02167139|Adalimumab|adalimumab|mesh-list
25703354|NCT02167139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25703355|NCT02167139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25703356|NCT02167204|Alovudine|alovudine|mesh-list
24789980|NCT01939912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24789981|NCT01939912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789982|NCT01939912|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24748909|NCT01996267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748910|NCT01996267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24748911|NCT01996267|Immunologic Factors|immunologic factors|mesh-ancestor
24748912|NCT01996267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748913|NCT01996267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24791638|NCT03714880|Hormone Antagonists|hormone antagonists|mesh-ancestor
24748914|NCT01996267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24413280|NCT00193440|Rituximab|rituximab|mesh-list
24748989|NCT01898117|Alkylating Agents|alkylating agents|mesh-ancestor
24748990|NCT01898117|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24749314|NCT01204242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749315|NCT01190787|Prednisone|prednisone|mesh-list
24749316|NCT01190787|Cyclophosphamide|cyclophosphamide|mesh-list
24749317|NCT01190787|Melphalan|melphalan|mesh-list
24749354|NCT01166113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24413775|NCT00195195|Antifungal Agents|antifungal agents|mesh-ancestor
24413776|NCT00195195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24750106|NCT01696552|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24750107|NCT01696552|Histamine Antagonists|histamine antagonists|mesh-ancestor
24750108|NCT01696552|Histamine Agents|histamine agents|mesh-ancestor
24750109|NCT01696552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24750110|NCT01696552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750111|NCT01696552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750112|NCT01696552|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24750113|NCT01696552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24750114|NCT01696552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750116|NCT01696617|Antidepressive Agents|antidepressive agents|mesh-ancestor
24750117|NCT01696617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24750118|NCT01696617|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24750119|NCT01696617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24750120|NCT01696617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24750121|NCT01696617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750122|NCT01696617|Dopamine Agonists|dopamine agonists|mesh-ancestor
24750253|NCT01697293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24750334|NCT01697735|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24750335|NCT01697735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24750336|NCT01697735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24750341|NCT01697735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750342|NCT01697787|Artesunate|artesunate|mesh-list
24750343|NCT01697787|Lumefantrine|lumefantrine|mesh-list
24750344|NCT01697787|Artemether|artemether|mesh-list
24750345|NCT01697787|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24750346|NCT01697787|Amodiaquine|amodiaquine|mesh-list
24750347|NCT01697787|Antimalarials|antimalarials|mesh-ancestor
24750902|NCT01701076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24750903|NCT01701076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750904|NCT01701076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24750970|NCT01701349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24750971|NCT01701349|Tubulin Modulators|tubulin modulators|mesh-ancestor
24751242|NCT01702857|Immunologic Factors|immunologic factors|mesh-ancestor
24415675|NCT00200499|Nebivolol|nebivolol|mesh-list
24751280|NCT01703234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24751590|NCT01704898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24434312|NCT00262132|Mycophenolic Acid|mycophenolic acid|mesh-list
24751635|NCT01705249|Norethindrone Acetate|norethindrone acetate|mesh-list
24751637|NCT01705249|Estrogens|estrogens|mesh-ancestor
25703357|NCT02167204|Antiviral Agents|antiviral agents|mesh-ancestor
25703358|NCT02167204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25703359|NCT02167217|Prednisolone|prednisolone|mesh-list
25703360|NCT02167217|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25703361|NCT02167217|Methylprednisolone|methylprednisolone|mesh-list
25703362|NCT02167217|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25703363|NCT02167217|Prednisolone acetate|prednisolone acetate|mesh-list
25703364|NCT02167217|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25703365|NCT02167217|Prednisolone phosphate|prednisolone phosphate|mesh-list
24832458|NCT02171546|Anticoagulants|anticoagulants|mesh-ancestor
24751638|NCT01705249|Hormones|hormones|mesh-ancestor
24460313|NCT00348101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24790006|NCT01940172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751772|NCT01706120|Tubulin Modulators|tubulin modulators|mesh-ancestor
24751773|NCT01706120|Antimitotic Agents|antimitotic agents|mesh-ancestor
24751774|NCT01706120|Mitosis Modulators|mitosis modulators|mesh-ancestor
24751796|NCT01706211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751797|NCT01706341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24751798|NCT01706354|Anesthetics|anesthetics|mesh-list
24751799|NCT01706354|Anesthetics, Local|anesthetics, local|mesh-list
24751818|NCT01706471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24751819|NCT01706471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751820|NCT01706510|Clopidogrel|clopidogrel|mesh-list
24751821|NCT01706510|Ticagrelor|ticagrelor|mesh-list
24434661|NCT00263094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24752127|NCT01708616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752129|NCT01708616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24752130|NCT01708616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24752131|NCT01708616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24752132|NCT01708616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24790007|NCT01940224|Pregabalin|pregabalin|mesh-list
24752133|NCT01708616|Dopamine Agents|dopamine agents|mesh-ancestor
24752134|NCT01708642|Epinephrine|epinephrine|mesh-list
24752245|NCT01709370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752246|NCT01709370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24752247|NCT01709630|Magnesium Sulfate|magnesium sulfate|mesh-list
24752249|NCT01709630|Sensory System Agents|sensory system agents|mesh-ancestor
24752250|NCT01709630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24752251|NCT01709630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752252|NCT01709630|Anesthetics|anesthetics|mesh-ancestor
24752253|NCT01709630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24752254|NCT01709630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24752255|NCT01709630|Anticonvulsants|anticonvulsants|mesh-ancestor
24752256|NCT01709630|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24752257|NCT01709630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24752258|NCT01709630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752259|NCT01709630|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24752260|NCT01709630|Tocolytic Agents|tocolytic agents|mesh-ancestor
24752262|NCT01709656|Celecoxib|celecoxib|mesh-list
24619178|NCT01051271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24619179|NCT01051271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24416875|NCT00204347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24752376|NCT01710072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24752542|NCT01710761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752543|NCT01710761|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24752544|NCT01710761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752545|NCT01710761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752647|NCT01711463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24752648|NCT01711463|Respiratory System Agents|respiratory system agents|mesh-ancestor
24564984|NCT00778401|Analgesics|analgesics|mesh-ancestor
24565026|NCT00778544|Amoxicillin|amoxicillin|mesh-list
24752649|NCT01711463|Dermatologic Agents|dermatologic agents|mesh-ancestor
24753185|NCT01714115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24753186|NCT01714115|Growth Substances|growth substances|mesh-ancestor
24753187|NCT01714115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753188|NCT01714115|Growth Inhibitors|growth inhibitors|mesh-ancestor
24753189|NCT01714115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24619955|NCT01054677|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24443190|NCT00293917|Immunologic Factors|immunologic factors|mesh-ancestor
24443191|NCT00293917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443192|NCT00293917|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24753227|NCT01714206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753228|NCT01714206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753229|NCT01714206|Protective Agents|protective agents|mesh-ancestor
24753230|NCT01714206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703366|NCT02167217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25703367|NCT02167217|Glucocorticoids|glucocorticoids|mesh-ancestor
24753282|NCT01714427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25703368|NCT02167217|Hormones|hormones|mesh-ancestor
25703369|NCT02167217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25703370|NCT02167217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753285|NCT01714427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24753449|NCT01715441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619299|NCT01051934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418046|NCT00208520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24753805|NCT01717911|Isophane Insulin, Human|isophane insulin, human|mesh-list
25095888|NCT03216070|Dasatinib|dasatinib|mesh-list
24612548|NCT01014468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24753806|NCT01717911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24753807|NCT01717911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753808|NCT01717911|Incretins|incretins|mesh-ancestor
24753809|NCT01717911|Hormones|hormones|mesh-ancestor
24659748|NCT01279551|Sensory System Agents|sensory system agents|mesh-ancestor
24753810|NCT01717911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24753811|NCT01717911|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24753812|NCT01717911|Protease Inhibitors|protease inhibitors|mesh-ancestor
24753813|NCT01717911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753814|NCT01717911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753816|NCT01717950|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24753817|NCT01717950|Immunologic Factors|immunologic factors|mesh-ancestor
24753818|NCT01717950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753819|NCT01717950|Antacids|antacids|mesh-ancestor
24435535|NCT00266747|Amibegron|amibegron|mesh-list
25007113|NCT04161248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25007114|NCT04161248|Antimetabolites|antimetabolites|mesh-ancestor
25007115|NCT04161248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007116|NCT04161248|Antiviral Agents|antiviral agents|mesh-ancestor
25007117|NCT04161248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25007118|NCT04161248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25007119|NCT04161248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24754882|NCT01723527|Sensory System Agents|sensory system agents|mesh-ancestor
24754883|NCT01723527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24754884|NCT01723527|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24754885|NCT01723527|Antitussive Agents|antitussive agents|mesh-ancestor
24754886|NCT01723527|Respiratory System Agents|respiratory system agents|mesh-ancestor
24754914|NCT01723748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24754915|NCT01723748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754917|NCT01723800|Pemetrexed|pemetrexed|mesh-list
24754918|NCT01723800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24754955|NCT01724138|Chelating Agents|chelating agents|mesh-ancestor
24754956|NCT01724138|Sequestering Agents|sequestering agents|mesh-ancestor
24436548|NCT00270426|Benazepril|benazepril|mesh-list
24755399|NCT01726465|Prednisolone|prednisolone|mesh-list
24755400|NCT01726465|Prednisolone acetate|prednisolone acetate|mesh-list
24755401|NCT01726465|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24755402|NCT01726465|Prednisolone phosphate|prednisolone phosphate|mesh-list
24755403|NCT01726465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24755476|NCT01726686|Sensory System Agents|sensory system agents|mesh-ancestor
24755477|NCT01726686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24755479|NCT01726725|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24755480|NCT01726725|Anesthetics, General|anesthetics, general|mesh-ancestor
24755481|NCT01726725|Anesthetics|anesthetics|mesh-ancestor
24755483|NCT01726725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755484|NCT01726764|Metformin|metformin|mesh-list
24755485|NCT01726764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24755486|NCT01726764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755487|NCT01726777|Vitamin D|vitamin d|mesh-list
24755488|NCT01726777|Ergocalciferols|ergocalciferols|mesh-list
24755489|NCT01726777|Cholecalciferol|cholecalciferol|mesh-list
24755608|NCT01727531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24755633|NCT01727843|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24755634|NCT01727843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24755635|NCT01727843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24755637|NCT01727843|Coagulants|coagulants|mesh-ancestor
24755638|NCT01727869|Cetuximab|cetuximab|mesh-list
24755640|NCT01727869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24755641|NCT01727869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755642|NCT01727869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24755861|NCT01729481|Micronutrients|micronutrients|mesh-ancestor
24755862|NCT01729481|Hematinics|hematinics|mesh-ancestor
25703371|NCT02167217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25703372|NCT02167217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25703373|NCT02167217|Antiemetics|antiemetics|mesh-ancestor
24832663|NCT02171988|Bisoprolol|bisoprolol|mesh-list
24755863|NCT01729663|Interferons|interferons|mesh-list
24755864|NCT01729663|Interferon-alpha|interferon-alpha|mesh-list
24755865|NCT01729663|Interferon alpha-2|interferon alpha-2|mesh-list
24755866|NCT01729663|Molgramostim|molgramostim|mesh-list
24755867|NCT01729663|Sargramostim|sargramostim|mesh-list
24755868|NCT01729663|BCG Vaccine|bcg vaccine|mesh-list
24756107|NCT01731184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24756108|NCT01731184|Anesthetics, General|anesthetics, general|mesh-ancestor
24756110|NCT01731184|GABA Modulators|gaba modulators|mesh-ancestor
24756111|NCT01731184|GABA Agents|gaba agents|mesh-ancestor
24756112|NCT01731184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24756113|NCT01731184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436949|NCT00272285|Ramosetron|ramosetron|mesh-list
24756232|NCT01731756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24420938|NCT00217295|Topiramate|topiramate|mesh-list
24756295|NCT01732094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756296|NCT01732094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24756297|NCT01732094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24756298|NCT01732094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24756300|NCT01732146|Hematinics|hematinics|mesh-ancestor
24756301|NCT01732198|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24756302|NCT01732198|Immunologic Factors|immunologic factors|mesh-ancestor
24756303|NCT01732198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756304|NCT01732224|Tenofovir|tenofovir|mesh-list
24619658|NCT01053338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24619659|NCT01053338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24619660|NCT01053338|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24546713|NCT00699894|Serotonin Agents|serotonin agents|mesh-ancestor
24756305|NCT01732224|Telbivudine|telbivudine|mesh-list
24756306|NCT01732224|Antiviral Agents|antiviral agents|mesh-ancestor
24756307|NCT01732224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24756308|NCT01732224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24756309|NCT01732224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24756310|NCT01732224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756311|NCT01732224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756312|NCT01732224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24756313|NCT01732224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24756316|NCT01732250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24756317|NCT01732250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24756318|NCT01732276|Gefitinib|gefitinib|mesh-list
24756465|NCT01733485|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24756466|NCT01733485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756467|NCT01733485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24619674|NCT01053338|Dermatologic Agents|dermatologic agents|mesh-ancestor
24619675|NCT01053377|Oseltamivir|oseltamivir|mesh-list
24619676|NCT01053377|Antiviral Agents|antiviral agents|mesh-ancestor
24619677|NCT01053377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24619678|NCT01053377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421283|NCT00218231|Bupropion|bupropion|mesh-list
24756653|NCT01734954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24756654|NCT01734954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756655|NCT01734954|Sensory System Agents|sensory system agents|mesh-ancestor
24756656|NCT01734954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24756819|NCT01735890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756820|NCT01735890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24756821|NCT01735890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756837|NCT01736020|Sensory System Agents|sensory system agents|mesh-ancestor
24756838|NCT01736020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24756840|NCT01736020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24756841|NCT01736020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24756842|NCT01736020|Adrenergic Agents|adrenergic agents|mesh-ancestor
24756843|NCT01736020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24756844|NCT01736020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756845|NCT01736020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24612549|NCT01014468|Growth Substances|growth substances|mesh-ancestor
25703374|NCT02167217|Autonomic Agents|autonomic agents|mesh-ancestor
24449504|NCT00315861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24449505|NCT00315861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24449507|NCT00315874|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24449508|NCT00315874|Narcotics|narcotics|mesh-ancestor
24612550|NCT01014468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612551|NCT01014468|Growth Inhibitors|growth inhibitors|mesh-ancestor
24612552|NCT01014481|Tenofovir|tenofovir|mesh-list
24612553|NCT01014481|Lamivudine|lamivudine|mesh-list
24612554|NCT01014481|Efavirenz|efavirenz|mesh-list
24612555|NCT01014481|Antiviral Agents|antiviral agents|mesh-ancestor
24612556|NCT01014481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24612557|NCT01014481|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24612558|NCT01014481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24756846|NCT01736020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24756847|NCT01736020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24756848|NCT01736020|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24756850|NCT01736033|Finasteride|finasteride|mesh-list
24756851|NCT01736033|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24756852|NCT01736033|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24756853|NCT01736033|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24756854|NCT01736033|Adrenergic Agents|adrenergic agents|mesh-ancestor
24756855|NCT01736033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24756856|NCT01736033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756857|NCT01736033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756858|NCT01736033|Urological Agents|urological agents|mesh-ancestor
24756859|NCT01736033|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24756860|NCT01736033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24756861|NCT01736033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756862|NCT01736033|Hormone Antagonists|hormone antagonists|mesh-ancestor
24756863|NCT01736033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24756864|NCT01736150|Sevelamer|sevelamer|mesh-list
24756865|NCT01736150|Chelating Agents|chelating agents|mesh-ancestor
24437404|NCT00273546|Docetaxel|docetaxel|mesh-list
24756903|NCT01736488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24612563|NCT01014481|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24612564|NCT01014481|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24612576|NCT01014507|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24612577|NCT01014520|Gabapentin|gabapentin|mesh-list
24612578|NCT01014520|Amitriptyline|amitriptyline|mesh-list
24612579|NCT01014520|Analgesics|analgesics|mesh-ancestor
24612580|NCT01014520|Sensory System Agents|sensory system agents|mesh-ancestor
24612581|NCT01014520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24612583|NCT01014520|Anticonvulsants|anticonvulsants|mesh-ancestor
24695855|NCT01425996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24695856|NCT01425996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695857|NCT01426022|Ethanol|ethanol|mesh-list
24695858|NCT01426022|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24695859|NCT01426022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24695860|NCT01426022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24695861|NCT01426022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695862|NCT01426074|Bevacizumab|bevacizumab|mesh-list
24695863|NCT01426074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24695864|NCT01426074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24695865|NCT01426074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24695866|NCT01426074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24695867|NCT01426074|Growth Substances|growth substances|mesh-ancestor
24643032|NCT01183442|Vitamin D|vitamin d|mesh-list
25703375|NCT02167217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25703376|NCT02167217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25703377|NCT02167217|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25703378|NCT02167217|Protective Agents|protective agents|mesh-ancestor
25703379|NCT02167256|Saracatinib|saracatinib|mesh-list
25703380|NCT02167256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25703381|NCT02167256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703382|NCT02167256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703383|NCT02167451|Maraviroc|maraviroc|mesh-list
25703384|NCT02167451|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25703385|NCT02167451|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25703386|NCT02167451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695868|NCT01426074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695896|NCT01426256|Vitamin D|vitamin d|mesh-list
24695917|NCT01426334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24695919|NCT01426399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24695920|NCT01426399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695921|NCT01426464|Latanoprost|latanoprost|mesh-list
24756904|NCT01736488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24756906|NCT01736488|Autonomic Agents|autonomic agents|mesh-ancestor
24756907|NCT01736488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24756908|NCT01736488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662531|NCT01295177|Insulin|insulin|mesh-list
24756909|NCT01736488|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24756910|NCT01736488|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24756911|NCT01736488|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24756912|NCT01736488|Adrenergic Agents|adrenergic agents|mesh-ancestor
24756913|NCT01736488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24756914|NCT01736488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756915|NCT01736514|Allopurinol|allopurinol|mesh-list
24756916|NCT01736514|Febuxostat|febuxostat|mesh-list
24756917|NCT01736514|Antimetabolites|antimetabolites|mesh-ancestor
24756918|NCT01736514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756919|NCT01736514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756920|NCT01736514|Gout Suppressants|gout suppressants|mesh-ancestor
24756962|NCT01736800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24756963|NCT01736800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756965|NCT01736813|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24756966|NCT01736813|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24756967|NCT01736813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756968|NCT01736813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24756969|NCT01736813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24756970|NCT01736813|Antiviral Agents|antiviral agents|mesh-ancestor
24756971|NCT01736813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24756972|NCT01736813|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24756974|NCT01736878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24756975|NCT01736878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24756976|NCT01736878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756977|NCT01736878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756978|NCT01736891|Rasagiline|rasagiline|mesh-list
24756979|NCT01736891|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24756980|NCT01736891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756985|NCT01737008|Cisplatin|cisplatin|mesh-list
24756986|NCT01737008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24757041|NCT01737346|Lomustine|lomustine|mesh-list
24757042|NCT01737346|Procarbazine|procarbazine|mesh-list
24757043|NCT01737346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24757044|NCT01737346|Alkylating Agents|alkylating agents|mesh-ancestor
24757045|NCT01737346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757046|NCT01737346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24757047|NCT01737359|Tenofovir|tenofovir|mesh-list
24619726|NCT01053559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24619727|NCT01053559|Immunologic Factors|immunologic factors|mesh-ancestor
24757119|NCT01738087|Fluticasone|fluticasone|mesh-list
24757121|NCT01738087|Formoterol Fumarate|formoterol fumarate|mesh-list
24757122|NCT01738087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24757123|NCT01738087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24757124|NCT01738087|Autonomic Agents|autonomic agents|mesh-ancestor
24757125|NCT01738087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24757126|NCT01738087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757127|NCT01738087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24757128|NCT01738087|Respiratory System Agents|respiratory system agents|mesh-ancestor
25007133|NCT04149145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007134|NCT04149145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007135|NCT04136548|Fentanyl|fentanyl|mesh-list
24443219|NCT00294008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24443220|NCT00294008|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24443221|NCT00294008|Dopamine Agents|dopamine agents|mesh-ancestor
24443223|NCT00294086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24443224|NCT00294086|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25007136|NCT04136548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25007137|NCT04136548|Narcotics|narcotics|mesh-ancestor
25007138|NCT04136548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25007139|NCT04136548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007140|NCT04136548|Analgesics|analgesics|mesh-ancestor
25007141|NCT04136548|Sensory System Agents|sensory system agents|mesh-ancestor
25007142|NCT04136548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25007143|NCT04136548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25007144|NCT04136548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25007145|NCT04136548|Anesthetics, General|anesthetics, general|mesh-ancestor
25007146|NCT04136548|Anesthetics|anesthetics|mesh-ancestor
25007147|NCT04111627|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24757163|NCT01738178|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24757164|NCT01738178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757165|NCT01738178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24757166|NCT01738178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757170|NCT01738178|Purinergic Agents|purinergic agents|mesh-ancestor
24757370|NCT01739556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757371|NCT01739556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24757446|NCT01739985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24757477|NCT01740271|Epirubicin|epirubicin|mesh-list
24422145|NCT00221481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24757605|NCT01741285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24757607|NCT01741324|Ergocalciferols|ergocalciferols|mesh-list
24757609|NCT01741324|Vitamins|vitamins|mesh-list
24757610|NCT01741324|Micronutrients|micronutrients|mesh-ancestor
24757657|NCT01741558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757659|NCT01741558|Dermatologic Agents|dermatologic agents|mesh-ancestor
24757660|NCT01741558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757661|NCT01741558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24757662|NCT01741558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24757663|NCT01741558|Immunologic Factors|immunologic factors|mesh-ancestor
24757664|NCT01741558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24757665|NCT01741558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24757666|NCT01741558|Vitamin B Complex|vitamin b complex|mesh-ancestor
24757667|NCT01741558|Vitamins|vitamins|mesh-ancestor
24757668|NCT01741558|Micronutrients|micronutrients|mesh-ancestor
24757932|NCT01743014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24757933|NCT01743014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757968|NCT01743144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24757969|NCT01743144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757970|NCT01743144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24757971|NCT01743144|Tocolytic Agents|tocolytic agents|mesh-ancestor
24757972|NCT01743144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24757973|NCT01743157|Bevacizumab|bevacizumab|mesh-list
24757975|NCT01743157|Interleukin-2|interleukin-2|mesh-list
24757976|NCT01743157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24757977|NCT01743157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438558|NCT00276172|Natalizumab|natalizumab|mesh-list
24758038|NCT01743378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758039|NCT01743378|Sensory System Agents|sensory system agents|mesh-ancestor
24758040|NCT01743378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24758041|NCT01743456|Anesthetics|anesthetics|mesh-list
24758042|NCT01743456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24758043|NCT01743456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758044|NCT01743508|Misoprostol|misoprostol|mesh-list
24422769|NCT00223691|Anesthetics|anesthetics|mesh-ancestor
24758075|NCT01743755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24758076|NCT01743755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758077|NCT01743794|Ropivacaine|ropivacaine|mesh-list
24758078|NCT01743794|Anesthetics, Local|anesthetics, local|mesh-ancestor
24758079|NCT01743794|Anesthetics|anesthetics|mesh-ancestor
24758080|NCT01743794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24758081|NCT01743794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758082|NCT01743794|Sensory System Agents|sensory system agents|mesh-ancestor
24758083|NCT01743794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24758086|NCT01743820|Artenimol|artenimol|mesh-list
24758087|NCT01743820|Antimalarials|antimalarials|mesh-ancestor
24758152|NCT01744184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24758153|NCT01744184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24758158|NCT01744184|GABA Agents|gaba agents|mesh-ancestor
24758218|NCT01744314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24758219|NCT01744314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24758220|NCT01744366|Goserelin|goserelin|mesh-list
24758221|NCT01744366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24758222|NCT01744366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758363|NCT01745575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24619953|NCT01054651|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24619954|NCT01054651|Renal Agents|renal agents|mesh-ancestor
24619956|NCT01054677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24619958|NCT01054781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24619959|NCT01054781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24619960|NCT01054781|Immunologic Factors|immunologic factors|mesh-ancestor
24619961|NCT01054781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619962|NCT01054781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24619963|NCT01054872|Vaccines|vaccines|mesh-list
24619964|NCT01054872|Immunologic Factors|immunologic factors|mesh-ancestor
24619965|NCT01054872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619966|NCT01055041|Budesonide|budesonide|mesh-list
24619967|NCT01055041|Doxofylline|doxofylline|mesh-list
24619968|NCT01055041|Montelukast|montelukast|mesh-list
24619969|NCT01055041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24619970|NCT01055041|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24619971|NCT01055041|Autonomic Agents|autonomic agents|mesh-ancestor
24619972|NCT01055041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24619973|NCT01055041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619974|NCT01055041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24758490|NCT01746277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758491|NCT01746277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24758494|NCT01746485|Treprostinil|treprostinil|mesh-list
24758680|NCT01747252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758681|NCT01747252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24758682|NCT01747278|Trimethoprim|trimethoprim|mesh-list
24758683|NCT01747278|Sulfamethoxazole|sulfamethoxazole|mesh-list
24758684|NCT01747278|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24758685|NCT01747278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24758686|NCT01747278|Renal Agents|renal agents|mesh-ancestor
24758687|NCT01747278|Antimalarials|antimalarials|mesh-ancestor
24758688|NCT01747278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24758689|NCT01747278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24758690|NCT01747278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24620082|NCT01055379|Protective Agents|protective agents|mesh-ancestor
24423746|NCT00226746|Antimetabolites|antimetabolites|mesh-ancestor
24450832|NCT00320697|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24450833|NCT00320697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24450834|NCT00320697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25703388|NCT02167451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25703389|NCT02167451|Antiviral Agents|antiviral agents|mesh-ancestor
25703390|NCT02167451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25703391|NCT02167451|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25703392|NCT02167893|Leuprolide|leuprolide|mesh-list
25703393|NCT02167893|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25703394|NCT02167893|Fertility Agents|fertility agents|mesh-ancestor
25703395|NCT02167893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25709617|NCT02271217|4-Aminopyridine|4-aminopyridine|mesh-list
24790122|NCT01940978|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24790123|NCT01940978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24790124|NCT01940978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790125|NCT01940978|Dopamine Agents|dopamine agents|mesh-ancestor
24790126|NCT01940978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24790127|NCT01940978|Antipruritics|antipruritics|mesh-ancestor
24790131|NCT01940978|Histamine Antagonists|histamine antagonists|mesh-ancestor
24790132|NCT01940978|Histamine Agents|histamine agents|mesh-ancestor
24790135|NCT01940978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24790136|NCT01941004|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24790137|NCT01941004|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24790138|NCT01941004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790139|NCT01941004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24790140|NCT01941004|Immunologic Factors|immunologic factors|mesh-ancestor
24695922|NCT01426464|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24695923|NCT01426464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24695924|NCT01426490|Vitamins|vitamins|mesh-list
25007151|NCT04111627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007152|NCT04111627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25007153|NCT04111627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007154|NCT04111627|Analgesics|analgesics|mesh-ancestor
25007155|NCT04111627|Sensory System Agents|sensory system agents|mesh-ancestor
25007156|NCT04111627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25007157|NCT04111627|Antidepressive Agents|antidepressive agents|mesh-ancestor
25007158|NCT04111627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25007159|NCT04111627|Dopamine Agents|dopamine agents|mesh-ancestor
25007160|NCT04087395|Lidocaine|lidocaine|mesh-list
25007161|NCT04087395|Anesthetics|anesthetics|mesh-list
25007162|NCT04087395|Anesthetics, Local|anesthetics, local|mesh-ancestor
25007163|NCT04087395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25007164|NCT04087395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007165|NCT04087395|Sensory System Agents|sensory system agents|mesh-ancestor
25007166|NCT04087395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25007167|NCT04087395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25007168|NCT04087395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25007169|NCT04087395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25703396|NCT02167893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703397|NCT02167893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25703398|NCT02167893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25703399|NCT02168062|Leuprolide|leuprolide|mesh-list
25007170|NCT04087395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24394693|NCT00134030|Interferon alpha-2|interferon alpha-2|mesh-list
24394724|NCT00134030|Antiviral Agents|antiviral agents|mesh-ancestor
24394725|NCT00134030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24695925|NCT01426490|Ascorbic Acid|ascorbic acid|mesh-list
24695926|NCT01426490|Folic Acid|folic acid|mesh-list
24695927|NCT01426490|Pyridoxine|pyridoxine|mesh-list
24695928|NCT01426490|Pyridoxal|pyridoxal|mesh-list
24695929|NCT01426490|Vitamin B 6|vitamin b 6|mesh-list
24695930|NCT01426490|Vitamin B Complex|vitamin b complex|mesh-list
24394726|NCT00134030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24394727|NCT00134030|Alkylating Agents|alkylating agents|mesh-ancestor
24395087|NCT00135057|Insulin Glargine|insulin glargine|mesh-list
24395088|NCT00135057|Insulin glulisine|insulin glulisine|mesh-list
24395089|NCT00135057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24395197|NCT00135434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395198|NCT00135434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395199|NCT00135434|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24395200|NCT00135434|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24395201|NCT00135434|Antiviral Agents|antiviral agents|mesh-ancestor
24395230|NCT00135499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24395231|NCT00135499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24395232|NCT00135499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24395775|NCT00136851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24396581|NCT00139282|Squalamine|squalamine|mesh-list
24396582|NCT00139282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24396583|NCT00139282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24396584|NCT00139282|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24396585|NCT00139282|Protective Agents|protective agents|mesh-ancestor
24439557|NCT00279344|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24396761|NCT00139867|Dopamine Agonists|dopamine agonists|mesh-ancestor
24396762|NCT00139867|Dopamine Agents|dopamine agents|mesh-ancestor
24396763|NCT00139867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412009|NCT00190619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24396937|NCT00140452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24397111|NCT00140803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24397112|NCT00140803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397113|NCT00140803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24397114|NCT00140803|Immunologic Factors|immunologic factors|mesh-ancestor
24397116|NCT00140803|Dermatologic Agents|dermatologic agents|mesh-ancestor
24397117|NCT00140868|Phenobarbital|phenobarbital|mesh-list
24397118|NCT00140868|Anticonvulsants|anticonvulsants|mesh-ancestor
24397119|NCT00140868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24397120|NCT00140868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24459825|NCT00346502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24397142|NCT00140894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24397143|NCT00140894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24397145|NCT00140920|Rofecoxib|rofecoxib|mesh-list
24397146|NCT00140920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24397147|NCT00140920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24397191|NCT00141050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397192|NCT00141050|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24397193|NCT00141050|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24397194|NCT00141050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24397306|NCT00141336|Pregabalin|pregabalin|mesh-list
24397307|NCT00141336|Analgesics|analgesics|mesh-ancestor
24397319|NCT00141336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24397320|NCT00141362|Pregabalin|pregabalin|mesh-list
24397321|NCT00141362|Analgesics|analgesics|mesh-ancestor
24397500|NCT00141648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24397502|NCT00141700|Rituximab|rituximab|mesh-list
24397503|NCT00141700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24397504|NCT00141700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24397505|NCT00141700|Immunologic Factors|immunologic factors|mesh-ancestor
24397537|NCT00141804|Antifungal Agents|antifungal agents|mesh-ancestor
24397538|NCT00141804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24397539|NCT00141804|Immunologic Factors|immunologic factors|mesh-ancestor
24397540|NCT00141804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397541|NCT00141830|Methotrexate|methotrexate|mesh-list
25703400|NCT02168062|Goserelin|goserelin|mesh-list
25703401|NCT02168062|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25703402|NCT02168062|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24397545|NCT00141830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397546|NCT00141830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24397547|NCT00141830|Antimetabolites|antimetabolites|mesh-ancestor
24397651|NCT00142207|Pyrimethamine|pyrimethamine|mesh-list
24397652|NCT00142207|Sulfadoxine|sulfadoxine|mesh-list
24397653|NCT00142207|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24397654|NCT00142207|Antimalarials|antimalarials|mesh-ancestor
24397655|NCT00142207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24397656|NCT00142207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24397657|NCT00142207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24397658|NCT00142207|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24397659|NCT00142207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24397796|NCT00142571|Antimitotic Agents|antimitotic agents|mesh-ancestor
24397797|NCT00142571|Mitosis Modulators|mitosis modulators|mesh-ancestor
24397834|NCT00142844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397863|NCT00142883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24397865|NCT00142883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24398128|NCT00143559|Immunologic Factors|immunologic factors|mesh-ancestor
24398738|NCT00145444|Dopamine Agents|dopamine agents|mesh-ancestor
24398977|NCT00146289|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24398978|NCT00146289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399012|NCT00146497|Pulmonary Surfactants|pulmonary surfactants|mesh-list
24399013|NCT00146497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24399014|NCT00146497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24399016|NCT00146497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24399017|NCT00146497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459865|NCT00346684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24399369|NCT00147615|Eplerenone|eplerenone|mesh-list
24399370|NCT00147615|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24399371|NCT00147615|Hormone Antagonists|hormone antagonists|mesh-ancestor
24399372|NCT00147615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24399403|NCT00147654|Cholinergic Agents|cholinergic agents|mesh-ancestor
24399404|NCT00147667|Erythromycin|erythromycin|mesh-list
24399405|NCT00147667|Erythromycin Estolate|erythromycin estolate|mesh-list
24399406|NCT00147667|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24399407|NCT00147667|Erythromycin stearate|erythromycin stearate|mesh-list
24399408|NCT00147667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24399409|NCT00147667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24399410|NCT00147667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24399411|NCT00147667|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24399412|NCT00147667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24399413|NCT00147667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399414|NCT00147680|Paclitaxel|paclitaxel|mesh-list
24399415|NCT00147680|Carboplatin|carboplatin|mesh-list
24399997|NCT00149240|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24399998|NCT00149240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24399999|NCT00149240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400000|NCT00149240|Cholinergic Agents|cholinergic agents|mesh-ancestor
24400001|NCT00149240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24400002|NCT00149240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703403|NCT02168062|Fertility Agents|fertility agents|mesh-ancestor
25703404|NCT02168062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25703405|NCT02168062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703406|NCT02168062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24400124|NCT00149903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24400125|NCT00149903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24400127|NCT00149903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24400128|NCT00149903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24400217|NCT00150085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400245|NCT00150137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24400246|NCT00150137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400249|NCT00150215|Autonomic Agents|autonomic agents|mesh-ancestor
24400250|NCT00150215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24400251|NCT00150215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400252|NCT00150215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24400253|NCT00150215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24400254|NCT00150215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24400255|NCT00150215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24400256|NCT00150215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24400257|NCT00150215|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24400258|NCT00150215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24400259|NCT00150215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24758999|NCT01748929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24400342|NCT00150371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25007193|NCT04055753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25007194|NCT04055753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007195|NCT04055753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25007196|NCT04055753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25007197|NCT04055753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24440847|NCT00285051|Antipruritics|antipruritics|mesh-ancestor
24400947|NCT00151736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400948|NCT00151736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24400949|NCT00151736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24400950|NCT00151736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24400952|NCT00151736|Sensory System Agents|sensory system agents|mesh-ancestor
24400953|NCT00151736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24462856|NCT00357682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24403999|NCT00162383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24404732|NCT00164736|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24404733|NCT00164736|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24404734|NCT00164736|Protease Inhibitors|protease inhibitors|mesh-ancestor
24404735|NCT00164736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404736|NCT00164736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404746|NCT00164736|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24404747|NCT00164736|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24404749|NCT00164749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24404750|NCT00164749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24404752|NCT00164749|Sensory System Agents|sensory system agents|mesh-ancestor
24404753|NCT00164749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24404754|NCT00164749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404755|NCT00164749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24404756|NCT00164749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24404757|NCT00164749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24404758|NCT00164749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407464|NCT00174577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24790201|NCT01941316|Irinotecan|irinotecan|mesh-list
25007205|NCT03919773|Immunoglobulins|immunoglobulins|mesh-list
25007206|NCT03919773|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25007207|NCT03919773|gamma-Globulins|gamma-globulins|mesh-list
25007208|NCT03919773|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25007209|NCT03919773|Immunologic Factors|immunologic factors|mesh-ancestor
25007210|NCT03919773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007211|NCT03911713|Ivacaftor|ivacaftor|mesh-list
25703407|NCT02168062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25703408|NCT02168062|Luteolytic Agents|luteolytic agents|mesh-ancestor
25703409|NCT02168062|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25703410|NCT02168062|Contraceptive Agents|contraceptive agents|mesh-ancestor
25703411|NCT02168062|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25703412|NCT02168101|Ixazomib|ixazomib|mesh-list
25007212|NCT03911713|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25007213|NCT03911713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25007214|NCT03911713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007215|NCT03852459|Ibuprofen|ibuprofen|mesh-list
25007216|NCT03852459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25007217|NCT03852459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25007218|NCT03852459|Analgesics|analgesics|mesh-ancestor
25007219|NCT03852459|Sensory System Agents|sensory system agents|mesh-ancestor
25007220|NCT03852459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25007221|NCT03852459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007222|NCT03852459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25007223|NCT03852459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25007224|NCT03852459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25007225|NCT03852459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25007226|NCT03852459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007227|NCT03849768|Gefitinib|gefitinib|mesh-list
25007228|NCT03849768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007229|NCT03849768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25007230|NCT03849768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25007231|NCT03849768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007232|NCT03824808|Lidocaine|lidocaine|mesh-list
24790202|NCT01941316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24415984|NCT00201695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24408361|NCT00177528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408362|NCT00177528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24408363|NCT00177528|Antidepressive Agents|antidepressive agents|mesh-ancestor
24408456|NCT00177749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24759005|NCT01748929|Mitosis Modulators|mitosis modulators|mesh-ancestor
24408659|NCT00179023|Nasal Decongestants|nasal decongestants|mesh-ancestor
24408663|NCT00179023|Adrenergic Agents|adrenergic agents|mesh-ancestor
24893116|NCT04453735|Antimetabolites|antimetabolites|mesh-ancestor
24408664|NCT00179023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24408665|NCT00179023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408666|NCT00179023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24408667|NCT00179023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24408668|NCT00179023|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
24408669|NCT00179023|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24408670|NCT00179023|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24408671|NCT00179023|Cholinergic Agents|cholinergic agents|mesh-ancestor
24408672|NCT00179023|Vasodilator Agents|vasodilator agents|mesh-ancestor
24408674|NCT00179062|Risperidone|risperidone|mesh-list
24790253|NCT01941771|Mitosis Modulators|mitosis modulators|mesh-ancestor
24790254|NCT01941810|Lactoferrin|lactoferrin|mesh-list
24790255|NCT01941810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24790261|NCT01941888|Midazolam|midazolam|mesh-list
24409063|NCT00180843|Anticonvulsants|anticonvulsants|mesh-ancestor
24409064|NCT00180843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24409065|NCT00180843|Autonomic Agents|autonomic agents|mesh-ancestor
24409066|NCT00180843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24409067|NCT00180843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409068|NCT00180843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24409069|NCT00180843|Respiratory System Agents|respiratory system agents|mesh-ancestor
24409070|NCT00180843|Tocolytic Agents|tocolytic agents|mesh-ancestor
24409071|NCT00180843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25007300|NCT03797560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007301|NCT03797560|Anticonvulsants|anticonvulsants|mesh-ancestor
25007302|NCT03797560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25007303|NCT03797560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25007304|NCT03797560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109807|NCT03121807|Oxaliplatin|oxaliplatin|mesh-list
24409238|NCT00181571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24410431|NCT00185237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24410580|NCT00186264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410581|NCT00186264|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24410583|NCT00186264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24410585|NCT00186277|Oxaliplatin|oxaliplatin|mesh-list
24410586|NCT00186277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411324|NCT00188669|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24411325|NCT00188669|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24459946|NCT00346879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24459947|NCT00346879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24459948|NCT00346918|Sirolimus|sirolimus|mesh-list
24459949|NCT00346918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24459950|NCT00346918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24411873|NCT00190294|Luteolytic Agents|luteolytic agents|mesh-ancestor
24411874|NCT00190294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24411875|NCT00190294|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24411908|NCT00190411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24411909|NCT00190411|Sympathomimetics|sympathomimetics|mesh-ancestor
24411910|NCT00190411|Autonomic Agents|autonomic agents|mesh-ancestor
24411911|NCT00190411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24411912|NCT00190411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413418|NCT00193856|Zoledronic Acid|zoledronic acid|mesh-list
24414527|NCT00197912|Immunologic Factors|immunologic factors|mesh-ancestor
24414528|NCT00197912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414529|NCT00197912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24414530|NCT00197912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24414729|NCT00198523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24417089|NCT00205283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780077|NCT01881074|Antimetabolites|antimetabolites|mesh-ancestor
24417090|NCT00205283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417092|NCT00205283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24417094|NCT00205283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24417095|NCT00205322|Leucovorin|leucovorin|mesh-list
24417096|NCT00205322|Capecitabine|capecitabine|mesh-list
24417097|NCT00205322|Oxaliplatin|oxaliplatin|mesh-list
24417128|NCT00205634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24417129|NCT00205725|Olanzapine|olanzapine|mesh-list
24417130|NCT00205725|Ziprasidone|ziprasidone|mesh-list
24417131|NCT00205725|Antiemetics|antiemetics|mesh-ancestor
24417132|NCT00205725|Autonomic Agents|autonomic agents|mesh-ancestor
24429253|NCT00243035|Bortezomib|bortezomib|mesh-list
24417935|NCT00208195|GABA Agents|gaba agents|mesh-ancestor
24420708|NCT00216632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24420709|NCT00216632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420710|NCT00216632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420711|NCT00216632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24420712|NCT00216632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24420713|NCT00216632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24442108|NCT00290069|Sirolimus|sirolimus|mesh-list
24421579|NCT00219713|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24421580|NCT00219713|Anesthetics, General|anesthetics, general|mesh-ancestor
24421581|NCT00219713|Anesthetics|anesthetics|mesh-ancestor
24421582|NCT00219713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24421583|NCT00219713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421584|NCT00219713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24421585|NCT00219713|Analgesics|analgesics|mesh-ancestor
24421586|NCT00219713|Sensory System Agents|sensory system agents|mesh-ancestor
24421587|NCT00219713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24421588|NCT00219726|Imatinib Mesylate|imatinib mesylate|mesh-list
24421589|NCT00219726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421686|NCT00219895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24421687|NCT00219895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24421688|NCT00219895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421689|NCT00219895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421690|NCT00219908|Mitoxantrone|mitoxantrone|mesh-list
24421721|NCT00220064|Irinotecan|irinotecan|mesh-list
24421722|NCT00220064|Antimetabolites|antimetabolites|mesh-ancestor
25703413|NCT02168101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25703414|NCT02168101|Protease Inhibitors|protease inhibitors|mesh-ancestor
25703415|NCT02168101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703416|NCT02168101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703417|NCT02168309|Labetalol|labetalol|mesh-list
25703418|NCT02168309|Nifedipine|nifedipine|mesh-list
25703419|NCT02168309|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25703420|NCT02168309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25703421|NCT02168309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421723|NCT00220064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422675|NCT00223509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24422676|NCT00223509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422677|NCT00223509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24422678|NCT00223509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422679|NCT00223509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24422680|NCT00223509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24422681|NCT00223509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24422682|NCT00223509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24429954|NCT00245609|Anticonvulsants|anticonvulsants|mesh-ancestor
24422807|NCT00223691|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24460093|NCT00347399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24423261|NCT00225173|Mitosis Modulators|mitosis modulators|mesh-ancestor
24424101|NCT00227955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24424102|NCT00227955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24460137|NCT00347425|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24460139|NCT00347490|Anticoagulants|anticoagulants|mesh-ancestor
24424141|NCT00228020|Antifungal Agents|antifungal agents|mesh-ancestor
24424616|NCT00230035|Immunosuppressive Agents|immunosuppressive agents|mesh-list
24424617|NCT00230035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24424618|NCT00230035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424619|NCT00230035|Immunologic Factors|immunologic factors|mesh-ancestor
24424620|NCT00230035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424621|NCT00230035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24417734|NCT00207428|Analgesics|analgesics|mesh-ancestor
24424795|NCT00230776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24424796|NCT00230789|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24424797|NCT00230789|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24424798|NCT00230789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24424803|NCT00230789|Urological Agents|urological agents|mesh-ancestor
24424804|NCT00230815|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24424805|NCT00230815|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24424834|NCT00230984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424835|NCT00230984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24424836|NCT00230984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424837|NCT00230984|Anabolic Agents|anabolic agents|mesh-ancestor
25007359|NCT03647488|Spartalizumab|spartalizumab|mesh-list
24425017|NCT00231621|Topiramate|topiramate|mesh-list
24425018|NCT00231621|Anticonvulsants|anticonvulsants|mesh-ancestor
24425019|NCT00231621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24425020|NCT00231621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425241|NCT00232414|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24425242|NCT00232414|Antidepressive Agents|antidepressive agents|mesh-ancestor
24425243|NCT00232414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24425244|NCT00232414|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24425245|NCT00232414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24425246|NCT00232414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24425247|NCT00232414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425249|NCT00232492|Analgesics|analgesics|mesh-ancestor
24425250|NCT00232492|Sensory System Agents|sensory system agents|mesh-ancestor
24425251|NCT00232492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24425252|NCT00232492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425253|NCT00232492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24425254|NCT00232492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24425255|NCT00232492|Anesthetics, General|anesthetics, general|mesh-ancestor
24425257|NCT00232492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24425258|NCT00232492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24425259|NCT00232492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24425260|NCT00232492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24425287|NCT00232648|Autonomic Agents|autonomic agents|mesh-ancestor
24425288|NCT00232648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24430588|NCT00248313|Antifungal Agents|antifungal agents|mesh-ancestor
24425329|NCT00232687|Dopamine Agents|dopamine agents|mesh-ancestor
24425330|NCT00232687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24425331|NCT00232687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425496|NCT00233532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24425497|NCT00233545|Miltefosine|miltefosine|mesh-list
24425498|NCT00233545|Antifungal Agents|antifungal agents|mesh-ancestor
24425499|NCT00233545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24430755|NCT00249197|Ofloxacin|ofloxacin|mesh-list
24425526|NCT00233584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24425529|NCT00233584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425530|NCT00233584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24832985|NCT02172482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24832986|NCT02172482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832987|NCT02172482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24425531|NCT00233584|Respiratory System Agents|respiratory system agents|mesh-ancestor
24425532|NCT00233584|Glucocorticoids|glucocorticoids|mesh-ancestor
24426018|NCT00234936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426019|NCT00234936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24426020|NCT00234936|Dermatologic Agents|dermatologic agents|mesh-ancestor
24426021|NCT00234936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24426022|NCT00234936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24426023|NCT00234936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24426024|NCT00234936|Immunologic Factors|immunologic factors|mesh-ancestor
24790358|NCT01942187|Antidepressive Agents|antidepressive agents|mesh-ancestor
24790359|NCT01942187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24790360|NCT01942187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24790361|NCT01942187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24790362|NCT01942187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25007387|NCT03618537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25007388|NCT03618537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25007390|NCT03618537|Protease Inhibitors|protease inhibitors|mesh-ancestor
24426307|NCT00235729|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24426308|NCT00235729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24426309|NCT00235729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24460163|NCT00347555|Immunologic Factors|immunologic factors|mesh-ancestor
24460164|NCT00347555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426335|NCT00235859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24426337|NCT00235859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426360|NCT00235898|Protective Agents|protective agents|mesh-ancestor
24426361|NCT00235898|Vitamin B Complex|vitamin b complex|mesh-ancestor
24426392|NCT00235937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24426393|NCT00235937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426395|NCT00235950|Atorvastatin|atorvastatin|mesh-list
24426396|NCT00235950|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24426397|NCT00235950|Simvastatin|simvastatin|mesh-list
24426399|NCT00235950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24426400|NCT00235950|Antimetabolites|antimetabolites|mesh-ancestor
24426401|NCT00235950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426402|NCT00235950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24426403|NCT00235950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24426404|NCT00235950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24426502|NCT00236223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24426562|NCT00236301|Contraceptive Agents|contraceptive agents|mesh-ancestor
24426563|NCT00236301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24426564|NCT00236301|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24426696|NCT00236509|Anticonvulsants|anticonvulsants|mesh-ancestor
24426697|NCT00236509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24460166|NCT00347555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426698|NCT00236509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426866|NCT00236782|Estradiol|estradiol|mesh-list
24426867|NCT00236782|Estrogens|estrogens|mesh-ancestor
24426868|NCT00236782|Hormones|hormones|mesh-ancestor
24426965|NCT00236912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431079|NCT00250237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24426985|NCT00237068|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24427092|NCT00237367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24427093|NCT00237367|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24427094|NCT00237367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460179|NCT00347581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24460180|NCT00347581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25703422|NCT02168309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25703423|NCT02168309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703424|NCT02168309|Vasodilator Agents|vasodilator agents|mesh-ancestor
25703425|NCT02168309|Tocolytic Agents|tocolytic agents|mesh-ancestor
25703426|NCT02168309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25703427|NCT02168309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24427129|NCT00237484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24427131|NCT00237497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24427132|NCT00237497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24427133|NCT00237497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427351|NCT00238017|Artesunate|artesunate|mesh-list
24427352|NCT00238017|Amodiaquine|amodiaquine|mesh-list
24427353|NCT00238017|Antimalarials|antimalarials|mesh-ancestor
24427444|NCT00238199|Mitosis Modulators|mitosis modulators|mesh-ancestor
24427445|NCT00238199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427446|NCT00238199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24427738|NCT00238927|Respiratory System Agents|respiratory system agents|mesh-ancestor
24427739|NCT00238927|Dermatologic Agents|dermatologic agents|mesh-ancestor
24427740|NCT00238927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24427742|NCT00238940|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24427743|NCT00238940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427744|NCT00238940|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24427745|NCT00238940|Antitubercular Agents|antitubercular agents|mesh-ancestor
24427746|NCT00238940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24427747|NCT00238940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24427748|NCT00238940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427749|NCT00238940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427750|NCT00238953|Mycophenolic Acid|mycophenolic acid|mesh-list
24427751|NCT00238953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24427752|NCT00238953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429639|NCT00244556|Immunologic Factors|immunologic factors|mesh-ancestor
24429640|NCT00244556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24429641|NCT00244556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24429642|NCT00244556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24429643|NCT00244556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24429645|NCT00244556|Sensory System Agents|sensory system agents|mesh-ancestor
24429646|NCT00244556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24429774|NCT00245024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430394|NCT00247559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430395|NCT00247559|Cholinergic Agents|cholinergic agents|mesh-ancestor
24430396|NCT00247559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431752|NCT00252863|Fluticasone|fluticasone|mesh-list
24430447|NCT00247715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430448|NCT00247715|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24430449|NCT00247715|Histamine Antagonists|histamine antagonists|mesh-ancestor
24430450|NCT00247715|Histamine Agents|histamine agents|mesh-ancestor
24430451|NCT00247715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430452|NCT00247715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430470|NCT00247910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24430471|NCT00247910|Diuretics|diuretics|mesh-ancestor
24430472|NCT00247910|Natriuretic Agents|natriuretic agents|mesh-ancestor
24430473|NCT00247910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430474|NCT00247910|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24430475|NCT00247910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24430476|NCT00247910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695932|NCT01426490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430573|NCT00248261|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24430574|NCT00248261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24430575|NCT00248261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24430576|NCT00248261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24430577|NCT00248261|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24430578|NCT00248261|Dopamine Agents|dopamine agents|mesh-ancestor
24430580|NCT00248300|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24430581|NCT00248300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24430582|NCT00248300|Disinfectants|disinfectants|mesh-ancestor
24430819|NCT00249366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24430820|NCT00249366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24430821|NCT00249366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24430822|NCT00249366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24460244|NCT00347828|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24460245|NCT00347828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24460246|NCT00347828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24460247|NCT00347828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24430823|NCT00249366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24430824|NCT00249366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24791762|NCT03118232|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24791763|NCT03118232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24791765|NCT03118232|Dermatologic Agents|dermatologic agents|mesh-ancestor
24791766|NCT03118232|Plasma Substitutes|plasma substitutes|mesh-ancestor
24431173|NCT00250692|Sensory System Agents|sensory system agents|mesh-ancestor
24431174|NCT00250692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24431177|NCT00250744|Fosaprepitant|fosaprepitant|mesh-list
24431178|NCT00250744|Analgesics|analgesics|mesh-ancestor
24431179|NCT00250744|Sensory System Agents|sensory system agents|mesh-ancestor
24431180|NCT00250744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24431181|NCT00250744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431581|NCT00252317|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24431582|NCT00252317|Protease Inhibitors|protease inhibitors|mesh-ancestor
24431583|NCT00252317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431584|NCT00252317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431585|NCT00252317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24431586|NCT00252330|Amibegron|amibegron|mesh-list
24431587|NCT00252330|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24431588|NCT00252330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24431589|NCT00252330|Adrenergic Agents|adrenergic agents|mesh-ancestor
24431590|NCT00252330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431591|NCT00252330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431592|NCT00252330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431593|NCT00252343|Amibegron|amibegron|mesh-list
24432169|NCT00253929|Adenosine|adenosine|mesh-list
24431800|NCT00252889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24431801|NCT00252889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431802|NCT00252889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097090|NCT03206944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25097100|NCT03206671|Cytarabine|cytarabine|mesh-list
24431805|NCT00252928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24431806|NCT00252928|Antiviral Agents|antiviral agents|mesh-ancestor
24431807|NCT00252928|Disinfectants|disinfectants|mesh-ancestor
24431808|NCT00252954|Levetiracetam|levetiracetam|mesh-list
24431809|NCT00252954|Anticonvulsants|anticonvulsants|mesh-ancestor
24432221|NCT00254020|Citalopram|citalopram|mesh-list
25007418|NCT03579160|Timolol|timolol|mesh-list
25007419|NCT03579160|Petrolatum|petrolatum|mesh-list
25007420|NCT03579160|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25007421|NCT03579160|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25007422|NCT03579160|Adrenergic Agents|adrenergic agents|mesh-ancestor
25007423|NCT03579160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25007454|NCT03531736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007455|NCT03531736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007456|NCT03531736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25007457|NCT03531736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24431849|NCT00253123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24431850|NCT00253123|Dopamine Agents|dopamine agents|mesh-ancestor
24431851|NCT00253136|Risperidone|risperidone|mesh-list
24431852|NCT00253136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24432024|NCT00253474|Antiviral Agents|antiviral agents|mesh-ancestor
24432025|NCT00253474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24432026|NCT00253474|Immunologic Factors|immunologic factors|mesh-ancestor
24432027|NCT00253474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432028|NCT00253487|Temozolomide|temozolomide|mesh-list
24432029|NCT00253487|Busulfan|busulfan|mesh-list
24432030|NCT00253487|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
24432031|NCT00253487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24432032|NCT00253487|Alkylating Agents|alkylating agents|mesh-ancestor
24432033|NCT00253487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432034|NCT00253487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432328|NCT00254371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432330|NCT00254436|Hematinics|hematinics|mesh-ancestor
24432331|NCT00254449|Capsaicin|capsaicin|mesh-list
24432569|NCT00255450|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24432570|NCT00255450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24432571|NCT00255463|Gefitinib|gefitinib|mesh-list
24432572|NCT00255463|Anastrozole|anastrozole|mesh-list
24432573|NCT00255463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432574|NCT00255463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24432575|NCT00255463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432576|NCT00255463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703428|NCT02168309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25703429|NCT02168309|Adrenergic Agents|adrenergic agents|mesh-ancestor
25703430|NCT02168309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24432577|NCT00255463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24432578|NCT00255463|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24433542|NCT00258791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433543|NCT00258791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24433544|NCT00258791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24435531|NCT00266669|Vasodilator Agents|vasodilator agents|mesh-ancestor
24435532|NCT00266721|Pancrelipase|pancrelipase|mesh-list
24436806|NCT00271427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436807|NCT00271427|Protective Agents|protective agents|mesh-ancestor
24433745|NCT00259805|Rituximab|rituximab|mesh-list
24437252|NCT00273065|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24437253|NCT00273065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24433921|NCT00260624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24437413|NCT00273559|Hormones|hormones|mesh-ancestor
24437499|NCT00273871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24437570|NCT00274014|Autonomic Agents|autonomic agents|mesh-ancestor
24437571|NCT00274014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24437618|NCT00274053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437619|NCT00274066|Fenoterol|fenoterol|mesh-list
24438433|NCT00275938|Interferon-alpha|interferon-alpha|mesh-list
24438434|NCT00275938|Interferon alpha-2|interferon alpha-2|mesh-list
24438435|NCT00275938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438436|NCT00275938|Antiviral Agents|antiviral agents|mesh-ancestor
24438437|NCT00275938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24438438|NCT00275938|Antimetabolites|antimetabolites|mesh-ancestor
24438439|NCT00275938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438440|NCT00275938|Immunologic Factors|immunologic factors|mesh-ancestor
24438441|NCT00275938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438442|NCT00275951|Cetuximab|cetuximab|mesh-list
24790455|NCT01942577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790456|NCT01942681|Propiverine|propiverine|mesh-list
24790457|NCT01942681|Parasympatholytics|parasympatholytics|mesh-ancestor
24884373|NCT00783263|Ezetimibe|ezetimibe|mesh-list
24438736|NCT00276705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24438737|NCT00276705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24438738|NCT00276705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25007488|NCT03498014|Analgesics, Opioid|analgesics, opioid|mesh-list
25007489|NCT03498014|Narcotics|narcotics|mesh-ancestor
25007490|NCT03498014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25007491|NCT03498014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439013|NCT00277082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439015|NCT00277108|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24439016|NCT00277108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24439017|NCT00277108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24439018|NCT00277108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439019|NCT00277108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25007493|NCT03498014|Sensory System Agents|sensory system agents|mesh-ancestor
24439023|NCT00277108|Antidepressive Agents|antidepressive agents|mesh-ancestor
24439024|NCT00277108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24439026|NCT00277199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24437841|NCT00274560|Autonomic Agents|autonomic agents|mesh-ancestor
24439140|NCT00277654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24439141|NCT00277654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24439142|NCT00277654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24439143|NCT00277654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24439194|NCT00277862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439195|NCT00278070|Vinorelbine|vinorelbine|mesh-list
24439196|NCT00278070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24439215|NCT00278083|Gasotransmitters|gasotransmitters|mesh-ancestor
24439216|NCT00278083|Protective Agents|protective agents|mesh-ancestor
24439217|NCT00278122|Paclitaxel|paclitaxel|mesh-list
24439218|NCT00278122|Sargramostim|sargramostim|mesh-list
24439219|NCT00278122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24439220|NCT00278122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439221|NCT00278122|Tubulin Modulators|tubulin modulators|mesh-ancestor
24439222|NCT00278122|Antimitotic Agents|antimitotic agents|mesh-ancestor
24439223|NCT00278122|Mitosis Modulators|mitosis modulators|mesh-ancestor
24440204|NCT00281983|Cyclosporine|cyclosporine|mesh-list
24440205|NCT00281983|Mycophenolic Acid|mycophenolic acid|mesh-list
24440206|NCT00281983|Cyclophosphamide|cyclophosphamide|mesh-list
24440207|NCT00281983|Busulfan|busulfan|mesh-list
24440208|NCT00281983|Rituximab|rituximab|mesh-list
24440209|NCT00281983|Methotrexate|methotrexate|mesh-list
24440210|NCT00281983|Fludarabine|fludarabine|mesh-list
24440295|NCT00282165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695933|NCT01426490|Antioxidants|antioxidants|mesh-ancestor
24695934|NCT01426490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695935|NCT01426490|Protective Agents|protective agents|mesh-ancestor
24695936|NCT01426490|Hematinics|hematinics|mesh-ancestor
24695937|NCT01426542|Topiramate|topiramate|mesh-list
24440433|NCT00283088|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24440434|NCT00283088|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24440435|NCT00283088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24440436|NCT00283088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440437|NCT00283101|Dacetuzumab|dacetuzumab|mesh-list
24440438|NCT00283101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24440439|NCT00283101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440473|NCT00283218|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24440476|NCT00283309|Riluzole|riluzole|mesh-list
24440477|NCT00283309|Memantine|memantine|mesh-list
24440478|NCT00283309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24440479|NCT00283309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24440480|NCT00283309|Dopamine Agents|dopamine agents|mesh-ancestor
24440481|NCT00283309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24440482|NCT00283309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440483|NCT00283309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440484|NCT00283309|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24440485|NCT00283309|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24440486|NCT00283309|Anticonvulsants|anticonvulsants|mesh-ancestor
24440487|NCT00283309|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24440569|NCT00283751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440570|NCT00283764|Latanoprost|latanoprost|mesh-list
24440571|NCT00283764|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25007495|NCT03458247|Abiraterone Acetate|abiraterone acetate|mesh-list
24460404|NCT00348387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460405|NCT00348400|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24460406|NCT00348400|Dorzolamide|dorzolamide|mesh-list
24440574|NCT00283777|Picolinic acid|picolinic acid|mesh-list
24440575|NCT00283777|Trace Elements|trace elements|mesh-ancestor
24440578|NCT00283777|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24440586|NCT00283790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440587|NCT00283790|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24440588|NCT00283790|GABA Agonists|gaba agonists|mesh-ancestor
24440589|NCT00283790|GABA Agents|gaba agents|mesh-ancestor
24440940|NCT00285389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24440941|NCT00285389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24440942|NCT00285389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24440945|NCT00285389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24441049|NCT00285805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24441050|NCT00285844|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
24441051|NCT00285844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24441052|NCT00285844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441054|NCT00285883|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24441304|NCT00287105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24441305|NCT00287105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441306|NCT00287105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441308|NCT00287157|Analgesics|analgesics|mesh-ancestor
24441309|NCT00287157|Sensory System Agents|sensory system agents|mesh-ancestor
24441310|NCT00287157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24441313|NCT00287157|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24460422|NCT00348413|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24460423|NCT00348413|Prednisolone|prednisolone|mesh-list
24460424|NCT00348413|Prednisolone acetate|prednisolone acetate|mesh-list
24460425|NCT00348413|Methotrexate|methotrexate|mesh-list
24460426|NCT00348413|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24423255|NCT00225173|Hormones|hormones|mesh-ancestor
24441314|NCT00287157|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24441315|NCT00287157|Parasympatholytics|parasympatholytics|mesh-ancestor
24441416|NCT00287352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24441417|NCT00287352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24441418|NCT00287352|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24441419|NCT00287352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24441420|NCT00287352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24695938|NCT01426542|Anticonvulsants|anticonvulsants|mesh-ancestor
24695939|NCT01426542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24441421|NCT00287352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441422|NCT00287352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24441424|NCT00287352|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24441425|NCT00287352|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24441426|NCT00287352|Antiviral Agents|antiviral agents|mesh-ancestor
24441427|NCT00287352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24441428|NCT00287352|Dopamine Agents|dopamine agents|mesh-ancestor
24441429|NCT00287352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24441430|NCT00287352|Analgesics|analgesics|mesh-ancestor
24435816|NCT00268255|Gefitinib|gefitinib|mesh-list
24441477|NCT00287534|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24441478|NCT00287534|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24441479|NCT00287534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24441480|NCT00287534|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24441481|NCT00287534|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24441482|NCT00287534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441483|NCT00287534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441485|NCT00287560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24441522|NCT00287781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24460431|NCT00348413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460432|NCT00348413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24441557|NCT00287820|Risperidone|risperidone|mesh-list
24435864|NCT00268398|Leucovorin|leucovorin|mesh-list
24441720|NCT00288171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442249|NCT00290628|Dermatologic Agents|dermatologic agents|mesh-ancestor
24442250|NCT00290628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24442251|NCT00290628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24442252|NCT00290628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24442902|NCT00293163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007550|NCT03311308|Metformin|metformin|mesh-list
25007571|NCT03255096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25097446|NCT03204045|Anesthetics, General|anesthetics, general|mesh-ancestor
24695940|NCT01426542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695944|NCT01426633|Antimetabolites|antimetabolites|mesh-ancestor
24395728|NCT00136747|Dopamine Agents|dopamine agents|mesh-ancestor
25703431|NCT02168309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25703432|NCT02168309|Sympathomimetics|sympathomimetics|mesh-ancestor
25703433|NCT02168309|Autonomic Agents|autonomic agents|mesh-ancestor
25703434|NCT02168309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25703435|NCT02168309|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25703436|NCT02168309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25703437|NCT02168361|Interferons|interferons|mesh-list
25703438|NCT02168361|Ribavirin|ribavirin|mesh-list
25703439|NCT02168361|Interferon-alpha|interferon-alpha|mesh-list
24442942|NCT00293332|Mitosis Modulators|mitosis modulators|mesh-ancestor
24442943|NCT00293332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442948|NCT00293345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442977|NCT00293371|Hormones|hormones|mesh-ancestor
24460457|NCT00348426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460458|NCT00348439|Fibrinolysin|fibrinolysin|mesh-list
25007555|NCT03311308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007556|NCT03292133|Gefitinib|gefitinib|mesh-list
25007557|NCT03292133|Nazartinib|nazartinib|mesh-list
25007558|NCT03292133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007559|NCT03292133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25007560|NCT03292133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25007561|NCT03292133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007562|NCT03267589|Durvalumab|durvalumab|mesh-list
25007563|NCT03267589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25007564|NCT03267589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007565|NCT03255096|Rituximab|rituximab|mesh-list
25007566|NCT03255096|Venetoclax|venetoclax|mesh-list
25007567|NCT03255096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24781702|NCT01891461|Hemostatics|hemostatics|mesh-list
25007568|NCT03255096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007569|NCT03255096|Immunologic Factors|immunologic factors|mesh-ancestor
25007570|NCT03255096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007580|NCT03221751|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25007581|NCT03221751|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25007582|NCT03221751|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25007583|NCT03221751|Adrenergic Agents|adrenergic agents|mesh-ancestor
25007584|NCT03221751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25007585|NCT03221751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007586|NCT03221751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007587|NCT03191084|Dronabinol|dronabinol|mesh-list
25007588|NCT03191084|Hallucinogens|hallucinogens|mesh-ancestor
25007589|NCT03191084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007590|NCT03191084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25007591|NCT03191084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25007592|NCT03191084|Analgesics|analgesics|mesh-ancestor
25007593|NCT03191084|Sensory System Agents|sensory system agents|mesh-ancestor
25007594|NCT03191084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25007595|NCT03191084|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25007596|NCT03191084|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25007597|NCT03191084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25007598|NCT03191084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007599|NCT03191084|Hormones|hormones|mesh-ancestor
25007600|NCT03191084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24443017|NCT00293475|Mannitol|mannitol|mesh-list
24443018|NCT00293475|Antibodies|antibodies|mesh-list
24443019|NCT00293475|Immunoglobulins|immunoglobulins|mesh-list
24567488|NCT00791297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567489|NCT00791297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24567490|NCT00791349|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24567565|NCT00791544|Sorafenib|sorafenib|mesh-list
24437761|NCT00274430|Hormones|hormones|mesh-ancestor
24790591|NCT01943812|Progesterone|progesterone|mesh-list
24790592|NCT01943812|Estrogens|estrogens|mesh-ancestor
24790593|NCT01943812|Hormones|hormones|mesh-ancestor
24695963|NCT01426737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695964|NCT01426802|Vildagliptin|vildagliptin|mesh-list
24695965|NCT01426802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24790594|NCT01943812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24790595|NCT01943812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790596|NCT01943812|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24790597|NCT01943812|Contraceptive Agents|contraceptive agents|mesh-ancestor
24460480|NCT00348491|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24460481|NCT00348491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25703440|NCT02168361|Interferon alpha-2|interferon alpha-2|mesh-list
25703441|NCT02168361|Sofosbuvir|sofosbuvir|mesh-list
25703442|NCT02168361|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25703443|NCT02168361|Simeprevir|simeprevir|mesh-list
25703444|NCT02168361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25703445|NCT02168361|Antiviral Agents|antiviral agents|mesh-ancestor
25703446|NCT02168361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25703447|NCT02168361|Antimetabolites|antimetabolites|mesh-ancestor
25703448|NCT02168361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833352|NCT02173756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833354|NCT02173756|Sensory System Agents|sensory system agents|mesh-ancestor
24460482|NCT00348491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443234|NCT00294112|Remestemcel-l|remestemcel-l|mesh-list
24443235|NCT00294112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24443236|NCT00294112|Antiviral Agents|antiviral agents|mesh-ancestor
24443237|NCT00294112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24443238|NCT00294164|Hormones|hormones|mesh-list
25007614|NCT03161912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25007615|NCT03161912|Growth Substances|growth substances|mesh-ancestor
25007616|NCT03161912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007624|NCT03149809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007625|NCT03149809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443275|NCT00294359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24443287|NCT00294385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24443288|NCT00294385|Antiviral Agents|antiviral agents|mesh-ancestor
24443289|NCT00294385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24443290|NCT00294385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443291|NCT00294385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24443292|NCT00294385|Immunologic Factors|immunologic factors|mesh-ancestor
24443293|NCT00294385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443294|NCT00294385|Tubulin Modulators|tubulin modulators|mesh-ancestor
24443295|NCT00294385|Antimitotic Agents|antimitotic agents|mesh-ancestor
24443296|NCT00294385|Mitosis Modulators|mitosis modulators|mesh-ancestor
24443297|NCT00294437|Zoledronic Acid|zoledronic acid|mesh-list
24443298|NCT00294437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24443299|NCT00294437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007627|NCT03104400|Adalimumab|adalimumab|mesh-list
24443300|NCT00294463|Tibolone|tibolone|mesh-list
24790606|NCT01943942|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24790607|NCT01943942|Hormone Antagonists|hormone antagonists|mesh-ancestor
24790608|NCT01943942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24790609|NCT01943942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790611|NCT01943942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24583171|NCT00873509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583172|NCT00873535|Varenicline|varenicline|mesh-list
24885519|NCT05171530|Taxane|taxane|mesh-list
25703449|NCT02168361|Immunologic Factors|immunologic factors|mesh-ancestor
25703450|NCT02168361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703451|NCT02168361|Protease Inhibitors|protease inhibitors|mesh-ancestor
25703452|NCT02168361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703453|NCT02168387|Acetylcysteine|acetylcysteine|mesh-list
25703454|NCT02168387|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25703455|NCT02168387|Antiviral Agents|antiviral agents|mesh-ancestor
25703456|NCT02168387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24460505|NCT00348504|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24460506|NCT00348504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24460507|NCT00348504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24460508|NCT00348504|Adrenergic Agents|adrenergic agents|mesh-ancestor
25007628|NCT03104400|Upadacitinib|upadacitinib|mesh-list
25007629|NCT03104400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25007630|NCT03104400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25007631|NCT03104400|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25007632|NCT03104400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25007633|NCT03104400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25097850|NCT03200847|Tretinoin|tretinoin|mesh-list
24695967|NCT01426802|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24695969|NCT01426802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24695970|NCT01426802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695971|NCT01426815|Golimumab|golimumab|mesh-list
24695972|NCT01426815|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24695973|NCT01426815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24695974|NCT01426815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25007635|NCT03104374|Upadacitinib|upadacitinib|mesh-list
25007636|NCT03104374|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25007637|NCT03104374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25007638|NCT03104374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25007639|NCT03104374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007640|NCT03104374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25007641|NCT03098654|Metformin|metformin|mesh-list
25007642|NCT03098654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25007643|NCT03098654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007644|NCT03072043|Azacitidine|azacitidine|mesh-list
25007645|NCT03072043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24443360|NCT00294606|Oxymetazoline|oxymetazoline|mesh-list
24443409|NCT00294892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443411|NCT00294892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24443412|NCT00294892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24443429|NCT00294918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24443431|NCT00294931|Bevacizumab|bevacizumab|mesh-list
24443432|NCT00294931|Carboplatin|carboplatin|mesh-list
24460512|NCT00348517|Lubricant Eye Drops|lubricant eye drops|mesh-list
24460513|NCT00348517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24695975|NCT01426815|Immunologic Factors|immunologic factors|mesh-ancestor
24695976|NCT01426815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695978|NCT01426880|Carboplatin|carboplatin|mesh-list
24695979|NCT01426880|Lapatinib|lapatinib|mesh-list
24695980|NCT01426880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25407486|NCT03499249|Respiratory System Agents|respiratory system agents|mesh-ancestor
24833715|NCT02175381|Antiviral Agents|antiviral agents|mesh-ancestor
24460527|NCT00348582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24460528|NCT00348582|Analgesics|analgesics|mesh-ancestor
24460529|NCT00348582|Sensory System Agents|sensory system agents|mesh-ancestor
24460530|NCT00348582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24460531|NCT00348582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460532|NCT00348582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24460533|NCT00348582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24460534|NCT00348582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24460535|NCT00348582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460536|NCT00348582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460538|NCT00348634|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24460539|NCT00348634|Serotonin Agents|serotonin agents|mesh-ancestor
24460540|NCT00348634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25007657|NCT03016013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460576|NCT00348920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460577|NCT00348920|Sensory System Agents|sensory system agents|mesh-ancestor
24460578|NCT00348920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24460581|NCT00348972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460636|NCT00349115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24460637|NCT00349115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24460638|NCT00349115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24460639|NCT00349115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24460640|NCT00349115|Growth Substances|growth substances|mesh-ancestor
24460641|NCT00349115|Growth Inhibitors|growth inhibitors|mesh-ancestor
24460642|NCT00349115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460644|NCT00349128|Fenofibrate|fenofibrate|mesh-list
24460645|NCT00349128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24460646|NCT00349128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460647|NCT00349128|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24460648|NCT00349128|Antimetabolites|antimetabolites|mesh-ancestor
24460649|NCT00349128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460650|NCT00349128|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24460651|NCT00349180|Enoxaparin|enoxaparin|mesh-list
25007659|NCT03016013|Dermatologic Agents|dermatologic agents|mesh-ancestor
24621752|NCT01063816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621753|NCT01063816|Antiviral Agents|antiviral agents|mesh-ancestor
24621754|NCT01063816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25703457|NCT02168387|Expectorants|expectorants|mesh-ancestor
25703458|NCT02168387|Respiratory System Agents|respiratory system agents|mesh-ancestor
25703459|NCT02168387|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25703460|NCT02168387|Antioxidants|antioxidants|mesh-ancestor
25703461|NCT02168387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703462|NCT02168387|Protective Agents|protective agents|mesh-ancestor
25703463|NCT02168387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703464|NCT02168387|Antidotes|antidotes|mesh-ancestor
25703465|NCT02168439|Midazolam|midazolam|mesh-list
24621755|NCT01063816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621756|NCT01063816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24621757|NCT01063816|Immunologic Factors|immunologic factors|mesh-ancestor
24621758|NCT01063816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621759|NCT01063816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24621760|NCT01063842|Acetaminophen|acetaminophen|mesh-list
24621761|NCT01063842|Tramadol|tramadol|mesh-list
24621762|NCT01063842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24621763|NCT01063842|Analgesics|analgesics|mesh-ancestor
24621764|NCT01063842|Sensory System Agents|sensory system agents|mesh-ancestor
25007675|NCT03011307|Oxytocics|oxytocics|mesh-ancestor
25007676|NCT03011307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25007677|NCT03011307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439287|NCT00278265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007711|NCT02880293|Tacrolimus|tacrolimus|mesh-list
24427638|NCT00238667|Aspirin|aspirin|mesh-list
24790632|NCT01944033|Autonomic Agents|autonomic agents|mesh-ancestor
24790635|NCT01944033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25007719|NCT02880293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007720|NCT02880293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25007721|NCT02880293|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25007722|NCT02880293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25007723|NCT02880293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25007724|NCT02880293|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25007725|NCT02880293|Antitubercular Agents|antitubercular agents|mesh-ancestor
25007726|NCT02880293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25007727|NCT02880293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25007729|NCT02853500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25007730|NCT02853500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007731|NCT02853500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25007732|NCT02853500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25703466|NCT02168439|Dexmedetomidine|dexmedetomidine|mesh-list
25703467|NCT02168439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25703468|NCT02168439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25703469|NCT02168439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703470|NCT02168439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25703471|NCT02168439|Analgesics|analgesics|mesh-ancestor
25703472|NCT02168439|Sensory System Agents|sensory system agents|mesh-ancestor
25703473|NCT02168439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25703474|NCT02168439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25007733|NCT02853500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460837|NCT00349635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460838|NCT00349635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24460839|NCT00349674|Methotrexate|methotrexate|mesh-list
24460840|NCT00349674|Azathioprine|azathioprine|mesh-list
24460902|NCT00350090|Hematinics|hematinics|mesh-ancestor
24460903|NCT00350116|Vitamin B 12|vitamin b 12|mesh-list
24460904|NCT00350116|Hydroxocobalamin|hydroxocobalamin|mesh-list
24460905|NCT00350116|Vitamins|vitamins|mesh-ancestor
24460906|NCT00350116|Micronutrients|micronutrients|mesh-ancestor
24460907|NCT00350116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460908|NCT00350116|Vitamin B Complex|vitamin b complex|mesh-ancestor
24460909|NCT00350116|Hematinics|hematinics|mesh-ancestor
24460910|NCT00350155|Lumiracoxib|lumiracoxib|mesh-list
24460911|NCT00350155|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24460912|NCT00350155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24460999|NCT00350467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461000|NCT00350467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24461001|NCT00350467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24461002|NCT00350467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24461003|NCT00350467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24461004|NCT00350467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24461005|NCT00350467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24440218|NCT00281983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24790657|NCT01944085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25703475|NCT02168439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24790658|NCT01944085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25007734|NCT02853500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007735|NCT02842827|Tretinoin|tretinoin|mesh-list
25007736|NCT02842827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007737|NCT02842827|Keratolytic Agents|keratolytic agents|mesh-ancestor
25007738|NCT02842827|Dermatologic Agents|dermatologic agents|mesh-ancestor
25007739|NCT02837029|Nivolumab|nivolumab|mesh-list
24440462|NCT00283192|Sertraline|sertraline|mesh-list
24443625|NCT00295542|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24443626|NCT00295542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24461159|NCT00351143|Dermatologic Agents|dermatologic agents|mesh-ancestor
24461160|NCT00351143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24461161|NCT00351143|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24461165|NCT00351143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24461166|NCT00351143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703476|NCT02168439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24461167|NCT00351169|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24696004|NCT01426906|Antifungal Agents|antifungal agents|mesh-ancestor
24696005|NCT01426906|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25703477|NCT02168439|Adrenergic Agents|adrenergic agents|mesh-ancestor
25703478|NCT02168439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25703479|NCT02168439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703480|NCT02168439|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25703481|NCT02168439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25703482|NCT02168439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25703483|NCT02168439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25703484|NCT02168439|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25703485|NCT02168439|Anesthetics, General|anesthetics, general|mesh-ancestor
25703486|NCT02168439|Anesthetics|anesthetics|mesh-ancestor
25703487|NCT02168439|GABA Modulators|gaba modulators|mesh-ancestor
24696008|NCT01426906|Hormone Antagonists|hormone antagonists|mesh-ancestor
24440683|NCT00284271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007787|NCT02740127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24790691|NCT01944384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24790692|NCT01944384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790693|NCT01944384|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24583252|NCT00873808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24790695|NCT01944384|Natriuretic Agents|natriuretic agents|mesh-ancestor
24790696|NCT01944410|Mitogens|mitogens|mesh-list
24790697|NCT01944410|Mitosis Modulators|mitosis modulators|mesh-ancestor
24790699|NCT01944436|Rivastigmine|rivastigmine|mesh-list
24461209|NCT00351364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24461210|NCT00351364|Respiratory System Agents|respiratory system agents|mesh-ancestor
24461211|NCT00351364|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24461212|NCT00351364|Hormone Antagonists|hormone antagonists|mesh-ancestor
24461213|NCT00351364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25007788|NCT02740127|Analgesics|analgesics|mesh-ancestor
25007789|NCT02740127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25007790|NCT02740127|Sympatholytics|sympatholytics|mesh-ancestor
25007791|NCT02740127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25007792|NCT02737475|Cyclophosphamide|cyclophosphamide|mesh-list
25007793|NCT02737475|Nivolumab|nivolumab|mesh-list
25007794|NCT02737475|Ipilimumab|ipilimumab|mesh-list
24461237|NCT00351546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461238|NCT00351585|Vildagliptin|vildagliptin|mesh-list
24461239|NCT00351585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24461240|NCT00351585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551511|NCT05373680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25007815|NCT02703714|Sargramostim|sargramostim|mesh-list
25007816|NCT02703714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25007817|NCT02703714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007818|NCT02703714|Immunologic Factors|immunologic factors|mesh-ancestor
25007819|NCT02703714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007821|NCT02642965|Fludarabine|fludarabine|mesh-list
25007822|NCT02642965|Fludarabine phosphate|fludarabine phosphate|mesh-list
25007823|NCT02642965|Daunorubicin|daunorubicin|mesh-list
25007824|NCT02642965|Lenograstim|lenograstim|mesh-list
25007825|NCT02642965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25007826|NCT02642965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25007827|NCT02642965|Antimetabolites|antimetabolites|mesh-ancestor
25007828|NCT02642965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007829|NCT02642965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25007830|NCT02642965|Immunologic Factors|immunologic factors|mesh-ancestor
25007831|NCT02642965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007832|NCT02642965|Antiviral Agents|antiviral agents|mesh-ancestor
25007833|NCT02642965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24550702|NCT00721773|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24550703|NCT00721773|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24550704|NCT00721773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550705|NCT00721773|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24550753|NCT00722150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24550754|NCT00722150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24550755|NCT00722150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550756|NCT00722150|Antiviral Agents|antiviral agents|mesh-ancestor
24550757|NCT00722150|Schistosomicides|schistosomicides|mesh-ancestor
24550758|NCT00722150|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24550759|NCT00722150|Anthelmintics|anthelmintics|mesh-ancestor
24550760|NCT00722176|Risperidone|risperidone|mesh-list
24550761|NCT00722176|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24550762|NCT00722176|Serotonin Agents|serotonin agents|mesh-ancestor
24551000|NCT00723515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007888|NCT02582775|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25007889|NCT02582775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25007890|NCT02582775|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25007891|NCT02582775|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25007892|NCT02582775|Antitubercular Agents|antitubercular agents|mesh-ancestor
25007893|NCT02582775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24551238|NCT00724672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24551239|NCT00724672|Analgesics|analgesics|mesh-ancestor
24551240|NCT00724672|Sensory System Agents|sensory system agents|mesh-ancestor
24551241|NCT00724672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24551242|NCT00724672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703488|NCT02168439|GABA Agents|gaba agents|mesh-ancestor
25703489|NCT02168478|Neomycin|neomycin|mesh-list
25703490|NCT02168478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25703491|NCT02168478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25703492|NCT02168478|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25703493|NCT02168478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703494|NCT02168478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703495|NCT02168491|Insulin Glargine|insulin glargine|mesh-list
25703496|NCT02168491|Lixisenatide|lixisenatide|mesh-list
25703497|NCT02168491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25703498|NCT02168491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703499|NCT02168660|Vitamin D|vitamin d|mesh-list
24551269|NCT00724724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24551270|NCT00724724|Protective Agents|protective agents|mesh-ancestor
24551271|NCT00724802|Triacetin|triacetin|mesh-list
24551272|NCT00724802|Antifungal Agents|antifungal agents|mesh-ancestor
24551273|NCT00724802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24551274|NCT00724880|Clopidogrel|clopidogrel|mesh-list
24551275|NCT00724880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24551276|NCT00724880|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24551277|NCT00724880|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24551278|NCT00724880|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24551303|NCT00725218|Analgesics|analgesics|mesh-ancestor
24551304|NCT00725218|Sensory System Agents|sensory system agents|mesh-ancestor
24551305|NCT00725218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24551306|NCT00725218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461670|NCT00353041|Sensory System Agents|sensory system agents|mesh-ancestor
24551307|NCT00725218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24551308|NCT00725218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24551309|NCT00725218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24551310|NCT00725218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24551311|NCT00725218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24551312|NCT00725218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24551313|NCT00725218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551314|NCT00725231|Alemtuzumab|alemtuzumab|mesh-list
24551323|NCT00725231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551339|NCT00725478|Dopamine Agents|dopamine agents|mesh-ancestor
24551340|NCT00725478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24551341|NCT00725478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551342|NCT00725478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551343|NCT00725517|Icodextrin|icodextrin|mesh-list
24551344|NCT00725517|Dialysis Solutions|dialysis solutions|mesh-ancestor
24551345|NCT00725517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24551346|NCT00725634|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24551347|NCT00725634|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24551348|NCT00725634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24551349|NCT00725634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24551350|NCT00725634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24551351|NCT00725634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551352|NCT00725634|Immunologic Factors|immunologic factors|mesh-ancestor
24551353|NCT00725634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551354|NCT00725777|Lumefantrine|lumefantrine|mesh-list
24551355|NCT00725777|Artemether|artemether|mesh-list
24551356|NCT00725777|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24551357|NCT00725777|Antimalarials|antimalarials|mesh-ancestor
24551358|NCT00725777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24551359|NCT00725777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24551430|NCT00726570|Anticoagulants|anticoagulants|mesh-list
24551431|NCT00726570|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24551432|NCT00726570|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24551433|NCT00726570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551435|NCT00726687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24551436|NCT00726687|Antimetabolites|antimetabolites|mesh-ancestor
24551437|NCT00726687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551508|NCT05373680|Metformin|metformin|mesh-list
24551709|NCT05124275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551840|NCT04921371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24442470|NCT00291148|Pregabalin|pregabalin|mesh-list
24551902|NCT04742660|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
24551903|NCT04742660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24551904|NCT04733092|Ethiodized Oil|ethiodized oil|mesh-list
24551905|NCT04733092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24551906|NCT04713098|Coal Tar|coal tar|mesh-list
24551907|NCT04713098|Keratolytic Agents|keratolytic agents|mesh-ancestor
24551908|NCT04713098|Dermatologic Agents|dermatologic agents|mesh-ancestor
24551910|NCT04620304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24551911|NCT04620304|Antiviral Agents|antiviral agents|mesh-ancestor
24551912|NCT04620304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24551914|NCT04620291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24551915|NCT04620291|Antiviral Agents|antiviral agents|mesh-ancestor
24551916|NCT04620291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24551949|NCT04480463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25703500|NCT02168660|Cholecalciferol|cholecalciferol|mesh-list
25703501|NCT02168660|Vitamins|vitamins|mesh-ancestor
24835477|NCT02183012|Ibuprofen|ibuprofen|mesh-list
24835478|NCT02183012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24551950|NCT04429503|Aflibercept|aflibercept|mesh-list
24551951|NCT04429503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24551952|NCT04429503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24551953|NCT04429503|Growth Substances|growth substances|mesh-ancestor
24551954|NCT04429503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551955|NCT04429503|Growth Inhibitors|growth inhibitors|mesh-ancestor
24551956|NCT04429503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24551958|NCT04426240|Cyclosporins|cyclosporins|mesh-list
24551959|NCT04426240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24551960|NCT04426240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551961|NCT04426240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24551962|NCT04426240|Immunologic Factors|immunologic factors|mesh-ancestor
24551963|NCT04426240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551964|NCT04426240|Antifungal Agents|antifungal agents|mesh-ancestor
24551965|NCT04426240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24551966|NCT04426240|Dermatologic Agents|dermatologic agents|mesh-ancestor
24551967|NCT04426240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24551968|NCT04426240|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24551969|NCT04406727|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24442566|NCT00291707|Pemetrexed|pemetrexed|mesh-list
24552058|NCT04213794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552059|NCT04213794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24552060|NCT04213794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24552061|NCT04213794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24552321|NCT03512418|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24552322|NCT03512418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24552323|NCT03512418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24552392|NCT03479268|Enzyme Inhibitors|enzyme inhibitors|mesh-list
24552393|NCT03479268|Pevonedistat|pevonedistat|mesh-list
24552394|NCT03479268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552395|NCT03475004|Bevacizumab|bevacizumab|mesh-list
24552396|NCT03475004|Pembrolizumab|pembrolizumab|mesh-list
24552578|NCT02227927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552579|NCT02227927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24552659|NCT00522145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24552660|NCT00522145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552661|NCT00364780|XL647|xl647|mesh-list
24552662|NCT00364780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552663|NCT00364780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24552664|NCT00364780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24552665|NCT00364780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552666|NCT00321698|Docetaxel|docetaxel|mesh-list
24552667|NCT00321698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552668|NCT00321698|Tubulin Modulators|tubulin modulators|mesh-ancestor
24552669|NCT00321698|Antimitotic Agents|antimitotic agents|mesh-ancestor
25008006|NCT02339740|Vitamin A|vitamin a|mesh-list
25008007|NCT02339740|Cytarabine|cytarabine|mesh-list
25008008|NCT02339740|Dexamethasone|dexamethasone|mesh-list
25008009|NCT02339740|Dexamethasone acetate|dexamethasone acetate|mesh-list
25008010|NCT02339740|Mitoxantrone|mitoxantrone|mesh-list
25008011|NCT02339740|Idarubicin|idarubicin|mesh-list
25008012|NCT02339740|Retinol palmitate|retinol palmitate|mesh-list
25008013|NCT02339740|Tretinoin|tretinoin|mesh-list
25008014|NCT02339740|Arsenic Trioxide|arsenic trioxide|mesh-list
25008015|NCT02339740|BB 1101|bb 1101|mesh-list
25008016|NCT02339740|Micronutrients|micronutrients|mesh-ancestor
25008017|NCT02339740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008018|NCT02339740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25008019|NCT02339740|Antiemetics|antiemetics|mesh-ancestor
25008020|NCT02339740|Autonomic Agents|autonomic agents|mesh-ancestor
25703502|NCT02168660|Micronutrients|micronutrients|mesh-ancestor
25703503|NCT02168660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008021|NCT02339740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25008023|NCT02339740|Glucocorticoids|glucocorticoids|mesh-ancestor
25008029|NCT02339740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407487|NCT03499249|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25703504|NCT02168660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25703505|NCT02168660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25703506|NCT02168803|Evacetrapib|evacetrapib|mesh-list
25703507|NCT02168803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25703508|NCT02168803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25703509|NCT02168803|Antimetabolites|antimetabolites|mesh-ancestor
25703510|NCT02168803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008030|NCT02339740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008035|NCT02339740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25008036|NCT02339740|Immunologic Factors|immunologic factors|mesh-ancestor
25008037|NCT02339740|Analgesics|analgesics|mesh-ancestor
25008038|NCT02339740|Sensory System Agents|sensory system agents|mesh-ancestor
25008039|NCT02339740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25008040|NCT02339740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25008041|NCT02339740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25008042|NCT02339740|Antioxidants|antioxidants|mesh-ancestor
25008043|NCT02339740|Protective Agents|protective agents|mesh-ancestor
25008059|NCT02124902|Docetaxel|docetaxel|mesh-list
25008060|NCT02124902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552671|NCT00321698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552672|NCT00726804|Adalimumab|adalimumab|mesh-list
24552673|NCT00726804|Etanercept|etanercept|mesh-list
24552674|NCT00726804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24552675|NCT00726804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24552676|NCT00726804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24552677|NCT00726804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24552678|NCT00726804|Analgesics|analgesics|mesh-ancestor
24552679|NCT00726804|Sensory System Agents|sensory system agents|mesh-ancestor
24552710|NCT00727038|Ranibizumab|ranibizumab|mesh-list
24552711|NCT00727038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24552712|NCT00727038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24552713|NCT00727038|Growth Substances|growth substances|mesh-ancestor
24552714|NCT00727038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552715|NCT00727038|Growth Inhibitors|growth inhibitors|mesh-ancestor
24552716|NCT00727038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552717|NCT00727077|Interferons|interferons|mesh-list
24552718|NCT00727077|Ribavirin|ribavirin|mesh-list
24552719|NCT00727077|Interferon-alpha|interferon-alpha|mesh-list
24552720|NCT00727077|Interferon alpha-2|interferon alpha-2|mesh-list
24552721|NCT00727077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552722|NCT00727077|Antiviral Agents|antiviral agents|mesh-ancestor
24552723|NCT00727077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24552724|NCT00727077|Antimetabolites|antimetabolites|mesh-ancestor
24552740|NCT00727129|Hormones|hormones|mesh-ancestor
24552741|NCT00727129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24552742|NCT00727129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552743|NCT00727129|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24552744|NCT00727129|Contraceptive Agents|contraceptive agents|mesh-ancestor
24552745|NCT00727129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24552746|NCT00727129|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24552758|NCT00727493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24552759|NCT00727493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552761|NCT00727545|Sequestering Agents|sequestering agents|mesh-ancestor
24552794|NCT00727831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24552795|NCT00727831|Antimetabolites|antimetabolites|mesh-ancestor
24552796|NCT00727831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552797|NCT00727831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552798|NCT00727831|Dermatologic Agents|dermatologic agents|mesh-ancestor
24552799|NCT00727831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24552800|NCT00727831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24552837|NCT00727948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24552838|NCT00727948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552839|NCT00727948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24552840|NCT00727948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24552843|NCT00727987|Golimumab|golimumab|mesh-list
24552844|NCT00727987|Methotrexate|methotrexate|mesh-list
24552845|NCT00727987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24552846|NCT00727987|Abortifacient Agents|abortifacient agents|mesh-ancestor
24552847|NCT00727987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24552848|NCT00727987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552849|NCT00727987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24552850|NCT00727987|Antimetabolites|antimetabolites|mesh-ancestor
24552851|NCT00727987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552852|NCT00727987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552853|NCT00727987|Dermatologic Agents|dermatologic agents|mesh-ancestor
24552855|NCT00727987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24552856|NCT00727987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24552857|NCT00727987|Immunologic Factors|immunologic factors|mesh-ancestor
24552858|NCT00727987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24552859|NCT00727987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25703512|NCT02168816|Moxifloxacin|moxifloxacin|mesh-list
24552860|NCT00727987|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24552861|NCT00727987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24552872|NCT00728000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24552873|NCT00728000|Immunologic Factors|immunologic factors|mesh-ancestor
24552892|NCT00728078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24552893|NCT00728078|Growth Substances|growth substances|mesh-ancestor
24552894|NCT00728078|Growth Inhibitors|growth inhibitors|mesh-ancestor
24552895|NCT00728078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552897|NCT00728156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24552898|NCT00728156|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24552899|NCT00728156|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24552900|NCT00728156|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24552901|NCT00728156|Purinergic Agents|purinergic agents|mesh-ancestor
24552902|NCT00728156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24450007|NCT00317577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24552903|NCT00728156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552904|NCT00728156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552906|NCT00728195|N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|n-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|mesh-list
24552907|NCT00728195|Antiemetics|antiemetics|mesh-ancestor
24552908|NCT00728195|Autonomic Agents|autonomic agents|mesh-ancestor
24552909|NCT00728195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24552910|NCT00728195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552911|NCT00728195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24552912|NCT00728195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24552913|NCT00728195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24552915|NCT00728195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24552964|NCT00728559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24552965|NCT00728559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552966|NCT00728559|Sensory System Agents|sensory system agents|mesh-ancestor
24552967|NCT00728559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24552994|NCT00728715|Glucocorticoids|glucocorticoids|mesh-ancestor
24552996|NCT00728715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24552997|NCT00728715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24552998|NCT00728715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24552999|NCT00728715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24553000|NCT00728715|Adrenergic Agents|adrenergic agents|mesh-ancestor
24553001|NCT00728715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24553002|NCT00728715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553003|NCT00728780|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24553004|NCT00728780|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24553005|NCT00728780|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24553006|NCT00728780|Antimetabolites|antimetabolites|mesh-ancestor
24553007|NCT00728780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008062|NCT02124902|Antimitotic Agents|antimitotic agents|mesh-ancestor
24790953|NCT05410093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24553126|NCT00729638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24553127|NCT00729638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24553128|NCT00729664|Atezolizumab|atezolizumab|mesh-list
24553129|NCT00729664|BMS-936559|bms-936559|mesh-list
24553130|NCT00729664|Antibodies|antibodies|mesh-list
24553131|NCT00729664|Immunoglobulins|immunoglobulins|mesh-list
24553132|NCT00729664|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24553133|NCT00729664|Immunologic Factors|immunologic factors|mesh-ancestor
24554551|NCT00736970|Antifungal Agents|antifungal agents|mesh-ancestor
24553141|NCT00729742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553143|NCT00729768|Mycophenolic Acid|mycophenolic acid|mesh-list
24553144|NCT00729768|Cyclosporins|cyclosporins|mesh-list
24553145|NCT00729768|Basiliximab|basiliximab|mesh-list
24553146|NCT00729768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553147|NCT00729768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550780|NCT00722215|Tocolytic Agents|tocolytic agents|mesh-ancestor
24696009|NCT01426906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24553294|NCT00730223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24550811|NCT00722631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24790995|NCT05408247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25703513|NCT02168816|Metronidazole|metronidazole|mesh-list
25703514|NCT02168816|Vancomycin|vancomycin|mesh-list
25703515|NCT02168816|Ciprofloxacin|ciprofloxacin|mesh-list
25703516|NCT02168816|Clindamycin|clindamycin|mesh-list
25703517|NCT02168816|Meropenem|meropenem|mesh-list
24836000|NCT02183701|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24836001|NCT02183701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24836003|NCT02183779|Antifungal Agents|antifungal agents|mesh-ancestor
24790997|NCT05408247|Respiratory System Agents|respiratory system agents|mesh-ancestor
24790998|NCT05408247|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24790999|NCT05408247|Antioxidants|antioxidants|mesh-ancestor
25008071|NCT02097680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24791000|NCT05408247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791001|NCT05408247|Protective Agents|protective agents|mesh-ancestor
25008072|NCT02097680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008073|NCT02097680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25008074|NCT02097680|Hormone Antagonists|hormone antagonists|mesh-ancestor
24550880|NCT00723060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24553339|NCT00730392|Immunologic Factors|immunologic factors|mesh-ancestor
24553340|NCT00730418|Doxazosin|doxazosin|mesh-list
24550924|NCT00723268|Colchicine|colchicine|mesh-list
24553854|NCT00733083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24553855|NCT00733083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553869|NCT00733148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553870|NCT00733174|Rosiglitazone|rosiglitazone|mesh-list
24553871|NCT00733174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24553872|NCT00733174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553935|NCT00733473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24553936|NCT00733473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24553937|NCT00733473|Autonomic Agents|autonomic agents|mesh-ancestor
24553986|NCT00733616|Antimitotic Agents|antimitotic agents|mesh-ancestor
24553987|NCT00733616|Mitosis Modulators|mitosis modulators|mesh-ancestor
24553988|NCT00733616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553989|NCT00733616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24553990|NCT00733616|Antimetabolites|antimetabolites|mesh-ancestor
24553991|NCT00733668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24553992|NCT00733668|Antidepressive Agents|antidepressive agents|mesh-ancestor
24553993|NCT00733668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24553994|NCT00733668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24554086|NCT00734123|Protease Inhibitors|protease inhibitors|mesh-ancestor
24554087|NCT00734123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25008108|NCT01850888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008109|NCT01850888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24791006|NCT05406895|Anesthetics, Local|anesthetics, local|mesh-ancestor
24554179|NCT00734773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24554180|NCT00734773|Antiviral Agents|antiviral agents|mesh-ancestor
24554181|NCT00734773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24554182|NCT00734773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24554183|NCT00734773|Tubulin Modulators|tubulin modulators|mesh-ancestor
24554184|NCT00734773|Antimitotic Agents|antimitotic agents|mesh-ancestor
24554185|NCT00734773|Mitosis Modulators|mitosis modulators|mesh-ancestor
24554186|NCT00734773|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24554187|NCT00734864|Anticonvulsants|anticonvulsants|mesh-list
24554255|NCT00735124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24554263|NCT00735228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24554265|NCT00735241|Folic Acid|folic acid|mesh-list
24554266|NCT00735241|Bevacizumab|bevacizumab|mesh-list
24554267|NCT00735241|Fluorouracil|fluorouracil|mesh-list
24554268|NCT00735241|Oxaliplatin|oxaliplatin|mesh-list
24554269|NCT00735241|Levoleucovorin|levoleucovorin|mesh-list
24554270|NCT00735241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24554271|NCT00735241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24554272|NCT00735241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24554273|NCT00735241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24554274|NCT00735241|Growth Substances|growth substances|mesh-ancestor
24554275|NCT00735241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554363|NCT00736021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24759009|NCT01749072|Ifosfamide|ifosfamide|mesh-list
24554373|NCT00736164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554374|NCT00736164|Protective Agents|protective agents|mesh-ancestor
25703518|NCT02168816|Tazobactam|tazobactam|mesh-list
25703519|NCT02168816|Linezolid|linezolid|mesh-list
25703520|NCT02168816|Piperacillin|piperacillin|mesh-list
25703521|NCT02168816|Daptomycin|daptomycin|mesh-list
25703522|NCT02168816|Cefepime|cefepime|mesh-list
25703523|NCT02168816|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25703524|NCT02168816|Aztreonam|aztreonam|mesh-list
25703525|NCT02168816|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25703526|NCT02168816|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
25703527|NCT02168816|Trimethoprim|trimethoprim|mesh-list
24554375|NCT00736164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554376|NCT00736164|Trace Elements|trace elements|mesh-ancestor
24554377|NCT00736164|Micronutrients|micronutrients|mesh-ancestor
24554378|NCT00736294|Ramipril|ramipril|mesh-list
24554379|NCT00736294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24554420|NCT00736463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554421|NCT00736463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24554422|NCT00736463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24554423|NCT00736463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24554424|NCT00736515|Insulin|insulin|mesh-list
24554435|NCT00736541|Expectorants|expectorants|mesh-ancestor
24554436|NCT00736541|Respiratory System Agents|respiratory system agents|mesh-ancestor
24554437|NCT00736541|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24554438|NCT00736541|Antioxidants|antioxidants|mesh-ancestor
24554439|NCT00736541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554440|NCT00736541|Protective Agents|protective agents|mesh-ancestor
24554441|NCT00736541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554442|NCT00736541|Antidotes|antidotes|mesh-ancestor
24554443|NCT00736541|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
24554444|NCT00736541|Protease Inhibitors|protease inhibitors|mesh-ancestor
24554445|NCT00736541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24554446|NCT00736606|Simvastatin|simvastatin|mesh-list
24554447|NCT00736606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24554448|NCT00736606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24554449|NCT00736606|Antimetabolites|antimetabolites|mesh-ancestor
24554450|NCT00736606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554541|NCT00736931|GABA Agents|gaba agents|mesh-ancestor
24554542|NCT00736931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24554543|NCT00736931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554544|NCT00736970|Sirolimus|sirolimus|mesh-list
24569921|NCT00802321|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24569922|NCT00802321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24569923|NCT00802321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24554545|NCT00736970|Trastuzumab|trastuzumab|mesh-list
24554546|NCT00736970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25008111|NCT01759836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24791008|NCT05406895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24791009|NCT05406895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791010|NCT05406895|Sensory System Agents|sensory system agents|mesh-ancestor
24791011|NCT05406895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24791012|NCT05406895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25008112|NCT01759836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25008113|NCT01759836|Antimetabolites|antimetabolites|mesh-ancestor
25008114|NCT01759836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008115|NCT01759836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25008117|NCT01759836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24554550|NCT00736970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24554552|NCT00736970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24554553|NCT00736970|Immunologic Factors|immunologic factors|mesh-ancestor
24555468|NCT00741741|Rilpivirine|rilpivirine|mesh-list
24554554|NCT00736970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554555|NCT00736983|Ciprofloxacin|ciprofloxacin|mesh-list
24554556|NCT00736983|Adalimumab|adalimumab|mesh-list
24554557|NCT00736983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24554558|NCT00736983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24554559|NCT00736983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24554604|NCT00737191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24554605|NCT00737191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24554607|NCT00737191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24554678|NCT00737659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554680|NCT00737685|Fludarabine|fludarabine|mesh-list
24554681|NCT00737685|Thymoglobulin|thymoglobulin|mesh-list
24554682|NCT00737685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24554683|NCT00737685|Immunologic Factors|immunologic factors|mesh-ancestor
24554684|NCT00737685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554685|NCT00737685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24554686|NCT00737685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24554687|NCT00737685|Alkylating Agents|alkylating agents|mesh-ancestor
24554688|NCT00737685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554711|NCT00737724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24554713|NCT00737724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24554714|NCT00737776|Insulin Aspart|insulin aspart|mesh-list
24554715|NCT00737776|Biphasic Insulins|biphasic insulins|mesh-list
24554716|NCT00737776|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24554717|NCT00737776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24554718|NCT00737776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554719|NCT00737789|Mesalamine|mesalamine|mesh-list
24551557|NCT05373134|Vasodilator Agents|vasodilator agents|mesh-ancestor
24554776|NCT00737997|Sensory System Agents|sensory system agents|mesh-ancestor
24551626|NCT05292001|Iron-Dextran Complex|iron-dextran complex|mesh-list
24554923|NCT00738751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554924|NCT00738777|Tamoxifen|tamoxifen|mesh-list
24554925|NCT00738777|Fulvestrant|fulvestrant|mesh-list
24554926|NCT00738777|Anastrozole|anastrozole|mesh-list
24554927|NCT00738777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25099731|NCT03187795|Mirabegron|mirabegron|mesh-list
24696010|NCT01426906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696011|NCT01426906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24696013|NCT01426971|Caffeine|caffeine|mesh-list
24696014|NCT01426971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24696015|NCT01426971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24696016|NCT01426971|Analgesics|analgesics|mesh-ancestor
24696017|NCT01426971|Sensory System Agents|sensory system agents|mesh-ancestor
24696018|NCT01426971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24696019|NCT01426971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696020|NCT01426971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24554928|NCT00738777|Hormone Antagonists|hormone antagonists|mesh-ancestor
24554929|NCT00738777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24554930|NCT00738777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554931|NCT00738777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24554932|NCT00738777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24554933|NCT00738777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24554934|NCT00738777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24554935|NCT00738777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24554936|NCT00738777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24554937|NCT00738777|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24554938|NCT00738777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24554939|NCT00738777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24554940|NCT00738777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554941|NCT00738829|Vidarabine|vidarabine|mesh-list
24554942|NCT00738829|Rituximab|rituximab|mesh-list
24555458|NCT00741663|Diuretics|diuretics|mesh-ancestor
24555459|NCT00741663|Natriuretic Agents|natriuretic agents|mesh-ancestor
24555460|NCT00741663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555461|NCT00741663|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24555462|NCT00741663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24555463|NCT00741663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555464|NCT00741663|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24555465|NCT00741663|Hormone Antagonists|hormone antagonists|mesh-ancestor
24759011|NCT01749072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25008194|NCT01042522|Mitosis Modulators|mitosis modulators|mesh-ancestor
24555555|NCT00742040|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25703528|NCT02168816|Sulfamethoxazole|sulfamethoxazole|mesh-list
25703529|NCT02168816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25703530|NCT02168816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25703531|NCT02168816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25703532|NCT02168816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703533|NCT02168816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703534|NCT02168816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24555556|NCT00742040|Protease Inhibitors|protease inhibitors|mesh-ancestor
24555557|NCT00742040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24555558|NCT00742040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555559|NCT00742040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24555562|NCT00742066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24555563|NCT00742066|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24555564|NCT00742066|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24555565|NCT00742066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555566|NCT00742066|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24555567|NCT00742066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24555568|NCT00742066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24555569|NCT00742066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24555570|NCT00742066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555571|NCT00742066|Vasodilator Agents|vasodilator agents|mesh-ancestor
24555572|NCT00742092|Miglustat|miglustat|mesh-list
24555574|NCT00742092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555575|NCT00742092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24555576|NCT00742092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24555577|NCT00742092|Antiviral Agents|antiviral agents|mesh-ancestor
24555701|NCT00742820|Chelating Agents|chelating agents|mesh-ancestor
24555702|NCT00742820|Sequestering Agents|sequestering agents|mesh-ancestor
24555703|NCT00742820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555704|NCT00742846|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24555705|NCT00742846|Triamcinolone|triamcinolone|mesh-list
24555706|NCT00742846|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24555708|NCT00742846|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24555709|NCT00742846|Anesthetics, Local|anesthetics, local|mesh-ancestor
24555710|NCT00742846|Anesthetics|anesthetics|mesh-ancestor
24555711|NCT00742846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24555712|NCT00742846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555713|NCT00742846|Sensory System Agents|sensory system agents|mesh-ancestor
24583814|NCT00877097|Hormones|hormones|mesh-ancestor
24583815|NCT00877097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24583816|NCT00877097|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24583817|NCT00877110|Cyclophosphamide|cyclophosphamide|mesh-list
24583818|NCT00877110|Vincristine|vincristine|mesh-list
24583819|NCT00877110|Topotecan|topotecan|mesh-list
24791066|NCT05371223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555755|NCT00743327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555756|NCT00743470|Ritonavir|ritonavir|mesh-list
24555757|NCT00743470|Lopinavir|lopinavir|mesh-list
24555758|NCT00743470|Rifabutin|rifabutin|mesh-list
24555759|NCT00743470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24555760|NCT00743470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24555806|NCT00743782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24555808|NCT00743782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24555809|NCT00743834|Fluvoxamine|fluvoxamine|mesh-list
24555810|NCT00743834|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24555811|NCT00743834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25008244|NCT00826462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25008245|NCT00826462|Analgesics|analgesics|mesh-ancestor
24696021|NCT01426971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24696022|NCT01426971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24612614|NCT01014559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612615|NCT01014559|Analgesics|analgesics|mesh-ancestor
24612616|NCT01014559|Sensory System Agents|sensory system agents|mesh-ancestor
24612617|NCT01014559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24612618|NCT01014559|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25008259|NCT00710970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25008260|NCT00685919|Carbidopa|carbidopa|mesh-list
25008261|NCT00685919|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25008262|NCT00685919|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25008263|NCT00685919|Dopamine Agents|dopamine agents|mesh-ancestor
25008264|NCT00685919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25008265|NCT00685919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008266|NCT00685919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008267|NCT00685919|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25008268|NCT00685919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24555893|NCT00744185|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25099929|NCT03186547|Botulinum Toxins|botulinum toxins|mesh-list
24612622|NCT01014637|Clotrimazole|clotrimazole|mesh-list
24612623|NCT01014637|Miconazole|miconazole|mesh-list
24555894|NCT00744185|Adrenergic Agents|adrenergic agents|mesh-ancestor
24836435|NCT02185859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24555895|NCT00744185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24555896|NCT00744185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555897|NCT00744185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555898|NCT00744185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24555966|NCT00744419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24556001|NCT00744549|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24556003|NCT00744549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556034|NCT00744718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24556035|NCT00744718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24556036|NCT00744718|Growth Substances|growth substances|mesh-ancestor
24556037|NCT00744718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556038|NCT00744718|Growth Inhibitors|growth inhibitors|mesh-ancestor
24556039|NCT00744770|Rilpivirine|rilpivirine|mesh-list
24556137|NCT00745173|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24556138|NCT00745173|Estrogens|estrogens|mesh-ancestor
24556139|NCT00745173|Hormones|hormones|mesh-ancestor
24556175|NCT00745511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556198|NCT00745953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556200|NCT00745953|Natriuretic Agents|natriuretic agents|mesh-ancestor
24556201|NCT00745953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556202|NCT00745953|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24556203|NCT00745953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24556485|NCT00747968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24556487|NCT00748007|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
24556488|NCT00748007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556489|NCT00748007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556724|NCT00749359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24556725|NCT00749359|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25109851|NCT03121417|Nivolumab|nivolumab|mesh-list
24791174|NCT05068063|Anesthetics, Local|anesthetics, local|mesh-ancestor
24791176|NCT05068063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24791177|NCT05068063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791178|NCT05068063|Sensory System Agents|sensory system agents|mesh-ancestor
24791179|NCT05068063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24791180|NCT05049707|Magnesium Sulfate|magnesium sulfate|mesh-list
24791181|NCT05049707|Analgesics|analgesics|mesh-ancestor
24648982|NCT01217970|Ibudilast|ibudilast|mesh-list
24556970|NCT00750581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556971|NCT00750581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24557004|NCT00750802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24557005|NCT00750802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24557006|NCT00750802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24557007|NCT00750802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24557008|NCT00750802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24557009|NCT00750802|GABA Modulators|gaba modulators|mesh-ancestor
24557010|NCT00750802|GABA Agents|gaba agents|mesh-ancestor
24557011|NCT00750802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24557012|NCT00750802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557013|NCT00750997|Dextrans|dextrans|mesh-list
24557014|NCT00750997|Anticoagulants|anticoagulants|mesh-ancestor
24557056|NCT00751153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24557058|NCT00751153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24557059|NCT00751153|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24557061|NCT00751153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557062|NCT00751153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557063|NCT00751153|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24557064|NCT00751153|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24557065|NCT00751153|Protease Inhibitors|protease inhibitors|mesh-ancestor
24557169|NCT00751556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25703535|NCT02168816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25703536|NCT02168816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25703537|NCT02168816|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25703538|NCT02168816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25703539|NCT02168816|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25703540|NCT02168816|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25703541|NCT02168816|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25703542|NCT02168816|Renal Agents|renal agents|mesh-ancestor
25703543|NCT02168816|Antimalarials|antimalarials|mesh-ancestor
24557171|NCT00751556|Sensory System Agents|sensory system agents|mesh-ancestor
24557459|NCT00752635|Hormones|hormones|mesh-ancestor
24557460|NCT00752635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24570746|NCT00806481|Sequestering Agents|sequestering agents|mesh-ancestor
24570747|NCT00806481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570750|NCT00806611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24557462|NCT00752635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24557463|NCT00752635|Contraceptive Agents|contraceptive agents|mesh-ancestor
24557464|NCT00752635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24557610|NCT00753103|Azathioprine|azathioprine|mesh-list
24557611|NCT00753103|Infliximab|infliximab|mesh-list
24557612|NCT00753103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24557721|NCT00753571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557722|NCT00753597|Rituximab|rituximab|mesh-list
24557723|NCT00753597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24557724|NCT00753597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24557725|NCT00753597|Immunologic Factors|immunologic factors|mesh-ancestor
24557726|NCT00753597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557727|NCT00753597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24557728|NCT00753727|Sunitinib|sunitinib|mesh-list
24557729|NCT00753727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24557899|NCT00754780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557931|NCT00754871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24557933|NCT00754871|Androgens|androgens|mesh-ancestor
24557934|NCT00754871|Hormones|hormones|mesh-ancestor
24557935|NCT00754871|Anabolic Agents|anabolic agents|mesh-ancestor
24557936|NCT00754884|Calcitonin|calcitonin|mesh-list
24557937|NCT00754884|Salmon calcitonin|salmon calcitonin|mesh-list
24557938|NCT00754884|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
24557939|NCT00754884|Glycerol|glycerol|mesh-list
24557940|NCT00754884|Katacalcin|katacalcin|mesh-list
24557941|NCT00754884|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24557943|NCT00754884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557944|NCT00754884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24557945|NCT00754884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24557946|NCT00754884|Vasodilator Agents|vasodilator agents|mesh-ancestor
24557947|NCT00754910|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
24557948|NCT00754910|Trioxsalen|trioxsalen|mesh-list
24557949|NCT00754910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791224|NCT04946396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24791225|NCT04946396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791226|NCT04946396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24791227|NCT04946396|Analgesics|analgesics|mesh-ancestor
24570854|NCT00806923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24791228|NCT04946396|Sensory System Agents|sensory system agents|mesh-ancestor
24791229|NCT04946396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24791230|NCT04946396|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24791231|NCT04946396|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24791232|NCT04946396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24791233|NCT04946396|Adrenergic Agents|adrenergic agents|mesh-ancestor
24791234|NCT04946396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24791235|NCT04946396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557952|NCT00754962|Protriptyline|protriptyline|mesh-list
24557953|NCT00754962|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24558019|NCT00755118|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24558020|NCT00755118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24558021|NCT00755118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24558022|NCT00755118|Antidotes|antidotes|mesh-ancestor
24558023|NCT00755118|Protective Agents|protective agents|mesh-ancestor
24558024|NCT00755118|Vitamin B Complex|vitamin b complex|mesh-ancestor
24558026|NCT00755118|Micronutrients|micronutrients|mesh-ancestor
24558027|NCT00755157|Bevacizumab|bevacizumab|mesh-list
24558028|NCT00755157|Docetaxel|docetaxel|mesh-list
24558048|NCT00755170|Growth Inhibitors|growth inhibitors|mesh-ancestor
24791244|NCT04887389|Fluorides|fluorides|mesh-list
24558049|NCT00755170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24558050|NCT00755170|Tubulin Modulators|tubulin modulators|mesh-ancestor
24558051|NCT00755170|Antimitotic Agents|antimitotic agents|mesh-ancestor
24558052|NCT00755170|Mitosis Modulators|mitosis modulators|mesh-ancestor
24558069|NCT00755313|Immunologic Factors|immunologic factors|mesh-ancestor
24558070|NCT00755313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558071|NCT00755313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24558072|NCT00755313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24558073|NCT00755313|Alkylating Agents|alkylating agents|mesh-ancestor
24558074|NCT00755313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558075|NCT00755313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24558076|NCT00755313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24558077|NCT00755313|Tubulin Modulators|tubulin modulators|mesh-ancestor
24558236|NCT00755872|Risedronic Acid|risedronic acid|mesh-list
24558238|NCT00755872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24558239|NCT00755872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24558240|NCT00755872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558241|NCT00755872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24558242|NCT00755872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558280|NCT00755963|Hormones|hormones|mesh-ancestor
24558312|NCT00755989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24558313|NCT00756067|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24558314|NCT00756067|Immunologic Factors|immunologic factors|mesh-ancestor
24558315|NCT00756067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558316|NCT00756171|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
24558317|NCT00756171|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24558318|NCT00756171|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24558319|NCT00756171|Antimetabolites|antimetabolites|mesh-ancestor
24558454|NCT00757315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24558455|NCT00757315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558456|NCT00757380|Diminazene aceturate|diminazene aceturate|mesh-list
24558492|NCT00757458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558493|NCT00757458|Antidotes|antidotes|mesh-ancestor
24558494|NCT00757458|Protective Agents|protective agents|mesh-ancestor
24558495|NCT00757458|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24791284|NCT04812028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24791285|NCT04812028|Anticonvulsants|anticonvulsants|mesh-ancestor
24813505|NCT02058706|Hormones|hormones|mesh-ancestor
24791286|NCT04812028|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24791287|NCT04812028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24791288|NCT04812028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791289|NCT04812028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24791290|NCT04812028|Tocolytic Agents|tocolytic agents|mesh-ancestor
25008382|NCT05209295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008383|NCT05209295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008384|NCT05209295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25008385|NCT05209256|Pemetrexed|pemetrexed|mesh-list
25008386|NCT05209256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008387|NCT05209256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25008388|NCT05209256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008389|NCT05209256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25008390|NCT05209256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25008392|NCT05208931|Endothelial Growth Factors|endothelial growth factors|mesh-list
25008393|NCT05208931|Mitosis Modulators|mitosis modulators|mesh-ancestor
25008394|NCT05208931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008395|NCT05208931|Growth Substances|growth substances|mesh-ancestor
25008396|NCT05208931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008397|NCT05208879|Carotenoids|carotenoids|mesh-list
25008398|NCT05208879|Antioxidants|antioxidants|mesh-ancestor
25008400|NCT05208879|Protective Agents|protective agents|mesh-ancestor
25008407|NCT05208827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008408|NCT05208827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25008409|NCT05208827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25008410|NCT05208801|Morphine|morphine|mesh-list
25008411|NCT05208801|Bupivacaine|bupivacaine|mesh-list
25008412|NCT05208801|Anesthetics, Local|anesthetics, local|mesh-ancestor
25008413|NCT05208801|Anesthetics|anesthetics|mesh-ancestor
24558813|NCT05434377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558910|NCT05414305|Lidocaine|lidocaine|mesh-list
24558911|NCT05414305|Heparin|heparin|mesh-list
24558912|NCT05414305|Anesthetics, Local|anesthetics, local|mesh-ancestor
24558913|NCT05414305|Anesthetics|anesthetics|mesh-ancestor
24558962|NCT05382338|Sodium thiosulfate|sodium thiosulfate|mesh-list
25703544|NCT02168816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25703545|NCT02168816|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25703546|NCT02168816|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25703547|NCT02168842|Isradipine|isradipine|mesh-list
24559038|NCT05319730|Mitosis Modulators|mitosis modulators|mesh-ancestor
24559039|NCT05319730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571285|NCT00809029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24559165|NCT05230901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24559166|NCT05230901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24559167|NCT05230901|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24559169|NCT05230901|Natriuretic Agents|natriuretic agents|mesh-ancestor
24559170|NCT05230901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24612624|NCT01014637|Amorolfine|amorolfine|mesh-list
24612625|NCT01014637|Ciclopirox|ciclopirox|mesh-list
24612626|NCT01014637|Keratolytic Agents|keratolytic agents|mesh-list
24612632|NCT01014637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612633|NCT01014637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24612634|NCT01014637|Hormone Antagonists|hormone antagonists|mesh-ancestor
24612635|NCT01014637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24612636|NCT01014637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612637|NCT01014637|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24612638|NCT01014637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24612639|NCT01014637|Dermatologic Agents|dermatologic agents|mesh-ancestor
24696068|NCT01427127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24696069|NCT01427127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24696070|NCT01427127|Serotonin Agents|serotonin agents|mesh-ancestor
25008471|NCT05207514|Docetaxel|docetaxel|mesh-list
25008472|NCT05207514|Doxorubicin|doxorubicin|mesh-list
25008473|NCT05207514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25008474|NCT05207514|Immunologic Factors|immunologic factors|mesh-ancestor
25008475|NCT05207514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008476|NCT05207514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25008477|NCT05207514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25082347|NCT03323385|Meloxicam|meloxicam|mesh-list
25008478|NCT05207514|Alkylating Agents|alkylating agents|mesh-ancestor
25008479|NCT05207514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008480|NCT05207514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008481|NCT05207514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25008482|NCT05207514|Tubulin Modulators|tubulin modulators|mesh-ancestor
24559464|NCT04767061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24559465|NCT04767061|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24559467|NCT04767061|Protective Agents|protective agents|mesh-ancestor
24559468|NCT04767061|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25703548|NCT02168842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25703549|NCT02168842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25703550|NCT02168842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25703551|NCT02168842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703552|NCT02168842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25703553|NCT02168842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703554|NCT02168842|Vasodilator Agents|vasodilator agents|mesh-ancestor
25703555|NCT02168855|Nicotine|nicotine|mesh-list
25703556|NCT02168855|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24559470|NCT04767061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24559517|NCT04757584|Serotonin Agents|serotonin agents|mesh-ancestor
24559519|NCT04741438|Ipilimumab|ipilimumab|mesh-list
24559522|NCT04741438|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24559523|NCT04741438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24559788|NCT04391348|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24559789|NCT04391348|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24559790|NCT04391348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24559791|NCT04387136|Sufentanil|sufentanil|mesh-list
24559792|NCT04387136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24559793|NCT04387136|Narcotics|narcotics|mesh-ancestor
24559794|NCT04387136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24559936|NCT04007809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24559937|NCT04007809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791327|NCT04773392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25008486|NCT05207514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25008487|NCT05207514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25008488|NCT05207514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25008489|NCT05207514|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25008490|NCT05207514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25008525|NCT05182892|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25008526|NCT05182892|Sympathomimetics|sympathomimetics|mesh-ancestor
25008527|NCT05182892|Autonomic Agents|autonomic agents|mesh-ancestor
25008528|NCT05182892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25008529|NCT05182892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008556|NCT05149287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25008557|NCT05149287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24560086|NCT03584009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24560087|NCT03584009|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24560089|NCT03584009|Hormone Antagonists|hormone antagonists|mesh-ancestor
24560090|NCT03584009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24560091|NCT03584009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24560093|NCT03583359|Anesthetics, Local|anesthetics, local|mesh-ancestor
24560094|NCT03583359|Anesthetics|anesthetics|mesh-ancestor
24560095|NCT03583359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24560096|NCT03583359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24560097|NCT03583359|Sensory System Agents|sensory system agents|mesh-ancestor
24560098|NCT03583359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24560200|NCT03274687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563568|NCT00772473|Serotonin Agents|serotonin agents|mesh-ancestor
24560325|NCT02927847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560327|NCT02915224|Chlorambucil|chlorambucil|mesh-list
24560328|NCT02915224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24560329|NCT02915224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24561186|NCT00758732|Tubulin Modulators|tubulin modulators|mesh-ancestor
24561187|NCT00758732|Antimitotic Agents|antimitotic agents|mesh-ancestor
24561188|NCT00758732|Mitosis Modulators|mitosis modulators|mesh-ancestor
24561194|NCT00758914|Vitamin E|vitamin e|mesh-list
24561195|NCT00758914|Vitamins|vitamins|mesh-ancestor
24561196|NCT00758914|Micronutrients|micronutrients|mesh-ancestor
24561229|NCT00759070|Antiviral Agents|antiviral agents|mesh-ancestor
24561230|NCT00759070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24561231|NCT00759070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24561232|NCT00759070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25703557|NCT02168855|Autonomic Agents|autonomic agents|mesh-ancestor
25703558|NCT02168855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25703559|NCT02168855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836714|NCT02187107|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24836715|NCT02187107|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24836716|NCT02187107|Protease Inhibitors|protease inhibitors|mesh-ancestor
24836717|NCT02187107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836719|NCT02187107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24561233|NCT00759070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24561234|NCT00759070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24566025|NCT00783926|Vaccines|vaccines|mesh-list
24561235|NCT00759070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24561406|NCT00760032|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24561407|NCT00760032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24561408|NCT00760045|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24561522|NCT00761241|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
24561524|NCT00761241|Oxaliplatin|oxaliplatin|mesh-list
24561622|NCT00761670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24561623|NCT00761670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24561624|NCT00761670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24561625|NCT00761670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24561626|NCT00761670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24561627|NCT00761670|Dopamine Agents|dopamine agents|mesh-ancestor
24561628|NCT00761670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24561629|NCT00761670|Antidepressive Agents|antidepressive agents|mesh-ancestor
24553981|NCT00733616|Docetaxel|docetaxel|mesh-list
24561703|NCT00762398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24561704|NCT00762398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562288|NCT00765427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562289|NCT00765557|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24562291|NCT00765557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24562292|NCT00765921|Ranibizumab|ranibizumab|mesh-list
24562293|NCT00765921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24562294|NCT00765921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24562295|NCT00765921|Growth Substances|growth substances|mesh-ancestor
24562296|NCT00765921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562297|NCT00765921|Growth Inhibitors|growth inhibitors|mesh-ancestor
24562298|NCT00765921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562299|NCT00765934|Lidocaine|lidocaine|mesh-list
24562352|NCT00766155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562353|NCT00766181|Lidocaine|lidocaine|mesh-list
24562354|NCT00766181|Anesthetics, Local|anesthetics, local|mesh-ancestor
24562355|NCT00766181|Anesthetics|anesthetics|mesh-ancestor
24562356|NCT00766181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24562357|NCT00766181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562358|NCT00766181|Sensory System Agents|sensory system agents|mesh-ancestor
24562359|NCT00766181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24791418|NCT04476979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24791420|NCT04476979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584229|NCT00879099|Timolol|timolol|mesh-list
25008570|NCT05122130|Protective Agents|protective agents|mesh-ancestor
25008571|NCT05122130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008572|NCT05122130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25008573|NCT05081206|Propofol|propofol|mesh-list
25008574|NCT05081206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25008575|NCT05081206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25109860|NCT03121313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109862|NCT03121352|Carboplatin|carboplatin|mesh-list
25109863|NCT03121352|Pembrolizumab|pembrolizumab|mesh-list
25109864|NCT03121352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25109865|NCT03121352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109866|NCT03121352|Tubulin Modulators|tubulin modulators|mesh-ancestor
24554243|NCT00735020|Vaccines|vaccines|mesh-list
24562572|NCT00767091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562573|NCT00767091|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24562574|NCT00767091|Protective Agents|protective agents|mesh-ancestor
24562681|NCT00767715|Antiemetics|antiemetics|mesh-ancestor
24562682|NCT00767715|Autonomic Agents|autonomic agents|mesh-ancestor
24562683|NCT00767715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24562684|NCT00767715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703560|NCT02168855|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25703561|NCT02168855|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25703562|NCT02168855|Cholinergic Agents|cholinergic agents|mesh-ancestor
25703563|NCT02168855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25703564|NCT02168855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703565|NCT02168946|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24562942|NCT00769054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24562944|NCT00769093|Hematinics|hematinics|mesh-ancestor
24562945|NCT00769093|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24562946|NCT00769093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24562947|NCT00769145|Ranibizumab|ranibizumab|mesh-list
24554366|NCT00736021|Serotonin Agents|serotonin agents|mesh-ancestor
24563076|NCT00769990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563077|NCT00769990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24563078|NCT00769990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24563079|NCT00769990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563080|NCT00769990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008580|NCT05047939|Propofol|propofol|mesh-list
24791504|NCT04150614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791505|NCT04150614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24791506|NCT04150614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24791507|NCT04150614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24791508|NCT04150614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24791509|NCT04150614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24584304|NCT00879723|Vitamins|vitamins|mesh-list
24791510|NCT04127851|Cyclosporine|cyclosporine|mesh-list
24791511|NCT04127851|Cyclosporins|cyclosporins|mesh-list
24791512|NCT04127851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24791513|NCT04127851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791514|NCT04127851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24791515|NCT04127851|Immunologic Factors|immunologic factors|mesh-ancestor
24791516|NCT04127851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791517|NCT04127851|Antifungal Agents|antifungal agents|mesh-ancestor
24791518|NCT04127851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24791519|NCT04127851|Dermatologic Agents|dermatologic agents|mesh-ancestor
25008581|NCT05047939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25008582|NCT05047939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25008583|NCT05047939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554427|NCT00736515|Gliclazide|gliclazide|mesh-list
25008635|NCT04879368|Paclitaxel|paclitaxel|mesh-list
25008636|NCT04879368|Docetaxel|docetaxel|mesh-list
24563567|NCT00772473|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24563227|NCT00770666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24563266|NCT00770744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24563267|NCT00770744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24563268|NCT00770744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24563269|NCT00770744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24563297|NCT00770900|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24563298|NCT00770900|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24554516|NCT00736905|Rilpivirine|rilpivirine|mesh-list
24563465|NCT00771680|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24791562|NCT03920007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24791563|NCT03920007|Glucocorticoids|glucocorticoids|mesh-ancestor
24791565|NCT03920007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24791566|NCT03920007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008643|NCT04879368|Mitosis Modulators|mitosis modulators|mesh-ancestor
25008644|NCT04879368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008645|NCT04879368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25008646|NCT04879368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25008647|NCT04879368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25008648|NCT04879368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25008649|NCT04879368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25008650|NCT04879368|Antimetabolites|antimetabolites|mesh-ancestor
25008651|NCT04879368|Antiviral Agents|antiviral agents|mesh-ancestor
25008652|NCT04879368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25008653|NCT04739865|Psilocybin|psilocybin|mesh-list
25008654|NCT04739865|Hallucinogens|hallucinogens|mesh-ancestor
25008655|NCT04739865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008656|NCT04739865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25008663|NCT04720963|Dexmedetomidine|dexmedetomidine|mesh-list
24563513|NCT00772161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101019|NCT03178123|Antiviral Agents|antiviral agents|mesh-ancestor
24628131|NCT01096706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24696077|NCT01427192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696078|NCT01427192|Diuretics|diuretics|mesh-ancestor
24696079|NCT01427192|Natriuretic Agents|natriuretic agents|mesh-ancestor
24696080|NCT01427192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696082|NCT01427205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24696083|NCT01427205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24696084|NCT01427244|Trastuzumab|trastuzumab|mesh-list
24696085|NCT01427244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24696086|NCT01427244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24696087|NCT01427270|Oxycodone|oxycodone|mesh-list
24696088|NCT01427270|Naloxone|naloxone|mesh-list
24696089|NCT01427270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24696090|NCT01427270|Narcotics|narcotics|mesh-ancestor
24696092|NCT01427270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696124|NCT01427400|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24696125|NCT01427400|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24696126|NCT01427400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24563531|NCT00772187|Analgesics|analgesics|mesh-ancestor
24563532|NCT00772187|Sensory System Agents|sensory system agents|mesh-ancestor
24563533|NCT00772187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24563534|NCT00772187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24563535|NCT00772187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24563536|NCT00772187|Anesthetics, General|anesthetics, general|mesh-ancestor
24563538|NCT00772265|Isophane Insulin, Human|isophane insulin, human|mesh-list
24563539|NCT00772265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24554635|NCT00737373|Docetaxel|docetaxel|mesh-list
24563564|NCT00772395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563565|NCT00772395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24563566|NCT00772473|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
24563569|NCT00772473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24563591|NCT00772499|Sympatholytics|sympatholytics|mesh-ancestor
24563592|NCT00772499|Autonomic Agents|autonomic agents|mesh-ancestor
24563593|NCT00772499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24563594|NCT00772499|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24563595|NCT00772499|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24563596|NCT00772499|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24563597|NCT00772499|Adrenergic Agents|adrenergic agents|mesh-ancestor
24563598|NCT00772499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24563599|NCT00772551|Raltegravir Potassium|raltegravir potassium|mesh-list
24563600|NCT00772551|Ezetimibe|ezetimibe|mesh-list
24563601|NCT00772551|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24563602|NCT00772551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24563603|NCT00772551|Antimetabolites|antimetabolites|mesh-ancestor
24563604|NCT00772551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563652|NCT00772720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24563653|NCT00772720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24563654|NCT00772720|Antiviral Agents|antiviral agents|mesh-ancestor
24563655|NCT00772720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24563656|NCT00772720|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24563657|NCT00772720|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24563658|NCT00772720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563659|NCT00772720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563660|NCT00772759|AZD-3199|azd-3199|mesh-list
24563661|NCT00772759|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24563662|NCT00772759|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24563663|NCT00772759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24563664|NCT00772759|Adrenergic Agents|adrenergic agents|mesh-ancestor
24563665|NCT00772759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24563683|NCT00772837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24563684|NCT00772837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24563685|NCT00772837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24563686|NCT00772837|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24563687|NCT00772837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563688|NCT00772837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563689|NCT00772837|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24563690|NCT00772837|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24563691|NCT00772837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24563692|NCT00772863|Docetaxel|docetaxel|mesh-list
24563693|NCT00772863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24563694|NCT00772863|Tubulin Modulators|tubulin modulators|mesh-ancestor
24563695|NCT00772863|Antimitotic Agents|antimitotic agents|mesh-ancestor
24563696|NCT00772863|Mitosis Modulators|mitosis modulators|mesh-ancestor
24563697|NCT00772863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563698|NCT00772902|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24572022|NCT00812682|Respiratory System Agents|respiratory system agents|mesh-ancestor
25008668|NCT04720963|Analgesics|analgesics|mesh-ancestor
25008669|NCT04720963|Sensory System Agents|sensory system agents|mesh-ancestor
25008688|NCT04699357|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25008689|NCT04699357|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25008690|NCT04699357|Cholinergic Agents|cholinergic agents|mesh-ancestor
25008691|NCT04699357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25008692|NCT04699357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008693|NCT04690192|Gemcitabine|gemcitabine|mesh-list
25008694|NCT04690192|Melphalan|melphalan|mesh-list
25008695|NCT04690192|Busulfan|busulfan|mesh-list
25008696|NCT04690192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25008697|NCT04690192|Antimetabolites|antimetabolites|mesh-ancestor
25008698|NCT04690192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008699|NCT04690192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008700|NCT04690192|Antiviral Agents|antiviral agents|mesh-ancestor
25008701|NCT04690192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25008702|NCT04690192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564325|NCT00775905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24564326|NCT00775905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24671028|NCT01323257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24564327|NCT00775905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564328|NCT00775905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24564329|NCT00775905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572127|NCT00813241|Celecoxib|celecoxib|mesh-list
24564331|NCT00775918|Doxycycline|doxycycline|mesh-list
24564332|NCT00775918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24564346|NCT00775996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24564347|NCT00775996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564433|NCT00776438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564434|NCT00776477|Aspirin|aspirin|mesh-list
24564463|NCT00776503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24564464|NCT00776503|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24564465|NCT00776503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564468|NCT00776516|Mirabegron|mirabegron|mesh-list
24564524|NCT00776633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24564525|NCT00776646|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24564526|NCT00776646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24564528|NCT00776646|Natriuretic Agents|natriuretic agents|mesh-ancestor
24564529|NCT00776646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564530|NCT00776646|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24564571|NCT00776763|Growth Inhibitors|growth inhibitors|mesh-ancestor
24564573|NCT00776802|Etoposide|etoposide|mesh-list
24564574|NCT00776802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24564575|NCT00776802|Antiemetics|antiemetics|mesh-ancestor
24564576|NCT00776802|Autonomic Agents|autonomic agents|mesh-ancestor
24564577|NCT00776802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24572240|NCT00813735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24572241|NCT00813735|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24572242|NCT00813735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24572243|NCT00813735|Cholinergic Agents|cholinergic agents|mesh-ancestor
24564578|NCT00776802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564579|NCT00776802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24564610|NCT00777114|Bortezomib|bortezomib|mesh-list
24564611|NCT00777114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24564638|NCT00777218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24564641|NCT00777244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24564656|NCT00777439|Domperidone|domperidone|mesh-list
24564657|NCT00777439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564658|NCT00777439|Antiemetics|antiemetics|mesh-ancestor
24564659|NCT00777439|Autonomic Agents|autonomic agents|mesh-ancestor
24564660|NCT00777439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24564661|NCT00777439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564662|NCT00777439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24564667|NCT00777478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24564668|NCT00777478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24564669|NCT00777478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24564670|NCT00777478|Growth Substances|growth substances|mesh-ancestor
24564672|NCT00777478|Growth Inhibitors|growth inhibitors|mesh-ancestor
24564789|NCT00777972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24564790|NCT00777972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008895|NCT03837873|Dexamethasone|dexamethasone|mesh-list
24564791|NCT00777972|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24564792|NCT00777972|Protease Inhibitors|protease inhibitors|mesh-ancestor
24564793|NCT00777972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564795|NCT00777985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24564796|NCT00777985|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24564797|NCT00777985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564798|NCT00777998|Ferrous fumarate|ferrous fumarate|mesh-list
24564799|NCT00777998|Thalidomide|thalidomide|mesh-list
24564800|NCT00777998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24564801|NCT00777998|Immunologic Factors|immunologic factors|mesh-ancestor
24564802|NCT00777998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564803|NCT00777998|Leprostatic Agents|leprostatic agents|mesh-ancestor
24564804|NCT00777998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24564805|NCT00777998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24564813|NCT00778011|Ondansetron|ondansetron|mesh-list
24564814|NCT00778011|Metoclopramide|metoclopramide|mesh-list
24564836|NCT00778024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24564837|NCT00778024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24564838|NCT00778024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564840|NCT00778024|Serotonin Agents|serotonin agents|mesh-ancestor
24555580|NCT00742092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24564906|NCT00778141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24564907|NCT00778141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564909|NCT00778180|Diuretics|diuretics|mesh-ancestor
24564910|NCT00778180|Natriuretic Agents|natriuretic agents|mesh-ancestor
24564911|NCT00778180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564912|NCT00778180|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24564913|NCT00778180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24564914|NCT00778180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564915|NCT00778193|Aspirin|aspirin|mesh-list
24564916|NCT00778193|Celecoxib|celecoxib|mesh-list
24564920|NCT00778193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24564921|NCT00778193|Analgesics|analgesics|mesh-ancestor
24564922|NCT00778193|Sensory System Agents|sensory system agents|mesh-ancestor
24564923|NCT00778193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24564924|NCT00778193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564925|NCT00778193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24564926|NCT00778193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24564927|NCT00778193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24564928|NCT00778193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24564935|NCT00778193|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24564936|NCT00778193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24564937|NCT00778193|Purinergic Agents|purinergic agents|mesh-ancestor
24564938|NCT00778193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24564939|NCT00778193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24564950|NCT00778232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24564951|NCT00778232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24564952|NCT00778232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24564953|NCT00778232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24564954|NCT00778232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564955|NCT00778232|Antimanic Agents|antimanic agents|mesh-ancestor
24564957|NCT00778245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25703566|NCT02168946|Meropenem|meropenem|mesh-list
25703567|NCT02168946|Vaborbactam|vaborbactam|mesh-list
25703568|NCT02168946|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25703569|NCT02168946|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
25703570|NCT02168946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24564959|NCT00778271|Gabapentin|gabapentin|mesh-list
24564960|NCT00778271|Analgesics|analgesics|mesh-ancestor
24494200|NCT00494338|Docetaxel|docetaxel|mesh-list
24564981|NCT00778349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24564982|NCT00778349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564985|NCT00778401|Sensory System Agents|sensory system agents|mesh-ancestor
24564986|NCT00778401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24564987|NCT00778401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564988|NCT00778401|Anticonvulsants|anticonvulsants|mesh-ancestor
24565025|NCT00778505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24565027|NCT00778544|Clavulanic Acids|clavulanic acids|mesh-list
24565028|NCT00778544|Clavulanic Acid|clavulanic acid|mesh-list
24565029|NCT00778544|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24565030|NCT00778544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24565031|NCT00778544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24565032|NCT00778544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565033|NCT00778544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565034|NCT00778544|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24565052|NCT00778609|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
24565053|NCT00778609|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24565054|NCT00778609|Contraceptive Agents|contraceptive agents|mesh-ancestor
24565055|NCT00778609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24565056|NCT00778609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565057|NCT00778609|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24565058|NCT00778609|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24565059|NCT00778609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24565060|NCT00778609|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24565061|NCT00778609|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24565062|NCT00778609|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
24565063|NCT00778609|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24565064|NCT00778609|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24565065|NCT00778661|Amoxicillin|amoxicillin|mesh-list
24565068|NCT00778674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24565071|NCT00778674|Diuretics|diuretics|mesh-ancestor
24791656|NCT03623633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791657|NCT03623633|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24791658|NCT03623633|Hormone Antagonists|hormone antagonists|mesh-ancestor
24792279|NCT05384951|Cholecalciferol|cholecalciferol|mesh-list
24572536|NCT00815373|Latanoprost|latanoprost|mesh-list
24572537|NCT00815373|Maleic acid|maleic acid|mesh-list
24565304|NCT00779714|Immunologic Factors|immunologic factors|mesh-ancestor
24584528|NCT00880815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584530|NCT00880815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584547|NCT00880841|Naloxone|naloxone|mesh-list
24584548|NCT00880841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25008751|NCT04503148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25008752|NCT04503148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25008753|NCT04503148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008754|NCT04503148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25008755|NCT04498468|Dexamethasone|dexamethasone|mesh-list
25008756|NCT04498468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25008757|NCT04498468|Antiemetics|antiemetics|mesh-ancestor
25008758|NCT04498468|Autonomic Agents|autonomic agents|mesh-ancestor
25008759|NCT04498468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25008760|NCT04498468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008761|NCT04498468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24565080|NCT00778713|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24565081|NCT00778713|Fosinopril|fosinopril|mesh-list
24565100|NCT00778726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565101|NCT00778726|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24565103|NCT00778726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565115|NCT00778765|Gabapentin|gabapentin|mesh-list
24565116|NCT00778765|Analgesics|analgesics|mesh-ancestor
24565117|NCT00778765|Sensory System Agents|sensory system agents|mesh-ancestor
24565118|NCT00778765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24565119|NCT00778765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565120|NCT00778765|Anticonvulsants|anticonvulsants|mesh-ancestor
25703571|NCT02168946|Antitubercular Agents|antitubercular agents|mesh-ancestor
25703572|NCT02168946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565122|NCT00778765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24565123|NCT00778765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24565124|NCT00778765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24565125|NCT00778765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24565126|NCT00778765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24565127|NCT00778765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24565128|NCT00778765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565129|NCT00778765|Antimanic Agents|antimanic agents|mesh-ancestor
24565130|NCT00778778|Cefprozil|cefprozil|mesh-list
24565133|NCT00778791|Metformin|metformin|mesh-list
24565170|NCT00779129|Cyclophosphamide|cyclophosphamide|mesh-list
24565171|NCT00779129|Doxorubicin|doxorubicin|mesh-list
24565172|NCT00779129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24565173|NCT00779129|Immunologic Factors|immunologic factors|mesh-ancestor
24565174|NCT00779129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565175|NCT00779129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24565238|NCT00779376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24565239|NCT00779376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24565240|NCT00779376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24565241|NCT00779389|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24565243|NCT00779389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24565244|NCT00779389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24565245|NCT00779389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565262|NCT00779454|Antimetabolites|antimetabolites|mesh-ancestor
24555926|NCT00744250|Pancreatin|pancreatin|mesh-list
24565303|NCT00779714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24565339|NCT00779805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24565340|NCT00779805|Respiratory System Agents|respiratory system agents|mesh-ancestor
24565462|NCT00780650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565463|NCT00780650|Adrenergic Agents|adrenergic agents|mesh-ancestor
24565464|NCT00780650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24565498|NCT00780780|Sensory System Agents|sensory system agents|mesh-ancestor
24565499|NCT00780780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24565500|NCT00780780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24565502|NCT00780793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24565503|NCT00780832|Caffeine|caffeine|mesh-list
24565504|NCT00780832|Cholinergic Antagonists|cholinergic antagonists|mesh-list
24565505|NCT00780832|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24565506|NCT00780832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565579|NCT00781300|Autonomic Agents|autonomic agents|mesh-ancestor
24565580|NCT00781300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24565581|NCT00781300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565582|NCT00781300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24565583|NCT00781300|Glucocorticoids|glucocorticoids|mesh-ancestor
24565584|NCT00781300|Hormones|hormones|mesh-ancestor
24565586|NCT00781300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24565873|NCT00783107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565874|NCT00783107|Antifungal Agents|antifungal agents|mesh-ancestor
24565875|NCT00783107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24565876|NCT00783107|Dermatologic Agents|dermatologic agents|mesh-ancestor
24565877|NCT00783107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24565878|NCT00783107|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24565879|NCT00783172|Gemcitabine|gemcitabine|mesh-list
24565881|NCT00783172|Enkephalins|enkephalins|mesh-list
24565882|NCT00783172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24565883|NCT00783172|Antimetabolites|antimetabolites|mesh-ancestor
25703573|NCT02168946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703574|NCT02169115|Omalizumab|omalizumab|mesh-list
25703575|NCT02169115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25703576|NCT02169115|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25703577|NCT02169115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25703578|NCT02169115|Respiratory System Agents|respiratory system agents|mesh-ancestor
25008782|NCT04400799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25008783|NCT04400799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008784|NCT04368910|Artesunate|artesunate|mesh-list
25008785|NCT04368910|Chloroquine|chloroquine|mesh-list
25008786|NCT04368910|Pyronaridine|pyronaridine|mesh-list
25008787|NCT04368910|Antimalarials|antimalarials|mesh-ancestor
25008788|NCT04368910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25008789|NCT04368910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25008790|NCT04368910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25008791|NCT04368910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24565926|NCT00783471|Mitosis Modulators|mitosis modulators|mesh-ancestor
24565927|NCT00783471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565928|NCT00783471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24565929|NCT00783471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565931|NCT00783484|Darunavir|darunavir|mesh-list
24565932|NCT00783484|Midazolam|midazolam|mesh-list
24565933|NCT00783484|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24565934|NCT00783484|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24565935|NCT00783484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24565936|NCT00783484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565937|NCT00783484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24565938|NCT00783484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24565939|NCT00783484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24565940|NCT00783484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24565976|NCT00783653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24565977|NCT00783653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24565978|NCT00783653|Growth Substances|growth substances|mesh-ancestor
24566013|NCT00783900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24566014|NCT00783900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24566015|NCT00783900|Sympatholytics|sympatholytics|mesh-ancestor
24566016|NCT00783900|Autonomic Agents|autonomic agents|mesh-ancestor
24566017|NCT00783900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24566018|NCT00783900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566019|NCT00783900|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24566020|NCT00783900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24566021|NCT00783900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24566022|NCT00783900|Adrenergic Agents|adrenergic agents|mesh-ancestor
24566023|NCT00783900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24566024|NCT00783900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566037|NCT00784082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24566039|NCT00784186|Mifepristone|mifepristone|mesh-list
24566040|NCT00784186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24566041|NCT00784186|Abortifacient Agents|abortifacient agents|mesh-ancestor
24450008|NCT00317577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24572949|NCT00817284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25008812|NCT04365985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008813|NCT04365985|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25008814|NCT04365985|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25109910|NCT03121261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25109911|NCT03121261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25109912|NCT03121261|Adrenergic Agents|adrenergic agents|mesh-ancestor
25109913|NCT03121261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25109914|NCT03121261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109915|NCT03121261|Anesthetics, Local|anesthetics, local|mesh-ancestor
25109917|NCT03121261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25109919|NCT03121222|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25109920|NCT03121222|Antiviral Agents|antiviral agents|mesh-ancestor
25109921|NCT03121222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24566184|NCT00784680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24566185|NCT00784680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24566186|NCT00784680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24566187|NCT00784680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566188|NCT00784680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566189|NCT00784732|Mometasone Furoate|mometasone furoate|mesh-list
24566190|NCT00784732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24566191|NCT00784732|Dermatologic Agents|dermatologic agents|mesh-ancestor
24566192|NCT00784732|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24566194|NCT00784745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24566272|NCT00784940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566279|NCT00784940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566281|NCT00784966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24566282|NCT00784966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24566283|NCT00784966|Analgesics|analgesics|mesh-ancestor
24837395|NCT02191189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24837396|NCT02191189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24837397|NCT02191189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24837398|NCT02191189|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24837406|NCT02191215|Nevirapine|nevirapine|mesh-list
24566284|NCT00784966|Sensory System Agents|sensory system agents|mesh-ancestor
24566285|NCT00784966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24566286|NCT00784966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566287|NCT00784966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24566288|NCT00784966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24566289|NCT00784966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24566290|NCT00784966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24566291|NCT00784966|Immunologic Factors|immunologic factors|mesh-ancestor
24566292|NCT00785018|Complement C1s|complement c1s|mesh-list
24566293|NCT00785018|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
24566294|NCT00785018|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
24566295|NCT00785018|Immunologic Factors|immunologic factors|mesh-ancestor
24566384|NCT00785434|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24566385|NCT00785434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24566386|NCT00785434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24566387|NCT00785434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566388|NCT00785434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24566389|NCT00785434|Serotonin Agents|serotonin agents|mesh-ancestor
24566390|NCT00785434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566391|NCT00785434|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25008852|NCT04146324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008854|NCT04141579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25008855|NCT04141579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25008856|NCT04141579|Antimetabolites|antimetabolites|mesh-ancestor
24566592|NCT00786552|Tubulin Modulators|tubulin modulators|mesh-ancestor
24566624|NCT00786669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24566626|NCT00786695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24566627|NCT00786695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24566628|NCT00786695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24566629|NCT00786695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566630|NCT00786695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566687|NCT00787436|Nadolol|nadolol|mesh-list
24566688|NCT00787436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24566689|NCT00787436|Immunologic Factors|immunologic factors|mesh-ancestor
24566690|NCT00787436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566691|NCT00787436|Leprostatic Agents|leprostatic agents|mesh-ancestor
24893632|NCT04447443|Loperamide|loperamide|mesh-list
24566951|NCT00788749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566952|NCT00788749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24566953|NCT00788749|Respiratory System Agents|respiratory system agents|mesh-ancestor
24566954|NCT00788749|Dermatologic Agents|dermatologic agents|mesh-ancestor
24566955|NCT00788749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24567030|NCT00789308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24567031|NCT00789308|Dermatologic Agents|dermatologic agents|mesh-ancestor
24567032|NCT00789308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24567033|NCT00789308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24567034|NCT00789308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24567035|NCT00789308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24567036|NCT00789308|Antitubercular Agents|antitubercular agents|mesh-ancestor
24567037|NCT00789308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24567038|NCT00789308|Anticoagulants|anticoagulants|mesh-ancestor
24567039|NCT00789308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24567040|NCT00789308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24567041|NCT00789308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24567042|NCT00789308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24567464|NCT00791271|Immunologic Factors|immunologic factors|mesh-ancestor
24567465|NCT00791271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567466|NCT00791271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24567467|NCT00791271|Antimetabolites|antimetabolites|mesh-ancestor
24567468|NCT00791271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567469|NCT00791271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567470|NCT00791284|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24567471|NCT00791284|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25703579|NCT02169115|Immunologic Factors|immunologic factors|mesh-ancestor
25703580|NCT02169115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703581|NCT02169219|Prednisone|prednisone|mesh-list
25703582|NCT02169219|Rituximab|rituximab|mesh-list
25703583|NCT02169219|Glucocorticoids|glucocorticoids|mesh-list
24837834|NCT02193893|Keratolytic Agents|keratolytic agents|mesh-ancestor
24567472|NCT00791284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24567473|NCT00791284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24567474|NCT00791284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567475|NCT00791284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24567476|NCT00791284|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24567477|NCT00791284|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25008888|NCT03917381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24567692|NCT00792181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24557573|NCT00753038|Antimitotic Agents|antimitotic agents|mesh-ancestor
24567844|NCT00793052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24567845|NCT00793052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24567846|NCT00793052|Analgesics|analgesics|mesh-ancestor
24567847|NCT00793052|Sensory System Agents|sensory system agents|mesh-ancestor
24567848|NCT00793052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24567849|NCT00793052|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24567850|NCT00793052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24567851|NCT00793052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567852|NCT00793052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567853|NCT00793091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24567854|NCT00793091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24557689|NCT00753402|Mydriatics|mydriatics|mesh-ancestor
24567981|NCT00793754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567982|NCT00793754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24568052|NCT00794209|Analgesics|analgesics|mesh-ancestor
24568101|NCT00794638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24568103|NCT00794638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568105|NCT00794638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24568106|NCT00794638|Alkylating Agents|alkylating agents|mesh-ancestor
24568107|NCT00794638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568108|NCT00794703|Itraconazole|itraconazole|mesh-list
24568109|NCT00794703|Micafungin|micafungin|mesh-list
24568110|NCT00794703|Antifungal Agents|antifungal agents|mesh-ancestor
24568111|NCT00794703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24568112|NCT00794703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24568113|NCT00794703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24568114|NCT00794703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25008891|NCT03917381|Mitosis Modulators|mitosis modulators|mesh-ancestor
25008892|NCT03917381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008893|NCT03917381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25008894|NCT03837873|Cytarabine|cytarabine|mesh-list
24568115|NCT00794703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568116|NCT00794703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24568117|NCT00794703|Hormone Antagonists|hormone antagonists|mesh-ancestor
24568139|NCT00794859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568141|NCT00794885|Vitamin B Complex|vitamin b complex|mesh-list
24568142|NCT00794885|Enalapril|enalapril|mesh-list
24568143|NCT00794885|Enalaprilat|enalaprilat|mesh-list
24568144|NCT00794885|Maleic acid|maleic acid|mesh-list
24568145|NCT00794885|Hematinics|hematinics|mesh-ancestor
24568170|NCT00794976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24568171|NCT00794976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24568172|NCT00794976|Protease Inhibitors|protease inhibitors|mesh-ancestor
24568173|NCT00794976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24568232|NCT00795314|Butorphanol|butorphanol|mesh-list
24568233|NCT00795314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24568234|NCT00795314|Narcotics|narcotics|mesh-ancestor
24568235|NCT00795314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24568236|NCT00795314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568237|NCT00795314|Analgesics|analgesics|mesh-ancestor
24568238|NCT00795314|Sensory System Agents|sensory system agents|mesh-ancestor
24568239|NCT00795314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24568240|NCT00795314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24568241|NCT00795314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24568242|NCT00795314|Anesthetics, General|anesthetics, general|mesh-ancestor
24568243|NCT00795314|Anesthetics|anesthetics|mesh-ancestor
24568244|NCT00795314|Antitussive Agents|antitussive agents|mesh-ancestor
24568245|NCT00795314|Respiratory System Agents|respiratory system agents|mesh-ancestor
24568246|NCT00795314|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24568247|NCT00795353|Alefacept|alefacept|mesh-list
24568248|NCT00795353|Dermatologic Agents|dermatologic agents|mesh-ancestor
24568249|NCT00795353|Immunologic Factors|immunologic factors|mesh-ancestor
24568250|NCT00795353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568251|NCT00795444|Maraviroc|maraviroc|mesh-list
24568252|NCT00795444|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24568253|NCT00795444|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24568254|NCT00795444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568256|NCT00795444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24568257|NCT00795444|Antiviral Agents|antiviral agents|mesh-ancestor
24568260|NCT00795457|Poly I-C|poly i-c|mesh-list
24568298|NCT00795613|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24568299|NCT00795613|Vincristine|vincristine|mesh-list
24568300|NCT00795613|Procarbazine|procarbazine|mesh-list
24568301|NCT00795613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24568302|NCT00795613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24568303|NCT00795613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24568304|NCT00795613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24568306|NCT00795613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568307|NCT00795613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24568308|NCT00795613|Tubulin Modulators|tubulin modulators|mesh-ancestor
24568309|NCT00795613|Antimitotic Agents|antimitotic agents|mesh-ancestor
24568310|NCT00795613|Mitosis Modulators|mitosis modulators|mesh-ancestor
24568311|NCT00795678|Gemcitabine|gemcitabine|mesh-list
24568312|NCT00795678|Paclitaxel|paclitaxel|mesh-list
24568313|NCT00795678|Vinorelbine|vinorelbine|mesh-list
24568314|NCT00795678|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24568315|NCT00795678|Cyclophosphamide|cyclophosphamide|mesh-list
24568537|NCT00796263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24568538|NCT00796263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24568589|NCT00796471|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24568658|NCT00796887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568660|NCT00796887|Vasodilator Agents|vasodilator agents|mesh-ancestor
24568661|NCT00796887|Vitamin B Complex|vitamin b complex|mesh-ancestor
24568662|NCT00796887|Vitamins|vitamins|mesh-ancestor
24568663|NCT00796887|Micronutrients|micronutrients|mesh-ancestor
24568664|NCT00796887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568665|NCT00796900|Dantrolene|dantrolene|mesh-list
24568666|NCT00796900|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24568667|NCT00796900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568726|NCT00797264|Sensory System Agents|sensory system agents|mesh-ancestor
24568804|NCT00797693|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24568805|NCT00797693|Abortifacient Agents|abortifacient agents|mesh-ancestor
24568806|NCT00797693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24568807|NCT00797693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629173|NCT01103518|Estradiol|estradiol|mesh-list
24568809|NCT00797693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24568810|NCT00797693|Oxytocics|oxytocics|mesh-ancestor
24568887|NCT00798070|Cyclophosphamide|cyclophosphamide|mesh-list
24568888|NCT00798070|Fluorouracil|fluorouracil|mesh-list
24568890|NCT00798070|Epirubicin|epirubicin|mesh-list
24568932|NCT00798083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24568933|NCT00798083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24568934|NCT00798083|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24558457|NCT00757380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24568969|NCT00798252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24568973|NCT00798343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568974|NCT00798395|Zopiclone|zopiclone|mesh-list
24568975|NCT00798395|Mirtazapine|mirtazapine|mesh-list
24568976|NCT00798395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24568977|NCT00798395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24568978|NCT00798395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568979|NCT00798395|Antidepressive Agents|antidepressive agents|mesh-ancestor
24568980|NCT00798395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24568981|NCT00798395|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24568982|NCT00798395|Histamine Antagonists|histamine antagonists|mesh-ancestor
24568983|NCT00798395|Histamine Agents|histamine agents|mesh-ancestor
24568984|NCT00798395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24568985|NCT00798395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568986|NCT00798395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24569065|NCT00798915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008959|NCT03753555|Calcium, Dietary|calcium, dietary|mesh-list
25008960|NCT03753555|Atorvastatin|atorvastatin|mesh-list
25008961|NCT03753555|Probucol|probucol|mesh-list
25008962|NCT03753555|Calcium|calcium|mesh-list
25008963|NCT03753555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24569214|NCT00799266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569216|NCT00799448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24569217|NCT00799448|Repaglinide|repaglinide|mesh-list
24569236|NCT00799539|Hormones|hormones|mesh-ancestor
24569237|NCT00799539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24569238|NCT00799539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569239|NCT00799539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24569240|NCT00799539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24569241|NCT00799539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24569242|NCT00799539|Alkylating Agents|alkylating agents|mesh-ancestor
24569243|NCT00799539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569244|NCT00799539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25008987|NCT03734029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533324|NCT00643136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24573561|NCT00820690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24573582|NCT00820911|Everolimus|everolimus|mesh-list
25008988|NCT03734029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25008989|NCT03734029|Antimetabolites|antimetabolites|mesh-ancestor
25008990|NCT03734029|Antiviral Agents|antiviral agents|mesh-ancestor
25008991|NCT03734029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25008992|NCT03734029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25008993|NCT03734029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25008994|NCT03734029|Immunologic Factors|immunologic factors|mesh-ancestor
25008995|NCT03734029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008996|NCT03734029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25008997|NCT03734029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25008998|NCT03734029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25009000|NCT03716609|Citric Acid|citric acid|mesh-list
25009001|NCT03716609|Sodium Citrate|sodium citrate|mesh-list
25009002|NCT03716609|Anticoagulants|anticoagulants|mesh-ancestor
25009003|NCT03716609|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25009004|NCT03716609|Chelating Agents|chelating agents|mesh-ancestor
25009005|NCT03716609|Sequestering Agents|sequestering agents|mesh-ancestor
25009006|NCT03716609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791913|NCT02553460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24791914|NCT02553460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24791915|NCT02553460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24791916|NCT02553460|Antiviral Agents|antiviral agents|mesh-ancestor
24791918|NCT02553460|Antidotes|antidotes|mesh-ancestor
24569424|NCT00800527|Sensory System Agents|sensory system agents|mesh-ancestor
24569425|NCT00800527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24569426|NCT00800527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569427|NCT00800527|Anticonvulsants|anticonvulsants|mesh-ancestor
24569484|NCT00800748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569486|NCT00800748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24569487|NCT00800761|Deferiprone|deferiprone|mesh-list
24569524|NCT00800917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24569525|NCT00800917|Growth Substances|growth substances|mesh-ancestor
24569526|NCT00800917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569527|NCT00800917|Growth Inhibitors|growth inhibitors|mesh-ancestor
24569528|NCT00800917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24569529|NCT00800917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24569530|NCT00800917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24569531|NCT00800917|Antifungal Agents|antifungal agents|mesh-ancestor
24569532|NCT00800917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24569533|NCT00800917|Immunologic Factors|immunologic factors|mesh-ancestor
24569535|NCT00800930|Histamine Antagonists|histamine antagonists|mesh-ancestor
24569536|NCT00800930|Histamine Agents|histamine agents|mesh-ancestor
24569537|NCT00800930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24569538|NCT00800930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569540|NCT00800943|Alemtuzumab|alemtuzumab|mesh-list
24569604|NCT00801281|Immunologic Factors|immunologic factors|mesh-ancestor
24569605|NCT00801281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968331|NCT03751761|Paclitaxel|paclitaxel|mesh-list
24569606|NCT00801281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24569607|NCT00801281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24569608|NCT00801281|Alkylating Agents|alkylating agents|mesh-ancestor
24569609|NCT00801281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791961|NCT02138617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24791962|NCT02138617|Immunologic Factors|immunologic factors|mesh-ancestor
24791963|NCT02138617|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25009039|NCT03709355|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25009040|NCT03709355|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25009041|NCT03709355|Antitubercular Agents|antitubercular agents|mesh-ancestor
25009042|NCT03709355|Leprostatic Agents|leprostatic agents|mesh-ancestor
25009043|NCT03709355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25009044|NCT03709355|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25009045|NCT03709355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25009046|NCT03709355|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25009047|NCT03709355|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25009048|NCT03709355|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25009049|NCT03709355|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24569614|NCT00801281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24569615|NCT00801281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24569616|NCT00801281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24569630|NCT00801294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24569631|NCT00801294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569632|NCT00801359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24569633|NCT00801385|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24569634|NCT00801385|Sorafenib|sorafenib|mesh-list
24569635|NCT00801385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24569636|NCT00801385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24559162|NCT05230901|Spironolactone|spironolactone|mesh-list
24569671|NCT00801450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569726|NCT00801580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24569727|NCT00801580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569729|NCT00801606|Trace Elements|trace elements|mesh-list
24569752|NCT00801853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24569794|NCT00801918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569795|NCT00801918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24569796|NCT00801918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24569797|NCT00801918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24569798|NCT00801918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24569799|NCT00801918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24569800|NCT00801918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24569801|NCT00801918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24569802|NCT00801918|Analgesics|analgesics|mesh-ancestor
24569803|NCT00801918|Sensory System Agents|sensory system agents|mesh-ancestor
24569804|NCT00801918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24569805|NCT00801944|Solifenacin Succinate|solifenacin succinate|mesh-list
24569806|NCT00801944|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24569807|NCT00801944|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24569809|NCT00801944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24569810|NCT00801944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569811|NCT00801944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569812|NCT00801944|Urological Agents|urological agents|mesh-ancestor
24569813|NCT00801957|Hydrocortisone|hydrocortisone|mesh-list
24569821|NCT00801957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569916|NCT00802308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569918|NCT00802308|Sensory System Agents|sensory system agents|mesh-ancestor
24569919|NCT00802308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24792016|NCT00504712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792017|NCT05413200|Isotretinoin|isotretinoin|mesh-list
24792018|NCT05413200|Dermatologic Agents|dermatologic agents|mesh-ancestor
25009095|NCT03498391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25009096|NCT03498391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25009097|NCT03498391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009098|NCT03498391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25009099|NCT03498391|Anesthetics, General|anesthetics, general|mesh-ancestor
25009100|NCT03498391|Anesthetics|anesthetics|mesh-ancestor
25009101|NCT03498391|Analgesics|analgesics|mesh-ancestor
25009102|NCT03498391|Sensory System Agents|sensory system agents|mesh-ancestor
24792042|NCT05413096|Sensory System Agents|sensory system agents|mesh-ancestor
24792043|NCT05413096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25009103|NCT03498391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25009104|NCT03498391|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25009105|NCT03498391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25009106|NCT03498391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25009107|NCT03498391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24569949|NCT00802373|Urological Agents|urological agents|mesh-ancestor
24569951|NCT00802451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24569952|NCT00802451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24569954|NCT00802451|Sensory System Agents|sensory system agents|mesh-ancestor
24569955|NCT00802451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25407488|NCT03499249|Antioxidants|antioxidants|mesh-ancestor
24569956|NCT00802451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569990|NCT00802646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569991|NCT00802646|Sensory System Agents|sensory system agents|mesh-ancestor
24569992|NCT00802646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24569993|NCT00802646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24569994|NCT00802646|Narcotics|narcotics|mesh-ancestor
24569995|NCT00802646|Analgesics|analgesics|mesh-ancestor
24569996|NCT00802646|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24569997|NCT00802646|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24570042|NCT00802815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24570043|NCT00802815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24696127|NCT01427400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696128|NCT01427400|Cholinergic Agents|cholinergic agents|mesh-ancestor
24696129|NCT01427400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24570044|NCT00802815|Immunologic Factors|immunologic factors|mesh-ancestor
24570045|NCT00802828|Famotidine|famotidine|mesh-list
24570046|NCT00802828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24570047|NCT00802828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24570048|NCT00802828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24570049|NCT00802828|Histamine Antagonists|histamine antagonists|mesh-ancestor
24570068|NCT00802958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24570069|NCT00802958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570071|NCT00803166|Halobetasol|halobetasol|mesh-list
24570072|NCT00803166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24570073|NCT00803166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24570074|NCT00803166|Glucocorticoids|glucocorticoids|mesh-ancestor
24570125|NCT00803439|Clobetasol|clobetasol|mesh-list
24447422|NCT00308451|Picolinic acid|picolinic acid|mesh-list
24447423|NCT00308451|Trace Elements|trace elements|mesh-ancestor
24447424|NCT00308451|Micronutrients|micronutrients|mesh-ancestor
24447425|NCT00308451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447426|NCT00308451|Vitamin B Complex|vitamin b complex|mesh-ancestor
24447427|NCT00308451|Vitamins|vitamins|mesh-ancestor
24447428|NCT00308451|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24570126|NCT00803439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24570128|NCT00803439|Hormones|hormones|mesh-ancestor
24570129|NCT00803439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24570130|NCT00803439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570131|NCT00803465|Fluticasone|fluticasone|mesh-list
24570133|NCT00803465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24570134|NCT00803465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24570135|NCT00803465|Autonomic Agents|autonomic agents|mesh-ancestor
24570136|NCT00803465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24570137|NCT00803465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570138|NCT00803465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24570139|NCT00803465|Respiratory System Agents|respiratory system agents|mesh-ancestor
24570140|NCT00803465|Dermatologic Agents|dermatologic agents|mesh-ancestor
24570141|NCT00803465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24570187|NCT00803764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24570188|NCT00803764|Gout Suppressants|gout suppressants|mesh-ancestor
24570189|NCT00803764|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24570190|NCT00803764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24570191|NCT00803764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570192|NCT00803803|Pilocarpine|pilocarpine|mesh-list
24570193|NCT00803803|Miotics|miotics|mesh-ancestor
24570194|NCT00803803|Autonomic Agents|autonomic agents|mesh-ancestor
24570195|NCT00803803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24570196|NCT00803803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570197|NCT00803803|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24570198|NCT00803803|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24570199|NCT00803803|Cholinergic Agents|cholinergic agents|mesh-ancestor
24570200|NCT00803803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24570950|NCT00807443|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24570255|NCT00803972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24570256|NCT00803972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570257|NCT00804050|Vitamins|vitamins|mesh-list
24570310|NCT00804310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24570311|NCT00804310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24570312|NCT00804310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570313|NCT00804336|Everolimus|everolimus|mesh-list
24570314|NCT00804336|Pasireotide|pasireotide|mesh-list
24570342|NCT00804440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24840042|NCT02207335|Capecitabine|capecitabine|mesh-list
24570343|NCT00804440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24570344|NCT00804440|Analgesics|analgesics|mesh-ancestor
24570345|NCT00804440|Sensory System Agents|sensory system agents|mesh-ancestor
24570346|NCT00804440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24570347|NCT00804440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570348|NCT00804440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24570349|NCT00804440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24574336|NCT00825045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24570350|NCT00804440|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24570351|NCT00804440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24629358|NCT01104844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24570352|NCT00804440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009141|NCT03340727|Caffeine|caffeine|mesh-list
24570357|NCT00804531|Prednisolone acetate|prednisolone acetate|mesh-list
24570424|NCT00804856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570425|NCT00804895|Cortivazol|cortivazol|mesh-list
24570426|NCT00804895|Verapamil|verapamil|mesh-list
24570427|NCT00804895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24570428|NCT00804895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24570429|NCT00804895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24570430|NCT00804895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570431|NCT00804895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24570432|NCT00804895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570433|NCT00804895|Vasodilator Agents|vasodilator agents|mesh-ancestor
24570434|NCT00804895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24570435|NCT00804921|Bevacizumab|bevacizumab|mesh-list
24570436|NCT00804921|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24570437|NCT00804921|Acetazolamide|acetazolamide|mesh-list
24570438|NCT00804921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24570439|NCT00804921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570442|NCT00804921|Growth Substances|growth substances|mesh-ancestor
24570443|NCT00804921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570444|NCT00804921|Growth Inhibitors|growth inhibitors|mesh-ancestor
24559796|NCT04387136|Analgesics|analgesics|mesh-ancestor
24570473|NCT00804947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570475|NCT00804960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570476|NCT00804960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24570951|NCT00807443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24570503|NCT00805090|Itraconazole|itraconazole|mesh-list
24570505|NCT00805090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24570506|NCT00805090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24570507|NCT00805090|Analgesics|analgesics|mesh-ancestor
24570508|NCT00805090|Sensory System Agents|sensory system agents|mesh-ancestor
24570509|NCT00805090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24570510|NCT00805090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570511|NCT00805090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24570512|NCT00805090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24570513|NCT00805090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24570514|NCT00805090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24570515|NCT00805090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570557|NCT00805298|Glucocorticoids|glucocorticoids|mesh-ancestor
24570558|NCT00805298|Hormones|hormones|mesh-ancestor
24570559|NCT00805298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24570560|NCT00805298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24570561|NCT00805298|Protective Agents|protective agents|mesh-ancestor
24570562|NCT00805298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24570563|NCT00805298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24570564|NCT00805298|Adrenergic Agents|adrenergic agents|mesh-ancestor
24570565|NCT00805298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24570566|NCT00805298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570567|NCT00805298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24570568|NCT00805298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24570569|NCT00805298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24570570|NCT00805298|Respiratory System Agents|respiratory system agents|mesh-ancestor
24570571|NCT00805298|Mydriatics|mydriatics|mesh-ancestor
24570572|NCT00805298|Sympathomimetics|sympathomimetics|mesh-ancestor
25703584|NCT02169219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24570757|NCT00806663|Growth Substances|growth substances|mesh-ancestor
24570758|NCT00806663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570759|NCT00806663|Growth Inhibitors|growth inhibitors|mesh-ancestor
24570760|NCT00806663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24570761|NCT00806663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24570762|NCT00806663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570763|NCT00806741|Phenylephrine|phenylephrine|mesh-list
24570764|NCT00806741|Oxymetazoline|oxymetazoline|mesh-list
24570765|NCT00806741|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
24570766|NCT00806741|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24570788|NCT00806754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570789|NCT00806754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24570790|NCT00806754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24570791|NCT00806754|Autonomic Agents|autonomic agents|mesh-ancestor
24570792|NCT00806754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24570793|NCT00806754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24570794|NCT00806754|Respiratory System Agents|respiratory system agents|mesh-ancestor
24570795|NCT00806754|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24570796|NCT00806754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24570797|NCT00806754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570798|NCT00806754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24570799|NCT00806754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24570851|NCT00806923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24570852|NCT00806923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570911|NCT00807196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24570912|NCT00807222|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
24570913|NCT00807222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24570914|NCT00807222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570915|NCT00807222|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24571600|NCT00811005|5-Methoxypsoralen|5-methoxypsoralen|mesh-list
24570916|NCT00807222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24570917|NCT00807222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24570946|NCT00807443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24570947|NCT00807443|Antiviral Agents|antiviral agents|mesh-ancestor
24570948|NCT00807443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24570949|NCT00807443|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24571082|NCT00808054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24571086|NCT00808145|Gemcitabine|gemcitabine|mesh-list
24571283|NCT00809016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571284|NCT00809029|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
24571286|NCT00809029|Incretins|incretins|mesh-ancestor
24571288|NCT00809029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24571321|NCT00809172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571322|NCT00809172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24571324|NCT00809172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571354|NCT00809237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24571365|NCT00809393|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24571366|NCT00809393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24571367|NCT00809393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571368|NCT00809393|Hemostatics|hemostatics|mesh-ancestor
24571369|NCT00809393|Coagulants|coagulants|mesh-ancestor
24571370|NCT00809536|Metformin|metformin|mesh-list
24571371|NCT00809536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24571372|NCT00809536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571373|NCT00809549|Lenograstim|lenograstim|mesh-list
24571374|NCT00809549|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24571375|NCT00809549|Immunologic Factors|immunologic factors|mesh-ancestor
24571376|NCT00809549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571377|NCT00809627|Caffeine|caffeine|mesh-list
24571378|NCT00809627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24571379|NCT00809627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571380|NCT00809627|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24571381|NCT00809627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25009167|NCT03269344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009168|NCT03269344|Antimanic Agents|antimanic agents|mesh-ancestor
25009169|NCT03215095|Durvalumab|durvalumab|mesh-list
25009170|NCT03215095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25009171|NCT03215095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009200|NCT02966093|Lenvatinib|lenvatinib|mesh-list
24571462|NCT00810121|Ketoprofen|ketoprofen|mesh-list
24571463|NCT00810121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24840883|NCT02213029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24840884|NCT02213029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840886|NCT02213081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24840887|NCT02213081|Contraceptive Agents|contraceptive agents|mesh-ancestor
24571464|NCT00810121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24571465|NCT00810121|Analgesics|analgesics|mesh-ancestor
24571466|NCT00810121|Sensory System Agents|sensory system agents|mesh-ancestor
24571467|NCT00810121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24571468|NCT00810121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571469|NCT00810121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24571470|NCT00810121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24571471|NCT00810121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24571472|NCT00810121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571473|NCT00810121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571475|NCT00810316|Alprazolam|alprazolam|mesh-list
24571476|NCT00810316|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24759018|NCT01749072|Alkylating Agents|alkylating agents|mesh-ancestor
24571502|NCT00810446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571503|NCT00810446|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24571504|NCT00810446|Antitubercular Agents|antitubercular agents|mesh-ancestor
24571505|NCT00810524|Lamivudine|lamivudine|mesh-list
24571506|NCT00810524|Adefovir|adefovir|mesh-list
24571559|NCT00810849|Hormones|hormones|mesh-ancestor
24571563|NCT00810849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24571566|NCT00810862|Cathartics|cathartics|mesh-ancestor
24571567|NCT00810862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24571568|NCT00810862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24571569|NCT00810862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24571570|NCT00810862|Analgesics|analgesics|mesh-ancestor
24571571|NCT00810862|Sensory System Agents|sensory system agents|mesh-ancestor
24571572|NCT00810862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24571573|NCT00810862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571574|NCT00810862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24571575|NCT00810862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24571576|NCT00810862|Dermatologic Agents|dermatologic agents|mesh-ancestor
24571577|NCT00810862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24571599|NCT00810953|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24571602|NCT00811005|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24571603|NCT00811005|Dermatologic Agents|dermatologic agents|mesh-ancestor
24571604|NCT00811005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25009263|NCT02520063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25009264|NCT02520063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009265|NCT02520063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24896481|NCT04435743|Lenalidomide|lenalidomide|mesh-list
24571704|NCT00811369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24571705|NCT00811369|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24571706|NCT00811369|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24571707|NCT00811369|Hormone Antagonists|hormone antagonists|mesh-ancestor
24571708|NCT00811369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24571709|NCT00811369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571711|NCT00811408|Carboplatin|carboplatin|mesh-list
24571712|NCT00811408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24571744|NCT00811460|Hormones|hormones|mesh-ancestor
24969432|NCT03742713|Docetaxel|docetaxel|mesh-list
24571745|NCT00811460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24571746|NCT00811460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571784|NCT00811837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24571785|NCT00811837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571787|NCT00811837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24571788|NCT00811837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24571789|NCT00811837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24571790|NCT00811837|Anesthetics, General|anesthetics, general|mesh-ancestor
24571791|NCT00811837|Anesthetics|anesthetics|mesh-ancestor
24571792|NCT00811837|GABA Modulators|gaba modulators|mesh-ancestor
24571793|NCT00811837|GABA Agents|gaba agents|mesh-ancestor
24571794|NCT00811837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24571850|NCT00811993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571852|NCT00811993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24571853|NCT00811993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25703585|NCT02169219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25703586|NCT02169219|Immunologic Factors|immunologic factors|mesh-ancestor
25703587|NCT02169219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703588|NCT02169219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25703589|NCT02169219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24571907|NCT00812214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24571908|NCT00812214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571909|NCT00812266|Carboplatin|carboplatin|mesh-list
24571910|NCT00812266|Etoposide|etoposide|mesh-list
24571911|NCT00812266|Topotecan|topotecan|mesh-list
24571951|NCT00812370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24571953|NCT00812370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571954|NCT00812370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571956|NCT00812396|Methyltestosterone|methyltestosterone|mesh-list
24571957|NCT00812396|Testosterone|testosterone|mesh-list
24571958|NCT00812396|Testosterone undecanoate|testosterone undecanoate|mesh-list
24571959|NCT00812396|Testosterone enanthate|testosterone enanthate|mesh-list
24571960|NCT00812396|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24571961|NCT00812396|Androgens|androgens|mesh-ancestor
24571962|NCT00812396|Hormones|hormones|mesh-ancestor
24572010|NCT00812669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572011|NCT00812669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25009285|NCT02425644|Teriflunomide|teriflunomide|mesh-list
25009315|NCT02270957|Immunologic Factors|immunologic factors|mesh-ancestor
25009316|NCT02270957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009317|NCT02270957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25009318|NCT02204085|Decitabine|decitabine|mesh-list
25009319|NCT02204085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25009320|NCT02204085|Antimetabolites|antimetabolites|mesh-ancestor
25009321|NCT02204085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009322|NCT02204085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009323|NCT02204085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25009324|NCT02133573|Progesterone|progesterone|mesh-list
25009325|NCT02133573|Progestins|progestins|mesh-ancestor
25009326|NCT02133573|Hormones|hormones|mesh-ancestor
25109945|NCT03120962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24572024|NCT00812760|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24572064|NCT00812851|Sensory System Agents|sensory system agents|mesh-ancestor
24572065|NCT00812851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24572066|NCT00812851|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24572074|NCT00812864|Antimetabolites|antimetabolites|mesh-ancestor
24572075|NCT00812864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572076|NCT00812864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25703590|NCT02169219|Hormones|hormones|mesh-ancestor
25703591|NCT02169219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25703592|NCT02169219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25703593|NCT02169271|Aspirin|aspirin|mesh-list
24572077|NCT00812994|Citalopram|citalopram|mesh-list
24572080|NCT00812994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24572081|NCT00812994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572082|NCT00812994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24572083|NCT00812994|Serotonin Agents|serotonin agents|mesh-ancestor
24572084|NCT00812994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572085|NCT00812994|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24572086|NCT00812994|Antidepressive Agents|antidepressive agents|mesh-ancestor
24572087|NCT00812994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24572088|NCT00813059|Bevacizumab|bevacizumab|mesh-list
24572089|NCT00813059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24572091|NCT00813059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24572092|NCT00813059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24572093|NCT00813059|Growth Substances|growth substances|mesh-ancestor
24572094|NCT00813059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572095|NCT00813059|Growth Inhibitors|growth inhibitors|mesh-ancestor
24572097|NCT00813072|Irinotecan|irinotecan|mesh-list
24572098|NCT00813072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572118|NCT00813228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24572119|NCT00813228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572121|NCT00813228|Hormones|hormones|mesh-ancestor
24572205|NCT00813722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572207|NCT00813722|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24572208|NCT00813722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24572209|NCT00813722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572210|NCT00813722|Vasodilator Agents|vasodilator agents|mesh-ancestor
24572211|NCT00813722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24572212|NCT00813722|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24572213|NCT00813722|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24572227|NCT00813735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24572228|NCT00813735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24572229|NCT00813735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572230|NCT00813735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24572231|NCT00813735|Serotonin Agents|serotonin agents|mesh-ancestor
24572232|NCT00813735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572236|NCT00813735|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24572237|NCT00813735|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24572238|NCT00813735|Parasympatholytics|parasympatholytics|mesh-ancestor
24572239|NCT00813735|Autonomic Agents|autonomic agents|mesh-ancestor
24572261|NCT00814021|Sunitinib|sunitinib|mesh-list
24572262|NCT00814021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572287|NCT00814086|Tubulin Modulators|tubulin modulators|mesh-ancestor
24572335|NCT00814268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24572336|NCT00814268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24572338|NCT00814268|Antipyretics|antipyretics|mesh-ancestor
24572339|NCT00814268|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24572342|NCT00814268|Purinergic Agents|purinergic agents|mesh-ancestor
24671067|NCT01323465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24572395|NCT00814541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572397|NCT00814593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24572398|NCT00814593|Alkylating Agents|alkylating agents|mesh-ancestor
24572422|NCT00814736|Vasodilator Agents|vasodilator agents|mesh-ancestor
24792269|NCT05387525|Analgesics|analgesics|mesh-ancestor
25009333|NCT02054104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009335|NCT02054104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25009336|NCT02054104|Alkylating Agents|alkylating agents|mesh-ancestor
25009337|NCT02054104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009338|NCT02054104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009339|NCT02054104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25009340|NCT02054104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24572607|NCT00815854|Folic Acid|folic acid|mesh-list
24572608|NCT00815854|Hematinics|hematinics|mesh-ancestor
24572609|NCT00815854|Vitamin B Complex|vitamin b complex|mesh-ancestor
24572610|NCT00815854|Vitamins|vitamins|mesh-ancestor
24572611|NCT00815854|Micronutrients|micronutrients|mesh-ancestor
24572612|NCT00815854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572613|NCT00815867|Epoetin Alfa|epoetin alfa|mesh-list
24572614|NCT00815867|Hematinics|hematinics|mesh-ancestor
24572615|NCT00815893|Dexmedetomidine|dexmedetomidine|mesh-list
24572616|NCT00815893|Propofol|propofol|mesh-list
24572772|NCT00816673|Melatonin|melatonin|mesh-list
25009396|NCT01468831|Growth Substances|growth substances|mesh-ancestor
24842014|NCT02219412|Sensory System Agents|sensory system agents|mesh-ancestor
24842015|NCT02219412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24842016|NCT02219412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009397|NCT01468831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009398|NCT01468831|Growth Inhibitors|growth inhibitors|mesh-ancestor
25009399|NCT01468831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25009400|NCT01468831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25009402|NCT01383109|Antimalarials|antimalarials|mesh-ancestor
25009403|NCT01383109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25009404|NCT01383109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25009405|NCT01383109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24572822|NCT00816855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24572823|NCT00816855|Immunologic Factors|immunologic factors|mesh-ancestor
24572824|NCT00816855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572871|NCT00817011|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24572873|NCT00817011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24572874|NCT00817011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24561538|NCT00761254|Domperidone|domperidone|mesh-list
24572948|NCT00817284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572981|NCT00817375|Adrenergic Agents|adrenergic agents|mesh-ancestor
24572982|NCT00817375|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24572983|NCT00817375|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24572984|NCT00817375|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24574242|NCT00824239|GABA Agents|gaba agents|mesh-ancestor
24573022|NCT00817583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573025|NCT00817622|Micronutrients|micronutrients|mesh-ancestor
24573026|NCT00817622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573027|NCT00817622|Antioxidants|antioxidants|mesh-ancestor
24573028|NCT00817622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573029|NCT00817622|Protective Agents|protective agents|mesh-ancestor
24573030|NCT00817648|Risperidone|risperidone|mesh-list
24573031|NCT00817648|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24573032|NCT00817648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24573033|NCT00817648|Serotonin Agents|serotonin agents|mesh-ancestor
24573034|NCT00817648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24573035|NCT00817648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573036|NCT00817648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573037|NCT00817648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24573038|NCT00817648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24573039|NCT00817648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24573040|NCT00817648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24573041|NCT00817648|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24573042|NCT00817648|Dopamine Agents|dopamine agents|mesh-ancestor
24573043|NCT00817648|Antidepressive Agents|antidepressive agents|mesh-ancestor
24573113|NCT00817895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573143|NCT00818103|Atorvastatin|atorvastatin|mesh-list
24573144|NCT00818103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24573145|NCT00818103|Antiviral Agents|antiviral agents|mesh-ancestor
24573171|NCT00818194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573265|NCT00819000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573266|NCT00819000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24573267|NCT00819000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24573496|NCT00820404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573497|NCT00820404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24573498|NCT00820404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24573499|NCT00820417|Cetuximab|cetuximab|mesh-list
24573500|NCT00820417|Gefitinib|gefitinib|mesh-list
24573501|NCT00820417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24573502|NCT00820417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24575383|NCT00830895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24575384|NCT00830895|Immunologic Factors|immunologic factors|mesh-ancestor
24573503|NCT00820417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24573504|NCT00820417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573505|NCT00820417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573506|NCT00820469|Rituximab|rituximab|mesh-list
25703594|NCT02169271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25703595|NCT02169271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25703596|NCT02169271|Analgesics|analgesics|mesh-ancestor
24573507|NCT00820469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25703597|NCT02169271|Sensory System Agents|sensory system agents|mesh-ancestor
25703598|NCT02169271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25703599|NCT02169271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703600|NCT02169271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24842402|NCT02220868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24842403|NCT02221024|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24842405|NCT02221063|Vitamin B Complex|vitamin b complex|mesh-ancestor
24842406|NCT02221063|Vitamins|vitamins|mesh-ancestor
24842407|NCT02221063|Micronutrients|micronutrients|mesh-ancestor
24842437|NCT02221180|Metformin|metformin|mesh-list
24573508|NCT00820469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24573509|NCT00820469|Immunologic Factors|immunologic factors|mesh-ancestor
24573510|NCT00820469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561980|NCT00763906|Sympathomimetics|sympathomimetics|mesh-ancestor
24573551|NCT00820690|Antimitotic Agents|antimitotic agents|mesh-ancestor
24573552|NCT00820690|Mitosis Modulators|mitosis modulators|mesh-ancestor
24573553|NCT00820690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573554|NCT00820690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24573555|NCT00820690|Immunologic Factors|immunologic factors|mesh-ancestor
24573805|NCT00822133|Ketamine|ketamine|mesh-list
24573806|NCT00822133|Anesthetics, Local|anesthetics, local|mesh-ancestor
24573807|NCT00822133|Anesthetics|anesthetics|mesh-ancestor
24573808|NCT00822133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24573809|NCT00822133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573810|NCT00822133|Sensory System Agents|sensory system agents|mesh-ancestor
24573811|NCT00822133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24573812|NCT00822133|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24573813|NCT00822133|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24573814|NCT00822133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24562169|NCT00764907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562170|NCT00764907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24562171|NCT00764907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24562172|NCT00764907|Alkylating Agents|alkylating agents|mesh-ancestor
24562173|NCT00764907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562175|NCT00764907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25009523|NCT05213988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24573909|NCT00822536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24573910|NCT00822536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629858|NCT01108198|Mometasone Furoate|mometasone furoate|mesh-list
24573911|NCT00822536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24573912|NCT00822536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24573913|NCT00822536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24573914|NCT00822536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24574158|NCT00823875|Antioxidants|antioxidants|mesh-ancestor
24574191|NCT00824135|Rituximab|rituximab|mesh-list
24574192|NCT00824135|Melphalan|melphalan|mesh-list
24574193|NCT00824135|Thiotepa|thiotepa|mesh-list
24574194|NCT00824135|Clofarabine|clofarabine|mesh-list
24574195|NCT00824135|Muromonab-CD3|muromonab-cd3|mesh-list
24671091|NCT01323465|Analgesics|analgesics|mesh-ancestor
24574196|NCT00824135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24574197|NCT00824135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24792690|NCT04792385|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24574198|NCT00824135|Immunologic Factors|immunologic factors|mesh-ancestor
24574199|NCT00824135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574200|NCT00824135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24574201|NCT00824135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24577899|NCT00846326|Xhance|xhance|mesh-list
24574209|NCT00824135|Alkylating Agents|alkylating agents|mesh-ancestor
24574210|NCT00824135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24574211|NCT00824135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24759020|NCT01749072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574243|NCT00824239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24562347|NCT00766155|Capecitabine|capecitabine|mesh-list
24574334|NCT00825045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574335|NCT00825045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574337|NCT00825045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25103621|NCT03159741|Glucagon|glucagon|mesh-list
25703601|NCT02169271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25703602|NCT02169271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25703603|NCT02169271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25703604|NCT02169271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703605|NCT02169271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24842558|NCT02221765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696160|NCT01427686|Dopamine Agents|dopamine agents|mesh-ancestor
24696161|NCT01427699|Antibodies|antibodies|mesh-list
24696162|NCT01427699|Immunologic Factors|immunologic factors|mesh-ancestor
24696163|NCT01427699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696164|NCT01427842|Vancomycin|vancomycin|mesh-list
24696165|NCT01427842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24574338|NCT00825045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24574339|NCT00825045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24574340|NCT00825045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24574341|NCT00825045|Dopamine Agents|dopamine agents|mesh-ancestor
24574343|NCT00825058|Amibegron|amibegron|mesh-list
24574386|NCT00825097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24562423|NCT00766402|Acetaminophen|acetaminophen|mesh-list
24574399|NCT00825123|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24574400|NCT00825123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24574401|NCT00825123|Adrenergic Agents|adrenergic agents|mesh-ancestor
24574402|NCT00825123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24574403|NCT00825123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574404|NCT00825149|Prednisone|prednisone|mesh-list
24574405|NCT00825149|Cyclophosphamide|cyclophosphamide|mesh-list
24574406|NCT00825149|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24574407|NCT00825149|Doxorubicin|doxorubicin|mesh-list
24574408|NCT00825149|Fludarabine|fludarabine|mesh-list
25009525|NCT05213884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24574443|NCT00825188|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24562576|NCT00767117|Lopinavir|lopinavir|mesh-list
24562577|NCT00767117|Etravirine|etravirine|mesh-list
24562578|NCT00767117|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24562579|NCT00767117|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24562580|NCT00767117|Protease Inhibitors|protease inhibitors|mesh-ancestor
24562581|NCT00767117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562582|NCT00767117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562583|NCT00767117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24574632|NCT00826566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574633|NCT00826566|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24574659|NCT00826826|Amiodarone|amiodarone|mesh-list
24574660|NCT00826826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24574661|NCT00826826|Vasodilator Agents|vasodilator agents|mesh-ancestor
24574662|NCT00826826|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24574663|NCT00826826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24574664|NCT00826826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574665|NCT00826826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24574666|NCT00826826|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24574667|NCT00826826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24574669|NCT00826826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24792523|NCT05085002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24792524|NCT05085002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574727|NCT00827151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574729|NCT00827177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24574730|NCT00827177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24970293|NCT03734614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574773|NCT00827346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574774|NCT00827346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574812|NCT00827554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574814|NCT00827580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574815|NCT00827580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574816|NCT00827671|Cetuximab|cetuximab|mesh-list
24574817|NCT00827671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24575223|NCT00830323|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24575224|NCT00830323|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24575225|NCT00830323|Dopamine Agents|dopamine agents|mesh-ancestor
24630989|NCT01115439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24630990|NCT01115439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25703606|NCT02169271|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24842872|NCT02224131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24842873|NCT02224131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842874|NCT02224131|Antipyretics|antipyretics|mesh-ancestor
24842967|NCT02224534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24630991|NCT01115439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630992|NCT01115439|Antiviral Agents|antiviral agents|mesh-ancestor
24575226|NCT00830323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24631000|NCT01115439|Renal Agents|renal agents|mesh-ancestor
24575227|NCT00830323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575228|NCT00830323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24575523|NCT00832234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24575525|NCT00832234|Autonomic Agents|autonomic agents|mesh-ancestor
24575526|NCT00832234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24575527|NCT00832234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24575528|NCT00832234|Glucocorticoids|glucocorticoids|mesh-ancestor
24575529|NCT00832234|Hormones|hormones|mesh-ancestor
24575530|NCT00832234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24575533|NCT00832286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24563276|NCT00770744|Serotonin Agents|serotonin agents|mesh-ancestor
24575618|NCT00832806|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24575619|NCT00832806|Cholinergic Agents|cholinergic agents|mesh-ancestor
24575620|NCT00832806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24575621|NCT00832806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575622|NCT00832806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575624|NCT00832884|Anticonvulsants|anticonvulsants|mesh-ancestor
24575625|NCT00832884|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24575626|NCT00832884|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24575627|NCT00832884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24575629|NCT00833079|Tacrolimus|tacrolimus|mesh-list
24575636|NCT00833157|Ibuprofen|ibuprofen|mesh-list
25009683|NCT05210192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24575779|NCT00834379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24575780|NCT00834379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24575781|NCT00834379|Antimetabolites|antimetabolites|mesh-ancestor
24575782|NCT00834379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575783|NCT00834379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24575784|NCT00834379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24575785|NCT00834379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575786|NCT00834457|Ritonavir|ritonavir|mesh-list
24575787|NCT00834457|Lopinavir|lopinavir|mesh-list
24575788|NCT00834457|Zidovudine|zidovudine|mesh-list
24575789|NCT00834457|Lamivudine|lamivudine|mesh-list
24575838|NCT00834665|Molgramostim|molgramostim|mesh-list
24575839|NCT00834665|Sargramostim|sargramostim|mesh-list
24575840|NCT00834665|Immunologic Factors|immunologic factors|mesh-ancestor
24575841|NCT00834665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575908|NCT00835393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24575909|NCT00835393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24575910|NCT00835393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575911|NCT00835393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575912|NCT00835471|Docetaxel|docetaxel|mesh-list
24575913|NCT00835471|Pemetrexed|pemetrexed|mesh-list
24575914|NCT00835471|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24575915|NCT00835471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24575916|NCT00835471|Tubulin Modulators|tubulin modulators|mesh-ancestor
24575917|NCT00835471|Antimitotic Agents|antimitotic agents|mesh-ancestor
25009703|NCT05210140|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25009704|NCT05210140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25009705|NCT05210140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25009706|NCT05210140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009707|NCT05210140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25009708|NCT05210140|Serotonin Agents|serotonin agents|mesh-ancestor
24575922|NCT00835471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24575923|NCT00835471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24575927|NCT00835627|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24575928|NCT00835627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24575929|NCT00835627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24575930|NCT00835627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575931|NCT00835627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24575932|NCT00835627|Serotonin Agents|serotonin agents|mesh-ancestor
25703607|NCT02169271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703608|NCT02169271|Antipyretics|antipyretics|mesh-ancestor
25703609|NCT02169284|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25703610|NCT02169284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843321|NCT02226926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24843322|NCT02226926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843323|NCT02226926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24843324|NCT02226926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24843325|NCT02226926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24843326|NCT02226926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24843327|NCT02226926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843328|NCT02226926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24843329|NCT02226926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24843330|NCT02226926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24843331|NCT02226926|Antipyretics|antipyretics|mesh-ancestor
24843332|NCT02226926|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24843333|NCT02226926|Vasodilator Agents|vasodilator agents|mesh-ancestor
24575933|NCT00835627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575934|NCT00835744|Clomiphene|clomiphene|mesh-list
24575935|NCT00835744|Enclomiphene|enclomiphene|mesh-list
24575936|NCT00835744|Zuclomiphene|zuclomiphene|mesh-list
25103980|NCT03156361|Insulin|insulin|mesh-list
24575943|NCT00835744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24563571|NCT00772473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576001|NCT00836212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24576008|NCT00836212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24576009|NCT00836212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24576010|NCT00836212|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24792732|NCT04755244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24576140|NCT00837044|Serotonin Agents|serotonin agents|mesh-ancestor
24576198|NCT00837564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24576199|NCT00837564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24576200|NCT00837564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24576201|NCT00837564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576202|NCT00837564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576203|NCT00837564|Serotonin Agents|serotonin agents|mesh-ancestor
24576204|NCT00837564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576205|NCT00837564|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24576206|NCT00837564|Antidepressive Agents|antidepressive agents|mesh-ancestor
24576207|NCT00837564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24576208|NCT00837655|Calcium Carbonate|calcium carbonate|mesh-list
24576209|NCT00837655|Calcium|calcium|mesh-list
24576210|NCT00837655|Sevelamer|sevelamer|mesh-list
24576211|NCT00837655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24576213|NCT00837655|Antacids|antacids|mesh-ancestor
24576343|NCT00838032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24576344|NCT00838032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24576293|NCT00837928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24576345|NCT00838032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24576346|NCT00838032|Dopamine Agents|dopamine agents|mesh-ancestor
24576347|NCT00838032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576348|NCT00838032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576349|NCT00838032|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24576350|NCT00838071|Immunoglobulins|immunoglobulins|mesh-list
24576351|NCT00838071|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24576353|NCT00838071|Immunologic Factors|immunologic factors|mesh-ancestor
24576354|NCT00838071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576355|NCT00838214|Prednisone|prednisone|mesh-list
24576356|NCT00838214|Budesonide|budesonide|mesh-list
24576357|NCT00838214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24576358|NCT00838214|Glucocorticoids|glucocorticoids|mesh-ancestor
24576359|NCT00838214|Hormones|hormones|mesh-ancestor
25703611|NCT02169284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25703612|NCT02169284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703613|NCT02169284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703614|NCT02169336|Dexmedetomidine|dexmedetomidine|mesh-list
25703615|NCT02169336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25703616|NCT02169336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25703617|NCT02169336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703618|NCT02169336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25703619|NCT02169336|Analgesics|analgesics|mesh-ancestor
25703620|NCT02169336|Sensory System Agents|sensory system agents|mesh-ancestor
25703621|NCT02169336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25703622|NCT02169336|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25703623|NCT02169336|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25703624|NCT02169336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25703625|NCT02169336|Adrenergic Agents|adrenergic agents|mesh-ancestor
25703626|NCT02169336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24843517|NCT02228005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24755933|NCT01730222|Antimetabolites|antimetabolites|mesh-ancestor
24576362|NCT00838214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24576363|NCT00838214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24576364|NCT00838214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24576365|NCT00838214|Autonomic Agents|autonomic agents|mesh-ancestor
24576366|NCT00838214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24576367|NCT00838214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24576378|NCT00838240|Idarubicin|idarubicin|mesh-list
24563827|NCT00773812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24576389|NCT00838240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24576423|NCT00838370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576424|NCT00838396|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
24576425|NCT00838396|Baclofen|baclofen|mesh-list
24576426|NCT00838396|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24576430|NCT00838396|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24576432|NCT00838396|GABA Agents|gaba agents|mesh-ancestor
24576433|NCT00838396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24759023|NCT01749085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24576448|NCT00838656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24576449|NCT00838656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24576450|NCT00838656|Immunologic Factors|immunologic factors|mesh-ancestor
24576451|NCT00838656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576452|NCT00838669|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24576453|NCT00838669|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24576454|NCT00838669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24576455|NCT00838669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24576456|NCT00838669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576457|NCT00838669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24576458|NCT00838669|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24576459|NCT00838669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24576507|NCT00838968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576509|NCT00839059|Immunologic Factors|immunologic factors|mesh-ancestor
24576510|NCT00839059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576511|NCT00839059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24576512|NCT00839059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24576513|NCT00839059|Growth Substances|growth substances|mesh-ancestor
24576514|NCT00839059|Growth Inhibitors|growth inhibitors|mesh-ancestor
24576515|NCT00839059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24576516|NCT00839085|Ascorbic Acid|ascorbic acid|mesh-list
24576517|NCT00839085|Grape Seed Extract|grape seed extract|mesh-list
24576518|NCT00839085|Antioxidants|antioxidants|mesh-ancestor
24576519|NCT00839085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576520|NCT00839085|Protective Agents|protective agents|mesh-ancestor
24576582|NCT00839358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24576583|NCT00839358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576584|NCT00839358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24576585|NCT00839358|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24576586|NCT00839358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24576587|NCT00839358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24576621|NCT00839449|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
24576622|NCT00839449|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24576624|NCT00839462|Pantothenic Acid|pantothenic acid|mesh-list
24576625|NCT00839462|Vitamin B Complex|vitamin b complex|mesh-ancestor
25703627|NCT02169336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703628|NCT02169414|Levodopa|levodopa|mesh-list
25703629|NCT02169414|Carbidopa|carbidopa|mesh-list
25703630|NCT02169414|Opicapone|opicapone|mesh-list
25703631|NCT02169414|Benserazide|benserazide|mesh-list
25703632|NCT02169414|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25703633|NCT02169414|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25703634|NCT02169414|Dopamine Agents|dopamine agents|mesh-ancestor
25703635|NCT02169414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576627|NCT00839462|Micronutrients|micronutrients|mesh-ancestor
24576628|NCT00839462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576629|NCT00839488|Pantoprazole|pantoprazole|mesh-list
24576630|NCT00839488|Famotidine|famotidine|mesh-list
24576631|NCT00839488|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24576651|NCT00839553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24576652|NCT00839605|Dexmedetomidine|dexmedetomidine|mesh-list
24576653|NCT00839605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24576654|NCT00839605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25009769|NCT05190627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25009779|NCT05188326|Azacitidine|azacitidine|mesh-list
25009780|NCT05188326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25009781|NCT05188326|Antimetabolites|antimetabolites|mesh-ancestor
24564057|NCT00774982|Immunologic Factors|immunologic factors|mesh-ancestor
24576703|NCT00839826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576704|NCT00839826|Anticoagulants|anticoagulants|mesh-ancestor
24576705|NCT00839826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24576706|NCT00839826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24576707|NCT00840112|Vitamin E|vitamin e|mesh-list
24576708|NCT00840112|Tocopherols|tocopherols|mesh-list
24576709|NCT00840112|alpha-Tocopherol|alpha-tocopherol|mesh-list
24576710|NCT00840112|Vitamins|vitamins|mesh-ancestor
24576757|NCT00840333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576759|NCT00840333|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24576760|NCT00840333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24576761|NCT00840346|Panobinostat|panobinostat|mesh-list
24576762|NCT00840346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24576763|NCT00840346|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24576769|NCT00840385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24576770|NCT00840385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24576771|NCT00840385|Antimetabolites|antimetabolites|mesh-ancestor
24576898|NCT00840918|Lidocaine|lidocaine|mesh-list
24576899|NCT00840918|Anesthetics, Local|anesthetics, local|mesh-ancestor
24576900|NCT00840918|Anesthetics|anesthetics|mesh-ancestor
24576901|NCT00840918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24576964|NCT00841191|Immunoglobulins|immunoglobulins|mesh-list
24577003|NCT00841633|Norepinephrine|norepinephrine|mesh-list
24577033|NCT00841789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24577034|NCT00841789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24577035|NCT00841789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24577036|NCT00841789|Immunologic Factors|immunologic factors|mesh-ancestor
24577038|NCT00841802|Glucocorticoids|glucocorticoids|mesh-list
24577039|NCT00841802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24577040|NCT00841802|Hormones|hormones|mesh-ancestor
24577041|NCT00841802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24577042|NCT00841802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577043|NCT00841802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24444033|NCT00296608|Calcium|calcium|mesh-list
24794259|NCT05328141|Antioxidants|antioxidants|mesh-ancestor
24577076|NCT00841880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577077|NCT00841880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24577078|NCT00841880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24577079|NCT00841880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24577080|NCT00841880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24577081|NCT00841880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24577082|NCT00841880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577143|NCT00842114|Antimitotic Agents|antimitotic agents|mesh-ancestor
24577144|NCT00842114|Mitosis Modulators|mitosis modulators|mesh-ancestor
24577145|NCT00842127|Methylphenidate|methylphenidate|mesh-list
24577146|NCT00842127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24577147|NCT00842127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577148|NCT00842127|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24577149|NCT00842127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24577150|NCT00842127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24577151|NCT00842127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577152|NCT00842127|Dopamine Agents|dopamine agents|mesh-ancestor
24577153|NCT00842127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24577154|NCT00842140|Metformin|metformin|mesh-list
24577155|NCT00842140|Spironolactone|spironolactone|mesh-list
24577195|NCT00842491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577197|NCT00842491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24577198|NCT00842491|Growth Substances|growth substances|mesh-ancestor
24577236|NCT00842595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24576751|NCT00840333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24577334|NCT00843063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24577335|NCT00843063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577337|NCT00843154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24577338|NCT00843154|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24577339|NCT00843154|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24577340|NCT00843154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577341|NCT00843323|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
24577342|NCT00843323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24792813|NCT04655391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009802|NCT05186454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009803|NCT05186454|Anesthetics, Local|anesthetics, local|mesh-ancestor
25009805|NCT05186454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25009806|NCT05186454|Sensory System Agents|sensory system agents|mesh-ancestor
25009807|NCT05186454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25009808|NCT05186454|Narcotics|narcotics|mesh-ancestor
25009809|NCT05186454|Analgesics|analgesics|mesh-ancestor
25009810|NCT05186454|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24577422|NCT00844064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577457|NCT00844207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24577458|NCT00844207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24577460|NCT00844207|Sensory System Agents|sensory system agents|mesh-ancestor
24577461|NCT00844207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24577462|NCT00844207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577463|NCT00844207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24577464|NCT00844207|Filaricides|filaricides|mesh-ancestor
24577465|NCT00844207|Antinematodal Agents|antinematodal agents|mesh-ancestor
24577466|NCT00844207|Anthelmintics|anthelmintics|mesh-ancestor
24577467|NCT00844233|Irinotecan|irinotecan|mesh-list
24577468|NCT00844233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24577469|NCT00844233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24577470|NCT00844233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577471|NCT00844233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577472|NCT00844233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577473|NCT00844285|Certolizumab Pegol|certolizumab pegol|mesh-list
24632208|NCT01122602|Antipyretics|antipyretics|mesh-ancestor
24577568|NCT00844727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577569|NCT00844727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24577570|NCT00844727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24577572|NCT00844727|Sensory System Agents|sensory system agents|mesh-ancestor
24577573|NCT00844727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24577574|NCT00844727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577575|NCT00844727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24577576|NCT00844727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24577577|NCT00844740|Cinacalcet|cinacalcet|mesh-list
24577578|NCT00844740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24577579|NCT00844740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577580|NCT00844740|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24577611|NCT00845104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24577612|NCT00845104|Growth Substances|growth substances|mesh-ancestor
24577613|NCT00845104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577614|NCT00845104|Growth Inhibitors|growth inhibitors|mesh-ancestor
24577615|NCT00845104|Immunologic Factors|immunologic factors|mesh-ancestor
24577616|NCT00845104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24632226|NCT01122641|Vildagliptin|vildagliptin|mesh-list
24577617|NCT00845104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24577618|NCT00845104|Antimetabolites|antimetabolites|mesh-ancestor
24577619|NCT00845104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577620|NCT00845104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24577621|NCT00845156|Thioctic Acid|thioctic acid|mesh-list
24577622|NCT00845156|Antioxidants|antioxidants|mesh-ancestor
24577623|NCT00845156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577624|NCT00845156|Protective Agents|protective agents|mesh-ancestor
24577625|NCT00845156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577626|NCT00845156|Vitamin B Complex|vitamin b complex|mesh-ancestor
24577627|NCT00845156|Vitamins|vitamins|mesh-ancestor
24577628|NCT00845156|Micronutrients|micronutrients|mesh-ancestor
24444038|NCT00296608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792837|NCT04597437|Zanamivir|zanamivir|mesh-list
24792838|NCT04597437|Antiviral Agents|antiviral agents|mesh-ancestor
24792839|NCT04597437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24792840|NCT04597437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24792841|NCT04597437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792845|NCT04515719|Belimumab|belimumab|mesh-list
24792846|NCT04515719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24792847|NCT04515719|Immunologic Factors|immunologic factors|mesh-ancestor
24792848|NCT04515719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792849|NCT04493333|Calcium polycarbophil|calcium polycarbophil|mesh-list
25009827|NCT05176080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25009829|NCT05162898|Lenvatinib|lenvatinib|mesh-list
25009833|NCT05162898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009865|NCT05134857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25009866|NCT05134857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009867|NCT05134857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24577658|NCT00845546|Pseudoephedrine|pseudoephedrine|mesh-list
24577659|NCT00845546|Ephedrine|ephedrine|mesh-list
24577693|NCT00845572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24577694|NCT00845572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24577699|NCT00845598|Fluticasone|fluticasone|mesh-list
24792807|NCT04655391|Venetoclax|venetoclax|mesh-list
24792808|NCT04655391|Ivosidenib|ivosidenib|mesh-list
24792809|NCT04655391|Maleic acid|maleic acid|mesh-list
24792810|NCT04655391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24792811|NCT04655391|Antimetabolites|antimetabolites|mesh-ancestor
24577740|NCT00845754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24577741|NCT00845754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577742|NCT00845754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24444041|NCT00296608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24444042|NCT00296608|Immunologic Factors|immunologic factors|mesh-ancestor
24444043|NCT00296608|Antidotes|antidotes|mesh-ancestor
24444044|NCT00296608|Protective Agents|protective agents|mesh-ancestor
24577767|NCT00845819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24577768|NCT00845819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24577840|NCT00845988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24577841|NCT00845988|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24444045|NCT00296608|Vitamin B Complex|vitamin b complex|mesh-ancestor
24577870|NCT00846144|Protective Agents|protective agents|mesh-ancestor
24577872|NCT00846144|Autonomic Agents|autonomic agents|mesh-ancestor
24577873|NCT00846144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24577874|NCT00846144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24577875|NCT00846196|Risedronic Acid|risedronic acid|mesh-list
24577876|NCT00846196|Etidronic Acid|etidronic acid|mesh-list
24577877|NCT00846196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24577878|NCT00846196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24564747|NCT00777673|Growth Substances|growth substances|mesh-ancestor
24577421|NCT00844064|Trabedersen|trabedersen|mesh-list
24577903|NCT00846326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24577904|NCT00846326|Autonomic Agents|autonomic agents|mesh-ancestor
24577905|NCT00846326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24577906|NCT00846326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696166|NCT01427842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24696167|NCT01427868|Maleic acid|maleic acid|mesh-list
24696168|NCT01427868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24696169|NCT01427868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696193|NCT01427985|Respiratory System Agents|respiratory system agents|mesh-ancestor
24696194|NCT01427985|Mydriatics|mydriatics|mesh-ancestor
24696195|NCT01427985|Parasympatholytics|parasympatholytics|mesh-ancestor
24449133|NCT00314509|Hormones|hormones|mesh-ancestor
24696201|NCT01427985|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24577907|NCT00846326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24577908|NCT00846326|Respiratory System Agents|respiratory system agents|mesh-ancestor
24577909|NCT00846326|Dermatologic Agents|dermatologic agents|mesh-ancestor
24577910|NCT00846326|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24577911|NCT00846326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24577912|NCT00846326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24577913|NCT00846326|Adrenergic Agents|adrenergic agents|mesh-ancestor
25709618|NCT02271217|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25709619|NCT02271217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25709620|NCT02271217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709621|NCT02271425|Evacetrapib|evacetrapib|mesh-list
24844436|NCT02232724|Choline|choline|mesh-list
24577914|NCT00846326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24577915|NCT00846326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577916|NCT00846326|Sympathomimetics|sympathomimetics|mesh-ancestor
24577917|NCT00846326|Nasal Decongestants|nasal decongestants|mesh-ancestor
24577918|NCT00846326|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24577919|NCT00846326|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24577920|NCT00846326|Mydriatics|mydriatics|mesh-ancestor
24577921|NCT00846326|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24577922|NCT00846326|Protective Agents|protective agents|mesh-ancestor
24577924|NCT00846339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24577925|NCT00846339|Antidepressive Agents|antidepressive agents|mesh-ancestor
24577926|NCT00846339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24577927|NCT00846339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24577928|NCT00846339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24577929|NCT00846339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24577930|NCT00846339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577931|NCT00846339|Dopamine Agents|dopamine agents|mesh-ancestor
24577932|NCT00846339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24577933|NCT00846339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577934|NCT00846339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24632291|NCT01123031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577970|NCT00846443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577997|NCT00846625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24577998|NCT00846625|Glucocorticoids|glucocorticoids|mesh-ancestor
24578000|NCT00846625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24578001|NCT00846677|Vitamin D|vitamin d|mesh-list
24578002|NCT00846677|Ergocalciferols|ergocalciferols|mesh-list
24578003|NCT00846677|Cholecalciferol|cholecalciferol|mesh-list
24578004|NCT00846677|Vitamins|vitamins|mesh-list
25009868|NCT05134857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578006|NCT00846677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578007|NCT00846677|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24578008|NCT00846677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24578009|NCT00846690|Lidocaine|lidocaine|mesh-list
24578010|NCT00846690|Phenylephrine|phenylephrine|mesh-list
24578011|NCT00846690|Benzocaine|benzocaine|mesh-list
24899700|NCT04401085|Antibodies|antibodies|mesh-list
24577523|NCT00844454|Ethanol|ethanol|mesh-list
24577524|NCT00844454|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24578012|NCT00846690|Tetracaine|tetracaine|mesh-list
24578013|NCT00846690|Anesthetics, Local|anesthetics, local|mesh-ancestor
24578014|NCT00846690|Anesthetics|anesthetics|mesh-ancestor
24578015|NCT00846690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24578016|NCT00846690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578017|NCT00846690|Sensory System Agents|sensory system agents|mesh-ancestor
24578018|NCT00846690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24578019|NCT00846690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24578020|NCT00846690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24578031|NCT00846690|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24578032|NCT00846690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24578068|NCT00846703|Mitosis Modulators|mitosis modulators|mesh-ancestor
24578069|NCT00846716|Pioglitazone|pioglitazone|mesh-list
24578070|NCT00846716|Biguanides|biguanides|mesh-list
24578071|NCT00846716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24578072|NCT00846716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578073|NCT00846755|Propylthiouracil|propylthiouracil|mesh-list
24578074|NCT00846755|Antimetabolites|antimetabolites|mesh-ancestor
24578075|NCT00846755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578076|NCT00846755|Antithyroid Agents|antithyroid agents|mesh-ancestor
24578077|NCT00846755|Hormone Antagonists|hormone antagonists|mesh-ancestor
24578078|NCT00846755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24578079|NCT00846755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578080|NCT00846859|Varenicline|varenicline|mesh-list
24578081|NCT00846859|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24578082|NCT00846859|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24578083|NCT00846859|Cholinergic Agents|cholinergic agents|mesh-ancestor
24578084|NCT00846859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24844838|NCT02234843|Anticoagulants|anticoagulants|mesh-ancestor
24578086|NCT00846859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578116|NCT00846950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24578117|NCT00846950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578118|NCT00846950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24578137|NCT00846976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24578138|NCT00846976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578169|NCT00847106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578172|NCT00847119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24578173|NCT00847119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578174|NCT00847119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24578175|NCT00847119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24578176|NCT00847119|Growth Substances|growth substances|mesh-ancestor
24578177|NCT00847119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444048|NCT00296634|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24578213|NCT00847639|Lenalidomide|lenalidomide|mesh-list
24578214|NCT00847639|Immunologic Factors|immunologic factors|mesh-ancestor
24578215|NCT00847639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578216|NCT00847639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24578234|NCT00847821|Bazedoxifene|bazedoxifene|mesh-list
24578235|NCT00847821|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24578236|NCT00847821|Hormone Antagonists|hormone antagonists|mesh-ancestor
24578237|NCT00847821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24578238|NCT00847821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578239|NCT00847821|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24578240|NCT00847821|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24578241|NCT00847821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24578242|NCT00847834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24578243|NCT00847834|Irbesartan|irbesartan|mesh-list
24578244|NCT00847834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24578270|NCT00847860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24578271|NCT00847860|Autonomic Agents|autonomic agents|mesh-ancestor
24578272|NCT00847860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24578273|NCT00847860|Respiratory System Agents|respiratory system agents|mesh-ancestor
24578304|NCT00848432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24578305|NCT00848432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578306|NCT00848432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578307|NCT00848432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24578308|NCT00848432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24578309|NCT00848432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25009869|NCT05113290|Sorafenib|sorafenib|mesh-list
24971438|NCT03725995|Lidocaine|lidocaine|mesh-list
24585953|NCT00888342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585954|NCT00888342|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24585955|NCT00888394|Imidacloprid|imidacloprid|mesh-list
25009870|NCT05113290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009871|NCT05113290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25009872|NCT05113290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25110021|NCT03120442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25110022|NCT03120442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25110023|NCT03120442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25110024|NCT03120442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25110025|NCT03120442|Adrenergic Agents|adrenergic agents|mesh-ancestor
25110026|NCT03120442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25110027|NCT03120442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110028|NCT03120442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25110030|NCT03120442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25110031|NCT03120468|Topiramate|topiramate|mesh-list
25110032|NCT03120468|Acetylcysteine|acetylcysteine|mesh-list
25110033|NCT03120468|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25110034|NCT03120468|Anticonvulsants|anticonvulsants|mesh-ancestor
25110035|NCT03120468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25110036|NCT03120468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110037|NCT03120468|Antiviral Agents|antiviral agents|mesh-ancestor
25110038|NCT03120468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25110039|NCT03120468|Expectorants|expectorants|mesh-ancestor
25110040|NCT03120468|Respiratory System Agents|respiratory system agents|mesh-ancestor
25110041|NCT03120468|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25110042|NCT03120468|Antioxidants|antioxidants|mesh-ancestor
25110043|NCT03120468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110045|NCT03120468|Antidotes|antidotes|mesh-ancestor
25110046|NCT03120715|Heparin|heparin|mesh-list
25703636|NCT02169414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844997|NCT02235519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110047|NCT03120715|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24578402|NCT00848939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24578403|NCT00848991|Dexmedetomidine|dexmedetomidine|mesh-list
24578404|NCT00848991|Propofol|propofol|mesh-list
24578405|NCT00848991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24578406|NCT00848991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24578407|NCT00848991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578408|NCT00848991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24578409|NCT00848991|Anesthetics, General|anesthetics, general|mesh-ancestor
24578410|NCT00848991|Anesthetics|anesthetics|mesh-ancestor
24578411|NCT00848991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24578412|NCT00848991|Analgesics|analgesics|mesh-ancestor
24578413|NCT00848991|Sensory System Agents|sensory system agents|mesh-ancestor
24578414|NCT00848991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24578415|NCT00848991|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24578416|NCT00848991|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24578417|NCT00848991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24578418|NCT00848991|Adrenergic Agents|adrenergic agents|mesh-ancestor
24578419|NCT00848991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24578420|NCT00848991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578422|NCT00849030|Anastrozole|anastrozole|mesh-list
24578459|NCT00849095|Glucocorticoids|glucocorticoids|mesh-ancestor
24578460|NCT00849095|Hormones|hormones|mesh-ancestor
24578461|NCT00849095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24578462|NCT00849095|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24578463|NCT00849095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24578464|NCT00849095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24578512|NCT00849329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578513|NCT00849329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578514|NCT00849329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24578515|NCT00849342|Insulin Detemir|insulin detemir|mesh-list
24578516|NCT00849342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24578517|NCT00849342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578518|NCT00849355|Rituximab|rituximab|mesh-list
24578519|NCT00849355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24971531|NCT03725228|Lidocaine|lidocaine|mesh-list
24578520|NCT00849355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578521|NCT00849355|Immunologic Factors|immunologic factors|mesh-ancestor
24578522|NCT00849355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578523|NCT00849355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24578524|NCT00849368|Azathioprine|azathioprine|mesh-list
24578525|NCT00849368|Allopurinol|allopurinol|mesh-list
24578526|NCT00849368|Antimetabolites|antimetabolites|mesh-ancestor
25009874|NCT05107778|Entecavir|entecavir|mesh-list
24900252|NCT04396067|Tretinoin|tretinoin|mesh-list
24578527|NCT00849368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578528|NCT00849368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24578529|NCT00849368|Gout Suppressants|gout suppressants|mesh-ancestor
24578530|NCT00849368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24578531|NCT00849368|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24578532|NCT00849368|Antioxidants|antioxidants|mesh-ancestor
24578595|NCT00849615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24578618|NCT00849966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24578619|NCT00849966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632366|NCT01123486|Hydromorphone|hydromorphone|mesh-list
24578620|NCT00849966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578622|NCT00849992|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24578623|NCT00849992|Immunologic Factors|immunologic factors|mesh-ancestor
24578624|NCT00849992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578625|NCT00849992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578626|NCT00849992|Interferon Inducers|interferon inducers|mesh-ancestor
24578627|NCT00850005|Immunoglobulins|immunoglobulins|mesh-list
24578628|NCT00850005|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24578632|NCT00850005|Immunologic Factors|immunologic factors|mesh-ancestor
24578633|NCT00850005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009894|NCT05095857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009895|NCT05095857|Antidepressive Agents|antidepressive agents|mesh-ancestor
25009896|NCT05095857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25009897|NCT05058872|Levonorgestrel|levonorgestrel|mesh-list
25703637|NCT02169414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703638|NCT02169414|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24452659|NCT05457855|Fluticasone|fluticasone|mesh-list
24452660|NCT05457855|Montelukast|montelukast|mesh-list
24452661|NCT05457855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24452662|NCT05457855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24452663|NCT05457855|Autonomic Agents|autonomic agents|mesh-ancestor
24452664|NCT05457855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24452665|NCT05457855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009898|NCT05058872|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25009901|NCT05058872|Hormones|hormones|mesh-ancestor
25009902|NCT05058872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25009903|NCT05058872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009911|NCT04976049|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25009912|NCT04976049|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25009913|NCT04976049|Dermatologic Agents|dermatologic agents|mesh-ancestor
25009914|NCT04968366|Temozolomide|temozolomide|mesh-list
25009915|NCT04968366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25009916|NCT04968366|Alkylating Agents|alkylating agents|mesh-ancestor
25009917|NCT04968366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009918|NCT04968366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578639|NCT00850044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578640|NCT00850044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24578641|NCT00850044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24578733|NCT00851344|Histamine Antagonists|histamine antagonists|mesh-ancestor
24578734|NCT00851344|Histamine Agents|histamine agents|mesh-ancestor
24578735|NCT00851344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24578736|NCT00851344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578737|NCT00851344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578738|NCT00851370|Omalizumab|omalizumab|mesh-list
24578739|NCT00851370|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24578740|NCT00851370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24578741|NCT00851370|Respiratory System Agents|respiratory system agents|mesh-ancestor
24578742|NCT00851461|Goserelin|goserelin|mesh-list
24578743|NCT00851461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24578744|NCT00851461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24578745|NCT00851487|Amoxicillin|amoxicillin|mesh-list
24578746|NCT00851487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24578747|NCT00851487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24578748|NCT00851513|Lidocaine|lidocaine|mesh-list
24444115|NCT00296751|Anesthetics|anesthetics|mesh-ancestor
24578759|NCT00851513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578776|NCT00851708|Protective Agents|protective agents|mesh-ancestor
24578777|NCT00851708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578778|NCT00851708|Antidotes|antidotes|mesh-ancestor
24578779|NCT00851734|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24578780|NCT00851734|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24578781|NCT00851864|Tinzaparin|tinzaparin|mesh-list
24578782|NCT00851864|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24578783|NCT00851864|Dalteparin|dalteparin|mesh-list
24578784|NCT00851864|Anticoagulants|anticoagulants|mesh-ancestor
24578785|NCT00851864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24578786|NCT00851864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24578787|NCT00851864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792971|NCT04321551|Testosterone enanthate|testosterone enanthate|mesh-list
24578788|NCT00851929|Ambrisentan|ambrisentan|mesh-list
24578800|NCT00852046|Sensory System Agents|sensory system agents|mesh-ancestor
24578801|NCT00852046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24578802|NCT00852046|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24578803|NCT00852046|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24578804|NCT00852046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24578805|NCT00852046|Adrenergic Agents|adrenergic agents|mesh-ancestor
24578806|NCT00852046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24578807|NCT00852046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578808|NCT00852059|Methylphenidate|methylphenidate|mesh-list
24578809|NCT00852059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24578810|NCT00852059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578836|NCT00852189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25703639|NCT02169414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703640|NCT02169414|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25703641|NCT02169427|Opicapone|opicapone|mesh-list
25703642|NCT02169427|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25703643|NCT02169427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703644|NCT02169427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578838|NCT00852189|Antimitotic Agents|antimitotic agents|mesh-ancestor
24578839|NCT00852189|Mitosis Modulators|mitosis modulators|mesh-ancestor
24565525|NCT00781131|Pregabalin|pregabalin|mesh-list
24578910|NCT00852410|Mydriatics|mydriatics|mesh-ancestor
24578911|NCT00852410|Sympathomimetics|sympathomimetics|mesh-ancestor
24578912|NCT00852410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24578961|NCT00852683|Sensory System Agents|sensory system agents|mesh-ancestor
24578962|NCT00852683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24578963|NCT00852683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578964|NCT00852683|Anticonvulsants|anticonvulsants|mesh-ancestor
24578965|NCT00852683|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24578966|NCT00852683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24578967|NCT00852683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578968|NCT00852683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24578969|NCT00852683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24578983|NCT00852709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24578984|NCT00852709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24578985|NCT00852709|Antimetabolites|antimetabolites|mesh-ancestor
24578987|NCT00852787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24578988|NCT00852787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24578989|NCT00852787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24578990|NCT00852787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24578991|NCT00852787|Protective Agents|protective agents|mesh-ancestor
24578992|NCT00852787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578993|NCT00852800|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24578997|NCT00852956|Histamine Agents|histamine agents|mesh-ancestor
24579038|NCT00853008|Tubulin Modulators|tubulin modulators|mesh-ancestor
24792972|NCT04321551|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24792973|NCT04321551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24792974|NCT04321551|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24792975|NCT04321551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24792976|NCT04321551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24792977|NCT04321551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792978|NCT04321551|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24792991|NCT04305158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792992|NCT04305158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24792993|NCT04305158|Analgesics|analgesics|mesh-ancestor
24792994|NCT04305158|Sensory System Agents|sensory system agents|mesh-ancestor
24792995|NCT04305158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24792996|NCT04302324|Clarithromycin|clarithromycin|mesh-list
24792997|NCT04302324|Dexamethasone|dexamethasone|mesh-list
24792998|NCT04302324|Daratumumab|daratumumab|mesh-list
24792999|NCT04302324|Pomalidomide|pomalidomide|mesh-list
24579039|NCT00853008|Antimitotic Agents|antimitotic agents|mesh-ancestor
24579040|NCT00853008|Mitosis Modulators|mitosis modulators|mesh-ancestor
24579041|NCT00853008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24579042|NCT00853008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24579043|NCT00853008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24579044|NCT00853008|Analgesics|analgesics|mesh-ancestor
24579045|NCT00853008|Sensory System Agents|sensory system agents|mesh-ancestor
24579047|NCT00853177|Anesthetics, Local|anesthetics, local|mesh-ancestor
24579048|NCT00853177|Anesthetics|anesthetics|mesh-ancestor
24579049|NCT00853177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25009934|NCT04884308|BCG Vaccine|bcg vaccine|mesh-list
25009935|NCT04884308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25009936|NCT04884308|Immunologic Factors|immunologic factors|mesh-ancestor
25009937|NCT04884308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009938|NCT04880707|Anesthetics|anesthetics|mesh-list
25009939|NCT04880707|Anesthetics, Local|anesthetics, local|mesh-list
25009940|NCT04880707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25009941|NCT04880707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579083|NCT00853216|Sensory System Agents|sensory system agents|mesh-ancestor
24579084|NCT00853216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24579086|NCT00853268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24579088|NCT00853268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24579089|NCT00853268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579090|NCT00853268|Analgesics|analgesics|mesh-ancestor
24579091|NCT00853268|Sensory System Agents|sensory system agents|mesh-ancestor
24579092|NCT00853268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24579093|NCT00853294|Chlorpheniramine|chlorpheniramine|mesh-list
24579094|NCT00853294|Hydrocodone|hydrocodone|mesh-list
24579095|NCT00853294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579096|NCT00853294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24579097|NCT00853294|Narcotics|narcotics|mesh-ancestor
24632440|NCT01123967|Nicotine|nicotine|mesh-list
24579132|NCT00853450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24579134|NCT00853450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845900|NCT02239913|Autonomic Agents|autonomic agents|mesh-ancestor
24845901|NCT02239913|Adrenergic Agents|adrenergic agents|mesh-ancestor
24845902|NCT02239952|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24579135|NCT00853450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579136|NCT00853450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579137|NCT00853502|Methyltestosterone|methyltestosterone|mesh-list
24579138|NCT00853502|Testosterone|testosterone|mesh-list
24579139|NCT00853502|Testosterone undecanoate|testosterone undecanoate|mesh-list
24579140|NCT00853502|Testosterone enanthate|testosterone enanthate|mesh-list
24579141|NCT00853502|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24579142|NCT00853502|Androgens|androgens|mesh-ancestor
24579143|NCT00853502|Hormones|hormones|mesh-ancestor
24579144|NCT00853502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24579145|NCT00853502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579146|NCT00853502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24579147|NCT00853502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579148|NCT00853502|Anabolic Agents|anabolic agents|mesh-ancestor
24579149|NCT00853554|Hydromorphone|hydromorphone|mesh-list
24578449|NCT00849095|Terbutaline|terbutaline|mesh-list
24579163|NCT00853684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579164|NCT00853684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24579165|NCT00853684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24579167|NCT00853684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579168|NCT00853684|Growth Inhibitors|growth inhibitors|mesh-ancestor
24900627|NCT04392375|Nifedipine|nifedipine|mesh-list
24579169|NCT00853697|Methyltestosterone|methyltestosterone|mesh-list
24579170|NCT00853697|Testosterone|testosterone|mesh-list
24579171|NCT00853697|Testosterone undecanoate|testosterone undecanoate|mesh-list
24579209|NCT00853879|Vitamin B 6|vitamin b 6|mesh-list
24579210|NCT00853879|Pyridoxal|pyridoxal|mesh-list
24579211|NCT00853879|Pyridoxine|pyridoxine|mesh-list
24579212|NCT00853879|Vitamin B Complex|vitamin b complex|mesh-list
24579213|NCT00853879|Micronutrients|micronutrients|mesh-ancestor
24579214|NCT00853879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579215|NCT00853879|Hematinics|hematinics|mesh-ancestor
24579216|NCT00853892|Oxycodone|oxycodone|mesh-list
24579217|NCT00853892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24579218|NCT00853892|Narcotics|narcotics|mesh-ancestor
24579219|NCT00853892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24579220|NCT00853892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579221|NCT00853892|Analgesics|analgesics|mesh-ancestor
24579222|NCT00853892|Sensory System Agents|sensory system agents|mesh-ancestor
24579223|NCT00853892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24579224|NCT00853931|Panitumumab|panitumumab|mesh-list
24579225|NCT00853931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24579226|NCT00853931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579227|NCT00853944|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24579243|NCT00854009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579244|NCT00854009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579253|NCT00854035|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24579254|NCT00854035|Protease Inhibitors|protease inhibitors|mesh-ancestor
24579255|NCT00854035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579256|NCT00854035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579257|NCT00854139|Cyclosporine|cyclosporine|mesh-list
24579258|NCT00854139|Cyclophosphamide|cyclophosphamide|mesh-list
24579259|NCT00854139|Cyclosporins|cyclosporins|mesh-list
24579260|NCT00854139|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24579349|NCT00854646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579350|NCT00854646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24579351|NCT00854646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579352|NCT00854646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579353|NCT00854711|Nitric Oxide|nitric oxide|mesh-list
24579354|NCT00854711|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24579355|NCT00854711|Autonomic Agents|autonomic agents|mesh-ancestor
24579356|NCT00854711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24579357|NCT00854711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579370|NCT00854750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24579371|NCT00854750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579373|NCT00854763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24579407|NCT00854841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24579408|NCT00854841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703645|NCT02169427|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25703646|NCT02169427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25703647|NCT02169440|Opicapone|opicapone|mesh-list
24846065|NCT02241083|Norepinephrine|norepinephrine|mesh-list
24579409|NCT00854841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579410|NCT00854919|Antipsychotic Agents|antipsychotic agents|mesh-list
24579411|NCT00854919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24579412|NCT00854919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24579422|NCT00855049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579425|NCT00855088|Darunavir|darunavir|mesh-list
24579426|NCT00855088|Etravirine|etravirine|mesh-list
24579427|NCT00855088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24579428|NCT00855088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24579429|NCT00855088|Protease Inhibitors|protease inhibitors|mesh-ancestor
24579430|NCT00855088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579431|NCT00855088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579432|NCT00855088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24579433|NCT00855088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24579434|NCT00855088|Antiviral Agents|antiviral agents|mesh-ancestor
24579435|NCT00855088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24579436|NCT00855088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24579437|NCT00855088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24579438|NCT00855088|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24671117|NCT01323569|Hormones|hormones|mesh-ancestor
24579443|NCT00855101|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24579444|NCT00855101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24579445|NCT00855101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25009954|NCT04827979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24579556|NCT00856063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579576|NCT00856310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579577|NCT00856362|Moxidectin|moxidectin|mesh-list
24579578|NCT00856362|Midazolam|midazolam|mesh-list
24579579|NCT00856362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24579580|NCT00856362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24579581|NCT00856362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24579582|NCT00856362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579583|NCT00856362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24579584|NCT00856362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24579585|NCT00856362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24579586|NCT00856362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24579587|NCT00856362|Anesthetics, General|anesthetics, general|mesh-ancestor
24579611|NCT00856505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579612|NCT00856505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579614|NCT00856570|Mirabegron|mirabegron|mesh-list
24579615|NCT00856570|Anticoagulants|anticoagulants|mesh-ancestor
24579616|NCT00856570|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24579617|NCT00856570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24579618|NCT00856570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24579666|NCT00856804|Growth Substances|growth substances|mesh-ancestor
24579667|NCT00856804|Growth Inhibitors|growth inhibitors|mesh-ancestor
24579668|NCT00856804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579670|NCT00856882|Chelating Agents|chelating agents|mesh-ancestor
24579671|NCT00856882|Sequestering Agents|sequestering agents|mesh-ancestor
24632515|NCT01124383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24579676|NCT00856960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24579677|NCT00856960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24579678|NCT00856960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579680|NCT00857038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24579681|NCT00857038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24579682|NCT00857038|Antimalarials|antimalarials|mesh-ancestor
24579684|NCT00857038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24579685|NCT00857077|Pyrimethamine|pyrimethamine|mesh-list
24579686|NCT00857077|Sulfadoxine|sulfadoxine|mesh-list
24579687|NCT00857077|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24579725|NCT00857155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579726|NCT00857155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579728|NCT00857168|Androgens|androgens|mesh-ancestor
24579730|NCT00857168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24579732|NCT00857324|Vorinostat|vorinostat|mesh-list
24579733|NCT00857324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579734|NCT00857324|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24579781|NCT00857597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632534|NCT01124435|Analgesics|analgesics|mesh-ancestor
25703648|NCT02169440|Warfarin|warfarin|mesh-list
25703649|NCT02169440|Anticoagulants|anticoagulants|mesh-ancestor
24579782|NCT00857597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579784|NCT00857753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24579815|NCT00857909|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24579816|NCT00857909|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24579817|NCT00857909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24579818|NCT00857909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579819|NCT00857909|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24579821|NCT00857935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579822|NCT00857935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579824|NCT00857987|Respiratory System Agents|respiratory system agents|mesh-ancestor
24579825|NCT00858182|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24579826|NCT00858195|Indomethacin|indomethacin|mesh-list
24579827|NCT00858195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24579828|NCT00858195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24579829|NCT00858195|Analgesics|analgesics|mesh-ancestor
24579830|NCT00858195|Sensory System Agents|sensory system agents|mesh-ancestor
24579831|NCT00858195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24579832|NCT00858195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579833|NCT00858195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24579834|NCT00858195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24579835|NCT00858195|Gout Suppressants|gout suppressants|mesh-ancestor
24579836|NCT00858195|Tocolytic Agents|tocolytic agents|mesh-ancestor
24579837|NCT00858195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24579838|NCT00858195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24579892|NCT00858624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24579893|NCT00858624|Anesthetics, General|anesthetics, general|mesh-ancestor
24579894|NCT00858624|Anesthetics|anesthetics|mesh-ancestor
24579895|NCT00858624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24579896|NCT00858624|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24793085|NCT04232683|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24793086|NCT04232683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24793087|NCT04232683|Adrenergic Agents|adrenergic agents|mesh-ancestor
24793088|NCT04232683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24793089|NCT04232683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793090|NCT04232683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793091|NCT04232683|Urological Agents|urological agents|mesh-ancestor
24793092|NCT04225026|Avasopasem manganese|avasopasem manganese|mesh-list
24793093|NCT04225026|Antioxidants|antioxidants|mesh-ancestor
24579897|NCT00858624|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24579898|NCT00858624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24579899|NCT00858624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579911|NCT00858715|Aspirin|aspirin|mesh-list
24579912|NCT00858715|Clopidogrel|clopidogrel|mesh-list
24579913|NCT00858715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24579914|NCT00858715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24579915|NCT00858715|Analgesics|analgesics|mesh-ancestor
24579916|NCT00858715|Sensory System Agents|sensory system agents|mesh-ancestor
24579917|NCT00858715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24579965|NCT00859079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579967|NCT00859079|Hormones|hormones|mesh-ancestor
24579968|NCT00859079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24579969|NCT00859105|Imiquimod|imiquimod|mesh-list
25010001|NCT04789304|Midazolam|midazolam|mesh-list
25010002|NCT04789304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25010003|NCT04789304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25010004|NCT04789304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25010005|NCT04789304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010006|NCT04789304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25010007|NCT04789304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25010008|NCT04789304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25010009|NCT04789304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24579970|NCT00859105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24579971|NCT00859105|Immunologic Factors|immunologic factors|mesh-ancestor
24579972|NCT00859105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579973|NCT00859105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579974|NCT00859105|Interferon Inducers|interferon inducers|mesh-ancestor
24579976|NCT00859118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579977|NCT00859118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24579978|NCT00859118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579979|NCT00859118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579980|NCT00859183|Sirolimus|sirolimus|mesh-list
24579981|NCT00859183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24580036|NCT00859872|Risperidone|risperidone|mesh-list
24452756|NCT05453045|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24452757|NCT05453045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24452758|NCT05453045|Tubulin Modulators|tubulin modulators|mesh-ancestor
24452759|NCT05453045|Antimitotic Agents|antimitotic agents|mesh-ancestor
24452760|NCT05453045|Mitosis Modulators|mitosis modulators|mesh-ancestor
24846521|NCT02242877|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24580037|NCT00859872|Haloperidol decanoate|haloperidol decanoate|mesh-list
24580038|NCT00859872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24580039|NCT00859872|Serotonin Agents|serotonin agents|mesh-ancestor
24580040|NCT00859872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24580041|NCT00859872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580059|NCT00859885|Sensory System Agents|sensory system agents|mesh-ancestor
24580060|NCT00859885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24580066|NCT00859885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580067|NCT00859885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24580068|NCT00859885|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24580116|NCT00860340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580117|NCT00860340|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24580118|NCT00860340|Diuretics|diuretics|mesh-ancestor
24580119|NCT00860340|Natriuretic Agents|natriuretic agents|mesh-ancestor
24580121|NCT00860366|Antioxidants|antioxidants|mesh-ancestor
24580122|NCT00860366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580123|NCT00860366|Protective Agents|protective agents|mesh-ancestor
24580124|NCT00860366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580125|NCT00860496|Cyclosporine|cyclosporine|mesh-list
24580191|NCT00860977|Valacyclovir|valacyclovir|mesh-list
24901227|NCT04387630|Metformin|metformin|mesh-list
24580195|NCT00861016|Felodipine|felodipine|mesh-list
24580196|NCT00861016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24580197|NCT00861016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24580199|NCT00861016|Autonomic Agents|autonomic agents|mesh-ancestor
24580200|NCT00861016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24580201|NCT00861016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580202|NCT00861016|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24580203|NCT00861016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24580204|NCT00861016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24580205|NCT00861016|Adrenergic Agents|adrenergic agents|mesh-ancestor
24580206|NCT00861016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24580207|NCT00861016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580208|NCT00861016|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24580209|NCT00861016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24580210|NCT00861016|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24580211|NCT00861016|Vasodilator Agents|vasodilator agents|mesh-ancestor
24580212|NCT00861029|Moxifloxacin|moxifloxacin|mesh-list
25010010|NCT04789304|Anesthetics, General|anesthetics, general|mesh-ancestor
24580250|NCT00861094|Immunologic Factors|immunologic factors|mesh-ancestor
24580251|NCT00861094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580252|NCT00861094|Antidotes|antidotes|mesh-ancestor
24580253|NCT00861094|Protective Agents|protective agents|mesh-ancestor
24580254|NCT00861094|Vitamin B Complex|vitamin b complex|mesh-ancestor
25703650|NCT02169440|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25703651|NCT02169440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703652|NCT02169440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703653|NCT02169440|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25703654|NCT02169440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25703655|NCT02169453|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25703656|NCT02169453|Opicapone|opicapone|mesh-list
25703657|NCT02169453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25703658|NCT02169453|Immunologic Factors|immunologic factors|mesh-ancestor
25703659|NCT02169453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703660|NCT02169453|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25703661|NCT02169453|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25703662|NCT02169453|Dopamine Agonists|dopamine agonists|mesh-ancestor
25703663|NCT02169453|Dopamine Agents|dopamine agents|mesh-ancestor
25703664|NCT02169453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24846609|NCT02243241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846648|NCT02243436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580255|NCT00861094|Vitamins|vitamins|mesh-ancestor
24580256|NCT00861094|Micronutrients|micronutrients|mesh-ancestor
24580257|NCT00861094|Hematinics|hematinics|mesh-ancestor
24580258|NCT00861107|Vaccines|vaccines|mesh-list
24580259|NCT00861107|Immunologic Factors|immunologic factors|mesh-ancestor
24580260|NCT00861107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580261|NCT00861120|Doxorubicin|doxorubicin|mesh-list
24580262|NCT00861120|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24580263|NCT00861120|Panitumumab|panitumumab|mesh-list
24580264|NCT00861120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24580265|NCT00861120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24580266|NCT00861120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24580267|NCT00861120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24580268|NCT00861120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580269|NCT00861120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580270|NCT00861120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24580272|NCT00861250|Bortezomib|bortezomib|mesh-list
24580273|NCT00861250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24580274|NCT00861250|Antiemetics|antiemetics|mesh-ancestor
24580275|NCT00861250|Autonomic Agents|autonomic agents|mesh-ancestor
24580276|NCT00861250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24580352|NCT00861419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24580353|NCT00861419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580393|NCT00861523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24580444|NCT00861861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580495|NCT00861939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24580496|NCT00861939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580499|NCT00861952|Dermatologic Agents|dermatologic agents|mesh-ancestor
24580500|NCT00862043|Sildenafil Citrate|sildenafil citrate|mesh-list
24580501|NCT00862043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580502|NCT00862043|Vasodilator Agents|vasodilator agents|mesh-ancestor
24580503|NCT00862043|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24580504|NCT00862043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24580505|NCT00862043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580506|NCT00862043|Urological Agents|urological agents|mesh-ancestor
24580508|NCT00862095|Propranolol|propranolol|mesh-list
24580509|NCT00862095|Amitriptyline|amitriptyline|mesh-list
24580510|NCT00862095|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24580511|NCT00862095|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24580535|NCT00862108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24793125|NCT04074460|Propofol|propofol|mesh-list
24793126|NCT04074460|Sevoflurane|sevoflurane|mesh-list
24793127|NCT04074460|Desflurane|desflurane|mesh-list
24793128|NCT04074460|Isoflurane|isoflurane|mesh-list
24793129|NCT04074460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24566907|NCT00788515|Volinanserin|volinanserin|mesh-list
25010062|NCT04681079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010063|NCT04681079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25010064|NCT04681079|Respiratory System Agents|respiratory system agents|mesh-ancestor
25703665|NCT02169453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703666|NCT02169453|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25703667|NCT02169453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703668|NCT02169466|Opicapone|opicapone|mesh-list
25703669|NCT02169466|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
25703670|NCT02169466|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25703671|NCT02169466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703672|NCT02169466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703673|NCT02169466|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25703674|NCT02169466|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25703675|NCT02169466|Dopamine Agents|dopamine agents|mesh-ancestor
25010065|NCT04681079|Tocolytic Agents|tocolytic agents|mesh-ancestor
25010066|NCT04681079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25010067|NCT04681079|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25703676|NCT02169466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25010068|NCT04681079|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25010069|NCT04681079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25010070|NCT04681079|Adrenergic Agents|adrenergic agents|mesh-ancestor
24580542|NCT00862264|Formoterol Fumarate|formoterol fumarate|mesh-list
24580543|NCT00862264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24580544|NCT00862264|Autonomic Agents|autonomic agents|mesh-ancestor
24580545|NCT00862264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24580546|NCT00862264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580547|NCT00862264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24580548|NCT00862264|Respiratory System Agents|respiratory system agents|mesh-ancestor
24580549|NCT00862264|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24580566|NCT00862342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24580568|NCT00862342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24580569|NCT00862342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24580570|NCT00862342|Growth Substances|growth substances|mesh-ancestor
24580571|NCT00862342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580572|NCT00862342|Growth Inhibitors|growth inhibitors|mesh-ancestor
24580573|NCT00862381|Hydrocortisone|hydrocortisone|mesh-list
24580574|NCT00862381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24580575|NCT00862394|Formoterol Fumarate|formoterol fumarate|mesh-list
24580576|NCT00862394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24580577|NCT00862394|Autonomic Agents|autonomic agents|mesh-ancestor
24580578|NCT00862394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24580579|NCT00862394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580580|NCT00862394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24580581|NCT00862394|Respiratory System Agents|respiratory system agents|mesh-ancestor
24580582|NCT00862394|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24580583|NCT00862394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24580651|NCT00862888|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24580652|NCT00862888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580653|NCT00862888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580654|NCT00862888|Urological Agents|urological agents|mesh-ancestor
24580656|NCT00862966|Anticoagulants|anticoagulants|mesh-ancestor
24580657|NCT00862966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580658|NCT00862966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24580660|NCT00863096|Vaccines|vaccines|mesh-list
24580661|NCT00863096|Immunologic Factors|immunologic factors|mesh-ancestor
24580662|NCT00863096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580663|NCT00863148|Busulfan|busulfan|mesh-list
24580664|NCT00863148|Clofarabine|clofarabine|mesh-list
24580665|NCT00863148|Alkylating Agents|alkylating agents|mesh-ancestor
24580666|NCT00863148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580667|NCT00863148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24580668|NCT00863148|Immunologic Factors|immunologic factors|mesh-ancestor
24580712|NCT00863291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24580713|NCT00863291|Narcotics|narcotics|mesh-ancestor
24580714|NCT00863291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24580715|NCT00863291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580716|NCT00863291|Analgesics|analgesics|mesh-ancestor
24580717|NCT00863291|Sensory System Agents|sensory system agents|mesh-ancestor
24580718|NCT00863291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24580719|NCT00863291|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24580720|NCT00863395|Lidocaine|lidocaine|mesh-list
24580721|NCT00863395|Anesthetics, Local|anesthetics, local|mesh-ancestor
24580722|NCT00863395|Anesthetics|anesthetics|mesh-ancestor
24580723|NCT00863395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24580724|NCT00863395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703677|NCT02169466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703678|NCT02169479|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25703679|NCT02169479|Opicapone|opicapone|mesh-list
25703680|NCT02169479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25703681|NCT02169479|Immunologic Factors|immunologic factors|mesh-ancestor
25703682|NCT02169479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703683|NCT02169479|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24580771|NCT00863499|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24580772|NCT00863499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24580773|NCT00863499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24580774|NCT00863499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580775|NCT00863499|Dopamine Agents|dopamine agents|mesh-ancestor
24580776|NCT00863499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24580777|NCT00863577|Bemiparin|bemiparin|mesh-list
24580784|NCT00863668|Efavirenz|efavirenz|mesh-list
24632682|NCT01125124|Silver Nitrate|silver nitrate|mesh-list
24580785|NCT00863668|Raltegravir Potassium|raltegravir potassium|mesh-list
24580786|NCT00863668|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24580787|NCT00863668|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
24580788|NCT00863668|Integrase Inhibitors|integrase inhibitors|mesh-list
24580789|NCT00863668|Antiviral Agents|antiviral agents|mesh-ancestor
24580790|NCT00863668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24580791|NCT00863668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24580792|NCT00863668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24580793|NCT00863668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580794|NCT00863668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24793192|NCT03817125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24793193|NCT03817125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793194|NCT03817125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24793195|NCT03817125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793196|NCT03817125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24793198|NCT03814005|Docetaxel|docetaxel|mesh-list
24793199|NCT03814005|Carboplatin|carboplatin|mesh-list
24793200|NCT03814005|Azacitidine|azacitidine|mesh-list
24793201|NCT03814005|Pevonedistat|pevonedistat|mesh-list
24793202|NCT03814005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24793203|NCT03814005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793204|NCT03814005|Tubulin Modulators|tubulin modulators|mesh-ancestor
24793205|NCT03814005|Antimitotic Agents|antimitotic agents|mesh-ancestor
24793206|NCT03814005|Mitosis Modulators|mitosis modulators|mesh-ancestor
24793207|NCT03814005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793208|NCT03814005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24793209|NCT03814005|Antimetabolites|antimetabolites|mesh-ancestor
24793210|NCT03814005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567229|NCT00790153|Insulin|insulin|mesh-list
25010120|NCT04625803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010121|NCT04623567|Metformin|metformin|mesh-list
25010122|NCT04623567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24586353|NCT00890279|Protease Inhibitors|protease inhibitors|mesh-ancestor
25010127|NCT04617821|Paclitaxel|paclitaxel|mesh-list
24580881|NCT00863941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24580882|NCT00863941|Antidepressive Agents|antidepressive agents|mesh-ancestor
24580883|NCT00863941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24580884|NCT00863941|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24580885|NCT00863941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24580886|NCT00863941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24580887|NCT00863941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580888|NCT00863941|Dopamine Agents|dopamine agents|mesh-ancestor
24580904|NCT00864006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580906|NCT00864006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24580907|NCT00864006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703684|NCT02169479|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25703685|NCT02169479|Dopamine Agonists|dopamine agonists|mesh-ancestor
25703686|NCT02169479|Dopamine Agents|dopamine agents|mesh-ancestor
25703687|NCT02169479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25709622|NCT02271425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24580909|NCT00864006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24580910|NCT00864006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24580911|NCT00864006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24580913|NCT00864019|Antidepressive Agents|antidepressive agents|mesh-ancestor
24580914|NCT00864019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24580915|NCT00864019|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24580916|NCT00864019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24580920|NCT00864019|Serotonin Agents|serotonin agents|mesh-ancestor
24581010|NCT00864214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581011|NCT00864214|Estrogens|estrogens|mesh-ancestor
24581012|NCT00864240|Clobetasol|clobetasol|mesh-list
24581013|NCT00864240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24581014|NCT00864240|Glucocorticoids|glucocorticoids|mesh-ancestor
24581015|NCT00864240|Hormones|hormones|mesh-ancestor
24581016|NCT00864240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24581017|NCT00864240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581018|NCT00864279|Cetirizine|cetirizine|mesh-list
24581019|NCT00864279|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24581031|NCT00864305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581033|NCT00864305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24581034|NCT00864305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24900830|NCT04390984|Apatinib|apatinib|mesh-list
24579555|NCT00856063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24579575|NCT00856310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24581057|NCT00864344|Sertraline|sertraline|mesh-list
24581058|NCT00864344|Antidepressive Agents|antidepressive agents|mesh-ancestor
24581059|NCT00864344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24581060|NCT00864344|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24581061|NCT00864344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24581062|NCT00864344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24581063|NCT00864344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581064|NCT00864344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581065|NCT00864344|Serotonin Agents|serotonin agents|mesh-ancestor
24581066|NCT00864344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581067|NCT00864357|Ibuprofen|ibuprofen|mesh-list
24581068|NCT00864357|Oxycodone|oxycodone|mesh-list
24581069|NCT00864357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24581070|NCT00864357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24581071|NCT00864357|Analgesics|analgesics|mesh-ancestor
24581072|NCT00864357|Sensory System Agents|sensory system agents|mesh-ancestor
24581073|NCT00864357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24581074|NCT00864357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581075|NCT00864357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24581076|NCT00864357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24696202|NCT01427985|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24581077|NCT00864357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24581078|NCT00864357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581079|NCT00864357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581080|NCT00864357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24581082|NCT00864357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24581143|NCT00864526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24581144|NCT00864526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581145|NCT00864526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581146|NCT00864526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24581406|NCT00865085|Dexetimide|dexetimide|mesh-list
24586352|NCT00890279|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24901847|NCT04380376|Melphalan|melphalan|mesh-list
24581147|NCT00864526|Narcotics|narcotics|mesh-ancestor
24581148|NCT00864526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24581149|NCT00864552|Factor VIII|factor viii|mesh-list
24581150|NCT00864552|Coagulants|coagulants|mesh-ancestor
24581151|NCT00864565|Fentanyl|fentanyl|mesh-list
24581152|NCT00864565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24581153|NCT00864565|Narcotics|narcotics|mesh-ancestor
24581154|NCT00864565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24581155|NCT00864565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581156|NCT00864565|Analgesics|analgesics|mesh-ancestor
24581157|NCT00864565|Sensory System Agents|sensory system agents|mesh-ancestor
24581158|NCT00864565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24581159|NCT00864565|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24581160|NCT00864565|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24581161|NCT00864565|Anesthetics, General|anesthetics, general|mesh-ancestor
25709623|NCT02271425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25709624|NCT02271425|Antimetabolites|antimetabolites|mesh-ancestor
24581162|NCT00864565|Anesthetics|anesthetics|mesh-ancestor
24581163|NCT00864591|Adenosine|adenosine|mesh-list
24581164|NCT00864591|Analgesics|analgesics|mesh-ancestor
24581229|NCT00864760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24581230|NCT00864760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24581231|NCT00864760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24581232|NCT00864760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24579679|NCT00857038|Doxycycline|doxycycline|mesh-list
24581233|NCT00864760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24581234|NCT00864760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25010147|NCT04581148|Immunoglobulins|immunoglobulins|mesh-list
25010148|NCT04581148|Immunologic Factors|immunologic factors|mesh-ancestor
24581267|NCT00864812|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24581268|NCT00864812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24581269|NCT00864812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24581270|NCT00864812|Adrenergic Agents|adrenergic agents|mesh-ancestor
24581271|NCT00864812|Glucocorticoids|glucocorticoids|mesh-ancestor
24581272|NCT00864812|Hormones|hormones|mesh-ancestor
24581273|NCT00864812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24581274|NCT00864812|Sympathomimetics|sympathomimetics|mesh-ancestor
24581307|NCT00864864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24581308|NCT00864864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581309|NCT00864864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581310|NCT00864890|Dexetimide|dexetimide|mesh-list
24581311|NCT00864890|Citalopram|citalopram|mesh-list
24581312|NCT00864890|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24581313|NCT00864890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24581314|NCT00864890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24581315|NCT00864890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581317|NCT00864890|Serotonin Agents|serotonin agents|mesh-ancestor
24581328|NCT00864890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24581330|NCT00864942|Lenalidomide|lenalidomide|mesh-list
24581331|NCT00864942|Rituximab|rituximab|mesh-list
24581332|NCT00864942|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24581342|NCT00864942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24581343|NCT00864942|Alkylating Agents|alkylating agents|mesh-ancestor
24581344|NCT00864942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581345|NCT00864968|Nabumetone|nabumetone|mesh-list
24581346|NCT00864968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24581347|NCT00864968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24581348|NCT00864968|Analgesics|analgesics|mesh-ancestor
24581349|NCT00864968|Sensory System Agents|sensory system agents|mesh-ancestor
24581350|NCT00864968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24581351|NCT00864968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581352|NCT00864968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24581353|NCT00864968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24581354|NCT00864968|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24581355|NCT00864968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24581356|NCT00864968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581397|NCT00865059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24581398|NCT00865059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24581399|NCT00865059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24581400|NCT00865059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581401|NCT00865059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581402|NCT00865059|Antimanic Agents|antimanic agents|mesh-ancestor
24581403|NCT00865072|Metformin|metformin|mesh-list
24581404|NCT00865072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24581405|NCT00865072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581407|NCT00865085|Citalopram|citalopram|mesh-list
24581408|NCT00865085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24581409|NCT00865085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24581410|NCT00865085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24581448|NCT00865176|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24581449|NCT00865176|Hormone Antagonists|hormone antagonists|mesh-ancestor
24581450|NCT00865176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24581451|NCT00865176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581452|NCT00865176|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24581454|NCT00865176|Natriuretic Agents|natriuretic agents|mesh-ancestor
24632749|NCT01125527|Vaccines|vaccines|mesh-list
24581455|NCT00865176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24581457|NCT00865215|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24581458|NCT00865215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24581459|NCT00865215|Adrenergic Agents|adrenergic agents|mesh-ancestor
24581460|NCT00865215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581461|NCT00865215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581462|NCT00865215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581463|NCT00865215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24581464|NCT00865215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24581465|NCT00865215|Vasodilator Agents|vasodilator agents|mesh-ancestor
24581467|NCT00865241|Glyburide|glyburide|mesh-list
24581468|NCT00865241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24581469|NCT00865241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581470|NCT00865267|Halobetasol|halobetasol|mesh-list
24586354|NCT00890279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24586355|NCT00890279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24586356|NCT00890318|Ketoconazole|ketoconazole|mesh-list
24586357|NCT00890318|Antifungal Agents|antifungal agents|mesh-ancestor
24586358|NCT00890318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24586359|NCT00890318|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24586360|NCT00890318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24586361|NCT00890318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581479|NCT00865371|Bupropion|bupropion|mesh-list
24581480|NCT00865371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24581481|NCT00865371|Antidepressive Agents|antidepressive agents|mesh-ancestor
24581482|NCT00865371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24581483|NCT00865371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24581490|NCT00865371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24581491|NCT00865371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24581492|NCT00865371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581493|NCT00865384|Mirtazapine|mirtazapine|mesh-list
25010151|NCT04574232|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25010152|NCT04574232|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25010153|NCT04574232|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25010154|NCT04574232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25010155|NCT04574232|Glucocorticoids|glucocorticoids|mesh-ancestor
25010156|NCT04574232|Hormones|hormones|mesh-ancestor
25010157|NCT04574232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25010158|NCT04574232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010159|NCT04574232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25010160|NCT04574232|Immunologic Factors|immunologic factors|mesh-ancestor
25010161|NCT04574232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25010162|NCT04574232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010177|NCT04548973|Esketamine|esketamine|mesh-list
25010178|NCT04548973|Antidepressive Agents|antidepressive agents|mesh-ancestor
24581528|NCT00865410|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24581529|NCT00865410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581530|NCT00865423|Gabapentin|gabapentin|mesh-list
24581531|NCT00865423|Analgesics|analgesics|mesh-ancestor
24581532|NCT00865423|Sensory System Agents|sensory system agents|mesh-ancestor
24581533|NCT00865423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24581534|NCT00865423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581535|NCT00865423|Anticonvulsants|anticonvulsants|mesh-ancestor
24581536|NCT00865423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24581537|NCT00865423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24581538|NCT00865423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24581567|NCT00865462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581568|NCT00865462|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24581569|NCT00865462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24581570|NCT00865462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581571|NCT00865501|Spironolactone|spironolactone|mesh-list
24581667|NCT00865696|Histamine Agents|histamine agents|mesh-ancestor
24581668|NCT00865696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581669|NCT00865696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581670|NCT00865696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581671|NCT00865696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24581738|NCT00865943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24581739|NCT00865943|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24581740|NCT00865943|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24581741|NCT00865943|Parasympatholytics|parasympatholytics|mesh-ancestor
24581742|NCT00865943|Autonomic Agents|autonomic agents|mesh-ancestor
24581743|NCT00865943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24581744|NCT00865943|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24581745|NCT00865943|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24793222|NCT03747042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24696203|NCT01427985|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24696205|NCT01428037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24696206|NCT01428037|Abortifacient Agents|abortifacient agents|mesh-ancestor
24696207|NCT01428037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24696208|NCT01428037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696209|NCT01428037|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24696210|NCT01428037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24696211|NCT01428037|Oxytocics|oxytocics|mesh-ancestor
24567864|NCT00793221|Immunologic Factors|immunologic factors|mesh-ancestor
24581765|NCT00866008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24581767|NCT00866008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24581769|NCT00866021|Lopinavir|lopinavir|mesh-list
24581770|NCT00866021|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25010186|NCT04539548|Prednisolone|prednisolone|mesh-list
25010187|NCT04539548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25010188|NCT04539548|Glucocorticoids|glucocorticoids|mesh-ancestor
25010189|NCT04539548|Hormones|hormones|mesh-ancestor
25010190|NCT04539548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25010191|NCT04539548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010192|NCT04539548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25010193|NCT04539548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010194|NCT04538040|Tenofovir|tenofovir|mesh-list
25010195|NCT04538040|Emtricitabine|emtricitabine|mesh-list
24581780|NCT00866021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24581782|NCT00866060|Donepezil|donepezil|mesh-list
24581783|NCT00866060|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24581784|NCT00866060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581785|NCT00866060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581787|NCT00866060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581788|NCT00866060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581789|NCT00866060|Nootropic Agents|nootropic agents|mesh-ancestor
24581809|NCT00866229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581818|NCT00866437|Estrone|estrone|mesh-list
24581819|NCT00866437|Progesterone|progesterone|mesh-list
24581820|NCT00866437|Estrogens|estrogens|mesh-ancestor
24581821|NCT00866437|Hormones|hormones|mesh-ancestor
24581822|NCT00866437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24581823|NCT00866437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581824|NCT00866437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24581825|NCT00866437|Contraceptive Agents|contraceptive agents|mesh-ancestor
24581826|NCT00866437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24581827|NCT00866437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24581828|NCT00866437|Progestins|progestins|mesh-ancestor
24581829|NCT00866450|Calcium, Dietary|calcium, dietary|mesh-list
24581830|NCT00866450|Calcium|calcium|mesh-list
24581831|NCT00866450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24581832|NCT00866450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581833|NCT00866450|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24581835|NCT00866463|Vasodilator Agents|vasodilator agents|mesh-ancestor
24581836|NCT00866463|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24581837|NCT00866463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24581838|NCT00866463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759025|NCT01749085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24581847|NCT00866515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581848|NCT00866515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24581849|NCT00866515|Hormone Antagonists|hormone antagonists|mesh-ancestor
24581850|NCT00866515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24581851|NCT00866515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581852|NCT00866515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24581861|NCT00866554|Bicalutamide|bicalutamide|mesh-list
24581862|NCT00866554|Dutasteride|dutasteride|mesh-list
24581863|NCT00866554|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24581864|NCT00866554|Hormone Antagonists|hormone antagonists|mesh-ancestor
24581865|NCT00866554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24581866|NCT00866554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581867|NCT00866554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24581868|NCT00866554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24581869|NCT00866554|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24581870|NCT00866554|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24581871|NCT00866554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24581872|NCT00866554|Androgen Antagonists|androgen antagonists|mesh-ancestor
24581873|NCT00866554|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24581874|NCT00866554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24581875|NCT00866554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581876|NCT00866554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581878|NCT00866593|Citalopram|citalopram|mesh-list
24581879|NCT00866593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24581880|NCT00866593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24581881|NCT00866593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24581882|NCT00866593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581888|NCT00866593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24581889|NCT00866593|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24581890|NCT00866593|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24581891|NCT00866593|Parasympatholytics|parasympatholytics|mesh-ancestor
24581893|NCT00866593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24581894|NCT00866593|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24581895|NCT00866593|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24581896|NCT00866593|Cholinergic Agents|cholinergic agents|mesh-ancestor
24581897|NCT00866645|Haloperidol|haloperidol|mesh-list
24581898|NCT00866645|Haloperidol decanoate|haloperidol decanoate|mesh-list
24581917|NCT00866684|Cyclosporine|cyclosporine|mesh-list
24581935|NCT00866684|Antimetabolites|antimetabolites|mesh-ancestor
24581936|NCT00866684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24581938|NCT00866736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24581939|NCT00866736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24581940|NCT00866736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581941|NCT00866736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581942|NCT00866762|Vorinostat|vorinostat|mesh-list
24581943|NCT00866762|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
24581944|NCT00866762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581945|NCT00866762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581946|NCT00866762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793250|NCT03690011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24581956|NCT00866853|Simeprevir|simeprevir|mesh-list
24581984|NCT00866944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581985|NCT00866944|Antidotes|antidotes|mesh-ancestor
24581988|NCT00866944|Vitamins|vitamins|mesh-ancestor
24581991|NCT00866983|Vasodilator Agents|vasodilator agents|mesh-ancestor
24581992|NCT00866983|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24581993|NCT00866983|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24581994|NCT00866983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581995|NCT00866983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581996|NCT00866983|Urological Agents|urological agents|mesh-ancestor
24582032|NCT00867152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24582033|NCT00867152|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24582034|NCT00867152|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24582035|NCT00867152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24582036|NCT00867152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24582038|NCT00867295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24582039|NCT00867295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24582040|NCT00867672|Decitabine|decitabine|mesh-list
24582041|NCT00867672|Tretinoin|tretinoin|mesh-list
24582042|NCT00867672|Valproic Acid|valproic acid|mesh-list
24582043|NCT00867672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24582044|NCT00867672|Antimetabolites|antimetabolites|mesh-ancestor
24448331|NCT00311337|Bortezomib|bortezomib|mesh-list
24582045|NCT00867672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582046|NCT00867672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582047|NCT00867672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24582048|NCT00867672|Keratolytic Agents|keratolytic agents|mesh-ancestor
24582049|NCT00867672|Dermatologic Agents|dermatologic agents|mesh-ancestor
24582063|NCT00867737|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24582065|NCT00867737|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24582066|NCT00867737|Autonomic Agents|autonomic agents|mesh-ancestor
24582067|NCT00867737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24582068|NCT00867737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582069|NCT00867737|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24582070|NCT00867737|Respiratory System Agents|respiratory system agents|mesh-ancestor
24582071|NCT00867737|Dermatologic Agents|dermatologic agents|mesh-ancestor
24582081|NCT00867737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582082|NCT00867737|Sympathomimetics|sympathomimetics|mesh-ancestor
24582083|NCT00867867|Ferrous fumarate|ferrous fumarate|mesh-list
24582084|NCT00867867|Trace Elements|trace elements|mesh-ancestor
24582085|NCT00867867|Micronutrients|micronutrients|mesh-ancestor
25110071|NCT03120403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24793251|NCT03690011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24793252|NCT03690011|Alkylating Agents|alkylating agents|mesh-ancestor
25010210|NCT04530305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25110079|NCT03120494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110081|NCT03120494|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25110082|NCT03120637|Methylene Blue|methylene blue|mesh-list
25110083|NCT03120637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25110084|NCT03120637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110085|NCT03120663|Amoxicillin|amoxicillin|mesh-list
25110086|NCT03120663|Clindamycin|clindamycin|mesh-list
25110087|NCT03120663|Meropenem|meropenem|mesh-list
25110088|NCT03120663|Tazobactam|tazobactam|mesh-list
25110089|NCT03120663|Piperacillin|piperacillin|mesh-list
25110090|NCT03120663|Clavulanic Acids|clavulanic acids|mesh-list
25110091|NCT03120663|Clavulanic Acid|clavulanic acid|mesh-list
25110092|NCT03120663|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25110093|NCT03120663|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25110094|NCT03120663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25110095|NCT03120663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25110096|NCT03120663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25110097|NCT03120663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25110098|NCT03120663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110099|NCT03120663|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25110101|NCT03120273|Dexlansoprazole|dexlansoprazole|mesh-list
25110102|NCT03120273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25110103|NCT03120273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25110104|NCT03120273|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25110105|NCT03120273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25110106|NCT03120273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110107|NCT03120247|Dexmedetomidine|dexmedetomidine|mesh-list
25110108|NCT03120247|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25110109|NCT03120247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25110110|NCT03120247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110111|NCT03120247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25110112|NCT03120247|Analgesics|analgesics|mesh-ancestor
25110113|NCT03120247|Sensory System Agents|sensory system agents|mesh-ancestor
25110114|NCT03120247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25110115|NCT03120247|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25110116|NCT03120247|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25110117|NCT03120247|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25110118|NCT03120247|Adrenergic Agents|adrenergic agents|mesh-ancestor
24580320|NCT00861367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24580321|NCT00861367|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24580322|NCT00861367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24580326|NCT00861367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25110120|NCT03120247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582088|NCT00868010|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24582102|NCT00868023|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24582104|NCT00868023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24976294|NCT04192370|Anticonvulsants|anticonvulsants|mesh-ancestor
24976295|NCT04188028|Dextromethorphan|dextromethorphan|mesh-list
24582152|NCT00868426|Autonomic Agents|autonomic agents|mesh-ancestor
24582153|NCT00868426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24582154|NCT00868426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582155|NCT00868426|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25703688|NCT02169479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703689|NCT02169479|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25703690|NCT02169479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24582156|NCT00868426|Respiratory System Agents|respiratory system agents|mesh-ancestor
24582182|NCT00868491|Tubulin Modulators|tubulin modulators|mesh-ancestor
24582183|NCT00868491|Antimitotic Agents|antimitotic agents|mesh-ancestor
24582184|NCT00868491|Mitosis Modulators|mitosis modulators|mesh-ancestor
24582185|NCT00868491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582186|NCT00868491|Antimetabolites|antimetabolites|mesh-ancestor
24582187|NCT00868491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24582188|NCT00868491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24582199|NCT00868569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24582200|NCT00868569|Immunologic Factors|immunologic factors|mesh-ancestor
24582201|NCT00868569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582242|NCT00868829|Sirolimus|sirolimus|mesh-list
24632855|NCT01125943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632856|NCT01125943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24632857|NCT01125943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24632858|NCT01125943|Growth Substances|growth substances|mesh-ancestor
24632859|NCT01125943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632860|NCT01125943|Growth Inhibitors|growth inhibitors|mesh-ancestor
24976296|NCT04188028|Paroxetine|paroxetine|mesh-list
24696212|NCT01428050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24696213|NCT01428154|Darbepoetin alfa|darbepoetin alfa|mesh-list
24696214|NCT01428154|Hematinics|hematinics|mesh-ancestor
24696215|NCT01428180|Ibuprofen|ibuprofen|mesh-list
24632862|NCT01125943|Vasodilator Agents|vasodilator agents|mesh-ancestor
24582243|NCT00868829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24582252|NCT00868829|Micronutrients|micronutrients|mesh-ancestor
24582253|NCT00868855|Bradykinin|bradykinin|mesh-list
24582254|NCT00868855|Kininogens|kininogens|mesh-list
24582255|NCT00868855|Vasodilator Agents|vasodilator agents|mesh-ancestor
24580422|NCT00861783|Irinotecan|irinotecan|mesh-list
24582256|NCT00868855|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
24582257|NCT00868855|Protease Inhibitors|protease inhibitors|mesh-ancestor
24582258|NCT00868855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24582259|NCT00868855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582260|NCT00868894|Latanoprost|latanoprost|mesh-list
24582261|NCT00868894|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24582262|NCT00868894|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24582263|NCT00868907|Risedronic Acid|risedronic acid|mesh-list
24582264|NCT00868907|Etidronic Acid|etidronic acid|mesh-list
24582265|NCT00868907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24582266|NCT00868907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24582267|NCT00868907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582268|NCT00868907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24582269|NCT00868907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582271|NCT00868946|Ribavirin|ribavirin|mesh-list
24582301|NCT00869180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24582302|NCT00869180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582303|NCT00869193|Grape Seed Extract|grape seed extract|mesh-list
24582304|NCT00869193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24582305|NCT00869193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582306|NCT00869193|Antioxidants|antioxidants|mesh-ancestor
24582307|NCT00869193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010222|NCT04477265|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24582308|NCT00869193|Protective Agents|protective agents|mesh-ancestor
24582407|NCT00869570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24582409|NCT00869570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582410|NCT00869570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582411|NCT00869570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24582412|NCT00869570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703692|NCT02169505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25703693|NCT02169505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25703694|NCT02169791|Ixazomib|ixazomib|mesh-list
25703695|NCT02169791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582413|NCT00869596|Fluticasone|fluticasone|mesh-list
24582415|NCT00869596|Albuterol|albuterol|mesh-list
24582416|NCT00869596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24582417|NCT00869596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24582418|NCT00869596|Autonomic Agents|autonomic agents|mesh-ancestor
24582419|NCT00869596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24582420|NCT00869596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582421|NCT00869596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24582422|NCT00869596|Respiratory System Agents|respiratory system agents|mesh-ancestor
24582423|NCT00869596|Dermatologic Agents|dermatologic agents|mesh-ancestor
24582424|NCT00869596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24582475|NCT00869908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24582476|NCT00869908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582477|NCT00869973|Dexamethasone|dexamethasone|mesh-list
24582478|NCT00869973|Aprepitant|aprepitant|mesh-list
24582479|NCT00869973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24582480|NCT00869973|Antiemetics|antiemetics|mesh-ancestor
24582481|NCT00869973|Autonomic Agents|autonomic agents|mesh-ancestor
24582482|NCT00869973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24582483|NCT00869973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582527|NCT00870272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582528|NCT00870272|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24582529|NCT00870272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24582531|NCT00870298|Trimethoprim|trimethoprim|mesh-list
24582532|NCT00870298|Sulfamethoxazole|sulfamethoxazole|mesh-list
24582534|NCT00870298|Anticoagulants|anticoagulants|mesh-ancestor
24582535|NCT00870298|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24582536|NCT00870298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24582537|NCT00870298|Renal Agents|renal agents|mesh-ancestor
24582538|NCT00870298|Antimalarials|antimalarials|mesh-ancestor
24582566|NCT00870402|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24582567|NCT00870402|Diuretics|diuretics|mesh-ancestor
24582568|NCT00870402|Natriuretic Agents|natriuretic agents|mesh-ancestor
24582569|NCT00870441|Valacyclovir|valacyclovir|mesh-list
24582570|NCT00870441|Antiviral Agents|antiviral agents|mesh-ancestor
24582571|NCT00870441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24582572|NCT00870480|Finasteride|finasteride|mesh-list
24582581|NCT00870532|Sorafenib|sorafenib|mesh-list
24582582|NCT00870532|Vinorelbine|vinorelbine|mesh-list
24582583|NCT00870532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582584|NCT00870532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24582585|NCT00870532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24582586|NCT00870532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582587|NCT00870532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24582624|NCT00870714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582625|NCT00870714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24582627|NCT00870779|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24582628|NCT00870779|Dermatologic Agents|dermatologic agents|mesh-ancestor
24582629|NCT00870883|Acetylcysteine|acetylcysteine|mesh-list
24582630|NCT00870883|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24582631|NCT00870883|Deferoxamine|deferoxamine|mesh-list
24582632|NCT00870883|Antiviral Agents|antiviral agents|mesh-ancestor
24582633|NCT00870883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24582634|NCT00870883|Expectorants|expectorants|mesh-ancestor
24582635|NCT00870883|Respiratory System Agents|respiratory system agents|mesh-ancestor
24582636|NCT00870883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24582661|NCT00871039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24582662|NCT00871039|Anesthetics, General|anesthetics, general|mesh-ancestor
24582664|NCT00871039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24582665|NCT00871039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24582666|NCT00871039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24582667|NCT00871039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24582668|NCT00871039|GABA Modulators|gaba modulators|mesh-ancestor
24582669|NCT00871039|GABA Agents|gaba agents|mesh-ancestor
24582670|NCT00871039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24582671|NCT00871039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582673|NCT00871052|Calcipotriene|calcipotriene|mesh-list
24582674|NCT00871052|Vitamins|vitamins|mesh-ancestor
24582675|NCT00871052|Micronutrients|micronutrients|mesh-ancestor
24582676|NCT00871052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582677|NCT00871052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24582678|NCT00871052|Dermatologic Agents|dermatologic agents|mesh-ancestor
24582679|NCT00871065|Sildenafil Citrate|sildenafil citrate|mesh-list
24582714|NCT00871208|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24582715|NCT00871208|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
24582716|NCT00871208|Dermatologic Agents|dermatologic agents|mesh-ancestor
24582717|NCT00871208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25010234|NCT04464070|Sensory System Agents|sensory system agents|mesh-ancestor
25010235|NCT04464070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25010236|NCT04464070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010237|NCT04464070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25010238|NCT04464070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25010239|NCT04464070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25010240|NCT04464070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25010241|NCT04464070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010242|NCT04464070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24568680|NCT00797017|Anesthetics, General|anesthetics, general|mesh-ancestor
25010274|NCT04313075|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25010275|NCT04313075|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25010276|NCT04313075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010277|NCT04313075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25010278|NCT04313075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25010279|NCT04313075|Antiviral Agents|antiviral agents|mesh-ancestor
25010280|NCT04313075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25010281|NCT04305795|Pembrolizumab|pembrolizumab|mesh-list
25010282|NCT04305795|Cemiplimab|cemiplimab|mesh-list
25010283|NCT04305795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25010284|NCT04305795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582727|NCT00871247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582736|NCT00871364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24582737|NCT00871364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24582738|NCT00871364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582739|NCT00871364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24582740|NCT00871364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582741|NCT00871364|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24582742|NCT00871364|Antidepressive Agents|antidepressive agents|mesh-ancestor
24582743|NCT00871364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24582745|NCT00871442|Bupivacaine|bupivacaine|mesh-list
24582746|NCT00871442|Anesthetics|anesthetics|mesh-list
24582747|NCT00871442|Anesthetics, Local|anesthetics, local|mesh-ancestor
24582748|NCT00871442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24582749|NCT00871442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582750|NCT00871442|Sensory System Agents|sensory system agents|mesh-ancestor
24582816|NCT00871910|Dermatologic Agents|dermatologic agents|mesh-ancestor
24582817|NCT00871910|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24582818|NCT00871910|Serotonin Agents|serotonin agents|mesh-ancestor
24582819|NCT00871910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24582820|NCT00871910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582821|NCT00871910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24582822|NCT00871910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24582823|NCT00871910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24582824|NCT00871910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24582825|NCT00871910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24582828|NCT00871949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24582829|NCT00871949|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24582830|NCT00871949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24582831|NCT00871949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582832|NCT00872131|Sertraline|sertraline|mesh-list
24582833|NCT00872131|Antidepressive Agents|antidepressive agents|mesh-ancestor
24582834|NCT00872131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24582835|NCT00872131|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24582861|NCT00872235|Natriuretic Agents|natriuretic agents|mesh-ancestor
24632932|NCT01126229|Resveratrol|resveratrol|mesh-list
24582864|NCT00872235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24582865|NCT00872235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582866|NCT00872235|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24582867|NCT00872235|Protease Inhibitors|protease inhibitors|mesh-ancestor
24582887|NCT00872378|Incretins|incretins|mesh-ancestor
24582888|NCT00872378|Hormones|hormones|mesh-ancestor
24582889|NCT00872378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24582890|NCT00872417|Lamivudine|lamivudine|mesh-list
25703696|NCT02169791|Protease Inhibitors|protease inhibitors|mesh-ancestor
25703697|NCT02169791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24582891|NCT00872417|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24582892|NCT00872417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24582894|NCT00872417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582895|NCT00872417|Antiviral Agents|antiviral agents|mesh-ancestor
24582896|NCT00872417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24582897|NCT00872417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24582898|NCT00872417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24582899|NCT00872469|Tranexamic Acid|tranexamic acid|mesh-list
24582900|NCT00872469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24582901|NCT00872469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24582950|NCT00872651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582951|NCT00872651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24582952|NCT00872651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24582953|NCT00872651|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24582954|NCT00872651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24582955|NCT00872664|Carotenoids|carotenoids|mesh-list
24582956|NCT00872664|Antioxidants|antioxidants|mesh-ancestor
24582957|NCT00872664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582965|NCT00872716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24582966|NCT00872716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582967|NCT00872781|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24582968|NCT00872781|Quinapril|quinapril|mesh-list
24582969|NCT00872781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24582970|NCT00872781|Diuretics|diuretics|mesh-ancestor
24582971|NCT00872781|Natriuretic Agents|natriuretic agents|mesh-ancestor
24696216|NCT01428180|Indomethacin|indomethacin|mesh-list
24582972|NCT00872781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582973|NCT00872781|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24583009|NCT00873197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583010|NCT00873197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24583011|NCT00873197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24583013|NCT00873197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24583014|NCT00873197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583015|NCT00873210|Sunitinib|sunitinib|mesh-list
24583016|NCT00873210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583017|NCT00873210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24583018|NCT00873210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24583020|NCT00873210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583021|NCT00873210|Growth Inhibitors|growth inhibitors|mesh-ancestor
24583022|NCT00873210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24583023|NCT00873210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24583024|NCT00873210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583025|NCT00873223|Liraglutide|liraglutide|mesh-list
24583026|NCT00873223|Insulin Detemir|insulin detemir|mesh-list
24583027|NCT00873223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24632961|NCT01126450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632962|NCT01126450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24443874|NCT00296023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24443875|NCT00296023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24583035|NCT00873236|Bevacizumab|bevacizumab|mesh-list
24583036|NCT00873236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24583037|NCT00873236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583038|NCT00873236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24583039|NCT00873236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24583040|NCT00873236|Growth Substances|growth substances|mesh-ancestor
24583041|NCT00873236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583042|NCT00873236|Growth Inhibitors|growth inhibitors|mesh-ancestor
24583043|NCT00873236|Antiviral Agents|antiviral agents|mesh-ancestor
24583044|NCT00873236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24583045|NCT00873236|Immunologic Factors|immunologic factors|mesh-ancestor
24583046|NCT00873262|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24583047|NCT00873262|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24583060|NCT00873262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24583061|NCT00873262|Progestins|progestins|mesh-ancestor
24793434|NCT03504644|Vincristine|vincristine|mesh-list
24793436|NCT03504644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24793437|NCT03504644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793438|NCT03504644|Tubulin Modulators|tubulin modulators|mesh-ancestor
24793445|NCT03485534|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24793446|NCT03485534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24793448|NCT03485534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793449|NCT03485534|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25010291|NCT04301934|Estrogens|estrogens|mesh-list
25010292|NCT04301934|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25010293|NCT04301934|Hormones|hormones|mesh-ancestor
25010294|NCT04301934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25010295|NCT04301934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010296|NCT04233840|Nivolumab|nivolumab|mesh-list
25010297|NCT04233840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25010298|NCT04233840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010299|NCT04233840|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25010300|NCT04233840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010301|NCT04229290|Dolutegravir|dolutegravir|mesh-list
25010302|NCT04229290|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25010303|NCT04229290|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25010304|NCT04229290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25010305|NCT04229290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010306|NCT04229290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25010307|NCT04229290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25010308|NCT04229290|Antiviral Agents|antiviral agents|mesh-ancestor
25010309|NCT04229290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24793450|NCT03485534|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24583157|NCT00873496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24583158|NCT00873496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24583159|NCT00873496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901683|NCT04382300|Thalidomide|thalidomide|mesh-list
24580865|NCT00863902|Cetirizine|cetirizine|mesh-list
24580866|NCT00863902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24580874|NCT00863915|Ramipril|ramipril|mesh-list
24583160|NCT00873496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583161|NCT00873496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24583162|NCT00873509|Buspirone|buspirone|mesh-list
24583199|NCT00873639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24583296|NCT00874003|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24583297|NCT00874003|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24583298|NCT00874003|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24583316|NCT00874068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632972|NCT01126528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110122|NCT05465330|Desflurane|desflurane|mesh-list
24583323|NCT00874107|Tubulin Modulators|tubulin modulators|mesh-ancestor
24583324|NCT00874107|Antimitotic Agents|antimitotic agents|mesh-ancestor
24580999|NCT00864188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583325|NCT00874107|Mitosis Modulators|mitosis modulators|mesh-ancestor
24583326|NCT00874107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583327|NCT00874107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24583328|NCT00874107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24583329|NCT00874107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24583330|NCT00874107|Growth Substances|growth substances|mesh-ancestor
24583331|NCT00874107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703698|NCT02169791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703699|NCT02169869|Levonorgestrel|levonorgestrel|mesh-list
25703700|NCT02169869|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25703701|NCT02169869|Contraceptive Agents|contraceptive agents|mesh-ancestor
25703702|NCT02169869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25703703|NCT02169869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703704|NCT02169869|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25703705|NCT02169869|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25703706|NCT02169869|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25703707|NCT02169895|Opicapone|opicapone|mesh-list
24583332|NCT00874107|Growth Inhibitors|growth inhibitors|mesh-ancestor
24583333|NCT00874133|Domperidone|domperidone|mesh-list
24583334|NCT00874133|Antiemetics|antiemetics|mesh-ancestor
24583335|NCT00874133|Autonomic Agents|autonomic agents|mesh-ancestor
24583336|NCT00874133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24583337|NCT00874133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583338|NCT00874133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24583339|NCT00874133|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24583340|NCT00874133|Dopamine Agents|dopamine agents|mesh-ancestor
24696292|NCT01428492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24696293|NCT01428492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696294|NCT01428492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24696295|NCT01428492|Glucocorticoids|glucocorticoids|mesh-ancestor
24696296|NCT01428492|Hormones|hormones|mesh-ancestor
24696297|NCT01428492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24696298|NCT01428492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24696299|NCT01428492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24696300|NCT01428518|Lamotrigine|lamotrigine|mesh-list
24696301|NCT01428518|Anticonvulsants|anticonvulsants|mesh-ancestor
24696305|NCT01428518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24696306|NCT01428518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696307|NCT01428518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24583342|NCT00874133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583343|NCT00874172|Analgesics|analgesics|mesh-list
24583344|NCT00874172|Sensory System Agents|sensory system agents|mesh-ancestor
24583345|NCT00874172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24583346|NCT00874172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583347|NCT00874315|Cyclosporine|cyclosporine|mesh-list
24583348|NCT00874315|Mycophenolic Acid|mycophenolic acid|mesh-list
24583349|NCT00874315|Fludarabine|fludarabine|mesh-list
24583350|NCT00874315|Fludarabine phosphate|fludarabine phosphate|mesh-list
24583351|NCT00874315|Busulfan|busulfan|mesh-list
24583352|NCT00874315|Tacrolimus|tacrolimus|mesh-list
24583353|NCT00874315|Cyclosporins|cyclosporins|mesh-list
24583354|NCT00874315|Thymoglobulin|thymoglobulin|mesh-list
24583355|NCT00874315|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24583356|NCT00874315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583357|NCT00874315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24583384|NCT00874393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24583385|NCT00874393|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24583386|NCT00874393|Sympathomimetics|sympathomimetics|mesh-ancestor
24583387|NCT00874393|Autonomic Agents|autonomic agents|mesh-ancestor
24583388|NCT00874393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24583389|NCT00874393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696308|NCT01428518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24396727|NCT00139815|Enoxaparin|enoxaparin|mesh-list
24696364|NCT01429025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696366|NCT01429025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24696367|NCT01429025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24696368|NCT01429025|Growth Substances|growth substances|mesh-ancestor
24696369|NCT01429025|Growth Inhibitors|growth inhibitors|mesh-ancestor
24696370|NCT01429025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24696371|NCT01429025|Alkylating Agents|alkylating agents|mesh-ancestor
24696375|NCT01429090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24696376|NCT01429090|Cholinergic Agents|cholinergic agents|mesh-ancestor
24696377|NCT01429090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24696378|NCT01429090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696379|NCT01429090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696380|NCT01429129|Nicotine|nicotine|mesh-list
24696381|NCT01429129|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24696382|NCT01429129|Autonomic Agents|autonomic agents|mesh-ancestor
24696383|NCT01429129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24696384|NCT01429129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696385|NCT01429129|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24696386|NCT01429129|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25703708|NCT02169895|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
25703709|NCT02169895|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25703710|NCT02169895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24696387|NCT01429129|Cholinergic Agents|cholinergic agents|mesh-ancestor
24696388|NCT01429129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25703711|NCT02169895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848020|NCT05248633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24848021|NCT05248633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696389|NCT01429129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696390|NCT01429181|Methadone|methadone|mesh-list
24696391|NCT01429181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24696392|NCT01429181|Narcotics|narcotics|mesh-ancestor
24696393|NCT01429181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24696394|NCT01429181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696395|NCT01429181|Analgesics|analgesics|mesh-ancestor
24696396|NCT01429181|Sensory System Agents|sensory system agents|mesh-ancestor
24583390|NCT00874393|Dopamine Agents|dopamine agents|mesh-ancestor
24583391|NCT00874393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24583392|NCT00874393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583393|NCT00874393|Protective Agents|protective agents|mesh-ancestor
24583396|NCT00874406|Oxaliplatin|oxaliplatin|mesh-list
24583397|NCT00874406|Antimetabolites|antimetabolites|mesh-ancestor
24583398|NCT00874406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583399|NCT00874406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24583400|NCT00874406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583401|NCT00874406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24583402|NCT00874406|Immunologic Factors|immunologic factors|mesh-ancestor
24583403|NCT00874406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583404|NCT00874406|Antidotes|antidotes|mesh-ancestor
24583405|NCT00874406|Protective Agents|protective agents|mesh-ancestor
24583406|NCT00874406|Vitamin B Complex|vitamin b complex|mesh-ancestor
24583407|NCT00874406|Vitamins|vitamins|mesh-ancestor
24583408|NCT00874406|Micronutrients|micronutrients|mesh-ancestor
24583409|NCT00874419|Gemcitabine|gemcitabine|mesh-list
24583410|NCT00874419|Carboplatin|carboplatin|mesh-list
24793470|NCT03439345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24793472|NCT03427736|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24793473|NCT03427736|Ketamine|ketamine|mesh-list
24793474|NCT03427736|Morphine|morphine|mesh-list
24793475|NCT03427736|Oxycodone|oxycodone|mesh-list
24793476|NCT03427736|Hydromorphone|hydromorphone|mesh-list
24793477|NCT03427736|Analgesics|analgesics|mesh-ancestor
24793478|NCT03427736|Sensory System Agents|sensory system agents|mesh-ancestor
24696398|NCT01429181|Antitussive Agents|antitussive agents|mesh-ancestor
25010341|NCT04218240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25010342|NCT04218240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25010343|NCT04218240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25010344|NCT04218240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25010345|NCT04218240|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25010346|NCT04218240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24583460|NCT00874601|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24583462|NCT00874601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583463|NCT00874653|Levonorgestrel|levonorgestrel|mesh-list
24583464|NCT00874653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24583465|NCT00874653|Contraceptive Agents|contraceptive agents|mesh-ancestor
24583466|NCT00874653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24583467|NCT00874653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583468|NCT00874653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24583469|NCT00874653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24583470|NCT00874653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24583471|NCT00874679|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24583472|NCT00874679|Vasodilator Agents|vasodilator agents|mesh-ancestor
24583473|NCT00874679|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24583474|NCT00874679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24583488|NCT00874744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583489|NCT00874744|Growth Inhibitors|growth inhibitors|mesh-ancestor
24583490|NCT00874744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24583491|NCT00874744|Glucocorticoids|glucocorticoids|mesh-ancestor
24583492|NCT00874744|Hormones|hormones|mesh-ancestor
24583493|NCT00874744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24583494|NCT00874744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24583495|NCT00874744|Immunologic Factors|immunologic factors|mesh-ancestor
24583496|NCT00874744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632999|NCT01126697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24633000|NCT01126697|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24633001|NCT01126697|Protective Agents|protective agents|mesh-ancestor
24633002|NCT01126697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703712|NCT02169895|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25703713|NCT02169895|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24583518|NCT00874978|Growth Substances|growth substances|mesh-ancestor
24583519|NCT00874978|Growth Inhibitors|growth inhibitors|mesh-ancestor
24583520|NCT00874978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583524|NCT00875030|Antimalarials|antimalarials|mesh-ancestor
24583525|NCT00875030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24583526|NCT00875030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24583543|NCT00875082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24583544|NCT00875082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583573|NCT00875355|Temozolomide|temozolomide|mesh-list
24583574|NCT00875355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24583575|NCT00875355|Alkylating Agents|alkylating agents|mesh-ancestor
24583576|NCT00875355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583577|NCT00875355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583578|NCT00875368|Maraviroc|maraviroc|mesh-list
24583579|NCT00875368|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24583580|NCT00875368|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24583581|NCT00875368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583582|NCT00875368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24583583|NCT00875368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24583584|NCT00875368|Antiviral Agents|antiviral agents|mesh-ancestor
24583585|NCT00875368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24583586|NCT00875368|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24583587|NCT00875407|3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|mesh-list
24583588|NCT00875407|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24583589|NCT00875407|Dopamine Agents|dopamine agents|mesh-ancestor
24583590|NCT00875407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24569460|NCT00800592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24583624|NCT00875784|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24583625|NCT00875784|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24583626|NCT00875784|Serotonin Agents|serotonin agents|mesh-ancestor
24583627|NCT00875784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24976828|NCT05040984|Mirabegron|mirabegron|mesh-list
24583628|NCT00875784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583629|NCT00875784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583631|NCT00875849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583632|NCT00875849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24583633|NCT00875875|Rifaximin|rifaximin|mesh-list
24583634|NCT00875875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24583635|NCT00875875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24583636|NCT00875875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24583637|NCT00875927|Zinc|zinc|mesh-list
24583638|NCT00875927|Propolis|propolis|mesh-list
24583639|NCT00875927|Trace Elements|trace elements|mesh-ancestor
24583640|NCT00875927|Micronutrients|micronutrients|mesh-ancestor
24583641|NCT00875927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703714|NCT02169895|Dopamine Agents|dopamine agents|mesh-ancestor
25703715|NCT02169895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25703716|NCT02169895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703717|NCT02170025|Riociguat|riociguat|mesh-list
25703718|NCT02170025|Enzyme Activators|enzyme activators|mesh-ancestor
25703719|NCT02170025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703720|NCT02170064|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25703721|NCT02170064|Anticonvulsants|anticonvulsants|mesh-ancestor
25703722|NCT02170064|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25703723|NCT02170064|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25703724|NCT02170064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24583644|NCT00875966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24583645|NCT00875966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24583646|NCT00876044|Aflibercept|aflibercept|mesh-list
24583647|NCT00876044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24633015|NCT01126814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633016|NCT01126866|Bevacizumab|bevacizumab|mesh-list
24633017|NCT01126866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24633018|NCT01126866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633019|NCT01126866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24633020|NCT01126866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24633021|NCT01126866|Growth Substances|growth substances|mesh-ancestor
24633022|NCT01126866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633023|NCT01126866|Growth Inhibitors|growth inhibitors|mesh-ancestor
24633024|NCT01127009|Cytarabine|cytarabine|mesh-list
24583648|NCT00876044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24583654|NCT00876135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24583655|NCT00876135|Autonomic Agents|autonomic agents|mesh-ancestor
24583678|NCT00876226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24583679|NCT00876317|Etoricoxib|etoricoxib|mesh-list
24583680|NCT00876317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24583681|NCT00876317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24583682|NCT00876317|Analgesics|analgesics|mesh-ancestor
24583683|NCT00876317|Sensory System Agents|sensory system agents|mesh-ancestor
24583684|NCT00876317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24583685|NCT00876317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583686|NCT00876317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24583687|NCT00876317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24583688|NCT00876317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24583689|NCT00876317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24583691|NCT00876317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583692|NCT00876330|Antihypertensive Agents|antihypertensive agents|mesh-list
24583693|NCT00876421|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24583694|NCT00876421|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24583695|NCT00876421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24583910|NCT00877591|Rifampin|rifampin|mesh-list
24583715|NCT00876577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24583716|NCT00876577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24793554|NCT03150329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793555|NCT03150329|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24793556|NCT03150329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24793557|NCT03150329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583719|NCT00876577|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24583720|NCT00876577|Contraceptive Agents|contraceptive agents|mesh-ancestor
24583721|NCT00876577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24583722|NCT00876577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583723|NCT00876577|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24583724|NCT00876577|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24583725|NCT00876577|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24583726|NCT00876616|Mycophenolic Acid|mycophenolic acid|mesh-list
24583727|NCT00876616|Cyclophosphamide|cyclophosphamide|mesh-list
24583728|NCT00876616|Tacrolimus|tacrolimus|mesh-list
24583729|NCT00876616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24583730|NCT00876616|Immunologic Factors|immunologic factors|mesh-ancestor
24583731|NCT00876616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583732|NCT00876616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24583733|NCT00876616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24583734|NCT00876616|Alkylating Agents|alkylating agents|mesh-ancestor
24583735|NCT00876616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583736|NCT00876616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583737|NCT00876616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25703725|NCT02170064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703726|NCT02170077|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25703727|NCT02170077|Anticonvulsants|anticonvulsants|mesh-ancestor
24583742|NCT00876616|Antitubercular Agents|antitubercular agents|mesh-ancestor
25010400|NCT04181476|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25010402|NCT04181476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010403|NCT04181476|Dermatologic Agents|dermatologic agents|mesh-ancestor
24696399|NCT01429181|Respiratory System Agents|respiratory system agents|mesh-ancestor
25010404|NCT04162015|Carboplatin|carboplatin|mesh-list
25010405|NCT04162015|Nivolumab|nivolumab|mesh-list
25010406|NCT04162015|Pemetrexed|pemetrexed|mesh-list
25010407|NCT04162015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010408|NCT04162015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25010409|NCT04162015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25010410|NCT04162015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010411|NCT04162015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25010412|NCT04162015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25010413|NCT04162015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25010414|NCT04129723|Tin Fluorides|tin fluorides|mesh-list
25010415|NCT04129723|Cariostatic Agents|cariostatic agents|mesh-ancestor
25010416|NCT04129723|Protective Agents|protective agents|mesh-ancestor
25010417|NCT04129723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793558|NCT03123913|Methyltestosterone|methyltestosterone|mesh-list
24583743|NCT00876616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24583744|NCT00876616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24583745|NCT00876655|Tedizolid phosphate|tedizolid phosphate|mesh-list
24583746|NCT00876655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24583780|NCT00876889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24583781|NCT00876889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24583782|NCT00876889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24583783|NCT00876889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696474|NCT01429701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24696500|NCT01429714|Nasal Decongestants|nasal decongestants|mesh-ancestor
24696501|NCT01429714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24696502|NCT01429714|Respiratory System Agents|respiratory system agents|mesh-ancestor
24696503|NCT01429818|Metformin|metformin|mesh-list
24696504|NCT01429818|Glimepiride|glimepiride|mesh-list
24696505|NCT01429818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24696506|NCT01429818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696507|NCT01429818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24696508|NCT01429818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24696509|NCT01429818|Immunologic Factors|immunologic factors|mesh-ancestor
24696510|NCT01429831|Aripiprazole|aripiprazole|mesh-list
24583784|NCT00876889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583788|NCT00876902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24583789|NCT00876902|Immunologic Factors|immunologic factors|mesh-ancestor
24583820|NCT00877110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24583821|NCT00877110|Immunologic Factors|immunologic factors|mesh-ancestor
24583822|NCT00877110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583823|NCT00877110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25703728|NCT02170077|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25703729|NCT02170077|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25703730|NCT02170077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25703731|NCT02170077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703732|NCT02170207|Lansoprazole|lansoprazole|mesh-list
25703733|NCT02170207|Dexlansoprazole|dexlansoprazole|mesh-list
25703734|NCT02170207|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25703735|NCT02170207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25703736|NCT02170207|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24583824|NCT00877110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24583825|NCT00877110|Alkylating Agents|alkylating agents|mesh-ancestor
24583827|NCT00877110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583828|NCT00877110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24583829|NCT00877110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24583830|NCT00877110|Tubulin Modulators|tubulin modulators|mesh-ancestor
24583831|NCT00877110|Antimitotic Agents|antimitotic agents|mesh-ancestor
24583832|NCT00877110|Mitosis Modulators|mitosis modulators|mesh-ancestor
24583833|NCT00877110|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24583834|NCT00877110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24583835|NCT00877110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24583837|NCT00877123|Vitamins|vitamins|mesh-ancestor
24583838|NCT00877123|Micronutrients|micronutrients|mesh-ancestor
24583839|NCT00877123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583840|NCT00877123|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24583841|NCT00877149|Telbivudine|telbivudine|mesh-list
24583842|NCT00877149|Antiviral Agents|antiviral agents|mesh-ancestor
24583843|NCT00877149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24583844|NCT00877149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24583845|NCT00877149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633066|NCT01127100|Sensory System Agents|sensory system agents|mesh-ancestor
24583847|NCT00877175|Phenylephrine|phenylephrine|mesh-list
24583859|NCT00877175|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24583860|NCT00877175|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24583861|NCT00877175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24583862|NCT00877175|Adrenergic Agents|adrenergic agents|mesh-ancestor
24583863|NCT00877175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24633084|NCT01127178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633085|NCT01127178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633086|NCT01127204|Lamivudine|lamivudine|mesh-list
24583894|NCT00877422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24583895|NCT00877422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24583896|NCT00877539|Fluticasone|fluticasone|mesh-list
24583899|NCT00877539|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24583900|NCT00877539|Autonomic Agents|autonomic agents|mesh-ancestor
24583901|NCT00877539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24583902|NCT00877539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583903|NCT00877539|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24583904|NCT00877539|Respiratory System Agents|respiratory system agents|mesh-ancestor
24583905|NCT00877539|Dermatologic Agents|dermatologic agents|mesh-ancestor
24583906|NCT00877539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24583907|NCT00877591|Ritonavir|ritonavir|mesh-list
24583908|NCT00877591|Darunavir|darunavir|mesh-list
24583909|NCT00877591|Fosamprenavir|fosamprenavir|mesh-list
24583913|NCT00877591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24583914|NCT00877591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24583915|NCT00877591|Protease Inhibitors|protease inhibitors|mesh-ancestor
24583916|NCT00877591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24583917|NCT00877591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583934|NCT00877591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24583954|NCT00877734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24583955|NCT00877734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583956|NCT00877760|Interferons|interferons|mesh-list
24583959|NCT00877760|Antiviral Agents|antiviral agents|mesh-ancestor
24583960|NCT00877760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24583961|NCT00877812|Glycine|glycine|mesh-list
24583962|NCT00877812|Glycine Agents|glycine agents|mesh-ancestor
24583963|NCT00877812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24583964|NCT00877812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583965|NCT00877812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583966|NCT00877955|Alprazolam|alprazolam|mesh-list
24583967|NCT00877955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24583968|NCT00877955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24583969|NCT00877955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583970|NCT00877955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24583971|NCT00877955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24583972|NCT00877955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24583973|NCT00877955|GABA Modulators|gaba modulators|mesh-ancestor
24583975|NCT00877955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24583976|NCT00877955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583977|NCT00877981|Parathyroid Hormone|parathyroid hormone|mesh-list
24583978|NCT00877981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24583979|NCT00877981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583980|NCT00878124|Ubiquinone|ubiquinone|mesh-list
24488056|NCT00466401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24583981|NCT00878124|Coenzyme Q10|coenzyme q10|mesh-list
24583982|NCT00878124|Micronutrients|micronutrients|mesh-ancestor
24583983|NCT00878124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583984|NCT00878124|Vitamins|vitamins|mesh-ancestor
24584084|NCT00878449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584086|NCT00878514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24584087|NCT00878514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24584088|NCT00878514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584089|NCT00878514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24584090|NCT00878514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24584091|NCT00878514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24584092|NCT00878514|GABA Modulators|gaba modulators|mesh-ancestor
24584094|NCT00878514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24584095|NCT00878514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584096|NCT00878540|Mirtazapine|mirtazapine|mesh-list
24903788|NCT04361474|Glucocorticoids|glucocorticoids|mesh-ancestor
24569861|NCT00802087|Acetaminophen|acetaminophen|mesh-list
24584109|NCT00878540|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24584110|NCT00878540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24584111|NCT00878540|Adrenergic Agents|adrenergic agents|mesh-ancestor
24584112|NCT00878540|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24584113|NCT00878540|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24584114|NCT00878540|Serotonin Agents|serotonin agents|mesh-ancestor
24584115|NCT00878540|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24584117|NCT00878631|Anticoagulants|anticoagulants|mesh-ancestor
24584118|NCT00878631|Plasma Substitutes|plasma substitutes|mesh-ancestor
24584119|NCT00878631|Blood Substitutes|blood substitutes|mesh-ancestor
24584121|NCT00878657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24584122|NCT00878657|Antimetabolites|antimetabolites|mesh-ancestor
24584124|NCT00878657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584161|NCT00878865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24584162|NCT00878865|GABA Modulators|gaba modulators|mesh-ancestor
24584163|NCT00878865|GABA Agents|gaba agents|mesh-ancestor
24584164|NCT00878865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24584165|NCT00878865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584166|NCT00878904|Epirubicin|epirubicin|mesh-list
24584167|NCT00878904|Panobinostat|panobinostat|mesh-list
24584509|NCT00880815|Methotrexate|methotrexate|mesh-list
24584172|NCT00878904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584173|NCT00878904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584174|NCT00878904|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24793577|NCT03091881|Antiemetics|antiemetics|mesh-ancestor
24793578|NCT03091881|Autonomic Agents|autonomic agents|mesh-ancestor
24793579|NCT03091881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24793580|NCT03091881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793581|NCT03091881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24793582|NCT03091881|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24584190|NCT00879008|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24584191|NCT00879008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24584211|NCT00879021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24584212|NCT00879021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24584213|NCT00879021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584214|NCT00879021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24584215|NCT00879021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25703737|NCT02170207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703738|NCT02170207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703739|NCT02170220|Vortioxetine|vortioxetine|mesh-list
25703740|NCT02170220|Antidepressive Agents|antidepressive agents|mesh-ancestor
25703741|NCT02170220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25703742|NCT02170220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25703743|NCT02170220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25703744|NCT02170220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24584216|NCT00879021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24584217|NCT00879021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24584219|NCT00879047|Ethanol|ethanol|mesh-list
24584220|NCT00879047|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24584221|NCT00879047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24628855|NCT01101685|Citalopram|citalopram|mesh-list
24584222|NCT00879047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24584223|NCT00879047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584226|NCT00879073|Alkylating Agents|alkylating agents|mesh-ancestor
24584240|NCT00879099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584241|NCT00879099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24633152|NCT01127386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633154|NCT01127464|Interferon Inducers|interferon inducers|mesh-ancestor
24584242|NCT00879099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24584243|NCT00879099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24584245|NCT00879099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24584246|NCT00879099|Antidepressive Agents|antidepressive agents|mesh-ancestor
24584247|NCT00879099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24584248|NCT00879099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24584249|NCT00879099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24584250|NCT00879164|Bupivacaine|bupivacaine|mesh-list
24696511|NCT01429831|Antidepressive Agents|antidepressive agents|mesh-ancestor
24696512|NCT01429831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24696513|NCT01429831|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24584251|NCT00879164|Anesthetics, Local|anesthetics, local|mesh-ancestor
24584253|NCT00879164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24584254|NCT00879164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584290|NCT00879424|Cholecalciferol|cholecalciferol|mesh-list
24584291|NCT00879424|Vitamins|vitamins|mesh-ancestor
24584292|NCT00879424|Micronutrients|micronutrients|mesh-ancestor
24584293|NCT00879424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584294|NCT00879424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24584295|NCT00879424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24584296|NCT00879476|Ramipril|ramipril|mesh-list
24584297|NCT00879476|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24584298|NCT00879476|Protease Inhibitors|protease inhibitors|mesh-ancestor
24584299|NCT00879476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584300|NCT00879476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584301|NCT00879476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24584302|NCT00879541|Factor VIII|factor viii|mesh-list
24584303|NCT00879541|Coagulants|coagulants|mesh-ancestor
24584305|NCT00879723|Micronutrients|micronutrients|mesh-ancestor
24584510|NCT00880815|Fludarabine|fludarabine|mesh-list
24584308|NCT00879788|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24584310|NCT00879788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584311|NCT00879788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584312|NCT00879788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24584314|NCT00879827|Anticoagulants|anticoagulants|mesh-ancestor
24584315|NCT00879827|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24584316|NCT00879827|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24584317|NCT00879827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584319|NCT00879892|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24584320|NCT00879892|Anesthetics, General|anesthetics, general|mesh-ancestor
24584321|NCT00879892|Anesthetics|anesthetics|mesh-ancestor
24584322|NCT00879892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24584351|NCT00879931|Protective Agents|protective agents|mesh-ancestor
24696514|NCT01429831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24696515|NCT01429831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24696516|NCT01429831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584352|NCT00879931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24584353|NCT00879931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584354|NCT00879957|Heparin|heparin|mesh-list
24584355|NCT00879957|Calcium heparin|calcium heparin|mesh-list
24584356|NCT00879957|Anticoagulants|anticoagulants|mesh-ancestor
24584357|NCT00879957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24584358|NCT00879957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24584359|NCT00879957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584360|NCT00879983|Azithromycin|azithromycin|mesh-list
24584361|NCT00879983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24584362|NCT00879983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24584364|NCT00880178|Niacinamide|niacinamide|mesh-list
24584365|NCT00880178|Nicotinic Acids|nicotinic acids|mesh-list
24584366|NCT00880178|Simvastatin|simvastatin|mesh-list
24584367|NCT00880178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24584368|NCT00880178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24584369|NCT00880178|Antimetabolites|antimetabolites|mesh-ancestor
24584370|NCT00880178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584371|NCT00880178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24584372|NCT00880178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24584374|NCT00880178|Vasodilator Agents|vasodilator agents|mesh-ancestor
24584375|NCT00880178|Vitamin B Complex|vitamin b complex|mesh-ancestor
24584451|NCT00880386|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24584452|NCT00880386|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24570204|NCT00803816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24584478|NCT00880529|Anesthetics, Local|anesthetics, local|mesh-ancestor
24584479|NCT00880529|Anesthetics|anesthetics|mesh-ancestor
24584480|NCT00880529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24584481|NCT00880529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584482|NCT00880529|Sensory System Agents|sensory system agents|mesh-ancestor
24584483|NCT00880529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24633202|NCT01127568|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24584500|NCT00880672|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24584501|NCT00880672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24584502|NCT00880672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584503|NCT00880672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584504|NCT00880672|Hormone Antagonists|hormone antagonists|mesh-ancestor
24584505|NCT00880672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24584506|NCT00880672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584507|NCT00880815|Rituximab|rituximab|mesh-list
24584508|NCT00880815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24584511|NCT00880815|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24584512|NCT00880815|Antibodies|antibodies|mesh-list
24584513|NCT00880815|Immunoglobulins|immunoglobulins|mesh-list
24584514|NCT00880815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24584515|NCT00880815|Lenograstim|lenograstim|mesh-list
24584516|NCT00880815|Tacrolimus|tacrolimus|mesh-list
24584574|NCT00881088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24696517|NCT01429831|Dopamine Agonists|dopamine agonists|mesh-ancestor
24696518|NCT01429831|Dopamine Agents|dopamine agents|mesh-ancestor
24696519|NCT01429831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24696520|NCT01429831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584575|NCT00881088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584576|NCT00881088|Anticoagulants|anticoagulants|mesh-ancestor
24584577|NCT00881088|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24584578|NCT00881088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24584579|NCT00881101|Paclitaxel|paclitaxel|mesh-list
24584580|NCT00881101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24584581|NCT00881101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793610|NCT02996825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793611|NCT02996825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24793612|NCT02996825|Tubulin Modulators|tubulin modulators|mesh-ancestor
24793613|NCT02996825|Antimitotic Agents|antimitotic agents|mesh-ancestor
24793614|NCT02996825|Mitosis Modulators|mitosis modulators|mesh-ancestor
24793615|NCT02989636|Nivolumab|nivolumab|mesh-list
24793616|NCT02989636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24793617|NCT02989636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793618|NCT02989636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24793619|NCT02989636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793621|NCT02910414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24793622|NCT02910414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24793623|NCT02910414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25703745|NCT02170220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703746|NCT02170220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25703747|NCT02170220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25703748|NCT02170220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25703749|NCT02170220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703750|NCT02170220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25703751|NCT02170220|Serotonin Agents|serotonin agents|mesh-ancestor
24793631|NCT02897063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24584627|NCT00881153|Cephalosporins|cephalosporins|mesh-list
24584628|NCT00881153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24584629|NCT00881153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24584630|NCT00881166|Paclitaxel|paclitaxel|mesh-list
24584631|NCT00881166|Etoposide|etoposide|mesh-list
24584632|NCT00881166|Docetaxel|docetaxel|mesh-list
24584633|NCT00881166|Carboplatin|carboplatin|mesh-list
24584634|NCT00881166|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24584635|NCT00881166|Topotecan|topotecan|mesh-list
24584636|NCT00881166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24584637|NCT00881166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584638|NCT00881166|Tubulin Modulators|tubulin modulators|mesh-ancestor
24584639|NCT00881166|Antimitotic Agents|antimitotic agents|mesh-ancestor
24584640|NCT00881166|Mitosis Modulators|mitosis modulators|mesh-ancestor
24584641|NCT00881166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584642|NCT00881166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24584643|NCT00881166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24584644|NCT00881166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584645|NCT00881166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24584652|NCT00881179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584653|NCT00881179|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24584654|NCT00881179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24584656|NCT00881218|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
24633209|NCT01127568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24633210|NCT01127568|Vasodilator Agents|vasodilator agents|mesh-ancestor
24633211|NCT01127594|Temozolomide|temozolomide|mesh-list
24633212|NCT01127594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24633213|NCT01127594|Alkylating Agents|alkylating agents|mesh-ancestor
24633214|NCT01127594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633216|NCT01127620|Cetirizine|cetirizine|mesh-list
24633217|NCT01127620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24584657|NCT00881218|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24584658|NCT00881218|Purinergic Agonists|purinergic agonists|mesh-ancestor
24584659|NCT00881218|Purinergic Agents|purinergic agents|mesh-ancestor
24584660|NCT00881218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24584661|NCT00881218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584662|NCT00881218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584664|NCT00881231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24998391|NCT02960646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24998393|NCT02960646|Antibodies|antibodies|mesh-list
24998394|NCT02960646|Immunoglobulins|immunoglobulins|mesh-list
24998395|NCT02960646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24998396|NCT02960646|Lenograstim|lenograstim|mesh-list
24998397|NCT02960646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24998398|NCT02960646|Immunologic Factors|immunologic factors|mesh-ancestor
24584665|NCT00881231|Autonomic Agents|autonomic agents|mesh-ancestor
25703752|NCT02170220|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25703753|NCT02170220|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25703754|NCT02170220|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25703755|NCT02170220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25703756|NCT02170376|Levodopa|levodopa|mesh-list
25703757|NCT02170376|Carbidopa|carbidopa|mesh-list
25703758|NCT02170376|Opicapone|opicapone|mesh-list
25703759|NCT02170376|Entacapone|entacapone|mesh-list
25703760|NCT02170376|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24584666|NCT00881231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25703761|NCT02170376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25703762|NCT02170376|Dopamine Agents|dopamine agents|mesh-ancestor
25703763|NCT02170376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24584667|NCT00881231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584693|NCT00881387|Rituximab|rituximab|mesh-list
24584694|NCT00881387|Vinorelbine|vinorelbine|mesh-list
24584695|NCT00881387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24584696|NCT00881387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584697|NCT00881387|Immunologic Factors|immunologic factors|mesh-ancestor
24584698|NCT00881387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584699|NCT00881387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24584701|NCT00881387|Antimetabolites|antimetabolites|mesh-ancestor
24584702|NCT00881387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584703|NCT00881387|Antiviral Agents|antiviral agents|mesh-ancestor
24584704|NCT00881387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24584705|NCT00881387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584706|NCT00881387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24584707|NCT00881387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24584712|NCT00881400|Cephalosporins|cephalosporins|mesh-list
24584713|NCT00881400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24584714|NCT00881400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24584715|NCT00881413|Esomeprazole|esomeprazole|mesh-list
24584716|NCT00881413|Pantoprazole|pantoprazole|mesh-list
24584741|NCT00881543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584742|NCT00881543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584743|NCT00881556|Fludarabine|fludarabine|mesh-list
24584744|NCT00881556|Busulfan|busulfan|mesh-list
24584745|NCT00881556|Alemtuzumab|alemtuzumab|mesh-list
24584752|NCT00881556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584753|NCT00881556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24584754|NCT00881556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584755|NCT00881556|Alkylating Agents|alkylating agents|mesh-ancestor
24584756|NCT00881556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24584757|NCT00881556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24584758|NCT00881556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24584760|NCT00881556|Antiemetics|antiemetics|mesh-ancestor
24584761|NCT00881556|Autonomic Agents|autonomic agents|mesh-ancestor
24584762|NCT00881556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24584763|NCT00881556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24584764|NCT00881556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24584765|NCT00881556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24584769|NCT00881556|GABA Modulators|gaba modulators|mesh-ancestor
24584770|NCT00881556|GABA Agents|gaba agents|mesh-ancestor
24584771|NCT00881556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24584772|NCT00881582|Interferons|interferons|mesh-list
24584781|NCT00881595|Temozolomide|temozolomide|mesh-list
24696521|NCT01429831|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24696522|NCT01429831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24696523|NCT01429831|Serotonin Agents|serotonin agents|mesh-ancestor
24696524|NCT01429831|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24696525|NCT01429831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24584782|NCT00881595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24584783|NCT00881595|Alkylating Agents|alkylating agents|mesh-ancestor
24584784|NCT00881595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448726|NCT00312806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584785|NCT00881595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584786|NCT00881634|Cetirizine|cetirizine|mesh-list
24584787|NCT00881634|Pseudoephedrine|pseudoephedrine|mesh-list
24584788|NCT00881634|Ephedrine|ephedrine|mesh-list
24584789|NCT00881634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24584790|NCT00881634|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24584791|NCT00881634|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24584792|NCT00881634|Histamine Antagonists|histamine antagonists|mesh-ancestor
24584793|NCT00881634|Histamine Agents|histamine agents|mesh-ancestor
24584794|NCT00881634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24584795|NCT00881634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584796|NCT00881634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584797|NCT00881634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25703764|NCT02170376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703765|NCT02170376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703766|NCT02170376|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25703767|NCT02170376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703768|NCT02170376|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25703769|NCT02170519|Iloprost|iloprost|mesh-list
24584798|NCT00881634|Autonomic Agents|autonomic agents|mesh-ancestor
24584799|NCT00881634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24584800|NCT00881634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24584801|NCT00881634|Respiratory System Agents|respiratory system agents|mesh-ancestor
24584802|NCT00881634|Nasal Decongestants|nasal decongestants|mesh-ancestor
24584803|NCT00881634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24584804|NCT00881634|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24584813|NCT00881673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24584814|NCT00881673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584815|NCT00881673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24584816|NCT00881673|Glucocorticoids|glucocorticoids|mesh-ancestor
24584817|NCT00881673|Hormones|hormones|mesh-ancestor
24584821|NCT00881686|Adenosine|adenosine|mesh-list
24584834|NCT00881725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24584835|NCT00881725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584836|NCT00881738|Clarithromycin|clarithromycin|mesh-list
24584837|NCT00881738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24584838|NCT00881738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24584839|NCT00881738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24584840|NCT00881738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584841|NCT00881738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584842|NCT00881738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24584843|NCT00881738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24584844|NCT00881764|Anesthetics|anesthetics|mesh-list
24584845|NCT00881764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24570574|NCT00805311|Aspirin|aspirin|mesh-list
24584878|NCT00882024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24584879|NCT00882024|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24584880|NCT00882024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24584881|NCT00882024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584882|NCT00882024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24584883|NCT00882024|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24584884|NCT00882024|Histamine Antagonists|histamine antagonists|mesh-ancestor
24584885|NCT00882024|Histamine Agents|histamine agents|mesh-ancestor
24584886|NCT00882024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24584887|NCT00882024|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24584888|NCT00882024|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24584890|NCT00882076|Mitoxantrone|mitoxantrone|mesh-list
24584891|NCT00882076|Etoposide phosphate|etoposide phosphate|mesh-list
24584892|NCT00882076|Clofarabine|clofarabine|mesh-list
24584893|NCT00882076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24584894|NCT00882076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584896|NCT00882076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24584967|NCT00882388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24584968|NCT00882388|Purinergic Agents|purinergic agents|mesh-ancestor
24584969|NCT00882388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24584970|NCT00882388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24584972|NCT00882401|Ergocalciferols|ergocalciferols|mesh-list
24584973|NCT00882401|Vitamins|vitamins|mesh-ancestor
24584974|NCT00882401|Micronutrients|micronutrients|mesh-ancestor
24584975|NCT00882401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584976|NCT00882401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24584977|NCT00882401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24584978|NCT00882414|Ferric Compounds|ferric compounds|mesh-list
24584979|NCT00882414|Hematinics|hematinics|mesh-ancestor
24584980|NCT00882453|Interferons|interferons|mesh-list
24584981|NCT00882453|Interferon-beta|interferon-beta|mesh-list
24584982|NCT00882453|Interferon beta-1b|interferon beta-1b|mesh-list
24584983|NCT00882453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584984|NCT00882453|Antiviral Agents|antiviral agents|mesh-ancestor
24584985|NCT00882453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24584986|NCT00882453|Immunologic Factors|immunologic factors|mesh-ancestor
24584987|NCT00882453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584988|NCT00882453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24584989|NCT00882466|Epoetin Alfa|epoetin alfa|mesh-list
24584990|NCT00882466|Hematinics|hematinics|mesh-ancestor
24584992|NCT00882531|Dermatologic Agents|dermatologic agents|mesh-ancestor
24584993|NCT00882570|Cefdinir|cefdinir|mesh-list
24584994|NCT00882570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24584995|NCT00882570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24585015|NCT00882739|Purinergic Agents|purinergic agents|mesh-ancestor
24585016|NCT00882739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24696558|NCT01429935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397126|NCT00140868|GABA Modulators|gaba modulators|mesh-ancestor
24612671|NCT01015040|Cholinergic Agents|cholinergic agents|mesh-ancestor
24612672|NCT01015040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24612673|NCT01015040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612674|NCT01015040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612675|NCT01015040|Urological Agents|urological agents|mesh-ancestor
24612676|NCT01015053|Ropivacaine|ropivacaine|mesh-list
24612677|NCT01015053|Anesthetics, Local|anesthetics, local|mesh-ancestor
24612678|NCT01015053|Anesthetics|anesthetics|mesh-ancestor
24612679|NCT01015053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24612680|NCT01015053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612681|NCT01015053|Sensory System Agents|sensory system agents|mesh-ancestor
24612682|NCT01015053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24585017|NCT00882739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585018|NCT00882739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585019|NCT00882765|Genistein|genistein|mesh-list
24585020|NCT00882765|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24585021|NCT00882765|Protective Agents|protective agents|mesh-ancestor
24585035|NCT00882856|Autonomic Agents|autonomic agents|mesh-ancestor
24585036|NCT00882856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24585037|NCT00882856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585038|NCT00882856|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24585039|NCT00882856|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24585040|NCT00882856|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24585041|NCT00882856|Adrenergic Agents|adrenergic agents|mesh-ancestor
24585042|NCT00882856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24585043|NCT00882856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585045|NCT00882869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585061|NCT00882960|Sensory System Agents|sensory system agents|mesh-ancestor
24585062|NCT00882960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24585063|NCT00882960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24585064|NCT00882960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24585065|NCT00882960|Anesthetics, General|anesthetics, general|mesh-ancestor
24585137|NCT00883623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24585148|NCT00883662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24585150|NCT00883727|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24585151|NCT00883727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24585152|NCT00883818|Azithromycin|azithromycin|mesh-list
24585153|NCT00883818|Doxycycline|doxycycline|mesh-list
24585154|NCT00883818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24585155|NCT00883818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24585156|NCT00883818|Antimalarials|antimalarials|mesh-ancestor
24585157|NCT00883818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24585158|NCT00883818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24585160|NCT00883870|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24585161|NCT00883870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24585162|NCT00883883|Cefdinir|cefdinir|mesh-list
24585163|NCT00883883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24585164|NCT00883883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24585165|NCT00883909|Dutasteride|dutasteride|mesh-list
24585166|NCT00883909|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24585167|NCT00883909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24585168|NCT00883909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703770|NCT02170519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25703771|NCT02170519|Vasodilator Agents|vasodilator agents|mesh-ancestor
24585169|NCT00883909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585170|NCT00883909|Hormone Antagonists|hormone antagonists|mesh-ancestor
24585171|NCT00883909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24585172|NCT00883909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585173|NCT00883935|Ritonavir|ritonavir|mesh-list
24585174|NCT00883935|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24585212|NCT00884416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24585213|NCT00884416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585214|NCT00884442|Nifedipine|nifedipine|mesh-list
24585215|NCT00884442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24585216|NCT00884442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24585217|NCT00884442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585218|NCT00884442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24585220|NCT00884442|Vasodilator Agents|vasodilator agents|mesh-ancestor
24585224|NCT00884481|Immunologic Factors|immunologic factors|mesh-ancestor
24585225|NCT00884481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585289|NCT00884767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24585291|NCT00884767|Antimetabolites|antimetabolites|mesh-ancestor
24585292|NCT00884767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585293|NCT00884767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24585294|NCT00884767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25085645|NCT03296306|Cisplatin|cisplatin|mesh-list
24585295|NCT00884767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24585296|NCT00884767|Immunologic Factors|immunologic factors|mesh-ancestor
24585297|NCT00884767|Antidotes|antidotes|mesh-ancestor
24585298|NCT00884767|Protective Agents|protective agents|mesh-ancestor
24585299|NCT00884767|Vitamin B Complex|vitamin b complex|mesh-ancestor
24585301|NCT00884767|Micronutrients|micronutrients|mesh-ancestor
24585302|NCT00884819|Fenofibrate|fenofibrate|mesh-list
24585303|NCT00884819|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24585304|NCT00884819|Antimetabolites|antimetabolites|mesh-ancestor
24585305|NCT00884819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585306|NCT00884819|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24585307|NCT00884845|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24585308|NCT00884845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585309|NCT00884845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24586741|NCT00892073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586742|NCT00892073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24586743|NCT00892073|Vasodilator Agents|vasodilator agents|mesh-ancestor
24585319|NCT00884858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24585320|NCT00884858|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24585321|NCT00884884|Topiramate|topiramate|mesh-list
24585322|NCT00884884|Aripiprazole|aripiprazole|mesh-list
24633302|NCT01128218|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24633303|NCT01128218|Dermatologic Agents|dermatologic agents|mesh-ancestor
24633304|NCT01128257|Alendronate|alendronate|mesh-list
24633305|NCT01128257|Ibandronic Acid|ibandronic acid|mesh-list
24612685|NCT01015066|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
24612686|NCT01015066|Naloxone|naloxone|mesh-list
24612687|NCT01015066|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24612688|NCT01015066|Narcotics|narcotics|mesh-ancestor
24612689|NCT01015066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24612690|NCT01015066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612691|NCT01015066|Analgesics|analgesics|mesh-ancestor
24697490|NCT01435213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24585348|NCT00885066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585349|NCT00885066|Antiviral Agents|antiviral agents|mesh-ancestor
24585350|NCT00885066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24585351|NCT00885066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24585352|NCT00885066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24585396|NCT00885326|Growth Inhibitors|growth inhibitors|mesh-ancestor
24585397|NCT00885326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24585398|NCT00885404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25703772|NCT02170532|Albuterol|albuterol|mesh-list
25703773|NCT02170532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25703774|NCT02170532|Autonomic Agents|autonomic agents|mesh-ancestor
25703775|NCT02170532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25703776|NCT02170532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703777|NCT02170532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24585399|NCT00885404|Plasma-lyte 148|plasma-lyte 148|mesh-list
24585400|NCT00885404|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24633346|NCT01128712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24585402|NCT00885443|Sevoflurane|sevoflurane|mesh-list
24585403|NCT00885443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24585404|NCT00885443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24585405|NCT00885443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585406|NCT00885443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24585436|NCT00885599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24585472|NCT00885690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24585473|NCT00885690|Serotonin Agents|serotonin agents|mesh-ancestor
24585475|NCT00885781|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24585483|NCT00885794|Growth Inhibitors|growth inhibitors|mesh-ancestor
24585484|NCT00885794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585486|NCT00885820|Methylprednisolone|methylprednisolone|mesh-list
24585487|NCT00885820|Tacrolimus|tacrolimus|mesh-list
24585504|NCT00885820|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24585505|NCT00885820|Protective Agents|protective agents|mesh-ancestor
24585506|NCT00885833|Fludarabine|fludarabine|mesh-list
24585507|NCT00885833|Busulfan|busulfan|mesh-list
24585508|NCT00885833|Thymoglobulin|thymoglobulin|mesh-list
24585509|NCT00885833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585510|NCT00885833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585511|NCT00885833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24585512|NCT00885833|Immunologic Factors|immunologic factors|mesh-ancestor
24585513|NCT00885833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585514|NCT00885833|Alkylating Agents|alkylating agents|mesh-ancestor
24585515|NCT00885833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24585516|NCT00885833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24585517|NCT00885872|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24585518|NCT00885872|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24585519|NCT00885872|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24585521|NCT00885872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585522|NCT00885872|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24585523|NCT00885872|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24633510|NCT01129739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585570|NCT00886106|GABA Agents|gaba agents|mesh-ancestor
24585571|NCT00886106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24585572|NCT00886106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585573|NCT00886106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24585574|NCT00886106|Narcotics|narcotics|mesh-ancestor
24585594|NCT00886275|Analgesics|analgesics|mesh-ancestor
24585595|NCT00886275|Sensory System Agents|sensory system agents|mesh-ancestor
24585596|NCT00886275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24585597|NCT00886275|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24585598|NCT00886275|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24585599|NCT00886275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24585600|NCT00886275|Adrenergic Agents|adrenergic agents|mesh-ancestor
24585601|NCT00886275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24585602|NCT00886275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633585|NCT01130181|Micronutrients|micronutrients|mesh-ancestor
24585603|NCT00886275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24585604|NCT00886275|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24585605|NCT00886275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24585606|NCT00886275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24585607|NCT00886275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24585634|NCT00886457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585653|NCT00886574|Cilostazol|cilostazol|mesh-list
24585654|NCT00886574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24585655|NCT00886574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24585656|NCT00886574|Analgesics|analgesics|mesh-ancestor
24585657|NCT00886574|Sensory System Agents|sensory system agents|mesh-ancestor
24585658|NCT00886574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24585659|NCT00886574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696638|NCT01430520|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24696719|NCT01431118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24696721|NCT01431118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24696722|NCT01431118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24696723|NCT01431118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696724|NCT01431326|Vancomycin|vancomycin|mesh-list
24696725|NCT01431326|Ciprofloxacin|ciprofloxacin|mesh-list
24696726|NCT01431326|Tazobactam|tazobactam|mesh-list
24696730|NCT01431326|Fosfomycin|fosfomycin|mesh-list
24696731|NCT01431326|Cefepime|cefepime|mesh-list
24696732|NCT01431326|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24696733|NCT01431326|Nafcillin|nafcillin|mesh-list
24696734|NCT01431326|Cidofovir|cidofovir|mesh-list
24696735|NCT01431326|Methylprednisolone|methylprednisolone|mesh-list
24696736|NCT01431326|Bosentan|bosentan|mesh-list
24696737|NCT01431326|Labetalol|labetalol|mesh-list
24696738|NCT01431326|Nifedipine|nifedipine|mesh-list
24696739|NCT01431326|Spironolactone|spironolactone|mesh-list
24696740|NCT01431326|Pentobarbital|pentobarbital|mesh-list
24633625|NCT01130376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24633626|NCT01130376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24585660|NCT00886574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24585661|NCT00886574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24633627|NCT01130376|Antiviral Agents|antiviral agents|mesh-ancestor
24585662|NCT00886574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24585663|NCT00886574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24585664|NCT00886574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585669|NCT00886574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24585671|NCT00886574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24585672|NCT00886574|Respiratory System Agents|respiratory system agents|mesh-ancestor
24585673|NCT00886574|Vasodilator Agents|vasodilator agents|mesh-ancestor
24585674|NCT00886574|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24585675|NCT00886574|Protective Agents|protective agents|mesh-ancestor
24585676|NCT00886574|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24585678|NCT00886678|Carboplatin|carboplatin|mesh-list
24585679|NCT00886678|Pemetrexed|pemetrexed|mesh-list
24571250|NCT00808795|Antidotes|antidotes|mesh-ancestor
24585716|NCT00886873|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24585718|NCT00886886|Antidepressive Agents|antidepressive agents|mesh-ancestor
24585719|NCT00886886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24585762|NCT00887003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24585763|NCT00887003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585765|NCT00887029|Travoprost|travoprost|mesh-list
24585766|NCT00887029|Latanoprost|latanoprost|mesh-list
24585767|NCT00887029|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24585768|NCT00887029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24585769|NCT00887029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24585770|NCT00887029|Adrenergic Agents|adrenergic agents|mesh-ancestor
24793642|NCT02864368|Temozolomide|temozolomide|mesh-list
24793643|NCT02864368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24793644|NCT02864368|Alkylating Agents|alkylating agents|mesh-ancestor
24793645|NCT02864368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793646|NCT02864368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793647|NCT02856698|Midazolam|midazolam|mesh-list
24793648|NCT02856698|Morphine|morphine|mesh-list
24793649|NCT02856698|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24793650|NCT02856698|Narcotics|narcotics|mesh-ancestor
24793651|NCT02856698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25703778|NCT02170532|Respiratory System Agents|respiratory system agents|mesh-ancestor
25703779|NCT02170532|Tocolytic Agents|tocolytic agents|mesh-ancestor
25703780|NCT02170532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25703781|NCT02170532|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24793652|NCT02856698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703782|NCT02170532|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25703783|NCT02170532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25703784|NCT02170532|Adrenergic Agents|adrenergic agents|mesh-ancestor
24454177|NCT04326257|Ipilimumab|ipilimumab|mesh-list
24793653|NCT02856698|Analgesics|analgesics|mesh-ancestor
24793658|NCT02856698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25010484|NCT03936218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010485|NCT03927521|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25010486|NCT03927521|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25010487|NCT03927521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585782|NCT00887042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24585783|NCT00887042|Immunologic Factors|immunologic factors|mesh-ancestor
24585784|NCT00887042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585785|NCT00887042|Alkylating Agents|alkylating agents|mesh-ancestor
24585786|NCT00887042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24585787|NCT00887042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24585789|NCT00887081|Interferon-alpha|interferon-alpha|mesh-list
24585790|NCT00887081|Interferon alpha-2|interferon alpha-2|mesh-list
24585791|NCT00887081|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
24585792|NCT00887081|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24585793|NCT00887081|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24585794|NCT00887081|Antimetabolites|antimetabolites|mesh-ancestor
24585818|NCT00887120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24585820|NCT00887211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24585821|NCT00887211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24585822|NCT00887211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24585823|NCT00887211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585859|NCT00887380|Anastrozole|anastrozole|mesh-list
24585860|NCT00887380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24585862|NCT00887380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24585881|NCT00887627|Natriuretic Agents|natriuretic agents|mesh-ancestor
24585882|NCT00887627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010506|NCT03897244|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25010507|NCT03897244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25010516|NCT03855046|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25010517|NCT03855046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25010518|NCT03855046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25010519|NCT03855046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010520|NCT03855046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25010521|NCT03855046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24696741|NCT01431326|Oxycodone|oxycodone|mesh-list
24696742|NCT01431326|Alfentanil|alfentanil|mesh-list
24696743|NCT01431326|Haloperidol|haloperidol|mesh-list
24696744|NCT01431326|Zolpidem|zolpidem|mesh-list
24696745|NCT01431326|Ziprasidone|ziprasidone|mesh-list
24696746|NCT01431326|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
24571477|NCT00810316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25703785|NCT02170532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25703786|NCT02170532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703787|NCT02170649|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25703788|NCT02170649|Anticonvulsants|anticonvulsants|mesh-ancestor
24696799|NCT01431326|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25703789|NCT02170649|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25703790|NCT02170649|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25703791|NCT02170649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24696822|NCT01431326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24696828|NCT01431326|Anesthetics, General|anesthetics, general|mesh-ancestor
24696831|NCT01431326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24696833|NCT01431352|Letrozole|letrozole|mesh-list
24696834|NCT01431352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24696835|NCT01431352|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24696836|NCT01431352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24696837|NCT01431352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24696838|NCT01431352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696839|NCT01431352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24696840|NCT01431352|Hormone Antagonists|hormone antagonists|mesh-ancestor
24696841|NCT01431352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24696842|NCT01431352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696843|NCT01431404|Etanercept|etanercept|mesh-list
24696844|NCT01431404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24696878|NCT01431456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010550|NCT03737136|Bortezomib|bortezomib|mesh-list
25010551|NCT03737136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010552|NCT03736265|Carvedilol|carvedilol|mesh-list
25010553|NCT03736265|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25010554|NCT03736265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25010555|NCT03736265|Adrenergic Agents|adrenergic agents|mesh-ancestor
25010556|NCT03736265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25010557|NCT03736265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010558|NCT03736265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010559|NCT03736265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25010560|NCT03736265|Antioxidants|antioxidants|mesh-ancestor
25010561|NCT03736265|Protective Agents|protective agents|mesh-ancestor
25010562|NCT03736265|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25010563|NCT03736265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25010564|NCT03736265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25010565|NCT03736265|Vasodilator Agents|vasodilator agents|mesh-ancestor
25010566|NCT03736265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25010567|NCT03736265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25010599|NCT03617731|Dexamethasone|dexamethasone|mesh-list
25010600|NCT03617731|Lenalidomide|lenalidomide|mesh-list
25010601|NCT03617731|Bortezomib|bortezomib|mesh-list
25010602|NCT03617731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25010610|NCT03617731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25010611|NCT03617731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25010612|NCT03617731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010613|NCT03617731|Immunologic Factors|immunologic factors|mesh-ancestor
25010614|NCT03617731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24448843|NCT00313235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24448846|NCT00313261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24448847|NCT00313274|Clevudine|clevudine|mesh-list
24448848|NCT00313274|Antiviral Agents|antiviral agents|mesh-ancestor
24696944|NCT01431924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696946|NCT01431924|Respiratory System Agents|respiratory system agents|mesh-ancestor
24696947|NCT01431924|Dermatologic Agents|dermatologic agents|mesh-ancestor
24696948|NCT01431924|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24696949|NCT01431924|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25086674|NCT03287336|Coagulants|coagulants|mesh-ancestor
24696950|NCT01431924|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24696951|NCT01431924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24696952|NCT01431924|Adrenergic Agents|adrenergic agents|mesh-ancestor
24696953|NCT01431924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24643396|NCT01185418|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24696954|NCT01431924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696955|NCT01432028|Drospirenone|drospirenone|mesh-list
24696956|NCT01432028|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24696957|NCT01432028|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24696958|NCT01432028|Estradiol|estradiol|mesh-list
24696959|NCT01432028|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24696960|NCT01432028|Progesterone|progesterone|mesh-list
24696990|NCT01432080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24696991|NCT01432080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24696992|NCT01432080|Respiratory System Agents|respiratory system agents|mesh-ancestor
24696993|NCT01432080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24696994|NCT01432080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24696995|NCT01432080|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24696996|NCT01432080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24696997|NCT01432080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24696998|NCT01432080|Adrenergic Agents|adrenergic agents|mesh-ancestor
24612732|NCT01015235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24612733|NCT01015235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24612734|NCT01015235|Analgesics|analgesics|mesh-ancestor
24612735|NCT01015235|Sensory System Agents|sensory system agents|mesh-ancestor
24612736|NCT01015235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24612737|NCT01015235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612738|NCT01015235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24612739|NCT01015235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24612740|NCT01015235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24612741|NCT01015235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25110173|NCT05464979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24697049|NCT01432496|Ropivacaine|ropivacaine|mesh-list
24697050|NCT01432496|Anesthetics, Local|anesthetics, local|mesh-ancestor
24697095|NCT01432665|Urological Agents|urological agents|mesh-ancestor
24697096|NCT01432704|Cholecalciferol|cholecalciferol|mesh-list
24697136|NCT01432977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24697137|NCT01432977|Analgesics|analgesics|mesh-ancestor
24697138|NCT01432977|Sensory System Agents|sensory system agents|mesh-ancestor
24697139|NCT01432977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24697140|NCT01432977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697141|NCT01432977|Antipyretics|antipyretics|mesh-ancestor
24697142|NCT01432977|Antiemetics|antiemetics|mesh-ancestor
24697143|NCT01432977|Autonomic Agents|autonomic agents|mesh-ancestor
24697144|NCT01432977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24697145|NCT01432977|Antipruritics|antipruritics|mesh-ancestor
24697197|NCT01433614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24697198|NCT01433614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24697199|NCT01433614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24697200|NCT01433614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24697202|NCT01433627|Bivalirudin|bivalirudin|mesh-list
24697203|NCT01433627|Antithrombins|antithrombins|mesh-ancestor
24697204|NCT01433627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24697205|NCT01433627|Protease Inhibitors|protease inhibitors|mesh-ancestor
24697206|NCT01433627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492741|NCT00487773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24697264|NCT01434017|Dermatologic Agents|dermatologic agents|mesh-ancestor
24697265|NCT01434017|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24697266|NCT01434017|Serotonin Agents|serotonin agents|mesh-ancestor
24697267|NCT01434017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24697268|NCT01434017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24697269|NCT01434017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25110176|NCT05464979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25110177|NCT05464979|Anesthetics, General|anesthetics, general|mesh-ancestor
25110179|NCT05464979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25110181|NCT05464979|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24571582|NCT00810914|Bupivacaine|bupivacaine|mesh-list
25110192|NCT05464979|GABA Agents|gaba agents|mesh-ancestor
25110193|NCT05464979|Antidepressive Agents|antidepressive agents|mesh-ancestor
25110194|NCT05464966|Insulin|insulin|mesh-list
25110195|NCT05464966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25110196|NCT05464966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110197|NCT05464953|Triamcinolone|triamcinolone|mesh-list
24697322|NCT01434147|Growth Substances|growth substances|mesh-ancestor
24697330|NCT01434160|Contraceptive Agents|contraceptive agents|mesh-ancestor
24697331|NCT01434160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24697332|NCT01434160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697387|NCT01434225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697388|NCT01434251|Antihypertensive Agents|antihypertensive agents|mesh-list
24697389|NCT01434277|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24697390|NCT01434277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24697411|NCT01434381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697412|NCT01434381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24697414|NCT01434394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24697415|NCT01434394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697416|NCT01434459|Gemcitabine|gemcitabine|mesh-list
24697417|NCT01434459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24697418|NCT01434459|Antimetabolites|antimetabolites|mesh-ancestor
24612771|NCT01015352|Azacitidine|azacitidine|mesh-list
24612772|NCT01015352|Epoetin Alfa|epoetin alfa|mesh-list
24612773|NCT01015352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24612774|NCT01015352|Antimetabolites|antimetabolites|mesh-ancestor
24612775|NCT01015352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612776|NCT01015352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612777|NCT01015352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612778|NCT01015352|Hematinics|hematinics|mesh-ancestor
24612779|NCT01015391|Azathioprine|azathioprine|mesh-list
24612780|NCT01015391|Antimetabolites|antimetabolites|mesh-ancestor
24612781|NCT01015391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612782|NCT01015391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24448931|NCT00313599|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24448932|NCT00313599|Lapatinib|lapatinib|mesh-list
24448933|NCT00313599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24448934|NCT00313599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448935|NCT00313599|Tubulin Modulators|tubulin modulators|mesh-ancestor
24448936|NCT00313599|Antimitotic Agents|antimitotic agents|mesh-ancestor
24448937|NCT00313599|Mitosis Modulators|mitosis modulators|mesh-ancestor
24448938|NCT00313599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697483|NCT01435161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697484|NCT01435161|Vasodilator Agents|vasodilator agents|mesh-ancestor
24697485|NCT01435161|Tocolytic Agents|tocolytic agents|mesh-ancestor
24697486|NCT01435161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24697487|NCT01435200|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24697489|NCT01435213|Insulin|insulin|mesh-list
24697492|NCT01435213|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24697494|NCT01435213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24697512|NCT01435213|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24697513|NCT01435213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24697514|NCT01435213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24697516|NCT01435252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24697517|NCT01435252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697518|NCT01435291|Tacrolimus|tacrolimus|mesh-list
24697519|NCT01435291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24697520|NCT01435291|Immunologic Factors|immunologic factors|mesh-ancestor
24697521|NCT01435291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697548|NCT01435395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25703792|NCT02170649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703793|NCT02170662|Bimatoprost|bimatoprost|mesh-list
24697580|NCT01435707|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24697581|NCT01435707|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24697582|NCT01435707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24697676|NCT01436474|Varenicline|varenicline|mesh-list
24697677|NCT01436474|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24697678|NCT01436474|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24697679|NCT01436474|Cholinergic Agents|cholinergic agents|mesh-ancestor
24697680|NCT01436474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24697681|NCT01436474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697682|NCT01436474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398207|NCT00143741|Antimetabolites|antimetabolites|mesh-ancestor
24697725|NCT01436916|Cholecalciferol|cholecalciferol|mesh-list
24697726|NCT01436916|Vitamin D|vitamin d|mesh-list
24697727|NCT01436916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24697728|NCT01436916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697729|NCT01436916|Vitamins|vitamins|mesh-ancestor
24697730|NCT01436916|Micronutrients|micronutrients|mesh-ancestor
24697731|NCT01436916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24697746|NCT01436994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24697747|NCT01436994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697748|NCT01437020|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24697749|NCT01437020|Antifungal Agents|antifungal agents|mesh-ancestor
24697750|NCT01437020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24697751|NCT01437020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24697752|NCT01437020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24697753|NCT01437046|Doxazosin|doxazosin|mesh-list
24697754|NCT01437046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24697755|NCT01437046|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24697756|NCT01437046|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24697757|NCT01437046|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24697758|NCT01437046|Adrenergic Agents|adrenergic agents|mesh-ancestor
24697786|NCT01437293|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24697788|NCT01437293|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24697800|NCT01437306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697803|NCT01437371|Lisinopril|lisinopril|mesh-list
24697841|NCT01437592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697842|NCT01437618|Bevacizumab|bevacizumab|mesh-list
24697843|NCT01437618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24697844|NCT01437618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697845|NCT01437618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24657221|NCT01266213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24657222|NCT01266213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657223|NCT01266213|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24657224|NCT01266213|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24657225|NCT01266213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657235|NCT01266252|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24657236|NCT01266252|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24657237|NCT01266252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24657238|NCT01266252|Adrenergic Agents|adrenergic agents|mesh-ancestor
24657239|NCT01266252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24657240|NCT01266252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703795|NCT02171130|Glucagon|glucagon|mesh-list
25703796|NCT02171130|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25703797|NCT02171130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25703798|NCT02171130|Hormones|hormones|mesh-ancestor
25703799|NCT02171130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25703800|NCT02171130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703801|NCT02171130|Incretins|incretins|mesh-ancestor
25703802|NCT02171195|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25703803|NCT02171195|Anticonvulsants|anticonvulsants|mesh-ancestor
24657253|NCT01266499|Polymyxins|polymyxins|mesh-list
24657254|NCT01266499|Gentamicins|gentamicins|mesh-list
24657255|NCT01266499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24657256|NCT01266499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24948604|NCT03918265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948605|NCT03918265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24657257|NCT01266499|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24657258|NCT01266499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657259|NCT01266499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657260|NCT01266512|Docetaxel|docetaxel|mesh-list
24657261|NCT01266512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657267|NCT01266655|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24657268|NCT01266655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657269|NCT01266655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24657270|NCT01266655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24657271|NCT01266655|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24657272|NCT01266655|GABA Agonists|gaba agonists|mesh-ancestor
24657273|NCT01266655|GABA Agents|gaba agents|mesh-ancestor
24657274|NCT01266655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24657292|NCT01266694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24657293|NCT01266694|Tubulin Modulators|tubulin modulators|mesh-ancestor
24657294|NCT01266694|Antimitotic Agents|antimitotic agents|mesh-ancestor
24657297|NCT01266694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657298|NCT01266707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
24657300|NCT01266707|Immunologic Factors|immunologic factors|mesh-ancestor
24657301|NCT01266707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657307|NCT01266720|Immunologic Factors|immunologic factors|mesh-ancestor
24657308|NCT01266720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24948606|NCT03918265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24948607|NCT03918265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774698|NCT01847404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24799183|NCT01967758|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24799184|NCT01967758|Trimethoprim|trimethoprim|mesh-list
24799185|NCT01967758|Sulfamethoxazole|sulfamethoxazole|mesh-list
24799186|NCT01967758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24799187|NCT01967758|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24799188|NCT01967758|Renal Agents|renal agents|mesh-ancestor
24799189|NCT01967758|Antimalarials|antimalarials|mesh-ancestor
24799190|NCT01967758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24799191|NCT01967758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24799192|NCT01967758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24799193|NCT01967758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24799194|NCT01967758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799195|NCT01967758|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24799196|NCT01967758|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24847206|NCT02245451|Narcotics|narcotics|mesh-ancestor
24657328|NCT01266772|Budesonide|budesonide|mesh-list
24657412|NCT01267214|Viscosupplements|viscosupplements|mesh-ancestor
24657413|NCT01267214|Protective Agents|protective agents|mesh-ancestor
24657414|NCT01267305|Calcium, Dietary|calcium, dietary|mesh-list
24657416|NCT01267305|Nadroparin|nadroparin|mesh-list
24657417|NCT01267305|Fondaparinux|fondaparinux|mesh-list
24657418|NCT01267305|Calcium|calcium|mesh-list
24657419|NCT01267305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24657420|NCT01267305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657421|NCT01267305|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24657428|NCT01267305|Anticoagulants|anticoagulants|mesh-ancestor
24657429|NCT01267305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24657430|NCT01267305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24657431|NCT01267344|Gemcitabine|gemcitabine|mesh-list
24657432|NCT01267344|Oxaliplatin|oxaliplatin|mesh-list
24657434|NCT01267344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24657435|NCT01267344|Antimetabolites|antimetabolites|mesh-ancestor
24657436|NCT01267344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657437|NCT01267344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657438|NCT01267344|Antiviral Agents|antiviral agents|mesh-ancestor
24657439|NCT01267344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24657440|NCT01267344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657441|NCT01267344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24657442|NCT01267344|Immunologic Factors|immunologic factors|mesh-ancestor
24657443|NCT01267344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657444|NCT01267344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24657446|NCT01267383|Antidepressive Agents|antidepressive agents|mesh-ancestor
24657448|NCT01267383|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24657449|NCT01267383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24657456|NCT01267396|Antidepressive Agents|antidepressive agents|mesh-ancestor
24657457|NCT01267396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24657463|NCT01267396|Serotonin Agents|serotonin agents|mesh-ancestor
24657464|NCT01267396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657466|NCT01267448|Saxagliptin|saxagliptin|mesh-list
24657467|NCT01267448|Glipizide|glipizide|mesh-list
24657468|NCT01267448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24657469|NCT01267448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657470|NCT01267448|Incretins|incretins|mesh-ancestor
24799200|NCT01967823|Cyclophosphamide|cyclophosphamide|mesh-list
24799201|NCT01967823|Fludarabine|fludarabine|mesh-list
24799202|NCT01967823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24799203|NCT01967823|Immunologic Factors|immunologic factors|mesh-ancestor
24799204|NCT01967823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703807|NCT02171195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703808|NCT02171234|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25703809|NCT02171234|Anticonvulsants|anticonvulsants|mesh-ancestor
25703810|NCT02171234|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24851492|NCT02256943|Cholinergic Agents|cholinergic agents|mesh-ancestor
24851493|NCT02256943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24851494|NCT02256943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851495|NCT02256943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851496|NCT02256943|Urological Agents|urological agents|mesh-ancestor
25088566|NCT03545464|Levocetirizine|levocetirizine|mesh-list
25088568|NCT03545464|Glucocorticoids|glucocorticoids|mesh-ancestor
24799205|NCT01967823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24799206|NCT01967823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24657471|NCT01267448|Hormones|hormones|mesh-ancestor
24657472|NCT01267448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24657474|NCT01267448|Protease Inhibitors|protease inhibitors|mesh-ancestor
24657502|NCT01267669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24657503|NCT01267669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657535|NCT01268033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657536|NCT01268033|Immunologic Factors|immunologic factors|mesh-ancestor
24657537|NCT01268033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657538|NCT01268033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24657539|NCT01268163|Docetaxel|docetaxel|mesh-list
24657540|NCT01268163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657542|NCT01268163|Antimitotic Agents|antimitotic agents|mesh-ancestor
24657543|NCT01268163|Mitosis Modulators|mitosis modulators|mesh-ancestor
24657544|NCT01268163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657545|NCT01268176|Vitamin D|vitamin d|mesh-list
24657587|NCT01268384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24657588|NCT01268384|Immunologic Factors|immunologic factors|mesh-ancestor
24657589|NCT01268384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657590|NCT01268579|Ribavirin|ribavirin|mesh-list
24657591|NCT01268579|Antimetabolites|antimetabolites|mesh-ancestor
24657592|NCT01268579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657593|NCT01268579|Antiviral Agents|antiviral agents|mesh-ancestor
24657594|NCT01268579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24657595|NCT01268631|Pregabalin|pregabalin|mesh-list
24657596|NCT01268631|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24657597|NCT01268631|Analgesics|analgesics|mesh-ancestor
24657598|NCT01268631|Sensory System Agents|sensory system agents|mesh-ancestor
24657599|NCT01268631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24657603|NCT01268631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24657604|NCT01268631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657605|NCT01268631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24799207|NCT01967823|Alkylating Agents|alkylating agents|mesh-ancestor
24799208|NCT01967823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703811|NCT02171234|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25703812|NCT02171234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25703813|NCT02171234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703814|NCT02171429|Adalimumab|adalimumab|mesh-list
25703815|NCT02171429|Etrolizumab|etrolizumab|mesh-list
25703816|NCT02171429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25703817|NCT02171429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25703818|NCT02171429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25703819|NCT02171429|Immunologic Factors|immunologic factors|mesh-ancestor
25703820|NCT02171429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703821|NCT02171611|Dabigatran|dabigatran|mesh-list
25703822|NCT02171611|Antithrombins|antithrombins|mesh-ancestor
25703823|NCT02171611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25703824|NCT02171611|Protease Inhibitors|protease inhibitors|mesh-ancestor
24799209|NCT01967823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799210|NCT01967823|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24799211|NCT01967823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24657607|NCT01268631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24657628|NCT01268670|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24657630|NCT01268670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24657631|NCT01268709|Doxepin|doxepin|mesh-list
24657632|NCT01268709|Nortriptyline|nortriptyline|mesh-list
24657633|NCT01268709|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24657634|NCT01268709|Antidepressive Agents|antidepressive agents|mesh-ancestor
24657635|NCT01268709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24657690|NCT01268917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24657691|NCT01268917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657692|NCT01268917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24657693|NCT01268917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24657694|NCT01268917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24799219|NCT01967875|Antimitotic Agents|antimitotic agents|mesh-ancestor
24799220|NCT01967875|Mitosis Modulators|mitosis modulators|mesh-ancestor
24799221|NCT01967875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799222|NCT01967875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24799224|NCT01967927|Imidazole|imidazole|mesh-list
24799225|NCT01967927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24799226|NCT01967927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799227|NCT01967979|Itraconazole|itraconazole|mesh-list
24799228|NCT01967979|Fluoxetine|fluoxetine|mesh-list
24799229|NCT01967979|Antifungal Agents|antifungal agents|mesh-ancestor
24799230|NCT01967979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24799231|NCT01967979|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24799232|NCT01967979|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24799233|NCT01967979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657695|NCT01268917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24657736|NCT01269099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657738|NCT01269099|Sensory System Agents|sensory system agents|mesh-ancestor
24799234|NCT01967979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799235|NCT01967979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25703827|NCT02171611|Anticoagulants|anticoagulants|mesh-ancestor
25703828|NCT02172040|Celecoxib|celecoxib|mesh-list
25703829|NCT02172040|Amlodipine|amlodipine|mesh-list
25703830|NCT02172040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25703831|NCT02172040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25703832|NCT02172040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24799237|NCT01967979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24799238|NCT01967979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799239|NCT01967979|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24799240|NCT01967979|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24799241|NCT01967979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24799242|NCT01967979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24799243|NCT01967979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24948754|NCT03917082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24948755|NCT03917394|Iron|iron|mesh-list
24948756|NCT03917394|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24948757|NCT03917394|Trace Elements|trace elements|mesh-ancestor
24948758|NCT03917394|Micronutrients|micronutrients|mesh-ancestor
24948759|NCT03917394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657739|NCT01269099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24657740|NCT01269099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24657756|NCT01269151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24657757|NCT01269151|Growth Substances|growth substances|mesh-ancestor
24657758|NCT01269151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657759|NCT01269151|Growth Inhibitors|growth inhibitors|mesh-ancestor
24657760|NCT01269151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657761|NCT01269203|Curcumin|curcumin|mesh-list
24657762|NCT01269203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24657763|NCT01269203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24657764|NCT01269203|Analgesics|analgesics|mesh-ancestor
24657765|NCT01269203|Sensory System Agents|sensory system agents|mesh-ancestor
24657766|NCT01269203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24631806|NCT01120314|Otamixaban|otamixaban|mesh-list
24657770|NCT01269203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25703834|NCT02172040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25703835|NCT02172040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703836|NCT02172040|Vasodilator Agents|vasodilator agents|mesh-ancestor
25703837|NCT02172040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25703838|NCT02172040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25703839|NCT02172040|Analgesics|analgesics|mesh-ancestor
25703840|NCT02172040|Sensory System Agents|sensory system agents|mesh-ancestor
24657771|NCT01269203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24948761|NCT03917186|Sevoflurane|sevoflurane|mesh-list
24948762|NCT03917186|Desflurane|desflurane|mesh-list
24948763|NCT03917186|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24948764|NCT03917186|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24948765|NCT03917186|Anesthetics, General|anesthetics, general|mesh-ancestor
24948766|NCT03917186|Anesthetics|anesthetics|mesh-ancestor
24948767|NCT03917186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24948768|NCT03917186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657774|NCT01269216|Irinotecan|irinotecan|mesh-list
24657775|NCT01269216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24657776|NCT01269216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24657777|NCT01269216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657778|NCT01269216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657779|NCT01269216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657781|NCT01269216|Protective Agents|protective agents|mesh-ancestor
24657782|NCT01269216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657783|NCT01269216|Vitamin B Complex|vitamin b complex|mesh-ancestor
24657784|NCT01269216|Vitamins|vitamins|mesh-ancestor
24657785|NCT01269216|Micronutrients|micronutrients|mesh-ancestor
24657786|NCT01269242|Bindarit|bindarit|mesh-list
24657787|NCT01269242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24657788|NCT01269242|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24657789|NCT01269242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657799|NCT01269281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657800|NCT01269281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657801|NCT01269294|Moxifloxacin|moxifloxacin|mesh-list
24657803|NCT01269294|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24657804|NCT01269294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24657805|NCT01269294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24657809|NCT01269294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657810|NCT01269294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657811|NCT01269294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25703841|NCT02172040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25703842|NCT02172040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25703843|NCT02172040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25703844|NCT02172040|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25703845|NCT02172040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25703846|NCT02172040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703847|NCT02172742|Digoxin|digoxin|mesh-list
25703848|NCT02172742|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25703849|NCT02172742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25703850|NCT02172742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24657814|NCT01269294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657815|NCT01269294|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24657817|NCT01269294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24948770|NCT05402865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24948771|NCT05402865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657821|NCT01269307|Propofol|propofol|mesh-list
24657822|NCT01269307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24657823|NCT01269307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24657824|NCT01269307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657825|NCT01269307|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24657826|NCT01269307|Anesthetics, General|anesthetics, general|mesh-ancestor
24657827|NCT01269307|Anesthetics|anesthetics|mesh-ancestor
24657828|NCT01269307|Analgesics|analgesics|mesh-ancestor
24657829|NCT01269307|Sensory System Agents|sensory system agents|mesh-ancestor
24657830|NCT01269307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24657831|NCT01269307|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24657832|NCT01269307|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24657833|NCT01269307|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24657834|NCT01269307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24657835|NCT01269307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657836|NCT01269333|Fluvoxamine|fluvoxamine|mesh-list
24657837|NCT01269333|Omeprazole|omeprazole|mesh-list
24657839|NCT01269333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24657840|NCT01269333|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24657841|NCT01269333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657842|NCT01269333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657843|NCT01269333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24657844|NCT01269333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24657845|NCT01269333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24657846|NCT01269333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657847|NCT01269333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24657848|NCT01269333|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24657866|NCT01269437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657867|NCT01269437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24657869|NCT01269437|Glucocorticoids|glucocorticoids|mesh-ancestor
24657878|NCT01269463|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24657879|NCT01269463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657880|NCT01269463|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24657881|NCT01269463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24657887|NCT01269476|Methanesulfonyl fluoride|methanesulfonyl fluoride|mesh-list
25089484|NCT03265899|Lactitol|lactitol|mesh-list
24657888|NCT01269476|Cariostatic Agents|cariostatic agents|mesh-ancestor
24657889|NCT01269476|Protective Agents|protective agents|mesh-ancestor
24657890|NCT01269476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657891|NCT01269476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24657892|NCT01269476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657893|NCT01269476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657894|NCT01269476|Cholinergic Agents|cholinergic agents|mesh-ancestor
24657895|NCT01269476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24657901|NCT01269515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24657902|NCT01269515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657903|NCT01269515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24799247|NCT01967979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24799248|NCT01967979|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24799249|NCT01968005|Etodolac|etodolac|mesh-list
24799250|NCT01968005|Lidocaine|lidocaine|mesh-list
24799251|NCT01968005|Anesthetics, Local|anesthetics, local|mesh-ancestor
24799252|NCT01968005|Anesthetics|anesthetics|mesh-ancestor
24799253|NCT01968005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24799254|NCT01968005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799255|NCT01968005|Sensory System Agents|sensory system agents|mesh-ancestor
25703851|NCT02172742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703852|NCT02172742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703853|NCT02172742|Protective Agents|protective agents|mesh-ancestor
25703854|NCT02172742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703855|NCT02172742|Anticonvulsants|anticonvulsants|mesh-ancestor
25703856|NCT02172742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24799256|NCT01968005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24799257|NCT01968005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24799258|NCT01968005|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24799259|NCT01968005|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24799260|NCT01968005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24657904|NCT01269515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24657975|NCT01269684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657977|NCT01269788|Omeprazole|omeprazole|mesh-list
24657978|NCT01269788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24657979|NCT01269788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24948855|NCT05401370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657980|NCT01269788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24657981|NCT01269788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657994|NCT01269827|Pentoxifylline|pentoxifylline|mesh-list
24657995|NCT01269827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24657996|NCT01269827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657997|NCT01269827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658064|NCT01270191|Hormones|hormones|mesh-ancestor
24658065|NCT01270191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24658066|NCT01270308|Lansoprazole|lansoprazole|mesh-list
24658067|NCT01270308|Dexlansoprazole|dexlansoprazole|mesh-list
24658068|NCT01270308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24658069|NCT01270308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24658070|NCT01270308|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24658071|NCT01270308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24658072|NCT01270308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658073|NCT01270373|Docetaxel|docetaxel|mesh-list
24658074|NCT01270373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24658075|NCT01270373|Tubulin Modulators|tubulin modulators|mesh-ancestor
24658076|NCT01270373|Antimitotic Agents|antimitotic agents|mesh-ancestor
24658077|NCT01270373|Mitosis Modulators|mitosis modulators|mesh-ancestor
24774701|NCT01847404|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25703857|NCT02172742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25703858|NCT02172742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25703859|NCT02172755|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25703860|NCT02172755|Anticonvulsants|anticonvulsants|mesh-ancestor
25703861|NCT02172755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25703862|NCT02172755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25089547|NCT03264651|Anastrozole|anastrozole|mesh-list
25703863|NCT02172755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24658113|NCT01270438|Antidotes|antidotes|mesh-ancestor
24658114|NCT01270438|Protective Agents|protective agents|mesh-ancestor
24658115|NCT01270438|Vitamin B Complex|vitamin b complex|mesh-ancestor
24658116|NCT01270438|Vitamins|vitamins|mesh-ancestor
24658117|NCT01270438|Micronutrients|micronutrients|mesh-ancestor
24658118|NCT01270438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24658119|NCT01270451|Insulin|insulin|mesh-list
24658120|NCT01270451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24658121|NCT01270451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658122|NCT01270490|Interferons|interferons|mesh-list
24658123|NCT01270490|Interferon-gamma|interferon-gamma|mesh-list
24658146|NCT01270672|Serotonin Agents|serotonin agents|mesh-ancestor
24658147|NCT01270672|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24658148|NCT01270672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24658149|NCT01270724|Gemcitabine|gemcitabine|mesh-list
24658150|NCT01270724|Paclitaxel|paclitaxel|mesh-list
24658151|NCT01270724|Oxaliplatin|oxaliplatin|mesh-list
24658152|NCT01270724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24658153|NCT01270724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24658154|NCT01270724|Tubulin Modulators|tubulin modulators|mesh-ancestor
24658155|NCT01270724|Antimitotic Agents|antimitotic agents|mesh-ancestor
24658156|NCT01270724|Mitosis Modulators|mitosis modulators|mesh-ancestor
24658157|NCT01270724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658158|NCT01270724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24658159|NCT01270724|Antimetabolites|antimetabolites|mesh-ancestor
24658160|NCT01270724|Antiviral Agents|antiviral agents|mesh-ancestor
24658161|NCT01270724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24658162|NCT01270724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24658186|NCT01270789|Incretins|incretins|mesh-ancestor
24658187|NCT01270789|Hormones|hormones|mesh-ancestor
24658188|NCT01270789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24658189|NCT01270815|Pregabalin|pregabalin|mesh-list
24658190|NCT01270815|Analgesics|analgesics|mesh-ancestor
24658191|NCT01270815|Sensory System Agents|sensory system agents|mesh-ancestor
24658192|NCT01270815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658193|NCT01270815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658194|NCT01270815|Anticonvulsants|anticonvulsants|mesh-ancestor
24658195|NCT01270815|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24658283|NCT01271153|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24658284|NCT01271153|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24658285|NCT01271153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24658286|NCT01271153|Adrenergic Agents|adrenergic agents|mesh-ancestor
24658287|NCT01271153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24658288|NCT01271153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658289|NCT01271153|Protective Agents|protective agents|mesh-ancestor
24658291|NCT01271166|Bevacizumab|bevacizumab|mesh-list
24658292|NCT01271166|Fluorouracil|fluorouracil|mesh-list
24658293|NCT01271166|Oxaliplatin|oxaliplatin|mesh-list
24658294|NCT01271166|Imatinib Mesylate|imatinib mesylate|mesh-list
24658295|NCT01271166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24658296|NCT01271166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24658297|NCT01271166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24658298|NCT01271166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24658299|NCT01271166|Growth Substances|growth substances|mesh-ancestor
24658300|NCT01271166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658301|NCT01271166|Growth Inhibitors|growth inhibitors|mesh-ancestor
24949384|NCT04880655|Dermatologic Agents|dermatologic agents|mesh-ancestor
24949385|NCT04880655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24949386|NCT04880655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24949387|NCT04880655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24774792|NCT01848106|Bivalirudin|bivalirudin|mesh-list
24799262|NCT01968005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24799263|NCT01968005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24799264|NCT01968005|Analgesics|analgesics|mesh-ancestor
24799265|NCT01968005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24799266|NCT01968005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24799267|NCT01968005|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24799268|NCT01968005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24847311|NCT02246049|Antimetabolites|antimetabolites|mesh-ancestor
24658302|NCT01271166|Antimetabolites|antimetabolites|mesh-ancestor
24658329|NCT01271179|Antimetabolites|antimetabolites|mesh-ancestor
24658330|NCT01271179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24658331|NCT01271179|Gout Suppressants|gout suppressants|mesh-ancestor
24658332|NCT01271179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24658333|NCT01271179|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24658334|NCT01271179|Antioxidants|antioxidants|mesh-ancestor
24658337|NCT01271231|Azithromycin|azithromycin|mesh-list
24658358|NCT01271348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24658359|NCT01271348|Analgesics|analgesics|mesh-ancestor
24658360|NCT01271348|Sensory System Agents|sensory system agents|mesh-ancestor
24658361|NCT01271348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658362|NCT01271348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658363|NCT01271348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24658364|NCT01271348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24658365|NCT01271348|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25703865|NCT02173054|Adapalene|adapalene|mesh-list
24658366|NCT01271348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25703866|NCT02173054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25703867|NCT02173054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25703868|NCT02173054|Analgesics|analgesics|mesh-ancestor
25703869|NCT02173054|Sensory System Agents|sensory system agents|mesh-ancestor
25703870|NCT02173054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24591851|NCT00919295|Antidepressive Agents|antidepressive agents|mesh-ancestor
24658367|NCT01271348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24658391|NCT01271374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658392|NCT01271374|Vasodilator Agents|vasodilator agents|mesh-ancestor
24658405|NCT01271439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24658406|NCT01271478|Telmisartan|telmisartan|mesh-list
24658407|NCT01271478|Captopril|captopril|mesh-list
24658408|NCT01271478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24799270|NCT01968018|Acetaminophen|acetaminophen|mesh-list
24799271|NCT01968018|Tramadol|tramadol|mesh-list
24799272|NCT01968018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24799273|NCT01968018|Analgesics|analgesics|mesh-ancestor
24799274|NCT01968018|Sensory System Agents|sensory system agents|mesh-ancestor
24799275|NCT01968018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24799276|NCT01968018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799277|NCT01968018|Antipyretics|antipyretics|mesh-ancestor
25049679|NCT00578955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25049680|NCT00578955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25049682|NCT00578955|Protease Inhibitors|protease inhibitors|mesh-ancestor
25049683|NCT00578955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24827748|NCT02141139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25049684|NCT00578955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847322|NCT02246049|Vitamins|vitamins|mesh-ancestor
24658409|NCT01271478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24658410|NCT01271478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24658411|NCT01271478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658412|NCT01271478|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24658457|NCT01271660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24658458|NCT01271660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658459|NCT01271660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24658460|NCT01271660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24658461|NCT01271660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24658462|NCT01271660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24658463|NCT01271660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24658465|NCT01271881|Anticoagulants|anticoagulants|mesh-ancestor
24658466|NCT01271881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24658467|NCT01271881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24658468|NCT01271881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658469|NCT01271894|Efavirenz|efavirenz|mesh-list
24658470|NCT01271894|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24658471|NCT01271894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24658472|NCT01271894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24658473|NCT01271894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658493|NCT01272089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658494|NCT01272089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24658496|NCT01272089|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24658497|NCT01272089|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25049686|NCT00578955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25049687|NCT00578773|Moxifloxacin|moxifloxacin|mesh-list
24658532|NCT01272310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658533|NCT01272310|Antimalarials|antimalarials|mesh-ancestor
24658534|NCT01272310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24658535|NCT01272310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24658536|NCT01272310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24658537|NCT01272310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25703871|NCT02173054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703872|NCT02173054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25703873|NCT02173054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25703874|NCT02173054|Dermatologic Agents|dermatologic agents|mesh-ancestor
24658538|NCT01272414|Botulinum Toxins|botulinum toxins|mesh-list
24658539|NCT01272414|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24658540|NCT01272414|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24658541|NCT01272414|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24658542|NCT01272414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24449064|NCT00314158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449081|NCT00314171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24449082|NCT00314171|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24449083|NCT00314171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449084|NCT00314184|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24449085|NCT00314184|Antidepressive Agents|antidepressive agents|mesh-ancestor
24449086|NCT00314184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24449087|NCT00314184|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24449088|NCT00314184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24449091|NCT00314210|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24658543|NCT01272414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658544|NCT01272414|Cholinergic Agents|cholinergic agents|mesh-ancestor
24658545|NCT01272414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24658546|NCT01272414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658584|NCT01272778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658585|NCT01272778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658603|NCT01272856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24658604|NCT01272986|Immunoglobulin G|immunoglobulin g|mesh-list
24658605|NCT01272986|Immunologic Factors|immunologic factors|mesh-ancestor
24658606|NCT01272986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658607|NCT01273051|Capecitabine|capecitabine|mesh-list
24658608|NCT01273051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24658609|NCT01273051|Antimetabolites|antimetabolites|mesh-ancestor
24658610|NCT01273051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658615|NCT01273090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658616|NCT01273090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24658634|NCT01273298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658636|NCT01273402|Immunoglobulins|immunoglobulins|mesh-list
24658647|NCT01273441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24658648|NCT01273441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24658649|NCT01273441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658650|NCT01273441|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24658651|NCT01273441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24658652|NCT01273454|Hydromorphone|hydromorphone|mesh-list
24658653|NCT01273454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24658654|NCT01273454|Narcotics|narcotics|mesh-ancestor
24658655|NCT01273454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24658656|NCT01273454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658657|NCT01273454|Analgesics|analgesics|mesh-ancestor
24658658|NCT01273454|Sensory System Agents|sensory system agents|mesh-ancestor
24658659|NCT01273454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658660|NCT01273493|Dexamethasone|dexamethasone|mesh-list
24658661|NCT01273493|Trabectedin|trabectedin|mesh-list
24658662|NCT01273493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24658663|NCT01273493|Antiemetics|antiemetics|mesh-ancestor
24658664|NCT01273493|Autonomic Agents|autonomic agents|mesh-ancestor
24658665|NCT01273493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658666|NCT01273493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658667|NCT01273493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24658668|NCT01273493|Glucocorticoids|glucocorticoids|mesh-ancestor
24658672|NCT01273493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24658673|NCT01273493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24658674|NCT01273493|Alkylating Agents|alkylating agents|mesh-ancestor
24658676|NCT01273506|Tapentadol|tapentadol|mesh-list
24658688|NCT01273506|Adrenergic Agents|adrenergic agents|mesh-ancestor
24658689|NCT01273506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24658694|NCT01273532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658696|NCT01273532|Sensory System Agents|sensory system agents|mesh-ancestor
24658697|NCT01273532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25049688|NCT00578773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25049689|NCT00578773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25049690|NCT00578773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25049691|NCT00578773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25049693|NCT00578773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049694|NCT00578773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049695|NCT00578773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25049697|NCT00578474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25049698|NCT00578474|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25049699|NCT00578474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25049700|NCT00578474|Renal Agents|renal agents|mesh-ancestor
25049701|NCT00578474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24658698|NCT01273532|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24658699|NCT01273532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24658700|NCT01273532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24658738|NCT01273727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24658740|NCT01273727|Hormones|hormones|mesh-ancestor
24658741|NCT01273727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24658742|NCT01273727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24658743|NCT01273727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24658744|NCT01273727|Protease Inhibitors|protease inhibitors|mesh-ancestor
24658745|NCT01273727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24658746|NCT01273727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658840|NCT01274260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24658841|NCT01274260|Antiemetics|antiemetics|mesh-ancestor
24658842|NCT01274260|Autonomic Agents|autonomic agents|mesh-ancestor
24658843|NCT01274260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658844|NCT01274260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658926|NCT01274624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24658927|NCT01274624|Immunologic Factors|immunologic factors|mesh-ancestor
24658928|NCT01274624|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24658929|NCT01274624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25049702|NCT00578474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25049703|NCT00578474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25049704|NCT00578474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049705|NCT00578474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049706|NCT00578474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25049707|NCT00578474|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25049708|NCT00578474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24852748|NCT02264015|Moxifloxacin|moxifloxacin|mesh-list
24852749|NCT02264015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24852750|NCT02264015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24593920|NCT00931645|Cytarabine|cytarabine|mesh-list
25049709|NCT00577148|Rimonabant|rimonabant|mesh-list
25049710|NCT00577148|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24658936|NCT01274780|Ritonavir|ritonavir|mesh-list
24658937|NCT01274780|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24658938|NCT01274780|Darunavir|darunavir|mesh-list
24658939|NCT01274780|Tenofovir|tenofovir|mesh-list
24658945|NCT01274780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658948|NCT01274780|Antiviral Agents|antiviral agents|mesh-ancestor
24658949|NCT01274780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24658950|NCT01274780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24658951|NCT01274780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24658952|NCT01274780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24658970|NCT01274988|Respiratory System Agents|respiratory system agents|mesh-ancestor
24658972|NCT01275014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24658973|NCT01275014|Antiemetics|antiemetics|mesh-ancestor
24658974|NCT01275014|Autonomic Agents|autonomic agents|mesh-ancestor
24658975|NCT01275014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658987|NCT01275183|Tubulin Modulators|tubulin modulators|mesh-ancestor
24658988|NCT01275183|Antimitotic Agents|antimitotic agents|mesh-ancestor
24658989|NCT01275183|Mitosis Modulators|mitosis modulators|mesh-ancestor
24449100|NCT00314314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658990|NCT01275183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658991|NCT01275183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24658992|NCT01275183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24658993|NCT01275183|Antiviral Agents|antiviral agents|mesh-ancestor
24658994|NCT01275183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24658995|NCT01275183|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24658996|NCT01275183|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24658997|NCT01275183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24658999|NCT01275248|Antiemetics|antiemetics|mesh-ancestor
24659000|NCT01275248|Autonomic Agents|autonomic agents|mesh-ancestor
24659001|NCT01275248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24659002|NCT01275248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659003|NCT01275248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24659004|NCT01275248|Antipruritics|antipruritics|mesh-ancestor
24659005|NCT01275248|Dermatologic Agents|dermatologic agents|mesh-ancestor
24659006|NCT01275248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25703875|NCT02173392|Brodalumab|brodalumab|mesh-list
25703876|NCT02173392|Dermatologic Agents|dermatologic agents|mesh-ancestor
25703877|NCT02173548|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25703878|NCT02173548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25703879|NCT02173769|Tiotropium Bromide|tiotropium bromide|mesh-list
25703880|NCT02173769|Olodaterol|olodaterol|mesh-list
25703881|NCT02173769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25703882|NCT02173769|Autonomic Agents|autonomic agents|mesh-ancestor
25049714|NCT00577148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049716|NCT00577148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25049717|NCT00577148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049718|NCT00576810|Picosulfate sodium|picosulfate sodium|mesh-list
25049719|NCT00576810|Cathartics|cathartics|mesh-ancestor
25049720|NCT00576810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24659007|NCT01275248|Serotonin Agents|serotonin agents|mesh-ancestor
24659008|NCT01275248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24659009|NCT01275248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659010|NCT01275248|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24659011|NCT01275248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24659012|NCT01275248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24659013|NCT01275248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24659014|NCT01275248|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24659015|NCT01275274|Tretinoin|tretinoin|mesh-list
24659030|NCT01275352|Diuretics|diuretics|mesh-ancestor
24659032|NCT01275352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24659033|NCT01275443|Rilpivirine|rilpivirine|mesh-list
24659034|NCT01275443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24659094|NCT01275599|Sensory System Agents|sensory system agents|mesh-ancestor
24659095|NCT01275599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24659096|NCT01275599|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24659097|NCT01275638|Prednisolone|prednisolone|mesh-list
24659098|NCT01275638|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24659099|NCT01275638|Methylprednisolone|methylprednisolone|mesh-list
24659100|NCT01275638|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24659101|NCT01275638|Prednisolone acetate|prednisolone acetate|mesh-list
24659102|NCT01275638|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24659103|NCT01275638|Prednisolone phosphate|prednisolone phosphate|mesh-list
24659104|NCT01275638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24659105|NCT01275638|Glucocorticoids|glucocorticoids|mesh-ancestor
24659106|NCT01275638|Hormones|hormones|mesh-ancestor
24659107|NCT01275638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24659108|NCT01275638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659109|NCT01275638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24659112|NCT01275638|Autonomic Agents|autonomic agents|mesh-ancestor
24659138|NCT01275885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25703884|NCT02173769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703885|NCT02173769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24659145|NCT01275911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24659147|NCT01275911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24659148|NCT01275911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659150|NCT01275911|Sensory System Agents|sensory system agents|mesh-ancestor
25049722|NCT00576667|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25049723|NCT00576667|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
25049724|NCT00576667|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24659151|NCT01275911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24659152|NCT01275911|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24659153|NCT01275911|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24659188|NCT01276067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659191|NCT01276080|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24659192|NCT01276080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24659193|NCT01276080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659194|NCT01276080|Cholinergic Agents|cholinergic agents|mesh-ancestor
24659195|NCT01276080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24659196|NCT01276080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659229|NCT01276262|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24659233|NCT01276431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24659234|NCT01276431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659235|NCT01276431|Analgesics|analgesics|mesh-ancestor
24659236|NCT01276431|Sensory System Agents|sensory system agents|mesh-ancestor
24659237|NCT01276431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24659238|NCT01276431|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24659239|NCT01276496|Paclitaxel|paclitaxel|mesh-list
24659240|NCT01276496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24659241|NCT01276496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24659242|NCT01276496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659243|NCT01276496|Tubulin Modulators|tubulin modulators|mesh-ancestor
24659247|NCT01276548|Carboplatin|carboplatin|mesh-list
24659266|NCT01276613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24659267|NCT01276613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24659268|NCT01276613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24659269|NCT01276613|Immunologic Factors|immunologic factors|mesh-ancestor
24659270|NCT01276613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659271|NCT01276613|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24659272|NCT01276613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24659273|NCT01276613|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24659275|NCT01276691|Aspirin|aspirin|mesh-list
24659281|NCT01276691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049726|NCT00576667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049728|NCT00576667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25049729|NCT00576667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049730|NCT00576537|Vaccines|vaccines|mesh-list
25703886|NCT02173769|Respiratory System Agents|respiratory system agents|mesh-ancestor
25703887|NCT02173769|Parasympatholytics|parasympatholytics|mesh-ancestor
25703888|NCT02173769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25703889|NCT02173769|Cholinergic Agents|cholinergic agents|mesh-ancestor
25703890|NCT02173769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25049736|NCT00576342|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25049737|NCT00576342|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25049738|NCT00576342|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25049740|NCT00576342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25049741|NCT00576342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799278|NCT01968018|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24799279|NCT01968018|Narcotics|narcotics|mesh-ancestor
24659282|NCT01276691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24659283|NCT01276691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24659284|NCT01276691|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24659285|NCT01276691|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24659286|NCT01276691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659287|NCT01276691|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24659288|NCT01276691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24659289|NCT01276691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24659290|NCT01276691|Antipyretics|antipyretics|mesh-ancestor
24659309|NCT01276730|Dermatologic Agents|dermatologic agents|mesh-ancestor
24659311|NCT01276769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24659312|NCT01276769|Carboplatin|carboplatin|mesh-list
24659313|NCT01276769|Epirubicin|epirubicin|mesh-list
24659314|NCT01276769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24659336|NCT01276925|Anesthetics, Local|anesthetics, local|mesh-ancestor
24659337|NCT01276925|Anesthetics|anesthetics|mesh-ancestor
24659338|NCT01276925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24659355|NCT01277016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24659356|NCT01277016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24659357|NCT01277016|Immunologic Factors|immunologic factors|mesh-ancestor
24659358|NCT01277016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659359|NCT01277107|Zaleplon|zaleplon|mesh-list
24659360|NCT01277107|Anticonvulsants|anticonvulsants|mesh-ancestor
24659361|NCT01277107|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24659362|NCT01277107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24659363|NCT01277107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659364|NCT01277107|GABA Modulators|gaba modulators|mesh-ancestor
24659365|NCT01277107|GABA Agents|gaba agents|mesh-ancestor
24659366|NCT01277107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24799280|NCT01968018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24799281|NCT01968044|Linagliptin|linagliptin|mesh-list
24799282|NCT01968044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24799283|NCT01968044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659374|NCT01277172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659375|NCT01277172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598248|NCT00954785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24598249|NCT00954785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24852957|NCT02264847|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24662796|NCT01296971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659376|NCT01277172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24659377|NCT01277185|Calcium, Dietary|calcium, dietary|mesh-list
24659404|NCT01277497|Calcium acetate|calcium acetate|mesh-list
24659405|NCT01277497|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24659406|NCT01277497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659407|NCT01277497|Chelating Agents|chelating agents|mesh-ancestor
24659408|NCT01277497|Sequestering Agents|sequestering agents|mesh-ancestor
24659409|NCT01277497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659411|NCT01277627|Nevirapine|nevirapine|mesh-list
24659412|NCT01277627|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
24659413|NCT01277627|Protease Inhibitors|protease inhibitors|mesh-list
24659414|NCT01277627|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24659424|NCT01277627|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24659450|NCT01277731|Glucocorticoids|glucocorticoids|mesh-ancestor
24659452|NCT01277731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24659453|NCT01277731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24659454|NCT01277731|Protective Agents|protective agents|mesh-ancestor
24659455|NCT01277731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24659456|NCT01277731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659458|NCT01277770|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24659459|NCT01277770|Immunologic Factors|immunologic factors|mesh-ancestor
24659460|NCT01277770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659461|NCT01277770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24659462|NCT01277835|Lidocaine|lidocaine|mesh-list
24659463|NCT01277835|Anesthetics, Local|anesthetics, local|mesh-ancestor
24659464|NCT01277835|Anesthetics|anesthetics|mesh-ancestor
24659465|NCT01277835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24659466|NCT01277835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659467|NCT01277835|Sensory System Agents|sensory system agents|mesh-ancestor
24659468|NCT01277835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24659469|NCT01277835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24659470|NCT01277835|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24659471|NCT01277835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24659473|NCT01277835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659475|NCT01277913|Ergocalciferols|ergocalciferols|mesh-list
24659476|NCT01277913|Cholecalciferol|cholecalciferol|mesh-list
24659477|NCT01277913|Vitamins|vitamins|mesh-list
24659497|NCT01278082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659498|NCT01278082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24659499|NCT01278082|Respiratory System Agents|respiratory system agents|mesh-ancestor
24659500|NCT01278082|Glucocorticoids|glucocorticoids|mesh-ancestor
24659501|NCT01278082|Hormones|hormones|mesh-ancestor
24659502|NCT01278082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24950495|NCT03915340|Propafenone|propafenone|mesh-list
24402612|NCT00158028|Risperidone|risperidone|mesh-list
25703891|NCT02173769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703892|NCT02174276|Tenofovir|tenofovir|mesh-list
25703893|NCT02174276|Antiviral Agents|antiviral agents|mesh-ancestor
25703894|NCT02174276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25703895|NCT02174276|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25703896|NCT02174276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25703897|NCT02174276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25703898|NCT02174276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703899|NCT02174276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25703900|NCT02174276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25703901|NCT02174419|Nalbuphine|nalbuphine|mesh-list
25703902|NCT02174419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25703903|NCT02174419|Narcotics|narcotics|mesh-ancestor
25703904|NCT02174419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24599257|NCT04919369|Keratolytic Agents|keratolytic agents|mesh-ancestor
24599258|NCT04919369|Dermatologic Agents|dermatologic agents|mesh-ancestor
24599790|NCT03908437|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
24599792|NCT03908437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24599793|NCT03908437|Narcotics|narcotics|mesh-ancestor
24799286|NCT01968044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24799287|NCT01968044|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24799288|NCT01968044|Protease Inhibitors|protease inhibitors|mesh-ancestor
24799289|NCT01968044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24799290|NCT01968044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799291|NCT01968083|Vaccines|vaccines|mesh-list
24799292|NCT01968083|Immunologic Factors|immunologic factors|mesh-ancestor
24799293|NCT01968083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799302|NCT01968200|Protease Inhibitors|protease inhibitors|mesh-ancestor
24799303|NCT01968200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24799304|NCT01968200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799305|NCT01968200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24799306|NCT01968239|Ranibizumab|ranibizumab|mesh-list
24799307|NCT01968239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24799308|NCT01968239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24847397|NCT02246816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24847425|NCT02246920|Xhance|xhance|mesh-list
24659503|NCT01278186|Paclitaxel|paclitaxel|mesh-list
24659504|NCT01278186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24659505|NCT01278186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659506|NCT01278186|Tubulin Modulators|tubulin modulators|mesh-ancestor
24659507|NCT01278186|Antimitotic Agents|antimitotic agents|mesh-ancestor
24659508|NCT01278186|Mitosis Modulators|mitosis modulators|mesh-ancestor
24659509|NCT01278186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659510|NCT01278238|Phenylephrine|phenylephrine|mesh-list
24659511|NCT01278238|Oxymetazoline|oxymetazoline|mesh-list
24659512|NCT01278238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24659513|NCT01278238|Mydriatics|mydriatics|mesh-ancestor
24659514|NCT01278238|Autonomic Agents|autonomic agents|mesh-ancestor
24659515|NCT01278238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24659516|NCT01278238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659517|NCT01278238|Sympathomimetics|sympathomimetics|mesh-ancestor
24659518|NCT01278238|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24659519|NCT01278238|Nasal Decongestants|nasal decongestants|mesh-ancestor
25703905|NCT02174419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703906|NCT02174419|Analgesics|analgesics|mesh-ancestor
25703907|NCT02174419|Sensory System Agents|sensory system agents|mesh-ancestor
25703908|NCT02174419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25703909|NCT02174432|Nalbuphine|nalbuphine|mesh-list
25703910|NCT02174432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25703911|NCT02174432|Narcotics|narcotics|mesh-ancestor
25703912|NCT02174432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25703913|NCT02174432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703914|NCT02174432|Analgesics|analgesics|mesh-ancestor
25703915|NCT02174432|Sensory System Agents|sensory system agents|mesh-ancestor
25703916|NCT02174432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25703917|NCT02174510|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25703918|NCT02174510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24799311|NCT01968239|Growth Inhibitors|growth inhibitors|mesh-ancestor
24593209|NCT00927498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24593210|NCT00927498|Immunologic Factors|immunologic factors|mesh-ancestor
24847427|NCT02246920|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24659540|NCT01278290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24659541|NCT01278290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659542|NCT01278290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24659543|NCT01278290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24659544|NCT01278290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659545|NCT01278290|Hormones|hormones|mesh-ancestor
24659546|NCT01278290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24659547|NCT01278446|Caseins|caseins|mesh-list
24659548|NCT01278446|Chelating Agents|chelating agents|mesh-ancestor
24659549|NCT01278446|Sequestering Agents|sequestering agents|mesh-ancestor
24659551|NCT01278459|Atorvastatin|atorvastatin|mesh-list
24593219|NCT00927511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593220|NCT00927524|Insulin|insulin|mesh-list
24593221|NCT00927524|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24593222|NCT00927524|Insulin glulisine|insulin glulisine|mesh-list
24949577|NCT04460183|Nitric Oxide|nitric oxide|mesh-list
24949644|NCT04006288|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24949645|NCT04006288|Antithrombins|antithrombins|mesh-ancestor
24949646|NCT04006288|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24949647|NCT04006288|Protease Inhibitors|protease inhibitors|mesh-ancestor
24949648|NCT04006288|Anticoagulants|anticoagulants|mesh-ancestor
24949651|NCT03942328|Vaccines|vaccines|mesh-list
24949652|NCT03942328|Immunologic Factors|immunologic factors|mesh-ancestor
24949653|NCT03942328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949654|NCT03906292|Niacinamide|niacinamide|mesh-list
24949655|NCT03906292|Imatinib Mesylate|imatinib mesylate|mesh-list
24949656|NCT03906292|Dasatinib|dasatinib|mesh-list
24949657|NCT03906292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24949658|NCT03906292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24949659|NCT03906292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24949660|NCT03906292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24949661|NCT03906292|Vitamin B Complex|vitamin b complex|mesh-ancestor
24949662|NCT03906292|Vitamins|vitamins|mesh-ancestor
24949663|NCT03906292|Micronutrients|micronutrients|mesh-ancestor
24847436|NCT02247128|Clopidogrel|clopidogrel|mesh-list
24659613|NCT01278849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659614|NCT01279083|Timolol|timolol|mesh-list
24659615|NCT01279083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24659616|NCT01279083|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24949664|NCT03906292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949666|NCT03898895|Immunologic Factors|immunologic factors|mesh-ancestor
24949667|NCT03898895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24949668|NCT03853395|Antibodies|antibodies|mesh-list
24949669|NCT03853395|Immunologic Factors|immunologic factors|mesh-ancestor
24949670|NCT03853395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950090|NCT02655692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24950091|NCT02655692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24950092|NCT02655692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950093|NCT02633059|Dexamethasone|dexamethasone|mesh-list
24950094|NCT02633059|Dexamethasone acetate|dexamethasone acetate|mesh-list
24950095|NCT02633059|Ixazomib|ixazomib|mesh-list
24950096|NCT02633059|Ichthammol|ichthammol|mesh-list
24659631|NCT01279096|Autonomic Agents|autonomic agents|mesh-ancestor
24659632|NCT01279096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24603029|NCT00972101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24659646|NCT01279096|Sensory System Agents|sensory system agents|mesh-ancestor
24659647|NCT01279096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24950098|NCT02633059|Glycine|glycine|mesh-list
24950099|NCT02633059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24950100|NCT02633059|Antiemetics|antiemetics|mesh-ancestor
24950101|NCT02633059|Autonomic Agents|autonomic agents|mesh-ancestor
24950105|NCT02633059|Glucocorticoids|glucocorticoids|mesh-ancestor
24799345|NCT01968564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799346|NCT01968564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24799347|NCT01968564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24799348|NCT01968564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799349|NCT01968564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24799350|NCT01968564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799351|NCT01968577|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24659792|NCT01279707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659793|NCT01279707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659794|NCT01279811|Dopamine|dopamine|mesh-list
24659795|NCT01279811|Norepinephrine|norepinephrine|mesh-list
24659796|NCT01279811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
24659797|NCT01279811|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24659798|NCT01279811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24659799|NCT01279811|Adrenergic Agents|adrenergic agents|mesh-ancestor
24659800|NCT01279811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24659801|NCT01279811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659802|NCT01279811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659803|NCT01279811|Sympathomimetics|sympathomimetics|mesh-ancestor
24659804|NCT01279811|Autonomic Agents|autonomic agents|mesh-ancestor
24659805|NCT01279811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24659806|NCT01279811|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24659808|NCT01279811|Protective Agents|protective agents|mesh-ancestor
24659809|NCT01279876|Melatonin|melatonin|mesh-list
24659810|NCT01279876|Antioxidants|antioxidants|mesh-ancestor
24659811|NCT01279876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659812|NCT01279876|Protective Agents|protective agents|mesh-ancestor
24659838|NCT01280006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24659839|NCT01280006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659840|NCT01280006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24659841|NCT01280006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24659842|NCT01280006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24659843|NCT01280006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24659895|NCT01280305|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24659896|NCT01280305|Hormone Antagonists|hormone antagonists|mesh-ancestor
24659897|NCT01280305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24659898|NCT01280305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659899|NCT01280305|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24659900|NCT01280305|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24799354|NCT01968577|Antimetabolites|antimetabolites|mesh-ancestor
24799355|NCT01968577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799356|NCT01968577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24799357|NCT01968577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25703919|NCT02174510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25703920|NCT02174510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25703921|NCT02174510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703922|NCT02174510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25703923|NCT02174510|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25703924|NCT02174510|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25703925|NCT02174510|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24799358|NCT01968577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24799359|NCT01968616|Ranibizumab|ranibizumab|mesh-list
24799360|NCT01968616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24799361|NCT01968616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24799362|NCT01968616|Growth Substances|growth substances|mesh-ancestor
24799363|NCT01968616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799364|NCT01968616|Growth Inhibitors|growth inhibitors|mesh-ancestor
24799365|NCT01968616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799366|NCT01968655|Factor VIII|factor viii|mesh-list
24799367|NCT01968655|Coagulants|coagulants|mesh-ancestor
24799368|NCT01968759|Ramipril|ramipril|mesh-list
24799369|NCT01968759|Irbesartan|irbesartan|mesh-list
24799371|NCT01968759|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24799373|NCT01968759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950582|NCT03913884|Mitogens|mitogens|mesh-list
25049742|NCT00576342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049743|NCT00576342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25049744|NCT00576342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25049745|NCT00576342|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25049746|NCT00576342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049747|NCT00570986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25049748|NCT00570986|Immunologic Factors|immunologic factors|mesh-ancestor
25049749|NCT00570986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049750|NCT00570752|Atorvastatin|atorvastatin|mesh-list
24408418|NCT00177580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25049751|NCT00570752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25049752|NCT00570752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25049753|NCT00570752|Antimetabolites|antimetabolites|mesh-ancestor
25049755|NCT00570752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25049759|NCT00569387|Immunologic Factors|immunologic factors|mesh-ancestor
25049760|NCT00569387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049761|NCT00566202|Citalopram|citalopram|mesh-list
24799374|NCT01968759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799375|NCT01968759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24799376|NCT01968759|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24799377|NCT01968759|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24828179|NCT02143934|Chloroquine|chloroquine|mesh-list
24799439|NCT01969032|Capecitabine|capecitabine|mesh-list
25049770|NCT00566202|Antidepressive Agents|antidepressive agents|mesh-ancestor
25049771|NCT00566202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25049772|NCT00564421|Epinastine|epinastine|mesh-list
25049773|NCT00564421|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25049774|NCT00564421|Histamine Antagonists|histamine antagonists|mesh-ancestor
25049775|NCT00564421|Histamine Agents|histamine agents|mesh-ancestor
24799378|NCT01968759|Chelating Agents|chelating agents|mesh-ancestor
24799379|NCT01968759|Sequestering Agents|sequestering agents|mesh-ancestor
24799380|NCT01968798|Aspirin|aspirin|mesh-list
24799381|NCT01968798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24799382|NCT01968798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24799383|NCT01968798|Analgesics|analgesics|mesh-ancestor
24799384|NCT01968798|Sensory System Agents|sensory system agents|mesh-ancestor
24799385|NCT01968798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24847562|NCT02247596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659908|NCT01280669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24659909|NCT01280669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659910|NCT01280669|Antifungal Agents|antifungal agents|mesh-ancestor
24659911|NCT01280669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24828211|NCT02144194|Vinorelbine|vinorelbine|mesh-list
25703926|NCT02174510|Adrenergic Agents|adrenergic agents|mesh-ancestor
25703927|NCT02174510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25703928|NCT02174510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703929|NCT02174510|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25703930|NCT02174510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25703931|NCT02174510|Serotonin Agents|serotonin agents|mesh-ancestor
25703932|NCT02174510|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25703933|NCT02174510|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25703934|NCT02174510|Dopamine Agents|dopamine agents|mesh-ancestor
24604412|NCT00979186|Coagulants|coagulants|mesh-ancestor
24604434|NCT00979537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24604435|NCT00979537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604436|NCT00979537|Vasodilator Agents|vasodilator agents|mesh-ancestor
24659912|NCT01280669|Immunologic Factors|immunologic factors|mesh-ancestor
24659913|NCT01280669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659915|NCT01280682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24659916|NCT01280682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659917|NCT01280682|Immunologic Factors|immunologic factors|mesh-ancestor
24659918|NCT01280682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799386|NCT01968798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799387|NCT01968798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24799388|NCT01968798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24799389|NCT01968798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24799390|NCT01968798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24799391|NCT01968798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449180|NCT00314639|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24449181|NCT00314639|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24449182|NCT00314639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449184|NCT00314652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24449185|NCT00314652|Narcotics|narcotics|mesh-ancestor
24449186|NCT00314652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24799392|NCT01968798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24847583|NCT02247687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847584|NCT02247687|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24847585|NCT02247986|Methylphenidate|methylphenidate|mesh-list
24847586|NCT02247986|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24847587|NCT02247986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847588|NCT02247986|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24659970|NCT01281150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24659972|NCT01281163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659973|NCT01281163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24659974|NCT01281163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24659975|NCT01281163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950650|NCT03913468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950652|NCT03913468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950653|NCT03913468|Vitamins|vitamins|mesh-ancestor
24950654|NCT03913468|Micronutrients|micronutrients|mesh-ancestor
24950672|NCT03912974|Citalopram|citalopram|mesh-list
24950678|NCT03912974|Serotonin Agents|serotonin agents|mesh-ancestor
24950679|NCT03912974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950681|NCT03912974|Antidepressive Agents|antidepressive agents|mesh-ancestor
24950682|NCT03912974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24950683|NCT03912857|Apatinib|apatinib|mesh-list
24799398|NCT01968850|Vitamins|vitamins|mesh-ancestor
24799399|NCT01968850|Micronutrients|micronutrients|mesh-ancestor
24799400|NCT01968850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799401|NCT01968850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25703935|NCT02174523|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25703936|NCT02174523|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25703937|NCT02174523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25703938|NCT02174523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25703939|NCT02174523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703940|NCT02174523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25703941|NCT02174523|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24604904|NCT00982215|Antipyretics|antipyretics|mesh-ancestor
25703943|NCT02174523|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24799402|NCT01968915|Paclitaxel|paclitaxel|mesh-list
24799403|NCT01968915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24799404|NCT01968915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799405|NCT01968915|Tubulin Modulators|tubulin modulators|mesh-ancestor
24847626|NCT02248155|Pramipexole|pramipexole|mesh-list
24659980|NCT01281228|Incretins|incretins|mesh-ancestor
24659981|NCT01281228|Hormones|hormones|mesh-ancestor
24659982|NCT01281228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24659983|NCT01281514|Carboplatin|carboplatin|mesh-list
24659984|NCT01281514|Doxorubicin|doxorubicin|mesh-list
24659985|NCT01281514|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24659986|NCT01281514|Everolimus|everolimus|mesh-list
24659987|NCT01281514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660006|NCT01281527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660011|NCT01281540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24660012|NCT01281540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24799406|NCT01968915|Antimitotic Agents|antimitotic agents|mesh-ancestor
24799407|NCT01968915|Mitosis Modulators|mitosis modulators|mesh-ancestor
24799408|NCT01968915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799409|NCT01969006|Bupivacaine|bupivacaine|mesh-list
24799410|NCT01969006|Anesthetics, Local|anesthetics, local|mesh-ancestor
24799411|NCT01969006|Anesthetics|anesthetics|mesh-ancestor
24799412|NCT01969006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24799413|NCT01969006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799414|NCT01969006|Sensory System Agents|sensory system agents|mesh-ancestor
24799415|NCT01969006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24799418|NCT01969019|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24799419|NCT01969019|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24799420|NCT01969019|Prednisolone|prednisolone|mesh-list
24799421|NCT01969019|Prednisolone acetate|prednisolone acetate|mesh-list
24799422|NCT01969019|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24799423|NCT01969019|Prednisolone phosphate|prednisolone phosphate|mesh-list
24799424|NCT01969019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24799425|NCT01969019|Glucocorticoids|glucocorticoids|mesh-ancestor
24799426|NCT01969019|Hormones|hormones|mesh-ancestor
24799427|NCT01969019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24799428|NCT01969019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411158|NCT00188045|Vasodilator Agents|vasodilator agents|mesh-ancestor
24411159|NCT00188045|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24799429|NCT01969019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24799430|NCT01969019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799431|NCT01969019|Antiemetics|antiemetics|mesh-ancestor
24799432|NCT01969019|Autonomic Agents|autonomic agents|mesh-ancestor
24660013|NCT01281540|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24660014|NCT01281540|Serotonin Agents|serotonin agents|mesh-ancestor
24660015|NCT01281540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24660016|NCT01281540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660017|NCT01281540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660019|NCT01281553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24660020|NCT01281553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24660021|NCT01281553|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24660022|NCT01281553|Serotonin Agents|serotonin agents|mesh-ancestor
24660037|NCT01281579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24660045|NCT01281657|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25703944|NCT02174523|Adrenergic Agents|adrenergic agents|mesh-ancestor
25703945|NCT02174523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25703946|NCT02174523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703947|NCT02174523|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25703948|NCT02174523|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25703949|NCT02174523|Serotonin Agents|serotonin agents|mesh-ancestor
24605164|NCT00983450|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24660046|NCT01281657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660048|NCT01281657|Immunologic Factors|immunologic factors|mesh-ancestor
24660049|NCT01281657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660050|NCT01281696|Bevacizumab|bevacizumab|mesh-list
24660051|NCT01281696|Methotrexate|methotrexate|mesh-list
24660052|NCT01281696|Etoposide|etoposide|mesh-list
24799440|NCT01969032|Cyclophosphamide|cyclophosphamide|mesh-list
24799434|NCT01969019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24799435|NCT01969019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24799436|NCT01969019|Protective Agents|protective agents|mesh-ancestor
24799437|NCT01969032|Paclitaxel|paclitaxel|mesh-list
24660055|NCT01281696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24660056|NCT01281696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24660057|NCT01281696|Growth Substances|growth substances|mesh-ancestor
24660058|NCT01281696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660059|NCT01281696|Growth Inhibitors|growth inhibitors|mesh-ancestor
24453179|NCT05238831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24453180|NCT05238831|Endothelial Growth Factors|endothelial growth factors|mesh-list
24453181|NCT05238831|Antibodies|antibodies|mesh-list
24660060|NCT01281696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24660061|NCT01281696|Abortifacient Agents|abortifacient agents|mesh-ancestor
24660062|NCT01281696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24660071|NCT01281696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24660072|NCT01281696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24660073|NCT01281696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24660074|NCT01281696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24660075|NCT01281696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24660076|NCT01281748|Methylprednisolone|methylprednisolone|mesh-list
24660077|NCT01281748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24799447|NCT01969032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607414|NCT04665037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24660116|NCT01281787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660119|NCT01281787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24660122|NCT01281787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24660123|NCT01281787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24660124|NCT01281787|Adrenergic Agents|adrenergic agents|mesh-ancestor
24660125|NCT01281787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24660127|NCT01281800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24660128|NCT01281800|Antimetabolites|antimetabolites|mesh-ancestor
24660130|NCT01281800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799457|NCT01969032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24799458|NCT01969032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24799459|NCT01969032|Alkylating Agents|alkylating agents|mesh-ancestor
24799460|NCT01969032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24847660|NCT02248207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847661|NCT02248207|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24847662|NCT02248207|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24847663|NCT02248207|Dopamine Agonists|dopamine agonists|mesh-ancestor
24847664|NCT02248207|Dopamine Agents|dopamine agents|mesh-ancestor
24847665|NCT02248207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24847666|NCT02248220|Pramipexole|pramipexole|mesh-list
24847667|NCT02248220|Antioxidants|antioxidants|mesh-ancestor
24847668|NCT02248220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24847669|NCT02248220|Protective Agents|protective agents|mesh-ancestor
24635814|NCT01141244|Antifungal Agents|antifungal agents|mesh-ancestor
24660143|NCT01281813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799474|NCT01969071|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24799475|NCT01969071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24627678|NCT01094444|Vitamin K|vitamin k|mesh-list
24799476|NCT01969071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24799477|NCT01969071|Adrenergic Agents|adrenergic agents|mesh-ancestor
24799478|NCT01969071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24799479|NCT01969149|Insulin|insulin|mesh-list
24799480|NCT01969149|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24799486|NCT01969149|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24799488|NCT01969149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24799489|NCT01969227|Ketamine|ketamine|mesh-list
24799490|NCT01969227|Analgesics|analgesics|mesh-ancestor
24606064|NCT00988780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606065|NCT00988780|Antiviral Agents|antiviral agents|mesh-ancestor
24606066|NCT00988780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24606067|NCT00988780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24847676|NCT02248233|Nimodipine|nimodipine|mesh-list
24660172|NCT01281891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24660173|NCT01281891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660174|NCT01281891|Analgesics|analgesics|mesh-ancestor
24660175|NCT01281891|Sensory System Agents|sensory system agents|mesh-ancestor
24660176|NCT01281891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24660178|NCT01281943|Doxorubicin|doxorubicin|mesh-list
24660179|NCT01281943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24660180|NCT01281943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24660181|NCT01281943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951645|NCT03902782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24449276|NCT00314860|Ropinirole|ropinirole|mesh-list
24799501|NCT01969227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24799502|NCT01969227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799503|NCT01969318|Metformin|metformin|mesh-list
24828497|NCT02145767|Progesterone|progesterone|mesh-list
24449281|NCT00314860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24449282|NCT00314860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449283|NCT00314860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449284|NCT00314873|Imatinib Mesylate|imatinib mesylate|mesh-list
24799507|NCT01969357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24799508|NCT01969357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799510|NCT01969357|Hormones|hormones|mesh-ancestor
24799511|NCT01969357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24799512|NCT01969357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24799513|NCT01969357|Protease Inhibitors|protease inhibitors|mesh-ancestor
24799514|NCT01969357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24799515|NCT01969357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660192|NCT01282047|Lenalidomide|lenalidomide|mesh-list
24660193|NCT01282047|Immunologic Factors|immunologic factors|mesh-ancestor
24660194|NCT01282047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703950|NCT02174523|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25703951|NCT02174523|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25703952|NCT02174523|Dopamine Agents|dopamine agents|mesh-ancestor
25703953|NCT02174731|Epoetin Alfa|epoetin alfa|mesh-list
25703954|NCT02174731|Hematinics|hematinics|mesh-ancestor
25703955|NCT02174848|Deferiprone|deferiprone|mesh-list
24412099|NCT00190827|Analgesics|analgesics|mesh-ancestor
25703956|NCT02174848|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25703957|NCT02174848|Chelating Agents|chelating agents|mesh-ancestor
25703958|NCT02174848|Sequestering Agents|sequestering agents|mesh-ancestor
24606379|NCT00990197|Cholinergic Agents|cholinergic agents|mesh-ancestor
24606380|NCT00990197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24606406|NCT00990301|Protease Inhibitors|protease inhibitors|mesh-ancestor
24606407|NCT00990301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606408|NCT00990392|Polymyxins|polymyxins|mesh-list
24606409|NCT00990392|Bacitracin|bacitracin|mesh-list
24606410|NCT00990392|Polymyxin B|polymyxin b|mesh-list
24660195|NCT01282047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24660196|NCT01282047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24660197|NCT01282047|Growth Substances|growth substances|mesh-ancestor
24660198|NCT01282047|Growth Inhibitors|growth inhibitors|mesh-ancestor
24660199|NCT01282047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660200|NCT01282073|Cyclosporine|cyclosporine|mesh-list
24660205|NCT01282073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24660207|NCT01282073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660208|NCT01282073|Antifungal Agents|antifungal agents|mesh-ancestor
24660209|NCT01282073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24660210|NCT01282073|Dermatologic Agents|dermatologic agents|mesh-ancestor
24660211|NCT01282073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24660212|NCT01282073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24660213|NCT01282073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24660214|NCT01282073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660215|NCT01282073|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24799516|NCT01969578|Paclitaxel|paclitaxel|mesh-list
24799518|NCT01969578|Doxorubicin|doxorubicin|mesh-list
24799519|NCT01969578|Bicalutamide|bicalutamide|mesh-list
24799520|NCT01969578|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24799521|NCT01969578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24799522|NCT01969578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799523|NCT01969578|Tubulin Modulators|tubulin modulators|mesh-ancestor
24799524|NCT01969578|Antimitotic Agents|antimitotic agents|mesh-ancestor
24799525|NCT01969578|Mitosis Modulators|mitosis modulators|mesh-ancestor
24799526|NCT01969578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799527|NCT01969578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24799528|NCT01969578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24799530|NCT01969578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24799531|NCT01969578|Androgen Antagonists|androgen antagonists|mesh-ancestor
24799532|NCT01969578|Hormone Antagonists|hormone antagonists|mesh-ancestor
24799533|NCT01969578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24799534|NCT01969578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799535|NCT01969578|Luteolytic Agents|luteolytic agents|mesh-ancestor
24799536|NCT01969578|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24799537|NCT01969578|Contraceptive Agents|contraceptive agents|mesh-ancestor
24799538|NCT01969578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24799539|NCT01969578|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24799540|NCT01969578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24799541|NCT01969617|Naltrexone|naltrexone|mesh-list
24799542|NCT01969617|Nalmefene|nalmefene|mesh-list
24593486|NCT00929799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25703959|NCT02174848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703960|NCT02174913|Fentanyl|fentanyl|mesh-list
25703961|NCT02174913|Propofol|propofol|mesh-list
25703962|NCT02174913|Atracurium|atracurium|mesh-list
25703963|NCT02174913|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25703964|NCT02174913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25703965|NCT02174913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703966|NCT02174913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24593487|NCT00929799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593488|NCT00929812|Glucagon|glucagon|mesh-list
24593489|NCT00929812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24593490|NCT00929812|Hormones|hormones|mesh-ancestor
24593491|NCT00929812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24593494|NCT00929851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24593495|NCT00929851|Autonomic Agents|autonomic agents|mesh-ancestor
24593496|NCT00929851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24593497|NCT00929851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593498|NCT00929851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24593499|NCT00929851|Respiratory System Agents|respiratory system agents|mesh-ancestor
24593500|NCT00929851|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24593501|NCT00929851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24593502|NCT00929851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24593503|NCT00929851|Adrenergic Agents|adrenergic agents|mesh-ancestor
24593504|NCT00929851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24593505|NCT00929851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660216|NCT01282073|Antitubercular Agents|antitubercular agents|mesh-ancestor
24660217|NCT01282073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24660219|NCT01282151|Pemetrexed|pemetrexed|mesh-list
24660220|NCT01282151|Docetaxel|docetaxel|mesh-list
24660221|NCT01282151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24593506|NCT00929877|Ketoprofen|ketoprofen|mesh-list
24593507|NCT00929877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24847760|NCT02248506|Miconazole|miconazole|mesh-list
24593508|NCT00929877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24593509|NCT00929877|Analgesics|analgesics|mesh-ancestor
24593510|NCT00929877|Sensory System Agents|sensory system agents|mesh-ancestor
24593511|NCT00929877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24593512|NCT00929877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593513|NCT00929877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24593515|NCT00929877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24799564|NCT01969669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25049776|NCT00564421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25049777|NCT00564421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049778|NCT00564421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049779|NCT00564226|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25049780|NCT00564226|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25049781|NCT00564226|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25049782|NCT00564226|Cholinergic Agents|cholinergic agents|mesh-ancestor
25049783|NCT00564226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25049784|NCT00564226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049785|NCT00564226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049786|NCT00564226|Urological Agents|urological agents|mesh-ancestor
25049787|NCT00563563|Naltrexone|naltrexone|mesh-list
25049788|NCT00563563|Bupropion|bupropion|mesh-list
25049789|NCT00563563|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25049790|NCT00563563|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25049791|NCT00563563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049792|NCT00563563|Sensory System Agents|sensory system agents|mesh-ancestor
25049793|NCT00563563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25049796|NCT00563563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25049797|NCT00563563|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25049799|NCT00563563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25049800|NCT00563563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049801|NCT00563563|Dopamine Agents|dopamine agents|mesh-ancestor
25049802|NCT00563563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25049803|NCT00563563|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25049804|NCT00563563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25049805|NCT00563563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049806|NCT00563459|Topiramate|topiramate|mesh-list
25049807|NCT00563459|Levetiracetam|levetiracetam|mesh-list
25049808|NCT00563459|Anticonvulsants|anticonvulsants|mesh-ancestor
25049809|NCT00563459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25049810|NCT00563459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049811|NCT00563459|Nootropic Agents|nootropic agents|mesh-ancestor
25049812|NCT00562887|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25049813|NCT00562887|Immunologic Factors|immunologic factors|mesh-ancestor
25049814|NCT00562887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049815|NCT00562497|Remestemcel-l|remestemcel-l|mesh-list
25049817|NCT00562497|Methylprednisolone|methylprednisolone|mesh-list
25049818|NCT00562497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25049819|NCT00562497|Glucocorticoids|glucocorticoids|mesh-ancestor
25049820|NCT00562497|Hormones|hormones|mesh-ancestor
25049821|NCT00562497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24847799|NCT05353816|Heparin|heparin|mesh-list
24660222|NCT01282151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660223|NCT01282151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660224|NCT01282151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24413158|NCT00193232|Docetaxel|docetaxel|mesh-list
24455592|NCT00327925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660225|NCT01282151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24660226|NCT01282151|Tubulin Modulators|tubulin modulators|mesh-ancestor
24660227|NCT01282151|Antimitotic Agents|antimitotic agents|mesh-ancestor
24660228|NCT01282151|Mitosis Modulators|mitosis modulators|mesh-ancestor
24660229|NCT01282333|Gemcitabine|gemcitabine|mesh-list
24660231|NCT01282333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660248|NCT01282385|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24660249|NCT01282385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660250|NCT01282398|Simvastatin|simvastatin|mesh-list
24660251|NCT01282398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24660252|NCT01282398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24660253|NCT01282398|Antimetabolites|antimetabolites|mesh-ancestor
24660254|NCT01282398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660255|NCT01282398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24799573|NCT01969682|Venetoclax|venetoclax|mesh-list
24660257|NCT01282398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660259|NCT01282502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660260|NCT01282502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24660298|NCT01282632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660299|NCT01282632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660301|NCT01282632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24660302|NCT01282632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24950859|NCT03910634|Immunologic Factors|immunologic factors|mesh-ancestor
24950860|NCT03910634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24950861|NCT03910712|Trastuzumab|trastuzumab|mesh-list
24950862|NCT03910712|Letrozole|letrozole|mesh-list
24950863|NCT03910712|Anastrozole|anastrozole|mesh-list
24950864|NCT03910712|Exemestane|exemestane|mesh-list
24950865|NCT03910712|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24950866|NCT03910712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24950867|NCT03910712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24950868|NCT03910712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24950869|NCT03910712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24950870|NCT03910712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24950871|NCT03910712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24950872|NCT03910712|Hormone Antagonists|hormone antagonists|mesh-ancestor
24950873|NCT03910712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24950874|NCT03910712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847815|NCT05353673|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24660303|NCT01282632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24660304|NCT01282632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24660305|NCT01282632|Dopamine Agents|dopamine agents|mesh-ancestor
24660306|NCT01282632|Antiemetics|antiemetics|mesh-ancestor
24660307|NCT01282632|Autonomic Agents|autonomic agents|mesh-ancestor
24660308|NCT01282632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24660309|NCT01282632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24660365|NCT01283100|Dolutegravir|dolutegravir|mesh-list
24660366|NCT01283100|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24660367|NCT01283100|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24660368|NCT01283100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660369|NCT01283100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660370|NCT01283100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24660371|NCT01283100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24660372|NCT01283100|Antiviral Agents|antiviral agents|mesh-ancestor
24660373|NCT01283100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24660374|NCT01283126|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24660375|NCT01283126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660420|NCT01283412|Dexmedetomidine|dexmedetomidine|mesh-list
24660421|NCT01283412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24660422|NCT01283412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24660423|NCT01283412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660424|NCT01283412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24660425|NCT01283412|Analgesics|analgesics|mesh-ancestor
24660426|NCT01283412|Sensory System Agents|sensory system agents|mesh-ancestor
24950875|NCT03910712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24799565|NCT01969669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24799566|NCT01969669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799567|NCT01969669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24799568|NCT01969669|Hormone Antagonists|hormone antagonists|mesh-ancestor
25092450|NCT03242096|Mitosis Modulators|mitosis modulators|mesh-ancestor
24799569|NCT01969669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24799570|NCT01969669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799571|NCT01969669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24799572|NCT01969682|Rifampin|rifampin|mesh-list
24799574|NCT01969682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799575|NCT01969682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24799576|NCT01969682|Antitubercular Agents|antitubercular agents|mesh-ancestor
24799577|NCT01969682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24740681|NCT01689753|Citric Acid|citric acid|mesh-list
24799583|NCT01969682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24799584|NCT01969682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24799585|NCT01969682|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24799586|NCT01969682|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24660427|NCT01283412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24660428|NCT01283412|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24660429|NCT01283412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24660430|NCT01283412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24660431|NCT01283412|Adrenergic Agents|adrenergic agents|mesh-ancestor
24660432|NCT01283412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24660433|NCT01283412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660434|NCT01283646|Vitamins|vitamins|mesh-list
24660435|NCT01283646|Ascorbic Acid|ascorbic acid|mesh-list
24660436|NCT01283646|Folic Acid|folic acid|mesh-list
24660437|NCT01283646|Vitamin B Complex|vitamin b complex|mesh-list
24660438|NCT01283646|Micronutrients|micronutrients|mesh-ancestor
24660439|NCT01283646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660440|NCT01283646|Antioxidants|antioxidants|mesh-ancestor
24660441|NCT01283646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660447|NCT01283724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24660448|NCT01283724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799608|NCT01969903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799609|NCT01969903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24799610|NCT01969903|Analgesics|analgesics|mesh-ancestor
24799611|NCT01969903|Sensory System Agents|sensory system agents|mesh-ancestor
24799612|NCT01969903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24847848|NCT05353205|HH-GV-678|hh-gv-678|mesh-list
24660451|NCT01283724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24660452|NCT01283724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24660520|NCT01284166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24660521|NCT01284166|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24660522|NCT01284166|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24660523|NCT01284166|Adrenergic Agents|adrenergic agents|mesh-ancestor
24660524|NCT01284166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24660525|NCT01284166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660526|NCT01284166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660527|NCT01284166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24660528|NCT01284166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24660529|NCT01284166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24799631|NCT01969955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24799632|NCT01969955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799633|NCT01969955|Tubulin Modulators|tubulin modulators|mesh-ancestor
24799634|NCT01969955|Antimitotic Agents|antimitotic agents|mesh-ancestor
24799635|NCT01969955|Mitosis Modulators|mitosis modulators|mesh-ancestor
24660531|NCT01284166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25703967|NCT02174913|Anesthetics, General|anesthetics, general|mesh-ancestor
25703968|NCT02174913|Anesthetics|anesthetics|mesh-ancestor
25703969|NCT02174913|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24660532|NCT01284166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24660533|NCT01284166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660535|NCT01284205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24660536|NCT01284205|Immunologic Factors|immunologic factors|mesh-ancestor
24660537|NCT01284205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093055|NCT03237624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24660587|NCT01284556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660588|NCT01284556|GABA Modulators|gaba modulators|mesh-ancestor
24660589|NCT01284556|GABA Agents|gaba agents|mesh-ancestor
24660590|NCT01284556|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24660591|NCT01284556|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24660592|NCT01284556|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24660593|NCT01284647|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
24660594|NCT01284647|Sucralfate|sucralfate|mesh-list
24660595|NCT01284647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24660604|NCT01284725|Antitubercular Agents|antitubercular agents|mesh-ancestor
24660617|NCT01284764|Serotonin Agents|serotonin agents|mesh-ancestor
24660618|NCT01284764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24660619|NCT01284764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660620|NCT01284764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660621|NCT01284855|Antivenins|antivenins|mesh-list
24660622|NCT01284855|Immunologic Factors|immunologic factors|mesh-ancestor
24660623|NCT01284855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660624|NCT01284868|Propranolol|propranolol|mesh-list
24660625|NCT01284868|Bisoprolol|bisoprolol|mesh-list
24660626|NCT01284868|Mirabegron|mirabegron|mesh-list
24660627|NCT01284868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24799660|NCT01970059|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24799661|NCT01970059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24799662|NCT01970072|Midazolam|midazolam|mesh-list
24799663|NCT01970072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24799664|NCT01970072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24799665|NCT01970072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24799666|NCT01970072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593518|NCT00929955|Ondansetron|ondansetron|mesh-list
24799702|NCT01970449|Immunologic Factors|immunologic factors|mesh-ancestor
24449531|NCT00315900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449532|NCT00315900|Anticonvulsants|anticonvulsants|mesh-ancestor
24449533|NCT00315900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449534|NCT00315900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799703|NCT01970449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799705|NCT01970553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24799706|NCT01970553|Antimetabolites|antimetabolites|mesh-ancestor
24799707|NCT01970553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703970|NCT02174913|Narcotics|narcotics|mesh-ancestor
25703971|NCT02174913|Analgesics|analgesics|mesh-ancestor
25703972|NCT02174913|Sensory System Agents|sensory system agents|mesh-ancestor
25703973|NCT02174913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25703974|NCT02174913|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24660630|NCT01284868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24660632|NCT01284868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660649|NCT01284907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24660703|NCT01285375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660705|NCT01285375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24660706|NCT01285375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660707|NCT01285375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660774|NCT01285674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660775|NCT01285765|Rituximab|rituximab|mesh-list
24660776|NCT01285765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24660777|NCT01285765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660778|NCT01285765|Immunologic Factors|immunologic factors|mesh-ancestor
24660779|NCT01285765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660780|NCT01285765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24660781|NCT01285778|Panitumumab|panitumumab|mesh-list
24660782|NCT01285778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24660783|NCT01285778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660784|NCT01285817|Celecoxib|celecoxib|mesh-list
24660785|NCT01285817|Cyclophosphamide|cyclophosphamide|mesh-list
24660786|NCT01285817|Methotrexate|methotrexate|mesh-list
24660845|NCT01286233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24660846|NCT01286233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660847|NCT01286246|Progesterone|progesterone|mesh-list
24660848|NCT01286246|Progestins|progestins|mesh-ancestor
24660877|NCT01286857|Trace Elements|trace elements|mesh-ancestor
24660878|NCT01286857|Micronutrients|micronutrients|mesh-ancestor
24799716|NCT01970579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24799717|NCT01970579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799718|NCT01970579|Tubulin Modulators|tubulin modulators|mesh-ancestor
24799719|NCT01970579|Antimitotic Agents|antimitotic agents|mesh-ancestor
24799720|NCT01970579|Mitosis Modulators|mitosis modulators|mesh-ancestor
24799721|NCT01970579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799723|NCT01970748|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24799724|NCT01970748|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24799725|NCT01970748|Adrenergic Agents|adrenergic agents|mesh-ancestor
24799726|NCT01970748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24799727|NCT01970748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799728|NCT01970748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799729|NCT01970748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24799730|NCT01970748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24799731|NCT01970748|Vasodilator Agents|vasodilator agents|mesh-ancestor
24799732|NCT01970800|Hormones|hormones|mesh-list
24799733|NCT01970800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24799734|NCT01970800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799735|NCT01970904|Ribavirin|ribavirin|mesh-list
24660885|NCT01286896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660886|NCT01286896|Growth Inhibitors|growth inhibitors|mesh-ancestor
24660887|NCT01286896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24660888|NCT01286896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660889|NCT01286896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660890|NCT01286909|Lycopene|lycopene|mesh-list
24660891|NCT01286909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24660892|NCT01286909|Antioxidants|antioxidants|mesh-ancestor
24660933|NCT01287247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660934|NCT01287247|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24660935|NCT01287247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24660936|NCT01287260|Nifedipine|nifedipine|mesh-list
24660937|NCT01287260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24660938|NCT01287260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24660939|NCT01287260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660942|NCT01287260|Vasodilator Agents|vasodilator agents|mesh-ancestor
24660943|NCT01287260|Tocolytic Agents|tocolytic agents|mesh-ancestor
24660944|NCT01287260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24660945|NCT01287338|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
24799743|NCT01971034|Metformin|metformin|mesh-list
24799744|NCT01971034|Paclitaxel|paclitaxel|mesh-list
24799745|NCT01971034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24799746|NCT01971034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799747|NCT01971034|Tubulin Modulators|tubulin modulators|mesh-ancestor
24799748|NCT01971034|Antimitotic Agents|antimitotic agents|mesh-ancestor
24799749|NCT01971034|Mitosis Modulators|mitosis modulators|mesh-ancestor
24799750|NCT01971034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799751|NCT01971034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24799752|NCT01971034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847924|NCT05340452|Clarithromycin|clarithromycin|mesh-list
24660946|NCT01287338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24660947|NCT01287338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24661048|NCT01287689|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24661051|NCT01287689|Immunologic Factors|immunologic factors|mesh-ancestor
24661052|NCT01287689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661053|NCT01287715|Etanercept|etanercept|mesh-list
24661054|NCT01287715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24661057|NCT01287715|Sensory System Agents|sensory system agents|mesh-ancestor
24661058|NCT01287715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24661059|NCT01287715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661060|NCT01287715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24661061|NCT01287715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24661062|NCT01287715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24661063|NCT01287715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24661064|NCT01287715|Immunologic Factors|immunologic factors|mesh-ancestor
24661065|NCT01287741|Prednisone|prednisone|mesh-list
24661067|NCT01287741|Rituximab|rituximab|mesh-list
24661105|NCT01287793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24661106|NCT01287793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661107|NCT01287793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661108|NCT01287793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661109|NCT01287793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24661110|NCT01287806|Urinastatin|urinastatin|mesh-list
24661111|NCT01287806|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24661112|NCT01287806|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24661113|NCT01287806|Protease Inhibitors|protease inhibitors|mesh-ancestor
24661114|NCT01287806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24455650|NCT00328432|Celecoxib|celecoxib|mesh-list
24661115|NCT01287806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661117|NCT01287962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799754|NCT01971047|Insulin Lispro|insulin lispro|mesh-list
24799755|NCT01971047|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24799756|NCT01971047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24799757|NCT01971047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799758|NCT01971190|Aflibercept|aflibercept|mesh-list
24661123|NCT01288131|Cyclosporine|cyclosporine|mesh-list
24661124|NCT01288131|Mycophenolic Acid|mycophenolic acid|mesh-list
24661125|NCT01288131|Cyclophosphamide|cyclophosphamide|mesh-list
24661126|NCT01288131|Cyclosporins|cyclosporins|mesh-list
24661127|NCT01288131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24661128|NCT01288131|Immunologic Factors|immunologic factors|mesh-ancestor
24661129|NCT01288131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661130|NCT01288131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24661166|NCT01288326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661167|NCT01288326|Incretins|incretins|mesh-ancestor
24661168|NCT01288326|Hormones|hormones|mesh-ancestor
24661169|NCT01288326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24661170|NCT01288339|Leucovorin|leucovorin|mesh-list
24661171|NCT01288339|Fluorouracil|fluorouracil|mesh-list
24661173|NCT01288339|Panitumumab|panitumumab|mesh-list
24661174|NCT01288339|Antimetabolites|antimetabolites|mesh-ancestor
24661175|NCT01288339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661176|NCT01288339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24661177|NCT01288339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661178|NCT01288339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24661179|NCT01288339|Immunologic Factors|immunologic factors|mesh-ancestor
24661180|NCT01288339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661181|NCT01288339|Antidotes|antidotes|mesh-ancestor
24661182|NCT01288339|Protective Agents|protective agents|mesh-ancestor
24661184|NCT01288339|Vitamins|vitamins|mesh-ancestor
24799770|NCT01971242|Hormones|hormones|mesh-ancestor
24799771|NCT01971242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24799772|NCT01971268|Cimetidine|cimetidine|mesh-list
24799773|NCT01971268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24799774|NCT01971268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24799775|NCT01971268|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24799776|NCT01971268|Histamine Antagonists|histamine antagonists|mesh-ancestor
24799777|NCT01971268|Histamine Agents|histamine agents|mesh-ancestor
25703975|NCT02174913|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25703976|NCT02174913|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25703977|NCT02174913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25703978|NCT02174913|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25703979|NCT02174913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24799778|NCT01971268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25703980|NCT02174913|Cholinergic Agents|cholinergic agents|mesh-ancestor
24799810|NCT01971424|Magnesium Oxide|magnesium oxide|mesh-list
24799781|NCT01971268|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24799782|NCT01971268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24799783|NCT01971268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24799784|NCT01971281|Gemcitabine|gemcitabine|mesh-list
24799786|NCT01971281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24799787|NCT01971281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799788|NCT01971281|Tubulin Modulators|tubulin modulators|mesh-ancestor
24799789|NCT01971281|Antimitotic Agents|antimitotic agents|mesh-ancestor
24799790|NCT01971281|Mitosis Modulators|mitosis modulators|mesh-ancestor
24799791|NCT01971281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799792|NCT01971281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24661199|NCT01288404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661200|NCT01288404|Growth Inhibitors|growth inhibitors|mesh-ancestor
24661202|NCT01288404|Glucocorticoids|glucocorticoids|mesh-ancestor
24799794|NCT01971281|Antiviral Agents|antiviral agents|mesh-ancestor
24799795|NCT01971281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24799796|NCT01971281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24799797|NCT01971281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24799798|NCT01971281|Immunologic Factors|immunologic factors|mesh-ancestor
24799799|NCT01971281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799800|NCT01971411|Calcium, Dietary|calcium, dietary|mesh-list
24799801|NCT01971411|Vitamin D|vitamin d|mesh-list
24799802|NCT01971411|Ergocalciferols|ergocalciferols|mesh-list
24799803|NCT01971411|Cholecalciferol|cholecalciferol|mesh-list
24799804|NCT01971411|Vitamins|vitamins|mesh-list
24799805|NCT01971411|Calcium|calcium|mesh-list
24661316|NCT01288885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661317|NCT01288885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24661318|NCT01288885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661319|NCT01288898|Ipragliflozin|ipragliflozin|mesh-list
24661320|NCT01288898|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24661321|NCT01288898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661349|NCT01288963|Antiviral Agents|antiviral agents|mesh-ancestor
24661350|NCT01288963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24661351|NCT01289054|Imatinib Mesylate|imatinib mesylate|mesh-list
24661352|NCT01289054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661353|NCT01289054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24661354|NCT01289054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661355|NCT01289054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661356|NCT01289132|Candesartan|candesartan|mesh-list
24661357|NCT01289132|Candesartan cilexetil|candesartan cilexetil|mesh-list
24661358|NCT01289132|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
24661395|NCT01289301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661397|NCT01289301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24661398|NCT01289301|Dermatologic Agents|dermatologic agents|mesh-ancestor
24661399|NCT01289301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24661400|NCT01289301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661401|NCT01289301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24661402|NCT01289301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24661403|NCT01289327|Midazolam|midazolam|mesh-list
24661404|NCT01289327|Alfentanil|alfentanil|mesh-list
24661405|NCT01289327|Propofol|propofol|mesh-list
24661406|NCT01289327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24661407|NCT01289327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24661408|NCT01289327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661409|NCT01289327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24661410|NCT01289327|Anesthetics, General|anesthetics, general|mesh-ancestor
24799806|NCT01971411|Micronutrients|micronutrients|mesh-ancestor
24799807|NCT01971411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661434|NCT01289496|Ribavirin|ribavirin|mesh-list
24661435|NCT01289496|Interferon-alpha|interferon-alpha|mesh-list
24661436|NCT01289496|Interferon alpha-2|interferon alpha-2|mesh-list
24661438|NCT01289496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661439|NCT01289496|Antiviral Agents|antiviral agents|mesh-ancestor
24661440|NCT01289496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24661441|NCT01289496|Antimetabolites|antimetabolites|mesh-ancestor
24661442|NCT01289496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661452|NCT01289561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24661453|NCT01289561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24661455|NCT01289561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661471|NCT01289730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24661472|NCT01289730|Analgesics|analgesics|mesh-ancestor
24661473|NCT01289730|Sensory System Agents|sensory system agents|mesh-ancestor
24661474|NCT01289730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24799812|NCT01971424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799813|NCT01971424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24799814|NCT01971450|Iloprost|iloprost|mesh-list
24799815|NCT01971450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24799816|NCT01971450|Vasodilator Agents|vasodilator agents|mesh-ancestor
24799817|NCT01971489|Gemcitabine|gemcitabine|mesh-list
24799818|NCT01971489|Cisplatin|cisplatin|mesh-list
25049823|NCT00562497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25703981|NCT02174913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25703982|NCT02174913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703983|NCT02175212|Ascorbic Acid|ascorbic acid|mesh-list
25703984|NCT02175212|Methyltestosterone|methyltestosterone|mesh-list
25703985|NCT02175212|Androgens|androgens|mesh-list
25703986|NCT02175212|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25703987|NCT02175212|Hormones|hormones|mesh-ancestor
25703988|NCT02175212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25049834|NCT00561743|Doxorubicin|doxorubicin|mesh-list
25049835|NCT00561743|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25049836|NCT00561743|Bortezomib|bortezomib|mesh-list
25049843|NCT00561743|Glucocorticoids|glucocorticoids|mesh-ancestor
25049845|NCT00561743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25049846|NCT00561743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25049848|NCT00561743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25049849|NCT00561743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24661475|NCT01289730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661476|NCT01289730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24661477|NCT01289730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24661478|NCT01289730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24661479|NCT01289730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24661480|NCT01289730|Immunologic Factors|immunologic factors|mesh-ancestor
24661481|NCT01289743|Etanercept|etanercept|mesh-list
24661501|NCT01289756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049850|NCT00561743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25049851|NCT00561743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049852|NCT00561743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951078|NCT03908528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24951079|NCT03908528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951080|NCT03908528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24951081|NCT03908528|Tubulin Modulators|tubulin modulators|mesh-ancestor
24951082|NCT03908528|Antimitotic Agents|antimitotic agents|mesh-ancestor
24951083|NCT03908528|Mitosis Modulators|mitosis modulators|mesh-ancestor
24661506|NCT01289756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24661507|NCT01289756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24661508|NCT01289756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24661510|NCT01289756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661511|NCT01289756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24661512|NCT01289756|Antidepressive Agents|antidepressive agents|mesh-ancestor
24661513|NCT01289756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24661514|NCT01289756|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24661515|NCT01289756|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24661553|NCT01289938|Sensory System Agents|sensory system agents|mesh-ancestor
24661554|NCT01289938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24661556|NCT01289938|Autonomic Agents|autonomic agents|mesh-ancestor
24661557|NCT01289938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24661558|NCT01289938|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24661562|NCT01289938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661564|NCT01289938|Antipruritics|antipruritics|mesh-ancestor
24661593|NCT01290120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661594|NCT01290120|Immunologic Factors|immunologic factors|mesh-ancestor
24951085|NCT03908528|Protective Agents|protective agents|mesh-ancestor
24951086|NCT03908528|Vitamin B Complex|vitamin b complex|mesh-ancestor
24951088|NCT03908528|Micronutrients|micronutrients|mesh-ancestor
24951089|NCT03908814|Antibodies|antibodies|mesh-list
24951090|NCT03908814|Immunologic Factors|immunologic factors|mesh-ancestor
24951091|NCT03908814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951092|NCT03908489|Allyl sulfide|allyl sulfide|mesh-list
24951093|NCT03908489|Antioxidants|antioxidants|mesh-ancestor
24951094|NCT03908489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951095|NCT03908489|Protective Agents|protective agents|mesh-ancestor
24951096|NCT03908489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951097|NCT03908489|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24951098|NCT03908489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951099|NCT03908489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24951100|NCT03908489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24568063|NCT00794235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094818|NCT03222206|Analgesics|analgesics|mesh-ancestor
24661617|NCT01290146|Protective Agents|protective agents|mesh-ancestor
24661619|NCT01290172|Hormones|hormones|mesh-ancestor
24661620|NCT01290172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24661621|NCT01290172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661622|NCT01290198|Fluconazole|fluconazole|mesh-list
24661623|NCT01290198|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
24661624|NCT01290198|Antifungal Agents|antifungal agents|mesh-ancestor
24661625|NCT01290198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24661626|NCT01290198|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24661627|NCT01290198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24661628|NCT01290198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661629|NCT01290198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661630|NCT01290198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24661631|NCT01290198|Hormone Antagonists|hormone antagonists|mesh-ancestor
25703989|NCT02175212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25703990|NCT02175212|Antioxidants|antioxidants|mesh-ancestor
25703991|NCT02175212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25703992|NCT02175212|Protective Agents|protective agents|mesh-ancestor
25703993|NCT02175212|Vitamins|vitamins|mesh-ancestor
25703994|NCT02175212|Micronutrients|micronutrients|mesh-ancestor
25703995|NCT02175212|Estrogens|estrogens|mesh-ancestor
24624326|NCT01075776|Acetylcholine|acetylcholine|mesh-list
24661712|NCT01290432|Micronutrients|micronutrients|mesh-ancestor
24661714|NCT01290458|Ascorbic Acid|ascorbic acid|mesh-list
24661715|NCT01290458|Vitamin E|vitamin e|mesh-list
24661716|NCT01290458|Tocopherols|tocopherols|mesh-list
24661717|NCT01290458|alpha-Tocopherol|alpha-tocopherol|mesh-list
24661719|NCT01290458|Micronutrients|micronutrients|mesh-ancestor
24799819|NCT01971489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799820|NCT01971489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24799821|NCT01971489|Antimetabolites|antimetabolites|mesh-ancestor
24799822|NCT01971489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799823|NCT01971489|Antiviral Agents|antiviral agents|mesh-ancestor
24799824|NCT01971489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24799825|NCT01971489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661720|NCT01290458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661778|NCT01290939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661779|NCT01290939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24661780|NCT01290939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24661781|NCT01290939|Growth Substances|growth substances|mesh-ancestor
24661782|NCT01290939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661783|NCT01290939|Growth Inhibitors|growth inhibitors|mesh-ancestor
24661784|NCT01290939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24661785|NCT01290939|Alkylating Agents|alkylating agents|mesh-ancestor
24661786|NCT01290939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661787|NCT01291069|Tadalafil|tadalafil|mesh-list
24661788|NCT01291069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661789|NCT01291069|Vasodilator Agents|vasodilator agents|mesh-ancestor
24661799|NCT01291121|Growth Substances|growth substances|mesh-ancestor
24661800|NCT01291121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661801|NCT01291121|Growth Inhibitors|growth inhibitors|mesh-ancestor
24661802|NCT01291121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661803|NCT01291186|Epinephrine|epinephrine|mesh-list
24661804|NCT01291186|Racepinephrine|racepinephrine|mesh-list
24661805|NCT01291186|Bupivacaine|bupivacaine|mesh-list
24661806|NCT01291186|Epinephryl borate|epinephryl borate|mesh-list
24661807|NCT01291186|Anesthetics, Local|anesthetics, local|mesh-ancestor
24661808|NCT01291186|Anesthetics|anesthetics|mesh-ancestor
24661809|NCT01291186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24661810|NCT01291186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661811|NCT01291186|Sensory System Agents|sensory system agents|mesh-ancestor
24661812|NCT01291186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24661813|NCT01291186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24661814|NCT01291186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24661815|NCT01291186|Adrenergic Agents|adrenergic agents|mesh-ancestor
24661816|NCT01291186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24661817|NCT01291186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661818|NCT01291186|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24799837|NCT01971515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24799838|NCT01971515|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24661848|NCT01291316|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24661849|NCT01291316|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24661850|NCT01291316|Cholinergic Agents|cholinergic agents|mesh-ancestor
24661851|NCT01291316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24661852|NCT01291316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661859|NCT01291316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24661860|NCT01291316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24661861|NCT01291316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24661862|NCT01291316|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24661865|NCT01291433|Tocopherols|tocopherols|mesh-list
24661866|NCT01291433|Vitamin E|vitamin e|mesh-list
25703996|NCT02175212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25703997|NCT02175212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25703998|NCT02175212|Anabolic Agents|anabolic agents|mesh-ancestor
25703999|NCT02175225|Deferoxamine|deferoxamine|mesh-list
25704000|NCT02175225|Siderophores|siderophores|mesh-ancestor
25704001|NCT02175225|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25704002|NCT02175225|Chelating Agents|chelating agents|mesh-ancestor
24661869|NCT01291433|Pentoxifylline|pentoxifylline|mesh-list
24661870|NCT01291433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24661871|NCT01291433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661872|NCT01291433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661874|NCT01291433|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24661882|NCT01291433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24661883|NCT01291459|Tenofovir|tenofovir|mesh-list
24661884|NCT01291459|Emtricitabine|emtricitabine|mesh-list
24661885|NCT01291459|Raltegravir Potassium|raltegravir potassium|mesh-list
24661886|NCT01291459|Maraviroc|maraviroc|mesh-list
24661887|NCT01291459|Antiviral Agents|antiviral agents|mesh-ancestor
24661888|NCT01291459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24661889|NCT01291459|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24661890|NCT01291459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24455745|NCT00328874|Ubiquinone|ubiquinone|mesh-list
24661903|NCT01291472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24661905|NCT01291472|Sensory System Agents|sensory system agents|mesh-ancestor
24661906|NCT01291472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24661907|NCT01291472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661908|NCT01291472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24661909|NCT01291472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24799839|NCT01971515|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24799840|NCT01971515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24799841|NCT01971606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24799842|NCT01971606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24799843|NCT01971606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24799844|NCT01971606|Antimetabolites|antimetabolites|mesh-ancestor
24799845|NCT01971606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956969|NCT03848533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24799846|NCT01971606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24799847|NCT01971606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25704004|NCT02175225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704005|NCT02175277|Darbepoetin alfa|darbepoetin alfa|mesh-list
25704006|NCT02175277|Hematinics|hematinics|mesh-ancestor
25704007|NCT02175745|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
25704008|NCT02175745|Dopamine Agents|dopamine agents|mesh-ancestor
25704009|NCT02175745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25704010|NCT02175745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704011|NCT02175745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704012|NCT02175758|Ribavirin|ribavirin|mesh-list
24799848|NCT01971606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925486|NCT04149678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925487|NCT04149678|Antifungal Agents|antifungal agents|mesh-ancestor
24925488|NCT04149678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24925489|NCT04149678|Dermatologic Agents|dermatologic agents|mesh-ancestor
24799850|NCT01971632|Naloxone|naloxone|mesh-list
24799851|NCT01971632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24799852|NCT01971632|Narcotics|narcotics|mesh-ancestor
24799853|NCT01971632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24799854|NCT01971632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661935|NCT01291537|Immunologic Factors|immunologic factors|mesh-ancestor
24661936|NCT01291537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661937|NCT01291537|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24661938|NCT01291537|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24661939|NCT01291537|Dopamine Agonists|dopamine agonists|mesh-ancestor
24661940|NCT01291537|Dopamine Agents|dopamine agents|mesh-ancestor
24661942|NCT01291537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095856|NCT03215875|Torsemide|torsemide|mesh-list
24799861|NCT01971658|Cyclophosphamide|cyclophosphamide|mesh-list
24799863|NCT01971658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24799864|NCT01971658|Immunologic Factors|immunologic factors|mesh-ancestor
24799865|NCT01971658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799866|NCT01971658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24799867|NCT01971658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24799868|NCT01971658|Alkylating Agents|alkylating agents|mesh-ancestor
24799869|NCT01971658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799870|NCT01971658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799871|NCT01971658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24799872|NCT01971658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24799873|NCT01971658|Antiemetics|antiemetics|mesh-ancestor
24799874|NCT01971658|Autonomic Agents|autonomic agents|mesh-ancestor
24661943|NCT01291563|Moxifloxacin|moxifloxacin|mesh-list
24661944|NCT01291563|Bedaquiline|bedaquiline|mesh-list
24661945|NCT01291563|Diarylquinolines|diarylquinolines|mesh-list
24661956|NCT01291563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24661957|NCT01291563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661958|NCT01291563|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24661959|NCT01291563|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24661960|NCT01291563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24661961|NCT01291563|Antitubercular Agents|antitubercular agents|mesh-ancestor
24661963|NCT01291602|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24661964|NCT01291602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661965|NCT01291602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662001|NCT01291641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24662002|NCT01291641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24662003|NCT01291641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24662005|NCT01291641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24662006|NCT01291641|Antioxidants|antioxidants|mesh-ancestor
24662007|NCT01291654|Acetaminophen|acetaminophen|mesh-list
24662008|NCT01291654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24662009|NCT01291654|Analgesics|analgesics|mesh-ancestor
24662046|NCT01292083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662047|NCT01292083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799876|NCT01971658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25704013|NCT02175758|Sofosbuvir|sofosbuvir|mesh-list
25704014|NCT02175758|Antimetabolites|antimetabolites|mesh-ancestor
25704015|NCT02175758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704016|NCT02175758|Antiviral Agents|antiviral agents|mesh-ancestor
25704017|NCT02175758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25704018|NCT02175771|Fluticasone|fluticasone|mesh-list
24799877|NCT01971658|Glucocorticoids|glucocorticoids|mesh-ancestor
24799878|NCT01971658|Hormones|hormones|mesh-ancestor
25704019|NCT02175771|Xhance|xhance|mesh-list
25704020|NCT02175771|Albuterol|albuterol|mesh-list
25704021|NCT02175771|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24662149|NCT01293058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662150|NCT01293058|Sensory System Agents|sensory system agents|mesh-ancestor
24662151|NCT01293058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24662152|NCT01293071|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24662153|NCT01293071|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24662154|NCT01293071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24662155|NCT01293071|Antitubercular Agents|antitubercular agents|mesh-ancestor
24662156|NCT01293097|Atorvastatin|atorvastatin|mesh-list
24662157|NCT01293097|Pravastatin|pravastatin|mesh-list
24662158|NCT01293097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24662159|NCT01293097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24662160|NCT01293097|Antimetabolites|antimetabolites|mesh-ancestor
24662161|NCT01293097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662162|NCT01293097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24662163|NCT01293097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24662165|NCT01293136|Analgesics, Opioid|analgesics, opioid|mesh-list
24662166|NCT01293136|Narcotics|narcotics|mesh-ancestor
24662167|NCT01293136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24662168|NCT01293136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662169|NCT01293136|Analgesics|analgesics|mesh-ancestor
24662170|NCT01293136|Sensory System Agents|sensory system agents|mesh-ancestor
24662198|NCT01293162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24662199|NCT01293162|Antimetabolites|antimetabolites|mesh-ancestor
24799882|NCT01971658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24799883|NCT01971658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24799884|NCT01971658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24799885|NCT01971658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24799887|NCT01971658|Growth Inhibitors|growth inhibitors|mesh-ancestor
24799888|NCT01971684|Mycophenolic Acid|mycophenolic acid|mesh-list
24799889|NCT01971684|Sirolimus|sirolimus|mesh-list
24799890|NCT01971684|Mercaptopurine|mercaptopurine|mesh-list
24799891|NCT01971684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799892|NCT01971684|Immunologic Factors|immunologic factors|mesh-ancestor
24799893|NCT01971684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799894|NCT01971684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24848081|NCT05197062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24848084|NCT05147233|Antiemetics|antiemetics|mesh-ancestor
24848085|NCT05147233|Autonomic Agents|autonomic agents|mesh-ancestor
24848086|NCT05147233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24848087|NCT05147233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848088|NCT05147233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24848089|NCT05147233|Glucocorticoids|glucocorticoids|mesh-ancestor
24662248|NCT01293643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662249|NCT01293643|Antifungal Agents|antifungal agents|mesh-ancestor
24662250|NCT01293643|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24662251|NCT01293643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24662309|NCT01293942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24662310|NCT01293942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662311|NCT01293942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24799895|NCT01971684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24799896|NCT01971684|Antitubercular Agents|antitubercular agents|mesh-ancestor
24799897|NCT01971684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24799898|NCT01971684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24799899|NCT01971684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24662625|NCT01295775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24958228|NCT03835507|Hematinics|hematinics|mesh-ancestor
24799909|NCT01971801|Micronutrients|micronutrients|mesh-ancestor
24799910|NCT01971801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799911|NCT01971801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24799912|NCT01971801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24799913|NCT01971814|Infliximab|infliximab|mesh-list
24799914|NCT01971814|Dermatologic Agents|dermatologic agents|mesh-ancestor
24799915|NCT01971814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24799916|NCT01971814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24662314|NCT01293942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662321|NCT01293942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24662323|NCT01294059|Levomilnacipran|levomilnacipran|mesh-list
24662325|NCT01294059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24622214|NCT01066169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24622216|NCT01066195|Gefitinib|gefitinib|mesh-list
24622217|NCT01066195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622218|NCT01066195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622219|NCT01066195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622220|NCT01066195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24622221|NCT01066195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24622222|NCT01066195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24622223|NCT01066247|Midazolam|midazolam|mesh-list
24622224|NCT01066247|Morphine|morphine|mesh-list
24622225|NCT01066247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24622226|NCT01066247|Narcotics|narcotics|mesh-ancestor
24662364|NCT01294215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24622227|NCT01066247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24622228|NCT01066247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622232|NCT01066247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24622233|NCT01066247|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25704022|NCT02175771|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25704023|NCT02175771|Adrenergic Agonists|adrenergic agonists|mesh-list
25704024|NCT02175771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25704025|NCT02175771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25704026|NCT02175771|Autonomic Agents|autonomic agents|mesh-ancestor
25704027|NCT02175771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25704028|NCT02175771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704029|NCT02175771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25704030|NCT02175771|Respiratory System Agents|respiratory system agents|mesh-ancestor
25704031|NCT02175771|Dermatologic Agents|dermatologic agents|mesh-ancestor
25704032|NCT02175771|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24662498|NCT01295099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24662499|NCT01295099|Immunologic Factors|immunologic factors|mesh-ancestor
24662500|NCT01295099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662501|NCT01295099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24662502|NCT01295099|Glucocorticoids|glucocorticoids|mesh-ancestor
24662504|NCT01295099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24662505|NCT01295138|Lactulose|lactulose|mesh-list
24662506|NCT01295138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24662507|NCT01295151|Adalimumab|adalimumab|mesh-list
24662508|NCT01295151|Etanercept|etanercept|mesh-list
24662509|NCT01295151|Golimumab|golimumab|mesh-list
24662510|NCT01295151|Rituximab|rituximab|mesh-list
25049858|NCT00560183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049859|NCT00560183|Analgesics|analgesics|mesh-ancestor
25049863|NCT00559247|Protease Inhibitors|protease inhibitors|mesh-ancestor
25049864|NCT00559247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049865|NCT00559247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049866|NCT00558207|Gemcitabine|gemcitabine|mesh-list
25049867|NCT00558207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25049868|NCT00558207|Antimetabolites|antimetabolites|mesh-ancestor
25049869|NCT00558207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049870|NCT00558207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25049871|NCT00558207|Antiviral Agents|antiviral agents|mesh-ancestor
25049872|NCT00558207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25049873|NCT00558207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049881|NCT00557973|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24662511|NCT01295151|Abatacept|abatacept|mesh-list
24662512|NCT01295151|Infliximab|infliximab|mesh-list
24662513|NCT01295151|Certolizumab Pegol|certolizumab pegol|mesh-list
24662514|NCT01295151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24662563|NCT01295307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24662564|NCT01295307|Antimetabolites|antimetabolites|mesh-ancestor
24662565|NCT01295307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662566|NCT01295307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662567|NCT01295372|Risperidone|risperidone|mesh-list
24662568|NCT01295372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24662569|NCT01295372|Serotonin Agents|serotonin agents|mesh-ancestor
24662570|NCT01295372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24662571|NCT01295372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662572|NCT01295372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662573|NCT01295372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24662574|NCT01295372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24662576|NCT01295372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24662585|NCT01295502|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24662586|NCT01295502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24662587|NCT01295502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662588|NCT01295502|Tubulin Modulators|tubulin modulators|mesh-ancestor
24662589|NCT01295502|Antimitotic Agents|antimitotic agents|mesh-ancestor
24662590|NCT01295502|Mitosis Modulators|mitosis modulators|mesh-ancestor
24662591|NCT01295502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662592|NCT01295567|Dipyridamole|dipyridamole|mesh-list
24662593|NCT01295567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24662594|NCT01295567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24662595|NCT01295567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662633|NCT01295866|Nitric Oxide|nitric oxide|mesh-list
24662634|NCT01295866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25704033|NCT02175771|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25704034|NCT02175771|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24662638|NCT01295866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24951255|NCT03906669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24951256|NCT03906669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24951257|NCT03906669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24951258|NCT03906669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24951259|NCT03906669|Hormone Antagonists|hormone antagonists|mesh-ancestor
24951260|NCT03906669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24951261|NCT03906669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951262|NCT03906669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25096973|NCT03208426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24951263|NCT03906669|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24951264|NCT03906669|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24951265|NCT03906669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24951266|NCT03906669|Progestins|progestins|mesh-ancestor
24799451|NCT01969032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622245|NCT01066299|Oxytocics|oxytocics|mesh-ancestor
24662654|NCT01296074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24662656|NCT01296074|Glucocorticoids|glucocorticoids|mesh-ancestor
24622246|NCT01066299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24622247|NCT01066299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622248|NCT01066351|Epoetin Alfa|epoetin alfa|mesh-list
24622249|NCT01066351|Hematinics|hematinics|mesh-ancestor
24622251|NCT01066377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24622252|NCT01066377|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24622253|NCT01066377|Renal Agents|renal agents|mesh-ancestor
24622261|NCT01066403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622263|NCT01066429|Dexamethasone|dexamethasone|mesh-list
24622264|NCT01066429|Dexamethasone acetate|dexamethasone acetate|mesh-list
24622265|NCT01066429|BB 1101|bb 1101|mesh-list
24799935|NCT01972230|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24799936|NCT01972230|Anesthetics, General|anesthetics, general|mesh-ancestor
24799937|NCT01972230|Anesthetics|anesthetics|mesh-ancestor
24799938|NCT01972230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24799939|NCT01972230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662658|NCT01296074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24662659|NCT01296074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662660|NCT01296074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24662661|NCT01296074|Protective Agents|protective agents|mesh-ancestor
24662662|NCT01296074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24662663|NCT01296074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662664|NCT01296139|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24662665|NCT01296139|Hematinics|hematinics|mesh-ancestor
24662666|NCT01296139|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24662667|NCT01296139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24662668|NCT01296178|Idarubicin|idarubicin|mesh-list
24662669|NCT01296178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24662675|NCT01296204|Antibodies|antibodies|mesh-list
25704035|NCT02175771|Adrenergic Agents|adrenergic agents|mesh-ancestor
25704036|NCT02175771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25704037|NCT02175771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704038|NCT02175771|Tocolytic Agents|tocolytic agents|mesh-ancestor
25704039|NCT02175771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25704040|NCT02175771|Glucocorticoids|glucocorticoids|mesh-ancestor
25704041|NCT02175771|Hormones|hormones|mesh-ancestor
24799954|NCT01972269|Sensory System Agents|sensory system agents|mesh-ancestor
24799955|NCT01972269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24799956|NCT01972269|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24799957|NCT01972269|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24799958|NCT01972269|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24799959|NCT01972269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24799960|NCT01972269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662708|NCT01296438|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24662709|NCT01296438|Insulin Aspart|insulin aspart|mesh-list
24662710|NCT01296438|Insulin, Long-Acting|insulin, long-acting|mesh-list
24662711|NCT01296438|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24662712|NCT01296438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24662713|NCT01296438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662714|NCT01296464|Carbidopa|carbidopa|mesh-list
24662822|NCT01297023|Cholecalciferol|cholecalciferol|mesh-list
24662824|NCT01297023|Calcium|calcium|mesh-list
24662825|NCT01297023|Micronutrients|micronutrients|mesh-ancestor
24662837|NCT01297101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24662838|NCT01297101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662839|NCT01297101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24662840|NCT01297101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24662862|NCT01297179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24662863|NCT01297179|Contraceptive Agents|contraceptive agents|mesh-ancestor
24525698|NCT02869217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24525699|NCT02869217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24525748|NCT02799134|Hormones|hormones|mesh-ancestor
24662864|NCT01297179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24662865|NCT01297179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24799961|NCT01972269|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24799962|NCT01972269|Narcotics|narcotics|mesh-ancestor
24799963|NCT01972269|Analgesics|analgesics|mesh-ancestor
24799964|NCT01972269|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24799965|NCT01972269|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24799966|NCT01972269|Anesthetics, General|anesthetics, general|mesh-ancestor
24799967|NCT01972373|Bevacizumab|bevacizumab|mesh-list
24799968|NCT01972373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24799969|NCT01972373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24799970|NCT01972373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24799971|NCT01972373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24799972|NCT01972373|Growth Substances|growth substances|mesh-ancestor
24799973|NCT01972373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24799974|NCT01972373|Growth Inhibitors|growth inhibitors|mesh-ancestor
24799975|NCT01972490|Bevacizumab|bevacizumab|mesh-list
24799976|NCT01972490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24800001|NCT01972711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800002|NCT01972711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24800003|NCT01972711|Antidepressive Agents|antidepressive agents|mesh-ancestor
24800004|NCT01972763|Ranibizumab|ranibizumab|mesh-list
24800005|NCT01972763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24800006|NCT01972763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24800007|NCT01972763|Growth Substances|growth substances|mesh-ancestor
24800008|NCT01972763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800009|NCT01972763|Growth Inhibitors|growth inhibitors|mesh-ancestor
24800010|NCT01972763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662925|NCT01297686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24662926|NCT01297686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24662927|NCT01297686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662928|NCT01297764|Dexamethasone|dexamethasone|mesh-list
24662929|NCT01297764|Dexamethasone acetate|dexamethasone acetate|mesh-list
24662930|NCT01297764|Lenalidomide|lenalidomide|mesh-list
24662932|NCT01297764|BB 1101|bb 1101|mesh-list
24662933|NCT01297764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24662944|NCT01297764|Protease Inhibitors|protease inhibitors|mesh-ancestor
24662945|NCT01297764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24662946|NCT01297764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662947|NCT01297764|Immunologic Factors|immunologic factors|mesh-ancestor
24662971|NCT01297829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24662972|NCT01297829|Analgesics|analgesics|mesh-ancestor
24662973|NCT01297829|Sensory System Agents|sensory system agents|mesh-ancestor
24662975|NCT01297829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662976|NCT01297829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24662977|NCT01297829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24663024|NCT01297998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663025|NCT01297998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24663026|NCT01297998|Antimetabolites|antimetabolites|mesh-ancestor
24800018|NCT01972880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594045|NCT00932048|Antimetabolites|antimetabolites|mesh-ancestor
24594046|NCT00932048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594047|NCT00932048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24594048|NCT00932048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24594049|NCT00932048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594050|NCT00932100|Heparin|heparin|mesh-list
24594051|NCT00932100|Calcium heparin|calcium heparin|mesh-list
25704042|NCT02175771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25704043|NCT02175771|Sympathomimetics|sympathomimetics|mesh-ancestor
25704044|NCT02175966|Ribavirin|ribavirin|mesh-list
25704045|NCT02175966|Sofosbuvir|sofosbuvir|mesh-list
25704046|NCT02175966|Antimetabolites|antimetabolites|mesh-ancestor
24927773|NCT04129736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927774|NCT04129736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24927775|NCT04129736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24927776|NCT04129736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24927777|NCT04129736|Immunologic Factors|immunologic factors|mesh-ancestor
24525887|NCT02519777|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24594052|NCT00932100|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24594054|NCT00932100|Dalteparin|dalteparin|mesh-list
24594055|NCT00932100|Anticoagulants|anticoagulants|mesh-ancestor
24594056|NCT00932100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24663027|NCT01297998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663028|NCT01297998|Antiviral Agents|antiviral agents|mesh-ancestor
24663029|NCT01297998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24663030|NCT01297998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663031|NCT01297998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24663032|NCT01297998|Immunologic Factors|immunologic factors|mesh-ancestor
24663033|NCT01297998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663034|NCT01298011|Gemcitabine|gemcitabine|mesh-list
24663035|NCT01298011|Paclitaxel|paclitaxel|mesh-list
24663036|NCT01298011|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24663037|NCT01298011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24663038|NCT01298011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663039|NCT01298011|Tubulin Modulators|tubulin modulators|mesh-ancestor
24663050|NCT01298011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663051|NCT01298076|Dexamethasone|dexamethasone|mesh-list
24663052|NCT01298076|Bevacizumab|bevacizumab|mesh-list
24663053|NCT01298076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24663054|NCT01298076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663055|NCT01298076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24663056|NCT01298076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24663057|NCT01298076|Growth Substances|growth substances|mesh-ancestor
24663058|NCT01298076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663059|NCT01298076|Growth Inhibitors|growth inhibitors|mesh-ancestor
24663060|NCT01298076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24663061|NCT01298076|Antiemetics|antiemetics|mesh-ancestor
24663062|NCT01298076|Autonomic Agents|autonomic agents|mesh-ancestor
24663063|NCT01298076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663064|NCT01298076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24663065|NCT01298076|Glucocorticoids|glucocorticoids|mesh-ancestor
24663066|NCT01298076|Hormones|hormones|mesh-ancestor
24663067|NCT01298076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24663068|NCT01298076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24663075|NCT01298271|Adrenergic Agents|adrenergic agents|mesh-ancestor
24663076|NCT01298271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24663077|NCT01298271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663083|NCT01298284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24663084|NCT01298284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24663085|NCT01298284|Adrenergic Agents|adrenergic agents|mesh-ancestor
24663086|NCT01298284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24663087|NCT01298284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663088|NCT01298284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704047|NCT02175966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704048|NCT02175966|Antiviral Agents|antiviral agents|mesh-ancestor
25704049|NCT02175966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25704050|NCT02176005|Moxifloxacin|moxifloxacin|mesh-list
25704051|NCT02176005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24663089|NCT01298284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25704052|NCT02176005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25704053|NCT02176005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25704054|NCT02176005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25704055|NCT02176005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25704056|NCT02176005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663141|NCT01298466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663143|NCT01298466|Anticonvulsants|anticonvulsants|mesh-ancestor
24663144|NCT01298466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24663145|NCT01298466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24663146|NCT01298466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663147|NCT01298466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24663149|NCT01298466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24663150|NCT01298466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24663151|NCT01298466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24663152|NCT01298505|Fexofenadine|fexofenadine|mesh-list
24663153|NCT01298505|Terfenadine|terfenadine|mesh-list
24663154|NCT01298505|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24663155|NCT01298505|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24663156|NCT01298505|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24663157|NCT01298505|Histamine Antagonists|histamine antagonists|mesh-ancestor
24663158|NCT01298505|Histamine Agents|histamine agents|mesh-ancestor
24663159|NCT01298505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24663160|NCT01298505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663416|NCT01301040|Immunologic Factors|immunologic factors|mesh-ancestor
24663161|NCT01298505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663163|NCT01298713|Everolimus|everolimus|mesh-list
24663164|NCT01298713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663165|NCT01298713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24663166|NCT01298713|Immunologic Factors|immunologic factors|mesh-ancestor
24663168|NCT01298713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24663172|NCT01298713|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24663173|NCT01298713|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24663183|NCT01298934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663184|NCT01298934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622267|NCT01066429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622268|NCT01066429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24622269|NCT01066429|Antiemetics|antiemetics|mesh-ancestor
24622270|NCT01066429|Autonomic Agents|autonomic agents|mesh-ancestor
24622271|NCT01066429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24622272|NCT01066429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24622273|NCT01066429|Glucocorticoids|glucocorticoids|mesh-ancestor
24622274|NCT01066429|Hormones|hormones|mesh-ancestor
24800019|NCT01972906|Ibuprofen|ibuprofen|mesh-list
24951361|NCT03905655|Nitazoxanide|nitazoxanide|mesh-list
24663185|NCT01299012|Liraglutide|liraglutide|mesh-list
24663186|NCT01299012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24663187|NCT01299012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663188|NCT01299012|Incretins|incretins|mesh-ancestor
24663253|NCT01299857|Immunologic Factors|immunologic factors|mesh-ancestor
24474749|NCT00407251|Antimitotic Agents|antimitotic agents|mesh-ancestor
24663254|NCT01299857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663255|NCT01299857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24663256|NCT01299922|Cyclosporine|cyclosporine|mesh-list
24663257|NCT01299922|Mycophenolic Acid|mycophenolic acid|mesh-list
24663258|NCT01299922|Cyclosporins|cyclosporins|mesh-list
24928129|NCT04125706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24928130|NCT04125706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24928132|NCT04125706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24403588|NCT00161018|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24663259|NCT01299922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663260|NCT01299922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663261|NCT01299922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24663262|NCT01299922|Immunologic Factors|immunologic factors|mesh-ancestor
24663263|NCT01299922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663278|NCT01299948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24663279|NCT01299948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663280|NCT01299948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24663281|NCT01299948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663282|NCT01300026|N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine|mesh-list
24663283|NCT01300026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800020|NCT01972906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24800021|NCT01972906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24800023|NCT01972906|Sensory System Agents|sensory system agents|mesh-ancestor
24800024|NCT01972906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663313|NCT01300364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24663314|NCT01300364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663315|NCT01300364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24663317|NCT01300364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663318|NCT01300364|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24663319|NCT01300364|Antidepressive Agents|antidepressive agents|mesh-ancestor
24663320|NCT01300364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24663321|NCT01300364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24663322|NCT01300364|Adrenergic Agents|adrenergic agents|mesh-ancestor
24663324|NCT01300377|Bupivacaine|bupivacaine|mesh-list
24663325|NCT01300377|Anesthetics, Local|anesthetics, local|mesh-ancestor
24663326|NCT01300377|Anesthetics|anesthetics|mesh-ancestor
24663327|NCT01300377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24663328|NCT01300377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663329|NCT01300377|Sensory System Agents|sensory system agents|mesh-ancestor
24663330|NCT01300377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663331|NCT01300377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24455809|NCT00329095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24663333|NCT01300377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24663370|NCT01300780|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24663371|NCT01300780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24663372|NCT01300780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663373|NCT01300780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663374|NCT01300793|Rituximab|rituximab|mesh-list
24663375|NCT01300793|Carboplatin|carboplatin|mesh-list
24663376|NCT01300793|Etoposide|etoposide|mesh-list
24663377|NCT01300793|Bortezomib|bortezomib|mesh-list
24663378|NCT01300793|Ifosfamide|ifosfamide|mesh-list
24663379|NCT01300793|Isophosphamide mustard|isophosphamide mustard|mesh-list
24663380|NCT01300793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24663381|NCT01300793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663387|NCT01300793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24663388|NCT01300793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663389|NCT01300793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663390|NCT01300793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24663391|NCT01300793|Alkylating Agents|alkylating agents|mesh-ancestor
24663392|NCT01300962|Capecitabine|capecitabine|mesh-list
24663393|NCT01300962|Trastuzumab|trastuzumab|mesh-list
24663395|NCT01300962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24663396|NCT01300962|Antimetabolites|antimetabolites|mesh-ancestor
24663397|NCT01300962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663398|NCT01300962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25704057|NCT02176005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25704058|NCT02176018|Quinidine|quinidine|mesh-list
25704059|NCT02176018|Dextromethorphan|dextromethorphan|mesh-list
25704060|NCT02176018|Antitussive Agents|antitussive agents|mesh-ancestor
25704061|NCT02176018|Respiratory System Agents|respiratory system agents|mesh-ancestor
25704062|NCT02176018|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25704063|NCT02176018|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24800046|NCT01973010|Sensory System Agents|sensory system agents|mesh-ancestor
24800047|NCT01973010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24800048|NCT01973010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800049|NCT01973010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24800050|NCT01973010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24800052|NCT01973010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800053|NCT01973010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800054|NCT01973101|Gemcitabine|gemcitabine|mesh-list
24800056|NCT01973101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800057|NCT01973101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24800058|NCT01973101|Antimetabolites|antimetabolites|mesh-ancestor
24848357|NCT04553003|Choline|choline|mesh-list
24848358|NCT04553003|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
24848359|NCT04553003|Glucocorticoids|glucocorticoids|mesh-list
24848360|NCT04553003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24848361|NCT04553003|Hormones|hormones|mesh-ancestor
24663411|NCT01300988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663412|NCT01301040|Cyclophosphamide|cyclophosphamide|mesh-list
24663413|NCT01301040|Docetaxel|docetaxel|mesh-list
24663414|NCT01301040|Epirubicin|epirubicin|mesh-list
24663415|NCT01301040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24663432|NCT01301053|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24663433|NCT01301053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24663434|NCT01301053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663438|NCT01301222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663441|NCT01301248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663442|NCT01301248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24663443|NCT01301313|Simendan|simendan|mesh-list
24800059|NCT01973101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800060|NCT01973101|Antiviral Agents|antiviral agents|mesh-ancestor
24800061|NCT01973101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24800062|NCT01973101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800063|NCT01973101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24800064|NCT01973101|Immunologic Factors|immunologic factors|mesh-ancestor
24800065|NCT01973101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800066|NCT01973114|Latanoprost|latanoprost|mesh-list
24800067|NCT01973114|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24800068|NCT01973114|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24800069|NCT01973140|Tolvaptan|tolvaptan|mesh-list
24663462|NCT01301599|Adrenergic Agents|adrenergic agents|mesh-ancestor
24663463|NCT01301599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24455821|NCT00329134|Sensory System Agents|sensory system agents|mesh-ancestor
24663464|NCT01301599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663465|NCT01301599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663466|NCT01301599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24663467|NCT01301599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663468|NCT01301599|Hormone Antagonists|hormone antagonists|mesh-ancestor
24663469|NCT01301599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24663471|NCT01301612|Nimotuzumab|nimotuzumab|mesh-list
24663472|NCT01301612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663473|NCT01301612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24663474|NCT01301677|Hydrocortisone|hydrocortisone|mesh-list
24663475|NCT01301677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24663476|NCT01301716|Paclitaxel|paclitaxel|mesh-list
24663477|NCT01301716|Bevacizumab|bevacizumab|mesh-list
24663478|NCT01301716|Carboplatin|carboplatin|mesh-list
24663479|NCT01301716|Pemetrexed|pemetrexed|mesh-list
24663504|NCT01301820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24663506|NCT01301820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663507|NCT01301820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663508|NCT01301924|Meglumine Antimoniate|meglumine antimoniate|mesh-list
24663509|NCT01301924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24663510|NCT01301924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24663511|NCT01301924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24663512|NCT01301937|Meglumine Antimoniate|meglumine antimoniate|mesh-list
24663513|NCT01301937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24663514|NCT01301937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24663524|NCT01302093|Racecadotril|racecadotril|mesh-list
24800075|NCT01973309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25704064|NCT02176018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25704065|NCT02176018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704066|NCT02176018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704067|NCT02176018|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25704068|NCT02176018|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25704069|NCT02176018|Adrenergic Agents|adrenergic agents|mesh-ancestor
25704070|NCT02176018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25704071|NCT02176018|Antimalarials|antimalarials|mesh-ancestor
25704072|NCT02176018|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25704073|NCT02176018|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24800077|NCT01973309|Tubulin Modulators|tubulin modulators|mesh-ancestor
24800078|NCT01973309|Antimitotic Agents|antimitotic agents|mesh-ancestor
24800079|NCT01973309|Mitosis Modulators|mitosis modulators|mesh-ancestor
24800080|NCT01973309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800082|NCT01973322|Complement Factor H|complement factor h|mesh-list
24800083|NCT01973322|Immunologic Factors|immunologic factors|mesh-ancestor
24800084|NCT01973322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848385|NCT04509336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24848387|NCT04509336|GABA Agonists|gaba agonists|mesh-ancestor
24663534|NCT01302106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663535|NCT01302106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663536|NCT01302132|Ipragliflozin|ipragliflozin|mesh-list
24663537|NCT01302132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24663542|NCT01302145|Ipragliflozin|ipragliflozin|mesh-list
24663545|NCT01302145|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24663546|NCT01302145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663549|NCT01302158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24663550|NCT01302158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24800085|NCT01973322|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24800086|NCT01973322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24800087|NCT01973400|Tocotrienols|tocotrienols|mesh-list
24800089|NCT01973400|Tocopherols|tocopherols|mesh-list
24800090|NCT01973400|Antioxidants|antioxidants|mesh-ancestor
24800091|NCT01973400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800092|NCT01973400|Protective Agents|protective agents|mesh-ancestor
25049910|NCT00556920|Carvedilol|carvedilol|mesh-list
25049911|NCT00556920|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25049912|NCT00556920|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25049913|NCT00556920|Adrenergic Agents|adrenergic agents|mesh-ancestor
25049914|NCT00556920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25049915|NCT00556920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049916|NCT00556920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049917|NCT00556920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25049918|NCT00556920|Antioxidants|antioxidants|mesh-ancestor
25049919|NCT00556920|Protective Agents|protective agents|mesh-ancestor
25049920|NCT00556920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25049921|NCT00556920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25049922|NCT00556920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25049923|NCT00556920|Vasodilator Agents|vasodilator agents|mesh-ancestor
25049924|NCT00556920|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25049925|NCT00556920|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25049926|NCT00555789|Tacrolimus|tacrolimus|mesh-list
25098309|NCT03197779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24663596|NCT01302340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24663597|NCT01302353|Isoflurane|isoflurane|mesh-list
24663598|NCT01302353|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24663599|NCT01302353|Anesthetics, General|anesthetics, general|mesh-ancestor
24663600|NCT01302353|Anesthetics|anesthetics|mesh-ancestor
24663601|NCT01302353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24663628|NCT01302613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704074|NCT02176018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25704075|NCT02176018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25704076|NCT02176018|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25704077|NCT02176018|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25704078|NCT02176018|Cholinergic Agents|cholinergic agents|mesh-ancestor
25704079|NCT02176018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24663629|NCT01302613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663630|NCT01302613|Antidotes|antidotes|mesh-ancestor
24663631|NCT01302613|Protective Agents|protective agents|mesh-ancestor
24663632|NCT01302613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663633|NCT01302613|Vitamin B Complex|vitamin b complex|mesh-ancestor
24663634|NCT01302613|Vitamins|vitamins|mesh-ancestor
24663635|NCT01302613|Micronutrients|micronutrients|mesh-ancestor
24663636|NCT01302756|Folic Acid|folic acid|mesh-list
25049927|NCT00555789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25049928|NCT00555789|Immunologic Factors|immunologic factors|mesh-ancestor
25049929|NCT00555789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049930|NCT00555789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25049931|NCT00555789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049932|NCT00555789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049933|NCT00555035|Dolutegravir|dolutegravir|mesh-list
25049934|NCT00555035|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25049935|NCT00555035|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25049936|NCT00555035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049937|NCT00555035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049938|NCT00555035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25049939|NCT00555035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25049940|NCT00555035|Antiviral Agents|antiviral agents|mesh-ancestor
25049941|NCT00555035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24663661|NCT01303029|Antimetabolites|antimetabolites|mesh-ancestor
25049946|NCT00553657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25049947|NCT00553657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049948|NCT00553657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25049949|NCT00553657|Urological Agents|urological agents|mesh-ancestor
25049950|NCT00553306|Aldesleukin|aldesleukin|mesh-list
25049951|NCT00553306|Cyclophosphamide|cyclophosphamide|mesh-list
25049952|NCT00553306|Interleukin-2|interleukin-2|mesh-list
25049953|NCT00553306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24951431|NCT03904745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951432|NCT03904745|Tocolytic Agents|tocolytic agents|mesh-ancestor
24951433|NCT03904745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24951434|NCT03904563|Bevacizumab|bevacizumab|mesh-list
24951435|NCT03904563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24663662|NCT01303029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663663|NCT01303029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663664|NCT01303029|Antiviral Agents|antiviral agents|mesh-ancestor
24663665|NCT01303029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24663666|NCT01303029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663678|NCT01303055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663679|NCT01303055|Incretins|incretins|mesh-ancestor
24663680|NCT01303055|Hormones|hormones|mesh-ancestor
25704080|NCT02176018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25704081|NCT02176018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25704082|NCT02176018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25704083|NCT02176018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25704084|NCT02176031|Methylprednisolone|methylprednisolone|mesh-list
25704085|NCT02176031|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25704086|NCT02176031|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24663684|NCT01303055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663685|NCT01303055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663747|NCT01303549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24663748|NCT01303549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24663749|NCT01303549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24663781|NCT01303614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663782|NCT01303614|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24663783|NCT01303640|Everolimus|everolimus|mesh-list
24663784|NCT01303640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663785|NCT01303640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24663786|NCT01303640|Immunologic Factors|immunologic factors|mesh-ancestor
24663788|NCT01303679|Paclitaxel|paclitaxel|mesh-list
24663815|NCT01303705|Alkylating Agents|alkylating agents|mesh-ancestor
24663816|NCT01303705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663817|NCT01303705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663818|NCT01303705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24663820|NCT01303731|Bupivacaine|bupivacaine|mesh-list
24663821|NCT01303731|Anesthetics, Local|anesthetics, local|mesh-ancestor
24663822|NCT01303731|Anesthetics|anesthetics|mesh-ancestor
24663823|NCT01303731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24663824|NCT01303731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663825|NCT01303731|Sensory System Agents|sensory system agents|mesh-ancestor
24663826|NCT01303731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24663827|NCT01303731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24663828|NCT01303731|Narcotics|narcotics|mesh-ancestor
24663829|NCT01303731|Analgesics|analgesics|mesh-ancestor
24663830|NCT01303731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24663831|NCT01303731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24663832|NCT01303731|Anesthetics, General|anesthetics, general|mesh-ancestor
24663833|NCT01303874|Etanercept|etanercept|mesh-list
24800101|NCT01973504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24800102|NCT01973504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800103|NCT01973504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25704087|NCT02176031|Prednisolone|prednisolone|mesh-list
25704088|NCT02176031|Prednisolone acetate|prednisolone acetate|mesh-list
25704089|NCT02176031|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25704090|NCT02176031|Prednisolone phosphate|prednisolone phosphate|mesh-list
25704091|NCT02176031|Natalizumab|natalizumab|mesh-list
25704092|NCT02176031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25704093|NCT02176031|Antiemetics|antiemetics|mesh-ancestor
25704094|NCT02176031|Autonomic Agents|autonomic agents|mesh-ancestor
25704095|NCT02176031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24931909|NCT04084171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931929|NCT04083911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24931930|NCT04083911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24800104|NCT01973504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24800105|NCT01973517|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24800107|NCT01973517|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24800108|NCT01973517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24663843|NCT01303874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24663844|NCT01303874|Immunologic Factors|immunologic factors|mesh-ancestor
24663845|NCT01303887|Prednisolone|prednisolone|mesh-list
24663846|NCT01303887|Cyclophosphamide|cyclophosphamide|mesh-list
24663847|NCT01303887|Rituximab|rituximab|mesh-list
24663848|NCT01303887|Fludarabine|fludarabine|mesh-list
24663849|NCT01303887|Vincristine|vincristine|mesh-list
24663850|NCT01303887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24663851|NCT01303887|Immunologic Factors|immunologic factors|mesh-ancestor
24663852|NCT01303887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663853|NCT01303887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24663854|NCT01303887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24663856|NCT01303887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663857|NCT01303887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663858|NCT01303887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24663859|NCT01303887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24663881|NCT01303926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24663882|NCT01303926|Growth Substances|growth substances|mesh-ancestor
24663893|NCT01304069|Etoricoxib|etoricoxib|mesh-list
24663936|NCT01304212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24663937|NCT01304212|Adrenergic Agents|adrenergic agents|mesh-ancestor
24663938|NCT01304212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24663939|NCT01304212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663940|NCT01304212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24663941|NCT01304212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24663942|NCT01304212|Autonomic Agents|autonomic agents|mesh-ancestor
24663943|NCT01304212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24663944|NCT01304212|Respiratory System Agents|respiratory system agents|mesh-ancestor
24663946|NCT01304212|Sympathomimetics|sympathomimetics|mesh-ancestor
24663947|NCT01304212|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24663948|NCT01304212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24663949|NCT01304212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24663950|NCT01304212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24663951|NCT01304212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24663996|NCT01304472|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24663997|NCT01304472|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24663998|NCT01304472|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24663999|NCT01304472|Purinergic Agents|purinergic agents|mesh-ancestor
24664000|NCT01304472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24664001|NCT01304472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664002|NCT01304472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664003|NCT01304537|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
24664005|NCT01304537|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24664062|NCT01304836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24664063|NCT01304836|Immunologic Factors|immunologic factors|mesh-ancestor
24664064|NCT01304836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664065|NCT01304836|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24664066|NCT01304836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24664067|NCT01304836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664068|NCT01304836|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24664069|NCT01304836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24664070|NCT01304836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24664071|NCT01304836|Antitubercular Agents|antitubercular agents|mesh-ancestor
24664072|NCT01304836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24664073|NCT01304836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25704096|NCT02176031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704097|NCT02176031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25704098|NCT02176031|Glucocorticoids|glucocorticoids|mesh-ancestor
25704099|NCT02176031|Hormones|hormones|mesh-ancestor
25704100|NCT02176031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25704101|NCT02176031|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24625254|NCT01081353|Sensory System Agents|sensory system agents|mesh-ancestor
24664074|NCT01304836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24664075|NCT01304836|Antiemetics|antiemetics|mesh-ancestor
24664076|NCT01304836|Autonomic Agents|autonomic agents|mesh-ancestor
24664077|NCT01304836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24664078|NCT01304836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24664079|NCT01304836|Glucocorticoids|glucocorticoids|mesh-ancestor
24664081|NCT01304836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24664082|NCT01304836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24664083|NCT01304836|Protective Agents|protective agents|mesh-ancestor
24664084|NCT01304836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24664086|NCT01304901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24664093|NCT01304901|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24664094|NCT01304901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664096|NCT01304927|Cholecalciferol|cholecalciferol|mesh-list
24800147|NCT01973790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800148|NCT01973790|Cholinergic Agents|cholinergic agents|mesh-ancestor
24664108|NCT01305083|Udenafil|udenafil|mesh-list
24664109|NCT01305083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24664110|NCT01305083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24664111|NCT01305083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24664112|NCT01305083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664113|NCT01305135|Azacitidine|azacitidine|mesh-list
24664114|NCT01305135|Idarubicin|idarubicin|mesh-list
24664123|NCT01305148|Warfarin|warfarin|mesh-list
24664140|NCT01305317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24800153|NCT01973816|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24800154|NCT01973816|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24800155|NCT01973816|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24800157|NCT01973816|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24800158|NCT01973816|Cyproterone|cyproterone|mesh-list
24800159|NCT01973816|Estrogens|estrogens|mesh-ancestor
24800160|NCT01973816|Hormones|hormones|mesh-ancestor
24800161|NCT01973816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25099129|NCT03193424|Tubulin Modulators|tubulin modulators|mesh-ancestor
24848528|NCT03993912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24848529|NCT03993912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24452477|NCT05458674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24848530|NCT03993912|Immunologic Factors|immunologic factors|mesh-ancestor
24848533|NCT03993912|Growth Substances|growth substances|mesh-ancestor
24848534|NCT03993912|Growth Inhibitors|growth inhibitors|mesh-ancestor
25704103|NCT02176031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25704104|NCT02176031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25704105|NCT02176031|Immunologic Factors|immunologic factors|mesh-ancestor
25704106|NCT02176291|Buprenorphine|buprenorphine|mesh-list
25704107|NCT02176291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25704108|NCT02176291|Narcotics|narcotics|mesh-ancestor
25704109|NCT02176291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24664152|NCT01305395|Immunologic Factors|immunologic factors|mesh-ancestor
24664153|NCT01305395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664154|NCT01305551|Metformin|metformin|mesh-list
24664163|NCT01305551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24664164|NCT01305551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664165|NCT01305603|Bupivacaine|bupivacaine|mesh-list
24664166|NCT01305603|Anesthetics, Local|anesthetics, local|mesh-list
24664167|NCT01305603|Anesthetics|anesthetics|mesh-list
24829428|NCT02152332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24664168|NCT01305603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24664169|NCT01305603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664170|NCT01305603|Sensory System Agents|sensory system agents|mesh-ancestor
24664171|NCT01305603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24664173|NCT01305707|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24664187|NCT01305707|Paroxetine|paroxetine|mesh-list
24664188|NCT01305707|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24664279|NCT01305733|Mydriatics|mydriatics|mesh-ancestor
24664280|NCT01305733|Sympathomimetics|sympathomimetics|mesh-ancestor
24664281|NCT01305733|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24664282|NCT01305837|Methylprednisolone|methylprednisolone|mesh-list
24664283|NCT01305837|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24664284|NCT01305837|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24664285|NCT01305837|Prednisolone|prednisolone|mesh-list
24664286|NCT01305837|Prednisolone acetate|prednisolone acetate|mesh-list
24664287|NCT01305837|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24664288|NCT01305837|Prednisolone phosphate|prednisolone phosphate|mesh-list
24664289|NCT01305837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24664290|NCT01305837|Antiemetics|antiemetics|mesh-ancestor
24664291|NCT01305837|Autonomic Agents|autonomic agents|mesh-ancestor
24664292|NCT01305837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24664293|NCT01305837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664294|NCT01305837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24664295|NCT01305837|Glucocorticoids|glucocorticoids|mesh-ancestor
24800180|NCT01973842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24800181|NCT01973842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800182|NCT01973855|Ribavirin|ribavirin|mesh-list
24800183|NCT01973855|Antimetabolites|antimetabolites|mesh-ancestor
24800184|NCT01973855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800185|NCT01973855|Antiviral Agents|antiviral agents|mesh-ancestor
24848540|NCT03970096|Methotrexate|methotrexate|mesh-list
24664309|NCT01305850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664310|NCT01305850|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24664311|NCT01305850|Protease Inhibitors|protease inhibitors|mesh-ancestor
24664312|NCT01305850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24664313|NCT01306006|Vaccines|vaccines|mesh-list
24664314|NCT01306006|Immunologic Factors|immunologic factors|mesh-ancestor
24664315|NCT01306006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664316|NCT01306097|Zinc|zinc|mesh-list
24664317|NCT01306097|Zinc Sulfate|zinc sulfate|mesh-list
24664318|NCT01306097|Trace Elements|trace elements|mesh-ancestor
24664319|NCT01306097|Micronutrients|micronutrients|mesh-ancestor
24664381|NCT01306565|Atorvastatin|atorvastatin|mesh-list
24664382|NCT01306565|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24664383|NCT01306565|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24664384|NCT01306565|Antimetabolites|antimetabolites|mesh-ancestor
24664385|NCT01306565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664386|NCT01306565|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24664387|NCT01306565|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24664388|NCT01306565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933527|NCT04069858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24933528|NCT04069234|Clopidogrel|clopidogrel|mesh-list
24664389|NCT01306591|Bevacizumab|bevacizumab|mesh-list
24800211|NCT01974024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24800212|NCT01974024|Antiemetics|antiemetics|mesh-ancestor
24800213|NCT01974024|Autonomic Agents|autonomic agents|mesh-ancestor
24800214|NCT01974024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24800215|NCT01974024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800216|NCT01974024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24800217|NCT01974024|Glucocorticoids|glucocorticoids|mesh-ancestor
24848575|NCT03954379|Autonomic Agents|autonomic agents|mesh-ancestor
24848576|NCT03954379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24848577|NCT03954379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848578|NCT03954379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24848579|NCT03954379|Glucocorticoids|glucocorticoids|mesh-ancestor
24848580|NCT03954379|Hormones|hormones|mesh-ancestor
24848582|NCT03954379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24800238|NCT01974258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800239|NCT01974258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24800240|NCT01974258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800241|NCT01974258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800242|NCT01974297|Atorvastatin|atorvastatin|mesh-list
24800243|NCT01974297|Fenofibric acid|fenofibric acid|mesh-list
24800244|NCT01974297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24800245|NCT01974297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24800246|NCT01974297|Antimetabolites|antimetabolites|mesh-ancestor
25049954|NCT00553306|Immunologic Factors|immunologic factors|mesh-ancestor
24800247|NCT01974297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800248|NCT01974297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24800249|NCT01974297|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24800250|NCT01974297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24848599|NCT03910387|Antimetabolites|antimetabolites|mesh-ancestor
24664448|NCT01306760|Sensory System Agents|sensory system agents|mesh-ancestor
24800251|NCT01974336|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24664470|NCT01306981|Growth Inhibitors|growth inhibitors|mesh-ancestor
24664473|NCT01307189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24664474|NCT01307189|Autonomic Agents|autonomic agents|mesh-ancestor
24664475|NCT01307189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24664476|NCT01307189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664477|NCT01307189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24664478|NCT01307189|Respiratory System Agents|respiratory system agents|mesh-ancestor
24627783|NCT01094964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24800277|NCT01974518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24800278|NCT01974518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24800279|NCT01974518|Alkylating Agents|alkylating agents|mesh-ancestor
24800280|NCT01974518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800281|NCT01974518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800282|NCT01974518|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25704110|NCT02176291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704111|NCT02176291|Analgesics|analgesics|mesh-ancestor
25704112|NCT02176291|Sensory System Agents|sensory system agents|mesh-ancestor
25704113|NCT02176291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25704114|NCT02176291|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25704115|NCT02176356|Bimatoprost|bimatoprost|mesh-list
25704116|NCT02176356|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25704117|NCT02176356|Botulinum Toxins|botulinum toxins|mesh-list
25704118|NCT02176356|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25704119|NCT02176356|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24664502|NCT01307215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24664503|NCT01307215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664504|NCT01307215|Sensory System Agents|sensory system agents|mesh-ancestor
24664505|NCT01307215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24664506|NCT01307332|Alemtuzumab|alemtuzumab|mesh-list
24800286|NCT01974622|Dermatologic Agents|dermatologic agents|mesh-ancestor
24800287|NCT01974648|Remifentanil|remifentanil|mesh-list
24800289|NCT01974648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24800290|NCT01974648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24800291|NCT01974648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800292|NCT01974648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24800293|NCT01974648|Anesthetics, General|anesthetics, general|mesh-ancestor
24800294|NCT01974648|Anesthetics|anesthetics|mesh-ancestor
24800295|NCT01974648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24800296|NCT01974648|Narcotics|narcotics|mesh-ancestor
24800297|NCT01974648|Analgesics|analgesics|mesh-ancestor
24800298|NCT01974648|Sensory System Agents|sensory system agents|mesh-ancestor
24800299|NCT01974648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24800300|NCT01974843|Bupivacaine|bupivacaine|mesh-list
24800301|NCT01974843|Levobupivacaine|levobupivacaine|mesh-list
24800302|NCT01974843|Anesthetics, Local|anesthetics, local|mesh-ancestor
24800303|NCT01974843|Anesthetics|anesthetics|mesh-ancestor
24800304|NCT01974843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24800305|NCT01974843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800306|NCT01974843|Sensory System Agents|sensory system agents|mesh-ancestor
24800307|NCT01974843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24800308|NCT01974934|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24848665|NCT03728361|Nivolumab|nivolumab|mesh-list
24848666|NCT03728361|Temozolomide|temozolomide|mesh-list
24664520|NCT01307475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664521|NCT01307488|Ritonavir|ritonavir|mesh-list
24664522|NCT01307488|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24664523|NCT01307488|Lamivudine|lamivudine|mesh-list
24664524|NCT01307488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24664525|NCT01307488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24664526|NCT01307488|Protease Inhibitors|protease inhibitors|mesh-ancestor
24664527|NCT01307488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24664528|NCT01307488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664529|NCT01307488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24664543|NCT01307527|Dermatologic Agents|dermatologic agents|mesh-ancestor
24664547|NCT01307592|Lenalidomide|lenalidomide|mesh-list
25704120|NCT02176356|Hyaluronic Acid|hyaluronic acid|mesh-list
25704121|NCT02176356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25704122|NCT02176356|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25704123|NCT02176356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25704124|NCT02176356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704125|NCT02176356|Cholinergic Agents|cholinergic agents|mesh-ancestor
25704126|NCT02176356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25704127|NCT02176356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704128|NCT02176356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25049985|NCT00552708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25049986|NCT00552708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25049987|NCT00552708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25049988|NCT00552708|Vasodilator Agents|vasodilator agents|mesh-ancestor
25049989|NCT00552708|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25049990|NCT00552708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25049991|NCT00549744|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
25049992|NCT00549744|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24452495|NCT05458492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24452496|NCT05458492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24452497|NCT05458492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25049993|NCT00549744|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25049994|NCT00549744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25049995|NCT00549744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25049996|NCT00549679|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
25049997|NCT00549679|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25049998|NCT00549679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25049999|NCT00549679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050000|NCT00549679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050001|NCT00549510|Lisinopril|lisinopril|mesh-list
24848727|NCT03617328|Poly ICLC|poly iclc|mesh-list
24951624|NCT03902782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24951625|NCT03902782|Glucocorticoids|glucocorticoids|mesh-ancestor
24951626|NCT03902782|Hormones|hormones|mesh-ancestor
24951627|NCT03902782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24951628|NCT03902782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24951629|NCT03902782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951630|NCT03902782|Anesthetics, Local|anesthetics, local|mesh-ancestor
24951631|NCT03902782|Anesthetics|anesthetics|mesh-ancestor
24951632|NCT03902782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24951633|NCT03902782|Sensory System Agents|sensory system agents|mesh-ancestor
24951634|NCT03902782|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24951635|NCT03902782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24848748|NCT03529110|Trastuzumab|trastuzumab|mesh-list
24848749|NCT03529110|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24848750|NCT03529110|Maytansine|maytansine|mesh-list
24848751|NCT03529110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24848752|NCT03529110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25704129|NCT02176356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25704130|NCT02176356|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25704131|NCT02176356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25704132|NCT02176356|Immunologic Factors|immunologic factors|mesh-ancestor
25704133|NCT02176356|Viscosupplements|viscosupplements|mesh-ancestor
25704134|NCT02176356|Protective Agents|protective agents|mesh-ancestor
25704135|NCT02176382|Zoledronic Acid|zoledronic acid|mesh-list
25704136|NCT02176382|Denosumab|denosumab|mesh-list
25704137|NCT02176382|Teriparatide|teriparatide|mesh-list
25704138|NCT02176382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24951642|NCT03902782|Respiratory System Agents|respiratory system agents|mesh-ancestor
24951643|NCT03902782|Mydriatics|mydriatics|mesh-ancestor
24951644|NCT03902782|Sympathomimetics|sympathomimetics|mesh-ancestor
24800316|NCT01974934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24800317|NCT01975012|Rilpivirine|rilpivirine|mesh-list
24800318|NCT01975012|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24800319|NCT01975012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24800320|NCT01975012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800321|NCT01975012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800322|NCT01975012|Antiviral Agents|antiviral agents|mesh-ancestor
24800323|NCT01975012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24965910|NCT03773367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800324|NCT01975012|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24800325|NCT01975012|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24664587|NCT01307865|Mannitol|mannitol|mesh-list
24664611|NCT01307969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24664638|NCT01308086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664656|NCT01308203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24664657|NCT01308203|Antimetabolites|antimetabolites|mesh-ancestor
24800326|NCT01975051|Miltefosine|miltefosine|mesh-list
24800327|NCT01975051|Antifungal Agents|antifungal agents|mesh-ancestor
24800328|NCT01975051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24800329|NCT01975051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800330|NCT01975051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24800331|NCT01975051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24800332|NCT01975064|Propofol|propofol|mesh-list
24800333|NCT01975064|Sevoflurane|sevoflurane|mesh-list
24800334|NCT01975064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24800335|NCT01975064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24800336|NCT01975064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800337|NCT01975064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24800338|NCT01975064|Anesthetics, General|anesthetics, general|mesh-ancestor
24800339|NCT01975064|Anesthetics|anesthetics|mesh-ancestor
24800340|NCT01975064|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24800341|NCT01975064|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24800342|NCT01975129|Oxytocin|oxytocin|mesh-list
24800343|NCT01975129|Oxytocics|oxytocics|mesh-ancestor
24800360|NCT01975194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24800361|NCT01975194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24800362|NCT01975194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800364|NCT01975259|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
24800365|NCT01975259|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24800366|NCT01975259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24800367|NCT01975259|Hormones|hormones|mesh-ancestor
24759663|NCT01753453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24759641|NCT01753349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24759642|NCT01753349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704139|NCT02176382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704140|NCT02176382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25704141|NCT02176421|Lidocaine|lidocaine|mesh-list
25704142|NCT02176421|Anesthetics, Local|anesthetics, local|mesh-ancestor
25704143|NCT02176421|Anesthetics|anesthetics|mesh-ancestor
24759660|NCT01753453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24759661|NCT01753453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24759662|NCT01753453|Antiviral Agents|antiviral agents|mesh-ancestor
24759664|NCT01753596|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24759665|NCT01753596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24625471|NCT01082263|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24625472|NCT01082263|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24625473|NCT01082263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24625474|NCT01082263|Adrenergic Agents|adrenergic agents|mesh-ancestor
24625475|NCT01082263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24625476|NCT01082263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625477|NCT01082263|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24625478|NCT01082263|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24664712|NCT01308268|Albendazole|albendazole|mesh-list
24664713|NCT01308268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24935230|NCT04053400|Sensory System Agents|sensory system agents|mesh-ancestor
24935231|NCT04053400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24935232|NCT04053400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935233|NCT04053400|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24935234|NCT04053400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24935235|NCT04053400|Anesthetics, General|anesthetics, general|mesh-ancestor
24935236|NCT04053400|Anesthetics|anesthetics|mesh-ancestor
24935237|NCT04053400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24935238|NCT04053400|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24935242|NCT04053491|Anesthetics|anesthetics|mesh-list
24935260|NCT04052867|Anesthetics, Local|anesthetics, local|mesh-ancestor
24935261|NCT04052867|Anesthetics|anesthetics|mesh-ancestor
24935262|NCT04052867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24935263|NCT04052867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935264|NCT04052867|Sensory System Agents|sensory system agents|mesh-ancestor
25050002|NCT00549510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24935265|NCT04052867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24935266|NCT04052867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24935267|NCT04052867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24935268|NCT04052867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24935269|NCT04052867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24935270|NCT04052867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935271|NCT04053205|Paclitaxel|paclitaxel|mesh-list
24935272|NCT04053205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24935273|NCT04053205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935274|NCT04053205|Tubulin Modulators|tubulin modulators|mesh-ancestor
24848937|NCT03257163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848939|NCT03249714|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24848940|NCT03249714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639794|NCT01164215|Leucovorin|leucovorin|mesh-list
24664769|NCT01308606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24664770|NCT01308606|Protease Inhibitors|protease inhibitors|mesh-ancestor
24664771|NCT01308606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24664772|NCT01308606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664774|NCT01308632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24664775|NCT01308632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24664776|NCT01308632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24664781|NCT01308658|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24664782|NCT01308658|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24935297|NCT04052178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935299|NCT04051723|Ropivacaine|ropivacaine|mesh-list
24935300|NCT04051723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24935301|NCT04051723|Antiemetics|antiemetics|mesh-ancestor
24935302|NCT04051723|Autonomic Agents|autonomic agents|mesh-ancestor
24935303|NCT04051723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24935304|NCT04051723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935305|NCT04051723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24935306|NCT04051723|Glucocorticoids|glucocorticoids|mesh-ancestor
24935307|NCT04051723|Hormones|hormones|mesh-ancestor
24935308|NCT04051723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24935309|NCT04051723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24935310|NCT04051723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935311|NCT04051723|Anesthetics, Local|anesthetics, local|mesh-ancestor
24935312|NCT04051723|Anesthetics|anesthetics|mesh-ancestor
24935313|NCT04051723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24935314|NCT04051723|Sensory System Agents|sensory system agents|mesh-ancestor
24935315|NCT04051853|Sorafenib|sorafenib|mesh-list
24935316|NCT04051853|Midazolam|midazolam|mesh-list
24664799|NCT01308684|Bevacizumab|bevacizumab|mesh-list
24456305|NCT00330824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456306|NCT00330824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24456307|NCT00330824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24668464|NCT04918147|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24668465|NCT04918147|Histamine Antagonists|histamine antagonists|mesh-ancestor
24664800|NCT01308684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24664801|NCT01308684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24664802|NCT01308684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24935321|NCT04051853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24935322|NCT04051853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24935323|NCT04051853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24759740|NCT01754324|Methadone|methadone|mesh-list
24935324|NCT04051853|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24935358|NCT04051567|Aspirin|aspirin|mesh-list
24935359|NCT04051567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24935360|NCT04051567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24935361|NCT04051567|Analgesics|analgesics|mesh-ancestor
24935362|NCT04051567|Sensory System Agents|sensory system agents|mesh-ancestor
24935363|NCT04051567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24935364|NCT04051567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935365|NCT04051567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24935366|NCT04051567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24935367|NCT04051567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24935368|NCT04051567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24935369|NCT04051567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050003|NCT00549510|Protease Inhibitors|protease inhibitors|mesh-ancestor
24951827|NCT03900858|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24664858|NCT01309022|Antifungal Agents|antifungal agents|mesh-ancestor
24951832|NCT03900858|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25050004|NCT00549510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050005|NCT00549510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050006|NCT00549510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25050007|NCT00549510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25050008|NCT00549510|Protective Agents|protective agents|mesh-ancestor
24848967|NCT03170882|Dexamethasone|dexamethasone|mesh-list
24664803|NCT01308684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24664804|NCT01308684|Growth Substances|growth substances|mesh-ancestor
24664805|NCT01308684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664806|NCT01308684|Growth Inhibitors|growth inhibitors|mesh-ancestor
24664807|NCT01308723|Sorafenib|sorafenib|mesh-list
24664808|NCT01308723|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24664809|NCT01308723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24664810|NCT01308723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24664811|NCT01308723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050009|NCT00549510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050011|NCT00547651|Amrubicin|amrubicin|mesh-list
25704144|NCT02176421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25704145|NCT02176421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704146|NCT02176421|Sensory System Agents|sensory system agents|mesh-ancestor
25704147|NCT02176421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25704148|NCT02176421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25704149|NCT02176421|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25704150|NCT02176421|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25050012|NCT00547651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24664834|NCT01308983|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24664835|NCT01309009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24664837|NCT01309009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24664838|NCT01309009|Autonomic Agents|autonomic agents|mesh-ancestor
24664853|NCT01309022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24664854|NCT01309022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24664855|NCT01309022|Antitubercular Agents|antitubercular agents|mesh-ancestor
24664856|NCT01309022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24664857|NCT01309022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24664862|NCT01309074|Sensory System Agents|sensory system agents|mesh-ancestor
24664863|NCT01309074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24664864|NCT01309074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664865|NCT01309074|Anticonvulsants|anticonvulsants|mesh-ancestor
24664866|NCT01309074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24664867|NCT01309074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25704153|NCT02176486|Ixazomib|ixazomib|mesh-list
25704154|NCT02176486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25704155|NCT02176486|Protease Inhibitors|protease inhibitors|mesh-ancestor
25704156|NCT02176486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25704157|NCT02176486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704158|NCT02176642|Oxybutynin|oxybutynin|mesh-list
24668876|NCT04543968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24668877|NCT04543968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24412656|NCT00191737|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24664868|NCT01309074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664875|NCT01309074|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24664876|NCT01309074|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24664877|NCT01309074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24664880|NCT01309126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24664881|NCT01309126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050016|NCT00547651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050018|NCT00547066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050020|NCT00546793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050021|NCT00546780|Bortezomib|bortezomib|mesh-list
25050022|NCT00546780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050023|NCT00546273|Vaccines|vaccines|mesh-list
25050024|NCT00546273|Immunologic Factors|immunologic factors|mesh-ancestor
25050025|NCT00546273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050026|NCT00544960|Docetaxel|docetaxel|mesh-list
25050027|NCT00544960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24951852|NCT03900637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24951853|NCT03900637|Hormone Antagonists|hormone antagonists|mesh-ancestor
24951854|NCT03900637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24951855|NCT03900637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24951856|NCT03900637|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24951858|NCT03900637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24951860|NCT03900377|Rituximab|rituximab|mesh-list
24935371|NCT04051567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24935372|NCT04051567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935373|NCT04051567|Antipyretics|antipyretics|mesh-ancestor
24935374|NCT04051255|Metronidazole|metronidazole|mesh-list
24935375|NCT04051255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24935376|NCT04051255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24935377|NCT04051255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24849041|NCT03041740|Perflubron|perflubron|mesh-list
24664892|NCT01309139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24664893|NCT01309139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664894|NCT01309178|Mannitol|mannitol|mesh-list
24664895|NCT01309178|Amitriptyline|amitriptyline|mesh-list
24664896|NCT01309178|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24664898|NCT01309178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24664932|NCT01309425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25704159|NCT02176642|Parasympatholytics|parasympatholytics|mesh-ancestor
25704160|NCT02176642|Autonomic Agents|autonomic agents|mesh-ancestor
25704161|NCT02176642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25704162|NCT02176642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704163|NCT02176642|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25704164|NCT02176642|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25704165|NCT02176642|Cholinergic Agents|cholinergic agents|mesh-ancestor
25704166|NCT02176642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25704167|NCT02176642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704168|NCT02176642|Urological Agents|urological agents|mesh-ancestor
24664933|NCT01309438|Erythromycin|erythromycin|mesh-list
24664934|NCT01309438|Erythromycin Estolate|erythromycin estolate|mesh-list
24935384|NCT04051047|Antiviral Agents|antiviral agents|mesh-ancestor
24935385|NCT04051047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24935386|NCT04051047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935387|NCT04051047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24665011|NCT01309685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665012|NCT01309698|Inositol|inositol|mesh-list
24665013|NCT01309698|Vildagliptin|vildagliptin|mesh-list
24665014|NCT01309698|Voglibose|voglibose|mesh-list
24665015|NCT01309698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24665016|NCT01309698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665017|NCT01309698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24665018|NCT01309698|Protease Inhibitors|protease inhibitors|mesh-ancestor
24665019|NCT01309698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24665020|NCT01309698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665021|NCT01309698|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24665022|NCT01309698|Vitamin B Complex|vitamin b complex|mesh-ancestor
24665023|NCT01309698|Vitamins|vitamins|mesh-ancestor
24665024|NCT01309698|Micronutrients|micronutrients|mesh-ancestor
24665025|NCT01309776|Citalopram|citalopram|mesh-list
24665026|NCT01309776|Tianeptine|tianeptine|mesh-list
24665027|NCT01309776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24935388|NCT04051047|Immunologic Factors|immunologic factors|mesh-ancestor
24935389|NCT04051047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935390|NCT04051099|Dexmedetomidine|dexmedetomidine|mesh-list
24935391|NCT04051099|Bupivacaine|bupivacaine|mesh-list
24935392|NCT04051099|Propofol|propofol|mesh-list
24665055|NCT01309789|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24665056|NCT01309789|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24665057|NCT01309789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24665058|NCT01309789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24665059|NCT01309789|Glucocorticoids|glucocorticoids|mesh-ancestor
24665060|NCT01309789|Hormones|hormones|mesh-ancestor
24665061|NCT01309789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24665062|NCT01309789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24665063|NCT01309789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24665064|NCT01309789|Tubulin Modulators|tubulin modulators|mesh-ancestor
24665065|NCT01309789|Antimitotic Agents|antimitotic agents|mesh-ancestor
24665094|NCT01310166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665095|NCT01310166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24665109|NCT01310244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24935409|NCT04051099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759920|NCT01755494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24759921|NCT01755494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759922|NCT01755494|Incretins|incretins|mesh-ancestor
24935410|NCT04050592|Estradiol|estradiol|mesh-list
24759923|NCT01755494|Hormones|hormones|mesh-ancestor
24531808|NCT00637234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531809|NCT00637234|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24531810|NCT00637234|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24531827|NCT00637403|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24531828|NCT00637403|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24531829|NCT00637403|Contraceptive Agents|contraceptive agents|mesh-ancestor
24531830|NCT00637403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24531831|NCT00637403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531832|NCT00637403|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24935412|NCT04050592|Hormones|hormones|mesh-ancestor
24935414|NCT04050592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935432|NCT04050826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24665111|NCT01310244|Tubulin Modulators|tubulin modulators|mesh-ancestor
24665112|NCT01310244|Antimitotic Agents|antimitotic agents|mesh-ancestor
24665113|NCT01310244|Mitosis Modulators|mitosis modulators|mesh-ancestor
24665114|NCT01310244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665115|NCT01310244|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24665116|NCT01310244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24665118|NCT01310283|Fluorides, Topical|fluorides, topical|mesh-list
24665122|NCT01310296|Lofexidine|lofexidine|mesh-list
24665146|NCT01310452|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24665147|NCT01310452|Insulin Detemir|insulin detemir|mesh-list
24665148|NCT01310452|Protamines|protamines|mesh-list
24665150|NCT01310452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935433|NCT04050826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935435|NCT04050488|Astringents|astringents|mesh-ancestor
24935436|NCT04050488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935479|NCT04050059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24849159|NCT02533232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24849160|NCT02533232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24849161|NCT02506959|Gemcitabine|gemcitabine|mesh-list
24849162|NCT02506959|Melphalan|melphalan|mesh-list
24849163|NCT02506959|Busulfan|busulfan|mesh-list
24849164|NCT02506959|Mechlorethamine|mechlorethamine|mesh-list
24665151|NCT01310452|Heparin Antagonists|heparin antagonists|mesh-ancestor
24665152|NCT01310452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665154|NCT01310465|Zoledronic Acid|zoledronic acid|mesh-list
24665155|NCT01310465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24665156|NCT01310465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665157|NCT01310478|Endostatins|endostatins|mesh-list
24665159|NCT01310478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24665160|NCT01310478|Growth Substances|growth substances|mesh-ancestor
24665161|NCT01310478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665162|NCT01310478|Growth Inhibitors|growth inhibitors|mesh-ancestor
25704169|NCT02176655|Aspirin|aspirin|mesh-list
25704170|NCT02176655|Sumatriptan|sumatriptan|mesh-list
25704171|NCT02176655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25704172|NCT02176655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25704173|NCT02176655|Analgesics|analgesics|mesh-ancestor
25704174|NCT02176655|Sensory System Agents|sensory system agents|mesh-ancestor
25704175|NCT02176655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25704176|NCT02176655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704177|NCT02176655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25704178|NCT02176655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25704179|NCT02176655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25704180|NCT02176655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25704181|NCT02176655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704182|NCT02176655|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25704183|NCT02176655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25704184|NCT02176655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25704185|NCT02176655|Antipyretics|antipyretics|mesh-ancestor
25704186|NCT02176655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25704187|NCT02176655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24669375|NCT04058717|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24669379|NCT04058717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665163|NCT01310478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665164|NCT01310621|Pulmonary Surfactants|pulmonary surfactants|mesh-list
24665165|NCT01310621|Respiratory System Agents|respiratory system agents|mesh-ancestor
24665166|NCT01310647|Estradiol|estradiol|mesh-list
25704188|NCT02176655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24665167|NCT01310647|Testosterone|testosterone|mesh-list
25704189|NCT02176655|Serotonin Agents|serotonin agents|mesh-ancestor
24665168|NCT01310647|Estrogens|estrogens|mesh-ancestor
24935481|NCT04050059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935482|NCT04050059|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24935484|NCT04049916|Piperaquine|piperaquine|mesh-list
24935485|NCT04049916|Primaquine|primaquine|mesh-list
24935486|NCT04049916|Artenimol|artenimol|mesh-list
24935487|NCT04049916|Pyronaridine|pyronaridine|mesh-list
24935488|NCT04049916|Antimalarials|antimalarials|mesh-ancestor
24935489|NCT04049916|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24935490|NCT04049916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24935491|NCT04049916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24935492|NCT04049916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935493|NCT04049916|Antiviral Agents|antiviral agents|mesh-ancestor
24935494|NCT04049916|Schistosomicides|schistosomicides|mesh-ancestor
24935495|NCT04049916|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24935496|NCT04049916|Anthelmintics|anthelmintics|mesh-ancestor
24935497|NCT04050098|Metformin|metformin|mesh-list
24935498|NCT04050098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24849165|NCT02506959|Panobinostat|panobinostat|mesh-list
24665252|NCT01311076|Insulin|insulin|mesh-list
24665261|NCT01311167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24665262|NCT01311167|Antiemetics|antiemetics|mesh-ancestor
24935499|NCT04050098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935500|NCT04049747|Bicalutamide|bicalutamide|mesh-list
24935501|NCT04049747|Finasteride|finasteride|mesh-list
24935502|NCT04049747|Androgen Antagonists|androgen antagonists|mesh-ancestor
24935505|NCT04049747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935506|NCT04049747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935507|NCT04049747|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24935508|NCT04049747|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24935509|NCT04049747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24665263|NCT01311167|Autonomic Agents|autonomic agents|mesh-ancestor
24665264|NCT01311167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24455993|NCT00329498|Micronutrients|micronutrients|mesh-ancestor
24665304|NCT01311570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24665305|NCT01311570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24665313|NCT01311700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24665314|NCT01311700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665315|NCT01311700|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24665316|NCT01311700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25105382|NCT03146390|Listerine|listerine|mesh-list
24452619|NCT05457959|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24452621|NCT05457959|Poly ICLC|poly iclc|mesh-list
24452622|NCT05457959|Immunologic Factors|immunologic factors|mesh-ancestor
24452623|NCT05457959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665317|NCT01311700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24665318|NCT01311700|Adrenergic Agents|adrenergic agents|mesh-ancestor
24665319|NCT01311700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665338|NCT01311778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24935510|NCT04049747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704190|NCT02176655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25704191|NCT02177032|Vaccines|vaccines|mesh-list
25704192|NCT02177032|Immunoglobulins|immunoglobulins|mesh-list
25704193|NCT02177032|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25704194|NCT02177032|Antibodies|antibodies|mesh-list
25704195|NCT02177032|Immunologic Factors|immunologic factors|mesh-ancestor
24935511|NCT04049747|Urological Agents|urological agents|mesh-ancestor
24532271|NCT00638833|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24532272|NCT00638833|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24935513|NCT04049409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24935514|NCT04049409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935515|NCT04049539|Cytarabine|cytarabine|mesh-list
24935516|NCT04049539|Daunorubicin|daunorubicin|mesh-list
24935517|NCT04049539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24935518|NCT04049539|Antimetabolites|antimetabolites|mesh-ancestor
24935519|NCT04049539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935520|NCT04049539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665360|NCT01311882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24665361|NCT01311882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665362|NCT01311882|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24665363|NCT01311882|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
24665364|NCT01311882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665365|NCT01311882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665366|NCT01311947|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24665367|NCT01311947|Antiviral Agents|antiviral agents|mesh-ancestor
24665368|NCT01311947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24665370|NCT01311960|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24935530|NCT04049513|Cyclophosphamide|cyclophosphamide|mesh-list
24935531|NCT04049513|Fludarabine|fludarabine|mesh-list
24935532|NCT04049513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24935533|NCT04049513|Immunologic Factors|immunologic factors|mesh-ancestor
24935534|NCT04049513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935535|NCT04049513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24935536|NCT04049513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24935537|NCT04049513|Alkylating Agents|alkylating agents|mesh-ancestor
25050056|NCT00544115|Cyclosporins|cyclosporins|mesh-list
24935545|NCT04049344|Antimetabolites|antimetabolites|mesh-ancestor
24665371|NCT01311960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24665372|NCT01311960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665373|NCT01311960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24665374|NCT01311960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24665375|NCT01311960|Growth Substances|growth substances|mesh-ancestor
25704196|NCT02177032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704197|NCT02177786|Selonsertib|selonsertib|mesh-list
25704198|NCT02177786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25704199|NCT02177786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25704200|NCT02177786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704201|NCT02177838|Cisplatin|cisplatin|mesh-list
25704202|NCT02177838|Cetuximab|cetuximab|mesh-list
25704203|NCT02177838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25704204|NCT02177838|Antibodies|antibodies|mesh-list
25704205|NCT02177838|Immunoglobulins|immunoglobulins|mesh-list
25704206|NCT02177838|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25704207|NCT02177838|Immunologic Factors|immunologic factors|mesh-ancestor
24665395|NCT01312077|Levobupivacaine|levobupivacaine|mesh-list
24665396|NCT01312077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24665398|NCT01312077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24665399|NCT01312077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665400|NCT01312077|Analgesics|analgesics|mesh-ancestor
24665401|NCT01312077|Sensory System Agents|sensory system agents|mesh-ancestor
24665402|NCT01312077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24665403|NCT01312077|Anesthetics, Local|anesthetics, local|mesh-ancestor
24665405|NCT01312298|Bupivacaine|bupivacaine|mesh-list
25704208|NCT02177838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704209|NCT02177838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25704210|NCT02177942|Micronutrients|micronutrients|mesh-list
25704211|NCT02177942|Trace Elements|trace elements|mesh-list
25704212|NCT02177942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704213|NCT02178059|Terbutaline|terbutaline|mesh-list
25704214|NCT02178059|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25704215|NCT02178059|Autonomic Agents|autonomic agents|mesh-ancestor
25704216|NCT02178059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25704217|NCT02178059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665410|NCT01312298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24665435|NCT01312337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24665436|NCT01312337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665438|NCT01312350|Fluorouracil|fluorouracil|mesh-list
24665439|NCT01312350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665440|NCT01312350|Tubulin Modulators|tubulin modulators|mesh-ancestor
24665441|NCT01312350|Antimitotic Agents|antimitotic agents|mesh-ancestor
24665442|NCT01312350|Mitosis Modulators|mitosis modulators|mesh-ancestor
24665443|NCT01312350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935562|NCT04049201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935563|NCT04049253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24935597|NCT04048811|Propofol|propofol|mesh-list
24935598|NCT04048811|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24935599|NCT04048811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24935600|NCT04048811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935601|NCT04048811|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24935602|NCT04048811|Anesthetics, General|anesthetics, general|mesh-ancestor
24935603|NCT04048811|Anesthetics|anesthetics|mesh-ancestor
24935604|NCT04048577|Natalizumab|natalizumab|mesh-list
24935605|NCT04048577|Immunologic Factors|immunologic factors|mesh-ancestor
24935606|NCT04048577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935607|NCT04048655|Neostigmine|neostigmine|mesh-list
24935608|NCT04048655|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24935609|NCT04048655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935610|NCT04048655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935615|NCT04048655|Autonomic Agents|autonomic agents|mesh-ancestor
25050039|NCT00544466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25050040|NCT00544466|Immunologic Factors|immunologic factors|mesh-ancestor
25050041|NCT00544466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050042|NCT00544466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24665444|NCT01312350|Antimetabolites|antimetabolites|mesh-ancestor
25050044|NCT00544466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25050045|NCT00544115|Cyclosporine|cyclosporine|mesh-list
25050046|NCT00544115|Sirolimus|sirolimus|mesh-list
25050047|NCT00544115|Mycophenolic Acid|mycophenolic acid|mesh-list
25050048|NCT00544115|Cyclophosphamide|cyclophosphamide|mesh-list
25704218|NCT02178059|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25704219|NCT02178059|Respiratory System Agents|respiratory system agents|mesh-ancestor
25704220|NCT02178059|Sympathomimetics|sympathomimetics|mesh-ancestor
25704221|NCT02178059|Tocolytic Agents|tocolytic agents|mesh-ancestor
25704222|NCT02178059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25704223|NCT02178059|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25704224|NCT02178059|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25704225|NCT02178059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25704226|NCT02178059|Adrenergic Agents|adrenergic agents|mesh-ancestor
25704227|NCT02178059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25704228|NCT02178059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050049|NCT00544115|Melphalan|melphalan|mesh-list
25050050|NCT00544115|Busulfan|busulfan|mesh-list
24513388|NCT00581009|Serotonin Agents|serotonin agents|mesh-ancestor
24533232|NCT00642655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24533234|NCT00642681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24533235|NCT00642681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533236|NCT00642733|Gemcitabine|gemcitabine|mesh-list
24533241|NCT00642733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24533242|NCT00642733|Antiviral Agents|antiviral agents|mesh-ancestor
24533243|NCT00642733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25050051|NCT00544115|Methotrexate|methotrexate|mesh-list
25050052|NCT00544115|Fludarabine|fludarabine|mesh-list
25050053|NCT00544115|Fludarabine phosphate|fludarabine phosphate|mesh-list
25050054|NCT00544115|Etoposide|etoposide|mesh-list
25050055|NCT00544115|Tacrolimus|tacrolimus|mesh-list
25050058|NCT00544115|Immunologic Factors|immunologic factors|mesh-ancestor
25050059|NCT00544115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050060|NCT00544115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24665445|NCT01312350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24665446|NCT01312350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24665447|NCT01312350|Immunologic Factors|immunologic factors|mesh-ancestor
24665448|NCT01312350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665449|NCT01312363|Rivastigmine|rivastigmine|mesh-list
24665458|NCT01312376|Cyclophosphamide|cyclophosphamide|mesh-list
24665473|NCT01312376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24665474|NCT01312376|Growth Substances|growth substances|mesh-ancestor
24665475|NCT01312376|Growth Inhibitors|growth inhibitors|mesh-ancestor
24665476|NCT01312402|Brinzolamide|brinzolamide|mesh-list
24665477|NCT01312402|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24665478|NCT01312402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24665479|NCT01312402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665480|NCT01312415|Morphine|morphine|mesh-list
24665481|NCT01312415|Levobupivacaine|levobupivacaine|mesh-list
24665482|NCT01312415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24665483|NCT01312415|Narcotics|narcotics|mesh-ancestor
24665484|NCT01312415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24665485|NCT01312415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665486|NCT01312415|Analgesics|analgesics|mesh-ancestor
24665487|NCT01312415|Sensory System Agents|sensory system agents|mesh-ancestor
24665488|NCT01312415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24665489|NCT01312415|Anesthetics, Local|anesthetics, local|mesh-ancestor
24665490|NCT01312415|Anesthetics|anesthetics|mesh-ancestor
24665491|NCT01312441|Ergocalciferols|ergocalciferols|mesh-list
24665493|NCT01312441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24665494|NCT01312441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665495|NCT01312441|Vitamins|vitamins|mesh-ancestor
24665526|NCT01313143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665527|NCT01313247|Acetaminophen|acetaminophen|mesh-list
24665528|NCT01313247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24665529|NCT01313247|Analgesics|analgesics|mesh-ancestor
24665530|NCT01313247|Sensory System Agents|sensory system agents|mesh-ancestor
24665531|NCT01313247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24665532|NCT01313247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665533|NCT01313247|Antipyretics|antipyretics|mesh-ancestor
24665534|NCT01313377|Gemcitabine|gemcitabine|mesh-list
24665535|NCT01313377|Oxaliplatin|oxaliplatin|mesh-list
24665536|NCT01313377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25704229|NCT02178241|Gemcitabine|gemcitabine|mesh-list
25704230|NCT02178241|Halichondrin B|halichondrin b|mesh-list
25704231|NCT02178241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25704232|NCT02178241|Antimetabolites|antimetabolites|mesh-ancestor
25704233|NCT02178241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704234|NCT02178241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25704235|NCT02178241|Antiviral Agents|antiviral agents|mesh-ancestor
25704236|NCT02178241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24665537|NCT01313377|Antimetabolites|antimetabolites|mesh-ancestor
24665538|NCT01313377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665539|NCT01313377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24452719|NCT05457530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24452726|NCT05457361|Azacitidine|azacitidine|mesh-list
24665578|NCT01313585|Beclomethasone|beclomethasone|mesh-list
24665580|NCT01313585|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24665581|NCT01313585|Autonomic Agents|autonomic agents|mesh-ancestor
24665582|NCT01313585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24665583|NCT01313585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665584|NCT01313585|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24665585|NCT01313585|Respiratory System Agents|respiratory system agents|mesh-ancestor
24665587|NCT01313585|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24665588|NCT01313585|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24665589|NCT01313585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24665590|NCT01313585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24665591|NCT01313585|Adrenergic Agents|adrenergic agents|mesh-ancestor
24665592|NCT01313585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665593|NCT01313585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665594|NCT01313585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24665595|NCT01313585|Glucocorticoids|glucocorticoids|mesh-ancestor
25704237|NCT02178241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25704238|NCT02178241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25704239|NCT02178241|Immunologic Factors|immunologic factors|mesh-ancestor
25704240|NCT02178241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704241|NCT02178241|Tubulin Modulators|tubulin modulators|mesh-ancestor
25704242|NCT02178241|Antimitotic Agents|antimitotic agents|mesh-ancestor
25704243|NCT02178241|Mitosis Modulators|mitosis modulators|mesh-ancestor
25704244|NCT02178540|Tobramycin|tobramycin|mesh-list
25704245|NCT02178540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25704246|NCT02178540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25704247|NCT02178553|Bupivacaine|bupivacaine|mesh-list
25704248|NCT02178553|Anesthetics, Local|anesthetics, local|mesh-ancestor
24665643|NCT01313819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665644|NCT01313819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24665645|NCT01313819|Analgesics|analgesics|mesh-ancestor
24640860|NCT01170429|Procaterol|procaterol|mesh-list
25704249|NCT02178553|Anesthetics|anesthetics|mesh-ancestor
25704250|NCT02178553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25704251|NCT02178553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704252|NCT02178553|Sensory System Agents|sensory system agents|mesh-ancestor
25704253|NCT02178553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25704254|NCT02178696|Antidepressive Agents|antidepressive agents|mesh-list
25704255|NCT02178696|Citalopram|citalopram|mesh-list
25704256|NCT02178696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25704257|NCT02178696|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25704258|NCT02178696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25050085|NCT00543582|Azacitidine|azacitidine|mesh-list
25050098|NCT00542724|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25050099|NCT00542724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25050100|NCT00542724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050102|NCT00542633|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25050103|NCT00542633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24952074|NCT03898466|Autonomic Agents|autonomic agents|mesh-ancestor
24952075|NCT03898466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24952076|NCT03898466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24952077|NCT03898466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24952078|NCT03898466|Respiratory System Agents|respiratory system agents|mesh-ancestor
24952079|NCT03898466|Dermatologic Agents|dermatologic agents|mesh-ancestor
24952080|NCT03898466|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24799529|NCT01969578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25050104|NCT00542633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050105|NCT00540358|Gemcitabine|gemcitabine|mesh-list
25050106|NCT00540358|Carboplatin|carboplatin|mesh-list
25050107|NCT00540358|Iniparib|iniparib|mesh-list
24935626|NCT04048707|Autonomic Agents|autonomic agents|mesh-ancestor
24665649|NCT01313845|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24665650|NCT01313845|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24665651|NCT01313845|Antiviral Agents|antiviral agents|mesh-ancestor
24665653|NCT01313845|Dopamine Agents|dopamine agents|mesh-ancestor
24665687|NCT01314144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24665688|NCT01314209|Dexmedetomidine|dexmedetomidine|mesh-list
24935642|NCT04048317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24935643|NCT04048317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935644|NCT04048317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24935645|NCT04048317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24414722|NCT00198523|Antiemetics|antiemetics|mesh-ancestor
24935646|NCT04048317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935647|NCT04048317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935648|NCT04048226|Dexmedetomidine|dexmedetomidine|mesh-list
24935650|NCT04048226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24935651|NCT04048226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24935652|NCT04048226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849374|NCT00436254|Molgramostim|molgramostim|mesh-list
24665689|NCT01314209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24665690|NCT01314209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24665691|NCT01314209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665692|NCT01314209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24665702|NCT01314274|Bevacizumab|bevacizumab|mesh-list
24665738|NCT01314352|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25704260|NCT02178696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704261|NCT02178696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25704262|NCT02178696|Serotonin Agents|serotonin agents|mesh-ancestor
25704263|NCT02178696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704264|NCT02178696|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25704265|NCT02178800|Cabotegravir|cabotegravir|mesh-list
25704266|NCT02178800|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25704267|NCT02178800|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25704268|NCT02178800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25704269|NCT02178800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704270|NCT02178800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24665780|NCT01314833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24665781|NCT01314833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665782|NCT01314833|Tubulin Modulators|tubulin modulators|mesh-ancestor
24665783|NCT01314833|Antimitotic Agents|antimitotic agents|mesh-ancestor
24935655|NCT04048226|Sensory System Agents|sensory system agents|mesh-ancestor
24935656|NCT04048226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24935657|NCT04048226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24935658|NCT04048226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24935659|NCT04048226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24935660|NCT04048226|Adrenergic Agents|adrenergic agents|mesh-ancestor
24665788|NCT01314833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665789|NCT01314833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24665790|NCT01314833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24665791|NCT01314833|Alkylating Agents|alkylating agents|mesh-ancestor
24665792|NCT01314833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24665793|NCT01314833|Antimetabolites|antimetabolites|mesh-ancestor
24665803|NCT01314859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665805|NCT01314859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665806|NCT01314859|Vasodilator Agents|vasodilator agents|mesh-ancestor
24665807|NCT01314859|Tocolytic Agents|tocolytic agents|mesh-ancestor
24665808|NCT01314859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24665809|NCT01314859|Hormone Antagonists|hormone antagonists|mesh-ancestor
24665819|NCT01314937|Mebendazole|mebendazole|mesh-list
24665820|NCT01314937|Piperazine|piperazine|mesh-list
24665821|NCT01314937|Piperazine citrate|piperazine citrate|mesh-list
24665822|NCT01314937|DMP 777|dmp 777|mesh-list
24665823|NCT01314937|Antinematodal Agents|antinematodal agents|mesh-ancestor
24665824|NCT01314937|Anthelmintics|anthelmintics|mesh-ancestor
24665825|NCT01314937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24665826|NCT01314937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24665827|NCT01314937|Tubulin Modulators|tubulin modulators|mesh-ancestor
24665828|NCT01314937|Antimitotic Agents|antimitotic agents|mesh-ancestor
24665829|NCT01314937|Mitosis Modulators|mitosis modulators|mesh-ancestor
24665830|NCT01314937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665831|NCT01314937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665836|NCT01314976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24665837|NCT01314976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24665839|NCT01314989|Antipruritics|antipruritics|mesh-ancestor
24665840|NCT01314989|Dermatologic Agents|dermatologic agents|mesh-ancestor
24665841|NCT01314989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24665842|NCT01314989|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24665843|NCT01314989|Histamine Antagonists|histamine antagonists|mesh-ancestor
24665844|NCT01314989|Histamine Agents|histamine agents|mesh-ancestor
24665845|NCT01314989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665846|NCT01314989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935663|NCT04048226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24935664|NCT04048226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24935665|NCT04048226|Anesthetics, General|anesthetics, general|mesh-ancestor
24935666|NCT04048226|Anesthetics|anesthetics|mesh-ancestor
24935667|NCT04048226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24935668|NCT04048226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24935669|NCT04048200|Fentanyl|fentanyl|mesh-list
24935670|NCT04048200|Dexmedetomidine|dexmedetomidine|mesh-list
24935671|NCT04048200|Ketamine|ketamine|mesh-list
24935672|NCT04048200|Analgesics, Opioid|analgesics, opioid|mesh-list
24935673|NCT04048200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24935674|NCT04048200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24935675|NCT04048200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935676|NCT04048200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25704271|NCT02178800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24935677|NCT04048200|Analgesics|analgesics|mesh-ancestor
24935678|NCT04048200|Sensory System Agents|sensory system agents|mesh-ancestor
24935679|NCT04048200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24455631|NCT00328367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455632|NCT00328367|Dopamine Agonists|dopamine agonists|mesh-ancestor
24455633|NCT00328367|Dopamine Agents|dopamine agents|mesh-ancestor
24455634|NCT00328367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24455635|NCT00328367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455636|NCT00328367|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24455637|NCT00328367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24849380|NCT00358163|Vatalanib|vatalanib|mesh-list
24849381|NCT00358163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24665847|NCT01314989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665848|NCT01314989|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24665849|NCT01314989|Serotonin Agents|serotonin agents|mesh-ancestor
24665850|NCT01314989|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24665851|NCT01315093|Heparin|heparin|mesh-list
24665852|NCT01315093|Calcium heparin|calcium heparin|mesh-list
24665853|NCT01315093|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24665854|NCT01315093|Tinzaparin|tinzaparin|mesh-list
24665863|NCT01315262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24665864|NCT01315262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24665865|NCT01315262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665866|NCT01315262|Urological Agents|urological agents|mesh-ancestor
24665867|NCT01315275|Ranibizumab|ranibizumab|mesh-list
24665868|NCT01315275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24665869|NCT01315275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24665870|NCT01315275|Growth Substances|growth substances|mesh-ancestor
24665871|NCT01315275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665872|NCT01315275|Growth Inhibitors|growth inhibitors|mesh-ancestor
24665873|NCT01315275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665874|NCT01315431|Capecitabine|capecitabine|mesh-list
24665875|NCT01315431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24665876|NCT01315431|Antimetabolites|antimetabolites|mesh-ancestor
24665877|NCT01315431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665918|NCT01315912|Hormone Antagonists|hormone antagonists|mesh-ancestor
24665919|NCT01315912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24665920|NCT01315912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665921|NCT01315938|Abatacept|abatacept|mesh-list
24665922|NCT01315938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24665923|NCT01315938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665924|NCT01315938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665925|NCT01315938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24665926|NCT01315938|Immunologic Factors|immunologic factors|mesh-ancestor
24665927|NCT01315938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665929|NCT01315951|Petrolatum|petrolatum|mesh-list
24665930|NCT01315951|Emollients|emollients|mesh-ancestor
24935680|NCT04048200|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24935681|NCT04048200|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24935682|NCT04048200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24935687|NCT04048200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24935688|NCT04048200|Anesthetics, General|anesthetics, general|mesh-ancestor
24935689|NCT04048200|Anesthetics|anesthetics|mesh-ancestor
24935690|NCT04048200|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24935691|NCT04048200|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24935692|NCT04048200|Narcotics|narcotics|mesh-ancestor
24935693|NCT04048200|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24935694|NCT04048070|Flurbiprofen|flurbiprofen|mesh-list
25704272|NCT02178800|Antiviral Agents|antiviral agents|mesh-ancestor
25704273|NCT02178800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25704274|NCT02178995|Methylphenidate|methylphenidate|mesh-list
25704275|NCT02178995|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25704276|NCT02178995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704277|NCT02178995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25704278|NCT02178995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24455704|NCT00328718|Respiratory System Agents|respiratory system agents|mesh-ancestor
24935695|NCT04048070|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
24935697|NCT04048070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24935698|NCT04048070|Narcotics|narcotics|mesh-ancestor
24935699|NCT04048070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24935700|NCT04048070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665931|NCT01315951|Dermatologic Agents|dermatologic agents|mesh-ancestor
24665932|NCT01315990|Cetuximab|cetuximab|mesh-list
24665933|NCT01315990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24665934|NCT01315990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665944|NCT01316068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665945|NCT01316081|Vitamins|vitamins|mesh-list
24665946|NCT01316081|Ascorbic Acid|ascorbic acid|mesh-list
24665947|NCT01316081|Vitamin E|vitamin e|mesh-list
24665948|NCT01316081|Tocopherols|tocopherols|mesh-list
24665949|NCT01316081|Tocotrienols|tocotrienols|mesh-list
24665950|NCT01316081|alpha-Tocopherol|alpha-tocopherol|mesh-list
24665951|NCT01316081|Micronutrients|micronutrients|mesh-ancestor
24665961|NCT01316107|Ipragliflozin|ipragliflozin|mesh-list
24665962|NCT01316107|Nateglinide|nateglinide|mesh-list
24665963|NCT01316107|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24665964|NCT01316107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665965|NCT01316107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24665966|NCT01316107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665967|NCT01316133|Tacrolimus|tacrolimus|mesh-list
24665978|NCT01316445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665979|NCT01316445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24665980|NCT01316445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24665981|NCT01316445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24935701|NCT04048070|Analgesics|analgesics|mesh-ancestor
24935702|NCT04048070|Sensory System Agents|sensory system agents|mesh-ancestor
24935703|NCT04048070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24935704|NCT04048070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24935705|NCT04048070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24935706|NCT04048070|Anesthetics, General|anesthetics, general|mesh-ancestor
24935707|NCT04048070|Anesthetics|anesthetics|mesh-ancestor
24935708|NCT04048070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24935709|NCT04048070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24935710|NCT04048070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24935711|NCT04048070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24935712|NCT04048070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24935713|NCT04048070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935714|NCT04048070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935715|NCT04047654|Anticoagulants|anticoagulants|mesh-list
24935717|NCT04047706|Temozolomide|temozolomide|mesh-list
24935719|NCT04047706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24935720|NCT04047706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935721|NCT04047706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24666018|NCT01316744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666019|NCT01316757|Paclitaxel|paclitaxel|mesh-list
24666020|NCT01316757|Carboplatin|carboplatin|mesh-list
24666021|NCT01316757|Cetuximab|cetuximab|mesh-list
24666022|NCT01316757|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24666023|NCT01316757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24666024|NCT01316757|Antibodies|antibodies|mesh-list
24666025|NCT01316757|Immunoglobulins|immunoglobulins|mesh-list
24666026|NCT01316757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24666027|NCT01316757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24666028|NCT01316757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24666029|NCT01316757|Tubulin Modulators|tubulin modulators|mesh-ancestor
24666030|NCT01316757|Antimitotic Agents|antimitotic agents|mesh-ancestor
24666031|NCT01316757|Mitosis Modulators|mitosis modulators|mesh-ancestor
24666032|NCT01316757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666033|NCT01316757|Immunologic Factors|immunologic factors|mesh-ancestor
24666034|NCT01316757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666035|NCT01316757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24935725|NCT04047706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935726|NCT04047940|Metformin|metformin|mesh-list
24935727|NCT04047940|Valsartan|valsartan|mesh-list
24935728|NCT04047940|Atorvastatin|atorvastatin|mesh-list
25704279|NCT02178995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24935735|NCT04047940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24935740|NCT04047940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24935741|NCT04047758|Letrozole|letrozole|mesh-list
24935742|NCT04047758|Palbociclib|palbociclib|mesh-list
24935743|NCT04047758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935744|NCT04047758|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24666036|NCT01316757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666037|NCT01316861|Acarbose|acarbose|mesh-list
24666038|NCT01316861|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24666039|NCT01316861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666040|NCT01316861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666041|NCT01316861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24666042|NCT01316861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666043|NCT01316874|Valrubicin|valrubicin|mesh-list
24666044|NCT01316874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24666145|NCT01317589|Antitussive Agents|antitussive agents|mesh-ancestor
24935746|NCT04047758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935747|NCT04047758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935754|NCT04047849|Amoxicillin|amoxicillin|mesh-list
24935755|NCT04047849|Azithromycin|azithromycin|mesh-list
24935756|NCT04047849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24935757|NCT04047914|Mupirocin|mupirocin|mesh-list
24935758|NCT04047914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24935759|NCT04047914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24935760|NCT04047914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24935761|NCT04047914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935762|NCT04047914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935763|NCT04047875|Norethindrone|norethindrone|mesh-list
24760300|NCT01757236|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24760323|NCT01757262|Clopidogrel|clopidogrel|mesh-list
24760324|NCT01757262|Ticagrelor|ticagrelor|mesh-list
24760325|NCT01757262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24760326|NCT01757262|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24760327|NCT01757262|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24760328|NCT01757262|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24935764|NCT04047875|Norethindrone Acetate|norethindrone acetate|mesh-list
24935765|NCT04047875|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24935766|NCT04047875|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24935767|NCT04047875|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24935768|NCT04047875|Contraceptive Agents|contraceptive agents|mesh-ancestor
24935769|NCT04047875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24935770|NCT04047875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935771|NCT04047875|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24666065|NCT01316978|Ibuprofen|ibuprofen|mesh-list
24935778|NCT04047745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935779|NCT04047745|Sensory System Agents|sensory system agents|mesh-ancestor
24935780|NCT04047745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24935781|NCT04047680|Ritonavir|ritonavir|mesh-list
24935782|NCT04047680|Sofosbuvir|sofosbuvir|mesh-list
24935783|NCT04047680|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
24666066|NCT01316978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24666067|NCT01316978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24666068|NCT01316978|Analgesics|analgesics|mesh-ancestor
24666069|NCT01316978|Sensory System Agents|sensory system agents|mesh-ancestor
24666070|NCT01316978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24666143|NCT01317589|Anesthetics, General|anesthetics, general|mesh-ancestor
24666144|NCT01317589|Anesthetics|anesthetics|mesh-ancestor
24666146|NCT01317589|Respiratory System Agents|respiratory system agents|mesh-ancestor
24474339|NCT00405717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935787|NCT04047680|Velpatasvir|velpatasvir|mesh-list
24935788|NCT04047680|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
24935789|NCT04047680|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24935790|NCT04047680|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24935791|NCT04047680|Protease Inhibitors|protease inhibitors|mesh-ancestor
24935792|NCT04047680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935793|NCT04047680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935794|NCT04047680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24935795|NCT04047680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24666147|NCT01317784|Antibodies|antibodies|mesh-list
24666148|NCT01317784|Immunoglobulins|immunoglobulins|mesh-list
24666149|NCT01317784|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
24666150|NCT01317784|Immunologic Factors|immunologic factors|mesh-ancestor
24666151|NCT01317784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666152|NCT01317849|Vitamins|vitamins|mesh-list
24666153|NCT01317849|Folic Acid|folic acid|mesh-list
24666154|NCT01317849|Vitamin B 12|vitamin b 12|mesh-list
24666155|NCT01317849|Pyridoxine|pyridoxine|mesh-list
24666158|NCT01317849|Vitamin B Complex|vitamin b complex|mesh-list
24666159|NCT01317849|Micronutrients|micronutrients|mesh-ancestor
24666160|NCT01317849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666161|NCT01317849|Hematinics|hematinics|mesh-ancestor
24666162|NCT01317927|Belinostat|belinostat|mesh-list
24666163|NCT01317927|Warfarin|warfarin|mesh-list
24666164|NCT01317927|Anticoagulants|anticoagulants|mesh-ancestor
24453070|NCT05309629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24666165|NCT01317927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24666166|NCT01317927|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24666168|NCT01317927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666169|NCT01317953|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24666170|NCT01317953|Antioxidants|antioxidants|mesh-ancestor
24666171|NCT01317953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666172|NCT01317953|Protective Agents|protective agents|mesh-ancestor
24452185|NCT00326352|Anesthetics|anesthetics|mesh-ancestor
24666173|NCT01317953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666174|NCT01317953|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24666175|NCT01317953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24666176|NCT01317953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24666177|NCT01317953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24666178|NCT01317966|Rituximab|rituximab|mesh-list
24666179|NCT01317966|Oprelvekin|oprelvekin|mesh-list
24666189|NCT01317992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666306|NCT01318369|Anesthetics|anesthetics|mesh-ancestor
24666190|NCT01317992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24666202|NCT01318005|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24404673|NCT00164424|Acyclovir|acyclovir|mesh-list
24935796|NCT04047680|Antiviral Agents|antiviral agents|mesh-ancestor
24935797|NCT04047680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24935798|NCT04047680|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24935799|NCT04047680|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24935801|NCT04047576|Prednisone|prednisone|mesh-list
24935802|NCT04047576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24935803|NCT04047576|Glucocorticoids|glucocorticoids|mesh-ancestor
24935804|NCT04047576|Hormones|hormones|mesh-ancestor
24935809|NCT04047576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24935810|NCT04047576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24935811|NCT04047576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24935812|NCT04047576|Antifungal Agents|antifungal agents|mesh-ancestor
24935815|NCT04047797|Rituximab|rituximab|mesh-list
24935824|NCT04047797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935825|NCT04047797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25075928|NCT03377257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24849538|NCT02249013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24666253|NCT01318161|Anesthetics, Local|anesthetics, local|mesh-ancestor
24666255|NCT01318187|Acetaminophen|acetaminophen|mesh-list
24666256|NCT01318187|Morphine|morphine|mesh-list
24666257|NCT01318187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24666258|NCT01318187|Narcotics|narcotics|mesh-ancestor
24666259|NCT01318187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24666269|NCT01318265|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24666270|NCT01318265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24666271|NCT01318265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666272|NCT01318265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666273|NCT01318265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24666274|NCT01318265|Hormone Antagonists|hormone antagonists|mesh-ancestor
24666276|NCT01318265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666300|NCT01318369|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24666301|NCT01318369|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24666302|NCT01318369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24666303|NCT01318369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24666304|NCT01318369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24666305|NCT01318369|Anesthetics, General|anesthetics, general|mesh-ancestor
24935826|NCT04047797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935827|NCT04047797|Protease Inhibitors|protease inhibitors|mesh-ancestor
24935828|NCT04047797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935830|NCT04047797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24935831|NCT04047329|Anesthetics|anesthetics|mesh-list
24416692|NCT00203775|Serotonin Agents|serotonin agents|mesh-ancestor
24935832|NCT04047329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24935833|NCT04047329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935834|NCT04047394|Rasburicase|rasburicase|mesh-list
24935835|NCT04047394|Gout Suppressants|gout suppressants|mesh-ancestor
24935836|NCT04047394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24935837|NCT04047355|Propranolol|propranolol|mesh-list
24935838|NCT04047355|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24849544|NCT02249026|Buprenorphine|buprenorphine|mesh-list
24666309|NCT01318460|Simendan|simendan|mesh-list
24666315|NCT01318460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666318|NCT01318564|Metformin|metformin|mesh-list
24666319|NCT01318564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24666320|NCT01318564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666321|NCT01318590|Triamcinolone|triamcinolone|mesh-list
24666322|NCT01318590|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24666324|NCT01318590|Bupivacaine|bupivacaine|mesh-list
24935840|NCT04047355|Adrenergic Agents|adrenergic agents|mesh-ancestor
24935841|NCT04047355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050109|NCT00540358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25050111|NCT00540358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050112|NCT00540358|Antiviral Agents|antiviral agents|mesh-ancestor
25050113|NCT00540358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25050114|NCT00540358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050115|NCT00540358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25050119|NCT00539721|Ondansetron|ondansetron|mesh-list
24666334|NCT01318590|Hormones|hormones|mesh-ancestor
24666335|NCT01318590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24666336|NCT01318590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24666337|NCT01318590|Immunologic Factors|immunologic factors|mesh-ancestor
24666338|NCT01318590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666339|NCT01318590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666340|NCT01318655|Naloxegol|naloxegol|mesh-list
24666341|NCT01318655|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24666365|NCT01318681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666367|NCT01318837|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24666368|NCT01318837|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24666369|NCT01318837|Cholinergic Agents|cholinergic agents|mesh-ancestor
24666370|NCT01318837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24666371|NCT01318837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666372|NCT01318837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666374|NCT01318928|Metronidazole|metronidazole|mesh-list
24666375|NCT01318928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24666376|NCT01318928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25050128|NCT00539721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25050129|NCT00539721|Serotonin Agents|serotonin agents|mesh-ancestor
25050130|NCT00539721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050131|NCT00539721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050132|NCT00539721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25050133|NCT00539721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25050134|NCT00539721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24666377|NCT01318928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24666378|NCT01318928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24666379|NCT01318941|Ranibizumab|ranibizumab|mesh-list
24666380|NCT01318941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24666381|NCT01318941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24666382|NCT01318941|Growth Substances|growth substances|mesh-ancestor
24666383|NCT01318941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666384|NCT01318941|Growth Inhibitors|growth inhibitors|mesh-ancestor
24666385|NCT01318941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24666387|NCT01319006|Glycine Agents|glycine agents|mesh-ancestor
24666389|NCT01319006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666390|NCT01319006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666391|NCT01319019|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24666392|NCT01319019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24666393|NCT01319019|Autonomic Agents|autonomic agents|mesh-ancestor
24666394|NCT01319019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24666406|NCT01319188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24666408|NCT01319188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666409|NCT01319188|Growth Inhibitors|growth inhibitors|mesh-ancestor
24666410|NCT01319188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24666412|NCT01319214|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24666413|NCT01319214|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24666414|NCT01319214|Adrenergic Agents|adrenergic agents|mesh-ancestor
24666415|NCT01319214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24666416|NCT01319214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666417|NCT01319214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050143|NCT00537043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050144|NCT00537043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050145|NCT00537043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25050146|NCT00537043|Antioxidants|antioxidants|mesh-ancestor
25050147|NCT00537043|Protective Agents|protective agents|mesh-ancestor
24952239|NCT03895892|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24952240|NCT03895892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952241|NCT03895892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952242|NCT03895892|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24952243|NCT03895892|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24952244|NCT03895892|Purinergic Agents|purinergic agents|mesh-ancestor
24952253|NCT03896217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952254|NCT03895788|Niraparib|niraparib|mesh-list
24952255|NCT03895788|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24952256|NCT03895788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952257|NCT03895788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935842|NCT04047355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935843|NCT04047355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935844|NCT04047355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24935845|NCT04047355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24935846|NCT04047355|Vasodilator Agents|vasodilator agents|mesh-ancestor
24666448|NCT01319279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24666449|NCT01319279|Antitussive Agents|antitussive agents|mesh-ancestor
24666450|NCT01319279|Respiratory System Agents|respiratory system agents|mesh-ancestor
24666451|NCT01319331|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
24666452|NCT01319331|Protein C Inhibitor|protein c inhibitor|mesh-list
24666453|NCT01319331|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24666454|NCT01319331|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24666455|NCT01319331|Protease Inhibitors|protease inhibitors|mesh-ancestor
24666502|NCT01319461|Hyaluronic Acid|hyaluronic acid|mesh-list
24666503|NCT01319461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24666504|NCT01319461|Immunologic Factors|immunologic factors|mesh-ancestor
24666505|NCT01319461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666512|NCT01319682|Anesthetics|anesthetics|mesh-ancestor
24666513|NCT01319682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24666514|NCT01319682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666515|NCT01319682|Sensory System Agents|sensory system agents|mesh-ancestor
24666516|NCT01319682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24666524|NCT01319695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24666525|NCT01319695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666528|NCT01319734|Vitamins|vitamins|mesh-ancestor
24666529|NCT01319734|Micronutrients|micronutrients|mesh-ancestor
25704280|NCT02178995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704281|NCT02178995|Dopamine Agents|dopamine agents|mesh-ancestor
25704282|NCT02178995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25704283|NCT02179177|Apixaban|apixaban|mesh-list
25704284|NCT02179177|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25704285|NCT02179177|Antithrombins|antithrombins|mesh-ancestor
25704286|NCT02179177|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24666530|NCT01319734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456108|NCT00330018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24666532|NCT01319734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666533|NCT01319734|Protective Agents|protective agents|mesh-ancestor
24666534|NCT01319734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24666536|NCT01319825|Levomilnacipran|levomilnacipran|mesh-list
24666537|NCT01319825|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24666538|NCT01319825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24666539|NCT01319825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24666540|NCT01319825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666541|NCT01319825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24666542|NCT01319825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666543|NCT01319825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24666544|NCT01319825|Analgesics|analgesics|mesh-ancestor
24666669|NCT01320436|Aminosalicylic Acid|aminosalicylic acid|mesh-list
24666671|NCT01320436|Mesalamine|mesalamine|mesh-list
24666672|NCT01320436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24666673|NCT01320436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24666692|NCT01320475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24666693|NCT01320475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666694|NCT01320475|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24666695|NCT01320475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24666696|NCT01320475|Anesthetics, General|anesthetics, general|mesh-ancestor
24666697|NCT01320475|Anesthetics|anesthetics|mesh-ancestor
24666698|NCT01320475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24666699|NCT01320475|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24935923|NCT04046679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935924|NCT04046029|Heparin|heparin|mesh-list
24935925|NCT04046029|Bivalirudin|bivalirudin|mesh-list
24935926|NCT04046029|Anticoagulants|anticoagulants|mesh-ancestor
24935927|NCT04046029|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24935928|NCT04046029|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24800378|NCT01975324|4-Aminopyridine|4-aminopyridine|mesh-list
24935929|NCT04046029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666700|NCT01320475|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24666701|NCT01320475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24666702|NCT01320475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666703|NCT01320475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24666704|NCT01320475|Narcotics|narcotics|mesh-ancestor
24666705|NCT01320475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24666706|NCT01320501|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24666707|NCT01320501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24666708|NCT01320501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24666709|NCT01320501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666710|NCT01320501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666711|NCT01320514|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24666742|NCT01320709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666744|NCT01320878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24666745|NCT01320878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24666746|NCT01320878|Vasodilator Agents|vasodilator agents|mesh-ancestor
24666747|NCT01320917|Levonorgestrel|levonorgestrel|mesh-list
24666748|NCT01320917|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24666749|NCT01320917|Contraceptive Agents|contraceptive agents|mesh-ancestor
24666750|NCT01320917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24666751|NCT01320917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666752|NCT01320917|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24666753|NCT01320917|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24666754|NCT01320917|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24666768|NCT01320982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666769|NCT01320982|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24666770|NCT01320982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24666771|NCT01320982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666772|NCT01320982|Antipyretics|antipyretics|mesh-ancestor
25704287|NCT02179177|Protease Inhibitors|protease inhibitors|mesh-ancestor
25704288|NCT02179177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935934|NCT04046016|Paclitaxel|paclitaxel|mesh-list
24935935|NCT04046016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24935936|NCT04046016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24666796|NCT01321021|Sensory System Agents|sensory system agents|mesh-ancestor
24666797|NCT01321021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24666798|NCT01321021|Antiemetics|antiemetics|mesh-ancestor
24666799|NCT01321021|Autonomic Agents|autonomic agents|mesh-ancestor
24666801|NCT01321021|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24666802|NCT01321021|Histamine Antagonists|histamine antagonists|mesh-ancestor
24666803|NCT01321021|Histamine Agents|histamine agents|mesh-ancestor
24666811|NCT01321034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666812|NCT01321034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24666813|NCT01321034|Vasodilator Agents|vasodilator agents|mesh-ancestor
24666814|NCT01321034|Vitamin B Complex|vitamin b complex|mesh-ancestor
24666816|NCT01321034|Micronutrients|micronutrients|mesh-ancestor
24666817|NCT01321034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666818|NCT01321047|Propofol|propofol|mesh-list
24666819|NCT01321047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24666820|NCT01321047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24666821|NCT01321047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666822|NCT01321047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24666823|NCT01321047|Anesthetics, General|anesthetics, general|mesh-ancestor
24666824|NCT01321047|Anesthetics|anesthetics|mesh-ancestor
24666825|NCT01321099|Ascorbic Acid|ascorbic acid|mesh-list
24666826|NCT01321099|Fe(III)-EDTA|fe(iii)-edta|mesh-list
24666827|NCT01321099|Vitamins|vitamins|mesh-ancestor
24666828|NCT01321099|Micronutrients|micronutrients|mesh-ancestor
24666829|NCT01321099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666830|NCT01321099|Antioxidants|antioxidants|mesh-ancestor
24666831|NCT01321099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666832|NCT01321099|Protective Agents|protective agents|mesh-ancestor
24666833|NCT01321099|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24666834|NCT01321099|Chelating Agents|chelating agents|mesh-ancestor
24666835|NCT01321099|Sequestering Agents|sequestering agents|mesh-ancestor
24666851|NCT01321138|Analgesics|analgesics|mesh-ancestor
24666857|NCT01321255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24666858|NCT01321255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24666859|NCT01321255|Analgesics|analgesics|mesh-ancestor
24666860|NCT01321255|Sensory System Agents|sensory system agents|mesh-ancestor
24456142|NCT00330252|Rituximab|rituximab|mesh-list
24666868|NCT01321255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24666869|NCT01321255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24666870|NCT01321255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666872|NCT01321255|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24666873|NCT01321255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24666874|NCT01321255|Antimetabolites|antimetabolites|mesh-ancestor
24666875|NCT01321255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24935937|NCT04046016|Tubulin Modulators|tubulin modulators|mesh-ancestor
24935938|NCT04046016|Antimitotic Agents|antimitotic agents|mesh-ancestor
24935939|NCT04046016|Mitosis Modulators|mitosis modulators|mesh-ancestor
24935940|NCT04046016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935941|NCT04046289|Calcium, Dietary|calcium, dietary|mesh-list
24935942|NCT04046289|Calcium Carbonate|calcium carbonate|mesh-list
24935943|NCT04046289|Calcium|calcium|mesh-list
24935944|NCT04046289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24935945|NCT04046289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935946|NCT04046289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24935947|NCT04046289|Antacids|antacids|mesh-ancestor
24935948|NCT04046289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935949|NCT04046289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24935950|NCT04046133|Pembrolizumab|pembrolizumab|mesh-list
24935951|NCT04046133|Capecitabine|capecitabine|mesh-list
24935952|NCT04046133|Mitomycins|mitomycins|mesh-list
24935953|NCT04046133|Mitomycin|mitomycin|mesh-list
24935954|NCT04046133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24935955|NCT04046133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935956|NCT04046133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24935957|NCT04046133|Antimetabolites|antimetabolites|mesh-ancestor
24849705|NCT02249741|Ibandronic Acid|ibandronic acid|mesh-list
24849706|NCT02249741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24849707|NCT02249741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849708|NCT02249780|Parathyroid Hormone|parathyroid hormone|mesh-list
24849709|NCT02249780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24666878|NCT01321255|Protease Inhibitors|protease inhibitors|mesh-ancestor
24666879|NCT01321255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24666880|NCT01321268|Beta Carotene|beta carotene|mesh-list
24666881|NCT01321268|Lycopene|lycopene|mesh-list
24666882|NCT01321268|Resveratrol|resveratrol|mesh-list
24666886|NCT01321268|Protective Agents|protective agents|mesh-ancestor
24666887|NCT01321268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666888|NCT01321268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666889|NCT01321268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24935958|NCT04046133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935959|NCT04046133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24935960|NCT04046133|Alkylating Agents|alkylating agents|mesh-ancestor
24935961|NCT04046133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25704289|NCT02179177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704290|NCT02179177|Anticoagulants|anticoagulants|mesh-ancestor
25704291|NCT02179671|Docetaxel|docetaxel|mesh-list
25704292|NCT02179671|Gefitinib|gefitinib|mesh-list
25704293|NCT02179671|Tremelimumab|tremelimumab|mesh-list
25704294|NCT02179671|Osimertinib|osimertinib|mesh-list
25704295|NCT02179671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935964|NCT04046302|Oxytocics|oxytocics|mesh-ancestor
24935965|NCT04046302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24453169|NCT05238831|Irinotecan|irinotecan|mesh-list
24935966|NCT04046302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935967|NCT04045678|Rotigotine|rotigotine|mesh-list
24935968|NCT04045678|Dopamine Agonists|dopamine agonists|mesh-ancestor
24666895|NCT01321268|Vitamins|vitamins|mesh-ancestor
24666896|NCT01321268|Micronutrients|micronutrients|mesh-ancestor
24666897|NCT01321346|Cytarabine|cytarabine|mesh-list
24666898|NCT01321346|Panobinostat|panobinostat|mesh-list
24666899|NCT01321346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24666900|NCT01321346|Antimetabolites|antimetabolites|mesh-ancestor
24666901|NCT01321346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666902|NCT01321346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24666903|NCT01321346|Antiviral Agents|antiviral agents|mesh-ancestor
24666911|NCT01321489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666912|NCT01321489|Vasodilator Agents|vasodilator agents|mesh-ancestor
24666913|NCT01321489|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24666914|NCT01321489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24666915|NCT01321489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666916|NCT01321489|Urological Agents|urological agents|mesh-ancestor
24666917|NCT01321502|Famciclovir|famciclovir|mesh-list
24666918|NCT01321502|Antiviral Agents|antiviral agents|mesh-ancestor
24666919|NCT01321502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24666920|NCT01321502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24666921|NCT01321502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666922|NCT01321502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666923|NCT01321515|Famciclovir|famciclovir|mesh-list
24666924|NCT01321515|Antiviral Agents|antiviral agents|mesh-ancestor
24666925|NCT01321515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24666926|NCT01321515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24666927|NCT01321515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666928|NCT01321515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666929|NCT01321567|Rabeprazole|rabeprazole|mesh-list
24666930|NCT01321567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24666931|NCT01321567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24666932|NCT01321567|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24666933|NCT01321567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666934|NCT01321567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935969|NCT04045678|Dopamine Agents|dopamine agents|mesh-ancestor
24935970|NCT04045678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24935979|NCT04045769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666937|NCT01321671|Sensory System Agents|sensory system agents|mesh-ancestor
24666938|NCT01321671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24666939|NCT01321671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666940|NCT01321671|Anticonvulsants|anticonvulsants|mesh-ancestor
24666941|NCT01321671|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24666942|NCT01321671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24666943|NCT01321671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666953|NCT01321775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24666955|NCT01321775|Tubulin Modulators|tubulin modulators|mesh-ancestor
24666956|NCT01321775|Antimitotic Agents|antimitotic agents|mesh-ancestor
24666957|NCT01321775|Mitosis Modulators|mitosis modulators|mesh-ancestor
24666958|NCT01321775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666959|NCT01321775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24666960|NCT01321775|Immunologic Factors|immunologic factors|mesh-ancestor
24666961|NCT01321775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666962|NCT01321775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24666963|NCT01321775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24667148|NCT01322477|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24666964|NCT01321775|Alkylating Agents|alkylating agents|mesh-ancestor
24666968|NCT01321775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24666969|NCT01321775|Growth Substances|growth substances|mesh-ancestor
24666979|NCT01321801|Analgesics|analgesics|mesh-ancestor
24666980|NCT01321801|Sensory System Agents|sensory system agents|mesh-ancestor
24666981|NCT01321801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24666982|NCT01321801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666983|NCT01321801|Anticonvulsants|anticonvulsants|mesh-ancestor
24666984|NCT01321801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24935981|NCT04045730|Gemcitabine|gemcitabine|mesh-list
24935982|NCT04045730|Paclitaxel|paclitaxel|mesh-list
24935983|NCT04045730|Pembrolizumab|pembrolizumab|mesh-list
24935984|NCT04045730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24935985|NCT04045730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935986|NCT04045730|Tubulin Modulators|tubulin modulators|mesh-ancestor
24935987|NCT04045730|Antimitotic Agents|antimitotic agents|mesh-ancestor
24935988|NCT04045730|Mitosis Modulators|mitosis modulators|mesh-ancestor
24935989|NCT04045730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935990|NCT04045730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24935991|NCT04045730|Antimetabolites|antimetabolites|mesh-ancestor
24935992|NCT04045730|Antiviral Agents|antiviral agents|mesh-ancestor
24849749|NCT02250209|Capecitabine|capecitabine|mesh-list
24666985|NCT01321801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24666986|NCT01321801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666987|NCT01321801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24666988|NCT01321801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24666989|NCT01321801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24666990|NCT01321801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24666991|NCT01321801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24666992|NCT01321827|Itraconazole|itraconazole|mesh-list
24666993|NCT01321827|Prednisolone|prednisolone|mesh-list
24667001|NCT01321827|Antifungal Agents|antifungal agents|mesh-ancestor
24667002|NCT01321827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24667003|NCT01321827|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24667004|NCT01321827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24667005|NCT01321827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24667006|NCT01321827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24667007|NCT01321827|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24667008|NCT01321827|Hormone Antagonists|hormone antagonists|mesh-ancestor
24667009|NCT01321827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24667010|NCT01321905|Vitamin D|vitamin d|mesh-list
24667011|NCT01321905|Ergocalciferols|ergocalciferols|mesh-list
24667012|NCT01321905|Vitamins|vitamins|mesh-ancestor
24667013|NCT01321905|Micronutrients|micronutrients|mesh-ancestor
24667014|NCT01321905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667015|NCT01321905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24667016|NCT01321905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24667017|NCT01321931|Nicotine|nicotine|mesh-list
24667018|NCT01321931|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24667019|NCT01321931|Autonomic Agents|autonomic agents|mesh-ancestor
24667027|NCT01321944|Nicotine|nicotine|mesh-list
24667045|NCT01321957|Growth Substances|growth substances|mesh-ancestor
24760453|NCT01758120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24935993|NCT04045730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24667049|NCT01321957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24667050|NCT01321957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24667084|NCT01322139|Sensory System Agents|sensory system agents|mesh-ancestor
24667085|NCT01322139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24667087|NCT01322152|Irinotecan|irinotecan|mesh-list
24667088|NCT01322152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24667089|NCT01322152|Antimetabolites|antimetabolites|mesh-ancestor
24667090|NCT01322152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24667091|NCT01322152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24667092|NCT01322152|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24667093|NCT01322152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24667094|NCT01322152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24667095|NCT01322178|Cetuximab|cetuximab|mesh-list
24667096|NCT01322178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24667097|NCT01322178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25704296|NCT02179671|Tubulin Modulators|tubulin modulators|mesh-ancestor
25704297|NCT02179671|Antimitotic Agents|antimitotic agents|mesh-ancestor
25704298|NCT02179671|Mitosis Modulators|mitosis modulators|mesh-ancestor
25704299|NCT02179671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704300|NCT02179671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25704301|NCT02179671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25704302|NCT02179788|Metformin|metformin|mesh-list
25704303|NCT02179788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25704304|NCT02179788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704305|NCT02179892|Acetaminophen|acetaminophen|mesh-list
25704306|NCT02179892|Dexamethasone|dexamethasone|mesh-list
25704307|NCT02179892|Dexamethasone acetate|dexamethasone acetate|mesh-list
25704308|NCT02179892|Bupivacaine|bupivacaine|mesh-list
25704309|NCT02179892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25704310|NCT02179892|Antiemetics|antiemetics|mesh-ancestor
25704311|NCT02179892|Autonomic Agents|autonomic agents|mesh-ancestor
25704312|NCT02179892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25704313|NCT02179892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704314|NCT02179892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25704315|NCT02179892|Glucocorticoids|glucocorticoids|mesh-ancestor
25704316|NCT02179892|Hormones|hormones|mesh-ancestor
24667133|NCT01322438|Leprostatic Agents|leprostatic agents|mesh-ancestor
24667134|NCT01322438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24667135|NCT01322438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24667136|NCT01322438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24667137|NCT01322438|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24667138|NCT01322438|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24667139|NCT01322438|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24667140|NCT01322438|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24667141|NCT01322438|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24935994|NCT04045730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935995|NCT04045730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24935996|NCT04045730|Immunologic Factors|immunologic factors|mesh-ancestor
24935997|NCT04045730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935998|NCT04045730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24936001|NCT04045821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24936002|NCT04045821|Antiviral Agents|antiviral agents|mesh-ancestor
24936003|NCT04045821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24936004|NCT04045548|Dinoprostone|dinoprostone|mesh-list
24667142|NCT01322438|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24667143|NCT01322464|Nabiximols|nabiximols|mesh-list
24667144|NCT01322464|Analgesics|analgesics|mesh-ancestor
24667145|NCT01322464|Sensory System Agents|sensory system agents|mesh-ancestor
24667146|NCT01322464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24667147|NCT01322464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667149|NCT01322477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24667150|NCT01322477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24667151|NCT01322711|Atorvastatin|atorvastatin|mesh-list
24667152|NCT01322711|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24667153|NCT01322711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24667154|NCT01322711|Antimetabolites|antimetabolites|mesh-ancestor
24667155|NCT01322711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24667156|NCT01322711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24667159|NCT01322776|Cyclophosphamide|cyclophosphamide|mesh-list
24667160|NCT01322776|Fludarabine|fludarabine|mesh-list
24667162|NCT01322776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24667163|NCT01322776|Immunologic Factors|immunologic factors|mesh-ancestor
24667164|NCT01322776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667165|NCT01322776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24667166|NCT01322776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24667167|NCT01322776|Alkylating Agents|alkylating agents|mesh-ancestor
24667168|NCT01322776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24667169|NCT01322776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24667170|NCT01322776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24667171|NCT01322867|Alprazolam|alprazolam|mesh-list
24667172|NCT01322867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24667173|NCT01322867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24667174|NCT01322867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667175|NCT01322867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24667207|NCT05461053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704317|NCT02179892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25704318|NCT02179892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25704319|NCT02179892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25704320|NCT02179892|Anesthetics, Local|anesthetics, local|mesh-ancestor
25704321|NCT02179892|Anesthetics|anesthetics|mesh-ancestor
25704322|NCT02179892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25704323|NCT02179892|Sensory System Agents|sensory system agents|mesh-ancestor
24936023|NCT04046159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849771|NCT02250534|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24667222|NCT05460858|Acetylcysteine|acetylcysteine|mesh-list
24667223|NCT05460858|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24667224|NCT05460858|Antiviral Agents|antiviral agents|mesh-ancestor
24667225|NCT05460858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24667255|NCT05460377|Immunologic Factors|immunologic factors|mesh-ancestor
24667256|NCT05460377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667264|NCT05460195|Immunologic Factors|immunologic factors|mesh-list
24667265|NCT05460195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667266|NCT05459974|Colchicine|colchicine|mesh-list
24453251|NCT05210621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667268|NCT05459974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24667269|NCT05459974|Tubulin Modulators|tubulin modulators|mesh-ancestor
24667270|NCT05459974|Antimitotic Agents|antimitotic agents|mesh-ancestor
24667271|NCT05459974|Mitosis Modulators|mitosis modulators|mesh-ancestor
24667272|NCT05459974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24667273|NCT05459974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24667274|NCT05459857|Menthol|menthol|mesh-list
24936024|NCT04046159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24936025|NCT04046159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24936026|NCT04046159|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24936027|NCT04046159|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24936028|NCT04046159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24936030|NCT04045431|Viscosupplements|viscosupplements|mesh-ancestor
24936031|NCT04045431|Protective Agents|protective agents|mesh-ancestor
24453252|NCT05198960|Aspirin|aspirin|mesh-list
24453253|NCT05198960|Anticoagulants|anticoagulants|mesh-list
24453254|NCT05198960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24453255|NCT05198960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24453256|NCT05198960|Analgesics|analgesics|mesh-ancestor
25704324|NCT02179892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25704325|NCT02179892|Analgesics|analgesics|mesh-ancestor
25704326|NCT02179892|Antipyretics|antipyretics|mesh-ancestor
25704327|NCT02179918|Pembrolizumab|pembrolizumab|mesh-list
25704328|NCT02179918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25704329|NCT02179918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25704330|NCT02180061|Pembrolizumab|pembrolizumab|mesh-list
25704331|NCT02180061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24667310|NCT05459649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24667311|NCT05459649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24667312|NCT05459649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24667313|NCT05459649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24667314|NCT05459649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24667315|NCT05459649|Immunologic Factors|immunologic factors|mesh-ancestor
24667316|NCT05459649|Antifungal Agents|antifungal agents|mesh-ancestor
24667317|NCT05459649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24667377|NCT05455697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24667378|NCT05455697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24667379|NCT05455697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24667382|NCT05455697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24667383|NCT05455697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24667386|NCT05455697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24667387|NCT05455697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24667388|NCT05455697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24667389|NCT05455697|Tubulin Modulators|tubulin modulators|mesh-ancestor
24667390|NCT05455697|Antimitotic Agents|antimitotic agents|mesh-ancestor
24667391|NCT05455697|Mitosis Modulators|mitosis modulators|mesh-ancestor
24667637|NCT05352815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24936065|NCT04044378|Ifosfamide|ifosfamide|mesh-list
24936066|NCT04044378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24936067|NCT04044378|Alkylating Agents|alkylating agents|mesh-ancestor
24936068|NCT04044378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936069|NCT04044378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24760600|NCT01758913|Sensory System Agents|sensory system agents|mesh-ancestor
24760601|NCT01758913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24760602|NCT01758913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760604|NCT01758913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24760605|NCT01758913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24636686|NCT01146977|Cytarabine|cytarabine|mesh-list
24625491|NCT01082276|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24625492|NCT01082276|Adrenergic Agents|adrenergic agents|mesh-ancestor
24625493|NCT01082276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24474341|NCT00405730|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25704332|NCT02180061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25704333|NCT02180100|Fluconazole|fluconazole|mesh-list
25704334|NCT02180100|Terconazole|terconazole|mesh-list
25704335|NCT02180100|Antifungal Agents|antifungal agents|mesh-ancestor
25704336|NCT02180100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25704337|NCT02180100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25704338|NCT02180100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25704339|NCT02180100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25704340|NCT02180100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050168|NCT00535366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25050169|NCT00535366|Cholinergic Agents|cholinergic agents|mesh-ancestor
25050170|NCT00535366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050172|NCT00535366|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25050173|NCT00535366|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25050174|NCT00535366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24667626|NCT05359224|Clopidogrel|clopidogrel|mesh-list
24667627|NCT05359224|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24667628|NCT05359224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24667629|NCT05359224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24667630|NCT05359224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24667632|NCT05359224|Purinergic Agents|purinergic agents|mesh-ancestor
24667633|NCT05359224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24667634|NCT05359224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24667635|NCT05359224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050178|NCT00535366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24952498|NCT03893591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24952499|NCT03893591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24952500|NCT03893591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952501|NCT03893864|Ubiquinone|ubiquinone|mesh-list
24952502|NCT03893864|Coenzyme Q10|coenzyme q10|mesh-list
24667684|NCT05327296|Isoflurane|isoflurane|mesh-list
24667826|NCT05275907|Amlodipine|amlodipine|mesh-list
24667827|NCT05275907|Chlorthalidone|chlorthalidone|mesh-list
24667838|NCT05274633|Ravulizumab|ravulizumab|mesh-list
24667839|NCT05274633|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24667840|NCT05274633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24667841|NCT05274633|Immunologic Factors|immunologic factors|mesh-ancestor
24667870|NCT05261516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24667874|NCT05261516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24625499|NCT01082276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24625501|NCT01082289|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
24625502|NCT01082289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24625503|NCT01082289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24667917|NCT05247619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24667918|NCT05247619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24667919|NCT05247619|Tubulin Modulators|tubulin modulators|mesh-ancestor
24667920|NCT05247619|Antimitotic Agents|antimitotic agents|mesh-ancestor
24667921|NCT05247619|Mitosis Modulators|mitosis modulators|mesh-ancestor
24667922|NCT05247619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24667923|NCT05247619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24667930|NCT05242484|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24667932|NCT05242484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24667933|NCT05242484|Immunologic Factors|immunologic factors|mesh-ancestor
24667972|NCT05200884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667973|NCT05200884|Sensory System Agents|sensory system agents|mesh-ancestor
24667974|NCT05200884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24667975|NCT05200884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24667976|NCT05200884|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24667977|NCT05200884|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24667978|NCT05200884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24667979|NCT05200884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24668022|NCT05163496|Psilocybin|psilocybin|mesh-list
24668023|NCT05163496|Hallucinogens|hallucinogens|mesh-ancestor
24668024|NCT05163496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24668025|NCT05163496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24625511|NCT01082289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24625512|NCT01082289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625513|NCT01082289|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24625514|NCT01082289|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24625515|NCT01082289|Serotonin Agents|serotonin agents|mesh-ancestor
24637327|NCT01149902|Tubulin Modulators|tubulin modulators|mesh-ancestor
24625516|NCT01082289|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24625517|NCT01082289|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24812017|NCT02049268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812018|NCT02049268|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24812019|NCT02049268|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24812020|NCT02049268|Cholinergic Agents|cholinergic agents|mesh-ancestor
24812021|NCT02049268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24812022|NCT02049268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812023|NCT02049268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24812024|NCT02049268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24812025|NCT02049268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24812027|NCT02049294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25704342|NCT02180100|Hormone Antagonists|hormone antagonists|mesh-ancestor
25704343|NCT02180100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25704344|NCT02180100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704345|NCT02180100|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25704346|NCT02180100|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25704347|NCT02180165|Voriconazole|voriconazole|mesh-list
24668162|NCT05069896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24668163|NCT05069896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24668172|NCT05050305|Dexamethasone|dexamethasone|mesh-list
24668173|NCT05050305|Pomalidomide|pomalidomide|mesh-list
24668174|NCT05050305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24668175|NCT05050305|Antiemetics|antiemetics|mesh-ancestor
24668176|NCT05050305|Autonomic Agents|autonomic agents|mesh-ancestor
24668177|NCT05050305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24668178|NCT05050305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24668179|NCT05050305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24668180|NCT05050305|Glucocorticoids|glucocorticoids|mesh-ancestor
24668181|NCT05050305|Hormones|hormones|mesh-ancestor
24668182|NCT05050305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24849865|NCT02250924|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24849866|NCT02250924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24849867|NCT02250924|Purinergic Agents|purinergic agents|mesh-ancestor
24849868|NCT02250924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24849869|NCT02251015|Salicylic Acid|salicylic acid|mesh-list
24643295|NCT01185067|Quercetin|quercetin|mesh-list
24936115|NCT04043897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24936117|NCT04043858|Sympathomimetics|sympathomimetics|mesh-ancestor
24936118|NCT04043858|Autonomic Agents|autonomic agents|mesh-ancestor
24849874|NCT02251041|Tocopherols|tocopherols|mesh-list
24849875|NCT02251041|Vitamin E|vitamin e|mesh-list
24849876|NCT02251041|alpha-Tocopherol|alpha-tocopherol|mesh-list
24668337|NCT04948697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24668338|NCT04948697|Growth Inhibitors|growth inhibitors|mesh-ancestor
24668342|NCT04943341|Triamcinolone|triamcinolone|mesh-list
24668343|NCT04943341|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24668344|NCT04943341|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24668345|NCT04943341|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24668346|NCT04943341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24668347|NCT04943341|Glucocorticoids|glucocorticoids|mesh-ancestor
24668348|NCT04943341|Hormones|hormones|mesh-ancestor
24668356|NCT04936763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24936121|NCT04043858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24936122|NCT04043858|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24936123|NCT04043858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24936124|NCT04043858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24936125|NCT04043858|Adrenergic Agents|adrenergic agents|mesh-ancestor
24936126|NCT04043858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24849881|NCT02251041|Antithrombins|antithrombins|mesh-list
24668440|NCT04918147|Elotuzumab|elotuzumab|mesh-list
24668441|NCT04918147|Famotidine|famotidine|mesh-list
24668442|NCT04918147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24668443|NCT04918147|Glucocorticoids|glucocorticoids|mesh-ancestor
24668444|NCT04918147|Hormones|hormones|mesh-ancestor
24668445|NCT04918147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24668446|NCT04918147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24668451|NCT04918147|Sensory System Agents|sensory system agents|mesh-ancestor
24668452|NCT04918147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24668453|NCT04918147|Antipyretics|antipyretics|mesh-ancestor
24668454|NCT04918147|Antiemetics|antiemetics|mesh-ancestor
24936127|NCT04043858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936131|NCT04044079|Misoprostol|misoprostol|mesh-list
24936132|NCT04044079|Dinoprostone|dinoprostone|mesh-list
24936133|NCT04044079|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24936134|NCT04044079|Abortifacient Agents|abortifacient agents|mesh-ancestor
24936135|NCT04044079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25704350|NCT02180165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25704351|NCT02180165|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25704352|NCT02180165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25704353|NCT02180165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25704354|NCT02180165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704355|NCT02180165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25704356|NCT02180165|Hormone Antagonists|hormone antagonists|mesh-ancestor
24444433|NCT00297960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444435|NCT00297960|Serotonin Agents|serotonin agents|mesh-ancestor
24444436|NCT00297960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24444437|NCT00297960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24444438|NCT00297960|Dopamine Agents|dopamine agents|mesh-ancestor
24444439|NCT00298012|Methotrexate|methotrexate|mesh-list
24444440|NCT00298012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24444441|NCT00298012|Abortifacient Agents|abortifacient agents|mesh-ancestor
24444445|NCT00298012|Antimetabolites|antimetabolites|mesh-ancestor
24936174|NCT04043624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24936176|NCT04043624|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24936177|NCT04043624|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24533530|NCT00644306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24533531|NCT00644306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24533532|NCT00644306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24533533|NCT00644306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24533534|NCT00644306|Growth Substances|growth substances|mesh-ancestor
25704357|NCT02180165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25704358|NCT02180165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704359|NCT02180165|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25704360|NCT02180165|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25704361|NCT02180165|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25704362|NCT02180165|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25704363|NCT02180438|Tenofovir|tenofovir|mesh-list
25704364|NCT02180438|Emtricitabine|emtricitabine|mesh-list
25704365|NCT02180438|Cobicistat|cobicistat|mesh-list
25704366|NCT02180438|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25704367|NCT02180438|Elvitegravir|elvitegravir|mesh-list
25704368|NCT02180438|Antiviral Agents|antiviral agents|mesh-ancestor
24533546|NCT00644319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24533547|NCT00644319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24936193|NCT04043494|Pegaspargase|pegaspargase|mesh-list
24936194|NCT04043494|Vindesine|vindesine|mesh-list
24936195|NCT04043494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24936196|NCT04043494|Immunologic Factors|immunologic factors|mesh-ancestor
24936197|NCT04043494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936198|NCT04043494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24936199|NCT04043494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24936200|NCT04043494|Alkylating Agents|alkylating agents|mesh-ancestor
24849945|NCT02251145|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24849946|NCT02251145|Protease Inhibitors|protease inhibitors|mesh-ancestor
24936201|NCT04043494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936203|NCT04043494|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24936204|NCT04043494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24936205|NCT04043494|Antiemetics|antiemetics|mesh-ancestor
24936206|NCT04043494|Autonomic Agents|autonomic agents|mesh-ancestor
24936207|NCT04043494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24936208|NCT04043494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24936209|NCT04043494|Glucocorticoids|glucocorticoids|mesh-ancestor
24849953|NCT02251145|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24849954|NCT02251145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24849955|NCT02251145|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24849956|NCT02251145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25704369|NCT02180438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25704370|NCT02180438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25704371|NCT02180438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25704372|NCT02180438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25704373|NCT02180438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704374|NCT02180438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25704375|NCT02180438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25704376|NCT02180438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25704377|NCT02180438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25704378|NCT02180438|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25704379|NCT02180659|Buprenorphine|buprenorphine|mesh-list
24936214|NCT04043494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24936215|NCT04043494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24936217|NCT04043494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24936218|NCT04043494|Abortifacient Agents|abortifacient agents|mesh-ancestor
24936219|NCT04043494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24849961|NCT02251158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24849962|NCT02251158|Protease Inhibitors|protease inhibitors|mesh-ancestor
24849963|NCT02251158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24849965|NCT02251158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24533601|NCT00644605|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24533602|NCT00644605|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24533603|NCT00644605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533604|NCT00644605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533605|NCT00644605|Urological Agents|urological agents|mesh-ancestor
24533614|NCT00644618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25704380|NCT02180659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25704381|NCT02180659|Narcotics|narcotics|mesh-ancestor
25704382|NCT02180659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25704383|NCT02180659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704384|NCT02180659|Analgesics|analgesics|mesh-ancestor
25704385|NCT02180659|Sensory System Agents|sensory system agents|mesh-ancestor
25704386|NCT02180659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25704387|NCT02180659|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25704388|NCT02180672|Fluticasone|fluticasone|mesh-list
24936235|NCT04043325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936237|NCT04042948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24936238|NCT04042948|Analgesics|analgesics|mesh-ancestor
24936239|NCT04042948|Sensory System Agents|sensory system agents|mesh-ancestor
24936240|NCT04042948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24936244|NCT04043195|Nivolumab|nivolumab|mesh-list
24936245|NCT04043195|Ipilimumab|ipilimumab|mesh-list
24936246|NCT04043195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24936247|NCT04043195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24936248|NCT04043195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25075932|NCT03377218|Selenium|selenium|mesh-list
24533659|NCT00644735|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25704391|NCT02180672|Autonomic Agents|autonomic agents|mesh-ancestor
25704392|NCT02180672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25704393|NCT02180672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704394|NCT02180672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25704395|NCT02180672|Respiratory System Agents|respiratory system agents|mesh-ancestor
25704396|NCT02180672|Dermatologic Agents|dermatologic agents|mesh-ancestor
25704397|NCT02180672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24760906|NCT01760278|Hormone Antagonists|hormone antagonists|mesh-ancestor
24760907|NCT01760330|Acetaminophen|acetaminophen|mesh-list
24760910|NCT01760330|Sensory System Agents|sensory system agents|mesh-ancestor
24760911|NCT01760330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24760912|NCT01760330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24760914|NCT01760421|Hydroxychloroquine|hydroxychloroquine|mesh-list
24760915|NCT01760421|Antimalarials|antimalarials|mesh-ancestor
24936330|NCT04041843|Apixaban|apixaban|mesh-list
24897690|NCT04423276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24760916|NCT01760421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24760917|NCT01760421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24936345|NCT04041791|Amoxicillin|amoxicillin|mesh-list
24936346|NCT04041791|Gentamicins|gentamicins|mesh-list
24936347|NCT04041791|Ceftriaxone|ceftriaxone|mesh-list
24936348|NCT04041791|Clavulanic Acid|clavulanic acid|mesh-list
24936349|NCT04041791|Clavulanic Acids|clavulanic acids|mesh-list
24936351|NCT04041791|Ampicillin|ampicillin|mesh-list
24474342|NCT00405730|Nepafenac|nepafenac|mesh-list
24936367|NCT04041349|Mitosis Modulators|mitosis modulators|mesh-ancestor
24936368|NCT04041349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936370|NCT04041427|Anthelmintics|anthelmintics|mesh-ancestor
24936371|NCT04041427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24936372|NCT04041427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24936373|NCT04041427|Anticestodal Agents|anticestodal agents|mesh-ancestor
24936374|NCT04041427|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24936375|NCT04041427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24936376|NCT04041427|Tubulin Modulators|tubulin modulators|mesh-ancestor
24936377|NCT04041427|Antimitotic Agents|antimitotic agents|mesh-ancestor
24936378|NCT04041427|Mitosis Modulators|mitosis modulators|mesh-ancestor
24936379|NCT04041427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936380|NCT04041427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449031|NCT00313963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449032|NCT00313963|Anesthetics|anesthetics|mesh-ancestor
24449033|NCT00313963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25704406|NCT02180828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704407|NCT02180828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25704408|NCT02180828|Hormone Antagonists|hormone antagonists|mesh-ancestor
25704409|NCT02180828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25704410|NCT02180828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704411|NCT02180828|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24936382|NCT04041167|Antioxidants|antioxidants|mesh-ancestor
25704412|NCT02180828|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24936392|NCT04041128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936394|NCT04041648|Treprostinil|treprostinil|mesh-list
24936395|NCT04041648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24936396|NCT04041648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24936397|NCT04040491|Gemcitabine|gemcitabine|mesh-list
24936399|NCT04040491|Antibodies|antibodies|mesh-list
24936400|NCT04040491|Antibodies, Blocking|antibodies, blocking|mesh-list
24830752|NCT02161055|Insulin|insulin|mesh-list
24936402|NCT04040491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936403|NCT04040491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24936404|NCT04040491|Antimetabolites|antimetabolites|mesh-ancestor
24850120|NCT02251795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24850121|NCT02251795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850122|NCT02251795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24850123|NCT02251795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24850124|NCT02251795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850125|NCT02251795|Antipyretics|antipyretics|mesh-ancestor
24850126|NCT02251795|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24850127|NCT02251795|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24850128|NCT02251795|Protease Inhibitors|protease inhibitors|mesh-ancestor
24850129|NCT02251795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24850130|NCT02251795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24850131|NCT02251795|Antiviral Agents|antiviral agents|mesh-ancestor
24936412|NCT04040491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24936413|NCT04040491|Growth Substances|growth substances|mesh-ancestor
24936414|NCT04040491|Growth Inhibitors|growth inhibitors|mesh-ancestor
24850133|NCT02251795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24850134|NCT02251795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24850135|NCT02251847|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24850137|NCT02251847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24850138|NCT02251847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24850139|NCT02251847|Antimetabolites|antimetabolites|mesh-ancestor
24850140|NCT02251847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850141|NCT02251847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24850142|NCT02251847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24936426|NCT04040465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24936427|NCT04040465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24936428|NCT04040465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24850143|NCT02251847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850147|NCT02251925|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24850148|NCT02251925|Estrogens|estrogens|mesh-ancestor
24850149|NCT02251925|Hormones|hormones|mesh-ancestor
24850150|NCT02251925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24850151|NCT02251925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850152|NCT02251925|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24850153|NCT02251925|Contraceptive Agents|contraceptive agents|mesh-ancestor
24850154|NCT02251925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24936429|NCT04040465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936457|NCT04040309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850155|NCT02251925|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24850156|NCT02251951|Paclitaxel|paclitaxel|mesh-list
24850157|NCT02251951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24850158|NCT02251951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850159|NCT02251951|Tubulin Modulators|tubulin modulators|mesh-ancestor
24850160|NCT02251951|Antimitotic Agents|antimitotic agents|mesh-ancestor
24850161|NCT02251951|Mitosis Modulators|mitosis modulators|mesh-ancestor
24850162|NCT02251951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936464|NCT04039854|Desflurane|desflurane|mesh-list
24936465|NCT04039854|Isoflurane|isoflurane|mesh-list
24936466|NCT04039854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24936467|NCT04039854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24936468|NCT04039854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936469|NCT04039854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24936470|NCT04039854|Anesthetics, General|anesthetics, general|mesh-ancestor
24936471|NCT04039854|Anesthetics|anesthetics|mesh-ancestor
24936472|NCT04039854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24936473|NCT04039854|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24936475|NCT04039828|Zinc Sulfate|zinc sulfate|mesh-list
24850171|NCT02251977|Capecitabine|capecitabine|mesh-list
24850172|NCT02251977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850173|NCT02251977|Antimetabolites|antimetabolites|mesh-ancestor
24850174|NCT02251977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850175|NCT02251977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25704413|NCT02180828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25704414|NCT02180828|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25704415|NCT02181075|Doxorubicin|doxorubicin|mesh-list
25704416|NCT02181075|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25704417|NCT02181075|Liver Extracts|liver extracts|mesh-list
25704418|NCT02181075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25704419|NCT02181075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25704420|NCT02181075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25704421|NCT02181075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24936488|NCT04039815|Thiamine|thiamine|mesh-list
24936489|NCT04039815|Hydrocortisone|hydrocortisone|mesh-list
24936490|NCT04039815|Vitamins|vitamins|mesh-ancestor
24936491|NCT04039815|Micronutrients|micronutrients|mesh-ancestor
24936492|NCT04039815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050180|NCT00534027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25050181|NCT00534027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850185|NCT02252107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24850186|NCT02252107|Antimetabolites|antimetabolites|mesh-ancestor
24850187|NCT02252107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850188|NCT02252107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850189|NCT02252107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850190|NCT02252263|Elotuzumab|elotuzumab|mesh-list
24850191|NCT02252263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850192|NCT02252302|Albuterol|albuterol|mesh-list
24850193|NCT02252302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24850194|NCT02252302|Autonomic Agents|autonomic agents|mesh-ancestor
24850195|NCT02252302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24850196|NCT02252302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850197|NCT02252302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24850198|NCT02252302|Respiratory System Agents|respiratory system agents|mesh-ancestor
24645101|NCT01195727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645102|NCT01195727|Anticoagulants|anticoagulants|mesh-ancestor
25050182|NCT00532311|Atorvastatin|atorvastatin|mesh-list
25050186|NCT00532311|Lovastatin|lovastatin|mesh-list
25050187|NCT00532311|L 647318|l 647318|mesh-list
25050188|NCT00532311|Dihydromevinolin|dihydromevinolin|mesh-list
25050189|NCT00532311|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
25050190|NCT00532311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25050191|NCT00532311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25050192|NCT00532311|Antimetabolites|antimetabolites|mesh-ancestor
25050193|NCT00532311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050194|NCT00532311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25050195|NCT00532311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050196|NCT00532038|Ketoprofen|ketoprofen|mesh-list
25050197|NCT00532038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25050198|NCT00532038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25050199|NCT00532038|Analgesics|analgesics|mesh-ancestor
24850199|NCT02252302|Tocolytic Agents|tocolytic agents|mesh-ancestor
24850200|NCT02252302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24850201|NCT02252302|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24850202|NCT02252302|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24850203|NCT02252302|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24850204|NCT02252302|Adrenergic Agents|adrenergic agents|mesh-ancestor
24850205|NCT02252302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24812032|NCT02049320|Narcotics|narcotics|mesh-ancestor
24850206|NCT02252302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850208|NCT02252328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24850209|NCT02252328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24850210|NCT02252328|Antimetabolites|antimetabolites|mesh-ancestor
24850211|NCT02252328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850212|NCT02252328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24850213|NCT02252328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24850220|NCT02252341|Respiratory System Agents|respiratory system agents|mesh-ancestor
24850221|NCT02252341|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24850222|NCT02252341|Antioxidants|antioxidants|mesh-ancestor
24850223|NCT02252341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850224|NCT02252341|Protective Agents|protective agents|mesh-ancestor
24952858|NCT03891472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25704425|NCT02181127|Glucagon|glucagon|mesh-list
25704426|NCT02181127|Pancrelipase|pancrelipase|mesh-list
25704427|NCT02181127|Pancreatin|pancreatin|mesh-list
25704428|NCT02181127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25704429|NCT02181127|Hormones|hormones|mesh-ancestor
25704430|NCT02181127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25704431|NCT02181127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704432|NCT02181231|Buprenorphine|buprenorphine|mesh-list
24471250|NCT00394186|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24471251|NCT00394186|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24471252|NCT00394186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24471253|NCT00394186|Adrenergic Agents|adrenergic agents|mesh-ancestor
24471254|NCT00394186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24471255|NCT00394186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24952859|NCT03891420|Galidesivir|galidesivir|mesh-list
24850236|NCT02252419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24850237|NCT02252419|Antiemetics|antiemetics|mesh-ancestor
24850238|NCT02252419|Autonomic Agents|autonomic agents|mesh-ancestor
24850239|NCT02252419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24850240|NCT02252419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850241|NCT02252419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24850242|NCT02252419|Glucocorticoids|glucocorticoids|mesh-ancestor
24850243|NCT02252419|Hormones|hormones|mesh-ancestor
24850244|NCT02252419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24850245|NCT02252419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24850246|NCT02252419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850247|NCT02252419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24952864|NCT03891433|Piperacillin|piperacillin|mesh-list
24952868|NCT03891433|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24952869|NCT03891433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24952870|NCT03891433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850248|NCT02252419|Analgesics|analgesics|mesh-ancestor
24850249|NCT02252419|Sensory System Agents|sensory system agents|mesh-ancestor
24850250|NCT02252419|Antipyretics|antipyretics|mesh-ancestor
24850251|NCT02252458|Fentanyl|fentanyl|mesh-list
24850252|NCT02252458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24850253|NCT02252458|Narcotics|narcotics|mesh-ancestor
24850254|NCT02252458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24850255|NCT02252458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850256|NCT02252458|Analgesics|analgesics|mesh-ancestor
24850257|NCT02252458|Sensory System Agents|sensory system agents|mesh-ancestor
24850258|NCT02252458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24850259|NCT02252458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24952876|NCT03891550|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
24952877|NCT03891550|Antiviral Agents|antiviral agents|mesh-ancestor
24952878|NCT03891550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25704433|NCT02181231|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25704434|NCT02181231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25704435|NCT02181231|Narcotics|narcotics|mesh-ancestor
25704436|NCT02181231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25704437|NCT02181231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704438|NCT02181231|Analgesics|analgesics|mesh-ancestor
25704439|NCT02181231|Sensory System Agents|sensory system agents|mesh-ancestor
24593514|NCT00929877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25050228|NCT00529503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24474343|NCT00405730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25050229|NCT00529503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25050230|NCT00529503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24936493|NCT04039815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24936494|NCT04039815|Vitamin B Complex|vitamin b complex|mesh-ancestor
24444237|NCT00297076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444238|NCT00297076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24444239|NCT00297076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24444261|NCT00297219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24444262|NCT00297219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936496|NCT04039815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936497|NCT04039815|Protective Agents|protective agents|mesh-ancestor
24936499|NCT04039698|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
24936500|NCT04039698|Velpatasvir|velpatasvir|mesh-list
24936501|NCT04039698|Antiviral Agents|antiviral agents|mesh-ancestor
24936502|NCT04039698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24936503|NCT04039958|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
24936504|NCT04039958|Antiviral Agents|antiviral agents|mesh-ancestor
24936505|NCT04039958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24936506|NCT04039373|Mycophenolic Acid|mycophenolic acid|mesh-list
24936507|NCT04039373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24936508|NCT04039373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850260|NCT02252458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24850261|NCT02252458|Anesthetics, General|anesthetics, general|mesh-ancestor
24850262|NCT02252458|Anesthetics|anesthetics|mesh-ancestor
24850263|NCT02252497|Tranexamic Acid|tranexamic acid|mesh-list
24850264|NCT02252497|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24936509|NCT04039373|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24936510|NCT04039373|Antitubercular Agents|antitubercular agents|mesh-ancestor
24936521|NCT04039126|Tetracycline|tetracycline|mesh-list
24812034|NCT02049320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812035|NCT02049320|Analgesics|analgesics|mesh-ancestor
24812036|NCT02049320|Sensory System Agents|sensory system agents|mesh-ancestor
24812037|NCT02049320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812038|NCT02049346|Epoetin Alfa|epoetin alfa|mesh-list
24812039|NCT02049346|Darbepoetin alfa|darbepoetin alfa|mesh-list
24812040|NCT02049346|Hematinics|hematinics|mesh-ancestor
24812041|NCT02049411|Ketamine|ketamine|mesh-list
24812042|NCT02049411|Analgesics|analgesics|mesh-ancestor
24812043|NCT02049411|Sensory System Agents|sensory system agents|mesh-ancestor
24812044|NCT02049411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812045|NCT02049411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812046|NCT02049411|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24533846|NCT00645281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533847|NCT00645281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533848|NCT00645281|Urological Agents|urological agents|mesh-ancestor
24897691|NCT04423276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444313|NCT00297388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24444314|NCT00297388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24533853|NCT00645294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24533854|NCT00645294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24936522|NCT04039126|Povidone|povidone|mesh-list
24936523|NCT04039126|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24936524|NCT04039126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24936525|NCT04039126|Trace Elements|trace elements|mesh-ancestor
24936526|NCT04039126|Micronutrients|micronutrients|mesh-ancestor
24936527|NCT04039126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444315|NCT00297388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24444316|NCT00297388|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24444317|NCT00297388|Dopamine Agents|dopamine agents|mesh-ancestor
24444318|NCT00297466|Nicotine|nicotine|mesh-list
24444319|NCT00297466|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24444320|NCT00297466|Autonomic Agents|autonomic agents|mesh-ancestor
24936533|NCT04039126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444396|NCT00297765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24444397|NCT00297765|Immunologic Factors|immunologic factors|mesh-ancestor
24444398|NCT00297765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444399|NCT00297765|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24444402|NCT00297804|Paclitaxel|paclitaxel|mesh-list
24444417|NCT00297947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24812048|NCT02049411|Anesthetics, General|anesthetics, general|mesh-ancestor
24812049|NCT02049411|Anesthetics|anesthetics|mesh-ancestor
24812050|NCT02049411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24812051|NCT02049411|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24812052|NCT02049411|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24812053|NCT02049411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24812054|NCT02049411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812055|NCT02049515|Ofatumumab|ofatumumab|mesh-list
24812056|NCT02049515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812057|NCT02049541|Rituximab|rituximab|mesh-list
24812058|NCT02049541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24812059|NCT02049541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812060|NCT02049541|Immunologic Factors|immunologic factors|mesh-ancestor
24812061|NCT02049541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812062|NCT02049541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24936557|NCT04038970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24812064|NCT02049580|Thiotepa|thiotepa|mesh-list
24812065|NCT02049580|Fludarabine|fludarabine|mesh-list
24812066|NCT02049580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24812067|NCT02049580|Immunologic Factors|immunologic factors|mesh-ancestor
24812068|NCT02049580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812069|NCT02049580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24812070|NCT02049580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24812071|NCT02049580|Alkylating Agents|alkylating agents|mesh-ancestor
24812072|NCT02049580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812073|NCT02049580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812074|NCT02049580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24936561|NCT04038853|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
25704440|NCT02181231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25704441|NCT02181231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24936563|NCT04038853|Vitamins|vitamins|mesh-ancestor
25704442|NCT02181231|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25704443|NCT02181231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25704444|NCT02181231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25704445|NCT02181231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704446|NCT02181231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25704447|NCT02181231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25704448|NCT02181231|Antidepressive Agents|antidepressive agents|mesh-ancestor
25704449|NCT02181231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25704450|NCT02181296|Ropivacaine|ropivacaine|mesh-list
24936564|NCT04038853|Micronutrients|micronutrients|mesh-ancestor
24444561|NCT00298506|Mycophenolic Acid|mycophenolic acid|mesh-list
24936565|NCT04038853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936566|NCT04038853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24936567|NCT04038853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24936568|NCT04038853|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24936569|NCT04038853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24936570|NCT04038853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812086|NCT02049606|Nabumetone|nabumetone|mesh-list
24812087|NCT02049606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24812088|NCT02049606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24812089|NCT02049606|Analgesics|analgesics|mesh-ancestor
24812101|NCT02049671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850288|NCT02252614|Sensory System Agents|sensory system agents|mesh-ancestor
24850289|NCT02252614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24850290|NCT02252614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850291|NCT02252614|Antipyretics|antipyretics|mesh-ancestor
24850292|NCT02252614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24936605|NCT04038671|Anti-Infective Agents|anti-infective agents|mesh-list
24936606|NCT04038671|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24936607|NCT04038671|Charcoal|charcoal|mesh-list
24936608|NCT04038671|Antidotes|antidotes|mesh-ancestor
24936609|NCT04038671|Protective Agents|protective agents|mesh-ancestor
24850293|NCT02252614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24850294|NCT02252614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24850295|NCT02252614|Gout Suppressants|gout suppressants|mesh-ancestor
24850296|NCT02252614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24850297|NCT02252614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850298|NCT02252614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850299|NCT02252614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24850304|NCT02252627|Phenylephrine|phenylephrine|mesh-list
24850305|NCT02252627|Oxymetazoline|oxymetazoline|mesh-list
24850306|NCT02252627|Ephedrine|ephedrine|mesh-list
24850307|NCT02252627|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24850308|NCT02252627|Mydriatics|mydriatics|mesh-ancestor
24850309|NCT02252627|Autonomic Agents|autonomic agents|mesh-ancestor
24850310|NCT02252627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25704451|NCT02181296|Anesthetics, Local|anesthetics, local|mesh-ancestor
25704452|NCT02181296|Anesthetics|anesthetics|mesh-ancestor
25704453|NCT02181296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25704454|NCT02181296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704455|NCT02181296|Sensory System Agents|sensory system agents|mesh-ancestor
24761266|NCT01761994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761267|NCT01761994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24761269|NCT01761994|Anticoagulants|anticoagulants|mesh-ancestor
24761270|NCT01761994|Protease Inhibitors|protease inhibitors|mesh-ancestor
24850311|NCT02252627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850312|NCT02252627|Sympathomimetics|sympathomimetics|mesh-ancestor
24850313|NCT02252627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24850314|NCT02252627|Nasal Decongestants|nasal decongestants|mesh-ancestor
24850315|NCT02252627|Respiratory System Agents|respiratory system agents|mesh-ancestor
24850316|NCT02252627|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24850317|NCT02252627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24850318|NCT02252627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24830797|NCT02161614|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24761271|NCT01761994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050231|NCT00529503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25050233|NCT00529503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050234|NCT00529503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25050235|NCT00529503|Alkylating Agents|alkylating agents|mesh-ancestor
25050236|NCT00529178|Pravastatin|pravastatin|mesh-list
25050237|NCT00529178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25050238|NCT00529178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25050239|NCT00529178|Antimetabolites|antimetabolites|mesh-ancestor
24850349|NCT02252796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24850350|NCT02252796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850351|NCT02252796|Tubulin Modulators|tubulin modulators|mesh-ancestor
24850352|NCT02252796|Antimitotic Agents|antimitotic agents|mesh-ancestor
24850353|NCT02252796|Mitosis Modulators|mitosis modulators|mesh-ancestor
24850354|NCT02252796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850355|NCT02252809|Methylprednisolone|methylprednisolone|mesh-list
24850356|NCT02252809|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24850357|NCT02252809|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24850358|NCT02252809|Prednisolone|prednisolone|mesh-list
24481791|NCT00436787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24481792|NCT00436800|Gemcitabine|gemcitabine|mesh-list
24481793|NCT00436800|Oxaliplatin|oxaliplatin|mesh-list
24481794|NCT00436800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25050256|NCT00528697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050258|NCT00528333|Lintuzumab|lintuzumab|mesh-list
25050259|NCT00528333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25050260|NCT00528333|Antimetabolites|antimetabolites|mesh-ancestor
25050261|NCT00528333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050262|NCT00528333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050263|NCT00528333|Antiviral Agents|antiviral agents|mesh-ancestor
25050264|NCT00528333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24850359|NCT02252809|Prednisolone acetate|prednisolone acetate|mesh-list
24850360|NCT02252809|Adalimumab|adalimumab|mesh-list
24850361|NCT02252809|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24850362|NCT02252809|Prednisolone phosphate|prednisolone phosphate|mesh-list
24850363|NCT02252809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24850364|NCT02252809|Antiemetics|antiemetics|mesh-ancestor
24850365|NCT02252809|Autonomic Agents|autonomic agents|mesh-ancestor
24850366|NCT02252809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24850367|NCT02252809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850368|NCT02252809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24444572|NCT00298506|Antitubercular Agents|antitubercular agents|mesh-ancestor
24830820|NCT02161653|Antioxidants|antioxidants|mesh-ancestor
24533880|NCT00645320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24533881|NCT00645320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24533882|NCT00645320|Dopamine Agents|dopamine agents|mesh-ancestor
24533883|NCT00645372|Risperidone|risperidone|mesh-list
24533884|NCT00645372|Ziprasidone|ziprasidone|mesh-list
24533885|NCT00645372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24533886|NCT00645372|Serotonin Agents|serotonin agents|mesh-ancestor
24533887|NCT00645372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050265|NCT00528333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25050266|NCT00528333|Immunologic Factors|immunologic factors|mesh-ancestor
25050267|NCT00528333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050268|NCT00528333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25050269|NCT00526227|Clotrimazole|clotrimazole|mesh-list
25050270|NCT00526227|Miconazole|miconazole|mesh-list
25050273|NCT00526227|Antifungal Agents|antifungal agents|mesh-ancestor
24850369|NCT02252809|Glucocorticoids|glucocorticoids|mesh-ancestor
24850371|NCT02252809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24850372|NCT02252809|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24850373|NCT02252809|Protective Agents|protective agents|mesh-ancestor
24850374|NCT02252809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24850375|NCT02252809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850376|NCT02252809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25704456|NCT02181296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25704457|NCT02181387|Acetaminophen|acetaminophen|mesh-list
25704458|NCT02181387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25704459|NCT02181387|Analgesics|analgesics|mesh-ancestor
25704460|NCT02181387|Sensory System Agents|sensory system agents|mesh-ancestor
25704461|NCT02181387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25704462|NCT02181387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704463|NCT02181387|Antipyretics|antipyretics|mesh-ancestor
25704464|NCT02181426|Ketorolac|ketorolac|mesh-list
25704465|NCT02181426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25050274|NCT00526227|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25050275|NCT00526227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25050277|NCT00526227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953030|NCT03889379|Albuterol|albuterol|mesh-list
24953031|NCT03889379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24953032|NCT03889379|Autonomic Agents|autonomic agents|mesh-ancestor
24850382|NCT02252887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850383|NCT02252887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850384|NCT02252887|Antiviral Agents|antiviral agents|mesh-ancestor
24850385|NCT02252887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24850386|NCT02252887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24953036|NCT03889379|Respiratory System Agents|respiratory system agents|mesh-ancestor
24953037|NCT03889379|Tocolytic Agents|tocolytic agents|mesh-ancestor
24953038|NCT03889379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24953039|NCT03889379|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24953040|NCT03889379|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24953041|NCT03889379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24953042|NCT03889379|Adrenergic Agents|adrenergic agents|mesh-ancestor
24953043|NCT03889379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24953044|NCT03889379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953045|NCT03889626|Capecitabine|capecitabine|mesh-list
24953046|NCT03889626|Apatinib|apatinib|mesh-list
24953047|NCT03889626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24953048|NCT03889626|Antimetabolites|antimetabolites|mesh-ancestor
24953049|NCT03889626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953050|NCT03889626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24953051|NCT03889626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24953052|NCT03889626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24799589|NCT01969695|Venetoclax|venetoclax|mesh-list
24850387|NCT02252887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24850388|NCT02252887|Immunologic Factors|immunologic factors|mesh-ancestor
24850389|NCT02252887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850390|NCT02252887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24850391|NCT02252913|Docetaxel|docetaxel|mesh-list
24850392|NCT02252913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850393|NCT02252913|Tubulin Modulators|tubulin modulators|mesh-ancestor
24625536|NCT01082393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24625537|NCT01082393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24625538|NCT01082393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24850410|NCT02252926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25704466|NCT02181426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25704467|NCT02181426|Analgesics|analgesics|mesh-ancestor
25704468|NCT02181426|Sensory System Agents|sensory system agents|mesh-ancestor
25704469|NCT02181426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25704470|NCT02181426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704471|NCT02181426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25704472|NCT02181426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25704473|NCT02181426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25704474|NCT02181426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850411|NCT02252926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24850412|NCT02252926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850413|NCT02252926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24850414|NCT02252926|Narcotics|narcotics|mesh-ancestor
24625540|NCT01082393|Sensory System Agents|sensory system agents|mesh-ancestor
24936673|NCT04037566|Cyclophosphamide|cyclophosphamide|mesh-list
24936674|NCT04037566|Fludarabine|fludarabine|mesh-list
24936681|NCT04037566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936683|NCT04037566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24850444|NCT02253004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24850445|NCT02253004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850446|NCT02253004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24850447|NCT02253004|Vasodilator Agents|vasodilator agents|mesh-ancestor
24850448|NCT02253004|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24850449|NCT02253004|Protective Agents|protective agents|mesh-ancestor
24850450|NCT02253004|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24850451|NCT02253004|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24850452|NCT02253004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850453|NCT02253069|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
24812102|NCT02049736|Telbivudine|telbivudine|mesh-list
24812103|NCT02049736|Antiviral Agents|antiviral agents|mesh-ancestor
24812104|NCT02049736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24646525|NCT01204164|Hormones|hormones|mesh-ancestor
24936689|NCT04037657|Anesthetics, General|anesthetics, general|mesh-ancestor
24936690|NCT04037657|Anesthetics|anesthetics|mesh-ancestor
24936695|NCT04037514|Acetaminophen|acetaminophen|mesh-list
24936696|NCT04037514|Ibuprofen|ibuprofen|mesh-list
24936697|NCT04037514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24936698|NCT04037514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24936699|NCT04037514|Analgesics|analgesics|mesh-ancestor
24936700|NCT04037514|Sensory System Agents|sensory system agents|mesh-ancestor
24812105|NCT02049736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24812106|NCT02049736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812107|NCT02049736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812108|NCT02049762|Aspirin|aspirin|mesh-list
24812109|NCT02049762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24812110|NCT02049762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24812111|NCT02049762|Analgesics|analgesics|mesh-ancestor
24812112|NCT02049762|Sensory System Agents|sensory system agents|mesh-ancestor
24812113|NCT02049762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812114|NCT02049762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444796|NCT00299091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25704475|NCT02181426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704476|NCT02181504|Ranibizumab|ranibizumab|mesh-list
25704477|NCT02181504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25704478|NCT02181504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25704479|NCT02181504|Growth Substances|growth substances|mesh-ancestor
24484197|NCT00446979|Antiviral Agents|antiviral agents|mesh-ancestor
25704480|NCT02181504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427162|NCT00237575|Sargramostim|sargramostim|mesh-list
24484390|NCT00448110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812120|NCT02049762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24812121|NCT02049762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24812125|NCT02049801|Idarubicin|idarubicin|mesh-list
24936715|NCT04037085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24936716|NCT04037085|Anesthetics, General|anesthetics, general|mesh-ancestor
25704481|NCT02181504|Growth Inhibitors|growth inhibitors|mesh-ancestor
25704482|NCT02181504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25704483|NCT02181517|Ranibizumab|ranibizumab|mesh-list
25704484|NCT02181517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25704485|NCT02181517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25704486|NCT02181517|Growth Substances|growth substances|mesh-ancestor
25704487|NCT02181517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936718|NCT04037085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24936719|NCT04037085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24936720|NCT04037085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24936721|NCT04037085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24936722|NCT04037085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936724|NCT04036721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24936725|NCT04036721|Glucocorticoids|glucocorticoids|mesh-ancestor
24936726|NCT04036721|Hormones|hormones|mesh-ancestor
24936727|NCT04036721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24936728|NCT04036721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936729|NCT04036721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24936730|NCT04036721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24936731|NCT04036890|Minocycline|minocycline|mesh-list
24812136|NCT02049801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24812137|NCT02049801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24812138|NCT02049801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812139|NCT02049970|Dexmedetomidine|dexmedetomidine|mesh-list
24812140|NCT02049970|Bupivacaine|bupivacaine|mesh-list
24812141|NCT02049970|Anesthetics, Local|anesthetics, local|mesh-ancestor
24812142|NCT02049970|Anesthetics|anesthetics|mesh-ancestor
24812143|NCT02049970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24812144|NCT02049970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812149|NCT02049970|Analgesics|analgesics|mesh-ancestor
24936733|NCT04036890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24936734|NCT04036981|Botulinum Toxins|botulinum toxins|mesh-list
24936735|NCT04036981|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24936736|NCT04036981|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24936737|NCT04036981|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24936738|NCT04036981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24936739|NCT04036981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936740|NCT04036981|Cholinergic Agents|cholinergic agents|mesh-ancestor
24936741|NCT04036981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24936742|NCT04036981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936743|NCT04036981|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24489418|NCT00473070|Hormones|hormones|mesh-ancestor
24489569|NCT00474071|Sensory System Agents|sensory system agents|mesh-ancestor
24489570|NCT00474071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489571|NCT00474110|Ketamine|ketamine|mesh-list
24489572|NCT00474110|Hydromorphone|hydromorphone|mesh-list
24489573|NCT00474110|Analgesics|analgesics|mesh-ancestor
24490083|NCT00476268|Hormones|hormones|mesh-ancestor
24812157|NCT02050009|Paclitaxel|paclitaxel|mesh-list
24812158|NCT02050009|Carboplatin|carboplatin|mesh-list
24812159|NCT02050009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24812160|NCT02050009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812161|NCT02050009|Tubulin Modulators|tubulin modulators|mesh-ancestor
24812162|NCT02050009|Antimitotic Agents|antimitotic agents|mesh-ancestor
24812163|NCT02050009|Mitosis Modulators|mitosis modulators|mesh-ancestor
24936745|NCT04036487|Propofol|propofol|mesh-list
24936746|NCT04036487|Desflurane|desflurane|mesh-list
24936747|NCT04036487|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24936751|NCT04036487|Anesthetics, General|anesthetics, general|mesh-ancestor
24936752|NCT04036487|Anesthetics|anesthetics|mesh-ancestor
24936753|NCT04036487|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24936754|NCT04036500|Estradiol|estradiol|mesh-list
24936755|NCT04036500|Estrogens|estrogens|mesh-ancestor
24936756|NCT04036500|Hormones|hormones|mesh-ancestor
24936757|NCT04036500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24812164|NCT02050009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812165|NCT02050009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24812166|NCT02050009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812167|NCT02050074|Metformin|metformin|mesh-list
24812168|NCT02050074|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
24812169|NCT02050074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24850454|NCT02253069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24936802|NCT04035850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24953173|NCT03887650|Hormones|hormones|mesh-ancestor
24953174|NCT03887650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24953175|NCT03887650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24936803|NCT04035850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936804|NCT04035850|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24610404|NCT01001845|Tocopherols|tocopherols|mesh-list
24850456|NCT02253095|Trace Elements|trace elements|mesh-list
25704488|NCT02181517|Growth Inhibitors|growth inhibitors|mesh-ancestor
25704489|NCT02181517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25704490|NCT02181556|Aflibercept|aflibercept|mesh-list
25704491|NCT02181556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25704492|NCT02181556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25704493|NCT02181556|Growth Substances|growth substances|mesh-ancestor
25704494|NCT02181556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704495|NCT02181556|Growth Inhibitors|growth inhibitors|mesh-ancestor
25704496|NCT02181556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491176|NCT00481481|Tacrolimus|tacrolimus|mesh-list
24850484|NCT02253199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24850486|NCT02253199|Adrenergic Agents|adrenergic agents|mesh-ancestor
24850487|NCT02253199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24850488|NCT02253199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850489|NCT02253212|Carboplatin|carboplatin|mesh-list
24850490|NCT02253212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850491|NCT02253264|Rituximab|rituximab|mesh-list
24850492|NCT02253264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24850493|NCT02253264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850494|NCT02253264|Immunologic Factors|immunologic factors|mesh-ancestor
24936824|NCT04035889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24761313|NCT01762202|Ofatumumab|ofatumumab|mesh-list
24936825|NCT04035993|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24936826|NCT04035993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936828|NCT04035798|Memantine|memantine|mesh-list
24936861|NCT04035135|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24936862|NCT04035135|Immunologic Factors|immunologic factors|mesh-ancestor
25050279|NCT00526227|Hormone Antagonists|hormone antagonists|mesh-ancestor
25050280|NCT00526227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25050281|NCT00526227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936863|NCT04035135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936864|NCT04035330|Etidronic Acid|etidronic acid|mesh-list
24936865|NCT04035330|Sodium Hypochlorite|sodium hypochlorite|mesh-list
24936866|NCT04035330|Eusol|eusol|mesh-list
24936867|NCT04035330|Disinfectants|disinfectants|mesh-ancestor
24936868|NCT04035330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24850527|NCT02253420|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24850528|NCT02253446|Diclofenac|diclofenac|mesh-list
24850529|NCT02253446|Piroxicam|piroxicam|mesh-list
24850530|NCT02253446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24850531|NCT02253446|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24936869|NCT04035330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24936870|NCT04035330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936871|NCT04035096|Ascorbic Acid|ascorbic acid|mesh-list
24936872|NCT04035096|Antioxidants|antioxidants|mesh-ancestor
24936873|NCT04035096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936874|NCT04035096|Protective Agents|protective agents|mesh-ancestor
24936875|NCT04035096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936876|NCT04035096|Vitamins|vitamins|mesh-ancestor
24850548|NCT02253485|Antiviral Agents|antiviral agents|mesh-ancestor
24850549|NCT02253485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24850550|NCT02253485|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24850551|NCT02253485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850552|NCT02253485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850553|NCT02253524|Metoclopramide|metoclopramide|mesh-list
24850554|NCT02253524|Dimenhydrinate|dimenhydrinate|mesh-list
24936888|NCT04034823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24936890|NCT04035070|Clindamycin palmitate|clindamycin palmitate|mesh-list
24936891|NCT04035070|Clindamycin phosphate|clindamycin phosphate|mesh-list
24936892|NCT04035070|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24936893|NCT04035070|Sodium Hypochlorite|sodium hypochlorite|mesh-list
24936894|NCT04035070|Eusol|eusol|mesh-list
25704497|NCT02181634|Gemcitabine|gemcitabine|mesh-list
25704498|NCT02181634|Paclitaxel|paclitaxel|mesh-list
25704499|NCT02181634|Antimetabolites|antimetabolites|mesh-list
25704500|NCT02181634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25704501|NCT02181634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25704502|NCT02181634|Tubulin Modulators|tubulin modulators|mesh-ancestor
25704503|NCT02181634|Antimitotic Agents|antimitotic agents|mesh-ancestor
25704504|NCT02181634|Mitosis Modulators|mitosis modulators|mesh-ancestor
24936896|NCT04035070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24936897|NCT04035070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24850563|NCT02253524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24936899|NCT04035070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24936900|NCT04035070|Disinfectants|disinfectants|mesh-ancestor
24936901|NCT04035070|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24936902|NCT04034771|Propofol|propofol|mesh-list
24936903|NCT04034771|Melatonin|melatonin|mesh-list
24936904|NCT04034771|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24936905|NCT04034771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24936906|NCT04034771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24936907|NCT04034771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24936908|NCT04034771|Anesthetics, General|anesthetics, general|mesh-ancestor
24936909|NCT04034771|Anesthetics|anesthetics|mesh-ancestor
24936910|NCT04034771|Antioxidants|antioxidants|mesh-ancestor
24444722|NCT00298974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24850578|NCT02253602|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24850579|NCT02253758|Propofol|propofol|mesh-list
24850580|NCT02253758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24850581|NCT02253758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24850582|NCT02253758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850583|NCT02253758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24850584|NCT02253758|Anesthetics, General|anesthetics, general|mesh-ancestor
24936953|NCT04034368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850597|NCT02253784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24850598|NCT02253784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850599|NCT02253784|Anesthetics, Local|anesthetics, local|mesh-ancestor
24850600|NCT02253784|Anesthetics|anesthetics|mesh-ancestor
24850601|NCT02253784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24850603|NCT02253797|Ritonavir|ritonavir|mesh-list
24850604|NCT02253797|Tipranavir|tipranavir|mesh-list
24850605|NCT02253797|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24850606|NCT02253797|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24850607|NCT02253797|Protease Inhibitors|protease inhibitors|mesh-ancestor
24850608|NCT02253797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850609|NCT02253797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533892|NCT00645372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24936955|NCT04034368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24850626|NCT02253836|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24850627|NCT02253836|Protease Inhibitors|protease inhibitors|mesh-ancestor
24850628|NCT02253836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850629|NCT02253836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850630|NCT02253836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24850631|NCT02253836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24850632|NCT02253836|Antiviral Agents|antiviral agents|mesh-ancestor
24850633|NCT02253836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24533894|NCT00645372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24533895|NCT00645372|Dopamine Agents|dopamine agents|mesh-ancestor
24533896|NCT00645398|Pregabalin|pregabalin|mesh-list
24533897|NCT00645398|Analgesics|analgesics|mesh-ancestor
24936974|NCT04034225|Pembrolizumab|pembrolizumab|mesh-list
24936975|NCT04034225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24936997|NCT04033562|Lidocaine|lidocaine|mesh-list
24936998|NCT04033562|Bupivacaine|bupivacaine|mesh-list
24936999|NCT04033562|Anesthetics, Local|anesthetics, local|mesh-ancestor
24937000|NCT04033562|Anesthetics|anesthetics|mesh-ancestor
24937003|NCT04033562|Sensory System Agents|sensory system agents|mesh-ancestor
24937017|NCT04033471|Sensory System Agents|sensory system agents|mesh-ancestor
24937018|NCT04033471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937019|NCT04033471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24937021|NCT04033471|Analgesics|analgesics|mesh-ancestor
24499327|NCT00519012|Paroxetine|paroxetine|mesh-list
24499328|NCT00519012|Antidepressive Agents|antidepressive agents|mesh-ancestor
24499329|NCT00519012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24499476|NCT00519688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24499477|NCT00519688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24499486|NCT00519701|Hydroxyurea|hydroxyurea|mesh-list
24499548|NCT00520000|Antimitotic Agents|antimitotic agents|mesh-ancestor
24937022|NCT04033471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24937033|NCT04033250|Bisacodyl|bisacodyl|mesh-list
24779171|NCT01874314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24779172|NCT01874314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24779173|NCT01874314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24779174|NCT01874314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24779175|NCT01874314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24779181|NCT01874470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779182|NCT01874561|Moxifloxacin|moxifloxacin|mesh-list
24779183|NCT01874561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24779184|NCT01874561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24779190|NCT01874574|Triamcinolone|triamcinolone|mesh-list
24937048|NCT04033172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24937049|NCT04033172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24937050|NCT04033172|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24937051|NCT04033172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24937052|NCT04033172|Hormone Antagonists|hormone antagonists|mesh-ancestor
24937053|NCT04033172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24937054|NCT04033172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937055|NCT04033029|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24937056|NCT04033029|Tazobactam|tazobactam|mesh-list
24937057|NCT04033029|Piperacillin|piperacillin|mesh-list
24937058|NCT04033029|Daptomycin|daptomycin|mesh-list
24937059|NCT04033029|Ceftazidime|ceftazidime|mesh-list
24937060|NCT04033029|Cefepime|cefepime|mesh-list
24761608|NCT01763463|Hormones|hormones|mesh-ancestor
24937063|NCT04033029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24937064|NCT04033029|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24850725|NCT02253901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24850727|NCT02253914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24850728|NCT02253914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24850729|NCT02253914|Protease Inhibitors|protease inhibitors|mesh-ancestor
24850730|NCT02253914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850731|NCT02253914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850732|NCT02253914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24850733|NCT02253914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25704505|NCT02181634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704506|NCT02181634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25704507|NCT02181634|Antiviral Agents|antiviral agents|mesh-ancestor
25704508|NCT02181634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25704509|NCT02181634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25704510|NCT02181634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25704511|NCT02181634|Immunologic Factors|immunologic factors|mesh-ancestor
24850734|NCT02253914|Antiviral Agents|antiviral agents|mesh-ancestor
24850735|NCT02253914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24506182|NCT00544232|Antimitotic Agents|antimitotic agents|mesh-ancestor
24506183|NCT00544232|Mitosis Modulators|mitosis modulators|mesh-ancestor
24525606|NCT03015974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506421|NCT00545194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24506422|NCT00545194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506423|NCT00545207|Ibandronic Acid|ibandronic acid|mesh-list
24506424|NCT00545207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24506425|NCT00545207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761679|NCT01763671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24761680|NCT01763671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24761681|NCT01763671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24761682|NCT01763671|Growth Substances|growth substances|mesh-ancestor
24761684|NCT01763671|Growth Inhibitors|growth inhibitors|mesh-ancestor
24761686|NCT01763710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25050283|NCT00526227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25050284|NCT00525941|Indiplon|indiplon|mesh-list
25050285|NCT00525941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25050286|NCT00525941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25050287|NCT00525941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050288|NCT00525941|GABA Modulators|gaba modulators|mesh-ancestor
25050289|NCT00525941|GABA Agents|gaba agents|mesh-ancestor
25050290|NCT00525941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050291|NCT00525941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050292|NCT00525330|Metformin|metformin|mesh-list
25050293|NCT00525330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25050294|NCT00525330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050295|NCT00524277|Molgramostim|molgramostim|mesh-list
25050296|NCT00524277|Vaccines|vaccines|mesh-list
24850736|NCT02253914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24850737|NCT02253914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25050297|NCT00524277|Sargramostim|sargramostim|mesh-list
25050298|NCT00524277|Immunologic Factors|immunologic factors|mesh-ancestor
24953409|NCT03885388|Dactinomycin|dactinomycin|mesh-list
24625541|NCT01082393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24625542|NCT01082393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24625543|NCT01082445|Acetylcysteine|acetylcysteine|mesh-list
24625544|NCT01082445|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24625545|NCT01082445|Antiviral Agents|antiviral agents|mesh-ancestor
24625546|NCT01082445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24625547|NCT01082445|Expectorants|expectorants|mesh-ancestor
24625548|NCT01082445|Respiratory System Agents|respiratory system agents|mesh-ancestor
24625549|NCT01082445|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24625550|NCT01082445|Antioxidants|antioxidants|mesh-ancestor
24937075|NCT04033094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24937076|NCT04033094|Narcotics|narcotics|mesh-ancestor
24937077|NCT04033094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25704512|NCT02181634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704513|NCT02181673|Golimumab|golimumab|mesh-list
25704514|NCT02181673|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25704515|NCT02181673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25704516|NCT02181673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25704517|NCT02181673|Immunologic Factors|immunologic factors|mesh-ancestor
25704518|NCT02181673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709625|NCT02271425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709626|NCT02271425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25709627|NCT02271698|Dexamethasone|dexamethasone|mesh-list
25709628|NCT02271698|Dexamethasone acetate|dexamethasone acetate|mesh-list
25709629|NCT02271698|BB 1101|bb 1101|mesh-list
25709630|NCT02271698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25709631|NCT02271698|Antiemetics|antiemetics|mesh-ancestor
25709632|NCT02271698|Autonomic Agents|autonomic agents|mesh-ancestor
25709633|NCT02271698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25709634|NCT02271698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709635|NCT02271698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25709636|NCT02271698|Glucocorticoids|glucocorticoids|mesh-ancestor
25709637|NCT02271698|Hormones|hormones|mesh-ancestor
25709638|NCT02271698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25709639|NCT02271698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24520650|NCT05335460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24520651|NCT05335460|Antimetabolites|antimetabolites|mesh-ancestor
24520652|NCT05335460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520653|NCT05335460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520654|NCT05335278|Nintedanib|nintedanib|mesh-list
24520660|NCT05335122|Travoprost|travoprost|mesh-list
24527613|NCT00617656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520742|NCT05333640|Paclitaxel|paclitaxel|mesh-list
24937078|NCT04033094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937080|NCT04033094|Sensory System Agents|sensory system agents|mesh-ancestor
24937082|NCT04033276|Rituximab|rituximab|mesh-list
24937083|NCT04033276|Immunoglobulins|immunoglobulins|mesh-list
24937084|NCT04033276|Antibodies|antibodies|mesh-list
24937085|NCT04033276|gamma-Globulins|gamma-globulins|mesh-list
24937086|NCT04033276|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24937087|NCT04033276|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24937088|NCT04033276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24937089|NCT04033276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24937090|NCT04033276|Immunologic Factors|immunologic factors|mesh-ancestor
24937091|NCT04033276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937093|NCT04032691|Clonidine|clonidine|mesh-list
24937094|NCT04032691|Analgesics|analgesics|mesh-ancestor
24937095|NCT04032691|Sensory System Agents|sensory system agents|mesh-ancestor
24937096|NCT04032691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937097|NCT04032691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937098|NCT04032691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24937099|NCT04032691|Sympatholytics|sympatholytics|mesh-ancestor
24937100|NCT04032691|Autonomic Agents|autonomic agents|mesh-ancestor
24937101|NCT04032691|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24937102|NCT04032691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24937103|NCT04032691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24850806|NCT02254005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24850807|NCT02254005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850808|NCT02254005|Tubulin Modulators|tubulin modulators|mesh-ancestor
24850809|NCT02254005|Antimitotic Agents|antimitotic agents|mesh-ancestor
24850810|NCT02254005|Mitosis Modulators|mitosis modulators|mesh-ancestor
24850811|NCT02254005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937163|NCT04032366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850815|NCT02254018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24850816|NCT02254018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25704519|NCT02181738|Doxorubicin|doxorubicin|mesh-list
25704520|NCT02181738|Nivolumab|nivolumab|mesh-list
25704521|NCT02181738|Dacarbazine|dacarbazine|mesh-list
25704522|NCT02181738|Vinblastine|vinblastine|mesh-list
25704523|NCT02181738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25704524|NCT02181738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25704525|NCT02181738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25704526|NCT02181738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24850817|NCT02254018|Tubulin Modulators|tubulin modulators|mesh-ancestor
25704527|NCT02181738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850820|NCT02254018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850821|NCT02254018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24850823|NCT02254031|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
24937168|NCT04032366|Protective Agents|protective agents|mesh-ancestor
24937172|NCT04032132|Analgesics|analgesics|mesh-ancestor
24850830|NCT02254031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24850831|NCT02254044|Maytansine|maytansine|mesh-list
24850832|NCT02254044|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
24850833|NCT02254044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24850834|NCT02254044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24850835|NCT02254044|Tubulin Modulators|tubulin modulators|mesh-ancestor
24937182|NCT04032184|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24937183|NCT04032184|Fluorides|fluorides|mesh-list
24937184|NCT04032184|Cariostatic Agents|cariostatic agents|mesh-ancestor
24937185|NCT04032184|Protective Agents|protective agents|mesh-ancestor
24937186|NCT04032184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937187|NCT04032184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24937188|NCT04032184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24937189|NCT04032184|Disinfectants|disinfectants|mesh-ancestor
24850839|NCT02254044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24850841|NCT02254148|Digoxin|digoxin|mesh-list
24850842|NCT02254148|Midazolam|midazolam|mesh-list
24850843|NCT02254148|Caffeine|caffeine|mesh-list
24850844|NCT02254148|Omeprazole|omeprazole|mesh-list
24850845|NCT02254148|Warfarin|warfarin|mesh-list
24850846|NCT02254148|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24850847|NCT02254148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24850848|NCT02254148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24444822|NCT00299234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704528|NCT02181738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704529|NCT02181738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25704530|NCT02181738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25704531|NCT02181738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25704532|NCT02181738|Alkylating Agents|alkylating agents|mesh-ancestor
25704533|NCT02181738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25704534|NCT02181738|Tubulin Modulators|tubulin modulators|mesh-ancestor
25704535|NCT02181738|Antimitotic Agents|antimitotic agents|mesh-ancestor
25704536|NCT02181738|Mitosis Modulators|mitosis modulators|mesh-ancestor
25704537|NCT02181816|Amlodipine|amlodipine|mesh-list
24937207|NCT04032210|Zinc|zinc|mesh-list
24937208|NCT04032210|Fluorides|fluorides|mesh-list
24937209|NCT04032210|Cariostatic Agents|cariostatic agents|mesh-ancestor
24937210|NCT04032210|Protective Agents|protective agents|mesh-ancestor
24937211|NCT04032210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937212|NCT04032210|Trace Elements|trace elements|mesh-ancestor
24533932|NCT00645502|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24533933|NCT00645502|Serotonin Agents|serotonin agents|mesh-ancestor
24937216|NCT04031859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24937217|NCT04031859|Analgesics|analgesics|mesh-ancestor
24937218|NCT04031859|Sensory System Agents|sensory system agents|mesh-ancestor
24937219|NCT04031859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937220|NCT04031859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937221|NCT04031859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24937222|NCT04031859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24937223|NCT04031859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24937224|NCT04031859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24937225|NCT04031859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953557|NCT03884036|Micronutrients|micronutrients|mesh-ancestor
24953558|NCT03884036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953559|NCT03884036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24937226|NCT04031859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24937227|NCT04031859|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24937228|NCT04031859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24937230|NCT04031872|Capecitabine|capecitabine|mesh-list
24937231|NCT04031872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24937232|NCT04031872|Antimetabolites|antimetabolites|mesh-ancestor
24937233|NCT04031872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937266|NCT04031027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24937267|NCT04031027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24937268|NCT04031027|Analgesics|analgesics|mesh-ancestor
24937269|NCT04031027|Sensory System Agents|sensory system agents|mesh-ancestor
24937270|NCT04031027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937271|NCT04031027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937272|NCT04031027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24937273|NCT04031027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24937274|NCT04031027|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24937275|NCT04031027|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24937276|NCT04031027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850893|NCT02254174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850894|NCT02254174|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24850896|NCT02254174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24850897|NCT02254174|Adrenergic Agents|adrenergic agents|mesh-ancestor
24850898|NCT02254187|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24850899|NCT02254187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24850900|NCT02254187|Autonomic Agents|autonomic agents|mesh-ancestor
24850901|NCT02254187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25050302|NCT00523250|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25050303|NCT00523042|Insulin|insulin|mesh-list
25050304|NCT00523042|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25050305|NCT00523042|Insulin Aspart|insulin aspart|mesh-list
25050306|NCT00523042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24761929|NCT01765309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24761930|NCT01765374|Rituximab|rituximab|mesh-list
24761931|NCT01765374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24937277|NCT04031027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050307|NCT00523042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937280|NCT04030663|Vasodilator Agents|vasodilator agents|mesh-ancestor
24937281|NCT04030663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24937282|NCT04030663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24937283|NCT04030663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937284|NCT04030663|Urological Agents|urological agents|mesh-ancestor
24937285|NCT04030988|Dexamethasone|dexamethasone|mesh-list
24850910|NCT02254187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850911|NCT02254226|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24850912|NCT02254226|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24850913|NCT02254226|Autonomic Agents|autonomic agents|mesh-ancestor
24937286|NCT04030988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24937287|NCT04030988|Antiemetics|antiemetics|mesh-ancestor
24937288|NCT04030988|Autonomic Agents|autonomic agents|mesh-ancestor
24937289|NCT04030988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937290|NCT04030988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937291|NCT04030988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24937292|NCT04030988|Glucocorticoids|glucocorticoids|mesh-ancestor
24937293|NCT04030988|Hormones|hormones|mesh-ancestor
24937294|NCT04030988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24937295|NCT04030988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24937296|NCT04030988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24937297|NCT04030715|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24937298|NCT04030715|Bismuth|bismuth|mesh-list
24937299|NCT04030715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24937300|NCT04030715|Antacids|antacids|mesh-ancestor
24937301|NCT04030715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850925|NCT02254239|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24850926|NCT02254239|Everolimus|everolimus|mesh-list
24850927|NCT02254239|Antibodies|antibodies|mesh-list
24937322|NCT04030572|Analgesics|analgesics|mesh-ancestor
24937323|NCT04030572|Sensory System Agents|sensory system agents|mesh-ancestor
24937324|NCT04030572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937325|NCT04030572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937326|NCT04030572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24937327|NCT04030572|Sympatholytics|sympatholytics|mesh-ancestor
24937328|NCT04030572|Autonomic Agents|autonomic agents|mesh-ancestor
24937329|NCT04030572|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24850941|NCT02254525|Ibuprofen|ibuprofen|mesh-list
24533990|NCT00645606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24533991|NCT00645632|Doxorubicin|doxorubicin|mesh-list
24533992|NCT00645632|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24533993|NCT00645632|Methotrexate|methotrexate|mesh-list
24534024|NCT00645801|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24534025|NCT00645801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24534026|NCT00645801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446051|NCT00303758|Leucovorin|leucovorin|mesh-list
24534027|NCT00645814|Adalimumab|adalimumab|mesh-list
24534028|NCT00645814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24534029|NCT00645814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24534030|NCT00645866|Docetaxel|docetaxel|mesh-list
24534031|NCT00645866|Capecitabine|capecitabine|mesh-list
24534032|NCT00645866|Epirubicin|epirubicin|mesh-list
24534033|NCT00645866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24534034|NCT00645866|Tubulin Modulators|tubulin modulators|mesh-ancestor
24534035|NCT00645866|Antimitotic Agents|antimitotic agents|mesh-ancestor
24534088|NCT00646009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24534090|NCT00646009|Adrenergic Agents|adrenergic agents|mesh-ancestor
24534091|NCT00646009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24937354|NCT04029831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24937355|NCT04029831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24937356|NCT04029831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937357|NCT04029831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24937358|NCT04029831|Anesthetics, General|anesthetics, general|mesh-ancestor
24937359|NCT04029831|Anesthetics|anesthetics|mesh-ancestor
24937360|NCT04029831|Analgesics|analgesics|mesh-ancestor
24937361|NCT04029831|Sensory System Agents|sensory system agents|mesh-ancestor
24937362|NCT04029831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937363|NCT04029831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24937364|NCT04029831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24937365|NCT04029831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24937366|NCT04029831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24937367|NCT04029831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937369|NCT04029675|Vitamins|vitamins|mesh-ancestor
24937370|NCT04029675|Micronutrients|micronutrients|mesh-ancestor
24937371|NCT04029675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937374|NCT04029675|Protective Agents|protective agents|mesh-ancestor
24937376|NCT04029636|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24937377|NCT04029636|Anesthetics, General|anesthetics, general|mesh-ancestor
24937378|NCT04029636|Anesthetics|anesthetics|mesh-ancestor
24534115|NCT00646087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24534116|NCT00646087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534117|NCT00646087|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24937379|NCT04029636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24534133|NCT00646126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24534140|NCT00646126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534141|NCT00646126|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24534143|NCT00646139|Tirbanibulin|tirbanibulin|mesh-list
24851080|NCT02255253|Diuretics|diuretics|mesh-ancestor
24937426|NCT04028778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937427|NCT04028856|Interferons|interferons|mesh-list
24937428|NCT04028856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24937429|NCT04028856|Antiviral Agents|antiviral agents|mesh-ancestor
24937430|NCT04028856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24937431|NCT04028830|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24937432|NCT04028830|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24937433|NCT04028830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24937434|NCT04028830|Antitubercular Agents|antitubercular agents|mesh-ancestor
24851004|NCT02254915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24851005|NCT02254915|Immunologic Factors|immunologic factors|mesh-ancestor
24851006|NCT02254915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851007|NCT02254954|Temozolomide|temozolomide|mesh-list
24851008|NCT02254954|Macitentan|macitentan|mesh-list
24851009|NCT02254954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24851010|NCT02254954|Alkylating Agents|alkylating agents|mesh-ancestor
24851011|NCT02254954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851012|NCT02254954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24851013|NCT02254954|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
24851014|NCT02254954|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24851015|NCT02254954|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
24937452|NCT04028804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24937453|NCT04028739|Curcumin|curcumin|mesh-list
24937454|NCT04028739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24937455|NCT04028739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24937456|NCT04028739|Analgesics|analgesics|mesh-ancestor
24937457|NCT04028739|Sensory System Agents|sensory system agents|mesh-ancestor
24851021|NCT02254980|Vitamins|vitamins|mesh-ancestor
24851022|NCT02254980|Micronutrients|micronutrients|mesh-ancestor
24851023|NCT02254980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851024|NCT02254980|Antioxidants|antioxidants|mesh-ancestor
24534148|NCT00646152|Immunologic Factors|immunologic factors|mesh-ancestor
24534149|NCT00646152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534150|NCT00646178|Adalimumab|adalimumab|mesh-list
24534151|NCT00646178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24534152|NCT00646178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24534153|NCT00646191|Adalimumab|adalimumab|mesh-list
24937458|NCT04028739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937459|NCT04028739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937460|NCT04028739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24937461|NCT04028739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24937462|NCT04028739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24937463|NCT04028739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24937464|NCT04028739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851081|NCT02255253|Natriuretic Agents|natriuretic agents|mesh-ancestor
24534180|NCT00646321|Glucocorticoids|glucocorticoids|mesh-ancestor
24534181|NCT00646321|Hormones|hormones|mesh-ancestor
24534182|NCT00646321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24534183|NCT00646321|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24851061|NCT02255162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24851062|NCT02255162|Antimetabolites|antimetabolites|mesh-ancestor
24851063|NCT02255162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937510|NCT04028141|Propofol|propofol|mesh-list
24937511|NCT04028141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24937512|NCT04028141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24937513|NCT04028141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953794|NCT03881644|Serotonin Agents|serotonin agents|mesh-ancestor
24953795|NCT03881644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24953796|NCT03881644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24953797|NCT03881644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24953798|NCT03881644|Growth Substances|growth substances|mesh-ancestor
24953799|NCT03881644|Vasodilator Agents|vasodilator agents|mesh-ancestor
24851064|NCT02255162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24851065|NCT02255162|Antiviral Agents|antiviral agents|mesh-ancestor
24851066|NCT02255162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24851067|NCT02255162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24851068|NCT02255162|Immunologic Factors|immunologic factors|mesh-ancestor
24534191|NCT00646386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24534193|NCT00646425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24534194|NCT00646425|Immunologic Factors|immunologic factors|mesh-ancestor
24534195|NCT00646425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534196|NCT00646503|Telbivudine|telbivudine|mesh-list
24953801|NCT03881787|Antibodies|antibodies|mesh-list
24953802|NCT03881787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24953803|NCT03881787|Immunologic Factors|immunologic factors|mesh-ancestor
24953804|NCT03881787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937514|NCT04028141|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24937515|NCT04028141|Anesthetics, General|anesthetics, general|mesh-ancestor
24937516|NCT04028141|Anesthetics|anesthetics|mesh-ancestor
24937517|NCT04028141|Analgesics|analgesics|mesh-ancestor
24937518|NCT04028141|Sensory System Agents|sensory system agents|mesh-ancestor
24851074|NCT02255227|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24851075|NCT02255227|Immunologic Factors|immunologic factors|mesh-ancestor
24851076|NCT02255227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851077|NCT02255253|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24851078|NCT02255253|Telmisartan|telmisartan|mesh-list
24851079|NCT02255253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24937519|NCT04028141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937520|NCT04028141|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24937521|NCT04028141|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24937522|NCT04028141|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24937523|NCT04028141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24937524|NCT04028141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937537|NCT04027972|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24937538|NCT04027972|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24937540|NCT04027829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24937541|NCT04027829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24851082|NCT02255253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937551|NCT04027829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24937552|NCT04027829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937554|NCT04027764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24937555|NCT04027764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24937556|NCT04027764|Tubulin Modulators|tubulin modulators|mesh-ancestor
24937557|NCT04027764|Antimitotic Agents|antimitotic agents|mesh-ancestor
24937558|NCT04027764|Mitosis Modulators|mitosis modulators|mesh-ancestor
25075935|NCT03377218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24851086|NCT02255253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24851087|NCT02255253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24851088|NCT02255266|Liraglutide|liraglutide|mesh-list
24851089|NCT02255266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24649465|NCT01220076|Tamoxifen|tamoxifen|mesh-list
24937566|NCT04027751|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24937567|NCT04027751|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24937568|NCT04027751|Serotonin Agents|serotonin agents|mesh-ancestor
24937569|NCT04027751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24937570|NCT04027751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937571|NCT04028024|Urinastatin|urinastatin|mesh-list
24937572|NCT04028024|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24937573|NCT04028024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24851090|NCT02255266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851091|NCT02255266|Incretins|incretins|mesh-ancestor
24851093|NCT02255266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24851094|NCT02255292|Cannabidiol|cannabidiol|mesh-list
24851095|NCT02255292|Anticonvulsants|anticonvulsants|mesh-ancestor
24851096|NCT02255305|Anti-Infective Agents|anti-infective agents|mesh-list
24851097|NCT02255305|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24851098|NCT02255370|Curcumin|curcumin|mesh-list
24851099|NCT02255370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24851100|NCT02255370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24851101|NCT02255370|Analgesics|analgesics|mesh-ancestor
24534203|NCT00646516|Formoterol Fumarate|formoterol fumarate|mesh-list
24534204|NCT00646516|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24937574|NCT04028024|Protease Inhibitors|protease inhibitors|mesh-ancestor
24937575|NCT04028024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075936|NCT03377218|Trace Elements|trace elements|mesh-ancestor
24534205|NCT00646516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24553172|NCT00729794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553173|NCT00729794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24553174|NCT00729794|Glucocorticoids|glucocorticoids|mesh-ancestor
24553175|NCT00729794|Hormones|hormones|mesh-ancestor
24851108|NCT02255370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851109|NCT02255370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851110|NCT02255396|Estradiol|estradiol|mesh-list
24851111|NCT02255396|Estrogens|estrogens|mesh-ancestor
24851112|NCT02255396|Hormones|hormones|mesh-ancestor
24851113|NCT02255396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24851114|NCT02255396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851115|NCT02255578|Clomiphene|clomiphene|mesh-list
24851116|NCT02255578|Enclomiphene|enclomiphene|mesh-list
24851117|NCT02255578|Zuclomiphene|zuclomiphene|mesh-list
24851118|NCT02255578|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24851119|NCT02255578|Hormone Antagonists|hormone antagonists|mesh-ancestor
24553176|NCT00729794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24795336|NCT02999230|Listerine|listerine|mesh-list
24553185|NCT00729794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24553186|NCT00729794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24553187|NCT00729794|Respiratory System Agents|respiratory system agents|mesh-ancestor
24553188|NCT00729794|Mydriatics|mydriatics|mesh-ancestor
24553189|NCT00729794|Sympathomimetics|sympathomimetics|mesh-ancestor
24553190|NCT00729794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24553191|NCT00729794|Hemostatics|hemostatics|mesh-ancestor
24553192|NCT00729794|Coagulants|coagulants|mesh-ancestor
24553193|NCT00729794|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24851128|NCT02255591|Epinephrine|epinephrine|mesh-list
24851129|NCT02255591|Racepinephrine|racepinephrine|mesh-list
24851130|NCT02255591|Epinephryl borate|epinephryl borate|mesh-list
24851134|NCT02255591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851135|NCT02255591|Sensory System Agents|sensory system agents|mesh-ancestor
24851136|NCT02255591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851137|NCT02255591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24851138|NCT02255591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24851139|NCT02255591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24534220|NCT00646516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534222|NCT00646529|Formoterol Fumarate|formoterol fumarate|mesh-list
24534223|NCT00646529|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24534224|NCT00646529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24553194|NCT00729794|Natriuretic Agents|natriuretic agents|mesh-ancestor
24533340|NCT00643227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24937607|NCT04027179|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24937608|NCT04027179|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24937609|NCT04027179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24937610|NCT04027179|Disinfectants|disinfectants|mesh-ancestor
24937611|NCT04027179|Dermatologic Agents|dermatologic agents|mesh-ancestor
24937635|NCT04027283|Vasodilator Agents|vasodilator agents|mesh-ancestor
24937636|NCT04026841|Antibodies|antibodies|mesh-list
24937637|NCT04026841|Immunologic Factors|immunologic factors|mesh-ancestor
24937638|NCT04026841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937639|NCT04026685|Phenylephrine|phenylephrine|mesh-list
24937640|NCT04026685|Oxymetazoline|oxymetazoline|mesh-list
24851186|NCT02255942|Zinc|zinc|mesh-list
24937641|NCT04026685|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24937642|NCT04026685|Mydriatics|mydriatics|mesh-ancestor
24937643|NCT04026685|Autonomic Agents|autonomic agents|mesh-ancestor
24937644|NCT04026685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937645|NCT04026685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937646|NCT04026685|Sympathomimetics|sympathomimetics|mesh-ancestor
24937647|NCT04026685|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24937648|NCT04026685|Nasal Decongestants|nasal decongestants|mesh-ancestor
24937649|NCT04026685|Respiratory System Agents|respiratory system agents|mesh-ancestor
24851200|NCT02255955|Codeine|codeine|mesh-list
24851201|NCT02255955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24851202|NCT02255955|Analgesics|analgesics|mesh-ancestor
24851203|NCT02255955|Sensory System Agents|sensory system agents|mesh-ancestor
24534248|NCT00646594|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24444662|NCT00298857|Valproic Acid|valproic acid|mesh-list
24534249|NCT00646594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24534250|NCT00646594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24937650|NCT04026685|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25704538|NCT02181816|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25704539|NCT02181816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24937651|NCT04026685|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24937652|NCT04026685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24937653|NCT04026685|Adrenergic Agents|adrenergic agents|mesh-ancestor
24937654|NCT04026685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24937656|NCT04026685|Protective Agents|protective agents|mesh-ancestor
24937672|NCT04026464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24851215|NCT02255955|Narcotics|narcotics|mesh-ancestor
24851216|NCT02255955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24851217|NCT02255955|Antitussive Agents|antitussive agents|mesh-ancestor
24851218|NCT02255955|Respiratory System Agents|respiratory system agents|mesh-ancestor
24812197|NCT02050178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24812198|NCT02050178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812199|NCT02050178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24812200|NCT02050178|Immunologic Factors|immunologic factors|mesh-ancestor
24534253|NCT00646594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534254|NCT00646594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24534255|NCT00646594|Respiratory System Agents|respiratory system agents|mesh-ancestor
24534256|NCT00646594|Dermatologic Agents|dermatologic agents|mesh-ancestor
24534257|NCT00646594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24534258|NCT00646594|Glucocorticoids|glucocorticoids|mesh-ancestor
24534259|NCT00646594|Hormones|hormones|mesh-ancestor
24534260|NCT00646594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24534264|NCT00646594|Adrenergic Agents|adrenergic agents|mesh-ancestor
24534265|NCT00646594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24937674|NCT04026464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24937675|NCT04026464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24937676|NCT04026464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24937677|NCT04026464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937678|NCT04026074|Clonidine|clonidine|mesh-list
24937679|NCT04026074|Fentanyl|fentanyl|mesh-list
24937680|NCT04026074|Remifentanil|remifentanil|mesh-list
24534266|NCT00646594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534267|NCT00646594|Sympathomimetics|sympathomimetics|mesh-ancestor
24534268|NCT00646607|Leucovorin|leucovorin|mesh-list
24534269|NCT00646607|Fluorouracil|fluorouracil|mesh-list
24534270|NCT00646607|Oxaliplatin|oxaliplatin|mesh-list
24534271|NCT00646607|Levoleucovorin|levoleucovorin|mesh-list
24534272|NCT00646607|Antimetabolites|antimetabolites|mesh-ancestor
24534273|NCT00646607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534274|NCT00646607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24534275|NCT00646607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24534276|NCT00646607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24534277|NCT00646607|Immunologic Factors|immunologic factors|mesh-ancestor
24534278|NCT00646607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937688|NCT04026074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937689|NCT04026074|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24937690|NCT04026074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24937691|NCT04026074|Anesthetics, General|anesthetics, general|mesh-ancestor
24937692|NCT04026074|Anesthetics|anesthetics|mesh-ancestor
24937693|NCT04026074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24937695|NCT04026074|Autonomic Agents|autonomic agents|mesh-ancestor
24534284|NCT00646620|Fluticasone|fluticasone|mesh-list
24534285|NCT00646620|Budesonide|budesonide|mesh-list
24534286|NCT00646620|Albuterol|albuterol|mesh-list
24534287|NCT00646620|Formoterol Fumarate|formoterol fumarate|mesh-list
25704540|NCT02181816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25704541|NCT02181816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25704542|NCT02181816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704543|NCT02181816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25704544|NCT02181816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704545|NCT02181816|Vasodilator Agents|vasodilator agents|mesh-ancestor
24937716|NCT04026282|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24937718|NCT04026282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24937719|NCT04026282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937720|NCT04026230|Atorvastatin|atorvastatin|mesh-list
24937721|NCT04026230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24937722|NCT04026230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24937723|NCT04026230|Antimetabolites|antimetabolites|mesh-ancestor
25075937|NCT03377218|Micronutrients|micronutrients|mesh-ancestor
24851252|NCT02256150|Analgesics|analgesics|mesh-ancestor
24851253|NCT02256150|Sensory System Agents|sensory system agents|mesh-ancestor
24851255|NCT02256150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24937726|NCT04026230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24937731|NCT04025736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937733|NCT04025736|Coagulants|coagulants|mesh-ancestor
24937734|NCT04025671|Naloxone|naloxone|mesh-list
24851261|NCT02256150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24851262|NCT02256150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851263|NCT02256215|Vitamin D|vitamin d|mesh-list
24851264|NCT02256215|Vitamins|vitamins|mesh-ancestor
24851265|NCT02256215|Micronutrients|micronutrients|mesh-ancestor
24851266|NCT02256215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851267|NCT02256215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24444844|NCT00299351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24937736|NCT04025671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937737|NCT04025671|Sensory System Agents|sensory system agents|mesh-ancestor
24937738|NCT04025671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937739|NCT04025840|Dexamethasone|dexamethasone|mesh-list
24937740|NCT04025840|Glucocorticoids|glucocorticoids|mesh-list
24937741|NCT04025840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24937742|NCT04025840|Antiemetics|antiemetics|mesh-ancestor
24937743|NCT04025840|Autonomic Agents|autonomic agents|mesh-ancestor
24937744|NCT04025840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851269|NCT02256228|Anesthetics, Local|anesthetics, local|mesh-ancestor
24851270|NCT02256228|Anesthetics|anesthetics|mesh-ancestor
24851271|NCT02256228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24851272|NCT02256228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851273|NCT02256228|Sensory System Agents|sensory system agents|mesh-ancestor
24851274|NCT02256228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851275|NCT02256254|Simvastatin|simvastatin|mesh-list
24851276|NCT02256254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24851277|NCT02256254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24851278|NCT02256254|Antimetabolites|antimetabolites|mesh-ancestor
24937747|NCT04025840|Hormones|hormones|mesh-ancestor
24937748|NCT04025840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24937749|NCT04025840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24937750|NCT04025840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24937751|NCT04025918|Phenylephrine|phenylephrine|mesh-list
24937752|NCT04025918|Oxymetazoline|oxymetazoline|mesh-list
24937753|NCT04025918|Ephedrine|ephedrine|mesh-list
24937754|NCT04025918|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
24937755|NCT04025918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24937756|NCT04025918|Mydriatics|mydriatics|mesh-ancestor
24937757|NCT04025918|Autonomic Agents|autonomic agents|mesh-ancestor
25704546|NCT02181816|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25704547|NCT02181816|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25704548|NCT02181842|Pioglitazone|pioglitazone|mesh-list
25704549|NCT02181842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25704550|NCT02181842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704551|NCT02182115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
25704552|NCT02182115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25704553|NCT02182492|Clarithromycin|clarithromycin|mesh-list
24937758|NCT04025918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937759|NCT04025918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937761|NCT04025918|Nasal Decongestants|nasal decongestants|mesh-ancestor
24937762|NCT04025918|Respiratory System Agents|respiratory system agents|mesh-ancestor
24937763|NCT04025918|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24937764|NCT04025918|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24937765|NCT04025918|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24937766|NCT04025918|Adrenergic Agents|adrenergic agents|mesh-ancestor
24937767|NCT04025918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24937768|NCT04025918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937769|NCT04025918|Protective Agents|protective agents|mesh-ancestor
24937770|NCT04025918|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24937771|NCT04025567|Vancomycin|vancomycin|mesh-list
24937786|NCT04025593|Alkylating Agents|alkylating agents|mesh-ancestor
24937787|NCT04025593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937788|NCT04025593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24937789|NCT04025593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24937790|NCT04025593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24937791|NCT04025593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24937792|NCT04025593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24937793|NCT04025593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24937794|NCT04025593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24937795|NCT04025593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24937796|NCT04025593|Glucocorticoids|glucocorticoids|mesh-ancestor
24851318|NCT02256423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851319|NCT02256423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851320|NCT02256423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24851321|NCT02256423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24851322|NCT02256423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24851323|NCT02256423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851324|NCT02256423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851325|NCT02256462|Adalimumab|adalimumab|mesh-list
24851326|NCT02256462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24851327|NCT02256462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24851328|NCT02256605|Vitamin D|vitamin d|mesh-list
24851329|NCT02256605|Cholecalciferol|cholecalciferol|mesh-list
24444846|NCT00299364|Androgen Antagonists|androgen antagonists|mesh-ancestor
24534288|NCT00646620|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24534289|NCT00646620|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24444858|NCT00299377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24534290|NCT00646620|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24851330|NCT02256605|Vitamins|vitamins|mesh-ancestor
24851331|NCT02256605|Micronutrients|micronutrients|mesh-ancestor
24851332|NCT02256605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851333|NCT02256605|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24762628|NCT01768897|Sensory System Agents|sensory system agents|mesh-ancestor
24762629|NCT01768897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851342|NCT02256683|Anticoagulants|anticoagulants|mesh-ancestor
24762634|NCT01768897|Protective Agents|protective agents|mesh-ancestor
24762635|NCT01768897|Vitamin B Complex|vitamin b complex|mesh-ancestor
24762637|NCT01768897|Micronutrients|micronutrients|mesh-ancestor
24851367|NCT02256722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25704554|NCT02182492|Glucocorticoids|glucocorticoids|mesh-list
25704555|NCT02182492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25704556|NCT02182492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25704557|NCT02182492|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25704558|NCT02182492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25704559|NCT02182492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704560|NCT02182492|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25704561|NCT02182492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24534322|NCT00646659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24534323|NCT00646659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24534325|NCT00646659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534326|NCT00646659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24534327|NCT00646711|Valproic Acid|valproic acid|mesh-list
24534330|NCT00646711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534370|NCT00646841|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24534371|NCT00646841|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24534372|NCT00646841|Adrenergic Agents|adrenergic agents|mesh-ancestor
24534373|NCT00646841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24534374|NCT00646841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534395|NCT00646854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24534396|NCT00646854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534416|NCT00646932|Vitamins|vitamins|mesh-ancestor
24451022|NCT00321490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24446098|NCT00303784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446099|NCT00303784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24446100|NCT00303784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446101|NCT00303797|Bortezomib|bortezomib|mesh-list
24446102|NCT00303797|Sorafenib|sorafenib|mesh-list
24534463|NCT00647127|Fentanyl|fentanyl|mesh-list
24779912|NCT01879605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24779913|NCT01879605|Laxatives|laxatives|mesh-ancestor
24779914|NCT01879748|Rasagiline|rasagiline|mesh-list
24937907|NCT04024241|Mitoxantrone|mitoxantrone|mesh-list
24937871|NCT04024865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937872|NCT04024865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24937873|NCT04024865|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24937874|NCT04024865|Dopamine Agents|dopamine agents|mesh-ancestor
24937875|NCT04024865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24937876|NCT04024865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937877|NCT04024813|Seladelpar|seladelpar|mesh-list
24937879|NCT04024813|Antimetabolites|antimetabolites|mesh-ancestor
24937880|NCT04024813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534582|NCT00647647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937881|NCT04024813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24937882|NCT04024527|Amoxicillin|amoxicillin|mesh-list
24937883|NCT04024527|Metronidazole|metronidazole|mesh-list
24937884|NCT04024527|Esomeprazole|esomeprazole|mesh-list
24937885|NCT04024527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24937886|NCT04024527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24937887|NCT04024527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24937888|NCT04024527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25709640|NCT02271698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25709641|NCT02271698|Protease Inhibitors|protease inhibitors|mesh-ancestor
25709642|NCT02271698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709643|NCT02271698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709644|NCT02271854|Diclofenac|diclofenac|mesh-list
25709645|NCT02271854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25709646|NCT02271854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25709647|NCT02271854|Analgesics|analgesics|mesh-ancestor
25709648|NCT02271854|Sensory System Agents|sensory system agents|mesh-ancestor
24701596|NCT01459627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24613314|NCT01018251|Alovudine|alovudine|mesh-list
24534707|NCT00647868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24534708|NCT00647868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534710|NCT00647881|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24534711|NCT00647881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24534712|NCT00647881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24534713|NCT00647881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534714|NCT00647881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24534715|NCT00647881|Serotonin Agents|serotonin agents|mesh-ancestor
24534718|NCT00647881|Antidepressive Agents|antidepressive agents|mesh-ancestor
24937908|NCT04024241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24937916|NCT04024241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937918|NCT04024241|Sensory System Agents|sensory system agents|mesh-ancestor
25050320|NCT00520923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25050321|NCT00520923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25050322|NCT00520923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25050323|NCT00520923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25050324|NCT00520923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25050325|NCT00520923|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25050326|NCT00520923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24937919|NCT04024241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25704563|NCT02182492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25704564|NCT02182492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704565|NCT02182830|Empagliflozin|empagliflozin|mesh-list
25704566|NCT02182830|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25704567|NCT02182830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704568|NCT02182830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25704569|NCT02182830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704570|NCT02182895|Saxagliptin|saxagliptin|mesh-list
24701642|NCT01460030|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24701643|NCT01460030|Hormone Antagonists|hormone antagonists|mesh-ancestor
24701644|NCT01460030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24701646|NCT01460069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24701647|NCT01460069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937920|NCT04024241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24937921|NCT04024241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24851461|NCT02256826|Ritonavir|ritonavir|mesh-list
24937926|NCT04024163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937927|NCT04024163|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24937928|NCT04024163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24937929|NCT04024163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24937930|NCT04024163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24937931|NCT04024072|Brinzolamide|brinzolamide|mesh-list
24937932|NCT04024072|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24937933|NCT04024072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075938|NCT03377218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851483|NCT02256878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24851484|NCT02256878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24534752|NCT00647946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24534754|NCT00647946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24534755|NCT00647946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534756|NCT00647946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534757|NCT00647946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24534758|NCT00647946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24534759|NCT00647959|Doxycycline|doxycycline|mesh-list
24534760|NCT00647959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24534761|NCT00647959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24534762|NCT00647959|Antimalarials|antimalarials|mesh-ancestor
24534763|NCT00647959|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24534764|NCT00647959|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24534765|NCT00647972|Olanzapine|olanzapine|mesh-list
24534766|NCT00647972|Antiemetics|antiemetics|mesh-ancestor
24534767|NCT00647972|Autonomic Agents|autonomic agents|mesh-ancestor
24534768|NCT00647972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24534769|NCT00647972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444220|NCT00297011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24937934|NCT04024072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937936|NCT04023760|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24937937|NCT04023760|Antithrombins|antithrombins|mesh-ancestor
24937938|NCT04023760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24937939|NCT04023760|Protease Inhibitors|protease inhibitors|mesh-ancestor
24937940|NCT04023760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800379|NCT01975324|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24937941|NCT04023760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937943|NCT04023565|Perindopril|perindopril|mesh-list
24937944|NCT04023565|Moxonidine|moxonidine|mesh-list
24937945|NCT04023565|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24937946|NCT04023565|Protease Inhibitors|protease inhibitors|mesh-ancestor
24937947|NCT04023565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25075939|NCT03377218|Antioxidants|antioxidants|mesh-ancestor
25704571|NCT02182895|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25704572|NCT02182895|Incretins|incretins|mesh-ancestor
25704573|NCT02182895|Hormones|hormones|mesh-ancestor
25704574|NCT02182895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25704575|NCT02182895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704576|NCT02182895|Protease Inhibitors|protease inhibitors|mesh-ancestor
24702507|NCT01466231|Everolimus|everolimus|mesh-list
24812216|NCT02050529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812217|NCT02050529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24812219|NCT02050529|Autonomic Agents|autonomic agents|mesh-ancestor
24812220|NCT02050529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812221|NCT02050529|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24534815|NCT00648063|Letrozole|letrozole|mesh-list
24534816|NCT00648063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24534817|NCT00648063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24534818|NCT00648063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24534825|NCT00648076|Valproic Acid|valproic acid|mesh-list
24937968|NCT04023630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24937969|NCT04023630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937970|NCT04023630|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24937971|NCT04023630|Antithrombins|antithrombins|mesh-ancestor
24937972|NCT04023630|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24937973|NCT04023630|Protease Inhibitors|protease inhibitors|mesh-ancestor
24937974|NCT04023630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24937975|NCT04023630|Anticoagulants|anticoagulants|mesh-ancestor
24812231|NCT02050672|Vitamins|vitamins|mesh-ancestor
24812232|NCT02050672|Micronutrients|micronutrients|mesh-ancestor
24812233|NCT02050672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812234|NCT02050724|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
25704577|NCT02182895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25704578|NCT02182895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704579|NCT02182895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25704580|NCT02182999|Ropivacaine|ropivacaine|mesh-list
24534843|NCT00648128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24534845|NCT00648141|Diclofenac|diclofenac|mesh-list
24534846|NCT00648141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24534847|NCT00648141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24534848|NCT00648141|Analgesics|analgesics|mesh-ancestor
24534849|NCT00648141|Sensory System Agents|sensory system agents|mesh-ancestor
24534850|NCT00648141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24534851|NCT00648141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534852|NCT00648141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24534853|NCT00648141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24937976|NCT04023149|Aldesleukin|aldesleukin|mesh-list
24937977|NCT04023149|Interleukin-2|interleukin-2|mesh-list
24937978|NCT04023149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24937979|NCT04023149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24937980|NCT04023149|Analgesics|analgesics|mesh-ancestor
24937981|NCT04023149|Sensory System Agents|sensory system agents|mesh-ancestor
24937982|NCT04023149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24937983|NCT04023149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24937984|NCT04023149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24937985|NCT04023149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24937986|NCT04023149|Antiviral Agents|antiviral agents|mesh-ancestor
24937987|NCT04023149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24812240|NCT02050802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24534857|NCT00648141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534858|NCT00648154|Letrozole|letrozole|mesh-list
24534859|NCT00648154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24534860|NCT00648154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24938075|NCT04022304|Isophane Insulin, Human|isophane insulin, human|mesh-list
24938076|NCT04022304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24938077|NCT04022304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534892|NCT00648219|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24534893|NCT00648219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534894|NCT00648245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24534897|NCT00648258|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24534898|NCT00648258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24534899|NCT00648258|Analgesics|analgesics|mesh-ancestor
24534900|NCT00648258|Sensory System Agents|sensory system agents|mesh-ancestor
24534901|NCT00648258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24534902|NCT00648258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534903|NCT00648258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25704581|NCT02182999|Anesthetics, Local|anesthetics, local|mesh-ancestor
25704582|NCT02182999|Anesthetics|anesthetics|mesh-ancestor
25704583|NCT02182999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25704584|NCT02182999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704585|NCT02182999|Sensory System Agents|sensory system agents|mesh-ancestor
25704586|NCT02182999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24534904|NCT00648258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24534905|NCT00648258|Gout Suppressants|gout suppressants|mesh-ancestor
24534906|NCT00648258|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24938078|NCT04022473|Dimethyl Fumarate|dimethyl fumarate|mesh-list
24938079|NCT04022473|Dermatologic Agents|dermatologic agents|mesh-ancestor
24938088|NCT04022525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938090|NCT04022161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24938091|NCT04022161|Autonomic Agents|autonomic agents|mesh-ancestor
24938092|NCT04022161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24938093|NCT04022161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851527|NCT02256956|Adrenergic Agents|adrenergic agents|mesh-ancestor
24534944|NCT00648310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534950|NCT00648310|Urological Agents|urological agents|mesh-ancestor
24534952|NCT00648323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24534953|NCT00648323|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24534954|NCT00648323|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24534955|NCT00648323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24534956|NCT00648323|Adrenergic Agents|adrenergic agents|mesh-ancestor
24534957|NCT00648323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24534958|NCT00648323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534959|NCT00648323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534960|NCT00648336|Mercaptopurine|mercaptopurine|mesh-list
24534961|NCT00648336|Antimetabolites|antimetabolites|mesh-ancestor
24534962|NCT00648336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704049|NCT01476358|Vitamin A|vitamin a|mesh-list
24534968|NCT00648336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24534970|NCT00648349|Rabeprazole|rabeprazole|mesh-list
24938094|NCT04022161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24938095|NCT04022161|Respiratory System Agents|respiratory system agents|mesh-ancestor
24938096|NCT04022161|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24534984|NCT00648388|Autonomic Agents|autonomic agents|mesh-ancestor
24534985|NCT00648388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24534986|NCT00648388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534987|NCT00648388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24534988|NCT00648388|Respiratory System Agents|respiratory system agents|mesh-ancestor
24535031|NCT00648427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24535033|NCT00648440|Midodrine|midodrine|mesh-list
24535034|NCT00648440|Sympathomimetics|sympathomimetics|mesh-ancestor
24535035|NCT00648440|Autonomic Agents|autonomic agents|mesh-ancestor
24535036|NCT00648440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24445087|NCT00300339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24445088|NCT00300339|Purinergic Agents|purinergic agents|mesh-ancestor
24445089|NCT00300339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24445090|NCT00300339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445091|NCT00300339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445092|NCT00300352|Folic Acid|folic acid|mesh-list
24445093|NCT00300352|Hematinics|hematinics|mesh-ancestor
24445094|NCT00300352|Vitamin B Complex|vitamin b complex|mesh-ancestor
24445095|NCT00300352|Vitamins|vitamins|mesh-ancestor
24445096|NCT00300352|Micronutrients|micronutrients|mesh-ancestor
25704587|NCT02183519|Capsaicin|capsaicin|mesh-list
25704588|NCT02183519|Antipruritics|antipruritics|mesh-ancestor
25704589|NCT02183519|Dermatologic Agents|dermatologic agents|mesh-ancestor
25704590|NCT02183519|Sensory System Agents|sensory system agents|mesh-ancestor
25704591|NCT02183519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25704592|NCT02183519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704593|NCT02183675|Amlodipine|amlodipine|mesh-list
25704594|NCT02183675|Telmisartan|telmisartan|mesh-list
25704595|NCT02183675|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25704596|NCT02183675|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
25704597|NCT02183675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25704598|NCT02183675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25704599|NCT02183675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24938121|NCT04022291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24938122|NCT04022291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938124|NCT04022317|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24938125|NCT04022317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24938126|NCT04022317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938127|NCT04022135|Folic Acid|folic acid|mesh-list
24938132|NCT04022135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938134|NCT04021992|Rituximab|rituximab|mesh-list
24938135|NCT04021992|Doxorubicin|doxorubicin|mesh-list
24938136|NCT04021992|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24938138|NCT04021992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24938140|NCT04021992|Immunologic Factors|immunologic factors|mesh-ancestor
24535064|NCT00648492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535067|NCT00648505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24535104|NCT00648570|Parasympatholytics|parasympatholytics|mesh-ancestor
24535105|NCT00648570|Autonomic Agents|autonomic agents|mesh-ancestor
24535106|NCT00648570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24445332|NCT00301236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24445333|NCT00301236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445335|NCT00301236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24445336|NCT00301236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24535107|NCT00648570|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24535108|NCT00648570|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24535109|NCT00648570|Cholinergic Agents|cholinergic agents|mesh-ancestor
25704600|NCT02183675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535110|NCT00648583|Ondansetron|ondansetron|mesh-list
24535111|NCT00648583|Antiemetics|antiemetics|mesh-ancestor
24535112|NCT00648583|Autonomic Agents|autonomic agents|mesh-ancestor
24535113|NCT00648583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25704601|NCT02183675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25704602|NCT02183675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704603|NCT02183675|Vasodilator Agents|vasodilator agents|mesh-ancestor
25704604|NCT02183675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25704605|NCT02183675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25704606|NCT02183675|Diuretics|diuretics|mesh-ancestor
25704607|NCT02183675|Natriuretic Agents|natriuretic agents|mesh-ancestor
24445403|NCT00301522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24445404|NCT00301522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445405|NCT00301522|Tubulin Modulators|tubulin modulators|mesh-ancestor
24445504|NCT00301665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535117|NCT00648583|Dermatologic Agents|dermatologic agents|mesh-ancestor
24535118|NCT00648583|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24535119|NCT00648583|Serotonin Agents|serotonin agents|mesh-ancestor
24535120|NCT00648583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535121|NCT00648583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535122|NCT00648583|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24535123|NCT00648583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24535124|NCT00648583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24535125|NCT00648583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24535126|NCT00648583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24535127|NCT00648596|Sildenafil Citrate|sildenafil citrate|mesh-list
24535128|NCT00648596|Vasodilator Agents|vasodilator agents|mesh-ancestor
24535129|NCT00648596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24535130|NCT00648596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24535131|NCT00648596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535132|NCT00648596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445505|NCT00301665|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24445507|NCT00301730|Aldesleukin|aldesleukin|mesh-list
24535133|NCT00648596|Urological Agents|urological agents|mesh-ancestor
24535135|NCT00648622|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24938159|NCT04022005|Oxaliplatin|oxaliplatin|mesh-list
24938160|NCT04022005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24938161|NCT04022005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24938162|NCT04022005|Immunologic Factors|immunologic factors|mesh-ancestor
24938163|NCT04022005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705619|NCT01485835|Hormones|hormones|mesh-ancestor
24451142|NCT00322400|Docetaxel|docetaxel|mesh-list
24451143|NCT00322400|Motesanib diphosphate|motesanib diphosphate|mesh-list
24451144|NCT00322400|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24938167|NCT04022005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938168|NCT04022005|Antiviral Agents|antiviral agents|mesh-ancestor
24938169|NCT04022005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24938170|NCT04022005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445821|NCT00302666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445823|NCT00302666|Hormones|hormones|mesh-ancestor
24445824|NCT00302666|Anabolic Agents|anabolic agents|mesh-ancestor
24445825|NCT00302692|Metoprolol|metoprolol|mesh-list
24445826|NCT00302692|Esmolol|esmolol|mesh-list
24938171|NCT04022005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24938172|NCT04021498|Simvastatin|simvastatin|mesh-list
24938173|NCT04021498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24938174|NCT04021498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24938192|NCT04021433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24938193|NCT04021433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938195|NCT04021420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24851590|NCT02257398|Contraceptive Agents|contraceptive agents|mesh-ancestor
24535195|NCT00648778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24535196|NCT00648778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24535197|NCT00648778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938196|NCT04021420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24938197|NCT04021420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24938198|NCT04021420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938199|NCT04021225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24938200|NCT04021225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24938201|NCT04021017|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24938202|NCT04021017|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24938203|NCT04021017|Estradiol|estradiol|mesh-list
24938204|NCT04021017|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24938207|NCT04021017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24851623|NCT02257502|Aflibercept|aflibercept|mesh-list
24535243|NCT00648830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535244|NCT00648830|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25704608|NCT02183675|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24762957|NCT01770301|Bevacizumab|bevacizumab|mesh-list
24851635|NCT02257671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851640|NCT02257671|Estrogens|estrogens|mesh-ancestor
24535245|NCT00648830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24535247|NCT00648843|Parasympatholytics|parasympatholytics|mesh-ancestor
24938256|NCT04020588|Minocycline|minocycline|mesh-list
24938258|NCT04020588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24938259|NCT04020588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24938260|NCT04020588|Analgesics|analgesics|mesh-ancestor
24938261|NCT04020588|Sensory System Agents|sensory system agents|mesh-ancestor
24938262|NCT04020588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24938263|NCT04020588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938264|NCT04020588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24938265|NCT04020588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24851645|NCT02257697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24851646|NCT02257697|Immunologic Factors|immunologic factors|mesh-ancestor
24851648|NCT02257697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24938269|NCT04020588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938270|NCT04020588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24938271|NCT04020588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24938272|NCT04020705|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
24938273|NCT04020705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24938274|NCT04020705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24938276|NCT04020536|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24938277|NCT04020536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24851668|NCT02257788|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24851669|NCT02257788|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24851670|NCT02257788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851671|NCT02257788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24851672|NCT02257788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24851673|NCT02257788|Antiviral Agents|antiviral agents|mesh-ancestor
24851674|NCT02257788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24851675|NCT02257918|Ceftriaxone|ceftriaxone|mesh-list
24851676|NCT02257918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24851677|NCT02257918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24851678|NCT02258009|Ranibizumab|ranibizumab|mesh-list
24851679|NCT02258009|Aflibercept|aflibercept|mesh-list
24938279|NCT04020380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24938280|NCT04020380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24938281|NCT04020406|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24938282|NCT04020406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24938283|NCT04020445|Insulin|insulin|mesh-list
24938284|NCT04020445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24535283|NCT00648921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535284|NCT00648921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535285|NCT00648921|Serotonin Agents|serotonin agents|mesh-ancestor
24535287|NCT00648934|Anticonvulsants|anticonvulsants|mesh-ancestor
24535312|NCT00648973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24535313|NCT00648973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24535314|NCT00648973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535316|NCT00648973|Anesthetics|anesthetics|mesh-ancestor
24938288|NCT04020328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24938289|NCT04020328|Glucocorticoids|glucocorticoids|mesh-ancestor
24938291|NCT04020328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24938292|NCT04020328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938293|NCT04020328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24938294|NCT04020328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24938295|NCT04020328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851689|NCT02258204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851690|NCT02258204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851691|NCT02258204|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24851692|NCT02258204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24851693|NCT02258204|Anesthetics, General|anesthetics, general|mesh-ancestor
24938296|NCT04020328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938297|NCT04020328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24938298|NCT04020328|Immunologic Factors|immunologic factors|mesh-ancestor
24938299|NCT04020263|Simendan|simendan|mesh-list
24938301|NCT04020263|Vasodilator Agents|vasodilator agents|mesh-ancestor
24938302|NCT04020263|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24938303|NCT04020263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24938304|NCT04020263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24938305|NCT04020263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938306|NCT04020263|Protective Agents|protective agents|mesh-ancestor
24859055|NCT02301494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24444924|NCT00299676|Nootropic Agents|nootropic agents|mesh-ancestor
24444925|NCT00299754|Misoprostol|misoprostol|mesh-list
24444926|NCT00299754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24938328|NCT04020133|Bupivacaine|bupivacaine|mesh-list
24938329|NCT04020133|Anesthetics, Local|anesthetics, local|mesh-ancestor
24938330|NCT04020133|Anesthetics|anesthetics|mesh-ancestor
24938331|NCT04020133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24938332|NCT04020133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938333|NCT04020133|Sensory System Agents|sensory system agents|mesh-ancestor
24938334|NCT04020133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24938335|NCT04020133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24851726|NCT02258607|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
24851727|NCT02258607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24851728|NCT02258607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24851729|NCT02258607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535325|NCT00648973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535326|NCT00648973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535327|NCT00648973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24535328|NCT00648973|Antipruritics|antipruritics|mesh-ancestor
24535329|NCT00648973|Dermatologic Agents|dermatologic agents|mesh-ancestor
24535330|NCT00648973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24535331|NCT00648973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24535332|NCT00648973|Respiratory System Agents|respiratory system agents|mesh-ancestor
24535333|NCT00648973|Nasal Decongestants|nasal decongestants|mesh-ancestor
24535339|NCT00648986|Dermatologic Agents|dermatologic agents|mesh-ancestor
24535340|NCT00648986|Keratolytic Agents|keratolytic agents|mesh-ancestor
24535342|NCT00648999|Lopinavir|lopinavir|mesh-list
24535343|NCT00648999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24938336|NCT04020133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24938337|NCT04020133|Adrenergic Agents|adrenergic agents|mesh-ancestor
24938338|NCT04020133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535348|NCT00648999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24535353|NCT00648999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24938349|NCT04019782|Viscosupplements|viscosupplements|mesh-ancestor
24938350|NCT04019782|Protective Agents|protective agents|mesh-ancestor
24938351|NCT04019782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938353|NCT04019496|Salmon calcitonin|salmon calcitonin|mesh-list
24938354|NCT04019496|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
24938355|NCT04019496|Antibodies|antibodies|mesh-list
24938356|NCT04019496|Katacalcin|katacalcin|mesh-list
24938357|NCT04019496|Immunologic Factors|immunologic factors|mesh-ancestor
25050328|NCT00520923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050329|NCT00520923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050330|NCT00520923|Serotonin Agents|serotonin agents|mesh-ancestor
25050331|NCT00519142|Mitiglinide|mitiglinide|mesh-list
25050332|NCT00519142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25050333|NCT00519142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812294|NCT02051231|Oxytocin|oxytocin|mesh-list
24535365|NCT00649038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535366|NCT00649038|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24535367|NCT00649038|Protease Inhibitors|protease inhibitors|mesh-ancestor
25050338|NCT00517439|Immunologic Factors|immunologic factors|mesh-ancestor
24831996|NCT02170038|Contraceptive Agents|contraceptive agents|mesh-ancestor
25704609|NCT02183792|Furosemide|furosemide|mesh-list
25704610|NCT02183792|Tolvaptan|tolvaptan|mesh-list
25704611|NCT02183792|Diuretics|diuretics|mesh-ancestor
25704612|NCT02183792|Natriuretic Agents|natriuretic agents|mesh-ancestor
25704613|NCT02183792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704614|NCT02183792|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25704615|NCT02183792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25704616|NCT02183792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709649|NCT02271854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24708382|NCT01501136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24708383|NCT01501136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24708384|NCT01501136|Alkylating Agents|alkylating agents|mesh-ancestor
24708386|NCT01501149|Gemcitabine|gemcitabine|mesh-list
25050342|NCT00517153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812306|NCT02051387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812307|NCT02051387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851739|NCT02258620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851740|NCT02258620|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24851741|NCT02258620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851742|NCT02258763|Amoxicillin|amoxicillin|mesh-list
24445145|NCT00300573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445146|NCT00300573|Antiviral Agents|antiviral agents|mesh-ancestor
24445147|NCT00300573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24445148|NCT00300573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24445149|NCT00300573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24445150|NCT00300586|Gemcitabine|gemcitabine|mesh-list
24445151|NCT00300586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24445152|NCT00300586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24445153|NCT00300586|Antimetabolites|antimetabolites|mesh-ancestor
24445154|NCT00300586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445155|NCT00300586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445156|NCT00300586|Antiviral Agents|antiviral agents|mesh-ancestor
24445157|NCT00300586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24445158|NCT00300586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050344|NCT00517153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25050345|NCT00517153|Antiviral Agents|antiviral agents|mesh-ancestor
25050346|NCT00517153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24851743|NCT02258763|Clavulanic Acid|clavulanic acid|mesh-list
24851744|NCT02258763|Clavulanic Acids|clavulanic acids|mesh-list
24535381|NCT00649064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535383|NCT00649064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24535384|NCT00649064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25050354|NCT00517049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704617|NCT02183792|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25704618|NCT02184572|Vaccines|vaccines|mesh-list
25704619|NCT02184572|Immunologic Factors|immunologic factors|mesh-ancestor
25704620|NCT02184572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704621|NCT02184611|Bromides|bromides|mesh-list
25704622|NCT02184611|Anticonvulsants|anticonvulsants|mesh-ancestor
25704623|NCT02185014|Adalimumab|adalimumab|mesh-list
25704624|NCT02185014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25704625|NCT02185014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24494633|NCT00496223|Sunitinib|sunitinib|mesh-list
24614024|NCT01022047|Hormones|hormones|mesh-ancestor
25050355|NCT00517049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25050356|NCT00514371|Bortezomib|bortezomib|mesh-list
25050357|NCT00514371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050358|NCT00514267|Prednisone|prednisone|mesh-list
25050359|NCT00514267|Docetaxel|docetaxel|mesh-list
24446083|NCT00303771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25050360|NCT00514267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050361|NCT00514267|Tubulin Modulators|tubulin modulators|mesh-ancestor
25050362|NCT00514267|Antimitotic Agents|antimitotic agents|mesh-ancestor
25050363|NCT00514267|Mitosis Modulators|mitosis modulators|mesh-ancestor
24851754|NCT02258828|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25050370|NCT00514267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24954464|NCT03876444|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24954465|NCT03876444|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24954466|NCT03876444|Prednisolone|prednisolone|mesh-list
24851762|NCT02258906|Urinastatin|urinastatin|mesh-list
25704626|NCT02185131|Mirtazapine|mirtazapine|mesh-list
24535402|NCT00649090|Exemestane|exemestane|mesh-list
25704627|NCT02185131|Antidepressive Agents|antidepressive agents|mesh-ancestor
25704628|NCT02185131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25704629|NCT02185131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25704630|NCT02185131|Histamine Antagonists|histamine antagonists|mesh-ancestor
25704631|NCT02185131|Histamine Agents|histamine agents|mesh-ancestor
25704632|NCT02185131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25704633|NCT02185131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954467|NCT03876444|Prednisolone acetate|prednisolone acetate|mesh-list
24954468|NCT03876444|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24954469|NCT03876444|Prednisolone phosphate|prednisolone phosphate|mesh-list
24954470|NCT03876444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24954472|NCT03876444|Autonomic Agents|autonomic agents|mesh-ancestor
24954473|NCT03876444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24954474|NCT03876444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954475|NCT03876444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24954476|NCT03876444|Glucocorticoids|glucocorticoids|mesh-ancestor
24954477|NCT03876444|Hormones|hormones|mesh-ancestor
24954478|NCT03876444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24954479|NCT03876444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24954480|NCT03876444|Protective Agents|protective agents|mesh-ancestor
24954481|NCT03876444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24954482|NCT03876444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24851768|NCT02259075|Botulinum Toxins|botulinum toxins|mesh-list
24763167|NCT01771874|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
24535503|NCT00649259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535504|NCT00649259|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24535505|NCT00649259|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24535506|NCT00649259|Cholinergic Agents|cholinergic agents|mesh-ancestor
24535507|NCT00649259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535508|NCT00649259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535509|NCT00649259|Urological Agents|urological agents|mesh-ancestor
24535510|NCT00649272|Oxybutynin|oxybutynin|mesh-list
24535511|NCT00649272|Parasympatholytics|parasympatholytics|mesh-ancestor
24535512|NCT00649272|Autonomic Agents|autonomic agents|mesh-ancestor
24535513|NCT00649272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24535514|NCT00649272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535515|NCT00649272|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24535516|NCT00649272|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24535517|NCT00649272|Cholinergic Agents|cholinergic agents|mesh-ancestor
24535518|NCT00649272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24938370|NCT04019574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24938371|NCT04019574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24938372|NCT04019574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24938373|NCT04019574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938374|NCT04019574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24938383|NCT04019652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24938384|NCT04019652|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24938385|NCT04019652|Contraceptive Agents|contraceptive agents|mesh-ancestor
24938386|NCT04019652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24938387|NCT04019652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938388|NCT04019652|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24938389|NCT04019652|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24938408|NCT04019106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24709364|NCT01505231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24709365|NCT01505231|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24851792|NCT02259179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535519|NCT00649272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535520|NCT00649272|Urological Agents|urological agents|mesh-ancestor
24535522|NCT00649285|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24535523|NCT00649285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24535524|NCT00649285|Renal Agents|renal agents|mesh-ancestor
24446205|NCT00304018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24446206|NCT00304018|Antimetabolites|antimetabolites|mesh-ancestor
24535526|NCT00649311|Losartan|losartan|mesh-list
24535527|NCT00649311|Eplerenone|eplerenone|mesh-list
24535528|NCT00649311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24535529|NCT00649311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24535530|NCT00649311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24535531|NCT00649311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24535532|NCT00649311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938419|NCT04018833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24763160|NCT01771822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763161|NCT01771822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24763163|NCT01771822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24763164|NCT01771822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763165|NCT01771822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763166|NCT01771874|Bupropion|bupropion|mesh-list
24763168|NCT01771874|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24763169|NCT01771874|Antidepressive Agents|antidepressive agents|mesh-ancestor
24763170|NCT01771874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24763171|NCT01771874|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24535551|NCT00649363|Ondansetron|ondansetron|mesh-list
24535552|NCT00649363|Antiemetics|antiemetics|mesh-ancestor
24535553|NCT00649363|Autonomic Agents|autonomic agents|mesh-ancestor
24535554|NCT00649363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24535555|NCT00649363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535556|NCT00649363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24535557|NCT00649363|Antipruritics|antipruritics|mesh-ancestor
24763174|NCT01771874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763176|NCT01771874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24763177|NCT01771874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763178|NCT01771874|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24763179|NCT01771874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24763180|NCT01771874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24763181|NCT01771874|Hallucinogens|hallucinogens|mesh-ancestor
24938420|NCT04018833|Growth Substances|growth substances|mesh-ancestor
24938421|NCT04018833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938422|NCT04018833|Growth Inhibitors|growth inhibitors|mesh-ancestor
24938423|NCT04018833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24938424|NCT04018482|Povidone-Iodine|povidone-iodine|mesh-list
24938425|NCT04018482|Povidone|povidone|mesh-list
24938426|NCT04018482|Plasma Substitutes|plasma substitutes|mesh-ancestor
24938427|NCT04018482|Blood Substitutes|blood substitutes|mesh-ancestor
24938428|NCT04018482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24938429|NCT04018482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24535575|NCT00649376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535576|NCT00649376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535578|NCT00649402|Benazepril|benazepril|mesh-list
25704634|NCT02185131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704635|NCT02185131|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24710042|NCT01508143|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24710048|NCT01508143|Oxytocics|oxytocics|mesh-ancestor
24535579|NCT00649402|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24535580|NCT00649402|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24535581|NCT00649402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24535613|NCT00649441|Protease Inhibitors|protease inhibitors|mesh-ancestor
24535614|NCT00649441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535615|NCT00649454|Metformin|metformin|mesh-list
24535616|NCT00649454|Glipizide|glipizide|mesh-list
24535617|NCT00649454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24535618|NCT00649454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535619|NCT00649467|Topiramate|topiramate|mesh-list
24535620|NCT00649467|Anticonvulsants|anticonvulsants|mesh-ancestor
24535621|NCT00649467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24535622|NCT00649467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535623|NCT00649480|Balsalazide|balsalazide|mesh-list
24535624|NCT00649480|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24535625|NCT00649480|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24535626|NCT00649480|Analgesics|analgesics|mesh-ancestor
24535627|NCT00649480|Sensory System Agents|sensory system agents|mesh-ancestor
24535628|NCT00649480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24535629|NCT00649480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535630|NCT00649480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24535631|NCT00649480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24535632|NCT00649480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24535633|NCT00649493|Rabeprazole|rabeprazole|mesh-list
25704636|NCT02185131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25704637|NCT02185131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25704638|NCT02185131|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25704639|NCT02185131|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25704640|NCT02185131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25704641|NCT02185131|Adrenergic Agents|adrenergic agents|mesh-ancestor
25704642|NCT02185131|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25704643|NCT02185131|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25704644|NCT02185131|Serotonin Agents|serotonin agents|mesh-ancestor
25704645|NCT02185131|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25704646|NCT02185339|Rocuronium|rocuronium|mesh-list
24535691|NCT00649584|Antiviral Agents|antiviral agents|mesh-ancestor
24535692|NCT00649584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446314|NCT00304434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446315|NCT00304434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446316|NCT00304434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446317|NCT00304434|Uricosuric Agents|uricosuric agents|mesh-ancestor
24446318|NCT00304434|Gout Suppressants|gout suppressants|mesh-ancestor
24446321|NCT00304447|Gemtuzumab|gemtuzumab|mesh-list
24535693|NCT00649584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535694|NCT00649584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24535695|NCT00649584|Immunologic Factors|immunologic factors|mesh-ancestor
24535696|NCT00649584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535697|NCT00649584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24535698|NCT00649597|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24535749|NCT00649649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24535751|NCT00649662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24535752|NCT00649662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24535753|NCT00649662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24535754|NCT00649662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24535755|NCT00649662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535756|NCT00649662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535757|NCT00649662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24535768|NCT00649675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24938437|NCT04018703|Sensory System Agents|sensory system agents|mesh-ancestor
24553997|NCT00733668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938438|NCT04018703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24938439|NCT04018703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24938440|NCT04018703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24445536|NCT00301795|Rituximab|rituximab|mesh-list
24535769|NCT00649675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24535770|NCT00649675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24535771|NCT00649675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446324|NCT00304460|Aldesleukin|aldesleukin|mesh-list
24535804|NCT00649727|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24535811|NCT00649740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24446362|NCT00304616|Olanzapine|olanzapine|mesh-list
24446365|NCT00304616|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24446366|NCT00304616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24446367|NCT00304616|Serotonin Agents|serotonin agents|mesh-ancestor
24938449|NCT04018703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24938450|NCT04018703|Anesthetics, General|anesthetics, general|mesh-ancestor
24938451|NCT04018703|Anesthetics|anesthetics|mesh-ancestor
24938452|NCT04018703|GABA Modulators|gaba modulators|mesh-ancestor
24938453|NCT04018703|GABA Agents|gaba agents|mesh-ancestor
24938454|NCT04018690|Triamcinolone|triamcinolone|mesh-list
24938455|NCT04018690|Ropivacaine|ropivacaine|mesh-list
24446368|NCT00304616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24938463|NCT04018690|Glucocorticoids|glucocorticoids|mesh-ancestor
24938464|NCT04018690|Hormones|hormones|mesh-ancestor
24535844|NCT00649818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24535845|NCT00649818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24535846|NCT00649818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24535847|NCT00649818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24535849|NCT00649818|GABA Agents|gaba agents|mesh-ancestor
24535850|NCT00649818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535851|NCT00649818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535852|NCT00649831|Amoxicillin|amoxicillin|mesh-list
24535853|NCT00649831|Azithromycin|azithromycin|mesh-list
24535854|NCT00649831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24938465|NCT04018690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24938466|NCT04018417|Amphotericin B|amphotericin b|mesh-list
24938467|NCT04018417|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24535893|NCT00649922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24446512|NCT00304993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24446513|NCT00304993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446514|NCT00304993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24446515|NCT00304993|Antimetabolites|antimetabolites|mesh-ancestor
24938478|NCT04018365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938480|NCT04018768|Ibuprofen|ibuprofen|mesh-list
24938481|NCT04018768|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
24938482|NCT04018768|Oxycodone|oxycodone|mesh-list
24938483|NCT04018768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24938484|NCT04018768|Analgesics|analgesics|mesh-ancestor
24938485|NCT04018768|Sensory System Agents|sensory system agents|mesh-ancestor
24938486|NCT04018768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24938487|NCT04018768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938488|NCT04018768|Antipyretics|antipyretics|mesh-ancestor
24938489|NCT04018768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24938490|NCT04018768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24938491|NCT04018768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24938492|NCT04018768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24938493|NCT04018768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24851895|NCT02259790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535929|NCT00650013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535930|NCT00650013|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24535931|NCT00650013|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24535932|NCT00650013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24535933|NCT00650013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24535938|NCT00650026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24535939|NCT00650026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24535940|NCT00650039|Valdecoxib|valdecoxib|mesh-list
24535941|NCT00650039|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24535942|NCT00650039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24535943|NCT00650039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535944|NCT00650039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535945|NCT00650039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24535946|NCT00650039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24535947|NCT00650039|Analgesics|analgesics|mesh-ancestor
24535948|NCT00650039|Sensory System Agents|sensory system agents|mesh-ancestor
24535949|NCT00650039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24535956|NCT00650052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24535957|NCT00650052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535958|NCT00650052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24938494|NCT04018768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938495|NCT04018768|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24536011|NCT00650182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536012|NCT00650182|Analgesics|analgesics|mesh-ancestor
24536013|NCT00650182|Sensory System Agents|sensory system agents|mesh-ancestor
24536014|NCT00650182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24536015|NCT00650182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24536016|NCT00650182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24536017|NCT00650182|Anesthetics, General|anesthetics, general|mesh-ancestor
24536018|NCT00650182|Anesthetics|anesthetics|mesh-ancestor
24536019|NCT00650182|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24536020|NCT00650182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24536021|NCT00650195|Metolazone|metolazone|mesh-list
24536022|NCT00650195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24536023|NCT00650195|Diuretics|diuretics|mesh-ancestor
24536024|NCT00650195|Natriuretic Agents|natriuretic agents|mesh-ancestor
24536025|NCT00650195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536029|NCT00650208|Lamotrigine|lamotrigine|mesh-list
24712245|NCT01519310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24712250|NCT01519336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24712261|NCT01519401|Drospirenone|drospirenone|mesh-list
24938503|NCT04018378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938504|NCT04018378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938506|NCT04018157|Ketamine|ketamine|mesh-list
24938507|NCT04018157|Propofol|propofol|mesh-list
24536041|NCT00650221|Pravastatin|pravastatin|mesh-list
25704647|NCT02185339|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25704648|NCT02185339|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25704649|NCT02185339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25704650|NCT02185339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25704651|NCT02185339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704652|NCT02185534|Clopidogrel|clopidogrel|mesh-list
25704653|NCT02185534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25704654|NCT02185534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25704655|NCT02185534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24938508|NCT04018157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24938509|NCT04018157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24938510|NCT04018157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938511|NCT04018157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24938512|NCT04018157|Anesthetics, General|anesthetics, general|mesh-ancestor
24938513|NCT04018157|Anesthetics|anesthetics|mesh-ancestor
24938514|NCT04018157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24938515|NCT04018157|Analgesics|analgesics|mesh-ancestor
24938516|NCT04018157|Sensory System Agents|sensory system agents|mesh-ancestor
24938517|NCT04018157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24938518|NCT04018157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24938519|NCT04018157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24938520|NCT04018157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24536101|NCT00650351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24536102|NCT00650351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536103|NCT00650351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536104|NCT00650351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24536105|NCT00650351|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24536106|NCT00650351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24536108|NCT00650364|Sympathomimetics|sympathomimetics|mesh-ancestor
24536109|NCT00650364|Autonomic Agents|autonomic agents|mesh-ancestor
24536110|NCT00650364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24938521|NCT04018157|Adrenergic Agents|adrenergic agents|mesh-ancestor
24938522|NCT04018157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24938523|NCT04018157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938524|NCT04018157|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24938525|NCT04018157|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24938526|NCT04018157|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24451194|NCT00322595|Antidepressive Agents|antidepressive agents|mesh-ancestor
24451195|NCT00322595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24451196|NCT00322595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24451197|NCT00322595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24451198|NCT00322595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24451199|NCT00322595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451200|NCT00322595|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24451201|NCT00322595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24451202|NCT00322595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24451203|NCT00322595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451204|NCT00322595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24451205|NCT00322595|Serotonin Agents|serotonin agents|mesh-ancestor
24451206|NCT00322595|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24549260|NCT00714103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24451207|NCT00322595|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24451208|NCT00322595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24938538|NCT04018274|Estradiol|estradiol|mesh-list
24938539|NCT04018274|Estrogens|estrogens|mesh-ancestor
24938540|NCT04018274|Hormones|hormones|mesh-ancestor
24938541|NCT04018274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24938542|NCT04018274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536186|NCT00650455|Valdecoxib|valdecoxib|mesh-list
24536187|NCT00650455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24536188|NCT00650455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24536190|NCT00650455|Sensory System Agents|sensory system agents|mesh-ancestor
24938543|NCT04018274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24938544|NCT04018274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24938545|NCT04018274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24938546|NCT04018274|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24938547|NCT04018274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24938548|NCT04017897|Pembrolizumab|pembrolizumab|mesh-list
24938549|NCT04017897|Nivolumab|nivolumab|mesh-list
24938550|NCT04017897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24938551|NCT04017897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24938552|NCT04017897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24851946|NCT02259855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24851951|NCT02259868|Ritonavir|ritonavir|mesh-list
24938553|NCT04017897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938557|NCT04017741|Methylprednisolone|methylprednisolone|mesh-list
24938558|NCT04017741|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24938559|NCT04017741|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24938560|NCT04017741|Prednisolone|prednisolone|mesh-list
24938561|NCT04017741|Prednisolone acetate|prednisolone acetate|mesh-list
24938562|NCT04017741|Lidocaine|lidocaine|mesh-list
24536206|NCT00650468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24536207|NCT00650468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536208|NCT00650468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24536209|NCT00650468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24536210|NCT00650468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24536211|NCT00650468|Immunologic Factors|immunologic factors|mesh-ancestor
24536212|NCT00650468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24536213|NCT00650468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536214|NCT00650468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536215|NCT00650468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24536216|NCT00650468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24536217|NCT00650468|Antitubercular Agents|antitubercular agents|mesh-ancestor
24536218|NCT00650468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24536219|NCT00650468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24536220|NCT00650481|Oxybutynin|oxybutynin|mesh-list
24536222|NCT00650481|Autonomic Agents|autonomic agents|mesh-ancestor
24536223|NCT00650481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24536224|NCT00650481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536225|NCT00650481|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24536226|NCT00650481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24851971|NCT02259946|Olodaterol|olodaterol|mesh-list
24446652|NCT00305539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24446653|NCT00305552|Thalidomide|thalidomide|mesh-list
24536232|NCT00650494|Antiviral Agents|antiviral agents|mesh-ancestor
24536233|NCT00650494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24536234|NCT00650520|Bromocriptine|bromocriptine|mesh-list
24536235|NCT00650520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24536236|NCT00650520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24536237|NCT00650520|Hormone Antagonists|hormone antagonists|mesh-ancestor
24938573|NCT04017741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24938574|NCT04017741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24938575|NCT04017741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24954652|NCT03874000|Metformin|metformin|mesh-list
24536273|NCT00650611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24536274|NCT00650611|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24536275|NCT00650611|Dopamine Agents|dopamine agents|mesh-ancestor
24536277|NCT00650624|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24536278|NCT00650624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24536279|NCT00650624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536286|NCT00650624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536287|NCT00650624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24536288|NCT00650624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24536289|NCT00650637|Calcium, Dietary|calcium, dietary|mesh-list
24536290|NCT00650637|Lamivudine|lamivudine|mesh-list
24536291|NCT00650637|Zidovudine|zidovudine|mesh-list
24536295|NCT00650637|Loperamide|loperamide|mesh-list
24536296|NCT00650637|Antidiarrheals|antidiarrheals|mesh-list
24536297|NCT00650637|Calcium|calcium|mesh-list
24536298|NCT00650637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24536299|NCT00650637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536300|NCT00650637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24536301|NCT00650637|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24536302|NCT00650637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24536303|NCT00650637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536304|NCT00650637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536305|NCT00650637|Antiviral Agents|antiviral agents|mesh-ancestor
24536306|NCT00650637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24536307|NCT00650637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24536308|NCT00650637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24536309|NCT00650637|Antimetabolites|antimetabolites|mesh-ancestor
24536311|NCT00650637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24536312|NCT00650637|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24536313|NCT00650637|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24536314|NCT00650637|Protease Inhibitors|protease inhibitors|mesh-ancestor
24536328|NCT00650793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24536329|NCT00650793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938579|NCT04017741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24938580|NCT04017741|Glucocorticoids|glucocorticoids|mesh-ancestor
24938581|NCT04017741|Hormones|hormones|mesh-ancestor
24938582|NCT04017741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24938583|NCT04017741|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24938584|NCT04017741|Protective Agents|protective agents|mesh-ancestor
24938585|NCT04017741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24938586|NCT04017741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24938587|NCT04018131|Cimetidine|cimetidine|mesh-list
24938588|NCT04018131|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24938589|NCT04018131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24938590|NCT04018131|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24938591|NCT04018131|Histamine Antagonists|histamine antagonists|mesh-ancestor
24938592|NCT04018131|Histamine Agents|histamine agents|mesh-ancestor
24938593|NCT04018131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24938594|NCT04018131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938595|NCT04018131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938596|NCT04018131|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24938597|NCT04018131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24938598|NCT04018131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24938599|NCT04017845|Tribenoside|tribenoside|mesh-list
24938600|NCT04017845|Lidocaine|lidocaine|mesh-list
24938601|NCT04017845|Diltiazem|diltiazem|mesh-list
24938602|NCT04017845|Calcium Channel Blockers|calcium channel blockers|mesh-list
24938603|NCT04017845|Nitroglycerin|nitroglycerin|mesh-list
24938604|NCT04017845|Bisacodyl|bisacodyl|mesh-list
24938605|NCT04017845|Anesthetics, Local|anesthetics, local|mesh-ancestor
24938606|NCT04017845|Anesthetics|anesthetics|mesh-ancestor
24536331|NCT00650793|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24536332|NCT00650793|Dopamine Agents|dopamine agents|mesh-ancestor
24536333|NCT00650871|Casopitant|casopitant|mesh-list
24938607|NCT04017845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24938608|NCT04017845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938609|NCT04017845|Sensory System Agents|sensory system agents|mesh-ancestor
24938610|NCT04017845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24938611|NCT04017845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24938612|NCT04017845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24938613|NCT04017845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24938614|NCT04017845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24938615|NCT04017845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536355|NCT00650910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24536356|NCT00650910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24536357|NCT00650910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536358|NCT00650910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536359|NCT00650910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24536360|NCT00650910|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24536361|NCT00650910|Protective Agents|protective agents|mesh-ancestor
24938619|NCT04017845|Cathartics|cathartics|mesh-ancestor
24938686|NCT04016922|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24938687|NCT04016922|Hematinics|hematinics|mesh-ancestor
24938688|NCT04017104|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24938689|NCT04017104|Edotreotide|edotreotide|mesh-list
24938690|NCT04017104|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24938691|NCT04017104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763366|NCT01773096|Cathartics|cathartics|mesh-ancestor
24938693|NCT04016389|Carboplatin|carboplatin|mesh-list
24938694|NCT04016389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24536556|NCT00651612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24536557|NCT00651612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24536558|NCT00651651|Budesonide|budesonide|mesh-list
24536559|NCT00651651|Formoterol Fumarate|formoterol fumarate|mesh-list
24938698|NCT04016389|Mitosis Modulators|mitosis modulators|mesh-ancestor
24938699|NCT04016389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938700|NCT04016740|Dexmedetomidine|dexmedetomidine|mesh-list
24763438|NCT01773616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24763439|NCT01773616|Glucocorticoids|glucocorticoids|mesh-ancestor
24763441|NCT01773616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24763442|NCT01773616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24763443|NCT01773616|Antiemetics|antiemetics|mesh-ancestor
24763444|NCT01773616|Autonomic Agents|autonomic agents|mesh-ancestor
24763445|NCT01773616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24763446|NCT01773616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24763447|NCT01773616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24763448|NCT01773616|Protective Agents|protective agents|mesh-ancestor
24763449|NCT01773681|Certolizumab Pegol|certolizumab pegol|mesh-list
24536560|NCT00651651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24536561|NCT00651651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24536562|NCT00651651|Autonomic Agents|autonomic agents|mesh-ancestor
24536563|NCT00651651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24536564|NCT00651651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536565|NCT00651651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24536566|NCT00651651|Respiratory System Agents|respiratory system agents|mesh-ancestor
24536567|NCT00651651|Glucocorticoids|glucocorticoids|mesh-ancestor
24536568|NCT00651651|Hormones|hormones|mesh-ancestor
24536576|NCT00651690|Botulinum Toxins|botulinum toxins|mesh-list
24536577|NCT00651690|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24536578|NCT00651690|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24536579|NCT00651690|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24536580|NCT00651690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24536581|NCT00651690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536588|NCT00651703|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
24536589|NCT00651703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24536590|NCT00651703|Immunologic Factors|immunologic factors|mesh-ancestor
24536591|NCT00651703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536592|NCT00651703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24536593|NCT00651703|Interferon Inducers|interferon inducers|mesh-ancestor
24536594|NCT00651729|Botulinum Toxins|botulinum toxins|mesh-list
24536595|NCT00651729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24536596|NCT00651729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24536597|NCT00651729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24536598|NCT00651729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24536599|NCT00651729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536607|NCT00651768|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24536608|NCT00651768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24536609|NCT00651768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24536616|NCT00651768|Hormones|hormones|mesh-ancestor
24536617|NCT00651768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24536618|NCT00651768|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24536619|NCT00651768|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24536620|NCT00651768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24536621|NCT00651768|Adrenergic Agents|adrenergic agents|mesh-ancestor
24938714|NCT04016740|Analgesics|analgesics|mesh-ancestor
24938715|NCT04016740|Sensory System Agents|sensory system agents|mesh-ancestor
24938717|NCT04016740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24938718|NCT04016740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24938719|NCT04016740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24938720|NCT04016740|Adrenergic Agents|adrenergic agents|mesh-ancestor
24938721|NCT04016740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24549705|NCT00717145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938722|NCT04016740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938723|NCT04016740|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25050373|NCT00512317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050374|NCT00512317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050375|NCT00512317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050376|NCT00512317|GABA Modulators|gaba modulators|mesh-ancestor
25050377|NCT00512317|GABA Agents|gaba agents|mesh-ancestor
25050378|NCT00511459|Paclitaxel|paclitaxel|mesh-list
25050379|NCT00511459|Bevacizumab|bevacizumab|mesh-list
25050380|NCT00511459|Trebananib|trebananib|mesh-list
25050381|NCT00511459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25050382|NCT00511459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050383|NCT00511459|Tubulin Modulators|tubulin modulators|mesh-ancestor
24536661|NCT00652002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24536662|NCT00652002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24536663|NCT00652002|Autonomic Agents|autonomic agents|mesh-ancestor
24536664|NCT00652002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24536665|NCT00652002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536666|NCT00652002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24536667|NCT00652002|Respiratory System Agents|respiratory system agents|mesh-ancestor
24536668|NCT00652002|Glucocorticoids|glucocorticoids|mesh-ancestor
25050387|NCT00511459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25050393|NCT00511043|Vatalanib|vatalanib|mesh-list
25050410|NCT00508989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050411|NCT00508625|Paclitaxel|paclitaxel|mesh-list
25050412|NCT00508625|Bevacizumab|bevacizumab|mesh-list
25050413|NCT00508625|Carboplatin|carboplatin|mesh-list
25050414|NCT00508625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25050415|NCT00508625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050416|NCT00508625|Tubulin Modulators|tubulin modulators|mesh-ancestor
25050417|NCT00508625|Antimitotic Agents|antimitotic agents|mesh-ancestor
25050418|NCT00508625|Mitosis Modulators|mitosis modulators|mesh-ancestor
25050419|NCT00508625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938780|NCT04015908|Pregabalin|pregabalin|mesh-list
25050421|NCT00508625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25050422|NCT00508625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25050423|NCT00508625|Growth Substances|growth substances|mesh-ancestor
24852110|NCT02260557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24852111|NCT02260570|Tolcapone|tolcapone|mesh-list
24852112|NCT02260570|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24852113|NCT02260570|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24852114|NCT02260570|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24852115|NCT02260570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852116|NCT02260570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852117|NCT02260661|Fulvestrant|fulvestrant|mesh-list
24852118|NCT02260661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24536691|NCT00652106|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24536692|NCT00652106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24536693|NCT00652106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25050424|NCT00508625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050425|NCT00508625|Growth Inhibitors|growth inhibitors|mesh-ancestor
25050426|NCT00508066|Bupivacaine|bupivacaine|mesh-list
25050427|NCT00508066|Anesthetics, Local|anesthetics, local|mesh-ancestor
25050428|NCT00508066|Anesthetics|anesthetics|mesh-ancestor
25050429|NCT00508066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25050430|NCT00508066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050431|NCT00508066|Sensory System Agents|sensory system agents|mesh-ancestor
25050432|NCT00508066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25050433|NCT00507936|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25050434|NCT00507936|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24954800|NCT03872011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24954801|NCT03872011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24954802|NCT03872011|Antioxidants|antioxidants|mesh-ancestor
24954803|NCT03872011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536720|NCT00652132|Sodium thiosulfate|sodium thiosulfate|mesh-list
24536729|NCT00652132|Chelating Agents|chelating agents|mesh-ancestor
24536730|NCT00652132|Sequestering Agents|sequestering agents|mesh-ancestor
24536731|NCT00652171|Lamotrigine|lamotrigine|mesh-list
24536732|NCT00652171|Anticonvulsants|anticonvulsants|mesh-ancestor
24536733|NCT00652171|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24536734|NCT00652171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24536735|NCT00652171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24799647|NCT01970059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050435|NCT00507936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25050436|NCT00507936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24938731|NCT04016740|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24938732|NCT04016740|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24938735|NCT04016246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24938736|NCT04016246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24536746|NCT00652184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24536748|NCT00652184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536749|NCT00652262|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24536750|NCT00652262|Vasodilator Agents|vasodilator agents|mesh-ancestor
24536751|NCT00652262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24536752|NCT00652262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24536753|NCT00652262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536754|NCT00652262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536755|NCT00652262|Urological Agents|urological agents|mesh-ancestor
24536757|NCT00652288|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24536758|NCT00652288|Insulin Glargine|insulin glargine|mesh-list
24536759|NCT00652288|Insulin Aspart|insulin aspart|mesh-list
24536760|NCT00652288|Insulin, Long-Acting|insulin, long-acting|mesh-list
24536761|NCT00652288|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24852152|NCT02260947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24536772|NCT00652379|Hormones|hormones|mesh-ancestor
24536774|NCT00652379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536775|NCT00652392|Budesonide|budesonide|mesh-list
24536776|NCT00652392|Formoterol Fumarate|formoterol fumarate|mesh-list
24536777|NCT00652392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24536778|NCT00652392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24536779|NCT00652392|Autonomic Agents|autonomic agents|mesh-ancestor
24536784|NCT00652392|Glucocorticoids|glucocorticoids|mesh-ancestor
24938762|NCT04016090|Hematinics|hematinics|mesh-ancestor
24536813|NCT00652600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536814|NCT00652600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536815|NCT00652600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24451221|NCT00322660|Autonomic Agents|autonomic agents|mesh-ancestor
24938763|NCT04016090|Vitamin B Complex|vitamin b complex|mesh-ancestor
24938764|NCT04016090|Vitamins|vitamins|mesh-ancestor
24938765|NCT04016090|Micronutrients|micronutrients|mesh-ancestor
24938766|NCT04016090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938767|NCT04016220|Budesonide|budesonide|mesh-list
24938768|NCT04016220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24938769|NCT04016220|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24938770|NCT04016220|Autonomic Agents|autonomic agents|mesh-ancestor
24938771|NCT04016220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24938772|NCT04016220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938773|NCT04016220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24938774|NCT04016220|Respiratory System Agents|respiratory system agents|mesh-ancestor
24938775|NCT04016220|Glucocorticoids|glucocorticoids|mesh-ancestor
24938776|NCT04016220|Hormones|hormones|mesh-ancestor
24938777|NCT04016220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24938778|NCT04015908|Acetaminophen|acetaminophen|mesh-list
24938779|NCT04015908|Celecoxib|celecoxib|mesh-list
24938797|NCT04015908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24938798|NCT04015908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24938799|NCT04015908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24938800|NCT04015908|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24938801|NCT04015908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24938802|NCT04015908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24938803|NCT04015908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24938804|NCT04015908|Narcotics|narcotics|mesh-ancestor
24938805|NCT04016207|Guanfacine|guanfacine|mesh-list
24938806|NCT04016207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24938807|NCT04016207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24938808|NCT04016207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24938809|NCT04016207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24852201|NCT02261090|Pramipexole|pramipexole|mesh-list
24451222|NCT00322660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24938810|NCT04016207|Adrenergic Agents|adrenergic agents|mesh-ancestor
24938811|NCT04016207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24938812|NCT04016207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938813|NCT04016207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938814|NCT04015869|Pregnanolone|pregnanolone|mesh-list
24938815|NCT04015869|Anesthetics|anesthetics|mesh-ancestor
24938816|NCT04015869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24938821|NCT04015596|Analgesics|analgesics|mesh-ancestor
24938822|NCT04015596|Sensory System Agents|sensory system agents|mesh-ancestor
24938823|NCT04015596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24938824|NCT04015596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24938825|NCT04015596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24938826|NCT04015596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24938827|NCT04015596|Gout Suppressants|gout suppressants|mesh-ancestor
24938828|NCT04015596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24852218|NCT02261103|Dopamine Agonists|dopamine agonists|mesh-ancestor
24938854|NCT04015557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24938855|NCT04015557|Expectorants|expectorants|mesh-ancestor
24938856|NCT04015557|Respiratory System Agents|respiratory system agents|mesh-ancestor
24938857|NCT04015557|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24938858|NCT04015557|Antioxidants|antioxidants|mesh-ancestor
24938859|NCT04015557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938860|NCT04015557|Protective Agents|protective agents|mesh-ancestor
24938861|NCT04015557|Antidotes|antidotes|mesh-ancestor
24938862|NCT04015492|Factor VIII|factor viii|mesh-list
24938863|NCT04015492|BAX 855|bax 855|mesh-list
24938875|NCT04015687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24852271|NCT02261675|Dexmedetomidine|dexmedetomidine|mesh-list
24954954|NCT03870256|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24954955|NCT03870256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24954956|NCT03870256|Oxytocics|oxytocics|mesh-ancestor
24852285|NCT02261779|Tretinoin|tretinoin|mesh-list
24954961|NCT03870022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24954962|NCT03870022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537001|NCT00653237|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25050441|NCT00507936|Sensory System Agents|sensory system agents|mesh-ancestor
25050442|NCT00507936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25050443|NCT00507936|Antidepressive Agents|antidepressive agents|mesh-ancestor
25050444|NCT00507936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24537036|NCT00653341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537038|NCT00653354|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25050445|NCT00507936|Dopamine Agents|dopamine agents|mesh-ancestor
25050446|NCT00501709|Abatacept|abatacept|mesh-list
25050447|NCT00501709|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25050448|NCT00501709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25050449|NCT00501709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050450|NCT00501709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050452|NCT00501709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050453|NCT00501709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25050454|NCT00498836|Sorafenib|sorafenib|mesh-list
25050455|NCT00498836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050456|NCT00498836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24852315|NCT02261896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24938883|NCT04015778|Antimitotic Agents|antimitotic agents|mesh-ancestor
24938884|NCT04015778|Mitosis Modulators|mitosis modulators|mesh-ancestor
24938906|NCT04015219|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24938907|NCT04015219|Lifitegrast|lifitegrast|mesh-list
24938908|NCT04015219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24938909|NCT04014634|Methylprednisolone|methylprednisolone|mesh-list
24938910|NCT04014634|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24938911|NCT04014634|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24938912|NCT04014634|Prednisolone|prednisolone|mesh-list
24938913|NCT04014634|Prednisolone acetate|prednisolone acetate|mesh-list
24938914|NCT04014634|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24938915|NCT04014634|Prednisolone phosphate|prednisolone phosphate|mesh-list
24938916|NCT04014634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24537056|NCT00653393|Tranylcypromine|tranylcypromine|mesh-list
24537057|NCT00653393|Antidepressive Agents|antidepressive agents|mesh-ancestor
24537058|NCT00653393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24537059|NCT00653393|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24537060|NCT00653393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537061|NCT00653393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537062|NCT00653393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24537063|NCT00653393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24537064|NCT00653393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25704656|NCT02185534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25704657|NCT02185534|Purinergic Agents|purinergic agents|mesh-ancestor
25704658|NCT02185534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25704659|NCT02185534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704660|NCT02185534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704661|NCT02185729|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25704662|NCT02185729|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24537129|NCT00653562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24537133|NCT00653562|GABA Agents|gaba agents|mesh-ancestor
24537134|NCT00653562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24537135|NCT00653562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537136|NCT00653588|Atorvastatin|atorvastatin|mesh-list
24537137|NCT00653588|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24537138|NCT00653588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24537139|NCT00653588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24537140|NCT00653588|Antimetabolites|antimetabolites|mesh-ancestor
24537141|NCT00653588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537142|NCT00653588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24763660|NCT01775631|Immunologic Factors|immunologic factors|mesh-ancestor
24763661|NCT01775631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763662|NCT01775631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24554400|NCT00736320|Alkylating Agents|alkylating agents|mesh-ancestor
24625591|NCT01082627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24537143|NCT00653588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24537144|NCT00653588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537145|NCT00653614|Drospirenone|drospirenone|mesh-list
24445577|NCT00301886|Ibandronic Acid|ibandronic acid|mesh-list
24625592|NCT01082627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625593|NCT01082679|Buprenorphine|buprenorphine|mesh-list
24625594|NCT01082679|Methadone|methadone|mesh-list
24625595|NCT01082679|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
24625596|NCT01082679|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24625597|NCT01082679|Narcotics|narcotics|mesh-ancestor
24538103|NCT00657475|Calcium heparin|calcium heparin|mesh-list
24625601|NCT01082679|Sensory System Agents|sensory system agents|mesh-ancestor
24625602|NCT01082679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24625603|NCT01082679|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24625604|NCT01082679|Antitussive Agents|antitussive agents|mesh-ancestor
24625605|NCT01082679|Respiratory System Agents|respiratory system agents|mesh-ancestor
24625606|NCT01082705|Lumefantrine|lumefantrine|mesh-list
24625607|NCT01082705|Artemether|artemether|mesh-list
24537219|NCT00653965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24537220|NCT00653965|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24537221|NCT00653965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537222|NCT00654017|Sildenafil Citrate|sildenafil citrate|mesh-list
24537223|NCT00654017|Vasodilator Agents|vasodilator agents|mesh-ancestor
24537224|NCT00654017|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24537225|NCT00654017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24537250|NCT00654108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24537251|NCT00654108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24537252|NCT00654108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24537253|NCT00654108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24537254|NCT00654108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537255|NCT00654108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537256|NCT00654108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24537259|NCT00654108|Antioxidants|antioxidants|mesh-ancestor
24537275|NCT00654160|Antimetabolites|antimetabolites|mesh-ancestor
24938942|NCT04014192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938943|NCT04014192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24938950|NCT04014244|Triamcinolone|triamcinolone|mesh-list
24537304|NCT00654225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537305|NCT00654225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24537306|NCT00654225|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24537307|NCT00654225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24938951|NCT04014244|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24938952|NCT04014244|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24938953|NCT04014244|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24938954|NCT04014244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24938956|NCT04014244|Hormones|hormones|mesh-ancestor
24537331|NCT00654290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537332|NCT00654290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537333|NCT00654290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24537334|NCT00654290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24537335|NCT00654290|Vasodilator Agents|vasodilator agents|mesh-ancestor
24537336|NCT00654290|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24537337|NCT00654290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24537341|NCT00654290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537564|NCT00655174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24537565|NCT00655174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24537566|NCT00655174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24537567|NCT00655174|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24537568|NCT00655174|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24537569|NCT00655174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24537570|NCT00655174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537571|NCT00655174|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24537572|NCT00655200|Insulin Detemir|insulin detemir|mesh-list
24537573|NCT00655200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24938960|NCT04014244|Immunologic Factors|immunologic factors|mesh-ancestor
24938961|NCT04014244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24938962|NCT04014244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24938963|NCT04014361|Itraconazole|itraconazole|mesh-list
24938964|NCT04014361|Antifungal Agents|antifungal agents|mesh-ancestor
24938965|NCT04014361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24938966|NCT04014361|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24938967|NCT04014361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24938969|NCT04014361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537667|NCT00655655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537668|NCT00655681|Pamidronate|pamidronate|mesh-list
24537669|NCT00655681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24537670|NCT00655681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537671|NCT00655772|Chlorine dioxide|chlorine dioxide|mesh-list
24537672|NCT00655772|Dental Disinfectants|dental disinfectants|mesh-ancestor
24537673|NCT00655772|Disinfectants|disinfectants|mesh-ancestor
24537674|NCT00655772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24537675|NCT00655785|Gemcitabine|gemcitabine|mesh-list
24537676|NCT00655785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24938970|NCT04014361|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24938971|NCT04014361|Hormone Antagonists|hormone antagonists|mesh-ancestor
24938972|NCT04014361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24938973|NCT04014361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537700|NCT00655837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24537701|NCT00655837|Antimetabolites|antimetabolites|mesh-ancestor
24537702|NCT00655837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537703|NCT00655837|Antiviral Agents|antiviral agents|mesh-ancestor
24939005|NCT04013620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939006|NCT04013620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24736911|NCT01665638|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24736915|NCT01665638|Hormones|hormones|mesh-ancestor
24737271|NCT01667874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24737272|NCT01667874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24939009|NCT04013620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939011|NCT04013958|Ketamine|ketamine|mesh-list
24939012|NCT04013958|Analgesics|analgesics|mesh-ancestor
25075942|NCT03377101|Fulvestrant|fulvestrant|mesh-list
24537818|NCT00656331|Amlodipine|amlodipine|mesh-list
24537819|NCT00656331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24537820|NCT00656331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24537821|NCT00656331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24537823|NCT00656331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24537835|NCT00656435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24537836|NCT00656435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24537863|NCT00656552|Antidepressive Agents|antidepressive agents|mesh-ancestor
24537864|NCT00656552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24537866|NCT00656591|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24537867|NCT00656591|Abortifacient Agents|abortifacient agents|mesh-ancestor
24537868|NCT00656591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24537869|NCT00656591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537870|NCT00656591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24537871|NCT00656591|Antimetabolites|antimetabolites|mesh-ancestor
24537873|NCT00656591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24955120|NCT03868033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704663|NCT02185729|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25704664|NCT02185729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25704665|NCT02186015|Vitamin D|vitamin d|mesh-list
25704666|NCT02186015|Ergocalciferols|ergocalciferols|mesh-list
25704667|NCT02186015|Cholecalciferol|cholecalciferol|mesh-list
25704668|NCT02186015|Vitamins|vitamins|mesh-list
25704669|NCT02186015|Micronutrients|micronutrients|mesh-ancestor
25704670|NCT02186015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537908|NCT00656747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24537909|NCT00656747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24537910|NCT00656747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24537911|NCT00656747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24537912|NCT00656747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537913|NCT00656747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537914|NCT00656747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24537943|NCT00656786|Vitamins|vitamins|mesh-ancestor
24537944|NCT00656786|Micronutrients|micronutrients|mesh-ancestor
24537945|NCT00656786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537946|NCT00656812|Rituximab|rituximab|mesh-list
24537947|NCT00656812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24537948|NCT00656812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24537949|NCT00656812|Immunologic Factors|immunologic factors|mesh-ancestor
24537950|NCT00656812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537951|NCT00656812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24537952|NCT00656864|Pioglitazone|pioglitazone|mesh-list
24537968|NCT00657033|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24537969|NCT00657033|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24537970|NCT00657033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537971|NCT00657033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537972|NCT00657033|Urological Agents|urological agents|mesh-ancestor
24537973|NCT00657059|Mycophenolic Acid|mycophenolic acid|mesh-list
24537974|NCT00657059|Prednisone|prednisone|mesh-list
24537975|NCT00657059|Methylprednisolone|methylprednisolone|mesh-list
24537976|NCT00657059|Irbesartan|irbesartan|mesh-list
24537977|NCT00657059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24537978|NCT00657059|Glucocorticoids|glucocorticoids|mesh-ancestor
24537979|NCT00657059|Hormones|hormones|mesh-ancestor
24955133|NCT03867994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24955134|NCT03867994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24955136|NCT03867994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955140|NCT03867994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24955141|NCT03867994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24955142|NCT03867994|Adrenergic Agents|adrenergic agents|mesh-ancestor
24955143|NCT03867994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050462|NCT00498212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852509|NCT02262637|Diuretics|diuretics|mesh-ancestor
24538094|NCT00657449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24538095|NCT00657449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24538096|NCT00657449|Analgesics|analgesics|mesh-ancestor
24538097|NCT00657449|Sensory System Agents|sensory system agents|mesh-ancestor
24538098|NCT00657449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24538099|NCT00657449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538100|NCT00657449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24538101|NCT00657449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24538102|NCT00657475|Heparin|heparin|mesh-list
24538104|NCT00657475|Anticoagulants|anticoagulants|mesh-ancestor
24538105|NCT00657475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24538106|NCT00657475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25050464|NCT00495885|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25050465|NCT00495885|Serotonin Agents|serotonin agents|mesh-ancestor
25050466|NCT00495885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050467|NCT00495885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050468|NCT00495885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050470|NCT00495131|Ribavirin|ribavirin|mesh-list
25050471|NCT00495131|Interferon-alpha|interferon-alpha|mesh-list
24538149|NCT00657748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538150|NCT00657748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538151|NCT00657748|Antimanic Agents|antimanic agents|mesh-ancestor
24451254|NCT00322907|Antimalarials|antimalarials|mesh-ancestor
24451255|NCT00322907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24451256|NCT00322907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24538162|NCT00657761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24538163|NCT00657761|Antiviral Agents|antiviral agents|mesh-ancestor
24538164|NCT00657761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24538166|NCT00657774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24538167|NCT00657774|Glucocorticoids|glucocorticoids|mesh-ancestor
24538174|NCT00657839|Vasodilator Agents|vasodilator agents|mesh-ancestor
24538284|NCT00658463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24538285|NCT00658463|Antimetabolites|antimetabolites|mesh-ancestor
24538286|NCT00658463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538287|NCT00658463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24538288|NCT00658463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24538289|NCT00658463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538290|NCT00658580|Etoposide|etoposide|mesh-list
24538291|NCT00658580|Etoposide phosphate|etoposide phosphate|mesh-list
24538292|NCT00658580|Epirubicin|epirubicin|mesh-list
24538293|NCT00658580|Ifosfamide|ifosfamide|mesh-list
24451724|NCT00324610|Capecitabine|capecitabine|mesh-list
24538325|NCT00658840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538326|NCT00658840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538328|NCT00658892|Immunologic Factors|immunologic factors|mesh-ancestor
24538329|NCT00658892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538330|NCT00658918|Ciclesonide|ciclesonide|mesh-list
24538333|NCT00658918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24538335|NCT00658918|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24538336|NCT00658931|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24538337|NCT00658931|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24538385|NCT00659074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24538387|NCT00659074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24538388|NCT00659074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939038|NCT04013880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939039|NCT04013542|Nivolumab|nivolumab|mesh-list
24939040|NCT04013542|Ipilimumab|ipilimumab|mesh-list
24939041|NCT04013542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24939042|NCT04013542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939043|NCT04013542|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24939044|NCT04013542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852545|NCT02262741|Durvalumab|durvalumab|mesh-list
24538438|NCT00659386|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24538439|NCT00659386|Antibodies|antibodies|mesh-list
24740103|NCT01686386|Glucocorticoids|glucocorticoids|mesh-ancestor
24740245|NCT01687348|Anesthetics|anesthetics|mesh-ancestor
24740248|NCT01687348|Sensory System Agents|sensory system agents|mesh-ancestor
24538519|NCT00659685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538540|NCT00659776|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25050487|NCT00491738|Growth Substances|growth substances|mesh-ancestor
24939045|NCT04013386|Dexamethasone|dexamethasone|mesh-list
24939046|NCT04013386|Dexamethasone acetate|dexamethasone acetate|mesh-list
24939047|NCT04013386|Aprepitant|aprepitant|mesh-list
24939048|NCT04013386|Mirtazapine|mirtazapine|mesh-list
24939049|NCT04013386|BB 1101|bb 1101|mesh-list
24939050|NCT04013386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24538545|NCT00659841|Glucocorticoids|glucocorticoids|mesh-ancestor
24538546|NCT00659841|Hormones|hormones|mesh-ancestor
24538698|NCT00660426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24538699|NCT00660426|Antimetabolites|antimetabolites|mesh-ancestor
24538700|NCT00660426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446494|NCT00304980|Lumefantrine|lumefantrine|mesh-list
24538701|NCT00660426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538709|NCT00660582|Folic Acid|folic acid|mesh-list
24939055|NCT04013386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24939056|NCT04013386|Glucocorticoids|glucocorticoids|mesh-ancestor
24939057|NCT04013386|Hormones|hormones|mesh-ancestor
24939058|NCT04013386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24939059|NCT04013386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24939060|NCT04013386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939061|NCT04013386|Protease Inhibitors|protease inhibitors|mesh-ancestor
24939062|NCT04013386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451361|NCT00323323|Glucocorticoids|glucocorticoids|mesh-ancestor
25704671|NCT02186015|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25704672|NCT02186015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24538735|NCT00660621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538736|NCT00660621|Growth Inhibitors|growth inhibitors|mesh-ancestor
25704673|NCT02186301|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25704674|NCT02186301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24740890|NCT01690559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740891|NCT01690559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24740894|NCT01690572|Paclitaxel|paclitaxel|mesh-list
24741080|NCT01691677|Beclomethasone|beclomethasone|mesh-list
24741081|NCT01691677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24741082|NCT01691677|Glucocorticoids|glucocorticoids|mesh-ancestor
24741085|NCT01691677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939086|NCT04013438|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24939087|NCT04013438|Estrogens|estrogens|mesh-ancestor
24939088|NCT04013438|Hormones|hormones|mesh-ancestor
24939089|NCT04013438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24939090|NCT04013438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939091|NCT04013438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24939092|NCT04013438|Contraceptive Agents|contraceptive agents|mesh-ancestor
24939093|NCT04013438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24939094|NCT04013438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24939095|NCT04013438|Urological Agents|urological agents|mesh-ancestor
24939096|NCT04013477|Donepezil|donepezil|mesh-list
24939097|NCT04013477|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24939105|NCT04013243|Analgesics|analgesics|mesh-ancestor
25704675|NCT02186301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25704676|NCT02186301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25704677|NCT02186301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704678|NCT02186652|Pantoprazole|pantoprazole|mesh-list
25704679|NCT02186652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25704680|NCT02186652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25704681|NCT02186652|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25704682|NCT02186652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709650|NCT02271854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741932|NCT05294679|Propofol|propofol|mesh-list
24742007|NCT05294393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24742008|NCT05294393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704683|NCT02186652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704684|NCT02186665|Calcitriol|calcitriol|mesh-list
24742009|NCT05294393|Sensory System Agents|sensory system agents|mesh-ancestor
24742063|NCT05293704|Mizoribine|mizoribine|mesh-list
24939106|NCT04013243|Sensory System Agents|sensory system agents|mesh-ancestor
24763731|NCT01776437|Talazoparib|talazoparib|mesh-list
24939110|NCT04013243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24939111|NCT04013243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24939112|NCT04013243|Anticonvulsants|anticonvulsants|mesh-ancestor
24939113|NCT04013243|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24939116|NCT04013243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24939118|NCT04013243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24939119|NCT04013464|Citalopram|citalopram|mesh-list
24538743|NCT00660725|Gemcitabine|gemcitabine|mesh-list
24538744|NCT00660725|Oxaliplatin|oxaliplatin|mesh-list
24538745|NCT00660725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24538746|NCT00660725|Antimetabolites|antimetabolites|mesh-ancestor
24538747|NCT00660725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538765|NCT00660751|Antidepressive Agents|antidepressive agents|mesh-ancestor
24538766|NCT00660751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25704685|NCT02186665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25704686|NCT02186665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704687|NCT02186665|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25704688|NCT02186665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25704689|NCT02186665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742795|NCT05217706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742797|NCT05159427|Rifaximin|rifaximin|mesh-list
24742798|NCT05159427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24742799|NCT05159427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24742800|NCT05159427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24742801|NCT05159427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24742802|NCT05159427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742809|NCT05150795|Pregabalin|pregabalin|mesh-list
24939120|NCT04013464|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24939121|NCT04013464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24939122|NCT04013464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24939123|NCT04013464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763807|NCT01777100|Anesthetics, General|anesthetics, general|mesh-ancestor
24763808|NCT01777100|Anesthetics|anesthetics|mesh-ancestor
24852616|NCT02263170|GABA Modulators|gaba modulators|mesh-ancestor
25704690|NCT02186665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25704691|NCT02186665|Vitamins|vitamins|mesh-ancestor
25704692|NCT02186665|Micronutrients|micronutrients|mesh-ancestor
25704693|NCT02186665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25704694|NCT02186821|Ceritinib|ceritinib|mesh-list
25704695|NCT02186821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25704696|NCT02186821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25704697|NCT02186821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538803|NCT00660855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24538804|NCT00660855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451417|NCT00323583|Protective Agents|protective agents|mesh-ancestor
24451418|NCT00323583|Vitamin B Complex|vitamin b complex|mesh-ancestor
24451420|NCT00323583|Micronutrients|micronutrients|mesh-ancestor
24451421|NCT00323648|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24451422|NCT00323648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24538861|NCT00661063|Clonidine|clonidine|mesh-list
24451423|NCT00323687|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24451424|NCT00323687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24451425|NCT00323687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24763809|NCT01777347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24763810|NCT01777464|Histamine|histamine|mesh-list
24763811|NCT01777464|Histamine Agonists|histamine agonists|mesh-ancestor
24763812|NCT01777464|Histamine Agents|histamine agents|mesh-ancestor
24763813|NCT01777464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24763814|NCT01777464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24763815|NCT01777464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763816|NCT01777477|Gemcitabine|gemcitabine|mesh-list
24763817|NCT01777477|Chloroquine|chloroquine|mesh-list
24763818|NCT01777477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25704698|NCT02186821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704699|NCT02186873|Golimumab|golimumab|mesh-list
25704700|NCT02186873|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25704701|NCT02186873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25704702|NCT02186873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25704703|NCT02186873|Immunologic Factors|immunologic factors|mesh-ancestor
25704704|NCT02186873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704705|NCT02187016|Listerine|listerine|mesh-list
24743392|NCT04847193|Xanthohumol|xanthohumol|mesh-list
24743393|NCT04847193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24743400|NCT04843631|Dermatologic Agents|dermatologic agents|mesh-ancestor
24743402|NCT04838743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24743403|NCT04838743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24763819|NCT01777477|Antimetabolites|antimetabolites|mesh-ancestor
24763820|NCT01777477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812367|NCT02051868|Carboplatin|carboplatin|mesh-list
24538810|NCT00660868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538811|NCT00660868|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24538812|NCT00660868|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24538813|NCT00660868|Protective Agents|protective agents|mesh-ancestor
24538814|NCT00660868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538815|NCT00660868|Vasodilator Agents|vasodilator agents|mesh-ancestor
24538816|NCT00660868|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24538817|NCT00660868|Antioxidants|antioxidants|mesh-ancestor
24538819|NCT00660894|Tegafur|tegafur|mesh-list
24538820|NCT00660894|Calcium|calcium|mesh-list
25704706|NCT02187016|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25704707|NCT02187016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25704708|NCT02187055|Adalimumab|adalimumab|mesh-list
25704709|NCT02187055|Methotrexate|methotrexate|mesh-list
25704710|NCT02187055|Tofacitinib|tofacitinib|mesh-list
25704711|NCT02187055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25704712|NCT02187055|Abortifacient Agents|abortifacient agents|mesh-ancestor
25704713|NCT02187055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24743815|NCT04606797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24743816|NCT04606797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743822|NCT04602078|Gemcitabine|gemcitabine|mesh-list
24743856|NCT04588857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24743857|NCT04588857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24743858|NCT04588857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24743860|NCT04584684|Hydrogen Peroxide|hydrogen peroxide|mesh-list
24743861|NCT04584684|Cetylpyridinium|cetylpyridinium|mesh-list
24743862|NCT04584684|Povidone|povidone|mesh-list
24743880|NCT04577001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24743930|NCT04564885|Sensory System Agents|sensory system agents|mesh-ancestor
24538823|NCT00660894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538824|NCT00660894|Antidotes|antidotes|mesh-ancestor
24538825|NCT00660894|Protective Agents|protective agents|mesh-ancestor
24538826|NCT00660894|Vitamin B Complex|vitamin b complex|mesh-ancestor
24538827|NCT00660894|Vitamins|vitamins|mesh-ancestor
24538828|NCT00660894|Micronutrients|micronutrients|mesh-ancestor
24538829|NCT00660894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24939131|NCT04012918|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24939133|NCT04012918|Antimetabolites|antimetabolites|mesh-ancestor
24939134|NCT04012918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939135|NCT04012918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939140|NCT04012918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24939142|NCT04012541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
24939143|NCT04012619|Cisplatin|cisplatin|mesh-list
24939144|NCT04012619|Carboplatin|carboplatin|mesh-list
24812390|NCT02051894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24812393|NCT02051946|Ethacrynic Acid|ethacrynic acid|mesh-list
25704714|NCT02187055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704715|NCT02187055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25704716|NCT02187055|Antimetabolites|antimetabolites|mesh-ancestor
25704717|NCT02187055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704718|NCT02187055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25704719|NCT02187055|Dermatologic Agents|dermatologic agents|mesh-ancestor
25704720|NCT02187055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25704721|NCT02187055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25704722|NCT02187055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25704723|NCT02187055|Immunologic Factors|immunologic factors|mesh-ancestor
24538840|NCT00660972|Tenofovir|tenofovir|mesh-list
24538841|NCT00660972|Emtricitabine|emtricitabine|mesh-list
24538842|NCT00660972|Raltegravir Potassium|raltegravir potassium|mesh-list
24538843|NCT00660972|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24538844|NCT00660972|Antiviral Agents|antiviral agents|mesh-ancestor
24538845|NCT00660972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24538846|NCT00660972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24538847|NCT00660972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24538848|NCT00660972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538849|NCT00660972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538850|NCT00660972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24538854|NCT00660998|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24538855|NCT00660998|Vasodilator Agents|vasodilator agents|mesh-ancestor
24538856|NCT00660998|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24538857|NCT00660998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24538858|NCT00660998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538859|NCT00660998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538860|NCT00660998|Urological Agents|urological agents|mesh-ancestor
24538862|NCT00661063|Ketamine|ketamine|mesh-list
24538863|NCT00661063|Analgesics|analgesics|mesh-ancestor
24538864|NCT00661063|Sensory System Agents|sensory system agents|mesh-ancestor
24538865|NCT00661063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24745261|NCT03846570|Formoterol Fumarate|formoterol fumarate|mesh-list
24745262|NCT03846570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24745263|NCT03846570|Autonomic Agents|autonomic agents|mesh-ancestor
24939156|NCT04012606|Etoposide|etoposide|mesh-list
24939157|NCT04012606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939158|NCT04012606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24812415|NCT02052128|Fertility Agents|fertility agents|mesh-ancestor
24538887|NCT00661076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24538888|NCT00661076|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24538889|NCT00661076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24538890|NCT00661076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538891|NCT00661076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538904|NCT00661154|Bevacizumab|bevacizumab|mesh-list
24538905|NCT00661154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25704724|NCT02187055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25704725|NCT02187055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25704726|NCT02187055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25704727|NCT02187055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25704728|NCT02187159|Pregabalin|pregabalin|mesh-list
25704729|NCT02187159|Analgesics|analgesics|mesh-ancestor
25704730|NCT02187159|Sensory System Agents|sensory system agents|mesh-ancestor
25704731|NCT02187159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24745669|NCT03651102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745670|NCT03651102|Leprostatic Agents|leprostatic agents|mesh-ancestor
24745671|NCT03651102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24745677|NCT03651102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745708|NCT03649802|Vitamin D|vitamin d|mesh-list
24745709|NCT03649802|Ergocalciferols|ergocalciferols|mesh-list
24745758|NCT03596385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24745759|NCT03596385|Sympatholytics|sympatholytics|mesh-ancestor
24745760|NCT03596385|Autonomic Agents|autonomic agents|mesh-ancestor
24745761|NCT03596385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24745762|NCT03596385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745763|NCT03596385|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24745764|NCT03596385|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24745765|NCT03596385|Adrenergic Agents|adrenergic agents|mesh-ancestor
24745766|NCT03596385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24745767|NCT03596385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745804|NCT03590652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745805|NCT03584711|Panitumumab|panitumumab|mesh-list
24745806|NCT03584711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24745807|NCT03584711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745808|NCT03582475|Cisplatin|cisplatin|mesh-list
24939177|NCT04012424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955320|NCT03865550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24955321|NCT03865550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24955322|NCT03865550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24955323|NCT03865550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24955324|NCT03865550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955325|NCT03865563|Gemcitabine|gemcitabine|mesh-list
24955326|NCT03865563|Ethiodized Oil|ethiodized oil|mesh-list
24955327|NCT03865563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24955328|NCT03865563|Antimetabolites|antimetabolites|mesh-ancestor
24812424|NCT02052167|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25704732|NCT02187159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704733|NCT02187159|Anticonvulsants|anticonvulsants|mesh-ancestor
25704734|NCT02187159|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25704735|NCT02187159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25704736|NCT02187159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704737|NCT02187159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25704738|NCT02187159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25704739|NCT02187159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25704740|NCT02187159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25704741|NCT02187159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25704742|NCT02187172|Ustekinumab|ustekinumab|mesh-list
25704743|NCT02187172|Dermatologic Agents|dermatologic agents|mesh-ancestor
25704744|NCT02187471|Pregabalin|pregabalin|mesh-list
25704745|NCT02187471|Analgesics|analgesics|mesh-ancestor
25704746|NCT02187471|Sensory System Agents|sensory system agents|mesh-ancestor
25704747|NCT02187471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25704748|NCT02187471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704749|NCT02187471|Anticonvulsants|anticonvulsants|mesh-ancestor
25704750|NCT02187471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25704751|NCT02187471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25704752|NCT02187471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746580|NCT05006079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24654477|NCT01249690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24746647|NCT04590586|Sensory System Agents|sensory system agents|mesh-ancestor
24746648|NCT04590586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24746649|NCT04590586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746650|NCT04590586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24746651|NCT04590586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24746652|NCT04590586|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24451436|NCT00323778|Viscosupplements|viscosupplements|mesh-ancestor
24955329|NCT03865563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24955330|NCT03865563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24955332|NCT03865563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24955333|NCT03865563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24955334|NCT03865563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24939178|NCT04012307|Candesartan|candesartan|mesh-list
24939179|NCT04012307|Candesartan cilexetil|candesartan cilexetil|mesh-list
24939180|NCT04012307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24939181|NCT04012307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24939182|NCT04012307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24939183|NCT04012307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939184|NCT04012073|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
24939185|NCT04012073|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24939186|NCT04012073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24394244|NCT00132652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24939187|NCT04012073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939189|NCT04012268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24939190|NCT04012268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25704753|NCT02187471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25704754|NCT02187471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25704755|NCT02187471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25704756|NCT02187471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25704757|NCT02187471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25704758|NCT02187744|Carboplatin|carboplatin|mesh-list
25704759|NCT02187744|Docetaxel|docetaxel|mesh-list
25704760|NCT02187744|Trastuzumab|trastuzumab|mesh-list
25704761|NCT02187744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451434|NCT00323778|Immunologic Factors|immunologic factors|mesh-ancestor
24451435|NCT00323778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505227|NCT00540501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505228|NCT00540527|Plasminogen|plasminogen|mesh-list
24505229|NCT00540527|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24505230|NCT00540527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24505231|NCT00540527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24505232|NCT00540527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505234|NCT00540605|Antiviral Agents|antiviral agents|mesh-ancestor
24505235|NCT00540605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24505236|NCT00540605|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24505237|NCT00540605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24505255|NCT00540787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
24505256|NCT00540787|Propafenone|propafenone|mesh-list
24505257|NCT00540787|Dofetilide|dofetilide|mesh-list
24505258|NCT00540787|Cifenline|cifenline|mesh-list
24451438|NCT00323791|Gemcitabine|gemcitabine|mesh-list
24451439|NCT00323791|Imatinib Mesylate|imatinib mesylate|mesh-list
24451440|NCT00323791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24451441|NCT00323791|Antimetabolites|antimetabolites|mesh-ancestor
24939192|NCT04012268|Sensory System Agents|sensory system agents|mesh-ancestor
24939193|NCT04012268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24939194|NCT04012268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939195|NCT04012268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24939196|NCT04012268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24939197|NCT04012268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24939198|NCT04012268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24538942|NCT00661336|Melphalan|melphalan|mesh-list
24538943|NCT00661336|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
24538944|NCT00661336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24538945|NCT00661336|Alkylating Agents|alkylating agents|mesh-ancestor
24538946|NCT00661336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538947|NCT00661336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538948|NCT00661336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24538949|NCT00661336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24538950|NCT00661336|Immunologic Factors|immunologic factors|mesh-ancestor
24538951|NCT00661336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538952|NCT00661336|Antimetabolites|antimetabolites|mesh-ancestor
24538953|NCT00661336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24538954|NCT00661336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538955|NCT00661336|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24538956|NCT00661336|Protective Agents|protective agents|mesh-ancestor
24505259|NCT00540787|Calcium Channel Blockers|calcium channel blockers|mesh-list
24505260|NCT00540787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24505261|NCT00540787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505262|NCT00540787|Vasodilator Agents|vasodilator agents|mesh-ancestor
24505263|NCT00540787|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24505323|NCT00540930|Growth Substances|growth substances|mesh-ancestor
24538957|NCT00661349|Ritonavir|ritonavir|mesh-list
24451461|NCT00323817|Cholinergic Agents|cholinergic agents|mesh-ancestor
24451462|NCT00323817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24451463|NCT00323817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451464|NCT00323817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25704762|NCT02187744|Tubulin Modulators|tubulin modulators|mesh-ancestor
25704763|NCT02187744|Antimitotic Agents|antimitotic agents|mesh-ancestor
25704764|NCT02187744|Mitosis Modulators|mitosis modulators|mesh-ancestor
25704765|NCT02187744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704766|NCT02187744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25704767|NCT02187809|Clobazam|clobazam|mesh-list
25704768|NCT02187809|Anticonvulsants|anticonvulsants|mesh-ancestor
25704769|NCT02187809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24749370|NCT01160107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24749371|NCT01160107|Immunologic Factors|immunologic factors|mesh-ancestor
24618861|NCT01049880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618862|NCT01049880|Antioxidants|antioxidants|mesh-ancestor
24618863|NCT01049880|Protective Agents|protective agents|mesh-ancestor
24655507|NCT01257048|Budesonide|budesonide|mesh-list
24749775|NCT00379340|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24749779|NCT00304070|Etoposide|etoposide|mesh-list
24939199|NCT04012268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939200|NCT04012268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24939201|NCT04012268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24939202|NCT04012268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939203|NCT04012268|Antipyretics|antipyretics|mesh-ancestor
24939204|NCT04012047|Cromakalim|cromakalim|mesh-list
24939205|NCT04012047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24939206|NCT04012047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24939207|NCT04012047|Autonomic Agents|autonomic agents|mesh-ancestor
24939208|NCT04012047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658886|NCT01274403|Thalidomide|thalidomide|mesh-list
24505432|NCT00541125|Bevacizumab|bevacizumab|mesh-list
24538972|NCT00661349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24538973|NCT00661349|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24538974|NCT00661349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24538976|NCT00661375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538977|NCT00661375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24538978|NCT00661375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939210|NCT04012047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24939211|NCT04012047|Respiratory System Agents|respiratory system agents|mesh-ancestor
24939212|NCT04012047|Parasympatholytics|parasympatholytics|mesh-ancestor
24939213|NCT04012047|Vasodilator Agents|vasodilator agents|mesh-ancestor
24939215|NCT04012294|Antimetabolites|antimetabolites|mesh-ancestor
24939216|NCT04012294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939217|NCT04012294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050488|NCT00491738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050489|NCT00491738|Growth Inhibitors|growth inhibitors|mesh-ancestor
25050490|NCT00491738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25050491|NCT00491738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050492|NCT00491738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050493|NCT00489203|Beclomethasone|beclomethasone|mesh-list
25704770|NCT02187809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25704771|NCT02187809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25704772|NCT02187809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704773|NCT02187809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25704774|NCT02187809|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25704775|NCT02187809|GABA Agonists|gaba agonists|mesh-ancestor
25704776|NCT02187809|GABA Agents|gaba agents|mesh-ancestor
25704777|NCT02187809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24750421|NCT01698541|Immunologic Factors|immunologic factors|mesh-ancestor
24750499|NCT01698788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24750500|NCT01698788|Protease Inhibitors|protease inhibitors|mesh-ancestor
24540604|NCT00668616|Immunologic Factors|immunologic factors|mesh-ancestor
24750501|NCT01698788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750502|NCT01698788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750503|NCT01698931|Glyburide|glyburide|mesh-list
24750504|NCT01698931|Repaglinide|repaglinide|mesh-list
24750505|NCT01698931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24750506|NCT01698931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750507|NCT01699113|Rabeprazole|rabeprazole|mesh-list
24750508|NCT01699113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24750509|NCT01699113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24538979|NCT00661375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538981|NCT00661401|Immunologic Factors|immunologic factors|mesh-ancestor
24538982|NCT00661401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538983|NCT00661596|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24538984|NCT00661596|Vasodilator Agents|vasodilator agents|mesh-ancestor
24538985|NCT00661596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24538986|NCT00661596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24538987|NCT00661596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538988|NCT00661596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538998|NCT00661635|Sensory System Agents|sensory system agents|mesh-ancestor
24538999|NCT00661635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24539000|NCT00661635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539016|NCT00661739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939230|NCT04011930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24939231|NCT04011930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24939232|NCT04011930|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24505698|NCT00542022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25704778|NCT02187809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704779|NCT02187861|Rituximab|rituximab|mesh-list
25704780|NCT02187861|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25704781|NCT02187861|Venetoclax|venetoclax|mesh-list
25704782|NCT02187861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25704783|NCT02187861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25704784|NCT02187861|Immunologic Factors|immunologic factors|mesh-ancestor
25704785|NCT02187861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704786|NCT02187861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25704787|NCT02187861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25704788|NCT02187861|Alkylating Agents|alkylating agents|mesh-ancestor
25704789|NCT02187861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704790|NCT02188160|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25704791|NCT02188160|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24751121|NCT01702181|Tacrolimus|tacrolimus|mesh-list
24505699|NCT00542022|Nasal Decongestants|nasal decongestants|mesh-ancestor
24505700|NCT00542022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24505701|NCT00542022|Respiratory System Agents|respiratory system agents|mesh-ancestor
24505703|NCT00542074|Emollients|emollients|mesh-list
24505704|NCT00542074|Dermatologic Agents|dermatologic agents|mesh-ancestor
24505705|NCT00542074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24505706|NCT00542074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24505708|NCT00542074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505724|NCT00542139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24505725|NCT00542139|Respiratory System Agents|respiratory system agents|mesh-ancestor
24505726|NCT00542152|Cyclosporine|cyclosporine|mesh-list
24505727|NCT00542152|Infliximab|infliximab|mesh-list
24505728|NCT00542152|Cyclosporins|cyclosporins|mesh-list
24505729|NCT00542152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505730|NCT00542152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939233|NCT04011930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24852700|NCT02263924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539031|NCT00661856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539032|NCT00661856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539034|NCT00661856|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24505731|NCT00542152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24505732|NCT00542152|Immunologic Factors|immunologic factors|mesh-ancestor
24505733|NCT00542152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505734|NCT00542152|Antifungal Agents|antifungal agents|mesh-ancestor
24505735|NCT00542152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24505736|NCT00542152|Dermatologic Agents|dermatologic agents|mesh-ancestor
24505737|NCT00542152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24505738|NCT00542152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24505739|NCT00542152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24505740|NCT00542165|Alfuzosin|alfuzosin|mesh-list
24505742|NCT00542165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24505756|NCT00542243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505757|NCT00542243|Urological Agents|urological agents|mesh-ancestor
24505760|NCT00542295|Parasympatholytics|parasympatholytics|mesh-ancestor
24505761|NCT00542295|Autonomic Agents|autonomic agents|mesh-ancestor
24539035|NCT00661856|Estrogens|estrogens|mesh-ancestor
24446137|NCT00303810|Antimitotic Agents|antimitotic agents|mesh-ancestor
24446139|NCT00303836|Aldesleukin|aldesleukin|mesh-list
24939265|NCT04011345|Vitamins|vitamins|mesh-ancestor
24505763|NCT00542295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505764|NCT00542295|Anticonvulsants|anticonvulsants|mesh-ancestor
24505765|NCT00542347|Esomeprazole|esomeprazole|mesh-list
24505766|NCT00542347|Omeprazole|omeprazole|mesh-list
24752160|NCT01708707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24505872|NCT00542984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24505873|NCT00542984|Vasodilator Agents|vasodilator agents|mesh-ancestor
24505874|NCT00543023|Teriparatide|teriparatide|mesh-list
24505876|NCT00543023|Salmon calcitonin|salmon calcitonin|mesh-list
24939234|NCT04011930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939235|NCT04011930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24939236|NCT04011813|Antioxidants|antioxidants|mesh-list
24939237|NCT04011813|Hypotaurine|hypotaurine|mesh-list
24939238|NCT04011813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939239|NCT04011813|Protective Agents|protective agents|mesh-ancestor
24939240|NCT04011813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939241|NCT04011670|Caffeine|caffeine|mesh-list
24505877|NCT00543023|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
24505878|NCT00543023|Katacalcin|katacalcin|mesh-list
24505879|NCT00543023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24505914|NCT00543205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505915|NCT00543218|Teriparatide|teriparatide|mesh-list
24505916|NCT00543218|Calcitonin|calcitonin|mesh-list
24505917|NCT00543218|Salmon calcitonin|salmon calcitonin|mesh-list
24505918|NCT00543218|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
24505919|NCT00543218|Katacalcin|katacalcin|mesh-list
24505920|NCT00543218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24505921|NCT00543218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505922|NCT00543218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24505923|NCT00543218|Vasodilator Agents|vasodilator agents|mesh-ancestor
24505924|NCT00543231|Oblimersen|oblimersen|mesh-list
24505925|NCT00543231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505926|NCT00543244|Interferons|interferons|mesh-list
24939266|NCT04011345|Micronutrients|micronutrients|mesh-ancestor
24539037|NCT00661856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24939255|NCT04011878|Mitomycin|mitomycin|mesh-list
24939256|NCT04011878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24939257|NCT04011878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939258|NCT04011878|Alkylating Agents|alkylating agents|mesh-ancestor
24939259|NCT04011878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852724|NCT02263976|Anticonvulsants|anticonvulsants|mesh-ancestor
24505928|NCT00543244|Interferon-alpha|interferon-alpha|mesh-list
24505929|NCT00543244|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24505930|NCT00543244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505931|NCT00543244|Antiviral Agents|antiviral agents|mesh-ancestor
24505932|NCT00543244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24505933|NCT00543244|Antimetabolites|antimetabolites|mesh-ancestor
24505934|NCT00543244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505935|NCT00543244|Immunologic Factors|immunologic factors|mesh-ancestor
24505967|NCT00543504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505968|NCT00543608|Vancomycin|vancomycin|mesh-list
24505969|NCT00543608|Iclaprim|iclaprim|mesh-list
24505970|NCT00543608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24505971|NCT00543608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25704792|NCT02188459|Bupropion|bupropion|mesh-list
24505983|NCT00543634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25704793|NCT02188459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25704794|NCT02188459|Antidepressive Agents|antidepressive agents|mesh-ancestor
25704795|NCT02188459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25704796|NCT02188459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25704797|NCT02188459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25704798|NCT02188459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24539071|NCT00662233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24539073|NCT00662233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539075|NCT00662233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24506031|NCT00543842|Bevacizumab|bevacizumab|mesh-list
24506032|NCT00543842|Capecitabine|capecitabine|mesh-list
24506033|NCT00543842|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24506034|NCT00543842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24506035|NCT00543842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506087|NCT00544037|Antiviral Agents|antiviral agents|mesh-ancestor
24939260|NCT04011878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24939261|NCT04011878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939263|NCT04011345|Hematinics|hematinics|mesh-ancestor
24939264|NCT04011345|Vitamin B Complex|vitamin b complex|mesh-ancestor
24939269|NCT04011280|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24939270|NCT04011280|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24939271|NCT04011280|Cholinergic Agents|cholinergic agents|mesh-ancestor
24939272|NCT04011280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24939273|NCT04011280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939274|NCT04011280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939275|NCT04011124|Rifampin|rifampin|mesh-list
24939276|NCT04011124|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24939277|NCT04011124|Antitubercular Agents|antitubercular agents|mesh-ancestor
24939295|NCT04010955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939296|NCT04010955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939297|NCT04010955|Anticoagulants|anticoagulants|mesh-ancestor
24939299|NCT04011410|Antimalarials|antimalarials|mesh-ancestor
24506091|NCT00544037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24506092|NCT00544050|Levetiracetam|levetiracetam|mesh-list
24506093|NCT00544050|Anticonvulsants|anticonvulsants|mesh-ancestor
24506094|NCT00544050|Nootropic Agents|nootropic agents|mesh-ancestor
24506095|NCT00544063|Oxaliplatin|oxaliplatin|mesh-list
24539076|NCT00662233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24539077|NCT00662233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24539078|NCT00662233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24539079|NCT00662233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506299|NCT00544596|Gossypol|gossypol|mesh-list
24506300|NCT00544596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506312|NCT00544596|Protective Agents|protective agents|mesh-ancestor
24506313|NCT00544596|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24506314|NCT00544596|Contraceptive Agents|contraceptive agents|mesh-ancestor
24506315|NCT00544596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24506316|NCT00544596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24506317|NCT00544596|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
24506318|NCT00544596|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
24506320|NCT00544609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939300|NCT04011410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24474829|NCT00407589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24506321|NCT00544609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24506322|NCT00544609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506324|NCT00544687|Mometasone Furoate|mometasone furoate|mesh-list
24506402|NCT00545142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24506403|NCT00545142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506404|NCT00545142|Dopamine Agonists|dopamine agonists|mesh-ancestor
24506405|NCT00545142|Dopamine Agents|dopamine agents|mesh-ancestor
24506406|NCT00545142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24506407|NCT00545142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506408|NCT00545142|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24506412|NCT00545142|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24539130|NCT00662454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24939312|NCT04011241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704799|NCT02188459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704800|NCT02188459|Dopamine Agents|dopamine agents|mesh-ancestor
25704801|NCT02188459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25704802|NCT02188459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704803|NCT02188459|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25704804|NCT02188459|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25704805|NCT02188459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25704806|NCT02188576|Tranexamic Acid|tranexamic acid|mesh-list
24443678|NCT00295776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443679|NCT00295776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24443680|NCT00295776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24443681|NCT00295776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24443682|NCT00295776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24443683|NCT00295776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24443684|NCT00295789|Paclitaxel|paclitaxel|mesh-list
24539141|NCT00662467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24539142|NCT00662467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539143|NCT00662467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24539144|NCT00662467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24539145|NCT00662467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24539146|NCT00662467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24539147|NCT00662467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539149|NCT00662467|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24539151|NCT00662467|Antipyretics|antipyretics|mesh-ancestor
24443714|NCT00295893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24443715|NCT00295893|Trastuzumab|trastuzumab|mesh-list
24506921|NCT00547547|Antimetabolites|antimetabolites|mesh-ancestor
24506922|NCT00547547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506923|NCT00547547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506924|NCT00547547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24506925|NCT00547547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24506926|NCT00547547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506927|NCT00547547|Antioxidants|antioxidants|mesh-ancestor
24506928|NCT00547547|Protective Agents|protective agents|mesh-ancestor
24506929|NCT00547547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506930|NCT00547547|Trace Elements|trace elements|mesh-ancestor
24506952|NCT00547625|Vasodilator Agents|vasodilator agents|mesh-ancestor
24506953|NCT00547625|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24506954|NCT00547625|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24506955|NCT00547625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506956|NCT00547625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506957|NCT00547625|Urological Agents|urological agents|mesh-ancestor
24506959|NCT00547664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24506960|NCT00547664|Narcotics|narcotics|mesh-ancestor
24539155|NCT00662467|Purinergic Agents|purinergic agents|mesh-ancestor
24539156|NCT00662467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24506961|NCT00547664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24622403|NCT01066845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622404|NCT01066845|Urological Agents|urological agents|mesh-ancestor
24507026|NCT00548288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24507027|NCT00548288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507029|NCT00548301|Cyclosporins|cyclosporins|mesh-list
24507030|NCT00548301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507031|NCT00548301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507032|NCT00548301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24507033|NCT00548301|Immunologic Factors|immunologic factors|mesh-ancestor
24507034|NCT00548301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507035|NCT00548301|Antifungal Agents|antifungal agents|mesh-ancestor
24507036|NCT00548301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24507037|NCT00548301|Dermatologic Agents|dermatologic agents|mesh-ancestor
24507038|NCT00548301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24507039|NCT00548301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24939319|NCT04011098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24939320|NCT04011098|Narcotics|narcotics|mesh-ancestor
24939321|NCT04011098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24939322|NCT04011098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507075|NCT00548561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507116|NCT00548704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507117|NCT00548704|Antimitotic Agents|antimitotic agents|mesh-ancestor
24507118|NCT00548704|Mitosis Modulators|mitosis modulators|mesh-ancestor
24507120|NCT00548821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507121|NCT00548834|Certolizumab Pegol|certolizumab pegol|mesh-list
24507122|NCT00548834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24507123|NCT00548834|Immunologic Factors|immunologic factors|mesh-ancestor
24507124|NCT00548834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507125|NCT00548834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24507126|NCT00548899|Sorafenib|sorafenib|mesh-list
24507127|NCT00548899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507128|NCT00548899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24507129|NCT00548899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507130|NCT00548899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507132|NCT00548938|Carmustine|carmustine|mesh-list
24507133|NCT00548938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24939325|NCT04011098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24539175|NCT00662610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24539176|NCT00662610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539177|NCT00662610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539178|NCT00662610|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24539179|NCT00662636|Dasatinib|dasatinib|mesh-list
24539180|NCT00662636|Lapatinib|lapatinib|mesh-list
24539181|NCT00662636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24539182|NCT00662636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24507134|NCT00548938|Alkylating Agents|alkylating agents|mesh-ancestor
24507135|NCT00548938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507136|NCT00548938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507137|NCT00548964|Ketamine|ketamine|mesh-list
24507138|NCT00548964|Lithium Carbonate|lithium carbonate|mesh-list
24507139|NCT00548964|Analgesics|analgesics|mesh-ancestor
24507140|NCT00548964|Sensory System Agents|sensory system agents|mesh-ancestor
24507141|NCT00548964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24421999|NCT00220857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24539183|NCT00662636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539184|NCT00662636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539185|NCT00662714|Insulin|insulin|mesh-list
24507142|NCT00548964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507143|NCT00548964|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24507144|NCT00548964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24507261|NCT00549419|Protective Agents|protective agents|mesh-ancestor
24507262|NCT00549471|Botulinum Toxins|botulinum toxins|mesh-list
24507263|NCT00549471|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24507264|NCT00549471|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24507265|NCT00549471|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24507514|NCT00550992|Etoposide|etoposide|mesh-list
24539186|NCT00662714|Repaglinide|repaglinide|mesh-list
24539187|NCT00662714|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24939326|NCT04011098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24939328|NCT04011098|Anesthetics, General|anesthetics, general|mesh-ancestor
24539188|NCT00662714|Insulin, Short-Acting|insulin, short-acting|mesh-list
24539189|NCT00662714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24539190|NCT00662714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539191|NCT00662779|Formoterol Fumarate|formoterol fumarate|mesh-list
24539192|NCT00662779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24539193|NCT00662779|Autonomic Agents|autonomic agents|mesh-ancestor
24539194|NCT00662779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24539195|NCT00662779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539219|NCT00662805|Adrenergic Agents|adrenergic agents|mesh-ancestor
24539220|NCT00662805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24539221|NCT00662805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539222|NCT00662844|Vitamin D|vitamin d|mesh-list
24539223|NCT00662844|Cholecalciferol|cholecalciferol|mesh-list
24539224|NCT00662844|Vitamins|vitamins|mesh-ancestor
24539225|NCT00662844|Micronutrients|micronutrients|mesh-ancestor
24539226|NCT00662844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507556|NCT00550992|Vitamins|vitamins|mesh-ancestor
24507557|NCT00550992|Micronutrients|micronutrients|mesh-ancestor
24757795|NCT01742429|Antacids|antacids|mesh-ancestor
24507558|NCT00550992|Tubulin Modulators|tubulin modulators|mesh-ancestor
24507559|NCT00550992|Antimitotic Agents|antimitotic agents|mesh-ancestor
24507560|NCT00550992|Mitosis Modulators|mitosis modulators|mesh-ancestor
24507561|NCT00550992|Antifungal Agents|antifungal agents|mesh-ancestor
24507573|NCT00551005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507574|NCT00551005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507575|NCT00551005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24507576|NCT00551005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24507578|NCT00551005|Sensory System Agents|sensory system agents|mesh-ancestor
24507579|NCT00551005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24539326|NCT00663286|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24507585|NCT00551018|Tenofovir|tenofovir|mesh-list
24507586|NCT00551018|Emtricitabine|emtricitabine|mesh-list
24507587|NCT00551018|Antiviral Agents|antiviral agents|mesh-ancestor
24507588|NCT00551018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24507589|NCT00551018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24507595|NCT00551044|Bicalutamide|bicalutamide|mesh-list
24539239|NCT00662883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24539240|NCT00662883|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24539241|NCT00662883|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24539242|NCT00662883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24446224|NCT00304135|Antiviral Agents|antiviral agents|mesh-ancestor
24539260|NCT00662896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539261|NCT00662896|Gout Suppressants|gout suppressants|mesh-ancestor
24539262|NCT00662896|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25704807|NCT02188576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25704808|NCT02188576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25704809|NCT02188576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704810|NCT02188576|Hemostatics|hemostatics|mesh-ancestor
25704811|NCT02188576|Coagulants|coagulants|mesh-ancestor
25704812|NCT02188719|Acetaminophen|acetaminophen|mesh-list
25704813|NCT02188719|Diphenhydramine|diphenhydramine|mesh-list
25704814|NCT02188719|Promethazine|promethazine|mesh-list
25704815|NCT02188719|Mycophenolic Acid|mycophenolic acid|mesh-list
25704816|NCT02188719|Valganciclovir|valganciclovir|mesh-list
25704819|NCT02188719|Prednisone|prednisone|mesh-list
24539264|NCT00662948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24539277|NCT00663052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24539278|NCT00663052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539279|NCT00663052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24539280|NCT00663052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24539281|NCT00663052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24539282|NCT00663052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24539283|NCT00663052|Immunologic Factors|immunologic factors|mesh-ancestor
24539284|NCT00663130|Tadalafil|tadalafil|mesh-list
24539285|NCT00663130|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24539286|NCT00663130|Vasodilator Agents|vasodilator agents|mesh-ancestor
24507929|NCT00553345|Micronutrients|micronutrients|mesh-ancestor
24507931|NCT00553345|Antioxidants|antioxidants|mesh-ancestor
24507975|NCT00553683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24507976|NCT00553683|Immunologic Factors|immunologic factors|mesh-ancestor
24507977|NCT00553683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507978|NCT00553683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24507979|NCT00553683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24507980|NCT00553683|Alkylating Agents|alkylating agents|mesh-ancestor
24507981|NCT00553683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507982|NCT00553683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507983|NCT00553683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24507984|NCT00553683|Interferon Inducers|interferon inducers|mesh-ancestor
24507985|NCT00553709|Nicotine|nicotine|mesh-list
24508064|NCT00554138|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24508065|NCT00554138|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24508066|NCT00554138|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24539287|NCT00663130|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24539288|NCT00663130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24539289|NCT00663130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539290|NCT00663130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539291|NCT00663130|Urological Agents|urological agents|mesh-ancestor
24539292|NCT00663182|Entecavir|entecavir|mesh-list
24539293|NCT00663182|Antiviral Agents|antiviral agents|mesh-ancestor
24539294|NCT00663182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24539301|NCT00663195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24539302|NCT00663195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539309|NCT00663221|Vitamins|vitamins|mesh-ancestor
24852785|NCT02264119|Pantoprazole|pantoprazole|mesh-list
24539310|NCT00663221|Micronutrients|micronutrients|mesh-ancestor
24539311|NCT00663221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539312|NCT00663221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24539313|NCT00663221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24539314|NCT00663247|Mesalamine|mesalamine|mesh-list
24539315|NCT00663247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24539316|NCT00663247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24539317|NCT00663247|Analgesics|analgesics|mesh-ancestor
24539318|NCT00663247|Sensory System Agents|sensory system agents|mesh-ancestor
24539319|NCT00663247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24539320|NCT00663247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474830|NCT00407589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24539321|NCT00663247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25704820|NCT02188719|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25704821|NCT02188719|Everolimus|everolimus|mesh-list
25704822|NCT02188719|Liver Extracts|liver extracts|mesh-list
25704823|NCT02188719|Tacrolimus|tacrolimus|mesh-list
25704824|NCT02188719|Thymoglobulin|thymoglobulin|mesh-list
25704825|NCT02188719|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25704826|NCT02188719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24758991|NCT01748838|Mannitol|mannitol|mesh-list
24539322|NCT00663247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24539323|NCT00663286|Clindamycin|clindamycin|mesh-list
24539324|NCT00663286|Clindamycin palmitate|clindamycin palmitate|mesh-list
24539325|NCT00663286|Clindamycin phosphate|clindamycin phosphate|mesh-list
24539328|NCT00663286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24539329|NCT00663286|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24539330|NCT00663286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539331|NCT00663286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539332|NCT00663286|Dermatologic Agents|dermatologic agents|mesh-ancestor
24539333|NCT00663312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
24539334|NCT00663312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24539367|NCT00663455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24539368|NCT00663455|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24539369|NCT00663481|Leucovorin|leucovorin|mesh-list
24508584|NCT00556127|Sensory System Agents|sensory system agents|mesh-ancestor
24508585|NCT00556127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24508586|NCT00556153|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
24508588|NCT00556192|Rituximab|rituximab|mesh-list
24508647|NCT00556361|Ketamine|ketamine|mesh-list
24508670|NCT00556387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24508671|NCT00556387|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24508672|NCT00556387|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24539370|NCT00663481|Antidotes|antidotes|mesh-ancestor
24539371|NCT00663481|Protective Agents|protective agents|mesh-ancestor
24939344|NCT04011033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939345|NCT04011033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24939346|NCT04011033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24939347|NCT04011033|Alkylating Agents|alkylating agents|mesh-ancestor
24939348|NCT04011033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939349|NCT04011033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24539372|NCT00663481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539373|NCT00663481|Vitamin B Complex|vitamin b complex|mesh-ancestor
24539374|NCT00663481|Vitamins|vitamins|mesh-ancestor
24539375|NCT00663481|Micronutrients|micronutrients|mesh-ancestor
24539376|NCT00663559|Sunitinib|sunitinib|mesh-list
24539377|NCT00663559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509112|NCT00558506|Immunologic Factors|immunologic factors|mesh-ancestor
24509113|NCT00558506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509114|NCT00558506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24509115|NCT00558623|Calcium Carbonate|calcium carbonate|mesh-list
24509116|NCT00558623|Calcium|calcium|mesh-list
24509118|NCT00558623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704827|NCT02188719|Glucocorticoids|glucocorticoids|mesh-ancestor
25704828|NCT02188719|Hormones|hormones|mesh-ancestor
25704829|NCT02188719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25704830|NCT02188719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704831|NCT02188719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25704832|NCT02188719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25704833|NCT02188719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25704834|NCT02188719|Immunologic Factors|immunologic factors|mesh-ancestor
25704835|NCT02188719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25704836|NCT02188719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24509236|NCT00559455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24509237|NCT00559455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509238|NCT00559455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24539385|NCT00663559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539386|NCT00663598|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24509318|NCT00559689|Hormones|hormones|mesh-ancestor
24509319|NCT00559689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24509320|NCT00559702|Natalizumab|natalizumab|mesh-list
24509321|NCT00559702|Immunologic Factors|immunologic factors|mesh-ancestor
24509322|NCT00559702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509323|NCT00559715|Bevacizumab|bevacizumab|mesh-list
24509324|NCT00559715|Ranibizumab|ranibizumab|mesh-list
24509325|NCT00559715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24509326|NCT00559715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509327|NCT00559715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24509328|NCT00559715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24509329|NCT00559715|Growth Substances|growth substances|mesh-ancestor
24509330|NCT00559715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509331|NCT00559715|Growth Inhibitors|growth inhibitors|mesh-ancestor
24509332|NCT00559741|Leucovorin|leucovorin|mesh-list
24509333|NCT00559741|Fluorouracil|fluorouracil|mesh-list
24539387|NCT00663598|Vasodilator Agents|vasodilator agents|mesh-ancestor
24939350|NCT04011033|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24939351|NCT04011033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24939353|NCT04011033|Sensory System Agents|sensory system agents|mesh-ancestor
24540232|NCT00667043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24509354|NCT00559741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24509355|NCT00559858|Pyridoxine|pyridoxine|mesh-list
24509356|NCT00559858|Vitamin B 6|vitamin b 6|mesh-list
24509357|NCT00559858|Vitamin B Complex|vitamin b complex|mesh-ancestor
24539428|NCT00663845|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24539429|NCT00663845|Vasodilator Agents|vasodilator agents|mesh-ancestor
24539430|NCT00663845|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24509360|NCT00559858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509361|NCT00559975|Vaccines|vaccines|mesh-list
24509362|NCT00559975|Immunologic Factors|immunologic factors|mesh-ancestor
24509413|NCT00560209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509414|NCT00560209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509415|NCT00560209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24509416|NCT00560222|Lactoferrin|lactoferrin|mesh-list
24509417|NCT00560222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24509418|NCT00560274|Ribavirin|ribavirin|mesh-list
24509419|NCT00560274|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24509420|NCT00560274|Antimetabolites|antimetabolites|mesh-ancestor
24509421|NCT00560274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509422|NCT00560274|Antiviral Agents|antiviral agents|mesh-ancestor
24509423|NCT00560274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24509424|NCT00560300|Vitamin D|vitamin d|mesh-list
24509425|NCT00560300|Cholecalciferol|cholecalciferol|mesh-list
24539527|NCT00664248|Clindamycin phosphate|clindamycin phosphate|mesh-list
24539528|NCT00664248|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24539529|NCT00664248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24539530|NCT00664248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24539531|NCT00664248|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24539532|NCT00664248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539533|NCT00664248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539534|NCT00664248|Dermatologic Agents|dermatologic agents|mesh-ancestor
24539535|NCT00664287|Niacin|niacin|mesh-list
24539536|NCT00664287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24539537|NCT00664287|Antimetabolites|antimetabolites|mesh-ancestor
24539548|NCT00664313|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24539549|NCT00664313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24509743|NCT00561990|Nimotuzumab|nimotuzumab|mesh-list
24509744|NCT00561990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24509745|NCT00561990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509746|NCT00562055|Reboxetine|reboxetine|mesh-list
24939358|NCT04010929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939359|NCT04010929|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24509779|NCT00562068|Mitosis Modulators|mitosis modulators|mesh-ancestor
24509780|NCT00562068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24509781|NCT00562068|Glucocorticoids|glucocorticoids|mesh-ancestor
24509852|NCT00562289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24509853|NCT00562289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509854|NCT00562289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24398627|NCT00145171|Apomorphine|apomorphine|mesh-list
24509855|NCT00562289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24509857|NCT00562289|Antipyretics|antipyretics|mesh-ancestor
24509858|NCT00562289|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24509859|NCT00562289|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24509860|NCT00562289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24509916|NCT00562640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509917|NCT00562640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24509985|NCT00563056|Fluticasone|fluticasone|mesh-list
24509986|NCT00563056|Formoterol Fumarate|formoterol fumarate|mesh-list
24539666|NCT00664846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24539667|NCT00664846|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24539669|NCT00664846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24509987|NCT00563056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24509988|NCT00563056|Autonomic Agents|autonomic agents|mesh-ancestor
24509989|NCT00563056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24509990|NCT00563056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509991|NCT00563056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24509992|NCT00563056|Respiratory System Agents|respiratory system agents|mesh-ancestor
24509993|NCT00563056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24509994|NCT00563056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24539807|NCT00665678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539808|NCT00665717|Raltegravir Potassium|raltegravir potassium|mesh-list
24539809|NCT00665717|Pravastatin|pravastatin|mesh-list
24539810|NCT00665717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24539811|NCT00665717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24539812|NCT00665717|Antiviral Agents|antiviral agents|mesh-ancestor
24539813|NCT00665717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24539814|NCT00665717|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24539817|NCT00665717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539824|NCT00665743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24539825|NCT00665743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24539826|NCT00665743|Analgesics|analgesics|mesh-ancestor
24539827|NCT00665743|Sensory System Agents|sensory system agents|mesh-ancestor
24539828|NCT00665743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24510127|NCT00563485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510137|NCT00563589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24510143|NCT00563589|Dermatologic Agents|dermatologic agents|mesh-ancestor
24510144|NCT00563589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510145|NCT00563589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24510146|NCT00563589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24510181|NCT00563771|Gout Suppressants|gout suppressants|mesh-ancestor
24510182|NCT00563771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25704837|NCT02188719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704838|NCT02188719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25704839|NCT02188719|Analgesics|analgesics|mesh-ancestor
25704840|NCT02188719|Sensory System Agents|sensory system agents|mesh-ancestor
25704841|NCT02188719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25704842|NCT02188719|Antipyretics|antipyretics|mesh-ancestor
25704843|NCT02188719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25704844|NCT02188719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25704845|NCT02188719|Antitubercular Agents|antitubercular agents|mesh-ancestor
25704846|NCT02188719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25704847|NCT02188719|Hematinics|hematinics|mesh-ancestor
24539829|NCT00665743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539830|NCT00665743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24539831|NCT00665743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24539832|NCT00665743|Gout Suppressants|gout suppressants|mesh-ancestor
24539833|NCT00665743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24539834|NCT00665743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939363|NCT04010942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24939364|NCT04010942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939365|NCT04010942|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24539838|NCT00665756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24539839|NCT00665756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24539840|NCT00665756|Alkylating Agents|alkylating agents|mesh-ancestor
24539841|NCT00665756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539842|NCT00665756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24539843|NCT00665756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539857|NCT00665834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539858|NCT00665834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24539859|NCT00665834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24764100|NCT01779401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24539875|NCT00665951|Protease Inhibitors|protease inhibitors|mesh-ancestor
24539876|NCT00665951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539877|NCT00665951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539878|NCT00665951|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24539879|NCT00665951|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24539880|NCT00665951|Antiviral Agents|antiviral agents|mesh-ancestor
24539881|NCT00665951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24539882|NCT00665951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24539883|NCT00665951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24539884|NCT00665977|Triamcinolone|triamcinolone|mesh-list
24539885|NCT00665977|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24510816|NCT00565682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510818|NCT00565708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24510820|NCT00565708|Analgesics|analgesics|mesh-ancestor
24510821|NCT00565708|Sensory System Agents|sensory system agents|mesh-ancestor
24510822|NCT00565708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24510823|NCT00565708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510824|NCT00565708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24443959|NCT00296348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24510833|NCT00565955|Montelukast|montelukast|mesh-list
24510834|NCT00565955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24510835|NCT00565955|Respiratory System Agents|respiratory system agents|mesh-ancestor
24510836|NCT00565955|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24510837|NCT00565955|Hormone Antagonists|hormone antagonists|mesh-ancestor
24540233|NCT00667043|GABA Modulators|gaba modulators|mesh-ancestor
24510850|NCT00565968|Alkylating Agents|alkylating agents|mesh-ancestor
24510851|NCT00565968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24510852|NCT00565968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24510853|NCT00565968|Immunologic Factors|immunologic factors|mesh-ancestor
24510854|NCT00565968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510855|NCT00565981|Fludarabine|fludarabine|mesh-list
24510856|NCT00565981|Fludarabine phosphate|fludarabine phosphate|mesh-list
24510887|NCT00566267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24510888|NCT00566267|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24510890|NCT00566332|Fludarabine|fludarabine|mesh-list
24511223|NCT00567866|Antidepressive Agents|antidepressive agents|mesh-ancestor
24540095|NCT00666575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540096|NCT00666575|Antimanic Agents|antimanic agents|mesh-ancestor
24540097|NCT00666601|Tedizolid phosphate|tedizolid phosphate|mesh-list
24540098|NCT00666601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24540099|NCT00666601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24540101|NCT00666627|Risedronic Acid|risedronic acid|mesh-list
24540102|NCT00666627|Ibandronic Acid|ibandronic acid|mesh-list
24540103|NCT00666627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24540104|NCT00666627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540105|NCT00666627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24540106|NCT00666627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24540107|NCT00666627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540108|NCT00666627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24540228|NCT00667043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24540229|NCT00667043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24540230|NCT00667043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24540231|NCT00667043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24540234|NCT00667043|GABA Agents|gaba agents|mesh-ancestor
24540235|NCT00667043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24540236|NCT00667043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443771|NCT00295971|Fludarabine phosphate|fludarabine phosphate|mesh-list
24445041|NCT00300118|Glucocorticoids|glucocorticoids|mesh-ancestor
24445058|NCT00300196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445059|NCT00300222|Capsaicin|capsaicin|mesh-list
24445060|NCT00300222|Antipruritics|antipruritics|mesh-ancestor
24764110|NCT01779466|Hemostatics|hemostatics|mesh-ancestor
24445105|NCT00300378|Antidepressive Agents|antidepressive agents|mesh-ancestor
24540272|NCT00667108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24540273|NCT00667108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540274|NCT00667108|Antimanic Agents|antimanic agents|mesh-ancestor
24540275|NCT00667147|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24540277|NCT00667147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445133|NCT00300508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445134|NCT00300508|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24445135|NCT00300508|Hormone Antagonists|hormone antagonists|mesh-ancestor
24511615|NCT00569881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24511616|NCT00569881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24511617|NCT00569881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24511618|NCT00569881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24511620|NCT00569881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511621|NCT00569881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511622|NCT00569881|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24511623|NCT00569881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24511624|NCT00569920|Dexamethasone|dexamethasone|mesh-list
24511625|NCT00569920|Dexamethasone acetate|dexamethasone acetate|mesh-list
24511627|NCT00569920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24511628|NCT00569920|Antiemetics|antiemetics|mesh-ancestor
24511629|NCT00569920|Autonomic Agents|autonomic agents|mesh-ancestor
24511630|NCT00569920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24764116|NCT01779479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24764117|NCT01779479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24764118|NCT01779479|Tubulin Modulators|tubulin modulators|mesh-ancestor
24445176|NCT00300729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24540300|NCT00667199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24540302|NCT00667264|Anesthetics, Local|anesthetics, local|mesh-ancestor
24540303|NCT00667264|Anesthetics|anesthetics|mesh-ancestor
24540304|NCT00667264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24540305|NCT00667264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540306|NCT00667264|Sensory System Agents|sensory system agents|mesh-ancestor
24511668|NCT00570193|Growth Substances|growth substances|mesh-ancestor
24511669|NCT00570193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511670|NCT00570193|Growth Inhibitors|growth inhibitors|mesh-ancestor
24511671|NCT00570193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511672|NCT00570193|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24511673|NCT00570193|Dermatologic Agents|dermatologic agents|mesh-ancestor
24511674|NCT00570219|Valproic Acid|valproic acid|mesh-list
24511675|NCT00570219|Anticonvulsants|anticonvulsants|mesh-ancestor
24511676|NCT00570219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444016|NCT00296530|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24444017|NCT00296530|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24444018|NCT00296530|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24444019|NCT00296530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24444020|NCT00296530|Adrenergic Agents|adrenergic agents|mesh-ancestor
24511959|NCT00571740|Micronutrients|micronutrients|mesh-ancestor
24511960|NCT00571753|Isoniazid|isoniazid|mesh-list
24511961|NCT00571753|Antitubercular Agents|antitubercular agents|mesh-ancestor
24511962|NCT00571753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24511963|NCT00571753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24511964|NCT00571753|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24511965|NCT00571753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24511966|NCT00571753|Antimetabolites|antimetabolites|mesh-ancestor
24511967|NCT00571753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511968|NCT00571753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24511969|NCT00571805|Varenicline|varenicline|mesh-list
24511970|NCT00571805|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24512023|NCT00572208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512024|NCT00572208|Anticonvulsants|anticonvulsants|mesh-ancestor
24512025|NCT00572208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24512026|NCT00572208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24512027|NCT00572208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24512028|NCT00572208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24512029|NCT00572208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24512030|NCT00572208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24512031|NCT00572208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24540403|NCT00667797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24540404|NCT00667797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540407|NCT00667901|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24540408|NCT00667901|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24541372|NCT00672464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24444070|NCT00296686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24444071|NCT00296686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24444088|NCT00296712|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24444089|NCT00296712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24512032|NCT00572208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512033|NCT00572208|Antimanic Agents|antimanic agents|mesh-ancestor
24512034|NCT00572299|Alendronate|alendronate|mesh-list
24512048|NCT00572312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512049|NCT00572312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24512050|NCT00572312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24512051|NCT00572312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512053|NCT00572364|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
24512054|NCT00572364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512057|NCT00572390|Estrogens|estrogens|mesh-list
24512120|NCT00572884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512121|NCT00573001|Ritonavir|ritonavir|mesh-list
24540411|NCT00667901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540412|NCT00667901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24939406|NCT04010071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24939407|NCT04010071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939408|NCT04010071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939409|NCT04009759|Ketamine|ketamine|mesh-list
24939410|NCT04009759|Morphine|morphine|mesh-list
24939411|NCT04009759|Analgesics|analgesics|mesh-ancestor
24939412|NCT04009759|Sensory System Agents|sensory system agents|mesh-ancestor
24939413|NCT04009759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24939414|NCT04009759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939415|NCT04009759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24939416|NCT04009759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24939418|NCT04009759|Anesthetics|anesthetics|mesh-ancestor
24540463|NCT00668044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24540464|NCT00668044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24540465|NCT00668044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24540466|NCT00668044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512247|NCT00573690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512248|NCT00573690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512249|NCT00573690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24512250|NCT00573690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24512251|NCT00573690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24512252|NCT00573742|Candesartan|candesartan|mesh-list
24812471|NCT02052336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540506|NCT00668135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24540507|NCT00668135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540513|NCT00668239|Hormones|hormones|mesh-ancestor
24540519|NCT00668304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24540520|NCT00668304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24540521|NCT00668304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24540522|NCT00668304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540523|NCT00668304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540524|NCT00668304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24540525|NCT00668304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24540526|NCT00668304|Contraceptive Agents|contraceptive agents|mesh-ancestor
24540527|NCT00668304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24512253|NCT00573742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24512254|NCT00573742|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24512255|NCT00573742|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24540548|NCT00668343|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24540558|NCT00668356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24955589|NCT03863691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24955590|NCT03863691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24955591|NCT03863691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24955592|NCT03863691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573326|NCT00819351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24955593|NCT03863691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24955594|NCT03863691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24939424|NCT04009759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24939425|NCT04009759|Narcotics|narcotics|mesh-ancestor
24939426|NCT04009772|Metronidazole|metronidazole|mesh-list
24939427|NCT04009772|Cefuroxime|cefuroxime|mesh-list
24812478|NCT02052492|Vitamin D|vitamin d|mesh-list
24540597|NCT00668616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24540605|NCT00668616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540606|NCT00668616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24540607|NCT00668616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24540608|NCT00668616|Alkylating Agents|alkylating agents|mesh-ancestor
24939428|NCT04009772|Cefuroxime axetil|cefuroxime axetil|mesh-list
24939429|NCT04009772|Cefepime|cefepime|mesh-list
24939435|NCT04009889|Trace Elements|trace elements|mesh-ancestor
24939436|NCT04009889|Micronutrients|micronutrients|mesh-ancestor
24939437|NCT04009889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939438|NCT04009616|Chlorhexidine|chlorhexidine|mesh-list
24939439|NCT04009616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24939440|NCT04009616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24939441|NCT04009616|Disinfectants|disinfectants|mesh-ancestor
24939444|NCT04009603|Metformin|metformin|mesh-list
24540669|NCT00668967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24512477|NCT00575406|Immunologic Factors|immunologic factors|mesh-ancestor
24512668|NCT00576069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24512669|NCT00576069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512670|NCT00576069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24540670|NCT00668967|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24540685|NCT00669149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24939469|NCT04009525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25050506|NCT00489203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24512671|NCT00576069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050509|NCT00489203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25050510|NCT00489203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25050511|NCT00489203|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24852842|NCT02264184|Serotonin Agents|serotonin agents|mesh-ancestor
24425414|NCT00232934|Thalidomide|thalidomide|mesh-list
25050512|NCT00489203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25050513|NCT00489203|Glucocorticoids|glucocorticoids|mesh-ancestor
25050514|NCT00489203|Hormones|hormones|mesh-ancestor
25050515|NCT00489203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24540712|NCT00669344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24540713|NCT00669344|Protective Agents|protective agents|mesh-ancestor
24540715|NCT00669370|Capecitabine|capecitabine|mesh-list
24540716|NCT00669370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24540737|NCT00669435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24540793|NCT00669656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24939474|NCT04009525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24939475|NCT04009525|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24939476|NCT04009525|Antifungal Agents|antifungal agents|mesh-ancestor
24939477|NCT04009525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24540800|NCT00669656|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24540801|NCT00669656|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24540802|NCT00669656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24540803|NCT00669656|Phytoestrogens|phytoestrogens|mesh-ancestor
24540832|NCT00669773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540833|NCT00669773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24540834|NCT00669773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24540835|NCT00669773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24540836|NCT00669773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540838|NCT00669786|Hormones|hormones|mesh-list
24513180|NCT00579644|Methotrexate|methotrexate|mesh-list
24540839|NCT00669786|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24540840|NCT00669786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24540841|NCT00669786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939480|NCT04009525|Antitubercular Agents|antitubercular agents|mesh-ancestor
24939481|NCT04009525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24939483|NCT04009317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939484|NCT04009317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24939485|NCT04009317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939486|NCT04009317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939487|NCT04008979|Aspirin|aspirin|mesh-list
24939488|NCT04008979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24939489|NCT04008979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24939490|NCT04008979|Analgesics|analgesics|mesh-ancestor
24540876|NCT00669812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24540877|NCT00669812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24540878|NCT00669812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24513359|NCT00580905|Vasodilator Agents|vasodilator agents|mesh-ancestor
24513360|NCT00580905|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24513361|NCT00580905|Purinergic Agonists|purinergic agonists|mesh-ancestor
24513369|NCT00580931|Nicotinic Acids|nicotinic acids|mesh-list
24513370|NCT00580931|Vitamin B Complex|vitamin b complex|mesh-ancestor
24513371|NCT00580931|Vitamins|vitamins|mesh-ancestor
24513372|NCT00580931|Micronutrients|micronutrients|mesh-ancestor
24513373|NCT00580931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513374|NCT00580931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24513375|NCT00580931|Antimetabolites|antimetabolites|mesh-ancestor
24540911|NCT00669890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540912|NCT00669890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24540913|NCT00669890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24540914|NCT00669890|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24540915|NCT00669890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24939501|NCT04008979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939502|NCT04008979|Antipyretics|antipyretics|mesh-ancestor
24939503|NCT04009018|Anesthetics|anesthetics|mesh-list
24597463|NCT00949455|Lapatinib|lapatinib|mesh-list
24541017|NCT00670475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541018|NCT00670475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541019|NCT00670501|Vitamin D|vitamin d|mesh-list
24939504|NCT04009018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24939505|NCT04009018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939506|NCT04008732|Nitroglycerin|nitroglycerin|mesh-list
24939507|NCT04008732|Vasodilator Agents|vasodilator agents|mesh-ancestor
24833824|NCT02175901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24541028|NCT00670553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541029|NCT00670553|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24541030|NCT00670553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541145|NCT00671151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24541146|NCT00671151|Purinergic Agents|purinergic agents|mesh-ancestor
24541147|NCT00671151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24541148|NCT00671203|Erythromycin|erythromycin|mesh-list
24434065|NCT00261352|Fenofibrate|fenofibrate|mesh-list
24541368|NCT00672399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24541369|NCT00672464|Metformin|metformin|mesh-list
24541370|NCT00672464|Olanzapine|olanzapine|mesh-list
24541371|NCT00672464|Simvastatin|simvastatin|mesh-list
24541373|NCT00672464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541374|NCT00672464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24541375|NCT00672464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24446959|NCT00306735|Serotonin Agents|serotonin agents|mesh-ancestor
24446960|NCT00306735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24446961|NCT00306735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541383|NCT00672464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24541384|NCT00672464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24939526|NCT04008784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24939527|NCT04008784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541385|NCT00672464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24541386|NCT00672464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24541387|NCT00672464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24541388|NCT00672464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24541389|NCT00672464|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24541390|NCT00672464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24541391|NCT00672464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24939528|NCT04008784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24939529|NCT04008784|Immunologic Factors|immunologic factors|mesh-ancestor
24541559|NCT00673621|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24541560|NCT00673621|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24541561|NCT00673621|Cholinergic Agents|cholinergic agents|mesh-ancestor
24541562|NCT00673686|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
24541563|NCT00673686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24541564|NCT00673686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939543|NCT04008966|Contraceptive Agents|contraceptive agents|mesh-ancestor
24939544|NCT04008966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24939545|NCT04008966|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24852937|NCT02264834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24514950|NCT00593580|Vitamins|vitamins|mesh-ancestor
24514951|NCT00593580|Micronutrients|micronutrients|mesh-ancestor
24515022|NCT00593996|Ergocalciferols|ergocalciferols|mesh-list
24515023|NCT00593996|Vitamins|vitamins|mesh-ancestor
24515024|NCT00593996|Micronutrients|micronutrients|mesh-ancestor
24939546|NCT04008966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24939547|NCT04008966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939548|NCT04008966|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24939549|NCT04008966|Fertility Agents|fertility agents|mesh-ancestor
24515114|NCT00594555|Immunologic Factors|immunologic factors|mesh-ancestor
24515141|NCT00594867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24515142|NCT00594867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515153|NCT00595049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24515154|NCT00595049|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24515157|NCT00595140|Dopamine|dopamine|mesh-list
24541602|NCT00674063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541610|NCT00674141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24541611|NCT00674141|Antiemetics|antiemetics|mesh-ancestor
24541612|NCT00674141|Autonomic Agents|autonomic agents|mesh-ancestor
24541613|NCT00674141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24541614|NCT00674141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541615|NCT00674141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24541616|NCT00674141|Glucocorticoids|glucocorticoids|mesh-ancestor
24541724|NCT00674752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24541725|NCT00674752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541726|NCT00674752|Anticonvulsants|anticonvulsants|mesh-ancestor
24541727|NCT00674752|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24541728|NCT00674752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24541729|NCT00674752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24541730|NCT00674752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24541731|NCT00674752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24541732|NCT00674752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24541733|NCT00674752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24541734|NCT00674752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541735|NCT00674752|Antimanic Agents|antimanic agents|mesh-ancestor
24541736|NCT00674856|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
24939558|NCT04008888|Autonomic Agents|autonomic agents|mesh-ancestor
24939559|NCT04008888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24939560|NCT04008888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939561|NCT04008888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24939562|NCT04008888|Glucocorticoids|glucocorticoids|mesh-ancestor
24939563|NCT04008888|Hormones|hormones|mesh-ancestor
24764210|NCT01780181|Docetaxel|docetaxel|mesh-list
24541773|NCT00675194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541774|NCT00675194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24505098|NCT00539799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24515225|NCT00596037|Hormones|hormones|mesh-list
24515226|NCT00596037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24515227|NCT00596037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515228|NCT00596050|Lidocaine|lidocaine|mesh-list
24515266|NCT00596115|Protective Agents|protective agents|mesh-ancestor
24515267|NCT00596115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515268|NCT00596115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24442215|NCT00290602|Prednisolone phosphate|prednisolone phosphate|mesh-list
24442217|NCT00290602|Antiemetics|antiemetics|mesh-ancestor
24442387|NCT00290836|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24442449|NCT00291109|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24442450|NCT00291109|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24939604|NCT04008225|Sequestering Agents|sequestering agents|mesh-ancestor
24939608|NCT04008186|Itraconazole|itraconazole|mesh-list
24939609|NCT04008186|Digoxin|digoxin|mesh-list
24939610|NCT04008186|Verapamil|verapamil|mesh-list
24541848|NCT00675688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24541849|NCT00675688|Hormone Antagonists|hormone antagonists|mesh-ancestor
24541850|NCT00675688|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24541851|NCT00675688|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24541852|NCT00675688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24541854|NCT00675701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24541855|NCT00675701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24541856|NCT00675701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24541857|NCT00675701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24446687|NCT00305669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446688|NCT00305708|Fludarabine|fludarabine|mesh-list
24446689|NCT00305708|Fludarabine phosphate|fludarabine phosphate|mesh-list
24541874|NCT00675714|Nandrolone|nandrolone|mesh-list
24515319|NCT00596219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24515537|NCT00598169|Immunologic Factors|immunologic factors|mesh-ancestor
24515538|NCT00598169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541895|NCT00675714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24541922|NCT00675779|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24541923|NCT00675779|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24541925|NCT00675779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24541926|NCT00675896|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24446692|NCT00305708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446693|NCT00305708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24939618|NCT04008186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24939619|NCT04008186|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24939620|NCT04008186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24939621|NCT04008186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24939622|NCT04008186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24939623|NCT04008186|Anesthetics, General|anesthetics, general|mesh-ancestor
24939624|NCT04008186|Anesthetics|anesthetics|mesh-ancestor
24764342|NCT01780740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24764343|NCT01780740|Antimetabolites|antimetabolites|mesh-ancestor
24542060|NCT00676637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542061|NCT00676637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25704848|NCT02188719|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25704849|NCT02188719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25704850|NCT02188719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25704851|NCT02188719|Anesthetics, Local|anesthetics, local|mesh-ancestor
25704852|NCT02188719|Anesthetics|anesthetics|mesh-ancestor
25704853|NCT02188719|Antiemetics|antiemetics|mesh-ancestor
25704854|NCT02188719|Autonomic Agents|autonomic agents|mesh-ancestor
25704855|NCT02188719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25704857|NCT02188719|Histamine Antagonists|histamine antagonists|mesh-ancestor
24452982|NCT05378113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24438259|NCT00275197|Serotonin Agents|serotonin agents|mesh-ancestor
24438260|NCT00275197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438261|NCT00275210|Oxaliplatin|oxaliplatin|mesh-list
24764344|NCT01780740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24764346|NCT01780740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24764347|NCT01780740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24764348|NCT01780753|Primaquine|primaquine|mesh-list
24542250|NCT00677755|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24446282|NCT00304317|Celecoxib|celecoxib|mesh-list
24542258|NCT00678106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24542259|NCT00678132|Gemcitabine|gemcitabine|mesh-list
24542261|NCT00678132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542262|NCT00678132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24542263|NCT00678132|Antimetabolites|antimetabolites|mesh-ancestor
24542264|NCT00678132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542265|NCT00678132|Antiviral Agents|antiviral agents|mesh-ancestor
24542266|NCT00678132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24542267|NCT00678132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542268|NCT00678132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24764349|NCT01780753|Antimalarials|antimalarials|mesh-ancestor
24764350|NCT01780753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24764351|NCT01780753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24764352|NCT01780753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24764353|NCT01780883|Melatonin|melatonin|mesh-list
25704858|NCT02188719|Histamine Agents|histamine agents|mesh-ancestor
25704859|NCT02188719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25704860|NCT02188719|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25704861|NCT02188719|Antipruritics|antipruritics|mesh-ancestor
25704862|NCT02188719|Dermatologic Agents|dermatologic agents|mesh-ancestor
25704863|NCT02188719|Antiviral Agents|antiviral agents|mesh-ancestor
25704864|NCT02188719|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25704865|NCT02188719|Protective Agents|protective agents|mesh-ancestor
25704866|NCT02188784|Iron|iron|mesh-list
24460878|NCT00350038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24542293|NCT00678145|Sympathomimetics|sympathomimetics|mesh-ancestor
24542294|NCT00678145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24542295|NCT00678145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24542296|NCT00678184|Atorvastatin|atorvastatin|mesh-list
24542297|NCT00678184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25704867|NCT02188784|Trace Elements|trace elements|mesh-ancestor
25704868|NCT02188784|Micronutrients|micronutrients|mesh-ancestor
25704869|NCT02188784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704870|NCT02189122|Aspirin|aspirin|mesh-list
25704871|NCT02189122|Bradykinin|bradykinin|mesh-list
25704872|NCT02189122|Kininogens|kininogens|mesh-list
25704873|NCT02189122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25704874|NCT02189122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25704875|NCT02189122|Analgesics|analgesics|mesh-ancestor
24550933|NCT00723268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24550934|NCT00723268|Tubulin Modulators|tubulin modulators|mesh-ancestor
24550935|NCT00723268|Antimitotic Agents|antimitotic agents|mesh-ancestor
24551119|NCT00724035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24551120|NCT00724035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551121|NCT00724035|Sensory System Agents|sensory system agents|mesh-ancestor
24551123|NCT00724035|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24551142|NCT00724074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24551143|NCT00724113|Lidocaine|lidocaine|mesh-list
24542399|NCT00678483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542400|NCT00678509|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
24542401|NCT00678509|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24542409|NCT00678522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24542844|NCT00680511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24542876|NCT00680641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542877|NCT00680641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24764365|NCT01780909|Autonomic Agents|autonomic agents|mesh-ancestor
24764366|NCT01780909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24764367|NCT01780909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516471|NCT00602095|Misoprostol|misoprostol|mesh-list
24516472|NCT00602095|Dinoprostone|dinoprostone|mesh-list
24516473|NCT00602095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24516474|NCT00602095|Abortifacient Agents|abortifacient agents|mesh-ancestor
24764368|NCT01780909|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24939625|NCT04008186|GABA Modulators|gaba modulators|mesh-ancestor
24852992|NCT02265276|Pioglitazone|pioglitazone|mesh-list
24542927|NCT00680940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542928|NCT00681005|Rabeprazole|rabeprazole|mesh-list
24542929|NCT00681005|Pantoprazole|pantoprazole|mesh-list
24542930|NCT00681005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24542931|NCT00681005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24542932|NCT00681005|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24516495|NCT00602173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25704876|NCT02189122|Sensory System Agents|sensory system agents|mesh-ancestor
25704877|NCT02189122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25704878|NCT02189122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704879|NCT02189122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25704880|NCT02189122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25704881|NCT02189122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25704882|NCT02189122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25704883|NCT02189122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543052|NCT00681772|Vasodilator Agents|vasodilator agents|mesh-ancestor
24543053|NCT00681772|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24543054|NCT00681772|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24543055|NCT00681772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543096|NCT00681928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543097|NCT00681928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24543098|NCT00681928|Hormone Antagonists|hormone antagonists|mesh-ancestor
24543099|NCT00681928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24955744|NCT03862144|Palonosetron|palonosetron|mesh-list
24955745|NCT03862144|Antiemetics|antiemetics|mesh-ancestor
24955746|NCT03862144|Autonomic Agents|autonomic agents|mesh-ancestor
24955747|NCT03862144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955748|NCT03862144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955749|NCT03862144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24955750|NCT03862144|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24955751|NCT03862144|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24543155|NCT00682019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543156|NCT00682019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543157|NCT00682019|Urological Agents|urological agents|mesh-ancestor
24543158|NCT00682136|Ropivacaine|ropivacaine|mesh-list
24543204|NCT00682383|Antimitotic Agents|antimitotic agents|mesh-ancestor
24543205|NCT00682383|Mitosis Modulators|mitosis modulators|mesh-ancestor
24543206|NCT00682383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543207|NCT00682383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25704884|NCT02189122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25704885|NCT02189122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24448205|NCT00310765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24543232|NCT00682578|Anthelmintics|anthelmintics|mesh-ancestor
24543233|NCT00682578|Amebicides|amebicides|mesh-ancestor
24543234|NCT00682578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24543235|NCT00682578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24543236|NCT00682578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939642|NCT04008186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24939643|NCT04008186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24543295|NCT00683111|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24543318|NCT00683137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543319|NCT00683137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24543320|NCT00683137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24543338|NCT00683202|Aspirin|aspirin|mesh-list
24543339|NCT00683202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24543340|NCT00683202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24543341|NCT00683202|Analgesics|analgesics|mesh-ancestor
24543342|NCT00683202|Sensory System Agents|sensory system agents|mesh-ancestor
24543343|NCT00683202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24543344|NCT00683202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543345|NCT00683202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24543519|NCT00684112|Gabapentin|gabapentin|mesh-list
24543520|NCT00684112|Analgesics|analgesics|mesh-ancestor
24543521|NCT00684112|Sensory System Agents|sensory system agents|mesh-ancestor
24543522|NCT00684112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24939644|NCT04008186|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24939645|NCT04008186|Protective Agents|protective agents|mesh-ancestor
24939646|NCT04008186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24939647|NCT04008186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24543523|NCT00684112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543524|NCT00684112|Anticonvulsants|anticonvulsants|mesh-ancestor
24543525|NCT00684112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24543526|NCT00684112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24543527|NCT00684112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24543529|NCT00684112|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24543572|NCT00684229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24543573|NCT00684229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543644|NCT00684827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24543646|NCT00684853|Bevacizumab|bevacizumab|mesh-list
24543656|NCT00684866|Autonomic Agents|autonomic agents|mesh-ancestor
24543657|NCT00684866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24543658|NCT00684866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543659|NCT00684866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24543660|NCT00684866|Respiratory System Agents|respiratory system agents|mesh-ancestor
24543661|NCT00684866|Tocolytic Agents|tocolytic agents|mesh-ancestor
24543662|NCT00684866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24543663|NCT00684866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24543664|NCT00684866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24543665|NCT00684866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24543666|NCT00684866|Adrenergic Agents|adrenergic agents|mesh-ancestor
24543667|NCT00684866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24543668|NCT00684866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543669|NCT00684905|Leuprolide|leuprolide|mesh-list
24543670|NCT00684905|Bicalutamide|bicalutamide|mesh-list
24516972|NCT00605098|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24543690|NCT00685022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24939648|NCT04008186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24543701|NCT00685022|Adrenergic Agents|adrenergic agents|mesh-ancestor
25704886|NCT02189122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25704887|NCT02189122|Antipyretics|antipyretics|mesh-ancestor
25704888|NCT02189122|Vasodilator Agents|vasodilator agents|mesh-ancestor
25704889|NCT02189122|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25704890|NCT02189122|Protease Inhibitors|protease inhibitors|mesh-ancestor
25704891|NCT02189213|Sertraline|sertraline|mesh-list
24446651|NCT00305539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24543702|NCT00685022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24543703|NCT00685022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543704|NCT00685061|Alemtuzumab|alemtuzumab|mesh-list
24543705|NCT00685061|Thymoglobulin|thymoglobulin|mesh-list
24543706|NCT00685061|Daclizumab|daclizumab|mesh-list
24543718|NCT00685126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24543720|NCT00685126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24801861|NCT01985893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543721|NCT00685126|Autonomic Agents|autonomic agents|mesh-ancestor
24543722|NCT00685126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24543723|NCT00685126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543724|NCT00685126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24543725|NCT00685126|Respiratory System Agents|respiratory system agents|mesh-ancestor
24543726|NCT00685126|Tocolytic Agents|tocolytic agents|mesh-ancestor
24543727|NCT00685126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24516973|NCT00605098|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24516974|NCT00605098|Protease Inhibitors|protease inhibitors|mesh-ancestor
24517099|NCT00605930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24517101|NCT00605930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517117|NCT00606099|Antiviral Agents|antiviral agents|mesh-ancestor
24517118|NCT00606099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24517119|NCT00606099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24517120|NCT00606099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24517121|NCT00606099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543728|NCT00685126|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24543729|NCT00685126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24543733|NCT00685126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543735|NCT00685191|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24939659|NCT04008433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24853032|NCT02265575|Viscosupplements|viscosupplements|mesh-ancestor
24543782|NCT00685464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25704892|NCT02189213|Antidepressive Agents|antidepressive agents|mesh-ancestor
25704893|NCT02189213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25704894|NCT02189213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25704895|NCT02189213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25704896|NCT02189213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25704897|NCT02189213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704898|NCT02189213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24556616|NCT00748423|Nitric Oxide|nitric oxide|mesh-list
24543823|NCT00685594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24543824|NCT00685594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24543825|NCT00685607|Simethicone|simethicone|mesh-list
24543826|NCT00685607|Loperamide|loperamide|mesh-list
24939660|NCT04008433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24939661|NCT04008433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24939662|NCT04008433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939663|NCT04008316|Colchicine|colchicine|mesh-list
24543827|NCT00685607|Antidiarrheals|antidiarrheals|mesh-list
24543828|NCT00685607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24543834|NCT00685633|Androgen Antagonists|androgen antagonists|mesh-ancestor
24543840|NCT00685646|Androgen Antagonists|androgen antagonists|mesh-list
24517413|NCT00607750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517414|NCT00607750|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24517415|NCT00607750|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24517416|NCT00607750|Cholinergic Agents|cholinergic agents|mesh-ancestor
24517417|NCT00607750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050523|NCT00488839|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25050524|NCT00488839|GABA Agonists|gaba agonists|mesh-ancestor
25050525|NCT00488839|GABA Agents|gaba agents|mesh-ancestor
25050526|NCT00488839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25050527|NCT00488839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050529|NCT00488267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24543884|NCT00685841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24543885|NCT00685841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24543886|NCT00685841|Adrenergic Agents|adrenergic agents|mesh-ancestor
24543887|NCT00685841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24543897|NCT00685906|Levonorgestrel|levonorgestrel|mesh-list
24543898|NCT00685906|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24543899|NCT00685906|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25704899|NCT02189213|Serotonin Agents|serotonin agents|mesh-ancestor
25704900|NCT02189213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704901|NCT02189317|Bupivacaine|bupivacaine|mesh-list
25704902|NCT02189317|Anesthetics, Local|anesthetics, local|mesh-ancestor
25704903|NCT02189317|Anesthetics|anesthetics|mesh-ancestor
25704904|NCT02189317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25704905|NCT02189317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704906|NCT02189317|Sensory System Agents|sensory system agents|mesh-ancestor
25704907|NCT02189317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25704908|NCT02189629|Trifarotene|trifarotene|mesh-list
25704909|NCT02189629|Dermatologic Agents|dermatologic agents|mesh-ancestor
25704910|NCT02189668|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25704911|NCT02189668|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25704912|NCT02189668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25704913|NCT02189668|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24557544|NCT00752934|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24557545|NCT00752934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24557546|NCT00752934|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24557547|NCT00752934|GABA Agonists|gaba agonists|mesh-ancestor
24557548|NCT00752934|GABA Agents|gaba agents|mesh-ancestor
24557549|NCT00752934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24557551|NCT00752947|Moxifloxacin|moxifloxacin|mesh-list
24543900|NCT00685906|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
24543901|NCT00685906|Estradiol|estradiol|mesh-list
24543902|NCT00685906|Estrogens|estrogens|mesh-ancestor
24543903|NCT00685906|Hormones|hormones|mesh-ancestor
25050532|NCT00488267|Sensory System Agents|sensory system agents|mesh-ancestor
24517448|NCT00607971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050533|NCT00488267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24939664|NCT04008316|Gout Suppressants|gout suppressants|mesh-ancestor
24939665|NCT04008316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24939666|NCT04008316|Tubulin Modulators|tubulin modulators|mesh-ancestor
24543908|NCT00685906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24543909|NCT00685906|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24543910|NCT00685906|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24543911|NCT00685906|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24543912|NCT00685906|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24543913|NCT00685906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24543919|NCT00685906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543920|NCT00685906|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24543921|NCT00685906|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
24543935|NCT00685971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24543937|NCT00686010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24543956|NCT00686140|Sensory System Agents|sensory system agents|mesh-ancestor
24543957|NCT00686140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24543958|NCT00686140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543959|NCT00686140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24939671|NCT04008043|Acetaminophen|acetaminophen|mesh-list
24939672|NCT04008043|Dexamethasone|dexamethasone|mesh-list
24939673|NCT04008043|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
24544015|NCT00686478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24544037|NCT00686556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24544038|NCT00686556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24544039|NCT00686556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25704914|NCT02189668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25704915|NCT02189668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704916|NCT02189837|Atorvastatin|atorvastatin|mesh-list
25704917|NCT02189837|Evolocumab|evolocumab|mesh-list
25704918|NCT02189837|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25704919|NCT02189837|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25704920|NCT02189837|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25704921|NCT02189837|Antimetabolites|antimetabolites|mesh-ancestor
24560319|NCT02927847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24560320|NCT02927847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24560340|NCT02912572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560341|NCT02912572|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24560342|NCT02892149|Darbepoetin alfa|darbepoetin alfa|mesh-list
24560343|NCT02892149|Hematinics|hematinics|mesh-ancestor
24560429|NCT02677545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24560430|NCT02677545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24544040|NCT00686556|Antitubercular Agents|antitubercular agents|mesh-ancestor
24544041|NCT00686556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24544042|NCT00686556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24544043|NCT00686621|Posaconazole|posaconazole|mesh-list
24544044|NCT00686621|Antifungal Agents|antifungal agents|mesh-ancestor
24544045|NCT00686621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24544046|NCT00686621|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24544047|NCT00686621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24544048|NCT00686621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24544049|NCT00686621|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24544050|NCT00686621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24544051|NCT00686621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544052|NCT00686621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939682|NCT04008043|Hormones|hormones|mesh-ancestor
24939683|NCT04008043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24939684|NCT04008043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24939685|NCT04008043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939700|NCT04007835|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24939701|NCT04007835|Gefitinib|gefitinib|mesh-list
24939702|NCT04007835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939703|NCT04007835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24939704|NCT04007835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24853067|NCT02265770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24853071|NCT02265770|Antimetabolites|antimetabolites|mesh-ancestor
24544054|NCT00686621|Hormone Antagonists|hormone antagonists|mesh-ancestor
24544117|NCT00687388|Celecoxib|celecoxib|mesh-list
24544118|NCT00687388|Doxazosin|doxazosin|mesh-list
24544119|NCT00687388|Prazosin|prazosin|mesh-list
24544120|NCT00687388|Tamsulosin|tamsulosin|mesh-list
24544121|NCT00687388|Alfuzosin|alfuzosin|mesh-list
24447094|NCT00307502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704922|NCT02189837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704923|NCT02189837|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25704924|NCT02189837|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25704925|NCT02189837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25704926|NCT02189837|Immunologic Factors|immunologic factors|mesh-ancestor
25704927|NCT02189837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704928|NCT02189889|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25704929|NCT02189889|Hematinics|hematinics|mesh-ancestor
25704930|NCT02189889|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25704931|NCT02189889|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25704932|NCT02189941|Deferiprone|deferiprone|mesh-list
25704933|NCT02189941|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25704934|NCT02189941|Chelating Agents|chelating agents|mesh-ancestor
25704935|NCT02189941|Sequestering Agents|sequestering agents|mesh-ancestor
25704936|NCT02189941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709651|NCT02271854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24561777|NCT00762749|Sensory System Agents|sensory system agents|mesh-ancestor
24561827|NCT00762983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24561829|NCT00762983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939705|NCT04007835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939706|NCT04008017|Eosinophil Cationic Protein|eosinophil cationic protein|mesh-list
24939708|NCT04008017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939710|NCT04007562|Antimalarials|antimalarials|mesh-ancestor
24939711|NCT04007562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24939712|NCT04007562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24939713|NCT04007562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24544164|NCT00687648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544165|NCT00687648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544166|NCT00687648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24544167|NCT00687648|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24544168|NCT00687648|Abortifacient Agents|abortifacient agents|mesh-ancestor
24544169|NCT00687648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24939714|NCT04007562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939715|NCT04007562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939716|NCT04007562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24939718|NCT04007588|Ipilimumab|ipilimumab|mesh-list
24939719|NCT04007588|Linrodostat|linrodostat|mesh-list
24939720|NCT04007588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24939721|NCT04007588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939722|NCT04007588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24939723|NCT04007588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939724|NCT04007588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939725|NCT04007328|Methylprednisolone|methylprednisolone|mesh-list
24853091|NCT02265809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24544277|NCT00688272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24544278|NCT00688272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24939726|NCT04007328|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24939727|NCT04007328|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24939729|NCT04007328|Prednisolone acetate|prednisolone acetate|mesh-list
24939730|NCT04007328|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24544280|NCT00688298|Cholinergic Agents|cholinergic agents|mesh-ancestor
24544281|NCT00688298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24447120|NCT00307580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447121|NCT00307593|Rituximab|rituximab|mesh-list
24447122|NCT00307593|Infliximab|infliximab|mesh-list
24447123|NCT00307593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24447124|NCT00307593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447125|NCT00307593|Immunologic Factors|immunologic factors|mesh-ancestor
24939735|NCT04007328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24939736|NCT04007328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939737|NCT04007328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24939738|NCT04007328|Glucocorticoids|glucocorticoids|mesh-ancestor
24939739|NCT04007328|Hormones|hormones|mesh-ancestor
24939740|NCT04007328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24939741|NCT04007328|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24939742|NCT04007328|Protective Agents|protective agents|mesh-ancestor
24939743|NCT04007328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25704937|NCT02190903|Anesthetics|anesthetics|mesh-list
25704938|NCT02190903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25704939|NCT02190903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704940|NCT02191033|Nicotine|nicotine|mesh-list
25704941|NCT02191033|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25704942|NCT02191033|Autonomic Agents|autonomic agents|mesh-ancestor
25704943|NCT02191033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25704944|NCT02191033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704945|NCT02191033|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25704946|NCT02191033|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24939744|NCT04007328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544547|NCT00689494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24544548|NCT00689520|Vitamin K|vitamin k|mesh-list
24544549|NCT00689520|Tinzaparin|tinzaparin|mesh-list
24544550|NCT00689520|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24544577|NCT00689559|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24544578|NCT00689559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24544580|NCT00689559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24939745|NCT04007341|Dexmedetomidine|dexmedetomidine|mesh-list
24939746|NCT04007341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24797345|NCT01955187|Antiemetics|antiemetics|mesh-ancestor
24939747|NCT04007341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24544623|NCT00689715|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24544624|NCT00689715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24544625|NCT00689715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544672|NCT00689832|Respiratory System Agents|respiratory system agents|mesh-ancestor
24447177|NCT00307645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447178|NCT00307645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447179|NCT00307645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24544709|NCT00689845|Abortifacient Agents|abortifacient agents|mesh-ancestor
24544710|NCT00689845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24544711|NCT00689845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24544712|NCT00689845|Antimetabolites|antimetabolites|mesh-ancestor
24939748|NCT04007341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939749|NCT04007341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24939751|NCT04007341|Sensory System Agents|sensory system agents|mesh-ancestor
24939752|NCT04007341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24939753|NCT04007341|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24939754|NCT04007341|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24447203|NCT00307658|gamma-Globulins|gamma-globulins|mesh-list
24447204|NCT00307658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24447205|NCT00307658|Immunologic Factors|immunologic factors|mesh-ancestor
24447206|NCT00307658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517882|NCT00610506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24517883|NCT00610506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24517885|NCT00610506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24517902|NCT00610545|Antimetabolites|antimetabolites|mesh-ancestor
24517903|NCT00610545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517962|NCT00610909|Paroxetine|paroxetine|mesh-list
24517963|NCT00610909|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24517964|NCT00610909|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24517965|NCT00610909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24517966|NCT00610909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544894|NCT00690872|Antimetabolites|antimetabolites|mesh-ancestor
24517994|NCT00610948|Vitamins|vitamins|mesh-ancestor
24567951|NCT00793663|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24544899|NCT00690872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24544900|NCT00690872|Immunologic Factors|immunologic factors|mesh-ancestor
24544901|NCT00690872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544902|NCT00690885|Interferons|interferons|mesh-list
24544903|NCT00690885|Interferon-alpha|interferon-alpha|mesh-list
25050534|NCT00488267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544936|NCT00691067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24544937|NCT00691067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24518306|NCT05320731|Sensory System Agents|sensory system agents|mesh-ancestor
24518307|NCT05320731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24518308|NCT05320731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24544938|NCT00691067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24544939|NCT00691067|Contraceptive Agents|contraceptive agents|mesh-ancestor
24544941|NCT00691067|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24544942|NCT00691067|Hormone Antagonists|hormone antagonists|mesh-ancestor
24544943|NCT00691067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24544944|NCT00691067|Luteolytic Agents|luteolytic agents|mesh-ancestor
24544945|NCT00691067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24544946|NCT00691067|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24545010|NCT00691379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24447290|NCT00307996|Micronutrients|micronutrients|mesh-ancestor
24545013|NCT00691379|Growth Substances|growth substances|mesh-ancestor
24545014|NCT00691379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545015|NCT00691379|Growth Inhibitors|growth inhibitors|mesh-ancestor
24545017|NCT00691392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24545018|NCT00691392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24518947|NCT03889756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24545019|NCT00691392|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24545020|NCT00691392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24545021|NCT00691392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545022|NCT00691405|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24545023|NCT00691405|Formoterol Fumarate|formoterol fumarate|mesh-list
24545024|NCT00691405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24545025|NCT00691405|Autonomic Agents|autonomic agents|mesh-ancestor
25704947|NCT02191033|Cholinergic Agents|cholinergic agents|mesh-ancestor
25704948|NCT02191033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25704949|NCT02191033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704950|NCT02191137|Riociguat|riociguat|mesh-list
25704951|NCT02191137|Enzyme Activators|enzyme activators|mesh-ancestor
25704952|NCT02191137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704953|NCT02191397|Dexetimide|dexetimide|mesh-list
24939775|NCT04007003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939777|NCT04006873|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24939778|NCT04006873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24939779|NCT04006873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545048|NCT00691795|Fentanyl|fentanyl|mesh-list
24545049|NCT00691795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24545050|NCT00691795|Narcotics|narcotics|mesh-ancestor
24545051|NCT00691795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24545052|NCT00691795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545053|NCT00691795|Analgesics|analgesics|mesh-ancestor
24545054|NCT00691795|Sensory System Agents|sensory system agents|mesh-ancestor
24545055|NCT00691795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24545056|NCT00691795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24545057|NCT00691795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24545058|NCT00691795|Anesthetics, General|anesthetics, general|mesh-ancestor
24545059|NCT00691795|Anesthetics|anesthetics|mesh-ancestor
24545060|NCT00691795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24448694|NCT00312598|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24448695|NCT00312650|Gemcitabine|gemcitabine|mesh-list
24446612|NCT00305474|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24446613|NCT00305474|Serotonin Agents|serotonin agents|mesh-ancestor
24446614|NCT00305474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24939785|NCT04006821|Apatinib|apatinib|mesh-list
24572349|NCT00814281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24572350|NCT00814281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572351|NCT00814281|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24520194|NCT03576885|Gasotransmitters|gasotransmitters|mesh-ancestor
24520733|NCT05333744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24545099|NCT00691912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24545100|NCT00691951|Budesonide|budesonide|mesh-list
24545101|NCT00691951|Formoterol Fumarate|formoterol fumarate|mesh-list
24545102|NCT00691951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24545103|NCT00691951|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24545104|NCT00691951|Autonomic Agents|autonomic agents|mesh-ancestor
24545105|NCT00691951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24939790|NCT04006821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24939791|NCT04006821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939792|NCT04006821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939794|NCT04006470|Tin Fluorides|tin fluorides|mesh-list
24939795|NCT04006470|Cariostatic Agents|cariostatic agents|mesh-ancestor
24545159|NCT00692172|Dermatologic Agents|dermatologic agents|mesh-ancestor
24545160|NCT00692172|Immunologic Factors|immunologic factors|mesh-ancestor
24545161|NCT00692172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545162|NCT00692250|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
24545163|NCT00692250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24545164|NCT00692250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24545165|NCT00692250|Antimetabolites|antimetabolites|mesh-ancestor
24939809|NCT04006262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24939810|NCT04006262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939811|NCT04006262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24939812|NCT04006262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939813|NCT04006691|Mitomycins|mitomycins|mesh-list
24939814|NCT04006691|Mitomycin|mitomycin|mesh-list
24939815|NCT04006691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24939816|NCT04006691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939817|NCT04006691|Alkylating Agents|alkylating agents|mesh-ancestor
24545166|NCT00692250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545167|NCT00692250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24545168|NCT00692263|Tramadol|tramadol|mesh-list
24545169|NCT00692263|Citalopram|citalopram|mesh-list
24446657|NCT00305552|Leprostatic Agents|leprostatic agents|mesh-ancestor
24545195|NCT00692328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24545196|NCT00692328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545197|NCT00692328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545198|NCT00692354|Tosedostat|tosedostat|mesh-list
24545199|NCT00692354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24545201|NCT00692510|Rosiglitazone|rosiglitazone|mesh-list
24446678|NCT00305630|Hormones|hormones|mesh-ancestor
24446679|NCT00305630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25704954|NCT02191397|Citalopram|citalopram|mesh-list
25704955|NCT02191397|Bupropion|bupropion|mesh-list
25704956|NCT02191397|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25704957|NCT02191397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25704958|NCT02191397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25704959|NCT02191397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704960|NCT02191397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24446680|NCT00305630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446681|NCT00305630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24446682|NCT00305630|Immunologic Factors|immunologic factors|mesh-ancestor
24446683|NCT00305630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24521030|NCT05199194|Tenecteplase|tenecteplase|mesh-list
24545267|NCT00692731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545268|NCT00692731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24545269|NCT00692731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24545270|NCT00692731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545271|NCT00692731|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24545272|NCT00692731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24545284|NCT00692900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545285|NCT00692952|Benzalkonium Compounds|benzalkonium compounds|mesh-list
24545286|NCT00692952|Contraceptive Agents|contraceptive agents|mesh-list
24545287|NCT00692952|Nonoxynol|nonoxynol|mesh-list
24545298|NCT00693004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24797397|NCT01955421|Gefitinib|gefitinib|mesh-list
24939820|NCT04006691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24521549|NCT04690322|Immunologic Factors|immunologic factors|mesh-ancestor
24939821|NCT04006080|Vedolizumab|vedolizumab|mesh-list
24939822|NCT04006080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24939823|NCT04006093|Apixaban|apixaban|mesh-list
24939824|NCT04006093|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24545335|NCT00693069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24545336|NCT00693069|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24574679|NCT00826839|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24574694|NCT00826865|Anticonvulsants|anticonvulsants|mesh-ancestor
24574695|NCT00826865|Nootropic Agents|nootropic agents|mesh-ancestor
24574696|NCT00826891|Topotecan|topotecan|mesh-list
24521816|NCT04493203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24521817|NCT04493203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939825|NCT04006093|Antithrombins|antithrombins|mesh-ancestor
24939834|NCT04006041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939835|NCT04006041|Tubulin Modulators|tubulin modulators|mesh-ancestor
24545427|NCT00693381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545428|NCT00693381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24545429|NCT00693381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24545430|NCT00693381|Antitubercular Agents|antitubercular agents|mesh-ancestor
24545431|NCT00693381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24545432|NCT00693381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24545433|NCT00693381|Antiemetics|antiemetics|mesh-ancestor
24545434|NCT00693381|Autonomic Agents|autonomic agents|mesh-ancestor
24545435|NCT00693381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24545436|NCT00693381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24545437|NCT00693381|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24545438|NCT00693381|Protective Agents|protective agents|mesh-ancestor
24545439|NCT00693407|Capsaicin|capsaicin|mesh-list
24545440|NCT00693407|Antipruritics|antipruritics|mesh-ancestor
24545441|NCT00693407|Dermatologic Agents|dermatologic agents|mesh-ancestor
24545442|NCT00693407|Sensory System Agents|sensory system agents|mesh-ancestor
24521909|NCT04432935|Lactoferrin|lactoferrin|mesh-list
25050535|NCT00488267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24955939|NCT03859362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24955940|NCT03859362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24955942|NCT03859375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24955943|NCT03859141|Vaccines|vaccines|mesh-list
24955944|NCT03859141|Immunologic Factors|immunologic factors|mesh-ancestor
24955945|NCT03859141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955946|NCT03859102|Acetaminophen|acetaminophen|mesh-list
25704961|NCT02191397|Serotonin Agents|serotonin agents|mesh-ancestor
25704962|NCT02191397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704963|NCT02191397|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25704964|NCT02191397|Antidepressive Agents|antidepressive agents|mesh-ancestor
25704965|NCT02191397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25704966|NCT02191397|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25704967|NCT02191397|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25704968|NCT02191397|Parasympatholytics|parasympatholytics|mesh-ancestor
25704969|NCT02191397|Autonomic Agents|autonomic agents|mesh-ancestor
25704970|NCT02191397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955948|NCT03859102|Gabapentin|gabapentin|mesh-list
24955949|NCT03859102|Ondansetron|ondansetron|mesh-list
24545462|NCT00693433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24545463|NCT00693433|Immunologic Factors|immunologic factors|mesh-ancestor
24545464|NCT00693446|Sirolimus|sirolimus|mesh-list
24545465|NCT00693446|Tacrolimus|tacrolimus|mesh-list
24545466|NCT00693446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24545467|NCT00693446|Immunologic Factors|immunologic factors|mesh-ancestor
24545468|NCT00693446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522049|NCT04340882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522050|NCT04340882|Tubulin Modulators|tubulin modulators|mesh-ancestor
24522051|NCT04340882|Antimitotic Agents|antimitotic agents|mesh-ancestor
24545484|NCT00693524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24545485|NCT00693524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545486|NCT00693524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24545532|NCT00693680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24545547|NCT00693732|Antidepressive Agents|antidepressive agents|mesh-ancestor
24545548|NCT00693732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24545549|NCT00693758|Adenosine|adenosine|mesh-list
24545550|NCT00693758|Analgesics|analgesics|mesh-ancestor
24545551|NCT00693758|Sensory System Agents|sensory system agents|mesh-ancestor
24955957|NCT03859102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24955958|NCT03859102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24955959|NCT03859102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24955960|NCT03859102|Glucocorticoids|glucocorticoids|mesh-ancestor
24955961|NCT03859102|Hormones|hormones|mesh-ancestor
24939839|NCT04006353|Rifampin|rifampin|mesh-list
24939840|NCT04006353|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24939841|NCT04006353|Antitubercular Agents|antitubercular agents|mesh-ancestor
25704971|NCT02191397|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25704972|NCT02191397|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25704973|NCT02191397|Cholinergic Agents|cholinergic agents|mesh-ancestor
25704974|NCT02191397|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25704975|NCT02191397|Dopamine Agents|dopamine agents|mesh-ancestor
25704976|NCT02191397|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25709652|NCT02271854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24576489|NCT00838864|Ceftriaxone|ceftriaxone|mesh-list
24939842|NCT04006353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24939843|NCT04006353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24939844|NCT04006353|Leprostatic Agents|leprostatic agents|mesh-ancestor
24939845|NCT04006353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24939846|NCT04006353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939847|NCT04006353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939848|NCT04006353|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24939849|NCT04006353|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24545552|NCT00693758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24545553|NCT00693758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545554|NCT00693758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24545555|NCT00693758|Vasodilator Agents|vasodilator agents|mesh-ancestor
24545556|NCT00693758|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24545557|NCT00693758|Purinergic Agonists|purinergic agonists|mesh-ancestor
24545558|NCT00693758|Purinergic Agents|purinergic agents|mesh-ancestor
24545559|NCT00693758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24545560|NCT00693758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545561|NCT00693771|Insulin Glargine|insulin glargine|mesh-list
24523107|NCT02588248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523108|NCT02588248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24545584|NCT00693862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24545606|NCT00694005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24545607|NCT00694005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24545608|NCT00694005|Tubulin Modulators|tubulin modulators|mesh-ancestor
24545609|NCT00694005|Antimitotic Agents|antimitotic agents|mesh-ancestor
24545610|NCT00694005|Mitosis Modulators|mitosis modulators|mesh-ancestor
25050536|NCT00488267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25050537|NCT00488267|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25050538|NCT00488267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050539|NCT00488267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050541|NCT00486512|Calcium, Dietary|calcium, dietary|mesh-list
25050542|NCT00486512|Calcitriol|calcitriol|mesh-list
24836093|NCT02184104|Caffeine|caffeine|mesh-list
24523110|NCT02584309|Doxorubicin|doxorubicin|mesh-list
24447359|NCT00308321|Hormones|hormones|mesh-ancestor
24545693|NCT00694408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25704977|NCT02191397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25704978|NCT02191397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25704979|NCT02191579|Topiramate|topiramate|mesh-list
25704980|NCT02191579|Botulinum Toxins|botulinum toxins|mesh-list
25704981|NCT02191579|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25704982|NCT02191579|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25704983|NCT02191579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25704984|NCT02191579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24545694|NCT00694408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545695|NCT00694408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24545697|NCT00694408|Hormones|hormones|mesh-ancestor
24545698|NCT00694408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24545699|NCT00694408|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25050546|NCT00486512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24545700|NCT00694408|Protective Agents|protective agents|mesh-ancestor
24545746|NCT00694733|Estrogens|estrogens|mesh-list
24545747|NCT00694733|Testosterone|testosterone|mesh-list
24545748|NCT00694733|Testosterone undecanoate|testosterone undecanoate|mesh-list
24545811|NCT00695045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545812|NCT00695045|Analgesics|analgesics|mesh-ancestor
24545813|NCT00695045|Sensory System Agents|sensory system agents|mesh-ancestor
24545814|NCT00695045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24545815|NCT00695071|Itraconazole|itraconazole|mesh-list
24545816|NCT00695071|Antifungal Agents|antifungal agents|mesh-ancestor
24545817|NCT00695071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24545818|NCT00695071|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24802103|NCT01987297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24545819|NCT00695071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24545820|NCT00695071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25050547|NCT00486512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050548|NCT00486512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24836133|NCT02184260|Analgesics|analgesics|mesh-ancestor
24545822|NCT00695071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24545823|NCT00695071|Hormone Antagonists|hormone antagonists|mesh-ancestor
24545824|NCT00695071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24545825|NCT00695071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545826|NCT00695071|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24523735|NCT05340803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24545827|NCT00695201|Oxaliplatin|oxaliplatin|mesh-list
24545828|NCT00695201|Irinotecan|irinotecan|mesh-list
24545829|NCT00695201|Floxuridine|floxuridine|mesh-list
24545830|NCT00695201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24545831|NCT00695201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24545832|NCT00695201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24545833|NCT00695201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24545834|NCT00695201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545835|NCT00695201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24545836|NCT00695201|Antimetabolites|antimetabolites|mesh-ancestor
24545845|NCT00695331|Oxytocin|oxytocin|mesh-list
24545866|NCT00695344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545868|NCT00695344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24545870|NCT00695604|Fluticasone|fluticasone|mesh-list
24545880|NCT00695630|Flumazenil|flumazenil|mesh-list
24545886|NCT00695630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24545887|NCT00695630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545891|NCT00695643|Analgesics|analgesics|mesh-ancestor
24545892|NCT00695643|Sensory System Agents|sensory system agents|mesh-ancestor
24545893|NCT00695643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24523736|NCT05340803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24545894|NCT00695643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545895|NCT00695643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24545896|NCT00695643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24545897|NCT00695682|Infliximab|infliximab|mesh-list
24545898|NCT00695682|Dermatologic Agents|dermatologic agents|mesh-ancestor
24545899|NCT00695682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24545900|NCT00695682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24545901|NCT00695929|Simendan|simendan|mesh-list
24545902|NCT00695929|Milrinone|milrinone|mesh-list
25050549|NCT00486512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25050550|NCT00486512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25050551|NCT00486512|Analgesics|analgesics|mesh-ancestor
25050552|NCT00486512|Sensory System Agents|sensory system agents|mesh-ancestor
25050553|NCT00486512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25050554|NCT00486512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25050555|NCT00486512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24939850|NCT04006353|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24545914|NCT00695994|Docetaxel|docetaxel|mesh-list
24545915|NCT00695994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24545916|NCT00695994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24545917|NCT00695994|Antimetabolites|antimetabolites|mesh-ancestor
24545918|NCT00695994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545919|NCT00695994|Antiviral Agents|antiviral agents|mesh-ancestor
24545920|NCT00695994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24545921|NCT00695994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24545922|NCT00695994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24939859|NCT04006054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24939861|NCT04006054|Sensory System Agents|sensory system agents|mesh-ancestor
24939862|NCT04006054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24853250|NCT02265484|Dopamine Agents|dopamine agents|mesh-ancestor
24545923|NCT00695994|Immunologic Factors|immunologic factors|mesh-ancestor
24545924|NCT00695994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545925|NCT00695994|Tubulin Modulators|tubulin modulators|mesh-ancestor
24524393|NCT04977453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24524394|NCT04977453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24524395|NCT04977453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24524396|NCT04977453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24524397|NCT04977453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455145|NCT02676791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24545941|NCT00696033|Anticonvulsants|anticonvulsants|mesh-ancestor
24545944|NCT00696033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24545945|NCT00696033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545946|NCT00696033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24545949|NCT00696033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24545977|NCT00696111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545979|NCT00696111|Fertility Agents|fertility agents|mesh-ancestor
24545980|NCT00696111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24545981|NCT00696111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24546005|NCT00696475|Lipotropic Agents|lipotropic agents|mesh-ancestor
24546006|NCT00696475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24939863|NCT04006054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24939864|NCT04006054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24939865|NCT04006054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24939866|NCT04006054|Adrenergic Agents|adrenergic agents|mesh-ancestor
24525120|NCT03933904|Sirolimus|sirolimus|mesh-list
24525419|NCT03405090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24546039|NCT00696540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24546040|NCT00696540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546041|NCT00696566|Rifampin|rifampin|mesh-list
24546042|NCT00696566|Clopidogrel|clopidogrel|mesh-list
24546043|NCT00696566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25704985|NCT02191579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704986|NCT02191579|Cholinergic Agents|cholinergic agents|mesh-ancestor
24585439|NCT00885625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546044|NCT00696566|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24546045|NCT00696566|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24939867|NCT04006054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24939868|NCT04006054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525420|NCT03405090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24525421|NCT03405090|Anesthetics, General|anesthetics, general|mesh-ancestor
24525842|NCT02644369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939869|NCT04006054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24546064|NCT00696579|Gemcitabine|gemcitabine|mesh-list
24546065|NCT00696579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24546074|NCT00696579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546075|NCT00696592|Bevacizumab|bevacizumab|mesh-list
24546076|NCT00696592|Verteporfin|verteporfin|mesh-list
24546077|NCT00696592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24939870|NCT04006054|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24764635|NCT01782950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24764637|NCT01782976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24764638|NCT01782976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24764639|NCT01782976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24853263|NCT02266927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24546122|NCT00696826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24546123|NCT00696826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546124|NCT00696930|Edotreotide|edotreotide|mesh-list
24546125|NCT00696930|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24546126|NCT00696930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546127|NCT00696956|Paclitaxel|paclitaxel|mesh-list
24546128|NCT00696956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24546129|NCT00696956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25704987|NCT02191579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25704988|NCT02191579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25704989|NCT02191579|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25704990|NCT02191579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25704991|NCT02191579|Anticonvulsants|anticonvulsants|mesh-ancestor
25704992|NCT02191579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25704993|NCT02191865|Nintedanib|nintedanib|mesh-list
25704994|NCT02191865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24546130|NCT00696956|Tubulin Modulators|tubulin modulators|mesh-ancestor
24546192|NCT00697034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546194|NCT00697060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24764640|NCT01782976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24802122|NCT01987570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802124|NCT01987570|Gout Suppressants|gout suppressants|mesh-ancestor
24764641|NCT01782976|Growth Substances|growth substances|mesh-ancestor
24764642|NCT01782976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764643|NCT01782976|Growth Inhibitors|growth inhibitors|mesh-ancestor
24764644|NCT01782989|Doxycycline|doxycycline|mesh-list
24764645|NCT01782989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24764646|NCT01782989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24764647|NCT01782989|Antimalarials|antimalarials|mesh-ancestor
24764648|NCT01782989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24764649|NCT01782989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24764650|NCT01783002|Carbon-11 methionine|carbon-11 methionine|mesh-list
24764651|NCT01783002|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24546196|NCT00697060|Antimitotic Agents|antimitotic agents|mesh-ancestor
24546197|NCT00697060|Mitosis Modulators|mitosis modulators|mesh-ancestor
24546222|NCT00697151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24546223|NCT00697151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24546225|NCT00697151|Sensory System Agents|sensory system agents|mesh-ancestor
24546229|NCT00697151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24546234|NCT00697151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24546235|NCT00697151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24546236|NCT00697151|Antipyretics|antipyretics|mesh-ancestor
24546237|NCT00697151|Anticoagulants|anticoagulants|mesh-ancestor
24527570|NCT00617474|Epoetin Alfa|epoetin alfa|mesh-list
24625655|NCT01082796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24546260|NCT00697437|Ketoconazole|ketoconazole|mesh-list
24546261|NCT00697437|Docetaxel|docetaxel|mesh-list
24546262|NCT00697437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24546263|NCT00697437|Tubulin Modulators|tubulin modulators|mesh-ancestor
24546264|NCT00697437|Antimitotic Agents|antimitotic agents|mesh-ancestor
24546265|NCT00697437|Mitosis Modulators|mitosis modulators|mesh-ancestor
24546354|NCT00697879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
24546355|NCT00697879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24546356|NCT00697879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546357|NCT00697892|Ritonavir|ritonavir|mesh-list
24546358|NCT00697892|Lopinavir|lopinavir|mesh-list
24546359|NCT00697892|Efavirenz|efavirenz|mesh-list
24546360|NCT00697892|Lumefantrine|lumefantrine|mesh-list
24546361|NCT00697892|Artemether|artemether|mesh-list
24546362|NCT00697892|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24625644|NCT01082744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24637640|NCT01151878|Cathartics|cathartics|mesh-ancestor
24637648|NCT01152047|Oxytocin|oxytocin|mesh-list
24625645|NCT01082744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637873|NCT01153750|Imatinib Mesylate|imatinib mesylate|mesh-list
24637952|NCT01154387|Mycophenolic Acid|mycophenolic acid|mesh-list
24625646|NCT01082744|Sensory System Agents|sensory system agents|mesh-ancestor
24625647|NCT01082744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24625648|NCT01082744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24625649|NCT01082744|Narcotics|narcotics|mesh-ancestor
24625650|NCT01082744|Analgesics|analgesics|mesh-ancestor
24625651|NCT01082744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24625652|NCT01082744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24625653|NCT01082744|Anesthetics, General|anesthetics, general|mesh-ancestor
24625654|NCT01082796|Glipizide|glipizide|mesh-list
24625660|NCT01082809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24853299|NCT02267239|Sodium Fluoride|sodium fluoride|mesh-list
24546363|NCT00697892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24546364|NCT00697892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24546365|NCT00697892|Protease Inhibitors|protease inhibitors|mesh-ancestor
24546366|NCT00697892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24546368|NCT00697892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24546376|NCT00697892|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24546377|NCT00697892|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24546378|NCT00697892|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24546379|NCT00697892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24625661|NCT01082809|Growth Substances|growth substances|mesh-ancestor
24939884|NCT04005781|Hydroxychloroquine|hydroxychloroquine|mesh-list
24939885|NCT04005781|Antimalarials|antimalarials|mesh-ancestor
24939886|NCT04005781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24939887|NCT04005781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24939888|NCT04005781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24546420|NCT00698269|Biphasic Insulins|biphasic insulins|mesh-list
24529383|NCT00625859|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24546421|NCT00698269|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24546424|NCT00698334|Rifampin|rifampin|mesh-list
24546448|NCT00698464|Pasireotide|pasireotide|mesh-list
24546449|NCT00698464|Hormones|hormones|mesh-ancestor
24546467|NCT00698607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24546468|NCT00698607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24546469|NCT00698607|Antifungal Agents|antifungal agents|mesh-ancestor
24635368|NCT01138774|Vitamins|vitamins|mesh-ancestor
24546470|NCT00698724|Prednisolone acetate|prednisolone acetate|mesh-list
24546471|NCT00698724|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24546520|NCT00698945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24546521|NCT00698945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24546522|NCT00698945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24546523|NCT00698945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24546524|NCT00698945|Adrenergic Agents|adrenergic agents|mesh-ancestor
24546525|NCT00698945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24546596|NCT00699296|Panobinostat|panobinostat|mesh-list
24529733|NCT00627666|Antidotes|antidotes|mesh-ancestor
24546597|NCT00699296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24546598|NCT00699296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24546599|NCT00699296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24546600|NCT00699296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546601|NCT00699322|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24546604|NCT00699322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546605|NCT00699322|Incretins|incretins|mesh-ancestor
24546606|NCT00699322|Hormones|hormones|mesh-ancestor
24546656|NCT00699504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24546657|NCT00699504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24546658|NCT00699504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546659|NCT00699504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24546660|NCT00699504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546661|NCT00699504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24546662|NCT00699504|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24546663|NCT00699504|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24546664|NCT00699504|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24546665|NCT00699504|Purinergic Agents|purinergic agents|mesh-ancestor
24546666|NCT00699504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24546689|NCT00699764|Vaccines|vaccines|mesh-list
24546709|NCT00699894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24546710|NCT00699894|Antipruritics|antipruritics|mesh-ancestor
24546711|NCT00699894|Dermatologic Agents|dermatologic agents|mesh-ancestor
24530718|NCT00631995|Vaccines|vaccines|mesh-list
24546712|NCT00699894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24546714|NCT00699894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24546715|NCT00699894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546716|NCT00699894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24546717|NCT00699894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24546718|NCT00699894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24546719|NCT00699894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24546720|NCT00699894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24939906|NCT04005612|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24939907|NCT04005612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24853342|NCT02267681|Fentanyl|fentanyl|mesh-list
24546721|NCT00699894|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24546727|NCT00699946|Olanzapine|olanzapine|mesh-list
24546864|NCT00700895|Anticoagulants|anticoagulants|mesh-ancestor
24546886|NCT00700947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24546887|NCT00700947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24546889|NCT00700960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24546890|NCT00700960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546891|NCT00701155|Insulin Detemir|insulin detemir|mesh-list
24546892|NCT00701155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24546893|NCT00701155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546894|NCT00701220|Atorvastatin|atorvastatin|mesh-list
24546895|NCT00701220|Calcium|calcium|mesh-list
24546896|NCT00701220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24939908|NCT04005443|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
24939909|NCT04005443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939910|NCT04005664|Phenylephrine|phenylephrine|mesh-list
24939911|NCT04005664|Oxymetazoline|oxymetazoline|mesh-list
24939912|NCT04005664|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24531656|NCT00636896|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24939913|NCT04005664|Mydriatics|mydriatics|mesh-ancestor
25704995|NCT02191865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24939914|NCT04005664|Autonomic Agents|autonomic agents|mesh-ancestor
24853344|NCT02267681|Propofol|propofol|mesh-list
24546897|NCT00701220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546898|NCT00701220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24546899|NCT00701220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24836414|NCT02185768|Idarubicin|idarubicin|mesh-list
24546904|NCT00701220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24546905|NCT00701233|Botulinum Toxins|botulinum toxins|mesh-list
24546906|NCT00701233|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24546907|NCT00701233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24546908|NCT00701233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546909|NCT00701233|Cholinergic Agents|cholinergic agents|mesh-ancestor
24546910|NCT00701233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24546912|NCT00701246|Folic Acid|folic acid|mesh-list
24546936|NCT00701298|Interferon alpha-2|interferon alpha-2|mesh-list
24546937|NCT00701298|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24546938|NCT00701298|Decitabine|decitabine|mesh-list
24546939|NCT00701298|Azacitidine|azacitidine|mesh-list
24546940|NCT00701298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24546941|NCT00701298|Antiviral Agents|antiviral agents|mesh-ancestor
24546965|NCT00701428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24546966|NCT00701428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546967|NCT00701493|Topiramate|topiramate|mesh-list
24546968|NCT00701493|Anticonvulsants|anticonvulsants|mesh-ancestor
24546969|NCT00701493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24546970|NCT00701493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546984|NCT00701623|Anticoagulants|anticoagulants|mesh-ancestor
24546985|NCT00701623|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24546986|NCT00701623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24546988|NCT00701740|Isotretinoin|isotretinoin|mesh-list
24547009|NCT00701909|Sensory System Agents|sensory system agents|mesh-ancestor
24547010|NCT00701909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24547011|NCT00701909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547012|NCT00701909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24547013|NCT00701909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24547014|NCT00701909|Anesthetics, General|anesthetics, general|mesh-ancestor
24547019|NCT00701909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24547020|NCT00701909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547021|NCT00701909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24547022|NCT00701909|Narcotics|narcotics|mesh-ancestor
24547023|NCT00701961|Artesunate|artesunate|mesh-list
24547112|NCT00702442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24547113|NCT00702442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24547114|NCT00702442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24547115|NCT00702442|Dopamine Agents|dopamine agents|mesh-ancestor
24547116|NCT00702442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24547117|NCT00702442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547118|NCT00702481|Nimotuzumab|nimotuzumab|mesh-list
24547137|NCT00702572|Growth Inhibitors|growth inhibitors|mesh-ancestor
24547202|NCT00702975|Carboplatin|carboplatin|mesh-list
24547203|NCT00702975|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24547204|NCT00702975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24547205|NCT00702975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547206|NCT00702975|Tubulin Modulators|tubulin modulators|mesh-ancestor
24939915|NCT04005664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24939916|NCT04005664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939917|NCT04005664|Sympathomimetics|sympathomimetics|mesh-ancestor
24939918|NCT04005664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24939919|NCT04005664|Nasal Decongestants|nasal decongestants|mesh-ancestor
24939920|NCT04005664|Respiratory System Agents|respiratory system agents|mesh-ancestor
24547209|NCT00702975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547210|NCT00702975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24547211|NCT00702975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24531820|NCT00637325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24532110|NCT00637988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532111|NCT00637988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24532112|NCT00637988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24597028|NCT00946907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24547231|NCT00703144|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24547232|NCT00703144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547233|NCT00703144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547234|NCT00703170|Sirolimus|sirolimus|mesh-list
24547235|NCT00703170|Doxorubicin|doxorubicin|mesh-list
24547236|NCT00703170|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24547237|NCT00703170|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24547238|NCT00703170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547239|NCT00703170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24547240|NCT00703170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24939954|NCT04005365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24532113|NCT00637988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532114|NCT00637988|Antipyretics|antipyretics|mesh-ancestor
24532115|NCT00637988|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24532116|NCT00637988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24532117|NCT00637988|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24532118|NCT00637988|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24532167|NCT00638300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24532168|NCT00638300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532169|NCT00638300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24532170|NCT00638326|Clopidogrel|clopidogrel|mesh-list
24939955|NCT04005365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24939956|NCT04005365|Vasodilator Agents|vasodilator agents|mesh-ancestor
24939957|NCT04005222|Selenium|selenium|mesh-list
24939958|NCT04005222|Melatonin|melatonin|mesh-list
24939959|NCT04005222|Antioxidants|antioxidants|mesh-ancestor
24939960|NCT04005222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24939961|NCT04005222|Protective Agents|protective agents|mesh-ancestor
24939962|NCT04005222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939964|NCT04005222|Trace Elements|trace elements|mesh-ancestor
24547309|NCT00703365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547310|NCT00703365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547311|NCT00703365|Antiviral Agents|antiviral agents|mesh-ancestor
24547312|NCT00703365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24547313|NCT00703365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24939968|NCT04005417|Cariostatic Agents|cariostatic agents|mesh-ancestor
24939969|NCT04005417|Protective Agents|protective agents|mesh-ancestor
24939970|NCT04005417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24939971|NCT04004754|Miltefosine|miltefosine|mesh-list
24939972|NCT04004754|Antifungal Agents|antifungal agents|mesh-ancestor
24939973|NCT04004754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24939974|NCT04004754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24939975|NCT04004754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24547314|NCT00703365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24547315|NCT00703365|Immunologic Factors|immunologic factors|mesh-ancestor
24547316|NCT00703365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547334|NCT00703469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24547335|NCT00703469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547336|NCT00703469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24547337|NCT00703469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547338|NCT00703482|Coenzyme Q10|coenzyme q10|mesh-list
24547340|NCT00703482|Fenofibrate|fenofibrate|mesh-list
24547343|NCT00703482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547353|NCT00703586|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24547354|NCT00703586|Antiviral Agents|antiviral agents|mesh-ancestor
24853383|NCT02267915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24447508|NCT00308607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24447509|NCT00308607|Alkylating Agents|alkylating agents|mesh-ancestor
24447510|NCT00308607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447511|NCT00308763|Bupropion|bupropion|mesh-list
24447512|NCT00308763|Nicotine|nicotine|mesh-list
24547376|NCT00703638|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24547377|NCT00703638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24547378|NCT00703638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24547379|NCT00703651|Vaccines|vaccines|mesh-list
25704996|NCT02191865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25704997|NCT02191865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25704998|NCT02192190|Celecoxib|celecoxib|mesh-list
24599390|NCT04619082|Antiviral Agents|antiviral agents|mesh-ancestor
24599391|NCT04619082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24599392|NCT04619082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24599393|NCT04619082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24599429|NCT04588948|Growth Inhibitors|growth inhibitors|mesh-ancestor
24600082|NCT02703584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24393832|NCT00131040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24393833|NCT00131040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393834|NCT00131053|Cytarabine|cytarabine|mesh-list
24547380|NCT00703651|Immunologic Factors|immunologic factors|mesh-ancestor
24547381|NCT00703651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547382|NCT00703690|Fenofibrate|fenofibrate|mesh-list
24547383|NCT00703690|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24547384|NCT00703690|Antimetabolites|antimetabolites|mesh-ancestor
24547385|NCT00703690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547386|NCT00703690|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24547388|NCT00703703|Darifenacin|darifenacin|mesh-list
24547389|NCT00703703|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24547390|NCT00703703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24547391|NCT00703703|Cholinergic Agents|cholinergic agents|mesh-ancestor
24547392|NCT00703703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24939988|NCT04004871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24939990|NCT04004871|Tubulin Modulators|tubulin modulators|mesh-ancestor
24939991|NCT04004871|Antimitotic Agents|antimitotic agents|mesh-ancestor
24939992|NCT04004871|Mitosis Modulators|mitosis modulators|mesh-ancestor
24853393|NCT02267980|Anesthetics|anesthetics|mesh-ancestor
24547422|NCT00703807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24547423|NCT00703807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547425|NCT00703872|Interferons|interferons|mesh-list
24547426|NCT00703872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547427|NCT00703872|Antiviral Agents|antiviral agents|mesh-ancestor
24547428|NCT00703872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24532373|NCT00639587|Histamine Antagonists|histamine antagonists|mesh-ancestor
24532374|NCT00639587|Histamine Agents|histamine agents|mesh-ancestor
24532375|NCT00639587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24532376|NCT00639587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532488|NCT00640081|Vitamins|vitamins|mesh-ancestor
24532489|NCT00640081|Micronutrients|micronutrients|mesh-ancestor
24532490|NCT00640081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24532535|NCT00640263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24532672|NCT00640796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24547429|NCT00703898|Nevirapine|nevirapine|mesh-list
24547430|NCT00703898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24547431|NCT00703898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24547432|NCT00703898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547433|NCT00703898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547434|NCT00703898|Antiviral Agents|antiviral agents|mesh-ancestor
24547435|NCT00703898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24547436|NCT00703898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24547437|NCT00703898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24547438|NCT00703898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24547441|NCT00703989|Benphothiamine|benphothiamine|mesh-list
24547442|NCT00703989|Antioxidants|antioxidants|mesh-ancestor
24547443|NCT00703989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547444|NCT00703989|Protective Agents|protective agents|mesh-ancestor
24547445|NCT00703989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547446|NCT00703989|Vitamin B Complex|vitamin b complex|mesh-ancestor
24547447|NCT00703989|Vitamins|vitamins|mesh-ancestor
24547448|NCT00703989|Micronutrients|micronutrients|mesh-ancestor
24547449|NCT00703989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24547450|NCT00703989|Immunologic Factors|immunologic factors|mesh-ancestor
24547451|NCT00703989|Chelating Agents|chelating agents|mesh-ancestor
24547452|NCT00703989|Sequestering Agents|sequestering agents|mesh-ancestor
24547453|NCT00704080|Temozolomide|temozolomide|mesh-list
24547454|NCT00704080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24547455|NCT00704080|Alkylating Agents|alkylating agents|mesh-ancestor
25704999|NCT02192190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25705000|NCT02192190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25705001|NCT02192190|Analgesics|analgesics|mesh-ancestor
25705002|NCT02192190|Sensory System Agents|sensory system agents|mesh-ancestor
25705003|NCT02192190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25705004|NCT02192190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705005|NCT02192190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24542898|NCT00680732|Vitamins|vitamins|mesh-ancestor
24863110|NCT03111732|Antimetabolites|antimetabolites|mesh-ancestor
24863111|NCT03111732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684964|NCT03121534|Autonomic Agents|autonomic agents|mesh-ancestor
24684965|NCT03121534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24547459|NCT00704106|Antiviral Agents|antiviral agents|mesh-ancestor
24547460|NCT00704106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24547461|NCT00704145|Paclitaxel|paclitaxel|mesh-list
24393966|NCT00131404|Hormones|hormones|mesh-ancestor
24547462|NCT00704145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24547463|NCT00704145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547464|NCT00704145|Tubulin Modulators|tubulin modulators|mesh-ancestor
24532831|NCT00641212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24532832|NCT00641212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532833|NCT00641212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24532834|NCT00641212|Respiratory System Agents|respiratory system agents|mesh-ancestor
24532862|NCT00641407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532864|NCT00641433|Silver Sulfadiazine|silver sulfadiazine|mesh-list
24532865|NCT00641433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24532866|NCT00641433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24532867|NCT00641433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24532868|NCT00641433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24532869|NCT00641433|Coccidiostats|coccidiostats|mesh-ancestor
24940000|NCT04004884|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24940001|NCT04004884|Contraceptive Agents|contraceptive agents|mesh-ancestor
24940002|NCT04004884|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24940003|NCT04004884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547565|NCT00704678|Chelating Agents|chelating agents|mesh-ancestor
24532870|NCT00641433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24547566|NCT00704678|Sequestering Agents|sequestering agents|mesh-ancestor
24547567|NCT00704678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705006|NCT02192190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25705007|NCT02192190|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25705008|NCT02192190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25705009|NCT02192190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25705010|NCT02192190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705011|NCT02192541|Aflibercept|aflibercept|mesh-list
25705012|NCT02192541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25705013|NCT02192541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25705014|NCT02192541|Growth Substances|growth substances|mesh-ancestor
25705015|NCT02192541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705016|NCT02192541|Growth Inhibitors|growth inhibitors|mesh-ancestor
25705017|NCT02192541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25705018|NCT02192684|Pioglitazone|pioglitazone|mesh-list
25705019|NCT02192684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24547568|NCT00704691|Lenalidomide|lenalidomide|mesh-list
24547569|NCT00704691|Immunologic Factors|immunologic factors|mesh-ancestor
24547578|NCT00704704|Immunologic Factors|immunologic factors|mesh-ancestor
24547579|NCT00704704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547616|NCT00704899|Sensory System Agents|sensory system agents|mesh-ancestor
24547617|NCT00704899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24547618|NCT00704899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547619|NCT00704899|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24547620|NCT00704899|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24547621|NCT00704899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24547622|NCT00704899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547623|NCT00704899|Adrenergic Agents|adrenergic agents|mesh-ancestor
24547624|NCT00704899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24547626|NCT00704925|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24547627|NCT00704925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24547628|NCT00704925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547630|NCT00704925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24547631|NCT00704925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547632|NCT00704951|Posaconazole|posaconazole|mesh-list
24547633|NCT00704951|Antifungal Agents|antifungal agents|mesh-ancestor
24547634|NCT00704951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24547635|NCT00704951|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24533073|NCT00642161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050556|NCT00486512|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24940008|NCT04004988|Incretins|incretins|mesh-ancestor
24940009|NCT04004988|Hormones|hormones|mesh-ancestor
24940010|NCT04004988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24547688|NCT00705120|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24547689|NCT00705198|Temozolomide|temozolomide|mesh-list
24802286|NCT01989312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24802287|NCT01989312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24802288|NCT01989312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24547690|NCT00705198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24547691|NCT00705198|Alkylating Agents|alkylating agents|mesh-ancestor
24547725|NCT00705419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24547744|NCT00705510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24547745|NCT00705510|Dermatologic Agents|dermatologic agents|mesh-ancestor
24940020|NCT04004507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24940021|NCT04004507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24940022|NCT04004507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940023|NCT04004507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24940024|NCT04004572|Pegaspargase|pegaspargase|mesh-list
24940025|NCT04004572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24940026|NCT04004234|Manganese|manganese|mesh-list
24940027|NCT04004234|Gemcitabine|gemcitabine|mesh-list
24940028|NCT04004234|Paclitaxel|paclitaxel|mesh-list
24940029|NCT04004234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24940030|NCT04004234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24940031|NCT04004234|Antibodies|antibodies|mesh-list
24940032|NCT04004234|Immunoglobulins|immunoglobulins|mesh-list
24940033|NCT04004234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24940034|NCT04004234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547760|NCT00705549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24547761|NCT00705549|Immunologic Factors|immunologic factors|mesh-ancestor
24547762|NCT00705549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547763|NCT00705549|Tubulin Modulators|tubulin modulators|mesh-ancestor
24547764|NCT00705549|Antimitotic Agents|antimitotic agents|mesh-ancestor
24547765|NCT00705549|Mitosis Modulators|mitosis modulators|mesh-ancestor
24547766|NCT00705549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24547767|NCT00705562|Caseins|caseins|mesh-list
24547768|NCT00705562|Chelating Agents|chelating agents|mesh-ancestor
24547769|NCT00705562|Sequestering Agents|sequestering agents|mesh-ancestor
24547770|NCT00705562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547771|NCT00705588|Tadalafil|tadalafil|mesh-list
24547772|NCT00705588|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24547773|NCT00705588|Vasodilator Agents|vasodilator agents|mesh-ancestor
24547774|NCT00705588|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24547775|NCT00705588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24547776|NCT00705588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547808|NCT00705796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24547821|NCT00705822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547822|NCT00705822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24547823|NCT00705822|Glucocorticoids|glucocorticoids|mesh-ancestor
24547825|NCT00705822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24547826|NCT00705822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547827|NCT00705822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24547834|NCT00705835|Antacids|antacids|mesh-ancestor
24547835|NCT00705835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547836|NCT00705835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24547837|NCT00705900|Calcipotriene|calcipotriene|mesh-list
24547838|NCT00705900|Dermatologic Agents|dermatologic agents|mesh-ancestor
24547839|NCT00705926|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24547840|NCT00705926|Antiviral Agents|antiviral agents|mesh-ancestor
24547841|NCT00705926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24547842|NCT00705978|Pancreatin|pancreatin|mesh-list
24547843|NCT00705978|Pancrelipase|pancrelipase|mesh-list
24547844|NCT00705978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24547845|NCT00706017|Insulin Detemir|insulin detemir|mesh-list
24547846|NCT00706017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24547847|NCT00706017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547848|NCT00706069|Capecitabine|capecitabine|mesh-list
24547849|NCT00706069|Vinorelbine|vinorelbine|mesh-list
24547852|NCT00706069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547853|NCT00706069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547854|NCT00706069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24547855|NCT00706069|Tubulin Modulators|tubulin modulators|mesh-ancestor
24547856|NCT00706069|Antimitotic Agents|antimitotic agents|mesh-ancestor
24547857|NCT00706069|Mitosis Modulators|mitosis modulators|mesh-ancestor
24547859|NCT00706173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24547860|NCT00706186|Sodium Oxybate|sodium oxybate|mesh-list
24547861|NCT00706186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24547862|NCT00706186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24764729|NCT01783756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24940051|NCT04004117|Narcotics|narcotics|mesh-ancestor
24940052|NCT04004117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24940079|NCT04003844|Sensory System Agents|sensory system agents|mesh-ancestor
24940080|NCT04003844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24940081|NCT04003844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24940082|NCT04003844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24940083|NCT04003844|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24940084|NCT04003844|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24940088|NCT04003844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24940089|NCT04003844|Antipyretics|antipyretics|mesh-ancestor
24940093|NCT04003792|Bevacizumab|bevacizumab|mesh-list
24940094|NCT04003792|Oxaliplatin|oxaliplatin|mesh-list
24547941|NCT00706888|Vitamin B Complex|vitamin b complex|mesh-ancestor
24547943|NCT00706927|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24547944|NCT00706927|Latanoprost|latanoprost|mesh-list
24547945|NCT00706927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24547947|NCT00706927|Adrenergic Agents|adrenergic agents|mesh-ancestor
24547948|NCT00706927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24547949|NCT00706927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547950|NCT00706927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547951|NCT00706927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24547952|NCT00706927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24547953|NCT00706927|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24547954|NCT00706927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24547955|NCT00706927|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24547956|NCT00706927|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24547957|NCT00706927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24547959|NCT00706953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24547960|NCT00706953|Bortezomib|bortezomib|mesh-list
24547961|NCT00706953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24547962|NCT00706953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547963|NCT00706953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24547964|NCT00706953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24940095|NCT04003792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24940096|NCT04003792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24940097|NCT04003792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24940098|NCT04003792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24940099|NCT04003792|Growth Substances|growth substances|mesh-ancestor
24940100|NCT04003792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547965|NCT00706953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547970|NCT00707070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24940101|NCT04003792|Growth Inhibitors|growth inhibitors|mesh-ancestor
24764879|NCT01784718|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
24764880|NCT01784718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24764882|NCT01784900|Antibodies, Bispecific|antibodies, bispecific|mesh-list
24764883|NCT01784900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25705022|NCT02192814|Anticonvulsants|anticonvulsants|mesh-ancestor
25705023|NCT02192814|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25705024|NCT02192814|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25705025|NCT02192814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25705026|NCT02192814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705027|NCT02192970|Bevacizumab|bevacizumab|mesh-list
24548035|NCT00707330|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24548036|NCT00707330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548037|NCT00707330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548038|NCT00707330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24548039|NCT00707330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24548091|NCT00707551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548117|NCT00707772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24548118|NCT00707772|Interferon-alpha|interferon-alpha|mesh-list
24548137|NCT00707824|Analgesics|analgesics|mesh-ancestor
24764884|NCT01784900|Immunologic Factors|immunologic factors|mesh-ancestor
24764885|NCT01784900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24764886|NCT01784913|Sargramostim|sargramostim|mesh-list
24764887|NCT01784913|Immunologic Factors|immunologic factors|mesh-ancestor
24764888|NCT01784913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050557|NCT00486512|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25050558|NCT00486512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25050559|NCT00486512|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25050560|NCT00486512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25050561|NCT00486512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24463582|NCT00361452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25050562|NCT00486512|Antipyretics|antipyretics|mesh-ancestor
25050564|NCT00486512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25050565|NCT00486512|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25050566|NCT00486512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25050567|NCT00486512|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24548138|NCT00707824|Sensory System Agents|sensory system agents|mesh-ancestor
24548142|NCT00707850|Interferon-alpha|interferon-alpha|mesh-list
24548143|NCT00707850|Antimetabolites|antimetabolites|mesh-ancestor
24548144|NCT00707850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548145|NCT00707850|Antiviral Agents|antiviral agents|mesh-ancestor
24548146|NCT00707850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24548147|NCT00707850|Immunologic Factors|immunologic factors|mesh-ancestor
24548151|NCT00707876|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24548152|NCT00707876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24548154|NCT00707902|Lidocaine|lidocaine|mesh-list
24548160|NCT00707902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24548161|NCT00707902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24548162|NCT00707902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24548163|NCT00707902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24548164|NCT00707902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24548165|NCT00707902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548166|NCT00707902|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25705028|NCT02192970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25705029|NCT02192970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25705030|NCT02192970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25705031|NCT02192970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24863746|NCT03490058|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24863747|NCT03490058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24863749|NCT03490058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24863787|NCT03328845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24863788|NCT03328845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863790|NCT03305341|Sargramostim|sargramostim|mesh-list
25050568|NCT00486512|Vitamins|vitamins|mesh-ancestor
25050569|NCT00486512|Micronutrients|micronutrients|mesh-ancestor
25050570|NCT00486200|Valacyclovir|valacyclovir|mesh-list
25050571|NCT00486200|Antiviral Agents|antiviral agents|mesh-ancestor
25050572|NCT00486200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24548219|NCT00708344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24548220|NCT00708344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25705032|NCT02192970|Growth Substances|growth substances|mesh-ancestor
25705033|NCT02192970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705034|NCT02192970|Growth Inhibitors|growth inhibitors|mesh-ancestor
25705035|NCT02193165|Triclosan|triclosan|mesh-list
25705036|NCT02193165|Cetylpyridinium|cetylpyridinium|mesh-list
25705037|NCT02193165|Fluorides|fluorides|mesh-list
25705038|NCT02193165|Tin Fluorides|tin fluorides|mesh-list
25705039|NCT02193165|Cariostatic Agents|cariostatic agents|mesh-ancestor
25705040|NCT02193165|Protective Agents|protective agents|mesh-ancestor
25705041|NCT02193165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548249|NCT00708578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24548250|NCT00708578|Immunologic Factors|immunologic factors|mesh-ancestor
24548251|NCT00708591|Sirolimus|sirolimus|mesh-list
25050574|NCT00485563|Vitamin B Complex|vitamin b complex|mesh-list
25050575|NCT00485563|Interferons|interferons|mesh-list
25050576|NCT00485563|Interferon-alpha|interferon-alpha|mesh-list
25050577|NCT00485563|Interleukin-2|interleukin-2|mesh-list
25050578|NCT00485563|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
25050579|NCT00485563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25050580|NCT00485563|Antiviral Agents|antiviral agents|mesh-ancestor
25050581|NCT00485563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25050582|NCT00485563|Immunologic Factors|immunologic factors|mesh-ancestor
25050583|NCT00485563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548252|NCT00708591|Ketoconazole|ketoconazole|mesh-list
24548253|NCT00708591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24548293|NCT00708812|Carboplatin|carboplatin|mesh-list
24548294|NCT00708812|Endostar protein|endostar protein|mesh-list
24548295|NCT00708812|Endostatins|endostatins|mesh-list
24548296|NCT00708812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24548297|NCT00708812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24548298|NCT00708812|Tubulin Modulators|tubulin modulators|mesh-ancestor
24548299|NCT00708812|Antimitotic Agents|antimitotic agents|mesh-ancestor
24548300|NCT00708812|Mitosis Modulators|mitosis modulators|mesh-ancestor
24548301|NCT00708812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548302|NCT00708812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24449759|NCT00316927|Dexamethasone|dexamethasone|mesh-list
25705042|NCT02193165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25705043|NCT02193165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25705044|NCT02193165|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25705045|NCT02193165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25705046|NCT02193165|Antimetabolites|antimetabolites|mesh-ancestor
25705047|NCT02193165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705048|NCT02193165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25705049|NCT02193347|Temozolomide|temozolomide|mesh-list
24548307|NCT00708903|Moxifloxacin|moxifloxacin|mesh-list
24863939|NCT02837783|Enzyme Activators|enzyme activators|mesh-ancestor
24548308|NCT00708903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24548309|NCT00708903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24548310|NCT00708903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24548320|NCT00709046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24548321|NCT00709046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24548322|NCT00709046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548323|NCT00709046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548325|NCT00709137|Spironolactone|spironolactone|mesh-list
24548326|NCT00709137|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24548327|NCT00709137|Hormone Antagonists|hormone antagonists|mesh-ancestor
24548328|NCT00709137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25050593|NCT00484419|Rosiglitazone|rosiglitazone|mesh-list
25705050|NCT02193347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25705051|NCT02193347|Alkylating Agents|alkylating agents|mesh-ancestor
25705052|NCT02193347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447592|NCT00309192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24447593|NCT00309192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24548363|NCT00709215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548364|NCT00709215|Antifungal Agents|antifungal agents|mesh-ancestor
25050607|NCT00484419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25050608|NCT00483977|Oxycodone|oxycodone|mesh-list
25050609|NCT00483977|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25050610|NCT00483977|Narcotics|narcotics|mesh-ancestor
24548372|NCT00709254|Sensory System Agents|sensory system agents|mesh-ancestor
24548373|NCT00709254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24548379|NCT00709267|Hematinics|hematinics|mesh-ancestor
24548380|NCT00709267|Vitamin B Complex|vitamin b complex|mesh-ancestor
24548381|NCT00709267|Vitamins|vitamins|mesh-ancestor
24548382|NCT00709267|Micronutrients|micronutrients|mesh-ancestor
24548383|NCT00709267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548384|NCT00709293|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24548385|NCT00709293|Immunologic Factors|immunologic factors|mesh-ancestor
24548386|NCT00709293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548387|NCT00709293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25050612|NCT00483977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25050613|NCT00483977|Analgesics|analgesics|mesh-ancestor
25050614|NCT00483977|Sensory System Agents|sensory system agents|mesh-ancestor
25705053|NCT02193347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864266|NCT05112861|Growth Inhibitors|growth inhibitors|mesh-ancestor
25705055|NCT02193776|Rifampin|rifampin|mesh-list
25705056|NCT02193776|Isoniazid|isoniazid|mesh-list
24548424|NCT00709436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24548425|NCT00709436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548426|NCT00709449|Papaverine|papaverine|mesh-list
24548427|NCT00709449|Moxaverine|moxaverine|mesh-list
24548428|NCT00709449|Parasympatholytics|parasympatholytics|mesh-ancestor
24548429|NCT00709449|Autonomic Agents|autonomic agents|mesh-ancestor
24548430|NCT00709449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24548431|NCT00709449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548432|NCT00709449|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24548433|NCT00709449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548434|NCT00709449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548436|NCT00709449|Urological Agents|urological agents|mesh-ancestor
24548437|NCT00709475|Insulin Detemir|insulin detemir|mesh-list
24548438|NCT00709475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24548439|NCT00709475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548440|NCT00709488|Talaporfin|talaporfin|mesh-list
24548441|NCT00709488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24956154|NCT03856970|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24956155|NCT03856970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24956156|NCT03856970|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24956157|NCT03856970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548443|NCT00709488|Dermatologic Agents|dermatologic agents|mesh-ancestor
24548444|NCT00709553|Midazolam|midazolam|mesh-list
24548446|NCT00709553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25705057|NCT02193776|Pyrazinamide|pyrazinamide|mesh-list
25705058|NCT02193776|Ethambutol|ethambutol|mesh-list
25705059|NCT02193776|Bedaquiline|bedaquiline|mesh-list
25705060|NCT02193776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25705061|NCT02193776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25705062|NCT02193776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25705063|NCT02193776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25705064|NCT02193776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548448|NCT00709553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548449|NCT00709553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24548450|NCT00709553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24548451|NCT00709553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24548452|NCT00709553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24548453|NCT00709553|Anesthetics, General|anesthetics, general|mesh-ancestor
24956165|NCT03856658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24956166|NCT03856658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24781937|NCT01893060|Povidone|povidone|mesh-list
25050615|NCT00483977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25050616|NCT00482092|Remestemcel-l|remestemcel-l|mesh-list
24956167|NCT03856671|Metronidazole|metronidazole|mesh-list
24555695|NCT00742820|Calcium, Dietary|calcium, dietary|mesh-list
24555696|NCT00742820|Calcium|calcium|mesh-list
24555697|NCT00742820|Calcium acetate|calcium acetate|mesh-list
24555698|NCT00742820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24625666|NCT01082809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625668|NCT01082848|Antidepressive Agents|antidepressive agents|mesh-ancestor
24625669|NCT01082848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24625670|NCT01082848|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24625671|NCT01082848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24625672|NCT01082848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24625673|NCT01082848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625674|NCT01082848|Dopamine Agonists|dopamine agonists|mesh-ancestor
24449917|NCT00317408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25709654|NCT02271854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709655|NCT02271854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709656|NCT02271906|Afatinib|afatinib|mesh-list
25709657|NCT02271906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25709658|NCT02271906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25709659|NCT02271906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709660|NCT02271906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864869|NCT05148767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24548556|NCT00710216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24625676|NCT01082848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24548557|NCT00710216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548558|NCT00710216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548559|NCT00710216|Antiviral Agents|antiviral agents|mesh-ancestor
24548560|NCT00710216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24548561|NCT00710216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24548576|NCT00710268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24548577|NCT00710268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24548578|NCT00710268|Growth Substances|growth substances|mesh-ancestor
24548602|NCT00710437|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24548604|NCT00710437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24548605|NCT00710437|Adrenergic Agents|adrenergic agents|mesh-ancestor
24548606|NCT00710437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24548607|NCT00710437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548608|NCT00710528|Idelalisib|idelalisib|mesh-list
24548641|NCT00711074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24548647|NCT00711165|Dermatologic Agents|dermatologic agents|mesh-ancestor
24625677|NCT01082848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625678|NCT01082848|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24625679|NCT01082848|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24548648|NCT00711165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24548649|NCT00711178|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24548650|NCT00711178|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
24548686|NCT00711620|Thymalfasin|thymalfasin|mesh-list
24548687|NCT00711620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24548688|NCT00711620|Immunologic Factors|immunologic factors|mesh-ancestor
24548689|NCT00711620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548690|NCT00711698|Analgesics, Opioid|analgesics, opioid|mesh-list
25705065|NCT02193776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705066|NCT02193776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25705067|NCT02193776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25705068|NCT02193776|Antitubercular Agents|antitubercular agents|mesh-ancestor
25705069|NCT02193776|Leprostatic Agents|leprostatic agents|mesh-ancestor
25705070|NCT02193776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25705071|NCT02193776|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25705072|NCT02193776|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25705073|NCT02193776|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25705074|NCT02193776|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25705075|NCT02193776|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24865226|NCT04177654|Tubulin Modulators|tubulin modulators|mesh-ancestor
24865227|NCT04177654|Antimitotic Agents|antimitotic agents|mesh-ancestor
24865228|NCT04177654|Mitosis Modulators|mitosis modulators|mesh-ancestor
24447627|NCT00309218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447628|NCT00309257|Valsartan|valsartan|mesh-list
24447629|NCT00309257|Benazepril|benazepril|mesh-list
24447630|NCT00309257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24447631|NCT00309257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24447632|NCT00309257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24447633|NCT00309257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447634|NCT00309257|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24447635|NCT00309257|Protease Inhibitors|protease inhibitors|mesh-ancestor
24447636|NCT00309257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24447637|NCT00309270|Alemtuzumab|alemtuzumab|mesh-list
24447638|NCT00309270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24447639|NCT00309270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447640|NCT00309283|Somatostatin|somatostatin|mesh-list
24447641|NCT00309283|Hormones|hormones|mesh-ancestor
24447642|NCT00309283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24447643|NCT00309283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548691|NCT00711698|Narcotics|narcotics|mesh-ancestor
24548692|NCT00711698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24548693|NCT00711698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548694|NCT00711698|Analgesics|analgesics|mesh-ancestor
24548695|NCT00711698|Sensory System Agents|sensory system agents|mesh-ancestor
25105759|NCT05012865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105761|NCT04935476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25105762|NCT04935476|Antimalarials|antimalarials|mesh-ancestor
25105763|NCT04935476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25105764|NCT04935476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25105765|NCT04935476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25105766|NCT04935476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25105767|NCT04935476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105768|NCT04935476|Leprostatic Agents|leprostatic agents|mesh-ancestor
25105769|NCT04935476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25105770|NCT04930107|Fluconazole|fluconazole|mesh-list
24418431|NCT00209612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24418432|NCT00209612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24418441|NCT00209625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24418468|NCT00209664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418470|NCT00209677|Gemcitabine|gemcitabine|mesh-list
24418492|NCT00209690|Immunologic Factors|immunologic factors|mesh-ancestor
24418493|NCT00209690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418495|NCT00209703|Fluorouracil|fluorouracil|mesh-list
24418496|NCT00209703|Oxaliplatin|oxaliplatin|mesh-list
24418508|NCT00209703|Vitamins|vitamins|mesh-ancestor
24418517|NCT00209716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418518|NCT00209716|Antimetabolites|antimetabolites|mesh-ancestor
24418519|NCT00209716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24418520|NCT00209716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25705076|NCT02193776|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25705077|NCT02193776|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25705078|NCT02193776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24418521|NCT00209716|Immunologic Factors|immunologic factors|mesh-ancestor
24418522|NCT00209716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418524|NCT00209729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24418525|NCT00209729|Tubulin Modulators|tubulin modulators|mesh-ancestor
25705079|NCT02193776|Antimetabolites|antimetabolites|mesh-ancestor
25705080|NCT02193776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25705081|NCT02193815|Calcitriol|calcitriol|mesh-list
25705082|NCT02193815|Calcipotriene|calcipotriene|mesh-list
25705083|NCT02193815|Tofacitinib|tofacitinib|mesh-list
25705084|NCT02193815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25705085|NCT02193815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25705086|NCT02193815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705087|NCT02193815|Dermatologic Agents|dermatologic agents|mesh-ancestor
25709661|NCT02271984|Praziquantel|praziquantel|mesh-list
24418526|NCT00209729|Antimitotic Agents|antimitotic agents|mesh-ancestor
24418527|NCT00209729|Mitosis Modulators|mitosis modulators|mesh-ancestor
24418528|NCT00209729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105771|NCT04930107|Antifungal Agents|antifungal agents|mesh-ancestor
25105772|NCT04930107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25105773|NCT04930107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24795356|NCT02959697|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24795357|NCT02959697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24418608|NCT00209833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24418609|NCT00209833|Antiviral Agents|antiviral agents|mesh-ancestor
24418610|NCT00209833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24418611|NCT00209833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24418612|NCT00209846|Gaboxadol|gaboxadol|mesh-list
24418613|NCT00209846|Analgesics|analgesics|mesh-ancestor
24418614|NCT00209846|Sensory System Agents|sensory system agents|mesh-ancestor
24418615|NCT00209846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24418616|NCT00209846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418617|NCT00209846|Anticonvulsants|anticonvulsants|mesh-ancestor
24418618|NCT00209846|GABA Agonists|gaba agonists|mesh-ancestor
24418619|NCT00209846|GABA Agents|gaba agents|mesh-ancestor
24418620|NCT00209846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24418621|NCT00209846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418622|NCT00209859|Cyclosporine|cyclosporine|mesh-list
24418623|NCT00209859|Betamethasone|betamethasone|mesh-list
24418690|NCT00209885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24418693|NCT00209885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418694|NCT00209885|Analgesics|analgesics|mesh-ancestor
24418695|NCT00209885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24418696|NCT00209885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24418697|NCT00209885|Anesthetics, General|anesthetics, general|mesh-ancestor
24418698|NCT00209885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24418699|NCT00209885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24418700|NCT00209885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24418701|NCT00209885|Anticonvulsants|anticonvulsants|mesh-ancestor
24418702|NCT00209885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24418703|NCT00209885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24418704|NCT00209885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24418705|NCT00209885|Antimanic Agents|antimanic agents|mesh-ancestor
24418706|NCT00209885|Antidepressive Agents|antidepressive agents|mesh-ancestor
24418707|NCT00209885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24418708|NCT00209885|Antiemetics|antiemetics|mesh-ancestor
24418709|NCT00209885|Autonomic Agents|autonomic agents|mesh-ancestor
24418734|NCT00209937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418735|NCT00209950|Gaboxadol|gaboxadol|mesh-list
24418736|NCT00209950|Analgesics|analgesics|mesh-ancestor
24418737|NCT00209950|Sensory System Agents|sensory system agents|mesh-ancestor
24418738|NCT00209950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24418739|NCT00209950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418740|NCT00209950|Anticonvulsants|anticonvulsants|mesh-ancestor
24418741|NCT00209950|GABA Agonists|gaba agonists|mesh-ancestor
24418742|NCT00209950|GABA Agents|gaba agents|mesh-ancestor
24418743|NCT00209950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24418744|NCT00209950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418745|NCT00209963|Gaboxadol|gaboxadol|mesh-list
24865796|NCT04933058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865884|NCT04597372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418746|NCT00209963|Analgesics|analgesics|mesh-ancestor
24418747|NCT00209963|Sensory System Agents|sensory system agents|mesh-ancestor
24418748|NCT00209963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24418749|NCT00209963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418750|NCT00209963|Anticonvulsants|anticonvulsants|mesh-ancestor
24418751|NCT00209963|GABA Agonists|gaba agonists|mesh-ancestor
24418752|NCT00209963|GABA Agents|gaba agents|mesh-ancestor
24418753|NCT00209963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24418754|NCT00209963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418755|NCT00209989|Tipifarnib|tipifarnib|mesh-list
24978158|NCT05158491|Irinotecan|irinotecan|mesh-list
24978159|NCT05158491|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24978160|NCT05158491|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24978161|NCT05158491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978162|NCT05158491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978163|NCT05158491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978170|NCT05121714|Fluvoxamine|fluvoxamine|mesh-list
24978171|NCT05121714|Caffeine|caffeine|mesh-list
24978180|NCT05121714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24978181|NCT05121714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24978182|NCT05121714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24978183|NCT05121714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24978184|NCT05121714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24978185|NCT05121714|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24978186|NCT05121714|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24978187|NCT05121714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24978188|NCT05121714|Serotonin Agents|serotonin agents|mesh-ancestor
24418775|NCT00210041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418776|NCT00210041|Antiviral Agents|antiviral agents|mesh-ancestor
24418777|NCT00210041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24418778|NCT00210041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24418779|NCT00210041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24978191|NCT05121714|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24978192|NCT05121714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24978193|NCT05121714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24978194|NCT05117710|Ebselen|ebselen|mesh-list
24978195|NCT05117710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24978196|NCT05117710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24978197|NCT05117710|Analgesics|analgesics|mesh-ancestor
24978198|NCT05117710|Sensory System Agents|sensory system agents|mesh-ancestor
24978199|NCT05117710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24978200|NCT05117710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978201|NCT05117710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24978202|NCT05117710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24418787|NCT00210132|Sensory System Agents|sensory system agents|mesh-ancestor
24418788|NCT00210132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24418789|NCT00210158|Nitrous Oxide|nitrous oxide|mesh-list
24418790|NCT00210158|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24418791|NCT00210158|Anesthetics, General|anesthetics, general|mesh-ancestor
24418792|NCT00210158|Anesthetics|anesthetics|mesh-ancestor
25705088|NCT02193815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25705089|NCT02193815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705090|NCT02193815|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25705091|NCT02193815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24418793|NCT00210158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24418794|NCT00210158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418795|NCT00210158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24418796|NCT00210158|Analgesics|analgesics|mesh-ancestor
24418813|NCT00210301|Modafinil|modafinil|mesh-list
24418850|NCT00210366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24418851|NCT00210366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24418919|NCT00210548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418921|NCT00210548|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24418922|NCT00210548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24418923|NCT00210548|Serotonin Agents|serotonin agents|mesh-ancestor
24418924|NCT00210548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24463955|NCT00362869|Renal Agents|renal agents|mesh-ancestor
24418925|NCT00210548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418926|NCT00210548|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24418927|NCT00210548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24418928|NCT00210548|Dopamine Agents|dopamine agents|mesh-ancestor
24418929|NCT00210561|Acetaminophen|acetaminophen|mesh-list
24418930|NCT00210561|Tramadol|tramadol|mesh-list
24418931|NCT00210561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24418932|NCT00210561|Analgesics|analgesics|mesh-ancestor
24418933|NCT00210561|Sensory System Agents|sensory system agents|mesh-ancestor
24978217|NCT05035303|Adrenergic Agents|adrenergic agents|mesh-ancestor
24978218|NCT05035303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24978219|NCT05035303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978220|NCT05035303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978221|NCT05035303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24978222|NCT05035303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24978223|NCT05035303|Autonomic Agents|autonomic agents|mesh-ancestor
24419026|NCT00210847|Sensory System Agents|sensory system agents|mesh-ancestor
24419036|NCT00210860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419038|NCT00210873|Anticonvulsants|anticonvulsants|mesh-ancestor
24419039|NCT00210873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24419040|NCT00210873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419041|NCT00210886|Levofloxacin|levofloxacin|mesh-list
24419042|NCT00210886|Ofloxacin|ofloxacin|mesh-list
24419043|NCT00210886|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24419044|NCT00210886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25705092|NCT02193815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25705093|NCT02193815|Vitamins|vitamins|mesh-ancestor
25705094|NCT02193815|Micronutrients|micronutrients|mesh-ancestor
25705095|NCT02193815|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24419045|NCT00210886|Renal Agents|renal agents|mesh-ancestor
24419046|NCT00210886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25705096|NCT02193880|Cyclophosphamide|cyclophosphamide|mesh-list
24814325|NCT02064010|Calcium, Dietary|calcium, dietary|mesh-list
24814335|NCT02064023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814336|NCT02064036|Leuprolide|leuprolide|mesh-list
24814337|NCT02064036|Goserelin|goserelin|mesh-list
24866627|NCT05258474|Niacin|niacin|mesh-list
24419047|NCT00210886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24419048|NCT00210886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24419049|NCT00210886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419050|NCT00210886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419051|NCT00210886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419052|NCT00210886|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24419053|NCT00210886|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24419054|NCT00210899|Vancomycin|vancomycin|mesh-list
24978239|NCT05018481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978240|NCT05018481|Viscosupplements|viscosupplements|mesh-ancestor
24419063|NCT00210912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419065|NCT00210925|Anticonvulsants|anticonvulsants|mesh-ancestor
24419066|NCT00210925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24419067|NCT00210925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419068|NCT00210938|Doripenem|doripenem|mesh-list
24419069|NCT00210938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24419070|NCT00210938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24419071|NCT00210990|Doripenem|doripenem|mesh-list
24419072|NCT00210990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24419073|NCT00210990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24419074|NCT00211003|Doripenem|doripenem|mesh-list
24419075|NCT00211003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24419076|NCT00211003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24419133|NCT00211315|Growth Inhibitors|growth inhibitors|mesh-ancestor
24978248|NCT05011149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978249|NCT05011149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24978250|NCT05011149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24978251|NCT05011149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24419172|NCT00211380|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24419173|NCT00211380|Serotonin Agents|serotonin agents|mesh-ancestor
24419175|NCT00211380|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24419208|NCT00211419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24419209|NCT00211419|Growth Substances|growth substances|mesh-ancestor
24419210|NCT00211419|Growth Inhibitors|growth inhibitors|mesh-ancestor
24419211|NCT00211419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419212|NCT00211432|Anecortave|anecortave|mesh-list
24419213|NCT00211432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24978252|NCT05011149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978253|NCT05011149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978254|NCT04995978|Pioglitazone|pioglitazone|mesh-list
24978255|NCT04995978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24450080|NCT00317759|Immunologic Factors|immunologic factors|mesh-ancestor
24978288|NCT04939636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24978289|NCT04939636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24978290|NCT04929548|Maleic acid|maleic acid|mesh-list
24978291|NCT04929548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978292|NCT04929548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978293|NCT04921722|Sirolimus|sirolimus|mesh-list
24978294|NCT04921722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25705097|NCT02193880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25705098|NCT02193880|Immunologic Factors|immunologic factors|mesh-ancestor
25705099|NCT02193880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705100|NCT02193880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25705101|NCT02193880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25705102|NCT02193880|Alkylating Agents|alkylating agents|mesh-ancestor
24867035|NCT03739593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419270|NCT00211588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419271|NCT00211588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419272|NCT00211588|Cholinergic Agents|cholinergic agents|mesh-ancestor
24419273|NCT00211588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24419274|NCT00211588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419275|NCT00211588|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24419276|NCT00211588|Autonomic Agents|autonomic agents|mesh-ancestor
24419277|NCT00211588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24419278|NCT00211588|Nootropic Agents|nootropic agents|mesh-ancestor
24419279|NCT00211614|Lansoprazole|lansoprazole|mesh-list
24419280|NCT00211614|Dexlansoprazole|dexlansoprazole|mesh-list
24419281|NCT00211614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24978305|NCT04745845|Adrenergic Agents|adrenergic agents|mesh-ancestor
24978306|NCT04745845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24795360|NCT02953509|Rituximab|rituximab|mesh-list
24978316|NCT04740294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24978317|NCT04740294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978319|NCT04740294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24978320|NCT04740294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24978321|NCT04740294|Anticonvulsants|anticonvulsants|mesh-ancestor
24978322|NCT04740294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24419291|NCT00211653|Respiratory System Agents|respiratory system agents|mesh-ancestor
24419292|NCT00211653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24419293|NCT00211653|Antioxidants|antioxidants|mesh-ancestor
24419305|NCT00211679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24419348|NCT00211848|Antimetabolites|antimetabolites|mesh-ancestor
25705103|NCT02193880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705104|NCT02193880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25705105|NCT02193880|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25705106|NCT02194062|Fluticasone|fluticasone|mesh-list
25705107|NCT02194062|Xhance|xhance|mesh-list
25705108|NCT02194062|Budesonide|budesonide|mesh-list
25705109|NCT02194062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25705110|NCT02194062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25705111|NCT02194062|Autonomic Agents|autonomic agents|mesh-ancestor
25705112|NCT02194062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25709662|NCT02271984|Anthelmintics|anthelmintics|mesh-ancestor
24867243|NCT02553161|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24978339|NCT04728646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978340|NCT04708886|Alendronate|alendronate|mesh-list
24978341|NCT04708886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24978342|NCT04708886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795358|NCT02959697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795359|NCT02953509|Gemcitabine|gemcitabine|mesh-list
24795365|NCT02953509|Immunologic Factors|immunologic factors|mesh-ancestor
24795366|NCT02953509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795367|NCT02953509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24795368|NCT02953509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24978350|NCT04594408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24978351|NCT04594408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24978352|NCT04594408|Adrenergic Agents|adrenergic agents|mesh-ancestor
24419380|NCT00211978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24419382|NCT00211978|Chelating Agents|chelating agents|mesh-ancestor
24419383|NCT00211978|Sequestering Agents|sequestering agents|mesh-ancestor
24419384|NCT00211978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419385|NCT00212004|Pioglitazone|pioglitazone|mesh-list
24419386|NCT00212004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24419387|NCT00212004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419389|NCT00212017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24419390|NCT00212017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419391|NCT00212017|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24419392|NCT00212017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419393|NCT00212017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419394|NCT00212030|Nicorandil|nicorandil|mesh-list
24419395|NCT00212030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24419396|NCT00212030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24419397|NCT00212030|Vasodilator Agents|vasodilator agents|mesh-ancestor
24419453|NCT00212095|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24419456|NCT00212108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24419457|NCT00212108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24419524|NCT00212342|Contraceptive Agents|contraceptive agents|mesh-ancestor
24419525|NCT00212342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24419526|NCT00212342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419527|NCT00212342|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24419529|NCT00212342|Hormones|hormones|mesh-ancestor
24419530|NCT00212342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24978355|NCT04594408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978356|NCT04594408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24978357|NCT04594408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24978358|NCT04594408|Autonomic Agents|autonomic agents|mesh-ancestor
24978359|NCT04594408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24978360|NCT04594408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24978361|NCT04594408|Respiratory System Agents|respiratory system agents|mesh-ancestor
24978362|NCT04594408|Mydriatics|mydriatics|mesh-ancestor
24978363|NCT04594408|Sympathomimetics|sympathomimetics|mesh-ancestor
24419531|NCT00212342|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24419532|NCT00212472|Factor VIII|factor viii|mesh-list
24419533|NCT00212472|Coagulants|coagulants|mesh-ancestor
24419575|NCT00212654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24419576|NCT00212680|Landiolol|landiolol|mesh-list
24419577|NCT00212680|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24419578|NCT00212680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24419579|NCT00212680|Adrenergic Agents|adrenergic agents|mesh-ancestor
24419580|NCT00212680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24419582|NCT00212680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419584|NCT00212810|Topiramate|topiramate|mesh-list
24419613|NCT00213096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24419615|NCT00213096|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24419616|NCT00213096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24419617|NCT00213096|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24419618|NCT00213096|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25105781|NCT04930107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25105782|NCT04930107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25105787|NCT04873453|Cannabidiol|cannabidiol|mesh-list
25705113|NCT02194062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705114|NCT02194062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24867381|NCT00585195|Hormone Antagonists|hormone antagonists|mesh-ancestor
24867382|NCT00585195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24867383|NCT00585195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867384|NCT00585195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24610153|NCT01000116|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24610154|NCT01000116|Hemostatics|hemostatics|mesh-ancestor
24867385|NCT00585195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25105788|NCT04873453|Anticonvulsants|anticonvulsants|mesh-ancestor
24978397|NCT04555811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24978402|NCT04545424|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
24419677|NCT00213252|Respiratory System Agents|respiratory system agents|mesh-ancestor
24419678|NCT00213252|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24419689|NCT00213278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419690|NCT00213278|Tubulin Modulators|tubulin modulators|mesh-ancestor
24419691|NCT00213278|Antimitotic Agents|antimitotic agents|mesh-ancestor
24419692|NCT00213278|Mitosis Modulators|mitosis modulators|mesh-ancestor
24978405|NCT04545424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978409|NCT04529720|Vaccines|vaccines|mesh-list
24978410|NCT04529720|Immunologic Factors|immunologic factors|mesh-ancestor
24978411|NCT04529720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978412|NCT04522284|Capecitabine|capecitabine|mesh-list
24978413|NCT04522284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24419717|NCT00213538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419718|NCT00213538|Dermatologic Agents|dermatologic agents|mesh-ancestor
24419719|NCT00213538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419720|NCT00213538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24419721|NCT00213538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24419722|NCT00213538|Immunologic Factors|immunologic factors|mesh-ancestor
24419723|NCT00213538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24419724|NCT00213538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24419725|NCT00213551|Antioxidants|antioxidants|mesh-list
24978468|NCT04297605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978469|NCT04297605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24978470|NCT04297605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978471|NCT04297605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24978472|NCT04297605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24978473|NCT04274517|Chlorhexidine|chlorhexidine|mesh-list
24978474|NCT04274517|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24978475|NCT04274517|Povidone-Iodine|povidone-iodine|mesh-list
24978476|NCT04274517|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24978477|NCT04274517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24978478|NCT04274517|Disinfectants|disinfectants|mesh-ancestor
25705115|NCT02194062|Respiratory System Agents|respiratory system agents|mesh-ancestor
25705116|NCT02194062|Dermatologic Agents|dermatologic agents|mesh-ancestor
25705117|NCT02194062|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25705118|NCT02194062|Glucocorticoids|glucocorticoids|mesh-ancestor
25705119|NCT02194062|Hormones|hormones|mesh-ancestor
25705120|NCT02194062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25705121|NCT02194088|Diclofenac|diclofenac|mesh-list
25705122|NCT02194088|Atropine|atropine|mesh-list
25705123|NCT02194088|Analgesics|analgesics|mesh-list
24978479|NCT04274517|Dermatologic Agents|dermatologic agents|mesh-ancestor
24978480|NCT04222426|Atezolizumab|atezolizumab|mesh-list
24978481|NCT04222426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978482|NCT04195204|Tropisetron|tropisetron|mesh-list
24978483|NCT04195204|Antiemetics|antiemetics|mesh-ancestor
24795384|NCT02877550|Venetoclax|venetoclax|mesh-list
24419759|NCT00213590|Immunologic Factors|immunologic factors|mesh-ancestor
24419760|NCT00213590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419761|NCT00213590|Antifungal Agents|antifungal agents|mesh-ancestor
24419762|NCT00213590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24419768|NCT00213694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795401|NCT02807454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24978486|NCT04195204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978487|NCT04195204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24978488|NCT04195204|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24978489|NCT04195204|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24978490|NCT04195204|Serotonin Agents|serotonin agents|mesh-ancestor
24978491|NCT04195204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24978492|NCT04195204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978493|NCT04183101|Enalapril|enalapril|mesh-list
24978494|NCT04183101|Enalaprilat|enalaprilat|mesh-list
24978532|NCT04078568|Glucocorticoids|glucocorticoids|mesh-ancestor
24419769|NCT00213694|Tubulin Modulators|tubulin modulators|mesh-ancestor
24419770|NCT00213694|Antimitotic Agents|antimitotic agents|mesh-ancestor
24419771|NCT00213694|Mitosis Modulators|mitosis modulators|mesh-ancestor
24419772|NCT00213694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419773|NCT00213694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24419774|NCT00213694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24419787|NCT00213759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419788|NCT00214032|Pycnogenols|pycnogenols|mesh-list
24419804|NCT00214084|Antimetabolites|antimetabolites|mesh-ancestor
24419805|NCT00214084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419806|NCT00214084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419807|NCT00214084|Gout Suppressants|gout suppressants|mesh-ancestor
24419808|NCT00214084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24419809|NCT00214084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24419810|NCT00214084|Antioxidants|antioxidants|mesh-ancestor
24978552|NCT03948035|Antiemetics|antiemetics|mesh-ancestor
24978564|NCT03948035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24978565|NCT03948035|Growth Substances|growth substances|mesh-ancestor
24978566|NCT03948035|Growth Inhibitors|growth inhibitors|mesh-ancestor
24978575|NCT03861078|Nicotine|nicotine|mesh-list
24978576|NCT03861078|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24978577|NCT03861078|Autonomic Agents|autonomic agents|mesh-ancestor
24419900|NCT00214370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419901|NCT00214370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24419902|NCT00214370|Anesthetics, General|anesthetics, general|mesh-ancestor
24419903|NCT00214370|Anesthetics|anesthetics|mesh-ancestor
24419904|NCT00214370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24419905|NCT00214370|Narcotics|narcotics|mesh-ancestor
24419906|NCT00214370|Analgesics|analgesics|mesh-ancestor
24419907|NCT00214370|Sensory System Agents|sensory system agents|mesh-ancestor
24419908|NCT00214370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24419909|NCT00214370|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24419910|NCT00214435|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24978591|NCT03849443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24978592|NCT03849443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978597|NCT03810417|Digoxin|digoxin|mesh-list
24978598|NCT03810417|Antibodies|antibodies|mesh-list
24978599|NCT03810417|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
24978600|NCT03810417|Immunologic Factors|immunologic factors|mesh-ancestor
24783712|NCT01903421|Sensory System Agents|sensory system agents|mesh-ancestor
24783713|NCT01903421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25705124|NCT02194088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25705125|NCT02194088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25705126|NCT02194088|Sensory System Agents|sensory system agents|mesh-ancestor
24446499|NCT00304980|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24446500|NCT00304980|Antimalarials|antimalarials|mesh-ancestor
24446501|NCT00304980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24446502|NCT00304980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24450212|NCT00317993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24783715|NCT01903421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24783716|NCT01903421|Anesthetics, General|anesthetics, general|mesh-ancestor
24419964|NCT00214682|Vitamin B 12|vitamin b 12|mesh-list
24419965|NCT00214682|Hydroxocobalamin|hydroxocobalamin|mesh-list
24419967|NCT00214682|Micronutrients|micronutrients|mesh-ancestor
24419968|NCT00214682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419969|NCT00214682|Vitamin B Complex|vitamin b complex|mesh-ancestor
24419970|NCT00214682|Hematinics|hematinics|mesh-ancestor
24419971|NCT00214695|Dialysis Solutions|dialysis solutions|mesh-list
24419972|NCT00214695|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24419973|NCT00214721|Dialysis Solutions|dialysis solutions|mesh-list
25105807|NCT04860635|Celecoxib|celecoxib|mesh-list
25105808|NCT04860635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25105809|NCT04860635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25105810|NCT04860635|Analgesics|analgesics|mesh-ancestor
25105811|NCT04860635|Sensory System Agents|sensory system agents|mesh-ancestor
25105812|NCT04860635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25105813|NCT04860635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105836|NCT04850495|Antibodies|antibodies|mesh-list
24978601|NCT03810417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978602|NCT03810417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24978604|NCT03810417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978605|NCT03810417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978606|NCT03810417|Protective Agents|protective agents|mesh-ancestor
24978612|NCT03689582|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
24978613|NCT03689582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24978614|NCT03689582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978618|NCT03557749|Dimercaprol|dimercaprol|mesh-list
24419976|NCT00214825|Eplerenone|eplerenone|mesh-list
24978627|NCT03511599|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24978628|NCT03511599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24978629|NCT03511599|Renal Agents|renal agents|mesh-ancestor
24978630|NCT03511599|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24978631|NCT03511599|Antitubercular Agents|antitubercular agents|mesh-ancestor
24978632|NCT03511599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24978633|NCT03511599|Antimetabolites|antimetabolites|mesh-ancestor
24978634|NCT03511599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978635|NCT03441282|Fentanyl|fentanyl|mesh-list
24978636|NCT03441282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25705127|NCT02194088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25705128|NCT02194088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705129|NCT02194088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25705130|NCT02194088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25705131|NCT02194088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25705132|NCT02194088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25705133|NCT02194088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867995|NCT04454905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868009|NCT04285684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868010|NCT04144023|Molgramostim|molgramostim|mesh-list
24868012|NCT04144023|Sargramostim|sargramostim|mesh-list
24420099|NCT00215176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24420100|NCT00215176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420101|NCT00215202|Gefitinib|gefitinib|mesh-list
24420102|NCT00215202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420103|NCT00215202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24420104|NCT00215202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420105|NCT00215202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420106|NCT00215228|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24420107|NCT00215228|Citalopram|citalopram|mesh-list
24420108|NCT00215228|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24420109|NCT00215228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24420110|NCT00215228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24420113|NCT00215228|Serotonin Agents|serotonin agents|mesh-ancestor
24978686|NCT03399175|Immunosuppressive Agents|immunosuppressive agents|mesh-list
24978687|NCT03399175|Immunologic Factors|immunologic factors|mesh-ancestor
24978688|NCT03399175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978690|NCT03223883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24978691|NCT03223883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24978692|NCT03223883|Analgesics|analgesics|mesh-ancestor
24978693|NCT03223883|Sensory System Agents|sensory system agents|mesh-ancestor
24978694|NCT03223883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24978695|NCT03223883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978696|NCT03223883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24420241|NCT00215410|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24420242|NCT00215410|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24420254|NCT00215423|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24420255|NCT00215423|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24978697|NCT03223883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24978698|NCT03223883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978699|NCT03223883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978700|NCT03223883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978701|NCT03153514|Obinutuzumab|obinutuzumab|mesh-list
24978702|NCT03153514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24978703|NCT03153514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978704|NCT03125642|Cytarabine|cytarabine|mesh-list
24978705|NCT03125642|Cyclophosphamide|cyclophosphamide|mesh-list
24978706|NCT03125642|Melphalan|melphalan|mesh-list
24978707|NCT03125642|Carmustine|carmustine|mesh-list
24978708|NCT03125642|Etoposide|etoposide|mesh-list
24420312|NCT00215514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24420313|NCT00215514|Immunologic Factors|immunologic factors|mesh-ancestor
24420319|NCT00215579|Risperidone|risperidone|mesh-list
24420336|NCT00215592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24420337|NCT00215592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420338|NCT00215631|Tadalafil|tadalafil|mesh-list
24420339|NCT00215631|Vasodilator Agents|vasodilator agents|mesh-ancestor
24420340|NCT00215631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24978710|NCT03125642|Immunologic Factors|immunologic factors|mesh-ancestor
24978711|NCT03125642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978712|NCT03125642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24978713|NCT03125642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24978714|NCT03125642|Alkylating Agents|alkylating agents|mesh-ancestor
24978716|NCT03125642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25705134|NCT02194088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25705135|NCT02194088|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25705136|NCT02194088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24420599|NCT00216411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420600|NCT00216411|Cholinergic Agents|cholinergic agents|mesh-ancestor
24420618|NCT00216450|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24795433|NCT02758847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978740|NCT03007030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24978741|NCT03007030|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24978742|NCT03007030|Antibodies|antibodies|mesh-list
24978743|NCT03007030|Immunoglobulins|immunoglobulins|mesh-list
24978744|NCT03007030|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24978745|NCT03007030|Immunoconjugates|immunoconjugates|mesh-list
24978746|NCT03007030|Immunologic Factors|immunologic factors|mesh-ancestor
24978747|NCT03007030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978748|NCT03007030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978750|NCT02995252|Liver Extracts|liver extracts|mesh-list
24978751|NCT02995252|Antiviral Agents|antiviral agents|mesh-ancestor
24978752|NCT02995252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24978753|NCT02995252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24978755|NCT02995252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420670|NCT00216554|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24420671|NCT00216554|Serotonin Agents|serotonin agents|mesh-ancestor
24420672|NCT00216554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24420684|NCT00216567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420686|NCT00216580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24420687|NCT00216580|Serotonin Agents|serotonin agents|mesh-ancestor
24420688|NCT00216580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24420689|NCT00216580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420690|NCT00216580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705142|NCT02194088|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25705143|NCT02194088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25705144|NCT02194088|Cholinergic Agents|cholinergic agents|mesh-ancestor
25705145|NCT02194088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25705146|NCT02194465|Spironolactone|spironolactone|mesh-list
24814562|NCT02065466|Temozolomide|temozolomide|mesh-list
24814563|NCT02065466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24548511|NCT00709982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548512|NCT00709982|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24814564|NCT02065466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24814565|NCT02065466|Tubulin Modulators|tubulin modulators|mesh-ancestor
24814566|NCT02065466|Antimitotic Agents|antimitotic agents|mesh-ancestor
24548571|NCT00710229|Growth Inhibitors|growth inhibitors|mesh-ancestor
24420691|NCT00216580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24420728|NCT00216658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24420729|NCT00216658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420730|NCT00216658|Analgesics|analgesics|mesh-ancestor
24978790|NCT02903381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24978791|NCT02903381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24420744|NCT00216684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24420745|NCT00216684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24420746|NCT00216684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24420747|NCT00216684|Anesthetics, General|anesthetics, general|mesh-ancestor
24420748|NCT00216684|Anesthetics|anesthetics|mesh-ancestor
24420749|NCT00216697|Bortezomib|bortezomib|mesh-list
24420750|NCT00216697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420751|NCT00216723|Aripiprazole|aripiprazole|mesh-list
24420752|NCT00216723|Antidepressive Agents|antidepressive agents|mesh-ancestor
24420753|NCT00216723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24420766|NCT00216723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24420767|NCT00216723|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24420768|NCT00216723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24420769|NCT00216762|Rituximab|rituximab|mesh-list
24420770|NCT00216762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24421137|NCT00217815|Docetaxel|docetaxel|mesh-list
24420771|NCT00216762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420772|NCT00216762|Immunologic Factors|immunologic factors|mesh-ancestor
24420773|NCT00216762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420774|NCT00216762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24420775|NCT00216775|Interferons|interferons|mesh-list
24465021|NCT00367562|Valsartan|valsartan|mesh-list
24420776|NCT00216775|Ribavirin|ribavirin|mesh-list
24420777|NCT00216775|Interferon-alpha|interferon-alpha|mesh-list
24420778|NCT00216775|Interferon alpha-2|interferon alpha-2|mesh-list
24420779|NCT00216775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420780|NCT00216775|Antiviral Agents|antiviral agents|mesh-ancestor
24978793|NCT02903381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24978794|NCT02903381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24978795|NCT02903381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978796|NCT02903381|Immunologic Factors|immunologic factors|mesh-ancestor
24978797|NCT02903381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24978798|NCT02903381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24420956|NCT00217386|Etanercept|etanercept|mesh-list
24420957|NCT00217386|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24420958|NCT00217386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24420959|NCT00217386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24420960|NCT00217386|Analgesics|analgesics|mesh-ancestor
24420961|NCT00217386|Sensory System Agents|sensory system agents|mesh-ancestor
24420962|NCT00217386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24420963|NCT00217386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420964|NCT00217386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25705147|NCT02194465|Tadalafil|tadalafil|mesh-list
25705148|NCT02194465|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
25705149|NCT02194465|Mineralocorticoids|mineralocorticoids|mesh-list
25705150|NCT02194465|Vasodilator Agents|vasodilator agents|mesh-ancestor
25705151|NCT02194465|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25705152|NCT02194465|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25705153|NCT02194465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709663|NCT02271984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24420965|NCT00217386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24420966|NCT00217386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24420967|NCT00217386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24978812|NCT02774265|Dalteparin|dalteparin|mesh-list
24795434|NCT02734537|Cisplatin|cisplatin|mesh-list
24421135|NCT00217789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421138|NCT00217815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421139|NCT00217815|Tubulin Modulators|tubulin modulators|mesh-ancestor
24421140|NCT00217815|Antimitotic Agents|antimitotic agents|mesh-ancestor
24421184|NCT00218075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421186|NCT00218101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24421187|NCT00218101|Narcotics|narcotics|mesh-ancestor
24421189|NCT00218101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978819|NCT02774265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24978820|NCT02774265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24978821|NCT02774265|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24978822|NCT02774265|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24978823|NCT02774265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421252|NCT00218205|Epirubicin|epirubicin|mesh-list
24421253|NCT00218205|Estramustine|estramustine|mesh-list
24421254|NCT00218205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24421255|NCT00218205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24421256|NCT00218205|Analgesics|analgesics|mesh-ancestor
24421273|NCT00218218|Nicotine|nicotine|mesh-list
24421276|NCT00218218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24421277|NCT00218218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421279|NCT00218218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24421280|NCT00218218|Cholinergic Agents|cholinergic agents|mesh-ancestor
24421281|NCT00218218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24421282|NCT00218218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421284|NCT00218231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24421285|NCT00218231|Antidepressive Agents|antidepressive agents|mesh-ancestor
24421286|NCT00218231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24421287|NCT00218231|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24421288|NCT00218231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24421289|NCT00218231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24421290|NCT00218231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421330|NCT00218322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24421331|NCT00218322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421332|NCT00218322|Adrenergic Agents|adrenergic agents|mesh-ancestor
24802599|NCT01991158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24802600|NCT01991158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421335|NCT00218348|Amphetamine|amphetamine|mesh-list
24978832|NCT02695992|Metoprolol|metoprolol|mesh-list
24978833|NCT02695992|Diltiazem|diltiazem|mesh-list
24978838|NCT02695992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24978839|NCT02695992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978840|NCT02695992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24978841|NCT02695992|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24978842|NCT02695992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24421355|NCT00218361|Analgesics|analgesics|mesh-ancestor
24978858|NCT02652468|Fludarabine phosphate|fludarabine phosphate|mesh-list
24978859|NCT02652468|Tacrolimus|tacrolimus|mesh-list
24978860|NCT02652468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24978861|NCT02652468|Immunologic Factors|immunologic factors|mesh-ancestor
24978862|NCT02652468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978863|NCT02652468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24421426|NCT00218621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24421427|NCT00218621|Narcotics|narcotics|mesh-ancestor
24421457|NCT00219219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24421458|NCT00219219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421459|NCT00219232|Rivastigmine|rivastigmine|mesh-list
25705154|NCT02194465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705155|NCT02194465|Urological Agents|urological agents|mesh-ancestor
25705156|NCT02194465|Hormone Antagonists|hormone antagonists|mesh-ancestor
24422818|NCT00223691|Oxytocics|oxytocics|mesh-ancestor
24421505|NCT00219388|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24421595|NCT00219739|Imatinib Mesylate|imatinib mesylate|mesh-list
24421596|NCT00219739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421597|NCT00219739|Antiviral Agents|antiviral agents|mesh-ancestor
24421806|NCT00220233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24421807|NCT00220233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24421884|NCT00220480|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24421885|NCT00220480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24421889|NCT00220480|Serotonin Agents|serotonin agents|mesh-ancestor
24421984|NCT00220844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24421985|NCT00220844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24421986|NCT00220844|Analgesics|analgesics|mesh-ancestor
24421987|NCT00220844|Sensory System Agents|sensory system agents|mesh-ancestor
24421988|NCT00220844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24421989|NCT00220844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421990|NCT00220844|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24421991|NCT00220844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24422019|NCT00220922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24422101|NCT00221416|Dopamine Agonists|dopamine agonists|mesh-ancestor
24978910|NCT02448095|Ponatinib|ponatinib|mesh-list
24978911|NCT02448095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978912|NCT02448095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24978913|NCT02448095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978914|NCT02448095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978915|NCT02398825|Ponatinib|ponatinib|mesh-list
24978916|NCT02398825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978917|NCT02398825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24978918|NCT02398825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978920|NCT02393248|Gemcitabine|gemcitabine|mesh-list
24978925|NCT02393248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24978926|NCT02393248|Antimetabolites|antimetabolites|mesh-ancestor
24978927|NCT02393248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978928|NCT02393248|Antiviral Agents|antiviral agents|mesh-ancestor
24783773|NCT01903824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24783774|NCT01903824|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24783775|NCT01903824|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24783776|NCT01903824|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24783777|NCT01904045|Tacrolimus|tacrolimus|mesh-list
24422192|NCT00221598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24422193|NCT00221611|Baclofen|baclofen|mesh-list
24422203|NCT00221624|Ribavirin|ribavirin|mesh-list
24783779|NCT01904045|Immunologic Factors|immunologic factors|mesh-ancestor
25105851|NCT04850495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25105852|NCT04850495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25105853|NCT04850495|Glucocorticoids|glucocorticoids|mesh-ancestor
25105854|NCT04850495|Hormones|hormones|mesh-ancestor
25105855|NCT04850495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25105856|NCT04850495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24422249|NCT00221754|Pravastatin|pravastatin|mesh-list
25705157|NCT02194465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25705158|NCT02194465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705159|NCT02194465|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25705160|NCT02194465|Diuretics|diuretics|mesh-ancestor
25705161|NCT02194465|Natriuretic Agents|natriuretic agents|mesh-ancestor
25705162|NCT02194465|Hormones|hormones|mesh-ancestor
25705163|NCT02194933|Brexpiprazole|brexpiprazole|mesh-list
25705164|NCT02194933|Serotonin Agents|serotonin agents|mesh-ancestor
24422254|NCT00221754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24422256|NCT00221754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422258|NCT00221845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24422259|NCT00221845|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24422260|NCT00221845|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25105859|NCT04850495|Antimitotic Agents|antimitotic agents|mesh-ancestor
24422384|NCT00222261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422385|NCT00222261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24422386|NCT00222261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24422387|NCT00222261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422388|NCT00222261|Antipyretics|antipyretics|mesh-ancestor
24422389|NCT00222261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24422390|NCT00222261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24422391|NCT00222261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24422392|NCT00222261|Purinergic Agents|purinergic agents|mesh-ancestor
24422393|NCT00222261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24422395|NCT00222443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24422400|NCT00222469|Gemcitabine|gemcitabine|mesh-list
24422444|NCT00222495|Autonomic Agents|autonomic agents|mesh-ancestor
24422445|NCT00222495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24422446|NCT00222495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25105897|NCT04771923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25105898|NCT04771923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105899|NCT04771923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25105905|NCT04771923|Mydriatics|mydriatics|mesh-ancestor
25105917|NCT04754230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105919|NCT04754230|Coagulants|coagulants|mesh-ancestor
24978929|NCT02393248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24978930|NCT02393248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978931|NCT02393248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24978932|NCT02393248|Immunologic Factors|immunologic factors|mesh-ancestor
24978933|NCT02393248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978934|NCT02393248|Tubulin Modulators|tubulin modulators|mesh-ancestor
24978935|NCT02393248|Antimitotic Agents|antimitotic agents|mesh-ancestor
24978936|NCT02393248|Mitosis Modulators|mitosis modulators|mesh-ancestor
24978937|NCT02393248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24422530|NCT00222820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24422559|NCT00222872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24422561|NCT00222976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24422562|NCT00222976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24422573|NCT00223002|Chlorhexidine|chlorhexidine|mesh-list
24422574|NCT00223002|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24422575|NCT00223002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24422576|NCT00223002|Disinfectants|disinfectants|mesh-ancestor
24795452|NCT02581943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24795453|NCT02581943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24795454|NCT02581943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978947|NCT02307656|Cobicistat|cobicistat|mesh-list
24978948|NCT02307656|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24978949|NCT02307656|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24978950|NCT02307656|Protease Inhibitors|protease inhibitors|mesh-ancestor
24978951|NCT02307656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24814639|NCT02065947|Atracurium|atracurium|mesh-list
24978952|NCT02307656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978953|NCT02307656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24422658|NCT00223418|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24422659|NCT00223418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24422660|NCT00223418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422661|NCT00223418|Dopamine Agonists|dopamine agonists|mesh-ancestor
24422662|NCT00223418|Dopamine Agents|dopamine agents|mesh-ancestor
24422663|NCT00223418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24422664|NCT00223418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422665|NCT00223418|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24422667|NCT00223418|Serotonin Agents|serotonin agents|mesh-ancestor
24422737|NCT00223691|Sensory System Agents|sensory system agents|mesh-ancestor
24978966|NCT02216838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24978967|NCT02216838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978968|NCT02216838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24978969|NCT02216838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24978971|NCT02031250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24978972|NCT02015351|Bevacizumab|bevacizumab|mesh-list
24978973|NCT02015351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24422809|NCT00223691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24422810|NCT00223691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24422811|NCT00223691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24422812|NCT00223691|Urological Agents|urological agents|mesh-ancestor
24422813|NCT00223691|Antidepressive Agents|antidepressive agents|mesh-ancestor
24422814|NCT00223691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24422815|NCT00223691|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24422816|NCT00223691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24422864|NCT00223717|Urological Agents|urological agents|mesh-ancestor
24422945|NCT00224146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24422946|NCT00224146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422947|NCT00224146|Urological Agents|urological agents|mesh-ancestor
24422976|NCT00224315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24422977|NCT00224315|Dopamine Agents|dopamine agents|mesh-ancestor
24422978|NCT00224354|Interleukin-2|interleukin-2|mesh-list
24422979|NCT00224354|Denileukin diftitox|denileukin diftitox|mesh-list
24422980|NCT00224354|Immunotoxins|immunotoxins|mesh-list
24422981|NCT00224354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24422982|NCT00224354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24422983|NCT00224354|Analgesics|analgesics|mesh-ancestor
24422984|NCT00224354|Sensory System Agents|sensory system agents|mesh-ancestor
24422987|NCT00224354|Immunologic Factors|immunologic factors|mesh-ancestor
24423019|NCT00224445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24423024|NCT00224445|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24423025|NCT00224445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24423026|NCT00224458|Efavirenz|efavirenz|mesh-list
24423110|NCT00224692|Ketamine|ketamine|mesh-list
24423111|NCT00224692|Analgesics|analgesics|mesh-ancestor
24423112|NCT00224692|Sensory System Agents|sensory system agents|mesh-ancestor
24979038|NCT01761890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24979040|NCT01761890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979041|NCT01688076|Botulinum Toxins|botulinum toxins|mesh-list
24979042|NCT01688076|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24423186|NCT00225043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24824554|NCT02124070|Hormones|hormones|mesh-list
24423231|NCT00225173|Etoposide phosphate|etoposide phosphate|mesh-list
24423232|NCT00225173|Vincristine|vincristine|mesh-list
24423233|NCT00225173|Vinorelbine|vinorelbine|mesh-list
24423234|NCT00225173|Bleomycin|bleomycin|mesh-list
24423235|NCT00225173|Vinblastine|vinblastine|mesh-list
24423236|NCT00225173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24423237|NCT00225173|Immunologic Factors|immunologic factors|mesh-ancestor
24423238|NCT00225173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423239|NCT00225173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24423240|NCT00225173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24423241|NCT00225173|Alkylating Agents|alkylating agents|mesh-ancestor
24423335|NCT00225511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24423336|NCT00225511|Analgesics|analgesics|mesh-ancestor
24423337|NCT00225511|Sensory System Agents|sensory system agents|mesh-ancestor
24450413|NCT00318994|Meropenem|meropenem|mesh-list
24450414|NCT00318994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24450415|NCT00318994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24423338|NCT00225511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24423350|NCT00225589|Calcium|calcium|mesh-list
24423614|NCT00226434|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24423617|NCT00226447|Interferons|interferons|mesh-list
24423619|NCT00226447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24423620|NCT00226447|Antiviral Agents|antiviral agents|mesh-ancestor
24423624|NCT00226447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423648|NCT00226538|Sensory System Agents|sensory system agents|mesh-ancestor
24423649|NCT00226538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24423650|NCT00226538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423651|NCT00226538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24423652|NCT00226538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24465303|NCT00368862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24465304|NCT00368862|Serotonin Agents|serotonin agents|mesh-ancestor
24423653|NCT00226538|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24423654|NCT00226538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423656|NCT00226538|Antifungal Agents|antifungal agents|mesh-ancestor
24423803|NCT00226902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423804|NCT00226902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24423805|NCT00226902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24423806|NCT00226915|Paclitaxel|paclitaxel|mesh-list
24423807|NCT00226915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24423808|NCT00226915|Carboplatin|carboplatin|mesh-list
24979144|NCT05181033|Letrozole|letrozole|mesh-list
24979152|NCT05181033|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24979153|NCT05181033|Hormone Antagonists|hormone antagonists|mesh-ancestor
24979154|NCT05181033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24979155|NCT05181033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979156|NCT05181033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24979157|NCT05181033|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24979158|NCT05181033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24979159|NCT05180799|Nivolumab|nivolumab|mesh-list
24979160|NCT05180799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24979161|NCT05180799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979162|NCT05180799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24979163|NCT05180799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979164|NCT05180461|Ivermectin|ivermectin|mesh-list
24979165|NCT05180461|Emodepside|emodepside|mesh-list
24979166|NCT05180461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24423818|NCT00226967|Octreotide|octreotide|mesh-list
24423819|NCT00226967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24423820|NCT00226967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24423821|NCT00226967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24423822|NCT00226980|Thalidomide|thalidomide|mesh-list
24423823|NCT00226980|Capecitabine|capecitabine|mesh-list
24423825|NCT00226980|Antimetabolites|antimetabolites|mesh-ancestor
24979206|NCT05140694|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24979207|NCT05140694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979209|NCT05140694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979210|NCT05140694|Immunologic Factors|immunologic factors|mesh-ancestor
24979211|NCT05135312|Etanercept|etanercept|mesh-list
24979212|NCT05135312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24979213|NCT05135312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24869379|NCT04234477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869396|NCT04156698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24869397|NCT04156698|Tubulin Modulators|tubulin modulators|mesh-ancestor
24869398|NCT04156698|Antimitotic Agents|antimitotic agents|mesh-ancestor
24869399|NCT04156698|Mitosis Modulators|mitosis modulators|mesh-ancestor
24979214|NCT05135312|Analgesics|analgesics|mesh-ancestor
24424046|NCT00227734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24424047|NCT00227734|Antimetabolites|antimetabolites|mesh-ancestor
24621212|NCT01060969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621213|NCT01061060|Epoprostenol|epoprostenol|mesh-list
24621214|NCT01061060|Beraprost|beraprost|mesh-list
24621215|NCT01061060|Tezosentan|tezosentan|mesh-list
24621219|NCT01061112|Tolbutamide|tolbutamide|mesh-list
24424048|NCT00227734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424049|NCT00227734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424050|NCT00227734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24424056|NCT00227747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424057|NCT00227773|Octreotide|octreotide|mesh-list
24424058|NCT00227773|Hormones|hormones|mesh-list
24424059|NCT00227773|Somatostatin|somatostatin|mesh-list
24424121|NCT00227981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24424123|NCT00228007|Antidepressive Agents|antidepressive agents|mesh-list
24424124|NCT00228007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24424125|NCT00228020|Cyclosporine|cyclosporine|mesh-list
24424126|NCT00228020|Mycophenolic Acid|mycophenolic acid|mesh-list
24424127|NCT00228020|Prednisone|prednisone|mesh-list
24424128|NCT00228020|Cyclosporins|cyclosporins|mesh-list
24424129|NCT00228020|Basiliximab|basiliximab|mesh-list
25105965|NCT04718025|Analgesics|analgesics|mesh-ancestor
25105966|NCT04718025|Sensory System Agents|sensory system agents|mesh-ancestor
25105967|NCT04718025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25105968|NCT04718025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105969|NCT04718025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24424130|NCT00228020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24802715|NCT01991873|Antidotes|antidotes|mesh-ancestor
24424131|NCT00228020|Glucocorticoids|glucocorticoids|mesh-ancestor
24424153|NCT00228033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424154|NCT00228033|Antacids|antacids|mesh-ancestor
24424155|NCT00228033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424245|NCT00228410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24424246|NCT00228410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24424247|NCT00228410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24424248|NCT00228410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424249|NCT00228462|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24424250|NCT00228462|Antidepressive Agents|antidepressive agents|mesh-ancestor
24979265|NCT04938024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979266|NCT04938024|Protective Agents|protective agents|mesh-ancestor
24424419|NCT00229333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25705165|NCT02194933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25705166|NCT02194933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705167|NCT02194933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705168|NCT02194933|Dopamine Agonists|dopamine agonists|mesh-ancestor
25705169|NCT02194933|Dopamine Agents|dopamine agents|mesh-ancestor
25705170|NCT02194998|Ritonavir|ritonavir|mesh-list
25705171|NCT02194998|Ribavirin|ribavirin|mesh-list
24814687|NCT02065986|Emtricitabine|emtricitabine|mesh-list
24814688|NCT02065986|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24424420|NCT00229333|Serotonin Agents|serotonin agents|mesh-ancestor
24424421|NCT00229333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424422|NCT00229333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24424423|NCT00229333|Antidepressive Agents|antidepressive agents|mesh-ancestor
24424424|NCT00229333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24424425|NCT00229385|Ziprasidone|ziprasidone|mesh-list
24424426|NCT00229385|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24424427|NCT00229385|Serotonin Agents|serotonin agents|mesh-ancestor
24424428|NCT00229385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24424429|NCT00229385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424430|NCT00229385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424484|NCT00229528|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24424485|NCT00229528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24424486|NCT00229528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24424487|NCT00229528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424488|NCT00229528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24424533|NCT00229645|Antidepressive Agents|antidepressive agents|mesh-ancestor
24424534|NCT00229645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24424535|NCT00229645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24424536|NCT00229645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24424537|NCT00229645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24424554|NCT00229697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24424555|NCT00229697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424556|NCT00229775|Chloroquine|chloroquine|mesh-list
24424557|NCT00229775|Artemether|artemether|mesh-list
24424558|NCT00229775|Pyrimethamine|pyrimethamine|mesh-list
24424559|NCT00229775|Sulfadoxine|sulfadoxine|mesh-list
24424560|NCT00229775|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24424561|NCT00229775|Amebicides|amebicides|mesh-ancestor
24424562|NCT00229775|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24424563|NCT00229775|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24424630|NCT00230035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24424631|NCT00230035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24424632|NCT00230035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24424685|NCT00230399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24424687|NCT00230451|Fluorouracil|fluorouracil|mesh-list
24424688|NCT00230451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24424689|NCT00230451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424690|NCT00230451|Tubulin Modulators|tubulin modulators|mesh-ancestor
24424823|NCT00230958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424824|NCT00230958|Immunologic Factors|immunologic factors|mesh-ancestor
24425059|NCT00231829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425061|NCT00231855|Topotecan|topotecan|mesh-list
24425062|NCT00231855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24425063|NCT00231855|Tubulin Modulators|tubulin modulators|mesh-ancestor
24425064|NCT00231855|Antimitotic Agents|antimitotic agents|mesh-ancestor
24425065|NCT00231855|Mitosis Modulators|mitosis modulators|mesh-ancestor
24979313|NCT04772313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24979315|NCT04772313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979316|NCT04772313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979317|NCT04772313|Dermatologic Agents|dermatologic agents|mesh-ancestor
24979318|NCT04772313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24979319|NCT04772313|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24979320|NCT04772313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24979321|NCT04772313|Immunologic Factors|immunologic factors|mesh-ancestor
24979322|NCT04772313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24979323|NCT04772313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24425066|NCT00231855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425070|NCT00231959|Pramipexole|pramipexole|mesh-list
25705172|NCT02194998|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25705173|NCT02194998|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24425107|NCT00232011|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25705174|NCT02194998|Protease Inhibitors|protease inhibitors|mesh-ancestor
25705175|NCT02194998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25705176|NCT02194998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705177|NCT02194998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24869659|NCT01717586|Pravastatin|pravastatin|mesh-list
24610463|NCT01002183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24610464|NCT01002300|Oxytocin|oxytocin|mesh-list
24610465|NCT01002300|Oxytocics|oxytocics|mesh-ancestor
24549606|NCT00716248|Antimetabolites|antimetabolites|mesh-ancestor
24623257|NCT01070706|Growth Inhibitors|growth inhibitors|mesh-ancestor
24623258|NCT01070706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24623259|NCT01070732|Acetaminophen|acetaminophen|mesh-list
24425270|NCT00232531|Vitamins|vitamins|mesh-ancestor
24425271|NCT00232531|Micronutrients|micronutrients|mesh-ancestor
24425272|NCT00232531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425273|NCT00232570|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24425274|NCT00232570|Antidepressive Agents|antidepressive agents|mesh-ancestor
24425275|NCT00232570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24425276|NCT00232570|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24425277|NCT00232570|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24425278|NCT00232570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24425279|NCT00232570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425280|NCT00232622|Streptokinase|streptokinase|mesh-list
24425356|NCT00232765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24425357|NCT00232765|Immunologic Factors|immunologic factors|mesh-ancestor
24425358|NCT00232765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425643|NCT00233818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425644|NCT00233883|Enfuvirtide|enfuvirtide|mesh-list
24425645|NCT00233883|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24425648|NCT00233883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24425705|NCT00234091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24425706|NCT00234091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425707|NCT00234091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24425708|NCT00234091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24840394|NCT02209909|Antipyretics|antipyretics|mesh-ancestor
24425724|NCT00234117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24425725|NCT00234117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24425726|NCT00234117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425727|NCT00234143|Darbepoetin alfa|darbepoetin alfa|mesh-list
24425729|NCT00234182|Interferons|interferons|mesh-list
24425730|NCT00234182|Interferon-alpha|interferon-alpha|mesh-list
24425731|NCT00234182|Interferon alpha-2|interferon alpha-2|mesh-list
24425732|NCT00234182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24425733|NCT00234182|Antiviral Agents|antiviral agents|mesh-ancestor
24425815|NCT00234416|Antimetabolites|antimetabolites|mesh-ancestor
24425901|NCT00234676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24425902|NCT00234676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425903|NCT00234689|Naltrexone|naltrexone|mesh-list
24425904|NCT00234689|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24425905|NCT00234689|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24425906|NCT00234689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425907|NCT00234689|Sensory System Agents|sensory system agents|mesh-ancestor
24425908|NCT00234689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24425909|NCT00234819|Bazedoxifene|bazedoxifene|mesh-list
24425911|NCT00234819|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24425914|NCT00234819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425991|NCT00234923|Ritonavir|ritonavir|mesh-list
25705178|NCT02194998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25705179|NCT02194998|Antiviral Agents|antiviral agents|mesh-ancestor
25705180|NCT02194998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25705181|NCT02194998|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25705182|NCT02194998|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25705183|NCT02194998|Antimetabolites|antimetabolites|mesh-ancestor
25705184|NCT02195232|Quercetin|quercetin|mesh-list
25705185|NCT02195232|Antioxidants|antioxidants|mesh-ancestor
25705186|NCT02195232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705187|NCT02195232|Protective Agents|protective agents|mesh-ancestor
25705188|NCT02195232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870430|NCT05161975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870431|NCT05161975|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24870432|NCT05161975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24870433|NCT05161975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870434|NCT05161975|Hemostatics|hemostatics|mesh-ancestor
24426002|NCT00234923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24426003|NCT00234923|Antiviral Agents|antiviral agents|mesh-ancestor
24426004|NCT00234923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24426063|NCT00235001|Verapamil|verapamil|mesh-list
24426117|NCT00235079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426118|NCT00235079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24426119|NCT00235092|Sirolimus|sirolimus|mesh-list
24426120|NCT00235092|Paclitaxel|paclitaxel|mesh-list
24426121|NCT00235092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24426122|NCT00235092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24426123|NCT00235092|Tubulin Modulators|tubulin modulators|mesh-ancestor
24426124|NCT00235092|Antimitotic Agents|antimitotic agents|mesh-ancestor
24426439|NCT00236054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24426440|NCT00236054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24426441|NCT00236054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426442|NCT00236054|GABA Agents|gaba agents|mesh-ancestor
24426443|NCT00236054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24426444|NCT00236054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426445|NCT00236067|Tiagabine|tiagabine|mesh-list
24426446|NCT00236067|Anticonvulsants|anticonvulsants|mesh-ancestor
24426447|NCT00236067|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
24426448|NCT00236067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24426449|NCT00236067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24426450|NCT00236067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426488|NCT00236145|Anesthetics|anesthetics|mesh-ancestor
24426499|NCT00236223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24426546|NCT00236288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426547|NCT00236288|Dopamine Agents|dopamine agents|mesh-ancestor
24426549|NCT00236288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426550|NCT00236288|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24426551|NCT00236288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24426552|NCT00236288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24426553|NCT00236301|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24426554|NCT00236301|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24426555|NCT00236301|Estradiol|estradiol|mesh-list
24426602|NCT00236379|Risperidone|risperidone|mesh-list
24426604|NCT00236379|Serotonin Agents|serotonin agents|mesh-ancestor
24795466|NCT02512718|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24426617|NCT00236379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24426618|NCT00236379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24426619|NCT00236379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24426620|NCT00236379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24426641|NCT00236431|Autonomic Agents|autonomic agents|mesh-ancestor
24426642|NCT00236431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24426643|NCT00236431|Nootropic Agents|nootropic agents|mesh-ancestor
24426644|NCT00236444|Risperidone|risperidone|mesh-list
24426645|NCT00236444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24426646|NCT00236444|Serotonin Agents|serotonin agents|mesh-ancestor
24426647|NCT00236444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24426648|NCT00236444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426649|NCT00236444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705189|NCT02195518|Tenofovir|tenofovir|mesh-list
25705190|NCT02195518|Antiviral Agents|antiviral agents|mesh-ancestor
25705191|NCT02195518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25705192|NCT02195518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25705193|NCT02195518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25705194|NCT02195518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24802830|NCT01992653|Doxorubicin|doxorubicin|mesh-list
25705195|NCT02195518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705196|NCT02195518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25705197|NCT02195518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25705198|NCT02195583|Zinc|zinc|mesh-list
25705199|NCT02195583|Listerine|listerine|mesh-list
24870844|NCT03376763|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25705200|NCT02195583|Fluorides|fluorides|mesh-list
25705201|NCT02195583|Sodium Fluoride|sodium fluoride|mesh-list
24870845|NCT03376763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24870846|NCT03376763|Serotonin Agents|serotonin agents|mesh-ancestor
24870848|NCT03376763|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24871202|NCT04565392|Histamine Antagonists|histamine antagonists|mesh-ancestor
24871203|NCT04565392|Histamine Agents|histamine agents|mesh-ancestor
24426650|NCT00236444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24426651|NCT00236444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24426652|NCT00236444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24426653|NCT00236444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24426654|NCT00236444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24426832|NCT00236717|Analgesics|analgesics|mesh-ancestor
24426833|NCT00236717|Sensory System Agents|sensory system agents|mesh-ancestor
24426834|NCT00236717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24426835|NCT00236717|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24426836|NCT00236717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24426837|NCT00236717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24426838|NCT00236717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24426839|NCT00236730|Topiramate|topiramate|mesh-list
24426840|NCT00236730|Anticonvulsants|anticonvulsants|mesh-ancestor
24426841|NCT00236730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24426842|NCT00236730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426843|NCT00236743|Topiramate|topiramate|mesh-list
24795467|NCT02512718|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24979359|NCT04663464|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
24979360|NCT04663464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24426844|NCT00236743|Anticonvulsants|anticonvulsants|mesh-ancestor
24426845|NCT00236743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24426884|NCT00236795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426885|NCT00236795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24426886|NCT00236795|Contraceptive Agents|contraceptive agents|mesh-ancestor
24427024|NCT00237211|Letrozole|letrozole|mesh-list
24427169|NCT00237575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427170|NCT00237575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24427171|NCT00237575|Immunologic Factors|immunologic factors|mesh-ancestor
24427172|NCT00237575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427173|NCT00237588|Losartan|losartan|mesh-list
24427174|NCT00237588|Amlodipine|amlodipine|mesh-list
24427229|NCT00237783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24427230|NCT00237861|Olanzapine|olanzapine|mesh-list
24427231|NCT00237861|Risperidone|risperidone|mesh-list
24427519|NCT00238316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427520|NCT00238316|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24427521|NCT00238316|Hormone Antagonists|hormone antagonists|mesh-ancestor
24427522|NCT00238316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24427535|NCT00238329|Leprostatic Agents|leprostatic agents|mesh-ancestor
24427536|NCT00238329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24427537|NCT00238329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24427538|NCT00238329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24427539|NCT00238329|Growth Substances|growth substances|mesh-ancestor
24427540|NCT00238329|Growth Inhibitors|growth inhibitors|mesh-ancestor
24427542|NCT00238368|Prednisone|prednisone|mesh-list
24427543|NCT00238368|Methylprednisolone|methylprednisolone|mesh-list
24427544|NCT00238368|Cyclophosphamide|cyclophosphamide|mesh-list
24427545|NCT00238368|Busulfan|busulfan|mesh-list
24427546|NCT00238368|Rituximab|rituximab|mesh-list
24427547|NCT00238368|Doxorubicin|doxorubicin|mesh-list
24427548|NCT00238368|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24427549|NCT00238368|Etoposide|etoposide|mesh-list
25705202|NCT02195583|Cariostatic Agents|cariostatic agents|mesh-ancestor
25705203|NCT02195583|Protective Agents|protective agents|mesh-ancestor
25705204|NCT02195583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705205|NCT02195583|Trace Elements|trace elements|mesh-ancestor
25705206|NCT02195583|Micronutrients|micronutrients|mesh-ancestor
25705207|NCT02195583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25705208|NCT02195583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25705209|NCT02195687|Botulinum Toxins|botulinum toxins|mesh-list
25705210|NCT02195687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24427550|NCT00238368|Vincristine|vincristine|mesh-list
24427551|NCT00238368|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24427583|NCT00238368|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24871597|NCT05164848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871598|NCT05164770|Prednisone|prednisone|mesh-list
24427584|NCT00238368|Protective Agents|protective agents|mesh-ancestor
24427585|NCT00238368|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24427587|NCT00238394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427588|NCT00238394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427664|NCT00238667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24427665|NCT00238667|Purinergic Agents|purinergic agents|mesh-ancestor
24427666|NCT00238667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24427667|NCT00238667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24427668|NCT00238667|Vasodilator Agents|vasodilator agents|mesh-ancestor
24427669|NCT00238719|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24427670|NCT00238719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24427671|NCT00238719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24979383|NCT04540380|Cyclophosphamide|cyclophosphamide|mesh-list
24979384|NCT04540380|Rituximab|rituximab|mesh-list
24979385|NCT04540380|Fludarabine|fludarabine|mesh-list
24979386|NCT04540380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24979387|NCT04540380|Immunologic Factors|immunologic factors|mesh-ancestor
24427917|NCT00239278|Adrenergic Agents|adrenergic agents|mesh-ancestor
24404957|NCT00165191|Antimetabolites|antimetabolites|mesh-ancestor
24428183|NCT00239863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427672|NCT00238719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24427673|NCT00238719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427674|NCT00238719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24427675|NCT00238719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427676|NCT00238719|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24427677|NCT00238719|Antidepressive Agents|antidepressive agents|mesh-ancestor
24427708|NCT00238784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24427709|NCT00238784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24427710|NCT00238784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24427717|NCT00238797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427718|NCT00238797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427719|NCT00238849|Oxaliplatin|oxaliplatin|mesh-list
24427720|NCT00238849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427721|NCT00238901|Basiliximab|basiliximab|mesh-list
24427777|NCT00238992|Mycophenolic Acid|mycophenolic acid|mesh-list
24427778|NCT00238992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24427788|NCT00239018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427789|NCT00239018|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24427790|NCT00239018|Antitubercular Agents|antitubercular agents|mesh-ancestor
24427791|NCT00239018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24427792|NCT00239018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24427793|NCT00239018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427794|NCT00239018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427840|NCT00239096|Losartan|losartan|mesh-list
24427863|NCT00239109|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24427864|NCT00239109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24427875|NCT00239161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427876|NCT00239161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427877|NCT00239161|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24427878|NCT00239161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24427880|NCT00239174|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24427881|NCT00239174|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24427882|NCT00239174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25705211|NCT02195687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25705212|NCT02195687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25705213|NCT02195687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25705214|NCT02195687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705215|NCT02195687|Cholinergic Agents|cholinergic agents|mesh-ancestor
25705216|NCT02195687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25705217|NCT02195687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872061|NCT05399576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814949|NCT02067442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24814950|NCT02067442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814951|NCT02067442|Antipyretics|antipyretics|mesh-ancestor
24872143|NCT05398679|Clindamycin phosphate|clindamycin phosphate|mesh-list
24872223|NCT05398393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24872224|NCT05398393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24872270|NCT05397938|Alendronate|alendronate|mesh-list
24427883|NCT00239174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427887|NCT00239200|Lapatinib|lapatinib|mesh-list
24427888|NCT00239200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427889|NCT00239200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24427890|NCT00239200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427907|NCT00239278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24427908|NCT00239278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427909|NCT00239278|Autonomic Agents|autonomic agents|mesh-ancestor
24427910|NCT00239278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24427911|NCT00239278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24427912|NCT00239278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24427913|NCT00239278|Respiratory System Agents|respiratory system agents|mesh-ancestor
24427914|NCT00239278|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24427915|NCT00239278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24427916|NCT00239278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24979404|NCT04469595|Aflibercept|aflibercept|mesh-list
24979405|NCT04469595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24979406|NCT04469595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24979407|NCT04469595|Growth Substances|growth substances|mesh-ancestor
24979408|NCT04469595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979409|NCT04469595|Growth Inhibitors|growth inhibitors|mesh-ancestor
24979410|NCT04469595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979411|NCT04469595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24979412|NCT04469595|Glucocorticoids|glucocorticoids|mesh-ancestor
24979413|NCT04469595|Hormones|hormones|mesh-ancestor
24979414|NCT04469595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24979422|NCT04454424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24979423|NCT04454424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24979424|NCT04454424|Anesthetics, General|anesthetics, general|mesh-ancestor
24979425|NCT04454424|Anesthetics|anesthetics|mesh-ancestor
24979426|NCT04454424|GABA Modulators|gaba modulators|mesh-ancestor
24979427|NCT04454424|GABA Agents|gaba agents|mesh-ancestor
24979428|NCT04454424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24979429|NCT04454424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979430|NCT04338828|Nitric Oxide|nitric oxide|mesh-list
24979431|NCT04338828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24979432|NCT04338828|Autonomic Agents|autonomic agents|mesh-ancestor
24979433|NCT04338828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24979434|NCT04338828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428267|NCT00240045|Autonomic Agents|autonomic agents|mesh-ancestor
24428268|NCT00240045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24428269|NCT00240045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428270|NCT00240045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24428271|NCT00240045|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24428272|NCT00240045|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24428273|NCT00240045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24428493|NCT00240630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24428494|NCT00240630|Analgesics|analgesics|mesh-ancestor
24428495|NCT00240630|Sensory System Agents|sensory system agents|mesh-ancestor
25705219|NCT02195687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25705220|NCT02195895|Calcium, Dietary|calcium, dietary|mesh-list
25705221|NCT02195895|Vitamin D|vitamin d|mesh-list
25705222|NCT02195895|Ergocalciferols|ergocalciferols|mesh-list
25705223|NCT02195895|Cholecalciferol|cholecalciferol|mesh-list
25705224|NCT02195895|Alendronate|alendronate|mesh-list
25705225|NCT02195895|Vitamins|vitamins|mesh-list
25705226|NCT02195895|Calcium Carbonate|calcium carbonate|mesh-list
25705227|NCT02195895|Antacids|antacids|mesh-list
25705228|NCT02195895|Calcium|calcium|mesh-list
24465968|NCT00371410|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24803115|NCT01994668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24803116|NCT01994668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25705229|NCT02195895|Micronutrients|micronutrients|mesh-ancestor
25705230|NCT02195895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709664|NCT02271984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24428496|NCT00240630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24428497|NCT00240630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428498|NCT00240630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24783869|NCT01904643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24783870|NCT01904643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783871|NCT01904643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24783872|NCT01904643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24783873|NCT01904643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783874|NCT01904643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783875|NCT01904643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24783877|NCT01904643|Antiviral Agents|antiviral agents|mesh-ancestor
24783878|NCT01904643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783879|NCT01904643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24783880|NCT01904643|Immunologic Factors|immunologic factors|mesh-ancestor
24783881|NCT01904643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428538|NCT00240682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24428587|NCT00240773|Sensory System Agents|sensory system agents|mesh-ancestor
24428651|NCT00240838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24428652|NCT00240838|Analgesics|analgesics|mesh-ancestor
24428653|NCT00240838|Sensory System Agents|sensory system agents|mesh-ancestor
24428654|NCT00240838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24428655|NCT00240838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428656|NCT00240838|Antipyretics|antipyretics|mesh-ancestor
24428657|NCT00240851|Acetaminophen|acetaminophen|mesh-list
24428684|NCT00240942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24428873|NCT00241423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24428874|NCT00241436|Anastrozole|anastrozole|mesh-list
24428875|NCT00241436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24428876|NCT00241436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24428908|NCT00241488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24428943|NCT00241605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428944|NCT00241618|Interferons|interferons|mesh-list
24428945|NCT00241618|Ribavirin|ribavirin|mesh-list
24428946|NCT00241618|Interferon-alpha|interferon-alpha|mesh-list
24428947|NCT00241618|Interferon alpha-2|interferon alpha-2|mesh-list
24428948|NCT00241618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24428949|NCT00241618|Antiviral Agents|antiviral agents|mesh-ancestor
24428950|NCT00241618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24428951|NCT00241618|Antimetabolites|antimetabolites|mesh-ancestor
24429124|NCT00242775|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24429125|NCT00242775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24429126|NCT00242775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24429127|NCT00242775|Autonomic Agents|autonomic agents|mesh-ancestor
24429128|NCT00242775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24429188|NCT00242879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24429258|NCT00243100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24429259|NCT00243100|Antimetabolites|antimetabolites|mesh-ancestor
24429260|NCT00243100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429261|NCT00243100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429262|NCT00243100|Antiviral Agents|antiviral agents|mesh-ancestor
24429263|NCT00243100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24429264|NCT00243100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429265|NCT00243100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24429352|NCT00243724|Esomeprazole|esomeprazole|mesh-list
24429353|NCT00243724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24429354|NCT00243724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24429355|NCT00243724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24429356|NCT00243724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429357|NCT00243724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429359|NCT00243737|Mefloquine|mefloquine|mesh-list
24429360|NCT00243737|Antimalarials|antimalarials|mesh-ancestor
25105995|NCT04688203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25105996|NCT04688203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25709665|NCT02272413|Bevacizumab|bevacizumab|mesh-list
25709666|NCT02272413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24815122|NCT02068209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24815123|NCT02068209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24815124|NCT02068209|Analgesics|analgesics|mesh-ancestor
24815125|NCT02068209|Sensory System Agents|sensory system agents|mesh-ancestor
24815126|NCT02068209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24429501|NCT00244166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429502|NCT00244166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24429503|NCT00244166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429559|NCT00244348|Immunologic Factors|immunologic factors|mesh-ancestor
24429560|NCT00244348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429561|NCT00244361|Rituximab|rituximab|mesh-list
24429562|NCT00244361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25106001|NCT04688203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25106002|NCT04688203|Tocolytic Agents|tocolytic agents|mesh-ancestor
24429762|NCT00244998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429764|NCT00245024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24429765|NCT00245024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24429766|NCT00245024|Analgesics|analgesics|mesh-ancestor
24429767|NCT00245024|Sensory System Agents|sensory system agents|mesh-ancestor
24429768|NCT00245024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24429769|NCT00245024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429770|NCT00245024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24429818|NCT00245141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429824|NCT00245141|Mitosis Modulators|mitosis modulators|mesh-ancestor
24429825|NCT00245141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24429826|NCT00245141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24429827|NCT00245141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24432323|NCT00254345|Protective Agents|protective agents|mesh-ancestor
25106010|NCT04688203|Autonomic Agents|autonomic agents|mesh-ancestor
25106011|NCT04688203|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25106012|NCT04688203|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24430334|NCT00247169|Progestins|progestins|mesh-ancestor
24430351|NCT00247364|Levetiracetam|levetiracetam|mesh-list
24430352|NCT00247364|Anticonvulsants|anticonvulsants|mesh-ancestor
24430353|NCT00247364|Nootropic Agents|nootropic agents|mesh-ancestor
24430354|NCT00247403|Deoxyglucose|deoxyglucose|mesh-list
24430355|NCT00247403|Antimetabolites|antimetabolites|mesh-ancestor
24430356|NCT00247403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430508|NCT00248118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24430509|NCT00248118|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24430544|NCT00248209|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24430545|NCT00248209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24430546|NCT00248209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24430589|NCT00248313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24430591|NCT00248313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979467|NCT04217135|Hydralazine|hydralazine|mesh-list
24430601|NCT00248430|Melphalan|melphalan|mesh-list
24430793|NCT00249236|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24430794|NCT00249236|Serotonin Agents|serotonin agents|mesh-ancestor
24430795|NCT00249236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430796|NCT00249236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430797|NCT00249236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430798|NCT00249236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25705231|NCT02195895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25705232|NCT02195895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25705233|NCT02195895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705234|NCT02195895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25705235|NCT02195921|Antiemetics|antiemetics|mesh-list
25705236|NCT02195921|Autonomic Agents|autonomic agents|mesh-ancestor
25705237|NCT02195921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24873589|NCT05129748|Antitubercular Agents|antitubercular agents|mesh-ancestor
24873590|NCT05129748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24873591|NCT05129748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24430828|NCT00249366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430830|NCT00249405|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24430873|NCT00249509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24430874|NCT00249509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430881|NCT00249574|Naloxone|naloxone|mesh-list
24430945|NCT00249847|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24979473|NCT04205838|Fludarabine phosphate|fludarabine phosphate|mesh-list
24979474|NCT04205838|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24979475|NCT04205838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24979476|NCT04205838|Immunologic Factors|immunologic factors|mesh-ancestor
24979477|NCT04205838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979478|NCT04205838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24979479|NCT04205838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24979480|NCT04205838|Alkylating Agents|alkylating agents|mesh-ancestor
24979481|NCT04205838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979482|NCT04205838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979483|NCT04205838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24979492|NCT04170972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24979493|NCT04170972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979494|NCT04133623|Ibuprofen|ibuprofen|mesh-list
24979495|NCT04133623|Ketorolac|ketorolac|mesh-list
24979496|NCT04133623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24979497|NCT04133623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24979498|NCT04133623|Analgesics|analgesics|mesh-ancestor
24795468|NCT02512718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24431199|NCT00250796|Thalidomide|thalidomide|mesh-list
24431200|NCT00250796|Octreotide|octreotide|mesh-list
24431201|NCT00250796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431287|NCT00251082|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24431288|NCT00251082|Estradiol|estradiol|mesh-list
24431289|NCT00251082|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24431290|NCT00251082|Dydrogesterone|dydrogesterone|mesh-list
24431291|NCT00251082|Estrogens|estrogens|mesh-ancestor
24431292|NCT00251082|Hormones|hormones|mesh-ancestor
24431293|NCT00251082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24431294|NCT00251082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431295|NCT00251082|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24431296|NCT00251082|Contraceptive Agents|contraceptive agents|mesh-ancestor
24431297|NCT00251082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24431298|NCT00251082|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24431299|NCT00251082|Progestins|progestins|mesh-ancestor
24431301|NCT00251095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24431302|NCT00251095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431303|NCT00251095|Tubulin Modulators|tubulin modulators|mesh-ancestor
24431304|NCT00251095|Antimitotic Agents|antimitotic agents|mesh-ancestor
24431305|NCT00251095|Mitosis Modulators|mitosis modulators|mesh-ancestor
24431309|NCT00251186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24431371|NCT00251524|Bevacizumab|bevacizumab|mesh-list
24431372|NCT00251524|Oxaliplatin|oxaliplatin|mesh-list
24431374|NCT00251524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24431375|NCT00251524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431376|NCT00251524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24431377|NCT00251524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24431378|NCT00251524|Growth Substances|growth substances|mesh-ancestor
24431380|NCT00251524|Growth Inhibitors|growth inhibitors|mesh-ancestor
24431445|NCT00251732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24431446|NCT00251732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24431456|NCT00251784|Sildenafil Citrate|sildenafil citrate|mesh-list
25705238|NCT02195921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705239|NCT02195921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25705240|NCT02196168|Cisplatin|cisplatin|mesh-list
25705241|NCT02196168|Adavosertib|adavosertib|mesh-list
25705242|NCT02196168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25705243|NCT02196168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25705244|NCT02196168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705245|NCT02196259|Ketamine|ketamine|mesh-list
25705246|NCT02196259|Anesthetics, Dissociative|anesthetics, dissociative|mesh-list
24979509|NCT04064411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24979510|NCT04064411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979511|NCT04064411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24979513|NCT04057937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24979514|NCT04057937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24979516|NCT04057937|Sensory System Agents|sensory system agents|mesh-ancestor
24979517|NCT04057937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24979518|NCT04057937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979519|NCT04057937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24979520|NCT04057937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24979521|NCT04057937|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24979522|NCT04057937|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24979523|NCT04057937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431495|NCT00251901|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24431496|NCT00251901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24431596|NCT00252343|Adrenergic Agents|adrenergic agents|mesh-ancestor
24431597|NCT00252343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24783889|NCT01904682|ON 01910|on 01910|mesh-list
24431678|NCT00252668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24431679|NCT00252668|Analgesics|analgesics|mesh-ancestor
24431680|NCT00252668|Sensory System Agents|sensory system agents|mesh-ancestor
24431681|NCT00252668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24431724|NCT00252798|Antimitotic Agents|antimitotic agents|mesh-ancestor
24431725|NCT00252798|Mitosis Modulators|mitosis modulators|mesh-ancestor
24431726|NCT00252798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431727|NCT00252798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24431728|NCT00252798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431729|NCT00252811|Gefitinib|gefitinib|mesh-list
24431730|NCT00252811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431734|NCT00252824|Budesonide|budesonide|mesh-list
24431783|NCT00252863|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24431785|NCT00252863|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24431786|NCT00252863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24431787|NCT00252863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24979524|NCT04057937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979528|NCT04042831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979529|NCT04042831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431895|NCT00253188|Cholinergic Agents|cholinergic agents|mesh-ancestor
24431896|NCT00253188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431905|NCT00253201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431906|NCT00253201|Cholinergic Agents|cholinergic agents|mesh-ancestor
24431907|NCT00253201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431908|NCT00253201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431909|NCT00253201|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24431910|NCT00253201|Autonomic Agents|autonomic agents|mesh-ancestor
24431995|NCT00253396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24431996|NCT00253396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431997|NCT00253422|Fulvestrant|fulvestrant|mesh-list
24431998|NCT00253422|Anastrozole|anastrozole|mesh-list
24432000|NCT00253422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25705247|NCT02196259|Anesthetics|anesthetics|mesh-list
25705248|NCT02196259|Analgesics|analgesics|mesh-ancestor
25705249|NCT02196259|Sensory System Agents|sensory system agents|mesh-ancestor
25705250|NCT02196259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25705251|NCT02196259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705252|NCT02196259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25705253|NCT02196259|Anesthetics, General|anesthetics, general|mesh-ancestor
25705254|NCT02196259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25705255|NCT02196259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24874700|NCT04592809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24874701|NCT04592809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24874702|NCT04592809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24874703|NCT04592809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24803783|NCT01998503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24874704|NCT04592809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24874705|NCT04592809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24432001|NCT00253422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432002|NCT00253422|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24432003|NCT00253422|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24432004|NCT00253422|Hormone Antagonists|hormone antagonists|mesh-ancestor
24432005|NCT00253422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24432006|NCT00253422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432115|NCT00253565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24432116|NCT00253565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432118|NCT00253578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432119|NCT00253578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24432120|NCT00253578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432122|NCT00253591|Vinorelbine|vinorelbine|mesh-list
24979544|NCT03905889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24432236|NCT00254033|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24432237|NCT00254033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24432238|NCT00254033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24432239|NCT00254033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432240|NCT00254033|Dopamine Agents|dopamine agents|mesh-ancestor
24432241|NCT00254033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24432245|NCT00254046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432312|NCT00254319|Bevacizumab|bevacizumab|mesh-list
24432313|NCT00254319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24432314|NCT00254319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432315|NCT00254319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24432316|NCT00254319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24432317|NCT00254319|Growth Substances|growth substances|mesh-ancestor
24432318|NCT00254319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432319|NCT00254319|Growth Inhibitors|growth inhibitors|mesh-ancestor
24432320|NCT00254345|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
24432321|NCT00254345|Vasodilator Agents|vasodilator agents|mesh-ancestor
24432322|NCT00254345|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24432324|NCT00254345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432352|NCT00254553|Testosterone enanthate|testosterone enanthate|mesh-list
24432409|NCT00254735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24432410|NCT00254735|Serotonin Agents|serotonin agents|mesh-ancestor
24432411|NCT00254748|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24432412|NCT00254748|Antidepressive Agents|antidepressive agents|mesh-ancestor
24432413|NCT00254748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24432414|NCT00254748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24432501|NCT00254930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24432502|NCT00254930|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24432503|NCT00254930|Dopamine Agents|dopamine agents|mesh-ancestor
24432504|NCT00254956|Ciclesonide|ciclesonide|mesh-list
24432517|NCT00255073|GABA Agents|gaba agents|mesh-ancestor
24432519|NCT00255073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432520|NCT00255242|Simvastatin|simvastatin|mesh-list
24432523|NCT00255242|Antimetabolites|antimetabolites|mesh-ancestor
24432551|NCT00255268|Hormone Antagonists|hormone antagonists|mesh-ancestor
24432589|NCT00255489|Gefitinib|gefitinib|mesh-list
24432590|NCT00255489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432591|NCT00255489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25705256|NCT02196259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25705257|NCT02196259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25705258|NCT02196259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705259|NCT02196324|Serlopitant|serlopitant|mesh-list
25705260|NCT02196324|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25705261|NCT02196324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25705262|NCT02196324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24875919|NCT03813147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24875920|NCT03813147|Antiviral Agents|antiviral agents|mesh-ancestor
24432592|NCT00255489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432593|NCT00255489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432594|NCT00255502|Metoprolol|metoprolol|mesh-list
24432595|NCT00255502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24432596|NCT00255502|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24432597|NCT00255502|Sympatholytics|sympatholytics|mesh-ancestor
24432598|NCT00255502|Autonomic Agents|autonomic agents|mesh-ancestor
24432599|NCT00255502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24432600|NCT00255502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432601|NCT00255502|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24432602|NCT00255502|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24432603|NCT00255502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24432604|NCT00255502|Adrenergic Agents|adrenergic agents|mesh-ancestor
24432605|NCT00255502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24432606|NCT00255502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432607|NCT00255515|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24432608|NCT00255515|Antidepressive Agents|antidepressive agents|mesh-ancestor
24432623|NCT00255528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24432624|NCT00255528|Adrenergic Agents|adrenergic agents|mesh-ancestor
24979545|NCT03905889|Growth Substances|growth substances|mesh-ancestor
24979546|NCT03905889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979547|NCT03905889|Growth Inhibitors|growth inhibitors|mesh-ancestor
24979548|NCT03905889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24842025|NCT02219412|Antipyretics|antipyretics|mesh-ancestor
24979549|NCT03905889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24979550|NCT03905889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979551|NCT03847311|Sulfasalazine|sulfasalazine|mesh-list
24979552|NCT03847311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24979553|NCT03847311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24979554|NCT03847311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24979555|NCT03847311|Analgesics|analgesics|mesh-ancestor
24979556|NCT03847311|Sensory System Agents|sensory system agents|mesh-ancestor
24979557|NCT03847311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24979558|NCT03847311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979559|NCT03847311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24979560|NCT03847311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24979561|NCT03847311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24979562|NCT03823989|Mitomycins|mitomycins|mesh-list
24979563|NCT03823989|Mitomycin|mitomycin|mesh-list
24979565|NCT03823989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979566|NCT03823989|Alkylating Agents|alkylating agents|mesh-ancestor
24979567|NCT03823989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432625|NCT00255528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24432626|NCT00255528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432627|NCT00255541|Glyburide|glyburide|mesh-list
25705263|NCT02196324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705264|NCT02196506|Brexpiprazole|brexpiprazole|mesh-list
25705265|NCT02196506|Serotonin Agents|serotonin agents|mesh-ancestor
25705266|NCT02196506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25705267|NCT02196506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705268|NCT02196506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705269|NCT02196506|Dopamine Agonists|dopamine agonists|mesh-ancestor
25705270|NCT02196506|Dopamine Agents|dopamine agents|mesh-ancestor
25705271|NCT02196558|Quetmolimab|quetmolimab|mesh-list
25705272|NCT02196558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24876748|NCT03249792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24876749|NCT03249792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611253|NCT01008020|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24611254|NCT01008020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611255|NCT01008020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24623375|NCT01071135|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24623376|NCT01071135|Antidepressive Agents|antidepressive agents|mesh-ancestor
24623377|NCT01071135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24432628|NCT00255541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24432630|NCT00255554|Citalopram|citalopram|mesh-list
24432723|NCT00255762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432782|NCT00256100|Anticoagulants|anticoagulants|mesh-ancestor
24432783|NCT00256100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24432784|NCT00256100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24432785|NCT00256178|Simvastatin|simvastatin|mesh-list
24432786|NCT00256178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24432787|NCT00256178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24432792|NCT00256178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433048|NCT00257387|Immunologic Factors|immunologic factors|mesh-ancestor
24433226|NCT00257959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24433227|NCT00257959|Adrenergic Agents|adrenergic agents|mesh-ancestor
24450481|NCT00319306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433228|NCT00257959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24433229|NCT00257959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433230|NCT00257959|Sympatholytics|sympatholytics|mesh-ancestor
24433231|NCT00257959|Autonomic Agents|autonomic agents|mesh-ancestor
24433350|NCT00258245|Dexamethasone|dexamethasone|mesh-list
24433351|NCT00258245|Dexamethasone acetate|dexamethasone acetate|mesh-list
24433352|NCT00258245|Aspirin, aluminum hydroxide, magnesium hydroxide drug combination|aspirin, aluminum hydroxide, magnesium hydroxide drug combination|mesh-list
24433353|NCT00258245|Bortezomib|bortezomib|mesh-list
24433354|NCT00258245|Arsenic Trioxide|arsenic trioxide|mesh-list
24433355|NCT00258245|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24433356|NCT00258245|BB 1101|bb 1101|mesh-list
24433357|NCT00258245|Micronutrients|micronutrients|mesh-ancestor
24433358|NCT00258245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433359|NCT00258245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24433360|NCT00258245|Antiemetics|antiemetics|mesh-ancestor
24433361|NCT00258245|Autonomic Agents|autonomic agents|mesh-ancestor
24433362|NCT00258245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24433363|NCT00258245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24433364|NCT00258245|Glucocorticoids|glucocorticoids|mesh-ancestor
24450484|NCT00319306|Glucocorticoids|glucocorticoids|mesh-ancestor
24433365|NCT00258245|Hormones|hormones|mesh-ancestor
24433366|NCT00258245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24979637|NCT03373188|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24979638|NCT03373188|Immunologic Factors|immunologic factors|mesh-ancestor
24433374|NCT00258245|Analgesics|analgesics|mesh-ancestor
24433393|NCT00258258|Zoledronic Acid|zoledronic acid|mesh-list
24433394|NCT00258258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24433409|NCT00258271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433410|NCT00258284|Docetaxel|docetaxel|mesh-list
24433411|NCT00258284|Capecitabine|capecitabine|mesh-list
24433413|NCT00258284|Tubulin Modulators|tubulin modulators|mesh-ancestor
24433414|NCT00258284|Antimitotic Agents|antimitotic agents|mesh-ancestor
24433415|NCT00258284|Mitosis Modulators|mitosis modulators|mesh-ancestor
24433416|NCT00258284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433417|NCT00258284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24433418|NCT00258284|Antimetabolites|antimetabolites|mesh-ancestor
24433419|NCT00258297|Gefitinib|gefitinib|mesh-list
25705273|NCT02196701|Adalimumab|adalimumab|mesh-list
25705274|NCT02196701|Methotrexate|methotrexate|mesh-list
25705275|NCT02196701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25705276|NCT02196701|Abortifacient Agents|abortifacient agents|mesh-ancestor
25705277|NCT02196701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25705278|NCT02196701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705279|NCT02196701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25705280|NCT02196701|Antimetabolites|antimetabolites|mesh-ancestor
24433420|NCT00258297|Enzyme Inhibitors|enzyme inhibitors|mesh-list
24433421|NCT00258297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24878665|NCT01281176|Paclitaxel|paclitaxel|mesh-list
24979639|NCT03373188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979640|NCT03373188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24979641|NCT03373188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979642|NCT03373188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24979643|NCT03373188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979644|NCT03369665|Cladribine|cladribine|mesh-list
24979646|NCT03369665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24979649|NCT03220178|Letrozole|letrozole|mesh-list
24433467|NCT00258479|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24433468|NCT00258479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433470|NCT00258557|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24433472|NCT00258557|Protease Inhibitors|protease inhibitors|mesh-ancestor
24433473|NCT00258557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433481|NCT00258596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24433482|NCT00258596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24433483|NCT00258596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433484|NCT00258596|Antifungal Agents|antifungal agents|mesh-ancestor
24433500|NCT00258622|Anesthetics, Local|anesthetics, local|mesh-ancestor
24433502|NCT00258622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24433503|NCT00258622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433504|NCT00258622|Sensory System Agents|sensory system agents|mesh-ancestor
24433505|NCT00258622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24433506|NCT00258622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24433511|NCT00258739|Gemcitabine|gemcitabine|mesh-list
24433512|NCT00258739|Carboplatin|carboplatin|mesh-list
24433513|NCT00258739|Docetaxel|docetaxel|mesh-list
24433514|NCT00258739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433516|NCT00258739|Antimetabolites|antimetabolites|mesh-ancestor
24433559|NCT00259051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433560|NCT00259064|Gefitinib|gefitinib|mesh-list
24433561|NCT00259064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433562|NCT00259064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24433565|NCT00259077|Omeprazole|omeprazole|mesh-list
24433599|NCT00259155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24433601|NCT00259168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24433604|NCT00259181|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24433605|NCT00259181|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
24433606|NCT00259181|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24433607|NCT00259181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24433608|NCT00259181|Disinfectants|disinfectants|mesh-ancestor
24433609|NCT00259181|Dermatologic Agents|dermatologic agents|mesh-ancestor
24433610|NCT00259181|Vasodilator Agents|vasodilator agents|mesh-ancestor
24433611|NCT00259181|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24433612|NCT00259181|Protective Agents|protective agents|mesh-ancestor
24433613|NCT00259181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433614|NCT00259220|Erythromycin|erythromycin|mesh-list
24433615|NCT00259220|Erythromycin Estolate|erythromycin estolate|mesh-list
24433626|NCT00259376|Dronedarone|dronedarone|mesh-list
24433627|NCT00259376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24433628|NCT00259402|Fluorouracil|fluorouracil|mesh-list
24433629|NCT00259402|Oxaliplatin|oxaliplatin|mesh-list
24433631|NCT00259402|Antimetabolites|antimetabolites|mesh-ancestor
24795476|NCT02238496|Sirolimus|sirolimus|mesh-list
24433665|NCT00259675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25705281|NCT02196701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705282|NCT02196701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25705283|NCT02196701|Dermatologic Agents|dermatologic agents|mesh-ancestor
25705284|NCT02196701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25705285|NCT02196701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25705286|NCT02196701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24433666|NCT00259675|Antimetabolites|antimetabolites|mesh-ancestor
25705287|NCT02196701|Immunologic Factors|immunologic factors|mesh-ancestor
25705288|NCT02196701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25705289|NCT02196701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25705290|NCT02196701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25705291|NCT02196714|Glycopyrrolate|glycopyrrolate|mesh-list
25705292|NCT02196714|Formoterol Fumarate|formoterol fumarate|mesh-list
25705293|NCT02196714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24433726|NCT00259779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433728|NCT00259792|Formoterol Fumarate|formoterol fumarate|mesh-list
24433729|NCT00259792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24433730|NCT00259792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24433731|NCT00259792|Autonomic Agents|autonomic agents|mesh-ancestor
24433732|NCT00259792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24433733|NCT00259792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433737|NCT00259792|Hormones|hormones|mesh-ancestor
24433738|NCT00259792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24433739|NCT00259792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24433740|NCT00259792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24433741|NCT00259792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24433742|NCT00259792|Adrenergic Agents|adrenergic agents|mesh-ancestor
24433806|NCT00259987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433808|NCT00260026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433809|NCT00260026|Tubulin Modulators|tubulin modulators|mesh-ancestor
24433810|NCT00260026|Antimitotic Agents|antimitotic agents|mesh-ancestor
24433811|NCT00260026|Mitosis Modulators|mitosis modulators|mesh-ancestor
24433812|NCT00260026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433813|NCT00260039|Vaccines|vaccines|mesh-list
24433814|NCT00260039|Immunologic Factors|immunologic factors|mesh-ancestor
24433815|NCT00260039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433981|NCT00261118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795477|NCT02238496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24795478|NCT02238496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24804569|NCT02003209|Mitosis Modulators|mitosis modulators|mesh-ancestor
24795479|NCT02238496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24795480|NCT02238496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795481|NCT02238496|Antifungal Agents|antifungal agents|mesh-ancestor
24795482|NCT02238496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24795483|NCT02238496|Immunologic Factors|immunologic factors|mesh-ancestor
24795484|NCT02238496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434106|NCT00261508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24434107|NCT00261508|Serotonin Agents|serotonin agents|mesh-ancestor
24434156|NCT00261586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24434157|NCT00261586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24434158|NCT00261586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24434159|NCT00261586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434160|NCT00261586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24434161|NCT00261586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24434162|NCT00261586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434163|NCT00261586|Antipyretics|antipyretics|mesh-ancestor
25705294|NCT02196714|Autonomic Agents|autonomic agents|mesh-ancestor
25705295|NCT02196714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25705296|NCT02196714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705297|NCT02196714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24879665|NCT04560660|Anesthetics, General|anesthetics, general|mesh-ancestor
24879666|NCT04560660|Anesthetics|anesthetics|mesh-ancestor
24879667|NCT04560660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24879668|NCT04560660|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24879669|NCT04560660|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24815848|NCT02072278|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24815849|NCT02072278|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24434164|NCT00261586|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24434165|NCT00261586|Gout Suppressants|gout suppressants|mesh-ancestor
24795500|NCT02220426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24795501|NCT02220426|Anesthetics, General|anesthetics, general|mesh-ancestor
24795502|NCT02220426|Anesthetics|anesthetics|mesh-ancestor
24795503|NCT02220426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24434406|NCT00262405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24979732|NCT02821013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24979733|NCT02821013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979734|NCT02821013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979736|NCT02784704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24783882|NCT01904643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24783883|NCT01904643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24783884|NCT01904643|Growth Substances|growth substances|mesh-ancestor
24783885|NCT01904643|Growth Inhibitors|growth inhibitors|mesh-ancestor
24783887|NCT01904643|Sensory System Agents|sensory system agents|mesh-ancestor
24783888|NCT01904643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24434545|NCT00262769|Antiviral Agents|antiviral agents|mesh-ancestor
24434546|NCT00262769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25705298|NCT02196714|Respiratory System Agents|respiratory system agents|mesh-ancestor
25705299|NCT02196714|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25705300|NCT02196714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25705301|NCT02196714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25705302|NCT02196714|Adrenergic Agents|adrenergic agents|mesh-ancestor
25705303|NCT02196714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25705304|NCT02196714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705305|NCT02196714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25705306|NCT02196714|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25705307|NCT02196714|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25705308|NCT02196714|Cholinergic Agents|cholinergic agents|mesh-ancestor
25705309|NCT02196831|Tesamorelin|tesamorelin|mesh-list
25705310|NCT02196831|Growth Substances|growth substances|mesh-ancestor
25705311|NCT02196831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880190|NCT03986996|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24880191|NCT03986996|Antimalarials|antimalarials|mesh-ancestor
24702467|NCT01465984|Acetaminophen|acetaminophen|mesh-list
24880274|NCT03902418|Tenofovir|tenofovir|mesh-list
24880278|NCT03902418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24880279|NCT03902418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24880280|NCT03902418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24880281|NCT03902418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880282|NCT03902418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24880283|NCT03902418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24880284|NCT03897998|Naloxone|naloxone|mesh-list
24434619|NCT00263003|Irbesartan|irbesartan|mesh-list
24434620|NCT00263003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24434621|NCT00263003|Diuretics|diuretics|mesh-ancestor
24434622|NCT00263003|Natriuretic Agents|natriuretic agents|mesh-ancestor
24434623|NCT00263003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434624|NCT00263003|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24434734|NCT00263393|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25705312|NCT02196857|Azacitidine|azacitidine|mesh-list
24434735|NCT00263393|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24434736|NCT00263393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24434737|NCT00263393|Diuretics|diuretics|mesh-ancestor
24434738|NCT00263393|Natriuretic Agents|natriuretic agents|mesh-ancestor
24434739|NCT00263393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434740|NCT00263393|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24434741|NCT00263393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24434742|NCT00263393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434743|NCT00263393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24434744|NCT00263393|Sympatholytics|sympatholytics|mesh-ancestor
24434861|NCT00264134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783904|NCT01904734|Clomiphene|clomiphene|mesh-list
24783915|NCT01904734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25106018|NCT04636437|Tenofovir|tenofovir|mesh-list
25106019|NCT04636437|Lamivudine|lamivudine|mesh-list
25106020|NCT04636437|Emtricitabine|emtricitabine|mesh-list
25106021|NCT04636437|Integrase Inhibitors|integrase inhibitors|mesh-list
25106022|NCT04636437|Antiviral Agents|antiviral agents|mesh-ancestor
25106023|NCT04636437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25106024|NCT04636437|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25106025|NCT04636437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25106026|NCT04636437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25106027|NCT04636437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434905|NCT00264225|Analgesics|analgesics|mesh-ancestor
24434906|NCT00264225|Sensory System Agents|sensory system agents|mesh-ancestor
24434913|NCT00264277|Vitamin K|vitamin k|mesh-list
24434972|NCT00264615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25106028|NCT04636437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25106029|NCT04636437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25705313|NCT02196857|Sorafenib|sorafenib|mesh-list
25705314|NCT02196857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25705315|NCT02196857|Antimetabolites|antimetabolites|mesh-ancestor
25705316|NCT02196857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705317|NCT02196857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25705318|NCT02196857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25705319|NCT02196857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25705320|NCT02197065|Atorvastatin|atorvastatin|mesh-list
25705321|NCT02197065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25705322|NCT02197065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25705323|NCT02197065|Antimetabolites|antimetabolites|mesh-ancestor
25705324|NCT02197065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705325|NCT02197065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24435051|NCT00264953|Vinblastine|vinblastine|mesh-list
24435052|NCT00264953|Procarbazine|procarbazine|mesh-list
24435053|NCT00264953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24435054|NCT00264953|Glucocorticoids|glucocorticoids|mesh-ancestor
24435055|NCT00264953|Hormones|hormones|mesh-ancestor
24435083|NCT00265018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24435084|NCT00265018|Tubulin Modulators|tubulin modulators|mesh-ancestor
24435085|NCT00265018|Antimitotic Agents|antimitotic agents|mesh-ancestor
24435086|NCT00265018|Mitosis Modulators|mitosis modulators|mesh-ancestor
24435087|NCT00265031|Prednisone|prednisone|mesh-list
24435088|NCT00265031|Cyclophosphamide|cyclophosphamide|mesh-list
24435089|NCT00265031|Etoposide|etoposide|mesh-list
24435133|NCT00265265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24435134|NCT00265265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435135|NCT00265278|Modafinil|modafinil|mesh-list
24435136|NCT00265278|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24435137|NCT00265278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435138|NCT00265278|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24435139|NCT00265278|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24435142|NCT00265291|Fluoxetine|fluoxetine|mesh-list
24804911|NCT02005770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24435179|NCT00265408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435419|NCT00266214|Sensory System Agents|sensory system agents|mesh-ancestor
24435420|NCT00266214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24435421|NCT00266214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24435422|NCT00266214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24435423|NCT00266214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24435424|NCT00266214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24435471|NCT00266539|Fentanyl|fentanyl|mesh-list
24435472|NCT00266539|Morphine|morphine|mesh-list
24435473|NCT00266539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24435474|NCT00266539|Narcotics|narcotics|mesh-ancestor
24435475|NCT00266539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24435540|NCT00266747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435541|NCT00266747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435542|NCT00266786|Ketorolac|ketorolac|mesh-list
24435543|NCT00266786|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24435544|NCT00266786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25106052|NCT04594746|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25106053|NCT04594746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25106054|NCT04594746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106055|NCT04594746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24979737|NCT02784704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24979738|NCT05241431|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
24979739|NCT05241431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979740|NCT05241431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24979748|NCT05241249|Antimitotic Agents|antimitotic agents|mesh-ancestor
24979749|NCT05241249|Mitosis Modulators|mitosis modulators|mesh-ancestor
24979750|NCT05241249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979751|NCT05241249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24979752|NCT05241249|Antimetabolites|antimetabolites|mesh-ancestor
24435581|NCT00267176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24435582|NCT00267176|Analgesics|analgesics|mesh-ancestor
25705326|NCT02197065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25705327|NCT02197065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25705328|NCT02197247|Rifampin|rifampin|mesh-list
25705329|NCT02197247|Osimertinib|osimertinib|mesh-list
25705330|NCT02197247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25705331|NCT02197247|Antitubercular Agents|antitubercular agents|mesh-ancestor
24435583|NCT00267176|Sensory System Agents|sensory system agents|mesh-ancestor
24435691|NCT00267657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24435692|NCT00267683|Insulin Aspart|insulin aspart|mesh-list
24435693|NCT00267683|Glyburide|glyburide|mesh-list
24979753|NCT05241249|Antiviral Agents|antiviral agents|mesh-ancestor
24979754|NCT05241249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24979755|NCT05241249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24979756|NCT05241249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24979757|NCT05241249|Immunologic Factors|immunologic factors|mesh-ancestor
24979758|NCT05241249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979759|NCT05241249|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24979760|NCT05241249|Autonomic Agents|autonomic agents|mesh-ancestor
24979761|NCT05241249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24979762|NCT05241249|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24979763|NCT05241249|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24979764|NCT05241249|Cholinergic Agents|cholinergic agents|mesh-ancestor
24979765|NCT05241249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24979766|NCT05241132|Paclitaxel|paclitaxel|mesh-list
24979767|NCT05241132|Cisplatin|cisplatin|mesh-list
24979768|NCT05241132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24979769|NCT05241132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435694|NCT00267683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24435695|NCT00267683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435696|NCT00267709|Visilizumab|visilizumab|mesh-list
24435697|NCT00267709|Immunologic Factors|immunologic factors|mesh-ancestor
24436093|NCT00268918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24436094|NCT00268918|Tubulin Modulators|tubulin modulators|mesh-ancestor
24436095|NCT00268918|Antimitotic Agents|antimitotic agents|mesh-ancestor
24436096|NCT00268918|Mitosis Modulators|mitosis modulators|mesh-ancestor
24436137|NCT00269126|Respiratory System Agents|respiratory system agents|mesh-ancestor
24436138|NCT00269126|Dermatologic Agents|dermatologic agents|mesh-ancestor
24436139|NCT00269126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24436142|NCT00269126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24436143|NCT00269126|Adrenergic Agents|adrenergic agents|mesh-ancestor
24436144|NCT00269126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24436435|NCT00269893|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24436530|NCT00270374|Natriuretic Agents|natriuretic agents|mesh-ancestor
24436531|NCT00270374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979792|NCT05241054|Anesthetics|anesthetics|mesh-ancestor
24979793|NCT05241054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24979794|NCT05241054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979795|NCT05241054|Sensory System Agents|sensory system agents|mesh-ancestor
24979796|NCT05241054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24979797|NCT05241054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24979798|NCT05241054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24979799|NCT05241054|Anesthetics, General|anesthetics, general|mesh-ancestor
24979800|NCT05241054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24979825|NCT05240456|Cholinergic Antagonists|cholinergic antagonists|mesh-list
24979826|NCT05240456|Adrenergic Agents|adrenergic agents|mesh-list
24436538|NCT00270413|Sunitinib|sunitinib|mesh-list
24436661|NCT00270777|Autonomic Agents|autonomic agents|mesh-ancestor
24436662|NCT00270777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24436697|NCT00270881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436698|NCT00270881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24436699|NCT00270881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24436700|NCT00270881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24436701|NCT00270881|Antimetabolites|antimetabolites|mesh-ancestor
24436702|NCT00270881|Antiviral Agents|antiviral agents|mesh-ancestor
24436703|NCT00270881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24979833|NCT05240456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979834|NCT05240456|Urological Agents|urological agents|mesh-ancestor
24979835|NCT05240456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24979839|NCT05240261|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24979840|NCT05240261|Antidepressive Agents|antidepressive agents|mesh-ancestor
24979841|NCT05240261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24979842|NCT05240261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24979843|NCT05240261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24979844|NCT05240261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24437026|NCT00272467|Antioxidants|antioxidants|mesh-ancestor
24437027|NCT00272467|Protective Agents|protective agents|mesh-ancestor
24437028|NCT00272467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437029|NCT00272480|Lamivudine|lamivudine|mesh-list
24437030|NCT00272480|Zidovudine|zidovudine|mesh-list
24437031|NCT00272480|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24437032|NCT00272480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24437033|NCT00272480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24437034|NCT00272480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437035|NCT00272480|Antiviral Agents|antiviral agents|mesh-ancestor
24437036|NCT00272480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24437037|NCT00272480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24437038|NCT00272480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24437039|NCT00272480|Antimetabolites|antimetabolites|mesh-ancestor
24437081|NCT00272636|Vasodilator Agents|vasodilator agents|mesh-ancestor
24979854|NCT05186623|Ustekinumab|ustekinumab|mesh-list
24795514|NCT01968213|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24795516|NCT01968213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795520|NCT01894308|Testosterone|testosterone|mesh-list
24795521|NCT01894308|Androgens|androgens|mesh-ancestor
24795522|NCT01894308|Hormones|hormones|mesh-ancestor
24795523|NCT01894308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24795524|NCT01894308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705332|NCT02197247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25705333|NCT02197247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25705334|NCT02197247|Leprostatic Agents|leprostatic agents|mesh-ancestor
25705335|NCT02197247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25705336|NCT02197247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25705337|NCT02197247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467400|NCT00377481|Darbepoetin alfa|darbepoetin alfa|mesh-list
25705338|NCT02197247|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25705339|NCT02197247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25705340|NCT02197247|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25705341|NCT02197247|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25705342|NCT02197247|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25705343|NCT02197247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25705345|NCT02197247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24881469|NCT02260102|Temocillin|temocillin|mesh-list
24881470|NCT02260102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24881471|NCT02260102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25705346|NCT02197273|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25705347|NCT02197273|Epinephrine|epinephrine|mesh-list
25705348|NCT02197273|Fentanyl|fentanyl|mesh-list
24437266|NCT00273299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24437267|NCT00273299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24437268|NCT00273299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24437269|NCT00273299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437271|NCT00273299|Natriuretic Agents|natriuretic agents|mesh-ancestor
24437272|NCT00273299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437273|NCT00273299|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24437274|NCT00273299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24437275|NCT00273312|Epothilone B|epothilone b|mesh-list
24437276|NCT00273312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24437277|NCT00273312|Tubulin Modulators|tubulin modulators|mesh-ancestor
24437278|NCT00273312|Antimitotic Agents|antimitotic agents|mesh-ancestor
24437279|NCT00273312|Mitosis Modulators|mitosis modulators|mesh-ancestor
24437280|NCT00273312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437281|NCT00273338|Calcitriol|calcitriol|mesh-list
24437439|NCT00273676|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24437440|NCT00273676|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24437441|NCT00273676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24437442|NCT00273676|Antitubercular Agents|antitubercular agents|mesh-ancestor
24437443|NCT00273689|Albuterol|albuterol|mesh-list
24437444|NCT00273689|Montelukast|montelukast|mesh-list
24437445|NCT00273689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24437446|NCT00273689|Respiratory System Agents|respiratory system agents|mesh-ancestor
24437447|NCT00273689|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24437448|NCT00273689|Hormone Antagonists|hormone antagonists|mesh-ancestor
24437450|NCT00273689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437473|NCT00273702|Protective Agents|protective agents|mesh-ancestor
24437474|NCT00273702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437475|NCT00273702|Antidotes|antidotes|mesh-ancestor
24437476|NCT00273741|Methylphenidate|methylphenidate|mesh-list
24437477|NCT00273741|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24437498|NCT00273871|Dermatologic Agents|dermatologic agents|mesh-ancestor
24437500|NCT00273884|Cytarabine|cytarabine|mesh-list
24437501|NCT00273884|Amonafide|amonafide|mesh-list
24437502|NCT00273884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24437503|NCT00273884|Antimetabolites|antimetabolites|mesh-ancestor
24437504|NCT00273884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437505|NCT00273884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25705349|NCT02197273|Morphine|morphine|mesh-list
25705350|NCT02197273|Bupivacaine|bupivacaine|mesh-list
25705351|NCT02197273|Ropivacaine|ropivacaine|mesh-list
25705352|NCT02197273|Anesthetics, Local|anesthetics, local|mesh-ancestor
25705353|NCT02197273|Anesthetics|anesthetics|mesh-ancestor
25705354|NCT02197273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25705355|NCT02197273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705356|NCT02197273|Sensory System Agents|sensory system agents|mesh-ancestor
25705357|NCT02197273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25705358|NCT02197273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24881704|NCT01720836|Poly ICLC|poly iclc|mesh-list
24882000|NCT00006455|Hormones|hormones|mesh-ancestor
24437506|NCT00273884|Antiviral Agents|antiviral agents|mesh-ancestor
24437507|NCT00273884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24437508|NCT00273884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24437509|NCT00273884|Immunologic Factors|immunologic factors|mesh-ancestor
24437510|NCT00273884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437511|NCT00273884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24437512|NCT00273949|Lactulose|lactulose|mesh-list
24467788|NCT00378716|Protective Agents|protective agents|mesh-ancestor
24437538|NCT00273975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437539|NCT00273975|Antiviral Agents|antiviral agents|mesh-ancestor
24437540|NCT00273975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24437541|NCT00273975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24437542|NCT00273975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24437543|NCT00273975|Antimetabolites|antimetabolites|mesh-ancestor
24437544|NCT00273975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24437545|NCT00273975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24437546|NCT00273988|Nevirapine|nevirapine|mesh-list
24437547|NCT00273988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24437548|NCT00273988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24437549|NCT00273988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24437550|NCT00273988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437551|NCT00273988|Antiviral Agents|antiviral agents|mesh-ancestor
24437552|NCT00273988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24437553|NCT00273988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24437554|NCT00273988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24437555|NCT00273988|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24437556|NCT00273988|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24437558|NCT00274001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24437559|NCT00274001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24437560|NCT00274001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24437576|NCT00274014|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24437577|NCT00274014|Cholinergic Agents|cholinergic agents|mesh-ancestor
24437581|NCT00274027|Tiotropium Bromide|tiotropium bromide|mesh-list
25705359|NCT02197273|Narcotics|narcotics|mesh-ancestor
24437585|NCT00274027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979938|NCT04933383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24979940|NCT04926571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24979941|NCT04926571|Antiemetics|antiemetics|mesh-ancestor
24979942|NCT04926571|Autonomic Agents|autonomic agents|mesh-ancestor
24979943|NCT04926571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24979944|NCT04926571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979945|NCT04926571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24979946|NCT04926571|Glucocorticoids|glucocorticoids|mesh-ancestor
24979947|NCT04926571|Hormones|hormones|mesh-ancestor
24979948|NCT04926571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24979949|NCT04926571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24979950|NCT04926571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24979951|NCT04904562|Angiotensin II|angiotensin ii|mesh-list
24979952|NCT04904562|Giapreza|giapreza|mesh-list
24979953|NCT04904562|Angiotensinogen|angiotensinogen|mesh-list
24979954|NCT04904562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24979955|NCT04904562|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24979956|NCT04904562|Protease Inhibitors|protease inhibitors|mesh-ancestor
25106056|NCT04594746|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24979957|NCT04904562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24979958|NCT04904562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24979959|NCT04851522|Sodium Hypochlorite|sodium hypochlorite|mesh-list
24979961|NCT04851522|Petrolatum|petrolatum|mesh-list
24979965|NCT04851522|Dermatologic Agents|dermatologic agents|mesh-ancestor
24979966|NCT04834024|Antibodies|antibodies|mesh-list
24437590|NCT00274027|Cholinergic Agents|cholinergic agents|mesh-ancestor
24437591|NCT00274027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24437592|NCT00274027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437593|NCT00274027|Anticonvulsants|anticonvulsants|mesh-ancestor
24437594|NCT00274040|Tiotropium Bromide|tiotropium bromide|mesh-list
24437595|NCT00274040|Ipratropium|ipratropium|mesh-list
24437596|NCT00274040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24437606|NCT00274040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437608|NCT00274053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24437609|NCT00274053|Autonomic Agents|autonomic agents|mesh-ancestor
24437611|NCT00274053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437612|NCT00274053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24437613|NCT00274053|Respiratory System Agents|respiratory system agents|mesh-ancestor
24437614|NCT00274053|Parasympatholytics|parasympatholytics|mesh-ancestor
24437615|NCT00274053|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24437616|NCT00274053|Cholinergic Agents|cholinergic agents|mesh-ancestor
24437617|NCT00274053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24437627|NCT00274066|Respiratory System Agents|respiratory system agents|mesh-ancestor
24437628|NCT00274066|Parasympatholytics|parasympatholytics|mesh-ancestor
24437629|NCT00274066|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24437630|NCT00274066|Cholinergic Agents|cholinergic agents|mesh-ancestor
24437631|NCT00274066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24437632|NCT00274066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437633|NCT00274066|Sympathomimetics|sympathomimetics|mesh-ancestor
24437646|NCT00274079|Respiratory System Agents|respiratory system agents|mesh-ancestor
24437647|NCT00274079|Parasympatholytics|parasympatholytics|mesh-ancestor
24437648|NCT00274079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24437705|NCT00274235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24437706|NCT00274235|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24437708|NCT00274235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437709|NCT00274235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24437769|NCT00274430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437770|NCT00274430|Urological Agents|urological agents|mesh-ancestor
24437771|NCT00274443|Carboplatin|carboplatin|mesh-list
24437772|NCT00274443|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24437773|NCT00274443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24437774|NCT00274495|Rosiglitazone|rosiglitazone|mesh-list
24437775|NCT00274495|Ribavirin|ribavirin|mesh-list
24437776|NCT00274495|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24437777|NCT00274495|Antimetabolites|antimetabolites|mesh-ancestor
24437778|NCT00274495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437779|NCT00274495|Antiviral Agents|antiviral agents|mesh-ancestor
24437780|NCT00274495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24437781|NCT00274495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24437827|NCT00274547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24437828|NCT00274547|Autonomic Agents|autonomic agents|mesh-ancestor
24437829|NCT00274547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24437830|NCT00274547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437831|NCT00274547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24437832|NCT00274547|Respiratory System Agents|respiratory system agents|mesh-ancestor
24437833|NCT00274547|Parasympatholytics|parasympatholytics|mesh-ancestor
24437834|NCT00274547|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24437835|NCT00274547|Cholinergic Agents|cholinergic agents|mesh-ancestor
24437836|NCT00274547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24437837|NCT00274547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437838|NCT00274560|Tiotropium Bromide|tiotropium bromide|mesh-list
24979974|NCT04821141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24979975|NCT04821141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979976|NCT04821141|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24437911|NCT00274677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24437913|NCT00274677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24437915|NCT00274690|Antiemetics|antiemetics|mesh-ancestor
24437916|NCT00274690|Autonomic Agents|autonomic agents|mesh-ancestor
24437917|NCT00274690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24437918|NCT00274690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437919|NCT00274690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24437920|NCT00274690|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24437921|NCT00274690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24437922|NCT00274690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437970|NCT00274820|Leprostatic Agents|leprostatic agents|mesh-ancestor
24437973|NCT00274820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24437974|NCT00274820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25705360|NCT02197273|Analgesics|analgesics|mesh-ancestor
25705361|NCT02197273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25705362|NCT02197273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25705363|NCT02197273|Anesthetics, General|anesthetics, general|mesh-ancestor
25705364|NCT02197273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25705365|NCT02197273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25705366|NCT02197273|Adrenergic Agents|adrenergic agents|mesh-ancestor
25705367|NCT02197273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25705368|NCT02197273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882626|NCT05167851|Lazertinib|lazertinib|mesh-list
24437975|NCT00274820|Growth Substances|growth substances|mesh-ancestor
24437976|NCT00274820|Growth Inhibitors|growth inhibitors|mesh-ancestor
24437977|NCT00274833|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24437979|NCT00274833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24437984|NCT00274833|Alkylating Agents|alkylating agents|mesh-ancestor
24437985|NCT00274859|Gemcitabine|gemcitabine|mesh-list
24437986|NCT00274859|Oxaliplatin|oxaliplatin|mesh-list
24437987|NCT00274859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24437988|NCT00274859|Antimetabolites|antimetabolites|mesh-ancestor
24437989|NCT00274859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437990|NCT00274859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24437992|NCT00274859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24437993|NCT00274859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24437994|NCT00274859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24437995|NCT00274859|Immunologic Factors|immunologic factors|mesh-ancestor
24437996|NCT00274859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437997|NCT00274872|Leucovorin|leucovorin|mesh-list
24437998|NCT00274872|Fluorouracil|fluorouracil|mesh-list
24979999|NCT04756765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438008|NCT00274872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24438009|NCT00274872|Immunologic Factors|immunologic factors|mesh-ancestor
24438010|NCT00274872|Antidotes|antidotes|mesh-ancestor
24438011|NCT00274872|Protective Agents|protective agents|mesh-ancestor
24438012|NCT00274872|Vitamin B Complex|vitamin b complex|mesh-ancestor
24438013|NCT00274872|Vitamins|vitamins|mesh-ancestor
24438014|NCT00274872|Micronutrients|micronutrients|mesh-ancestor
24438015|NCT00274885|Oxaliplatin|oxaliplatin|mesh-list
24438016|NCT00274885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438017|NCT00274898|Celecoxib|celecoxib|mesh-list
24438018|NCT00274898|Docetaxel|docetaxel|mesh-list
24438019|NCT00274898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438020|NCT00274898|Tubulin Modulators|tubulin modulators|mesh-ancestor
24438037|NCT00274911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25705369|NCT02197273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25705370|NCT02197273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25705371|NCT02197273|Autonomic Agents|autonomic agents|mesh-ancestor
25705372|NCT02197273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25705373|NCT02197273|Respiratory System Agents|respiratory system agents|mesh-ancestor
25705374|NCT02197273|Mydriatics|mydriatics|mesh-ancestor
25705375|NCT02197273|Sympathomimetics|sympathomimetics|mesh-ancestor
25705376|NCT02197273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25705377|NCT02197273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24438066|NCT00274963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438067|NCT00274963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438068|NCT00274963|Analgesics|analgesics|mesh-ancestor
24438069|NCT00274963|Sensory System Agents|sensory system agents|mesh-ancestor
25705378|NCT02197273|Glucocorticoids|glucocorticoids|mesh-ancestor
24882688|NCT05144698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882689|NCT05144698|Antifungal Agents|antifungal agents|mesh-ancestor
24438071|NCT00274963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438072|NCT00274963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24438073|NCT00274963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24438074|NCT00274963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438075|NCT00274976|Alemtuzumab|alemtuzumab|mesh-list
24438076|NCT00274976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24438077|NCT00274976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438078|NCT00274989|Rituximab|rituximab|mesh-list
24438079|NCT00274989|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24438080|NCT00274989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24438081|NCT00274989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438082|NCT00274989|Immunologic Factors|immunologic factors|mesh-ancestor
24438083|NCT00274989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438084|NCT00274989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24438085|NCT00274989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24438086|NCT00274989|Alkylating Agents|alkylating agents|mesh-ancestor
24438087|NCT00274989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438129|NCT00275041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24438136|NCT00275054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24438137|NCT00275054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24438138|NCT00275054|Alkylating Agents|alkylating agents|mesh-ancestor
24438139|NCT00275054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438140|NCT00275054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438141|NCT00275054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24438142|NCT00275054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24438143|NCT00275067|Temozolomide|temozolomide|mesh-list
24438144|NCT00275067|Arsenic Trioxide|arsenic trioxide|mesh-list
24438145|NCT00275067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24438149|NCT00275080|Decitabine|decitabine|mesh-list
24438151|NCT00275080|Vorinostat|vorinostat|mesh-list
24438152|NCT00275080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24438153|NCT00275080|Antimetabolites|antimetabolites|mesh-ancestor
24438154|NCT00275080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438155|NCT00275080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438156|NCT00275080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438191|NCT00275106|Antiemetics|antiemetics|mesh-ancestor
24980027|NCT04710732|Enoxaparin sodium|enoxaparin sodium|mesh-list
24980028|NCT04710732|Anticoagulants|anticoagulants|mesh-ancestor
24980029|NCT04710732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24980030|NCT04710732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24918030|NCT04224103|Autonomic Agents|autonomic agents|mesh-ancestor
24980031|NCT04710732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980033|NCT04671875|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25705379|NCT02197273|Hormones|hormones|mesh-ancestor
25705380|NCT02197273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25705381|NCT02197273|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25705382|NCT02197273|Protective Agents|protective agents|mesh-ancestor
25705383|NCT02197273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25705384|NCT02197273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25705385|NCT02197377|Chlorhexidine|chlorhexidine|mesh-list
25705386|NCT02197377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24980035|NCT04671875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438293|NCT00275418|Protective Agents|protective agents|mesh-ancestor
24438294|NCT00275418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438510|NCT00276068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438511|NCT00276068|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24438512|NCT00276068|Antidepressive Agents|antidepressive agents|mesh-ancestor
24438715|NCT00276692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438716|NCT00276692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438717|NCT00276692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438718|NCT00276705|Thalidomide|thalidomide|mesh-list
24438719|NCT00276705|Cyclophosphamide|cyclophosphamide|mesh-list
24439197|NCT00278070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439198|NCT00278070|Tubulin Modulators|tubulin modulators|mesh-ancestor
24439199|NCT00278070|Antimitotic Agents|antimitotic agents|mesh-ancestor
24439200|NCT00278070|Mitosis Modulators|mitosis modulators|mesh-ancestor
24439201|NCT00278070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439202|NCT00278083|Nitric Oxide|nitric oxide|mesh-list
24439203|NCT00278083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24439204|NCT00278083|Autonomic Agents|autonomic agents|mesh-ancestor
24439205|NCT00278083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24439206|NCT00278083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439207|NCT00278083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24439270|NCT00278252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24439271|NCT00278252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439272|NCT00278252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24439273|NCT00278252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24439274|NCT00278252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24439286|NCT00278265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439288|NCT00278265|Dermatologic Agents|dermatologic agents|mesh-ancestor
24439289|NCT00278265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24439290|NCT00278265|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24439291|NCT00278265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25705391|NCT02197416|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25705392|NCT02197416|Protease Inhibitors|protease inhibitors|mesh-ancestor
25705393|NCT02197416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25705394|NCT02197416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705395|NCT02197416|Anticoagulants|anticoagulants|mesh-ancestor
25705396|NCT02197455|Tofacitinib|tofacitinib|mesh-list
25705397|NCT02197455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25705398|NCT02197455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25705399|NCT02197455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439292|NCT00278265|Immunologic Factors|immunologic factors|mesh-ancestor
24439293|NCT00278265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24980068|NCT05442190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24980069|NCT05442190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980070|NCT05442190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24980071|NCT05442190|Immunologic Factors|immunologic factors|mesh-ancestor
24980072|NCT05442190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980078|NCT05442008|Erenumab|erenumab|mesh-list
24980080|NCT05442008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439294|NCT00278265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24439295|NCT00278265|Antiviral Agents|antiviral agents|mesh-ancestor
24439296|NCT00278265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24439297|NCT00278278|Prednisone|prednisone|mesh-list
24439298|NCT00278278|Methotrexate|methotrexate|mesh-list
24439299|NCT00278278|Etoposide|etoposide|mesh-list
24439301|NCT00278278|Ifosfamide|ifosfamide|mesh-list
24439329|NCT00278278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24439330|NCT00278278|Alkylating Agents|alkylating agents|mesh-ancestor
24439331|NCT00278330|Vorinostat|vorinostat|mesh-list
24439332|NCT00278330|Alvocidib|alvocidib|mesh-list
24439333|NCT00278330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439334|NCT00278330|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24439335|NCT00278330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24439340|NCT00278330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24439341|NCT00278343|Cediranib|cediranib|mesh-list
24439393|NCT00278421|Prednisone|prednisone|mesh-list
24439589|NCT00279461|Micronutrients|micronutrients|mesh-ancestor
24439590|NCT00279461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439591|NCT00279461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24439596|NCT00279487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24439867|NCT00280605|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24439868|NCT00280605|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24439869|NCT00280605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24980082|NCT05442008|Sensory System Agents|sensory system agents|mesh-ancestor
24980083|NCT05442008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24980084|NCT05442008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439870|NCT00280605|Adrenergic Agents|adrenergic agents|mesh-ancestor
24439950|NCT00280969|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24439951|NCT00280969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24439952|NCT00280969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24439953|NCT00280969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25705400|NCT02197520|Insulin|insulin|mesh-list
25705401|NCT02197520|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25705402|NCT02197520|Insulin Glargine|insulin glargine|mesh-list
25705403|NCT02197520|Insulin Lispro|insulin lispro|mesh-list
25705404|NCT02197520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25705405|NCT02197520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440146|NCT00281905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24440147|NCT00281905|Alkylating Agents|alkylating agents|mesh-ancestor
24440148|NCT00281905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440149|NCT00281905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440150|NCT00281905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24440151|NCT00281905|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24440152|NCT00281905|Abortifacient Agents|abortifacient agents|mesh-ancestor
24440186|NCT00281944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980098|NCT05441761|Gemcitabine|gemcitabine|mesh-list
24440272|NCT00282139|Antidepressive Agents|antidepressive agents|mesh-ancestor
24440273|NCT00282139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24440370|NCT00282594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24440371|NCT00282594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440373|NCT00282607|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24440374|NCT00282607|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24440375|NCT00282607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24440376|NCT00282607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440378|NCT00282698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24440379|NCT00282698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440380|NCT00282724|Liarozole|liarozole|mesh-list
24440381|NCT00282724|Androgen Antagonists|androgen antagonists|mesh-ancestor
24440382|NCT00282724|Hormone Antagonists|hormone antagonists|mesh-ancestor
24440383|NCT00282724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24440384|NCT00282724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440429|NCT00283036|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24440430|NCT00283036|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24440449|NCT00283179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440451|NCT00283179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24440452|NCT00283179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24440453|NCT00283179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24980103|NCT05441761|Antiemetics|antiemetics|mesh-ancestor
24440515|NCT00283543|Temozolomide|temozolomide|mesh-list
24440516|NCT00283543|Carmustine|carmustine|mesh-list
24470230|NCT00389285|Sorafenib|sorafenib|mesh-list
24440517|NCT00283543|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24440542|NCT00283634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440544|NCT00283634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24440611|NCT00283985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24440612|NCT00283985|Antiemetics|antiemetics|mesh-ancestor
24440613|NCT00283985|Autonomic Agents|autonomic agents|mesh-ancestor
24440614|NCT00283985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24440615|NCT00283985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440616|NCT00283985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24783926|NCT01904786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24783928|NCT01904981|Valsartan|valsartan|mesh-list
24883126|NCT04452383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24883127|NCT04452383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24883128|NCT04452383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883129|NCT04452383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24883130|NCT04452383|Anesthetics, General|anesthetics, general|mesh-ancestor
24883131|NCT04452383|Anesthetics|anesthetics|mesh-ancestor
24883132|NCT04452383|Analgesics|analgesics|mesh-ancestor
24783929|NCT01904981|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24441602|NCT00287924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24441603|NCT00287924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441604|NCT00287924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24441606|NCT00287924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441766|NCT00288262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441767|NCT00288262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24441768|NCT00288353|Aripiprazole|aripiprazole|mesh-list
24441769|NCT00288353|Ziprasidone|ziprasidone|mesh-list
24441770|NCT00288353|Antidepressive Agents|antidepressive agents|mesh-ancestor
24441771|NCT00288353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24441772|NCT00288353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24441773|NCT00288353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24783930|NCT01904981|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24783931|NCT01904981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24441787|NCT00288379|Budesonide|budesonide|mesh-list
24441979|NCT00289419|Epinephrine|epinephrine|mesh-list
24441980|NCT00289419|Racepinephrine|racepinephrine|mesh-list
24441981|NCT00289419|Morphine|morphine|mesh-list
24442092|NCT00290017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442142|NCT00290108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24442143|NCT00290108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442144|NCT00290108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24442145|NCT00290108|Anesthetics, General|anesthetics, general|mesh-ancestor
24783941|NCT01904981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24783942|NCT01904981|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24783943|NCT01904994|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24783944|NCT01904994|Antiviral Agents|antiviral agents|mesh-ancestor
24783945|NCT01904994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783946|NCT01905059|Lamivudine|lamivudine|mesh-list
24783947|NCT01905059|Lopinavir|lopinavir|mesh-list
24783948|NCT01905059|Darunavir|darunavir|mesh-list
24783949|NCT01905059|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
24783950|NCT01905059|Protease Inhibitors|protease inhibitors|mesh-list
24783951|NCT01905059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24825691|NCT02129634|Paclitaxel|paclitaxel|mesh-list
24980105|NCT05441761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24980106|NCT05441761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980107|NCT05441761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24980108|NCT05441761|Glucocorticoids|glucocorticoids|mesh-ancestor
24980109|NCT05441761|Hormones|hormones|mesh-ancestor
24980110|NCT05441761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24980111|NCT05441761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24980112|NCT05441761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24442724|NCT00292279|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24442725|NCT00292279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24442728|NCT00292344|Antidiarrheals|antidiarrheals|mesh-list
25705406|NCT02197767|Rituximab|rituximab|mesh-list
25705407|NCT02197767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25705408|NCT02197767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25705409|NCT02197767|Immunologic Factors|immunologic factors|mesh-ancestor
25705410|NCT02197767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705411|NCT02197767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25705412|NCT02197897|Tamoxifen|tamoxifen|mesh-list
25705413|NCT02197897|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25705414|NCT02197897|Hormone Antagonists|hormone antagonists|mesh-ancestor
24442729|NCT00292344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24442730|NCT00292344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24442731|NCT00292344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24442732|NCT00292409|Aripiprazole|aripiprazole|mesh-list
24442733|NCT00292409|Antidepressive Agents|antidepressive agents|mesh-ancestor
24442734|NCT00292409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24442735|NCT00292409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24442736|NCT00292409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24442739|NCT00292409|Dopamine Agonists|dopamine agonists|mesh-ancestor
24442970|NCT00293371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442971|NCT00293371|Tubulin Modulators|tubulin modulators|mesh-ancestor
24442972|NCT00293371|Antimitotic Agents|antimitotic agents|mesh-ancestor
24442973|NCT00293371|Mitosis Modulators|mitosis modulators|mesh-ancestor
25705415|NCT02197897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25705416|NCT02197897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705417|NCT02197897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25705418|NCT02197897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25705419|NCT02197897|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25705420|NCT02197897|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25705421|NCT02197897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24393774|NCT00130975|Candesartan|candesartan|mesh-list
24980125|NCT05441631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24980140|NCT05441410|Artesunate|artesunate|mesh-list
25705422|NCT02198235|Dexamethasone|dexamethasone|mesh-list
25705423|NCT02198235|Buprenorphine|buprenorphine|mesh-list
25705424|NCT02198235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25705425|NCT02198235|Antiemetics|antiemetics|mesh-ancestor
25705426|NCT02198235|Autonomic Agents|autonomic agents|mesh-ancestor
25705427|NCT02198235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25705428|NCT02198235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705429|NCT02198235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24980209|NCT05440578|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24980211|NCT05440578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980212|NCT05437796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
24980213|NCT05437796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24980214|NCT05437796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980215|NCT05431075|Amoxicillin|amoxicillin|mesh-list
24980216|NCT05431075|Tetracycline|tetracycline|mesh-list
24795594|NCT01503632|Antimetabolites|antimetabolites|mesh-ancestor
24443163|NCT00293800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443164|NCT00293800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443165|NCT00293800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24443170|NCT00293839|Oxybutynin|oxybutynin|mesh-list
24980243|NCT05420467|Docetaxel|docetaxel|mesh-list
24980244|NCT05420467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24980245|NCT05420467|Cyclophosphamide|cyclophosphamide|mesh-list
24980256|NCT05420467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24980257|NCT05420467|Immunologic Factors|immunologic factors|mesh-ancestor
24980258|NCT05420467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980259|NCT05420467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25705430|NCT02198235|Glucocorticoids|glucocorticoids|mesh-ancestor
25705431|NCT02198235|Hormones|hormones|mesh-ancestor
25705432|NCT02198235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25705433|NCT02198235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25705434|NCT02198235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25705435|NCT02198235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25705436|NCT02198235|Narcotics|narcotics|mesh-ancestor
25705437|NCT02198235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24805481|NCT02009540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24795601|NCT01503632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24795602|NCT01503632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795604|NCT01498458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24795605|NCT01498458|Antimetabolites|antimetabolites|mesh-ancestor
24653546|NCT01244256|Beclomethasone|beclomethasone|mesh-list
24795606|NCT01498458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980281|NCT05420454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845019|NCT02235584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24845020|NCT02235584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24980327|NCT05375097|Sensory System Agents|sensory system agents|mesh-ancestor
24980328|NCT05375097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24980329|NCT05375097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980330|NCT05356728|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24980331|NCT05356728|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24980332|NCT05353829|Methotrexate|methotrexate|mesh-list
24980333|NCT05353829|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24980334|NCT05353829|Abortifacient Agents|abortifacient agents|mesh-ancestor
24980335|NCT05353829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24980336|NCT05353829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980363|NCT05352321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25705439|NCT02198235|Sensory System Agents|sensory system agents|mesh-ancestor
25705440|NCT02198235|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25705441|NCT02198651|Adalimumab|adalimumab|mesh-list
25705442|NCT02198651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25705443|NCT02198651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25705444|NCT02199041|Mycophenolic Acid|mycophenolic acid|mesh-list
25705445|NCT02199041|Methylprednisolone|methylprednisolone|mesh-list
25705446|NCT02199041|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24883744|NCT05004038|Immunologic Factors|immunologic factors|mesh-ancestor
24883745|NCT05004038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883750|NCT04978272|Piperaquine|piperaquine|mesh-list
24980364|NCT05352321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24980365|NCT05352321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24980366|NCT05352321|Immunologic Factors|immunologic factors|mesh-ancestor
24980367|NCT05352321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980375|NCT05303727|Cyclosporine|cyclosporine|mesh-list
24980376|NCT05303727|Mycophenolic Acid|mycophenolic acid|mesh-list
24980377|NCT05303727|Cyclophosphamide|cyclophosphamide|mesh-list
24980378|NCT05303727|Melphalan|melphalan|mesh-list
24980379|NCT05303727|Busulfan|busulfan|mesh-list
24980380|NCT05303727|Thiotepa|thiotepa|mesh-list
24443205|NCT00293969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24795609|NCT01427712|Pancreatin|pancreatin|mesh-list
24588971|NCT00905047|Folic Acid|folic acid|mesh-list
24588972|NCT00905047|Tegafur|tegafur|mesh-list
24588973|NCT00905047|Levoleucovorin|levoleucovorin|mesh-list
24588974|NCT00905047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24588975|NCT00905047|Antimetabolites|antimetabolites|mesh-ancestor
24588976|NCT00905047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588977|NCT00905047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588978|NCT00905047|Antidotes|antidotes|mesh-ancestor
24588979|NCT00905047|Protective Agents|protective agents|mesh-ancestor
25705447|NCT02199041|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25705448|NCT02199041|Prednisolone|prednisolone|mesh-list
25705449|NCT02199041|Prednisolone acetate|prednisolone acetate|mesh-list
25705450|NCT02199041|Cyclophosphamide|cyclophosphamide|mesh-list
25705451|NCT02199041|Melphalan|melphalan|mesh-list
25705452|NCT02199041|Mechlorethamine|mechlorethamine|mesh-list
25705453|NCT02199041|Thiotepa|thiotepa|mesh-list
25705454|NCT02199041|Fludarabine|fludarabine|mesh-list
25705455|NCT02199041|Tacrolimus|tacrolimus|mesh-list
25705456|NCT02199041|Lenograstim|lenograstim|mesh-list
24883871|NCT04631536|Nicorandil|nicorandil|mesh-list
24980548|NCT05182073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980549|NCT05182073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24980550|NCT05182073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24980551|NCT05182073|Alkylating Agents|alkylating agents|mesh-ancestor
24980552|NCT05182073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980562|NCT05132101|Palbociclib|palbociclib|mesh-list
24980563|NCT05132101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980564|NCT05132101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24805526|NCT02010411|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
24805527|NCT02010411|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24980565|NCT05132101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24980566|NCT05132101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106086|NCT04509973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106087|NCT04509973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24443425|NCT00294892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24443426|NCT00294892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24443427|NCT00294892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24443430|NCT00294918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622030|NCT01065259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24622031|NCT01065259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24622032|NCT01065259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622039|NCT01065272|Autonomic Agents|autonomic agents|mesh-ancestor
24622040|NCT01065272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24622041|NCT01065272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622042|NCT01065272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24980788|NCT04945616|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24980806|NCT04902040|Pembrolizumab|pembrolizumab|mesh-list
24980807|NCT04902040|Nivolumab|nivolumab|mesh-list
24980808|NCT04902040|Durvalumab|durvalumab|mesh-list
24980809|NCT04902040|Avelumab|avelumab|mesh-list
24980812|NCT04902040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24980813|NCT04902040|Immunoglobulin G|immunoglobulin g|mesh-list
24980814|NCT04902040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24980815|NCT04902040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980816|NCT04902040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24980817|NCT04902040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980819|NCT04902040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980820|NCT04896697|Pembrolizumab|pembrolizumab|mesh-list
24980821|NCT04896697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24980822|NCT04896697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980824|NCT04874610|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24980825|NCT04874610|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24980826|NCT04874610|Prednisolone|prednisolone|mesh-list
24980827|NCT04874610|Prednisolone acetate|prednisolone acetate|mesh-list
24980828|NCT04874610|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24980829|NCT04874610|Prednisolone phosphate|prednisolone phosphate|mesh-list
24980830|NCT04874610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24980831|NCT04874610|Antiemetics|antiemetics|mesh-ancestor
24980832|NCT04874610|Autonomic Agents|autonomic agents|mesh-ancestor
24980833|NCT04874610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24980834|NCT04874610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24980835|NCT04874610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24980836|NCT04874610|Glucocorticoids|glucocorticoids|mesh-ancestor
24980837|NCT04874610|Hormones|hormones|mesh-ancestor
24980840|NCT04874610|Protective Agents|protective agents|mesh-ancestor
24980856|NCT04823052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980857|NCT04823052|Anticonvulsants|anticonvulsants|mesh-ancestor
24980858|NCT04823052|GABA Agonists|gaba agonists|mesh-ancestor
24980859|NCT04823052|GABA Agents|gaba agents|mesh-ancestor
24980860|NCT04823052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24980861|NCT04783857|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24980862|NCT04783857|Medroxyprogesterone|medroxyprogesterone|mesh-list
24980863|NCT04783857|Progesterone|progesterone|mesh-list
24980864|NCT04783857|Progestins|progestins|mesh-ancestor
24980866|NCT04783857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24980867|NCT04783857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450551|NCT00319566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24980868|NCT04783857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24980869|NCT04783857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24980870|NCT04783857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24980871|NCT04783857|Contraceptive Agents|contraceptive agents|mesh-ancestor
24980872|NCT04783857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24783970|NCT01905137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783971|NCT01905137|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24783972|NCT01905137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24448450|NCT00311870|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24783974|NCT01905150|Ascorbic Acid|ascorbic acid|mesh-list
24783975|NCT01905150|Gemcitabine|gemcitabine|mesh-list
24783976|NCT01905150|Fluorouracil|fluorouracil|mesh-list
24783977|NCT01905150|Docetaxel|docetaxel|mesh-list
24783978|NCT01905150|Oxaliplatin|oxaliplatin|mesh-list
24783979|NCT01905150|Irinotecan|irinotecan|mesh-list
24783980|NCT01905150|Mitomycins|mitomycins|mesh-list
24783981|NCT01905150|Mitomycin|mitomycin|mesh-list
24783982|NCT01905150|Levoleucovorin|levoleucovorin|mesh-list
24783983|NCT01905150|Vitamins|vitamins|mesh-ancestor
25106116|NCT04443569|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25106117|NCT04443569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25106118|NCT04443569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106120|NCT04356638|Dexmedetomidine|dexmedetomidine|mesh-list
25106121|NCT04356638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25705457|NCT02199041|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24884207|NCT02687386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884208|NCT02687386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24884209|NCT02687386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24884210|NCT02687386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24884211|NCT02687386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505779|NCT00542412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24505780|NCT00542412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106122|NCT04356638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25106123|NCT04356638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448430|NCT00311753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24980902|NCT04774393|Decitabine|decitabine|mesh-list
24980903|NCT04774393|Venetoclax|venetoclax|mesh-list
24980904|NCT04774393|Ivosidenib|ivosidenib|mesh-list
24980905|NCT04774393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24980906|NCT04774393|Antimetabolites|antimetabolites|mesh-ancestor
24980907|NCT04774393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24980908|NCT04774393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24980909|NCT04774393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24980940|NCT04739358|Tepotinib|tepotinib|mesh-list
24980958|NCT04715763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24980959|NCT04715763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24980960|NCT04715763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24980961|NCT04715763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448590|NCT00312273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25705458|NCT02199041|Prednisolone phosphate|prednisolone phosphate|mesh-list
25705459|NCT02199041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25705460|NCT02199041|Immunologic Factors|immunologic factors|mesh-ancestor
25705461|NCT02199041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705462|NCT02199041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25705463|NCT02199041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25705464|NCT02199041|Alkylating Agents|alkylating agents|mesh-ancestor
25705465|NCT02199041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705466|NCT02199041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25705467|NCT02199041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24506444|NCT00545311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506445|NCT00545311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448591|NCT00312273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448592|NCT00312273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448594|NCT00312273|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24980996|NCT04634409|Antiviral Agents|antiviral agents|mesh-ancestor
24980997|NCT04634409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24981001|NCT04606914|Maytansine|maytansine|mesh-list
24981002|NCT04606914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24981003|NCT04606914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24981004|NCT04606914|Tubulin Modulators|tubulin modulators|mesh-ancestor
24981005|NCT04606914|Antimitotic Agents|antimitotic agents|mesh-ancestor
24981006|NCT04606914|Mitosis Modulators|mitosis modulators|mesh-ancestor
24981007|NCT04606914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981008|NCT04551144|Methyltestosterone|methyltestosterone|mesh-list
24981009|NCT04551144|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24981010|NCT04551144|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24981011|NCT04551144|Estradiol|estradiol|mesh-list
24981012|NCT04551144|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24981013|NCT04551144|Testosterone|testosterone|mesh-list
24795617|NCT01369147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795618|NCT01369147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24795619|NCT01369147|Anesthetics, General|anesthetics, general|mesh-ancestor
24795620|NCT01369147|Anesthetics|anesthetics|mesh-ancestor
24795621|NCT01369147|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24795622|NCT01369147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24981040|NCT04521114|Leronlimab|leronlimab|mesh-list
24981041|NCT04521114|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24981042|NCT04521114|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24981044|NCT04521114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24981061|NCT04504942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24981062|NCT04504942|Antiviral Agents|antiviral agents|mesh-ancestor
24981063|NCT04504942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24981122|NCT04420195|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24981123|NCT04420195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24981124|NCT04420195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919155|NCT04214054|Calcium|calcium|mesh-list
24981155|NCT04373369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24981156|NCT04373369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24981157|NCT04373369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981158|NCT04360551|Telmisartan|telmisartan|mesh-list
24981159|NCT04360551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24981160|NCT04360551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24981161|NCT04360551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24981162|NCT04360551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981163|NCT04354025|Cytarabine|cytarabine|mesh-list
25705468|NCT02199041|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25705469|NCT02199041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25705470|NCT02199041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25705471|NCT02199041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25705472|NCT02199041|Antitubercular Agents|antitubercular agents|mesh-ancestor
25705473|NCT02199041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25705474|NCT02199041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25705475|NCT02199041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25106180|NCT04233749|Coagulants|coagulants|mesh-ancestor
24784017|NCT01905371|Dopamine Agents|dopamine agents|mesh-ancestor
24784018|NCT01905371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24784019|NCT01905371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784020|NCT01905371|Adrenergic Agents|adrenergic agents|mesh-ancestor
24784021|NCT01905371|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24784022|NCT01905371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24459194|NCT00343850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24784028|NCT01905566|Clopidogrel|clopidogrel|mesh-list
24784030|NCT01905566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24784031|NCT01905566|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24784038|NCT01905618|Nicotine|nicotine|mesh-list
25106128|NCT04356638|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25106129|NCT04356638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25106130|NCT04356638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25106131|NCT04356638|Adrenergic Agents|adrenergic agents|mesh-ancestor
25106132|NCT04356638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25106133|NCT04356638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106134|NCT04356638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25106135|NCT04356638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25106136|NCT04356638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25106137|NCT04356638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25106138|NCT04356638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25106139|NCT04356638|Anesthetics, General|anesthetics, general|mesh-ancestor
25106153|NCT04346108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106155|NCT04327310|Antiviral Agents|antiviral agents|mesh-ancestor
25106156|NCT04327310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25106157|NCT04237792|Dexmedetomidine|dexmedetomidine|mesh-list
25106158|NCT04237792|Propofol|propofol|mesh-list
25106159|NCT04237792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25106160|NCT04237792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25106161|NCT04237792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106162|NCT04237792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25106163|NCT04237792|Anesthetics, General|anesthetics, general|mesh-ancestor
25106164|NCT04237792|Anesthetics|anesthetics|mesh-ancestor
25106165|NCT04237792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25106166|NCT04237792|Analgesics|analgesics|mesh-ancestor
25106167|NCT04237792|Sensory System Agents|sensory system agents|mesh-ancestor
24981270|NCT04022876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795625|NCT01197066|Certolizumab Pegol|certolizumab pegol|mesh-list
24805810|NCT02012088|Hormones|hormones|mesh-ancestor
24795626|NCT01197066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24981276|NCT04022876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24981346|NCT03648892|Fallypride|fallypride|mesh-list
24981347|NCT03648892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24981348|NCT03648892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24981349|NCT03648892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24981350|NCT03648892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981351|NCT03648892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24981352|NCT03648892|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24981436|NCT03367715|Ipilimumab|ipilimumab|mesh-list
24981438|NCT03367715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24981439|NCT03367715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24981440|NCT03367715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449286|NCT00314873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24449287|NCT00314873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449288|NCT00314873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449290|NCT00314912|Anticonvulsants|anticonvulsants|mesh-ancestor
24449345|NCT00315042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24449347|NCT00315081|Bromocriptine|bromocriptine|mesh-list
24795633|NCT01124695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24981477|NCT03132454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981478|NCT03132454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24981501|NCT03092817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24981502|NCT03092817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24981504|NCT03075462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24981505|NCT03075462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24981506|NCT03075462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24981507|NCT03075462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981508|NCT03040999|Cisplatin|cisplatin|mesh-list
25705476|NCT02199041|Antiemetics|antiemetics|mesh-ancestor
25705477|NCT02199041|Autonomic Agents|autonomic agents|mesh-ancestor
25705478|NCT02199041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25705479|NCT02199041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25705480|NCT02199041|Glucocorticoids|glucocorticoids|mesh-ancestor
25705481|NCT02199041|Hormones|hormones|mesh-ancestor
25705482|NCT02199041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25705483|NCT02199041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25705484|NCT02199041|Protective Agents|protective agents|mesh-ancestor
25705485|NCT02199041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24449475|NCT00315744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24981538|NCT02820519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24981539|NCT02820519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981543|NCT02795182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24981544|NCT02795182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981555|NCT02682511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25705486|NCT02199041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25705487|NCT02199080|Fibrin fragment D|fibrin fragment d|mesh-list
25705488|NCT02199080|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25705489|NCT02199080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25705490|NCT02199080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705491|NCT02199080|Hemostatics|hemostatics|mesh-ancestor
25705492|NCT02199080|Coagulants|coagulants|mesh-ancestor
25705493|NCT02199197|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
24981612|NCT02343042|Immunologic Factors|immunologic factors|mesh-ancestor
24981613|NCT02343042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24981614|NCT02343042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24981615|NCT02343042|Growth Substances|growth substances|mesh-ancestor
24981616|NCT02343042|Growth Inhibitors|growth inhibitors|mesh-ancestor
24981617|NCT02343042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25705494|NCT02199197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25705495|NCT02199314|Desflurane|desflurane|mesh-list
25705496|NCT02199314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25705497|NCT02199314|Anesthetics, General|anesthetics, general|mesh-ancestor
25705498|NCT02199314|Anesthetics|anesthetics|mesh-ancestor
25705499|NCT02199314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25705500|NCT02199314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705501|NCT02199496|Ustekinumab|ustekinumab|mesh-list
25106195|NCT04210180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106196|NCT04175886|Tofacitinib|tofacitinib|mesh-list
25106197|NCT04175886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25705502|NCT02199496|Dermatologic Agents|dermatologic agents|mesh-ancestor
25705503|NCT02199509|Levetiracetam|levetiracetam|mesh-list
25705504|NCT02199509|Anticonvulsants|anticonvulsants|mesh-ancestor
25705505|NCT02199509|Nootropic Agents|nootropic agents|mesh-ancestor
25705506|NCT02199574|Bupivacaine|bupivacaine|mesh-list
25705507|NCT02199574|Anesthetics, Local|anesthetics, local|mesh-ancestor
25705508|NCT02199574|Anesthetics|anesthetics|mesh-ancestor
25705509|NCT02199574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25705510|NCT02199574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705511|NCT02199574|Sensory System Agents|sensory system agents|mesh-ancestor
24981793|NCT01759238|Antimetabolites|antimetabolites|mesh-ancestor
24981794|NCT01759238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24981795|NCT01495598|Pomalidomide|pomalidomide|mesh-list
24981796|NCT01495598|Immunologic Factors|immunologic factors|mesh-ancestor
24981797|NCT01495598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24981798|NCT01495598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24981799|NCT01495598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24981800|NCT01495598|Growth Substances|growth substances|mesh-ancestor
24981801|NCT01495598|Growth Inhibitors|growth inhibitors|mesh-ancestor
24981802|NCT01495598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24981803|NCT01320280|Afatinib|afatinib|mesh-list
24459420|NCT00344617|Bevacizumab|bevacizumab|mesh-list
24795661|NCT01097746|Immunologic Factors|immunologic factors|mesh-ancestor
24784091|NCT01905904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24784093|NCT01906073|Fentanyl|fentanyl|mesh-list
25705513|NCT02199652|Prazosin|prazosin|mesh-list
25705514|NCT02199652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25705515|NCT02199652|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25705516|NCT02199652|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25705517|NCT02199652|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25705518|NCT02199652|Adrenergic Agents|adrenergic agents|mesh-ancestor
25705519|NCT02199652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25705520|NCT02199652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705525|NCT02199743|Perphenazine|perphenazine|mesh-list
25705526|NCT02199743|Antiemetics|antiemetics|mesh-ancestor
25705527|NCT02199743|Autonomic Agents|autonomic agents|mesh-ancestor
25705528|NCT02199743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25705529|NCT02199743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705530|NCT02199743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25705535|NCT02199743|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25705536|NCT02199743|Dopamine Agents|dopamine agents|mesh-ancestor
25705537|NCT02199743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25705538|NCT02199743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106306|NCT03095456|Tiotropium Bromide|tiotropium bromide|mesh-list
25106307|NCT03095456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25106308|NCT03095456|Autonomic Agents|autonomic agents|mesh-ancestor
25106309|NCT03095456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25106310|NCT03095456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106311|NCT03095456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25705556|NCT02199964|Antifungal Agents|antifungal agents|mesh-ancestor
25705557|NCT02199964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25705558|NCT02199964|Dermatologic Agents|dermatologic agents|mesh-ancestor
25705559|NCT02199964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25705560|NCT02199964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25705561|NCT02199964|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25705562|NCT02199964|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25705563|NCT02201212|Everolimus|everolimus|mesh-list
25705564|NCT02201212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24982123|NCT04245436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982124|NCT04245436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24982125|NCT04245436|Serotonin Agents|serotonin agents|mesh-ancestor
24982126|NCT04245436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982127|NCT04245436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24982128|NCT04245436|Antidepressive Agents|antidepressive agents|mesh-ancestor
24982129|NCT04245436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24982130|NCT04245436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24982131|NCT04245436|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24982132|NCT04245436|Analgesics|analgesics|mesh-ancestor
24982133|NCT04245436|Sensory System Agents|sensory system agents|mesh-ancestor
24982134|NCT04245436|Dopamine Agents|dopamine agents|mesh-ancestor
24982135|NCT04221997|Sertraline|sertraline|mesh-list
24982150|NCT04130828|Ferrous fumarate|ferrous fumarate|mesh-list
24982151|NCT04130828|Trace Elements|trace elements|mesh-ancestor
24982152|NCT04130828|Micronutrients|micronutrients|mesh-ancestor
24982153|NCT04130828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982154|NCT03881059|Ustekinumab|ustekinumab|mesh-list
24982155|NCT03881059|BMS-986165|bms-986165|mesh-list
24982156|NCT03881059|Dermatologic Agents|dermatologic agents|mesh-ancestor
24982157|NCT03881059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24982158|NCT03881059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24982323|NCT03073785|Fluorouracil|fluorouracil|mesh-list
24982159|NCT03881059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982160|NCT03837860|Oxycodone|oxycodone|mesh-list
24982161|NCT03837860|Risperidone|risperidone|mesh-list
25705572|NCT02201329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25705573|NCT02201329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25705574|NCT02201394|Aspirin|aspirin|mesh-list
25705575|NCT02201394|Ticagrelor|ticagrelor|mesh-list
25705576|NCT02201394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25705577|NCT02201394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25705578|NCT02201394|Analgesics|analgesics|mesh-ancestor
25705579|NCT02201394|Sensory System Agents|sensory system agents|mesh-ancestor
25705580|NCT02201394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25705581|NCT02201394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705582|NCT02201394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24982190|NCT03583697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982191|NCT03582137|Cannabidiol|cannabidiol|mesh-list
24982192|NCT03582137|Anticonvulsants|anticonvulsants|mesh-ancestor
24982193|NCT03526848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24982194|NCT03526848|Antibodies|antibodies|mesh-list
24982195|NCT03526848|Immunoglobulins|immunoglobulins|mesh-list
24982196|NCT03526848|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24982197|NCT03526848|Immunologic Factors|immunologic factors|mesh-ancestor
24982198|NCT03526848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982199|NCT03526848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24982200|NCT03501381|Aldesleukin|aldesleukin|mesh-list
24982201|NCT03501381|Interleukin-2|interleukin-2|mesh-list
24982202|NCT03501381|Entinostat|entinostat|mesh-list
24982203|NCT03501381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25705589|NCT02201394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25705590|NCT02201394|Antipyretics|antipyretics|mesh-ancestor
25705591|NCT02201394|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24982331|NCT03073785|Immunologic Factors|immunologic factors|mesh-ancestor
24982332|NCT03073785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982333|NCT03073785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24982334|NCT03073785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24982335|NCT03047135|Olaparib|olaparib|mesh-list
24982336|NCT03047135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24982337|NCT03047135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24982338|NCT03047135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982339|NCT03047135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24982340|NCT03035630|Sunitinib|sunitinib|mesh-list
24982341|NCT03035630|Avelumab|avelumab|mesh-list
24982342|NCT03035630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784194|NCT01906814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24784195|NCT01906814|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25106319|NCT03084523|Hematinics|hematinics|mesh-ancestor
25106320|NCT03084523|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25106321|NCT03084523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25106322|NCT03070301|Everolimus|everolimus|mesh-list
25106323|NCT03070301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106339|NCT03049540|Vasodilator Agents|vasodilator agents|mesh-ancestor
25106340|NCT03049540|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25106341|NCT03049540|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25106342|NCT03049540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25106343|NCT03049540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106344|NCT03049540|Urological Agents|urological agents|mesh-ancestor
25106345|NCT02940769|Methamphetamine|methamphetamine|mesh-list
25106346|NCT02940769|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25106347|NCT02940769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106348|NCT02940769|Sympathomimetics|sympathomimetics|mesh-ancestor
25106349|NCT02940769|Autonomic Agents|autonomic agents|mesh-ancestor
25705609|NCT02201771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25705610|NCT02201771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25705611|NCT02201771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25705612|NCT02201771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705613|NCT02201771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25705614|NCT02201771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25705615|NCT02201771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24890360|NCT04483596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24453445|NCT05008224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24453446|NCT05008224|Alkylating Agents|alkylating agents|mesh-ancestor
24453447|NCT05008224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24453448|NCT05008224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24453449|NCT05008224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24453450|NCT05008224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24453451|NCT05008224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24453452|NCT05008224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24453453|NCT05008224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24453454|NCT05008224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24453455|NCT05008224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25106366|NCT02919683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25106368|NCT02919683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25106369|NCT02919683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106373|NCT02890459|Denatonium|denatonium|mesh-list
25106374|NCT02890459|Aversive Agents|aversive agents|mesh-ancestor
25106375|NCT02890459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106376|NCT02890459|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
25106377|NCT02890459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106378|NCT02890459|Sensory System Agents|sensory system agents|mesh-ancestor
25106379|NCT02890459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25106380|NCT02820311|Moxifloxacin|moxifloxacin|mesh-list
25106381|NCT02820311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25106382|NCT02820311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25106383|NCT02820311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25106384|NCT02820311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25106385|NCT02820311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25705616|NCT02201771|Antipyretics|antipyretics|mesh-ancestor
25705617|NCT02201771|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25705618|NCT02201771|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25705619|NCT02201771|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25705620|NCT02201771|Purinergic Agents|purinergic agents|mesh-ancestor
25705621|NCT02201771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25705622|NCT02201784|Ropivacaine|ropivacaine|mesh-list
25705623|NCT02201784|Levobupivacaine|levobupivacaine|mesh-list
25705624|NCT02201784|Anesthetics, Local|anesthetics, local|mesh-ancestor
25705625|NCT02201784|Anesthetics|anesthetics|mesh-ancestor
25106389|NCT02812667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24982344|NCT03035630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24982345|NCT03035630|Growth Substances|growth substances|mesh-ancestor
24982346|NCT03035630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982347|NCT03035630|Growth Inhibitors|growth inhibitors|mesh-ancestor
24982348|NCT03035630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24982349|NCT03035630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24982350|NCT03035630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982351|NCT03035630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24982352|NCT02962297|Vitamin E|vitamin e|mesh-list
24982353|NCT02962297|Vitamins|vitamins|mesh-ancestor
24982354|NCT02962297|Micronutrients|micronutrients|mesh-ancestor
24982355|NCT02962297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982356|NCT02962297|Antioxidants|antioxidants|mesh-ancestor
24982357|NCT02962297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982358|NCT02962297|Protective Agents|protective agents|mesh-ancestor
24982360|NCT02913664|Amlodipine|amlodipine|mesh-list
24982361|NCT02913664|Calcium Channel Blockers|calcium channel blockers|mesh-list
24982390|NCT02818582|Antimetabolites|antimetabolites|mesh-ancestor
24982391|NCT02818582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982392|NCT02818582|Antiviral Agents|antiviral agents|mesh-ancestor
24982393|NCT02818582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24982394|NCT02703623|Prednisone|prednisone|mesh-list
24982395|NCT02703623|Cortisone|cortisone|mesh-list
24982403|NCT02703623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24982411|NCT02703623|Hormone Antagonists|hormone antagonists|mesh-ancestor
24982412|NCT02703623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24982475|NCT02596503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24982477|NCT02581215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24982478|NCT02554253|Ketamine|ketamine|mesh-list
24982479|NCT02554253|Propofol|propofol|mesh-list
24982480|NCT02554253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24982481|NCT02554253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24982482|NCT02554253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982483|NCT02554253|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24982484|NCT02554253|Anesthetics, General|anesthetics, general|mesh-ancestor
24982485|NCT02554253|Anesthetics|anesthetics|mesh-ancestor
24982486|NCT02554253|Analgesics|analgesics|mesh-ancestor
24982487|NCT02554253|Sensory System Agents|sensory system agents|mesh-ancestor
24982488|NCT02554253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24982553|NCT02308527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24982554|NCT02308527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24982555|NCT02308527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24982556|NCT02308527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24982557|NCT02308527|Growth Substances|growth substances|mesh-ancestor
24982558|NCT02308527|Growth Inhibitors|growth inhibitors|mesh-ancestor
24982559|NCT02308527|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24982560|NCT02308527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24982561|NCT02308527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24982563|NCT02121184|Oxytocics|oxytocics|mesh-ancestor
24982564|NCT02121184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24982565|NCT02121184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106395|NCT02797275|Autonomic Agents|autonomic agents|mesh-ancestor
24795775|NCT01945983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24795776|NCT01945983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795777|NCT01945983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795778|NCT01945983|Sympathomimetics|sympathomimetics|mesh-ancestor
24795779|NCT01945983|Autonomic Agents|autonomic agents|mesh-ancestor
24795780|NCT01945983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24795789|NCT01946035|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24795790|NCT01946035|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24795791|NCT01946035|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24795792|NCT01946035|Adrenergic Agents|adrenergic agents|mesh-ancestor
24795793|NCT01946035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24795794|NCT01946035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705628|NCT02201784|Sensory System Agents|sensory system agents|mesh-ancestor
25705629|NCT02201784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25705631|NCT02201901|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25705632|NCT02201901|Velpatasvir|velpatasvir|mesh-list
25705633|NCT02201901|Antiviral Agents|antiviral agents|mesh-ancestor
24982670|NCT01041807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24982689|NCT00739674|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24982690|NCT00739674|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24982691|NCT00739674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982693|NCT00739674|Natriuretic Agents|natriuretic agents|mesh-ancestor
24982694|NCT00739674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24982695|NCT00739674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24982696|NCT00731757|Adalimumab|adalimumab|mesh-list
24982697|NCT00731757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24982698|NCT00731757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24982699|NCT00730717|Adalimumab|adalimumab|mesh-list
24982700|NCT00730717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24982701|NCT00730717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24982702|NCT00546754|Losartan|losartan|mesh-list
24982704|NCT00546754|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24982705|NCT00546754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24982706|NCT00546754|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24982707|NCT00546754|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24982708|NCT00546754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982709|NCT00546754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24982710|NCT00546754|Diuretics|diuretics|mesh-ancestor
24982711|NCT00546754|Natriuretic Agents|natriuretic agents|mesh-ancestor
24982712|NCT00546754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982713|NCT00546754|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24982714|NCT00546754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25705634|NCT02201901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25705635|NCT02201940|Sofosbuvir|sofosbuvir|mesh-list
25705636|NCT02201940|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25705637|NCT02201940|Velpatasvir|velpatasvir|mesh-list
25705638|NCT02201940|Antiviral Agents|antiviral agents|mesh-ancestor
25705639|NCT02201940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25705640|NCT02201953|Sofosbuvir|sofosbuvir|mesh-list
25705641|NCT02201953|Antiviral Agents|antiviral agents|mesh-ancestor
25705642|NCT02201953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24891418|NCT04470908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24982740|NCT00479713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982741|NCT00479713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24982742|NCT00479713|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24982743|NCT00479713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24982745|NCT00457275|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24795795|NCT01946035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795796|NCT01946061|Oxaliplatin|oxaliplatin|mesh-list
24795797|NCT01946061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795799|NCT01946256|Erythromycin|erythromycin|mesh-list
24795800|NCT01946256|Erythromycin Estolate|erythromycin estolate|mesh-list
24450892|NCT00320853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24450894|NCT00320879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24450895|NCT00320879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24450896|NCT00320879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24795805|NCT01946256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24795806|NCT01946256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24795808|NCT01946256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795809|NCT01946295|Famotidine|famotidine|mesh-list
24795810|NCT01946295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24795811|NCT01946295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24795812|NCT01946295|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24795813|NCT01946295|Histamine Antagonists|histamine antagonists|mesh-ancestor
24795814|NCT01946295|Histamine Agents|histamine agents|mesh-ancestor
24795815|NCT01946295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24920631|NCT04200885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24982746|NCT00457275|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24444423|NCT00297960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24444424|NCT00297960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444425|NCT00297960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24444426|NCT00297960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24444427|NCT00297960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24444428|NCT00297960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24444429|NCT00297960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24982757|NCT00406783|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25705643|NCT02202135|Vancomycin|vancomycin|mesh-list
25705644|NCT02202135|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
25705645|NCT02202135|Aztreonam|aztreonam|mesh-list
25705646|NCT02202135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25705647|NCT02202135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25705648|NCT02202161|Metformin|metformin|mesh-list
25705649|NCT02202161|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25705650|NCT02202161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25705651|NCT02202161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705652|NCT02202161|Incretins|incretins|mesh-ancestor
24891528|NCT04470310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24891553|NCT04470050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24891554|NCT04470050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891556|NCT04469829|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24891557|NCT04469829|Abortifacient Agents|abortifacient agents|mesh-ancestor
24982758|NCT00406783|Cholinergic Agents|cholinergic agents|mesh-ancestor
24982759|NCT00406783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24982760|NCT00406783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982761|NCT00406783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982762|NCT00406783|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24982763|NCT00406783|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24982764|NCT00406783|Histamine Antagonists|histamine antagonists|mesh-ancestor
24982768|NCT00405964|Cholinergic Agents|cholinergic agents|mesh-ancestor
24982769|NCT00405964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24982770|NCT00405964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982771|NCT00405964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982772|NCT00405964|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24982773|NCT00405964|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24982774|NCT00405964|Histamine Antagonists|histamine antagonists|mesh-ancestor
24784371|NCT01907633|Domperidone|domperidone|mesh-list
24784372|NCT01907633|Antiemetics|antiemetics|mesh-ancestor
24784373|NCT01907633|Autonomic Agents|autonomic agents|mesh-ancestor
24784374|NCT01907633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24784375|NCT01907633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784376|NCT01907633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24784377|NCT01907633|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24784378|NCT01907633|Dopamine Agents|dopamine agents|mesh-ancestor
24784379|NCT01907633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24784380|NCT01907633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784381|NCT01907685|Docetaxel|docetaxel|mesh-list
24784382|NCT01907685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784383|NCT01907685|Tubulin Modulators|tubulin modulators|mesh-ancestor
24784384|NCT01907685|Antimitotic Agents|antimitotic agents|mesh-ancestor
24784385|NCT01907685|Mitosis Modulators|mitosis modulators|mesh-ancestor
24982830|NCT00383552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982831|NCT00383552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24982832|NCT00383552|Dermatologic Agents|dermatologic agents|mesh-ancestor
25705653|NCT02202161|Hormones|hormones|mesh-ancestor
25705654|NCT02202161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25705655|NCT02202161|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25705656|NCT02202161|Protease Inhibitors|protease inhibitors|mesh-ancestor
25705657|NCT02202161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25705658|NCT02202161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705659|NCT02202499|Varenicline|varenicline|mesh-list
25705660|NCT02202499|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25705661|NCT02202499|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25705662|NCT02202499|Cholinergic Agents|cholinergic agents|mesh-ancestor
25705663|NCT02202499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24982833|NCT00383552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24982834|NCT00383435|Mometasone Furoate|mometasone furoate|mesh-list
24982835|NCT00383435|Formoterol Fumarate|formoterol fumarate|mesh-list
24982836|NCT00383435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24982837|NCT00383435|Autonomic Agents|autonomic agents|mesh-ancestor
24982838|NCT00383435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24982839|NCT00383435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982840|NCT00383435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24982841|NCT00383435|Respiratory System Agents|respiratory system agents|mesh-ancestor
24982842|NCT00383435|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24982868|NCT00379288|Fluticasone|fluticasone|mesh-list
24982883|NCT00379288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24982884|NCT00379288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24982885|NCT00379288|Adrenergic Agents|adrenergic agents|mesh-ancestor
24982886|NCT00379288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24982887|NCT00379288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982888|NCT00379288|Glucocorticoids|glucocorticoids|mesh-ancestor
24906944|NCT04334993|Blinatumomab|blinatumomab|mesh-list
24982895|NCT00378378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24982897|NCT00338260|Adrenergic Agents|adrenergic agents|mesh-ancestor
24982898|NCT00338260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24982899|NCT00338260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982900|NCT00338260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982901|NCT00338260|Autonomic Agents|autonomic agents|mesh-ancestor
24982902|NCT00338260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24982903|NCT00338260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24982904|NCT00338260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24982905|NCT00338260|Sympatholytics|sympatholytics|mesh-ancestor
24982906|NCT00338260|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24982908|NCT00338260|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24394550|NCT00133523|Immunologic Factors|immunologic factors|mesh-ancestor
24982909|NCT00308347|Losartan|losartan|mesh-list
24982910|NCT00308347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24982911|NCT00308347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24982912|NCT00308347|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24982913|NCT00308347|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24982914|NCT00308347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982915|NCT00307060|Losartan|losartan|mesh-list
24982916|NCT00307060|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24982917|NCT00307060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24982918|NCT00307060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24982919|NCT00307060|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24982926|NCT00307060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24982927|NCT00157963|Losartan|losartan|mesh-list
25705664|NCT02202499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705665|NCT02202499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705666|NCT02202551|Amantadine|amantadine|mesh-list
25705667|NCT02202551|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25705668|NCT02202551|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25705669|NCT02202551|Antiviral Agents|antiviral agents|mesh-ancestor
25705670|NCT02202551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25705671|NCT02202551|Dopamine Agents|dopamine agents|mesh-ancestor
24982929|NCT00157963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24394552|NCT00133549|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24394554|NCT00133549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394556|NCT00133562|Glycine Agents|glycine agents|mesh-ancestor
24455269|NCT01972217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24455270|NCT01972217|Glucocorticoids|glucocorticoids|mesh-ancestor
24455271|NCT01972217|Hormones|hormones|mesh-ancestor
24455272|NCT01972217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24455273|NCT01972217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455274|NCT01972217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24455275|NCT01972217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24455276|NCT01972217|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24455277|NCT01972217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24982935|NCT00157963|Natriuretic Agents|natriuretic agents|mesh-ancestor
24982938|NCT00157963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24982939|NCT00151424|Olanzapine|olanzapine|mesh-list
24982940|NCT00151424|Asenapine|asenapine|mesh-list
24982941|NCT00151424|Antiemetics|antiemetics|mesh-ancestor
24982942|NCT00151424|Autonomic Agents|autonomic agents|mesh-ancestor
24982943|NCT00151424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24982944|NCT00151424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24982945|NCT00151424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24982946|NCT00151424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24982947|NCT00151424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24982948|NCT00151424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24982949|NCT00151424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24982950|NCT00151424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24982951|NCT00151424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24982952|NCT00151424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24907063|NCT04333628|Chloroquine|chloroquine|mesh-list
24907064|NCT04333628|Amebicides|amebicides|mesh-ancestor
24982953|NCT00151424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982954|NCT00151424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24982955|NCT00151424|Serotonin Agents|serotonin agents|mesh-ancestor
24982984|NCT00092651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24982985|NCT00092638|Ezetimibe|ezetimibe|mesh-list
24982986|NCT00092638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24982987|NCT00092638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24982988|NCT00092638|Antimetabolites|antimetabolites|mesh-ancestor
24982989|NCT00092638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24982990|NCT00092638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25106506|NCT02642315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106507|NCT02642315|Antimanic Agents|antimanic agents|mesh-ancestor
25106513|NCT02631447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106515|NCT02586831|Aldesleukin|aldesleukin|mesh-list
25106516|NCT02586831|Adalimumab|adalimumab|mesh-list
25106517|NCT02586831|Interleukin-2|interleukin-2|mesh-list
24455314|NCT01808599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24892018|NCT04466241|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24892019|NCT04466241|Protease Inhibitors|protease inhibitors|mesh-ancestor
24892020|NCT04466241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24816917|NCT02079727|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24816918|NCT02079727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24892055|NCT04465942|Tubulin Modulators|tubulin modulators|mesh-ancestor
24892056|NCT04465942|Antimitotic Agents|antimitotic agents|mesh-ancestor
24892057|NCT04465942|Mitosis Modulators|mitosis modulators|mesh-ancestor
24892058|NCT04465942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892059|NCT04465942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24892060|NCT04465942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24455315|NCT01808599|Immunologic Factors|immunologic factors|mesh-ancestor
24455316|NCT01808599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455317|NCT01808599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24455318|NCT01808599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25106518|NCT02586831|Thymoglobulin|thymoglobulin|mesh-list
25106519|NCT02586831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25106520|NCT02586831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25106521|NCT02586831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25106522|NCT02586831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106523|NCT02586831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25106524|NCT02586831|Analgesics|analgesics|mesh-ancestor
25106525|NCT02586831|Sensory System Agents|sensory system agents|mesh-ancestor
25106532|NCT02586831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25106533|NCT02586831|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25106534|NCT02586831|Incretins|incretins|mesh-ancestor
25106536|NCT02586831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25106537|NCT02586831|Immunologic Factors|immunologic factors|mesh-ancestor
24455319|NCT01808599|Alkylating Agents|alkylating agents|mesh-ancestor
24455320|NCT01808599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455322|NCT01795586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24394577|NCT00133692|Atenolol|atenolol|mesh-list
24394578|NCT00133692|Verapamil|verapamil|mesh-list
24394579|NCT00133692|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24983064|NCT00090181|Sensory System Agents|sensory system agents|mesh-ancestor
24983065|NCT00090181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25705672|NCT02202551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25705673|NCT02202551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705674|NCT02202551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705675|NCT02202551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25705676|NCT02202551|Analgesics|analgesics|mesh-ancestor
25705677|NCT02202551|Sensory System Agents|sensory system agents|mesh-ancestor
25705678|NCT02202551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25705679|NCT02202616|Glycopyrrolate|glycopyrrolate|mesh-list
25705680|NCT02202616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705681|NCT02202616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25705682|NCT02202616|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24983066|NCT00090181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983067|NCT00090181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24892173|NCT04465396|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24892174|NCT04465396|Protective Agents|protective agents|mesh-ancestor
24983068|NCT00090181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24983069|NCT00090181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24983070|NCT00090181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24983071|NCT00090181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983072|NCT00090181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24983075|NCT00090168|Ezetimibe|ezetimibe|mesh-list
24983076|NCT00090168|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24983077|NCT00090168|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24983078|NCT00090168|Antimetabolites|antimetabolites|mesh-ancestor
24983079|NCT00090168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983080|NCT00090168|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24983081|NCT00090168|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24983082|NCT00090168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24983083|NCT00089895|Eptifibatide|eptifibatide|mesh-list
24983084|NCT00089895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24983085|NCT02765854|Dexamethasone|dexamethasone|mesh-list
24983086|NCT02765854|Lenalidomide|lenalidomide|mesh-list
24983087|NCT02765854|Ixazomib|ixazomib|mesh-list
24983096|NCT02765854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24983097|NCT02765854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24983143|NCT02118610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24795823|NCT01946373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24444668|NCT00298857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444670|NCT00298857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24444702|NCT00298909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444703|NCT00298922|Azithromycin|azithromycin|mesh-list
24444704|NCT00298922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24444705|NCT00298922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24444706|NCT00298974|Acetaminophen|acetaminophen|mesh-list
24444707|NCT00298974|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
24444708|NCT00298974|Hydrocodone|hydrocodone|mesh-list
24444709|NCT00298974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24444710|NCT00298974|Analgesics|analgesics|mesh-ancestor
24444711|NCT00298974|Sensory System Agents|sensory system agents|mesh-ancestor
24444712|NCT00298974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24444713|NCT00298974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444714|NCT00298974|Antipyretics|antipyretics|mesh-ancestor
24444715|NCT00298974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24444716|NCT00298974|Narcotics|narcotics|mesh-ancestor
24394665|NCT00133861|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24394666|NCT00133861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24394667|NCT00133861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795832|NCT01946373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24795837|NCT01946373|Analgesics|analgesics|mesh-ancestor
24795838|NCT01946373|Sensory System Agents|sensory system agents|mesh-ancestor
24795839|NCT01946373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24795840|NCT01946386|Betamethasone|betamethasone|mesh-list
24795841|NCT01946386|Betamethasone Valerate|betamethasone valerate|mesh-list
24795842|NCT01946386|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24795843|NCT01946386|Betamethasone benzoate|betamethasone benzoate|mesh-list
24795845|NCT01946386|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24444717|NCT00298974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24444718|NCT00298974|Antitussive Agents|antitussive agents|mesh-ancestor
25705683|NCT02202616|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25705684|NCT02202616|Cholinergic Agents|cholinergic agents|mesh-ancestor
25705685|NCT02202616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25705686|NCT02202616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705687|NCT02202837|Etanercept|etanercept|mesh-list
25705688|NCT02202837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25705689|NCT02202837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25705690|NCT02202837|Analgesics|analgesics|mesh-ancestor
24907839|NCT04326959|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24892353|NCT04463875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24892354|NCT04463784|Efavirenz|efavirenz|mesh-list
24892357|NCT04463784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24513552|NCT00583271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24444759|NCT00299039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24394668|NCT00133861|Cholinergic Agents|cholinergic agents|mesh-ancestor
24394669|NCT00133861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24795846|NCT01946386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24795847|NCT01946386|Glucocorticoids|glucocorticoids|mesh-ancestor
24795848|NCT01946386|Hormones|hormones|mesh-ancestor
24795849|NCT01946386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24795854|NCT01946399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24795855|NCT01946399|Antiemetics|antiemetics|mesh-ancestor
24795856|NCT01946399|Autonomic Agents|autonomic agents|mesh-ancestor
24795857|NCT01946399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24795858|NCT01946399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795859|NCT01946399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24795860|NCT01946399|Glucocorticoids|glucocorticoids|mesh-ancestor
24795861|NCT01946399|Hormones|hormones|mesh-ancestor
24795862|NCT01946399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24795863|NCT01946399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24795864|NCT01946399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795865|NCT01946555|Fentanyl|fentanyl|mesh-list
24795866|NCT01946555|Morphine|morphine|mesh-list
24983171|NCT02083250|Alkylating Agents|alkylating agents|mesh-ancestor
24983172|NCT02083250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24983173|NCT02083250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24983174|NCT02083250|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24983175|NCT02083250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24983176|NCT01857934|Aldesleukin|aldesleukin|mesh-list
24983177|NCT01857934|Cyclophosphamide|cyclophosphamide|mesh-list
24983178|NCT01857934|Melphalan|melphalan|mesh-list
24983179|NCT01857934|Busulfan|busulfan|mesh-list
24983180|NCT01857934|Mechlorethamine|mechlorethamine|mesh-list
24983181|NCT01857934|Doxorubicin|doxorubicin|mesh-list
24983182|NCT01857934|Etoposide|etoposide|mesh-list
24983183|NCT01857934|Vincristine|vincristine|mesh-list
24983184|NCT01857934|Topotecan|topotecan|mesh-list
24983185|NCT01857934|Interleukin-2|interleukin-2|mesh-list
25705691|NCT02202837|Sensory System Agents|sensory system agents|mesh-ancestor
25705692|NCT02202837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25705693|NCT02202837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705694|NCT02202837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25705695|NCT02202837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25705696|NCT02202837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24983186|NCT01857934|Molgramostim|molgramostim|mesh-list
24983187|NCT01857934|Dinutuximab|dinutuximab|mesh-list
24983188|NCT01857934|Levetiracetam|levetiracetam|mesh-list
24983189|NCT01857934|Isotretinoin|isotretinoin|mesh-list
25705697|NCT02202837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25705698|NCT02202837|Immunologic Factors|immunologic factors|mesh-ancestor
25705699|NCT02202850|Etanercept|etanercept|mesh-list
24892465|NCT04462822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24892466|NCT04462822|Respiratory System Agents|respiratory system agents|mesh-ancestor
24892467|NCT04462822|Dermatologic Agents|dermatologic agents|mesh-ancestor
24892468|NCT04462822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24892469|NCT04462822|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24892470|NCT04462822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24892471|NCT04462822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24892472|NCT04462822|Adrenergic Agents|adrenergic agents|mesh-ancestor
24892473|NCT04462822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24892474|NCT04462822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892475|NCT04462822|Glucocorticoids|glucocorticoids|mesh-ancestor
24892476|NCT04462822|Hormones|hormones|mesh-ancestor
24892477|NCT04462822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24892478|NCT04462822|Sympathomimetics|sympathomimetics|mesh-ancestor
24892479|NCT04462809|Talazoparib|talazoparib|mesh-list
24892480|NCT04462809|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24983190|NCT01857934|Antibodies|antibodies|mesh-list
24983192|NCT01857934|Lenograstim|lenograstim|mesh-list
24983193|NCT01857934|Sargramostim|sargramostim|mesh-list
25705700|NCT02202850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25705701|NCT02202850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25705702|NCT02202850|Analgesics|analgesics|mesh-ancestor
24908030|NCT04325061|Dexamethasone|dexamethasone|mesh-list
25705703|NCT02202850|Sensory System Agents|sensory system agents|mesh-ancestor
25705704|NCT02202850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25705705|NCT02202850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705706|NCT02202850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25705707|NCT02202850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25705708|NCT02202850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25705709|NCT02202850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25705710|NCT02202850|Immunologic Factors|immunologic factors|mesh-ancestor
25705711|NCT02202980|Sofosbuvir|sofosbuvir|mesh-list
25705712|NCT02202980|Antiviral Agents|antiviral agents|mesh-ancestor
25705713|NCT02202980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25705714|NCT02203019|Fentanyl|fentanyl|mesh-list
25705715|NCT02203019|Dexmedetomidine|dexmedetomidine|mesh-list
25705716|NCT02203019|Propofol|propofol|mesh-list
25705717|NCT02203019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24513565|NCT00583427|Anticoagulants|anticoagulants|mesh-ancestor
24513566|NCT00583427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24513567|NCT00583427|Antimetabolites|antimetabolites|mesh-ancestor
24513568|NCT00583427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513569|NCT00583427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24892696|NCT04460443|Antiviral Agents|antiviral agents|mesh-ancestor
25106588|NCT02245672|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25106589|NCT02245672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25106590|NCT02245672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25106591|NCT02245672|Autonomic Agents|autonomic agents|mesh-ancestor
25106592|NCT02245672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25106593|NCT02245672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983233|NCT01841177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983235|NCT01697527|Cyclophosphamide|cyclophosphamide|mesh-list
24983236|NCT01697527|Fludarabine|fludarabine|mesh-list
24983237|NCT01697527|Fludarabine phosphate|fludarabine phosphate|mesh-list
24983238|NCT01697527|Interleukin-2|interleukin-2|mesh-list
24983239|NCT01697527|Vaccines|vaccines|mesh-list
24983240|NCT01697527|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24983241|NCT01697527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24983242|NCT01697527|Immunologic Factors|immunologic factors|mesh-ancestor
24983243|NCT01697527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983244|NCT01697527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24983245|NCT01697527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24983253|NCT01697527|Analgesics|analgesics|mesh-ancestor
24983254|NCT01697527|Sensory System Agents|sensory system agents|mesh-ancestor
24983255|NCT01697527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24983256|NCT01697527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24983257|NCT01697527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24983258|NCT01697527|Antiviral Agents|antiviral agents|mesh-ancestor
24983259|NCT01697527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24983260|NCT01697527|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24983293|NCT01444092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24983294|NCT01444092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983295|NCT01444092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24983296|NCT01444092|Respiratory System Agents|respiratory system agents|mesh-ancestor
24983297|NCT01444092|Glucocorticoids|glucocorticoids|mesh-ancestor
24983298|NCT01444092|Hormones|hormones|mesh-ancestor
24983299|NCT01444092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24983303|NCT01265784|Ertapenem|ertapenem|mesh-list
24983304|NCT01265784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24983305|NCT01265784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24983306|NCT00719966|Letrozole|letrozole|mesh-list
24983307|NCT00719966|Anastrozole|anastrozole|mesh-list
24983308|NCT00719966|Exemestane|exemestane|mesh-list
24983309|NCT00719966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784469|NCT01908257|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24784470|NCT01908257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24784471|NCT01908257|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24784472|NCT01908257|Histamine Antagonists|histamine antagonists|mesh-ancestor
25705718|NCT02203019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25705719|NCT02203019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705720|NCT02203019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25705721|NCT02203019|Anesthetics, General|anesthetics, general|mesh-ancestor
25705722|NCT02203019|Anesthetics|anesthetics|mesh-ancestor
25705723|NCT02203019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25705724|NCT02203019|Analgesics|analgesics|mesh-ancestor
25705725|NCT02203019|Sensory System Agents|sensory system agents|mesh-ancestor
25705726|NCT02203019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25705727|NCT02203019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25705728|NCT02203019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25705729|NCT02203019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25705730|NCT02203019|Adrenergic Agents|adrenergic agents|mesh-ancestor
24893029|NCT04455958|Protease Inhibitors|protease inhibitors|mesh-ancestor
24893030|NCT04455958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893031|NCT04455958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893033|NCT04455958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24893034|NCT04455958|Antiviral Agents|antiviral agents|mesh-ancestor
24893035|NCT04455958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24784473|NCT01908257|Histamine Agents|histamine agents|mesh-ancestor
24784474|NCT01908257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24784475|NCT01908257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784481|NCT01908283|Vaccines|vaccines|mesh-list
25106614|NCT02129751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106615|NCT02129751|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25106616|NCT02129751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25106617|NCT02129751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444829|NCT00299247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25106622|NCT01959633|Interferons|interferons|mesh-list
25106623|NCT01959633|Vemurafenib|vemurafenib|mesh-list
25106624|NCT01959633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106625|NCT01959633|Antiviral Agents|antiviral agents|mesh-ancestor
25106626|NCT01959633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24983371|NCT00392327|Mitosis Modulators|mitosis modulators|mesh-ancestor
24983372|NCT00392327|Keratolytic Agents|keratolytic agents|mesh-ancestor
24983373|NCT00392327|Dermatologic Agents|dermatologic agents|mesh-ancestor
24983374|NCT00116220|Goserelin|goserelin|mesh-list
24983375|NCT00116220|Flutamide|flutamide|mesh-list
24983410|NCT00085202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24983411|NCT00085202|Tubulin Modulators|tubulin modulators|mesh-ancestor
24983412|NCT00085202|Antimitotic Agents|antimitotic agents|mesh-ancestor
24983413|NCT00085202|Mitosis Modulators|mitosis modulators|mesh-ancestor
24983414|NCT05187507|Theobromine|theobromine|mesh-list
24983415|NCT05187507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24983416|NCT05187507|Autonomic Agents|autonomic agents|mesh-ancestor
24983417|NCT05187507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25705731|NCT02203019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25705732|NCT02203019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705733|NCT02203019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25705734|NCT02203019|Narcotics|narcotics|mesh-ancestor
25705735|NCT02203019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25705736|NCT02203032|Ustekinumab|ustekinumab|mesh-list
25705737|NCT02203032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25705738|NCT02203032|Dermatologic Agents|dermatologic agents|mesh-ancestor
24893590|NCT04447612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983418|NCT05187507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983419|NCT05187507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24983420|NCT05187507|Respiratory System Agents|respiratory system agents|mesh-ancestor
24983421|NCT05187507|Vasodilator Agents|vasodilator agents|mesh-ancestor
24983481|NCT05185869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24983491|NCT05185869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24983492|NCT05185869|Immunologic Factors|immunologic factors|mesh-ancestor
24983493|NCT05185869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983494|NCT05185804|Enoxaparin|enoxaparin|mesh-list
24983495|NCT05185804|Enoxaparin sodium|enoxaparin sodium|mesh-list
24983496|NCT05185804|Anticoagulants|anticoagulants|mesh-ancestor
24983497|NCT05185804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24983498|NCT05185804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24409711|NCT00182741|Analgesics|analgesics|mesh-ancestor
24983499|NCT05185804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983502|NCT05185544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24983512|NCT05185505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24983513|NCT05185505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24983514|NCT05185505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24983515|NCT05185505|Growth Substances|growth substances|mesh-ancestor
24983516|NCT05185505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983517|NCT05185505|Growth Inhibitors|growth inhibitors|mesh-ancestor
24983518|NCT05185284|Remdesivir|remdesivir|mesh-list
24983519|NCT05185284|Favipiravir|favipiravir|mesh-list
24983540|NCT05184517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983541|NCT05184517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25106627|NCT01959633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24983542|NCT05184517|Immunologic Factors|immunologic factors|mesh-ancestor
24983543|NCT05184517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983544|NCT05184517|Antifungal Agents|antifungal agents|mesh-ancestor
24983545|NCT05184517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24983546|NCT05184517|Dermatologic Agents|dermatologic agents|mesh-ancestor
24983547|NCT05184517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24983548|NCT05184517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24983550|NCT05184465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24983551|NCT05184465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983552|NCT05184374|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25705739|NCT02203032|Immunologic Factors|immunologic factors|mesh-ancestor
24983553|NCT05184374|Hormones|hormones|mesh-ancestor
25705740|NCT02203032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705741|NCT02203149|Grazoprevir|grazoprevir|mesh-list
25705742|NCT02203149|Antiviral Agents|antiviral agents|mesh-ancestor
25705743|NCT02203149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25705744|NCT02203331|Anastrozole|anastrozole|mesh-list
25705745|NCT02203331|Leuprolide|leuprolide|mesh-list
25705746|NCT02203331|Levonorgestrel|levonorgestrel|mesh-list
25705747|NCT02203331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24817135|NCT02081287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24817136|NCT02081287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24817137|NCT02081287|Vitamin B Complex|vitamin b complex|mesh-ancestor
24817138|NCT02081287|Vitamins|vitamins|mesh-ancestor
24817139|NCT02081287|Micronutrients|micronutrients|mesh-ancestor
24817140|NCT02081339|Ranibizumab|ranibizumab|mesh-list
24817141|NCT02081339|Aflibercept|aflibercept|mesh-list
24817142|NCT02081339|Verteporfin|verteporfin|mesh-list
24817143|NCT02081339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24817144|NCT02081339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24817145|NCT02081339|Growth Substances|growth substances|mesh-ancestor
24513778|NCT00585091|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24894184|NCT04443647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24983554|NCT05184374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24983555|NCT05184374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983556|NCT05184179|Olmesartan|olmesartan|mesh-list
24983557|NCT05184179|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24983558|NCT05184179|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24983562|NCT05184179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983563|NCT05184179|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24983564|NCT05184179|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24983565|NCT05184179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24983566|NCT05184179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24983580|NCT05184049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983581|NCT05184049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24909084|NCT04312880|Hemostatics|hemostatics|mesh-ancestor
24983582|NCT05184049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983584|NCT05183997|Thrombin|thrombin|mesh-list
24983585|NCT05183997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25705748|NCT02203331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25705749|NCT02203331|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25705750|NCT02203331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25705751|NCT02203331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25705752|NCT02203331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705753|NCT02203331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25705754|NCT02203331|Hormone Antagonists|hormone antagonists|mesh-ancestor
25705755|NCT02203331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25705756|NCT02203331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705757|NCT02203331|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25705758|NCT02203331|Fertility Agents|fertility agents|mesh-ancestor
25705759|NCT02203331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24983586|NCT05183997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24983587|NCT05183997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24983588|NCT05183997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983603|NCT05183841|Cholinergic Agents|cholinergic agents|mesh-ancestor
24983604|NCT05183841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24983605|NCT05183841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983606|NCT05183841|Sympathomimetics|sympathomimetics|mesh-ancestor
24983607|NCT05183841|Tocolytic Agents|tocolytic agents|mesh-ancestor
24983608|NCT05183841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24983609|NCT05183841|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24983610|NCT05183841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24983611|NCT05183841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24983612|NCT05183841|Adrenergic Agents|adrenergic agents|mesh-ancestor
24983615|NCT05183555|Edotreotide|edotreotide|mesh-list
24983616|NCT05183555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25106628|NCT01959633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24983625|NCT05183334|Urological Agents|urological agents|mesh-ancestor
24983617|NCT05183555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983618|NCT05183334|Sildenafil Citrate|sildenafil citrate|mesh-list
24983619|NCT05183334|Tramadol|tramadol|mesh-list
24983620|NCT05183334|Vasodilator Agents|vasodilator agents|mesh-ancestor
24894741|NCT05388123|Vemurafenib|vemurafenib|mesh-list
24894742|NCT05388123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24894743|NCT05388123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894744|NCT05388123|Immunologic Factors|immunologic factors|mesh-ancestor
24894745|NCT05388123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894746|NCT05388123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24894747|NCT05388123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24894748|NCT05388123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24894749|NCT05388123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894750|NCT05387967|Valsartan|valsartan|mesh-list
24983621|NCT05183334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24983622|NCT05183334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24795889|NCT01946555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795890|NCT01946555|Adrenergic Agents|adrenergic agents|mesh-ancestor
24795891|NCT01946555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24795892|NCT01946568|Dalbavancin|dalbavancin|mesh-list
24795893|NCT01946568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24444965|NCT00299884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24444966|NCT00299884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24444967|NCT00299884|Antimetabolites|antimetabolites|mesh-ancestor
24444986|NCT00299923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444987|NCT00299923|Antiviral Agents|antiviral agents|mesh-ancestor
24444994|NCT00299923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24444995|NCT00299923|Analgesics|analgesics|mesh-ancestor
24444996|NCT00299923|Sensory System Agents|sensory system agents|mesh-ancestor
24444997|NCT00299923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24444998|NCT00299936|Ribavirin|ribavirin|mesh-list
24444999|NCT00299936|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25705760|NCT02203331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25705761|NCT02203331|Contraceptive Agents|contraceptive agents|mesh-ancestor
25705762|NCT02203331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25705763|NCT02203331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25705764|NCT02203331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25705765|NCT02203565|Sodium Hypochlorite|sodium hypochlorite|mesh-list
25705766|NCT02203565|Eusol|eusol|mesh-list
25705767|NCT02203565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25705768|NCT02203565|Disinfectants|disinfectants|mesh-ancestor
25705769|NCT02203565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25705770|NCT02203578|Romidepsin|romidepsin|mesh-list
24445000|NCT00299936|Antimetabolites|antimetabolites|mesh-ancestor
24474424|NCT00406003|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24514365|NCT00590070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514366|NCT00590070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24514367|NCT00590070|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24445001|NCT00299936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445085|NCT00300339|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24445110|NCT00300404|Levoleucovorin|levoleucovorin|mesh-list
24445111|NCT00300404|Antidotes|antidotes|mesh-ancestor
24445112|NCT00300404|Protective Agents|protective agents|mesh-ancestor
24445113|NCT00300404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445114|NCT00300404|Vitamin B Complex|vitamin b complex|mesh-ancestor
24445115|NCT00300404|Vitamins|vitamins|mesh-ancestor
24445116|NCT00300404|Micronutrients|micronutrients|mesh-ancestor
24983662|NCT05182112|Gemcitabine|gemcitabine|mesh-list
24445173|NCT00300716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24445174|NCT00300716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24445190|NCT00300768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24445191|NCT00300768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24445193|NCT00300768|Antinematodal Agents|antinematodal agents|mesh-ancestor
24445194|NCT00300794|Ketamine|ketamine|mesh-list
24445195|NCT00300794|Analgesics|analgesics|mesh-ancestor
24445240|NCT00300924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445242|NCT00300924|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24445243|NCT00300924|Serotonin Agents|serotonin agents|mesh-ancestor
24445265|NCT00301002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445267|NCT00301054|Sulfadoxine|sulfadoxine|mesh-list
24445268|NCT00301054|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24445269|NCT00301054|Antimalarials|antimalarials|mesh-ancestor
24445270|NCT00301054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24983682|NCT05180292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983684|NCT05180292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24983685|NCT05180292|Antioxidants|antioxidants|mesh-ancestor
24445303|NCT00301171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24445304|NCT00301171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445305|NCT00301171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24445306|NCT00301171|Respiratory System Agents|respiratory system agents|mesh-ancestor
24445307|NCT00301171|Dermatologic Agents|dermatologic agents|mesh-ancestor
24445308|NCT00301171|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24445309|NCT00301210|Tramadol|tramadol|mesh-list
24445310|NCT00301210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24445311|NCT00301210|Narcotics|narcotics|mesh-ancestor
24445345|NCT00301301|Immunologic Factors|immunologic factors|mesh-ancestor
25705771|NCT02203578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25705772|NCT02203578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25705773|NCT02203591|Ethanol|ethanol|mesh-list
24983686|NCT05180292|Protective Agents|protective agents|mesh-ancestor
25705774|NCT02203591|Chlorhexidine|chlorhexidine|mesh-list
25705775|NCT02203591|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25705776|NCT02203591|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25705777|NCT02203591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25705778|NCT02203591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24817280|NCT02082327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817281|NCT02082327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817282|NCT02082405|Dexamethasone|dexamethasone|mesh-list
24817283|NCT02082405|Cyclophosphamide|cyclophosphamide|mesh-list
24817285|NCT02082405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24817286|NCT02082405|Immunologic Factors|immunologic factors|mesh-ancestor
24895147|NCT04950608|Psilocybin|psilocybin|mesh-list
24787201|NCT01924000|Minoxidil|minoxidil|mesh-list
24983687|NCT05180292|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24983688|NCT05180292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24983689|NCT05180292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24983690|NCT05180292|Vasodilator Agents|vasodilator agents|mesh-ancestor
24983691|NCT05180292|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24450616|NCT00319865|Doxorubicin|doxorubicin|mesh-list
24445346|NCT00301301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445349|NCT00301301|Antimetabolites|antimetabolites|mesh-ancestor
24784496|NCT01908296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784498|NCT01908296|Serotonin Agents|serotonin agents|mesh-ancestor
24784506|NCT01908322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24784507|NCT01908322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25106630|NCT01936688|Etanercept|etanercept|mesh-list
25106640|NCT01936688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25106641|NCT01936688|Immunologic Factors|immunologic factors|mesh-ancestor
25106642|NCT01861496|Cisplatin|cisplatin|mesh-list
25106643|NCT01861496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106644|NCT01826838|Dasatinib|dasatinib|mesh-list
25106645|NCT01826838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106646|NCT01826838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25106647|NCT01826838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25106648|NCT01826838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106649|NCT01767675|Carboplatin|carboplatin|mesh-list
25106650|NCT01767675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106651|NCT00970866|Folic Acid|folic acid|mesh-list
25106652|NCT00970866|Micronutrients|micronutrients|mesh-list
25106653|NCT00970866|Trace Elements|trace elements|mesh-list
25106654|NCT00970866|Hematinics|hematinics|mesh-ancestor
25106655|NCT00970866|Vitamin B Complex|vitamin b complex|mesh-ancestor
25106656|NCT00970866|Vitamins|vitamins|mesh-ancestor
25106657|NCT00970866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106658|NCT00799396|Aspirin|aspirin|mesh-list
25106659|NCT00799396|Clopidogrel|clopidogrel|mesh-list
24445516|NCT00301730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24445517|NCT00301730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24445518|NCT00301730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25106675|NCT00799396|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25106676|NCT00799396|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25106677|NCT00799396|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25106678|NCT00799396|Purinergic Agents|purinergic agents|mesh-ancestor
24445579|NCT00301886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445582|NCT00301899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25106685|NCT00069238|Alemtuzumab|alemtuzumab|mesh-list
25106686|NCT00069238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24445726|NCT00302367|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24445727|NCT00302367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445730|NCT00302367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25705779|NCT02203591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705780|NCT02203591|Disinfectants|disinfectants|mesh-ancestor
25705781|NCT02203591|Dermatologic Agents|dermatologic agents|mesh-ancestor
25705782|NCT02203630|Phenylephrine|phenylephrine|mesh-list
25705783|NCT02203630|Oxymetazoline|oxymetazoline|mesh-list
25705784|NCT02203630|Norepinephrine|norepinephrine|mesh-list
25705785|NCT02203630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25705786|NCT02203630|Mydriatics|mydriatics|mesh-ancestor
25705787|NCT02203630|Autonomic Agents|autonomic agents|mesh-ancestor
25705788|NCT02203630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24514712|NCT00592410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445731|NCT00302367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445732|NCT00302367|Dopamine Agents|dopamine agents|mesh-ancestor
24445733|NCT00302367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24445734|NCT00302393|Methylphenidate|methylphenidate|mesh-list
24445735|NCT00302393|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24445736|NCT00302393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445742|NCT00302393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24445743|NCT00302406|Methylphenidate|methylphenidate|mesh-list
24445744|NCT00302406|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24983956|NCT05031494|Paclitaxel|paclitaxel|mesh-list
24983716|NCT05177939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24983717|NCT05177939|Immunologic Factors|immunologic factors|mesh-ancestor
24983721|NCT05171166|Leucovorin|leucovorin|mesh-list
24983722|NCT05171166|Fluorouracil|fluorouracil|mesh-list
24983723|NCT05171166|Oxaliplatin|oxaliplatin|mesh-list
24983724|NCT05171166|Chlorotrianisene|chlorotrianisene|mesh-list
24983730|NCT05171166|Immunologic Factors|immunologic factors|mesh-ancestor
24983731|NCT05171166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983732|NCT05171166|Antidotes|antidotes|mesh-ancestor
24983733|NCT05171166|Protective Agents|protective agents|mesh-ancestor
24983734|NCT05171166|Vitamin B Complex|vitamin b complex|mesh-ancestor
24983735|NCT05171166|Vitamins|vitamins|mesh-ancestor
24983736|NCT05171166|Micronutrients|micronutrients|mesh-ancestor
24983737|NCT05171166|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24983738|NCT05171166|Estrogens|estrogens|mesh-ancestor
24983739|NCT05171166|Hormones|hormones|mesh-ancestor
24983740|NCT05171166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24983741|NCT05171166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24983742|NCT05170139|Caffeine|caffeine|mesh-list
24983743|NCT05170139|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24445878|NCT00302822|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25705789|NCT02203630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705790|NCT02203630|Sympathomimetics|sympathomimetics|mesh-ancestor
25705791|NCT02203630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25705792|NCT02203630|Nasal Decongestants|nasal decongestants|mesh-ancestor
25705793|NCT02203630|Respiratory System Agents|respiratory system agents|mesh-ancestor
25705794|NCT02203630|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25705795|NCT02203630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25705796|NCT02203630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24983793|NCT05153772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24983794|NCT05153772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24983795|NCT05151159|Antibodies|antibodies|mesh-list
24983796|NCT05151159|Immunologic Factors|immunologic factors|mesh-ancestor
24983797|NCT05151159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445901|NCT00303004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24445902|NCT00303004|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24446003|NCT00303550|Iclaprim|iclaprim|mesh-list
24446004|NCT00303550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24983852|NCT05130060|Vaccines|vaccines|mesh-list
24983853|NCT05130060|Immunologic Factors|immunologic factors|mesh-ancestor
24983854|NCT05130060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983855|NCT05130060|Antimetabolites|antimetabolites|mesh-ancestor
24983856|NCT05130060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983857|NCT05130060|Antiviral Agents|antiviral agents|mesh-ancestor
24983858|NCT05130060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24983882|NCT05111262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24983883|NCT05111262|Respiratory System Agents|respiratory system agents|mesh-ancestor
24983884|NCT05111262|Glucocorticoids|glucocorticoids|mesh-ancestor
24983885|NCT05111262|Hormones|hormones|mesh-ancestor
24983886|NCT05111262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24983887|NCT05111262|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24983888|NCT05111262|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24983889|NCT05111262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24983890|NCT05111262|Adrenergic Agents|adrenergic agents|mesh-ancestor
24784563|NCT01908621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24784564|NCT01908621|Antimetabolites|antimetabolites|mesh-ancestor
24784565|NCT01908621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784566|NCT01908621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784567|NCT01908621|Antiviral Agents|antiviral agents|mesh-ancestor
25106702|NCT00069238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25106703|NCT00069238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25106704|NCT00069238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25106705|NCT00069238|Tubulin Modulators|tubulin modulators|mesh-ancestor
25106706|NCT00069238|Antimitotic Agents|antimitotic agents|mesh-ancestor
25106707|NCT00069238|Mitosis Modulators|mitosis modulators|mesh-ancestor
24914770|NCT04252521|Ketoprofen|ketoprofen|mesh-list
25106708|NCT00069238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25106709|NCT03145467|Acetaminophen|acetaminophen|mesh-list
25106710|NCT03145467|Zolmitriptan|zolmitriptan|mesh-list
25106711|NCT03145467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25106712|NCT03145467|Analgesics|analgesics|mesh-ancestor
25106713|NCT03145467|Sensory System Agents|sensory system agents|mesh-ancestor
25106714|NCT03145467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25106715|NCT03145467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106716|NCT03145467|Antipyretics|antipyretics|mesh-ancestor
24983909|NCT05089643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24983910|NCT05089643|Antimetabolites|antimetabolites|mesh-ancestor
24983911|NCT05089643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983912|NCT05089643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24983914|NCT05072600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24983915|NCT05072600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24983916|NCT05072600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24983917|NCT05072600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983919|NCT05064488|Digoxin|digoxin|mesh-list
24983920|NCT05064488|Sumatriptan|sumatriptan|mesh-list
24983921|NCT05064488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24983922|NCT05064488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24983923|NCT05064488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983924|NCT05064488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24983955|NCT05031494|Gemcitabine|gemcitabine|mesh-list
24983960|NCT05031494|Antimitotic Agents|antimitotic agents|mesh-ancestor
24983961|NCT05031494|Mitosis Modulators|mitosis modulators|mesh-ancestor
24983962|NCT05031494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983963|NCT05031494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24983964|NCT05031494|Antimetabolites|antimetabolites|mesh-ancestor
24983965|NCT05031494|Antiviral Agents|antiviral agents|mesh-ancestor
24983966|NCT05031494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24983967|NCT05031494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24983968|NCT05031494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24983969|NCT05031494|Immunologic Factors|immunologic factors|mesh-ancestor
24983976|NCT05000710|Durvalumab|durvalumab|mesh-list
24983977|NCT05000710|Tremelimumab|tremelimumab|mesh-list
24983978|NCT05000710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24983979|NCT05000710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24983980|NCT04965519|Trastuzumab|trastuzumab|mesh-list
24983981|NCT04965519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24983982|NCT04965519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24983983|NCT04952389|Budesonide|budesonide|mesh-list
24450787|NCT00320580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24446239|NCT00304200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446240|NCT00304200|Growth Inhibitors|growth inhibitors|mesh-ancestor
24446241|NCT00304200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24983985|NCT04952389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24983994|NCT04943549|Bupivacaine|bupivacaine|mesh-list
24983995|NCT04943549|Anesthetics, Local|anesthetics, local|mesh-ancestor
24983996|NCT04943549|Anesthetics|anesthetics|mesh-ancestor
24983997|NCT04943549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24983998|NCT04943549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24983999|NCT04943549|Sensory System Agents|sensory system agents|mesh-ancestor
24795945|NCT01946984|Diclofenac|diclofenac|mesh-list
24795946|NCT01946984|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
24484874|NCT00450320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24984022|NCT04842643|Immunoglobulins|immunoglobulins|mesh-list
24484875|NCT00450320|Immunologic Factors|immunologic factors|mesh-ancestor
24984023|NCT04842643|Immunologic Factors|immunologic factors|mesh-ancestor
24984024|NCT04842643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984025|NCT04842422|Imiquimod|imiquimod|mesh-list
24984026|NCT04842422|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24984031|NCT04840641|Efavirenz|efavirenz|mesh-list
24453556|NCT04935177|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24453557|NCT04935177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24515182|NCT00595322|Growth Substances|growth substances|mesh-ancestor
25106742|NCT03145285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784640|NCT01909752|Vaccines|vaccines|mesh-list
24984056|NCT04840641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24984057|NCT04840641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24984058|NCT04840641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24984060|NCT04840641|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24984061|NCT04840641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24984062|NCT04840641|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24984063|NCT04840641|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24984064|NCT04840641|Purinergic Agents|purinergic agents|mesh-ancestor
24984065|NCT04840641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24984066|NCT04840641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24984067|NCT04840641|Antiviral Agents|antiviral agents|mesh-ancestor
24984090|NCT04802863|Imipenem|imipenem|mesh-list
24984091|NCT04802863|Cilastatin|cilastatin|mesh-list
24984092|NCT04802863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24984093|NCT04802863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24984094|NCT04802863|Protease Inhibitors|protease inhibitors|mesh-ancestor
24984095|NCT04802863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984096|NCT04802863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984097|NCT04802746|Alprazolam|alprazolam|mesh-list
24984098|NCT04802746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24984099|NCT04802746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24984100|NCT04802746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984101|NCT04802746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24984102|NCT04802746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24984103|NCT04802746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24539551|NCT00664417|Vaccines|vaccines|mesh-list
24984123|NCT04787562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24984126|NCT04787562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984127|NCT04786756|Bupivacaine|bupivacaine|mesh-list
24984128|NCT04786756|Anesthetics, Local|anesthetics, local|mesh-ancestor
24984129|NCT04786756|Anesthetics|anesthetics|mesh-ancestor
24984130|NCT04786756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24984131|NCT04786756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984132|NCT04786756|Sensory System Agents|sensory system agents|mesh-ancestor
24984133|NCT04786756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24446426|NCT00304668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24446427|NCT00304668|Antiviral Agents|antiviral agents|mesh-ancestor
24446447|NCT00304772|Antifungal Agents|antifungal agents|mesh-ancestor
24446448|NCT00304772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446449|NCT00304772|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24446450|NCT00304772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24446451|NCT00304772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984139|NCT04782791|Nivolumab|nivolumab|mesh-list
24984147|NCT04768426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24984148|NCT04768426|Antimetabolites|antimetabolites|mesh-ancestor
24984149|NCT04768426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984150|NCT04768426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24984151|NCT04762836|Cycloserine|cycloserine|mesh-list
24984152|NCT04762836|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24984153|NCT04762836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24984155|NCT04762836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24984156|NCT04762836|Antitubercular Agents|antitubercular agents|mesh-ancestor
24984157|NCT04762836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24984158|NCT04762836|Antimetabolites|antimetabolites|mesh-ancestor
24984159|NCT04762836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984160|NCT04758949|Nivolumab|nivolumab|mesh-list
24984161|NCT04758949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24984162|NCT04758949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24984163|NCT04758949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24984164|NCT04758949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705797|NCT02203630|Adrenergic Agents|adrenergic agents|mesh-ancestor
25705798|NCT02203630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25705799|NCT02203630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705800|NCT02203630|Protective Agents|protective agents|mesh-ancestor
25705801|NCT02203786|Haloperidol|haloperidol|mesh-list
25705802|NCT02203786|Haloperidol decanoate|haloperidol decanoate|mesh-list
25705803|NCT02203786|Fluphenazine|fluphenazine|mesh-list
25705804|NCT02203786|Fluphenazine depot|fluphenazine depot|mesh-list
24915242|NCT03854019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24616064|NCT01033760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24616065|NCT01033760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25705805|NCT02203786|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
24515301|NCT00596154|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24515302|NCT00596154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24984165|NCT04750395|Haloperidol|haloperidol|mesh-list
24984166|NCT04750395|Olanzapine|olanzapine|mesh-list
24984178|NCT04750395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24984179|NCT04750395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24984180|NCT04750395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984181|NCT04750395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24984182|NCT04750395|Serotonin Agents|serotonin agents|mesh-ancestor
24984183|NCT04750395|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24984184|NCT04750395|Dopamine Agents|dopamine agents|mesh-ancestor
24984185|NCT04750395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24984186|NCT04739735|Anesthetics|anesthetics|mesh-list
24984187|NCT04739735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24984188|NCT04739735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984189|NCT04735965|Meperidine|meperidine|mesh-list
24446454|NCT00304772|Hormone Antagonists|hormone antagonists|mesh-ancestor
24984215|NCT04734379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24795975|NCT01947062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24795976|NCT01947062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24795980|NCT01947114|Propofol|propofol|mesh-list
24795981|NCT01947114|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24795982|NCT01947114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24795983|NCT01947114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795984|NCT01947114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24795985|NCT01947114|Anesthetics, General|anesthetics, general|mesh-ancestor
24795986|NCT01947114|Anesthetics|anesthetics|mesh-ancestor
24795987|NCT01947114|Analgesics|analgesics|mesh-ancestor
24795988|NCT01947114|Sensory System Agents|sensory system agents|mesh-ancestor
24795989|NCT01947114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24589346|NCT00907036|Cyclosporine|cyclosporine|mesh-list
24795990|NCT01947114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24795991|NCT01947114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24795992|NCT01947114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24795993|NCT01947114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24795994|NCT01947114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795995|NCT01947114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24795997|NCT01947140|Romidepsin|romidepsin|mesh-list
24795998|NCT01947140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24795999|NCT01947140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796000|NCT01947192|Chlorhexidine|chlorhexidine|mesh-list
24796022|NCT01947309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796023|NCT01947465|Vaccines|vaccines|mesh-list
24796024|NCT01947465|Immunologic Factors|immunologic factors|mesh-ancestor
24796025|NCT01947465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796026|NCT01947556|Insulin Aspart|insulin aspart|mesh-list
24796027|NCT01947556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24796028|NCT01947556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796029|NCT01947608|Ceritinib|ceritinib|mesh-list
24796030|NCT01947608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796031|NCT01947608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24796032|NCT01947608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984231|NCT04714190|Mitosis Modulators|mitosis modulators|mesh-ancestor
24984250|NCT04702802|Immunologic Factors|immunologic factors|mesh-ancestor
24984251|NCT04702802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705806|NCT02203786|Amphetamine|amphetamine|mesh-list
25705807|NCT02203786|Dextroamphetamine|dextroamphetamine|mesh-list
25705808|NCT02203786|Antiemetics|antiemetics|mesh-ancestor
25705809|NCT02203786|Autonomic Agents|autonomic agents|mesh-ancestor
25705810|NCT02203786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24984252|NCT04702802|Viscosupplements|viscosupplements|mesh-ancestor
24984253|NCT04702802|Protective Agents|protective agents|mesh-ancestor
24984254|NCT04702789|Timolol|timolol|mesh-list
24984255|NCT04702789|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24984256|NCT04702789|Dorzolamide|dorzolamide|mesh-list
25705811|NCT02203786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705812|NCT02203786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25705813|NCT02203786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25705814|NCT02203786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24984258|NCT04702789|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24984259|NCT04702789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24984275|NCT04702776|Immunologic Factors|immunologic factors|mesh-ancestor
24984276|NCT04702776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984277|NCT04702776|Viscosupplements|viscosupplements|mesh-ancestor
24984278|NCT04702776|Protective Agents|protective agents|mesh-ancestor
24984279|NCT04699422|Pirinitramide|pirinitramide|mesh-list
24984280|NCT04699422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24984281|NCT04699422|Narcotics|narcotics|mesh-ancestor
24984282|NCT04699422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24636776|NCT01147289|Meloxicam|meloxicam|mesh-list
25106795|NCT03144843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25106796|NCT03144843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25106797|NCT03144843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25106798|NCT03144843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106799|NCT03144713|Terlipressin|terlipressin|mesh-list
25106800|NCT03144713|Midodrine|midodrine|mesh-list
25106801|NCT03144713|Sympathomimetics|sympathomimetics|mesh-ancestor
25106802|NCT03144713|Autonomic Agents|autonomic agents|mesh-ancestor
24984283|NCT04699422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984284|NCT04699422|Analgesics|analgesics|mesh-ancestor
24984285|NCT04699422|Sensory System Agents|sensory system agents|mesh-ancestor
24984286|NCT04699422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24984287|NCT04693429|Bepotastine besilate|bepotastine besilate|mesh-list
24984288|NCT04693429|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24984289|NCT04686773|Vaccines|vaccines|mesh-list
24984290|NCT04686773|Immunologic Factors|immunologic factors|mesh-ancestor
24984291|NCT04686773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984292|NCT04684953|Hormones|hormones|mesh-list
24984293|NCT04684953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24984299|NCT04674020|Analgesics|analgesics|mesh-ancestor
24984307|NCT04667637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24984308|NCT04667637|Protective Agents|protective agents|mesh-ancestor
24984309|NCT04667637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984310|NCT04659317|Oxycodone|oxycodone|mesh-list
24984311|NCT04659317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24984312|NCT04659317|Narcotics|narcotics|mesh-ancestor
24984313|NCT04659317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24984314|NCT04659317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984315|NCT04659317|Analgesics|analgesics|mesh-ancestor
24984316|NCT04659317|Sensory System Agents|sensory system agents|mesh-ancestor
24984317|NCT04659317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24984318|NCT04655690|Insulin Aspart|insulin aspart|mesh-list
24984319|NCT04655690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24984320|NCT04655690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984321|NCT04641312|Dulaglutide|dulaglutide|mesh-list
24984322|NCT04641312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24984323|NCT04641312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984324|NCT04635423|Vaccines|vaccines|mesh-list
24984325|NCT04635423|Immunologic Factors|immunologic factors|mesh-ancestor
24984326|NCT04635423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984327|NCT04611763|Flurbiprofen|flurbiprofen|mesh-list
24984328|NCT04611763|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
24984402|NCT04592536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24984403|NCT04592536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984405|NCT04552535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24984406|NCT04552535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24984407|NCT04552535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25705815|NCT02203786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25705816|NCT02203786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25705817|NCT02203786|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25705818|NCT02203786|Dopamine Agents|dopamine agents|mesh-ancestor
25705819|NCT02203786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25705820|NCT02203786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515426|NCT00597064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24895998|NCT02677181|Antimetabolites|antimetabolites|mesh-ancestor
24515450|NCT00597389|Propranolol|propranolol|mesh-list
24984408|NCT04552535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984409|NCT04541797|Empagliflozin|empagliflozin|mesh-list
24984410|NCT04541797|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24984411|NCT04541797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984412|NCT04541797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24916181|NCT04243850|Empagliflozin|empagliflozin|mesh-list
24984413|NCT04541797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984421|NCT04529265|Methylene Blue|methylene blue|mesh-list
24984422|NCT04529265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984423|NCT04529265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984424|NCT04520685|Cannabidiol|cannabidiol|mesh-list
24984425|NCT04520685|Anticonvulsants|anticonvulsants|mesh-ancestor
24984458|NCT04508790|Protease Inhibitors|protease inhibitors|mesh-ancestor
24984459|NCT04508790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984460|NCT04508790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984487|NCT04503668|Glucocorticoids|glucocorticoids|mesh-ancestor
24984488|NCT04503668|Hormones|hormones|mesh-ancestor
24984489|NCT04503668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24984490|NCT04503668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24984491|NCT04503668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24984492|NCT04503668|Antipruritics|antipruritics|mesh-ancestor
24984493|NCT04503668|Dermatologic Agents|dermatologic agents|mesh-ancestor
24984494|NCT04503668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24984495|NCT04503668|Serotonin Agents|serotonin agents|mesh-ancestor
24984496|NCT04503668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24984497|NCT04503668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984498|NCT04503668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24984499|NCT04503668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24984500|NCT04503668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24984501|NCT04503668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24984502|NCT04503668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24984503|NCT04503668|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24784703|NCT01910090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784704|NCT01910090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784705|NCT01910090|Analgesics|analgesics|mesh-ancestor
24984510|NCT04502550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24922261|NCT04182399|Zonisamide|zonisamide|mesh-list
24984511|NCT04502550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984512|NCT04502550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24984513|NCT04502550|Anesthetics, General|anesthetics, general|mesh-ancestor
24984514|NCT04502550|Anesthetics|anesthetics|mesh-ancestor
24984515|NCT04481672|Magnesium Sulfate|magnesium sulfate|mesh-list
24984516|NCT04481672|Analgesics|analgesics|mesh-ancestor
24984517|NCT04481672|Sensory System Agents|sensory system agents|mesh-ancestor
24984518|NCT04481672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24984519|NCT04481672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984520|NCT04481672|Anesthetics|anesthetics|mesh-ancestor
24984521|NCT04481672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24796033|NCT01947608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796034|NCT01947660|Anesthetics|anesthetics|mesh-list
25705821|NCT02203786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25705822|NCT02203786|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25705823|NCT02203786|Sympathomimetics|sympathomimetics|mesh-ancestor
25705824|NCT02203786|Adrenergic Agents|adrenergic agents|mesh-ancestor
25705825|NCT02203786|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25705826|NCT02203786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25705827|NCT02203786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25705828|NCT02203786|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24817388|NCT02083328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24817389|NCT02083328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473115|NCT00402038|Methylnaltrexone|methylnaltrexone|mesh-list
24796035|NCT01947660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24796036|NCT01947660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796037|NCT01947699|Glyburide|glyburide|mesh-list
24796038|NCT01947699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24796045|NCT01947777|Leprostatic Agents|leprostatic agents|mesh-ancestor
24796046|NCT01947777|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24796047|NCT01947777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796048|NCT01947777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796049|NCT01947777|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24796050|NCT01947777|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24796051|NCT01947777|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25106821|NCT03144882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24796058|NCT01947790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984533|NCT04470778|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24984534|NCT04470778|Histamine Antagonists|histamine antagonists|mesh-ancestor
24984535|NCT04470778|Histamine Agents|histamine agents|mesh-ancestor
24984536|NCT04470778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24984537|NCT04470778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984538|NCT04470778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984539|NCT04418427|Aflibercept|aflibercept|mesh-list
24984540|NCT04418427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24984579|NCT04385433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984580|NCT04377711|Ciclesonide|ciclesonide|mesh-list
24984581|NCT04377711|Glucocorticoids|glucocorticoids|mesh-ancestor
24984582|NCT04377711|Hormones|hormones|mesh-ancestor
24984583|NCT04377711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24984584|NCT04377711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984585|NCT04377711|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24984586|NCT04369560|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24984587|NCT04369560|Hematinics|hematinics|mesh-ancestor
24984588|NCT04369560|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24984589|NCT04369560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24984602|NCT04352101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24984603|NCT04352101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984604|NCT04352101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24984605|NCT04352101|Serotonin Agents|serotonin agents|mesh-ancestor
24984606|NCT04352101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984607|NCT04352101|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25705829|NCT02203838|Risperidone|risperidone|mesh-list
25705830|NCT02203838|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25705831|NCT02203838|Serotonin Agents|serotonin agents|mesh-ancestor
25705832|NCT02203838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25705833|NCT02203838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705834|NCT02203838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705835|NCT02203838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25705836|NCT02203838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25705837|NCT02203838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25705838|NCT02203838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25705839|NCT02203838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24817445|NCT02083874|Cannabidiol|cannabidiol|mesh-list
24817446|NCT02083874|Anticonvulsants|anticonvulsants|mesh-ancestor
24817447|NCT02083991|Prednisolone|prednisolone|mesh-list
24817448|NCT02083991|Thymoglobulin|thymoglobulin|mesh-list
24817449|NCT02083991|Basiliximab|basiliximab|mesh-list
24817450|NCT02083991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24984608|NCT04352101|Antidepressive Agents|antidepressive agents|mesh-ancestor
24984609|NCT04352101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24984610|NCT04352101|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24984611|NCT04352101|Dopamine Agents|dopamine agents|mesh-ancestor
24984612|NCT04352101|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24984613|NCT04352101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24984614|NCT04352101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984615|NCT04347408|Antibodies|antibodies|mesh-list
24984616|NCT04347408|Immunologic Factors|immunologic factors|mesh-ancestor
24984617|NCT04347408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796135|NCT01948115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24796136|NCT01948115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796137|NCT01948115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24796138|NCT01948115|Analgesics|analgesics|mesh-ancestor
24984687|NCT04177706|Analgesics|analgesics|mesh-ancestor
24984688|NCT04177706|Sensory System Agents|sensory system agents|mesh-ancestor
25106835|NCT03144453|Atropine|atropine|mesh-list
25106836|NCT03144453|Neostigmine|neostigmine|mesh-list
25106837|NCT03144453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25106838|NCT03144453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25106839|NCT03144453|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25106840|NCT03144453|Autonomic Agents|autonomic agents|mesh-ancestor
25106841|NCT03144453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25106870|NCT03144128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106871|NCT03144128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25705840|NCT02203838|Dopamine Agents|dopamine agents|mesh-ancestor
25705841|NCT02203916|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25705842|NCT02203916|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25705843|NCT02203916|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25705844|NCT02203916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705845|NCT02204410|Methylphenidate|methylphenidate|mesh-list
25106872|NCT03144245|Pembrolizumab|pembrolizumab|mesh-list
25106873|NCT03144245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25705846|NCT02204410|Amphetamine|amphetamine|mesh-list
25705847|NCT02204410|Adderall|adderall|mesh-list
25705848|NCT02204410|Dextroamphetamine|dextroamphetamine|mesh-list
24896490|NCT04435704|Oxytocics|oxytocics|mesh-ancestor
24896491|NCT04435704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24896492|NCT04435704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896493|NCT04435717|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24896494|NCT04435587|Ritonavir|ritonavir|mesh-list
25106874|NCT03144245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24576843|NCT00840671|Cerebrolysin|cerebrolysin|mesh-list
24984778|NCT04068831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984779|NCT04068831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984790|NCT04040959|Niacinamide|niacinamide|mesh-list
24984791|NCT04040959|Niacin|niacin|mesh-list
24984792|NCT04040959|Nicotinic Acids|nicotinic acids|mesh-list
24984793|NCT04040959|Vitamin B Complex|vitamin b complex|mesh-ancestor
24984794|NCT04040959|Vitamins|vitamins|mesh-ancestor
24984795|NCT04040959|Micronutrients|micronutrients|mesh-ancestor
24984796|NCT04040959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984797|NCT04040959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24984798|NCT04040959|Antimetabolites|antimetabolites|mesh-ancestor
24984823|NCT04001894|Purinergic Agents|purinergic agents|mesh-ancestor
24984824|NCT04001894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24984825|NCT04001894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984826|NCT04001894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984827|NCT03988920|Sevelamer|sevelamer|mesh-list
24859968|NCT02306902|Antimetabolites|antimetabolites|mesh-ancestor
24859969|NCT02306902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859970|NCT02306902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24859971|NCT02306954|Aldesleukin|aldesleukin|mesh-list
24859972|NCT02306954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859973|NCT02306954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24859974|NCT02306954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24859975|NCT02306954|Antiviral Agents|antiviral agents|mesh-ancestor
24859976|NCT02306954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24859977|NCT02307006|Vancomycin|vancomycin|mesh-list
24859978|NCT02307006|Cefazolin|cefazolin|mesh-list
24859979|NCT02307006|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
24859982|NCT02307045|Nicotine|nicotine|mesh-list
25705849|NCT02204410|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25705850|NCT02204410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705851|NCT02204410|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25705852|NCT02204410|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25705853|NCT02204410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25705854|NCT02204410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705855|NCT02204410|Dopamine Agents|dopamine agents|mesh-ancestor
25705856|NCT02204410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25705857|NCT02204410|Sympathomimetics|sympathomimetics|mesh-ancestor
25705858|NCT02204410|Autonomic Agents|autonomic agents|mesh-ancestor
25705859|NCT02204410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24984896|NCT03926052|Dopamine Agents|dopamine agents|mesh-ancestor
24984909|NCT03922880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24984910|NCT03922880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24984920|NCT03902314|Anesthetics, Local|anesthetics, local|mesh-ancestor
24984921|NCT03902314|Anesthetics|anesthetics|mesh-ancestor
24984922|NCT03902314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24984923|NCT03902314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984924|NCT03902314|Sensory System Agents|sensory system agents|mesh-ancestor
24984925|NCT03902314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24984926|NCT03902314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24984927|NCT03902314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24984928|NCT03902314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24984929|NCT03902314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24984936|NCT03894501|Methadone|methadone|mesh-list
24984937|NCT03894501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24984938|NCT03894501|Narcotics|narcotics|mesh-ancestor
24984939|NCT03894501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25106876|NCT03143946|Micronutrients|micronutrients|mesh-ancestor
24984940|NCT03894501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984941|NCT03894501|Analgesics|analgesics|mesh-ancestor
24984942|NCT03894501|Sensory System Agents|sensory system agents|mesh-ancestor
24984943|NCT03894501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24984944|NCT03894501|Antitussive Agents|antitussive agents|mesh-ancestor
24984945|NCT03894501|Respiratory System Agents|respiratory system agents|mesh-ancestor
24984946|NCT03879538|Nitrous Oxide|nitrous oxide|mesh-list
24984947|NCT03879538|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24984948|NCT03879538|Anesthetics, General|anesthetics, general|mesh-ancestor
24860070|NCT02307396|Risperidone|risperidone|mesh-list
24860071|NCT02307396|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24860072|NCT02307396|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24860073|NCT02307396|Ziprasidone|ziprasidone|mesh-list
24860074|NCT02307396|Amisulpride|amisulpride|mesh-list
24860075|NCT02307396|Perphenazine|perphenazine|mesh-list
24984949|NCT03879538|Anesthetics|anesthetics|mesh-ancestor
24984950|NCT03879538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24984951|NCT03879538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984952|NCT03879538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24984953|NCT03879538|Analgesics|analgesics|mesh-ancestor
24984954|NCT03879538|Sensory System Agents|sensory system agents|mesh-ancestor
24984955|NCT03879538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24984956|NCT03853317|Avelumab|avelumab|mesh-list
24984957|NCT03853317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24984958|NCT03853317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24984959|NCT03831165|Acyclovir|acyclovir|mesh-list
24984960|NCT03831165|Melatonin|melatonin|mesh-list
24984961|NCT03831165|Antioxidants|antioxidants|mesh-ancestor
24984962|NCT03831165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984963|NCT03831165|Protective Agents|protective agents|mesh-ancestor
24984964|NCT03831165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984965|NCT03831165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24984966|NCT03831165|Antiviral Agents|antiviral agents|mesh-ancestor
24984967|NCT03831165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25705860|NCT02204410|Adrenergic Agents|adrenergic agents|mesh-ancestor
25705861|NCT02204410|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25705862|NCT02204982|Rituximab|rituximab|mesh-list
25705863|NCT02204982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25705864|NCT02204982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25705865|NCT02204982|Immunologic Factors|immunologic factors|mesh-ancestor
25705866|NCT02204982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705867|NCT02204982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25705868|NCT02205333|Rituximab|rituximab|mesh-list
25705869|NCT02205333|Durvalumab|durvalumab|mesh-list
24984975|NCT03829007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24984978|NCT03806166|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24984979|NCT03806166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24984980|NCT03801863|Ropivacaine|ropivacaine|mesh-list
24984981|NCT03801863|Anesthetics, Local|anesthetics, local|mesh-ancestor
24984982|NCT03801863|Anesthetics|anesthetics|mesh-ancestor
24984983|NCT03801863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24984984|NCT03801863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984985|NCT03801863|Sensory System Agents|sensory system agents|mesh-ancestor
24984986|NCT03801863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24984987|NCT03800641|Dexmedetomidine|dexmedetomidine|mesh-list
24495559|NCT00501111|Donepezil|donepezil|mesh-list
24984988|NCT03800641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24984989|NCT03800641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24984990|NCT03800641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984991|NCT03800641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24984992|NCT03800641|Analgesics|analgesics|mesh-ancestor
24984993|NCT03800641|Sensory System Agents|sensory system agents|mesh-ancestor
25106877|NCT03143946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106879|NCT03143933|Propofol|propofol|mesh-list
25106880|NCT03143933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25106881|NCT03143933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25106882|NCT03143933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576935|NCT00841074|Chlorhexidine|chlorhexidine|mesh-list
25106883|NCT03143933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25106884|NCT03143933|Anesthetics, General|anesthetics, general|mesh-ancestor
25106885|NCT03143933|Anesthetics|anesthetics|mesh-ancestor
25106886|NCT03143933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25106887|NCT03143933|Narcotics|narcotics|mesh-ancestor
25106888|NCT03143933|Analgesics|analgesics|mesh-ancestor
25106891|NCT03143933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25106892|NCT03143998|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25106893|NCT03143998|Grazoprevir|grazoprevir|mesh-list
25106894|NCT03143998|Antiviral Agents|antiviral agents|mesh-ancestor
25106895|NCT03143998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25106896|NCT03143972|Dexmedetomidine|dexmedetomidine|mesh-list
25106898|NCT03143972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25106899|NCT03143972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25106900|NCT03143972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985027|NCT03734237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985028|NCT03730337|Nivolumab|nivolumab|mesh-list
24985029|NCT03730337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24985030|NCT03730337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985031|NCT03730337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24985032|NCT03730337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985075|NCT03706898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516306|NCT00601432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516307|NCT00601432|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24516308|NCT00601432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24985100|NCT03691727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24985101|NCT03647852|Methylprednisolone|methylprednisolone|mesh-list
24985102|NCT03647852|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24985108|NCT03647852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24985109|NCT03647852|Antiemetics|antiemetics|mesh-ancestor
24985110|NCT03647852|Autonomic Agents|autonomic agents|mesh-ancestor
24985111|NCT03647852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24985112|NCT03647852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705870|NCT02205333|Tremelimumab|tremelimumab|mesh-list
25705871|NCT02205333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25705872|NCT02205333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25705873|NCT02205333|Immunologic Factors|immunologic factors|mesh-ancestor
25705874|NCT02205333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705875|NCT02205333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25705876|NCT02205801|Bupivacaine|bupivacaine|mesh-list
25705877|NCT02205801|Anesthetics, Local|anesthetics, local|mesh-ancestor
25705878|NCT02205801|Anesthetics|anesthetics|mesh-ancestor
24985150|NCT03629327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24985151|NCT03629327|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24985152|NCT03629327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24985153|NCT03629327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985154|NCT03629327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24985155|NCT03629327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24985156|NCT03629327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24985157|NCT03629327|Antipyretics|antipyretics|mesh-ancestor
24985158|NCT03604159|Buprenorphine|buprenorphine|mesh-list
24921070|NCT04194658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985159|NCT03604159|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
24985160|NCT03604159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24985161|NCT03604159|Narcotics|narcotics|mesh-ancestor
24985162|NCT03604159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24985163|NCT03604159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985164|NCT03604159|Analgesics|analgesics|mesh-ancestor
24985165|NCT03604159|Sensory System Agents|sensory system agents|mesh-ancestor
24985166|NCT03604159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24784813|NCT01910415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985169|NCT03592693|Ascorbic Acid|ascorbic acid|mesh-list
24985170|NCT03592693|Hydrocortisone|hydrocortisone|mesh-list
24985171|NCT03592693|Micronutrients|micronutrients|mesh-ancestor
24985172|NCT03592693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985173|NCT03592693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24985174|NCT03592693|Antioxidants|antioxidants|mesh-ancestor
25106917|NCT03143530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25106918|NCT03143530|Sensory System Agents|sensory system agents|mesh-ancestor
24985187|NCT03578172|Menotropins|menotropins|mesh-list
24985188|NCT03578172|Hormones|hormones|mesh-list
24985216|NCT03578081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985217|NCT03578081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24985218|NCT03578081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24985219|NCT03578081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24985220|NCT03578081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24985221|NCT03578081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24985222|NCT03578081|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24985267|NCT03532451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24985268|NCT03532451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985269|NCT03522844|Citalopram|citalopram|mesh-list
24985270|NCT03522844|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24985271|NCT03522844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25705879|NCT02205801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25705880|NCT02205801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705881|NCT02205801|Sensory System Agents|sensory system agents|mesh-ancestor
25705882|NCT02205801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25705883|NCT02205814|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|mesh-list
24985273|NCT03522844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985274|NCT03522844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24985275|NCT03522844|Serotonin Agents|serotonin agents|mesh-ancestor
24985283|NCT03514719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985284|NCT03514719|Immunologic Factors|immunologic factors|mesh-ancestor
24985285|NCT03514719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985290|NCT03513770|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24985291|NCT03513770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24985292|NCT03513770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24985293|NCT03513770|Analgesics|analgesics|mesh-ancestor
24985294|NCT03513770|Sensory System Agents|sensory system agents|mesh-ancestor
24985295|NCT03513770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24985316|NCT03476642|Anesthetics|anesthetics|mesh-ancestor
24985317|NCT03476642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24784814|NCT01910415|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24784815|NCT01910415|Contraceptive Agents|contraceptive agents|mesh-ancestor
24784816|NCT01910415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24784817|NCT01910415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784818|NCT01910415|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24784819|NCT01910415|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24784820|NCT01910415|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24784821|NCT01910415|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24784822|NCT01910415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24860467|NCT02310074|Hormones|hormones|mesh-list
24784835|NCT01910480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784836|NCT01910480|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24784838|NCT01910506|Gout Suppressants|gout suppressants|mesh-ancestor
24784839|NCT01910506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24784840|NCT01910532|Clevidipine|clevidipine|mesh-list
24784841|NCT01910532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24860504|NCT02310347|Dronabinol|dronabinol|mesh-list
24985325|NCT03476642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985326|NCT03476642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24985327|NCT03476642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24985328|NCT03476642|Autonomic Agents|autonomic agents|mesh-ancestor
24985329|NCT03476642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24985332|NCT03476642|Sympathomimetics|sympathomimetics|mesh-ancestor
24985333|NCT03476642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24985334|NCT03465280|Interferons|interferons|mesh-list
24985335|NCT03465280|Acyclovir|acyclovir|mesh-list
24985336|NCT03465280|Cidofovir|cidofovir|mesh-list
24985337|NCT03465280|Interferon-alpha|interferon-alpha|mesh-list
25705884|NCT02205814|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
25705885|NCT02205814|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
25705886|NCT02205814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705887|NCT02205814|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25705888|NCT02205814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25705889|NCT02205814|Immunologic Factors|immunologic factors|mesh-ancestor
25705890|NCT02205814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985346|NCT03465280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985347|NCT03465280|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24796169|NCT01948336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24796170|NCT01948336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796172|NCT01948336|Anesthetics, General|anesthetics, general|mesh-ancestor
24796173|NCT01948336|Anesthetics|anesthetics|mesh-ancestor
24796174|NCT01948336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24796175|NCT01948336|Analgesics|analgesics|mesh-ancestor
24796176|NCT01948336|Sensory System Agents|sensory system agents|mesh-ancestor
24796177|NCT01948336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24796184|NCT01948336|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24796185|NCT01948336|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24796186|NCT01948336|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24796187|NCT01948362|Sulforaphane|sulforaphane|mesh-list
24796188|NCT01948362|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24796189|NCT01948362|Protective Agents|protective agents|mesh-ancestor
24796190|NCT01948362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796191|NCT01948362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796192|NCT01948401|Prednisolone|prednisolone|mesh-list
24796193|NCT01948401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24796194|NCT01948401|Glucocorticoids|glucocorticoids|mesh-ancestor
24985362|NCT03465280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24985363|NCT03465280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24985365|NCT03465280|Sensory System Agents|sensory system agents|mesh-ancestor
24985366|NCT03465280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24985367|NCT03465280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24985368|NCT03465280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24985369|NCT03465280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24985370|NCT03465280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24985371|NCT03465280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24985372|NCT03465280|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24860559|NCT02311010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860560|NCT02311088|Caffeine|caffeine|mesh-list
24860562|NCT02311088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985380|NCT03465280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24985381|NCT03465280|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24985382|NCT03465280|Protective Agents|protective agents|mesh-ancestor
24985388|NCT03439657|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24985389|NCT03439657|Immunologic Factors|immunologic factors|mesh-ancestor
24985390|NCT03439657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985391|NCT03421041|Dexamethasone|dexamethasone|mesh-list
24985392|NCT03421041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24985393|NCT03421041|Antiemetics|antiemetics|mesh-ancestor
24505849|NCT00542802|Analgesics|analgesics|mesh-ancestor
24985462|NCT03337594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985463|NCT03319316|Durvalumab|durvalumab|mesh-list
24985472|NCT03300518|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24985473|NCT03300518|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24985474|NCT03300518|Estradiol|estradiol|mesh-list
24985475|NCT03300518|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24985476|NCT03300518|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24985477|NCT03300518|Ganirelix|ganirelix|mesh-list
24985478|NCT03300518|Estrogens|estrogens|mesh-ancestor
24985479|NCT03300518|Hormones|hormones|mesh-ancestor
24985480|NCT03300518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24985481|NCT03300518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985482|NCT03300518|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24985483|NCT03300518|Contraceptive Agents|contraceptive agents|mesh-ancestor
24985484|NCT03300518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24985486|NCT03300518|Hormone Antagonists|hormone antagonists|mesh-ancestor
24985492|NCT03294109|Sensory System Agents|sensory system agents|mesh-ancestor
24985493|NCT03294109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24985494|NCT03273413|Pravastatin|pravastatin|mesh-list
24985495|NCT03273413|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24985496|NCT03273413|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24985497|NCT03273413|Antimetabolites|antimetabolites|mesh-ancestor
24985498|NCT03273413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985499|NCT03273413|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25705891|NCT02205983|Acetaminophen|acetaminophen|mesh-list
25705892|NCT02205983|Hydromorphone|hydromorphone|mesh-list
25705893|NCT02205983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25705894|NCT02205983|Analgesics|analgesics|mesh-ancestor
25705895|NCT02205983|Sensory System Agents|sensory system agents|mesh-ancestor
25705896|NCT02205983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25705897|NCT02205983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705898|NCT02205983|Antipyretics|antipyretics|mesh-ancestor
25705899|NCT02205983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24985500|NCT03273413|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24985551|NCT03187769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25106962|NCT03143244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25106963|NCT03143244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25106967|NCT03143244|Sensory System Agents|sensory system agents|mesh-ancestor
25106968|NCT03143244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25106969|NCT03143244|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25106970|NCT03143244|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25106971|NCT03143244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25106972|NCT03143244|Adrenergic Agents|adrenergic agents|mesh-ancestor
25106973|NCT03143244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25106974|NCT03143244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985552|NCT03187769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24985558|NCT03168438|Immunologic Factors|immunologic factors|mesh-ancestor
24985559|NCT03168438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985560|NCT03168438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24985561|NCT03168438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24985562|NCT03168438|Alkylating Agents|alkylating agents|mesh-ancestor
24985563|NCT03168438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985564|NCT03168438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985565|NCT03168438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24985566|NCT03168438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24985598|NCT03110380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985599|NCT03110380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24985600|NCT03110380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24985601|NCT03110380|Antiviral Agents|antiviral agents|mesh-ancestor
24985602|NCT03110380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24985603|NCT03110380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24985604|NCT03110380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24985606|NCT03078478|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24985607|NCT03078478|Insulin Glargine|insulin glargine|mesh-list
24985608|NCT03078478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24985609|NCT03078478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985610|NCT03046927|Vitamin D|vitamin d|mesh-list
24985611|NCT03046927|Ergocalciferols|ergocalciferols|mesh-list
24985612|NCT03046927|Vitamins|vitamins|mesh-ancestor
24985613|NCT03046927|Micronutrients|micronutrients|mesh-ancestor
24985614|NCT03046927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985615|NCT03046927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24985616|NCT03046927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24985617|NCT03016377|Cyclophosphamide|cyclophosphamide|mesh-list
24985618|NCT03016377|Fludarabine|fludarabine|mesh-list
24985619|NCT03016377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24985620|NCT03016377|Immunologic Factors|immunologic factors|mesh-ancestor
24985621|NCT03016377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985622|NCT03016377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24985623|NCT03016377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24985624|NCT03016377|Alkylating Agents|alkylating agents|mesh-ancestor
24985625|NCT03016377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985626|NCT03016377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985627|NCT03016377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24985628|NCT03009487|Amlodipine|amlodipine|mesh-list
24985629|NCT03009487|Olmesartan|olmesartan|mesh-list
24985630|NCT03009487|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24985631|NCT03009487|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
24985634|NCT03009487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24985635|NCT03009487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24985636|NCT03009487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985637|NCT03009487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24985638|NCT03009487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985639|NCT03009487|Vasodilator Agents|vasodilator agents|mesh-ancestor
24985640|NCT03009487|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25705900|NCT02205983|Narcotics|narcotics|mesh-ancestor
25705901|NCT02205983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25705902|NCT02206152|Acetylcysteine|acetylcysteine|mesh-list
25705903|NCT02206152|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24897428|NCT04425642|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24985641|NCT03009487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24985642|NCT03009487|Antimetabolites|antimetabolites|mesh-ancestor
24985643|NCT03009487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24985645|NCT03009487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796234|NCT01948804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796235|NCT01948804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24796236|NCT01948804|Hormone Antagonists|hormone antagonists|mesh-ancestor
24796237|NCT01948804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24796238|NCT01948804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796240|NCT01948804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24796241|NCT01948804|Fertility Agents|fertility agents|mesh-ancestor
24796242|NCT01948804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24796243|NCT01948804|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24796244|NCT01948804|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24796245|NCT01948817|Deferasirox|deferasirox|mesh-list
24796246|NCT01948817|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24985665|NCT02927249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24985666|NCT02927249|Analgesics|analgesics|mesh-ancestor
24985667|NCT02927249|Sensory System Agents|sensory system agents|mesh-ancestor
24985668|NCT02927249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24985669|NCT02927249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985670|NCT02927249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24985671|NCT02927249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24985672|NCT02927249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24985673|NCT02927249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24985675|NCT02927249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24985676|NCT02927249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24985677|NCT02927249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24985678|NCT02927249|Antipyretics|antipyretics|mesh-ancestor
24985680|NCT02924272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985684|NCT02908087|Liraglutide|liraglutide|mesh-list
24985685|NCT02908087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24985686|NCT02908087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985687|NCT02908087|Incretins|incretins|mesh-ancestor
24985688|NCT02908087|Hormones|hormones|mesh-ancestor
24985689|NCT02908087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24985690|NCT02901483|Cisplatin|cisplatin|mesh-list
24985692|NCT02874651|Apatinib|apatinib|mesh-list
24985727|NCT02818868|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24985728|NCT02818868|Antithrombins|antithrombins|mesh-ancestor
24985729|NCT02818868|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24985730|NCT02818868|Protease Inhibitors|protease inhibitors|mesh-ancestor
24985731|NCT02818868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474425|NCT00406003|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25705904|NCT02206152|Antiviral Agents|antiviral agents|mesh-ancestor
25705905|NCT02206152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25705906|NCT02206152|Expectorants|expectorants|mesh-ancestor
25705907|NCT02206152|Respiratory System Agents|respiratory system agents|mesh-ancestor
25705908|NCT02206152|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24897521|NCT04425226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897522|NCT04424901|Dipyridamole|dipyridamole|mesh-list
24897523|NCT04424901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24897524|NCT04424901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24897525|NCT04424901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985732|NCT02818868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985733|NCT02818868|Anticoagulants|anticoagulants|mesh-ancestor
24985736|NCT02809131|Clindamycin|clindamycin|mesh-list
24985737|NCT02809131|Clindamycin palmitate|clindamycin palmitate|mesh-list
24985738|NCT02809131|Clindamycin phosphate|clindamycin phosphate|mesh-list
24985739|NCT02809131|Cephalexin|cephalexin|mesh-list
24985740|NCT02809131|Polymyxins|polymyxins|mesh-list
24985759|NCT02785952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24985805|NCT02730429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24985806|NCT02730429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985807|NCT02730429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24985808|NCT02730416|Paclitaxel|paclitaxel|mesh-list
24985809|NCT02730416|Carboplatin|carboplatin|mesh-list
24985810|NCT02730416|Nintedanib|nintedanib|mesh-list
24985811|NCT02730416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24985812|NCT02730416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985813|NCT02730416|Tubulin Modulators|tubulin modulators|mesh-ancestor
24985814|NCT02730416|Antimitotic Agents|antimitotic agents|mesh-ancestor
24985815|NCT02730416|Mitosis Modulators|mitosis modulators|mesh-ancestor
24985816|NCT02730416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985817|NCT02730416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24985818|NCT02730416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24985819|NCT02693821|Gabapentin|gabapentin|mesh-list
24985820|NCT02693821|Analgesics|analgesics|mesh-ancestor
24985821|NCT02693821|Sensory System Agents|sensory system agents|mesh-ancestor
24985822|NCT02693821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24985823|NCT02693821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985824|NCT02693821|Anticonvulsants|anticonvulsants|mesh-ancestor
24985825|NCT02693821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24796268|NCT01948960|Everolimus|everolimus|mesh-list
24796269|NCT01948960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796270|NCT01948960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24796271|NCT01948960|Immunologic Factors|immunologic factors|mesh-ancestor
24505552|NCT00541411|Antimitotic Agents|antimitotic agents|mesh-ancestor
24505553|NCT00541411|Mitosis Modulators|mitosis modulators|mesh-ancestor
24505672|NCT00541905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24505673|NCT00541905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505674|NCT00541905|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24505675|NCT00541905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24505692|NCT00542022|Adrenergic Agents|adrenergic agents|mesh-ancestor
24796272|NCT01948960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796273|NCT01948999|Anesthetics|anesthetics|mesh-list
24796274|NCT01948999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24796275|NCT01948999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796276|NCT01949038|Alprazolam|alprazolam|mesh-list
24796277|NCT01949038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24796278|NCT01949038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24589718|NCT00908713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24589719|NCT00908713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589720|NCT00908713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24589721|NCT00908713|Glucocorticoids|glucocorticoids|mesh-ancestor
24589722|NCT00908713|Hormones|hormones|mesh-ancestor
24589723|NCT00908713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24589724|NCT00908713|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24589725|NCT00908713|Protective Agents|protective agents|mesh-ancestor
24589726|NCT00908713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25705909|NCT02206152|Antioxidants|antioxidants|mesh-ancestor
25705910|NCT02206152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705911|NCT02206152|Protective Agents|protective agents|mesh-ancestor
25705912|NCT02206152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705913|NCT02206152|Antidotes|antidotes|mesh-ancestor
25705914|NCT02206620|Donepezil|donepezil|mesh-list
25705915|NCT02206620|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25705916|NCT02206620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24589728|NCT00908726|Propofol|propofol|mesh-list
24589729|NCT00908726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24589730|NCT00908726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24589731|NCT00908726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24589732|NCT00908726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24589733|NCT00908726|Anesthetics, General|anesthetics, general|mesh-ancestor
24589734|NCT00908726|Anesthetics|anesthetics|mesh-ancestor
24622061|NCT01065467|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24622062|NCT01065467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622063|NCT01065467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622064|NCT01065519|Umirolimus|umirolimus|mesh-list
24505693|NCT00542022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24505694|NCT00542022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622065|NCT01065519|Everolimus|everolimus|mesh-list
24622066|NCT01065519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622067|NCT01065519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24622068|NCT01065519|Immunologic Factors|immunologic factors|mesh-ancestor
24622069|NCT01065519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622070|NCT01065519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24622071|NCT01065532|Paclitaxel|paclitaxel|mesh-list
24622072|NCT01065532|Everolimus|everolimus|mesh-list
24622073|NCT01065532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24622074|NCT01065532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622075|NCT01065532|Tubulin Modulators|tubulin modulators|mesh-ancestor
24622076|NCT01065532|Antimitotic Agents|antimitotic agents|mesh-ancestor
24985826|NCT02693821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24985827|NCT02693821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24985828|NCT02693821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24985829|NCT02693821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24985833|NCT02693821|Antimanic Agents|antimanic agents|mesh-ancestor
24505846|NCT00542802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505847|NCT00542802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24505848|NCT00542802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24505855|NCT00542802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24505856|NCT00542802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24505858|NCT00542841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24505870|NCT00542984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24505871|NCT00542984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505936|NCT00543244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505937|NCT00543335|Sorafenib|sorafenib|mesh-list
24505942|NCT00543361|Metformin|metformin|mesh-list
24505951|NCT00543504|Bevacizumab|bevacizumab|mesh-list
24505952|NCT00543504|Trastuzumab|trastuzumab|mesh-list
24640683|NCT01169597|Hormones|hormones|mesh-ancestor
24505963|NCT00543504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505964|NCT00543504|Growth Inhibitors|growth inhibitors|mesh-ancestor
24505965|NCT00543504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24505966|NCT00543504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506036|NCT00543842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24506037|NCT00543842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24506038|NCT00543842|Growth Substances|growth substances|mesh-ancestor
24506355|NCT00544804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24506356|NCT00544804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506357|NCT00544804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506395|NCT00545129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506396|NCT00545142|Valproic Acid|valproic acid|mesh-list
24506397|NCT00545142|Aripiprazole|aripiprazole|mesh-list
24506398|NCT00545142|Antidepressive Agents|antidepressive agents|mesh-ancestor
24506399|NCT00545142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24506400|NCT00545142|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24506401|NCT00545142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24506486|NCT00545519|Thymoglobulin|thymoglobulin|mesh-list
24506751|NCT00546832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24506752|NCT00546832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506753|NCT00546832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24506754|NCT00546832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24507076|NCT00548561|Protective Agents|protective agents|mesh-ancestor
24507077|NCT00548561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507078|NCT00548561|Antimitotic Agents|antimitotic agents|mesh-ancestor
24507079|NCT00548561|Mitosis Modulators|mitosis modulators|mesh-ancestor
24507080|NCT00548574|Mesalamine|mesalamine|mesh-list
24985948|NCT02507505|Anesthetics|anesthetics|mesh-list
24507081|NCT00548574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24507082|NCT00548574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24507083|NCT00548574|Analgesics|analgesics|mesh-ancestor
24507084|NCT00548574|Sensory System Agents|sensory system agents|mesh-ancestor
24507088|NCT00548574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24507108|NCT00548704|Razoxane|razoxane|mesh-list
25705917|NCT02206620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705918|NCT02206620|Cholinergic Agents|cholinergic agents|mesh-ancestor
25705919|NCT02206620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25705920|NCT02206620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507109|NCT00548704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25705921|NCT02206620|Nootropic Agents|nootropic agents|mesh-ancestor
25705922|NCT02206685|Methadone|methadone|mesh-list
25705923|NCT02206685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25705924|NCT02206685|Narcotics|narcotics|mesh-ancestor
25705925|NCT02206685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25705926|NCT02206685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705927|NCT02206685|Analgesics|analgesics|mesh-ancestor
24897848|NCT04421300|Viscosupplements|viscosupplements|mesh-ancestor
24897849|NCT04421300|Protective Agents|protective agents|mesh-ancestor
24897850|NCT04421209|Propranolol|propranolol|mesh-list
24897851|NCT04421209|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24507110|NCT00548704|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24507115|NCT00548704|Protective Agents|protective agents|mesh-ancestor
24507145|NCT00548964|Anesthetics, General|anesthetics, general|mesh-ancestor
24507179|NCT00549120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24507180|NCT00549120|Adrenergic Agents|adrenergic agents|mesh-ancestor
24507181|NCT00549120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24507182|NCT00549120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507183|NCT00549120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507184|NCT00549120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24507185|NCT00549120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24507186|NCT00549120|Vasodilator Agents|vasodilator agents|mesh-ancestor
24507187|NCT00549120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24507188|NCT00549120|Autonomic Agents|autonomic agents|mesh-ancestor
24507219|NCT00549146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24507220|NCT00549146|Adrenergic Agents|adrenergic agents|mesh-ancestor
24507221|NCT00549146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24507222|NCT00549146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507235|NCT00549289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24507236|NCT00549289|Dermatologic Agents|dermatologic agents|mesh-ancestor
24507237|NCT00549289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24507238|NCT00549289|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24507239|NCT00549341|Botulinum Toxins|botulinum toxins|mesh-list
24507240|NCT00549341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24507241|NCT00549341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24507242|NCT00549341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507243|NCT00549341|Cholinergic Agents|cholinergic agents|mesh-ancestor
24507244|NCT00549341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24860965|NCT02314195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985949|NCT02507505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24985950|NCT02507505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985956|NCT02465593|Fluorouracil|fluorouracil|mesh-list
24985957|NCT02465593|Capecitabine|capecitabine|mesh-list
24985958|NCT02465593|Antimetabolites|antimetabolites|mesh-ancestor
24985959|NCT02465593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24985960|NCT02465593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24985961|NCT02465593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24985974|NCT02424019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24985975|NCT02424019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24985977|NCT02422368|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24985991|NCT02422368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25705928|NCT02206685|Sensory System Agents|sensory system agents|mesh-ancestor
25705929|NCT02206685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25705930|NCT02206685|Antitussive Agents|antitussive agents|mesh-ancestor
25705931|NCT02206685|Respiratory System Agents|respiratory system agents|mesh-ancestor
25705932|NCT02206776|Midazolam|midazolam|mesh-list
25705933|NCT02206776|Ketamine|ketamine|mesh-list
25705934|NCT02206776|Analgesics|analgesics|mesh-ancestor
25705935|NCT02206776|Sensory System Agents|sensory system agents|mesh-ancestor
25705936|NCT02206776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24898174|NCT04417452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898175|NCT04417335|BCG Vaccine|bcg vaccine|mesh-list
24898176|NCT04417335|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24475258|NCT00409643|Amlodipine|amlodipine|mesh-list
24985993|NCT02422368|Protective Agents|protective agents|mesh-ancestor
24985994|NCT02422368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24985995|NCT02422368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784878|NCT01910766|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24784879|NCT01910766|Micronutrients|micronutrients|mesh-ancestor
24784881|NCT01910844|Cyclophosphamide|cyclophosphamide|mesh-list
24784882|NCT01910844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24590670|NCT00913549|Clemastine|clemastine|mesh-list
25106977|NCT03143244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25106978|NCT03143244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24507257|NCT00549419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25106979|NCT03143244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25106980|NCT03143244|Anesthetics, General|anesthetics, general|mesh-ancestor
25106981|NCT03143244|Anesthetics|anesthetics|mesh-ancestor
25106982|NCT03143244|GABA Modulators|gaba modulators|mesh-ancestor
25106983|NCT03143244|GABA Agents|gaba agents|mesh-ancestor
25106984|NCT03143244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25106985|NCT03143244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25106986|NCT03143244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25106987|NCT03143244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25106988|NCT03143244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25106989|NCT03143036|Thalidomide|thalidomide|mesh-list
25106990|NCT03143036|Dexamethasone|dexamethasone|mesh-list
25106991|NCT03143036|Daratumumab|daratumumab|mesh-list
25106992|NCT03143036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25106993|NCT03143036|Antiemetics|antiemetics|mesh-ancestor
25106994|NCT03143036|Autonomic Agents|autonomic agents|mesh-ancestor
24622080|NCT01065532|Immunologic Factors|immunologic factors|mesh-ancestor
24622081|NCT01065532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622082|NCT01065545|Clofarabine|clofarabine|mesh-list
24622083|NCT01065545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24622084|NCT01065545|Antimetabolites|antimetabolites|mesh-ancestor
24622086|NCT01065545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622088|NCT01065610|Oxytocics|oxytocics|mesh-ancestor
25705937|NCT02206776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705938|NCT02206776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25705939|NCT02206776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25705940|NCT02206776|Anesthetics, General|anesthetics, general|mesh-ancestor
25705941|NCT02206776|Anesthetics|anesthetics|mesh-ancestor
25705942|NCT02206776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25705943|NCT02206776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25705944|NCT02206776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25705945|NCT02206776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24622089|NCT01065610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24622090|NCT01065610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622091|NCT01065649|Nortriptyline|nortriptyline|mesh-list
24898432|NCT04414566|Gemcitabine|gemcitabine|mesh-list
24622092|NCT01065649|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24622093|NCT01065649|Antidepressive Agents|antidepressive agents|mesh-ancestor
24622094|NCT01065649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24622095|NCT01065649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24622096|NCT01065649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24541296|NCT00672113|Nifedipine|nifedipine|mesh-list
24507270|NCT00549471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507271|NCT00549471|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24507272|NCT00549471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24507273|NCT00549536|Calcium, Dietary|calcium, dietary|mesh-list
24507319|NCT00549666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507320|NCT00549874|Rosiglitazone|rosiglitazone|mesh-list
24796300|NCT01949129|Immunoglobulins|immunoglobulins|mesh-list
24796301|NCT01949129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24796302|NCT01949129|Immunologic Factors|immunologic factors|mesh-ancestor
24796303|NCT01949129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796304|NCT01949129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24796305|NCT01949129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24796306|NCT01949129|Alkylating Agents|alkylating agents|mesh-ancestor
24796307|NCT01949129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796308|NCT01949129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24860998|NCT02314312|Cyclosporins|cyclosporins|mesh-list
24507326|NCT00549887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24507327|NCT00549887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507328|NCT00549926|Atorvastatin|atorvastatin|mesh-list
24507329|NCT00549926|Pravastatin|pravastatin|mesh-list
24507330|NCT00549926|Pitavastatin|pitavastatin|mesh-list
24507331|NCT00549926|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24507332|NCT00549926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24507333|NCT00549926|Antimetabolites|antimetabolites|mesh-ancestor
24507397|NCT00550303|Bazedoxifene|bazedoxifene|mesh-list
24507398|NCT00550303|Estrogens|estrogens|mesh-list
24507419|NCT00550433|Hormones|hormones|mesh-ancestor
24507420|NCT00550433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24507421|NCT00550433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507422|NCT00550433|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24507423|NCT00550433|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24507424|NCT00550433|Hormone Antagonists|hormone antagonists|mesh-ancestor
24507425|NCT00550433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24507426|NCT00550485|Citalopram|citalopram|mesh-list
24507427|NCT00550485|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24507445|NCT00550628|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24507446|NCT00550628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507447|NCT00550693|Chlorhexidine|chlorhexidine|mesh-list
24507448|NCT00550693|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24507449|NCT00550693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24507450|NCT00550693|Disinfectants|disinfectants|mesh-ancestor
24507451|NCT00550784|Paclitaxel|paclitaxel|mesh-list
24507452|NCT00550784|Cyclophosphamide|cyclophosphamide|mesh-list
24507453|NCT00550784|Melphalan|melphalan|mesh-list
24507454|NCT00550784|Topotecan|topotecan|mesh-list
24986074|NCT02333162|Melphalan|melphalan|mesh-list
24986075|NCT02333162|Tacrolimus|tacrolimus|mesh-list
24986076|NCT02333162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986077|NCT02333162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24986078|NCT02333162|Antimetabolites|antimetabolites|mesh-ancestor
24986095|NCT02304991|Glycerol|glycerol|mesh-list
24986096|NCT02304991|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24986097|NCT02304991|Protective Agents|protective agents|mesh-ancestor
25705946|NCT02206776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705947|NCT02206776|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24517193|NCT00606450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24517194|NCT00606450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24898739|NCT04411160|Vasodilator Agents|vasodilator agents|mesh-ancestor
24986098|NCT02304991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986099|NCT02303821|Cytarabine|cytarabine|mesh-list
24986100|NCT02303821|Dexamethasone|dexamethasone|mesh-list
24986101|NCT02303821|Hydrocortisone|hydrocortisone|mesh-list
24986102|NCT02303821|Cyclophosphamide|cyclophosphamide|mesh-list
24507569|NCT00551005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24507570|NCT00551005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507571|NCT00551005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24507572|NCT00551005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24507663|NCT00551252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507664|NCT00551252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24507665|NCT00551265|Cyclophosphamide|cyclophosphamide|mesh-list
24507666|NCT00551265|Oregovomab|oregovomab|mesh-list
24507667|NCT00551265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24507668|NCT00551265|Antibodies|antibodies|mesh-list
24507669|NCT00551265|Immunoglobulins|immunoglobulins|mesh-list
24986103|NCT02303821|Methotrexate|methotrexate|mesh-list
24986104|NCT02303821|Vincristine|vincristine|mesh-list
24986105|NCT02303821|Daunorubicin|daunorubicin|mesh-list
24986106|NCT02303821|Asparaginase|asparaginase|mesh-list
24986107|NCT02303821|Mitoxantrone|mitoxantrone|mesh-list
24986108|NCT02303821|Mercaptopurine|mercaptopurine|mesh-list
24986109|NCT02303821|Pegaspargase|pegaspargase|mesh-list
24986110|NCT02303821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24986111|NCT02303821|Immunologic Factors|immunologic factors|mesh-ancestor
24986112|NCT02303821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986113|NCT02303821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24986122|NCT02303821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24986123|NCT02303821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24986124|NCT02303821|Glucocorticoids|glucocorticoids|mesh-ancestor
24986125|NCT02303821|Hormones|hormones|mesh-ancestor
24986136|NCT02303821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24986138|NCT02303821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24986139|NCT02303821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24986140|NCT02303821|Tubulin Modulators|tubulin modulators|mesh-ancestor
24986141|NCT02303821|Antimitotic Agents|antimitotic agents|mesh-ancestor
25705948|NCT02206776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25705949|NCT02206776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25705950|NCT02206776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25705951|NCT02206776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25705952|NCT02206776|GABA Modulators|gaba modulators|mesh-ancestor
25705953|NCT02206776|GABA Agents|gaba agents|mesh-ancestor
24899055|NCT04407234|Antipyretics|antipyretics|mesh-ancestor
24817762|NCT02085577|Anesthetics, General|anesthetics, general|mesh-ancestor
24817763|NCT02085577|Anesthetics|anesthetics|mesh-ancestor
24986142|NCT02303821|Mitosis Modulators|mitosis modulators|mesh-ancestor
24986143|NCT02303821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24986144|NCT02303821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24986145|NCT02303821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24986202|NCT02220309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24986203|NCT02220309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24986204|NCT02220309|Dopamine Agonists|dopamine agonists|mesh-ancestor
24986205|NCT02220309|Dopamine Agents|dopamine agents|mesh-ancestor
24986206|NCT02220309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24986207|NCT02141282|Venetoclax|venetoclax|mesh-list
24986208|NCT02141282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986209|NCT02126553|Lenalidomide|lenalidomide|mesh-list
24986210|NCT02126553|Immunologic Factors|immunologic factors|mesh-ancestor
24986211|NCT02126553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986212|NCT02126553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24986213|NCT02126553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24507670|NCT00551265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24507671|NCT00551265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24507672|NCT00551265|Immunologic Factors|immunologic factors|mesh-ancestor
24507673|NCT00551265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507674|NCT00551265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24507675|NCT00551265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24507676|NCT00551265|Alkylating Agents|alkylating agents|mesh-ancestor
24507677|NCT00551265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507678|NCT00551265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507679|NCT00551265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24507680|NCT00551317|Darapladib|darapladib|mesh-list
24507681|NCT00551317|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
24507767|NCT00551889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24507768|NCT00551889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24507769|NCT00551889|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24507770|NCT00551889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24507771|NCT00551889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507772|NCT00551954|Acarbose|acarbose|mesh-list
24507847|NCT00552682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24507848|NCT00552682|Antidepressive Agents|antidepressive agents|mesh-ancestor
24507849|NCT00552682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24507851|NCT00552734|Insulin|insulin|mesh-list
24507852|NCT00552734|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24507853|NCT00552734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24507855|NCT00552747|Fenofibrate|fenofibrate|mesh-list
24507856|NCT00552747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24507857|NCT00552747|Antimetabolites|antimetabolites|mesh-ancestor
25109526|NCT03123289|Gallium citrate|gallium citrate|mesh-list
24507896|NCT00553124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507897|NCT00553124|Antioxidants|antioxidants|mesh-ancestor
24507898|NCT00553124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507899|NCT00553124|Protective Agents|protective agents|mesh-ancestor
24507900|NCT00553124|Trace Elements|trace elements|mesh-ancestor
24507901|NCT00553137|Fluconazole|fluconazole|mesh-list
25705954|NCT02207088|Ritonavir|ritonavir|mesh-list
25705955|NCT02207088|Ribavirin|ribavirin|mesh-list
25705956|NCT02207088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25705957|NCT02207088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25705958|NCT02207088|Protease Inhibitors|protease inhibitors|mesh-ancestor
24517554|NCT00608673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24986221|NCT02122198|Estrogens|estrogens|mesh-ancestor
24508499|NCT00555984|Anesthetics, General|anesthetics, general|mesh-ancestor
24508500|NCT00555984|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24508758|NCT00556959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24508759|NCT00556959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24508760|NCT00556959|Adrenergic Agents|adrenergic agents|mesh-ancestor
24508761|NCT00556959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24508762|NCT00556959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508763|NCT00557011|Amphetamine|amphetamine|mesh-list
24508833|NCT00557219|Fenoldopam|fenoldopam|mesh-list
24508834|NCT00557219|Ketanserin|ketanserin|mesh-list
24508835|NCT00557219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24508836|NCT00557219|Vasodilator Agents|vasodilator agents|mesh-ancestor
24508837|NCT00557219|Dopamine Agonists|dopamine agonists|mesh-ancestor
24986224|NCT02122198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986225|NCT02122198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24986226|NCT02122198|Contraceptive Agents|contraceptive agents|mesh-ancestor
24986227|NCT02122198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24986228|NCT02122198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24508838|NCT00557219|Dopamine Agents|dopamine agents|mesh-ancestor
24508839|NCT00557219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24508859|NCT00557427|Serotonin Agents|serotonin agents|mesh-ancestor
24508924|NCT00557739|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24508996|NCT00557960|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24508997|NCT00557960|Sympathomimetics|sympathomimetics|mesh-ancestor
24509029|NCT00558142|Antiviral Agents|antiviral agents|mesh-ancestor
24509030|NCT00558142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24509031|NCT00558142|Expectorants|expectorants|mesh-ancestor
24509032|NCT00558142|Respiratory System Agents|respiratory system agents|mesh-ancestor
24509033|NCT00558142|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24509034|NCT00558142|Antioxidants|antioxidants|mesh-ancestor
24509036|NCT00558142|Protective Agents|protective agents|mesh-ancestor
24509136|NCT00558818|Antiviral Agents|antiviral agents|mesh-ancestor
24509138|NCT00558883|Acarbose|acarbose|mesh-list
24509230|NCT00559429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509233|NCT00559455|Oxaliplatin|oxaliplatin|mesh-list
24509234|NCT00559455|Antimetabolites|antimetabolites|mesh-ancestor
24509235|NCT00559455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509457|NCT00560378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24509458|NCT00560378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509459|NCT00560430|Telmisartan|telmisartan|mesh-list
24509460|NCT00560430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24509463|NCT00560430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509465|NCT00560443|Tramadol|tramadol|mesh-list
24509466|NCT00560443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24509467|NCT00560443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24509468|NCT00560443|Analgesics|analgesics|mesh-ancestor
24509469|NCT00560443|Sensory System Agents|sensory system agents|mesh-ancestor
24509470|NCT00560443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24986241|NCT02079948|Abortifacient Agents|abortifacient agents|mesh-ancestor
24986242|NCT02079948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24986243|NCT02079948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705959|NCT02207088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25705960|NCT02207088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705961|NCT02207088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25705962|NCT02207088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25705963|NCT02207088|Antiviral Agents|antiviral agents|mesh-ancestor
25705964|NCT02207088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25705965|NCT02207088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25705966|NCT02207088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25705967|NCT02207088|Antimetabolites|antimetabolites|mesh-ancestor
25705968|NCT02207231|Adalimumab|adalimumab|mesh-list
25705969|NCT02207231|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25705970|NCT02207231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25705971|NCT02207231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25705972|NCT02207231|Immunologic Factors|immunologic factors|mesh-ancestor
25705973|NCT02207231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986244|NCT02079948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24986245|NCT02079948|Antimetabolites|antimetabolites|mesh-ancestor
24986246|NCT02079948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986247|NCT02079948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509655|NCT00561379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509681|NCT00561613|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
24509682|NCT00561613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509686|NCT00561691|Nimotuzumab|nimotuzumab|mesh-list
24509687|NCT00561691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24509688|NCT00561691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509696|NCT00561717|Loratadine|loratadine|mesh-list
24509739|NCT00561964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24986248|NCT02079948|Dermatologic Agents|dermatologic agents|mesh-ancestor
24986249|NCT02079948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24986250|NCT02079948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24986251|NCT02079948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24986252|NCT02079948|Immunologic Factors|immunologic factors|mesh-ancestor
24986253|NCT02079948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24986254|NCT02079948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24986255|NCT02079948|Hematinics|hematinics|mesh-ancestor
24986256|NCT02079948|Vitamins|vitamins|mesh-ancestor
24986257|NCT02079948|Micronutrients|micronutrients|mesh-ancestor
24986258|NCT02060188|Nivolumab|nivolumab|mesh-list
24986259|NCT02060188|Ipilimumab|ipilimumab|mesh-list
25705974|NCT02207244|Adalimumab|adalimumab|mesh-list
24986260|NCT02060188|Daratumumab|daratumumab|mesh-list
24986261|NCT02060188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24986262|NCT02060188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986263|NCT02060188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25705975|NCT02207244|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25705976|NCT02207244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25705977|NCT02207244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25705978|NCT02207244|Immunologic Factors|immunologic factors|mesh-ancestor
25705979|NCT02207244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705980|NCT02207374|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25705981|NCT02207374|Protease Inhibitors|protease inhibitors|mesh-ancestor
25705982|NCT02207374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25705983|NCT02207374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25705984|NCT02207374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24986264|NCT02060188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986265|NCT02055053|Bupivacaine|bupivacaine|mesh-list
24986266|NCT02055053|Anesthetics, Local|anesthetics, local|mesh-ancestor
24986267|NCT02055053|Anesthetics|anesthetics|mesh-ancestor
24986268|NCT02055053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24986269|NCT02055053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986270|NCT02055053|Sensory System Agents|sensory system agents|mesh-ancestor
24986271|NCT02055053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24986272|NCT02004275|Dexamethasone|dexamethasone|mesh-list
24986273|NCT02004275|Pomalidomide|pomalidomide|mesh-list
24986275|NCT02004275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24986276|NCT02004275|Antiemetics|antiemetics|mesh-ancestor
24509769|NCT00562068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509770|NCT00562068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509771|NCT00562068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24509772|NCT00562068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24509773|NCT00562068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24509774|NCT00562068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24509775|NCT00562068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24930444|NCT04101578|Dermatologic Agents|dermatologic agents|mesh-ancestor
24509776|NCT00562068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24509777|NCT00562068|Tubulin Modulators|tubulin modulators|mesh-ancestor
24986278|NCT02004275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24986279|NCT02004275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986280|NCT02004275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24986281|NCT02004275|Glucocorticoids|glucocorticoids|mesh-ancestor
24986283|NCT02004275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24796352|NCT01949519|Antioxidants|antioxidants|mesh-ancestor
24796353|NCT01949519|Protective Agents|protective agents|mesh-ancestor
24796356|NCT01949519|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24796357|NCT01949571|Mirtazapine|mirtazapine|mesh-list
24796358|NCT01949571|Antidepressive Agents|antidepressive agents|mesh-ancestor
24796359|NCT01949571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24796360|NCT01949571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24796361|NCT01949571|Histamine Antagonists|histamine antagonists|mesh-ancestor
24509996|NCT00563056|Adrenergic Agents|adrenergic agents|mesh-ancestor
24509997|NCT00563056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24510476|NCT00564655|Bupivacaine|bupivacaine|mesh-list
24443940|NCT00296309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24443941|NCT00296309|Immunologic Factors|immunologic factors|mesh-ancestor
24861168|NCT02315547|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24986335|NCT01854385|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24986336|NCT01854385|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24986337|NCT01854385|Serotonin Agents|serotonin agents|mesh-ancestor
24986338|NCT01854385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24986339|NCT01854385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986340|NCT01854385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986341|NCT01844856|Ertapenem|ertapenem|mesh-list
24986342|NCT01844856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24986343|NCT01844856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24986344|NCT01817166|Vitamin D|vitamin d|mesh-list
24986345|NCT01817166|Cholecalciferol|cholecalciferol|mesh-list
24986346|NCT01817166|Vitamins|vitamins|mesh-ancestor
24986349|NCT01817166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24986350|NCT01817166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24796395|NCT01949805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24796396|NCT01949818|Prednisone|prednisone|mesh-list
24796397|NCT01949818|Prednisolone|prednisolone|mesh-list
24796398|NCT01949818|Cyclophosphamide|cyclophosphamide|mesh-list
24796399|NCT01949818|Doxorubicin|doxorubicin|mesh-list
24986381|NCT01712789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24986382|NCT01712789|Antiemetics|antiemetics|mesh-ancestor
24986383|NCT01712789|Autonomic Agents|autonomic agents|mesh-ancestor
24986384|NCT01712789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24986385|NCT01712789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986386|NCT01712789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24986387|NCT01712789|Glucocorticoids|glucocorticoids|mesh-ancestor
24986389|NCT01712789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24986390|NCT01712789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24986393|NCT01712789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24986394|NCT01712789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24986395|NCT01712789|Growth Substances|growth substances|mesh-ancestor
24986396|NCT01712789|Growth Inhibitors|growth inhibitors|mesh-ancestor
24986397|NCT01665794|Dexamethasone|dexamethasone|mesh-list
24986398|NCT01665794|Daratumumab|daratumumab|mesh-list
24986399|NCT01665794|Pomalidomide|pomalidomide|mesh-list
24986400|NCT01665794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24986401|NCT01665794|Antiemetics|antiemetics|mesh-ancestor
24986402|NCT01665794|Autonomic Agents|autonomic agents|mesh-ancestor
24986403|NCT01665794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24986442|NCT01560572|Antitubercular Agents|antitubercular agents|mesh-ancestor
24986443|NCT01560572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24986444|NCT01560572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24986445|NCT01543633|Propofol|propofol|mesh-list
24861198|NCT02315651|Ubiquinone|ubiquinone|mesh-list
24510338|NCT00564252|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24510339|NCT00564252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24510340|NCT00564252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510341|NCT00564252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510348|NCT00564330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24510349|NCT00564330|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24510350|NCT00564330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25705986|NCT02207400|Listerine|listerine|mesh-list
25705987|NCT02207400|Fluorides|fluorides|mesh-list
25705988|NCT02207400|Sodium Fluoride|sodium fluoride|mesh-list
25705989|NCT02207400|Cariostatic Agents|cariostatic agents|mesh-ancestor
25705990|NCT02207400|Protective Agents|protective agents|mesh-ancestor
25705991|NCT02207400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705992|NCT02207400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25705993|NCT02207400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25705994|NCT02207413|Vaccines|vaccines|mesh-list
24510352|NCT00564408|Carbachol|carbachol|mesh-list
24986494|NCT01147666|Hematinics|hematinics|mesh-ancestor
24986495|NCT00982111|Pemetrexed|pemetrexed|mesh-list
24986496|NCT00982111|Necitumumab|necitumumab|mesh-list
24986497|NCT00982111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986498|NCT00982111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24986499|NCT00982111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986500|NCT00982111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24986501|NCT00982111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24986502|NCT00982111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24986503|NCT00670358|Prednisone|prednisone|mesh-list
24986504|NCT00670358|Cyclophosphamide|cyclophosphamide|mesh-list
24986505|NCT00670358|Rituximab|rituximab|mesh-list
24986506|NCT00670358|Doxorubicin|doxorubicin|mesh-list
24986507|NCT00670358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24986508|NCT00670358|Vincristine|vincristine|mesh-list
24510475|NCT00564655|Racepinephrine|racepinephrine|mesh-list
24510878|NCT00566241|Mecasermin|mecasermin|mesh-list
24510879|NCT00566241|Growth Substances|growth substances|mesh-ancestor
24510880|NCT00566241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510881|NCT00566267|Simvastatin|simvastatin|mesh-list
24510882|NCT00566267|Ezetimibe|ezetimibe|mesh-list
24510883|NCT00566267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24510884|NCT00566267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24511091|NCT00567411|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24511092|NCT00567411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24511093|NCT00567411|Adrenergic Agents|adrenergic agents|mesh-ancestor
24511094|NCT00567411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24511095|NCT00567411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511096|NCT00567411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511097|NCT00567450|Ropivacaine|ropivacaine|mesh-list
24511098|NCT00567450|Mepivacaine|mepivacaine|mesh-list
24511099|NCT00567450|Anesthetics, Local|anesthetics, local|mesh-ancestor
24511100|NCT00567450|Anesthetics|anesthetics|mesh-ancestor
24861241|NCT02316327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25705995|NCT02207413|Immunologic Factors|immunologic factors|mesh-ancestor
25705996|NCT02207413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25705997|NCT02207491|Timolol|timolol|mesh-list
24784915|NCT01910987|Dexamethasone acetate|dexamethasone acetate|mesh-list
24784918|NCT01910987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25705998|NCT02207491|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25705999|NCT02207491|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25706000|NCT02207491|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25706001|NCT02207491|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25706002|NCT02207491|Adrenergic Agents|adrenergic agents|mesh-ancestor
24899922|NCT04399083|Purinergic Agents|purinergic agents|mesh-ancestor
24899923|NCT04399083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24784920|NCT01910987|Autonomic Agents|autonomic agents|mesh-ancestor
24784921|NCT01910987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24784922|NCT01910987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784923|NCT01910987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24784924|NCT01910987|Glucocorticoids|glucocorticoids|mesh-ancestor
24784925|NCT01910987|Hormones|hormones|mesh-ancestor
24784926|NCT01910987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24784927|NCT01910987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24784928|NCT01910987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784929|NCT01910987|Protease Inhibitors|protease inhibitors|mesh-ancestor
24784930|NCT01910987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24784931|NCT01910987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577037|NCT00841802|Prednisone|prednisone|mesh-list
24784933|NCT01911195|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24784934|NCT01911195|Anesthetics, General|anesthetics, general|mesh-ancestor
24784935|NCT01911195|Anesthetics|anesthetics|mesh-ancestor
24784936|NCT01911195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24511157|NCT00567554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24511158|NCT00567554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24511160|NCT00567606|Calcium|calcium|mesh-list
24511161|NCT00567606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24511162|NCT00567606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511163|NCT00567606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24511164|NCT00567606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24511165|NCT00567606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784946|NCT01911299|Glycerol|glycerol|mesh-list
24784947|NCT01911299|Lipotropic Agents|lipotropic agents|mesh-ancestor
24924241|NCT04161586|Sensory System Agents|sensory system agents|mesh-ancestor
24986531|NCT00670358|Antimitotic Agents|antimitotic agents|mesh-ancestor
24986532|NCT00670358|Mitosis Modulators|mitosis modulators|mesh-ancestor
24986533|NCT00670358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24986534|NCT00670358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24986535|NCT00670358|Growth Substances|growth substances|mesh-ancestor
24986536|NCT00670358|Growth Inhibitors|growth inhibitors|mesh-ancestor
24986538|NCT00193219|Bevacizumab|bevacizumab|mesh-list
24986539|NCT00193219|Cetuximab|cetuximab|mesh-list
24986540|NCT00193219|Fluorouracil|fluorouracil|mesh-list
24986541|NCT00193219|Oxaliplatin|oxaliplatin|mesh-list
24986542|NCT00193219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24986543|NCT00193219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986544|NCT00193219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24986545|NCT00193219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25706003|NCT02207491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25706004|NCT02207491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706005|NCT02207491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706006|NCT02207491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25706007|NCT02207491|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25706008|NCT02207530|Durvalumab|durvalumab|mesh-list
25706009|NCT02207530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25706010|NCT02207530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24900541|NCT04393025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900567|NCT04392427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24511274|NCT00568074|Gliquidone|gliquidone|mesh-list
24511355|NCT00568347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24511356|NCT00568347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511358|NCT00568347|Hormones|hormones|mesh-ancestor
24511359|NCT00568347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24511360|NCT00568347|Sympathomimetics|sympathomimetics|mesh-ancestor
24511361|NCT00568412|Pimecrolimus|pimecrolimus|mesh-list
24511362|NCT00568412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24511363|NCT00568412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24511364|NCT00568412|Analgesics|analgesics|mesh-ancestor
24511365|NCT00568412|Sensory System Agents|sensory system agents|mesh-ancestor
24511366|NCT00568412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24511369|NCT00568412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24986556|NCT00193219|Vitamin B Complex|vitamin b complex|mesh-ancestor
24986558|NCT00193219|Micronutrients|micronutrients|mesh-ancestor
24986559|NCT00116142|Ascorbic Acid|ascorbic acid|mesh-list
24986560|NCT00116142|Docetaxel|docetaxel|mesh-list
24986561|NCT00116142|Methyltestosterone|methyltestosterone|mesh-list
24986562|NCT00116142|Androgens|androgens|mesh-list
24813338|NCT02057926|Tetracycline|tetracycline|mesh-list
24511469|NCT00568841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511470|NCT00568841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24511471|NCT00568841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24511472|NCT00568841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511495|NCT00569088|Mannitol|mannitol|mesh-list
24986565|NCT00116142|Tubulin Modulators|tubulin modulators|mesh-ancestor
24986566|NCT00116142|Antimitotic Agents|antimitotic agents|mesh-ancestor
24986567|NCT00116142|Mitosis Modulators|mitosis modulators|mesh-ancestor
24986568|NCT00116142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986569|NCT00116142|Hormones|hormones|mesh-ancestor
24986570|NCT00116142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24986571|NCT00116142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986572|NCT00116142|Antioxidants|antioxidants|mesh-ancestor
24986573|NCT00116142|Protective Agents|protective agents|mesh-ancestor
24986574|NCT00116142|Vitamins|vitamins|mesh-ancestor
24986575|NCT00116142|Micronutrients|micronutrients|mesh-ancestor
24511544|NCT00569465|Expectorants|expectorants|mesh-ancestor
24511545|NCT00569465|Respiratory System Agents|respiratory system agents|mesh-ancestor
24511546|NCT00569465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24511547|NCT00569465|Antioxidants|antioxidants|mesh-ancestor
24511548|NCT00569465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511608|NCT00569816|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24511609|NCT00569816|Anesthetics, General|anesthetics, general|mesh-ancestor
25706011|NCT02207556|Doxycycline|doxycycline|mesh-list
25706012|NCT02207556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25706013|NCT02207556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25706014|NCT02207556|Antimalarials|antimalarials|mesh-ancestor
25706015|NCT02207556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25706016|NCT02207556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25709674|NCT02272725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25709675|NCT02272725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25709676|NCT02272725|Analgesics|analgesics|mesh-ancestor
25709677|NCT02272725|Sensory System Agents|sensory system agents|mesh-ancestor
25709678|NCT02272725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25709679|NCT02272725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709680|NCT02272725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25709681|NCT02272725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25709682|NCT02272725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24900818|NCT04391127|Hydroxychloroquine|hydroxychloroquine|mesh-list
24511677|NCT00570219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511725|NCT00570479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24511778|NCT00570882|Growth Substances|growth substances|mesh-ancestor
24511779|NCT00570882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511780|NCT00570882|Growth Inhibitors|growth inhibitors|mesh-ancestor
24511781|NCT00570882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24511782|NCT00570882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24511783|NCT00570882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511847|NCT00571246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24511849|NCT00571246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24511850|NCT00571246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24986577|NCT00116142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24986578|NCT00116142|Anabolic Agents|anabolic agents|mesh-ancestor
24986579|NCT00070018|Prednisone|prednisone|mesh-list
24986580|NCT00070018|Cyclophosphamide|cyclophosphamide|mesh-list
24986581|NCT00070018|Rituximab|rituximab|mesh-list
24986582|NCT00070018|Doxorubicin|doxorubicin|mesh-list
24986583|NCT00070018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24986584|NCT00070018|Vincristine|vincristine|mesh-list
24986585|NCT00070018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24986586|NCT00070018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24813363|NCT02058173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813364|NCT02058173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24813365|NCT02058173|Filaricides|filaricides|mesh-ancestor
24813366|NCT02058173|Antinematodal Agents|antinematodal agents|mesh-ancestor
24511931|NCT00571714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24511932|NCT00571727|Mecasermin|mecasermin|mesh-list
24511933|NCT00571727|Growth Substances|growth substances|mesh-ancestor
24511934|NCT00571727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511935|NCT00571740|Leucovorin|leucovorin|mesh-list
24511936|NCT00571740|Bevacizumab|bevacizumab|mesh-list
24511937|NCT00571740|Cetuximab|cetuximab|mesh-list
24511942|NCT00571740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24511943|NCT00571740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25706017|NCT02207608|Hyaluronic Acid|hyaluronic acid|mesh-list
25706018|NCT02207608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25706019|NCT02207608|Immunologic Factors|immunologic factors|mesh-ancestor
25706020|NCT02207608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706021|NCT02207608|Viscosupplements|viscosupplements|mesh-ancestor
25706022|NCT02207608|Protective Agents|protective agents|mesh-ancestor
25706023|NCT02207621|Timolol|timolol|mesh-list
25706024|NCT02207621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25706025|NCT02207621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24518742|NCT04417049|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24518743|NCT04417049|Protective Agents|protective agents|mesh-ancestor
24518744|NCT04417049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518745|NCT04417049|Vasodilator Agents|vasodilator agents|mesh-ancestor
24518754|NCT04372927|Immunoglobulins|immunoglobulins|mesh-list
24901072|NCT04389229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511944|NCT00571740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24511945|NCT00571740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24511946|NCT00571740|Growth Substances|growth substances|mesh-ancestor
24511971|NCT00571805|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24511972|NCT00571805|Cholinergic Agents|cholinergic agents|mesh-ancestor
24511973|NCT00571805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24511974|NCT00571805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512013|NCT00572065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512014|NCT00572078|Sorafenib|sorafenib|mesh-list
24512015|NCT00572078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512016|NCT00572078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24512017|NCT00572078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512018|NCT00572078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512019|NCT00572208|Gabapentin|gabapentin|mesh-list
24512020|NCT00572208|Analgesics|analgesics|mesh-ancestor
24512021|NCT00572208|Sensory System Agents|sensory system agents|mesh-ancestor
24512058|NCT00572390|Hormones|hormones|mesh-ancestor
24986595|NCT00070018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24986596|NCT00070018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24986597|NCT00070018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24986600|NCT00070018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24986601|NCT00070018|Glucocorticoids|glucocorticoids|mesh-ancestor
24986602|NCT00070018|Hormones|hormones|mesh-ancestor
24986603|NCT00070018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24986604|NCT00070018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24986605|NCT00070018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24813373|NCT02058199|Rivaroxaban|rivaroxaban|mesh-list
24512070|NCT00572637|Protease Inhibitors|protease inhibitors|mesh-ancestor
24512071|NCT00572637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512073|NCT00572650|Vildagliptin|vildagliptin|mesh-list
24512103|NCT00572741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512104|NCT00572741|Antioxidants|antioxidants|mesh-ancestor
24512105|NCT00572741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512184|NCT00573547|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24512185|NCT00573547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24512186|NCT00573547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24512187|NCT00573547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512188|NCT00573547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24512189|NCT00573547|Serotonin Agents|serotonin agents|mesh-ancestor
24512294|NCT00573963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706026|NCT02207621|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25706027|NCT02207621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25706028|NCT02207621|Adrenergic Agents|adrenergic agents|mesh-ancestor
25706029|NCT02207621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25706030|NCT02207621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706031|NCT02207621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512295|NCT00573963|Sensory System Agents|sensory system agents|mesh-ancestor
25706032|NCT02207621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25706033|NCT02207621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24518811|NCT04177953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24518812|NCT04177953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518813|NCT04177953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512296|NCT00573963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24512298|NCT00574015|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
24512299|NCT00574015|Hydrocodone|hydrocodone|mesh-list
24512598|NCT00575848|Glycine Agents|glycine agents|mesh-ancestor
24512599|NCT00575848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24512600|NCT00575848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512601|NCT00575848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512648|NCT00576017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24512649|NCT00576017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512650|NCT00576017|Analgesics|analgesics|mesh-ancestor
24512651|NCT00576017|Sensory System Agents|sensory system agents|mesh-ancestor
24512652|NCT00576017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24512653|NCT00576017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24512654|NCT00576017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24512655|NCT00576017|Anesthetics, General|anesthetics, general|mesh-ancestor
24512656|NCT00576017|Anesthetics|anesthetics|mesh-ancestor
24512657|NCT00576069|Fluticasone|fluticasone|mesh-list
24512658|NCT00576069|Mometasone Furoate|mometasone furoate|mesh-list
24986642|NCT05189184|Mitosis Modulators|mitosis modulators|mesh-ancestor
24986643|NCT05189184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986644|NCT05189184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24986649|NCT05189093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986650|NCT05189067|Paclitaxel|paclitaxel|mesh-list
24986651|NCT05189067|Docetaxel|docetaxel|mesh-list
24986652|NCT05189067|Trastuzumab|trastuzumab|mesh-list
24986653|NCT05189067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24986654|NCT05189067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986655|NCT05189067|Tubulin Modulators|tubulin modulators|mesh-ancestor
24986656|NCT05189067|Antimitotic Agents|antimitotic agents|mesh-ancestor
24986657|NCT05189067|Mitosis Modulators|mitosis modulators|mesh-ancestor
24512754|NCT00576433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24986659|NCT05189067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24986666|NCT05188911|Prednisone|prednisone|mesh-list
24986667|NCT05188911|Androgens|androgens|mesh-list
24986668|NCT05188911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24986669|NCT05188911|Glucocorticoids|glucocorticoids|mesh-ancestor
24986670|NCT05188911|Hormones|hormones|mesh-ancestor
24986671|NCT05188911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24541622|NCT00674167|Capecitabine|capecitabine|mesh-list
24513135|NCT00579085|Analgesics|analgesics|mesh-ancestor
24513136|NCT00579085|Sensory System Agents|sensory system agents|mesh-ancestor
24513137|NCT00579085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24796422|NCT01949818|Mitosis Modulators|mitosis modulators|mesh-ancestor
25706034|NCT02207634|Evolocumab|evolocumab|mesh-list
25706035|NCT02207634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25706036|NCT02207634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25706037|NCT02207634|Antimetabolites|antimetabolites|mesh-ancestor
25706038|NCT02207634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706039|NCT02207634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25706040|NCT02207816|Vaccines|vaccines|mesh-list
25706041|NCT02207816|Immunologic Factors|immunologic factors|mesh-ancestor
25709683|NCT02272725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901356|NCT04385602|Dexmedetomidine|dexmedetomidine|mesh-list
24901357|NCT04385602|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24901358|NCT04385602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24901359|NCT04385602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901361|NCT04385602|Analgesics|analgesics|mesh-ancestor
24818125|NCT02087007|Vasodilator Agents|vasodilator agents|mesh-ancestor
24513138|NCT00579085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513139|NCT00579085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24986672|NCT05188911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861317|NCT02316964|Analgesics|analgesics|mesh-ancestor
24986673|NCT05188911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24986674|NCT05188911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986675|NCT05188859|Pemetrexed|pemetrexed|mesh-list
24986676|NCT05188859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986677|NCT05188859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24986678|NCT05188859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986679|NCT05188859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24986680|NCT05188859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24986681|NCT05188833|Paroxetine|paroxetine|mesh-list
24986682|NCT05188833|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24986683|NCT05188833|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24986684|NCT05188833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24986685|NCT05188833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986687|NCT05188833|Serotonin Agents|serotonin agents|mesh-ancestor
24986688|NCT05188833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986689|NCT05188833|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24986690|NCT05188833|Antidepressive Agents|antidepressive agents|mesh-ancestor
24986691|NCT05188833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24986692|NCT05188833|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24986693|NCT05188833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24986694|NCT05188833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24986695|NCT05188781|Pembrolizumab|pembrolizumab|mesh-list
24986696|NCT05188781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24986697|NCT05188781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986698|NCT05188768|Mitogens|mitogens|mesh-list
24986699|NCT05188768|Mitosis Modulators|mitosis modulators|mesh-ancestor
24986700|NCT05188768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986701|NCT05188742|Mirabegron|mirabegron|mesh-list
24986702|NCT05188742|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24986703|NCT05188742|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24986707|NCT05188742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24986708|NCT05188742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986709|NCT05188742|Urological Agents|urological agents|mesh-ancestor
24796409|NCT01949818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24796410|NCT01949818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24796411|NCT01949818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24796412|NCT01949818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24796413|NCT01949818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541635|NCT00674232|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24861327|NCT02317146|Sensory System Agents|sensory system agents|mesh-ancestor
24861328|NCT02317146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24861329|NCT02317146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796414|NCT01949818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25706042|NCT02207816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706043|NCT02207829|Tiotropium Bromide|tiotropium bromide|mesh-list
25706044|NCT02207829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25706045|NCT02207829|Autonomic Agents|autonomic agents|mesh-ancestor
25706046|NCT02207829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25706047|NCT02207829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706048|NCT02207829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25706049|NCT02207829|Respiratory System Agents|respiratory system agents|mesh-ancestor
24901568|NCT04383548|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24901570|NCT04383548|Immunologic Factors|immunologic factors|mesh-ancestor
24901571|NCT04383548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796415|NCT01949818|Glucocorticoids|glucocorticoids|mesh-ancestor
24796416|NCT01949818|Hormones|hormones|mesh-ancestor
24796417|NCT01949818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24796418|NCT01949818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24796419|NCT01949818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24796420|NCT01949818|Tubulin Modulators|tubulin modulators|mesh-ancestor
24796421|NCT01949818|Antimitotic Agents|antimitotic agents|mesh-ancestor
24986721|NCT05188131|Diclofenac|diclofenac|mesh-list
24986722|NCT05188131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24986723|NCT05188131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24986724|NCT05188131|Analgesics|analgesics|mesh-ancestor
24467862|NCT00379015|Docetaxel|docetaxel|mesh-list
24986725|NCT05188131|Sensory System Agents|sensory system agents|mesh-ancestor
24986726|NCT05188131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24986727|NCT05188131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24986728|NCT05188131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24986744|NCT05188118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24446621|NCT00305474|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24541660|NCT00674557|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
24541661|NCT00674557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986745|NCT05188118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24986746|NCT05187663|Chlorhexidine|chlorhexidine|mesh-list
24986747|NCT05187663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24986748|NCT05187663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24986749|NCT05187663|Disinfectants|disinfectants|mesh-ancestor
24986750|NCT05169424|Fluticasone|fluticasone|mesh-list
24986751|NCT05169424|Xhance|xhance|mesh-list
24986752|NCT05169424|Tiotropium Bromide|tiotropium bromide|mesh-list
24986753|NCT05169424|Olodaterol|olodaterol|mesh-list
24986754|NCT05169424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24986755|NCT05169424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24986756|NCT05169424|Autonomic Agents|autonomic agents|mesh-ancestor
24986757|NCT05169424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24541668|NCT00674557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24541669|NCT00674557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541670|NCT00674557|Chelating Agents|chelating agents|mesh-ancestor
24541671|NCT00674557|Sequestering Agents|sequestering agents|mesh-ancestor
24541672|NCT00674557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24861389|NCT02317419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986805|NCT05160896|Bevacizumab|bevacizumab|mesh-list
24986806|NCT05160896|Cetuximab|cetuximab|mesh-list
24986807|NCT05160896|Irinotecan|irinotecan|mesh-list
24986808|NCT05160896|Raltitrexed|raltitrexed|mesh-list
24986809|NCT05160896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24986810|NCT05160896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24986811|NCT05160896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24986812|NCT05160896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24513535|NCT00583193|Dopamine Agents|dopamine agents|mesh-ancestor
24513537|NCT00583258|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24513538|NCT00583258|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24513539|NCT00583258|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24513540|NCT00583258|Adrenergic Agents|adrenergic agents|mesh-ancestor
25706050|NCT02207829|Parasympatholytics|parasympatholytics|mesh-ancestor
25706051|NCT02207829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25706052|NCT02207829|Cholinergic Agents|cholinergic agents|mesh-ancestor
25706053|NCT02207829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25706054|NCT02207829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706055|NCT02207907|Listerine|listerine|mesh-list
25706056|NCT02207907|Fluorides|fluorides|mesh-list
25706057|NCT02207907|Sodium Fluoride|sodium fluoride|mesh-list
25706058|NCT02207907|Cariostatic Agents|cariostatic agents|mesh-ancestor
24541686|NCT00674674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541687|NCT00674674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541688|NCT00674687|Gabapentin|gabapentin|mesh-list
24784970|NCT01911364|Parasympatholytics|parasympatholytics|mesh-ancestor
24784971|NCT01911364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24784972|NCT01911364|Cholinergic Agents|cholinergic agents|mesh-ancestor
24784973|NCT01911364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24784974|NCT01911364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784975|NCT01911377|Botulinum Toxins|botulinum toxins|mesh-list
24986855|NCT05076409|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24861441|NCT02317770|Anesthetics|anesthetics|mesh-ancestor
24541694|NCT00674687|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24986856|NCT05076409|Nootropic Agents|nootropic agents|mesh-ancestor
24924530|NCT04159155|Antimitotic Agents|antimitotic agents|mesh-ancestor
25107033|NCT03143010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25107034|NCT03143010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25107035|NCT03143010|Adrenergic Agents|adrenergic agents|mesh-ancestor
25107036|NCT03143010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25107037|NCT03143010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107038|NCT03142776|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25107039|NCT03142776|Clarithromycin|clarithromycin|mesh-list
25107040|NCT03142776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25107041|NCT03142776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24513576|NCT00583518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24513652|NCT00584376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24513653|NCT00584376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513654|NCT00584376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24513655|NCT00584376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24513656|NCT00584376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24513657|NCT00584376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24513658|NCT00584376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24861453|NCT02317861|Benzbromarone|benzbromarone|mesh-list
25107045|NCT03142776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25107046|NCT03142880|Ropivacaine|ropivacaine|mesh-list
25107047|NCT03142880|Anesthetics, Local|anesthetics, local|mesh-ancestor
25107048|NCT03142880|Anesthetics|anesthetics|mesh-ancestor
25107049|NCT03142880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25107050|NCT03142880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107051|NCT03142880|Sensory System Agents|sensory system agents|mesh-ancestor
24796465|NCT01950182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796466|NCT01950182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24796467|NCT01950182|Immunologic Factors|immunologic factors|mesh-ancestor
24796468|NCT01950182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796469|NCT01950182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24796470|NCT01950182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24796471|NCT01950182|Tubulin Modulators|tubulin modulators|mesh-ancestor
24796472|NCT01950182|Antimitotic Agents|antimitotic agents|mesh-ancestor
24796473|NCT01950182|Mitosis Modulators|mitosis modulators|mesh-ancestor
24796474|NCT01950182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24796475|NCT01950182|Hormone Antagonists|hormone antagonists|mesh-ancestor
24796476|NCT01950182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24796477|NCT01950182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24796478|NCT01950182|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24796479|NCT01950182|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24796480|NCT01950182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24796481|NCT01950182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24796483|NCT01950195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24796484|NCT01950195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796485|NCT01950195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24901841|NCT04380220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796486|NCT01950195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796487|NCT01950403|Linaclotide|linaclotide|mesh-list
24796488|NCT01950403|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
24796489|NCT01950403|Enzyme Activators|enzyme activators|mesh-ancestor
24796491|NCT01950403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24796496|NCT01950416|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24796497|NCT01950416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24796498|NCT01950416|Purinergic Agents|purinergic agents|mesh-ancestor
24491577|NCT00483067|Antimetabolites|antimetabolites|mesh-ancestor
24491578|NCT00483067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796499|NCT01950416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24796500|NCT01950416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796501|NCT01950416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796502|NCT01950481|Ceritinib|ceritinib|mesh-list
24796503|NCT01950481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796504|NCT01950481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24796505|NCT01950481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796506|NCT01950481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796507|NCT01950494|Hand Sanitizers|hand sanitizers|mesh-list
24796508|NCT01950494|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24796509|NCT01950494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24796510|NCT01950494|Disinfectants|disinfectants|mesh-ancestor
24796511|NCT01950507|Fluconazole|fluconazole|mesh-list
24796512|NCT01950507|Voriconazole|voriconazole|mesh-list
24796513|NCT01950507|Micafungin|micafungin|mesh-list
24796514|NCT01950507|Budesonide|budesonide|mesh-list
24796564|NCT01950793|Immunologic Factors|immunologic factors|mesh-ancestor
24796515|NCT01950507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24513703|NCT00584610|Copper|copper|mesh-list
24483080|NCT00441740|Gemcitabine|gemcitabine|mesh-list
24513719|NCT00584636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513720|NCT00584636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24513721|NCT00584636|Respiratory System Agents|respiratory system agents|mesh-ancestor
24513734|NCT00584662|Autonomic Agents|autonomic agents|mesh-ancestor
24513735|NCT00584662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24513736|NCT00584662|Nasal Decongestants|nasal decongestants|mesh-ancestor
24513737|NCT00584662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24513738|NCT00584662|Respiratory System Agents|respiratory system agents|mesh-ancestor
24513739|NCT00584662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24513740|NCT00584662|Mydriatics|mydriatics|mesh-ancestor
24513741|NCT00584662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24513742|NCT00584662|Protective Agents|protective agents|mesh-ancestor
24513748|NCT00584688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24513749|NCT00584688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513750|NCT00584779|Gabapentin|gabapentin|mesh-list
24513751|NCT00584779|Analgesics|analgesics|mesh-ancestor
24513752|NCT00584779|Sensory System Agents|sensory system agents|mesh-ancestor
24513753|NCT00584779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24513754|NCT00584779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513755|NCT00584779|Anticonvulsants|anticonvulsants|mesh-ancestor
24513756|NCT00584779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24513757|NCT00584779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24987013|NCT04589832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24987055|NCT04447287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24987056|NCT04447287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833850|NCT02175927|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25706059|NCT02207907|Protective Agents|protective agents|mesh-ancestor
25706060|NCT02207907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706061|NCT02207907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25706062|NCT02207907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25706063|NCT02207946|Botulinum Toxins|botulinum toxins|mesh-list
25706064|NCT02207946|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25706065|NCT02207946|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25706066|NCT02207946|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25706067|NCT02207946|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24902207|NCT04376814|Antiviral Agents|antiviral agents|mesh-ancestor
24987058|NCT04416048|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24987060|NCT04416048|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24987061|NCT04416048|Protease Inhibitors|protease inhibitors|mesh-ancestor
24987062|NCT04416048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24987063|NCT04416048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987064|NCT04416048|Anticoagulants|anticoagulants|mesh-ancestor
24987065|NCT04410562|Hydroxychloroquine|hydroxychloroquine|mesh-list
24987066|NCT04410562|Antimalarials|antimalarials|mesh-ancestor
24987067|NCT04410562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24987068|NCT04410562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24987069|NCT04410562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24987070|NCT04410562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24987071|NCT04410562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987072|NCT04410562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24987073|NCT04393350|Pembrolizumab|pembrolizumab|mesh-list
24987075|NCT04393350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24987076|NCT04393350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987077|NCT04393350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24987078|NCT04393350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796556|NCT01950793|Hyaluronic Acid|hyaluronic acid|mesh-list
24796557|NCT01950793|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24796558|NCT01950793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24796559|NCT01950793|Glucocorticoids|glucocorticoids|mesh-ancestor
24796560|NCT01950793|Hormones|hormones|mesh-ancestor
24796561|NCT01950793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24796562|NCT01950793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796563|NCT01950793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24796565|NCT01950793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24514146|NCT00588172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24796569|NCT01950793|Protective Agents|protective agents|mesh-ancestor
24796571|NCT01950884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24796572|NCT01950884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24796573|NCT01950884|Antimetabolites|antimetabolites|mesh-ancestor
24796574|NCT01950884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796575|NCT01950884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24796576|NCT01950923|Sildenafil Citrate|sildenafil citrate|mesh-list
24796578|NCT01950923|Vasodilator Agents|vasodilator agents|mesh-ancestor
24987134|NCT03913195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24987135|NCT03913195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24987136|NCT03913195|Antiviral Agents|antiviral agents|mesh-ancestor
24987137|NCT03913195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24987138|NCT03695172|Ropivacaine|ropivacaine|mesh-list
24987139|NCT03695172|Anesthetics, Local|anesthetics, local|mesh-ancestor
24784995|NCT01911468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24784996|NCT01911494|Magnesium Sulfate|magnesium sulfate|mesh-list
24784997|NCT01911494|Methyldopa|methyldopa|mesh-list
24784998|NCT01911494|Analgesics|analgesics|mesh-ancestor
24784999|NCT01911494|Sensory System Agents|sensory system agents|mesh-ancestor
25706068|NCT02207946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25706069|NCT02207946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706070|NCT02207946|Cholinergic Agents|cholinergic agents|mesh-ancestor
25706071|NCT02207946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25706072|NCT02207946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706073|NCT02207946|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25706074|NCT02207946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25706075|NCT02208037|Mycophenolic Acid|mycophenolic acid|mesh-list
25706076|NCT02208037|Maraviroc|maraviroc|mesh-list
25706077|NCT02208037|Cyclophosphamide|cyclophosphamide|mesh-list
24902333|NCT04374318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902334|NCT04374318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24902336|NCT04374318|Sensory System Agents|sensory system agents|mesh-ancestor
24785000|NCT01911494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24785001|NCT01911494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785002|NCT01911494|Anesthetics|anesthetics|mesh-ancestor
24785003|NCT01911494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24785004|NCT01911494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24513845|NCT00585559|Antipyretics|antipyretics|mesh-ancestor
24513846|NCT00585559|Antiviral Agents|antiviral agents|mesh-ancestor
24513847|NCT00585559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24513848|NCT00585559|Expectorants|expectorants|mesh-ancestor
24513849|NCT00585559|Respiratory System Agents|respiratory system agents|mesh-ancestor
24513850|NCT00585559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24513851|NCT00585559|Antioxidants|antioxidants|mesh-ancestor
24514140|NCT00588133|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24514141|NCT00588133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24514142|NCT00588133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514143|NCT00588133|Hemostatics|hemostatics|mesh-ancestor
24514144|NCT00588133|Coagulants|coagulants|mesh-ancestor
24514145|NCT00588172|Metformin|metformin|mesh-list
24514147|NCT00588172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514149|NCT00588302|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24514150|NCT00588302|Protease Inhibitors|protease inhibitors|mesh-ancestor
25107089|NCT03142620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24861786|NCT02320084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861787|NCT02320240|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24861788|NCT02320240|Fluvoxamine|fluvoxamine|mesh-list
24861789|NCT02320240|Citalopram|citalopram|mesh-list
24861790|NCT02320240|Fluoxetine|fluoxetine|mesh-list
25107099|NCT03142607|Chlorhexidine|chlorhexidine|mesh-list
25107100|NCT03142607|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25107101|NCT03142607|Metronidazole|metronidazole|mesh-list
25107102|NCT03142607|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24987159|NCT03554044|Mitosis Modulators|mitosis modulators|mesh-ancestor
24987160|NCT03554044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987161|NCT03554044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24987162|NCT03554044|Antimetabolites|antimetabolites|mesh-ancestor
24987163|NCT03554044|Antiviral Agents|antiviral agents|mesh-ancestor
24987164|NCT03554044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24987165|NCT03554044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24987166|NCT03554044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24987167|NCT03554044|Immunologic Factors|immunologic factors|mesh-ancestor
24987168|NCT03554044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987169|NCT03554044|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24987170|NCT03554044|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24987171|NCT03554044|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24987172|NCT03554044|Hormone Antagonists|hormone antagonists|mesh-ancestor
24987198|NCT03470675|Anesthetics|anesthetics|mesh-ancestor
24987261|NCT03412799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24987262|NCT03412799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24987263|NCT03412799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25706078|NCT02208037|Methotrexate|methotrexate|mesh-list
25706079|NCT02208037|Bortezomib|bortezomib|mesh-list
25706080|NCT02208037|Tacrolimus|tacrolimus|mesh-list
25706081|NCT02208037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25706082|NCT02208037|Immunologic Factors|immunologic factors|mesh-ancestor
25706083|NCT02208037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706084|NCT02208037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25706085|NCT02208037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25706086|NCT02208037|Alkylating Agents|alkylating agents|mesh-ancestor
24987264|NCT03412799|Immunologic Factors|immunologic factors|mesh-ancestor
24987265|NCT03412799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987266|NCT03405870|SMOFlipid|smoflipid|mesh-list
24987267|NCT03405870|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24987268|NCT03405870|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24987269|NCT03405870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24987272|NCT03391882|Apomorphine|apomorphine|mesh-list
24987273|NCT03391882|Emetics|emetics|mesh-ancestor
24987274|NCT03391882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987327|NCT02553941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987328|NCT02553941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24987341|NCT02420574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24987342|NCT02420574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24987343|NCT02420574|Anticestodal Agents|anticestodal agents|mesh-ancestor
24987344|NCT02420574|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24987345|NCT02420574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24987346|NCT02420574|Tubulin Modulators|tubulin modulators|mesh-ancestor
24987347|NCT02420574|Antimitotic Agents|antimitotic agents|mesh-ancestor
24987348|NCT02420574|Mitosis Modulators|mitosis modulators|mesh-ancestor
24987349|NCT02420574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987350|NCT02420574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987352|NCT02403193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24987353|NCT02403193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514151|NCT00588302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24514152|NCT00588302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987354|NCT02403193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987355|NCT02358681|Ketorolac|ketorolac|mesh-list
24987356|NCT02358681|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24987357|NCT02358681|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24987358|NCT02358681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24987360|NCT02358681|Sensory System Agents|sensory system agents|mesh-ancestor
24987361|NCT02358681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24987362|NCT02358681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987363|NCT02358681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24987365|NCT02358681|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24987366|NCT02358681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796593|NCT01951053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24796597|NCT01951053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24514439|NCT00590603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514440|NCT00590603|Vitamins|vitamins|mesh-ancestor
24514441|NCT00590603|Micronutrients|micronutrients|mesh-ancestor
24590107|NCT00910754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24590108|NCT00910754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590109|NCT00910754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590110|NCT00910754|Hormone Antagonists|hormone antagonists|mesh-ancestor
25706087|NCT02208037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706088|NCT02208037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25706089|NCT02208037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25706090|NCT02208037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25706091|NCT02208037|Abortifacient Agents|abortifacient agents|mesh-ancestor
25706092|NCT02208037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25706093|NCT02208037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24902768|NCT04371107|Azithromycin|azithromycin|mesh-list
24902769|NCT04371107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24902770|NCT04371107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902779|NCT04370431|Antioxidants|antioxidants|mesh-ancestor
24902879|NCT04369222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24902880|NCT04369222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24902881|NCT04369222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24902882|NCT04368819|Allopurinol|allopurinol|mesh-list
24902883|NCT04368819|Antimetabolites|antimetabolites|mesh-ancestor
24902884|NCT04368819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902885|NCT04368819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902886|NCT04368819|Gout Suppressants|gout suppressants|mesh-ancestor
24902887|NCT04368819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24902888|NCT04368819|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24902923|NCT04368598|Acetylcysteine|acetylcysteine|mesh-list
24590111|NCT00910754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24590112|NCT00910767|Insulin|insulin|mesh-list
24590114|NCT00910767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590115|NCT00910780|Olanzapine|olanzapine|mesh-list
24590116|NCT00910780|Aripiprazole|aripiprazole|mesh-list
24590117|NCT00910780|Antidepressive Agents|antidepressive agents|mesh-ancestor
24861997|NCT02321852|Diuretics|diuretics|mesh-ancestor
24987405|NCT02101788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24987406|NCT02101788|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24987407|NCT02101788|Protective Agents|protective agents|mesh-ancestor
24987408|NCT02101788|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24987409|NCT02101788|Antioxidants|antioxidants|mesh-ancestor
24987410|NCT02081378|Niacinamide|niacinamide|mesh-list
24987411|NCT02081378|Imatinib Mesylate|imatinib mesylate|mesh-list
24987412|NCT02081378|Dasatinib|dasatinib|mesh-list
24987413|NCT02081378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987414|NCT02081378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24987415|NCT02081378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24987416|NCT02081378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987417|NCT02081378|Vitamin B Complex|vitamin b complex|mesh-ancestor
24987418|NCT02081378|Vitamins|vitamins|mesh-ancestor
24987419|NCT02081378|Micronutrients|micronutrients|mesh-ancestor
24987420|NCT02081378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987421|NCT01970410|Teriflunomide|teriflunomide|mesh-list
24541930|NCT00675896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24796653|NCT01951430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796654|NCT01951430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796655|NCT01951430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24796656|NCT01951430|Hormone Antagonists|hormone antagonists|mesh-ancestor
24541931|NCT00675896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25706094|NCT02208037|Antimetabolites|antimetabolites|mesh-ancestor
25706095|NCT02208037|Dermatologic Agents|dermatologic agents|mesh-ancestor
25706096|NCT02208037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25706097|NCT02208037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25706098|NCT02208037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25706099|NCT02208037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25706100|NCT02208037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25706101|NCT02208037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25706102|NCT02208037|Antitubercular Agents|antitubercular agents|mesh-ancestor
25706103|NCT02208037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25706104|NCT02208037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25706105|NCT02208037|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25706106|NCT02208037|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25706107|NCT02208037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25706108|NCT02208037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25706109|NCT02208037|Antiviral Agents|antiviral agents|mesh-ancestor
24474426|NCT00406003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25706110|NCT02208037|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24796657|NCT01951430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24796658|NCT01951430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497234|NCT00508976|Lidocaine|lidocaine|mesh-list
24796662|NCT01951430|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24813426|NCT02058446|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24813428|NCT02058485|Dexmedetomidine|dexmedetomidine|mesh-list
24813429|NCT02058485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24813430|NCT02058485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24813431|NCT02058485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987527|NCT00924326|Cyclophosphamide|cyclophosphamide|mesh-list
24987528|NCT00924326|Fludarabine|fludarabine|mesh-list
24987529|NCT00924326|Fludarabine phosphate|fludarabine phosphate|mesh-list
24987530|NCT00924326|Interleukin-2|interleukin-2|mesh-list
24987531|NCT00924326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24987532|NCT00924326|Immunologic Factors|immunologic factors|mesh-ancestor
24987533|NCT00924326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987534|NCT00924326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24987535|NCT00924326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24987536|NCT00924326|Alkylating Agents|alkylating agents|mesh-ancestor
24987537|NCT00924326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987538|NCT00924326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987539|NCT00924326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24987540|NCT00924326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24514671|NCT00592215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514672|NCT00592215|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24514673|NCT00592215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24514674|NCT00592215|Oxytocics|oxytocics|mesh-ancestor
24514675|NCT00592215|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24514676|NCT00592215|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24514677|NCT00592215|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24514678|NCT00592215|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24514687|NCT00592241|Insulin|insulin|mesh-list
24987543|NCT00924326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24987544|NCT00924326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24987545|NCT00924326|Analgesics|analgesics|mesh-ancestor
24987546|NCT00924326|Sensory System Agents|sensory system agents|mesh-ancestor
24987547|NCT00924326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24987548|NCT00924326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24987549|NCT00924326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24987550|NCT00591318|Ceftriaxone|ceftriaxone|mesh-list
24987551|NCT00591318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24987553|NCT00321100|Bevacizumab|bevacizumab|mesh-list
24987554|NCT00321100|Cetuximab|cetuximab|mesh-list
24987555|NCT00321100|Capecitabine|capecitabine|mesh-list
24987556|NCT00321100|Oxaliplatin|oxaliplatin|mesh-list
24987557|NCT00321100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24987558|NCT00321100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987559|NCT00321100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24987560|NCT00321100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24987561|NCT00321100|Growth Substances|growth substances|mesh-ancestor
24987562|NCT00321100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987563|NCT00321100|Growth Inhibitors|growth inhibitors|mesh-ancestor
24514797|NCT00592969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514798|NCT00593008|Gemcitabine|gemcitabine|mesh-list
24514800|NCT00593008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24514801|NCT00593008|Antimetabolites|antimetabolites|mesh-ancestor
24514865|NCT00593164|Anesthetics|anesthetics|mesh-ancestor
24514866|NCT00593164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24514867|NCT00593164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24987564|NCT00321100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25706112|NCT02208050|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25706113|NCT02208050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25706114|NCT02208050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706115|NCT02208063|Vancomycin|vancomycin|mesh-list
25706116|NCT02208063|Cefazolin|cefazolin|mesh-list
25706117|NCT02208063|Daptomycin|daptomycin|mesh-list
24904135|NCT04358562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24904136|NCT04358562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904137|NCT04358562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904138|NCT04358146|Locust bean gum|locust bean gum|mesh-list
24904139|NCT04358146|Antidiarrheals|antidiarrheals|mesh-ancestor
24904140|NCT04358146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24813465|NCT02058576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24813466|NCT02058641|Darapladib|darapladib|mesh-list
24813467|NCT02058641|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
24813468|NCT02058641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813469|NCT02058641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813470|NCT02058667|Paclitaxel|paclitaxel|mesh-list
24987593|NCT05190952|Bupivacaine|bupivacaine|mesh-list
24987594|NCT05190952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24987595|NCT05190952|Antiemetics|antiemetics|mesh-ancestor
24987596|NCT05190952|Autonomic Agents|autonomic agents|mesh-ancestor
24987597|NCT05190952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24987598|NCT05190952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987599|NCT05190952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24987600|NCT05190952|Glucocorticoids|glucocorticoids|mesh-ancestor
24987601|NCT05190952|Hormones|hormones|mesh-ancestor
24987602|NCT05190952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24987603|NCT05190952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24987604|NCT05190952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987605|NCT05190952|Anesthetics, Local|anesthetics, local|mesh-ancestor
24987606|NCT05190952|Anesthetics|anesthetics|mesh-ancestor
24987607|NCT05190952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24987608|NCT05190952|Sensory System Agents|sensory system agents|mesh-ancestor
24987609|NCT05190952|Analgesics|analgesics|mesh-ancestor
24987610|NCT05190952|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24987611|NCT05190952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24987612|NCT05190952|Anesthetics, General|anesthetics, general|mesh-ancestor
24987613|NCT05190952|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24987614|NCT05190952|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24514918|NCT00593463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24514919|NCT00593463|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24514920|NCT00593463|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24514921|NCT00593463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24514922|NCT00593463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514924|NCT00593463|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24514925|NCT00593463|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24514926|NCT00593463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24514927|NCT00593463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24514928|NCT00593463|Vasodilator Agents|vasodilator agents|mesh-ancestor
24514929|NCT00593463|Tocolytic Agents|tocolytic agents|mesh-ancestor
25706118|NCT02208063|Penicillins|penicillins|mesh-list
25706119|NCT02208063|Cloxacillin|cloxacillin|mesh-list
25706120|NCT02208063|Oxacillin|oxacillin|mesh-list
25706121|NCT02208063|Nafcillin|nafcillin|mesh-list
25706122|NCT02208063|Telavancin|telavancin|mesh-list
25706123|NCT02208063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25706124|NCT02208063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25706125|NCT02208297|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25706126|NCT02208297|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25706127|NCT02208310|Vitamin D|vitamin d|mesh-list
24904266|NCT04357093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706128|NCT02208310|Ergocalciferols|ergocalciferols|mesh-list
25706129|NCT02208310|Cholecalciferol|cholecalciferol|mesh-list
25706131|NCT02208310|Micronutrients|micronutrients|mesh-ancestor
25107110|NCT03142516|Folic Acid|folic acid|mesh-list
25107111|NCT03142516|Fluorouracil|fluorouracil|mesh-list
24515063|NCT00594269|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24515064|NCT00594269|Dopamine Agents|dopamine agents|mesh-ancestor
24515065|NCT00594269|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24515066|NCT00594269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24515172|NCT00595140|Protective Agents|protective agents|mesh-ancestor
24515229|NCT00596050|Fentanyl|fentanyl|mesh-list
25107164|NCT03142256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25107165|NCT03142256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24862144|NCT02323399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24862145|NCT02323399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862146|NCT02323399|Sympathomimetics|sympathomimetics|mesh-ancestor
24862147|NCT02323399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24862148|NCT02323399|Nasal Decongestants|nasal decongestants|mesh-ancestor
25107166|NCT03142256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25107167|NCT03142360|Beraprost|beraprost|mesh-list
25107168|NCT03142360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25107169|NCT03142360|Vasodilator Agents|vasodilator agents|mesh-ancestor
24515351|NCT00596375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24515352|NCT00596375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515353|NCT00596414|Midazolam|midazolam|mesh-list
24515354|NCT00596414|Meperidine|meperidine|mesh-list
24515355|NCT00596414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24515356|NCT00596414|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24515357|NCT00596414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24515358|NCT00596414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515359|NCT00596414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24515360|NCT00596414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25706132|NCT02208310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706133|NCT02208310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25706134|NCT02208310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25706135|NCT02208466|Fluoxetine|fluoxetine|mesh-list
25706136|NCT02208466|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25706137|NCT02208466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25706138|NCT02208466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24987685|NCT05186883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987688|NCT05167084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24987689|NCT05167084|Antimetabolites|antimetabolites|mesh-ancestor
24987690|NCT05167084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987691|NCT05167084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796676|NCT01951482|Growth Substances|growth substances|mesh-ancestor
24987692|NCT05165992|Fentanyl|fentanyl|mesh-list
24987693|NCT05165992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24987694|NCT05165992|Narcotics|narcotics|mesh-ancestor
24987695|NCT05165992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24987696|NCT05165992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987697|NCT05165992|Analgesics|analgesics|mesh-ancestor
24987698|NCT05165992|Sensory System Agents|sensory system agents|mesh-ancestor
24987699|NCT05165992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24987700|NCT05165992|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24987701|NCT05165992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24987702|NCT05165992|Anesthetics, General|anesthetics, general|mesh-ancestor
24987703|NCT05165992|Anesthetics|anesthetics|mesh-ancestor
24987704|NCT05154968|Mannitol|mannitol|mesh-list
24987705|NCT05154968|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24515409|NCT00596986|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24987746|NCT05042947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515478|NCT00597623|Adalimumab|adalimumab|mesh-list
24515479|NCT00597623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24862196|NCT02323516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24862197|NCT02323516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862198|NCT02323516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24862199|NCT02323516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24862200|NCT02323516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24862201|NCT02323516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24987707|NCT05154968|Natriuretic Agents|natriuretic agents|mesh-ancestor
24987708|NCT05154968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987709|NCT05118256|Pirfenidone|pirfenidone|mesh-list
24987710|NCT05118256|Analgesics|analgesics|mesh-ancestor
24987711|NCT05118256|Sensory System Agents|sensory system agents|mesh-ancestor
24987712|NCT05118256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24987713|NCT05118256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987714|NCT05118256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24987715|NCT05118256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24987716|NCT05118256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24987717|NCT05118256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24987718|NCT05118256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987719|NCT05106335|Docetaxel|docetaxel|mesh-list
24987720|NCT05106335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987721|NCT05106335|Tubulin Modulators|tubulin modulators|mesh-ancestor
24987722|NCT05106335|Antimitotic Agents|antimitotic agents|mesh-ancestor
24987723|NCT05106335|Mitosis Modulators|mitosis modulators|mesh-ancestor
24987724|NCT05106335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987731|NCT05060965|Nicotine|nicotine|mesh-list
24987732|NCT05060965|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24987737|NCT05060965|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24987738|NCT05060965|Cholinergic Agents|cholinergic agents|mesh-ancestor
24987739|NCT05060965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24987740|NCT05060965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987741|NCT05042947|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24987742|NCT05042947|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
24987743|NCT05042947|beta-Endorphin|beta-endorphin|mesh-list
24987745|NCT05042947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24987750|NCT05033847|Immunologic Factors|immunologic factors|mesh-ancestor
24512499|NCT00575419|Acetylcysteine|acetylcysteine|mesh-list
24987751|NCT05033847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515527|NCT00598156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515528|NCT00598156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515529|NCT00598169|Dexamethasone|dexamethasone|mesh-list
24515530|NCT00598169|Rituximab|rituximab|mesh-list
24515531|NCT00598169|Carboplatin|carboplatin|mesh-list
24987752|NCT05019560|Sevoflurane|sevoflurane|mesh-list
24987753|NCT05019560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24987754|NCT05019560|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24515532|NCT00598169|Etoposide|etoposide|mesh-list
24515585|NCT00598247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24515586|NCT00598247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24515587|NCT00598247|Tubulin Modulators|tubulin modulators|mesh-ancestor
24444127|NCT00296777|Bupropion|bupropion|mesh-list
24515588|NCT00598247|Antimitotic Agents|antimitotic agents|mesh-ancestor
24515722|NCT00598897|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24515723|NCT00598897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24905467|NCT04347577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24905537|NCT04346797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905538|NCT04346667|Hydroxychloroquine|hydroxychloroquine|mesh-list
24905539|NCT04346667|Chloroquine|chloroquine|mesh-list
24905540|NCT04346667|Antimalarials|antimalarials|mesh-ancestor
24515726|NCT00598923|Topiramate|topiramate|mesh-list
24515737|NCT00598962|Azithromycin|azithromycin|mesh-list
24515807|NCT00599287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24987758|NCT05019560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987760|NCT04990323|Cyclophosphamide|cyclophosphamide|mesh-list
24987761|NCT04990323|Busulfan|busulfan|mesh-list
24987762|NCT04990323|Thiotepa|thiotepa|mesh-list
24987763|NCT04990323|Fludarabine|fludarabine|mesh-list
24987764|NCT04990323|Fludarabine phosphate|fludarabine phosphate|mesh-list
24987765|NCT04990323|Clofarabine|clofarabine|mesh-list
24987766|NCT04990323|Tacrolimus|tacrolimus|mesh-list
24987767|NCT04990323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24987768|NCT04990323|Immunologic Factors|immunologic factors|mesh-ancestor
24987769|NCT04990323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862229|NCT02323607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24862231|NCT02323737|Cisplatin|cisplatin|mesh-list
24515854|NCT00599625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24515855|NCT00599625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515897|NCT00599898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24515900|NCT00599911|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24515930|NCT00600041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515931|NCT00600054|Nimotuzumab|nimotuzumab|mesh-list
24862240|NCT02323737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25706139|NCT02208466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706140|NCT02208466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25706141|NCT02208466|Serotonin Agents|serotonin agents|mesh-ancestor
25706142|NCT02208466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706143|NCT02208466|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25706144|NCT02208466|Antidepressive Agents|antidepressive agents|mesh-ancestor
25706145|NCT02208466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24987770|NCT04990323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24987771|NCT04990323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24987772|NCT04990323|Alkylating Agents|alkylating agents|mesh-ancestor
24796677|NCT01951482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796678|NCT01951482|Growth Inhibitors|growth inhibitors|mesh-ancestor
24796679|NCT01951482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796680|NCT01951482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796681|NCT01951482|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24515958|NCT00600145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515959|NCT00600145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515960|NCT00600145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24515961|NCT00600145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24515985|NCT00600158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24515986|NCT00600158|Narcotics|narcotics|mesh-ancestor
24515987|NCT00600158|Analgesics|analgesics|mesh-ancestor
24796723|NCT01951729|Autonomic Agents|autonomic agents|mesh-ancestor
24796724|NCT01951729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24796725|NCT01951729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796726|NCT01951729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24796727|NCT01951729|Respiratory System Agents|respiratory system agents|mesh-ancestor
24516034|NCT00600366|Biphasic Insulins|biphasic insulins|mesh-list
24519614|NCT05332106|Anabolic Agents|anabolic agents|mesh-ancestor
24516035|NCT00600366|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24516036|NCT00600366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24516037|NCT00600366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516038|NCT00600405|Ibuprofen|ibuprofen|mesh-list
24516040|NCT00600405|Tamsulosin|tamsulosin|mesh-list
24796735|NCT01951846|Nintedanib|nintedanib|mesh-list
24906076|NCT04342910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24906077|NCT04342910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796745|NCT01951872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796746|NCT01951872|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24796747|NCT01951872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24796749|NCT01951872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24796750|NCT01951885|Mycophenolic Acid|mycophenolic acid|mesh-list
24796752|NCT01951885|Tacrolimus|tacrolimus|mesh-list
24796753|NCT01951885|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24796756|NCT01951885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987773|NCT04990323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987775|NCT04990323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24987776|NCT04990323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24987777|NCT04990323|Antimetabolites|antimetabolites|mesh-ancestor
24516193|NCT00600912|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24516194|NCT00600912|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24516195|NCT00600912|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24516196|NCT00600964|Obatoclax|obatoclax|mesh-list
24516197|NCT00600964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516198|NCT00600964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987800|NCT04939090|Megestrol|megestrol|mesh-list
24987801|NCT04939090|Megestrol Acetate|megestrol acetate|mesh-list
24987802|NCT04939090|Olanzapine|olanzapine|mesh-list
24987803|NCT04939090|Antiemetics|antiemetics|mesh-ancestor
24862284|NCT02324166|Cefazolin|cefazolin|mesh-list
24516212|NCT00601016|Imiquimod|imiquimod|mesh-list
24987804|NCT04939090|Autonomic Agents|autonomic agents|mesh-ancestor
24862296|NCT02324166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706146|NCT02208466|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25706147|NCT02208466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25706148|NCT02208466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25706149|NCT02208843|Afatinib|afatinib|mesh-list
25706150|NCT02208843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25706151|NCT02208843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25706152|NCT02208843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25706153|NCT02208843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906297|NCT04341727|Azithromycin|azithromycin|mesh-list
24906300|NCT04341727|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24906301|NCT04341727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24906302|NCT04341727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24906303|NCT04341727|Antimalarials|antimalarials|mesh-ancestor
24906304|NCT04341727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24906305|NCT04341727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24906306|NCT04341727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24862297|NCT02324166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24862298|NCT02324166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24862300|NCT02324257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24862301|NCT02324257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24862302|NCT02324296|Cisplatin|cisplatin|mesh-list
24862303|NCT02324296|Etoposide|etoposide|mesh-list
24987805|NCT04939090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24987806|NCT04939090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987807|NCT04939090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24987808|NCT04939090|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24987809|NCT04939090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24987810|NCT04939090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24987821|NCT04939090|Contraceptive Agents|contraceptive agents|mesh-ancestor
24987822|NCT04939090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24987823|NCT04939090|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24516227|NCT00601042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516228|NCT00601042|Respiratory System Agents|respiratory system agents|mesh-ancestor
24987824|NCT04939090|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24987825|NCT04939090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24987826|NCT04939090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987828|NCT04939090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24987829|NCT04924166|Hydrocortisone|hydrocortisone|mesh-list
24987830|NCT04924166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24987831|NCT04865497|Vaccines|vaccines|mesh-list
24987832|NCT04865497|Immunologic Factors|immunologic factors|mesh-ancestor
24516259|NCT00601276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516260|NCT00601276|Androgen Antagonists|androgen antagonists|mesh-ancestor
24516261|NCT00601276|Hormone Antagonists|hormone antagonists|mesh-ancestor
24516262|NCT00601276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24516263|NCT00601276|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24516264|NCT00601276|Contraceptive Agents|contraceptive agents|mesh-ancestor
24516273|NCT00601302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24516274|NCT00601302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516275|NCT00601302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24862336|NCT02324452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24862337|NCT02324452|Immunologic Factors|immunologic factors|mesh-ancestor
24862338|NCT02324452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987875|NCT04787965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24987877|NCT04770272|Cyclophosphamide|cyclophosphamide|mesh-list
25706154|NCT02209181|Acetaminophen|acetaminophen|mesh-list
25706155|NCT02209181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25706156|NCT02209181|Analgesics|analgesics|mesh-ancestor
25706157|NCT02209181|Sensory System Agents|sensory system agents|mesh-ancestor
25706158|NCT02209181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25706159|NCT02209181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706160|NCT02209181|Antipyretics|antipyretics|mesh-ancestor
25706161|NCT02209272|Lidocaine|lidocaine|mesh-list
25706162|NCT02209272|Benzyl Alcohol|benzyl alcohol|mesh-list
25706163|NCT02209272|Anesthetics, Local|anesthetics, local|mesh-ancestor
24987879|NCT04770272|Atezolizumab|atezolizumab|mesh-list
24987880|NCT04770272|Epirubicin|epirubicin|mesh-list
24785092|NCT01911949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24785094|NCT01911975|Anticonvulsants|anticonvulsants|mesh-ancestor
24785095|NCT01911975|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24785096|NCT01911975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24785097|NCT01911975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24785098|NCT01911975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785099|NCT01912053|Gemcitabine|gemcitabine|mesh-list
24785100|NCT01912053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24785101|NCT01912053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24785102|NCT01912053|Antimetabolites|antimetabolites|mesh-ancestor
24785103|NCT01912053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785104|NCT01912053|Antiviral Agents|antiviral agents|mesh-ancestor
24785105|NCT01912053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24516319|NCT00601536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24516320|NCT00601536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24862344|NCT02324491|Growth Inhibitors|growth inhibitors|mesh-ancestor
24862345|NCT02324491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24785108|NCT01912053|Immunologic Factors|immunologic factors|mesh-ancestor
24785109|NCT01912053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785110|NCT01912066|Aceclofenac|aceclofenac|mesh-list
24785111|NCT01912066|Misoprostol|misoprostol|mesh-list
24785112|NCT01912066|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24785113|NCT01912066|Abortifacient Agents|abortifacient agents|mesh-ancestor
24785114|NCT01912066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25107179|NCT03141970|Prednisolone|prednisolone|mesh-list
25107180|NCT03141970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25107181|NCT03141970|Glucocorticoids|glucocorticoids|mesh-ancestor
25107182|NCT03141970|Hormones|hormones|mesh-ancestor
25107183|NCT03141970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25107184|NCT03141970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107185|NCT03141970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25107186|NCT03141970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25107187|NCT03141658|Ketamine|ketamine|mesh-list
25107196|NCT03141658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24785115|NCT01912066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107207|NCT03141645|Antipruritics|antipruritics|mesh-ancestor
25107208|NCT03141645|Dermatologic Agents|dermatologic agents|mesh-ancestor
25107209|NCT03141645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25107210|NCT03141645|Serotonin Agents|serotonin agents|mesh-ancestor
25107211|NCT03141645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25107212|NCT03141645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907027|NCT04334382|Antimalarials|antimalarials|mesh-ancestor
24907028|NCT04334382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24907029|NCT04334382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24907030|NCT04334382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907031|NCT04334382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907032|NCT04334382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24818812|NCT02090933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24818813|NCT02090933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24818814|NCT02090933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24862379|NCT02324933|Anesthetics|anesthetics|mesh-ancestor
25107223|NCT03141918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25107224|NCT03141918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107225|NCT03141918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25107226|NCT03141918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25107227|NCT03141918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987881|NCT04770272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24987882|NCT04770272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24987883|NCT04770272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987884|NCT04770272|Tubulin Modulators|tubulin modulators|mesh-ancestor
24987885|NCT04770272|Antimitotic Agents|antimitotic agents|mesh-ancestor
24987889|NCT04770272|Immunologic Factors|immunologic factors|mesh-ancestor
24987890|NCT04770272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987891|NCT04770272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24987893|NCT04770272|Alkylating Agents|alkylating agents|mesh-ancestor
24516769|NCT00603317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516770|NCT00603317|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24516771|NCT00603343|Propiverine|propiverine|mesh-list
25706164|NCT02209272|Anesthetics|anesthetics|mesh-ancestor
25706165|NCT02209272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25706166|NCT02209272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706167|NCT02209272|Sensory System Agents|sensory system agents|mesh-ancestor
25706168|NCT02209272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25706169|NCT02209272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25706170|NCT02209272|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25706171|NCT02209272|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25706172|NCT02209272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25706173|NCT02209272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706174|NCT02209454|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
24987903|NCT04713358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987904|NCT04713358|Sensory System Agents|sensory system agents|mesh-ancestor
24987905|NCT04713358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24987906|NCT04696952|Zopiclone|zopiclone|mesh-list
24987907|NCT04696952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24516834|NCT00604006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24516835|NCT00604006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516836|NCT00604006|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24516892|NCT00604435|Endostatins|endostatins|mesh-list
24516893|NCT00604435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516894|NCT00604435|Tubulin Modulators|tubulin modulators|mesh-ancestor
24516895|NCT00604435|Antimitotic Agents|antimitotic agents|mesh-ancestor
24516896|NCT00604435|Mitosis Modulators|mitosis modulators|mesh-ancestor
24516919|NCT00604656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24516920|NCT00604656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516921|NCT00604682|Apremilast|apremilast|mesh-list
24987941|NCT04631471|Respiratory System Agents|respiratory system agents|mesh-ancestor
24987942|NCT04631471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24987943|NCT04631471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24987944|NCT04631471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987945|NCT04631471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24987946|NCT04631471|Vasodilator Agents|vasodilator agents|mesh-ancestor
24987947|NCT04602598|Zanubrutinib|zanubrutinib|mesh-list
24987948|NCT04602598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24987949|NCT04602598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24987950|NCT04602598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529708|NCT00627653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24987951|NCT04602598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987952|NCT04562896|Carbon Fiber|carbon fiber|mesh-list
24987953|NCT04562896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24987954|NCT04562896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24987955|NCT04558502|Amoxicillin|amoxicillin|mesh-list
24987956|NCT04558502|Clarithromycin|clarithromycin|mesh-list
24517029|NCT00605605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987997|NCT04479267|Immunologic Factors|immunologic factors|mesh-ancestor
24987998|NCT04479267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987999|NCT04479267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24988000|NCT04479267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24988001|NCT04479267|Alkylating Agents|alkylating agents|mesh-ancestor
24988002|NCT04479267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988003|NCT04479267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988004|NCT04479267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24988005|NCT04479267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24988006|NCT04479267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24988007|NCT04479267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24988008|NCT04479267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24988009|NCT04479267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988010|NCT04479267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24988011|NCT04479267|Glucocorticoids|glucocorticoids|mesh-ancestor
24988012|NCT04479267|Hormones|hormones|mesh-ancestor
24988015|NCT04479267|Antiemetics|antiemetics|mesh-ancestor
24988016|NCT04479267|Autonomic Agents|autonomic agents|mesh-ancestor
24988017|NCT04479267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25706175|NCT02209454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25706176|NCT02209454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24907479|NCT04330443|Pulmonary Surfactants|pulmonary surfactants|mesh-list
24907480|NCT04330443|Respiratory System Agents|respiratory system agents|mesh-ancestor
24907481|NCT04330495|Hydroxychloroquine|hydroxychloroquine|mesh-list
24907524|NCT04329611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24988018|NCT04479267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24988019|NCT04479267|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24988020|NCT04479267|Protective Agents|protective agents|mesh-ancestor
24988021|NCT04471597|Bupivacaine|bupivacaine|mesh-list
24988022|NCT04471597|Anesthetics, Local|anesthetics, local|mesh-ancestor
24988023|NCT04471597|Anesthetics|anesthetics|mesh-ancestor
24862453|NCT02325362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862454|NCT02325440|Natalizumab|natalizumab|mesh-list
24862455|NCT02325440|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24862456|NCT02325440|Immunologic Factors|immunologic factors|mesh-ancestor
24862457|NCT02325440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862460|NCT02325440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24988033|NCT04420455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988034|NCT04420455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988035|NCT04420455|Protective Agents|protective agents|mesh-ancestor
24988036|NCT04420455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988037|NCT04419337|Metformin|metformin|mesh-list
24988038|NCT04419337|Pioglitazone|pioglitazone|mesh-list
24988039|NCT04419337|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
24988040|NCT04419337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24988041|NCT04419337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988042|NCT04419337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988043|NCT04318717|Pembrolizumab|pembrolizumab|mesh-list
24542269|NCT00678132|Immunologic Factors|immunologic factors|mesh-ancestor
24813496|NCT02058706|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24813497|NCT02058706|Fertility Agents|fertility agents|mesh-ancestor
24813498|NCT02058706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24813499|NCT02058706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813500|NCT02058706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24813501|NCT02058706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813502|NCT02058706|Androgen Antagonists|androgen antagonists|mesh-ancestor
24988052|NCT04297592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24988053|NCT04297592|Antimalarials|antimalarials|mesh-ancestor
24988054|NCT04297592|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24988055|NCT04297592|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24862480|NCT02325583|GABA Modulators|gaba modulators|mesh-ancestor
24862481|NCT02325583|GABA Agents|gaba agents|mesh-ancestor
24862482|NCT02325583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24862483|NCT02325583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862484|NCT02325882|Fentanyl|fentanyl|mesh-list
24862485|NCT02325882|Dexmedetomidine|dexmedetomidine|mesh-list
24862486|NCT02325882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24517189|NCT00606450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517210|NCT00606515|Tubulin Modulators|tubulin modulators|mesh-ancestor
24517211|NCT00606515|Antimitotic Agents|antimitotic agents|mesh-ancestor
24517212|NCT00606515|Mitosis Modulators|mitosis modulators|mesh-ancestor
25706177|NCT02209454|Analgesics|analgesics|mesh-ancestor
25706178|NCT02209454|Sensory System Agents|sensory system agents|mesh-ancestor
25706179|NCT02209454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25706180|NCT02209454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706181|NCT02209454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25706182|NCT02209454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24517213|NCT00606515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517215|NCT00606541|Antidepressive Agents|antidepressive agents|mesh-ancestor
24517216|NCT00606541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24517217|NCT00606541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24517218|NCT00606541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24517219|NCT00606541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24517220|NCT00606541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517222|NCT00606775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24517223|NCT00606775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24517224|NCT00606775|Adrenergic Agents|adrenergic agents|mesh-ancestor
24517225|NCT00606775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24517226|NCT00606775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988058|NCT04251715|Dexamethasone acetate|dexamethasone acetate|mesh-list
24988059|NCT04251715|Fluorouracil|fluorouracil|mesh-list
24988060|NCT04251715|Oxaliplatin|oxaliplatin|mesh-list
24988061|NCT04251715|Irinotecan|irinotecan|mesh-list
24988062|NCT04251715|Floxuridine|floxuridine|mesh-list
24796757|NCT01951885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24796758|NCT01951885|Antimetabolites|antimetabolites|mesh-ancestor
24796759|NCT01951885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796760|NCT01951885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796761|NCT01951885|Dermatologic Agents|dermatologic agents|mesh-ancestor
24796762|NCT01951885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796763|NCT01951885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24796764|NCT01951885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24796765|NCT01951885|Immunologic Factors|immunologic factors|mesh-ancestor
24796766|NCT01951885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24796767|NCT01951885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24796768|NCT01951885|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24796769|NCT01951885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24517377|NCT00607581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24517378|NCT00607581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24517379|NCT00607581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24517381|NCT00607581|Growth Substances|growth substances|mesh-ancestor
24517382|NCT00607581|Growth Inhibitors|growth inhibitors|mesh-ancestor
24517383|NCT00607646|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24517384|NCT00607646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24517385|NCT00607646|Immunologic Factors|immunologic factors|mesh-ancestor
24517386|NCT00607646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517387|NCT00607685|Fluorouracil|fluorouracil|mesh-list
24517388|NCT00607685|Hyaluronic Acid|hyaluronic acid|mesh-list
24517389|NCT00607685|Antimetabolites|antimetabolites|mesh-ancestor
24517390|NCT00607685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517391|NCT00607685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24517392|NCT00607685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517393|NCT00607685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24517394|NCT00607685|Immunologic Factors|immunologic factors|mesh-ancestor
24517399|NCT00607711|Isophosphamide mustard|isophosphamide mustard|mesh-list
24517400|NCT00607711|Ifosfamide|ifosfamide|mesh-list
24517464|NCT00608075|Antimanic Agents|antimanic agents|mesh-ancestor
24517465|NCT00608075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24517466|NCT00608075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24517467|NCT00608075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517468|NCT00608101|Dexamethasone|dexamethasone|mesh-list
24517469|NCT00608101|Fludrocortisone|fludrocortisone|mesh-list
24517470|NCT00608101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24517471|NCT00608101|Antiemetics|antiemetics|mesh-ancestor
24796777|NCT01951898|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24796778|NCT01951898|Hormone Antagonists|hormone antagonists|mesh-ancestor
24796779|NCT01951898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24796780|NCT01951898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796781|NCT01951898|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24796782|NCT01951898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24796783|NCT01951898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796784|NCT01951911|Ketamine|ketamine|mesh-list
24796811|NCT01952314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24796812|NCT01952314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24988071|NCT04251715|Glucocorticoids|glucocorticoids|mesh-ancestor
24988073|NCT04251715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24988075|NCT04251715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988076|NCT04251715|Protease Inhibitors|protease inhibitors|mesh-ancestor
24988077|NCT04251715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988078|NCT04251715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988079|NCT04251715|Antimetabolites|antimetabolites|mesh-ancestor
24988080|NCT04251715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24988081|NCT04251715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24988082|NCT04251715|Immunologic Factors|immunologic factors|mesh-ancestor
24988083|NCT04251715|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24988084|NCT04251715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24988085|NCT04251715|Antidotes|antidotes|mesh-ancestor
24988086|NCT04251715|Protective Agents|protective agents|mesh-ancestor
24988087|NCT04251715|Vitamin B Complex|vitamin b complex|mesh-ancestor
24988088|NCT04251715|Vitamins|vitamins|mesh-ancestor
24988089|NCT04251715|Micronutrients|micronutrients|mesh-ancestor
24517487|NCT00608179|Immunologic Factors|immunologic factors|mesh-ancestor
24517488|NCT00608218|Ciclesonide|ciclesonide|mesh-list
24517489|NCT00608218|Glucocorticoids|glucocorticoids|mesh-ancestor
24517490|NCT00608218|Hormones|hormones|mesh-ancestor
24517491|NCT00608218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24517492|NCT00608218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517493|NCT00608218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24862681|NCT04722952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24623675|NCT01073111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623676|NCT01073111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24623677|NCT01073111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24623678|NCT01073111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24908120|NCT04324060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908153|NCT04323527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24988147|NCT04198805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988148|NCT04198805|Antioxidants|antioxidants|mesh-ancestor
24988149|NCT04198805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988150|NCT04198805|Protective Agents|protective agents|mesh-ancestor
24988151|NCT04183868|Empagliflozin|empagliflozin|mesh-list
24988152|NCT04183868|Glimepiride|glimepiride|mesh-list
24862552|NCT05142865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24517495|NCT00608231|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24517496|NCT00608231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24517497|NCT00608231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517498|NCT00608231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24517500|NCT00608231|Sensory System Agents|sensory system agents|mesh-ancestor
24517501|NCT00608231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24988153|NCT04183868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24988154|NCT04183868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988155|NCT04183868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24988156|NCT04183868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988157|NCT04183868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24988158|NCT04183868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24988159|NCT04183868|Immunologic Factors|immunologic factors|mesh-ancestor
24988160|NCT04161755|Atezolizumab|atezolizumab|mesh-list
24988161|NCT04161755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988162|NCT04118387|Acetazolamide|acetazolamide|mesh-list
24988163|NCT04118387|Zolpidem|zolpidem|mesh-list
24988164|NCT04118387|Buspirone|buspirone|mesh-list
24988165|NCT04118387|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24988166|NCT04118387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24988167|NCT04118387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24988173|NCT04118387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988175|NCT04118387|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24988176|NCT04118387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988177|NCT04118387|Diuretics|diuretics|mesh-ancestor
24988178|NCT04118387|Natriuretic Agents|natriuretic agents|mesh-ancestor
24988179|NCT04118387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24988180|NCT04118387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24988181|NCT04118387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24988227|NCT03724942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24988228|NCT03724942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988229|NCT03724942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988230|NCT03724942|Dopamine Agonists|dopamine agonists|mesh-ancestor
24988258|NCT03615664|Antiemetics|antiemetics|mesh-ancestor
24988259|NCT03615664|Autonomic Agents|autonomic agents|mesh-ancestor
24988260|NCT03615664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24988261|NCT03615664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706183|NCT02209519|Metronidazole|metronidazole|mesh-list
25706184|NCT02209519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25706185|NCT02209519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25706186|NCT02209519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25706187|NCT02209519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25706188|NCT02209597|Bupropion|bupropion|mesh-list
25706189|NCT02209597|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25706190|NCT02209597|Antidepressive Agents|antidepressive agents|mesh-ancestor
25706191|NCT02209597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25706192|NCT02209597|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25706193|NCT02209597|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25706194|NCT02209597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25706195|NCT02209597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908381|NCT04321070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908382|NCT04321096|Camostat|camostat|mesh-list
24988262|NCT03615664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24988263|NCT03615664|Glucocorticoids|glucocorticoids|mesh-ancestor
24988265|NCT03615664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24988266|NCT03615664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24988267|NCT03615664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988268|NCT03615664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24988269|NCT03615664|Antimetabolites|antimetabolites|mesh-ancestor
24988270|NCT03615664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796813|NCT01952314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24796824|NCT01952626|Autonomic Agents|autonomic agents|mesh-ancestor
24796825|NCT01952626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24796826|NCT01952626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796827|NCT01952626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24796828|NCT01952626|Antipruritics|antipruritics|mesh-ancestor
24796829|NCT01952626|Dermatologic Agents|dermatologic agents|mesh-ancestor
24796830|NCT01952626|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24796831|NCT01952626|Serotonin Agents|serotonin agents|mesh-ancestor
24796832|NCT01952626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24796833|NCT01952626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107229|NCT03141918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835384|NCT02182739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24988317|NCT03345823|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
24988318|NCT03345823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24988319|NCT03345823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988320|NCT03345823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926146|NCT04144439|Histamine Antagonists|histamine antagonists|mesh-ancestor
24988393|NCT02887248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988394|NCT02887248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24988395|NCT02887248|Immunologic Factors|immunologic factors|mesh-ancestor
24988396|NCT02887248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988398|NCT02849990|Cortisone|cortisone|mesh-list
24988399|NCT02849990|Indomethacin|indomethacin|mesh-list
24988400|NCT02849990|Abiraterone Acetate|abiraterone acetate|mesh-list
24988401|NCT02849990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24988402|NCT02849990|Glucocorticoids|glucocorticoids|mesh-ancestor
24988403|NCT02849990|Hormones|hormones|mesh-ancestor
24988430|NCT02817347|BB 1101|bb 1101|mesh-list
24988431|NCT02817347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24862702|NCT04715191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24862713|NCT04703361|Niacin|niacin|mesh-list
24517602|NCT00608790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24517603|NCT00608790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24517604|NCT00608790|Adrenergic Agents|adrenergic agents|mesh-ancestor
24988473|NCT02673151|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24988474|NCT02653092|Heparin|heparin|mesh-list
25706196|NCT02209597|Dopamine Agents|dopamine agents|mesh-ancestor
25706197|NCT02209597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24707145|NCT01494363|Oxaliplatin|oxaliplatin|mesh-list
25706198|NCT02209597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706199|NCT02209597|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25706200|NCT02209597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25706201|NCT02209597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25706202|NCT02209610|Fentanyl|fentanyl|mesh-list
25706203|NCT02209610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25706204|NCT02209610|Narcotics|narcotics|mesh-ancestor
25706205|NCT02209610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25706206|NCT02209610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706207|NCT02209610|Analgesics|analgesics|mesh-ancestor
25706208|NCT02209610|Sensory System Agents|sensory system agents|mesh-ancestor
24988475|NCT02653092|Anticoagulants|anticoagulants|mesh-list
24796843|NCT01952652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24796844|NCT01952652|Analgesics|analgesics|mesh-ancestor
24796845|NCT01952652|Sensory System Agents|sensory system agents|mesh-ancestor
24796846|NCT01952652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24796847|NCT01952652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796848|NCT01952652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24796849|NCT01952652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24796850|NCT01952652|Gout Suppressants|gout suppressants|mesh-ancestor
24796851|NCT01952652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24796852|NCT01952652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796853|NCT01952652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517606|NCT00608790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517608|NCT00608803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24517609|NCT00608803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517610|NCT00608803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24517611|NCT00608803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24517612|NCT00608803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517613|NCT00608803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517614|NCT00608816|Epinephrine|epinephrine|mesh-list
24988597|NCT02296801|Letrozole|letrozole|mesh-list
24813521|NCT02058875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24813522|NCT02058875|Glucocorticoids|glucocorticoids|mesh-ancestor
24813523|NCT02058875|Hormones|hormones|mesh-ancestor
24542546|NCT00679237|Diuretics|diuretics|mesh-list
24542547|NCT00679237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24988490|NCT02593175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24988491|NCT02593175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24988492|NCT02593175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988493|NCT02593175|Tubulin Modulators|tubulin modulators|mesh-ancestor
24988494|NCT02593175|Antimitotic Agents|antimitotic agents|mesh-ancestor
24988495|NCT02593175|Mitosis Modulators|mitosis modulators|mesh-ancestor
24988496|NCT02593175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988534|NCT02452554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988535|NCT02452554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24988537|NCT02432560|Everolimus|everolimus|mesh-list
24988538|NCT02432560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988539|NCT02432560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24988540|NCT02432560|Immunologic Factors|immunologic factors|mesh-ancestor
24988541|NCT02432560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988542|NCT02432560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24988543|NCT02432560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24988544|NCT02432560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24988545|NCT02432560|Antifungal Agents|antifungal agents|mesh-ancestor
24988546|NCT02359175|Acetaminophen|acetaminophen|mesh-list
24988547|NCT02359175|Fentanyl|fentanyl|mesh-list
24988548|NCT02359175|Analgesics, Opioid|analgesics, opioid|mesh-list
24988549|NCT02359175|Bupivacaine|bupivacaine|mesh-list
24988550|NCT02359175|Anesthetics, Local|anesthetics, local|mesh-ancestor
24988551|NCT02359175|Anesthetics|anesthetics|mesh-ancestor
24988552|NCT02359175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24518322|NCT05291403|Erythromycin|erythromycin|mesh-list
24988553|NCT02359175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517615|NCT00608816|Racepinephrine|racepinephrine|mesh-list
24517616|NCT00608816|Epinephryl borate|epinephryl borate|mesh-list
24517618|NCT00608816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24988554|NCT02359175|Sensory System Agents|sensory system agents|mesh-ancestor
24542571|NCT00679315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24813548|NCT02058901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24813549|NCT02058901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813550|NCT02058901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813551|NCT02058979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24813552|NCT02058979|Cefazolin|cefazolin|mesh-list
24813553|NCT02058979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24813554|NCT02059018|Diclofenac|diclofenac|mesh-list
24813555|NCT02059018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
24542572|NCT00679315|Adrenergic Agents|adrenergic agents|mesh-ancestor
25706209|NCT02209610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25706210|NCT02209610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25706211|NCT02209610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25706212|NCT02209610|Anesthetics, General|anesthetics, general|mesh-ancestor
25706213|NCT02209610|Anesthetics|anesthetics|mesh-ancestor
25706214|NCT02209948|Temozolomide|temozolomide|mesh-list
24909456|NCT04308850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24909458|NCT04308525|Narcotics|narcotics|mesh-ancestor
24909471|NCT04308317|Antiviral Agents|antiviral agents|mesh-ancestor
24909472|NCT04308317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24542573|NCT00679315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24542574|NCT00679315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542575|NCT00679315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988555|NCT02359175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24988556|NCT02359175|Narcotics|narcotics|mesh-ancestor
24988557|NCT02359175|Analgesics|analgesics|mesh-ancestor
24988558|NCT02359175|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24988559|NCT02359175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24988560|NCT02359175|Anesthetics, General|anesthetics, general|mesh-ancestor
24988561|NCT02359175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24988562|NCT02359175|Antipyretics|antipyretics|mesh-ancestor
24988584|NCT02323659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988585|NCT02323659|Dermatologic Agents|dermatologic agents|mesh-ancestor
24988586|NCT02323659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988587|NCT02323659|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24988595|NCT02318277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24988596|NCT02318277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988598|NCT02296801|Palbociclib|palbociclib|mesh-list
24988599|NCT02296801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988600|NCT02296801|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24988601|NCT02296801|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24988602|NCT02296801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988603|NCT02296801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988604|NCT02296801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24988605|NCT02296801|Hormone Antagonists|hormone antagonists|mesh-ancestor
24988606|NCT02296801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24988607|NCT02296801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988608|NCT02296801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24988609|NCT02283853|Interferons|interferons|mesh-list
24988610|NCT02283853|Interferon-beta|interferon-beta|mesh-list
24988611|NCT02283853|Interferon beta-1a|interferon beta-1a|mesh-list
24988612|NCT02283853|Dimethyl Fumarate|dimethyl fumarate|mesh-list
24988613|NCT02283853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988614|NCT02283853|Antiviral Agents|antiviral agents|mesh-ancestor
24988615|NCT02283853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24988616|NCT02283853|Dermatologic Agents|dermatologic agents|mesh-ancestor
24988617|NCT02283853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24988660|NCT02073097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24988661|NCT02073097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24862805|NCT04364997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24517628|NCT00608816|Respiratory System Agents|respiratory system agents|mesh-ancestor
24517630|NCT00608816|Sympathomimetics|sympathomimetics|mesh-ancestor
24517631|NCT00608816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24517635|NCT00608946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517636|NCT00608972|Bevacizumab|bevacizumab|mesh-list
24517637|NCT00608972|Carboplatin|carboplatin|mesh-list
24517638|NCT00608972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24517639|NCT00608972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517640|NCT00608972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24517641|NCT00608972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24710497|NCT01510977|Laxatives|laxatives|mesh-ancestor
25706215|NCT02209948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25706216|NCT02209948|Alkylating Agents|alkylating agents|mesh-ancestor
25706217|NCT02209948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706218|NCT02209948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25706219|NCT02210091|Factor VIII|factor viii|mesh-list
25706220|NCT02210091|BAX 855|bax 855|mesh-list
25706221|NCT02210091|Coagulants|coagulants|mesh-ancestor
25706222|NCT02210195|Aprepitant|aprepitant|mesh-list
25706223|NCT02210195|Antiemetics|antiemetics|mesh-ancestor
25706224|NCT02210195|Autonomic Agents|autonomic agents|mesh-ancestor
24988662|NCT02073097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988663|NCT02073097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24988664|NCT02073097|Glucocorticoids|glucocorticoids|mesh-ancestor
24988714|NCT01335581|Dermatologic Agents|dermatologic agents|mesh-ancestor
24988715|NCT00882895|Mycophenolic Acid|mycophenolic acid|mesh-list
24988716|NCT00882895|Methylprednisolone|methylprednisolone|mesh-list
24988717|NCT00882895|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24988718|NCT00882895|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24988720|NCT00882895|Prednisolone acetate|prednisolone acetate|mesh-list
24988721|NCT00882895|Tacrolimus|tacrolimus|mesh-list
24988722|NCT00882895|Thymoglobulin|thymoglobulin|mesh-list
24988723|NCT00882895|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24988724|NCT00882895|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24988725|NCT00882895|Prednisolone phosphate|prednisolone phosphate|mesh-list
24988726|NCT00882895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24988727|NCT00882895|Immunologic Factors|immunologic factors|mesh-ancestor
24988730|NCT00882895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988731|NCT00882895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542672|NCT00679666|Vitamin B Complex|vitamin b complex|mesh-ancestor
24542673|NCT00679666|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24862875|NCT04107168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988732|NCT00882895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24988733|NCT00882895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988734|NCT00882895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24988735|NCT00882895|Antitubercular Agents|antitubercular agents|mesh-ancestor
24988736|NCT00882895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24988737|NCT00882895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24909934|NCT04303988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24909935|NCT04303988|Alkylating Agents|alkylating agents|mesh-ancestor
24909936|NCT04303988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988757|NCT00867178|Tretinoin|tretinoin|mesh-list
24988758|NCT00867178|Etoposide phosphate|etoposide phosphate|mesh-list
24988759|NCT00867178|Isotretinoin|isotretinoin|mesh-list
24988760|NCT00867178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24988761|NCT00867178|Immunologic Factors|immunologic factors|mesh-ancestor
24988762|NCT00867178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988763|NCT00867178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24862896|NCT04097730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862897|NCT04097730|Vitamin B Complex|vitamin b complex|mesh-ancestor
24517680|NCT00609193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24517681|NCT00609193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517683|NCT00609284|Cetuximab|cetuximab|mesh-list
24988775|NCT00867178|Tubulin Modulators|tubulin modulators|mesh-ancestor
24988776|NCT00867178|Antimitotic Agents|antimitotic agents|mesh-ancestor
24988777|NCT00867178|Mitosis Modulators|mitosis modulators|mesh-ancestor
24988778|NCT00867178|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24988779|NCT00867178|Keratolytic Agents|keratolytic agents|mesh-ancestor
24988780|NCT00867178|Dermatologic Agents|dermatologic agents|mesh-ancestor
24988781|NCT00787176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24988782|NCT00787176|Oxytocin|oxytocin|mesh-list
24517724|NCT00609557|Antidepressive Agents|antidepressive agents|mesh-ancestor
24517725|NCT00609557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24517726|NCT00609557|Dopamine Agents|dopamine agents|mesh-ancestor
24517727|NCT00609570|Calcium|calcium|mesh-list
24517728|NCT00609570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24988838|NCT05193370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24988839|NCT05193370|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24988840|NCT05193370|Natriuretic Agents|natriuretic agents|mesh-ancestor
24988841|NCT05193370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988870|NCT05193227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24988871|NCT05193227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24988872|NCT05193227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24988873|NCT05193227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24988874|NCT05193227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24988875|NCT05193227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988876|NCT05193214|Antibodies|antibodies|mesh-list
24517765|NCT00609895|Insulin Glargine|insulin glargine|mesh-list
24517766|NCT00609895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24517767|NCT00609895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517768|NCT00609934|Sorafenib|sorafenib|mesh-list
24517769|NCT00609934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517770|NCT00609934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25706225|NCT02210195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25706226|NCT02210195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706227|NCT02210195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25706228|NCT02210195|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25706229|NCT02210195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25706230|NCT02210195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706231|NCT02210247|Bupivacaine|bupivacaine|mesh-list
25706232|NCT02210247|Anesthetics, Local|anesthetics, local|mesh-ancestor
25706233|NCT02210247|Anesthetics|anesthetics|mesh-ancestor
25706234|NCT02210247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24517772|NCT00609934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517781|NCT00609960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24517782|NCT00609960|Anesthetics, General|anesthetics, general|mesh-ancestor
24517783|NCT00609960|Anesthetics|anesthetics|mesh-ancestor
24517784|NCT00609960|GABA Modulators|gaba modulators|mesh-ancestor
24517785|NCT00609960|GABA Agents|gaba agents|mesh-ancestor
24517787|NCT00609960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517788|NCT00609999|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24517790|NCT00609999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517791|NCT00609999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24517792|NCT00609999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988912|NCT05191914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24988913|NCT05191914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988915|NCT05191888|Metronidazole|metronidazole|mesh-list
24988916|NCT05191888|Clarithromycin|clarithromycin|mesh-list
24988917|NCT05191888|Rabeprazole|rabeprazole|mesh-list
24988918|NCT05191888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24988919|NCT05191888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24988920|NCT05191888|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24988951|NCT05168527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24988952|NCT05168527|Tubulin Modulators|tubulin modulators|mesh-ancestor
24988953|NCT05168527|Antimitotic Agents|antimitotic agents|mesh-ancestor
24988954|NCT05168527|Mitosis Modulators|mitosis modulators|mesh-ancestor
25107237|NCT03141593|Micronutrients|micronutrients|mesh-ancestor
24988955|NCT05168527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988956|NCT05168527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24988957|NCT05168527|Antimetabolites|antimetabolites|mesh-ancestor
24988958|NCT05168527|Antiviral Agents|antiviral agents|mesh-ancestor
24988959|NCT05168527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24988960|NCT05168527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988961|NCT05168527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24988962|NCT05168527|Immunologic Factors|immunologic factors|mesh-ancestor
24988963|NCT05168527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988964|NCT05166811|Magnesium Sulfate|magnesium sulfate|mesh-list
24988965|NCT05166811|Analgesics|analgesics|mesh-ancestor
24988966|NCT05166811|Sensory System Agents|sensory system agents|mesh-ancestor
24988967|NCT05166811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24988968|NCT05166811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988969|NCT05166811|Anesthetics|anesthetics|mesh-ancestor
24988984|NCT05149365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24988985|NCT05149365|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24988986|NCT05149365|Protease Inhibitors|protease inhibitors|mesh-ancestor
24988987|NCT05149365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988988|NCT05149365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988989|NCT05133297|Tofacitinib|tofacitinib|mesh-list
24988990|NCT05133297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24988991|NCT05133297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24988992|NCT05133297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24988993|NCT05123820|Midazolam|midazolam|mesh-list
24988994|NCT05123820|Omeprazole|omeprazole|mesh-list
24988995|NCT05123820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24988996|NCT05123820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25706235|NCT02210247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706236|NCT02210247|Sensory System Agents|sensory system agents|mesh-ancestor
25706237|NCT02210247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25706238|NCT02210689|Clindamycin|clindamycin|mesh-list
25706239|NCT02210689|Clindamycin palmitate|clindamycin palmitate|mesh-list
25706240|NCT02210689|Clindamycin phosphate|clindamycin phosphate|mesh-list
25706241|NCT02210689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24988997|NCT05123820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24517936|NCT00610610|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24988998|NCT05123820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24988999|NCT05123820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24989000|NCT05123820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24989001|NCT05123820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24989002|NCT05123820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24989003|NCT05123820|Anesthetics, General|anesthetics, general|mesh-ancestor
24989004|NCT05123820|Anesthetics|anesthetics|mesh-ancestor
24989005|NCT05123820|GABA Modulators|gaba modulators|mesh-ancestor
24989006|NCT05123820|GABA Agents|gaba agents|mesh-ancestor
24785164|NCT01912534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24785165|NCT01912534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24785166|NCT01912534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785168|NCT01912573|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24785169|NCT01912573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785170|NCT01912573|Sensory System Agents|sensory system agents|mesh-ancestor
24785171|NCT01912573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24785172|NCT01912586|Sildenafil Citrate|sildenafil citrate|mesh-list
24785173|NCT01912586|Vasodilator Agents|vasodilator agents|mesh-ancestor
24785174|NCT01912586|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24785175|NCT01912586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24785176|NCT01912586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24785177|NCT01912586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785178|NCT01912586|Urological Agents|urological agents|mesh-ancestor
24836223|NCT02184533|Selenious Acid|selenious acid|mesh-list
24796947|NCT01953419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926729|NCT04138420|Bevacizumab|bevacizumab|mesh-list
24989066|NCT04933149|Ketamine|ketamine|mesh-list
24989067|NCT04933149|Analgesics|analgesics|mesh-ancestor
24989068|NCT04933149|Sensory System Agents|sensory system agents|mesh-ancestor
24863115|NCT03088059|Afatinib|afatinib|mesh-list
24518070|NCT05331651|Glycopyrrolate|glycopyrrolate|mesh-list
24989071|NCT04933149|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24989072|NCT04933149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24989074|NCT04933149|Anesthetics|anesthetics|mesh-ancestor
24989075|NCT04933149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24989076|NCT04933149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24989077|NCT04933149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24989078|NCT04933149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24989079|NCT04933149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989084|NCT04871165|Immunoglobulins|immunoglobulins|mesh-list
25706242|NCT02210689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25706243|NCT02210689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25706244|NCT02210689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25706245|NCT02210689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706246|NCT02211014|Acalabrutinib|acalabrutinib|mesh-list
25706247|NCT02211014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25706248|NCT02211638|Candesartan|candesartan|mesh-list
25706249|NCT02211638|Candesartan cilexetil|candesartan cilexetil|mesh-list
25706250|NCT02211638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24518181|NCT05330377|Immunologic Factors|immunologic factors|mesh-ancestor
24518182|NCT05330377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518183|NCT05330377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24518185|NCT05330377|Sensory System Agents|sensory system agents|mesh-ancestor
24518186|NCT05330377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24518187|NCT05330377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24518188|NCT05330377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24989085|NCT04871165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24989087|NCT04871165|Immunologic Factors|immunologic factors|mesh-ancestor
24989088|NCT04871165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989089|NCT04735185|Anesthetics|anesthetics|mesh-list
24989090|NCT04735185|Anesthetics, Local|anesthetics, local|mesh-list
24989091|NCT04735185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24989092|NCT04735185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989093|NCT04735185|Sensory System Agents|sensory system agents|mesh-ancestor
24989094|NCT04735185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24989095|NCT04666389|Atorvastatin|atorvastatin|mesh-list
24989096|NCT04666389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24989097|NCT04666389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24989098|NCT04666389|Antimetabolites|antimetabolites|mesh-ancestor
24989099|NCT04666389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989100|NCT04666389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24989101|NCT04666389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24518189|NCT05330377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24518190|NCT05330273|Efavirenz|efavirenz|mesh-list
24518191|NCT05330273|Lumefantrine|lumefantrine|mesh-list
24518206|NCT05330273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24518207|NCT05330078|Botulinum Toxins|botulinum toxins|mesh-list
24518208|NCT05330078|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24518209|NCT05330078|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24518210|NCT05330078|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24518211|NCT05330078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24518212|NCT05330078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518213|NCT05330078|Cholinergic Agents|cholinergic agents|mesh-ancestor
24518214|NCT05330078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24518265|NCT05329740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24518266|NCT05329740|Glucocorticoids|glucocorticoids|mesh-ancestor
24518267|NCT05329740|Hormones|hormones|mesh-ancestor
24518268|NCT05329740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24518269|NCT05329740|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24518270|NCT05329740|Protective Agents|protective agents|mesh-ancestor
24518271|NCT05329740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24518272|NCT05329740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24518273|NCT05329454|Ibuprofen|ibuprofen|mesh-list
24518274|NCT05329454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24518275|NCT05329454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24518276|NCT05329454|Analgesics|analgesics|mesh-ancestor
24518277|NCT05329454|Sensory System Agents|sensory system agents|mesh-ancestor
24518291|NCT05327348|Micronutrients|micronutrients|mesh-ancestor
24989127|NCT04553419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24989130|NCT04527549|Hydroxychloroquine|hydroxychloroquine|mesh-list
24989131|NCT04527549|Trametinib|trametinib|mesh-list
24989132|NCT04527549|Dabrafenib|dabrafenib|mesh-list
24989133|NCT04527549|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
24989134|NCT04527549|Antimalarials|antimalarials|mesh-ancestor
24989135|NCT04527549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24989136|NCT04527549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24989137|NCT04527549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24989138|NCT04527549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24518462|NCT04967508|Ustekinumab|ustekinumab|mesh-list
24910653|NCT04295408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24910654|NCT04295408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910657|NCT04295317|Capecitabine|capecitabine|mesh-list
24518470|NCT04939467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24518471|NCT04939467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24518472|NCT04939467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518473|NCT04939467|Analgesics|analgesics|mesh-ancestor
24518474|NCT04939467|Sensory System Agents|sensory system agents|mesh-ancestor
24518529|NCT04901676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24518530|NCT04901676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24518531|NCT04901676|Antiviral Agents|antiviral agents|mesh-ancestor
24519208|NCT03007329|Hormones|hormones|mesh-ancestor
24519209|NCT03007329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24519210|NCT02977052|Nivolumab|nivolumab|mesh-list
24519211|NCT02977052|Ipilimumab|ipilimumab|mesh-list
24519212|NCT02977052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24519284|NCT02543255|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24519368|NCT01791920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519370|NCT01791920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24519544|NCT05332496|Bevacizumab|bevacizumab|mesh-list
24519721|NCT05242874|Antiemetics|antiemetics|mesh-list
24989195|NCT04347239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24989196|NCT04347239|Antiviral Agents|antiviral agents|mesh-ancestor
24989197|NCT04347239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24989198|NCT04315181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
24989199|NCT04315181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24989200|NCT04315181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989201|NCT04285086|Anagrelide|anagrelide|mesh-list
24989202|NCT04285086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24989203|NCT04285086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24989206|NCT04249167|Paclitaxel|paclitaxel|mesh-list
24796952|NCT01953445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796963|NCT01953536|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24796964|NCT01953536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24796965|NCT01953536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796966|NCT01953536|Tubulin Modulators|tubulin modulators|mesh-ancestor
24796967|NCT01953536|Antimitotic Agents|antimitotic agents|mesh-ancestor
24796968|NCT01953536|Mitosis Modulators|mitosis modulators|mesh-ancestor
24796969|NCT01953536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24796970|NCT01953536|Hematinics|hematinics|mesh-ancestor
24796971|NCT01953536|Vitamin B Complex|vitamin b complex|mesh-ancestor
24796972|NCT01953536|Vitamins|vitamins|mesh-ancestor
24796992|NCT01953679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24796993|NCT01953679|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24796994|NCT01953731|Rifampin|rifampin|mesh-list
24796995|NCT01953731|Palbociclib|palbociclib|mesh-list
24796996|NCT01953731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24796997|NCT01953731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24796998|NCT01953731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796999|NCT01953731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797000|NCT01953731|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24797001|NCT01953731|Antitubercular Agents|antitubercular agents|mesh-ancestor
24797002|NCT01953731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24797003|NCT01953731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24797004|NCT01953731|Leprostatic Agents|leprostatic agents|mesh-ancestor
24927021|NCT04136535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24989225|NCT04230265|Cyclophosphamide|cyclophosphamide|mesh-list
24989226|NCT04230265|Fludarabine|fludarabine|mesh-list
24989227|NCT04230265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24989228|NCT04230265|Immunologic Factors|immunologic factors|mesh-ancestor
24989229|NCT04230265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989230|NCT04230265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24863310|NCT00838981|Respiratory System Agents|respiratory system agents|mesh-ancestor
24863311|NCT00838981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24863316|NCT00730639|Nivolumab|nivolumab|mesh-list
24989231|NCT04230265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24989232|NCT04230265|Alkylating Agents|alkylating agents|mesh-ancestor
25706251|NCT02211638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25706252|NCT02211638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25706253|NCT02211638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706254|NCT02212028|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25706255|NCT02212028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25706256|NCT02212106|Vaccines|vaccines|mesh-list
24910780|NCT04294992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24450918|NCT00320970|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24450919|NCT00320970|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24450920|NCT00320970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450921|NCT00320983|Topotecan|topotecan|mesh-list
24450922|NCT00320983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24989233|NCT04230265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989236|NCT04218656|Rivaroxaban|rivaroxaban|mesh-list
24989256|NCT04198363|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24989257|NCT04198363|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24813591|NCT02059564|Incretins|incretins|mesh-ancestor
24813593|NCT02059564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24813594|NCT02059564|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24520198|NCT03573648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520199|NCT03573648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24520200|NCT03573648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24520510|NCT00630565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24520511|NCT00630565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24520512|NCT00630565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24520763|NCT05327647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24520764|NCT05327647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520766|NCT05326425|Lazertinib|lazertinib|mesh-list
24520881|NCT05258747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24520882|NCT05258747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520883|NCT05258747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520884|NCT05246007|Dexmedetomidine|dexmedetomidine|mesh-list
24989338|NCT05365425|Nootropic Agents|nootropic agents|mesh-ancestor
24989339|NCT05365425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24989340|NCT05365425|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24989341|NCT05365178|Fulvestrant|fulvestrant|mesh-list
24989342|NCT05365178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24989343|NCT05365178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24989344|NCT05365178|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24989345|NCT05365178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24989346|NCT05365178|Hormone Antagonists|hormone antagonists|mesh-ancestor
24989348|NCT05365178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989364|NCT05347316|Gout Suppressants|gout suppressants|mesh-ancestor
24989365|NCT05347316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24989366|NCT05347316|Tubulin Modulators|tubulin modulators|mesh-ancestor
24989367|NCT05347316|Antimitotic Agents|antimitotic agents|mesh-ancestor
24989368|NCT05347316|Mitosis Modulators|mitosis modulators|mesh-ancestor
24989369|NCT05347316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989370|NCT05347316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24989371|NCT05324423|Colchicine|colchicine|mesh-list
24989372|NCT05324423|Febuxostat|febuxostat|mesh-list
24521448|NCT04763135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24521449|NCT04763135|Histamine Antagonists|histamine antagonists|mesh-ancestor
24521450|NCT04763135|Histamine Agents|histamine agents|mesh-ancestor
24521451|NCT04763135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24521457|NCT04763135|Adrenergic Agents|adrenergic agents|mesh-ancestor
24521509|NCT04745728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24521510|NCT04745728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24521511|NCT04745728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24521512|NCT04745728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24521513|NCT04745728|Glucocorticoids|glucocorticoids|mesh-ancestor
24521514|NCT04745728|Hormones|hormones|mesh-ancestor
25706257|NCT02212106|Immunologic Factors|immunologic factors|mesh-ancestor
25706258|NCT02212106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706259|NCT02212197|Leuprolide|leuprolide|mesh-list
25706260|NCT02212197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25706261|NCT02212197|Fertility Agents|fertility agents|mesh-ancestor
25706262|NCT02212197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25706263|NCT02212197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706264|NCT02212197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24910878|NCT04292886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25107266|NCT03140956|Levodopa|levodopa|mesh-list
25107293|NCT03140943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24785195|NCT01912677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24785196|NCT01912677|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25107294|NCT03140943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25107295|NCT03140943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25107296|NCT03140943|Growth Substances|growth substances|mesh-ancestor
25107297|NCT03140943|Growth Inhibitors|growth inhibitors|mesh-ancestor
25107298|NCT03140553|Cyclophosphamide|cyclophosphamide|mesh-list
25107299|NCT03140553|Carboplatin|carboplatin|mesh-list
25107300|NCT03140553|Docetaxel|docetaxel|mesh-list
25107301|NCT03140553|Trastuzumab|trastuzumab|mesh-list
25107302|NCT03140553|Epirubicin|epirubicin|mesh-list
25107303|NCT03140553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25107304|NCT03140553|Immunologic Factors|immunologic factors|mesh-ancestor
25107305|NCT03140553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521969|NCT04388683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521970|NCT04388683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24522072|NCT04329832|Antimalarials|antimalarials|mesh-ancestor
24522073|NCT04329832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24522406|NCT03862157|Antimetabolites|antimetabolites|mesh-ancestor
24522407|NCT03862157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522408|NCT03862157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522409|NCT03853044|Prednisone|prednisone|mesh-list
24522410|NCT03853044|Cyclophosphamide|cyclophosphamide|mesh-list
24522411|NCT03853044|Doxorubicin|doxorubicin|mesh-list
24522412|NCT03853044|Vincristine|vincristine|mesh-list
24522413|NCT03853044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24522414|NCT03853044|Immunologic Factors|immunologic factors|mesh-ancestor
24522415|NCT03853044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989413|NCT05305248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24989414|NCT05305248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24989415|NCT05305248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24989416|NCT05305248|Adrenergic Agents|adrenergic agents|mesh-ancestor
24989417|NCT05305248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24989429|NCT05261321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24989430|NCT05261321|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24863484|NCT04834362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24522426|NCT03853044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24522428|NCT03853044|Hormones|hormones|mesh-ancestor
24522429|NCT03853044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24522432|NCT03853044|Tubulin Modulators|tubulin modulators|mesh-ancestor
24522433|NCT03853044|Antimitotic Agents|antimitotic agents|mesh-ancestor
24522434|NCT03853044|Mitosis Modulators|mitosis modulators|mesh-ancestor
24522435|NCT03847857|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24522436|NCT03847857|Hemostatics|hemostatics|mesh-ancestor
24522437|NCT03847857|Coagulants|coagulants|mesh-ancestor
24522438|NCT03843645|Anesthetics|anesthetics|mesh-list
24522439|NCT03843645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24522440|NCT03843645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522441|NCT03826303|Ethanol|ethanol|mesh-list
24522442|NCT03826303|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25706265|NCT02212197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25706266|NCT02212379|Raltegravir Potassium|raltegravir potassium|mesh-list
25706267|NCT02212379|Etravirine|etravirine|mesh-list
25706268|NCT02212379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25706269|NCT02212379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25706270|NCT02212379|Antiviral Agents|antiviral agents|mesh-ancestor
25706271|NCT02212379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25706272|NCT02212379|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24910988|NCT04292236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24911061|NCT04291209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911062|NCT04291209|Protective Agents|protective agents|mesh-ancestor
24911063|NCT04291209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911100|NCT04291066|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24911101|NCT04291066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911102|NCT04291066|Antiviral Agents|antiviral agents|mesh-ancestor
24911103|NCT04291066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24911104|NCT04291066|Expectorants|expectorants|mesh-ancestor
24911105|NCT04291066|Respiratory System Agents|respiratory system agents|mesh-ancestor
24522443|NCT03826303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24522444|NCT03826303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24522445|NCT03826303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522446|NCT03805594|Pembrolizumab|pembrolizumab|mesh-list
24522447|NCT03805594|177Lu-PSMA-617|177lu-psma-617|mesh-list
24522448|NCT03805594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24989435|NCT05261321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24989436|NCT05224050|Nicotine|nicotine|mesh-list
24989437|NCT05224050|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24989438|NCT05224050|Autonomic Agents|autonomic agents|mesh-ancestor
24989439|NCT05224050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24989440|NCT05224050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797005|NCT01953731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24797006|NCT01953731|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24797007|NCT01953731|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24797008|NCT01953731|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24797009|NCT01953731|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24797010|NCT01953731|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24797011|NCT01953731|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24797012|NCT01953744|Fluconazole|fluconazole|mesh-list
24797013|NCT01953744|Meglumine Antimoniate|meglumine antimoniate|mesh-list
24797014|NCT01953744|Antifungal Agents|antifungal agents|mesh-ancestor
24797015|NCT01953744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24863500|NCT04802356|Autonomic Agents|autonomic agents|mesh-ancestor
24863501|NCT04802356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24522602|NCT03628066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24522603|NCT03628066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24522615|NCT03568097|Avelumab|avelumab|mesh-list
24522624|NCT03567720|Mitosis Modulators|mitosis modulators|mesh-ancestor
24522625|NCT03567720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522671|NCT03421756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24522672|NCT03421756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522673|NCT03421756|Antifungal Agents|antifungal agents|mesh-ancestor
24836674|NCT02186886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797018|NCT01953744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24797019|NCT01953744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797020|NCT01953744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24797021|NCT01953744|Hormone Antagonists|hormone antagonists|mesh-ancestor
24797022|NCT01953744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24797023|NCT01953744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797024|NCT01953744|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24797025|NCT01953744|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24797042|NCT01953770|Glucocorticoids|glucocorticoids|mesh-ancestor
24797044|NCT01953770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24797045|NCT01953770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706273|NCT02212379|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25706274|NCT02212379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25706275|NCT02212379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706276|NCT02212379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25706277|NCT02212379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25706278|NCT02212678|Acetylcysteine|acetylcysteine|mesh-list
25706279|NCT02212678|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25706280|NCT02212678|Antiviral Agents|antiviral agents|mesh-ancestor
25706281|NCT02212678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25706282|NCT02212678|Expectorants|expectorants|mesh-ancestor
25706283|NCT02212678|Respiratory System Agents|respiratory system agents|mesh-ancestor
25706284|NCT02212678|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24797046|NCT01953770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24797047|NCT01953770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797048|NCT01953770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24797049|NCT01953770|Abortifacient Agents|abortifacient agents|mesh-ancestor
24797050|NCT01953770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24989449|NCT05200143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24989450|NCT05200143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24989452|NCT05179421|Oxytocin|oxytocin|mesh-list
24989481|NCT05154994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24989482|NCT05154994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989483|NCT05154994|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24989484|NCT05154994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24989486|NCT05148546|Ipilimumab|ipilimumab|mesh-list
24609378|NCT00996229|Antioxidants|antioxidants|mesh-ancestor
24609379|NCT00996229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609380|NCT00996229|Protective Agents|protective agents|mesh-ancestor
24609382|NCT00996229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24523388|NCT01503606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24523389|NCT01503606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24523490|NCT05342558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24523491|NCT05342532|Amoxicillin|amoxicillin|mesh-list
24523492|NCT05342532|Clarithromycin|clarithromycin|mesh-list
24523493|NCT05342532|Omeprazole|omeprazole|mesh-list
24523497|NCT05342532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24523498|NCT05342532|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24523499|NCT05342532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24523500|NCT05342532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523501|NCT05342532|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24523502|NCT05342532|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24523513|NCT05342389|Apatinib|apatinib|mesh-list
24523548|NCT05341999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24523549|NCT05341999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24523550|NCT05341999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24989515|NCT05133531|Ravulizumab|ravulizumab|mesh-list
24989516|NCT05133531|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24989517|NCT05133531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24989518|NCT05133531|Immunologic Factors|immunologic factors|mesh-ancestor
24989526|NCT05114486|Pilocarpine|pilocarpine|mesh-list
25107316|NCT03140553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24836820|NCT02187562|Analgesics|analgesics|mesh-ancestor
24989564|NCT05008887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989565|NCT05008887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24719412|NCT01561209|Amitriptyline|amitriptyline|mesh-list
24989566|NCT05008887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24989567|NCT05008887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24989568|NCT05008887|Immunologic Factors|immunologic factors|mesh-ancestor
24989569|NCT05008887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989570|NCT05008887|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24989571|NCT05008887|Abortifacient Agents|abortifacient agents|mesh-ancestor
24989572|NCT05008887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24989573|NCT05008887|Dermatologic Agents|dermatologic agents|mesh-ancestor
24989574|NCT05008887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24989575|NCT05008887|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24989576|NCT05008887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24989577|NCT05008887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24989578|NCT05007522|Ketotifen|ketotifen|mesh-list
24523990|NCT05338320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25706286|NCT02212678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706287|NCT02212678|Protective Agents|protective agents|mesh-ancestor
24911458|NCT04287803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911459|NCT04287777|Mupirocin|mupirocin|mesh-list
24911460|NCT04287777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24486072|NCT00456235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24523991|NCT05338320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24523992|NCT05338320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24523993|NCT05338320|Anesthetics, General|anesthetics, general|mesh-ancestor
24523998|NCT05338190|Immunologic Factors|immunologic factors|mesh-ancestor
24989579|NCT05007522|Indomethacin|indomethacin|mesh-list
24927307|NCT04134052|Anesthetics, General|anesthetics, general|mesh-ancestor
24989580|NCT05007522|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24989598|NCT05007522|Histamine Agents|histamine agents|mesh-ancestor
24989599|NCT05007522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24989600|NCT05007522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24863615|NCT04182997|Dexamethasone|dexamethasone|mesh-list
24524626|NCT04646837|Tubulin Modulators|tubulin modulators|mesh-ancestor
24524627|NCT04646837|Antimitotic Agents|antimitotic agents|mesh-ancestor
24524628|NCT04646837|Mitosis Modulators|mitosis modulators|mesh-ancestor
24524629|NCT04646837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524630|NCT04646837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24524631|NCT04643470|Zanubrutinib|zanubrutinib|mesh-list
24785271|NCT01913015|Hormone Antagonists|hormone antagonists|mesh-ancestor
24989642|NCT04969276|Immunologic Factors|immunologic factors|mesh-ancestor
24989643|NCT04969276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989644|NCT04959760|Antibodies|antibodies|mesh-list
24989645|NCT04959760|Immunoglobulins|immunoglobulins|mesh-list
24989650|NCT04944771|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24989651|NCT04944771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24989652|NCT04944771|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24989653|NCT04944771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24989656|NCT04930887|Anesthetics, Local|anesthetics, local|mesh-ancestor
24927376|NCT04133155|Gemcitabine|gemcitabine|mesh-list
24989657|NCT04930887|Anesthetics|anesthetics|mesh-ancestor
24989658|NCT04930887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24989680|NCT04878510|Dexmedetomidine|dexmedetomidine|mesh-list
24989681|NCT04878510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24989682|NCT04878510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24989683|NCT04878510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989684|NCT04878510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24989685|NCT04878510|Analgesics|analgesics|mesh-ancestor
24989686|NCT04878510|Sensory System Agents|sensory system agents|mesh-ancestor
24989690|NCT04878510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24525576|NCT03112434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525577|NCT03112434|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24525579|NCT03100786|Dexamethasone|dexamethasone|mesh-list
24525655|NCT02974049|Anticestodal Agents|anticestodal agents|mesh-ancestor
25706288|NCT02212678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706289|NCT02212678|Antidotes|antidotes|mesh-ancestor
25706290|NCT02212730|Pembrolizumab|pembrolizumab|mesh-list
25706291|NCT02212730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25706292|NCT02212730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25706293|NCT02213042|Trastuzumab|trastuzumab|mesh-list
25706294|NCT02213042|Lapatinib|lapatinib|mesh-list
25706295|NCT02213042|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25706296|NCT02213042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24525656|NCT02974049|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24525657|NCT02974049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25706297|NCT02213042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519962|NCT04333407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519964|NCT04333407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24519965|NCT04333407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24519966|NCT04333407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25706298|NCT02213042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24525658|NCT02974049|Tubulin Modulators|tubulin modulators|mesh-ancestor
24525663|NCT02974049|Filaricides|filaricides|mesh-ancestor
24526383|NCT00611416|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24526384|NCT00611416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526385|NCT00611416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24526386|NCT00611494|Mycophenolic Acid|mycophenolic acid|mesh-list
24526387|NCT00611494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24989760|NCT04820205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24989761|NCT04820205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24989762|NCT04820205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989763|NCT04820205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24989764|NCT04820205|Analgesics|analgesics|mesh-ancestor
24989765|NCT04820205|Sensory System Agents|sensory system agents|mesh-ancestor
24837031|NCT02188511|Nicotine|nicotine|mesh-list
24989766|NCT04820205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24989767|NCT04820205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24989768|NCT04820205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24989769|NCT04820205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24989772|NCT04820205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989797|NCT04739995|Naltrexone|naltrexone|mesh-list
24989798|NCT04739995|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24989799|NCT04739995|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24989800|NCT04739995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989801|NCT04739995|Sensory System Agents|sensory system agents|mesh-ancestor
24989847|NCT04624984|Vinorelbine|vinorelbine|mesh-list
24989848|NCT04624984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24989849|NCT04624984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24989850|NCT04624984|Antimetabolites|antimetabolites|mesh-ancestor
24989851|NCT04624984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989852|NCT04624984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24989853|NCT04624984|Antiviral Agents|antiviral agents|mesh-ancestor
24989854|NCT04624984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24989855|NCT04624984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24989856|NCT04624984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24989857|NCT04624984|Immunologic Factors|immunologic factors|mesh-ancestor
24989858|NCT04624984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989859|NCT04624984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24989860|NCT04624984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24989888|NCT04620252|Sequestering Agents|sequestering agents|mesh-ancestor
24989889|NCT04620252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863822|NCT03277261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24863823|NCT03277261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24863826|NCT03277248|Teriflunomide|teriflunomide|mesh-list
24527387|NCT00616382|Tocolytic Agents|tocolytic agents|mesh-ancestor
24527388|NCT00616382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24527389|NCT00616382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24527390|NCT00616382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527391|NCT00616382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527860|NCT00618501|Dermatologic Agents|dermatologic agents|mesh-ancestor
24527861|NCT00618501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527862|NCT00618501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24527863|NCT00618501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24527864|NCT00618501|Immunologic Factors|immunologic factors|mesh-ancestor
24527865|NCT00618501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24527866|NCT00618501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24785275|NCT01913054|Fentanyl|fentanyl|mesh-list
24785276|NCT01913054|Propofol|propofol|mesh-list
24785277|NCT01913054|Etomidate|etomidate|mesh-list
24785278|NCT01913054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24785279|NCT01913054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24785280|NCT01913054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615396|NCT01029522|Atorvastatin|atorvastatin|mesh-list
24785281|NCT01913054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25706299|NCT02213042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25706300|NCT02213042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706301|NCT02213042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25706302|NCT02213042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25706303|NCT02213042|Hormone Antagonists|hormone antagonists|mesh-ancestor
24912108|NCT04280874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24912109|NCT04280874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912110|NCT04280588|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24912155|NCT04279106|Listerine|listerine|mesh-list
24785282|NCT01913054|Anesthetics, General|anesthetics, general|mesh-ancestor
24785283|NCT01913054|Anesthetics|anesthetics|mesh-ancestor
24785284|NCT01913054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24785285|NCT01913054|Narcotics|narcotics|mesh-ancestor
24785286|NCT01913054|Analgesics|analgesics|mesh-ancestor
24785287|NCT01913054|Sensory System Agents|sensory system agents|mesh-ancestor
24785288|NCT01913054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24785289|NCT01913054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25107334|NCT03140787|Sensory System Agents|sensory system agents|mesh-ancestor
25107335|NCT03140787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25107336|NCT03140787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25107337|NCT03140787|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25107338|NCT03140787|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25107339|NCT03140787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25107340|NCT03140787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107341|NCT03140384|Misoprostol|misoprostol|mesh-list
25107342|NCT03140384|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25107345|NCT03140384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785300|NCT01913379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24785301|NCT01913379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25107346|NCT03140384|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25107347|NCT03140384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25107348|NCT03140384|Oxytocics|oxytocics|mesh-ancestor
25107349|NCT03140449|Calcitriol|calcitriol|mesh-list
25107350|NCT03140449|Sirolimus|sirolimus|mesh-list
25107351|NCT03140449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25107352|NCT03140449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24863899|NCT03026348|Antacids|antacids|mesh-ancestor
24864012|NCT02229149|Vinorelbine|vinorelbine|mesh-list
24863900|NCT03026348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529838|NCT00627965|Vasodilator Agents|vasodilator agents|mesh-ancestor
24530231|NCT00629473|Hormones|hormones|mesh-ancestor
25107353|NCT03140449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25107354|NCT03140449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25107355|NCT03140449|Antifungal Agents|antifungal agents|mesh-ancestor
25107356|NCT03140449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25107357|NCT03140449|Immunologic Factors|immunologic factors|mesh-ancestor
25107358|NCT03140449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107359|NCT03140449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25107360|NCT03140449|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25107361|NCT03140449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25107362|NCT03140449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107372|NCT03140488|Oxytocics|oxytocics|mesh-ancestor
25107373|NCT03140488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24989908|NCT04613024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989909|NCT04613024|Antimanic Agents|antimanic agents|mesh-ancestor
24989910|NCT04613024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24989911|NCT04594759|Isotretinoin|isotretinoin|mesh-list
24989912|NCT04594759|Dermatologic Agents|dermatologic agents|mesh-ancestor
24989913|NCT04588688|Mifepristone|mifepristone|mesh-list
25706304|NCT02213042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25706305|NCT02213042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706306|NCT02213055|Permethrin|permethrin|mesh-list
25706307|NCT02213055|Malathion|malathion|mesh-list
25706308|NCT02213055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25706309|NCT02213055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706310|NCT02213055|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25706311|NCT02213055|Cholinergic Agents|cholinergic agents|mesh-ancestor
25706312|NCT02213055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24424193|NCT00228254|Vitamins|vitamins|mesh-ancestor
24989914|NCT04588688|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24989915|NCT04588688|Abortifacient Agents|abortifacient agents|mesh-ancestor
24989916|NCT04588688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24989917|NCT04588688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989918|NCT04588688|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24797082|NCT01953835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24797084|NCT01953835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24797109|NCT01953887|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24797110|NCT01953887|Cholinergic Agents|cholinergic agents|mesh-ancestor
24989919|NCT04588688|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24989920|NCT04588688|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24989921|NCT04588688|Contraceptive Agents|contraceptive agents|mesh-ancestor
24989922|NCT04588688|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24989923|NCT04588688|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24989924|NCT04588688|Hormone Antagonists|hormone antagonists|mesh-ancestor
24989926|NCT04588688|Luteolytic Agents|luteolytic agents|mesh-ancestor
24530843|NCT00632645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24530844|NCT00632645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24530845|NCT00632645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24989937|NCT04585893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24989938|NCT04585893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24989939|NCT04585893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24989940|NCT04585893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24989978|NCT04442022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24989979|NCT04442022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24864010|NCT02338609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864011|NCT02229149|Paclitaxel|paclitaxel|mesh-list
24531300|NCT00634959|Antiviral Agents|antiviral agents|mesh-ancestor
24531301|NCT00634959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24531338|NCT00635258|Luteolytic Agents|luteolytic agents|mesh-ancestor
24531346|NCT00635284|Sirolimus|sirolimus|mesh-list
24531562|NCT00636415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24531563|NCT00636415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531564|NCT00636415|Analgesics|analgesics|mesh-ancestor
24531626|NCT00636870|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24531627|NCT00636870|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24531628|NCT00636870|Histamine Antagonists|histamine antagonists|mesh-ancestor
24531629|NCT00636870|Histamine Agents|histamine agents|mesh-ancestor
24531630|NCT00636870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24531633|NCT00636883|Gemcitabine|gemcitabine|mesh-list
24531642|NCT00636883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24990008|NCT04342715|Anthelmintics|anthelmintics|mesh-ancestor
24990009|NCT04269213|Cytarabine|cytarabine|mesh-list
24990010|NCT04269213|Daunorubicin|daunorubicin|mesh-list
24990011|NCT04269213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24990012|NCT04269213|Antimetabolites|antimetabolites|mesh-ancestor
24990013|NCT04269213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990014|NCT04269213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990015|NCT04269213|Antiviral Agents|antiviral agents|mesh-ancestor
24990016|NCT04269213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24990017|NCT04269213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24990018|NCT04269213|Immunologic Factors|immunologic factors|mesh-ancestor
24990048|NCT04045795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990049|NCT04045795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24912383|NCT04276545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24990050|NCT04045795|Glucocorticoids|glucocorticoids|mesh-ancestor
24990051|NCT04045795|Hormones|hormones|mesh-ancestor
24990052|NCT04045795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24990053|NCT04045795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24990054|NCT04045795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990055|NCT04045795|Immunologic Factors|immunologic factors|mesh-ancestor
24990056|NCT04045795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24990057|NCT04045795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24990058|NCT04045795|Growth Substances|growth substances|mesh-ancestor
24990059|NCT04045795|Growth Inhibitors|growth inhibitors|mesh-ancestor
24797115|NCT01953978|Ibuprofen|ibuprofen|mesh-list
24797116|NCT01953978|Morphine|morphine|mesh-list
24789321|NCT01936285|Colchicine|colchicine|mesh-list
24864043|NCT01802086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864044|NCT01802086|Sensory System Agents|sensory system agents|mesh-ancestor
24864045|NCT01802086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24864046|NCT01802086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24864047|NCT01802086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24531780|NCT00637143|Tacrolimus|tacrolimus|mesh-list
24531788|NCT00637143|Antifungal Agents|antifungal agents|mesh-ancestor
24531789|NCT00637143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24531790|NCT00637143|Dermatologic Agents|dermatologic agents|mesh-ancestor
25107377|NCT03140358|Atropine|atropine|mesh-list
25107378|NCT03140358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25107379|NCT03140358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25107380|NCT03140358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25107381|NCT03140358|Autonomic Agents|autonomic agents|mesh-ancestor
25107382|NCT03140358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25107383|NCT03140358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107384|NCT03140358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25107385|NCT03140358|Respiratory System Agents|respiratory system agents|mesh-ancestor
25107386|NCT03140358|Mydriatics|mydriatics|mesh-ancestor
25107393|NCT03140293|Lidocaine|lidocaine|mesh-list
24531851|NCT00637455|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24531852|NCT00637455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24531853|NCT00637455|Histamine Antagonists|histamine antagonists|mesh-ancestor
24531854|NCT00637455|Histamine Agents|histamine agents|mesh-ancestor
24531855|NCT00637455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24531856|NCT00637455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531857|NCT00637455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531858|NCT00637468|Aspirin|aspirin|mesh-list
24531859|NCT00637468|Heparin|heparin|mesh-list
24990140|NCT03654768|Imatinib Mesylate|imatinib mesylate|mesh-list
24990142|NCT03654768|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
24990143|NCT03654768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990144|NCT03654768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24990145|NCT03654768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24990175|NCT03575572|Mitosis Modulators|mitosis modulators|mesh-ancestor
24990176|NCT03575572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990177|NCT03575572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990179|NCT03557359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25706313|NCT02213055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706314|NCT02213094|Vitamins|vitamins|mesh-list
25706315|NCT02213094|Niacinamide|niacinamide|mesh-list
25706316|NCT02213094|Niacin|niacin|mesh-list
25706317|NCT02213094|Nicotinic Acids|nicotinic acids|mesh-list
25706318|NCT02213094|Vitamin B Complex|vitamin b complex|mesh-list
25706319|NCT02213094|Micronutrients|micronutrients|mesh-ancestor
25706320|NCT02213094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706321|NCT02213094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24912607|NCT04273763|Respiratory System Agents|respiratory system agents|mesh-ancestor
24990180|NCT03557359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990181|NCT03557359|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24531985|NCT00637767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24531986|NCT00637793|(S)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one|(s)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one|mesh-list
24531987|NCT00637793|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24531992|NCT00637793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531993|NCT00637819|Leflunomide|leflunomide|mesh-list
24531994|NCT00637819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24531995|NCT00637819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990328|NCT03256045|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24990329|NCT03256045|Dermatologic Agents|dermatologic agents|mesh-ancestor
24532155|NCT00638131|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24532156|NCT00638131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532157|NCT00638209|Insulin|insulin|mesh-list
24532158|NCT00638209|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24532159|NCT00638209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24532160|NCT00638209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532161|NCT00638248|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
24532162|NCT00638248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24532163|NCT00638248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24532176|NCT00638326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24532177|NCT00638326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532178|NCT00638326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532179|NCT00638391|Anastrozole|anastrozole|mesh-list
24532180|NCT00638391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24532181|NCT00638391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24532232|NCT00638729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24532233|NCT00638729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532234|NCT00638729|Analgesics|analgesics|mesh-ancestor
24532235|NCT00638729|Sensory System Agents|sensory system agents|mesh-ancestor
24532236|NCT00638729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24532277|NCT00638976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24532279|NCT00639015|Oxymetazoline|oxymetazoline|mesh-list
25107406|NCT03140332|Sorafenib|sorafenib|mesh-list
24532433|NCT00639938|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24532434|NCT00639938|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24532435|NCT00639938|Immunologic Factors|immunologic factors|mesh-ancestor
24532436|NCT00639938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706322|NCT02213094|Antimetabolites|antimetabolites|mesh-ancestor
25706323|NCT02213094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706324|NCT02213094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25706325|NCT02213094|Vasodilator Agents|vasodilator agents|mesh-ancestor
25706326|NCT02213263|Rituximab|rituximab|mesh-list
25706327|NCT02213263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25706328|NCT02213263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25706329|NCT02213263|Immunologic Factors|immunologic factors|mesh-ancestor
25706330|NCT02213263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797207|NCT01954355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797210|NCT01954368|Narcotics|narcotics|mesh-ancestor
24797211|NCT01954368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24797213|NCT01954368|Analgesics|analgesics|mesh-ancestor
24797230|NCT01954693|Immunologic Factors|immunologic factors|mesh-ancestor
24797231|NCT01954693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797232|NCT01954732|Metformin|metformin|mesh-list
24797233|NCT01954732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24990341|NCT03186456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24990342|NCT03186456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990343|NCT03186456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24990344|NCT03186456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24990345|NCT03186456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24864331|NCT04874311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24864332|NCT04874311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864333|NCT04874311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24864334|NCT04874311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24864335|NCT04874311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864336|NCT04874311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532617|NCT00640627|Analgesics|analgesics|mesh-ancestor
24532618|NCT00640627|Sensory System Agents|sensory system agents|mesh-ancestor
24532619|NCT00640627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24532620|NCT00640627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532621|NCT00640627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24532622|NCT00640627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24532623|NCT00640627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24532624|NCT00640627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24532625|NCT00640627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24990347|NCT03186456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990348|NCT03186456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24990349|NCT03186456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24990352|NCT03184935|Decitabine|decitabine|mesh-list
24990353|NCT03184935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24990354|NCT03184935|Antimetabolites|antimetabolites|mesh-ancestor
24990355|NCT03184935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990356|NCT03184935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990357|NCT03184935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24990359|NCT03176498|Atorvastatin|atorvastatin|mesh-list
24990360|NCT03176498|Calcium|calcium|mesh-list
24990361|NCT03176498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24990362|NCT03176498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990363|NCT03176498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24990364|NCT03176498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24990365|NCT03176498|Analgesics|analgesics|mesh-ancestor
24864346|NCT04817956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24864347|NCT04817956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864348|NCT04817956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864349|NCT04817956|Immunologic Factors|immunologic factors|mesh-ancestor
24864350|NCT04817956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24864351|NCT04817956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532710|NCT00640887|Ritonavir|ritonavir|mesh-list
24532711|NCT00640887|Lopinavir|lopinavir|mesh-list
24532712|NCT00640887|Nevirapine|nevirapine|mesh-list
24532713|NCT00640887|Efavirenz|efavirenz|mesh-list
24532714|NCT00640887|Rifabutin|rifabutin|mesh-list
24532715|NCT00640887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24532719|NCT00640887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532720|NCT00640887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24990366|NCT03176498|Sensory System Agents|sensory system agents|mesh-ancestor
24990367|NCT03176498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24990368|NCT03176498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24990369|NCT03176498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25706331|NCT02213263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25706332|NCT02213289|Nivolumab|nivolumab|mesh-list
25706333|NCT02213289|Trastuzumab|trastuzumab|mesh-list
25706334|NCT02213289|Bemarituzumab|bemarituzumab|mesh-list
25706335|NCT02213289|Ramucirumab|ramucirumab|mesh-list
25706336|NCT02213289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25706337|NCT02213289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990417|NCT03117010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24990418|NCT03117010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990419|NCT03117010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24990420|NCT03117010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990421|NCT03117010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24990422|NCT03117010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24990423|NCT03117010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24990424|NCT03046836|Oxytocin|oxytocin|mesh-list
24990425|NCT03046836|Oxytocics|oxytocics|mesh-ancestor
24990426|NCT03046836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24990427|NCT03046836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990428|NCT03038594|Hormones|hormones|mesh-list
24990430|NCT03038594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990433|NCT03009838|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24990434|NCT03009838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24990435|NCT03009838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24990436|NCT03009838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990437|NCT03009838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24990438|NCT03009838|Hormone Antagonists|hormone antagonists|mesh-ancestor
24990439|NCT03009838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24990440|NCT03009838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990496|NCT02870738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24990497|NCT02870738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990498|NCT02859896|Calcitriol|calcitriol|mesh-list
24990499|NCT02859896|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
24990500|NCT02859896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24990502|NCT02859896|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24990503|NCT02859896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24990505|NCT02859896|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24533047|NCT00642135|Tropicamide|tropicamide|mesh-list
24533048|NCT00642135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24990514|NCT02821026|Mycophenolic Acid|mycophenolic acid|mesh-list
24990516|NCT02821026|Etanercept|etanercept|mesh-list
24990517|NCT02821026|Tacrolimus|tacrolimus|mesh-list
24990518|NCT02821026|Thymoglobulin|thymoglobulin|mesh-list
24990519|NCT02821026|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24990520|NCT02821026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24990521|NCT02821026|Immunologic Factors|immunologic factors|mesh-ancestor
24990522|NCT02821026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990523|NCT02821026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24990524|NCT02821026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24990525|NCT02821026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990526|NCT02821026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24864461|NCT04124588|Hemostatics|hemostatics|mesh-list
24990604|NCT02659020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24990605|NCT02659020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24990606|NCT02659020|Immunologic Factors|immunologic factors|mesh-ancestor
24990607|NCT02659020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990608|NCT02659020|Tubulin Modulators|tubulin modulators|mesh-ancestor
24990609|NCT02659020|Antimitotic Agents|antimitotic agents|mesh-ancestor
24990610|NCT02659020|Mitosis Modulators|mitosis modulators|mesh-ancestor
24990611|NCT02584920|Rituximab|rituximab|mesh-list
24990612|NCT02584920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24990613|NCT02584920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990614|NCT02584920|Immunologic Factors|immunologic factors|mesh-ancestor
24913399|NCT04265001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913400|NCT04265001|Viscosupplements|viscosupplements|mesh-ancestor
24913401|NCT04265001|Protective Agents|protective agents|mesh-ancestor
24913402|NCT04264858|Immunoglobulins|immunoglobulins|mesh-list
24913403|NCT04264858|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24913404|NCT04264858|Antibodies|antibodies|mesh-list
24913405|NCT04264858|gamma-Globulins|gamma-globulins|mesh-list
24990615|NCT02584920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990616|NCT02584920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24990617|NCT02565914|Ivacaftor|ivacaftor|mesh-list
24990618|NCT02565914|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24990619|NCT02565914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24990620|NCT02565914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24990621|NCT02535832|Pioglitazone|pioglitazone|mesh-list
24990622|NCT02535832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24990627|NCT02513186|Bortezomib|bortezomib|mesh-list
24928367|NCT04123249|Propofol|propofol|mesh-list
24990692|NCT01816139|Hormones|hormones|mesh-ancestor
24990693|NCT01816139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24990694|NCT01816139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990695|NCT01684397|Bevacizumab|bevacizumab|mesh-list
24990696|NCT01684397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24990697|NCT01684397|Endothelial Growth Factors|endothelial growth factors|mesh-list
24990698|NCT01684397|Antibodies|antibodies|mesh-list
24990699|NCT01684397|Immunoglobulins|immunoglobulins|mesh-list
24990700|NCT01684397|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24990701|NCT01684397|Immunoglobulin G|immunoglobulin g|mesh-list
24990702|NCT01684397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990703|NCT01684397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24990704|NCT01684397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24990733|NCT00936936|Gemcitabine|gemcitabine|mesh-list
24990734|NCT00936936|Carboplatin|carboplatin|mesh-list
24990735|NCT00936936|Docetaxel|docetaxel|mesh-list
24990736|NCT00936936|Etoposide|etoposide|mesh-list
24990737|NCT00936936|Melphalan|melphalan|mesh-list
24990738|NCT00936936|Ifosfamide|ifosfamide|mesh-list
24990739|NCT00936936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990740|NCT00936936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24990741|NCT00936936|Antimetabolites|antimetabolites|mesh-ancestor
24797257|NCT01954784|Growth Substances|growth substances|mesh-ancestor
24797258|NCT01954784|Growth Inhibitors|growth inhibitors|mesh-ancestor
24990778|NCT00783536|Sensory System Agents|sensory system agents|mesh-ancestor
24990779|NCT00783536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24990780|NCT00783536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24990781|NCT00783536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24990782|NCT00695214|Propofol|propofol|mesh-list
24990783|NCT00695214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24990784|NCT00695214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24990785|NCT00695214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990786|NCT00695214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24990787|NCT00695214|Anesthetics, General|anesthetics, general|mesh-ancestor
24990788|NCT00695214|Anesthetics|anesthetics|mesh-ancestor
25706338|NCT02213289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25706339|NCT02213289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706340|NCT02213900|Haloperidol|haloperidol|mesh-list
25706341|NCT02213900|Haloperidol decanoate|haloperidol decanoate|mesh-list
25706342|NCT02213900|Antiemetics|antiemetics|mesh-ancestor
25706343|NCT02213900|Autonomic Agents|autonomic agents|mesh-ancestor
25706344|NCT02213900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24990789|NCT00511134|Eszopiclone|eszopiclone|mesh-list
25706345|NCT02213900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706346|NCT02213900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25706347|NCT02213900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24913688|NCT04262193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24913689|NCT04262193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24913690|NCT04262193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913691|NCT04262193|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
24913692|NCT04262193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24913694|NCT04262089|Pembrolizumab|pembrolizumab|mesh-list
24913744|NCT04261517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913745|NCT04261517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24864677|NCT02799641|Anesthetics, Local|anesthetics, local|mesh-ancestor
24533064|NCT00642135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24533248|NCT00642733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25706348|NCT02213900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25706349|NCT02213900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25706350|NCT02213900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25706351|NCT02213900|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25706352|NCT02213900|Dopamine Agents|dopamine agents|mesh-ancestor
25706353|NCT02213900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25706354|NCT02213900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706355|NCT02213900|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25706356|NCT02214121|Ticagrelor|ticagrelor|mesh-list
24913888|NCT04260269|Immunologic Factors|immunologic factors|mesh-ancestor
24913889|NCT04260269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913892|NCT04260113|Apatinib|apatinib|mesh-list
24533314|NCT00643136|Pregabalin|pregabalin|mesh-list
24990890|NCT03728179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24990891|NCT03728179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24990892|NCT03728179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24990893|NCT03728179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24990894|NCT03728179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24990895|NCT03728179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24990897|NCT03728179|Sensory System Agents|sensory system agents|mesh-ancestor
24990898|NCT03728179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24990899|NCT03728179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24990900|NCT03728179|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24928651|NCT04120519|Thalidomide|thalidomide|mesh-list
24544676|NCT00689845|Prednisone|prednisone|mesh-list
24990930|NCT03556358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24990931|NCT03556358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24990932|NCT03556358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24990933|NCT03556358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24990934|NCT03556358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24990936|NCT03555578|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24544690|NCT00689845|Immunologic Factors|immunologic factors|mesh-ancestor
24864794|NCT02050308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24864795|NCT02050308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864796|NCT01869361|Indomethacin|indomethacin|mesh-list
24864797|NCT01869361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24864799|NCT01869361|Analgesics|analgesics|mesh-ancestor
24864810|NCT01869361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864811|NCT01578967|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24864812|NCT01578967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24990977|NCT03417999|Sensory System Agents|sensory system agents|mesh-ancestor
24797268|NCT01954992|Fluorouracil|fluorouracil|mesh-list
25706357|NCT02214121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25706358|NCT02214121|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25706359|NCT02214121|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24864820|NCT00943618|Antidepressive Agents|antidepressive agents|mesh-ancestor
25706360|NCT02214121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25706361|NCT02214121|Purinergic Agents|purinergic agents|mesh-ancestor
25706362|NCT02214121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25706363|NCT02214121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706364|NCT02214121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488713|NCT00469781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24488714|NCT00469781|Analgesics|analgesics|mesh-ancestor
24914092|NCT04258371|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24914093|NCT04258371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914094|NCT04258371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24914095|NCT04258371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914096|NCT04258098|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24914097|NCT04258098|Metronidazole|metronidazole|mesh-list
24533350|NCT00643292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24533351|NCT00643292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24533352|NCT00643292|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24533353|NCT00643292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533354|NCT00643292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533355|NCT00643357|Nitrous Oxide|nitrous oxide|mesh-list
24533356|NCT00643357|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24533357|NCT00643357|Anesthetics, General|anesthetics, general|mesh-ancestor
24533358|NCT00643357|Anesthetics|anesthetics|mesh-ancestor
24533360|NCT00643357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990979|NCT03417999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24990980|NCT03417999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24990981|NCT03417999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24990982|NCT03417999|Adrenergic Agents|adrenergic agents|mesh-ancestor
24990983|NCT03417999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24990984|NCT03417999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864886|NCT05148689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24864887|NCT05148689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864888|NCT05148689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864889|NCT05148689|Sympathomimetics|sympathomimetics|mesh-ancestor
24864890|NCT05148689|Autonomic Agents|autonomic agents|mesh-ancestor
24864891|NCT05148689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24864892|NCT05148689|Nasal Decongestants|nasal decongestants|mesh-ancestor
24864893|NCT05148689|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25706365|NCT02214225|Vaccines|vaccines|mesh-list
25706366|NCT02214225|Immunologic Factors|immunologic factors|mesh-ancestor
25706367|NCT02214225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706368|NCT02214290|Caffeine|caffeine|mesh-list
25706369|NCT02214290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25706370|NCT02214290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706371|NCT02214290|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25706372|NCT02214290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991028|NCT03082729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991030|NCT03082729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24991031|NCT03082729|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24991032|NCT03082729|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24991033|NCT03082729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991036|NCT03029611|Carboplatin|carboplatin|mesh-list
24991037|NCT03029611|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24991038|NCT03029611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24991053|NCT02891798|Clonidine|clonidine|mesh-list
24449603|NCT00316212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24449604|NCT00316212|Purinergic Agents|purinergic agents|mesh-ancestor
24449605|NCT00316212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24449606|NCT00316212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449607|NCT00316212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449608|NCT00316238|Olanzapine|olanzapine|mesh-list
24449609|NCT00316238|Antiemetics|antiemetics|mesh-ancestor
24449610|NCT00316238|Autonomic Agents|autonomic agents|mesh-ancestor
24991135|NCT02614690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706373|NCT02214290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706374|NCT02214290|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25706375|NCT02214290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25706376|NCT02214290|Purinergic Agents|purinergic agents|mesh-ancestor
25706377|NCT02214290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25706378|NCT02214420|Ribavirin|ribavirin|mesh-list
25706379|NCT02214420|Sofosbuvir|sofosbuvir|mesh-list
25706380|NCT02214420|Simeprevir|simeprevir|mesh-list
24914350|NCT04255498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24914351|NCT04255498|Analgesics|analgesics|mesh-ancestor
24914352|NCT04255498|Sensory System Agents|sensory system agents|mesh-ancestor
24914353|NCT04255498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24819470|NCT02095704|Analgesics|analgesics|mesh-ancestor
24819471|NCT02095704|Sensory System Agents|sensory system agents|mesh-ancestor
24914608|NCT04253678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24729444|NCT01621698|Propofol|propofol|mesh-list
24914609|NCT04253678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24914610|NCT04253678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24914611|NCT04253678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24914612|NCT04253678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914613|NCT04253678|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24914614|NCT04253678|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24914615|NCT04253678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24991160|NCT02417142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24991161|NCT02417142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991162|NCT02417142|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24991163|NCT02417142|Incretins|incretins|mesh-ancestor
24991164|NCT02417142|Hormones|hormones|mesh-ancestor
24991166|NCT02368886|Clobetasol|clobetasol|mesh-list
24991173|NCT02354703|Antiemetics|antiemetics|mesh-ancestor
24991174|NCT02354703|Autonomic Agents|autonomic agents|mesh-ancestor
24991175|NCT02354703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24991176|NCT02354703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706381|NCT02214420|Antimetabolites|antimetabolites|mesh-ancestor
25706382|NCT02214420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706383|NCT02214420|Antiviral Agents|antiviral agents|mesh-ancestor
25706384|NCT02214420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25706385|NCT02214420|Protease Inhibitors|protease inhibitors|mesh-ancestor
25706386|NCT02214420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25706387|NCT02214615|Carbamazepine|carbamazepine|mesh-list
25706388|NCT02214615|Anticonvulsants|anticonvulsants|mesh-ancestor
25706389|NCT02214615|Antimanic Agents|antimanic agents|mesh-ancestor
25706390|NCT02214615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25706391|NCT02214615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25706392|NCT02214615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706393|NCT02214615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25706394|NCT02214615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25706395|NCT02214615|Analgesics|analgesics|mesh-ancestor
25706396|NCT02214615|Sensory System Agents|sensory system agents|mesh-ancestor
25706397|NCT02214615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25706398|NCT02214615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24991177|NCT02354703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24991178|NCT02354703|Antipruritics|antipruritics|mesh-ancestor
24449672|NCT00316472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24449673|NCT00316472|Antimetabolites|antimetabolites|mesh-ancestor
24991181|NCT02354703|Serotonin Agents|serotonin agents|mesh-ancestor
24991182|NCT02354703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24991183|NCT02354703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797295|NCT01955070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797299|NCT01955135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24797300|NCT01955135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24797301|NCT01955135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797302|NCT01955135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24797303|NCT01955135|Anesthetics, General|anesthetics, general|mesh-ancestor
24797304|NCT01955135|Anesthetics|anesthetics|mesh-ancestor
24797305|NCT01955135|Analgesics|analgesics|mesh-ancestor
24797306|NCT01955135|Sensory System Agents|sensory system agents|mesh-ancestor
24991195|NCT00796068|Cyclosporine|cyclosporine|mesh-list
24991196|NCT00796068|Mycophenolic Acid|mycophenolic acid|mesh-list
24991197|NCT00796068|Fludarabine|fludarabine|mesh-list
24991198|NCT00796068|Fludarabine phosphate|fludarabine phosphate|mesh-list
24991199|NCT00796068|Treosulfan|treosulfan|mesh-list
24991200|NCT00796068|Busulfan|busulfan|mesh-list
24991201|NCT00796068|Cyclosporins|cyclosporins|mesh-list
24991202|NCT00796068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865038|NCT04920942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24991203|NCT00796068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24991204|NCT00796068|Antimetabolites|antimetabolites|mesh-ancestor
24991205|NCT00796068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991206|NCT00796068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24991207|NCT00796068|Immunologic Factors|immunologic factors|mesh-ancestor
24991208|NCT00796068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991209|NCT00796068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991210|NCT00796068|Antifungal Agents|antifungal agents|mesh-ancestor
24991211|NCT00796068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24991212|NCT00796068|Dermatologic Agents|dermatologic agents|mesh-ancestor
24991213|NCT00796068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24991214|NCT00796068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24991215|NCT00796068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24991216|NCT00796068|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24991217|NCT00796068|Antitubercular Agents|antitubercular agents|mesh-ancestor
24991218|NCT00796068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24991219|NCT00796068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24991220|NCT00796068|Alkylating Agents|alkylating agents|mesh-ancestor
24991257|NCT05197504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991258|NCT05197504|Growth Inhibitors|growth inhibitors|mesh-ancestor
24991261|NCT05197101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24991262|NCT05197101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991263|NCT05197088|Tamsulosin|tamsulosin|mesh-list
24991264|NCT05197088|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24991265|NCT05197088|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24991266|NCT05197088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24991267|NCT05197088|Adrenergic Agents|adrenergic agents|mesh-ancestor
24544966|NCT00691184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706399|NCT02214615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25706400|NCT02214615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706401|NCT02214615|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24991362|NCT05194852|Anesthetics, Local|anesthetics, local|mesh-list
24991363|NCT05194852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24991364|NCT05194852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991365|NCT05194852|Sensory System Agents|sensory system agents|mesh-ancestor
24797307|NCT01955135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24797308|NCT01955135|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24797309|NCT01955135|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24797310|NCT01955135|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24797311|NCT01955135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24797312|NCT01955135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797313|NCT01955135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24797314|NCT01955135|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24449702|NCT00316680|Immunologic Factors|immunologic factors|mesh-ancestor
24449703|NCT00316680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449705|NCT00316745|Fluorouracil|fluorouracil|mesh-list
24991377|NCT05194046|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24991378|NCT05194046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24991379|NCT05193838|Allopurinol|allopurinol|mesh-list
24991380|NCT05193838|Antimetabolites|antimetabolites|mesh-ancestor
24991381|NCT05193838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991382|NCT05193838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991383|NCT05193838|Gout Suppressants|gout suppressants|mesh-ancestor
25706402|NCT02214615|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25706403|NCT02214628|Becaplermin|becaplermin|mesh-list
25706404|NCT02214628|Anticoagulants|anticoagulants|mesh-ancestor
25706405|NCT02214628|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
25706406|NCT02214628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25706407|NCT02214628|Growth Substances|growth substances|mesh-ancestor
25107453|NCT03139708|Nasal Decongestants|nasal decongestants|mesh-ancestor
25107454|NCT03139708|Respiratory System Agents|respiratory system agents|mesh-ancestor
25107455|NCT03139708|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25107456|NCT03139708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25107457|NCT03139708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25107458|NCT03139708|Adrenergic Agents|adrenergic agents|mesh-ancestor
25107459|NCT03139708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25107460|NCT03139708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107461|NCT03139708|Protective Agents|protective agents|mesh-ancestor
25107466|NCT03139708|Cholinergic Agents|cholinergic agents|mesh-ancestor
25107469|NCT03140033|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
25107470|NCT03140033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25107471|NCT03140033|Abortifacient Agents|abortifacient agents|mesh-ancestor
25107472|NCT03140033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25107473|NCT03140033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107474|NCT03140033|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25107475|NCT03140033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25107477|NCT03140033|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25107478|NCT03140033|Histamine Antagonists|histamine antagonists|mesh-ancestor
25107479|NCT03140033|Histamine Agents|histamine agents|mesh-ancestor
25107480|NCT03140033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25107481|NCT03140033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107482|NCT03139474|Hormones|hormones|mesh-list
25107483|NCT03139474|Hormone Antagonists|hormone antagonists|mesh-list
25107484|NCT03139474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25107485|NCT03139474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107486|NCT03139487|Dalteparin|dalteparin|mesh-list
25107487|NCT03139487|Tinzaparin|tinzaparin|mesh-list
25107488|NCT03139487|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25107489|NCT03139487|Rivaroxaban|rivaroxaban|mesh-list
25107490|NCT03139487|Apixaban|apixaban|mesh-list
25107491|NCT03139487|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25107492|NCT03139487|Antithrombins|antithrombins|mesh-ancestor
25107493|NCT03139487|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25107494|NCT03139487|Protease Inhibitors|protease inhibitors|mesh-ancestor
25107495|NCT03139487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25706409|NCT02215070|Pasireotide|pasireotide|mesh-list
25706410|NCT02215070|Hormones|hormones|mesh-ancestor
25706411|NCT02215070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25706412|NCT02215070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706413|NCT02215200|Lenograstim|lenograstim|mesh-list
25706414|NCT02215200|Thymoglobulin|thymoglobulin|mesh-list
25706415|NCT02215200|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25107498|NCT03139487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25107499|NCT03139487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25107500|NCT03139253|Amoxicillin|amoxicillin|mesh-list
25107501|NCT03139253|Clarithromycin|clarithromycin|mesh-list
25107502|NCT03139253|Levofloxacin|levofloxacin|mesh-list
25107504|NCT03139253|Tetracycline|tetracycline|mesh-list
25107506|NCT03139253|Furazolidone|furazolidone|mesh-list
25107507|NCT03139253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25107508|NCT03139253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25107509|NCT03139253|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25107510|NCT03139253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107511|NCT03139253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107512|NCT03139253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25107513|NCT03139253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24865291|NCT03962894|Prednisolone|prednisolone|mesh-list
24991498|NCT05150652|Tamoxifen|tamoxifen|mesh-list
24991499|NCT05150652|Letrozole|letrozole|mesh-list
24991500|NCT05150652|Anastrozole|anastrozole|mesh-list
24991501|NCT05150652|Exemestane|exemestane|mesh-list
24991502|NCT05150652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24991503|NCT05150652|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24991504|NCT05150652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24991505|NCT05150652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25406097|NCT03579615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706416|NCT02215200|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25706417|NCT02215200|Immunologic Factors|immunologic factors|mesh-ancestor
25706418|NCT02215200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706419|NCT02215200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25706420|NCT02215252|Pregabalin|pregabalin|mesh-list
25706421|NCT02215252|Analgesics|analgesics|mesh-ancestor
25706422|NCT02215252|Sensory System Agents|sensory system agents|mesh-ancestor
25706423|NCT02215252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25706424|NCT02215252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706425|NCT02215252|Anticonvulsants|anticonvulsants|mesh-ancestor
24917498|NCT04229264|Anticoagulants|anticoagulants|mesh-ancestor
24917500|NCT04229355|Lenvatinib|lenvatinib|mesh-list
24917501|NCT04229355|Chlorotrianisene|chlorotrianisene|mesh-list
24917502|NCT04229355|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24917503|NCT04229355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917505|NCT04229355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917609|NCT04227808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917610|NCT04227808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917611|NCT04227704|Ketamine|ketamine|mesh-list
24991506|NCT05150652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991507|NCT05150652|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24991508|NCT05150652|Hormone Antagonists|hormone antagonists|mesh-ancestor
24991509|NCT05150652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24991516|NCT05143489|Anesthetics, Local|anesthetics, local|mesh-ancestor
24991517|NCT05143489|Anesthetics|anesthetics|mesh-ancestor
24991518|NCT05143489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24991519|NCT05143489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991520|NCT05143489|Sensory System Agents|sensory system agents|mesh-ancestor
24991521|NCT05143489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24991522|NCT05143489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24991523|NCT05143489|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24991524|NCT05143489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24991525|NCT05143489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24865309|NCT03893318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24865310|NCT03893318|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24865311|NCT03893318|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24865312|NCT03893318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24865313|NCT03893318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865314|NCT03832010|Triamcinolone|triamcinolone|mesh-list
24865315|NCT03832010|Hydrocortisone|hydrocortisone|mesh-list
24865316|NCT03832010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24991532|NCT05139875|Triamcinolone|triamcinolone|mesh-list
24991533|NCT05139875|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24991534|NCT05139875|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24991535|NCT05139875|Betamethasone|betamethasone|mesh-list
24991536|NCT05139875|Betamethasone Valerate|betamethasone valerate|mesh-list
24991537|NCT05139875|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24991538|NCT05139875|Betamethasone benzoate|betamethasone benzoate|mesh-list
24991539|NCT05139875|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
24839136|NCT02202304|Thymol|thymol|mesh-list
24991540|NCT05139875|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24991541|NCT05139875|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24991572|NCT05129644|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24991574|NCT05129644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24991576|NCT05123170|Dexmedetomidine|dexmedetomidine|mesh-list
24991577|NCT05123170|Anesthetics, Local|anesthetics, local|mesh-ancestor
24991578|NCT05123170|Anesthetics|anesthetics|mesh-ancestor
24991579|NCT05123170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24991580|NCT05123170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706426|NCT02215252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25706427|NCT02215252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25706428|NCT02215252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706429|NCT02215252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25706430|NCT02215252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25706431|NCT02215252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25706432|NCT02215252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25706433|NCT02215252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25706434|NCT02215967|Cyclophosphamide|cyclophosphamide|mesh-list
24918133|NCT04223219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24918134|NCT04223219|Anticonvulsants|anticonvulsants|mesh-ancestor
24918135|NCT04223219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24991581|NCT05123170|Sensory System Agents|sensory system agents|mesh-ancestor
24449812|NCT00317070|Antioxidants|antioxidants|mesh-ancestor
24774721|NCT01847495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24449813|NCT00317070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449815|NCT00317096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24449816|NCT00317096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449817|NCT00317096|Immunologic Factors|immunologic factors|mesh-ancestor
24449818|NCT00317096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449819|NCT00317096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24991593|NCT05123170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24991594|NCT05123170|Adrenergic Agents|adrenergic agents|mesh-ancestor
24797338|NCT01955187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797339|NCT01955187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797340|NCT01955187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25706435|NCT02215967|Fludarabine|fludarabine|mesh-list
25706436|NCT02215967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25706437|NCT02215967|Immunologic Factors|immunologic factors|mesh-ancestor
25706438|NCT02215967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706439|NCT02215967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25706440|NCT02215967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25706441|NCT02215967|Alkylating Agents|alkylating agents|mesh-ancestor
24797368|NCT01955200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24797369|NCT01955200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24797370|NCT01955200|Respiratory System Agents|respiratory system agents|mesh-ancestor
24797371|NCT01955200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24797372|NCT01955200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24797373|NCT01955200|Vasodilator Agents|vasodilator agents|mesh-ancestor
24797374|NCT01955200|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24797375|NCT01955200|Protective Agents|protective agents|mesh-ancestor
24797376|NCT01955200|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24797377|NCT01955200|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24797378|NCT01955200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24797379|NCT01955213|Methylnaltrexone|methylnaltrexone|mesh-list
24797380|NCT01955213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24590911|NCT00914212|Appetite Depressants|appetite depressants|mesh-ancestor
24590912|NCT00914212|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24590915|NCT00914277|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24590916|NCT00914277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24590917|NCT00914277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590918|NCT00914277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590919|NCT00914277|Urological Agents|urological agents|mesh-ancestor
24590920|NCT00914368|Clopidogrel|clopidogrel|mesh-list
24797391|NCT01955408|Cholinergic Antagonists|cholinergic antagonists|mesh-list
24797392|NCT01955408|Cholinergic Agents|cholinergic agents|mesh-ancestor
24797393|NCT01955408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24797394|NCT01955408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797395|NCT01955408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797396|NCT01955421|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25706442|NCT02215967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706443|NCT02215967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25706447|NCT02216071|Dexamethasone acetate|dexamethasone acetate|mesh-list
25706448|NCT02216071|BB 1101|bb 1101|mesh-list
25706449|NCT02216071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25706450|NCT02216071|Antiemetics|antiemetics|mesh-ancestor
24918880|NCT04215614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24493853|NCT00492661|Tacrolimus|tacrolimus|mesh-list
24918884|NCT04215588|Hemostatics|hemostatics|mesh-list
24797398|NCT01955421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797399|NCT01955421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24797400|NCT01955421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24797401|NCT01955421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797403|NCT01955460|Cyclophosphamide|cyclophosphamide|mesh-list
24991642|NCT05081089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24991643|NCT05081089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24991644|NCT05081089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24991645|NCT05081089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24991646|NCT05081089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991647|NCT05081089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991648|NCT05081089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24991649|NCT05081089|Renal Agents|renal agents|mesh-ancestor
24991651|NCT05068661|Bupivacaine|bupivacaine|mesh-list
24991652|NCT05068661|Ropivacaine|ropivacaine|mesh-list
24991653|NCT05068661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24991654|NCT05068661|Anesthetics, Local|anesthetics, local|mesh-ancestor
24991655|NCT05068661|Anesthetics|anesthetics|mesh-ancestor
25706451|NCT02216071|Autonomic Agents|autonomic agents|mesh-ancestor
25706452|NCT02216071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25706453|NCT02216071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991656|NCT05068661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24991657|NCT05068661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991658|NCT05068661|Sensory System Agents|sensory system agents|mesh-ancestor
24991659|NCT05068661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24991660|NCT05068661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24991661|NCT05068661|Narcotics|narcotics|mesh-ancestor
24991662|NCT05068661|Analgesics|analgesics|mesh-ancestor
24991663|NCT05068661|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24991668|NCT05064800|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24991669|NCT05064800|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24991670|NCT05064800|Protease Inhibitors|protease inhibitors|mesh-ancestor
25107520|NCT03139253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25107521|NCT03139253|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25107522|NCT03139253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25107523|NCT03139253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25107524|NCT03139253|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25107525|NCT03139253|Alkylating Agents|alkylating agents|mesh-ancestor
25107526|NCT03139591|Dexamethasone|dexamethasone|mesh-list
25107527|NCT03139591|Lidocaine|lidocaine|mesh-list
25107528|NCT03139591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25107529|NCT03139591|Antiemetics|antiemetics|mesh-ancestor
25107530|NCT03139591|Autonomic Agents|autonomic agents|mesh-ancestor
25107531|NCT03139591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25107532|NCT03139591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107533|NCT03139591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25107534|NCT03139591|Glucocorticoids|glucocorticoids|mesh-ancestor
24991671|NCT05064800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991672|NCT05064800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991673|NCT05064800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24991674|NCT05064800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24991675|NCT05064800|Antiviral Agents|antiviral agents|mesh-ancestor
24991676|NCT05064800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24991677|NCT05064800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24991678|NCT05064800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24991679|NCT05064800|Antithrombins|antithrombins|mesh-ancestor
24991680|NCT05064800|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24991681|NCT05064800|Anticoagulants|anticoagulants|mesh-ancestor
24593138|NCT00926965|Serotonin Agents|serotonin agents|mesh-ancestor
25706454|NCT02216071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25706455|NCT02216071|Glucocorticoids|glucocorticoids|mesh-ancestor
25706456|NCT02216071|Hormones|hormones|mesh-ancestor
25706457|NCT02216071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25706458|NCT02216071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25706459|NCT02216071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25706460|NCT02216071|Protease Inhibitors|protease inhibitors|mesh-ancestor
24919586|NCT04209920|Trace Elements|trace elements|mesh-ancestor
24919587|NCT04209920|Micronutrients|micronutrients|mesh-ancestor
24521310|NCT04898894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24521311|NCT04898894|Antiviral Agents|antiviral agents|mesh-ancestor
24618110|NCT01046838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991706|NCT05057806|Empagliflozin|empagliflozin|mesh-list
24991707|NCT05057806|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24991708|NCT05057806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991709|NCT05057806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24991710|NCT05057806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991711|NCT05042505|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24991712|NCT05042505|Dapagliflozin|dapagliflozin|mesh-list
24991713|NCT05042505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24991714|NCT05042505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991715|NCT05042505|Incretins|incretins|mesh-ancestor
24991716|NCT05042505|Hormones|hormones|mesh-ancestor
24991718|NCT05042505|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24991741|NCT05032950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24865526|NCT01291004|Natriuretic Agents|natriuretic agents|mesh-ancestor
24991747|NCT05032950|Anesthetics, General|anesthetics, general|mesh-ancestor
24991748|NCT05032950|Anesthetics|anesthetics|mesh-ancestor
24991749|NCT05032950|GABA Modulators|gaba modulators|mesh-ancestor
24991750|NCT05032950|GABA Agents|gaba agents|mesh-ancestor
24991751|NCT05032950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24991752|NCT05032950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991929|NCT04720976|Osimertinib|osimertinib|mesh-list
25706461|NCT02216071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25706462|NCT02216071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706463|NCT02216071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25706464|NCT02216071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25706465|NCT02216071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25706466|NCT02216071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25706467|NCT02216071|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25706468|NCT02216071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25706469|NCT02216123|Chloroquine|chloroquine|mesh-list
25706470|NCT02216123|Primaquine|primaquine|mesh-list
25706471|NCT02216123|Tafenoquine|tafenoquine|mesh-list
25706472|NCT02216123|Amebicides|amebicides|mesh-ancestor
24991779|NCT05008276|Plasma Substitutes|plasma substitutes|mesh-ancestor
24991780|NCT05008276|Blood Substitutes|blood substitutes|mesh-ancestor
24991782|NCT05005312|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24991783|NCT05005312|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24991784|NCT05005312|Protease Inhibitors|protease inhibitors|mesh-ancestor
24991785|NCT05005312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24865563|NCT00112411|Respiratory System Agents|respiratory system agents|mesh-ancestor
24865564|NCT00109668|Beclomethasone|beclomethasone|mesh-list
24865565|NCT00109668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24991791|NCT05005312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24991792|NCT05005312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24991793|NCT04995120|Paclitaxel|paclitaxel|mesh-list
24991794|NCT04995120|Cisplatin|cisplatin|mesh-list
24991795|NCT04995120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24991796|NCT04995120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24991797|NCT04995120|Tubulin Modulators|tubulin modulators|mesh-ancestor
24991798|NCT04995120|Antimitotic Agents|antimitotic agents|mesh-ancestor
24991799|NCT04995120|Mitosis Modulators|mitosis modulators|mesh-ancestor
24991800|NCT04995120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991801|NCT04964960|Paclitaxel|paclitaxel|mesh-list
24991802|NCT04964960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24991803|NCT04964960|Carboplatin|carboplatin|mesh-list
25706474|NCT02216123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24991804|NCT04964960|Pembrolizumab|pembrolizumab|mesh-list
24991805|NCT04964960|Pemetrexed|pemetrexed|mesh-list
24991806|NCT04964960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25706475|NCT02216123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25706476|NCT02216123|Antimalarials|antimalarials|mesh-ancestor
25706477|NCT02216123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25706478|NCT02216214|Mirabegron|mirabegron|mesh-list
25706479|NCT02216214|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24920104|NCT04205201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24920105|NCT04205201|Adrenergic Agents|adrenergic agents|mesh-ancestor
24991807|NCT04964960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24991808|NCT04964960|Tubulin Modulators|tubulin modulators|mesh-ancestor
24991809|NCT04964960|Antimitotic Agents|antimitotic agents|mesh-ancestor
24991810|NCT04964960|Mitosis Modulators|mitosis modulators|mesh-ancestor
24991811|NCT04964960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991812|NCT04964960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24991813|NCT04964960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991814|NCT04964960|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24991815|NCT04964960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24991816|NCT04958044|Calcium|calcium|mesh-list
24991817|NCT04958044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24991818|NCT04958044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865614|NCT05151874|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24865615|NCT05151874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24865616|NCT05151796|Aspirin|aspirin|mesh-list
24991823|NCT04885881|Lidocaine|lidocaine|mesh-list
24991824|NCT04885881|Anesthetics, Local|anesthetics, local|mesh-ancestor
24991825|NCT04885881|Anesthetics|anesthetics|mesh-ancestor
24991826|NCT04885881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24991827|NCT04885881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991828|NCT04885881|Sensory System Agents|sensory system agents|mesh-ancestor
24991829|NCT04885881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24991830|NCT04885881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24991831|NCT04885881|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24991832|NCT04885881|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24991834|NCT04885881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991835|NCT04885257|Methylphenidate|methylphenidate|mesh-list
24991836|NCT04885257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24991837|NCT04885257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991838|NCT04885257|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24593749|NCT00930839|Antipyretics|antipyretics|mesh-ancestor
24991839|NCT04885257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24991840|NCT04885257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24991841|NCT04885257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991843|NCT04885257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24991844|NCT04871360|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24797409|NCT01955460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797410|NCT01955460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24797411|NCT01955460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24797412|NCT01955460|Alkylating Agents|alkylating agents|mesh-ancestor
24797413|NCT01955460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706480|NCT02216214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25706481|NCT02216214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25706482|NCT02216214|Adrenergic Agents|adrenergic agents|mesh-ancestor
25706483|NCT02216214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25706484|NCT02216214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706485|NCT02216214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706486|NCT02216214|Urological Agents|urological agents|mesh-ancestor
24797425|NCT01955460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24797427|NCT01955512|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24797428|NCT01955512|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24797429|NCT01955512|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24797430|NCT01955512|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24797431|NCT01955512|Purinergic Agents|purinergic agents|mesh-ancestor
24797432|NCT01955512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24797433|NCT01955512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797434|NCT01955512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797435|NCT01955577|Vitamin D|vitamin d|mesh-list
24797436|NCT01955577|Cholecalciferol|cholecalciferol|mesh-list
24797437|NCT01955577|Vitamins|vitamins|mesh-ancestor
24797438|NCT01955577|Micronutrients|micronutrients|mesh-ancestor
24797439|NCT01955577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797440|NCT01955577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24797441|NCT01955577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24797443|NCT01955642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24797444|NCT01955642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24797445|NCT01955642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24655516|NCT01257048|Glucocorticoids|glucocorticoids|mesh-ancestor
24797446|NCT01955642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24797447|NCT01955642|Purinergic Agents|purinergic agents|mesh-ancestor
24797448|NCT01955642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24797449|NCT01955642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797450|NCT01955642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797451|NCT01955655|Baclofen|baclofen|mesh-list
24920727|NCT04198571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24451535|NCT00324051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24451541|NCT00324077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451542|NCT00324077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24451543|NCT00324077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24785520|NCT01914900|Antimetabolites|antimetabolites|mesh-ancestor
24785521|NCT01914900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24785522|NCT01914900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24785523|NCT01914900|Immunologic Factors|immunologic factors|mesh-ancestor
24785524|NCT01914900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785529|NCT01914965|Bupropion|bupropion|mesh-list
24785530|NCT01914965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24785531|NCT01914965|Antidepressive Agents|antidepressive agents|mesh-ancestor
24785532|NCT01914965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24774726|NCT01847521|Quercetin|quercetin|mesh-list
24449910|NCT00317408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24449911|NCT00317408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24449912|NCT00317408|Antimetabolites|antimetabolites|mesh-ancestor
24449913|NCT00317408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449914|NCT00317408|Dermatologic Agents|dermatologic agents|mesh-ancestor
24449915|NCT00317408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25706487|NCT02216357|Ifetroban|ifetroban|mesh-list
25706488|NCT02216357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25709684|NCT02272725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709685|NCT02272777|Imatinib Mesylate|imatinib mesylate|mesh-list
25709686|NCT02272777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25709687|NCT02272777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25709688|NCT02272777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709689|NCT02272777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107551|NCT03139409|Disinfectants|disinfectants|mesh-ancestor
25107552|NCT03139422|Tranexamic Acid|tranexamic acid|mesh-list
25107553|NCT03139422|Calcium Dobesilate|calcium dobesilate|mesh-list
24865695|NCT05150899|Fexofenadine|fexofenadine|mesh-list
25706492|NCT02216422|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25706493|NCT02216422|Protease Inhibitors|protease inhibitors|mesh-ancestor
25706494|NCT02216422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25706495|NCT02216422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706496|NCT02216422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25706497|NCT02216422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25107558|NCT03139422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25107559|NCT03139422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107561|NCT03139422|Coagulants|coagulants|mesh-ancestor
25107562|NCT03139513|Vemurafenib|vemurafenib|mesh-list
25107563|NCT03139513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25107564|NCT03139513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25107565|NCT03139513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107566|NCT03139513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107567|NCT03139565|Vaccines|vaccines|mesh-list
25107568|NCT03139565|Immunologic Factors|immunologic factors|mesh-ancestor
24449948|NCT00317421|Urological Agents|urological agents|mesh-ancestor
25107570|NCT03139305|Glucagon|glucagon|mesh-list
25107571|NCT03139305|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25107572|NCT03139305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25107573|NCT03139305|Hormones|hormones|mesh-ancestor
24921665|NCT04188106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24921666|NCT04188106|Histamine Antagonists|histamine antagonists|mesh-ancestor
24921667|NCT04188106|Histamine Agents|histamine agents|mesh-ancestor
24622377|NCT01066754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622378|NCT01066754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107574|NCT03139305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25107575|NCT03139305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839570|NCT02205398|Cetuximab|cetuximab|mesh-list
24797453|NCT01955655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797454|NCT01955655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24929645|NCT04110535|Anesthetics|anesthetics|mesh-ancestor
24991877|NCT04796948|Fluorouracil|fluorouracil|mesh-list
24991878|NCT04796948|Oxaliplatin|oxaliplatin|mesh-list
24991879|NCT04796948|Irinotecan|irinotecan|mesh-list
24991880|NCT04796948|Calcium|calcium|mesh-list
24991881|NCT04796948|Levoleucovorin|levoleucovorin|mesh-list
24991882|NCT04796948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24991883|NCT04796948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991884|NCT04796948|Antimetabolites|antimetabolites|mesh-ancestor
24991885|NCT04796948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991886|NCT04796948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24991887|NCT04796948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24991888|NCT04796948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24991889|NCT04796948|Immunologic Factors|immunologic factors|mesh-ancestor
24991897|NCT04796948|Micronutrients|micronutrients|mesh-ancestor
24991898|NCT04788563|Antihypertensive Agents|antihypertensive agents|mesh-list
24991910|NCT04750824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991912|NCT04731233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24991913|NCT04731233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24991914|NCT04731233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24991915|NCT04731233|Mitogens|mitogens|mesh-list
24991916|NCT04731233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24991917|NCT04731233|Glucocorticoids|glucocorticoids|mesh-ancestor
24991918|NCT04731233|Hormones|hormones|mesh-ancestor
24991919|NCT04731233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24991920|NCT04731233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991921|NCT04731233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24991922|NCT04731233|Immunologic Factors|immunologic factors|mesh-ancestor
24991923|NCT04731233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991924|NCT04731233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706498|NCT02216422|Antiviral Agents|antiviral agents|mesh-ancestor
25706499|NCT02216422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25706500|NCT02216422|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25706501|NCT02216422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25706502|NCT02216422|Antimetabolites|antimetabolites|mesh-ancestor
25706503|NCT02216812|Ascorbic Acid|ascorbic acid|mesh-list
25706504|NCT02216812|Vitamins|vitamins|mesh-ancestor
25706505|NCT02216812|Micronutrients|micronutrients|mesh-ancestor
25706506|NCT02216812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991927|NCT04726475|Anticonvulsants|anticonvulsants|mesh-ancestor
24991928|NCT04720976|Pembrolizumab|pembrolizumab|mesh-list
24991930|NCT04720976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24991931|NCT04720976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24991932|NCT04720976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25706507|NCT02216812|Antioxidants|antioxidants|mesh-ancestor
25706508|NCT02216812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706509|NCT02216812|Protective Agents|protective agents|mesh-ancestor
25706510|NCT02217332|Pramipexole|pramipexole|mesh-list
25706511|NCT02217332|Antioxidants|antioxidants|mesh-ancestor
25706512|NCT02217332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706513|NCT02217332|Protective Agents|protective agents|mesh-ancestor
25706514|NCT02217332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922368|NCT04181489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24922369|NCT04181489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24922371|NCT04181489|Tubulin Modulators|tubulin modulators|mesh-ancestor
24922602|NCT04178512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922603|NCT04178512|Protease Inhibitors|protease inhibitors|mesh-ancestor
24922604|NCT04178512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24922605|NCT04178512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922606|NCT04178512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24922607|NCT04178512|Narcotics|narcotics|mesh-ancestor
24922608|NCT04178512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24922609|NCT04178512|Analgesics|analgesics|mesh-ancestor
24922610|NCT04178512|Sensory System Agents|sensory system agents|mesh-ancestor
24922611|NCT04178512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24922612|NCT04178512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24449953|NCT00317434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449954|NCT00317447|Prednisone|prednisone|mesh-list
24449955|NCT00317447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24449956|NCT00317447|Glucocorticoids|glucocorticoids|mesh-ancestor
24449957|NCT00317447|Hormones|hormones|mesh-ancestor
24449958|NCT00317447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24449959|NCT00317447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449960|NCT00317447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24449961|NCT00317447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449962|NCT00317499|Etanercept|etanercept|mesh-list
24594438|NCT00933985|Razoxane|razoxane|mesh-list
24594439|NCT00933985|Obatoclax|obatoclax|mesh-list
24991944|NCT04717362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24991945|NCT04717362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24991946|NCT04717362|Androgens|androgens|mesh-ancestor
24991947|NCT04707326|Lamivudine|lamivudine|mesh-list
24991948|NCT04707326|Dolutegravir|dolutegravir|mesh-list
25107576|NCT03139305|Incretins|incretins|mesh-ancestor
24991949|NCT04707326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24991950|NCT04707326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24991951|NCT04707326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24991952|NCT04707326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991953|NCT04707326|Antiviral Agents|antiviral agents|mesh-ancestor
24991954|NCT04707326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24991955|NCT04707326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24450979|NCT00321230|Ascorbic Acid|ascorbic acid|mesh-list
24450980|NCT00321230|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24450981|NCT00321230|Antioxidants|antioxidants|mesh-ancestor
24991956|NCT04707326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25706515|NCT02217332|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25706516|NCT02217332|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25706517|NCT02217332|Dopamine Agonists|dopamine agonists|mesh-ancestor
25706518|NCT02217332|Dopamine Agents|dopamine agents|mesh-ancestor
25706519|NCT02217332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25706520|NCT02217410|Mycophenolic Acid|mycophenolic acid|mesh-list
25706521|NCT02217410|Tacrolimus|tacrolimus|mesh-list
25706522|NCT02217410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25706523|NCT02217410|Immunologic Factors|immunologic factors|mesh-ancestor
25706524|NCT02217410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706525|NCT02217410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25706526|NCT02217410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25706527|NCT02217410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706528|NCT02217410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25706529|NCT02217410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25706530|NCT02217410|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24600998|NCT00961844|Temozolomide|temozolomide|mesh-list
24991957|NCT04707326|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24991958|NCT04707326|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24991959|NCT04703101|Leucovorin|leucovorin|mesh-list
24991960|NCT04703101|Fluorouracil|fluorouracil|mesh-list
24991961|NCT04703101|Capecitabine|capecitabine|mesh-list
24991962|NCT04703101|Oxaliplatin|oxaliplatin|mesh-list
24991963|NCT04703101|Antimetabolites|antimetabolites|mesh-ancestor
24991964|NCT04703101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24991965|NCT04703101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24797465|NCT01955694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797466|NCT01955694|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24797467|NCT01955694|Diuretics|diuretics|mesh-ancestor
24797468|NCT01955694|Natriuretic Agents|natriuretic agents|mesh-ancestor
24797469|NCT01955694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24797471|NCT01955759|Bisoprolol|bisoprolol|mesh-list
24450991|NCT00321347|Anesthetics|anesthetics|mesh-ancestor
24450992|NCT00321347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24450993|NCT00321347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450994|NCT00321347|Sensory System Agents|sensory system agents|mesh-ancestor
24797472|NCT01955759|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24797473|NCT01955759|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24797474|NCT01955759|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24797475|NCT01955759|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24797476|NCT01955759|Antimetabolites|antimetabolites|mesh-ancestor
24797477|NCT01955759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797478|NCT01955759|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24797479|NCT01955759|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24797480|NCT01955759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24797481|NCT01955759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24797482|NCT01955759|Vasodilator Agents|vasodilator agents|mesh-ancestor
24797483|NCT01955759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24797484|NCT01955759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24797485|NCT01955759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24797499|NCT01955759|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24797500|NCT01955824|Lidocaine|lidocaine|mesh-list
24797501|NCT01955824|Anesthetics, Local|anesthetics, local|mesh-ancestor
24797502|NCT01955824|Anesthetics|anesthetics|mesh-ancestor
24797503|NCT01955824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24797504|NCT01955824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797505|NCT01955824|Sensory System Agents|sensory system agents|mesh-ancestor
24865845|NCT04761887|Anesthetics, Local|anesthetics, local|mesh-ancestor
25706531|NCT02217410|Antitubercular Agents|antitubercular agents|mesh-ancestor
24797508|NCT01955824|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24797509|NCT01955824|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24991968|NCT04703101|Immunologic Factors|immunologic factors|mesh-ancestor
24991978|NCT04690023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24992014|NCT04635254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992016|NCT04625946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24992017|NCT04625946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992018|NCT04591002|Osimertinib|osimertinib|mesh-list
24992019|NCT04591002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992020|NCT04591002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24992021|NCT04591002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24992022|NCT04591002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992023|NCT04589351|Ezetimibe|ezetimibe|mesh-list
24992024|NCT04589351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24992025|NCT04589351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24992030|NCT04583592|Camostat|camostat|mesh-list
24992033|NCT04583592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992034|NCT04583592|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24992035|NCT04583592|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24992042|NCT04523961|Lidocaine|lidocaine|mesh-list
24992043|NCT04523961|Tetracaine|tetracaine|mesh-list
24992044|NCT04523961|Prilocaine|prilocaine|mesh-list
24992045|NCT04523961|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24992046|NCT04523961|Anesthetics, Local|anesthetics, local|mesh-ancestor
24992047|NCT04523961|Anesthetics|anesthetics|mesh-ancestor
24992048|NCT04523961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24992049|NCT04523961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992053|NCT04523961|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24992054|NCT04523961|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24992055|NCT04523961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24449986|NCT00317538|Infliximab|infliximab|mesh-list
24449987|NCT00317538|Dermatologic Agents|dermatologic agents|mesh-ancestor
24594992|NCT00936429|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24992077|NCT04500470|Sensory System Agents|sensory system agents|mesh-ancestor
24992078|NCT04500470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24992079|NCT04500470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992080|NCT04500470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24992081|NCT04500470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24992082|NCT04500470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24992083|NCT04500470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24992084|NCT04500470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992086|NCT04457297|Antimetabolites|antimetabolites|mesh-ancestor
24992087|NCT04457297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992088|NCT04457297|Antiviral Agents|antiviral agents|mesh-ancestor
24992089|NCT04457297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24992090|NCT04441073|Lidocaine|lidocaine|mesh-list
24992091|NCT04441073|Anesthetics, Local|anesthetics, local|mesh-ancestor
24992092|NCT04441073|Anesthetics|anesthetics|mesh-ancestor
24992093|NCT04441073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24992094|NCT04441073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992095|NCT04441073|Sensory System Agents|sensory system agents|mesh-ancestor
24992096|NCT04441073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24992097|NCT04441073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24992098|NCT04441073|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24595046|NCT00936676|Rasagiline|rasagiline|mesh-list
25406098|NCT03579472|Halichondrin B|halichondrin b|mesh-list
24992099|NCT04441073|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24992100|NCT04441073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24992101|NCT04441073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992102|NCT04409665|Ketamine|ketamine|mesh-list
24992103|NCT04409665|Analgesics|analgesics|mesh-ancestor
24992104|NCT04409665|Sensory System Agents|sensory system agents|mesh-ancestor
24992105|NCT04409665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24992106|NCT04409665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992107|NCT04409665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24992108|NCT04409665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24992111|NCT04409665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24992112|NCT04409665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24992113|NCT04409665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24992114|NCT04409665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24992115|NCT04409665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992116|NCT04382937|Ribavirin|ribavirin|mesh-list
24992117|NCT04382937|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24992118|NCT04382937|Antimetabolites|antimetabolites|mesh-ancestor
24992119|NCT04382937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992120|NCT04382937|Antiviral Agents|antiviral agents|mesh-ancestor
24814193|NCT02063139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865919|NCT04365088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24992121|NCT04382937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24992122|NCT04380090|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
24992123|NCT04380090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24992124|NCT04380090|Antidiarrheals|antidiarrheals|mesh-ancestor
24992125|NCT04377620|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
24992126|NCT04377620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24992128|NCT04377620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992130|NCT04351698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24992131|NCT04351698|Respiratory System Agents|respiratory system agents|mesh-ancestor
24603802|NCT00975754|Glucocorticoids|glucocorticoids|mesh-ancestor
24603803|NCT00975754|Hormones|hormones|mesh-ancestor
24603804|NCT00975754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24603805|NCT00975767|Docetaxel|docetaxel|mesh-list
24603806|NCT00975767|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24603807|NCT00975767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603808|NCT00975767|Tubulin Modulators|tubulin modulators|mesh-ancestor
24992132|NCT04351698|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24992133|NCT04351698|Hormone Antagonists|hormone antagonists|mesh-ancestor
24992134|NCT04351698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24992135|NCT04351698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992136|NCT04351698|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24992137|NCT04351698|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24992138|NCT04351698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992187|NCT04197310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992191|NCT04168112|Prednisolone|prednisolone|mesh-list
24992192|NCT04168112|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24992193|NCT04168112|Methylprednisolone|methylprednisolone|mesh-list
24992194|NCT04168112|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24839947|NCT02206737|Cholinergic Agents|cholinergic agents|mesh-ancestor
24992195|NCT04168112|Prednisolone acetate|prednisolone acetate|mesh-list
24992196|NCT04168112|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24992197|NCT04168112|Prednisolone phosphate|prednisolone phosphate|mesh-list
24992198|NCT04168112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24992199|NCT04168112|Antiemetics|antiemetics|mesh-ancestor
24992200|NCT04168112|Autonomic Agents|autonomic agents|mesh-ancestor
24992201|NCT04168112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24992202|NCT04168112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992203|NCT04168112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24992204|NCT04168112|Glucocorticoids|glucocorticoids|mesh-ancestor
24992205|NCT04168112|Hormones|hormones|mesh-ancestor
24797510|NCT01955824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24797511|NCT01955824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797512|NCT01955967|Lidocaine|lidocaine|mesh-list
24797513|NCT01955967|Anesthetics, Local|anesthetics, local|mesh-ancestor
24797514|NCT01955967|Anesthetics|anesthetics|mesh-ancestor
24797515|NCT01955967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24797516|NCT01955967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797517|NCT01955967|Sensory System Agents|sensory system agents|mesh-ancestor
24797518|NCT01955967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24797519|NCT01955967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24797520|NCT01955967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24797521|NCT01955967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24797522|NCT01955967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24797523|NCT01955967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797524|NCT01956006|Milrinone|milrinone|mesh-list
24797525|NCT01956006|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24797526|NCT01956006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25706532|NCT02217410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25706533|NCT02217410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25706534|NCT02217475|Cenicriviroc|cenicriviroc|mesh-list
25706535|NCT02217475|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25706536|NCT02217475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706537|NCT02217475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25709690|NCT02272816|Carboplatin|carboplatin|mesh-list
24797527|NCT01956006|Vasodilator Agents|vasodilator agents|mesh-ancestor
24797528|NCT01956006|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24797529|NCT01956006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24797530|NCT01956006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24797537|NCT01956201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24797538|NCT01956201|Antimetabolites|antimetabolites|mesh-ancestor
24797539|NCT01956201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797542|NCT01956201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24797544|NCT01956305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24797545|NCT01956305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797546|NCT01956474|Riboflavin|riboflavin|mesh-list
24797556|NCT01956487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24785554|NCT01915069|Vasodilator Agents|vasodilator agents|mesh-ancestor
24546052|NCT00696566|Antitubercular Agents|antitubercular agents|mesh-ancestor
25107585|NCT03139500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25107587|NCT03139500|Anesthetics|anesthetics|mesh-ancestor
25107588|NCT03139500|GABA Modulators|gaba modulators|mesh-ancestor
25107589|NCT03139500|GABA Agents|gaba agents|mesh-ancestor
25107590|NCT03139500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25107591|NCT03139500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450077|NCT00317759|Antimetabolites|antimetabolites|mesh-ancestor
24450078|NCT00317759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450079|NCT00317759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25107601|NCT03139383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25107602|NCT03138759|Probenecid|probenecid|mesh-list
25107603|NCT03138759|Uricosuric Agents|uricosuric agents|mesh-ancestor
25107604|NCT03138759|Gout Suppressants|gout suppressants|mesh-ancestor
25107605|NCT03138759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25107606|NCT03138759|Renal Agents|renal agents|mesh-ancestor
25107607|NCT03138603|Metoprolol|metoprolol|mesh-list
25107608|NCT03138603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24866075|NCT03678753|Cenobamate|cenobamate|mesh-list
24866076|NCT03678753|Anticonvulsants|anticonvulsants|mesh-ancestor
24866077|NCT03598777|Botulinum Toxins|botulinum toxins|mesh-list
24866078|NCT03598777|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24866079|NCT03598777|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24866080|NCT03598777|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24866081|NCT03598777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24992273|NCT04032301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24866082|NCT03598777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866083|NCT03598777|Cholinergic Agents|cholinergic agents|mesh-ancestor
24866084|NCT03598777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24636864|NCT01147705|Antioxidants|antioxidants|mesh-ancestor
25107617|NCT03138603|Adrenergic Agents|adrenergic agents|mesh-ancestor
25107618|NCT03138603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25107619|NCT03138603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107620|NCT03138681|Phosphocreatine|phosphocreatine|mesh-list
25107621|NCT03138681|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25107622|NCT03138681|Protective Agents|protective agents|mesh-ancestor
25107623|NCT03138681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107624|NCT03138668|Ropivacaine|ropivacaine|mesh-list
25107625|NCT03138668|Anesthetics, Local|anesthetics, local|mesh-ancestor
25107626|NCT03138668|Anesthetics|anesthetics|mesh-ancestor
25107627|NCT03138668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25107628|NCT03138668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107629|NCT03138668|Sensory System Agents|sensory system agents|mesh-ancestor
25107630|NCT03138668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25107631|NCT03138785|Itraconazole|itraconazole|mesh-list
25107632|NCT03138785|Voriconazole|voriconazole|mesh-list
25107633|NCT03138785|Levofloxacin|levofloxacin|mesh-list
25107634|NCT03138785|Ofloxacin|ofloxacin|mesh-list
25107635|NCT03138785|Antifungal Agents|antifungal agents|mesh-ancestor
25107636|NCT03138785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25107637|NCT03138785|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25107638|NCT03138785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25107639|NCT03138785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107640|NCT03138785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107641|NCT03138785|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24992225|NCT04088890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24992226|NCT04088890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24992227|NCT04088890|Alkylating Agents|alkylating agents|mesh-ancestor
24992228|NCT04088890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992229|NCT04088890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992230|NCT04088890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24992271|NCT04032301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24992272|NCT04032301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24785620|NCT01915472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785622|NCT01915472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25107643|NCT03138785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25107648|NCT03138785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24866301|NCT01067521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24992481|NCT03625388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24992482|NCT03625388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24992483|NCT03625388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992484|NCT03567057|Amantadine|amantadine|mesh-list
24992485|NCT03567057|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24992486|NCT03567057|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24992487|NCT03567057|Antiviral Agents|antiviral agents|mesh-ancestor
24992488|NCT03567057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24992489|NCT03567057|Dopamine Agents|dopamine agents|mesh-ancestor
24992490|NCT03567057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24992491|NCT03567057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992492|NCT03567057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866329|NCT05153785|Lidocaine|lidocaine|mesh-list
25706538|NCT02217475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25706539|NCT02217475|Antiviral Agents|antiviral agents|mesh-ancestor
25706540|NCT02217475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25706541|NCT02217501|Aspirin|aspirin|mesh-list
25706542|NCT02217501|Clopidogrel|clopidogrel|mesh-list
25706543|NCT02217501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25706544|NCT02217501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25706545|NCT02217501|Analgesics|analgesics|mesh-ancestor
24607500|NCT04469842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24607501|NCT04469842|Immunologic Factors|immunologic factors|mesh-ancestor
24607502|NCT04469842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24607689|NCT03979352|Empagliflozin|empagliflozin|mesh-list
24992501|NCT03552068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992502|NCT03552068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24992503|NCT03552068|Sympatholytics|sympatholytics|mesh-ancestor
24992535|NCT03496610|Anesthetics, Local|anesthetics, local|mesh-ancestor
24992536|NCT03496610|Anesthetics|anesthetics|mesh-ancestor
24992537|NCT03496610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24992538|NCT03496610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992539|NCT03496610|Sensory System Agents|sensory system agents|mesh-ancestor
24866361|NCT05153200|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
24866362|NCT05153200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25706546|NCT02217501|Sensory System Agents|sensory system agents|mesh-ancestor
25706547|NCT02217501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25706548|NCT02217501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706549|NCT02217501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25706550|NCT02217501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24450148|NCT00317850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24450149|NCT00317850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24450150|NCT00317850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24450151|NCT00317850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24450152|NCT00317850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450153|NCT00317850|Antimanic Agents|antimanic agents|mesh-ancestor
24992541|NCT03446456|Vasopressins|vasopressins|mesh-list
24992542|NCT03446456|Arginine Vasopressin|arginine vasopressin|mesh-list
24992543|NCT03446456|Hemostatics|hemostatics|mesh-ancestor
24992544|NCT03446456|Coagulants|coagulants|mesh-ancestor
24992545|NCT03446456|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24992546|NCT03446456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24992547|NCT03446456|Natriuretic Agents|natriuretic agents|mesh-ancestor
24992548|NCT03446456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992550|NCT03396692|Ropivacaine|ropivacaine|mesh-list
24992551|NCT03396692|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24992552|NCT03396692|Narcotics|narcotics|mesh-ancestor
24992553|NCT03396692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24992554|NCT03396692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992555|NCT03396692|Analgesics|analgesics|mesh-ancestor
24992556|NCT03396692|Sensory System Agents|sensory system agents|mesh-ancestor
24992557|NCT03396692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24992559|NCT03396692|Anesthetics|anesthetics|mesh-ancestor
24596733|NCT00944996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24596734|NCT00944996|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24596736|NCT00944996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24797589|NCT01956695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797590|NCT01956695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24797591|NCT01956695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24797592|NCT01956695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24797593|NCT01956695|Growth Substances|growth substances|mesh-ancestor
24797594|NCT01956695|Growth Inhibitors|growth inhibitors|mesh-ancestor
24797595|NCT01956734|Temozolomide|temozolomide|mesh-list
24797596|NCT01956734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24797597|NCT01956734|Alkylating Agents|alkylating agents|mesh-ancestor
24797598|NCT01956734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797599|NCT01956734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797600|NCT01956786|Amlodipine|amlodipine|mesh-list
24797601|NCT01956786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24797602|NCT01956786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24609130|NCT00995059|Bortezomib|bortezomib|mesh-list
24797603|NCT01956786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24797604|NCT01956786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992818|NCT02828761|Calcium, Dietary|calcium, dietary|mesh-list
24797635|NCT01956981|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24797636|NCT01956981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24797637|NCT01956981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24797638|NCT01956981|Adrenergic Agents|adrenergic agents|mesh-ancestor
24797639|NCT01956981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24797640|NCT01956981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785681|NCT01916057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785683|NCT01916174|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24785684|NCT01916174|Liraglutide|liraglutide|mesh-list
24785685|NCT01916174|Insulin, Long-Acting|insulin, long-acting|mesh-list
24785686|NCT01916174|Xultophy|xultophy|mesh-list
24785687|NCT01916174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24785688|NCT01916174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785689|NCT01916174|Incretins|incretins|mesh-ancestor
24785690|NCT01916174|Hormones|hormones|mesh-ancestor
24785691|NCT01916174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24785692|NCT01916187|Imetelstat|imetelstat|mesh-list
24785693|NCT01916187|Motesanib diphosphate|motesanib diphosphate|mesh-list
24785694|NCT01916187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24992577|NCT03388190|Levoleucovorin|levoleucovorin|mesh-list
24992578|NCT03388190|Antimetabolites|antimetabolites|mesh-ancestor
24992579|NCT03388190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992580|NCT03388190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24992581|NCT03388190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992582|NCT03388190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24992583|NCT03388190|Immunologic Factors|immunologic factors|mesh-ancestor
24992584|NCT03388190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992585|NCT03388190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24992586|NCT03388190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24992587|NCT03388190|Antidotes|antidotes|mesh-ancestor
24992588|NCT03388190|Protective Agents|protective agents|mesh-ancestor
24992589|NCT03388190|Vitamin B Complex|vitamin b complex|mesh-ancestor
24992590|NCT03388190|Vitamins|vitamins|mesh-ancestor
25107691|NCT03137615|Anesthetics|anesthetics|mesh-list
25107692|NCT03137615|Anesthetics, Local|anesthetics, local|mesh-list
25107693|NCT03137615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25107694|NCT03137615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107695|NCT03137615|Sensory System Agents|sensory system agents|mesh-ancestor
24814349|NCT02064049|Velpatasvir|velpatasvir|mesh-list
24814351|NCT02064049|Antiviral Agents|antiviral agents|mesh-ancestor
24992630|NCT03302286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24992631|NCT03302286|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24992632|NCT03302286|Diuretics|diuretics|mesh-ancestor
24992633|NCT03302286|Natriuretic Agents|natriuretic agents|mesh-ancestor
24992634|NCT03302286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992635|NCT03271021|Minocycline|minocycline|mesh-list
24992636|NCT03271021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24992637|NCT03271021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24930482|NCT04101760|Lenograstim|lenograstim|mesh-list
24992638|NCT03264352|Amlodipine|amlodipine|mesh-list
24992639|NCT03264352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24992640|NCT03264352|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24992641|NCT03264352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24992642|NCT03264352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992645|NCT03264352|Vasodilator Agents|vasodilator agents|mesh-ancestor
24992691|NCT03150173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24992693|NCT03085095|Leuprolide|leuprolide|mesh-list
24992694|NCT03085095|Relugolix|relugolix|mesh-list
24992695|NCT03085095|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24992696|NCT03085095|Fertility Agents|fertility agents|mesh-ancestor
24992697|NCT03085095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24992698|NCT03085095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992699|NCT03085095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24992700|NCT03085095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992701|NCT03085095|Androgen Antagonists|androgen antagonists|mesh-ancestor
24992703|NCT03085095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24992704|NCT03065062|Palbociclib|palbociclib|mesh-list
24992705|NCT03065062|Gedatolisib|gedatolisib|mesh-list
25706551|NCT02217501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24609300|NCT00995995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609321|NCT00996021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24609322|NCT00996021|Antiviral Agents|antiviral agents|mesh-ancestor
24992706|NCT03065062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992707|NCT03065062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24992708|NCT03065062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24992710|NCT03057431|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24992748|NCT02984800|Anesthetics|anesthetics|mesh-list
24992751|NCT02910843|Capecitabine|capecitabine|mesh-list
24992752|NCT02910843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24992753|NCT02910843|Antimetabolites|antimetabolites|mesh-ancestor
24992754|NCT02910843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992755|NCT02910843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992756|NCT02891811|Thalidomide|thalidomide|mesh-list
24992757|NCT02891811|Dexamethasone|dexamethasone|mesh-list
24992758|NCT02891811|Lenalidomide|lenalidomide|mesh-list
24992759|NCT02891811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24992760|NCT02891811|Antiemetics|antiemetics|mesh-ancestor
24992761|NCT02891811|Autonomic Agents|autonomic agents|mesh-ancestor
24992762|NCT02891811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24992763|NCT02891811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992764|NCT02891811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24992765|NCT02891811|Glucocorticoids|glucocorticoids|mesh-ancestor
24992766|NCT02891811|Hormones|hormones|mesh-ancestor
24992767|NCT02891811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24992768|NCT02891811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24992769|NCT02891811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992770|NCT02891811|Immunologic Factors|immunologic factors|mesh-ancestor
24992781|NCT02876510|Cyclophosphamide|cyclophosphamide|mesh-list
24992783|NCT02876510|Fludarabine phosphate|fludarabine phosphate|mesh-list
24992784|NCT02876510|Atezolizumab|atezolizumab|mesh-list
24992785|NCT02876510|Interleukin-2|interleukin-2|mesh-list
24992786|NCT02876510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24992787|NCT02876510|Immunologic Factors|immunologic factors|mesh-ancestor
24992788|NCT02876510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992789|NCT02876510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24992790|NCT02876510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24930636|NCT04099407|Pirfenidone|pirfenidone|mesh-list
24992791|NCT02876510|Alkylating Agents|alkylating agents|mesh-ancestor
24992792|NCT02876510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992793|NCT02876510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992794|NCT02876510|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24992795|NCT02876510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24992796|NCT02876510|Antimetabolites|antimetabolites|mesh-ancestor
24992797|NCT02876510|Antiviral Agents|antiviral agents|mesh-ancestor
24992798|NCT02876510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24992799|NCT02876510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24992800|NCT02876510|Analgesics|analgesics|mesh-ancestor
24992801|NCT02876510|Sensory System Agents|sensory system agents|mesh-ancestor
25706552|NCT02217501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25706553|NCT02217501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751750|NCT01705951|Autonomic Agents|autonomic agents|mesh-ancestor
25706554|NCT02217501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25706555|NCT02217501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24450185|NCT00317915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706556|NCT02217501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450186|NCT00317928|Metformin|metformin|mesh-list
24450187|NCT00317928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24992802|NCT02876510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24992803|NCT02876510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24992804|NCT02876510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24992815|NCT02835690|Pembrolizumab|pembrolizumab|mesh-list
24992816|NCT02835690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24992817|NCT02835690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24992820|NCT02828761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24992821|NCT02828761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992822|NCT02828761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24992823|NCT02815280|Minocycline|minocycline|mesh-list
24992824|NCT02815280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24992825|NCT02815280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24992826|NCT02815267|Minocycline|minocycline|mesh-list
24992827|NCT02815267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24992828|NCT02815267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24992829|NCT02811783|Naloxone|naloxone|mesh-list
24992830|NCT02811783|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24785715|NCT01916213|Viscosupplements|viscosupplements|mesh-ancestor
24785716|NCT01916213|Protective Agents|protective agents|mesh-ancestor
24785717|NCT01916252|Dexamethasone|dexamethasone|mesh-list
24785718|NCT01916252|Dexamethasone acetate|dexamethasone acetate|mesh-list
24785719|NCT01916252|Lenalidomide|lenalidomide|mesh-list
24785720|NCT01916252|Bortezomib|bortezomib|mesh-list
24785721|NCT01916252|Melphalan|melphalan|mesh-list
24785722|NCT01916252|Busulfan|busulfan|mesh-list
24785723|NCT01916252|BB 1101|bb 1101|mesh-list
24785724|NCT01916252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24785725|NCT01916252|Antiemetics|antiemetics|mesh-ancestor
24785726|NCT01916252|Autonomic Agents|autonomic agents|mesh-ancestor
24785727|NCT01916252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25107696|NCT03137615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25107697|NCT03137498|Ketorolac|ketorolac|mesh-list
25107698|NCT03137498|Lidocaine|lidocaine|mesh-list
25107699|NCT03137498|Prilocaine|prilocaine|mesh-list
25107700|NCT03137498|Anesthetics, Local|anesthetics, local|mesh-ancestor
25107701|NCT03137498|Anesthetics|anesthetics|mesh-ancestor
25107702|NCT03137498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25107703|NCT03137498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107704|NCT03137498|Sensory System Agents|sensory system agents|mesh-ancestor
25107705|NCT03137498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24866703|NCT05137626|Digoxin|digoxin|mesh-list
24450188|NCT00317928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450189|NCT00317954|Spironolactone|spironolactone|mesh-list
24450190|NCT00317954|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24450191|NCT00317954|Hormone Antagonists|hormone antagonists|mesh-ancestor
25706557|NCT02217501|Antipyretics|antipyretics|mesh-ancestor
25706558|NCT02217501|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25706559|NCT02217501|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25706560|NCT02217501|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25706561|NCT02217501|Purinergic Agents|purinergic agents|mesh-ancestor
25706562|NCT02217501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24450192|NCT00317954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24450193|NCT00317954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450194|NCT00317954|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24450195|NCT00317954|Diuretics|diuretics|mesh-ancestor
25706563|NCT02217566|Prednisone|prednisone|mesh-list
25706564|NCT02217566|Abiraterone Acetate|abiraterone acetate|mesh-list
24785728|NCT01916252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785729|NCT01916252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25107720|NCT03137316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25107721|NCT03137316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107722|NCT03137316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25107724|NCT03137134|Esomeprazole|esomeprazole|mesh-list
25107725|NCT03137134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25107726|NCT03137134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25107727|NCT03137134|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25107728|NCT03137134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107729|NCT03137134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107730|NCT03137134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25107731|NCT03137134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25107732|NCT03137368|Tamoxifen|tamoxifen|mesh-list
24992894|NCT02539693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992895|NCT02539693|Sensory System Agents|sensory system agents|mesh-ancestor
24992896|NCT02539693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24992897|NCT02539693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24992898|NCT02539693|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24992899|NCT02539693|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24992900|NCT02539693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24992901|NCT02539693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992902|NCT02539693|Analgesics|analgesics|mesh-ancestor
24992903|NCT02539693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24992904|NCT02539693|Sympatholytics|sympatholytics|mesh-ancestor
24992905|NCT02539693|Autonomic Agents|autonomic agents|mesh-ancestor
24992906|NCT02539693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24992907|NCT02539693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24992908|NCT02539693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24992909|NCT02539693|Adrenergic Agents|adrenergic agents|mesh-ancestor
24797671|NCT01957189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24797673|NCT01957293|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24797674|NCT01957293|Autonomic Agents|autonomic agents|mesh-ancestor
24797675|NCT01957293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24797676|NCT01957293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797677|NCT01957293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24797678|NCT01957293|Respiratory System Agents|respiratory system agents|mesh-ancestor
24797679|NCT01957293|Tocolytic Agents|tocolytic agents|mesh-ancestor
24797680|NCT01957293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25107743|NCT03137368|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24450197|NCT00317967|Atorvastatin|atorvastatin|mesh-list
24450198|NCT00317967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24450199|NCT00317967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24797691|NCT01957319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797692|NCT01957319|Antioxidants|antioxidants|mesh-ancestor
24797693|NCT01957319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797694|NCT01957319|Protective Agents|protective agents|mesh-ancestor
24797695|NCT01957319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24797696|NCT01957319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797697|NCT01957436|Docetaxel|docetaxel|mesh-list
24797698|NCT01957436|Abiraterone Acetate|abiraterone acetate|mesh-list
24797699|NCT01957436|Androgens|androgens|mesh-list
24797700|NCT01957436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797701|NCT01957436|Tubulin Modulators|tubulin modulators|mesh-ancestor
24797702|NCT01957436|Antimitotic Agents|antimitotic agents|mesh-ancestor
24797703|NCT01957436|Mitosis Modulators|mitosis modulators|mesh-ancestor
24992910|NCT02539693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24992911|NCT02534012|Anesthetics|anesthetics|mesh-list
24992912|NCT02534012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24610182|NCT01000441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24610183|NCT01000441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24610184|NCT01000441|Dermatologic Agents|dermatologic agents|mesh-ancestor
24610185|NCT01000441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24610188|NCT01000441|Analgesics|analgesics|mesh-ancestor
24610206|NCT01000597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24992913|NCT02534012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24992914|NCT02505204|Clonidine|clonidine|mesh-list
24992915|NCT02505204|Analgesics|analgesics|mesh-ancestor
24992916|NCT02505204|Sensory System Agents|sensory system agents|mesh-ancestor
24992917|NCT02505204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24992930|NCT02487979|Immunotoxins|immunotoxins|mesh-list
24993005|NCT01881048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24993006|NCT01881048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24993007|NCT01881048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993008|NCT01838187|Vorinostat|vorinostat|mesh-list
24993009|NCT01838187|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24993010|NCT01838187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993011|NCT01838187|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24993012|NCT01838187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24993013|NCT01838187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993014|NCT01838187|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24993083|NCT01358201|Mitosis Modulators|mitosis modulators|mesh-ancestor
24993084|NCT01358201|Antiviral Agents|antiviral agents|mesh-ancestor
24993085|NCT01358201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24993086|NCT01338636|Ambrisentan|ambrisentan|mesh-list
24993087|NCT01338636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24993088|NCT01308034|Sunitinib|sunitinib|mesh-list
24993089|NCT01308034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993090|NCT01308034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25107759|NCT03137186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107760|NCT03137030|Acetaminophen|acetaminophen|mesh-list
25107761|NCT03137030|Hydrocodone|hydrocodone|mesh-list
25107762|NCT03137030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25107763|NCT03137030|Analgesics|analgesics|mesh-ancestor
25107764|NCT03137030|Sensory System Agents|sensory system agents|mesh-ancestor
25107765|NCT03137030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25107766|NCT03137030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107767|NCT03137030|Antipyretics|antipyretics|mesh-ancestor
25107768|NCT03137030|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25107769|NCT03137030|Narcotics|narcotics|mesh-ancestor
25107770|NCT03137030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25706565|NCT02217566|Androgens|androgens|mesh-list
25706566|NCT02217566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25706567|NCT02217566|Glucocorticoids|glucocorticoids|mesh-ancestor
25706568|NCT02217566|Hormones|hormones|mesh-ancestor
25706569|NCT02217566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25706570|NCT02217566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706571|NCT02217566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25706572|NCT02217566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25706573|NCT02217566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25107771|NCT03137030|Antitussive Agents|antitussive agents|mesh-ancestor
25107772|NCT03137030|Respiratory System Agents|respiratory system agents|mesh-ancestor
25107773|NCT03137017|Acetaminophen|acetaminophen|mesh-list
25107774|NCT03137017|Hydrocodone|hydrocodone|mesh-list
25107775|NCT03137017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25107776|NCT03137017|Analgesics|analgesics|mesh-ancestor
25107777|NCT03137017|Sensory System Agents|sensory system agents|mesh-ancestor
25107778|NCT03137017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25107779|NCT03137017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107780|NCT03137017|Antipyretics|antipyretics|mesh-ancestor
25107781|NCT03137017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24993146|NCT00579826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24993147|NCT00579826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24993148|NCT00579826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993149|NCT00579826|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24993150|NCT00579826|Hormone Antagonists|hormone antagonists|mesh-ancestor
24993151|NCT00579826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24993152|NCT00579826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993153|NCT00186888|Cyclophosphamide|cyclophosphamide|mesh-list
24993154|NCT00186888|Carboplatin|carboplatin|mesh-list
24993155|NCT00186888|Doxorubicin|doxorubicin|mesh-list
24993156|NCT00186888|Etoposide|etoposide|mesh-list
24993157|NCT00186888|Etoposide phosphate|etoposide phosphate|mesh-list
24993158|NCT00186888|Vincristine|vincristine|mesh-list
24797704|NCT01957436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797705|NCT01957436|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24797706|NCT01957436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24797707|NCT01957436|Hormone Antagonists|hormone antagonists|mesh-ancestor
24797708|NCT01957436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24797730|NCT01957540|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24797731|NCT01957540|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24797732|NCT01957540|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24797733|NCT01957540|Purinergic Agents|purinergic agents|mesh-ancestor
24797734|NCT01957540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24797735|NCT01957540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797736|NCT01957540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797737|NCT01957631|Methylprednisolone|methylprednisolone|mesh-list
24931012|NCT04094909|Growth Substances|growth substances|mesh-ancestor
24993165|NCT00186888|Alkylating Agents|alkylating agents|mesh-ancestor
24758352|NCT01745562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24993166|NCT00186888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993167|NCT00186888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993199|NCT05200299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993200|NCT05200299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24993201|NCT05200299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993202|NCT05200299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24993203|NCT05200299|Immunologic Factors|immunologic factors|mesh-ancestor
24993204|NCT05200299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993205|NCT05200299|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24993206|NCT05200299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24993207|NCT05200299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24993208|NCT05200299|Antidotes|antidotes|mesh-ancestor
24993209|NCT05200299|Protective Agents|protective agents|mesh-ancestor
24993210|NCT05200299|Vitamin B Complex|vitamin b complex|mesh-ancestor
24993211|NCT05200299|Vitamins|vitamins|mesh-ancestor
24993212|NCT05200299|Micronutrients|micronutrients|mesh-ancestor
24993213|NCT05200260|Niraparib|niraparib|mesh-list
25706574|NCT02217566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24993214|NCT05200260|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25107783|NCT03137017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24993231|NCT05199727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993232|NCT05199727|Urological Agents|urological agents|mesh-ancestor
24993235|NCT05199103|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24993238|NCT05199103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993239|NCT05199103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24993240|NCT05198947|Ivermectin|ivermectin|mesh-list
24993241|NCT05198947|Permethrin|permethrin|mesh-list
24993242|NCT05198947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24993256|NCT05198856|Growth Inhibitors|growth inhibitors|mesh-ancestor
24993257|NCT05198856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993258|NCT05198609|Apatinib|apatinib|mesh-list
24993259|NCT05198609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993269|NCT05198141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24993270|NCT05198141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24993271|NCT05198141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24993272|NCT05198141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993273|NCT05198141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24993274|NCT05198141|Hormone Antagonists|hormone antagonists|mesh-ancestor
24993275|NCT05198141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24993276|NCT05198141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993277|NCT05198050|Letrozole|letrozole|mesh-list
24993278|NCT05198050|Alprostadil|alprostadil|mesh-list
24993279|NCT05198050|Misoprostol|misoprostol|mesh-list
24993280|NCT05198050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993281|NCT05198050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24993282|NCT05198050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24993283|NCT05198050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24797740|NCT01957631|Prednisolone|prednisolone|mesh-list
24993331|NCT05139849|Antiemetics|antiemetics|mesh-ancestor
24993332|NCT05139849|Autonomic Agents|autonomic agents|mesh-ancestor
24993333|NCT05139849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24993334|NCT05139849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785804|NCT01916642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785805|NCT01916642|Sensory System Agents|sensory system agents|mesh-ancestor
24785806|NCT01916642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24785807|NCT01916642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24672155|NCT01329809|Immunologic Factors|immunologic factors|mesh-ancestor
24785808|NCT01916642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24785809|NCT01916642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24785810|NCT01916642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24578038|NCT00846703|Methotrexate|methotrexate|mesh-list
24993391|NCT05062135|Progestins|progestins|mesh-ancestor
24993393|NCT05062135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24993394|NCT05062135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993395|NCT05005182|Hydroxyurea|hydroxyurea|mesh-list
24993396|NCT05005182|Luspatercept|luspatercept|mesh-list
24993397|NCT05005182|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
24993398|NCT05005182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993399|NCT05005182|Antisickling Agents|antisickling agents|mesh-ancestor
24395407|NCT00135941|Insulin|insulin|mesh-list
24993400|NCT05005182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24797795|NCT01958138|Anesthetics|anesthetics|mesh-ancestor
24993401|NCT05005182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993402|NCT05005182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24993404|NCT05005182|Immunologic Factors|immunologic factors|mesh-ancestor
24993405|NCT05005182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797757|NCT01957631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24797758|NCT01957631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24797759|NCT01957631|Protective Agents|protective agents|mesh-ancestor
24797760|NCT01957631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24797761|NCT01957631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797762|NCT01957839|Cabergoline|cabergoline|mesh-list
24797763|NCT01957839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24797764|NCT01957839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24797765|NCT01957839|Dopamine Agonists|dopamine agonists|mesh-ancestor
24797766|NCT01957839|Dopamine Agents|dopamine agents|mesh-ancestor
24797767|NCT01957839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24797768|NCT01957839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797769|NCT01957839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797771|NCT01957852|Hemostatics|hemostatics|mesh-ancestor
24797772|NCT01957852|Coagulants|coagulants|mesh-ancestor
24797773|NCT01957943|SMOFlipid|smoflipid|mesh-list
25709691|NCT02272816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672483|NCT01332370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24797774|NCT01957943|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24797787|NCT01957995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797789|NCT01958138|Isoflurane|isoflurane|mesh-list
24797790|NCT01958138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24591341|NCT00915915|Progestins|progestins|mesh-ancestor
24591342|NCT00915915|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24591343|NCT00916045|Vidarabine|vidarabine|mesh-list
24591344|NCT00916045|Cyclosporine|cyclosporine|mesh-list
24797791|NCT01958138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24797792|NCT01958138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797793|NCT01958138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24797794|NCT01958138|Anesthetics, General|anesthetics, general|mesh-ancestor
24993494|NCT04560127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993495|NCT04560127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24993496|NCT04560127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24993497|NCT04560127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993498|NCT04544098|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25706575|NCT02217566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706576|NCT02217566|Hormone Antagonists|hormone antagonists|mesh-ancestor
25706577|NCT02217566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25706578|NCT02217800|Octreotide|octreotide|mesh-list
25706579|NCT02217800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25706580|NCT02217800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25706581|NCT02217800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25706582|NCT02217878|Morphine|morphine|mesh-list
25706583|NCT02217878|Ticagrelor|ticagrelor|mesh-list
25706584|NCT02217878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24993544|NCT05416827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993547|NCT05416827|Hormones|hormones|mesh-ancestor
24993552|NCT05416762|Antidepressive Agents|antidepressive agents|mesh-ancestor
24993553|NCT05416762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24993554|NCT05416762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24993555|NCT05416762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24993556|NCT05416762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24993559|NCT05416762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24993560|NCT05416762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24993573|NCT05416580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24867687|NCT03179475|Naloxone|naloxone|mesh-list
24993598|NCT05416073|Sufentanil|sufentanil|mesh-list
24993599|NCT05416073|Esketamine|esketamine|mesh-list
24993600|NCT05416073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24993601|NCT05416073|Narcotics|narcotics|mesh-ancestor
24993602|NCT05416073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24993603|NCT05416073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993604|NCT05416073|Analgesics|analgesics|mesh-ancestor
24993605|NCT05416073|Sensory System Agents|sensory system agents|mesh-ancestor
24993606|NCT05416073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24993607|NCT05416073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24455485|NCT00107198|Hormones|hormones|mesh-ancestor
24993608|NCT05416073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24993609|NCT05416073|Anesthetics, General|anesthetics, general|mesh-ancestor
24993805|NCT05400109|Antiviral Agents|antiviral agents|mesh-ancestor
24993620|NCT05415917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24993621|NCT05415917|Antimetabolites|antimetabolites|mesh-ancestor
24993642|NCT05415826|Dexamethasone|dexamethasone|mesh-list
24993643|NCT05415826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24993644|NCT05415826|Antiemetics|antiemetics|mesh-ancestor
24993645|NCT05415826|Autonomic Agents|autonomic agents|mesh-ancestor
24993646|NCT05415826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24993647|NCT05415826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993648|NCT05415826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24993649|NCT05415826|Glucocorticoids|glucocorticoids|mesh-ancestor
24993700|NCT05415254|Micronutrients|micronutrients|mesh-ancestor
24993701|NCT05415254|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24993702|NCT05415228|Edetic Acid|edetic acid|mesh-list
24993703|NCT05415228|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
24993767|NCT05409872|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24993768|NCT05409872|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24993769|NCT05409872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993770|NCT05409872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24993800|NCT05400109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993801|NCT05400109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24993802|NCT05400109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24993803|NCT05400109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24993804|NCT05400109|Antimetabolites|antimetabolites|mesh-ancestor
24993813|NCT05392361|Anticonvulsants|anticonvulsants|mesh-ancestor
24993814|NCT05392361|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24993815|NCT05392361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24993816|NCT05392361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24993817|NCT05392361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24993818|NCT05392361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24993819|NCT05392361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24993820|NCT05392361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24993821|NCT05392361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993822|NCT05392361|Antimanic Agents|antimanic agents|mesh-ancestor
24993823|NCT05392361|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24993824|NCT05392361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24993842|NCT05348122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797822|NCT01958580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797823|NCT01958580|Tubulin Modulators|tubulin modulators|mesh-ancestor
24993919|NCT05199311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24993920|NCT05199311|Antiemetics|antiemetics|mesh-ancestor
24993948|NCT05125276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993949|NCT05125276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24993950|NCT05125276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24993951|NCT05125276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24993952|NCT05125276|Antipyretics|antipyretics|mesh-ancestor
24993963|NCT05054842|Metformin|metformin|mesh-list
24993964|NCT05054842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24993965|NCT05054842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24993966|NCT05054751|Fulvestrant|fulvestrant|mesh-list
24993977|NCT05053867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993978|NCT05053867|Hemostatics|hemostatics|mesh-ancestor
24993979|NCT05053867|Coagulants|coagulants|mesh-ancestor
24993980|NCT05048264|Dexamethasone|dexamethasone|mesh-list
24993981|NCT05048264|Methylprednisolone|methylprednisolone|mesh-list
24993982|NCT05048264|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24993983|NCT05048264|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24993984|NCT05048264|Prednisolone|prednisolone|mesh-list
24993985|NCT05048264|Prednisolone acetate|prednisolone acetate|mesh-list
24993986|NCT05048264|Triamcinolone|triamcinolone|mesh-list
24993987|NCT05048264|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24993988|NCT05048264|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24674234|NCT01342627|Sorafenib|sorafenib|mesh-list
24674393|NCT05249933|Sensory System Agents|sensory system agents|mesh-ancestor
24674394|NCT05249933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24674395|NCT05249751|Arginine Vasopressin|arginine vasopressin|mesh-list
24674396|NCT05249751|Hemostatics|hemostatics|mesh-ancestor
24674397|NCT05249751|Coagulants|coagulants|mesh-ancestor
24674398|NCT05249751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24610540|NCT01002911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24610544|NCT01003002|Dopamine Agents|dopamine agents|mesh-ancestor
24993989|NCT05048264|Betamethasone|betamethasone|mesh-list
24401088|NCT00152178|Tamoxifen|tamoxifen|mesh-list
24993990|NCT05048264|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24993991|NCT05048264|Prednisolone phosphate|prednisolone phosphate|mesh-list
24993992|NCT05048264|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24993993|NCT05048264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24993994|NCT05048264|Antiemetics|antiemetics|mesh-ancestor
24993995|NCT05048264|Autonomic Agents|autonomic agents|mesh-ancestor
24993996|NCT05048264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24547983|NCT00707083|Glucocorticoids|glucocorticoids|mesh-ancestor
24994001|NCT05048264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24994002|NCT05048264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24994003|NCT05048264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994004|NCT05048264|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24994005|NCT05048264|Protective Agents|protective agents|mesh-ancestor
24994006|NCT05048264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24994007|NCT05048264|Immunologic Factors|immunologic factors|mesh-ancestor
24994076|NCT04930744|Metformin|metformin|mesh-list
24994077|NCT04930744|Rifampin|rifampin|mesh-list
24797825|NCT01958580|Mitosis Modulators|mitosis modulators|mesh-ancestor
24797826|NCT01958684|Copper|copper|mesh-list
24797827|NCT01958684|Levonorgestrel|levonorgestrel|mesh-list
24797828|NCT01958684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24797829|NCT01958684|Contraceptive Agents|contraceptive agents|mesh-ancestor
24797830|NCT01958684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24797837|NCT01958775|Glucagon|glucagon|mesh-list
24451571|NCT00324324|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24451572|NCT00324324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24451573|NCT00324324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24451574|NCT00324324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24451575|NCT00324324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25706585|NCT02217878|Narcotics|narcotics|mesh-ancestor
25706586|NCT02217878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25706587|NCT02217878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706588|NCT02217878|Analgesics|analgesics|mesh-ancestor
25706589|NCT02217878|Sensory System Agents|sensory system agents|mesh-ancestor
25706590|NCT02217878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25706591|NCT02217878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25706592|NCT02217878|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25706593|NCT02217878|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25706594|NCT02217878|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24994180|NCT04824417|Itraconazole|itraconazole|mesh-list
24994208|NCT04771520|Piperazine citrate|piperazine citrate|mesh-list
24994209|NCT04771520|DMP 777|dmp 777|mesh-list
24994210|NCT04771520|Antinematodal Agents|antinematodal agents|mesh-ancestor
24994211|NCT04771520|Anthelmintics|anthelmintics|mesh-ancestor
24994212|NCT04771520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24994213|NCT04771520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24994214|NCT04771520|Tubulin Modulators|tubulin modulators|mesh-ancestor
24994215|NCT04771520|Antimitotic Agents|antimitotic agents|mesh-ancestor
24994216|NCT04771520|Mitosis Modulators|mitosis modulators|mesh-ancestor
24994217|NCT04771520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994218|NCT04771520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994219|NCT04771520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24994220|NCT04770740|Vitamin K|vitamin k|mesh-list
24994221|NCT04770740|Vitamin K 2|vitamin k 2|mesh-list
24994222|NCT04770740|Vitamin MK 7|vitamin mk 7|mesh-list
24994223|NCT04770740|Vitamins|vitamins|mesh-ancestor
24994224|NCT04770740|Micronutrients|micronutrients|mesh-ancestor
24994225|NCT04770740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706595|NCT02217878|Purinergic Agents|purinergic agents|mesh-ancestor
25706596|NCT02217878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25706597|NCT02217878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706598|NCT02217904|Islatravir|islatravir|mesh-list
25706599|NCT02217904|Antiviral Agents|antiviral agents|mesh-ancestor
25706600|NCT02217904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25706601|NCT02217904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25706602|NCT02217904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994226|NCT04770740|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24994227|NCT04770740|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24674792|NCT04409964|Dexmedetomidine|dexmedetomidine|mesh-list
24674793|NCT04409964|Remifentanil|remifentanil|mesh-list
24674794|NCT04409964|Anesthetics, Local|anesthetics, local|mesh-ancestor
25107862|NCT03136237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25107863|NCT03136237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25107864|NCT03136237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25107865|NCT03136237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24548148|NCT00707850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107866|NCT03136237|Antimetabolites|antimetabolites|mesh-ancestor
25107867|NCT03136237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25107868|NCT03136237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25107869|NCT03136237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25107870|NCT03136237|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25107871|NCT03136237|Protective Agents|protective agents|mesh-ancestor
24994228|NCT04770740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994230|NCT04770740|Coagulants|coagulants|mesh-ancestor
24994244|NCT04744831|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24994245|NCT04744831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24994246|NCT04744831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24994247|NCT04744831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994248|NCT04744831|Immunologic Factors|immunologic factors|mesh-ancestor
24994249|NCT04744831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994250|NCT04730219|Paclitaxel|paclitaxel|mesh-list
24994251|NCT04730219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24994252|NCT04730219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994253|NCT04730219|Tubulin Modulators|tubulin modulators|mesh-ancestor
24994254|NCT04730219|Antimitotic Agents|antimitotic agents|mesh-ancestor
24994255|NCT04730219|Mitosis Modulators|mitosis modulators|mesh-ancestor
24994256|NCT04730219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994257|NCT04725695|Lidocaine|lidocaine|mesh-list
24994266|NCT04725695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24548182|NCT00708149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548183|NCT00708240|Citalopram|citalopram|mesh-list
24548184|NCT00708240|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24548185|NCT00708240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24868209|NCT02536183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868210|NCT02523313|Nivolumab|nivolumab|mesh-list
24868211|NCT02523313|Ipilimumab|ipilimumab|mesh-list
24994299|NCT04700176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24994300|NCT04700176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24994301|NCT04700176|Growth Substances|growth substances|mesh-ancestor
24994302|NCT04700176|Growth Inhibitors|growth inhibitors|mesh-ancestor
24994303|NCT04700176|Keratolytic Agents|keratolytic agents|mesh-ancestor
24994304|NCT04700176|Dermatologic Agents|dermatologic agents|mesh-ancestor
24994306|NCT04664829|Bexarotene|bexarotene|mesh-list
24994307|NCT04664829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24994308|NCT04664829|Antimetabolites|antimetabolites|mesh-ancestor
24994342|NCT04499053|Durvalumab|durvalumab|mesh-list
24994343|NCT04499053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24994344|NCT04499053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994345|NCT04478942|Misoprostol|misoprostol|mesh-list
24994346|NCT04478942|Oxytocin|oxytocin|mesh-list
24994347|NCT04478942|Oxytocics|oxytocics|mesh-ancestor
24994348|NCT04478942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24994349|NCT04478942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994350|NCT04478942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25706603|NCT02217904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25706604|NCT02217904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25706605|NCT02217904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25706606|NCT02217982|Simethicone|simethicone|mesh-list
25706607|NCT02217982|Loperamide|loperamide|mesh-list
25706608|NCT02217982|Antidiarrheals|antidiarrheals|mesh-list
25706609|NCT02217982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24994351|NCT04478942|Abortifacient Agents|abortifacient agents|mesh-ancestor
24994352|NCT04478942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24994353|NCT04478942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24797898|NCT01959022|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24797899|NCT01959022|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24797901|NCT01959022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24797903|NCT01959022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994405|NCT04300231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25107873|NCT03136406|Paclitaxel|paclitaxel|mesh-list
24842502|NCT02221570|Baclofen|baclofen|mesh-list
24994407|NCT04300231|Analgesics|analgesics|mesh-ancestor
24994408|NCT04239950|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
24994409|NCT04239950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24994410|NCT04239950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24994411|NCT04234360|Prednisone|prednisone|mesh-list
24994412|NCT04234360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24994413|NCT04234360|Glucocorticoids|glucocorticoids|mesh-ancestor
24994414|NCT04234360|Hormones|hormones|mesh-ancestor
24994463|NCT04096170|Lidocaine|lidocaine|mesh-list
24994464|NCT04096170|Anesthetics, Local|anesthetics, local|mesh-ancestor
24994466|NCT04096170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24994467|NCT04096170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994468|NCT04096170|Sensory System Agents|sensory system agents|mesh-ancestor
24994469|NCT04096170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24548348|NCT00709189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24994475|NCT04085887|Panitumumab|panitumumab|mesh-list
24994484|NCT04066491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24994485|NCT04066491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25706610|NCT02217982|Antifoaming Agents|antifoaming agents|mesh-ancestor
25706611|NCT02217982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706612|NCT02217982|Emollients|emollients|mesh-ancestor
24994486|NCT04066491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25706613|NCT02217982|Dermatologic Agents|dermatologic agents|mesh-ancestor
25706614|NCT02218190|Alvimopan|alvimopan|mesh-list
25706615|NCT02218190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25706616|NCT02218203|Lidocaine|lidocaine|mesh-list
24994487|NCT04066491|Immunologic Factors|immunologic factors|mesh-ancestor
24994488|NCT04066491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994489|NCT04052932|Allopurinol|allopurinol|mesh-list
24994490|NCT04052932|Antimetabolites|antimetabolites|mesh-ancestor
24994491|NCT04052932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994492|NCT04052932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24994493|NCT04052932|Gout Suppressants|gout suppressants|mesh-ancestor
24994494|NCT04052932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24994495|NCT04052932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24994496|NCT04052932|Antioxidants|antioxidants|mesh-ancestor
24994497|NCT04052932|Protective Agents|protective agents|mesh-ancestor
24994498|NCT04052932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107874|NCT03136406|Cyclophosphamide|cyclophosphamide|mesh-list
24785896|NCT01917045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24785903|NCT01917058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25107875|NCT03136406|Bevacizumab|bevacizumab|mesh-list
25107876|NCT03136406|Fluorouracil|fluorouracil|mesh-list
25107877|NCT03136406|Capecitabine|capecitabine|mesh-list
25107878|NCT03136406|Oxaliplatin|oxaliplatin|mesh-list
25107879|NCT03136406|Avelumab|avelumab|mesh-list
25107880|NCT03136406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25107881|NCT03136406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25107882|NCT03136406|Tubulin Modulators|tubulin modulators|mesh-ancestor
25107883|NCT03136406|Antimitotic Agents|antimitotic agents|mesh-ancestor
25107884|NCT03136406|Mitosis Modulators|mitosis modulators|mesh-ancestor
25107885|NCT03136406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25107886|NCT03136406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25107887|NCT03136406|Immunologic Factors|immunologic factors|mesh-ancestor
25107888|NCT03136406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107889|NCT03136406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25107890|NCT03136406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25107891|NCT03136406|Alkylating Agents|alkylating agents|mesh-ancestor
25107892|NCT03136406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25107893|NCT03136406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25107894|NCT03136406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25107895|NCT03136406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25107896|NCT03136406|Growth Substances|growth substances|mesh-ancestor
25107897|NCT03136406|Growth Inhibitors|growth inhibitors|mesh-ancestor
25107898|NCT03136406|Antimetabolites|antimetabolites|mesh-ancestor
25107900|NCT03136406|Antidotes|antidotes|mesh-ancestor
25107932|NCT03135795|Sevoflurane|sevoflurane|mesh-list
24785904|NCT01917058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25107933|NCT03135795|Citric Acid|citric acid|mesh-list
25107934|NCT03135795|Sodium Citrate|sodium citrate|mesh-list
25107935|NCT03135795|Rocuronium|rocuronium|mesh-list
25107936|NCT03135795|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25107937|NCT03135795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25107938|NCT03135795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25107939|NCT03135795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25107940|NCT03135795|Anesthetics, General|anesthetics, general|mesh-ancestor
25107941|NCT03135795|Anesthetics|anesthetics|mesh-ancestor
25107942|NCT03135795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25107943|NCT03135795|Analgesics|analgesics|mesh-ancestor
25107944|NCT03135795|Sensory System Agents|sensory system agents|mesh-ancestor
24675738|NCT01344681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24637809|NCT01153217|Abacavir|abacavir|mesh-list
24994528|NCT03984578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994529|NCT03984578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24994530|NCT03984578|Antimetabolites|antimetabolites|mesh-ancestor
24994531|NCT03984578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994533|NCT03930745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24994534|NCT03869268|Aspirin|aspirin|mesh-list
24994535|NCT03869268|Ticagrelor|ticagrelor|mesh-list
24797916|NCT01959074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24797917|NCT01959074|Analgesics|analgesics|mesh-ancestor
24797918|NCT01959074|Sensory System Agents|sensory system agents|mesh-ancestor
24591646|NCT00918034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591647|NCT00918034|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24591648|NCT00918034|Dermatologic Agents|dermatologic agents|mesh-ancestor
24591649|NCT00918047|Oxcarbazepine|oxcarbazepine|mesh-list
24591650|NCT00918047|Anticonvulsants|anticonvulsants|mesh-ancestor
24591651|NCT00918047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24591652|NCT00918047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24591653|NCT00918047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24994563|NCT03836014|Antiemetics|antiemetics|mesh-ancestor
24994564|NCT03836014|Autonomic Agents|autonomic agents|mesh-ancestor
24994565|NCT03836014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24994569|NCT03836014|Hormones|hormones|mesh-ancestor
24785967|NCT01917331|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24785968|NCT01917331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24785969|NCT01917331|Adrenergic Agents|adrenergic agents|mesh-ancestor
24785970|NCT01917331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24785971|NCT01917331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785972|NCT01917331|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24785973|NCT01917331|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24785974|NCT01917331|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24785976|NCT01917331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24785977|NCT01917331|Glucocorticoids|glucocorticoids|mesh-ancestor
24785978|NCT01917331|Hormones|hormones|mesh-ancestor
24994580|NCT03836014|Growth Inhibitors|growth inhibitors|mesh-ancestor
25107952|NCT03135795|Anticoagulants|anticoagulants|mesh-ancestor
25107953|NCT03135795|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25107954|NCT03135795|Chelating Agents|chelating agents|mesh-ancestor
25107955|NCT03135795|Sequestering Agents|sequestering agents|mesh-ancestor
25107956|NCT03135795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25107961|NCT03135795|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24868596|NCT04194814|Hormones|hormones|mesh-ancestor
24994628|NCT03668041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994629|NCT03668041|Anticonvulsants|anticonvulsants|mesh-ancestor
24994630|NCT03668041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24994691|NCT03413995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24994712|NCT03315741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25706617|NCT02218203|Dextromethorphan|dextromethorphan|mesh-list
25706618|NCT02218203|Anesthetics, Local|anesthetics, local|mesh-ancestor
25706619|NCT02218203|Anesthetics|anesthetics|mesh-ancestor
25706620|NCT02218203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25706621|NCT02218203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706622|NCT02218203|Sensory System Agents|sensory system agents|mesh-ancestor
25706623|NCT02218203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25706624|NCT02218203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24675930|NCT01346800|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24675933|NCT01346800|Protease Inhibitors|protease inhibitors|mesh-ancestor
24994881|NCT01466686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994882|NCT01466686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994883|NCT00921115|Fulvestrant|fulvestrant|mesh-list
24994884|NCT00921115|Anastrozole|anastrozole|mesh-list
24994885|NCT00921115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24994886|NCT00921115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24790324|NCT01942070|Everolimus|everolimus|mesh-list
25706625|NCT02218203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25706626|NCT02218203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24994887|NCT00921115|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25706627|NCT02218203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25706628|NCT02218203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706629|NCT02218203|Antitussive Agents|antitussive agents|mesh-ancestor
25706630|NCT02218203|Respiratory System Agents|respiratory system agents|mesh-ancestor
25706631|NCT02218203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25706632|NCT02218203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25706633|NCT02218203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25706634|NCT02218307|Mupirocin|mupirocin|mesh-list
25706635|NCT02218307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24676434|NCT01350063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24994888|NCT00921115|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24994889|NCT00921115|Hormone Antagonists|hormone antagonists|mesh-ancestor
24994890|NCT00921115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24994891|NCT00921115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24994892|NCT00921115|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24994893|NCT00921115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24994894|NCT00921115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24994895|NCT00921115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994896|NCT00913705|Carboplatin|carboplatin|mesh-list
24994897|NCT00913705|Paclitaxel|paclitaxel|mesh-list
25107966|NCT03135795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25107967|NCT03135795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25107968|NCT03135795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25107969|NCT03135795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25107970|NCT03135795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25107999|NCT03135769|Avelumab|avelumab|mesh-list
25108000|NCT03135769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25108001|NCT03135769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108002|NCT03135340|Anesthetics|anesthetics|mesh-list
25108003|NCT03135340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25108004|NCT03135340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108005|NCT03135171|Trastuzumab|trastuzumab|mesh-list
24868923|NCT05158647|Sensory System Agents|sensory system agents|mesh-ancestor
24868924|NCT05158647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24868926|NCT05158647|Anesthetics|anesthetics|mesh-ancestor
25706636|NCT02218307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25706637|NCT02218307|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25706638|NCT02218307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25706639|NCT02218307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706640|NCT02218320|Raltegravir Potassium|raltegravir potassium|mesh-list
25706641|NCT02218320|Dolutegravir|dolutegravir|mesh-list
25706642|NCT02218320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25706643|NCT02218320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24622118|NCT01065701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622119|NCT01065701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24622121|NCT01065701|Sensory System Agents|sensory system agents|mesh-ancestor
25706646|NCT02218320|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25706647|NCT02218320|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25706648|NCT02218320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25706649|NCT02218320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706650|NCT02218372|Vancomycin|vancomycin|mesh-list
25706651|NCT02218372|Fidaxomicin|fidaxomicin|mesh-list
25706652|NCT02218372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24622126|NCT01065701|Adrenergic Agents|adrenergic agents|mesh-ancestor
24994981|NCT05418686|Tubulin Modulators|tubulin modulators|mesh-ancestor
24994982|NCT05418686|Antimitotic Agents|antimitotic agents|mesh-ancestor
24994983|NCT05418686|Mitosis Modulators|mitosis modulators|mesh-ancestor
24994984|NCT05418686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994985|NCT05418686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994986|NCT05418660|Pembrolizumab|pembrolizumab|mesh-list
24994990|NCT05418660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24994991|NCT05418660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24994992|NCT05418660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994993|NCT05418647|Dialysis Solutions|dialysis solutions|mesh-list
24994994|NCT05418647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24868985|NCT05157360|Vitamins|vitamins|mesh-list
24451070|NCT00321750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24995011|NCT05418556|Aspirin|aspirin|mesh-list
24995012|NCT05418556|Clopidogrel|clopidogrel|mesh-list
24995013|NCT05418556|Ticagrelor|ticagrelor|mesh-list
24995014|NCT05418556|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24995015|NCT05418556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24995016|NCT05418556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24995017|NCT05418556|Analgesics|analgesics|mesh-ancestor
24995018|NCT05418556|Sensory System Agents|sensory system agents|mesh-ancestor
24995019|NCT05418556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24995020|NCT05418556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995021|NCT05418556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24995022|NCT05418556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24995023|NCT05418556|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24995024|NCT05418556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24995025|NCT05418556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995026|NCT05418556|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24869003|NCT05080946|Analgesics|analgesics|mesh-ancestor
24995028|NCT05418556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24995072|NCT05418244|Serotonin Agents|serotonin agents|mesh-ancestor
24995073|NCT05418244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24995074|NCT05418244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995075|NCT05418244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24995076|NCT05418244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24995077|NCT05418244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24995078|NCT05418244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25706653|NCT02218372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25706654|NCT02218463|Estradiol|estradiol|mesh-list
25706655|NCT02218463|Estrogens|estrogens|mesh-ancestor
25706656|NCT02218463|Hormones|hormones|mesh-ancestor
25706657|NCT02218463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25706658|NCT02218463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706659|NCT02218489|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25706660|NCT02218489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25706661|NCT02218736|Aticaprant|aticaprant|mesh-list
24995084|NCT05418166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995085|NCT05418166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24995086|NCT05418114|Magnesium Sulfate|magnesium sulfate|mesh-list
24995087|NCT05418114|Analgesics|analgesics|mesh-ancestor
24995088|NCT05418114|Sensory System Agents|sensory system agents|mesh-ancestor
24869056|NCT04947592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24995097|NCT05418114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995098|NCT05418114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24995100|NCT05418114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24995117|NCT05418010|Natalizumab|natalizumab|mesh-list
24995137|NCT05417997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24995138|NCT05417997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24995139|NCT05417997|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24995140|NCT05417997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24995141|NCT05417997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549073|NCT00713271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24786045|NCT01917721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24786067|NCT01917799|Antipyretics|antipyretics|mesh-ancestor
24786077|NCT01917877|Growth Inhibitors|growth inhibitors|mesh-ancestor
24786078|NCT01917877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24786080|NCT01917877|Autonomic Agents|autonomic agents|mesh-ancestor
24786081|NCT01917877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24786082|NCT01917877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25108028|NCT03135106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25108029|NCT03135106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108030|NCT03135106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25108031|NCT03135106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25108032|NCT03135106|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25108033|NCT03134872|Carboplatin|carboplatin|mesh-list
25108034|NCT03134872|Pemetrexed|pemetrexed|mesh-list
25108035|NCT03134872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108036|NCT03134872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25108037|NCT03134872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108039|NCT03134872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25108040|NCT03134677|Bupivacaine|bupivacaine|mesh-list
25108041|NCT03134677|Sevoflurane|sevoflurane|mesh-list
25108042|NCT03134677|Anesthetics, Local|anesthetics, local|mesh-ancestor
25108043|NCT03134677|Anesthetics|anesthetics|mesh-ancestor
25108044|NCT03134677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25108045|NCT03134677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108046|NCT03134677|Sensory System Agents|sensory system agents|mesh-ancestor
25706662|NCT02218736|Narcotic Antagonists|narcotic antagonists|mesh-list
25706663|NCT02218736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706664|NCT02218736|Sensory System Agents|sensory system agents|mesh-ancestor
25706665|NCT02218736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25706666|NCT02219009|Aripiprazole|aripiprazole|mesh-list
25706667|NCT02219009|Antidepressive Agents|antidepressive agents|mesh-ancestor
25706668|NCT02219009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25706669|NCT02219009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24678173|NCT01360060|Anticonvulsants|anticonvulsants|mesh-ancestor
25108047|NCT03134677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108048|NCT03134677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25108049|NCT03134677|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25108054|NCT03134729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24869199|NCT04278404|Metformin|metformin|mesh-list
25108067|NCT03134638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108068|NCT03134638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25108069|NCT03134638|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25108070|NCT03134638|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25108071|NCT03134638|Hormone Antagonists|hormone antagonists|mesh-ancestor
25108072|NCT03134638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25108073|NCT03134638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843409|NCT02227212|Insulin|insulin|mesh-list
24995220|NCT05417308|Minoxidil|minoxidil|mesh-list
24995221|NCT05417308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24995222|NCT05417308|Vasodilator Agents|vasodilator agents|mesh-ancestor
24995223|NCT05417269|Dimethyl Fumarate|dimethyl fumarate|mesh-list
24995224|NCT05417269|Dermatologic Agents|dermatologic agents|mesh-ancestor
24995225|NCT05417269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24995226|NCT05417269|Immunologic Factors|immunologic factors|mesh-ancestor
24995227|NCT05417269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995228|NCT05417165|Vaccines|vaccines|mesh-list
24995232|NCT05417087|Vortioxetine|vortioxetine|mesh-list
24995244|NCT05417087|Serotonin Agents|serotonin agents|mesh-ancestor
24995245|NCT05417087|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24995246|NCT05417087|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24995247|NCT05417087|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24603814|NCT00975819|Sirolimus|sirolimus|mesh-list
24995249|NCT05417035|Testosterone undecanoate|testosterone undecanoate|mesh-list
25706670|NCT02219009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25706671|NCT02219009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24995250|NCT05417035|Androgens|androgens|mesh-ancestor
24995251|NCT05417035|Hormones|hormones|mesh-ancestor
25706672|NCT02219009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706673|NCT02219009|Dopamine Agonists|dopamine agonists|mesh-ancestor
25706674|NCT02219009|Dopamine Agents|dopamine agents|mesh-ancestor
25706675|NCT02219009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25706676|NCT02219009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706677|NCT02219009|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24678477|NCT01362218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24995252|NCT05417035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24995253|NCT05417035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995255|NCT05416957|Antidepressive Agents|antidepressive agents|mesh-ancestor
24995256|NCT05416957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24995257|NCT05416957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24995258|NCT05416957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24995259|NCT05416957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24995260|NCT05416957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995261|NCT05416957|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24933099|NCT04073550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24797970|NCT01959204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24797971|NCT01959386|Trastuzumab|trastuzumab|mesh-list
24797972|NCT01959386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24797973|NCT01959386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24797974|NCT01959399|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24797975|NCT01959399|Peficitinib|peficitinib|mesh-list
24797976|NCT01959399|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24797977|NCT01959399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24656060|NCT01259817|Aspirin|aspirin|mesh-list
24797978|NCT01959399|Antimetabolites|antimetabolites|mesh-ancestor
24797979|NCT01959399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24797980|NCT01959399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24797981|NCT01959399|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24797982|NCT01959399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24797983|NCT01959399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24797984|NCT01959399|Immunologic Factors|immunologic factors|mesh-ancestor
24797985|NCT01959399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797986|NCT01959438|Selenious Acid|selenious acid|mesh-list
24797987|NCT01959438|Sodium Selenite|sodium selenite|mesh-list
24797988|NCT01959438|Trace Elements|trace elements|mesh-ancestor
24797989|NCT01959438|Micronutrients|micronutrients|mesh-ancestor
24797990|NCT01959438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797991|NCT01959451|Clopidogrel|clopidogrel|mesh-list
24797992|NCT01959451|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24797993|NCT01959451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24797994|NCT01959451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24797995|NCT01959451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24995302|NCT05366192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24995303|NCT05366192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24995304|NCT05366192|Antiviral Agents|antiviral agents|mesh-ancestor
24995305|NCT05366192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24995306|NCT05366192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24995307|NCT05366192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24995341|NCT05270057|Rituximab|rituximab|mesh-list
24995342|NCT05270057|Doxorubicin|doxorubicin|mesh-list
24995343|NCT05270057|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24995344|NCT05270057|Etoposide|etoposide|mesh-list
24995345|NCT05270057|Vincristine|vincristine|mesh-list
24995346|NCT05270057|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
24995347|NCT05270057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24995357|NCT05270057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24995358|NCT05270057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24995359|NCT05270057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24995360|NCT05270057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24995361|NCT05270057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24995362|NCT05270057|Glucocorticoids|glucocorticoids|mesh-ancestor
24995363|NCT05270057|Hormones|hormones|mesh-ancestor
24995364|NCT05270057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24995365|NCT05270057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25108075|NCT03134547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24995366|NCT05270057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24995367|NCT05270057|Tubulin Modulators|tubulin modulators|mesh-ancestor
24995368|NCT05270057|Antimitotic Agents|antimitotic agents|mesh-ancestor
25706678|NCT02219009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25706679|NCT02219009|Serotonin Agents|serotonin agents|mesh-ancestor
25706680|NCT02219009|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24679492|NCT01368848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995369|NCT05270057|Mitosis Modulators|mitosis modulators|mesh-ancestor
24869494|NCT03238534|Omeprazole|omeprazole|mesh-list
24995417|NCT05212025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995418|NCT05212025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24995419|NCT05212025|Antiviral Agents|antiviral agents|mesh-ancestor
24995420|NCT05212025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24995421|NCT05212025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24995422|NCT05212025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24995423|NCT05212025|Immunologic Factors|immunologic factors|mesh-ancestor
24995424|NCT05212025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995425|NCT05197270|Aflibercept|aflibercept|mesh-list
24995426|NCT05197270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24439980|NCT00281125|Pemetrexed|pemetrexed|mesh-list
24814658|NCT02065947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24995429|NCT05197270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995430|NCT05197270|Growth Inhibitors|growth inhibitors|mesh-ancestor
24995431|NCT05197270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24621306|NCT01061437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621307|NCT01061437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814671|NCT02065947|Adrenergic Agents|adrenergic agents|mesh-ancestor
24621308|NCT01061450|Simvastatin|simvastatin|mesh-list
24621309|NCT01061450|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24621310|NCT01061450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25108076|NCT03134547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25108077|NCT03134547|Anesthetics, General|anesthetics, general|mesh-ancestor
25108081|NCT03134443|Andrographolide|andrographolide|mesh-list
25108082|NCT03134443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25108083|NCT03134443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25108084|NCT03134443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25108085|NCT03134443|Analgesics|analgesics|mesh-ancestor
25108086|NCT03134443|Sensory System Agents|sensory system agents|mesh-ancestor
25108087|NCT03134443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108088|NCT03134443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108089|NCT03134443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25108090|NCT03134443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25108091|NCT03134443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25706681|NCT02219009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25706682|NCT02219009|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25706683|NCT02219009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25706684|NCT02219087|Bupivacaine|bupivacaine|mesh-list
25706685|NCT02219087|Anesthetics, Local|anesthetics, local|mesh-ancestor
25706686|NCT02219087|Anesthetics|anesthetics|mesh-ancestor
25706687|NCT02219087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25706688|NCT02219087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680984|NCT01377324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24680985|NCT01377324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25108092|NCT03134443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25108093|NCT03134443|Antiviral Agents|antiviral agents|mesh-ancestor
25108094|NCT03134443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25108095|NCT03134612|Lidocaine|lidocaine|mesh-list
25108102|NCT03134612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108103|NCT03134612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25108104|NCT03134612|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25108105|NCT03134612|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25108106|NCT03134612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25108107|NCT03134612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108108|NCT03134612|Antiemetics|antiemetics|mesh-ancestor
25108134|NCT03134417|Cholecalciferol|cholecalciferol|mesh-list
25108135|NCT03134417|Vitamins|vitamins|mesh-list
25108136|NCT03134417|Micronutrients|micronutrients|mesh-ancestor
25108137|NCT03134417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869550|NCT02891538|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24995454|NCT05166096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24995455|NCT05166096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995456|NCT05166096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24995457|NCT05166096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24995458|NCT05166096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24995459|NCT05166096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24995460|NCT05166096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995461|NCT05166096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24995462|NCT05166096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24798040|NCT01960049|Anesthetics, Local|anesthetics, local|mesh-ancestor
24798042|NCT01960049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24798043|NCT01960049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798044|NCT01960049|Sensory System Agents|sensory system agents|mesh-ancestor
24798045|NCT01960049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24798046|NCT01960153|Tadalafil|tadalafil|mesh-list
24798047|NCT01960153|Vasodilator Agents|vasodilator agents|mesh-ancestor
24798048|NCT01960153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24798049|NCT01960153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24442009|NCT00289419|Mydriatics|mydriatics|mesh-ancestor
24798050|NCT01960153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24995476|NCT05136677|Carboplatin|carboplatin|mesh-list
24995477|NCT05136677|Nivolumab|nivolumab|mesh-list
24995478|NCT05136677|Pemetrexed|pemetrexed|mesh-list
24995479|NCT05136677|Ipilimumab|ipilimumab|mesh-list
24995501|NCT05128344|Vigabatrin|vigabatrin|mesh-list
24995502|NCT05128344|Anticonvulsants|anticonvulsants|mesh-ancestor
24995503|NCT05128344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24995504|NCT05128344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995505|NCT05128344|GABA Agents|gaba agents|mesh-ancestor
24995506|NCT05128344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24995507|NCT05128344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995508|NCT05110638|Luliconazole|luliconazole|mesh-list
24995509|NCT05110638|Antifungal Agents|antifungal agents|mesh-ancestor
25706689|NCT02219087|Sensory System Agents|sensory system agents|mesh-ancestor
25706690|NCT02219087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25706691|NCT02219321|Lidocaine|lidocaine|mesh-list
25706692|NCT02219321|Anesthetics, Local|anesthetics, local|mesh-ancestor
25706693|NCT02219321|Anesthetics|anesthetics|mesh-ancestor
25706694|NCT02219321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25706695|NCT02219321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706696|NCT02219321|Sensory System Agents|sensory system agents|mesh-ancestor
25706697|NCT02219321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24995510|NCT05110638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24995522|NCT05101564|Infigratinib|infigratinib|mesh-list
24995523|NCT05101564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24995524|NCT05101564|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24995525|NCT05101564|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24995526|NCT05101564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24995527|NCT05101564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995528|NCT05101564|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24995529|NCT05101564|Hormone Antagonists|hormone antagonists|mesh-ancestor
24995530|NCT05101564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24995531|NCT05101564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995532|NCT05101564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24995575|NCT05053503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995585|NCT05026905|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24995586|NCT05026905|Oxaliplatin|oxaliplatin|mesh-list
24995588|NCT05026905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24995589|NCT05026905|Tubulin Modulators|tubulin modulators|mesh-ancestor
24995590|NCT05026905|Antimitotic Agents|antimitotic agents|mesh-ancestor
24995591|NCT05026905|Mitosis Modulators|mitosis modulators|mesh-ancestor
24869662|NCT01717586|Antimetabolites|antimetabolites|mesh-ancestor
24869663|NCT01717586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869664|NCT01717586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24869666|NCT01717586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24995592|NCT05026905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995593|NCT05026905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24995594|NCT05026905|Antimetabolites|antimetabolites|mesh-ancestor
24995595|NCT05026905|Antiviral Agents|antiviral agents|mesh-ancestor
24995596|NCT05026905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24995597|NCT05026905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24995598|NCT05026905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24995599|NCT05026905|Immunologic Factors|immunologic factors|mesh-ancestor
24995600|NCT05026905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995602|NCT05026905|Protective Agents|protective agents|mesh-ancestor
24995603|NCT05026905|Vitamin B Complex|vitamin b complex|mesh-ancestor
24995604|NCT05026905|Vitamins|vitamins|mesh-ancestor
24995605|NCT05026905|Micronutrients|micronutrients|mesh-ancestor
24995647|NCT04995536|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
25706698|NCT02219321|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25706699|NCT02219321|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25706700|NCT02219321|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25706701|NCT02219321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25706702|NCT02219321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706703|NCT02219477|Ritonavir|ritonavir|mesh-list
25706704|NCT02219477|Ribavirin|ribavirin|mesh-list
25706705|NCT02219477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25706706|NCT02219477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25706707|NCT02219477|Protease Inhibitors|protease inhibitors|mesh-ancestor
25706708|NCT02219477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25706709|NCT02219477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706710|NCT02219477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25706711|NCT02219477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25706712|NCT02219477|Antiviral Agents|antiviral agents|mesh-ancestor
25706713|NCT02219477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25706714|NCT02219477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25706715|NCT02219477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25706716|NCT02219477|Antimetabolites|antimetabolites|mesh-ancestor
25706717|NCT02219503|Ritonavir|ritonavir|mesh-list
25706718|NCT02219503|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24683651|NCT01393288|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24683652|NCT01393288|Anticonvulsants|anticonvulsants|mesh-ancestor
24683720|NCT01393756|Growth Substances|growth substances|mesh-ancestor
24683721|NCT01393756|Growth Inhibitors|growth inhibitors|mesh-ancestor
24683722|NCT01393756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24683724|NCT01393769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24683725|NCT01393769|Alkylating Agents|alkylating agents|mesh-ancestor
24683726|NCT01393769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995648|NCT04995536|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24995649|NCT04995536|Immunologic Factors|immunologic factors|mesh-ancestor
24995650|NCT04995536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995653|NCT04961593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24995654|NCT04961593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605756|NCT00987168|Octreotide|octreotide|mesh-list
24995668|NCT04943900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605847|NCT00987662|Irbesartan|irbesartan|mesh-list
24995678|NCT04894994|Ipilimumab|ipilimumab|mesh-list
24995679|NCT04894994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24995680|NCT04894994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24995681|NCT04894994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24995682|NCT04894994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798059|NCT01960205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798060|NCT01960205|Incretins|incretins|mesh-ancestor
24798061|NCT01960205|Hormones|hormones|mesh-ancestor
24798062|NCT01960205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24798063|NCT01960205|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24798064|NCT01960205|Protease Inhibitors|protease inhibitors|mesh-ancestor
24798065|NCT01960205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24798066|NCT01960205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798067|NCT01960283|Methotrexate|methotrexate|mesh-list
24798068|NCT01960283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24798069|NCT01960283|Abortifacient Agents|abortifacient agents|mesh-ancestor
24798081|NCT01960283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24798082|NCT01960283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24798084|NCT01960426|Infliximab|infliximab|mesh-list
24798085|NCT01960426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24869778|NCT05159674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869781|NCT05159674|Analgesics|analgesics|mesh-ancestor
25706719|NCT02219503|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25706720|NCT02219503|Protease Inhibitors|protease inhibitors|mesh-ancestor
25706721|NCT02219503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25706722|NCT02219503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706723|NCT02219503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25706724|NCT02219503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25706725|NCT02219503|Antiviral Agents|antiviral agents|mesh-ancestor
25706726|NCT02219503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25709692|NCT02272842|Vitamin B 12|vitamin b 12|mesh-list
24798087|NCT01960426|Dermatologic Agents|dermatologic agents|mesh-ancestor
24798088|NCT01960426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24798091|NCT01960543|Levobupivacaine|levobupivacaine|mesh-list
24798092|NCT01960543|Anesthetics, Local|anesthetics, local|mesh-ancestor
24995684|NCT04870957|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24995685|NCT04870957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24995686|NCT04870957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24995687|NCT04870957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995688|NCT04870957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24995689|NCT04870957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995690|NCT04870957|Analgesics|analgesics|mesh-ancestor
24995691|NCT04870957|Sensory System Agents|sensory system agents|mesh-ancestor
24995692|NCT04870957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24995808|NCT04639115|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24995809|NCT04639115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706727|NCT02219503|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25706728|NCT02219503|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25706729|NCT02219516|Verinurad|verinurad|mesh-list
25706730|NCT02219516|Gout Suppressants|gout suppressants|mesh-ancestor
25706731|NCT02219516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25706732|NCT02219685|Sofosbuvir|sofosbuvir|mesh-list
25706733|NCT02219685|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25706734|NCT02219685|Ledipasvir|ledipasvir|mesh-list
25706735|NCT02219685|Antiviral Agents|antiviral agents|mesh-ancestor
25706736|NCT02219685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25706737|NCT02219932|4-Aminopyridine|4-aminopyridine|mesh-list
25706738|NCT02219932|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25706739|NCT02219932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24686179|NCT05007561|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24686183|NCT05002738|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24686214|NCT04997759|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24686215|NCT04997759|Autonomic Agents|autonomic agents|mesh-ancestor
24995810|NCT04639115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24995811|NCT04639115|Immunologic Factors|immunologic factors|mesh-ancestor
24995812|NCT04639115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995813|NCT04638881|Magnesium Sulfate|magnesium sulfate|mesh-list
24995814|NCT04638881|Analgesics|analgesics|mesh-ancestor
24995815|NCT04638881|Sensory System Agents|sensory system agents|mesh-ancestor
24869866|NCT05141240|Palbociclib|palbociclib|mesh-list
24995838|NCT04608344|Antimetabolites|antimetabolites|mesh-ancestor
24995844|NCT04564547|Antiviral Agents|antiviral agents|mesh-ancestor
24995845|NCT04564547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24995846|NCT04564547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24995847|NCT04564547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995848|NCT04564547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24995849|NCT04564547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24995850|NCT04564547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24995922|NCT04482803|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24995923|NCT04482803|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
24995924|NCT04482803|beta-Endorphin|beta-endorphin|mesh-list
24995925|NCT04482803|Hormones|hormones|mesh-ancestor
24995926|NCT04482803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24995927|NCT04482803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814702|NCT02066077|Propofol|propofol|mesh-list
24995938|NCT04468776|Zolpidem|zolpidem|mesh-list
24995939|NCT04468776|Trazodone|trazodone|mesh-list
24995940|NCT04468776|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24995941|NCT04468776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24995942|NCT04468776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24995943|NCT04468776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24995944|NCT04468776|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25706740|NCT02219932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706741|NCT02219997|Methamphetamine|methamphetamine|mesh-list
25706742|NCT02219997|beta-Endorphin|beta-endorphin|mesh-list
25706743|NCT02219997|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25706744|NCT02219997|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
25706745|NCT02219997|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25706746|NCT02219997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706747|NCT02219997|Sympathomimetics|sympathomimetics|mesh-ancestor
25706748|NCT02219997|Autonomic Agents|autonomic agents|mesh-ancestor
25706749|NCT02219997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25706750|NCT02219997|Dopamine Agents|dopamine agents|mesh-ancestor
25706751|NCT02219997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25709693|NCT02272842|Hydroxocobalamin|hydroxocobalamin|mesh-list
24687546|NCT03913819|Cholinergic Antagonists|cholinergic antagonists|mesh-list
24687547|NCT03913819|Cholinergic Agents|cholinergic agents|mesh-ancestor
24687548|NCT03913819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24687549|NCT03913819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687550|NCT03913819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687552|NCT03897439|Nicotine|nicotine|mesh-list
25706752|NCT02219997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995980|NCT04452877|Dabrafenib|dabrafenib|mesh-list
24995981|NCT04452877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24995982|NCT04452877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24995983|NCT04452877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24995984|NCT04452877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933948|NCT04065919|Epinephrine|epinephrine|mesh-list
24786128|NCT01918124|Tubulin Modulators|tubulin modulators|mesh-ancestor
24786129|NCT01918124|Antimitotic Agents|antimitotic agents|mesh-ancestor
24786130|NCT01918124|Mitosis Modulators|mitosis modulators|mesh-ancestor
24786131|NCT01918124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786132|NCT01918124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24786133|NCT01918124|Immunologic Factors|immunologic factors|mesh-ancestor
24786134|NCT01918124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786135|NCT01918124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24786136|NCT01918124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24786137|NCT01918124|Alkylating Agents|alkylating agents|mesh-ancestor
24786138|NCT01918124|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24786139|NCT01918124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24786140|NCT01918124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24996007|NCT04421248|Methylphenidate|methylphenidate|mesh-list
24996008|NCT04421248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24996009|NCT04421248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996010|NCT04421248|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24996011|NCT04421248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24996012|NCT04421248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24996014|NCT04421248|Dopamine Agents|dopamine agents|mesh-ancestor
25108139|NCT03134417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25108140|NCT03134378|Amoxicillin|amoxicillin|mesh-list
25108141|NCT03134378|Clarithromycin|clarithromycin|mesh-list
25108142|NCT03134378|Rabeprazole|rabeprazole|mesh-list
25108143|NCT03134378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25108144|NCT03134378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25108145|NCT03134378|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25108146|NCT03134378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25108147|NCT03134378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108148|NCT03134378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25108149|NCT03134378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25108150|NCT03134378|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25108151|NCT03134378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25108152|NCT03134378|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25108154|NCT03134846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24798198|NCT01961453|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24996032|NCT04397354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996033|NCT04352205|Thalidomide|thalidomide|mesh-list
24996034|NCT04352205|Dexamethasone|dexamethasone|mesh-list
24996035|NCT04352205|Dexamethasone acetate|dexamethasone acetate|mesh-list
25706753|NCT02219997|Adrenergic Agents|adrenergic agents|mesh-ancestor
25706754|NCT02219997|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25706755|NCT02219997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25706756|NCT02219997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25706757|NCT02219997|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25706758|NCT02219997|Hormones|hormones|mesh-ancestor
25709694|NCT02272842|Vitamins|vitamins|mesh-ancestor
25709695|NCT02272842|Micronutrients|micronutrients|mesh-ancestor
25709696|NCT02272842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709697|NCT02272842|Vitamin B Complex|vitamin b complex|mesh-ancestor
25709698|NCT02272842|Hematinics|hematinics|mesh-ancestor
25709699|NCT02273050|Metformin|metformin|mesh-list
25709700|NCT02273050|Saxagliptin|saxagliptin|mesh-list
25709701|NCT02273050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25709702|NCT02273050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709703|NCT02273050|Incretins|incretins|mesh-ancestor
24688254|NCT03215940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24688255|NCT03215940|Analgesics|analgesics|mesh-ancestor
24688256|NCT03215940|Sensory System Agents|sensory system agents|mesh-ancestor
24688257|NCT03215940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24798115|NCT01960595|Anesthetics, Local|anesthetics, local|mesh-ancestor
24798116|NCT01960595|Anesthetics|anesthetics|mesh-ancestor
24996036|NCT04352205|Lenalidomide|lenalidomide|mesh-list
24996037|NCT04352205|Bortezomib|bortezomib|mesh-list
24996038|NCT04352205|Daratumumab|daratumumab|mesh-list
24996039|NCT04352205|Ichthammol|ichthammol|mesh-list
24996040|NCT04352205|BB 1101|bb 1101|mesh-list
24996041|NCT04352205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24996042|NCT04352205|Antiemetics|antiemetics|mesh-ancestor
24996043|NCT04352205|Autonomic Agents|autonomic agents|mesh-ancestor
24996044|NCT04352205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24996045|NCT04352205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996046|NCT04352205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24996047|NCT04352205|Glucocorticoids|glucocorticoids|mesh-ancestor
24996048|NCT04352205|Hormones|hormones|mesh-ancestor
24996049|NCT04352205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24996050|NCT04352205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24996051|NCT04352205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24814723|NCT02066207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24996053|NCT04352205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996054|NCT04352205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996055|NCT04352205|Immunologic Factors|immunologic factors|mesh-ancestor
24996056|NCT04352205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24996057|NCT04352205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24996058|NCT04352205|Growth Substances|growth substances|mesh-ancestor
24996059|NCT04352205|Growth Inhibitors|growth inhibitors|mesh-ancestor
24996060|NCT04352205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24996061|NCT04352205|Leprostatic Agents|leprostatic agents|mesh-ancestor
24996062|NCT04352205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24996063|NCT04352205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24934014|NCT04065230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996072|NCT04344873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24996074|NCT04306900|Paclitaxel|paclitaxel|mesh-list
24996075|NCT04306900|Docetaxel|docetaxel|mesh-list
24996076|NCT04306900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24996077|NCT04306900|Pembrolizumab|pembrolizumab|mesh-list
24996078|NCT04306900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24996079|NCT04306900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996080|NCT04306900|Tubulin Modulators|tubulin modulators|mesh-ancestor
24996081|NCT04306900|Antimitotic Agents|antimitotic agents|mesh-ancestor
24996082|NCT04306900|Mitosis Modulators|mitosis modulators|mesh-ancestor
24996083|NCT04306900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996084|NCT04306900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24996085|NCT04306900|Antimetabolites|antimetabolites|mesh-ancestor
24996086|NCT04306900|Antiviral Agents|antiviral agents|mesh-ancestor
24996087|NCT04306900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24996088|NCT04306900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24798141|NCT01961154|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24798142|NCT01961154|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24798145|NCT01961154|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24996111|NCT04215471|Antibodies|antibodies|mesh-list
24996112|NCT04215471|Immunoglobulins|immunoglobulins|mesh-list
24996113|NCT04215471|Immunologic Factors|immunologic factors|mesh-ancestor
24996114|NCT04215471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706759|NCT02219997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25706760|NCT02220712|Aripiprazole|aripiprazole|mesh-list
25706761|NCT02220712|Antidepressive Agents|antidepressive agents|mesh-ancestor
25706762|NCT02220712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24996115|NCT04203641|Doxorubicin|doxorubicin|mesh-list
25706763|NCT02220712|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25706764|NCT02220712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25706765|NCT02220712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24688660|NCT02810457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24688661|NCT02810457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24688662|NCT02810457|Growth Substances|growth substances|mesh-ancestor
24688663|NCT02810457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688664|NCT02810457|Growth Inhibitors|growth inhibitors|mesh-ancestor
24473825|NCT00404261|Hormones|hormones|mesh-ancestor
24611816|NCT01010945|Antimitotic Agents|antimitotic agents|mesh-ancestor
24611817|NCT01010945|Mitosis Modulators|mitosis modulators|mesh-ancestor
24611841|NCT01011010|Mitomycins|mitomycins|mesh-list
24996116|NCT04203641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24870146|NCT03703778|Antioxidants|antioxidants|mesh-ancestor
24996117|NCT04203641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996118|NCT04203641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24996120|NCT04203641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996131|NCT04188119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996132|NCT04188119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24996133|NCT04188119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24996134|NCT04188119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24996135|NCT04188119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24996136|NCT04188119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790800|NCT01945437|Tocolytic Agents|tocolytic agents|mesh-ancestor
24996137|NCT04188119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24996138|NCT04188119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24996139|NCT04188119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996140|NCT04188119|Antipyretics|antipyretics|mesh-ancestor
24996141|NCT04188119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24996142|NCT04188119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996143|NCT04188119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24996144|NCT04188119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24996145|NCT04188119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24996146|NCT04173338|Pemetrexed|pemetrexed|mesh-list
24996147|NCT04173338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996148|NCT04173338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996149|NCT04173338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996150|NCT04173338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24870215|NCT03122431|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24996190|NCT04162873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996191|NCT04162873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24996192|NCT04162873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24996193|NCT04162873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24996194|NCT04162873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24996195|NCT04162873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996196|NCT04162873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996197|NCT04162873|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24996198|NCT04113538|Aflibercept|aflibercept|mesh-list
24996199|NCT04113538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24996200|NCT04113538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24996201|NCT04113538|Growth Substances|growth substances|mesh-ancestor
24996202|NCT04113538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996203|NCT04113538|Growth Inhibitors|growth inhibitors|mesh-ancestor
25706766|NCT02220712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706767|NCT02220712|Dopamine Agonists|dopamine agonists|mesh-ancestor
25706768|NCT02220712|Dopamine Agents|dopamine agents|mesh-ancestor
25706769|NCT02220712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25706770|NCT02220712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706771|NCT02220712|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25706772|NCT02220712|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25706773|NCT02220712|Serotonin Agents|serotonin agents|mesh-ancestor
25706774|NCT02220712|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25706775|NCT02220712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25706776|NCT02220712|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25706777|NCT02220712|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24688829|NCT02636322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24688831|NCT02636322|Immunoglobulins|immunoglobulins|mesh-list
24688880|NCT02619552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24688910|NCT02578368|Vitamin B Complex|vitamin b complex|mesh-ancestor
24688912|NCT02578368|Micronutrients|micronutrients|mesh-ancestor
24688913|NCT02575963|Cytarabine|cytarabine|mesh-list
24688914|NCT02575963|Lintuzumab|lintuzumab|mesh-list
24688915|NCT02575963|Furosemide|furosemide|mesh-list
24688916|NCT02575963|Spironolactone|spironolactone|mesh-list
24996204|NCT04113538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996205|NCT04113187|Propranolol|propranolol|mesh-list
24996206|NCT04113187|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24996207|NCT04113187|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24996208|NCT04113187|Adrenergic Agents|adrenergic agents|mesh-ancestor
24996209|NCT04113187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24996210|NCT04113187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996211|NCT04113187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996212|NCT04113187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24996236|NCT04011475|Tiotropium Bromide|tiotropium bromide|mesh-list
24996237|NCT04011475|Olodaterol|olodaterol|mesh-list
24996238|NCT04011475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24996239|NCT04011475|Autonomic Agents|autonomic agents|mesh-ancestor
24996240|NCT04011475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24996241|NCT04011475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996262|NCT03941964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24996263|NCT03941964|Antimetabolites|antimetabolites|mesh-ancestor
24996264|NCT03941964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996265|NCT03941964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996266|NCT03941964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996310|NCT03774472|Letrozole|letrozole|mesh-list
24996341|NCT03711422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24996342|NCT03711422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996343|NCT03711422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996344|NCT03674567|Pembrolizumab|pembrolizumab|mesh-list
24996345|NCT03674567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24996346|NCT03674567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996358|NCT03639558|Antiemetics|antiemetics|mesh-ancestor
24996359|NCT03639558|Autonomic Agents|autonomic agents|mesh-ancestor
24996360|NCT03639558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25706778|NCT02220907|Canagliflozin|canagliflozin|mesh-list
25706779|NCT02220907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25706780|NCT02220907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706781|NCT02220907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25706782|NCT02220907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706783|NCT02220920|Canagliflozin|canagliflozin|mesh-list
25706784|NCT02220920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25706785|NCT02220920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709704|NCT02273050|Hormones|hormones|mesh-ancestor
25709705|NCT02273050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25709706|NCT02273050|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25709707|NCT02273050|Protease Inhibitors|protease inhibitors|mesh-ancestor
25709708|NCT02273050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709709|NCT02273050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709710|NCT02273115|Oxytocin|oxytocin|mesh-list
25709711|NCT02273115|Oxytocics|oxytocics|mesh-ancestor
25709712|NCT02273115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25709713|NCT02273115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709714|NCT02273180|Insulin|insulin|mesh-list
25709715|NCT02273180|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25709716|NCT02273180|Insulin Glargine|insulin glargine|mesh-list
25709717|NCT02273180|Insulin Lispro|insulin lispro|mesh-list
25709718|NCT02273180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24611885|NCT01011127|Pravastatin|pravastatin|mesh-list
24611886|NCT01011127|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24611887|NCT01011127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24996361|NCT03639558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996362|NCT03639558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24996363|NCT03639558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24996364|NCT03639558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24996365|NCT03639558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24996366|NCT03639558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24996367|NCT03639558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24996368|NCT03639558|Dopamine Agents|dopamine agents|mesh-ancestor
24996369|NCT03639558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24786155|NCT01918176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24786156|NCT01918176|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24786167|NCT01918254|Mitosis Modulators|mitosis modulators|mesh-ancestor
24786168|NCT01918254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786169|NCT01918254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24786170|NCT01918358|Valsartan|valsartan|mesh-list
24786171|NCT01918358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24786173|NCT01918358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24786174|NCT01918358|Antimetabolites|antimetabolites|mesh-ancestor
24786176|NCT01918358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24786177|NCT01918358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24786178|NCT01918358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996382|NCT03639558|Sensory System Agents|sensory system agents|mesh-ancestor
24996383|NCT03568708|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24996384|NCT03568708|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24996386|NCT03568708|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24996387|NCT03568708|Estrogens|estrogens|mesh-list
24798146|NCT01961154|Autonomic Agents|autonomic agents|mesh-ancestor
24798147|NCT01961154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24798148|NCT01961154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798149|NCT01961154|Glucocorticoids|glucocorticoids|mesh-ancestor
24798150|NCT01961154|Hormones|hormones|mesh-ancestor
24798151|NCT01961154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24798152|NCT01961154|Sympathomimetics|sympathomimetics|mesh-ancestor
25108165|NCT03134339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108166|NCT03133975|Vitamin D|vitamin d|mesh-list
25108167|NCT03133975|Cholecalciferol|cholecalciferol|mesh-list
25706786|NCT02220920|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25706787|NCT02220920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706788|NCT02220998|Sofosbuvir|sofosbuvir|mesh-list
25706789|NCT02220998|Antiviral Agents|antiviral agents|mesh-ancestor
25706790|NCT02220998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25706791|NCT02221219|Indomethacin|indomethacin|mesh-list
25706792|NCT02221219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25706793|NCT02221219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25706794|NCT02221219|Analgesics|analgesics|mesh-ancestor
25706795|NCT02221219|Sensory System Agents|sensory system agents|mesh-ancestor
25706796|NCT02221219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25706797|NCT02221219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706798|NCT02221219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25706799|NCT02221219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25706800|NCT02221219|Gout Suppressants|gout suppressants|mesh-ancestor
25706801|NCT02221219|Tocolytic Agents|tocolytic agents|mesh-ancestor
25706802|NCT02221219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25108175|NCT03133832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25108176|NCT03133832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25108178|NCT03133845|Midazolam|midazolam|mesh-list
25108179|NCT03133845|Morphine|morphine|mesh-list
25108180|NCT03133845|Anesthetics|anesthetics|mesh-list
25108181|NCT03133845|Propofol|propofol|mesh-list
25108182|NCT03133845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25108183|NCT03133845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108184|NCT03133845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25108185|NCT03133845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25108186|NCT03133845|Anesthetics, General|anesthetics, general|mesh-ancestor
25108187|NCT03133845|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25108188|NCT03133845|Narcotics|narcotics|mesh-ancestor
25108189|NCT03133845|Analgesics|analgesics|mesh-ancestor
24870420|NCT05162183|Immunologic Factors|immunologic factors|mesh-ancestor
24996651|NCT03033095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24996451|NCT03463265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996452|NCT03463265|Growth Inhibitors|growth inhibitors|mesh-ancestor
24996453|NCT03463265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24996454|NCT03463265|Alkylating Agents|alkylating agents|mesh-ancestor
24996455|NCT03463265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996456|NCT03463265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24996457|NCT03463265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24996458|NCT03463265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24996459|NCT03463265|Antifungal Agents|antifungal agents|mesh-ancestor
24996460|NCT03463265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24996461|NCT03463265|Immunologic Factors|immunologic factors|mesh-ancestor
24996462|NCT03451578|alpha-MSH|alpha-msh|mesh-list
24996463|NCT03451578|Hormones|hormones|mesh-ancestor
24996464|NCT03451578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24996465|NCT03451578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996466|NCT03439462|Sirolimus|sirolimus|mesh-list
24996467|NCT03439462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24996468|NCT03439462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24996469|NCT03439462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24996470|NCT03439462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996471|NCT03439462|Antifungal Agents|antifungal agents|mesh-ancestor
24996472|NCT03439462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24996473|NCT03439462|Immunologic Factors|immunologic factors|mesh-ancestor
24870519|NCT05046522|Palmidrol|palmidrol|mesh-list
24996474|NCT03439462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996475|NCT03437005|Ketoconazole|ketoconazole|mesh-list
24996476|NCT03437005|Desonide|desonide|mesh-list
24996477|NCT03437005|Antifungal Agents|antifungal agents|mesh-ancestor
24996478|NCT03437005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24996479|NCT03437005|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24996480|NCT03437005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24996481|NCT03437005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996482|NCT03437005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996483|NCT03437005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24996484|NCT03437005|Hormone Antagonists|hormone antagonists|mesh-ancestor
24996485|NCT03437005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25706803|NCT02221219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25706804|NCT02221219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25706805|NCT02221219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706806|NCT02221284|Alogliptin|alogliptin|mesh-list
25706807|NCT02221284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25706808|NCT02221284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706809|NCT02221284|Incretins|incretins|mesh-ancestor
25706810|NCT02221284|Hormones|hormones|mesh-ancestor
24996486|NCT03437005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996487|NCT03437005|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24996488|NCT03437005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24996489|NCT03422666|Teduglutide|teduglutide|mesh-list
24996499|NCT03387852|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24996500|NCT03387852|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24996501|NCT03387852|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24996502|NCT03387852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24996503|NCT03387852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24996504|NCT03387852|Autonomic Agents|autonomic agents|mesh-ancestor
24996519|NCT03387852|Hormones|hormones|mesh-ancestor
24996520|NCT03387852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24996521|NCT03387852|Sympathomimetics|sympathomimetics|mesh-ancestor
24996522|NCT03382574|Denosumab|denosumab|mesh-list
24996523|NCT03382574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24996524|NCT03382574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996525|NCT03377361|Nivolumab|nivolumab|mesh-list
24996526|NCT03377361|Ipilimumab|ipilimumab|mesh-list
24996527|NCT03377361|Trametinib|trametinib|mesh-list
24996528|NCT03377361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24996529|NCT03377361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996530|NCT03377361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24996531|NCT03377361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996532|NCT03377361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24996533|NCT03377361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996534|NCT03367689|Olaparib|olaparib|mesh-list
24996535|NCT03367689|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24996536|NCT03367689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996537|NCT03367689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996538|NCT03367689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996572|NCT03265145|Muscarinic Antagonists|muscarinic antagonists|mesh-list
24996573|NCT03265145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24996574|NCT03265145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996575|NCT03265145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996576|NCT03265145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24996577|NCT03219164|Aztreonam|aztreonam|mesh-list
24996578|NCT03219164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24996579|NCT03219164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24786180|NCT01918358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24786181|NCT01918358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24786182|NCT01918384|Arbekacin|arbekacin|mesh-list
24996599|NCT03159702|Fludarabine|fludarabine|mesh-list
24996600|NCT03159702|Melphalan|melphalan|mesh-list
24996601|NCT03159702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996642|NCT03091491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996644|NCT03033095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24996646|NCT03033095|Analgesics|analgesics|mesh-ancestor
24996647|NCT03033095|Sensory System Agents|sensory system agents|mesh-ancestor
24996648|NCT03033095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24996649|NCT03033095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996650|NCT03033095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24996670|NCT02921789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24996671|NCT02921789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996672|NCT02921789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24996673|NCT02921789|Immunologic Factors|immunologic factors|mesh-ancestor
24996674|NCT02921789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24996675|NCT02921789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996676|NCT02921789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996677|NCT02921789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24996678|NCT02921789|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24996679|NCT02921789|Antitubercular Agents|antitubercular agents|mesh-ancestor
24996680|NCT02921789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24996681|NCT02921789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24996682|NCT02898077|Paclitaxel|paclitaxel|mesh-list
24996683|NCT02898077|Ramucirumab|ramucirumab|mesh-list
24996684|NCT02898077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24996685|NCT02898077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996686|NCT02898077|Tubulin Modulators|tubulin modulators|mesh-ancestor
24996687|NCT02898077|Antimitotic Agents|antimitotic agents|mesh-ancestor
24996688|NCT02898077|Mitosis Modulators|mitosis modulators|mesh-ancestor
24996689|NCT02898077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612027|NCT01011699|Niacinamide|niacinamide|mesh-list
24996699|NCT02718066|Nivolumab|nivolumab|mesh-list
24996700|NCT02718066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24996701|NCT02718066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996702|NCT02718066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24798167|NCT01961193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798168|NCT01961219|Anesthetics|anesthetics|mesh-list
24798173|NCT01961336|Hormones|hormones|mesh-ancestor
24798174|NCT01961336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24798175|NCT01961336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798176|NCT01961388|Metformin|metformin|mesh-list
24798177|NCT01961388|Acarbose|acarbose|mesh-list
24798178|NCT01961388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24798179|NCT01961388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798180|NCT01961388|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24798181|NCT01961388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24798182|NCT01961388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996708|NCT02666599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996710|NCT02666547|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24996711|NCT02666547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996712|NCT02653963|Triamcinolone|triamcinolone|mesh-list
24996713|NCT02653963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24996715|NCT02653963|Hormones|hormones|mesh-ancestor
24996733|NCT02470585|Carboplatin|carboplatin|mesh-list
24996734|NCT02470585|Veliparib|veliparib|mesh-list
24996735|NCT02470585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24996736|NCT02470585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996737|NCT02470585|Tubulin Modulators|tubulin modulators|mesh-ancestor
24996738|NCT02470585|Antimitotic Agents|antimitotic agents|mesh-ancestor
24996739|NCT02470585|Mitosis Modulators|mitosis modulators|mesh-ancestor
24996740|NCT02470585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996741|NCT02470585|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24996742|NCT02470585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996744|NCT02163694|Carboplatin|carboplatin|mesh-list
24996745|NCT02163694|Veliparib|veliparib|mesh-list
24996746|NCT02163694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24996747|NCT02163694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996748|NCT02163694|Tubulin Modulators|tubulin modulators|mesh-ancestor
24996749|NCT02163694|Antimitotic Agents|antimitotic agents|mesh-ancestor
24996750|NCT02163694|Mitosis Modulators|mitosis modulators|mesh-ancestor
24996751|NCT02163694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996752|NCT02163694|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24996753|NCT02163694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996754|NCT02133404|Cinacalcet|cinacalcet|mesh-list
24996790|NCT01966471|Alkylating Agents|alkylating agents|mesh-ancestor
24996791|NCT01966471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24996792|NCT01966471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24996793|NCT01966471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24996794|NCT01966471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24996795|NCT01966471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996796|NCT01966471|Antimetabolites|antimetabolites|mesh-ancestor
24996797|NCT01966471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24996798|NCT01966471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24996799|NCT01926197|Leucovorin|leucovorin|mesh-list
24996800|NCT01926197|Oxaliplatin|oxaliplatin|mesh-list
24845211|NCT02237027|Antiviral Agents|antiviral agents|mesh-ancestor
24996801|NCT01926197|Irinotecan|irinotecan|mesh-list
24996802|NCT01926197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996803|NCT01926197|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25709719|NCT02273180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709720|NCT02273726|Epoetin Alfa|epoetin alfa|mesh-list
25709721|NCT02273726|Hematinics|hematinics|mesh-ancestor
25709722|NCT02273973|Letrozole|letrozole|mesh-list
24996809|NCT01926197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996810|NCT01926197|Vitamin B Complex|vitamin b complex|mesh-ancestor
24996811|NCT01926197|Vitamins|vitamins|mesh-ancestor
24996812|NCT01926197|Micronutrients|micronutrients|mesh-ancestor
24996813|NCT01672762|Ipragliflozin|ipragliflozin|mesh-list
24996814|NCT01672762|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24996815|NCT01672762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996816|NCT01672762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24996838|NCT01465334|Ofatumumab|ofatumumab|mesh-list
24996839|NCT01465334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24996840|NCT01465334|Prednisolone phosphate|prednisolone phosphate|mesh-list
24996846|NCT01465334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24996848|NCT01465334|Hormones|hormones|mesh-ancestor
24996849|NCT01465334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24996850|NCT01465334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24996851|NCT01465334|Protective Agents|protective agents|mesh-ancestor
24996852|NCT01465334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24996853|NCT01465334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996854|NCT01465334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24996855|NCT01307423|Thalidomide|thalidomide|mesh-list
24996856|NCT01307423|Apremilast|apremilast|mesh-list
24996857|NCT01307423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24996858|NCT01307423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24996859|NCT01307423|Analgesics|analgesics|mesh-ancestor
24996860|NCT01307423|Sensory System Agents|sensory system agents|mesh-ancestor
24996861|NCT01307423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24798191|NCT01961453|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24798192|NCT01961453|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
24798193|NCT01961453|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24798194|NCT01961453|Diuretics|diuretics|mesh-ancestor
24798195|NCT01961453|Natriuretic Agents|natriuretic agents|mesh-ancestor
24798196|NCT01961453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798197|NCT01961453|Vasodilator Agents|vasodilator agents|mesh-ancestor
24798199|NCT01961453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798200|NCT01961635|Cimetidine|cimetidine|mesh-list
24798201|NCT01961635|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24798202|NCT01961635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24798203|NCT01961635|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24798204|NCT01961635|Histamine Antagonists|histamine antagonists|mesh-ancestor
24798205|NCT01961635|Histamine Agents|histamine agents|mesh-ancestor
24798206|NCT01961635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24798207|NCT01961635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24798208|NCT01961635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24798209|NCT01961635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24798210|NCT01961635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24798211|NCT01961635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996890|NCT00911183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24996891|NCT00911183|Immunologic Factors|immunologic factors|mesh-ancestor
24996892|NCT00911183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693092|NCT01418183|Anesthetics, Local|anesthetics, local|mesh-ancestor
24693138|NCT01418443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693139|NCT01418443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693140|NCT01418456|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24996893|NCT00911183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24996894|NCT00911183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24996895|NCT00911183|Alkylating Agents|alkylating agents|mesh-ancestor
24996896|NCT00911183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996897|NCT00911183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996898|NCT00911183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24996899|NCT00911183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24996900|NCT00911183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24996901|NCT00911183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24996902|NCT00911183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24996903|NCT00911183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996904|NCT00911183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24996905|NCT00911183|Glucocorticoids|glucocorticoids|mesh-ancestor
24996906|NCT00911183|Hormones|hormones|mesh-ancestor
24996907|NCT00911183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24996908|NCT00911183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24996909|NCT00911183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24996910|NCT00911183|Tubulin Modulators|tubulin modulators|mesh-ancestor
24996911|NCT00911183|Antimitotic Agents|antimitotic agents|mesh-ancestor
24996912|NCT00911183|Mitosis Modulators|mitosis modulators|mesh-ancestor
24996913|NCT00655876|Paclitaxel|paclitaxel|mesh-list
24996914|NCT00655876|Cetuximab|cetuximab|mesh-list
24996915|NCT00655876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24996916|NCT00655876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996917|NCT00655876|Tubulin Modulators|tubulin modulators|mesh-ancestor
24996922|NCT00602576|Temozolomide|temozolomide|mesh-list
24996924|NCT00602576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24996925|NCT00602576|Alkylating Agents|alkylating agents|mesh-ancestor
24996926|NCT00602576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996927|NCT00602576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996928|NCT00602576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24996929|NCT00602576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24996931|NCT00265941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996932|NCT00265941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24996933|NCT00114140|Temozolomide|temozolomide|mesh-list
24996934|NCT00114140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24996935|NCT00114140|Alkylating Agents|alkylating agents|mesh-ancestor
24996936|NCT00114140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996937|NCT00114140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996938|NCT00047008|Cisplatin|cisplatin|mesh-list
24996939|NCT00047008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996940|NCT05420948|Paclitaxel|paclitaxel|mesh-list
24996941|NCT05420948|Carboplatin|carboplatin|mesh-list
24996942|NCT05420948|Pembrolizumab|pembrolizumab|mesh-list
24996949|NCT05420948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24996950|NCT05420935|Immunoglobulin G|immunoglobulin g|mesh-list
24996951|NCT05420935|Immunoglobulin E|immunoglobulin e|mesh-list
24996952|NCT05420935|Immunologic Factors|immunologic factors|mesh-ancestor
25706811|NCT02221284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25706812|NCT02221284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25706813|NCT02221284|Protease Inhibitors|protease inhibitors|mesh-ancestor
25706814|NCT02221284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709723|NCT02273973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24693980|NCT01423240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693987|NCT01423292|Bupivacaine|bupivacaine|mesh-list
24612334|NCT01013506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612335|NCT01013506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24996953|NCT05420935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24996955|NCT05420922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24996956|NCT05420922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996957|NCT05420922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24934855|NCT04057261|Liraglutide|liraglutide|mesh-list
24996967|NCT05420441|Chitosan|chitosan|mesh-list
24996968|NCT05420441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24996969|NCT05420441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24996970|NCT05420441|Antimetabolites|antimetabolites|mesh-ancestor
24996971|NCT05420441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996972|NCT05420441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24996973|NCT05420441|Chelating Agents|chelating agents|mesh-ancestor
24996974|NCT05420441|Sequestering Agents|sequestering agents|mesh-ancestor
24996975|NCT05420441|Hemostatics|hemostatics|mesh-ancestor
24996976|NCT05420441|Coagulants|coagulants|mesh-ancestor
24996985|NCT05420324|Paclitaxel|paclitaxel|mesh-list
24996986|NCT05420324|Pembrolizumab|pembrolizumab|mesh-list
24996987|NCT05420324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24996988|NCT05420324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996989|NCT05420324|Tubulin Modulators|tubulin modulators|mesh-ancestor
24996990|NCT05420324|Antimitotic Agents|antimitotic agents|mesh-ancestor
24996991|NCT05420324|Mitosis Modulators|mitosis modulators|mesh-ancestor
24996992|NCT05420324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996993|NCT05420324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24996995|NCT05420285|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24996996|NCT05420285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996997|NCT05420285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24996998|NCT05420285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997011|NCT05419921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24997012|NCT05419921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997017|NCT05419674|Clarithromycin|clarithromycin|mesh-list
24997018|NCT05419674|Rabeprazole|rabeprazole|mesh-list
24997019|NCT05419674|Bismuth|bismuth|mesh-list
24997020|NCT05419674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24997021|NCT05419674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24997022|NCT05419674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24997023|NCT05419674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24997033|NCT05419466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997034|NCT05419466|Protective Agents|protective agents|mesh-ancestor
24997035|NCT05419466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871076|NCT05162937|Antibodies|antibodies|mesh-list
25706815|NCT02221284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706816|NCT02221349|Listerine|listerine|mesh-list
25706817|NCT02221349|Fluorides|fluorides|mesh-list
25706818|NCT02221349|Sodium Fluoride|sodium fluoride|mesh-list
25706819|NCT02221349|Tin Fluorides|tin fluorides|mesh-list
25706820|NCT02221349|Cariostatic Agents|cariostatic agents|mesh-ancestor
25706821|NCT02221349|Protective Agents|protective agents|mesh-ancestor
25706822|NCT02221349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706823|NCT02221349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25706825|NCT02221648|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25706826|NCT02221648|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25706827|NCT02221648|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25706828|NCT02221648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25706829|NCT02221648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695109|NCT04510051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24695110|NCT04510051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24695111|NCT04425902|Flurbiprofen|flurbiprofen|mesh-list
24997041|NCT05419297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24997042|NCT05419297|Narcotics|narcotics|mesh-ancestor
24997043|NCT05419297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24997044|NCT05419297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997045|NCT05419297|Analgesics|analgesics|mesh-ancestor
24997046|NCT05419297|Sensory System Agents|sensory system agents|mesh-ancestor
24997047|NCT05419297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24997048|NCT05419297|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24997049|NCT05419193|Ceftriaxone|ceftriaxone|mesh-list
24997050|NCT05419193|Propranolol|propranolol|mesh-list
24997051|NCT05419193|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24997052|NCT05419193|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24997053|NCT05419193|Adrenergic Agents|adrenergic agents|mesh-ancestor
24997054|NCT05419193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24997055|NCT05419193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871102|NCT05141422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24871105|NCT05137678|Glyburide|glyburide|mesh-list
24997058|NCT05419193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24997060|NCT05419193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24997061|NCT05419193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24997064|NCT05419115|Furosemide|furosemide|mesh-list
24997065|NCT05419115|Diuretics|diuretics|mesh-ancestor
24997066|NCT05419115|Natriuretic Agents|natriuretic agents|mesh-ancestor
24997067|NCT05419115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997068|NCT05419115|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24997069|NCT05419115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24997070|NCT05419115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997073|NCT05417841|Insulin|insulin|mesh-list
24997074|NCT05417841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24997075|NCT05417841|Insulin Aspart|insulin aspart|mesh-list
24997076|NCT05417841|Insulin, Long-Acting|insulin, long-acting|mesh-list
24997077|NCT05417841|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24997078|NCT05417841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24997079|NCT05417841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997080|NCT05416840|Amlodipine|amlodipine|mesh-list
24997081|NCT05416840|Clonidine|clonidine|mesh-list
24997082|NCT05416840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24997083|NCT05416840|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24997107|NCT05411991|Diuretics|diuretics|mesh-list
24997111|NCT05411991|Anticonvulsants|anticonvulsants|mesh-ancestor
24997112|NCT05411991|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24997113|NCT05411991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24997114|NCT05411991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706830|NCT02221648|Cholinergic Agents|cholinergic agents|mesh-ancestor
25706831|NCT02221648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25706832|NCT02221648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706833|NCT02221648|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24997115|NCT05411991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24997152|NCT05351151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24997153|NCT05351151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24997154|NCT05351151|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24997155|NCT05351151|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24561022|NCT00662792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24997156|NCT05351151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24997157|NCT05351151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24997160|NCT05344495|Anesthetics, Local|anesthetics, local|mesh-ancestor
24997161|NCT05344495|Anesthetics|anesthetics|mesh-ancestor
24997162|NCT05344495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24997163|NCT05344495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997164|NCT05344495|Sensory System Agents|sensory system agents|mesh-ancestor
24997165|NCT05344495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24997166|NCT05344495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24997167|NCT05344495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24997168|NCT05344495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24997169|NCT05344495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24997226|NCT05279898|Dexmedetomidine|dexmedetomidine|mesh-list
24997227|NCT05279898|Ketamine|ketamine|mesh-list
24997228|NCT05279898|Remifentanil|remifentanil|mesh-list
24997229|NCT05279898|Propofol|propofol|mesh-list
24997230|NCT05279898|Ropivacaine|ropivacaine|mesh-list
24997231|NCT05279898|Rocuronium|rocuronium|mesh-list
24997232|NCT05279898|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24997233|NCT05279898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24997234|NCT05279898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24997235|NCT05279898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24997236|NCT05279898|Anesthetics, General|anesthetics, general|mesh-ancestor
24997255|NCT05279898|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24997256|NCT05279898|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24854937|NCT02276378|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24854938|NCT02276378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24854939|NCT02276378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854940|NCT02276378|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24854941|NCT02276378|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24854942|NCT02276391|Telmisartan|telmisartan|mesh-list
24854943|NCT02276391|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24854944|NCT02276391|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24854945|NCT02276391|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24854946|NCT02276391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854947|NCT02276495|Ketorolac|ketorolac|mesh-list
24854948|NCT02276495|Clonidine|clonidine|mesh-list
24854949|NCT02276495|Epinephrine|epinephrine|mesh-list
24812837|NCT02054936|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24812838|NCT02054936|Antithrombins|antithrombins|mesh-ancestor
24812839|NCT02054936|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24812840|NCT02054936|Protease Inhibitors|protease inhibitors|mesh-ancestor
24812841|NCT02054936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812842|NCT02054936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786185|NCT01918475|Oxytocics|oxytocics|mesh-ancestor
24786186|NCT01918475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24458511|NCT00338247|Lapatinib|lapatinib|mesh-list
24856093|NCT02282774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24856094|NCT02282774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24856095|NCT02282774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24856096|NCT02282774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856098|NCT02282787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24856140|NCT02282956|Narcotics|narcotics|mesh-ancestor
24856141|NCT02282956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24856142|NCT02282956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856143|NCT02282956|Analgesics|analgesics|mesh-ancestor
24856144|NCT02282956|Sensory System Agents|sensory system agents|mesh-ancestor
24856145|NCT02282956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25706834|NCT02221648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25706835|NCT02221674|Tapentadol|tapentadol|mesh-list
25706836|NCT02221674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25706837|NCT02221674|Narcotics|narcotics|mesh-ancestor
25706838|NCT02221674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25706839|NCT02221674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695565|NCT02926833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24856146|NCT02282956|Anesthetics, Local|anesthetics, local|mesh-ancestor
25706841|NCT02221674|Sensory System Agents|sensory system agents|mesh-ancestor
25706842|NCT02221674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25706843|NCT02221674|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25706844|NCT02221674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25706845|NCT02221674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24856147|NCT02282956|Anesthetics|anesthetics|mesh-ancestor
24856148|NCT02282956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24856149|NCT02282956|Antiemetics|antiemetics|mesh-ancestor
24458576|NCT00338390|Lamivudine|lamivudine|mesh-list
24856294|NCT02283515|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24856295|NCT02283515|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24856296|NCT02283515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24856297|NCT02283515|Antimetabolites|antimetabolites|mesh-ancestor
24856298|NCT02283515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856299|NCT02283515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24856300|NCT02283515|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24856301|NCT02283515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856302|NCT02283554|Metformin|metformin|mesh-list
24856423|NCT02284230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856424|NCT02284230|Incretins|incretins|mesh-ancestor
24856425|NCT02284230|Hormones|hormones|mesh-ancestor
24856426|NCT02284230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24856427|NCT02284269|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
24856428|NCT02284269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458874|NCT00342862|Alefacept|alefacept|mesh-list
24812929|NCT02055300|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24857147|NCT02289482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24857148|NCT02289482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24857149|NCT02289495|Ritonavir|ritonavir|mesh-list
24857150|NCT02289495|GSK-2838232|gsk-2838232|mesh-list
24857151|NCT02289495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24857152|NCT02289495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24857153|NCT02289495|Protease Inhibitors|protease inhibitors|mesh-ancestor
24857154|NCT02289495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857177|NCT02289586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24857178|NCT02289586|Anesthetics, General|anesthetics, general|mesh-ancestor
24857179|NCT02289586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24857181|NCT02289586|Analgesics|analgesics|mesh-ancestor
24857182|NCT02289586|Sensory System Agents|sensory system agents|mesh-ancestor
24857183|NCT02289586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857184|NCT02289586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24857185|NCT02289586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24857186|NCT02289586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24857187|NCT02289586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24857188|NCT02289586|GABA Modulators|gaba modulators|mesh-ancestor
24857189|NCT02289586|GABA Agents|gaba agents|mesh-ancestor
24857190|NCT02289586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24871402|NCT03050814|Bevacizumab|bevacizumab|mesh-list
24858166|NCT02295709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24858167|NCT02295709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858169|NCT02295709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24858170|NCT02295709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858172|NCT02295722|Melphalan|melphalan|mesh-list
24858173|NCT02295722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24858174|NCT02295722|Antimetabolites|antimetabolites|mesh-ancestor
24858175|NCT02295722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858176|NCT02295722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24858177|NCT02295722|Antiviral Agents|antiviral agents|mesh-ancestor
24858178|NCT02295722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24858179|NCT02295722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709724|NCT02273973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24858196|NCT02295787|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24858197|NCT02295787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24695805|NCT01231906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24695806|NCT01231906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24695807|NCT01231906|Tubulin Modulators|tubulin modulators|mesh-ancestor
24695808|NCT01231906|Antimitotic Agents|antimitotic agents|mesh-ancestor
24695809|NCT01231906|Mitosis Modulators|mitosis modulators|mesh-ancestor
24695810|NCT01231906|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24695811|NCT01231906|Keratolytic Agents|keratolytic agents|mesh-ancestor
24858238|NCT02296021|Amoxicillin|amoxicillin|mesh-list
24858239|NCT02296021|Clarithromycin|clarithromycin|mesh-list
24858240|NCT02296021|Esomeprazole|esomeprazole|mesh-list
24679816|NCT01370915|Vitamins|vitamins|mesh-list
24858241|NCT02296021|Bismuth|bismuth|mesh-list
24858242|NCT02296021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24858243|NCT02296021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24858245|NCT02296021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24858246|NCT02296021|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24858247|NCT02296021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24858248|NCT02296021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858249|NCT02296021|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24858250|NCT02296021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24858251|NCT02296021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24858252|NCT02296021|Antacids|antacids|mesh-ancestor
24858253|NCT02296047|Bromides|bromides|mesh-list
24858254|NCT02296047|Albuterol|albuterol|mesh-list
24858266|NCT02296047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24871483|NCT02375555|Antiemetics|antiemetics|mesh-ancestor
24858267|NCT02296047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24858268|NCT02296047|Adrenergic Agents|adrenergic agents|mesh-ancestor
24858269|NCT02296047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24858270|NCT02296047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858271|NCT02296047|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24858272|NCT02296047|Cholinergic Agents|cholinergic agents|mesh-ancestor
24858273|NCT02296073|Fentanyl|fentanyl|mesh-list
24858274|NCT02296073|Midazolam|midazolam|mesh-list
24858275|NCT02296073|Dexmedetomidine|dexmedetomidine|mesh-list
24858276|NCT02296073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24858277|NCT02296073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24858278|NCT02296073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858279|NCT02296073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24858280|NCT02296073|Analgesics|analgesics|mesh-ancestor
24858296|NCT02296073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24858297|NCT02296073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24858298|NCT02296073|GABA Modulators|gaba modulators|mesh-ancestor
24858299|NCT02296073|GABA Agents|gaba agents|mesh-ancestor
24858301|NCT02296203|Cetuximab|cetuximab|mesh-list
24460667|NCT00349206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24461032|NCT00350662|Deferiprone|deferiprone|mesh-list
24858855|NCT02299908|Anesthetics, Local|anesthetics, local|mesh-list
24871514|NCT01322971|Metronidazole|metronidazole|mesh-list
25108211|NCT03133897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24858857|NCT02299908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24858858|NCT02299908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24858859|NCT02299908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706846|NCT02221674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706847|NCT02221674|Adrenergic Agents|adrenergic agents|mesh-ancestor
25706848|NCT02221674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25706849|NCT02221739|Ipilimumab|ipilimumab|mesh-list
25706850|NCT02221739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25706851|NCT02221739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25706852|NCT02221739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24858860|NCT02299908|Sensory System Agents|sensory system agents|mesh-ancestor
24858861|NCT02299908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858862|NCT02300038|Lidocaine|lidocaine|mesh-list
24858863|NCT02300038|Anesthetics, Local|anesthetics, local|mesh-ancestor
24858864|NCT02300038|Anesthetics|anesthetics|mesh-ancestor
24858865|NCT02300038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25706853|NCT02221739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695985|NCT01426880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695986|NCT01426880|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24858866|NCT02300038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858867|NCT02300038|Sensory System Agents|sensory system agents|mesh-ancestor
24858878|NCT02300194|Morphine|morphine|mesh-list
24858900|NCT02300363|Antimetabolites|antimetabolites|mesh-ancestor
24858901|NCT02300363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858902|NCT02300363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24858903|NCT02300363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24813205|NCT02056899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813206|NCT02056899|Anticonvulsants|anticonvulsants|mesh-ancestor
24813207|NCT02056899|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24813208|NCT02056899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24813209|NCT02056899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24813210|NCT02056899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24800743|NCT01978301|Hormones|hormones|mesh-ancestor
24858949|NCT02300649|Dexmedetomidine|dexmedetomidine|mesh-list
24858950|NCT02300649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24858951|NCT02300649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24858952|NCT02300649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858953|NCT02300649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24858954|NCT02300649|Analgesics|analgesics|mesh-ancestor
24858955|NCT02300649|Sensory System Agents|sensory system agents|mesh-ancestor
24858956|NCT02300649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858957|NCT02300649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24594667|NCT00934973|Alverine|alverine|mesh-list
24594668|NCT00934973|Anticonvulsants|anticonvulsants|mesh-ancestor
24594669|NCT00934973|Parasympatholytics|parasympatholytics|mesh-ancestor
24594670|NCT00934973|Autonomic Agents|autonomic agents|mesh-ancestor
24594671|NCT00934973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24594672|NCT00934973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594683|NCT00935116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24594684|NCT00935116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800572|NCT01976520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800648|NCT01977300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800649|NCT01977300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800650|NCT01977300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24800651|NCT01977300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24800652|NCT01977300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24800653|NCT01977300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24800654|NCT01977300|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24800655|NCT01977300|Dopamine Agents|dopamine agents|mesh-ancestor
24800656|NCT01977300|Antiemetics|antiemetics|mesh-ancestor
24800657|NCT01977300|Autonomic Agents|autonomic agents|mesh-ancestor
24800658|NCT01977300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24800659|NCT01977300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24800660|NCT01977300|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24800661|NCT01977300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24800662|NCT01977300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24800663|NCT01977300|Antidepressive Agents|antidepressive agents|mesh-ancestor
24800664|NCT01977300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800665|NCT01977300|Antimanic Agents|antimanic agents|mesh-ancestor
24800666|NCT01977300|Anticonvulsants|anticonvulsants|mesh-ancestor
25108212|NCT03133897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25108213|NCT03133923|Vaccines|vaccines|mesh-list
25108214|NCT03133923|Immunologic Factors|immunologic factors|mesh-ancestor
25108215|NCT03133923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800667|NCT01977300|GABA Agents|gaba agents|mesh-ancestor
24800668|NCT01977339|Bupivacaine|bupivacaine|mesh-list
24800669|NCT01977339|Anesthetics, Local|anesthetics, local|mesh-ancestor
24800671|NCT01977339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24800714|NCT01978015|Bimatoprost|bimatoprost|mesh-list
24800717|NCT01978015|Latanoprost|latanoprost|mesh-list
24800718|NCT01978015|Maleic acid|maleic acid|mesh-list
24800719|NCT01978015|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24800720|NCT01978015|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24800721|NCT01978015|Adrenergic Agents|adrenergic agents|mesh-ancestor
24800722|NCT01978015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24800723|NCT01978015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706854|NCT02221947|Bryostatin 1|bryostatin 1|mesh-list
25706855|NCT02221947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25706856|NCT02221947|Immunologic Factors|immunologic factors|mesh-ancestor
24800724|NCT01978015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800725|NCT01978015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24800726|NCT01978015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24800727|NCT01978015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800728|NCT01978015|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24800729|NCT01978015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24800730|NCT01978015|Anticoagulants|anticoagulants|mesh-ancestor
24800731|NCT01978015|Plasma Substitutes|plasma substitutes|mesh-ancestor
24800732|NCT01978015|Blood Substitutes|blood substitutes|mesh-ancestor
24800733|NCT01978041|Fluorides|fluorides|mesh-list
24800734|NCT01978041|Cariostatic Agents|cariostatic agents|mesh-ancestor
24800735|NCT01978041|Protective Agents|protective agents|mesh-ancestor
24800943|NCT01979679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24800944|NCT01979679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800946|NCT01979679|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24800947|NCT01979679|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24800948|NCT01979679|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24800949|NCT01979679|Adrenergic Agents|adrenergic agents|mesh-ancestor
24800950|NCT01979679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24800951|NCT01979679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802791|NCT01992341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24802793|NCT01992341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802794|NCT01992341|Growth Inhibitors|growth inhibitors|mesh-ancestor
24802795|NCT01992562|Ziconotide|ziconotide|mesh-list
24802796|NCT01992562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24802797|NCT01992562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24802798|NCT01992562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622604|NCT01067677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622605|NCT01067677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24622606|NCT01067677|Antipruritics|antipruritics|mesh-ancestor
24622607|NCT01067677|Dermatologic Agents|dermatologic agents|mesh-ancestor
24622608|NCT01067677|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24622609|NCT01067677|Serotonin Agents|serotonin agents|mesh-ancestor
24622610|NCT01067677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24622611|NCT01067677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622612|NCT01067677|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24622613|NCT01067677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24622614|NCT01067677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24622615|NCT01067677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24846240|NCT02242240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24622616|NCT01067677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24622617|NCT01067677|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24622618|NCT01067677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24622619|NCT01067677|Anesthetics, Local|anesthetics, local|mesh-ancestor
24622620|NCT01067677|Anesthetics|anesthetics|mesh-ancestor
24622621|NCT01067677|Sensory System Agents|sensory system agents|mesh-ancestor
24622622|NCT01067677|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24803158|NCT01994941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803159|NCT01994967|Bupivacaine|bupivacaine|mesh-list
24803160|NCT01994967|Levobupivacaine|levobupivacaine|mesh-list
24803161|NCT01994967|Anesthetics, Local|anesthetics, local|mesh-ancestor
24803162|NCT01994967|Anesthetics|anesthetics|mesh-ancestor
24803163|NCT01994967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24803190|NCT01995019|Prednisolone acetate|prednisolone acetate|mesh-list
24803191|NCT01995019|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24803198|NCT01995019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24803199|NCT01995019|Glucocorticoids|glucocorticoids|mesh-ancestor
24803200|NCT01995019|Hormones|hormones|mesh-ancestor
24803201|NCT01995019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24803205|NCT01995019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24803207|NCT01995032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24803208|NCT01995032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803210|NCT01995058|Abiraterone Acetate|abiraterone acetate|mesh-list
25706857|NCT02221947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706858|NCT02221947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25706859|NCT02222129|Bupivacaine|bupivacaine|mesh-list
24803211|NCT01995058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24803259|NCT01995331|Alkylating Agents|alkylating agents|mesh-ancestor
24803260|NCT01995331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803261|NCT01995331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24803263|NCT01995331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24803264|NCT01995331|Antifungal Agents|antifungal agents|mesh-ancestor
24803265|NCT01995331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24803266|NCT01995331|Dermatologic Agents|dermatologic agents|mesh-ancestor
24803267|NCT01995331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24803268|NCT01995344|Cyclophosphamide|cyclophosphamide|mesh-list
24803269|NCT01995344|Fludarabine|fludarabine|mesh-list
24574485|NCT00825591|Melatonin|melatonin|mesh-list
24803517|NCT01996683|Chelating Agents|chelating agents|mesh-ancestor
25108216|NCT03134001|Analgesics|analgesics|mesh-list
24803518|NCT01996683|Sequestering Agents|sequestering agents|mesh-ancestor
24803520|NCT01996683|Siderophores|siderophores|mesh-ancestor
24803521|NCT01996696|Metformin|metformin|mesh-list
24803522|NCT01996696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24803523|NCT01996696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803524|NCT01996735|Ticagrelor|ticagrelor|mesh-list
24803525|NCT01996735|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24803526|NCT01996735|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24803595|NCT01997255|Everolimus|everolimus|mesh-list
24803596|NCT01997255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24803597|NCT01997255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24803636|NCT01997658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24803637|NCT01997658|Antiemetics|antiemetics|mesh-ancestor
24803638|NCT01997658|Autonomic Agents|autonomic agents|mesh-ancestor
24803639|NCT01997658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803640|NCT01997658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803641|NCT01997658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24803642|NCT01997658|Glucocorticoids|glucocorticoids|mesh-ancestor
24598092|NCT00953641|Oxytocics|oxytocics|mesh-ancestor
24803644|NCT01997658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24598163|NCT00954252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24598164|NCT00954252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24598165|NCT00954252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598166|NCT00954252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598167|NCT00954265|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24662065|NCT01292213|Dimercaprol|dimercaprol|mesh-list
24598168|NCT00954265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24622628|NCT01067677|Dopamine Agents|dopamine agents|mesh-ancestor
24622629|NCT01067690|Indinavir|indinavir|mesh-list
24622630|NCT01067690|Bleomycin|bleomycin|mesh-list
24622631|NCT01067690|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24622632|NCT01067690|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24574646|NCT00826657|Vitamin B 12|vitamin b 12|mesh-list
24574647|NCT00826657|Hydroxocobalamin|hydroxocobalamin|mesh-list
24622658|NCT01067989|Celecoxib|celecoxib|mesh-list
24622661|NCT01067989|Methotrexate|methotrexate|mesh-list
24622662|NCT01067989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24622663|NCT01067989|Immunologic Factors|immunologic factors|mesh-ancestor
24622664|NCT01067989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622665|NCT01067989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25706860|NCT02222129|Anesthetics, Local|anesthetics, local|mesh-ancestor
24696317|NCT01428531|Protease Inhibitors|protease inhibitors|mesh-ancestor
24696354|NCT01428986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24696355|NCT01428986|Antiviral Agents|antiviral agents|mesh-ancestor
24696356|NCT01428986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24696357|NCT01428986|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24696359|NCT01429025|Lenalidomide|lenalidomide|mesh-list
24696360|NCT01429025|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24696361|NCT01429025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24622666|NCT01067989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24622667|NCT01067989|Alkylating Agents|alkylating agents|mesh-ancestor
24622668|NCT01067989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622669|NCT01067989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622670|NCT01067989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24622671|NCT01067989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24622672|NCT01067989|Antimetabolites|antimetabolites|mesh-ancestor
24803645|NCT01997658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24803646|NCT01997658|Protective Agents|protective agents|mesh-ancestor
24803647|NCT01997658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24803648|NCT01997658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24803650|NCT01997762|Antioxidants|antioxidants|mesh-ancestor
24803651|NCT01997762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803652|NCT01997762|Protective Agents|protective agents|mesh-ancestor
24803653|NCT01997762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803654|NCT01997762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574668|NCT00826826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24803838|NCT01998698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803839|NCT01998698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24871884|NCT03934671|Antioxidants|antioxidants|mesh-list
24786195|NCT01918488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24786196|NCT01918488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786197|NCT01918488|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24786198|NCT01918488|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24786199|NCT01918514|Magnesium Sulfate|magnesium sulfate|mesh-list
24786201|NCT01918514|Sensory System Agents|sensory system agents|mesh-ancestor
24786202|NCT01918514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24786203|NCT01918514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786204|NCT01918514|Anesthetics|anesthetics|mesh-ancestor
24786207|NCT01918514|Anticonvulsants|anticonvulsants|mesh-ancestor
24598412|NCT00956098|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24598413|NCT00956098|Anthelmintics|anthelmintics|mesh-ancestor
24598414|NCT00956098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24598415|NCT00956098|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24598416|NCT00956098|Protective Agents|protective agents|mesh-ancestor
24622687|NCT01067989|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24803867|NCT01999153|Ropivacaine|ropivacaine|mesh-list
24803874|NCT01999270|Bevacizumab|bevacizumab|mesh-list
24803875|NCT01999270|Irinotecan|irinotecan|mesh-list
24803876|NCT01999270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25706861|NCT02222129|Anesthetics|anesthetics|mesh-ancestor
25706862|NCT02222129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25706863|NCT02222129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706864|NCT02222129|Sensory System Agents|sensory system agents|mesh-ancestor
25706865|NCT02222129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25706866|NCT02222207|Ranibizumab|ranibizumab|mesh-list
25706867|NCT02222207|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25706868|NCT02222207|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24803878|NCT01999270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24803879|NCT01999270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24803880|NCT01999270|Growth Substances|growth substances|mesh-ancestor
24803881|NCT01999270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803884|NCT01999270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24803885|NCT01999270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24803886|NCT01999270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803887|NCT01999309|Simvastatin|simvastatin|mesh-list
25108218|NCT03134001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108219|NCT03134001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108220|NCT03133780|Midazolam|midazolam|mesh-list
25108221|NCT03133780|Ketamine|ketamine|mesh-list
25108222|NCT03133780|Analgesics|analgesics|mesh-ancestor
25108223|NCT03133780|Sensory System Agents|sensory system agents|mesh-ancestor
25108224|NCT03133780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25108225|NCT03133780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108226|NCT03133780|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25108227|NCT03133780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25108228|NCT03133780|Anesthetics, General|anesthetics, general|mesh-ancestor
25108229|NCT03133780|Anesthetics|anesthetics|mesh-ancestor
25108232|NCT03133780|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25108233|NCT03133780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25108234|NCT03133780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25108235|NCT03133780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24804138|NCT02001259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804202|NCT02001571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804203|NCT02001571|Hormone Antagonists|hormone antagonists|mesh-ancestor
24804204|NCT02001571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24804205|NCT02001571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804206|NCT02001571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24804208|NCT02001584|Baclofen|baclofen|mesh-list
24804209|NCT02001584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24804210|NCT02001584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24804211|NCT02001584|Dopamine Agents|dopamine agents|mesh-ancestor
24804212|NCT02001584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24804213|NCT02001584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804214|NCT02001584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804215|NCT02001584|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24804216|NCT02001584|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24804217|NCT02001584|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24804218|NCT02001584|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24804219|NCT02001584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24575433|NCT00831597|Rituximab|rituximab|mesh-list
24804252|NCT02001883|Simvastatin|simvastatin|mesh-list
24804253|NCT02001883|Red yeast rice|red yeast rice|mesh-list
24804254|NCT02001883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24804255|NCT02001883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24804256|NCT02001883|Antimetabolites|antimetabolites|mesh-ancestor
24804257|NCT02001883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804258|NCT02001883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24804259|NCT02001883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24804260|NCT02001883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24804261|NCT02001883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24575442|NCT00831597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804325|NCT02002065|Immunologic Factors|immunologic factors|mesh-ancestor
24804326|NCT02002065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804327|NCT02002078|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24804333|NCT02002078|Prednisolone phosphate|prednisolone phosphate|mesh-list
24804334|NCT02002078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24804335|NCT02002078|Antiemetics|antiemetics|mesh-ancestor
24804336|NCT02002078|Autonomic Agents|autonomic agents|mesh-ancestor
24804337|NCT02002078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804338|NCT02002078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804339|NCT02002078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24804340|NCT02002078|Glucocorticoids|glucocorticoids|mesh-ancestor
24804341|NCT02002078|Hormones|hormones|mesh-ancestor
24804342|NCT02002078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24622690|NCT01068054|Tacrolimus|tacrolimus|mesh-list
24622691|NCT01068054|Cyclosporins|cyclosporins|mesh-list
24622692|NCT01068054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24622693|NCT01068054|Immunologic Factors|immunologic factors|mesh-ancestor
24622694|NCT01068054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622695|NCT01068054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24622696|NCT01068054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622700|NCT01068054|Dermatologic Agents|dermatologic agents|mesh-ancestor
24622701|NCT01068054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24622703|NCT01068067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24622704|NCT01068067|Immunologic Factors|immunologic factors|mesh-ancestor
24622705|NCT01068067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622706|NCT01068067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24622707|NCT01068067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622708|NCT01068067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622709|NCT01068093|Ezetimibe|ezetimibe|mesh-list
24622710|NCT01068093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24622711|NCT01068093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24622712|NCT01068093|Antimetabolites|antimetabolites|mesh-ancestor
24804416|NCT02002377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24804417|NCT02002377|Growth Substances|growth substances|mesh-ancestor
24804418|NCT02002377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804419|NCT02002377|Growth Inhibitors|growth inhibitors|mesh-ancestor
24804421|NCT02002390|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24804456|NCT02002598|Alkylating Agents|alkylating agents|mesh-ancestor
24804458|NCT02002611|Anticoagulants|anticoagulants|mesh-ancestor
24804459|NCT02002663|Methylprednisolone|methylprednisolone|mesh-list
24804460|NCT02002663|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24804498|NCT02002715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24599103|NCT05212012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599104|NCT05212012|Analgesics|analgesics|mesh-ancestor
24599105|NCT05212012|Sensory System Agents|sensory system agents|mesh-ancestor
24599106|NCT05212012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24599107|NCT05212012|Antitussive Agents|antitussive agents|mesh-ancestor
24599108|NCT05212012|Respiratory System Agents|respiratory system agents|mesh-ancestor
24599121|NCT05194969|Petrolatum|petrolatum|mesh-list
24804660|NCT02004197|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24804661|NCT02004197|Histamine Antagonists|histamine antagonists|mesh-ancestor
24804662|NCT02004197|Histamine Agents|histamine agents|mesh-ancestor
24804663|NCT02004197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24804664|NCT02004197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804666|NCT02004301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24804668|NCT02004301|Analgesics|analgesics|mesh-ancestor
24804669|NCT02004301|Sensory System Agents|sensory system agents|mesh-ancestor
24599313|NCT04770493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24599314|NCT04770493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24599315|NCT04770493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25706869|NCT02222207|Growth Substances|growth substances|mesh-ancestor
24697550|NCT01435395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24697551|NCT01435395|Growth Substances|growth substances|mesh-ancestor
25706870|NCT02222207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804670|NCT02004301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804671|NCT02004301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804676|NCT02004301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804787|NCT02005289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804788|NCT02005302|Vitamin D|vitamin d|mesh-list
24804789|NCT02005302|Ergocalciferols|ergocalciferols|mesh-list
24804790|NCT02005302|Cholecalciferol|cholecalciferol|mesh-list
24804791|NCT02005302|Vitamins|vitamins|mesh-list
24804792|NCT02005302|Micronutrients|micronutrients|mesh-ancestor
24804793|NCT02005302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804794|NCT02005302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24804795|NCT02005302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24804796|NCT02005315|Gemcitabine|gemcitabine|mesh-list
24804797|NCT02005315|Paclitaxel|paclitaxel|mesh-list
24804959|NCT02006173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24804960|NCT02006173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24804961|NCT02006173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24804962|NCT02006173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24804963|NCT02006173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804964|NCT02006225|Plerixafor|plerixafor|mesh-list
24804965|NCT02006225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24804966|NCT02006225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24804967|NCT02006225|Antiviral Agents|antiviral agents|mesh-ancestor
24804968|NCT02006225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24804969|NCT02006277|Crizotinib|crizotinib|mesh-list
24806406|NCT02015650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601239|NCT00963573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601240|NCT00963664|Interferons|interferons|mesh-list
24601241|NCT00963664|Interferon-alpha|interferon-alpha|mesh-list
24601242|NCT00963664|Interferon alpha-2|interferon alpha-2|mesh-list
24601243|NCT00963664|Lovastatin|lovastatin|mesh-list
24601244|NCT00963664|L 647318|l 647318|mesh-list
24585373|NCT00885300|Heparin|heparin|mesh-list
24806425|NCT02015728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24806426|NCT02015728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24806427|NCT02015728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24806428|NCT02015728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806430|NCT02015728|Immunologic Factors|immunologic factors|mesh-ancestor
24806431|NCT02015728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806432|NCT02015728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24806433|NCT02015728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24806454|NCT02015988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706871|NCT02222207|Growth Inhibitors|growth inhibitors|mesh-ancestor
25706872|NCT02222207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25706873|NCT02222246|Morphine|morphine|mesh-list
25706874|NCT02222246|Hydromorphone|hydromorphone|mesh-list
25706875|NCT02222246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25706876|NCT02222246|Narcotics|narcotics|mesh-ancestor
25706877|NCT02222246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25706878|NCT02222246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706879|NCT02222246|Analgesics|analgesics|mesh-ancestor
24698181|NCT01439399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24698182|NCT01439399|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24698183|NCT01439399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24698184|NCT01439399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24698185|NCT01439399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698188|NCT01439399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24806455|NCT02015988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24806456|NCT02015988|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24806457|NCT02015988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24806459|NCT02016001|Cariostatic Agents|cariostatic agents|mesh-ancestor
24806469|NCT02016157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806471|NCT02016196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24806472|NCT02016196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24806473|NCT02016196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24806475|NCT02016209|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24806476|NCT02016209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24806477|NCT02016209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806478|NCT02016209|Tubulin Modulators|tubulin modulators|mesh-ancestor
24806479|NCT02016209|Antimitotic Agents|antimitotic agents|mesh-ancestor
24806480|NCT02016209|Mitosis Modulators|mitosis modulators|mesh-ancestor
24806481|NCT02016209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806482|NCT02016261|Fluvoxamine|fluvoxamine|mesh-list
24806483|NCT02016261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24806484|NCT02016261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24806485|NCT02016261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24806559|NCT02016443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806560|NCT02016443|Anticonvulsants|anticonvulsants|mesh-ancestor
24806561|NCT02016443|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24806645|NCT02017197|Warfarin|warfarin|mesh-list
24806646|NCT02017197|Anticoagulants|anticoagulants|mesh-ancestor
24806647|NCT02017314|Morphine|morphine|mesh-list
24806648|NCT02017314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24806649|NCT02017314|Narcotics|narcotics|mesh-ancestor
24806650|NCT02017314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24806698|NCT02017613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24806700|NCT02017639|Simvastatin|simvastatin|mesh-list
24806701|NCT02017639|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24806702|NCT02017639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24806703|NCT02017639|Antimetabolites|antimetabolites|mesh-ancestor
24806704|NCT02017639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806705|NCT02017639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24806706|NCT02017639|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24806707|NCT02017639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24806708|NCT02017704|Leucovorin|leucovorin|mesh-list
24806709|NCT02017704|Capecitabine|capecitabine|mesh-list
24806710|NCT02017704|Oxaliplatin|oxaliplatin|mesh-list
24806793|NCT02018159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24806794|NCT02018159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806795|NCT02018250|Benzyl Alcohol|benzyl alcohol|mesh-list
25706880|NCT02222246|Sensory System Agents|sensory system agents|mesh-ancestor
25706881|NCT02222246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25706882|NCT02222493|Infliximab|infliximab|mesh-list
25706883|NCT02222493|Dermatologic Agents|dermatologic agents|mesh-ancestor
25706884|NCT02222493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25706885|NCT02222493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25706886|NCT02222558|Testosterone|testosterone|mesh-list
24806822|NCT02018276|Lidocaine|lidocaine|mesh-list
25706887|NCT02222558|Androgens|androgens|mesh-ancestor
25706888|NCT02222558|Hormones|hormones|mesh-ancestor
24698535|NCT01441700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698536|NCT01441804|Ribavirin|ribavirin|mesh-list
24698537|NCT01441804|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24698578|NCT01441947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806823|NCT02018276|Anesthetics, Local|anesthetics, local|mesh-ancestor
24806824|NCT02018276|Anesthetics|anesthetics|mesh-ancestor
24806825|NCT02018276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24601512|NCT00964561|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24811951|NCT02048969|GABA Agents|gaba agents|mesh-ancestor
24811952|NCT02048969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24811953|NCT02048969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811954|NCT02049034|Lixisenatide|lixisenatide|mesh-list
24811955|NCT02049034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24821656|NCT02107079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24821657|NCT02107118|Complement Factor H|complement factor h|mesh-list
24821658|NCT02107118|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24822253|NCT02110719|Hormones|hormones|mesh-ancestor
24822382|NCT02111421|Dexmedetomidine|dexmedetomidine|mesh-list
24823652|NCT02118311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823654|NCT02118311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24823655|NCT02118376|Exenatide|exenatide|mesh-list
24823656|NCT02118376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24823657|NCT02118376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823658|NCT02118376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24823659|NCT02118376|Incretins|incretins|mesh-ancestor
24823660|NCT02118376|Hormones|hormones|mesh-ancestor
24823689|NCT02118467|Coagulants|coagulants|mesh-ancestor
24823661|NCT02118376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24823662|NCT02118467|Phenylephrine|phenylephrine|mesh-list
24823663|NCT02118467|Vasopressins|vasopressins|mesh-list
24823664|NCT02118467|Arginine Vasopressin|arginine vasopressin|mesh-list
24823665|NCT02118467|Epinephrine|epinephrine|mesh-list
24823666|NCT02118467|Oxymetazoline|oxymetazoline|mesh-list
25706889|NCT02222558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25706890|NCT02222558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706891|NCT02222610|Ranibizumab|ranibizumab|mesh-list
25706892|NCT02222610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25706893|NCT02222610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25706894|NCT02222610|Growth Substances|growth substances|mesh-ancestor
25706895|NCT02222610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823670|NCT02118467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24823671|NCT02118467|Adrenergic Agents|adrenergic agents|mesh-ancestor
24823672|NCT02118467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24823673|NCT02118467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823674|NCT02118467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25108238|NCT03133780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24823675|NCT02118467|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24823676|NCT02118467|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24823677|NCT02118467|Autonomic Agents|autonomic agents|mesh-ancestor
24823678|NCT02118467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24823679|NCT02118467|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24823680|NCT02118467|Respiratory System Agents|respiratory system agents|mesh-ancestor
24823681|NCT02118467|Mydriatics|mydriatics|mesh-ancestor
24823682|NCT02118467|Sympathomimetics|sympathomimetics|mesh-ancestor
24823684|NCT02118467|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24823685|NCT02118467|Nasal Decongestants|nasal decongestants|mesh-ancestor
24823686|NCT02118467|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24823687|NCT02118467|Protective Agents|protective agents|mesh-ancestor
24823688|NCT02118467|Hemostatics|hemostatics|mesh-ancestor
24823690|NCT02118467|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24823691|NCT02118467|Natriuretic Agents|natriuretic agents|mesh-ancestor
24824574|NCT02124148|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24824575|NCT02124148|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24824576|NCT02124148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24824577|NCT02124174|Azacitidine|azacitidine|mesh-list
24824578|NCT02124174|Valproic Acid|valproic acid|mesh-list
24824579|NCT02124174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24824580|NCT02124174|Antimetabolites|antimetabolites|mesh-ancestor
24824581|NCT02124174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824582|NCT02124174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24824583|NCT02124174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824586|NCT02124174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24824587|NCT02124174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824588|NCT02124174|Antimanic Agents|antimanic agents|mesh-ancestor
24824589|NCT02124174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24824590|NCT02124174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24824591|NCT02124174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24824592|NCT02124200|Nicotine|nicotine|mesh-list
24824593|NCT02124200|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24824594|NCT02124200|Autonomic Agents|autonomic agents|mesh-ancestor
24824595|NCT02124200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24824596|NCT02124200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824597|NCT02124200|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24824598|NCT02124200|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24824599|NCT02124200|Cholinergic Agents|cholinergic agents|mesh-ancestor
24824600|NCT02124200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24451290|NCT00323011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826072|NCT02132234|Sensory System Agents|sensory system agents|mesh-ancestor
24706680|NCT01491191|Palmidrol|palmidrol|mesh-list
24826203|NCT02133118|Pioglitazone|pioglitazone|mesh-list
24826204|NCT02133118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24826205|NCT02133118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826310|NCT02133989|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24826311|NCT02133989|Purinergic Agents|purinergic agents|mesh-ancestor
24826312|NCT02133989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24826313|NCT02133989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826314|NCT02133989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826315|NCT02133989|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24826316|NCT02133989|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24707820|NCT01497990|Ertapenem|ertapenem|mesh-list
24786211|NCT01918514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24786212|NCT01918514|Tocolytic Agents|tocolytic agents|mesh-ancestor
24786213|NCT01918514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24451297|NCT00323011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451298|NCT00323011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24451299|NCT00323011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24786216|NCT01918527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24827900|NCT02142192|Immunologic Factors|immunologic factors|mesh-ancestor
24827901|NCT02142192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827902|NCT02142205|Natalizumab|natalizumab|mesh-list
24827903|NCT02142205|Immunologic Factors|immunologic factors|mesh-ancestor
24827904|NCT02142205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827905|NCT02142218|Nivolumab|nivolumab|mesh-list
24827906|NCT02142218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24827907|NCT02142218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827908|NCT02142218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24451307|NCT00323011|Vitamins|vitamins|mesh-ancestor
24451308|NCT00323011|Micronutrients|micronutrients|mesh-ancestor
24451309|NCT00323011|Hematinics|hematinics|mesh-ancestor
24451310|NCT00323011|Anticoagulants|anticoagulants|mesh-ancestor
24451311|NCT00323011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24451325|NCT00323206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24827954|NCT02142556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827955|NCT02142569|Tocotrienols|tocotrienols|mesh-list
24827956|NCT02142569|Vitamin E|vitamin e|mesh-list
24827957|NCT02142569|Tocopherols|tocopherols|mesh-list
24827958|NCT02142569|Red yeast rice|red yeast rice|mesh-list
24827959|NCT02142569|Antioxidants|antioxidants|mesh-ancestor
24827960|NCT02142569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828021|NCT02142790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828022|NCT02142790|Tubulin Modulators|tubulin modulators|mesh-ancestor
24828023|NCT02142790|Antimitotic Agents|antimitotic agents|mesh-ancestor
24828024|NCT02142790|Mitosis Modulators|mitosis modulators|mesh-ancestor
24828080|NCT02143323|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24828081|NCT02143323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24585117|NCT00883506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24828082|NCT02143323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24828083|NCT02143323|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24828084|NCT02143323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828085|NCT02143323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828086|NCT02143362|Remifentanil|remifentanil|mesh-list
24828087|NCT02143362|Anesthetics|anesthetics|mesh-list
24828088|NCT02143362|Propofol|propofol|mesh-list
24828089|NCT02143362|Cisatracurium|cisatracurium|mesh-list
24828090|NCT02143362|Atracurium|atracurium|mesh-list
24872375|NCT05396144|Sensory System Agents|sensory system agents|mesh-ancestor
24828156|NCT02143570|Urological Agents|urological agents|mesh-ancestor
24828158|NCT02143622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24828159|NCT02143622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828161|NCT02143687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24828162|NCT02143687|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24828163|NCT02143687|Anesthetics, General|anesthetics, general|mesh-ancestor
24828164|NCT02143687|Anesthetics|anesthetics|mesh-ancestor
24828165|NCT02143687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24615513|NCT01030081|Tocolytic Agents|tocolytic agents|mesh-ancestor
24828201|NCT02144025|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24828202|NCT02144064|Heparin|heparin|mesh-list
24828204|NCT02144064|Anticoagulants|anticoagulants|mesh-ancestor
24828205|NCT02144064|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24828206|NCT02144064|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24828207|NCT02144064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828369|NCT02145338|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24828370|NCT02145338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25706896|NCT02222610|Growth Inhibitors|growth inhibitors|mesh-ancestor
24828372|NCT02145338|Antimalarials|antimalarials|mesh-ancestor
24828407|NCT02145546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24828780|NCT02147678|Etomidate|etomidate|mesh-list
24828781|NCT02147678|Anesthetics|anesthetics|mesh-ancestor
24828782|NCT02147678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24828783|NCT02147678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828817|NCT02147925|Insulin Glargine|insulin glargine|mesh-list
24828818|NCT02147925|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24828819|NCT02147925|Liraglutide|liraglutide|mesh-list
24828820|NCT02147925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24828821|NCT02147925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828822|NCT02147925|Incretins|incretins|mesh-ancestor
24828823|NCT02147925|Hormones|hormones|mesh-ancestor
24828824|NCT02147925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24828825|NCT02147925|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24828998|NCT02148978|Incretins|incretins|mesh-ancestor
24828999|NCT02148978|Hormones|hormones|mesh-ancestor
24829000|NCT02148978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24829001|NCT02148978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829002|NCT02148978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24829003|NCT02148978|Protease Inhibitors|protease inhibitors|mesh-ancestor
24569003|NCT00798460|Antiviral Agents|antiviral agents|mesh-ancestor
24829004|NCT02148978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829005|NCT02148978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829006|NCT02148978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24829130|NCT02150031|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24451335|NCT00323219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24451336|NCT00323219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24451337|NCT00323219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24451338|NCT00323219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24450202|NCT00317967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25706897|NCT02222610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25706898|NCT02222714|Protein C|protein c|mesh-list
25706899|NCT02222714|Anticoagulants|anticoagulants|mesh-ancestor
25706900|NCT02222714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25706901|NCT02222714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25706902|NCT02222714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706903|NCT02222870|Vaccines|vaccines|mesh-list
25706904|NCT02222870|Immunologic Factors|immunologic factors|mesh-ancestor
25706905|NCT02222870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706906|NCT02222896|Chlorhexidine|chlorhexidine|mesh-list
25706907|NCT02222896|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24450203|NCT00317967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24533980|NCT00645580|Antidepressive Agents|antidepressive agents|mesh-ancestor
24533981|NCT00645580|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24458372|NCT00337649|Trastuzumab|trastuzumab|mesh-list
25706908|NCT02222896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25706909|NCT02222896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24458376|NCT00337649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458382|NCT00337701|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24458383|NCT00337701|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24458384|NCT00337701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635150|NCT01137253|Vasodilator Agents|vasodilator agents|mesh-ancestor
24450287|NCT00318513|Growth Inhibitors|growth inhibitors|mesh-ancestor
24458388|NCT00337701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24404900|NCT00165178|Leucovorin|leucovorin|mesh-list
24534154|NCT00646191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24634461|NCT01133483|Sympathomimetics|sympathomimetics|mesh-ancestor
25706910|NCT02222896|Disinfectants|disinfectants|mesh-ancestor
25706911|NCT02222896|Dermatologic Agents|dermatologic agents|mesh-ancestor
25706912|NCT02222922|Fluconazole|fluconazole|mesh-list
25706913|NCT02222922|Avelumab|avelumab|mesh-list
25706914|NCT02222922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25706915|NCT02222922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25706916|NCT02222922|Antifungal Agents|antifungal agents|mesh-ancestor
25706917|NCT02222922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25706918|NCT02222922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25706919|NCT02222922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25706920|NCT02222922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25706921|NCT02222922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635595|NCT01140412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24635596|NCT01140412|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24534213|NCT00646516|Hormones|hormones|mesh-ancestor
24635830|NCT01141439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25706922|NCT02222922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25706923|NCT02222922|Hormone Antagonists|hormone antagonists|mesh-ancestor
25706924|NCT02222922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25706925|NCT02222922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706926|NCT02222922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25706927|NCT02222922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24534299|NCT00646620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25706928|NCT02223065|Dapagliflozin|dapagliflozin|mesh-list
25706929|NCT02223065|Saxagliptin|saxagliptin|mesh-list
25706930|NCT02223065|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25706931|NCT02223065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706932|NCT02223065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24637795|NCT01153204|Sildenafil Citrate|sildenafil citrate|mesh-list
24637796|NCT01153204|Citric Acid|citric acid|mesh-list
24450403|NCT00318968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706933|NCT02223065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706934|NCT02223065|Incretins|incretins|mesh-ancestor
24458394|NCT00337740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458395|NCT00337740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636797|NCT01147432|Capsaicin|capsaicin|mesh-list
24636835|NCT01147588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24636883|NCT01147731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24636885|NCT01147757|Remifentanil|remifentanil|mesh-list
24636969|NCT01148264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24534502|NCT00647218|Paclitaxel|paclitaxel|mesh-list
24637140|NCT01148992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25706935|NCT02223065|Hormones|hormones|mesh-ancestor
25706936|NCT02223065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24640498|NCT01168531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24640653|NCT01169415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451391|NCT00323544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24451392|NCT00323544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24534575|NCT00647634|GABA Agents|gaba agents|mesh-ancestor
24534576|NCT00647634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24534577|NCT00647634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534578|NCT00647647|Terbinafine|terbinafine|mesh-list
24534579|NCT00647647|Antifungal Agents|antifungal agents|mesh-ancestor
24534580|NCT00647647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24637316|NCT01149902|Cyclophosphamide|cyclophosphamide|mesh-list
24534621|NCT00647712|Anticonvulsants|anticonvulsants|mesh-ancestor
24637454|NCT01150344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24637455|NCT01150344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24637456|NCT01150344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637457|NCT01150344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637459|NCT01150448|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25706937|NCT02223065|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25706938|NCT02223065|Protease Inhibitors|protease inhibitors|mesh-ancestor
25706939|NCT02223065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25706940|NCT02223260|Dabigatran|dabigatran|mesh-list
25706942|NCT02223260|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24637493|NCT01150630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24637494|NCT01150630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24637496|NCT01150747|Ceftriaxone|ceftriaxone|mesh-list
24637497|NCT01150747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24637498|NCT01150747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24637500|NCT01150786|Antioxidants|antioxidants|mesh-ancestor
24458424|NCT00337792|GABA Modulators|gaba modulators|mesh-ancestor
24534674|NCT00647816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458466|NCT00338052|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24458467|NCT00338052|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24458475|NCT00338091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458476|NCT00338091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24458477|NCT00338091|Protease Inhibitors|protease inhibitors|mesh-ancestor
24458478|NCT00338091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534694|NCT00647842|Narcotics|narcotics|mesh-ancestor
24534695|NCT00647842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24534696|NCT00647842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450454|NCT00319163|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24450455|NCT00319189|Nateglinide|nateglinide|mesh-list
24450456|NCT00319189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25706943|NCT02223260|Protease Inhibitors|protease inhibitors|mesh-ancestor
25706944|NCT02223260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25706945|NCT02223260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706946|NCT02223260|Anticoagulants|anticoagulants|mesh-ancestor
25706947|NCT02223338|Ciprofloxacin|ciprofloxacin|mesh-list
25706948|NCT02223338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25706949|NCT02223338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24641414|NCT01173510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641415|NCT01173510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24641417|NCT01173536|Moxifloxacin|moxifloxacin|mesh-list
24641449|NCT01173627|Analgesics|analgesics|mesh-ancestor
24641450|NCT01173627|Sensory System Agents|sensory system agents|mesh-ancestor
24450457|NCT00319189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450458|NCT00319202|Candesartan|candesartan|mesh-list
24450459|NCT00319202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24450460|NCT00319202|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24450461|NCT00319202|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24450462|NCT00319202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450463|NCT00319215|Zopiclone|zopiclone|mesh-list
24450464|NCT00319215|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24458483|NCT00338117|Cholinergic Agents|cholinergic agents|mesh-ancestor
24458484|NCT00338117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24451469|NCT00323830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458485|NCT00338117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458486|NCT00338117|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24458487|NCT00338117|Autonomic Agents|autonomic agents|mesh-ancestor
24458488|NCT00338117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24458489|NCT00338117|Nootropic Agents|nootropic agents|mesh-ancestor
24407137|NCT00171990|Famciclovir|famciclovir|mesh-list
24458490|NCT00338130|Temozolomide|temozolomide|mesh-list
24458493|NCT00338130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458497|NCT00338195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458498|NCT00338195|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24458499|NCT00338195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458500|NCT00338195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458501|NCT00338195|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24458502|NCT00338195|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24458503|NCT00338195|Purinergic Agents|purinergic agents|mesh-ancestor
24458504|NCT00338195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24458506|NCT00338221|Glycine Agents|glycine agents|mesh-ancestor
24458507|NCT00338221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25706950|NCT02223338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25706951|NCT02223338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25706952|NCT02223338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25706953|NCT02223338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706954|NCT02223338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638538|NCT01156948|Oxytocics|oxytocics|mesh-ancestor
24643480|NCT01185847|Antimetabolites|antimetabolites|mesh-ancestor
24534855|NCT00648141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24458615|NCT00338546|Analgesics|analgesics|mesh-ancestor
24458616|NCT00338546|Sensory System Agents|sensory system agents|mesh-ancestor
24458617|NCT00338546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24458618|NCT00338546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24458619|NCT00338546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24458620|NCT00338546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24458621|NCT00338546|Adrenergic Agents|adrenergic agents|mesh-ancestor
24458622|NCT00338546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24458623|NCT00338546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451499|NCT00323973|Bisoprolol|bisoprolol|mesh-list
24458662|NCT00338767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24458663|NCT00338767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24458664|NCT00338767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24458665|NCT00338767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24523526|NCT05342272|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24458666|NCT00338780|Lamivudine|lamivudine|mesh-list
24458667|NCT00338780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25706956|NCT02223338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24458762|NCT00339196|Azacitidine|azacitidine|mesh-list
24458763|NCT00339196|Tretinoin|tretinoin|mesh-list
24458764|NCT00339196|Valproic Acid|valproic acid|mesh-list
24407428|NCT00174512|Moxifloxacin|moxifloxacin|mesh-list
24458765|NCT00339196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24458766|NCT00339196|Antimetabolites|antimetabolites|mesh-ancestor
24458780|NCT00339417|Ivermectin|ivermectin|mesh-list
24458781|NCT00339417|Albendazole|albendazole|mesh-list
24458827|NCT00340574|Immunologic Factors|immunologic factors|mesh-ancestor
24458828|NCT00340574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458829|NCT00340574|Antacids|antacids|mesh-ancestor
24571052|NCT00807950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458830|NCT00340574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458831|NCT00340574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24458832|NCT00340613|Insulin Glargine|insulin glargine|mesh-list
24458833|NCT00340613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24535265|NCT00648856|Serotonin Agents|serotonin agents|mesh-ancestor
24458835|NCT00340691|Doxycycline|doxycycline|mesh-list
24458836|NCT00340691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24458837|NCT00340691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24458838|NCT00340691|Antimalarials|antimalarials|mesh-ancestor
24458839|NCT00340691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24458840|NCT00340691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24458841|NCT00341055|Epoetin Alfa|epoetin alfa|mesh-list
25706957|NCT02223351|Ritonavir|ritonavir|mesh-list
24458842|NCT00341055|Hematinics|hematinics|mesh-ancestor
24458865|NCT00342381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24458866|NCT00342381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458869|NCT00342849|Protective Agents|protective agents|mesh-ancestor
24458870|NCT00342849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458871|NCT00342849|Chelating Agents|chelating agents|mesh-ancestor
24458872|NCT00342849|Sequestering Agents|sequestering agents|mesh-ancestor
24458873|NCT00342849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458875|NCT00342862|Dermatologic Agents|dermatologic agents|mesh-ancestor
24458876|NCT00342862|Immunologic Factors|immunologic factors|mesh-ancestor
24458877|NCT00342862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458887|NCT00343070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24458888|NCT00343070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24458889|NCT00343070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458890|NCT00343070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24458891|NCT00343070|Serotonin Agents|serotonin agents|mesh-ancestor
24458892|NCT00343070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458893|NCT00343070|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24458894|NCT00343070|Antidepressive Agents|antidepressive agents|mesh-ancestor
24458895|NCT00343070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24458897|NCT00343096|Anticonvulsants|anticonvulsants|mesh-ancestor
24458899|NCT00343096|Autonomic Agents|autonomic agents|mesh-ancestor
24458900|NCT00343096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24458901|NCT00343096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458902|NCT00343096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24458903|NCT00343096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24458905|NCT00343096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24458912|NCT00343135|Amoxicillin|amoxicillin|mesh-list
24458913|NCT00343135|Clavulanic Acid|clavulanic acid|mesh-list
24458914|NCT00343135|Clavulanic Acids|clavulanic acids|mesh-list
24458915|NCT00343135|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24458916|NCT00343135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24458918|NCT00343135|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24458919|NCT00343135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648321|NCT01213563|Insulin|insulin|mesh-list
24458921|NCT00343161|Esomeprazole|esomeprazole|mesh-list
24458932|NCT00343161|Antacids|antacids|mesh-ancestor
24458933|NCT00343174|Ancrod|ancrod|mesh-list
24458934|NCT00343174|Anticoagulants|anticoagulants|mesh-ancestor
24458935|NCT00343174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24458936|NCT00343174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24458937|NCT00343174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458938|NCT00343187|Dapsone|dapsone|mesh-list
24458939|NCT00343187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24458940|NCT00343187|Antimalarials|antimalarials|mesh-ancestor
25706960|NCT02223351|Protease Inhibitors|protease inhibitors|mesh-ancestor
25706961|NCT02223351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458941|NCT00343187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24458942|NCT00343187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25706962|NCT02223351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458943|NCT00343187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24571513|NCT00810524|Antiviral Agents|antiviral agents|mesh-ancestor
24458945|NCT00343187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458946|NCT00343187|Leprostatic Agents|leprostatic agents|mesh-ancestor
24458947|NCT00343187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24458986|NCT00343369|Doxorubicin|doxorubicin|mesh-list
24458975|NCT00343265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458976|NCT00343278|Valacyclovir|valacyclovir|mesh-list
24458977|NCT00343278|Antiviral Agents|antiviral agents|mesh-ancestor
24458978|NCT00343278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24458979|NCT00343317|Cefoxitin|cefoxitin|mesh-list
24458980|NCT00343317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24406440|NCT00170378|Enoxaparin|enoxaparin|mesh-list
24641734|NCT01174953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641735|NCT01174953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25706963|NCT02223351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25706964|NCT02223351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25706965|NCT02223351|Antiviral Agents|antiviral agents|mesh-ancestor
25706966|NCT02223351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24649255|NCT01219088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24649256|NCT01219088|Narcotics|narcotics|mesh-ancestor
24649257|NCT01219088|Analgesics|analgesics|mesh-ancestor
24649258|NCT01219101|Citric Acid|citric acid|mesh-list
24649259|NCT01219101|Sodium Citrate|sodium citrate|mesh-list
24649260|NCT01219101|Clomiphene|clomiphene|mesh-list
24458984|NCT00343369|Prednisolone|prednisolone|mesh-list
24458985|NCT00343369|Cyclophosphamide|cyclophosphamide|mesh-list
24458987|NCT00343369|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24458988|NCT00343369|Methotrexate|methotrexate|mesh-list
24458989|NCT00343369|Vincristine|vincristine|mesh-list
24458990|NCT00343369|Daunorubicin|daunorubicin|mesh-list
24459023|NCT00343369|Dermatologic Agents|dermatologic agents|mesh-ancestor
24459024|NCT00343369|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24459025|NCT00343369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24459027|NCT00343369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24459028|NCT00343369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24459029|NCT00343369|Tubulin Modulators|tubulin modulators|mesh-ancestor
24459030|NCT00343369|Antimitotic Agents|antimitotic agents|mesh-ancestor
24459031|NCT00343369|Mitosis Modulators|mitosis modulators|mesh-ancestor
24459032|NCT00343408|Leucovorin|leucovorin|mesh-list
25706967|NCT02223351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25706968|NCT02223351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25706969|NCT02223364|Bupivacaine|bupivacaine|mesh-list
25706970|NCT02223364|Ropivacaine|ropivacaine|mesh-list
25706971|NCT02223364|Anesthetics, Local|anesthetics, local|mesh-ancestor
25706972|NCT02223364|Anesthetics|anesthetics|mesh-ancestor
25706973|NCT02223364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25706974|NCT02223364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706975|NCT02223364|Sensory System Agents|sensory system agents|mesh-ancestor
25706976|NCT02223364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25706977|NCT02223429|Vasopressins|vasopressins|mesh-list
24926453|NCT04141787|Cefazolin|cefazolin|mesh-list
24459217|NCT00343980|Insulin|insulin|mesh-list
24643059|NCT01183572|Iron|iron|mesh-list
24459244|NCT00344006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459245|NCT00344006|Leprostatic Agents|leprostatic agents|mesh-ancestor
24459246|NCT00344006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24459247|NCT00344006|Antimetabolites|antimetabolites|mesh-ancestor
25706978|NCT02223429|Arginine Vasopressin|arginine vasopressin|mesh-list
25706979|NCT02223429|Oxytocin|oxytocin|mesh-list
25706980|NCT02223429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25706981|NCT02223429|Oxytocics|oxytocics|mesh-ancestor
25706982|NCT02223429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25706983|NCT02223429|Hemostatics|hemostatics|mesh-ancestor
25706984|NCT02223429|Coagulants|coagulants|mesh-ancestor
25706985|NCT02223429|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24649886|NCT01222442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459249|NCT00344058|Analgesics|analgesics|mesh-ancestor
24459250|NCT00344058|Sensory System Agents|sensory system agents|mesh-ancestor
24459251|NCT00344058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24459252|NCT00344058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459253|NCT00344058|Anesthetics|anesthetics|mesh-ancestor
24459254|NCT00344058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24459255|NCT00344058|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24571801|NCT00811876|Leuprolide|leuprolide|mesh-list
24459256|NCT00344058|Anticonvulsants|anticonvulsants|mesh-ancestor
24459257|NCT00344058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24459258|NCT00344058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24459259|NCT00344058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459260|NCT00344058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24459261|NCT00344058|Tocolytic Agents|tocolytic agents|mesh-ancestor
24459262|NCT00344058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24536158|NCT00650416|Vasodilator Agents|vasodilator agents|mesh-ancestor
24450652|NCT00319878|Antifungal Agents|antifungal agents|mesh-ancestor
24450653|NCT00319878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24450654|NCT00319878|Dermatologic Agents|dermatologic agents|mesh-ancestor
24459322|NCT00344383|Hormones|hormones|mesh-ancestor
24643281|NCT01184911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643282|NCT01184911|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24643283|NCT01184911|Renal Agents|renal agents|mesh-ancestor
24643290|NCT01185015|Micronutrients|micronutrients|mesh-ancestor
24459265|NCT00344123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24459266|NCT00344123|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24408006|NCT00176241|Antimetabolites|antimetabolites|mesh-ancestor
24459267|NCT00344123|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24459268|NCT00344123|Protease Inhibitors|protease inhibitors|mesh-ancestor
25706986|NCT02223429|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25706987|NCT02223429|Natriuretic Agents|natriuretic agents|mesh-ancestor
25706988|NCT02223702|Amoxicillin|amoxicillin|mesh-list
25706989|NCT02223702|Moxifloxacin|moxifloxacin|mesh-list
25706990|NCT02223702|Metronidazole|metronidazole|mesh-list
25706991|NCT02223702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25706992|NCT02223702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24459269|NCT00344123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459270|NCT00344123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459272|NCT00344123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24450661|NCT00319917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24450662|NCT00319917|Immunologic Factors|immunologic factors|mesh-ancestor
24450663|NCT00319917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450697|NCT00320060|Pyridoxamine|pyridoxamine|mesh-list
24450698|NCT00320060|Vitamin B Complex|vitamin b complex|mesh-ancestor
24450700|NCT00320060|Micronutrients|micronutrients|mesh-ancestor
24450701|NCT00320060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450702|NCT00320073|Pemetrexed|pemetrexed|mesh-list
24459316|NCT00344253|Antiviral Agents|antiviral agents|mesh-ancestor
24459317|NCT00344253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24459318|NCT00344383|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24459320|NCT00344383|Estradiol|estradiol|mesh-list
24459321|NCT00344383|Estrogens|estrogens|mesh-ancestor
24643730|NCT01186887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24643731|NCT01186887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24650718|NCT01227603|Nifedipine|nifedipine|mesh-list
24650719|NCT01227603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24650720|NCT01227603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24643947|NCT01188031|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24459379|NCT00344513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459381|NCT00344526|Melphalan|melphalan|mesh-list
24459382|NCT00344526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24459383|NCT00344526|Antiemetics|antiemetics|mesh-ancestor
24459384|NCT00344526|Autonomic Agents|autonomic agents|mesh-ancestor
24459385|NCT00344526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24459386|NCT00344526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459387|NCT00344526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24450885|NCT00320827|Antibodies|antibodies|mesh-list
24450754|NCT00320359|Cisplatin|cisplatin|mesh-list
24459389|NCT00344526|Hormones|hormones|mesh-ancestor
24459390|NCT00344526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24459391|NCT00344526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25706993|NCT02223702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25706994|NCT02223702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25706995|NCT02223702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459392|NCT00344526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25706996|NCT02223702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459395|NCT00344526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459396|NCT00344526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24459397|NCT00344526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24459398|NCT00344526|Immunologic Factors|immunologic factors|mesh-ancestor
24459399|NCT00344539|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24459400|NCT00344539|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24459402|NCT00344539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459403|NCT00344539|Antacids|antacids|mesh-ancestor
24459404|NCT00344539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459405|NCT00344539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24459406|NCT00344552|Paclitaxel|paclitaxel|mesh-list
24459407|NCT00344552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24459408|NCT00344552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459409|NCT00344552|Tubulin Modulators|tubulin modulators|mesh-ancestor
24459410|NCT00344552|Antimitotic Agents|antimitotic agents|mesh-ancestor
24459411|NCT00344552|Mitosis Modulators|mitosis modulators|mesh-ancestor
24459412|NCT00344552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459413|NCT00344565|Modafinil|modafinil|mesh-list
24536603|NCT00651729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24459449|NCT00344695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24459450|NCT00344695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459451|NCT00344695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24407509|NCT00174642|Insulin|insulin|mesh-list
25706997|NCT02223702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25706998|NCT02223702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25706999|NCT02223702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25707000|NCT02223871|Lumefantrine|lumefantrine|mesh-list
25707001|NCT02223871|Artemether|artemether|mesh-list
25707002|NCT02223871|Primaquine|primaquine|mesh-list
25707003|NCT02223871|Antimalarials|antimalarials|mesh-ancestor
25707004|NCT02223871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25707005|NCT02223871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24450799|NCT00320632|Desipramine|desipramine|mesh-list
24450800|NCT00320632|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24450801|NCT00320632|Antidepressive Agents|antidepressive agents|mesh-ancestor
24450802|NCT00320632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24450803|NCT00320632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459518|NCT00344942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24459519|NCT00344942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459520|NCT00344942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24459521|NCT00344942|Immunologic Factors|immunologic factors|mesh-ancestor
24459522|NCT00344942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459523|NCT00344942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459524|NCT00344955|Atorvastatin|atorvastatin|mesh-list
24459554|NCT00345059|Gemcitabine|gemcitabine|mesh-list
24459555|NCT00345059|Capecitabine|capecitabine|mesh-list
24459557|NCT00345059|Vinorelbine|vinorelbine|mesh-list
24459558|NCT00345059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24459559|NCT00345059|Antimetabolites|antimetabolites|mesh-ancestor
24407714|NCT00175123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24459565|NCT00345059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24459566|NCT00345059|Immunologic Factors|immunologic factors|mesh-ancestor
24459567|NCT00345059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459568|NCT00345059|Tubulin Modulators|tubulin modulators|mesh-ancestor
24459569|NCT00345059|Antimitotic Agents|antimitotic agents|mesh-ancestor
24459570|NCT00345059|Mitosis Modulators|mitosis modulators|mesh-ancestor
24459571|NCT00345059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24459573|NCT00345098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24459579|NCT00345137|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
24653282|NCT01243060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653283|NCT01243086|Dexamethasone|dexamethasone|mesh-list
24653284|NCT01243086|Ranibizumab|ranibizumab|mesh-list
24459580|NCT00345137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459581|NCT00345137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645112|NCT01195805|Diuretics|diuretics|mesh-ancestor
24459588|NCT00345163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459589|NCT00345163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24459590|NCT00345163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24459591|NCT00345163|Growth Substances|growth substances|mesh-ancestor
24459592|NCT00345163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459593|NCT00345163|Growth Inhibitors|growth inhibitors|mesh-ancestor
24459594|NCT00345163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24459595|NCT00345163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24450869|NCT00320736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24450882|NCT00320814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450883|NCT00320814|Growth Inhibitors|growth inhibitors|mesh-ancestor
24450884|NCT00320814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450886|NCT00320827|Immunologic Factors|immunologic factors|mesh-ancestor
24450887|NCT00320827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450888|NCT00320853|Vitamin D|vitamin d|mesh-list
24450889|NCT00320853|Vitamins|vitamins|mesh-ancestor
24450890|NCT00320853|Micronutrients|micronutrients|mesh-ancestor
25707006|NCT02223871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25707007|NCT02224053|Osimertinib|osimertinib|mesh-list
25707008|NCT02224053|Omeprazole|omeprazole|mesh-list
25707009|NCT02224053|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25707010|NCT02224053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25707011|NCT02224053|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24654122|NCT01247805|Sildenafil Citrate|sildenafil citrate|mesh-list
24654161|NCT01247961|Autonomic Agents|autonomic agents|mesh-ancestor
25707012|NCT02224053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25707013|NCT02224053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450891|NCT00320853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459617|NCT00345644|Risedronic Acid|risedronic acid|mesh-list
24459618|NCT00345644|Etidronic Acid|etidronic acid|mesh-list
24450450|NCT00319163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24450451|NCT00319163|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24450452|NCT00319163|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24459643|NCT00345696|Oxaliplatin|oxaliplatin|mesh-list
25707014|NCT02224053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25707015|NCT02224053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25709725|NCT02273973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25709726|NCT02273973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709727|NCT02273973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459620|NCT00345644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24459622|NCT00345644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24459623|NCT00345644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459624|NCT00345644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24459626|NCT00345657|Lovastatin|lovastatin|mesh-list
24537054|NCT00653380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25707017|NCT02224157|Terbutaline|terbutaline|mesh-list
25707018|NCT02224157|Formoterol Fumarate|formoterol fumarate|mesh-list
24655859|NCT01258439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24655861|NCT01258439|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24655862|NCT01258491|Nicotinic Acids|nicotinic acids|mesh-list
24655864|NCT01258491|Niacinamide|niacinamide|mesh-list
24459627|NCT00345657|L 647318|l 647318|mesh-list
24459628|NCT00345657|Dihydromevinolin|dihydromevinolin|mesh-list
24459629|NCT00345657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24459630|NCT00345657|Antimetabolites|antimetabolites|mesh-ancestor
24459631|NCT00345657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459632|NCT00345657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24459633|NCT00345657|Vasodilator Agents|vasodilator agents|mesh-ancestor
24459634|NCT00345657|Vitamin B Complex|vitamin b complex|mesh-ancestor
24459635|NCT00345657|Vitamins|vitamins|mesh-ancestor
24459636|NCT00345657|Micronutrients|micronutrients|mesh-ancestor
24459637|NCT00345657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459638|NCT00345657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24459639|NCT00345657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24459640|NCT00345657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459641|NCT00345696|Bevacizumab|bevacizumab|mesh-list
24459642|NCT00345696|Capecitabine|capecitabine|mesh-list
24645568|NCT01198665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645569|NCT01198665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24645592|NCT01198821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24459649|NCT00345696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459650|NCT00345696|Growth Inhibitors|growth inhibitors|mesh-ancestor
24459651|NCT00345696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24459652|NCT00345696|Antimetabolites|antimetabolites|mesh-ancestor
24459653|NCT00345696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459654|NCT00345735|Fentanyl|fentanyl|mesh-list
24459655|NCT00345735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25707019|NCT02224157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25707020|NCT02224157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25707021|NCT02224157|Autonomic Agents|autonomic agents|mesh-ancestor
25707022|NCT02224157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25707023|NCT02224157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707024|NCT02224157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25707025|NCT02224157|Respiratory System Agents|respiratory system agents|mesh-ancestor
25707026|NCT02224157|Glucocorticoids|glucocorticoids|mesh-ancestor
25707027|NCT02224157|Hormones|hormones|mesh-ancestor
24459682|NCT00345787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24459683|NCT00345787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459685|NCT00345787|Sensory System Agents|sensory system agents|mesh-ancestor
24459686|NCT00345787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24459687|NCT00345787|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24459694|NCT00345800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459695|NCT00345826|Dasatinib|dasatinib|mesh-list
24459696|NCT00345826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459697|NCT00345826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24459698|NCT00345826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459699|NCT00345826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459700|NCT00345982|Sertindole|sertindole|mesh-list
24645709|NCT01199432|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24459701|NCT00345982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24459702|NCT00345982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24537193|NCT00653926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25707028|NCT02224157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24445664|NCT00301990|Bevacizumab|bevacizumab|mesh-list
24658921|NCT01274624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707029|NCT02224157|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24459703|NCT00345982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24394246|NCT00132652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394247|NCT00132652|Antiviral Agents|antiviral agents|mesh-ancestor
24394248|NCT00132652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24394249|NCT00132652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24394250|NCT00132652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24394252|NCT00132743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24394253|NCT00132743|Autonomic Agents|autonomic agents|mesh-ancestor
24394254|NCT00132743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24394255|NCT00132743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394256|NCT00132743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24394257|NCT00132743|Respiratory System Agents|respiratory system agents|mesh-ancestor
24394258|NCT00132743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24394259|NCT00132743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24394262|NCT00132743|Vasodilator Agents|vasodilator agents|mesh-ancestor
24394292|NCT00132821|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24394293|NCT00132821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24394294|NCT00132821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394295|NCT00132860|Azithromycin|azithromycin|mesh-list
24394296|NCT00132860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24394306|NCT00132899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24394307|NCT00132899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394308|NCT00132899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24394309|NCT00132899|Antimetabolites|antimetabolites|mesh-ancestor
24394311|NCT00132899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24394333|NCT00132951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24394334|NCT00133003|Abciximab|abciximab|mesh-list
24394335|NCT00133003|Anticoagulants|anticoagulants|mesh-ancestor
24394336|NCT00133003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24394337|NCT00133029|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24394338|NCT00133029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24394339|NCT00133042|Omalizumab|omalizumab|mesh-list
24394340|NCT00133042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24459705|NCT00345982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24459706|NCT00346047|Buprenorphine|buprenorphine|mesh-list
25707030|NCT02224157|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25707031|NCT02224157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24394428|NCT00133276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24394429|NCT00133276|Serotonin Agents|serotonin agents|mesh-ancestor
24394430|NCT00133276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394431|NCT00133276|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24394432|NCT00133276|Antidepressive Agents|antidepressive agents|mesh-ancestor
24394433|NCT00133276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24394435|NCT00133315|Etanercept|etanercept|mesh-list
24394436|NCT00133315|Infliximab|infliximab|mesh-list
24394507|NCT00133393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24394508|NCT00133393|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24394509|NCT00133393|Protective Agents|protective agents|mesh-ancestor
24394510|NCT00133393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394511|NCT00133393|Vasodilator Agents|vasodilator agents|mesh-ancestor
24394512|NCT00133393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24394513|NCT00133393|Antioxidants|antioxidants|mesh-ancestor
24394514|NCT00133406|Vitamin A|vitamin a|mesh-list
24394515|NCT00133406|Glycine|glycine|mesh-list
24394516|NCT00133406|Vitamins|vitamins|mesh-ancestor
24394517|NCT00133406|Micronutrients|micronutrients|mesh-ancestor
24394518|NCT00133406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394519|NCT00133406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394613|NCT00133731|Protease Inhibitors|protease inhibitors|mesh-ancestor
24394615|NCT00133744|Folic Acid|folic acid|mesh-list
24394634|NCT00133757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394636|NCT00133770|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24394637|NCT00133770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24394670|NCT00133861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394671|NCT00133874|Retapamulin|retapamulin|mesh-list
24394672|NCT00133874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24394673|NCT00133874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24394674|NCT00133887|Sirolimus|sirolimus|mesh-list
24394675|NCT00133887|Cyclosporine|cyclosporine|mesh-list
24394676|NCT00133887|Tacrolimus|tacrolimus|mesh-list
24394677|NCT00133887|Cyclosporins|cyclosporins|mesh-list
24394694|NCT00134030|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24394695|NCT00134030|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
24394696|NCT00134030|Cisplatin|cisplatin|mesh-list
24394697|NCT00134030|Doxorubicin|doxorubicin|mesh-list
24394698|NCT00134030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24394699|NCT00134030|Methotrexate|methotrexate|mesh-list
24394700|NCT00134030|Etoposide|etoposide|mesh-list
24394701|NCT00134030|Etoposide phosphate|etoposide phosphate|mesh-list
24394702|NCT00134030|Ifosfamide|ifosfamide|mesh-list
24394703|NCT00134030|Isophosphamide mustard|isophosphamide mustard|mesh-list
24394704|NCT00134030|Podophyllotoxin|podophyllotoxin|mesh-list
24660708|NCT01285375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394715|NCT00134030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24459714|NCT00346047|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25707032|NCT02224157|Adrenergic Agents|adrenergic agents|mesh-ancestor
25707033|NCT02224157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707034|NCT02224157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707035|NCT02224157|Sympathomimetics|sympathomimetics|mesh-ancestor
25707036|NCT02224157|Tocolytic Agents|tocolytic agents|mesh-ancestor
25707037|NCT02224157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25707038|NCT02224274|Clopidogrel|clopidogrel|mesh-list
25707039|NCT02224274|Ticagrelor|ticagrelor|mesh-list
24459721|NCT00346099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24459722|NCT00346099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24459723|NCT00346190|Alendronate|alendronate|mesh-list
24459724|NCT00346190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24648857|NCT01217099|Protective Agents|protective agents|mesh-ancestor
24666267|NCT01318265|Antifungal Agents|antifungal agents|mesh-ancestor
25707040|NCT02224274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24649964|NCT01222923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24539094|NCT00662337|Anesthetics|anesthetics|mesh-ancestor
24650205|NCT01224509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24650206|NCT01224509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650207|NCT01224509|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24650208|NCT01224509|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24650209|NCT01224509|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25707041|NCT02224274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25707042|NCT02224274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25707043|NCT02224274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24443693|NCT00295815|Lomustine|lomustine|mesh-list
24459755|NCT00346359|Fludarabine|fludarabine|mesh-list
24459756|NCT00346359|Busulfan|busulfan|mesh-list
24459757|NCT00346359|Tacrolimus|tacrolimus|mesh-list
24410150|NCT00184795|Estradiol|estradiol|mesh-list
24539201|NCT00662779|Adrenergic Agents|adrenergic agents|mesh-ancestor
24459758|NCT00346359|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24459759|NCT00346359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25707044|NCT02224274|Purinergic Agents|purinergic agents|mesh-ancestor
24650802|NCT01228045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24650987|NCT01228630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24650989|NCT01228630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24650992|NCT01228630|Nasal Decongestants|nasal decongestants|mesh-ancestor
24859073|NCT02301676|Dexmedetomidine|dexmedetomidine|mesh-list
24859074|NCT02301676|Propofol|propofol|mesh-list
24859075|NCT02301676|Sevoflurane|sevoflurane|mesh-list
24859081|NCT02301676|Anesthetics|anesthetics|mesh-ancestor
24859091|NCT02301676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859092|NCT02301676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24859094|NCT02301715|Oxytocin|oxytocin|mesh-list
24859155|NCT02302274|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24859156|NCT02302274|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24651362|NCT01231165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24651363|NCT01231165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24859196|NCT02302495|Melphalan|melphalan|mesh-list
24859197|NCT02302495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24859199|NCT02302495|Hormones|hormones|mesh-ancestor
24859200|NCT02302495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24859201|NCT02302495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859202|NCT02302495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24651440|NCT01231542|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24859343|NCT02303106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24859344|NCT02303119|Rituximab|rituximab|mesh-list
24859345|NCT02303119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24859346|NCT02303119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859347|NCT02303119|Immunologic Factors|immunologic factors|mesh-ancestor
24859444|NCT02303639|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24859445|NCT02303639|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24859446|NCT02303639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24859497|NCT02303886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859499|NCT02303899|Imatinib Mesylate|imatinib mesylate|mesh-list
24859500|NCT02303899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24859501|NCT02303899|Antimetabolites|antimetabolites|mesh-ancestor
24859503|NCT02303899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24859743|NCT02305615|Bevacizumab|bevacizumab|mesh-list
24859744|NCT02305615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24859745|NCT02305615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813310|NCT02057796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24813311|NCT02057796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24859878|NCT02306187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24859879|NCT02306187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859881|NCT02306239|Norepinephrine|norepinephrine|mesh-list
24859882|NCT02306239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24859883|NCT02306239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24859884|NCT02306239|Adrenergic Agents|adrenergic agents|mesh-ancestor
24859885|NCT02306239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24859886|NCT02306239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24859887|NCT02306239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859888|NCT02306239|Sympathomimetics|sympathomimetics|mesh-ancestor
24859889|NCT02306239|Autonomic Agents|autonomic agents|mesh-ancestor
24859890|NCT02306239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24859891|NCT02306239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24540383|NCT00667771|Naltrexone|naltrexone|mesh-list
24446607|NCT00305461|Hormones|hormones|mesh-ancestor
24859939|NCT02306772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24859940|NCT02306772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859941|NCT02306772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24859942|NCT02306772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24859943|NCT02306785|Mesalamine|mesalamine|mesh-list
24859944|NCT02306785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24859945|NCT02306785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24859946|NCT02306785|Analgesics|analgesics|mesh-ancestor
24859947|NCT02306785|Sensory System Agents|sensory system agents|mesh-ancestor
24859948|NCT02306785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24859949|NCT02306785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24859950|NCT02306785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24859951|NCT02306785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24859952|NCT02306798|Mesalamine|mesalamine|mesh-list
24859953|NCT02306798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24860052|NCT02307305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24860055|NCT02307305|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25709728|NCT02273973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25709729|NCT02273973|Hormone Antagonists|hormone antagonists|mesh-ancestor
25709730|NCT02273973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25709731|NCT02273973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709732|NCT02274038|Pemetrexed|pemetrexed|mesh-list
25709733|NCT02274038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25709734|NCT02274038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709735|NCT02274038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535255|NCT00648843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535256|NCT00648843|Urological Agents|urological agents|mesh-ancestor
24451147|NCT00322400|Antimitotic Agents|antimitotic agents|mesh-ancestor
24451148|NCT00322400|Mitosis Modulators|mitosis modulators|mesh-ancestor
24451149|NCT00322400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451150|NCT00322400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24813324|NCT02057796|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24681826|NCT01382147|Analgesics|analgesics|mesh-ancestor
24860201|NCT02308098|Budesonide|budesonide|mesh-list
24860212|NCT02308098|Hormones|hormones|mesh-ancestor
24653404|NCT01243788|Xhance|xhance|mesh-list
24450809|NCT00320632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707045|NCT02224274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707046|NCT02224274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707047|NCT02224274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707048|NCT02224313|Estradiol|estradiol|mesh-list
24860311|NCT02309177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860312|NCT02309177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24860314|NCT02309177|Antiviral Agents|antiviral agents|mesh-ancestor
24860315|NCT02309177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24860316|NCT02309177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540702|NCT00669149|Antithrombins|antithrombins|mesh-ancestor
24540703|NCT00669149|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24540704|NCT00669149|Protease Inhibitors|protease inhibitors|mesh-ancestor
24540728|NCT00669435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24540729|NCT00669435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540730|NCT00669435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24540746|NCT00669487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24540747|NCT00669487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451247|NCT00322803|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24451248|NCT00322803|GABA Agonists|gaba agonists|mesh-ancestor
24860412|NCT02309879|Anesthetics|anesthetics|mesh-ancestor
24860413|NCT02309879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24860414|NCT02309879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860415|NCT02309879|Sensory System Agents|sensory system agents|mesh-ancestor
24860416|NCT02309879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24860442|NCT02309970|Sensory System Agents|sensory system agents|mesh-ancestor
24860443|NCT02309970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24860444|NCT02309970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860445|NCT02309970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24654201|NCT01248195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24860449|NCT02309970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860491|NCT02310295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24860492|NCT02310295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24860493|NCT02310295|Growth Substances|growth substances|mesh-ancestor
24860494|NCT02310295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860495|NCT02310295|Growth Inhibitors|growth inhibitors|mesh-ancestor
24451318|NCT00323154|Narcotics|narcotics|mesh-ancestor
25707050|NCT02224313|Estrogens|estrogens|mesh-ancestor
25707051|NCT02224313|Hormones|hormones|mesh-ancestor
25707052|NCT02224313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25707053|NCT02224313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707054|NCT02224313|Progestins|progestins|mesh-ancestor
25707055|NCT02224625|Chlorhexidine|chlorhexidine|mesh-list
25707056|NCT02224625|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25707057|NCT02224625|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25707058|NCT02224625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25707059|NCT02224625|Disinfectants|disinfectants|mesh-ancestor
25707060|NCT02224625|Dermatologic Agents|dermatologic agents|mesh-ancestor
25707061|NCT02224729|Dexamethasone|dexamethasone|mesh-list
25707062|NCT02224729|Bortezomib|bortezomib|mesh-list
24860565|NCT02311088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860567|NCT02311088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24860568|NCT02311088|Purinergic Agents|purinergic agents|mesh-ancestor
24540924|NCT00669994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24451263|NCT00322907|Analgesics|analgesics|mesh-ancestor
24860577|NCT02311101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860578|NCT02311179|Cimetidine|cimetidine|mesh-list
24860584|NCT02311179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24860585|NCT02311179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540937|NCT00670215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24540938|NCT00670215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540939|NCT00670215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540942|NCT00670215|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24860592|NCT02311205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24860593|NCT02311205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860595|NCT02311231|Heparin|heparin|mesh-list
24860601|NCT02311231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540944|NCT00670254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24540945|NCT00670293|Raclopride|raclopride|mesh-list
24540946|NCT00670293|Methylphenidate|methylphenidate|mesh-list
24540947|NCT00670293|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24540948|NCT00670293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540949|NCT00670293|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24540950|NCT00670293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24540951|NCT00670293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24540952|NCT00670293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540953|NCT00670293|Dopamine Agents|dopamine agents|mesh-ancestor
24540954|NCT00670293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24540955|NCT00670293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24860631|NCT02311569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860633|NCT02311608|Octreotide|octreotide|mesh-list
24860634|NCT02311608|Terlipressin|terlipressin|mesh-list
24860635|NCT02311608|Somatostatin|somatostatin|mesh-list
24540969|NCT00670345|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24540970|NCT00670345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24540972|NCT00670345|Hemostatics|hemostatics|mesh-ancestor
24860639|NCT02311608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24860640|NCT02311608|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24860641|NCT02311608|Hormones|hormones|mesh-ancestor
24860642|NCT02311608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24540990|NCT00670423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540991|NCT00670423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24540992|NCT00670423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540993|NCT00670423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540994|NCT00670423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24540995|NCT00670423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24540996|NCT00670423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24860658|NCT02311777|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24860659|NCT02311777|Anesthetics, General|anesthetics, general|mesh-ancestor
24860660|NCT02311777|Anesthetics|anesthetics|mesh-ancestor
24860661|NCT02311777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24860662|NCT02311777|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24540998|NCT00670423|Antifungal Agents|antifungal agents|mesh-ancestor
24540999|NCT00670436|Paclitaxel|paclitaxel|mesh-list
24541000|NCT00670436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24541001|NCT00670436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24541002|NCT00670436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541003|NCT00670436|Tubulin Modulators|tubulin modulators|mesh-ancestor
24541004|NCT00670436|Antimitotic Agents|antimitotic agents|mesh-ancestor
24541005|NCT00670436|Mitosis Modulators|mitosis modulators|mesh-ancestor
24541006|NCT00670436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541007|NCT00670475|Piroxicam|piroxicam|mesh-list
24860683|NCT02312037|Antibodies|antibodies|mesh-list
24860684|NCT02312037|Immunoconjugates|immunoconjugates|mesh-list
24541020|NCT00670501|Teriparatide|teriparatide|mesh-list
24541021|NCT00670501|Calcium|calcium|mesh-list
24541022|NCT00670501|Vitamins|vitamins|mesh-ancestor
24541023|NCT00670501|Micronutrients|micronutrients|mesh-ancestor
24541024|NCT00670501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541025|NCT00670501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24541026|NCT00670501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24541027|NCT00670553|Panobinostat|panobinostat|mesh-list
24655010|NCT01253473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24655011|NCT01253473|Autonomic Agents|autonomic agents|mesh-ancestor
24860685|NCT02312037|Immunologic Factors|immunologic factors|mesh-ancestor
24860686|NCT02312037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860687|NCT02312037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24860688|NCT02312037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24860689|NCT02312076|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24860690|NCT02312076|Luteolytic Agents|luteolytic agents|mesh-ancestor
24860691|NCT02312076|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24860692|NCT02312076|Contraceptive Agents|contraceptive agents|mesh-ancestor
24860693|NCT02312076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24860697|NCT02312076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541041|NCT00670566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24541042|NCT00670566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24541044|NCT00670618|Cariostatic Agents|cariostatic agents|mesh-ancestor
24541045|NCT00670618|Protective Agents|protective agents|mesh-ancestor
24541046|NCT00670618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541047|NCT00670657|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24541048|NCT00670657|Antifungal Agents|antifungal agents|mesh-ancestor
24541053|NCT00670670|Caseins|caseins|mesh-list
24860729|NCT02312232|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24860730|NCT02312232|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24860731|NCT02312232|Dopamine Agents|dopamine agents|mesh-ancestor
24860733|NCT02312232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860734|NCT02312232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860735|NCT02312232|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24860736|NCT02312232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860738|NCT02312297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24860751|NCT02312427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860752|NCT02312427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24860753|NCT02312427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860754|NCT02312440|Tranexamic Acid|tranexamic acid|mesh-list
24860755|NCT02312440|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24860756|NCT02312440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24860757|NCT02312440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860759|NCT02312440|Coagulants|coagulants|mesh-ancestor
24860760|NCT02312492|Palmitic Acid|palmitic acid|mesh-list
24682401|NCT01386242|Interferons|interferons|mesh-list
24860761|NCT02312492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860762|NCT02312492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860763|NCT02312531|Immunoglobulins|immunoglobulins|mesh-list
24860764|NCT02312531|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24860765|NCT02312531|Antibodies|antibodies|mesh-list
24860766|NCT02312531|Immunologic Factors|immunologic factors|mesh-ancestor
24860767|NCT02312531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860768|NCT02312544|Timolol|timolol|mesh-list
24860769|NCT02312544|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24860770|NCT02312544|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24860771|NCT02312544|Adrenergic Agents|adrenergic agents|mesh-ancestor
24860772|NCT02312544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24860776|NCT02312544|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24860778|NCT02312609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24860779|NCT02312609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24860781|NCT02312635|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24860800|NCT02312804|Paclitaxel|paclitaxel|mesh-list
24860801|NCT02312804|Carboplatin|carboplatin|mesh-list
24860802|NCT02312804|Infigratinib|infigratinib|mesh-list
24860803|NCT02312804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24860804|NCT02312804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541118|NCT00670878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541120|NCT00671008|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24541121|NCT00671008|Insulin Aspart|insulin aspart|mesh-list
24541122|NCT00671008|Insulin Detemir|insulin detemir|mesh-list
24655285|NCT01255579|Autonomic Agents|autonomic agents|mesh-ancestor
24655286|NCT01255579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24860805|NCT02312804|Tubulin Modulators|tubulin modulators|mesh-ancestor
24860806|NCT02312804|Antimitotic Agents|antimitotic agents|mesh-ancestor
24860807|NCT02312804|Mitosis Modulators|mitosis modulators|mesh-ancestor
24860809|NCT02312908|Clonazepam|clonazepam|mesh-list
24860813|NCT02312908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24860814|NCT02312908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860815|NCT02312908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860816|NCT02312999|Plasma-lyte 148|plasma-lyte 148|mesh-list
24860817|NCT02312999|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24860818|NCT02312999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24860819|NCT02313051|Everolimus|everolimus|mesh-list
24860820|NCT02313051|Letrozole|letrozole|mesh-list
24860821|NCT02313051|Goserelin|goserelin|mesh-list
24860822|NCT02313051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24860823|NCT02313051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24860824|NCT02313051|Immunologic Factors|immunologic factors|mesh-ancestor
24860825|NCT02313051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860826|NCT02313051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24860827|NCT02313051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24860828|NCT02313051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860829|NCT02313051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860830|NCT02313051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24541127|NCT00671112|Everolimus|everolimus|mesh-list
25707063|NCT02224729|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25707064|NCT02224729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25707065|NCT02224729|Antiemetics|antiemetics|mesh-ancestor
24860871|NCT02313337|Atracurium|atracurium|mesh-list
24860872|NCT02313337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24860873|NCT02313337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860874|NCT02313337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24860875|NCT02313337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24860876|NCT02313337|Anesthetics, General|anesthetics, general|mesh-ancestor
24860877|NCT02313337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24860878|NCT02313337|Narcotics|narcotics|mesh-ancestor
24541174|NCT00671320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24541175|NCT00671320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541176|NCT00671320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541182|NCT00671372|Cetuximab|cetuximab|mesh-list
24860994|NCT02314286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860883|NCT02313337|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24860884|NCT02313337|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24860885|NCT02313337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24860886|NCT02313337|GABA Modulators|gaba modulators|mesh-ancestor
24860887|NCT02313337|GABA Agents|gaba agents|mesh-ancestor
24860888|NCT02313337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24860889|NCT02313337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860890|NCT02313337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24860901|NCT02313584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860902|NCT02313584|Anticoagulants|anticoagulants|mesh-ancestor
24860904|NCT02313727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24860905|NCT02313727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24562181|NCT00764907|Glucocorticoids|glucocorticoids|mesh-ancestor
24860907|NCT02313805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24860908|NCT02313805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24860909|NCT02313883|Taurolidine|taurolidine|mesh-list
24860910|NCT02313883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24860911|NCT02313883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24860912|NCT02313883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24860913|NCT02313922|Etanercept|etanercept|mesh-list
24860914|NCT02313922|Methotrexate|methotrexate|mesh-list
24860915|NCT02313922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24860916|NCT02313922|Abortifacient Agents|abortifacient agents|mesh-ancestor
24860917|NCT02313922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24860918|NCT02313922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707066|NCT02224729|Autonomic Agents|autonomic agents|mesh-ancestor
25707067|NCT02224729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24860919|NCT02313922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24860920|NCT02313922|Antimetabolites|antimetabolites|mesh-ancestor
24860921|NCT02313922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860922|NCT02313922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24860923|NCT02313922|Dermatologic Agents|dermatologic agents|mesh-ancestor
24860924|NCT02313922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24860932|NCT02313922|Analgesics|analgesics|mesh-ancestor
24541233|NCT00671593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24541234|NCT00671632|Triazolam|triazolam|mesh-list
24541235|NCT00671632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24541236|NCT00671632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24541237|NCT00671632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24541238|NCT00671632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24541239|NCT00671632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541240|NCT00671632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24860939|NCT02314013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24860940|NCT02314013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24541243|NCT00671632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24541244|NCT00671632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541245|NCT00671645|Bevacizumab|bevacizumab|mesh-list
24541246|NCT00671645|Capecitabine|capecitabine|mesh-list
24541247|NCT00671645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24541248|NCT00671645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541249|NCT00671645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24541257|NCT00671697|Decitabine|decitabine|mesh-list
24860972|NCT02314208|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24541270|NCT00671801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24541271|NCT00671801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541272|NCT00671801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541273|NCT00671801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24860991|NCT02314286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24860993|NCT02314286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24451427|NCT00323687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451428|NCT00323687|Antiviral Agents|antiviral agents|mesh-ancestor
24451429|NCT00323687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24623229|NCT01070680|Sensory System Agents|sensory system agents|mesh-ancestor
24623230|NCT01070680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24623231|NCT01070680|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24623232|NCT01070680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24861005|NCT02314312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24861007|NCT02314312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24861008|NCT02314312|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24861009|NCT02314312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861010|NCT02314312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24861011|NCT02314312|Glucocorticoids|glucocorticoids|mesh-ancestor
24861013|NCT02314312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24861014|NCT02314312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24861015|NCT02314325|Factor VIII|factor viii|mesh-list
24541306|NCT00672165|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24541307|NCT00672165|Immunologic Factors|immunologic factors|mesh-ancestor
24541308|NCT00672165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541309|NCT00672282|Bicalutamide|bicalutamide|mesh-list
24541310|NCT00672282|Androgen Antagonists|androgen antagonists|mesh-ancestor
24541311|NCT00672282|Hormone Antagonists|hormone antagonists|mesh-ancestor
24541312|NCT00672282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24861094|NCT02314754|Luteolytic Agents|luteolytic agents|mesh-ancestor
24861095|NCT02314754|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24861097|NCT02314806|Clindamycin|clindamycin|mesh-list
24861113|NCT02314871|Analgesics|analgesics|mesh-ancestor
24861114|NCT02314871|Sensory System Agents|sensory system agents|mesh-ancestor
24450811|NCT00320658|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24541410|NCT00672659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24541411|NCT00672659|Antidepressive Agents|antidepressive agents|mesh-ancestor
24541412|NCT00672659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24541413|NCT00672659|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24541414|NCT00672659|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24541415|NCT00672659|Parasympatholytics|parasympatholytics|mesh-ancestor
24861126|NCT02315118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861127|NCT02315118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24861128|NCT02315157|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24861129|NCT02315157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24861130|NCT02315157|Alkylating Agents|alkylating agents|mesh-ancestor
24861131|NCT02315157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861132|NCT02315157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861133|NCT02315196|Paclitaxel|paclitaxel|mesh-list
24861134|NCT02315196|Carboplatin|carboplatin|mesh-list
24861165|NCT02315495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861166|NCT02315495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24861167|NCT02315495|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24541460|NCT00672919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541461|NCT00672971|Permethrin|permethrin|mesh-list
24541462|NCT00672971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25707069|NCT02224729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25707070|NCT02224729|Glucocorticoids|glucocorticoids|mesh-ancestor
25707071|NCT02224729|Hormones|hormones|mesh-ancestor
25707072|NCT02224729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25707073|NCT02224729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25707074|NCT02224729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541479|NCT00673218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24541480|NCT00673218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25707075|NCT02224729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25707076|NCT02224729|Alkylating Agents|alkylating agents|mesh-ancestor
25707077|NCT02224729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707078|NCT02224846|Tadalafil|tadalafil|mesh-list
25707079|NCT02224846|Vasodilator Agents|vasodilator agents|mesh-ancestor
25707080|NCT02224846|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25707081|NCT02224846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25707082|NCT02224846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25707083|NCT02224846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707084|NCT02224846|Urological Agents|urological agents|mesh-ancestor
25707085|NCT02225106|Methylphenidate|methylphenidate|mesh-list
24861206|NCT02315690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24861207|NCT02315690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24861208|NCT02315690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24541497|NCT00673426|Anticoagulants|anticoagulants|mesh-ancestor
24541498|NCT00673426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24541499|NCT00673426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24541500|NCT00673426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541501|NCT00673504|Gemcitabine|gemcitabine|mesh-list
24861212|NCT02315950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861213|NCT02315950|Cholinergic Agents|cholinergic agents|mesh-ancestor
24861214|NCT02315950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24861215|NCT02315950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861217|NCT02316028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24861218|NCT02316028|Antimetabolites|antimetabolites|mesh-ancestor
24861219|NCT02316028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861220|NCT02316028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861221|NCT02316028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24861224|NCT02316197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24861225|NCT02316197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861227|NCT02316249|Hormones|hormones|mesh-ancestor
24861228|NCT02316249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24861229|NCT02316249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861230|NCT02316249|Estrogens|estrogens|mesh-ancestor
24861231|NCT02316301|Misoprostol|misoprostol|mesh-list
25707088|NCT02225106|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25707089|NCT02225106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25707090|NCT02225106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25707091|NCT02225106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707092|NCT02225106|Dopamine Agents|dopamine agents|mesh-ancestor
25707093|NCT02225106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707094|NCT02225132|Hydroxyurea|hydroxyurea|mesh-list
24541510|NCT00673504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24861232|NCT02316301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24861233|NCT02316301|Abortifacient Agents|abortifacient agents|mesh-ancestor
24861234|NCT02316301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24861235|NCT02316301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861242|NCT02316327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861243|NCT02316327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24861244|NCT02316327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24861245|NCT02316327|Growth Substances|growth substances|mesh-ancestor
24861246|NCT02316327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541542|NCT00673621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861269|NCT02316379|Anesthetics, General|anesthetics, general|mesh-ancestor
24861271|NCT02316379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24861272|NCT02316379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861273|NCT02316496|Irinotecan|irinotecan|mesh-list
24861274|NCT02316496|Cetuximab|cetuximab|mesh-list
24861275|NCT02316496|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24813333|NCT02057796|Antimetabolites|antimetabolites|mesh-ancestor
24541544|NCT00673621|Autonomic Agents|autonomic agents|mesh-ancestor
24541545|NCT00673621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24541546|NCT00673621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24656764|NCT01263860|Immunologic Factors|immunologic factors|mesh-ancestor
24656765|NCT01263860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656766|NCT01263951|Everolimus|everolimus|mesh-list
24656767|NCT01263951|Sorafenib|sorafenib|mesh-list
25707096|NCT02225132|Antisickling Agents|antisickling agents|mesh-ancestor
25707099|NCT02225132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24541632|NCT00674232|Abortifacient Agents|abortifacient agents|mesh-ancestor
24541633|NCT00674232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24541634|NCT00674232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861331|NCT02317146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24861342|NCT02317159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24541649|NCT00674310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24541650|NCT00674310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657275|NCT01266655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541651|NCT00674310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541652|NCT00674414|Trastuzumab|trastuzumab|mesh-list
24541653|NCT00674414|Everolimus|everolimus|mesh-list
24861349|NCT02317198|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24861350|NCT02317198|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24861351|NCT02317198|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24861353|NCT02317198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24861354|NCT02317198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861355|NCT02317198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861356|NCT02317237|Anesthetics|anesthetics|mesh-list
24861357|NCT02317237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24541663|NCT00674557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24541664|NCT00674557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541665|NCT00674557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541666|NCT00674557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24861362|NCT02317263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24861363|NCT02317263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861364|NCT02317341|Midazolam|midazolam|mesh-list
24861365|NCT02317341|Ketamine|ketamine|mesh-list
24861366|NCT02317341|Analgesics|analgesics|mesh-ancestor
24861367|NCT02317341|Sensory System Agents|sensory system agents|mesh-ancestor
24657299|NCT01266707|Vaccines|vaccines|mesh-list
25707100|NCT02225353|Progesterone|progesterone|mesh-list
25707101|NCT02225353|Progestins|progestins|mesh-ancestor
25707102|NCT02225353|Hormones|hormones|mesh-ancestor
25707103|NCT02225353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24861408|NCT02317484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861409|NCT02317497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
24861411|NCT02317601|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24861413|NCT02317601|Prednisolone|prednisolone|mesh-list
24861420|NCT02317601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24861421|NCT02317601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541678|NCT00674596|Protease Inhibitors|protease inhibitors|mesh-ancestor
24541679|NCT00674596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24861438|NCT02317679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861442|NCT02317770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24861443|NCT02317770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861444|NCT02317770|Sensory System Agents|sensory system agents|mesh-ancestor
24861445|NCT02317770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24861446|NCT02317770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24861447|NCT02317770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24861448|NCT02317770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24861449|NCT02317770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24861450|NCT02317770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861451|NCT02317861|Febuxostat|febuxostat|mesh-list
24541695|NCT00674687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24541696|NCT00674687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24541697|NCT00674687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24541698|NCT00674687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24541699|NCT00674687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25707106|NCT02225587|Immunologic Factors|immunologic factors|mesh-ancestor
25707107|NCT02225587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707108|NCT02225665|Cyclophosphamide|cyclophosphamide|mesh-list
25707109|NCT02225665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25707110|NCT02225665|Immunologic Factors|immunologic factors|mesh-ancestor
25707111|NCT02225665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707112|NCT02225665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25707113|NCT02225665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24541704|NCT00674713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24541714|NCT00674713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24541715|NCT00674713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541716|NCT00674713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24541717|NCT00674713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24541718|NCT00674713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24541719|NCT00674713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24541720|NCT00674713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24541722|NCT00674752|Analgesics|analgesics|mesh-ancestor
24861482|NCT02318043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24861483|NCT02318043|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24861484|NCT02318043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24861485|NCT02318043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24861486|NCT02318043|Adrenergic Agents|adrenergic agents|mesh-ancestor
24861488|NCT02318043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861489|NCT02318043|Sympathomimetics|sympathomimetics|mesh-ancestor
24861490|NCT02318056|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24861492|NCT02318056|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24861521|NCT02318225|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24861522|NCT02318225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24861523|NCT02318225|Oxytocics|oxytocics|mesh-ancestor
24861524|NCT02318290|Analgesics|analgesics|mesh-list
24861525|NCT02318290|Narcotics|narcotics|mesh-list
24861526|NCT02318290|Sensory System Agents|sensory system agents|mesh-ancestor
24861527|NCT02318290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24861528|NCT02318290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861530|NCT02318433|Dexamethasone|dexamethasone|mesh-list
24861543|NCT02318446|Hematinics|hematinics|mesh-ancestor
24861544|NCT02318446|Vitamin B Complex|vitamin b complex|mesh-ancestor
24861545|NCT02318446|Vitamins|vitamins|mesh-ancestor
24861546|NCT02318446|Micronutrients|micronutrients|mesh-ancestor
24861547|NCT02318446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861548|NCT02318511|Hyaluronic Acid|hyaluronic acid|mesh-list
24861554|NCT02318537|Cannabidiol|cannabidiol|mesh-list
24861555|NCT02318537|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24861556|NCT02318537|Anticonvulsants|anticonvulsants|mesh-ancestor
24861557|NCT02318563|Cannabidiol|cannabidiol|mesh-list
24861558|NCT02318563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24861559|NCT02318563|Anticonvulsants|anticonvulsants|mesh-ancestor
24861560|NCT02318758|Ethanol|ethanol|mesh-list
24861561|NCT02318758|Treprostinil|treprostinil|mesh-list
24861562|NCT02318758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24861563|NCT02318758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24861564|NCT02318758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24813404|NCT02058303|Sensory System Agents|sensory system agents|mesh-ancestor
24861568|NCT02318771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25707115|NCT02225665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861569|NCT02318771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24861570|NCT02318810|Rocuronium|rocuronium|mesh-list
25707116|NCT02225665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25707117|NCT02225665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25707118|NCT02226003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24541748|NCT00674999|Nystatin|nystatin|mesh-list
24541749|NCT00674999|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24541750|NCT00674999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24541751|NCT00674999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24541752|NCT00674999|Antifungal Agents|antifungal agents|mesh-ancestor
24541753|NCT00674999|Ionophores|ionophores|mesh-ancestor
24541754|NCT00674999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24541755|NCT00674999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541756|NCT00675012|Capecitabine|capecitabine|mesh-list
24541757|NCT00675012|Oxaliplatin|oxaliplatin|mesh-list
24541758|NCT00675012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24541760|NCT00675012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541761|NCT00675012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541762|NCT00675181|Melatonin|melatonin|mesh-list
24541763|NCT00675181|Antioxidants|antioxidants|mesh-ancestor
24541764|NCT00675181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861587|NCT02318836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861588|NCT02318888|Icodextrin|icodextrin|mesh-list
24861589|NCT02318888|Dialysis Solutions|dialysis solutions|mesh-ancestor
24861590|NCT02318888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24861591|NCT02319018|Calcium, Dietary|calcium, dietary|mesh-list
24861592|NCT02319018|Leucovorin|leucovorin|mesh-list
24861593|NCT02319018|Folic Acid|folic acid|mesh-list
24861594|NCT02319018|Fluorouracil|fluorouracil|mesh-list
24861595|NCT02319018|Oxaliplatin|oxaliplatin|mesh-list
24861596|NCT02319018|Calcium|calcium|mesh-list
24861597|NCT02319018|Levoleucovorin|levoleucovorin|mesh-list
24861601|NCT02319018|Antimetabolites|antimetabolites|mesh-ancestor
24541775|NCT00675194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24541776|NCT00675194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541777|NCT00675207|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24541778|NCT00675207|Dorzolamide|dorzolamide|mesh-list
24541779|NCT00675207|Brinzolamide|brinzolamide|mesh-list
24541780|NCT00675207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24541781|NCT00675207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24541782|NCT00675207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24541783|NCT00675207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25707119|NCT02226003|Glimepiride|glimepiride|mesh-list
25707120|NCT02226003|Ertugliflozin|ertugliflozin|mesh-list
25707121|NCT02226003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25707122|NCT02226003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707123|NCT02226003|Incretins|incretins|mesh-ancestor
25707124|NCT02226003|Hormones|hormones|mesh-ancestor
25707125|NCT02226003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25707126|NCT02226003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25707127|NCT02226003|Protease Inhibitors|protease inhibitors|mesh-ancestor
24657657|NCT01268761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24657659|NCT01268839|Rilpivirine|rilpivirine|mesh-list
24657660|NCT01268839|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24861655|NCT02319278|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24861656|NCT02319278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24861657|NCT02319343|Methylprednisolone|methylprednisolone|mesh-list
24861689|NCT02319564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24861690|NCT02319564|Autonomic Agents|autonomic agents|mesh-ancestor
24861691|NCT02319564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24861692|NCT02319564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861693|NCT02319564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24861694|NCT02319564|Respiratory System Agents|respiratory system agents|mesh-ancestor
24861695|NCT02319564|Tocolytic Agents|tocolytic agents|mesh-ancestor
24861696|NCT02319564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24861697|NCT02319564|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24861698|NCT02319564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24861699|NCT02319564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24861700|NCT02319564|Adrenergic Agents|adrenergic agents|mesh-ancestor
24861701|NCT02319564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24861702|NCT02319564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861703|NCT02319564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24861704|NCT02319564|Glucocorticoids|glucocorticoids|mesh-ancestor
24861706|NCT02319564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24861707|NCT02319577|Vinorelbine|vinorelbine|mesh-list
24541790|NCT00675220|Insulin Aspart|insulin aspart|mesh-list
24541800|NCT00675246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24541801|NCT00675246|Respiratory System Agents|respiratory system agents|mesh-ancestor
24541802|NCT00675246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24541803|NCT00675246|Autonomic Agents|autonomic agents|mesh-ancestor
24541804|NCT00675246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24541805|NCT00675272|Hydrocortisone|hydrocortisone|mesh-list
24541806|NCT00675272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24541807|NCT00675285|Montelukast|montelukast|mesh-list
24541808|NCT00675285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24861747|NCT02319915|Coagulants|coagulants|mesh-ancestor
24861748|NCT02319941|Clopidogrel|clopidogrel|mesh-list
24861749|NCT02319941|Ticagrelor|ticagrelor|mesh-list
25707130|NCT02226003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25707131|NCT02226003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25707132|NCT02226003|Immunologic Factors|immunologic factors|mesh-ancestor
25707133|NCT02226003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25707134|NCT02226120|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24541819|NCT00675350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541820|NCT00675350|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24541821|NCT00675350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541822|NCT00675350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861761|NCT02320032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24861762|NCT02320032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24861763|NCT02320032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24861766|NCT02320032|Dopamine Agonists|dopamine agonists|mesh-ancestor
24861767|NCT02320032|Dopamine Agents|dopamine agents|mesh-ancestor
24861768|NCT02320032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24861769|NCT02320032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24861770|NCT02320032|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24861771|NCT02320032|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24861772|NCT02320032|Serotonin Agents|serotonin agents|mesh-ancestor
24861773|NCT02320032|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24861774|NCT02320032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24861775|NCT02320032|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24861792|NCT02320240|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24541824|NCT00675493|Biphasic Insulins|biphasic insulins|mesh-list
24541825|NCT00675493|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24541826|NCT00675493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24541828|NCT00675545|Carboplatin|carboplatin|mesh-list
24541829|NCT00675545|Docetaxel|docetaxel|mesh-list
25707135|NCT02226120|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25707136|NCT02226120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707137|NCT02226198|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25707138|NCT02226198|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25707139|NCT02226198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25707140|NCT02226198|Antimetabolites|antimetabolites|mesh-ancestor
25707141|NCT02226198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707142|NCT02226198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25707143|NCT02226198|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25707144|NCT02226198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451545|NCT00324129|Mocetinostat|mocetinostat|mesh-list
24451546|NCT00324129|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24451547|NCT00324129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24861898|NCT02321267|Dermatologic Agents|dermatologic agents|mesh-ancestor
24861899|NCT02321280|Denosumab|denosumab|mesh-list
24861900|NCT02321280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24861901|NCT02321280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861902|NCT02321293|Curcumin|curcumin|mesh-list
24861911|NCT02321293|Analgesics|analgesics|mesh-ancestor
24861912|NCT02321293|Sensory System Agents|sensory system agents|mesh-ancestor
24861913|NCT02321293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24861915|NCT02321293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24541846|NCT00675688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24541847|NCT00675688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451548|NCT00324129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707145|NCT02226549|Sofosbuvir|sofosbuvir|mesh-list
25707146|NCT02226549|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25707147|NCT02226549|Ledipasvir|ledipasvir|mesh-list
25707148|NCT02226549|Antiviral Agents|antiviral agents|mesh-ancestor
25707149|NCT02226549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25707150|NCT02226562|Listerine|listerine|mesh-list
25707151|NCT02226562|Fluorides|fluorides|mesh-list
25707152|NCT02226562|Sodium Fluoride|sodium fluoride|mesh-list
25707153|NCT02226562|Cariostatic Agents|cariostatic agents|mesh-ancestor
25707154|NCT02226562|Protective Agents|protective agents|mesh-ancestor
25707155|NCT02226562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707156|NCT02226562|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25707157|NCT02226562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25707158|NCT02226653|Evacetrapib|evacetrapib|mesh-list
24541889|NCT00675714|Vasodilator Agents|vasodilator agents|mesh-ancestor
24541890|NCT00675714|Antifungal Agents|antifungal agents|mesh-ancestor
24541891|NCT00675714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24541892|NCT00675714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24861970|NCT02321579|Vitamins|vitamins|mesh-ancestor
24861971|NCT02321579|Micronutrients|micronutrients|mesh-ancestor
24861972|NCT02321579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24861973|NCT02321579|Vitamin B Complex|vitamin b complex|mesh-ancestor
24861974|NCT02321761|Amantadine|amantadine|mesh-list
24861975|NCT02321761|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24861976|NCT02321761|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24861977|NCT02321761|Antiviral Agents|antiviral agents|mesh-ancestor
24861979|NCT02321761|Dopamine Agents|dopamine agents|mesh-ancestor
24541903|NCT00675714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24861998|NCT02321852|Natriuretic Agents|natriuretic agents|mesh-ancestor
24861999|NCT02321852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862000|NCT02321852|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24862002|NCT02321878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24862003|NCT02321878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862004|NCT02321878|Incretins|incretins|mesh-ancestor
24862005|NCT02321878|Hormones|hormones|mesh-ancestor
24862006|NCT02321878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24862007|NCT02322008|Adalimumab|adalimumab|mesh-list
24862008|NCT02322008|Infliximab|infliximab|mesh-list
24862074|NCT02322658|Eszopiclone|eszopiclone|mesh-list
24862075|NCT02322658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24862076|NCT02322658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24813433|NCT02058485|Analgesics|analgesics|mesh-ancestor
24813434|NCT02058485|Sensory System Agents|sensory system agents|mesh-ancestor
24541938|NCT00675961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24541939|NCT00676039|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24541940|NCT00676039|Citalopram|citalopram|mesh-list
24541941|NCT00676039|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24541942|NCT00676039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24541943|NCT00676039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25707160|NCT02226653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25707161|NCT02226653|Antimetabolites|antimetabolites|mesh-ancestor
25707162|NCT02226653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707163|NCT02226653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25707164|NCT02227108|Immunotoxin HA22|immunotoxin ha22|mesh-list
24862139|NCT02323399|Phenylephrine|phenylephrine|mesh-list
24862140|NCT02323399|Oxymetazoline|oxymetazoline|mesh-list
24862141|NCT02323399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24862142|NCT02323399|Mydriatics|mydriatics|mesh-ancestor
24862143|NCT02323399|Autonomic Agents|autonomic agents|mesh-ancestor
24542032|NCT00676468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24542033|NCT00676468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542034|NCT00676533|Ciprofloxacin|ciprofloxacin|mesh-list
24444155|NCT00296790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24444156|NCT00296790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444157|NCT00296803|Clopidogrel|clopidogrel|mesh-list
24444158|NCT00296803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24444163|NCT00296803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707166|NCT02227316|Acetaminophen|acetaminophen|mesh-list
25707167|NCT02227316|Ibuprofen|ibuprofen|mesh-list
25707168|NCT02227316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25707169|NCT02227316|Analgesics|analgesics|mesh-ancestor
25707170|NCT02227316|Sensory System Agents|sensory system agents|mesh-ancestor
25707171|NCT02227316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24862213|NCT02323594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25707174|NCT02227316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24542173|NCT00677300|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24542174|NCT00677300|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25709740|NCT02274311|Zuclomiphene|zuclomiphene|mesh-list
25709741|NCT02274311|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25709742|NCT02274311|Hormone Antagonists|hormone antagonists|mesh-ancestor
24542324|NCT00678314|Ropivacaine|ropivacaine|mesh-list
24542325|NCT00678314|Anesthetics, Local|anesthetics, local|mesh-ancestor
24542326|NCT00678314|Anesthetics|anesthetics|mesh-ancestor
24542327|NCT00678314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24542328|NCT00678314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542329|NCT00678314|Sensory System Agents|sensory system agents|mesh-ancestor
24862563|NCT05118737|Tubulin Modulators|tubulin modulators|mesh-ancestor
24862564|NCT05118737|Antimitotic Agents|antimitotic agents|mesh-ancestor
24862565|NCT05118737|Mitosis Modulators|mitosis modulators|mesh-ancestor
24862566|NCT05118737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862567|NCT05118737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24862569|NCT05118685|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24862570|NCT05118685|Hormones|hormones|mesh-ancestor
24862571|NCT05118685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24862572|NCT05118685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542354|NCT00678327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24542355|NCT00678327|Tubulin Modulators|tubulin modulators|mesh-ancestor
24542356|NCT00678327|Antimitotic Agents|antimitotic agents|mesh-ancestor
24542357|NCT00678327|Mitosis Modulators|mitosis modulators|mesh-ancestor
24542358|NCT00678327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25707182|NCT02227329|Calcium heparin|calcium heparin|mesh-list
25707183|NCT02227329|Anticoagulants|anticoagulants|mesh-ancestor
25707184|NCT02227329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24542359|NCT00678327|Glucocorticoids|glucocorticoids|mesh-ancestor
24542360|NCT00678327|Hormones|hormones|mesh-ancestor
24542361|NCT00678327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24542362|NCT00678327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24542363|NCT00678431|Resveratrol|resveratrol|mesh-list
25707185|NCT02227329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25707186|NCT02227329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707187|NCT02227329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24862612|NCT05021913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24862639|NCT04881955|Dopamine Agents|dopamine agents|mesh-ancestor
24862640|NCT04881955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24862641|NCT04881955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24862642|NCT04850222|Fluoxetine|fluoxetine|mesh-list
24862643|NCT04850222|Calcium|calcium|mesh-list
24862644|NCT04850222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24542421|NCT00678613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24542422|NCT00678626|Docetaxel|docetaxel|mesh-list
24542423|NCT00678626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542424|NCT00678626|Tubulin Modulators|tubulin modulators|mesh-ancestor
24542425|NCT00678626|Antimitotic Agents|antimitotic agents|mesh-ancestor
24542426|NCT00678626|Mitosis Modulators|mitosis modulators|mesh-ancestor
24542427|NCT00678626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542428|NCT00678704|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24542429|NCT00678704|Vasodilator Agents|vasodilator agents|mesh-ancestor
24542430|NCT00678704|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24542431|NCT00678704|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24542432|NCT00678704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542456|NCT00678769|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24542457|NCT00678769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24862703|NCT04715191|Immunologic Factors|immunologic factors|mesh-ancestor
24862704|NCT04715191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707188|NCT02227329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25707189|NCT02227329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25707190|NCT02227329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707191|NCT02227368|Aspirin|aspirin|mesh-list
24862720|NCT04703361|Vitamins|vitamins|mesh-ancestor
24862721|NCT04703361|Micronutrients|micronutrients|mesh-ancestor
25707192|NCT02227368|Ticagrelor|ticagrelor|mesh-list
25707193|NCT02227368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25707194|NCT02227368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25707195|NCT02227368|Analgesics|analgesics|mesh-ancestor
25707196|NCT02227368|Sensory System Agents|sensory system agents|mesh-ancestor
25707197|NCT02227368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24444113|NCT00296751|Bupivacaine|bupivacaine|mesh-list
24444114|NCT00296751|Anesthetics, Local|anesthetics, local|mesh-ancestor
25707198|NCT02227368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540627|NCT00668759|Amiodarone|amiodarone|mesh-list
24862722|NCT04703361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862723|NCT04674241|Dexmedetomidine|dexmedetomidine|mesh-list
24862724|NCT04674241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24862725|NCT04674241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24862726|NCT04674241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24862727|NCT04674241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24862728|NCT04674241|Analgesics|analgesics|mesh-ancestor
24862729|NCT04674241|Sensory System Agents|sensory system agents|mesh-ancestor
24542484|NCT00678964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24542485|NCT00678964|Tubulin Modulators|tubulin modulators|mesh-ancestor
24542486|NCT00678964|Antimitotic Agents|antimitotic agents|mesh-ancestor
24862747|NCT04600895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24862748|NCT04558359|Angiotensin II|angiotensin ii|mesh-list
24862750|NCT04558359|Angiotensinogen|angiotensinogen|mesh-list
24862751|NCT04558359|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24862752|NCT04558359|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24862763|NCT04496908|Abortifacient Agents|abortifacient agents|mesh-ancestor
24862764|NCT04496908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24542536|NCT00679146|Mitosis Modulators|mitosis modulators|mesh-ancestor
24862780|NCT04382924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24862785|NCT04382924|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24813508|NCT02058823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24813509|NCT02058823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24813510|NCT02058823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24813511|NCT02058823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813512|NCT02058823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24542537|NCT00679146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542538|NCT00679159|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24542539|NCT00679159|Immunologic Factors|immunologic factors|mesh-ancestor
24542540|NCT00679159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542541|NCT00679224|Ambrisentan|ambrisentan|mesh-list
24542542|NCT00679224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24542543|NCT00679237|Metformin|metformin|mesh-list
24542544|NCT00679237|Glimepiride|glimepiride|mesh-list
24542545|NCT00679237|Ezetimibe|ezetimibe|mesh-list
24813533|NCT02058875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24813534|NCT02058875|Dermatologic Agents|dermatologic agents|mesh-ancestor
24813535|NCT02058875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24813536|NCT02058875|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24813537|NCT02058875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24813538|NCT02058875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24813539|NCT02058875|Antitubercular Agents|antitubercular agents|mesh-ancestor
24813540|NCT02058875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24813541|NCT02058901|Sunitinib|sunitinib|mesh-list
24813542|NCT02058901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813543|NCT02058901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24813544|NCT02058901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24813545|NCT02058901|Growth Substances|growth substances|mesh-ancestor
24813546|NCT02058901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707199|NCT02227368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25707200|NCT02227368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25707201|NCT02227368|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25707202|NCT02227368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24813547|NCT02058901|Growth Inhibitors|growth inhibitors|mesh-ancestor
25707203|NCT02227368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707204|NCT02227368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25707205|NCT02227368|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25707206|NCT02227368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25707207|NCT02227368|Antipyretics|antipyretics|mesh-ancestor
24542771|NCT00680329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542833|NCT00680498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24542834|NCT00680498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24542835|NCT00680498|Growth Substances|growth substances|mesh-ancestor
24474812|NCT00407459|Bevacizumab|bevacizumab|mesh-list
24628505|NCT01099436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24806120|NCT02013856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806121|NCT02013856|Protective Agents|protective agents|mesh-ancestor
24806122|NCT02013856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806124|NCT02013856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24806125|NCT02013856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24806126|NCT02013895|Technetium Tc 99m DTPA-galactosyl-human serum albumin|technetium tc 99m dtpa-galactosyl-human serum albumin|mesh-list
24806127|NCT02013895|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24806128|NCT02013895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806129|NCT02013960|Misoprostol|misoprostol|mesh-list
24806130|NCT02013960|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24806153|NCT02013986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806154|NCT02014064|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24806155|NCT02014064|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24806156|NCT02014064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24806157|NCT02014064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24806158|NCT02014064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806159|NCT02014064|Adrenergic Agents|adrenergic agents|mesh-ancestor
24806160|NCT02014064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24806161|NCT02014064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806162|NCT02014103|Tacrolimus|tacrolimus|mesh-list
24806163|NCT02014103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24806164|NCT02014103|Immunologic Factors|immunologic factors|mesh-ancestor
24806165|NCT02014103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446631|NCT00305500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24475224|NCT00409461|Antifungal Agents|antifungal agents|mesh-ancestor
24475226|NCT00409526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24475227|NCT00409526|Vasodilator Agents|vasodilator agents|mesh-ancestor
24475229|NCT00409591|Lopinavir|lopinavir|mesh-list
24475230|NCT00409591|Zidovudine|zidovudine|mesh-list
24475231|NCT00409591|Nevirapine|nevirapine|mesh-list
25707217|NCT02227485|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25707218|NCT02227485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25707219|NCT02227485|Disinfectants|disinfectants|mesh-ancestor
25707220|NCT02227667|Durvalumab|durvalumab|mesh-list
25707221|NCT02227667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25707222|NCT02227667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25707223|NCT02227706|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25707224|NCT02227706|Hemostatics|hemostatics|mesh-ancestor
24475232|NCT00409591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24475233|NCT00409591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24475234|NCT00409591|Protease Inhibitors|protease inhibitors|mesh-ancestor
24475245|NCT00409591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24600967|NCT00961467|Immunologic Factors|immunologic factors|mesh-ancestor
24600968|NCT00961467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24806186|NCT02014428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24806187|NCT02014428|Immunologic Factors|immunologic factors|mesh-ancestor
24806188|NCT02014428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806189|NCT02014428|Viscosupplements|viscosupplements|mesh-ancestor
24446700|NCT00305708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24446701|NCT00305708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24446704|NCT00305734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24446705|NCT00305734|Antimetabolites|antimetabolites|mesh-ancestor
24475315|NCT00409890|Autonomic Agents|autonomic agents|mesh-ancestor
24475327|NCT00409903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24475351|NCT00409994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24475352|NCT00409994|Antifungal Agents|antifungal agents|mesh-ancestor
24475353|NCT00409994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24475354|NCT00409994|Immunologic Factors|immunologic factors|mesh-ancestor
24475355|NCT00409994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475387|NCT00410306|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24475388|NCT00410306|Androgens|androgens|mesh-ancestor
24475389|NCT00410306|Hormones|hormones|mesh-ancestor
24475395|NCT00410345|Mifepristone|mifepristone|mesh-list
24475422|NCT00410371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24806209|NCT02014506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24806210|NCT02014506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24475453|NCT00410553|Gemcitabine|gemcitabine|mesh-list
24475454|NCT00410553|Halichondrin B|halichondrin b|mesh-list
24475455|NCT00410553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24475456|NCT00410553|Antimetabolites|antimetabolites|mesh-ancestor
24475457|NCT00410553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475458|NCT00410553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24475459|NCT00410553|Antiviral Agents|antiviral agents|mesh-ancestor
24475460|NCT00410553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24475461|NCT00410553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24475462|NCT00410553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24475463|NCT00410553|Immunologic Factors|immunologic factors|mesh-ancestor
24806212|NCT02014506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806214|NCT02014506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24575553|NCT00832364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24475532|NCT00410657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475533|NCT00410657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24475534|NCT00410657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24475535|NCT00410657|Antiemetics|antiemetics|mesh-ancestor
24475536|NCT00410657|Autonomic Agents|autonomic agents|mesh-ancestor
24806218|NCT02014532|Respiratory System Agents|respiratory system agents|mesh-ancestor
24806219|NCT02014532|Hormone Antagonists|hormone antagonists|mesh-ancestor
24806220|NCT02014532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24806223|NCT02014532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24806224|NCT02014532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806226|NCT02014545|Schistosomicides|schistosomicides|mesh-ancestor
24806227|NCT02014545|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24806228|NCT02014545|Anthelmintics|anthelmintics|mesh-ancestor
24806229|NCT02014545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24806230|NCT02014545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24475537|NCT00410657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24475538|NCT00410657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24475539|NCT00410657|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24475540|NCT00410657|Protective Agents|protective agents|mesh-ancestor
24475541|NCT00410657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24475542|NCT00410696|Lenograstim|lenograstim|mesh-list
24475543|NCT00410696|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24475544|NCT00410696|Immunologic Factors|immunologic factors|mesh-ancestor
24475545|NCT00410696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475546|NCT00410735|Pranlukast|pranlukast|mesh-list
24475547|NCT00410735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24475553|NCT00410748|Hydromorphone|hydromorphone|mesh-list
24475554|NCT00410748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24475555|NCT00410748|Narcotics|narcotics|mesh-ancestor
24475556|NCT00410748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24475557|NCT00410748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806248|NCT02014558|Antifungal Agents|antifungal agents|mesh-ancestor
24475589|NCT00410852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475590|NCT00410878|Hydromorphone|hydromorphone|mesh-list
24475591|NCT00410878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24475592|NCT00410878|Narcotics|narcotics|mesh-ancestor
24475593|NCT00410878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24475594|NCT00410878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475595|NCT00410878|Analgesics|analgesics|mesh-ancestor
24475596|NCT00410878|Sensory System Agents|sensory system agents|mesh-ancestor
24475597|NCT00410878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24475598|NCT00410943|Hydromorphone|hydromorphone|mesh-list
24475599|NCT00410943|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24475600|NCT00410943|Narcotics|narcotics|mesh-ancestor
24475601|NCT00410943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24475670|NCT00411047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24475671|NCT00411047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24475672|NCT00411047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475673|NCT00411073|Darapladib|darapladib|mesh-list
24475674|NCT00411073|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
24475675|NCT00411073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24475676|NCT00411073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475677|NCT00411125|Calcitonin|calcitonin|mesh-list
24475678|NCT00411125|Salmon calcitonin|salmon calcitonin|mesh-list
24475679|NCT00411125|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
24475680|NCT00411125|Katacalcin|katacalcin|mesh-list
24806251|NCT02014558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24806252|NCT02014558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24806253|NCT02014558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24806254|NCT02014558|Hormone Antagonists|hormone antagonists|mesh-ancestor
24806255|NCT02014558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24475693|NCT00411190|Acetaminophen|acetaminophen|mesh-list
24475695|NCT00411190|Atorvastatin|atorvastatin|mesh-list
24475696|NCT00411190|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24475697|NCT00411190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24475698|NCT00411190|Antimetabolites|antimetabolites|mesh-ancestor
24475712|NCT00411190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24475714|NCT00411203|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25707225|NCT02227706|Coagulants|coagulants|mesh-ancestor
25707226|NCT02227784|Atorvastatin|atorvastatin|mesh-list
25707227|NCT02227784|Ezetimibe|ezetimibe|mesh-list
25707228|NCT02227784|Evacetrapib|evacetrapib|mesh-list
25707229|NCT02227784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25707230|NCT02227784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25707231|NCT02227784|Antimetabolites|antimetabolites|mesh-ancestor
25707232|NCT02227784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707233|NCT02227784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25707234|NCT02227784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25707235|NCT02227784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24475745|NCT00411281|Immunologic Factors|immunologic factors|mesh-ancestor
24475746|NCT00411281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475747|NCT00411307|Hydromorphone|hydromorphone|mesh-list
24475748|NCT00411307|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24475749|NCT00411307|Narcotics|narcotics|mesh-ancestor
24475752|NCT00411307|Analgesics|analgesics|mesh-ancestor
24806308|NCT02014922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806309|NCT02014922|Protective Agents|protective agents|mesh-ancestor
24806310|NCT02014922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806311|NCT02014922|Vitamins|vitamins|mesh-ancestor
24806312|NCT02014922|Micronutrients|micronutrients|mesh-ancestor
24806313|NCT02015156|Trastuzumab|trastuzumab|mesh-list
24806314|NCT02015156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24585125|NCT00883532|Autonomic Agents|autonomic agents|mesh-ancestor
24475783|NCT00411372|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24475793|NCT00411372|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24475794|NCT00411372|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24475795|NCT00411372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24475796|NCT00411372|Adrenergic Agents|adrenergic agents|mesh-ancestor
24475797|NCT00411372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24475801|NCT00411372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24475802|NCT00411372|Sympathomimetics|sympathomimetics|mesh-ancestor
24475803|NCT00411437|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24475804|NCT00411437|Oxybutynin|oxybutynin|mesh-list
24475805|NCT00411437|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24475806|NCT00411437|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25707236|NCT02227849|Canagliflozin|canagliflozin|mesh-list
25707237|NCT02227849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25707238|NCT02227849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707239|NCT02227849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24806315|NCT02015156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806317|NCT02015169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806318|NCT02015169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24806319|NCT02015169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24806320|NCT02015169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806321|NCT02015182|Bupivacaine|bupivacaine|mesh-list
24806322|NCT02015182|Anesthetics, Local|anesthetics, local|mesh-ancestor
24806323|NCT02015182|Anesthetics|anesthetics|mesh-ancestor
24475834|NCT00411541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24475835|NCT00411541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24475836|NCT00411541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24475837|NCT00411541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24475940|NCT00412035|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24475963|NCT00412152|Narcotics|narcotics|mesh-ancestor
24475964|NCT00412152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24475965|NCT00412152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475966|NCT00412152|Analgesics|analgesics|mesh-ancestor
24806343|NCT02015299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475973|NCT00412191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475974|NCT00412191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24475978|NCT00412191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24806371|NCT02015403|Antidotes|antidotes|mesh-ancestor
24601168|NCT00963222|Vitamin A|vitamin a|mesh-list
24806373|NCT02015494|Immunologic Factors|immunologic factors|mesh-ancestor
24806374|NCT02015494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576666|NCT00839657|Warfarin|warfarin|mesh-list
24806378|NCT02015507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24806379|NCT02015507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24806380|NCT02015507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24806381|NCT02015507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24806382|NCT02015507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24806383|NCT02015507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806384|NCT02015507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806385|NCT02015507|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24806386|NCT02015507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24806387|NCT02015507|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24806388|NCT02015507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24806389|NCT02015559|Protective Agents|protective agents|mesh-list
24806390|NCT02015559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806391|NCT02015598|Carbocysteine|carbocysteine|mesh-list
24806392|NCT02015598|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24806393|NCT02015598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24542973|NCT00681213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543020|NCT00681603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543022|NCT00681720|Flumazenil|flumazenil|mesh-list
24543023|NCT00681720|Antidotes|antidotes|mesh-ancestor
24543024|NCT00681720|Protective Agents|protective agents|mesh-ancestor
24806499|NCT02016261|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24806502|NCT02016274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24806504|NCT02016274|Tubulin Modulators|tubulin modulators|mesh-ancestor
24806505|NCT02016274|Antimitotic Agents|antimitotic agents|mesh-ancestor
24806506|NCT02016274|Mitosis Modulators|mitosis modulators|mesh-ancestor
24806507|NCT02016274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806509|NCT02016287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24806510|NCT02016287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806511|NCT02016287|Tubulin Modulators|tubulin modulators|mesh-ancestor
24806512|NCT02016287|Antimitotic Agents|antimitotic agents|mesh-ancestor
24806513|NCT02016287|Mitosis Modulators|mitosis modulators|mesh-ancestor
24806514|NCT02016287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806515|NCT02016365|Doxycycline|doxycycline|mesh-list
24806516|NCT02016365|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24806517|NCT02016365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24806518|NCT02016365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24806519|NCT02016365|Antimalarials|antimalarials|mesh-ancestor
24806520|NCT02016365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24806521|NCT02016365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24806522|NCT02016365|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24806523|NCT02016365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24806524|NCT02016391|Dexmedetomidine|dexmedetomidine|mesh-list
24806525|NCT02016391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24806552|NCT02016417|Tubulin Modulators|tubulin modulators|mesh-ancestor
24806553|NCT02016417|Antimitotic Agents|antimitotic agents|mesh-ancestor
24806554|NCT02016417|Mitosis Modulators|mitosis modulators|mesh-ancestor
24806555|NCT02016443|Tizanidine|tizanidine|mesh-list
24806556|NCT02016443|Analgesics|analgesics|mesh-ancestor
24806557|NCT02016443|Sensory System Agents|sensory system agents|mesh-ancestor
24806558|NCT02016443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24806563|NCT02016443|Parasympatholytics|parasympatholytics|mesh-ancestor
24806588|NCT02016664|Sensory System Agents|sensory system agents|mesh-ancestor
24806589|NCT02016664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24806590|NCT02016664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806591|NCT02016664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24806593|NCT02016664|Anesthetics, General|anesthetics, general|mesh-ancestor
24806594|NCT02016664|Anesthetics|anesthetics|mesh-ancestor
24806595|NCT02016664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24806596|NCT02016664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24806597|NCT02016664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24806598|NCT02016664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24806599|NCT02016664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806600|NCT02016703|Erythritol|erythritol|mesh-list
24806601|NCT02016703|Vasodilator Agents|vasodilator agents|mesh-ancestor
24806602|NCT02016729|Trametinib|trametinib|mesh-list
24806603|NCT02016729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806604|NCT02016729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24475980|NCT00412191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24475982|NCT00412204|Tiotropium Bromide|tiotropium bromide|mesh-list
24806609|NCT02016807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24806610|NCT02016820|Omeprazole|omeprazole|mesh-list
24806611|NCT02016820|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24806612|NCT02016820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24806613|NCT02016820|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24806614|NCT02016820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24806615|NCT02016820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806616|NCT02016846|Liraglutide|liraglutide|mesh-list
24806623|NCT02016976|Meperidine|meperidine|mesh-list
25707240|NCT02227849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707241|NCT02228408|Hydralazine|hydralazine|mesh-list
25707242|NCT02228408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25707243|NCT02228408|Vasodilator Agents|vasodilator agents|mesh-ancestor
25707244|NCT02228590|Apomorphine|apomorphine|mesh-list
25707245|NCT02228590|Emetics|emetics|mesh-ancestor
25707246|NCT02228590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707247|NCT02228590|Autonomic Agents|autonomic agents|mesh-ancestor
25707248|NCT02228590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24543589|NCT00684385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543591|NCT00684385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24806624|NCT02016976|Analgesics|analgesics|mesh-list
24806625|NCT02016976|Sensory System Agents|sensory system agents|mesh-ancestor
24806626|NCT02016976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24806627|NCT02016976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806628|NCT02016976|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24806629|NCT02016976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24806630|NCT02016976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24806631|NCT02016976|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24806632|NCT02016976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24806633|NCT02016976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24806634|NCT02016976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24806635|NCT02016976|Anesthetics, General|anesthetics, general|mesh-ancestor
24806636|NCT02016976|Anesthetics|anesthetics|mesh-ancestor
24806637|NCT02016976|GABA Modulators|gaba modulators|mesh-ancestor
24806638|NCT02016976|GABA Agents|gaba agents|mesh-ancestor
24806658|NCT02017340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24806659|NCT02017340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806660|NCT02017340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24806661|NCT02017340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806662|NCT02017392|Lidocaine|lidocaine|mesh-list
24806663|NCT02017392|Anesthetics, Local|anesthetics, local|mesh-ancestor
24806664|NCT02017392|Anesthetics|anesthetics|mesh-ancestor
24663069|NCT01298180|Hormones|hormones|mesh-list
24806667|NCT02017392|Sensory System Agents|sensory system agents|mesh-ancestor
24476016|NCT00412503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806668|NCT02017392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24806669|NCT02017392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24806670|NCT02017392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24806671|NCT02017392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24806672|NCT02017392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24806673|NCT02017392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806674|NCT02017405|Immunoglobulins|immunoglobulins|mesh-list
24806675|NCT02017405|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24806677|NCT02017405|Immunologic Factors|immunologic factors|mesh-ancestor
24806678|NCT02017405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806679|NCT02017457|Azacitidine|azacitidine|mesh-list
24806680|NCT02017457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24806681|NCT02017457|Antimetabolites|antimetabolites|mesh-ancestor
24806682|NCT02017457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806683|NCT02017457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806684|NCT02017457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24806685|NCT02017561|Metformin|metformin|mesh-list
24806686|NCT02017561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24806687|NCT02017561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806688|NCT02017600|Fluorouracil|fluorouracil|mesh-list
24806689|NCT02017600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806690|NCT02017600|Antimetabolites|antimetabolites|mesh-ancestor
24806691|NCT02017600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806723|NCT02017873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24806724|NCT02018055|Aspirin|aspirin|mesh-list
24806725|NCT02018055|Clopidogrel|clopidogrel|mesh-list
24806726|NCT02018055|Ticagrelor|ticagrelor|mesh-list
24806727|NCT02018055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24806728|NCT02018055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24806729|NCT02018055|Analgesics|analgesics|mesh-ancestor
25707249|NCT02228590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25707250|NCT02228590|Dopamine Agonists|dopamine agonists|mesh-ancestor
25707251|NCT02228590|Dopamine Agents|dopamine agents|mesh-ancestor
25707252|NCT02228590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707253|NCT02228590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707254|NCT02228681|Tamoxifen|tamoxifen|mesh-list
25707255|NCT02228681|Everolimus|everolimus|mesh-list
25707256|NCT02228681|Letrozole|letrozole|mesh-list
25707257|NCT02228681|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25707258|NCT02228681|Medroxyprogesterone|medroxyprogesterone|mesh-list
25707259|NCT02228681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544061|NCT00686816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544062|NCT00686816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24544064|NCT00686868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544065|NCT00686985|Carboplatin|carboplatin|mesh-list
24544066|NCT00686985|Docetaxel|docetaxel|mesh-list
24544067|NCT00686985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806730|NCT02018055|Sensory System Agents|sensory system agents|mesh-ancestor
24806731|NCT02018055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24806732|NCT02018055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806733|NCT02018055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24806734|NCT02018055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24806735|NCT02018055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24806736|NCT02018055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24806737|NCT02018055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806738|NCT02018055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24806739|NCT02018055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24806740|NCT02018055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24806741|NCT02018055|Antipyretics|antipyretics|mesh-ancestor
24806742|NCT02018055|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24585717|NCT00886886|Reboxetine|reboxetine|mesh-list
24476034|NCT00412581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806765|NCT02018094|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24806769|NCT02018094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24585788|NCT00887081|Ribavirin|ribavirin|mesh-list
24476035|NCT00412581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24476036|NCT00412581|Alkylating Agents|alkylating agents|mesh-ancestor
24806775|NCT02018094|Micronutrients|micronutrients|mesh-ancestor
24806776|NCT02018094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806777|NCT02018094|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24806778|NCT02018094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601664|NCT00965315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601666|NCT00965393|Kininogens|kininogens|mesh-list
24601667|NCT00965393|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-list
24601668|NCT00965393|Vasodilator Agents|vasodilator agents|mesh-ancestor
24601669|NCT00965393|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
24601670|NCT00965393|Protease Inhibitors|protease inhibitors|mesh-ancestor
24601671|NCT00965393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601672|NCT00965393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806827|NCT02018276|Sensory System Agents|sensory system agents|mesh-ancestor
24806828|NCT02018276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24806829|NCT02018276|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24806830|NCT02018276|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25707260|NCT02228681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25707261|NCT02228681|Immunologic Factors|immunologic factors|mesh-ancestor
25707262|NCT02228681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707263|NCT02228681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25707264|NCT02228681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25707265|NCT02228681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581000|NCT00864188|Provitamins|provitamins|mesh-ancestor
25707266|NCT02228681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707267|NCT02228681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24446726|NCT00305786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24663431|NCT01301053|Insulin|insulin|mesh-list
24806898|NCT02018757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806899|NCT02018757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24806900|NCT02018757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806902|NCT02018783|Sodium Fluoride|sodium fluoride|mesh-list
24806903|NCT02018783|Cariostatic Agents|cariostatic agents|mesh-ancestor
24806904|NCT02018783|Protective Agents|protective agents|mesh-ancestor
24806905|NCT02018783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806914|NCT02018796|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24806915|NCT02018796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24806916|NCT02018796|Oxytocics|oxytocics|mesh-ancestor
24806917|NCT02018796|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24806918|NCT02018796|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24806919|NCT02018796|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24806920|NCT02018796|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24806921|NCT02018796|Contraceptive Agents|contraceptive agents|mesh-ancestor
24806922|NCT02018796|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24476111|NCT00413075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476117|NCT00413127|Lidocaine|lidocaine|mesh-list
24476118|NCT00413127|Anesthetics, Local|anesthetics, local|mesh-ancestor
24476119|NCT00413127|Anesthetics|anesthetics|mesh-ancestor
24806978|NCT02019095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806979|NCT02019160|Silver Nitrate|silver nitrate|mesh-list
24806980|NCT02019160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24806981|NCT02019160|Fluorides|fluorides|mesh-list
24806982|NCT02019160|Sodium Fluoride|sodium fluoride|mesh-list
24806983|NCT02019160|Cariostatic Agents|cariostatic agents|mesh-ancestor
24806984|NCT02019160|Protective Agents|protective agents|mesh-ancestor
24806985|NCT02019160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806986|NCT02019160|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24806987|NCT02019160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24806988|NCT02019186|Vitamins|vitamins|mesh-list
24806989|NCT02019186|Ascorbic Acid|ascorbic acid|mesh-list
24806990|NCT02019186|Vitamin E|vitamin e|mesh-list
24806991|NCT02019186|Micronutrients|micronutrients|mesh-ancestor
24806992|NCT02019186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806993|NCT02019186|Antioxidants|antioxidants|mesh-ancestor
24806994|NCT02019186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806995|NCT02019186|Protective Agents|protective agents|mesh-ancestor
24806996|NCT02019290|Midazolam|midazolam|mesh-list
24806997|NCT02019290|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24477483|NCT00418782|Gout Suppressants|gout suppressants|mesh-ancestor
24806998|NCT02019290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24806999|NCT02019290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24663623|NCT01302613|Leucovorin|leucovorin|mesh-list
24807000|NCT02019290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707268|NCT02228681|Hormone Antagonists|hormone antagonists|mesh-ancestor
25707269|NCT02228681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25707270|NCT02228681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25707271|NCT02228681|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25707272|NCT02228681|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25707273|NCT02228681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25707274|NCT02228681|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24545141|NCT00692055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24545142|NCT00692055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24807002|NCT02019290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24807015|NCT02019329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807016|NCT02019329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807017|NCT02019329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24807018|NCT02019329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24807019|NCT02019329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24807020|NCT02019329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24807021|NCT02019329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24807022|NCT02019329|Dopamine Agents|dopamine agents|mesh-ancestor
24807023|NCT02019355|Fluorouracil|fluorouracil|mesh-list
24807024|NCT02019355|Calcipotriene|calcipotriene|mesh-list
24807026|NCT02019355|Antimetabolites|antimetabolites|mesh-ancestor
24807027|NCT02019355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807028|NCT02019355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24807036|NCT02019381|Ergocalciferols|ergocalciferols|mesh-list
24807065|NCT02019485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24807066|NCT02019485|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24807067|NCT02019485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24807068|NCT02019485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24807069|NCT02019485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807077|NCT02019524|Immunologic Factors|immunologic factors|mesh-ancestor
24807078|NCT02019524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807079|NCT02019524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807080|NCT02019524|Hematinics|hematinics|mesh-ancestor
24807081|NCT02019524|Vitamins|vitamins|mesh-ancestor
24807082|NCT02019524|Micronutrients|micronutrients|mesh-ancestor
24807083|NCT02019784|Rifaximin|rifaximin|mesh-list
24807084|NCT02019784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24807085|NCT02019784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24807086|NCT02019784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24807087|NCT02019797|Desflurane|desflurane|mesh-list
24807088|NCT02019797|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24807089|NCT02019797|Anesthetics, General|anesthetics, general|mesh-ancestor
24807090|NCT02019797|Anesthetics|anesthetics|mesh-ancestor
24663841|NCT01303874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24663842|NCT01303874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24476366|NCT00414349|Analgesics|analgesics|mesh-list
24476367|NCT00414349|Sensory System Agents|sensory system agents|mesh-ancestor
24476373|NCT00414414|Hormones|hormones|mesh-ancestor
24476572|NCT00415779|Antimitotic Agents|antimitotic agents|mesh-ancestor
24476573|NCT00415779|Mitosis Modulators|mitosis modulators|mesh-ancestor
24476574|NCT00415779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476575|NCT00415779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24476576|NCT00415779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707275|NCT02228681|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25707276|NCT02228681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25707277|NCT02228681|Contraceptive Agents|contraceptive agents|mesh-ancestor
25707278|NCT02228681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25707279|NCT02228681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25707280|NCT02228681|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25707281|NCT02228681|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25707282|NCT02228720|Mometasone Furoate|mometasone furoate|mesh-list
25707283|NCT02228720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25707284|NCT02228720|Dermatologic Agents|dermatologic agents|mesh-ancestor
25707285|NCT02228720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25707286|NCT02228824|Nicotine|nicotine|mesh-list
24476577|NCT00415792|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25707287|NCT02228824|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24545706|NCT00694590|Plerixafor|plerixafor|mesh-list
24476578|NCT00415792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24476607|NCT00415844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476608|NCT00415844|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24476609|NCT00415844|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24476610|NCT00415844|Immunologic Factors|immunologic factors|mesh-ancestor
24476611|NCT00415844|Dopamine Agonists|dopamine agonists|mesh-ancestor
24426601|NCT00236379|Olanzapine|olanzapine|mesh-list
24476612|NCT00415883|Valsartan|valsartan|mesh-list
24476613|NCT00415883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24476614|NCT00415883|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24476615|NCT00415883|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24664270|NCT01305733|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24664272|NCT01305733|Adrenergic Agents|adrenergic agents|mesh-ancestor
24664273|NCT01305733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24664274|NCT01305733|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24476790|NCT00416507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24583448|NCT00874562|Immunologic Factors|immunologic factors|mesh-ancestor
24476791|NCT00416507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24476792|NCT00416507|Immunologic Factors|immunologic factors|mesh-ancestor
24476793|NCT00416507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476839|NCT00416676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476840|NCT00416676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24476841|NCT00416676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24476842|NCT00416676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24476843|NCT00416676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24476844|NCT00416676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476845|NCT00416676|Tubulin Modulators|tubulin modulators|mesh-ancestor
24476910|NCT00416832|Prednisone|prednisone|mesh-list
24476911|NCT00416832|Cyclophosphamide|cyclophosphamide|mesh-list
24476912|NCT00416832|Dacarbazine|dacarbazine|mesh-list
24477001|NCT00416962|Amantadine|amantadine|mesh-list
24477002|NCT00416962|Antiviral Agents|antiviral agents|mesh-ancestor
24477003|NCT00416962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24477004|NCT00416962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477005|NCT00416962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477062|NCT00417066|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24477111|NCT00417326|Sivelestat|sivelestat|mesh-list
24477112|NCT00417326|Glycine|glycine|mesh-list
24477113|NCT00417326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24477114|NCT00417326|Protease Inhibitors|protease inhibitors|mesh-ancestor
24477115|NCT00417326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477116|NCT00417326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477117|NCT00417326|Glycine Agents|glycine agents|mesh-ancestor
24477118|NCT00417326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24664411|NCT01306708|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24664412|NCT01306708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24664413|NCT01306708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24664414|NCT01306708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664415|NCT01306708|Adrenergic Agents|adrenergic agents|mesh-ancestor
24664416|NCT01306708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24664417|NCT01306721|Fexofenadine|fexofenadine|mesh-list
25707288|NCT02228824|Autonomic Agents|autonomic agents|mesh-ancestor
25707289|NCT02228824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25707290|NCT02228824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707291|NCT02228824|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25707292|NCT02228824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25707293|NCT02228824|Cholinergic Agents|cholinergic agents|mesh-ancestor
25707294|NCT02228824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707295|NCT02228824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707296|NCT02228980|Vaccines|vaccines|mesh-list
25707297|NCT02228980|Immunologic Factors|immunologic factors|mesh-ancestor
25707298|NCT02228980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546117|NCT00696826|Incretins|incretins|mesh-ancestor
24546118|NCT00696826|Hormones|hormones|mesh-ancestor
24546119|NCT00696826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24546120|NCT00696826|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24546121|NCT00696826|Protease Inhibitors|protease inhibitors|mesh-ancestor
24664418|NCT01306721|Pseudoephedrine|pseudoephedrine|mesh-list
24664420|NCT01306721|Terfenadine|terfenadine|mesh-list
24664421|NCT01306721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24664422|NCT01306721|Autonomic Agents|autonomic agents|mesh-ancestor
24664425|NCT01306721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24477119|NCT00417326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477120|NCT00417404|Vitamins|vitamins|mesh-list
24477121|NCT00417404|Vitamin A|vitamin a|mesh-list
24477122|NCT00417404|Retinol palmitate|retinol palmitate|mesh-list
24477123|NCT00417404|Micronutrients|micronutrients|mesh-ancestor
24477193|NCT00417768|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24477194|NCT00417768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24477632|NCT00419536|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24477198|NCT00417794|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24477199|NCT00417794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24477200|NCT00417794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477234|NCT00417898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477236|NCT00417898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24477240|NCT00417911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477241|NCT00417937|Azelaic acid|azelaic acid|mesh-list
24477242|NCT00417937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477303|NCT00418171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24584269|NCT00879268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24477304|NCT00418171|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24477305|NCT00418171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24477306|NCT00418171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24477307|NCT00418171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477308|NCT00418171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24477309|NCT00418171|Serotonin Agents|serotonin agents|mesh-ancestor
24477310|NCT00418171|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24477311|NCT00418171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24477312|NCT00418171|Dopamine Agents|dopamine agents|mesh-ancestor
24477313|NCT00418249|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
24477314|NCT00418249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24477315|NCT00418249|Immunologic Factors|immunologic factors|mesh-ancestor
24477316|NCT00418249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477336|NCT00418288|Incretins|incretins|mesh-ancestor
24602152|NCT00967408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24477357|NCT00418353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24477379|NCT00418431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24477380|NCT00418431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24477381|NCT00418431|Growth Substances|growth substances|mesh-ancestor
24477382|NCT00418431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477383|NCT00418431|Growth Inhibitors|growth inhibitors|mesh-ancestor
24477384|NCT00418470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24477385|NCT00418470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24477386|NCT00418470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24477387|NCT00418470|Antitubercular Agents|antitubercular agents|mesh-ancestor
24477389|NCT00418483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24477390|NCT00418483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24477391|NCT00418483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707299|NCT02229214|Topiramate|topiramate|mesh-list
25707300|NCT02229214|Phentermine|phentermine|mesh-list
25707301|NCT02229214|Anticonvulsants|anticonvulsants|mesh-ancestor
25707302|NCT02229214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25707303|NCT02229214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707304|NCT02229214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25707305|NCT02229214|Appetite Depressants|appetite depressants|mesh-ancestor
25707306|NCT02229214|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25707307|NCT02229214|Sympathomimetics|sympathomimetics|mesh-ancestor
25707308|NCT02229214|Autonomic Agents|autonomic agents|mesh-ancestor
24477393|NCT00418496|Sorafenib|sorafenib|mesh-list
24477394|NCT00418496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477395|NCT00418496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24477396|NCT00418496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477398|NCT00418496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24477412|NCT00418509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24477413|NCT00418509|Adrenergic Agents|adrenergic agents|mesh-ancestor
24477414|NCT00418509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24477415|NCT00418509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477436|NCT00418587|Vitamins|vitamins|mesh-list
24477437|NCT00418587|Micronutrients|micronutrients|mesh-ancestor
24477438|NCT00418587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477439|NCT00418587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24477481|NCT00418782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24477482|NCT00418782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24477485|NCT00418782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477486|NCT00418782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477488|NCT00418847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622718|NCT01068223|Cetirizine|cetirizine|mesh-list
24622719|NCT01068223|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24807148|NCT02020122|Pregabalin|pregabalin|mesh-list
24477523|NCT00418873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24477524|NCT00418873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477525|NCT00418873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477526|NCT00418873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24477527|NCT00418873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24478474|NCT00423007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24477543|NCT00418925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584689|NCT00881296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24477545|NCT00418925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24477567|NCT00419146|Vitamin E|vitamin e|mesh-list
24477586|NCT00419172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24477588|NCT00419172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477589|NCT00419172|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24477590|NCT00419172|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24477591|NCT00419172|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24477592|NCT00419172|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24477593|NCT00419172|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24807149|NCT02020122|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24807150|NCT02020122|Analgesics|analgesics|mesh-ancestor
24807151|NCT02020122|Sensory System Agents|sensory system agents|mesh-ancestor
24807152|NCT02020122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24807153|NCT02020122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807154|NCT02020122|Anticonvulsants|anticonvulsants|mesh-ancestor
24807155|NCT02020122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24807156|NCT02020122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24477594|NCT00419172|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24477608|NCT00419302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477619|NCT00419471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24477620|NCT00419471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477621|NCT00419471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24477622|NCT00419471|Serotonin Agents|serotonin agents|mesh-ancestor
24546840|NCT00700687|Analgesics|analgesics|mesh-ancestor
24477623|NCT00419471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477624|NCT00419471|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24477625|NCT00419471|Antidepressive Agents|antidepressive agents|mesh-ancestor
24477626|NCT00419471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24477628|NCT00419484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24477629|NCT00419484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477630|NCT00419536|Panobinostat|panobinostat|mesh-list
24477631|NCT00419536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477633|NCT00419536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477656|NCT00419601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24477657|NCT00419601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24477658|NCT00419601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24477661|NCT00419653|Haloperidol|haloperidol|mesh-list
24477663|NCT00419653|Haloperidol decanoate|haloperidol decanoate|mesh-list
24477664|NCT00419653|Amisulpride|amisulpride|mesh-list
24477665|NCT00419653|Antiemetics|antiemetics|mesh-ancestor
24477666|NCT00419653|Autonomic Agents|autonomic agents|mesh-ancestor
24477667|NCT00419653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24477668|NCT00419653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477669|NCT00419653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24477670|NCT00419653|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24477671|NCT00419653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24807163|NCT02020122|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24807164|NCT02020122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24807165|NCT02020122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24807166|NCT02020122|Antidepressive Agents|antidepressive agents|mesh-ancestor
24807167|NCT02020122|Dopamine Agents|dopamine agents|mesh-ancestor
24807169|NCT02020161|Idarubicin|idarubicin|mesh-list
24807170|NCT02020161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24807171|NCT02020161|Abortifacient Agents|abortifacient agents|mesh-ancestor
24807172|NCT02020161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24587507|NCT00895167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24477679|NCT00419653|Serotonin Agents|serotonin agents|mesh-ancestor
24477680|NCT00419653|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24477681|NCT00419653|Dopamine Agents|dopamine agents|mesh-ancestor
24477682|NCT00419653|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24477683|NCT00419653|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24477684|NCT00419653|Antidepressive Agents|antidepressive agents|mesh-ancestor
24477685|NCT00419692|Ropinirole|ropinirole|mesh-list
24477686|NCT00419692|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24477687|NCT00419692|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24477743|NCT00419796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477744|NCT00419796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24477760|NCT00419848|Antimalarials|antimalarials|mesh-ancestor
24477761|NCT00419848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24477762|NCT00419848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24664851|NCT01309022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664852|NCT01309022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24477763|NCT00419887|Vildagliptin|vildagliptin|mesh-list
24477764|NCT00419887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24477765|NCT00419887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477766|NCT00419887|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24477767|NCT00419887|Protease Inhibitors|protease inhibitors|mesh-ancestor
24477774|NCT00419991|Tigecycline|tigecycline|mesh-list
24477779|NCT00419991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807176|NCT02020161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807177|NCT02020161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477786|NCT00420043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477787|NCT00420043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477789|NCT00420082|Fexofenadine|fexofenadine|mesh-list
25707309|NCT02229214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25707310|NCT02229214|Adrenergic Agents|adrenergic agents|mesh-ancestor
25707311|NCT02229214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707312|NCT02229214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707313|NCT02229227|Insulin|insulin|mesh-list
25707314|NCT02229227|Insulin Glargine|insulin glargine|mesh-list
25707315|NCT02229227|Insulin Lispro|insulin lispro|mesh-list
25707316|NCT02229227|rGLP-1 protein|rglp-1 protein|mesh-list
25707317|NCT02229227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25707318|NCT02229227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477790|NCT00420082|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24477791|NCT00420082|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24477792|NCT00420082|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24477793|NCT00420082|Histamine Antagonists|histamine antagonists|mesh-ancestor
24477794|NCT00420082|Histamine Agents|histamine agents|mesh-ancestor
24477795|NCT00420082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24477796|NCT00420082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477797|NCT00420082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477798|NCT00420277|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24477799|NCT00420277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24477802|NCT00420355|Ritonavir|ritonavir|mesh-list
24477803|NCT00420355|Lopinavir|lopinavir|mesh-list
24477804|NCT00420355|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24477805|NCT00420355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24477850|NCT00420537|Dermatologic Agents|dermatologic agents|mesh-ancestor
24477851|NCT00420537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24477852|NCT00420537|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24478008|NCT00421122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24478009|NCT00421122|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24478010|NCT00421122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24478023|NCT00421187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24478024|NCT00421187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24478025|NCT00421187|Antifungal Agents|antifungal agents|mesh-ancestor
24478026|NCT00421200|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24807205|NCT02020213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478052|NCT00421369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24478053|NCT00421369|Serotonin Agents|serotonin agents|mesh-ancestor
24478054|NCT00421369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478055|NCT00421369|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24807206|NCT02020213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478128|NCT00421538|Anticoagulants|anticoagulants|mesh-ancestor
24478129|NCT00421538|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24478130|NCT00421538|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24478131|NCT00421538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478132|NCT00421551|Ritonavir|ritonavir|mesh-list
24478133|NCT00421551|Darunavir|darunavir|mesh-list
24478134|NCT00421551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24478135|NCT00421551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24478140|NCT00421551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24478174|NCT00421785|Antioxidants|antioxidants|mesh-ancestor
24478175|NCT00421785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478176|NCT00421785|Protective Agents|protective agents|mesh-ancestor
24478177|NCT00421785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478180|NCT00421811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24807239|NCT02020603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24588286|NCT00901849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24478247|NCT00421967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24478248|NCT00421967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24478249|NCT00421967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24478250|NCT00421967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478251|NCT00421967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478252|NCT00421967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24478253|NCT00421967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24478254|NCT00421967|Adrenergic Agents|adrenergic agents|mesh-ancestor
24478255|NCT00421967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24478256|NCT00421967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24478257|NCT00421967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24478259|NCT00421967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24478276|NCT00422123|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24478277|NCT00422123|Antidepressive Agents|antidepressive agents|mesh-ancestor
24478325|NCT00422344|Sunitinib|sunitinib|mesh-list
24478326|NCT00422344|Everolimus|everolimus|mesh-list
24478327|NCT00422344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478328|NCT00422344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24478329|NCT00422344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24478330|NCT00422344|Growth Substances|growth substances|mesh-ancestor
24478331|NCT00422344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478332|NCT00422344|Growth Inhibitors|growth inhibitors|mesh-ancestor
24478333|NCT00422344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24478334|NCT00422344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24807240|NCT02020603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807241|NCT02020603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807242|NCT02020603|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24807243|NCT02020603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24478335|NCT00422344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478336|NCT00422344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24478337|NCT00422344|Immunologic Factors|immunologic factors|mesh-ancestor
24478338|NCT00422396|Fenofibrate|fenofibrate|mesh-list
24478344|NCT00422435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24478347|NCT00422435|Antimitotic Agents|antimitotic agents|mesh-ancestor
24478431|NCT00422708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478433|NCT00422773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24478434|NCT00422773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478467|NCT00423007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24478469|NCT00423007|Analgesics|analgesics|mesh-ancestor
24478470|NCT00423007|Sensory System Agents|sensory system agents|mesh-ancestor
24478471|NCT00423007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24478472|NCT00423007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478473|NCT00423007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24478477|NCT00423059|Bevacizumab|bevacizumab|mesh-list
24478478|NCT00423059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24478479|NCT00423059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478480|NCT00423059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24478481|NCT00423059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24478482|NCT00423059|Growth Substances|growth substances|mesh-ancestor
24478483|NCT00423059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807280|NCT02020980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24588417|NCT00902603|Vasodilator Agents|vasodilator agents|mesh-ancestor
24807285|NCT02021097|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24807286|NCT02021097|Estradiol|estradiol|mesh-list
24807287|NCT02021097|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25707319|NCT02229227|Incretins|incretins|mesh-ancestor
25707320|NCT02229227|Hormones|hormones|mesh-ancestor
25707321|NCT02229227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25707322|NCT02229383|Exenatide|exenatide|mesh-list
25707323|NCT02229383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25707324|NCT02229383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707325|NCT02229383|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24807288|NCT02021097|Estrogens|estrogens|mesh-ancestor
24807289|NCT02021097|Hormones|hormones|mesh-ancestor
24807290|NCT02021097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24807291|NCT02021097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478489|NCT00423163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24807298|NCT02021097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24807299|NCT02021110|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24807300|NCT02021110|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24807301|NCT02021110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24807303|NCT02021123|Antifungal Agents|antifungal agents|mesh-ancestor
24807304|NCT02021123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24807305|NCT02021201|Risperidone|risperidone|mesh-list
24807306|NCT02021201|Sertindole|sertindole|mesh-list
24807307|NCT02021201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24807308|NCT02021201|Serotonin Agents|serotonin agents|mesh-ancestor
24807318|NCT02021214|Methylphenidate|methylphenidate|mesh-list
24807319|NCT02021214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24807320|NCT02021214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807321|NCT02021214|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24807322|NCT02021214|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24807323|NCT02021214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24807324|NCT02021214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807325|NCT02021214|Dopamine Agents|dopamine agents|mesh-ancestor
24807326|NCT02021214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24807328|NCT02021240|Ketamine|ketamine|mesh-list
24807329|NCT02021240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24807330|NCT02021240|Antiemetics|antiemetics|mesh-ancestor
24807331|NCT02021240|Autonomic Agents|autonomic agents|mesh-ancestor
24807336|NCT02021240|Hormones|hormones|mesh-ancestor
24478557|NCT00423514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24478558|NCT00423514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24478559|NCT00423514|Alkylating Agents|alkylating agents|mesh-ancestor
24478560|NCT00423514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24478563|NCT00423527|Levetiracetam|levetiracetam|mesh-list
24478564|NCT00423527|Anticonvulsants|anticonvulsants|mesh-ancestor
24478565|NCT00423527|Nootropic Agents|nootropic agents|mesh-ancestor
24478566|NCT00423540|Magnesium Sulfate|magnesium sulfate|mesh-list
24478567|NCT00423540|Analgesics|analgesics|mesh-ancestor
24478568|NCT00423540|Sensory System Agents|sensory system agents|mesh-ancestor
24478569|NCT00423540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24478570|NCT00423540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478571|NCT00423540|Anesthetics|anesthetics|mesh-ancestor
24478599|NCT00423696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24478600|NCT00423696|Immunologic Factors|immunologic factors|mesh-ancestor
24478610|NCT00423709|Melphalan|melphalan|mesh-list
24478611|NCT00423709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478612|NCT00423709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478613|NCT00423709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24478614|NCT00423709|Immunologic Factors|immunologic factors|mesh-ancestor
24807356|NCT02021422|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24807358|NCT02021422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807359|NCT02021422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24807360|NCT02021422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478621|NCT00423761|Midazolam|midazolam|mesh-list
24478622|NCT00423761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24478623|NCT00423761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24478624|NCT00423761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24478625|NCT00423761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478626|NCT00423761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24478627|NCT00423761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24478628|NCT00423761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24478629|NCT00423761|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24478630|NCT00423761|Anesthetics, General|anesthetics, general|mesh-ancestor
24478631|NCT00423761|Anesthetics|anesthetics|mesh-ancestor
24478632|NCT00423761|GABA Modulators|gaba modulators|mesh-ancestor
24478633|NCT00423761|GABA Agents|gaba agents|mesh-ancestor
24478634|NCT00423761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24478635|NCT00423761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478637|NCT00423826|Mycophenolic Acid|mycophenolic acid|mesh-list
24478638|NCT00423826|Fludarabine|fludarabine|mesh-list
24478639|NCT00423826|Fludarabine phosphate|fludarabine phosphate|mesh-list
24478640|NCT00423826|Busulfan|busulfan|mesh-list
24478641|NCT00423826|Tacrolimus|tacrolimus|mesh-list
24478642|NCT00423826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807381|NCT02021500|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24807382|NCT02021500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807383|NCT02021539|Tocolytic Agents|tocolytic agents|mesh-list
24807384|NCT02021539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24807385|NCT02021539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807386|NCT02021604|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
24807387|NCT02021604|Dopamine Agents|dopamine agents|mesh-ancestor
24807388|NCT02021604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24807389|NCT02021604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807390|NCT02021604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807391|NCT02021825|Mitoxantrone|mitoxantrone|mesh-list
24807392|NCT02021825|Analgesics|analgesics|mesh-ancestor
24807401|NCT02021851|Dexamethasone|dexamethasone|mesh-list
24807402|NCT02021851|Dexamethasone acetate|dexamethasone acetate|mesh-list
24478643|NCT00423826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24478644|NCT00423826|Antimetabolites|antimetabolites|mesh-ancestor
24807454|NCT02022228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24807455|NCT02022228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807456|NCT02022241|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24807457|NCT02022241|Luteolytic Agents|luteolytic agents|mesh-ancestor
24807458|NCT02022241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24807459|NCT02022241|Contraceptive Agents|contraceptive agents|mesh-ancestor
24807460|NCT02022241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24807461|NCT02022241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807462|NCT02022241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24807463|NCT02022241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24807467|NCT02022254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24807468|NCT02022254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707326|NCT02229383|Incretins|incretins|mesh-ancestor
25707327|NCT02229383|Hormones|hormones|mesh-ancestor
25707328|NCT02229383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25707329|NCT02229396|Dapagliflozin|dapagliflozin|mesh-list
25707330|NCT02229396|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25707331|NCT02229396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707332|NCT02229396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24447667|NCT00309361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24447668|NCT00309361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447669|NCT00309361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478896|NCT00424853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478897|NCT00424853|Tubulin Modulators|tubulin modulators|mesh-ancestor
24478898|NCT00424853|Antimitotic Agents|antimitotic agents|mesh-ancestor
24478899|NCT00424853|Mitosis Modulators|mitosis modulators|mesh-ancestor
24478900|NCT00424892|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24478901|NCT00424892|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24478902|NCT00424892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24478903|NCT00424892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24478904|NCT00424892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478905|NCT00424892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24478906|NCT00424892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478907|NCT00424892|Antidepressive Agents|antidepressive agents|mesh-ancestor
24478908|NCT00424892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24478910|NCT00424931|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24478931|NCT00425009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24478932|NCT00425009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807469|NCT02022254|Anticoagulants|anticoagulants|mesh-ancestor
24807478|NCT02022293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24807479|NCT02022293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24807480|NCT02022293|Antimetabolites|antimetabolites|mesh-ancestor
24807481|NCT02022293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807482|NCT02022293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24807483|NCT02022293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24807484|NCT02022293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24807485|NCT02022358|Leucovorin|leucovorin|mesh-list
24478934|NCT00425035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24478935|NCT00425035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478936|NCT00425074|Aspirin|aspirin|mesh-list
24478937|NCT00425074|Salicylic Acid|salicylic acid|mesh-list
24478938|NCT00425074|Salicylates|salicylates|mesh-list
24478939|NCT00425074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24478940|NCT00425074|Antifungal Agents|antifungal agents|mesh-ancestor
24478941|NCT00425074|Keratolytic Agents|keratolytic agents|mesh-ancestor
24478942|NCT00425074|Dermatologic Agents|dermatologic agents|mesh-ancestor
24478943|NCT00425074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24478944|NCT00425074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24478945|NCT00425074|Analgesics|analgesics|mesh-ancestor
24807488|NCT02022358|Levoleucovorin|levoleucovorin|mesh-list
24807489|NCT02022358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24807490|NCT02022358|Abortifacient Agents|abortifacient agents|mesh-ancestor
24807491|NCT02022358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24807492|NCT02022358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807493|NCT02022358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24807494|NCT02022358|Antimetabolites|antimetabolites|mesh-ancestor
24807495|NCT02022358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479046|NCT00425360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479047|NCT00425425|Fluorouracil|fluorouracil|mesh-list
24479048|NCT00425425|Oxaliplatin|oxaliplatin|mesh-list
24479049|NCT00425425|Cetuximab|cetuximab|mesh-list
24479050|NCT00425425|Antimetabolites|antimetabolites|mesh-ancestor
24479051|NCT00425425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479052|NCT00425425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24479053|NCT00425425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479054|NCT00425425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24479055|NCT00425425|Immunologic Factors|immunologic factors|mesh-ancestor
24479056|NCT00425425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479057|NCT00425425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24479058|NCT00425451|Chlorhexidine|chlorhexidine|mesh-list
24479059|NCT00425451|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25707333|NCT02229396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707334|NCT02229461|Aspirin|aspirin|mesh-list
25707335|NCT02229461|Naproxen|naproxen|mesh-list
24479060|NCT00425451|Flurbiprofen|flurbiprofen|mesh-list
25707336|NCT02229461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25707337|NCT02229461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25707338|NCT02229461|Analgesics|analgesics|mesh-ancestor
25707339|NCT02229461|Sensory System Agents|sensory system agents|mesh-ancestor
25707340|NCT02229461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24479062|NCT00425451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24479063|NCT00425451|Disinfectants|disinfectants|mesh-ancestor
24479064|NCT00425451|Dermatologic Agents|dermatologic agents|mesh-ancestor
24479065|NCT00425451|Analgesics|analgesics|mesh-ancestor
24479101|NCT00425516|Mitosis Modulators|mitosis modulators|mesh-ancestor
24479102|NCT00425516|Antimetabolites|antimetabolites|mesh-ancestor
24479103|NCT00425516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24807503|NCT02022358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24807505|NCT02022358|Protective Agents|protective agents|mesh-ancestor
24479189|NCT00425932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479190|NCT00425932|Immunologic Factors|immunologic factors|mesh-ancestor
24479191|NCT00425932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479192|NCT00425932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24479194|NCT00425997|Valsartan|valsartan|mesh-list
24479195|NCT00425997|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24479196|NCT00425997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24479197|NCT00425997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24479198|NCT00425997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24479199|NCT00425997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479242|NCT00426049|Immunologic Factors|immunologic factors|mesh-ancestor
24479243|NCT00426049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479244|NCT00426101|Cyclosporine|cyclosporine|mesh-list
24479245|NCT00426101|Dexamethasone|dexamethasone|mesh-list
24479246|NCT00426101|Etoposide|etoposide|mesh-list
24479247|NCT00426101|Cyclosporins|cyclosporins|mesh-list
24479248|NCT00426101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24479249|NCT00426101|Antiemetics|antiemetics|mesh-ancestor
24479255|NCT00426101|Hormones|hormones|mesh-ancestor
24479266|NCT00426101|Antifungal Agents|antifungal agents|mesh-ancestor
24479267|NCT00426101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24479268|NCT00426101|Dermatologic Agents|dermatologic agents|mesh-ancestor
24479269|NCT00426101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24479270|NCT00426101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24479271|NCT00426140|Epothilone B|epothilone b|mesh-list
24479272|NCT00426140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479273|NCT00426140|Tubulin Modulators|tubulin modulators|mesh-ancestor
24479274|NCT00426140|Antimitotic Agents|antimitotic agents|mesh-ancestor
24479275|NCT00426140|Mitosis Modulators|mitosis modulators|mesh-ancestor
24479276|NCT00426140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602529|NCT00969176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622720|NCT01068223|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24622721|NCT01068223|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24622722|NCT01068223|Histamine Antagonists|histamine antagonists|mesh-ancestor
24622723|NCT01068223|Histamine Agents|histamine agents|mesh-ancestor
24622724|NCT01068223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24622725|NCT01068223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622726|NCT01068223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622728|NCT01068301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24589144|NCT00905983|Immunologic Factors|immunologic factors|mesh-ancestor
24479450|NCT00426946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479451|NCT00426972|Estradiol|estradiol|mesh-list
24479452|NCT00426972|Estrogens|estrogens|mesh-ancestor
24479453|NCT00426972|Hormones|hormones|mesh-ancestor
24479454|NCT00426972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24479519|NCT00427167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622729|NCT01068301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24622730|NCT01068301|Antiviral Agents|antiviral agents|mesh-ancestor
24622731|NCT01068301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24622733|NCT01068327|Gemcitabine|gemcitabine|mesh-list
24622734|NCT01068327|Nelfinavir|nelfinavir|mesh-list
24622735|NCT01068327|Fluorouracil|fluorouracil|mesh-list
24622736|NCT01068327|Calcium|calcium|mesh-list
24622737|NCT01068327|Levoleucovorin|levoleucovorin|mesh-list
24622738|NCT01068327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24479528|NCT00427232|BQ 788|bq 788|mesh-list
24479535|NCT00427245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24479536|NCT00427245|Immunologic Factors|immunologic factors|mesh-ancestor
24479537|NCT00427245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479538|NCT00427245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24479539|NCT00427245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24479540|NCT00427245|Alkylating Agents|alkylating agents|mesh-ancestor
24479541|NCT00427245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479542|NCT00427245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479543|NCT00427245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24479544|NCT00427245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24479650|NCT00427596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24479651|NCT00427596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479652|NCT00427596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479653|NCT00427609|Penicillin G Benzathine|penicillin g benzathine|mesh-list
24479654|NCT00427609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24479655|NCT00427609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24479657|NCT00427713|Oxaliplatin|oxaliplatin|mesh-list
24479658|NCT00427713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24479659|NCT00427713|Antimetabolites|antimetabolites|mesh-ancestor
24479660|NCT00427713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479661|NCT00427713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479662|NCT00427882|Alfuzosin|alfuzosin|mesh-list
24479663|NCT00427882|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24479664|NCT00427882|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24479665|NCT00427882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24479666|NCT00427882|Adrenergic Agents|adrenergic agents|mesh-ancestor
24479667|NCT00427882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24807538|NCT02022488|GABA Modulators|gaba modulators|mesh-ancestor
24479723|NCT00428142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24479726|NCT00428142|Glucocorticoids|glucocorticoids|mesh-ancestor
24479728|NCT00428142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24479731|NCT00428142|Tubulin Modulators|tubulin modulators|mesh-ancestor
24479736|NCT00428168|Histamine Agonists|histamine agonists|mesh-ancestor
24479737|NCT00428168|Histamine Agents|histamine agents|mesh-ancestor
24479738|NCT00428168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24479739|NCT00428168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479740|NCT00428168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479742|NCT00428181|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24479743|NCT00428181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24479744|NCT00428181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24479745|NCT00428181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479746|NCT00428194|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24479777|NCT00428311|Hormone Antagonists|hormone antagonists|mesh-ancestor
24479778|NCT00428311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479779|NCT00428311|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24479780|NCT00428350|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24479781|NCT00428350|Antidepressive Agents|antidepressive agents|mesh-ancestor
24479782|NCT00428350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24479783|NCT00428350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24479784|NCT00428350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24479785|NCT00428350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24479786|NCT00428350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479797|NCT00428428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24479798|NCT00428428|Respiratory System Agents|respiratory system agents|mesh-ancestor
24479799|NCT00428428|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24479800|NCT00428428|Sympathomimetics|sympathomimetics|mesh-ancestor
24479801|NCT00428428|Protective Agents|protective agents|mesh-ancestor
24479803|NCT00428454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24479804|NCT00428454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24479805|NCT00428454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24479806|NCT00428454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479807|NCT00428454|Antifungal Agents|antifungal agents|mesh-ancestor
24479808|NCT00428454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24807512|NCT02022475|Vitamins|vitamins|mesh-ancestor
24479854|NCT00428558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479855|NCT00428558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24479856|NCT00428558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24479857|NCT00428558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24479859|NCT00428649|Selenium|selenium|mesh-list
24479860|NCT00428649|Antioxidants|antioxidants|mesh-ancestor
24479869|NCT00428701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24479870|NCT00428701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479871|NCT00428701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479872|NCT00428727|Nitric Oxide|nitric oxide|mesh-list
24479873|NCT00428727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24479874|NCT00428727|Autonomic Agents|autonomic agents|mesh-ancestor
24479875|NCT00428727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24807536|NCT02022488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24807537|NCT02022488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24807541|NCT02022488|Narcotics|narcotics|mesh-ancestor
24807543|NCT02022527|Salicylic Acid|salicylic acid|mesh-list
24807544|NCT02022527|Salicylates|salicylates|mesh-list
24807545|NCT02022527|Warfarin|warfarin|mesh-list
24807546|NCT02022527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24807547|NCT02022527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24807548|NCT02022527|Analgesics|analgesics|mesh-ancestor
24807573|NCT02022540|Growth Inhibitors|growth inhibitors|mesh-ancestor
24807579|NCT02022644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807580|NCT02022644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807645|NCT02022930|Hormones|hormones|mesh-ancestor
24807646|NCT02022930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24807647|NCT02022930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807648|NCT02022930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24807649|NCT02022930|Immunologic Factors|immunologic factors|mesh-ancestor
24807650|NCT02022930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24807651|NCT02022930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807691|NCT02023164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24807692|NCT02023164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807693|NCT02023164|Anesthetics, Local|anesthetics, local|mesh-ancestor
24807695|NCT02023164|Sensory System Agents|sensory system agents|mesh-ancestor
24807696|NCT02023164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24807697|NCT02023164|Antiemetics|antiemetics|mesh-ancestor
24479907|NCT00428883|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24479908|NCT00428883|Antiviral Agents|antiviral agents|mesh-ancestor
24479910|NCT00428883|Expectorants|expectorants|mesh-ancestor
24479986|NCT00429442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479987|NCT00429442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24479988|NCT00429442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24479989|NCT00429442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480016|NCT00429533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24480017|NCT00429533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24480018|NCT00429533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24480019|NCT00429533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480021|NCT00429533|Leprostatic Agents|leprostatic agents|mesh-ancestor
24480022|NCT00429533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24480023|NCT00429559|Gemcitabine|gemcitabine|mesh-list
24480024|NCT00429559|Topotecan|topotecan|mesh-list
24480025|NCT00429559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24480026|NCT00429559|Antimetabolites|antimetabolites|mesh-ancestor
24480027|NCT00429559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480028|NCT00429559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480029|NCT00429559|Antiviral Agents|antiviral agents|mesh-ancestor
24480030|NCT00429559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24480031|NCT00429559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480032|NCT00429559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24480033|NCT00429559|Immunologic Factors|immunologic factors|mesh-ancestor
24480037|NCT00429624|Acetaminophen|acetaminophen|mesh-list
24480049|NCT00429676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807725|NCT02023424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807726|NCT02023424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24807727|NCT02023424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24807730|NCT02023450|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24807731|NCT02023450|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24807732|NCT02023450|Protease Inhibitors|protease inhibitors|mesh-ancestor
24807733|NCT02023450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24807734|NCT02023450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807735|NCT02023450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24807756|NCT02023554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480187|NCT00430079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480188|NCT00430105|Cyclophosphamide|cyclophosphamide|mesh-list
24480264|NCT00430170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24480265|NCT00430170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480266|NCT00430170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480267|NCT00430170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24480268|NCT00430170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24480269|NCT00430170|Purinergic Agents|purinergic agents|mesh-ancestor
24480270|NCT00430170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24480271|NCT00430170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24480272|NCT00430170|Vasodilator Agents|vasodilator agents|mesh-ancestor
24480283|NCT00430196|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24480284|NCT00430196|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24480285|NCT00430196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24480287|NCT00430196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24480288|NCT00430196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480289|NCT00430235|Sorafenib|sorafenib|mesh-list
24480290|NCT00430235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25707341|NCT02229461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707342|NCT02229461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25707343|NCT02229461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25707344|NCT02229461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25707345|NCT02229461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25707346|NCT02229461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707347|NCT02229461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25707348|NCT02229461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25707349|NCT02229461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25707350|NCT02229461|Antipyretics|antipyretics|mesh-ancestor
25707351|NCT02229461|Gout Suppressants|gout suppressants|mesh-ancestor
25707352|NCT02229539|Diphenhydramine|diphenhydramine|mesh-list
25707353|NCT02229539|Promethazine|promethazine|mesh-list
25707354|NCT02229539|Lidocaine|lidocaine|mesh-list
24480291|NCT00430235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24480292|NCT00430235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480293|NCT00430235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480294|NCT00430261|Sunitinib|sunitinib|mesh-list
24807760|NCT02023554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480340|NCT00430651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480341|NCT00430664|Povidone-Iodine|povidone-iodine|mesh-list
24480342|NCT00430664|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24480343|NCT00430664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24480344|NCT00430742|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
24480345|NCT00430742|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24480346|NCT00430742|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24480347|NCT00430742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24480348|NCT00430742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480350|NCT00430742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24480412|NCT00431028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480414|NCT00431028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24480415|NCT00431028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24480416|NCT00431028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24480417|NCT00431028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480418|NCT00431028|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24480446|NCT00431080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24480447|NCT00431080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24480448|NCT00431080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480449|NCT00431080|Antimetabolites|antimetabolites|mesh-ancestor
24480450|NCT00431080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24480451|NCT00431106|Gemcitabine|gemcitabine|mesh-list
24807768|NCT02023567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
24480459|NCT00431106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24480461|NCT00431106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24480462|NCT00431106|Immunologic Factors|immunologic factors|mesh-ancestor
24480463|NCT00431106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480464|NCT00431106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24480465|NCT00431106|Tubulin Modulators|tubulin modulators|mesh-ancestor
24480480|NCT00431119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24480512|NCT00431197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480513|NCT00431197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24480514|NCT00431197|Hormone Antagonists|hormone antagonists|mesh-ancestor
24480515|NCT00431197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24480516|NCT00431197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480517|NCT00431197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24480559|NCT00431249|Protective Agents|protective agents|mesh-ancestor
24480560|NCT00431249|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24480561|NCT00431249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24480562|NCT00431249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480564|NCT00431262|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24480565|NCT00431262|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
24480566|NCT00431262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480567|NCT00431262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480568|NCT00431275|Tremelimumab|tremelimumab|mesh-list
24480570|NCT00431275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480571|NCT00431275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24480572|NCT00431275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24602766|NCT00970931|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24602767|NCT00970931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25707355|NCT02229539|Doxepin|doxepin|mesh-list
25707356|NCT02229539|Antacids|antacids|mesh-list
25707357|NCT02229539|Anesthetics, Local|anesthetics, local|mesh-ancestor
25707358|NCT02229539|Anesthetics|anesthetics|mesh-ancestor
25707359|NCT02229539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25707360|NCT02229539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707361|NCT02229539|Sensory System Agents|sensory system agents|mesh-ancestor
24807811|NCT02023710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25707362|NCT02229539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25707363|NCT02229539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24480586|NCT00431353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480588|NCT00431379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24480589|NCT00431379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24480590|NCT00431379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480592|NCT00431392|Propranolol|propranolol|mesh-list
24480593|NCT00431392|Phenylephrine|phenylephrine|mesh-list
24480594|NCT00431392|Oxymetazoline|oxymetazoline|mesh-list
24480595|NCT00431392|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
24480596|NCT00431392|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24480597|NCT00431392|Mydriatics|mydriatics|mesh-ancestor
24480598|NCT00431392|Autonomic Agents|autonomic agents|mesh-ancestor
24480601|NCT00431392|Sympathomimetics|sympathomimetics|mesh-ancestor
24480602|NCT00431392|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24480606|NCT00431392|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24480607|NCT00431392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24480608|NCT00431392|Adrenergic Agents|adrenergic agents|mesh-ancestor
24480611|NCT00431392|Protective Agents|protective agents|mesh-ancestor
24480612|NCT00431392|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24480613|NCT00431392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24480614|NCT00431392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24480615|NCT00431392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24480616|NCT00431392|Parasympatholytics|parasympatholytics|mesh-ancestor
24480617|NCT00431392|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24480618|NCT00431392|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24480644|NCT00431561|Lomustine|lomustine|mesh-list
24480645|NCT00431561|Trabedersen|trabedersen|mesh-list
24480646|NCT00431561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24480647|NCT00431561|Alkylating Agents|alkylating agents|mesh-ancestor
24480648|NCT00431561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480649|NCT00431561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602768|NCT00970931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602770|NCT00970931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24807785|NCT02023593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807802|NCT02023684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24807803|NCT02023684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24807804|NCT02023684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24807805|NCT02023684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24807806|NCT02023684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480656|NCT00431613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480657|NCT00431613|Antiviral Agents|antiviral agents|mesh-ancestor
24480658|NCT00431613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24480659|NCT00431613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480660|NCT00431613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24480661|NCT00431613|Immunologic Factors|immunologic factors|mesh-ancestor
24480662|NCT00431613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480663|NCT00431613|Tubulin Modulators|tubulin modulators|mesh-ancestor
24480664|NCT00431613|Antimitotic Agents|antimitotic agents|mesh-ancestor
24480665|NCT00431613|Mitosis Modulators|mitosis modulators|mesh-ancestor
24480666|NCT00431665|Heparin|heparin|mesh-list
24480667|NCT00431665|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24480668|NCT00431665|Somatostatin|somatostatin|mesh-list
24480669|NCT00431665|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
24807810|NCT02023710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24807813|NCT02023710|Antimitotic Agents|antimitotic agents|mesh-ancestor
24807814|NCT02023710|Mitosis Modulators|mitosis modulators|mesh-ancestor
24807815|NCT02023710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807816|NCT02023710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25707364|NCT02229539|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25707365|NCT02229539|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24807817|NCT02023710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25707366|NCT02229539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25707367|NCT02229539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707368|NCT02229539|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24807818|NCT02023710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24807819|NCT02023710|Growth Substances|growth substances|mesh-ancestor
24807820|NCT02023710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807821|NCT02023710|Growth Inhibitors|growth inhibitors|mesh-ancestor
24480670|NCT00431665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480674|NCT00431665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480675|NCT00431665|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24480676|NCT00431665|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24480677|NCT00431665|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24480679|NCT00431665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24480680|NCT00431665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480747|NCT00432016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480749|NCT00432016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24480750|NCT00432016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24480751|NCT00432016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24807851|NCT02024009|Paclitaxel|paclitaxel|mesh-list
24807852|NCT02024009|Capecitabine|capecitabine|mesh-list
24807853|NCT02024009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24807854|NCT02024009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24807855|NCT02024009|Tubulin Modulators|tubulin modulators|mesh-ancestor
24480813|NCT00432354|Atorvastatin|atorvastatin|mesh-list
24480814|NCT00432354|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24480815|NCT00432354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24480816|NCT00432354|Antimetabolites|antimetabolites|mesh-ancestor
24480817|NCT00432354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480818|NCT00432354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24667238|NCT05460416|Aspirin|aspirin|mesh-list
24667239|NCT05460416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24667240|NCT05460416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24667241|NCT05460416|Analgesics|analgesics|mesh-ancestor
24667242|NCT05460416|Sensory System Agents|sensory system agents|mesh-ancestor
24667243|NCT05460416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24667244|NCT05460416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667245|NCT05460416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24667246|NCT05460416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24667254|NCT05460377|Vaccines|vaccines|mesh-list
24807862|NCT02024009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24807863|NCT02024009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24807864|NCT02024009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24807865|NCT02024009|Immunologic Factors|immunologic factors|mesh-ancestor
24807866|NCT02024009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24807867|NCT02024009|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24807868|NCT02024009|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24807869|NCT02024009|Protease Inhibitors|protease inhibitors|mesh-ancestor
24807870|NCT02024009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24807871|NCT02024009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24807872|NCT02024022|Picosulfate sodium|picosulfate sodium|mesh-list
24480883|NCT00432549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480884|NCT00432549|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24480885|NCT00432549|Serotonin Agents|serotonin agents|mesh-ancestor
24480886|NCT00432549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24480887|NCT00432549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480888|NCT00432575|Surinabant|surinabant|mesh-list
24480889|NCT00432575|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24480890|NCT00432575|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25707369|NCT02229539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25707370|NCT02229539|Antiemetics|antiemetics|mesh-ancestor
25707371|NCT02229539|Autonomic Agents|autonomic agents|mesh-ancestor
25707372|NCT02229539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25707373|NCT02229539|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25707374|NCT02229539|Histamine Antagonists|histamine antagonists|mesh-ancestor
25707375|NCT02229539|Histamine Agents|histamine agents|mesh-ancestor
25707376|NCT02229539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707377|NCT02229539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25707378|NCT02229539|Antipruritics|antipruritics|mesh-ancestor
24807877|NCT02024152|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24807878|NCT02024152|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24807879|NCT02024152|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24807880|NCT02024152|Histamine Antagonists|histamine antagonists|mesh-ancestor
24807881|NCT02024152|Histamine Agents|histamine agents|mesh-ancestor
24807882|NCT02024152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24807883|NCT02024152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24807884|NCT02024152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481005|NCT00433095|Tubulin Modulators|tubulin modulators|mesh-ancestor
24481006|NCT00433095|Antimitotic Agents|antimitotic agents|mesh-ancestor
24481015|NCT00433121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481016|NCT00433121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481017|NCT00433121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24481018|NCT00433121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24481019|NCT00433121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24481020|NCT00433121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24481021|NCT00433121|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24481039|NCT00433173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24481040|NCT00433173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481041|NCT00433173|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24481042|NCT00433173|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24481043|NCT00433173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481044|NCT00433173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481088|NCT00433225|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24481089|NCT00433225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24481090|NCT00433225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24481091|NCT00433225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24481103|NCT00433277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24481104|NCT00433277|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24481105|NCT00433277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24481107|NCT00433316|Anesthetics, Local|anesthetics, local|mesh-ancestor
24481108|NCT00433316|Anesthetics|anesthetics|mesh-ancestor
24481109|NCT00433316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24481110|NCT00433316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481111|NCT00433316|Sensory System Agents|sensory system agents|mesh-ancestor
24481112|NCT00433316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24481113|NCT00433342|Floxacillin|floxacillin|mesh-list
24481149|NCT00433459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24481150|NCT00433459|Tubulin Modulators|tubulin modulators|mesh-ancestor
24481151|NCT00433459|Antimitotic Agents|antimitotic agents|mesh-ancestor
24807900|NCT02024256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24481221|NCT00433732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481234|NCT00433784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481236|NCT00433823|Atorvastatin|atorvastatin|mesh-list
24481237|NCT00433823|Ezetimibe|ezetimibe|mesh-list
24481238|NCT00433823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24481239|NCT00433823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24481240|NCT00433823|Antimetabolites|antimetabolites|mesh-ancestor
24481309|NCT00434031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24481312|NCT00434031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481314|NCT00434031|Tubulin Modulators|tubulin modulators|mesh-ancestor
24481315|NCT00434031|Antimitotic Agents|antimitotic agents|mesh-ancestor
24481316|NCT00434031|Mitosis Modulators|mitosis modulators|mesh-ancestor
24481317|NCT00434031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24481346|NCT00434083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481347|NCT00434083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481348|NCT00434083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24481349|NCT00434083|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24481358|NCT00434096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481359|NCT00434096|Hormones|hormones|mesh-ancestor
24481360|NCT00434096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24481361|NCT00434096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481385|NCT00434174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481387|NCT00434174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25707379|NCT02229539|Dermatologic Agents|dermatologic agents|mesh-ancestor
25707380|NCT02229539|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24481388|NCT00434174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24481389|NCT00434174|Immunologic Factors|immunologic factors|mesh-ancestor
24481390|NCT00434174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481408|NCT00434382|Desflurane|desflurane|mesh-list
24481409|NCT00434382|Isoflurane|isoflurane|mesh-list
24481410|NCT00434382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24481411|NCT00434382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24481413|NCT00434382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24481464|NCT00434863|Botulinum Toxins|botulinum toxins|mesh-list
24481465|NCT00434863|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24481466|NCT00434863|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24481467|NCT00434863|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24481468|NCT00434863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24481469|NCT00434863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481470|NCT00434863|Cholinergic Agents|cholinergic agents|mesh-ancestor
24481471|NCT00434863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24481472|NCT00434863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481473|NCT00434863|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24481474|NCT00434863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24481475|NCT00434941|Capecitabine|capecitabine|mesh-list
24481476|NCT00434941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24481477|NCT00434941|Antimetabolites|antimetabolites|mesh-ancestor
24481478|NCT00434941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481479|NCT00434941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481480|NCT00435058|Timolol|timolol|mesh-list
24481481|NCT00435058|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24481482|NCT00435058|Travoprost|travoprost|mesh-list
24807965|NCT02024555|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24807970|NCT02024568|Pregabalin|pregabalin|mesh-list
24481558|NCT00435448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24481559|NCT00435448|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24481560|NCT00435448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24481617|NCT00435981|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24481618|NCT00435981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24481619|NCT00435981|Immunologic Factors|immunologic factors|mesh-ancestor
24481620|NCT00435981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481621|NCT00435981|Antacids|antacids|mesh-ancestor
24481622|NCT00435981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481629|NCT00436033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481630|NCT00436033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24481631|NCT00436033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481632|NCT00436033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24481633|NCT00436033|Analgesics|analgesics|mesh-ancestor
24481634|NCT00436033|Sensory System Agents|sensory system agents|mesh-ancestor
24481635|NCT00436033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24481636|NCT00436033|Antidepressive Agents|antidepressive agents|mesh-ancestor
24481637|NCT00436033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24481638|NCT00436059|Bortezomib|bortezomib|mesh-list
24481639|NCT00436059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481640|NCT00436072|Irinotecan|irinotecan|mesh-list
24481641|NCT00436072|Cetuximab|cetuximab|mesh-list
24481754|NCT00436761|Cyclosporins|cyclosporins|mesh-list
24481755|NCT00436761|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24481756|NCT00436761|Sargramostim|sargramostim|mesh-list
24481757|NCT00436761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808024|NCT02024906|Sequestering Agents|sequestering agents|mesh-ancestor
24808025|NCT02024906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808026|NCT02024919|Diltiazem|diltiazem|mesh-list
24808027|NCT02024919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24808034|NCT02024945|Propiverine|propiverine|mesh-list
24808041|NCT02024945|Cholinergic Agents|cholinergic agents|mesh-ancestor
24432337|NCT00254475|Valsartan|valsartan|mesh-list
24591225|NCT00915616|Melatonin|melatonin|mesh-list
24482057|NCT00437814|Ketamine|ketamine|mesh-list
24482165|NCT00438087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24482166|NCT00438087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24482167|NCT00438087|Protective Agents|protective agents|mesh-ancestor
24482168|NCT00438087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24482169|NCT00438087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24482171|NCT00438113|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24482172|NCT00438113|Terazosin|terazosin|mesh-list
24808069|NCT02025010|Hormone Antagonists|hormone antagonists|mesh-ancestor
24808070|NCT02025010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24808071|NCT02025023|Triamcinolone|triamcinolone|mesh-list
24808072|NCT02025023|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24482340|NCT00438737|Protective Agents|protective agents|mesh-ancestor
24482341|NCT00438737|Vitamin B Complex|vitamin b complex|mesh-ancestor
24482342|NCT00438737|Vitamins|vitamins|mesh-ancestor
24482343|NCT00438737|Micronutrients|micronutrients|mesh-ancestor
24482349|NCT00438776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24482351|NCT00438776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25707381|NCT02229539|Antidepressive Agents|antidepressive agents|mesh-ancestor
25707382|NCT02229539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25707383|NCT02230306|Vemurafenib|vemurafenib|mesh-list
25707384|NCT02230306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25707385|NCT02230306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25707386|NCT02230306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24482352|NCT00438776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24482353|NCT00438776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24482354|NCT00438776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24482355|NCT00438776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25707387|NCT02230306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707388|NCT02230332|Alendronate|alendronate|mesh-list
24482356|NCT00438776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24482358|NCT00438776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24622815|NCT01068756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24622816|NCT01068756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24482361|NCT00438789|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24482362|NCT00438789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24482363|NCT00438789|Immunologic Factors|immunologic factors|mesh-ancestor
24482364|NCT00438789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482366|NCT00438828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24482367|NCT00438828|Antiemetics|antiemetics|mesh-ancestor
24622831|NCT01068847|Tizanidine|tizanidine|mesh-list
24622832|NCT01068847|Naloxone|naloxone|mesh-list
24622833|NCT01068847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24622834|NCT01068847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808124|NCT02025348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24808125|NCT02025348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24808126|NCT02025348|Sympatholytics|sympatholytics|mesh-ancestor
24808127|NCT02025348|Autonomic Agents|autonomic agents|mesh-ancestor
24808128|NCT02025348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24808129|NCT02025348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808130|NCT02025348|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24808131|NCT02025348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24808132|NCT02025348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24808133|NCT02025348|Adrenergic Agents|adrenergic agents|mesh-ancestor
24808134|NCT02025348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24808135|NCT02025348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808136|NCT02025361|Lidocaine|lidocaine|mesh-list
24808137|NCT02025361|Anesthetics, Local|anesthetics, local|mesh-ancestor
24808138|NCT02025361|Anesthetics|anesthetics|mesh-ancestor
24808139|NCT02025361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24808140|NCT02025361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482596|NCT00439972|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24482597|NCT00439972|Contraceptive Agents|contraceptive agents|mesh-ancestor
24482633|NCT00440128|Docetaxel|docetaxel|mesh-list
24482642|NCT00440128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24808154|NCT02025374|Sensory System Agents|sensory system agents|mesh-ancestor
24808155|NCT02025374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24808156|NCT02025465|Metoprolol|metoprolol|mesh-list
24808157|NCT02025465|Diltiazem|diltiazem|mesh-list
24808158|NCT02025465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24808159|NCT02025465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24808160|NCT02025465|Sympatholytics|sympatholytics|mesh-ancestor
24808161|NCT02025465|Autonomic Agents|autonomic agents|mesh-ancestor
24808162|NCT02025465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24482668|NCT00440167|Gemcitabine|gemcitabine|mesh-list
24482669|NCT00440167|Capecitabine|capecitabine|mesh-list
24482707|NCT00440258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24482708|NCT00440258|Dopamine Agonists|dopamine agonists|mesh-ancestor
24482718|NCT00440323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24482726|NCT00440336|Latanoprost|latanoprost|mesh-list
24808184|NCT02025608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808185|NCT02025608|Protective Agents|protective agents|mesh-ancestor
24808186|NCT02025608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808187|NCT02025608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24808188|NCT02025608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24808189|NCT02025608|Dopamine Agonists|dopamine agonists|mesh-ancestor
24808191|NCT02025608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24482735|NCT00440349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482736|NCT00440349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24482773|NCT00440609|Growth Substances|growth substances|mesh-ancestor
24482774|NCT00440609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482775|NCT00440609|Growth Inhibitors|growth inhibitors|mesh-ancestor
24482776|NCT00440609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24482779|NCT00440622|Trastuzumab|trastuzumab|mesh-list
24482780|NCT00440622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24482795|NCT00440648|Sequestering Agents|sequestering agents|mesh-ancestor
24808207|NCT02025803|Antimetabolites|antimetabolites|mesh-ancestor
24808208|NCT02025803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808209|NCT02025803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808210|NCT02025855|Methadone|methadone|mesh-list
24808211|NCT02025855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24808212|NCT02025855|Narcotics|narcotics|mesh-ancestor
24482796|NCT00440648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482797|NCT00440661|Diacetylrhein|diacetylrhein|mesh-list
24482798|NCT00440661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24482799|NCT00440674|Paclitaxel|paclitaxel|mesh-list
24482836|NCT00440739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24482838|NCT00440739|Analgesics|analgesics|mesh-ancestor
24482839|NCT00440739|Sensory System Agents|sensory system agents|mesh-ancestor
24482840|NCT00440739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24482844|NCT00440739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24808213|NCT02025855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24808214|NCT02025855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483118|NCT00441922|Tubulin Modulators|tubulin modulators|mesh-ancestor
24483119|NCT00441922|Antimitotic Agents|antimitotic agents|mesh-ancestor
24483223|NCT00442403|Chloroquine|chloroquine|mesh-list
24483224|NCT00442403|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24483225|NCT00442403|Amebicides|amebicides|mesh-ancestor
24483226|NCT00442403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24483227|NCT00442403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24483228|NCT00442403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24483229|NCT00442403|Antimalarials|antimalarials|mesh-ancestor
24483230|NCT00442403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24483231|NCT00442403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483514|NCT00443794|Diuretics|diuretics|mesh-ancestor
24483515|NCT00443794|Natriuretic Agents|natriuretic agents|mesh-ancestor
24483516|NCT00443924|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24483517|NCT00443924|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24483617|NCT00444314|Growth Inhibitors|growth inhibitors|mesh-ancestor
24483618|NCT00444314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24483619|NCT00444314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483620|NCT00444314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483622|NCT00444340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24483623|NCT00444340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24483624|NCT00444340|Analgesics|analgesics|mesh-ancestor
24483625|NCT00444340|Sensory System Agents|sensory system agents|mesh-ancestor
24483626|NCT00444340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24483628|NCT00444340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24483630|NCT00444340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24483631|NCT00444340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24483632|NCT00444340|Immunologic Factors|immunologic factors|mesh-ancestor
24483633|NCT00444379|Ritonavir|ritonavir|mesh-list
24483634|NCT00444379|Lopinavir|lopinavir|mesh-list
24483635|NCT00444379|Tenofovir|tenofovir|mesh-list
24483636|NCT00444379|Emtricitabine|emtricitabine|mesh-list
24483637|NCT00444379|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24483638|NCT00444379|Efavirenz|efavirenz|mesh-list
24483639|NCT00444379|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24483650|NCT00444379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24808259|NCT02025998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808260|NCT02025998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24483689|NCT00444548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24483690|NCT00444548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483766|NCT00444834|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24483768|NCT00444873|Lanreotide|lanreotide|mesh-list
24483769|NCT00444873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24483770|NCT00444886|Botulinum Toxins|botulinum toxins|mesh-list
24434367|NCT00262275|Purinergic Agents|purinergic agents|mesh-ancestor
24483771|NCT00444886|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24483772|NCT00444886|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24483844|NCT00445276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24483846|NCT00445406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24483847|NCT00445406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24483848|NCT00445406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24483849|NCT00445406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24483850|NCT00445406|Growth Substances|growth substances|mesh-ancestor
24483865|NCT00445497|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24483866|NCT00445497|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24483867|NCT00445497|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24483868|NCT00445510|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
24483869|NCT00445510|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24808280|NCT02026219|Ticagrelor|ticagrelor|mesh-list
24808292|NCT02026310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808293|NCT02026310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24808294|NCT02026310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24808295|NCT02026310|Immunologic Factors|immunologic factors|mesh-ancestor
24808297|NCT02026479|Dexamethasone acetate|dexamethasone acetate|mesh-list
24808298|NCT02026479|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24808300|NCT02026479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24808301|NCT02026479|Antiemetics|antiemetics|mesh-ancestor
24484049|NCT00446368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484050|NCT00446420|Fentanyl|fentanyl|mesh-list
24484051|NCT00446420|Midazolam|midazolam|mesh-list
24484052|NCT00446420|Propofol|propofol|mesh-list
24484053|NCT00446420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24484111|NCT00446589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484112|NCT00446589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24484113|NCT00446602|Epoetin Alfa|epoetin alfa|mesh-list
24484114|NCT00446602|Hematinics|hematinics|mesh-ancestor
24484115|NCT00446667|Mannitol|mannitol|mesh-list
24484116|NCT00446667|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24484117|NCT00446667|Diuretics|diuretics|mesh-ancestor
24484118|NCT00446667|Natriuretic Agents|natriuretic agents|mesh-ancestor
24484119|NCT00446667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484121|NCT00446680|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24484122|NCT00446680|Diuretics|diuretics|mesh-ancestor
24484123|NCT00446680|Natriuretic Agents|natriuretic agents|mesh-ancestor
24484125|NCT00446771|Mannitol|mannitol|mesh-list
24484126|NCT00446771|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24484127|NCT00446771|Diuretics|diuretics|mesh-ancestor
24484128|NCT00446771|Natriuretic Agents|natriuretic agents|mesh-ancestor
24484175|NCT00446901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484176|NCT00446901|Trace Elements|trace elements|mesh-ancestor
24484266|NCT00447369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484267|NCT00447369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24484268|NCT00447369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24484269|NCT00447369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24484270|NCT00447369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24484271|NCT00447369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24484295|NCT00447577|Loteprednol Etabonate|loteprednol etabonate|mesh-list
24484297|NCT00447577|Dexamethasone|dexamethasone|mesh-list
24484298|NCT00447577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24484299|NCT00447577|Antiemetics|antiemetics|mesh-ancestor
24808355|NCT02026778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24808415|NCT02027064|Interferon-alpha|interferon-alpha|mesh-list
24808416|NCT02027064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808417|NCT02027064|Antiviral Agents|antiviral agents|mesh-ancestor
24808418|NCT02027064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24808419|NCT02027064|Immunologic Factors|immunologic factors|mesh-ancestor
24808420|NCT02027064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808421|NCT02027103|Metformin|metformin|mesh-list
24808422|NCT02027103|Pioglitazone|pioglitazone|mesh-list
24808423|NCT02027103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24808424|NCT02027103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808425|NCT02027220|Dexamethasone|dexamethasone|mesh-list
24808426|NCT02027220|Cyclophosphamide|cyclophosphamide|mesh-list
24808435|NCT02027220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808436|NCT02027220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24808437|NCT02027220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24808475|NCT02027337|Estrogens|estrogens|mesh-ancestor
24808476|NCT02027337|Hormones|hormones|mesh-ancestor
24628789|NCT01101412|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24622854|NCT01068847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24622855|NCT01068847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24622856|NCT01068847|Parasympatholytics|parasympatholytics|mesh-ancestor
24622857|NCT01068847|Autonomic Agents|autonomic agents|mesh-ancestor
24622858|NCT01068847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24622859|NCT01068847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24622860|NCT01068847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24622861|NCT01068847|Adrenergic Agents|adrenergic agents|mesh-ancestor
24622862|NCT01068847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24484356|NCT00447928|Vasodilator Agents|vasodilator agents|mesh-ancestor
24622872|NCT01068977|Bevacizumab|bevacizumab|mesh-list
24622873|NCT01068977|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24622874|NCT01068977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24622875|NCT01068977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622876|NCT01068977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24484358|NCT00447967|Fluorouracil|fluorouracil|mesh-list
24484359|NCT00447967|Oxaliplatin|oxaliplatin|mesh-list
24484361|NCT00447967|Antimetabolites|antimetabolites|mesh-ancestor
24484362|NCT00447967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484372|NCT00447967|Protective Agents|protective agents|mesh-ancestor
24484373|NCT00447967|Vitamin B Complex|vitamin b complex|mesh-ancestor
24484374|NCT00447967|Vitamins|vitamins|mesh-ancestor
24484375|NCT00447967|Micronutrients|micronutrients|mesh-ancestor
24484376|NCT00448097|Docetaxel|docetaxel|mesh-list
24484377|NCT00448097|Cetuximab|cetuximab|mesh-list
24484378|NCT00448097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484379|NCT00448097|Tubulin Modulators|tubulin modulators|mesh-ancestor
24484380|NCT00448097|Antimitotic Agents|antimitotic agents|mesh-ancestor
24484381|NCT00448097|Mitosis Modulators|mitosis modulators|mesh-ancestor
24484386|NCT00448110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24484388|NCT00448110|Analgesics|analgesics|mesh-ancestor
24484420|NCT00448266|Immunologic Factors|immunologic factors|mesh-ancestor
24484421|NCT00448266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484422|NCT00448266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24484423|NCT00448266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24484479|NCT00448643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484480|NCT00448734|Docetaxel|docetaxel|mesh-list
24484481|NCT00448734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484482|NCT00448734|Tubulin Modulators|tubulin modulators|mesh-ancestor
24484483|NCT00448734|Antimitotic Agents|antimitotic agents|mesh-ancestor
24484484|NCT00448734|Mitosis Modulators|mitosis modulators|mesh-ancestor
24484485|NCT00448734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484486|NCT00448786|Niacinamide|niacinamide|mesh-list
24484487|NCT00448786|Motesanib diphosphate|motesanib diphosphate|mesh-list
24484488|NCT00448786|Imetelstat|imetelstat|mesh-list
24484489|NCT00448786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24484490|NCT00448786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484491|NCT00448786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484499|NCT00448825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484500|NCT00448838|Gemcitabine|gemcitabine|mesh-list
24484501|NCT00448838|Oxaliplatin|oxaliplatin|mesh-list
24484502|NCT00448838|Cetuximab|cetuximab|mesh-list
24484503|NCT00448838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24808510|NCT02027493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24592703|NCT00924014|Furosemide|furosemide|mesh-list
24484504|NCT00448838|Antimetabolites|antimetabolites|mesh-ancestor
24484505|NCT00448838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484506|NCT00448838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484507|NCT00448838|Antiviral Agents|antiviral agents|mesh-ancestor
24484508|NCT00448838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24484509|NCT00448838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484510|NCT00448838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24484511|NCT00448838|Immunologic Factors|immunologic factors|mesh-ancestor
24484512|NCT00448838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484513|NCT00448838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24484514|NCT00448903|Bemiparin|bemiparin|mesh-list
24484518|NCT00448942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24484519|NCT00448942|Disinfectants|disinfectants|mesh-ancestor
24484520|NCT00448981|Hand Sanitizers|hand sanitizers|mesh-list
24484521|NCT00448981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24484523|NCT00448981|Disinfectants|disinfectants|mesh-ancestor
24484524|NCT00449020|Carboplatin|carboplatin|mesh-list
24484525|NCT00449020|Docetaxel|docetaxel|mesh-list
24484526|NCT00449020|Irinotecan|irinotecan|mesh-list
24484527|NCT00449020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484528|NCT00449020|Tubulin Modulators|tubulin modulators|mesh-ancestor
24484529|NCT00449020|Antimitotic Agents|antimitotic agents|mesh-ancestor
24484572|NCT00449280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24484589|NCT00449397|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24484590|NCT00449397|Antidepressive Agents|antidepressive agents|mesh-ancestor
24484591|NCT00449397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24484592|NCT00449397|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24484593|NCT00449397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24484850|NCT00450203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24484851|NCT00450203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24484852|NCT00450203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24484853|NCT00450203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484854|NCT00450203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24484855|NCT00450229|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
24484856|NCT00450229|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24484857|NCT00450229|Protective Agents|protective agents|mesh-ancestor
24808553|NCT02027922|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
24808555|NCT02027922|Protective Agents|protective agents|mesh-ancestor
24808556|NCT02027922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808558|NCT02027961|Trametinib|trametinib|mesh-list
24484868|NCT00450320|Sirolimus|sirolimus|mesh-list
24484869|NCT00450320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24484870|NCT00450320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24484871|NCT00450320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24484872|NCT00450320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484873|NCT00450320|Antifungal Agents|antifungal agents|mesh-ancestor
24808565|NCT02027987|Valproic Acid|valproic acid|mesh-list
24484907|NCT00450736|Analgesics|analgesics|mesh-ancestor
24484931|NCT00450827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24808580|NCT02028026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24808581|NCT02028026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808582|NCT02028026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24808583|NCT02028026|Serotonin Agents|serotonin agents|mesh-ancestor
24808584|NCT02028026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808585|NCT02028026|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24808586|NCT02028026|Antidepressive Agents|antidepressive agents|mesh-ancestor
24484932|NCT00450827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25707389|NCT02230332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25707390|NCT02230332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707391|NCT02230527|Clopidogrel|clopidogrel|mesh-list
25707392|NCT02230527|Ticagrelor|ticagrelor|mesh-list
25707393|NCT02230527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25707394|NCT02230527|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25707395|NCT02230527|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25707396|NCT02230527|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24484938|NCT00450827|Growth Inhibitors|growth inhibitors|mesh-ancestor
24484939|NCT00450827|Immunologic Factors|immunologic factors|mesh-ancestor
24485067|NCT00451386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24485069|NCT00451399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24485070|NCT00451399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485072|NCT00451412|Calcium heparin|calcium heparin|mesh-list
24485087|NCT00451568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485095|NCT00451594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24485097|NCT00451594|Hormones|hormones|mesh-ancestor
24485098|NCT00451594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24485099|NCT00451594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24485100|NCT00451594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485101|NCT00451620|Glyburide|glyburide|mesh-list
24808609|NCT02028312|Loteprednol Etabonate|loteprednol etabonate|mesh-list
24808610|NCT02028312|Lubricant Eye Drops|lubricant eye drops|mesh-list
24808616|NCT02028403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24808617|NCT02028403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808618|NCT02028403|Immunologic Factors|immunologic factors|mesh-ancestor
24808619|NCT02028403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808620|NCT02028416|Thymoglobulin|thymoglobulin|mesh-list
24485104|NCT00451646|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24485105|NCT00451646|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24485106|NCT00451646|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24485107|NCT00451646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24485108|NCT00451672|Bromocriptine|bromocriptine|mesh-list
24485109|NCT00451672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24485110|NCT00451672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24485111|NCT00451672|Hormone Antagonists|hormone antagonists|mesh-ancestor
24485112|NCT00451672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24485113|NCT00451672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485114|NCT00451672|Dopamine Agonists|dopamine agonists|mesh-ancestor
24485115|NCT00451672|Dopamine Agents|dopamine agents|mesh-ancestor
24485116|NCT00451672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24808634|NCT02028494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808636|NCT02028507|Capecitabine|capecitabine|mesh-list
24808637|NCT02028507|Fulvestrant|fulvestrant|mesh-list
24808638|NCT02028507|Palbociclib|palbociclib|mesh-list
25707397|NCT02230527|Purinergic Agents|purinergic agents|mesh-ancestor
25707398|NCT02230527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707399|NCT02230527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707400|NCT02230527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707401|NCT02230696|Fluticasone|fluticasone|mesh-list
25707403|NCT02230696|Azelastine|azelastine|mesh-list
25707404|NCT02230696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25707405|NCT02230696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25707406|NCT02230696|Autonomic Agents|autonomic agents|mesh-ancestor
25707407|NCT02230696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24485393|NCT00452881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485394|NCT00452881|Antiviral Agents|antiviral agents|mesh-ancestor
24485395|NCT00452881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24485408|NCT00452907|Lumefantrine|lumefantrine|mesh-list
24485409|NCT00452907|Pyrimethamine|pyrimethamine|mesh-list
24485410|NCT00452907|Sulfadoxine|sulfadoxine|mesh-list
24485411|NCT00452907|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24485412|NCT00452907|Antimalarials|antimalarials|mesh-ancestor
24808697|NCT02028689|Gout Suppressants|gout suppressants|mesh-ancestor
24808698|NCT02028689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24808699|NCT02028689|Uricosuric Agents|uricosuric agents|mesh-ancestor
24808700|NCT02028689|Renal Agents|renal agents|mesh-ancestor
24808702|NCT02028806|Oxaliplatin|oxaliplatin|mesh-list
24808703|NCT02028806|Irinotecan|irinotecan|mesh-list
24808704|NCT02028806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808705|NCT02028806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24808706|NCT02028806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24808707|NCT02028806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808708|NCT02028806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808709|NCT02028806|Antidotes|antidotes|mesh-ancestor
24808710|NCT02028806|Protective Agents|protective agents|mesh-ancestor
24593404|NCT00928811|Basiliximab|basiliximab|mesh-list
24485413|NCT00452907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24485414|NCT00452907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24485415|NCT00452907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24485416|NCT00452907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485417|NCT00452907|Antiviral Agents|antiviral agents|mesh-ancestor
24485418|NCT00452907|Schistosomicides|schistosomicides|mesh-ancestor
24485419|NCT00452907|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24485420|NCT00452907|Anthelmintics|anthelmintics|mesh-ancestor
24485421|NCT00452907|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24485422|NCT00452907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485423|NCT00452907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485441|NCT00452985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485442|NCT00453050|Imiquimod|imiquimod|mesh-list
24485443|NCT00453050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24485444|NCT00453050|Immunologic Factors|immunologic factors|mesh-ancestor
24485445|NCT00453050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485528|NCT00453492|Risedronic Acid|risedronic acid|mesh-list
24485452|NCT00453076|Antimitotic Agents|antimitotic agents|mesh-ancestor
24485453|NCT00453076|Mitosis Modulators|mitosis modulators|mesh-ancestor
24485454|NCT00453076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485455|NCT00453115|Gemcitabine|gemcitabine|mesh-list
24485456|NCT00453115|Oxaliplatin|oxaliplatin|mesh-list
24808711|NCT02028806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808712|NCT02028806|Vitamin B Complex|vitamin b complex|mesh-ancestor
24808713|NCT02028806|Vitamins|vitamins|mesh-ancestor
24808722|NCT02028819|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24808723|NCT02028819|Antiviral Agents|antiviral agents|mesh-ancestor
24808724|NCT02028819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24808725|NCT02028910|Ondansetron|ondansetron|mesh-list
24808726|NCT02028910|Antiemetics|antiemetics|mesh-ancestor
24808727|NCT02028910|Autonomic Agents|autonomic agents|mesh-ancestor
24808728|NCT02028910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24808729|NCT02028910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808730|NCT02028910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24808731|NCT02028910|Antipruritics|antipruritics|mesh-ancestor
24808732|NCT02028910|Dermatologic Agents|dermatologic agents|mesh-ancestor
24808733|NCT02028910|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24808734|NCT02028910|Serotonin Agents|serotonin agents|mesh-ancestor
24808735|NCT02028910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24808736|NCT02028910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808737|NCT02028910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24808738|NCT02028910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24808739|NCT02028910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24808740|NCT02028910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24808741|NCT02028910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24808743|NCT02028923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24485457|NCT00453115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24485458|NCT00453115|Antimetabolites|antimetabolites|mesh-ancestor
24808752|NCT02028949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24593542|NCT00930020|Minocycline|minocycline|mesh-list
24485485|NCT00453167|Antiviral Agents|antiviral agents|mesh-ancestor
24485486|NCT00453167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24485487|NCT00453167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485513|NCT00453375|Protective Agents|protective agents|mesh-ancestor
24485514|NCT00453375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485515|NCT00453401|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
24485516|NCT00453401|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
24485527|NCT00453453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485535|NCT00453609|Naltrexone|naltrexone|mesh-list
24485536|NCT00453609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24485537|NCT00453609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24485538|NCT00453609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485539|NCT00453609|Sensory System Agents|sensory system agents|mesh-ancestor
24485540|NCT00453609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24485541|NCT00453635|Carboplatin|carboplatin|mesh-list
24485542|NCT00453635|Docetaxel|docetaxel|mesh-list
24485543|NCT00453635|Trastuzumab|trastuzumab|mesh-list
24485544|NCT00453635|Vinorelbine|vinorelbine|mesh-list
24485572|NCT00453778|Fluticasone|fluticasone|mesh-list
24808766|NCT02029001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808767|NCT02029001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24808768|NCT02029001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808769|NCT02029001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808770|NCT02029001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24593610|NCT00930306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24485586|NCT00453804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485588|NCT00453804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24485589|NCT00453856|Pyrimethamine|pyrimethamine|mesh-list
24485590|NCT00453856|Sulfadoxine|sulfadoxine|mesh-list
24485591|NCT00453856|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24485592|NCT00453856|Antimalarials|antimalarials|mesh-ancestor
24485593|NCT00453856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24485594|NCT00453856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24485595|NCT00453856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24485596|NCT00453856|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24485597|NCT00453856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485634|NCT00454259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24485635|NCT00454259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24485636|NCT00454259|Anesthetics, General|anesthetics, general|mesh-ancestor
24485637|NCT00454259|Anesthetics|anesthetics|mesh-ancestor
24485640|NCT00454272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24485641|NCT00454272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24485642|NCT00454350|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
24485675|NCT00454480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485676|NCT00454480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24485677|NCT00454480|Antimetabolites|antimetabolites|mesh-ancestor
24485678|NCT00454480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485679|NCT00454480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24485860|NCT00455286|Abortifacient Agents|abortifacient agents|mesh-ancestor
24485861|NCT00455286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24485862|NCT00455286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485863|NCT00455286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24485903|NCT00455364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24485905|NCT00455416|Selenium|selenium|mesh-list
24485906|NCT00455416|Allicin|allicin|mesh-list
24486053|NCT00455936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808842|NCT02029534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808843|NCT02029534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24808844|NCT02029534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24808845|NCT02029534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808846|NCT02029573|Temozolomide|temozolomide|mesh-list
24808847|NCT02029573|Atorvastatin|atorvastatin|mesh-list
24808848|NCT02029573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24808849|NCT02029573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24808850|NCT02029573|Antimetabolites|antimetabolites|mesh-ancestor
24486057|NCT00456027|Immunologic Factors|immunologic factors|mesh-ancestor
25022278|NCT03664414|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24486058|NCT00456027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486059|NCT00456027|Antacids|antacids|mesh-ancestor
24486060|NCT00456027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486061|NCT00456027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24486062|NCT00456144|Hormones|hormones|mesh-list
24486063|NCT00456144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24486064|NCT00456144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486065|NCT00456235|Mycophenolic Acid|mycophenolic acid|mesh-list
24486066|NCT00456235|Cyclosporine|cyclosporine|mesh-list
24486067|NCT00456235|Tacrolimus|tacrolimus|mesh-list
24486068|NCT00456235|Cyclosporins|cyclosporins|mesh-list
24486073|NCT00456235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808851|NCT02029573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808854|NCT02029573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808876|NCT02029599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808877|NCT02029599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24808878|NCT02029599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24486074|NCT00456235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486075|NCT00456235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24486076|NCT00456235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808880|NCT02029599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24808881|NCT02029599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24808887|NCT02029612|Nicotine|nicotine|mesh-list
24486239|NCT00456898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24486124|NCT00456430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24486147|NCT00456560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486148|NCT00456560|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24486149|NCT00456560|Antidepressive Agents|antidepressive agents|mesh-ancestor
24486150|NCT00456560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24486151|NCT00456560|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24486152|NCT00456560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24486153|NCT00456560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486154|NCT00456560|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24486155|NCT00456560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24486156|NCT00456560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24486157|NCT00456560|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24486158|NCT00456560|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24486160|NCT00456586|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
25707408|NCT02230696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707409|NCT02230696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25707410|NCT02230696|Respiratory System Agents|respiratory system agents|mesh-ancestor
24486162|NCT00456586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24486163|NCT00456586|Purinergic Agents|purinergic agents|mesh-ancestor
24808898|NCT02029625|Ezetimibe|ezetimibe|mesh-list
24486171|NCT00456716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808928|NCT02029937|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24808929|NCT02029937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24808932|NCT02029950|Podophyllotoxin|podophyllotoxin|mesh-list
24808933|NCT02029950|Daunorubicin|daunorubicin|mesh-list
24808934|NCT02029950|Idarubicin|idarubicin|mesh-list
24808935|NCT02029950|Etoposide phosphate|etoposide phosphate|mesh-list
24808936|NCT02029950|Pomalidomide|pomalidomide|mesh-list
24808937|NCT02029950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24808938|NCT02029950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808939|NCT02029950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24808940|NCT02029950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24808941|NCT02029950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24808942|NCT02029950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808943|NCT02029950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24808944|NCT02029950|Antimetabolites|antimetabolites|mesh-ancestor
24808945|NCT02029950|Antiviral Agents|antiviral agents|mesh-ancestor
24808946|NCT02029950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24808947|NCT02029950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24486210|NCT00456833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486211|NCT00456872|Lidocaine|lidocaine|mesh-list
24486212|NCT00456872|Anesthetics, Local|anesthetics, local|mesh-ancestor
24486213|NCT00456872|Anesthetics|anesthetics|mesh-ancestor
24486214|NCT00456872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24486215|NCT00456872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486216|NCT00456872|Sensory System Agents|sensory system agents|mesh-ancestor
24486217|NCT00456872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24486218|NCT00456872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24486219|NCT00456872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24486220|NCT00456872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24486221|NCT00456872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24486222|NCT00456872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486223|NCT00456898|Codeine|codeine|mesh-list
24486224|NCT00456898|Paroxetine|paroxetine|mesh-list
24486225|NCT00456898|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24486226|NCT00456898|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24486227|NCT00456898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24486228|NCT00456898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24486236|NCT00456898|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24486237|NCT00456898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24486238|NCT00456898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486240|NCT00456898|Narcotics|narcotics|mesh-ancestor
24808989|NCT02030483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24808990|NCT02030483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486290|NCT00457067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24486291|NCT00457067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24486292|NCT00457067|Growth Substances|growth substances|mesh-ancestor
24486295|NCT00457067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486297|NCT00457093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24486298|NCT00457093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486299|NCT00457106|Risperidone|risperidone|mesh-list
25707411|NCT02230696|Dermatologic Agents|dermatologic agents|mesh-ancestor
25707412|NCT02230696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25707413|NCT02230696|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25707414|NCT02230696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25707415|NCT02230696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707416|NCT02230696|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25707417|NCT02230696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24486323|NCT00457119|Immunologic Factors|immunologic factors|mesh-ancestor
24486379|NCT00457678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24486380|NCT00457678|Antiemetics|antiemetics|mesh-ancestor
24486381|NCT00457678|Autonomic Agents|autonomic agents|mesh-ancestor
24809006|NCT02030639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809007|NCT02030678|Irinotecan|irinotecan|mesh-list
24809008|NCT02030678|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24486382|NCT00457678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24486383|NCT00457678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486384|NCT00457678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24486385|NCT00457678|Glucocorticoids|glucocorticoids|mesh-ancestor
24486386|NCT00457678|Hormones|hormones|mesh-ancestor
24486387|NCT00457678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24486388|NCT00457678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24486389|NCT00457678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486390|NCT00457678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24486391|NCT00457678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24486393|NCT00457678|Growth Inhibitors|growth inhibitors|mesh-ancestor
24486394|NCT00457678|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24486509|NCT00458250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24809009|NCT02030678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24486510|NCT00458250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24486511|NCT00458250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24486513|NCT00458263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25023836|NCT03651219|Irinotecan|irinotecan|mesh-list
24486514|NCT00458263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486521|NCT00458315|Antimitotic Agents|antimitotic agents|mesh-ancestor
24486522|NCT00458315|Mitosis Modulators|mitosis modulators|mesh-ancestor
24486523|NCT00458315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486524|NCT00458315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24486525|NCT00458315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24486526|NCT00458315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24486527|NCT00458315|Growth Substances|growth substances|mesh-ancestor
24486528|NCT00458315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486529|NCT00458315|Growth Inhibitors|growth inhibitors|mesh-ancestor
24486581|NCT00458510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486583|NCT00458510|Sensory System Agents|sensory system agents|mesh-ancestor
24486584|NCT00458510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24486585|NCT00458510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25707418|NCT02230696|Histamine Antagonists|histamine antagonists|mesh-ancestor
25707419|NCT02230696|Histamine Agents|histamine agents|mesh-ancestor
25707420|NCT02230696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707421|NCT02230904|Rotigotine|rotigotine|mesh-list
25707422|NCT02230904|Dopamine Agonists|dopamine agonists|mesh-ancestor
25707423|NCT02230904|Dopamine Agents|dopamine agents|mesh-ancestor
25707424|NCT02230904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707425|NCT02230904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486785|NCT00460083|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24486786|NCT00460083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486787|NCT00460083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486789|NCT00460148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24486790|NCT00460148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24486791|NCT00460148|Dopamine Agonists|dopamine agonists|mesh-ancestor
24486792|NCT00460148|Dopamine Agents|dopamine agents|mesh-ancestor
24486793|NCT00460148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24486794|NCT00460148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486809|NCT00460174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24809014|NCT02030717|Anesthetics|anesthetics|mesh-list
24594745|NCT00935415|Montelukast|montelukast|mesh-list
24486972|NCT00460759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24486974|NCT00460759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486975|NCT00460759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486976|NCT00460759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24486977|NCT00460759|Antitubercular Agents|antitubercular agents|mesh-ancestor
24486978|NCT00460759|Leprostatic Agents|leprostatic agents|mesh-ancestor
24486979|NCT00460785|Analgesics, Opioid|analgesics, opioid|mesh-list
24486980|NCT00460785|Narcotics|narcotics|mesh-ancestor
24486981|NCT00460785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24486982|NCT00460785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487034|NCT00461084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487036|NCT00461084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24487037|NCT00461084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24487040|NCT00461149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24487041|NCT00461149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487042|NCT00461266|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24487043|NCT00461266|Enfuvirtide|enfuvirtide|mesh-list
24487044|NCT00461266|Antiviral Agents|antiviral agents|mesh-ancestor
24487045|NCT00461266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24487046|NCT00461266|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24487047|NCT00461266|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24487048|NCT00461266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487049|NCT00461266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24487051|NCT00461344|Doxorubicin|doxorubicin|mesh-list
24487052|NCT00461344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487053|NCT00461344|Tubulin Modulators|tubulin modulators|mesh-ancestor
24487054|NCT00461344|Antimitotic Agents|antimitotic agents|mesh-ancestor
24487071|NCT00461422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24487072|NCT00461422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487073|NCT00461565|Sildenafil Citrate|sildenafil citrate|mesh-list
24487074|NCT00461565|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24487075|NCT00461565|Vasodilator Agents|vasodilator agents|mesh-ancestor
24487076|NCT00461565|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24487077|NCT00461565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24487078|NCT00461565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487079|NCT00461565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487080|NCT00461565|Urological Agents|urological agents|mesh-ancestor
24487082|NCT00461578|Dapsone|dapsone|mesh-list
24489083|NCT00471393|Antioxidants|antioxidants|mesh-ancestor
24487192|NCT00461916|Contraceptive Agents|contraceptive agents|mesh-ancestor
24487193|NCT00461916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24809062|NCT02030977|Resveratrol|resveratrol|mesh-list
24809074|NCT02031016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809076|NCT02031016|Sensory System Agents|sensory system agents|mesh-ancestor
24809077|NCT02031016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24809078|NCT02031016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24809079|NCT02031016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24809080|NCT02031016|Anesthetics, General|anesthetics, general|mesh-ancestor
24809081|NCT02031016|Anesthetics|anesthetics|mesh-ancestor
24809082|NCT02031055|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24487194|NCT00461916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487195|NCT00461916|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24809083|NCT02031081|Prucalopride|prucalopride|mesh-list
24809084|NCT02031081|Laxatives|laxatives|mesh-ancestor
24809085|NCT02031081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24809163|NCT02031601|Tubulin Modulators|tubulin modulators|mesh-ancestor
25707426|NCT02230904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809086|NCT02031081|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24809087|NCT02031081|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24809088|NCT02031081|Serotonin Agents|serotonin agents|mesh-ancestor
24809089|NCT02031081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24487199|NCT00461916|Fertility Agents|fertility agents|mesh-ancestor
24487200|NCT00461968|Simvastatin|simvastatin|mesh-list
24487202|NCT00461968|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24487203|NCT00461968|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24487204|NCT00461968|Antimetabolites|antimetabolites|mesh-ancestor
24487205|NCT00461968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487206|NCT00461968|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24487207|NCT00461968|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24487208|NCT00461968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487209|NCT00462111|Indomethacin|indomethacin|mesh-list
24487210|NCT00462111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24487260|NCT00462540|Autonomic Agents|autonomic agents|mesh-ancestor
24487261|NCT00462540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24487266|NCT00462540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24487267|NCT00462540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24809110|NCT02031289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809111|NCT02031289|Hematinics|hematinics|mesh-ancestor
24809112|NCT02031289|Vitamin B Complex|vitamin b complex|mesh-ancestor
24809113|NCT02031367|Triamcinolone|triamcinolone|mesh-list
24809114|NCT02031367|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24809115|NCT02031367|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24487299|NCT00462592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487301|NCT00462592|Respiratory System Agents|respiratory system agents|mesh-ancestor
24487304|NCT00462592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24487432|NCT00463073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24487433|NCT00463073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487434|NCT00463073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24487435|NCT00463073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24487436|NCT00463073|Growth Substances|growth substances|mesh-ancestor
24487437|NCT00463073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487438|NCT00463073|Growth Inhibitors|growth inhibitors|mesh-ancestor
24487439|NCT00463073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24487440|NCT00463073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24487456|NCT00463112|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24487457|NCT00463203|Bevacizumab|bevacizumab|mesh-list
24487458|NCT00463203|Irinotecan|irinotecan|mesh-list
24487459|NCT00463203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24487460|NCT00463203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487527|NCT00463710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24487529|NCT00463723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24487530|NCT00463736|Magnesium Sulfate|magnesium sulfate|mesh-list
24487531|NCT00463736|Analgesics|analgesics|mesh-ancestor
24487532|NCT00463736|Sensory System Agents|sensory system agents|mesh-ancestor
24487533|NCT00463736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24487534|NCT00463736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487535|NCT00463736|Anesthetics|anesthetics|mesh-ancestor
24487536|NCT00463736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24487553|NCT00463762|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24487555|NCT00463775|Topiramate|topiramate|mesh-list
24487556|NCT00463775|Anticonvulsants|anticonvulsants|mesh-ancestor
24487557|NCT00463775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24487558|NCT00463775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487559|NCT00463827|Atorvastatin|atorvastatin|mesh-list
24487560|NCT00463827|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24487561|NCT00463827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24487562|NCT00463827|Antimetabolites|antimetabolites|mesh-ancestor
25707427|NCT02230956|Botulinum Toxins|botulinum toxins|mesh-list
25707428|NCT02230956|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24487563|NCT00463827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487567|NCT00463879|Galantamine|galantamine|mesh-list
25707429|NCT02230956|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25707430|NCT02230956|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25707431|NCT02230956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25707432|NCT02230956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707433|NCT02230956|Cholinergic Agents|cholinergic agents|mesh-ancestor
25707434|NCT02230956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24809168|NCT02031601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24809207|NCT02031965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24487679|NCT00464399|Immunologic Factors|immunologic factors|mesh-ancestor
24487680|NCT00464399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487681|NCT00464451|Dexmedetomidine|dexmedetomidine|mesh-list
24487682|NCT00464451|Chloral Hydrate|chloral hydrate|mesh-list
24487714|NCT00464763|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24487715|NCT00464763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24487716|NCT00464763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487717|NCT00464763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24487719|NCT00464763|Sensory System Agents|sensory system agents|mesh-ancestor
24487720|NCT00464763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24487800|NCT00465192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809210|NCT02031965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24809211|NCT02031965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809212|NCT02031965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24809213|NCT02031965|Glucocorticoids|glucocorticoids|mesh-ancestor
24809215|NCT02031965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24809218|NCT02031991|Bevacizumab|bevacizumab|mesh-list
24809229|NCT02032043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24809230|NCT02032043|Anthelmintics|anthelmintics|mesh-ancestor
24809231|NCT02032043|Anticestodal Agents|anticestodal agents|mesh-ancestor
24809232|NCT02032043|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24809233|NCT02032043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24809234|NCT02032043|Tubulin Modulators|tubulin modulators|mesh-ancestor
24809235|NCT02032043|Antimitotic Agents|antimitotic agents|mesh-ancestor
24809236|NCT02032043|Mitosis Modulators|mitosis modulators|mesh-ancestor
24809237|NCT02032043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487801|NCT00465192|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24487802|NCT00465192|Contraceptive Agents|contraceptive agents|mesh-ancestor
24487803|NCT00465192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24487804|NCT00465192|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24487806|NCT00465205|Antiviral Agents|antiviral agents|mesh-ancestor
24487807|NCT00465205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24487809|NCT00465231|Bupivacaine|bupivacaine|mesh-list
24487810|NCT00465231|Anesthetics, Local|anesthetics, local|mesh-ancestor
24487811|NCT00465231|Anesthetics|anesthetics|mesh-ancestor
24487812|NCT00465231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25025248|NCT03638869|Analgesics|analgesics|mesh-ancestor
24487813|NCT00465231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487814|NCT00465231|Sensory System Agents|sensory system agents|mesh-ancestor
24487816|NCT00465231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24487939|NCT00465751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24487971|NCT00466102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24487972|NCT00466102|Immunologic Factors|immunologic factors|mesh-ancestor
24487973|NCT00466102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488001|NCT00466154|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25707435|NCT02230956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707436|NCT02230956|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25707437|NCT02230956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25707438|NCT02230995|Metformin|metformin|mesh-list
25707439|NCT02230995|Empagliflozin|empagliflozin|mesh-list
25707440|NCT02230995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25707441|NCT02230995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707442|NCT02230995|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25707443|NCT02230995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707444|NCT02231086|Leucovorin|leucovorin|mesh-list
25707445|NCT02231086|Fluorouracil|fluorouracil|mesh-list
25707446|NCT02231086|Capecitabine|capecitabine|mesh-list
25707447|NCT02231086|Oxaliplatin|oxaliplatin|mesh-list
24488017|NCT00466219|Ribavirin|ribavirin|mesh-list
24809266|NCT02032303|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24809267|NCT02032303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24809268|NCT02032303|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24809269|NCT02032303|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24809270|NCT02032303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24809271|NCT02032303|Purinergic Agents|purinergic agents|mesh-ancestor
24809272|NCT02032303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24809273|NCT02032303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809274|NCT02032303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809275|NCT02032355|Anesthetics|anesthetics|mesh-list
24809276|NCT02032355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24488097|NCT00466570|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24488098|NCT00466596|Vitamins|vitamins|mesh-list
24488125|NCT00466609|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24488126|NCT00466609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24488132|NCT00466713|Rosiglitazone|rosiglitazone|mesh-list
24809301|NCT02032836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24488259|NCT00467454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24488260|NCT00467467|Alfuzosin|alfuzosin|mesh-list
24488261|NCT00467467|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24488262|NCT00467467|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24488263|NCT00467467|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24488264|NCT00467467|Adrenergic Agents|adrenergic agents|mesh-ancestor
24488265|NCT00467467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24488266|NCT00467467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488267|NCT00467467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488268|NCT00467467|Urological Agents|urological agents|mesh-ancestor
24488269|NCT00467493|Anastrozole|anastrozole|mesh-list
24488270|NCT00467493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24446910|NCT00306475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24446911|NCT00306540|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24446912|NCT00306540|Antidepressive Agents|antidepressive agents|mesh-ancestor
24446913|NCT00306540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24446914|NCT00306540|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24488507|NCT00469053|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24488510|NCT00469131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24488511|NCT00469131|Immunologic Factors|immunologic factors|mesh-ancestor
24488565|NCT00469404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488567|NCT00469404|Sensory System Agents|sensory system agents|mesh-ancestor
24488568|NCT00469404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24488569|NCT00469404|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24488570|NCT00469417|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24488571|NCT00469417|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
24488572|NCT00469417|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24488573|NCT00469417|Dermatologic Agents|dermatologic agents|mesh-ancestor
24488611|NCT00469469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707448|NCT02231086|Antimetabolites|antimetabolites|mesh-ancestor
25707449|NCT02231086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707450|NCT02231086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25707451|NCT02231086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25707452|NCT02231086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25707453|NCT02231086|Immunologic Factors|immunologic factors|mesh-ancestor
25707454|NCT02231086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707455|NCT02231086|Antidotes|antidotes|mesh-ancestor
24809318|NCT02032927|Respiratory System Agents|respiratory system agents|mesh-ancestor
24809319|NCT02032953|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
24488744|NCT00469885|Cholinergic Agents|cholinergic agents|mesh-ancestor
24488745|NCT00469885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24488777|NCT00469976|Antimetabolites|antimetabolites|mesh-ancestor
24488778|NCT00469976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488779|NCT00469976|Antiviral Agents|antiviral agents|mesh-ancestor
24488780|NCT00469976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24488781|NCT00469976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488782|NCT00469976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24488783|NCT00469976|Immunologic Factors|immunologic factors|mesh-ancestor
24488785|NCT00470015|Interleukin-2|interleukin-2|mesh-list
24488808|NCT00470197|Mitoxantrone|mitoxantrone|mesh-list
24488809|NCT00470197|Alvocidib|alvocidib|mesh-list
24488810|NCT00470197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24488811|NCT00470197|Antimetabolites|antimetabolites|mesh-ancestor
24488812|NCT00470197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488813|NCT00470197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488819|NCT00470197|Analgesics|analgesics|mesh-ancestor
24488876|NCT00470353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24488877|NCT00470405|Oxaliplatin|oxaliplatin|mesh-list
24488878|NCT00470405|Pemetrexed|pemetrexed|mesh-list
24488879|NCT00470405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488880|NCT00470405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488885|NCT00470483|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24488886|NCT00470483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24488888|NCT00470483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488910|NCT00470522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488911|NCT00470522|Dermatologic Agents|dermatologic agents|mesh-ancestor
24488912|NCT00470522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25707457|NCT02231086|Vitamin B Complex|vitamin b complex|mesh-ancestor
25707458|NCT02231086|Vitamins|vitamins|mesh-ancestor
25707459|NCT02231086|Micronutrients|micronutrients|mesh-ancestor
25707460|NCT02231164|Docetaxel|docetaxel|mesh-list
25707461|NCT02231164|Nintedanib|nintedanib|mesh-list
25707462|NCT02231164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25707463|NCT02231164|Tubulin Modulators|tubulin modulators|mesh-ancestor
25707464|NCT02231164|Antimitotic Agents|antimitotic agents|mesh-ancestor
25707465|NCT02231164|Mitosis Modulators|mitosis modulators|mesh-ancestor
25707466|NCT02231164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707467|NCT02231164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24489363|NCT00472810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24488927|NCT00470561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24488928|NCT00470561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488929|NCT00470561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24488930|NCT00470561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24488931|NCT00470561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24809320|NCT02032953|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24809321|NCT02032953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24809323|NCT02033018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24809324|NCT02033018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24809325|NCT02033018|Growth Substances|growth substances|mesh-ancestor
24809326|NCT02033018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809327|NCT02033018|Growth Inhibitors|growth inhibitors|mesh-ancestor
24809328|NCT02033018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24809329|NCT02033031|Bevacizumab|bevacizumab|mesh-list
24488932|NCT00470561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24488933|NCT00470561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488934|NCT00470561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24488935|NCT00470561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24488936|NCT00470561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488937|NCT00470561|Antipyretics|antipyretics|mesh-ancestor
24489033|NCT00471094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24489034|NCT00471094|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24451030|NCT00321490|Analgesics|analgesics|mesh-ancestor
24489077|NCT00471393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24489078|NCT00471393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24489079|NCT00471393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489080|NCT00471393|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24489081|NCT00471393|Protective Agents|protective agents|mesh-ancestor
24489082|NCT00471393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24489239|NCT00471952|Purinergic Agents|purinergic agents|mesh-ancestor
24489240|NCT00471952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24809333|NCT02033031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24809334|NCT02033031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24809335|NCT02033031|Growth Substances|growth substances|mesh-ancestor
24809336|NCT02033031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809337|NCT02033031|Growth Inhibitors|growth inhibitors|mesh-ancestor
24489353|NCT00472550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489355|NCT00472758|Immunologic Factors|immunologic factors|mesh-ancestor
24489356|NCT00472758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489357|NCT00472810|Mitomycins|mitomycins|mesh-list
24489358|NCT00472810|Mitomycin|mitomycin|mesh-list
24489359|NCT00472810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24489360|NCT00472810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489361|NCT00472810|Alkylating Agents|alkylating agents|mesh-ancestor
24489362|NCT00472810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489364|NCT00472810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24489526|NCT00473915|Respiratory System Agents|respiratory system agents|mesh-ancestor
24489527|NCT00473915|Dermatologic Agents|dermatologic agents|mesh-ancestor
24489528|NCT00473915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24489530|NCT00473980|Indomethacin|indomethacin|mesh-list
24489531|NCT00473980|Esomeprazole|esomeprazole|mesh-list
24489532|NCT00473980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24489534|NCT00473980|Analgesics|analgesics|mesh-ancestor
24489537|NCT00473980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489538|NCT00473980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24489539|NCT00473980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24489540|NCT00473980|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24489784|NCT00475397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489786|NCT00475397|Sensory System Agents|sensory system agents|mesh-ancestor
24489787|NCT00475397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489788|NCT00475397|Antidepressive Agents|antidepressive agents|mesh-ancestor
24489789|NCT00475397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24489790|NCT00475397|Dopamine Agents|dopamine agents|mesh-ancestor
24489791|NCT00475410|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25707468|NCT02231164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24489829|NCT00475553|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24489830|NCT00475553|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24489831|NCT00475553|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24489832|NCT00475553|Etonogestrel|etonogestrel|mesh-list
24489870|NCT00475696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24489871|NCT00475696|Dopamine Agents|dopamine agents|mesh-ancestor
24489872|NCT00475800|Lumiracoxib|lumiracoxib|mesh-list
24489873|NCT00475800|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24489874|NCT00475800|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24489875|NCT00475800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24809372|NCT02033408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24809373|NCT02033408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24809374|NCT02033408|Antimalarials|antimalarials|mesh-ancestor
24489894|NCT00475813|Respiratory System Agents|respiratory system agents|mesh-ancestor
24489896|NCT00475813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24489897|NCT00475813|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24489898|NCT00475813|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24489916|NCT00475917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24489917|NCT00475917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24489918|NCT00475917|Immunologic Factors|immunologic factors|mesh-ancestor
24489919|NCT00475917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490165|NCT00476918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24490166|NCT00476918|Glucocorticoids|glucocorticoids|mesh-ancestor
24490168|NCT00476918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24490169|NCT00476918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490170|NCT00476918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24490171|NCT00476918|Immunologic Factors|immunologic factors|mesh-ancestor
24490172|NCT00476918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490173|NCT00476918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490203|NCT00477035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490204|NCT00477035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24490205|NCT00477035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24490206|NCT00477035|Antimetabolites|antimetabolites|mesh-ancestor
24490207|NCT00477035|Antiviral Agents|antiviral agents|mesh-ancestor
24490208|NCT00477035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24490209|NCT00477035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490210|NCT00477035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24490301|NCT00477581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490302|NCT00477581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490303|NCT00477581|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24490304|NCT00477711|Capecitabine|capecitabine|mesh-list
24490305|NCT00477711|Cetuximab|cetuximab|mesh-list
24490306|NCT00477711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490307|NCT00477711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24490308|NCT00477711|Antimetabolites|antimetabolites|mesh-ancestor
24490309|NCT00477711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490310|NCT00477711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24490646|NCT00479362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490747|NCT00479908|Urological Agents|urological agents|mesh-ancestor
24490748|NCT00479934|Imatinib Mesylate|imatinib mesylate|mesh-list
24490749|NCT00479934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490750|NCT00479934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24490751|NCT00479934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490752|NCT00479934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441816|NCT00288431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24490753|NCT00479986|Pioglitazone|pioglitazone|mesh-list
24490754|NCT00479986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25707469|NCT02231177|Tiotropium Bromide|tiotropium bromide|mesh-list
24490755|NCT00479986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707470|NCT02231177|Olodaterol|olodaterol|mesh-list
25707471|NCT02231177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25707472|NCT02231177|Autonomic Agents|autonomic agents|mesh-ancestor
25707473|NCT02231177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25707474|NCT02231177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707475|NCT02231177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25707476|NCT02231177|Respiratory System Agents|respiratory system agents|mesh-ancestor
25707477|NCT02231177|Parasympatholytics|parasympatholytics|mesh-ancestor
25707478|NCT02231177|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24490756|NCT00480064|Cytarabine|cytarabine|mesh-list
24490866|NCT00480363|Lenalidomide|lenalidomide|mesh-list
24490867|NCT00480363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25707479|NCT02231177|Cholinergic Agents|cholinergic agents|mesh-ancestor
25707480|NCT02231177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707481|NCT02231177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490868|NCT00480363|Antiemetics|antiemetics|mesh-ancestor
24490869|NCT00480363|Autonomic Agents|autonomic agents|mesh-ancestor
24490870|NCT00480363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24490887|NCT00480376|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24490888|NCT00480376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490889|NCT00480376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490890|NCT00480376|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24490892|NCT00480376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24490893|NCT00480376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24809407|NCT02033538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491049|NCT00480896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24491050|NCT00480896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491072|NCT00481013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24491074|NCT00481143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24491075|NCT00481143|Chelating Agents|chelating agents|mesh-ancestor
24491076|NCT00481143|Sequestering Agents|sequestering agents|mesh-ancestor
24491077|NCT00481143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491079|NCT00481169|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24491080|NCT00481169|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24491081|NCT00481169|Hormone Antagonists|hormone antagonists|mesh-ancestor
24491087|NCT00481182|Methadone|methadone|mesh-list
24491319|NCT00482079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491322|NCT00482079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24491323|NCT00482079|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24491324|NCT00482079|Protease Inhibitors|protease inhibitors|mesh-ancestor
24491325|NCT00482079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491326|NCT00482079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491328|NCT00482183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24491361|NCT00482222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491362|NCT00482222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24491363|NCT00482222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491364|NCT00482222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24491365|NCT00482222|Immunologic Factors|immunologic factors|mesh-ancestor
24491369|NCT00482222|Vitamins|vitamins|mesh-ancestor
24534246|NCT00646594|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24534247|NCT00646594|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25707482|NCT02231918|Pramipexole|pramipexole|mesh-list
25707483|NCT02231918|Antioxidants|antioxidants|mesh-ancestor
25707484|NCT02231918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707485|NCT02231918|Protective Agents|protective agents|mesh-ancestor
25707486|NCT02231918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707487|NCT02231918|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25707488|NCT02231918|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24491635|NCT00483301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491636|NCT00483314|Acetylcysteine|acetylcysteine|mesh-list
24491637|NCT00483314|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24491638|NCT00483314|Antiviral Agents|antiviral agents|mesh-ancestor
24491639|NCT00483314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24491854|NCT00484133|Dopamine Agents|dopamine agents|mesh-ancestor
24491855|NCT00484133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24491856|NCT00484133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24491857|NCT00484133|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24491858|NCT00484133|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24491859|NCT00484133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491866|NCT00484237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491867|NCT00484237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24491868|NCT00484237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24491869|NCT00484237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24491870|NCT00484237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24491871|NCT00484237|Immunologic Factors|immunologic factors|mesh-ancestor
24491872|NCT00484250|Metronidazole|metronidazole|mesh-list
24491873|NCT00484250|Doxycycline|doxycycline|mesh-list
24491874|NCT00484250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24491875|NCT00484250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24491945|NCT00484692|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24491946|NCT00484692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24491947|NCT00484692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24491948|NCT00484692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491949|NCT00484692|Dopamine Agents|dopamine agents|mesh-ancestor
24491950|NCT00484692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24491951|NCT00484692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491952|NCT00484692|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24491965|NCT00484744|Analgesics|analgesics|mesh-ancestor
24491975|NCT00484744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491976|NCT00484770|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24491977|NCT00484770|Natriuretic Agents|natriuretic agents|mesh-ancestor
24491978|NCT00484770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491980|NCT00484809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24492072|NCT00485108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492127|NCT00485407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492128|NCT00485407|Adrenergic Agents|adrenergic agents|mesh-ancestor
24492129|NCT00485407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492393|NCT00486083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492394|NCT00486083|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24492395|NCT00486083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24492396|NCT00486083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24492403|NCT00486122|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24492404|NCT00486122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24492405|NCT00486122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24492406|NCT00486122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492408|NCT00486122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492409|NCT00486122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492411|NCT00486174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492412|NCT00486174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809457|NCT02033733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809458|NCT02033798|Tamsulosin|tamsulosin|mesh-list
24809459|NCT02033798|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24809460|NCT02033798|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24809461|NCT02033798|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24809462|NCT02033798|Adrenergic Agents|adrenergic agents|mesh-ancestor
24809463|NCT02033798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24809464|NCT02033798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24809465|NCT02033798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492466|NCT00486421|Rituximab|rituximab|mesh-list
24492467|NCT00486421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24492468|NCT00486421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24492469|NCT00486421|Immunologic Factors|immunologic factors|mesh-ancestor
24492534|NCT00486668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24604625|NCT00980473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604626|NCT00980473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604627|NCT00980473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24604628|NCT00980473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24604629|NCT00980551|Carboplatin|carboplatin|mesh-list
24492602|NCT00487032|Respiratory System Agents|respiratory system agents|mesh-ancestor
24492603|NCT00487032|Dermatologic Agents|dermatologic agents|mesh-ancestor
24604639|NCT00980551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24604640|NCT00980551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622953|NCT01069263|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24622954|NCT01069263|Protective Agents|protective agents|mesh-ancestor
24622955|NCT01069263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622956|NCT01069263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24622957|NCT01069263|Antioxidants|antioxidants|mesh-ancestor
24622959|NCT01069302|Clopidogrel|clopidogrel|mesh-list
24492643|NCT00487123|Diuretics|diuretics|mesh-ancestor
24492644|NCT00487123|Natriuretic Agents|natriuretic agents|mesh-ancestor
24492645|NCT00487123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492646|NCT00487123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24492673|NCT00487227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534366|NCT00646815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492776|NCT00487799|Diuretics|diuretics|mesh-ancestor
24492777|NCT00487799|Natriuretic Agents|natriuretic agents|mesh-ancestor
24492778|NCT00487812|Dobutamine|dobutamine|mesh-list
24492797|NCT00487994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24492798|NCT00487994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492800|NCT00488137|Laxatives|laxatives|mesh-ancestor
24492801|NCT00488137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24492802|NCT00488137|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24492803|NCT00488137|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24492804|NCT00488137|Serotonin Agents|serotonin agents|mesh-ancestor
24492970|NCT00488787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492971|NCT00488787|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24493016|NCT00489073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493018|NCT00489073|Sensory System Agents|sensory system agents|mesh-ancestor
24493019|NCT00489073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24493020|NCT00489073|Antidepressive Agents|antidepressive agents|mesh-ancestor
24493021|NCT00489073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24493022|NCT00489073|Dopamine Agents|dopamine agents|mesh-ancestor
24493024|NCT00489099|Immunologic Factors|immunologic factors|mesh-ancestor
24493029|NCT00489151|Lamivudine|lamivudine|mesh-list
24493087|NCT00489398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493089|NCT00489437|Antibodies|antibodies|mesh-list
24493090|NCT00489437|Immunologic Factors|immunologic factors|mesh-ancestor
24493091|NCT00489437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493093|NCT00489437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24493094|NCT00489437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24493095|NCT00489437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493097|NCT00489528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24493102|NCT00489593|Autonomic Agents|autonomic agents|mesh-ancestor
24493121|NCT00489645|Pramlintide|pramlintide|mesh-list
24493133|NCT00489658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24493134|NCT00489658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24493135|NCT00489658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493136|NCT00489658|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
24493137|NCT00489658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493142|NCT00489723|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24493143|NCT00489723|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24493144|NCT00489723|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24493145|NCT00489723|Adrenergic Agents|adrenergic agents|mesh-ancestor
24493150|NCT00489775|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24493151|NCT00489775|Paroxetine|paroxetine|mesh-list
24493152|NCT00489775|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24493153|NCT00489775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24493154|NCT00489775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24493155|NCT00489775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493156|NCT00489775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24493157|NCT00489775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493158|NCT00489775|Analgesics|analgesics|mesh-ancestor
24493159|NCT00489775|Sensory System Agents|sensory system agents|mesh-ancestor
24493160|NCT00489775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24493161|NCT00489775|Antidepressive Agents|antidepressive agents|mesh-ancestor
24493162|NCT00489775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24493358|NCT00490685|Sorafenib|sorafenib|mesh-list
24493463|NCT00490997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24493465|NCT00491049|Levofloxacin|levofloxacin|mesh-list
24493514|NCT00491166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24493532|NCT00491192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24493533|NCT00491192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493534|NCT00491192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493535|NCT00491348|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24493536|NCT00491348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24493537|NCT00491348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24493538|NCT00491348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24493539|NCT00491348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493540|NCT00491348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24493541|NCT00491348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493542|NCT00491348|Analgesics|analgesics|mesh-ancestor
24493543|NCT00491348|Sensory System Agents|sensory system agents|mesh-ancestor
24493546|NCT00491348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24493562|NCT00491426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25026847|NCT03624959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493617|NCT00491790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24493618|NCT00491790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493619|NCT00491790|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24493620|NCT00491790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24622984|NCT01069328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24622985|NCT01069328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622986|NCT01069536|Metoclopramide|metoclopramide|mesh-list
24493712|NCT00492128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24493713|NCT00492128|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24493714|NCT00492128|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24493715|NCT00492128|Diuretics|diuretics|mesh-ancestor
24493772|NCT00492414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493813|NCT00492505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493814|NCT00492505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24493815|NCT00492505|Hormone Antagonists|hormone antagonists|mesh-ancestor
25707489|NCT02231918|Dopamine Agonists|dopamine agonists|mesh-ancestor
25707490|NCT02231918|Dopamine Agents|dopamine agents|mesh-ancestor
25707491|NCT02231918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707492|NCT02232061|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25707493|NCT02232061|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25707494|NCT02232061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707495|NCT02232061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24493816|NCT00492505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24493817|NCT00492505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493818|NCT00492505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24493819|NCT00492505|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24493820|NCT00492505|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24493821|NCT00492505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24493823|NCT00492518|Theophylline|theophylline|mesh-list
24493982|NCT00493233|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24493983|NCT00493233|Dopamine Agents|dopamine agents|mesh-ancestor
24494027|NCT00493428|Baclofen|baclofen|mesh-list
24494182|NCT00494156|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24494183|NCT00494156|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24494184|NCT00494156|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24494185|NCT00494156|Purinergic Agents|purinergic agents|mesh-ancestor
24494186|NCT00494156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24494187|NCT00494156|Anticoagulants|anticoagulants|mesh-ancestor
24494189|NCT00494208|Androgens|androgens|mesh-ancestor
24494319|NCT00494832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24494320|NCT00494832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24494321|NCT00494832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24494322|NCT00494832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24494323|NCT00494832|Adrenergic Agents|adrenergic agents|mesh-ancestor
24494324|NCT00494832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24494325|NCT00494832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494331|NCT00494884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24494332|NCT00494884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494334|NCT00494897|Prednisone|prednisone|mesh-list
24443078|NCT00293631|Lornoxicam|lornoxicam|mesh-list
24494335|NCT00494897|Cyclophosphamide|cyclophosphamide|mesh-list
24494509|NCT00495352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24494510|NCT00495352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24494511|NCT00495365|Epoetin Alfa|epoetin alfa|mesh-list
24494523|NCT00495560|Misoprostol|misoprostol|mesh-list
24494524|NCT00495560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24494525|NCT00495560|Abortifacient Agents|abortifacient agents|mesh-ancestor
24494526|NCT00495560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24494527|NCT00495560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494528|NCT00495560|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24494529|NCT00495560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24494530|NCT00495560|Oxytocics|oxytocics|mesh-ancestor
24494531|NCT00495573|Acyclovir|acyclovir|mesh-list
24494534|NCT00495651|Isoniazid|isoniazid|mesh-list
24494543|NCT00495651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24494727|NCT00496665|Cyclophosphamide|cyclophosphamide|mesh-list
24494728|NCT00496665|Methotrexate|methotrexate|mesh-list
24494729|NCT00496665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24494730|NCT00496665|Immunologic Factors|immunologic factors|mesh-ancestor
24494996|NCT00497913|Botulinum Toxins|botulinum toxins|mesh-list
24494997|NCT00497913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24494998|NCT00497913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24494999|NCT00497913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24495000|NCT00497913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24495001|NCT00497913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495002|NCT00497913|Cholinergic Agents|cholinergic agents|mesh-ancestor
24495003|NCT00497913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24495004|NCT00497913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495055|NCT00498251|Autonomic Agents|autonomic agents|mesh-ancestor
24495056|NCT00498251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25707496|NCT02232061|Immunologic Factors|immunologic factors|mesh-ancestor
25707497|NCT02232061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707498|NCT02232178|Bupivacaine|bupivacaine|mesh-list
25707499|NCT02232178|Anesthetics, Local|anesthetics, local|mesh-ancestor
25707500|NCT02232178|Anesthetics|anesthetics|mesh-ancestor
25707501|NCT02232178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25707502|NCT02232178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707503|NCT02232178|Sensory System Agents|sensory system agents|mesh-ancestor
25707504|NCT02232178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25707505|NCT02232243|Hydroxychloroquine|hydroxychloroquine|mesh-list
25707506|NCT02232243|Antimalarials|antimalarials|mesh-ancestor
24495057|NCT00498251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495058|NCT00498251|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24495115|NCT00498537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24495117|NCT00498537|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24495118|NCT00498537|Diuretics|diuretics|mesh-ancestor
24495119|NCT00498537|Natriuretic Agents|natriuretic agents|mesh-ancestor
24495120|NCT00498589|Methotrexate|methotrexate|mesh-list
24495121|NCT00498589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24495122|NCT00498589|Abortifacient Agents|abortifacient agents|mesh-ancestor
24495190|NCT00498953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495191|NCT00498953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24495193|NCT00498953|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24495194|NCT00498979|Interferons|interferons|mesh-list
24495195|NCT00498979|Interferon-alpha|interferon-alpha|mesh-list
24495196|NCT00498979|Interferon alpha-2|interferon alpha-2|mesh-list
24495197|NCT00498979|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
24495198|NCT00498979|Dacarbazine|dacarbazine|mesh-list
24495199|NCT00498979|Vinblastine|vinblastine|mesh-list
24495200|NCT00498979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495201|NCT00498979|Antiviral Agents|antiviral agents|mesh-ancestor
24495247|NCT00499018|Lenograstim|lenograstim|mesh-list
24495248|NCT00499018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24495249|NCT00499018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495250|NCT00499018|Immunologic Factors|immunologic factors|mesh-ancestor
24495251|NCT00499018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495252|NCT00499018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24495253|NCT00499018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24495254|NCT00499018|Glucocorticoids|glucocorticoids|mesh-ancestor
24495255|NCT00499018|Hormones|hormones|mesh-ancestor
24495256|NCT00499018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24495377|NCT00499837|Protein C Inhibitor|protein c inhibitor|mesh-list
24495378|NCT00499837|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24495379|NCT00499837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24495380|NCT00499837|Protease Inhibitors|protease inhibitors|mesh-ancestor
24495381|NCT00499837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495382|NCT00499837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027498|NCT03619785|Acetaminophen|acetaminophen|mesh-list
24495510|NCT00500604|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24495511|NCT00500604|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24495512|NCT00500604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495513|NCT00500604|Diuretics|diuretics|mesh-ancestor
24495514|NCT00500604|Natriuretic Agents|natriuretic agents|mesh-ancestor
24495515|NCT00500604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495521|NCT00500721|Desipramine|desipramine|mesh-list
24495522|NCT00500721|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24495523|NCT00500721|Antidepressive Agents|antidepressive agents|mesh-ancestor
24495524|NCT00500721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24495537|NCT00500864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495560|NCT00501111|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24495561|NCT00501111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495562|NCT00501111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495630|NCT00501384|Natriuretic Agents|natriuretic agents|mesh-ancestor
24495631|NCT00501384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495632|NCT00501397|Ketoconazole|ketoconazole|mesh-list
24495633|NCT00501397|Antifungal Agents|antifungal agents|mesh-ancestor
24495634|NCT00501397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24495635|NCT00501397|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24495780|NCT00501982|Respiratory System Agents|respiratory system agents|mesh-ancestor
24495781|NCT00502034|Interferons|interferons|mesh-list
24495782|NCT00502034|Interferon-alpha|interferon-alpha|mesh-list
24495783|NCT00502034|Interferon alpha-2|interferon alpha-2|mesh-list
24495784|NCT00502034|Interleukin-2|interleukin-2|mesh-list
24495785|NCT00502034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495786|NCT00502034|Antiviral Agents|antiviral agents|mesh-ancestor
24495787|NCT00502034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24495788|NCT00502034|Immunologic Factors|immunologic factors|mesh-ancestor
24495789|NCT00502034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495790|NCT00502034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24495791|NCT00502034|Analgesics|analgesics|mesh-ancestor
24495792|NCT00502034|Sensory System Agents|sensory system agents|mesh-ancestor
24495793|NCT00502034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24495794|NCT00502060|Cediranib|cediranib|mesh-list
24495795|NCT00502060|Gefitinib|gefitinib|mesh-list
24495796|NCT00502060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495797|NCT00502060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24495906|NCT00502528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495907|NCT00502541|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
24495908|NCT00502541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24495910|NCT00502541|Hormones|hormones|mesh-ancestor
24495911|NCT00502541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24495912|NCT00502541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495913|NCT00502567|Leucovorin|leucovorin|mesh-list
24495914|NCT00502567|Docetaxel|docetaxel|mesh-list
24495915|NCT00502567|Fluorouracil|fluorouracil|mesh-list
24495916|NCT00502567|Oxaliplatin|oxaliplatin|mesh-list
24495917|NCT00502567|Irinotecan|irinotecan|mesh-list
24495918|NCT00502567|Pemetrexed|pemetrexed|mesh-list
24495928|NCT00502567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24495929|NCT00502567|Immunologic Factors|immunologic factors|mesh-ancestor
24495933|NCT00502567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495935|NCT00502567|Protective Agents|protective agents|mesh-ancestor
24495936|NCT00502567|Vitamin B Complex|vitamin b complex|mesh-ancestor
24495947|NCT00502684|Propranolol|propranolol|mesh-list
24495948|NCT00502684|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24495949|NCT00502684|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24496018|NCT00503126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496019|NCT00503126|Anticoagulants|anticoagulants|mesh-ancestor
24496020|NCT00503152|Valsartan|valsartan|mesh-list
24496037|NCT00503243|Mesalamine|mesalamine|mesh-list
24496038|NCT00503243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24496039|NCT00503243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24496040|NCT00503243|Analgesics|analgesics|mesh-ancestor
24496041|NCT00503243|Sensory System Agents|sensory system agents|mesh-ancestor
24496042|NCT00503243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24496043|NCT00503243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496044|NCT00503243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24496126|NCT00503516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24809793|NCT02036242|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24809794|NCT02036242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24809795|NCT02036242|Anesthetics, General|anesthetics, general|mesh-ancestor
24809796|NCT02036255|Taurolidine|taurolidine|mesh-list
24809797|NCT02036255|Heparin|heparin|mesh-list
24809798|NCT02036255|Anticoagulants|anticoagulants|mesh-ancestor
24809799|NCT02036255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24809850|NCT02036489|Glucocorticoids|glucocorticoids|mesh-ancestor
24809851|NCT02036489|Hormones|hormones|mesh-ancestor
24809852|NCT02036489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24809853|NCT02036489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809854|NCT02036489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24496327|NCT00504283|Morphine|morphine|mesh-list
24496330|NCT00504283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24496331|NCT00504283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496332|NCT00504283|Analgesics|analgesics|mesh-ancestor
24496333|NCT00504283|Sensory System Agents|sensory system agents|mesh-ancestor
24496334|NCT00504283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25707507|NCT02232243|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25707508|NCT02232243|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25707509|NCT02232243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24496335|NCT00504283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24496336|NCT00504283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24496337|NCT00504283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24496338|NCT00504283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25707510|NCT02232243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25707511|NCT02232243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707512|NCT02232243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24496339|NCT00504283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24496340|NCT00504283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496341|NCT00504283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496342|NCT00504296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
24496343|NCT00504296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496344|NCT00504296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496345|NCT00504400|Ranibizumab|ranibizumab|mesh-list
24496358|NCT00504413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24496401|NCT00504491|Rituximab|rituximab|mesh-list
24809878|NCT02036528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24809879|NCT02036528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24496413|NCT00504634|Bortezomib|bortezomib|mesh-list
24496414|NCT00504634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496415|NCT00504673|Insulin|insulin|mesh-list
24496416|NCT00504673|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24496417|NCT00504673|Insulin Aspart|insulin aspart|mesh-list
24809921|NCT02036723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24809922|NCT02036723|Growth Substances|growth substances|mesh-ancestor
24809923|NCT02036723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24809924|NCT02036723|Growth Inhibitors|growth inhibitors|mesh-ancestor
24809926|NCT02036736|Anesthetics|anesthetics|mesh-list
24601016|NCT00961909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601017|NCT00962026|Rilonacept|rilonacept|mesh-list
24601018|NCT00962026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24496435|NCT00504816|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
24496436|NCT00504816|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24496437|NCT00504855|Calpastatin|calpastatin|mesh-list
24496438|NCT00504855|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
24496439|NCT00504855|Protease Inhibitors|protease inhibitors|mesh-ancestor
25028260|NCT03612401|Mirabegron|mirabegron|mesh-list
24496440|NCT00504855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496441|NCT00504855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496442|NCT00504933|Cetirizine|cetirizine|mesh-list
24496443|NCT00504933|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24810017|NCT02037412|Purinergic Agents|purinergic agents|mesh-ancestor
24810018|NCT02037412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24810019|NCT02037412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810020|NCT02037412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810021|NCT02037464|Capsaicin|capsaicin|mesh-list
24810022|NCT02037464|Antipruritics|antipruritics|mesh-ancestor
24810023|NCT02037464|Dermatologic Agents|dermatologic agents|mesh-ancestor
24810024|NCT02037464|Sensory System Agents|sensory system agents|mesh-ancestor
24810025|NCT02037464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24810026|NCT02037464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810027|NCT02037503|Ketamine|ketamine|mesh-list
24810028|NCT02037503|Analgesics|analgesics|mesh-ancestor
24810077|NCT02037724|Micronutrients|micronutrients|mesh-ancestor
24810078|NCT02037724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810079|NCT02037737|Abatacept|abatacept|mesh-list
24810080|NCT02037737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24810081|NCT02037737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810082|NCT02037737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810083|NCT02037737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24810084|NCT02037737|Immunologic Factors|immunologic factors|mesh-ancestor
24810085|NCT02037737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601299|NCT00963833|Interferons|interferons|mesh-list
24496699|NCT00506207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496700|NCT00506207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496701|NCT00506246|Propofol|propofol|mesh-list
24496702|NCT00506246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24496703|NCT00506246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24496704|NCT00506246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496705|NCT00506246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24496706|NCT00506246|Anesthetics, General|anesthetics, general|mesh-ancestor
24496707|NCT00506246|Anesthetics|anesthetics|mesh-ancestor
24496708|NCT00506259|Melatonin|melatonin|mesh-list
24496709|NCT00506259|Antioxidants|antioxidants|mesh-ancestor
24496710|NCT00506259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448618|NCT00312416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448646|NCT00312520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499392|NCT00519246|Analgesics, Opioid|analgesics, opioid|mesh-list
24496721|NCT00506298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496722|NCT00506298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24496723|NCT00506298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24496724|NCT00506298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24496726|NCT00506298|Sensory System Agents|sensory system agents|mesh-ancestor
24496727|NCT00506298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24496728|NCT00506298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496777|NCT00506701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496780|NCT00506727|Adderall|adderall|mesh-list
24496781|NCT00506727|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24496782|NCT00506727|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24496783|NCT00506727|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24496784|NCT00506727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24496785|NCT00506727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496786|NCT00506727|Adrenergic Agents|adrenergic agents|mesh-ancestor
24496787|NCT00506727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24496788|NCT00506727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496789|NCT00506727|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24496790|NCT00506727|Sympathomimetics|sympathomimetics|mesh-ancestor
24496791|NCT00506727|Autonomic Agents|autonomic agents|mesh-ancestor
24496792|NCT00506727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24496793|NCT00506727|Dopamine Agents|dopamine agents|mesh-ancestor
24496794|NCT00506727|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24496795|NCT00506844|Capecitabine|capecitabine|mesh-list
24810097|NCT02037802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24810098|NCT02037802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24810099|NCT02037802|Anesthetics, General|anesthetics, general|mesh-ancestor
24810100|NCT02037802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24810101|NCT02037802|Narcotics|narcotics|mesh-ancestor
24496810|NCT00506935|GABA Agents|gaba agents|mesh-ancestor
24810115|NCT02037919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810116|NCT02037919|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24810117|NCT02037919|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24810118|NCT02037919|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24810119|NCT02037919|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24810121|NCT02037919|Hormones|hormones|mesh-ancestor
24810122|NCT02037919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24810123|NCT02037958|Chlorhexidine|chlorhexidine|mesh-list
24810124|NCT02037958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25707514|NCT02232802|Enoxaparin sodium|enoxaparin sodium|mesh-list
25707515|NCT02232802|Anticoagulants|anticoagulants|mesh-ancestor
25707516|NCT02232802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25707517|NCT02232802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25707518|NCT02232802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707519|NCT02233101|Tranexamic Acid|tranexamic acid|mesh-list
25707520|NCT02233101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25707521|NCT02233101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25707522|NCT02233101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707523|NCT02233101|Hemostatics|hemostatics|mesh-ancestor
25707524|NCT02233101|Coagulants|coagulants|mesh-ancestor
25707525|NCT02233296|Lasmiditan|lasmiditan|mesh-list
25707526|NCT02233296|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24810125|NCT02037958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24810126|NCT02037958|Disinfectants|disinfectants|mesh-ancestor
24810127|NCT02037997|Docetaxel|docetaxel|mesh-list
24622990|NCT01069536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622991|NCT01069536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24622992|NCT01069536|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24622993|NCT01069536|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24622994|NCT01069536|Dopamine Agents|dopamine agents|mesh-ancestor
24496909|NCT00507195|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24623026|NCT01069796|Growth Inhibitors|growth inhibitors|mesh-ancestor
24623027|NCT01069796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24623028|NCT01069796|Antimetabolites|antimetabolites|mesh-ancestor
24623029|NCT01069822|Midazolam|midazolam|mesh-list
24623030|NCT01069822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24496910|NCT00507195|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24496911|NCT00507221|Albendazole|albendazole|mesh-list
24496912|NCT00507221|Praziquantel|praziquantel|mesh-list
24496913|NCT00507221|Anthelmintics|anthelmintics|mesh-ancestor
24496914|NCT00507221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24496915|NCT00507221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24496916|NCT00507221|Anticestodal Agents|anticestodal agents|mesh-ancestor
24496917|NCT00507221|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24496918|NCT00507221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24496926|NCT00507234|Autonomic Agents|autonomic agents|mesh-ancestor
24496927|NCT00507234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24496937|NCT00507247|Daptomycin|daptomycin|mesh-list
24496938|NCT00507247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24496939|NCT00507247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24496940|NCT00507286|Alprostadil|alprostadil|mesh-list
24499393|NCT00519246|Narcotics|narcotics|mesh-ancestor
24496941|NCT00507286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24496943|NCT00507286|Urological Agents|urological agents|mesh-ancestor
24496944|NCT00507403|Infliximab|infliximab|mesh-list
24810142|NCT02038062|Anesthetics, General|anesthetics, general|mesh-ancestor
24496992|NCT00507663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24496993|NCT00507663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24496994|NCT00507663|Adrenergic Agents|adrenergic agents|mesh-ancestor
24496995|NCT00507663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24498328|NCT00513981|Abortifacient Agents|abortifacient agents|mesh-ancestor
24497014|NCT00507832|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24497016|NCT00507832|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24497018|NCT00507832|Tacrolimus|tacrolimus|mesh-list
24497019|NCT00507832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24497020|NCT00507832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24497021|NCT00507832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24497033|NCT00507845|Felodipine|felodipine|mesh-list
24810145|NCT02038062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497054|NCT00507858|Glucocorticoids|glucocorticoids|mesh-ancestor
24497056|NCT00507858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24497062|NCT00507858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24497063|NCT00507949|Megestrol|megestrol|mesh-list
24497064|NCT00507949|Megestrol Acetate|megestrol acetate|mesh-list
24497065|NCT00507949|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24497066|NCT00507949|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24497067|NCT00507949|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24497068|NCT00507949|Contraceptive Agents|contraceptive agents|mesh-ancestor
24497069|NCT00507949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24497070|NCT00507949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497071|NCT00507949|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24497072|NCT00507949|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24497073|NCT00507949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24497074|NCT00507949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497075|NCT00507949|Appetite Stimulants|appetite stimulants|mesh-ancestor
24497076|NCT00507949|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24497077|NCT00507962|Cisplatin|cisplatin|mesh-list
24497078|NCT00507962|Doxorubicin|doxorubicin|mesh-list
25707528|NCT02233296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24497116|NCT00508209|Bortezomib|bortezomib|mesh-list
25707529|NCT02233296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707530|NCT02233296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707531|NCT02233309|Anesthetics|anesthetics|mesh-list
25707532|NCT02233309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24497119|NCT00508287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24497120|NCT00508287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497121|NCT00508287|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24497123|NCT00508287|Hormones|hormones|mesh-ancestor
24497124|NCT00508287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24497125|NCT00508326|Paclitaxel|paclitaxel|mesh-list
24497126|NCT00508326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24497127|NCT00508326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497128|NCT00508326|Tubulin Modulators|tubulin modulators|mesh-ancestor
24497132|NCT00508365|Carvedilol|carvedilol|mesh-list
24497140|NCT00508365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24497141|NCT00508365|Antioxidants|antioxidants|mesh-ancestor
24497142|NCT00508365|Protective Agents|protective agents|mesh-ancestor
24497143|NCT00508365|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24497144|NCT00508365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24497145|NCT00508365|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24497146|NCT00508365|Vasodilator Agents|vasodilator agents|mesh-ancestor
24810152|NCT02038335|Medroxyprogesterone|medroxyprogesterone|mesh-list
24810153|NCT02038335|Etonogestrel|etonogestrel|mesh-list
24810154|NCT02038335|Norethindrone|norethindrone|mesh-list
24810155|NCT02038335|Estradiol|estradiol|mesh-list
24497147|NCT00508365|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24497148|NCT00508365|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24497166|NCT00508664|Docetaxel|docetaxel|mesh-list
24497192|NCT00508859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24497193|NCT00508859|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24497194|NCT00508859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24497195|NCT00508859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24497196|NCT00508859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497197|NCT00508859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24497199|NCT00508859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497232|NCT00508963|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24497238|NCT00508976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24497239|NCT00508976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497240|NCT00508976|Sensory System Agents|sensory system agents|mesh-ancestor
24497241|NCT00508976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24497242|NCT00508976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24497243|NCT00508976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24497404|NCT00509990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24497405|NCT00509990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497406|NCT00509990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24497433|NCT00510016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497434|NCT00510016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24497435|NCT00510016|Sympatholytics|sympatholytics|mesh-ancestor
24497436|NCT00510016|Autonomic Agents|autonomic agents|mesh-ancestor
24497437|NCT00510016|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24497438|NCT00510016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24497439|NCT00510016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24497440|NCT00510016|Adrenergic Agents|adrenergic agents|mesh-ancestor
24497441|NCT00510016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24497442|NCT00510016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497444|NCT00510081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24497445|NCT00510081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497446|NCT00510107|Oxaliplatin|oxaliplatin|mesh-list
24497447|NCT00510107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497466|NCT00510172|Vasodilator Agents|vasodilator agents|mesh-ancestor
24497467|NCT00510211|Olanzapine|olanzapine|mesh-list
24497468|NCT00510211|Antiemetics|antiemetics|mesh-ancestor
24497469|NCT00510211|Autonomic Agents|autonomic agents|mesh-ancestor
24497470|NCT00510211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24497471|NCT00510211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497472|NCT00510211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24497473|NCT00510211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24497474|NCT00510211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24497475|NCT00510211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24497512|NCT00510354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497513|NCT00510354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24810181|NCT02038452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810182|NCT02038452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24497609|NCT00510666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24497610|NCT00510666|Narcotics|narcotics|mesh-ancestor
24497611|NCT00510666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24497612|NCT00510666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497613|NCT00510666|Analgesics|analgesics|mesh-ancestor
24497614|NCT00510666|Sensory System Agents|sensory system agents|mesh-ancestor
24810185|NCT02038452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24810186|NCT02038452|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24497627|NCT00510913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497718|NCT00511576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497719|NCT00511576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24497720|NCT00511576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497721|NCT00511602|Insulin|insulin|mesh-list
24497722|NCT00511602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24497723|NCT00511602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497724|NCT00511628|Risperidone|risperidone|mesh-list
24497725|NCT00511628|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24497772|NCT00511823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24497773|NCT00511823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24497774|NCT00511823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24497775|NCT00511823|Serotonin Agents|serotonin agents|mesh-ancestor
24497784|NCT00511849|Tubulin Modulators|tubulin modulators|mesh-ancestor
24497958|NCT00512824|Calcium|calcium|mesh-list
24497959|NCT00512824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24497960|NCT00512824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497961|NCT00512824|Antacids|antacids|mesh-ancestor
24497962|NCT00512824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497963|NCT00512824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24497964|NCT00512850|Folic Acid|folic acid|mesh-list
24497965|NCT00512850|Hematinics|hematinics|mesh-ancestor
24497966|NCT00512850|Vitamin B Complex|vitamin b complex|mesh-ancestor
24497967|NCT00512850|Vitamins|vitamins|mesh-ancestor
24497968|NCT00512850|Micronutrients|micronutrients|mesh-ancestor
24497969|NCT00512850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497970|NCT00512863|Adalimumab|adalimumab|mesh-list
24497971|NCT00512863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24497973|NCT00512928|Vitamin K 2|vitamin k 2|mesh-list
24602507|NCT00969085|Antioxidants|antioxidants|mesh-ancestor
24498029|NCT00513110|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24498030|NCT00513110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498031|NCT00513110|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24498032|NCT00513110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498033|NCT00513110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498043|NCT00513149|Purinergic Agents|purinergic agents|mesh-ancestor
24498044|NCT00513149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24498045|NCT00513149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031445|NCT03587558|Flecainide|flecainide|mesh-list
24498046|NCT00513149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498048|NCT00513162|Valproic Acid|valproic acid|mesh-list
24498101|NCT00513188|Antidotes|antidotes|mesh-ancestor
24498102|NCT00513188|Protective Agents|protective agents|mesh-ancestor
24498103|NCT00513188|Vitamin B Complex|vitamin b complex|mesh-ancestor
24498104|NCT00513188|Vitamins|vitamins|mesh-ancestor
24498106|NCT00513188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24443243|NCT00294190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24443244|NCT00294190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443245|NCT00294190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810205|NCT02038634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24810206|NCT02038634|Glucocorticoids|glucocorticoids|mesh-ancestor
24810207|NCT02038634|Hormones|hormones|mesh-ancestor
24810208|NCT02038634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24810209|NCT02038634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810210|NCT02038634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24498319|NCT00513968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498320|NCT00513968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498322|NCT00513981|Methotrexate|methotrexate|mesh-list
24498323|NCT00513981|Calcium|calcium|mesh-list
24498324|NCT00513981|Levoleucovorin|levoleucovorin|mesh-list
24498325|NCT00513981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24498326|NCT00513981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498327|NCT00513981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24498372|NCT00514202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24498373|NCT00514202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498374|NCT00514202|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24498375|NCT00514202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24498376|NCT00514202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24498377|NCT00514202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498378|NCT00514202|Dopamine Agents|dopamine agents|mesh-ancestor
24498379|NCT00514202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24498380|NCT00514228|Sunitinib|sunitinib|mesh-list
24498381|NCT00514228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498382|NCT00514228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24498519|NCT00515138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498520|NCT00515138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24498521|NCT00515138|Alkylating Agents|alkylating agents|mesh-ancestor
24498522|NCT00515151|Ethanol|ethanol|mesh-list
24498523|NCT00515151|Octenidine|octenidine|mesh-list
24498528|NCT00515190|Oxaliplatin|oxaliplatin|mesh-list
24810279|NCT02039362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24498626|NCT00515684|Growth Inhibitors|growth inhibitors|mesh-ancestor
24498627|NCT00515736|Vitamins|vitamins|mesh-list
24498628|NCT00515736|Vitamin E|vitamin e|mesh-list
24498629|NCT00515736|Thiamine|thiamine|mesh-list
24498630|NCT00515736|Zinc|zinc|mesh-list
24498631|NCT00515736|Selenium|selenium|mesh-list
24498632|NCT00515736|Micronutrients|micronutrients|mesh-ancestor
24498633|NCT00515736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498652|NCT00515801|Glyburide|glyburide|mesh-list
24498653|NCT00515801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24498654|NCT00515801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498655|NCT00515866|Gemcitabine|gemcitabine|mesh-list
24498656|NCT00515866|Olaparib|olaparib|mesh-list
24498667|NCT00515866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498668|NCT00515892|Immunotoxin HA22|immunotoxin ha22|mesh-list
24498762|NCT00516191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498832|NCT00516464|Ranibizumab|ranibizumab|mesh-list
24498833|NCT00516464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24498834|NCT00516464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24498865|NCT00516672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24498866|NCT00516672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498867|NCT00516672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498909|NCT00516802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498914|NCT00516828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25032385|NCT03580967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24498916|NCT00516828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498917|NCT00516828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498918|NCT00516828|Antiviral Agents|antiviral agents|mesh-ancestor
24499160|NCT00518102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24499161|NCT00518102|Growth Substances|growth substances|mesh-ancestor
24499162|NCT00518102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499164|NCT00518141|Salicylic Acid|salicylic acid|mesh-list
24499165|NCT00518141|Salicylates|salicylates|mesh-list
24499166|NCT00518141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24499167|NCT00518141|Antifungal Agents|antifungal agents|mesh-ancestor
24499178|NCT00518141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24499320|NCT00518947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499321|NCT00518947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24499322|NCT00518947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24499323|NCT00518947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24499332|NCT00519012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24810306|NCT02039492|Spironolactone|spironolactone|mesh-list
24810307|NCT02039492|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24810308|NCT02039492|Hormone Antagonists|hormone antagonists|mesh-ancestor
24499333|NCT00519012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499397|NCT00519246|Sensory System Agents|sensory system agents|mesh-ancestor
24499398|NCT00519246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24499399|NCT00519246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24499421|NCT00519324|Everolimus|everolimus|mesh-list
24499521|NCT00519870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499522|NCT00519870|Vasodilator Agents|vasodilator agents|mesh-ancestor
24499523|NCT00519870|Tocolytic Agents|tocolytic agents|mesh-ancestor
24499524|NCT00519870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24499526|NCT00519909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24499527|NCT00519909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499533|NCT00519987|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24499534|NCT00519987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24499535|NCT00519987|Anesthetics, General|anesthetics, general|mesh-ancestor
24499536|NCT00519987|Anesthetics|anesthetics|mesh-ancestor
24499537|NCT00519987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24499639|NCT00520338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24499640|NCT00520338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24499699|NCT00520585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24499700|NCT00520585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499702|NCT00520650|Antidepressive Agents|antidepressive agents|mesh-ancestor
24499703|NCT00520650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24499704|NCT00520650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24499705|NCT00520650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25707533|NCT02233309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707534|NCT02233543|Glycopyrrolate|glycopyrrolate|mesh-list
25707535|NCT02233543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25707536|NCT02233543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25707537|NCT02233543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25707538|NCT02233543|Cholinergic Agents|cholinergic agents|mesh-ancestor
25707539|NCT02233543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707540|NCT02233543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707541|NCT02233543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707542|NCT02233647|Cocaine|cocaine|mesh-list
24499706|NCT00520650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24499707|NCT00520650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499715|NCT00520650|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24499716|NCT00520650|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24499717|NCT00520650|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24499755|NCT00520949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24810324|NCT02039518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810325|NCT02039531|Mitogens|mitogens|mesh-list
24499845|NCT00521261|Immunologic Factors|immunologic factors|mesh-ancestor
24499846|NCT00521261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499847|NCT00521274|Docetaxel|docetaxel|mesh-list
24499848|NCT00521274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24499849|NCT00521274|Tubulin Modulators|tubulin modulators|mesh-ancestor
24499850|NCT00521274|Antimitotic Agents|antimitotic agents|mesh-ancestor
24499851|NCT00521274|Mitosis Modulators|mitosis modulators|mesh-ancestor
24499852|NCT00521274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499853|NCT00521300|Octreotide|octreotide|mesh-list
24499854|NCT00521300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24810333|NCT02039531|Protective Agents|protective agents|mesh-ancestor
24810335|NCT02039661|Anesthetics, Local|anesthetics, local|mesh-ancestor
24810336|NCT02039661|Anesthetics|anesthetics|mesh-ancestor
24810337|NCT02039661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24810338|NCT02039661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499925|NCT00521612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499926|NCT00521690|Insulin Detemir|insulin detemir|mesh-list
24499927|NCT00521690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24499928|NCT00521690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499929|NCT00521703|Lidocaine|lidocaine|mesh-list
24499930|NCT00521703|Anesthetics, Local|anesthetics, local|mesh-ancestor
24499931|NCT00521703|Anesthetics|anesthetics|mesh-ancestor
24499932|NCT00521703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24499933|NCT00521703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499934|NCT00521703|Sensory System Agents|sensory system agents|mesh-ancestor
24499935|NCT00521703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24499936|NCT00521703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24499980|NCT00521950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24499981|NCT00521950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24499982|NCT00521950|Immunologic Factors|immunologic factors|mesh-ancestor
24499983|NCT00521950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499984|NCT00521950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24499985|NCT00521950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499986|NCT00521950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24500103|NCT00522665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24500104|NCT00522665|Immunologic Factors|immunologic factors|mesh-ancestor
24500105|NCT00522665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500107|NCT00522743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24500108|NCT00522743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500110|NCT00522782|Nitric Oxide|nitric oxide|mesh-list
24500111|NCT00522782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25707543|NCT02233647|Anesthetics, Local|anesthetics, local|mesh-ancestor
24500112|NCT00522782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24500113|NCT00522782|Autonomic Agents|autonomic agents|mesh-ancestor
25707544|NCT02233647|Anesthetics|anesthetics|mesh-ancestor
25707545|NCT02233647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25707546|NCT02233647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707547|NCT02233647|Sensory System Agents|sensory system agents|mesh-ancestor
25707548|NCT02233647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25707549|NCT02233647|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25707550|NCT02233647|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25707551|NCT02233647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24500121|NCT00522782|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24500154|NCT00523055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24500155|NCT00523055|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24500156|NCT00523055|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24500160|NCT00523068|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24500207|NCT00523185|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24500209|NCT00523185|Anesthetics, General|anesthetics, general|mesh-ancestor
24500212|NCT00523263|Anticoagulants|anticoagulants|mesh-ancestor
24500308|NCT00523692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24500309|NCT00523692|Immunologic Factors|immunologic factors|mesh-ancestor
24500310|NCT00523692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24500311|NCT00523692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24500312|NCT00523692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24500313|NCT00523692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24500379|NCT00524069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500380|NCT00524069|Growth Inhibitors|growth inhibitors|mesh-ancestor
24500381|NCT00524069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24500425|NCT00524186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24500426|NCT00524186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24500427|NCT00524186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24500428|NCT00524186|Immunologic Factors|immunologic factors|mesh-ancestor
24500429|NCT00524186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24500487|NCT00524667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500488|NCT00524667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500489|NCT00524667|Anticonvulsants|anticonvulsants|mesh-ancestor
24500490|NCT00524667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24810380|NCT02039869|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24810381|NCT02039869|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24810382|NCT02039869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24500491|NCT00524667|GABA Agents|gaba agents|mesh-ancestor
24500492|NCT00524667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24500493|NCT00524667|Antimanic Agents|antimanic agents|mesh-ancestor
24500640|NCT00525278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24500641|NCT00525278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24500642|NCT00525278|Histamine Antagonists|histamine antagonists|mesh-ancestor
24500643|NCT00525278|Histamine Agents|histamine agents|mesh-ancestor
24500644|NCT00525278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24500645|NCT00525278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500716|NCT00525564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24500717|NCT00525564|Respiratory System Agents|respiratory system agents|mesh-ancestor
24500718|NCT00525564|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24500719|NCT00525564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24500720|NCT00525564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24500721|NCT00525564|Adrenergic Agents|adrenergic agents|mesh-ancestor
24500722|NCT00525564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707552|NCT02233647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25707553|NCT02233647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707554|NCT02233647|Dopamine Agents|dopamine agents|mesh-ancestor
25707555|NCT02233647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707556|NCT02233751|Methyltestosterone|methyltestosterone|mesh-list
25707557|NCT02233751|Testosterone|testosterone|mesh-list
25707558|NCT02233751|Testosterone undecanoate|testosterone undecanoate|mesh-list
25707559|NCT02233751|Testosterone enanthate|testosterone enanthate|mesh-list
25707560|NCT02233751|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25707561|NCT02233751|Androgens|androgens|mesh-ancestor
25707562|NCT02233751|Hormones|hormones|mesh-ancestor
24500723|NCT00525564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500725|NCT00525577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24500726|NCT00525577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24500728|NCT00525577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500729|NCT00525577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24500730|NCT00525577|Antioxidants|antioxidants|mesh-ancestor
24500731|NCT00525577|Protective Agents|protective agents|mesh-ancestor
24500732|NCT00525577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500734|NCT00525616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24500735|NCT00525616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24500736|NCT00525616|Immunologic Factors|immunologic factors|mesh-ancestor
24500739|NCT00525642|Cyclophosphamide|cyclophosphamide|mesh-list
24500745|NCT00525642|Immunologic Factors|immunologic factors|mesh-ancestor
24500747|NCT00525642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24605695|NCT00986778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605696|NCT00986778|Antiviral Agents|antiviral agents|mesh-ancestor
24605697|NCT00986778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24605698|NCT00986778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24605700|NCT00986804|Decitabine|decitabine|mesh-list
24605709|NCT00986843|Irinotecan|irinotecan|mesh-list
24500853|NCT00525967|Narcotics|narcotics|mesh-ancestor
24500854|NCT00525967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24500855|NCT00525967|Antitussive Agents|antitussive agents|mesh-ancestor
24500856|NCT00525967|Respiratory System Agents|respiratory system agents|mesh-ancestor
24500858|NCT00525993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24500859|NCT00525993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24500860|NCT00525993|Analgesics|analgesics|mesh-ancestor
24500861|NCT00525993|Sensory System Agents|sensory system agents|mesh-ancestor
24500862|NCT00525993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24500863|NCT00525993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500864|NCT00525993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24500865|NCT00525993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24500866|NCT00525993|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24500867|NCT00525993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24500868|NCT00525993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24500870|NCT00526006|Esomeprazole|esomeprazole|mesh-list
24500935|NCT00526305|Daunorubicin|daunorubicin|mesh-list
24500936|NCT00526305|Asparaginase|asparaginase|mesh-list
24500943|NCT00526305|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24500944|NCT00526305|Alkylating Agents|alkylating agents|mesh-ancestor
24500945|NCT00526305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500946|NCT00526305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24500947|NCT00526305|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24500948|NCT00526305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24500949|NCT00526305|Antiemetics|antiemetics|mesh-ancestor
24500950|NCT00526305|Autonomic Agents|autonomic agents|mesh-ancestor
24500996|NCT00526318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24500997|NCT00526318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24500998|NCT00526318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24500999|NCT00526318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24501000|NCT00526318|Tubulin Modulators|tubulin modulators|mesh-ancestor
24501001|NCT00526318|Antimitotic Agents|antimitotic agents|mesh-ancestor
24501002|NCT00526318|Mitosis Modulators|mitosis modulators|mesh-ancestor
24501003|NCT00526318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24501004|NCT00526318|Dermatologic Agents|dermatologic agents|mesh-ancestor
24501005|NCT00526318|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24501006|NCT00526383|Antidepressive Agents|antidepressive agents|mesh-list
24501007|NCT00526383|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
24501008|NCT00526383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24501010|NCT00526396|Etoposide|etoposide|mesh-list
24501011|NCT00526396|Etoposide phosphate|etoposide phosphate|mesh-list
24501012|NCT00526396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501013|NCT00526396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24501014|NCT00526396|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24501062|NCT00526448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24501063|NCT00526513|Insulin glulisine|insulin glulisine|mesh-list
24501064|NCT00526513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24623048|NCT01069874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501074|NCT00526643|Gemcitabine|gemcitabine|mesh-list
24501075|NCT00526643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501076|NCT00526643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24501077|NCT00526643|Antimetabolites|antimetabolites|mesh-ancestor
24501085|NCT00526695|Sevoflurane|sevoflurane|mesh-list
24623053|NCT01069913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24623054|NCT01069913|Immunologic Factors|immunologic factors|mesh-ancestor
24623055|NCT01069913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501208|NCT00527449|Docetaxel|docetaxel|mesh-list
24501209|NCT00527449|Epirubicin|epirubicin|mesh-list
24501210|NCT00527449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501211|NCT00527449|Tubulin Modulators|tubulin modulators|mesh-ancestor
24501212|NCT00527449|Antimitotic Agents|antimitotic agents|mesh-ancestor
24501213|NCT00527449|Mitosis Modulators|mitosis modulators|mesh-ancestor
24501214|NCT00527449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501215|NCT00527449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24501216|NCT00527449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24501339|NCT00528151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24501340|NCT00528151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24501341|NCT00528151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501342|NCT00528151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501343|NCT00528151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501344|NCT00528177|Morphine|morphine|mesh-list
24501345|NCT00528177|Oxycodone|oxycodone|mesh-list
24501346|NCT00528177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24501347|NCT00528177|Narcotics|narcotics|mesh-ancestor
24501350|NCT00528177|Analgesics|analgesics|mesh-ancestor
24501554|NCT00529425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24501555|NCT00529594|Etoricoxib|etoricoxib|mesh-list
24501556|NCT00529594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24501557|NCT00529594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24501558|NCT00529594|Analgesics|analgesics|mesh-ancestor
24501559|NCT00529594|Sensory System Agents|sensory system agents|mesh-ancestor
24501560|NCT00529594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24501561|NCT00529594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501589|NCT00529646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501590|NCT00529646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501592|NCT00529750|Irbesartan|irbesartan|mesh-list
24501593|NCT00529750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24501594|NCT00529750|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24501595|NCT00529750|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24501641|NCT00530140|Immunologic Factors|immunologic factors|mesh-ancestor
24501642|NCT00530140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501643|NCT00530361|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24501644|NCT00530361|Natriuretic Agents|natriuretic agents|mesh-ancestor
24501646|NCT00530387|Ibuprofen|ibuprofen|mesh-list
25707563|NCT02233751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25707564|NCT02233751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707565|NCT02233751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25707566|NCT02233751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25707567|NCT02233751|Anabolic Agents|anabolic agents|mesh-ancestor
25707568|NCT02233803|Budesonide|budesonide|mesh-list
25707569|NCT02233803|Albuterol|albuterol|mesh-list
25707570|NCT02233803|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24501674|NCT00530400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24501675|NCT00530413|Phenobarbital|phenobarbital|mesh-list
24501676|NCT00530413|Anticonvulsants|anticonvulsants|mesh-ancestor
24501677|NCT00530413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24501678|NCT00530413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24501679|NCT00530413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501680|NCT00530413|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24501797|NCT00531115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501977|NCT00531895|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24501978|NCT00531895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24501979|NCT00531895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24501980|NCT00531895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501981|NCT00531895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24501986|NCT00531895|Antidepressive Agents|antidepressive agents|mesh-ancestor
24501988|NCT00531895|Dopamine Agents|dopamine agents|mesh-ancestor
24502041|NCT05319912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502043|NCT05319912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24502044|NCT05319912|Antimetabolites|antimetabolites|mesh-ancestor
24810441|NCT02040285|Dopamine Agents|dopamine agents|mesh-ancestor
24810442|NCT02040285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24810443|NCT02040285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810444|NCT02040285|Cathartics|cathartics|mesh-ancestor
24810445|NCT02040285|Laxatives|laxatives|mesh-ancestor
24810446|NCT02040311|Topiramate|topiramate|mesh-list
24810447|NCT02040311|Anticonvulsants|anticonvulsants|mesh-ancestor
24810448|NCT02040311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24810449|NCT02040311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810450|NCT02040350|Pralidoxime|pralidoxime|mesh-list
24810451|NCT02040350|Antidotes|antidotes|mesh-ancestor
24810452|NCT02040350|Protective Agents|protective agents|mesh-ancestor
24671207|NCT01324245|Dopamine Agonists|dopamine agonists|mesh-ancestor
24671208|NCT01324245|Dopamine Agents|dopamine agents|mesh-ancestor
24671209|NCT01324245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24502051|NCT05319912|Growth Substances|growth substances|mesh-ancestor
24502098|NCT05319756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24810454|NCT02040350|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
24605534|NCT00985855|Etoposide|etoposide|mesh-list
24502130|NCT05319639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24502131|NCT05319639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24502132|NCT05319639|Antidotes|antidotes|mesh-ancestor
24502133|NCT05319639|Protective Agents|protective agents|mesh-ancestor
24502134|NCT05319639|Vitamin B Complex|vitamin b complex|mesh-ancestor
24502135|NCT05319639|Vitamins|vitamins|mesh-ancestor
24502136|NCT05319639|Micronutrients|micronutrients|mesh-ancestor
24502496|NCT05034536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24502497|NCT05034536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24502498|NCT05034536|Dermatologic Agents|dermatologic agents|mesh-ancestor
24502499|NCT05034536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24502503|NCT05013892|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24502505|NCT05013892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24502517|NCT04988685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24502518|NCT04988685|Tubulin Modulators|tubulin modulators|mesh-ancestor
24502858|NCT04151667|Immunologic Factors|immunologic factors|mesh-ancestor
24502859|NCT04151667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24502860|NCT04151667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24502861|NCT04151667|Growth Substances|growth substances|mesh-ancestor
24502862|NCT04151667|Growth Inhibitors|growth inhibitors|mesh-ancestor
24502863|NCT04137770|Ketorolac|ketorolac|mesh-list
24502864|NCT04137770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24502865|NCT04137770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24502880|NCT04107675|Immunologic Factors|immunologic factors|mesh-ancestor
24502886|NCT04107675|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24502888|NCT04093167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24810488|NCT02040454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503066|NCT03403569|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
24503067|NCT03403569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503068|NCT03403569|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24503069|NCT03403569|Contraceptive Agents|contraceptive agents|mesh-ancestor
24503070|NCT03403569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24503071|NCT03403569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24503072|NCT03403569|Immunologic Factors|immunologic factors|mesh-ancestor
24503073|NCT03403569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24503074|NCT03403569|Alkylating Agents|alkylating agents|mesh-ancestor
24503075|NCT03403569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503076|NCT03403569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503111|NCT03283566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24503130|NCT03153150|Warfarin|warfarin|mesh-list
24503184|NCT02971956|Pembrolizumab|pembrolizumab|mesh-list
24810495|NCT02040571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810527|NCT02040649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24810528|NCT02040649|Anesthetics, General|anesthetics, general|mesh-ancestor
24810529|NCT02040649|Anesthetics|anesthetics|mesh-ancestor
24810530|NCT02040649|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24810531|NCT02040649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24810532|NCT02040649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24810533|NCT02040649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24810534|NCT02040649|GABA Modulators|gaba modulators|mesh-ancestor
24810535|NCT02040649|GABA Agents|gaba agents|mesh-ancestor
24810536|NCT02040649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24810537|NCT02040649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810538|NCT02040662|Morphine|morphine|mesh-list
24503347|NCT01840566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24503348|NCT01840566|Antimetabolites|antimetabolites|mesh-ancestor
24503388|NCT01655225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24503389|NCT01655225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25707573|NCT02233803|Autonomic Agents|autonomic agents|mesh-ancestor
25707574|NCT02233803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25707575|NCT02233803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707576|NCT02233803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25707577|NCT02233803|Respiratory System Agents|respiratory system agents|mesh-ancestor
25707578|NCT02233803|Glucocorticoids|glucocorticoids|mesh-ancestor
25707579|NCT02233803|Hormones|hormones|mesh-ancestor
24503390|NCT01655225|Hormone Antagonists|hormone antagonists|mesh-ancestor
24503391|NCT01655225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24503392|NCT01655225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24810553|NCT02040818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810554|NCT02040818|Antiviral Agents|antiviral agents|mesh-ancestor
24503393|NCT01655225|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24503395|NCT01614171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24503396|NCT01614171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503397|NCT01582776|Lenalidomide|lenalidomide|mesh-list
24503398|NCT01582776|Obinutuzumab|obinutuzumab|mesh-list
24503399|NCT01582776|Immunologic Factors|immunologic factors|mesh-ancestor
24503400|NCT01582776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503401|NCT01582776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24503460|NCT01342952|Ambrisentan|ambrisentan|mesh-list
24503461|NCT01342952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24503719|NCT00532675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503720|NCT00532688|Acetylcysteine|acetylcysteine|mesh-list
24503761|NCT00532818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503762|NCT00532818|GABA Agents|gaba agents|mesh-ancestor
24503763|NCT00532818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24810593|NCT02040883|Antidepressive Agents|antidepressive agents|mesh-ancestor
24810594|NCT02040883|Dopamine Agonists|dopamine agonists|mesh-ancestor
24810595|NCT02040883|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24810599|NCT02040883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24503836|NCT00533039|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
24503837|NCT00533039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503838|NCT00533039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503839|NCT00533065|Donepezil|donepezil|mesh-list
24503840|NCT00533065|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24503841|NCT00533065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503842|NCT00533065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503843|NCT00533065|Cholinergic Agents|cholinergic agents|mesh-ancestor
24503844|NCT00533065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24503845|NCT00533065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503846|NCT00533065|Nootropic Agents|nootropic agents|mesh-ancestor
24503847|NCT00533091|Sifalimumab|sifalimumab|mesh-list
24504091|NCT00533988|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24504092|NCT00534014|Ascorbic Acid|ascorbic acid|mesh-list
24504093|NCT00534014|Vitamins|vitamins|mesh-ancestor
24504094|NCT00534014|Micronutrients|micronutrients|mesh-ancestor
24504095|NCT00534014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504096|NCT00534014|Antioxidants|antioxidants|mesh-ancestor
24504097|NCT00534014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504098|NCT00534014|Protective Agents|protective agents|mesh-ancestor
24504099|NCT00534144|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24504100|NCT00534144|Ferric gluconate|ferric gluconate|mesh-list
24504101|NCT00534144|Hematinics|hematinics|mesh-ancestor
24504102|NCT00534183|Haloperidol|haloperidol|mesh-list
24504103|NCT00534183|Olanzapine|olanzapine|mesh-list
24504104|NCT00534183|Risperidone|risperidone|mesh-list
24504105|NCT00534183|Haloperidol decanoate|haloperidol decanoate|mesh-list
24504119|NCT00534183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24504120|NCT00534183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24504121|NCT00534183|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24504122|NCT00534183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24504123|NCT00534183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24504124|NCT00534183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24504125|NCT00534261|Interferons|interferons|mesh-list
25707580|NCT02233803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25707581|NCT02233803|Tocolytic Agents|tocolytic agents|mesh-ancestor
25707582|NCT02233803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25707583|NCT02233803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25707584|NCT02233803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25707585|NCT02233803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25707586|NCT02233803|Adrenergic Agents|adrenergic agents|mesh-ancestor
25036017|NCT03551067|Midazolam|midazolam|mesh-list
24810634|NCT02041273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810635|NCT02041338|Paclitaxel|paclitaxel|mesh-list
24810636|NCT02041338|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24810638|NCT02041338|Epirubicin|epirubicin|mesh-list
24810639|NCT02041338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24810667|NCT02041455|Sensory System Agents|sensory system agents|mesh-ancestor
24810668|NCT02041455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24810669|NCT02041455|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24810670|NCT02041455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24504248|NCT00534651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24504307|NCT00535119|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24504315|NCT00535158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24504317|NCT00535340|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24504318|NCT00535340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24504319|NCT00535340|Adrenergic Agents|adrenergic agents|mesh-ancestor
24504320|NCT00535340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24504321|NCT00535340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504343|NCT00535418|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24504344|NCT00535418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24504345|NCT00535418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504346|NCT00535418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504347|NCT00535418|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24504348|NCT00535418|Hormone Antagonists|hormone antagonists|mesh-ancestor
24504349|NCT00535418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24504350|NCT00535418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504351|NCT00535470|Mechlorethamine|mechlorethamine|mesh-list
24504352|NCT00535470|Alkylating Agents|alkylating agents|mesh-ancestor
24504379|NCT00535808|Sevoflurane|sevoflurane|mesh-list
24504381|NCT00535808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24810700|NCT02041650|Purinergic Agents|purinergic agents|mesh-ancestor
24607489|NCT04469842|Mycophenolic Acid|mycophenolic acid|mesh-list
24504448|NCT00536276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25707587|NCT02233803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707588|NCT02233803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504509|NCT00536692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24504521|NCT00536705|Respiratory System Agents|respiratory system agents|mesh-ancestor
24504522|NCT00536705|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24504523|NCT00536705|Hormone Antagonists|hormone antagonists|mesh-ancestor
24504524|NCT00536705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24504525|NCT00536705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504526|NCT00536705|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24504527|NCT00536705|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24504528|NCT00536705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504620|NCT00537355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504622|NCT00537420|Antidepressive Agents|antidepressive agents|mesh-ancestor
24504623|NCT00537420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24504624|NCT00537420|Appetite Depressants|appetite depressants|mesh-ancestor
24504625|NCT00537420|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24483782|NCT00445016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24483783|NCT00445016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483784|NCT00445042|Sorafenib|sorafenib|mesh-list
24483785|NCT00445042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24483786|NCT00445042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24483787|NCT00445042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483788|NCT00445042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483789|NCT00445055|Droperidol|droperidol|mesh-list
24606027|NCT00988715|Antimetabolites|antimetabolites|mesh-ancestor
24606040|NCT00988715|Antitubercular Agents|antitubercular agents|mesh-ancestor
24606041|NCT00988715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24810712|NCT02042027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810714|NCT02042170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24810715|NCT02042170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810716|NCT02042196|Cetrorelix|cetrorelix|mesh-list
24504740|NCT00537966|Rilpivirine|rilpivirine|mesh-list
24504741|NCT00537966|Elvitegravir|elvitegravir|mesh-list
24504742|NCT00537966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24504743|NCT00537966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24504744|NCT00537966|Protease Inhibitors|protease inhibitors|mesh-ancestor
24504745|NCT00537966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25707589|NCT02233998|Listerine|listerine|mesh-list
25707590|NCT02233998|Sodium Fluoride|sodium fluoride|mesh-list
25707591|NCT02233998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25707592|NCT02233998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25707593|NCT02233998|Cariostatic Agents|cariostatic agents|mesh-ancestor
25707594|NCT02233998|Protective Agents|protective agents|mesh-ancestor
25707595|NCT02233998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536817|NCT00652600|Vasodilator Agents|vasodilator agents|mesh-ancestor
24536818|NCT00652639|Clonazepam|clonazepam|mesh-list
24504879|NCT00538421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24504882|NCT00538486|Amlodipine|amlodipine|mesh-list
24504883|NCT00538486|Telmisartan|telmisartan|mesh-list
24504884|NCT00538486|Candesartan|candesartan|mesh-list
24504885|NCT00538486|Candesartan cilexetil|candesartan cilexetil|mesh-list
24504886|NCT00538486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24504887|NCT00538486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504888|NCT00538486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24504889|NCT00538486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24504890|NCT00538486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24504904|NCT00538499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24504905|NCT00538499|Narcotics|narcotics|mesh-ancestor
24504906|NCT00538499|Analgesics|analgesics|mesh-ancestor
24504996|NCT00538889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24504997|NCT00538889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504998|NCT00538889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24505045|NCT00539331|Mitosis Modulators|mitosis modulators|mesh-ancestor
24505046|NCT00539331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505047|NCT00539331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24505048|NCT00539331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505050|NCT00539396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24505051|NCT00539396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505069|NCT00539565|Glucocorticoids|glucocorticoids|mesh-ancestor
24505070|NCT00539565|Hormones|hormones|mesh-ancestor
24505120|NCT00539968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759043|NCT01749098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24759044|NCT01749098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24759045|NCT01749098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24759046|NCT01749098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759048|NCT01749111|Methotrexate|methotrexate|mesh-list
24759210|NCT01749579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549890|NCT00717938|Etoposide|etoposide|mesh-list
24759211|NCT01750060|Fentanyl|fentanyl|mesh-list
24759212|NCT01750060|Naltrexone|naltrexone|mesh-list
24759230|NCT01750099|Anesthetics, Local|anesthetics, local|mesh-ancestor
24759231|NCT01750099|Anesthetics|anesthetics|mesh-ancestor
24759232|NCT01750099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24759233|NCT01750099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759360|NCT01750801|Propolis|propolis|mesh-list
24759361|NCT01750801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24759362|NCT01750801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24759363|NCT01750801|Disinfectants|disinfectants|mesh-ancestor
24759364|NCT01750866|Prednisone|prednisone|mesh-list
24759366|NCT01750866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24759368|NCT01750866|Hormones|hormones|mesh-ancestor
24759369|NCT01750866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24759370|NCT01750866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759371|NCT01750866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24759372|NCT01750866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759373|NCT01750866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24759467|NCT01751763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24759468|NCT01751763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759469|NCT01751763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759471|NCT01751828|Antidepressive Agents|antidepressive agents|mesh-ancestor
24759472|NCT01751828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24759473|NCT01751828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24759474|NCT01751828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24759475|NCT01751828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24759477|NCT01751828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24759578|NCT01752699|Sensory System Agents|sensory system agents|mesh-ancestor
24759579|NCT01752699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24759580|NCT01752699|Antitussive Agents|antitussive agents|mesh-ancestor
24759581|NCT01752699|Respiratory System Agents|respiratory system agents|mesh-ancestor
24759583|NCT01752790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24759584|NCT01752790|Antimetabolites|antimetabolites|mesh-ancestor
24759585|NCT01752790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759586|NCT01752790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24759587|NCT01752790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759588|NCT01752790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24759589|NCT01752790|Immunologic Factors|immunologic factors|mesh-ancestor
24759590|NCT01752790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759591|NCT01752881|Vaccines|vaccines|mesh-list
24810827|NCT02042690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24810828|NCT02042690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24810829|NCT02042690|Antiemetics|antiemetics|mesh-ancestor
24759595|NCT01752959|Esmolol|esmolol|mesh-list
24810835|NCT02042690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24810837|NCT02042690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24810838|NCT02042690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24810839|NCT02042690|Abortifacient Agents|abortifacient agents|mesh-ancestor
24458596|NCT00338481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24458597|NCT00338481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458598|NCT00338481|Analgesics|analgesics|mesh-ancestor
24458599|NCT00338481|Sensory System Agents|sensory system agents|mesh-ancestor
24458600|NCT00338481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24458601|NCT00338494|Clofarabine|clofarabine|mesh-list
24458603|NCT00338494|Antimetabolites|antimetabolites|mesh-ancestor
24407917|NCT00175890|Anticonvulsants|anticonvulsants|mesh-ancestor
24460592|NCT00348998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460593|NCT00348998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24460594|NCT00348998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24460595|NCT00348998|Growth Substances|growth substances|mesh-ancestor
24810840|NCT02042690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24460615|NCT00349076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460616|NCT00349076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24460618|NCT00349076|Immunologic Factors|immunologic factors|mesh-ancestor
24460714|NCT00349284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24460715|NCT00349310|Pramipexole|pramipexole|mesh-list
24460716|NCT00349310|Antioxidants|antioxidants|mesh-ancestor
24460717|NCT00349310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461338|NCT00351975|Antimetabolites|antimetabolites|mesh-ancestor
24461339|NCT00351975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461340|NCT00351975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461341|NCT00351975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461342|NCT00351975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24461343|NCT00352079|Gefitinib|gefitinib|mesh-list
24461344|NCT00352079|BCG Vaccine|bcg vaccine|mesh-list
24461345|NCT00352079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461346|NCT00352079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24461347|NCT00352079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461348|NCT00352079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461375|NCT00352170|Calcium|calcium|mesh-list
24461376|NCT00352170|Vitamins|vitamins|mesh-ancestor
24461377|NCT00352170|Micronutrients|micronutrients|mesh-ancestor
24461378|NCT00352170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461379|NCT00352170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24461383|NCT00352183|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24461442|NCT00352339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24461443|NCT00352339|Serotonin Agents|serotonin agents|mesh-ancestor
24461444|NCT00352339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24461445|NCT00352339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24461446|NCT00352339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24810863|NCT02043054|Liraglutide|liraglutide|mesh-list
24810864|NCT02043054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24810865|NCT02043054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810867|NCT02043054|Hormones|hormones|mesh-ancestor
24810868|NCT02043054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24461552|NCT00352651|Analgesics|analgesics|mesh-ancestor
24461553|NCT00352651|Sensory System Agents|sensory system agents|mesh-ancestor
24429939|NCT00245505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24461554|NCT00352651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24810875|NCT02043171|Cholecalciferol|cholecalciferol|mesh-list
24810876|NCT02043171|Vitamins|vitamins|mesh-list
24810877|NCT02043171|Micronutrients|micronutrients|mesh-ancestor
24810878|NCT02043171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810879|NCT02043171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24810880|NCT02043171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24810881|NCT02043223|Vitamins|vitamins|mesh-list
24810882|NCT02043223|Vitamin A|vitamin a|mesh-list
24810883|NCT02043223|Retinol palmitate|retinol palmitate|mesh-list
24810884|NCT02043223|Micronutrients|micronutrients|mesh-ancestor
24810885|NCT02043223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24810886|NCT02043223|Antioxidants|antioxidants|mesh-ancestor
24810900|NCT02043288|Immunologic Factors|immunologic factors|mesh-ancestor
24810901|NCT02043288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707596|NCT02234115|Leuprolide|leuprolide|mesh-list
25707597|NCT02234115|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25707598|NCT02234115|Fertility Agents|fertility agents|mesh-ancestor
25707599|NCT02234115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25707600|NCT02234115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707601|NCT02234115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25707602|NCT02234115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25707603|NCT02234141|Selonsertib|selonsertib|mesh-list
25707604|NCT02234141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25707605|NCT02234141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25707606|NCT02234141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707607|NCT02234362|Vortioxetine|vortioxetine|mesh-list
25707608|NCT02234362|Antidepressive Agents|antidepressive agents|mesh-ancestor
25707609|NCT02234362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24537132|NCT00653562|GABA Agonists|gaba agonists|mesh-ancestor
24810903|NCT02043314|Antitubercular Agents|antitubercular agents|mesh-ancestor
24810904|NCT02043314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24810905|NCT02043314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24461657|NCT00353028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24461658|NCT00353028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24461659|NCT00353028|Serotonin Agents|serotonin agents|mesh-ancestor
24461660|NCT00353028|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24461661|NCT00353028|Antidepressive Agents|antidepressive agents|mesh-ancestor
24461662|NCT00353028|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24461663|NCT00353028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24461664|NCT00353028|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24461666|NCT00353041|Anesthetics, Local|anesthetics, local|mesh-ancestor
24461667|NCT00353041|Anesthetics|anesthetics|mesh-ancestor
24461668|NCT00353041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24461702|NCT00353145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24461703|NCT00353145|Antimetabolites|antimetabolites|mesh-ancestor
24461704|NCT00353145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461705|NCT00353145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461706|NCT00353145|Antiviral Agents|antiviral agents|mesh-ancestor
24461707|NCT00353145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24461708|NCT00353145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461709|NCT00353145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24461710|NCT00353145|Immunologic Factors|immunologic factors|mesh-ancestor
24461711|NCT00353145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461712|NCT00353184|Montelukast|montelukast|mesh-list
24461713|NCT00353184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24461714|NCT00353184|Respiratory System Agents|respiratory system agents|mesh-ancestor
24461716|NCT00353184|Hormone Antagonists|hormone antagonists|mesh-ancestor
24810925|NCT02043730|Paclitaxel|paclitaxel|mesh-list
24810926|NCT02043730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24810927|NCT02043730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810928|NCT02043730|Tubulin Modulators|tubulin modulators|mesh-ancestor
24810929|NCT02043730|Antimitotic Agents|antimitotic agents|mesh-ancestor
24810930|NCT02043730|Mitosis Modulators|mitosis modulators|mesh-ancestor
24810931|NCT02043730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810932|NCT02043730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24810933|NCT02043730|Antimetabolites|antimetabolites|mesh-ancestor
24810934|NCT02043730|Antiviral Agents|antiviral agents|mesh-ancestor
24810935|NCT02043730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24810936|NCT02043730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24810941|NCT02043756|Analgesics|analgesics|mesh-ancestor
24461845|NCT00354094|Antidepressive Agents|antidepressive agents|mesh-ancestor
24461846|NCT00354094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24461847|NCT00354094|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24461848|NCT00354094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24461849|NCT00354094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24461850|NCT00354094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461851|NCT00354094|Adrenergic Agents|adrenergic agents|mesh-ancestor
24461852|NCT00354094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24461906|NCT00354302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24810954|NCT02043821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24810956|NCT02043886|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24810957|NCT02043886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24810958|NCT02043886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24810959|NCT02043886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24810960|NCT02043886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461907|NCT00354302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24461908|NCT00354354|Ipratropium|ipratropium|mesh-list
24461909|NCT00354354|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24461911|NCT00354354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24461912|NCT00354354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461913|NCT00354354|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24461914|NCT00354354|Respiratory System Agents|respiratory system agents|mesh-ancestor
24461915|NCT00354354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24461916|NCT00354354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461938|NCT00354393|Methotrexate|methotrexate|mesh-list
24461961|NCT00354406|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24461962|NCT00354419|Cyclosporine|cyclosporine|mesh-list
24461963|NCT00354419|Mycophenolic Acid|mycophenolic acid|mesh-list
24461964|NCT00354419|Cyclophosphamide|cyclophosphamide|mesh-list
24461965|NCT00354419|Cyclosporins|cyclosporins|mesh-list
24461966|NCT00354419|Thymoglobulin|thymoglobulin|mesh-list
24461967|NCT00354419|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24461968|NCT00354419|Lenograstim|lenograstim|mesh-list
24461969|NCT00354419|Immunoglobulins|immunoglobulins|mesh-list
24461970|NCT00354419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24461971|NCT00354419|Immunologic Factors|immunologic factors|mesh-ancestor
24461972|NCT00354419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461973|NCT00354419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24505091|NCT00539786|Rabeprazole|rabeprazole|mesh-list
24461990|NCT00354458|Diuretics|diuretics|mesh-ancestor
24461991|NCT00354458|Natriuretic Agents|natriuretic agents|mesh-ancestor
24462006|NCT00354549|Carboplatin|carboplatin|mesh-list
24462007|NCT00354549|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24462008|NCT00354549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24462009|NCT00354549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24462010|NCT00354549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24462011|NCT00354549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24462012|NCT00354549|Growth Substances|growth substances|mesh-ancestor
24462013|NCT00354549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431300|NCT00251095|Paclitaxel|paclitaxel|mesh-list
24462014|NCT00354549|Growth Inhibitors|growth inhibitors|mesh-ancestor
24462015|NCT00354549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25039523|NCT03786770|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24462017|NCT00354549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462018|NCT00354549|Antiviral Agents|antiviral agents|mesh-ancestor
24462019|NCT00354549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24462020|NCT00354549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462021|NCT00354549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24462022|NCT00354549|Immunologic Factors|immunologic factors|mesh-ancestor
24462024|NCT00354562|Docetaxel|docetaxel|mesh-list
24462041|NCT00354653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462043|NCT00354653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24431340|NCT00251394|Immunologic Factors|immunologic factors|mesh-ancestor
24462044|NCT00354653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24431385|NCT00251550|Pemetrexed|pemetrexed|mesh-list
24462045|NCT00354653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24462046|NCT00354692|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24462052|NCT00354731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462053|NCT00354731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24462054|NCT00354731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24462055|NCT00354731|Protective Agents|protective agents|mesh-ancestor
24462056|NCT00354731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462057|NCT00354731|Vasodilator Agents|vasodilator agents|mesh-ancestor
24462058|NCT00354731|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24462085|NCT00354874|Respiratory System Agents|respiratory system agents|mesh-ancestor
24462086|NCT00354874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24462087|NCT00354874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24462088|NCT00354874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24462089|NCT00354874|Adrenergic Agents|adrenergic agents|mesh-ancestor
24462090|NCT00354874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24462091|NCT00354874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462093|NCT00354900|Hemostatics|hemostatics|mesh-ancestor
24462094|NCT00354900|Coagulants|coagulants|mesh-ancestor
24462095|NCT00354900|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24462192|NCT00355459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24462193|NCT00355459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24462194|NCT00355459|Antimalarials|antimalarials|mesh-ancestor
24462195|NCT00355459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24462196|NCT00355459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24462197|NCT00355459|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24462198|NCT00355459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462199|NCT00355459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462200|NCT00355524|Ritonavir|ritonavir|mesh-list
24462201|NCT00355524|Darunavir|darunavir|mesh-list
24462202|NCT00355524|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24462203|NCT00355524|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24462204|NCT00355524|Protease Inhibitors|protease inhibitors|mesh-ancestor
24462239|NCT00355589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462255|NCT00355602|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24462257|NCT00355602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24462258|NCT00355602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24462259|NCT00355602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24462260|NCT00355602|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24462261|NCT00355602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462289|NCT00355628|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24462290|NCT00355628|Chelating Agents|chelating agents|mesh-ancestor
24462291|NCT00355628|Sequestering Agents|sequestering agents|mesh-ancestor
24537415|NCT00654537|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24462401|NCT00356005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24462402|NCT00356005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24462403|NCT00356005|Antimalarials|antimalarials|mesh-ancestor
24462404|NCT00356005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24462406|NCT00356005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24462407|NCT00356005|Antiviral Agents|antiviral agents|mesh-ancestor
24462408|NCT00356005|Schistosomicides|schistosomicides|mesh-ancestor
24462409|NCT00356005|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24462410|NCT00356005|Anthelmintics|anthelmintics|mesh-ancestor
24462411|NCT00356070|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24462543|NCT00356928|Cyclophosphamide|cyclophosphamide|mesh-list
24462544|NCT00356928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24462545|NCT00356928|Immunologic Factors|immunologic factors|mesh-ancestor
24537462|NCT00654667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537463|NCT00654667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537464|NCT00654667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24537497|NCT00654914|Vasodilator Agents|vasodilator agents|mesh-ancestor
24537499|NCT00654914|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24462546|NCT00356928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462547|NCT00356928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24462548|NCT00356928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24462549|NCT00356928|Alkylating Agents|alkylating agents|mesh-ancestor
24435778|NCT00268177|Adrenergic Agents|adrenergic agents|mesh-ancestor
24462550|NCT00356928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462551|NCT00356928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24462552|NCT00356928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24462553|NCT00356941|Docetaxel|docetaxel|mesh-list
24462554|NCT00356941|Oxaliplatin|oxaliplatin|mesh-list
24462587|NCT00357045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24462589|NCT00357045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462590|NCT00357045|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24462591|NCT00357045|Antidepressive Agents|antidepressive agents|mesh-ancestor
24436123|NCT00269035|Dopamine Agents|dopamine agents|mesh-ancestor
24462653|NCT00357188|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24462654|NCT00357188|Efavirenz|efavirenz|mesh-list
24437897|NCT00274638|Diuretics|diuretics|mesh-ancestor
24462655|NCT00357188|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24462656|NCT00357188|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24462657|NCT00357188|Protease Inhibitors|protease inhibitors|mesh-ancestor
24462658|NCT00357188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24810996|NCT02044133|Vitamins|vitamins|mesh-ancestor
24810997|NCT02044133|Micronutrients|micronutrients|mesh-ancestor
24810998|NCT02044133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606430|NCT00990418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24606431|NCT00990418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606432|NCT00990418|Analgesics|analgesics|mesh-ancestor
24606433|NCT00990418|Sensory System Agents|sensory system agents|mesh-ancestor
24609870|NCT00998634|Antimanic Agents|antimanic agents|mesh-ancestor
24393621|NCT00130507|Capecitabine|capecitabine|mesh-list
24462659|NCT00357188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462661|NCT00357188|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24462662|NCT00357188|Antiviral Agents|antiviral agents|mesh-ancestor
24462663|NCT00357188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24462664|NCT00357188|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24462665|NCT00357188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24462666|NCT00357188|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24462667|NCT00357188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24462668|NCT00357188|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24462724|NCT00357318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24462725|NCT00357318|Growth Substances|growth substances|mesh-ancestor
24440982|NCT00285597|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24462726|NCT00357318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462727|NCT00357318|Growth Inhibitors|growth inhibitors|mesh-ancestor
24462728|NCT00357318|Immunologic Factors|immunologic factors|mesh-ancestor
24462729|NCT00357318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24462730|NCT00357318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462821|NCT00357630|Antimetabolites|antimetabolites|mesh-ancestor
24462822|NCT00357630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462823|NCT00357630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24462824|NCT00357630|Antiviral Agents|antiviral agents|mesh-ancestor
24462825|NCT00357630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24628832|NCT01101620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628864|NCT01101685|Antidepressive Agents|antidepressive agents|mesh-ancestor
24628865|NCT01101685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24628867|NCT01101698|Cholecalciferol|cholecalciferol|mesh-list
24628876|NCT01101698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24505094|NCT00539786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24628905|NCT01101802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628907|NCT01101815|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24628908|NCT01101815|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24628909|NCT01101815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628921|NCT01101919|Tofacitinib|tofacitinib|mesh-list
24629031|NCT01102686|Antidotes|antidotes|mesh-ancestor
24629032|NCT01102686|Protective Agents|protective agents|mesh-ancestor
24629033|NCT01102686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629038|NCT01102686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24629039|NCT01102686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24629040|NCT01102686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24629124|NCT01103336|Vitamins|vitamins|mesh-ancestor
24629125|NCT01103336|Micronutrients|micronutrients|mesh-ancestor
24629126|NCT01103336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629127|NCT01103375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24629128|NCT01103375|Isotretinoin|isotretinoin|mesh-list
24629129|NCT01103375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629130|NCT01103375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24629131|NCT01103375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537608|NCT00655512|Clobetasol|clobetasol|mesh-list
24629215|NCT01103648|Simvastatin|simvastatin|mesh-list
24629216|NCT01103648|Ezetimibe|ezetimibe|mesh-list
24629217|NCT01103648|Hypolipidemic Agents|hypolipidemic agents|mesh-list
24629218|NCT01103648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
24629219|NCT01103648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24629220|NCT01103648|Antimetabolites|antimetabolites|mesh-ancestor
24629221|NCT01103648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629222|NCT01103648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24629223|NCT01103648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24629224|NCT01103739|Simvastatin|simvastatin|mesh-list
24629225|NCT01103739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24629226|NCT01103739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24629227|NCT01103739|Antimetabolites|antimetabolites|mesh-ancestor
24623063|NCT01070030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24623064|NCT01070030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623065|NCT01070030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24623066|NCT01070030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707610|NCT02234362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25707611|NCT02234362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24623067|NCT01070030|Vasodilator Agents|vasodilator agents|mesh-ancestor
24623068|NCT01070030|Diuretics|diuretics|mesh-ancestor
24623069|NCT01070030|Natriuretic Agents|natriuretic agents|mesh-ancestor
24623070|NCT01070030|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24623071|NCT01070108|Ketamine|ketamine|mesh-list
24629260|NCT01103830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24629291|NCT01104259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629292|NCT01104259|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24629293|NCT01104259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24629294|NCT01104298|Doxorubicin|doxorubicin|mesh-list
24629295|NCT01104298|Trabectedin|trabectedin|mesh-list
24629296|NCT01104298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24629297|NCT01104298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629298|NCT01104298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24629429|NCT01105273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24629466|NCT01105390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629467|NCT01105390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24629468|NCT01105390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629502|NCT01105611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24629503|NCT01105611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629504|NCT01105611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24629505|NCT01105611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24629506|NCT01105611|Antiviral Agents|antiviral agents|mesh-ancestor
24629528|NCT01105871|Sensory System Agents|sensory system agents|mesh-ancestor
24629529|NCT01105871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24629531|NCT01105910|Lubricant Eye Drops|lubricant eye drops|mesh-list
24629532|NCT01105910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24629533|NCT01106001|Levobupivacaine|levobupivacaine|mesh-list
24629597|NCT01106547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24629656|NCT01107054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24629657|NCT01107054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629658|NCT01107054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629660|NCT01107067|Androgens|androgens|mesh-ancestor
24629662|NCT01107067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24629663|NCT01107067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629786|NCT01107938|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24629787|NCT01107938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24665131|NCT01310296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24629788|NCT01107938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629791|NCT01107951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24629792|NCT01107951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629793|NCT01107951|Immunologic Factors|immunologic factors|mesh-ancestor
24629794|NCT01107951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629795|NCT01107951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24629798|NCT01107951|Autonomic Agents|autonomic agents|mesh-ancestor
24629854|NCT01108146|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24629855|NCT01108146|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24629856|NCT01108146|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24629857|NCT01108146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24629859|NCT01108198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24629860|NCT01108198|Dermatologic Agents|dermatologic agents|mesh-ancestor
24629861|NCT01108198|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24629862|NCT01108289|Oxytocin|oxytocin|mesh-list
24629863|NCT01108289|Oxytocics|oxytocics|mesh-ancestor
24629864|NCT01108289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24811060|NCT02044601|Paclitaxel|paclitaxel|mesh-list
24811078|NCT02044627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707612|NCT02234362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25707613|NCT02234362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707614|NCT02234362|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25707615|NCT02234362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25707616|NCT02234362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25707617|NCT02234362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707618|NCT02234362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24811079|NCT02044653|Darbepoetin alfa|darbepoetin alfa|mesh-list
24811080|NCT02044653|Hematinics|hematinics|mesh-ancestor
24811081|NCT02044809|Cannabidiol|cannabidiol|mesh-list
24630118|NCT01109615|Antiviral Agents|antiviral agents|mesh-ancestor
24630119|NCT01109615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24630120|NCT01109615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24630121|NCT01109615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24630122|NCT01109615|Immunologic Factors|immunologic factors|mesh-ancestor
24630123|NCT01109615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630124|NCT01109615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24811083|NCT02044952|Mesalamine|mesalamine|mesh-list
24630431|NCT01111656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630433|NCT01111669|Tranexamic Acid|tranexamic acid|mesh-list
24630434|NCT01111669|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24630435|NCT01111669|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24630436|NCT01111669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630438|NCT01111669|Coagulants|coagulants|mesh-ancestor
24630439|NCT01111682|Mannitol|mannitol|mesh-list
24630440|NCT01111682|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24630441|NCT01111682|Diuretics|diuretics|mesh-ancestor
24811105|NCT02044965|Trimethoprim|trimethoprim|mesh-list
24811106|NCT02044965|Sulfamethoxazole|sulfamethoxazole|mesh-list
24811107|NCT02044965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24811108|NCT02044965|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24811109|NCT02044965|Renal Agents|renal agents|mesh-ancestor
24811110|NCT02044965|Antimalarials|antimalarials|mesh-ancestor
24811111|NCT02044965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24811112|NCT02044965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24811113|NCT02044965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24811114|NCT02044965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811115|NCT02044965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630853|NCT01114100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24630854|NCT01114100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630856|NCT01114100|Serotonin Agents|serotonin agents|mesh-ancestor
24630857|NCT01114100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630858|NCT01114191|Ketoconazole|ketoconazole|mesh-list
24630859|NCT01114191|Antifungal Agents|antifungal agents|mesh-ancestor
24631122|NCT01116167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24631123|NCT01116167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631125|NCT01116180|Angiotensin II|angiotensin ii|mesh-list
24631126|NCT01116180|Giapreza|giapreza|mesh-list
24631127|NCT01116180|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24631150|NCT01116193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24631151|NCT01116193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24631152|NCT01116193|Growth Substances|growth substances|mesh-ancestor
24631153|NCT01116193|Growth Inhibitors|growth inhibitors|mesh-ancestor
24631154|NCT01116206|Prucalopride|prucalopride|mesh-list
24631155|NCT01116206|Laxatives|laxatives|mesh-ancestor
24631156|NCT01116206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24631157|NCT01116206|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24631158|NCT01116206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24631159|NCT01116206|Serotonin Agents|serotonin agents|mesh-ancestor
24631160|NCT01116206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24811143|NCT02045030|Growth Substances|growth substances|mesh-ancestor
24811150|NCT02045056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811153|NCT02045056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24811154|NCT02045056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811155|NCT02045069|Ivermectin|ivermectin|mesh-list
24811156|NCT02045069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24811157|NCT02045069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24811158|NCT02045290|Metformin|metformin|mesh-list
24811159|NCT02045290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24811161|NCT02045368|Methotrexate|methotrexate|mesh-list
24811183|NCT02045589|Antiviral Agents|antiviral agents|mesh-ancestor
24631385|NCT01117298|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24631386|NCT01117298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24631387|NCT01117298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631388|NCT01117298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631389|NCT01117298|Urological Agents|urological agents|mesh-ancestor
24631390|NCT01117376|Erythromycin|erythromycin|mesh-list
24631391|NCT01117376|Erythromycin Estolate|erythromycin estolate|mesh-list
24631392|NCT01117376|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24631393|NCT01117376|Erythromycin stearate|erythromycin stearate|mesh-list
24631394|NCT01117376|Methylnaltrexone|methylnaltrexone|mesh-list
24631395|NCT01117376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24631396|NCT01117376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24631399|NCT01117376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631400|NCT01117376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631428|NCT01117662|Rituximab|rituximab|mesh-list
24631443|NCT01118039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631445|NCT01118065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24631501|NCT01118572|Analgesics|analgesics|mesh-ancestor
24631638|NCT01119196|Icodextrin|icodextrin|mesh-list
24631639|NCT01119196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24631640|NCT01119209|Ropivacaine|ropivacaine|mesh-list
24631641|NCT01119209|Anesthetics, Local|anesthetics, local|mesh-ancestor
24631642|NCT01119209|Anesthetics|anesthetics|mesh-ancestor
24631643|NCT01119209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24631644|NCT01119209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631651|NCT01119430|Fluoxetine|fluoxetine|mesh-list
24631805|NCT01120171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631808|NCT01120314|Antithrombins|antithrombins|mesh-ancestor
24631809|NCT01120314|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24631810|NCT01120314|Protease Inhibitors|protease inhibitors|mesh-ancestor
24631811|NCT01120314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631812|NCT01120314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631813|NCT01120314|Anticoagulants|anticoagulants|mesh-ancestor
24631815|NCT01120327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24631816|NCT01120327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24631817|NCT01120327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24631818|NCT01120327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631819|NCT01120327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24631821|NCT01120327|Vasodilator Agents|vasodilator agents|mesh-ancestor
24631850|NCT01120418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24631851|NCT01120418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24631852|NCT01120418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24665406|NCT01312298|Anesthetics|anesthetics|mesh-list
24631853|NCT01120418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631854|NCT01120418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24631855|NCT01120431|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24631857|NCT01120444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24631858|NCT01120444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632101|NCT01122004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24632102|NCT01122004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24632103|NCT01122004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24632105|NCT01122056|Interferon beta-1b|interferon beta-1b|mesh-list
24632106|NCT01122056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632107|NCT01122056|Antiviral Agents|antiviral agents|mesh-ancestor
24632108|NCT01122056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24632109|NCT01122056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24632110|NCT01122056|Immunologic Factors|immunologic factors|mesh-ancestor
24632111|NCT01122056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632113|NCT01122121|Flutamide|flutamide|mesh-list
24632114|NCT01122121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24632253|NCT01122940|Anticonvulsants|anticonvulsants|mesh-ancestor
24632254|NCT01122940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24632255|NCT01122940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24632256|NCT01122940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24632325|NCT01123408|Haloperidol|haloperidol|mesh-list
24632326|NCT01123408|Olanzapine|olanzapine|mesh-list
24632327|NCT01123408|Haloperidol decanoate|haloperidol decanoate|mesh-list
24632383|NCT01123525|Purinergic Agents|purinergic agents|mesh-ancestor
24632384|NCT01123525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24632385|NCT01123525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632386|NCT01123538|Chlormadinone Acetate|chlormadinone acetate|mesh-list
24632388|NCT01123538|Progestins|progestins|mesh-ancestor
24632390|NCT01123538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24632391|NCT01123538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632392|NCT01123538|Androgen Antagonists|androgen antagonists|mesh-ancestor
24632393|NCT01123538|Hormone Antagonists|hormone antagonists|mesh-ancestor
24632394|NCT01123538|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24632395|NCT01123538|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24632396|NCT01123538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24632410|NCT01123564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24632411|NCT01123564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24632412|NCT01123564|Growth Substances|growth substances|mesh-ancestor
24632413|NCT01123564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632414|NCT01123564|Growth Inhibitors|growth inhibitors|mesh-ancestor
24632415|NCT01123564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632417|NCT01123811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24632449|NCT01123967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632450|NCT01124032|Methylphenidate|methylphenidate|mesh-list
24632451|NCT01124032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24632457|NCT01124032|Dopamine Agents|dopamine agents|mesh-ancestor
24632651|NCT01125020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632686|NCT01125150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24632687|NCT01125150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632688|NCT01125215|Capsaicin|capsaicin|mesh-list
24632689|NCT01125215|Antipruritics|antipruritics|mesh-ancestor
24632690|NCT01125215|Dermatologic Agents|dermatologic agents|mesh-ancestor
24462839|NCT00357682|Aspirin|aspirin|mesh-list
24632691|NCT01125215|Sensory System Agents|sensory system agents|mesh-ancestor
24632694|NCT01125254|Amlodipine|amlodipine|mesh-list
24632788|NCT01125696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632789|NCT01125696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632791|NCT01125696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24632792|NCT01125696|Antiviral Agents|antiviral agents|mesh-ancestor
24518629|NCT04623944|Cytarabine|cytarabine|mesh-list
24632930|NCT01126216|Mitosis Modulators|mitosis modulators|mesh-ancestor
24632931|NCT01126216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632933|NCT01126229|Antioxidants|antioxidants|mesh-ancestor
24632934|NCT01126229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633415|NCT01129323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24633416|NCT01129375|Omeprazole|omeprazole|mesh-list
24633417|NCT01129375|Clopidogrel|clopidogrel|mesh-list
24394969|NCT00134758|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24394970|NCT00134758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24394971|NCT00134810|Botulinum Toxins|botulinum toxins|mesh-list
24394972|NCT00134810|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24394973|NCT00134810|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24394974|NCT00134810|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24394975|NCT00134810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24395180|NCT00135408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395182|NCT00135408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24395183|NCT00135408|Autonomic Agents|autonomic agents|mesh-ancestor
24671603|NCT01326754|Antimalarials|antimalarials|mesh-ancestor
24395184|NCT00135408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24395185|NCT00135408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395186|NCT00135408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24395187|NCT00135408|Respiratory System Agents|respiratory system agents|mesh-ancestor
24395188|NCT00135408|Glucocorticoids|glucocorticoids|mesh-ancestor
24395189|NCT00135408|Hormones|hormones|mesh-ancestor
24395202|NCT00135434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24395203|NCT00135434|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24444125|NCT00296751|Anesthetics, General|anesthetics, general|mesh-ancestor
24395251|NCT00135525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24395252|NCT00135525|Antidepressive Agents|antidepressive agents|mesh-ancestor
24395253|NCT00135525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24395254|NCT00135525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24395266|NCT00135551|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24395296|NCT00135681|Respiratory System Agents|respiratory system agents|mesh-ancestor
24395297|NCT00135681|Glucocorticoids|glucocorticoids|mesh-ancestor
24395299|NCT00135681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24395300|NCT00135681|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
24811296|NCT02046304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811298|NCT02046304|Antiviral Agents|antiviral agents|mesh-ancestor
24811299|NCT02046304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24811300|NCT02046304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811301|NCT02046304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24395301|NCT00135681|Immunologic Factors|immunologic factors|mesh-ancestor
24395302|NCT00135681|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24395303|NCT00135720|Etanercept|etanercept|mesh-list
24395304|NCT00135720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24395305|NCT00135720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24395310|NCT00135720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24395311|NCT00135720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24395312|NCT00135720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24395330|NCT00135759|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24395331|NCT00135759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24395332|NCT00135759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395333|NCT00135759|Sensory System Agents|sensory system agents|mesh-ancestor
24395334|NCT00135759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24395336|NCT00135785|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24395337|NCT00135785|Antidepressive Agents|antidepressive agents|mesh-ancestor
24395338|NCT00135785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24395339|NCT00135785|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24395462|NCT00135993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395463|NCT00135993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395465|NCT00136045|Dopamine Agonists|dopamine agonists|mesh-ancestor
24395466|NCT00136045|Dopamine Agents|dopamine agents|mesh-ancestor
24395467|NCT00136045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24395468|NCT00136045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395469|NCT00136045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395470|NCT00136058|Alendronate|alendronate|mesh-list
24395471|NCT00136058|Risedronic Acid|risedronic acid|mesh-list
24444134|NCT00296777|Serotonin Agents|serotonin agents|mesh-ancestor
24395496|NCT00136175|Mitosis Modulators|mitosis modulators|mesh-ancestor
24395497|NCT00136175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395652|NCT00136539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24395653|NCT00136539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24395654|NCT00136539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395675|NCT00136565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24395676|NCT00136565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24395677|NCT00136565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24395678|NCT00136565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24395679|NCT00136565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24395680|NCT00136565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395681|NCT00136565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24395684|NCT00136565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24395685|NCT00136565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24395686|NCT00136565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24395781|NCT00136851|Protease Inhibitors|protease inhibitors|mesh-ancestor
24395782|NCT00136851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24455385|NCT01539447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395783|NCT00136929|Fibrinolytic Agents|fibrinolytic agents|mesh-list
24395784|NCT00136929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24395787|NCT00136942|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24395861|NCT00137033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395863|NCT00137059|Acetaminophen|acetaminophen|mesh-list
24395864|NCT00137059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24395865|NCT00137059|Analgesics|analgesics|mesh-ancestor
24395866|NCT00137059|Sensory System Agents|sensory system agents|mesh-ancestor
24395867|NCT00137059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24396024|NCT00137657|Antimalarials|antimalarials|mesh-ancestor
24396025|NCT00137657|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24396026|NCT00137657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24606758|NCT05408845|Tubulin Modulators|tubulin modulators|mesh-ancestor
24606759|NCT05408845|Antimitotic Agents|antimitotic agents|mesh-ancestor
24606760|NCT05408845|Mitosis Modulators|mitosis modulators|mesh-ancestor
24550685|NCT00721747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396027|NCT00137657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24396028|NCT00137657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396029|NCT00137657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396030|NCT00137657|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24396031|NCT00137657|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24396161|NCT00137995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24396167|NCT00137995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24606761|NCT05408845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606762|NCT05408845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24623121|NCT01070277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24396168|NCT00137995|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24396169|NCT00137995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24396170|NCT00137995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396171|NCT00137995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396289|NCT00138411|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24396290|NCT00138411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24396292|NCT00138515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24396297|NCT00138515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396299|NCT00138541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24396300|NCT00138541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396301|NCT00138541|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24396302|NCT00138541|Protease Inhibitors|protease inhibitors|mesh-ancestor
24396303|NCT00138541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396304|NCT00138541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396305|NCT00138554|Pioglitazone|pioglitazone|mesh-list
24396306|NCT00138554|Vildagliptin|vildagliptin|mesh-list
24396417|NCT00138970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24396418|NCT00138970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396419|NCT00138970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396420|NCT00138970|Antifungal Agents|antifungal agents|mesh-ancestor
24396421|NCT00138970|Dermatologic Agents|dermatologic agents|mesh-ancestor
24396422|NCT00138970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24396425|NCT00138970|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24396426|NCT00138983|Vitamin D|vitamin d|mesh-list
24396427|NCT00138983|Alendronate|alendronate|mesh-list
24396428|NCT00138983|Alfacalcidol|alfacalcidol|mesh-list
24396429|NCT00138983|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
24396430|NCT00138983|Vitamins|vitamins|mesh-ancestor
24396431|NCT00138983|Micronutrients|micronutrients|mesh-ancestor
24396432|NCT00138983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396433|NCT00138983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24396434|NCT00139009|Cyclosporine|cyclosporine|mesh-list
24396506|NCT00139217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396507|NCT00139217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24396508|NCT00139217|Respiratory System Agents|respiratory system agents|mesh-ancestor
24396509|NCT00139217|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24396538|NCT00139230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24623130|NCT01070290|Capecitabine|capecitabine|mesh-list
24396644|NCT00139581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24396645|NCT00139581|Analgesics|analgesics|mesh-ancestor
24396646|NCT00139581|Sensory System Agents|sensory system agents|mesh-ancestor
24396784|NCT00139893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24396821|NCT00140075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24396822|NCT00140075|Immunologic Factors|immunologic factors|mesh-ancestor
24396823|NCT00140075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396824|NCT00140075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24396825|NCT00140075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24396826|NCT00140075|Alkylating Agents|alkylating agents|mesh-ancestor
24396827|NCT00140075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396828|NCT00140075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396829|NCT00140075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24396830|NCT00140075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24396831|NCT00140075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24396832|NCT00140075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24396833|NCT00140075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396909|NCT00140309|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24396964|NCT00140478|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24397289|NCT00141258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397290|NCT00141258|Anticonvulsants|anticonvulsants|mesh-ancestor
24397291|NCT00141258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24397292|NCT00141258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24397293|NCT00141258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397294|NCT00141258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24397295|NCT00141258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24397420|NCT00141544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25707619|NCT02234362|Serotonin Agents|serotonin agents|mesh-ancestor
25707620|NCT02234362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25707621|NCT02234362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25707622|NCT02234362|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25707623|NCT02234362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25707625|NCT02234427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24397422|NCT00141544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24397424|NCT00141544|Anabolic Agents|anabolic agents|mesh-ancestor
24455451|NCT00945724|Antimitotic Agents|antimitotic agents|mesh-ancestor
24455452|NCT00945724|Mitosis Modulators|mitosis modulators|mesh-ancestor
24455453|NCT00945724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24397666|NCT00142233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24397671|NCT00142246|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24397672|NCT00142246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24397673|NCT00142246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24397675|NCT00142324|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24397677|NCT00142324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397678|NCT00142324|Cholinergic Agents|cholinergic agents|mesh-ancestor
24397679|NCT00142324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24397680|NCT00142324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397681|NCT00142324|Nootropic Agents|nootropic agents|mesh-ancestor
24397682|NCT00142337|Zidovudine|zidovudine|mesh-list
24397683|NCT00142337|Didanosine|didanosine|mesh-list
24397684|NCT00142337|Antimetabolites|antimetabolites|mesh-ancestor
24397685|NCT00142337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397686|NCT00142337|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24397687|NCT00142337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24397760|NCT00142493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24397761|NCT00142493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24397762|NCT00142493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24397763|NCT00142493|Adrenergic Agents|adrenergic agents|mesh-ancestor
24397764|NCT00142493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24397765|NCT00142493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397766|NCT00142493|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24397767|NCT00142493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24397800|NCT00142610|Micronutrients|micronutrients|mesh-ancestor
24397801|NCT00142610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397802|NCT00142610|Antioxidants|antioxidants|mesh-ancestor
24397884|NCT00142948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24397885|NCT00142961|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24397886|NCT00142961|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24397887|NCT00142961|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24397888|NCT00142961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24397889|NCT00142961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397890|NCT00142961|Adrenergic Agents|adrenergic agents|mesh-ancestor
24397939|NCT00143091|Serotonin Agents|serotonin agents|mesh-ancestor
24397940|NCT00143091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397942|NCT00143104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24397943|NCT00143104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397945|NCT00143130|Analgesics|analgesics|mesh-ancestor
24397976|NCT00143156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397977|NCT00143156|Anticonvulsants|anticonvulsants|mesh-ancestor
24398026|NCT00143234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25707626|NCT02234427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25707627|NCT02234427|Analgesics|analgesics|mesh-ancestor
25707628|NCT02234427|Sensory System Agents|sensory system agents|mesh-ancestor
25707629|NCT02234427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25707630|NCT02234427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707631|NCT02234427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25707632|NCT02234427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25707633|NCT02234427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24398027|NCT00143234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24398028|NCT00143234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398029|NCT00143234|Vasodilator Agents|vasodilator agents|mesh-ancestor
24398030|NCT00143260|Sildenafil Citrate|sildenafil citrate|mesh-list
24398768|NCT00145561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24398071|NCT00143351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24398307|NCT00144144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398308|NCT00144144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24398309|NCT00144157|Zidovudine|zidovudine|mesh-list
24398310|NCT00144157|Nevirapine|nevirapine|mesh-list
24398311|NCT00144157|Antimetabolites|antimetabolites|mesh-ancestor
24398312|NCT00144157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398350|NCT00144209|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24398351|NCT00144209|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24398353|NCT00144209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24398354|NCT00144209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398355|NCT00144209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398356|NCT00144209|Antioxidants|antioxidants|mesh-ancestor
24398357|NCT00144209|Protective Agents|protective agents|mesh-ancestor
24398358|NCT00144209|Dopamine Agonists|dopamine agonists|mesh-ancestor
24398359|NCT00144209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398360|NCT00144222|Telmisartan|telmisartan|mesh-list
24398526|NCT00144807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24398527|NCT00144807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24398528|NCT00144807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24398566|NCT00144872|Lamotrigine|lamotrigine|mesh-list
24398567|NCT00144872|Anticonvulsants|anticonvulsants|mesh-ancestor
24398568|NCT00144872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24398569|NCT00144872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24398570|NCT00144872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398571|NCT00144872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24398572|NCT00144872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398668|NCT00145236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398693|NCT00145314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24398695|NCT00145314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24398697|NCT00145314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398698|NCT00145314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24398699|NCT00145314|Antidotes|antidotes|mesh-ancestor
24398700|NCT00145314|Protective Agents|protective agents|mesh-ancestor
24398701|NCT00145314|Vitamin B Complex|vitamin b complex|mesh-ancestor
24398702|NCT00145314|Vitamins|vitamins|mesh-ancestor
24398703|NCT00145314|Micronutrients|micronutrients|mesh-ancestor
24398704|NCT00145314|Hematinics|hematinics|mesh-ancestor
24398705|NCT00145340|Pioglitazone|pioglitazone|mesh-list
24398706|NCT00145340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24398707|NCT00145340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398708|NCT00145353|Insulin Aspart|insulin aspart|mesh-list
24398709|NCT00145353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24398710|NCT00145353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398711|NCT00145379|Metformin|metformin|mesh-list
24398756|NCT00145522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24398757|NCT00145522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24398758|NCT00145522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24398759|NCT00145522|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24398760|NCT00145522|Anabolic Agents|anabolic agents|mesh-ancestor
24398761|NCT00145561|Ritonavir|ritonavir|mesh-list
24398762|NCT00145561|Saquinavir|saquinavir|mesh-list
24398763|NCT00145561|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24398764|NCT00145561|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24398765|NCT00145561|Protease Inhibitors|protease inhibitors|mesh-ancestor
24398766|NCT00145561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398767|NCT00145561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398910|NCT00146146|Methyltestosterone|methyltestosterone|mesh-list
24398911|NCT00146146|Dutasteride|dutasteride|mesh-list
24398925|NCT00146146|Androgens|androgens|mesh-ancestor
24398926|NCT00146146|Hormones|hormones|mesh-ancestor
24398927|NCT00146146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24398928|NCT00146146|Anabolic Agents|anabolic agents|mesh-ancestor
24462927|NCT00357942|Analgesics|analgesics|mesh-ancestor
24462928|NCT00357942|Sensory System Agents|sensory system agents|mesh-ancestor
24462929|NCT00357942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24462930|NCT00357981|Contraceptive Agents|contraceptive agents|mesh-list
24398929|NCT00146146|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24398930|NCT00146159|Mitoxantrone|mitoxantrone|mesh-list
24398955|NCT00146250|Anesthetics, General|anesthetics, general|mesh-ancestor
24398956|NCT00146250|Anesthetics|anesthetics|mesh-ancestor
24398957|NCT00146250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24398960|NCT00146250|Analgesics|analgesics|mesh-ancestor
24398997|NCT00146380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24398998|NCT00146380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24399036|NCT00146523|Luteolytic Agents|luteolytic agents|mesh-ancestor
24399037|NCT00146523|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24399038|NCT00146523|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24811383|NCT02046538|Oxaliplatin|oxaliplatin|mesh-list
24811385|NCT02046538|Antimetabolites|antimetabolites|mesh-ancestor
24811386|NCT02046538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674364|NCT05250245|Urological Agents|urological agents|mesh-ancestor
24399040|NCT00146549|Vinorelbine|vinorelbine|mesh-list
24399041|NCT00146549|Docetaxel|docetaxel|mesh-list
24399042|NCT00146549|Trastuzumab|trastuzumab|mesh-list
24399043|NCT00146549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24399044|NCT00146549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399045|NCT00146549|Tubulin Modulators|tubulin modulators|mesh-ancestor
24399046|NCT00146549|Antimitotic Agents|antimitotic agents|mesh-ancestor
24399047|NCT00146549|Mitosis Modulators|mitosis modulators|mesh-ancestor
24399048|NCT00146549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399049|NCT00146549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24399050|NCT00146562|Paclitaxel|paclitaxel|mesh-list
24399051|NCT00146562|Cyclophosphamide|cyclophosphamide|mesh-list
24399052|NCT00146562|Doxorubicin|doxorubicin|mesh-list
24399053|NCT00146562|Darbepoetin alfa|darbepoetin alfa|mesh-list
24399055|NCT00146562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399056|NCT00146562|Tubulin Modulators|tubulin modulators|mesh-ancestor
24399057|NCT00146562|Antimitotic Agents|antimitotic agents|mesh-ancestor
24399058|NCT00146562|Mitosis Modulators|mitosis modulators|mesh-ancestor
24399059|NCT00146562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399060|NCT00146562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24399063|NCT00146562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24399064|NCT00146562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24399065|NCT00146562|Alkylating Agents|alkylating agents|mesh-ancestor
24399066|NCT00146562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24399067|NCT00146562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24399109|NCT00146601|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24399110|NCT00146601|Hormone Antagonists|hormone antagonists|mesh-ancestor
24399111|NCT00146601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24399112|NCT00146601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399114|NCT00146614|Methotrexate|methotrexate|mesh-list
24399115|NCT00146614|Tacrolimus|tacrolimus|mesh-list
24399116|NCT00146614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24399117|NCT00146614|Abortifacient Agents|abortifacient agents|mesh-ancestor
24399277|NCT00147355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25707634|NCT02234427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25707635|NCT02234427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707636|NCT02234427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25707637|NCT02234427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25707638|NCT02234427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25707639|NCT02234427|Antipyretics|antipyretics|mesh-ancestor
25707640|NCT02234570|Oxfendazole|oxfendazole|mesh-list
25707641|NCT02234570|Anthelmintics|anthelmintics|mesh-ancestor
24399281|NCT00147355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24399282|NCT00147355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399284|NCT00147355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24399298|NCT00147355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24399299|NCT00147355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24399300|NCT00147355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24399301|NCT00147355|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24399302|NCT00147355|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24399575|NCT00148083|Dopamine Agents|dopamine agents|mesh-ancestor
24399576|NCT00148135|Gemcitabine|gemcitabine|mesh-list
24399577|NCT00148135|Carboplatin|carboplatin|mesh-list
24399578|NCT00148135|Capecitabine|capecitabine|mesh-list
24399579|NCT00148135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399580|NCT00148135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24399581|NCT00148135|Antimetabolites|antimetabolites|mesh-ancestor
24399582|NCT00148135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399583|NCT00148135|Antiviral Agents|antiviral agents|mesh-ancestor
24399584|NCT00148135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24399585|NCT00148135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24399586|NCT00148135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24399587|NCT00148135|Immunologic Factors|immunologic factors|mesh-ancestor
24399588|NCT00148135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399589|NCT00148148|Amphotericin B|amphotericin b|mesh-list
24399590|NCT00148148|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24399684|NCT00148395|Antimitotic Agents|antimitotic agents|mesh-ancestor
24399685|NCT00148395|Mitosis Modulators|mitosis modulators|mesh-ancestor
24399686|NCT00148408|Montelukast|montelukast|mesh-list
24399687|NCT00148408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24399688|NCT00148408|Respiratory System Agents|respiratory system agents|mesh-ancestor
24399689|NCT00148408|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24399690|NCT00148408|Hormone Antagonists|hormone antagonists|mesh-ancestor
24399691|NCT00148408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24399692|NCT00148408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399693|NCT00148408|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24399696|NCT00148421|Epoetin Alfa|epoetin alfa|mesh-list
24811405|NCT02046551|Adrenergic Agents|adrenergic agents|mesh-ancestor
24811406|NCT02046551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24811407|NCT02046551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811409|NCT02046577|Cholecalciferol|cholecalciferol|mesh-list
24811411|NCT02046577|Micronutrients|micronutrients|mesh-ancestor
24811412|NCT02046577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399810|NCT00148681|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24399811|NCT00148681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24399812|NCT00148681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24399813|NCT00148681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24399814|NCT00148681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24399815|NCT00148681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24399816|NCT00148694|Cisplatin|cisplatin|mesh-list
24399817|NCT00148694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399818|NCT00148707|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
24399819|NCT00148707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399827|NCT00148746|Pimecrolimus|pimecrolimus|mesh-list
24399828|NCT00148746|Prednicarbate|prednicarbate|mesh-list
24399829|NCT00148746|Tacrolimus|tacrolimus|mesh-list
24399830|NCT00148746|Cyclosporins|cyclosporins|mesh-list
24399831|NCT00148746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24399901|NCT00148863|Interferon-gamma|interferon-gamma|mesh-list
24399945|NCT00149084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24399946|NCT00149084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24399962|NCT00149123|Hydrocortisone|hydrocortisone|mesh-list
24399963|NCT00149123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24399964|NCT00149136|Imatinib Mesylate|imatinib mesylate|mesh-list
24399965|NCT00149136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399966|NCT00149136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24400015|NCT00149253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24400021|NCT00149292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24400022|NCT00149292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400023|NCT00149292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24400024|NCT00149292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24400104|NCT00149851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24400105|NCT00149851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400106|NCT00149851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400107|NCT00149864|Mycophenolic Acid|mycophenolic acid|mesh-list
24400108|NCT00149864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24400109|NCT00149864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24400110|NCT00149864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24400146|NCT00149929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24811423|NCT02046629|Cholestyramine Resin|cholestyramine resin|mesh-list
24811424|NCT02046629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24811425|NCT02046629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24811426|NCT02046629|Analgesics|analgesics|mesh-ancestor
24674735|NCT04721132|Growth Substances|growth substances|mesh-ancestor
24400147|NCT00149929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400148|NCT00149929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400149|NCT00149942|Mycophenolic Acid|mycophenolic acid|mesh-list
24400150|NCT00149942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24400151|NCT00149942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24400152|NCT00149942|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24400202|NCT00150059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24400204|NCT00150059|Dermatologic Agents|dermatologic agents|mesh-ancestor
24400205|NCT00150059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24400206|NCT00150059|Immunologic Factors|immunologic factors|mesh-ancestor
24400207|NCT00150059|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24400208|NCT00150059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400209|NCT00150059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400210|NCT00150072|Imatinib Mesylate|imatinib mesylate|mesh-list
24400215|NCT00150085|Cyclosporine|cyclosporine|mesh-list
24400247|NCT00150215|Olanzapine|olanzapine|mesh-list
24400354|NCT00150384|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24400355|NCT00150384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24400356|NCT00150384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24400357|NCT00150384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400358|NCT00150384|Vasodilator Agents|vasodilator agents|mesh-ancestor
24400359|NCT00150410|Insulin|insulin|mesh-list
24400360|NCT00150410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24400361|NCT00150410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400362|NCT00150423|Pregabalin|pregabalin|mesh-list
24400363|NCT00150423|Analgesics|analgesics|mesh-ancestor
24400364|NCT00150423|Sensory System Agents|sensory system agents|mesh-ancestor
24400365|NCT00150423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24400366|NCT00150423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400367|NCT00150423|Anticonvulsants|anticonvulsants|mesh-ancestor
24400368|NCT00150423|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24400433|NCT00150553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24400434|NCT00150553|Analgesics|analgesics|mesh-ancestor
24400877|NCT00151541|Adapalene|adapalene|mesh-list
24400437|NCT00150553|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24400438|NCT00150553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24400440|NCT00150553|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24400558|NCT00150839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24400559|NCT00150839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24400560|NCT00150839|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24400561|NCT00150839|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25707642|NCT02234570|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25707643|NCT02234570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25707644|NCT02234570|Antinematodal Agents|antinematodal agents|mesh-ancestor
25707645|NCT02234596|Nintedanib|nintedanib|mesh-list
25707646|NCT02234596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25707647|NCT02234596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25707648|NCT02234596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25707649|NCT02234596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707650|NCT02234752|Memantine|memantine|mesh-list
25707651|NCT02234752|Galantamine|galantamine|mesh-list
25707652|NCT02234752|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25707653|NCT02234752|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25707654|NCT02234752|Dopamine Agents|dopamine agents|mesh-ancestor
24400562|NCT00150839|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24400563|NCT00150839|Adrenergic Agents|adrenergic agents|mesh-ancestor
24400564|NCT00150839|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24400565|NCT00150839|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24400566|NCT00150839|Serotonin Agents|serotonin agents|mesh-ancestor
24400585|NCT00150891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400586|NCT00150891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24400587|NCT00150891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400588|NCT00150891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400589|NCT00150891|Antifungal Agents|antifungal agents|mesh-ancestor
24400590|NCT00150891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24400591|NCT00150891|Dermatologic Agents|dermatologic agents|mesh-ancestor
24400592|NCT00150891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24400593|NCT00150891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24400594|NCT00150891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24400595|NCT00150891|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24400596|NCT00150891|Antitubercular Agents|antitubercular agents|mesh-ancestor
24400597|NCT00150891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24539209|NCT00662805|Autonomic Agents|autonomic agents|mesh-ancestor
24400642|NCT00151047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400643|NCT00151047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24400644|NCT00151047|Antimetabolites|antimetabolites|mesh-ancestor
24400646|NCT00151060|Etoposide|etoposide|mesh-list
24400647|NCT00151060|Estramustine|estramustine|mesh-list
24400648|NCT00151060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24400649|NCT00151060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24400650|NCT00151060|Tubulin Modulators|tubulin modulators|mesh-ancestor
24400651|NCT00151060|Antimitotic Agents|antimitotic agents|mesh-ancestor
24400652|NCT00151060|Mitosis Modulators|mitosis modulators|mesh-ancestor
24400653|NCT00151060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400654|NCT00151060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24400660|NCT00151073|Zoledronic Acid|zoledronic acid|mesh-list
24400681|NCT00151086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24400683|NCT00151086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24400684|NCT00151112|Anesthetics|anesthetics|mesh-list
24400718|NCT00151203|Hormones|hormones|mesh-ancestor
24400719|NCT00151203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24400720|NCT00151203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24400721|NCT00151203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24400722|NCT00151203|Immunologic Factors|immunologic factors|mesh-ancestor
24400723|NCT00151203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24400724|NCT00151203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24400725|NCT00151203|Growth Substances|growth substances|mesh-ancestor
24400726|NCT00151203|Growth Inhibitors|growth inhibitors|mesh-ancestor
24400727|NCT00151203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24400728|NCT00151203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24400729|NCT00151203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24400730|NCT00151203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400732|NCT00151203|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24400733|NCT00151203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24400734|NCT00151242|Cytarabine|cytarabine|mesh-list
24400735|NCT00151242|Etoposide|etoposide|mesh-list
24400736|NCT00151242|Idarubicin|idarubicin|mesh-list
24400760|NCT00151255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400761|NCT00151255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25707655|NCT02234752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707656|NCT02234752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707657|NCT02234752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707658|NCT02234752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25707659|NCT02234752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25707660|NCT02234752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24676084|NCT01348009|Cisplatin|cisplatin|mesh-list
25707661|NCT02234752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400762|NCT00151255|Antiviral Agents|antiviral agents|mesh-ancestor
24400763|NCT00151255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24400764|NCT00151255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24400765|NCT00151255|Immunologic Factors|immunologic factors|mesh-ancestor
24400766|NCT00151255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400794|NCT00151294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24400795|NCT00151294|Cholinergic Agents|cholinergic agents|mesh-ancestor
24400797|NCT00151346|Bupivacaine|bupivacaine|mesh-list
24400798|NCT00151346|Anesthetics, Local|anesthetics, local|mesh-ancestor
24400799|NCT00151346|Anesthetics|anesthetics|mesh-ancestor
24400800|NCT00151346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24400804|NCT00151346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24811444|NCT02046668|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24811445|NCT02046668|Diuretics|diuretics|mesh-ancestor
24811446|NCT02046668|Natriuretic Agents|natriuretic agents|mesh-ancestor
24811447|NCT02046720|Propofol|propofol|mesh-list
24811448|NCT02046720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24811449|NCT02046720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24811450|NCT02046720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811451|NCT02046720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24811452|NCT02046720|Anesthetics, General|anesthetics, general|mesh-ancestor
24811453|NCT02046720|Anesthetics|anesthetics|mesh-ancestor
24400805|NCT00151346|Narcotics|narcotics|mesh-ancestor
24400806|NCT00151346|Analgesics|analgesics|mesh-ancestor
24400807|NCT00151346|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24400808|NCT00151346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24400809|NCT00151346|Anesthetics, General|anesthetics, general|mesh-ancestor
24400810|NCT00151450|Pregabalin|pregabalin|mesh-list
24400811|NCT00151450|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24400812|NCT00151450|Analgesics|analgesics|mesh-ancestor
24400813|NCT00151450|Sensory System Agents|sensory system agents|mesh-ancestor
24400814|NCT00151450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24400815|NCT00151450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400816|NCT00151450|Anticonvulsants|anticonvulsants|mesh-ancestor
24400817|NCT00151450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24400818|NCT00151450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24531137|NCT00634205|Anticonvulsants|anticonvulsants|mesh-ancestor
24400819|NCT00151450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400820|NCT00151450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24400821|NCT00151450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24400822|NCT00151450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24400823|NCT00151450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24400824|NCT00151450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24400846|NCT00151489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24400847|NCT00151489|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24400858|NCT00151502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400860|NCT00151515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24400861|NCT00151515|Vasodilator Agents|vasodilator agents|mesh-ancestor
24400862|NCT00151528|Pregabalin|pregabalin|mesh-list
24400863|NCT00151528|Analgesics|analgesics|mesh-ancestor
24400864|NCT00151528|Sensory System Agents|sensory system agents|mesh-ancestor
24400865|NCT00151528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24400866|NCT00151528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400867|NCT00151528|Anticonvulsants|anticonvulsants|mesh-ancestor
24400868|NCT00151528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24400869|NCT00151528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24400880|NCT00151541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24400881|NCT00151541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24400882|NCT00151541|Analgesics|analgesics|mesh-ancestor
24400883|NCT00151541|Sensory System Agents|sensory system agents|mesh-ancestor
24400884|NCT00151541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24400915|NCT00151619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400916|NCT00151619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24400917|NCT00151619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676920|NCT01353339|Levofloxacin|levofloxacin|mesh-list
24400926|NCT00151632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400927|NCT00151632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24400928|NCT00151632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25707662|NCT02234752|Cholinergic Agents|cholinergic agents|mesh-ancestor
25707663|NCT02234752|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25707664|NCT02234752|Autonomic Agents|autonomic agents|mesh-ancestor
25707665|NCT02234752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25707666|NCT02234752|Nootropic Agents|nootropic agents|mesh-ancestor
25707667|NCT02235064|Sertraline|sertraline|mesh-list
24400929|NCT00151632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24400930|NCT00151632|Antitubercular Agents|antitubercular agents|mesh-ancestor
24400931|NCT00151632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24400932|NCT00151632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24400934|NCT00151684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24400935|NCT00151684|Vasodilator Agents|vasodilator agents|mesh-ancestor
24400940|NCT00151710|Pioglitazone|pioglitazone|mesh-list
24400960|NCT00151749|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
24400961|NCT00151749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24400962|NCT00151749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24400963|NCT00151749|Antimetabolites|antimetabolites|mesh-ancestor
24400964|NCT00151749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400965|NCT00151749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24400966|NCT00151762|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
24400967|NCT00151762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24400968|NCT00151762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24400969|NCT00151762|Antimetabolites|antimetabolites|mesh-ancestor
24400970|NCT00151762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400971|NCT00151762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24400973|NCT00151801|Interferon-beta|interferon-beta|mesh-list
24400974|NCT00151801|Interferon beta-1a|interferon beta-1a|mesh-list
24400975|NCT00151801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24400976|NCT00151801|Antiviral Agents|antiviral agents|mesh-ancestor
24400986|NCT00151827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24811457|NCT02046733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24811458|NCT02046733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24811459|NCT02046733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811460|NCT02046785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24401003|NCT00151944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24401004|NCT00151957|Methylphenidate|methylphenidate|mesh-list
24401005|NCT00151957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24401006|NCT00151957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401007|NCT00151957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24401008|NCT00151957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24401009|NCT00151957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24401010|NCT00151957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401011|NCT00151957|Dopamine Agents|dopamine agents|mesh-ancestor
24401012|NCT00151957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24401013|NCT00151970|Methylphenidate|methylphenidate|mesh-list
24401014|NCT00151970|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24401095|NCT00152178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401096|NCT00152178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25707668|NCT02235064|Antidepressive Agents|antidepressive agents|mesh-ancestor
25707669|NCT02235064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25707670|NCT02235064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25707671|NCT02235064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25707672|NCT02235064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25707673|NCT02235064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707674|NCT02235064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707675|NCT02235064|Serotonin Agents|serotonin agents|mesh-ancestor
25707676|NCT02235064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401097|NCT00152178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25707677|NCT02235077|Spironolactone|spironolactone|mesh-list
24678215|NCT01360190|Serotonin Agents|serotonin agents|mesh-ancestor
25707678|NCT02235077|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25707679|NCT02235077|Hormone Antagonists|hormone antagonists|mesh-ancestor
25707680|NCT02235077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25707681|NCT02235077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401098|NCT00152178|Alkylating Agents|alkylating agents|mesh-ancestor
24401099|NCT00152178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401100|NCT00152178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24401101|NCT00152178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24401102|NCT00152178|Antimetabolites|antimetabolites|mesh-ancestor
24401103|NCT00152178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24401158|NCT00152243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24401159|NCT00152243|Antimetabolites|antimetabolites|mesh-ancestor
24401160|NCT00152243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401161|NCT00152243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24401162|NCT00152282|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24401163|NCT00152282|Estrogens|estrogens|mesh-ancestor
24401164|NCT00152282|Hormones|hormones|mesh-ancestor
24443746|NCT00295919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24443747|NCT00295919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24401180|NCT00152308|Immunologic Factors|immunologic factors|mesh-ancestor
24401181|NCT00152308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401182|NCT00152308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24401183|NCT00152308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24401185|NCT00152360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24401186|NCT00152360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401187|NCT00152360|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24401188|NCT00152360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24401189|NCT00152373|Levetiracetam|levetiracetam|mesh-list
24401190|NCT00152373|Anticonvulsants|anticonvulsants|mesh-ancestor
24401191|NCT00152373|Nootropic Agents|nootropic agents|mesh-ancestor
24401192|NCT00152386|Certolizumab Pegol|certolizumab pegol|mesh-list
24401193|NCT00152386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24539345|NCT00663377|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24539346|NCT00663377|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24539351|NCT00663442|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24401233|NCT00152542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539366|NCT00663455|Dermatologic Agents|dermatologic agents|mesh-ancestor
25707682|NCT02235077|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25707683|NCT02235077|Diuretics|diuretics|mesh-ancestor
25707684|NCT02235077|Natriuretic Agents|natriuretic agents|mesh-ancestor
25707685|NCT02235298|Metformin|metformin|mesh-list
25707686|NCT02235298|Dapagliflozin|dapagliflozin|mesh-list
25707687|NCT02235298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24401301|NCT00152646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24401302|NCT00152646|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24401303|NCT00152646|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24401304|NCT00152646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24401327|NCT00152724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24401328|NCT00152724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24401329|NCT00152724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24401330|NCT00152724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24401331|NCT00152724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401332|NCT00152724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24401334|NCT00152724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24401491|NCT00153049|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24401492|NCT00153049|Telmisartan|telmisartan|mesh-list
24401493|NCT00153049|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
24401494|NCT00153049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24401495|NCT00153049|Diuretics|diuretics|mesh-ancestor
24401496|NCT00153049|Natriuretic Agents|natriuretic agents|mesh-ancestor
24401497|NCT00153049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401498|NCT00153049|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24401527|NCT00153088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401529|NCT00153114|Laxatives|laxatives|mesh-ancestor
24401530|NCT00153114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24401531|NCT00153127|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24401533|NCT00153127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24401534|NCT00153140|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24401539|NCT00153153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24401540|NCT00153192|Dronabinol|dronabinol|mesh-list
24401541|NCT00153192|Hallucinogens|hallucinogens|mesh-ancestor
24401542|NCT00153192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401544|NCT00153192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24401560|NCT00153244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401561|NCT00153244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24401562|NCT00153244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24401660|NCT00153634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401661|NCT00153634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24401677|NCT00153660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24401723|NCT00153881|Antimitotic Agents|antimitotic agents|mesh-ancestor
24401724|NCT00153881|Mitosis Modulators|mitosis modulators|mesh-ancestor
24401725|NCT00153881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401726|NCT00153881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24401728|NCT00153907|Capecitabine|capecitabine|mesh-list
24401729|NCT00153907|Vinorelbine|vinorelbine|mesh-list
24401730|NCT00153907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24401779|NCT00153998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24401780|NCT00153998|Antidotes|antidotes|mesh-ancestor
24401781|NCT00153998|Protective Agents|protective agents|mesh-ancestor
24401782|NCT00153998|Vitamin B Complex|vitamin b complex|mesh-ancestor
24401783|NCT00153998|Vitamins|vitamins|mesh-ancestor
24401784|NCT00153998|Micronutrients|micronutrients|mesh-ancestor
24401785|NCT00153998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24401786|NCT00153998|Hematinics|hematinics|mesh-ancestor
24401787|NCT00154011|Rosiglitazone|rosiglitazone|mesh-list
24401788|NCT00154011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24401789|NCT00154011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401790|NCT00154024|Irbesartan|irbesartan|mesh-list
24539476|NCT00664014|Tolvaptan|tolvaptan|mesh-list
24401814|NCT00154050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24401815|NCT00154050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401816|NCT00154050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24401847|NCT00154115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24401848|NCT00154115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24401849|NCT00154115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401850|NCT00154115|Protective Agents|protective agents|mesh-ancestor
24401851|NCT00154115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401852|NCT00154128|Salicylic Acid|salicylic acid|mesh-list
24401853|NCT00154128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24401854|NCT00154128|Antifungal Agents|antifungal agents|mesh-ancestor
24401855|NCT00154128|Keratolytic Agents|keratolytic agents|mesh-ancestor
24401856|NCT00154128|Dermatologic Agents|dermatologic agents|mesh-ancestor
24401860|NCT00154167|Phentolamine|phentolamine|mesh-list
24401861|NCT00154167|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24811486|NCT02046915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24401911|NCT00154219|Analgesics|analgesics|mesh-ancestor
24401912|NCT00154219|Sensory System Agents|sensory system agents|mesh-ancestor
24401913|NCT00154219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24401914|NCT00154219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401915|NCT00154219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24606924|NCT05407155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24675728|NCT01344681|Itraconazole|itraconazole|mesh-list
24401957|NCT00154323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401958|NCT00154323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24401959|NCT00154323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24401960|NCT00154336|Methotrexate|methotrexate|mesh-list
24401961|NCT00154336|Imatinib Mesylate|imatinib mesylate|mesh-list
24401962|NCT00154336|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24401963|NCT00154336|Abortifacient Agents|abortifacient agents|mesh-ancestor
24401964|NCT00154336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24401965|NCT00154336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539538|NCT00664287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401966|NCT00154336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24401993|NCT00154388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24401994|NCT00154388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24401995|NCT00154388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401996|NCT00154401|Liraglutide|liraglutide|mesh-list
24401997|NCT00154401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24401998|NCT00154401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401999|NCT00154401|Incretins|incretins|mesh-ancestor
24402000|NCT00154401|Hormones|hormones|mesh-ancestor
24402014|NCT00154440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24402015|NCT00154440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24402016|NCT00154440|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24539569|NCT00664586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539570|NCT00664586|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24539571|NCT00664586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539572|NCT00664586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24402093|NCT00154791|Antiviral Agents|antiviral agents|mesh-ancestor
24402094|NCT00154791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402095|NCT00154791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402103|NCT00154804|Tubulin Modulators|tubulin modulators|mesh-ancestor
24402104|NCT00154804|Antimitotic Agents|antimitotic agents|mesh-ancestor
24402105|NCT00154804|Mitosis Modulators|mitosis modulators|mesh-ancestor
24402106|NCT00154804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402107|NCT00154843|Lycopene|lycopene|mesh-list
24402108|NCT00154843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24402109|NCT00154843|Antioxidants|antioxidants|mesh-ancestor
24539573|NCT00664586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24539574|NCT00664586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24539575|NCT00664586|Analgesics|analgesics|mesh-ancestor
24539576|NCT00664586|Sensory System Agents|sensory system agents|mesh-ancestor
24539577|NCT00664586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24539578|NCT00664586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24539579|NCT00664586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24539580|NCT00664599|Rituximab|rituximab|mesh-list
24539581|NCT00664599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24539582|NCT00664599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24539583|NCT00664599|Immunologic Factors|immunologic factors|mesh-ancestor
24539584|NCT00664599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539585|NCT00664599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24623162|NCT01070511|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24623163|NCT01070511|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24623164|NCT01070511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402111|NCT00154843|Protective Agents|protective agents|mesh-ancestor
24402112|NCT00154843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402113|NCT00154843|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24402114|NCT00154843|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24402115|NCT00154843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402116|NCT00154869|Ribavirin|ribavirin|mesh-list
24402117|NCT00154869|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24402118|NCT00154869|Antimetabolites|antimetabolites|mesh-ancestor
24539588|NCT00664677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539589|NCT00664677|Protective Agents|protective agents|mesh-ancestor
24539590|NCT00664677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539591|NCT00664677|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24539592|NCT00664677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539593|NCT00664677|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24539594|NCT00664677|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24539595|NCT00664677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24539597|NCT00664677|Sensory System Agents|sensory system agents|mesh-ancestor
24539598|NCT00664677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24539599|NCT00664677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24539600|NCT00664677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24539601|NCT00664690|Celecoxib|celecoxib|mesh-list
24402124|NCT00154882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24402125|NCT00154882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402126|NCT00154882|Tubulin Modulators|tubulin modulators|mesh-ancestor
24402128|NCT00154882|Mitosis Modulators|mitosis modulators|mesh-ancestor
24402129|NCT00154882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623166|NCT01070511|Urological Agents|urological agents|mesh-ancestor
24623168|NCT01070524|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24623169|NCT01070524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24623170|NCT01070524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24623172|NCT01070524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24623173|NCT01070524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623174|NCT01070524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24623175|NCT01070524|Respiratory System Agents|respiratory system agents|mesh-ancestor
24675929|NCT01346800|Ritonavir|ritonavir|mesh-list
24402212|NCT00155558|Protective Agents|protective agents|mesh-ancestor
24402254|NCT00156286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402255|NCT00156286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402257|NCT00156299|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
24402259|NCT00156299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24402260|NCT00156299|Antiemetics|antiemetics|mesh-ancestor
24402261|NCT00156299|Autonomic Agents|autonomic agents|mesh-ancestor
24402340|NCT00156650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24402341|NCT00156650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24402342|NCT00156650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24402343|NCT00156650|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24402373|NCT00156975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402374|NCT00156988|Sulfadiazine|sulfadiazine|mesh-list
24402375|NCT00156988|Silver Sulfadiazine|silver sulfadiazine|mesh-list
24402376|NCT00156988|Cerium nitrate|cerium nitrate|mesh-list
24402377|NCT00156988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24402378|NCT00156988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24402379|NCT00156988|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24402380|NCT00156988|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24402381|NCT00156988|Coccidiostats|coccidiostats|mesh-ancestor
24402382|NCT00156988|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24402383|NCT00157040|Factor VIII|factor viii|mesh-list
24402384|NCT00157040|Coagulants|coagulants|mesh-ancestor
24402385|NCT00157053|Factor VIII|factor viii|mesh-list
24402386|NCT00157053|Coagulants|coagulants|mesh-ancestor
24402387|NCT00157066|Ergocalciferols|ergocalciferols|mesh-list
24402389|NCT00157066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24402415|NCT00157131|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24402416|NCT00157131|Hemostatics|hemostatics|mesh-ancestor
24402500|NCT00157547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24402501|NCT00157547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24402502|NCT00157547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402771|NCT00158457|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24402772|NCT00158457|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24403701|NCT00161291|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24402876|NCT00158652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402877|NCT00158678|Cisplatin|cisplatin|mesh-list
24402878|NCT00158678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402879|NCT00158691|Amifostine|amifostine|mesh-list
24402880|NCT00158691|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24623183|NCT01070615|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24403099|NCT00159224|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24403100|NCT00159224|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24403101|NCT00159302|Nitric Oxide|nitric oxide|mesh-list
24403102|NCT00159302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24403103|NCT00159302|Autonomic Agents|autonomic agents|mesh-ancestor
24403104|NCT00159302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24403105|NCT00159302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403106|NCT00159302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24403107|NCT00159302|Respiratory System Agents|respiratory system agents|mesh-ancestor
24403108|NCT00159302|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24403330|NCT00159770|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24403331|NCT00159770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24403332|NCT00159770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24403333|NCT00159770|Antidepressive Agents|antidepressive agents|mesh-ancestor
24403335|NCT00159809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403346|NCT00159835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403349|NCT00159835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811491|NCT02046915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24811492|NCT02046915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24403417|NCT00160316|Dydrogesterone|dydrogesterone|mesh-list
24403418|NCT00160316|Estrogens|estrogens|mesh-ancestor
24403498|NCT00160576|Levetiracetam|levetiracetam|mesh-list
24403499|NCT00160576|Anticonvulsants|anticonvulsants|mesh-ancestor
24403500|NCT00160576|Nootropic Agents|nootropic agents|mesh-ancestor
24403501|NCT00160589|Levocetirizine|levocetirizine|mesh-list
24403502|NCT00160589|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24403503|NCT00160589|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24403504|NCT00160589|Histamine Antagonists|histamine antagonists|mesh-ancestor
24403505|NCT00160589|Histamine Agents|histamine agents|mesh-ancestor
24403506|NCT00160589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24403507|NCT00160589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403508|NCT00160589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403509|NCT00160602|Certolizumab Pegol|certolizumab pegol|mesh-list
24403510|NCT00160602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24403541|NCT00160875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403542|NCT00160875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403543|NCT00160888|Nitroprusside|nitroprusside|mesh-list
24403544|NCT00160888|Acetylcholine|acetylcholine|mesh-list
24403545|NCT00160888|Bradykinin|bradykinin|mesh-list
24403546|NCT00160888|Kininogens|kininogens|mesh-list
24403547|NCT00160888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24403548|NCT00160888|Vasodilator Agents|vasodilator agents|mesh-ancestor
24403549|NCT00160888|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24451580|NCT00324324|Contraceptive Agents|contraceptive agents|mesh-ancestor
24403624|NCT00161070|Antipyretics|antipyretics|mesh-ancestor
24403625|NCT00161070|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24403626|NCT00161070|Vasodilator Agents|vasodilator agents|mesh-ancestor
24403627|NCT00161083|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24403628|NCT00161083|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24403629|NCT00161083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24403630|NCT00161096|Pantoprazole|pantoprazole|mesh-list
24403631|NCT00161096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24403640|NCT00161200|Pantoprazole|pantoprazole|mesh-list
24451627|NCT00324467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24403702|NCT00161291|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24403703|NCT00161291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403704|NCT00161291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403705|NCT00161291|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24403706|NCT00161291|Hormone Antagonists|hormone antagonists|mesh-ancestor
24403707|NCT00161291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24463606|NCT00361621|Rituximab|rituximab|mesh-list
24403708|NCT00161304|Methyltestosterone|methyltestosterone|mesh-list
24403709|NCT00161304|Testosterone|testosterone|mesh-list
24403710|NCT00161304|Testosterone undecanoate|testosterone undecanoate|mesh-list
24403711|NCT00161304|Testosterone enanthate|testosterone enanthate|mesh-list
24811500|NCT02046915|Growth Inhibitors|growth inhibitors|mesh-ancestor
24811501|NCT02047006|Rivaroxaban|rivaroxaban|mesh-list
24811502|NCT02047006|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24403805|NCT00161590|Alemtuzumab|alemtuzumab|mesh-list
24403843|NCT00161681|Contraceptive Agents|contraceptive agents|mesh-ancestor
24403844|NCT00161681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24403845|NCT00161681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24403846|NCT00161681|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24403847|NCT00161681|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24403848|NCT00161681|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24403849|NCT00161707|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
24403850|NCT00161707|Protein C Inhibitor|protein c inhibitor|mesh-list
24403851|NCT00161707|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24403852|NCT00161707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24403853|NCT00161707|Protease Inhibitors|protease inhibitors|mesh-ancestor
24403854|NCT00161707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403855|NCT00161707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403857|NCT00161720|Anticoagulants|anticoagulants|mesh-ancestor
24811506|NCT02047006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811507|NCT02047006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811509|NCT02047019|Candesartan|candesartan|mesh-list
24403858|NCT00161720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24403859|NCT00161720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24403860|NCT00161720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403861|NCT00161733|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24403866|NCT00161759|Hemostatics|hemostatics|mesh-ancestor
24403867|NCT00161759|Coagulants|coagulants|mesh-ancestor
24403908|NCT00162149|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24854724|NCT02275013|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24403909|NCT00162149|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24403910|NCT00162149|Protease Inhibitors|protease inhibitors|mesh-ancestor
24403911|NCT00162149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403912|NCT00162149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403931|NCT00162188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24444991|NCT00299923|Dopamine Agents|dopamine agents|mesh-ancestor
24403932|NCT00162188|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24403933|NCT00162188|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24403934|NCT00162188|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24403935|NCT00162188|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24403937|NCT00162201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24403938|NCT00162201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403939|NCT00162201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403940|NCT00162201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24403941|NCT00162201|Immunologic Factors|immunologic factors|mesh-ancestor
24403942|NCT00162201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403944|NCT00162214|Ketoconazole|ketoconazole|mesh-list
24403967|NCT00162227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24403968|NCT00162227|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24403969|NCT00162227|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24403970|NCT00162227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24403971|NCT00162227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25707688|NCT02235298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707689|NCT02235298|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25707690|NCT02235298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707691|NCT02235311|Pantoprazole|pantoprazole|mesh-list
25707692|NCT02235311|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25707693|NCT02235311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25707694|NCT02235311|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24403972|NCT00162305|Dapagliflozin|dapagliflozin|mesh-list
24403973|NCT00162305|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24403974|NCT00162305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403975|NCT00162305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24403976|NCT00162305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403977|NCT00162318|Cetuximab|cetuximab|mesh-list
24403978|NCT00162318|Gefitinib|gefitinib|mesh-list
24403979|NCT00162318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24403980|NCT00162318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403981|NCT00162318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24403982|NCT00162318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443768|NCT00295958|Immunologic Factors|immunologic factors|mesh-ancestor
24404016|NCT00162383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24404017|NCT00162383|Adrenergic Agents|adrenergic agents|mesh-ancestor
24404018|NCT00162383|Anticonvulsants|anticonvulsants|mesh-ancestor
24404019|NCT00162396|Albuterol|albuterol|mesh-list
24404020|NCT00162396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24404021|NCT00162396|Autonomic Agents|autonomic agents|mesh-ancestor
24404022|NCT00162396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24404023|NCT00162396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404024|NCT00162396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24404025|NCT00162396|Respiratory System Agents|respiratory system agents|mesh-ancestor
24404026|NCT00162396|Tocolytic Agents|tocolytic agents|mesh-ancestor
24404027|NCT00162396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24404028|NCT00162396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24404029|NCT00162396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24404045|NCT00162422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24404046|NCT00162422|Respiratory System Agents|respiratory system agents|mesh-ancestor
24404048|NCT00162422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25707695|NCT02235311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25707696|NCT02235311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707697|NCT02235987|Octreotide|octreotide|mesh-list
25707698|NCT02235987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25707699|NCT02235987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25707700|NCT02235987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25707701|NCT02236130|Acetaminophen|acetaminophen|mesh-list
25707702|NCT02236130|Morphine|morphine|mesh-list
25707703|NCT02236130|Hydrocodone|hydrocodone|mesh-list
25707704|NCT02236130|Analgesics|analgesics|mesh-list
25707705|NCT02236130|Anesthetics|anesthetics|mesh-list
25707706|NCT02236130|Ropivacaine|ropivacaine|mesh-list
25707707|NCT02236130|Anesthetics, Local|anesthetics, local|mesh-list
24812645|NCT02053922|Carbetocin|carbetocin|mesh-list
24404078|NCT00162487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24404079|NCT00162487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404086|NCT00162487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24404087|NCT00162487|Adrenergic Agents|adrenergic agents|mesh-ancestor
24404088|NCT00162487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24404091|NCT00162526|Vitamin E|vitamin e|mesh-list
24436915|NCT00272064|Insulin|insulin|mesh-list
24436916|NCT00272064|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24436917|NCT00272064|Metformin|metformin|mesh-list
24436918|NCT00272064|Insulin Glargine|insulin glargine|mesh-list
24404097|NCT00162526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404098|NCT00162526|Vitamins|vitamins|mesh-ancestor
24404099|NCT00162526|Micronutrients|micronutrients|mesh-ancestor
24404100|NCT00162552|Pentoxifylline|pentoxifylline|mesh-list
24404101|NCT00162552|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24445097|NCT00300352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445098|NCT00300378|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24540237|NCT00667056|Tacrolimus|tacrolimus|mesh-list
24404115|NCT00162565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404116|NCT00162565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404117|NCT00162591|Remifentanil|remifentanil|mesh-list
24404118|NCT00162591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24404119|NCT00162591|Narcotics|narcotics|mesh-ancestor
24404120|NCT00162591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24540251|NCT00667069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24540252|NCT00667069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24540253|NCT00667082|Vorinostat|vorinostat|mesh-list
24540254|NCT00667082|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
24540255|NCT00667082|Proteasome Inhibitors|proteasome inhibitors|mesh-list
24540256|NCT00667082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24404121|NCT00162591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404122|NCT00162591|Analgesics|analgesics|mesh-ancestor
24404123|NCT00162591|Sensory System Agents|sensory system agents|mesh-ancestor
24404124|NCT00162591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24404126|NCT00162604|Cefuroxime axetil|cefuroxime axetil|mesh-list
24404127|NCT00162604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24404128|NCT00162604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24404129|NCT00162643|Ritonavir|ritonavir|mesh-list
24404130|NCT00162643|Lopinavir|lopinavir|mesh-list
24404131|NCT00162643|Lamivudine|lamivudine|mesh-list
24404132|NCT00162643|Zidovudine|zidovudine|mesh-list
24404133|NCT00162643|Efavirenz|efavirenz|mesh-list
24404134|NCT00162643|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24404135|NCT00162643|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24404136|NCT00162643|Protease Inhibitors|protease inhibitors|mesh-ancestor
24404139|NCT00162643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24404140|NCT00162643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24404141|NCT00162643|Antiviral Agents|antiviral agents|mesh-ancestor
24404161|NCT00162656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24404184|NCT00162695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404185|NCT00162695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24404186|NCT00162695|Alkylating Agents|alkylating agents|mesh-ancestor
24404187|NCT00162695|Tubulin Modulators|tubulin modulators|mesh-ancestor
24404188|NCT00162695|Antimitotic Agents|antimitotic agents|mesh-ancestor
24404189|NCT00162695|Mitosis Modulators|mitosis modulators|mesh-ancestor
24404190|NCT00162695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24404206|NCT00162734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24404207|NCT00162734|Antimetabolites|antimetabolites|mesh-ancestor
24404208|NCT00162734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404209|NCT00162760|Thalidomide|thalidomide|mesh-list
24404210|NCT00162760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24404211|NCT00162760|Immunologic Factors|immunologic factors|mesh-ancestor
24404212|NCT00162760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404213|NCT00162760|Leprostatic Agents|leprostatic agents|mesh-ancestor
24404214|NCT00162760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24404215|NCT00162760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24404216|NCT00162760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24811534|NCT02047149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404246|NCT00162864|Hormone Antagonists|hormone antagonists|mesh-ancestor
24404263|NCT00162916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404264|NCT00162916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24404265|NCT00162916|Serotonin Agents|serotonin agents|mesh-ancestor
24404266|NCT00162916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404267|NCT00162916|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24404268|NCT00162916|Antidepressive Agents|antidepressive agents|mesh-ancestor
24404269|NCT00162916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24404271|NCT00162955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24404276|NCT00162968|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24404280|NCT00162968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24404281|NCT00162968|Serotonin Agents|serotonin agents|mesh-ancestor
24404282|NCT00162968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811545|NCT02047149|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24811546|NCT02047149|Hormone Antagonists|hormone antagonists|mesh-ancestor
24676861|NCT01352611|GABA Agents|gaba agents|mesh-ancestor
24404299|NCT00163046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404319|NCT00163111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404321|NCT00163111|Hormone Antagonists|hormone antagonists|mesh-ancestor
24404322|NCT00163111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24404323|NCT00163111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404324|NCT00163111|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24404325|NCT00163111|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24404326|NCT00163137|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
24404327|NCT00163137|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24404328|NCT00163137|Hormone Antagonists|hormone antagonists|mesh-ancestor
24404329|NCT00163137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24404333|NCT00163137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24404335|NCT00163150|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24404336|NCT00163150|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24404337|NCT00163150|Antimetabolites|antimetabolites|mesh-ancestor
24404338|NCT00163150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404339|NCT00163150|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24540301|NCT00667264|Ropivacaine|ropivacaine|mesh-list
24404340|NCT00163150|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24404342|NCT00163202|Atorvastatin|atorvastatin|mesh-list
24811547|NCT02047149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24811548|NCT02047149|Antisickling Agents|antisickling agents|mesh-ancestor
24811549|NCT02047149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24404349|NCT00163202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404350|NCT00163241|Celecoxib|celecoxib|mesh-list
24404351|NCT00163241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24404352|NCT00163241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24404353|NCT00163241|Analgesics|analgesics|mesh-ancestor
24404365|NCT00163254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24404390|NCT00163332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24404391|NCT00163332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404392|NCT00163332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24404393|NCT00163345|Ciclesonide|ciclesonide|mesh-list
24404394|NCT00163345|Glucocorticoids|glucocorticoids|mesh-ancestor
24404396|NCT00163345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24404397|NCT00163345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404398|NCT00163345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24404399|NCT00163358|Ciclesonide|ciclesonide|mesh-list
24404400|NCT00163358|Glucocorticoids|glucocorticoids|mesh-ancestor
24404401|NCT00163358|Hormones|hormones|mesh-ancestor
24404402|NCT00163358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24404403|NCT00163358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404404|NCT00163358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24404405|NCT00163371|Ciclesonide|ciclesonide|mesh-list
24404407|NCT00163371|Hormones|hormones|mesh-ancestor
24404408|NCT00163371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24404409|NCT00163371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404410|NCT00163371|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24404411|NCT00163384|Ciclesonide|ciclesonide|mesh-list
24404414|NCT00163384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24404426|NCT00163410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24404427|NCT00163410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404428|NCT00163410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24404429|NCT00163423|Ciclesonide|ciclesonide|mesh-list
24404430|NCT00163423|Glucocorticoids|glucocorticoids|mesh-ancestor
24404431|NCT00163423|Hormones|hormones|mesh-ancestor
24683063|NCT01389713|Fertility Agents|fertility agents|mesh-ancestor
24404432|NCT00163423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24811553|NCT02047162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811554|NCT02047162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24811555|NCT02047162|Antidiarrheals|antidiarrheals|mesh-ancestor
24811556|NCT02047175|Niacin|niacin|mesh-list
24811557|NCT02047175|Amlodipine|amlodipine|mesh-list
24811558|NCT02047175|Telmisartan|telmisartan|mesh-list
24811559|NCT02047175|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24811560|NCT02047175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24811561|NCT02047175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24811562|NCT02047175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24811563|NCT02047175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811564|NCT02047175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24811570|NCT02047175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24404434|NCT00163423|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24404435|NCT00163436|Ciclesonide|ciclesonide|mesh-list
24404436|NCT00163436|Glucocorticoids|glucocorticoids|mesh-ancestor
24404437|NCT00163436|Hormones|hormones|mesh-ancestor
24404438|NCT00163436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24404439|NCT00163436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404440|NCT00163436|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24404441|NCT00163449|Ciclesonide|ciclesonide|mesh-list
24404444|NCT00163449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25707708|NCT02236130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25707709|NCT02236130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707710|NCT02236130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25707711|NCT02236130|Narcotics|narcotics|mesh-ancestor
25707712|NCT02236130|Sensory System Agents|sensory system agents|mesh-ancestor
25707713|NCT02236130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25707714|NCT02236130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25707715|NCT02236130|Antipyretics|antipyretics|mesh-ancestor
24404447|NCT00163462|Ciclesonide|ciclesonide|mesh-list
24404448|NCT00163462|Glucocorticoids|glucocorticoids|mesh-ancestor
24404449|NCT00163462|Hormones|hormones|mesh-ancestor
24404450|NCT00163462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24404457|NCT00163488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404458|NCT00163488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24404459|NCT00163501|Ciclesonide|ciclesonide|mesh-list
24404460|NCT00163501|Glucocorticoids|glucocorticoids|mesh-ancestor
24404461|NCT00163501|Hormones|hormones|mesh-ancestor
24404462|NCT00163501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24404463|NCT00163501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404464|NCT00163501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24811572|NCT02047175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811573|NCT02047175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24811574|NCT02047175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24811575|NCT02047175|Vitamin B Complex|vitamin b complex|mesh-ancestor
25707716|NCT02236130|Antitussive Agents|antitussive agents|mesh-ancestor
25707717|NCT02236130|Respiratory System Agents|respiratory system agents|mesh-ancestor
25707718|NCT02236520|Chlorthalidone|chlorthalidone|mesh-list
25707719|NCT02236520|Spironolactone|spironolactone|mesh-list
25707720|NCT02236520|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25707721|NCT02236520|Hormone Antagonists|hormone antagonists|mesh-ancestor
25707722|NCT02236520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24811576|NCT02047175|Vitamins|vitamins|mesh-ancestor
24811577|NCT02047175|Micronutrients|micronutrients|mesh-ancestor
24404465|NCT00163514|Ciclesonide|ciclesonide|mesh-list
24404466|NCT00163514|Glucocorticoids|glucocorticoids|mesh-ancestor
24404467|NCT00163514|Hormones|hormones|mesh-ancestor
24404468|NCT00163514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24404469|NCT00163514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404470|NCT00163514|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24404471|NCT00163540|Formaldehyde|formaldehyde|mesh-list
24404472|NCT00163540|Disinfectants|disinfectants|mesh-ancestor
24404473|NCT00163540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24404475|NCT00163553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24404476|NCT00163553|Narcotics|narcotics|mesh-ancestor
24404477|NCT00163553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24404478|NCT00163553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404479|NCT00163553|Analgesics|analgesics|mesh-ancestor
24404497|NCT00163605|Coagulants|coagulants|mesh-ancestor
24404498|NCT00163618|Formaldehyde|formaldehyde|mesh-list
24404499|NCT00163618|Disinfectants|disinfectants|mesh-ancestor
24404500|NCT00163618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24404501|NCT00163748|Gemcitabine|gemcitabine|mesh-list
24404502|NCT00163748|Vinorelbine|vinorelbine|mesh-list
24404503|NCT00163748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24404504|NCT00163748|Antimetabolites|antimetabolites|mesh-ancestor
24404505|NCT00163748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404506|NCT00163748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24404507|NCT00163748|Antiviral Agents|antiviral agents|mesh-ancestor
24404508|NCT00163748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24404509|NCT00163748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404510|NCT00163748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24404528|NCT00163761|Immunologic Factors|immunologic factors|mesh-ancestor
24404542|NCT00163969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24404543|NCT00163969|Anesthetics, General|anesthetics, general|mesh-ancestor
24404544|NCT00163969|Anesthetics|anesthetics|mesh-ancestor
24540334|NCT00667433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24811579|NCT02047201|Fluorouracil|fluorouracil|mesh-list
24811580|NCT02047201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24811581|NCT02047201|Tubulin Modulators|tubulin modulators|mesh-ancestor
24404545|NCT00163969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24404546|NCT00163969|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24404547|NCT00163969|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24404548|NCT00163969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24404549|NCT00163969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404550|NCT00163982|Norfloxacin|norfloxacin|mesh-list
24404551|NCT00163982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24404552|NCT00163982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24404553|NCT00163982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24404556|NCT00163982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404558|NCT00163982|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24404559|NCT00163982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24404560|NCT00164008|Zoledronic Acid|zoledronic acid|mesh-list
24404562|NCT00164008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24404563|NCT00164008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404564|NCT00164047|Nitrous Oxide|nitrous oxide|mesh-list
24404565|NCT00164047|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24404566|NCT00164047|Anesthetics, General|anesthetics, general|mesh-ancestor
24404567|NCT00164047|Anesthetics|anesthetics|mesh-ancestor
24404568|NCT00164047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24404569|NCT00164047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404570|NCT00164047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24404571|NCT00164047|Analgesics|analgesics|mesh-ancestor
24404572|NCT00164047|Sensory System Agents|sensory system agents|mesh-ancestor
24404573|NCT00164047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24404574|NCT00164086|Atorvastatin|atorvastatin|mesh-list
24540348|NCT00667485|Sirolimus|sirolimus|mesh-list
24404575|NCT00164086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24404576|NCT00164086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24404577|NCT00164086|Antimetabolites|antimetabolites|mesh-ancestor
24404578|NCT00164086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404579|NCT00164086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24404580|NCT00164086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24404581|NCT00164086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404588|NCT00164112|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24404589|NCT00164112|Renal Agents|renal agents|mesh-ancestor
24404590|NCT00164112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24404591|NCT00164112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24404592|NCT00164112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404593|NCT00164112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404594|NCT00164112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24533420|NCT00643799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25707723|NCT02236520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707724|NCT02236520|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25707725|NCT02236520|Diuretics|diuretics|mesh-ancestor
25707726|NCT02236520|Natriuretic Agents|natriuretic agents|mesh-ancestor
25707727|NCT02236520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25707728|NCT02236520|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25707729|NCT02236520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24404660|NCT00164359|Antiviral Agents|antiviral agents|mesh-ancestor
24404661|NCT00164359|Schistosomicides|schistosomicides|mesh-ancestor
24811584|NCT02047201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811586|NCT02047201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24811587|NCT02047201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24811588|NCT02047201|Immunologic Factors|immunologic factors|mesh-ancestor
24811589|NCT02047201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811590|NCT02047292|Tacrine|tacrine|mesh-list
24811591|NCT02047292|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24404669|NCT00164411|Vaccines|vaccines|mesh-list
24404713|NCT00164710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24404714|NCT00164710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24404715|NCT00164710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24404716|NCT00164710|Antiviral Agents|antiviral agents|mesh-ancestor
24404717|NCT00164710|Schistosomicides|schistosomicides|mesh-ancestor
24404737|NCT00164736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24404738|NCT00164736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24404739|NCT00164736|Antiviral Agents|antiviral agents|mesh-ancestor
24404740|NCT00164736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24540405|NCT00667901|Riluzole|riluzole|mesh-list
24404741|NCT00164736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24404779|NCT00164801|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24404780|NCT00164801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404781|NCT00164801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24404782|NCT00164801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24404783|NCT00164801|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24404784|NCT00164801|GABA Agonists|gaba agonists|mesh-ancestor
24404785|NCT00164801|GABA Agents|gaba agents|mesh-ancestor
24404786|NCT00164801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24404787|NCT00164801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404788|NCT00164801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24404789|NCT00164801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24404790|NCT00164801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24404791|NCT00164801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24404793|NCT00164840|Esomeprazole|esomeprazole|mesh-list
24404804|NCT00164866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404805|NCT00164892|Rofecoxib|rofecoxib|mesh-list
24404806|NCT00164892|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24404807|NCT00164892|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24404808|NCT00164892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404809|NCT00164892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404812|NCT00164892|Analgesics|analgesics|mesh-ancestor
24404813|NCT00164892|Sensory System Agents|sensory system agents|mesh-ancestor
24404814|NCT00164892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24404815|NCT00164892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404816|NCT00164892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24404817|NCT00164892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24404828|NCT00164970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404829|NCT00164970|Vitamin B Complex|vitamin b complex|mesh-ancestor
24404832|NCT00164996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24404833|NCT00164996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404834|NCT00165035|Paclitaxel|paclitaxel|mesh-list
24404867|NCT00165087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404868|NCT00165087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24404869|NCT00165087|Protective Agents|protective agents|mesh-ancestor
24404870|NCT00165087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404871|NCT00165087|Antimitotic Agents|antimitotic agents|mesh-ancestor
24404872|NCT00165087|Mitosis Modulators|mitosis modulators|mesh-ancestor
24404873|NCT00165139|Cyclophosphamide|cyclophosphamide|mesh-list
24404874|NCT00165139|Melphalan|melphalan|mesh-list
24404875|NCT00165139|Ifosfamide|ifosfamide|mesh-list
24404876|NCT00165139|Carboplatin|carboplatin|mesh-list
24404877|NCT00165139|Etoposide|etoposide|mesh-list
24404878|NCT00165139|Vincristine|vincristine|mesh-list
24404879|NCT00165139|Doxorubicin|doxorubicin|mesh-list
24404880|NCT00165139|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24404881|NCT00165139|Lenograstim|lenograstim|mesh-list
24404882|NCT00165139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24404883|NCT00165139|Immunologic Factors|immunologic factors|mesh-ancestor
24404884|NCT00165139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445634|NCT00301938|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
24611644|NCT01010178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24540444|NCT00668005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540445|NCT00668005|Urological Agents|urological agents|mesh-ancestor
24404935|NCT00165178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24404936|NCT00165178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24404937|NCT00165178|Antiviral Agents|antiviral agents|mesh-ancestor
24404938|NCT00165178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24404939|NCT00165178|Antidotes|antidotes|mesh-ancestor
24404940|NCT00165178|Protective Agents|protective agents|mesh-ancestor
24404941|NCT00165178|Vitamin B Complex|vitamin b complex|mesh-ancestor
24404942|NCT00165178|Vitamins|vitamins|mesh-ancestor
24404943|NCT00165178|Micronutrients|micronutrients|mesh-ancestor
24404944|NCT00165178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24404970|NCT00165204|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24404971|NCT00165204|Anabolic Agents|anabolic agents|mesh-ancestor
24404973|NCT00165217|Thalidomide|thalidomide|mesh-list
24404974|NCT00165217|Capecitabine|capecitabine|mesh-list
24404975|NCT00165217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24404976|NCT00165217|Antimetabolites|antimetabolites|mesh-ancestor
24404977|NCT00165217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404978|NCT00165217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24404979|NCT00165217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24404980|NCT00165217|Immunologic Factors|immunologic factors|mesh-ancestor
24404981|NCT00165217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404982|NCT00165217|Leprostatic Agents|leprostatic agents|mesh-ancestor
24404983|NCT00165217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24404984|NCT00165217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24540467|NCT00668044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540468|NCT00668044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24540469|NCT00668044|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24404998|NCT00165230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24404999|NCT00165230|Growth Substances|growth substances|mesh-ancestor
24405000|NCT00165230|Growth Inhibitors|growth inhibitors|mesh-ancestor
24405001|NCT00165230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405002|NCT00165230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24405003|NCT00165230|Alkylating Agents|alkylating agents|mesh-ancestor
24405004|NCT00165230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405006|NCT00165295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405045|NCT00165373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405046|NCT00165373|Growth Inhibitors|growth inhibitors|mesh-ancestor
24405048|NCT00165399|Goserelin|goserelin|mesh-list
24405049|NCT00165399|Bicalutamide|bicalutamide|mesh-list
25707730|NCT02236520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707731|NCT02236611|Glycopyrrolate|glycopyrrolate|mesh-list
25707732|NCT02236611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25707733|NCT02236611|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25707734|NCT02236611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25707735|NCT02236611|Cholinergic Agents|cholinergic agents|mesh-ancestor
25707736|NCT02236611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707737|NCT02236611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707738|NCT02236611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405050|NCT00165399|Estramustine|estramustine|mesh-list
24540518|NCT00668304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24405061|NCT00165399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24405062|NCT00165399|Alkylating Agents|alkylating agents|mesh-ancestor
24405064|NCT00165451|Celecoxib|celecoxib|mesh-list
24405065|NCT00165451|Cyclophosphamide|cyclophosphamide|mesh-list
24405066|NCT00165451|Etoposide|etoposide|mesh-list
24405067|NCT00165451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24405068|NCT00165451|Immunologic Factors|immunologic factors|mesh-ancestor
24405069|NCT00165451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405085|NCT00165451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24405086|NCT00165451|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24405087|NCT00165451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24405088|NCT00165451|Leprostatic Agents|leprostatic agents|mesh-ancestor
24405089|NCT00165451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24405090|NCT00165451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24405091|NCT00165451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24405092|NCT00165451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24405093|NCT00165451|Growth Substances|growth substances|mesh-ancestor
24405094|NCT00165451|Growth Inhibitors|growth inhibitors|mesh-ancestor
24405095|NCT00165464|Irinotecan|irinotecan|mesh-list
24405096|NCT00165464|Docetaxel|docetaxel|mesh-list
24405097|NCT00165464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405100|NCT00165464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405101|NCT00165464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405108|NCT00165477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24405109|NCT00165477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24405110|NCT00165477|Growth Substances|growth substances|mesh-ancestor
24405111|NCT00165477|Growth Inhibitors|growth inhibitors|mesh-ancestor
24405112|NCT00165477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405113|NCT00165490|Irinotecan|irinotecan|mesh-list
24405129|NCT00165516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24405134|NCT00165555|Protective Agents|protective agents|mesh-ancestor
24405135|NCT00165555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405136|NCT00165555|Antioxidants|antioxidants|mesh-ancestor
24811615|NCT02047422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24811616|NCT02047474|Leucovorin|leucovorin|mesh-list
25707739|NCT02236988|Thalidomide|thalidomide|mesh-list
25707740|NCT02236988|Apremilast|apremilast|mesh-list
25707741|NCT02236988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25707742|NCT02236988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24811617|NCT02047474|Fluorouracil|fluorouracil|mesh-list
24811618|NCT02047474|Oxaliplatin|oxaliplatin|mesh-list
24811619|NCT02047474|Irinotecan|irinotecan|mesh-list
24405138|NCT00165555|Antitubercular Agents|antitubercular agents|mesh-ancestor
25707743|NCT02236988|Analgesics|analgesics|mesh-ancestor
25707744|NCT02236988|Sensory System Agents|sensory system agents|mesh-ancestor
25707745|NCT02236988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25707746|NCT02236988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707747|NCT02236988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25707748|NCT02236988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24405143|NCT00165568|Bevacizumab|bevacizumab|mesh-list
24405144|NCT00165568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24405145|NCT00165568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405146|NCT00165568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24540537|NCT00668330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24540538|NCT00668330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540539|NCT00668330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24540540|NCT00668330|Vitamins|vitamins|mesh-ancestor
24540541|NCT00668330|Micronutrients|micronutrients|mesh-ancestor
24540542|NCT00668343|Simvastatin|simvastatin|mesh-list
24540543|NCT00668343|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24540544|NCT00668343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24540545|NCT00668343|Antimetabolites|antimetabolites|mesh-ancestor
24540546|NCT00668343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405150|NCT00165568|Growth Inhibitors|growth inhibitors|mesh-ancestor
24405151|NCT00165594|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
24405152|NCT00165594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405153|NCT00165594|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24405154|NCT00165594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405155|NCT00165594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405156|NCT00165633|Vitamin K 2|vitamin k 2|mesh-list
24405157|NCT00165633|Menatetrenone|menatetrenone|mesh-list
24405158|NCT00165633|Hemostatics|hemostatics|mesh-ancestor
24405159|NCT00165633|Coagulants|coagulants|mesh-ancestor
24405160|NCT00165633|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24540551|NCT00668356|Antimetabolites|antimetabolites|mesh-ancestor
24540552|NCT00668356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540553|NCT00668356|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24540554|NCT00668356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24540555|NCT00668356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405182|NCT00165737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405183|NCT00165737|Cholinergic Agents|cholinergic agents|mesh-ancestor
24405187|NCT00165750|Donepezil|donepezil|mesh-list
24405188|NCT00165750|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24405255|NCT00166244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24405256|NCT00166244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405257|NCT00166244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24405258|NCT00166244|Antitubercular Agents|antitubercular agents|mesh-ancestor
24405259|NCT00166244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24405260|NCT00166244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24405261|NCT00166244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405262|NCT00166244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405263|NCT00166400|Metoprolol|metoprolol|mesh-list
24405264|NCT00166400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24405265|NCT00166400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24405266|NCT00166400|Sympatholytics|sympatholytics|mesh-ancestor
24405267|NCT00166400|Autonomic Agents|autonomic agents|mesh-ancestor
24405268|NCT00166400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24405269|NCT00166400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405270|NCT00166400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24405271|NCT00166400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24405272|NCT00166400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24405313|NCT00166465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405315|NCT00166465|Protective Agents|protective agents|mesh-ancestor
24405326|NCT00166478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405327|NCT00166478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24405328|NCT00166478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24405329|NCT00166478|Analgesics|analgesics|mesh-ancestor
24405330|NCT00166478|Sensory System Agents|sensory system agents|mesh-ancestor
24405331|NCT00166478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24811641|NCT02047539|Analgesics|analgesics|mesh-ancestor
24540613|NCT00668616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405366|NCT00166621|Serotonin Agents|serotonin agents|mesh-ancestor
24405367|NCT00166621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24405368|NCT00166621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405370|NCT00166686|Analgesics|analgesics|mesh-ancestor
24405375|NCT00166686|Sympatholytics|sympatholytics|mesh-ancestor
24405377|NCT00166686|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24405378|NCT00166686|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24405379|NCT00166686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24405380|NCT00166686|Adrenergic Agents|adrenergic agents|mesh-ancestor
24405381|NCT00166686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24405382|NCT00166686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405387|NCT00166803|Rosiglitazone|rosiglitazone|mesh-list
24405388|NCT00166803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24405389|NCT00166803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405390|NCT00166816|Cyclosporine|cyclosporine|mesh-list
24405391|NCT00166816|Sirolimus|sirolimus|mesh-list
24405392|NCT00166816|Tacrolimus|tacrolimus|mesh-list
24405393|NCT00166816|Cyclosporins|cyclosporins|mesh-list
24405394|NCT00166816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24405395|NCT00166816|Immunologic Factors|immunologic factors|mesh-ancestor
24811652|NCT02047539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811682|NCT02047630|Latanoprost|latanoprost|mesh-list
24405411|NCT00166829|Immunologic Factors|immunologic factors|mesh-ancestor
24405412|NCT00166829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405414|NCT00166829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405415|NCT00166829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405416|NCT00166829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24405417|NCT00166829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405418|NCT00166829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24811690|NCT02047799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811691|NCT02047799|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24811692|NCT02047799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24811693|NCT02047799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811694|NCT02047799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24405419|NCT00166829|Antitubercular Agents|antitubercular agents|mesh-ancestor
24405420|NCT00166829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24540650|NCT00668837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540651|NCT00668837|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24405442|NCT00166868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24405443|NCT00166868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24405444|NCT00166868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405453|NCT00166881|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24405454|NCT00166881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24811698|NCT02047838|Hormones|hormones|mesh-list
24623196|NCT01070628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24623197|NCT01070628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623198|NCT01070628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623199|NCT01070628|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24623200|NCT01070628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623201|NCT01070628|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24623202|NCT01070628|Immunologic Factors|immunologic factors|mesh-ancestor
24623203|NCT01070628|Dopamine Agonists|dopamine agonists|mesh-ancestor
24623204|NCT01070628|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24623205|NCT01070641|Carvedilol|carvedilol|mesh-list
24623206|NCT01070641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24623207|NCT01070641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24623208|NCT01070641|Adrenergic Agents|adrenergic agents|mesh-ancestor
24405493|NCT00167401|Antimitotic Agents|antimitotic agents|mesh-ancestor
24405494|NCT00167401|Mitosis Modulators|mitosis modulators|mesh-ancestor
24405495|NCT00167401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405496|NCT00167479|Risperidone|risperidone|mesh-list
24405497|NCT00167479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24405498|NCT00167479|Serotonin Agents|serotonin agents|mesh-ancestor
24405499|NCT00167479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24405502|NCT00167479|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24623214|NCT01070641|Protective Agents|protective agents|mesh-ancestor
24623215|NCT01070641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24623216|NCT01070641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24623217|NCT01070641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24623218|NCT01070641|Vasodilator Agents|vasodilator agents|mesh-ancestor
24623219|NCT01070641|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24623220|NCT01070641|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24623221|NCT01070667|Dronedarone|dronedarone|mesh-list
24623222|NCT01070667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24623223|NCT01070680|Dexmedetomidine|dexmedetomidine|mesh-list
24623224|NCT01070680|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24623225|NCT01070680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24623226|NCT01070680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623227|NCT01070680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24811702|NCT02048007|Azithromycin|azithromycin|mesh-list
24811703|NCT02048007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24811704|NCT02048007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24811705|NCT02048020|Paclitaxel|paclitaxel|mesh-list
24811706|NCT02048020|Carboplatin|carboplatin|mesh-list
25707749|NCT02236988|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25707750|NCT02236988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25707751|NCT02236988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405548|NCT00167609|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24405549|NCT00167609|Immunologic Factors|immunologic factors|mesh-ancestor
24405550|NCT00167609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405552|NCT00167648|Goserelin|goserelin|mesh-list
24405553|NCT00167648|Estradiol|estradiol|mesh-list
24405566|NCT00167674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405567|NCT00167674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24405568|NCT00167674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24405569|NCT00167674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405570|NCT00167674|Antiviral Agents|antiviral agents|mesh-ancestor
24405571|NCT00167674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24405572|NCT00167674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24405573|NCT00167674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24405574|NCT00167674|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24811755|NCT02048228|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24405591|NCT00167713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405592|NCT00167713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24405593|NCT00167713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24405594|NCT00167713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24405595|NCT00167713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405596|NCT00167713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405649|NCT00167843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24405650|NCT00167843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24405651|NCT00167843|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24405652|NCT00167843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405653|NCT00167843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405654|NCT00167843|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24405656|NCT00167856|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24405657|NCT00167856|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24540717|NCT00669370|Tubulin Modulators|tubulin modulators|mesh-ancestor
24540718|NCT00669370|Antimitotic Agents|antimitotic agents|mesh-ancestor
24405659|NCT00167856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24540721|NCT00669370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24540722|NCT00669370|Antimetabolites|antimetabolites|mesh-ancestor
24540723|NCT00669435|Losartan|losartan|mesh-list
24540724|NCT00669435|Amlodipine|amlodipine|mesh-list
24405681|NCT00167921|Hormones|hormones|mesh-ancestor
24405682|NCT00167921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24405685|NCT00167947|Sirolimus|sirolimus|mesh-list
24405687|NCT00167947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405688|NCT00167947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405814|NCT00168480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405822|NCT00168493|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
24811788|NCT02048358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811789|NCT02048358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24811790|NCT02048358|Glucocorticoids|glucocorticoids|mesh-ancestor
24811791|NCT02048358|Hormones|hormones|mesh-ancestor
24811792|NCT02048358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24405823|NCT00168493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24405824|NCT00168493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24405825|NCT00168493|Serotonin Agents|serotonin agents|mesh-ancestor
24405826|NCT00168493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24405856|NCT00168597|Vitamin A|vitamin a|mesh-list
24811794|NCT02048358|Protective Agents|protective agents|mesh-ancestor
24405950|NCT00168870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405951|NCT00168870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24811858|NCT02048644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24811859|NCT02048644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811860|NCT02048644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24811861|NCT02048644|Glucocorticoids|glucocorticoids|mesh-ancestor
24811862|NCT02048644|Hormones|hormones|mesh-ancestor
24811863|NCT02048644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24405986|NCT00168922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24405987|NCT00168922|Alkylating Agents|alkylating agents|mesh-ancestor
24405988|NCT00168922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405989|NCT00168922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405990|NCT00168948|Pyrimethamine|pyrimethamine|mesh-list
24405991|NCT00168948|Antimalarials|antimalarials|mesh-ancestor
24405992|NCT00168948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24405993|NCT00168948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24405994|NCT00168948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24405995|NCT00168948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24405996|NCT00168948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445893|NCT00303004|Bosentan|bosentan|mesh-list
24811866|NCT02048683|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24811867|NCT02048683|Anesthetics, General|anesthetics, general|mesh-ancestor
24811869|NCT02048683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24811870|NCT02048683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811872|NCT02048761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24811873|NCT02048761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811874|NCT02048800|Treosulfan|treosulfan|mesh-list
24811875|NCT02048800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24811876|NCT02048800|Alkylating Agents|alkylating agents|mesh-ancestor
24811877|NCT02048800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811878|NCT02048800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24811879|NCT02048852|Menthol|menthol|mesh-list
24811880|NCT02048852|Nicotine|nicotine|mesh-list
24811886|NCT02048852|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24811887|NCT02048852|Cholinergic Agents|cholinergic agents|mesh-ancestor
24811888|NCT02048852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24859030|NCT02301221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24406061|NCT00169065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24406062|NCT00169065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24406063|NCT00169065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24406064|NCT00169065|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24551871|NCT04781972|Methylphenidate|methylphenidate|mesh-list
24406109|NCT00169130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406111|NCT00169130|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24406112|NCT00169130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24406113|NCT00169130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24811922|NCT02048930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24811923|NCT02048930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811924|NCT02048930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24811925|NCT02048930|Respiratory System Agents|respiratory system agents|mesh-ancestor
24811926|NCT02048930|Glucocorticoids|glucocorticoids|mesh-ancestor
24811927|NCT02048930|Hormones|hormones|mesh-ancestor
24811928|NCT02048930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24811929|NCT02048943|Gemcitabine|gemcitabine|mesh-list
24811930|NCT02048943|Paclitaxel|paclitaxel|mesh-list
24811931|NCT02048943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24406125|NCT00169156|Doxorubicin|doxorubicin|mesh-list
24406126|NCT00169156|Vincristine|vincristine|mesh-list
24406127|NCT00169156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24406128|NCT00169156|Immunologic Factors|immunologic factors|mesh-ancestor
24406129|NCT00169156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406130|NCT00169156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24406131|NCT00169156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24406132|NCT00169156|Alkylating Agents|alkylating agents|mesh-ancestor
24406133|NCT00169156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24811934|NCT02048943|Tubulin Modulators|tubulin modulators|mesh-ancestor
24811935|NCT02048943|Antimitotic Agents|antimitotic agents|mesh-ancestor
24811936|NCT02048943|Mitosis Modulators|mitosis modulators|mesh-ancestor
24550460|NCT00720590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24811937|NCT02048943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551084|NCT00723983|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24551085|NCT00723983|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24551086|NCT00723983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24811939|NCT02048943|Antimetabolites|antimetabolites|mesh-ancestor
24811940|NCT02048943|Antiviral Agents|antiviral agents|mesh-ancestor
24551252|NCT00724724|Aspirin|aspirin|mesh-list
24551468|NCT00726726|Vitamin K|vitamin k|mesh-list
24552019|NCT04254627|Contraceptive Agents|contraceptive agents|mesh-ancestor
24406134|NCT00169156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406138|NCT00169156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24406139|NCT00169156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24406140|NCT00169156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24406141|NCT00169156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24406143|NCT00169156|Hormones|hormones|mesh-ancestor
24554006|NCT00733720|Analgesics|analgesics|mesh-ancestor
24554007|NCT00733720|Sensory System Agents|sensory system agents|mesh-ancestor
24554008|NCT00733720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24554009|NCT00733720|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24554010|NCT00733720|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24554069|NCT00734123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24554074|NCT00734123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24811945|NCT02048943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811946|NCT02048969|Flumazenil|flumazenil|mesh-list
24811947|NCT02048969|Antidotes|antidotes|mesh-ancestor
24811948|NCT02048969|Protective Agents|protective agents|mesh-ancestor
24811949|NCT02048969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811950|NCT02048969|GABA Modulators|gaba modulators|mesh-ancestor
24811962|NCT02049073|Methylprednisolone|methylprednisolone|mesh-list
24811963|NCT02049073|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24607397|NCT04710628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24607398|NCT04710628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607399|NCT04710628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24607400|NCT04710628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24607401|NCT04710628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607402|NCT04665037|Posaconazole|posaconazole|mesh-list
24406168|NCT00169182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24406169|NCT00169182|Antimetabolites|antimetabolites|mesh-ancestor
24406170|NCT00169182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24406171|NCT00169182|Vasodilator Agents|vasodilator agents|mesh-ancestor
24406173|NCT00169195|Rituximab|rituximab|mesh-list
24406174|NCT00169195|Oxaliplatin|oxaliplatin|mesh-list
24406175|NCT00169195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24406176|NCT00169195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406177|NCT00169195|Immunologic Factors|immunologic factors|mesh-ancestor
24406178|NCT00169195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406179|NCT00169195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24406180|NCT00169195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24406182|NCT00169195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406183|NCT00169195|Antiviral Agents|antiviral agents|mesh-ancestor
24406184|NCT00169195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24406185|NCT00169195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24406186|NCT00169195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24406187|NCT00169208|Rituximab|rituximab|mesh-list
24406188|NCT00169208|Fludarabine|fludarabine|mesh-list
24406189|NCT00169208|Mitoxantrone|mitoxantrone|mesh-list
24406204|NCT00169221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24406205|NCT00169221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24406206|NCT00169221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406207|NCT00169234|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24406208|NCT00169234|Immunologic Factors|immunologic factors|mesh-ancestor
24406209|NCT00169234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406211|NCT00169247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406220|NCT00169299|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24406222|NCT00169299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24406239|NCT00169468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24406241|NCT00169520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406242|NCT00169520|Tubulin Modulators|tubulin modulators|mesh-ancestor
24406243|NCT00169520|Antimitotic Agents|antimitotic agents|mesh-ancestor
24406244|NCT00169520|Mitosis Modulators|mitosis modulators|mesh-ancestor
24406255|NCT00169546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24406273|NCT00169559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24406274|NCT00169572|Dexamethasone|dexamethasone|mesh-list
24406275|NCT00169572|Ondansetron|ondansetron|mesh-list
24556012|NCT00744640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24556223|NCT00746070|Natriuretic Agents|natriuretic agents|mesh-ancestor
24556383|NCT00747409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24556384|NCT00747409|Insulin Aspart|insulin aspart|mesh-list
24556385|NCT00747409|Insulin Detemir|insulin detemir|mesh-list
24556386|NCT00747409|Insulin, Long-Acting|insulin, long-acting|mesh-list
24556518|NCT00748059|Mydriatics|mydriatics|mesh-ancestor
24556720|NCT00749359|Serotonin Agents|serotonin agents|mesh-ancestor
24406276|NCT00169572|Aprepitant|aprepitant|mesh-list
24406277|NCT00169572|Fosaprepitant|fosaprepitant|mesh-list
24406278|NCT00169572|Casopitant|casopitant|mesh-list
24406279|NCT00169572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24406280|NCT00169572|Antiemetics|antiemetics|mesh-ancestor
24406281|NCT00169572|Autonomic Agents|autonomic agents|mesh-ancestor
24406282|NCT00169572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24406283|NCT00169572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406284|NCT00169572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24406285|NCT00169572|Glucocorticoids|glucocorticoids|mesh-ancestor
24406286|NCT00169572|Hormones|hormones|mesh-ancestor
24406287|NCT00169572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24406288|NCT00169572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24406289|NCT00169572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406290|NCT00169572|Antipruritics|antipruritics|mesh-ancestor
24406291|NCT00169572|Dermatologic Agents|dermatologic agents|mesh-ancestor
24406292|NCT00169572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24406327|NCT00169624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406329|NCT00169728|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24406330|NCT00169728|Immunologic Factors|immunologic factors|mesh-ancestor
24406331|NCT00169728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406332|NCT00169819|Abciximab|abciximab|mesh-list
24406333|NCT00169819|Anticoagulants|anticoagulants|mesh-ancestor
24406334|NCT00169819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24406335|NCT00169832|Rosiglitazone|rosiglitazone|mesh-list
24406336|NCT00169832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24406337|NCT00169832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406338|NCT00169845|Tocopherols|tocopherols|mesh-list
25707752|NCT02236988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466834|NCT00375258|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24406347|NCT00169845|Vitamins|vitamins|mesh-ancestor
24406411|NCT00170196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820344|NCT02099240|Renal Agents|renal agents|mesh-ancestor
24406418|NCT00170209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24406419|NCT00170209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24406421|NCT00170209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24406422|NCT00170209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557897|NCT00754780|Sensory System Agents|sensory system agents|mesh-ancestor
24558025|NCT00755118|Vitamins|vitamins|mesh-ancestor
24558165|NCT00755573|Pregabalin|pregabalin|mesh-list
24558230|NCT00755859|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24558305|NCT00755989|Morphine|morphine|mesh-list
24558481|NCT00757458|Pentetic Acid|pentetic acid|mesh-list
24558482|NCT00757458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24558485|NCT00757458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24541071|NCT00670722|Insulin|insulin|mesh-list
24558554|NCT00757835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24558616|NCT00758199|Hormones|hormones|mesh-ancestor
24559280|NCT05122221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24559466|NCT04767061|Antioxidants|antioxidants|mesh-ancestor
24560076|NCT03617458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24560140|NCT03557307|Respiratory System Agents|respiratory system agents|mesh-ancestor
24560212|NCT03205137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24560781|NCT01451515|Immunologic Factors|immunologic factors|mesh-ancestor
24671023|NCT01323257|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24561588|NCT00761540|Liraglutide|liraglutide|mesh-list
24859031|NCT02301221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24561895|NCT00763633|Pyridoxal|pyridoxal|mesh-list
24562185|NCT00764907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24406423|NCT00170209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406424|NCT00170209|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24406426|NCT00170209|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24406427|NCT00170209|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24406428|NCT00170209|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24406445|NCT00170404|Vitamins|vitamins|mesh-list
24406456|NCT00170404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406458|NCT00170430|Fluconazole|fluconazole|mesh-list
24406459|NCT00170430|Antifungal Agents|antifungal agents|mesh-ancestor
24406460|NCT00170430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24406461|NCT00170430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24406462|NCT00170430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24406463|NCT00170430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541086|NCT00670761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24406464|NCT00170430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406465|NCT00170430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24406466|NCT00170430|Hormone Antagonists|hormone antagonists|mesh-ancestor
24406467|NCT00170430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24406468|NCT00170430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406469|NCT00170430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24406470|NCT00170430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24406471|NCT00170456|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24406472|NCT00170456|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25406099|NCT03579472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25707753|NCT02236988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25707754|NCT02236988|Immunologic Factors|immunologic factors|mesh-ancestor
25707755|NCT02236988|Leprostatic Agents|leprostatic agents|mesh-ancestor
25707756|NCT02236988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25707757|NCT02236988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25707758|NCT02236988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25707759|NCT02236988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25707760|NCT02236988|Growth Substances|growth substances|mesh-ancestor
25707761|NCT02236988|Growth Inhibitors|growth inhibitors|mesh-ancestor
24466940|NCT00375661|Interferon-alpha|interferon-alpha|mesh-list
24466941|NCT00375661|Interferon alpha-2|interferon alpha-2|mesh-list
24466942|NCT00375661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562642|NCT00767546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24541098|NCT00670787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541101|NCT00670813|Modafinil|modafinil|mesh-list
24562643|NCT00767546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406483|NCT00170469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406484|NCT00170469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24406485|NCT00170547|Vaccines|vaccines|mesh-list
24406529|NCT00170729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406530|NCT00170729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24406531|NCT00170729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406532|NCT00170729|Antiemetics|antiemetics|mesh-ancestor
24406533|NCT00170729|Autonomic Agents|autonomic agents|mesh-ancestor
24406534|NCT00170729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24406535|NCT00170729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24406536|NCT00170729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24406537|NCT00170729|Protective Agents|protective agents|mesh-ancestor
24406538|NCT00170742|Octreotide|octreotide|mesh-list
24406539|NCT00170742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24406540|NCT00170742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24406541|NCT00170742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406542|NCT00170755|Darifenacin|darifenacin|mesh-list
24406543|NCT00170755|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24406544|NCT00170755|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24607408|NCT04665037|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24700592|NCT01453504|Everolimus|everolimus|mesh-list
24607409|NCT04665037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24562768|NCT00768157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562907|NCT00768859|Antimitotic Agents|antimitotic agents|mesh-ancestor
24562908|NCT00768859|Mitosis Modulators|mitosis modulators|mesh-ancestor
24562909|NCT00768859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563430|NCT00771498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24563504|NCT00772135|Sildenafil Citrate|sildenafil citrate|mesh-list
24563854|NCT00774007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24563855|NCT00774020|Zoledronic Acid|zoledronic acid|mesh-list
24563920|NCT00774423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24563921|NCT00774423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24563922|NCT00774423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563923|NCT00774423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563991|NCT00774683|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24564196|NCT00775580|Autonomic Agents|autonomic agents|mesh-ancestor
24564197|NCT00775580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24564198|NCT00775580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707762|NCT02236988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25707763|NCT02237157|Gemcitabine|gemcitabine|mesh-list
25707764|NCT02237157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25707765|NCT02237157|Antimetabolites|antimetabolites|mesh-ancestor
25707766|NCT02237157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707767|NCT02237157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25707768|NCT02237157|Antiviral Agents|antiviral agents|mesh-ancestor
25707769|NCT02237157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25707770|NCT02237157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25707771|NCT02237157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25707772|NCT02237157|Immunologic Factors|immunologic factors|mesh-ancestor
24406599|NCT00170872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406600|NCT00170872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24406601|NCT00170872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24406602|NCT00170872|Analgesics|analgesics|mesh-ancestor
24406603|NCT00170872|Sensory System Agents|sensory system agents|mesh-ancestor
24406604|NCT00170872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24406605|NCT00170872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406606|NCT00170872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24406617|NCT00170898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406620|NCT00170898|Analgesics|analgesics|mesh-ancestor
24541222|NCT00671541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541223|NCT00671541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24541225|NCT00671593|Glycerol|glycerol|mesh-list
24541226|NCT00671593|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24406635|NCT00170937|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24406636|NCT00170937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406637|NCT00170937|Diuretics|diuretics|mesh-ancestor
24406638|NCT00170937|Natriuretic Agents|natriuretic agents|mesh-ancestor
24406639|NCT00170937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406640|NCT00170937|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24406641|NCT00170937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24406642|NCT00170963|Amlodipine|amlodipine|mesh-list
24406643|NCT00170963|Valsartan|valsartan|mesh-list
24406644|NCT00170963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24406645|NCT00170963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24406646|NCT00170963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24406647|NCT00170963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406687|NCT00171015|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25707773|NCT02237157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707774|NCT02237196|Immunologic Factors|immunologic factors|mesh-list
25707775|NCT02237196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707776|NCT02237417|Aripiprazole|aripiprazole|mesh-list
25707777|NCT02237417|Antipsychotic Agents|antipsychotic agents|mesh-list
25707778|NCT02237417|Antidepressive Agents|antidepressive agents|mesh-ancestor
25707779|NCT02237417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24406689|NCT00171015|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24406690|NCT00171015|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24406691|NCT00171015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406692|NCT00171015|Diuretics|diuretics|mesh-ancestor
24406693|NCT00171015|Natriuretic Agents|natriuretic agents|mesh-ancestor
24406694|NCT00171015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406695|NCT00171015|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24406696|NCT00171015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24406698|NCT00171028|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24406699|NCT00171028|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24406700|NCT00171028|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24406701|NCT00171028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406702|NCT00171041|Valsartan|valsartan|mesh-list
24406705|NCT00171041|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24406706|NCT00171041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406707|NCT00171067|Valsartan|valsartan|mesh-list
24406708|NCT00171067|Lisinopril|lisinopril|mesh-list
24406719|NCT00171080|Valsartan|valsartan|mesh-list
24406720|NCT00171080|Irbesartan|irbesartan|mesh-list
24406721|NCT00171080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24406722|NCT00171080|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24406725|NCT00171093|Valsartan|valsartan|mesh-list
24406735|NCT00171093|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24406763|NCT00171132|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24406764|NCT00171132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24406765|NCT00171132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24406766|NCT00171132|Adrenergic Agents|adrenergic agents|mesh-ancestor
24406767|NCT00171132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24406768|NCT00171145|Darifenacin|darifenacin|mesh-list
24406798|NCT00171327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24406799|NCT00171327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406800|NCT00171353|Valsartan|valsartan|mesh-list
24406801|NCT00171353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24406802|NCT00171353|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24406803|NCT00171353|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24406804|NCT00171353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406805|NCT00171366|Amlodipine|amlodipine|mesh-list
24406810|NCT00171366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406811|NCT00171366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24406814|NCT00171366|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24406815|NCT00171366|Protease Inhibitors|protease inhibitors|mesh-ancestor
24406816|NCT00171366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24406817|NCT00171379|Mycophenolic Acid|mycophenolic acid|mesh-list
24406818|NCT00171379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24406909|NCT00171535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24406911|NCT00171561|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24406912|NCT00171561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24406913|NCT00171561|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24467166|NCT00376480|Fludarabine phosphate|fludarabine phosphate|mesh-list
24467167|NCT00376480|Thiotepa|thiotepa|mesh-list
24467168|NCT00376480|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24467177|NCT00376480|Antiemetics|antiemetics|mesh-ancestor
24406914|NCT00171561|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24406915|NCT00171561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406916|NCT00171561|Diuretics|diuretics|mesh-ancestor
24406917|NCT00171561|Natriuretic Agents|natriuretic agents|mesh-ancestor
24406921|NCT00171574|Valsartan|valsartan|mesh-list
24406940|NCT00171600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24406941|NCT00171600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24406942|NCT00171600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406943|NCT00171600|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24406944|NCT00171600|Protease Inhibitors|protease inhibitors|mesh-ancestor
24406945|NCT00171600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24406946|NCT00171600|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24406947|NCT00171600|Protective Agents|protective agents|mesh-ancestor
24406948|NCT00171600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406949|NCT00171613|Octreotide|octreotide|mesh-list
24406950|NCT00171613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24406951|NCT00171613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24406952|NCT00171613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406953|NCT00171626|Diclofenac|diclofenac|mesh-list
24820012|NCT02098460|Protective Agents|protective agents|mesh-ancestor
24820013|NCT02098460|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24820014|NCT02098460|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24820015|NCT02098460|Antioxidants|antioxidants|mesh-ancestor
24820016|NCT02098486|Moxifloxacin|moxifloxacin|mesh-list
24820017|NCT02098486|Ceftriaxone|ceftriaxone|mesh-list
24820018|NCT02098486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24820019|NCT02098486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24820020|NCT02098486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24820021|NCT02098486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24820022|NCT02098486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820023|NCT02098486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820024|NCT02098486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24820025|NCT02098499|Diphenhydramine|diphenhydramine|mesh-list
24406965|NCT00171639|Zoledronic Acid|zoledronic acid|mesh-list
24406966|NCT00171639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24406967|NCT00171639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406969|NCT00171652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24406970|NCT00171652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24406971|NCT00171652|Analgesics|analgesics|mesh-ancestor
24451683|NCT00324480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24451684|NCT00324506|Mycophenolic Acid|mycophenolic acid|mesh-list
24451685|NCT00324506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24451686|NCT00324506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406975|NCT00171652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24406991|NCT00171665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406992|NCT00171678|Diclofenac|diclofenac|mesh-list
24406993|NCT00171678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24406994|NCT00171678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24406995|NCT00171678|Analgesics|analgesics|mesh-ancestor
25707780|NCT02237417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25707781|NCT02237417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25707782|NCT02237417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406996|NCT00171678|Sensory System Agents|sensory system agents|mesh-ancestor
24406997|NCT00171678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24542629|NCT00679614|Antipyretics|antipyretics|mesh-ancestor
25707783|NCT02237417|Dopamine Agonists|dopamine agonists|mesh-ancestor
25707784|NCT02237417|Dopamine Agents|dopamine agents|mesh-ancestor
25707785|NCT02237417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707786|NCT02237417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406998|NCT00171678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406999|NCT00171678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24407000|NCT00171678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24820027|NCT02098499|Haloperidol|haloperidol|mesh-list
24407003|NCT00171678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407004|NCT00171691|Diclofenac|diclofenac|mesh-list
24451687|NCT00324506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24407005|NCT00171691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24407006|NCT00171691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24407007|NCT00171691|Analgesics|analgesics|mesh-ancestor
24407008|NCT00171691|Sensory System Agents|sensory system agents|mesh-ancestor
24407009|NCT00171691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24407010|NCT00171691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407090|NCT00171821|Chelating Agents|chelating agents|mesh-ancestor
24407091|NCT00171821|Sequestering Agents|sequestering agents|mesh-ancestor
24407092|NCT00171821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407093|NCT00171847|Trastuzumab|trastuzumab|mesh-list
24407094|NCT00171847|Letrozole|letrozole|mesh-list
24407095|NCT00171847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24407096|NCT00171847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407097|NCT00171847|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24407098|NCT00171847|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24407099|NCT00171847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407100|NCT00171847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407101|NCT00171847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24407102|NCT00171847|Hormone Antagonists|hormone antagonists|mesh-ancestor
24407104|NCT00171847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407125|NCT00171938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407126|NCT00171938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24407127|NCT00171938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820055|NCT02098499|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24820056|NCT02098512|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24575837|NCT00834600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24820057|NCT02098512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24407170|NCT00172302|Ascorbic Acid|ascorbic acid|mesh-list
24407200|NCT00172419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24407201|NCT00172419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407202|NCT00172809|Interferons|interferons|mesh-list
24820058|NCT02098512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24820059|NCT02098590|Chloroquine|chloroquine|mesh-list
24820060|NCT02098590|Atovaquone|atovaquone|mesh-list
24820061|NCT02098590|Proguanil|proguanil|mesh-list
24820062|NCT02098590|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
24820063|NCT02098590|Amebicides|amebicides|mesh-ancestor
24820064|NCT02098590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24407255|NCT00173888|Antimetabolites|antimetabolites|mesh-ancestor
24407256|NCT00173888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407257|NCT00173888|Antiviral Agents|antiviral agents|mesh-ancestor
24407258|NCT00173888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24407274|NCT00174174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24407275|NCT00174174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407276|NCT00174200|Risperidone|risperidone|mesh-list
24407280|NCT00174200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407281|NCT00174200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407282|NCT00174200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24407283|NCT00174200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24407328|NCT00174304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24407329|NCT00174304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407330|NCT00174304|Vasodilator Agents|vasodilator agents|mesh-ancestor
24407333|NCT00174317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24407335|NCT00174317|Analgesics|analgesics|mesh-ancestor
24407347|NCT00174330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24407348|NCT00174330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24407349|NCT00174330|Antimetabolites|antimetabolites|mesh-ancestor
24407353|NCT00174330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407364|NCT00174343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407365|NCT00174343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407366|NCT00174343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24407367|NCT00174343|Hormone Antagonists|hormone antagonists|mesh-ancestor
24407368|NCT00174343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24407369|NCT00174343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407394|NCT00174434|Growth Substances|growth substances|mesh-ancestor
24407396|NCT00174434|Growth Inhibitors|growth inhibitors|mesh-ancestor
24820069|NCT02098590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820073|NCT02098616|Protease Inhibitors|protease inhibitors|mesh-ancestor
24820074|NCT02098616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24820075|NCT02098616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820076|NCT02098629|Milrinone|milrinone|mesh-list
24820077|NCT02098629|Esmolol|esmolol|mesh-list
24820078|NCT02098629|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24680386|NCT01374581|Analgesics|analgesics|mesh-ancestor
24407423|NCT00174499|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24407424|NCT00174499|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24407425|NCT00174499|Cholinergic Agents|cholinergic agents|mesh-ancestor
24407426|NCT00174499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24407427|NCT00174499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707787|NCT02237417|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25707788|NCT02237417|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25707789|NCT02237417|Serotonin Agents|serotonin agents|mesh-ancestor
25707790|NCT02237417|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25707791|NCT02237417|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25707792|NCT02237417|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25707793|NCT02237417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25707794|NCT02237898|Carbon Monoxide|carbon monoxide|mesh-list
24407429|NCT00174512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24407430|NCT00174512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24541548|NCT00673621|Tocolytic Agents|tocolytic agents|mesh-ancestor
24541549|NCT00673621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24541550|NCT00673621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24407475|NCT00174590|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24407476|NCT00174590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24407477|NCT00174590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24407478|NCT00174590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24407479|NCT00174590|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24407488|NCT00174616|Capecitabine|capecitabine|mesh-list
24407489|NCT00174616|Oxaliplatin|oxaliplatin|mesh-list
24407490|NCT00174616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24407491|NCT00174616|Antimetabolites|antimetabolites|mesh-ancestor
24407492|NCT00174616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820079|NCT02098629|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24820080|NCT02098629|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24820081|NCT02098629|Adrenergic Agents|adrenergic agents|mesh-ancestor
24407493|NCT00174616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407520|NCT00174655|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24407521|NCT00174655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24407538|NCT00174668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24407539|NCT00174668|Insulin Glargine|insulin glargine|mesh-list
24407540|NCT00174668|Insulin glulisine|insulin glulisine|mesh-list
24407541|NCT00174668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24407542|NCT00174668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407544|NCT00174681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24407545|NCT00174681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407546|NCT00174694|Telithromycin|telithromycin|mesh-list
24407549|NCT00174707|Cyclophosphamide|cyclophosphamide|mesh-list
24407564|NCT00174707|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24407566|NCT00174707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24407567|NCT00174707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24407568|NCT00174707|Antimetabolites|antimetabolites|mesh-ancestor
24407569|NCT00174707|Dermatologic Agents|dermatologic agents|mesh-ancestor
24407570|NCT00174707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407571|NCT00174707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24407572|NCT00174707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24407573|NCT00174720|Ciclesonide|ciclesonide|mesh-list
24407574|NCT00174720|Glucocorticoids|glucocorticoids|mesh-ancestor
24407576|NCT00174720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24407577|NCT00174720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407578|NCT00174720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24407582|NCT00174733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24407585|NCT00174759|Clopidogrel|clopidogrel|mesh-list
24407586|NCT00174759|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24407587|NCT00174759|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24407588|NCT00174759|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24407589|NCT00174759|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24407590|NCT00174759|Purinergic Agents|purinergic agents|mesh-ancestor
24407592|NCT00174759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407593|NCT00174759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407624|NCT00174876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24820086|NCT02098629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24820087|NCT02098629|Vasodilator Agents|vasodilator agents|mesh-ancestor
24407675|NCT00175032|Naproxen|naproxen|mesh-list
24407681|NCT00175032|Sensory System Agents|sensory system agents|mesh-ancestor
24407682|NCT00175032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24407683|NCT00175032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407684|NCT00175032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24407685|NCT00175032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24407686|NCT00175032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24407710|NCT00175123|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24407711|NCT00175123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24407712|NCT00175123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407713|NCT00175123|Cholinergic Agents|cholinergic agents|mesh-ancestor
24407715|NCT00175162|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
24407716|NCT00175162|Vasodilator Agents|vasodilator agents|mesh-ancestor
24407717|NCT00175162|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24407718|NCT00175162|Protective Agents|protective agents|mesh-ancestor
24407720|NCT00175227|Furosemide|furosemide|mesh-list
24407741|NCT00175305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24407742|NCT00175305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407743|NCT00175357|Methadone|methadone|mesh-list
24407754|NCT00175370|Vancomycin|vancomycin|mesh-list
24407787|NCT00175435|Vaccines|vaccines|mesh-list
24407788|NCT00175435|Immunologic Factors|immunologic factors|mesh-ancestor
24407789|NCT00175435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407790|NCT00175513|Valacyclovir|valacyclovir|mesh-list
24407791|NCT00175513|Antiviral Agents|antiviral agents|mesh-ancestor
24407792|NCT00175513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24407793|NCT00175565|Fluticasone|fluticasone|mesh-list
24407794|NCT00175565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24407795|NCT00175565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24407796|NCT00175565|Autonomic Agents|autonomic agents|mesh-ancestor
24407797|NCT00175565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24407798|NCT00175565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407799|NCT00175565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24407800|NCT00175565|Respiratory System Agents|respiratory system agents|mesh-ancestor
24407831|NCT00175643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407832|NCT00175643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407833|NCT00175643|Interferon Inducers|interferon inducers|mesh-ancestor
24407835|NCT00175682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24407836|NCT00175682|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24407837|NCT00175682|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24407838|NCT00175682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24407839|NCT00175682|Adrenergic Agents|adrenergic agents|mesh-ancestor
24407844|NCT00175695|Protein C|protein c|mesh-list
24407851|NCT00175734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24407852|NCT00175734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24407853|NCT00175734|Analgesics|analgesics|mesh-ancestor
24407854|NCT00175734|Sensory System Agents|sensory system agents|mesh-ancestor
24407883|NCT00175812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24407884|NCT00175812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24407885|NCT00175812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24407886|NCT00175812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24407887|NCT00175812|Autonomic Agents|autonomic agents|mesh-ancestor
24407888|NCT00175812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24407889|NCT00175812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24407890|NCT00175812|Respiratory System Agents|respiratory system agents|mesh-ancestor
24407905|NCT00175838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24820111|NCT02098824|Dopamine Agents|dopamine agents|mesh-ancestor
24407909|NCT00175838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24407910|NCT00175838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24407911|NCT00175838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407914|NCT00175838|Antisickling Agents|antisickling agents|mesh-ancestor
24407915|NCT00175838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24407918|NCT00175890|Nootropic Agents|nootropic agents|mesh-ancestor
24407919|NCT00175903|Carbamazepine|carbamazepine|mesh-list
24407920|NCT00175903|Levetiracetam|levetiracetam|mesh-list
24407921|NCT00175903|Valproic Acid|valproic acid|mesh-list
24407922|NCT00175903|Anticonvulsants|anticonvulsants|mesh-ancestor
24407923|NCT00175903|Nootropic Agents|nootropic agents|mesh-ancestor
24407924|NCT00175903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407925|NCT00175903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407926|NCT00175903|GABA Agents|gaba agents|mesh-ancestor
24407927|NCT00175903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24407928|NCT00175903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407929|NCT00175903|Antimanic Agents|antimanic agents|mesh-ancestor
24407930|NCT00175903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24407931|NCT00175903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24407932|NCT00175903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24407933|NCT00175903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24407934|NCT00175903|Analgesics|analgesics|mesh-ancestor
24407935|NCT00175903|Sensory System Agents|sensory system agents|mesh-ancestor
24407936|NCT00175903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24407937|NCT00175903|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24407938|NCT00175903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24407939|NCT00175903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24542630|NCT00679614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24407996|NCT00176098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451739|NCT00324623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407997|NCT00176241|Gemcitabine|gemcitabine|mesh-list
24407998|NCT00176241|Paclitaxel|paclitaxel|mesh-list
24407999|NCT00176241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24408000|NCT00176241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408001|NCT00176241|Tubulin Modulators|tubulin modulators|mesh-ancestor
24408002|NCT00176241|Antimitotic Agents|antimitotic agents|mesh-ancestor
24408003|NCT00176241|Mitosis Modulators|mitosis modulators|mesh-ancestor
24408004|NCT00176241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408005|NCT00176241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24408007|NCT00176241|Antiviral Agents|antiviral agents|mesh-ancestor
24408008|NCT00176241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24408009|NCT00176241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408014|NCT00176267|Carboplatin|carboplatin|mesh-list
24408015|NCT00176267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24408016|NCT00176267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541621|NCT00674167|Docetaxel|docetaxel|mesh-list
24408052|NCT00176293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408053|NCT00176332|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24408139|NCT00176670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24408154|NCT00176761|Analgesics|analgesics|mesh-ancestor
24408155|NCT00176761|Sensory System Agents|sensory system agents|mesh-ancestor
24408156|NCT00176761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24408157|NCT00176761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408158|NCT00176774|Leucovorin|leucovorin|mesh-list
24408160|NCT00176774|Irinotecan|irinotecan|mesh-list
24408161|NCT00176774|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
24408175|NCT00176774|Vitamins|vitamins|mesh-ancestor
24408186|NCT00176787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408187|NCT00176787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408188|NCT00176813|Gemcitabine|gemcitabine|mesh-list
24408189|NCT00176813|Celecoxib|celecoxib|mesh-list
24408190|NCT00176813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408191|NCT00176813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24408203|NCT00176813|Sensory System Agents|sensory system agents|mesh-ancestor
24408204|NCT00176813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24408205|NCT00176813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24408247|NCT00177008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24541680|NCT00674596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408301|NCT00177281|Belotecan|belotecan|mesh-list
24408302|NCT00177281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24408303|NCT00177281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24408331|NCT00177372|Luteolytic Agents|luteolytic agents|mesh-ancestor
24408332|NCT00177372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24408333|NCT00177372|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24408335|NCT00177398|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24408336|NCT00177398|Insulin Glargine|insulin glargine|mesh-list
24408337|NCT00177398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24408338|NCT00177398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408340|NCT00177411|Parathyroid Hormone|parathyroid hormone|mesh-list
24408341|NCT00177411|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
24408429|NCT00177684|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24408430|NCT00177684|Amebicides|amebicides|mesh-ancestor
24408431|NCT00177684|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24408432|NCT00177684|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24408433|NCT00177684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24408434|NCT00177684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24408435|NCT00177684|Antifungal Agents|antifungal agents|mesh-ancestor
24408436|NCT00177710|Amphotericin B|amphotericin b|mesh-list
24408437|NCT00177710|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24408438|NCT00177710|Amebicides|amebicides|mesh-ancestor
24408439|NCT00177710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24408440|NCT00177710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24408441|NCT00177710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24820187|NCT02099240|Vancomycin|vancomycin|mesh-list
24468026|NCT00379457|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24468027|NCT00379457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24468028|NCT00379457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24820209|NCT02099240|Erythromycin|erythromycin|mesh-list
24820210|NCT02099240|Erythromycin Estolate|erythromycin estolate|mesh-list
24820211|NCT02099240|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24820212|NCT02099240|Erythromycin stearate|erythromycin stearate|mesh-list
24820213|NCT02099240|Amikacin|amikacin|mesh-list
24408444|NCT00177749|Posaconazole|posaconazole|mesh-list
24408445|NCT00177749|Antifungal Agents|antifungal agents|mesh-ancestor
24408446|NCT00177749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24408484|NCT00177996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408485|NCT00178035|Paroxetine|paroxetine|mesh-list
24446067|NCT00303758|Antidotes|antidotes|mesh-ancestor
24820236|NCT02099240|Cefoxitin|cefoxitin|mesh-list
24820237|NCT02099240|Sulbactam|sulbactam|mesh-list
24820238|NCT02099240|Gatifloxacin|gatifloxacin|mesh-list
24408581|NCT00178763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408582|NCT00178802|Interferons|interferons|mesh-list
24408583|NCT00178802|Doxorubicin|doxorubicin|mesh-list
24408584|NCT00178802|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24408585|NCT00178802|Fluorouracil|fluorouracil|mesh-list
24408586|NCT00178802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24408587|NCT00178802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408588|NCT00178802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24408589|NCT00178802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24408590|NCT00178802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408620|NCT00178854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408621|NCT00178854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408622|NCT00178854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24408623|NCT00178854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24408624|NCT00178854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24408625|NCT00178854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24408626|NCT00178854|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24408627|NCT00178854|Dopamine Agents|dopamine agents|mesh-ancestor
24408628|NCT00178945|Botulinum Toxins|botulinum toxins|mesh-list
24408629|NCT00178945|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24408719|NCT00179231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24408720|NCT00179231|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24408721|NCT00179231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24408722|NCT00179231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24408723|NCT00179231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408724|NCT00179231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707795|NCT02237898|Antimetabolites|antimetabolites|mesh-ancestor
25707796|NCT02237898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707797|NCT02237898|Gasotransmitters|gasotransmitters|mesh-ancestor
24408725|NCT00179231|Serotonin Agents|serotonin agents|mesh-ancestor
24408726|NCT00179231|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24408727|NCT00179231|GABA Antagonists|gaba antagonists|mesh-ancestor
24408728|NCT00179231|GABA Agents|gaba agents|mesh-ancestor
24408729|NCT00179244|Bupropion|bupropion|mesh-list
24408730|NCT00179244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24408731|NCT00179244|Antidepressive Agents|antidepressive agents|mesh-ancestor
25707798|NCT02237898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707799|NCT02237898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707800|NCT02237950|Metronidazole|metronidazole|mesh-list
25707801|NCT02237950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25707802|NCT02237950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25707803|NCT02237950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25707804|NCT02237950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24408742|NCT00179244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408744|NCT00179257|Antidepressive Agents|antidepressive agents|mesh-ancestor
24408747|NCT00179257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24408748|NCT00179257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24408749|NCT00179257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408750|NCT00179257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24408752|NCT00179257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408754|NCT00179283|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24408755|NCT00179283|Antidepressive Agents|antidepressive agents|mesh-ancestor
24408756|NCT00179283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24408757|NCT00179283|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24408758|NCT00179283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24408759|NCT00179283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24408761|NCT00179283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24408763|NCT00179283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707806|NCT02237989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25707807|NCT02237989|Analgesics|analgesics|mesh-ancestor
25707808|NCT02237989|Sensory System Agents|sensory system agents|mesh-ancestor
25707809|NCT02237989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25707810|NCT02237989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707811|NCT02237989|Antipyretics|antipyretics|mesh-ancestor
25707812|NCT02238080|Epoetin Alfa|epoetin alfa|mesh-list
25707813|NCT02238080|Hematinics|hematinics|mesh-ancestor
25707814|NCT02238379|Oxytocin|oxytocin|mesh-list
25707815|NCT02238379|Oxytocics|oxytocics|mesh-ancestor
25707816|NCT02238379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25707817|NCT02238379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707818|NCT02238483|AZD7624|azd7624|mesh-list
24408768|NCT00179465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24820350|NCT02099240|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24820351|NCT02099240|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24820638|NCT02100553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408770|NCT00179465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820362|NCT02099240|Sensory System Agents|sensory system agents|mesh-ancestor
24820363|NCT02099240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24820364|NCT02099240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24820365|NCT02099240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24820366|NCT02099240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24820367|NCT02099240|Protease Inhibitors|protease inhibitors|mesh-ancestor
24820368|NCT02099240|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24820369|NCT02099240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24820370|NCT02099240|Coccidiostats|coccidiostats|mesh-ancestor
24820371|NCT02099240|Anesthetics, Local|anesthetics, local|mesh-ancestor
24820372|NCT02099240|Anesthetics|anesthetics|mesh-ancestor
24820373|NCT02099240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24820374|NCT02099240|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24820375|NCT02099240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24820376|NCT02099240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24820377|NCT02099240|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24541924|NCT00675779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24408775|NCT00179465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24408776|NCT00179465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820422|NCT02099396|Tubulin Modulators|tubulin modulators|mesh-ancestor
24408839|NCT00179738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25406100|NCT03579472|Tubulin Modulators|tubulin modulators|mesh-ancestor
24408943|NCT00180089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24408945|NCT00180102|Mitoxantrone|mitoxantrone|mesh-list
24408946|NCT00180102|Amsacrine|amsacrine|mesh-list
24408947|NCT00180102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24408948|NCT00180102|Antimetabolites|antimetabolites|mesh-ancestor
24408949|NCT00180102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408950|NCT00180102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408951|NCT00180102|Antiviral Agents|antiviral agents|mesh-ancestor
24408952|NCT00180102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24408953|NCT00180102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24408954|NCT00180102|Immunologic Factors|immunologic factors|mesh-ancestor
24408955|NCT00180102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408956|NCT00180102|Analgesics|analgesics|mesh-ancestor
24408957|NCT00180102|Sensory System Agents|sensory system agents|mesh-ancestor
24408958|NCT00180102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24408959|NCT00180102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24820456|NCT02099617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820457|NCT02099617|Sympathomimetics|sympathomimetics|mesh-ancestor
24820458|NCT02099617|Autonomic Agents|autonomic agents|mesh-ancestor
24820459|NCT02099617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24820460|NCT02099617|Nasal Decongestants|nasal decongestants|mesh-ancestor
24820461|NCT02099617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24820462|NCT02099617|Respiratory System Agents|respiratory system agents|mesh-ancestor
24820464|NCT02099695|Parasympatholytics|parasympatholytics|mesh-ancestor
24820465|NCT02099695|Autonomic Agents|autonomic agents|mesh-ancestor
24820466|NCT02099695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24409099|NCT00180908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24409101|NCT00180908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409102|NCT00180908|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24820524|NCT02099890|Protective Agents|protective agents|mesh-ancestor
24820525|NCT02099916|Menotropins|menotropins|mesh-list
24820526|NCT02099916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820527|NCT02099916|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24820528|NCT02099916|Fertility Agents|fertility agents|mesh-ancestor
24820529|NCT02099916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24820530|NCT02099955|Vitamin D|vitamin d|mesh-list
24820531|NCT02099955|Cholecalciferol|cholecalciferol|mesh-list
24409133|NCT00180960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24409134|NCT00180960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542038|NCT00676533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24542040|NCT00676533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409173|NCT00181181|Antimetabolites|antimetabolites|mesh-ancestor
24542078|NCT00676741|Insulin, Long-Acting|insulin, long-acting|mesh-list
24542079|NCT00676741|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24409186|NCT00181220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24409281|NCT00181675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409187|NCT00181220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24409188|NCT00181220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24576428|NCT00838396|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24576429|NCT00838396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24576431|NCT00838396|GABA Agonists|gaba agonists|mesh-ancestor
24820612|NCT02100462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24820613|NCT02100462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820614|NCT02100462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24820615|NCT02100462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24820616|NCT02100462|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24667384|NCT05455697|Glucocorticoids|glucocorticoids|mesh-ancestor
24820617|NCT02100462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24820618|NCT02100462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820635|NCT02100553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24820636|NCT02100553|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24820637|NCT02100553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24820640|NCT02100553|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24820641|NCT02100553|Hormone Antagonists|hormone antagonists|mesh-ancestor
24820642|NCT02100553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24820643|NCT02100553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820644|NCT02100553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24820645|NCT02100605|Nasal Decongestants|nasal decongestants|mesh-list
24820646|NCT02100605|Pseudoephedrine|pseudoephedrine|mesh-list
24820647|NCT02100605|Ephedrine|ephedrine|mesh-list
24409221|NCT00181532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24820677|NCT02100852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24820678|NCT02100852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24820679|NCT02100852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24820680|NCT02100852|Alkylating Agents|alkylating agents|mesh-ancestor
24576495|NCT00838955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24576496|NCT00838955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409264|NCT00181636|Autonomic Agents|autonomic agents|mesh-ancestor
24409265|NCT00181636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24409266|NCT00181636|Nootropic Agents|nootropic agents|mesh-ancestor
24409268|NCT00181662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24409269|NCT00181662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24409271|NCT00181662|Sensory System Agents|sensory system agents|mesh-ancestor
24409272|NCT00181662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24409273|NCT00181662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409274|NCT00181662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24409275|NCT00181662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24409276|NCT00181662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409277|NCT00181662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409278|NCT00181662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409279|NCT00181675|Galantamine|galantamine|mesh-list
24409280|NCT00181675|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24409282|NCT00181675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409283|NCT00181675|Cholinergic Agents|cholinergic agents|mesh-ancestor
24820713|NCT02101138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820714|NCT02101138|Protective Agents|protective agents|mesh-ancestor
24820715|NCT02101138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820716|NCT02101138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24820717|NCT02101138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24820718|NCT02101138|Dopamine Agonists|dopamine agonists|mesh-ancestor
24820719|NCT02101138|Dopamine Agents|dopamine agents|mesh-ancestor
24409369|NCT00181870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24409371|NCT00181896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24409372|NCT00181896|Antidepressive Agents|antidepressive agents|mesh-ancestor
24409373|NCT00181896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24409374|NCT00181896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24409375|NCT00181896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24409403|NCT00181935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24409404|NCT00181935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24409405|NCT00181935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24409406|NCT00181935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24409407|NCT00181935|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24409408|NCT00181935|Dopamine Agents|dopamine agents|mesh-ancestor
24409416|NCT00181948|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24409417|NCT00181948|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24409418|NCT00181948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24409419|NCT00181948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24409420|NCT00181948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409421|NCT00181948|Adrenergic Agents|adrenergic agents|mesh-ancestor
24409422|NCT00181948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24542103|NCT00676936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24542104|NCT00676936|Prednisolone phosphate|prednisolone phosphate|mesh-list
24542105|NCT00676936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24542106|NCT00676936|Antiemetics|antiemetics|mesh-ancestor
24409449|NCT00182013|Dopamine Agents|dopamine agents|mesh-ancestor
24409450|NCT00182013|Antiemetics|antiemetics|mesh-ancestor
24409451|NCT00182013|Autonomic Agents|autonomic agents|mesh-ancestor
24409452|NCT00182013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24409453|NCT00182013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24409454|NCT00182013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24409455|NCT00182013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24820731|NCT02101164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820732|NCT02101203|Buspirone|buspirone|mesh-list
24820733|NCT02101203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24820734|NCT02101203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24820735|NCT02101203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24820736|NCT02101203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820742|NCT02101216|Abacavir|abacavir|mesh-list
24542107|NCT00676936|Autonomic Agents|autonomic agents|mesh-ancestor
24542108|NCT00676936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24409490|NCT00182221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24409491|NCT00182221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409492|NCT00182221|Hemostatics|hemostatics|mesh-ancestor
24409493|NCT00182221|Coagulants|coagulants|mesh-ancestor
24409494|NCT00182260|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24820761|NCT02101476|Acetaminophen|acetaminophen|mesh-list
24820762|NCT02101476|Oxycodone|oxycodone|mesh-list
24820763|NCT02101476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24409503|NCT00182312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409504|NCT00182312|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24409505|NCT00182312|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24409506|NCT00182312|Purinergic Agents|purinergic agents|mesh-ancestor
24409507|NCT00182312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24409508|NCT00182351|Fibrin fragment D|fibrin fragment d|mesh-list
24409509|NCT00182351|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24409510|NCT00182351|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24409533|NCT00182429|Antitubercular Agents|antitubercular agents|mesh-ancestor
24409534|NCT00182429|Leprostatic Agents|leprostatic agents|mesh-ancestor
24409535|NCT00182429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24409536|NCT00182429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409648|NCT00182663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24409649|NCT00182663|Antiemetics|antiemetics|mesh-ancestor
24820795|NCT02101840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24820796|NCT02101840|Narcotics|narcotics|mesh-ancestor
24820797|NCT02101840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24820798|NCT02101840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820799|NCT02101840|Analgesics|analgesics|mesh-ancestor
24820800|NCT02101840|Sensory System Agents|sensory system agents|mesh-ancestor
24820801|NCT02101840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24820802|NCT02101892|Amitriptyline|amitriptyline|mesh-list
24820833|NCT02102139|Propofol|propofol|mesh-list
24820891|NCT02102516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820894|NCT02102555|Analgesics|analgesics|mesh-ancestor
24820895|NCT02102555|Sensory System Agents|sensory system agents|mesh-ancestor
24820896|NCT02102555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24820897|NCT02102555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24820898|NCT02102555|Antipyretics|antipyretics|mesh-ancestor
24820899|NCT02102594|Bortezomib|bortezomib|mesh-list
24820900|NCT02102594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24820901|NCT02102620|Lidocaine|lidocaine|mesh-list
24820911|NCT02102620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24820912|NCT02102620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24820914|NCT02102633|Antithrombins|antithrombins|mesh-ancestor
24820915|NCT02102633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24820916|NCT02102633|Protease Inhibitors|protease inhibitors|mesh-ancestor
24542191|NCT00677443|Oxaliplatin|oxaliplatin|mesh-list
24820917|NCT02102633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24542205|NCT00677521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542206|NCT00677521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24542207|NCT00677521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542209|NCT00677664|Mannitol|mannitol|mesh-list
24409914|NCT00183859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24409915|NCT00183859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409916|NCT00183859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542210|NCT00677664|(T,G)-A-L|(t,g)-a-l|mesh-list
24542217|NCT00677664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24451880|NCT00325026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24409957|NCT00183924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24409958|NCT00183937|Docetaxel|docetaxel|mesh-list
24409959|NCT00183937|Bortezomib|bortezomib|mesh-list
24409960|NCT00183937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409965|NCT00183950|Noscapine|noscapine|mesh-list
24821026|NCT02103049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24821027|NCT02103166|Scopolamine|scopolamine|mesh-list
24821028|NCT02103166|Bromides|bromides|mesh-list
25406101|NCT03579472|Antimitotic Agents|antimitotic agents|mesh-ancestor
24410337|NCT00185107|Antimetabolites|antimetabolites|mesh-ancestor
24410458|NCT00185419|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24410459|NCT00185419|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24410460|NCT00185419|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24410461|NCT00185419|Contraceptive Agents|contraceptive agents|mesh-ancestor
24410462|NCT00185419|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24410555|NCT00185952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24410556|NCT00185952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410557|NCT00185952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24410558|NCT00185952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821216|NCT02103881|Haloperidol|haloperidol|mesh-list
24821217|NCT02103881|Haloperidol decanoate|haloperidol decanoate|mesh-list
24821218|NCT02103881|Analgesics|analgesics|mesh-ancestor
24821219|NCT02103881|Sensory System Agents|sensory system agents|mesh-ancestor
24821220|NCT02103881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24821221|NCT02103881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821222|NCT02103881|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24683528|NCT01392768|Levetiracetam|levetiracetam|mesh-list
24410690|NCT00186966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410691|NCT00186966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24410692|NCT00186966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24410693|NCT00186966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24410694|NCT00186966|Antimetabolites|antimetabolites|mesh-ancestor
24821327|NCT02104648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24821328|NCT02104648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24821329|NCT02104648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24821330|NCT02104648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24821331|NCT02104648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24821332|NCT02104648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821333|NCT02104648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24821334|NCT02104648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24821335|NCT02104648|Contraceptive Agents|contraceptive agents|mesh-ancestor
24410814|NCT00187057|Dermatologic Agents|dermatologic agents|mesh-ancestor
24410815|NCT00187057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24410816|NCT00187057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24821345|NCT02104661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24411001|NCT00187174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24411002|NCT00187174|Immunologic Factors|immunologic factors|mesh-ancestor
24411003|NCT00187174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411004|NCT00187330|Acetylcysteine|acetylcysteine|mesh-list
24411005|NCT00187330|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24411006|NCT00187330|Antiviral Agents|antiviral agents|mesh-ancestor
24411008|NCT00187330|Expectorants|expectorants|mesh-ancestor
24411054|NCT00187525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24542626|NCT00679614|Sensory System Agents|sensory system agents|mesh-ancestor
24542627|NCT00679614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24542628|NCT00679614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821592|NCT02106650|Protective Agents|protective agents|mesh-ancestor
24821593|NCT02106650|Vitamin B Complex|vitamin b complex|mesh-ancestor
25406102|NCT03579472|Mitosis Modulators|mitosis modulators|mesh-ancestor
25707819|NCT02238483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25707820|NCT02238483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25707821|NCT02238483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707822|NCT02238626|Ibudilast|ibudilast|mesh-list
25707823|NCT02238626|Riluzole|riluzole|mesh-list
25707824|NCT02238626|Anticonvulsants|anticonvulsants|mesh-ancestor
25707825|NCT02238626|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25707826|NCT02238626|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25707827|NCT02238626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707828|NCT02238626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707829|NCT02238626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707830|NCT02238626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24411861|NCT00190294|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24411862|NCT00190294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24411863|NCT00190294|Oxytocics|oxytocics|mesh-ancestor
24821751|NCT02107729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24821752|NCT02107729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641561|NCT01174290|Haloperidol|haloperidol|mesh-list
24821754|NCT02107729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24542853|NCT00680563|Epoetin Alfa|epoetin alfa|mesh-list
24411926|NCT00190437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24411927|NCT00190463|Amphotericin B|amphotericin b|mesh-list
24542854|NCT00680563|Hematinics|hematinics|mesh-ancestor
24411929|NCT00190463|Amebicides|amebicides|mesh-ancestor
24412209|NCT00190970|Ruboxistaurin|ruboxistaurin|mesh-list
24412210|NCT00190970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412248|NCT00191035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24821835|NCT02108353|Melatonin|melatonin|mesh-list
24412529|NCT00191555|Serotonin Agents|serotonin agents|mesh-ancestor
24412530|NCT00191555|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24412531|NCT00191555|Dopamine Agents|dopamine agents|mesh-ancestor
24412532|NCT00191555|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24412534|NCT00191568|Oxaliplatin|oxaliplatin|mesh-list
24412535|NCT00191568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24412536|NCT00191568|Antimetabolites|antimetabolites|mesh-ancestor
24412537|NCT00191568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821938|NCT02108808|Purinergic Agents|purinergic agents|mesh-ancestor
24821939|NCT02108808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24821940|NCT02108808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24821941|NCT02108808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821942|NCT02108847|Ropivacaine|ropivacaine|mesh-list
24412696|NCT00191828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24821977|NCT02109289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24821978|NCT02109289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24821979|NCT02109289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24821980|NCT02109289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24821981|NCT02109289|Immunologic Factors|immunologic factors|mesh-ancestor
24821982|NCT02109315|Ascorbic Acid|ascorbic acid|mesh-list
24821983|NCT02109315|Liraglutide|liraglutide|mesh-list
24821984|NCT02109315|Vitamins|vitamins|mesh-ancestor
24821985|NCT02109315|Micronutrients|micronutrients|mesh-ancestor
24821986|NCT02109315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24821988|NCT02109315|Incretins|incretins|mesh-ancestor
24822013|NCT02109510|Dexmedetomidine|dexmedetomidine|mesh-list
24822015|NCT02109510|Anesthetics|anesthetics|mesh-list
24822016|NCT02109510|Propofol|propofol|mesh-list
24822017|NCT02109510|Sevoflurane|sevoflurane|mesh-list
24412730|NCT00191919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412731|NCT00191919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412732|NCT00191919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412733|NCT00191919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412734|NCT00191919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412735|NCT00191919|Analgesics|analgesics|mesh-ancestor
24412736|NCT00191919|Sensory System Agents|sensory system agents|mesh-ancestor
24412737|NCT00191919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24412738|NCT00191919|Antidepressive Agents|antidepressive agents|mesh-ancestor
24412739|NCT00191919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24412740|NCT00191919|Dopamine Agents|dopamine agents|mesh-ancestor
24412921|NCT00192660|Efavirenz|efavirenz|mesh-list
24412922|NCT00192660|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24412923|NCT00192660|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24412924|NCT00192660|Protease Inhibitors|protease inhibitors|mesh-ancestor
24412925|NCT00192660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412926|NCT00192660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412927|NCT00192660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24412928|NCT00192660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24412929|NCT00192660|Antiviral Agents|antiviral agents|mesh-ancestor
24412930|NCT00192660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24412931|NCT00192660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24412932|NCT00192660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24412933|NCT00192660|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24412934|NCT00192660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24412935|NCT00192660|Antimetabolites|antimetabolites|mesh-ancestor
24412936|NCT00192660|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24412937|NCT00192660|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24412941|NCT00192660|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24822021|NCT02109510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822022|NCT02109510|Sensory System Agents|sensory system agents|mesh-ancestor
24642320|NCT01178996|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24822023|NCT02109510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24822024|NCT02109510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24822025|NCT02109510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24822026|NCT02109510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24543068|NCT00681876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543069|NCT00681876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24413093|NCT00193102|Growth Substances|growth substances|mesh-ancestor
24413094|NCT00193102|Growth Inhibitors|growth inhibitors|mesh-ancestor
24413095|NCT00193115|Cyclophosphamide|cyclophosphamide|mesh-list
24413251|NCT00193362|Paclitaxel|paclitaxel|mesh-list
24413262|NCT00193362|Antiviral Agents|antiviral agents|mesh-ancestor
24413288|NCT00193466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24413289|NCT00193466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413290|NCT00193466|Immunologic Factors|immunologic factors|mesh-ancestor
24413291|NCT00193466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413292|NCT00193466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24413294|NCT00193505|Carboplatin|carboplatin|mesh-list
24413512|NCT00194064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24413513|NCT00194064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24413514|NCT00194064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24413515|NCT00194064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24413516|NCT00194064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24413517|NCT00194064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24413519|NCT00194064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24822090|NCT02109783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24822091|NCT02109783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822095|NCT02109783|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24822097|NCT02109783|Purinergic Agents|purinergic agents|mesh-ancestor
24413534|NCT00194272|Methotrexate|methotrexate|mesh-list
24413535|NCT00194272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24413536|NCT00194272|Abortifacient Agents|abortifacient agents|mesh-ancestor
24413537|NCT00194272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24413568|NCT00194402|Atorvastatin|atorvastatin|mesh-list
24413571|NCT00194402|Antimetabolites|antimetabolites|mesh-ancestor
24822125|NCT02109913|Exemestane|exemestane|mesh-list
24822126|NCT02109913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822127|NCT02109913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24822128|NCT02109913|Immunologic Factors|immunologic factors|mesh-ancestor
24822129|NCT02109913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822130|NCT02109913|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24413609|NCT00194649|Miglustat|miglustat|mesh-list
24413626|NCT00194727|Tubulin Modulators|tubulin modulators|mesh-ancestor
24413627|NCT00194727|Antimitotic Agents|antimitotic agents|mesh-ancestor
24413628|NCT00194727|Mitosis Modulators|mitosis modulators|mesh-ancestor
24413629|NCT00194740|Docetaxel|docetaxel|mesh-list
24413630|NCT00194740|Vinorelbine|vinorelbine|mesh-list
24413631|NCT00194740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413632|NCT00194740|Tubulin Modulators|tubulin modulators|mesh-ancestor
24413633|NCT00194740|Antimitotic Agents|antimitotic agents|mesh-ancestor
24413634|NCT00194740|Mitosis Modulators|mitosis modulators|mesh-ancestor
24413635|NCT00194740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707831|NCT02238626|Protective Agents|protective agents|mesh-ancestor
24413637|NCT00194753|Paclitaxel|paclitaxel|mesh-list
24413691|NCT00194948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24413692|NCT00194948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24413693|NCT00194948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413694|NCT00194948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24413695|NCT00194948|Serotonin Agents|serotonin agents|mesh-ancestor
24413701|NCT00194961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24413702|NCT00194961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413713|NCT00194974|Autonomic Agents|autonomic agents|mesh-ancestor
24413735|NCT00195000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413737|NCT00195000|Antiviral Agents|antiviral agents|mesh-ancestor
24413738|NCT00195000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24413739|NCT00195000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24413740|NCT00195000|Immunologic Factors|immunologic factors|mesh-ancestor
24413741|NCT00195000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413742|NCT00195000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24413744|NCT00195078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413745|NCT00195078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24413746|NCT00195078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413747|NCT00195078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413748|NCT00195104|Cytarabine|cytarabine|mesh-list
24413749|NCT00195104|Arsenic Trioxide|arsenic trioxide|mesh-list
24413750|NCT00195104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24413752|NCT00195104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413768|NCT00195156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24413769|NCT00195156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24413771|NCT00195195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24413824|NCT00195377|Analgesics|analgesics|mesh-ancestor
24413847|NCT00195416|Immunologic Factors|immunologic factors|mesh-ancestor
24413848|NCT00195455|Estradiol|estradiol|mesh-list
24413849|NCT00195455|Estrogens|estrogens|mesh-ancestor
24413850|NCT00195455|Hormones|hormones|mesh-ancestor
24413851|NCT00195455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24413852|NCT00195455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413853|NCT00195468|Cyclosporine|cyclosporine|mesh-list
24413895|NCT00195559|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24413897|NCT00195572|Levoleucovorin|levoleucovorin|mesh-list
24413898|NCT00195572|Antidotes|antidotes|mesh-ancestor
24413899|NCT00195572|Protective Agents|protective agents|mesh-ancestor
24413900|NCT00195572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413901|NCT00195572|Vitamin B Complex|vitamin b complex|mesh-ancestor
24413902|NCT00195572|Vitamins|vitamins|mesh-ancestor
24413903|NCT00195572|Micronutrients|micronutrients|mesh-ancestor
24413904|NCT00195585|Leucovorin|leucovorin|mesh-list
24413905|NCT00195585|Levoleucovorin|levoleucovorin|mesh-list
24413906|NCT00195585|Antidotes|antidotes|mesh-ancestor
24414026|NCT00195806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24414028|NCT00195845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24414029|NCT00195845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414030|NCT00195845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414031|NCT00195845|Cholinergic Agents|cholinergic agents|mesh-ancestor
24414034|NCT00195845|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24414035|NCT00195845|Autonomic Agents|autonomic agents|mesh-ancestor
24414036|NCT00195845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24414037|NCT00195845|Nootropic Agents|nootropic agents|mesh-ancestor
24414077|NCT00195871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24414079|NCT00195910|Hydromorphone|hydromorphone|mesh-list
24822210|NCT02110459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24822211|NCT02110524|Paclitaxel|paclitaxel|mesh-list
24822212|NCT02110524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24822213|NCT02110524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25707832|NCT02238626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25707833|NCT02238626|Autonomic Agents|autonomic agents|mesh-ancestor
25707834|NCT02238626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25707835|NCT02238626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25707836|NCT02238626|Respiratory System Agents|respiratory system agents|mesh-ancestor
25707837|NCT02238626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25707838|NCT02238626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25707840|NCT02238626|Vasodilator Agents|vasodilator agents|mesh-ancestor
25707841|NCT02238977|Bupropion|bupropion|mesh-list
25707842|NCT02238977|Fluoxetine|fluoxetine|mesh-list
25707843|NCT02238977|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24471360|NCT00394810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471362|NCT00394966|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24471364|NCT00394966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471365|NCT00394966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471366|NCT00394992|Bevacizumab|bevacizumab|mesh-list
24471367|NCT00394992|Capecitabine|capecitabine|mesh-list
24822214|NCT02110524|Tubulin Modulators|tubulin modulators|mesh-ancestor
24822218|NCT02110537|Flecainide|flecainide|mesh-list
24822298|NCT02110810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543397|NCT00683436|Adipiplon|adipiplon|mesh-list
24822320|NCT02110966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543398|NCT00683436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24543399|NCT00683436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543400|NCT00683436|GABA Agonists|gaba agonists|mesh-ancestor
24543401|NCT00683436|GABA Agents|gaba agents|mesh-ancestor
24543402|NCT00683436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24822321|NCT02110966|Analgesics|analgesics|mesh-ancestor
24822326|NCT02110992|Docetaxel|docetaxel|mesh-list
24414276|NCT00196690|Cholinergic Agents|cholinergic agents|mesh-ancestor
24414277|NCT00196690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24414278|NCT00196690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414297|NCT00196768|Arsenic Trioxide|arsenic trioxide|mesh-list
24414298|NCT00196768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24414299|NCT00196820|Capecitabine|capecitabine|mesh-list
24414300|NCT00196820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24414417|NCT00197548|Vitamins|vitamins|mesh-ancestor
24414418|NCT00197548|Micronutrients|micronutrients|mesh-ancestor
24822477|NCT02112097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24822333|NCT02111044|Somatostatin|somatostatin|mesh-list
24822334|NCT02111044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24822335|NCT02111044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24822336|NCT02111044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822337|NCT02111044|Hormones|hormones|mesh-ancestor
24822338|NCT02111044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24822339|NCT02111044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822340|NCT02111122|Sodium Oxybate|sodium oxybate|mesh-list
24822341|NCT02111122|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24822342|NCT02111122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24822343|NCT02111122|Anesthetics, General|anesthetics, general|mesh-ancestor
24414421|NCT00197561|Selenium|selenium|mesh-list
24543471|NCT00683943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24414465|NCT00197639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414466|NCT00197639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822394|NCT02111421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24822395|NCT02111421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822396|NCT02111434|Testosterone|testosterone|mesh-list
24414499|NCT00197821|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24414500|NCT00197821|Immunologic Factors|immunologic factors|mesh-ancestor
24414501|NCT00197821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414503|NCT00197834|Anticonvulsants|anticonvulsants|mesh-ancestor
24414504|NCT00197834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25707844|NCT02238977|Antidepressive Agents|antidepressive agents|mesh-ancestor
25707845|NCT02238977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25707846|NCT02238977|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25707847|NCT02238977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25707848|NCT02238977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25707849|NCT02238977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707850|NCT02238977|Dopamine Agents|dopamine agents|mesh-ancestor
25406178|NCT03575403|Analgesics|analgesics|mesh-ancestor
24822450|NCT02111928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24414776|NCT00198614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24822463|NCT02112032|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24414777|NCT00198614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24414778|NCT00198614|Adrenergic Agents|adrenergic agents|mesh-ancestor
24543536|NCT00684164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414859|NCT00198978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24414860|NCT00198978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24414861|NCT00198978|Tubulin Modulators|tubulin modulators|mesh-ancestor
24822474|NCT02112097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24822475|NCT02112097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822476|NCT02112097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24414937|NCT00199004|Alkylating Agents|alkylating agents|mesh-ancestor
24414938|NCT00199004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414939|NCT00199004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24414940|NCT00199004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24414941|NCT00199004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24415010|NCT00199017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24415011|NCT00199017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24415012|NCT00199017|Tubulin Modulators|tubulin modulators|mesh-ancestor
24822478|NCT02112097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24578568|NCT00849550|Growth Substances|growth substances|mesh-ancestor
24822479|NCT02112097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24822480|NCT02112097|Immunologic Factors|immunologic factors|mesh-ancestor
24822482|NCT02112162|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24822483|NCT02112162|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24822484|NCT02112162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822485|NCT02112162|Antimetabolites|antimetabolites|mesh-ancestor
24822486|NCT02112162|Antiviral Agents|antiviral agents|mesh-ancestor
24822487|NCT02112162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24822488|NCT02112175|Lenalidomide|lenalidomide|mesh-list
24822489|NCT02112175|Immunologic Factors|immunologic factors|mesh-ancestor
24822490|NCT02112175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822491|NCT02112175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24822492|NCT02112175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24822493|NCT02112175|Growth Substances|growth substances|mesh-ancestor
24822494|NCT02112175|Growth Inhibitors|growth inhibitors|mesh-ancestor
25707851|NCT02238977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707852|NCT02238977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707853|NCT02238977|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25707854|NCT02238977|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25707855|NCT02238977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25707856|NCT02238977|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25707857|NCT02238977|Serotonin Agents|serotonin agents|mesh-ancestor
25707858|NCT02239094|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
24822495|NCT02112175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822498|NCT02112214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415020|NCT00199030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24415021|NCT00199030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415022|NCT00199030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24822526|NCT02112305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24822527|NCT02112305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822528|NCT02112305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24822529|NCT02112305|Tocolytic Agents|tocolytic agents|mesh-ancestor
24686988|NCT04454203|Anesthetics|anesthetics|mesh-list
24415080|NCT00199056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24415081|NCT00199056|Tubulin Modulators|tubulin modulators|mesh-ancestor
24822571|NCT02112578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24822572|NCT02112578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415269|NCT00199147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415271|NCT00199147|Immunologic Factors|immunologic factors|mesh-ancestor
24415272|NCT00199147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415273|NCT00199147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24415429|NCT00199446|Istradefylline|istradefylline|mesh-list
24415430|NCT00199446|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
24415431|NCT00199446|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24415432|NCT00199446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24415433|NCT00199446|Purinergic Agents|purinergic agents|mesh-ancestor
24415434|NCT00199446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24415480|NCT00199667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24415481|NCT00199667|Antitubercular Agents|antitubercular agents|mesh-ancestor
24415482|NCT00199667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24415483|NCT00199667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24415484|NCT00199667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24415485|NCT00199667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415487|NCT00199719|Antimetabolites|antimetabolites|mesh-ancestor
24415598|NCT00200226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24415599|NCT00200226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24415600|NCT00200226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24415631|NCT00200421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24415633|NCT00200434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24415634|NCT00200434|Vasodilator Agents|vasodilator agents|mesh-ancestor
24415635|NCT00200434|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24415636|NCT00200434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24415637|NCT00200434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24415846|NCT00201318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24415847|NCT00201318|Tubulin Modulators|tubulin modulators|mesh-ancestor
24415848|NCT00201318|Antimitotic Agents|antimitotic agents|mesh-ancestor
24415849|NCT00201318|Mitosis Modulators|mitosis modulators|mesh-ancestor
24415850|NCT00201318|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24415851|NCT00201318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24415852|NCT00201318|Antiviral Agents|antiviral agents|mesh-ancestor
24822669|NCT02112916|2-Aminopurine|2-aminopurine|mesh-list
24822670|NCT02112916|Levoleucovorin|levoleucovorin|mesh-list
24822750|NCT02113150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822751|NCT02113150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24822752|NCT02113150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24822753|NCT02113150|Anesthetics, General|anesthetics, general|mesh-ancestor
24822754|NCT02113150|Anesthetics|anesthetics|mesh-ancestor
24417616|NCT00206947|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24822755|NCT02113150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24822756|NCT02113150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24822757|NCT02113150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24822758|NCT02113150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24822759|NCT02113150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822760|NCT02113150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24822762|NCT02113176|Minocycline|minocycline|mesh-list
24416569|NCT00203385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24822780|NCT02113319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24822781|NCT02113319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822782|NCT02113332|Liraglutide|liraglutide|mesh-list
24822783|NCT02113332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24416629|NCT00203606|Ribavirin|ribavirin|mesh-list
24416630|NCT00203606|Interferon-alpha|interferon-alpha|mesh-list
24416631|NCT00203606|Interferon alpha-2|interferon alpha-2|mesh-list
24416632|NCT00203606|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24416633|NCT00203606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24416634|NCT00203606|Antiviral Agents|antiviral agents|mesh-ancestor
24416635|NCT00203606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24416636|NCT00203606|Antimetabolites|antimetabolites|mesh-ancestor
24416637|NCT00203606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416638|NCT00203606|Immunologic Factors|immunologic factors|mesh-ancestor
24416639|NCT00203606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822784|NCT02113332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822785|NCT02113332|Incretins|incretins|mesh-ancestor
24822786|NCT02113332|Hormones|hormones|mesh-ancestor
24822788|NCT02113397|Tobramycin|tobramycin|mesh-list
24416677|NCT00203736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24416678|NCT00203736|Antiviral Agents|antiviral agents|mesh-ancestor
24416679|NCT00203736|Schistosomicides|schistosomicides|mesh-ancestor
24416680|NCT00203736|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24416681|NCT00203736|Anthelmintics|anthelmintics|mesh-ancestor
24416682|NCT00203736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24416683|NCT00203736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416686|NCT00203736|Renal Agents|renal agents|mesh-ancestor
24822811|NCT02113566|Sensory System Agents|sensory system agents|mesh-ancestor
24822812|NCT02113566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24822813|NCT02113566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822814|NCT02113566|Antipyretics|antipyretics|mesh-ancestor
24822815|NCT02113631|Interferons|interferons|mesh-list
24822816|NCT02113631|Ribavirin|ribavirin|mesh-list
24822817|NCT02113631|Interferon-alpha|interferon-alpha|mesh-list
24822818|NCT02113631|Interferon alpha-2|interferon alpha-2|mesh-list
24822819|NCT02113631|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24822820|NCT02113631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24822821|NCT02113631|Antiviral Agents|antiviral agents|mesh-ancestor
24416781|NCT00204022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24416782|NCT00204022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24416783|NCT00204022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24416784|NCT00204022|Antitubercular Agents|antitubercular agents|mesh-ancestor
24416785|NCT00204022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24416786|NCT00204022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24416787|NCT00204022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416860|NCT00204308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24416861|NCT00204308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417018|NCT00204737|Glucocorticoids|glucocorticoids|mesh-ancestor
24417019|NCT00204737|Hormones|hormones|mesh-ancestor
24417020|NCT00204737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24417021|NCT00204737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417022|NCT00204737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24417036|NCT00204789|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
24417038|NCT00204789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417039|NCT00204893|Calcium|calcium|mesh-list
24417042|NCT00204906|Vitamin D|vitamin d|mesh-list
24417098|NCT00205322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24417099|NCT00205322|Antimetabolites|antimetabolites|mesh-ancestor
24417100|NCT00205322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417101|NCT00205322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417102|NCT00205322|Antidotes|antidotes|mesh-ancestor
24417103|NCT00205322|Protective Agents|protective agents|mesh-ancestor
24417104|NCT00205322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417106|NCT00205322|Vitamins|vitamins|mesh-ancestor
24417284|NCT00206154|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24417285|NCT00206154|Respiratory System Agents|respiratory system agents|mesh-ancestor
24822932|NCT02114346|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24822933|NCT02114346|Antimetabolites|antimetabolites|mesh-ancestor
24688460|NCT03061643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417491|NCT00206622|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24417492|NCT00206622|Estrogens|estrogens|mesh-ancestor
24417623|NCT00206960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417624|NCT00206960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417625|NCT00206960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24417626|NCT00206960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24544246|NCT00688077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579123|NCT00853411|Hormones|hormones|mesh-ancestor
24688594|NCT02924064|Metformin|metformin|mesh-list
24417657|NCT00206999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417658|NCT00206999|Adrenergic Agents|adrenergic agents|mesh-ancestor
24417659|NCT00206999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24417660|NCT00206999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417661|NCT00207051|Cetuximab|cetuximab|mesh-list
24417694|NCT00207311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417695|NCT00207311|Antiviral Agents|antiviral agents|mesh-ancestor
24417696|NCT00207311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24417697|NCT00207311|Immunologic Factors|immunologic factors|mesh-ancestor
24417698|NCT00207311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544272|NCT00688272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24544273|NCT00688272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24822955|NCT02114463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24822956|NCT02114463|Sensory System Agents|sensory system agents|mesh-ancestor
24822957|NCT02114463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24417753|NCT00207558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417767|NCT00207675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24417769|NCT00207688|Dermatologic Agents|dermatologic agents|mesh-ancestor
24417771|NCT00207688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24417773|NCT00207701|Dermatologic Agents|dermatologic agents|mesh-ancestor
24417774|NCT00207701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24417775|NCT00207701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24417777|NCT00207753|Albendazole|albendazole|mesh-list
24417778|NCT00207753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24417864|NCT00208117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24418131|NCT00208702|Antidepressive Agents|antidepressive agents|mesh-ancestor
24418132|NCT00208702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24418133|NCT00208702|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24418134|NCT00208702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24418135|NCT00208702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24418136|NCT00208702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418186|NCT00208819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24418188|NCT00208819|Antidepressive Agents|antidepressive agents|mesh-ancestor
24418190|NCT00208819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24418214|NCT00208923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24418215|NCT00208923|Immunologic Factors|immunologic factors|mesh-ancestor
24822991|NCT02114502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24822992|NCT02114502|Antiviral Agents|antiviral agents|mesh-ancestor
24822993|NCT02114502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24822994|NCT02114502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24822995|NCT02114502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24822996|NCT02114502|Immunologic Factors|immunologic factors|mesh-ancestor
24822997|NCT02114502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24822998|NCT02114502|Alkylating Agents|alkylating agents|mesh-ancestor
24823002|NCT02114502|Vitamins|vitamins|mesh-ancestor
24418319|NCT00209222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418320|NCT00209222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24418321|NCT00209222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24823003|NCT02114502|Micronutrients|micronutrients|mesh-ancestor
24823004|NCT02114528|Amiodarone|amiodarone|mesh-list
24823005|NCT02114528|Sotalol|sotalol|mesh-list
24823006|NCT02114528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
24823007|NCT02114528|Mexiletine|mexiletine|mesh-list
24823008|NCT02114528|Procainamide|procainamide|mesh-list
24823009|NCT02114528|Vasodilator Agents|vasodilator agents|mesh-ancestor
24418322|NCT00209222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24418323|NCT00209222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24418324|NCT00209222|Antiemetics|antiemetics|mesh-ancestor
24418325|NCT00209222|Autonomic Agents|autonomic agents|mesh-ancestor
24823012|NCT02114528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823013|NCT02114528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24823014|NCT02114528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24823015|NCT02114528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24823016|NCT02114528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823017|NCT02114528|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24689129|NCT02299999|Antiviral Agents|antiviral agents|mesh-ancestor
24418425|NCT00209612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24418426|NCT00209612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24418427|NCT00209612|Tubulin Modulators|tubulin modulators|mesh-ancestor
24418428|NCT00209612|Antimitotic Agents|antimitotic agents|mesh-ancestor
24418446|NCT00209625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24418589|NCT00209807|Antidepressive Agents|antidepressive agents|mesh-ancestor
24418590|NCT00209807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24418591|NCT00209807|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24418592|NCT00209807|Adrenergic Agents|adrenergic agents|mesh-ancestor
24418593|NCT00209833|Cytarabine|cytarabine|mesh-list
24418594|NCT00209833|Fludarabine|fludarabine|mesh-list
24418595|NCT00209833|Etoposide|etoposide|mesh-list
24418596|NCT00209833|Idarubicin|idarubicin|mesh-list
24418597|NCT00209833|Daunorubicin|daunorubicin|mesh-list
24418598|NCT00209833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24418599|NCT00209833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24418650|NCT00209872|Lidocaine|lidocaine|mesh-list
24418716|NCT00209924|Analgesics|analgesics|mesh-ancestor
24418717|NCT00209924|Sensory System Agents|sensory system agents|mesh-ancestor
24418718|NCT00209924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24418719|NCT00209924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420696|NCT00216580|Dopamine Agents|dopamine agents|mesh-ancestor
24419086|NCT00211198|Denileukin diftitox|denileukin diftitox|mesh-list
24419087|NCT00211198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419088|NCT00211224|Riluzole|riluzole|mesh-list
24419089|NCT00211224|Anticonvulsants|anticonvulsants|mesh-ancestor
24419090|NCT00211224|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24419091|NCT00211224|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24419092|NCT00211224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24419262|NCT00211562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24419263|NCT00211562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419474|NCT00212173|Antidepressive Agents|antidepressive agents|mesh-ancestor
24419475|NCT00212173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24419510|NCT00212277|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24419511|NCT00212277|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24419514|NCT00212290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24419515|NCT00212290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419516|NCT00212316|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
24419517|NCT00212316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823118|NCT02115152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24823119|NCT02115152|Antimetabolites|antimetabolites|mesh-ancestor
24823120|NCT02115152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24823121|NCT02115152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24823126|NCT02115204|Docetaxel|docetaxel|mesh-list
24419601|NCT00213070|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24419602|NCT00213096|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24419603|NCT00213096|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24419604|NCT00213096|Levonorgestrel|levonorgestrel|mesh-list
24420064|NCT00215046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420065|NCT00215046|Dermatologic Agents|dermatologic agents|mesh-ancestor
24420066|NCT00215046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420067|NCT00215046|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24420068|NCT00215046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24420069|NCT00215046|Immunologic Factors|immunologic factors|mesh-ancestor
24420070|NCT00215046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25707859|NCT02239094|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25707860|NCT02239094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25707861|NCT02239094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25707862|NCT02239094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707863|NCT02239094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24420071|NCT00215046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24420072|NCT00215046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24420073|NCT00215046|Tubulin Modulators|tubulin modulators|mesh-ancestor
24420074|NCT00215046|Antimitotic Agents|antimitotic agents|mesh-ancestor
24420075|NCT00215046|Mitosis Modulators|mitosis modulators|mesh-ancestor
24420077|NCT00215124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24420079|NCT00215124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420080|NCT00215163|Paroxetine|paroxetine|mesh-list
24420081|NCT00215163|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24420082|NCT00215163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24420083|NCT00215163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24420111|NCT00215228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823160|NCT02115360|Salmon calcitonin|salmon calcitonin|mesh-list
24708269|NCT01500863|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24823161|NCT02115360|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
24823163|NCT02115360|Katacalcin|katacalcin|mesh-list
24823164|NCT02115360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24823165|NCT02115360|Narcotics|narcotics|mesh-ancestor
24823166|NCT02115360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24823167|NCT02115360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823168|NCT02115360|Analgesics|analgesics|mesh-ancestor
24823169|NCT02115360|Sensory System Agents|sensory system agents|mesh-ancestor
24823170|NCT02115360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24823171|NCT02115360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24579439|NCT00855088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24823172|NCT02115360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24823173|NCT02115360|Anesthetics, General|anesthetics, general|mesh-ancestor
24823174|NCT02115360|Anesthetics|anesthetics|mesh-ancestor
24420397|NCT00215891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420589|NCT00216385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24420658|NCT00216528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24420659|NCT00216528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420660|NCT00216528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420661|NCT00216528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24420662|NCT00216528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24420663|NCT00216528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24420664|NCT00216528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24420665|NCT00216528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24420666|NCT00216528|Dopamine Agents|dopamine agents|mesh-ancestor
24420667|NCT00216541|Epoetin Alfa|epoetin alfa|mesh-list
24420668|NCT00216541|Hematinics|hematinics|mesh-ancestor
24420692|NCT00216580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24420693|NCT00216580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24420694|NCT00216580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24420695|NCT00216580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24420919|NCT00217243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420920|NCT00217282|Gemcitabine|gemcitabine|mesh-list
24420921|NCT00217282|Bevacizumab|bevacizumab|mesh-list
24420922|NCT00217282|Oxaliplatin|oxaliplatin|mesh-list
24420923|NCT00217282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24420924|NCT00217282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420925|NCT00217282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24420926|NCT00217282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24420927|NCT00217282|Growth Substances|growth substances|mesh-ancestor
24472213|NCT00398554|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24420928|NCT00217282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420929|NCT00217282|Growth Inhibitors|growth inhibitors|mesh-ancestor
24420930|NCT00217282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24420931|NCT00217282|Antimetabolites|antimetabolites|mesh-ancestor
24420933|NCT00217282|Antiviral Agents|antiviral agents|mesh-ancestor
24421079|NCT00217568|Docetaxel|docetaxel|mesh-list
24421080|NCT00217568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421081|NCT00217568|Tubulin Modulators|tubulin modulators|mesh-ancestor
24421082|NCT00217568|Antimitotic Agents|antimitotic agents|mesh-ancestor
24421083|NCT00217568|Mitosis Modulators|mitosis modulators|mesh-ancestor
24421084|NCT00217568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421085|NCT00217607|Paclitaxel|paclitaxel|mesh-list
24421086|NCT00217607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24421107|NCT00217659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24421109|NCT00217698|Gemcitabine|gemcitabine|mesh-list
24421110|NCT00217698|Gefitinib|gefitinib|mesh-list
24421111|NCT00217698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421112|NCT00217698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24421113|NCT00217698|Antimetabolites|antimetabolites|mesh-ancestor
24421114|NCT00217698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421115|NCT00217698|Antiviral Agents|antiviral agents|mesh-ancestor
24421116|NCT00217698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24421117|NCT00217698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708454|NCT01501396|Megestrol|megestrol|mesh-list
24644939|NCT01194037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708468|NCT01501396|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24708469|NCT01501396|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24708470|NCT01501396|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24708471|NCT01501396|Adrenergic Agents|adrenergic agents|mesh-ancestor
24421146|NCT00217828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24421147|NCT00217828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24421148|NCT00217828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24421149|NCT00217828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421150|NCT00217828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24421151|NCT00217828|Serotonin Agents|serotonin agents|mesh-ancestor
24421349|NCT00218348|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24421351|NCT00218361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24421352|NCT00218361|Narcotics|narcotics|mesh-ancestor
24421353|NCT00218361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24421354|NCT00218361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421384|NCT00218504|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24421410|NCT00218530|Adrenergic Agents|adrenergic agents|mesh-ancestor
24421428|NCT00218621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24421429|NCT00218621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421431|NCT00218621|Sensory System Agents|sensory system agents|mesh-ancestor
24823253|NCT02116010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24823254|NCT02116010|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24823255|NCT02116010|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24823256|NCT02116010|Coccidiostats|coccidiostats|mesh-ancestor
24823257|NCT02116010|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24823258|NCT02116036|Rivaroxaban|rivaroxaban|mesh-list
24823259|NCT02116036|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24823260|NCT02116036|Antithrombins|antithrombins|mesh-ancestor
24823261|NCT02116036|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24823262|NCT02116036|Protease Inhibitors|protease inhibitors|mesh-ancestor
24823263|NCT02116036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823264|NCT02116036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823265|NCT02116036|Anticoagulants|anticoagulants|mesh-ancestor
24421451|NCT00218855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24421452|NCT00218855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24421453|NCT00218855|Growth Substances|growth substances|mesh-ancestor
24421454|NCT00218855|Growth Inhibitors|growth inhibitors|mesh-ancestor
24421455|NCT00218855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421640|NCT00219778|Hormone Antagonists|hormone antagonists|mesh-ancestor
24421641|NCT00219778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24421642|NCT00219778|Luteolytic Agents|luteolytic agents|mesh-ancestor
24421643|NCT00219778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24421644|NCT00219778|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24421645|NCT00219804|Tetrabenazine|tetrabenazine|mesh-list
24823280|NCT02116348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823281|NCT02116348|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24823282|NCT02116348|Protective Agents|protective agents|mesh-ancestor
24823283|NCT02116348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823284|NCT02116348|Nootropic Agents|nootropic agents|mesh-ancestor
24421705|NCT00219921|Analgesics|analgesics|mesh-ancestor
24421712|NCT00219973|Anticoagulants|anticoagulants|mesh-ancestor
24421714|NCT00220051|Oxaliplatin|oxaliplatin|mesh-list
24421715|NCT00220051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24421716|NCT00220051|Antimetabolites|antimetabolites|mesh-ancestor
24421719|NCT00220064|Leucovorin|leucovorin|mesh-list
24421754|NCT00220129|Epirubicin|epirubicin|mesh-list
24421755|NCT00220129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421756|NCT00220129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24421757|NCT00220129|Antimetabolites|antimetabolites|mesh-ancestor
24421787|NCT00220194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24421788|NCT00220194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24421789|NCT00220194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421790|NCT00220220|Amlodipine|amlodipine|mesh-list
24421791|NCT00220220|Olmesartan|olmesartan|mesh-list
24421792|NCT00220220|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24421793|NCT00220220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24421794|NCT00220220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24421795|NCT00220220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24421796|NCT00220220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421809|NCT00220233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421813|NCT00220233|Diuretics|diuretics|mesh-ancestor
24421930|NCT00220649|Gemcitabine|gemcitabine|mesh-list
24421931|NCT00220649|Fluorouracil|fluorouracil|mesh-list
24421932|NCT00220649|Oxaliplatin|oxaliplatin|mesh-list
24421933|NCT00220649|Irinotecan|irinotecan|mesh-list
24421934|NCT00220649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24421935|NCT00220649|Antimetabolites|antimetabolites|mesh-ancestor
24823341|NCT02116790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823342|NCT02116790|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24823343|NCT02116790|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24823345|NCT02116790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24823346|NCT02116790|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24823347|NCT02116790|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24823348|NCT02116790|Immunologic Factors|immunologic factors|mesh-ancestor
24823349|NCT02116790|Dopamine Agonists|dopamine agonists|mesh-ancestor
24823351|NCT02116842|Bupivacaine|bupivacaine|mesh-list
24823352|NCT02116842|Anesthetics, Local|anesthetics, local|mesh-ancestor
24823353|NCT02116842|Anesthetics|anesthetics|mesh-ancestor
24823354|NCT02116842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24823355|NCT02116842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823356|NCT02116842|Sensory System Agents|sensory system agents|mesh-ancestor
24823357|NCT02116842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24421968|NCT00220818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24421969|NCT00220818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24421970|NCT00220818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24421971|NCT00220818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25707864|NCT02239094|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24421972|NCT00220818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422003|NCT00220896|Donepezil|donepezil|mesh-list
24422020|NCT00220922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24422021|NCT00220922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24422022|NCT00220922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422023|NCT00220987|Insulin|insulin|mesh-list
24422024|NCT00220987|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24422025|NCT00220987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24422026|NCT00220987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422027|NCT00221000|Methoxsalen|methoxsalen|mesh-list
24422031|NCT00221026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24422032|NCT00221026|Dermatologic Agents|dermatologic agents|mesh-ancestor
24422033|NCT00221039|Methoxsalen|methoxsalen|mesh-list
24422036|NCT00221052|Diclofenac|diclofenac|mesh-list
24422037|NCT00221052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24422038|NCT00221052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24422039|NCT00221052|Analgesics|analgesics|mesh-ancestor
24422040|NCT00221052|Sensory System Agents|sensory system agents|mesh-ancestor
24422041|NCT00221052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24823358|NCT02116842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24823359|NCT02116842|Narcotics|narcotics|mesh-ancestor
24823360|NCT02116842|Analgesics|analgesics|mesh-ancestor
24823361|NCT02116842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24422066|NCT00221286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24422067|NCT00221286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24422068|NCT00221286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422069|NCT00221286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422070|NCT00221286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24422071|NCT00221286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24422072|NCT00221286|Immunologic Factors|immunologic factors|mesh-ancestor
24422073|NCT00221286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422074|NCT00221312|Alendronate|alendronate|mesh-list
24422075|NCT00221312|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24422077|NCT00221325|Rituximab|rituximab|mesh-list
24422146|NCT00221481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24422147|NCT00221481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24422148|NCT00221481|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24422149|NCT00221481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24422150|NCT00221481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24422152|NCT00221481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24422328|NCT00222079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422331|NCT00222144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823411|NCT02117128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24422345|NCT00222183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24422465|NCT00222547|Micronutrients|micronutrients|mesh-ancestor
24422466|NCT00222547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422467|NCT00222547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823484|NCT02117583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707865|NCT02239094|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25707866|NCT02239094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25707867|NCT02239094|Adrenergic Agents|adrenergic agents|mesh-ancestor
25707868|NCT02239094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707869|NCT02239094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707870|NCT02239094|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24823551|NCT02117752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24823552|NCT02117752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24823553|NCT02117752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823554|NCT02117752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823558|NCT02117765|Dermatologic Agents|dermatologic agents|mesh-ancestor
24823560|NCT02117830|Enclomiphene|enclomiphene|mesh-list
24579806|NCT00857909|Amiloride|amiloride|mesh-list
24823561|NCT02117830|Clomiphene|clomiphene|mesh-list
24823562|NCT02117830|Zuclomiphene|zuclomiphene|mesh-list
24823563|NCT02117830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24823564|NCT02117830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24823565|NCT02117830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24823566|NCT02117830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24823567|NCT02117830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24823568|NCT02117830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823569|NCT02117830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823570|NCT02117830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24823571|NCT02117830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823572|NCT02117830|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24823573|NCT02117830|Hormone Antagonists|hormone antagonists|mesh-ancestor
24823586|NCT02117986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24823587|NCT02117986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24823588|NCT02118051|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24823589|NCT02118051|Progesterone|progesterone|mesh-list
24823591|NCT02118051|Progestins|progestins|mesh-ancestor
24823592|NCT02118051|Hormones|hormones|mesh-ancestor
24823593|NCT02118051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24823594|NCT02118051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422514|NCT00222677|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24422531|NCT00222820|Serotonin Agents|serotonin agents|mesh-ancestor
24422532|NCT00222820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422533|NCT00222820|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24422534|NCT00222820|Antidepressive Agents|antidepressive agents|mesh-ancestor
24422535|NCT00222820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24422537|NCT00222833|Antidepressive Agents|antidepressive agents|mesh-ancestor
24422587|NCT00223028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24422588|NCT00223028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24422589|NCT00223028|Antifungal Agents|antifungal agents|mesh-ancestor
24422590|NCT00223028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24422591|NCT00223028|Immunologic Factors|immunologic factors|mesh-ancestor
24422592|NCT00223028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422593|NCT00223054|Cyclosporine|cyclosporine|mesh-list
24422594|NCT00223054|Sirolimus|sirolimus|mesh-list
24422595|NCT00223054|Everolimus|everolimus|mesh-list
24422596|NCT00223054|Tacrolimus|tacrolimus|mesh-list
24422597|NCT00223054|Cyclosporins|cyclosporins|mesh-list
24422598|NCT00223054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24422599|NCT00223054|Immunologic Factors|immunologic factors|mesh-ancestor
24422624|NCT00223249|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24422625|NCT00223249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24823700|NCT02118675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24823701|NCT02118675|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24422784|NCT00223691|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24422785|NCT00223691|Diuretics|diuretics|mesh-ancestor
24422786|NCT00223691|Natriuretic Agents|natriuretic agents|mesh-ancestor
24422787|NCT00223691|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24422788|NCT00223691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24422789|NCT00223691|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24422790|NCT00223691|Cholinergic Agents|cholinergic agents|mesh-ancestor
24422826|NCT00223717|Eplerenone|eplerenone|mesh-list
24422827|NCT00223717|Nebivolol|nebivolol|mesh-list
24422828|NCT00223717|Bosentan|bosentan|mesh-list
24422829|NCT00223717|Diltiazem|diltiazem|mesh-list
24422830|NCT00223717|Guanfacine|guanfacine|mesh-list
24823733|NCT02118753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24823734|NCT02118753|Hormone Antagonists|hormone antagonists|mesh-ancestor
24422857|NCT00223717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24422858|NCT00223717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24422859|NCT00223717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24422879|NCT00223717|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24423248|NCT00225173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24423249|NCT00225173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423250|NCT00225173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24423264|NCT00225225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423266|NCT00225238|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24423269|NCT00225238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423324|NCT00225511|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24423325|NCT00225511|Levomilnacipran|levomilnacipran|mesh-list
24423326|NCT00225511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24423355|NCT00225589|Antimetabolites|antimetabolites|mesh-ancestor
24823810|NCT02119117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823811|NCT02119143|Vitamins|vitamins|mesh-list
24823812|NCT02119143|Micronutrients|micronutrients|mesh-ancestor
24823813|NCT02119143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823814|NCT02119234|Beclomethasone|beclomethasone|mesh-list
24823815|NCT02119234|Glycopyrrolate|glycopyrrolate|mesh-list
24823816|NCT02119234|Formoterol Fumarate|formoterol fumarate|mesh-list
24823817|NCT02119234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24823818|NCT02119234|Autonomic Agents|autonomic agents|mesh-ancestor
24823819|NCT02119234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24692602|NCT01415505|Diuretics|diuretics|mesh-ancestor
24423366|NCT00225615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423367|NCT00225615|Vasodilator Agents|vasodilator agents|mesh-ancestor
24423368|NCT00225667|Irbesartan|irbesartan|mesh-list
24423369|NCT00225667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24423370|NCT00225667|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24423371|NCT00225667|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24423372|NCT00225667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423417|NCT00225862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423418|NCT00225875|Rituximab|rituximab|mesh-list
24423419|NCT00225875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24423420|NCT00225875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24423421|NCT00225875|Immunologic Factors|immunologic factors|mesh-ancestor
25707871|NCT02239094|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25707872|NCT02239094|Serotonin Agents|serotonin agents|mesh-ancestor
25707873|NCT02239094|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25707874|NCT02239094|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25707875|NCT02239094|Dopamine Agents|dopamine agents|mesh-ancestor
25707876|NCT02239120|Dabigatran|dabigatran|mesh-list
25707877|NCT02239120|Antithrombins|antithrombins|mesh-ancestor
25707878|NCT02239120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25707879|NCT02239120|Protease Inhibitors|protease inhibitors|mesh-ancestor
25707880|NCT02239120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25707881|NCT02239120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707882|NCT02239120|Anticoagulants|anticoagulants|mesh-ancestor
24423422|NCT00225875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423423|NCT00225875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24823870|NCT02119806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24823871|NCT02119806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823872|NCT02119806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24823873|NCT02119806|Anesthetics, General|anesthetics, general|mesh-ancestor
24823874|NCT02119806|Anesthetics|anesthetics|mesh-ancestor
24823875|NCT02119806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24823876|NCT02119806|Narcotics|narcotics|mesh-ancestor
24823877|NCT02119806|Analgesics|analgesics|mesh-ancestor
24823878|NCT02119806|Sensory System Agents|sensory system agents|mesh-ancestor
24823879|NCT02119806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24823880|NCT02119806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24823881|NCT02119806|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24823882|NCT02119806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24823883|NCT02119806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24823884|NCT02119806|GABA Modulators|gaba modulators|mesh-ancestor
24823885|NCT02119806|GABA Agents|gaba agents|mesh-ancestor
24823886|NCT02119806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24823887|NCT02119806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823888|NCT02119858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24823900|NCT02120066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24823902|NCT02120092|Ticagrelor|ticagrelor|mesh-list
24823903|NCT02120092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24823904|NCT02120092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24423452|NCT00226044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24823977|NCT02120612|Naloxone|naloxone|mesh-list
24823978|NCT02120612|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24823979|NCT02120612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24823980|NCT02120612|Sensory System Agents|sensory system agents|mesh-ancestor
24823981|NCT02120612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24823982|NCT02120638|Pyrazinamide|pyrazinamide|mesh-list
24823983|NCT02120638|Antitubercular Agents|antitubercular agents|mesh-ancestor
24692877|NCT01416974|Cyclophosphamide|cyclophosphamide|mesh-list
24423570|NCT00226343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24423571|NCT00226343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24423572|NCT00226356|Betaine|betaine|mesh-list
24423588|NCT00226395|Oxymorphone|oxymorphone|mesh-list
24423596|NCT00226395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24423597|NCT00226408|Interferons|interferons|mesh-list
24423598|NCT00226408|Interferon-alpha|interferon-alpha|mesh-list
24423599|NCT00226408|Interferon alpha-2|interferon alpha-2|mesh-list
24423600|NCT00226408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24423601|NCT00226408|Antiviral Agents|antiviral agents|mesh-ancestor
24423602|NCT00226408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24423603|NCT00226408|Immunologic Factors|immunologic factors|mesh-ancestor
24423604|NCT00226408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423605|NCT00226421|Oxymorphone|oxymorphone|mesh-list
24423670|NCT00226538|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25707883|NCT02239380|Lorazepam|lorazepam|mesh-list
25707884|NCT02239380|Anticonvulsants|anticonvulsants|mesh-ancestor
25707885|NCT02239380|Antiemetics|antiemetics|mesh-ancestor
25707886|NCT02239380|Autonomic Agents|autonomic agents|mesh-ancestor
24423671|NCT00226538|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24423676|NCT00226538|Anticonvulsants|anticonvulsants|mesh-ancestor
24423693|NCT00226551|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24423694|NCT00226551|Sympathomimetics|sympathomimetics|mesh-ancestor
24423695|NCT00226551|Protective Agents|protective agents|mesh-ancestor
24545808|NCT00695045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24545810|NCT00695045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24423697|NCT00226564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24423698|NCT00226564|Narcotics|narcotics|mesh-ancestor
24423699|NCT00226564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24423700|NCT00226564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423701|NCT00226564|Analgesics|analgesics|mesh-ancestor
24423702|NCT00226564|Sensory System Agents|sensory system agents|mesh-ancestor
24824054|NCT02121197|Autonomic Agents|autonomic agents|mesh-ancestor
24824055|NCT02121197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24423768|NCT00226798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24423769|NCT00226798|Antimetabolites|antimetabolites|mesh-ancestor
24423770|NCT00226798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423771|NCT00226798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24423772|NCT00226824|Galantamine|galantamine|mesh-list
24423773|NCT00226824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24423774|NCT00226824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423775|NCT00226824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423776|NCT00226824|Cholinergic Agents|cholinergic agents|mesh-ancestor
24423783|NCT00226837|Nitrous Oxide|nitrous oxide|mesh-list
24824060|NCT02121197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24824061|NCT02121197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24824062|NCT02121197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24824063|NCT02121288|Clopidogrel|clopidogrel|mesh-list
24824064|NCT02121288|Ticagrelor|ticagrelor|mesh-list
24423865|NCT00227136|Serotonin Agents|serotonin agents|mesh-ancestor
24824090|NCT02121444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24824091|NCT02121444|Immunologic Factors|immunologic factors|mesh-ancestor
24824092|NCT02121444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824093|NCT02121444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24824094|NCT02121457|Selenium|selenium|mesh-list
24824095|NCT02121457|Antioxidants|antioxidants|mesh-ancestor
24423892|NCT00227331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24423893|NCT00227331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24423894|NCT00227357|Buprenorphine|buprenorphine|mesh-list
24423895|NCT00227357|Methadone|methadone|mesh-list
24423896|NCT00227357|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
24423901|NCT00227357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423902|NCT00227357|Analgesics|analgesics|mesh-ancestor
24423903|NCT00227357|Sensory System Agents|sensory system agents|mesh-ancestor
24423904|NCT00227357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24423907|NCT00227357|Respiratory System Agents|respiratory system agents|mesh-ancestor
24423946|NCT00227474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423947|NCT00227500|Pravastatin|pravastatin|mesh-list
24423948|NCT00227500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24423949|NCT00227500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24423950|NCT00227500|Antimetabolites|antimetabolites|mesh-ancestor
24423952|NCT00227500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24423959|NCT00227513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423960|NCT00227513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423961|NCT00227565|Carboplatin|carboplatin|mesh-list
24423962|NCT00227565|Pemetrexed|pemetrexed|mesh-list
24423963|NCT00227565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24423984|NCT00227656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24424006|NCT00227682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24424007|NCT00227682|Antiemetics|antiemetics|mesh-ancestor
24424008|NCT00227682|Autonomic Agents|autonomic agents|mesh-ancestor
24424009|NCT00227682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24424010|NCT00227682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424011|NCT00227682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24424012|NCT00227682|Glucocorticoids|glucocorticoids|mesh-ancestor
24424013|NCT00227682|Hormones|hormones|mesh-ancestor
24424069|NCT00227773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424070|NCT00227773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24424071|NCT00227812|Bupropion|bupropion|mesh-list
24424072|NCT00227812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24424073|NCT00227812|Antidepressive Agents|antidepressive agents|mesh-ancestor
24424074|NCT00227812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24424075|NCT00227812|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24424076|NCT00227812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25707887|NCT02239380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25707888|NCT02239380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424077|NCT00227812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24424078|NCT00227812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824137|NCT02121951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824138|NCT02121951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24647955|NCT01211509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824139|NCT02121951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24824140|NCT02121951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24824141|NCT02121951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24824143|NCT02121990|Bevacizumab|bevacizumab|mesh-list
24824144|NCT02121990|Olaparib|olaparib|mesh-list
24824145|NCT02121990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24824146|NCT02121990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424177|NCT00228046|Antimanic Agents|antimanic agents|mesh-ancestor
24424178|NCT00228046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24424179|NCT00228046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24424180|NCT00228046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24424214|NCT00228319|Protective Agents|protective agents|mesh-ancestor
24424215|NCT00228358|Cyclophosphamide|cyclophosphamide|mesh-list
24424216|NCT00228358|Interleukin-2|interleukin-2|mesh-list
24424217|NCT00228358|Denileukin diftitox|denileukin diftitox|mesh-list
24424218|NCT00228358|Immunotoxins|immunotoxins|mesh-list
24424219|NCT00228358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24424220|NCT00228358|Immunologic Factors|immunologic factors|mesh-ancestor
24824183|NCT02122055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824184|NCT02122055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24424234|NCT00228397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24424235|NCT00228397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24424236|NCT00228397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424241|NCT00228410|Vancomycin|vancomycin|mesh-list
24824250|NCT02122510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824251|NCT02122510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24824252|NCT02122510|Analgesics|analgesics|mesh-ancestor
24424282|NCT00228527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24424283|NCT00228527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24424284|NCT00228527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24424285|NCT00228527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424286|NCT00228540|Modafinil|modafinil|mesh-list
24424287|NCT00228540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24424288|NCT00228540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424289|NCT00228540|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24424290|NCT00228540|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24824259|NCT02122510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24424341|NCT00228904|Insulin Aspart|insulin aspart|mesh-list
24424342|NCT00228904|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24424343|NCT00228904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24424344|NCT00228904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424345|NCT00228930|Tamoxifen|tamoxifen|mesh-list
24424346|NCT00228930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24424347|NCT00228930|Hormone Antagonists|hormone antagonists|mesh-ancestor
24424351|NCT00228930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424372|NCT00229112|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24424373|NCT00229112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24424374|NCT00229125|Gabapentin|gabapentin|mesh-list
24824265|NCT02122536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24824266|NCT02122536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824267|NCT02122536|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24824268|NCT02122536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24824269|NCT02122536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424376|NCT00229125|Analgesics|analgesics|mesh-ancestor
24424377|NCT00229125|Sensory System Agents|sensory system agents|mesh-ancestor
24424378|NCT00229125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24424506|NCT00229567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24424507|NCT00229567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24424508|NCT00229567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25707889|NCT02239380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25707890|NCT02239380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24424509|NCT00229567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424511|NCT00229567|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24424512|NCT00229567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24424513|NCT00229567|Anesthetics, General|anesthetics, general|mesh-ancestor
24424514|NCT00229567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24648456|NCT01214772|Anticoagulants|anticoagulants|mesh-ancestor
24424515|NCT00229567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24424516|NCT00229567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24424538|NCT00229645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424540|NCT00229684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24424541|NCT00229684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824284|NCT02122627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24612312|NCT01013480|Baclofen|baclofen|mesh-list
24424592|NCT00229996|Contraceptives, Oral|contraceptives, oral|mesh-list
24424593|NCT00229996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24424594|NCT00229996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424595|NCT00229996|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24424597|NCT00229996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24424598|NCT00229996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424633|NCT00230035|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24424634|NCT00230035|Antitubercular Agents|antitubercular agents|mesh-ancestor
24424635|NCT00230035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24424636|NCT00230035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24424637|NCT00230035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24424638|NCT00230035|Antiemetics|antiemetics|mesh-ancestor
24424639|NCT00230035|Autonomic Agents|autonomic agents|mesh-ancestor
24424640|NCT00230035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24424641|NCT00230035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24424642|NCT00230035|Glucocorticoids|glucocorticoids|mesh-ancestor
24424648|NCT00230204|Immunologic Factors|immunologic factors|mesh-ancestor
24424649|NCT00230204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424650|NCT00230217|Rasburicase|rasburicase|mesh-list
24424753|NCT00230568|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24424754|NCT00230568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24424755|NCT00230568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424948|NCT00231452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24424949|NCT00231452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24425000|NCT00231582|Antimitotic Agents|antimitotic agents|mesh-ancestor
24425001|NCT00231582|Mitosis Modulators|mitosis modulators|mesh-ancestor
24425002|NCT00231582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425003|NCT00231582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24425004|NCT00231582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24425030|NCT00231660|Anticonvulsants|anticonvulsants|mesh-ancestor
24425031|NCT00231660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24425032|NCT00231660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425034|NCT00231673|Anticonvulsants|anticonvulsants|mesh-ancestor
24425035|NCT00231673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24425036|NCT00231673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425142|NCT00232076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24425143|NCT00232076|Immunologic Factors|immunologic factors|mesh-ancestor
24425144|NCT00232076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425145|NCT00232076|Antifungal Agents|antifungal agents|mesh-ancestor
24425146|NCT00232076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24425147|NCT00232076|Dermatologic Agents|dermatologic agents|mesh-ancestor
24425148|NCT00232076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24425149|NCT00232076|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24425151|NCT00232089|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24425152|NCT00232089|Serotonin Agents|serotonin agents|mesh-ancestor
24425153|NCT00232089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24425154|NCT00232089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425155|NCT00232089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425179|NCT00232154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24425180|NCT00232167|Indiplon|indiplon|mesh-list
24425181|NCT00232167|Sertraline|sertraline|mesh-list
24425182|NCT00232167|Antidepressive Agents|antidepressive agents|mesh-ancestor
24425183|NCT00232167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24425184|NCT00232167|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24425185|NCT00232167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24425229|NCT00232349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425230|NCT00232349|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24425231|NCT00232349|Autonomic Agents|autonomic agents|mesh-ancestor
24425232|NCT00232349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24425233|NCT00232349|Nootropic Agents|nootropic agents|mesh-ancestor
24425442|NCT00233025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24425443|NCT00233025|Antidepressive Agents|antidepressive agents|mesh-ancestor
24425444|NCT00233025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24425445|NCT00233025|Dopamine Agents|dopamine agents|mesh-ancestor
24425446|NCT00233038|Ethanol|ethanol|mesh-list
24425447|NCT00233038|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24546414|NCT00698269|Insulin|insulin|mesh-list
24546415|NCT00698269|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24425557|NCT00233623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425558|NCT00233623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24425559|NCT00233623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24425560|NCT00233623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24425561|NCT00233623|Antidotes|antidotes|mesh-ancestor
24425562|NCT00233623|Protective Agents|protective agents|mesh-ancestor
24425563|NCT00233623|Vitamin B Complex|vitamin b complex|mesh-ancestor
24425564|NCT00233623|Vitamins|vitamins|mesh-ancestor
24425565|NCT00233623|Micronutrients|micronutrients|mesh-ancestor
24425594|NCT00233766|Sirolimus|sirolimus|mesh-list
24425595|NCT00233766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24425596|NCT00233766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24425597|NCT00233766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24425598|NCT00233766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24425599|NCT00233766|Antifungal Agents|antifungal agents|mesh-ancestor
24425817|NCT00234416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24425818|NCT00234416|Antiviral Agents|antiviral agents|mesh-ancestor
24425819|NCT00234416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24425820|NCT00234416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24425821|NCT00234416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24425822|NCT00234416|Immunologic Factors|immunologic factors|mesh-ancestor
24425823|NCT00234416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425824|NCT00234416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24425826|NCT00234429|Raltitrexed|raltitrexed|mesh-list
24425827|NCT00234429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24425828|NCT00234429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24425829|NCT00234429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24425830|NCT00234429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425878|NCT00234598|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24425879|NCT00234598|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24425880|NCT00234598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24426013|NCT00234936|Abortifacient Agents|abortifacient agents|mesh-ancestor
24426014|NCT00234936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24426015|NCT00234936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426016|NCT00234936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24426040|NCT00234962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24426041|NCT00234962|Antiviral Agents|antiviral agents|mesh-ancestor
24426042|NCT00234962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24426043|NCT00234962|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24426044|NCT00234962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24426045|NCT00234975|Ritonavir|ritonavir|mesh-list
24426046|NCT00234975|Lopinavir|lopinavir|mesh-list
24426047|NCT00234975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24426048|NCT00234975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24426049|NCT00234975|Protease Inhibitors|protease inhibitors|mesh-ancestor
24426050|NCT00234975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25707891|NCT02239380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25707892|NCT02239380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25707893|NCT02239380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25707894|NCT02239380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25707895|NCT02239380|GABA Modulators|gaba modulators|mesh-ancestor
25707896|NCT02239380|GABA Agents|gaba agents|mesh-ancestor
25707897|NCT02239380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707898|NCT02239380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426051|NCT00234975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426053|NCT00234975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24824361|NCT02123056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824362|NCT02123069|Nitroprusside|nitroprusside|mesh-list
24824363|NCT02123069|Phenylephrine|phenylephrine|mesh-list
24824364|NCT02123069|Oxymetazoline|oxymetazoline|mesh-list
24824365|NCT02123069|Norepinephrine|norepinephrine|mesh-list
24824366|NCT02123069|Acetylcholine|acetylcholine|mesh-list
24612423|NCT01013909|Terbinafine|terbinafine|mesh-list
24426081|NCT00235014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426148|NCT00235157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24426149|NCT00235157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24426150|NCT00235157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24426151|NCT00235157|Antifungal Agents|antifungal agents|mesh-ancestor
24426152|NCT00235157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24426153|NCT00235157|Immunologic Factors|immunologic factors|mesh-ancestor
24426154|NCT00235157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426156|NCT00235196|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24426157|NCT00235209|Anti-Infective Agents|anti-infective agents|mesh-list
24426158|NCT00235209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24426159|NCT00235222|Stavudine|stavudine|mesh-list
24546747|NCT00700024|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24426160|NCT00235222|Antimetabolites|antimetabolites|mesh-ancestor
24426161|NCT00235222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426164|NCT00235222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24426250|NCT00235287|Enalapril|enalapril|mesh-list
24426251|NCT00235287|Enalaprilat|enalaprilat|mesh-list
24426252|NCT00235287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24426253|NCT00235287|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24426254|NCT00235287|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24426255|NCT00235287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426256|NCT00235287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24426271|NCT00235313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24426272|NCT00235313|Cholinergic Agents|cholinergic agents|mesh-ancestor
24426273|NCT00235313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24426274|NCT00235313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426275|NCT00235508|Eszopiclone|eszopiclone|mesh-list
24426276|NCT00235508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24426277|NCT00235508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24426295|NCT00235651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24426296|NCT00235651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24426297|NCT00235651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24426298|NCT00235651|Antifungal Agents|antifungal agents|mesh-ancestor
24426299|NCT00235703|Anti-Infective Agents|anti-infective agents|mesh-list
24426300|NCT00235703|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24426479|NCT00236145|Narcotics|narcotics|mesh-ancestor
24426480|NCT00236145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24426481|NCT00236145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426482|NCT00236145|Analgesics|analgesics|mesh-ancestor
25707899|NCT02239510|Linaclotide|linaclotide|mesh-list
25707900|NCT02239510|Sennosides|sennosides|mesh-list
25707901|NCT02239510|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25707902|NCT02239510|Enzyme Activators|enzyme activators|mesh-ancestor
25707903|NCT02239510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707904|NCT02239510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25707905|NCT02239510|Laxatives|laxatives|mesh-ancestor
25707906|NCT02239679|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25707907|NCT02239679|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24426483|NCT00236145|Sensory System Agents|sensory system agents|mesh-ancestor
24426484|NCT00236145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24426485|NCT00236145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24426486|NCT00236145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24426487|NCT00236145|Anesthetics, General|anesthetics, general|mesh-ancestor
24426501|NCT00236223|Hormones|hormones|mesh-ancestor
24426503|NCT00236223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24426504|NCT00236223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24426505|NCT00236223|Analgesics|analgesics|mesh-ancestor
24426506|NCT00236223|Sensory System Agents|sensory system agents|mesh-ancestor
24426507|NCT00236223|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24546934|NCT00701298|Interferons|interferons|mesh-list
24546935|NCT00701298|Interferon-alpha|interferon-alpha|mesh-list
24426525|NCT00236249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426526|NCT00236249|Sensory System Agents|sensory system agents|mesh-ancestor
24426535|NCT00236275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24426734|NCT00236548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24426735|NCT00236548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24426736|NCT00236548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24426737|NCT00236548|Dopamine Agents|dopamine agents|mesh-ancestor
24426740|NCT00236561|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24426741|NCT00236561|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24426742|NCT00236561|Adrenergic Agents|adrenergic agents|mesh-ancestor
24426743|NCT00236561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24426762|NCT00236587|Risperidone|risperidone|mesh-list
24426763|NCT00236587|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24426764|NCT00236587|Serotonin Agents|serotonin agents|mesh-ancestor
24426765|NCT00236587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24426783|NCT00236626|Anticonvulsants|anticonvulsants|mesh-ancestor
24426785|NCT00236626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426786|NCT00236639|Topiramate|topiramate|mesh-list
24426787|NCT00236639|Anticonvulsants|anticonvulsants|mesh-ancestor
24426788|NCT00236639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24426790|NCT00236652|Levofloxacin|levofloxacin|mesh-list
24426870|NCT00236782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426871|NCT00236782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24426872|NCT00236782|Contraceptive Agents|contraceptive agents|mesh-ancestor
24426873|NCT00236782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24426874|NCT00236782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24426875|NCT00236782|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24426876|NCT00236782|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24426877|NCT00236795|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24426878|NCT00236795|Norelgestromin|norelgestromin|mesh-list
24426879|NCT00236795|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
24426880|NCT00236795|Estradiol|estradiol|mesh-list
24426881|NCT00236795|Estrogens|estrogens|mesh-ancestor
24426882|NCT00236795|Hormones|hormones|mesh-ancestor
24426924|NCT00236834|Imipenem|imipenem|mesh-list
24426925|NCT00236834|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24426926|NCT00236834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24426927|NCT00236834|Renal Agents|renal agents|mesh-ancestor
24426928|NCT00236834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24426929|NCT00236834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24824429|NCT02123355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24824430|NCT02123355|Cholinergic Agents|cholinergic agents|mesh-ancestor
24824431|NCT02123368|Hyaluronic Acid|hyaluronic acid|mesh-list
24824432|NCT02123368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24824433|NCT02123368|Immunologic Factors|immunologic factors|mesh-ancestor
24426930|NCT00236834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24426931|NCT00236834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24426932|NCT00236834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426933|NCT00236834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24426936|NCT00236847|Topiramate|topiramate|mesh-list
24824436|NCT02123368|Protective Agents|protective agents|mesh-ancestor
24824438|NCT02123381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24824439|NCT02123381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24824442|NCT02123433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824444|NCT02123498|Pantoprazole|pantoprazole|mesh-list
24824445|NCT02123498|Ranitidine|ranitidine|mesh-list
24824446|NCT02123498|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
24427010|NCT00237172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427011|NCT00237172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24427012|NCT00237172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427013|NCT00237172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427014|NCT00237198|Letrozole|letrozole|mesh-list
24427015|NCT00237198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427016|NCT00237198|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24427018|NCT00237198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427045|NCT00237237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24427046|NCT00237237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427052|NCT00237250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24427053|NCT00237250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427054|NCT00237250|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24427055|NCT00237250|Protease Inhibitors|protease inhibitors|mesh-ancestor
24427056|NCT00237250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427057|NCT00237250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427059|NCT00237263|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24427060|NCT00237263|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24427061|NCT00237263|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24427062|NCT00237263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427197|NCT00237627|Doxorubicin|doxorubicin|mesh-list
24427198|NCT00237627|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24427200|NCT00237627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24427201|NCT00237627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427202|NCT00237627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24427203|NCT00237627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24427204|NCT00237627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427205|NCT00237627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427206|NCT00237653|Valganciclovir|valganciclovir|mesh-list
24427207|NCT00237653|Antiviral Agents|antiviral agents|mesh-ancestor
24427208|NCT00237653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24427209|NCT00237705|Metoclopramide|metoclopramide|mesh-list
24427210|NCT00237705|Antiemetics|antiemetics|mesh-ancestor
24427211|NCT00237705|Autonomic Agents|autonomic agents|mesh-ancestor
24427212|NCT00237705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24427213|NCT00237705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427214|NCT00237705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24427215|NCT00237705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24427216|NCT00237705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24427217|NCT00237705|Dopamine Agents|dopamine agents|mesh-ancestor
24427220|NCT00237731|Morphine|morphine|mesh-list
24427238|NCT00237861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24427241|NCT00237861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24427242|NCT00237861|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24427243|NCT00237861|Dopamine Agents|dopamine agents|mesh-ancestor
24427244|NCT00237861|Antiemetics|antiemetics|mesh-ancestor
24427245|NCT00237861|Autonomic Agents|autonomic agents|mesh-ancestor
24427246|NCT00237861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24427247|NCT00237861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24427248|NCT00237861|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24427249|NCT00237861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24427250|NCT00237861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24427251|NCT00237861|Antidepressive Agents|antidepressive agents|mesh-ancestor
24427270|NCT00237887|Adalimumab|adalimumab|mesh-list
25707908|NCT02239679|Dermatologic Agents|dermatologic agents|mesh-ancestor
25707909|NCT02239692|Picosulfate sodium|picosulfate sodium|mesh-list
24427283|NCT00237900|Antidotes|antidotes|mesh-ancestor
25707910|NCT02239692|Cathartics|cathartics|mesh-ancestor
25707911|NCT02239692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25707912|NCT02239770|Nicotine|nicotine|mesh-list
25707913|NCT02239770|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25707914|NCT02239770|Autonomic Agents|autonomic agents|mesh-ancestor
25707915|NCT02239770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25707916|NCT02239770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427284|NCT00237900|Protective Agents|protective agents|mesh-ancestor
24427288|NCT00237900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24427336|NCT00237952|Chelating Agents|chelating agents|mesh-list
24427337|NCT00237952|Sequestering Agents|sequestering agents|mesh-ancestor
24427338|NCT00237952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427339|NCT00238004|Nicotinic Acids|nicotinic acids|mesh-list
24427365|NCT00238056|Antiemetics|antiemetics|mesh-ancestor
24427366|NCT00238056|Autonomic Agents|autonomic agents|mesh-ancestor
24427367|NCT00238056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24427368|NCT00238056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427369|NCT00238056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24427370|NCT00238056|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24427371|NCT00238056|Dopamine Agents|dopamine agents|mesh-ancestor
24427372|NCT00238056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24447507|NCT00308607|Immunologic Factors|immunologic factors|mesh-ancestor
24427373|NCT00238056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427374|NCT00238082|Beclomethasone|beclomethasone|mesh-list
24427375|NCT00238082|Norflurane|norflurane|mesh-list
24427376|NCT00238082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24824473|NCT02123589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824475|NCT02123589|Sensory System Agents|sensory system agents|mesh-ancestor
24824476|NCT02123589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24824477|NCT02123589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24824478|NCT02123589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24427377|NCT00238082|Glucocorticoids|glucocorticoids|mesh-ancestor
24427417|NCT00238173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427418|NCT00238173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427419|NCT00238173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24427420|NCT00238173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24427421|NCT00238173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24427422|NCT00238173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24427471|NCT00238225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24427472|NCT00238225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427473|NCT00238225|Antifungal Agents|antifungal agents|mesh-ancestor
24427474|NCT00238225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24427475|NCT00238225|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24427476|NCT00238225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24427477|NCT00238225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427478|NCT00238225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427479|NCT00238225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24427480|NCT00238225|Hormone Antagonists|hormone antagonists|mesh-ancestor
24427481|NCT00238225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24427482|NCT00238225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24427483|NCT00238225|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24427484|NCT00238225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24427485|NCT00238225|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24427486|NCT00238225|Vitamins|vitamins|mesh-ancestor
24427487|NCT00238225|Micronutrients|micronutrients|mesh-ancestor
24427511|NCT00238290|Hormone Antagonists|hormone antagonists|mesh-ancestor
24427569|NCT00238368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24427570|NCT00238368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24427571|NCT00238368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24427572|NCT00238368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24473312|NCT00402545|Docetaxel|docetaxel|mesh-list
24427574|NCT00238368|Antiviral Agents|antiviral agents|mesh-ancestor
24427575|NCT00238368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24427576|NCT00238368|Tubulin Modulators|tubulin modulators|mesh-ancestor
24427577|NCT00238368|Antimitotic Agents|antimitotic agents|mesh-ancestor
24427578|NCT00238368|Mitosis Modulators|mitosis modulators|mesh-ancestor
24427580|NCT00238368|Autonomic Agents|autonomic agents|mesh-ancestor
24427581|NCT00238368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24427582|NCT00238368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24427597|NCT00238459|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24427599|NCT00238459|Immunologic Factors|immunologic factors|mesh-ancestor
24427600|NCT00238459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427601|NCT00238459|Antiviral Agents|antiviral agents|mesh-ancestor
24427602|NCT00238459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24427603|NCT00238472|Nateglinide|nateglinide|mesh-list
24427604|NCT00238472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24427605|NCT00238472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427606|NCT00238498|Vildagliptin|vildagliptin|mesh-list
24427607|NCT00238498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24427608|NCT00238498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427609|NCT00238498|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24427610|NCT00238498|Protease Inhibitors|protease inhibitors|mesh-ancestor
24427611|NCT00238498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427612|NCT00238498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824496|NCT02123615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824498|NCT02123628|Doxycycline|doxycycline|mesh-list
24824499|NCT02123628|Ciprofloxacin|ciprofloxacin|mesh-list
24824500|NCT02123628|Levofloxacin|levofloxacin|mesh-list
24824501|NCT02123628|Rifampin|rifampin|mesh-list
24824502|NCT02123628|Ceftriaxone|ceftriaxone|mesh-list
24824503|NCT02123628|Linezolid|linezolid|mesh-list
24824530|NCT02123628|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24824531|NCT02123628|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24824532|NCT02123628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24824534|NCT02123628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24824540|NCT02123654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824551|NCT02124005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824553|NCT02124005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24824556|NCT02124070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824625|NCT02124317|Antimitotic Agents|antimitotic agents|mesh-ancestor
24824626|NCT02124317|Mitosis Modulators|mitosis modulators|mesh-ancestor
24651350|NCT01231139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824627|NCT02124317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824629|NCT02124330|Antidotes|antidotes|mesh-ancestor
24824630|NCT02124330|Protective Agents|protective agents|mesh-ancestor
25707917|NCT02239770|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25707918|NCT02239770|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25707919|NCT02239770|Cholinergic Agents|cholinergic agents|mesh-ancestor
25707920|NCT02239770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707921|NCT02239770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707922|NCT02240030|Levodopa|levodopa|mesh-list
25707923|NCT02240030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25707924|NCT02240030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24824631|NCT02124330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824632|NCT02124369|Gemcitabine|gemcitabine|mesh-list
24824633|NCT02124369|Paclitaxel|paclitaxel|mesh-list
24824634|NCT02124369|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24824635|NCT02124369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24824636|NCT02124369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427702|NCT00238784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427703|NCT00238784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24427704|NCT00238784|Respiratory System Agents|respiratory system agents|mesh-ancestor
24427705|NCT00238784|Glucocorticoids|glucocorticoids|mesh-ancestor
24427706|NCT00238784|Hormones|hormones|mesh-ancestor
24427707|NCT00238784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24824660|NCT02124525|Antiviral Agents|antiviral agents|mesh-ancestor
24824661|NCT02124525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24824662|NCT02124525|Expectorants|expectorants|mesh-ancestor
24824663|NCT02124525|Respiratory System Agents|respiratory system agents|mesh-ancestor
24427722|NCT00238901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24824696|NCT02124850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24824697|NCT02124850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824710|NCT02124954|GABA Modulators|gaba modulators|mesh-ancestor
24824711|NCT02124954|GABA Agents|gaba agents|mesh-ancestor
24824712|NCT02124954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24824713|NCT02124954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824714|NCT02124954|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24824715|NCT02124954|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24824716|NCT02124954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824717|NCT02124954|Protective Agents|protective agents|mesh-ancestor
24824719|NCT02125084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24824720|NCT02125084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24824721|NCT02125084|Immunologic Factors|immunologic factors|mesh-ancestor
24824722|NCT02125084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824723|NCT02125188|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24427797|NCT00239031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427798|NCT00239031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24427799|NCT00239031|Antitubercular Agents|antitubercular agents|mesh-ancestor
24427800|NCT00239031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24427801|NCT00239031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24427841|NCT00239096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24427842|NCT00239096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24427843|NCT00239096|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24427844|NCT00239096|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24427853|NCT00239109|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24427854|NCT00239109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24427855|NCT00239109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24427856|NCT00239109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24427857|NCT00239109|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24427858|NCT00239109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24427891|NCT00239200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427892|NCT00239239|Darbepoetin alfa|darbepoetin alfa|mesh-list
24427893|NCT00239239|Hematinics|hematinics|mesh-ancestor
24427894|NCT00239252|Interferons|interferons|mesh-list
24427895|NCT00239252|Interferon alfacon-1|interferon alfacon-1|mesh-list
24427896|NCT00239252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427897|NCT00239252|Antiviral Agents|antiviral agents|mesh-ancestor
24427900|NCT00239278|Budesonide|budesonide|mesh-list
24427901|NCT00239278|Formoterol Fumarate|formoterol fumarate|mesh-list
24427902|NCT00239278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24427903|NCT00239278|Glucocorticoids|glucocorticoids|mesh-ancestor
24427904|NCT00239278|Hormones|hormones|mesh-ancestor
24427905|NCT00239278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24427906|NCT00239278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427921|NCT00239291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24824742|NCT02125227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24824743|NCT02125227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24824744|NCT02125227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824745|NCT02125227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24824746|NCT02125227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24824748|NCT02125227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824749|NCT02125227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24547687|NCT00705120|Dermatologic Agents|dermatologic agents|mesh-ancestor
24824750|NCT02125227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24824751|NCT02125227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824752|NCT02125305|Metformin|metformin|mesh-list
24824761|NCT02125344|Cyclophosphamide|cyclophosphamide|mesh-list
24824762|NCT02125344|Carboplatin|carboplatin|mesh-list
24427970|NCT00239395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24427971|NCT00239395|Analgesics|analgesics|mesh-ancestor
24427972|NCT00239395|Sensory System Agents|sensory system agents|mesh-ancestor
24427984|NCT00239408|Autonomic Agents|autonomic agents|mesh-ancestor
24427985|NCT00239408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24427986|NCT00239408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427987|NCT00239408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24427988|NCT00239408|Respiratory System Agents|respiratory system agents|mesh-ancestor
24427989|NCT00239408|Parasympatholytics|parasympatholytics|mesh-ancestor
24427990|NCT00239408|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24824781|NCT02125344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24428030|NCT00239434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24428031|NCT00239434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428032|NCT00239434|Anticonvulsants|anticonvulsants|mesh-ancestor
24428033|NCT00239447|Tiotropium Bromide|tiotropium bromide|mesh-list
24428034|NCT00239447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24428035|NCT00239447|Autonomic Agents|autonomic agents|mesh-ancestor
24428036|NCT00239447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24428037|NCT00239447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428038|NCT00239447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24428039|NCT00239447|Respiratory System Agents|respiratory system agents|mesh-ancestor
24428040|NCT00239447|Parasympatholytics|parasympatholytics|mesh-ancestor
24428041|NCT00239447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24428042|NCT00239447|Cholinergic Agents|cholinergic agents|mesh-ancestor
24428050|NCT00239460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24428051|NCT00239460|Respiratory System Agents|respiratory system agents|mesh-ancestor
24428052|NCT00239460|Parasympatholytics|parasympatholytics|mesh-ancestor
24428053|NCT00239460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24428054|NCT00239460|Cholinergic Agents|cholinergic agents|mesh-ancestor
24428101|NCT00239512|Ibuprofen|ibuprofen|mesh-list
24428120|NCT00239538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24428121|NCT00239538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24428124|NCT00239538|Diuretics|diuretics|mesh-ancestor
24428132|NCT00239551|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24428133|NCT00239551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824808|NCT02125409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24824810|NCT02125409|Antipyretics|antipyretics|mesh-ancestor
24428195|NCT00239889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428196|NCT00239889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24428197|NCT00239889|Vasodilator Agents|vasodilator agents|mesh-ancestor
24428198|NCT00239902|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24428199|NCT00239902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24428200|NCT00239902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428201|NCT00239902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25707925|NCT02240030|Dopamine Agents|dopamine agents|mesh-ancestor
24428228|NCT00239980|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24428229|NCT00239980|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25707926|NCT02240030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707927|NCT02240030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707928|NCT02240030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707929|NCT02240108|Rifaximin|rifaximin|mesh-list
25707930|NCT02240108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25707931|NCT02240108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25707932|NCT02240108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25707933|NCT02240121|Rifaximin|rifaximin|mesh-list
24428230|NCT00239980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428231|NCT00239993|Glatiramer Acetate|glatiramer acetate|mesh-list
24428233|NCT00239993|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24428234|NCT00239993|Immunologic Factors|immunologic factors|mesh-ancestor
24428244|NCT00240019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24428245|NCT00240019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428247|NCT00240032|Glatiramer Acetate|glatiramer acetate|mesh-list
24428248|NCT00240032|(T,G)-A-L|(t,g)-a-l|mesh-list
24428249|NCT00240032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25707934|NCT02240121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25707935|NCT02240121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25707936|NCT02240121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25707937|NCT02240329|Capsaicin|capsaicin|mesh-list
25707938|NCT02240329|Antipruritics|antipruritics|mesh-ancestor
25707939|NCT02240329|Dermatologic Agents|dermatologic agents|mesh-ancestor
25707940|NCT02240329|Sensory System Agents|sensory system agents|mesh-ancestor
25707941|NCT02240329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24428250|NCT00240032|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24428251|NCT00240032|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24428252|NCT00240032|Histamine Antagonists|histamine antagonists|mesh-ancestor
24428253|NCT00240032|Histamine Agents|histamine agents|mesh-ancestor
24428254|NCT00240032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24428255|NCT00240032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428256|NCT00240032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824834|NCT02125565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824836|NCT02125578|Interferon-beta|interferon-beta|mesh-list
24824837|NCT02125578|Interferon beta-1a|interferon beta-1a|mesh-list
24824839|NCT02125578|Antiviral Agents|antiviral agents|mesh-ancestor
24428360|NCT00240292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428361|NCT00240292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24428362|NCT00240292|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24428363|NCT00240292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428364|NCT00240305|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24428365|NCT00240305|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24428374|NCT00240318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24428375|NCT00240318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428376|NCT00240318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24428377|NCT00240318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24428378|NCT00240318|Antimetabolites|antimetabolites|mesh-ancestor
24428379|NCT00240318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428380|NCT00240318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24428381|NCT00240318|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24428382|NCT00240318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428384|NCT00240396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24428428|NCT00240448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24428429|NCT00240448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24428548|NCT00240695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24428456|NCT00240513|Keratolytic Agents|keratolytic agents|mesh-ancestor
24428457|NCT00240513|Dermatologic Agents|dermatologic agents|mesh-ancestor
24428458|NCT00240552|Fosamprenavir|fosamprenavir|mesh-list
24428459|NCT00240552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24428460|NCT00240552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24428478|NCT00240617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428479|NCT00240617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24428480|NCT00240617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24428481|NCT00240617|Gout Suppressants|gout suppressants|mesh-ancestor
24428482|NCT00240617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24428483|NCT00240617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428484|NCT00240617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428485|NCT00240617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24428499|NCT00240630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24428500|NCT00240630|Gout Suppressants|gout suppressants|mesh-ancestor
24428501|NCT00240630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25707942|NCT02240329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474080|NCT00404833|Prednisolone|prednisolone|mesh-list
24428511|NCT00240656|Spironolactone|spironolactone|mesh-list
24428512|NCT00240656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24428513|NCT00240656|Hormone Antagonists|hormone antagonists|mesh-ancestor
24428515|NCT00240656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428516|NCT00240656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24428517|NCT00240656|Diuretics|diuretics|mesh-ancestor
24428521|NCT00240656|Adrenergic Agents|adrenergic agents|mesh-ancestor
24428522|NCT00240656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24824848|NCT02125617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24824849|NCT02125617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24824850|NCT02125617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24824851|NCT02125617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24428541|NCT00240695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428542|NCT00240695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428543|NCT00240695|Cholinergic Agents|cholinergic agents|mesh-ancestor
24428544|NCT00240695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24428545|NCT00240695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428546|NCT00240695|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24428547|NCT00240695|Autonomic Agents|autonomic agents|mesh-ancestor
24428554|NCT00240708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428555|NCT00240708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428557|NCT00240708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24428558|NCT00240708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24428625|NCT00240812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428626|NCT00240812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24428627|NCT00240812|Autonomic Agents|autonomic agents|mesh-ancestor
24428633|NCT00240812|Sympathomimetics|sympathomimetics|mesh-ancestor
24824860|NCT02125643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824861|NCT02125643|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24581384|NCT00865007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24824863|NCT02125643|Purinergic Agents|purinergic agents|mesh-ancestor
24428641|NCT00240825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24428642|NCT00240825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428643|NCT00240825|Antipyretics|antipyretics|mesh-ancestor
24428644|NCT00240825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24428645|NCT00240825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24428646|NCT00240825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24428647|NCT00240825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24428648|NCT00240825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428675|NCT00240864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24428676|NCT00240864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428677|NCT00240864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428678|NCT00240929|Palivizumab|palivizumab|mesh-list
24428679|NCT00240929|Antiviral Agents|antiviral agents|mesh-ancestor
24428680|NCT00240929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24428681|NCT00240942|Letrozole|letrozole|mesh-list
24428722|NCT00241046|Hormone Antagonists|hormone antagonists|mesh-ancestor
24428729|NCT00241059|Antitubercular Agents|antitubercular agents|mesh-ancestor
24428730|NCT00241059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24428731|NCT00241059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24428732|NCT00241059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25707943|NCT02240589|Memantine|memantine|mesh-list
25707944|NCT02240589|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25707945|NCT02240589|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25707946|NCT02240589|Dopamine Agents|dopamine agents|mesh-ancestor
25707947|NCT02240589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25707948|NCT02240589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707949|NCT02240589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707950|NCT02240589|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25707951|NCT02240589|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25707953|NCT02240628|Tetracaine|tetracaine|mesh-list
25707954|NCT02240628|Anesthetics, Local|anesthetics, local|mesh-ancestor
24428733|NCT00241059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428735|NCT00241072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24657370|NCT01266837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24428736|NCT00241072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24824884|NCT02125890|Tranexamic Acid|tranexamic acid|mesh-list
24428755|NCT00241124|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24428756|NCT00241124|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24428757|NCT00241124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428758|NCT00241124|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24428768|NCT00241137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428770|NCT00241150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24428771|NCT00241150|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24428772|NCT00241150|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24428773|NCT00241150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428775|NCT00241163|Hemostatics|hemostatics|mesh-ancestor
24428776|NCT00241163|Coagulants|coagulants|mesh-ancestor
24428777|NCT00241189|Sirolimus|sirolimus|mesh-list
24428778|NCT00241189|Methotrexate|methotrexate|mesh-list
24428779|NCT00241189|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24428780|NCT00241189|Abortifacient Agents|abortifacient agents|mesh-ancestor
24428781|NCT00241189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24824895|NCT02125903|Sensory System Agents|sensory system agents|mesh-ancestor
24824896|NCT02125903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24824898|NCT02125968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24824899|NCT02125968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24824900|NCT02125968|Adrenergic Agents|adrenergic agents|mesh-ancestor
24824901|NCT02125968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24428857|NCT00241345|Antiviral Agents|antiviral agents|mesh-ancestor
24428858|NCT00241345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24428859|NCT00241345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24428860|NCT00241345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428861|NCT00241345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428863|NCT00241371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24428864|NCT00241371|Antimetabolites|antimetabolites|mesh-ancestor
24428865|NCT00241371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774854|NCT01848236|Micronutrients|micronutrients|mesh-ancestor
24428889|NCT00241449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24428890|NCT00241449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428891|NCT00241449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24548153|NCT00707902|Chlorhexidine|chlorhexidine|mesh-list
24428892|NCT00241449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24428901|NCT00241475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428903|NCT00241488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24824906|NCT02125968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24824907|NCT02125968|Nasal Decongestants|nasal decongestants|mesh-ancestor
24824908|NCT02125968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24824909|NCT02125968|Respiratory System Agents|respiratory system agents|mesh-ancestor
24824910|NCT02126020|Infliximab|infliximab|mesh-list
24824911|NCT02126020|Dermatologic Agents|dermatologic agents|mesh-ancestor
24824912|NCT02126020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24824913|NCT02126020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24824914|NCT02126137|Ezetimibe|ezetimibe|mesh-list
24824915|NCT02126137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25707955|NCT02240628|Anesthetics|anesthetics|mesh-ancestor
25707956|NCT02240628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25707957|NCT02240628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707958|NCT02240628|Sensory System Agents|sensory system agents|mesh-ancestor
25707959|NCT02240628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24697299|NCT01434134|Metoprolol|metoprolol|mesh-list
24428954|NCT00241618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428955|NCT00241670|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24428956|NCT00241670|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24428957|NCT00241670|Dermatologic Agents|dermatologic agents|mesh-ancestor
24428959|NCT00241722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24428960|NCT00241982|Prednisolone|prednisolone|mesh-list
24428961|NCT00241982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24428962|NCT00241982|Glucocorticoids|glucocorticoids|mesh-ancestor
24775911|NCT01855568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774741|NCT01847612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774743|NCT01847664|Rifamycin SV|rifamycin sv|mesh-list
24774744|NCT01847664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24774745|NCT01847664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24774746|NCT01847664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24774747|NCT01847677|Paclitaxel|paclitaxel|mesh-list
24774748|NCT01847677|Bevacizumab|bevacizumab|mesh-list
24774749|NCT01847677|Carboplatin|carboplatin|mesh-list
24774750|NCT01847677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24774751|NCT01847677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774752|NCT01847677|Tubulin Modulators|tubulin modulators|mesh-ancestor
24774753|NCT01847677|Antimitotic Agents|antimitotic agents|mesh-ancestor
24774754|NCT01847677|Mitosis Modulators|mitosis modulators|mesh-ancestor
24774755|NCT01847677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774756|NCT01847677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24774757|NCT01847677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24774793|NCT01848106|Antithrombins|antithrombins|mesh-ancestor
25081332|NCT03331211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774803|NCT01848119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774805|NCT01848119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24774806|NCT01848119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24774807|NCT01848119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24774808|NCT01848119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24774809|NCT01848119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24774810|NCT01848119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24774811|NCT01848119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24774812|NCT01848119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774813|NCT01848119|Antimanic Agents|antimanic agents|mesh-ancestor
24774814|NCT01848132|Prednisone|prednisone|mesh-list
24774815|NCT01848132|Cyclophosphamide|cyclophosphamide|mesh-list
24774816|NCT01848132|Rituximab|rituximab|mesh-list
24774817|NCT01848132|Doxorubicin|doxorubicin|mesh-list
24774818|NCT01848132|Vincristine|vincristine|mesh-list
24774819|NCT01848132|Bortezomib|bortezomib|mesh-list
24774825|NCT01848132|Alkylating Agents|alkylating agents|mesh-ancestor
24774826|NCT01848132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774827|NCT01848132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774828|NCT01848132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24774829|NCT01848132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24774830|NCT01848132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24774831|NCT01848132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24774832|NCT01848132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24774833|NCT01848132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774846|NCT01848197|Tubulin Modulators|tubulin modulators|mesh-ancestor
24774847|NCT01848197|Antimitotic Agents|antimitotic agents|mesh-ancestor
24774848|NCT01848197|Mitosis Modulators|mitosis modulators|mesh-ancestor
24774849|NCT01848197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774850|NCT01848236|Vitamin D|vitamin d|mesh-list
24774851|NCT01848236|Ergocalciferols|ergocalciferols|mesh-list
24774852|NCT01848236|Cholecalciferol|cholecalciferol|mesh-list
24566096|NCT00784420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24566097|NCT00784420|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24566098|NCT00784420|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24566099|NCT00784420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566100|NCT00784420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566101|NCT00784446|Bevacizumab|bevacizumab|mesh-list
25707961|NCT02240628|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25707962|NCT02240628|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25707963|NCT02240628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24446535|NCT00305266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446543|NCT00305331|Domperidone|domperidone|mesh-list
24566102|NCT00784446|Capecitabine|capecitabine|mesh-list
24566103|NCT00784446|Oxaliplatin|oxaliplatin|mesh-list
24774853|NCT01848236|Vitamins|vitamins|mesh-list
24774887|NCT01848639|Hormone Antagonists|hormone antagonists|mesh-ancestor
24774888|NCT01848639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24774889|NCT01848639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774890|NCT01848639|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24774891|NCT01848639|Diuretics|diuretics|mesh-ancestor
24774892|NCT01848639|Natriuretic Agents|natriuretic agents|mesh-ancestor
24774893|NCT01848652|Doxorubicin|doxorubicin|mesh-list
24774894|NCT01848652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24774895|NCT01848652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24774896|NCT01848652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24659384|NCT01277289|Antiemetics|antiemetics|mesh-ancestor
24774897|NCT01848652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24774898|NCT01848652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774899|NCT01848652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24774900|NCT01848665|Indomethacin|indomethacin|mesh-list
24774901|NCT01848665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24774902|NCT01848665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24774903|NCT01848665|Analgesics|analgesics|mesh-ancestor
24774904|NCT01848665|Sensory System Agents|sensory system agents|mesh-ancestor
24774905|NCT01848665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24774906|NCT01848665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774907|NCT01848665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24774908|NCT01848665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24774909|NCT01848665|Gout Suppressants|gout suppressants|mesh-ancestor
24774910|NCT01848665|Tocolytic Agents|tocolytic agents|mesh-ancestor
24774911|NCT01848665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24774912|NCT01848665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24774913|NCT01848665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24774921|NCT01848743|Tenofovir|tenofovir|mesh-list
24774922|NCT01848743|Lamivudine|lamivudine|mesh-list
24774934|NCT01848769|Autonomic Agents|autonomic agents|mesh-ancestor
24774935|NCT01848769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24774936|NCT01848769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24774937|NCT01848769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24774938|NCT01848769|Respiratory System Agents|respiratory system agents|mesh-ancestor
24774939|NCT01848769|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24774940|NCT01848769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24774941|NCT01848769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24774942|NCT01848769|Adrenergic Agents|adrenergic agents|mesh-ancestor
24774943|NCT01848769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24794072|NCT05414058|Dopamine Agents|dopamine agents|mesh-ancestor
24794073|NCT05414058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24794074|NCT05414032|Cetuximab|cetuximab|mesh-list
24794075|NCT05414032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24794076|NCT05414032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24627322|NCT01091818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24627324|NCT01091818|Anesthetics|anesthetics|mesh-ancestor
24627325|NCT01091818|GABA Modulators|gaba modulators|mesh-ancestor
24627326|NCT01091818|GABA Agents|gaba agents|mesh-ancestor
24774957|NCT01848873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485154|NCT00451776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485155|NCT00451776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24485156|NCT00451776|Anesthetics, General|anesthetics, general|mesh-ancestor
25081343|NCT03330990|Anesthetics, General|anesthetics, general|mesh-ancestor
25081345|NCT03330990|GABA Modulators|gaba modulators|mesh-ancestor
25707964|NCT02240628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709743|NCT02274311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25709744|NCT02274311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709745|NCT02274311|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25709746|NCT02274311|Fertility Agents|fertility agents|mesh-ancestor
25081346|NCT03330990|GABA Agents|gaba agents|mesh-ancestor
25081347|NCT03330990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25709747|NCT02274311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25709748|NCT02274311|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25707965|NCT02240667|Vitamin K|vitamin k|mesh-list
25707966|NCT02240667|Dabigatran|dabigatran|mesh-list
25081348|NCT03330990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081349|NCT03330990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25081350|NCT03330990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25081351|NCT03330886|Atezolizumab|atezolizumab|mesh-list
24485192|NCT00451971|Leflunomide|leflunomide|mesh-list
24485193|NCT00451971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485194|NCT00451971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485196|NCT00451971|Immunologic Factors|immunologic factors|mesh-ancestor
24775049|NCT01849926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775050|NCT01849926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775051|NCT01849926|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24660815|NCT01285817|Tubulin Modulators|tubulin modulators|mesh-ancestor
24775052|NCT01849926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24775053|NCT01849926|Renal Agents|renal agents|mesh-ancestor
24775054|NCT01849926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24775055|NCT01849939|Immunosuppressive Agents|immunosuppressive agents|mesh-list
24775056|NCT01849939|Immunologic Factors|immunologic factors|mesh-ancestor
24775057|NCT01849939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775058|NCT01850017|Dexmedetomidine|dexmedetomidine|mesh-list
24775059|NCT01850017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24775060|NCT01850017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24775061|NCT01850017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775062|NCT01850017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24775063|NCT01850017|Analgesics|analgesics|mesh-ancestor
24775064|NCT01850017|Sensory System Agents|sensory system agents|mesh-ancestor
24775065|NCT01850017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24775066|NCT01850017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24775067|NCT01850017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24775068|NCT01850017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24775069|NCT01850017|Adrenergic Agents|adrenergic agents|mesh-ancestor
24775070|NCT01850017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24912525|NCT04274608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24485259|NCT00452244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24485260|NCT00452244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24775071|NCT01850017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775073|NCT01850095|Estradiol|estradiol|mesh-list
24775074|NCT01850095|Estrogens|estrogens|mesh-ancestor
24775085|NCT01850147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24775086|NCT01850147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24775087|NCT01850147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24775088|NCT01850147|Growth Substances|growth substances|mesh-ancestor
24775089|NCT01850147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775090|NCT01850147|Growth Inhibitors|growth inhibitors|mesh-ancestor
24775091|NCT01850147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24775092|NCT01850147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775093|NCT01850147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775095|NCT01850160|Chlorthalidone|chlorthalidone|mesh-list
24775096|NCT01850160|Antihypertensive Agents|antihypertensive agents|mesh-list
24775097|NCT01850160|Angiotensin II|angiotensin ii|mesh-list
24775098|NCT01850160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24775099|NCT01850160|Diuretics|diuretics|mesh-list
24775100|NCT01850160|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
24775101|NCT01850160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24775102|NCT01850160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775103|NCT01850160|Natriuretic Agents|natriuretic agents|mesh-ancestor
24775104|NCT01850160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566378|NCT00785421|Micronutrients|micronutrients|mesh-ancestor
24775105|NCT01850160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24775134|NCT01850303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25707967|NCT02240667|Phenprocoumon|phenprocoumon|mesh-list
25707968|NCT02240667|Vitamins|vitamins|mesh-ancestor
25707969|NCT02240667|Micronutrients|micronutrients|mesh-ancestor
25707970|NCT02240667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707971|NCT02240667|Antithrombins|antithrombins|mesh-ancestor
25707972|NCT02240667|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25707973|NCT02240667|Protease Inhibitors|protease inhibitors|mesh-ancestor
24775135|NCT01850303|Immunologic Factors|immunologic factors|mesh-ancestor
24775145|NCT01850511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775146|NCT01850511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775148|NCT01850511|Autonomic Agents|autonomic agents|mesh-ancestor
24775149|NCT01850511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24775150|NCT01850511|Nasal Decongestants|nasal decongestants|mesh-ancestor
24775151|NCT01850511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24775154|NCT01850511|Mydriatics|mydriatics|mesh-ancestor
24661667|NCT01290276|Antipruritics|antipruritics|mesh-ancestor
24775155|NCT01850511|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24775156|NCT01850511|Protective Agents|protective agents|mesh-ancestor
24775157|NCT01850628|Paclitaxel|paclitaxel|mesh-list
24775158|NCT01850628|Trastuzumab|trastuzumab|mesh-list
24775159|NCT01850628|Pertuzumab|pertuzumab|mesh-list
24775160|NCT01850628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24775161|NCT01850628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24775162|NCT01850628|Tubulin Modulators|tubulin modulators|mesh-ancestor
24775163|NCT01850628|Antimitotic Agents|antimitotic agents|mesh-ancestor
24775164|NCT01850628|Mitosis Modulators|mitosis modulators|mesh-ancestor
24775165|NCT01850628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775166|NCT01850628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24775167|NCT01850680|Folic Acid|folic acid|mesh-list
24566452|NCT00785863|Ketorolac|ketorolac|mesh-list
24566535|NCT00786318|Serotonin Agents|serotonin agents|mesh-ancestor
24566536|NCT00786318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24566537|NCT00786318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566538|NCT00786318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566539|NCT00786318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24566540|NCT00786318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24566541|NCT00786318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24566542|NCT00786318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24566543|NCT00786318|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24566544|NCT00786318|Dopamine Agents|dopamine agents|mesh-ancestor
24566545|NCT00786331|Carboplatin|carboplatin|mesh-list
24566546|NCT00786331|Pemetrexed|pemetrexed|mesh-list
24566547|NCT00786331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566548|NCT00786331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566549|NCT00786331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566550|NCT00786331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24566551|NCT00786331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24620776|NCT01058915|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24620777|NCT01058915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775190|NCT01850940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775191|NCT01850940|Natriuretic Agents|natriuretic agents|mesh-ancestor
24775192|NCT01850940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775193|NCT01850953|Varenicline|varenicline|mesh-list
24775194|NCT01850953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24775216|NCT01851005|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24775217|NCT01851005|Anesthetics, General|anesthetics, general|mesh-ancestor
24775218|NCT01851005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24775219|NCT01851005|Analgesics|analgesics|mesh-ancestor
24775220|NCT01851005|Sensory System Agents|sensory system agents|mesh-ancestor
24775221|NCT01851005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24775222|NCT01851005|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24775223|NCT01851005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24775224|NCT01851005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24775225|NCT01851005|Adrenergic Agents|adrenergic agents|mesh-ancestor
24775226|NCT01851005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24775227|NCT01851005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775228|NCT01851005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24775230|NCT01851005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24775231|NCT01851005|Narcotics|narcotics|mesh-ancestor
24775232|NCT01851005|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24775233|NCT01851005|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24775234|NCT01851005|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24775235|NCT01851148|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
24775236|NCT01851148|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24775237|NCT01851148|Serotonin Agents|serotonin agents|mesh-ancestor
24627352|NCT01092130|Vitamin D|vitamin d|mesh-list
24627353|NCT01092130|Vitamins|vitamins|mesh-ancestor
25707974|NCT02240667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25707975|NCT02240667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707976|NCT02240667|Anticoagulants|anticoagulants|mesh-ancestor
24627354|NCT01092130|Micronutrients|micronutrients|mesh-ancestor
24627355|NCT01092130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627356|NCT01092130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24627357|NCT01092221|Allopurinol|allopurinol|mesh-list
24627358|NCT01092221|Antimetabolites|antimetabolites|mesh-ancestor
24627359|NCT01092221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627360|NCT01092221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627361|NCT01092221|Gout Suppressants|gout suppressants|mesh-ancestor
24627362|NCT01092221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24627363|NCT01092221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24627364|NCT01092221|Antioxidants|antioxidants|mesh-ancestor
24627366|NCT01092221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627367|NCT01092351|Nitrofurantoin|nitrofurantoin|mesh-list
24775274|NCT01851408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775275|NCT01851473|Quinine|quinine|mesh-list
24775276|NCT01851473|Acetazolamide|acetazolamide|mesh-list
24775277|NCT01851473|Cocaine|cocaine|mesh-list
24775283|NCT01851473|Natriuretic Agents|natriuretic agents|mesh-ancestor
24775284|NCT01851473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775322|NCT01851512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775323|NCT01851551|Rituximab|rituximab|mesh-list
24775324|NCT01851551|Vincristine|vincristine|mesh-list
24775325|NCT01851551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24775326|NCT01851551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24775327|NCT01851551|Immunologic Factors|immunologic factors|mesh-ancestor
24775328|NCT01851551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775329|NCT01851551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24775381|NCT01851941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775382|NCT01851941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24775383|NCT01851941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081385|NCT03330639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790109|NCT01940952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775384|NCT01851941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24775385|NCT01851941|Immunologic Factors|immunologic factors|mesh-ancestor
24775386|NCT01851941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775387|NCT01851941|Antidotes|antidotes|mesh-ancestor
24775388|NCT01851941|Protective Agents|protective agents|mesh-ancestor
24775389|NCT01851941|Vitamin B Complex|vitamin b complex|mesh-ancestor
24775452|NCT01852318|Histamine Antagonists|histamine antagonists|mesh-ancestor
24775453|NCT01852318|Histamine Agents|histamine agents|mesh-ancestor
24775454|NCT01852318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24775455|NCT01852409|Bevacizumab|bevacizumab|mesh-list
24775456|NCT01852409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24775457|NCT01852409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24775458|NCT01852409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24775459|NCT01852409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24775460|NCT01852409|Growth Substances|growth substances|mesh-ancestor
24566850|NCT00788112|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24566851|NCT00788112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566852|NCT00788112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566853|NCT00788138|Vitamin D|vitamin d|mesh-list
24566854|NCT00788138|Cholecalciferol|cholecalciferol|mesh-list
24566855|NCT00788138|Vitamins|vitamins|mesh-ancestor
24566856|NCT00788138|Micronutrients|micronutrients|mesh-ancestor
24566857|NCT00788138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566858|NCT00788138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24566859|NCT00788138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24566860|NCT00788164|Imiquimod|imiquimod|mesh-list
24582799|NCT00871767|Antiviral Agents|antiviral agents|mesh-ancestor
24775500|NCT01852604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24775501|NCT01852604|Antiviral Agents|antiviral agents|mesh-ancestor
24775502|NCT01852604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24775503|NCT01852604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24775504|NCT01852604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24775505|NCT01852604|Protease Inhibitors|protease inhibitors|mesh-ancestor
24775506|NCT01852604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775507|NCT01852604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775508|NCT01852604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24775509|NCT01852604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24775514|NCT01852630|Cefepime|cefepime|mesh-list
24775515|NCT01852630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24775516|NCT01852630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24775517|NCT01852786|Contraceptive Agents|contraceptive agents|mesh-list
24775518|NCT01852786|Contraceptives, Oral|contraceptives, oral|mesh-list
24775519|NCT01852786|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
24475383|NCT00410306|Methyltestosterone|methyltestosterone|mesh-list
24775520|NCT01852786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24775521|NCT01852786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775532|NCT01852903|Protective Agents|protective agents|mesh-ancestor
24663336|NCT01300611|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
24775533|NCT01852994|Methyltestosterone|methyltestosterone|mesh-list
24775534|NCT01852994|Testosterone|testosterone|mesh-list
24775535|NCT01852994|Testosterone undecanoate|testosterone undecanoate|mesh-list
24775536|NCT01852994|Testosterone enanthate|testosterone enanthate|mesh-list
24775537|NCT01852994|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24775538|NCT01852994|Androgens|androgens|mesh-ancestor
24775539|NCT01852994|Hormones|hormones|mesh-ancestor
24775540|NCT01852994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24775541|NCT01852994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775542|NCT01852994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24775543|NCT01852994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24775544|NCT01852994|Anabolic Agents|anabolic agents|mesh-ancestor
24775545|NCT01853111|Aldesleukin|aldesleukin|mesh-list
24775546|NCT01853111|Interleukin-2|interleukin-2|mesh-list
24775547|NCT01853111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24775548|NCT01853111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24775549|NCT01853111|Analgesics|analgesics|mesh-ancestor
24775552|NCT01853111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775553|NCT01853111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24775554|NCT01853111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24775555|NCT01853111|Antiviral Agents|antiviral agents|mesh-ancestor
24775556|NCT01853111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24775558|NCT01853306|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24775559|NCT01853306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775560|NCT01853306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775562|NCT01853423|Sirolimus|sirolimus|mesh-list
24775577|NCT01853449|Sensory System Agents|sensory system agents|mesh-ancestor
24587551|NCT00895609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794682|NCT04776850|Antiemetics|antiemetics|mesh-ancestor
24794788|NCT04636034|Anesthetics, Local|anesthetics, local|mesh-list
24794789|NCT04636034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24794790|NCT04636034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794791|NCT04636034|Sensory System Agents|sensory system agents|mesh-ancestor
24794792|NCT04636034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24794793|NCT04547946|Trametinib|trametinib|mesh-list
24794794|NCT04547946|Dabrafenib|dabrafenib|mesh-list
24794795|NCT04547946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24794796|NCT04547946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24794797|NCT04547946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24794798|NCT04547946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794799|NCT04524663|Camostat|camostat|mesh-list
24794800|NCT04524663|Protease Inhibitors|protease inhibitors|mesh-ancestor
24627372|NCT01092455|Heparin|heparin|mesh-list
24627376|NCT01092455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24627377|NCT01092455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081393|NCT03330223|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25081394|NCT03330223|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25081395|NCT03330223|Purinergic Agents|purinergic agents|mesh-ancestor
25081396|NCT03330223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25081397|NCT03330223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081398|NCT03330223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081399|NCT03330171|Vaccines|vaccines|mesh-list
25081400|NCT03330171|Immunologic Factors|immunologic factors|mesh-ancestor
25081401|NCT03330171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081402|NCT03330132|Vaccines|vaccines|mesh-list
25081403|NCT03330132|Hemagglutinins|hemagglutinins|mesh-list
25081404|NCT03330132|Immunologic Factors|immunologic factors|mesh-ancestor
25081405|NCT03330132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081406|NCT03330132|Agglutinins|agglutinins|mesh-ancestor
25081407|NCT03330106|Paclitaxel|paclitaxel|mesh-list
25081408|NCT03330106|Docetaxel|docetaxel|mesh-list
25081409|NCT03330106|Carboplatin|carboplatin|mesh-list
25081410|NCT03330106|Pevonedistat|pevonedistat|mesh-list
25707977|NCT02240667|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25707978|NCT02240667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25081411|NCT03330106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25081412|NCT03330106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081413|NCT03330106|Tubulin Modulators|tubulin modulators|mesh-ancestor
25081414|NCT03330106|Antimitotic Agents|antimitotic agents|mesh-ancestor
24775606|NCT01853787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24775607|NCT01853787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24775608|NCT01853787|Adrenergic Agents|adrenergic agents|mesh-ancestor
24775609|NCT01853787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24775610|NCT01853787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775611|NCT01853800|Rivaroxaban|rivaroxaban|mesh-list
24775612|NCT01853800|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24775613|NCT01853800|Antithrombins|antithrombins|mesh-ancestor
24775614|NCT01853800|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24775628|NCT01853852|Antiviral Agents|antiviral agents|mesh-ancestor
24775629|NCT01853852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24775630|NCT01853852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775631|NCT01853852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775632|NCT01853956|Alprazolam|alprazolam|mesh-list
24775633|NCT01853956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24775634|NCT01853956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24775635|NCT01853956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775637|NCT01853956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24775638|NCT01853956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24775639|NCT01853956|GABA Modulators|gaba modulators|mesh-ancestor
24775641|NCT01853956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24775642|NCT01853956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775643|NCT01854021|Anesthetics|anesthetics|mesh-list
24775644|NCT01854021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24775645|NCT01854021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775646|NCT01854073|Scopolamine|scopolamine|mesh-list
24775647|NCT01854073|Bromides|bromides|mesh-list
24775648|NCT01854073|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24775649|NCT01854073|Anticonvulsants|anticonvulsants|mesh-ancestor
24775650|NCT01854073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24775669|NCT01854203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24775670|NCT01854203|Antimetabolites|antimetabolites|mesh-ancestor
24775671|NCT01854203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775672|NCT01854203|Antiviral Agents|antiviral agents|mesh-ancestor
24775673|NCT01854203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24775674|NCT01854203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775675|NCT01854203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24775676|NCT01854203|Immunologic Factors|immunologic factors|mesh-ancestor
24775677|NCT01854203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775678|NCT01854216|Rotigotine|rotigotine|mesh-list
24775679|NCT01854216|Dopamine Agonists|dopamine agonists|mesh-ancestor
24775680|NCT01854216|Dopamine Agents|dopamine agents|mesh-ancestor
24775681|NCT01854216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24775682|NCT01854216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775683|NCT01854216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775684|NCT01854411|Analgesics|analgesics|mesh-list
24775685|NCT01854411|Sensory System Agents|sensory system agents|mesh-ancestor
24775686|NCT01854411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24775687|NCT01854411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775688|NCT01854424|Dimercaprol|dimercaprol|mesh-list
24775689|NCT01854424|Chelating Agents|chelating agents|mesh-ancestor
24775690|NCT01854424|Sequestering Agents|sequestering agents|mesh-ancestor
24775691|NCT01854424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775692|NCT01854463|Vitamin D|vitamin d|mesh-list
24775693|NCT01854463|Cholecalciferol|cholecalciferol|mesh-list
24775694|NCT01854463|Vitamins|vitamins|mesh-ancestor
24775695|NCT01854463|Micronutrients|micronutrients|mesh-ancestor
24775696|NCT01854463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775697|NCT01854463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24776572|NCT01858571|Leprostatic Agents|leprostatic agents|mesh-ancestor
24775701|NCT01854476|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24775702|NCT01854476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775703|NCT01854476|Hemostatics|hemostatics|mesh-ancestor
24775704|NCT01854476|Coagulants|coagulants|mesh-ancestor
25707979|NCT02240667|Hemostatics|hemostatics|mesh-ancestor
25707980|NCT02240667|Coagulants|coagulants|mesh-ancestor
24775705|NCT01854489|Rifampin|rifampin|mesh-list
24775709|NCT01854489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25707981|NCT02240680|Linagliptin|linagliptin|mesh-list
25707982|NCT02240680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25707983|NCT02240680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25707984|NCT02240680|Incretins|incretins|mesh-ancestor
24775710|NCT01854489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666687|NCT01320449|Hematinics|hematinics|mesh-ancestor
24666688|NCT01320475|Sufentanil|sufentanil|mesh-list
24775712|NCT01854489|Sensory System Agents|sensory system agents|mesh-ancestor
24775713|NCT01854489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24775714|NCT01854489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24775715|NCT01854489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24775716|NCT01854489|Antitubercular Agents|antitubercular agents|mesh-ancestor
24775717|NCT01854489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24775718|NCT01854489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24775719|NCT01854489|Leprostatic Agents|leprostatic agents|mesh-ancestor
24627389|NCT01092520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24627390|NCT01092520|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24627391|NCT01092520|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24627392|NCT01092520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24627393|NCT01092520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627394|NCT01092520|Antimanic Agents|antimanic agents|mesh-ancestor
24775804|NCT01855009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775805|NCT01855009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24775806|NCT01855009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24775807|NCT01855009|Antacids|antacids|mesh-ancestor
24775824|NCT01855061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775825|NCT01855100|Rivaroxaban|rivaroxaban|mesh-list
24775826|NCT01855100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24775827|NCT01855100|Antithrombins|antithrombins|mesh-ancestor
24775828|NCT01855100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24775829|NCT01855100|Protease Inhibitors|protease inhibitors|mesh-ancestor
24775830|NCT01855100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24775831|NCT01855100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775832|NCT01855100|Anticoagulants|anticoagulants|mesh-ancestor
24775833|NCT01855139|Rivaroxaban|rivaroxaban|mesh-list
24775834|NCT01855139|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24775835|NCT01855139|Antithrombins|antithrombins|mesh-ancestor
24775836|NCT01855139|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24775837|NCT01855139|Protease Inhibitors|protease inhibitors|mesh-ancestor
24775847|NCT01855256|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24775848|NCT01855256|Cholinergic Agents|cholinergic agents|mesh-ancestor
24775869|NCT01855451|Cetuximab|cetuximab|mesh-list
24775870|NCT01855451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776077|NCT01856413|Immunoglobulins|immunoglobulins|mesh-list
24775871|NCT01855451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24775872|NCT01855490|Exenatide|exenatide|mesh-list
24775873|NCT01855490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24775874|NCT01855490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775875|NCT01855490|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24775876|NCT01855490|Incretins|incretins|mesh-ancestor
24775877|NCT01855490|Hormones|hormones|mesh-ancestor
25081429|NCT03329898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25081430|NCT03329898|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25081431|NCT03329898|Progestins|progestins|mesh-ancestor
25081432|NCT03329781|Curcumin|curcumin|mesh-list
25081433|NCT03329781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24913289|NCT04267042|Budesonide|budesonide|mesh-list
24485296|NCT00452556|Fertility Agents|fertility agents|mesh-ancestor
24485297|NCT00452556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24485298|NCT00452556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485299|NCT00452556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25081434|NCT03329781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25081435|NCT03329781|Analgesics|analgesics|mesh-ancestor
25081436|NCT03329781|Sensory System Agents|sensory system agents|mesh-ancestor
24913321|NCT04266509|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24775908|NCT01855568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775909|NCT01855568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24775910|NCT01855568|Dermatologic Agents|dermatologic agents|mesh-ancestor
24775912|NCT01855568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24775913|NCT01855568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24775914|NCT01855568|Immunologic Factors|immunologic factors|mesh-ancestor
24775915|NCT01855568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24775916|NCT01855568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24775918|NCT01855581|Propofol|propofol|mesh-list
25707985|NCT02240680|Hormones|hormones|mesh-ancestor
24775919|NCT01855581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24775920|NCT01855581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24775921|NCT01855581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775922|NCT01855581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24775923|NCT01855581|Anesthetics, General|anesthetics, general|mesh-ancestor
24775924|NCT01855581|Anesthetics|anesthetics|mesh-ancestor
24567238|NCT00790179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24775944|NCT01855607|Dermatologic Agents|dermatologic agents|mesh-ancestor
24775945|NCT01855711|Alosetron|alosetron|mesh-list
24775946|NCT01855711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24775947|NCT01855711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24775949|NCT01855711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24775950|NCT01855711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24775951|NCT01855711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24775952|NCT01855724|Gemcitabine|gemcitabine|mesh-list
24775953|NCT01855724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24775954|NCT01855724|Antimetabolites|antimetabolites|mesh-ancestor
24775956|NCT01855724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776008|NCT01856062|Autonomic Agents|autonomic agents|mesh-ancestor
24776009|NCT01856062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24776010|NCT01856062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776011|NCT01856062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24776012|NCT01856062|Glucocorticoids|glucocorticoids|mesh-ancestor
24776013|NCT01856062|Hormones|hormones|mesh-ancestor
24776014|NCT01856062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24776015|NCT01856062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24776016|NCT01856062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776017|NCT01856101|Dactolisib|dactolisib|mesh-list
24776018|NCT01856101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776019|NCT01856127|Sertraline|sertraline|mesh-list
24776020|NCT01856127|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
24776022|NCT01856127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24776023|NCT01856127|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24776024|NCT01856127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24776025|NCT01856127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24776026|NCT01856127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776027|NCT01856127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24776028|NCT01856127|Serotonin Agents|serotonin agents|mesh-ancestor
24776029|NCT01856127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776072|NCT01856374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776073|NCT01856374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24776074|NCT01856374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24776075|NCT01856374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24776076|NCT01856374|Antifungal Agents|antifungal agents|mesh-ancestor
24567370|NCT00790946|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24776078|NCT01856413|Immunologic Factors|immunologic factors|mesh-ancestor
24790792|NCT01945437|Anesthetics|anesthetics|mesh-ancestor
24568276|NCT00795496|Histamine|histamine|mesh-list
24776094|NCT01856556|Glycine|glycine|mesh-list
24776095|NCT01856556|Glycine Agents|glycine agents|mesh-ancestor
24776096|NCT01856556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24776097|NCT01856556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081464|NCT03329508|Protective Agents|protective agents|mesh-ancestor
24776116|NCT01856738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776117|NCT01856738|Cholinergic Agents|cholinergic agents|mesh-ancestor
24776118|NCT01856738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24776119|NCT01856738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776120|NCT01856738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24776121|NCT01856738|Protective Agents|protective agents|mesh-ancestor
24776122|NCT01856803|Thymoglobulin|thymoglobulin|mesh-list
24776128|NCT01856946|Cholecalciferol|cholecalciferol|mesh-list
24776129|NCT01856946|Vitamins|vitamins|mesh-ancestor
24776130|NCT01856946|Micronutrients|micronutrients|mesh-ancestor
24776131|NCT01856946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776132|NCT01856946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24776133|NCT01856946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24776134|NCT01856959|Magnesium Sulfate|magnesium sulfate|mesh-list
24776135|NCT01856959|Albuterol|albuterol|mesh-list
24776182|NCT01856998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24776183|NCT01856998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776184|NCT01856998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24776185|NCT01856998|Anesthetics, General|anesthetics, general|mesh-ancestor
24776186|NCT01856998|Anesthetics|anesthetics|mesh-ancestor
24776188|NCT01857011|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24776190|NCT01857011|Ferric Compounds|ferric compounds|mesh-list
25707986|NCT02240680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25707987|NCT02240680|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25707988|NCT02240680|Protease Inhibitors|protease inhibitors|mesh-ancestor
24776191|NCT01857011|Trace Elements|trace elements|mesh-ancestor
24776192|NCT01857011|Micronutrients|micronutrients|mesh-ancestor
24776193|NCT01857011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776194|NCT01857011|Hematinics|hematinics|mesh-ancestor
24776195|NCT01857024|Sevelamer|sevelamer|mesh-list
24776196|NCT01857024|Chelating Agents|chelating agents|mesh-ancestor
24776197|NCT01857024|Sequestering Agents|sequestering agents|mesh-ancestor
24913633|NCT04262765|Atorvastatin|atorvastatin|mesh-list
24776226|NCT01857193|Everolimus|everolimus|mesh-list
24776227|NCT01857193|Exemestane|exemestane|mesh-list
24776228|NCT01857193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776229|NCT01857193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24776230|NCT01857193|Immunologic Factors|immunologic factors|mesh-ancestor
24776245|NCT01857349|Ethanol|ethanol|mesh-list
24776246|NCT01857349|Chlorhexidine|chlorhexidine|mesh-list
24776247|NCT01857349|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24776248|NCT01857349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24776250|NCT01857349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24776251|NCT01857349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776252|NCT01857349|Disinfectants|disinfectants|mesh-ancestor
24776253|NCT01857349|Dermatologic Agents|dermatologic agents|mesh-ancestor
24776254|NCT01857375|Insulin|insulin|mesh-list
24776255|NCT01857375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24776256|NCT01857375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776258|NCT01857453|Carboplatin|carboplatin|mesh-list
24776260|NCT01857453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776307|NCT01857596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24776308|NCT01857596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24776309|NCT01857596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24776310|NCT01857596|Serotonin Agents|serotonin agents|mesh-ancestor
24776311|NCT01857609|Metformin|metformin|mesh-list
24776312|NCT01857609|Rabeprazole|rabeprazole|mesh-list
24776313|NCT01857609|Pantoprazole|pantoprazole|mesh-list
24567630|NCT00791804|Anesthetics|anesthetics|mesh-ancestor
24776359|NCT01857817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24776360|NCT01857817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24776361|NCT01857817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776362|NCT01857843|Everolimus|everolimus|mesh-list
24776363|NCT01857843|Simvastatin|simvastatin|mesh-list
24776364|NCT01857843|Ezetimibe|ezetimibe|mesh-list
24776365|NCT01857843|Pravastatin|pravastatin|mesh-list
24776366|NCT01857843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776367|NCT01857843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24776368|NCT01857843|Immunologic Factors|immunologic factors|mesh-ancestor
24776369|NCT01857843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776370|NCT01857843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24776371|NCT01857843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24776372|NCT01857843|Antimetabolites|antimetabolites|mesh-ancestor
24776373|NCT01857843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776374|NCT01857843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24776375|NCT01857843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24776376|NCT01857843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776377|NCT01857856|Eplerenone|eplerenone|mesh-list
24776396|NCT01857921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24776397|NCT01857921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24776398|NCT01857921|Antimetabolites|antimetabolites|mesh-ancestor
24776399|NCT01857921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776400|NCT01857921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24776401|NCT01857921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24776402|NCT01857921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776403|NCT01857921|Vasodilator Agents|vasodilator agents|mesh-ancestor
24776404|NCT01857999|Losartan|losartan|mesh-list
24776405|NCT01857999|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24776406|NCT01857999|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24776407|NCT01857999|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24913792|NCT04260711|Glatiramer Acetate|glatiramer acetate|mesh-list
25707989|NCT02240680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25707990|NCT02240680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707991|NCT02240693|BI 409306|bi 409306|mesh-list
24486569|NCT00458458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24486570|NCT00458458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486571|NCT00458458|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24486572|NCT00458458|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24486573|NCT00458458|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24486574|NCT00458458|Contraceptive Agents|contraceptive agents|mesh-ancestor
24486575|NCT00458458|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24486576|NCT00458458|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24486577|NCT00458510|Fentanyl|fentanyl|mesh-list
24486578|NCT00458510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24486579|NCT00458510|Narcotics|narcotics|mesh-ancestor
24776420|NCT01858025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24776421|NCT01858025|Alkylating Agents|alkylating agents|mesh-ancestor
24776422|NCT01858025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24776423|NCT01858025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24776424|NCT01858051|Cholecalciferol|cholecalciferol|mesh-list
24776425|NCT01858051|Vitamin D|vitamin d|mesh-list
24776426|NCT01858051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24486692|NCT00459420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24486693|NCT00459420|Purinergic Agents|purinergic agents|mesh-ancestor
24486694|NCT00459420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25081491|NCT03329339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081492|NCT03329339|Protective Agents|protective agents|mesh-ancestor
25081493|NCT03329339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627423|NCT01092624|Cholinergic Agents|cholinergic agents|mesh-ancestor
25081495|NCT03329339|Micronutrients|micronutrients|mesh-ancestor
25081496|NCT03329261|Clopidogrel|clopidogrel|mesh-list
25081497|NCT03329261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25081498|NCT03329261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25081499|NCT03329261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25081500|NCT03329261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25081501|NCT03329261|Purinergic Agents|purinergic agents|mesh-ancestor
25081502|NCT03329261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25081503|NCT03329261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081504|NCT03329261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081505|NCT03329248|Leucovorin|leucovorin|mesh-list
25081506|NCT03329248|Paclitaxel|paclitaxel|mesh-list
25081507|NCT03329248|Cyclophosphamide|cyclophosphamide|mesh-list
25081508|NCT03329248|Bevacizumab|bevacizumab|mesh-list
25081509|NCT03329248|Fluorouracil|fluorouracil|mesh-list
25081510|NCT03329248|Capecitabine|capecitabine|mesh-list
24776465|NCT01858090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776466|NCT01858090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24776467|NCT01858090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24776468|NCT01858090|Autonomic Agents|autonomic agents|mesh-ancestor
24776469|NCT01858090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24776470|NCT01858090|Respiratory System Agents|respiratory system agents|mesh-ancestor
24776471|NCT01858090|Mydriatics|mydriatics|mesh-ancestor
24776472|NCT01858090|Parasympatholytics|parasympatholytics|mesh-ancestor
24776473|NCT01858090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24776474|NCT01858090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24776475|NCT01858090|Cholinergic Agents|cholinergic agents|mesh-ancestor
24776476|NCT01858090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24486960|NCT00460733|Micronutrients|micronutrients|mesh-ancestor
24486961|NCT00460733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486962|NCT00460733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24486963|NCT00460733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24486964|NCT00460733|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24776501|NCT01858168|Temozolomide|temozolomide|mesh-list
24776502|NCT01858168|Olaparib|olaparib|mesh-list
24776503|NCT01858168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24776504|NCT01858168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25081517|NCT03329248|Mitosis Modulators|mitosis modulators|mesh-ancestor
24791182|NCT05049707|Sensory System Agents|sensory system agents|mesh-ancestor
24776511|NCT01858207|Doxorubicin|doxorubicin|mesh-list
24776530|NCT01858402|Analgesics|analgesics|mesh-ancestor
24776531|NCT01858402|Sensory System Agents|sensory system agents|mesh-ancestor
24776532|NCT01858402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24776533|NCT01858402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776534|NCT01858402|Antipyretics|antipyretics|mesh-ancestor
24776570|NCT01858571|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24776571|NCT01858571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24776575|NCT01858571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24776576|NCT01858571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24776577|NCT01858571|Growth Substances|growth substances|mesh-ancestor
25707992|NCT02240693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24776578|NCT01858571|Growth Inhibitors|growth inhibitors|mesh-ancestor
24776579|NCT01858610|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24776581|NCT01858610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24914040|NCT04258163|Gemcitabine|gemcitabine|mesh-list
24914041|NCT04258163|Capecitabine|capecitabine|mesh-list
24914042|NCT04258163|Doxorubicin|doxorubicin|mesh-list
24914043|NCT04258163|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24914045|NCT04258163|Fulvestrant|fulvestrant|mesh-list
24914046|NCT04258163|Anastrozole|anastrozole|mesh-list
24914047|NCT04258163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24776601|NCT01858623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24776602|NCT01858649|Bevacizumab|bevacizumab|mesh-list
24620818|NCT01059331|Pregabalin|pregabalin|mesh-list
24620819|NCT01059331|Analgesics|analgesics|mesh-ancestor
24620820|NCT01059331|Sensory System Agents|sensory system agents|mesh-ancestor
24620821|NCT01059331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24620822|NCT01059331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620823|NCT01059331|Anticonvulsants|anticonvulsants|mesh-ancestor
24620824|NCT01059331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24620825|NCT01059331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24620826|NCT01059331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620827|NCT01059331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24620828|NCT01059331|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24620829|NCT01059331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24620830|NCT01059331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24620831|NCT01059331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24620832|NCT01059383|Esomeprazole|esomeprazole|mesh-list
24620833|NCT01059383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24776672|NCT01859234|Bevacizumab|bevacizumab|mesh-list
24776712|NCT01859481|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24776713|NCT01859481|Serotonin Agents|serotonin agents|mesh-ancestor
24776714|NCT01859481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24776715|NCT01859481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776716|NCT01859481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776717|NCT01859585|Ketorolac|ketorolac|mesh-list
24776718|NCT01859585|Parecoxib|parecoxib|mesh-list
24776719|NCT01859585|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24776720|NCT01859585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24776721|NCT01859585|Analgesics|analgesics|mesh-ancestor
24776722|NCT01859585|Sensory System Agents|sensory system agents|mesh-ancestor
24777010|NCT01861015|Hemostatics|hemostatics|mesh-ancestor
24776723|NCT01859585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24776724|NCT01859585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081519|NCT03329248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25081520|NCT03329248|Immunologic Factors|immunologic factors|mesh-ancestor
25081521|NCT03329248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081522|NCT03329248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25081523|NCT03329248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25081524|NCT03329248|Alkylating Agents|alkylating agents|mesh-ancestor
25081525|NCT03329248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25081526|NCT03329248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25081527|NCT03329248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25081528|NCT03329248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25081529|NCT03329248|Growth Substances|growth substances|mesh-ancestor
25081530|NCT03329248|Growth Inhibitors|growth inhibitors|mesh-ancestor
25081531|NCT03329248|Antimetabolites|antimetabolites|mesh-ancestor
25081532|NCT03329248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24776807|NCT01860066|Respiratory System Agents|respiratory system agents|mesh-ancestor
24776808|NCT01860066|Dermatologic Agents|dermatologic agents|mesh-ancestor
24776809|NCT01860066|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24776810|NCT01860066|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24776811|NCT01860066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24776812|NCT01860066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24776813|NCT01860066|Adrenergic Agents|adrenergic agents|mesh-ancestor
24776814|NCT01860066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24776816|NCT01860066|Glucocorticoids|glucocorticoids|mesh-ancestor
25707993|NCT02240693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429099|NCT00242697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25707994|NCT02240693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25707995|NCT02241486|Fentanyl|fentanyl|mesh-list
25707996|NCT02241486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25707997|NCT02241486|Narcotics|narcotics|mesh-ancestor
25707998|NCT02241486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24776818|NCT01860066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24776819|NCT01860066|Sympathomimetics|sympathomimetics|mesh-ancestor
24776820|NCT01860105|Clopidogrel|clopidogrel|mesh-list
24776821|NCT01860105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24776822|NCT01860105|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24776823|NCT01860105|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24776824|NCT01860105|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24776825|NCT01860105|Purinergic Agents|purinergic agents|mesh-ancestor
25081544|NCT03329118|Simvastatin|simvastatin|mesh-list
24776826|NCT01860105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24776827|NCT01860105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776828|NCT01860105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776829|NCT01860144|Bevacizumab|bevacizumab|mesh-list
24776830|NCT01860144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24776831|NCT01860144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24776832|NCT01860144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24776851|NCT01860196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24776852|NCT01860196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24776853|NCT01860196|Cholinergic Agents|cholinergic agents|mesh-ancestor
24776854|NCT01860196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24776855|NCT01860235|Anesthetics|anesthetics|mesh-list
24776856|NCT01860235|Benzocaine|benzocaine|mesh-list
24776857|NCT01860235|Anesthetics, Local|anesthetics, local|mesh-list
24776858|NCT01860235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24776859|NCT01860235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24776860|NCT01860235|Sensory System Agents|sensory system agents|mesh-ancestor
24776884|NCT01860469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24776977|NCT01860833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24776993|NCT01861015|Arginine Vasopressin|arginine vasopressin|mesh-list
24776995|NCT01861015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24776996|NCT01861015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24776997|NCT01861015|Adrenergic Agents|adrenergic agents|mesh-ancestor
24776998|NCT01861015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24776999|NCT01861015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777000|NCT01861015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777001|NCT01861015|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24777002|NCT01861015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24777003|NCT01861015|Autonomic Agents|autonomic agents|mesh-ancestor
24777004|NCT01861015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24777005|NCT01861015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24777006|NCT01861015|Respiratory System Agents|respiratory system agents|mesh-ancestor
24777007|NCT01861015|Mydriatics|mydriatics|mesh-ancestor
24777008|NCT01861015|Sympathomimetics|sympathomimetics|mesh-ancestor
24777009|NCT01861015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24777011|NCT01861015|Coagulants|coagulants|mesh-ancestor
24777053|NCT01861535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777054|NCT01861535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24777055|NCT01861535|Interferon Inducers|interferon inducers|mesh-ancestor
24777056|NCT01861561|Cyclophosphamide|cyclophosphamide|mesh-list
24777057|NCT01861561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24777058|NCT01861561|Immunologic Factors|immunologic factors|mesh-ancestor
24777059|NCT01861561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081547|NCT03329118|Antimetabolites|antimetabolites|mesh-ancestor
24627488|NCT01093092|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
24627489|NCT01093092|Gemcitabine|gemcitabine|mesh-list
25081567|NCT03328936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081569|NCT03328936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25081570|NCT03328936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25081571|NCT03328936|Immunologic Factors|immunologic factors|mesh-ancestor
25081572|NCT03328936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081574|NCT03328728|Viscosupplements|viscosupplements|mesh-ancestor
25081575|NCT03328728|Protective Agents|protective agents|mesh-ancestor
25081576|NCT03328728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081577|NCT03328533|Phenylephrine|phenylephrine|mesh-list
25081578|NCT03328533|Oxymetazoline|oxymetazoline|mesh-list
24777072|NCT01861951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24777073|NCT01861951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24777074|NCT01861951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24777091|NCT01862003|Fluorouracil|fluorouracil|mesh-list
24777092|NCT01862003|Irinotecan|irinotecan|mesh-list
24777093|NCT01862003|Levoleucovorin|levoleucovorin|mesh-list
24777137|NCT01862302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777138|NCT01862302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24777139|NCT01862302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24777140|NCT01862302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24777141|NCT01862302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24777142|NCT01862302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24777143|NCT01862302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24777144|NCT01862302|Dopamine Agents|dopamine agents|mesh-ancestor
24568593|NCT00796497|Antiemetics|antiemetics|mesh-ancestor
24568594|NCT00796497|Autonomic Agents|autonomic agents|mesh-ancestor
24568595|NCT00796497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24568596|NCT00796497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568597|NCT00796497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24568598|NCT00796497|Antipruritics|antipruritics|mesh-ancestor
24568599|NCT00796497|Dermatologic Agents|dermatologic agents|mesh-ancestor
24568600|NCT00796497|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24568601|NCT00796497|Serotonin Agents|serotonin agents|mesh-ancestor
24777176|NCT01862835|Estrogens|estrogens|mesh-list
24777177|NCT01862835|Androgens|androgens|mesh-ancestor
24777178|NCT01862835|Hormones|hormones|mesh-ancestor
24777179|NCT01862835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24777180|NCT01862835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791992|NCT01589523|Cholic Acids|cholic acids|mesh-list
24777181|NCT01862835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24777182|NCT01862835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24777183|NCT01862835|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24777184|NCT01862835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24777185|NCT01862835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24777186|NCT01862835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777187|NCT01862835|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24777188|NCT01862835|Hormone Antagonists|hormone antagonists|mesh-ancestor
24777189|NCT01862887|Moxifloxacin|moxifloxacin|mesh-list
24777190|NCT01862887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24777198|NCT01862926|Rituximab|rituximab|mesh-list
24777232|NCT01863147|Hormones|hormones|mesh-ancestor
24777233|NCT01863147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24777234|NCT01863147|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24777235|NCT01863147|Protease Inhibitors|protease inhibitors|mesh-ancestor
24777236|NCT01863147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24777237|NCT01863147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777238|NCT01863147|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24568694|NCT00797056|Aspirin|aspirin|mesh-list
24777253|NCT01863199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24777254|NCT01863199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25081579|NCT03328533|Norepinephrine|norepinephrine|mesh-list
24777255|NCT01863199|Growth Substances|growth substances|mesh-ancestor
24777256|NCT01863199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777257|NCT01863199|Growth Inhibitors|growth inhibitors|mesh-ancestor
24777258|NCT01863199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24777259|NCT01863225|Atorvastatin|atorvastatin|mesh-list
24777260|NCT01863225|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24777261|NCT01863225|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24777262|NCT01863225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24777263|NCT01863225|Antimetabolites|antimetabolites|mesh-ancestor
24777264|NCT01863225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777265|NCT01863225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24777266|NCT01863225|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24777267|NCT01863225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24777268|NCT01863238|Ivacaftor|ivacaftor|mesh-list
24777269|NCT01863238|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24777307|NCT01863407|Glucocorticoids|glucocorticoids|mesh-ancestor
24777308|NCT01863407|Hormones|hormones|mesh-ancestor
24777309|NCT01863407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24777310|NCT01863407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24430024|NCT00245921|Estrogens|estrogens|mesh-ancestor
24777311|NCT01863407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25707999|NCT02241486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708000|NCT02241486|Analgesics|analgesics|mesh-ancestor
24777312|NCT01863407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24777319|NCT01863459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777320|NCT01863459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25708001|NCT02241486|Sensory System Agents|sensory system agents|mesh-ancestor
25708002|NCT02241486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25708003|NCT02241486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25708004|NCT02241486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25708005|NCT02241486|Anesthetics, General|anesthetics, general|mesh-ancestor
25708006|NCT02241486|Anesthetics|anesthetics|mesh-ancestor
25708007|NCT02241512|Ibuprofen|ibuprofen|mesh-list
24777321|NCT01863459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24777322|NCT01863459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24777323|NCT01863459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777325|NCT01863459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24777326|NCT01863485|Vorolanib|vorolanib|mesh-list
24777327|NCT01863485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24777328|NCT01863485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24796376|NCT01949571|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24487140|NCT00461747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487141|NCT00461747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24487142|NCT00461747|Immunologic Factors|immunologic factors|mesh-ancestor
24487152|NCT00461799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627518|NCT01093235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627519|NCT01093235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24627520|NCT01093235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24627521|NCT01093235|Alkylating Agents|alkylating agents|mesh-ancestor
24627522|NCT01093235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627523|NCT01093235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24627524|NCT01093235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24627525|NCT01093235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24627526|NCT01093235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24627527|NCT01093235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24654264|NCT01248403|Everolimus|everolimus|mesh-list
24627528|NCT01093235|Growth Substances|growth substances|mesh-ancestor
24627529|NCT01093235|Growth Inhibitors|growth inhibitors|mesh-ancestor
24627530|NCT01093235|Tubulin Modulators|tubulin modulators|mesh-ancestor
24627531|NCT01093235|Antimitotic Agents|antimitotic agents|mesh-ancestor
24627532|NCT01093235|Mitosis Modulators|mitosis modulators|mesh-ancestor
24627533|NCT01093235|Antimetabolites|antimetabolites|mesh-ancestor
24777329|NCT01863485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777330|NCT01863511|Tolvaptan|tolvaptan|mesh-list
24777331|NCT01863511|Diuretics|diuretics|mesh-list
25081580|NCT03328533|Bupivacaine|bupivacaine|mesh-list
25081581|NCT03328533|Anesthetics, Local|anesthetics, local|mesh-ancestor
25081582|NCT03328533|Anesthetics|anesthetics|mesh-ancestor
25081583|NCT03328533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25081584|NCT03328533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081585|NCT03328533|Sensory System Agents|sensory system agents|mesh-ancestor
25081586|NCT03328533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25081587|NCT03328533|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25081588|NCT03328533|Mydriatics|mydriatics|mesh-ancestor
25081589|NCT03328533|Autonomic Agents|autonomic agents|mesh-ancestor
25081590|NCT03328533|Sympathomimetics|sympathomimetics|mesh-ancestor
25081591|NCT03328533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25081592|NCT03328533|Nasal Decongestants|nasal decongestants|mesh-ancestor
25081593|NCT03328533|Respiratory System Agents|respiratory system agents|mesh-ancestor
25081594|NCT03328533|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24614988|NCT01027377|Factor VIII|factor viii|mesh-list
25081595|NCT03328533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25081596|NCT03328533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25081597|NCT03328533|Adrenergic Agents|adrenergic agents|mesh-ancestor
24430167|NCT00246272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25081598|NCT03328533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25081599|NCT03328533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081600|NCT03328533|Protective Agents|protective agents|mesh-ancestor
25081602|NCT03328494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25081603|NCT03328494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25081604|NCT03328494|Tubulin Modulators|tubulin modulators|mesh-ancestor
25081605|NCT03328494|Antimitotic Agents|antimitotic agents|mesh-ancestor
25081606|NCT03328494|Mitosis Modulators|mitosis modulators|mesh-ancestor
25081607|NCT03328494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777409|NCT01863823|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24777411|NCT01863823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777412|NCT01863888|Teriflunomide|teriflunomide|mesh-list
24777413|NCT01863888|Cholestyramine Resin|cholestyramine resin|mesh-list
25708008|NCT02241512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25708009|NCT02241512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25708010|NCT02241512|Analgesics|analgesics|mesh-ancestor
25708011|NCT02241512|Sensory System Agents|sensory system agents|mesh-ancestor
24777414|NCT01863888|Charcoal|charcoal|mesh-list
24476968|NCT00416897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24777415|NCT01863888|Antidotes|antidotes|mesh-ancestor
24777416|NCT01863888|Protective Agents|protective agents|mesh-ancestor
24777435|NCT01863914|Antimetabolites|antimetabolites|mesh-ancestor
24777436|NCT01863914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777437|NCT01863914|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24777438|NCT01863914|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24777439|NCT01863914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24777440|NCT01864057|Thiamine|thiamine|mesh-list
24777441|NCT01864057|Vitamin B Complex|vitamin b complex|mesh-ancestor
24777442|NCT01864057|Vitamins|vitamins|mesh-ancestor
24777510|NCT01864616|Vitamin D|vitamin d|mesh-list
24777511|NCT01864616|Cholecalciferol|cholecalciferol|mesh-list
24777512|NCT01864616|Vitamins|vitamins|mesh-ancestor
24777513|NCT01864616|Micronutrients|micronutrients|mesh-ancestor
24777514|NCT01864616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777515|NCT01864616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24777516|NCT01864616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24777517|NCT01864655|Saracatinib|saracatinib|mesh-list
24777518|NCT01864655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24777519|NCT01864655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24777520|NCT01864655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777521|NCT01864681|Metformin|metformin|mesh-list
24777522|NCT01864681|Gefitinib|gefitinib|mesh-list
24777523|NCT01864681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24777524|NCT01864681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777525|NCT01864681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24777526|NCT01864681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24777527|NCT01864681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24777538|NCT01864824|Vitamin B 6|vitamin b 6|mesh-list
24777539|NCT01864824|Vitamin B Complex|vitamin b complex|mesh-list
24777540|NCT01864824|Micronutrients|micronutrients|mesh-ancestor
24777541|NCT01864824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777542|NCT01864824|Hematinics|hematinics|mesh-ancestor
24777592|NCT01865175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777593|NCT01865188|Amlodipine|amlodipine|mesh-list
24777594|NCT01865188|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24777595|NCT01865188|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24777596|NCT01865188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24777597|NCT01865188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24777598|NCT01865188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777600|NCT01865188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081637|NCT03328299|Dexmedetomidine|dexmedetomidine|mesh-list
25081638|NCT03328299|Bupivacaine|bupivacaine|mesh-list
25081639|NCT03328299|Anesthetics, Local|anesthetics, local|mesh-ancestor
25081640|NCT03328299|Anesthetics|anesthetics|mesh-ancestor
25081641|NCT03328299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25081642|NCT03328299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777689|NCT01865916|Ascorbic Acid|ascorbic acid|mesh-list
24777690|NCT01865916|Bisacodyl|bisacodyl|mesh-list
24777691|NCT01865916|Antioxidants|antioxidants|mesh-ancestor
24430288|NCT00247026|Curcumin|curcumin|mesh-list
24777692|NCT01865916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777693|NCT01865916|Protective Agents|protective agents|mesh-ancestor
24777694|NCT01865916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777695|NCT01865916|Vitamins|vitamins|mesh-ancestor
24777696|NCT01865916|Micronutrients|micronutrients|mesh-ancestor
24777697|NCT01865916|Cathartics|cathartics|mesh-ancestor
24777698|NCT01865916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24777699|NCT01865916|Laxatives|laxatives|mesh-ancestor
24777700|NCT01865968|Vaccines|vaccines|mesh-list
24777701|NCT01865968|Immunologic Factors|immunologic factors|mesh-ancestor
24777752|NCT01866397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777753|NCT01866488|Misoprostol|misoprostol|mesh-list
24777754|NCT01866488|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24777755|NCT01866488|Abortifacient Agents|abortifacient agents|mesh-ancestor
25708012|NCT02241512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24777756|NCT01866488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24777757|NCT01866488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708013|NCT02241512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708014|NCT02241512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24477110|NCT00417235|Disinfectants|disinfectants|mesh-ancestor
24477144|NCT00417443|Sympatholytics|sympatholytics|mesh-ancestor
24777759|NCT01866488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24777760|NCT01866488|Oxytocics|oxytocics|mesh-ancestor
24777762|NCT01866514|Anesthetics, Local|anesthetics, local|mesh-ancestor
24777838|NCT01867281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777839|NCT01867281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24777840|NCT01867281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24777841|NCT01867281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24777842|NCT01867281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24777843|NCT01867281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777844|NCT01867281|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24777845|NCT01867281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24777846|NCT01867281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24777848|NCT01867463|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24777849|NCT01867463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24777850|NCT01867463|Immunologic Factors|immunologic factors|mesh-ancestor
24777851|NCT01867463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777852|NCT01867463|Antacids|antacids|mesh-ancestor
24777853|NCT01867463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777854|NCT01867463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24777928|NCT01867892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24777929|NCT01867892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24777930|NCT01867892|Antiviral Agents|antiviral agents|mesh-ancestor
24777931|NCT01867892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24777932|NCT01867892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24777933|NCT01867892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24777934|NCT01867892|Immunologic Factors|immunologic factors|mesh-ancestor
24777935|NCT01867892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24777936|NCT01867892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24777997|NCT01868529|Insulin Glargine|insulin glargine|mesh-list
24777998|NCT01868529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24778008|NCT01868568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24778009|NCT01868568|Insulin Aspart|insulin aspart|mesh-list
24778010|NCT01868568|Insulin, Long-Acting|insulin, long-acting|mesh-list
24778011|NCT01868568|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24778016|NCT01868581|Insulin|insulin|mesh-list
24778092|NCT01869023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24778093|NCT01869023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24778094|NCT01869023|Antimetabolites|antimetabolites|mesh-ancestor
24778095|NCT01869023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778096|NCT01869023|Antiviral Agents|antiviral agents|mesh-ancestor
24778097|NCT01869023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24778098|NCT01869023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24778099|NCT01869023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24778100|NCT01869023|Immunologic Factors|immunologic factors|mesh-ancestor
24778101|NCT01869023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778102|NCT01869036|Morphine|morphine|mesh-list
24778103|NCT01869036|Anesthetics|anesthetics|mesh-list
24778104|NCT01869036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24778105|NCT01869036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778106|NCT01869036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24778107|NCT01869036|Narcotics|narcotics|mesh-ancestor
24778108|NCT01869036|Analgesics|analgesics|mesh-ancestor
24430533|NCT00248183|Naluzotan|naluzotan|mesh-list
24778109|NCT01869036|Sensory System Agents|sensory system agents|mesh-ancestor
24778110|NCT01869036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24778111|NCT01869205|Ivermectin|ivermectin|mesh-list
24778112|NCT01869205|Abamectin|abamectin|mesh-list
24778113|NCT01869205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24778114|NCT01869205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24778115|NCT01869205|Anthelmintics|anthelmintics|mesh-ancestor
24778116|NCT01869257|Triclosan|triclosan|mesh-list
24778117|NCT01869257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24778118|NCT01869257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24778119|NCT01869257|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24778120|NCT01869257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24778121|NCT01869257|Antimetabolites|antimetabolites|mesh-ancestor
24778122|NCT01869257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778127|NCT01869309|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24778128|NCT01869309|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24778129|NCT01869309|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24778130|NCT01869309|Purinergic Agents|purinergic agents|mesh-ancestor
24778131|NCT01869309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25406179|NCT03575403|Sensory System Agents|sensory system agents|mesh-ancestor
25708015|NCT02241512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25708016|NCT02241512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24778132|NCT01869309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778133|NCT01869309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778134|NCT01869413|Tranexamic Acid|tranexamic acid|mesh-list
24778135|NCT01869413|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24778136|NCT01869413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24778138|NCT01869413|Hemostatics|hemostatics|mesh-ancestor
24778179|NCT01869751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778180|NCT01869751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778182|NCT01869803|Calicheamicins|calicheamicins|mesh-list
24778183|NCT01869803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24778184|NCT01869803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24778185|NCT01869803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24778186|NCT01869881|Sarpogrelate|sarpogrelate|mesh-list
24778187|NCT01869881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24778188|NCT01869881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24778189|NCT01869881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778190|NCT01869881|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24778191|NCT01869881|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24778235|NCT01870024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24487242|NCT00462371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24778236|NCT01870024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778237|NCT01870024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24778238|NCT01870024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24778239|NCT01870024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24778240|NCT01870024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24778241|NCT01870024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24778242|NCT01870024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24778243|NCT01870024|GABA Modulators|gaba modulators|mesh-ancestor
24778244|NCT01870024|GABA Agents|gaba agents|mesh-ancestor
24778245|NCT01870024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24778246|NCT01870024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778247|NCT01870024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24778248|NCT01870024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24778250|NCT01870050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24778251|NCT01870050|Antimalarials|antimalarials|mesh-ancestor
24627616|NCT01094015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25081689|NCT03327831|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25081690|NCT03327831|Dermatologic Agents|dermatologic agents|mesh-ancestor
24778313|NCT01870167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778315|NCT01870219|Anesthetics|anesthetics|mesh-list
24778329|NCT01870219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24778330|NCT01870219|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24778332|NCT01870284|Ixekizumab|ixekizumab|mesh-list
24778333|NCT01870284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24778336|NCT01870427|Aflibercept|aflibercept|mesh-list
24778433|NCT01870804|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24778434|NCT01870804|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24778435|NCT01870804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24778436|NCT01870804|Antimetabolites|antimetabolites|mesh-ancestor
24778437|NCT01870804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778438|NCT01870804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25415966|NCT02980510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24778439|NCT01870804|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24778440|NCT01870804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24778442|NCT01870895|Antiemetics|antiemetics|mesh-ancestor
24778475|NCT01871311|Cetuximab|cetuximab|mesh-list
24797611|NCT01956864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797612|NCT01956864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24797613|NCT01956929|Metformin|metformin|mesh-list
24797614|NCT01956929|Lactulose|lactulose|mesh-list
24797615|NCT01956929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24797616|NCT01956929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24797617|NCT01956929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24620933|NCT01059955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24620934|NCT01060137|Fentanyl|fentanyl|mesh-list
24620935|NCT01060137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24620936|NCT01060137|Narcotics|narcotics|mesh-ancestor
24620937|NCT01060137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24620938|NCT01060137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24778625|NCT01871740|Hematinics|hematinics|mesh-ancestor
24778626|NCT01871740|Vitamin B Complex|vitamin b complex|mesh-ancestor
25081769|NCT03327272|Methylprednisolone|methylprednisolone|mesh-list
24797886|NCT01958944|Gasotransmitters|gasotransmitters|mesh-ancestor
24778627|NCT01871740|Vitamins|vitamins|mesh-ancestor
24778628|NCT01871740|Micronutrients|micronutrients|mesh-ancestor
24477721|NCT00419783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24477722|NCT00419783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24778709|NCT01871961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24778710|NCT01871961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24778711|NCT01871961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24778712|NCT01871961|Immunologic Factors|immunologic factors|mesh-ancestor
24778713|NCT01871961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24778714|NCT01871961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24778715|NCT01871974|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24778716|NCT01871974|Antidepressive Agents|antidepressive agents|mesh-ancestor
24778717|NCT01871974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24778802|NCT01872494|Autonomic Agents|autonomic agents|mesh-ancestor
24778803|NCT01872494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24625374|NCT01081964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24778804|NCT01872494|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24778805|NCT01872494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24778809|NCT01872494|Analgesics|analgesics|mesh-ancestor
24778810|NCT01872494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24778811|NCT01872494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24778812|NCT01872494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24778813|NCT01872494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24778814|NCT01872494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24778815|NCT01872494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24778817|NCT01872494|Narcotics|narcotics|mesh-ancestor
24778818|NCT01872494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24778819|NCT01872494|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24778821|NCT01872546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24778822|NCT01872546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24778823|NCT01872702|Piperaquine|piperaquine|mesh-list
24778824|NCT01872702|Primaquine|primaquine|mesh-list
24778825|NCT01872702|Artenimol|artenimol|mesh-list
24778826|NCT01872702|Antimalarials|antimalarials|mesh-ancestor
24778863|NCT01872858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24778864|NCT01872858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24570464|NCT00804947|Melphalan|melphalan|mesh-list
24778865|NCT01872858|Analgesics|analgesics|mesh-ancestor
24778866|NCT01872858|Sensory System Agents|sensory system agents|mesh-ancestor
24778925|NCT01872962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24778926|NCT01872962|Antimetabolites|antimetabolites|mesh-ancestor
24778927|NCT01872962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24778928|NCT01872962|Antiviral Agents|antiviral agents|mesh-ancestor
24570676|NCT00805649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24570677|NCT00805649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24570678|NCT00805649|Glucocorticoids|glucocorticoids|mesh-ancestor
24570679|NCT00805649|Hormones|hormones|mesh-ancestor
24570680|NCT00805649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24570681|NCT00805649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24570688|NCT00805649|GABA Agents|gaba agents|mesh-ancestor
24570689|NCT00805649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24570690|NCT00805649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570691|NCT00805662|Oxytocin|oxytocin|mesh-list
24570695|NCT00805701|Dutasteride|dutasteride|mesh-list
24570696|NCT00805701|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25415967|NCT02980510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24570697|NCT00805701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24779016|NCT01873313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24779019|NCT01873339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24779020|NCT01873339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24779021|NCT01873339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24779022|NCT01873339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779023|NCT01873339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24779024|NCT01873339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24779025|NCT01873339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25708017|NCT02241512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25708018|NCT02241512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708019|NCT02241655|Anesthetics|anesthetics|mesh-list
25708020|NCT02241655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24779026|NCT01873339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24779027|NCT01873339|Anesthetics, General|anesthetics, general|mesh-ancestor
24779028|NCT01873339|Anesthetics|anesthetics|mesh-ancestor
25708021|NCT02241655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708022|NCT02241785|Natalizumab|natalizumab|mesh-list
25708023|NCT02241785|Immunologic Factors|immunologic factors|mesh-ancestor
24779029|NCT01873339|GABA Modulators|gaba modulators|mesh-ancestor
24779030|NCT01873339|GABA Agents|gaba agents|mesh-ancestor
24779031|NCT01873339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24779032|NCT01873339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779033|NCT01873339|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
24627626|NCT01094158|Cholic Acids|cholic acids|mesh-list
24627627|NCT01094158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24627633|NCT01094249|Valproic Acid|valproic acid|mesh-list
25081797|NCT03327168|Purinergic Agonists|purinergic agonists|mesh-ancestor
25081798|NCT03327168|Purinergic Agents|purinergic agents|mesh-ancestor
25081799|NCT03327168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24627650|NCT01094249|GABA Agents|gaba agents|mesh-ancestor
24798136|NCT01960829|Everolimus|everolimus|mesh-list
24779104|NCT01873820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24779106|NCT01873820|Antioxidants|antioxidants|mesh-ancestor
24779107|NCT01873820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779108|NCT01873820|Protective Agents|protective agents|mesh-ancestor
24779109|NCT01873820|Vitamins|vitamins|mesh-ancestor
24779110|NCT01873820|Micronutrients|micronutrients|mesh-ancestor
24779111|NCT01873833|Cyclophosphamide|cyclophosphamide|mesh-list
24779112|NCT01873833|Capecitabine|capecitabine|mesh-list
24779113|NCT01873833|Trastuzumab|trastuzumab|mesh-list
24779114|NCT01873833|Lapatinib|lapatinib|mesh-list
24779115|NCT01873833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24627661|NCT01094275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779116|NCT01873833|Immunologic Factors|immunologic factors|mesh-ancestor
24779140|NCT01874028|Trientine|trientine|mesh-list
24627670|NCT01094340|Leprostatic Agents|leprostatic agents|mesh-ancestor
24627671|NCT01094340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24627672|NCT01094340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24627673|NCT01094340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24627674|NCT01094340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24627675|NCT01094340|Growth Substances|growth substances|mesh-ancestor
24627676|NCT01094340|Growth Inhibitors|growth inhibitors|mesh-ancestor
24794168|NCT05413343|Ceftazidime|ceftazidime|mesh-list
24779225|NCT01874730|Anesthetics|anesthetics|mesh-list
24779226|NCT01874730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24779227|NCT01874730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081843|NCT03326947|Mitosis Modulators|mitosis modulators|mesh-ancestor
25081844|NCT03326947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081845|NCT03326947|Antimetabolites|antimetabolites|mesh-ancestor
24794228|NCT05356936|Vitamin D|vitamin d|mesh-list
24779268|NCT01874860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24431660|NCT00252668|Etanercept|etanercept|mesh-list
24779269|NCT01874860|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24779270|NCT01874860|Protective Agents|protective agents|mesh-ancestor
24779271|NCT01874860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24779278|NCT01874964|Methadone|methadone|mesh-list
24487388|NCT00462852|Immunologic Factors|immunologic factors|mesh-ancestor
24487389|NCT00462852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487401|NCT00462956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487402|NCT00462956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487403|NCT00462995|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24487404|NCT00462995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487405|NCT00462995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24487406|NCT00462995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487407|NCT00462995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487409|NCT00463008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24487410|NCT00463008|Abortifacient Agents|abortifacient agents|mesh-ancestor
24620984|NCT01060228|Anticonvulsants|anticonvulsants|mesh-ancestor
24620985|NCT01060228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24620986|NCT01060228|GABA Agents|gaba agents|mesh-ancestor
24620999|NCT01060293|Furosemide|furosemide|mesh-list
24779300|NCT01875172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24779301|NCT01875172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779302|NCT01875172|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24779303|NCT01875172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24779304|NCT01875172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24779305|NCT01875185|Aspirin|aspirin|mesh-list
25708024|NCT02241785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708025|NCT02241889|Pancrelipase|pancrelipase|mesh-list
24477971|NCT00421083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24779306|NCT01875185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24779307|NCT01875185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24779308|NCT01875185|Analgesics|analgesics|mesh-ancestor
24779309|NCT01875185|Sensory System Agents|sensory system agents|mesh-ancestor
24779310|NCT01875185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24779367|NCT01875757|Micronutrients|micronutrients|mesh-ancestor
24779368|NCT01875757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779369|NCT01875757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24779371|NCT01875822|Curcumin|curcumin|mesh-list
24779372|NCT01875822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24779373|NCT01875822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24779374|NCT01875822|Analgesics|analgesics|mesh-ancestor
24779430|NCT01876121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779431|NCT01876121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24779432|NCT01876121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24779433|NCT01876121|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24779434|NCT01876121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24779435|NCT01876121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24627677|NCT01094340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24627679|NCT01094444|Vitamin K 3|vitamin k 3|mesh-list
24779484|NCT01876355|Autonomic Agents|autonomic agents|mesh-ancestor
24779485|NCT01876355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24779491|NCT01876433|Mirabegron|mirabegron|mesh-list
24487699|NCT00464503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24487700|NCT00464503|Antimetabolites|antimetabolites|mesh-ancestor
24487701|NCT00464503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487702|NCT00464503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24487703|NCT00464503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24779576|NCT01876966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779578|NCT01876966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24779579|NCT01876966|Antiviral Agents|antiviral agents|mesh-ancestor
24779580|NCT01876966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24779581|NCT01876966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24779582|NCT01876966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24779583|NCT01876966|Antimalarials|antimalarials|mesh-ancestor
24779584|NCT01876966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24779585|NCT01876966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24779586|NCT01876966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24432143|NCT00253773|Acetaminophen|acetaminophen|mesh-list
24779587|NCT01876966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24779589|NCT01877122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24779650|NCT01877746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24779651|NCT01877811|Agerafenib|agerafenib|mesh-list
24487845|NCT00465257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24487846|NCT00465257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487847|NCT00465257|Antiviral Agents|antiviral agents|mesh-ancestor
25708026|NCT02241889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25708027|NCT02242045|Idelalisib|idelalisib|mesh-list
25708028|NCT02242045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708029|NCT02242045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25708030|NCT02242045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708031|NCT02242201|Ketorolac|ketorolac|mesh-list
25708032|NCT02242201|Epinephrine|epinephrine|mesh-list
25708033|NCT02242201|Bupivacaine|bupivacaine|mesh-list
25708034|NCT02242201|Ropivacaine|ropivacaine|mesh-list
25708035|NCT02242201|Anesthetics, Local|anesthetics, local|mesh-ancestor
25708036|NCT02242201|Anesthetics|anesthetics|mesh-ancestor
25708037|NCT02242201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25708038|NCT02242201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708039|NCT02242201|Sensory System Agents|sensory system agents|mesh-ancestor
24478144|NCT00421551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24478146|NCT00421642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24478148|NCT00421694|Bicalutamide|bicalutamide|mesh-list
24487848|NCT00465257|Schistosomicides|schistosomicides|mesh-ancestor
24779652|NCT01877811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24779653|NCT01877811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24779654|NCT01877811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779655|NCT01877889|Dapagliflozin|dapagliflozin|mesh-list
24779656|NCT01877889|Canagliflozin|canagliflozin|mesh-list
24779657|NCT01877889|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24779658|NCT01877889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779659|NCT01877889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24779660|NCT01877889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779661|NCT01877954|Fluticasone|fluticasone|mesh-list
24779663|NCT01877954|Beclomethasone|beclomethasone|mesh-list
24779664|NCT01877954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24779665|NCT01877954|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24779666|NCT01877954|Autonomic Agents|autonomic agents|mesh-ancestor
24779667|NCT01877954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24779668|NCT01877954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779669|NCT01877954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24779670|NCT01877954|Respiratory System Agents|respiratory system agents|mesh-ancestor
24779671|NCT01877954|Dermatologic Agents|dermatologic agents|mesh-ancestor
24487927|NCT00465621|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24487978|NCT00466128|Sensory System Agents|sensory system agents|mesh-ancestor
24487979|NCT00466128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24487980|NCT00466128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487981|NCT00466128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24487982|NCT00466128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24487983|NCT00466128|Gout Suppressants|gout suppressants|mesh-ancestor
24487985|NCT00466128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24487986|NCT00466128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24487987|NCT00466128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487988|NCT00466128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487989|NCT00466154|Aspirin|aspirin|mesh-list
24487990|NCT00466154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24487991|NCT00466154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24487992|NCT00466154|Analgesics|analgesics|mesh-ancestor
25081872|NCT03326661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24779678|NCT01878136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24779679|NCT01878136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24779680|NCT01878136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779681|NCT01878188|BCG Vaccine|bcg vaccine|mesh-list
24779682|NCT01878188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24779683|NCT01878188|Immunologic Factors|immunologic factors|mesh-ancestor
24779684|NCT01878188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779686|NCT01878201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24779687|NCT01878201|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24779688|NCT01878201|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24779689|NCT01878201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779690|NCT01878227|Fenofibrate|fenofibrate|mesh-list
24779691|NCT01878227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24779692|NCT01878227|Antimetabolites|antimetabolites|mesh-ancestor
24779693|NCT01878227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779694|NCT01878227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24779695|NCT01878318|Methotrexate|methotrexate|mesh-list
24779696|NCT01878318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24779697|NCT01878318|Abortifacient Agents|abortifacient agents|mesh-ancestor
24779698|NCT01878318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24779699|NCT01878318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708040|NCT02242201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25708041|NCT02242201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25708042|NCT02242201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25708043|NCT02242201|Adrenergic Agents|adrenergic agents|mesh-ancestor
25708044|NCT02242201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25708045|NCT02242201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708046|NCT02242201|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25708047|NCT02242201|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25708048|NCT02242201|Autonomic Agents|autonomic agents|mesh-ancestor
24779742|NCT01878513|Serotonin Agents|serotonin agents|mesh-ancestor
24779743|NCT01878513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24779744|NCT01878513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779745|NCT01878513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779746|NCT01878513|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24487997|NCT00466154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24779805|NCT01878864|Anesthetics, Local|anesthetics, local|mesh-ancestor
24779807|NCT01878864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24779808|NCT01878864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779809|NCT01878864|Sensory System Agents|sensory system agents|mesh-ancestor
24779810|NCT01878864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24627691|NCT01094457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24627692|NCT01094457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24627693|NCT01094457|Analgesics|analgesics|mesh-ancestor
24627694|NCT01094457|Sensory System Agents|sensory system agents|mesh-ancestor
24627695|NCT01094457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24917216|NCT04232085|Melphalan|melphalan|mesh-list
24488000|NCT00466154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488036|NCT00466258|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24488180|NCT00466999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488181|NCT00466999|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24488182|NCT00466999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24488183|NCT00466999|Oxytocics|oxytocics|mesh-ancestor
24488184|NCT00467012|Paclitaxel|paclitaxel|mesh-list
25081864|NCT03326661|Penicillin V|penicillin v|mesh-list
25081865|NCT03326661|Metronidazole|metronidazole|mesh-list
24488187|NCT00467012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488188|NCT00467012|Tubulin Modulators|tubulin modulators|mesh-ancestor
24488189|NCT00467012|Antimitotic Agents|antimitotic agents|mesh-ancestor
25081866|NCT03326661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25081867|NCT03326661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25081868|NCT03326661|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25081869|NCT03326661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25081870|NCT03326661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25081871|NCT03326661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24779830|NCT01879007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24779831|NCT01879007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24779832|NCT01879007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24779833|NCT01879033|Insulin|insulin|mesh-list
24779834|NCT01879033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24571778|NCT00811785|Micronutrients|micronutrients|mesh-ancestor
24571779|NCT00811785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621002|NCT01060293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621003|NCT01060293|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24621004|NCT01060293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24621010|NCT01060293|Dopamine Agents|dopamine agents|mesh-ancestor
24779987|NCT01880372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24779988|NCT01880372|Vitamin B Complex|vitamin b complex|mesh-ancestor
24779989|NCT01880372|Vitamins|vitamins|mesh-ancestor
24779990|NCT01880372|Micronutrients|micronutrients|mesh-ancestor
24779991|NCT01880385|Cyclophosphamide|cyclophosphamide|mesh-list
24779992|NCT01880385|Bevacizumab|bevacizumab|mesh-list
24779993|NCT01880385|Docetaxel|docetaxel|mesh-list
24779994|NCT01880385|Fluorouracil|fluorouracil|mesh-list
24779995|NCT01880385|Trastuzumab|trastuzumab|mesh-list
24779996|NCT01880385|Epirubicin|epirubicin|mesh-list
24779997|NCT01880385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24779998|NCT01880385|Immunologic Factors|immunologic factors|mesh-ancestor
24779999|NCT01880385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780006|NCT01880385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24780056|NCT01880775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780057|NCT01880775|Sensory System Agents|sensory system agents|mesh-ancestor
24780058|NCT01880775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24780059|NCT01880931|Remifentanil|remifentanil|mesh-list
24780060|NCT01880931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24780061|NCT01880931|Narcotics|narcotics|mesh-ancestor
24780062|NCT01880931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24780063|NCT01880931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780064|NCT01880931|Analgesics|analgesics|mesh-ancestor
24780065|NCT01880931|Sensory System Agents|sensory system agents|mesh-ancestor
24780066|NCT01880931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24780067|NCT01881074|Listerine|listerine|mesh-list
24780068|NCT01881074|Triclosan|triclosan|mesh-list
24780069|NCT01881074|Sodium Fluoride|sodium fluoride|mesh-list
24478957|NCT00425074|Antipyretics|antipyretics|mesh-ancestor
24780070|NCT01881074|Cariostatic Agents|cariostatic agents|mesh-ancestor
24780071|NCT01881074|Protective Agents|protective agents|mesh-ancestor
24780072|NCT01881074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780073|NCT01881074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24780075|NCT01881074|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25081910|NCT03326128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25081911|NCT03326128|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25081912|NCT03326128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25081913|NCT03326128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25081914|NCT03326128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780104|NCT01881503|Blood Substitutes|blood substitutes|mesh-ancestor
24780112|NCT01881763|Methohexital|methohexital|mesh-list
24780113|NCT01881763|Analgesics|analgesics|mesh-ancestor
24780114|NCT01881763|Sensory System Agents|sensory system agents|mesh-ancestor
24780115|NCT01881763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24780116|NCT01881763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780117|NCT01881763|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24780118|NCT01881763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24780119|NCT01881763|Anesthetics, General|anesthetics, general|mesh-ancestor
24780120|NCT01881763|Anesthetics|anesthetics|mesh-ancestor
24780121|NCT01881763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24780122|NCT01881763|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24488306|NCT00467636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780162|NCT01882127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24780164|NCT01882127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24780249|NCT01883011|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24780250|NCT01883011|Protective Agents|protective agents|mesh-ancestor
24780251|NCT01883011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780252|NCT01883011|Nootropic Agents|nootropic agents|mesh-ancestor
24780253|NCT01883024|Insulin|insulin|mesh-list
24780254|NCT01883024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24780255|NCT01883024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780256|NCT01883102|Capsaicin|capsaicin|mesh-list
24780257|NCT01883102|Antipruritics|antipruritics|mesh-ancestor
24780258|NCT01883102|Dermatologic Agents|dermatologic agents|mesh-ancestor
24780259|NCT01883102|Sensory System Agents|sensory system agents|mesh-ancestor
24780260|NCT01883102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24572152|NCT00813332|Growth Inhibitors|growth inhibitors|mesh-ancestor
24572153|NCT00813410|Insulin|insulin|mesh-list
24572154|NCT00813410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24572155|NCT00813410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572156|NCT00813436|Oxytocin|oxytocin|mesh-list
24572157|NCT00813436|Oxytocics|oxytocics|mesh-ancestor
24572171|NCT00813475|Insulin|insulin|mesh-list
24780264|NCT01883167|Gout Suppressants|gout suppressants|mesh-ancestor
24780265|NCT01883167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24780266|NCT01883193|Micronutrients|micronutrients|mesh-list
24780319|NCT01883505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24780320|NCT01883505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780321|NCT01883505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780322|NCT01883505|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24780323|NCT01883505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780324|NCT01883518|Vaccines|vaccines|mesh-list
24780325|NCT01883518|Immunologic Factors|immunologic factors|mesh-ancestor
24780326|NCT01883518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488419|NCT00468429|Growth Substances|growth substances|mesh-ancestor
24780376|NCT01884272|Sensory System Agents|sensory system agents|mesh-ancestor
24780377|NCT01884272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24780378|NCT01884272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780379|NCT01884272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24780380|NCT01884272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24780381|NCT01884272|Gout Suppressants|gout suppressants|mesh-ancestor
24780382|NCT01884272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24780383|NCT01884272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780384|NCT01884272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780385|NCT01884272|Tocolytic Agents|tocolytic agents|mesh-ancestor
24780386|NCT01884272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24780413|NCT01884298|Analgesics|analgesics|mesh-ancestor
24780414|NCT01884402|Ribavirin|ribavirin|mesh-list
24780415|NCT01884402|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25081951|NCT03326050|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24795381|NCT02900560|Antimetabolites|antimetabolites|mesh-ancestor
24780416|NCT01884402|Antimetabolites|antimetabolites|mesh-ancestor
24572849|NCT00816959|Bleomycin|bleomycin|mesh-list
24780417|NCT01884402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780418|NCT01884402|Antiviral Agents|antiviral agents|mesh-ancestor
24780522|NCT01884636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24780523|NCT01884636|Immunologic Factors|immunologic factors|mesh-ancestor
24780524|NCT01884636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24780525|NCT01884636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24780526|NCT01884636|Antifungal Agents|antifungal agents|mesh-ancestor
24780527|NCT01884636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24780593|NCT01885013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24780594|NCT01885013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24780595|NCT01885013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780596|NCT01885091|Kinetin|kinetin|mesh-list
24780597|NCT01885091|Plant Growth Regulators|plant growth regulators|mesh-ancestor
24780598|NCT01885091|Growth Substances|growth substances|mesh-ancestor
24780599|NCT01885091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780666|NCT01885481|Respiratory System Agents|respiratory system agents|mesh-ancestor
24780667|NCT01885585|Apixaban|apixaban|mesh-list
24780668|NCT01885585|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24780669|NCT01885585|Antithrombins|antithrombins|mesh-ancestor
24780670|NCT01885585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24780671|NCT01885585|Protease Inhibitors|protease inhibitors|mesh-ancestor
24780672|NCT01885585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780674|NCT01885585|Anticoagulants|anticoagulants|mesh-ancestor
24627764|NCT01094925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24720378|NCT01567995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720379|NCT01568125|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24627765|NCT01094925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627767|NCT01094925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24627768|NCT01094925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24627769|NCT01094925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24627770|NCT01094925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24627771|NCT01094925|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24627772|NCT01094925|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24627773|NCT01094925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25081990|NCT03325790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25081991|NCT03325790|Analgesics|analgesics|mesh-ancestor
25081992|NCT03325790|Sensory System Agents|sensory system agents|mesh-ancestor
25081993|NCT03325790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25081994|NCT03325790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25081995|NCT03325790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25081996|NCT03325790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25081997|NCT03325790|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24780772|NCT01886248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780773|NCT01886248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780775|NCT01886352|Levobupivacaine|levobupivacaine|mesh-list
24780776|NCT01886352|Anesthetics, Local|anesthetics, local|mesh-ancestor
24780777|NCT01886352|Anesthetics|anesthetics|mesh-ancestor
24780785|NCT01886404|Efavirenz|efavirenz|mesh-list
24780786|NCT01886404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24780787|NCT01886404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24780788|NCT01886404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780789|NCT01886404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780790|NCT01886404|Antiviral Agents|antiviral agents|mesh-ancestor
24780872|NCT01886794|Hormones|hormones|mesh-ancestor
24780874|NCT01886794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24780894|NCT01887184|Sensory System Agents|sensory system agents|mesh-ancestor
24780895|NCT01887184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24780896|NCT01887184|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24780897|NCT01887184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24780898|NCT01887184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24780925|NCT01887249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24780926|NCT01887249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24780927|NCT01887249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24638100|NCT01154829|Serotonin Agents|serotonin agents|mesh-ancestor
24780928|NCT01887249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24780929|NCT01887249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24780930|NCT01887249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24780931|NCT01887249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780932|NCT01887249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24780933|NCT01887249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24780934|NCT01887249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24780935|NCT01887275|Interferons|interferons|mesh-list
24780936|NCT01887275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24780937|NCT01887275|Antiviral Agents|antiviral agents|mesh-ancestor
24780938|NCT01887275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24780939|NCT01887301|Nabiximols|nabiximols|mesh-list
24780940|NCT01887301|Analgesics|analgesics|mesh-ancestor
24780969|NCT01887405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24780970|NCT01887405|Autonomic Agents|autonomic agents|mesh-ancestor
24780971|NCT01887405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24780972|NCT01887405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24780973|NCT01887405|Respiratory System Agents|respiratory system agents|mesh-ancestor
24780974|NCT01887405|Mydriatics|mydriatics|mesh-ancestor
24780975|NCT01887405|Sympathomimetics|sympathomimetics|mesh-ancestor
24780976|NCT01887405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24780977|NCT01887457|Voriconazole|voriconazole|mesh-list
24780993|NCT01887561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24780994|NCT01887613|Gabapentin|gabapentin|mesh-list
24572956|NCT00817375|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24781026|NCT01887704|Clopidogrel|clopidogrel|mesh-list
24572980|NCT00817375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24781027|NCT01887704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24781028|NCT01887704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24781029|NCT01887704|Tubulin Modulators|tubulin modulators|mesh-ancestor
24781030|NCT01887704|Antimitotic Agents|antimitotic agents|mesh-ancestor
24781118|NCT01888107|Dopamine Agents|dopamine agents|mesh-ancestor
24720977|NCT01571791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24781120|NCT01888120|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24781121|NCT01888120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24781122|NCT01888120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781123|NCT01888120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24781124|NCT01888120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781209|NCT01888536|Urological Agents|urological agents|mesh-ancestor
24781211|NCT01888562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24781212|NCT01888562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24781213|NCT01888562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781214|NCT01888562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781215|NCT01888575|Aspirin|aspirin|mesh-list
24781216|NCT01888575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24781217|NCT01888575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24781218|NCT01888575|Analgesics|analgesics|mesh-ancestor
24781255|NCT01888744|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24781257|NCT01888744|Progestins|progestins|mesh-ancestor
24573164|NCT00818194|Tacrolimus|tacrolimus|mesh-list
24781258|NCT01888744|Hormones|hormones|mesh-ancestor
24781259|NCT01888744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24781260|NCT01888744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781261|NCT01888744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24781262|NCT01888744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24781263|NCT01888744|Fertility Agents|fertility agents|mesh-ancestor
25082012|NCT03325491|Antimetabolites|antimetabolites|mesh-ancestor
24781296|NCT01888822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781297|NCT01888822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24781298|NCT01888822|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24781299|NCT01888822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24781300|NCT01888822|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24781302|NCT01888835|Antidepressive Agents|antidepressive agents|mesh-ancestor
24781304|NCT01888835|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24781305|NCT01888835|Histamine Antagonists|histamine antagonists|mesh-ancestor
24781306|NCT01888835|Histamine Agents|histamine agents|mesh-ancestor
24781307|NCT01888835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24781308|NCT01888835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781309|NCT01888835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781318|NCT01888835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24781320|NCT01888835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24781322|NCT01888861|Antioxidants|antioxidants|mesh-ancestor
24781323|NCT01888861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781324|NCT01888861|Protective Agents|protective agents|mesh-ancestor
24781325|NCT01888861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781341|NCT01888978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24781342|NCT01888978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781343|NCT01888978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24781344|NCT01888978|Immunologic Factors|immunologic factors|mesh-ancestor
24781345|NCT01888978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781346|NCT01888978|Tubulin Modulators|tubulin modulators|mesh-ancestor
24781347|NCT01888978|Antimitotic Agents|antimitotic agents|mesh-ancestor
24781348|NCT01888978|Mitosis Modulators|mitosis modulators|mesh-ancestor
24781349|NCT01888978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24781350|NCT01888978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24781352|NCT01888978|Protective Agents|protective agents|mesh-ancestor
24781353|NCT01888978|Vitamin B Complex|vitamin b complex|mesh-ancestor
24781354|NCT01888978|Vitamins|vitamins|mesh-ancestor
24621060|NCT01060514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24621061|NCT01060514|Tubulin Modulators|tubulin modulators|mesh-ancestor
24621062|NCT01060514|Antimitotic Agents|antimitotic agents|mesh-ancestor
24621063|NCT01060514|Mitosis Modulators|mitosis modulators|mesh-ancestor
24621066|NCT01060566|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24621067|NCT01060566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24621068|NCT01060566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621069|NCT01060605|Sirolimus|sirolimus|mesh-list
24621070|NCT01060605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24621071|NCT01060605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24621072|NCT01060605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24621073|NCT01060605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24621074|NCT01060605|Antifungal Agents|antifungal agents|mesh-ancestor
24621075|NCT01060605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24621076|NCT01060605|Immunologic Factors|immunologic factors|mesh-ancestor
24621077|NCT01060605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621078|NCT01060618|Maraviroc|maraviroc|mesh-list
24621079|NCT01060618|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24621080|NCT01060618|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24621081|NCT01060618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621082|NCT01060618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24621083|NCT01060618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24621084|NCT01060618|Antiviral Agents|antiviral agents|mesh-ancestor
24621085|NCT01060618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24781427|NCT01889498|Diuretics|diuretics|mesh-ancestor
24781429|NCT01889498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781430|NCT01889576|Magnesium Oxide|magnesium oxide|mesh-list
24781431|NCT01889576|Antacids|antacids|mesh-ancestor
24781432|NCT01889576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708049|NCT02242201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25708050|NCT02242201|Respiratory System Agents|respiratory system agents|mesh-ancestor
25708051|NCT02242201|Mydriatics|mydriatics|mesh-ancestor
25708052|NCT02242201|Sympathomimetics|sympathomimetics|mesh-ancestor
25708053|NCT02242201|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25708054|NCT02242201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25708055|NCT02242201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25708056|NCT02242201|Analgesics|analgesics|mesh-ancestor
24781433|NCT01889576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24781434|NCT01889680|Leucovorin|leucovorin|mesh-list
24781435|NCT01889680|Fluorouracil|fluorouracil|mesh-list
24781436|NCT01889680|Oxaliplatin|oxaliplatin|mesh-list
24781437|NCT01889680|Aflibercept|aflibercept|mesh-list
24781438|NCT01889680|Levoleucovorin|levoleucovorin|mesh-list
24781439|NCT01889680|Antimetabolites|antimetabolites|mesh-ancestor
24781440|NCT01889680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781441|NCT01889680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24781442|NCT01889680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24781443|NCT01889680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24781444|NCT01889680|Immunologic Factors|immunologic factors|mesh-ancestor
24781445|NCT01889680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781446|NCT01889680|Antidotes|antidotes|mesh-ancestor
24781447|NCT01889680|Protective Agents|protective agents|mesh-ancestor
24781448|NCT01889680|Vitamin B Complex|vitamin b complex|mesh-ancestor
24781453|NCT01889680|Growth Substances|growth substances|mesh-ancestor
24781454|NCT01889680|Growth Inhibitors|growth inhibitors|mesh-ancestor
24781455|NCT01889758|Tacrolimus|tacrolimus|mesh-list
24781456|NCT01889758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24781457|NCT01889758|Immunologic Factors|immunologic factors|mesh-ancestor
24781458|NCT01889758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781459|NCT01889758|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24781460|NCT01889758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781461|NCT01889758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781462|NCT01889771|Nicotine|nicotine|mesh-list
24781472|NCT01889810|Vitamin D|vitamin d|mesh-list
24781476|NCT01889810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781477|NCT01889810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24781478|NCT01889810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24781480|NCT01889849|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24781481|NCT01889849|Antiviral Agents|antiviral agents|mesh-ancestor
24781482|NCT01889849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24781576|NCT01890772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24781577|NCT01890772|Antimetabolites|antimetabolites|mesh-ancestor
24781578|NCT01890772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781579|NCT01890772|Antiviral Agents|antiviral agents|mesh-ancestor
24781580|NCT01890772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24781581|NCT01890863|Fluticasone|fluticasone|mesh-list
24781583|NCT01890863|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24781584|NCT01890863|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24781585|NCT01890863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24781586|NCT01890863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24919145|NCT04213937|Topotecan|topotecan|mesh-list
24489559|NCT00474019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24489560|NCT00474019|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24781588|NCT01890863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24781589|NCT01890863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781593|NCT01890863|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24781594|NCT01890863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24781634|NCT01891019|Leprostatic Agents|leprostatic agents|mesh-ancestor
24781635|NCT01891019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24781636|NCT01891019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24781637|NCT01891019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24781638|NCT01891019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24781639|NCT01891019|Growth Substances|growth substances|mesh-ancestor
24781640|NCT01891019|Growth Inhibitors|growth inhibitors|mesh-ancestor
24781641|NCT01891019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24781649|NCT01891084|Antipyretics|antipyretics|mesh-ancestor
24781650|NCT01891084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24781651|NCT01891084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24919209|NCT04213885|Riboflavin|riboflavin|mesh-list
24781669|NCT01891227|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24781670|NCT01891227|Alkylating Agents|alkylating agents|mesh-ancestor
24489598|NCT00474136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24489599|NCT00474136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489600|NCT00474162|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24489601|NCT00474162|Plasma Substitutes|plasma substitutes|mesh-ancestor
24489602|NCT00474162|Blood Substitutes|blood substitutes|mesh-ancestor
24489604|NCT00474279|Secretagogues|secretagogues|mesh-list
24489607|NCT00474435|Tenofovir|tenofovir|mesh-list
24489627|NCT00474591|Antithrombins|antithrombins|mesh-ancestor
24489693|NCT00474890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489694|NCT00474890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24489695|NCT00474890|Respiratory System Agents|respiratory system agents|mesh-ancestor
24489696|NCT00474890|Nasal Decongestants|nasal decongestants|mesh-ancestor
24489697|NCT00474890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24489698|NCT00474890|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24489699|NCT00474890|Sympathomimetics|sympathomimetics|mesh-ancestor
24489700|NCT00474890|Adrenergic Agents|adrenergic agents|mesh-ancestor
24489701|NCT00474890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24573614|NCT00821080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24573615|NCT00821080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24573616|NCT00821080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24573617|NCT00821080|Antifungal Agents|antifungal agents|mesh-ancestor
24573618|NCT00821080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24573619|NCT00821080|Immunologic Factors|immunologic factors|mesh-ancestor
24573620|NCT00821080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573621|NCT00821158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24573623|NCT00821158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573624|NCT00821158|Protective Agents|protective agents|mesh-ancestor
24573625|NCT00821158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621090|NCT01060631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621091|NCT01060631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24621092|NCT01060631|Anesthetics, General|anesthetics, general|mesh-ancestor
24621093|NCT01060631|Anesthetics|anesthetics|mesh-ancestor
24621094|NCT01060683|Chrysarobin|chrysarobin|mesh-list
24621095|NCT01060683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24621096|NCT01060683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24621105|NCT01060696|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24621106|NCT01060696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24621109|NCT01060696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24621110|NCT01060696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621112|NCT01060696|Mydriatics|mydriatics|mesh-ancestor
24781694|NCT01891435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781695|NCT01891435|Antipyretics|antipyretics|mesh-ancestor
24781696|NCT01891435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24781697|NCT01891435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24781698|NCT01891435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24781699|NCT01891435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24489796|NCT00475462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24489798|NCT00475462|Autonomic Agents|autonomic agents|mesh-ancestor
24489799|NCT00475462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489800|NCT00475462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435263|NCT00265811|Cetuximab|cetuximab|mesh-list
24489801|NCT00475462|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24489802|NCT00475462|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24489803|NCT00475462|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24489804|NCT00475462|Adrenergic Agents|adrenergic agents|mesh-ancestor
24489805|NCT00475462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24489806|NCT00475462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781772|NCT01891708|Growth Substances|growth substances|mesh-ancestor
24781806|NCT01892098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781807|NCT01892098|Dermatologic Agents|dermatologic agents|mesh-ancestor
24781808|NCT01892150|Sunscreening Agents|sunscreening agents|mesh-list
24781809|NCT01892150|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24781810|NCT01892150|Protective Agents|protective agents|mesh-ancestor
24781811|NCT01892150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781814|NCT01892176|Coenzyme Q10|coenzyme q10|mesh-list
24781815|NCT01892176|Micronutrients|micronutrients|mesh-ancestor
24781816|NCT01892176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781817|NCT01892176|Vitamins|vitamins|mesh-ancestor
24781818|NCT01892241|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24781819|NCT01892241|Entecavir|entecavir|mesh-list
24781820|NCT01892241|Antiviral Agents|antiviral agents|mesh-ancestor
24781821|NCT01892241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24781822|NCT01892254|Metformin|metformin|mesh-list
24781823|NCT01892254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24781824|NCT01892254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781845|NCT01892332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24781846|NCT01892332|Anesthetics, General|anesthetics, general|mesh-ancestor
24781847|NCT01892384|BI 409306|bi 409306|mesh-list
25082060|NCT03325335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24781848|NCT01892384|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24781849|NCT01892384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781851|NCT01892488|Sultamicillin|sultamicillin|mesh-list
24781852|NCT01892488|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
24796816|NCT01952561|Dapivirine|dapivirine|mesh-list
24781899|NCT01892813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24781900|NCT01892813|Autonomic Agents|autonomic agents|mesh-ancestor
24617726|NCT01045278|Antimetabolites|antimetabolites|mesh-ancestor
24490079|NCT00476268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24490080|NCT00476268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490081|NCT00476268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24490082|NCT00476268|Glucocorticoids|glucocorticoids|mesh-ancestor
24658495|NCT01272089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24658695|NCT01273532|Analgesics|analgesics|mesh-ancestor
24627803|NCT01094990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24627804|NCT01094990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627805|NCT01094990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24627806|NCT01094990|Glucocorticoids|glucocorticoids|mesh-ancestor
24627808|NCT01094990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24781928|NCT01892995|Anesthetics|anesthetics|mesh-ancestor
24781929|NCT01892995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24781930|NCT01892995|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24781959|NCT01893229|Autonomic Agents|autonomic agents|mesh-ancestor
24781960|NCT01893229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24781961|NCT01893229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24781962|NCT01893229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24781963|NCT01893229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24781964|NCT01893229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24781965|NCT01893229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24781966|NCT01893229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24781967|NCT01893229|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24781968|NCT01893229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24781969|NCT01893229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24781970|NCT01893229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24781971|NCT01893229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24781972|NCT01893229|Serotonin Agents|serotonin agents|mesh-ancestor
24781973|NCT01893229|Antidepressive Agents|antidepressive agents|mesh-ancestor
24781974|NCT01893229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24781975|NCT01893229|Antimanic Agents|antimanic agents|mesh-ancestor
24781976|NCT01893229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24781977|NCT01893229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24781978|NCT01893229|Dopamine Agents|dopamine agents|mesh-ancestor
24781979|NCT01893229|Anticonvulsants|anticonvulsants|mesh-ancestor
24573985|NCT00822848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24573986|NCT00822848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24573987|NCT00822848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573988|NCT00822848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573990|NCT00822848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24573991|NCT00822848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24573992|NCT00822848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24573993|NCT00822848|Alkylating Agents|alkylating agents|mesh-ancestor
24490251|NCT00477126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24480804|NCT00432302|Sagopilone|sagopilone|mesh-list
24490278|NCT00477503|Protective Agents|protective agents|mesh-ancestor
24490279|NCT00477503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490280|NCT00477503|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24490369|NCT00477815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24490370|NCT00477815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490371|NCT00477815|Immunologic Factors|immunologic factors|mesh-ancestor
24490372|NCT00477815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621137|NCT01060774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621138|NCT01060774|Sensory System Agents|sensory system agents|mesh-ancestor
24782018|NCT01893424|Hormones|hormones|mesh-ancestor
24782088|NCT01894035|Vasodilator Agents|vasodilator agents|mesh-ancestor
24490387|NCT00477854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490388|NCT00477880|Cetuximab|cetuximab|mesh-list
24490389|NCT00477880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24490390|NCT00477880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490391|NCT00477893|Adalimumab|adalimumab|mesh-list
24490392|NCT00477893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24490393|NCT00477893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24490394|NCT00477945|Clofarabine|clofarabine|mesh-list
24490395|NCT00477945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24490396|NCT00477945|Antimetabolites|antimetabolites|mesh-ancestor
24490397|NCT00477945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490398|NCT00477945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24782089|NCT01894048|Beclomethasone|beclomethasone|mesh-list
24782090|NCT01894048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24782091|NCT01894048|Glucocorticoids|glucocorticoids|mesh-ancestor
24782092|NCT01894048|Hormones|hormones|mesh-ancestor
24782095|NCT01894048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24782124|NCT01894295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24782177|NCT01894685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24782178|NCT01894685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24782179|NCT01894685|Analgesics|analgesics|mesh-ancestor
24782180|NCT01894685|Sensory System Agents|sensory system agents|mesh-ancestor
24782181|NCT01894685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24782182|NCT01894685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919732|NCT04208594|Vasodilator Agents|vasodilator agents|mesh-ancestor
24490478|NCT00478504|Fertility Agents|fertility agents|mesh-ancestor
24490482|NCT00478517|Epoetin Alfa|epoetin alfa|mesh-list
24782221|NCT01894867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24782222|NCT01895010|Tropisetron|tropisetron|mesh-list
24782223|NCT01895010|Antiemetics|antiemetics|mesh-ancestor
24782224|NCT01895010|Autonomic Agents|autonomic agents|mesh-ancestor
24782225|NCT01895010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24782226|NCT01895010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782227|NCT01895010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24782228|NCT01895010|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24782230|NCT01895010|Serotonin Agents|serotonin agents|mesh-ancestor
24782231|NCT01895010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24782232|NCT01895010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782233|NCT01895023|Midazolam|midazolam|mesh-list
24919790|NCT04208399|JNJ-56136379|jnj-56136379|mesh-list
24490487|NCT00478543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490488|NCT00478543|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24490496|NCT00478634|Everolimus|everolimus|mesh-list
24490497|NCT00478634|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24490498|NCT00478634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24490499|NCT00478634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24490500|NCT00478634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490506|NCT00478660|Adalimumab|adalimumab|mesh-list
24782254|NCT01895023|Anesthetics, General|anesthetics, general|mesh-ancestor
24782255|NCT01895023|Anesthetics|anesthetics|mesh-ancestor
24782256|NCT01895023|GABA Agents|gaba agents|mesh-ancestor
24782257|NCT01895049|Mycophenolic Acid|mycophenolic acid|mesh-list
24782258|NCT01895049|Prednisone|prednisone|mesh-list
24782259|NCT01895049|Everolimus|everolimus|mesh-list
24782260|NCT01895049|Tacrolimus|tacrolimus|mesh-list
24782261|NCT01895049|Thymoglobulin|thymoglobulin|mesh-list
24782262|NCT01895049|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24782263|NCT01895049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24782264|NCT01895049|Glucocorticoids|glucocorticoids|mesh-ancestor
24782265|NCT01895049|Hormones|hormones|mesh-ancestor
24919811|NCT04208516|Autonomic Agents|autonomic agents|mesh-ancestor
24919815|NCT04208516|Glucocorticoids|glucocorticoids|mesh-ancestor
25406180|NCT03575403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24480996|NCT00433069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782266|NCT01895049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24490624|NCT00479206|Antiviral Agents|antiviral agents|mesh-ancestor
24490625|NCT00479206|Schistosomicides|schistosomicides|mesh-ancestor
24490626|NCT00479206|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24490627|NCT00479206|Anthelmintics|anthelmintics|mesh-ancestor
24491537|NCT00482963|Contraceptive Agents|contraceptive agents|mesh-ancestor
24490635|NCT00479362|Analgesics|analgesics|mesh-ancestor
24490647|NCT00479362|Antipyretics|antipyretics|mesh-ancestor
24490648|NCT00479362|Anticoagulants|anticoagulants|mesh-ancestor
24490649|NCT00479479|Vitamin B 12|vitamin b 12|mesh-list
24490682|NCT00479726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24490683|NCT00479726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490684|NCT00479726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24490685|NCT00479726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490686|NCT00479726|Analgesics|analgesics|mesh-ancestor
24490687|NCT00479726|Sensory System Agents|sensory system agents|mesh-ancestor
24490693|NCT00479739|Xhance|xhance|mesh-list
24621144|NCT01060774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621145|NCT01060787|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
24621146|NCT01060787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24621147|NCT01060787|Glucocorticoids|glucocorticoids|mesh-ancestor
24621149|NCT01060787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24621150|NCT01060787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621151|NCT01060826|Somatostatin|somatostatin|mesh-list
24782291|NCT01895205|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
24782308|NCT01895257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24782309|NCT01895257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24782310|NCT01895257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24782311|NCT01895257|Immunologic Factors|immunologic factors|mesh-ancestor
24782313|NCT01895296|Hormones|hormones|mesh-ancestor
24782314|NCT01895296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24782315|NCT01895296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782316|NCT01895348|Dexmedetomidine|dexmedetomidine|mesh-list
24782317|NCT01895348|Remifentanil|remifentanil|mesh-list
24782318|NCT01895348|Propofol|propofol|mesh-list
24782319|NCT01895348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24782320|NCT01895348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24782321|NCT01895348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782322|NCT01895348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24782323|NCT01895348|Anesthetics, General|anesthetics, general|mesh-ancestor
24782324|NCT01895348|Anesthetics|anesthetics|mesh-ancestor
24782342|NCT01895400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24782343|NCT01895400|Respiratory System Agents|respiratory system agents|mesh-ancestor
24782344|NCT01895400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24782345|NCT01895400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24782346|NCT01895400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782347|NCT01895400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24782348|NCT01895400|Vasodilator Agents|vasodilator agents|mesh-ancestor
24782349|NCT01895400|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24782350|NCT01895400|Protective Agents|protective agents|mesh-ancestor
24782351|NCT01895400|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24782352|NCT01895400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24782353|NCT01895400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24782355|NCT01895569|Pioglitazone|pioglitazone|mesh-list
24782356|NCT01895569|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24782357|NCT01895569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24782358|NCT01895569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782359|NCT01895569|Incretins|incretins|mesh-ancestor
24490864|NCT00480298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24490943|NCT00480597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24490944|NCT00480597|Antimetabolites|antimetabolites|mesh-ancestor
24490945|NCT00480597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490946|NCT00480597|Antiviral Agents|antiviral agents|mesh-ancestor
24782430|NCT01896180|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24782431|NCT01896180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24782432|NCT01896245|Sevoflurane|sevoflurane|mesh-list
24782433|NCT01896245|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25708057|NCT02242201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25708058|NCT02242201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24782434|NCT01896245|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24782435|NCT01896245|Anesthetics, General|anesthetics, general|mesh-ancestor
24782436|NCT01896245|Anesthetics|anesthetics|mesh-ancestor
24782437|NCT01896245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24782438|NCT01896245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782439|NCT01896284|Aflibercept|aflibercept|mesh-list
24782440|NCT01896284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24782441|NCT01896284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24782442|NCT01896284|Growth Substances|growth substances|mesh-ancestor
24782443|NCT01896284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919975|NCT04206176|Ticagrelor|ticagrelor|mesh-list
24490959|NCT00480610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490960|NCT00480610|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24491028|NCT00480870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24491029|NCT00480870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491030|NCT00480870|Nootropic Agents|nootropic agents|mesh-ancestor
24491031|NCT00480883|Meglumine Antimoniate|meglumine antimoniate|mesh-list
24491032|NCT00480883|Allopurinol|allopurinol|mesh-list
24491033|NCT00480883|Antimetabolites|antimetabolites|mesh-ancestor
24491109|NCT00481273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24491110|NCT00481273|Antimetabolites|antimetabolites|mesh-ancestor
24491111|NCT00481273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491112|NCT00481273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24782444|NCT01896284|Growth Inhibitors|growth inhibitors|mesh-ancestor
24782445|NCT01896284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24782446|NCT01896323|Ketoconazole|ketoconazole|mesh-list
24782447|NCT01896323|Antifungal Agents|antifungal agents|mesh-ancestor
24782448|NCT01896323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24782449|NCT01896323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24782450|NCT01896323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24782451|NCT01896323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24782452|NCT01896323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782453|NCT01896323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24782454|NCT01896323|Hormone Antagonists|hormone antagonists|mesh-ancestor
24782455|NCT01896323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24782458|NCT01896336|Zolpidem|zolpidem|mesh-list
24782508|NCT01896349|Sensory System Agents|sensory system agents|mesh-ancestor
24782509|NCT01896349|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24782510|NCT01896349|Histamine Antagonists|histamine antagonists|mesh-ancestor
24782511|NCT01896349|Histamine Agents|histamine agents|mesh-ancestor
24782512|NCT01896349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24782513|NCT01896349|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24782514|NCT01896349|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24782515|NCT01896349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24782516|NCT01896349|Adrenergic Agents|adrenergic agents|mesh-ancestor
24782517|NCT01896349|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24782518|NCT01896349|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24782519|NCT01896349|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24782520|NCT01896349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24491113|NCT00481273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491115|NCT00481312|Dexmedetomidine|dexmedetomidine|mesh-list
24491116|NCT00481312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24783242|NCT01900795|Analgesics|analgesics|mesh-ancestor
24627822|NCT01095016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24627823|NCT01095016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24627824|NCT01095016|Adrenergic Agents|adrenergic agents|mesh-ancestor
24627825|NCT01095016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24627847|NCT01095172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24491163|NCT00481442|Adrenergic Agents|adrenergic agents|mesh-ancestor
24491164|NCT00481442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24491165|NCT00481442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491166|NCT00481442|Protective Agents|protective agents|mesh-ancestor
24491167|NCT00481455|Temozolomide|temozolomide|mesh-list
24491168|NCT00481455|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
24491219|NCT00481663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491222|NCT00481689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24491298|NCT00481975|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24491299|NCT00481975|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24481776|NCT00436761|Protective Agents|protective agents|mesh-ancestor
24481777|NCT00436761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481778|NCT00436761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24491300|NCT00481975|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24491301|NCT00481975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24782560|NCT01896518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24782561|NCT01896518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782564|NCT01896609|Interferon-alpha|interferon-alpha|mesh-list
24782565|NCT01896609|Interferon alpha-2|interferon alpha-2|mesh-list
24782566|NCT01896609|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24782567|NCT01896609|Nitazoxanide|nitazoxanide|mesh-list
24782568|NCT01896609|Complement Factor H|complement factor h|mesh-list
24782569|NCT01896609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24782570|NCT01896609|Antiviral Agents|antiviral agents|mesh-ancestor
24782571|NCT01896609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24782572|NCT01896609|Antimetabolites|antimetabolites|mesh-ancestor
24574531|NCT00825864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24574532|NCT00825864|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24491311|NCT00482066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491321|NCT00482079|Hormones|hormones|mesh-ancestor
24491329|NCT00482183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491330|NCT00482209|Misoprostol|misoprostol|mesh-list
24491331|NCT00482209|Mifepristone|mifepristone|mesh-list
24491332|NCT00482209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24491333|NCT00482209|Abortifacient Agents|abortifacient agents|mesh-ancestor
24491334|NCT00482209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24491335|NCT00482209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491336|NCT00482209|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24491337|NCT00482209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24491338|NCT00482209|Oxytocics|oxytocics|mesh-ancestor
24491339|NCT00482209|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24491340|NCT00482209|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24491341|NCT00482209|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24491342|NCT00482209|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24782574|NCT01896609|Immunologic Factors|immunologic factors|mesh-ancestor
24782584|NCT01896622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24782585|NCT01896622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782586|NCT01896622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24782587|NCT01896622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24782588|NCT01896622|Antiviral Agents|antiviral agents|mesh-ancestor
24491507|NCT00482807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491508|NCT00482807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24491509|NCT00482807|Androgen Antagonists|androgen antagonists|mesh-ancestor
24491510|NCT00482807|Hormone Antagonists|hormone antagonists|mesh-ancestor
24491511|NCT00482807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24491536|NCT00482963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24782669|NCT01897337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782671|NCT01897337|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24782672|NCT01897337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24782674|NCT01897428|Bepotastine besilate|bepotastine besilate|mesh-list
24491610|NCT00483158|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24491611|NCT00483158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24491612|NCT00483158|Renal Agents|renal agents|mesh-ancestor
24491613|NCT00483158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24491614|NCT00483158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24491615|NCT00483158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24491616|NCT00483158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491641|NCT00483314|Respiratory System Agents|respiratory system agents|mesh-ancestor
24491642|NCT00483314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24491643|NCT00483314|Antioxidants|antioxidants|mesh-ancestor
24491644|NCT00483314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708059|NCT02242201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25708060|NCT02242201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25708061|NCT02242305|Scopolamine|scopolamine|mesh-list
25708062|NCT02242305|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25708063|NCT02242305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25708064|NCT02242305|Antiemetics|antiemetics|mesh-ancestor
25708065|NCT02242305|Autonomic Agents|autonomic agents|mesh-ancestor
25708066|NCT02242305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25708067|NCT02242305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708068|NCT02242305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25708069|NCT02242305|Mydriatics|mydriatics|mesh-ancestor
24491645|NCT00483314|Protective Agents|protective agents|mesh-ancestor
24491647|NCT00483314|Antidotes|antidotes|mesh-ancestor
24782746|NCT01897740|Sildenafil Citrate|sildenafil citrate|mesh-list
24782747|NCT01897740|Vasodilator Agents|vasodilator agents|mesh-ancestor
24782748|NCT01897740|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24782749|NCT01897740|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24782750|NCT01897740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24782758|NCT01897779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782759|NCT01897779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24782760|NCT01897779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24782761|NCT01897844|Somatostatin|somatostatin|mesh-list
24782805|NCT01898104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24782808|NCT01898169|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24782809|NCT01898169|Autonomic Agents|autonomic agents|mesh-ancestor
24782810|NCT01898169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24782811|NCT01898169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782812|NCT01898169|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24782813|NCT01898169|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24782814|NCT01898169|Cholinergic Agents|cholinergic agents|mesh-ancestor
24782815|NCT01898169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24782816|NCT01898169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782817|NCT01898182|Kinetin|kinetin|mesh-list
24782829|NCT01898338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25082140|NCT03324503|Hormones|hormones|mesh-ancestor
25082142|NCT03324503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082143|NCT03324503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25082145|NCT03324503|Antiemetics|antiemetics|mesh-ancestor
25082146|NCT03324503|Autonomic Agents|autonomic agents|mesh-ancestor
24574868|NCT00828087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574870|NCT00828087|Micronutrients|micronutrients|mesh-ancestor
24574871|NCT00828230|Budesonide|budesonide|mesh-list
24574875|NCT00828230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24574876|NCT00828230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574877|NCT00828230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24782895|NCT01898728|Plasma Substitutes|plasma substitutes|mesh-ancestor
24782896|NCT01898728|Blood Substitutes|blood substitutes|mesh-ancestor
24782897|NCT01898819|Dexmedetomidine|dexmedetomidine|mesh-list
24627861|NCT01095172|Antiemetics|antiemetics|mesh-ancestor
24782898|NCT01898819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24782899|NCT01898819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24782900|NCT01898819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782901|NCT01898819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24782902|NCT01898819|Analgesics|analgesics|mesh-ancestor
24782903|NCT01898819|Sensory System Agents|sensory system agents|mesh-ancestor
24782907|NCT01898819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24782910|NCT01898819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782911|NCT01899027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24782912|NCT01899027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24436928|NCT00272116|Vitamins|vitamins|mesh-list
24782913|NCT01899027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24782914|NCT01899027|Antimetabolites|antimetabolites|mesh-ancestor
24782946|NCT01899118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24782947|NCT01899118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24782948|NCT01899118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24782949|NCT01899170|Carfentanil|carfentanil|mesh-list
24782950|NCT01899170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24782951|NCT01899170|Narcotics|narcotics|mesh-ancestor
24782952|NCT01899170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24782953|NCT01899170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782954|NCT01899170|Analgesics|analgesics|mesh-ancestor
24782955|NCT01899170|Sensory System Agents|sensory system agents|mesh-ancestor
24782956|NCT01899170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24782957|NCT01899248|Sevoflurane|sevoflurane|mesh-list
24782958|NCT01899248|Desflurane|desflurane|mesh-list
24782959|NCT01899248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24782960|NCT01899248|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24782961|NCT01899248|Anesthetics, General|anesthetics, general|mesh-ancestor
24782962|NCT01899248|Anesthetics|anesthetics|mesh-ancestor
24782963|NCT01899248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24920379|NCT04203511|Pemetrexed|pemetrexed|mesh-list
24782974|NCT01899326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24782975|NCT01899326|Adrenergic Agents|adrenergic agents|mesh-ancestor
24782976|NCT01899326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24782977|NCT01899430|Metformin|metformin|mesh-list
24782978|NCT01899430|Liraglutide|liraglutide|mesh-list
24782979|NCT01899430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24782980|NCT01899430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24782981|NCT01899430|Incretins|incretins|mesh-ancestor
24491928|NCT00484575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24491929|NCT00484601|Doxorubicin|doxorubicin|mesh-list
24491930|NCT00484601|Ifosfamide|ifosfamide|mesh-list
24491931|NCT00484601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24491932|NCT00484601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491933|NCT00484601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24491934|NCT00484601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24491935|NCT00484601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783080|NCT01900106|Ritonavir|ritonavir|mesh-list
24783081|NCT01900106|Darunavir|darunavir|mesh-list
24783082|NCT01900106|Lamivudine|lamivudine|mesh-list
24783083|NCT01900106|Raltegravir Potassium|raltegravir potassium|mesh-list
24783084|NCT01900106|Abacavir|abacavir|mesh-list
24783085|NCT01900106|Dideoxynucleosides|dideoxynucleosides|mesh-list
24783086|NCT01900106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24492053|NCT00485056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492054|NCT00485108|Prednisolone|prednisolone|mesh-list
24492056|NCT00485108|Lubricant Eye Drops|lubricant eye drops|mesh-list
24492057|NCT00485108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24492058|NCT00485108|Glucocorticoids|glucocorticoids|mesh-ancestor
24492060|NCT00485108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24492061|NCT00485108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492062|NCT00485108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24492063|NCT00485108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783112|NCT01900158|Immunologic Factors|immunologic factors|mesh-ancestor
24783113|NCT01900158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783114|NCT01900197|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
24783115|NCT01900197|Hematinics|hematinics|mesh-ancestor
24783116|NCT01900301|Scopolamine|scopolamine|mesh-list
24783117|NCT01900301|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24627862|NCT01095172|Autonomic Agents|autonomic agents|mesh-ancestor
24783145|NCT01900405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783147|NCT01900405|Analgesics|analgesics|mesh-ancestor
24783148|NCT01900405|Sensory System Agents|sensory system agents|mesh-ancestor
24783149|NCT01900405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082159|NCT03324490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25082160|NCT03324490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25082161|NCT03324490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25082162|NCT03324490|Analgesics|analgesics|mesh-ancestor
25082163|NCT03324490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25082170|NCT03324490|Narcotics|narcotics|mesh-ancestor
24437713|NCT00274274|Insulin Aspart|insulin aspart|mesh-list
24783189|NCT01900587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24783190|NCT01900587|Narcotics|narcotics|mesh-ancestor
24783191|NCT01900587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24783192|NCT01900587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783193|NCT01900587|Analgesics|analgesics|mesh-ancestor
24783194|NCT01900587|Sensory System Agents|sensory system agents|mesh-ancestor
24783195|NCT01900587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24783196|NCT01900587|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24783202|NCT01900639|Aspirin|aspirin|mesh-list
24783203|NCT01900639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24783228|NCT01900717|Growth Inhibitors|growth inhibitors|mesh-ancestor
24783229|NCT01900717|Antimetabolites|antimetabolites|mesh-ancestor
24783230|NCT01900717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783231|NCT01900717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24575206|NCT00830245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783239|NCT01900795|Ibuprofen|ibuprofen|mesh-list
24783240|NCT01900795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24783241|NCT01900795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24783247|NCT01900795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24783260|NCT01900847|Anesthetics|anesthetics|mesh-ancestor
24783261|NCT01900847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24783262|NCT01900847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24783263|NCT01900847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24783264|NCT01900847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24783265|NCT01900847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783266|NCT01900847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24783267|NCT01900847|Narcotics|narcotics|mesh-ancestor
24783268|NCT01900860|Vitamin D|vitamin d|mesh-list
24783313|NCT01901003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24783314|NCT01901003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24783316|NCT01901003|GABA Agents|gaba agents|mesh-ancestor
24783317|NCT01901003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24783318|NCT01901003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783319|NCT01901120|Mirabegron|mirabegron|mesh-list
24783320|NCT01901120|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24783321|NCT01901120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24783322|NCT01901120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24783323|NCT01901120|Adrenergic Agents|adrenergic agents|mesh-ancestor
24627885|NCT01095445|Ribavirin|ribavirin|mesh-list
24798400|NCT01963442|Lactams|lactams|mesh-list
24783324|NCT01901120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24783325|NCT01901120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783326|NCT01901120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783327|NCT01901120|Urological Agents|urological agents|mesh-ancestor
24783329|NCT01901172|Antifungal Agents|antifungal agents|mesh-ancestor
24783330|NCT01901172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24783331|NCT01901172|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24783332|NCT01901172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24783333|NCT01901172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24783334|NCT01901172|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24783363|NCT01901432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492164|NCT00485511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24783385|NCT01901549|Autonomic Agents|autonomic agents|mesh-ancestor
24783386|NCT01901549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24783387|NCT01901549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783388|NCT01901549|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24783389|NCT01901549|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24783390|NCT01901549|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24783391|NCT01901549|Adrenergic Agents|adrenergic agents|mesh-ancestor
24783392|NCT01901549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24783619|NCT01902875|Tubulin Modulators|tubulin modulators|mesh-ancestor
24783620|NCT01902875|Antimitotic Agents|antimitotic agents|mesh-ancestor
24783621|NCT01902875|Mitosis Modulators|mitosis modulators|mesh-ancestor
24783622|NCT01902875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783623|NCT01903018|Cisplatin|cisplatin|mesh-list
24783624|NCT01903018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783625|NCT01903057|Azithromycin|azithromycin|mesh-list
24783626|NCT01903057|Ivermectin|ivermectin|mesh-list
24783627|NCT01903057|Albendazole|albendazole|mesh-list
24783666|NCT01903096|Antidepressive Agents|antidepressive agents|mesh-list
24783667|NCT01903096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24492227|NCT00485771|Autonomic Agents|autonomic agents|mesh-ancestor
24492228|NCT00485771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24492229|NCT00485771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783673|NCT01903109|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24783674|NCT01903109|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24783675|NCT01903109|Cholinergic Agents|cholinergic agents|mesh-ancestor
24783676|NCT01903109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24783677|NCT01903109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783678|NCT01903122|Cevimeline|cevimeline|mesh-list
24783679|NCT01903122|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24783733|NCT01903681|Antioxidants|antioxidants|mesh-ancestor
24783734|NCT01903681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783735|NCT01903681|Protective Agents|protective agents|mesh-ancestor
24783736|NCT01903681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783737|NCT01903681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24575741|NCT00833768|Sevelamer|sevelamer|mesh-list
24783739|NCT01903694|Pravastatin|pravastatin|mesh-list
24783740|NCT01903694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783741|NCT01903694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24783743|NCT01903694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783744|NCT01903694|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24783745|NCT01903694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24575806|NCT00834470|Atropine|atropine|mesh-list
24575872|NCT00834925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24575873|NCT00834925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24575878|NCT00834925|Vasodilator Agents|vasodilator agents|mesh-ancestor
24621188|NCT01060930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621189|NCT01060930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621190|NCT01060930|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24621191|NCT01060930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24783843|NCT01904487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24783844|NCT01904487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783845|NCT01904487|Anticonvulsants|anticonvulsants|mesh-ancestor
24824704|NCT02124954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24783916|NCT01904747|Palbociclib|palbociclib|mesh-list
24783917|NCT01904747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24783918|NCT01904747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24783919|NCT01904747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825278|NCT02128022|Glyburide|glyburide|mesh-list
24784037|NCT01905566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784039|NCT01905618|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24784040|NCT01905618|Autonomic Agents|autonomic agents|mesh-ancestor
24784041|NCT01905618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24784042|NCT01905618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784043|NCT01905618|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24784044|NCT01905618|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24784045|NCT01905618|Cholinergic Agents|cholinergic agents|mesh-ancestor
24784046|NCT01905618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24784047|NCT01905618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784048|NCT01905631|Diphenhydramine|diphenhydramine|mesh-list
24784049|NCT01905631|Promethazine|promethazine|mesh-list
24784050|NCT01905631|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24784051|NCT01905631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24784151|NCT01906671|Antimetabolites|antimetabolites|mesh-ancestor
24784152|NCT01906671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784153|NCT01906671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24784154|NCT01906671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24784155|NCT01906671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24784156|NCT01906671|Immunologic Factors|immunologic factors|mesh-ancestor
24438932|NCT00276900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439101|NCT00277550|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24784157|NCT01906671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785013|NCT01911494|Sympatholytics|sympatholytics|mesh-ancestor
24492445|NCT00486343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24784223|NCT01906944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24784224|NCT01906944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24784225|NCT01906944|Immunologic Factors|immunologic factors|mesh-ancestor
24784226|NCT01907009|Melphalan|melphalan|mesh-list
24784227|NCT01907009|Lenograstim|lenograstim|mesh-list
24784228|NCT01907009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24784229|NCT01907009|Alkylating Agents|alkylating agents|mesh-ancestor
24784230|NCT01907009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492517|NCT00486668|Trastuzumab|trastuzumab|mesh-list
24492518|NCT00486668|Lapatinib|lapatinib|mesh-list
24492519|NCT00486668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24492520|NCT00486668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24492538|NCT00486694|Artesunate|artesunate|mesh-list
24784239|NCT01907048|Antithrombins|antithrombins|mesh-ancestor
24784240|NCT01907048|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24784241|NCT01907048|Protease Inhibitors|protease inhibitors|mesh-ancestor
24784242|NCT01907048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24784243|NCT01907048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784244|NCT01907048|Anticoagulants|anticoagulants|mesh-ancestor
24784245|NCT01907061|Acetylcysteine|acetylcysteine|mesh-list
24784246|NCT01907061|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24784400|NCT01907802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784401|NCT01907867|Finafloxacin|finafloxacin|mesh-list
24784402|NCT01907867|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24828691|NCT02147015|Methylprednisolone|methylprednisolone|mesh-list
24784425|NCT01907984|Anesthetics, General|anesthetics, general|mesh-ancestor
24784426|NCT01907984|Anesthetics|anesthetics|mesh-ancestor
24784427|NCT01907984|GABA Modulators|gaba modulators|mesh-ancestor
24492749|NCT00487773|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24492751|NCT00487773|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24492752|NCT00487773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24784442|NCT01907997|Anesthetics|anesthetics|mesh-ancestor
24784443|NCT01907997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24784444|NCT01907997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24784445|NCT01907997|Sensory System Agents|sensory system agents|mesh-ancestor
24784446|NCT01907997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24784447|NCT01907997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24784448|NCT01907997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24784449|NCT01907997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24784450|NCT01907997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24784451|NCT01907997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24784452|NCT01908075|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24784453|NCT01908075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24784454|NCT01908075|Autonomic Agents|autonomic agents|mesh-ancestor
24784656|NCT01909830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830132|NCT02157467|BMS-955176|bms-955176|mesh-list
24492753|NCT00487773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492754|NCT00487773|Tocolytic Agents|tocolytic agents|mesh-ancestor
24492755|NCT00487773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24492756|NCT00487773|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24492757|NCT00487773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24492758|NCT00487773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24492759|NCT00487773|Adrenergic Agents|adrenergic agents|mesh-ancestor
24492760|NCT00487773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492761|NCT00487773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24492762|NCT00487773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24785012|NCT01911494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24785016|NCT01911494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24785017|NCT01911494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24785026|NCT01911598|Carboplatin|carboplatin|mesh-list
24785027|NCT01911598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24785028|NCT01911598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24785029|NCT01911598|Tubulin Modulators|tubulin modulators|mesh-ancestor
24785030|NCT01911598|Antimitotic Agents|antimitotic agents|mesh-ancestor
24785117|NCT01912066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24785118|NCT01912066|Oxytocics|oxytocics|mesh-ancestor
24785119|NCT01912066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24439526|NCT00279162|Dermatologic Agents|dermatologic agents|mesh-ancestor
24785120|NCT01912066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24785121|NCT01912066|Analgesics|analgesics|mesh-ancestor
24785122|NCT01912066|Sensory System Agents|sensory system agents|mesh-ancestor
24785123|NCT01912066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24785124|NCT01912066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24492792|NCT00487994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24492793|NCT00487994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24492794|NCT00487994|Antimetabolites|antimetabolites|mesh-ancestor
24492795|NCT00487994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492796|NCT00487994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24492849|NCT00488215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492850|NCT00488306|Tigecycline|tigecycline|mesh-list
24785423|NCT01914237|Castor Oil|castor oil|mesh-list
24785424|NCT01914237|Cathartics|cathartics|mesh-ancestor
24785425|NCT01914237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24785426|NCT01914250|Analgesics|analgesics|mesh-list
24785427|NCT01914250|Tetracaine|tetracaine|mesh-list
24785428|NCT01914250|Sensory System Agents|sensory system agents|mesh-ancestor
24785429|NCT01914250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24785430|NCT01914250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492851|NCT00488306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24492852|NCT00488306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24492853|NCT00488306|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24492854|NCT00488306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492858|NCT00488371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492860|NCT00488384|Keratolytic Agents|keratolytic agents|mesh-ancestor
24492946|NCT00488709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24492947|NCT00488709|Antimetabolites|antimetabolites|mesh-ancestor
24492948|NCT00488709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492949|NCT00488709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24492950|NCT00488709|Immunologic Factors|immunologic factors|mesh-ancestor
24492951|NCT00488709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492952|NCT00488709|Antiviral Agents|antiviral agents|mesh-ancestor
24785482|NCT01914692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24785483|NCT01914692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785484|NCT01914718|Rituximab|rituximab|mesh-list
24785485|NCT01914718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24785486|NCT01914718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24785487|NCT01914718|Immunologic Factors|immunologic factors|mesh-ancestor
24785488|NCT01914718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785489|NCT01914718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24785490|NCT01914744|Lamivudine|lamivudine|mesh-list
24785491|NCT01914744|Entecavir|entecavir|mesh-list
24785492|NCT01914744|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24785582|NCT01915186|Immunologic Factors|immunologic factors|mesh-ancestor
24785583|NCT01915186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785585|NCT01915264|Acarbose|acarbose|mesh-list
24785586|NCT01915264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24785587|NCT01915264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785588|NCT01915264|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24785589|NCT01915264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24785590|NCT01915264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24785591|NCT01915277|Dexmedetomidine|dexmedetomidine|mesh-list
24785592|NCT01915277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24785593|NCT01915277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24785594|NCT01915277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577864|NCT00846144|Copper|copper|mesh-list
24785645|NCT01915758|Tretinoin|tretinoin|mesh-list
24785646|NCT01915758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24785647|NCT01915758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24785648|NCT01915758|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24785663|NCT01915901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24785664|NCT01915901|Antidiarrheals|antidiarrheals|mesh-ancestor
24785665|NCT01915979|Betamethasone|betamethasone|mesh-list
24785666|NCT01915979|Mitogens|mitogens|mesh-list
24921639|NCT04188431|Glucocorticoids|glucocorticoids|mesh-ancestor
24492992|NCT00488891|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24492993|NCT00488891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24492994|NCT00488891|Serotonin Agents|serotonin agents|mesh-ancestor
24785933|NCT01917149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440259|NCT00282061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24785934|NCT01917149|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24785935|NCT01917149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24785936|NCT01917149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24785937|NCT01917149|Adrenergic Agents|adrenergic agents|mesh-ancestor
24785938|NCT01917149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24785939|NCT01917149|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24785940|NCT01917149|Protease Inhibitors|protease inhibitors|mesh-ancestor
24785941|NCT01917149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24786031|NCT01917617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24786032|NCT01917617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24786033|NCT01917617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24786034|NCT01917617|Immunologic Factors|immunologic factors|mesh-ancestor
24786035|NCT01917617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24786036|NCT01917708|Abatacept|abatacept|mesh-list
24786037|NCT01917708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24621314|NCT01061450|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24621316|NCT01061658|Vaccines|vaccines|mesh-list
24621317|NCT01061658|Immunologic Factors|immunologic factors|mesh-ancestor
24621318|NCT01061658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621319|NCT01061697|Pregabalin|pregabalin|mesh-list
24621320|NCT01061697|Analgesics|analgesics|mesh-ancestor
24621321|NCT01061697|Sensory System Agents|sensory system agents|mesh-ancestor
24621322|NCT01061697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24643460|NCT01185769|Vitamin E|vitamin e|mesh-list
24621323|NCT01061697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621324|NCT01061697|Anticonvulsants|anticonvulsants|mesh-ancestor
24621325|NCT01061697|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24786345|NCT01919255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24786346|NCT01919255|Antacids|antacids|mesh-ancestor
24786347|NCT01919294|Methyltestosterone|methyltestosterone|mesh-list
24786351|NCT01919294|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24786352|NCT01919294|Androgens|androgens|mesh-ancestor
24786353|NCT01919294|Hormones|hormones|mesh-ancestor
24786359|NCT01919346|Eculizumab|eculizumab|mesh-list
24621357|NCT01061853|Immunologic Factors|immunologic factors|mesh-ancestor
24621358|NCT01061853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621359|NCT01061853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24621360|NCT01061853|Glucocorticoids|glucocorticoids|mesh-ancestor
24621362|NCT01061853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24621363|NCT01061853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24621364|NCT01061853|Respiratory System Agents|respiratory system agents|mesh-ancestor
24621365|NCT01061996|Basiliximab|basiliximab|mesh-list
24786490|NCT01920269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24786491|NCT01920269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800854|NCT01978782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800855|NCT01978782|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24800856|NCT01978782|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24800857|NCT01978782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24800858|NCT01978782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24800859|NCT01978782|Serotonin Agents|serotonin agents|mesh-ancestor
24800860|NCT01978782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493059|NCT00489229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493088|NCT00489437|Heparin|heparin|mesh-list
24493103|NCT00489593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24493104|NCT00489593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082246|NCT03323697|Citalopram|citalopram|mesh-list
25082247|NCT03323697|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25082248|NCT03323697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25082249|NCT03323697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25082250|NCT03323697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786521|NCT01920516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24786522|NCT01920516|Alkylating Agents|alkylating agents|mesh-ancestor
24786523|NCT01920516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786524|NCT01920516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24786525|NCT01920516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24786722|NCT01921374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24786724|NCT01921374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24786726|NCT01921374|Immunologic Factors|immunologic factors|mesh-ancestor
24786727|NCT01921374|Progestins|progestins|mesh-ancestor
24786728|NCT01921374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24786729|NCT01921374|Analgesics|analgesics|mesh-ancestor
24786730|NCT01921374|Sensory System Agents|sensory system agents|mesh-ancestor
24786731|NCT01921374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24786732|NCT01921374|Vitamin B Complex|vitamin b complex|mesh-ancestor
24786733|NCT01921374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24786734|NCT01921374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24786735|NCT01921374|Antioxidants|antioxidants|mesh-ancestor
24786736|NCT01921374|Protective Agents|protective agents|mesh-ancestor
24786737|NCT01921374|Oxytocics|oxytocics|mesh-ancestor
24786738|NCT01921374|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24786800|NCT01921790|Growth Inhibitors|growth inhibitors|mesh-ancestor
24786802|NCT01921816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24786803|NCT01921868|Acetylcarnitine|acetylcarnitine|mesh-list
24786804|NCT01921868|Vitamin B Complex|vitamin b complex|mesh-ancestor
24786805|NCT01921868|Vitamins|vitamins|mesh-ancestor
24786806|NCT01921868|Micronutrients|micronutrients|mesh-ancestor
24786807|NCT01921868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708070|NCT02242305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25708071|NCT02242305|Cholinergic Agents|cholinergic agents|mesh-ancestor
24786811|NCT01921920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24786812|NCT01921920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24786813|NCT01921920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24786814|NCT01921920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853419|NCT02268019|Mydriatics|mydriatics|mesh-ancestor
24786834|NCT01921972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24786835|NCT01921972|Cholinergic Agents|cholinergic agents|mesh-ancestor
24787036|NCT01923259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787037|NCT01923259|Cholinergic Agents|cholinergic agents|mesh-ancestor
24787038|NCT01923259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24787039|NCT01923259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787040|NCT01923259|Nootropic Agents|nootropic agents|mesh-ancestor
24787042|NCT01923337|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24787043|NCT01923337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24787044|NCT01923337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24801120|NCT01981031|Insulin Lispro|insulin lispro|mesh-list
24787330|NCT01924468|Autonomic Agents|autonomic agents|mesh-ancestor
24787331|NCT01924468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24787332|NCT01924468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24787333|NCT01924468|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24787334|NCT01924468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24787335|NCT01924468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24787355|NCT01924481|Vasodilator Agents|vasodilator agents|mesh-ancestor
24787356|NCT01924520|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24787357|NCT01924520|Antidepressive Agents|antidepressive agents|mesh-ancestor
24787358|NCT01924520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24787359|NCT01924520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24787360|NCT01924520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24787361|NCT01924520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24787362|NCT01924520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787363|NCT01924624|Thalidomide|thalidomide|mesh-list
24787368|NCT01924624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24787369|NCT01924624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24787370|NCT01924624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24787372|NCT01924624|Growth Substances|growth substances|mesh-ancestor
24627927|NCT01095679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24627928|NCT01095731|Acetic Acid|acetic acid|mesh-list
24627929|NCT01095731|Retinol acetate|retinol acetate|mesh-list
24627931|NCT01095731|Glycine Agents|glycine agents|mesh-ancestor
24621444|NCT01062360|Sympathomimetics|sympathomimetics|mesh-ancestor
24621445|NCT01062360|Adrenergic Agents|adrenergic agents|mesh-ancestor
24621446|NCT01062360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24621448|NCT01062477|Immunologic Factors|immunologic factors|mesh-ancestor
24621449|NCT01062477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621450|NCT01062490|Treosulfan|treosulfan|mesh-list
24621451|NCT01062490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24621452|NCT01062490|Alkylating Agents|alkylating agents|mesh-ancestor
24621453|NCT01062490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787615|NCT01926041|Varenicline|varenicline|mesh-list
24787616|NCT01926041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24787617|NCT01926041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24787618|NCT01926041|Cholinergic Agents|cholinergic agents|mesh-ancestor
24787619|NCT01926041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24787647|NCT01926236|Antimetabolites|antimetabolites|mesh-ancestor
24787648|NCT01926236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787649|NCT01926236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24787651|NCT01926236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24787652|NCT01926236|Immunologic Factors|immunologic factors|mesh-ancestor
24787653|NCT01926236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787654|NCT01926236|Antidotes|antidotes|mesh-ancestor
24787655|NCT01926236|Protective Agents|protective agents|mesh-ancestor
24787656|NCT01926236|Vitamin B Complex|vitamin b complex|mesh-ancestor
24787657|NCT01926236|Vitamins|vitamins|mesh-ancestor
24787658|NCT01926236|Micronutrients|micronutrients|mesh-ancestor
24787659|NCT01926236|Hematinics|hematinics|mesh-ancestor
24787660|NCT01926288|Entecavir|entecavir|mesh-list
24484221|NCT00447031|Immunologic Factors|immunologic factors|mesh-ancestor
24484222|NCT00447031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25708072|NCT02242305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25708073|NCT02242305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787661|NCT01926288|Maleic acid|maleic acid|mesh-list
24787677|NCT01926392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24787678|NCT01926392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24787679|NCT01926392|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24787680|NCT01926392|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24787681|NCT01926392|Coccidiostats|coccidiostats|mesh-ancestor
24787682|NCT01926392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24787683|NCT01926548|Imatinib Mesylate|imatinib mesylate|mesh-list
24787684|NCT01926548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787686|NCT01926548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787687|NCT01926548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787688|NCT01926587|Azacitidine|azacitidine|mesh-list
24861849|NCT02320474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787712|NCT01926652|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24787780|NCT01927484|Abortifacient Agents|abortifacient agents|mesh-ancestor
24787781|NCT01927484|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24787782|NCT01927484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787783|NCT01927484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24627949|NCT01095809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24627950|NCT01095809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24627951|NCT01095809|Growth Substances|growth substances|mesh-ancestor
24627952|NCT01095809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24627953|NCT01095809|Growth Inhibitors|growth inhibitors|mesh-ancestor
24627954|NCT01095809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24627955|NCT01095809|Glucocorticoids|glucocorticoids|mesh-ancestor
24801197|NCT01981746|Ropivacaine|ropivacaine|mesh-list
24787845|NCT01927874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787846|NCT01927874|Sensory System Agents|sensory system agents|mesh-ancestor
24788128|NCT01929603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24788129|NCT01929603|Antitubercular Agents|antitubercular agents|mesh-ancestor
24788130|NCT01929603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24788131|NCT01929603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24788132|NCT01929603|Leprostatic Agents|leprostatic agents|mesh-ancestor
24788133|NCT01929603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24788134|NCT01929603|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24788135|NCT01929603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24621538|NCT01062958|Vitamin B 12|vitamin b 12|mesh-list
24621539|NCT01062958|Hydroxocobalamin|hydroxocobalamin|mesh-list
24788231|NCT01930370|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24788232|NCT01930370|Hemodialysis Solutions|hemodialysis solutions|mesh-list
24788233|NCT01930370|Dialysis Solutions|dialysis solutions|mesh-ancestor
24788235|NCT01930396|Calcium heparin|calcium heparin|mesh-list
24627973|NCT01095900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24627974|NCT01095900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788378|NCT01931085|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24788379|NCT01931085|Anthelmintics|anthelmintics|mesh-ancestor
24788380|NCT01931085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24788381|NCT01931085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24788456|NCT01931501|Montelukast|montelukast|mesh-list
24788457|NCT01931501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24788458|NCT01931501|Respiratory System Agents|respiratory system agents|mesh-ancestor
24788704|NCT01932918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788705|NCT01932918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788707|NCT01932931|Cholecalciferol|cholecalciferol|mesh-list
24788708|NCT01932931|Vitamins|vitamins|mesh-ancestor
24788709|NCT01932931|Micronutrients|micronutrients|mesh-ancestor
24788710|NCT01932931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788711|NCT01932931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24788712|NCT01932931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25708074|NCT02242305|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25708075|NCT02242305|Parasympatholytics|parasympatholytics|mesh-ancestor
25708076|NCT02242487|Levodopa|levodopa|mesh-list
25708077|NCT02242487|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25708078|NCT02242487|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25708079|NCT02242487|Dopamine Agents|dopamine agents|mesh-ancestor
24484555|NCT00449202|Oleoyl-estrone|oleoyl-estrone|mesh-list
24484556|NCT00449202|Estrone|estrone|mesh-list
24484557|NCT00449202|Estrogens|estrogens|mesh-ancestor
24484558|NCT00449202|Hormones|hormones|mesh-ancestor
24788713|NCT01933022|Leuprolide|leuprolide|mesh-list
24788714|NCT01933022|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24788718|NCT01933022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24788720|NCT01933061|Paclitaxel|paclitaxel|mesh-list
24788721|NCT01933061|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24788722|NCT01933061|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24788723|NCT01933061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24801145|NCT01981330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24788793|NCT01933906|Interferons|interferons|mesh-list
24493238|NCT00490087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24493239|NCT00490087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24493240|NCT00490113|Pyridoxamine|pyridoxamine|mesh-list
24627998|NCT01095991|Protease Inhibitors|protease inhibitors|mesh-ancestor
24628004|NCT01096082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628005|NCT01096082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628006|NCT01096082|Antimanic Agents|antimanic agents|mesh-ancestor
24628007|NCT01096082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24628009|NCT01096082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082348|NCT03323385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25082405|NCT03322969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25082406|NCT03322969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25082407|NCT03322969|Tubulin Modulators|tubulin modulators|mesh-ancestor
25082408|NCT03322969|Antimitotic Agents|antimitotic agents|mesh-ancestor
24801230|NCT01981941|Gabapentin|gabapentin|mesh-list
24789087|NCT01935518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24789286|NCT01936129|Glatiramer Acetate|glatiramer acetate|mesh-list
24789288|NCT01936129|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24789289|NCT01936129|Immunologic Factors|immunologic factors|mesh-ancestor
24789290|NCT01936129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789291|NCT01936129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25082409|NCT03322969|Mitosis Modulators|mitosis modulators|mesh-ancestor
24789293|NCT01936220|Antipsychotic Agents|antipsychotic agents|mesh-list
24789294|NCT01936220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24872785|NCT05226897|Dapagliflozin|dapagliflozin|mesh-list
24789475|NCT01937442|Growth Substances|growth substances|mesh-ancestor
24789476|NCT01937442|Growth Inhibitors|growth inhibitors|mesh-ancestor
24789477|NCT01937442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789478|NCT01937494|Benzyl Alcohol|benzyl alcohol|mesh-list
24789479|NCT01937494|Histamine|histamine|mesh-list
24789480|NCT01937494|Histamine Agonists|histamine agonists|mesh-ancestor
24789481|NCT01937494|Histamine Agents|histamine agents|mesh-ancestor
24628027|NCT01096212|Anesthetics, General|anesthetics, general|mesh-ancestor
24628028|NCT01096212|Anesthetics|anesthetics|mesh-ancestor
24628029|NCT01096212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24628030|NCT01096212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628032|NCT01096225|Immunologic Factors|immunologic factors|mesh-ancestor
24628033|NCT01096225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789761|NCT01939054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24789762|NCT01939093|Thiamine|thiamine|mesh-list
24789763|NCT01939093|Cinnarizine|cinnarizine|mesh-list
24789764|NCT01939093|Diazepam|diazepam|mesh-list
24789765|NCT01939093|Vitamins|vitamins|mesh-ancestor
24789766|NCT01939093|Micronutrients|micronutrients|mesh-ancestor
24789767|NCT01939093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789768|NCT01939093|Vitamin B Complex|vitamin b complex|mesh-ancestor
24789769|NCT01939093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25708080|NCT02242487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25708081|NCT02242487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708082|NCT02242487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708083|NCT02242630|Methylprednisolone|methylprednisolone|mesh-list
24789770|NCT01939093|Anticonvulsants|anticonvulsants|mesh-ancestor
24789771|NCT01939093|Antiemetics|antiemetics|mesh-ancestor
24789776|NCT01939093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24789777|NCT01939093|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24789779|NCT01939093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25708084|NCT02242630|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25708085|NCT02242630|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25708086|NCT02242630|Prednisolone|prednisolone|mesh-list
25708087|NCT02242630|Prednisolone acetate|prednisolone acetate|mesh-list
25708088|NCT02242630|Triamcinolone|triamcinolone|mesh-list
25708089|NCT02242630|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24789780|NCT01939093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24789781|NCT01939093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24789782|NCT01939093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24789783|NCT01939093|Anesthetics, General|anesthetics, general|mesh-ancestor
24789784|NCT01939093|Anesthetics|anesthetics|mesh-ancestor
24789896|NCT01939574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24789898|NCT01939574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789899|NCT01939574|Growth Inhibitors|growth inhibitors|mesh-ancestor
24789900|NCT01939574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24789901|NCT01939574|Alkylating Agents|alkylating agents|mesh-ancestor
24789902|NCT01939574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789903|NCT01939639|Oxytocin|oxytocin|mesh-list
24789904|NCT01939639|Oxytocics|oxytocics|mesh-ancestor
24789905|NCT01939639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24789906|NCT01939639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789907|NCT01939691|Prednisolone|prednisolone|mesh-list
24789908|NCT01939691|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24789909|NCT01939691|Methylprednisolone|methylprednisolone|mesh-list
24789911|NCT01939691|Prednisolone acetate|prednisolone acetate|mesh-list
24628067|NCT01096485|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24628068|NCT01096485|Contraceptive Agents|contraceptive agents|mesh-ancestor
24628069|NCT01096485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24628070|NCT01096485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628071|NCT01096485|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24628072|NCT01096485|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24628073|NCT01096485|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24628075|NCT01096498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24628076|NCT01096498|Contraceptive Agents|contraceptive agents|mesh-ancestor
24628077|NCT01096498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24628078|NCT01096498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628079|NCT01096498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24628080|NCT01096498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24628081|NCT01096498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24628082|NCT01096511|Moxifloxacin|moxifloxacin|mesh-list
24628083|NCT01096511|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24621701|NCT01063504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24621702|NCT01063504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621703|NCT01063504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24621705|NCT01063530|Cariostatic Agents|cariostatic agents|mesh-ancestor
24621706|NCT01063530|Protective Agents|protective agents|mesh-ancestor
24621707|NCT01063530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790178|NCT01941173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24790179|NCT01941173|Antidotes|antidotes|mesh-ancestor
24790180|NCT01941173|Protective Agents|protective agents|mesh-ancestor
24790181|NCT01941173|Vitamin B Complex|vitamin b complex|mesh-ancestor
24790182|NCT01941173|Vitamins|vitamins|mesh-ancestor
24790183|NCT01941173|Micronutrients|micronutrients|mesh-ancestor
24790184|NCT01941173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24790185|NCT01941173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24790186|NCT01941173|Growth Substances|growth substances|mesh-ancestor
24790187|NCT01941173|Growth Inhibitors|growth inhibitors|mesh-ancestor
24790188|NCT01941199|Metformin|metformin|mesh-list
24790189|NCT01941199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24790190|NCT01941199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790191|NCT01941225|Iloprost|iloprost|mesh-list
24790192|NCT01941225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24790193|NCT01941225|Vasodilator Agents|vasodilator agents|mesh-ancestor
24790194|NCT01941264|Lumefantrine|lumefantrine|mesh-list
24790195|NCT01941264|Artemether|artemether|mesh-list
24790196|NCT01941264|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24790203|NCT01941316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24790204|NCT01941316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24790206|NCT01941316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582787|NCT00871546|Bortezomib|bortezomib|mesh-list
24582788|NCT00871546|Alemtuzumab|alemtuzumab|mesh-list
24582789|NCT00871546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582790|NCT00871546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24582791|NCT00871598|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24582794|NCT00871767|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
24582795|NCT00871767|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24793593|NCT03032406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24582797|NCT00871767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24790225|NCT01941524|Respiratory System Agents|respiratory system agents|mesh-ancestor
24790226|NCT01941576|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24790227|NCT01941576|Natriuretic Agents|natriuretic agents|mesh-ancestor
24790228|NCT01941576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790229|NCT01941602|Enoxaparin|enoxaparin|mesh-list
24790468|NCT01942889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790470|NCT01942889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790472|NCT01943019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24790473|NCT01943019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790474|NCT01943019|Incretins|incretins|mesh-ancestor
24790475|NCT01943019|Hormones|hormones|mesh-ancestor
24790476|NCT01943019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24790477|NCT01943019|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24790573|NCT01943630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790574|NCT01943630|Antiviral Agents|antiviral agents|mesh-ancestor
24790575|NCT01943630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24790577|NCT01943760|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24790578|NCT01943760|Narcotics|narcotics|mesh-ancestor
24790579|NCT01943760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24790580|NCT01943760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790581|NCT01943760|Analgesics|analgesics|mesh-ancestor
24790814|NCT01945476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24790815|NCT01945476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24790928|NCT05410275|Anticoagulants|anticoagulants|mesh-ancestor
24790929|NCT05410158|Ketamine|ketamine|mesh-list
24790930|NCT05410158|Analgesics|analgesics|mesh-ancestor
24790931|NCT05410158|Sensory System Agents|sensory system agents|mesh-ancestor
24790932|NCT05410158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24790933|NCT05410158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790934|NCT05410158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24790936|NCT05410158|Anesthetics, General|anesthetics, general|mesh-ancestor
25082540|NCT03321955|Ziconotide|ziconotide|mesh-list
25082541|NCT03321955|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25082542|NCT03321955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25082546|NCT03321955|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24791050|NCT05375747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24791051|NCT05375747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791052|NCT05375747|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24791055|NCT05371223|Gemcitabine|gemcitabine|mesh-list
24791056|NCT05371223|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24791057|NCT05371223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24791058|NCT05371223|Antimetabolites|antimetabolites|mesh-ancestor
24791059|NCT05371223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791060|NCT05371223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791061|NCT05371223|Antiviral Agents|antiviral agents|mesh-ancestor
24791062|NCT05371223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24791063|NCT05371223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24791064|NCT05371223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24791065|NCT05371223|Immunologic Factors|immunologic factors|mesh-ancestor
24583790|NCT00876902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583791|NCT00876902|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24583792|NCT00876902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583793|NCT00876902|Antiviral Agents|antiviral agents|mesh-ancestor
24583794|NCT00876902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24583795|NCT00876902|Interferon Inducers|interferon inducers|mesh-ancestor
24583796|NCT00876902|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24583797|NCT00876902|Protective Agents|protective agents|mesh-ancestor
24583798|NCT00876967|Pyrithione zinc|pyrithione zinc|mesh-list
24583799|NCT00876967|Keratolytic Agents|keratolytic agents|mesh-ancestor
24791144|NCT05165082|Timolol|timolol|mesh-list
24485731|NCT00454714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24791145|NCT05165082|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24791221|NCT04967378|Psychotropic Drugs|psychotropic drugs|mesh-list
24791222|NCT04946396|Dexmedetomidine|dexmedetomidine|mesh-list
24628120|NCT01096693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628122|NCT01096706|Fluconazole|fluconazole|mesh-list
24628123|NCT01096706|Substance P|substance p|mesh-list
24628128|NCT01096706|Sensory System Agents|sensory system agents|mesh-ancestor
24628129|NCT01096706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24628130|NCT01096706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628135|NCT01096706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082559|NCT03321890|Etoposide|etoposide|mesh-list
25082560|NCT03321890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25082561|NCT03321890|Immunologic Factors|immunologic factors|mesh-ancestor
25082562|NCT03321890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082608|NCT03321773|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
25082609|NCT03321773|Pantoprazole|pantoprazole|mesh-list
25082610|NCT03321773|Bismuth|bismuth|mesh-list
25082611|NCT03321773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25082612|NCT03321773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25082613|NCT03321773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25082614|NCT03321773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25082615|NCT03321773|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25082616|NCT03321773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24802470|NCT01990378|Rabeprazole|rabeprazole|mesh-list
24791333|NCT04724655|Mineral Oil|mineral oil|mesh-list
24791334|NCT04724655|Emollients|emollients|mesh-ancestor
24791335|NCT04724655|Dermatologic Agents|dermatologic agents|mesh-ancestor
24791336|NCT04722835|Albuterol|albuterol|mesh-list
24791337|NCT04722835|Dimercaprol|dimercaprol|mesh-list
24791338|NCT04722835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24791341|NCT04722835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791342|NCT04722835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24791343|NCT04722835|Respiratory System Agents|respiratory system agents|mesh-ancestor
24791344|NCT04722835|Tocolytic Agents|tocolytic agents|mesh-ancestor
24791393|NCT04538053|Cephalexin|cephalexin|mesh-list
24791394|NCT04538053|Floxacillin|floxacillin|mesh-list
24791395|NCT04538053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24791396|NCT04538053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493418|NCT00490880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24493419|NCT00490880|Antimetabolites|antimetabolites|mesh-ancestor
24493420|NCT00490880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493421|NCT00490880|Antiviral Agents|antiviral agents|mesh-ancestor
24493428|NCT00490893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24791633|NCT03714880|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24791634|NCT03714880|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24791635|NCT03714880|Contraceptive Agents|contraceptive agents|mesh-ancestor
24791904|NCT02553460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24791905|NCT02553460|Abortifacient Agents|abortifacient agents|mesh-ancestor
24791906|NCT02553460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24791928|NCT02553460|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24791929|NCT02335099|Ticagrelor|ticagrelor|mesh-list
24791930|NCT02335099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24791931|NCT02335099|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24791932|NCT02335099|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24791933|NCT02335099|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24791934|NCT02335099|Purinergic Agents|purinergic agents|mesh-ancestor
24791935|NCT02335099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24791936|NCT02335099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791937|NCT02335099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791938|NCT02330562|Bevacizumab|bevacizumab|mesh-list
24792011|NCT00777036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792012|NCT00504712|Testosterone|testosterone|mesh-list
25708090|NCT02242630|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25708091|NCT02242630|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25708092|NCT02242630|Prednisolone phosphate|prednisolone phosphate|mesh-list
25708093|NCT02242630|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25708094|NCT02242630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25708095|NCT02242630|Antiemetics|antiemetics|mesh-ancestor
25708096|NCT02242630|Autonomic Agents|autonomic agents|mesh-ancestor
25708097|NCT02242630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25708098|NCT02242630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792013|NCT00504712|Androgens|androgens|mesh-ancestor
24792014|NCT00504712|Hormones|hormones|mesh-ancestor
24792015|NCT00504712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24792061|NCT05412914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792062|NCT05412914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24792063|NCT05412914|Anesthetics, General|anesthetics, general|mesh-ancestor
24792064|NCT05412914|Anesthetics|anesthetics|mesh-ancestor
24792065|NCT05412888|Coenzyme Q10|coenzyme q10|mesh-list
24792066|NCT05412888|Ubiquinone|ubiquinone|mesh-list
24792067|NCT05412888|Vitamins|vitamins|mesh-ancestor
24493642|NCT00491855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493643|NCT00491855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24493644|NCT00491855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24493645|NCT00491855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24803563|NCT01997099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803564|NCT01997112|Acetaminophen|acetaminophen|mesh-list
24803565|NCT01997112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24803566|NCT01997112|Analgesics|analgesics|mesh-ancestor
24803567|NCT01997112|Sensory System Agents|sensory system agents|mesh-ancestor
24803568|NCT01997112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803569|NCT01997112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803570|NCT01997112|Antipyretics|antipyretics|mesh-ancestor
24628160|NCT01096745|Immunologic Factors|immunologic factors|mesh-ancestor
24792145|NCT05411900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792146|NCT05411900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24792147|NCT05411900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24792148|NCT05411900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792149|NCT05411900|Cholinergic Agents|cholinergic agents|mesh-ancestor
24792150|NCT05411900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24792152|NCT05411887|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24792153|NCT05411887|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24792154|NCT05411887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24493798|NCT00492466|Hormones|hormones|mesh-ancestor
24493799|NCT00492466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24493800|NCT00492466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24493801|NCT00492466|Protective Agents|protective agents|mesh-ancestor
24493802|NCT00492466|Immunologic Factors|immunologic factors|mesh-ancestor
24493803|NCT00492466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24493804|NCT00492479|Kinetin|kinetin|mesh-list
24493805|NCT00492479|Plant Growth Regulators|plant growth regulators|mesh-ancestor
24493806|NCT00492479|Growth Substances|growth substances|mesh-ancestor
24792203|NCT05411718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24792255|NCT05405686|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24792256|NCT05405686|Hormones|hormones|mesh-ancestor
24792257|NCT05405686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24792258|NCT05405686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792259|NCT05396781|Proflavine|proflavine|mesh-list
24792260|NCT05396781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24792303|NCT05327595|Midazolam|midazolam|mesh-list
24792368|NCT05280704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24792369|NCT05280704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24792542|NCT05062902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24792543|NCT05062902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792544|NCT05062902|Cholinergic Agents|cholinergic agents|mesh-ancestor
24792545|NCT05062902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24792546|NCT05062902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792547|NCT05042674|Ergothioneine|ergothioneine|mesh-list
24792548|NCT05042674|Antioxidants|antioxidants|mesh-ancestor
24792549|NCT05042674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792550|NCT05042674|Protective Agents|protective agents|mesh-ancestor
24792551|NCT05042674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792552|NCT05028062|Naltrexone|naltrexone|mesh-list
24792553|NCT05028062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24792587|NCT04992312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792590|NCT04933552|Siponimod|siponimod|mesh-list
24792591|NCT04933552|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24792601|NCT04917055|Ropivacaine|ropivacaine|mesh-list
24792602|NCT04917055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24792603|NCT04917055|Antiemetics|antiemetics|mesh-ancestor
24803074|NCT01994460|Linezolid|linezolid|mesh-list
24792607|NCT04917055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24792609|NCT04917055|Hormones|hormones|mesh-ancestor
24792651|NCT04887831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24792653|NCT04887831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585629|NCT00886457|Interferons|interferons|mesh-list
24585925|NCT00888108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585926|NCT00888186|Levodopa|levodopa|mesh-list
24585927|NCT00888186|Carbidopa|carbidopa|mesh-list
24585928|NCT00888186|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24585929|NCT00888186|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25082638|NCT03321318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082640|NCT03321318|Micronutrients|micronutrients|mesh-ancestor
25082641|NCT03321318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25082642|NCT03321318|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25082643|NCT03321318|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25082667|NCT03321136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082668|NCT03321136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25082669|NCT03321136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25082670|NCT03321136|Serotonin Agents|serotonin agents|mesh-ancestor
25082671|NCT03321136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25082672|NCT03321136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585941|NCT00888303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585942|NCT00888303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24585943|NCT00888303|Glucocorticoids|glucocorticoids|mesh-ancestor
24585945|NCT00888303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24585946|NCT00888303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24585947|NCT00888303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585948|NCT00888342|Ethanol|ethanol|mesh-list
24494161|NCT00494104|Micronutrients|micronutrients|mesh-ancestor
24494162|NCT00494104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494163|NCT00494104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24494165|NCT00494156|Heparin|heparin|mesh-list
24792896|NCT04420598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24792897|NCT04420598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24792899|NCT04408118|Atezolizumab|atezolizumab|mesh-list
24792900|NCT04408118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24793009|NCT04302324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24793010|NCT04302324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793011|NCT04302324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24793012|NCT04302324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24793013|NCT04302324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24925076|NCT04154449|Insulin|insulin|mesh-list
24494198|NCT00494312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24494300|NCT00494741|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24494301|NCT00494741|Antitubercular Agents|antitubercular agents|mesh-ancestor
24494302|NCT00494741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24494303|NCT00494741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24494304|NCT00494741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24494305|NCT00494741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793135|NCT04074460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24793136|NCT04074460|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24793138|NCT04073303|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24793140|NCT04073303|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24793141|NCT04073303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24793142|NCT04073303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793143|NCT04073303|Cholinergic Agents|cholinergic agents|mesh-ancestor
24793267|NCT03655002|Cyclophosphamide|cyclophosphamide|mesh-list
24494460|NCT00495326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24494470|NCT00495326|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24494472|NCT00495326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24793291|NCT03581370|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24793292|NCT03581370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24793294|NCT03581370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24793295|NCT03581370|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24793296|NCT03581370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24793297|NCT03581370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443077|NCT00293631|Ketorolac|ketorolac|mesh-list
24793298|NCT03568604|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24793308|NCT03539055|Dabigatran|dabigatran|mesh-list
24925261|NCT04151823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24925262|NCT04151823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24925263|NCT04151849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
24925264|NCT04151849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925265|NCT04151849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24494707|NCT00496444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494708|NCT00496444|Antimanic Agents|antimanic agents|mesh-ancestor
24494709|NCT00496444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24494745|NCT00496665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24804051|NCT02000700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24804052|NCT02000700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804054|NCT02000726|Antidepressive Agents|antidepressive agents|mesh-list
24793460|NCT03467386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793461|NCT03467386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793462|NCT03467386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24793463|NCT03467386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24793588|NCT03032406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793589|NCT03032406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24793590|NCT03032406|Immunologic Factors|immunologic factors|mesh-ancestor
24793591|NCT03032406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793592|NCT03032406|Antimalarials|antimalarials|mesh-ancestor
24793597|NCT03032406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793599|NCT02996825|Gemcitabine|gemcitabine|mesh-list
24793600|NCT02996825|Maytansine|maytansine|mesh-list
24793601|NCT02996825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24793602|NCT02996825|Antimetabolites|antimetabolites|mesh-ancestor
24793603|NCT02996825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793604|NCT02996825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793605|NCT02996825|Antiviral Agents|antiviral agents|mesh-ancestor
24793606|NCT02996825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24967318|NCT03760770|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24967319|NCT03760770|Dermatologic Agents|dermatologic agents|mesh-ancestor
24967372|NCT03760445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24967373|NCT03760445|Antifungal Agents|antifungal agents|mesh-ancestor
24967374|NCT03760445|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24967375|NCT03760445|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24967376|NCT03760445|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24967377|NCT03760445|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24967378|NCT03760445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24967379|NCT03760445|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24967380|NCT03760445|Hormone Antagonists|hormone antagonists|mesh-ancestor
24494942|NCT00497562|Amitriptyline|amitriptyline|mesh-list
24494943|NCT00497562|Fluoxetine|fluoxetine|mesh-list
24494944|NCT00497562|Hormones|hormones|mesh-list
24967381|NCT03760445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24967415|NCT03760276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967416|NCT03760276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24967417|NCT03760276|Hormone Antagonists|hormone antagonists|mesh-ancestor
24967418|NCT03760276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24967419|NCT03760276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967420|NCT03760276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24967421|NCT03760198|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24967422|NCT03760198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24967423|NCT03760198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24967424|NCT03760198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967425|NCT03760198|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24967426|NCT03760198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24967427|NCT03760198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967428|NCT03760198|Cholinergic Agents|cholinergic agents|mesh-ancestor
24967429|NCT03760198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24967464|NCT03759782|Antimetabolites|antimetabolites|mesh-ancestor
24967465|NCT03759353|Lactoferrin|lactoferrin|mesh-list
24967466|NCT03759353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24967467|NCT03759301|Cetrorelix|cetrorelix|mesh-list
24967468|NCT03759301|Hormones|hormones|mesh-list
24967469|NCT03759301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24967470|NCT03759301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967471|NCT03759301|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24967472|NCT03759301|Fertility Agents|fertility agents|mesh-ancestor
24967473|NCT03759301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24925502|NCT04149626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24495137|NCT00498680|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24495216|NCT00498979|Anthelmintics|anthelmintics|mesh-ancestor
24495217|NCT00498992|Vitamin E|vitamin e|mesh-list
24495257|NCT00499018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24495258|NCT00499018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24495259|NCT00499018|Antimetabolites|antimetabolites|mesh-ancestor
24804065|NCT02000804|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
24804067|NCT02000804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628175|NCT01096927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628176|NCT01096927|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24495262|NCT00499018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24967508|NCT03759093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24967509|NCT03759093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24967511|NCT03759093|Autonomic Agents|autonomic agents|mesh-ancestor
24967512|NCT03759093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24967513|NCT03759093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24967514|NCT03759093|Glucocorticoids|glucocorticoids|mesh-ancestor
24967515|NCT03759093|Hormones|hormones|mesh-ancestor
24967516|NCT03759093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24967517|NCT03759093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24967518|NCT03759093|Protease Inhibitors|protease inhibitors|mesh-ancestor
24967519|NCT03759093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24967627|NCT03758079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24967628|NCT03758079|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24967629|NCT03758079|Antidepressive Agents|antidepressive agents|mesh-ancestor
24967630|NCT03758079|Histamine Antagonists|histamine antagonists|mesh-ancestor
24967631|NCT03758079|Histamine Agents|histamine agents|mesh-ancestor
24967632|NCT03758014|Lomustine|lomustine|mesh-list
24967633|NCT03758014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24967634|NCT03758014|Alkylating Agents|alkylating agents|mesh-ancestor
24967635|NCT03758014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967636|NCT03758014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967637|NCT03757923|Metformin|metformin|mesh-list
24967638|NCT03757923|Pioglitazone|pioglitazone|mesh-list
24967639|NCT03757923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24967640|NCT03757923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967641|NCT03757910|Corticosterone|corticosterone|mesh-list
24967642|NCT03757910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24967643|NCT03757858|Antibodies|antibodies|mesh-list
24967645|NCT03757858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967646|NCT03757650|Amoxicillin|amoxicillin|mesh-list
24967647|NCT03757650|Clarithromycin|clarithromycin|mesh-list
24967649|NCT03757650|Bismuth|bismuth|mesh-list
24967650|NCT03757650|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
24967651|NCT03757650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24967652|NCT03757650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24967653|NCT03757650|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24967654|NCT03757650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24967655|NCT03757650|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24967656|NCT03757650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24967657|NCT03757650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708099|NCT02242630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25708100|NCT02242630|Glucocorticoids|glucocorticoids|mesh-ancestor
25708101|NCT02242630|Hormones|hormones|mesh-ancestor
25708102|NCT02242630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25708103|NCT02242630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25708104|NCT02242630|Protective Agents|protective agents|mesh-ancestor
25708105|NCT02242630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25708106|NCT02242630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967658|NCT03757650|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24967659|NCT03757650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24967660|NCT03757650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24967662|NCT03757650|Antidiarrheals|antidiarrheals|mesh-ancestor
24967671|NCT03757403|Mebendazole|mebendazole|mesh-list
24967672|NCT03757403|Piperazine|piperazine|mesh-list
24967673|NCT03757403|Piperazine citrate|piperazine citrate|mesh-list
24967674|NCT03757403|DMP 777|dmp 777|mesh-list
24967675|NCT03757403|Antinematodal Agents|antinematodal agents|mesh-ancestor
24967676|NCT03757403|Anthelmintics|anthelmintics|mesh-ancestor
24967677|NCT03757403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24967678|NCT03757403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24967679|NCT03757403|Tubulin Modulators|tubulin modulators|mesh-ancestor
24967680|NCT03757403|Antimitotic Agents|antimitotic agents|mesh-ancestor
24495600|NCT00501254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24495601|NCT00501254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495604|NCT00501254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24495605|NCT00501254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495606|NCT00501254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495607|NCT00501254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24495608|NCT00501254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24495609|NCT00501254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24804932|NCT02005783|Mitosis Modulators|mitosis modulators|mesh-ancestor
24967739|NCT03757156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24967740|NCT03757156|Antipyretics|antipyretics|mesh-ancestor
24967741|NCT03757143|Ethanol|ethanol|mesh-list
24967764|NCT03756987|Sensory System Agents|sensory system agents|mesh-ancestor
24967765|NCT03756987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24967766|NCT03756896|Dexamethasone|dexamethasone|mesh-list
24967767|NCT03756896|Pomalidomide|pomalidomide|mesh-list
24967768|NCT03756896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24967769|NCT03756896|Antiemetics|antiemetics|mesh-ancestor
24967770|NCT03756896|Autonomic Agents|autonomic agents|mesh-ancestor
24967771|NCT03756896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24967772|NCT03756896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967773|NCT03756896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24967774|NCT03756896|Glucocorticoids|glucocorticoids|mesh-ancestor
24967775|NCT03756896|Hormones|hormones|mesh-ancestor
24925933|NCT04146259|Alfacalcidol|alfacalcidol|mesh-list
24925936|NCT04146259|Calcium|calcium|mesh-list
24495610|NCT00501254|Antipyretics|antipyretics|mesh-ancestor
24495611|NCT00501267|Oxybutynin|oxybutynin|mesh-list
24495612|NCT00501267|Solabegron|solabegron|mesh-list
24495613|NCT00501267|Parasympatholytics|parasympatholytics|mesh-ancestor
24495614|NCT00501267|Autonomic Agents|autonomic agents|mesh-ancestor
24495673|NCT00501566|Natriuretic Agents|natriuretic agents|mesh-ancestor
24495685|NCT00501579|Hormones|hormones|mesh-ancestor
24967809|NCT03756298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24967811|NCT03756298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495734|NCT00501748|Rituximab|rituximab|mesh-list
24495735|NCT00501748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24495736|NCT00501748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495737|NCT00501748|Immunologic Factors|immunologic factors|mesh-ancestor
24495738|NCT00501748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968264|NCT03752424|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24967864|NCT03756090|Antimitotic Agents|antimitotic agents|mesh-ancestor
24967865|NCT03756090|Mitosis Modulators|mitosis modulators|mesh-ancestor
24967866|NCT03756090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967867|NCT03756090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24967868|NCT03756090|Immunologic Factors|immunologic factors|mesh-ancestor
24967869|NCT03756090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967870|NCT03756090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24967871|NCT03756090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24967872|NCT03756090|Alkylating Agents|alkylating agents|mesh-ancestor
24967873|NCT03756090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24793727|NCT02625610|Vitamin B Complex|vitamin b complex|mesh-ancestor
24967874|NCT03756090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24967875|NCT03756090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24967877|NCT03756090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24967878|NCT03756090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24967879|NCT03756064|Carboplatin|carboplatin|mesh-list
24967880|NCT03756064|Docetaxel|docetaxel|mesh-list
24967881|NCT03756064|Trastuzumab|trastuzumab|mesh-list
24793728|NCT02625610|Vitamins|vitamins|mesh-ancestor
24793729|NCT02625610|Micronutrients|micronutrients|mesh-ancestor
24793730|NCT02625610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24793731|NCT02595489|Vitamin D|vitamin d|mesh-list
24793732|NCT02595489|Ergocalciferols|ergocalciferols|mesh-list
24793733|NCT02595489|Cholecalciferol|cholecalciferol|mesh-list
24793734|NCT02595489|Vitamins|vitamins|mesh-list
24793735|NCT02595489|Micronutrients|micronutrients|mesh-ancestor
24793736|NCT02595489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793737|NCT02595489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24793738|NCT02595489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24825970|NCT02131298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825971|NCT02131298|Antifungal Agents|antifungal agents|mesh-ancestor
24968265|NCT03752398|Ipilimumab|ipilimumab|mesh-list
24967905|NCT03755778|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24967906|NCT03755778|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24967907|NCT03755778|Antitubercular Agents|antitubercular agents|mesh-ancestor
24967908|NCT03755778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24495754|NCT00501839|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24495755|NCT00501878|Phenylephrine|phenylephrine|mesh-list
24495756|NCT00501878|Oxymetazoline|oxymetazoline|mesh-list
24495757|NCT00501878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24495758|NCT00501878|Mydriatics|mydriatics|mesh-ancestor
24495759|NCT00501878|Autonomic Agents|autonomic agents|mesh-ancestor
24495830|NCT00502112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24495831|NCT00502112|Growth Substances|growth substances|mesh-ancestor
24967909|NCT03755778|Leprostatic Agents|leprostatic agents|mesh-ancestor
24967910|NCT03755778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24967911|NCT03755778|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24967912|NCT03755778|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24804942|NCT02005848|Protein C Inhibitor|protein c inhibitor|mesh-list
24804943|NCT02005848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24804944|NCT02005848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804945|NCT02005848|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24804946|NCT02005848|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24599546|NCT04413799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24599547|NCT04413799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24599548|NCT04413799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599549|NCT04413799|Analgesics|analgesics|mesh-ancestor
24967936|NCT03755752|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24967937|NCT03755739|Pembrolizumab|pembrolizumab|mesh-list
24967938|NCT03755739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24967939|NCT03755739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24967941|NCT03755700|Acetylcysteine|acetylcysteine|mesh-list
24967942|NCT03755700|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24967943|NCT03755700|Vitamins|vitamins|mesh-ancestor
24967944|NCT03755700|Micronutrients|micronutrients|mesh-ancestor
24967945|NCT03755700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24967946|NCT03755700|Antioxidants|antioxidants|mesh-ancestor
24967947|NCT03755700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24967948|NCT03755700|Protective Agents|protective agents|mesh-ancestor
24967949|NCT03755700|Antiviral Agents|antiviral agents|mesh-ancestor
24967950|NCT03755700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24967951|NCT03755700|Expectorants|expectorants|mesh-ancestor
24967954|NCT03755700|Antidotes|antidotes|mesh-ancestor
25082766|NCT03320447|Dermatologic Agents|dermatologic agents|mesh-ancestor
25082767|NCT03320447|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24804364|NCT02002195|Antidotes|antidotes|mesh-ancestor
24968044|NCT03755037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24968045|NCT03755037|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24968046|NCT03755037|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24968047|NCT03755037|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24968049|NCT03754959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24968075|NCT03754816|Anesthetics|anesthetics|mesh-list
24968076|NCT03754816|Levobupivacaine|levobupivacaine|mesh-list
24968077|NCT03754816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24968078|NCT03754816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968079|NCT03754816|Anesthetics, Local|anesthetics, local|mesh-ancestor
24968080|NCT03754816|Sensory System Agents|sensory system agents|mesh-ancestor
24968081|NCT03754816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24926267|NCT04143165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926268|NCT04143165|Sensory System Agents|sensory system agents|mesh-ancestor
24926269|NCT04143165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24926275|NCT04143256|Menthol|menthol|mesh-list
24968101|NCT03754647|Ascorbic Acid|ascorbic acid|mesh-list
24968102|NCT03754647|Vitamins|vitamins|mesh-ancestor
24968103|NCT03754647|Micronutrients|micronutrients|mesh-ancestor
24968104|NCT03754647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968105|NCT03754647|Antioxidants|antioxidants|mesh-ancestor
24968106|NCT03754647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968107|NCT03754647|Protective Agents|protective agents|mesh-ancestor
24968108|NCT03754634|Diacetylrhein|diacetylrhein|mesh-list
24968109|NCT03754634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24495999|NCT00502892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24496000|NCT00502892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496001|NCT00502892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496002|NCT00502892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24496056|NCT00503321|Antiviral Agents|antiviral agents|mesh-ancestor
24496057|NCT00503321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24496058|NCT00503321|Interferon Inducers|interferon inducers|mesh-ancestor
24496059|NCT00503321|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24968134|NCT03754062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968135|NCT03754062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24968136|NCT03754062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24968137|NCT03754062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24926312|NCT04142840|Sensory System Agents|sensory system agents|mesh-ancestor
24926313|NCT04142840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24926321|NCT04142762|Rifampin|rifampin|mesh-list
24496096|NCT00503490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24496097|NCT00503490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24496098|NCT00503490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24496099|NCT00503490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496100|NCT00503490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496101|NCT00503490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496102|NCT00503490|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24496104|NCT00503503|Etanercept|etanercept|mesh-list
24968193|NCT03753477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793779|NCT02484924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793780|NCT02484924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793781|NCT02436733|Pemetrexed|pemetrexed|mesh-list
24793782|NCT02436733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24793783|NCT02436733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24793784|NCT02436733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793785|NCT02436733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24793787|NCT02352883|Hormones|hormones|mesh-list
24968252|NCT03752658|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24968253|NCT03752658|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24968254|NCT03752476|Lactams|lactams|mesh-list
24968255|NCT03752476|beta-Lactams|beta-lactams|mesh-list
24968256|NCT03752476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24968257|NCT03752476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24968258|NCT03752437|Heparin|heparin|mesh-list
24496140|NCT00503542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496141|NCT00503542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968259|NCT03752437|Anticoagulants|anticoagulants|mesh-ancestor
24968260|NCT03752437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24968261|NCT03752437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24968262|NCT03752437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968263|NCT03752424|Anti-Infective Agents|anti-infective agents|mesh-list
24968266|NCT03752398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24968268|NCT03752398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24487861|NCT00465296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968269|NCT03752398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968270|NCT03752333|Pembrolizumab|pembrolizumab|mesh-list
24968271|NCT03752333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24968272|NCT03752333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24968273|NCT03752294|Dabigatran|dabigatran|mesh-list
24968274|NCT03752294|Antithrombins|antithrombins|mesh-ancestor
24968275|NCT03752294|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24968276|NCT03752294|Protease Inhibitors|protease inhibitors|mesh-ancestor
24968277|NCT03752294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24968278|NCT03752294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968279|NCT03752294|Anticoagulants|anticoagulants|mesh-ancestor
24968280|NCT03752229|Diazepam|diazepam|mesh-list
24968281|NCT03752229|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24968282|NCT03752229|Anticonvulsants|anticonvulsants|mesh-ancestor
24968283|NCT03752229|Antiemetics|antiemetics|mesh-ancestor
24968284|NCT03752229|Autonomic Agents|autonomic agents|mesh-ancestor
24968285|NCT03752229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24968286|NCT03752229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968288|NCT03752229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24968289|NCT03752229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24968290|NCT03752229|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24968291|NCT03752229|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24968292|NCT03752229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24968293|NCT03752229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24968294|NCT03752229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24926467|NCT04141553|Diltiazem|diltiazem|mesh-list
24968296|NCT03752229|Anesthetics, General|anesthetics, general|mesh-ancestor
25082769|NCT03320187|Dinoprostone|dinoprostone|mesh-list
24826023|NCT02131688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082814|NCT03319784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25082815|NCT03319784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628211|NCT01097278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25082816|NCT03319784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25082817|NCT03319784|Immunologic Factors|immunologic factors|mesh-ancestor
25082818|NCT03319784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25082819|NCT03319784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968333|NCT03751761|Tremelimumab|tremelimumab|mesh-list
24968334|NCT03751761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24968335|NCT03751761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24968341|NCT03751514|Azithromycin|azithromycin|mesh-list
24968377|NCT03751358|Anesthetics|anesthetics|mesh-list
24968378|NCT03751358|Anesthetics, Local|anesthetics, local|mesh-list
24968379|NCT03751358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24906173|NCT04342247|Methyltestosterone|methyltestosterone|mesh-list
24968380|NCT03751358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968381|NCT03751358|Sensory System Agents|sensory system agents|mesh-ancestor
24968382|NCT03751358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24968383|NCT03751332|Tacrolimus|tacrolimus|mesh-list
24906248|NCT04341402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24968384|NCT03751332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24968385|NCT03751332|Immunologic Factors|immunologic factors|mesh-ancestor
24968386|NCT03751332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968412|NCT03751202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24968413|NCT03751202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968414|NCT03751202|Glucocorticoids|glucocorticoids|mesh-ancestor
24968415|NCT03751202|Hormones|hormones|mesh-ancestor
24968416|NCT03751202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24968417|NCT03751202|Sympathomimetics|sympathomimetics|mesh-ancestor
24968418|NCT03751176|Leucovorin|leucovorin|mesh-list
24968419|NCT03751176|Folic Acid|folic acid|mesh-list
24968482|NCT03750916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968483|NCT03750773|Gabapentin|gabapentin|mesh-list
24968485|NCT03750773|Sensory System Agents|sensory system agents|mesh-ancestor
24968486|NCT03750773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24968487|NCT03750773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968488|NCT03750773|Anticonvulsants|anticonvulsants|mesh-ancestor
24968499|NCT03750760|Ezetimibe|ezetimibe|mesh-list
24968528|NCT03750669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25708107|NCT02242630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24968529|NCT03750669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708108|NCT02242630|Immunologic Factors|immunologic factors|mesh-ancestor
25708109|NCT02242630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709749|NCT02274311|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24488154|NCT00466843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24488164|NCT00466869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488165|NCT00466869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488167|NCT00466895|Immunologic Factors|immunologic factors|mesh-ancestor
24488168|NCT00466895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488173|NCT00466895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488174|NCT00466986|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24968530|NCT03750669|Tubulin Modulators|tubulin modulators|mesh-ancestor
24968531|NCT03750669|Antimitotic Agents|antimitotic agents|mesh-ancestor
24968532|NCT03750669|Mitosis Modulators|mitosis modulators|mesh-ancestor
24968533|NCT03750669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968581|NCT03750383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968582|NCT03750383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25082837|NCT03319563|Anesthetics, Local|anesthetics, local|mesh-list
24968584|NCT03750383|Antifungal Agents|antifungal agents|mesh-ancestor
24968585|NCT03750383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24968586|NCT03750383|Dermatologic Agents|dermatologic agents|mesh-ancestor
24968587|NCT03750383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24968588|NCT03750383|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24968589|NCT03750136|Furosemide|furosemide|mesh-list
24968590|NCT03750136|Diuretics|diuretics|mesh-ancestor
24968644|NCT03749642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24968645|NCT03749642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968646|NCT03749642|Anticonvulsants|anticonvulsants|mesh-ancestor
24968647|NCT03749642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24968648|NCT03749642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24968649|NCT03749642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24968650|NCT03749642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24968651|NCT03749642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24968652|NCT03749642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24968653|NCT03749642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24968713|NCT03748940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24968714|NCT03748940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968715|NCT03748940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24968716|NCT03748940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24793849|NCT01442246|Leuprolide|leuprolide|mesh-list
24496738|NCT00506506|Antiviral Agents|antiviral agents|mesh-ancestor
24496739|NCT00506506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24793861|NCT01062399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793863|NCT01062399|Alkylating Agents|alkylating agents|mesh-ancestor
24793864|NCT01062399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793865|NCT00867048|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24793866|NCT00867048|Antiviral Agents|antiviral agents|mesh-ancestor
24793867|NCT00867048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24793868|NCT00712322|Darifenacin|darifenacin|mesh-list
24793869|NCT00712322|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24793870|NCT00712322|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24793879|NCT00572169|Cisplatin|cisplatin|mesh-list
24628243|NCT01097512|Immunologic Factors|immunologic factors|mesh-ancestor
24628244|NCT01097512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628245|NCT01097551|Phenylephrine|phenylephrine|mesh-list
24628246|NCT01097551|Acetylcholine|acetylcholine|mesh-list
24628247|NCT01097551|Nitroglycerin|nitroglycerin|mesh-list
25708110|NCT02242630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708111|NCT02243007|Gemcitabine|gemcitabine|mesh-list
25708112|NCT02243007|Paclitaxel|paclitaxel|mesh-list
25708113|NCT02243007|Capecitabine|capecitabine|mesh-list
25708114|NCT02243007|Folfirinox|folfirinox|mesh-list
25708115|NCT02243007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25708116|NCT02243007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708117|NCT02243007|Tubulin Modulators|tubulin modulators|mesh-ancestor
25708118|NCT02243007|Antimitotic Agents|antimitotic agents|mesh-ancestor
25708119|NCT02243007|Mitosis Modulators|mitosis modulators|mesh-ancestor
24488721|NCT00469781|Autonomic Agents|autonomic agents|mesh-ancestor
24488722|NCT00469781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25082851|NCT03319563|Mydriatics|mydriatics|mesh-ancestor
25082852|NCT03319563|Sympathomimetics|sympathomimetics|mesh-ancestor
25082853|NCT03319563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25082854|NCT03319563|Sensory System Agents|sensory system agents|mesh-ancestor
25082856|NCT03319550|Chelating Agents|chelating agents|mesh-ancestor
25082857|NCT03319550|Sequestering Agents|sequestering agents|mesh-ancestor
25082858|NCT03319550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24793902|NCT00572169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24793903|NCT00572169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24793904|NCT00572169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24793905|NCT00572169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24793906|NCT00572169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24793907|NCT00572169|Leprostatic Agents|leprostatic agents|mesh-ancestor
24968719|NCT03748537|Hydrocortisone|hydrocortisone|mesh-list
24497432|NCT00510016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24497479|NCT00510211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24497480|NCT00510211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968806|NCT03747900|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24968807|NCT03747900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24968808|NCT03747900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24968809|NCT03747900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968810|NCT03747900|Cholinergic Agents|cholinergic agents|mesh-ancestor
24968811|NCT03747900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24968812|NCT03747900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24968813|NCT03747900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24968814|NCT03747900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24968862|NCT03747536|Respiratory System Agents|respiratory system agents|mesh-ancestor
24968863|NCT03747536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24968864|NCT03747536|Cholinergic Agents|cholinergic agents|mesh-ancestor
24968865|NCT03747536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24968878|NCT03747341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24968879|NCT03747341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24968880|NCT03747341|Narcotics|narcotics|mesh-ancestor
24968881|NCT03747341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24497857|NCT00512265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24497867|NCT00512291|Fluoxetine|fluoxetine|mesh-list
24497919|NCT00512629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24497921|NCT00512668|Leuprolide|leuprolide|mesh-list
24497922|NCT00512668|Goserelin|goserelin|mesh-list
24497923|NCT00512668|Flutamide|flutamide|mesh-list
24497924|NCT00512668|Bicalutamide|bicalutamide|mesh-list
24498358|NCT00514111|Antimetabolites|antimetabolites|mesh-ancestor
24793912|NCT00572169|Growth Substances|growth substances|mesh-ancestor
24793913|NCT00572169|Growth Inhibitors|growth inhibitors|mesh-ancestor
24793914|NCT00323856|Factor VIII|factor viii|mesh-list
24793915|NCT00323856|Coagulants|coagulants|mesh-ancestor
24793916|NCT00240916|Vaccines|vaccines|mesh-list
24793917|NCT00240916|Immunologic Factors|immunologic factors|mesh-ancestor
24793919|NCT00103038|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24969020|NCT03746158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24927262|NCT04134598|Tamoxifen|tamoxifen|mesh-list
24969021|NCT03746158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24969022|NCT03746158|Analgesics|analgesics|mesh-ancestor
24969023|NCT03746158|Sensory System Agents|sensory system agents|mesh-ancestor
24969024|NCT03746158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969025|NCT03746158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969026|NCT03746158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24969031|NCT03746119|Nicotine|nicotine|mesh-list
25082882|NCT03319238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082883|NCT03319238|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25082884|NCT03319238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25708120|NCT02243007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708121|NCT02243007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25082885|NCT03319238|Anesthetics, General|anesthetics, general|mesh-ancestor
25082886|NCT03319238|Anesthetics|anesthetics|mesh-ancestor
25708122|NCT02243007|Antimetabolites|antimetabolites|mesh-ancestor
25708123|NCT02243007|Antiviral Agents|antiviral agents|mesh-ancestor
25708124|NCT02243007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25708125|NCT02243007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25708126|NCT02243007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24489115|NCT00471484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24489116|NCT00471484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24489307|NCT00472173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24489308|NCT00472173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489310|NCT00472225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24489311|NCT00472225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489312|NCT00472225|Immunologic Factors|immunologic factors|mesh-ancestor
24489313|NCT00472225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25082887|NCT03319238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25082888|NCT03319238|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25082889|NCT03319238|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24969055|NCT03746106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24969056|NCT03746106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24969057|NCT03746106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969058|NCT03746106|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24969059|NCT03746106|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24969060|NCT03746106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24969061|NCT03745911|Paclitaxel|paclitaxel|mesh-list
24969062|NCT03745911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24969063|NCT03745911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24969064|NCT03745911|Tubulin Modulators|tubulin modulators|mesh-ancestor
24969065|NCT03745911|Antimitotic Agents|antimitotic agents|mesh-ancestor
24969066|NCT03745911|Mitosis Modulators|mitosis modulators|mesh-ancestor
24969067|NCT03745911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969068|NCT03745807|Nivolumab|nivolumab|mesh-list
24969069|NCT03745807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24969070|NCT03745807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498879|NCT00516750|Doxorubicin|doxorubicin|mesh-list
24498880|NCT00516750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24498881|NCT00516750|Methotrexate|methotrexate|mesh-list
24498882|NCT00516750|Vinblastine|vinblastine|mesh-list
24498883|NCT00516750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24969085|NCT03745664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24969086|NCT03745664|Glucocorticoids|glucocorticoids|mesh-ancestor
24969087|NCT03745664|Hormones|hormones|mesh-ancestor
24969088|NCT03745664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24969089|NCT03745664|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24969090|NCT03745664|Protective Agents|protective agents|mesh-ancestor
24969091|NCT03745664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24969092|NCT03745664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24969093|NCT03745625|Propofol|propofol|mesh-list
24499122|NCT00517803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499123|NCT00517946|Cetirizine|cetirizine|mesh-list
24499124|NCT00517946|Pseudoephedrine|pseudoephedrine|mesh-list
24499125|NCT00517946|Ephedrine|ephedrine|mesh-list
24499126|NCT00517946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24499127|NCT00517946|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24499128|NCT00517946|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24499129|NCT00517946|Histamine Antagonists|histamine antagonists|mesh-ancestor
24499130|NCT00517946|Histamine Agents|histamine agents|mesh-ancestor
24499131|NCT00517946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24499132|NCT00517946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499135|NCT00517946|Autonomic Agents|autonomic agents|mesh-ancestor
24499169|NCT00518141|Dermatologic Agents|dermatologic agents|mesh-ancestor
24499170|NCT00518141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24499171|NCT00518141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24499172|NCT00518141|Analgesics|analgesics|mesh-ancestor
24499173|NCT00518141|Sensory System Agents|sensory system agents|mesh-ancestor
25708127|NCT02243007|Immunologic Factors|immunologic factors|mesh-ancestor
25708128|NCT02243007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708129|NCT02243176|Saxagliptin|saxagliptin|mesh-list
25708130|NCT02243176|Acarbose|acarbose|mesh-list
25708131|NCT02243176|Incretins|incretins|mesh-ancestor
25708132|NCT02243176|Hormones|hormones|mesh-ancestor
25708133|NCT02243176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25708134|NCT02243176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708135|NCT02243176|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24499174|NCT00518141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24499361|NCT00519116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24499362|NCT00519116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499363|NCT00519116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24499364|NCT00519116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24499368|NCT00519181|Valproic Acid|valproic acid|mesh-list
24499406|NCT00519259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499407|NCT00519259|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24499408|NCT00519259|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24499409|NCT00519259|Cholinergic Agents|cholinergic agents|mesh-ancestor
24499410|NCT00519259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24499411|NCT00519259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624538|NCT01076621|Contraceptive Agents|contraceptive agents|mesh-ancestor
24628866|NCT01101698|Vitamin D|vitamin d|mesh-list
24499607|NCT00520169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499609|NCT00520247|Enalapril|enalapril|mesh-list
24499610|NCT00520247|Hematinics|hematinics|mesh-ancestor
24499611|NCT00520247|Vitamin B Complex|vitamin b complex|mesh-ancestor
24617600|NCT01044238|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24617601|NCT01044238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24617602|NCT01044238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24617604|NCT01044238|Dopamine Agents|dopamine agents|mesh-ancestor
24499890|NCT00521430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24499891|NCT00521430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24969177|NCT03745157|Insulin|insulin|mesh-list
24969178|NCT03745157|Insulin Aspart|insulin aspart|mesh-list
24500144|NCT00522938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24500145|NCT00522938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24500146|NCT00522938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500148|NCT00523055|Anesthetics, Local|anesthetics, local|mesh-ancestor
24500149|NCT00523055|Anesthetics|anesthetics|mesh-ancestor
24500150|NCT00523055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24500151|NCT00523055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500152|NCT00523055|Sensory System Agents|sensory system agents|mesh-ancestor
24500153|NCT00523055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24500159|NCT00523068|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24501509|NCT00528983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24969228|NCT03744949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969229|NCT03744897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
24969230|NCT03744897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24969231|NCT03744897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969286|NCT03744104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969288|NCT03744091|Hallucinogens|hallucinogens|mesh-ancestor
24969289|NCT03744091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806284|NCT02014727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806285|NCT02014727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24806286|NCT02014753|Cobalt|cobalt|mesh-list
24806287|NCT02014753|Chromium|chromium|mesh-list
24806288|NCT02014753|Everolimus|everolimus|mesh-list
24806289|NCT02014753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24806290|NCT02014753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25082954|NCT03318835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25082955|NCT03318835|Alkylating Agents|alkylating agents|mesh-ancestor
25082956|NCT03318835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082957|NCT03318835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25082958|NCT03318835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24500625|NCT00525239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24969347|NCT03743805|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24969348|NCT03743805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969349|NCT03743805|Sensory System Agents|sensory system agents|mesh-ancestor
24969350|NCT03743805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969351|NCT03743805|Antidotes|antidotes|mesh-ancestor
24969352|NCT03743805|Protective Agents|protective agents|mesh-ancestor
24969353|NCT03743805|GABA Modulators|gaba modulators|mesh-ancestor
24969354|NCT03743805|GABA Agents|gaba agents|mesh-ancestor
24969355|NCT03743805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24969356|NCT03743805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969357|NCT03743727|Sofosbuvir|sofosbuvir|mesh-list
24969358|NCT03743727|Ledipasvir|ledipasvir|mesh-list
24969359|NCT03743727|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
24969360|NCT03743727|Antiviral Agents|antiviral agents|mesh-ancestor
24793992|NCT05414474|Ascorbic Acid|ascorbic acid|mesh-list
24793993|NCT05414474|Antioxidants|antioxidants|mesh-ancestor
24793994|NCT05414474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969386|NCT03743428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24969387|NCT03743428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24969388|NCT03743428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24969389|NCT03743428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24969390|NCT03743428|Growth Substances|growth substances|mesh-ancestor
24969391|NCT03743428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969392|NCT03743428|Growth Inhibitors|growth inhibitors|mesh-ancestor
24969393|NCT03743428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24969394|NCT03743428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24969395|NCT03743428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969397|NCT03743285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24500802|NCT00525759|Epirubicin|epirubicin|mesh-list
24500804|NCT00525759|Immunologic Factors|immunologic factors|mesh-ancestor
24500890|NCT00526175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500891|NCT00526175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24500892|NCT00526175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24500893|NCT00526175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24500894|NCT00526175|Glucocorticoids|glucocorticoids|mesh-ancestor
24500895|NCT00526175|Hormones|hormones|mesh-ancestor
24969429|NCT03742908|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24969430|NCT03742908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501512|NCT00529022|Valproic Acid|valproic acid|mesh-list
24969437|NCT03742713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969438|NCT03742557|Ketamine|ketamine|mesh-list
24969450|NCT03742557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24969451|NCT03742557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969453|NCT03742531|Oxytocics|oxytocics|mesh-ancestor
24969454|NCT03742531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24969455|NCT03742531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969456|NCT03742466|Methylprednisolone|methylprednisolone|mesh-list
24969486|NCT03742323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24969487|NCT03742323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24969488|NCT03742323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969546|NCT03742258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24969547|NCT03742258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24969548|NCT03742258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24969549|NCT03742258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24969550|NCT03742258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24969551|NCT03742258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24969552|NCT03742258|Glucocorticoids|glucocorticoids|mesh-ancestor
24969554|NCT03742258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24969555|NCT03742258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24501398|NCT00528359|Dopamine Agonists|dopamine agonists|mesh-ancestor
24501399|NCT00528359|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24501400|NCT00528359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24501401|NCT00528359|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24501402|NCT00528359|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24501403|NCT00528385|Spironolactone|spironolactone|mesh-list
24501404|NCT00528385|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24501405|NCT00528385|Hormone Antagonists|hormone antagonists|mesh-ancestor
24501406|NCT00528385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24501407|NCT00528385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501408|NCT00528385|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24501409|NCT00528385|Diuretics|diuretics|mesh-ancestor
24628326|NCT01098084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25082983|NCT03318757|Sensory System Agents|sensory system agents|mesh-ancestor
25082984|NCT03318757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25708136|NCT02243176|Protease Inhibitors|protease inhibitors|mesh-ancestor
25708137|NCT02243176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25708138|NCT02243176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708139|NCT02243176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24969601|NCT03742115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24969602|NCT03742115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24969603|NCT03742115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24969604|NCT03742115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24969605|NCT03742115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24969606|NCT03742115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24969607|NCT03742115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24969608|NCT03742115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969610|NCT03741933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24969611|NCT03741933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24969612|NCT03741933|Analgesics|analgesics|mesh-ancestor
24969613|NCT03741933|Sensory System Agents|sensory system agents|mesh-ancestor
24928003|NCT04126941|Calcium|calcium|mesh-list
24969686|NCT03740893|Olaparib|olaparib|mesh-list
24969687|NCT03740893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24969688|NCT03740893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24969718|NCT03740438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24969719|NCT03740438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24969720|NCT03740438|Analgesics|analgesics|mesh-ancestor
24501537|NCT00529295|Abortifacient Agents|abortifacient agents|mesh-ancestor
24501538|NCT00529295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24501539|NCT00529295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501540|NCT00529295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24501541|NCT00529295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24501542|NCT00529295|Oxytocics|oxytocics|mesh-ancestor
24501543|NCT00529360|Clofarabine|clofarabine|mesh-list
24501544|NCT00529360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24501545|NCT00529360|Antimetabolites|antimetabolites|mesh-ancestor
24501572|NCT00529620|Amodiaquine|amodiaquine|mesh-list
24969739|NCT03740373|Formoterol Fumarate|formoterol fumarate|mesh-list
24969740|NCT03740373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24969741|NCT03740373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24969742|NCT03740373|Autonomic Agents|autonomic agents|mesh-ancestor
24969743|NCT03740373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24969744|NCT03740373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969745|NCT03740373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24969746|NCT03740373|Respiratory System Agents|respiratory system agents|mesh-ancestor
24969747|NCT03740373|Glucocorticoids|glucocorticoids|mesh-ancestor
24969749|NCT03740373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24969751|NCT03740373|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24501719|NCT00530582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501720|NCT00530595|Losartan|losartan|mesh-list
24501721|NCT00530595|Valsartan|valsartan|mesh-list
24501722|NCT00530595|Candesartan|candesartan|mesh-list
24501723|NCT00530595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24501724|NCT00530595|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24443542|NCT00295373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501725|NCT00530595|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24501729|NCT00530868|Letrozole|letrozole|mesh-list
24501730|NCT00530868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24501731|NCT00530868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501732|NCT00530868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24501733|NCT00530868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24969808|NCT03739801|Irinotecan|irinotecan|mesh-list
24969809|NCT03739801|Ramucirumab|ramucirumab|mesh-list
24969810|NCT03739801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24969811|NCT03739801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24969812|NCT03739801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24969814|NCT03739801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501746|NCT00530907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24501748|NCT00530907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24969883|NCT03738956|Tofacitinib|tofacitinib|mesh-list
24969884|NCT03738956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24969885|NCT03738956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24969886|NCT03738956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969887|NCT03738943|Pyridoxine|pyridoxine|mesh-list
24969888|NCT03738943|Pyridoxal|pyridoxal|mesh-list
25709750|NCT02274766|Amantadine|amantadine|mesh-list
25709751|NCT02274766|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25709752|NCT02274766|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25709753|NCT02274766|Antiviral Agents|antiviral agents|mesh-ancestor
25709754|NCT02274766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25709755|NCT02274766|Dopamine Agents|dopamine agents|mesh-ancestor
25709756|NCT02274766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24501772|NCT00531024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24501773|NCT00531024|Growth Substances|growth substances|mesh-ancestor
24501774|NCT00531024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969940|NCT03738176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24969942|NCT03738176|Hormones|hormones|mesh-ancestor
24969943|NCT03738176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24969944|NCT03738176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628344|NCT01098344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628346|NCT01098357|Anticoagulants|anticoagulants|mesh-ancestor
24628347|NCT01098357|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
24628348|NCT01098357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24628349|NCT01098357|Growth Substances|growth substances|mesh-ancestor
24628350|NCT01098357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628351|NCT01098383|Acetylcholine|acetylcholine|mesh-list
24628352|NCT01098383|Donepezil|donepezil|mesh-list
24628353|NCT01098383|Choline|choline|mesh-list
24628354|NCT01098383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24628355|NCT01098383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628356|NCT01098383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083026|NCT03318471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083027|NCT03318471|Anesthetics|anesthetics|mesh-ancestor
25083028|NCT03318471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25083029|NCT03318471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25083030|NCT03318471|Anticonvulsants|anticonvulsants|mesh-ancestor
25083031|NCT03318471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25083032|NCT03318471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25083068|NCT03318211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083072|NCT03318211|Anticonvulsants|anticonvulsants|mesh-ancestor
25083073|NCT03318211|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24501839|NCT00531310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24501888|NCT00531440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24501889|NCT00531440|Immunologic Factors|immunologic factors|mesh-ancestor
24501890|NCT00531440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501891|NCT00531466|Tolperisone|tolperisone|mesh-list
24501892|NCT00531466|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24621895|NCT01064557|Tretinoin|tretinoin|mesh-list
24621896|NCT01064557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24621897|NCT01064557|Keratolytic Agents|keratolytic agents|mesh-ancestor
24621898|NCT01064557|Dermatologic Agents|dermatologic agents|mesh-ancestor
24969947|NCT03738137|Sufentanil|sufentanil|mesh-list
24969948|NCT03738137|Anesthetics, Local|anesthetics, local|mesh-ancestor
24969949|NCT03738137|Anesthetics|anesthetics|mesh-ancestor
24969950|NCT03738137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24969951|NCT03738137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969952|NCT03738137|Sensory System Agents|sensory system agents|mesh-ancestor
24969953|NCT03738137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24928419|NCT04122222|Vaccines|vaccines|mesh-list
24501946|NCT00531687|Gemcitabine|gemcitabine|mesh-list
24969964|NCT03738137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24969965|NCT03738137|Anesthetics, General|anesthetics, general|mesh-ancestor
24969966|NCT03738137|GABA Modulators|gaba modulators|mesh-ancestor
24969967|NCT03738137|GABA Agents|gaba agents|mesh-ancestor
24969968|NCT03738137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24969969|NCT03738137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24969970|NCT03738137|Narcotics|narcotics|mesh-ancestor
24969971|NCT03738137|Analgesics|analgesics|mesh-ancestor
24969972|NCT03738059|Dexmedetomidine|dexmedetomidine|mesh-list
24969973|NCT03738059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24969974|NCT03738059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24969975|NCT03738059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969976|NCT03738059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24621899|NCT01064570|Tretinoin|tretinoin|mesh-list
24502009|NCT00531986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25708140|NCT02243176|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24502031|NCT00531999|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24502032|NCT00531999|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24502033|NCT05319912|Molybdenum|molybdenum|mesh-list
24502034|NCT05319912|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
24502035|NCT05319912|Choline|choline|mesh-list
24502036|NCT05319912|Omeprazole|omeprazole|mesh-list
24502037|NCT05319912|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24502038|NCT05319912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24502039|NCT05319912|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24502055|NCT05319912|Trace Elements|trace elements|mesh-ancestor
24970025|NCT03737708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24970028|NCT03737708|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24970029|NCT03737708|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24970030|NCT03737708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24970031|NCT03737708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24970032|NCT03737656|Progesterone|progesterone|mesh-list
24970033|NCT03737656|Progestins|progestins|mesh-ancestor
24970035|NCT03737656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24970036|NCT03737656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970037|NCT03737474|Brexpiprazole|brexpiprazole|mesh-list
24970038|NCT03737474|Serotonin Agents|serotonin agents|mesh-ancestor
24970039|NCT03737474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24970040|NCT03737474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970041|NCT03737474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628383|NCT01098513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24628384|NCT01098513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24628385|NCT01098513|Antiviral Agents|antiviral agents|mesh-ancestor
24928613|NCT04120311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24502076|NCT05319899|Growth Inhibitors|growth inhibitors|mesh-ancestor
24502077|NCT05319899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24502079|NCT05319834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24502080|NCT05319834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24502081|NCT05319834|Analgesics|analgesics|mesh-ancestor
24502082|NCT05319834|Sensory System Agents|sensory system agents|mesh-ancestor
24502083|NCT05319834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24502084|NCT05319834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502085|NCT05319834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25083084|NCT03318159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25083085|NCT03318159|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24502230|NCT05317676|Antiviral Agents|antiviral agents|mesh-ancestor
24502258|NCT05317611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24502260|NCT05317572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24502261|NCT05317572|Narcotics|narcotics|mesh-ancestor
24502262|NCT05317572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24502263|NCT05317572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502264|NCT05317572|Analgesics|analgesics|mesh-ancestor
24502265|NCT05317572|Sensory System Agents|sensory system agents|mesh-ancestor
24502266|NCT05317572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24970160|NCT03735446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24970161|NCT03735446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24970175|NCT03735433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24621900|NCT01064570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24621903|NCT01064726|Fluticasone|fluticasone|mesh-list
24970177|NCT03735433|Analgesics|analgesics|mesh-ancestor
24928691|NCT04119921|Ketorolac|ketorolac|mesh-list
24970201|NCT03735368|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24970202|NCT03735368|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24970203|NCT03735368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24970204|NCT03735368|Adrenergic Agents|adrenergic agents|mesh-ancestor
24970205|NCT03735368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24970206|NCT03735368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502333|NCT05273671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24502334|NCT05273671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24502335|NCT05273671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24502336|NCT05273671|Adrenergic Agents|adrenergic agents|mesh-ancestor
24502339|NCT05273671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24970207|NCT03735368|Anticonvulsants|anticonvulsants|mesh-ancestor
25708141|NCT02243202|Canagliflozin|canagliflozin|mesh-list
24970208|NCT03735368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25708142|NCT02243202|Phentermine|phentermine|mesh-list
25708143|NCT02243202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25708144|NCT02243202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970209|NCT03735368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24970210|NCT03735368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24970211|NCT03735368|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24970212|NCT03735368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24970213|NCT03735368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24970214|NCT03735368|Anesthetics, Local|anesthetics, local|mesh-ancestor
24970256|NCT03735082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970257|NCT03735082|Tubulin Modulators|tubulin modulators|mesh-ancestor
24970258|NCT03735082|Antimitotic Agents|antimitotic agents|mesh-ancestor
24970259|NCT03735082|Mitosis Modulators|mitosis modulators|mesh-ancestor
24970260|NCT03735082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970261|NCT03735082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24970262|NCT03735082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24970263|NCT03734627|Acetaminophen|acetaminophen|mesh-list
24502439|NCT05085808|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24502441|NCT05085067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24502442|NCT05085067|Immunologic Factors|immunologic factors|mesh-ancestor
24970294|NCT03734614|Antipyretics|antipyretics|mesh-ancestor
24970295|NCT03734562|Amiodarone|amiodarone|mesh-list
24970296|NCT03734562|Sotalol|sotalol|mesh-list
24970297|NCT03734562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
24970298|NCT03734562|Vasodilator Agents|vasodilator agents|mesh-ancestor
24970299|NCT03734562|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24970317|NCT03734445|Vitamins|vitamins|mesh-list
24502466|NCT05061654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502467|NCT05061654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24502472|NCT05037279|BCG Vaccine|bcg vaccine|mesh-list
24502473|NCT05037279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24502474|NCT05037279|Immunologic Factors|immunologic factors|mesh-ancestor
24502475|NCT05037279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502476|NCT05035316|Aspirin|aspirin|mesh-list
24970321|NCT03734354|Serotonin Agents|serotonin agents|mesh-ancestor
24970322|NCT03734354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24970323|NCT03734354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970351|NCT03733873|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24970352|NCT03733873|Natriuretic Agents|natriuretic agents|mesh-ancestor
24970353|NCT03733873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970355|NCT03733860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24970356|NCT03733860|Vasodilator Agents|vasodilator agents|mesh-ancestor
24970357|NCT03733860|Urological Agents|urological agents|mesh-ancestor
24970358|NCT03733691|Lenalidomide|lenalidomide|mesh-list
24970359|NCT03733691|Ixazomib|ixazomib|mesh-list
24970360|NCT03733691|Immunologic Factors|immunologic factors|mesh-ancestor
24970361|NCT03733691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970362|NCT03733691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24628408|NCT01098656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24628409|NCT01098656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24628411|NCT01098656|Growth Inhibitors|growth inhibitors|mesh-ancestor
24628412|NCT01098656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24628413|NCT01098760|Sorafenib|sorafenib|mesh-list
24628414|NCT01098760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24628415|NCT01098760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24628416|NCT01098760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24628417|NCT01098760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24628418|NCT01098890|Plasminogen|plasminogen|mesh-list
24628419|NCT01098890|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24628420|NCT01098890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24628421|NCT01098890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24502483|NCT05035316|Sensory System Agents|sensory system agents|mesh-ancestor
24970412|NCT03733379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24970413|NCT03733379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24970414|NCT03733379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24970415|NCT03733340|Imipenem|imipenem|mesh-list
24970416|NCT03733340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24970417|NCT03733340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24970418|NCT03733327|Cyclophosphamide|cyclophosphamide|mesh-list
24970419|NCT03733327|Busulfan|busulfan|mesh-list
24970420|NCT03733327|Etoposide|etoposide|mesh-list
24970421|NCT03733327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24970422|NCT03733327|Immunologic Factors|immunologic factors|mesh-ancestor
24970434|NCT03733275|Lidocaine|lidocaine|mesh-list
24970469|NCT03732963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970470|NCT03732963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24970471|NCT03732703|Thalidomide|thalidomide|mesh-list
24502484|NCT05035316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24502485|NCT05035316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24502486|NCT05035316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24502487|NCT05035316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24502488|NCT05035316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24502489|NCT05035316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502490|NCT05035316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24502493|NCT05035316|Antipyretics|antipyretics|mesh-ancestor
24502506|NCT05013892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502542|NCT04974684|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24502543|NCT04974684|Antithrombins|antithrombins|mesh-ancestor
24502577|NCT04817033|Midazolam|midazolam|mesh-list
24502578|NCT04817033|Dexmedetomidine|dexmedetomidine|mesh-list
24502579|NCT04817033|Anesthetics|anesthetics|mesh-list
24502580|NCT04817033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24502581|NCT04817033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970517|NCT03732547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24970518|NCT03732547|Interferon Inducers|interferon inducers|mesh-ancestor
24970519|NCT03732547|Immunologic Factors|immunologic factors|mesh-ancestor
24970520|NCT03732547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970521|NCT03732508|Fluorouracil|fluorouracil|mesh-list
24970522|NCT03732508|Irinotecan|irinotecan|mesh-list
24970555|NCT03732391|Carboplatin|carboplatin|mesh-list
24970556|NCT03732391|Pembrolizumab|pembrolizumab|mesh-list
24970557|NCT03732391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970558|NCT03732391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24970559|NCT03732365|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24970560|NCT03732365|Cefazolin|cefazolin|mesh-list
24970561|NCT03732365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24970562|NCT03732287|Anesthetics|anesthetics|mesh-list
24970563|NCT03732287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24970564|NCT03732287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970565|NCT03732235|Bevacizumab|bevacizumab|mesh-list
24970566|NCT03732235|Chlorotrianisene|chlorotrianisene|mesh-list
24970567|NCT03732235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24970568|NCT03732235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970569|NCT03732235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24794098|NCT05413902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24794099|NCT05413902|Analgesics|analgesics|mesh-ancestor
24794100|NCT05413902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24794101|NCT05413902|Antipyretics|antipyretics|mesh-ancestor
24794102|NCT05413902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24794103|NCT05413902|Antiemetics|antiemetics|mesh-ancestor
24794104|NCT05413902|Autonomic Agents|autonomic agents|mesh-ancestor
24794105|NCT05413902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24794106|NCT05413902|Glucocorticoids|glucocorticoids|mesh-ancestor
24794108|NCT05413902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24502665|NCT04724044|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24502666|NCT04724044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502667|NCT04724044|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24502668|NCT04724044|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24502669|NCT04724044|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24502670|NCT04724044|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24502671|NCT04724044|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24502672|NCT04724044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24794147|NCT05413902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24970631|NCT03731832|Immunologic Factors|immunologic factors|mesh-ancestor
24970632|NCT03731832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970633|NCT03731832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24970634|NCT03731832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24970635|NCT03731832|Alkylating Agents|alkylating agents|mesh-ancestor
24443639|NCT00295594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24970636|NCT03731832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970637|NCT03731832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970638|NCT03731832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24970640|NCT03731832|Antiemetics|antiemetics|mesh-ancestor
24502782|NCT04447040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24502783|NCT04447040|Gout Suppressants|gout suppressants|mesh-ancestor
24970715|NCT03731286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24970716|NCT03731286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24970720|NCT03731286|Purinergic Agents|purinergic agents|mesh-ancestor
24807410|NCT02021851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083206|NCT03317457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25083207|NCT03317457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083208|NCT03317457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25083209|NCT03317457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25083210|NCT03317457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25083211|NCT03317457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083212|NCT03317457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25083213|NCT03317327|Nivolumab|nivolumab|mesh-list
24970736|NCT03731117|Natriuretic Agents|natriuretic agents|mesh-ancestor
24970737|NCT03731117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624745|NCT01078038|Sirolimus|sirolimus|mesh-list
24970854|NCT03730558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24970855|NCT03730558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24970856|NCT03730558|Growth Substances|growth substances|mesh-ancestor
24970857|NCT03730558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970858|NCT03730558|Growth Inhibitors|growth inhibitors|mesh-ancestor
25083224|NCT03317236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24970859|NCT03730558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970860|NCT03730402|Bupivacaine|bupivacaine|mesh-list
24970861|NCT03730402|Anesthetics, Local|anesthetics, local|mesh-ancestor
24970862|NCT03730402|Anesthetics|anesthetics|mesh-ancestor
24970863|NCT03730402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24807604|NCT02022722|Triamcinolone|triamcinolone|mesh-list
24970864|NCT03730402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970865|NCT03730402|Sensory System Agents|sensory system agents|mesh-ancestor
24970878|NCT03730272|Analgesics|analgesics|mesh-list
24970909|NCT03730038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24970910|NCT03730038|Antimetabolites|antimetabolites|mesh-ancestor
24970954|NCT03729804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24970955|NCT03729804|Immunologic Factors|immunologic factors|mesh-ancestor
24970956|NCT03729804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24970957|NCT03729804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24970958|NCT03729804|Growth Substances|growth substances|mesh-ancestor
24970959|NCT03729804|Growth Inhibitors|growth inhibitors|mesh-ancestor
24970960|NCT03729778|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24970961|NCT03729778|Immunologic Factors|immunologic factors|mesh-ancestor
24970962|NCT03729778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24970963|NCT03729687|Capecitabine|capecitabine|mesh-list
24970964|NCT03729687|Oxaliplatin|oxaliplatin|mesh-list
24970965|NCT03729687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24970966|NCT03729687|Antimetabolites|antimetabolites|mesh-ancestor
24970967|NCT03729687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24970969|NCT03729674|Infliximab|infliximab|mesh-list
24808107|NCT02025166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24808108|NCT02025192|Capecitabine|capecitabine|mesh-list
24808109|NCT02025192|Trastuzumab|trastuzumab|mesh-list
24808111|NCT02025192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24808112|NCT02025192|Antimetabolites|antimetabolites|mesh-ancestor
24808113|NCT02025192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24808114|NCT02025192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24808115|NCT02025192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24808116|NCT02025192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24971015|NCT03729284|Antidepressive Agents|antidepressive agents|mesh-ancestor
24971016|NCT03729284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24971017|NCT03729284|Dopamine Agents|dopamine agents|mesh-ancestor
24971018|NCT03729128|Memantine|memantine|mesh-list
24971019|NCT03729128|Dextromethorphan|dextromethorphan|mesh-list
24971020|NCT03729128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24971021|NCT03729128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24971022|NCT03729128|Dopamine Agents|dopamine agents|mesh-ancestor
24971025|NCT03729128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794253|NCT05352178|Micronutrients|micronutrients|mesh-ancestor
24794254|NCT05352178|Estrogens|estrogens|mesh-ancestor
24794255|NCT05352178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24794256|NCT05352178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24794257|NCT05352178|Anabolic Agents|anabolic agents|mesh-ancestor
24794258|NCT05328141|Ascorbic Acid|ascorbic acid|mesh-list
24794268|NCT05310916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083228|NCT03317236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083229|NCT03317210|Epoetin Alfa|epoetin alfa|mesh-list
25083230|NCT03317210|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25083231|NCT03317210|Hematinics|hematinics|mesh-ancestor
25083232|NCT03317197|Vasopressins|vasopressins|mesh-list
25083233|NCT03317197|Arginine Vasopressin|arginine vasopressin|mesh-list
25083234|NCT03317197|Epinephrine|epinephrine|mesh-list
24739534|NCT01682343|Calcium|calcium|mesh-list
24739535|NCT01682343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24739536|NCT01682343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739537|NCT01682408|Mannitol|mannitol|mesh-list
24739538|NCT01682408|Ranitidine|ranitidine|mesh-list
24794276|NCT05304533|Itraconazole|itraconazole|mesh-list
24794277|NCT05304533|Verapamil|verapamil|mesh-list
24739539|NCT01682408|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
24503485|NCT00971867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24503486|NCT00971867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503487|NCT00971867|Tubulin Modulators|tubulin modulators|mesh-ancestor
24503488|NCT00971867|Antimitotic Agents|antimitotic agents|mesh-ancestor
24503489|NCT00971867|Mitosis Modulators|mitosis modulators|mesh-ancestor
24503490|NCT00971867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503491|NCT00532025|Sorafenib|sorafenib|mesh-list
24503492|NCT00532025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503493|NCT00532025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24503494|NCT00532025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503495|NCT00532025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503496|NCT00532090|R04929097|r04929097|mesh-list
24503497|NCT00532090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24794279|NCT05304533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24794280|NCT05304533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24794281|NCT05304533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24794282|NCT05304533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24794283|NCT05304533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794284|NCT05304533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24794285|NCT05304533|Hormone Antagonists|hormone antagonists|mesh-ancestor
24794286|NCT05304533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24794287|NCT05304533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794288|NCT05304533|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24794289|NCT05304533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24794290|NCT05304533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24971079|NCT03728894|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24971080|NCT03728894|Histamine Antagonists|histamine antagonists|mesh-ancestor
24971081|NCT03728894|Histamine Agents|histamine agents|mesh-ancestor
24971082|NCT03728829|Carboplatin|carboplatin|mesh-list
24971083|NCT03728829|Docetaxel|docetaxel|mesh-list
24971084|NCT03728829|Trastuzumab|trastuzumab|mesh-list
24971085|NCT03728829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24971182|NCT03727646|Antimetabolites|antimetabolites|mesh-ancestor
24971187|NCT03727620|Metronidazole|metronidazole|mesh-list
24971188|NCT03727620|Doxycycline|doxycycline|mesh-list
24971189|NCT03727620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24971190|NCT03727620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24971191|NCT03727620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24971192|NCT03727620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24971193|NCT03727620|Antimalarials|antimalarials|mesh-ancestor
24971194|NCT03727607|Propofol|propofol|mesh-list
24971195|NCT03727607|Desflurane|desflurane|mesh-list
24971196|NCT03727607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24971197|NCT03727607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24971198|NCT03727607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971199|NCT03727607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24971200|NCT03727607|Anesthetics, General|anesthetics, general|mesh-ancestor
24971201|NCT03727607|Anesthetics|anesthetics|mesh-ancestor
24971203|NCT03727464|Propofol|propofol|mesh-list
24503498|NCT00532090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503499|NCT00532116|Selegiline|selegiline|mesh-list
24503500|NCT00532116|Antidepressive Agents|antidepressive agents|mesh-ancestor
24971207|NCT03727464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971208|NCT03727464|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24971209|NCT03727464|Anesthetics, General|anesthetics, general|mesh-ancestor
24971210|NCT03727464|Anesthetics|anesthetics|mesh-ancestor
24971211|NCT03727464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24971212|NCT03727464|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24971213|NCT03727412|Naproxen|naproxen|mesh-list
24971214|NCT03727412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24971215|NCT03727412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24971216|NCT03727412|Analgesics|analgesics|mesh-ancestor
24971217|NCT03727412|Sensory System Agents|sensory system agents|mesh-ancestor
24971218|NCT03727412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24587571|NCT00895687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587572|NCT00895687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24587573|NCT00895687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587574|NCT00895687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587575|NCT00895713|Immunoglobulins|immunoglobulins|mesh-list
24587576|NCT00895713|Antibodies|antibodies|mesh-list
24587577|NCT00895713|gamma-Globulins|gamma-globulins|mesh-list
24971219|NCT03727412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971220|NCT03727412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24971221|NCT03727412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24971222|NCT03727412|Gout Suppressants|gout suppressants|mesh-ancestor
24971223|NCT03727412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24503538|NCT00532168|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24503539|NCT00532168|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24971228|NCT03727295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971229|NCT03727295|Protective Agents|protective agents|mesh-ancestor
24971230|NCT03727295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971231|NCT03727282|Dobutamine|dobutamine|mesh-list
24971232|NCT03727282|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24971233|NCT03727282|Sympathomimetics|sympathomimetics|mesh-ancestor
24971234|NCT03727282|Autonomic Agents|autonomic agents|mesh-ancestor
24971235|NCT03727282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24971236|NCT03727282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971237|NCT03727282|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24971238|NCT03727282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24971239|NCT03727282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24971240|NCT03727282|Adrenergic Agents|adrenergic agents|mesh-ancestor
24971241|NCT03727282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24971242|NCT03727282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971243|NCT03727282|Protective Agents|protective agents|mesh-ancestor
24971244|NCT03727100|Clonidine|clonidine|mesh-list
24971245|NCT03727100|Analgesics|analgesics|mesh-ancestor
24971246|NCT03727100|Sensory System Agents|sensory system agents|mesh-ancestor
24971247|NCT03727100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24971248|NCT03727100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971249|NCT03727100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24971252|NCT03727100|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24971253|NCT03727100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24971254|NCT03727100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24503628|NCT00532428|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
24503629|NCT00532428|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24503630|NCT00532428|Hormone Antagonists|hormone antagonists|mesh-ancestor
24503631|NCT00532428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24503632|NCT00532428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503636|NCT00532454|Tamoxifen|tamoxifen|mesh-list
24971255|NCT03727100|Adrenergic Agents|adrenergic agents|mesh-ancestor
24971256|NCT03727100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24971257|NCT03727100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971258|NCT03727048|Ketorolac|ketorolac|mesh-list
24971259|NCT03727048|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24971260|NCT03727048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24971261|NCT03727048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24971262|NCT03727048|Analgesics|analgesics|mesh-ancestor
24971263|NCT03727048|Sensory System Agents|sensory system agents|mesh-ancestor
24971264|NCT03727048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24501949|NCT00531687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501950|NCT00531687|Tubulin Modulators|tubulin modulators|mesh-ancestor
24501951|NCT00531687|Antimitotic Agents|antimitotic agents|mesh-ancestor
24502022|NCT00531999|Protease Inhibitors|protease inhibitors|mesh-ancestor
24502023|NCT00531999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24971265|NCT03727048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971266|NCT03727048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24971267|NCT03727048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24971268|NCT03727048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24971269|NCT03727048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24971270|NCT03727048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971271|NCT03726788|Triamcinolone|triamcinolone|mesh-list
24971272|NCT03726788|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24971273|NCT03726788|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24971279|NCT03726788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24971280|NCT03726788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971281|NCT03726788|Cholinergic Agents|cholinergic agents|mesh-ancestor
24971282|NCT03726788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24971283|NCT03726788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971284|NCT03726788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24503637|NCT00532454|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24503638|NCT00532454|Hormone Antagonists|hormone antagonists|mesh-ancestor
24503639|NCT00532454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24503640|NCT00532454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503643|NCT00532454|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24503644|NCT00532454|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24503697|NCT00532662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24503698|NCT00532662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971285|NCT03726788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24971286|NCT03726788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24971287|NCT03726788|Glucocorticoids|glucocorticoids|mesh-ancestor
24971289|NCT03726788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24971290|NCT03726788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24971291|NCT03726788|Immunologic Factors|immunologic factors|mesh-ancestor
24971292|NCT03726788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24971304|NCT03726736|Docetaxel|docetaxel|mesh-list
24808387|NCT02026869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24808388|NCT02026869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24808389|NCT02026921|Carboplatin|carboplatin|mesh-list
24808390|NCT02026921|Docetaxel|docetaxel|mesh-list
24971311|NCT03726593|Mefloquine|mefloquine|mesh-list
24971312|NCT03726593|Atovaquone|atovaquone|mesh-list
24971313|NCT03726593|Proguanil|proguanil|mesh-list
24971314|NCT03726593|Pyronaridine|pyronaridine|mesh-list
24971315|NCT03726593|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
25083247|NCT03317197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25083248|NCT03317197|Respiratory System Agents|respiratory system agents|mesh-ancestor
25083249|NCT03317197|Mydriatics|mydriatics|mesh-ancestor
25083250|NCT03317197|Sympathomimetics|sympathomimetics|mesh-ancestor
25083251|NCT03317197|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25083252|NCT03317197|Hemostatics|hemostatics|mesh-ancestor
25083253|NCT03317197|Coagulants|coagulants|mesh-ancestor
25083254|NCT03317197|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25083255|NCT03317197|Natriuretic Agents|natriuretic agents|mesh-ancestor
25083272|NCT03317067|Analgesics|analgesics|mesh-ancestor
25083273|NCT03317067|Sensory System Agents|sensory system agents|mesh-ancestor
25083274|NCT03317067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25083275|NCT03317067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24971322|NCT03726593|Schistosomicides|schistosomicides|mesh-ancestor
25708145|NCT02243202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25708146|NCT02243202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708147|NCT02243202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25708148|NCT02243202|Appetite Depressants|appetite depressants|mesh-ancestor
25708149|NCT02243202|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25708150|NCT02243202|Sympathomimetics|sympathomimetics|mesh-ancestor
25708151|NCT02243202|Autonomic Agents|autonomic agents|mesh-ancestor
25708152|NCT02243202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24971323|NCT03726593|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24971339|NCT03726515|Pembrolizumab|pembrolizumab|mesh-list
24971340|NCT03726515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24971341|NCT03726515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24971342|NCT03726398|Macitentan|macitentan|mesh-list
24971343|NCT03726398|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
24971344|NCT03726398|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24971345|NCT03726398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971346|NCT03726398|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
24971347|NCT03726372|Bromides|bromides|mesh-list
24503699|NCT00532662|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24503700|NCT00532662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24503701|NCT00532662|Anesthetics, General|anesthetics, general|mesh-ancestor
24503702|NCT00532662|Anesthetics|anesthetics|mesh-ancestor
24503703|NCT00532662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24503704|NCT00532662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24971348|NCT03726372|Rocuronium|rocuronium|mesh-list
24971349|NCT03726372|Anticonvulsants|anticonvulsants|mesh-ancestor
24971352|NCT03726372|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24930106|NCT04105374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24971411|NCT03726125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971412|NCT03726099|Amoxicillin|amoxicillin|mesh-list
24971413|NCT03726099|Tetracycline|tetracycline|mesh-list
24971414|NCT03726099|Furazolidone|furazolidone|mesh-list
24971415|NCT03726099|Esomeprazole|esomeprazole|mesh-list
24971416|NCT03726099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24971417|NCT03726099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24971418|NCT03726099|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24971419|NCT03726099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24971420|NCT03726099|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24971421|NCT03726099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24971426|NCT03726099|Renal Agents|renal agents|mesh-ancestor
24971433|NCT03726021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503705|NCT00532662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24503706|NCT00532662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24503707|NCT00532662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503708|NCT00532675|Lenalidomide|lenalidomide|mesh-list
24503709|NCT00532675|Panobinostat|panobinostat|mesh-list
24503710|NCT00532675|Immunologic Factors|immunologic factors|mesh-ancestor
24503711|NCT00532675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503712|NCT00532675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24503713|NCT00532675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24503714|NCT00532675|Growth Substances|growth substances|mesh-ancestor
24503715|NCT00532675|Growth Inhibitors|growth inhibitors|mesh-ancestor
24503716|NCT00532675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503722|NCT00532688|Antiviral Agents|antiviral agents|mesh-ancestor
24503723|NCT00532688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24503724|NCT00532688|Expectorants|expectorants|mesh-ancestor
24503725|NCT00532688|Respiratory System Agents|respiratory system agents|mesh-ancestor
24503726|NCT00532688|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24503727|NCT00532688|Antioxidants|antioxidants|mesh-ancestor
24971434|NCT03726021|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24971435|NCT03726021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24971436|NCT03726021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24971437|NCT03726021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971440|NCT03725995|Anesthetics, Local|anesthetics, local|mesh-ancestor
24971441|NCT03725995|Anesthetics|anesthetics|mesh-ancestor
24971442|NCT03725995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24971443|NCT03725995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971444|NCT03725995|Sensory System Agents|sensory system agents|mesh-ancestor
24971445|NCT03725995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24971446|NCT03725995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24971458|NCT03725995|GABA Modulators|gaba modulators|mesh-ancestor
24971459|NCT03725995|GABA Agents|gaba agents|mesh-ancestor
24971460|NCT03725995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24502998|NCT03924440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502999|NCT03924440|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24503728|NCT00532688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503729|NCT00532688|Protective Agents|protective agents|mesh-ancestor
24503730|NCT00532688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503731|NCT00532688|Antidotes|antidotes|mesh-ancestor
24503732|NCT00532701|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24503733|NCT00532701|Interferon-alpha|interferon-alpha|mesh-list
24503735|NCT00532701|Antiviral Agents|antiviral agents|mesh-ancestor
24503736|NCT00532701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24503737|NCT00532701|Immunologic Factors|immunologic factors|mesh-ancestor
24503738|NCT00532701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503739|NCT00532701|Antimetabolites|antimetabolites|mesh-ancestor
24503740|NCT00532701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503741|NCT00532714|Capecitabine|capecitabine|mesh-list
24503743|NCT00532714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24503744|NCT00532714|Antimetabolites|antimetabolites|mesh-ancestor
24503767|NCT00532818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24503768|NCT00532818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24503769|NCT00532818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24971535|NCT03725228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24971536|NCT03725228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971537|NCT03725228|Sensory System Agents|sensory system agents|mesh-ancestor
24971565|NCT03724838|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24971566|NCT03724838|Chelating Agents|chelating agents|mesh-ancestor
24971567|NCT03724838|Sequestering Agents|sequestering agents|mesh-ancestor
24971568|NCT03724838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971569|NCT03724838|Vasodilator Agents|vasodilator agents|mesh-ancestor
24971570|NCT03724838|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24971571|NCT03724838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24971572|NCT03724838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24971573|NCT03724838|Urological Agents|urological agents|mesh-ancestor
24971574|NCT03724838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24971575|NCT03724838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24971576|NCT03724838|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24971577|NCT03724578|Anti-Infective Agents|anti-infective agents|mesh-list
24971578|NCT03724578|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24971579|NCT03724578|Grape Seed Extract|grape seed extract|mesh-list
24971580|NCT03724578|Fluorides|fluorides|mesh-list
24503802|NCT00532909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083281|NCT03317015|Fluticasone|fluticasone|mesh-list
25083282|NCT03317015|Triamcinolone|triamcinolone|mesh-list
25083283|NCT03317015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24808677|NCT02028598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25083284|NCT03317015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25083285|NCT03317015|Autonomic Agents|autonomic agents|mesh-ancestor
24808678|NCT02028598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25083286|NCT03317015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25083287|NCT03317015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083288|NCT03317015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25083289|NCT03317015|Respiratory System Agents|respiratory system agents|mesh-ancestor
25083290|NCT03317015|Dermatologic Agents|dermatologic agents|mesh-ancestor
25083291|NCT03317015|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25083292|NCT03317015|Glucocorticoids|glucocorticoids|mesh-ancestor
25083294|NCT03317015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25083295|NCT03316963|Neostigmine|neostigmine|mesh-list
25083296|NCT03316963|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25083297|NCT03316963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24971587|NCT03724578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971588|NCT03724266|Chitosan|chitosan|mesh-list
24971589|NCT03724266|Calcium|calcium|mesh-list
24971590|NCT03724266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24971591|NCT03724266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971592|NCT03724266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25708153|NCT02243202|Adrenergic Agents|adrenergic agents|mesh-ancestor
25708154|NCT02243202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24971593|NCT03724266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25708155|NCT02243293|Ribavirin|ribavirin|mesh-list
25708156|NCT02243293|Antimetabolites|antimetabolites|mesh-ancestor
25708157|NCT02243293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708158|NCT02243293|Antiviral Agents|antiviral agents|mesh-ancestor
25708159|NCT02243293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24503238|NCT02503839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503239|NCT02503839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24503252|NCT02384850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24503254|NCT02384850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24503255|NCT02384850|Immunologic Factors|immunologic factors|mesh-ancestor
24971594|NCT03724266|Antimetabolites|antimetabolites|mesh-ancestor
24971595|NCT03724266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971596|NCT03724266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24971597|NCT03724266|Chelating Agents|chelating agents|mesh-ancestor
24794331|NCT05263986|Adagrasib|adagrasib|mesh-list
24971666|NCT03723395|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24971667|NCT03723395|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24971668|NCT03723395|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24971669|NCT03723395|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24971670|NCT03723395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24971671|NCT03723395|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24971672|NCT03723395|Protective Agents|protective agents|mesh-ancestor
24971673|NCT03723395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24971678|NCT03723395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24971679|NCT03723395|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24971681|NCT03723291|Vitamin E|vitamin e|mesh-list
24971682|NCT03723291|Tocotrienols|tocotrienols|mesh-list
24971717|NCT03723096|Pomalidomide|pomalidomide|mesh-list
24971718|NCT03723096|Immunologic Factors|immunologic factors|mesh-ancestor
24971719|NCT03723096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971720|NCT03723096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24971721|NCT03723096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24971722|NCT03723096|Growth Substances|growth substances|mesh-ancestor
24971723|NCT03723096|Growth Inhibitors|growth inhibitors|mesh-ancestor
24971724|NCT03723096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24971725|NCT03723083|Thalidomide|thalidomide|mesh-list
24971726|NCT03723083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24971727|NCT03723083|Immunologic Factors|immunologic factors|mesh-ancestor
24971728|NCT03723083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971729|NCT03723083|Leprostatic Agents|leprostatic agents|mesh-ancestor
24971730|NCT03723083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24971731|NCT03723083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24971732|NCT03723083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24971733|NCT03723083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24971734|NCT03723083|Growth Substances|growth substances|mesh-ancestor
24971737|NCT03723031|Misoprostol|misoprostol|mesh-list
24971748|NCT03722940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24971749|NCT03722940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971750|NCT03722940|Anesthetics|anesthetics|mesh-ancestor
24971751|NCT03722940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24971753|NCT03722940|Anticonvulsants|anticonvulsants|mesh-ancestor
24971788|NCT03722498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24971789|NCT03722498|Immunologic Factors|immunologic factors|mesh-ancestor
24971790|NCT03722498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971792|NCT03722498|Protective Agents|protective agents|mesh-ancestor
24971793|NCT03722498|Vitamin B Complex|vitamin b complex|mesh-ancestor
24971794|NCT03722498|Vitamins|vitamins|mesh-ancestor
24971795|NCT03722498|Micronutrients|micronutrients|mesh-ancestor
24971796|NCT03722498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24971797|NCT03722498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24971798|NCT03722420|Imatinib Mesylate|imatinib mesylate|mesh-list
24971799|NCT03722420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708160|NCT02243371|Cyclophosphamide|cyclophosphamide|mesh-list
25708161|NCT02243371|Nivolumab|nivolumab|mesh-list
25708162|NCT02243371|Immunologic Factors|immunologic factors|mesh-ancestor
25708163|NCT02243371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708164|NCT02243371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25708165|NCT02243371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25708166|NCT02243371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25708167|NCT02243371|Alkylating Agents|alkylating agents|mesh-ancestor
24971800|NCT03722420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24971802|NCT03722420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971803|NCT03722381|Amlodipine|amlodipine|mesh-list
24971809|NCT03722381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971810|NCT03722381|Vasodilator Agents|vasodilator agents|mesh-ancestor
24971811|NCT03722355|Carmustine|carmustine|mesh-list
24971812|NCT03722355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24971813|NCT03722355|Alkylating Agents|alkylating agents|mesh-ancestor
24971814|NCT03722355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971815|NCT03722355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24971819|NCT03722329|Eculizumab|eculizumab|mesh-list
24971820|NCT03722329|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24971821|NCT03722329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24971822|NCT03722329|Immunologic Factors|immunologic factors|mesh-ancestor
24794359|NCT05259137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794360|NCT05259137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24971935|NCT03721614|Immunologic Factors|immunologic factors|mesh-ancestor
24971936|NCT03721614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971937|NCT03721614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24971938|NCT03721614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24971939|NCT03721614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24971940|NCT03721614|Antifungal Agents|antifungal agents|mesh-ancestor
24971953|NCT03721432|Pregabalin|pregabalin|mesh-list
24971954|NCT03721432|Analgesics|analgesics|mesh-ancestor
24971955|NCT03721432|Sensory System Agents|sensory system agents|mesh-ancestor
24971956|NCT03721432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24971975|NCT03721380|Antitussive Agents|antitussive agents|mesh-ancestor
24971976|NCT03721380|Respiratory System Agents|respiratory system agents|mesh-ancestor
24971978|NCT03721081|Anesthetics, Local|anesthetics, local|mesh-ancestor
24971979|NCT03721081|Anesthetics|anesthetics|mesh-ancestor
24971980|NCT03721081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24971981|NCT03721081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24971982|NCT03721081|Sensory System Agents|sensory system agents|mesh-ancestor
24971983|NCT03721081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24971994|NCT03720899|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24971995|NCT03720899|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24971996|NCT03720899|Cholinergic Agents|cholinergic agents|mesh-ancestor
24971997|NCT03720899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24971998|NCT03720899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24971999|NCT03720886|Teriparatide|teriparatide|mesh-list
24972000|NCT03720886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24972001|NCT03720886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972002|NCT03720886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24972003|NCT03720873|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24972004|NCT03720873|Gefitinib|gefitinib|mesh-list
24794369|NCT05252416|Carboplatin|carboplatin|mesh-list
24794370|NCT05252416|Fulvestrant|fulvestrant|mesh-list
24794371|NCT05252416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503945|NCT00533520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24503903|NCT00533390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503904|NCT00533390|Antiviral Agents|antiviral agents|mesh-ancestor
24503912|NCT00533416|ON 01910|on 01910|mesh-list
24794414|NCT05233709|Fesoterodine|fesoterodine|mesh-list
24794415|NCT05233709|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24972031|NCT03720665|Purinergic Agents|purinergic agents|mesh-ancestor
24972032|NCT03720665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24972033|NCT03720522|Adenosine|adenosine|mesh-list
24972034|NCT03720522|Analgesics|analgesics|mesh-ancestor
24972035|NCT03720522|Sensory System Agents|sensory system agents|mesh-ancestor
25708168|NCT02243371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708169|NCT02243371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708170|NCT02243371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25708171|NCT02243371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25708172|NCT02243371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25708173|NCT02243579|Pembrolizumab|pembrolizumab|mesh-list
25708174|NCT02243579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25708175|NCT02243579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708176|NCT02243943|Neostigmine|neostigmine|mesh-list
25708177|NCT02243943|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25708178|NCT02243943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503651|NCT00532519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24972036|NCT03720522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24972037|NCT03720522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972038|NCT03720522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24972039|NCT03720522|Vasodilator Agents|vasodilator agents|mesh-ancestor
24972040|NCT03720522|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24972041|NCT03720522|Purinergic Agonists|purinergic agonists|mesh-ancestor
24972042|NCT03720522|Purinergic Agents|purinergic agents|mesh-ancestor
24972043|NCT03720522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24972044|NCT03720522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972045|NCT03720483|Acetylcysteine|acetylcysteine|mesh-list
24972085|NCT03720223|Anesthetics|anesthetics|mesh-ancestor
24972086|NCT03720223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24972087|NCT03720223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972088|NCT03720223|Sensory System Agents|sensory system agents|mesh-ancestor
24972089|NCT03720223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24972090|NCT03720067|Propranolol|propranolol|mesh-list
24972091|NCT03720067|Carvedilol|carvedilol|mesh-list
24972092|NCT03720067|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24972093|NCT03720067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24972094|NCT03720067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24972095|NCT03720067|Antimetabolites|antimetabolites|mesh-ancestor
24443998|NCT00296478|Progesterone|progesterone|mesh-list
24972096|NCT03720067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972097|NCT03720067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24972098|NCT03720067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24972099|NCT03720067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972100|NCT03720067|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24972101|NCT03720067|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24972110|NCT03720067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24972111|NCT03720067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24972112|NCT03720067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24972113|NCT03720067|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24972114|NCT03720067|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24972115|NCT03720041|Dexamethasone|dexamethasone|mesh-list
24972143|NCT03719989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24972144|NCT03719989|Antimetabolites|antimetabolites|mesh-ancestor
24972145|NCT03719989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972146|NCT03719989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503916|NCT00533416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503917|NCT00533455|Gabapentin|gabapentin|mesh-list
24503918|NCT00533455|Analgesics|analgesics|mesh-ancestor
24503919|NCT00533455|Sensory System Agents|sensory system agents|mesh-ancestor
25708179|NCT02243943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708180|NCT02243943|Cholinergic Agents|cholinergic agents|mesh-ancestor
24503821|NCT00533026|Warfarin|warfarin|mesh-list
24503944|NCT00533520|Ranibizumab|ranibizumab|mesh-list
24972188|NCT03719625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972190|NCT03719625|Sympathomimetics|sympathomimetics|mesh-ancestor
24972191|NCT03719625|Autonomic Agents|autonomic agents|mesh-ancestor
24972192|NCT03719625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24972195|NCT03719560|Cytarabine|cytarabine|mesh-list
24972196|NCT03719560|Methotrexate|methotrexate|mesh-list
24972197|NCT03719560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24972198|NCT03719560|Abortifacient Agents|abortifacient agents|mesh-ancestor
24972199|NCT03719560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24972200|NCT03719560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972201|NCT03719560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24972202|NCT03719560|Antimetabolites|antimetabolites|mesh-ancestor
24972203|NCT03719560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972204|NCT03719560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24972205|NCT03719560|Dermatologic Agents|dermatologic agents|mesh-ancestor
24972206|NCT03719560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972207|NCT03719560|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24972208|NCT03719560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24972212|NCT03719560|Antiviral Agents|antiviral agents|mesh-ancestor
24972317|NCT03719053|Tenofovir|tenofovir|mesh-list
24972318|NCT03719053|Antiviral Agents|antiviral agents|mesh-ancestor
24504140|NCT00534287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24504141|NCT00534287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504142|NCT00534287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972353|NCT03718624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972355|NCT03718624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24794440|NCT05173896|Urological Agents|urological agents|mesh-ancestor
24794453|NCT05150236|Nivolumab|nivolumab|mesh-list
24794454|NCT05150236|Ipilimumab|ipilimumab|mesh-list
24794455|NCT05150236|177Lu-PSMA-617|177lu-psma-617|mesh-list
24794456|NCT05150236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24794457|NCT05150236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24794458|NCT05150236|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24504196|NCT00534573|Dopamine Agents|dopamine agents|mesh-ancestor
24504197|NCT00534573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24504198|NCT00534573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504199|NCT00534573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24504200|NCT00534573|Antidepressive Agents|antidepressive agents|mesh-ancestor
24504201|NCT00534573|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24794461|NCT05149560|Ticagrelor|ticagrelor|mesh-list
24794462|NCT05149560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24794463|NCT05149560|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24794464|NCT05149560|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24794465|NCT05149560|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24794466|NCT05149560|Purinergic Agents|purinergic agents|mesh-ancestor
24794467|NCT05149560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24910391|NCT04298528|Hormones|hormones|mesh-ancestor
24972426|NCT03718039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972427|NCT03718039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25708181|NCT02243943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24972428|NCT03718039|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24972429|NCT03718039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25708182|NCT02243943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708183|NCT02243943|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25708184|NCT02243943|Autonomic Agents|autonomic agents|mesh-ancestor
25708185|NCT02243943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25708186|NCT02244619|Acetaminophen|acetaminophen|mesh-list
25708187|NCT02244619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25708188|NCT02244619|Analgesics|analgesics|mesh-ancestor
25708189|NCT02244619|Sensory System Agents|sensory system agents|mesh-ancestor
24504272|NCT00534807|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24972484|NCT03717467|Sensory System Agents|sensory system agents|mesh-ancestor
24972485|NCT03717467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24972486|NCT03717467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972487|NCT03717467|Anesthetics|anesthetics|mesh-ancestor
24972488|NCT03717467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24972489|NCT03717467|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24972490|NCT03717467|Anticonvulsants|anticonvulsants|mesh-ancestor
24972491|NCT03717467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24972492|NCT03717467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24972493|NCT03717467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972494|NCT03717467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24972495|NCT03717467|Tocolytic Agents|tocolytic agents|mesh-ancestor
24972496|NCT03717467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24972497|NCT03717415|Carboplatin|carboplatin|mesh-list
24972498|NCT03717415|Rebastinib|rebastinib|mesh-list
24972499|NCT03717415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24972503|NCT03717350|Meropenem|meropenem|mesh-list
24972521|NCT03717038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24972522|NCT03716856|Cyclophosphamide|cyclophosphamide|mesh-list
24972523|NCT03716856|Fludarabine|fludarabine|mesh-list
24972524|NCT03716856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24972525|NCT03716856|Immunologic Factors|immunologic factors|mesh-ancestor
24972526|NCT03716856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972527|NCT03716856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24972528|NCT03716856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24972529|NCT03716856|Alkylating Agents|alkylating agents|mesh-ancestor
24972530|NCT03716856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972531|NCT03716856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24972533|NCT03716804|Ciprofloxacin|ciprofloxacin|mesh-list
24972587|NCT03716622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24972588|NCT03716622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24972589|NCT03716622|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24972590|NCT03716596|Antibodies|antibodies|mesh-list
24972591|NCT03716596|Immunologic Factors|immunologic factors|mesh-ancestor
24972592|NCT03716596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972593|NCT03716583|Melatonin|melatonin|mesh-list
24972594|NCT03716583|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
24972595|NCT03716583|Antioxidants|antioxidants|mesh-ancestor
24972596|NCT03716583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972597|NCT03716583|Protective Agents|protective agents|mesh-ancestor
24972598|NCT03716583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972607|NCT03716427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24972608|NCT03716427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24972609|NCT03716427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972611|NCT03716427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24972612|NCT03716427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24972613|NCT03716427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24972614|NCT03716427|Anesthetics, General|anesthetics, general|mesh-ancestor
24504284|NCT00534846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24504285|NCT00534846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504286|NCT00534846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24504577|NCT00537121|Irinotecan|irinotecan|mesh-list
24972624|NCT03716427|Antitussive Agents|antitussive agents|mesh-ancestor
24972625|NCT03716427|Respiratory System Agents|respiratory system agents|mesh-ancestor
24827118|NCT02137525|Morphine|morphine|mesh-list
24972626|NCT03716427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24972627|NCT03716427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24972628|NCT03716427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24972629|NCT03716388|Mesalamine|mesalamine|mesh-list
24972630|NCT03716388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24972631|NCT03716388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24972632|NCT03716388|Analgesics|analgesics|mesh-ancestor
24972633|NCT03716388|Sensory System Agents|sensory system agents|mesh-ancestor
24972634|NCT03716388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24972635|NCT03716388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910585|NCT04296175|Paclitaxel|paclitaxel|mesh-list
24972675|NCT03715777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24972676|NCT03715777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972677|NCT03715777|Cholinergic Agents|cholinergic agents|mesh-ancestor
24972678|NCT03715777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24972679|NCT03715725|Warfarin|warfarin|mesh-list
24972680|NCT03715725|Rivaroxaban|rivaroxaban|mesh-list
24972681|NCT03715725|Dabigatran|dabigatran|mesh-list
24504374|NCT00535691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24504375|NCT00535691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972683|NCT03715725|Anticoagulants|anticoagulants|mesh-ancestor
24972684|NCT03715725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24972685|NCT03715725|Antithrombins|antithrombins|mesh-ancestor
24972686|NCT03715725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24972687|NCT03715725|Protease Inhibitors|protease inhibitors|mesh-ancestor
24972688|NCT03715725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972689|NCT03715725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972690|NCT03715699|Prednisone|prednisone|mesh-list
24972691|NCT03715699|Leflunomide|leflunomide|mesh-list
24972692|NCT03715699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24972717|NCT03715556|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24972718|NCT03715556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24972719|NCT03715556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24972720|NCT03715556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24972721|NCT03715556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24972722|NCT03715556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24972723|NCT03715556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972724|NCT03715556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24809514|NCT02034253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24972725|NCT03715556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24972726|NCT03715556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24972728|NCT03715517|Hydromorphone|hydromorphone|mesh-list
24972729|NCT03715517|Bupivacaine|bupivacaine|mesh-list
24972730|NCT03715517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24972731|NCT03715517|Anesthetics, Local|anesthetics, local|mesh-ancestor
24972749|NCT03715478|Hormones|hormones|mesh-ancestor
24972758|NCT03715413|Tamoxifen|tamoxifen|mesh-list
24972759|NCT03715413|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24972760|NCT03715413|Hormone Antagonists|hormone antagonists|mesh-ancestor
24972761|NCT03715413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24972762|NCT03715413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972763|NCT03715413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24972764|NCT03715413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24972765|NCT03715413|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24972766|NCT03715413|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24972767|NCT03715413|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24972768|NCT03715387|Bacitracin|bacitracin|mesh-list
24972769|NCT03715387|Polymyxin B|polymyxin b|mesh-list
24972770|NCT03715387|Tacrolimus|tacrolimus|mesh-list
24504466|NCT00536419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24504467|NCT00536614|Cetuximab|cetuximab|mesh-list
25708190|NCT02244619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25708191|NCT02244619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708192|NCT02244619|Antipyretics|antipyretics|mesh-ancestor
25708193|NCT02244918|Nicotine|nicotine|mesh-list
25708194|NCT02244918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25708195|NCT02244918|Autonomic Agents|autonomic agents|mesh-ancestor
25708196|NCT02244918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25708197|NCT02244918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708198|NCT02244918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25708199|NCT02244918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24794491|NCT05111821|Sequestering Agents|sequestering agents|mesh-ancestor
24794492|NCT05111821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794493|NCT05105282|Anesthetics|anesthetics|mesh-list
24794494|NCT05105282|Anesthetics, Local|anesthetics, local|mesh-list
24794495|NCT05105282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24794496|NCT05105282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794497|NCT05105282|Sensory System Agents|sensory system agents|mesh-ancestor
24794498|NCT05105282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24794499|NCT05101122|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24794500|NCT05101122|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24794501|NCT05101122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24973284|NCT03710330|Tranexamic Acid|tranexamic acid|mesh-list
24972837|NCT03714867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24972838|NCT03714867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24972839|NCT03714867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24972840|NCT03714789|Dialysis Solutions|dialysis solutions|mesh-list
24972841|NCT03714789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24972842|NCT03714737|Vaccines|vaccines|mesh-list
24972843|NCT03714737|Immunologic Factors|immunologic factors|mesh-ancestor
24972844|NCT03714737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972845|NCT03714685|Firibastat|firibastat|mesh-list
24972846|NCT03714685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24972865|NCT03714594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24972866|NCT03714594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972868|NCT03714594|Hormones|hormones|mesh-ancestor
24972869|NCT03714594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24972870|NCT03714594|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24972871|NCT03714594|Protease Inhibitors|protease inhibitors|mesh-ancestor
24972872|NCT03714594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972873|NCT03714555|Copper|copper|mesh-list
24972874|NCT03714555|Gemcitabine|gemcitabine|mesh-list
24972875|NCT03714555|Paclitaxel|paclitaxel|mesh-list
24972876|NCT03714555|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24972877|NCT03714555|Folfirinox|folfirinox|mesh-list
24972878|NCT03714555|Disulfiram|disulfiram|mesh-list
24972879|NCT03714555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24972880|NCT03714555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24972881|NCT03714555|Tubulin Modulators|tubulin modulators|mesh-ancestor
24972889|NCT03714555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972890|NCT03714555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24972909|NCT03714165|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24972911|NCT03714165|alpha-Defensins|alpha-defensins|mesh-list
24972912|NCT03714165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24972913|NCT03714113|Antibodies|antibodies|mesh-list
24972914|NCT03714113|Immunologic Factors|immunologic factors|mesh-ancestor
24972915|NCT03714113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972916|NCT03713918|Lithium Carbonate|lithium carbonate|mesh-list
24972917|NCT03713918|Antidepressive Agents|antidepressive agents|mesh-ancestor
24972918|NCT03713918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24972919|NCT03713918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972924|NCT03713918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972925|NCT03713892|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
24972926|NCT03713892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24972935|NCT03713879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24972936|NCT03713879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24972937|NCT03713879|Gout Suppressants|gout suppressants|mesh-ancestor
24972938|NCT03713879|Tocolytic Agents|tocolytic agents|mesh-ancestor
24972939|NCT03713879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24504518|NCT00536692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504519|NCT00536705|Montelukast|montelukast|mesh-list
24504520|NCT00536705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24504529|NCT00536770|Calcitriol|calcitriol|mesh-list
24972951|NCT03713762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25708200|NCT02244918|Cholinergic Agents|cholinergic agents|mesh-ancestor
25708201|NCT02244918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25708202|NCT02244918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708203|NCT02245516|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25708204|NCT02245516|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25708205|NCT02246218|Glycerol|glycerol|mesh-list
25708206|NCT02246218|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25708207|NCT02246218|Protective Agents|protective agents|mesh-ancestor
25708208|NCT02246218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972953|NCT03713762|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24794554|NCT04998279|Immunologic Factors|immunologic factors|mesh-ancestor
24794555|NCT04998279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587802|NCT00897026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24587803|NCT00897026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24587804|NCT00897026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587805|NCT00897065|Antibodies|antibodies|mesh-list
24587806|NCT00897065|Immunologic Factors|immunologic factors|mesh-ancestor
24587807|NCT00897065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587808|NCT00897130|Azacitidine|azacitidine|mesh-list
24587809|NCT00897130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24587810|NCT00897130|Antimetabolites|antimetabolites|mesh-ancestor
24587811|NCT00897130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910986|NCT04292236|Protective Agents|protective agents|mesh-ancestor
24973005|NCT03712956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973006|NCT03712956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973054|NCT03712670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24973055|NCT03712670|Growth Substances|growth substances|mesh-ancestor
24973056|NCT03712670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973057|NCT03712670|Growth Inhibitors|growth inhibitors|mesh-ancestor
24973058|NCT03712670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973059|NCT03712670|Antioxidants|antioxidants|mesh-ancestor
24973060|NCT03712670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973061|NCT03712670|Protective Agents|protective agents|mesh-ancestor
24973062|NCT03712670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24973063|NCT03712670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24973064|NCT03712670|Analgesics|analgesics|mesh-ancestor
24973065|NCT03712670|Sensory System Agents|sensory system agents|mesh-ancestor
24973066|NCT03712670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24973067|NCT03712670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24973068|NCT03712670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24973069|NCT03712670|Gout Suppressants|gout suppressants|mesh-ancestor
24973070|NCT03712540|Rifampin|rifampin|mesh-list
24973071|NCT03712540|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24973072|NCT03712540|Antitubercular Agents|antitubercular agents|mesh-ancestor
24973073|NCT03712540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24973074|NCT03712540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24973075|NCT03712540|Leprostatic Agents|leprostatic agents|mesh-ancestor
24973076|NCT03712540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24973077|NCT03712540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973078|NCT03712540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973114|NCT03712241|Analgesics|analgesics|mesh-ancestor
24973115|NCT03712241|Sensory System Agents|sensory system agents|mesh-ancestor
24973116|NCT03712241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24973117|NCT03712241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741441|NCT05288829|Ravulizumab|ravulizumab|mesh-list
24741442|NCT05288829|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24741443|NCT05288829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24973133|NCT03712163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973134|NCT03712163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973135|NCT03712163|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24973136|NCT03712111|Norepinephrine|norepinephrine|mesh-list
24810016|NCT02037412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24973137|NCT03712111|Bupivacaine|bupivacaine|mesh-list
24973138|NCT03712111|Anesthetics, Local|anesthetics, local|mesh-ancestor
24973139|NCT03712111|Anesthetics|anesthetics|mesh-ancestor
24973140|NCT03712111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24973141|NCT03712111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973142|NCT03712111|Sensory System Agents|sensory system agents|mesh-ancestor
24973143|NCT03712111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24973144|NCT03712111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24973145|NCT03712111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24973146|NCT03712111|Adrenergic Agents|adrenergic agents|mesh-ancestor
24504594|NCT00537121|Vitamin B Complex|vitamin b complex|mesh-ancestor
24504596|NCT00537121|Micronutrients|micronutrients|mesh-ancestor
24504597|NCT00537121|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24504598|NCT00537173|Paclitaxel|paclitaxel|mesh-list
24504599|NCT00537173|Bevacizumab|bevacizumab|mesh-list
24973147|NCT03712111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24461532|NCT00352599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24973148|NCT03712111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973149|NCT03712111|Sympathomimetics|sympathomimetics|mesh-ancestor
24973168|NCT03711474|Autonomic Agents|autonomic agents|mesh-ancestor
24973169|NCT03711474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24973170|NCT03711474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973171|NCT03711474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24973172|NCT03711474|Glucocorticoids|glucocorticoids|mesh-ancestor
24973173|NCT03711474|Hormones|hormones|mesh-ancestor
24973174|NCT03711474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24973175|NCT03711474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24973176|NCT03711474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973177|NCT03711292|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24973178|NCT03711292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24973179|NCT03711279|Apatinib|apatinib|mesh-list
24504600|NCT00537173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24504601|NCT00537173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504602|NCT00537173|Tubulin Modulators|tubulin modulators|mesh-ancestor
24504603|NCT00537173|Antimitotic Agents|antimitotic agents|mesh-ancestor
24504604|NCT00537173|Mitosis Modulators|mitosis modulators|mesh-ancestor
24587832|NCT00897312|Dermatologic Agents|dermatologic agents|mesh-ancestor
24587833|NCT00897312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24504606|NCT00537173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24628455|NCT01099072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24973254|NCT03710434|Dexlansoprazole|dexlansoprazole|mesh-list
24973255|NCT03710434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24973256|NCT03710434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24973257|NCT03710434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24973258|NCT03710434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973259|NCT03710434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973261|NCT03710395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24973263|NCT03710395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973264|NCT03710395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24973265|NCT03710395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973266|NCT03710395|Vasodilator Agents|vasodilator agents|mesh-ancestor
24973267|NCT03710395|Tocolytic Agents|tocolytic agents|mesh-ancestor
24973268|NCT03710395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24973269|NCT03710369|Sildenafil Citrate|sildenafil citrate|mesh-list
24973270|NCT03710369|Vasodilator Agents|vasodilator agents|mesh-ancestor
24973271|NCT03710369|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24973272|NCT03710369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24973273|NCT03710369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973274|NCT03710369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973275|NCT03710369|Urological Agents|urological agents|mesh-ancestor
24973277|NCT03710356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24504686|NCT00537732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24504687|NCT00537732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504688|NCT00537732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708209|NCT02246582|Insulin|insulin|mesh-list
25708210|NCT02246582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25708211|NCT02246582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708212|NCT02246647|Mannitol|mannitol|mesh-list
25708213|NCT02246647|Lactulose|lactulose|mesh-list
25708214|NCT02246647|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25708215|NCT02246647|Diuretics|diuretics|mesh-ancestor
25708216|NCT02246647|Natriuretic Agents|natriuretic agents|mesh-ancestor
25708217|NCT02246647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708218|NCT02246647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25708219|NCT02246660|Resveratrol|resveratrol|mesh-list
25708220|NCT02246660|Antioxidants|antioxidants|mesh-ancestor
24462794|NCT00357604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24462795|NCT00357604|Contraceptive Agents|contraceptive agents|mesh-ancestor
24973286|NCT03710330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24973287|NCT03710330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973288|NCT03710330|Hemostatics|hemostatics|mesh-ancestor
24973289|NCT03710330|Coagulants|coagulants|mesh-ancestor
24973290|NCT03710317|Misoprostol|misoprostol|mesh-list
24973291|NCT03710317|Tranexamic Acid|tranexamic acid|mesh-list
24973292|NCT03710317|Carbetocin|carbetocin|mesh-list
24973293|NCT03710317|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24973294|NCT03710317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24973295|NCT03710317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973296|NCT03710317|Hemostatics|hemostatics|mesh-ancestor
24973297|NCT03710317|Coagulants|coagulants|mesh-ancestor
24973298|NCT03710317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24973299|NCT03710317|Abortifacient Agents|abortifacient agents|mesh-ancestor
24973300|NCT03710317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24973301|NCT03710317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973302|NCT03710317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24973303|NCT03710317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24973304|NCT03710317|Oxytocics|oxytocics|mesh-ancestor
24973305|NCT03710304|Misoprostol|misoprostol|mesh-list
24973306|NCT03710304|Tranexamic Acid|tranexamic acid|mesh-list
24973307|NCT03710304|Oxytocin|oxytocin|mesh-list
24973308|NCT03710304|Oxytocics|oxytocics|mesh-ancestor
24973309|NCT03710304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24973310|NCT03710304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931907|NCT04084171|Pancrelipase|pancrelipase|mesh-list
24973335|NCT03710174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24973336|NCT03710174|Antifungal Agents|antifungal agents|mesh-ancestor
24973337|NCT03710174|Keratolytic Agents|keratolytic agents|mesh-ancestor
24973338|NCT03710174|Dermatologic Agents|dermatologic agents|mesh-ancestor
24973339|NCT03710044|Cyclosporine|cyclosporine|mesh-list
24973340|NCT03710044|Cyclosporins|cyclosporins|mesh-list
24973341|NCT03710044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973342|NCT03710044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973343|NCT03710044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24973344|NCT03710044|Immunologic Factors|immunologic factors|mesh-ancestor
24973345|NCT03710044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973346|NCT03710044|Antifungal Agents|antifungal agents|mesh-ancestor
24973347|NCT03710044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24973348|NCT03710044|Dermatologic Agents|dermatologic agents|mesh-ancestor
24973349|NCT03710044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24973350|NCT03710044|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24973351|NCT03709992|Tamsulosin|tamsulosin|mesh-list
24973352|NCT03709992|Trospium chloride|trospium chloride|mesh-list
24973353|NCT03709992|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24973354|NCT03709992|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24973355|NCT03709992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24973356|NCT03709992|Adrenergic Agents|adrenergic agents|mesh-ancestor
24973372|NCT03709940|Methylphenidate|methylphenidate|mesh-list
24973373|NCT03709940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24973374|NCT03709940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973375|NCT03709940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24973388|NCT03709927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973389|NCT03709927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973390|NCT03709849|Citric Acid|citric acid|mesh-list
24973391|NCT03709849|Sodium Citrate|sodium citrate|mesh-list
25083327|NCT03316599|Antimitotic Agents|antimitotic agents|mesh-ancestor
24973393|NCT03709849|Enclomiphene|enclomiphene|mesh-list
24973394|NCT03709849|Zuclomiphene|zuclomiphene|mesh-list
24973395|NCT03709849|Anticoagulants|anticoagulants|mesh-ancestor
24973396|NCT03709849|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25708221|NCT02246660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708222|NCT02246660|Protective Agents|protective agents|mesh-ancestor
24973397|NCT03709849|Chelating Agents|chelating agents|mesh-ancestor
24973398|NCT03709849|Sequestering Agents|sequestering agents|mesh-ancestor
24973399|NCT03709849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973400|NCT03709849|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25708223|NCT02246660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708224|NCT02246660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25708225|NCT02246660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25708226|NCT02246673|Febuxostat|febuxostat|mesh-list
25708227|NCT02246673|Verinurad|verinurad|mesh-list
25708228|NCT02246673|Gout Suppressants|gout suppressants|mesh-ancestor
24629412|NCT01105234|Calcipotriene|calcipotriene|mesh-list
24629414|NCT01105234|Micronutrients|micronutrients|mesh-ancestor
24629421|NCT01105273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24629422|NCT01105273|Immunologic Factors|immunologic factors|mesh-ancestor
24629465|NCT01105390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24629469|NCT01105390|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24629470|NCT01105390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24973401|NCT03709849|Hormone Antagonists|hormone antagonists|mesh-ancestor
24973402|NCT03709849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24973403|NCT03709849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973404|NCT03709849|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24973405|NCT03709849|Fertility Agents|fertility agents|mesh-ancestor
24973406|NCT03709849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24973407|NCT03709849|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24973766|NCT03707418|Protease Inhibitors|protease inhibitors|mesh-ancestor
24973410|NCT03709745|Aflibercept|aflibercept|mesh-list
24504799|NCT00538174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24504800|NCT00538174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504802|NCT00538187|Obatoclax|obatoclax|mesh-list
24973414|NCT03709745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973415|NCT03709745|Growth Inhibitors|growth inhibitors|mesh-ancestor
24973416|NCT03709745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973417|NCT03709719|Blinatumomab|blinatumomab|mesh-list
24973418|NCT03709719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973419|NCT03709550|Decitabine|decitabine|mesh-list
24973420|NCT03709550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24973421|NCT03709550|Antimetabolites|antimetabolites|mesh-ancestor
24973422|NCT03709550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973423|NCT03709550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973424|NCT03709550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973425|NCT03709381|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
24973426|NCT03709381|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
24973427|NCT03709381|Cosyntropin|cosyntropin|mesh-list
24973428|NCT03709381|beta-Endorphin|beta-endorphin|mesh-list
24759040|NCT01749098|Anesthetics, General|anesthetics, general|mesh-ancestor
24759041|NCT01749098|Anesthetics|anesthetics|mesh-ancestor
24664379|NCT01306461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24759042|NCT01749098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24973431|NCT03709381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973432|NCT03709381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24973433|NCT03709381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973434|NCT03709160|Bumetanide|bumetanide|mesh-list
24973484|NCT03708926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24973485|NCT03708926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973486|NCT03708861|Ritonavir|ritonavir|mesh-list
24759171|NCT01749475|Anesthetics|anesthetics|mesh-ancestor
24973515|NCT03708848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24973516|NCT03708848|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24973517|NCT03708848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24973518|NCT03708848|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24973519|NCT03708848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973520|NCT03708848|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24973521|NCT03708848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24973522|NCT03708848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24973523|NCT03708848|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24973524|NCT03708848|Renal Agents|renal agents|mesh-ancestor
24973525|NCT03708848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24973529|NCT03708848|Antacids|antacids|mesh-ancestor
24973595|NCT03708458|Antioxidants|antioxidants|mesh-ancestor
25708229|NCT02246673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25708230|NCT02246764|Timolol|timolol|mesh-list
25708231|NCT02246764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25708232|NCT02246764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25708233|NCT02246764|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25708234|NCT02246764|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25708235|NCT02246764|Adrenergic Agents|adrenergic agents|mesh-ancestor
25708236|NCT02246764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24973596|NCT03708458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973597|NCT03708458|Protective Agents|protective agents|mesh-ancestor
24973598|NCT03708458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973599|NCT03708458|Antidotes|antidotes|mesh-ancestor
24973600|NCT03708458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24973601|NCT03708458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24973602|NCT03708458|Analgesics|analgesics|mesh-ancestor
24973603|NCT03708458|Sensory System Agents|sensory system agents|mesh-ancestor
24794616|NCT04875715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794617|NCT04875715|Protective Agents|protective agents|mesh-ancestor
24794618|NCT04875715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794619|NCT04875715|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24794621|NCT04868565|Caffeine citrate|caffeine citrate|mesh-list
24794622|NCT04868565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794623|NCT04868565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24794624|NCT04868565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794627|NCT04868565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24794628|NCT04868565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24794629|NCT04868565|Purinergic Agents|purinergic agents|mesh-ancestor
24932279|NCT04081376|Hydromorphone|hydromorphone|mesh-list
24932280|NCT04081376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24932281|NCT04081376|Narcotics|narcotics|mesh-ancestor
24932282|NCT04081376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24932283|NCT04081376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932284|NCT04081376|Analgesics|analgesics|mesh-ancestor
24932285|NCT04081376|Sensory System Agents|sensory system agents|mesh-ancestor
24932286|NCT04081376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24932287|NCT04081480|Valacyclovir|valacyclovir|mesh-list
24932288|NCT04081480|Antiviral Agents|antiviral agents|mesh-ancestor
24932289|NCT04081480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24973687|NCT03707795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973688|NCT03707795|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24973689|NCT03707795|Respiratory System Agents|respiratory system agents|mesh-ancestor
24973690|NCT03707795|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24973691|NCT03707795|Autonomic Agents|autonomic agents|mesh-ancestor
24973692|NCT03707795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24973694|NCT03707678|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24973695|NCT03707678|Autonomic Agents|autonomic agents|mesh-ancestor
24973696|NCT03707678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24973697|NCT03707678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973698|NCT03707678|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24973699|NCT03707678|Respiratory System Agents|respiratory system agents|mesh-ancestor
24973700|NCT03707678|Tocolytic Agents|tocolytic agents|mesh-ancestor
24973701|NCT03707678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24973702|NCT03707678|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24973703|NCT03707678|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24759219|NCT01750060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24759220|NCT01750060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24759221|NCT01750060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24759222|NCT01750060|Anesthetics, General|anesthetics, general|mesh-ancestor
24759223|NCT01750060|Anesthetics|anesthetics|mesh-ancestor
24759224|NCT01750060|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24759226|NCT01750099|Lidocaine|lidocaine|mesh-list
24759378|NCT01750983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759380|NCT01750983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24759381|NCT01750983|Growth Substances|growth substances|mesh-ancestor
24759382|NCT01750983|Growth Inhibitors|growth inhibitors|mesh-ancestor
24759383|NCT01750983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759384|NCT01750983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24759385|NCT01750983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24973704|NCT03707678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24973705|NCT03707678|Adrenergic Agents|adrenergic agents|mesh-ancestor
24973706|NCT03707678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24973707|NCT03707678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973708|NCT03707652|Vitamins|vitamins|mesh-list
24973709|NCT03707652|Niacinamide|niacinamide|mesh-list
24973711|NCT03707652|Nicotinic Acids|nicotinic acids|mesh-list
24630930|NCT01115062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24630931|NCT01115062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24630932|NCT01115062|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24630933|NCT01115062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24630934|NCT01115062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24630935|NCT01115062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973712|NCT03707652|Vitamin B Complex|vitamin b complex|mesh-list
24973713|NCT03707652|Micronutrients|micronutrients|mesh-ancestor
24973714|NCT03707652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973715|NCT03707652|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24973716|NCT03707652|Antimetabolites|antimetabolites|mesh-ancestor
24973717|NCT03707652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973756|NCT03707457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973758|NCT03707418|Calcium heparin|calcium heparin|mesh-list
24973759|NCT03707418|Bivalirudin|bivalirudin|mesh-list
24973760|NCT03707418|Anticoagulants|anticoagulants|mesh-ancestor
24973761|NCT03707418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24973762|NCT03707418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24973763|NCT03707418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973764|NCT03707418|Antithrombins|antithrombins|mesh-ancestor
24973765|NCT03707418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24973769|NCT03707249|Hematinics|hematinics|mesh-ancestor
24973770|NCT03707171|Liraglutide|liraglutide|mesh-list
24973771|NCT03707171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24973772|NCT03707171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973773|NCT03707171|Incretins|incretins|mesh-ancestor
24973774|NCT03707171|Hormones|hormones|mesh-ancestor
24973776|NCT03706950|Elsulfavirine|elsulfavirine|mesh-list
24973806|NCT03706755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24973807|NCT03706703|Carboplatin|carboplatin|mesh-list
24973808|NCT03706703|Docetaxel|docetaxel|mesh-list
24973809|NCT03706703|Pemetrexed|pemetrexed|mesh-list
24973822|NCT03706703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973823|NCT03706703|Growth Inhibitors|growth inhibitors|mesh-ancestor
24973824|NCT03706547|Cyclophosphamide|cyclophosphamide|mesh-list
24973825|NCT03706547|Fludarabine|fludarabine|mesh-list
24973826|NCT03706547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24973827|NCT03706547|Immunologic Factors|immunologic factors|mesh-ancestor
24973828|NCT03706547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973829|NCT03706547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24973830|NCT03706547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24973831|NCT03706547|Alkylating Agents|alkylating agents|mesh-ancestor
24973832|NCT03706547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973833|NCT03706547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973834|NCT03706547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24973835|NCT03706339|Tranexamic Acid|tranexamic acid|mesh-list
24973836|NCT03706339|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24973837|NCT03706339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24973838|NCT03706339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973839|NCT03706339|Hemostatics|hemostatics|mesh-ancestor
24973840|NCT03706339|Coagulants|coagulants|mesh-ancestor
24973841|NCT03706300|Phenylpropanolamine|phenylpropanolamine|mesh-list
24973842|NCT03706300|Pseudoephedrine|pseudoephedrine|mesh-list
24973843|NCT03706300|Ephedrine|ephedrine|mesh-list
24973844|NCT03706300|Guaifenesin|guaifenesin|mesh-list
24973845|NCT03706300|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
24973846|NCT03706300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24973847|NCT03706300|Autonomic Agents|autonomic agents|mesh-ancestor
24973848|NCT03706300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24973849|NCT03706300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973850|NCT03706300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24794650|NCT04809233|Tipifarnib|tipifarnib|mesh-list
24794654|NCT04776850|Dexamethasone acetate|dexamethasone acetate|mesh-list
24794655|NCT04776850|Cyclophosphamide|cyclophosphamide|mesh-list
24794656|NCT04776850|Busulfan|busulfan|mesh-list
24794657|NCT04776850|Rituximab|rituximab|mesh-list
25708237|NCT02246764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708238|NCT02246764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708239|NCT02246764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25708240|NCT02246764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25708241|NCT02246998|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24794659|NCT04776850|Fludarabine phosphate|fludarabine phosphate|mesh-list
24794661|NCT04776850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24794662|NCT04776850|Tacrolimus|tacrolimus|mesh-list
24794663|NCT04776850|Thymoglobulin|thymoglobulin|mesh-list
24794664|NCT04776850|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24794665|NCT04776850|Antibodies|antibodies|mesh-list
24794666|NCT04776850|Immunoglobulins|immunoglobulins|mesh-list
24794667|NCT04776850|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24794668|NCT04776850|gamma-Globulins|gamma-globulins|mesh-list
24794669|NCT04776850|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24794670|NCT04776850|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24794672|NCT04776850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24794673|NCT04776850|Immunologic Factors|immunologic factors|mesh-ancestor
24794674|NCT04776850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794675|NCT04776850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24794676|NCT04776850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24794677|NCT04776850|Alkylating Agents|alkylating agents|mesh-ancestor
24794678|NCT04776850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794679|NCT04776850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973894|NCT03705884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24973895|NCT03705884|Glucocorticoids|glucocorticoids|mesh-ancestor
24973896|NCT03705884|Hormones|hormones|mesh-ancestor
24973897|NCT03705884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24973898|NCT03705884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973899|NCT03705884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24973900|NCT03705884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973901|NCT03705858|Lintuzumab|lintuzumab|mesh-list
24932535|NCT04078659|Analgesics|analgesics|mesh-ancestor
24973911|NCT03705780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24973912|NCT03705780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24973913|NCT03705780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24973914|NCT03705780|Anesthetics, General|anesthetics, general|mesh-ancestor
24973915|NCT03705780|Anesthetics|anesthetics|mesh-ancestor
24973916|NCT03705728|Remifentanil|remifentanil|mesh-list
24973917|NCT03705728|Propofol|propofol|mesh-list
24973918|NCT03705728|Sevoflurane|sevoflurane|mesh-list
24973919|NCT03705728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24973920|NCT03705728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24973921|NCT03705728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973922|NCT03705728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24973923|NCT03705728|Anesthetics, General|anesthetics, general|mesh-ancestor
24973924|NCT03705728|Anesthetics|anesthetics|mesh-ancestor
24973925|NCT03705728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24973926|NCT03705728|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24973927|NCT03705728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24973928|NCT03705728|Narcotics|narcotics|mesh-ancestor
24973929|NCT03705728|Analgesics|analgesics|mesh-ancestor
24973931|NCT03705728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24973948|NCT05177666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973949|NCT05177666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24973950|NCT05177666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973951|NCT05177666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973952|NCT05177601|Cycloserine|cycloserine|mesh-list
24973953|NCT05177601|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24973954|NCT05177601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24973955|NCT05177601|Renal Agents|renal agents|mesh-ancestor
24973956|NCT05177601|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24973957|NCT05177601|Antitubercular Agents|antitubercular agents|mesh-ancestor
24973958|NCT05177601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24973959|NCT05177601|Antimetabolites|antimetabolites|mesh-ancestor
24794693|NCT04776850|Antimetabolites|antimetabolites|mesh-ancestor
24973981|NCT05177276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24973982|NCT05177276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24973983|NCT05177276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24973984|NCT05177276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24973985|NCT05177276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973986|NCT05177237|Endostar protein|endostar protein|mesh-list
24973987|NCT05177237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24973988|NCT05177237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24973989|NCT05177237|Growth Substances|growth substances|mesh-ancestor
24973990|NCT05177237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24973991|NCT05177237|Growth Inhibitors|growth inhibitors|mesh-ancestor
24973992|NCT05177237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24974025|NCT05176119|Analgesics|analgesics|mesh-ancestor
24974026|NCT05176119|Sensory System Agents|sensory system agents|mesh-ancestor
24974027|NCT05176119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24974028|NCT05176119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974029|NCT05176119|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24974030|NCT05176119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24974031|NCT05176119|Anesthetics, General|anesthetics, general|mesh-ancestor
24974032|NCT05176119|Anesthetics|anesthetics|mesh-ancestor
24974033|NCT05176119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24974034|NCT05176119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24974035|NCT05176119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24974062|NCT05175508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24974064|NCT05175508|Keratolytic Agents|keratolytic agents|mesh-ancestor
24974067|NCT05175430|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
24974068|NCT05175430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24974069|NCT05175430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24974070|NCT05175430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24974071|NCT05175430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974072|NCT05175430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24974073|NCT05175430|Serotonin Agents|serotonin agents|mesh-ancestor
24974074|NCT05175430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974075|NCT05175430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24974076|NCT05175430|Antidepressive Agents|antidepressive agents|mesh-ancestor
24974077|NCT05175430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24974078|NCT05175430|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24759601|NCT01752959|Sensory System Agents|sensory system agents|mesh-ancestor
24759602|NCT01752959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24759603|NCT01752959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24794694|NCT04776850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24742721|NCT05189444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24742722|NCT05189444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24742724|NCT05189444|Diuretics|diuretics|mesh-ancestor
24742725|NCT05189444|Natriuretic Agents|natriuretic agents|mesh-ancestor
24974242|NCT05038904|Acalabrutinib|acalabrutinib|mesh-list
24974243|NCT05038904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24974244|NCT05035277|Aspirin|aspirin|mesh-list
24974245|NCT05035277|Rivaroxaban|rivaroxaban|mesh-list
24974246|NCT05035277|Apixaban|apixaban|mesh-list
24460624|NCT00349089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460625|NCT00349089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24460626|NCT00349089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24460627|NCT00349089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24460628|NCT00349089|Tubulin Modulators|tubulin modulators|mesh-ancestor
24460719|NCT00349310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460721|NCT00349310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24460722|NCT00349310|Dopamine Agonists|dopamine agonists|mesh-ancestor
24460723|NCT00349310|Dopamine Agents|dopamine agents|mesh-ancestor
24460724|NCT00349310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24460726|NCT00349362|Androgens|androgens|mesh-ancestor
24460727|NCT00349362|Hormones|hormones|mesh-ancestor
24460728|NCT00349362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24460729|NCT00349362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460730|NCT00349375|Simvastatin|simvastatin|mesh-list
24460731|NCT00349375|Fenofibrate|fenofibrate|mesh-list
24460732|NCT00349375|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24460733|NCT00349375|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24460734|NCT00349375|Antimetabolites|antimetabolites|mesh-ancestor
24460735|NCT00349375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461329|NCT00351910|Analgesics|analgesics|mesh-ancestor
24461330|NCT00351910|Sensory System Agents|sensory system agents|mesh-ancestor
24461331|NCT00351910|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24794689|NCT04776850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24794690|NCT04776850|Protease Inhibitors|protease inhibitors|mesh-ancestor
24794691|NCT04776850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24794692|NCT04776850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24794725|NCT04742010|Zoledronic Acid|zoledronic acid|mesh-list
24794726|NCT04742010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24794727|NCT04742010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461335|NCT00351975|Azacitidine|azacitidine|mesh-list
24461336|NCT00351975|Belinostat|belinostat|mesh-list
24461360|NCT00352092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24461362|NCT00352092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461363|NCT00352092|Antifungal Agents|antifungal agents|mesh-ancestor
24461364|NCT00352092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24461365|NCT00352092|Immunologic Factors|immunologic factors|mesh-ancestor
24461366|NCT00352092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461367|NCT00352144|Eszopiclone|eszopiclone|mesh-list
24461369|NCT00352144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24974340|NCT04911361|Autonomic Agents|autonomic agents|mesh-ancestor
24974341|NCT04911361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24974342|NCT04911361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974343|NCT04911361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24974344|NCT04911361|Glucocorticoids|glucocorticoids|mesh-ancestor
24974345|NCT04911361|Hormones|hormones|mesh-ancestor
24974432|NCT04682860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24974433|NCT04682860|Cholinergic Agents|cholinergic agents|mesh-ancestor
24974434|NCT04682860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24461625|NCT00352950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24461626|NCT00352950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461627|NCT00353002|Lidocaine|lidocaine|mesh-list
24461628|NCT00353002|Tetracaine|tetracaine|mesh-list
24461629|NCT00353002|Anesthetics, Local|anesthetics, local|mesh-ancestor
24461695|NCT00353080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24461696|NCT00353080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461700|NCT00353145|Gemcitabine|gemcitabine|mesh-list
24461742|NCT00353379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461744|NCT00353561|Antifungal Agents|antifungal agents|mesh-ancestor
24461745|NCT00353561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24461746|NCT00353561|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24974435|NCT04682860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794780|NCT04641234|Aflibercept|aflibercept|mesh-list
24794781|NCT04641234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24794782|NCT04641234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24794783|NCT04641234|Growth Substances|growth substances|mesh-ancestor
24794784|NCT04641234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24794785|NCT04641234|Growth Inhibitors|growth inhibitors|mesh-ancestor
24794786|NCT04641234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24794787|NCT04636034|Anesthetics|anesthetics|mesh-list
24588112|NCT00900913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24974438|NCT04666636|Mirabegron|mirabegron|mesh-list
24974439|NCT04666636|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24974440|NCT04666636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24974441|NCT04666636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24974442|NCT04666636|Adrenergic Agents|adrenergic agents|mesh-ancestor
24974443|NCT04666636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24974444|NCT04666636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974445|NCT04666636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974446|NCT04666636|Urological Agents|urological agents|mesh-ancestor
24974447|NCT04664946|Neuroprotective Agents|neuroprotective agents|mesh-list
24974448|NCT04664946|Protective Agents|protective agents|mesh-ancestor
24974449|NCT04664946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24811361|NCT02046460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461865|NCT00354198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974486|NCT04602507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24974487|NCT04602507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24974499|NCT04576000|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
24974500|NCT04576000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24974501|NCT04576000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24974502|NCT04576000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974504|NCT04552197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24974505|NCT04552197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24974548|NCT04481009|Antiviral Agents|antiviral agents|mesh-ancestor
24974549|NCT04481009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24974550|NCT04481009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24974551|NCT04481009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24974552|NCT04481009|Immunologic Factors|immunologic factors|mesh-ancestor
24974553|NCT04481009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974554|NCT04475731|Ponatinib|ponatinib|mesh-list
24974555|NCT04475731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24974582|NCT04394481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24974583|NCT04394481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24974585|NCT04394481|Sensory System Agents|sensory system agents|mesh-ancestor
24912675|NCT04273282|Hormones|hormones|mesh-ancestor
24974586|NCT04394481|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24974587|NCT04394481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24974588|NCT04394481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24974589|NCT04394481|Adrenergic Agents|adrenergic agents|mesh-ancestor
24974590|NCT04394481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24974591|NCT04394481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974592|NCT04394481|Anesthetics, Local|anesthetics, local|mesh-ancestor
24974593|NCT04394481|Anesthetics|anesthetics|mesh-ancestor
24974601|NCT04370847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974602|NCT04370847|Sensory System Agents|sensory system agents|mesh-ancestor
24974603|NCT04370847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24974604|NCT04370847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24974605|NCT04370847|Narcotics|narcotics|mesh-ancestor
24974606|NCT04370847|Analgesics|analgesics|mesh-ancestor
24974607|NCT04370847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24974608|NCT04370847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24974609|NCT04370847|Anesthetics, General|anesthetics, general|mesh-ancestor
24974610|NCT04370847|Oxytocics|oxytocics|mesh-ancestor
24461988|NCT00354419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24462033|NCT00354627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462034|NCT00354627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462035|NCT00354627|Antiviral Agents|antiviral agents|mesh-ancestor
24462036|NCT00354627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24462037|NCT00354653|Lamivudine|lamivudine|mesh-list
24462038|NCT00354653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24462039|NCT00354653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24462040|NCT00354653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462042|NCT00354653|Antiviral Agents|antiviral agents|mesh-ancestor
24462097|NCT00354900|Protease Inhibitors|protease inhibitors|mesh-ancestor
24462098|NCT00354900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462102|NCT00354939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462103|NCT00354952|Azithromycin|azithromycin|mesh-list
24462104|NCT00354952|Clarithromycin|clarithromycin|mesh-list
24462105|NCT00354952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24462106|NCT00354952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24462107|NCT00354952|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24462108|NCT00354952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462109|NCT00354952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462110|NCT00354952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24462111|NCT00354952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24462112|NCT00354965|Amoxicillin|amoxicillin|mesh-list
24974638|NCT04353271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24588132|NCT00901069|Antimitotic Agents|antimitotic agents|mesh-ancestor
24588133|NCT00901069|Mitosis Modulators|mitosis modulators|mesh-ancestor
24588134|NCT00901069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24588135|NCT00901069|Antimetabolites|antimetabolites|mesh-ancestor
24588136|NCT00901069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588139|NCT00901147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588140|NCT00901147|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24588141|NCT00901147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588142|NCT00901147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621932|NCT01064973|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24621933|NCT01064973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621934|NCT01064973|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24621935|NCT01064973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24621965|NCT01064999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24621967|NCT01065038|Anagrelide|anagrelide|mesh-list
24621968|NCT01065038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24621969|NCT01065038|Antisickling Agents|antisickling agents|mesh-ancestor
24621970|NCT01065038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621971|NCT01065038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621972|NCT01065038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24462159|NCT00355277|Sensory System Agents|sensory system agents|mesh-ancestor
24462215|NCT00355537|Hormones|hormones|mesh-ancestor
24794813|NCT04443309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24794814|NCT04443309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24794815|NCT04443309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24794816|NCT04443309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794817|NCT04435795|Ciclesonide|ciclesonide|mesh-list
24432218|NCT00254007|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24432288|NCT00254241|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24462231|NCT00355576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462232|NCT00355576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24462233|NCT00355576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24462234|NCT00355589|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24462236|NCT00355589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24462237|NCT00355589|Diuretics|diuretics|mesh-ancestor
24462307|NCT00355667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24462308|NCT00355667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462309|NCT00355693|Propofol|propofol|mesh-list
24462310|NCT00355693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24462311|NCT00355693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24462312|NCT00355693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462313|NCT00355693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24462314|NCT00355693|Anesthetics, General|anesthetics, general|mesh-ancestor
24462315|NCT00355693|Anesthetics|anesthetics|mesh-ancestor
24462316|NCT00355719|Ritonavir|ritonavir|mesh-list
24462361|NCT00355862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24462362|NCT00355862|Glucocorticoids|glucocorticoids|mesh-ancestor
24462364|NCT00355862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24462365|NCT00355862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24794822|NCT04435795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24974736|NCT05303324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24974759|NCT05293366|Dermatologic Agents|dermatologic agents|mesh-list
24974760|NCT05291650|Hyaluronic Acid|hyaluronic acid|mesh-list
24974761|NCT05291650|Glucocorticoids|glucocorticoids|mesh-list
24974767|NCT05291650|Hormones|hormones|mesh-ancestor
25083330|NCT03316599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24607153|NCT05162690|Dapagliflozin|dapagliflozin|mesh-list
24974797|NCT05254847|Lenvatinib|lenvatinib|mesh-list
24974816|NCT05249699|Antitubercular Agents|antitubercular agents|mesh-list
24974817|NCT05249699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24974818|NCT05249699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24974819|NCT05249699|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24974820|NCT05249699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24974821|NCT05249699|Antimetabolites|antimetabolites|mesh-ancestor
24974822|NCT05249699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24974823|NCT05249699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24794875|NCT04233866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24794876|NCT04233866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24794877|NCT04233866|Tubulin Modulators|tubulin modulators|mesh-ancestor
24794878|NCT04233866|Antimitotic Agents|antimitotic agents|mesh-ancestor
24794879|NCT04233866|Mitosis Modulators|mitosis modulators|mesh-ancestor
24794880|NCT04233866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24794881|NCT04233866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24794882|NCT04233866|Antimetabolites|antimetabolites|mesh-ancestor
24794883|NCT04233866|Antiviral Agents|antiviral agents|mesh-ancestor
24794885|NCT04233866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24794886|NCT04233866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24974901|NCT05031897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24974902|NCT05031897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24974903|NCT05031897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24974904|NCT05031897|Antitubercular Agents|antitubercular agents|mesh-ancestor
24974905|NCT05031897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24974906|NCT05031897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24974908|NCT05023369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24974909|NCT05023369|Antiemetics|antiemetics|mesh-ancestor
24974910|NCT05023369|Autonomic Agents|autonomic agents|mesh-ancestor
24974911|NCT05023369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24462379|NCT00355953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24462380|NCT00355953|Protective Agents|protective agents|mesh-ancestor
24462381|NCT00355953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462382|NCT00355953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24462383|NCT00355953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24462385|NCT00355953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462386|NCT00355953|Phytoestrogens|phytoestrogens|mesh-ancestor
24462387|NCT00355953|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24462389|NCT00355953|Hormones|hormones|mesh-ancestor
25708242|NCT02246998|Antiviral Agents|antiviral agents|mesh-ancestor
25708243|NCT02246998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24396729|NCT00139815|Fondaparinux|fondaparinux|mesh-list
24974912|NCT05023369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974913|NCT05023369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24974914|NCT05023369|Glucocorticoids|glucocorticoids|mesh-ancestor
24974916|NCT05023369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24462390|NCT00355953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24462391|NCT00355966|Misoprostol|misoprostol|mesh-list
24462436|NCT00356096|Dopamine Agonists|dopamine agonists|mesh-ancestor
24462437|NCT00356096|Dopamine Agents|dopamine agents|mesh-ancestor
24462438|NCT00356096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24462439|NCT00356226|Clonidine|clonidine|mesh-list
24462440|NCT00356226|Analgesics|analgesics|mesh-ancestor
24462441|NCT00356226|Sensory System Agents|sensory system agents|mesh-ancestor
24462442|NCT00356226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24462457|NCT00356252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462458|NCT00356356|Etanercept|etanercept|mesh-list
24462459|NCT00356356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24462461|NCT00356356|Analgesics|analgesics|mesh-ancestor
24462462|NCT00356356|Sensory System Agents|sensory system agents|mesh-ancestor
24462463|NCT00356356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24974941|NCT04959812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974942|NCT04959812|Analgesics|analgesics|mesh-ancestor
24974943|NCT04959812|Sensory System Agents|sensory system agents|mesh-ancestor
24974944|NCT04959812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24974945|NCT04959812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24974946|NCT04959812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24974947|NCT04959812|Anesthetics, General|anesthetics, general|mesh-ancestor
24974948|NCT04959812|Anesthetics|anesthetics|mesh-ancestor
24974984|NCT04862585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24974986|NCT04862585|Autonomic Agents|autonomic agents|mesh-ancestor
24974987|NCT04862585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24974988|NCT04862585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24974989|NCT04862585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24974990|NCT04862585|Glucocorticoids|glucocorticoids|mesh-ancestor
24974991|NCT04862585|Hormones|hormones|mesh-ancestor
24974992|NCT04862585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24974993|NCT04862585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24974994|NCT04862585|Protease Inhibitors|protease inhibitors|mesh-ancestor
24974995|NCT04862585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24974996|NCT04862585|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24974997|NCT04862585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24974998|NCT04862585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24974999|NCT04862585|Anesthetics, Local|anesthetics, local|mesh-ancestor
24975000|NCT04862585|Anesthetics|anesthetics|mesh-ancestor
24975001|NCT04862585|Sensory System Agents|sensory system agents|mesh-ancestor
24975002|NCT04862585|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24975003|NCT04862585|Histamine Antagonists|histamine antagonists|mesh-ancestor
24975004|NCT04862585|Histamine Agents|histamine agents|mesh-ancestor
24975005|NCT04862585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24975006|NCT04862585|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24975007|NCT04862585|Antipruritics|antipruritics|mesh-ancestor
24975008|NCT04862585|Dermatologic Agents|dermatologic agents|mesh-ancestor
25083355|NCT03316534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25083356|NCT03316534|Antipyretics|antipyretics|mesh-ancestor
25083357|NCT03316482|Leuprolide|leuprolide|mesh-list
25083358|NCT03316482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25083359|NCT03316482|Fertility Agents|fertility agents|mesh-ancestor
25083360|NCT03316482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25083361|NCT03316482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083363|NCT03316482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083373|NCT03316469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25083374|NCT03316469|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25083375|NCT03316469|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25083377|NCT03316352|Anesthetics|anesthetics|mesh-list
25083424|NCT03316066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25083425|NCT03316066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083426|NCT03316066|Sensory System Agents|sensory system agents|mesh-ancestor
25708244|NCT02246998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25708245|NCT02246998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25708246|NCT02247193|Botulinum Toxins|botulinum toxins|mesh-list
25708247|NCT02247193|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25708248|NCT02247193|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25708249|NCT02247193|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25708250|NCT02247193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25083427|NCT03316066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25083428|NCT03315923|Rituximab|rituximab|mesh-list
24809733|NCT02036060|Glucocorticoids|glucocorticoids|mesh-ancestor
25083429|NCT03315923|Glatiramer Acetate|glatiramer acetate|mesh-list
25083430|NCT03315923|(T,G)-A-L|(t,g)-a-l|mesh-list
25083431|NCT03315923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25083432|NCT03315923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083433|NCT03315923|Immunologic Factors|immunologic factors|mesh-ancestor
25083494|NCT03315364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25083495|NCT03315364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25083496|NCT03315364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083497|NCT03315364|Tubulin Modulators|tubulin modulators|mesh-ancestor
25083498|NCT03315364|Antimitotic Agents|antimitotic agents|mesh-ancestor
25083499|NCT03315364|Mitosis Modulators|mitosis modulators|mesh-ancestor
25083500|NCT03315364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083501|NCT03315338|Prednisone|prednisone|mesh-list
25083502|NCT03315338|Cortisone|cortisone|mesh-list
25083503|NCT03315338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25083504|NCT03315338|Glucocorticoids|glucocorticoids|mesh-ancestor
25083505|NCT03315338|Hormones|hormones|mesh-ancestor
25083506|NCT03315338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25083507|NCT03315338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083508|NCT03315338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25083509|NCT03315338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083510|NCT03315312|Fluorides|fluorides|mesh-list
25083511|NCT03315312|Fluorides, Topical|fluorides, topical|mesh-list
25083512|NCT03315312|Cariostatic Agents|cariostatic agents|mesh-ancestor
25083513|NCT03315312|Protective Agents|protective agents|mesh-ancestor
25083514|NCT03315312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462500|NCT00356473|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24462501|NCT00356473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462503|NCT00356486|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24462504|NCT00356486|Interferon-alpha|interferon-alpha|mesh-list
24462505|NCT00356486|Antimetabolites|antimetabolites|mesh-ancestor
24435314|NCT00265928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24462506|NCT00356486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083526|NCT03315078|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25083527|NCT03315052|Mycophenolic Acid|mycophenolic acid|mesh-list
25083528|NCT03315052|Prednisone|prednisone|mesh-list
25083529|NCT03315052|Budesonide|budesonide|mesh-list
25083530|NCT03315052|Tacrolimus|tacrolimus|mesh-list
25083531|NCT03315052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25083532|NCT03315052|Glucocorticoids|glucocorticoids|mesh-ancestor
25083533|NCT03315052|Hormones|hormones|mesh-ancestor
25083534|NCT03315052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25083535|NCT03315052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083536|NCT03315052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25083537|NCT03315052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083538|NCT03315052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25083539|NCT03315052|Immunologic Factors|immunologic factors|mesh-ancestor
25083540|NCT03315052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25083541|NCT03315052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25083558|NCT03315000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25083559|NCT03315000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664419|NCT01306721|Ephedrine|ephedrine|mesh-list
24628507|NCT01099436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25083560|NCT03315000|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25083561|NCT03315000|Respiratory System Agents|respiratory system agents|mesh-ancestor
25083562|NCT03315000|Dermatologic Agents|dermatologic agents|mesh-ancestor
25083563|NCT03315000|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25083564|NCT03314792|Oxycodone|oxycodone|mesh-list
25083565|NCT03314792|Tapentadol|tapentadol|mesh-list
25083566|NCT03314792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25083567|NCT03314792|Narcotics|narcotics|mesh-ancestor
25083568|NCT03314792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25083639|NCT03314259|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25083640|NCT03314259|Adrenergic Agents|adrenergic agents|mesh-ancestor
25083641|NCT03314259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25083642|NCT03314259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083643|NCT03314259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083644|NCT03314259|Urological Agents|urological agents|mesh-ancestor
25083645|NCT03314064|Dolutegravir|dolutegravir|mesh-list
24933944|NCT04065906|Dopamine Agents|dopamine agents|mesh-ancestor
24462570|NCT00357019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24462584|NCT00357045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24462585|NCT00357045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24462586|NCT00357045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462602|NCT00357084|Methotrexate|methotrexate|mesh-list
24462603|NCT00357084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24462604|NCT00357084|Prednisolone phosphate|prednisolone phosphate|mesh-list
24462605|NCT00357084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24462606|NCT00357084|Glucocorticoids|glucocorticoids|mesh-ancestor
24744327|NCT04356742|Dapagliflozin|dapagliflozin|mesh-list
25083663|NCT03313960|Insulin|insulin|mesh-list
25083664|NCT03313960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25083665|NCT03313960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083666|NCT03313934|Hyaluronic Acid|hyaluronic acid|mesh-list
25083667|NCT03313934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25083668|NCT03313934|Immunologic Factors|immunologic factors|mesh-ancestor
25083713|NCT03313557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462624|NCT00357084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24436974|NCT00272324|Antipyretics|antipyretics|mesh-ancestor
25083714|NCT03313544|Nivolumab|nivolumab|mesh-list
25083715|NCT03313544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25083716|NCT03313544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25083717|NCT03313544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25083718|NCT03313544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083719|NCT03313531|Thrombin|thrombin|mesh-list
25083720|NCT03313531|Hemostatics|hemostatics|mesh-ancestor
25083721|NCT03313531|Coagulants|coagulants|mesh-ancestor
25083722|NCT03313479|Dexmedetomidine|dexmedetomidine|mesh-list
25083784|NCT03312478|Antibodies|antibodies|mesh-list
25083785|NCT03312478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25083786|NCT03312478|Immunologic Factors|immunologic factors|mesh-ancestor
25083787|NCT03312426|Linrodostat|linrodostat|mesh-list
25083788|NCT03312426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25083817|NCT03312257|Atropine|atropine|mesh-list
25083871|NCT03311971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25083878|NCT03311945|Lamivudine|lamivudine|mesh-list
25083879|NCT03311945|Raltegravir Potassium|raltegravir potassium|mesh-list
25083880|NCT03311945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25083881|NCT03311945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25083882|NCT03311945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25083883|NCT03311945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083884|NCT03311945|Antiviral Agents|antiviral agents|mesh-ancestor
25083885|NCT03311945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25083886|NCT03311945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25083887|NCT03311945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25083888|NCT03311945|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25083894|NCT03311906|Viscosupplements|viscosupplements|mesh-ancestor
25083931|NCT03311581|Propofol|propofol|mesh-list
25083932|NCT03311581|Sevoflurane|sevoflurane|mesh-list
25083933|NCT03311581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25083997|NCT03311178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25083998|NCT03311178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25083999|NCT03311178|Protective Agents|protective agents|mesh-ancestor
25084000|NCT03311139|Fibrinolytic Agents|fibrinolytic agents|mesh-list
25084001|NCT03311139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25084002|NCT03311139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084085|NCT03309644|Iodine|iodine|mesh-list
25084086|NCT03309644|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25084087|NCT03309644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25084088|NCT03309644|Trace Elements|trace elements|mesh-ancestor
25084089|NCT03309644|Micronutrients|micronutrients|mesh-ancestor
25084090|NCT03309644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084091|NCT03309618|Valsartan|valsartan|mesh-list
25084092|NCT03309618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24402927|NCT00158834|Xhance|xhance|mesh-list
25084093|NCT03309618|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25084094|NCT03309618|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25084095|NCT03309618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084102|NCT03309592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084103|NCT03309592|Urological Agents|urological agents|mesh-ancestor
24462717|NCT00357318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24439567|NCT00279435|Visilizumab|visilizumab|mesh-list
25084122|NCT03309527|Diphenhydramine|diphenhydramine|mesh-list
25084123|NCT03309527|Promethazine|promethazine|mesh-list
25084124|NCT03309527|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25084125|NCT03309527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25084126|NCT03309527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25084127|NCT03309527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084128|NCT03309527|Anesthetics, Local|anesthetics, local|mesh-ancestor
25084129|NCT03309527|Anesthetics|anesthetics|mesh-ancestor
25084130|NCT03309527|Sensory System Agents|sensory system agents|mesh-ancestor
25084131|NCT03309527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084132|NCT03309527|Antiemetics|antiemetics|mesh-ancestor
25084133|NCT03309527|Autonomic Agents|autonomic agents|mesh-ancestor
25084157|NCT03309319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25084158|NCT03309319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084159|NCT03309215|Nickel|nickel|mesh-list
25084160|NCT03309215|Trace Elements|trace elements|mesh-ancestor
25084161|NCT03309215|Micronutrients|micronutrients|mesh-ancestor
25084162|NCT03309215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084163|NCT03309176|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25084164|NCT03309176|Medroxyprogesterone|medroxyprogesterone|mesh-list
25084165|NCT03309176|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25084166|NCT03309176|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25084167|NCT03309176|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24628823|NCT01101581|Chelating Agents|chelating agents|mesh-ancestor
25084196|NCT03308955|Narcotics|narcotics|mesh-ancestor
25084197|NCT03308955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25084198|NCT03308955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084199|NCT03308955|Analgesics|analgesics|mesh-ancestor
25084200|NCT03308955|Sensory System Agents|sensory system agents|mesh-ancestor
25084201|NCT03308955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084204|NCT03308890|Entecavir|entecavir|mesh-list
25084205|NCT03308890|Antiviral Agents|antiviral agents|mesh-ancestor
24628838|NCT01101646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24628839|NCT01101646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25084253|NCT03308487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25084254|NCT03308487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25084255|NCT03308357|Infliximab|infliximab|mesh-list
25084256|NCT03308357|Dermatologic Agents|dermatologic agents|mesh-ancestor
25084257|NCT03308357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25084258|NCT03308357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25084259|NCT03308331|Nicotine|nicotine|mesh-list
25084260|NCT03308331|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25084261|NCT03308331|Autonomic Agents|autonomic agents|mesh-ancestor
25084262|NCT03308331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084263|NCT03308331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084264|NCT03308331|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25084265|NCT03308331|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25084294|NCT03308149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25084295|NCT03308149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084296|NCT03308149|Sensory System Agents|sensory system agents|mesh-ancestor
25084297|NCT03308149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084298|NCT03308149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25084299|NCT03308149|Glucocorticoids|glucocorticoids|mesh-ancestor
25084330|NCT03308084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25084331|NCT03308084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25084332|NCT03308084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25084333|NCT03308084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25084334|NCT03308084|Protective Agents|protective agents|mesh-ancestor
25084335|NCT03307941|Fluorouracil|fluorouracil|mesh-list
25084336|NCT03307941|Oxaliplatin|oxaliplatin|mesh-list
25084337|NCT03307941|Antimetabolites|antimetabolites|mesh-ancestor
25084338|NCT03307941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084339|NCT03307941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25084340|NCT03307941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25084341|NCT03307941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25084342|NCT03307941|Immunologic Factors|immunologic factors|mesh-ancestor
25084343|NCT03307941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084344|NCT03307902|Imiquimod|imiquimod|mesh-list
25084345|NCT03307902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25084346|NCT03307902|Immunologic Factors|immunologic factors|mesh-ancestor
25084347|NCT03307902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084348|NCT03307902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25084349|NCT03307902|Interferon Inducers|interferon inducers|mesh-ancestor
25084350|NCT03307863|Topiramate|topiramate|mesh-list
25084351|NCT03307863|Carbamazepine|carbamazepine|mesh-list
25084352|NCT03307863|Anticonvulsants|anticonvulsants|mesh-ancestor
25084353|NCT03307863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25084354|NCT03307863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084355|NCT03307863|Antimanic Agents|antimanic agents|mesh-ancestor
25084695|NCT03304080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25084359|NCT03307863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25084360|NCT03307863|Analgesics|analgesics|mesh-ancestor
25084361|NCT03307863|Sensory System Agents|sensory system agents|mesh-ancestor
25084362|NCT03307863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084363|NCT03307863|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25084364|NCT03307863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25084365|NCT03307863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084366|NCT03307863|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25084367|NCT03307863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25084369|NCT03307746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25084370|NCT03307746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25084371|NCT03307746|Immunologic Factors|immunologic factors|mesh-ancestor
25084372|NCT03307746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084373|NCT03307746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25084374|NCT03307720|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25084375|NCT03307720|Hormones|hormones|mesh-list
25084376|NCT03307720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25084377|NCT03307720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084378|NCT03307720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25084385|NCT03307590|Bupivacaine|bupivacaine|mesh-list
25084386|NCT03307590|Anesthetics, Local|anesthetics, local|mesh-ancestor
25084387|NCT03307590|Anesthetics|anesthetics|mesh-ancestor
25084388|NCT03307590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25084389|NCT03307590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084390|NCT03307590|Sensory System Agents|sensory system agents|mesh-ancestor
25084391|NCT03307590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084392|NCT03307590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25084393|NCT03307590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25084394|NCT03307590|Analgesics|analgesics|mesh-ancestor
25084395|NCT03307590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25084396|NCT03307590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25084397|NCT03307590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25084398|NCT03307590|Adrenergic Agents|adrenergic agents|mesh-ancestor
25084399|NCT03307590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25084400|NCT03307590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084401|NCT03307551|Propofol|propofol|mesh-list
25084402|NCT03307551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25084403|NCT03307551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25084404|NCT03307551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084405|NCT03307551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24403774|NCT00161486|Testosterone|testosterone|mesh-list
25084406|NCT03307551|Anesthetics, General|anesthetics, general|mesh-ancestor
25084407|NCT03307551|Anesthetics|anesthetics|mesh-ancestor
25084408|NCT03307512|Insulin|insulin|mesh-list
25084409|NCT03307512|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25084410|NCT03307512|Insulin Lispro|insulin lispro|mesh-list
25084411|NCT03307512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25084412|NCT03307512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084413|NCT03307213|Sirolimus|sirolimus|mesh-list
25084414|NCT03307213|Umirolimus|umirolimus|mesh-list
25084415|NCT03307213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25084420|NCT03307213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25084421|NCT03307213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25084422|NCT03307213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25084432|NCT03307148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084433|NCT03307148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25084435|NCT03307148|Antiviral Agents|antiviral agents|mesh-ancestor
25084436|NCT03307148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25084437|NCT03307148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25084820|NCT03302871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25084522|NCT03306472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25084523|NCT03306472|Appetite Stimulants|appetite stimulants|mesh-ancestor
25415968|NCT02980510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415969|NCT02980510|Antidotes|antidotes|mesh-ancestor
24628950|NCT01102244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24628965|NCT01102439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24628966|NCT01102439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24628968|NCT01102439|Sensory System Agents|sensory system agents|mesh-ancestor
24628969|NCT01102439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24628970|NCT01102439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628971|NCT01102439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24628972|NCT01102439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25084544|NCT03306212|Botulinum Toxins|botulinum toxins|mesh-list
25084545|NCT03306212|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25084546|NCT03306212|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25084547|NCT03306212|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25084548|NCT03306212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25084549|NCT03306212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084550|NCT03306212|Cholinergic Agents|cholinergic agents|mesh-ancestor
25084551|NCT03306212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25084556|NCT03305978|Selamectin|selamectin|mesh-list
25084605|NCT03305068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25084606|NCT03305068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25084607|NCT03305068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084608|NCT03304652|Zaleplon|zaleplon|mesh-list
25084609|NCT03304652|Anticonvulsants|anticonvulsants|mesh-ancestor
25084610|NCT03304652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25084611|NCT03304652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25084612|NCT03304652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084613|NCT03304652|GABA Modulators|gaba modulators|mesh-ancestor
25084614|NCT03304652|GABA Agents|gaba agents|mesh-ancestor
25084615|NCT03304652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25084616|NCT03304652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084617|NCT03304496|Nitroglycerin|nitroglycerin|mesh-list
25084618|NCT03304496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25084619|NCT03304496|Vasodilator Agents|vasodilator agents|mesh-ancestor
25084620|NCT03304457|Olanzapine|olanzapine|mesh-list
25084679|NCT03304093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25084680|NCT03304093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25084681|NCT03304093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25084682|NCT03304093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084683|NCT03304080|Trastuzumab|trastuzumab|mesh-list
25084684|NCT03304080|Pertuzumab|pertuzumab|mesh-list
25084685|NCT03304080|Palbociclib|palbociclib|mesh-list
25084686|NCT03304080|Anastrozole|anastrozole|mesh-list
25084687|NCT03304080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25084688|NCT03304080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25084689|NCT03304080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25084690|NCT03304080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25084691|NCT03304080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084692|NCT03304080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25084693|NCT03304080|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25084694|NCT03304080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25084696|NCT03304080|Hormone Antagonists|hormone antagonists|mesh-ancestor
25084746|NCT03303651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25084747|NCT03303651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084749|NCT03303651|Sensory System Agents|sensory system agents|mesh-ancestor
25084750|NCT03303651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084756|NCT03303495|Irinotecan|irinotecan|mesh-list
25084757|NCT03303495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25084758|NCT03303495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25084759|NCT03303495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25084760|NCT03303495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25084761|NCT03303495|Growth Substances|growth substances|mesh-ancestor
25084762|NCT03303495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084763|NCT03303495|Growth Inhibitors|growth inhibitors|mesh-ancestor
25084764|NCT03303495|Antimetabolites|antimetabolites|mesh-ancestor
25084765|NCT03303495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084766|NCT03303495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25084772|NCT03303495|Antidotes|antidotes|mesh-ancestor
25084802|NCT03303053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25084804|NCT03303053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25084805|NCT03303053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25084806|NCT03303053|Antimetabolites|antimetabolites|mesh-ancestor
25084807|NCT03303053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084808|NCT03303053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25084809|NCT03303053|Antithyroid Agents|antithyroid agents|mesh-ancestor
25084810|NCT03303053|Hormone Antagonists|hormone antagonists|mesh-ancestor
25084811|NCT03302871|Botulinum Toxins|botulinum toxins|mesh-list
24628997|NCT01102478|Losartan|losartan|mesh-list
24628998|NCT01102478|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24629049|NCT01102946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24629050|NCT01102946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24629052|NCT01102946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629053|NCT01102946|Growth Inhibitors|growth inhibitors|mesh-ancestor
24629054|NCT01102946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629055|NCT01103024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24629056|NCT01103024|Immunologic Factors|immunologic factors|mesh-ancestor
24629057|NCT01103024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629058|NCT01103050|Cetirizine|cetirizine|mesh-list
24629059|NCT01103050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24629060|NCT01103050|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24629061|NCT01103050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24629062|NCT01103050|Histamine Antagonists|histamine antagonists|mesh-ancestor
25084818|NCT03302871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25084819|NCT03302871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759956|NCT01755559|Amodiaquine|amodiaquine|mesh-list
25084826|NCT03302845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25084827|NCT03302845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25084828|NCT03302845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084829|NCT03302845|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25084830|NCT03302845|Histamine Antagonists|histamine antagonists|mesh-ancestor
25084831|NCT03302845|Histamine Agents|histamine agents|mesh-ancestor
25084832|NCT03302845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25084833|NCT03302845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084834|NCT03302754|Alemtuzumab|alemtuzumab|mesh-list
25084836|NCT03302754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407233|NCT00173862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24629093|NCT01103154|Vasodilator Agents|vasodilator agents|mesh-ancestor
24629094|NCT01103154|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24629095|NCT01103154|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24629096|NCT01103154|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24629137|NCT01103388|Immunologic Factors|immunologic factors|mesh-ancestor
24629159|NCT01103401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24629160|NCT01103401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629161|NCT01103401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25084938|NCT03302351|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25084939|NCT03302351|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25084941|NCT03302299|Vitamin B 6|vitamin b 6|mesh-list
25084942|NCT03302299|Isoniazid|isoniazid|mesh-list
25084943|NCT03302299|Vitamins|vitamins|mesh-ancestor
25084944|NCT03302299|Micronutrients|micronutrients|mesh-ancestor
25084945|NCT03302299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084946|NCT03302299|Vitamin B Complex|vitamin b complex|mesh-ancestor
25084947|NCT03302299|Antitubercular Agents|antitubercular agents|mesh-ancestor
25084948|NCT03302299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25084949|NCT03302299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25084950|NCT03302299|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25084951|NCT03302299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25084952|NCT03302299|Antimetabolites|antimetabolites|mesh-ancestor
25084953|NCT03302299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25084954|NCT03302299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25084955|NCT03302221|Ropivacaine|ropivacaine|mesh-list
25084956|NCT03302221|Anesthetics|anesthetics|mesh-ancestor
25084957|NCT03302221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25084958|NCT03302221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084959|NCT03302221|Anesthetics, Local|anesthetics, local|mesh-ancestor
25084962|NCT03302208|Pregabalin|pregabalin|mesh-list
25084963|NCT03302208|Analgesics|analgesics|mesh-ancestor
25084964|NCT03302208|Sensory System Agents|sensory system agents|mesh-ancestor
25084965|NCT03302208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25084966|NCT03302208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25084967|NCT03302208|Anticonvulsants|anticonvulsants|mesh-ancestor
25084987|NCT03302182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25084988|NCT03302182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25084989|NCT03302182|Antiviral Agents|antiviral agents|mesh-ancestor
25084990|NCT03302182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25084991|NCT03302182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25084992|NCT03302182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25084993|NCT03302065|Tiotropium Bromide|tiotropium bromide|mesh-list
25084994|NCT03302065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25084995|NCT03302065|Autonomic Agents|autonomic agents|mesh-ancestor
25085000|NCT03302065|Parasympatholytics|parasympatholytics|mesh-ancestor
25085001|NCT03302065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25085002|NCT03302065|Cholinergic Agents|cholinergic agents|mesh-ancestor
25085003|NCT03302065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25085004|NCT03302065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085005|NCT03302039|Phenylephrine|phenylephrine|mesh-list
25085006|NCT03302039|Oxymetazoline|oxymetazoline|mesh-list
25085007|NCT03302039|Bupivacaine|bupivacaine|mesh-list
25085012|NCT03302039|Sensory System Agents|sensory system agents|mesh-ancestor
24511650|NCT00569985|Alkylating Agents|alkylating agents|mesh-ancestor
24629168|NCT01103401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24629176|NCT01103518|Hormones|hormones|mesh-ancestor
24629248|NCT01103830|Artemisinins|artemisinins|mesh-list
24629249|NCT01103830|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24629250|NCT01103830|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24629251|NCT01103830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24629252|NCT01103830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24629253|NCT01103830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24629254|NCT01103830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24629255|NCT01103830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24629256|NCT01103830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629268|NCT01103843|Clopidogrel|clopidogrel|mesh-list
25085013|NCT03302039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25085014|NCT03302039|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25085015|NCT03302039|Mydriatics|mydriatics|mesh-ancestor
25085016|NCT03302039|Autonomic Agents|autonomic agents|mesh-ancestor
24629270|NCT01103843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24629271|NCT01103843|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24629272|NCT01103843|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24629273|NCT01103843|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24629274|NCT01103843|Purinergic Agents|purinergic agents|mesh-ancestor
24629275|NCT01103843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24629276|NCT01103843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629277|NCT01103843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085050|NCT03301454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25085051|NCT03301454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25085052|NCT03301454|Tubulin Modulators|tubulin modulators|mesh-ancestor
25085053|NCT03301454|Antimitotic Agents|antimitotic agents|mesh-ancestor
25085054|NCT03301454|Mitosis Modulators|mitosis modulators|mesh-ancestor
25085055|NCT03301454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085056|NCT03301350|Paclitaxel|paclitaxel|mesh-list
25085057|NCT03301350|Cyclophosphamide|cyclophosphamide|mesh-list
25085058|NCT03301350|Carboplatin|carboplatin|mesh-list
25085059|NCT03301350|Doxorubicin|doxorubicin|mesh-list
24629311|NCT01104467|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
24629312|NCT01104467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24629313|NCT01104467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24629314|NCT01104467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629315|NCT01104519|Niacin|niacin|mesh-list
24629316|NCT01104519|Nicotinic Acids|nicotinic acids|mesh-list
24629317|NCT01104519|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24629318|NCT01104519|Antimetabolites|antimetabolites|mesh-ancestor
24629319|NCT01104519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629320|NCT01104519|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25085091|NCT03301233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25085092|NCT03301233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25085093|NCT03301233|Vasodilator Agents|vasodilator agents|mesh-ancestor
25085094|NCT03301233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25085160|NCT03301181|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25085161|NCT03301181|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25085162|NCT03301181|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25085163|NCT03301181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25085164|NCT03301181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25085165|NCT03301025|Pregabalin|pregabalin|mesh-list
25085166|NCT03301025|Analgesics|analgesics|mesh-ancestor
25085167|NCT03301025|Sensory System Agents|sensory system agents|mesh-ancestor
25085168|NCT03301025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24629396|NCT01105013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24629398|NCT01105013|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25085254|NCT03299842|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25085255|NCT03299842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25085256|NCT03299842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085257|NCT03299842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24668764|NCT04621058|Vitamin D|vitamin d|mesh-list
24668765|NCT04621058|Vitamins|vitamins|mesh-list
24668766|NCT04621058|Micronutrients|micronutrients|mesh-ancestor
24668767|NCT04621058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24668768|NCT04621058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25085315|NCT03299296|Antithrombins|antithrombins|mesh-ancestor
25085316|NCT03299296|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25085409|NCT03298581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085410|NCT03298542|Golimumab|golimumab|mesh-list
25085411|NCT03298542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25085412|NCT03298542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25085413|NCT03298542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25085414|NCT03298542|Immunologic Factors|immunologic factors|mesh-ancestor
25085486|NCT03298009|Canagliflozin|canagliflozin|mesh-list
25085487|NCT03298009|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25085488|NCT03298009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085489|NCT03298009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25085490|NCT03298009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085491|NCT03297931|Iproplatin|iproplatin|mesh-list
25085492|NCT03297931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25085493|NCT03297879|Metformin|metformin|mesh-list
25085494|NCT03297879|Exenatide|exenatide|mesh-list
25085495|NCT03297879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25085496|NCT03297879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085497|NCT03297879|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25085498|NCT03297879|Incretins|incretins|mesh-ancestor
25085499|NCT03297879|Hormones|hormones|mesh-ancestor
25085545|NCT03296982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25085546|NCT03296982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25085547|NCT03296982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085548|NCT03296982|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25085549|NCT03296982|Antithrombins|antithrombins|mesh-ancestor
25085550|NCT03296982|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25085551|NCT03296982|Protease Inhibitors|protease inhibitors|mesh-ancestor
25085552|NCT03296982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24760840|NCT01760174|Bupivacaine|bupivacaine|mesh-list
25085554|NCT03296930|Ribavirin|ribavirin|mesh-list
25085555|NCT03296930|Sofosbuvir|sofosbuvir|mesh-list
24629483|NCT01105481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629484|NCT01105481|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24629485|NCT01105481|Antidepressive Agents|antidepressive agents|mesh-ancestor
24629486|NCT01105494|Epoetin Alfa|epoetin alfa|mesh-list
24629487|NCT01105494|Hematinics|hematinics|mesh-ancestor
24629488|NCT01105598|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
24629489|NCT01105598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25085564|NCT03296930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25085565|NCT03296930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25085566|NCT03296930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25085567|NCT03296930|Antimetabolites|antimetabolites|mesh-ancestor
25085568|NCT03296670|Nitroglycerin|nitroglycerin|mesh-list
25085569|NCT03296670|Alprostadil|alprostadil|mesh-list
25085570|NCT03296670|Vasodilator Agents|vasodilator agents|mesh-ancestor
25085572|NCT03296670|Urological Agents|urological agents|mesh-ancestor
25085641|NCT03296358|Hormones|hormones|mesh-ancestor
25085772|NCT03295214|Acetaminophen|acetaminophen|mesh-list
25085650|NCT03296189|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25085651|NCT03296189|BB 1101|bb 1101|mesh-list
25085652|NCT03296189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25085653|NCT03296189|Antiemetics|antiemetics|mesh-ancestor
25085654|NCT03296189|Autonomic Agents|autonomic agents|mesh-ancestor
25085655|NCT03296189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25085656|NCT03296189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085657|NCT03296189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25085658|NCT03296189|Glucocorticoids|glucocorticoids|mesh-ancestor
25085659|NCT03296189|Hormones|hormones|mesh-ancestor
24629632|NCT01106872|Growth Inhibitors|growth inhibitors|mesh-ancestor
24629633|NCT01106872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24629634|NCT01106872|Antimetabolites|antimetabolites|mesh-ancestor
25085660|NCT03296189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25085661|NCT03296189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25085662|NCT03296189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25085663|NCT03296189|Anesthetics, Local|anesthetics, local|mesh-ancestor
25085664|NCT03296189|Anesthetics|anesthetics|mesh-ancestor
25085665|NCT03296189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25085666|NCT03296189|Sensory System Agents|sensory system agents|mesh-ancestor
25085667|NCT03296189|Protease Inhibitors|protease inhibitors|mesh-ancestor
25085668|NCT03296189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085669|NCT03296189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629736|NCT01107522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629739|NCT01107574|Analgesics|analgesics|mesh-ancestor
24629740|NCT01107574|Sensory System Agents|sensory system agents|mesh-ancestor
24629741|NCT01107574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24629742|NCT01107574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629743|NCT01107574|Anticonvulsants|anticonvulsants|mesh-ancestor
24629744|NCT01107574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24629745|NCT01107574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24629746|NCT01107574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24629747|NCT01107574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24629748|NCT01107574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24629749|NCT01107574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24629750|NCT01107574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24629752|NCT01107574|Antimanic Agents|antimanic agents|mesh-ancestor
24629761|NCT01107756|Lenograstim|lenograstim|mesh-list
24629762|NCT01107756|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24629763|NCT01107756|Immunologic Factors|immunologic factors|mesh-ancestor
24629764|NCT01107756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410389|NCT00185185|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24629765|NCT01107782|Sildenafil Citrate|sildenafil citrate|mesh-list
24629766|NCT01107782|Vasodilator Agents|vasodilator agents|mesh-ancestor
24629767|NCT01107782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24629769|NCT01107782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24629771|NCT01107782|Urological Agents|urological agents|mesh-ancestor
25085708|NCT03295968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25085709|NCT03295968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085711|NCT03295955|Clavulanic Acid|clavulanic acid|mesh-list
25085712|NCT03295955|Clavulanic Acids|clavulanic acids|mesh-list
25085713|NCT03295955|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25085714|NCT03295955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25085715|NCT03295955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25085719|NCT03295903|Cannabidiol|cannabidiol|mesh-list
24629898|NCT01108588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629899|NCT01108588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25085770|NCT03295227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25085771|NCT03295227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25085776|NCT03295214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25085777|NCT03295214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085778|NCT03295214|Antipyretics|antipyretics|mesh-ancestor
25085779|NCT03295162|Melatonin|melatonin|mesh-list
25085780|NCT03295162|Antioxidants|antioxidants|mesh-ancestor
25085781|NCT03295162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085782|NCT03295162|Protective Agents|protective agents|mesh-ancestor
25085783|NCT03295162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085784|NCT03295162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25085786|NCT03295084|Capecitabine|capecitabine|mesh-list
25085811|NCT03294798|Interferon-alpha|interferon-alpha|mesh-list
25085812|NCT03294798|Interferon alpha-2|interferon alpha-2|mesh-list
25085813|NCT03294798|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25085814|NCT03294798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25085815|NCT03294798|Antiviral Agents|antiviral agents|mesh-ancestor
25085816|NCT03294798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25085817|NCT03294798|Immunologic Factors|immunologic factors|mesh-ancestor
25085818|NCT03294798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085940|NCT03294070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25085941|NCT03294070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25085942|NCT03294070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085943|NCT03294070|Vasodilator Agents|vasodilator agents|mesh-ancestor
25085944|NCT03293992|Latanoprost|latanoprost|mesh-list
25085945|NCT03293992|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25085946|NCT03293992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25085947|NCT03293927|Fentanyl|fentanyl|mesh-list
25085948|NCT03293927|Dexmedetomidine|dexmedetomidine|mesh-list
25085949|NCT03293927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25085950|NCT03293927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25085951|NCT03293927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085984|NCT03293641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25085985|NCT03293641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25085986|NCT03293641|Astringents|astringents|mesh-ancestor
25085987|NCT03293641|Dermatologic Agents|dermatologic agents|mesh-ancestor
25085988|NCT03293641|Antimalarials|antimalarials|mesh-ancestor
25085989|NCT03293641|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25085990|NCT03293641|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25085991|NCT03293641|Antimetabolites|antimetabolites|mesh-ancestor
24761220|NCT01761669|Vitamin D|vitamin d|mesh-list
25085993|NCT03293511|Oxytocics|oxytocics|mesh-ancestor
25085994|NCT03293511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25085995|NCT03293511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25085996|NCT03293472|Bupivacaine|bupivacaine|mesh-list
25085997|NCT03293472|Ropivacaine|ropivacaine|mesh-list
25085998|NCT03293472|Anesthetics, Local|anesthetics, local|mesh-ancestor
25085999|NCT03293472|Anesthetics|anesthetics|mesh-ancestor
25086000|NCT03293472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25086055|NCT03292965|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25086056|NCT03292965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25086057|NCT03292965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086059|NCT03292965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25708251|NCT02247193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086060|NCT03292965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086061|NCT03292965|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25086062|NCT03292965|Autonomic Agents|autonomic agents|mesh-ancestor
25086063|NCT03292965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25086064|NCT03292848|Brexpiprazole|brexpiprazole|mesh-list
25086065|NCT03292848|Serotonin Agents|serotonin agents|mesh-ancestor
25086066|NCT03292848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24761307|NCT01762163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24761308|NCT01762163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24629927|NCT01108627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24629928|NCT01108627|Adrenergic Agents|adrenergic agents|mesh-ancestor
24629929|NCT01108627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24629930|NCT01108627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24761379|NCT01762436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25086138|NCT03291821|Hormones|hormones|mesh-ancestor
25086139|NCT03291821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25086140|NCT03291821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086141|NCT03291821|Luteolytic Agents|luteolytic agents|mesh-ancestor
25086142|NCT03291821|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25086143|NCT03291821|Contraceptive Agents|contraceptive agents|mesh-ancestor
25086144|NCT03291821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25086145|NCT03291821|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25086168|NCT03291353|Pembrolizumab|pembrolizumab|mesh-list
25086169|NCT03291353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25086170|NCT03291353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25086171|NCT03291314|Avelumab|avelumab|mesh-list
25086172|NCT03291314|Axitinib|axitinib|mesh-list
25086173|NCT03291314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25086174|NCT03291314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25086175|NCT03291314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25086176|NCT03291314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25086177|NCT03291314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086178|NCT03291249|Omeprazole|omeprazole|mesh-list
25086179|NCT03291249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25086180|NCT03291249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25086181|NCT03291249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24629976|NCT01108926|Antiviral Agents|antiviral agents|mesh-ancestor
24629977|NCT01108926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24629978|NCT01108926|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24629980|NCT01108926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25086208|NCT03290963|Sensory System Agents|sensory system agents|mesh-ancestor
25086209|NCT03290963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25086210|NCT03290963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086211|NCT03290963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25086223|NCT03290859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086224|NCT03290859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25086225|NCT03290859|Anesthetics, General|anesthetics, general|mesh-ancestor
25086227|NCT03290846|Secretin|secretin|mesh-list
25086228|NCT03290846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25086229|NCT03290846|Hormones|hormones|mesh-ancestor
25086230|NCT03290846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25086231|NCT03290846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086249|NCT03290703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25086250|NCT03290703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25086251|NCT03290703|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25086252|NCT03290703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25086253|NCT03290703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086254|NCT03290625|Dexmedetomidine|dexmedetomidine|mesh-list
25086255|NCT03290625|Ketamine|ketamine|mesh-list
25086256|NCT03290625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25086324|NCT03290417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25086325|NCT03290417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25086326|NCT03290417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708252|NCT02247193|Cholinergic Agents|cholinergic agents|mesh-ancestor
25708253|NCT02247193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25708254|NCT02247193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708255|NCT02247193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25708256|NCT02247193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25708257|NCT02247440|Interferons|interferons|mesh-list
25708258|NCT02247440|Ribavirin|ribavirin|mesh-list
25708259|NCT02247440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708260|NCT02247440|Antiviral Agents|antiviral agents|mesh-ancestor
25086328|NCT03290417|Protective Agents|protective agents|mesh-ancestor
25086329|NCT03290365|Hyaluronic Acid|hyaluronic acid|mesh-list
25086330|NCT03290365|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25086331|NCT03290365|Immunologic Factors|immunologic factors|mesh-ancestor
25086332|NCT03290365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086333|NCT03290365|Viscosupplements|viscosupplements|mesh-ancestor
25086334|NCT03290365|Protective Agents|protective agents|mesh-ancestor
25086413|NCT03289520|Purinergic Agents|purinergic agents|mesh-ancestor
24761665|NCT01763658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630098|NCT01109498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630099|NCT01109498|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24630100|NCT01109498|Antitubercular Agents|antitubercular agents|mesh-ancestor
24630143|NCT01109693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24630145|NCT01109693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630146|NCT01109693|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24630147|NCT01109693|Histamine Antagonists|histamine antagonists|mesh-ancestor
25086496|NCT03289026|Dopamine Agonists|dopamine agonists|mesh-ancestor
25086497|NCT03289026|Dopamine Agents|dopamine agents|mesh-ancestor
25086498|NCT03289026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25086499|NCT03289026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086500|NCT03289026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25086501|NCT03289026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25086502|NCT03289026|Serotonin Agents|serotonin agents|mesh-ancestor
25086503|NCT03289026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25086507|NCT03288896|Ethanol|ethanol|mesh-list
24630182|NCT01109823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24630183|NCT01109823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630184|NCT01109823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630185|NCT01109823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24630186|NCT01109823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24630187|NCT01109888|Cetrorelix|cetrorelix|mesh-list
24630196|NCT01109927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086546|NCT03288610|Coagulants|coagulants|mesh-ancestor
25086547|NCT03288610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25086548|NCT03288610|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25086551|NCT03288597|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25086552|NCT03288597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25086553|NCT03288597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086554|NCT03288532|Durvalumab|durvalumab|mesh-list
25086555|NCT03288532|Tremelimumab|tremelimumab|mesh-list
25086556|NCT03288532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25086558|NCT03288428|Morphine|morphine|mesh-list
25086593|NCT03288077|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25086594|NCT03288077|Antidepressive Agents|antidepressive agents|mesh-ancestor
25086595|NCT03288077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25086596|NCT03288051|Dobutamine|dobutamine|mesh-list
25086597|NCT03288051|Norepinephrine|norepinephrine|mesh-list
25086667|NCT03287375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25086668|NCT03287375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086669|NCT03287336|Tranexamic Acid|tranexamic acid|mesh-list
25086670|NCT03287336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25086671|NCT03287336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24630285|NCT01110616|GABA Agents|gaba agents|mesh-ancestor
24630286|NCT01110616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24630334|NCT01110941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630335|NCT01110941|Vitamin B Complex|vitamin b complex|mesh-ancestor
24630336|NCT01110941|Vitamins|vitamins|mesh-ancestor
24630337|NCT01110941|Micronutrients|micronutrients|mesh-ancestor
24630338|NCT01111019|Hormones|hormones|mesh-list
24630339|NCT01111019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24452962|NCT05378113|Ondansetron|ondansetron|mesh-list
24452963|NCT05378113|Anesthetics, Local|anesthetics, local|mesh-ancestor
24630357|NCT01111227|Anesthetics, General|anesthetics, general|mesh-ancestor
24630358|NCT01111227|Anesthetics|anesthetics|mesh-ancestor
24630359|NCT01111227|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24630360|NCT01111253|Amoxicillin|amoxicillin|mesh-list
24630361|NCT01111253|Clavulanic Acid|clavulanic acid|mesh-list
24630362|NCT01111253|Clavulanic Acids|clavulanic acids|mesh-list
24630363|NCT01111253|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24630364|NCT01111253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24630365|NCT01111253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24630366|NCT01111253|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25086801|NCT03285906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086802|NCT03285802|Everolimus|everolimus|mesh-list
25086803|NCT03285802|Letrozole|letrozole|mesh-list
25086804|NCT03285802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630599|NCT01112644|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24630601|NCT01112722|Histamine Agonists|histamine agonists|mesh-ancestor
24630602|NCT01112722|Histamine Agents|histamine agents|mesh-ancestor
24630603|NCT01112722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24630722|NCT01113164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24630723|NCT01113164|Antidepressive Agents|antidepressive agents|mesh-ancestor
24630724|NCT01113164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24630725|NCT01113164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24630726|NCT01113164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24630728|NCT01113229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24630729|NCT01113229|Abortifacient Agents|abortifacient agents|mesh-ancestor
25086842|NCT03285503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25086843|NCT03285503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25086844|NCT03285503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25086845|NCT03285503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25086846|NCT03285503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25086847|NCT03285503|Dopamine Agonists|dopamine agonists|mesh-ancestor
25086915|NCT03284645|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25086916|NCT03284593|Azacitidine|azacitidine|mesh-list
25086917|NCT03284593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25086918|NCT03284593|Antimetabolites|antimetabolites|mesh-ancestor
25086919|NCT03284593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25086920|NCT03284593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25086921|NCT03284593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24762333|NCT01767610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24630887|NCT01114490|Antimetabolites|antimetabolites|mesh-ancestor
24630889|NCT01114490|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24630912|NCT01114958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630913|NCT01115036|Panobinostat|panobinostat|mesh-list
24630914|NCT01115036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630915|NCT01115036|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24630916|NCT01115036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24630918|NCT01115049|Chlorhexidine|chlorhexidine|mesh-list
24631037|NCT01115894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631039|NCT01115894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24631040|NCT01115946|Enalapril|enalapril|mesh-list
24631041|NCT01115946|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24631042|NCT01115946|Protease Inhibitors|protease inhibitors|mesh-ancestor
24631043|NCT01115946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415970|NCT02980510|Protective Agents|protective agents|mesh-ancestor
24631090|NCT01116128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24631091|NCT01116128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631093|NCT01116128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25087108|NCT03282643|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25087110|NCT03282643|Dalteparin|dalteparin|mesh-list
25087111|NCT03282643|Rivaroxaban|rivaroxaban|mesh-list
25087112|NCT03282643|Anticoagulants|anticoagulants|mesh-ancestor
25087113|NCT03282643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25087114|NCT03282643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25087115|NCT03282643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087143|NCT03282110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25087144|NCT03282110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25087145|NCT03282110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087146|NCT03282110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25087147|NCT03282110|Serotonin Agents|serotonin agents|mesh-ancestor
25708261|NCT02247440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25708262|NCT02247440|Antimetabolites|antimetabolites|mesh-ancestor
25087148|NCT03282110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087149|NCT03282110|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25087204|NCT03281187|Anabolic Agents|anabolic agents|mesh-ancestor
25087206|NCT03280927|Antifungal Agents|antifungal agents|mesh-ancestor
25087207|NCT03280927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25087208|NCT03280849|Chitosan|chitosan|mesh-list
25087209|NCT03280849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25087210|NCT03280849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25087211|NCT03280849|Antimetabolites|antimetabolites|mesh-ancestor
25087212|NCT03280849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087213|NCT03280849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25087214|NCT03280849|Chelating Agents|chelating agents|mesh-ancestor
24631348|NCT01117116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24631349|NCT01117116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24631350|NCT01117116|Adrenergic Agents|adrenergic agents|mesh-ancestor
24631351|NCT01117116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24631352|NCT01117116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631419|NCT01117636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24631420|NCT01117636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24631421|NCT01117636|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24631465|NCT01118286|Tocolytic Agents|tocolytic agents|mesh-ancestor
24631466|NCT01118286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24631468|NCT01118403|Sulbactam|sulbactam|mesh-list
24631469|NCT01118403|Sultamicillin|sultamicillin|mesh-list
24631470|NCT01118403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24631471|NCT01118403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24631472|NCT01118403|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24665369|NCT01311960|Bevacizumab|bevacizumab|mesh-list
24631473|NCT01118403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25087267|NCT03280277|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25087268|NCT03280277|Hematinics|hematinics|mesh-ancestor
25087269|NCT03280277|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25087270|NCT03280277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24631490|NCT01118559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24631491|NCT01118559|Antithrombins|antithrombins|mesh-ancestor
24631497|NCT01118572|Celecoxib|celecoxib|mesh-list
24631510|NCT01118572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631511|NCT01118598|Nicotinic Acids|nicotinic acids|mesh-list
25088099|NCT03273595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24631584|NCT01118923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631586|NCT01118936|Magnesium Hydroxide|magnesium hydroxide|mesh-list
24631587|NCT01118936|Antacids|antacids|mesh-ancestor
25087371|NCT03279809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25087372|NCT03279809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25087373|NCT03279809|Antipyretics|antipyretics|mesh-ancestor
25087374|NCT03279796|Betamethasone|betamethasone|mesh-list
25087375|NCT03279796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25087376|NCT03279796|Glucocorticoids|glucocorticoids|mesh-ancestor
25087377|NCT03279796|Hormones|hormones|mesh-ancestor
25087378|NCT03279796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25087545|NCT03278808|Sensory System Agents|sensory system agents|mesh-ancestor
25087546|NCT03278808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25087547|NCT03278808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087548|NCT03278808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25087549|NCT03278808|Filaricides|filaricides|mesh-ancestor
25087550|NCT03278808|Antinematodal Agents|antinematodal agents|mesh-ancestor
25087551|NCT03278808|Anthelmintics|anthelmintics|mesh-ancestor
25087552|NCT03278808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25087553|NCT03278808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087554|NCT03278808|Antimetabolites|antimetabolites|mesh-ancestor
25087674|NCT03277573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25087675|NCT03277573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25087676|NCT03277573|Analgesics|analgesics|mesh-ancestor
25087677|NCT03277573|Sensory System Agents|sensory system agents|mesh-ancestor
25087682|NCT03277482|Durvalumab|durvalumab|mesh-list
25087691|NCT03277430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25087692|NCT03277430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25087693|NCT03277391|Droperidol|droperidol|mesh-list
25087694|NCT03277391|Morphine|morphine|mesh-list
25087695|NCT03277391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25087714|NCT03277339|Paroxetine|paroxetine|mesh-list
25087813|NCT03276598|Vasodilator Agents|vasodilator agents|mesh-ancestor
25087814|NCT03276598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25087815|NCT03276598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25087816|NCT03276598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25087817|NCT03276598|Diuretics|diuretics|mesh-ancestor
25087818|NCT03276598|Natriuretic Agents|natriuretic agents|mesh-ancestor
25087819|NCT03276598|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25087820|NCT03276598|Sympatholytics|sympatholytics|mesh-ancestor
25087821|NCT03276598|Autonomic Agents|autonomic agents|mesh-ancestor
25087822|NCT03276598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25087831|NCT03276520|Ethanol|ethanol|mesh-list
24631659|NCT01119430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24631660|NCT01119430|Antidepressive Agents|antidepressive agents|mesh-ancestor
24631661|NCT01119430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24631662|NCT01119430|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24631663|NCT01119430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25087980|NCT03274895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25087981|NCT03274895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25087983|NCT03274895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25087984|NCT03274895|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25087985|NCT03274895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25087986|NCT03274895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25087987|NCT03274817|Citalopram|citalopram|mesh-list
24631671|NCT01119521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24631672|NCT01119521|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25088016|NCT03274596|Micronutrients|micronutrients|mesh-ancestor
25088017|NCT03274596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088018|NCT03274596|Antioxidants|antioxidants|mesh-ancestor
25088020|NCT03274596|Protective Agents|protective agents|mesh-ancestor
25088100|NCT03273595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25088101|NCT03273595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25088102|NCT03273595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25088104|NCT03273595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25088105|NCT03273556|Lidocaine|lidocaine|mesh-list
25088106|NCT03273556|Anesthetics, Local|anesthetics, local|mesh-ancestor
25088107|NCT03273556|Anesthetics|anesthetics|mesh-ancestor
25088147|NCT03273088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25088148|NCT03273088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24631759|NCT01120106|Vasodilator Agents|vasodilator agents|mesh-ancestor
24631760|NCT01120106|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24631761|NCT01120106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24631762|NCT01120106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631763|NCT01120106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631843|NCT01120366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25088175|NCT03272867|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25088176|NCT03272867|Diuretics|diuretics|mesh-ancestor
25088177|NCT03272867|Natriuretic Agents|natriuretic agents|mesh-ancestor
25088178|NCT03272867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088179|NCT03272802|Riluzole|riluzole|mesh-list
25088180|NCT03272802|Edaravone|edaravone|mesh-list
25088181|NCT03272802|Anticonvulsants|anticonvulsants|mesh-ancestor
25088182|NCT03272802|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25088183|NCT03272802|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25088190|NCT03272802|Antioxidants|antioxidants|mesh-ancestor
25088210|NCT05075460|Antimetabolites|antimetabolites|mesh-ancestor
25088211|NCT05075460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088212|NCT05075460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25088213|NCT05075460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25088214|NCT05075512|Fulvestrant|fulvestrant|mesh-list
25088215|NCT05075512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25088216|NCT05075512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25088217|NCT05075512|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25088218|NCT05075512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25088219|NCT05075512|Hormone Antagonists|hormone antagonists|mesh-ancestor
25088269|NCT05074589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088270|NCT05074589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25088271|NCT05074589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25088272|NCT05074589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25088273|NCT05074589|Immunologic Factors|immunologic factors|mesh-ancestor
25088274|NCT05074589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088275|NCT05074589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25088276|NCT05074589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25088277|NCT05074589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25088278|NCT05074589|Antidotes|antidotes|mesh-ancestor
25088279|NCT05074589|Protective Agents|protective agents|mesh-ancestor
25088280|NCT05074589|Vitamin B Complex|vitamin b complex|mesh-ancestor
25088281|NCT05074589|Vitamins|vitamins|mesh-ancestor
25088282|NCT05074589|Micronutrients|micronutrients|mesh-ancestor
25088283|NCT05074147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25088284|NCT05074147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25088317|NCT04962022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25088318|NCT04962022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088319|NCT04962022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25088320|NCT04962022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25088449|NCT04427904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25088480|NCT04149899|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25088481|NCT04149899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25088482|NCT04149899|Adrenergic Agents|adrenergic agents|mesh-ancestor
25088483|NCT04149899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25088484|NCT04149899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088485|NCT04149899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088486|NCT04149899|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25088501|NCT03920527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25088718|NCT03272477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25088719|NCT03272477|Tubulin Modulators|tubulin modulators|mesh-ancestor
25088720|NCT03272477|Antimitotic Agents|antimitotic agents|mesh-ancestor
25088721|NCT03272477|Mitosis Modulators|mitosis modulators|mesh-ancestor
25088722|NCT03272477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088723|NCT03272477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25088724|NCT03272477|Immunologic Factors|immunologic factors|mesh-ancestor
25088725|NCT03272477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088726|NCT03272477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25088727|NCT03272477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25088728|NCT03272477|Alkylating Agents|alkylating agents|mesh-ancestor
25088729|NCT03272477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25088730|NCT03272477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25088752|NCT03272503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25088814|NCT03271983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25088815|NCT03271983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25088817|NCT03271905|Albuterol|albuterol|mesh-list
25088818|NCT03271905|Ipratropium|ipratropium|mesh-list
25088819|NCT03271905|Anticonvulsants|anticonvulsants|mesh-ancestor
25088820|NCT03271905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24455872|NCT00329316|Progesterone|progesterone|mesh-list
24631998|NCT01121497|Cholinergic Agents|cholinergic agents|mesh-ancestor
24631999|NCT01121497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24632000|NCT01121497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632001|NCT01121497|Miotics|miotics|mesh-ancestor
24632002|NCT01121497|Autonomic Agents|autonomic agents|mesh-ancestor
24632003|NCT01121497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25088850|NCT03271450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088851|NCT03271502|Anesthetics|anesthetics|mesh-list
25088852|NCT03271502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24632027|NCT01121744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24632028|NCT01121744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24828815|NCT02147873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632029|NCT01121744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24632034|NCT01121744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451770|NCT00324766|Vasodilator Agents|vasodilator agents|mesh-ancestor
24451771|NCT00324766|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25088854|NCT03271164|Vitamin E|vitamin e|mesh-list
25088880|NCT03270969|Antiviral Agents|antiviral agents|mesh-ancestor
25088881|NCT03270969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25088882|NCT03270969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25088883|NCT03270969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25088884|NCT03270969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25088885|NCT03270969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25088886|NCT03270969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25088887|NCT03270969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25088890|NCT03270839|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25088947|NCT03269760|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25088948|NCT03269760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25088950|NCT03269760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25088951|NCT03269760|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25088952|NCT03269760|GABA Agonists|gaba agonists|mesh-ancestor
25088953|NCT03269760|GABA Agents|gaba agents|mesh-ancestor
24764775|NCT01784120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632072|NCT01121835|Insulin glulisine|insulin glulisine|mesh-list
24632073|NCT01121835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24632074|NCT01121835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632076|NCT01121848|Fluorouracil|fluorouracil|mesh-list
24632077|NCT01121848|Oxaliplatin|oxaliplatin|mesh-list
24632078|NCT01121848|Antimetabolites|antimetabolites|mesh-ancestor
24632079|NCT01121848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632080|NCT01121848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24632081|NCT01121848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25088960|NCT03270007|Antimitotic Agents|antimitotic agents|mesh-ancestor
25088961|NCT03270007|Mitosis Modulators|mitosis modulators|mesh-ancestor
25088991|NCT03270033|Sensory System Agents|sensory system agents|mesh-ancestor
25088992|NCT03270033|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25088993|NCT03270033|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25088994|NCT03270033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25088995|NCT03270033|Adrenergic Agents|adrenergic agents|mesh-ancestor
25088996|NCT03270033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25088997|NCT03269916|Hormones|hormones|mesh-list
25088998|NCT03269916|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25088999|NCT03269916|Estrogens|estrogens|mesh-list
25089000|NCT03269916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25089002|NCT03269747|Prednisone|prednisone|mesh-list
25089015|NCT03269721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089016|NCT03269955|Thrombin|thrombin|mesh-list
25089017|NCT03269955|Hemostatics|hemostatics|mesh-ancestor
25089018|NCT03269955|Coagulants|coagulants|mesh-ancestor
25089019|NCT03269604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25089020|NCT03269604|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25089041|NCT03269591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24632264|NCT01122953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24632265|NCT01122953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632266|NCT01122953|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24632267|NCT01122953|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24632268|NCT01122966|Bevacizumab|bevacizumab|mesh-list
24632269|NCT01122966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24632270|NCT01122966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632306|NCT01123265|Antimetabolites|antimetabolites|mesh-ancestor
24632307|NCT01123265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632308|NCT01123265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25089089|NCT03269058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089090|NCT03269318|Theophylline|theophylline|mesh-list
25089092|NCT03269318|Montelukast|montelukast|mesh-list
24632363|NCT01123473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24632364|NCT01123473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632365|NCT01123473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24632367|NCT01123486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24632368|NCT01123486|Narcotics|narcotics|mesh-ancestor
24632481|NCT01124253|Growth Substances|growth substances|mesh-ancestor
24632482|NCT01124253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632483|NCT01124253|Growth Inhibitors|growth inhibitors|mesh-ancestor
24632484|NCT01124253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632487|NCT01124383|Lidocaine|lidocaine|mesh-list
24632516|NCT01124383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24632531|NCT01124435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632601|NCT01124656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089238|NCT03267654|Gefitinib|gefitinib|mesh-list
25089239|NCT03267654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632658|NCT01125020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24632659|NCT01125020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24632660|NCT01125020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24456215|NCT00330707|BCG Vaccine|bcg vaccine|mesh-list
24632661|NCT01125033|Vitamins|vitamins|mesh-list
24632662|NCT01125033|Ascorbic Acid|ascorbic acid|mesh-list
24632719|NCT01125423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632746|NCT01125488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24632747|NCT01125488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24632748|NCT01125488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25089297|NCT03267316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089299|NCT03267329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25089349|NCT03266731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25089350|NCT03266731|Analgesics|analgesics|mesh-ancestor
25089351|NCT03266731|Sensory System Agents|sensory system agents|mesh-ancestor
25089352|NCT03266731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25089353|NCT03266731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632914|NCT01126138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24632915|NCT01126177|Interferons|interferons|mesh-list
24632916|NCT01126177|Interferon-beta|interferon-beta|mesh-list
24632917|NCT01126177|Interferon beta-1a|interferon beta-1a|mesh-list
24632918|NCT01126177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632919|NCT01126177|Antiviral Agents|antiviral agents|mesh-ancestor
24632920|NCT01126177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24632921|NCT01126177|Immunologic Factors|immunologic factors|mesh-ancestor
24632922|NCT01126177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632923|NCT01126177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24633033|NCT01127009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24633034|NCT01127009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633068|NCT01127100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24633069|NCT01127100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24633070|NCT01127100|Anesthetics, General|anesthetics, general|mesh-ancestor
24633071|NCT01127100|Anesthetics|anesthetics|mesh-ancestor
24633072|NCT01127100|Anticonvulsants|anticonvulsants|mesh-ancestor
24633073|NCT01127100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24633074|NCT01127100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24633075|NCT01127100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24633076|NCT01127100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24633179|NCT01127542|Immunologic Factors|immunologic factors|mesh-ancestor
24633180|NCT01127542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633181|NCT01127542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24633182|NCT01127542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24633183|NCT01127542|Growth Substances|growth substances|mesh-ancestor
24633184|NCT01127542|Growth Inhibitors|growth inhibitors|mesh-ancestor
25089464|NCT03265470|Dexmedetomidine|dexmedetomidine|mesh-list
25089465|NCT03265470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25089466|NCT03265470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25089467|NCT03265470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089468|NCT03265470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25089469|NCT03265470|Analgesics|analgesics|mesh-ancestor
25089470|NCT03265470|Sensory System Agents|sensory system agents|mesh-ancestor
25089471|NCT03265470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24633279|NCT01127906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633281|NCT01127906|Sensory System Agents|sensory system agents|mesh-ancestor
24633282|NCT01127906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24414290|NCT00196755|Sevelamer|sevelamer|mesh-list
24633283|NCT01127984|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24633284|NCT01127984|Hemostatics|hemostatics|mesh-ancestor
24633325|NCT01128322|Micronutrients|micronutrients|mesh-ancestor
24633326|NCT01128556|Bepotastine besilate|bepotastine besilate|mesh-list
24633327|NCT01128556|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24633328|NCT01128699|Bevacizumab|bevacizumab|mesh-list
24633329|NCT01128699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24633330|NCT01128699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633331|NCT01128699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24633354|NCT01128985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633355|NCT01128998|Sorafenib|sorafenib|mesh-list
24633356|NCT01128998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633357|NCT01128998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24633358|NCT01128998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633359|NCT01128998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633360|NCT01129063|Clopidogrel|clopidogrel|mesh-list
24633361|NCT01129063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24633362|NCT01129063|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24633363|NCT01129063|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24633364|NCT01129063|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24665586|NCT01313585|Tocolytic Agents|tocolytic agents|mesh-ancestor
24633365|NCT01129063|Purinergic Agents|purinergic agents|mesh-ancestor
24633366|NCT01129063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24633367|NCT01129063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633369|NCT01129089|Micronutrients|micronutrients|mesh-list
24633380|NCT01129180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633381|NCT01129180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633382|NCT01129258|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
24633384|NCT01129258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089544|NCT03264638|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25089545|NCT03264638|Contraceptive Agents|contraceptive agents|mesh-ancestor
25089546|NCT03264638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25089568|NCT03264781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25089569|NCT03264781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089570|NCT03264781|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25089586|NCT03264586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25089587|NCT03264586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25089588|NCT03264586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25089589|NCT03264586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089590|NCT03264586|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25089591|NCT03264625|Vitamin D|vitamin d|mesh-list
25089592|NCT03264625|Cholecalciferol|cholecalciferol|mesh-list
25089593|NCT03264625|Vitamins|vitamins|mesh-ancestor
25089594|NCT03264625|Micronutrients|micronutrients|mesh-ancestor
25089595|NCT03264625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089598|NCT03264547|Paclitaxel|paclitaxel|mesh-list
24633507|NCT01129739|Cyclosporine|cyclosporine|mesh-list
24633554|NCT01129934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24633555|NCT01129934|Antipruritics|antipruritics|mesh-ancestor
24633556|NCT01129934|Dermatologic Agents|dermatologic agents|mesh-ancestor
24633557|NCT01129934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24633558|NCT01129934|Histamine Antagonists|histamine antagonists|mesh-ancestor
24633559|NCT01129934|Histamine Agents|histamine agents|mesh-ancestor
24633638|NCT01130467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24633639|NCT01130467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24633640|NCT01130467|Adrenergic Agents|adrenergic agents|mesh-ancestor
24633643|NCT01130506|Vorinostat|vorinostat|mesh-list
24633644|NCT01130506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24633645|NCT01130506|Antimetabolites|antimetabolites|mesh-ancestor
24633646|NCT01130506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633647|NCT01130506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633648|NCT01130506|Antiviral Agents|antiviral agents|mesh-ancestor
24633649|NCT01130506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25708263|NCT02247440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708264|NCT02247466|Rocuronium|rocuronium|mesh-list
25708265|NCT02247466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25708266|NCT02247466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25708267|NCT02247466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25708268|NCT02247466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24414955|NCT00199004|Antimetabolites|antimetabolites|mesh-ancestor
24414956|NCT00199004|Dermatologic Agents|dermatologic agents|mesh-ancestor
24414957|NCT00199004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24415048|NCT00199056|Idarubicin|idarubicin|mesh-list
24633651|NCT01130506|Immunologic Factors|immunologic factors|mesh-ancestor
24633704|NCT01130805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633705|NCT01130805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633707|NCT01130909|Analgesics|analgesics|mesh-ancestor
24633708|NCT01130909|Sensory System Agents|sensory system agents|mesh-ancestor
24633709|NCT01130909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24633710|NCT01130909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24765627|NCT01789710|Dopamine Agents|dopamine agents|mesh-ancestor
25089795|NCT03263052|Tacrolimus|tacrolimus|mesh-list
25089729|NCT03263533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089731|NCT03263520|Dexamethasone|dexamethasone|mesh-list
25089732|NCT03263520|Dexamethasone acetate|dexamethasone acetate|mesh-list
25089733|NCT03263520|Nandrolone|nandrolone|mesh-list
25089734|NCT03263520|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
25089735|NCT03263520|BB 1101|bb 1101|mesh-list
24456766|NCT00332176|Antimetabolites|antimetabolites|mesh-ancestor
24394840|NCT00134394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394841|NCT00134394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25089741|NCT03263520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25089742|NCT03263520|Glucocorticoids|glucocorticoids|mesh-ancestor
25089743|NCT03263520|Hormones|hormones|mesh-ancestor
25089744|NCT03263520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25089745|NCT03263520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24395129|NCT00135135|Gefitinib|gefitinib|mesh-list
24395130|NCT00135135|Tretinoin|tretinoin|mesh-list
24395131|NCT00135135|Isotretinoin|isotretinoin|mesh-list
24395132|NCT00135135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24395137|NCT00135135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395138|NCT00135135|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24395139|NCT00135135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24395150|NCT00135187|Bortezomib|bortezomib|mesh-list
24395158|NCT00135187|Hormones|hormones|mesh-ancestor
24395159|NCT00135187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24395160|NCT00135187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24395268|NCT00135551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24395269|NCT00135551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25089746|NCT03263520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25089747|NCT03263520|Protease Inhibitors|protease inhibitors|mesh-ancestor
25089748|NCT03263520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25089749|NCT03263520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089750|NCT03263520|Androgens|androgens|mesh-ancestor
25089751|NCT03263520|Anabolic Agents|anabolic agents|mesh-ancestor
25089753|NCT03263208|Cyclophosphamide|cyclophosphamide|mesh-list
25089766|NCT03262857|Anesthetics, Local|anesthetics, local|mesh-ancestor
25089767|NCT03262857|Anesthetics|anesthetics|mesh-ancestor
25089768|NCT03262857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25089769|NCT03262857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539693|NCT00665054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539695|NCT00665054|Urological Agents|urological agents|mesh-ancestor
24395395|NCT00135902|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
24395396|NCT00135902|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
24395397|NCT00135902|Progestins|progestins|mesh-ancestor
24395398|NCT00135902|Hormones|hormones|mesh-ancestor
24395655|NCT00136539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24395662|NCT00136565|Prednisone|prednisone|mesh-list
25708269|NCT02247466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708270|NCT02247739|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
25708271|NCT02247739|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25708272|NCT02247739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25708273|NCT02247739|Immunologic Factors|immunologic factors|mesh-ancestor
25708274|NCT02247739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395663|NCT00136565|Cyclophosphamide|cyclophosphamide|mesh-list
25089786|NCT03262948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25089787|NCT03262948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25089788|NCT03262948|Tubulin Modulators|tubulin modulators|mesh-ancestor
25089789|NCT03262948|Antimitotic Agents|antimitotic agents|mesh-ancestor
25089790|NCT03262948|Mitosis Modulators|mitosis modulators|mesh-ancestor
25089791|NCT03262948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089793|NCT03263065|Cathartics|cathartics|mesh-ancestor
25089794|NCT03263065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25089796|NCT03263052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24539771|NCT00665522|Anesthetics|anesthetics|mesh-ancestor
24395826|NCT00136994|Dopamine Agents|dopamine agents|mesh-ancestor
24395827|NCT00137007|Azithromycin|azithromycin|mesh-list
24395828|NCT00137007|Ampicillin|ampicillin|mesh-list
24395829|NCT00137007|Sulbactam|sulbactam|mesh-list
24395830|NCT00137007|Sultamicillin|sultamicillin|mesh-list
24395831|NCT00137007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24395832|NCT00137007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24395833|NCT00137007|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24395834|NCT00137007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395871|NCT00137072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395872|NCT00137072|Vasodilator Agents|vasodilator agents|mesh-ancestor
25089804|NCT03263039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25089805|NCT03262961|Sildenafil Citrate|sildenafil citrate|mesh-list
25089806|NCT03262961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25089807|NCT03262961|Vasodilator Agents|vasodilator agents|mesh-ancestor
25089808|NCT03262961|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25089809|NCT03262961|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25089810|NCT03262961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25089811|NCT03262961|Urological Agents|urological agents|mesh-ancestor
25089812|NCT03262792|Andrographolide|andrographolide|mesh-list
25089813|NCT03262792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24396000|NCT00137553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24396001|NCT00137553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24396002|NCT00137553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24396003|NCT00137553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24396004|NCT00137553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396005|NCT00137553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396006|NCT00137553|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24396007|NCT00137553|Renal Agents|renal agents|mesh-ancestor
24396474|NCT00139074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24396475|NCT00139074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546451|NCT00698464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25089898|NCT03262077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25089899|NCT03262077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396681|NCT00139685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24396682|NCT00139685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396683|NCT00139685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24396684|NCT00139685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24396685|NCT00139685|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24396686|NCT00139685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24396687|NCT00139685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396688|NCT00139685|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24396689|NCT00139685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24396690|NCT00139685|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24396691|NCT00139698|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25089908|NCT03262090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25089909|NCT03262090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24397227|NCT00141154|Sensory System Agents|sensory system agents|mesh-ancestor
24397228|NCT00141154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24397229|NCT00141154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397285|NCT00141258|Pregabalin|pregabalin|mesh-list
24397366|NCT00141401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397376|NCT00141414|Pregabalin|pregabalin|mesh-list
24455425|NCT00945724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24455426|NCT00945724|Immunologic Factors|immunologic factors|mesh-ancestor
24455427|NCT00945724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455428|NCT00945724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24455429|NCT00945724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24397466|NCT00141596|Diuretics|diuretics|mesh-ancestor
24397467|NCT00141596|Natriuretic Agents|natriuretic agents|mesh-ancestor
24397554|NCT00141830|Immunologic Factors|immunologic factors|mesh-ancestor
24397555|NCT00141830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24397556|NCT00141830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24397558|NCT00141843|Coagulants|coagulants|mesh-ancestor
24397559|NCT00141882|Memantine|memantine|mesh-list
24397715|NCT00142467|Gemcitabine|gemcitabine|mesh-list
24397716|NCT00142467|Bevacizumab|bevacizumab|mesh-list
24397717|NCT00142467|Oxaliplatin|oxaliplatin|mesh-list
24397718|NCT00142467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24397771|NCT00142493|GABA Agents|gaba agents|mesh-ancestor
24397924|NCT00143065|Alemtuzumab|alemtuzumab|mesh-list
24397925|NCT00143065|Fludarabine|fludarabine|mesh-list
24397926|NCT00143065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24397927|NCT00143065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24397928|NCT00143065|Immunologic Factors|immunologic factors|mesh-ancestor
24397929|NCT00143065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397930|NCT00143065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24397931|NCT00143091|Sertraline|sertraline|mesh-list
24397932|NCT00143091|Antidepressive Agents|antidepressive agents|mesh-ancestor
24397933|NCT00143091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24397934|NCT00143091|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24397935|NCT00143091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24397936|NCT00143091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24397937|NCT00143091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397955|NCT00143130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24397975|NCT00143156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24397993|NCT00143169|Analgesics|analgesics|mesh-ancestor
24397994|NCT00143169|Sensory System Agents|sensory system agents|mesh-ancestor
24397995|NCT00143169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24398092|NCT00143442|Antidepressive Agents|antidepressive agents|mesh-ancestor
24398093|NCT00143442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24398094|NCT00143442|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25090170|NCT03260088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090172|NCT03259919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25090173|NCT03259919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090174|NCT03259958|Donepezil|donepezil|mesh-list
25090183|NCT03259529|Rituximab|rituximab|mesh-list
25090186|NCT03259529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25090187|NCT03259529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25090188|NCT03259529|Immunologic Factors|immunologic factors|mesh-ancestor
25090189|NCT03259529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090190|NCT03259529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25090191|NCT03259529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25090192|NCT03259529|Antimetabolites|antimetabolites|mesh-ancestor
24398234|NCT00143949|Losartan|losartan|mesh-list
25090201|NCT03259516|Cytarabine|cytarabine|mesh-list
25090202|NCT03259516|Cyclophosphamide|cyclophosphamide|mesh-list
25090203|NCT03259516|Melphalan|melphalan|mesh-list
25090204|NCT03259516|Nivolumab|nivolumab|mesh-list
25090205|NCT03259516|Fludarabine|fludarabine|mesh-list
25090206|NCT03259516|Azacitidine|azacitidine|mesh-list
25090207|NCT03259516|Tretinoin|tretinoin|mesh-list
24398445|NCT00144417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24398446|NCT00144417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24398447|NCT00144417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398449|NCT00144417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24398459|NCT00144417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24398694|NCT00145314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24398696|NCT00145314|Immunologic Factors|immunologic factors|mesh-ancestor
24398782|NCT00145639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24398783|NCT00145639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24399076|NCT00146575|Tubulin Modulators|tubulin modulators|mesh-ancestor
24399077|NCT00146575|Antimitotic Agents|antimitotic agents|mesh-ancestor
25708275|NCT02247804|Timolol|timolol|mesh-list
25708276|NCT02247804|Bimatoprost|bimatoprost|mesh-list
24399316|NCT00147381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399318|NCT00147381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399432|NCT00147758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399433|NCT00147758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24399435|NCT00147771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25090305|NCT03258684|Hydrocortisone|hydrocortisone|mesh-list
25090306|NCT03258684|Vitamins|vitamins|mesh-ancestor
25090307|NCT03258684|Micronutrients|micronutrients|mesh-ancestor
25090308|NCT03258684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090309|NCT03258684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25090310|NCT03258684|Antioxidants|antioxidants|mesh-ancestor
25090311|NCT03258684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090326|NCT03258866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25090327|NCT03258749|Formoterol Fumarate|formoterol fumarate|mesh-list
25090328|NCT03258749|Tiotropium Bromide|tiotropium bromide|mesh-list
25090329|NCT03258749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25090330|NCT03258749|Autonomic Agents|autonomic agents|mesh-ancestor
25090333|NCT03258749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24399629|NCT00148278|Respiratory System Agents|respiratory system agents|mesh-ancestor
24399630|NCT00148278|Mydriatics|mydriatics|mesh-ancestor
24399631|NCT00148278|Sympathomimetics|sympathomimetics|mesh-ancestor
24399632|NCT00148278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24399633|NCT00148278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24399714|NCT00148473|Misoprostol|misoprostol|mesh-list
25090401|NCT03258294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090402|NCT03258294|Protective Agents|protective agents|mesh-ancestor
25090403|NCT03258294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090404|NCT03258294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25090405|NCT03258398|Avelumab|avelumab|mesh-list
25090406|NCT03258398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25090407|NCT03258398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25090408|NCT03257930|Ethanol|ethanol|mesh-list
25090409|NCT03257930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24399772|NCT00148590|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24399773|NCT00148590|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24399774|NCT00148603|Montelukast|montelukast|mesh-list
24399775|NCT00148603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24399776|NCT00148603|Respiratory System Agents|respiratory system agents|mesh-ancestor
25090414|NCT03257943|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25090415|NCT03257943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25090416|NCT03257683|Ranolazine|ranolazine|mesh-list
25090417|NCT03257683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25090418|NCT03257683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24400398|NCT00150449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400399|NCT00150449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24400401|NCT00150449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24400402|NCT00150449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24400405|NCT00150527|Citalopram|citalopram|mesh-list
24400425|NCT00150527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24400485|NCT00150657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24400486|NCT00150657|Growth Substances|growth substances|mesh-ancestor
24400487|NCT00150657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400488|NCT00150657|Growth Inhibitors|growth inhibitors|mesh-ancestor
24400489|NCT00150657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24400490|NCT00150657|Antimetabolites|antimetabolites|mesh-ancestor
24400492|NCT00150657|Antiviral Agents|antiviral agents|mesh-ancestor
24400551|NCT00150839|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24400552|NCT00150839|Antidepressive Agents|antidepressive agents|mesh-ancestor
24400553|NCT00150839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24400554|NCT00150839|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24400555|NCT00150839|Histamine Antagonists|histamine antagonists|mesh-ancestor
24400605|NCT00150995|Chelating Agents|chelating agents|mesh-ancestor
24400606|NCT00150995|Sequestering Agents|sequestering agents|mesh-ancestor
24400607|NCT00150995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401200|NCT00152399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401202|NCT00152412|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24401203|NCT00152412|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24401204|NCT00152412|Histamine Antagonists|histamine antagonists|mesh-ancestor
24401206|NCT00152412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24401207|NCT00152412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401208|NCT00152412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401209|NCT00152425|Certolizumab Pegol|certolizumab pegol|mesh-list
24401210|NCT00152425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25090432|NCT03257722|Pembrolizumab|pembrolizumab|mesh-list
24401424|NCT00152893|Vasodilator Agents|vasodilator agents|mesh-ancestor
24401425|NCT00152893|Vitamin B Complex|vitamin b complex|mesh-ancestor
24401426|NCT00152893|Vitamins|vitamins|mesh-ancestor
24401427|NCT00152919|Meloxicam|meloxicam|mesh-list
24401428|NCT00152919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24401429|NCT00152919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24401430|NCT00152919|Analgesics|analgesics|mesh-ancestor
24401431|NCT00152919|Sensory System Agents|sensory system agents|mesh-ancestor
24401432|NCT00152919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24401433|NCT00152919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401631|NCT00153530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24401632|NCT00153530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24401633|NCT00153530|Immunologic Factors|immunologic factors|mesh-ancestor
24401634|NCT00153530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25090474|NCT03257800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25090475|NCT03257800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25090476|NCT03257800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25090477|NCT03257800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090502|NCT03257319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25090503|NCT03257319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090505|NCT03257319|Sensory System Agents|sensory system agents|mesh-ancestor
25090506|NCT03257319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25090507|NCT03257241|Cytarabine|cytarabine|mesh-list
25090508|NCT03257241|Fludarabine|fludarabine|mesh-list
25090509|NCT03257241|Daunorubicin|daunorubicin|mesh-list
25090538|NCT03257215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25090539|NCT03257124|Osimertinib|osimertinib|mesh-list
25090540|NCT03257124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25090541|NCT03257124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25090542|NCT03257124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090543|NCT03257124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090544|NCT03256903|Methoxyflurane|methoxyflurane|mesh-list
24402447|NCT00157326|Urological Agents|urological agents|mesh-ancestor
24402448|NCT00157378|Haloperidol|haloperidol|mesh-list
24402449|NCT00157378|Risperidone|risperidone|mesh-list
24513318|NCT00580619|Methyldopa|methyldopa|mesh-list
24402450|NCT00157378|Haloperidol decanoate|haloperidol decanoate|mesh-list
24402451|NCT00157378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24402452|NCT00157378|Serotonin Agents|serotonin agents|mesh-ancestor
24402468|NCT00157482|Ezetimibe|ezetimibe|mesh-list
24402474|NCT00157482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24402475|NCT00157482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402477|NCT00157508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25090557|NCT03256721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090558|NCT03256721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090564|NCT03256864|Everolimus|everolimus|mesh-list
24402607|NCT00157976|Dermatologic Agents|dermatologic agents|mesh-ancestor
24402609|NCT00158002|Anticonvulsants|anticonvulsants|mesh-ancestor
24402610|NCT00158002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25090942|NCT03252496|Analgesics|analgesics|mesh-ancestor
24402613|NCT00158028|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24402827|NCT00158548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25090587|NCT03256149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25090588|NCT03256149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090589|NCT03256149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25090591|NCT03256149|Hormones|hormones|mesh-ancestor
25090592|NCT03256149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25090593|NCT03256149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25090594|NCT03256149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24402915|NCT00158821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402916|NCT00158821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402917|NCT00158821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24402918|NCT00158821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24402919|NCT00158821|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25090603|NCT03256292|Hormones|hormones|mesh-ancestor
25090604|NCT03256292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25090605|NCT03256292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090606|NCT03255811|Apatinib|apatinib|mesh-list
25090607|NCT03255811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25090608|NCT03255811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25090609|NCT03255811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25090610|NCT03255811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090611|NCT03255642|Clonazepam|clonazepam|mesh-list
25090612|NCT03255642|Melatonin|melatonin|mesh-list
25090613|NCT03255642|Antioxidants|antioxidants|mesh-ancestor
25090614|NCT03255642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090615|NCT03255642|Protective Agents|protective agents|mesh-ancestor
25090616|NCT03255642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090618|NCT03255642|Anticonvulsants|anticonvulsants|mesh-ancestor
24402948|NCT00158847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24402949|NCT00158847|Autonomic Agents|autonomic agents|mesh-ancestor
24402950|NCT00158847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25090629|NCT03255226|Tolvaptan|tolvaptan|mesh-list
25090630|NCT03255226|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25090631|NCT03255226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25090632|NCT03255226|Natriuretic Agents|natriuretic agents|mesh-ancestor
25090634|NCT03255330|Dipyrone|dipyrone|mesh-list
24402998|NCT00158990|Antidepressive Agents|antidepressive agents|mesh-ancestor
24402999|NCT00158990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25090637|NCT03255330|Analgesics|analgesics|mesh-ancestor
25090638|NCT03255330|Sensory System Agents|sensory system agents|mesh-ancestor
25090639|NCT03255330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25090640|NCT03255330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090641|NCT03255330|Anticonvulsants|anticonvulsants|mesh-ancestor
25090642|NCT03255330|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24403001|NCT00158990|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24403026|NCT00159081|Antiemetics|antiemetics|mesh-ancestor
24403071|NCT00159146|Serotonin Agents|serotonin agents|mesh-ancestor
24403072|NCT00159146|Vasodilator Agents|vasodilator agents|mesh-ancestor
24403074|NCT00159159|Cyclosporins|cyclosporins|mesh-list
24403075|NCT00159159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403076|NCT00159159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403078|NCT00159159|Immunologic Factors|immunologic factors|mesh-ancestor
24403079|NCT00159159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403209|NCT00159653|Latanoprost|latanoprost|mesh-list
24403210|NCT00159653|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24403211|NCT00159653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24403228|NCT00159666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403279|NCT00159718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24403299|NCT00159757|Ziprasidone|ziprasidone|mesh-list
24403300|NCT00159757|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24403301|NCT00159757|Serotonin Agents|serotonin agents|mesh-ancestor
24403383|NCT00160160|Eprosartan|eprosartan|mesh-list
24403384|NCT00160160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24403463|NCT00160394|Sensory System Agents|sensory system agents|mesh-ancestor
25090747|NCT03254628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090748|NCT03254628|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25090749|NCT03254628|Abortifacient Agents|abortifacient agents|mesh-ancestor
25090750|NCT03254628|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25090751|NCT03254628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25090752|NCT03254641|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25090753|NCT03254641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25090754|NCT03254641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403590|NCT00161018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24403591|NCT00161018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403592|NCT00161018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403593|NCT00161018|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24403594|NCT00161018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24403595|NCT00161018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24403596|NCT00161018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24403597|NCT00161018|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24403598|NCT00161018|Dopamine Agents|dopamine agents|mesh-ancestor
24403653|NCT00161226|Levonorgestrel|levonorgestrel|mesh-list
24403730|NCT00161356|Antifungal Agents|antifungal agents|mesh-ancestor
24403731|NCT00161356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24403732|NCT00161356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24403733|NCT00161356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24403735|NCT00161421|Testosterone|testosterone|mesh-list
24403736|NCT00161421|Dutasteride|dutasteride|mesh-list
24403737|NCT00161421|Androgens|androgens|mesh-ancestor
24403738|NCT00161421|Hormones|hormones|mesh-ancestor
24403739|NCT00161421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24404248|NCT00162864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404249|NCT00162864|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24404250|NCT00162864|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24404251|NCT00162864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404254|NCT00162877|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24404255|NCT00162877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24405277|NCT00166413|Lenalidomide|lenalidomide|mesh-list
24405278|NCT00166413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24405279|NCT00166413|Immunologic Factors|immunologic factors|mesh-ancestor
24405338|NCT00166556|Tacrolimus|tacrolimus|mesh-list
25708277|NCT02247804|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25708278|NCT02247804|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25708279|NCT02247804|Adrenergic Agents|adrenergic agents|mesh-ancestor
25708280|NCT02247804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25708281|NCT02247804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708282|NCT02247804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708283|NCT02247804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25090852|NCT03253224|Tocolytic Agents|tocolytic agents|mesh-ancestor
24405832|NCT00168519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24405833|NCT00168519|Vasodilator Agents|vasodilator agents|mesh-ancestor
24405834|NCT00168519|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24406160|NCT00169182|Tubulin Modulators|tubulin modulators|mesh-ancestor
24406161|NCT00169182|Antimitotic Agents|antimitotic agents|mesh-ancestor
24406415|NCT00170209|Isoniazid|isoniazid|mesh-list
24406416|NCT00170209|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25090886|NCT03253133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24767242|NCT01799460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24767243|NCT01799460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24406494|NCT00170664|Paclitaxel|paclitaxel|mesh-list
24407600|NCT00174772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767245|NCT01799460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24767253|NCT01799460|Hormones|hormones|mesh-ancestor
25090887|NCT03253133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090888|NCT03253133|Analgesics|analgesics|mesh-ancestor
25090889|NCT03253133|Sensory System Agents|sensory system agents|mesh-ancestor
25090890|NCT03253133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25090891|NCT03253068|Pembrolizumab|pembrolizumab|mesh-list
25091712|NCT03247140|Vasodilator Agents|vasodilator agents|mesh-ancestor
25090916|NCT03252457|Antiemetics|antiemetics|mesh-ancestor
25090917|NCT03252457|Autonomic Agents|autonomic agents|mesh-ancestor
25090918|NCT03252457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25090919|NCT03252457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25090920|NCT03252457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25090921|NCT03252457|Glucocorticoids|glucocorticoids|mesh-ancestor
25090939|NCT03252496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25090940|NCT03252496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25090941|NCT03252496|Narcotics|narcotics|mesh-ancestor
24408462|NCT00177853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409117|NCT00180921|Imatinib Mesylate|imatinib mesylate|mesh-list
24409118|NCT00180921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409119|NCT00180921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24409120|NCT00180921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409122|NCT00180947|Vinorelbine|vinorelbine|mesh-list
25091001|NCT03251859|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25091002|NCT03251859|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25091003|NCT03251859|Purinergic Agents|purinergic agents|mesh-ancestor
25091004|NCT03251859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25091005|NCT03251859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091006|NCT03251859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091007|NCT03251768|Lenograstim|lenograstim|mesh-list
25091008|NCT03251768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25091009|NCT03251768|Immunologic Factors|immunologic factors|mesh-ancestor
25091010|NCT03251768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091011|NCT03251872|Olaparib|olaparib|mesh-list
25091012|NCT03251872|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25091013|NCT03251872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091014|NCT03251872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091015|NCT03251872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25091016|NCT03251521|Botulinum Toxins|botulinum toxins|mesh-list
25091017|NCT03251521|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25091052|NCT03251417|Apatinib|apatinib|mesh-list
25091053|NCT03251417|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25091113|NCT03251222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091114|NCT03250910|Ribavirin|ribavirin|mesh-list
25091115|NCT03250910|Sofosbuvir|sofosbuvir|mesh-list
25091116|NCT03250910|Velpatasvir|velpatasvir|mesh-list
25091117|NCT03250910|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25091118|NCT03250910|Antimetabolites|antimetabolites|mesh-ancestor
25091119|NCT03250910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091120|NCT03250910|Antiviral Agents|antiviral agents|mesh-ancestor
25091122|NCT03250962|Decitabine|decitabine|mesh-list
24451849|NCT00324974|Lansoprazole|lansoprazole|mesh-list
24451850|NCT00324974|Dexlansoprazole|dexlansoprazole|mesh-list
24451851|NCT00324974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24451852|NCT00324974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24451853|NCT00324974|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24451854|NCT00324974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409878|NCT00183807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24409879|NCT00183807|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24409880|NCT00183807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24409881|NCT00183820|Gemcitabine|gemcitabine|mesh-list
24410054|NCT00184106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24410105|NCT00184561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24410106|NCT00184561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410107|NCT00184574|Metformin|metformin|mesh-list
24410174|NCT00184821|Purinergic Agonists|purinergic agonists|mesh-ancestor
24410175|NCT00184821|Purinergic Agents|purinergic agents|mesh-ancestor
24410176|NCT00184821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24410177|NCT00184821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410178|NCT00184821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24410179|NCT00184821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24410180|NCT00184821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24410181|NCT00184847|Adenosine|adenosine|mesh-list
24410182|NCT00184847|Acetylcholine|acetylcholine|mesh-list
24410183|NCT00184847|Caffeine|caffeine|mesh-list
24410184|NCT00184847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24410185|NCT00184847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410186|NCT00184847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24410187|NCT00184847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091233|NCT03249870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25091234|NCT03249870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25091235|NCT03249740|Sunitinib|sunitinib|mesh-list
25091236|NCT03249740|Aflibercept|aflibercept|mesh-list
25091237|NCT03249740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25091238|NCT03249740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25091239|NCT03249740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25091246|NCT03249506|Dapagliflozin|dapagliflozin|mesh-list
24410671|NCT00186862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24410672|NCT00186862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410699|NCT00186966|Antiviral Agents|antiviral agents|mesh-ancestor
25091314|NCT03249311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25091315|NCT03249311|Antidepressive Agents|antidepressive agents|mesh-ancestor
25091316|NCT03249311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25091317|NCT03249311|Dopamine Agents|dopamine agents|mesh-ancestor
25091318|NCT03249311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25091319|NCT03249285|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25091320|NCT03249285|Perindopril|perindopril|mesh-list
25091321|NCT03249285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25091322|NCT03249285|Diuretics|diuretics|mesh-ancestor
25091323|NCT03249285|Natriuretic Agents|natriuretic agents|mesh-ancestor
24767655|NCT01802645|Irinotecan|irinotecan|mesh-list
25091324|NCT03249285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091325|NCT03249285|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25091403|NCT03248856|Hormones|hormones|mesh-ancestor
25091404|NCT03248856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24410759|NCT00187005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24410760|NCT00187005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24410761|NCT00187005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24410762|NCT00187005|Antiviral Agents|antiviral agents|mesh-ancestor
24410763|NCT00187005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24410764|NCT00187005|Tubulin Modulators|tubulin modulators|mesh-ancestor
24410765|NCT00187005|Antimitotic Agents|antimitotic agents|mesh-ancestor
24410766|NCT00187005|Mitosis Modulators|mitosis modulators|mesh-ancestor
24411186|NCT00188136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24411187|NCT00188136|Alkylating Agents|alkylating agents|mesh-ancestor
24411188|NCT00188136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25091465|NCT03248817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25091466|NCT03248817|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25091468|NCT03248817|Autonomic Agents|autonomic agents|mesh-ancestor
25091469|NCT03248817|Sympathomimetics|sympathomimetics|mesh-ancestor
25091470|NCT03248817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24411254|NCT00188552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24756482|NCT01733589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756483|NCT01733589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24756484|NCT01733589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24756485|NCT01733589|Growth Substances|growth substances|mesh-ancestor
24756488|NCT01733706|Nicotine|nicotine|mesh-list
24411255|NCT00188552|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24411256|NCT00188552|Protective Agents|protective agents|mesh-ancestor
24411257|NCT00188552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411258|NCT00188552|Vasodilator Agents|vasodilator agents|mesh-ancestor
24411259|NCT00188552|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24411260|NCT00188552|Antioxidants|antioxidants|mesh-ancestor
24411261|NCT00188552|Vitamins|vitamins|mesh-ancestor
24411262|NCT00188552|Micronutrients|micronutrients|mesh-ancestor
24411263|NCT00188565|Celecoxib|celecoxib|mesh-list
24411264|NCT00188565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24411265|NCT00188565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25091535|NCT03248700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091536|NCT03248700|Antioxidants|antioxidants|mesh-ancestor
25091537|NCT03248700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411303|NCT00188643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411304|NCT00188643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24411346|NCT00188773|Antioxidants|antioxidants|mesh-ancestor
24411347|NCT00188773|Protective Agents|protective agents|mesh-ancestor
24411348|NCT00188773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411349|NCT00188773|Antidotes|antidotes|mesh-ancestor
24411350|NCT00188773|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24411351|NCT00188773|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25091572|NCT03248401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25091573|NCT03248401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25091577|NCT03248401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25708284|NCT02247804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25091578|NCT03248401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091579|NCT03248401|Antipyretics|antipyretics|mesh-ancestor
25708285|NCT02247960|Ciprofloxacin|ciprofloxacin|mesh-list
25708286|NCT02247960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25708287|NCT02247960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25708288|NCT02247960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25708289|NCT02247960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25091580|NCT03248401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25091614|NCT03248427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25091615|NCT03248349|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25091616|NCT03248349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25091618|NCT03248271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25091619|NCT03248271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091624|NCT03247972|Evolocumab|evolocumab|mesh-list
25091625|NCT03247972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25091626|NCT03247972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25091627|NCT03247972|Antimetabolites|antimetabolites|mesh-ancestor
25091629|NCT03247972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25091697|NCT03247413|Glucocorticoids|glucocorticoids|mesh-ancestor
25091698|NCT03247413|Hormones|hormones|mesh-ancestor
24411760|NCT00189878|Immunologic Factors|immunologic factors|mesh-ancestor
25091704|NCT03247140|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
25091705|NCT03247140|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25091706|NCT03247140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25091707|NCT03247140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25091708|NCT03247140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25091709|NCT03247140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091710|NCT03247140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25091711|NCT03247140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091713|NCT03247140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25091714|NCT03247140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25091715|NCT03247140|Antimetabolites|antimetabolites|mesh-ancestor
25091716|NCT03247140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25091717|NCT03247140|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25091718|NCT03247140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091719|NCT03247140|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25091720|NCT03247140|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25091722|NCT03247400|Simvastatin|simvastatin|mesh-list
25091723|NCT03247400|Calcium|calcium|mesh-list
25091724|NCT03247400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24411843|NCT00190229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24411844|NCT00190229|Alkylating Agents|alkylating agents|mesh-ancestor
24411845|NCT00190229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411846|NCT00190229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411847|NCT00190229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24411849|NCT00190268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24411850|NCT00190268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24411950|NCT00190515|Leucovorin|leucovorin|mesh-list
24411951|NCT00190515|Levoleucovorin|levoleucovorin|mesh-list
24411989|NCT00190593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411991|NCT00190593|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24411992|NCT00190593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24411993|NCT00190606|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24411994|NCT00190606|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25091779|NCT03246776|Glucocorticoids|glucocorticoids|mesh-ancestor
24412075|NCT00190801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412076|NCT00190801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412101|NCT00190827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25091788|NCT03246880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25091789|NCT03246880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412143|NCT00190879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412144|NCT00190879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412145|NCT00190892|Carbamazepine|carbamazepine|mesh-list
24412147|NCT00190892|Antiemetics|antiemetics|mesh-ancestor
24412148|NCT00190892|Autonomic Agents|autonomic agents|mesh-ancestor
24412149|NCT00190892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24412150|NCT00190892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412151|NCT00190892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24412152|NCT00190892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25091805|NCT03246555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25091806|NCT03246555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091810|NCT03246620|Diazepam|diazepam|mesh-list
24412186|NCT00190918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091824|NCT03246620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25091825|NCT03246620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25091826|NCT03246620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091827|NCT03246620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25091828|NCT03246620|Serotonin Agents|serotonin agents|mesh-ancestor
25091829|NCT03246620|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25091830|NCT03246620|Dopamine Agents|dopamine agents|mesh-ancestor
25091831|NCT03246620|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25091832|NCT03246620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25091833|NCT03246620|Anticonvulsants|anticonvulsants|mesh-ancestor
25091834|NCT03246620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25091835|NCT03246620|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24412213|NCT00190996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24412233|NCT00191022|Paroxetine|paroxetine|mesh-list
24412280|NCT00191087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412282|NCT00191087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412283|NCT00191087|Analgesics|analgesics|mesh-ancestor
24412284|NCT00191087|Sensory System Agents|sensory system agents|mesh-ancestor
24412285|NCT00191087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24412286|NCT00191087|Antidepressive Agents|antidepressive agents|mesh-ancestor
25091890|NCT03246009|Immunologic Factors|immunologic factors|mesh-ancestor
25091891|NCT03246009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25091893|NCT03246399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25091894|NCT03246113|Temozolomide|temozolomide|mesh-list
25091895|NCT03246113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25091896|NCT03246113|Alkylating Agents|alkylating agents|mesh-ancestor
25091897|NCT03246113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25091898|NCT03246113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25091899|NCT03245853|Riboflavin|riboflavin|mesh-list
24412388|NCT00191347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24412389|NCT00191347|Immunologic Factors|immunologic factors|mesh-ancestor
24412390|NCT00191347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412392|NCT00191347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24412553|NCT00191594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412554|NCT00191594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412555|NCT00191594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412557|NCT00191594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412558|NCT00191594|Analgesics|analgesics|mesh-ancestor
24412559|NCT00191594|Sensory System Agents|sensory system agents|mesh-ancestor
24412560|NCT00191594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24412562|NCT00191594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24412563|NCT00191594|Dopamine Agents|dopamine agents|mesh-ancestor
24412564|NCT00191607|Gemcitabine|gemcitabine|mesh-list
24412565|NCT00191607|Doxorubicin|doxorubicin|mesh-list
24412566|NCT00191607|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24412628|NCT00191685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412629|NCT00191685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412630|NCT00191685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412642|NCT00191698|Adrenergic Agents|adrenergic agents|mesh-ancestor
24465931|NCT00371124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24465932|NCT00371124|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24465933|NCT00371124|Autonomic Agents|autonomic agents|mesh-ancestor
25092087|NCT03244488|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25092088|NCT03244488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25092090|NCT03244488|Autonomic Agents|autonomic agents|mesh-ancestor
25092091|NCT03244488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25092092|NCT03244488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092093|NCT03244488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25092094|NCT03244488|Mydriatics|mydriatics|mesh-ancestor
25092095|NCT03244488|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25092096|NCT03244488|Cholinergic Agents|cholinergic agents|mesh-ancestor
25092097|NCT03244488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25092098|NCT03244488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413445|NCT00193882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25092157|NCT03244540|Anesthetics|anesthetics|mesh-ancestor
25092158|NCT03244540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25092159|NCT03244540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092160|NCT03244540|Sensory System Agents|sensory system agents|mesh-ancestor
25092161|NCT03244540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25092162|NCT03244540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25092163|NCT03244540|Analgesics|analgesics|mesh-ancestor
25092164|NCT03244540|Antipyretics|antipyretics|mesh-ancestor
25092167|NCT03244540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25092217|NCT03243552|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25092218|NCT03243552|Dopamine Agents|dopamine agents|mesh-ancestor
25092219|NCT03243552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25092523|NCT03241641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092224|NCT03243500|Atracurium|atracurium|mesh-list
25092232|NCT03243500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25092233|NCT03243500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25092234|NCT03243500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25092235|NCT03243500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092236|NCT03243500|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25092237|NCT03243500|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25092238|NCT03243500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25092239|NCT03243500|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25092240|NCT03243500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25092241|NCT03243500|Cholinergic Agents|cholinergic agents|mesh-ancestor
25092242|NCT03243500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25092243|NCT03243643|Apatinib|apatinib|mesh-list
25092244|NCT03243643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25092245|NCT03243643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25092246|NCT03243643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092247|NCT03243643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092248|NCT03243604|Hormones|hormones|mesh-list
24768602|NCT01809340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25092264|NCT03243175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092265|NCT03243175|Anticoagulants|anticoagulants|mesh-ancestor
25092275|NCT03243032|Ibuprofen|ibuprofen|mesh-list
25092357|NCT03242499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25092358|NCT03242499|Antimetabolites|antimetabolites|mesh-ancestor
25092359|NCT03242499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092360|NCT03242499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25092361|NCT03242499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25092362|NCT03242499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092364|NCT03242616|Vinorelbine|vinorelbine|mesh-list
25092447|NCT03242096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438642|NCT00276588|Paclitaxel|paclitaxel|mesh-list
25092448|NCT03242096|Tubulin Modulators|tubulin modulators|mesh-ancestor
25092449|NCT03242096|Antimitotic Agents|antimitotic agents|mesh-ancestor
25092452|NCT03242096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25092453|NCT03242096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25092454|NCT03242096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25092456|NCT03242096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25092516|NCT03241602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25092517|NCT03241602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092519|NCT03241641|Antiviral Agents|antiviral agents|mesh-ancestor
25092520|NCT03241641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25092521|NCT03241641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25092522|NCT03241641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25092586|NCT03240822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092587|NCT03240822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092588|NCT03240939|Tadalafil|tadalafil|mesh-list
25092589|NCT03240939|Dutasteride|dutasteride|mesh-list
25092590|NCT03240939|Vasodilator Agents|vasodilator agents|mesh-ancestor
25092647|NCT03240120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092648|NCT03240120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092649|NCT03240120|Anticoagulants|anticoagulants|mesh-ancestor
25092650|NCT03240120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25092651|NCT03240120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25092652|NCT03240055|Etomidate|etomidate|mesh-list
25092653|NCT03240055|Anesthetics|anesthetics|mesh-ancestor
25092654|NCT03240055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25092655|NCT03240055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092656|NCT03240055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25092657|NCT03240055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25092658|NCT03240055|Anesthetics, General|anesthetics, general|mesh-ancestor
25092659|NCT03239691|ACT-709478|act-709478|mesh-list
25092714|NCT03239600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25092715|NCT03239600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092716|NCT03239600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25092717|NCT03239600|Antimetabolites|antimetabolites|mesh-ancestor
24829595|NCT02153177|Narcotics|narcotics|mesh-ancestor
25092718|NCT03239600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092719|NCT03239600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25092720|NCT03239600|Dermatologic Agents|dermatologic agents|mesh-ancestor
25092721|NCT03239600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25092722|NCT03239600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25092723|NCT03239600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25092724|NCT03239600|Immunologic Factors|immunologic factors|mesh-ancestor
25092725|NCT03239600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25092726|NCT03239600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25092782|NCT03239080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25092783|NCT03239080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25092784|NCT03238898|Botulinum Toxins|botulinum toxins|mesh-list
25092785|NCT03238898|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25092786|NCT03238898|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25092787|NCT03238898|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25092788|NCT03238898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25092789|NCT03238898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092790|NCT03238898|Cholinergic Agents|cholinergic agents|mesh-ancestor
25092791|NCT03238898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25092871|NCT03238482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25092872|NCT03238482|Adrenergic Agents|adrenergic agents|mesh-ancestor
25092873|NCT03238482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25092982|NCT03237741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25092983|NCT03237533|Promethazine|promethazine|mesh-list
25092985|NCT03237533|Nystatin|nystatin|mesh-list
25092986|NCT03237533|Dexamethasone|dexamethasone|mesh-list
25092987|NCT03237533|Triamcinolone|triamcinolone|mesh-list
25092988|NCT03237533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25093002|NCT03237533|Antimalarials|antimalarials|mesh-ancestor
25093003|NCT03237533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25093004|NCT03237533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25093054|NCT03237624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25093065|NCT03237117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093142|NCT03236883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25093143|NCT03236883|Antimetabolites|antimetabolites|mesh-ancestor
25093219|NCT03236987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25093220|NCT03236987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093221|NCT03236987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25093222|NCT03236987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25093223|NCT03236987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25093224|NCT03236987|Antitubercular Agents|antitubercular agents|mesh-ancestor
25093225|NCT03236987|Leprostatic Agents|leprostatic agents|mesh-ancestor
25093236|NCT03236493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093238|NCT03236584|Lamivudine|lamivudine|mesh-list
25093239|NCT03236584|Adefovir|adefovir|mesh-list
25093240|NCT03236584|Antiviral Agents|antiviral agents|mesh-ancestor
25093241|NCT03236584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25093242|NCT03236584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25093243|NCT03236584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25093244|NCT03236584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25093245|NCT03236584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093246|NCT03236584|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25093247|NCT03236584|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25093248|NCT03236623|Menthol|menthol|mesh-list
25093249|NCT03236623|Antipruritics|antipruritics|mesh-ancestor
25093250|NCT03236623|Dermatologic Agents|dermatologic agents|mesh-ancestor
25093251|NCT03236324|Epinephrine|epinephrine|mesh-list
25093299|NCT03235947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25093300|NCT03235947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093301|NCT03235947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25093302|NCT03235947|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25093303|NCT03235947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25093304|NCT03235947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25093305|NCT03236155|Analgesics, Opioid|analgesics, opioid|mesh-list
25093306|NCT03236155|Narcotics|narcotics|mesh-ancestor
25093383|NCT03235700|Vasodilator Agents|vasodilator agents|mesh-ancestor
25093384|NCT03235700|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25093385|NCT03235700|Purinergic Agonists|purinergic agonists|mesh-ancestor
25093386|NCT03235700|Purinergic Agents|purinergic agents|mesh-ancestor
25093387|NCT03235700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25093388|NCT03235700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093389|NCT03235700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25093390|NCT03235700|Vitamin B Complex|vitamin b complex|mesh-ancestor
25093391|NCT03235700|Vitamins|vitamins|mesh-ancestor
25093392|NCT03235700|Micronutrients|micronutrients|mesh-ancestor
25093393|NCT03235778|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
25093394|NCT03235778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25093396|NCT03235778|Analgesics|analgesics|mesh-ancestor
25093445|NCT03234816|Sympathomimetics|sympathomimetics|mesh-ancestor
25093446|NCT03234816|Autonomic Agents|autonomic agents|mesh-ancestor
25093447|NCT03234816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25093448|NCT03234751|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25093449|NCT03234751|Natriuretic Agents|natriuretic agents|mesh-ancestor
25093450|NCT03234751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093451|NCT03234842|Paclitaxel|paclitaxel|mesh-list
25093452|NCT03234842|Carboplatin|carboplatin|mesh-list
25093453|NCT03234842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25093541|NCT03234660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25093542|NCT03234660|Analgesics|analgesics|mesh-ancestor
25093543|NCT03234660|Sensory System Agents|sensory system agents|mesh-ancestor
25093544|NCT03234660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25093545|NCT03234660|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25093546|NCT03234660|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25093547|NCT03234660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25093548|NCT03234660|Adrenergic Agents|adrenergic agents|mesh-ancestor
25093549|NCT03234660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25093550|NCT03234660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093551|NCT03234296|Metronidazole|metronidazole|mesh-list
25093552|NCT03234296|Levofloxacin|levofloxacin|mesh-list
25093553|NCT03234296|Ertapenem|ertapenem|mesh-list
25093554|NCT03234296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25093555|NCT03234296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25093556|NCT03234296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25093557|NCT03234296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25093558|NCT03234296|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25093572|NCT03234387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25093573|NCT03234387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093619|NCT03233776|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25093620|NCT03233776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25093621|NCT03233321|Heparin|heparin|mesh-list
25093622|NCT03233321|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25093623|NCT03233321|Tinzaparin|tinzaparin|mesh-list
25093624|NCT03233321|Dalteparin|dalteparin|mesh-list
25093625|NCT03233321|Anticoagulants|anticoagulants|mesh-ancestor
25093626|NCT03233321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25093627|NCT03233321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25093628|NCT03233321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093629|NCT03233412|Imiquimod|imiquimod|mesh-list
25093635|NCT03233295|Vitamin D|vitamin d|mesh-list
25093688|NCT03232710|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25093689|NCT03232710|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25093690|NCT03232710|Serotonin Agents|serotonin agents|mesh-ancestor
25093691|NCT03232710|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25093692|NCT03232710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25093693|NCT03232710|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25093694|NCT03232710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25093696|NCT03232554|Trace Elements|trace elements|mesh-ancestor
25093697|NCT03232554|Micronutrients|micronutrients|mesh-ancestor
25093698|NCT03232554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093699|NCT03232450|Aspirin|aspirin|mesh-list
25093700|NCT03232450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25093701|NCT03232450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25093702|NCT03232450|Analgesics|analgesics|mesh-ancestor
25093703|NCT03232450|Sensory System Agents|sensory system agents|mesh-ancestor
25093756|NCT03232307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25093757|NCT03232307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093765|NCT03232320|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25093767|NCT03232320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25093768|NCT03232320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25093830|NCT03231683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25093831|NCT03231683|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25093832|NCT03231683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25093833|NCT03231683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25093834|NCT03231683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25093835|NCT03231683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093836|NCT03231683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25093837|NCT03231683|Narcotics|narcotics|mesh-ancestor
25093838|NCT03231683|Antidepressive Agents|antidepressive agents|mesh-ancestor
25093927|NCT03230227|Sensory System Agents|sensory system agents|mesh-ancestor
25093928|NCT03230227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25093929|NCT03230162|Heparin|heparin|mesh-list
25093930|NCT03230162|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25093931|NCT03230162|Tinzaparin|tinzaparin|mesh-list
25093932|NCT03230162|Dalteparin|dalteparin|mesh-list
25093933|NCT03230162|Sildenafil Citrate|sildenafil citrate|mesh-list
25093934|NCT03230162|Anticoagulants|anticoagulants|mesh-ancestor
25093935|NCT03230162|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25093936|NCT03230162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25093937|NCT03230162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25093938|NCT03230162|Vasodilator Agents|vasodilator agents|mesh-ancestor
25093939|NCT03230162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25093940|NCT03230162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25093941|NCT03230162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25093942|NCT03230162|Urological Agents|urological agents|mesh-ancestor
25093943|NCT03229954|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25093944|NCT03229954|Hematinics|hematinics|mesh-ancestor
25093945|NCT03229746|Hydroxychloroquine|hydroxychloroquine|mesh-list
25093946|NCT03229746|Vincristine|vincristine|mesh-list
25093947|NCT03229746|Azathioprine|azathioprine|mesh-list
25093949|NCT03229746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477407|NCT00418509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477408|NCT00418509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24477409|NCT00418509|Respiratory System Agents|respiratory system agents|mesh-ancestor
25093996|NCT03230058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24770651|NCT01821612|Gemcitabine|gemcitabine|mesh-list
24770652|NCT01821612|Fluorouracil|fluorouracil|mesh-list
24770653|NCT01821612|Capecitabine|capecitabine|mesh-list
24770654|NCT01821612|Oxaliplatin|oxaliplatin|mesh-list
24770655|NCT01821612|Irinotecan|irinotecan|mesh-list
25094069|NCT03228992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094070|NCT03228992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094071|NCT03229278|Pembrolizumab|pembrolizumab|mesh-list
25094072|NCT03229278|Nivolumab|nivolumab|mesh-list
25094073|NCT03229278|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25094074|NCT03229278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25094075|NCT03229278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25406181|NCT03575403|Antidepressive Agents|antidepressive agents|mesh-ancestor
25094145|NCT03228771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094146|NCT03228771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25094147|NCT03228771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25094148|NCT03228771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094150|NCT03228576|Tacrolimus|tacrolimus|mesh-list
25094221|NCT03228108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25094222|NCT03228108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25094223|NCT03228108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094226|NCT03228108|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25094227|NCT03228108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25094228|NCT03228108|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25094229|NCT03228108|Renal Agents|renal agents|mesh-ancestor
25094230|NCT03228108|Antimalarials|antimalarials|mesh-ancestor
25094231|NCT03228108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25094232|NCT03228108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25094233|NCT03228108|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25094234|NCT03228108|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25094235|NCT03228108|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25094237|NCT03228030|Thiamine|thiamine|mesh-list
25094276|NCT03227679|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25094277|NCT03227679|Autonomic Agents|autonomic agents|mesh-ancestor
24457028|NCT00333008|Rituximab|rituximab|mesh-list
25094285|NCT03227679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25094286|NCT03227679|Antidepressive Agents|antidepressive agents|mesh-ancestor
25094287|NCT03227679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25094288|NCT03227679|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25094289|NCT03227679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25094290|NCT03227679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25094291|NCT03227679|Dopamine Agents|dopamine agents|mesh-ancestor
25094295|NCT03227705|Progesterone|progesterone|mesh-list
25094348|NCT03227432|Nivolumab|nivolumab|mesh-list
25094349|NCT03227432|Pomalidomide|pomalidomide|mesh-list
25094350|NCT03227432|Elotuzumab|elotuzumab|mesh-list
25094351|NCT03227432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25094352|NCT03227432|Antiemetics|antiemetics|mesh-ancestor
25094353|NCT03227432|Autonomic Agents|autonomic agents|mesh-ancestor
25094358|NCT03227432|Hormones|hormones|mesh-ancestor
24478806|NCT00424606|Antimitotic Agents|antimitotic agents|mesh-ancestor
25094430|NCT03226340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25094431|NCT03226340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25094432|NCT03226340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479022|NCT00425243|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25094440|NCT03226340|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25094441|NCT03226340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25094442|NCT03226340|Antimetabolites|antimetabolites|mesh-ancestor
25094443|NCT03226340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25094444|NCT03226340|Vitamin B Complex|vitamin b complex|mesh-ancestor
25094445|NCT03226340|Vitamins|vitamins|mesh-ancestor
25094446|NCT03226340|Micronutrients|micronutrients|mesh-ancestor
25094447|NCT03226210|Insulin|insulin|mesh-list
25094448|NCT03226210|Insulin Aspart|insulin aspart|mesh-list
25094449|NCT03226210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25094450|NCT03226210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094451|NCT03225937|Trastuzumab|trastuzumab|mesh-list
25094452|NCT03225937|Pertuzumab|pertuzumab|mesh-list
25094453|NCT03225937|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25094454|NCT03225937|Lapatinib|lapatinib|mesh-list
25094455|NCT03225937|Maytansine|maytansine|mesh-list
25094456|NCT03225937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25094457|NCT03225937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25094458|NCT03225937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25094487|NCT03225924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094488|NCT03225924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25094489|NCT03225924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25094490|NCT03225924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25094491|NCT03225924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25094492|NCT03225924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25094521|NCT03226145|Parasympatholytics|parasympatholytics|mesh-ancestor
25094523|NCT03225950|Immunologic Factors|immunologic factors|mesh-ancestor
25094577|NCT03224923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25094578|NCT03224923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25094579|NCT03224923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25094580|NCT03224923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441753|NCT00288236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25708290|NCT02247960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25708291|NCT02247960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094581|NCT03224923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25094584|NCT03224923|Antipyretics|antipyretics|mesh-ancestor
25094604|NCT03224637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094614|NCT03224871|Nivolumab|nivolumab|mesh-list
25094615|NCT03224871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25094616|NCT03224871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25094617|NCT03224871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25094618|NCT03224871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094619|NCT03224871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25094620|NCT03224871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25094664|NCT03224039|Anesthetics|anesthetics|mesh-ancestor
25094665|NCT03224416|Ethanol|ethanol|mesh-list
25094666|NCT03224416|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25094667|NCT03224416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25094668|NCT03224416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25094669|NCT03224416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094675|NCT03223844|Dextroamphetamine|dextroamphetamine|mesh-list
25094676|NCT03223844|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25094678|NCT03223844|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25094731|NCT03223220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25094732|NCT03223220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094733|NCT03223220|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25094735|NCT03223220|Anesthetics, General|anesthetics, general|mesh-ancestor
25094736|NCT03223220|Anesthetics|anesthetics|mesh-ancestor
25094737|NCT03223220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25094738|NCT03223220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25094739|NCT03223220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25094740|NCT03223220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25094741|NCT03223220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094745|NCT03223220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25094746|NCT03223220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25094747|NCT03223220|GABA Modulators|gaba modulators|mesh-ancestor
25094748|NCT03223220|GABA Agents|gaba agents|mesh-ancestor
25094795|NCT03222687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25094796|NCT03222687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25094806|NCT03222518|Sensory System Agents|sensory system agents|mesh-ancestor
25094807|NCT03222518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25094808|NCT03222518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094809|NCT03222518|Antipyretics|antipyretics|mesh-ancestor
25094810|NCT03222518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25094811|NCT03222518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25094812|NCT03222518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25094813|NCT03222518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094814|NCT03222518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24771464|NCT01827293|Antipruritics|antipruritics|mesh-ancestor
25095546|NCT03218254|Dopamine Agents|dopamine agents|mesh-ancestor
25094819|NCT03222206|Sensory System Agents|sensory system agents|mesh-ancestor
25094820|NCT03222206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25094821|NCT03222206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25094822|NCT03222206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25094869|NCT03222310|Antifungal Agents|antifungal agents|mesh-ancestor
25094870|NCT03222310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25094871|NCT03222310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25094872|NCT03222310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25094873|NCT03222310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094874|NCT03222310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25094875|NCT03222310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25094876|NCT03222310|Hormone Antagonists|hormone antagonists|mesh-ancestor
25094880|NCT03222167|Grazoprevir|grazoprevir|mesh-list
25094890|NCT03221816|Micronutrients|micronutrients|mesh-ancestor
25094966|NCT03221569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25094967|NCT03221569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25094969|NCT03221504|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25708292|NCT02247960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708293|NCT02247960|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25708294|NCT02247960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25708295|NCT02248480|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25708296|NCT02248480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25708297|NCT02248480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25094978|NCT03221504|Nasal Decongestants|nasal decongestants|mesh-ancestor
25094979|NCT03221504|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25094980|NCT03221504|Respiratory System Agents|respiratory system agents|mesh-ancestor
25095056|NCT03220815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095057|NCT03220815|Sympathomimetics|sympathomimetics|mesh-ancestor
25095058|NCT03220815|Autonomic Agents|autonomic agents|mesh-ancestor
25095059|NCT03220815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25095122|NCT03220555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25095123|NCT03220555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095126|NCT03220256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25095127|NCT03220256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25095128|NCT03220256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095129|NCT03220256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25095130|NCT03220256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095131|NCT03220256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25095132|NCT03220256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25095193|NCT03220152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25095194|NCT03220464|Interferons|interferons|mesh-list
25095195|NCT03220464|Interferon-gamma|interferon-gamma|mesh-list
25095196|NCT03220464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095197|NCT03220464|Antiviral Agents|antiviral agents|mesh-ancestor
25095198|NCT03220464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25095199|NCT03220126|Mirikizumab|mirikizumab|mesh-list
25095200|NCT03220126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25095201|NCT03220126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25095202|NCT03220126|Analgesics|analgesics|mesh-ancestor
25095203|NCT03220126|Sensory System Agents|sensory system agents|mesh-ancestor
25095204|NCT03220126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25095205|NCT03220126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095206|NCT03220126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25095207|NCT03220126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25095273|NCT03219983|Bupivacaine|bupivacaine|mesh-list
25095274|NCT03219983|Ropivacaine|ropivacaine|mesh-list
25095275|NCT03219983|Anesthetics, Local|anesthetics, local|mesh-ancestor
25095276|NCT03219983|Anesthetics|anesthetics|mesh-ancestor
25095277|NCT03219983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25095278|NCT03219983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095279|NCT03219983|Sensory System Agents|sensory system agents|mesh-ancestor
25095280|NCT03219983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25095281|NCT03219710|Dexamethasone|dexamethasone|mesh-list
25095282|NCT03219710|Ondansetron|ondansetron|mesh-list
25095283|NCT03219710|Olanzapine|olanzapine|mesh-list
25095284|NCT03219710|Aprepitant|aprepitant|mesh-list
25095285|NCT03219710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25095286|NCT03219710|Antiemetics|antiemetics|mesh-ancestor
25095287|NCT03219710|Autonomic Agents|autonomic agents|mesh-ancestor
25095288|NCT03219710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25095292|NCT03219710|Hormones|hormones|mesh-ancestor
25095544|NCT03218254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25095545|NCT03218254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095548|NCT03218280|Ascorbic Acid|ascorbic acid|mesh-list
25095549|NCT03218280|Vitamins|vitamins|mesh-ancestor
25095550|NCT03218280|Micronutrients|micronutrients|mesh-ancestor
25095551|NCT03218280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095552|NCT03218280|Antioxidants|antioxidants|mesh-ancestor
25095553|NCT03218280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095622|NCT03217292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095623|NCT03217292|Analgesics|analgesics|mesh-ancestor
25095624|NCT03217292|Sensory System Agents|sensory system agents|mesh-ancestor
25095625|NCT03217292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25095626|NCT03217448|Warfarin|warfarin|mesh-list
25095627|NCT03217448|Dabigatran|dabigatran|mesh-list
25095628|NCT03217448|Anticoagulants|anticoagulants|mesh-ancestor
25095629|NCT03217448|Antithrombins|antithrombins|mesh-ancestor
25095630|NCT03217448|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25095631|NCT03217448|Protease Inhibitors|protease inhibitors|mesh-ancestor
25095632|NCT03217448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25095633|NCT03217448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095634|NCT03217474|Ganciclovir|ganciclovir|mesh-list
25708298|NCT02248480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25708299|NCT02248480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708300|NCT02248480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25708301|NCT02248480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095635|NCT03217474|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25095636|NCT03217474|Antiviral Agents|antiviral agents|mesh-ancestor
25095641|NCT03217734|Adalimumab|adalimumab|mesh-list
25095712|NCT03216876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25095713|NCT03216876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25095714|NCT03217084|Fluorides|fluorides|mesh-list
25095715|NCT03217084|Fluorides, Topical|fluorides, topical|mesh-list
25095716|NCT03217084|Cariostatic Agents|cariostatic agents|mesh-ancestor
25095717|NCT03217084|Protective Agents|protective agents|mesh-ancestor
25095718|NCT03217084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095719|NCT03216941|Ketamine|ketamine|mesh-list
25095720|NCT03216941|Olanzapine|olanzapine|mesh-list
25095721|NCT03216941|Analgesics|analgesics|mesh-ancestor
25095722|NCT03216941|Sensory System Agents|sensory system agents|mesh-ancestor
25095723|NCT03216941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25095724|NCT03216941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095725|NCT03216941|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25095733|NCT03216941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095734|NCT03216941|Antiemetics|antiemetics|mesh-ancestor
24772466|NCT01833819|Lidocaine|lidocaine|mesh-list
25095735|NCT03216941|Autonomic Agents|autonomic agents|mesh-ancestor
25095736|NCT03216941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25095737|NCT03216941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25095738|NCT03216941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25095739|NCT03216941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25095740|NCT03216941|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25095741|NCT03216941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25096522|NCT03211065|Immunologic Factors|immunologic factors|mesh-ancestor
25095742|NCT03216941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25095743|NCT03216941|Serotonin Agents|serotonin agents|mesh-ancestor
25095745|NCT03216707|Antipruritics|antipruritics|mesh-ancestor
25095746|NCT03216707|Dermatologic Agents|dermatologic agents|mesh-ancestor
25095747|NCT03216707|Sensory System Agents|sensory system agents|mesh-ancestor
25095764|NCT03216278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095766|NCT03216356|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25095768|NCT03216356|Renal Agents|renal agents|mesh-ancestor
24481731|NCT00436709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095773|NCT03216356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095774|NCT03216473|Botulinum Toxins|botulinum toxins|mesh-list
25095775|NCT03216473|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25095776|NCT03216473|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25095851|NCT03216538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25095852|NCT03216538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25095853|NCT03216538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25095854|NCT03216538|Antiviral Agents|antiviral agents|mesh-ancestor
25095857|NCT03215875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25095858|NCT03215875|Diuretics|diuretics|mesh-ancestor
25095913|NCT03215966|Urological Agents|urological agents|mesh-ancestor
25095914|NCT03215966|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25095915|NCT03215966|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25095916|NCT03215966|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25095918|NCT03215498|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25095919|NCT03215498|Insulin Aspart|insulin aspart|mesh-list
25095920|NCT03215498|Insulin, Long-Acting|insulin, long-acting|mesh-list
25095922|NCT03215498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25095982|NCT03214731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25095983|NCT03214731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25095984|NCT03214731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25095985|NCT03214731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25095986|NCT03214731|Antiviral Agents|antiviral agents|mesh-ancestor
25095987|NCT03214731|Schistosomicides|schistosomicides|mesh-ancestor
25095988|NCT03214731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25095989|NCT03214731|Anthelmintics|anthelmintics|mesh-ancestor
25095990|NCT03214536|Ropivacaine|ropivacaine|mesh-list
25095991|NCT03214536|Anesthetics|anesthetics|mesh-ancestor
25095992|NCT03214536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25095993|NCT03214536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25095994|NCT03214536|Anesthetics, Local|anesthetics, local|mesh-ancestor
25095995|NCT03214536|Sensory System Agents|sensory system agents|mesh-ancestor
25096049|NCT03214510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25096050|NCT03214510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25096051|NCT03214510|Anesthetics, General|anesthetics, general|mesh-ancestor
25096053|NCT03214354|Alemtuzumab|alemtuzumab|mesh-list
25096054|NCT03214354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25096055|NCT03214354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25708302|NCT02248480|Analgesics|analgesics|mesh-ancestor
25708303|NCT02248480|Sensory System Agents|sensory system agents|mesh-ancestor
25708304|NCT02248480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25708305|NCT02248480|Antidepressive Agents|antidepressive agents|mesh-ancestor
24443148|NCT00293787|Adrenergic Agents|adrenergic agents|mesh-ancestor
25096056|NCT03214354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25096057|NCT03214354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25096058|NCT03214354|Antifungal Agents|antifungal agents|mesh-ancestor
25096059|NCT03214354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25096060|NCT03214354|Immunologic Factors|immunologic factors|mesh-ancestor
25096063|NCT03214393|Antibodies|antibodies|mesh-list
24413784|NCT00195208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413786|NCT00195286|Piperacillin|piperacillin|mesh-list
24413788|NCT00195286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24413836|NCT00195416|Etanercept|etanercept|mesh-list
25096137|NCT03213977|Hormones|hormones|mesh-ancestor
25096138|NCT03213977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25096139|NCT03213977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25096140|NCT03213977|Tubulin Modulators|tubulin modulators|mesh-ancestor
25096141|NCT03213977|Antimitotic Agents|antimitotic agents|mesh-ancestor
25096142|NCT03213977|Mitosis Modulators|mitosis modulators|mesh-ancestor
24620709|NCT01058382|Hormones|hormones|mesh-ancestor
24772919|NCT01836614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24772920|NCT01836614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24772921|NCT01836614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24772922|NCT01836614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25096143|NCT03213834|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25096144|NCT03213834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25096145|NCT03213834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25096208|NCT03213353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25096209|NCT03213353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096210|NCT03213353|Antipyretics|antipyretics|mesh-ancestor
25096211|NCT03213353|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25096212|NCT03213353|Mydriatics|mydriatics|mesh-ancestor
25096213|NCT03213353|Autonomic Agents|autonomic agents|mesh-ancestor
25096214|NCT03213353|Sympathomimetics|sympathomimetics|mesh-ancestor
25096215|NCT03213353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25096216|NCT03213353|Nasal Decongestants|nasal decongestants|mesh-ancestor
25096217|NCT03213353|Respiratory System Agents|respiratory system agents|mesh-ancestor
24830346|NCT02158702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25096218|NCT03213353|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25096281|NCT03213002|Temozolomide|temozolomide|mesh-list
25096282|NCT03213002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25096283|NCT03213002|Antimetabolites|antimetabolites|mesh-ancestor
25096284|NCT03213002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096285|NCT03213002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24772991|NCT01837251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25096359|NCT03212352|Misoprostol|misoprostol|mesh-list
25096413|NCT03211871|Dexmedetomidine|dexmedetomidine|mesh-list
25096429|NCT03211897|Olanzapine|olanzapine|mesh-list
25096430|NCT03211897|Haloperidol decanoate|haloperidol decanoate|mesh-list
25096431|NCT03211897|Ziprasidone|ziprasidone|mesh-list
25096432|NCT03211897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25096433|NCT03211897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25096434|NCT03211897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25096435|NCT03211897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096436|NCT03211897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25096437|NCT03211897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25096438|NCT03211897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25096439|NCT03211897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25096440|NCT03211897|Anesthetics, General|anesthetics, general|mesh-ancestor
25096441|NCT03211897|Anesthetics|anesthetics|mesh-ancestor
24773218|NCT01838473|Lobeline|lobeline|mesh-list
25096502|NCT03211650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25708306|NCT02248480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25708307|NCT02248480|Dopamine Agents|dopamine agents|mesh-ancestor
25708308|NCT02248636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
25708309|NCT02248636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25708310|NCT02248636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708311|NCT02248636|Cholinergic Agents|cholinergic agents|mesh-ancestor
25708312|NCT02248636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25708313|NCT02248636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708314|NCT02248961|Losartan|losartan|mesh-list
25708315|NCT02248961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25096503|NCT03211650|Immunologic Factors|immunologic factors|mesh-ancestor
25096504|NCT03211650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096505|NCT03211650|Viscosupplements|viscosupplements|mesh-ancestor
25096511|NCT03211455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096512|NCT03211455|Sensory System Agents|sensory system agents|mesh-ancestor
25096513|NCT03211455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25096514|NCT03211455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25096515|NCT03211455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25096516|NCT03211455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25096517|NCT03211455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25096518|NCT03211455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096519|NCT03211065|Immunoglobulins|immunoglobulins|mesh-list
25096520|NCT03211065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25096559|NCT03211195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096560|NCT03211195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25096561|NCT03211195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096562|NCT03210662|Pembrolizumab|pembrolizumab|mesh-list
25096563|NCT03210662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25096564|NCT03210662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25096565|NCT03210610|Colchicine|colchicine|mesh-list
25096566|NCT03210610|Gout Suppressants|gout suppressants|mesh-ancestor
25096567|NCT03210610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25096568|NCT03210610|Tubulin Modulators|tubulin modulators|mesh-ancestor
25096569|NCT03210610|Antimitotic Agents|antimitotic agents|mesh-ancestor
25096570|NCT03210610|Mitosis Modulators|mitosis modulators|mesh-ancestor
25096571|NCT03210610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096638|NCT03210324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25096639|NCT03210324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25096640|NCT03210324|Contraceptive Agents|contraceptive agents|mesh-ancestor
25096641|NCT03210324|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25096642|NCT03210324|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25096643|NCT03210324|Hormone Antagonists|hormone antagonists|mesh-ancestor
25096644|NCT03210324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25096645|NCT03210324|Luteolytic Agents|luteolytic agents|mesh-ancestor
25096646|NCT03210324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25096648|NCT03210480|Lithium Carbonate|lithium carbonate|mesh-list
25096707|NCT03209856|Micronutrients|micronutrients|mesh-ancestor
25097305|NCT03204877|Melatonin|melatonin|mesh-list
25096713|NCT03209856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096714|NCT03209856|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25096715|NCT03209622|Nicotine|nicotine|mesh-list
25096716|NCT03209622|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25096717|NCT03209622|Autonomic Agents|autonomic agents|mesh-ancestor
25096774|NCT03209180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25096775|NCT03209180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25096776|NCT03209180|Adrenergic Agents|adrenergic agents|mesh-ancestor
25096777|NCT03209180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25096778|NCT03209180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096779|NCT03209180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096780|NCT03209180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25096781|NCT03209180|Antioxidants|antioxidants|mesh-ancestor
25096782|NCT03209180|Protective Agents|protective agents|mesh-ancestor
25096783|NCT03209180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25096854|NCT03208764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25096855|NCT03208764|Respiratory System Agents|respiratory system agents|mesh-ancestor
25096856|NCT03208764|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25096857|NCT03208764|Antioxidants|antioxidants|mesh-ancestor
25096858|NCT03208764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096859|NCT03208764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25096860|NCT03208764|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25096861|NCT03208764|Vasodilator Agents|vasodilator agents|mesh-ancestor
25708316|NCT02248961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25708317|NCT02248961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25708318|NCT02248961|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25708319|NCT02248961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096862|NCT03208764|Gasotransmitters|gasotransmitters|mesh-ancestor
25096863|NCT03208764|Protective Agents|protective agents|mesh-ancestor
25096864|NCT03208894|Furosemide|furosemide|mesh-list
25096865|NCT03208894|Diuretics|diuretics|mesh-ancestor
25096866|NCT03208894|Natriuretic Agents|natriuretic agents|mesh-ancestor
25096867|NCT03208894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096868|NCT03208894|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25096869|NCT03208894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25096870|NCT03208894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096871|NCT03208712|Atezolizumab|atezolizumab|mesh-list
25096873|NCT03208998|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25096906|NCT03208452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708320|NCT02249091|Cytarabine|cytarabine|mesh-list
25708321|NCT02249091|Idarubicin|idarubicin|mesh-list
25096907|NCT03208452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25096908|NCT03208452|Tocolytic Agents|tocolytic agents|mesh-ancestor
25096909|NCT03208452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25096910|NCT03208465|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25096912|NCT03208465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25096913|NCT03208465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096915|NCT03208465|Hormones|hormones|mesh-ancestor
25096922|NCT03208218|Lenalidomide|lenalidomide|mesh-list
25096923|NCT03208218|Immunologic Factors|immunologic factors|mesh-ancestor
25096924|NCT03208218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096925|NCT03208218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25096926|NCT03208218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25096927|NCT03208218|Growth Substances|growth substances|mesh-ancestor
25096928|NCT03208218|Growth Inhibitors|growth inhibitors|mesh-ancestor
25096972|NCT03208426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25096974|NCT03208426|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25096975|NCT03208426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25096977|NCT03208101|Immunologic Factors|immunologic factors|mesh-ancestor
25096978|NCT03208101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25096979|NCT03208361|Amoxicillin|amoxicillin|mesh-list
25096980|NCT03208361|Penicillins|penicillins|mesh-list
25096981|NCT03208361|Penicillin V|penicillin v|mesh-list
25096982|NCT03208361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25096983|NCT03208361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25096984|NCT03208335|Endostatins|endostatins|mesh-list
25096985|NCT03208335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25096986|NCT03208335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25096987|NCT03208335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25096991|NCT03207698|Metformin|metformin|mesh-list
25097027|NCT03207334|Cytarabine|cytarabine|mesh-list
24413998|NCT00195780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484203|NCT00447018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484204|NCT00447031|Triamcinolone|triamcinolone|mesh-list
24484205|NCT00447031|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25097039|NCT03207334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25097040|NCT03207165|Dobutamine|dobutamine|mesh-list
25097041|NCT03207165|Milrinone|milrinone|mesh-list
25097042|NCT03207165|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-list
25097043|NCT03207165|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25097044|NCT03207165|Sympathomimetics|sympathomimetics|mesh-ancestor
25097045|NCT03207165|Autonomic Agents|autonomic agents|mesh-ancestor
25097046|NCT03207165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25097047|NCT03207165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097048|NCT03207165|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25097130|NCT03206671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25097131|NCT03206671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25097132|NCT03206671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25708322|NCT02249091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25708323|NCT02249091|Antimetabolites|antimetabolites|mesh-ancestor
25708324|NCT02249091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708325|NCT02249091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708326|NCT02249091|Antiviral Agents|antiviral agents|mesh-ancestor
25708327|NCT02249091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25097133|NCT03206671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25097135|NCT03206671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25097136|NCT03206671|Abortifacient Agents|abortifacient agents|mesh-ancestor
25097137|NCT03206671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25097138|NCT03206671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25097139|NCT03206671|Antimetabolites|antimetabolites|mesh-ancestor
25097140|NCT03206671|Dermatologic Agents|dermatologic agents|mesh-ancestor
25097141|NCT03206671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25097142|NCT03206671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25097143|NCT03206671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25097144|NCT03206671|Antiviral Agents|antiviral agents|mesh-ancestor
25097145|NCT03206671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24773975|NCT01843179|Cytarabine|cytarabine|mesh-list
25097146|NCT03206671|Tubulin Modulators|tubulin modulators|mesh-ancestor
25097147|NCT03206671|Antimitotic Agents|antimitotic agents|mesh-ancestor
25097148|NCT03206671|Mitosis Modulators|mitosis modulators|mesh-ancestor
25097149|NCT03206723|Hydrocodone|hydrocodone|mesh-list
25097150|NCT03206723|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25097183|NCT03206138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25097184|NCT03206138|Immunologic Factors|immunologic factors|mesh-ancestor
25097185|NCT03206138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097186|NCT03206138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097187|NCT03206138|Interferon Inducers|interferon inducers|mesh-ancestor
25097188|NCT03206177|Paclitaxel|paclitaxel|mesh-list
25097288|NCT03204734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25097289|NCT03204734|Antimetabolites|antimetabolites|mesh-ancestor
25097292|NCT03204760|Dexamethasone|dexamethasone|mesh-list
25097293|NCT03204760|Prednisolone|prednisolone|mesh-list
25097294|NCT03204760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25097295|NCT03204760|Antiemetics|antiemetics|mesh-ancestor
25097296|NCT03204760|Autonomic Agents|autonomic agents|mesh-ancestor
25097297|NCT03204760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25097298|NCT03204760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097299|NCT03204760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25097300|NCT03204760|Glucocorticoids|glucocorticoids|mesh-ancestor
25097301|NCT03204760|Hormones|hormones|mesh-ancestor
25097302|NCT03204760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25097303|NCT03204760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25097304|NCT03204760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097306|NCT03204877|Antioxidants|antioxidants|mesh-ancestor
25097339|NCT03204331|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25097341|NCT03204331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25097342|NCT03204331|Androgen Antagonists|androgen antagonists|mesh-ancestor
25097343|NCT03204331|Hormone Antagonists|hormone antagonists|mesh-ancestor
25097344|NCT03204578|Midazolam|midazolam|mesh-list
25097345|NCT03204578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25097346|NCT03204578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25097347|NCT03204578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25097348|NCT03204578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097349|NCT03204578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25097350|NCT03204578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25097351|NCT03204578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25097408|NCT03204006|Sensory System Agents|sensory system agents|mesh-ancestor
24830725|NCT02160587|Dermatologic Agents|dermatologic agents|mesh-ancestor
25097409|NCT03204006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25097410|NCT03204006|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25097411|NCT03204006|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25097412|NCT03204006|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25708328|NCT02249091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25708329|NCT02249091|Immunologic Factors|immunologic factors|mesh-ancestor
25708330|NCT02249091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708331|NCT02249091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25708332|NCT02249091|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25708333|NCT02249091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25097413|NCT03204006|Adrenergic Agents|adrenergic agents|mesh-ancestor
25097414|NCT03204006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25097415|NCT03204006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097417|NCT03204032|Temozolomide|temozolomide|mesh-list
25097419|NCT03204032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25097420|NCT03204032|Alkylating Agents|alkylating agents|mesh-ancestor
25097421|NCT03204032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097422|NCT03204032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097423|NCT03204032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24414050|NCT00195871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24414051|NCT00195871|Alkylating Agents|alkylating agents|mesh-ancestor
25097477|NCT03204019|Growth Substances|growth substances|mesh-ancestor
25097478|NCT03204019|Growth Inhibitors|growth inhibitors|mesh-ancestor
25097479|NCT03204019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25097481|NCT03203746|Lycopene|lycopene|mesh-list
25097482|NCT03203746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25097483|NCT03203746|Antioxidants|antioxidants|mesh-ancestor
25097484|NCT03203746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097485|NCT03203746|Protective Agents|protective agents|mesh-ancestor
25097486|NCT03203746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097487|NCT03203746|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25097488|NCT03203746|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25097489|NCT03203746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097546|NCT03203174|Cholinergic Agents|cholinergic agents|mesh-ancestor
25097547|NCT03203174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25097548|NCT03203174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097549|NCT03203174|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25097550|NCT03203174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25097551|NCT03202836|Tocolytic Agents|tocolytic agents|mesh-list
25097552|NCT03202836|Progesterone|progesterone|mesh-list
25097553|NCT03202836|Progestins|progestins|mesh-ancestor
25097554|NCT03202836|Hormones|hormones|mesh-ancestor
25097555|NCT03202836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24414052|NCT00195871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097556|NCT03202836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097557|NCT03202836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25097558|NCT03202979|Trazodone|trazodone|mesh-list
25097559|NCT03202979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25097560|NCT03202979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25097618|NCT03202784|Berotralstat|berotralstat|mesh-list
25097619|NCT03202784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25097620|NCT03202784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097621|NCT03202758|Durvalumab|durvalumab|mesh-list
25097622|NCT03202758|Tremelimumab|tremelimumab|mesh-list
25097623|NCT03202758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25097624|NCT03202758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097625|NCT03202563|Metformin|metformin|mesh-list
25097695|NCT03201861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25097696|NCT03201861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097697|NCT03201861|Tubulin Modulators|tubulin modulators|mesh-ancestor
25097698|NCT03201861|Antimitotic Agents|antimitotic agents|mesh-ancestor
25097700|NCT03201861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708334|NCT02249091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25708335|NCT02249182|Ribavirin|ribavirin|mesh-list
25708336|NCT02249182|Sofosbuvir|sofosbuvir|mesh-list
25708337|NCT02249182|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25708338|NCT02249182|Ledipasvir|ledipasvir|mesh-list
25708339|NCT02249182|Antimetabolites|antimetabolites|mesh-ancestor
25708340|NCT02249182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708341|NCT02249182|Antiviral Agents|antiviral agents|mesh-ancestor
25708342|NCT02249182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25708344|NCT02249585|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24443266|NCT00294359|Mitomycins|mitomycins|mesh-list
24774590|NCT01846559|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25097701|NCT03202147|Cromolyn Sodium|cromolyn sodium|mesh-list
25097702|NCT03202147|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
25097703|NCT03202147|Immunologic Factors|immunologic factors|mesh-ancestor
25097704|NCT03202147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097705|NCT03202147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25097706|NCT03202147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25097707|NCT03202147|Respiratory System Agents|respiratory system agents|mesh-ancestor
25097708|NCT03201913|Estrogens|estrogens|mesh-list
25097709|NCT03201913|Hormones|hormones|mesh-ancestor
25097710|NCT03201913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25097711|NCT03201913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097712|NCT03201796|Levofloxacin|levofloxacin|mesh-list
25097715|NCT03201796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25097716|NCT03201796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25097717|NCT03201796|Renal Agents|renal agents|mesh-ancestor
25097718|NCT03201796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25097719|NCT03201796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25097720|NCT03201796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25097721|NCT03201796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25097722|NCT03201796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097742|NCT03201627|Antimanic Agents|antimanic agents|mesh-ancestor
25097743|NCT03201627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25097744|NCT03201627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25097745|NCT03201627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097746|NCT03201835|Nabiximols|nabiximols|mesh-list
25097747|NCT03201835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097748|NCT03201835|Analgesics|analgesics|mesh-ancestor
25097749|NCT03201835|Sensory System Agents|sensory system agents|mesh-ancestor
25097750|NCT03201835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25097752|NCT03201952|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25097753|NCT03201952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25097754|NCT03201393|Acetaminophen|acetaminophen|mesh-list
25097756|NCT03201393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25097757|NCT03201393|Analgesics|analgesics|mesh-ancestor
25097758|NCT03201393|Sensory System Agents|sensory system agents|mesh-ancestor
25097759|NCT03201393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25097760|NCT03201393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097761|NCT03201393|Antipyretics|antipyretics|mesh-ancestor
25097762|NCT03201393|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25097763|NCT03201393|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25097764|NCT03201185|Ramipril|ramipril|mesh-list
25097765|NCT03201185|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25097766|NCT03201185|Protease Inhibitors|protease inhibitors|mesh-ancestor
25097767|NCT03201185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25097768|NCT03201185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097769|NCT03201185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25097770|NCT03201601|Inositol|inositol|mesh-list
25097771|NCT03201601|Vitamin B Complex|vitamin b complex|mesh-ancestor
25097772|NCT03201601|Vitamins|vitamins|mesh-ancestor
25097773|NCT03201601|Micronutrients|micronutrients|mesh-ancestor
25097774|NCT03201601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097775|NCT03201250|Dexamethasone|dexamethasone|mesh-list
25097776|NCT03201250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25097777|NCT03201250|Antiemetics|antiemetics|mesh-ancestor
25708345|NCT02249585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25708346|NCT02249585|Trace Elements|trace elements|mesh-ancestor
25708347|NCT02249585|Micronutrients|micronutrients|mesh-ancestor
25708348|NCT02249585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708349|NCT02249767|Tretinoin|tretinoin|mesh-list
25708350|NCT02249767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708351|NCT02249767|Keratolytic Agents|keratolytic agents|mesh-ancestor
24774729|NCT01847521|Protective Agents|protective agents|mesh-ancestor
25708352|NCT02249767|Dermatologic Agents|dermatologic agents|mesh-ancestor
25097778|NCT03201250|Autonomic Agents|autonomic agents|mesh-ancestor
25097779|NCT03201250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25097780|NCT03201250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097781|NCT03201250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25097782|NCT03201250|Glucocorticoids|glucocorticoids|mesh-ancestor
25097784|NCT03201250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25097785|NCT03201250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25097786|NCT03201250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097787|NCT03201380|Choline|choline|mesh-list
25097788|NCT03201380|Lipotropic Agents|lipotropic agents|mesh-ancestor
24414059|NCT00195871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24414060|NCT00195871|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25097790|NCT03201380|Antimetabolites|antimetabolites|mesh-ancestor
25097791|NCT03201380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097792|NCT03201380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25097793|NCT03201380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25097794|NCT03201380|Nootropic Agents|nootropic agents|mesh-ancestor
25097795|NCT03201159|Pentamidine|pentamidine|mesh-list
25097796|NCT03201159|Antifungal Agents|antifungal agents|mesh-ancestor
25097797|NCT03201159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25097798|NCT03201159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25097799|NCT03201159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25097800|NCT03201159|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25097801|NCT03201146|Cisplatin|cisplatin|mesh-list
25097802|NCT03201146|Carboplatin|carboplatin|mesh-list
25097803|NCT03201146|Pemetrexed|pemetrexed|mesh-list
25097804|NCT03201146|Apatinib|apatinib|mesh-list
25097805|NCT03201146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097806|NCT03201146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25097807|NCT03201146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097808|NCT03201146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25097809|NCT03201146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25097810|NCT03201146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25097811|NCT03201367|Rivaroxaban|rivaroxaban|mesh-list
25097812|NCT03201367|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25097813|NCT03201367|Antithrombins|antithrombins|mesh-ancestor
25097814|NCT03201367|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25097815|NCT03201367|Protease Inhibitors|protease inhibitors|mesh-ancestor
25097816|NCT03201367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25097817|NCT03201367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097819|NCT03200964|Anesthetics|anesthetics|mesh-list
25097820|NCT03200964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25097821|NCT03200964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097822|NCT03200938|Zinc|zinc|mesh-list
25097823|NCT03200938|Zinc Oxide|zinc oxide|mesh-list
25097824|NCT03200938|Trace Elements|trace elements|mesh-ancestor
25097825|NCT03200938|Micronutrients|micronutrients|mesh-ancestor
25097826|NCT03200938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097829|NCT03200938|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25097830|NCT03200938|Protective Agents|protective agents|mesh-ancestor
25097831|NCT03200821|Gemcitabine|gemcitabine|mesh-list
25097832|NCT03200821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25097833|NCT03200821|Antimetabolites|antimetabolites|mesh-ancestor
25097834|NCT03200821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097835|NCT03200821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097836|NCT03200821|Antiviral Agents|antiviral agents|mesh-ancestor
25097837|NCT03200821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25097838|NCT03200821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25097839|NCT03200821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25708354|NCT02249949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708355|NCT02250612|Timolol|timolol|mesh-list
25708356|NCT02250612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25708357|NCT02250612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25708358|NCT02250612|Adrenergic Agents|adrenergic agents|mesh-ancestor
25708359|NCT02250612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25708360|NCT02250612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097840|NCT03200821|Immunologic Factors|immunologic factors|mesh-ancestor
25097841|NCT03200821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097842|NCT03200782|Empagliflozin|empagliflozin|mesh-list
25097843|NCT03200782|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25097844|NCT03200782|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25097845|NCT03200782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097849|NCT03200847|Pembrolizumab|pembrolizumab|mesh-list
25097859|NCT03200691|Immunologic Factors|immunologic factors|mesh-ancestor
25097860|NCT03200691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097862|NCT03200886|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25097863|NCT03200886|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25097864|NCT03200886|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25097865|NCT03200886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25097866|NCT03200886|Glucocorticoids|glucocorticoids|mesh-ancestor
25097867|NCT03200886|Hormones|hormones|mesh-ancestor
25097868|NCT03200886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25097869|NCT03200886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097870|NCT03200886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25097871|NCT03200886|Immunologic Factors|immunologic factors|mesh-ancestor
25097872|NCT03200886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25097873|NCT03200886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097874|NCT03200600|Dexamethasone|dexamethasone|mesh-list
25097875|NCT03200600|Dexamethasone acetate|dexamethasone acetate|mesh-list
25097876|NCT03200600|Flurbiprofen|flurbiprofen|mesh-list
25097877|NCT03200600|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
25097878|NCT03200600|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25097886|NCT03200600|Glucocorticoids|glucocorticoids|mesh-ancestor
25097887|NCT03200600|Hormones|hormones|mesh-ancestor
25097888|NCT03200600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24414187|NCT00196586|Antimetabolites|antimetabolites|mesh-ancestor
24414188|NCT00196586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414226|NCT00196612|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24414227|NCT00196612|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25097889|NCT03200600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25097890|NCT03200600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25097891|NCT03200600|Protease Inhibitors|protease inhibitors|mesh-ancestor
25097892|NCT03200600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25097893|NCT03200600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25097894|NCT03200600|Analgesics|analgesics|mesh-ancestor
25097895|NCT03200600|Sensory System Agents|sensory system agents|mesh-ancestor
25097896|NCT03200600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25097897|NCT03200600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25097898|NCT03200600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25097899|NCT03200600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25097900|NCT03200561|Prednisolone|prednisolone|mesh-list
25097901|NCT03200561|Immunoglobulins|immunoglobulins|mesh-list
25097902|NCT03200561|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25097903|NCT03200561|Antibodies|antibodies|mesh-list
25097904|NCT03200561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25708361|NCT02250612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708362|NCT02250612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25708363|NCT02250612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25708364|NCT02250651|Timolol|timolol|mesh-list
25708365|NCT02250651|Bimatoprost|bimatoprost|mesh-list
25708366|NCT02250651|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25708367|NCT02250651|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25708368|NCT02250651|Adrenergic Agents|adrenergic agents|mesh-ancestor
25708369|NCT02250651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25708370|NCT02250651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708371|NCT02250651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708372|NCT02250651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25097905|NCT03200561|Glucocorticoids|glucocorticoids|mesh-ancestor
25097906|NCT03200561|Hormones|hormones|mesh-ancestor
25097908|NCT03200561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097962|NCT03200236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25098359|NCT03197571|Immunologic Factors|immunologic factors|mesh-ancestor
25097968|NCT03200184|Antiviral Agents|antiviral agents|mesh-ancestor
25097969|NCT03200184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25097970|NCT03199989|Capecitabine|capecitabine|mesh-list
25097980|NCT03200002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25097981|NCT03200002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25097982|NCT03200002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25097983|NCT03200002|Alkylating Agents|alkylating agents|mesh-ancestor
25098042|NCT03199690|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25098043|NCT03199690|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25098044|NCT03199690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25098045|NCT03199690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25098046|NCT03199690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25098047|NCT03199690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25098048|NCT03199690|Antiviral Agents|antiviral agents|mesh-ancestor
25098049|NCT03199950|Haloperidol|haloperidol|mesh-list
25098050|NCT03199950|Haloperidol decanoate|haloperidol decanoate|mesh-list
25098051|NCT03199950|Antiemetics|antiemetics|mesh-ancestor
24490333|NCT00477776|Metoclopramide|metoclopramide|mesh-list
24414228|NCT00196612|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24414229|NCT00196612|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24414230|NCT00196612|Antimetabolites|antimetabolites|mesh-ancestor
24414232|NCT00196625|Amprenavir|amprenavir|mesh-list
24414233|NCT00196625|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24414234|NCT00196625|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24414235|NCT00196625|Protease Inhibitors|protease inhibitors|mesh-ancestor
25098052|NCT03199950|Autonomic Agents|autonomic agents|mesh-ancestor
25098053|NCT03199950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25098054|NCT03199950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098055|NCT03199950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25098056|NCT03199950|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25098057|NCT03199950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25098058|NCT03199950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25098059|NCT03199950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25098060|NCT03199950|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25098097|NCT03199339|GABA Modulators|gaba modulators|mesh-ancestor
25098098|NCT03199339|GABA Agents|gaba agents|mesh-ancestor
25098099|NCT03199339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25098100|NCT03199339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708373|NCT02250651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25708374|NCT02250703|Midazolam|midazolam|mesh-list
25708375|NCT02250703|Dexmedetomidine|dexmedetomidine|mesh-list
25708376|NCT02250703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25708377|NCT02250703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25708378|NCT02250703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708379|NCT02250703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25708380|NCT02250703|Analgesics|analgesics|mesh-ancestor
25708381|NCT02250703|Sensory System Agents|sensory system agents|mesh-ancestor
25708382|NCT02250703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25708383|NCT02250703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25708384|NCT02250703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25708385|NCT02250703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25708386|NCT02250703|Adrenergic Agents|adrenergic agents|mesh-ancestor
25708387|NCT02250703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25708388|NCT02250703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098101|NCT03199339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25098102|NCT03199339|Antidepressive Agents|antidepressive agents|mesh-ancestor
25098103|NCT03199339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25098104|NCT03199339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25098105|NCT03199339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25098107|NCT03199339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25098108|NCT03199339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25098109|NCT03199339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25098110|NCT03199261|Exenatide|exenatide|mesh-list
25098111|NCT03199261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25098112|NCT03199261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098113|NCT03199261|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25098114|NCT03199261|Incretins|incretins|mesh-ancestor
25098115|NCT03199261|Hormones|hormones|mesh-ancestor
25098116|NCT03199261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25098122|NCT03199482|Dexamethasone|dexamethasone|mesh-list
25098123|NCT03199482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25098140|NCT03199430|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25098156|NCT03199521|Coagulants|coagulants|mesh-ancestor
25098157|NCT03199170|Morphine|morphine|mesh-list
25098158|NCT03199170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25098159|NCT03199170|Narcotics|narcotics|mesh-ancestor
25098160|NCT03199170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25098193|NCT03198702|Botulinum Toxins|botulinum toxins|mesh-list
25098194|NCT03198702|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25098195|NCT03198702|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25098196|NCT03198702|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25098197|NCT03198702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25098198|NCT03198702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098199|NCT03198702|Cholinergic Agents|cholinergic agents|mesh-ancestor
25098200|NCT03198702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25098201|NCT03198702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098202|NCT03198702|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25098203|NCT03198702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25098204|NCT03198676|Poly I-C|poly i-c|mesh-list
25098205|NCT03198676|Antiviral Agents|antiviral agents|mesh-ancestor
25098206|NCT03198676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25098207|NCT03198676|Interferon Inducers|interferon inducers|mesh-ancestor
25098208|NCT03198676|Immunologic Factors|immunologic factors|mesh-ancestor
25098209|NCT03198676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098210|NCT03198585|Empagliflozin|empagliflozin|mesh-list
25098270|NCT03198195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098291|NCT03197961|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25098292|NCT03197961|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25098293|NCT03197961|Contraceptive Agents|contraceptive agents|mesh-ancestor
24730415|NCT01627873|Fentanyl|fentanyl|mesh-list
25098294|NCT03197961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25098295|NCT03197961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098296|NCT03197961|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25098297|NCT03197961|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25098298|NCT03197961|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25098299|NCT03197961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25098300|NCT03197961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25098301|NCT03197779|Aspirin|aspirin|mesh-list
25098302|NCT03197779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25098303|NCT03197779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25098304|NCT03197779|Analgesics|analgesics|mesh-ancestor
25098305|NCT03197779|Sensory System Agents|sensory system agents|mesh-ancestor
25098306|NCT03197779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25098307|NCT03197779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098308|NCT03197779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24775368|NCT01851824|Anticoagulants|anticoagulants|mesh-ancestor
25098313|NCT03197779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25098314|NCT03197779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25098315|NCT03197779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25098316|NCT03197779|Antipyretics|antipyretics|mesh-ancestor
25098317|NCT03197818|Budesonide|budesonide|mesh-list
25098340|NCT03197636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25098341|NCT03197623|Alendronate|alendronate|mesh-list
25098342|NCT03197623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25098343|NCT03197623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098344|NCT03197571|Leucovorin|leucovorin|mesh-list
25098345|NCT03197571|Paclitaxel|paclitaxel|mesh-list
25098346|NCT03197571|Cyclophosphamide|cyclophosphamide|mesh-list
25098347|NCT03197571|Bevacizumab|bevacizumab|mesh-list
25098348|NCT03197571|Fluorouracil|fluorouracil|mesh-list
25098349|NCT03197571|Capecitabine|capecitabine|mesh-list
25098350|NCT03197571|Fulvestrant|fulvestrant|mesh-list
25098351|NCT03197571|Avelumab|avelumab|mesh-list
25098352|NCT03197571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25098353|NCT03197571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25098354|NCT03197571|Tubulin Modulators|tubulin modulators|mesh-ancestor
25098355|NCT03197571|Antimitotic Agents|antimitotic agents|mesh-ancestor
25098356|NCT03197571|Mitosis Modulators|mitosis modulators|mesh-ancestor
25098357|NCT03197571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098358|NCT03197571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25098421|NCT03197584|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25098422|NCT03197584|Hormone Antagonists|hormone antagonists|mesh-ancestor
25098423|NCT03197584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25098424|NCT03197493|Levodopa|levodopa|mesh-list
25098425|NCT03197493|Carbidopa|carbidopa|mesh-list
25098426|NCT03197493|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25098427|NCT03197493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25098428|NCT03197493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25098429|NCT03197493|Dopamine Agents|dopamine agents|mesh-ancestor
25098430|NCT03197493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25098431|NCT03197493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098432|NCT03197493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098433|NCT03197493|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25098434|NCT03197493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25098435|NCT03197493|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25098436|NCT03197493|Immunologic Factors|immunologic factors|mesh-ancestor
25098437|NCT03197493|Dopamine Agonists|dopamine agonists|mesh-ancestor
25098445|NCT03197480|Aflibercept|aflibercept|mesh-list
25098446|NCT03197480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25098447|NCT03197480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24492362|NCT00485979|Trastuzumab|trastuzumab|mesh-list
24414236|NCT00196625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25098448|NCT03197480|Growth Substances|growth substances|mesh-ancestor
25098449|NCT03197480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098450|NCT03197480|Growth Inhibitors|growth inhibitors|mesh-ancestor
25098451|NCT03197480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25098452|NCT03197402|Caseins|caseins|mesh-list
25098453|NCT03197402|Chelating Agents|chelating agents|mesh-ancestor
25098454|NCT03197402|Sequestering Agents|sequestering agents|mesh-ancestor
25099127|NCT03193424|Apatinib|apatinib|mesh-list
25098455|NCT03197402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098456|NCT03197298|Clopidogrel|clopidogrel|mesh-list
25098458|NCT03197298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25098459|NCT03197298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25098460|NCT03197298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25098461|NCT03197298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25098462|NCT03197298|Purinergic Agents|purinergic agents|mesh-ancestor
25098463|NCT03197298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25098464|NCT03197298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098465|NCT03197298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098466|NCT03197207|Camphor|camphor|mesh-list
25098467|NCT03197207|Salicylates|salicylates|mesh-list
25708389|NCT02250703|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25708390|NCT02250703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25708391|NCT02250703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25708392|NCT02250703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25708393|NCT02250703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25708394|NCT02250703|Anesthetics, General|anesthetics, general|mesh-ancestor
25708395|NCT02250703|Anesthetics|anesthetics|mesh-ancestor
25708396|NCT02250703|GABA Modulators|gaba modulators|mesh-ancestor
25708397|NCT02250703|GABA Agents|gaba agents|mesh-ancestor
25708398|NCT02250807|Sofosbuvir|sofosbuvir|mesh-list
25098468|NCT03197207|Methyl salicylate|methyl salicylate|mesh-list
25098469|NCT03197207|Menthol|menthol|mesh-list
25098470|NCT03197207|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25098471|NCT03197207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25098472|NCT03197207|Antipruritics|antipruritics|mesh-ancestor
25098473|NCT03197207|Dermatologic Agents|dermatologic agents|mesh-ancestor
25098501|NCT03197233|Protective Agents|protective agents|mesh-ancestor
25098502|NCT03197233|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25098503|NCT03197233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25098504|NCT03197233|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25098505|NCT03197077|Contraceptive Agents|contraceptive agents|mesh-list
25098506|NCT03197077|Desogestrel|desogestrel|mesh-list
25098507|NCT03197077|Contraceptives, Oral|contraceptives, oral|mesh-list
25098508|NCT03197077|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25098509|NCT03197077|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25098510|NCT03197077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25098511|NCT03197077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098512|NCT03197077|Hormones|hormones|mesh-ancestor
25098513|NCT03197077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25098514|NCT03197077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25098518|NCT03197077|Progestins|progestins|mesh-ancestor
25098530|NCT03196986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25098531|NCT03196986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25098532|NCT03196986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25098533|NCT03196986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24775636|NCT01853956|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25098534|NCT03196986|Growth Substances|growth substances|mesh-ancestor
25098535|NCT03196986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098536|NCT03196986|Growth Inhibitors|growth inhibitors|mesh-ancestor
25098537|NCT03196934|Cannabidiol|cannabidiol|mesh-list
25098538|NCT03196934|Anticonvulsants|anticonvulsants|mesh-ancestor
25098539|NCT03197012|Octreotide|octreotide|mesh-list
25098540|NCT03197012|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
25098541|NCT03197012|Edotreotide|edotreotide|mesh-list
25098542|NCT03197012|Chelating Agents|chelating agents|mesh-ancestor
25098543|NCT03197012|Sequestering Agents|sequestering agents|mesh-ancestor
25098544|NCT03197012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098545|NCT03197012|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25098546|NCT03197012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25098547|NCT03197012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25098549|NCT03197103|Acetylcysteine|acetylcysteine|mesh-list
25098552|NCT03197103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25098553|NCT03197103|Expectorants|expectorants|mesh-ancestor
25098554|NCT03197103|Respiratory System Agents|respiratory system agents|mesh-ancestor
25098576|NCT03196817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25098577|NCT03196817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098578|NCT03196817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25098579|NCT03196817|Glucocorticoids|glucocorticoids|mesh-ancestor
25098580|NCT03196817|Hormones|hormones|mesh-ancestor
25708399|NCT02250807|Simeprevir|simeprevir|mesh-list
25708400|NCT02250807|Antiviral Agents|antiviral agents|mesh-ancestor
25708401|NCT02250807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25708402|NCT02250807|Protease Inhibitors|protease inhibitors|mesh-ancestor
25708403|NCT02250807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25708404|NCT02250807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708405|NCT02251236|Tenofovir|tenofovir|mesh-list
25708406|NCT02251236|Emtricitabine|emtricitabine|mesh-list
25708407|NCT02251236|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25708408|NCT02251236|Cobicistat|cobicistat|mesh-list
25708409|NCT02251236|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25709757|NCT02274766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708410|NCT02251236|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25708411|NCT02251236|Elvitegravir|elvitegravir|mesh-list
25098581|NCT03196817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25098582|NCT03196817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25098583|NCT03196817|Respiratory System Agents|respiratory system agents|mesh-ancestor
25098584|NCT03197155|Antiviral Agents|antiviral agents|mesh-list
25098585|NCT03197155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25098587|NCT03196882|Trace Elements|trace elements|mesh-ancestor
25098588|NCT03196882|Micronutrients|micronutrients|mesh-ancestor
25098589|NCT03196882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098590|NCT03196843|Raltitrexed|raltitrexed|mesh-list
25098591|NCT03196843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25098592|NCT03196843|Antimetabolites|antimetabolites|mesh-ancestor
25098635|NCT03196466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25098636|NCT03196466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25098638|NCT03196466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25098639|NCT03196466|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25098655|NCT03196466|GABA Agonists|gaba agonists|mesh-ancestor
25098656|NCT03196466|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
25098657|NCT03196466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25098682|NCT03196531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25098683|NCT03196531|Histamine Antagonists|histamine antagonists|mesh-ancestor
25098684|NCT03196531|Histamine Agents|histamine agents|mesh-ancestor
25098685|NCT03196531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25098686|NCT03196531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098687|NCT03196531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098688|NCT03196362|Metformin|metformin|mesh-list
25098689|NCT03196362|Pioglitazone|pioglitazone|mesh-list
25098690|NCT03196362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25098751|NCT03195673|Adrenergic Agents|adrenergic agents|mesh-ancestor
25098752|NCT03195673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25098753|NCT03195673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25098754|NCT03195673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25098755|NCT03195673|Urological Agents|urological agents|mesh-ancestor
25098756|NCT03195933|Hydrocortisone|hydrocortisone|mesh-list
25098762|NCT03195530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25098779|NCT03195491|Nivolumab|nivolumab|mesh-list
25098873|NCT03195023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25098875|NCT03195023|Vasodilator Agents|vasodilator agents|mesh-ancestor
25098876|NCT03195023|Diuretics|diuretics|mesh-ancestor
25098877|NCT03195023|Natriuretic Agents|natriuretic agents|mesh-ancestor
25098878|NCT03195023|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25098879|NCT03195023|Protease Inhibitors|protease inhibitors|mesh-ancestor
25098880|NCT03195023|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25098881|NCT03195023|Protective Agents|protective agents|mesh-ancestor
25098882|NCT03194815|Rituximab|rituximab|mesh-list
25098883|NCT03194815|Immunoglobulins|immunoglobulins|mesh-list
25098884|NCT03194815|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25098885|NCT03194815|Antibodies|antibodies|mesh-list
25098886|NCT03194815|gamma-Globulins|gamma-globulins|mesh-list
25098887|NCT03194815|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25098889|NCT03194815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25098968|NCT03194555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25099012|NCT03194061|Cisplatin|cisplatin|mesh-list
25099013|NCT03194061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099014|NCT03194074|Propofol|propofol|mesh-list
25099015|NCT03194074|Desflurane|desflurane|mesh-list
25099016|NCT03194074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25099017|NCT03194074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25099018|NCT03194074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099019|NCT03194074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25099020|NCT03194074|Anesthetics, General|anesthetics, general|mesh-ancestor
25099121|NCT03193502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25099122|NCT03193502|Protease Inhibitors|protease inhibitors|mesh-ancestor
25099123|NCT03193502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25708412|NCT02251236|Antiviral Agents|antiviral agents|mesh-ancestor
25708413|NCT02251236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25099124|NCT03193502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099125|NCT03193502|Anticoagulants|anticoagulants|mesh-ancestor
25099134|NCT03193424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25099135|NCT03193359|Botulinum Toxins|botulinum toxins|mesh-list
25099136|NCT03193359|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25099218|NCT03192943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099219|NCT03192943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25099221|NCT03193112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25099222|NCT03193112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25099225|NCT03192969|Glucocorticoids|glucocorticoids|mesh-list
25099226|NCT03192969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25099227|NCT03192969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099228|NCT03192969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099229|NCT03192969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25099230|NCT03192969|Immunologic Factors|immunologic factors|mesh-ancestor
25099231|NCT03192969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099233|NCT03192969|Hormones|hormones|mesh-ancestor
25099241|NCT03192566|Antipyretics|antipyretics|mesh-ancestor
25099242|NCT03192618|Leucovorin|leucovorin|mesh-list
25099243|NCT03192618|Oxaliplatin|oxaliplatin|mesh-list
25099244|NCT03192618|Calcium|calcium|mesh-list
25099245|NCT03192618|Levoleucovorin|levoleucovorin|mesh-list
25099246|NCT03192618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25099247|NCT03192618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099248|NCT03192618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099249|NCT03192618|Antidotes|antidotes|mesh-ancestor
25099250|NCT03192618|Protective Agents|protective agents|mesh-ancestor
25099251|NCT03192618|Vitamin B Complex|vitamin b complex|mesh-ancestor
25099252|NCT03192618|Vitamins|vitamins|mesh-ancestor
25099253|NCT03192618|Micronutrients|micronutrients|mesh-ancestor
25099254|NCT03192579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25099255|NCT03192579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25099256|NCT03192579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25099257|NCT03192579|Antimetabolites|antimetabolites|mesh-ancestor
25099258|NCT03192579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099259|NCT03192579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25099269|NCT03192644|Leucovorin|leucovorin|mesh-list
25099291|NCT03192527|Contraceptive Agents|contraceptive agents|mesh-ancestor
25099292|NCT03192527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25099293|NCT03192527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099294|NCT03192527|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25099295|NCT03192527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25099296|NCT03192527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25099297|NCT03192709|Sildenafil Citrate|sildenafil citrate|mesh-list
25099298|NCT03192709|Vasodilator Agents|vasodilator agents|mesh-ancestor
25099299|NCT03192709|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25099300|NCT03192709|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25099301|NCT03192709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25099302|NCT03192709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099303|NCT03192709|Urological Agents|urological agents|mesh-ancestor
25099304|NCT03192449|Albendazole|albendazole|mesh-list
25099305|NCT03192449|Anthelmintics|anthelmintics|mesh-ancestor
25099306|NCT03192449|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25099375|NCT03192059|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25099376|NCT03192059|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25099377|NCT03192059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25099484|NCT03190694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25099486|NCT03190694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099487|NCT03190603|Celecoxib|celecoxib|mesh-list
25099488|NCT03190603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25099489|NCT03190603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25099490|NCT03190603|Analgesics|analgesics|mesh-ancestor
25099491|NCT03190603|Sensory System Agents|sensory system agents|mesh-ancestor
25099494|NCT03190603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25099495|NCT03190603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25099584|NCT03189069|Dabigatran|dabigatran|mesh-list
25099585|NCT03189069|Apixaban|apixaban|mesh-list
25099586|NCT03189069|Anticoagulants|anticoagulants|mesh-ancestor
25099617|NCT03188835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099618|NCT03188445|Ascorbic Acid|ascorbic acid|mesh-list
25099619|NCT03188445|Ferrous fumarate|ferrous fumarate|mesh-list
25099620|NCT03188445|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25099621|NCT03188445|Antioxidants|antioxidants|mesh-ancestor
25099633|NCT03188471|Analgesics|analgesics|mesh-ancestor
25099634|NCT03188471|Sensory System Agents|sensory system agents|mesh-ancestor
25406182|NCT03575403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25708414|NCT02251236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25099635|NCT03188471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25099636|NCT03188471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25099747|NCT03187691|Amphotericin B|amphotericin b|mesh-list
25099748|NCT03187691|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25099749|NCT03187691|Amebicides|amebicides|mesh-ancestor
25099750|NCT03187691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25099751|NCT03187691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25099752|NCT03187691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25099753|NCT03187691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25099754|NCT03187691|Antifungal Agents|antifungal agents|mesh-ancestor
25099755|NCT03187626|Botulinum Toxins|botulinum toxins|mesh-list
25099756|NCT03187626|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25099757|NCT03187626|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25099758|NCT03187626|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25099759|NCT03187626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25099832|NCT03187496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25099833|NCT03187496|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25099834|NCT03187496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25099835|NCT03187496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099836|NCT03187496|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25099837|NCT03187496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25099838|NCT03187496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25099839|NCT03187496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25099840|NCT03187496|Anesthetics, General|anesthetics, general|mesh-ancestor
25099918|NCT03186664|Nabiximols|nabiximols|mesh-list
25099919|NCT03186664|Analgesics|analgesics|mesh-ancestor
25099920|NCT03186664|Sensory System Agents|sensory system agents|mesh-ancestor
25099921|NCT03186664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25099922|NCT03186664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099923|NCT03186586|Ulipristal acetate|ulipristal acetate|mesh-list
25099924|NCT03186586|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25099969|NCT03186053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25099970|NCT03186352|Anti-Infective Agents|anti-infective agents|mesh-list
25099971|NCT03186352|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24777228|NCT01863147|Acarbose|acarbose|mesh-list
25099984|NCT03186365|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25099986|NCT03186365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25099987|NCT03186443|Pregabalin|pregabalin|mesh-list
25099988|NCT03186443|Gabapentin|gabapentin|mesh-list
25099989|NCT03186443|Analgesics|analgesics|mesh-ancestor
25099990|NCT03186443|Sensory System Agents|sensory system agents|mesh-ancestor
25099991|NCT03186443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100000|NCT03186443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25100082|NCT03185364|Sildenafil Citrate|sildenafil citrate|mesh-list
25100083|NCT03185364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100084|NCT03185364|Vasodilator Agents|vasodilator agents|mesh-ancestor
25100089|NCT03185403|Sufentanil|sufentanil|mesh-list
25100114|NCT03185351|Sensory System Agents|sensory system agents|mesh-ancestor
25100115|NCT03185351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100116|NCT03185351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25100117|NCT03185351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25100118|NCT03185351|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25100119|NCT03185351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25100120|NCT03185351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25100121|NCT03185351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25100122|NCT03185351|Anesthetics, General|anesthetics, general|mesh-ancestor
25100123|NCT03185351|GABA Modulators|gaba modulators|mesh-ancestor
25100124|NCT03185351|GABA Agents|gaba agents|mesh-ancestor
25100125|NCT03185351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25100193|NCT03184870|Protective Agents|protective agents|mesh-ancestor
25100194|NCT03184870|Vitamin B Complex|vitamin b complex|mesh-ancestor
25100195|NCT03184870|Vitamins|vitamins|mesh-ancestor
25100206|NCT03185130|Sensory System Agents|sensory system agents|mesh-ancestor
25100207|NCT03185130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100208|NCT03185130|Antiemetics|antiemetics|mesh-ancestor
25100209|NCT03185130|Autonomic Agents|autonomic agents|mesh-ancestor
25100210|NCT03185130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25100293|NCT03184766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25100294|NCT03184766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25100295|NCT03184766|Analgesics|analgesics|mesh-ancestor
25100296|NCT03184766|Sensory System Agents|sensory system agents|mesh-ancestor
25100297|NCT03184766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25708415|NCT02251236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25100298|NCT03184766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708416|NCT02251236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100299|NCT03184766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25100300|NCT03184766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25100301|NCT03184766|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25100302|NCT03184766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100303|NCT03184766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100304|NCT03184766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25100305|NCT03184766|Autonomic Agents|autonomic agents|mesh-ancestor
25100325|NCT03184194|Nivolumab|nivolumab|mesh-list
25100359|NCT03183674|Oxytocin|oxytocin|mesh-list
25100360|NCT03183674|Oxytocics|oxytocics|mesh-ancestor
25100361|NCT03183674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25100362|NCT03183674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100363|NCT03183596|Dexamethasone|dexamethasone|mesh-list
25100364|NCT03183596|Bupivacaine|bupivacaine|mesh-list
25100365|NCT03183596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25100366|NCT03183596|Antiemetics|antiemetics|mesh-ancestor
25100367|NCT03183596|Autonomic Agents|autonomic agents|mesh-ancestor
25100370|NCT03183596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25100371|NCT03183596|Glucocorticoids|glucocorticoids|mesh-ancestor
25100372|NCT03183596|Hormones|hormones|mesh-ancestor
25100373|NCT03183596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25100374|NCT03183596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25100375|NCT03183596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25100376|NCT03183596|Anesthetics, Local|anesthetics, local|mesh-ancestor
25100377|NCT03183596|Anesthetics|anesthetics|mesh-ancestor
25100378|NCT03183596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25100379|NCT03183596|Sensory System Agents|sensory system agents|mesh-ancestor
25100380|NCT03183557|Vitamin D|vitamin d|mesh-list
25100381|NCT03183557|Zoledronic Acid|zoledronic acid|mesh-list
25100438|NCT03182894|Pembrolizumab|pembrolizumab|mesh-list
25100439|NCT03182894|Azacitidine|azacitidine|mesh-list
25100440|NCT03182894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25100441|NCT03182894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25100442|NCT03182894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25100489|NCT03182413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25100490|NCT03182413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25100491|NCT03182413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100492|NCT03182504|Meropenem|meropenem|mesh-list
25100493|NCT03182504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25100503|NCT03182218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25100570|NCT03181880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25100571|NCT03181880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100572|NCT03181880|Anticonvulsants|anticonvulsants|mesh-ancestor
25100573|NCT03182114|Bupivacaine|bupivacaine|mesh-list
25100574|NCT03182114|Anesthetics, Local|anesthetics, local|mesh-ancestor
25100575|NCT03182114|Anesthetics|anesthetics|mesh-ancestor
25100576|NCT03182114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25100577|NCT03182114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100578|NCT03182114|Sensory System Agents|sensory system agents|mesh-ancestor
25100579|NCT03182114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25100580|NCT03181763|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25100581|NCT03181763|Hallucinogens|hallucinogens|mesh-ancestor
25100582|NCT03181763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708417|NCT02251236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708418|NCT02251236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25708419|NCT02251236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25708420|NCT02251236|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25708421|NCT02251236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25708422|NCT02251236|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25708423|NCT02251275|Tolvaptan|tolvaptan|mesh-list
25708424|NCT02251275|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25708425|NCT02251275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708426|NCT02251275|Natriuretic Agents|natriuretic agents|mesh-ancestor
25708427|NCT02251275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100683|NCT03180723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25100684|NCT03180723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100685|NCT03180723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25100711|NCT03180632|GABA Agents|gaba agents|mesh-ancestor
25100712|NCT03180632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25100713|NCT03180632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100714|NCT03180671|Salicylic Acid|salicylic acid|mesh-list
25100715|NCT03180671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25100716|NCT03180671|Antifungal Agents|antifungal agents|mesh-ancestor
25100717|NCT03180671|Keratolytic Agents|keratolytic agents|mesh-ancestor
25100826|NCT03179839|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25100831|NCT03179813|Hydrocortisone|hydrocortisone|mesh-list
25100873|NCT03178994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100874|NCT03178994|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25100875|NCT03179254|Metformin|metformin|mesh-list
25100876|NCT03179254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25100877|NCT03179254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100879|NCT03178708|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25100880|NCT03178708|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25100881|NCT03178708|Antiviral Agents|antiviral agents|mesh-ancestor
25100882|NCT03178708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25100883|NCT03178708|Dopamine Agents|dopamine agents|mesh-ancestor
25100884|NCT03178708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25100965|NCT03178422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25100966|NCT03178422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25100967|NCT03178422|Cholinergic Agents|cholinergic agents|mesh-ancestor
25100968|NCT03178422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25100969|NCT03178422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100972|NCT03178396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25100973|NCT03178396|Protective Agents|protective agents|mesh-ancestor
25100974|NCT03178396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25100975|NCT03178396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25100976|NCT03178409|Liver Extracts|liver extracts|mesh-list
25100977|NCT03178409|Hematinics|hematinics|mesh-ancestor
25100978|NCT03178539|Diclofenac|diclofenac|mesh-list
25101047|NCT03177824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101048|NCT03177824|Vasodilator Agents|vasodilator agents|mesh-ancestor
25101049|NCT03177824|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25101050|NCT03177824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25101051|NCT03177824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25101052|NCT03177824|Urological Agents|urological agents|mesh-ancestor
25101053|NCT03177837|Acetazolamide|acetazolamide|mesh-list
25101113|NCT03177538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25101123|NCT03177174|Antimitotic Agents|antimitotic agents|mesh-ancestor
25101124|NCT03177174|Mitosis Modulators|mitosis modulators|mesh-ancestor
25101125|NCT03177174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101127|NCT03177252|Bupivacaine|bupivacaine|mesh-list
25101128|NCT03177252|Anesthetics, Local|anesthetics, local|mesh-ancestor
25101129|NCT03177252|Anesthetics|anesthetics|mesh-ancestor
25101130|NCT03177252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25406183|NCT03575325|Cytarabine|cytarabine|mesh-list
25708428|NCT02251379|Fluticasone|fluticasone|mesh-list
25708429|NCT02251379|Xhance|xhance|mesh-list
25708430|NCT02251379|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25708431|NCT02251379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25708432|NCT02251379|Autonomic Agents|autonomic agents|mesh-ancestor
25708433|NCT02251379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25708434|NCT02251379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708435|NCT02251379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25101289|NCT03175926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101290|NCT03175926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101291|NCT03175926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25101292|NCT03175926|Respiratory System Agents|respiratory system agents|mesh-ancestor
25101293|NCT03175926|Glucocorticoids|glucocorticoids|mesh-ancestor
25101294|NCT03175926|Hormones|hormones|mesh-ancestor
25101295|NCT03175926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25101296|NCT03175679|Interleukin-2|interleukin-2|mesh-list
25101397|NCT03175042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25101398|NCT03175042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25101399|NCT03175081|Ropivacaine|ropivacaine|mesh-list
25101400|NCT03175081|Anesthetics, Local|anesthetics, local|mesh-ancestor
25101401|NCT03175081|Anesthetics|anesthetics|mesh-ancestor
25101402|NCT03175081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25101403|NCT03175081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101404|NCT03175081|Sensory System Agents|sensory system agents|mesh-ancestor
25101405|NCT03175081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101498|NCT03174171|Everolimus|everolimus|mesh-list
25101518|NCT03174236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25101519|NCT03174236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25101520|NCT03174236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101521|NCT03174288|Spironolactone|spironolactone|mesh-list
25101522|NCT03174288|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25101523|NCT03174288|Hormone Antagonists|hormone antagonists|mesh-ancestor
25101524|NCT03174288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25101525|NCT03174288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101624|NCT03173417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25101625|NCT03173417|Alkylating Agents|alkylating agents|mesh-ancestor
25101626|NCT03173417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101627|NCT03173417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25101628|NCT03173417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25101667|NCT03173430|Blinatumomab|blinatumomab|mesh-list
25101668|NCT03173430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25101669|NCT03172858|Oxytocin|oxytocin|mesh-list
25101670|NCT03172858|Oxytocics|oxytocics|mesh-ancestor
25101770|NCT03172741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101771|NCT03172741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25101772|NCT03172741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25101773|NCT03172741|Analgesics|analgesics|mesh-ancestor
25101774|NCT03172741|Sensory System Agents|sensory system agents|mesh-ancestor
25101775|NCT03172741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101776|NCT03172741|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25101777|NCT03172741|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25101778|NCT03172741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25101779|NCT03172741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101780|NCT03172741|Hormones|hormones|mesh-ancestor
25101781|NCT03172741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25101782|NCT03172455|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25101783|NCT03172455|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25101784|NCT03172455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25101785|NCT03172455|Protease Inhibitors|protease inhibitors|mesh-ancestor
25101786|NCT03172455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25101787|NCT03172455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25101788|NCT03172377|Adalimumab|adalimumab|mesh-list
25101789|NCT03172377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25101790|NCT03172377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24515284|NCT00596154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25708436|NCT02251379|Respiratory System Agents|respiratory system agents|mesh-ancestor
25708437|NCT02251379|Glucocorticoids|glucocorticoids|mesh-ancestor
25708438|NCT02251379|Hormones|hormones|mesh-ancestor
25708439|NCT02251379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25708440|NCT02251379|Sympathomimetics|sympathomimetics|mesh-ancestor
25708441|NCT02251379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25708442|NCT02251379|Dermatologic Agents|dermatologic agents|mesh-ancestor
25708443|NCT02251379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25708444|NCT02251613|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25708445|NCT02251613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24516123|NCT00600639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25101849|NCT03171987|Flurbiprofen|flurbiprofen|mesh-list
25101850|NCT03171987|Lidocaine|lidocaine|mesh-list
25101851|NCT03171987|Anesthetics, Local|anesthetics, local|mesh-ancestor
25101852|NCT03171987|Anesthetics|anesthetics|mesh-ancestor
25101853|NCT03171987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25101854|NCT03171987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25101983|NCT03171610|Sensory System Agents|sensory system agents|mesh-ancestor
25101984|NCT03171610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25101985|NCT03171610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25101986|NCT03171610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25101987|NCT03171610|Anesthetics, General|anesthetics, general|mesh-ancestor
25101992|NCT03171389|Ponatinib|ponatinib|mesh-list
25102087|NCT03170323|Mycophenolic Acid|mycophenolic acid|mesh-list
25102088|NCT03170323|Cyclosporins|cyclosporins|mesh-list
25102089|NCT03170323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102090|NCT03170323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102091|NCT03170323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25102092|NCT03170323|Immunologic Factors|immunologic factors|mesh-ancestor
25102093|NCT03170323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102094|NCT03170323|Antifungal Agents|antifungal agents|mesh-ancestor
25102095|NCT03170323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25102207|NCT03169764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25102208|NCT03169764|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25102209|NCT03169764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25102230|NCT03169738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25102231|NCT03169738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25102232|NCT03169738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25102233|NCT03169738|Growth Substances|growth substances|mesh-ancestor
25102234|NCT03169738|Growth Inhibitors|growth inhibitors|mesh-ancestor
25102235|NCT03169738|Antimetabolites|antimetabolites|mesh-ancestor
24621008|NCT01060293|Autonomic Agents|autonomic agents|mesh-ancestor
25102325|NCT03169777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25102326|NCT03169777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25102327|NCT03169777|Growth Substances|growth substances|mesh-ancestor
25102328|NCT03169777|Growth Inhibitors|growth inhibitors|mesh-ancestor
25102329|NCT03169777|Antimetabolites|antimetabolites|mesh-ancestor
25102330|NCT03169777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25102331|NCT03169777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25102332|NCT03169777|Antidotes|antidotes|mesh-ancestor
25102333|NCT03169777|Protective Agents|protective agents|mesh-ancestor
25102334|NCT03169777|Vitamin B Complex|vitamin b complex|mesh-ancestor
25102335|NCT03169777|Vitamins|vitamins|mesh-ancestor
25102437|NCT03169127|Sensory System Agents|sensory system agents|mesh-ancestor
25102438|NCT03169127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25102439|NCT03169127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102447|NCT03168958|Narcotics|narcotics|mesh-ancestor
25102448|NCT03168958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25102450|NCT03168958|Analgesics|analgesics|mesh-ancestor
25102516|NCT03168074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25102517|NCT03168074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25102518|NCT03168087|Plasma-lyte 148|plasma-lyte 148|mesh-list
25102519|NCT03168087|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25102520|NCT03168087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25102522|NCT03168035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25102523|NCT03168100|Dexamethasone|dexamethasone|mesh-list
25102524|NCT03168100|Lenalidomide|lenalidomide|mesh-list
25102525|NCT03168100|Bortezomib|bortezomib|mesh-list
25102526|NCT03168100|Elotuzumab|elotuzumab|mesh-list
25708446|NCT02251613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25708447|NCT02251613|Epinastine|epinastine|mesh-list
25708448|NCT02251613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25708449|NCT02251613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25708450|NCT02251613|Analgesics|analgesics|mesh-ancestor
25708451|NCT02251613|Sensory System Agents|sensory system agents|mesh-ancestor
25102579|NCT03167957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25102580|NCT03167957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25102581|NCT03167957|Antifungal Agents|antifungal agents|mesh-ancestor
25102582|NCT03167853|Antibodies|antibodies|mesh-list
25102583|NCT03167853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25102584|NCT03167853|Immunologic Factors|immunologic factors|mesh-ancestor
25102585|NCT03167853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102593|NCT03167333|Hyaluronic Acid|hyaluronic acid|mesh-list
25102629|NCT03167216|Immunologic Factors|immunologic factors|mesh-ancestor
25102693|NCT03167112|Vitamin B Complex|vitamin b complex|mesh-ancestor
25102694|NCT03167112|Vitamins|vitamins|mesh-ancestor
25102695|NCT03167112|Micronutrients|micronutrients|mesh-ancestor
25102696|NCT03167034|Acetazolamide|acetazolamide|mesh-list
25102697|NCT03167034|Anticonvulsants|anticonvulsants|mesh-ancestor
24975619|NCT03434262|Antiviral Agents|antiviral agents|mesh-ancestor
25102821|NCT03166111|Anesthetics|anesthetics|mesh-ancestor
25102822|NCT03166111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25102823|NCT03166111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102824|NCT03166111|Sensory System Agents|sensory system agents|mesh-ancestor
25102825|NCT03166111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25102911|NCT03165591|Immunologic Factors|immunologic factors|mesh-ancestor
25102912|NCT03165591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25102913|NCT03165500|Midazolam|midazolam|mesh-list
25102914|NCT03165500|Diazepam|diazepam|mesh-list
25102915|NCT03165500|Nitrous Oxide|nitrous oxide|mesh-list
25102916|NCT03165500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25102917|NCT03165500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25102920|NCT03165500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25103036|NCT03164694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25103037|NCT03164694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103038|NCT03164694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25103039|NCT03164694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25103050|NCT03164590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25103051|NCT03164590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25103136|NCT03163914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25103137|NCT03163914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103138|NCT03163914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103139|NCT03163914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25103140|NCT03163914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25103142|NCT03163914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25103143|NCT03163914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25103144|NCT03163914|Respiratory System Agents|respiratory system agents|mesh-ancestor
25103147|NCT03163914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25103148|NCT03163914|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25103285|NCT03163212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25103286|NCT03163121|Vaccines|vaccines|mesh-list
25103287|NCT03163121|Immunologic Factors|immunologic factors|mesh-ancestor
25103288|NCT03163121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103289|NCT03162861|Anesthetics|anesthetics|mesh-list
25103290|NCT03162861|Propofol|propofol|mesh-list
25103291|NCT03162861|Sevoflurane|sevoflurane|mesh-list
25103294|NCT03162861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25103390|NCT03162094|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25103391|NCT03162094|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25103392|NCT03161977|Mannitol|mannitol|mesh-list
25103393|NCT03161977|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25103394|NCT03161977|Diuretics|diuretics|mesh-ancestor
25103395|NCT03161977|Natriuretic Agents|natriuretic agents|mesh-ancestor
25103430|NCT03161509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25103431|NCT03161509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103433|NCT03161509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25103434|NCT03161509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25103435|NCT03161509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103529|NCT03160807|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25103530|NCT03160807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25103531|NCT03160729|Dexamethasone|dexamethasone|mesh-list
25103532|NCT03160729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25103533|NCT03160729|Antiemetics|antiemetics|mesh-ancestor
25103534|NCT03160729|Autonomic Agents|autonomic agents|mesh-ancestor
25103535|NCT03160729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25708452|NCT02251613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25708453|NCT02251613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708454|NCT02251613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25103536|NCT03160729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708455|NCT02251613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25708456|NCT02251613|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25103537|NCT03160729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25103538|NCT03160729|Glucocorticoids|glucocorticoids|mesh-ancestor
25103541|NCT03160729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25103574|NCT03160339|Immunologic Factors|immunologic factors|mesh-ancestor
25103575|NCT03160339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103640|NCT03159845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103641|NCT03159845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25103642|NCT03159845|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25103643|NCT03159845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25103644|NCT03159845|Antifungal Agents|antifungal agents|mesh-ancestor
24414439|NCT00197613|Lamivudine|lamivudine|mesh-list
25103728|NCT03159234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25103729|NCT03159234|Autonomic Agents|autonomic agents|mesh-ancestor
25103730|NCT03159234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25103731|NCT03159234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24525202|NCT03823768|Tacrolimus|tacrolimus|mesh-list
25103745|NCT03158935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25103746|NCT03158935|Alkylating Agents|alkylating agents|mesh-ancestor
25103747|NCT03158935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25103748|NCT03158935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25103981|NCT03156361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25103982|NCT03156361|Insulin Lispro|insulin lispro|mesh-list
25103983|NCT03156361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25103984|NCT03156361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25103985|NCT03156296|Dexmedetomidine|dexmedetomidine|mesh-list
25103986|NCT03156296|Bupivacaine|bupivacaine|mesh-list
24573607|NCT00821054|Lapatinib|lapatinib|mesh-list
25103987|NCT03156296|Anesthetics, Local|anesthetics, local|mesh-ancestor
25103988|NCT03156296|Anesthetics|anesthetics|mesh-ancestor
25103991|NCT03156296|Sensory System Agents|sensory system agents|mesh-ancestor
25104133|NCT03155204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25104134|NCT03155204|Respiratory System Agents|respiratory system agents|mesh-ancestor
25104135|NCT03155204|Parasympatholytics|parasympatholytics|mesh-ancestor
25104136|NCT03155204|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25104137|NCT03155204|Cholinergic Agents|cholinergic agents|mesh-ancestor
25104138|NCT03155204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25104139|NCT03155204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104140|NCT03155048|Estradiol|estradiol|mesh-list
25104223|NCT03154567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25104224|NCT03154567|Adrenergic Agents|adrenergic agents|mesh-ancestor
25104225|NCT03154567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25104226|NCT03154567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104227|NCT03154567|Urological Agents|urological agents|mesh-ancestor
25104228|NCT03154645|Ibuprofen|ibuprofen|mesh-list
25104229|NCT03154645|Acetazolamide|acetazolamide|mesh-list
25104230|NCT03154645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25104231|NCT03154645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25104300|NCT03154125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104301|NCT03154125|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25104302|NCT03154125|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25104303|NCT03154125|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25104304|NCT03154125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25104305|NCT03154125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25104306|NCT03153852|Glycolic acid|glycolic acid|mesh-list
25104307|NCT03153852|Keratolytic Agents|keratolytic agents|mesh-ancestor
25104308|NCT03153852|Dermatologic Agents|dermatologic agents|mesh-ancestor
25104309|NCT03153813|Capsaicin|capsaicin|mesh-list
25104439|NCT03152955|Antipruritics|antipruritics|mesh-ancestor
25104440|NCT03152955|Dermatologic Agents|dermatologic agents|mesh-ancestor
25104441|NCT03152955|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25104442|NCT03152955|Serotonin Agents|serotonin agents|mesh-ancestor
25104443|NCT03152955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25104444|NCT03152955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25104445|NCT03152955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25708457|NCT02251613|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25708458|NCT02251613|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25708459|NCT02251613|Histamine Antagonists|histamine antagonists|mesh-ancestor
25104446|NCT03152955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25708460|NCT02251613|Histamine Agents|histamine agents|mesh-ancestor
25708461|NCT02251613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25104448|NCT03152955|Narcotics|narcotics|mesh-ancestor
25104450|NCT03152903|BCG Vaccine|bcg vaccine|mesh-list
25104554|NCT03152097|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
25104555|NCT03152097|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25104556|NCT03152097|Protective Agents|protective agents|mesh-ancestor
25104557|NCT03152097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104558|NCT03152097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24782209|NCT01894815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25104560|NCT03152149|Xhance|xhance|mesh-list
25104561|NCT03152149|Tiotropium Bromide|tiotropium bromide|mesh-list
25104562|NCT03152149|Olodaterol|olodaterol|mesh-list
25104563|NCT03152149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25104564|NCT03152149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25104622|NCT03151876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25104623|NCT03151876|Antiviral Agents|antiviral agents|mesh-ancestor
25104624|NCT03151876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25104625|NCT03151876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25104626|NCT03151876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25104627|NCT03151876|Immunologic Factors|immunologic factors|mesh-ancestor
25104628|NCT03151876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104629|NCT03151876|Alkylating Agents|alkylating agents|mesh-ancestor
25104630|NCT03151876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25104632|NCT03151720|Loratadine|loratadine|mesh-list
25104721|NCT03151603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25104727|NCT03151369|Morphine|morphine|mesh-list
25104752|NCT03151382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25104753|NCT03151382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25104754|NCT03151382|Cholinergic Agents|cholinergic agents|mesh-ancestor
25104755|NCT03151382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25104756|NCT03151382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104757|NCT03151382|Nootropic Agents|nootropic agents|mesh-ancestor
25104758|NCT03151382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25104759|NCT03151382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25104760|NCT03151382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25104761|NCT03151382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25104762|NCT03151382|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25104763|NCT03151382|Serotonin Agents|serotonin agents|mesh-ancestor
25104764|NCT03151174|Vitamin D|vitamin d|mesh-list
25104765|NCT03151174|Ergocalciferols|ergocalciferols|mesh-list
25104766|NCT03151174|Cholecalciferol|cholecalciferol|mesh-list
25104767|NCT03151174|Vitamins|vitamins|mesh-list
25104772|NCT03151044|Rituximab|rituximab|mesh-list
25104795|NCT03151096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25104802|NCT03151005|Contraceptives, Oral|contraceptives, oral|mesh-list
25104803|NCT03151005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25104886|NCT03150316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25104887|NCT03150316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25104888|NCT03150316|Immunologic Factors|immunologic factors|mesh-ancestor
25104889|NCT03150316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25104890|NCT03150316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25104891|NCT03150316|Growth Substances|growth substances|mesh-ancestor
25104892|NCT03150316|Growth Inhibitors|growth inhibitors|mesh-ancestor
25104894|NCT03150290|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25105003|NCT03149588|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25105004|NCT03149640|Amikacin|amikacin|mesh-list
25105005|NCT03149640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24736686|NCT01664650|Genistein|genistein|mesh-list
25105006|NCT03149640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25105007|NCT03149679|Cyclophosphamide|cyclophosphamide|mesh-list
25105008|NCT03149679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25105009|NCT03149679|Immunologic Factors|immunologic factors|mesh-ancestor
25105010|NCT03149679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105105|NCT03148535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25105106|NCT03148535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25105107|NCT03148535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708462|NCT02251613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708463|NCT02251717|Sofosbuvir|sofosbuvir|mesh-list
25708464|NCT02251717|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25105108|NCT03148509|Risperidone|risperidone|mesh-list
25105109|NCT03148509|Aripiprazole|aripiprazole|mesh-list
25105110|NCT03148509|Bupropion|bupropion|mesh-list
25105139|NCT03148522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25105260|NCT03147092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25406184|NCT03575325|Daunorubicin|daunorubicin|mesh-list
25708465|NCT02251717|Ledipasvir|ledipasvir|mesh-list
25105261|NCT03147092|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25105262|NCT03147092|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25105263|NCT03147092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105264|NCT03147092|Diuretics|diuretics|mesh-ancestor
25105265|NCT03147092|Natriuretic Agents|natriuretic agents|mesh-ancestor
25105266|NCT03147092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105267|NCT03147092|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25105268|NCT03147092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25105269|NCT03147092|Analgesics|analgesics|mesh-ancestor
25105270|NCT03147092|Sensory System Agents|sensory system agents|mesh-ancestor
25105271|NCT03147092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25105353|NCT03146689|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24975618|NCT03434262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24975168|NCT04689347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24975169|NCT04689347|Immunologic Factors|immunologic factors|mesh-ancestor
24975170|NCT04689347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24975192|NCT04672291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975193|NCT04672291|Laxatives|laxatives|mesh-ancestor
24975194|NCT04672291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24975195|NCT04672291|Antiviral Agents|antiviral agents|mesh-ancestor
24975196|NCT04672291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24975197|NCT04623684|Phenylephrine|phenylephrine|mesh-list
24975198|NCT04623684|Oxymetazoline|oxymetazoline|mesh-list
24975199|NCT04623684|Tropicamide|tropicamide|mesh-list
24975200|NCT04623684|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24975201|NCT04623684|Mydriatics|mydriatics|mesh-ancestor
24975202|NCT04623684|Autonomic Agents|autonomic agents|mesh-ancestor
24975203|NCT04623684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24975204|NCT04623684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975205|NCT04623684|Sympathomimetics|sympathomimetics|mesh-ancestor
24975206|NCT04623684|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24975207|NCT04623684|Nasal Decongestants|nasal decongestants|mesh-ancestor
24975208|NCT04623684|Respiratory System Agents|respiratory system agents|mesh-ancestor
25105388|NCT03146390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975209|NCT04623684|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24975237|NCT04546581|Antimetabolites|antimetabolites|mesh-ancestor
24975238|NCT04546581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975239|NCT04546581|Antiviral Agents|antiviral agents|mesh-ancestor
24975240|NCT04546581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24975241|NCT04511702|Methotrexate|methotrexate|mesh-list
24975242|NCT04511702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24975243|NCT04511702|Abortifacient Agents|abortifacient agents|mesh-ancestor
24975244|NCT04511702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24975245|NCT04511702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975246|NCT04511702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24975247|NCT04511702|Antimetabolites|antimetabolites|mesh-ancestor
24975248|NCT04511702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975249|NCT04511702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24975250|NCT04511702|Dermatologic Agents|dermatologic agents|mesh-ancestor
24975251|NCT04511702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24975252|NCT04511702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24975253|NCT04511702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24975254|NCT04511702|Immunologic Factors|immunologic factors|mesh-ancestor
24975255|NCT04511702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24975304|NCT04276493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975351|NCT04080804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24975352|NCT04080804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975354|NCT04005690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
24975355|NCT04005690|Onvansertib|onvansertib|mesh-list
24975356|NCT04005690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24975357|NCT04005690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975358|NCT04005690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24975359|NCT04005690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24975360|NCT03968822|Lidocaine|lidocaine|mesh-list
24975447|NCT03680274|Micronutrients|micronutrients|mesh-ancestor
24975448|NCT03680274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975449|NCT03680274|Antioxidants|antioxidants|mesh-ancestor
24820463|NCT02099695|Oxybutynin|oxybutynin|mesh-list
24975614|NCT03434262|Trametinib|trametinib|mesh-list
24913727|NCT04261465|Paclitaxel|paclitaxel|mesh-list
25708466|NCT02251717|Antiviral Agents|antiviral agents|mesh-ancestor
25708467|NCT02251717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25708468|NCT02251912|Oxytocin|oxytocin|mesh-list
25708469|NCT02251912|Oxytocics|oxytocics|mesh-ancestor
25708470|NCT02251912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24975615|NCT03434262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24975616|NCT03434262|Antimetabolites|antimetabolites|mesh-ancestor
24975617|NCT03434262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795029|NCT03859635|Bupivacaine|bupivacaine|mesh-list
24795030|NCT03859635|Anesthetics, Local|anesthetics, local|mesh-ancestor
24795031|NCT03859635|Anesthetics|anesthetics|mesh-ancestor
24627365|NCT01092221|Protective Agents|protective agents|mesh-ancestor
24795032|NCT03859635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24795033|NCT03859635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795034|NCT03859635|Sensory System Agents|sensory system agents|mesh-ancestor
24795035|NCT03859635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24975731|NCT03153111|Macitentan|macitentan|mesh-list
24975732|NCT03153111|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
24975733|NCT03153111|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24975734|NCT03153111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975735|NCT03153111|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
24975760|NCT03013998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24975761|NCT03013998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24975762|NCT03013998|Immunologic Factors|immunologic factors|mesh-ancestor
24975763|NCT03013998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975764|NCT03013998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24975765|NCT03013998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24975766|NCT03013998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24975768|NCT03011671|Temozolomide|temozolomide|mesh-list
24975769|NCT03011671|Acetazolamide|acetazolamide|mesh-list
24975770|NCT03011671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24975771|NCT03011671|Alkylating Agents|alkylating agents|mesh-ancestor
24975772|NCT03011671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975773|NCT03011671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24975774|NCT03011671|Anticonvulsants|anticonvulsants|mesh-ancestor
24975775|NCT03011671|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24975776|NCT03011671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24975835|NCT02836899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24975836|NCT02836899|Autonomic Agents|autonomic agents|mesh-ancestor
24975837|NCT02836899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24975838|NCT02836899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975839|NCT02836899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24975840|NCT02836899|Respiratory System Agents|respiratory system agents|mesh-ancestor
24975841|NCT02836899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24975842|NCT02836899|Antioxidants|antioxidants|mesh-ancestor
24975843|NCT02836899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975925|NCT02573233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24975926|NCT02573233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975927|NCT02439658|Sotalol|sotalol|mesh-list
24975928|NCT02439658|Dofetilide|dofetilide|mesh-list
24975929|NCT02439658|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24975930|NCT02439658|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24975931|NCT02439658|Adrenergic Agents|adrenergic agents|mesh-ancestor
24975932|NCT02439658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24975933|NCT02439658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24975934|NCT02439658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24975935|NCT02439658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24976020|NCT02088112|Gefitinib|gefitinib|mesh-list
24976044|NCT01946074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708471|NCT02251912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708472|NCT02251938|Sirolimus|sirolimus|mesh-list
25708473|NCT02251938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25708474|NCT02251938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25708475|NCT02251938|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25708476|NCT02251938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448097|NCT00310297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448098|NCT00310323|Dextromethorphan|dextromethorphan|mesh-list
24448099|NCT00310323|Caffeine|caffeine|mesh-list
24448113|NCT00310336|Interferons|interferons|mesh-list
25105522|NCT03145480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976063|NCT01732627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976064|NCT01702571|Trastuzumab|trastuzumab|mesh-list
24976065|NCT01702571|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24976066|NCT01702571|Maytansine|maytansine|mesh-list
24976067|NCT01702571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24976068|NCT01702571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25105524|NCT03145272|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25105525|NCT03145272|Narcotics|narcotics|mesh-ancestor
25105526|NCT03145272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25105527|NCT03145272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105528|NCT03145272|Analgesics|analgesics|mesh-ancestor
25105529|NCT03145272|Sensory System Agents|sensory system agents|mesh-ancestor
25105530|NCT03145272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24821180|NCT02103738|Ranibizumab|ranibizumab|mesh-list
24976069|NCT01702571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24976070|NCT01702571|Tubulin Modulators|tubulin modulators|mesh-ancestor
24976131|NCT01220531|Tacrolimus|tacrolimus|mesh-list
24976132|NCT01220531|Cyclosporins|cyclosporins|mesh-list
24976133|NCT01220531|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24976134|NCT01220531|Thymoglobulin|thymoglobulin|mesh-list
24976135|NCT01220531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24976136|NCT01220531|Immunologic Factors|immunologic factors|mesh-ancestor
24976137|NCT01220531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976138|NCT01220531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25105531|NCT05255575|Ertapenem|ertapenem|mesh-list
24976139|NCT01220531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24976140|NCT01220531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976141|NCT01220531|Antifungal Agents|antifungal agents|mesh-ancestor
24976142|NCT01220531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24976143|NCT01220531|Dermatologic Agents|dermatologic agents|mesh-ancestor
24976197|NCT00360425|Hematinics|hematinics|mesh-ancestor
24976203|NCT00346125|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24976204|NCT00346125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24976205|NCT00346125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976206|NCT00346125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24976263|NCT04279197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976264|NCT04279197|Protective Agents|protective agents|mesh-ancestor
24414591|NCT00198146|Immunologic Factors|immunologic factors|mesh-ancestor
24414592|NCT00198146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414593|NCT00198159|Gefitinib|gefitinib|mesh-list
24414594|NCT00198159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976327|NCT04154800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24976328|NCT04154800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976329|NCT04154800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24976330|NCT04154800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24976401|NCT03659578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24976402|NCT03659578|Immunologic Factors|immunologic factors|mesh-ancestor
24976403|NCT03659578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976405|NCT03629873|Cyclophosphamide|cyclophosphamide|mesh-list
24976406|NCT03629873|Carmustine|carmustine|mesh-list
24976407|NCT03629873|Etoposide|etoposide|mesh-list
24976408|NCT03629873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24976501|NCT03455517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24976502|NCT03455517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24976503|NCT03455517|Immunologic Factors|immunologic factors|mesh-ancestor
24976504|NCT03455517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976505|NCT03455517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24976506|NCT03419234|Ascorbic Acid|ascorbic acid|mesh-list
24976507|NCT03419234|Prednisone|prednisone|mesh-list
24976508|NCT03419234|Cortisone|cortisone|mesh-list
24976511|NCT03419234|Hormones|hormones|mesh-list
24588525|NCT00902967|Atorvastatin|atorvastatin|mesh-list
24588526|NCT00902967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24588527|NCT00902967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24588528|NCT00902967|Antimetabolites|antimetabolites|mesh-ancestor
24738506|NCT01675947|Sirolimus|sirolimus|mesh-list
24588529|NCT00902967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588530|NCT00902967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25708477|NCT02251938|Antifungal Agents|antifungal agents|mesh-ancestor
25708478|NCT02251938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25708479|NCT02251938|Immunologic Factors|immunologic factors|mesh-ancestor
25708480|NCT02251938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588531|NCT00902967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24588532|NCT00902967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621973|NCT01065038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24621974|NCT01065038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24976804|NCT05200312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24976805|NCT05200312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24976806|NCT05200312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24976807|NCT05200312|Glucocorticoids|glucocorticoids|mesh-ancestor
24976808|NCT05200312|Hormones|hormones|mesh-ancestor
24976809|NCT05200312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25105622|NCT05254652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24822047|NCT02109614|Niacin|niacin|mesh-list
24976810|NCT05200312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24976811|NCT05200312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24976812|NCT05200312|Tubulin Modulators|tubulin modulators|mesh-ancestor
24976865|NCT04973254|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24976866|NCT04949269|BMS-986165|bms-986165|mesh-list
24976867|NCT04949269|Famotidine|famotidine|mesh-list
24976868|NCT04949269|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24976869|NCT04949269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24976870|NCT04949269|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24976871|NCT04949269|Histamine Antagonists|histamine antagonists|mesh-ancestor
24976872|NCT04949269|Histamine Agents|histamine agents|mesh-ancestor
24976873|NCT04949269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24976874|NCT04949269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24976875|NCT04949269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976876|NCT04949269|Dermatologic Agents|dermatologic agents|mesh-ancestor
24976877|NCT04949269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24976878|NCT04949269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24976962|NCT04774666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24976970|NCT04707534|Dexamethasone|dexamethasone|mesh-list
24976971|NCT04707534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24976972|NCT04707534|Antiemetics|antiemetics|mesh-ancestor
24976973|NCT04707534|Autonomic Agents|autonomic agents|mesh-ancestor
24976977|NCT04707534|Glucocorticoids|glucocorticoids|mesh-ancestor
24977032|NCT04632459|Pembrolizumab|pembrolizumab|mesh-list
24977033|NCT04632459|Ramucirumab|ramucirumab|mesh-list
24977034|NCT04632459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24977105|NCT03622073|Misoprostol|misoprostol|mesh-list
24977106|NCT03622073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24977107|NCT03622073|Abortifacient Agents|abortifacient agents|mesh-ancestor
24977108|NCT03622073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24977109|NCT03622073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977110|NCT03622073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24977111|NCT03622073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24977126|NCT03448978|Fludarabine|fludarabine|mesh-list
24977127|NCT03448978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24977128|NCT03448978|Immunologic Factors|immunologic factors|mesh-ancestor
24977273|NCT02807805|Prednisone|prednisone|mesh-list
24977274|NCT02807805|Cortisone|cortisone|mesh-list
24977275|NCT02807805|Abiraterone Acetate|abiraterone acetate|mesh-list
24977276|NCT02807805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24977277|NCT02807805|Glucocorticoids|glucocorticoids|mesh-ancestor
24977278|NCT02807805|Hormones|hormones|mesh-ancestor
24977280|NCT02807805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977340|NCT01974609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24977341|NCT01974609|Analgesics|analgesics|mesh-ancestor
24977342|NCT01974609|Sensory System Agents|sensory system agents|mesh-ancestor
24977343|NCT01974609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25105634|NCT05254574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25105635|NCT05254574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25105636|NCT05254574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25105637|NCT05254574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25105638|NCT05254574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25708481|NCT02251990|Grazoprevir|grazoprevir|mesh-list
25708482|NCT02251990|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25708483|NCT02251990|Antiviral Agents|antiviral agents|mesh-ancestor
25708484|NCT02251990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25708485|NCT02252016|Grazoprevir|grazoprevir|mesh-list
25105639|NCT05254574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708486|NCT02252016|Antiviral Agents|antiviral agents|mesh-ancestor
25708487|NCT02252016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25708489|NCT02252081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25105640|NCT05254405|Brexanolone|brexanolone|mesh-list
24795226|NCT03578276|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24795227|NCT03578276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24795228|NCT03578276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24795229|NCT03578276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24795230|NCT03578276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795231|NCT03534804|Pembrolizumab|pembrolizumab|mesh-list
24795232|NCT03534804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24795233|NCT03534804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977516|NCT02965690|Histamine Antagonists|histamine antagonists|mesh-ancestor
24977517|NCT02965690|Histamine Agents|histamine agents|mesh-ancestor
24977518|NCT02965690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24977519|NCT02965690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977520|NCT02965690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977521|NCT02965690|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24977522|NCT02965690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24977523|NCT02965690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24977587|NCT02785224|Mydriatics|mydriatics|mesh-ancestor
24977588|NCT02785224|Sympathomimetics|sympathomimetics|mesh-ancestor
24977589|NCT02785224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24795247|NCT03491267|Dermatologic Agents|dermatologic agents|mesh-ancestor
24795249|NCT03464292|Antipruritics|antipruritics|mesh-ancestor
24977703|NCT02361125|Methylphenidate|methylphenidate|mesh-list
24977704|NCT02361125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24977705|NCT02361125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24977706|NCT02361125|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24977707|NCT02361125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24977708|NCT02361125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24977709|NCT02361125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977742|NCT02245308|Dopamine Agents|dopamine agents|mesh-ancestor
24977848|NCT01863550|Glucocorticoids|glucocorticoids|mesh-ancestor
24977849|NCT01863550|Hormones|hormones|mesh-ancestor
24977850|NCT01863550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24977854|NCT01863550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24977855|NCT01863550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24977856|NCT01863550|Growth Substances|growth substances|mesh-ancestor
24977857|NCT01863550|Growth Inhibitors|growth inhibitors|mesh-ancestor
24415201|NCT00199095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415202|NCT00199095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24415203|NCT00199095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24458241|NCT00337246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25105686|NCT05253768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783589|NCT01902771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24783593|NCT01902810|Propranolol|propranolol|mesh-list
24415313|NCT00199186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24415339|NCT00199225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24415340|NCT00199225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24415341|NCT00199225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24415342|NCT00199225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415343|NCT00199225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415344|NCT00199264|Albaconazole|albaconazole|mesh-list
24415345|NCT00199264|Antifungal Agents|antifungal agents|mesh-ancestor
24415346|NCT00199264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24415347|NCT00199277|Iron|iron|mesh-list
25708490|NCT02252081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708491|NCT02252354|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25708492|NCT02252354|Relugolix|relugolix|mesh-list
25708493|NCT02252354|Androgen Antagonists|androgen antagonists|mesh-ancestor
25708494|NCT02252354|Hormone Antagonists|hormone antagonists|mesh-ancestor
24415348|NCT00199277|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24415349|NCT00199277|Trace Elements|trace elements|mesh-ancestor
24415350|NCT00199277|Micronutrients|micronutrients|mesh-ancestor
24415385|NCT00199355|Purinergic Agents|purinergic agents|mesh-ancestor
24415439|NCT00199472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415441|NCT00199511|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24415442|NCT00199511|Diuretics|diuretics|mesh-ancestor
24415443|NCT00199511|Natriuretic Agents|natriuretic agents|mesh-ancestor
24415444|NCT00199511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415445|NCT00199563|Sildenafil Citrate|sildenafil citrate|mesh-list
24415446|NCT00199563|Vasodilator Agents|vasodilator agents|mesh-ancestor
24415447|NCT00199563|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24415448|NCT00199563|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24415474|NCT00199602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24415475|NCT00199602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24415476|NCT00199602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415477|NCT00199667|Mycophenolic Acid|mycophenolic acid|mesh-list
24415478|NCT00199667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24415479|NCT00199667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415486|NCT00199719|Ribavirin|ribavirin|mesh-list
24415488|NCT00199719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415489|NCT00199719|Antiviral Agents|antiviral agents|mesh-ancestor
24415490|NCT00199719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24415491|NCT00199745|Atorvastatin|atorvastatin|mesh-list
24415492|NCT00199745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24823266|NCT02116231|Cisplatin|cisplatin|mesh-list
24795250|NCT03464292|Dermatologic Agents|dermatologic agents|mesh-ancestor
24415687|NCT00200512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415780|NCT00200655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415795|NCT00200694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415796|NCT00200694|Diuretics|diuretics|mesh-ancestor
24415797|NCT00200694|Natriuretic Agents|natriuretic agents|mesh-ancestor
24415798|NCT00200694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415799|NCT00200694|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24415800|NCT00200694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24415801|NCT00200694|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24415802|NCT00200694|Protease Inhibitors|protease inhibitors|mesh-ancestor
24415803|NCT00200694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24415805|NCT00200941|Anticonvulsants|anticonvulsants|mesh-ancestor
24415879|NCT00201357|Growth Substances|growth substances|mesh-ancestor
24415880|NCT00201357|Growth Inhibitors|growth inhibitors|mesh-ancestor
24415881|NCT00201357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415882|NCT00201383|Cisplatin|cisplatin|mesh-list
24415883|NCT00201383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415884|NCT00201396|Leucovorin|leucovorin|mesh-list
24415885|NCT00201396|Fluorouracil|fluorouracil|mesh-list
24415886|NCT00201396|Epirubicin|epirubicin|mesh-list
24415887|NCT00201396|Mitomycins|mitomycins|mesh-list
24415928|NCT00201435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415929|NCT00201435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24415930|NCT00201435|Antimetabolites|antimetabolites|mesh-ancestor
24415932|NCT00201539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24415933|NCT00201539|Narcotics|narcotics|mesh-ancestor
24415934|NCT00201539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24415935|NCT00201539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415937|NCT00201539|Sensory System Agents|sensory system agents|mesh-ancestor
24415938|NCT00201539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24415939|NCT00201630|Alfuzosin|alfuzosin|mesh-list
24977933|NCT01261728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24977935|NCT01261728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977936|NCT01261728|Antiviral Agents|antiviral agents|mesh-ancestor
24977937|NCT01261728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24415940|NCT00201630|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24415941|NCT00201630|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24415942|NCT00201630|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24415943|NCT00201630|Adrenergic Agents|adrenergic agents|mesh-ancestor
24415946|NCT00201630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415947|NCT00201630|Urological Agents|urological agents|mesh-ancestor
24415948|NCT00201669|Clofarabine|clofarabine|mesh-list
25708495|NCT02252354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24448232|NCT00310778|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24448233|NCT00310778|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24448234|NCT00310778|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24448235|NCT00310778|Adrenergic Agents|adrenergic agents|mesh-ancestor
24448236|NCT00310778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24416030|NCT00201747|Alkylating Agents|alkylating agents|mesh-ancestor
24416031|NCT00201747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416032|NCT00201747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24416033|NCT00201747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416035|NCT00201786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24416036|NCT00201786|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
24416037|NCT00201786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451932|NCT00325325|Tacrolimus|tacrolimus|mesh-list
24416038|NCT00201786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416040|NCT00201799|Dermatologic Agents|dermatologic agents|mesh-ancestor
24416041|NCT00201799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24416092|NCT00202007|Serotonin Agents|serotonin agents|mesh-ancestor
24416176|NCT00202228|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24416177|NCT00202228|Dermatologic Agents|dermatologic agents|mesh-ancestor
24416178|NCT00202241|Testosterone|testosterone|mesh-list
24416179|NCT00202241|Androgens|androgens|mesh-ancestor
24416180|NCT00202241|Hormones|hormones|mesh-ancestor
24416213|NCT00202306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416214|NCT00202306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416215|NCT00202306|Antimanic Agents|antimanic agents|mesh-ancestor
24416216|NCT00202306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24416217|NCT00202306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24416218|NCT00202306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416219|NCT00202345|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24416220|NCT00202345|Hematinics|hematinics|mesh-ancestor
24416221|NCT00202358|Atenolol|atenolol|mesh-list
24416222|NCT00202358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24416223|NCT00202358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24416224|NCT00202358|Sympatholytics|sympatholytics|mesh-ancestor
24416225|NCT00202358|Autonomic Agents|autonomic agents|mesh-ancestor
24416226|NCT00202358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24416227|NCT00202358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416304|NCT00202696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416305|NCT00202696|Sensory System Agents|sensory system agents|mesh-ancestor
24416306|NCT00202696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24416307|NCT00202774|Fluorouracil|fluorouracil|mesh-list
24416308|NCT00202774|Capecitabine|capecitabine|mesh-list
24416309|NCT00202774|Oxaliplatin|oxaliplatin|mesh-list
24416310|NCT00202774|Antimetabolites|antimetabolites|mesh-ancestor
24416311|NCT00202774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795253|NCT03464292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24795254|NCT03390686|Paclitaxel|paclitaxel|mesh-list
24795255|NCT03390686|Bevacizumab|bevacizumab|mesh-list
24795256|NCT03390686|Carboplatin|carboplatin|mesh-list
24795257|NCT03390686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24795258|NCT03390686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795259|NCT03390686|Tubulin Modulators|tubulin modulators|mesh-ancestor
24795260|NCT03390686|Antimitotic Agents|antimitotic agents|mesh-ancestor
24795261|NCT03390686|Mitosis Modulators|mitosis modulators|mesh-ancestor
24795262|NCT03390686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24795263|NCT03390686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24795264|NCT03390686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24795265|NCT03390686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24795266|NCT03390686|Growth Substances|growth substances|mesh-ancestor
25708496|NCT02252354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708497|NCT02252406|Ranolazine|ranolazine|mesh-list
25708498|NCT02252406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25708499|NCT02252406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25708500|NCT02252406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708501|NCT02252445|Propofol|propofol|mesh-list
25708502|NCT02252445|Sevoflurane|sevoflurane|mesh-list
24416392|NCT00202995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24416393|NCT00203034|Rasagiline|rasagiline|mesh-list
24416394|NCT00203034|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24416395|NCT00203034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416403|NCT00203060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416404|NCT00203060|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24416405|NCT00203060|Protective Agents|protective agents|mesh-ancestor
24416406|NCT00203060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416407|NCT00203073|Mitoxantrone|mitoxantrone|mesh-list
24416408|NCT00203073|Glatiramer Acetate|glatiramer acetate|mesh-list
24416409|NCT00203073|(T,G)-A-L|(t,g)-a-l|mesh-list
24416428|NCT00203099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24416430|NCT00203099|Respiratory System Agents|respiratory system agents|mesh-ancestor
24416431|NCT00203099|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24416432|NCT00203099|Antioxidants|antioxidants|mesh-ancestor
24416433|NCT00203099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416434|NCT00203099|Protective Agents|protective agents|mesh-ancestor
24416435|NCT00203099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416436|NCT00203099|Antidotes|antidotes|mesh-ancestor
24416437|NCT00203099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24416438|NCT00203099|Immunologic Factors|immunologic factors|mesh-ancestor
24416439|NCT00203099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24416440|NCT00203099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24416441|NCT00203112|Minocycline|minocycline|mesh-list
24416442|NCT00203112|Glatiramer Acetate|glatiramer acetate|mesh-list
24416443|NCT00203112|(T,G)-A-L|(t,g)-a-l|mesh-list
24416444|NCT00203112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24795288|NCT03229538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24795289|NCT03229538|Glucocorticoids|glucocorticoids|mesh-ancestor
24416456|NCT00203125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24416457|NCT00203125|Protective Agents|protective agents|mesh-ancestor
24416458|NCT00203125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416459|NCT00203125|Sympathomimetics|sympathomimetics|mesh-ancestor
24416460|NCT00203125|Autonomic Agents|autonomic agents|mesh-ancestor
24416461|NCT00203125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24416462|NCT00203125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24416463|NCT00203125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24416464|NCT00203125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24416465|NCT00203125|Adrenergic Agents|adrenergic agents|mesh-ancestor
24416562|NCT00203385|Anticonvulsants|anticonvulsants|mesh-ancestor
24416563|NCT00203385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416618|NCT00203567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416619|NCT00203567|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24416620|NCT00203567|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24416621|NCT00203580|Tinzaparin|tinzaparin|mesh-list
24416622|NCT00203580|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24416623|NCT00203580|Dalteparin|dalteparin|mesh-list
24416652|NCT00203684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24795291|NCT03229538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24795292|NCT03229538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25105718|NCT05096442|Paclitaxel|paclitaxel|mesh-list
24795293|NCT03229538|Protective Agents|protective agents|mesh-ancestor
24795294|NCT03229538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24795295|NCT03229538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24977951|NCT01150890|Dermatologic Agents|dermatologic agents|mesh-ancestor
24977952|NCT01143779|Telbivudine|telbivudine|mesh-list
24977953|NCT01143779|Antiviral Agents|antiviral agents|mesh-ancestor
25708503|NCT02252445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25708504|NCT02252445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25708505|NCT02252445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708506|NCT02252445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25708507|NCT02252445|Anesthetics, General|anesthetics, general|mesh-ancestor
25708508|NCT02252445|Anesthetics|anesthetics|mesh-ancestor
25708509|NCT02252445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25708510|NCT02252445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25708511|NCT02252536|Gabapentin|gabapentin|mesh-list
25708512|NCT02252536|Analgesics|analgesics|mesh-ancestor
25708513|NCT02252536|Sensory System Agents|sensory system agents|mesh-ancestor
25708514|NCT02252536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24977954|NCT01143779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24977955|NCT01143779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24977956|NCT01143779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416653|NCT00203684|Respiratory System Agents|respiratory system agents|mesh-ancestor
24416655|NCT00203697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24416656|NCT00203697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24416657|NCT00203723|Risperidone|risperidone|mesh-list
24416658|NCT00203723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24416659|NCT00203723|Serotonin Agents|serotonin agents|mesh-ancestor
24416660|NCT00203723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24416661|NCT00203723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416662|NCT00203723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416663|NCT00203723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24416664|NCT00203723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24416665|NCT00203723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24416666|NCT00203723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24416667|NCT00203723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24416668|NCT00203723|Dopamine Agents|dopamine agents|mesh-ancestor
24416669|NCT00203736|Artesunate|artesunate|mesh-list
24416670|NCT00203736|Pyrimethamine|pyrimethamine|mesh-list
24416671|NCT00203736|Sulfadoxine|sulfadoxine|mesh-list
24416672|NCT00203736|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24416673|NCT00203736|Antimalarials|antimalarials|mesh-ancestor
24416674|NCT00203736|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24416691|NCT00203775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24416693|NCT00203775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24977970|NCT01127256|Zonisamide|zonisamide|mesh-list
24416702|NCT00203788|Risperidone|risperidone|mesh-list
24416703|NCT00203788|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24416764|NCT00203905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416765|NCT00203905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24416766|NCT00203905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24416767|NCT00203905|Immunologic Factors|immunologic factors|mesh-ancestor
24416768|NCT00203905|Antisickling Agents|antisickling agents|mesh-ancestor
24416797|NCT00204061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24416798|NCT00204061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24977985|NCT01127256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24450009|NCT00317577|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24416920|NCT00204503|Anticonvulsants|anticonvulsants|mesh-ancestor
24416921|NCT00204503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416922|NCT00204503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416923|NCT00204503|GABA Agents|gaba agents|mesh-ancestor
24416924|NCT00204503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24416925|NCT00204503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416926|NCT00204503|Antimanic Agents|antimanic agents|mesh-ancestor
24416927|NCT00204503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24416928|NCT00204503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24416929|NCT00204503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24416930|NCT00204529|Interferons|interferons|mesh-list
24416931|NCT00204529|Interferon-alpha|interferon-alpha|mesh-list
24416932|NCT00204529|Interferon alpha-2|interferon alpha-2|mesh-list
25708515|NCT02252536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708516|NCT02252536|Anticonvulsants|anticonvulsants|mesh-ancestor
25708517|NCT02252536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25708518|NCT02252536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25708519|NCT02252536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25708520|NCT02252536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24416933|NCT00204529|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24416934|NCT00204529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24416935|NCT00204529|Antiviral Agents|antiviral agents|mesh-ancestor
24416936|NCT00204529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24977993|NCT00769327|Imatinib Mesylate|imatinib mesylate|mesh-list
24977994|NCT00769327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417028|NCT00204776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417029|NCT00204776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417057|NCT00204984|Hydralazine|hydralazine|mesh-list
24977996|NCT00769327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24977997|NCT00769327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24977998|NCT00482833|Methotrexate|methotrexate|mesh-list
24977999|NCT00482833|Mercaptopurine|mercaptopurine|mesh-list
24978000|NCT00482833|Idarubicin|idarubicin|mesh-list
24978001|NCT00482833|Tretinoin|tretinoin|mesh-list
24978002|NCT00482833|Arsenic Trioxide|arsenic trioxide|mesh-list
24978013|NCT00482833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24978014|NCT00482833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24417248|NCT00206089|Ximelagatran|ximelagatran|mesh-list
24417250|NCT00206089|Antithrombins|antithrombins|mesh-ancestor
24417251|NCT00206089|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24417252|NCT00206089|Protease Inhibitors|protease inhibitors|mesh-ancestor
24417253|NCT00206089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417254|NCT00206089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24978023|NCT00381381|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24417278|NCT00206154|Formoterol Fumarate|formoterol fumarate|mesh-list
24417279|NCT00206154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24417280|NCT00206154|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24417281|NCT00206154|Autonomic Agents|autonomic agents|mesh-ancestor
24417282|NCT00206154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24417283|NCT00206154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24978051|NCT05179525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24417364|NCT00206232|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24417365|NCT00206232|Diuretics|diuretics|mesh-ancestor
24417366|NCT00206232|Natriuretic Agents|natriuretic agents|mesh-ancestor
24417384|NCT00206310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417417|NCT00206453|Mitosis Modulators|mitosis modulators|mesh-ancestor
24417418|NCT00206453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417419|NCT00206466|Docetaxel|docetaxel|mesh-list
24417420|NCT00206466|Doxorubicin|doxorubicin|mesh-list
24417421|NCT00206466|Cyclophosphamide|cyclophosphamide|mesh-list
24417422|NCT00206466|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24417423|NCT00206466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708521|NCT02252536|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25708522|NCT02252536|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25708523|NCT02252536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25708524|NCT02252536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708525|NCT02252536|Antimanic Agents|antimanic agents|mesh-ancestor
25708526|NCT02252588|Chlorhexidine|chlorhexidine|mesh-list
25708527|NCT02252588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24417424|NCT00206466|Tubulin Modulators|tubulin modulators|mesh-ancestor
24978124|NCT05178953|Antioxidants|antioxidants|mesh-ancestor
24978125|NCT05178953|Astringents|astringents|mesh-ancestor
24978126|NCT05178953|Dermatologic Agents|dermatologic agents|mesh-ancestor
24417482|NCT00206570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24417484|NCT00206596|Sargramostim|sargramostim|mesh-list
24448589|NCT00312273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24417485|NCT00206596|Immunologic Factors|immunologic factors|mesh-ancestor
24417494|NCT00206622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24417495|NCT00206622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417502|NCT00206635|Interferons|interferons|mesh-list
24417542|NCT00206765|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24417712|NCT00207363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417713|NCT00207363|Immunologic Factors|immunologic factors|mesh-ancestor
24417714|NCT00207363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417715|NCT00207402|Rosiglitazone|rosiglitazone|mesh-list
24795346|NCT02971761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24795348|NCT02959697|Anesthetics, Local|anesthetics, local|mesh-ancestor
24795349|NCT02959697|Anesthetics|anesthetics|mesh-ancestor
24795350|NCT02959697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24417833|NCT00208065|Ephedrine|ephedrine|mesh-list
24417834|NCT00208065|Almotriptan|almotriptan|mesh-list
24417841|NCT00208065|Nasal Decongestants|nasal decongestants|mesh-ancestor
24458287|NCT00337376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24417994|NCT00208273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24417995|NCT00208273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417996|NCT00208299|Adenosine|adenosine|mesh-list
24417997|NCT00208299|Regadenoson|regadenoson|mesh-list
24417998|NCT00208299|Analgesics|analgesics|mesh-ancestor
24417999|NCT00208299|Sensory System Agents|sensory system agents|mesh-ancestor
24418037|NCT00208520|Carbamazepine|carbamazepine|mesh-list
24418038|NCT00208520|Levetiracetam|levetiracetam|mesh-list
24418039|NCT00208520|Anticonvulsants|anticonvulsants|mesh-ancestor
24418040|NCT00208520|Nootropic Agents|nootropic agents|mesh-ancestor
24418041|NCT00208520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24418045|NCT00208520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418121|NCT00208585|Serotonin Agents|serotonin agents|mesh-ancestor
24418122|NCT00208585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418123|NCT00208611|Vitamins|vitamins|mesh-list
24418124|NCT00208611|Vitamin B 12|vitamin b 12|mesh-list
24418125|NCT00208611|Hydroxocobalamin|hydroxocobalamin|mesh-list
24783645|NCT01903070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24783646|NCT01903070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24783647|NCT01903070|Protease Inhibitors|protease inhibitors|mesh-ancestor
24783648|NCT01903070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24783649|NCT01903070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24783650|NCT01903083|Gemcitabine|gemcitabine|mesh-list
24418195|NCT00208858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24418196|NCT00208858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418197|NCT00208897|Fluoxetine|fluoxetine|mesh-list
24418198|NCT00208897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24783653|NCT01903083|Antimetabolites|antimetabolites|mesh-ancestor
24418272|NCT00209209|Prednisone|prednisone|mesh-list
24418357|NCT00209300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24418358|NCT00209300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24418360|NCT00209313|Antiviral Agents|antiviral agents|mesh-ancestor
24418361|NCT00209313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24533790|NCT00645190|Galantamine|galantamine|mesh-list
25708529|NCT02252588|Disinfectants|disinfectants|mesh-ancestor
25708530|NCT02252965|Metformin|metformin|mesh-list
25708531|NCT02252965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25708532|NCT02252965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708533|NCT02253160|Lenograstim|lenograstim|mesh-list
25708534|NCT02253160|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25708535|NCT02253160|Immunologic Factors|immunologic factors|mesh-ancestor
25708536|NCT02253160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452009|NCT00325689|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24452016|NCT00325715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857398|NCT02291536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857399|NCT02291536|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24534036|NCT00645866|Mitosis Modulators|mitosis modulators|mesh-ancestor
24534038|NCT00645866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24534098|NCT00646035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534100|NCT00646035|Micronutrients|micronutrients|mesh-ancestor
24534101|NCT00646035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24534102|NCT00646061|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24857413|NCT02291562|Sensory System Agents|sensory system agents|mesh-ancestor
24857414|NCT02291562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24534166|NCT00646230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24534167|NCT00646230|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24534168|NCT00646230|Protective Agents|protective agents|mesh-ancestor
24534169|NCT00646230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534197|NCT00646503|Antiviral Agents|antiviral agents|mesh-ancestor
24534198|NCT00646503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24534239|NCT00646529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534295|NCT00646620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534296|NCT00646620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24534297|NCT00646620|Respiratory System Agents|respiratory system agents|mesh-ancestor
24534298|NCT00646620|Dermatologic Agents|dermatologic agents|mesh-ancestor
24857454|NCT02291666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24857455|NCT02291666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24450946|NCT00321113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450947|NCT00321113|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24450948|NCT00321113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450949|NCT00321113|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24450950|NCT00321113|Antitubercular Agents|antitubercular agents|mesh-ancestor
24534305|NCT00646620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24702658|NCT01467115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702659|NCT01467115|Antimetabolites|antimetabolites|mesh-ancestor
24702660|NCT01467115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24702661|NCT01467115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24702662|NCT01467115|Immunologic Factors|immunologic factors|mesh-ancestor
24534405|NCT00646880|Cholinergic Agents|cholinergic agents|mesh-ancestor
24534406|NCT00646880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24534407|NCT00646880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534408|NCT00646880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534409|NCT00646880|Urological Agents|urological agents|mesh-ancestor
24534410|NCT00646880|Parasympatholytics|parasympatholytics|mesh-ancestor
24451003|NCT00321360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24451004|NCT00321360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451005|NCT00321360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24451006|NCT00321360|Anesthetics, General|anesthetics, general|mesh-ancestor
24451008|NCT00321477|Casopitant|casopitant|mesh-list
24534442|NCT00647049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813087|NCT02056379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813088|NCT02056379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24813089|NCT02056379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24813090|NCT02056379|Respiratory System Agents|respiratory system agents|mesh-ancestor
24534443|NCT00647049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24534444|NCT00647049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24534445|NCT00647049|Abortifacient Agents|abortifacient agents|mesh-ancestor
24534446|NCT00647049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24813091|NCT02056405|Mosapride|mosapride|mesh-list
24813092|NCT02056405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24813093|NCT02056405|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24459976|NCT00346996|Insulin|insulin|mesh-list
24534507|NCT00647218|Mitosis Modulators|mitosis modulators|mesh-ancestor
24534508|NCT00647218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534510|NCT00647244|Abacavir|abacavir|mesh-list
24534511|NCT00647244|Antiviral Agents|antiviral agents|mesh-ancestor
24534512|NCT00647244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24534513|NCT00647244|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24857463|NCT02291666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24857464|NCT02291666|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24857465|NCT02291666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24534520|NCT00647257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24534521|NCT00647257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25708537|NCT02253173|Estradiol|estradiol|mesh-list
25708538|NCT02253173|Estrogens|estrogens|mesh-ancestor
25708539|NCT02253173|Hormones|hormones|mesh-ancestor
25708540|NCT02253173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25708541|NCT02253173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708542|NCT02253654|Epoetin Alfa|epoetin alfa|mesh-list
25708543|NCT02253654|Hematinics|hematinics|mesh-ancestor
25708544|NCT02253992|Nivolumab|nivolumab|mesh-list
25708545|NCT02253992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25708546|NCT02253992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24534522|NCT00647257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24534523|NCT00647257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24534524|NCT00647257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534525|NCT00647322|Anticonvulsants|anticonvulsants|mesh-list
24534527|NCT00647491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24534528|NCT00647491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24534529|NCT00647530|Fluorouracil|fluorouracil|mesh-list
24534530|NCT00647530|Capecitabine|capecitabine|mesh-list
24534531|NCT00647530|Oxaliplatin|oxaliplatin|mesh-list
24534532|NCT00647530|Panitumumab|panitumumab|mesh-list
24534551|NCT00647608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24534552|NCT00647608|Adrenergic Agents|adrenergic agents|mesh-ancestor
24534553|NCT00647608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24534639|NCT00647738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24534640|NCT00647738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534641|NCT00647751|Lamotrigine|lamotrigine|mesh-list
24534642|NCT00647751|Anticonvulsants|anticonvulsants|mesh-ancestor
24534643|NCT00647751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24534644|NCT00647751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24534645|NCT00647751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534646|NCT00647751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24703611|NCT01472783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703613|NCT01472796|Cholecalciferol|cholecalciferol|mesh-list
24703614|NCT01472796|Vitamins|vitamins|mesh-ancestor
24703615|NCT01472796|Micronutrients|micronutrients|mesh-ancestor
24703616|NCT01472796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534744|NCT00647907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857505|NCT02292069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24857506|NCT02292069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857507|NCT02292069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24534783|NCT00647985|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24534784|NCT00647985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24534785|NCT00647985|Histamine Antagonists|histamine antagonists|mesh-ancestor
24534786|NCT00647985|Histamine Agents|histamine agents|mesh-ancestor
24857508|NCT02292069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24857509|NCT02292069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24857510|NCT02292069|Vasodilator Agents|vasodilator agents|mesh-ancestor
24444305|NCT00297375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24444306|NCT00297388|Risperidone|risperidone|mesh-list
24444307|NCT00297388|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24444322|NCT00297466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444323|NCT00297466|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24534854|NCT00648141|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25708547|NCT02253992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25708548|NCT02253992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708549|NCT02254252|Nicorandil|nicorandil|mesh-list
25708550|NCT02254252|Nitroglycerin|nitroglycerin|mesh-list
25708551|NCT02254252|Vasodilator Agents|vasodilator agents|mesh-ancestor
25708552|NCT02254252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24534872|NCT00648180|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24534873|NCT00648180|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24534882|NCT00648193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24534884|NCT00648193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24534886|NCT00648193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24534887|NCT00648193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24534889|NCT00648219|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24534890|NCT00648219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24534891|NCT00648219|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24451095|NCT00321945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451096|NCT00321945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451097|NCT00322036|Flurbiprofen|flurbiprofen|mesh-list
24451098|NCT00322036|Analgesics|analgesics|mesh-ancestor
24451099|NCT00322036|Sensory System Agents|sensory system agents|mesh-ancestor
24857561|NCT02292472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24857562|NCT02292472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857629|NCT02293148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24857630|NCT02293148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24857631|NCT02293148|Contraceptive Agents|contraceptive agents|mesh-ancestor
25708553|NCT02254252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25708554|NCT02254252|Vitamin B Complex|vitamin b complex|mesh-ancestor
25708555|NCT02254252|Vitamins|vitamins|mesh-ancestor
25708556|NCT02254252|Micronutrients|micronutrients|mesh-ancestor
25708557|NCT02254252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708558|NCT02254291|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25708559|NCT02254291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25708560|NCT02254291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708561|NCT02254291|Incretins|incretins|mesh-ancestor
24535005|NCT00648401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535006|NCT00648401|Vasodilator Agents|vasodilator agents|mesh-ancestor
24857632|NCT02293148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24857633|NCT02293148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535007|NCT00648414|Fentanyl|fentanyl|mesh-list
24535008|NCT00648414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24535009|NCT00648414|Narcotics|narcotics|mesh-ancestor
24535010|NCT00648414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24535011|NCT00648414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535012|NCT00648414|Analgesics|analgesics|mesh-ancestor
24535039|NCT00648440|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24535041|NCT00648440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25708562|NCT02254291|Hormones|hormones|mesh-ancestor
24535093|NCT00648570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24535094|NCT00648570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24535095|NCT00648570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708563|NCT02254291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25708564|NCT02254291|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25708565|NCT02254291|Protease Inhibitors|protease inhibitors|mesh-ancestor
25708566|NCT02254291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25708567|NCT02254291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708568|NCT02254304|Interferons|interferons|mesh-list
25708569|NCT02254304|Interferon-beta|interferon-beta|mesh-list
25708570|NCT02254304|Interferon beta-1a|interferon beta-1a|mesh-list
24535096|NCT00648570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535097|NCT00648570|Serotonin Agents|serotonin agents|mesh-ancestor
24535098|NCT00648570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535099|NCT00648570|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24535100|NCT00648570|Antidepressive Agents|antidepressive agents|mesh-ancestor
24535101|NCT00648570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24857645|NCT02293187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24857646|NCT02293291|Lithium Carbonate|lithium carbonate|mesh-list
24857647|NCT02293291|Antidepressive Agents|antidepressive agents|mesh-ancestor
24535191|NCT00648765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535192|NCT00648765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24451122|NCT00322114|Lycopene|lycopene|mesh-list
24451123|NCT00322114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24451124|NCT00322114|Antioxidants|antioxidants|mesh-ancestor
24451125|NCT00322114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460153|NCT00347503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24535372|NCT00649051|Natriuretic Agents|natriuretic agents|mesh-ancestor
25708571|NCT02254304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708572|NCT02254304|Antiviral Agents|antiviral agents|mesh-ancestor
25708573|NCT02254304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25708574|NCT02254304|Immunologic Factors|immunologic factors|mesh-ancestor
25708575|NCT02254304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708576|NCT02254304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25708577|NCT02254551|Bortezomib|bortezomib|mesh-list
24535373|NCT00649051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535374|NCT00649051|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24535375|NCT00649051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24535376|NCT00649051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535378|NCT00649064|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24535385|NCT00649064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24535558|NCT00649363|Dermatologic Agents|dermatologic agents|mesh-ancestor
24535559|NCT00649363|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24535560|NCT00649363|Serotonin Agents|serotonin agents|mesh-ancestor
24535561|NCT00649363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535562|NCT00649363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535563|NCT00649363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24535564|NCT00649363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24535565|NCT00649363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24451156|NCT00322543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24535569|NCT00649376|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24535571|NCT00649376|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24535763|NCT00649675|Analgesics|analgesics|mesh-ancestor
24535764|NCT00649675|Sensory System Agents|sensory system agents|mesh-ancestor
24535765|NCT00649675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24535766|NCT00649675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535767|NCT00649675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24535776|NCT00649688|Diuretics|diuretics|mesh-ancestor
24535902|NCT00649974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24535903|NCT00649987|Albuterol|albuterol|mesh-list
24535904|NCT00649987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24535905|NCT00649987|Autonomic Agents|autonomic agents|mesh-ancestor
24535906|NCT00649987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24535907|NCT00649987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535908|NCT00649987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24535995|NCT00650156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24535996|NCT00650156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25708578|NCT02254551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708579|NCT02254681|Gemcitabine|gemcitabine|mesh-list
25708580|NCT02254681|Cisplatin|cisplatin|mesh-list
25708581|NCT02254681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708582|NCT02254681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25708583|NCT02254681|Antimetabolites|antimetabolites|mesh-ancestor
25708584|NCT02254681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708585|NCT02254681|Antiviral Agents|antiviral agents|mesh-ancestor
24536026|NCT00650195|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24536027|NCT00650195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24536028|NCT00650195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536031|NCT00650208|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24536032|NCT00650208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24536033|NCT00650208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536065|NCT00650286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536066|NCT00650286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24536067|NCT00650286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24536068|NCT00650286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24536069|NCT00650286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536070|NCT00650299|Alprazolam|alprazolam|mesh-list
24451185|NCT00322569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24451193|NCT00322595|Paroxetine|paroxetine|mesh-list
24536439|NCT00651287|Protease Inhibitors|protease inhibitors|mesh-ancestor
24536477|NCT00651352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24706201|NCT01489202|Cobalt|cobalt|mesh-list
24536490|NCT00651456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24536491|NCT00651456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24536492|NCT00651456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24536493|NCT00651456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24536494|NCT00651456|Growth Substances|growth substances|mesh-ancestor
24536495|NCT00651456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536496|NCT00651456|Growth Inhibitors|growth inhibitors|mesh-ancestor
24536544|NCT00651612|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24536626|NCT00651846|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
24536627|NCT00651846|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
24536628|NCT00651846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24536629|NCT00651846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536630|NCT00651846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24536631|NCT00651846|Contraceptive Agents|contraceptive agents|mesh-ancestor
24536632|NCT00651846|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24536633|NCT00651846|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24536634|NCT00651846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24536635|NCT00651846|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24536654|NCT00651976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536655|NCT00651976|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24536656|NCT00651976|Hormone Antagonists|hormone antagonists|mesh-ancestor
24536657|NCT00651976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24536658|NCT00651976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536660|NCT00652002|Formoterol Fumarate|formoterol fumarate|mesh-list
24536718|NCT00652119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536719|NCT00652119|Growth Inhibitors|growth inhibitors|mesh-ancestor
24536721|NCT00652132|Antidotes|antidotes|mesh-ancestor
24536722|NCT00652132|Protective Agents|protective agents|mesh-ancestor
24536723|NCT00652132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536724|NCT00652132|Antioxidants|antioxidants|mesh-ancestor
24536725|NCT00652132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536726|NCT00652132|Antitubercular Agents|antitubercular agents|mesh-ancestor
24451228|NCT00322699|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
24451229|NCT00322699|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
25708586|NCT02254681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24451230|NCT00322699|Trioxsalen|trioxsalen|mesh-list
24451231|NCT00322699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451232|NCT00322699|Dermatologic Agents|dermatologic agents|mesh-ancestor
24451233|NCT00322699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24451234|NCT00322751|Topotecan|topotecan|mesh-list
24451235|NCT00322751|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24857748|NCT02293824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24857757|NCT02293889|Ergocalciferols|ergocalciferols|mesh-list
24857758|NCT02293889|Cholecalciferol|cholecalciferol|mesh-list
24857759|NCT02293889|Vitamins|vitamins|mesh-list
24857760|NCT02293889|Micronutrients|micronutrients|mesh-ancestor
24857761|NCT02293889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857762|NCT02293889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24536974|NCT00653016|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24536975|NCT00653016|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24536976|NCT00653042|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24536977|NCT00653042|Natriuretic Agents|natriuretic agents|mesh-ancestor
24536978|NCT00653042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536980|NCT00653055|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24444929|NCT00299754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537014|NCT00653250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24537015|NCT00653250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537016|NCT00653250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537018|NCT00653302|Insulin Glargine|insulin glargine|mesh-list
24445138|NCT00300560|Colistin|colistin|mesh-list
25708587|NCT02254681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25708588|NCT02254681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25708589|NCT02254681|Immunologic Factors|immunologic factors|mesh-ancestor
25708590|NCT02254681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708591|NCT02254772|Ipilimumab|ipilimumab|mesh-list
25708592|NCT02254772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25708593|NCT02254772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708594|NCT02254772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25708595|NCT02254772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537311|NCT00654277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24537400|NCT00654524|Micronutrients|micronutrients|mesh-ancestor
24537401|NCT00654524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537402|NCT00654524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24537404|NCT00654524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24537405|NCT00654524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24537770|NCT00656110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24857783|NCT02294071|Acetaminophen|acetaminophen|mesh-list
24857784|NCT02294071|Ibuprofen|ibuprofen|mesh-list
24537905|NCT00656747|Clavulanic Acid|clavulanic acid|mesh-list
24538278|NCT00658255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538300|NCT00658580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24460300|NCT00348101|Enoximone|enoximone|mesh-list
24538569|NCT00659958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24538570|NCT00659958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538571|NCT00659997|Albendazole|albendazole|mesh-list
25708596|NCT02255110|Doxorubicin|doxorubicin|mesh-list
25708597|NCT02255110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24538626|NCT00660062|Adrenergic Agents|adrenergic agents|mesh-ancestor
24538627|NCT00660140|Gemcitabine|gemcitabine|mesh-list
25708598|NCT02255110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708599|NCT02255110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25708600|NCT02255110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25708601|NCT02255110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25708602|NCT02255110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708603|NCT02255175|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24538628|NCT00660140|Carboplatin|carboplatin|mesh-list
24538629|NCT00660140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24538630|NCT00660140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24538637|NCT00660140|Immunologic Factors|immunologic factors|mesh-ancestor
24538638|NCT00660140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538640|NCT00660231|Bexarotene|bexarotene|mesh-list
24857808|NCT02294110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24538883|NCT00661076|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24538898|NCT00661115|Vasodilator Agents|vasodilator agents|mesh-ancestor
24538901|NCT00661115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539025|NCT00661856|Daidzein|daidzein|mesh-list
24539110|NCT00662441|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25708604|NCT02255175|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25708605|NCT02255175|Estradiol|estradiol|mesh-list
25708606|NCT02255175|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25708607|NCT02255175|Progesterone|progesterone|mesh-list
25708608|NCT02255175|Estrogens|estrogens|mesh-ancestor
25708609|NCT02255175|Hormones|hormones|mesh-ancestor
25708610|NCT02255175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25708611|NCT02255175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708612|NCT02255175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25708613|NCT02255175|Contraceptive Agents|contraceptive agents|mesh-ancestor
25708614|NCT02255175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24539131|NCT00662454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24539132|NCT00662454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24539133|NCT00662454|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24539134|NCT00662467|Aspirin|aspirin|mesh-list
24539135|NCT00662467|Warfarin|warfarin|mesh-list
24539136|NCT00662467|Clopidogrel|clopidogrel|mesh-list
24539137|NCT00662467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24539138|NCT00662467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24539139|NCT00662467|Analgesics|analgesics|mesh-ancestor
24539140|NCT00662467|Sensory System Agents|sensory system agents|mesh-ancestor
24446177|NCT00303940|Temozolomide|temozolomide|mesh-list
24539273|NCT00663052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24539274|NCT00663052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24539275|NCT00663052|Analgesics|analgesics|mesh-ancestor
24539276|NCT00663052|Sensory System Agents|sensory system agents|mesh-ancestor
24443932|NCT00296218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24444099|NCT00296712|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24444104|NCT00296712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24444105|NCT00296712|Cholinergic Agents|cholinergic agents|mesh-ancestor
24444106|NCT00296712|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24540511|NCT00668239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24540512|NCT00668239|Glucocorticoids|glucocorticoids|mesh-ancestor
25708615|NCT02255175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25708616|NCT02255175|Progestins|progestins|mesh-ancestor
25708617|NCT02255279|Vaccines|vaccines|mesh-list
25708618|NCT02255279|Immunologic Factors|immunologic factors|mesh-ancestor
25708619|NCT02255279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708620|NCT02255357|Oxytocin|oxytocin|mesh-list
24541333|NCT00672347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541334|NCT00672347|Sensory System Agents|sensory system agents|mesh-ancestor
24857844|NCT02294266|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24541575|NCT00674011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24543093|NCT00681928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24542667|NCT00679653|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24542668|NCT00679666|Riboflavin|riboflavin|mesh-list
24542669|NCT00679666|Vitamins|vitamins|mesh-ancestor
24542670|NCT00679666|Micronutrients|micronutrients|mesh-ancestor
24542718|NCT00679900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24542719|NCT00679900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542720|NCT00679900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24542721|NCT00679900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24542722|NCT00679965|Tavaborole|tavaborole|mesh-list
24542725|NCT00680095|Tavaborole|tavaborole|mesh-list
25708621|NCT02255357|Oxytocics|oxytocics|mesh-ancestor
25708622|NCT02255357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25708623|NCT02255357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708624|NCT02255461|Palbociclib|palbociclib|mesh-list
25708625|NCT02255461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708626|NCT02255461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25708627|NCT02255461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25708628|NCT02255461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708629|NCT02255500|Bupivacaine|bupivacaine|mesh-list
25708630|NCT02255500|Anesthetics, Local|anesthetics, local|mesh-ancestor
25708632|NCT02255500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25708633|NCT02255500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857939|NCT02294539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857941|NCT02294539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543070|NCT00681876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24543071|NCT00681876|Growth Substances|growth substances|mesh-ancestor
24543072|NCT00681876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543073|NCT00681876|Growth Inhibitors|growth inhibitors|mesh-ancestor
24543089|NCT00681902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543090|NCT00681928|Letrozole|letrozole|mesh-list
24543091|NCT00681928|Anastrozole|anastrozole|mesh-list
24543092|NCT00681928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543171|NCT00682149|Protective Agents|protective agents|mesh-ancestor
24543208|NCT00682383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24543209|NCT00682383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24543227|NCT00682578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24543228|NCT00682578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543229|NCT00682578|Antiviral Agents|antiviral agents|mesh-ancestor
24543230|NCT00682578|Schistosomicides|schistosomicides|mesh-ancestor
24543231|NCT00682578|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24543245|NCT00682630|Antiviral Agents|antiviral agents|mesh-ancestor
24543246|NCT00682630|Schistosomicides|schistosomicides|mesh-ancestor
24543247|NCT00682630|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24543248|NCT00682630|Anthelmintics|anthelmintics|mesh-ancestor
24543249|NCT00682656|Azithromycin|azithromycin|mesh-list
24543250|NCT00682656|Meglumine Antimoniate|meglumine antimoniate|mesh-list
25708634|NCT02255500|Sensory System Agents|sensory system agents|mesh-ancestor
25708635|NCT02255500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25708636|NCT02255513|Methylphenidate|methylphenidate|mesh-list
25708637|NCT02255513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25708638|NCT02255513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708639|NCT02255513|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25708640|NCT02255513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24543324|NCT00683137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446645|NCT00305513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543686|NCT00685009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24543687|NCT00685009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543795|NCT00685529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24543796|NCT00685529|Respiratory System Agents|respiratory system agents|mesh-ancestor
24543797|NCT00685529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25708641|NCT02255513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25708642|NCT02255513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708643|NCT02255513|Dopamine Agents|dopamine agents|mesh-ancestor
25708644|NCT02255513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25708645|NCT02255565|Methylphenidate|methylphenidate|mesh-list
25708646|NCT02255565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25708647|NCT02255565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543800|NCT00685529|Adrenergic Agents|adrenergic agents|mesh-ancestor
24543801|NCT00685529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24543802|NCT00685529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543804|NCT00685542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24543805|NCT00685568|Celecoxib|celecoxib|mesh-list
24543807|NCT00685568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24460455|NCT00348426|Botulinum Antitoxin|botulinum antitoxin|mesh-list
24543945|NCT00686114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543946|NCT00686114|Tubulin Modulators|tubulin modulators|mesh-ancestor
24543947|NCT00686114|Antimitotic Agents|antimitotic agents|mesh-ancestor
24543948|NCT00686114|Mitosis Modulators|mitosis modulators|mesh-ancestor
24543949|NCT00686114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543972|NCT00686179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543974|NCT00686192|Calcium|calcium|mesh-list
24543975|NCT00686192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24543976|NCT00686192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543977|NCT00686192|Antacids|antacids|mesh-ancestor
24543978|NCT00686192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543980|NCT00686218|Imatinib Mesylate|imatinib mesylate|mesh-list
24544030|NCT00686556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544031|NCT00686556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544032|NCT00686556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24857998|NCT02294643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24857999|NCT02294643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24544103|NCT00687245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24544104|NCT00687245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25708648|NCT02255565|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25708649|NCT02255565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25708650|NCT02255565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25708651|NCT02255565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708652|NCT02255565|Dopamine Agents|dopamine agents|mesh-ancestor
25708653|NCT02255565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24544238|NCT00687999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447114|NCT00307528|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24447115|NCT00307528|Immunologic Factors|immunologic factors|mesh-ancestor
24858014|NCT02294643|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24858015|NCT02294643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24544269|NCT00688272|Ciprofloxacin|ciprofloxacin|mesh-list
24544390|NCT00688883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24544391|NCT00688883|Antimetabolites|antimetabolites|mesh-ancestor
24544539|NCT00689442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544540|NCT00689494|Levonorgestrel|levonorgestrel|mesh-list
24544541|NCT00689494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24544542|NCT00689494|Contraceptive Agents|contraceptive agents|mesh-ancestor
24544613|NCT00689637|Anticoagulants|anticoagulants|mesh-ancestor
24544614|NCT00689702|Capecitabine|capecitabine|mesh-list
24544616|NCT00689702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24544617|NCT00689702|Antimetabolites|antimetabolites|mesh-ancestor
24544618|NCT00689702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544619|NCT00689702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544620|NCT00689702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24544638|NCT00689780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544639|NCT00689780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24544640|NCT00689780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24544641|NCT00689780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24544642|NCT00689780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24544643|NCT00689780|Anesthetics, General|anesthetics, general|mesh-ancestor
24544955|NCT00691158|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
24544956|NCT00691158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24544957|NCT00691158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544958|NCT00691158|Appetite Depressants|appetite depressants|mesh-ancestor
24544959|NCT00691158|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24544960|NCT00691158|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
24544961|NCT00691158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544962|NCT00691184|Terbinafine|terbinafine|mesh-list
24544963|NCT00691184|Antifungal Agents|antifungal agents|mesh-ancestor
24544964|NCT00691184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24813162|NCT02056743|GABA Modulators|gaba modulators|mesh-ancestor
24545114|NCT00691951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24545115|NCT00691951|Adrenergic Agents|adrenergic agents|mesh-ancestor
24545116|NCT00691951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24545117|NCT00691951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545118|NCT00692016|Naproxen|naproxen|mesh-list
24813103|NCT02056418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24833213|NCT02173145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24858092|NCT02295046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24858093|NCT02295046|Vasodilator Agents|vasodilator agents|mesh-ancestor
24858095|NCT02295124|Hydromorphone|hydromorphone|mesh-list
24858096|NCT02295124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24858103|NCT02295150|Nadroparin|nadroparin|mesh-list
24545188|NCT00692315|Micronutrients|micronutrients|mesh-ancestor
24545189|NCT00692315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545190|NCT00692315|Vitamin B Complex|vitamin b complex|mesh-ancestor
24545200|NCT00692354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545202|NCT00692510|Midazolam|midazolam|mesh-list
24545203|NCT00692510|Caffeine|caffeine|mesh-list
24545204|NCT00692510|Bupropion|bupropion|mesh-list
24447311|NCT00308165|Topotecan|topotecan|mesh-list
24545239|NCT00692510|Antioxidants|antioxidants|mesh-ancestor
24545240|NCT00692510|Protective Agents|protective agents|mesh-ancestor
24545241|NCT00692601|Capsaicin|capsaicin|mesh-list
24545242|NCT00692601|Antipruritics|antipruritics|mesh-ancestor
24545243|NCT00692601|Dermatologic Agents|dermatologic agents|mesh-ancestor
24545244|NCT00692601|Sensory System Agents|sensory system agents|mesh-ancestor
24545304|NCT00693030|Sirolimus|sirolimus|mesh-list
24545320|NCT00693043|Anesthetics, Local|anesthetics, local|mesh-ancestor
25708654|NCT02255760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25708655|NCT02255760|Immunologic Factors|immunologic factors|mesh-ancestor
25708656|NCT02255760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708657|NCT02256111|Androgens|androgens|mesh-list
25708658|NCT02256111|Hormones|hormones|mesh-ancestor
25708659|NCT02256111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25708660|NCT02256111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708661|NCT02256189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24545321|NCT00693043|Anesthetics|anesthetics|mesh-ancestor
24545322|NCT00693043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24545323|NCT00693043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545324|NCT00693043|Sensory System Agents|sensory system agents|mesh-ancestor
24545325|NCT00693043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24545326|NCT00693043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24858317|NCT02296281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460784|NCT00349518|Dasatinib|dasatinib|mesh-list
24460785|NCT00349518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708663|NCT02256189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708664|NCT02256189|Incretins|incretins|mesh-ancestor
25708665|NCT02256189|Hormones|hormones|mesh-ancestor
25708666|NCT02256189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25708667|NCT02256189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25708668|NCT02256189|Protease Inhibitors|protease inhibitors|mesh-ancestor
25708669|NCT02256189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25708670|NCT02256189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708671|NCT02256267|Rifampin|rifampin|mesh-list
25708672|NCT02256267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25708673|NCT02256267|Antitubercular Agents|antitubercular agents|mesh-ancestor
25708674|NCT02256267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25708675|NCT02256267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25708676|NCT02256267|Leprostatic Agents|leprostatic agents|mesh-ancestor
24545490|NCT00693524|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24545491|NCT00693524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24545492|NCT00693524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460787|NCT00349518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24545495|NCT00693524|Antitubercular Agents|antitubercular agents|mesh-ancestor
24545496|NCT00693524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24545497|NCT00693524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24545499|NCT00693576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24545500|NCT00693576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24813152|NCT02056743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24813153|NCT02056743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24813154|NCT02056743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24813155|NCT02056743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813156|NCT02056743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24813157|NCT02056743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24813158|NCT02056743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24813159|NCT02056743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24813160|NCT02056743|Anesthetics, General|anesthetics, general|mesh-ancestor
24813161|NCT02056743|Anesthetics|anesthetics|mesh-ancestor
25708677|NCT02256267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25708678|NCT02256267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24545586|NCT00693862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545587|NCT00693862|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24545589|NCT00693862|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24858365|NCT02296671|Antimetabolites|antimetabolites|mesh-ancestor
24858366|NCT02296671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858367|NCT02296671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24545596|NCT00693979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24545597|NCT00693979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24545640|NCT00694187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545648|NCT00694200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447352|NCT00308321|Methylprednisolone|methylprednisolone|mesh-list
24712249|NCT01519336|Darunavir|darunavir|mesh-list
24545666|NCT00694291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24545667|NCT00694291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24545668|NCT00694291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708679|NCT02256267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708680|NCT02256267|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25708681|NCT02256267|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24545772|NCT00694837|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24545773|NCT00694837|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24545774|NCT00694837|Protease Inhibitors|protease inhibitors|mesh-ancestor
24545775|NCT00694837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24545776|NCT00694837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614548|NCT01024712|Carboplatin|carboplatin|mesh-list
24614549|NCT01024712|Gefitinib|gefitinib|mesh-list
24858592|NCT02298283|Antimitotic Agents|antimitotic agents|mesh-ancestor
24858593|NCT02298283|Mitosis Modulators|mitosis modulators|mesh-ancestor
24858594|NCT02298283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24712670|NCT01522092|Serotonin Agents|serotonin agents|mesh-ancestor
24813171|NCT02056743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24813172|NCT02056743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24428734|NCT00241072|Valsartan|valsartan|mesh-list
24545966|NCT00696098|Histamine Antagonists|histamine antagonists|mesh-ancestor
24545967|NCT00696098|Histamine Agents|histamine agents|mesh-ancestor
24545968|NCT00696098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24545969|NCT00696098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546155|NCT00696982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24546157|NCT00696982|Protease Inhibitors|protease inhibitors|mesh-ancestor
24546158|NCT00696982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25708682|NCT02256267|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25708683|NCT02256267|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25708684|NCT02256267|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25708685|NCT02256267|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25708686|NCT02256358|Midazolam|midazolam|mesh-list
24546159|NCT00696982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858684|NCT02299063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24858685|NCT02299063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858686|NCT02299063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24546208|NCT00697138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24546209|NCT00697138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24546210|NCT00697138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858731|NCT02299232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24858732|NCT02299232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24858733|NCT02299232|Adrenergic Agents|adrenergic agents|mesh-ancestor
24858734|NCT02299232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24461207|NCT00351286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24858748|NCT02299271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858762|NCT02299401|Abortifacient Agents|abortifacient agents|mesh-ancestor
24858763|NCT02299401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24858764|NCT02299401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858765|NCT02299401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24858766|NCT02299401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24858768|NCT02299440|Ketamine|ketamine|mesh-list
24858769|NCT02299440|Analgesics|analgesics|mesh-ancestor
24546821|NCT00700583|Diuretics|diuretics|mesh-ancestor
24447433|NCT00308477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24447435|NCT00308477|Autonomic Agents|autonomic agents|mesh-ancestor
24447436|NCT00308477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24858793|NCT02299518|Antimetabolites|antimetabolites|mesh-ancestor
24858794|NCT02299518|Antiviral Agents|antiviral agents|mesh-ancestor
24858795|NCT02299518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24858796|NCT02299518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24858797|NCT02299518|Immunologic Factors|immunologic factors|mesh-ancestor
24858798|NCT02299518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24858845|NCT02299765|Immunologic Factors|immunologic factors|mesh-ancestor
24858934|NCT02300623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25708687|NCT02256358|Ketamine|ketamine|mesh-list
25708688|NCT02256358|Analgesics|analgesics|mesh-ancestor
25708689|NCT02256358|Sensory System Agents|sensory system agents|mesh-ancestor
25708690|NCT02256358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25708691|NCT02256358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708692|NCT02256358|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25708693|NCT02256358|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25708694|NCT02256358|Anesthetics, General|anesthetics, general|mesh-ancestor
25708695|NCT02256358|Anesthetics|anesthetics|mesh-ancestor
25708696|NCT02256358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25708697|NCT02256358|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24858935|NCT02300623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24858936|NCT02300623|Antiviral Agents|antiviral agents|mesh-ancestor
24858937|NCT02300623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24858938|NCT02300623|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24546391|NCT00697905|Antiviral Agents|antiviral agents|mesh-ancestor
24546392|NCT00697905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24546393|NCT00697905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24546394|NCT00697905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24546428|NCT00698334|Antitubercular Agents|antitubercular agents|mesh-ancestor
24546429|NCT00698334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24546430|NCT00698334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24546431|NCT00698334|Leprostatic Agents|leprostatic agents|mesh-ancestor
24546432|NCT00698334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24546433|NCT00698334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24546434|NCT00698334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546435|NCT00698334|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24546436|NCT00698334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24546437|NCT00698334|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24546438|NCT00698334|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24546441|NCT00698425|Citric Acid|citric acid|mesh-list
24800387|NCT01975363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24800388|NCT01975363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800389|NCT01975363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24800390|NCT01975363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24800391|NCT01975363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800392|NCT01975363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800393|NCT01975363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800395|NCT01975441|Albendazole|albendazole|mesh-list
24800396|NCT01975441|Diethylcarbamazine|diethylcarbamazine|mesh-list
24546629|NCT00699426|Esomeprazole|esomeprazole|mesh-list
24546630|NCT00699426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24546631|NCT00699426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24800464|NCT01975753|Analgesics|analgesics|mesh-ancestor
24550799|NCT00722488|Pevonedistat|pevonedistat|mesh-list
24546632|NCT00699426|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24546633|NCT00699426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24546634|NCT00699426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546635|NCT00699452|Candesartan|candesartan|mesh-list
24546636|NCT00699452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24546816|NCT00700544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24546817|NCT00700544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546818|NCT00700583|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24546820|NCT00700583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24546869|NCT00700921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24546947|NCT00701298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800477|NCT01975805|Disinfectants|disinfectants|mesh-ancestor
24800478|NCT01975805|Dermatologic Agents|dermatologic agents|mesh-ancestor
24800479|NCT01975805|Plasma Substitutes|plasma substitutes|mesh-ancestor
24800480|NCT01975805|Blood Substitutes|blood substitutes|mesh-ancestor
24800481|NCT01975961|Telmisartan|telmisartan|mesh-list
24800482|NCT01975961|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24800483|NCT01975961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24800484|NCT01975961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24800485|NCT01975961|Antimetabolites|antimetabolites|mesh-ancestor
24833357|NCT02173782|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
24833358|NCT02173782|Ipratropium|ipratropium|mesh-list
24547068|NCT00702182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24547070|NCT00702182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547071|NCT00702182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24547072|NCT00702182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547074|NCT00702182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24547076|NCT00702182|Antimitotic Agents|antimitotic agents|mesh-ancestor
24547077|NCT00702182|Mitosis Modulators|mitosis modulators|mesh-ancestor
25708698|NCT02256358|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25708699|NCT02256358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25708700|NCT02256358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708701|NCT02256358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24547079|NCT00702260|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24547119|NCT00702481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547179|NCT00702819|Growth Inhibitors|growth inhibitors|mesh-ancestor
24547180|NCT00702871|Ranitidine|ranitidine|mesh-list
24547181|NCT00702871|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
24547182|NCT00702871|Sucralfate|sucralfate|mesh-list
24547183|NCT00702871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24547184|NCT00702871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24547185|NCT00702871|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24547186|NCT00702871|Histamine Antagonists|histamine antagonists|mesh-ancestor
24547187|NCT00702871|Histamine Agents|histamine agents|mesh-ancestor
24800541|NCT01976182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24800542|NCT01976182|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24800544|NCT01976195|Thalidomide|thalidomide|mesh-list
24551246|NCT00724685|Anesthetics, Local|anesthetics, local|mesh-ancestor
24547518|NCT00704392|XL647|xl647|mesh-list
24547520|NCT00704392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24547521|NCT00704392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547522|NCT00704392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547523|NCT00704431|Darapladib|darapladib|mesh-list
24547524|NCT00704431|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
24547525|NCT00704431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547526|NCT00704431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547527|NCT00704509|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24547528|NCT00704509|Antidepressive Agents|antidepressive agents|mesh-ancestor
24547529|NCT00704509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24547530|NCT00704509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24547531|NCT00704509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24547532|NCT00704509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24800607|NCT01976780|Anthelmintics|anthelmintics|mesh-ancestor
24800633|NCT01977209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24800634|NCT01977209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800635|NCT01977235|Irinotecan|irinotecan|mesh-list
24800636|NCT01977235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800637|NCT01977235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24800638|NCT01977235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24551570|NCT05373004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24800755|NCT01978405|Vitamin B Complex|vitamin b complex|mesh-ancestor
24800756|NCT01978405|Vitamins|vitamins|mesh-ancestor
24800761|NCT01978418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24800762|NCT01978418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800772|NCT01978418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800773|NCT01978431|Cocaine|cocaine|mesh-list
24800774|NCT01978431|Methylphenidate|methylphenidate|mesh-list
25708702|NCT02256358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25708703|NCT02256358|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25708704|NCT02256358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25708705|NCT02256358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24800775|NCT01978431|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24800776|NCT01978431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708706|NCT02256358|GABA Modulators|gaba modulators|mesh-ancestor
25708707|NCT02256358|GABA Agents|gaba agents|mesh-ancestor
25708708|NCT02256436|Paclitaxel|paclitaxel|mesh-list
25708709|NCT02256436|Docetaxel|docetaxel|mesh-list
25708710|NCT02256436|Pembrolizumab|pembrolizumab|mesh-list
25708711|NCT02256436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24800777|NCT01978431|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24594856|NCT00935805|Metformin|metformin|mesh-list
24548099|NCT00707551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24548100|NCT00707551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24548101|NCT00707551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24548102|NCT00707551|Vasodilator Agents|vasodilator agents|mesh-ancestor
24548111|NCT00707707|Antimitotic Agents|antimitotic agents|mesh-ancestor
24548112|NCT00707707|Mitosis Modulators|mitosis modulators|mesh-ancestor
24548113|NCT00707707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548114|NCT00707707|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24594935|NCT00936195|Ritonavir|ritonavir|mesh-list
24800865|NCT01978873|Methyltestosterone|methyltestosterone|mesh-list
24800867|NCT01978873|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24800868|NCT01978873|Hormones|hormones|mesh-ancestor
24859002|NCT02300948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552108|NCT04176419|Analgesics|analgesics|mesh-ancestor
24552109|NCT04176419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24552110|NCT04176419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24552111|NCT04176419|Anesthetics, General|anesthetics, general|mesh-ancestor
24800869|NCT01978873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24800870|NCT01978873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800872|NCT01978873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800873|NCT01978873|Protective Agents|protective agents|mesh-ancestor
24800875|NCT01978873|Micronutrients|micronutrients|mesh-ancestor
24800876|NCT01978873|Estrogens|estrogens|mesh-ancestor
24800877|NCT01978873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24800888|NCT01979341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24800889|NCT01979341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800890|NCT01979354|Morphine|morphine|mesh-list
24800891|NCT01979354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24800892|NCT01979354|Narcotics|narcotics|mesh-ancestor
24800903|NCT01979510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24800904|NCT01979510|Analgesics|analgesics|mesh-ancestor
24800905|NCT01979510|Sensory System Agents|sensory system agents|mesh-ancestor
24800906|NCT01979510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24800907|NCT01979510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24800908|NCT01979510|Antipyretics|antipyretics|mesh-ancestor
24800983|NCT01980277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24800984|NCT01980277|Tubulin Modulators|tubulin modulators|mesh-ancestor
24800985|NCT01980277|Antimitotic Agents|antimitotic agents|mesh-ancestor
24800986|NCT01980277|Mitosis Modulators|mitosis modulators|mesh-ancestor
25406185|NCT03575325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25708712|NCT02256436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708713|NCT02256436|Tubulin Modulators|tubulin modulators|mesh-ancestor
25708714|NCT02256436|Antimitotic Agents|antimitotic agents|mesh-ancestor
25708715|NCT02256436|Mitosis Modulators|mitosis modulators|mesh-ancestor
25708716|NCT02256436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708717|NCT02256436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25708718|NCT02256540|Resveratrol|resveratrol|mesh-list
25708719|NCT02256540|Estradiol|estradiol|mesh-list
25708720|NCT02256540|Estrogens|estrogens|mesh-ancestor
25708721|NCT02256540|Hormones|hormones|mesh-ancestor
24800987|NCT01980277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24800988|NCT01980303|Esketamine|esketamine|mesh-list
24595152|NCT00937027|Aminopterin|aminopterin|mesh-list
24548238|NCT00708539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24548239|NCT00708539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548240|NCT00708565|Iloprost|iloprost|mesh-list
24548259|NCT00708591|Immunologic Factors|immunologic factors|mesh-ancestor
24548260|NCT00708591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548261|NCT00708591|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24548267|NCT00708591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24800999|NCT01980316|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24801000|NCT01980316|Protease Inhibitors|protease inhibitors|mesh-ancestor
24801001|NCT01980316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24801002|NCT01980316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24801004|NCT01980329|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24801005|NCT01980329|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24801012|NCT01980407|Leucovorin|leucovorin|mesh-list
24801062|NCT01980667|Cisplatin|cisplatin|mesh-list
24447594|NCT00309192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24447620|NCT00309218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25708722|NCT02256540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25708723|NCT02256540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708724|NCT02256540|Antioxidants|antioxidants|mesh-ancestor
25708725|NCT02256540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708726|NCT02256540|Protective Agents|protective agents|mesh-ancestor
25708727|NCT02256540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24447622|NCT00309218|Hormones|hormones|mesh-ancestor
24447623|NCT00309218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24548403|NCT00709332|Micronutrients|micronutrients|mesh-ancestor
24548404|NCT00709332|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24548405|NCT00709332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24548406|NCT00709332|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24548407|NCT00709423|Moxaverine|moxaverine|mesh-list
24548408|NCT00709423|Parasympatholytics|parasympatholytics|mesh-ancestor
24548409|NCT00709423|Autonomic Agents|autonomic agents|mesh-ancestor
24548410|NCT00709423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24548411|NCT00709423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548412|NCT00709436|Ketamine|ketamine|mesh-list
24548413|NCT00709436|Analgesics|analgesics|mesh-ancestor
24548414|NCT00709436|Sensory System Agents|sensory system agents|mesh-ancestor
24548415|NCT00709436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24548416|NCT00709436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548417|NCT00709436|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24548465|NCT00709644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24548466|NCT00709644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548467|NCT00709644|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24548469|NCT00709644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24548470|NCT00709644|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24548471|NCT00709644|Hematinics|hematinics|mesh-ancestor
24548485|NCT00709657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548486|NCT00709657|Growth Inhibitors|growth inhibitors|mesh-ancestor
24548487|NCT00709683|Insulin Aspart|insulin aspart|mesh-list
24548488|NCT00709683|Biphasic Insulins|biphasic insulins|mesh-list
24548490|NCT00709683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24548564|NCT00710229|Ranibizumab|ranibizumab|mesh-list
24548565|NCT00710229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24548566|NCT00710229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24548567|NCT00710229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24548568|NCT00710229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24553065|NCT00729300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447626|NCT00309218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24548677|NCT00711308|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24548678|NCT00711308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24548740|NCT00711854|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24548741|NCT00711854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25708728|NCT02256540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25708729|NCT02256969|Sulfacetamide|sulfacetamide|mesh-list
25708730|NCT02256969|Prednisolone|prednisolone|mesh-list
25708731|NCT02256969|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25708732|NCT02256969|Methylprednisolone|methylprednisolone|mesh-list
25708733|NCT02256969|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25708734|NCT02256969|Prednisolone acetate|prednisolone acetate|mesh-list
25708735|NCT02256969|Mineral Oil|mineral oil|mesh-list
25708736|NCT02256969|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25708737|NCT02256969|Prednisolone phosphate|prednisolone phosphate|mesh-list
24548742|NCT00711854|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24548744|NCT00711854|Antimalarials|antimalarials|mesh-ancestor
24548745|NCT00711854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24548746|NCT00711854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24548747|NCT00711854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24548748|NCT00711854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24548749|NCT00711854|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24548750|NCT00711854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24801225|NCT01981889|Hormones|hormones|mesh-ancestor
24801226|NCT01981889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24801227|NCT01981889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801228|NCT01981889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24801229|NCT01981889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24801231|NCT01981941|Analgesics|analgesics|mesh-ancestor
24801232|NCT01981941|Sensory System Agents|sensory system agents|mesh-ancestor
24549055|NCT00713193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24549056|NCT00713193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549057|NCT00713193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24801240|NCT01981941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24801241|NCT01981941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24801242|NCT01981941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24801243|NCT01981941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801244|NCT01981941|Antimanic Agents|antimanic agents|mesh-ancestor
24801245|NCT01982019|Hormones|hormones|mesh-list
24801246|NCT01982019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24549058|NCT00713193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549059|NCT00713193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549060|NCT00713193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549061|NCT00713193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24549062|NCT00713193|Immunologic Factors|immunologic factors|mesh-ancestor
24549063|NCT00713193|Antifungal Agents|antifungal agents|mesh-ancestor
24549064|NCT00713193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24549065|NCT00713193|Dermatologic Agents|dermatologic agents|mesh-ancestor
25708738|NCT02256969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25708739|NCT02256969|Glucocorticoids|glucocorticoids|mesh-ancestor
25708740|NCT02256969|Hormones|hormones|mesh-ancestor
25708741|NCT02256969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25708742|NCT02256969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708743|NCT02256969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24801248|NCT01982071|Micafungin|micafungin|mesh-list
24801255|NCT01982097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801256|NCT01982201|Lesinurad|lesinurad|mesh-list
24801257|NCT01982201|Gout Suppressants|gout suppressants|mesh-ancestor
24553516|NCT00731575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24553517|NCT00731575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24553518|NCT00731575|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24553519|NCT00731575|Protective Agents|protective agents|mesh-ancestor
24553520|NCT00731601|Pantoprazole|pantoprazole|mesh-list
24553521|NCT00731601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24549108|NCT00713440|Autonomic Agents|autonomic agents|mesh-ancestor
24549109|NCT00713440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24549110|NCT00713440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24801265|NCT01982396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24801266|NCT01982396|Antiviral Agents|antiviral agents|mesh-ancestor
24549112|NCT00713440|Protective Agents|protective agents|mesh-ancestor
24549113|NCT00713440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24549114|NCT00713440|Analgesics|analgesics|mesh-ancestor
24549115|NCT00713440|Sensory System Agents|sensory system agents|mesh-ancestor
24801267|NCT01982396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24553643|NCT00732446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24553644|NCT00732446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24553645|NCT00732446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549197|NCT00713921|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24549198|NCT00713921|Cholinergic Agents|cholinergic agents|mesh-ancestor
24549199|NCT00713921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24549200|NCT00713921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549201|NCT00713921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549202|NCT00713921|Urological Agents|urological agents|mesh-ancestor
24549203|NCT00713947|Amoxicillin|amoxicillin|mesh-list
24549204|NCT00713947|Metronidazole|metronidazole|mesh-list
24549205|NCT00713947|Clarithromycin|clarithromycin|mesh-list
24549218|NCT00713947|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24549219|NCT00713986|Tin Fluorides|tin fluorides|mesh-list
24549220|NCT00713986|Cariostatic Agents|cariostatic agents|mesh-ancestor
24549221|NCT00713986|Protective Agents|protective agents|mesh-ancestor
25708744|NCT02256969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708745|NCT02256969|Antiemetics|antiemetics|mesh-ancestor
25708746|NCT02256969|Autonomic Agents|autonomic agents|mesh-ancestor
25708747|NCT02256969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25708748|NCT02256969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25708749|NCT02256969|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25708750|NCT02256969|Protective Agents|protective agents|mesh-ancestor
25708751|NCT02256969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25708752|NCT02256969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25708753|NCT02256969|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25708754|NCT02256969|Renal Agents|renal agents|mesh-ancestor
25708755|NCT02256969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25708756|NCT02256969|Emollients|emollients|mesh-ancestor
24622312|NCT01066598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24622313|NCT01066598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622314|NCT01066598|Immunologic Factors|immunologic factors|mesh-ancestor
24622315|NCT01066598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622316|NCT01066598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24622317|NCT01066650|Everolimus|everolimus|mesh-list
24622318|NCT01066650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622319|NCT01066650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24622320|NCT01066650|Immunologic Factors|immunologic factors|mesh-ancestor
24622322|NCT01066663|Pyrimethamine|pyrimethamine|mesh-list
24549375|NCT00714883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549376|NCT00714883|Antifungal Agents|antifungal agents|mesh-ancestor
24549377|NCT00714883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24549378|NCT00714883|Immunologic Factors|immunologic factors|mesh-ancestor
24549379|NCT00714883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549380|NCT00714961|Clopidogrel|clopidogrel|mesh-list
24549381|NCT00714961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24549382|NCT00714961|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24549383|NCT00714961|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24549384|NCT00714961|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24549385|NCT00714961|Purinergic Agents|purinergic agents|mesh-ancestor
24549386|NCT00714961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24549387|NCT00714961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549388|NCT00714961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549389|NCT00715013|Epothilone B|epothilone b|mesh-list
24549416|NCT00715039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24549417|NCT00715039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24549418|NCT00715039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24549419|NCT00715039|GABA Modulators|gaba modulators|mesh-ancestor
24447718|NCT00309491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24447719|NCT00309491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447720|NCT00309491|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24549468|NCT00715377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24549469|NCT00715377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708757|NCT02256969|Dermatologic Agents|dermatologic agents|mesh-ancestor
25708758|NCT02256982|Gemcitabine|gemcitabine|mesh-list
25708759|NCT02256982|Cisplatin|cisplatin|mesh-list
25708760|NCT02256982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25708761|NCT02256982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25708762|NCT02256982|Antimetabolites|antimetabolites|mesh-ancestor
25708763|NCT02256982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549497|NCT00715663|Biphasic Insulins|biphasic insulins|mesh-list
24549498|NCT00715663|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24801294|NCT01982734|Analgesics|analgesics|mesh-ancestor
24801295|NCT01982734|Sensory System Agents|sensory system agents|mesh-ancestor
24801298|NCT01982734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24801299|NCT01982734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24554141|NCT00734526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549527|NCT00715780|Insulin, Isophane|insulin, isophane|mesh-list
24505106|NCT00539877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24549534|NCT00715858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24549535|NCT00715858|Antimalarials|antimalarials|mesh-ancestor
24549536|NCT00715858|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24549575|NCT00716001|Antioxidants|antioxidants|mesh-ancestor
24549576|NCT00716001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549577|NCT00716001|Protective Agents|protective agents|mesh-ancestor
24549578|NCT00716001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549579|NCT00716001|Antidotes|antidotes|mesh-ancestor
24549580|NCT00716170|Glucagon|glucagon|mesh-list
24801339|NCT01982929|Bupivacaine|bupivacaine|mesh-list
24801340|NCT01982929|Anesthetics, Local|anesthetics, local|mesh-ancestor
24801341|NCT01982929|Anesthetics|anesthetics|mesh-ancestor
24801342|NCT01982929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24549647|NCT00716547|Sensory System Agents|sensory system agents|mesh-ancestor
24549648|NCT00716547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24549649|NCT00716547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549650|NCT00716547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24549651|NCT00716547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24549674|NCT00716846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24549675|NCT00716846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549679|NCT00716911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24549680|NCT00716911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24549681|NCT00716911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24549682|NCT00716911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549683|NCT00716924|Clopidogrel|clopidogrel|mesh-list
24549684|NCT00716924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24549685|NCT00716924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24801356|NCT01982929|Mydriatics|mydriatics|mesh-ancestor
24801357|NCT01982929|Sympathomimetics|sympathomimetics|mesh-ancestor
24593086|NCT00926835|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24801360|NCT01983124|Fotemustine|fotemustine|mesh-list
24801361|NCT01983124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549698|NCT00716950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24549700|NCT00717145|Etidronic Acid|etidronic acid|mesh-list
24549701|NCT00717145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24549702|NCT00717145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24549703|NCT00717145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549706|NCT00717145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24549708|NCT00717210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24549709|NCT00717210|Alkylating Agents|alkylating agents|mesh-ancestor
24549711|NCT00717210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549777|NCT00717561|Clarithromycin|clarithromycin|mesh-list
24549778|NCT00717561|Ceftriaxone|ceftriaxone|mesh-list
24549779|NCT00717561|Clavulanic Acid|clavulanic acid|mesh-list
24549780|NCT00717561|Clavulanic Acids|clavulanic acids|mesh-list
24549781|NCT00717561|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24549782|NCT00717561|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24549783|NCT00717561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24447772|NCT00309556|Antimetabolites|antimetabolites|mesh-ancestor
24447773|NCT00309556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24447774|NCT00309556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24447775|NCT00309556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24447776|NCT00309556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24447777|NCT00309556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24447778|NCT00309569|Cyclophosphamide|cyclophosphamide|mesh-list
25708764|NCT02256982|Antiviral Agents|antiviral agents|mesh-ancestor
24447779|NCT00309569|Fluorouracil|fluorouracil|mesh-list
25708765|NCT02256982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25708766|NCT02256982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25708767|NCT02256982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25708768|NCT02256982|Immunologic Factors|immunologic factors|mesh-ancestor
25708769|NCT02256982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25708770|NCT02257372|Albuterol|albuterol|mesh-list
25708771|NCT02257372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25708772|NCT02257372|Autonomic Agents|autonomic agents|mesh-ancestor
24447781|NCT00309569|Epirubicin|epirubicin|mesh-list
24801369|NCT01983137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24801370|NCT01983137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24801371|NCT01983137|Analgesics|analgesics|mesh-ancestor
24801372|NCT01983137|Sensory System Agents|sensory system agents|mesh-ancestor
24801373|NCT01983137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24801374|NCT01983137|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24801375|NCT01983371|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24549849|NCT00717730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549851|NCT00717782|Botulinum Toxins|botulinum toxins|mesh-list
24549852|NCT00717782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24549853|NCT00717782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24549854|NCT00717782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549855|NCT00717782|Cholinergic Agents|cholinergic agents|mesh-ancestor
24549856|NCT00717782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24549931|NCT00718146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549932|NCT00718172|Ribavirin|ribavirin|mesh-list
24549933|NCT00718172|Antimetabolites|antimetabolites|mesh-ancestor
24549934|NCT00718172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549935|NCT00718172|Antiviral Agents|antiviral agents|mesh-ancestor
24549936|NCT00718172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24549937|NCT00718276|Vitamin D|vitamin d|mesh-list
24549938|NCT00718276|Cholecalciferol|cholecalciferol|mesh-list
24549939|NCT00718276|Vitamins|vitamins|mesh-ancestor
24549940|NCT00718276|Micronutrients|micronutrients|mesh-ancestor
24549941|NCT00718276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549942|NCT00718276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24549943|NCT00718276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24550002|NCT00718484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550003|NCT00718484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24550004|NCT00718484|Alkylating Agents|alkylating agents|mesh-ancestor
24550005|NCT00718536|Raltegravir Potassium|raltegravir potassium|mesh-list
24550103|NCT00719095|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24550104|NCT00719108|Insulin|insulin|mesh-list
24550105|NCT00719108|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24550106|NCT00719108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24550107|NCT00719108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550108|NCT00719121|Adapalene|adapalene|mesh-list
24550109|NCT00719121|R 115866|r 115866|mesh-list
24550110|NCT00719121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24550111|NCT00719121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24550112|NCT00719121|Analgesics|analgesics|mesh-ancestor
24550113|NCT00719121|Sensory System Agents|sensory system agents|mesh-ancestor
24550114|NCT00719121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24550115|NCT00719121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447813|NCT00309673|Prilocaine|prilocaine|mesh-list
24447814|NCT00309673|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24447815|NCT00309673|Anesthetics, Local|anesthetics, local|mesh-ancestor
24447816|NCT00309673|Anesthetics|anesthetics|mesh-ancestor
24550227|NCT00719758|Vasodilator Agents|vasodilator agents|mesh-ancestor
24550228|NCT00719797|Leucovorin|leucovorin|mesh-list
24550229|NCT00719797|Bevacizumab|bevacizumab|mesh-list
24550230|NCT00719797|Fluorouracil|fluorouracil|mesh-list
24550231|NCT00719797|Oxaliplatin|oxaliplatin|mesh-list
24550232|NCT00719797|Irinotecan|irinotecan|mesh-list
24550233|NCT00719797|Calcium|calcium|mesh-list
24550234|NCT00719797|Levoleucovorin|levoleucovorin|mesh-list
24550242|NCT00719797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24550243|NCT00719797|Antimetabolites|antimetabolites|mesh-ancestor
24550399|NCT00720512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24550400|NCT00720512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24550401|NCT00720512|Growth Substances|growth substances|mesh-ancestor
24550402|NCT00720512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550403|NCT00720512|Growth Inhibitors|growth inhibitors|mesh-ancestor
24550404|NCT00720512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24550438|NCT00720577|Simvastatin|simvastatin|mesh-list
24550439|NCT00720577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24447820|NCT00309673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24447821|NCT00309673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24447822|NCT00309673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24447823|NCT00309673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24447824|NCT00309673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24447825|NCT00309673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708879|NCT02259010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25708880|NCT02259010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25708881|NCT02259010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25708882|NCT02259010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25708883|NCT02259010|Hormone Antagonists|hormone antagonists|mesh-ancestor
25708884|NCT02259010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24393607|NCT00130468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393608|NCT00130468|Viscosupplements|viscosupplements|mesh-ancestor
24393609|NCT00130468|Protective Agents|protective agents|mesh-ancestor
24393610|NCT00130481|Atorvastatin|atorvastatin|mesh-list
24393611|NCT00130481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24463696|NCT00361894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24463697|NCT00361894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802473|NCT01990378|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24802474|NCT01990378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24802475|NCT01990378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463747|NCT00361998|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24802477|NCT01990404|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24802478|NCT01990404|Anesthetics, General|anesthetics, general|mesh-ancestor
24802479|NCT01990404|Anesthetics|anesthetics|mesh-ancestor
24802480|NCT01990404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25709008|NCT02260492|Glucocorticoids|glucocorticoids|mesh-ancestor
25709009|NCT02260492|Hormones|hormones|mesh-ancestor
25709010|NCT02260492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25709011|NCT02260492|Sympathomimetics|sympathomimetics|mesh-ancestor
25709012|NCT02260531|Trastuzumab|trastuzumab|mesh-list
25709013|NCT02260531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25709014|NCT02260531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25709015|NCT02260622|Aspirin|aspirin|mesh-list
25709028|NCT02260622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709029|NCT02260622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24835137|NCT02182336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24835138|NCT02182336|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24835139|NCT02182336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709031|NCT02260622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709032|NCT02260622|Antipyretics|antipyretics|mesh-ancestor
25709076|NCT02260882|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25709085|NCT02260934|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25709086|NCT02260934|Prednisolone|prednisolone|mesh-list
25709087|NCT02260934|Prednisolone acetate|prednisolone acetate|mesh-list
25709088|NCT02260934|Cyclophosphamide|cyclophosphamide|mesh-list
25709089|NCT02260934|Rituximab|rituximab|mesh-list
25709090|NCT02260934|Belimumab|belimumab|mesh-list
25709091|NCT02260934|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25709092|NCT02260934|Prednisolone phosphate|prednisolone phosphate|mesh-list
25709093|NCT02260934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25709094|NCT02260934|Immunologic Factors|immunologic factors|mesh-ancestor
25709095|NCT02260934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465070|NCT00367822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465071|NCT00367822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802612|NCT01991158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24802613|NCT01991158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24802614|NCT01991158|Immunologic Factors|immunologic factors|mesh-ancestor
24802615|NCT01991158|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24802616|NCT01991158|Abortifacient Agents|abortifacient agents|mesh-ancestor
24802617|NCT01991158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24802618|NCT01991158|Dermatologic Agents|dermatologic agents|mesh-ancestor
24802619|NCT01991158|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24802620|NCT01991158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24802621|NCT01991158|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24802623|NCT01991275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24802641|NCT01991288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24802643|NCT01991288|Adrenergic Agents|adrenergic agents|mesh-ancestor
24572598|NCT00815841|Methylphenidate|methylphenidate|mesh-list
25709123|NCT02260934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25709124|NCT02260934|Histamine Antagonists|histamine antagonists|mesh-ancestor
25709125|NCT02260934|Histamine Agents|histamine agents|mesh-ancestor
25709126|NCT02260934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25709127|NCT02260934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25709128|NCT02260934|Antipruritics|antipruritics|mesh-ancestor
25709129|NCT02260934|Dermatologic Agents|dermatologic agents|mesh-ancestor
25709130|NCT02260986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24465470|NCT00369811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24465471|NCT00369811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465473|NCT00369811|Sensory System Agents|sensory system agents|mesh-ancestor
24465474|NCT00369811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24465488|NCT00369863|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24465489|NCT00369863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24465491|NCT00369863|Hormones|hormones|mesh-ancestor
24465492|NCT00369863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24465493|NCT00369863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465498|NCT00369889|Bevacizumab|bevacizumab|mesh-list
24465499|NCT00369889|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24465500|NCT00369889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24465501|NCT00369889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25709771|NCT02274792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25709772|NCT02274792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25709773|NCT02274792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25709774|NCT02274792|Immunologic Factors|immunologic factors|mesh-ancestor
25709775|NCT02274870|Bupivacaine|bupivacaine|mesh-list
25709776|NCT02274870|Anesthetics, Local|anesthetics, local|mesh-ancestor
25709777|NCT02274870|Anesthetics|anesthetics|mesh-ancestor
25709778|NCT02274870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25709779|NCT02274870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709780|NCT02274870|Sensory System Agents|sensory system agents|mesh-ancestor
25709136|NCT02261467|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25709137|NCT02261467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24465502|NCT00369889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24465510|NCT00369954|Gemcitabine|gemcitabine|mesh-list
24802729|NCT01992133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24802730|NCT01992133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24802733|NCT01992146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802734|NCT01992146|Sensory System Agents|sensory system agents|mesh-ancestor
24802735|NCT01992146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24802736|NCT01992198|Chlorhexidine|chlorhexidine|mesh-list
24802737|NCT01992198|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24835224|NCT02182505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802738|NCT01992198|Metronidazole|metronidazole|mesh-list
24802739|NCT01992198|Meropenem|meropenem|mesh-list
24802740|NCT01992198|Cefoperazone|cefoperazone|mesh-list
24802741|NCT01992198|Sulperazone|sulperazone|mesh-list
24802742|NCT01992198|Somatostatin|somatostatin|mesh-list
24802743|NCT01992198|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24802744|NCT01992198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24802745|NCT01992198|Disinfectants|disinfectants|mesh-ancestor
24802746|NCT01992198|Dermatologic Agents|dermatologic agents|mesh-ancestor
24802747|NCT01992198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24802748|NCT01992198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24661087|NCT01287741|Hormones|hormones|mesh-ancestor
24802750|NCT01992198|Hormones|hormones|mesh-ancestor
24802751|NCT01992198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24465534|NCT00369993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24465549|NCT00370019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24465550|NCT00370019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24802764|NCT01992211|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24802765|NCT01992211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24802766|NCT01992263|Vitamin D|vitamin d|mesh-list
24802767|NCT01992263|Ergocalciferols|ergocalciferols|mesh-list
24802768|NCT01992263|Cholecalciferol|cholecalciferol|mesh-list
24802769|NCT01992263|Vitamins|vitamins|mesh-list
24802787|NCT01992341|Antimitotic Agents|antimitotic agents|mesh-ancestor
24802788|NCT01992341|Mitosis Modulators|mitosis modulators|mesh-ancestor
24802789|NCT01992341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802790|NCT01992341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24802792|NCT01992341|Growth Substances|growth substances|mesh-ancestor
24802805|NCT01992562|Sensory System Agents|sensory system agents|mesh-ancestor
24802806|NCT01992562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24802807|NCT01992588|Insulin|insulin|mesh-list
24802808|NCT01992588|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24802809|NCT01992588|Insulin Aspart|insulin aspart|mesh-list
24802810|NCT01992588|Insulin, Long-Acting|insulin, long-acting|mesh-list
24802811|NCT01992588|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24802812|NCT01992588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24802813|NCT01992588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802814|NCT01992601|Telmisartan|telmisartan|mesh-list
24802815|NCT01992601|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24802816|NCT01992601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24802817|NCT01992601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24802818|NCT01992601|Antimetabolites|antimetabolites|mesh-ancestor
24802819|NCT01992601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802820|NCT01992601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24802821|NCT01992601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25709138|NCT02261467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709139|NCT02261467|Cholinergic Agents|cholinergic agents|mesh-ancestor
24802822|NCT01992601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24802823|NCT01992601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25709140|NCT02261467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25709141|NCT02261467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709142|NCT02261467|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25709143|NCT02261467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25709144|NCT02261493|Botulinum Toxins|botulinum toxins|mesh-list
25709145|NCT02261493|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24802824|NCT01992601|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24802826|NCT01992653|Prednisone|prednisone|mesh-list
24465555|NCT00370019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24465556|NCT00370019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465557|NCT00370045|Bivalirudin|bivalirudin|mesh-list
24802828|NCT01992653|Cyclophosphamide|cyclophosphamide|mesh-list
24802829|NCT01992653|Rituximab|rituximab|mesh-list
24802834|NCT01992653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802835|NCT01992653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24802836|NCT01992653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24802837|NCT01992653|Alkylating Agents|alkylating agents|mesh-ancestor
24802838|NCT01992653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802840|NCT01992653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24802841|NCT01992653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24802847|NCT01992653|Glucocorticoids|glucocorticoids|mesh-ancestor
24622513|NCT01067365|Fertility Agents|fertility agents|mesh-ancestor
24622514|NCT01067365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24622515|NCT01067365|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24622516|NCT01067365|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24622517|NCT01067391|Tadalafil|tadalafil|mesh-list
24622518|NCT01067391|Vasodilator Agents|vasodilator agents|mesh-ancestor
24622519|NCT01067391|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24622520|NCT01067391|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24622521|NCT01067391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622522|NCT01067391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622523|NCT01067391|Urological Agents|urological agents|mesh-ancestor
24622524|NCT01067417|Hydroxychloroquine|hydroxychloroquine|mesh-list
24622525|NCT01067417|Antimalarials|antimalarials|mesh-ancestor
24622526|NCT01067417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24622527|NCT01067417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24622528|NCT01067417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24622529|NCT01067417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622530|NCT01067417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622531|NCT01067417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24622532|NCT01067430|Diclofenac|diclofenac|mesh-list
24622533|NCT01067430|Etoricoxib|etoricoxib|mesh-list
24622534|NCT01067430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24622535|NCT01067430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24622536|NCT01067430|Analgesics|analgesics|mesh-ancestor
24622537|NCT01067430|Sensory System Agents|sensory system agents|mesh-ancestor
24622545|NCT01067430|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24622546|NCT01067443|Amphotericin B|amphotericin b|mesh-list
24622547|NCT01067443|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24622548|NCT01067443|Miltefosine|miltefosine|mesh-list
24802851|NCT01992705|Fluorouracil|fluorouracil|mesh-list
24802852|NCT01992705|Oxaliplatin|oxaliplatin|mesh-list
24802853|NCT01992705|Irinotecan|irinotecan|mesh-list
24802854|NCT01992705|Folfirinox|folfirinox|mesh-list
24802855|NCT01992705|Antimetabolites|antimetabolites|mesh-ancestor
24802856|NCT01992705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24802857|NCT01992705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24802858|NCT01992705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24802859|NCT01992705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24802860|NCT01992705|Immunologic Factors|immunologic factors|mesh-ancestor
24802861|NCT01992705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802862|NCT01992705|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24802863|NCT01992705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24802864|NCT01992705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24802865|NCT01992796|Telmisartan|telmisartan|mesh-list
24465560|NCT00370045|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25709146|NCT02261493|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25709147|NCT02261493|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24465561|NCT00370045|Protease Inhibitors|protease inhibitors|mesh-ancestor
24465562|NCT00370045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709148|NCT02261493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25709149|NCT02261493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465563|NCT00370045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465566|NCT00370097|Fluticasone|fluticasone|mesh-list
24465607|NCT00370253|Autonomic Agents|autonomic agents|mesh-ancestor
24465608|NCT00370253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24465609|NCT00370266|Triamcinolone|triamcinolone|mesh-list
24465624|NCT00370318|Analgesics|analgesics|mesh-ancestor
24465625|NCT00370318|Sensory System Agents|sensory system agents|mesh-ancestor
24802903|NCT01993212|Fertility Agents|fertility agents|mesh-ancestor
24802904|NCT01993212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24802905|NCT01993212|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24802906|NCT01993212|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24802907|NCT01993225|Enclomiphene|enclomiphene|mesh-list
24802908|NCT01993225|Testosterone|testosterone|mesh-list
24802909|NCT01993225|Androgens|androgens|mesh-ancestor
24465626|NCT00370318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24465627|NCT00370318|Antipyretics|antipyretics|mesh-ancestor
24465628|NCT00370370|Triamcinolone|triamcinolone|mesh-list
24617293|NCT01042314|Donepezil|donepezil|mesh-list
24465629|NCT00370370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24465630|NCT00370370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24465631|NCT00370370|Bevacizumab|bevacizumab|mesh-list
24465632|NCT00370370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24465638|NCT00370370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465640|NCT00370370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24465641|NCT00370370|Glucocorticoids|glucocorticoids|mesh-ancestor
24802910|NCT01993225|Hormones|hormones|mesh-ancestor
24802911|NCT01993225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24802912|NCT01993225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802913|NCT01993225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24802914|NCT01993225|Hormone Antagonists|hormone antagonists|mesh-ancestor
24802915|NCT01993225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24802917|NCT01993225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24802919|NCT01993225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24802929|NCT01993290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24802930|NCT01993290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802931|NCT01993290|Sensory System Agents|sensory system agents|mesh-ancestor
24802932|NCT01993290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24802934|NCT01993459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24802935|NCT01993459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24802936|NCT01993459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24802957|NCT01993472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24802959|NCT01993472|Sensory System Agents|sensory system agents|mesh-ancestor
24802960|NCT01993472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24802961|NCT01993472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24802962|NCT01993472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24802963|NCT01993472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24802964|NCT01993472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24802965|NCT01993472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24802966|NCT01993472|Antiviral Agents|antiviral agents|mesh-ancestor
24803027|NCT01993979|Carboplatin|carboplatin|mesh-list
24803040|NCT01994031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24803041|NCT01994031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24803042|NCT01994031|Tubulin Modulators|tubulin modulators|mesh-ancestor
24803043|NCT01994031|Antimitotic Agents|antimitotic agents|mesh-ancestor
24803053|NCT01994096|Antifungal Agents|antifungal agents|mesh-ancestor
24803054|NCT01994096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24803055|NCT01994096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24465806|NCT00370747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465807|NCT00370747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465810|NCT00370760|Heparin|heparin|mesh-list
24465811|NCT00370760|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24465812|NCT00370760|Tinzaparin|tinzaparin|mesh-list
24465813|NCT00370760|Dalteparin|dalteparin|mesh-list
24465814|NCT00370760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24465828|NCT00370760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465829|NCT00370760|Gout Suppressants|gout suppressants|mesh-ancestor
24465830|NCT00370760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24465915|NCT00371111|Bevacizumab|bevacizumab|mesh-list
24465916|NCT00371111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24465917|NCT00371111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465918|NCT00371111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24465919|NCT00371111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24465920|NCT00371111|Growth Substances|growth substances|mesh-ancestor
24465921|NCT00371111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465922|NCT00371111|Growth Inhibitors|growth inhibitors|mesh-ancestor
24465936|NCT00371124|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24465962|NCT00371319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24465963|NCT00371332|Minocycline|minocycline|mesh-list
24465964|NCT00371332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24465965|NCT00371332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24465966|NCT00371410|Triamcinolone|triamcinolone|mesh-list
24465967|NCT00371410|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24803117|NCT01994668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24803118|NCT01994668|GABA Modulators|gaba modulators|mesh-ancestor
24803119|NCT01994668|GABA Agents|gaba agents|mesh-ancestor
24803120|NCT01994668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24803362|NCT01996085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24803121|NCT01994668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803122|NCT01994733|Calcium, Dietary|calcium, dietary|mesh-list
24803123|NCT01994733|Calcium Carbonate|calcium carbonate|mesh-list
24803124|NCT01994733|Calcium|calcium|mesh-list
24803142|NCT01994759|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24803143|NCT01994759|Protective Agents|protective agents|mesh-ancestor
24803144|NCT01994824|Thymoglobulin|thymoglobulin|mesh-list
24803145|NCT01994824|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24803146|NCT01994824|Immunologic Factors|immunologic factors|mesh-ancestor
24803148|NCT01994824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24622578|NCT01067547|Micronutrients|micronutrients|mesh-ancestor
24622579|NCT01067547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622580|NCT01067547|Hematinics|hematinics|mesh-ancestor
24622581|NCT01067599|Nicotine|nicotine|mesh-list
24622582|NCT01067599|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24622583|NCT01067599|Autonomic Agents|autonomic agents|mesh-ancestor
24622584|NCT01067599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24622585|NCT01067599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24622586|NCT01067599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24622587|NCT01067599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24622588|NCT01067599|Cholinergic Agents|cholinergic agents|mesh-ancestor
24622589|NCT01067599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24622590|NCT01067599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622591|NCT01067638|Tranexamic Acid|tranexamic acid|mesh-list
24622592|NCT01067638|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24622593|NCT01067638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24622594|NCT01067638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622595|NCT01067638|Hemostatics|hemostatics|mesh-ancestor
24622596|NCT01067638|Coagulants|coagulants|mesh-ancestor
24803171|NCT01995006|Dipyrone|dipyrone|mesh-list
24803172|NCT01995006|Naproxen|naproxen|mesh-list
24803175|NCT01995006|Analgesics|analgesics|mesh-ancestor
24803255|NCT01995331|Immunologic Factors|immunologic factors|mesh-ancestor
24803256|NCT01995331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803257|NCT01995331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24803287|NCT01995370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24803288|NCT01995370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24803289|NCT01995370|Analgesics|analgesics|mesh-ancestor
24803290|NCT01995370|Sensory System Agents|sensory system agents|mesh-ancestor
24803291|NCT01995370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803292|NCT01995370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803293|NCT01995370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24803294|NCT01995370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24803295|NCT01995370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24803296|NCT01995370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24803297|NCT01995370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803298|NCT01995370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24803323|NCT01995734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803324|NCT01995799|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24803325|NCT01995799|Hematinics|hematinics|mesh-ancestor
24803326|NCT01995799|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24803327|NCT01995799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24803329|NCT01995890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24803330|NCT01995890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24803331|NCT01995890|Analgesics|analgesics|mesh-ancestor
24803332|NCT01995890|Sensory System Agents|sensory system agents|mesh-ancestor
24803333|NCT01995890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803337|NCT01996085|Amlodipine|amlodipine|mesh-list
24803340|NCT01996085|Lisinopril|lisinopril|mesh-list
24803341|NCT01996085|Nebivolol|nebivolol|mesh-list
24803342|NCT01996085|Indapamide|indapamide|mesh-list
24803343|NCT01996085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24803344|NCT01996085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24803349|NCT01996085|Vasodilator Agents|vasodilator agents|mesh-ancestor
25709152|NCT02261493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709153|NCT02261493|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25709154|NCT02261493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25709155|NCT02261727|Prednisone|prednisone|mesh-list
25709156|NCT02261727|Cortisone|cortisone|mesh-list
25709157|NCT02261727|Theophylline|theophylline|mesh-list
25709158|NCT02261727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25709159|NCT02261727|Glucocorticoids|glucocorticoids|mesh-ancestor
25709160|NCT02261727|Hormones|hormones|mesh-ancestor
25709781|NCT02274870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803356|NCT01996085|Protease Inhibitors|protease inhibitors|mesh-ancestor
24803357|NCT01996085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709161|NCT02261727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25709162|NCT02261727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709163|NCT02261727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25709164|NCT02261727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24803358|NCT01996085|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24803359|NCT01996085|Protective Agents|protective agents|mesh-ancestor
24803360|NCT01996085|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24803361|NCT01996085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24803371|NCT01996189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803385|NCT01996306|Bevacizumab|bevacizumab|mesh-list
24803386|NCT01996306|Fluorouracil|fluorouracil|mesh-list
24597795|NCT00952003|Tubulin Modulators|tubulin modulators|mesh-ancestor
24597796|NCT00952003|Antimitotic Agents|antimitotic agents|mesh-ancestor
24597797|NCT00952003|Mitosis Modulators|mitosis modulators|mesh-ancestor
24803397|NCT01996306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803398|NCT01996306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24803399|NCT01996306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24803400|NCT01996306|Immunologic Factors|immunologic factors|mesh-ancestor
24803401|NCT01996306|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24803465|NCT01996475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24803466|NCT01996475|Antidepressive Agents|antidepressive agents|mesh-ancestor
24803467|NCT01996475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24803468|NCT01996475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24803469|NCT01996475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24803470|NCT01996475|Parasympatholytics|parasympatholytics|mesh-ancestor
24803485|NCT01996488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24803486|NCT01996488|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24803487|NCT01996488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24803488|NCT01996488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24803489|NCT01996488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803490|NCT01996488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24803491|NCT01996488|Serotonin Agents|serotonin agents|mesh-ancestor
24803493|NCT01996501|Antiemetics|antiemetics|mesh-ancestor
24803494|NCT01996501|Autonomic Agents|autonomic agents|mesh-ancestor
24803495|NCT01996501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803496|NCT01996501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803497|NCT01996501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24803498|NCT01996501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24803499|NCT01996501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24803500|NCT01996501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24803501|NCT01996501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24803581|NCT01997190|Antiviral Agents|antiviral agents|mesh-ancestor
24803598|NCT01997255|Immunologic Factors|immunologic factors|mesh-ancestor
24803599|NCT01997255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803605|NCT01997294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24803606|NCT01997294|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24803607|NCT01997294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24803608|NCT01997580|Citalopram|citalopram|mesh-list
24803609|NCT01997580|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24803610|NCT01997580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24803611|NCT01997580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24803612|NCT01997580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803613|NCT01997580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24466064|NCT00371735|Anthelmintics|anthelmintics|mesh-ancestor
24466065|NCT00371735|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24466066|NCT00371735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466074|NCT00371813|Cholinergic Agents|cholinergic agents|mesh-ancestor
25709165|NCT02261727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25709166|NCT02261727|Autonomic Agents|autonomic agents|mesh-ancestor
25709167|NCT02261727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25709168|NCT02261727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24466075|NCT00371813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24466076|NCT00371813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803625|NCT01997593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803626|NCT01997632|Vaccines|vaccines|mesh-list
24803627|NCT01997632|Immunologic Factors|immunologic factors|mesh-ancestor
24836167|NCT02184299|Nevirapine|nevirapine|mesh-list
24622635|NCT01067690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622637|NCT01067690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24622638|NCT01067690|Antiviral Agents|antiviral agents|mesh-ancestor
24622639|NCT01067690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24622640|NCT01067690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24622641|NCT01067690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622642|NCT01067898|Vitamin D|vitamin d|mesh-list
24622643|NCT01067898|Ergocalciferols|ergocalciferols|mesh-list
24622644|NCT01067898|Cholecalciferol|cholecalciferol|mesh-list
24622645|NCT01067898|Vitamins|vitamins|mesh-list
24622646|NCT01067898|Calcium Carbonate|calcium carbonate|mesh-list
24622647|NCT01067898|Micronutrients|micronutrients|mesh-ancestor
24622651|NCT01067898|Antacids|antacids|mesh-ancestor
24466090|NCT00371956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24466091|NCT00371956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24453510|NCT04960930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24453511|NCT04960930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24453512|NCT04942340|Dexmedetomidine|dexmedetomidine|mesh-list
24453513|NCT04942340|Caffeine|caffeine|mesh-list
24453514|NCT04942340|Atipamezole|atipamezole|mesh-list
24453515|NCT04942340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24453516|NCT04942340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24453517|NCT04942340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24453518|NCT04942340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24453519|NCT04942340|Analgesics|analgesics|mesh-ancestor
24453520|NCT04942340|Sensory System Agents|sensory system agents|mesh-ancestor
24803679|NCT01997801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24803681|NCT01997814|Immunologic Factors|immunologic factors|mesh-list
24803682|NCT01997814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
24803683|NCT01997814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803684|NCT01997879|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24803685|NCT01997879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24803686|NCT01997944|Interferons|interferons|mesh-list
24803687|NCT01997944|Interferon-alpha|interferon-alpha|mesh-list
24803711|NCT01998126|Crizotinib|crizotinib|mesh-list
24803712|NCT01998126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24803713|NCT01998126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24803724|NCT01998165|Sensory System Agents|sensory system agents|mesh-ancestor
24803725|NCT01998165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803726|NCT01998217|Flurbiprofen|flurbiprofen|mesh-list
24803727|NCT01998217|Remifentanil|remifentanil|mesh-list
24803728|NCT01998217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24803729|NCT01998217|Narcotics|narcotics|mesh-ancestor
24803730|NCT01998217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24803731|NCT01998217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803732|NCT01998217|Analgesics|analgesics|mesh-ancestor
24803733|NCT01998217|Sensory System Agents|sensory system agents|mesh-ancestor
24803734|NCT01998217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24803735|NCT01998217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24803736|NCT01998217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24803737|NCT01998217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24803738|NCT01998217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24803739|NCT01998217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24803740|NCT01998217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24803741|NCT01998217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803742|NCT01998295|Lumefantrine|lumefantrine|mesh-list
24803744|NCT01998295|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24803755|NCT01998347|Paclitaxel|paclitaxel|mesh-list
24803777|NCT01998503|Bortezomib|bortezomib|mesh-list
25709169|NCT02261727|Respiratory System Agents|respiratory system agents|mesh-ancestor
24803778|NCT01998503|Melphalan|melphalan|mesh-list
24803779|NCT01998503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24803835|NCT01998698|Anesthetics|anesthetics|mesh-ancestor
25709171|NCT02261727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709172|NCT02261727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709173|NCT02261727|Vasodilator Agents|vasodilator agents|mesh-ancestor
25709174|NCT02261727|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25709175|NCT02261727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24836316|NCT02185222|Vitamins|vitamins|mesh-ancestor
24803836|NCT01998698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24803837|NCT01998698|Sensory System Agents|sensory system agents|mesh-ancestor
24803840|NCT01998698|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24803841|NCT01998698|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24803842|NCT01998698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24803844|NCT01998763|Cholecalciferol|cholecalciferol|mesh-list
24622683|NCT01067989|Sensory System Agents|sensory system agents|mesh-ancestor
24622684|NCT01067989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24622685|NCT01067989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24622686|NCT01067989|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24803889|NCT01999309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24803890|NCT01999309|Antimetabolites|antimetabolites|mesh-ancestor
24803891|NCT01999309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24803892|NCT01999309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24803893|NCT01999309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24803894|NCT01999309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24803930|NCT01999686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803931|NCT01999738|Folic Acid|folic acid|mesh-list
24803932|NCT01999738|Hematinics|hematinics|mesh-ancestor
24803933|NCT01999738|Vitamin B Complex|vitamin b complex|mesh-ancestor
24803934|NCT01999738|Vitamins|vitamins|mesh-ancestor
24803935|NCT01999738|Micronutrients|micronutrients|mesh-ancestor
24803936|NCT01999738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466234|NCT00372658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466237|NCT00372658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24466238|NCT00372658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24803947|NCT01999842|Vaccines|vaccines|mesh-list
24466268|NCT00372788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24466270|NCT00372801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24466271|NCT00372801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24466272|NCT00372801|Analgesics|analgesics|mesh-ancestor
24466296|NCT00372853|Growth Substances|growth substances|mesh-ancestor
24466317|NCT00373048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24466318|NCT00373048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24466327|NCT00373087|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24466328|NCT00373087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24803984|NCT02000206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24803985|NCT02000206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24803986|NCT02000206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24804035|NCT02000401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24804036|NCT02000401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804038|NCT02000414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24804039|NCT02000414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24804040|NCT02000674|Rocuronium|rocuronium|mesh-list
24804041|NCT02000674|Succinylcholine|succinylcholine|mesh-list
24804042|NCT02000674|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24804043|NCT02000674|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24804044|NCT02000674|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24804045|NCT02000674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804068|NCT02000830|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
24804069|NCT02000830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24804071|NCT02000947|Durvalumab|durvalumab|mesh-list
24804072|NCT02000947|Tremelimumab|tremelimumab|mesh-list
24804073|NCT02000947|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25709176|NCT02261727|Purinergic Agents|purinergic agents|mesh-ancestor
25709177|NCT02261727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24453257|NCT05198960|Sensory System Agents|sensory system agents|mesh-ancestor
24453258|NCT05198960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24453259|NCT05198960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709178|NCT02261805|Doxorubicin|doxorubicin|mesh-list
24804074|NCT02000947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24466381|NCT00373412|Immunologic Factors|immunologic factors|mesh-ancestor
24466382|NCT00373412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466392|NCT00373451|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24804102|NCT02001103|Dopamine Agents|dopamine agents|mesh-ancestor
24804103|NCT02001103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24804104|NCT02001103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804106|NCT02001103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24804107|NCT02001103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24804108|NCT02001168|Docetaxel|docetaxel|mesh-list
24804109|NCT02001168|Pemetrexed|pemetrexed|mesh-list
24804110|NCT02001168|Cisplatin|cisplatin|mesh-list
24804111|NCT02001168|Endostatins|endostatins|mesh-list
24598746|NCT00957879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24598747|NCT00957879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598748|NCT00957879|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24598749|NCT00957879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24804165|NCT02001298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24804166|NCT02001298|Vasodilator Agents|vasodilator agents|mesh-ancestor
24804167|NCT02001298|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24804168|NCT02001298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804170|NCT02001311|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24804171|NCT02001311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24804172|NCT02001311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24804173|NCT02001311|Disinfectants|disinfectants|mesh-ancestor
24575366|NCT00830882|Albuterol|albuterol|mesh-list
24466393|NCT00373451|Protease Inhibitors|protease inhibitors|mesh-ancestor
24466394|NCT00373451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466395|NCT00373451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24466396|NCT00373464|Etoricoxib|etoricoxib|mesh-list
24466397|NCT00373464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24466398|NCT00373464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24466399|NCT00373464|Analgesics|analgesics|mesh-ancestor
24466413|NCT00373503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24466434|NCT00373542|Dopamine Agents|dopamine agents|mesh-ancestor
24804180|NCT02001363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24804181|NCT02001428|Piperaquine|piperaquine|mesh-list
24804182|NCT02001428|Artenimol|artenimol|mesh-list
24804183|NCT02001428|Antimalarials|antimalarials|mesh-ancestor
24804184|NCT02001428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24804185|NCT02001428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24804186|NCT02001428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24804187|NCT02001506|Docetaxel|docetaxel|mesh-list
24804188|NCT02001506|Epirubicin|epirubicin|mesh-list
24804189|NCT02001506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804194|NCT02001506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24804302|NCT02001948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804303|NCT02001948|Sensory System Agents|sensory system agents|mesh-ancestor
24804304|NCT02001948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804305|NCT02001948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24804306|NCT02001948|Narcotics|narcotics|mesh-ancestor
24804307|NCT02001948|Analgesics|analgesics|mesh-ancestor
25709179|NCT02261805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25709180|NCT02261805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25709181|NCT02261805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25709182|NCT02261805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25709183|NCT02261805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709184|NCT02261805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709185|NCT02261948|Simendan|simendan|mesh-list
24804308|NCT02001974|Paclitaxel|paclitaxel|mesh-list
25709186|NCT02261948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25709187|NCT02261948|Vasodilator Agents|vasodilator agents|mesh-ancestor
25709188|NCT02261948|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25709189|NCT02261948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24804312|NCT02001974|Antimitotic Agents|antimitotic agents|mesh-ancestor
24804313|NCT02001974|Mitosis Modulators|mitosis modulators|mesh-ancestor
24804314|NCT02001974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804315|NCT02002000|Vitamin D|vitamin d|mesh-list
24804395|NCT02002286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804396|NCT02002286|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24804397|NCT02002286|Contraceptive Agents|contraceptive agents|mesh-ancestor
24804398|NCT02002286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24804399|NCT02002286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24804400|NCT02002286|Immunologic Factors|immunologic factors|mesh-ancestor
24804401|NCT02002286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24804402|NCT02002286|Alkylating Agents|alkylating agents|mesh-ancestor
24804403|NCT02002286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804404|NCT02002286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804405|NCT02002312|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
24804406|NCT02002312|Chelating Agents|chelating agents|mesh-ancestor
24804409|NCT02002325|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24804411|NCT02002325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24599007|NCT05351229|Narcotics|narcotics|mesh-ancestor
24599008|NCT05351229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24599009|NCT05351229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599010|NCT05351229|Analgesics|analgesics|mesh-ancestor
24599011|NCT05351229|Sensory System Agents|sensory system agents|mesh-ancestor
24599012|NCT05351229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804472|NCT02002663|Analgesics|analgesics|mesh-ancestor
24804473|NCT02002663|Sensory System Agents|sensory system agents|mesh-ancestor
24804474|NCT02002663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804475|NCT02002663|Anesthetics, Local|anesthetics, local|mesh-ancestor
24804476|NCT02002663|Anesthetics|anesthetics|mesh-ancestor
24804477|NCT02002663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24804478|NCT02002663|Antiemetics|antiemetics|mesh-ancestor
24804479|NCT02002663|Autonomic Agents|autonomic agents|mesh-ancestor
24804480|NCT02002663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24804481|NCT02002663|Glucocorticoids|glucocorticoids|mesh-ancestor
24804482|NCT02002663|Hormones|hormones|mesh-ancestor
24804483|NCT02002663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24804484|NCT02002663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24804485|NCT02002663|Protective Agents|protective agents|mesh-ancestor
24804486|NCT02002663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24804487|NCT02002663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804488|NCT02002715|Budesonide|budesonide|mesh-list
24804489|NCT02002715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24804490|NCT02002715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24804491|NCT02002715|Autonomic Agents|autonomic agents|mesh-ancestor
24804492|NCT02002715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804493|NCT02002715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804494|NCT02002715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24804495|NCT02002715|Respiratory System Agents|respiratory system agents|mesh-ancestor
24804509|NCT02002754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804510|NCT02002754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804511|NCT02002754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24804512|NCT02002754|Respiratory System Agents|respiratory system agents|mesh-ancestor
24599089|NCT05254106|Paclitaxel|paclitaxel|mesh-list
24599090|NCT05254106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24599095|NCT05254106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599100|NCT05212012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24599101|NCT05212012|Narcotics|narcotics|mesh-ancestor
24599102|NCT05212012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24599123|NCT05194969|Dermatologic Agents|dermatologic agents|mesh-ancestor
24599124|NCT05178550|Heparin|heparin|mesh-list
24599125|NCT05178550|Anticoagulants|anticoagulants|mesh-ancestor
24804513|NCT02002806|Ethanol|ethanol|mesh-list
24804514|NCT02002806|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24804515|NCT02002806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24804537|NCT02002962|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24575732|NCT00833729|Analgesics|analgesics|mesh-ancestor
24466451|NCT00373581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804540|NCT02002962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804541|NCT02002962|Cholinergic Agents|cholinergic agents|mesh-ancestor
24804542|NCT02002962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24804543|NCT02002962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804544|NCT02002962|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24804545|NCT02002962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804546|NCT02003001|Botulinum Toxins|botulinum toxins|mesh-list
24804547|NCT02003001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24804548|NCT02003001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24804550|NCT02003001|Cholinergic Agents|cholinergic agents|mesh-ancestor
24466502|NCT00373659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24466504|NCT00373659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466505|NCT00373659|Growth Inhibitors|growth inhibitors|mesh-ancestor
24466506|NCT00373659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466507|NCT00373672|Modafinil|modafinil|mesh-list
24466508|NCT00373672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24466509|NCT00373672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466510|NCT00373672|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24466511|NCT00373672|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24466512|NCT00373672|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24804561|NCT02003209|Immunoglobulins|immunoglobulins|mesh-list
24804562|NCT02003209|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24804563|NCT02003209|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24804564|NCT02003209|Immunologic Factors|immunologic factors|mesh-ancestor
24804565|NCT02003209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804566|NCT02003209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804567|NCT02003209|Tubulin Modulators|tubulin modulators|mesh-ancestor
24804568|NCT02003209|Antimitotic Agents|antimitotic agents|mesh-ancestor
24804608|NCT02003768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24804610|NCT02003768|Anesthetics|anesthetics|mesh-ancestor
24804611|NCT02003768|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24804612|NCT02003885|Desflurane|desflurane|mesh-list
24804613|NCT02003885|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24804614|NCT02003885|Anesthetics, General|anesthetics, general|mesh-ancestor
24599286|NCT04916613|Androgens|androgens|mesh-list
24599287|NCT04916613|Hormones|hormones|mesh-ancestor
24599288|NCT04916613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24599289|NCT04916613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599290|NCT04913805|Niacinamide|niacinamide|mesh-list
24599291|NCT04913805|Niacin|niacin|mesh-list
24599292|NCT04913805|Nicotinic Acids|nicotinic acids|mesh-list
24599293|NCT04913805|Vitamin B Complex|vitamin b complex|mesh-ancestor
24599294|NCT04913805|Vitamins|vitamins|mesh-ancestor
24599295|NCT04913805|Micronutrients|micronutrients|mesh-ancestor
24599296|NCT04913805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599301|NCT04913805|Vasodilator Agents|vasodilator agents|mesh-ancestor
24804698|NCT02004574|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24804699|NCT02004574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24804700|NCT02004574|Glucocorticoids|glucocorticoids|mesh-ancestor
24804702|NCT02004574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24804703|NCT02004574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804704|NCT02004574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25709782|NCT02274948|Metformin|metformin|mesh-list
25709783|NCT02274948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25709784|NCT02274948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709785|NCT02275052|Albuterol|albuterol|mesh-list
25709786|NCT02275052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25709787|NCT02275052|Autonomic Agents|autonomic agents|mesh-ancestor
25709788|NCT02275052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25709789|NCT02275052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709790|NCT02275052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24804705|NCT02004574|Respiratory System Agents|respiratory system agents|mesh-ancestor
24804706|NCT02004574|Dermatologic Agents|dermatologic agents|mesh-ancestor
24804708|NCT02004652|Laxatives|laxatives|mesh-ancestor
24804709|NCT02004652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24804710|NCT02004652|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24804711|NCT02004652|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24804712|NCT02004652|Serotonin Agents|serotonin agents|mesh-ancestor
24804713|NCT02004652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24804714|NCT02004652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804715|NCT02004652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804716|NCT02004769|Docetaxel|docetaxel|mesh-list
24804718|NCT02004769|Trastuzumab|trastuzumab|mesh-list
24804719|NCT02004769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804720|NCT02004769|Tubulin Modulators|tubulin modulators|mesh-ancestor
24804721|NCT02004769|Antimitotic Agents|antimitotic agents|mesh-ancestor
24804722|NCT02004769|Mitosis Modulators|mitosis modulators|mesh-ancestor
24804723|NCT02004769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804727|NCT02004782|Prednisolone|prednisolone|mesh-list
24804745|NCT02004899|Fentanyl|fentanyl|mesh-list
24804746|NCT02004899|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24804747|NCT02004899|Narcotics|narcotics|mesh-ancestor
24804748|NCT02004899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24804749|NCT02004899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804750|NCT02004899|Analgesics|analgesics|mesh-ancestor
24804751|NCT02004899|Sensory System Agents|sensory system agents|mesh-ancestor
24804764|NCT02005107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24804765|NCT02005107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804766|NCT02005107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24804767|NCT02005107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576002|NCT00836212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24804771|NCT02005120|Bevacizumab|bevacizumab|mesh-list
24804826|NCT02005523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24804827|NCT02005523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24804829|NCT02005523|Sensory System Agents|sensory system agents|mesh-ancestor
24804830|NCT02005523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804831|NCT02005523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804832|NCT02005523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24804833|NCT02005523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24804834|NCT02005523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24804835|NCT02005575|Dexamethasone|dexamethasone|mesh-list
24804836|NCT02005575|Bupivacaine|bupivacaine|mesh-list
24804837|NCT02005575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24804838|NCT02005575|Antiemetics|antiemetics|mesh-ancestor
24804839|NCT02005575|Autonomic Agents|autonomic agents|mesh-ancestor
24804840|NCT02005575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804841|NCT02005575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804842|NCT02005575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24804843|NCT02005575|Glucocorticoids|glucocorticoids|mesh-ancestor
24804844|NCT02005575|Hormones|hormones|mesh-ancestor
24804845|NCT02005575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24804846|NCT02005575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24804847|NCT02005575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804848|NCT02005575|Anesthetics, Local|anesthetics, local|mesh-ancestor
24804849|NCT02005575|Anesthetics|anesthetics|mesh-ancestor
24804857|NCT02005588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804858|NCT02005588|Chelating Agents|chelating agents|mesh-ancestor
24804859|NCT02005588|Sequestering Agents|sequestering agents|mesh-ancestor
24804860|NCT02005588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466631|NCT00374348|Serotonin Agents|serotonin agents|mesh-ancestor
24466632|NCT00374348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24466633|NCT00374348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24466634|NCT00374348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24466635|NCT00374348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24466636|NCT00374387|NuvaRing|nuvaring|mesh-list
24466637|NCT00374387|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24804883|NCT02005718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24628369|NCT01098448|Amoxicillin|amoxicillin|mesh-list
24804884|NCT02005718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804885|NCT02005718|Vitamins|vitamins|mesh-ancestor
24804886|NCT02005718|Micronutrients|micronutrients|mesh-ancestor
24804887|NCT02005718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24804888|NCT02005757|Mizoribine|mizoribine|mesh-list
24804889|NCT02005757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24804890|NCT02005757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24804891|NCT02005757|Analgesics|analgesics|mesh-ancestor
24804892|NCT02005757|Sensory System Agents|sensory system agents|mesh-ancestor
24804893|NCT02005757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24804894|NCT02005757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804895|NCT02005757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24804896|NCT02005757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24804897|NCT02005757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24804898|NCT02005757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24804912|NCT02005770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24804913|NCT02005770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24804914|NCT02005770|Anesthetics, General|anesthetics, general|mesh-ancestor
24466780|NCT00374881|Protective Agents|protective agents|mesh-ancestor
24466781|NCT00374881|Cathartics|cathartics|mesh-ancestor
24466782|NCT00374881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24466783|NCT00374894|Succimer|succimer|mesh-list
24466784|NCT00374894|Antidotes|antidotes|mesh-ancestor
24466785|NCT00374894|Protective Agents|protective agents|mesh-ancestor
24804984|NCT02006485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24804985|NCT02006485|Alkylating Agents|alkylating agents|mesh-ancestor
24804986|NCT02006485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24804987|NCT02006485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24804988|NCT02006485|Immunologic Factors|immunologic factors|mesh-ancestor
24804989|NCT02006485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466928|NCT00375622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24466929|NCT00375622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805026|NCT02006966|Anesthetics, Local|anesthetics, local|mesh-ancestor
24805028|NCT02006966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24805029|NCT02006966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805030|NCT02006966|Sensory System Agents|sensory system agents|mesh-ancestor
24805031|NCT02006966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24805032|NCT02006966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24805033|NCT02006966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25709191|NCT02261948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709192|NCT02261948|Protective Agents|protective agents|mesh-ancestor
25709193|NCT02261948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709194|NCT02262130|Omalizumab|omalizumab|mesh-list
25709195|NCT02262130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25709196|NCT02262130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25709197|NCT02262130|Respiratory System Agents|respiratory system agents|mesh-ancestor
25709198|NCT02262728|Sofosbuvir|sofosbuvir|mesh-list
25709199|NCT02262728|Simeprevir|simeprevir|mesh-list
25709200|NCT02262728|Antiviral Agents|antiviral agents|mesh-ancestor
25709201|NCT02262728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25709202|NCT02262728|Protease Inhibitors|protease inhibitors|mesh-ancestor
24467195|NCT00376493|Antimalarials|antimalarials|mesh-ancestor
24467197|NCT00376519|Mycophenolic Acid|mycophenolic acid|mesh-list
24467198|NCT00376519|Cyclophosphamide|cyclophosphamide|mesh-list
24467199|NCT00376519|Fludarabine|fludarabine|mesh-list
24467200|NCT00376519|Fludarabine phosphate|fludarabine phosphate|mesh-list
24467249|NCT00376740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24467254|NCT00376792|Docetaxel|docetaxel|mesh-list
24805063|NCT02007161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805064|NCT02007174|Bevacizumab|bevacizumab|mesh-list
24805065|NCT02007174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24805066|NCT02007174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24805067|NCT02007174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24805068|NCT02007174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24805069|NCT02007174|Growth Substances|growth substances|mesh-ancestor
24805070|NCT02007174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805071|NCT02007174|Growth Inhibitors|growth inhibitors|mesh-ancestor
24805073|NCT02007330|Anesthetics, Local|anesthetics, local|mesh-ancestor
24805074|NCT02007330|Anesthetics|anesthetics|mesh-ancestor
24805075|NCT02007330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24805076|NCT02007330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805077|NCT02007330|Sensory System Agents|sensory system agents|mesh-ancestor
24805078|NCT02007330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24805079|NCT02007330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24805080|NCT02007330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24805081|NCT02007330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24805086|NCT02007408|Anesthetics|anesthetics|mesh-ancestor
24467325|NCT00377065|Antiviral Agents|antiviral agents|mesh-ancestor
24467345|NCT00377104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467346|NCT00377104|Growth Inhibitors|growth inhibitors|mesh-ancestor
24467356|NCT00377273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467357|NCT00377273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24467358|NCT00377273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467359|NCT00377273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24467360|NCT00377273|Immunologic Factors|immunologic factors|mesh-ancestor
24467361|NCT00377273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467363|NCT00377325|Cyclosporins|cyclosporins|mesh-list
24467364|NCT00377325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467365|NCT00377325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467366|NCT00377325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24467367|NCT00377325|Immunologic Factors|immunologic factors|mesh-ancestor
24467368|NCT00377325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467689|NCT00378456|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24467699|NCT00378547|Dexamethasone acetate|dexamethasone acetate|mesh-list
24467700|NCT00378547|Pregabalin|pregabalin|mesh-list
24467787|NCT00378716|Antidotes|antidotes|mesh-ancestor
24467794|NCT00378729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467812|NCT00378820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467814|NCT00378833|Niacinamide|niacinamide|mesh-list
24467815|NCT00378833|Nicotinic Acids|nicotinic acids|mesh-list
24467816|NCT00378833|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24467869|NCT00379015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24467895|NCT00379028|Glucocorticoids|glucocorticoids|mesh-ancestor
24467896|NCT00379028|Hormones|hormones|mesh-ancestor
24467897|NCT00379028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24467898|NCT00379028|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24467899|NCT00379028|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24467900|NCT00379028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24468016|NCT00379457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468017|NCT00379457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24468018|NCT00379457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24468019|NCT00379457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24468020|NCT00379457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24468021|NCT00379457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24468022|NCT00379457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24468023|NCT00379457|Tubulin Modulators|tubulin modulators|mesh-ancestor
24468024|NCT00379457|Antimitotic Agents|antimitotic agents|mesh-ancestor
24836718|NCT02187107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836720|NCT02187107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24805186|NCT02008006|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24805187|NCT02008006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24468034|NCT00379483|Sequestering Agents|sequestering agents|mesh-ancestor
24468035|NCT00379483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468036|NCT00379496|Antidepressive Agents|antidepressive agents|mesh-list
24468037|NCT00379496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24468039|NCT00379509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468048|NCT00379522|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24468049|NCT00379522|Natriuretic Agents|natriuretic agents|mesh-ancestor
24468050|NCT00379522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468051|NCT00379600|Rosiglitazone|rosiglitazone|mesh-list
24468052|NCT00379600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24468053|NCT00379600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468067|NCT00379691|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24468068|NCT00379691|Nasal Decongestants|nasal decongestants|mesh-ancestor
24468069|NCT00379691|Respiratory System Agents|respiratory system agents|mesh-ancestor
24468070|NCT00379691|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24468071|NCT00379691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24468072|NCT00379691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24468073|NCT00379691|Adrenergic Agents|adrenergic agents|mesh-ancestor
24468079|NCT00379717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468080|NCT00379717|Tubulin Modulators|tubulin modulators|mesh-ancestor
24468081|NCT00379717|Antimitotic Agents|antimitotic agents|mesh-ancestor
24468082|NCT00379717|Mitosis Modulators|mitosis modulators|mesh-ancestor
24468100|NCT00379847|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24468102|NCT00379847|Natriuretic Agents|natriuretic agents|mesh-ancestor
24468103|NCT00379847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468104|NCT00379886|Thiopental|thiopental|mesh-list
24468105|NCT00379886|Propofol|propofol|mesh-list
24468106|NCT00379886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24468107|NCT00379886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24468117|NCT00379951|Ertapenem|ertapenem|mesh-list
24468125|NCT00379977|Vaccines|vaccines|mesh-list
24468184|NCT00380380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24805216|NCT02008136|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24805217|NCT02008136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24805218|NCT02008136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805220|NCT02008136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24805221|NCT02008136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805222|NCT02008162|Bromides|bromides|mesh-list
24468251|NCT00380770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24468252|NCT00380770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24468253|NCT00380770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709203|NCT02262728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709204|NCT02262728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709205|NCT02262754|Naproxen|naproxen|mesh-list
25709206|NCT02262754|PF-06372865|pf-06372865|mesh-list
25709207|NCT02262754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25709208|NCT02262754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25709209|NCT02262754|Analgesics|analgesics|mesh-ancestor
25709210|NCT02262754|Sensory System Agents|sensory system agents|mesh-ancestor
24805256|NCT02008214|Vasodilator Agents|vasodilator agents|mesh-ancestor
24805257|NCT02008214|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24805258|NCT02008214|Antioxidants|antioxidants|mesh-ancestor
24805259|NCT02008383|Panitumumab|panitumumab|mesh-list
24805260|NCT02008383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24805261|NCT02008383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24805262|NCT02008422|Oxaliplatin|oxaliplatin|mesh-list
24468470|NCT00381732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24468471|NCT00381732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24468472|NCT00381732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468473|NCT00381732|Urological Agents|urological agents|mesh-ancestor
24805267|NCT02008422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24468668|NCT00382642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468669|NCT00382642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24468670|NCT00382642|Antipruritics|antipruritics|mesh-ancestor
24468671|NCT00382642|Dermatologic Agents|dermatologic agents|mesh-ancestor
24468679|NCT00382642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24836797|NCT02187523|Natriuretic Agents|natriuretic agents|mesh-ancestor
24836798|NCT02187523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836799|NCT02187523|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24468680|NCT00382642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24468681|NCT00382668|Dasatinib|dasatinib|mesh-list
24468884|NCT00383851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468893|NCT00383864|Interferons|interferons|mesh-list
24468894|NCT00383864|Ribavirin|ribavirin|mesh-list
24468895|NCT00383864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24805269|NCT02008422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805270|NCT02008422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24805271|NCT02008422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24805272|NCT02008422|Growth Substances|growth substances|mesh-ancestor
24468942|NCT00383994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24468943|NCT00383994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468945|NCT00383994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468946|NCT00383994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24468947|NCT00384020|Citalopram|citalopram|mesh-list
24469046|NCT00384436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24469047|NCT00384436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469049|NCT00384436|Serotonin Agents|serotonin agents|mesh-ancestor
24469050|NCT00384436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469078|NCT00384553|Rituximab|rituximab|mesh-list
24469148|NCT00384631|Growth Inhibitors|growth inhibitors|mesh-ancestor
24469150|NCT00384657|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24469151|NCT00384657|Trace Elements|trace elements|mesh-ancestor
24469152|NCT00384657|Micronutrients|micronutrients|mesh-ancestor
24469153|NCT00384657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469154|NCT00384657|Hematinics|hematinics|mesh-ancestor
24469155|NCT00384696|Nicotine|nicotine|mesh-list
24469156|NCT00384696|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24469157|NCT00384696|Autonomic Agents|autonomic agents|mesh-ancestor
25709214|NCT02262754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25709215|NCT02262754|Gout Suppressants|gout suppressants|mesh-ancestor
25709216|NCT02262754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24469158|NCT00384696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25709217|NCT02262754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709218|NCT02262754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709219|NCT02262754|GABA Modulators|gaba modulators|mesh-ancestor
24805273|NCT02008422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805274|NCT02008422|Growth Inhibitors|growth inhibitors|mesh-ancestor
24469218|NCT00384917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469219|NCT00384917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24469220|NCT00384917|Hormone Antagonists|hormone antagonists|mesh-ancestor
24805276|NCT02008461|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24805277|NCT02008461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24469301|NCT00385398|Alkylating Agents|alkylating agents|mesh-ancestor
24469304|NCT00385411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469305|NCT00385411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469306|NCT00385411|GABA Agents|gaba agents|mesh-ancestor
24469521|NCT00386191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24469522|NCT00386191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469523|NCT00386191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469524|NCT00386230|Zidovudine|zidovudine|mesh-list
24469525|NCT00386230|Antimetabolites|antimetabolites|mesh-ancestor
24469526|NCT00386230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469527|NCT00386230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24469528|NCT00386230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24805284|NCT02008578|Antibodies|antibodies|mesh-list
24805285|NCT02008578|Immunologic Factors|immunologic factors|mesh-ancestor
24805286|NCT02008578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805287|NCT02008721|Neuroprotective Agents|neuroprotective agents|mesh-list
24805288|NCT02008721|Protective Agents|protective agents|mesh-ancestor
24578156|NCT00847093|Anesthetics|anesthetics|mesh-ancestor
24469529|NCT00386230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709220|NCT02262754|GABA Agents|gaba agents|mesh-ancestor
25709221|NCT02262754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25709222|NCT02263079|Interferons|interferons|mesh-list
24472561|NCT00399659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24472564|NCT00399672|Interferons|interferons|mesh-list
24836884|NCT02187874|Oxytocin|oxytocin|mesh-list
25709223|NCT02263079|Interferon-alpha|interferon-alpha|mesh-list
25709224|NCT02263079|Lamivudine|lamivudine|mesh-list
25709225|NCT02263079|Interferon alpha-2|interferon alpha-2|mesh-list
25709226|NCT02263079|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25709227|NCT02263079|Entecavir|entecavir|mesh-list
25709228|NCT02263079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25709229|NCT02263079|Antiviral Agents|antiviral agents|mesh-ancestor
24469552|NCT00386282|Oxytocics|oxytocics|mesh-ancestor
24446814|NCT00306124|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24446815|NCT00306124|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24446816|NCT00306124|Dopamine Agents|dopamine agents|mesh-ancestor
24446817|NCT00306124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24446819|NCT00306124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469743|NCT00386984|Octreotide|octreotide|mesh-list
24469744|NCT00386984|Somatostatin|somatostatin|mesh-list
24469745|NCT00386984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24469746|NCT00386984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24469747|NCT00386984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24469748|NCT00386984|Hormones|hormones|mesh-ancestor
24805299|NCT02008747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805300|NCT02008747|Anesthetics|anesthetics|mesh-ancestor
24805301|NCT02008747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24805302|NCT02008747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24805303|NCT02008747|Anticonvulsants|anticonvulsants|mesh-ancestor
24805304|NCT02008747|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24805305|NCT02008747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24805306|NCT02008747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805307|NCT02008747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24578286|NCT00848302|Nitric Oxide|nitric oxide|mesh-list
24469855|NCT00387556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24469856|NCT00387556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24469858|NCT00387569|Immunologic Factors|immunologic factors|mesh-ancestor
24469859|NCT00387569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469860|NCT00387582|Ranibizumab|ranibizumab|mesh-list
24469861|NCT00387582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24469862|NCT00387582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24469972|NCT00388193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469974|NCT00388219|Buprenorphine|buprenorphine|mesh-list
24469975|NCT00388219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24469976|NCT00388219|Narcotics|narcotics|mesh-ancestor
24469977|NCT00388219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24469978|NCT00388219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469979|NCT00388219|Analgesics|analgesics|mesh-ancestor
24469980|NCT00388219|Sensory System Agents|sensory system agents|mesh-ancestor
24469981|NCT00388219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24469982|NCT00388219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24470101|NCT00388778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24470103|NCT00388778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24470104|NCT00388778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24470108|NCT00388856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470109|NCT00388856|Antioxidants|antioxidants|mesh-ancestor
24470110|NCT00388856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470111|NCT00388856|Protective Agents|protective agents|mesh-ancestor
24470112|NCT00388882|Bromides|bromides|mesh-list
24470113|NCT00388882|Albuterol|albuterol|mesh-list
24470114|NCT00388882|Tiotropium Bromide|tiotropium bromide|mesh-list
24470115|NCT00388882|Ipratropium|ipratropium|mesh-list
24470161|NCT00389025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25406262|NCT03573024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25709231|NCT02263079|Immunologic Factors|immunologic factors|mesh-ancestor
25709232|NCT02263079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709233|NCT02263079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25709234|NCT02263079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25709235|NCT02263079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709236|NCT02263079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709237|NCT02263079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24470730|NCT00391261|Metformin|metformin|mesh-list
24470731|NCT00391261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24470732|NCT00391261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470733|NCT00391313|Chloroquine|chloroquine|mesh-list
24470734|NCT00391313|Amebicides|amebicides|mesh-ancestor
24470735|NCT00391313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24470736|NCT00391313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24470737|NCT00391313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24470738|NCT00391313|Antimalarials|antimalarials|mesh-ancestor
24470739|NCT00391313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24470740|NCT00391404|Alendronate|alendronate|mesh-list
24470741|NCT00391404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24470761|NCT00391638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24805392|NCT02009280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805393|NCT02009280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24805394|NCT02009280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24470901|NCT00392431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24470902|NCT00392431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470948|NCT00392561|Protective Agents|protective agents|mesh-ancestor
24470955|NCT00392691|Rituximab|rituximab|mesh-list
24805400|NCT02009306|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24805401|NCT02009306|Narcotics|narcotics|mesh-ancestor
24805402|NCT02009306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24805403|NCT02009306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805404|NCT02009306|Analgesics|analgesics|mesh-ancestor
24805405|NCT02009306|Sensory System Agents|sensory system agents|mesh-ancestor
25406263|NCT03573024|Antimetabolites|antimetabolites|mesh-ancestor
25709238|NCT02263079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25709239|NCT02263326|Lamivudine|lamivudine|mesh-list
25709240|NCT02263326|Dolutegravir|dolutegravir|mesh-list
25709241|NCT02263326|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25709242|NCT02263326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25709243|NCT02263326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25709244|NCT02263326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24471707|NCT00396669|Antidepressive Agents|antidepressive agents|mesh-ancestor
24471708|NCT00396669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24471709|NCT00396669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24471710|NCT00396669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24738023|NCT01672359|Choline|choline|mesh-list
24471958|NCT00397592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24471959|NCT00397592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471961|NCT00397657|Ezetimibe|ezetimibe|mesh-list
24805479|NCT02009540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805488|NCT02009592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24471962|NCT00397657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24471963|NCT00397657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24472070|NCT00397956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24472071|NCT00397956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24472072|NCT00398008|Naltrexone|naltrexone|mesh-list
24454057|NCT04478019|Plasma Substitutes|plasma substitutes|mesh-ancestor
24454058|NCT04478019|Blood Substitutes|blood substitutes|mesh-ancestor
24454059|NCT04478019|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24454060|NCT04478019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24472144|NCT00398463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472145|NCT00398463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24805510|NCT02009748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472155|NCT00398463|Protective Agents|protective agents|mesh-ancestor
24472156|NCT00398489|Tamoxifen|tamoxifen|mesh-list
24472157|NCT00398489|Cyclophosphamide|cyclophosphamide|mesh-list
24472158|NCT00398489|Docetaxel|docetaxel|mesh-list
24472159|NCT00398489|Trastuzumab|trastuzumab|mesh-list
25709791|NCT02275052|Respiratory System Agents|respiratory system agents|mesh-ancestor
25709792|NCT02275052|Tocolytic Agents|tocolytic agents|mesh-ancestor
25709793|NCT02275052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25709794|NCT02275052|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25709795|NCT02275052|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25709796|NCT02275052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25709797|NCT02275052|Adrenergic Agents|adrenergic agents|mesh-ancestor
25709798|NCT02275052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24473040|NCT00401609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24473041|NCT00401609|Tubulin Modulators|tubulin modulators|mesh-ancestor
24473042|NCT00401609|Antimitotic Agents|antimitotic agents|mesh-ancestor
24473043|NCT00401609|Mitosis Modulators|mitosis modulators|mesh-ancestor
24473044|NCT00401635|Carboplatin|carboplatin|mesh-list
24473045|NCT00401635|Doxorubicin|doxorubicin|mesh-list
24473046|NCT00401635|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24473047|NCT00401635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473048|NCT00401635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24473049|NCT00401635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24473050|NCT00401635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24473051|NCT00401635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444671|NCT00298857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24444672|NCT00298857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24473189|NCT00402350|Anesthetics|anesthetics|mesh-ancestor
24473190|NCT00402376|Carvedilol|carvedilol|mesh-list
24805651|NCT02011620|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
24805652|NCT02011620|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24805653|NCT02011620|Diuretics|diuretics|mesh-ancestor
24805654|NCT02011620|Natriuretic Agents|natriuretic agents|mesh-ancestor
24805655|NCT02011620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24805656|NCT02011620|Vasodilator Agents|vasodilator agents|mesh-ancestor
24805657|NCT02011620|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24805658|NCT02011620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805659|NCT02011633|Metformin|metformin|mesh-list
24473191|NCT00402376|Perindopril|perindopril|mesh-list
24473245|NCT00402454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24473246|NCT00402454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24473248|NCT00402454|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24473249|NCT00402454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473251|NCT00402454|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24473625|NCT00403533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24473626|NCT00403533|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24473627|NCT00403533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473628|NCT00403611|Praziquantel|praziquantel|mesh-list
24473629|NCT00403611|Anthelmintics|anthelmintics|mesh-ancestor
24473630|NCT00403611|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24473631|NCT00403611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24473632|NCT00403624|Oxaliplatin|oxaliplatin|mesh-list
24473633|NCT00403624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473634|NCT00403637|Maleic acid|maleic acid|mesh-list
24473635|NCT00403637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473636|NCT00403637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24805748|NCT02011958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24805750|NCT02012036|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24581591|NCT00865540|Hormones|hormones|mesh-ancestor
24473735|NCT00403962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473736|NCT00403962|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24445541|NCT00301795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445542|NCT00301795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24445544|NCT00301847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473746|NCT00403988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473748|NCT00404040|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24473749|NCT00404040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24445545|NCT00301847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24445546|NCT00301847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445610|NCT00301925|Capecitabine|capecitabine|mesh-list
24445611|NCT00301925|Methotrexate|methotrexate|mesh-list
24445612|NCT00301925|Epirubicin|epirubicin|mesh-list
24445613|NCT00301925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24805790|NCT02012088|Cyclophosphamide|cyclophosphamide|mesh-list
24805811|NCT02012088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24805812|NCT02012088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24805813|NCT02012088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24805814|NCT02012088|Tubulin Modulators|tubulin modulators|mesh-ancestor
24805815|NCT02012088|Antimitotic Agents|antimitotic agents|mesh-ancestor
24805816|NCT02012088|Mitosis Modulators|mitosis modulators|mesh-ancestor
24805817|NCT02012140|Ticagrelor|ticagrelor|mesh-list
24805818|NCT02012140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24805819|NCT02012140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24446002|NCT00303550|Linezolid|linezolid|mesh-list
24446008|NCT00303550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446011|NCT00303576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24446012|NCT00303576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24446013|NCT00303576|Antiviral Agents|antiviral agents|mesh-ancestor
24446014|NCT00303576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446016|NCT00303589|beta-Lactams|beta-lactams|mesh-list
24473890|NCT00404404|Paclitaxel|paclitaxel|mesh-list
24473902|NCT00404404|Growth Substances|growth substances|mesh-ancestor
24473903|NCT00404404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473904|NCT00404404|Growth Inhibitors|growth inhibitors|mesh-ancestor
24473905|NCT00404417|Botulinum Toxins|botulinum toxins|mesh-list
24473906|NCT00404417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24473907|NCT00404417|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24473908|NCT00404417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24837051|NCT02188537|Hormones|hormones|mesh-ancestor
24473909|NCT00404417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24805835|NCT02012166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24473912|NCT00404417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24473913|NCT00404417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473914|NCT00404417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24473915|NCT00404417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24805847|NCT02012244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24805848|NCT02012244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24805849|NCT02012244|Anesthetics, General|anesthetics, general|mesh-ancestor
24473982|NCT00404599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473987|NCT00404625|Anti-Infective Agents|anti-infective agents|mesh-list
24473988|NCT00404703|Bevacizumab|bevacizumab|mesh-list
24473989|NCT00404703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25709799|NCT02275052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709800|NCT02275156|Evolocumab|evolocumab|mesh-list
25709801|NCT02275156|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24474427|NCT00406003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474428|NCT00406003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24806000|NCT02013232|Antidepressive Agents|antidepressive agents|mesh-ancestor
24806001|NCT02013232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24806033|NCT02013362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24806035|NCT02013362|Vitamin B Complex|vitamin b complex|mesh-ancestor
24806036|NCT02013427|Naproxen|naproxen|mesh-list
24474549|NCT00406497|Difluprednate|difluprednate|mesh-list
24806039|NCT02013427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24806040|NCT02013427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24806042|NCT02013427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24806045|NCT02013427|Analgesics|analgesics|mesh-ancestor
24905690|NCT04345445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24905691|NCT04345445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24905692|NCT04345445|Protective Agents|protective agents|mesh-ancestor
24905693|NCT04345445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24905694|NCT04345445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905695|NCT04345588|Dexamethasone|dexamethasone|mesh-list
24905696|NCT04345588|Dexamethasone acetate|dexamethasone acetate|mesh-list
24905728|NCT04345419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905729|NCT04345419|Antiviral Agents|antiviral agents|mesh-ancestor
24905730|NCT04345419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24818566|NCT02089399|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24905732|NCT04345406|Enalapril|enalapril|mesh-list
24905733|NCT04345406|Captopril|captopril|mesh-list
25709802|NCT02275156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25709803|NCT02275156|Antimetabolites|antimetabolites|mesh-ancestor
25709804|NCT02275156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905734|NCT04345406|Amebicides|amebicides|mesh-ancestor
24905735|NCT04345406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24905736|NCT04345406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25709805|NCT02275156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25709806|NCT02275338|Lanreotide|lanreotide|mesh-list
24905933|NCT04343885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905934|NCT04343885|Tubulin Modulators|tubulin modulators|mesh-ancestor
24905935|NCT04343885|Antimitotic Agents|antimitotic agents|mesh-ancestor
24905936|NCT04343885|Mitosis Modulators|mitosis modulators|mesh-ancestor
24905937|NCT04343885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905938|NCT04343885|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24905940|NCT04344158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905941|NCT04344158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24905942|NCT04344158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787053|NCT01923454|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24787054|NCT01923454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787062|NCT01923545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787063|NCT01923558|Donepezil|donepezil|mesh-list
24787064|NCT01923558|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24787065|NCT01923558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24787066|NCT01923558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787067|NCT01923558|Cholinergic Agents|cholinergic agents|mesh-ancestor
24787068|NCT01923558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24787069|NCT01923558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787070|NCT01923558|Nootropic Agents|nootropic agents|mesh-ancestor
24787071|NCT01923584|Ubiquinone|ubiquinone|mesh-list
24787072|NCT01923584|Micronutrients|micronutrients|mesh-ancestor
24787073|NCT01923584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787074|NCT01923597|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24787075|NCT01923597|Antioxidants|antioxidants|mesh-ancestor
24787076|NCT01923597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787077|NCT01923597|Protective Agents|protective agents|mesh-ancestor
24787078|NCT01923597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787079|NCT01923597|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24787080|NCT01923597|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24787081|NCT01923597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25709807|NCT02275338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25709808|NCT02275611|Oxytocin|oxytocin|mesh-list
25709809|NCT02275611|Oxytocics|oxytocics|mesh-ancestor
25709810|NCT02275611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25709811|NCT02275611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709812|NCT02276027|Ceritinib|ceritinib|mesh-list
25709813|NCT02276027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25709814|NCT02276027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24787082|NCT01923597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25109099|NCT03127189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25109100|NCT03127189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905945|NCT04343742|Dental Disinfectants|dental disinfectants|mesh-ancestor
24906190|NCT04342351|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24481807|NCT00436826|Interferon beta-1b|interferon beta-1b|mesh-list
24818633|NCT02089854|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24818634|NCT02089854|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24818657|NCT02089932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24818658|NCT02089932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818660|NCT02090036|Artemether|artemether|mesh-list
24818661|NCT02090036|Primaquine|primaquine|mesh-list
24818662|NCT02090036|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24818663|NCT02090036|Antimalarials|antimalarials|mesh-ancestor
24818664|NCT02090036|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24818665|NCT02090036|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24818666|NCT02090036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24818667|NCT02090101|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24818668|NCT02090101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24906314|NCT04341727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24906315|NCT04341727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906316|NCT04341727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24906317|NCT04341727|Filaricides|filaricides|mesh-ancestor
24906318|NCT04341727|Antinematodal Agents|antinematodal agents|mesh-ancestor
24906319|NCT04341727|Anthelmintics|anthelmintics|mesh-ancestor
24906320|NCT04341545|Letrozole|letrozole|mesh-list
24906321|NCT04341545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24906322|NCT04341545|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24906323|NCT04341545|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24906324|NCT04341545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906346|NCT04341181|Niraparib|niraparib|mesh-list
24906347|NCT04341181|Vemurafenib|vemurafenib|mesh-list
24906348|NCT04341181|Maytansine|maytansine|mesh-list
24906349|NCT04341181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24906350|NCT04341181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24906351|NCT04341181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24906352|NCT04341181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906353|NCT04341181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906354|NCT04341181|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24906355|NCT04341181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24906356|NCT04341181|Tubulin Modulators|tubulin modulators|mesh-ancestor
24906357|NCT04341181|Antimitotic Agents|antimitotic agents|mesh-ancestor
24906358|NCT04341181|Mitosis Modulators|mitosis modulators|mesh-ancestor
24906359|NCT04341038|Methylprednisolone|methylprednisolone|mesh-list
24906360|NCT04341038|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24906361|NCT04341038|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24906429|NCT04340778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24906430|NCT04340778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25404033|NCT03686696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709815|NCT02276027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709816|NCT02276027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709817|NCT02276040|Bupivacaine|bupivacaine|mesh-list
25709818|NCT02276040|Anesthetics, Local|anesthetics, local|mesh-ancestor
25709819|NCT02276040|Anesthetics|anesthetics|mesh-ancestor
25709820|NCT02276040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25709821|NCT02276040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709822|NCT02276040|Sensory System Agents|sensory system agents|mesh-ancestor
24906511|NCT04339816|Azithromycin|azithromycin|mesh-list
24906512|NCT04339816|Hydroxychloroquine|hydroxychloroquine|mesh-list
24906513|NCT04339816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24906514|NCT04339816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24906515|NCT04339816|Antimalarials|antimalarials|mesh-ancestor
24906526|NCT04339361|Lidocaine|lidocaine|mesh-list
24818705|NCT02090348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818706|NCT02090400|Bazedoxifene|bazedoxifene|mesh-list
24818708|NCT02090400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24818709|NCT02090400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818710|NCT02090400|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24818711|NCT02090400|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24818712|NCT02090400|Hormone Antagonists|hormone antagonists|mesh-ancestor
24818713|NCT02090400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24818714|NCT02090400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24729467|NCT01621750|Clopidogrel|clopidogrel|mesh-list
24906590|NCT04338763|Gemcitabine|gemcitabine|mesh-list
24906591|NCT04338763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24906593|NCT04338763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906594|NCT04338763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24906595|NCT04338763|Antiviral Agents|antiviral agents|mesh-ancestor
24906596|NCT04338763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24906597|NCT04338763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906598|NCT04338763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24906599|NCT04338763|Immunologic Factors|immunologic factors|mesh-ancestor
24906600|NCT04338763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729514|NCT01622283|Cetirizine|cetirizine|mesh-list
24906601|NCT04338906|Hydroxychloroquine|hydroxychloroquine|mesh-list
24906602|NCT04338906|Camostat|camostat|mesh-list
24906603|NCT04338906|Antimalarials|antimalarials|mesh-ancestor
25109141|NCT03127046|Sensory System Agents|sensory system agents|mesh-ancestor
25109142|NCT03127046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25109143|NCT03127046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109144|NCT03127046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25109145|NCT03127046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25109146|NCT03127046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25109147|NCT03126877|Mitomycins|mitomycins|mesh-list
24906811|NCT04336891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24906812|NCT04336891|Contraceptive Agents|contraceptive agents|mesh-ancestor
24906813|NCT04336891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24906814|NCT04336891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24482281|NCT00438321|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24482282|NCT00438321|Hormone Antagonists|hormone antagonists|mesh-ancestor
24482284|NCT00438386|Antidepressive Agents|antidepressive agents|mesh-ancestor
24482285|NCT00438386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24907004|NCT04334850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24907006|NCT04334512|Vitamins|vitamins|mesh-list
24907007|NCT04334512|Ascorbic Acid|ascorbic acid|mesh-list
24907008|NCT04334512|Azithromycin|azithromycin|mesh-list
24907009|NCT04334512|Hydroxychloroquine|hydroxychloroquine|mesh-list
24907010|NCT04334512|Micronutrients|micronutrients|mesh-ancestor
24907011|NCT04334512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907012|NCT04334512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24907013|NCT04334512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24907014|NCT04334512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24907015|NCT04334512|Antimalarials|antimalarials|mesh-ancestor
24907016|NCT04334512|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24907017|NCT04334512|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24907018|NCT04334512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907019|NCT04334512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818738|NCT02090504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24818739|NCT02090504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818740|NCT02090543|Rivaroxaban|rivaroxaban|mesh-list
24818741|NCT02090543|Phenprocoumon|phenprocoumon|mesh-list
24818742|NCT02090543|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24818743|NCT02090543|Antithrombins|antithrombins|mesh-ancestor
25404034|NCT03686124|Nivolumab|nivolumab|mesh-list
25770594|NCT03554018|Antipyretics|antipyretics|mesh-ancestor
25770595|NCT03554018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25770596|NCT03554018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25770597|NCT03554018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25770598|NCT03554018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25770599|NCT03554018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770600|NCT03554018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818746|NCT02090543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24818747|NCT02090543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818748|NCT02090543|Anticoagulants|anticoagulants|mesh-ancestor
24818820|NCT02091063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24907047|NCT04333992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24907048|NCT04333992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907049|NCT04333992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24907050|NCT04333992|Anesthetics, General|anesthetics, general|mesh-ancestor
24907051|NCT04333992|Anesthetics|anesthetics|mesh-ancestor
24907052|NCT04333992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24907053|NCT04333992|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24907054|NCT04333992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24907055|NCT04333992|Narcotics|narcotics|mesh-ancestor
24907056|NCT04333992|Analgesics|analgesics|mesh-ancestor
24907057|NCT04333992|Sensory System Agents|sensory system agents|mesh-ancestor
24907058|NCT04333992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24787119|NCT01923831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24787120|NCT01923831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787121|NCT01923831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24787126|NCT01923831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24787128|NCT01923831|Sensory System Agents|sensory system agents|mesh-ancestor
24787129|NCT01923831|Anesthetics|anesthetics|mesh-ancestor
25109159|NCT03126864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25109160|NCT03126864|Immunologic Factors|immunologic factors|mesh-ancestor
25109161|NCT03126864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109162|NCT03126864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25109173|NCT03126578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25109174|NCT03126578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25109175|NCT03126578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24907264|NCT04331418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24907266|NCT04331418|Sensory System Agents|sensory system agents|mesh-ancestor
24907267|NCT04331418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24907268|NCT04331418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24907269|NCT04331418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24907270|NCT04331418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24907271|NCT04331418|Adrenergic Agents|adrenergic agents|mesh-ancestor
24907272|NCT04331418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24907273|NCT04331418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907275|NCT04331470|Lopinavir|lopinavir|mesh-list
24907276|NCT04331470|Chloroquine|chloroquine|mesh-list
24907277|NCT04331470|Levamisole|levamisole|mesh-list
24907278|NCT04331470|Hydroxychloroquine|hydroxychloroquine|mesh-list
24907279|NCT04331470|Budesonide|budesonide|mesh-list
24907280|NCT04331470|Formoterol Fumarate|formoterol fumarate|mesh-list
24907281|NCT04331470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24907282|NCT04331470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24907283|NCT04331470|Protease Inhibitors|protease inhibitors|mesh-ancestor
24907284|NCT04331470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907285|NCT04331470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907286|NCT04331470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24907287|NCT04331470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24907288|NCT04331470|Antiviral Agents|antiviral agents|mesh-ancestor
24818866|NCT02091388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818867|NCT02091388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770601|NCT03554486|Insulin|insulin|mesh-list
25770602|NCT03554486|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25770603|NCT03554486|Insulin Aspart|insulin aspart|mesh-list
25770604|NCT03554486|Insulin, Long-Acting|insulin, long-acting|mesh-list
25770605|NCT03554486|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25770606|NCT03554486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25770607|NCT03554486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770608|NCT03554772|Celecoxib|celecoxib|mesh-list
25770609|NCT03554772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24787130|NCT01923831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25709825|NCT02276222|Tiotropium Bromide|tiotropium bromide|mesh-list
24482791|NCT00440635|Bortezomib|bortezomib|mesh-list
24907587|NCT04329585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907589|NCT04329572|Hydroxychloroquine|hydroxychloroquine|mesh-list
24907590|NCT04329572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24907591|NCT04329572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24907592|NCT04329572|Antimalarials|antimalarials|mesh-ancestor
24730487|NCT01628445|Hormones|hormones|mesh-ancestor
24907593|NCT04329572|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24907594|NCT04329572|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24907595|NCT04329572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907596|NCT04329572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907597|NCT04329572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24818873|NCT02091388|Dopamine Agents|dopamine agents|mesh-ancestor
24818874|NCT02091401|Magnesium Sulfate|magnesium sulfate|mesh-list
24818875|NCT02091401|Analgesics|analgesics|mesh-ancestor
24907669|NCT04328883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24907670|NCT04328883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907671|NCT04328883|Antipyretics|antipyretics|mesh-ancestor
24907672|NCT04328636|Magnesium Sulfate|magnesium sulfate|mesh-list
24907673|NCT04328636|Analgesics|analgesics|mesh-ancestor
24907674|NCT04328636|Sensory System Agents|sensory system agents|mesh-ancestor
24907675|NCT04328636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24907676|NCT04328636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907741|NCT04328272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24907742|NCT04328272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25109177|NCT03126578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24907743|NCT04328272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907744|NCT04328272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24907764|NCT04328064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24907765|NCT04328064|Antimetabolites|antimetabolites|mesh-ancestor
24907766|NCT04328064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907767|NCT04328064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24907768|NCT04328064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24907769|NCT04328064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907770|NCT04327726|Dexmedetomidine|dexmedetomidine|mesh-list
24907771|NCT04327726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24907772|NCT04327726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24907773|NCT04327726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907774|NCT04327726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24907775|NCT04327726|Analgesics|analgesics|mesh-ancestor
24907776|NCT04327726|Sensory System Agents|sensory system agents|mesh-ancestor
24907777|NCT04327726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24907778|NCT04327726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24907779|NCT04327726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24907780|NCT04327726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24623674|NCT01073111|Immunologic Factors|immunologic factors|mesh-ancestor
24730822|NCT01630655|Felodipine|felodipine|mesh-list
24907837|NCT04326959|Triamcinolone|triamcinolone|mesh-list
24907838|NCT04326959|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25709826|NCT02276222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25709827|NCT02276222|Autonomic Agents|autonomic agents|mesh-ancestor
25709828|NCT02276222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25709829|NCT02276222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709830|NCT02276222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25709831|NCT02276222|Respiratory System Agents|respiratory system agents|mesh-ancestor
25709832|NCT02276222|Parasympatholytics|parasympatholytics|mesh-ancestor
25709833|NCT02276222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24787135|NCT01923831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787136|NCT01923831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24787137|NCT01923831|Tocolytic Agents|tocolytic agents|mesh-ancestor
24787138|NCT01923831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24787139|NCT01923844|Pulmonary Surfactants|pulmonary surfactants|mesh-list
24787140|NCT01923844|Beractant|beractant|mesh-list
24787141|NCT01923844|Respiratory System Agents|respiratory system agents|mesh-ancestor
24787142|NCT01923857|Enclomiphene|enclomiphene|mesh-list
24787143|NCT01923857|Clomiphene|clomiphene|mesh-list
24787144|NCT01923857|Zuclomiphene|zuclomiphene|mesh-list
24787145|NCT01923857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24787146|NCT01923857|Hormone Antagonists|hormone antagonists|mesh-ancestor
24787147|NCT01923857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24787148|NCT01923857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787149|NCT01923857|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24787150|NCT01923857|Fertility Agents|fertility agents|mesh-ancestor
24787151|NCT01923857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24907885|NCT04326868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907889|NCT04326868|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24907890|NCT04326868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24907891|NCT04326868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24907892|NCT04326868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109178|NCT03126578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24907893|NCT04326764|Panobinostat|panobinostat|mesh-list
25109179|NCT03126578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25109180|NCT03126578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25109181|NCT03126578|Anesthetics, General|anesthetics, general|mesh-ancestor
25109182|NCT03126578|Anesthetics|anesthetics|mesh-ancestor
25109183|NCT03126578|GABA Modulators|gaba modulators|mesh-ancestor
25109184|NCT03126578|GABA Agents|gaba agents|mesh-ancestor
25109185|NCT03126578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25109186|NCT03126578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109187|NCT03126656|Methyltestosterone|methyltestosterone|mesh-list
25109188|NCT03126656|Testosterone|testosterone|mesh-list
25109189|NCT03126656|Testosterone undecanoate|testosterone undecanoate|mesh-list
25109190|NCT03126656|Testosterone enanthate|testosterone enanthate|mesh-list
24907932|NCT04326296|Immunologic Factors|immunologic factors|mesh-ancestor
24907933|NCT04326296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907934|NCT04326296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24907935|NCT04326296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24907936|NCT04326296|Growth Substances|growth substances|mesh-ancestor
24907937|NCT04326296|Growth Inhibitors|growth inhibitors|mesh-ancestor
24907938|NCT04326296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908022|NCT04325113|Sensory System Agents|sensory system agents|mesh-ancestor
24908023|NCT04325113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24908024|NCT04325191|Melatonin|melatonin|mesh-list
24908025|NCT04325191|Antioxidants|antioxidants|mesh-ancestor
24908026|NCT04325191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908027|NCT04325191|Protective Agents|protective agents|mesh-ancestor
24908032|NCT04325061|BB 1101|bb 1101|mesh-list
24908033|NCT04325061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24908034|NCT04325061|Antiemetics|antiemetics|mesh-ancestor
24908035|NCT04325061|Autonomic Agents|autonomic agents|mesh-ancestor
24908036|NCT04325061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24483151|NCT00442026|Tubulin Modulators|tubulin modulators|mesh-ancestor
24908060|NCT04324411|Antifungal Agents|antifungal agents|mesh-ancestor
24908061|NCT04324411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24908062|NCT04324411|Immunologic Factors|immunologic factors|mesh-ancestor
24908063|NCT04324411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908064|NCT04324346|Paclitaxel|paclitaxel|mesh-list
24908065|NCT04324346|Docetaxel|docetaxel|mesh-list
24908066|NCT04324346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24908067|NCT04324346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908068|NCT04324346|Tubulin Modulators|tubulin modulators|mesh-ancestor
24908069|NCT04324346|Antimitotic Agents|antimitotic agents|mesh-ancestor
25709834|NCT02276222|Cholinergic Agents|cholinergic agents|mesh-ancestor
25709835|NCT02276222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25709836|NCT02276222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709837|NCT02276222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25709838|NCT02276222|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25709839|NCT02276274|Alogliptin|alogliptin|mesh-list
25709840|NCT02276274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24908071|NCT04324346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908072|NCT04324307|Gemcitabine|gemcitabine|mesh-list
24908073|NCT04324307|Paclitaxel|paclitaxel|mesh-list
24908117|NCT04324060|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24908118|NCT04324060|Hormone Antagonists|hormone antagonists|mesh-ancestor
24908119|NCT04324060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24908179|NCT04322955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24908180|NCT04322955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908181|NCT04322955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24908182|NCT04322955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908183|NCT04323280|Dexamethasone|dexamethasone|mesh-list
24908184|NCT04323280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24908185|NCT04323280|Antiemetics|antiemetics|mesh-ancestor
24908186|NCT04323280|Autonomic Agents|autonomic agents|mesh-ancestor
24908187|NCT04323280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24908188|NCT04323280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908189|NCT04323280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24908190|NCT04323280|Glucocorticoids|glucocorticoids|mesh-ancestor
24731138|NCT01632657|Sumatriptan|sumatriptan|mesh-list
24908191|NCT04323280|Hormones|hormones|mesh-ancestor
24908192|NCT04323280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24908193|NCT04323280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24908194|NCT04323280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908195|NCT04323228|Antioxidants|antioxidants|mesh-list
24908196|NCT04323228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908197|NCT04323228|Protective Agents|protective agents|mesh-ancestor
24908198|NCT04323228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908199|NCT04322760|Lidocaine|lidocaine|mesh-list
24908200|NCT04322760|Dexmedetomidine|dexmedetomidine|mesh-list
24908238|NCT04322552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908239|NCT04322786|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24908240|NCT04322786|Protease Inhibitors|protease inhibitors|mesh-ancestor
24908241|NCT04322786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908243|NCT04322422|Montelukast|montelukast|mesh-list
24908301|NCT04321655|Sensory System Agents|sensory system agents|mesh-ancestor
24908302|NCT04321655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24908303|NCT04321655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908304|NCT04321655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24908305|NCT04321655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24908306|NCT04321655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24908339|NCT04321720|Mechlorethamine|mechlorethamine|mesh-list
24908340|NCT04321720|Alkylating Agents|alkylating agents|mesh-ancestor
24908612|NCT04318730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908614|NCT04318652|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24908615|NCT04318652|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24908616|NCT04318652|Prednisolone|prednisolone|mesh-list
24908617|NCT04318652|Prednisolone acetate|prednisolone acetate|mesh-list
24908618|NCT04318652|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24908619|NCT04318652|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24908620|NCT04318652|Prednisolone phosphate|prednisolone phosphate|mesh-list
24908621|NCT04318652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24908628|NCT04318652|Hormones|hormones|mesh-ancestor
24908629|NCT04318652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24908630|NCT04318652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24908631|NCT04318652|Protective Agents|protective agents|mesh-ancestor
24908632|NCT04318652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24908633|NCT04318652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908634|NCT04318652|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24908635|NCT04318158|Fentanyl|fentanyl|mesh-list
24908636|NCT04318158|Dexmedetomidine|dexmedetomidine|mesh-list
24818892|NCT02091492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24908653|NCT04318158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24908654|NCT04318158|Narcotics|narcotics|mesh-ancestor
24908655|NCT04318158|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24908656|NCT04318158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24908659|NCT04318223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908660|NCT04318223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24908661|NCT04318223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908662|NCT04318223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908663|NCT04318262|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25709841|NCT02276274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709842|NCT02276274|Incretins|incretins|mesh-ancestor
24908667|NCT04318067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908668|NCT04318067|Protective Agents|protective agents|mesh-ancestor
24908669|NCT04318067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908670|NCT04318067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24908671|NCT04317872|Dexamethasone|dexamethasone|mesh-list
24908672|NCT04317872|Dexamethasone acetate|dexamethasone acetate|mesh-list
24908673|NCT04317872|BB 1101|bb 1101|mesh-list
24908674|NCT04317872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24908675|NCT04317872|Antiemetics|antiemetics|mesh-ancestor
24908676|NCT04317872|Autonomic Agents|autonomic agents|mesh-ancestor
24908677|NCT04317872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24908678|NCT04317872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908679|NCT04317872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24483621|NCT00444340|Etanercept|etanercept|mesh-list
24483682|NCT00444548|Antidepressive Agents|antidepressive agents|mesh-ancestor
24483683|NCT00444548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24483684|NCT00444548|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24908786|NCT04316377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24908827|NCT04316039|Temozolomide|temozolomide|mesh-list
24908828|NCT04316039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24908862|NCT04315584|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
24908863|NCT04315584|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24908864|NCT04315584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908865|NCT04315584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908867|NCT04315584|Antiviral Agents|antiviral agents|mesh-ancestor
25109225|NCT03126695|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25109226|NCT03126695|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25109228|NCT03126695|Purinergic Agents|purinergic agents|mesh-ancestor
25109229|NCT03126695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25109230|NCT03126695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109231|NCT03126695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109236|NCT03126422|Dexmedetomidine|dexmedetomidine|mesh-list
25109237|NCT03126422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25109238|NCT03126422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25109239|NCT03126422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109240|NCT03126422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24909547|NCT04307693|Antimalarials|antimalarials|mesh-ancestor
24909548|NCT04307693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24909549|NCT04307693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24909550|NCT04307693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24818944|NCT02092012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24818945|NCT02092012|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24818946|NCT02092012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24818947|NCT02092012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24818948|NCT02092012|Adrenergic Agents|adrenergic agents|mesh-ancestor
25709843|NCT02276274|Hormones|hormones|mesh-ancestor
25709844|NCT02276274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25709845|NCT02276274|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25709846|NCT02276274|Protease Inhibitors|protease inhibitors|mesh-ancestor
25709847|NCT02276274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709848|NCT02276274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709849|NCT02276482|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24818949|NCT02092012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24818953|NCT02092012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24910285|NCT04301375|Trastuzumab|trastuzumab|mesh-list
24910286|NCT04301375|Pertuzumab|pertuzumab|mesh-list
24910287|NCT04301375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24910288|NCT04301375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484877|NCT00450398|polysaccharide-K|polysaccharide-k|mesh-list
24787192|NCT01923974|Melatonin|melatonin|mesh-list
24787193|NCT01923974|Antioxidants|antioxidants|mesh-ancestor
24787194|NCT01923974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787195|NCT01923974|Protective Agents|protective agents|mesh-ancestor
24787196|NCT01923974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787197|NCT01923974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24787198|NCT01923987|Cetuximab|cetuximab|mesh-list
24787199|NCT01923987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24819006|NCT02092506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25109248|NCT03126422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24819043|NCT02092766|Antimalarials|antimalarials|mesh-ancestor
24615317|NCT01028781|Immunologic Factors|immunologic factors|mesh-ancestor
24819044|NCT02092766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24819079|NCT02093000|Bevacizumab|bevacizumab|mesh-list
24819080|NCT02093000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24819081|NCT02093000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24819082|NCT02093000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24819083|NCT02093000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24819084|NCT02093000|Growth Substances|growth substances|mesh-ancestor
24819085|NCT02093000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819086|NCT02093000|Growth Inhibitors|growth inhibitors|mesh-ancestor
24819087|NCT02093091|Vitremer|vitremer|mesh-list
24819088|NCT02093091|Cariostatic Agents|cariostatic agents|mesh-ancestor
24819089|NCT02093091|Protective Agents|protective agents|mesh-ancestor
24819090|NCT02093091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910525|NCT04296422|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24910526|NCT04296578|Selenious Acid|selenious acid|mesh-list
24910527|NCT04296578|Sodium Selenite|sodium selenite|mesh-list
24819149|NCT02093728|Antifungal Agents|antifungal agents|mesh-ancestor
24819150|NCT02093728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24485549|NCT00453635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910922|NCT04292418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910923|NCT04292418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24910924|NCT04292418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910925|NCT04292418|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24911156|NCT04291118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24911222|NCT04290013|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24911223|NCT04290013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24911224|NCT04290013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911225|NCT04290013|Hemostatics|hemostatics|mesh-ancestor
24911226|NCT04290013|Coagulants|coagulants|mesh-ancestor
24911227|NCT04290013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24911397|NCT04288700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911398|NCT04288700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911399|NCT04288700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24911400|NCT04288700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24911401|NCT04288700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24911402|NCT04288700|Vasodilator Agents|vasodilator agents|mesh-ancestor
24911403|NCT04288700|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24911404|NCT04288700|Protease Inhibitors|protease inhibitors|mesh-ancestor
24911406|NCT04288349|Racepinephrine|racepinephrine|mesh-list
24911407|NCT04288349|Ropivacaine|ropivacaine|mesh-list
24623741|NCT01073527|Adenosine|adenosine|mesh-list
24623742|NCT01073527|Albuterol|albuterol|mesh-list
24623743|NCT01073527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24912193|NCT04278807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912195|NCT04278677|Antioxidants|antioxidants|mesh-ancestor
24912196|NCT04278677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912197|NCT04278677|Protective Agents|protective agents|mesh-ancestor
24912198|NCT04278677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912199|NCT04278677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24912200|NCT04278833|Dexamethasone|dexamethasone|mesh-list
24912201|NCT04278833|Triamcinolone|triamcinolone|mesh-list
24912202|NCT04278833|Betamethasone|betamethasone|mesh-list
25709850|NCT02276482|Metronidazole|metronidazole|mesh-list
24912203|NCT04278833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24912204|NCT04278833|Antiemetics|antiemetics|mesh-ancestor
24912205|NCT04278833|Autonomic Agents|autonomic agents|mesh-ancestor
24912206|NCT04278833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24912207|NCT04278833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912208|NCT04278833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24912325|NCT04276688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912326|NCT04276688|Antiviral Agents|antiviral agents|mesh-ancestor
24912347|NCT04276636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912348|NCT04276636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24912349|NCT04276389|Paclitaxel|paclitaxel|mesh-list
24912350|NCT04276389|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24912351|NCT04276389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24912352|NCT04276389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912353|NCT04276389|Tubulin Modulators|tubulin modulators|mesh-ancestor
24912354|NCT04276389|Antimitotic Agents|antimitotic agents|mesh-ancestor
24912355|NCT04276389|Mitosis Modulators|mitosis modulators|mesh-ancestor
24912356|NCT04276389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912357|NCT04276376|Atezolizumab|atezolizumab|mesh-list
24912358|NCT04276376|Rucaparib|rucaparib|mesh-list
24912359|NCT04276376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912360|NCT04276376|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24912361|NCT04276376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24912394|NCT04276090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24912395|NCT04276090|Antiemetics|antiemetics|mesh-ancestor
24912396|NCT04276090|Autonomic Agents|autonomic agents|mesh-ancestor
24912692|NCT04273191|Brexanolone|brexanolone|mesh-list
24912693|NCT04273191|Neurosteroids|neurosteroids|mesh-ancestor
24912694|NCT04273191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24912695|NCT04273191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487201|NCT00461968|Ezetimibe|ezetimibe|mesh-list
24912799|NCT04271839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912837|NCT04270994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819234|NCT02094274|Adrenergic Agents|adrenergic agents|mesh-ancestor
24819235|NCT02094274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24446904|NCT00306475|GABA Agents|gaba agents|mesh-ancestor
24446905|NCT00306475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24912913|NCT04270279|Vasodilator Agents|vasodilator agents|mesh-ancestor
24912915|NCT04270344|Pitavastatin|pitavastatin|mesh-list
24912916|NCT04270344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24912917|NCT04270344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24912918|NCT04270344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24913001|NCT04269187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913002|NCT04269187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24913003|NCT04269187|Respiratory System Agents|respiratory system agents|mesh-ancestor
24913004|NCT04269187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24913005|NCT04269187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24913006|NCT04269187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913007|NCT04269187|Vasodilator Agents|vasodilator agents|mesh-ancestor
24913008|NCT04269187|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24913009|NCT04269187|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24913076|NCT04268303|Dexmedetomidine|dexmedetomidine|mesh-list
24913077|NCT04268303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24913923|NCT04259476|Anesthetics, General|anesthetics, general|mesh-ancestor
24913924|NCT04259476|Anesthetics|anesthetics|mesh-ancestor
24615781|NCT01031875|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24615782|NCT01031875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819388|NCT02095132|Camptothecin|camptothecin|mesh-list
24615783|NCT01031888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24819389|NCT02095132|Adavosertib|adavosertib|mesh-list
24819390|NCT02095132|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25709851|NCT02276482|Vancomycin|vancomycin|mesh-list
25709852|NCT02276482|Clindamycin|clindamycin|mesh-list
25709853|NCT02276482|Cefazolin|cefazolin|mesh-list
25709854|NCT02276482|Linezolid|linezolid|mesh-list
25709855|NCT02276482|Cephalexin|cephalexin|mesh-list
25709856|NCT02276482|Aztreonam|aztreonam|mesh-list
25709857|NCT02276482|Tedizolid|tedizolid|mesh-list
25709858|NCT02276482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25709859|NCT02276482|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24914010|NCT04258475|Antiviral Agents|antiviral agents|mesh-ancestor
24914011|NCT04258475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25109281|NCT03126084|Bupivacaine|bupivacaine|mesh-list
25109282|NCT03126084|Anesthetics, Local|anesthetics, local|mesh-ancestor
25109283|NCT03126084|Anesthetics|anesthetics|mesh-ancestor
25109284|NCT03126084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25109285|NCT03126084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109286|NCT03126084|Sensory System Agents|sensory system agents|mesh-ancestor
25109287|NCT03126084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25109288|NCT03126084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25109289|NCT03126084|Analgesics|analgesics|mesh-ancestor
25109290|NCT03126084|Antipyretics|antipyretics|mesh-ancestor
25109291|NCT03126084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25109292|NCT03126084|Narcotics|narcotics|mesh-ancestor
24914651|NCT04253132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24914719|NCT04252456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24914720|NCT04252456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24914721|NCT04252456|Growth Substances|growth substances|mesh-ancestor
24914722|NCT04252456|Growth Inhibitors|growth inhibitors|mesh-ancestor
24914723|NCT04252456|Antidotes|antidotes|mesh-ancestor
24914724|NCT04252456|Protective Agents|protective agents|mesh-ancestor
24914725|NCT04252456|Vitamin B Complex|vitamin b complex|mesh-ancestor
24914727|NCT04252456|Micronutrients|micronutrients|mesh-ancestor
24914728|NCT04252456|Hematinics|hematinics|mesh-ancestor
24914729|NCT04252443|Analgesics, Opioid|analgesics, opioid|mesh-list
24914730|NCT04252443|Analgesics|analgesics|mesh-list
24914731|NCT04252443|Narcotics|narcotics|mesh-ancestor
24914732|NCT04252443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24489380|NCT00472927|Hormones|hormones|mesh-ancestor
24618471|NCT01048398|Sensory System Agents|sensory system agents|mesh-ancestor
24914773|NCT04252521|Autonomic Agents|autonomic agents|mesh-ancestor
24914774|NCT04252521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24914775|NCT04252521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914897|NCT05253508|Sensory System Agents|sensory system agents|mesh-ancestor
24914898|NCT05253508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24914899|NCT05253508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24914900|NCT05253508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24914901|NCT05253508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24914902|NCT05253508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24914903|NCT05253508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914904|NCT05253118|Pemetrexed|pemetrexed|mesh-list
24914905|NCT05253118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914906|NCT05253118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24915006|NCT05251662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24915007|NCT05251662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915008|NCT05251662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25709860|NCT02276482|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25709861|NCT02276482|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25709862|NCT02276482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709863|NCT02276482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709864|NCT02276612|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25709865|NCT02276612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24915055|NCT04938882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915056|NCT04938882|Sensory System Agents|sensory system agents|mesh-ancestor
24915057|NCT04938882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489780|NCT00475397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24915130|NCT04669132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24787238|NCT01924104|Calcium heparin|calcium heparin|mesh-list
24787239|NCT01924104|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24787240|NCT01924104|Tinzaparin|tinzaparin|mesh-list
24787241|NCT01924104|Dalteparin|dalteparin|mesh-list
24787242|NCT01924104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24787243|NCT01924104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24787244|NCT01924104|Analgesics|analgesics|mesh-ancestor
24787245|NCT01924104|Sensory System Agents|sensory system agents|mesh-ancestor
24787246|NCT01924104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25109298|NCT03125980|Antimetabolites|antimetabolites|mesh-ancestor
25109299|NCT03125980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109300|NCT03125980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109301|NCT03126097|Drospirenone|drospirenone|mesh-list
25109302|NCT03126097|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25109303|NCT03126097|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
25109311|NCT03126097|Estrogens|estrogens|mesh-ancestor
25109323|NCT03126071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24743879|NCT04577001|Letrozole|letrozole|mesh-list
25109324|NCT03126071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109325|NCT03126071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25109326|NCT03126071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25109327|NCT03126071|Growth Substances|growth substances|mesh-ancestor
25109328|NCT03126071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109329|NCT03126071|Growth Inhibitors|growth inhibitors|mesh-ancestor
25109330|NCT03126071|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25109331|NCT03126071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25109332|NCT03126071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25109333|NCT03126071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109334|NCT03126071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25109335|NCT03126071|Antimetabolites|antimetabolites|mesh-ancestor
25109336|NCT03126071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24787247|NCT01924104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915237|NCT03854019|Cholinergic Agents|cholinergic agents|mesh-ancestor
24915238|NCT03854019|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24915239|NCT03854019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24915240|NCT03854019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24915241|NCT03854019|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24616066|NCT01033760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25709868|NCT02276612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24915337|NCT03355157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24915338|NCT03355157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915339|NCT03355157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24915340|NCT03355157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24915341|NCT03355157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24915342|NCT03355157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24915372|NCT03196180|Antimetabolites|antimetabolites|mesh-ancestor
24915373|NCT03196180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915374|NCT03196180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24915375|NCT03196180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915376|NCT03196180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24915377|NCT03196180|Immunologic Factors|immunologic factors|mesh-ancestor
24915378|NCT03196180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915379|NCT03196180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24915384|NCT03075423|Nivolumab|nivolumab|mesh-list
24915419|NCT02631941|Autonomic Agents|autonomic agents|mesh-ancestor
24446928|NCT00306683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24616085|NCT01033955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24616086|NCT01033955|Antimetabolites|antimetabolites|mesh-ancestor
24616087|NCT01033955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819642|NCT02096380|Cisplatin|cisplatin|mesh-list
24819643|NCT02096380|Docetaxel|docetaxel|mesh-list
24819644|NCT02096380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24819645|NCT02096380|Tubulin Modulators|tubulin modulators|mesh-ancestor
24819646|NCT02096380|Antimitotic Agents|antimitotic agents|mesh-ancestor
24858563|NCT02298283|Prednisone|prednisone|mesh-list
24819647|NCT02096380|Mitosis Modulators|mitosis modulators|mesh-ancestor
24819648|NCT02096380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819649|NCT02096419|Clopidogrel|clopidogrel|mesh-list
24819650|NCT02096419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24819651|NCT02096419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24490182|NCT00476983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24915506|NCT01822288|Androgen Antagonists|androgen antagonists|mesh-ancestor
24915577|NCT04250506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24915578|NCT04250506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24915580|NCT04250506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915624|NCT04250116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24915625|NCT04250116|Anticoagulants|anticoagulants|mesh-ancestor
24738877|NCT01677962|Poly ICLC|poly iclc|mesh-list
24915627|NCT04250051|Cytarabine|cytarabine|mesh-list
24915628|NCT04250051|Fludarabine|fludarabine|mesh-list
24915629|NCT04250051|Fludarabine phosphate|fludarabine phosphate|mesh-list
24915630|NCT04250051|Ivosidenib|ivosidenib|mesh-list
24915631|NCT04250051|Lenograstim|lenograstim|mesh-list
24915632|NCT04250051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915633|NCT04250051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24915634|NCT04250051|Antimetabolites|antimetabolites|mesh-ancestor
24915636|NCT04250051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24915789|NCT04248205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24819657|NCT02096419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819659|NCT02096510|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25709869|NCT02276872|Treprostinil|treprostinil|mesh-list
25709870|NCT02276872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25709871|NCT02277249|Digoxin|digoxin|mesh-list
25709872|NCT02277249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25709873|NCT02277249|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25109338|NCT03125772|Everolimus|everolimus|mesh-list
24819660|NCT02096510|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25709874|NCT02277249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709875|NCT02277249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709876|NCT02277249|Protective Agents|protective agents|mesh-ancestor
24819661|NCT02096510|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24819662|NCT02096510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24819663|NCT02096536|Vancomycin|vancomycin|mesh-list
24819664|NCT02096536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24819665|NCT02096536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24915923|NCT04246723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24915924|NCT04246723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24915925|NCT04246723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24819722|NCT02097017|Anesthetics, Local|anesthetics, local|mesh-ancestor
24819723|NCT02097017|Anesthetics|anesthetics|mesh-ancestor
24819724|NCT02097017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24916101|NCT04244695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24916102|NCT04244695|Glucocorticoids|glucocorticoids|mesh-ancestor
24916104|NCT04244695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24916105|NCT04244695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24916106|NCT04244695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24916107|NCT04244591|Methylprednisolone|methylprednisolone|mesh-list
24916108|NCT04244591|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24916183|NCT04243850|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24916184|NCT04243850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916185|NCT04243850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24916186|NCT04243850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709877|NCT02277249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709878|NCT02277548|Pregabalin|pregabalin|mesh-list
24916265|NCT04242914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24916266|NCT04242914|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24916267|NCT04242914|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24916268|NCT04242914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25709879|NCT02277548|Analgesics|analgesics|mesh-ancestor
25709880|NCT02277548|Sensory System Agents|sensory system agents|mesh-ancestor
25709881|NCT02277548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25709882|NCT02277548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709883|NCT02277548|Anticonvulsants|anticonvulsants|mesh-ancestor
25709884|NCT02277548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25709885|NCT02277548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24819748|NCT02097082|Mitosis Modulators|mitosis modulators|mesh-ancestor
24819749|NCT02097082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109342|NCT03125772|Antimitotic Agents|antimitotic agents|mesh-ancestor
24787299|NCT01924325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24787300|NCT01924325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24916400|NCT04241458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916402|NCT04241276|Paclitaxel|paclitaxel|mesh-list
24916403|NCT04241276|Tretinoin|tretinoin|mesh-list
24916404|NCT04241276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24916405|NCT04241276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24916437|NCT04240756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916438|NCT04240756|Sympathomimetics|sympathomimetics|mesh-ancestor
24916439|NCT04240756|Autonomic Agents|autonomic agents|mesh-ancestor
24916440|NCT04240756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24916441|NCT04240756|Dopamine Agents|dopamine agents|mesh-ancestor
24916442|NCT04240756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24916443|NCT04240756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916641|NCT04238884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24916643|NCT04238884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24916644|NCT04238884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916645|NCT04238884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24916646|NCT04238702|Empagliflozin|empagliflozin|mesh-list
24916653|NCT04238702|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24916654|NCT04238702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24916655|NCT04238702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917393|NCT04230330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24917394|NCT04230330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24917395|NCT04230330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24917396|NCT04230330|Antimetabolites|antimetabolites|mesh-ancestor
24917397|NCT04230330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917398|NCT04230330|Antiviral Agents|antiviral agents|mesh-ancestor
24917399|NCT04230330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24917400|NCT04230330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917401|NCT04230330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24917402|NCT04230330|Immunologic Factors|immunologic factors|mesh-ancestor
24917600|NCT04227886|Antimetabolites|antimetabolites|mesh-ancestor
24492479|NCT00486460|Celecoxib|celecoxib|mesh-list
24492480|NCT00486460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24917669|NCT04227483|Glucocorticoids|glucocorticoids|mesh-ancestor
24917704|NCT04226963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24917705|NCT04226963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917804|NCT04225780|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
24917805|NCT04225780|Antiviral Agents|antiviral agents|mesh-ancestor
24917806|NCT04225780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24917807|NCT04225780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24917808|NCT04225780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24917950|NCT04224649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24917951|NCT04224649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579571|NCT00856310|Fasinumab|fasinumab|mesh-list
25109353|NCT03125694|Hormones|hormones|mesh-ancestor
25109354|NCT03125694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25109355|NCT03125694|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25109356|NCT03125694|Protease Inhibitors|protease inhibitors|mesh-ancestor
25109357|NCT03125694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25109358|NCT03125694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109359|NCT03125746|Exemestane|exemestane|mesh-list
25109360|NCT03125746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109361|NCT03125746|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24918130|NCT04223219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24918166|NCT04222686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24918167|NCT04222686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24918168|NCT04222686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24918169|NCT04222686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918170|NCT04222686|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24918171|NCT04222686|Protease Inhibitors|protease inhibitors|mesh-ancestor
24493076|NCT00489398|Sensory System Agents|sensory system agents|mesh-ancestor
24493077|NCT00489398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24493078|NCT00489398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493079|NCT00489398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24493080|NCT00489398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24493081|NCT00489398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24493082|NCT00489398|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24493083|NCT00489398|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24493084|NCT00489398|Histamine Antagonists|histamine antagonists|mesh-ancestor
24493085|NCT00489398|Histamine Agents|histamine agents|mesh-ancestor
24493086|NCT00489398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24918203|NCT04221906|Glucocorticoids|glucocorticoids|mesh-ancestor
24918204|NCT04221906|Hormones|hormones|mesh-ancestor
24918205|NCT04221906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24918206|NCT04221906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918207|NCT04221906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24918208|NCT04221906|Respiratory System Agents|respiratory system agents|mesh-ancestor
24918209|NCT04221906|Dermatologic Agents|dermatologic agents|mesh-ancestor
24918210|NCT04221919|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24918211|NCT04221919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24918212|NCT04221919|Adrenergic Agents|adrenergic agents|mesh-ancestor
24918213|NCT04221919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24493092|NCT00489437|Anticoagulants|anticoagulants|mesh-ancestor
24918573|NCT04218552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24918574|NCT04218552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918575|NCT04218552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24918576|NCT04218552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918577|NCT04218552|Vasodilator Agents|vasodilator agents|mesh-ancestor
24918578|NCT04218552|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24617422|NCT01043172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24617423|NCT01043172|Immunologic Factors|immunologic factors|mesh-ancestor
24617424|NCT01043172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617425|NCT01043211|Lidocaine|lidocaine|mesh-list
24617426|NCT01043211|Epinephrine|epinephrine|mesh-list
24617427|NCT01043211|Anesthetics, Local|anesthetics, local|mesh-ancestor
24918805|NCT04216771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918840|NCT04215653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24918841|NCT04215653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24918842|NCT04215653|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24918843|NCT04215653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918914|NCT04215536|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24918915|NCT04215536|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24918916|NCT04215536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918947|NCT04215445|Empagliflozin|empagliflozin|mesh-list
24918948|NCT04215445|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24918952|NCT04215432|Propolis|propolis|mesh-list
24920190|NCT04204798|Dexmedetomidine|dexmedetomidine|mesh-list
24920191|NCT04204798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24920192|NCT04204798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24920193|NCT04204798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920194|NCT04204798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24920195|NCT04204798|Analgesics|analgesics|mesh-ancestor
24920196|NCT04204798|Sensory System Agents|sensory system agents|mesh-ancestor
24920197|NCT04204798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24920232|NCT04204382|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24920233|NCT04204382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24619364|NCT01052181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619366|NCT01052181|Micronutrients|micronutrients|mesh-ancestor
24619367|NCT01052181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24619368|NCT01052246|Clindamycin|clindamycin|mesh-list
24619369|NCT01052246|Clindamycin palmitate|clindamycin palmitate|mesh-list
24619370|NCT01052246|Clindamycin phosphate|clindamycin phosphate|mesh-list
24619371|NCT01052246|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24619378|NCT01052259|Gusperimus|gusperimus|mesh-list
25109445|NCT03124082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25109447|NCT03124082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25109448|NCT03124082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109449|NCT03124082|Analgesics|analgesics|mesh-ancestor
25109450|NCT03124082|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25109451|NCT03124082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25109452|NCT03124082|Anesthetics, General|anesthetics, general|mesh-ancestor
24495481|NCT00500422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920348|NCT04203056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920349|NCT04203056|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24920350|NCT04203056|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24920493|NCT04202406|Respiratory System Agents|respiratory system agents|mesh-ancestor
24920495|NCT04202224|Ibuprofen|ibuprofen|mesh-list
24920496|NCT04202224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24920497|NCT04202224|Analgesics|analgesics|mesh-ancestor
24621270|NCT01061320|Protective Agents|protective agents|mesh-ancestor
24920939|NCT04195997|Antithrombins|antithrombins|mesh-ancestor
24920940|NCT04195997|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24920941|NCT04195997|Protease Inhibitors|protease inhibitors|mesh-ancestor
24744965|NCT04067648|Sufentanil|sufentanil|mesh-list
24744966|NCT04067648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24744967|NCT04067648|Narcotics|narcotics|mesh-ancestor
24920943|NCT04195828|Paclitaxel|paclitaxel|mesh-list
24920944|NCT04195828|Apatinib|apatinib|mesh-list
24920945|NCT04195828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24920946|NCT04195828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24920986|NCT04195243|Empagliflozin|empagliflozin|mesh-list
24920987|NCT04195243|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24920988|NCT04195243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842350|NCT02220660|Autonomic Agents|autonomic agents|mesh-ancestor
24921066|NCT04194658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921068|NCT04194658|Hormone Antagonists|hormone antagonists|mesh-ancestor
24921069|NCT04194658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24921594|NCT04188951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921595|NCT04188782|Sevoflurane|sevoflurane|mesh-list
25709886|NCT02277548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709887|NCT02277548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24444336|NCT00297505|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24444376|NCT00297674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921596|NCT04188782|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24921597|NCT04188782|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24921598|NCT04188782|Anesthetics, General|anesthetics, general|mesh-ancestor
24921599|NCT04188782|Anesthetics|anesthetics|mesh-ancestor
24496942|NCT00507286|Vasodilator Agents|vasodilator agents|mesh-ancestor
24921637|NCT04188431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496997|NCT00507793|Cyclosporine|cyclosporine|mesh-list
24622787|NCT01068405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24622788|NCT01068405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24622789|NCT01068405|Dermatologic Agents|dermatologic agents|mesh-ancestor
24622790|NCT01068405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24622791|NCT01068405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24622792|NCT01068405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24622793|NCT01068405|Immunologic Factors|immunologic factors|mesh-ancestor
24622794|NCT01068405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24622795|NCT01068405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24622796|NCT01068444|Pioglitazone|pioglitazone|mesh-list
24622797|NCT01068444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24622798|NCT01068444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624015|NCT01074346|Antiviral Agents|antiviral agents|mesh-ancestor
24921865|NCT04186299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24745358|NCT03809923|Analgesics|analgesics|mesh-ancestor
24921866|NCT04186013|Atezolizumab|atezolizumab|mesh-list
24921867|NCT04186013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921869|NCT04186026|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24921870|NCT04186026|Incretins|incretins|mesh-ancestor
24921872|NCT04186026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24921873|NCT04186026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921874|NCT04186026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24921875|NCT04185857|Olmesartan|olmesartan|mesh-list
24921876|NCT04185857|Canrenone|canrenone|mesh-list
24921877|NCT04185857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24921878|NCT04185857|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24921879|NCT04185857|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24921880|NCT04185857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921881|NCT04185857|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24921882|NCT04185857|Hormone Antagonists|hormone antagonists|mesh-ancestor
24921883|NCT04185857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24921884|NCT04185857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921885|NCT04185857|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24921886|NCT04185857|Diuretics|diuretics|mesh-ancestor
24921943|NCT04185077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921944|NCT04185077|Hemostatics|hemostatics|mesh-ancestor
24922020|NCT04184492|Insulin, Isophane|insulin, isophane|mesh-list
24922021|NCT04184492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24922022|NCT04184492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922023|NCT04184401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24922025|NCT04184505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24922026|NCT04184505|Antimetabolites|antimetabolites|mesh-ancestor
24922027|NCT04184505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922108|NCT04183491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922109|NCT04183491|Antiviral Agents|antiviral agents|mesh-ancestor
24922110|NCT04183491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24922111|NCT04183491|Immunologic Factors|immunologic factors|mesh-ancestor
24787395|NCT01924910|Vitamin D|vitamin d|mesh-list
24787396|NCT01924910|Cholecalciferol|cholecalciferol|mesh-list
24787397|NCT01924910|Vitamins|vitamins|mesh-ancestor
24787398|NCT01924910|Micronutrients|micronutrients|mesh-ancestor
24787399|NCT01924910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787400|NCT01924910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24787401|NCT01924910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24787402|NCT01925001|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25109459|NCT03124082|Sympatholytics|sympatholytics|mesh-ancestor
25709888|NCT02277548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25709889|NCT02277548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25709890|NCT02277548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25709891|NCT02277548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25109460|NCT03124082|Autonomic Agents|autonomic agents|mesh-ancestor
25109461|NCT03124082|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25109462|NCT03124082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25109465|NCT03123770|Cyclophosphamide|cyclophosphamide|mesh-list
25109471|NCT03123770|Immunologic Factors|immunologic factors|mesh-ancestor
25109472|NCT03123770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109473|NCT03123770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25109474|NCT03123770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25109475|NCT03123770|Alkylating Agents|alkylating agents|mesh-ancestor
25109476|NCT03123770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109477|NCT03123770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109478|NCT03123770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25109479|NCT03123770|Tubulin Modulators|tubulin modulators|mesh-ancestor
24497882|NCT00512291|Serotonin Agents|serotonin agents|mesh-ancestor
24497883|NCT00512291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24497884|NCT00512291|Antidepressive Agents|antidepressive agents|mesh-ancestor
24497885|NCT00512291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24497886|NCT00512291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24497887|NCT00512291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497888|NCT00512395|Fentanyl|fentanyl|mesh-list
24498174|NCT00513487|Fluticasone|fluticasone|mesh-list
24498212|NCT00513552|Rifabutin|rifabutin|mesh-list
24498215|NCT00513552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24498229|NCT00513578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24498230|NCT00513630|Metformin|metformin|mesh-list
24498231|NCT00513630|Glipizide|glipizide|mesh-list
24498234|NCT00513643|Insulin|insulin|mesh-list
24498262|NCT00513786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498263|NCT00513786|Growth Inhibitors|growth inhibitors|mesh-ancestor
24498265|NCT00513864|Codeine|codeine|mesh-list
24498266|NCT00513864|Dextromethorphan|dextromethorphan|mesh-list
24498267|NCT00513864|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24923041|NCT04173403|Ezetimibe|ezetimibe|mesh-list
24923042|NCT04173403|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24923043|NCT04173403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24498665|NCT00515866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24498666|NCT00515866|Immunologic Factors|immunologic factors|mesh-ancestor
24498709|NCT00516009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24498711|NCT00516009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25709892|NCT02277691|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
24498750|NCT00516152|Immunologic Factors|immunologic factors|mesh-ancestor
24498751|NCT00516152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25709893|NCT02277691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25709894|NCT02277691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25709895|NCT02277691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709896|NCT02277743|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25709897|NCT02277743|Immunologic Factors|immunologic factors|mesh-ancestor
25709898|NCT02277743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498856|NCT00516542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24498858|NCT00516607|Temozolomide|temozolomide|mesh-list
24498859|NCT00516607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24498860|NCT00516607|Alkylating Agents|alkylating agents|mesh-ancestor
24498862|NCT00516607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923361|NCT04170855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923362|NCT04170751|Vasopressins|vasopressins|mesh-list
24923363|NCT04170751|Arginine Vasopressin|arginine vasopressin|mesh-list
24499155|NCT00517985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24499191|NCT00518232|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24499192|NCT00518232|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24499193|NCT00518232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24499194|NCT00518232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787421|NCT01925092|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24787422|NCT01925092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24787423|NCT01925092|Contraceptive Agents|contraceptive agents|mesh-ancestor
24787424|NCT01925092|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24787425|NCT01925092|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24499259|NCT00518466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24499260|NCT00518466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923703|NCT04167306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923704|NCT04167306|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24923705|NCT04167306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24923706|NCT04167306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24923707|NCT04167306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24923708|NCT04167306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24923709|NCT04167306|Cholinergic Agents|cholinergic agents|mesh-ancestor
24923710|NCT04167696|Cyclophosphamide|cyclophosphamide|mesh-list
24923746|NCT04167280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624218|NCT01075464|Paclitaxel|paclitaxel|mesh-list
24624219|NCT01075464|Bevacizumab|bevacizumab|mesh-list
24747724|NCT03133260|Aspirin|aspirin|mesh-list
24923903|NCT04165902|Hyaluronic Acid|hyaluronic acid|mesh-list
24923904|NCT04165902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24923905|NCT04165902|Immunologic Factors|immunologic factors|mesh-ancestor
24923906|NCT04165902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923907|NCT04165902|Viscosupplements|viscosupplements|mesh-ancestor
24923908|NCT04165902|Protective Agents|protective agents|mesh-ancestor
24923909|NCT04165850|Ciprofloxacin|ciprofloxacin|mesh-list
24923910|NCT04165850|Celecoxib|celecoxib|mesh-list
24923979|NCT04164823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924060|NCT04163783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924061|NCT04163783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787482|NCT01925456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787483|NCT01925456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24787484|NCT01925456|Urological Agents|urological agents|mesh-ancestor
24787485|NCT01925547|Curcumin|curcumin|mesh-list
24860148|NCT02307695|Hormones|hormones|mesh-ancestor
24924062|NCT04163536|Methylprednisolone|methylprednisolone|mesh-list
24924063|NCT04163536|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24924064|NCT04163536|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24924065|NCT04163536|Prednisolone|prednisolone|mesh-list
24924066|NCT04163536|Prednisolone acetate|prednisolone acetate|mesh-list
24924067|NCT04163536|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24924068|NCT04163536|Prednisolone phosphate|prednisolone phosphate|mesh-list
24924069|NCT04163536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25709899|NCT02277769|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25709900|NCT02277769|Immunologic Factors|immunologic factors|mesh-ancestor
25709901|NCT02277769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709902|NCT02277990|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25709903|NCT02277990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25709904|NCT02278003|Propofol|propofol|mesh-list
25709905|NCT02278003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24924070|NCT04163536|Antiemetics|antiemetics|mesh-ancestor
24924071|NCT04163536|Autonomic Agents|autonomic agents|mesh-ancestor
24924072|NCT04163536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24924073|NCT04163536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924074|NCT04163536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24924075|NCT04163536|Glucocorticoids|glucocorticoids|mesh-ancestor
24500020|NCT00522184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24500021|NCT00522184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24500023|NCT00522184|Sensory System Agents|sensory system agents|mesh-ancestor
24924391|NCT04160676|Thiamine|thiamine|mesh-list
24924392|NCT04160676|Hydrocortisone|hydrocortisone|mesh-list
24500065|NCT00522444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24924461|NCT04160026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24410294|NCT00185055|Valsartan|valsartan|mesh-list
24925171|NCT04153084|Laxatives|laxatives|mesh-ancestor
25109487|NCT03123692|Chelating Agents|chelating agents|mesh-ancestor
25109488|NCT03123692|Sequestering Agents|sequestering agents|mesh-ancestor
25109489|NCT03123692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109490|NCT03123679|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
25109491|NCT03123679|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24924462|NCT04160026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24924463|NCT04160026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24843477|NCT02227823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843478|NCT02227823|Cholinergic Agents|cholinergic agents|mesh-ancestor
24843479|NCT02227823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24924464|NCT04160026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924465|NCT04160026|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24924468|NCT04159870|Norfloxacin|norfloxacin|mesh-list
24500195|NCT00523185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24500196|NCT00523185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24500197|NCT00523185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24500198|NCT00523185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24500199|NCT00523185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24500200|NCT00523185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24500201|NCT00523185|GABA Modulators|gaba modulators|mesh-ancestor
24500202|NCT00523185|GABA Agents|gaba agents|mesh-ancestor
24500203|NCT00523185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24500213|NCT00523263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24500214|NCT00523263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24500215|NCT00523263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500216|NCT00523289|Bupivacaine|bupivacaine|mesh-list
24500217|NCT00523289|Ropivacaine|ropivacaine|mesh-list
24500218|NCT00523289|Anesthetics, Local|anesthetics, local|mesh-ancestor
24500219|NCT00523289|Anesthetics|anesthetics|mesh-ancestor
24924771|NCT04156555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24924772|NCT04156555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24924773|NCT04156555|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24924774|NCT04156555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924775|NCT04156555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924776|NCT04156815|Isotretinoin|isotretinoin|mesh-list
24924777|NCT04156815|Dermatologic Agents|dermatologic agents|mesh-ancestor
24924779|NCT04156425|Dexetimide|dexetimide|mesh-list
24924780|NCT04156425|Citalopram|citalopram|mesh-list
24924965|NCT04154852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924966|NCT04154852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924967|NCT04154852|Dermatologic Agents|dermatologic agents|mesh-ancestor
24924968|NCT04154852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924969|NCT04154852|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25709906|NCT02278003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24500647|NCT00525382|Levocetirizine|levocetirizine|mesh-list
24925024|NCT04155008|Hormones|hormones|mesh-ancestor
25709907|NCT02278003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709908|NCT02278003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25709909|NCT02278003|Anesthetics, General|anesthetics, general|mesh-ancestor
25709910|NCT02278003|Anesthetics|anesthetics|mesh-ancestor
25709911|NCT02278263|Tranexamic Acid|tranexamic acid|mesh-list
25709912|NCT02278263|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25709913|NCT02278263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24925025|NCT04155008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24925026|NCT04155008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24925027|NCT04155008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24925028|NCT04155008|Antidepressive Agents|antidepressive agents|mesh-ancestor
24500724|NCT00525577|Probucol|probucol|mesh-list
24925168|NCT04153084|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24925169|NCT04153084|Cathartics|cathartics|mesh-ancestor
24925337|NCT04150965|Dexamethasone acetate|dexamethasone acetate|mesh-list
24925338|NCT04150965|Pomalidomide|pomalidomide|mesh-list
24925341|NCT04150965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24925342|NCT04150965|Antiemetics|antiemetics|mesh-ancestor
24925343|NCT04150965|Autonomic Agents|autonomic agents|mesh-ancestor
24925344|NCT04150965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24925712|NCT04148846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925713|NCT04148846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24925714|NCT04148846|Glucocorticoids|glucocorticoids|mesh-ancestor
24925715|NCT04148846|Hormones|hormones|mesh-ancestor
24925716|NCT04148846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24925717|NCT04148846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24925718|NCT04148846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24925726|NCT04148846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24925750|NCT04148261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24925751|NCT04148261|Adrenergic Agents|adrenergic agents|mesh-ancestor
24925752|NCT04148261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24925753|NCT04148261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925754|NCT04148261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925755|NCT04148261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24925756|NCT04148261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24925757|NCT04148261|Autonomic Agents|autonomic agents|mesh-ancestor
24925758|NCT04148261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24925759|NCT04148261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24925760|NCT04148261|Respiratory System Agents|respiratory system agents|mesh-ancestor
24925761|NCT04148261|Mydriatics|mydriatics|mesh-ancestor
24925762|NCT04148261|Sympathomimetics|sympathomimetics|mesh-ancestor
24925763|NCT04148261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24925764|NCT04148261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24925766|NCT04148183|Rosiglitazone|rosiglitazone|mesh-list
24925767|NCT04148183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24925868|NCT04147390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24624344|NCT01075789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24624345|NCT01075789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624347|NCT01075802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24624348|NCT01075802|Hormone Antagonists|hormone antagonists|mesh-ancestor
24926048|NCT04145336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926085|NCT04144933|Dexmedetomidine|dexmedetomidine|mesh-list
24926087|NCT04144933|Gabapentin|gabapentin|mesh-list
24926088|NCT04144933|Dsuvia|dsuvia|mesh-list
24926218|NCT04143685|Oxytocics|oxytocics|mesh-ancestor
24926222|NCT04143685|Abortifacient Agents|abortifacient agents|mesh-ancestor
24926226|NCT04143854|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24926227|NCT04143854|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25709914|NCT02278263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926228|NCT04143854|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24926229|NCT04143854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24926230|NCT04143854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709915|NCT02278263|Hemostatics|hemostatics|mesh-ancestor
25709916|NCT02278263|Coagulants|coagulants|mesh-ancestor
25709917|NCT02278341|Epoetin Alfa|epoetin alfa|mesh-list
25709918|NCT02278341|Darbepoetin alfa|darbepoetin alfa|mesh-list
25709919|NCT02278341|Hematinics|hematinics|mesh-ancestor
25709920|NCT02278471|Losartan|losartan|mesh-list
25709921|NCT02278471|Amlodipine|amlodipine|mesh-list
24926231|NCT04143854|Cholinergic Agents|cholinergic agents|mesh-ancestor
24926232|NCT04143854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24926365|NCT04142762|Leprostatic Agents|leprostatic agents|mesh-ancestor
24926366|NCT04142762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24926367|NCT04142762|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24926368|NCT04142762|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24926369|NCT04142762|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24926370|NCT04142762|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24926371|NCT04142762|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24926372|NCT04142762|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24926894|NCT04137640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24926895|NCT04137640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24926896|NCT04137536|Antibodies|antibodies|mesh-list
24926897|NCT04137536|Antibodies, Bispecific|antibodies, bispecific|mesh-list
24926898|NCT04137536|Immunologic Factors|immunologic factors|mesh-ancestor
24926899|NCT04137536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926900|NCT04137588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24926901|NCT04137588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
24926902|NCT04137588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926904|NCT04137588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24926905|NCT04137588|Growth Substances|growth substances|mesh-ancestor
24926906|NCT04137588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926907|NCT04137588|Growth Inhibitors|growth inhibitors|mesh-ancestor
24926909|NCT04137653|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24926910|NCT04137653|Carboplatin|carboplatin|mesh-list
24927675|NCT04130698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927676|NCT04130698|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24927677|NCT04130698|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24927678|NCT04130698|Cholinergic Agents|cholinergic agents|mesh-ancestor
24927679|NCT04130698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24927680|NCT04130698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927681|NCT04130815|Furosemide|furosemide|mesh-list
24503560|NCT00532272|Letrozole|letrozole|mesh-list
24746154|NCT03260504|Aldesleukin|aldesleukin|mesh-list
25109505|NCT03123718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109506|NCT03123718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109507|NCT03123718|Dermatologic Agents|dermatologic agents|mesh-ancestor
25109508|NCT03123718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25109509|NCT03123718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25109510|NCT03123718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25109511|NCT03123718|Immunologic Factors|immunologic factors|mesh-ancestor
25109512|NCT03123718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25109513|NCT03123718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25109514|NCT03123406|Cinacalcet|cinacalcet|mesh-list
24860615|NCT02311530|Felodipine|felodipine|mesh-list
24624637|NCT01077453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24624638|NCT01077453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624639|NCT01077466|Natalizumab|natalizumab|mesh-list
24927962|NCT04127721|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24927963|NCT04127721|Alkylating Agents|alkylating agents|mesh-ancestor
24927964|NCT04127721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24928180|NCT04124887|Protective Agents|protective agents|mesh-ancestor
24746201|NCT03237702|Antioxidants|antioxidants|mesh-ancestor
24928181|NCT04124887|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24928182|NCT04124887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24928183|NCT04124887|Chelating Agents|chelating agents|mesh-ancestor
24504151|NCT00534378|Midazolam|midazolam|mesh-list
24928483|NCT04121819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24928484|NCT04121819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24928485|NCT04121819|Immunologic Factors|immunologic factors|mesh-ancestor
24928486|NCT04121819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928873|NCT04117893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928874|NCT04117893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24928875|NCT04117893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928876|NCT04117893|Analgesics|analgesics|mesh-ancestor
24928877|NCT04117893|Sensory System Agents|sensory system agents|mesh-ancestor
25709922|NCT02278471|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24504880|NCT00538421|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24504981|NCT00538811|Dopamine Agents|dopamine agents|mesh-ancestor
24504982|NCT00538811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24504983|NCT00538811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24504984|NCT00538811|Analgesics|analgesics|mesh-ancestor
24504985|NCT00538811|Sensory System Agents|sensory system agents|mesh-ancestor
24504986|NCT00538811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24929273|NCT04113772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505275|NCT00540787|Adrenergic Agents|adrenergic agents|mesh-ancestor
24929361|NCT04113993|Bazedoxifene|bazedoxifene|mesh-list
24929362|NCT04113993|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24929363|NCT04113993|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24929364|NCT04113993|Hormone Antagonists|hormone antagonists|mesh-ancestor
24505368|NCT00541047|Leuprolide|leuprolide|mesh-list
24929382|NCT04113668|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24929383|NCT04113551|Guanfacine|guanfacine|mesh-list
24929384|NCT04113551|Methylphenidate|methylphenidate|mesh-list
24929385|NCT04113551|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24929386|NCT04113551|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24929387|NCT04113551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24929388|NCT04113551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24929389|NCT04113551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929391|NCT04113551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24929392|NCT04113551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929393|NCT04113551|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24929394|NCT04113551|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24929395|NCT04113551|Dopamine Agents|dopamine agents|mesh-ancestor
24929396|NCT04113551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24929397|NCT04113551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24929398|NCT04113551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24929399|NCT04113551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24929400|NCT04113226|Rituximab|rituximab|mesh-list
24929401|NCT04113226|Lenalidomide|lenalidomide|mesh-list
24929450|NCT04112550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24929451|NCT04112550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24929452|NCT04112212|Vedolizumab|vedolizumab|mesh-list
24929453|NCT04112212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24929455|NCT04112147|Micronutrients|micronutrients|mesh-ancestor
24929456|NCT04112147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505506|NCT00541281|Prednisone|prednisone|mesh-list
24929485|NCT04111822|Coagulants|coagulants|mesh-ancestor
24929507|NCT04111328|Hydromorphone|hydromorphone|mesh-list
24929729|NCT04110093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24844094|NCT02231281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24844095|NCT02231281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24844177|NCT02231606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24929730|NCT04110093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929731|NCT04110093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929732|NCT04110119|Diclofenac|diclofenac|mesh-list
24929733|NCT04110119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24929734|NCT04110119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24929735|NCT04110119|Analgesics|analgesics|mesh-ancestor
24929736|NCT04110119|Sensory System Agents|sensory system agents|mesh-ancestor
24929737|NCT04110119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24929738|NCT04110119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929772|NCT04109261|Palbociclib|palbociclib|mesh-list
24787536|NCT01925755|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24787538|NCT01925755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25109515|NCT03123406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25109516|NCT03123406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109517|NCT03123406|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
25109518|NCT03123406|Hormone Antagonists|hormone antagonists|mesh-ancestor
25109519|NCT03123406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25109520|NCT03123484|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24787539|NCT01925755|Protease Inhibitors|protease inhibitors|mesh-ancestor
25109521|NCT03123484|Gefitinib|gefitinib|mesh-list
25709923|NCT02278471|Atorvastatin|atorvastatin|mesh-list
25709924|NCT02278471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25709925|NCT02278471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25709926|NCT02278471|Antimetabolites|antimetabolites|mesh-ancestor
25709927|NCT02278471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709928|NCT02278471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25109522|NCT03123484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109538|NCT03123445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25109539|NCT03123445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25109540|NCT03123445|Immunologic Factors|immunologic factors|mesh-ancestor
25109541|NCT03123445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109542|NCT03123445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25109543|NCT03123445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25109544|NCT03123445|Growth Substances|growth substances|mesh-ancestor
25109545|NCT03123445|Growth Inhibitors|growth inhibitors|mesh-ancestor
25109546|NCT03123276|Gemcitabine|gemcitabine|mesh-list
25109547|NCT03123276|Pembrolizumab|pembrolizumab|mesh-list
25109548|NCT03123276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25109549|NCT03123276|Antimetabolites|antimetabolites|mesh-ancestor
25109550|NCT03123276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109551|NCT03123276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109552|NCT03123276|Antiviral Agents|antiviral agents|mesh-ancestor
25109553|NCT03123276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25109554|NCT03123276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25109555|NCT03123276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24929773|NCT04109261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929774|NCT04109261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24929775|NCT04109261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24929776|NCT04109261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929778|NCT04109339|Oxytocics|oxytocics|mesh-ancestor
24929779|NCT04109339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24929780|NCT04109339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505839|NCT00542802|Carbamazepine|carbamazepine|mesh-list
24929968|NCT04106752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929969|NCT04106752|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24929970|NCT04106752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24929971|NCT04106752|Purinergic Agents|purinergic agents|mesh-ancestor
24929972|NCT04106752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24929974|NCT04106700|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24929975|NCT04106700|Antithrombins|antithrombins|mesh-ancestor
24929976|NCT04106700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24929977|NCT04106700|Protease Inhibitors|protease inhibitors|mesh-ancestor
24929978|NCT04106700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24929979|NCT04106700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929980|NCT04106700|Anticoagulants|anticoagulants|mesh-ancestor
24929981|NCT04106804|Abatacept|abatacept|mesh-list
24929982|NCT04106804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24930443|NCT04101578|Antimetabolites|antimetabolites|mesh-ancestor
24929985|NCT04106804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24929986|NCT04106804|Immunologic Factors|immunologic factors|mesh-ancestor
24929987|NCT04106804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929988|NCT04106804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24929989|NCT04106791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
24929990|NCT04106557|Gaboxadol|gaboxadol|mesh-list
24929991|NCT04106557|Analgesics|analgesics|mesh-ancestor
24929992|NCT04106557|Sensory System Agents|sensory system agents|mesh-ancestor
24929993|NCT04106557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24929994|NCT04106557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930092|NCT04105764|Rocuronium|rocuronium|mesh-list
24930093|NCT04105764|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
24930094|NCT04105764|Anticonvulsants|anticonvulsants|mesh-ancestor
24930095|NCT04105764|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24930096|NCT04105764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24930097|NCT04105764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24930098|NCT04105764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930099|NCT04105374|Flucytosine|flucytosine|mesh-list
24930101|NCT04105374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24930102|NCT04105374|Alkylating Agents|alkylating agents|mesh-ancestor
24930103|NCT04105374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930104|NCT04105374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24930105|NCT04105374|Antifungal Agents|antifungal agents|mesh-ancestor
24930223|NCT04103684|Hormones|hormones|mesh-ancestor
24930224|NCT04103684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24930225|NCT04103684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24930227|NCT04103684|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24930432|NCT04101578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24930433|NCT04101578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24930434|NCT04101578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24930435|NCT04101578|Glucocorticoids|glucocorticoids|mesh-ancestor
24930437|NCT04101578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24930438|NCT04101578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24930439|NCT04101578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24930440|NCT04101578|Abortifacient Agents|abortifacient agents|mesh-ancestor
24930441|NCT04101578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24930442|NCT04101578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25109556|NCT03123276|Immunologic Factors|immunologic factors|mesh-ancestor
24624884|NCT01079286|Immunologic Factors|immunologic factors|mesh-ancestor
24624885|NCT01079286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624886|NCT01079286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24624887|NCT01079286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24624888|NCT01079286|Protease Inhibitors|protease inhibitors|mesh-ancestor
24624889|NCT01079286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24624890|NCT01079286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506641|NCT00546325|Rimonabant|rimonabant|mesh-list
24930600|NCT04100083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24930601|NCT04100083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930602|NCT04100083|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24930603|NCT04100083|Diuretics|diuretics|mesh-ancestor
24930604|NCT04100083|Natriuretic Agents|natriuretic agents|mesh-ancestor
24930605|NCT04099771|Ketamine|ketamine|mesh-list
24930606|NCT04099771|Analgesics|analgesics|mesh-ancestor
24930607|NCT04099771|Sensory System Agents|sensory system agents|mesh-ancestor
24930608|NCT04099771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24930609|NCT04099771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930610|NCT04099771|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24930676|NCT04098861|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24930677|NCT04098861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24930678|NCT04098653|Cyclophosphamide|cyclophosphamide|mesh-list
24930679|NCT04098653|Busulfan|busulfan|mesh-list
24930680|NCT04098653|Decitabine|decitabine|mesh-list
24930682|NCT04098653|Immunologic Factors|immunologic factors|mesh-ancestor
25777113|NCT03740659|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25777114|NCT03740659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25777115|NCT03740659|Protease Inhibitors|protease inhibitors|mesh-ancestor
25777116|NCT03740659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777117|NCT03740659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777118|NCT03740659|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25777119|NCT03740659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25777120|NCT03740659|Renal Agents|renal agents|mesh-ancestor
25709929|NCT02278471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25109573|NCT03123107|Vitamins|vitamins|mesh-ancestor
25109574|NCT03123107|Micronutrients|micronutrients|mesh-ancestor
25109575|NCT03123107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109577|NCT03123107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109578|NCT03123107|Protective Agents|protective agents|mesh-ancestor
25109579|NCT03122938|Lactoferrin|lactoferrin|mesh-list
25109580|NCT03122938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25109581|NCT03122782|Tranexamic Acid|tranexamic acid|mesh-list
25109582|NCT03122782|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24930890|NCT04095832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24930891|NCT04095832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930950|NCT04095013|Fentanyl|fentanyl|mesh-list
24931011|NCT04094909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24670747|NCT01998971|Alkylating Agents|alkylating agents|mesh-ancestor
24931017|NCT04094727|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24507205|NCT00549146|Xhance|xhance|mesh-list
24931070|NCT04093518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24931071|NCT04093518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931072|NCT04093505|Gemtuzumab|gemtuzumab|mesh-list
24931073|NCT04093505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24931074|NCT04093505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931160|NCT04092387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24931161|NCT04092387|Cholinergic Agents|cholinergic agents|mesh-ancestor
24931162|NCT04092387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24931163|NCT04092387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931164|NCT04092478|Anesthetics|anesthetics|mesh-list
24931165|NCT04092478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24931166|NCT04092478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507620|NCT00551122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931405|NCT04089592|Sensory System Agents|sensory system agents|mesh-ancestor
24507658|NCT00551252|Antiviral Agents|antiviral agents|mesh-ancestor
24931473|NCT04088461|Hormones|hormones|mesh-ancestor
24931474|NCT04088461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24931505|NCT04088032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24931506|NCT04088032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931507|NCT04088175|Menthol|menthol|mesh-list
24931508|NCT04088175|Nicotine|nicotine|mesh-list
24931509|NCT04088175|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24931510|NCT04088175|Autonomic Agents|autonomic agents|mesh-ancestor
24931511|NCT04088175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24931512|NCT04088175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931513|NCT04088175|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24931514|NCT04088175|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24931515|NCT04088175|Cholinergic Agents|cholinergic agents|mesh-ancestor
24931516|NCT04088175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24931517|NCT04088175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931518|NCT04088175|Antipruritics|antipruritics|mesh-ancestor
24931519|NCT04088175|Dermatologic Agents|dermatologic agents|mesh-ancestor
24931520|NCT04087915|Evolocumab|evolocumab|mesh-list
24931554|NCT04088110|Hormone Antagonists|hormone antagonists|mesh-ancestor
24931555|NCT04088110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25709930|NCT02278471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709931|NCT02278471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25709932|NCT02278471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25709933|NCT02278471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25709934|NCT02278471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25709935|NCT02278471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709936|NCT02278471|Vasodilator Agents|vasodilator agents|mesh-ancestor
25709937|NCT02278471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24931556|NCT04088110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931558|NCT04087746|Ranibizumab|ranibizumab|mesh-list
24931559|NCT04087746|Aflibercept|aflibercept|mesh-list
24625102|NCT01080547|Capecitabine|capecitabine|mesh-list
24625103|NCT01080547|Oxaliplatin|oxaliplatin|mesh-list
24625107|NCT01080547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931572|NCT04087967|Cytarabine|cytarabine|mesh-list
24931573|NCT04087967|Decitabine|decitabine|mesh-list
24931574|NCT04087967|Idarubicin|idarubicin|mesh-list
24931575|NCT04087967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24931576|NCT04087967|Antimetabolites|antimetabolites|mesh-ancestor
24931577|NCT04087967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931578|NCT04087967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24931579|NCT04087967|Antiviral Agents|antiviral agents|mesh-ancestor
24931580|NCT04087967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24931581|NCT04087967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24931582|NCT04087967|Immunologic Factors|immunologic factors|mesh-ancestor
24931583|NCT04087967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931584|NCT04087967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24931585|NCT04087967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24931586|NCT04087967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24931652|NCT04086719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24931653|NCT04086719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24931654|NCT04086719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24931655|NCT04086719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24931656|NCT04086719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24931657|NCT04086719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931660|NCT04086108|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
24931662|NCT04086108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24931806|NCT04085094|Cholinergic Agents|cholinergic agents|mesh-ancestor
24931807|NCT04085094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24931808|NCT04085094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931810|NCT04085354|Folic Acid|folic acid|mesh-list
24931811|NCT04085354|Vitamin B 12|vitamin b 12|mesh-list
24931812|NCT04085354|Hydroxocobalamin|hydroxocobalamin|mesh-list
24931813|NCT04085354|Micronutrients|micronutrients|mesh-ancestor
24931814|NCT04085354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931815|NCT04085354|Hematinics|hematinics|mesh-ancestor
24931816|NCT04085354|Vitamin B Complex|vitamin b complex|mesh-ancestor
24787584|NCT01925898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24787585|NCT01925898|GABA Modulators|gaba modulators|mesh-ancestor
24787586|NCT01925898|GABA Agents|gaba agents|mesh-ancestor
24787588|NCT01925911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24787589|NCT01925911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24746994|NCT02333292|Simeprevir|simeprevir|mesh-list
25709938|NCT02278471|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25709939|NCT02278471|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24746995|NCT02333292|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24787597|NCT01925911|Anesthetics|anesthetics|mesh-ancestor
25709940|NCT02278471|Diuretics|diuretics|mesh-ancestor
25709941|NCT02278471|Natriuretic Agents|natriuretic agents|mesh-ancestor
25709942|NCT02278471|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25709943|NCT02278562|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25709944|NCT02278562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24932436|NCT04079725|Alkylating Agents|alkylating agents|mesh-ancestor
24932439|NCT04079725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004929|NCT05201560|Narcotics|narcotics|mesh-ancestor
24932764|NCT04076865|Histamine Agents|histamine agents|mesh-ancestor
24932765|NCT04076865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24932766|NCT04077255|Paclitaxel|paclitaxel|mesh-list
24932767|NCT04077255|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24932768|NCT04077255|Antibodies|antibodies|mesh-list
24932769|NCT04077255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24932770|NCT04077255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24932771|NCT04077255|Tubulin Modulators|tubulin modulators|mesh-ancestor
24932825|NCT04076371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932826|NCT04076371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932827|NCT04076371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24932828|NCT04076371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24933268|NCT04072263|Antiviral Agents|antiviral agents|mesh-ancestor
24933269|NCT04072263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24933336|NCT04071639|Tetrabenazine|tetrabenazine|mesh-list
24933338|NCT04071639|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24933339|NCT04071639|Serotonin Agents|serotonin agents|mesh-ancestor
24933340|NCT04071639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24933341|NCT04071639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933342|NCT04071639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933343|NCT04071639|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24933344|NCT04071639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24933345|NCT04071639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24933346|NCT04071639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24933347|NCT04071639|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24933348|NCT04071639|Dopamine Agents|dopamine agents|mesh-ancestor
25004571|NCT02795988|Oxaliplatin|oxaliplatin|mesh-list
25004572|NCT02795988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25004573|NCT02795988|Antimetabolites|antimetabolites|mesh-ancestor
25004574|NCT02795988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004575|NCT02795988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25004576|NCT02795988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25004577|NCT02795988|Immunologic Factors|immunologic factors|mesh-ancestor
25004578|NCT02795988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004579|NCT02786329|Lidocaine|lidocaine|mesh-list
25004597|NCT02731352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24933630|NCT04068974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933631|NCT04068870|Contraceptive Agents|contraceptive agents|mesh-list
24933632|NCT04068870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24933794|NCT04067024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933796|NCT04067102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24933797|NCT04067102|Cyclophosphamide|cyclophosphamide|mesh-list
24933799|NCT04067102|Epirubicin|epirubicin|mesh-list
24933800|NCT04067102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24933801|NCT04067102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24933936|NCT04065906|Methylphenidate|methylphenidate|mesh-list
24933937|NCT04065906|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24934174|NCT04063189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24934175|NCT04063189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24934176|NCT04063189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934177|NCT04063189|Immunologic Factors|immunologic factors|mesh-ancestor
24934178|NCT04063189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24510589|NCT00565097|Lanreotide|lanreotide|mesh-list
24934287|NCT04062201|Leprostatic Agents|leprostatic agents|mesh-ancestor
24934288|NCT04062370|Ranibizumab|ranibizumab|mesh-list
24934289|NCT04062370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24934290|NCT04062370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24934291|NCT04062370|Growth Substances|growth substances|mesh-ancestor
24934292|NCT04062370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934323|NCT04061824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24934324|NCT04061824|Protease Inhibitors|protease inhibitors|mesh-ancestor
24934326|NCT04061772|Cyclophosphamide|cyclophosphamide|mesh-list
25709945|NCT02278614|Timolol|timolol|mesh-list
25709946|NCT02278614|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25709947|NCT02278614|Latanoprost|latanoprost|mesh-list
24934329|NCT04061772|Epirubicin|epirubicin|mesh-list
24934330|NCT04061772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24934331|NCT04061772|Immunologic Factors|immunologic factors|mesh-ancestor
24934332|NCT04061772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934333|NCT04061772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24934334|NCT04061772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24934335|NCT04061772|Alkylating Agents|alkylating agents|mesh-ancestor
24934423|NCT04061447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934579|NCT04060719|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24934580|NCT04060719|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24934581|NCT04060719|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24934582|NCT04060719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24934583|NCT04060381|Ibuprofen|ibuprofen|mesh-list
24934593|NCT04060381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24934594|NCT04060381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24934595|NCT04060381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24934596|NCT04060381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456845|NCT00332384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24934598|NCT04060381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24934599|NCT04060381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24934600|NCT04060381|Adrenergic Agents|adrenergic agents|mesh-ancestor
25004686|NCT02460900|Cholinergic Agents|cholinergic agents|mesh-ancestor
24934767|NCT04058899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24934768|NCT04058899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934769|NCT04058899|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24934770|NCT04058899|Narcotics|narcotics|mesh-ancestor
24934771|NCT04058964|Pembrolizumab|pembrolizumab|mesh-list
24934772|NCT04058964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24934773|NCT04058964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934774|NCT04058522|Triamcinolone|triamcinolone|mesh-list
24934775|NCT04058522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24934776|NCT04058522|Glucocorticoids|glucocorticoids|mesh-ancestor
24511115|NCT00567528|Ibuprofen|ibuprofen|mesh-list
24934889|NCT04057482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24934890|NCT04056923|Methylene Blue|methylene blue|mesh-list
24934891|NCT04056923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24934892|NCT04056923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934893|NCT04056949|Paclitaxel|paclitaxel|mesh-list
24934894|NCT04056949|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24934897|NCT04056949|Tubulin Modulators|tubulin modulators|mesh-ancestor
24934963|NCT04056754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24934964|NCT04056442|Cannabidiol|cannabidiol|mesh-list
24934965|NCT04056442|Anticonvulsants|anticonvulsants|mesh-ancestor
24934966|NCT04056325|Ivermectin|ivermectin|mesh-list
24934967|NCT04056325|Moxidectin|moxidectin|mesh-list
24934968|NCT04056325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24934969|NCT04056325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24934970|NCT04056325|Anthelmintics|anthelmintics|mesh-ancestor
24934971|NCT04056325|Antinematodal Agents|antinematodal agents|mesh-ancestor
24934972|NCT04056702|Ivacaftor|ivacaftor|mesh-list
24456339|NCT00330941|Sensory System Agents|sensory system agents|mesh-ancestor
24668956|NCT04406857|Capecitabine|capecitabine|mesh-list
24668957|NCT04406857|Ropidoxuridine|ropidoxuridine|mesh-list
25004605|NCT02726659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25004606|NCT02726659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004607|NCT02726659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25004608|NCT02726659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25004609|NCT02726659|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25004610|NCT02726659|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25004625|NCT02654132|Hormones|hormones|mesh-ancestor
25004662|NCT02600923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25004663|NCT02600923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004664|NCT02600923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004665|NCT02600923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25004666|NCT02600923|Hormone Antagonists|hormone antagonists|mesh-ancestor
24456547|NCT00331643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004682|NCT02484664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004683|NCT02460900|Varenicline|varenicline|mesh-list
25004684|NCT02460900|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25004685|NCT02460900|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25004732|NCT01945775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25004733|NCT01945775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25004735|NCT01858922|Dexamethasone|dexamethasone|mesh-list
25004736|NCT01858922|Prednisone|prednisone|mesh-list
24549912|NCT00717951|Mitosis Modulators|mitosis modulators|mesh-ancestor
25004823|NCT01416935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25004825|NCT01416935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24456846|NCT00332384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24456847|NCT00332384|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24456848|NCT00332384|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25004921|NCT05202275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25004923|NCT05202275|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24517494|NCT00608231|Dexmedetomidine|dexmedetomidine|mesh-list
25709951|NCT02278614|Adrenergic Agents|adrenergic agents|mesh-ancestor
25709952|NCT02278614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25709953|NCT02278614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467861|NCT00379015|Cyclophosphamide|cyclophosphamide|mesh-list
25709954|NCT02278614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709955|NCT02278614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25709956|NCT02278614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25709957|NCT02279407|Dapagliflozin|dapagliflozin|mesh-list
25709958|NCT02279407|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25709959|NCT02279407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709960|NCT02279407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24467949|NCT00379249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24471102|NCT00393328|Protease Inhibitors|protease inhibitors|mesh-ancestor
24471103|NCT00393328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24471104|NCT00393328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471105|NCT00393328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24471135|NCT00393445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24471137|NCT00393445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24471138|NCT00393471|Etanercept|etanercept|mesh-list
24519004|NCT03710772|Antiemetics|antiemetics|mesh-ancestor
24471294|NCT00394394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25004928|NCT05201560|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25004935|NCT05201560|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25004936|NCT05201560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25004938|NCT05201560|Anesthetics|anesthetics|mesh-ancestor
25004939|NCT05201560|Antitussive Agents|antitussive agents|mesh-ancestor
25004940|NCT05201560|Respiratory System Agents|respiratory system agents|mesh-ancestor
24476941|NCT00416845|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24476942|NCT00416845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476943|NCT00416845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24476944|NCT00416845|Immunologic Factors|immunologic factors|mesh-ancestor
24476945|NCT00416845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479083|NCT00425490|Protease Inhibitors|protease inhibitors|mesh-ancestor
24479084|NCT00425490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479085|NCT00425490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479136|NCT00425646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479138|NCT00425711|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24479139|NCT00425724|Cyclosporine|cyclosporine|mesh-list
24480148|NCT00429962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24480149|NCT00429962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24480150|NCT00429962|Growth Substances|growth substances|mesh-ancestor
24480151|NCT00429962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520807|NCT05324059|Narcotics|narcotics|mesh-ancestor
24480239|NCT00430118|Antimetabolites|antimetabolites|mesh-ancestor
24480240|NCT00430118|Dermatologic Agents|dermatologic agents|mesh-ancestor
24480241|NCT00430118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24481056|NCT00433225|Gatifloxacin|gatifloxacin|mesh-list
24481057|NCT00433225|Prednisolone|prednisolone|mesh-list
24481058|NCT00433225|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24481133|NCT00433459|Procarbazine|procarbazine|mesh-list
24481805|NCT00436826|Interferon-beta|interferon-beta|mesh-list
24481806|NCT00436826|Cladribine|cladribine|mesh-list
24481848|NCT00436943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481849|NCT00436943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24481850|NCT00436943|Antidepressive Agents|antidepressive agents|mesh-ancestor
24483078|NCT00441662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25004948|NCT05201326|Irinotecan|irinotecan|mesh-list
24457361|NCT00334126|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24483215|NCT00442325|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24483216|NCT00442325|Antimetabolites|antimetabolites|mesh-ancestor
24483217|NCT00442325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618817|NCT01049815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618818|NCT01049815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25709961|NCT02279407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709962|NCT02279641|Allopurinol|allopurinol|mesh-list
25709963|NCT02279641|Verinurad|verinurad|mesh-list
25709964|NCT02279641|Antimetabolites|antimetabolites|mesh-ancestor
24618819|NCT01049815|Chelating Agents|chelating agents|mesh-ancestor
25709965|NCT02279641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709966|NCT02279641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25709967|NCT02279641|Gout Suppressants|gout suppressants|mesh-ancestor
25709968|NCT02279641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25709969|NCT02279641|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25709971|NCT02279641|Protective Agents|protective agents|mesh-ancestor
25709972|NCT02279641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25709973|NCT02279667|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
24484005|NCT00446173|Cyclophosphamide|cyclophosphamide|mesh-list
24484006|NCT00446173|Busulfan|busulfan|mesh-list
24484007|NCT00446173|Sargramostim|sargramostim|mesh-list
24457417|NCT00334360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24457418|NCT00334360|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24457419|NCT00334360|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24457420|NCT00334360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24457421|NCT00334360|Adrenergic Agents|adrenergic agents|mesh-ancestor
24484153|NCT00446836|Paclitaxel|paclitaxel|mesh-list
24485214|NCT00451997|Immunologic Factors|immunologic factors|mesh-ancestor
24485215|NCT00451997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485216|NCT00451997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24485217|NCT00451997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485219|NCT00452062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24485220|NCT00452062|Antiemetics|antiemetics|mesh-ancestor
24485221|NCT00452062|Autonomic Agents|autonomic agents|mesh-ancestor
24485263|NCT00452244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24485264|NCT00452244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24485265|NCT00452244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485266|NCT00452244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485267|NCT00452244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24485268|NCT00452270|Xylometazoline|xylometazoline|mesh-list
24485269|NCT00452270|Nasal Decongestants|nasal decongestants|mesh-ancestor
24485270|NCT00452270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25004946|NCT05201352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24846182|NCT02241759|Moxifloxacin|moxifloxacin|mesh-list
24485271|NCT00452270|Respiratory System Agents|respiratory system agents|mesh-ancestor
24485272|NCT00452296|Insulin|insulin|mesh-list
24485273|NCT00452296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24485274|NCT00452296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485507|NCT00453323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485508|NCT00453323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24485510|NCT00453375|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
24485819|NCT00455130|Natriuretic Agents|natriuretic agents|mesh-ancestor
24522944|NCT03012971|Analgesics|analgesics|mesh-ancestor
24486517|NCT00458315|Bevacizumab|bevacizumab|mesh-list
24486518|NCT00458315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24486520|NCT00458315|Tubulin Modulators|tubulin modulators|mesh-ancestor
24486548|NCT00458367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24486549|NCT00458367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523015|NCT02947516|Liver Extracts|liver extracts|mesh-list
24486878|NCT00460382|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24437855|NCT00274573|Bromides|bromides|mesh-list
24489960|NCT00476073|Formoterol Fumarate|formoterol fumarate|mesh-list
24489961|NCT00476073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24787920|NCT01928407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24787921|NCT01928407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25004947|NCT05201326|Bevacizumab|bevacizumab|mesh-list
25004977|NCT05200663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25004978|NCT05200663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25004995|NCT05198531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25004996|NCT05198531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25004997|NCT05198531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25004998|NCT05198531|Immunologic Factors|immunologic factors|mesh-ancestor
25004999|NCT05198531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005001|NCT05180214|Bupivacaine|bupivacaine|mesh-list
25005002|NCT05180214|Anesthetics, Local|anesthetics, local|mesh-ancestor
25005003|NCT05180214|Anesthetics|anesthetics|mesh-ancestor
25005004|NCT05180214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25005005|NCT05180214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005006|NCT05180214|Sensory System Agents|sensory system agents|mesh-ancestor
24787922|NCT01928407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25005015|NCT05180214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005016|NCT05170893|Ubiquinone|ubiquinone|mesh-list
25709974|NCT02279667|Anticonvulsants|anticonvulsants|mesh-ancestor
25709975|NCT02279667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25709976|NCT02279667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25709977|NCT02279667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24489963|NCT00476073|Autonomic Agents|autonomic agents|mesh-ancestor
24489964|NCT00476073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489965|NCT00476073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489966|NCT00476073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24489967|NCT00476073|Respiratory System Agents|respiratory system agents|mesh-ancestor
24489968|NCT00476073|Dermatologic Agents|dermatologic agents|mesh-ancestor
24489969|NCT00476073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24489970|NCT00476073|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24489971|NCT00476073|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24489972|NCT00476073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24523557|NCT05341856|Diuretics|diuretics|mesh-ancestor
24446915|NCT00306540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24446916|NCT00306540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24446917|NCT00306540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446918|NCT00306618|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
24446919|NCT00306618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446920|NCT00306618|Tubulin Modulators|tubulin modulators|mesh-ancestor
24446921|NCT00306618|Antimitotic Agents|antimitotic agents|mesh-ancestor
24446922|NCT00306618|Mitosis Modulators|mitosis modulators|mesh-ancestor
24490705|NCT00479739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24490706|NCT00479739|Glucocorticoids|glucocorticoids|mesh-ancestor
24457520|NCT00334646|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24457521|NCT00334646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24457522|NCT00334672|Cyclosporine|cyclosporine|mesh-list
24457523|NCT00334672|Mycophenolic Acid|mycophenolic acid|mesh-list
24457524|NCT00334672|Dexamethasone|dexamethasone|mesh-list
24457525|NCT00334672|Hydrocortisone|hydrocortisone|mesh-list
24457526|NCT00334672|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24457527|NCT00334672|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24490707|NCT00479739|Hormones|hormones|mesh-ancestor
24490708|NCT00479739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24500881|NCT00526175|Daunorubicin|daunorubicin|mesh-list
24490872|NCT00480363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24490873|NCT00480363|Glucocorticoids|glucocorticoids|mesh-ancestor
24491022|NCT00480844|Dopamine Agents|dopamine agents|mesh-ancestor
24491051|NCT00480896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491052|NCT00480935|Sunitinib|sunitinib|mesh-list
24491053|NCT00480935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491054|NCT00480935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24491055|NCT00480935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24491056|NCT00480935|Growth Substances|growth substances|mesh-ancestor
24491057|NCT00480935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491058|NCT00480935|Growth Inhibitors|growth inhibitors|mesh-ancestor
24491059|NCT00480935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24491060|NCT00480935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491061|NCT00480935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491063|NCT00481013|Anticonvulsants|anticonvulsants|mesh-ancestor
24491064|NCT00481013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491065|NCT00481013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491066|NCT00481013|GABA Agents|gaba agents|mesh-ancestor
24491067|NCT00481013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24491068|NCT00481013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491069|NCT00481013|Antimanic Agents|antimanic agents|mesh-ancestor
24491070|NCT00481013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24491071|NCT00481013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24491107|NCT00481182|Respiratory System Agents|respiratory system agents|mesh-ancestor
24491185|NCT00481533|Oxytocics|oxytocics|mesh-ancestor
24491186|NCT00481533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24491187|NCT00481533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491188|NCT00481572|Terlipressin|terlipressin|mesh-list
24491189|NCT00481572|Vasopressins|vasopressins|mesh-list
24491190|NCT00481572|Arginine Vasopressin|arginine vasopressin|mesh-list
24491191|NCT00481572|Norepinephrine|norepinephrine|mesh-list
24491237|NCT00481728|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24491238|NCT00481728|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24491432|NCT00482495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491433|NCT00482495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24491434|NCT00482495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24491435|NCT00482495|Growth Substances|growth substances|mesh-ancestor
24457535|NCT00334672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24457536|NCT00334672|Immunologic Factors|immunologic factors|mesh-ancestor
25709978|NCT02279667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709979|NCT02279732|Paclitaxel|paclitaxel|mesh-list
24457537|NCT00334672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491436|NCT00482495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491958|NCT00484731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24491959|NCT00484731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491960|NCT00484731|Sensory System Agents|sensory system agents|mesh-ancestor
24492284|NCT00485823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24457539|NCT00334672|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24457540|NCT00334672|Alkylating Agents|alkylating agents|mesh-ancestor
24492285|NCT00485823|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24493549|NCT00491413|Hematinics|hematinics|mesh-ancestor
24493550|NCT00491426|Metronidazole|metronidazole|mesh-list
24493551|NCT00491426|Tazobactam|tazobactam|mesh-list
24493552|NCT00491426|Piperacillin|piperacillin|mesh-list
24493553|NCT00491426|Amphotericin B|amphotericin b|mesh-list
24457556|NCT00334672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24457557|NCT00334672|Antimetabolites|antimetabolites|mesh-ancestor
24457558|NCT00334672|Dermatologic Agents|dermatologic agents|mesh-ancestor
24457559|NCT00334672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493555|NCT00491426|Acyclovir|acyclovir|mesh-list
24493560|NCT00491426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493561|NCT00491426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24493588|NCT00491517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493590|NCT00491582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24493591|NCT00491582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493592|NCT00491634|Treosulfan|treosulfan|mesh-list
24493593|NCT00491634|Busulfan|busulfan|mesh-list
24493594|NCT00491634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24493595|NCT00491634|Alkylating Agents|alkylating agents|mesh-ancestor
24493596|NCT00491634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493597|NCT00491634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493598|NCT00491634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24493599|NCT00491634|Immunologic Factors|immunologic factors|mesh-ancestor
24493600|NCT00491634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493942|NCT00493116|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24493943|NCT00493129|Denileukin diftitox|denileukin diftitox|mesh-list
24457560|NCT00334672|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24457561|NCT00334672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24457562|NCT00334672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24457563|NCT00334672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24457564|NCT00334672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24457565|NCT00334672|Antifungal Agents|antifungal agents|mesh-ancestor
24494111|NCT00493857|Antibodies|antibodies|mesh-list
24494112|NCT00493857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24494113|NCT00493857|Immunologic Factors|immunologic factors|mesh-ancestor
24494114|NCT00493857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494148|NCT00493987|Anabolic Agents|anabolic agents|mesh-ancestor
24494149|NCT00493987|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24494150|NCT00493987|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24524261|NCT05074823|Anesthetics|anesthetics|mesh-ancestor
24495159|NCT00498888|Urological Agents|urological agents|mesh-ancestor
24495161|NCT00498901|Leuprolide|leuprolide|mesh-list
25709980|NCT02279732|Carboplatin|carboplatin|mesh-list
25709981|NCT02279732|Ipilimumab|ipilimumab|mesh-list
25709982|NCT02279732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25709983|NCT02279732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25709984|NCT02279732|Tubulin Modulators|tubulin modulators|mesh-ancestor
25709985|NCT02279732|Antimitotic Agents|antimitotic agents|mesh-ancestor
25709986|NCT02279732|Mitosis Modulators|mitosis modulators|mesh-ancestor
25709987|NCT02279732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709988|NCT02279732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24495162|NCT00498901|Goserelin|goserelin|mesh-list
24495163|NCT00498901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496021|NCT00503152|Benazepril|benazepril|mesh-list
24457580|NCT00334685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24457581|NCT00334685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457582|NCT00334685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24457583|NCT00334685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24457584|NCT00334685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24406252|NCT00169546|Xhance|xhance|mesh-list
24496982|NCT00507637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24496983|NCT00507637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24496984|NCT00507663|Atenolol|atenolol|mesh-list
24496985|NCT00507663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24497084|NCT00507962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498547|NCT00515255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24498548|NCT00515268|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
24498657|NCT00515866|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
24498658|NCT00515866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24498659|NCT00515866|Antimetabolites|antimetabolites|mesh-ancestor
24498660|NCT00515866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498661|NCT00515866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24498662|NCT00515866|Antiviral Agents|antiviral agents|mesh-ancestor
24498663|NCT00515866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24498664|NCT00515866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498791|NCT00516399|Povidone-Iodine|povidone-iodine|mesh-list
24498793|NCT00516399|Povidone|povidone|mesh-list
24498794|NCT00516399|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24499244|NCT00518427|Insulin Glargine|insulin glargine|mesh-list
24499245|NCT00518427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24499246|NCT00518427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499247|NCT00518466|Topiramate|topiramate|mesh-list
24499248|NCT00518466|Phentermine|phentermine|mesh-list
24499330|NCT00519012|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24499331|NCT00519012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24499365|NCT00519116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24499366|NCT00519116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24499367|NCT00519116|Antifungal Agents|antifungal agents|mesh-ancestor
24499402|NCT00519259|Lobeline|lobeline|mesh-list
24499403|NCT00519259|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24499404|NCT00519259|Autonomic Agents|autonomic agents|mesh-ancestor
24499457|NCT00519467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24499458|NCT00519480|Metformin|metformin|mesh-list
24499459|NCT00519480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24499681|NCT00520507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499682|NCT00520507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24499733|NCT00520819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499735|NCT00520819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499736|NCT00520897|Raltegravir Potassium|raltegravir potassium|mesh-list
24499737|NCT00520897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24499738|NCT00520897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24499739|NCT00520897|Antiviral Agents|antiviral agents|mesh-ancestor
24499740|NCT00520897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24524944|NCT04188873|Cholinergic Agents|cholinergic agents|mesh-ancestor
24500686|NCT00525473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24500687|NCT00525473|Immunologic Factors|immunologic factors|mesh-ancestor
24500737|NCT00525616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500738|NCT00525616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24500741|NCT00525642|Doxorubicin|doxorubicin|mesh-list
24500742|NCT00525642|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24500743|NCT00525642|Epirubicin|epirubicin|mesh-list
24500744|NCT00525642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24500880|NCT00526175|Vincristine|vincristine|mesh-list
25709989|NCT02279732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24500884|NCT00526175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24500885|NCT00526175|Immunologic Factors|immunologic factors|mesh-ancestor
25709990|NCT02279862|Ipilimumab|ipilimumab|mesh-list
25709991|NCT02279862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25709992|NCT02279862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25709993|NCT02279862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25709994|NCT02279862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25709995|NCT02280044|Rifaximin|rifaximin|mesh-list
25709996|NCT02280044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25709998|NCT02280044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25709999|NCT02280096|4-Aminopyridine|4-aminopyridine|mesh-list
25710000|NCT02280096|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24500886|NCT00526175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500887|NCT00526175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24500888|NCT00526175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24501046|NCT00526409|Mitosis Modulators|mitosis modulators|mesh-ancestor
24501501|NCT00528918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24501600|NCT00529750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24788025|NCT01929096|Protective Agents|protective agents|mesh-ancestor
24788026|NCT01929096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788027|NCT01929161|Oxytocin|oxytocin|mesh-list
24788028|NCT01929161|Oxytocics|oxytocics|mesh-ancestor
24788029|NCT01929161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24788030|NCT01929161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788031|NCT01929187|Amorolfine|amorolfine|mesh-list
24788032|NCT01929187|Antifungal Agents|antifungal agents|mesh-ancestor
24788033|NCT01929187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24788034|NCT01929213|Bosentan|bosentan|mesh-list
24788035|NCT01929213|Udenafil|udenafil|mesh-list
25005045|NCT05049343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005046|NCT05049343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25005047|NCT05049343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25005048|NCT05049343|Anesthetics, General|anesthetics, general|mesh-ancestor
25005049|NCT05049343|Anesthetics|anesthetics|mesh-ancestor
25005050|NCT05049343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25005051|NCT05049343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25005058|NCT05041322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25005059|NCT05041322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005060|NCT05041322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25005061|NCT05041322|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25005062|NCT05041322|Serotonin Agents|serotonin agents|mesh-ancestor
25005063|NCT05041322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25005064|NCT05041322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005065|NCT05028673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25005066|NCT05028673|Antacids|antacids|mesh-list
25005067|NCT05028673|Magnesium Hydroxide|magnesium hydroxide|mesh-list
25005086|NCT04941755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502738|NCT04497168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24502739|NCT04497168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24502740|NCT04497168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502747|NCT04480502|Ipilimumab|ipilimumab|mesh-list
24457662|NCT00334867|Immunologic Factors|immunologic factors|mesh-ancestor
24457663|NCT00334867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457664|NCT00334867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24846773|NCT02243826|Nitrous Oxide|nitrous oxide|mesh-list
24457665|NCT00334867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24457666|NCT00334867|Alkylating Agents|alkylating agents|mesh-ancestor
24457667|NCT00334867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505812|NCT00542607|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24505813|NCT00542607|Histamine Antagonists|histamine antagonists|mesh-ancestor
24457679|NCT00334867|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24457680|NCT00334867|Protective Agents|protective agents|mesh-ancestor
24457681|NCT00334880|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
24457682|NCT00334880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24506333|NCT00544687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24506334|NCT00544687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24506335|NCT00544687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506583|NCT00546065|Esomeprazole|esomeprazole|mesh-list
24506584|NCT00546065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25710001|NCT02280096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25710002|NCT02280096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710003|NCT02280421|Cyclosporine|cyclosporine|mesh-list
25710004|NCT02280421|Cyclosporins|cyclosporins|mesh-list
25710005|NCT02280421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710006|NCT02280421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710007|NCT02280421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25710008|NCT02280421|Immunologic Factors|immunologic factors|mesh-ancestor
25710009|NCT02280421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710010|NCT02280421|Antifungal Agents|antifungal agents|mesh-ancestor
25710011|NCT02280421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24506585|NCT00546065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24506586|NCT00546065|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24506587|NCT00546065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525639|NCT03013504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506774|NCT00546936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506776|NCT00546936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506777|NCT00546936|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24506779|NCT00547001|Estradiol|estradiol|mesh-list
24506780|NCT00547001|Estrogens|estrogens|mesh-ancestor
24507656|NCT00551252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507657|NCT00551252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507695|NCT00551382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24507760|NCT00551889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005104|NCT04856176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005106|NCT04856176|Antimitotic Agents|antimitotic agents|mesh-ancestor
25005107|NCT04856176|Mitosis Modulators|mitosis modulators|mesh-ancestor
25005113|NCT04856176|Immunologic Factors|immunologic factors|mesh-ancestor
25005114|NCT04856176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508134|NCT00554242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508135|NCT00554346|Etoricoxib|etoricoxib|mesh-list
24508136|NCT00554346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24508137|NCT00554346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24508335|NCT00555100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508336|NCT00555100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24508337|NCT00555100|Glucocorticoids|glucocorticoids|mesh-ancestor
24508338|NCT00555100|Hormones|hormones|mesh-ancestor
24508339|NCT00555100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24508340|NCT00555100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24508341|NCT00555100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509056|NCT00558181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24509057|NCT00558181|Glucocorticoids|glucocorticoids|mesh-ancestor
24509066|NCT00558298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24509067|NCT00558298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509068|NCT00558298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509069|NCT00558298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24509070|NCT00558298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24509071|NCT00558298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24509072|NCT00558298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24509818|NCT00562198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510215|NCT00563875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24510216|NCT00563875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24510217|NCT00563875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510218|NCT00563875|Antipyretics|antipyretics|mesh-ancestor
24510219|NCT00563914|Amodiaquine|amodiaquine|mesh-list
24510221|NCT00563914|Antimalarials|antimalarials|mesh-ancestor
24510222|NCT00563914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25710012|NCT02280421|Dermatologic Agents|dermatologic agents|mesh-ancestor
25710013|NCT02280421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25710014|NCT02280421|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25710015|NCT02280473|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25710016|NCT02280473|Laxatives|laxatives|mesh-ancestor
25710017|NCT02280473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25710018|NCT02280811|Aldesleukin|aldesleukin|mesh-list
24510390|NCT00564525|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24788107|NCT01929512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24788108|NCT01929512|Antimetabolites|antimetabolites|mesh-ancestor
24788112|NCT01929512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510498|NCT00564668|Biphasic Insulins|biphasic insulins|mesh-list
24510499|NCT00564668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24510500|NCT00564668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510501|NCT00564707|Botulinum Toxins|botulinum toxins|mesh-list
24526277|NCT00290511|Antimetabolites|antimetabolites|mesh-ancestor
24510574|NCT00565006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510575|NCT00565006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24512458|NCT00575341|Immunologic Factors|immunologic factors|mesh-ancestor
24512459|NCT00575341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512460|NCT00575354|Sevoflurane|sevoflurane|mesh-list
24512461|NCT00575354|Isoflurane|isoflurane|mesh-list
24512496|NCT00575406|Tubulin Modulators|tubulin modulators|mesh-ancestor
24513473|NCT00581789|Growth Inhibitors|growth inhibitors|mesh-ancestor
24513475|NCT00582582|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
24513476|NCT00582582|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
24513477|NCT00582582|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
24526591|NCT00612274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24526592|NCT00612274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24513893|NCT00586092|Growth Inhibitors|growth inhibitors|mesh-ancestor
24514056|NCT00587496|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24514057|NCT00587496|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24514077|NCT00587665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24514078|NCT00587665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24457748|NCT00335114|Antifungal Agents|antifungal agents|mesh-ancestor
24514124|NCT00588003|Hormone Antagonists|hormone antagonists|mesh-ancestor
24514285|NCT00589316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24514286|NCT00589316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24514287|NCT00589316|Antitubercular Agents|antitubercular agents|mesh-ancestor
24514288|NCT00589316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24514289|NCT00589316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24514290|NCT00589316|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24514291|NCT00589316|Trace Elements|trace elements|mesh-ancestor
24516906|NCT00604435|Growth Inhibitors|growth inhibitors|mesh-ancestor
24516907|NCT00604578|Pioglitazone|pioglitazone|mesh-list
24516908|NCT00604578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24516909|NCT00604578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516910|NCT00604591|Tolcapone|tolcapone|mesh-list
24516911|NCT00604591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24516912|NCT00604591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24516913|NCT00604591|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24516914|NCT00604591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516916|NCT00604630|Epoetin Alfa|epoetin alfa|mesh-list
24517266|NCT00607035|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24517267|NCT00607035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24517269|NCT00607035|Natriuretic Agents|natriuretic agents|mesh-ancestor
24517270|NCT00607035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517271|NCT00607035|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24517272|NCT00607035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24517273|NCT00607035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517328|NCT00607503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457767|NCT00335179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24457768|NCT00335179|Interferon Inducers|interferon inducers|mesh-ancestor
24518665|NCT04562090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24518666|NCT04562090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24518667|NCT04562090|Adrenergic Agents|adrenergic agents|mesh-ancestor
24518668|NCT04562090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24518669|NCT04562090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518704|NCT04524130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24518705|NCT04524130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24518706|NCT04484532|Vaccines|vaccines|mesh-list
24518707|NCT04484532|Immunologic Factors|immunologic factors|mesh-ancestor
24518708|NCT04484532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518709|NCT04479436|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
25710019|NCT02280811|Cyclophosphamide|cyclophosphamide|mesh-list
25710020|NCT02280811|Fludarabine|fludarabine|mesh-list
25710021|NCT02280811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25710022|NCT02280811|Immunologic Factors|immunologic factors|mesh-ancestor
25710023|NCT02280811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710024|NCT02280811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24518710|NCT04479436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24518711|NCT04479436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519498|NCT05333250|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24527550|NCT00617370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24527551|NCT00617370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527552|NCT00617370|Tubulin Modulators|tubulin modulators|mesh-ancestor
24527567|NCT00617448|Anesthetics|anesthetics|mesh-list
24520670|NCT05334316|Dexamethasone|dexamethasone|mesh-list
24580594|NCT00862420|Purinergic Agents|purinergic agents|mesh-ancestor
24580595|NCT00862420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24580596|NCT00862420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580597|NCT00862420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580598|NCT00862420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24580599|NCT00862420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24523599|NCT05341583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24457804|NCT00335270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24397676|NCT00142324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24524290|NCT05049525|Itraconazole|itraconazole|mesh-list
24524291|NCT05049525|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
24524292|NCT05049525|Terbinafine|terbinafine|mesh-list
24524293|NCT05049525|Antifungal Agents|antifungal agents|mesh-ancestor
24524294|NCT05049525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24524295|NCT05049525|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24524420|NCT04951362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24524421|NCT04951362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24524648|NCT04639986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524649|NCT04639986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24524650|NCT04639986|Tubulin Modulators|tubulin modulators|mesh-ancestor
24524651|NCT04639986|Antimitotic Agents|antimitotic agents|mesh-ancestor
24524652|NCT04639986|Mitosis Modulators|mitosis modulators|mesh-ancestor
24524678|NCT04532463|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24524679|NCT04532463|Hormone Antagonists|hormone antagonists|mesh-ancestor
24524681|NCT04532463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24621511|NCT01062906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621512|NCT01062906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24621514|NCT01062906|Analgesics|analgesics|mesh-ancestor
24621515|NCT01062906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24621516|NCT01062906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24621517|NCT01062906|Anesthetics, General|anesthetics, general|mesh-ancestor
24621518|NCT01062932|Cycloserine|cycloserine|mesh-list
24525473|NCT03326791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525474|NCT03326791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24525475|NCT03326791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24525476|NCT03326791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525477|NCT03326791|Antipyretics|antipyretics|mesh-ancestor
24525478|NCT03289741|Octreotide|octreotide|mesh-list
24525479|NCT03289741|Lanreotide|lanreotide|mesh-list
24525480|NCT03289741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24525504|NCT03255915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24525505|NCT03255915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525632|NCT03013504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24525633|NCT03013504|Immunologic Factors|immunologic factors|mesh-ancestor
24525634|NCT03013504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525635|NCT03013504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24525636|NCT03013504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24525637|NCT03013504|Alkylating Agents|alkylating agents|mesh-ancestor
24752061|NCT01708005|Cholecalciferol|cholecalciferol|mesh-list
25005294|NCT04295577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005295|NCT04295577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005296|NCT04251689|Mannitol|mannitol|mesh-list
25005297|NCT04251689|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25005298|NCT04251689|Diuretics|diuretics|mesh-ancestor
25005299|NCT04251689|Natriuretic Agents|natriuretic agents|mesh-ancestor
25005300|NCT04251689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005301|NCT04232423|Olanzapine|olanzapine|mesh-list
25005313|NCT04232423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25005314|NCT04232423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710025|NCT02280811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25710026|NCT02280811|Alkylating Agents|alkylating agents|mesh-ancestor
25710027|NCT02280811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710028|NCT02280811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710029|NCT02280811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25710030|NCT02280811|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24526031|NCT01999569|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24526127|NCT01188096|Immunologic Factors|immunologic factors|mesh-ancestor
24526128|NCT01188096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526129|NCT01114217|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24526130|NCT01114217|Hematinics|hematinics|mesh-ancestor
24526336|NCT00611195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526337|NCT00611195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24526338|NCT00611195|Anesthetics, General|anesthetics, general|mesh-ancestor
24526339|NCT00611195|Anesthetics|anesthetics|mesh-ancestor
24526340|NCT00611195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24526341|NCT00611195|Narcotics|narcotics|mesh-ancestor
24526342|NCT00611195|Analgesics|analgesics|mesh-ancestor
24526343|NCT00611195|Sensory System Agents|sensory system agents|mesh-ancestor
24526473|NCT00611793|Vatalanib|vatalanib|mesh-list
24526474|NCT00611793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24526507|NCT00611871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24526508|NCT00611871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526509|NCT00611871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526510|NCT00611871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24526511|NCT00611871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24526512|NCT00611871|Vasodilator Agents|vasodilator agents|mesh-ancestor
24526513|NCT00611910|Sirolimus|sirolimus|mesh-list
24526514|NCT00611910|Paclitaxel|paclitaxel|mesh-list
24526545|NCT00612079|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24526546|NCT00612079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24526547|NCT00612079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24526585|NCT00612274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526586|NCT00612274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24526704|NCT00612755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24526706|NCT00612794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24526707|NCT00612794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788316|NCT01930773|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24788317|NCT01930773|Purinergic Agents|purinergic agents|mesh-ancestor
24788318|NCT01930773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24788319|NCT01930773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788320|NCT01930773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526838|NCT00613457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24526839|NCT00613457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24526850|NCT00613457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24526851|NCT00613457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24526853|NCT00613457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24526854|NCT00613457|Tubulin Modulators|tubulin modulators|mesh-ancestor
24526855|NCT00613457|Antimitotic Agents|antimitotic agents|mesh-ancestor
24526856|NCT00613457|Mitosis Modulators|mitosis modulators|mesh-ancestor
24526857|NCT00613470|Citalopram|citalopram|mesh-list
24526858|NCT00613470|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24526868|NCT00613496|Irbesartan|irbesartan|mesh-list
24527491|NCT00616863|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24527492|NCT00616863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24527493|NCT00616863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527496|NCT00616876|Lactulose|lactulose|mesh-list
24527519|NCT00616993|Difluprednate|difluprednate|mesh-list
24527520|NCT00616993|Glucocorticoids|glucocorticoids|mesh-ancestor
24527521|NCT00616993|Hormones|hormones|mesh-ancestor
24527522|NCT00616993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24457852|NCT00335413|Diuretics|diuretics|mesh-ancestor
24527966|NCT00618969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527967|NCT00618969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24527968|NCT00618969|Immunologic Factors|immunologic factors|mesh-ancestor
24527969|NCT00618969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527970|NCT00618969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24527971|NCT00618969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527972|NCT00618969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24527974|NCT00619021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24527975|NCT00619021|Antimetabolites|antimetabolites|mesh-ancestor
24528012|NCT00619216|Mycophenolic Acid|mycophenolic acid|mesh-list
24528239|NCT00620477|Anesthetics, Local|anesthetics, local|mesh-ancestor
25710031|NCT02280811|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25710032|NCT02280811|Antiviral Agents|antiviral agents|mesh-ancestor
25710033|NCT02280811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25710034|NCT02281136|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25710035|NCT02281136|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25710036|NCT02281136|Dermatologic Agents|dermatologic agents|mesh-ancestor
25710037|NCT02281409|Mogamulizumab|mogamulizumab|mesh-list
24528241|NCT00620477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24528243|NCT00620477|Sensory System Agents|sensory system agents|mesh-ancestor
24528653|NCT00622141|Saquinavir|saquinavir|mesh-list
24528654|NCT00622141|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24528655|NCT00622141|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24528656|NCT00622141|Protease Inhibitors|protease inhibitors|mesh-ancestor
24528657|NCT00622141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528658|NCT00622141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528659|NCT00622141|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24528660|NCT00622141|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24528775|NCT00622752|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24528776|NCT00622752|Cholinergic Agents|cholinergic agents|mesh-ancestor
24528777|NCT00622752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24528778|NCT00622752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528779|NCT00622817|Epinephrine|epinephrine|mesh-list
24528780|NCT00622817|Xylometazoline|xylometazoline|mesh-list
24394225|NCT00132587|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24528788|NCT00622817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24528935|NCT00623415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24529121|NCT00624676|Antifungal Agents|antifungal agents|mesh-ancestor
24529122|NCT00624676|Keratolytic Agents|keratolytic agents|mesh-ancestor
24529123|NCT00624676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24529124|NCT00624676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24529422|NCT00625898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529424|NCT00625911|Morphine|morphine|mesh-list
24529425|NCT00625911|Analgesics|analgesics|mesh-ancestor
24529426|NCT00625911|Sensory System Agents|sensory system agents|mesh-ancestor
24457871|NCT00335543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24457872|NCT00335543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24457873|NCT00335543|Antimetabolites|antimetabolites|mesh-ancestor
24529660|NCT00627354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24529662|NCT00627432|Oxaliplatin|oxaliplatin|mesh-list
24529663|NCT00627432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24529702|NCT00627575|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24529703|NCT00627575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24529704|NCT00627653|Fenofibrate|fenofibrate|mesh-list
24529705|NCT00627653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24529706|NCT00627653|Antimetabolites|antimetabolites|mesh-ancestor
24529707|NCT00627653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005440|NCT04107727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25005441|NCT04107077|Mitomycins|mitomycins|mesh-list
25005442|NCT04107077|Mitomycin|mitomycin|mesh-list
25005443|NCT04107077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005444|NCT04107077|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25005445|NCT04107077|Alkylating Agents|alkylating agents|mesh-ancestor
25005448|NCT04107077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788397|NCT01931215|Ropivacaine|ropivacaine|mesh-list
24788416|NCT01931293|Folic Acid|folic acid|mesh-list
25109675|NCT03122353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109676|NCT03122353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25109677|NCT03122353|Vitamins|vitamins|mesh-ancestor
24530025|NCT00628732|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24530026|NCT00628732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25710038|NCT02281409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710039|NCT02281422|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25710040|NCT02281422|Anticonvulsants|anticonvulsants|mesh-ancestor
25710041|NCT02281422|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25710042|NCT02281422|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25710043|NCT02281422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24530029|NCT00628810|Bevacizumab|bevacizumab|mesh-list
24530030|NCT00628810|Fluorouracil|fluorouracil|mesh-list
24530031|NCT00628810|Irinotecan|irinotecan|mesh-list
24530032|NCT00628810|Calcium|calcium|mesh-list
24530033|NCT00628810|Levoleucovorin|levoleucovorin|mesh-list
24530034|NCT00628810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24530035|NCT00628810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530036|NCT00628810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24530059|NCT00628914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24530063|NCT00628914|Serotonin Agents|serotonin agents|mesh-ancestor
24530292|NCT00629720|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24457884|NCT00335582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24530364|NCT00630019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24530365|NCT00630019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24530366|NCT00630019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530459|NCT00630435|Hormones|hormones|mesh-ancestor
24445485|NCT00301639|Dopamine Agents|dopamine agents|mesh-ancestor
24530621|NCT00631514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24530622|NCT00631514|Analgesics|analgesics|mesh-ancestor
24530623|NCT00631514|Sensory System Agents|sensory system agents|mesh-ancestor
24530657|NCT00631592|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24531865|NCT00637468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531913|NCT00637585|Fexofenadine|fexofenadine|mesh-list
24531914|NCT00637585|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24531922|NCT00637611|Fexofenadine|fexofenadine|mesh-list
24457930|NCT00335686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005540|NCT03793010|FX006|fx006|mesh-list
24457968|NCT00335933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24457969|NCT00335933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24457970|NCT00335933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24457971|NCT00335933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24457972|NCT00335933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24458013|NCT00336245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458015|NCT00336245|Micronutrients|micronutrients|mesh-ancestor
24458016|NCT00336310|Repaglinide|repaglinide|mesh-list
24458017|NCT00336310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24753593|NCT01716377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458153|NCT00336791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24458154|NCT00336791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25710044|NCT02281422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710045|NCT02281448|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25710046|NCT02281448|Contraceptive Agents|contraceptive agents|mesh-list
25710047|NCT02281448|Contraceptives, Oral|contraceptives, oral|mesh-list
25710048|NCT02281448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25710049|NCT02281448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25710050|NCT02281448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710051|NCT02281448|Anticonvulsants|anticonvulsants|mesh-ancestor
25005564|NCT03596905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25005565|NCT03529942|FX006|fx006|mesh-list
25005566|NCT03529942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25005567|NCT03529942|Glucocorticoids|glucocorticoids|mesh-ancestor
25005568|NCT03529942|Hormones|hormones|mesh-ancestor
25005569|NCT03529942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24613288|NCT01017939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24613289|NCT01017939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24613290|NCT01017939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24613291|NCT01017939|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24613293|NCT01017939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24613294|NCT01017939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24613295|NCT01017939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24613296|NCT01017939|Vasodilator Agents|vasodilator agents|mesh-ancestor
24613297|NCT01017939|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24701869|NCT01462058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701870|NCT01462058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24701875|NCT01462214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701876|NCT01462214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24701877|NCT01462214|Immunologic Factors|immunologic factors|mesh-ancestor
24701878|NCT01462214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701879|NCT01462422|Misoprostol|misoprostol|mesh-list
24701880|NCT01462422|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24701881|NCT01462422|Abortifacient Agents|abortifacient agents|mesh-ancestor
24702141|NCT01464138|Clindamycin|clindamycin|mesh-list
24702142|NCT01464138|Clindamycin palmitate|clindamycin palmitate|mesh-list
24702143|NCT01464138|Clindamycin phosphate|clindamycin phosphate|mesh-list
24702144|NCT01464138|Fosmidomycin|fosmidomycin|mesh-list
24702145|NCT01464138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24702146|NCT01464138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24702147|NCT01464138|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24702169|NCT01464450|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24702172|NCT01464450|Protease Inhibitors|protease inhibitors|mesh-ancestor
24702173|NCT01464450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702174|NCT01464450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702175|NCT01464450|Anticoagulants|anticoagulants|mesh-ancestor
24702176|NCT01464476|Azimilide|azimilide|mesh-list
24702285|NCT01464983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24702286|NCT01464983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24702287|NCT01464983|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24702288|NCT01464983|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24702289|NCT01464983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702295|NCT01465009|Acetaminophen|acetaminophen|mesh-list
24702296|NCT01465009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24702297|NCT01465009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24702298|NCT01465009|Analgesics|analgesics|mesh-ancestor
24702299|NCT01465009|Sensory System Agents|sensory system agents|mesh-ancestor
24702300|NCT01465009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24702329|NCT01465113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25005627|NCT03019640|Etoposide|etoposide|mesh-list
25005628|NCT03019640|Lenalidomide|lenalidomide|mesh-list
25005629|NCT03019640|Etoposide phosphate|etoposide phosphate|mesh-list
25005630|NCT03019640|Melphalan|melphalan|mesh-list
25005631|NCT03019640|Mechlorethamine|mechlorethamine|mesh-list
25005632|NCT03019640|Carmustine|carmustine|mesh-list
25005633|NCT03019640|Podophyllotoxin|podophyllotoxin|mesh-list
25005634|NCT03019640|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25005635|NCT03019640|Antibodies|antibodies|mesh-list
25005636|NCT03019640|Immunoglobulins|immunoglobulins|mesh-list
25005637|NCT03019640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25005638|NCT03019640|Lenograstim|lenograstim|mesh-list
24754212|NCT01719640|Insulin|insulin|mesh-list
24702628|NCT01466959|Sequestering Agents|sequestering agents|mesh-ancestor
24702629|NCT01466959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702630|NCT01466959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25710052|NCT02281448|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25710053|NCT02281448|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25710054|NCT02281448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24702631|NCT01466959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24702632|NCT01466959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24702633|NCT01466959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24702634|NCT01466959|Immunologic Factors|immunologic factors|mesh-ancestor
24702635|NCT01466959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702636|NCT01466959|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24702637|NCT01466959|Protective Agents|protective agents|mesh-ancestor
24702638|NCT01466959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24702649|NCT01467115|Docetaxel|docetaxel|mesh-list
24702651|NCT01467115|Cetuximab|cetuximab|mesh-list
24702705|NCT01467297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702707|NCT01467297|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24702708|NCT01467297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24702709|NCT01467310|Trametinib|trametinib|mesh-list
24702710|NCT01467310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24702711|NCT01467310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24702712|NCT01467310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702713|NCT01467310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702714|NCT01467323|Insulin|insulin|mesh-list
24702715|NCT01467323|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24702716|NCT01467323|Insulin Aspart|insulin aspart|mesh-list
24702717|NCT01467323|Biphasic Insulins|biphasic insulins|mesh-list
24703044|NCT01469468|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24703045|NCT01469468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24703046|NCT01469468|Antimetabolites|antimetabolites|mesh-ancestor
24788643|NCT01932541|Adrenergic Agents|adrenergic agents|mesh-ancestor
24703047|NCT01469468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703048|NCT01469468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24703049|NCT01469468|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24754390|NCT01720303|Insulin|insulin|mesh-list
24754391|NCT01720303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24703553|NCT01472263|Antioxidants|antioxidants|mesh-ancestor
24703554|NCT01472315|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24703555|NCT01472315|Medroxyprogesterone|medroxyprogesterone|mesh-list
24703556|NCT01472315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24703557|NCT01472315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24703558|NCT01472315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24703559|NCT01472315|Contraceptive Agents|contraceptive agents|mesh-ancestor
24703560|NCT01472315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24703589|NCT01472666|Chelating Agents|chelating agents|mesh-ancestor
24703590|NCT01472666|Sequestering Agents|sequestering agents|mesh-ancestor
24703592|NCT01472731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24703847|NCT01475019|Sibutramine|sibutramine|mesh-list
24703848|NCT01475019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703849|NCT01475019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703850|NCT01475019|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24703851|NCT01475019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24704512|NCT01478568|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24704513|NCT01478568|Antidepressive Agents|antidepressive agents|mesh-ancestor
24704514|NCT01478568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24704515|NCT01478568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704516|NCT01478568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24704517|NCT01478568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24704518|NCT01478568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25005678|NCT02968563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25005679|NCT02968563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005680|NCT02931890|Paclitaxel|paclitaxel|mesh-list
25005681|NCT02931890|Docetaxel|docetaxel|mesh-list
24704806|NCT01480531|Clevidipine|clevidipine|mesh-list
24704807|NCT01480531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24704808|NCT01480531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24704809|NCT01480531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704812|NCT01480609|Ezogabine|ezogabine|mesh-list
24705083|NCT01481883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24705116|NCT01482156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705117|NCT01482156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25710055|NCT02281448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710056|NCT02281448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25710057|NCT02281526|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25710058|NCT02281526|Anticonvulsants|anticonvulsants|mesh-ancestor
25710059|NCT02281526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25710060|NCT02281526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25710061|NCT02281526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24705118|NCT01482156|Immunologic Factors|immunologic factors|mesh-ancestor
24705119|NCT01482156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705120|NCT01482299|Everolimus|everolimus|mesh-list
24705121|NCT01482299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705122|NCT01482299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24705123|NCT01482299|Immunologic Factors|immunologic factors|mesh-ancestor
24705124|NCT01482299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705125|NCT01482338|Drospirenone|drospirenone|mesh-list
24705126|NCT01482338|Desogestrel|desogestrel|mesh-list
24705127|NCT01482338|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24705158|NCT01482442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24876043|NCT03766126|Alkylating Agents|alkylating agents|mesh-ancestor
24876044|NCT03766126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24876045|NCT03766126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24876046|NCT03766126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24876047|NCT03761095|Dacarbazine|dacarbazine|mesh-list
24876057|NCT03745352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581049|NCT00864318|Antimitotic Agents|antimitotic agents|mesh-ancestor
24705496|NCT01485445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24705497|NCT01485445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24705498|NCT01485445|Autonomic Agents|autonomic agents|mesh-ancestor
24705499|NCT01485445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24705500|NCT01485445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705501|NCT01485445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24705502|NCT01485445|Respiratory System Agents|respiratory system agents|mesh-ancestor
24705503|NCT01485445|Dermatologic Agents|dermatologic agents|mesh-ancestor
24705504|NCT01485445|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24705505|NCT01485562|Misoprostol|misoprostol|mesh-list
24705506|NCT01485562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24705507|NCT01485562|Abortifacient Agents|abortifacient agents|mesh-ancestor
24705508|NCT01485562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24705509|NCT01485562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005707|NCT02817659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25005708|NCT02817659|Hormones|hormones|mesh-ancestor
24705991|NCT01488227|Ergocalciferols|ergocalciferols|mesh-list
24705992|NCT01488227|Cholecalciferol|cholecalciferol|mesh-list
24705993|NCT01488227|Vitamins|vitamins|mesh-list
24705994|NCT01488227|Micronutrients|micronutrients|mesh-ancestor
24705995|NCT01488227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705996|NCT01488227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24705997|NCT01488227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24705998|NCT01488253|Sirolimus|sirolimus|mesh-list
24705999|NCT01488253|Tacrolimus|tacrolimus|mesh-list
24706000|NCT01488253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24706110|NCT01488565|Azacitidine|azacitidine|mesh-list
24707142|NCT01494311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707276|NCT01495039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24707277|NCT01495039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707696|NCT01497431|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
24707730|NCT01497483|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24707774|NCT01497587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613887|NCT01021501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710062|NCT02281526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710063|NCT02281552|Tofacitinib|tofacitinib|mesh-list
25710064|NCT02281552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25710065|NCT02281552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710066|NCT02281552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710067|NCT02281591|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
24644798|NCT01193192|Vitamins|vitamins|mesh-list
24707864|NCT01498406|Ergocalciferols|ergocalciferols|mesh-list
24444897|NCT00299611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24444898|NCT00299611|Serotonin Agents|serotonin agents|mesh-ancestor
24444899|NCT00299611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444903|NCT00299650|Atracurium|atracurium|mesh-list
24707865|NCT01498406|Cholecalciferol|cholecalciferol|mesh-list
24707866|NCT01498406|Vitamins|vitamins|mesh-list
24707867|NCT01498406|Micronutrients|micronutrients|mesh-ancestor
24707868|NCT01498406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707869|NCT01498406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24707870|NCT01498406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24707871|NCT01498523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24707954|NCT01498926|Insulin Detemir|insulin detemir|mesh-list
24707955|NCT01498926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24707956|NCT01498926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708122|NCT01500018|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24708123|NCT01500018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24708124|NCT01500018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708188|NCT01500577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24708189|NCT01500577|Antimetabolites|antimetabolites|mesh-ancestor
24708248|NCT01500837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24708249|NCT01500837|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24708250|NCT01500837|Antitubercular Agents|antitubercular agents|mesh-ancestor
24708251|NCT01500837|Leprostatic Agents|leprostatic agents|mesh-ancestor
24708252|NCT01500837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24708253|NCT01500837|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24708254|NCT01500837|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24708255|NCT01500837|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24708256|NCT01500837|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24708257|NCT01500837|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24708258|NCT01500837|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24708259|NCT01500837|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24708459|NCT01501396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24708460|NCT01501396|Histamine Antagonists|histamine antagonists|mesh-ancestor
24708461|NCT01501396|Histamine Agents|histamine agents|mesh-ancestor
24708462|NCT01501396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24847412|NCT02246842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708463|NCT01501396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708464|NCT01501396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708465|NCT01501396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24708466|NCT01501396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24708467|NCT01501396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24708500|NCT01501448|Levonorgestrel|levonorgestrel|mesh-list
24708501|NCT01501448|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24708502|NCT01501448|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
24708978|NCT01503658|Sensory System Agents|sensory system agents|mesh-ancestor
24708979|NCT01503658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24708980|NCT01503658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709234|NCT01504646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709236|NCT01504659|Analgesics|analgesics|mesh-ancestor
24709237|NCT01504659|Sensory System Agents|sensory system agents|mesh-ancestor
24709238|NCT01504659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24709239|NCT01504659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709240|NCT01504659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24709241|NCT01504659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24709304|NCT01505088|Prednisolone acetate|prednisolone acetate|mesh-list
24709516|NCT01506037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709517|NCT01506037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709518|NCT01506037|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24709520|NCT01506037|Histamine Antagonists|histamine antagonists|mesh-ancestor
24709521|NCT01506037|Histamine Agents|histamine agents|mesh-ancestor
24709522|NCT01506050|Desloratadine|desloratadine|mesh-list
24709523|NCT01506050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24709524|NCT01506050|Cholinergic Agents|cholinergic agents|mesh-ancestor
24755405|NCT01726465|Antiemetics|antiemetics|mesh-ancestor
24788689|NCT01932580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788690|NCT01932918|Ketorolac|ketorolac|mesh-list
25710068|NCT02281591|Anticonvulsants|anticonvulsants|mesh-ancestor
25710069|NCT02281591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25710070|NCT02281591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25710071|NCT02281591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24445695|NCT00302289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24445719|NCT00302354|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24788692|NCT01932918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25005730|NCT02796261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25005731|NCT02796261|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25005732|NCT02796261|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24755490|NCT01726777|Vitamins|vitamins|mesh-list
24545807|NCT00695045|Morphine|morphine|mesh-list
24709700|NCT01506752|Cholinergic Agents|cholinergic agents|mesh-ancestor
24709701|NCT01506752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24709702|NCT01506752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709703|NCT01506752|Nootropic Agents|nootropic agents|mesh-ancestor
24709704|NCT01506765|Acetylcysteine|acetylcysteine|mesh-list
24709705|NCT01506765|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24709706|NCT01506765|Antiviral Agents|antiviral agents|mesh-ancestor
24709707|NCT01506765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24709708|NCT01506765|Expectorants|expectorants|mesh-ancestor
24709709|NCT01506765|Respiratory System Agents|respiratory system agents|mesh-ancestor
24709710|NCT01506765|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24709711|NCT01506765|Antioxidants|antioxidants|mesh-ancestor
24710000|NCT01507974|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24710001|NCT01507974|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24710003|NCT01507974|Sulfamethoxazole|sulfamethoxazole|mesh-list
24710004|NCT01507974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24710005|NCT01507974|Antitubercular Agents|antitubercular agents|mesh-ancestor
24710006|NCT01507974|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24710058|NCT01508195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710059|NCT01508195|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24710060|NCT01508195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710062|NCT01508221|Pentoxifylline|pentoxifylline|mesh-list
24710063|NCT01508221|Vitamins|vitamins|mesh-ancestor
24710064|NCT01508221|Micronutrients|micronutrients|mesh-ancestor
24710065|NCT01508221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710066|NCT01508221|Antioxidants|antioxidants|mesh-ancestor
24710205|NCT01508884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24710206|NCT01508884|Interferon Inducers|interferon inducers|mesh-ancestor
24710207|NCT01508897|Liraglutide|liraglutide|mesh-list
24710208|NCT01508897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24710209|NCT01508897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710211|NCT01508897|Hormones|hormones|mesh-ancestor
24710212|NCT01508897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24710213|NCT01508923|Liraglutide|liraglutide|mesh-list
24710214|NCT01508923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25005773|NCT02586675|Tamoxifen|tamoxifen|mesh-list
24710254|NCT01509209|Nasal Decongestants|nasal decongestants|mesh-ancestor
24710255|NCT01509209|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24710256|NCT01509209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24710257|NCT01509209|Sympathomimetics|sympathomimetics|mesh-ancestor
24710258|NCT01509209|Adrenergic Agents|adrenergic agents|mesh-ancestor
24710259|NCT01509261|Lansoprazole|lansoprazole|mesh-list
24710260|NCT01509261|Dexlansoprazole|dexlansoprazole|mesh-list
24710261|NCT01509261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24710592|NCT01511198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24710593|NCT01511211|Dexamethasone|dexamethasone|mesh-list
24710594|NCT01511211|Ropivacaine|ropivacaine|mesh-list
24710595|NCT01511211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24710596|NCT01511211|Antiemetics|antiemetics|mesh-ancestor
24710597|NCT01511211|Autonomic Agents|autonomic agents|mesh-ancestor
24710598|NCT01511211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24710599|NCT01511211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710705|NCT01511562|Alkylating Agents|alkylating agents|mesh-ancestor
24710706|NCT01511562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24710707|NCT01511627|Anesthetics|anesthetics|mesh-list
24710708|NCT01511627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25710072|NCT02281591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710073|NCT02281760|Trametinib|trametinib|mesh-list
24710709|NCT01511627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710710|NCT01511692|Liraglutide|liraglutide|mesh-list
24710711|NCT01511692|Glimepiride|glimepiride|mesh-list
24710797|NCT01511822|Estrogens|estrogens|mesh-ancestor
24710798|NCT01511822|Hormones|hormones|mesh-ancestor
25710074|NCT02281760|Dabrafenib|dabrafenib|mesh-list
25710075|NCT02281760|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
24710799|NCT01511822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24710800|NCT01511822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710801|NCT01511822|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24710810|NCT01511822|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24710811|NCT01511822|Hormone Antagonists|hormone antagonists|mesh-ancestor
24710812|NCT01511822|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24711052|NCT01513070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24711053|NCT01513070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24711054|NCT01513070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24711055|NCT01513070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24711056|NCT01513070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711057|NCT01513070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24711058|NCT01513070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24711059|NCT01513070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711060|NCT01513070|Antipyretics|antipyretics|mesh-ancestor
24711061|NCT01513070|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24711062|NCT01513070|Diuretics|diuretics|mesh-ancestor
24711063|NCT01513070|Natriuretic Agents|natriuretic agents|mesh-ancestor
24711064|NCT01513070|Vasodilator Agents|vasodilator agents|mesh-ancestor
24711112|NCT01513603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711113|NCT01513603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24711114|NCT01513603|Antiviral Agents|antiviral agents|mesh-ancestor
24711115|NCT01513603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24711116|NCT01513603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24711117|NCT01513603|Immunologic Factors|immunologic factors|mesh-ancestor
24645256|NCT01197014|Losartan|losartan|mesh-list
24711153|NCT01513720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25005850|NCT01822652|Cyclophosphamide|cyclophosphamide|mesh-list
25005851|NCT01822652|Pembrolizumab|pembrolizumab|mesh-list
25005868|NCT01821690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25005869|NCT01821690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24711188|NCT01513941|Interferon alpha-2|interferon alpha-2|mesh-list
24711189|NCT01513941|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24711190|NCT01513941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24711191|NCT01513941|Antiviral Agents|antiviral agents|mesh-ancestor
24711192|NCT01513941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24711193|NCT01513941|Antimetabolites|antimetabolites|mesh-ancestor
24711225|NCT01514123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24711226|NCT01514123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24711227|NCT01514123|Growth Substances|growth substances|mesh-ancestor
24711348|NCT01514838|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24711349|NCT01514838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711351|NCT01514838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24711427|NCT01515137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24711428|NCT01515137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24711429|NCT01515228|Paclitaxel|paclitaxel|mesh-list
24711430|NCT01515228|Everolimus|everolimus|mesh-list
24711431|NCT01515228|Cilostazol|cilostazol|mesh-list
24711432|NCT01515228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24711433|NCT01515228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24711434|NCT01515228|Tubulin Modulators|tubulin modulators|mesh-ancestor
24711435|NCT01515228|Antimitotic Agents|antimitotic agents|mesh-ancestor
24711436|NCT01515228|Mitosis Modulators|mitosis modulators|mesh-ancestor
24711437|NCT01515228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711910|NCT01517568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711911|NCT01517568|Incretins|incretins|mesh-ancestor
24711983|NCT01517932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24788832|NCT01934088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24788833|NCT01934088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24788834|NCT01934088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24788835|NCT01934088|Anesthetics, General|anesthetics, general|mesh-ancestor
24788836|NCT01934088|Anesthetics|anesthetics|mesh-ancestor
24788837|NCT01934088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24788838|NCT01934088|Narcotics|narcotics|mesh-ancestor
25710076|NCT02281760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710077|NCT02281760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25710078|NCT02281760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710079|NCT02281760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710080|NCT02281760|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25710081|NCT02281760|Protective Agents|protective agents|mesh-ancestor
25710082|NCT02281760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710083|NCT02281760|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25710084|NCT02281760|Antioxidants|antioxidants|mesh-ancestor
25710086|NCT02281773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25710087|NCT02281773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710088|NCT02281773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770610|NCT03554772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25770611|NCT03554772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24445918|NCT00303056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24445919|NCT00303056|Analgesics|analgesics|mesh-ancestor
24445920|NCT00303056|Sensory System Agents|sensory system agents|mesh-ancestor
24445921|NCT00303056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24445922|NCT00303056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445923|NCT00303056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24756532|NCT01734044|BB 1101|bb 1101|mesh-list
24614524|NCT01024543|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24614525|NCT01024543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24614526|NCT01024543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24614527|NCT01024543|Adrenergic Agents|adrenergic agents|mesh-ancestor
24614528|NCT01024543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24614529|NCT01024543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614530|NCT01024543|Protective Agents|protective agents|mesh-ancestor
24614531|NCT01024543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24614532|NCT01024543|Protease Inhibitors|protease inhibitors|mesh-ancestor
24614533|NCT01024543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24614534|NCT01024647|Certolizumab Pegol|certolizumab pegol|mesh-list
24614535|NCT01024647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24712857|NCT01523015|Antimetabolites|antimetabolites|mesh-ancestor
24712858|NCT01523015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24712859|NCT01523015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24614634|NCT01025544|Immunologic Factors|immunologic factors|mesh-ancestor
24614635|NCT01025544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614636|NCT01025570|Gemcitabine|gemcitabine|mesh-list
24614637|NCT01025570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24614638|NCT01025570|Antimetabolites|antimetabolites|mesh-ancestor
24614639|NCT01025570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614640|NCT01025570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614641|NCT01025570|Antiviral Agents|antiviral agents|mesh-ancestor
24614642|NCT01025570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24614643|NCT01025570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24712904|NCT01523093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24712905|NCT01523093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24712906|NCT01523093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24712907|NCT01523093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24712908|NCT01523093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24712910|NCT01523119|Antiemetics|antiemetics|mesh-ancestor
24713073|NCT01524081|Clavulanic Acids|clavulanic acids|mesh-list
24713074|NCT01524081|Clavulanic Acid|clavulanic acid|mesh-list
24788882|NCT01934569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24788884|NCT01934569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24788885|NCT01934569|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24788886|NCT01934569|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24713186|NCT01524575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24713187|NCT01524575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24713630|NCT01526837|Growth Substances|growth substances|mesh-ancestor
24713632|NCT01526837|Growth Inhibitors|growth inhibitors|mesh-ancestor
24713761|NCT01527422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24713762|NCT01527422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24713763|NCT01527422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24713789|NCT01527474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25770612|NCT03554772|Analgesics|analgesics|mesh-ancestor
25770613|NCT03554772|Sensory System Agents|sensory system agents|mesh-ancestor
25770614|NCT03554772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770615|NCT03554772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770616|NCT03554772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25770617|NCT03554772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24713791|NCT01527474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24713792|NCT01527539|Insulin Aspart|insulin aspart|mesh-list
24713793|NCT01527539|Biphasic Insulins|biphasic insulins|mesh-list
24714018|NCT01528800|Vitamin K 1|vitamin k 1|mesh-list
24714093|NCT01529164|Fluorouracil|fluorouracil|mesh-list
24714094|NCT01529164|Oxaliplatin|oxaliplatin|mesh-list
24714124|NCT01529177|Sequestering Agents|sequestering agents|mesh-ancestor
24714125|NCT01529177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24714126|NCT01529177|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24714127|NCT01529177|Hormone Antagonists|hormone antagonists|mesh-ancestor
24714129|NCT01529177|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25005931|NCT01178814|Immunologic Factors|immunologic factors|mesh-ancestor
25005939|NCT01125176|Rituximab|rituximab|mesh-list
24714220|NCT01529320|Protective Agents|protective agents|mesh-ancestor
24714221|NCT01529320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24714222|NCT01529320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24714223|NCT01529437|Immunologic Factors|immunologic factors|mesh-list
24714224|NCT01529437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714226|NCT01529476|Ofloxacin|ofloxacin|mesh-list
24714227|NCT01529476|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24714228|NCT01529476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714229|NCT01529476|Renal Agents|renal agents|mesh-ancestor
24714230|NCT01529476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24714238|NCT01529528|Anagliptin|anagliptin|mesh-list
24714284|NCT01529892|Methamphetamine|methamphetamine|mesh-list
24714285|NCT01529892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24714286|NCT01529892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714287|NCT01529892|Sympathomimetics|sympathomimetics|mesh-ancestor
24714288|NCT01529892|Autonomic Agents|autonomic agents|mesh-ancestor
24714289|NCT01529892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24714320|NCT01530048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24714321|NCT01530048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714322|NCT01530126|Becaplermin|becaplermin|mesh-list
24714323|NCT01530126|Anticoagulants|anticoagulants|mesh-ancestor
24714324|NCT01530126|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
24714325|NCT01530126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24714398|NCT01530490|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24714399|NCT01530490|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24714400|NCT01530490|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24714401|NCT01530490|Dopamine Agonists|dopamine agonists|mesh-ancestor
24714408|NCT01530503|Capecitabine|capecitabine|mesh-list
24714672|NCT01531790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714673|NCT01531790|Growth Inhibitors|growth inhibitors|mesh-ancestor
24714675|NCT01531829|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24714676|NCT01531829|Tinzaparin|tinzaparin|mesh-list
24714677|NCT01531829|Dalteparin|dalteparin|mesh-list
24714678|NCT01531829|Plasminogen|plasminogen|mesh-list
24714679|NCT01531829|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24714680|NCT01531829|Nadroparin|nadroparin|mesh-list
24714681|NCT01531829|Anticoagulants|anticoagulants|mesh-ancestor
24714682|NCT01531829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24714687|NCT01531855|Insulin|insulin|mesh-list
24714779|NCT01532843|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24714780|NCT01532843|Antiviral Agents|antiviral agents|mesh-ancestor
24714789|NCT01532856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24614785|NCT01026363|Ergocalciferols|ergocalciferols|mesh-list
24788947|NCT01934816|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24788948|NCT01934816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24788949|NCT01934829|Sorafenib|sorafenib|mesh-list
24788950|NCT01934829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24788951|NCT01934829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24788952|NCT01934829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24788955|NCT01934933|Celecoxib|celecoxib|mesh-list
25005980|NCT00070564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25005981|NCT00070564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25005982|NCT00070564|Immunologic Factors|immunologic factors|mesh-ancestor
25005983|NCT00070564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25005984|NCT00070564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25005985|NCT00070564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25005986|NCT00070564|Alkylating Agents|alkylating agents|mesh-ancestor
25005987|NCT00070564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25005988|NCT00070564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25005989|NCT00070564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25005990|NCT00070564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25005991|NCT00070564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757373|NCT01739556|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24715096|NCT01534442|Cholinergic Agents|cholinergic agents|mesh-ancestor
24715097|NCT01534442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24715098|NCT01534442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715099|NCT01534455|Lapatinib|lapatinib|mesh-list
24715100|NCT01534455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715101|NCT01534455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24614816|NCT01026415|Anesthetics, General|anesthetics, general|mesh-ancestor
24614817|NCT01026415|Anesthetics|anesthetics|mesh-ancestor
24614818|NCT01026415|GABA Modulators|gaba modulators|mesh-ancestor
24614819|NCT01026415|GABA Agents|gaba agents|mesh-ancestor
24614820|NCT01026415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24614821|NCT01026415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614823|NCT01026415|Antitubercular Agents|antitubercular agents|mesh-ancestor
24614824|NCT01026415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24715358|NCT01536028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715359|NCT01536054|Sirolimus|sirolimus|mesh-list
24715360|NCT01536054|Sargramostim|sargramostim|mesh-list
24715361|NCT01536054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24715362|NCT01536054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24715363|NCT01536054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24715364|NCT01536054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715399|NCT01536223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715401|NCT01536223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24715402|NCT01536223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24715534|NCT01537055|Ofloxacin|ofloxacin|mesh-list
25006011|NCT05206682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25006012|NCT05206682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006013|NCT05206448|Letrozole|letrozole|mesh-list
25006014|NCT05206448|Clomiphene|clomiphene|mesh-list
25006015|NCT05206448|Enclomiphene|enclomiphene|mesh-list
25006016|NCT05206448|Zuclomiphene|zuclomiphene|mesh-list
25006017|NCT05206448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006018|NCT05206448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006019|NCT05206448|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25006020|NCT05206448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25006021|NCT05206448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25006022|NCT05206448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25006023|NCT05206448|Hormone Antagonists|hormone antagonists|mesh-ancestor
24715969|NCT01539174|Hormones|hormones|mesh-ancestor
24715970|NCT01539174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24716004|NCT01539408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24716005|NCT01539408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24716006|NCT01539408|Oxytocics|oxytocics|mesh-ancestor
24716007|NCT01539473|Tedizolid phosphate|tedizolid phosphate|mesh-list
24716044|NCT01539603|Immunologic Factors|immunologic factors|mesh-ancestor
24716045|NCT01539603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614985|NCT01027182|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24614986|NCT01027182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24614987|NCT01027182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614989|NCT01027377|Coagulants|coagulants|mesh-ancestor
24614990|NCT01027429|Amoxicillin|amoxicillin|mesh-list
24614991|NCT01027429|Gentamicins|gentamicins|mesh-list
24614992|NCT01027429|Penicillins|penicillins|mesh-list
24716057|NCT01539655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716145|NCT01540110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716147|NCT01540110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24716148|NCT01540110|Tubulin Modulators|tubulin modulators|mesh-ancestor
24716149|NCT01540110|Antimitotic Agents|antimitotic agents|mesh-ancestor
24716150|NCT01540110|Mitosis Modulators|mitosis modulators|mesh-ancestor
24716151|NCT01540136|Nedaplatin|nedaplatin|mesh-list
24716152|NCT01540136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24716184|NCT01540500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24788998|NCT01935115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25006030|NCT05206448|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25006031|NCT05206318|Cysteamine|cysteamine|mesh-list
25006032|NCT05206318|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
25006033|NCT05206318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006091|NCT05205603|Analgesics|analgesics|mesh-ancestor
25710089|NCT02282293|Piperaquine|piperaquine|mesh-list
25006092|NCT05205603|Sensory System Agents|sensory system agents|mesh-ancestor
25710090|NCT02282293|Trimethoprim|trimethoprim|mesh-list
25006093|NCT05205603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25006094|NCT05205603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716271|NCT01540812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24716272|NCT01540812|Antimetabolites|antimetabolites|mesh-ancestor
24716273|NCT01540812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24716274|NCT01540812|Immunologic Factors|immunologic factors|mesh-ancestor
24716275|NCT01540812|Antiviral Agents|antiviral agents|mesh-ancestor
24716306|NCT01541059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716308|NCT01541059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24716498|NCT01542060|Insulin Aspart|insulin aspart|mesh-list
24716499|NCT01542060|Biphasic Insulins|biphasic insulins|mesh-list
24716500|NCT01542060|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24716501|NCT01542060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24716502|NCT01542060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716503|NCT01542099|Remifentanil|remifentanil|mesh-list
24716582|NCT01542476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24716583|NCT01542476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716585|NCT01542489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24716589|NCT01542489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716590|NCT01542697|Magnesium Sulfate|magnesium sulfate|mesh-list
24716591|NCT01542697|Analgesics|analgesics|mesh-ancestor
24716592|NCT01542697|Sensory System Agents|sensory system agents|mesh-ancestor
24716593|NCT01542697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24645863|NCT01200472|Apremilast|apremilast|mesh-list
24716595|NCT01542697|Anesthetics|anesthetics|mesh-ancestor
24716596|NCT01542697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24716597|NCT01542697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25109689|NCT03122197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109690|NCT03122158|Citalopram|citalopram|mesh-list
25109691|NCT03122158|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25109692|NCT03122158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25109693|NCT03122158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25109694|NCT03122158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109695|NCT03122158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25109696|NCT03122158|Serotonin Agents|serotonin agents|mesh-ancestor
25109697|NCT03122158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109698|NCT03122158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25109699|NCT03122158|Antidepressive Agents|antidepressive agents|mesh-ancestor
25109700|NCT03122158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25109701|NCT03121963|Acetaminophen|acetaminophen|mesh-list
25109702|NCT03121963|Celecoxib|celecoxib|mesh-list
25109704|NCT03121963|Oxycodone|oxycodone|mesh-list
24716948|NCT01544751|Atorvastatin|atorvastatin|mesh-list
24716949|NCT01544751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24716950|NCT01544751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716951|NCT01544751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24716952|NCT01544751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24716953|NCT01544751|Antimetabolites|antimetabolites|mesh-ancestor
24645889|NCT01200641|Gabapentin|gabapentin|mesh-list
24716954|NCT01544751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716955|NCT01544751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25415971|NCT02980510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716956|NCT01544751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24716957|NCT01544751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24716958|NCT01544829|Theobromine|theobromine|mesh-list
24717204|NCT01546558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717205|NCT01546597|Metformin|metformin|mesh-list
24717206|NCT01546597|Ranolazine|ranolazine|mesh-list
24717207|NCT01546597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24717208|NCT01546597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717209|NCT01546597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24717246|NCT01546961|Antimalarials|antimalarials|mesh-ancestor
24717247|NCT01546961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24717277|NCT01547104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24717278|NCT01547104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25710092|NCT02282293|Sulfamethoxazole|sulfamethoxazole|mesh-list
25710093|NCT02282293|Antimalarials|antimalarials|mesh-ancestor
25710094|NCT02282293|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25710095|NCT02282293|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25710096|NCT02282293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25710097|NCT02282293|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25710099|NCT02282293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24717279|NCT01547104|Protease Inhibitors|protease inhibitors|mesh-ancestor
24717280|NCT01547104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717281|NCT01547104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717282|NCT01547143|Cyclosporine|cyclosporine|mesh-list
24717283|NCT01547143|Dexamethasone|dexamethasone|mesh-list
24717284|NCT01547143|Etoposide|etoposide|mesh-list
24717285|NCT01547143|Cyclosporins|cyclosporins|mesh-list
24717286|NCT01547143|gamma-Globulins|gamma-globulins|mesh-list
24717287|NCT01547143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24789133|NCT01935648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24789134|NCT01935648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789135|NCT01935648|Sensory System Agents|sensory system agents|mesh-ancestor
24789136|NCT01935648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25006125|NCT05204979|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25006126|NCT05204979|Abortifacient Agents|abortifacient agents|mesh-ancestor
25006127|NCT05204979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25006128|NCT05204979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006129|NCT05204979|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25006130|NCT05204979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25006131|NCT05204979|Oxytocics|oxytocics|mesh-ancestor
24717531|NCT01548326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24717533|NCT01548326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24717667|NCT01549236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24717669|NCT01549301|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24717670|NCT01549301|Immunologic Factors|immunologic factors|mesh-ancestor
24717671|NCT01549301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717672|NCT01549418|Aspirin|aspirin|mesh-list
24717802|NCT01550055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24717803|NCT01550107|Allopurinol|allopurinol|mesh-list
24717804|NCT01550107|Antimetabolites|antimetabolites|mesh-ancestor
24717805|NCT01550107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717806|NCT01550107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718078|NCT01551719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718079|NCT01551797|Acetaminophen|acetaminophen|mesh-list
24718081|NCT01551797|Analgesics|analgesics|mesh-ancestor
24718082|NCT01551797|Sensory System Agents|sensory system agents|mesh-ancestor
24718083|NCT01551797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24718084|NCT01551797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718086|NCT01551810|Vaccines|vaccines|mesh-list
24504881|NCT00538486|Metformin|metformin|mesh-list
24718087|NCT01551810|Immunologic Factors|immunologic factors|mesh-ancestor
24718277|NCT01553435|Antitussive Agents|antitussive agents|mesh-ancestor
24718278|NCT01553435|Respiratory System Agents|respiratory system agents|mesh-ancestor
24718279|NCT01553435|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24718280|NCT01553435|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24718281|NCT01553435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24718282|NCT01553435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718283|NCT01553435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718290|NCT01553721|Udenafil|udenafil|mesh-list
24718291|NCT01553721|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24718292|NCT01553721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24615218|NCT01028443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615219|NCT01028443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24718373|NCT01554592|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24718374|NCT01554592|Antimetabolites|antimetabolites|mesh-ancestor
24718375|NCT01554592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718376|NCT01554592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718377|NCT01554592|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24718378|NCT01554631|Acarbose|acarbose|mesh-list
24718379|NCT01554631|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24718380|NCT01554631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24789176|NCT01935804|Pioglitazone|pioglitazone|mesh-list
24789177|NCT01935804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24789178|NCT01935804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789179|NCT01935817|Vitamin E|vitamin e|mesh-list
24789180|NCT01935817|Silybin|silybin|mesh-list
25710100|NCT02282293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710101|NCT02282293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789181|NCT01935817|Vitamins|vitamins|mesh-ancestor
24789182|NCT01935817|Micronutrients|micronutrients|mesh-ancestor
25710102|NCT02282293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25710103|NCT02282293|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25710104|NCT02282293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25710105|NCT02282514|Methylprednisolone|methylprednisolone|mesh-list
24789183|NCT01935817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789184|NCT01935817|Antioxidants|antioxidants|mesh-ancestor
24789185|NCT01935817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789186|NCT01935817|Protective Agents|protective agents|mesh-ancestor
24718394|NCT01554852|Thalidomide|thalidomide|mesh-list
24718395|NCT01554852|Dexamethasone|dexamethasone|mesh-list
24718396|NCT01554852|Dexamethasone acetate|dexamethasone acetate|mesh-list
24718397|NCT01554852|Cyclophosphamide|cyclophosphamide|mesh-list
24505465|NCT00541138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718584|NCT01555788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24718585|NCT01555814|Amisulpride|amisulpride|mesh-list
24718586|NCT01555814|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24718587|NCT01555814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24718588|NCT01555814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24718589|NCT01555814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718590|NCT01555814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24718591|NCT01555814|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24718592|NCT01555814|Dopamine Agents|dopamine agents|mesh-ancestor
24718593|NCT01555814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24718594|NCT01555814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718595|NCT01555814|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24718596|NCT01555814|Antidepressive Agents|antidepressive agents|mesh-ancestor
24718597|NCT01555853|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24718598|NCT01555853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24718599|NCT01555866|Isavuconazole|isavuconazole|mesh-list
24718600|NCT01555866|Antifungal Agents|antifungal agents|mesh-ancestor
24718601|NCT01555866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24718603|NCT01555879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24718604|NCT01555879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758671|NCT01747226|Fluorides|fluorides|mesh-list
24718607|NCT01555879|Immunologic Factors|immunologic factors|mesh-ancestor
24718608|NCT01555879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718609|NCT01555879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24718610|NCT01555918|Isavuconazole|isavuconazole|mesh-list
24718611|NCT01555918|Antifungal Agents|antifungal agents|mesh-ancestor
24718729|NCT01556737|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24718730|NCT01556737|Estrogens|estrogens|mesh-ancestor
24718731|NCT01556737|Hormones|hormones|mesh-ancestor
24718732|NCT01556737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24718733|NCT01556815|Sorafenib|sorafenib|mesh-list
24718871|NCT01557712|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24718872|NCT01557712|Analgesics|analgesics|mesh-ancestor
24718873|NCT01557712|Sensory System Agents|sensory system agents|mesh-ancestor
24789224|NCT01935973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719086|NCT01559051|Anesthetics|anesthetics|mesh-list
24719087|NCT01559051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25006162|NCT05204641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006168|NCT05204628|Crizotinib|crizotinib|mesh-list
24719093|NCT01559142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24719094|NCT01559142|Antimetabolites|antimetabolites|mesh-ancestor
24719095|NCT01559142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719096|NCT01559142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24719154|NCT01559480|Hormones|hormones|mesh-ancestor
24719155|NCT01559480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24719156|NCT01559545|Metronidazole|metronidazole|mesh-list
24719157|NCT01559545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24615263|NCT01028534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24615264|NCT01028534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615265|NCT01028534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24615266|NCT01028534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24615267|NCT01028547|Dexamethasone|dexamethasone|mesh-list
24615268|NCT01028547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24615269|NCT01028547|Antiemetics|antiemetics|mesh-ancestor
25710106|NCT02282514|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25710107|NCT02282514|Cyclophosphamide|cyclophosphamide|mesh-list
24615270|NCT01028547|Autonomic Agents|autonomic agents|mesh-ancestor
24615271|NCT01028547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25710108|NCT02282514|Rituximab|rituximab|mesh-list
24719173|NCT01559584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719175|NCT01559727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24719176|NCT01559727|Glucocorticoids|glucocorticoids|mesh-ancestor
24719177|NCT01559727|Hormones|hormones|mesh-ancestor
24719178|NCT01559727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24719179|NCT01559727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719180|NCT01559727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24719181|NCT01559727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719182|NCT01559740|Bupivacaine|bupivacaine|mesh-list
25006197|NCT05204069|Cyclopentolate|cyclopentolate|mesh-list
24719183|NCT01559740|Anesthetics, Local|anesthetics, local|mesh-ancestor
24719184|NCT01559740|Anesthetics|anesthetics|mesh-ancestor
24719185|NCT01559740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24719186|NCT01559740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719187|NCT01559740|Sensory System Agents|sensory system agents|mesh-ancestor
24719188|NCT01559740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24719189|NCT01559753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24719190|NCT01559753|Amoxicillin|amoxicillin|mesh-list
24719258|NCT01560117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719331|NCT01560689|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24719333|NCT01560689|Adrenergic Agents|adrenergic agents|mesh-ancestor
24719334|NCT01560689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24719335|NCT01560689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719336|NCT01560702|Epinephrine|epinephrine|mesh-list
24719337|NCT01560702|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24719338|NCT01560702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24719339|NCT01560702|Adrenergic Agents|adrenergic agents|mesh-ancestor
24719340|NCT01560702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24719444|NCT01561274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719445|NCT01561274|Sensory System Agents|sensory system agents|mesh-ancestor
24719446|NCT01561274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24719485|NCT01561781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24719486|NCT01561781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719487|NCT01561781|Protective Agents|protective agents|mesh-ancestor
24719488|NCT01561781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719489|NCT01561794|Ciprofloxacin|ciprofloxacin|mesh-list
24719490|NCT01561794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24719491|NCT01561794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24719492|NCT01561794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24719493|NCT01561794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24719494|NCT01561794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758951|NCT01748630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24719600|NCT01562717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24719601|NCT01562717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24719602|NCT01562717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24719603|NCT01562717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719604|NCT01562795|Fluorometholone|fluorometholone|mesh-list
24719605|NCT01562795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24719606|NCT01562795|Lubricant Eye Drops|lubricant eye drops|mesh-list
24719607|NCT01562795|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24719608|NCT01562795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24719609|NCT01562795|Glucocorticoids|glucocorticoids|mesh-ancestor
24719611|NCT01562795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24719612|NCT01562795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719613|NCT01562795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24719614|NCT01562808|Aripiprazole|aripiprazole|mesh-list
24719615|NCT01562808|Antidepressive Agents|antidepressive agents|mesh-ancestor
24789239|NCT01936025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24789240|NCT01936025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789241|NCT01936025|Incretins|incretins|mesh-ancestor
24789242|NCT01936025|Hormones|hormones|mesh-ancestor
24789243|NCT01936025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24789244|NCT01936025|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24789245|NCT01936025|Protease Inhibitors|protease inhibitors|mesh-ancestor
24789246|NCT01936025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25006205|NCT05204069|Cholinergic Agents|cholinergic agents|mesh-ancestor
25006206|NCT05204069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25006207|NCT05204069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006209|NCT05204056|Morphine|morphine|mesh-list
25006210|NCT05204056|Ropivacaine|ropivacaine|mesh-list
25006211|NCT05204056|Tranexamic Acid|tranexamic acid|mesh-list
25006212|NCT05204056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25710109|NCT02282514|Thymoglobulin|thymoglobulin|mesh-list
25710110|NCT02282514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24446702|NCT00305734|Gemcitabine|gemcitabine|mesh-list
25006213|NCT05204056|Narcotics|narcotics|mesh-ancestor
25006214|NCT05204056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25006215|NCT05204056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006216|NCT05204056|Analgesics|analgesics|mesh-ancestor
25006217|NCT05204056|Sensory System Agents|sensory system agents|mesh-ancestor
25006218|NCT05204056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25006219|NCT05204056|Anesthetics, Local|anesthetics, local|mesh-ancestor
25006220|NCT05204056|Anesthetics|anesthetics|mesh-ancestor
25006221|NCT05204056|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25006228|NCT05204056|Autonomic Agents|autonomic agents|mesh-ancestor
24719891|NCT01564810|Cetuximab|cetuximab|mesh-list
24615321|NCT01028781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24615353|NCT01029002|Vitamin D|vitamin d|mesh-list
24615354|NCT01029002|Vitamins|vitamins|mesh-ancestor
24615355|NCT01029002|Micronutrients|micronutrients|mesh-ancestor
24615356|NCT01029002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581714|NCT00865917|Metoprolol|metoprolol|mesh-list
25006275|NCT05203432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24872098|NCT05398861|Bevacizumab|bevacizumab|mesh-list
24719976|NCT01565512|Anesthetics, Local|anesthetics, local|mesh-ancestor
24719977|NCT01565512|Anesthetics|anesthetics|mesh-ancestor
24719978|NCT01565512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24719979|NCT01565512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719980|NCT01565512|Sensory System Agents|sensory system agents|mesh-ancestor
24720010|NCT01565733|Insulin Aspart|insulin aspart|mesh-list
24720011|NCT01565733|Biphasic Insulins|biphasic insulins|mesh-list
24720012|NCT01565733|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24720013|NCT01565733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24720017|NCT01565759|Lithium Carbonate|lithium carbonate|mesh-list
24720169|NCT01566760|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24720170|NCT01566760|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24720171|NCT01566760|Cholinergic Agents|cholinergic agents|mesh-ancestor
24489438|NCT00473239|Vitamins|vitamins|mesh-ancestor
24720172|NCT01566760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24720173|NCT01566760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720174|NCT01566760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720175|NCT01566760|Urological Agents|urological agents|mesh-ancestor
24720176|NCT01566799|Metformin|metformin|mesh-list
24720177|NCT01566799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24720178|NCT01566799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720179|NCT01566825|Amitriptyline|amitriptyline|mesh-list
24720278|NCT01567540|Hormones|hormones|mesh-ancestor
24720328|NCT01567657|Sensory System Agents|sensory system agents|mesh-ancestor
24720390|NCT01568268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24720391|NCT01568268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720392|NCT01568268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24720397|NCT01568268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720398|NCT01568281|Anastrozole|anastrozole|mesh-list
24720399|NCT01568281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24720400|NCT01568281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24720401|NCT01568281|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24720402|NCT01568281|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24720409|NCT01568294|Pomalidomide|pomalidomide|mesh-list
25710111|NCT02282514|Immunologic Factors|immunologic factors|mesh-ancestor
25710112|NCT02282514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710113|NCT02282514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25710114|NCT02282514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25710115|NCT02282514|Alkylating Agents|alkylating agents|mesh-ancestor
24615399|NCT01029522|Antimetabolites|antimetabolites|mesh-ancestor
24615419|NCT01029743|Aspirin|aspirin|mesh-list
24615421|NCT01029743|Rivaroxaban|rivaroxaban|mesh-list
24615422|NCT01029743|Fondaparinux|fondaparinux|mesh-list
24615423|NCT01029743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24615424|NCT01029743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24615425|NCT01029743|Analgesics|analgesics|mesh-ancestor
24615426|NCT01029743|Sensory System Agents|sensory system agents|mesh-ancestor
24615427|NCT01029743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24615428|NCT01029743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615429|NCT01029743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24615430|NCT01029743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24615431|NCT01029743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24615432|NCT01029743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24615433|NCT01029743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615434|NCT01029743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24720590|NCT01569204|Hormones|hormones|mesh-ancestor
24720591|NCT01569204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24720592|NCT01569204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24720593|NCT01569204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24720596|NCT01569204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720601|NCT01569256|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24720602|NCT01569256|Dopamine Agonists|dopamine agonists|mesh-ancestor
24720603|NCT01569256|Dopamine Agents|dopamine agents|mesh-ancestor
24720604|NCT01569256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24720605|NCT01569256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720606|NCT01569256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720607|NCT01569633|Erythromycin|erythromycin|mesh-list
24720608|NCT01569633|Erythromycin Estolate|erythromycin estolate|mesh-list
24720632|NCT01569659|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24720633|NCT01569659|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24720635|NCT01569685|Sertraline|sertraline|mesh-list
24720636|NCT01569685|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24720637|NCT01569685|Antidepressive Agents|antidepressive agents|mesh-ancestor
24720638|NCT01569685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24720639|NCT01569685|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24720640|NCT01569685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24720641|NCT01569685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24720642|NCT01569685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24720643|NCT01569685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24720644|NCT01569685|Serotonin Agents|serotonin agents|mesh-ancestor
24720648|NCT01569919|Folic Acid|folic acid|mesh-list
24720649|NCT01569919|Vitamin B 12|vitamin b 12|mesh-list
24720650|NCT01569919|Dexamethasone|dexamethasone|mesh-list
24720651|NCT01569919|Pemetrexed|pemetrexed|mesh-list
24720652|NCT01569919|Vitamins|vitamins|mesh-ancestor
24720653|NCT01569919|Micronutrients|micronutrients|mesh-ancestor
24720654|NCT01569919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24720686|NCT01569945|Hormone Antagonists|hormone antagonists|mesh-ancestor
24720687|NCT01569945|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24849589|NCT02249130|Antimetabolites|antimetabolites|mesh-ancestor
24720688|NCT01569945|Fertility Agents|fertility agents|mesh-ancestor
24720689|NCT01569945|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24720690|NCT01569945|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24720691|NCT01569984|Bevacizumab|bevacizumab|mesh-list
24720692|NCT01569984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25710116|NCT02282514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721046|NCT01572012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721047|NCT01572012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24721048|NCT01572012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24721049|NCT01572012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24721050|NCT01572012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24721051|NCT01572012|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24721052|NCT01572025|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24721053|NCT01572025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25109734|NCT03122132|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25109735|NCT03122132|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25109736|NCT03122132|Protease Inhibitors|protease inhibitors|mesh-ancestor
25109737|NCT03122132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25109738|NCT03122132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109739|NCT03122132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25109740|NCT03122132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25109741|NCT03122132|Antiviral Agents|antiviral agents|mesh-ancestor
25109742|NCT03122132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25109743|NCT03122132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25109744|NCT03122132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24789322|NCT01936285|Gout Suppressants|gout suppressants|mesh-ancestor
24789323|NCT01936285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24789324|NCT01936285|Tubulin Modulators|tubulin modulators|mesh-ancestor
24789325|NCT01936285|Antimitotic Agents|antimitotic agents|mesh-ancestor
24789326|NCT01936285|Mitosis Modulators|mitosis modulators|mesh-ancestor
24789327|NCT01936285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789328|NCT01936285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789329|NCT01936350|Sildenafil Citrate|sildenafil citrate|mesh-list
24789330|NCT01936350|Vasodilator Agents|vasodilator agents|mesh-ancestor
25006309|NCT05172050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24721580|NCT01575652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721581|NCT01575652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24721582|NCT01575652|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24721611|NCT01575795|Purinergic Agents|purinergic agents|mesh-ancestor
24721612|NCT01575795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24615539|NCT01030120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24615540|NCT01030120|Analgesics|analgesics|mesh-ancestor
24615541|NCT01030120|Sensory System Agents|sensory system agents|mesh-ancestor
24615549|NCT01030237|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24615550|NCT01030237|Lubricant Eye Drops|lubricant eye drops|mesh-list
24615551|NCT01030237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24615552|NCT01030302|Bortezomib|bortezomib|mesh-list
24615553|NCT01030302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24722120|NCT01578603|Sequestering Agents|sequestering agents|mesh-ancestor
24722122|NCT01578629|Aspirin|aspirin|mesh-list
24722159|NCT01578720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24722160|NCT01578824|Methacholine Chloride|methacholine chloride|mesh-list
24722161|NCT01578824|Miotics|miotics|mesh-ancestor
25710117|NCT02282514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710118|NCT02282514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25710119|NCT02282514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25710120|NCT02282514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25710121|NCT02282514|Antiemetics|antiemetics|mesh-ancestor
25710122|NCT02282514|Autonomic Agents|autonomic agents|mesh-ancestor
24722162|NCT01578824|Autonomic Agents|autonomic agents|mesh-ancestor
25710123|NCT02282514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25710124|NCT02282514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24722163|NCT01578824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24722164|NCT01578824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722165|NCT01578824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24722166|NCT01578824|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
24722169|NCT01578824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24722387|NCT01579929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722389|NCT01579994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24722390|NCT01579994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24722391|NCT01579994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722392|NCT01579994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722393|NCT01580007|Cholecalciferol|cholecalciferol|mesh-list
24722394|NCT01580007|Vitamin D|vitamin d|mesh-list
24722395|NCT01580007|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
24722396|NCT01580007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24722397|NCT01580007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722398|NCT01580007|Vitamins|vitamins|mesh-ancestor
25006354|NCT05136560|Autonomic Agents|autonomic agents|mesh-ancestor
25006355|NCT05136560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24615758|NCT01031667|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24615759|NCT01031667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24722855|NCT01583023|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24722856|NCT01583023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24722857|NCT01583023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722859|NCT01583036|Ezogabine|ezogabine|mesh-list
24722860|NCT01583036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24722861|NCT01583036|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24722862|NCT01583036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722915|NCT01583439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24722916|NCT01583439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24723040|NCT01584492|Albuterol|albuterol|mesh-list
24723041|NCT01584492|Formoterol Fumarate|formoterol fumarate|mesh-list
24723042|NCT01584492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24723043|NCT01584492|Autonomic Agents|autonomic agents|mesh-ancestor
24723225|NCT01586143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24723226|NCT01586143|Analgesics|analgesics|mesh-ancestor
24723227|NCT01586143|Sensory System Agents|sensory system agents|mesh-ancestor
24723228|NCT01586143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24723229|NCT01586143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789444|NCT01937182|Antidepressive Agents|antidepressive agents|mesh-ancestor
24789446|NCT01937182|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24789447|NCT01937234|Metoclopramide|metoclopramide|mesh-list
24789448|NCT01937234|Antiemetics|antiemetics|mesh-ancestor
24789449|NCT01937234|Autonomic Agents|autonomic agents|mesh-ancestor
24789450|NCT01937234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24723311|NCT01586507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24723312|NCT01586533|Mesalamine|mesalamine|mesh-list
24723313|NCT01586533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24723314|NCT01586533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24723315|NCT01586533|Analgesics|analgesics|mesh-ancestor
24723316|NCT01586533|Sensory System Agents|sensory system agents|mesh-ancestor
24723352|NCT01586845|Dermatologic Agents|dermatologic agents|mesh-ancestor
24723353|NCT01586845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24615768|NCT01031719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723354|NCT01587066|Valproic Acid|valproic acid|mesh-list
24723355|NCT01587066|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24723356|NCT01587066|Antidepressive Agents|antidepressive agents|mesh-ancestor
24723634|NCT01588704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24723635|NCT01588704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710125|NCT02282514|Glucocorticoids|glucocorticoids|mesh-ancestor
25710126|NCT02282514|Hormones|hormones|mesh-ancestor
25710127|NCT02282514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25710128|NCT02282514|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24723636|NCT01588704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24723637|NCT01588704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25710129|NCT02282514|Protective Agents|protective agents|mesh-ancestor
24723638|NCT01588704|Growth Substances|growth substances|mesh-ancestor
24723668|NCT01588782|Antifungal Agents|antifungal agents|mesh-ancestor
24723669|NCT01588782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24723670|NCT01588782|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24723995|NCT01590537|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24723996|NCT01590537|Trace Elements|trace elements|mesh-ancestor
24723997|NCT01590537|Micronutrients|micronutrients|mesh-ancestor
24397400|NCT00141427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24723998|NCT01590641|Vesatolimod|vesatolimod|mesh-list
24723999|NCT01590641|Antiviral Agents|antiviral agents|mesh-ancestor
24724000|NCT01590641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24724001|NCT01590654|Vesatolimod|vesatolimod|mesh-list
24724002|NCT01590654|Antiviral Agents|antiviral agents|mesh-ancestor
24724038|NCT01590732|Dermatologic Agents|dermatologic agents|mesh-ancestor
24724039|NCT01590732|Tubulin Modulators|tubulin modulators|mesh-ancestor
24724040|NCT01590732|Antimitotic Agents|antimitotic agents|mesh-ancestor
24724212|NCT01591850|Antifungal Agents|antifungal agents|mesh-ancestor
24724213|NCT01591850|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24724214|NCT01591850|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24724215|NCT01591850|Hormone Antagonists|hormone antagonists|mesh-ancestor
24724216|NCT01591850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24724217|NCT01591850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006471|NCT05003076|Autonomic Agents|autonomic agents|mesh-ancestor
25006472|NCT05003076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25006473|NCT05003076|Dopamine Agents|dopamine agents|mesh-ancestor
25006474|NCT05003076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25006475|NCT05003076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006476|NCT05003076|Adrenergic Agents|adrenergic agents|mesh-ancestor
25006477|NCT05003076|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25006478|NCT05003076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25006479|NCT05003076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25006480|NCT05003076|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25006481|NCT04984330|Dexamethasone|dexamethasone|mesh-list
25006482|NCT04984330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24724493|NCT01593306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24724494|NCT01593306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24724495|NCT01593306|Tubulin Modulators|tubulin modulators|mesh-ancestor
24724496|NCT01593306|Antimitotic Agents|antimitotic agents|mesh-ancestor
24724497|NCT01593306|Mitosis Modulators|mitosis modulators|mesh-ancestor
24724498|NCT01593306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724535|NCT01593410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24724536|NCT01593410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724653|NCT01594047|Anesthetics, General|anesthetics, general|mesh-ancestor
24724654|NCT01594047|Anesthetics|anesthetics|mesh-ancestor
24724655|NCT01594047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24724656|NCT01594047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24724657|NCT01594047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24724660|NCT01594047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25006514|NCT04917029|Bupivacaine|bupivacaine|mesh-list
24615905|NCT01032486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615907|NCT01032499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24615908|NCT01032499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24615909|NCT01032668|Clopidogrel|clopidogrel|mesh-list
24615910|NCT01032668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24615911|NCT01032668|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24615912|NCT01032668|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24725141|NCT01596647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24725142|NCT01596647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24725143|NCT01596647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725144|NCT01596647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24725145|NCT01596647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24725146|NCT01596647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24725235|NCT01596803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725237|NCT01596803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725238|NCT01596803|Vitamins|vitamins|mesh-ancestor
24615962|NCT01033149|Antidotes|antidotes|mesh-ancestor
24725426|NCT01597700|Ezetimibe|ezetimibe|mesh-list
24725427|NCT01597700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24725428|NCT01597700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24725429|NCT01597700|Antimetabolites|antimetabolites|mesh-ancestor
24725430|NCT01597700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710130|NCT02282514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25710132|NCT02282527|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25710133|NCT02282527|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25710134|NCT02282527|Protease Inhibitors|protease inhibitors|mesh-ancestor
25710135|NCT02282527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770618|NCT03554772|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24725431|NCT01597700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24725432|NCT01597713|Insulin Glargine|insulin glargine|mesh-list
24725433|NCT01597713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24725435|NCT01597726|Misoprostol|misoprostol|mesh-list
24725593|NCT01598402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24725594|NCT01598402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725624|NCT01598584|Immunologic Factors|immunologic factors|mesh-ancestor
24725625|NCT01598584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24849801|NCT02250729|Pholcodine|pholcodine|mesh-list
24725626|NCT01598584|Antidepressive Agents|antidepressive agents|mesh-ancestor
24725634|NCT01598584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24725635|NCT01598584|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24725636|NCT01598584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24725637|NCT01598584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24725839|NCT01599975|Dopamine Agents|dopamine agents|mesh-ancestor
24725840|NCT01599975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24725841|NCT01599988|Caseins|caseins|mesh-list
24725842|NCT01599988|Chelating Agents|chelating agents|mesh-ancestor
24725843|NCT01599988|Sequestering Agents|sequestering agents|mesh-ancestor
24725844|NCT01599988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725845|NCT01600235|Phenylephrine|phenylephrine|mesh-list
24725846|NCT01600235|Oxymetazoline|oxymetazoline|mesh-list
24726173|NCT01602029|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24726174|NCT01602029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24726175|NCT01602029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24726176|NCT01602029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24726177|NCT01602029|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24726178|NCT01602055|Azithromycin|azithromycin|mesh-list
24726179|NCT01602055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24726180|NCT01602055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24726182|NCT01602185|Dextromethorphan|dextromethorphan|mesh-list
24726183|NCT01602185|Antitussive Agents|antitussive agents|mesh-list
24726184|NCT01602185|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24726185|NCT01602185|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24726220|NCT01602302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24726373|NCT01603030|Moxifloxacin|moxifloxacin|mesh-list
24726374|NCT01603030|Prednisolone|prednisolone|mesh-list
24726375|NCT01603030|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24726376|NCT01603030|Methylprednisolone|methylprednisolone|mesh-list
24726377|NCT01603030|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24616294|NCT01035593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24616303|NCT01035671|Tocopherylquinone|tocopherylquinone|mesh-list
24401752|NCT00153946|Protective Agents|protective agents|mesh-ancestor
24616304|NCT01035671|Anticoagulants|anticoagulants|mesh-ancestor
24726661|NCT01605084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24726662|NCT01605084|Antiviral Agents|antiviral agents|mesh-ancestor
24726663|NCT01605084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24726664|NCT01605084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24726665|NCT01605084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24726666|NCT01605240|Acetaminophen|acetaminophen|mesh-list
24726667|NCT01605240|Ibuprofen|ibuprofen|mesh-list
24726668|NCT01605240|Codeine|codeine|mesh-list
24616320|NCT01035983|Serotonin Agents|serotonin agents|mesh-ancestor
24616321|NCT01035983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24616322|NCT01035983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616323|NCT01035983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616324|NCT01036035|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24616325|NCT01036035|Pilocarpine|pilocarpine|mesh-list
24726962|NCT01607086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726963|NCT01607086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24726964|NCT01607086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726965|NCT01607086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24726966|NCT01607086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24727065|NCT01607918|Metronidazole|metronidazole|mesh-list
24727066|NCT01607918|Clarithromycin|clarithromycin|mesh-list
24727067|NCT01607918|Lansoprazole|lansoprazole|mesh-list
24727068|NCT01607918|Dexlansoprazole|dexlansoprazole|mesh-list
24727069|NCT01607918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24727070|NCT01607918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24727071|NCT01607918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24727072|NCT01607918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24727073|NCT01607918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25710136|NCT02282527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710137|NCT02282605|Chlorhexidine|chlorhexidine|mesh-list
25710138|NCT02282605|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24727074|NCT01607918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24789610|NCT01938144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24616427|NCT01037140|Micronutrients|micronutrients|mesh-ancestor
24616428|NCT01037140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616429|NCT01037140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24616430|NCT01037140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24616431|NCT01037322|Cannabidiol|cannabidiol|mesh-list
24616432|NCT01037322|Anticonvulsants|anticonvulsants|mesh-ancestor
24616433|NCT01037335|Morphine|morphine|mesh-list
24616434|NCT01037335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24616435|NCT01037335|Narcotics|narcotics|mesh-ancestor
24616436|NCT01037335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24616437|NCT01037335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728823|NCT01618474|Antimetabolites|antimetabolites|mesh-ancestor
24727718|NCT01612273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24727719|NCT01612273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24727720|NCT01612273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24727749|NCT01612377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24727750|NCT01612377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727751|NCT01612377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24727752|NCT01612377|Vasodilator Agents|vasodilator agents|mesh-ancestor
24727753|NCT01612403|Zinc Sulfate|zinc sulfate|mesh-list
24727754|NCT01612403|Astringents|astringents|mesh-ancestor
24727755|NCT01612403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727756|NCT01612403|Dermatologic Agents|dermatologic agents|mesh-ancestor
24727757|NCT01612468|Liraglutide|liraglutide|mesh-list
24727758|NCT01612468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24727759|NCT01612468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727760|NCT01612468|Incretins|incretins|mesh-ancestor
24727761|NCT01612468|Hormones|hormones|mesh-ancestor
24727763|NCT01612507|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
24727967|NCT01613794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727968|NCT01613794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24727969|NCT01613794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24727970|NCT01613794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24727971|NCT01613807|Insulin|insulin|mesh-list
24727972|NCT01613807|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24727973|NCT01613807|Insulin Lispro|insulin lispro|mesh-list
24727975|NCT01613807|Insulin, Long-Acting|insulin, long-acting|mesh-list
24728168|NCT01614405|Emtricitabine|emtricitabine|mesh-list
24728169|NCT01614405|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24728170|NCT01614405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24728171|NCT01614405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24728172|NCT01614405|Protease Inhibitors|protease inhibitors|mesh-ancestor
24728173|NCT01614405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728174|NCT01614405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728175|NCT01614405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24728176|NCT01614405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24728177|NCT01614405|Antiviral Agents|antiviral agents|mesh-ancestor
24728385|NCT01615913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728386|NCT01615913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728387|NCT01615913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24728388|NCT01615913|Hormone Antagonists|hormone antagonists|mesh-ancestor
24648851|NCT01217099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24728820|NCT01618474|Mitosis Modulators|mitosis modulators|mesh-ancestor
24728821|NCT01618474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728822|NCT01618474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25710139|NCT02282605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25710140|NCT02282605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25710141|NCT02282605|Disinfectants|disinfectants|mesh-ancestor
24728836|NCT01618591|Levofloxacin|levofloxacin|mesh-list
25006622|NCT04843579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25710142|NCT02282605|Dermatologic Agents|dermatologic agents|mesh-ancestor
25710143|NCT02282813|Calcitriol|calcitriol|mesh-list
25006623|NCT04843579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25006624|NCT04843579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006625|NCT04843579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25006626|NCT04843579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25006627|NCT04843579|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25006628|NCT04843579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407107|NCT00171860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24407108|NCT00171860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25006630|NCT04843579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24616617|NCT01038349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24616618|NCT01038349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24616619|NCT01038388|Dexamethasone|dexamethasone|mesh-list
24728860|NCT01618643|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24454178|NCT04326257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24728861|NCT01618643|Protective Agents|protective agents|mesh-ancestor
24728862|NCT01618643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24728863|NCT01618760|Risperidone|risperidone|mesh-list
24728864|NCT01618760|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24728865|NCT01618760|Serotonin Agents|serotonin agents|mesh-ancestor
24728866|NCT01618760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24882493|NCT05170061|Valsartan|valsartan|mesh-list
24882494|NCT05170061|Nebivolol|nebivolol|mesh-list
24729081|NCT01619761|Cyclophosphamide|cyclophosphamide|mesh-list
24729115|NCT01619761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24729116|NCT01619813|Prednisone|prednisone|mesh-list
24729117|NCT01619813|Docetaxel|docetaxel|mesh-list
24729398|NCT01621386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729399|NCT01621386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24729400|NCT01621386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109768|NCT03122041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24729401|NCT01621386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24729402|NCT01621386|Respiratory System Agents|respiratory system agents|mesh-ancestor
24729403|NCT01621386|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24729404|NCT01621386|Hormone Antagonists|hormone antagonists|mesh-ancestor
24729405|NCT01621386|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24729406|NCT01621386|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24729412|NCT01621451|Analgesics|analgesics|mesh-ancestor
24729451|NCT01621698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24729454|NCT01621698|Anesthetics, General|anesthetics, general|mesh-ancestor
24616678|NCT01038583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24616679|NCT01038583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24616680|NCT01038583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729471|NCT01621750|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24729472|NCT01621750|Purinergic Agents|purinergic agents|mesh-ancestor
24729473|NCT01621750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24729474|NCT01621750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407867|NCT00175747|Glucocorticoids|glucocorticoids|mesh-ancestor
24729478|NCT01621763|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24729505|NCT01621971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729507|NCT01622075|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24729508|NCT01622075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24729509|NCT01622075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24729510|NCT01622075|Tubulin Modulators|tubulin modulators|mesh-ancestor
24729511|NCT01622075|Antimitotic Agents|antimitotic agents|mesh-ancestor
24729512|NCT01622075|Mitosis Modulators|mitosis modulators|mesh-ancestor
25710145|NCT02282813|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
25710146|NCT02282813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25710147|NCT02282813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710148|NCT02282813|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25710149|NCT02282813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25710150|NCT02282813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710151|NCT02282813|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25710152|NCT02282813|Vitamins|vitamins|mesh-ancestor
24729513|NCT01622075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517664|NCT00609154|Glucagon|glucagon|mesh-list
24729515|NCT01622283|Levocetirizine|levocetirizine|mesh-list
24729516|NCT01622283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24729517|NCT01622283|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24729518|NCT01622283|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24729519|NCT01622283|Histamine Antagonists|histamine antagonists|mesh-ancestor
24729520|NCT01622283|Histamine Agents|histamine agents|mesh-ancestor
24729521|NCT01622283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24729522|NCT01622283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729563|NCT01622439|Cyclophosphamide|cyclophosphamide|mesh-list
24729564|NCT01622439|Rituximab|rituximab|mesh-list
24729565|NCT01622439|Doxorubicin|doxorubicin|mesh-list
24729566|NCT01622439|Vincristine|vincristine|mesh-list
24729567|NCT01622439|Valproic Acid|valproic acid|mesh-list
24729568|NCT01622439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24729602|NCT01622504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24729603|NCT01622556|Fludarabine|fludarabine|mesh-list
24729604|NCT01622556|Busulfan|busulfan|mesh-list
24729605|NCT01622556|Thymoglobulin|thymoglobulin|mesh-list
24729606|NCT01622556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24729607|NCT01622556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729809|NCT01624038|Antisickling Agents|antisickling agents|mesh-ancestor
24729810|NCT01624038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24729811|NCT01624038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729812|NCT01624038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24729814|NCT01624051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24729815|NCT01624064|Calcium, Dietary|calcium, dietary|mesh-list
24729816|NCT01624064|Enalapril|enalapril|mesh-list
24729817|NCT01624064|Calcium|calcium|mesh-list
24729819|NCT01624064|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25006678|NCT04785625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25006679|NCT04785625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006680|NCT04785625|Sensory System Agents|sensory system agents|mesh-ancestor
25006681|NCT04785625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24729820|NCT01624064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24729822|NCT01624064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24729823|NCT01624064|Protease Inhibitors|protease inhibitors|mesh-ancestor
24729824|NCT01624064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729825|NCT01624064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24616724|NCT01038895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616725|NCT01038895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24616726|NCT01039025|Cyclophosphamide|cyclophosphamide|mesh-list
24729868|NCT01624207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24729933|NCT01624675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24729934|NCT01624675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24729935|NCT01624675|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24730097|NCT01625806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730098|NCT01625806|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24730099|NCT01625806|Hormone Antagonists|hormone antagonists|mesh-ancestor
24730100|NCT01625806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24730101|NCT01625806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730102|NCT01625806|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24730104|NCT01625871|Artemether|artemether|mesh-list
24730140|NCT01626443|Folic Acid|folic acid|mesh-list
24518356|NCT05188508|Olaparib|olaparib|mesh-list
24730141|NCT01626443|Vitamin B Complex|vitamin b complex|mesh-list
24730142|NCT01626443|Inositol|inositol|mesh-list
24616762|NCT01039103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24616764|NCT01039103|Autonomic Agents|autonomic agents|mesh-ancestor
24616765|NCT01039103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25710153|NCT02282813|Micronutrients|micronutrients|mesh-ancestor
25710154|NCT02282813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25710155|NCT02282904|Sirolimus|sirolimus|mesh-list
25710156|NCT02282904|Cyclophosphamide|cyclophosphamide|mesh-list
25710157|NCT02282904|Busulfan|busulfan|mesh-list
25710158|NCT02282904|Fludarabine|fludarabine|mesh-list
25710159|NCT02282904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25710160|NCT02282904|Immunologic Factors|immunologic factors|mesh-ancestor
25710161|NCT02282904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710162|NCT02282904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25710163|NCT02282904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24730405|NCT01627834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730406|NCT01627834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730408|NCT01627847|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24730409|NCT01627847|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24730434|NCT01627938|Analgesics|analgesics|mesh-ancestor
24730442|NCT01627938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730449|NCT01628055|gamma-Globulins|gamma-globulins|mesh-list
24730450|NCT01628055|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24730455|NCT01628211|Leucovorin|leucovorin|mesh-list
24616816|NCT01039350|Darbepoetin alfa|darbepoetin alfa|mesh-list
24616817|NCT01039350|Hematinics|hematinics|mesh-ancestor
24789663|NCT01938300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24616819|NCT01039363|Vorinostat|vorinostat|mesh-list
24616820|NCT01039363|Idarubicin|idarubicin|mesh-list
24616821|NCT01039363|Gemtuzumab|gemtuzumab|mesh-list
24616822|NCT01039363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24616823|NCT01039363|Antimetabolites|antimetabolites|mesh-ancestor
24730581|NCT01629173|Growth Substances|growth substances|mesh-ancestor
24730582|NCT01629173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730584|NCT01629199|Mitosis Modulators|mitosis modulators|mesh-ancestor
24730585|NCT01629199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730586|NCT01629212|Octylonium|octylonium|mesh-list
24730587|NCT01629212|Bromides|bromides|mesh-list
24730588|NCT01629212|Tiropramide|tiropramide|mesh-list
24730589|NCT01629212|Anticonvulsants|anticonvulsants|mesh-ancestor
24730590|NCT01629212|Parasympatholytics|parasympatholytics|mesh-ancestor
24730591|NCT01629212|Autonomic Agents|autonomic agents|mesh-ancestor
24730592|NCT01629212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24730593|NCT01629212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730594|NCT01629212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24730710|NCT01629875|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24730712|NCT01629875|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24730713|NCT01629875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24730714|NCT01629875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730715|NCT01629875|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24730716|NCT01629875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24730717|NCT01629875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730718|NCT01629875|Cholinergic Agents|cholinergic agents|mesh-ancestor
24730719|NCT01629875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24730722|NCT01630018|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24730750|NCT01630083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24730751|NCT01630083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24730752|NCT01630096|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24730753|NCT01630096|Laxatives|laxatives|mesh-ancestor
24730754|NCT01630096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24730755|NCT01630148|Bemiparin|bemiparin|mesh-list
24730756|NCT01630148|Anticoagulants|anticoagulants|mesh-ancestor
24730757|NCT01630187|Carbetocin|carbetocin|mesh-list
24409729|NCT00182806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789670|NCT01938417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24789672|NCT01938443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24789673|NCT01938443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24789674|NCT01938443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24789675|NCT01938443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789676|NCT01938456|Docetaxel|docetaxel|mesh-list
24789677|NCT01938456|Trametinib|trametinib|mesh-list
24789678|NCT01938456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24730766|NCT01630278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24730809|NCT01630564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24730810|NCT01630564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25710164|NCT02282904|Alkylating Agents|alkylating agents|mesh-ancestor
25710165|NCT02282904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24730811|NCT01630564|Antiviral Agents|antiviral agents|mesh-ancestor
24730839|NCT01630720|Protective Agents|protective agents|mesh-ancestor
25006692|NCT04716699|Lidocaine|lidocaine|mesh-list
25710166|NCT02282904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710167|NCT02282904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25710168|NCT02282904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25710169|NCT02282904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25006693|NCT04716699|Anesthetics, Local|anesthetics, local|mesh-ancestor
25006694|NCT04716699|Anesthetics|anesthetics|mesh-ancestor
25006695|NCT04716699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25006696|NCT04716699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006697|NCT04716699|Sensory System Agents|sensory system agents|mesh-ancestor
25006698|NCT04716699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25006699|NCT04716699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25006700|NCT04716699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25006701|NCT04716699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25006702|NCT04716699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24730895|NCT01631136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24730897|NCT01631201|KRM 1648|krm 1648|mesh-list
24730898|NCT01631201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24730899|NCT01631201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24730900|NCT01631201|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24730901|NCT01631201|Antitubercular Agents|antitubercular agents|mesh-ancestor
24730902|NCT01631201|Leprostatic Agents|leprostatic agents|mesh-ancestor
24730931|NCT01631383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24730989|NCT01631409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24730990|NCT01631409|Vasodilator Agents|vasodilator agents|mesh-ancestor
24730991|NCT01631409|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24730992|NCT01631409|Diuretics|diuretics|mesh-ancestor
24731017|NCT01631539|Irinotecan|irinotecan|mesh-list
24731018|NCT01631539|Cetuximab|cetuximab|mesh-list
24731019|NCT01631539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24731020|NCT01631539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24731024|NCT01631539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24731025|NCT01631604|Botulinum Toxins|botulinum toxins|mesh-list
24731026|NCT01631604|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24731027|NCT01631604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24731028|NCT01631604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731029|NCT01631604|Cholinergic Agents|cholinergic agents|mesh-ancestor
24731030|NCT01631604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24731031|NCT01631604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731032|NCT01631669|Celecoxib|celecoxib|mesh-list
24731033|NCT01631669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24731034|NCT01631669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24731035|NCT01631669|Analgesics|analgesics|mesh-ancestor
24731036|NCT01631669|Sensory System Agents|sensory system agents|mesh-ancestor
24731037|NCT01631669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24731248|NCT01633645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24731249|NCT01633645|Immunologic Factors|immunologic factors|mesh-ancestor
25710170|NCT02282904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25710171|NCT02282904|Antifungal Agents|antifungal agents|mesh-ancestor
25710172|NCT02283294|Warfarin|warfarin|mesh-list
25710173|NCT02283294|Apixaban|apixaban|mesh-list
25710174|NCT02283294|Anticoagulants|anticoagulants|mesh-ancestor
25710175|NCT02283294|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24731250|NCT01633645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731251|NCT01633658|Cholecalciferol|cholecalciferol|mesh-list
24731253|NCT01633658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24731254|NCT01633658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731255|NCT01633658|Vitamins|vitamins|mesh-ancestor
24731256|NCT01633658|Micronutrients|micronutrients|mesh-ancestor
24731257|NCT01633658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24731258|NCT01633749|Vaccines|vaccines|mesh-list
24731291|NCT01633970|Antidotes|antidotes|mesh-ancestor
24731292|NCT01633970|Protective Agents|protective agents|mesh-ancestor
24731293|NCT01633970|Vitamin B Complex|vitamin b complex|mesh-ancestor
24731295|NCT01633970|Micronutrients|micronutrients|mesh-ancestor
24731296|NCT01633970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731297|NCT01633970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24410872|NCT00187070|Renal Agents|renal agents|mesh-ancestor
24731298|NCT01633970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24731299|NCT01633983|Methotrexate|methotrexate|mesh-list
24731300|NCT01633983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24731301|NCT01633983|Abortifacient Agents|abortifacient agents|mesh-ancestor
24731302|NCT01633983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24731303|NCT01633983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731304|NCT01633983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24731333|NCT01634295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24731335|NCT01634295|Vitamins|vitamins|mesh-ancestor
24731336|NCT01634295|Micronutrients|micronutrients|mesh-ancestor
24731337|NCT01634321|Leuprolide|leuprolide|mesh-list
24731338|NCT01634321|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24731339|NCT01634321|Fertility Agents|fertility agents|mesh-ancestor
24731340|NCT01634321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24731341|NCT01634321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24731342|NCT01634321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24731343|NCT01634321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731344|NCT01634347|Propranolol|propranolol|mesh-list
24731345|NCT01634347|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24731346|NCT01634347|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24731347|NCT01634347|Adrenergic Agents|adrenergic agents|mesh-ancestor
24731348|NCT01634347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24731349|NCT01634347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731382|NCT01634412|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24731383|NCT01634412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24731384|NCT01634412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24731517|NCT01635296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731540|NCT01635426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24731541|NCT01635426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24731542|NCT01635426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731543|NCT01635426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24731544|NCT01635426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24731545|NCT01635426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24731546|NCT01635426|Antipyretics|antipyretics|mesh-ancestor
24731547|NCT01635426|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24731548|NCT01635426|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24731549|NCT01635426|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24731550|NCT01635426|Purinergic Agents|purinergic agents|mesh-ancestor
24616965|NCT01040091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24616967|NCT01040195|Methotrexate|methotrexate|mesh-list
24731984|NCT01637376|Dermatologic Agents|dermatologic agents|mesh-ancestor
24732016|NCT01637545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24732017|NCT01637545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732019|NCT01637545|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24732020|NCT01637545|Serotonin Agents|serotonin agents|mesh-ancestor
24732021|NCT01637545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24732022|NCT01637545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732024|NCT01637558|Lopinavir|lopinavir|mesh-list
24732025|NCT01637558|Nevirapine|nevirapine|mesh-list
24732026|NCT01637558|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24732074|NCT01637675|Citric Acid|citric acid|mesh-list
24732088|NCT01637675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24732125|NCT01637844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24732157|NCT01638182|Vitamin K 2|vitamin k 2|mesh-list
24732158|NCT01638182|Vitamin K 1|vitamin k 1|mesh-list
24732159|NCT01638182|Micronutrients|micronutrients|mesh-ancestor
24732160|NCT01638182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732161|NCT01638182|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24732162|NCT01638182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24732163|NCT01638182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732164|NCT01638182|Hemostatics|hemostatics|mesh-ancestor
24732165|NCT01638182|Coagulants|coagulants|mesh-ancestor
24732166|NCT01638234|Melatonin|melatonin|mesh-list
24732167|NCT01638234|Antioxidants|antioxidants|mesh-ancestor
24732168|NCT01638234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616992|NCT01040234|Sensory System Agents|sensory system agents|mesh-ancestor
24616993|NCT01040234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24616995|NCT01040273|Anesthetics, Local|anesthetics, local|mesh-ancestor
24616996|NCT01040273|Anesthetics|anesthetics|mesh-ancestor
24617034|NCT01040429|Clonidine|clonidine|mesh-list
24732247|NCT01638624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24732282|NCT01638689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732283|NCT01638689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24732284|NCT01638689|Serotonin Agents|serotonin agents|mesh-ancestor
24732285|NCT01638689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617074|NCT01040702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617075|NCT01040702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24617076|NCT01040702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24617077|NCT01040702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24617078|NCT01040702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617080|NCT01040702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24732344|NCT01638962|Tiaprofenic acid|tiaprofenic acid|mesh-list
24732345|NCT01638962|Analgesics|analgesics|mesh-list
24732346|NCT01638962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24732347|NCT01638962|Sensory System Agents|sensory system agents|mesh-ancestor
24732391|NCT01639066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24732392|NCT01639066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732393|NCT01639066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789685|NCT01938508|Minocycline|minocycline|mesh-list
24789686|NCT01938508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24789687|NCT01938508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24789688|NCT01938547|Clevidipine|clevidipine|mesh-list
24789689|NCT01938547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24789690|NCT01938547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24789691|NCT01938547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24789692|NCT01938547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24789693|NCT01938547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732697|NCT01640782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24732698|NCT01640782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24732699|NCT01640782|Immunologic Factors|immunologic factors|mesh-ancestor
24732700|NCT01640782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732701|NCT01640782|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24732702|NCT01640782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24732703|NCT01640782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732704|NCT01640782|Antidotes|antidotes|mesh-ancestor
24732705|NCT01640782|Protective Agents|protective agents|mesh-ancestor
24732706|NCT01640782|Vitamin B Complex|vitamin b complex|mesh-ancestor
24732708|NCT01640782|Micronutrients|micronutrients|mesh-ancestor
24732709|NCT01640990|GW 328267|gw 328267|mesh-list
24732710|NCT01640990|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
24505593|NCT00541554|Antidepressive Agents|antidepressive agents|mesh-ancestor
24732711|NCT01640990|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24732712|NCT01640990|Purinergic Agonists|purinergic agonists|mesh-ancestor
24732713|NCT01640990|Purinergic Agents|purinergic agents|mesh-ancestor
24732739|NCT01641250|Cytarabine|cytarabine|mesh-list
24732786|NCT01641406|Tubulin Modulators|tubulin modulators|mesh-ancestor
24732787|NCT01641406|Antimitotic Agents|antimitotic agents|mesh-ancestor
24732788|NCT01641406|Mitosis Modulators|mitosis modulators|mesh-ancestor
24732789|NCT01641406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24732790|NCT01641406|Antimetabolites|antimetabolites|mesh-ancestor
24732791|NCT01641406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24732994|NCT01642771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24732995|NCT01642771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24732996|NCT01642771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24732997|NCT01642862|Simvastatin|simvastatin|mesh-list
24732998|NCT01642862|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24732999|NCT01642862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24733001|NCT01642862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733009|NCT01642940|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24733010|NCT01642940|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24733011|NCT01642940|Purinergic Agents|purinergic agents|mesh-ancestor
24733012|NCT01642940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24733139|NCT01643499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24733173|NCT01643759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24733174|NCT01643759|Narcotics|narcotics|mesh-ancestor
24733175|NCT01643759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24733176|NCT01643759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733177|NCT01643759|Analgesics|analgesics|mesh-ancestor
24733178|NCT01643759|Sensory System Agents|sensory system agents|mesh-ancestor
24733179|NCT01643759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24733332|NCT01645254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24733364|NCT01645423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733365|NCT01645423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24733366|NCT01645423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24733367|NCT01645423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733368|NCT01645449|Atorvastatin|atorvastatin|mesh-list
24733370|NCT01645449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24733371|NCT01645449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733564|NCT01646853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733565|NCT01647152|Ustekinumab|ustekinumab|mesh-list
24733566|NCT01647152|Dermatologic Agents|dermatologic agents|mesh-ancestor
24733568|NCT01647165|Lenalidomide|lenalidomide|mesh-list
24733569|NCT01647165|Bortezomib|bortezomib|mesh-list
24733570|NCT01647165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24733571|NCT01647165|Antiemetics|antiemetics|mesh-ancestor
24733572|NCT01647165|Autonomic Agents|autonomic agents|mesh-ancestor
24733573|NCT01647165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24415110|NCT00199069|Antiemetics|antiemetics|mesh-ancestor
24733574|NCT01647165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733575|NCT01647165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24733576|NCT01647165|Glucocorticoids|glucocorticoids|mesh-ancestor
24733577|NCT01647165|Hormones|hormones|mesh-ancestor
24733578|NCT01647165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24617358|NCT01042704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24617359|NCT01042704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24617360|NCT01042704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24617361|NCT01042704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617365|NCT01042704|Antipyretics|antipyretics|mesh-ancestor
24733666|NCT01647828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733667|NCT01647828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24733669|NCT01647828|Antiviral Agents|antiviral agents|mesh-ancestor
24733670|NCT01647828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24733671|NCT01647828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733672|NCT01647828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24733673|NCT01647828|Immunologic Factors|immunologic factors|mesh-ancestor
24733674|NCT01647828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733675|NCT01647880|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24494871|NCT00497328|Protective Agents|protective agents|mesh-ancestor
24733676|NCT01647880|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24397875|NCT00142896|Analgesics|analgesics|mesh-ancestor
24733747|NCT01648231|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25710176|NCT02283294|Antithrombins|antithrombins|mesh-ancestor
24733748|NCT01648257|Cabotegravir|cabotegravir|mesh-list
24733749|NCT01648257|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24733750|NCT01648257|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24733751|NCT01648257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733752|NCT01648257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733754|NCT01648257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24733755|NCT01648257|Antiviral Agents|antiviral agents|mesh-ancestor
24733756|NCT01648257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24733757|NCT01648465|Everolimus|everolimus|mesh-list
24617411|NCT01042951|Vaccines|vaccines|mesh-list
24617419|NCT01043172|Antiviral Agents|antiviral agents|mesh-ancestor
24617420|NCT01043172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24617440|NCT01043211|Adrenergic Agents|adrenergic agents|mesh-ancestor
24617441|NCT01043211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24617442|NCT01043211|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24733799|NCT01648595|Anesthetics|anesthetics|mesh-ancestor
24733800|NCT01648608|Exemestane|exemestane|mesh-list
24398010|NCT00143221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24733842|NCT01648881|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24398050|NCT00143299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733864|NCT01649037|Respiratory System Agents|respiratory system agents|mesh-ancestor
24733865|NCT01649037|Mydriatics|mydriatics|mesh-ancestor
24733866|NCT01649037|Sympathomimetics|sympathomimetics|mesh-ancestor
24733867|NCT01649037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24748451|NCT02584829|Avelumab|avelumab|mesh-list
24733868|NCT01649037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24733869|NCT01649245|Interferons|interferons|mesh-list
24733870|NCT01649245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733871|NCT01649245|Antiviral Agents|antiviral agents|mesh-ancestor
24733872|NCT01649245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24733873|NCT01649258|Granisetron|granisetron|mesh-list
24733874|NCT01649258|Fosaprepitant|fosaprepitant|mesh-list
24733875|NCT01649258|Aprepitant|aprepitant|mesh-list
24733876|NCT01649258|Antiemetics|antiemetics|mesh-ancestor
24733877|NCT01649258|Autonomic Agents|autonomic agents|mesh-ancestor
24733878|NCT01649258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24733879|NCT01649258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733880|NCT01649258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24733881|NCT01649258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24733882|NCT01649258|Serotonin Agents|serotonin agents|mesh-ancestor
24733883|NCT01649258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24733884|NCT01649258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415705|NCT00200538|Memantine|memantine|mesh-list
24733887|NCT01649284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733888|NCT01649284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24733889|NCT01649284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733891|NCT01649336|Paclitaxel|paclitaxel|mesh-list
24789694|NCT01938612|Durvalumab|durvalumab|mesh-list
24789719|NCT01938729|Immunologic Factors|immunologic factors|mesh-ancestor
24789720|NCT01938755|Levobupivacaine|levobupivacaine|mesh-list
24789721|NCT01938755|Anesthetics, Local|anesthetics, local|mesh-ancestor
24789722|NCT01938755|Anesthetics|anesthetics|mesh-ancestor
24789723|NCT01938755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24789724|NCT01938755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24789725|NCT01938755|Sensory System Agents|sensory system agents|mesh-ancestor
24789726|NCT01938755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24789727|NCT01938781|Entecavir|entecavir|mesh-list
24789728|NCT01938781|Antiviral Agents|antiviral agents|mesh-ancestor
25006722|NCT04688177|Antimetabolites|antimetabolites|mesh-ancestor
25006723|NCT04688177|Gasotransmitters|gasotransmitters|mesh-ancestor
25006724|NCT04685590|Dasatinib|dasatinib|mesh-list
25006725|NCT04685590|Quercetin|quercetin|mesh-list
25006726|NCT04685590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25006727|NCT04685590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25006728|NCT04685590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25006729|NCT04685590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25006730|NCT04685590|Antioxidants|antioxidants|mesh-ancestor
25006731|NCT04685590|Protective Agents|protective agents|mesh-ancestor
25109778|NCT03121846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25109779|NCT03121846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25109780|NCT03121846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25109781|NCT03121846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710177|NCT02283294|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24734143|NCT01650740|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24734218|NCT01651312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24734219|NCT01651312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24734248|NCT01651377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734249|NCT01651377|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24734250|NCT01651377|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24734251|NCT01651377|Dopamine Agonists|dopamine agonists|mesh-ancestor
24734252|NCT01651377|Dopamine Agents|dopamine agents|mesh-ancestor
24734253|NCT01651377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24734255|NCT01651390|Paclitaxel|paclitaxel|mesh-list
24734256|NCT01651390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24734346|NCT01651962|Analgesics|analgesics|mesh-ancestor
24734347|NCT01651962|Sensory System Agents|sensory system agents|mesh-ancestor
24734348|NCT01651962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24734385|NCT01652014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24734386|NCT01652014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24734387|NCT01652014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24734388|NCT01652014|Antimetabolites|antimetabolites|mesh-ancestor
24734389|NCT01652014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24734390|NCT01652014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24734391|NCT01652014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24734614|NCT01652820|Docetaxel|docetaxel|mesh-list
24734615|NCT01652820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24734616|NCT01652820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24734644|NCT01652924|Anesthetics|anesthetics|mesh-list
24734660|NCT01653067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24734661|NCT01653067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24734662|NCT01653067|Immunologic Factors|immunologic factors|mesh-ancestor
24734663|NCT01653067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24734664|NCT01653067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24734665|NCT01653067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24734666|NCT01653067|Antiemetics|antiemetics|mesh-ancestor
24734695|NCT01653171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24734696|NCT01653171|Expectorants|expectorants|mesh-ancestor
24734697|NCT01653171|Respiratory System Agents|respiratory system agents|mesh-ancestor
24734698|NCT01653171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24734699|NCT01653171|Antioxidants|antioxidants|mesh-ancestor
24734701|NCT01653171|Protective Agents|protective agents|mesh-ancestor
24617542|NCT01043666|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24617543|NCT01043666|Cholinergic Agents|cholinergic agents|mesh-ancestor
24617544|NCT01043679|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24617545|NCT01043679|Antidepressive Agents|antidepressive agents|mesh-ancestor
24735033|NCT01655199|Adrenergic Agents|adrenergic agents|mesh-ancestor
24735034|NCT01655199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24735035|NCT01655199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735036|NCT01655199|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24735037|NCT01655199|Cholinergic Agents|cholinergic agents|mesh-ancestor
24735038|NCT01655212|Valganciclovir|valganciclovir|mesh-list
24735039|NCT01655212|Antiviral Agents|antiviral agents|mesh-ancestor
24735040|NCT01655212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24735041|NCT01655303|Propranolol|propranolol|mesh-list
24735071|NCT01655524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24735073|NCT01655524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24735074|NCT01655524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735075|NCT01655524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24735076|NCT01655524|Respiratory System Agents|respiratory system agents|mesh-ancestor
24735275|NCT01656070|Vitamins|vitamins|mesh-ancestor
24735276|NCT01656070|Micronutrients|micronutrients|mesh-ancestor
24735277|NCT01656070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735278|NCT01656070|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24735279|NCT01656070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25710178|NCT02283294|Protease Inhibitors|protease inhibitors|mesh-ancestor
25710179|NCT02283294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710180|NCT02283294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710181|NCT02283658|Everolimus|everolimus|mesh-list
25710182|NCT02283658|Letrozole|letrozole|mesh-list
25710183|NCT02283658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710184|NCT02283658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24506687|NCT00546520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24506688|NCT00546520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506689|NCT00546520|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24506693|NCT00546533|Analgesics|analgesics|mesh-ancestor
24506755|NCT00546832|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24506756|NCT00546832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24506757|NCT00546832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506758|NCT00546832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735280|NCT01656109|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24735281|NCT01656109|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24735282|NCT01656109|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24735283|NCT01656109|Protease Inhibitors|protease inhibitors|mesh-ancestor
24523928|NCT05338489|Itraconazole|itraconazole|mesh-list
24399663|NCT00148395|Carboplatin|carboplatin|mesh-list
24735343|NCT01656538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735344|NCT01656551|Gemcitabine|gemcitabine|mesh-list
24735345|NCT01656551|Pemetrexed|pemetrexed|mesh-list
24735346|NCT01656551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24735347|NCT01656551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24735348|NCT01656551|Antimetabolites|antimetabolites|mesh-ancestor
24735349|NCT01656551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735350|NCT01656551|Antiviral Agents|antiviral agents|mesh-ancestor
24735351|NCT01656551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24735352|NCT01656551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735353|NCT01656551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24735354|NCT01656551|Immunologic Factors|immunologic factors|mesh-ancestor
25006750|NCT04668365|Prednisone|prednisone|mesh-list
24735355|NCT01656551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735356|NCT01656551|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24735357|NCT01656551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24735358|NCT01656616|Antidotes|antidotes|mesh-list
24735359|NCT01656616|Protective Agents|protective agents|mesh-ancestor
24735360|NCT01656616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735361|NCT01656642|Atezolizumab|atezolizumab|mesh-list
24735362|NCT01656642|Vemurafenib|vemurafenib|mesh-list
24735363|NCT01656642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24735367|NCT01656668|Theobromine|theobromine|mesh-list
24735403|NCT01656811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24735404|NCT01656811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735405|NCT01656811|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24617609|NCT01044251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24617611|NCT01044251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617612|NCT01044329|Triamcinolone|triamcinolone|mesh-list
24735450|NCT01657071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24735451|NCT01657071|Purinergic Agents|purinergic agents|mesh-ancestor
24735452|NCT01657071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24735454|NCT01657110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24735455|NCT01657110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24735456|NCT01657136|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24735457|NCT01657136|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24735458|NCT01657136|Adrenergic Agents|adrenergic agents|mesh-ancestor
24735459|NCT01657136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24735460|NCT01657136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735461|NCT01657136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735462|NCT01657201|Voriconazole|voriconazole|mesh-list
24735463|NCT01657201|Antifungal Agents|antifungal agents|mesh-ancestor
24735464|NCT01657201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24735465|NCT01657201|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24735466|NCT01657201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24735467|NCT01657201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735495|NCT01657331|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25710185|NCT02283658|Immunologic Factors|immunologic factors|mesh-ancestor
25710186|NCT02283658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710187|NCT02283658|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25710188|NCT02283658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25710189|NCT02283658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710190|NCT02283658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710191|NCT02283658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25710192|NCT02283658|Hormone Antagonists|hormone antagonists|mesh-ancestor
25710193|NCT02283658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25710194|NCT02283749|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25710195|NCT02283749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24735496|NCT01657331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24735497|NCT01657331|Alkylating Agents|alkylating agents|mesh-ancestor
24735499|NCT01657331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24735579|NCT01657747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735580|NCT01657812|Dexmedetomidine|dexmedetomidine|mesh-list
24735581|NCT01657812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24735582|NCT01657812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24735591|NCT01657812|Adrenergic Agents|adrenergic agents|mesh-ancestor
24735592|NCT01657812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24735593|NCT01657812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735626|NCT01657851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24617633|NCT01044342|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24617634|NCT01044342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24617635|NCT01044342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617636|NCT01044342|Cholinergic Agents|cholinergic agents|mesh-ancestor
24735655|NCT01657513|Adalimumab|adalimumab|mesh-list
24735702|NCT01658124|Tranexamic Acid|tranexamic acid|mesh-list
24735703|NCT01658124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24735704|NCT01658124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24400096|NCT00149656|Trace Elements|trace elements|mesh-ancestor
24735733|NCT01658215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24735737|NCT01658215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735739|NCT01658319|Fludarabine phosphate|fludarabine phosphate|mesh-list
24735740|NCT01658319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24735741|NCT01658319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24735742|NCT01658319|Antimetabolites|antimetabolites|mesh-ancestor
24650651|NCT01227200|Tramadol|tramadol|mesh-list
24735906|NCT01659242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24420844|NCT00216892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24735946|NCT01659346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24524550|NCT04710277|Narcotics|narcotics|mesh-ancestor
24735947|NCT01659346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24735948|NCT01659346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24735949|NCT01659346|Vasodilator Agents|vasodilator agents|mesh-ancestor
24735950|NCT01659346|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24735951|NCT01659346|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24735952|NCT01659359|Lidocaine|lidocaine|mesh-list
24735953|NCT01659359|Anesthetics, Local|anesthetics, local|mesh-ancestor
24735954|NCT01659359|Anesthetics|anesthetics|mesh-ancestor
24735955|NCT01659359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24617792|NCT01045772|Rilonacept|rilonacept|mesh-list
24617793|NCT01045772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24736046|NCT01659827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24736047|NCT01659892|Montelukast|montelukast|mesh-list
25006804|NCT04629378|Amoxicillin|amoxicillin|mesh-list
25006805|NCT04629378|Meropenem|meropenem|mesh-list
25006806|NCT04629378|Clavulanic Acid|clavulanic acid|mesh-list
25006807|NCT04629378|Clavulanic Acids|clavulanic acids|mesh-list
25006808|NCT04629378|Pyrazinamide|pyrazinamide|mesh-list
25006809|NCT04629378|Bedaquiline|bedaquiline|mesh-list
25006810|NCT04629378|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24736059|NCT01659905|Respiratory System Agents|respiratory system agents|mesh-ancestor
24736060|NCT01659905|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24736061|NCT01659905|Hormone Antagonists|hormone antagonists|mesh-ancestor
24736381|NCT01661751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736383|NCT01661777|Histamine Antagonists|histamine antagonists|mesh-list
24736384|NCT01661777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
24736385|NCT01661777|Natriuretic Agents|natriuretic agents|mesh-ancestor
24400875|NCT00151528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24736469|NCT01662466|Testosterone|testosterone|mesh-list
25710196|NCT02283762|Riociguat|riociguat|mesh-list
25710197|NCT02283762|Enzyme Activators|enzyme activators|mesh-ancestor
25710198|NCT02283762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736470|NCT01662466|Testosterone undecanoate|testosterone undecanoate|mesh-list
24736471|NCT01662466|Testosterone enanthate|testosterone enanthate|mesh-list
24736472|NCT01662466|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24736733|NCT01664819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736773|NCT01665209|Morphine|morphine|mesh-list
24617860|NCT01045902|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24617861|NCT01045928|Rituximab|rituximab|mesh-list
24617862|NCT01045928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24617863|NCT01045928|Lenalidomide|lenalidomide|mesh-list
24617864|NCT01045928|Antibodies|antibodies|mesh-list
24617865|NCT01045928|Immunoglobulins|immunoglobulins|mesh-list
24617866|NCT01045928|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24617867|NCT01045928|Immunologic Factors|immunologic factors|mesh-ancestor
24617868|NCT01045928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617869|NCT01045928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617870|NCT01045928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24617871|NCT01045928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24617872|NCT01045928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24617875|NCT01045941|Gemcitabine|gemcitabine|mesh-list
24617885|NCT01045941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617886|NCT01045954|Insulin|insulin|mesh-list
24617887|NCT01045954|Insulin Glargine|insulin glargine|mesh-list
24737459|NCT01669044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737460|NCT01669044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24737461|NCT01669044|Anesthetics, General|anesthetics, general|mesh-ancestor
24737462|NCT01669044|Anesthetics|anesthetics|mesh-ancestor
24737463|NCT01669044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24737464|NCT01669044|Analgesics|analgesics|mesh-ancestor
24742406|NCT05267938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737849|NCT01670812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24737851|NCT01670812|Protective Agents|protective agents|mesh-ancestor
24737852|NCT01670890|Cisplatin|cisplatin|mesh-list
24737853|NCT01670890|Temozolomide|temozolomide|mesh-list
24737854|NCT01670890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738273|NCT01674517|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24738274|NCT01674517|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24738275|NCT01674517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738276|NCT01674530|Lubiprostone|lubiprostone|mesh-list
24738277|NCT01674530|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24738278|NCT01674530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24738279|NCT01674530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738280|NCT01674556|Gemcitabine|gemcitabine|mesh-list
24738560|NCT01675999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24738561|NCT01675999|Immunologic Factors|immunologic factors|mesh-ancestor
24738600|NCT01676285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24738601|NCT01676285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738602|NCT01676285|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24738603|NCT01676285|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24738604|NCT01676285|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24738605|NCT01676285|Adrenergic Agents|adrenergic agents|mesh-ancestor
24738606|NCT01676285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24738607|NCT01676285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738608|NCT01676363|Diflunisal|diflunisal|mesh-list
24739151|NCT01679574|Metformin|metformin|mesh-list
24739152|NCT01679574|Letrozole|letrozole|mesh-list
24739153|NCT01679574|Clomiphene|clomiphene|mesh-list
24739154|NCT01679574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24739155|NCT01679574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739156|NCT01679574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739157|NCT01679574|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24739223|NCT01679899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739224|NCT01679964|Raltegravir Potassium|raltegravir potassium|mesh-list
25006828|NCT04608318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25109783|NCT03122314|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
24739387|NCT01680952|Sirolimus|sirolimus|mesh-list
24739970|NCT01685489|Antiviral Agents|antiviral agents|mesh-ancestor
24739971|NCT01685489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24739972|NCT01685489|Interferon Inducers|interferon inducers|mesh-ancestor
24739973|NCT01685489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24739974|NCT01685489|Protective Agents|protective agents|mesh-ancestor
24739975|NCT01685502|Acarbose|acarbose|mesh-list
24740062|NCT01686126|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24740063|NCT01686126|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24740537|NCT01688947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745228|NCT03889314|Antimetabolites|antimetabolites|mesh-ancestor
24741355|NCT01693601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445836|NCT00302692|Adrenergic Agents|adrenergic agents|mesh-ancestor
24741356|NCT01693601|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24741357|NCT01693601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24741358|NCT01693601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741360|NCT01693640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24741367|NCT01693679|Lamivudine|lamivudine|mesh-list
24531577|NCT00636428|Anesthetics|anesthetics|mesh-ancestor
24742134|NCT05293171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24618307|NCT01047722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24618308|NCT01047722|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24618309|NCT01047722|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24406796|NCT00171327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24618341|NCT01047982|Folic Acid|folic acid|mesh-list
24742402|NCT05267938|Anesthetics|anesthetics|mesh-list
24742403|NCT05267938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24742404|NCT05267938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742405|NCT05267938|Sensory System Agents|sensory system agents|mesh-ancestor
24618345|NCT01047982|Vitamins|vitamins|mesh-ancestor
24743059|NCT05022901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743063|NCT05021809|Calcium|calcium|mesh-list
24743064|NCT05021809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24743065|NCT05021809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743066|NCT05013567|Ibuprofen|ibuprofen|mesh-list
24743067|NCT05013567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24743314|NCT04897802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743315|NCT04897802|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24743317|NCT04897802|Hormones|hormones|mesh-ancestor
24743318|NCT04897802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24743319|NCT04887948|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24743320|NCT04887948|Immunologic Factors|immunologic factors|mesh-ancestor
24743517|NCT04761159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24743518|NCT04761159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24743519|NCT04761159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743520|NCT04760496|Oxytocin|oxytocin|mesh-list
24743521|NCT04760496|Oxytocics|oxytocics|mesh-ancestor
24743522|NCT04760496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24618467|NCT01048398|Acetaminophen|acetaminophen|mesh-list
24618468|NCT01048398|Remifentanil|remifentanil|mesh-list
24746751|NCT03850483|PF-06700841|pf-06700841|mesh-list
24743864|NCT04584684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24743865|NCT04584684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24743866|NCT04584684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743867|NCT04584684|Plasma Substitutes|plasma substitutes|mesh-ancestor
24743868|NCT04584684|Blood Substitutes|blood substitutes|mesh-ancestor
24743869|NCT04582435|Insulin|insulin|mesh-list
24743870|NCT04582435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24743871|NCT04582435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533599|NCT00644605|Sildenafil Citrate|sildenafil citrate|mesh-list
24408718|NCT00179231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24744256|NCT04391179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744257|NCT04391179|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24744328|NCT04356742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24744329|NCT04356742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744330|NCT04356742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24744331|NCT04356742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744776|NCT04143711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24744777|NCT04143711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24744778|NCT04143711|Tubulin Modulators|tubulin modulators|mesh-ancestor
24744779|NCT04143711|Antimitotic Agents|antimitotic agents|mesh-ancestor
25006852|NCT04603846|Paclitaxel|paclitaxel|mesh-list
25006853|NCT04603846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24744813|NCT04132232|Gasotransmitters|gasotransmitters|mesh-ancestor
24744814|NCT04132232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24744815|NCT04132232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744821|NCT04129060|Cholinergic Agents|cholinergic agents|mesh-list
25006856|NCT04603846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745060|NCT04007289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24745061|NCT04007289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745062|NCT04007289|Anticoagulants|anticoagulants|mesh-ancestor
24745063|NCT04004910|Antineoplastic Agents|antineoplastic agents|mesh-list
24745107|NCT03993249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24745109|NCT03993249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24409579|NCT00182507|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24745142|NCT03944941|Cetuximab|cetuximab|mesh-list
24745143|NCT03944941|Avelumab|avelumab|mesh-list
24745144|NCT03944941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24745145|NCT03944941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745146|NCT03930615|Letermovir|letermovir|mesh-list
24745419|NCT03782142|Dolutegravir|dolutegravir|mesh-list
24745420|NCT03782142|Rilpivirine|rilpivirine|mesh-list
24745421|NCT03782142|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
24745422|NCT03782142|Antiviral Agents|antiviral agents|mesh-ancestor
24745929|NCT03518242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745930|NCT03518242|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24745931|NCT03518242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25006923|NCT04518046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24745932|NCT03518242|Antimetabolites|antimetabolites|mesh-ancestor
24745933|NCT03518242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24745934|NCT03518242|Abortifacient Agents|abortifacient agents|mesh-ancestor
24746021|NCT03460210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25006931|NCT04502381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25006932|NCT04502381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25006933|NCT04502381|Antifungal Agents|antifungal agents|mesh-ancestor
25006934|NCT04502381|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25006935|NCT04502381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25006937|NCT04472182|Fluorides|fluorides|mesh-list
25006938|NCT04472182|Fluorides, Topical|fluorides, topical|mesh-list
25006939|NCT04472182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25006940|NCT04472182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006941|NCT04472182|Cariostatic Agents|cariostatic agents|mesh-ancestor
25006942|NCT04472182|Protective Agents|protective agents|mesh-ancestor
25006949|NCT04462965|Temozolomide|temozolomide|mesh-list
25006969|NCT04409509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25006970|NCT04409509|Immunologic Factors|immunologic factors|mesh-ancestor
25006971|NCT04409509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25006972|NCT04401865|Riboflavin|riboflavin|mesh-list
25006973|NCT04401865|Vitamin B Complex|vitamin b complex|mesh-ancestor
24746548|NCT05145764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24746549|NCT05145764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746550|NCT05145764|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
24747578|NCT00496795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24747579|NCT00496795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24747580|NCT00496795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24621730|NCT01063621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621731|NCT01063647|Treosulfan|treosulfan|mesh-list
24621732|NCT01063647|Busulfan|busulfan|mesh-list
24879596|NCT04640376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24747944|NCT03012815|Anticonvulsants|anticonvulsants|mesh-ancestor
24747976|NCT03006432|Immunologic Factors|immunologic factors|mesh-ancestor
24747977|NCT03006432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24747978|NCT03006432|Antidotes|antidotes|mesh-ancestor
24747979|NCT03006432|Protective Agents|protective agents|mesh-ancestor
24747980|NCT03006432|Vitamin B Complex|vitamin b complex|mesh-ancestor
24748398|NCT02623998|Hormones|hormones|mesh-ancestor
24748399|NCT02623998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24655083|NCT01254383|Sildenafil Citrate|sildenafil citrate|mesh-list
24748409|NCT02608684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748411|NCT02608684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24879725|NCT04511728|Propofol|propofol|mesh-list
24748412|NCT02608684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24748413|NCT02608684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24748414|NCT02608684|Immunologic Factors|immunologic factors|mesh-ancestor
24748415|NCT02608684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412764|NCT00191971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748448|NCT02587520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748449|NCT02584829|Interferons|interferons|mesh-list
24748450|NCT02584829|Interferon-beta|interferon-beta|mesh-list
24749218|NCT01414777|Ondansetron|ondansetron|mesh-list
24749219|NCT01414777|Antiemetics|antiemetics|mesh-ancestor
24749220|NCT01414777|Autonomic Agents|autonomic agents|mesh-ancestor
25710199|NCT02283788|Moxifloxacin|moxifloxacin|mesh-list
25710200|NCT02283788|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25710201|NCT02283788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25710202|NCT02283788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25710203|NCT02283788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25710204|NCT02283788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24749221|NCT01414777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24749222|NCT01414777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749223|NCT01414777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24749225|NCT01414777|Dermatologic Agents|dermatologic agents|mesh-ancestor
24749226|NCT01414777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24749227|NCT01414777|Serotonin Agents|serotonin agents|mesh-ancestor
24749228|NCT01414777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24749230|NCT01414777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24618887|NCT01050114|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24618888|NCT01050114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24749764|NCT00379340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24749765|NCT00379340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24749949|NCT01695070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749951|NCT01695109|Liraglutide|liraglutide|mesh-list
24750102|NCT01696526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24750103|NCT01696552|Cimetidine|cimetidine|mesh-list
24750104|NCT01696552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24750105|NCT01696552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24750115|NCT01696617|Aripiprazole|aripiprazole|mesh-list
24750254|NCT01697293|Immunologic Factors|immunologic factors|mesh-ancestor
24750255|NCT01697293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750257|NCT01697293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24750258|NCT01697293|Alkylating Agents|alkylating agents|mesh-ancestor
24750518|NCT01699126|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24750520|NCT01699126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750645|NCT01699828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24750646|NCT01699828|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24750647|NCT01699828|Serotonin Agents|serotonin agents|mesh-ancestor
24750648|NCT01699828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24750649|NCT01699828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750650|NCT01699854|Capsaicin|capsaicin|mesh-list
24750651|NCT01699854|Antipruritics|antipruritics|mesh-ancestor
24750652|NCT01699854|Dermatologic Agents|dermatologic agents|mesh-ancestor
24750832|NCT01700881|Antioxidants|antioxidants|mesh-ancestor
24415262|NCT00199147|Cytarabine|cytarabine|mesh-list
24750973|NCT01701349|Mitosis Modulators|mitosis modulators|mesh-ancestor
24619027|NCT01050491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619030|NCT01050517|Praziquantel|praziquantel|mesh-list
24619031|NCT01050517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24619032|NCT01050517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24619033|NCT01050517|Anthelmintics|anthelmintics|mesh-ancestor
24619034|NCT01050517|Anticestodal Agents|anticestodal agents|mesh-ancestor
24619035|NCT01050517|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24619036|NCT01050517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24619037|NCT01050517|Tubulin Modulators|tubulin modulators|mesh-ancestor
25710205|NCT02283788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710206|NCT02283788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710207|NCT02283788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710208|NCT02283788|Anticonvulsants|anticonvulsants|mesh-ancestor
24619038|NCT01050517|Antimitotic Agents|antimitotic agents|mesh-ancestor
24619039|NCT01050517|Mitosis Modulators|mitosis modulators|mesh-ancestor
24619040|NCT01050517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751499|NCT01704638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751500|NCT01704638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24751501|NCT01704638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24751502|NCT01704638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24751503|NCT01704638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24751504|NCT01704638|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24751505|NCT01704638|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24751506|NCT01704638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24751507|NCT01704638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24751509|NCT01704638|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24751547|NCT01704716|Alkylating Agents|alkylating agents|mesh-ancestor
24751548|NCT01704716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751549|NCT01704716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751746|NCT01705938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24751747|NCT01705938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24751749|NCT01705951|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25007039|NCT04332211|Respiratory System Agents|respiratory system agents|mesh-ancestor
25007040|NCT04332211|Nasal Decongestants|nasal decongestants|mesh-ancestor
25007041|NCT04332211|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25007042|NCT04332211|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25007043|NCT04332211|Sympathomimetics|sympathomimetics|mesh-ancestor
25007044|NCT04332211|Adrenergic Agents|adrenergic agents|mesh-ancestor
25007045|NCT04332211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24751822|NCT01706510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24751823|NCT01706510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24751824|NCT01706510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24751889|NCT01707134|Isophane insulin, beef|isophane insulin, beef|mesh-list
24751890|NCT01707134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24751891|NCT01707134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751893|NCT01707160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24751894|NCT01707160|Insulin Aspart|insulin aspart|mesh-list
24751895|NCT01707160|Biphasic Insulins|biphasic insulins|mesh-list
24416380|NCT00202982|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24619130|NCT01050985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24619131|NCT01050985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24619132|NCT01050985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24657541|NCT01268163|Tubulin Modulators|tubulin modulators|mesh-ancestor
24619133|NCT01050985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24619134|NCT01050985|Antifungal Agents|antifungal agents|mesh-ancestor
24619135|NCT01050985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24657983|NCT01269788|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24752391|NCT01710163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752392|NCT01710163|Dopamine Agonists|dopamine agonists|mesh-ancestor
24752428|NCT01710384|Hormones|hormones|mesh-ancestor
25007060|NCT04284657|Sequestering Agents|sequestering agents|mesh-ancestor
24752429|NCT01710384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24752430|NCT01710384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753291|NCT01714427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24753292|NCT01714427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24753293|NCT01714557|Tazobactam|tazobactam|mesh-list
24753294|NCT01714557|Piperacillin|piperacillin|mesh-list
24753295|NCT01714557|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24753296|NCT01714557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24753297|NCT01714557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24753298|NCT01714557|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24753299|NCT01714557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753300|NCT01714557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753301|NCT01714570|Tazobactam|tazobactam|mesh-list
24753302|NCT01714570|Piperacillin|piperacillin|mesh-list
24753303|NCT01714570|Imipenem|imipenem|mesh-list
24753304|NCT01714570|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24880622|NCT03560934|Hormones|hormones|mesh-ancestor
24659079|NCT01275547|GABA Agents|gaba agents|mesh-ancestor
24753305|NCT01714570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24417909|NCT00208169|Dopamine Agents|dopamine agents|mesh-ancestor
24753445|NCT01715441|Sorafenib|sorafenib|mesh-list
24753446|NCT01715441|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24753447|NCT01715441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24753448|NCT01715441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24619298|NCT01051934|Mitosis Modulators|mitosis modulators|mesh-ancestor
24753820|NCT01717950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753821|NCT01717950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24754206|NCT01719627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007083|NCT04222816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24591855|NCT00919295|Histamine Agents|histamine agents|mesh-ancestor
25007084|NCT04222816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007092|NCT04179968|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
24754588|NCT01721655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24436029|NCT00268710|Antimitotic Agents|antimitotic agents|mesh-ancestor
24754659|NCT01722227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24419378|NCT00211978|Calcium|calcium|mesh-list
24754704|NCT01722409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24754705|NCT01722409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24754706|NCT01722409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24754715|NCT01722448|Choline|choline|mesh-list
24463165|NCT00359151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24463167|NCT00359164|Bevacizumab|bevacizumab|mesh-list
24505143|NCT00540098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24619523|NCT01052870|Urological Agents|urological agents|mesh-ancestor
24619524|NCT01052896|Gabapentin|gabapentin|mesh-list
24619605|NCT01053065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24619606|NCT01053169|Thrombin|thrombin|mesh-list
24619607|NCT01053169|Hemostatics|hemostatics|mesh-ancestor
24619608|NCT01053169|Coagulants|coagulants|mesh-ancestor
24619609|NCT01053208|Diphenhydramine|diphenhydramine|mesh-list
24619610|NCT01053208|Promethazine|promethazine|mesh-list
24619611|NCT01053208|Ibuprofen|ibuprofen|mesh-list
24619613|NCT01053208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24755347|NCT01726088|Modafinil|modafinil|mesh-list
24755952|NCT01730326|Antipyretics|antipyretics|mesh-ancestor
24755953|NCT01730326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24755954|NCT01730326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24420794|NCT00216827|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24420795|NCT00216827|Betamethasone benzoate|betamethasone benzoate|mesh-list
24420797|NCT00216827|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24756075|NCT01731132|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24756076|NCT01731132|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24756077|NCT01731132|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24756359|NCT01732666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756459|NCT01733485|Sensory System Agents|sensory system agents|mesh-ancestor
24756460|NCT01733485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24756461|NCT01733485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756462|NCT01733485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24756463|NCT01733485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24756464|NCT01733485|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24619673|NCT01053338|Antipruritics|antipruritics|mesh-ancestor
24756659|NCT01735006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756660|NCT01735019|Remifentanil|remifentanil|mesh-list
24756661|NCT01735019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24756662|NCT01735019|Narcotics|narcotics|mesh-ancestor
24756663|NCT01735019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24756664|NCT01735019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756665|NCT01735019|Analgesics|analgesics|mesh-ancestor
24756666|NCT01735019|Sensory System Agents|sensory system agents|mesh-ancestor
24756806|NCT01735825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756807|NCT01735825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24756808|NCT01735825|Immunologic Factors|immunologic factors|mesh-ancestor
24756809|NCT01735825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756811|NCT01735864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24756812|NCT01735864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24756813|NCT01735890|Amlodipine|amlodipine|mesh-list
24756814|NCT01735890|Valsartan|valsartan|mesh-list
24756815|NCT01735890|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
24756816|NCT01735890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24756817|NCT01735890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24547226|NCT00703144|Tazobactam|tazobactam|mesh-list
24756818|NCT01735890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24756868|NCT01736163|Hormones|hormones|mesh-list
24757038|NCT01737320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24757039|NCT01737320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24757040|NCT01737320|Antitubercular Agents|antitubercular agents|mesh-ancestor
24511947|NCT00571740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438133|NCT00275054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24757048|NCT01737359|Antiviral Agents|antiviral agents|mesh-ancestor
24619710|NCT01053403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24619711|NCT01053403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24619712|NCT01053403|Adrenergic Agents|adrenergic agents|mesh-ancestor
24619713|NCT01053442|Fe(III)-EDTA|fe(iii)-edta|mesh-list
24619714|NCT01053442|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24619715|NCT01053442|Chelating Agents|chelating agents|mesh-ancestor
24619716|NCT01053442|Sequestering Agents|sequestering agents|mesh-ancestor
24790101|NCT01940796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24790103|NCT01940952|Udenafil|udenafil|mesh-list
24790104|NCT01940952|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24790105|NCT01940952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24790106|NCT01940952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757449|NCT01739985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24757451|NCT01739985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24757452|NCT01739985|Protease Inhibitors|protease inhibitors|mesh-ancestor
24757453|NCT01739985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757454|NCT01739985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757455|NCT01739985|Antipruritics|antipruritics|mesh-ancestor
24757456|NCT01739985|Dermatologic Agents|dermatologic agents|mesh-ancestor
24757457|NCT01739985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24757458|NCT01739985|Serotonin Agents|serotonin agents|mesh-ancestor
24757459|NCT01739985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24757460|NCT01739985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24757461|NCT01739985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24757462|NCT01739985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24757463|NCT01739985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24757464|NCT01739985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24757465|NCT01739985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24757466|NCT01739985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24757981|NCT01743157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757982|NCT01743157|Growth Inhibitors|growth inhibitors|mesh-ancestor
24757983|NCT01743157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24757984|NCT01743157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619890|NCT01054118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619923|NCT01054508|Micronutrients|micronutrients|mesh-ancestor
24619924|NCT01054508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619925|NCT01054508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24619926|NCT01054508|Antimetabolites|antimetabolites|mesh-ancestor
24619927|NCT01054508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619928|NCT01054508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24619929|NCT01054508|Vasodilator Agents|vasodilator agents|mesh-ancestor
24619930|NCT01054547|Anesthetics|anesthetics|mesh-list
24619931|NCT01054547|Ropivacaine|ropivacaine|mesh-list
24619932|NCT01054547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24619933|NCT01054547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619934|NCT01054547|Anesthetics, Local|anesthetics, local|mesh-ancestor
24758085|NCT01743820|Primaquine|primaquine|mesh-list
24758159|NCT01744184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24758160|NCT01744184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758161|NCT01744184|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24758162|NCT01744184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24758164|NCT01744184|Sensory System Agents|sensory system agents|mesh-ancestor
24758214|NCT01744314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24758215|NCT01744314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24758216|NCT01744314|Gout Suppressants|gout suppressants|mesh-ancestor
24758217|NCT01744314|Tocolytic Agents|tocolytic agents|mesh-ancestor
24758338|NCT01745328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758339|NCT01745328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758340|NCT01745328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758341|NCT01745328|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25710209|NCT02283788|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25710210|NCT02283788|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25710211|NCT02283788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25710212|NCT02283814|Topiramate|topiramate|mesh-list
25710213|NCT02283814|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
24758342|NCT01745328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24758345|NCT01745549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24758346|NCT01745549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758348|NCT01745562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24758349|NCT01745562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24758350|NCT01745562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758351|NCT01745562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24758719|NCT01747590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758720|NCT01747590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758721|NCT01747590|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24758722|NCT01747590|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24758723|NCT01747590|Purinergic Agents|purinergic agents|mesh-ancestor
24758724|NCT01747590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24758725|NCT01747590|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24758726|NCT01747590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24758727|NCT01747590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24758792|NCT01747746|Protease Inhibitors|protease inhibitors|mesh-ancestor
24758793|NCT01747746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423628|NCT00226473|Dacarbazine|dacarbazine|mesh-list
24758921|NCT01748487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24620081|NCT01055379|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24450864|NCT00320736|Cholinergic Agents|cholinergic agents|mesh-ancestor
24450865|NCT00320736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24450866|NCT00320736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395322|NCT00135746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24395323|NCT00135746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395324|NCT00135746|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24395327|NCT00135746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24395328|NCT00135746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395329|NCT00135759|Naltrexone|naltrexone|mesh-list
24395362|NCT00135811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24395363|NCT00135811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395364|NCT00135811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395365|NCT00135811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24395366|NCT00135811|Immunologic Factors|immunologic factors|mesh-ancestor
24395367|NCT00135811|Antifungal Agents|antifungal agents|mesh-ancestor
24395368|NCT00135811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24395369|NCT00135811|Dermatologic Agents|dermatologic agents|mesh-ancestor
24395403|NCT00135928|Lenograstim|lenograstim|mesh-list
24439422|NCT00278434|Zoledronic Acid|zoledronic acid|mesh-list
24395404|NCT00135928|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24395620|NCT00136487|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24395621|NCT00136487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24395743|NCT00136773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395776|NCT00136851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395777|NCT00136851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24395778|NCT00136851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395779|NCT00136851|Vasodilator Agents|vasodilator agents|mesh-ancestor
24395780|NCT00136851|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24455363|NCT01640301|Analgesics|analgesics|mesh-ancestor
24455364|NCT01640301|Sensory System Agents|sensory system agents|mesh-ancestor
24455365|NCT01640301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24455366|NCT01640301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24455367|NCT01640301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24455368|NCT01640301|Antiviral Agents|antiviral agents|mesh-ancestor
24455369|NCT01640301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24395963|NCT00137410|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24395964|NCT00137410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395965|NCT00137410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395967|NCT00137462|Torcetrapib|torcetrapib|mesh-list
24395968|NCT00137462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24395969|NCT00137462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24395970|NCT00137462|Antimetabolites|antimetabolites|mesh-ancestor
24396331|NCT00138593|Protease Inhibitors|protease inhibitors|mesh-ancestor
24396332|NCT00138593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396449|NCT00139035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396451|NCT00139035|Immunologic Factors|immunologic factors|mesh-ancestor
24425150|NCT00232089|Tegaserod|tegaserod|mesh-list
24396843|NCT00140114|Abortifacient Agents|abortifacient agents|mesh-ancestor
24396844|NCT00140114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24396845|NCT00140114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396846|NCT00140114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24396847|NCT00140114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24396849|NCT00140153|Testosterone|testosterone|mesh-list
24396850|NCT00140153|Androgens|androgens|mesh-ancestor
24396852|NCT00140153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24396853|NCT00140153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396854|NCT00140166|Pyridoxine|pyridoxine|mesh-list
24396855|NCT00140166|Niacinamide|niacinamide|mesh-list
24396856|NCT00140166|Niacin|niacin|mesh-list
24396857|NCT00140166|Nicotinic Acids|nicotinic acids|mesh-list
24396927|NCT00140361|Antiviral Agents|antiviral agents|mesh-ancestor
24397269|NCT00141232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24397270|NCT00141232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24397272|NCT00141245|Analgesics|analgesics|mesh-ancestor
24397273|NCT00141245|Sensory System Agents|sensory system agents|mesh-ancestor
24397274|NCT00141245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24397275|NCT00141245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397982|NCT00143156|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24397983|NCT00143156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24397984|NCT00143156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24397985|NCT00143156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24397987|NCT00143169|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24397988|NCT00143169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24397989|NCT00143169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24397990|NCT00143169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397991|NCT00143169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24455480|NCT00107198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24455482|NCT00107198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24455483|NCT00107198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24455487|NCT00107198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24455488|NCT00107198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24455489|NCT00107198|Tubulin Modulators|tubulin modulators|mesh-ancestor
24455490|NCT00107198|Antimitotic Agents|antimitotic agents|mesh-ancestor
24398434|NCT00144378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24398435|NCT00144378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24399863|NCT00148785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24399864|NCT00148785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399865|NCT00148785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24399866|NCT00148785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24399867|NCT00148785|Antiviral Agents|antiviral agents|mesh-ancestor
24399868|NCT00148785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24399869|NCT00148785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24399870|NCT00148785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24399871|NCT00148824|Vaccines|vaccines|mesh-list
24399872|NCT00148824|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24399993|NCT00149201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399994|NCT00149240|Botulinum Toxins|botulinum toxins|mesh-list
24399995|NCT00149240|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24399996|NCT00149240|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24440633|NCT00283985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24400380|NCT00150436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400381|NCT00150436|Anticonvulsants|anticonvulsants|mesh-ancestor
24400382|NCT00150436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24400383|NCT00150436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24400384|NCT00150436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759000|NCT01748929|Anticestodal Agents|anticestodal agents|mesh-ancestor
24400449|NCT00150579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24400450|NCT00150579|Dopamine Agents|dopamine agents|mesh-ancestor
24400451|NCT00150579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25710214|NCT02283814|Anticonvulsants|anticonvulsants|mesh-ancestor
25710215|NCT02283814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24400452|NCT00150579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400453|NCT00150579|Adrenergic Agents|adrenergic agents|mesh-ancestor
24400454|NCT00150579|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24400619|NCT00151034|Carboplatin|carboplatin|mesh-list
24400620|NCT00151034|Trastuzumab|trastuzumab|mesh-list
24400621|NCT00151034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24400622|NCT00151034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24400623|NCT00151034|Tubulin Modulators|tubulin modulators|mesh-ancestor
24400624|NCT00151034|Antimitotic Agents|antimitotic agents|mesh-ancestor
24400625|NCT00151034|Mitosis Modulators|mitosis modulators|mesh-ancestor
24400628|NCT00151034|Antimetabolites|antimetabolites|mesh-ancestor
25007175|NCT04074785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25007176|NCT04074785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25007177|NCT04074785|Growth Substances|growth substances|mesh-ancestor
25007178|NCT04074785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007179|NCT04074785|Growth Inhibitors|growth inhibitors|mesh-ancestor
25007180|NCT04069585|Lidocaine|lidocaine|mesh-list
25007181|NCT04069585|Anesthetics|anesthetics|mesh-list
25007182|NCT04069585|Anesthetics, Local|anesthetics, local|mesh-ancestor
25007183|NCT04069585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25007184|NCT04069585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007185|NCT04069585|Sensory System Agents|sensory system agents|mesh-ancestor
25007202|NCT04029012|Anesthetics|anesthetics|mesh-ancestor
24400991|NCT00151827|Natriuretic Agents|natriuretic agents|mesh-ancestor
24400992|NCT00151827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400993|NCT00151827|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24400994|NCT00151827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24401077|NCT00152126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24401078|NCT00152126|Alkylating Agents|alkylating agents|mesh-ancestor
24401079|NCT00152126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401080|NCT00152126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24401081|NCT00152126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24401082|NCT00152126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24401083|NCT00152126|Immunologic Factors|immunologic factors|mesh-ancestor
24401084|NCT00152126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401085|NCT00152139|Antibodies|antibodies|mesh-list
24401086|NCT00152139|Immunologic Factors|immunologic factors|mesh-ancestor
24440946|NCT00285389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24440947|NCT00285389|Glucocorticoids|glucocorticoids|mesh-ancestor
24440949|NCT00285389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24404764|NCT00164775|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24404765|NCT00164775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24404766|NCT00164775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24404922|NCT00165178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24404923|NCT00165178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24404924|NCT00165178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404925|NCT00165178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404995|NCT00165230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24404996|NCT00165230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24405070|NCT00165451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24405071|NCT00165451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24405072|NCT00165451|Alkylating Agents|alkylating agents|mesh-ancestor
24405356|NCT00166595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24405357|NCT00166595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24405358|NCT00166595|Dopamine Agents|dopamine agents|mesh-ancestor
24405609|NCT00167739|Renal Agents|renal agents|mesh-ancestor
24405610|NCT00167739|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24405611|NCT00167739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405745|NCT00168181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24405746|NCT00168181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405747|NCT00168181|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24405748|NCT00168181|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24405749|NCT00168181|Cholinergic Agents|cholinergic agents|mesh-ancestor
24406376|NCT00169988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459899|NCT00346801|Sensory System Agents|sensory system agents|mesh-ancestor
24459900|NCT00346801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24406377|NCT00169988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406378|NCT00169988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25710216|NCT02283814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710217|NCT02283814|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24406379|NCT00169988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24407373|NCT00174356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407374|NCT00174356|Tubulin Modulators|tubulin modulators|mesh-ancestor
24407375|NCT00174356|Antimitotic Agents|antimitotic agents|mesh-ancestor
24407376|NCT00174356|Mitosis Modulators|mitosis modulators|mesh-ancestor
24407377|NCT00174356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407379|NCT00174395|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24407380|NCT00174395|Serotonin Agents|serotonin agents|mesh-ancestor
24407381|NCT00174395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24407382|NCT00174395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407383|NCT00174395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459905|NCT00346801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25007233|NCT03824808|Anesthetics, Local|anesthetics, local|mesh-ancestor
24407669|NCT00174928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407687|NCT00175032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24407688|NCT00175032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407689|NCT00175032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24407690|NCT00175032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24407691|NCT00175032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25007298|NCT03797560|Sensory System Agents|sensory system agents|mesh-ancestor
24409239|NCT00181571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24409240|NCT00181571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812453|NCT02052258|Oxytocics|oxytocics|mesh-ancestor
24416915|NCT00204451|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24416970|NCT00204568|Alkylating Agents|alkylating agents|mesh-ancestor
24416971|NCT00204581|Aldesleukin|aldesleukin|mesh-list
24416972|NCT00204581|Interleukin-2|interleukin-2|mesh-list
24416973|NCT00204581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24416974|NCT00204581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24416975|NCT00204581|Analgesics|analgesics|mesh-ancestor
24429299|NCT00243399|Hormones|hormones|mesh-ancestor
24460028|NCT00347139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24420200|NCT00215371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24420201|NCT00215371|Respiratory System Agents|respiratory system agents|mesh-ancestor
24421727|NCT00220064|Immunologic Factors|immunologic factors|mesh-ancestor
24420328|NCT00215579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24420329|NCT00215579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24420330|NCT00215579|Dopamine Agents|dopamine agents|mesh-ancestor
24420331|NCT00215592|Zonisamide|zonisamide|mesh-list
24442096|NCT00290030|Alfuzosin|alfuzosin|mesh-list
24420468|NCT00216112|Tubulin Modulators|tubulin modulators|mesh-ancestor
24420469|NCT00216112|Antimitotic Agents|antimitotic agents|mesh-ancestor
24420470|NCT00216112|Mitosis Modulators|mitosis modulators|mesh-ancestor
24420706|NCT00216632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24790264|NCT01941888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24790265|NCT01941888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790266|NCT01941888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24790267|NCT01941888|Anesthetics, General|anesthetics, general|mesh-ancestor
24790268|NCT01941888|Anesthetics|anesthetics|mesh-ancestor
24790269|NCT01941888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24790270|NCT01941888|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24790271|NCT01941888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24790272|NCT01941888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24790273|NCT01941888|GABA Modulators|gaba modulators|mesh-ancestor
24790274|NCT01941888|GABA Agents|gaba agents|mesh-ancestor
24790275|NCT01941888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24790279|NCT01941901|Calcium|calcium|mesh-list
24790280|NCT01941901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24790281|NCT01941901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790282|NCT01941901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24790283|NCT01941901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24790284|NCT01941901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24790285|NCT01941914|Calcium, Dietary|calcium, dietary|mesh-list
24790286|NCT01941914|Calcium|calcium|mesh-list
24790287|NCT01941914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24790288|NCT01941914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790289|NCT01941914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24790290|NCT01941953|Metformin|metformin|mesh-list
24420707|NCT00216632|Serotonin Agents|serotonin agents|mesh-ancestor
24420714|NCT00216632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24420715|NCT00216632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24420716|NCT00216632|Dopamine Agents|dopamine agents|mesh-ancestor
24420841|NCT00216879|Dermatologic Agents|dermatologic agents|mesh-ancestor
24420842|NCT00216892|Betamethasone|betamethasone|mesh-list
24421533|NCT00219466|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24421535|NCT00219479|Anticonvulsants|anticonvulsants|mesh-ancestor
24421536|NCT00219479|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24421537|NCT00219479|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24421570|NCT00219700|Sensory System Agents|sensory system agents|mesh-ancestor
24421571|NCT00219700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24421572|NCT00219700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460035|NCT00347139|Adrenergic Agents|adrenergic agents|mesh-ancestor
24460036|NCT00347139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24421573|NCT00219700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24421574|NCT00219700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24421575|NCT00219700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24421576|NCT00219700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24421577|NCT00219700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24421578|NCT00219713|Nitrous Oxide|nitrous oxide|mesh-list
24421724|NCT00220064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24421725|NCT00220064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421726|NCT00220064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24422174|NCT00221494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24422175|NCT00221494|Vasodilator Agents|vasodilator agents|mesh-ancestor
24422177|NCT00221520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24422178|NCT00221520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24422569|NCT00222976|Gout Suppressants|gout suppressants|mesh-ancestor
24422570|NCT00222976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24422571|NCT00222976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422572|NCT00222976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422637|NCT00223288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24422638|NCT00223288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422639|NCT00223288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24422640|NCT00223288|Serotonin Agents|serotonin agents|mesh-ancestor
24422641|NCT00223288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422642|NCT00223288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24422643|NCT00223288|Antidepressive Agents|antidepressive agents|mesh-ancestor
24422644|NCT00223288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24422645|NCT00223301|Mycophenolic Acid|mycophenolic acid|mesh-list
24422646|NCT00223301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24422647|NCT00223301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24460083|NCT00347295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460084|NCT00347295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24460085|NCT00347386|Zinc Sulfate|zinc sulfate|mesh-list
24408894|NCT00180011|Omalizumab|omalizumab|mesh-list
24460086|NCT00347386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460087|NCT00347386|Astringents|astringents|mesh-ancestor
24460088|NCT00347386|Dermatologic Agents|dermatologic agents|mesh-ancestor
24460089|NCT00347399|Bevacizumab|bevacizumab|mesh-list
24790291|NCT01941953|Fluorouracil|fluorouracil|mesh-list
24460090|NCT00347399|Verteporfin|verteporfin|mesh-list
24460091|NCT00347399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24460092|NCT00347399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424142|NCT00228020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24424143|NCT00228020|Dermatologic Agents|dermatologic agents|mesh-ancestor
24424144|NCT00228020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24424145|NCT00228020|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24424146|NCT00228020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24424147|NCT00228020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24424148|NCT00228020|Antitubercular Agents|antitubercular agents|mesh-ancestor
24424149|NCT00228020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24790305|NCT01941966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790306|NCT01941966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24790307|NCT01941966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24790308|NCT01941966|Alkylating Agents|alkylating agents|mesh-ancestor
24790309|NCT01941966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24790310|NCT01941966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24790311|NCT01941979|Leucovorin|leucovorin|mesh-list
24790312|NCT01941979|Capecitabine|capecitabine|mesh-list
24790313|NCT01941979|Oxaliplatin|oxaliplatin|mesh-list
24790314|NCT01941979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24790315|NCT01941979|Antimetabolites|antimetabolites|mesh-ancestor
24790316|NCT01941979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883095|NCT04535791|Vitamin D|vitamin d|mesh-list
24424807|NCT00230815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24424808|NCT00230815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424810|NCT00230867|Acyclovir|acyclovir|mesh-list
24425187|NCT00232167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425188|NCT00232167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24425189|NCT00232167|Serotonin Agents|serotonin agents|mesh-ancestor
24425190|NCT00232167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425191|NCT00232167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24425335|NCT00232687|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24425336|NCT00232687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24425387|NCT00232882|Sympatholytics|sympatholytics|mesh-ancestor
24425388|NCT00232882|Autonomic Agents|autonomic agents|mesh-ancestor
24425389|NCT00232882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24425390|NCT00232882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425391|NCT00232882|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24425392|NCT00232882|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24425393|NCT00232882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24425399|NCT00232895|Propofol|propofol|mesh-list
24425400|NCT00232895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24425401|NCT00232895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24425402|NCT00232895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425403|NCT00232895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24425404|NCT00232895|Anesthetics, General|anesthetics, general|mesh-ancestor
24425405|NCT00232895|Anesthetics|anesthetics|mesh-ancestor
24425487|NCT00233532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24425488|NCT00233532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24425490|NCT00233532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24425538|NCT00233610|Hormone Antagonists|hormone antagonists|mesh-ancestor
24425539|NCT00233610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24425540|NCT00233610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425541|NCT00233610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24425542|NCT00233610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24425543|NCT00233610|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24425544|NCT00233610|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24425545|NCT00233610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24425546|NCT00233610|Androgen Antagonists|androgen antagonists|mesh-ancestor
24425547|NCT00233623|Leucovorin|leucovorin|mesh-list
24425548|NCT00233623|Fluorouracil|fluorouracil|mesh-list
24425549|NCT00233623|Irinotecan|irinotecan|mesh-list
24425550|NCT00233623|Gefitinib|gefitinib|mesh-list
24425551|NCT00233623|Antimetabolites|antimetabolites|mesh-ancestor
24425552|NCT00233623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425715|NCT00234091|Antimetabolites|antimetabolites|mesh-ancestor
24425716|NCT00234091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24425717|NCT00234091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24425718|NCT00234091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24425719|NCT00234091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24425789|NCT00234390|Budesonide|budesonide|mesh-list
24425790|NCT00234390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24425791|NCT00234390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24425792|NCT00234390|Autonomic Agents|autonomic agents|mesh-ancestor
24430860|NCT00249509|Bupropion|bupropion|mesh-list
24425932|NCT00234845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24425933|NCT00234845|Immunologic Factors|immunologic factors|mesh-ancestor
24426017|NCT00234936|Antimetabolites|antimetabolites|mesh-ancestor
24426025|NCT00234936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24426026|NCT00234936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24426027|NCT00234936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24426028|NCT00234949|Cephalexin|cephalexin|mesh-list
24426029|NCT00234949|Cefdinir|cefdinir|mesh-list
24426030|NCT00234949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24790317|NCT01941979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24790319|NCT01941979|Protective Agents|protective agents|mesh-ancestor
24790320|NCT01941979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790321|NCT01941979|Vitamin B Complex|vitamin b complex|mesh-ancestor
24790322|NCT01941979|Vitamins|vitamins|mesh-ancestor
24790323|NCT01941979|Micronutrients|micronutrients|mesh-ancestor
24790327|NCT01942070|Immunologic Factors|immunologic factors|mesh-ancestor
24790328|NCT01942070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710218|NCT02283814|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25710219|NCT02283814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25770619|NCT03554772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25710220|NCT02283814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790330|NCT01942109|Furosemide|furosemide|mesh-list
24790331|NCT01942109|Diuretics|diuretics|mesh-ancestor
24790332|NCT01942109|Natriuretic Agents|natriuretic agents|mesh-ancestor
24790333|NCT01942109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24626827|NCT01088763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24790334|NCT01942109|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24426036|NCT00234962|Protease Inhibitors|protease inhibitors|mesh-ancestor
24426037|NCT00234962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24426038|NCT00234962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426039|NCT00234962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24426069|NCT00235001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24426070|NCT00235001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426071|NCT00235001|Vasodilator Agents|vasodilator agents|mesh-ancestor
24426072|NCT00235001|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24426073|NCT00235001|Protease Inhibitors|protease inhibitors|mesh-ancestor
24426074|NCT00235001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24426075|NCT00235001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24426076|NCT00235014|Verapamil|verapamil|mesh-list
24426077|NCT00235014|Trandolapril|trandolapril|mesh-list
24426078|NCT00235014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24426079|NCT00235014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24426080|NCT00235014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24426099|NCT00235053|Dermatologic Agents|dermatologic agents|mesh-ancestor
24426211|NCT00235248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24426212|NCT00235248|Antipyretics|antipyretics|mesh-ancestor
24426213|NCT00235248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24426214|NCT00235248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24426215|NCT00235248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24426216|NCT00235248|Purinergic Agents|purinergic agents|mesh-ancestor
24426217|NCT00235248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24426218|NCT00235248|Anticoagulants|anticoagulants|mesh-ancestor
24426219|NCT00235261|Dexamethasone|dexamethasone|mesh-list
24426220|NCT00235261|Pregabalin|pregabalin|mesh-list
24426268|NCT00235313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24426269|NCT00235313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426327|NCT00235820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24460156|NCT00347542|Vitamin D|vitamin d|mesh-list
24460157|NCT00347542|Vitamins|vitamins|mesh-ancestor
24460158|NCT00347542|Micronutrients|micronutrients|mesh-ancestor
24460159|NCT00347542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460160|NCT00347542|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24460162|NCT00347555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24426986|NCT00237068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24426987|NCT00237068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426989|NCT00237120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24426990|NCT00237120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24426991|NCT00237120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24426992|NCT00237120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427019|NCT00237198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427021|NCT00237198|Hormone Antagonists|hormone antagonists|mesh-ancestor
24427022|NCT00237198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24427123|NCT00237484|Antimetabolites|antimetabolites|mesh-ancestor
24427124|NCT00237484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24427125|NCT00237484|Immunologic Factors|immunologic factors|mesh-ancestor
24427126|NCT00237484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24427127|NCT00237484|Dermatologic Agents|dermatologic agents|mesh-ancestor
24427128|NCT00237484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24427779|NCT00238992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24427780|NCT00238992|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24427781|NCT00238992|Antitubercular Agents|antitubercular agents|mesh-ancestor
24428303|NCT00240084|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24428305|NCT00240084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428306|NCT00240123|Diphenhydramine|diphenhydramine|mesh-list
24428307|NCT00240123|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24428308|NCT00240123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24431427|NCT00251706|Amiodarone|amiodarone|mesh-list
25710221|NCT02283827|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25710222|NCT02283827|Phenytoin|phenytoin|mesh-list
25710223|NCT02283827|Anticonvulsants|anticonvulsants|mesh-ancestor
25710224|NCT02283827|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25710225|NCT02283827|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24428765|NCT00241137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24428766|NCT00241137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24428767|NCT00241137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24429285|NCT00243204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429286|NCT00243204|Tubulin Modulators|tubulin modulators|mesh-ancestor
24429287|NCT00243204|Antimitotic Agents|antimitotic agents|mesh-ancestor
24429288|NCT00243204|Mitosis Modulators|mitosis modulators|mesh-ancestor
24790371|NCT01942187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24883537|NCT05238064|Doxorubicin|doxorubicin|mesh-list
24460208|NCT00347724|Sensory System Agents|sensory system agents|mesh-ancestor
24460209|NCT00347724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24460211|NCT00347737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24429376|NCT00243750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429377|NCT00243750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429378|NCT00243750|Dermatologic Agents|dermatologic agents|mesh-ancestor
24429379|NCT00243750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429380|NCT00243750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24429414|NCT00243880|L 647318|l 647318|mesh-list
24429415|NCT00243880|Dihydromevinolin|dihydromevinolin|mesh-list
24430484|NCT00248053|Curcumin|curcumin|mesh-list
24460239|NCT00347815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24460240|NCT00347815|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24431020|NCT00250029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431021|NCT00250029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431023|NCT00250042|Arsenic Trioxide|arsenic trioxide|mesh-list
24431024|NCT00250042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431025|NCT00250042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24431039|NCT00250081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431066|NCT00250185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431067|NCT00250185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431068|NCT00250185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431176|NCT00250744|Aprepitant|aprepitant|mesh-list
24431186|NCT00250744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24431207|NCT00250796|Leprostatic Agents|leprostatic agents|mesh-ancestor
24431208|NCT00250796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25007414|NCT03614923|Mometasone Furoate|mometasone furoate|mesh-list
25007415|NCT03614923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25007416|NCT03614923|Dermatologic Agents|dermatologic agents|mesh-ancestor
25007417|NCT03614923|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25007424|NCT03579160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007425|NCT03579160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431943|NCT00253266|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24419737|NCT00213564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431944|NCT00253266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24431946|NCT00253266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431947|NCT00253266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24432302|NCT00254254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24432020|NCT00253474|Interferon-alpha|interferon-alpha|mesh-list
24432021|NCT00253474|Interferon alpha-2|interferon alpha-2|mesh-list
24432022|NCT00253474|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24432398|NCT00254735|Antidepressive Agents|antidepressive agents|mesh-ancestor
24439902|NCT00280787|Mitosis Modulators|mitosis modulators|mesh-ancestor
24432562|NCT00255424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24432563|NCT00255437|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24432564|NCT00255437|Hematinics|hematinics|mesh-ancestor
24432565|NCT00255437|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24432567|NCT00255450|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24432568|NCT00255450|Hematinics|hematinics|mesh-ancestor
24432583|NCT00255463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432584|NCT00255476|Gefitinib|gefitinib|mesh-list
24432585|NCT00255476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432586|NCT00255476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24432587|NCT00255476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432588|NCT00255476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433822|NCT00260143|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24433824|NCT00260143|Hormones|hormones|mesh-ancestor
24434060|NCT00261339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25710226|NCT02283827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25710227|NCT02283827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710228|NCT02283827|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24434061|NCT00261339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24434131|NCT00261560|Antipyretics|antipyretics|mesh-ancestor
24434132|NCT00261573|Galantamine|galantamine|mesh-list
24432907|NCT00256893|Ropinirole|ropinirole|mesh-list
24433119|NCT00257621|Ritonavir|ritonavir|mesh-list
24434707|NCT00263276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24434708|NCT00263276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434716|NCT00263302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434717|NCT00263302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24434720|NCT00263302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24434721|NCT00263302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24434722|NCT00263302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24434723|NCT00263315|Amphotericin B|amphotericin b|mesh-list
24435102|NCT00265031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435376|NCT00266123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435378|NCT00266136|Cyclophosphamide|cyclophosphamide|mesh-list
24435380|NCT00266136|Thioguanine|thioguanine|mesh-list
24435381|NCT00266136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24435382|NCT00266136|Immunologic Factors|immunologic factors|mesh-ancestor
24435383|NCT00266136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435384|NCT00266136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24435385|NCT00266136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24435386|NCT00266136|Alkylating Agents|alkylating agents|mesh-ancestor
24435451|NCT00266357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24435453|NCT00266357|Sensory System Agents|sensory system agents|mesh-ancestor
24435454|NCT00266357|Anticonvulsants|anticonvulsants|mesh-ancestor
24435455|NCT00266357|GABA Agonists|gaba agonists|mesh-ancestor
24435456|NCT00266357|GABA Agents|gaba agents|mesh-ancestor
24435457|NCT00266448|Chlorhexidine|chlorhexidine|mesh-list
24435492|NCT00266552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24435493|NCT00266552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24435494|NCT00266552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24435495|NCT00266552|Dopamine Agents|dopamine agents|mesh-ancestor
24435496|NCT00266578|Fluticasone|fluticasone|mesh-list
24435530|NCT00266669|Nitroglycerin|nitroglycerin|mesh-list
24435533|NCT00266721|Pancreatin|pancreatin|mesh-list
24435534|NCT00266721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24435611|NCT00267267|Atorvastatin|atorvastatin|mesh-list
24435612|NCT00267267|Simvastatin|simvastatin|mesh-list
24435613|NCT00267267|Ezetimibe|ezetimibe|mesh-list
24436545|NCT00270413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24436546|NCT00270413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24436781|NCT00271349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436782|NCT00271349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24437747|NCT00274417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24437748|NCT00274417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437749|NCT00274417|Hormone Antagonists|hormone antagonists|mesh-ancestor
24437800|NCT00274521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24460477|NCT00348452|Narcotics|narcotics|mesh-ancestor
24437902|NCT00274677|Lamotrigine|lamotrigine|mesh-list
24437903|NCT00274677|Anticonvulsants|anticonvulsants|mesh-ancestor
24437904|NCT00274677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24437905|NCT00274677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24434038|NCT00261287|Hormones|hormones|mesh-ancestor
24438099|NCT00275015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24438100|NCT00275015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24438130|NCT00275054|Cyclophosphamide|cyclophosphamide|mesh-list
24438131|NCT00275054|Rituximab|rituximab|mesh-list
24438132|NCT00275054|Fludarabine|fludarabine|mesh-list
24438416|NCT00275912|Anticonvulsants|anticonvulsants|mesh-ancestor
24438730|NCT00276705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24438733|NCT00276705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24438734|NCT00276705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438735|NCT00276705|Leprostatic Agents|leprostatic agents|mesh-ancestor
24790435|NCT01942447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24790436|NCT01942447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24790437|NCT01942460|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24438855|NCT00276809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24438856|NCT00276809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25770620|NCT03554772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438857|NCT00276809|Antimetabolites|antimetabolites|mesh-ancestor
24438858|NCT00276809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25770621|NCT03554772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770622|NCT03555305|Insulin|insulin|mesh-list
25770623|NCT03555305|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25770624|NCT03555305|Insulin Glargine|insulin glargine|mesh-list
25770625|NCT03555305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24438859|NCT00276809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24460364|NCT00348244|Sensory System Agents|sensory system agents|mesh-ancestor
24460365|NCT00348244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24460366|NCT00348244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24438860|NCT00276809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24439128|NCT00277641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24439129|NCT00277641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24439130|NCT00277641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24439131|NCT00277641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24439132|NCT00277641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24439133|NCT00277654|Risperidone|risperidone|mesh-list
24439134|NCT00277654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24439135|NCT00277654|Serotonin Agents|serotonin agents|mesh-ancestor
24439136|NCT00277654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24439137|NCT00277654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439138|NCT00277654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439139|NCT00277654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24439224|NCT00278122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439225|NCT00278122|Immunologic Factors|immunologic factors|mesh-ancestor
24439226|NCT00278122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439227|NCT00278174|Interferons|interferons|mesh-list
24439228|NCT00278174|Interferon-alpha|interferon-alpha|mesh-list
24439229|NCT00278174|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
24439230|NCT00278174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439231|NCT00278174|Antiviral Agents|antiviral agents|mesh-ancestor
24439232|NCT00278174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24439233|NCT00278174|Immunologic Factors|immunologic factors|mesh-ancestor
24439234|NCT00278174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439235|NCT00278187|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24439236|NCT00278187|Volociximab|volociximab|mesh-list
24439237|NCT00278187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439397|NCT00278421|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24439398|NCT00278421|Vincristine|vincristine|mesh-list
24439399|NCT00278421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24439400|NCT00278421|Immunologic Factors|immunologic factors|mesh-ancestor
24439401|NCT00278421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439402|NCT00278421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24439403|NCT00278421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24439404|NCT00278421|Alkylating Agents|alkylating agents|mesh-ancestor
24439512|NCT00279123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24439513|NCT00279123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24439618|NCT00279565|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24439619|NCT00279565|Buprenorphine|buprenorphine|mesh-list
24439620|NCT00279565|Methadone|methadone|mesh-list
24439621|NCT00279565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439622|NCT00279565|Antiviral Agents|antiviral agents|mesh-ancestor
24440447|NCT00283179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24440448|NCT00283179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440475|NCT00283218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441317|NCT00287157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24441318|NCT00287157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24441351|NCT00287209|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24441352|NCT00287209|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24441353|NCT00287209|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24441354|NCT00287261|Zoledronic Acid|zoledronic acid|mesh-list
24441355|NCT00287261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24441356|NCT00287261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441357|NCT00287300|Azithromycin|azithromycin|mesh-list
24441358|NCT00287300|Artesunate|artesunate|mesh-list
24441381|NCT00287313|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24441382|NCT00287313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24441409|NCT00287352|Antiemetics|antiemetics|mesh-ancestor
24441410|NCT00287352|Autonomic Agents|autonomic agents|mesh-ancestor
24441411|NCT00287352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24441412|NCT00287352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441413|NCT00287352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24441414|NCT00287352|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24441921|NCT00288873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24441922|NCT00288873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441923|NCT00288873|Vitamins|vitamins|mesh-ancestor
24441924|NCT00288873|Micronutrients|micronutrients|mesh-ancestor
24441925|NCT00288873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24441926|NCT00288951|Travoprost|travoprost|mesh-list
24441927|NCT00288951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25710229|NCT02283827|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25710230|NCT02283840|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25710231|NCT02283840|Anticonvulsants|anticonvulsants|mesh-ancestor
24516266|NCT00601289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24441928|NCT00289042|Enoxaparin|enoxaparin|mesh-list
24441929|NCT00289042|Anticoagulants|anticoagulants|mesh-ancestor
24441930|NCT00289042|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24441931|NCT00289042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24441933|NCT00289250|Artesunate|artesunate|mesh-list
25007503|NCT03458247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25007505|NCT03447262|VX-659|vx-659|mesh-list
25007506|NCT03447262|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25007507|NCT03447262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25007508|NCT03447262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25007513|NCT03417180|Remifentanil|remifentanil|mesh-list
25007514|NCT03417180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25007515|NCT03417180|Narcotics|narcotics|mesh-ancestor
25007516|NCT03417180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25007517|NCT03417180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109812|NCT03121807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25109813|NCT03121807|Immunologic Factors|immunologic factors|mesh-ancestor
25109814|NCT03121807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109816|NCT03121807|Protective Agents|protective agents|mesh-ancestor
25109817|NCT03121807|Vitamin B Complex|vitamin b complex|mesh-ancestor
25109818|NCT03121807|Vitamins|vitamins|mesh-ancestor
24442005|NCT00289419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24442007|NCT00289419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24442596|NCT00291759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790523|NCT01943409|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24790524|NCT01943409|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24460509|NCT00348504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24460510|NCT00348517|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24437137|NCT00272753|Glucocorticoids|glucocorticoids|mesh-ancestor
25710232|NCT02283840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25710233|NCT02283840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25710234|NCT02283840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25710235|NCT02283840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710236|NCT02284009|rGLP-1 protein|rglp-1 protein|mesh-list
24516391|NCT00601887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24516392|NCT00601887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24516394|NCT00601887|Sensory System Agents|sensory system agents|mesh-ancestor
24516395|NCT00601887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24460515|NCT00348517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24460517|NCT00348530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24460500|NCT00348504|Protective Agents|protective agents|mesh-ancestor
24460501|NCT00348504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460579|NCT00348972|Insulin Glargine|insulin glargine|mesh-list
24443498|NCT00295243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460590|NCT00348998|Bicalutamide|bicalutamide|mesh-list
24460591|NCT00348998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25007698|NCT02909036|Immunologic Factors|immunologic factors|mesh-ancestor
25007699|NCT02909036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007700|NCT02898506|Liraglutide|liraglutide|mesh-list
25007701|NCT02898506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25007702|NCT02898506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25007703|NCT02898506|Incretins|incretins|mesh-ancestor
25007704|NCT02898506|Hormones|hormones|mesh-ancestor
24460738|NCT00349375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460740|NCT00349401|Morphine|morphine|mesh-list
24460741|NCT00349401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24460742|NCT00349401|Narcotics|narcotics|mesh-ancestor
24460743|NCT00349401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24460744|NCT00349401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460745|NCT00349401|Analgesics|analgesics|mesh-ancestor
24460746|NCT00349401|Sensory System Agents|sensory system agents|mesh-ancestor
24460747|NCT00349401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25710237|NCT02284009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710238|NCT02284009|Incretins|incretins|mesh-ancestor
25710239|NCT02284009|Hormones|hormones|mesh-ancestor
25710240|NCT02284009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25710241|NCT02284126|Vancomycin|vancomycin|mesh-list
25710242|NCT02284126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25710243|NCT02284126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25710244|NCT02284243|Dexmedetomidine|dexmedetomidine|mesh-list
25710245|NCT02284243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24460748|NCT00349401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24460874|NCT00349986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24460875|NCT00349986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439860|NCT00280553|Anesthetics, Local|anesthetics, local|mesh-ancestor
24460887|NCT00350051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24461031|NCT00350597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461034|NCT00350662|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24461035|NCT00350662|Chelating Agents|chelating agents|mesh-ancestor
24461036|NCT00350662|Sequestering Agents|sequestering agents|mesh-ancestor
24461037|NCT00350662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461038|NCT00350662|Siderophores|siderophores|mesh-ancestor
24461039|NCT00350753|Bevacizumab|bevacizumab|mesh-list
24790639|NCT01944033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24790640|NCT01944033|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24790641|NCT01944033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24790642|NCT01944033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24790643|NCT01944033|Adrenergic Agents|adrenergic agents|mesh-ancestor
24790644|NCT01944033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24790645|NCT01944033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790646|NCT01944085|Acetaminophen|acetaminophen|mesh-list
24790647|NCT01944085|Ascorbic Acid|ascorbic acid|mesh-list
24790649|NCT01944085|Vitamins|vitamins|mesh-ancestor
25007779|NCT02740127|Adrenergic Agents|adrenergic agents|mesh-ancestor
25007780|NCT02740127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25007781|NCT02740127|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25007782|NCT02740127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25007783|NCT02740127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25007784|NCT02740127|Respiratory System Agents|respiratory system agents|mesh-ancestor
25007785|NCT02740127|Mydriatics|mydriatics|mesh-ancestor
25007786|NCT02740127|Sympathomimetics|sympathomimetics|mesh-ancestor
24461040|NCT00350753|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24461041|NCT00350753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24461042|NCT00350753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461043|NCT00350753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24461044|NCT00350753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24461045|NCT00350753|Growth Substances|growth substances|mesh-ancestor
24461075|NCT00350948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24461086|NCT00350961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461088|NCT00350961|Antiviral Agents|antiviral agents|mesh-ancestor
24461089|NCT00350961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24461090|NCT00350961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461091|NCT00350961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24461092|NCT00350961|Immunologic Factors|immunologic factors|mesh-ancestor
25710246|NCT02284243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25710247|NCT02284243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461136|NCT00351104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461137|NCT00351104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461139|NCT00351130|Valsartan|valsartan|mesh-list
24461140|NCT00351130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24461141|NCT00351130|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24886652|NCT04523844|Brinzolamide|brinzolamide|mesh-list
24461142|NCT00351130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24461143|NCT00351130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461144|NCT00351130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24461234|NCT00351546|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24461235|NCT00351546|Protease Inhibitors|protease inhibitors|mesh-ancestor
24461293|NCT00351884|Vildagliptin|vildagliptin|mesh-list
24461424|NCT00352300|Tubulin Modulators|tubulin modulators|mesh-ancestor
25710248|NCT02284243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25710249|NCT02284243|Analgesics|analgesics|mesh-ancestor
25710250|NCT02284243|Sensory System Agents|sensory system agents|mesh-ancestor
25710251|NCT02284243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25710252|NCT02284243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25710253|NCT02284243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25710254|NCT02284243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25710255|NCT02284243|Adrenergic Agents|adrenergic agents|mesh-ancestor
25710256|NCT02284243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25710257|NCT02284243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710258|NCT02284386|Bupivacaine|bupivacaine|mesh-list
24461425|NCT00352300|Antimitotic Agents|antimitotic agents|mesh-ancestor
24461426|NCT00352300|Mitosis Modulators|mitosis modulators|mesh-ancestor
24461427|NCT00352300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461429|NCT00352313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461431|NCT00352339|Antidepressive Agents|antidepressive agents|mesh-ancestor
24461433|NCT00352339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24461434|NCT00352339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24461483|NCT00352430|Gasotransmitters|gasotransmitters|mesh-ancestor
24461484|NCT00352430|Protective Agents|protective agents|mesh-ancestor
24461485|NCT00352443|Everolimus|everolimus|mesh-list
24461486|NCT00352443|Lapatinib|lapatinib|mesh-list
24461487|NCT00352443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461488|NCT00352443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24461489|NCT00352443|Immunologic Factors|immunologic factors|mesh-ancestor
24461490|NCT00352443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461491|NCT00352443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24461492|NCT00352443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461493|NCT00352443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461494|NCT00352469|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24461495|NCT00352469|Antidepressive Agents|antidepressive agents|mesh-ancestor
24461496|NCT00352469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24461497|NCT00352469|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24550752|NCT00722150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24550776|NCT00722215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550777|NCT00722215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24550778|NCT00722215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550779|NCT00722215|Vasodilator Agents|vasodilator agents|mesh-ancestor
24441442|NCT00287430|Hormones|hormones|mesh-list
24550808|NCT00722631|Glimepiride|glimepiride|mesh-list
24550809|NCT00722631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24441491|NCT00287651|Insulin|insulin|mesh-list
24550842|NCT00722852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24550843|NCT00722852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550844|NCT00722852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24550845|NCT00722852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24550846|NCT00722852|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24551125|NCT00724035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24551126|NCT00724035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24551127|NCT00724035|Anesthetics, General|anesthetics, general|mesh-ancestor
24551128|NCT00724035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24551129|NCT00724035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24551138|NCT00724074|Anesthetics|anesthetics|mesh-ancestor
24551139|NCT00724074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24551140|NCT00724074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551141|NCT00724074|Sensory System Agents|sensory system agents|mesh-ancestor
24441805|NCT00288431|Sirolimus|sirolimus|mesh-list
24551178|NCT00724256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24551180|NCT00724295|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24551181|NCT00724295|Antimetabolites|antimetabolites|mesh-ancestor
24551182|NCT00724295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551183|NCT00724295|Antiviral Agents|antiviral agents|mesh-ancestor
24551186|NCT00724321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24551187|NCT00724321|Vasodilator Agents|vasodilator agents|mesh-ancestor
24551188|NCT00724360|Trastuzumab|trastuzumab|mesh-list
24551189|NCT00724360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24790786|NCT01945268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790787|NCT01945437|Magnesium Sulfate|magnesium sulfate|mesh-list
24790788|NCT01945437|Analgesics|analgesics|mesh-ancestor
24790789|NCT01945437|Sensory System Agents|sensory system agents|mesh-ancestor
24790790|NCT01945437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24790791|NCT01945437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790793|NCT01945437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24790794|NCT01945437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24790795|NCT01945437|Anticonvulsants|anticonvulsants|mesh-ancestor
25710259|NCT02284386|Anesthetics, Local|anesthetics, local|mesh-ancestor
25710260|NCT02284386|Anesthetics|anesthetics|mesh-ancestor
25710261|NCT02284386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25710262|NCT02284386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710263|NCT02284386|Sensory System Agents|sensory system agents|mesh-ancestor
25710264|NCT02284386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25710265|NCT02284464|Prednisone|prednisone|mesh-list
24516971|NCT00605098|Lopinavir|lopinavir|mesh-list
24790796|NCT01945437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24790797|NCT01945437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24551838|NCT04921371|Listerine|listerine|mesh-list
24790803|NCT01945450|Clindamycin|clindamycin|mesh-list
24551251|NCT00724685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24551254|NCT00724724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24551255|NCT00724724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24551256|NCT00724724|Analgesics|analgesics|mesh-ancestor
24551257|NCT00724724|Sensory System Agents|sensory system agents|mesh-ancestor
24551258|NCT00724724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24551259|NCT00724724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551260|NCT00724724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24551261|NCT00724724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24551262|NCT00724724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24551263|NCT00724724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24551264|NCT00724724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551265|NCT00724724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24551266|NCT00724724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24551267|NCT00724724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24551268|NCT00724724|Antipyretics|antipyretics|mesh-ancestor
24551315|NCT00725231|Doxorubicin|doxorubicin|mesh-list
24551316|NCT00725231|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24551317|NCT00725231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24551318|NCT00725231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24551319|NCT00725231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24551320|NCT00725231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24551321|NCT00725231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24551322|NCT00725231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24551384|NCT00725985|Cladribine|cladribine|mesh-list
24551385|NCT00725985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24551386|NCT00725985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24442016|NCT00289445|Levoleucovorin|levoleucovorin|mesh-list
24551408|NCT00726258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24551409|NCT00726258|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24551410|NCT00726258|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25007933|NCT02430077|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
24551413|NCT00726466|Ranibizumab|ranibizumab|mesh-list
24551414|NCT00726466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24551415|NCT00726466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24551416|NCT00726466|Growth Substances|growth substances|mesh-ancestor
24551417|NCT00726466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790849|NCT01945684|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24790850|NCT01945684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24790851|NCT01945684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583545|NCT00875082|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24583546|NCT00875082|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24583547|NCT00875082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583548|NCT00875147|Bevacizumab|bevacizumab|mesh-list
24583549|NCT00875147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24583550|NCT00875147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24583551|NCT00875147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24583552|NCT00875147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24551522|NCT05373277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24551693|NCT05145296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24551694|NCT05145296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24551695|NCT05145296|Immunologic Factors|immunologic factors|mesh-ancestor
24551696|NCT05145296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24551697|NCT05145296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24551698|NCT05139225|Daratumumab|daratumumab|mesh-list
24551699|NCT05139225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24551700|NCT05124275|Pilocarpine|pilocarpine|mesh-list
24551701|NCT05124275|Miotics|miotics|mesh-ancestor
24551839|NCT04921371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24552032|NCT04250883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24552034|NCT04250883|Micronutrients|micronutrients|mesh-ancestor
24552035|NCT04250883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552036|NCT04237103|Methotrexate|methotrexate|mesh-list
24552037|NCT04237103|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24552038|NCT04237103|Abortifacient Agents|abortifacient agents|mesh-ancestor
24552039|NCT04237103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24552040|NCT04237103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552041|NCT04237103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24552042|NCT04237103|Antimetabolites|antimetabolites|mesh-ancestor
24552043|NCT04237103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552044|NCT04237103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552045|NCT04237103|Dermatologic Agents|dermatologic agents|mesh-ancestor
25109834|NCT03121664|Hormone Antagonists|hormone antagonists|mesh-ancestor
25109835|NCT03121664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25109836|NCT03121664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109837|NCT03121664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25109838|NCT03121573|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25109839|NCT03121573|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25109840|NCT03121573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25109841|NCT03121573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25109842|NCT03121573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109843|NCT03121573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25109844|NCT03121573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583556|NCT00875173|Selenium|selenium|mesh-list
24583557|NCT00875173|Antioxidants|antioxidants|mesh-list
25109845|NCT03121573|Analgesics|analgesics|mesh-ancestor
25109846|NCT03121573|Sensory System Agents|sensory system agents|mesh-ancestor
25109847|NCT03121573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25109848|NCT03121573|Antidepressive Agents|antidepressive agents|mesh-ancestor
24552159|NCT04130204|Tubulin Modulators|tubulin modulators|mesh-ancestor
24552160|NCT04130204|Antimitotic Agents|antimitotic agents|mesh-ancestor
24552161|NCT04130204|Mitosis Modulators|mitosis modulators|mesh-ancestor
24552609|NCT02060487|Sodium Citrate|sodium citrate|mesh-list
24552610|NCT02060487|Anticoagulants|anticoagulants|mesh-ancestor
25008058|NCT02124902|Carboplatin|carboplatin|mesh-list
24552725|NCT00727077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552726|NCT00727077|Immunologic Factors|immunologic factors|mesh-ancestor
24552727|NCT00727077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552728|NCT00727103|Varenicline|varenicline|mesh-list
24552729|NCT00727103|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24552730|NCT00727103|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24552731|NCT00727103|Cholinergic Agents|cholinergic agents|mesh-ancestor
24552732|NCT00727103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24552733|NCT00727103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552734|NCT00727103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552735|NCT00727129|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24552736|NCT00727129|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24552737|NCT00727129|Estradiol|estradiol|mesh-list
24552738|NCT00727129|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24552739|NCT00727129|Estrogens|estrogens|mesh-ancestor
24552801|NCT00727831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24552802|NCT00727831|Immunologic Factors|immunologic factors|mesh-ancestor
24552803|NCT00727831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24552804|NCT00727831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24552805|NCT00727831|Antidotes|antidotes|mesh-ancestor
24553038|NCT00729131|Sensory System Agents|sensory system agents|mesh-ancestor
24553039|NCT00729131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24553040|NCT00729131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553041|NCT00729131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24553042|NCT00729131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24553043|NCT00729131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24553044|NCT00729131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24553045|NCT00729131|Immunologic Factors|immunologic factors|mesh-ancestor
24553050|NCT00729222|Diuretics|diuretics|mesh-ancestor
24553109|NCT00729573|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24553110|NCT00729573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24553113|NCT00729573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24553197|NCT00729898|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
24553198|NCT00729898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24553201|NCT00729911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24553203|NCT00729911|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24553204|NCT00729911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24553205|NCT00729911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553206|NCT00729911|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24553236|NCT00730054|Remifentanil|remifentanil|mesh-list
24553330|NCT00730392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24553331|NCT00730392|Analgesics|analgesics|mesh-ancestor
24553332|NCT00730392|Sensory System Agents|sensory system agents|mesh-ancestor
24553333|NCT00730392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24553334|NCT00730392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553335|NCT00730392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24553336|NCT00730392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24553337|NCT00730392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24553338|NCT00730392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24790959|NCT05409391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790961|NCT05409339|Caffeine|caffeine|mesh-list
24790962|NCT05409339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24790963|NCT05409339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24790964|NCT05409339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24790966|NCT05409339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24790968|NCT05409339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25008093|NCT01986075|Dopamine Agents|dopamine agents|mesh-ancestor
25008094|NCT01986075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25008095|NCT01986075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008096|NCT01986075|Adrenergic Agents|adrenergic agents|mesh-ancestor
25008097|NCT01986075|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25008098|NCT01986075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25008099|NCT01986075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25008100|NCT01986075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25008101|NCT01935466|Pioglitazone|pioglitazone|mesh-list
25008102|NCT01935466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25008103|NCT01935466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008104|NCT01850888|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24553499|NCT00731562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553551|NCT00731926|Protective Agents|protective agents|mesh-ancestor
24553552|NCT00731952|Bortezomib|bortezomib|mesh-list
24553553|NCT00731952|Vorinostat|vorinostat|mesh-list
24553554|NCT00731952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24553555|NCT00731952|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24553556|NCT00731952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553590|NCT00732186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24553591|NCT00732186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24553609|NCT00732290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24791003|NCT05408247|Antidotes|antidotes|mesh-ancestor
24553610|NCT00732290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24553612|NCT00732290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24553613|NCT00732290|Antidepressive Agents|antidepressive agents|mesh-ancestor
24553614|NCT00732290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24554283|NCT00735241|Protective Agents|protective agents|mesh-ancestor
24554347|NCT00735852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24554348|NCT00735930|Lenalidomide|lenalidomide|mesh-list
24554349|NCT00735930|Alvocidib|alvocidib|mesh-list
24554350|NCT00735930|Immunologic Factors|immunologic factors|mesh-ancestor
24554351|NCT00735930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554352|NCT00735930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24554353|NCT00735930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24554354|NCT00735930|Growth Substances|growth substances|mesh-ancestor
24554355|NCT00735930|Growth Inhibitors|growth inhibitors|mesh-ancestor
24554356|NCT00735930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24554357|NCT00735930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24554358|NCT00735930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24554359|NCT00735930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24554360|NCT00736021|Citalopram|citalopram|mesh-list
24554361|NCT00736021|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24554362|NCT00736021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24554395|NCT00736320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24554399|NCT00736320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24554401|NCT00736346|Paroxetine|paroxetine|mesh-list
24554402|NCT00736346|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24554403|NCT00736346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24554404|NCT00736346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24554473|NCT00736801|Autonomic Agents|autonomic agents|mesh-ancestor
25008134|NCT01746849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008135|NCT01746849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25008136|NCT01746849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25008137|NCT01746849|Alkylating Agents|alkylating agents|mesh-ancestor
25008138|NCT01746849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008139|NCT01746849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008140|NCT01746849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25008141|NCT01745588|Clarithromycin|clarithromycin|mesh-list
25008142|NCT01745588|Dexamethasone|dexamethasone|mesh-list
25008143|NCT01745588|Pomalidomide|pomalidomide|mesh-list
25008144|NCT01745588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25008145|NCT01745588|Antiemetics|antiemetics|mesh-ancestor
25008146|NCT01745588|Autonomic Agents|autonomic agents|mesh-ancestor
24555789|NCT00743587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24554728|NCT00737815|Magnesium citrate|magnesium citrate|mesh-list
24554730|NCT00737815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24554731|NCT00737867|Gemcitabine|gemcitabine|mesh-list
24554732|NCT00737867|Carboplatin|carboplatin|mesh-list
24555251|NCT00740571|Sensory System Agents|sensory system agents|mesh-ancestor
24555252|NCT00740571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24555253|NCT00740571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555255|NCT00740571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24555256|NCT00740571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24555257|NCT00740571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555258|NCT00740571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24555444|NCT00741585|Protective Agents|protective agents|mesh-ancestor
24555445|NCT00741585|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24555446|NCT00741585|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24555447|NCT00741585|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24555448|NCT00741585|Protease Inhibitors|protease inhibitors|mesh-ancestor
24555449|NCT00741585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24555450|NCT00741585|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24555451|NCT00741585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24555470|NCT00741741|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24555471|NCT00741741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24555472|NCT00741741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555473|NCT00741741|Antiviral Agents|antiviral agents|mesh-ancestor
24555474|NCT00741741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24555475|NCT00741741|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24555476|NCT00741741|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24555477|NCT00741767|Fluticasone|fluticasone|mesh-list
24555478|NCT00741767|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24555479|NCT00741767|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24555480|NCT00741767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24555481|NCT00741767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24555700|NCT00742820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24791084|NCT05317689|Psilocybin|psilocybin|mesh-list
24791085|NCT05317689|Psilocin|psilocin|mesh-list
24791086|NCT05317689|Hallucinogens|hallucinogens|mesh-ancestor
24791087|NCT05317689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791088|NCT05317689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24791089|NCT05285124|Melatonin|melatonin|mesh-list
24791090|NCT05285124|Antioxidants|antioxidants|mesh-ancestor
24791091|NCT05285124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791092|NCT05285124|Protective Agents|protective agents|mesh-ancestor
25008196|NCT01042522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25008232|NCT00826462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25008233|NCT00826462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24555740|NCT00742976|Insulin|insulin|mesh-list
24555772|NCT00743470|Antitubercular Agents|antitubercular agents|mesh-ancestor
24555773|NCT00743496|Antibodies|antibodies|mesh-list
24555774|NCT00743496|Immunologic Factors|immunologic factors|mesh-ancestor
25008332|NCT00281658|Paclitaxel|paclitaxel|mesh-list
24555778|NCT00743587|Tramadol|tramadol|mesh-list
24555779|NCT00743587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24555780|NCT00743587|Narcotics|narcotics|mesh-ancestor
24555781|NCT00743587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24555782|NCT00743587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555783|NCT00743587|Analgesics|analgesics|mesh-ancestor
24555784|NCT00743587|Sensory System Agents|sensory system agents|mesh-ancestor
24555785|NCT00743587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24555786|NCT00743587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24555787|NCT00743587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24555788|NCT00743587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24555851|NCT00743964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24555852|NCT00743964|Antimetabolites|antimetabolites|mesh-ancestor
24555853|NCT00743964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555854|NCT00743964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24555855|NCT00743964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24555857|NCT00743964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24555859|NCT00743990|Menthol|menthol|mesh-list
24555860|NCT00743990|Petrolatum|petrolatum|mesh-list
24555861|NCT00743990|Antipruritics|antipruritics|mesh-ancestor
24555862|NCT00743990|Dermatologic Agents|dermatologic agents|mesh-ancestor
24555863|NCT00743990|Emollients|emollients|mesh-ancestor
24555864|NCT00743990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24555865|NCT00743990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24555866|NCT00744016|Mesalamine|mesalamine|mesh-list
24555867|NCT00744016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24555868|NCT00744016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24555869|NCT00744016|Analgesics|analgesics|mesh-ancestor
24555870|NCT00744016|Sensory System Agents|sensory system agents|mesh-ancestor
24555925|NCT00744250|Pancrelipase|pancrelipase|mesh-list
24555959|NCT00744406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24555960|NCT00744406|Serotonin Agents|serotonin agents|mesh-ancestor
24555961|NCT00744406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555962|NCT00744406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24555963|NCT00744406|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24555964|NCT00744419|Pantoprazole|pantoprazole|mesh-list
24555965|NCT00744419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24556040|NCT00744770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24556041|NCT00744770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24556042|NCT00744770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556074|NCT00744887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556075|NCT00744887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24556076|NCT00744887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24556077|NCT00744887|Antiviral Agents|antiviral agents|mesh-ancestor
24556078|NCT00744887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24556079|NCT00744900|Pemetrexed|pemetrexed|mesh-list
24556080|NCT00744900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556081|NCT00744900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556119|NCT00745043|Respiratory System Agents|respiratory system agents|mesh-ancestor
24556123|NCT00745069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24443142|NCT00293787|Travoprost|travoprost|mesh-list
24556251|NCT00746499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24556252|NCT00746499|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24556253|NCT00746499|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24556285|NCT00746720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24556286|NCT00746720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24556287|NCT00746720|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24556288|NCT00746720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24556289|NCT00746720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556290|NCT00746720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556291|NCT00746746|Interferons|interferons|mesh-list
24556292|NCT00746746|Interferon-alpha|interferon-alpha|mesh-list
24556293|NCT00746746|Interferon alpha-2|interferon alpha-2|mesh-list
24556294|NCT00746746|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24556295|NCT00746746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556373|NCT00747383|Hormones|hormones|mesh-ancestor
24552543|NCT02688530|Autonomic Agents|autonomic agents|mesh-ancestor
24556376|NCT00747383|Protease Inhibitors|protease inhibitors|mesh-ancestor
24556377|NCT00747383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556378|NCT00747383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556379|NCT00747383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24556437|NCT00747708|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24556438|NCT00747708|Immunologic Factors|immunologic factors|mesh-ancestor
24556439|NCT00747708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556440|NCT00747721|Dexmedetomidine|dexmedetomidine|mesh-list
24556441|NCT00747721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24556463|NCT00747799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24556464|NCT00747799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556465|NCT00747877|Cyclophosphamide|cyclophosphamide|mesh-list
24556466|NCT00747877|Melphalan|melphalan|mesh-list
24556480|NCT00747968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24556481|NCT00747968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556482|NCT00747968|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24556483|NCT00747968|Incretins|incretins|mesh-ancestor
24556484|NCT00747968|Hormones|hormones|mesh-ancestor
24556486|NCT00748007|Rivastigmine|rivastigmine|mesh-list
24556496|NCT00748046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556498|NCT00748059|Atropine|atropine|mesh-list
24556499|NCT00748059|Clonidine|clonidine|mesh-list
24556500|NCT00748059|Nitroprusside|nitroprusside|mesh-list
24556501|NCT00748059|Methyldopa|methyldopa|mesh-list
25710266|NCT02284464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24556502|NCT00748059|Phenylephrine|phenylephrine|mesh-list
24556503|NCT00748059|Isoproterenol|isoproterenol|mesh-list
24556504|NCT00748059|Metoclopramide|metoclopramide|mesh-list
24556505|NCT00748059|Yohimbine|yohimbine|mesh-list
24556506|NCT00748059|Tyramine|tyramine|mesh-list
24556507|NCT00748059|Edrophonium|edrophonium|mesh-list
24556508|NCT00748059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24556509|NCT00748059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24556510|NCT00748059|Adrenergic Agents|adrenergic agents|mesh-ancestor
24556511|NCT00748059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24556512|NCT00748059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556545|NCT00748059|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24759012|NCT01749072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556568|NCT00748163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24556569|NCT00748163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24556570|NCT00748163|Growth Substances|growth substances|mesh-ancestor
24556571|NCT00748163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556572|NCT00748163|Growth Inhibitors|growth inhibitors|mesh-ancestor
24556573|NCT00748163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24556574|NCT00748163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556575|NCT00748176|Anesthetics|anesthetics|mesh-list
24556583|NCT00748202|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24556584|NCT00748202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24556585|NCT00748345|Caspofungin|caspofungin|mesh-list
24556586|NCT00748345|Antifungal Agents|antifungal agents|mesh-ancestor
24556587|NCT00748345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24556588|NCT00748345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584140|NCT00878670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24556590|NCT00748358|Sunitinib|sunitinib|mesh-list
24556591|NCT00748358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556592|NCT00748358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24556593|NCT00748358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24556594|NCT00748358|Growth Substances|growth substances|mesh-ancestor
24556595|NCT00748358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556596|NCT00748358|Growth Inhibitors|growth inhibitors|mesh-ancestor
24556654|NCT00748644|Azathioprine|azathioprine|mesh-list
24556655|NCT00748644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24556656|NCT00748644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556657|NCT00748644|Immunologic Factors|immunologic factors|mesh-ancestor
24556658|NCT00748644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556659|NCT00748644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24556660|NCT00748644|Antimetabolites|antimetabolites|mesh-ancestor
24556661|NCT00748644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008323|NCT00344487|Protease Inhibitors|protease inhibitors|mesh-ancestor
25008324|NCT00344487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25008325|NCT00344487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008326|NCT00344487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25008327|NCT00344487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25008328|NCT00344487|Antiviral Agents|antiviral agents|mesh-ancestor
25008329|NCT00344487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25008330|NCT00344487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25008331|NCT00344487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24557079|NCT00751205|Hormones|hormones|mesh-ancestor
24759014|NCT01749072|Antimitotic Agents|antimitotic agents|mesh-ancestor
24557156|NCT00751517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24557157|NCT00751517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24557158|NCT00751517|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24557160|NCT00751517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24557161|NCT00751517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24557162|NCT00751517|Antimetabolites|antimetabolites|mesh-ancestor
24557163|NCT00751517|Dermatologic Agents|dermatologic agents|mesh-ancestor
24557164|NCT00751517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557165|NCT00751517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25710268|NCT02284464|Hormones|hormones|mesh-ancestor
25710269|NCT02284464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24557166|NCT00751517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24557167|NCT00751556|Naproxen|naproxen|mesh-list
25710270|NCT02284464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710271|NCT02284464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25710272|NCT02284464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710273|NCT02284516|Lifitegrast|lifitegrast|mesh-list
25710274|NCT02284516|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25710275|NCT02284516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25710277|NCT02284555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24557168|NCT00751556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24557396|NCT00752479|Mycophenolic Acid|mycophenolic acid|mesh-list
24558084|NCT00755313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24558085|NCT00755313|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24558086|NCT00755313|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24558087|NCT00755313|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24558088|NCT00755313|Hormone Antagonists|hormone antagonists|mesh-ancestor
24558089|NCT00755313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24558090|NCT00755352|Pravastatin|pravastatin|mesh-list
24558091|NCT00755352|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
24558092|NCT00755352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24558093|NCT00755352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24558094|NCT00755352|Antimetabolites|antimetabolites|mesh-ancestor
24584138|NCT00878670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24584139|NCT00878670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24559100|NCT05291364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24559101|NCT05291364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24559102|NCT05291364|Adrenergic Agents|adrenergic agents|mesh-ancestor
24559103|NCT05291364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24559104|NCT05291364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008423|NCT05208398|Anticoagulants|anticoagulants|mesh-ancestor
25008424|NCT05208398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25008425|NCT05208398|Antithrombins|antithrombins|mesh-ancestor
25008426|NCT05208398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25008427|NCT05208398|Protease Inhibitors|protease inhibitors|mesh-ancestor
25008428|NCT05208398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25008429|NCT05208398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008430|NCT05208294|Sulpiride|sulpiride|mesh-list
25008431|NCT05208294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25008432|NCT05208294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25008433|NCT05208294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25008434|NCT05208294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008435|NCT05208294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25008436|NCT05208294|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25008437|NCT05208294|Dopamine Agents|dopamine agents|mesh-ancestor
25008438|NCT05208294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25008442|NCT05208268|Rabeprazole|rabeprazole|mesh-list
24559455|NCT04767061|Adrenergic Agents|adrenergic agents|mesh-ancestor
24560040|NCT03724149|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
24560041|NCT03724149|Antiviral Agents|antiviral agents|mesh-ancestor
24560042|NCT03724149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24560043|NCT03719131|Rituximab|rituximab|mesh-list
24560044|NCT03719131|Nivolumab|nivolumab|mesh-list
24560046|NCT03719131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24560047|NCT03719131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24560049|NCT03719131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24560050|NCT03719131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24560051|NCT03719131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24560052|NCT03719131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560053|NCT03680352|Cefepime|cefepime|mesh-list
24560054|NCT03680352|Enmetazobactam|enmetazobactam|mesh-list
24560055|NCT03680352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24560056|NCT03680352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25008535|NCT05171673|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
25008536|NCT05171673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25008537|NCT05171673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25008538|NCT05171673|Analgesics|analgesics|mesh-ancestor
25008539|NCT05171673|Sensory System Agents|sensory system agents|mesh-ancestor
25008540|NCT05171673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25008541|NCT05171673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008542|NCT05171673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25008543|NCT05171673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25710278|NCT02284555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25710279|NCT02284555|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25710280|NCT02284555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770626|NCT03555305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008544|NCT05171673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25770627|NCT03555565|Metformin|metformin|mesh-list
25770628|NCT03555565|Alogliptin|alogliptin|mesh-list
25770629|NCT03555565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24518951|NCT03851627|Testosterone|testosterone|mesh-list
24518952|NCT03851627|Testosterone undecanoate|testosterone undecanoate|mesh-list
24518953|NCT03851627|Testosterone enanthate|testosterone enanthate|mesh-list
25008545|NCT05171673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25008546|NCT05171673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008548|NCT05166239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25008549|NCT05166239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25008550|NCT05166239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25008551|NCT05166239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008552|NCT05149287|Ceftriaxone|ceftriaxone|mesh-list
25008553|NCT05149287|Lidocaine|lidocaine|mesh-list
25008554|NCT05149287|Anesthetics, Local|anesthetics, local|mesh-ancestor
25008555|NCT05149287|Anesthetics|anesthetics|mesh-ancestor
24560088|NCT03584009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24560376|NCT02813824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24560377|NCT02813824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24560378|NCT02813824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24560379|NCT02813824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24560380|NCT02813824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24560381|NCT02813824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24560382|NCT02813824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24560383|NCT02813824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24560384|NCT02813824|Antipyretics|antipyretics|mesh-ancestor
24560385|NCT02783300|Pembrolizumab|pembrolizumab|mesh-list
24560386|NCT02783300|GSK-3326595|gsk-3326595|mesh-list
24560387|NCT02783300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24560388|NCT02783300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24560539|NCT02369458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24560637|NCT02106988|Autonomic Agents|autonomic agents|mesh-ancestor
24560787|NCT01451515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24560788|NCT01451515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24560789|NCT01451515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24560791|NCT01451515|Autonomic Agents|autonomic agents|mesh-ancestor
24560792|NCT01451515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24561060|NCT00567580|Luteolytic Agents|luteolytic agents|mesh-ancestor
24561270|NCT00759226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24561271|NCT00759226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24561272|NCT00759226|Antimetabolites|antimetabolites|mesh-ancestor
24561291|NCT00759239|Adrenergic Agents|adrenergic agents|mesh-ancestor
24561292|NCT00759239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24561293|NCT00759239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561294|NCT00759239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561295|NCT00759239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24561296|NCT00759239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24561297|NCT00759239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24561298|NCT00759291|Acipimox|acipimox|mesh-list
24561299|NCT00759291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24561300|NCT00759291|Antimetabolites|antimetabolites|mesh-ancestor
24561301|NCT00759291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561302|NCT00759291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24561303|NCT00759317|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24561304|NCT00759317|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24561305|NCT00759317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24561306|NCT00759317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24561307|NCT00759317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710281|NCT02284555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710282|NCT02284828|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25710283|NCT02284828|Anticonvulsants|anticonvulsants|mesh-ancestor
25710284|NCT02284828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25710285|NCT02284828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25710286|NCT02284828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25770630|NCT03555565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770631|NCT03555565|Incretins|incretins|mesh-ancestor
25770632|NCT03555565|Hormones|hormones|mesh-ancestor
25770633|NCT03555565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25770634|NCT03555565|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25770635|NCT03555565|Protease Inhibitors|protease inhibitors|mesh-ancestor
25770636|NCT03555565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770637|NCT03555565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770638|NCT03555890|Cetirizine|cetirizine|mesh-list
24519988|NCT04333407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24519989|NCT04333407|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24519991|NCT04290546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24519992|NCT04290546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24561345|NCT00759460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24561346|NCT00759460|Serotonin Agents|serotonin agents|mesh-ancestor
24561348|NCT00759551|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
24561503|NCT00760981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561504|NCT00761020|Mefloquine|mefloquine|mesh-list
24561505|NCT00761020|Antimalarials|antimalarials|mesh-ancestor
24561506|NCT00761020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24561507|NCT00761020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24561508|NCT00761020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24561962|NCT00763880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24561963|NCT00763880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24561964|NCT00763880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24561968|NCT00763893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24561969|NCT00763893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24561970|NCT00763893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24561971|NCT00763893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24561972|NCT00763893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561973|NCT00763906|Norepinephrine|norepinephrine|mesh-list
24561974|NCT00763906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24561975|NCT00763906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24561976|NCT00763906|Adrenergic Agents|adrenergic agents|mesh-ancestor
24561977|NCT00763906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24562066|NCT00764413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24562067|NCT00764413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24562068|NCT00764413|Protective Agents|protective agents|mesh-ancestor
24562069|NCT00764413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24562282|NCT00765427|Retinol acetate|retinol acetate|mesh-list
24562360|NCT00766181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24562361|NCT00766181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24562497|NCT00766805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008569|NCT05122130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791413|NCT04476979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24791414|NCT04476979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791415|NCT04476979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24791416|NCT04476979|Glucocorticoids|glucocorticoids|mesh-ancestor
24791417|NCT04476979|Hormones|hormones|mesh-ancestor
24791419|NCT04476979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25109868|NCT03121352|Mitosis Modulators|mitosis modulators|mesh-ancestor
25109869|NCT03121352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109870|NCT03121352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25109871|NCT03121599|Alovudine|alovudine|mesh-list
25109872|NCT03121599|Antiviral Agents|antiviral agents|mesh-ancestor
24562504|NCT00766805|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24562506|NCT00766818|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24562507|NCT00766818|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24562508|NCT00766818|Protease Inhibitors|protease inhibitors|mesh-ancestor
24562509|NCT00766818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562511|NCT00766818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25008612|NCT04947059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25008613|NCT04938609|Pembrolizumab|pembrolizumab|mesh-list
24563553|NCT00772291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24563554|NCT00772291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24563555|NCT00772356|Insulin|insulin|mesh-list
24563556|NCT00772356|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24563557|NCT00772356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24563558|NCT00772356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563559|NCT00772395|Risedronic Acid|risedronic acid|mesh-list
24563560|NCT00772395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24563766|NCT00773552|Solifenacin Succinate|solifenacin succinate|mesh-list
24563852|NCT00774007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563853|NCT00774007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24563856|NCT00774020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25710287|NCT02284828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710288|NCT02284854|Carbamazepine|carbamazepine|mesh-list
25710289|NCT02284854|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25710290|NCT02284854|Anticonvulsants|anticonvulsants|mesh-ancestor
25710291|NCT02284854|Antimanic Agents|antimanic agents|mesh-ancestor
25710292|NCT02284854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25710293|NCT02284854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24563857|NCT00774020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563859|NCT00774072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24563860|NCT00774072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24563862|NCT00774111|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24563863|NCT00774111|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24563864|NCT00774111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563865|NCT00774111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563866|NCT00774111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24563867|NCT00774111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24563868|NCT00774111|Antiviral Agents|antiviral agents|mesh-ancestor
24563869|NCT00774111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24563870|NCT00774189|Clarithromycin|clarithromycin|mesh-list
24563871|NCT00774189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25008664|NCT04720963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25008665|NCT04720963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25008670|NCT04720963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25008671|NCT04720963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24791616|NCT03785691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25008672|NCT04720963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24563977|NCT00774605|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24563978|NCT00774605|Cholinergic Agents|cholinergic agents|mesh-ancestor
24563979|NCT00774605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24563980|NCT00774605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563981|NCT00774605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563982|NCT00774644|Clarithromycin|clarithromycin|mesh-list
24563983|NCT00774644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24563984|NCT00774644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24564158|NCT00775294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564159|NCT00775294|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24564304|NCT00775814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24564305|NCT00775814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24564308|NCT00775827|Antimetabolites|antimetabolites|mesh-ancestor
24564309|NCT00775827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564555|NCT00776724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24564557|NCT00776724|Antimitotic Agents|antimitotic agents|mesh-ancestor
24564558|NCT00776724|Mitosis Modulators|mitosis modulators|mesh-ancestor
24564559|NCT00776724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564560|NCT00776724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24564561|NCT00776724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24564562|NCT00776724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24564563|NCT00776724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24564564|NCT00776763|Bevacizumab|bevacizumab|mesh-list
24564565|NCT00776763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24564566|NCT00776763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24564567|NCT00776763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24564568|NCT00776763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24564569|NCT00776763|Growth Substances|growth substances|mesh-ancestor
24564570|NCT00776763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564572|NCT00776802|Dexamethasone|dexamethasone|mesh-list
24564618|NCT00777166|Oxytocin|oxytocin|mesh-list
24564619|NCT00777166|Oxytocics|oxytocics|mesh-ancestor
24564620|NCT00777166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24564621|NCT00777166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564635|NCT00777218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24564636|NCT00777218|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24564637|NCT00777218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24564640|NCT00777244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24564696|NCT00777543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564697|NCT00777543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24564698|NCT00777543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24564699|NCT00777543|Anticoagulants|anticoagulants|mesh-ancestor
25710294|NCT02284854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710295|NCT02284854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25710296|NCT02284854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25710297|NCT02284854|Analgesics|analgesics|mesh-ancestor
25710298|NCT02284854|Sensory System Agents|sensory system agents|mesh-ancestor
25710299|NCT02284854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25710300|NCT02284854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24521074|NCT05116826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24521075|NCT05113368|Fulvestrant|fulvestrant|mesh-list
24521076|NCT05113368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24521186|NCT05018520|Tubulin Modulators|tubulin modulators|mesh-ancestor
24521187|NCT05018520|Antimitotic Agents|antimitotic agents|mesh-ancestor
24521188|NCT05018520|Mitosis Modulators|mitosis modulators|mesh-ancestor
24521189|NCT05018520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24521396|NCT04791059|Sufentanil|sufentanil|mesh-list
24564700|NCT00777543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24564701|NCT00777543|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24564702|NCT00777543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24564703|NCT00777543|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24564704|NCT00777543|Antioxidants|antioxidants|mesh-ancestor
24564705|NCT00777543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564707|NCT00777569|Nicotine|nicotine|mesh-list
24791646|NCT03659734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564885|NCT00778089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564886|NCT00778115|Simethicone|simethicone|mesh-list
24564888|NCT00778115|Antidiarrheals|antidiarrheals|mesh-list
24564889|NCT00778115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24564890|NCT00778115|Antifoaming Agents|antifoaming agents|mesh-ancestor
24564891|NCT00778115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564893|NCT00778115|Dermatologic Agents|dermatologic agents|mesh-ancestor
24564969|NCT00778271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24564970|NCT00778271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24564971|NCT00778271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24564972|NCT00778271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24564973|NCT00778271|Antimanic Agents|antimanic agents|mesh-ancestor
24564974|NCT00778284|Amoxicillin|amoxicillin|mesh-list
24564975|NCT00778284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24564976|NCT00778284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24565180|NCT00779129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24565181|NCT00779129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24565182|NCT00779129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24565183|NCT00779129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24565191|NCT00779194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24565192|NCT00779194|Immunologic Factors|immunologic factors|mesh-ancestor
24565193|NCT00779194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565216|NCT00779233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565217|NCT00779233|Antiviral Agents|antiviral agents|mesh-ancestor
24565218|NCT00779233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24565219|NCT00779233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24565229|NCT00779350|Serotonin Agents|serotonin agents|mesh-ancestor
24565305|NCT00779714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565319|NCT00779792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24565320|NCT00779792|Immunologic Factors|immunologic factors|mesh-ancestor
24565321|NCT00779792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565322|NCT00779792|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24565325|NCT00779792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24565326|NCT00779792|Glucocorticoids|glucocorticoids|mesh-ancestor
24565327|NCT00779792|Hormones|hormones|mesh-ancestor
24565328|NCT00779792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24565329|NCT00779792|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24565330|NCT00779792|Protective Agents|protective agents|mesh-ancestor
24565331|NCT00779792|Emollients|emollients|mesh-ancestor
24565332|NCT00779792|Dermatologic Agents|dermatologic agents|mesh-ancestor
24584558|NCT00880867|Poly ICLC|poly iclc|mesh-list
24565430|NCT00780325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25710301|NCT02284854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25710302|NCT02284854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710303|NCT02284854|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25710304|NCT02284854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25710305|NCT02284854|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25710306|NCT02284880|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25710307|NCT02284880|Anticonvulsants|anticonvulsants|mesh-ancestor
24565431|NCT00780325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24565432|NCT00780325|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24565433|NCT00780325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24565434|NCT00780325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565557|NCT00781196|Folic Acid|folic acid|mesh-list
24565558|NCT00781196|Hematinics|hematinics|mesh-ancestor
24565559|NCT00781196|Vitamin B Complex|vitamin b complex|mesh-ancestor
24565560|NCT00781196|Vitamins|vitamins|mesh-ancestor
24565561|NCT00781196|Micronutrients|micronutrients|mesh-ancestor
24565562|NCT00781196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565640|NCT00781521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24565641|NCT00781521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24565644|NCT00781521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24565645|NCT00781521|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24565646|NCT00781521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24565647|NCT00781547|Hormones|hormones|mesh-list
24565648|NCT00781547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24565649|NCT00781547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565650|NCT00781573|Clopidogrel|clopidogrel|mesh-list
24565732|NCT00782106|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24565733|NCT00782106|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24565734|NCT00782106|Immunoglobulin G|immunoglobulin g|mesh-list
24565735|NCT00782106|Immunologic Factors|immunologic factors|mesh-ancestor
24565736|NCT00782106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565737|NCT00782197|Hyaluronic Acid|hyaluronic acid|mesh-list
24565738|NCT00782197|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24565739|NCT00782197|Immunologic Factors|immunologic factors|mesh-ancestor
24565740|NCT00782197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24565741|NCT00782197|Viscosupplements|viscosupplements|mesh-ancestor
24565838|NCT00783042|Antimetabolites|antimetabolites|mesh-ancestor
24791668|NCT03583710|Etoposide|etoposide|mesh-list
24791669|NCT03583710|Etoposide phosphate|etoposide phosphate|mesh-list
24791670|NCT03583710|Podophyllotoxin|podophyllotoxin|mesh-list
24791671|NCT03583710|Mitotane|mitotane|mesh-list
24565951|NCT00783484|Antiviral Agents|antiviral agents|mesh-ancestor
24565952|NCT00783484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24565953|NCT00783484|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24565954|NCT00783484|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24565955|NCT00783484|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24565956|NCT00783484|Protease Inhibitors|protease inhibitors|mesh-ancestor
24565957|NCT00783484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24565958|NCT00783523|Doxycycline|doxycycline|mesh-list
24565959|NCT00783523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24565960|NCT00783523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24791694|NCT03559660|Certolizumab Pegol|certolizumab pegol|mesh-list
24566131|NCT00784498|Ketamine|ketamine|mesh-list
24566132|NCT00784498|Propofol|propofol|mesh-list
24566133|NCT00784498|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24566134|NCT00784498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24566137|NCT00784498|Anesthetics, General|anesthetics, general|mesh-ancestor
24566214|NCT00784797|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25710308|NCT02284880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25710309|NCT02284880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25710310|NCT02284880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25710311|NCT02284880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710312|NCT02284893|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25710313|NCT02284893|Dapagliflozin|dapagliflozin|mesh-list
25710314|NCT02284893|Saxagliptin|saxagliptin|mesh-list
24566215|NCT00784797|Contraceptive Agents|contraceptive agents|mesh-ancestor
24566216|NCT00784797|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25710315|NCT02284893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25710316|NCT02284893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710317|NCT02284893|Incretins|incretins|mesh-ancestor
25710318|NCT02284893|Hormones|hormones|mesh-ancestor
25710319|NCT02284893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24521914|NCT04425538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24522040|NCT04340882|Pembrolizumab|pembrolizumab|mesh-list
24522041|NCT04340882|Docetaxel|docetaxel|mesh-list
24522042|NCT04340882|Ramucirumab|ramucirumab|mesh-list
24522043|NCT04340882|Antibodies|antibodies|mesh-list
24522044|NCT04340882|Immunoglobulins|immunoglobulins|mesh-list
24522045|NCT04340882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24522046|NCT04340882|Lexatumumab|lexatumumab|mesh-list
24522047|NCT04340882|Immunologic Factors|immunologic factors|mesh-ancestor
24522048|NCT04340882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566217|NCT00784797|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24566218|NCT00784797|Hormone Antagonists|hormone antagonists|mesh-ancestor
24566237|NCT00784862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24566238|NCT00784862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566265|NCT00784940|Tamoxifen|tamoxifen|mesh-list
24566333|NCT00785330|Rituximab|rituximab|mesh-list
24566334|NCT00785330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24566335|NCT00785330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566336|NCT00785330|Immunologic Factors|immunologic factors|mesh-ancestor
24566337|NCT00785330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566338|NCT00785330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24566339|NCT00785382|Pregabalin|pregabalin|mesh-list
24566340|NCT00785382|Analgesics|analgesics|mesh-ancestor
24566341|NCT00785382|Sensory System Agents|sensory system agents|mesh-ancestor
24566342|NCT00785382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24566343|NCT00785382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566344|NCT00785382|Anticonvulsants|anticonvulsants|mesh-ancestor
24566418|NCT00785551|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24566438|NCT00785603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24566439|NCT00785603|Serotonin Agents|serotonin agents|mesh-ancestor
24566440|NCT00785603|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24566441|NCT00785603|Antidepressive Agents|antidepressive agents|mesh-ancestor
24566442|NCT00785603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24566443|NCT00785603|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24566444|NCT00785603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24566445|NCT00785603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566446|NCT00785811|N-Methylaspartate|n-methylaspartate|mesh-list
24566447|NCT00785811|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
24566490|NCT00786110|Mitosis Modulators|mitosis modulators|mesh-ancestor
24629025|NCT01102608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566491|NCT00786110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566492|NCT00786110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24566507|NCT00786149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566508|NCT00786149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566509|NCT00786240|Fesoterodine|fesoterodine|mesh-list
24566510|NCT00786240|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24566511|NCT00786240|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24566512|NCT00786240|Cholinergic Agents|cholinergic agents|mesh-ancestor
24566513|NCT00786240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24566514|NCT00786240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008839|NCT04231838|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25008840|NCT04231838|Autonomic Agents|autonomic agents|mesh-ancestor
25008841|NCT04231838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25710320|NCT02284893|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25710321|NCT02284893|Protease Inhibitors|protease inhibitors|mesh-ancestor
25710322|NCT02284893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710323|NCT02284893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710324|NCT02284893|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25710325|NCT02285010|Pregabalin|pregabalin|mesh-list
25710326|NCT02285010|Analgesics|analgesics|mesh-ancestor
25710327|NCT02285010|Sensory System Agents|sensory system agents|mesh-ancestor
25710328|NCT02285010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24500373|NCT00524069|Capecitabine|capecitabine|mesh-list
24522156|NCT04205136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24522157|NCT04205136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522158|NCT04205136|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24522159|NCT04205136|Diuretics|diuretics|mesh-ancestor
24522160|NCT04205136|Natriuretic Agents|natriuretic agents|mesh-ancestor
24522161|NCT04192903|Cisplatin|cisplatin|mesh-list
24522162|NCT04192903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522168|NCT04158440|Paclitaxel|paclitaxel|mesh-list
25710329|NCT02285010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522275|NCT04032964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25008842|NCT04231838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008843|NCT04231838|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25008844|NCT04231838|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25008845|NCT04231838|Cholinergic Agents|cholinergic agents|mesh-ancestor
25008846|NCT04231838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25008847|NCT04231838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25008848|NCT04146324|Nivolumab|nivolumab|mesh-list
25008849|NCT04146324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25008850|NCT04146324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566671|NCT00787371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24566672|NCT00787371|Immunologic Factors|immunologic factors|mesh-ancestor
24566673|NCT00787371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566674|NCT00787384|Imatinib Mesylate|imatinib mesylate|mesh-list
24566675|NCT00787384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566676|NCT00787384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24566677|NCT00787384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566678|NCT00787384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566680|NCT00787410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24566681|NCT00787410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24566682|NCT00787410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24791811|NCT03073694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566685|NCT00787436|Timolol|timolol|mesh-list
24566686|NCT00787436|Propranolol|propranolol|mesh-list
24566730|NCT00787501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566731|NCT00787501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24566732|NCT00787501|Serotonin Agents|serotonin agents|mesh-ancestor
24566733|NCT00787501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566734|NCT00787501|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24566735|NCT00787501|Antidepressive Agents|antidepressive agents|mesh-ancestor
24566736|NCT00787501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24566737|NCT00787501|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24566791|NCT00787969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24557106|NCT00751257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557107|NCT00751257|Protective Agents|protective agents|mesh-ancestor
24557108|NCT00751257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557110|NCT00751270|Valacyclovir|valacyclovir|mesh-list
24557111|NCT00751270|Antiviral Agents|antiviral agents|mesh-ancestor
24557112|NCT00751270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24557113|NCT00751374|Gentamicins|gentamicins|mesh-list
24557115|NCT00751374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24557116|NCT00751374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24566828|NCT00788060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24566990|NCT00789061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566992|NCT00789165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24566993|NCT00789165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24566994|NCT00789165|Adrenergic Agents|adrenergic agents|mesh-ancestor
24566995|NCT00789165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24566996|NCT00789165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710330|NCT02285010|Anticonvulsants|anticonvulsants|mesh-ancestor
25710331|NCT02285010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25710332|NCT02285010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25710333|NCT02285010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710334|NCT02285010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25710335|NCT02285010|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25710336|NCT02285010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25710337|NCT02285010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25710338|NCT02285010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25710339|NCT02285153|Aspirin|aspirin|mesh-list
25710340|NCT02285153|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
24523129|NCT02512926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523130|NCT02512926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24523131|NCT02512926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24523132|NCT02512926|Alkylating Agents|alkylating agents|mesh-ancestor
24523133|NCT02512926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523134|NCT02512926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24523395|NCT01293682|Calcitriol|calcitriol|mesh-list
24566997|NCT00789165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566998|NCT00789165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24566999|NCT00789165|Antimalarials|antimalarials|mesh-ancestor
24567000|NCT00789165|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24567001|NCT00789165|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24569001|NCT00798460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24791810|NCT03073694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24567101|NCT00789503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567102|NCT00789503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24567103|NCT00789503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24567104|NCT00789568|Moxifloxacin|moxifloxacin|mesh-list
24567105|NCT00789568|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24567106|NCT00789568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24567107|NCT00789568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24567108|NCT00789568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24567109|NCT00789568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24567110|NCT00789568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567111|NCT00789568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567112|NCT00789568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24567113|NCT00789568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24567114|NCT00789568|Contraceptive Agents|contraceptive agents|mesh-ancestor
24567115|NCT00789568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24567151|NCT00789711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567152|NCT00789763|Gemcitabine|gemcitabine|mesh-list
24567154|NCT00789763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24567155|NCT00789763|Antimetabolites|antimetabolites|mesh-ancestor
24567156|NCT00789763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567157|NCT00789763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24567158|NCT00789763|Antiviral Agents|antiviral agents|mesh-ancestor
24567159|NCT00789763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24567160|NCT00789763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567161|NCT00789763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25008858|NCT04141579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25008859|NCT04094519|Digoxin|digoxin|mesh-list
25008860|NCT04094519|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25008861|NCT04094519|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25008862|NCT04094519|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25008863|NCT04094519|Antimetabolites|antimetabolites|mesh-ancestor
25008865|NCT04094519|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24567195|NCT00790101|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
24567196|NCT00790101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24567197|NCT00790101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24567198|NCT00790101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567210|NCT00790114|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24567211|NCT00790114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24567212|NCT00790114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567213|NCT00790114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24567214|NCT00790114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25710341|NCT02285153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25710342|NCT02285153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25710343|NCT02285153|Analgesics|analgesics|mesh-ancestor
25710344|NCT02285153|Sensory System Agents|sensory system agents|mesh-ancestor
25710345|NCT02285153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25710346|NCT02285153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710347|NCT02285153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24523734|NCT05340803|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24523738|NCT05340803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24523739|NCT05340790|Anti-Infective Agents|anti-infective agents|mesh-list
24523840|NCT05339646|Antiviral Agents|antiviral agents|mesh-ancestor
24523841|NCT05339646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24567215|NCT00790114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24567272|NCT00790413|Alkylating Agents|alkylating agents|mesh-ancestor
24925211|NCT04152434|Analgesics|analgesics|mesh-ancestor
24567273|NCT00790413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24567274|NCT00790413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567275|NCT00790413|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24567276|NCT00790439|Cyclosporine|cyclosporine|mesh-list
24567277|NCT00790439|Sirolimus|sirolimus|mesh-list
24567279|NCT00790439|Heparin|heparin|mesh-list
24567366|NCT00790920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567367|NCT00790946|Valsartan|valsartan|mesh-list
25008876|NCT04064359|Immunoconjugates|immunoconjugates|mesh-list
24567402|NCT00791024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24567403|NCT00791024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567404|NCT00791024|Sensory System Agents|sensory system agents|mesh-ancestor
24567405|NCT00791024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24567406|NCT00791024|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24567407|NCT00791024|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24567408|NCT00791024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24567430|NCT00791193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24567431|NCT00791193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24567432|NCT00791193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567433|NCT00791193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24567576|NCT00791622|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24567577|NCT00791622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24567578|NCT00791622|Serotonin Agents|serotonin agents|mesh-ancestor
24567579|NCT00791622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24567580|NCT00791622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567581|NCT00791622|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24567582|NCT00791622|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24557505|NCT00752843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557517|NCT00752869|Dutasteride|dutasteride|mesh-list
24791819|NCT03049189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25710348|NCT02285153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25710349|NCT02285153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25710350|NCT02285153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25710351|NCT02285153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710352|NCT02285153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25710353|NCT02285153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25710354|NCT02285153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710355|NCT02285153|Antipyretics|antipyretics|mesh-ancestor
25710356|NCT02285283|Itraconazole|itraconazole|mesh-list
25710357|NCT02285283|Antifungal Agents|antifungal agents|mesh-ancestor
25710358|NCT02285283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24524399|NCT04973891|Canagliflozin|canagliflozin|mesh-list
24524400|NCT04973891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24567788|NCT00792714|Mannitol|mannitol|mesh-list
24557658|NCT00753207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557659|NCT00753207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567789|NCT00792714|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24567790|NCT00792714|Diuretics|diuretics|mesh-ancestor
24567791|NCT00792714|Natriuretic Agents|natriuretic agents|mesh-ancestor
24567792|NCT00792714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567793|NCT00792740|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
24567794|NCT00792740|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24567795|NCT00792740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567796|NCT00792740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24567798|NCT00792766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24567799|NCT00792766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24567800|NCT00792766|Immunologic Factors|immunologic factors|mesh-ancestor
24567801|NCT00792766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567802|NCT00792779|Propofol|propofol|mesh-list
24567803|NCT00792779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24567804|NCT00792779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24567805|NCT00792779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567859|NCT00793195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24567860|NCT00793221|Sirolimus|sirolimus|mesh-list
24567861|NCT00793221|Everolimus|everolimus|mesh-list
24567862|NCT00793221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24567863|NCT00793221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24567889|NCT00793377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24567940|NCT00793663|Antiemetics|antiemetics|mesh-ancestor
24567941|NCT00793663|Autonomic Agents|autonomic agents|mesh-ancestor
24567942|NCT00793663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24567943|NCT00793663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567944|NCT00793663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24567945|NCT00793663|Glucocorticoids|glucocorticoids|mesh-ancestor
24567946|NCT00793663|Hormones|hormones|mesh-ancestor
24567948|NCT00793663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24791824|NCT03049189|Immunologic Factors|immunologic factors|mesh-ancestor
24570460|NCT00804934|Growth Substances|growth substances|mesh-ancestor
24791825|NCT03049189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24791826|NCT03049189|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24791827|NCT03049189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568031|NCT00793923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568032|NCT00793923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24568033|NCT00793923|Glucocorticoids|glucocorticoids|mesh-ancestor
24568035|NCT00793923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24568036|NCT00793923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25710359|NCT02285283|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25710360|NCT02285283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25710361|NCT02285283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710362|NCT02285283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710363|NCT02285283|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25710364|NCT02285283|Hormone Antagonists|hormone antagonists|mesh-ancestor
25710365|NCT02285283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24525159|NCT03874715|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24525160|NCT03874715|Insulin Glargine|insulin glargine|mesh-list
24525161|NCT03874715|Insulin Aspart|insulin aspart|mesh-list
24525162|NCT03874715|Insulin, Long-Acting|insulin, long-acting|mesh-list
24525163|NCT03874715|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24525164|NCT03874715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24525165|NCT03874715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671042|NCT01323335|Uric Acid|uric acid|mesh-list
24568042|NCT00793975|Ramucirumab|ramucirumab|mesh-list
24568128|NCT00794755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568129|NCT00794755|Hemostatics|hemostatics|mesh-ancestor
24568130|NCT00794755|Coagulants|coagulants|mesh-ancestor
24568131|NCT00794807|Alefacept|alefacept|mesh-list
24568132|NCT00794807|Dermatologic Agents|dermatologic agents|mesh-ancestor
24568133|NCT00794807|Immunologic Factors|immunologic factors|mesh-ancestor
24568134|NCT00794807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568135|NCT00794859|Sorafenib|sorafenib|mesh-list
24568136|NCT00794859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24568228|NCT00795301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568229|NCT00795301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24568230|NCT00795301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24568282|NCT00795548|Azacitidine|azacitidine|mesh-list
24568283|NCT00795548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24568284|NCT00795548|Antimetabolites|antimetabolites|mesh-ancestor
24568285|NCT00795548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568286|NCT00795548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24568287|NCT00795548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24568288|NCT00795574|Infliximab|infliximab|mesh-list
24568289|NCT00795574|Dermatologic Agents|dermatologic agents|mesh-ancestor
24568290|NCT00795574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24568291|NCT00795574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24568292|NCT00795587|Mannitol|mannitol|mesh-list
24568293|NCT00795587|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24568294|NCT00795587|Diuretics|diuretics|mesh-ancestor
24791828|NCT03043313|Trastuzumab|trastuzumab|mesh-list
24568295|NCT00795587|Natriuretic Agents|natriuretic agents|mesh-ancestor
24568296|NCT00795587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568349|NCT00795756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568416|NCT00795912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25008899|NCT03837873|Etoposide|etoposide|mesh-list
25008900|NCT03837873|Vincristine|vincristine|mesh-list
25008901|NCT03837873|Lenalidomide|lenalidomide|mesh-list
25008902|NCT03837873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25008903|NCT03837873|Immunologic Factors|immunologic factors|mesh-ancestor
25008904|NCT03837873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008905|NCT03837873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25008906|NCT03837873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24568497|NCT00796211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24568498|NCT00796211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24568503|NCT00796250|Prednisolone|prednisolone|mesh-list
24568539|NCT00796263|Antiviral Agents|antiviral agents|mesh-ancestor
24568540|NCT00796263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24568541|NCT00796276|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24568542|NCT00796276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24568543|NCT00796276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24568544|NCT00796276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24568546|NCT00796276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24568547|NCT00796276|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24568569|NCT00796458|Docetaxel|docetaxel|mesh-list
24568646|NCT00796835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24568647|NCT00796835|Serotonin Agents|serotonin agents|mesh-ancestor
24568648|NCT00796835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25710366|NCT02285283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710367|NCT02285283|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25710368|NCT02285634|Lidocaine|lidocaine|mesh-list
25710369|NCT02285634|Phenylephrine|phenylephrine|mesh-list
25710370|NCT02285634|Epinephrine|epinephrine|mesh-list
25710371|NCT02285634|Oxymetazoline|oxymetazoline|mesh-list
25710372|NCT02285634|Anesthetics, Local|anesthetics, local|mesh-ancestor
25710373|NCT02285634|Anesthetics|anesthetics|mesh-ancestor
25710374|NCT02285634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24568649|NCT00796835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24568650|NCT00796835|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25770639|NCT03555890|Levocetirizine|levocetirizine|mesh-list
24568651|NCT00796835|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24568652|NCT00796835|Dopamine Agents|dopamine agents|mesh-ancestor
24568655|NCT00796887|Nicotinic Acids|nicotinic acids|mesh-list
24568656|NCT00796887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24568657|NCT00796887|Antimetabolites|antimetabolites|mesh-ancestor
24568730|NCT00797264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24568731|NCT00797264|Anesthetics, General|anesthetics, general|mesh-ancestor
24568733|NCT00797264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24568764|NCT00797472|Dacarbazine|dacarbazine|mesh-list
24568765|NCT00797472|Vinblastine|vinblastine|mesh-list
24568831|NCT00797784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24568832|NCT00797784|Analgesics|analgesics|mesh-ancestor
24568833|NCT00797784|Sensory System Agents|sensory system agents|mesh-ancestor
24568834|NCT00797784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24568835|NCT00797784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24568836|NCT00797784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24568837|NCT00797784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24568838|NCT00797784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24568865|NCT00797810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24568866|NCT00797810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24568867|NCT00797810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24629189|NCT01103583|Hydroxyurea|hydroxyurea|mesh-list
24568872|NCT00797810|Tubulin Modulators|tubulin modulators|mesh-ancestor
24569000|NCT00798460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24569140|NCT00799149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569141|NCT00799149|Anticonvulsants|anticonvulsants|mesh-ancestor
24569142|NCT00799149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24569143|NCT00799149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24569144|NCT00799149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24569145|NCT00799149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24569146|NCT00799149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24569147|NCT00799149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24791873|NCT02553460|Dexamethasone|dexamethasone|mesh-list
24791874|NCT02553460|Hydrocortisone|hydrocortisone|mesh-list
24791875|NCT02553460|Cyclophosphamide|cyclophosphamide|mesh-list
24791883|NCT02553460|Vorinostat|vorinostat|mesh-list
24791884|NCT02553460|Pegaspargase|pegaspargase|mesh-list
24791885|NCT02553460|Levoleucovorin|levoleucovorin|mesh-list
24791886|NCT02553460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24791887|NCT02553460|Immunologic Factors|immunologic factors|mesh-ancestor
24791889|NCT02553460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24791890|NCT02553460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24791891|NCT02553460|Alkylating Agents|alkylating agents|mesh-ancestor
24791892|NCT02553460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24791893|NCT02553460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24791894|NCT02553460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24569247|NCT00799656|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
24569248|NCT00799656|Enzyme Activators|enzyme activators|mesh-ancestor
24569249|NCT00799656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569250|NCT00799682|Travoprost|travoprost|mesh-list
24569251|NCT00799682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24569252|NCT00799682|Latanoprost|latanoprost|mesh-list
24569253|NCT00799682|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24671049|NCT01323374|Carbidopa|carbidopa|mesh-list
24569254|NCT00799682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24569255|NCT00799760|Oseltamivir|oseltamivir|mesh-list
24569339|NCT00800280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24569341|NCT00800293|Betamethasone|betamethasone|mesh-list
24569342|NCT00800293|Betamethasone Valerate|betamethasone valerate|mesh-list
24558851|NCT05428293|Sensory System Agents|sensory system agents|mesh-ancestor
24558854|NCT05428293|Antipyretics|antipyretics|mesh-ancestor
24569343|NCT00800293|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24569344|NCT00800293|Betamethasone benzoate|betamethasone benzoate|mesh-list
24569345|NCT00800293|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24569346|NCT00800293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24443698|NCT00295841|Cytarabine|cytarabine|mesh-list
24569358|NCT00800306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24569359|NCT00800306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24569360|NCT00800306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526994|NCT00614159|Sensory System Agents|sensory system agents|mesh-ancestor
24526995|NCT00614159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24526996|NCT00614159|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24569361|NCT00800306|Protective Agents|protective agents|mesh-ancestor
24569362|NCT00800306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25008973|NCT03753555|Antioxidants|antioxidants|mesh-ancestor
25008974|NCT03753555|Protective Agents|protective agents|mesh-ancestor
25008975|NCT03734029|Gemcitabine|gemcitabine|mesh-list
25008977|NCT03734029|Camptothecin|camptothecin|mesh-list
25008978|NCT03734029|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25008979|NCT03734029|Capecitabine|capecitabine|mesh-list
25008980|NCT03734029|Trastuzumab|trastuzumab|mesh-list
25008981|NCT03734029|Immunoconjugates|immunoconjugates|mesh-list
25008982|NCT03734029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24569456|NCT00800592|Sildenafil Citrate|sildenafil citrate|mesh-list
24569457|NCT00800592|Vasodilator Agents|vasodilator agents|mesh-ancestor
24569458|NCT00800592|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24569459|NCT00800592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24791978|NCT02035137|Vincristine|vincristine|mesh-list
24791979|NCT02035137|Vorinostat|vorinostat|mesh-list
24791980|NCT02035137|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24791981|NCT02035137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25009030|NCT03709355|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25009031|NCT03709355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25009032|NCT03709355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25009033|NCT03709355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24569663|NCT00801450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24569664|NCT00801450|Glucocorticoids|glucocorticoids|mesh-ancestor
24569666|NCT00801450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24569667|NCT00801450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569668|NCT00801450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24569669|NCT00801450|Immunologic Factors|immunologic factors|mesh-ancestor
24569670|NCT00801450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24569822|NCT00801957|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24569823|NCT00801957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24569824|NCT00801957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569825|NCT00801957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24569826|NCT00801957|Dermatologic Agents|dermatologic agents|mesh-ancestor
24569828|NCT00802009|Mepivacaine|mepivacaine|mesh-list
24569829|NCT00802009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24569830|NCT00802009|Antiemetics|antiemetics|mesh-ancestor
24569831|NCT00802009|Autonomic Agents|autonomic agents|mesh-ancestor
24569901|NCT00802230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569902|NCT00802243|Leflunomide|leflunomide|mesh-list
24569903|NCT00802243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24569904|NCT00802243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569905|NCT00802243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24569906|NCT00802243|Immunologic Factors|immunologic factors|mesh-ancestor
24569907|NCT00802243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009081|NCT03637491|Avelumab|avelumab|mesh-list
24570037|NCT00802815|Sensory System Agents|sensory system agents|mesh-ancestor
24570038|NCT00802815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24570039|NCT00802815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570040|NCT00802815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24570041|NCT00802815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24570075|NCT00803166|Hormones|hormones|mesh-ancestor
25415972|NCT02980510|Vitamin B Complex|vitamin b complex|mesh-ancestor
24570076|NCT00803166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24570077|NCT00803166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570078|NCT00803192|Famotidine|famotidine|mesh-list
24570079|NCT00803192|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24570080|NCT00803192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24570081|NCT00803192|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24570082|NCT00803192|Histamine Antagonists|histamine antagonists|mesh-ancestor
24570083|NCT00803192|Histamine Agents|histamine agents|mesh-ancestor
25710375|NCT02285634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710376|NCT02285634|Sensory System Agents|sensory system agents|mesh-ancestor
25710377|NCT02285634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25710378|NCT02285634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25710379|NCT02285634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25710380|NCT02285634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25710381|NCT02285634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25710382|NCT02285634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710383|NCT02285634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24570084|NCT00803192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24671055|NCT01323374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570085|NCT00803192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570086|NCT00803192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570265|NCT00804115|Adrenergic Agents|adrenergic agents|mesh-ancestor
24570266|NCT00804115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24570267|NCT00804115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570268|NCT00804115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570269|NCT00804115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24570270|NCT00804115|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24570453|NCT00804921|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24570454|NCT00804921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24570455|NCT00804921|Diuretics|diuretics|mesh-ancestor
24570456|NCT00804921|Natriuretic Agents|natriuretic agents|mesh-ancestor
24570457|NCT00804934|Ranibizumab|ranibizumab|mesh-list
24570458|NCT00804934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24570459|NCT00804934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24570461|NCT00804934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570462|NCT00804934|Growth Inhibitors|growth inhibitors|mesh-ancestor
24570463|NCT00804934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570465|NCT00804947|Busulfan|busulfan|mesh-list
24570634|NCT00805519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24570635|NCT00805519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24570636|NCT00805519|Analgesics|analgesics|mesh-ancestor
24570637|NCT00805519|Sensory System Agents|sensory system agents|mesh-ancestor
24570638|NCT00805519|Filaricides|filaricides|mesh-ancestor
24570639|NCT00805519|Antinematodal Agents|antinematodal agents|mesh-ancestor
24570640|NCT00805519|Anthelmintics|anthelmintics|mesh-ancestor
24570641|NCT00805558|Moxifloxacin|moxifloxacin|mesh-list
24570667|NCT00805649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570704|NCT00805857|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24570705|NCT00805857|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24570706|NCT00805857|Antiviral Agents|antiviral agents|mesh-ancestor
24570707|NCT00805857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24570708|NCT00806169|Triamcinolone|triamcinolone|mesh-list
24570709|NCT00806169|Bevacizumab|bevacizumab|mesh-list
24570710|NCT00806169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24570711|NCT00806169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24570712|NCT00806169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24570713|NCT00806169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24570714|NCT00806169|Growth Substances|growth substances|mesh-ancestor
24570715|NCT00806169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570716|NCT00806169|Growth Inhibitors|growth inhibitors|mesh-ancestor
24570717|NCT00806169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24570718|NCT00806169|Glucocorticoids|glucocorticoids|mesh-ancestor
24759016|NCT01749072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24570768|NCT00806741|Autonomic Agents|autonomic agents|mesh-ancestor
24570769|NCT00806741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24570770|NCT00806741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759017|NCT01749072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24570787|NCT00806754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24570853|NCT00806923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24570855|NCT00806923|Growth Substances|growth substances|mesh-ancestor
24570856|NCT00806923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24570857|NCT00806923|Growth Inhibitors|growth inhibitors|mesh-ancestor
24570858|NCT00806923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24570860|NCT00806923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571029|NCT00807859|Mitosis Modulators|mitosis modulators|mesh-ancestor
24571030|NCT00807859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571031|NCT00807859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24571032|NCT00807859|Antimetabolites|antimetabolites|mesh-ancestor
24571033|NCT00807859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24571034|NCT00807859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24571035|NCT00807859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24560138|NCT03557307|Benralizumab|benralizumab|mesh-list
24560139|NCT03557307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24571038|NCT00807859|Growth Substances|growth substances|mesh-ancestor
24571142|NCT00808184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571144|NCT00808223|Dermatologic Agents|dermatologic agents|mesh-ancestor
24896152|NCT01668719|Hormones|hormones|mesh-ancestor
24571145|NCT00808223|Immunologic Factors|immunologic factors|mesh-ancestor
25710384|NCT02285634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24528988|NCT00624130|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
24571146|NCT00808223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571166|NCT00808327|Bupivacaine|bupivacaine|mesh-list
24571167|NCT00808327|Anesthetics, Local|anesthetics, local|mesh-ancestor
24571168|NCT00808327|Anesthetics|anesthetics|mesh-ancestor
24571183|NCT00808366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571185|NCT00808366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24571186|NCT00808366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24571187|NCT00808366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571188|NCT00808366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571190|NCT00808366|Hormone Antagonists|hormone antagonists|mesh-ancestor
24571236|NCT00808743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571237|NCT00808743|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24571238|NCT00808743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24571240|NCT00808795|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24571241|NCT00808795|Antiviral Agents|antiviral agents|mesh-ancestor
24571242|NCT00808795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571243|NCT00808795|Expectorants|expectorants|mesh-ancestor
24571244|NCT00808795|Respiratory System Agents|respiratory system agents|mesh-ancestor
25009163|NCT03269344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25009164|NCT03269344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25009165|NCT03269344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25009166|NCT03269344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25009201|NCT02966093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009202|NCT02966093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25009203|NCT02966093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25009204|NCT02966093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009206|NCT02953093|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25009207|NCT02953093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25009208|NCT02953093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009209|NCT02953093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24571408|NCT00809718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571409|NCT00809718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571410|NCT00809718|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24571411|NCT00809718|Antitubercular Agents|antitubercular agents|mesh-ancestor
24571412|NCT00809718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24571413|NCT00809718|Leprostatic Agents|leprostatic agents|mesh-ancestor
24571414|NCT00809718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24571415|NCT00809718|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24571416|NCT00809718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24571417|NCT00809718|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24571433|NCT00809796|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24571435|NCT00809874|Chelating Agents|chelating agents|mesh-ancestor
24571436|NCT00809874|Sequestering Agents|sequestering agents|mesh-ancestor
24571437|NCT00809874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571438|NCT00809887|Micafungin|micafungin|mesh-list
24571439|NCT00809887|Antifungal Agents|antifungal agents|mesh-ancestor
24571440|NCT00809887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571441|NCT00809913|Ciprofloxacin|ciprofloxacin|mesh-list
24571611|NCT00811031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571613|NCT00811031|Glucocorticoids|glucocorticoids|mesh-ancestor
24571614|NCT00811031|Hormones|hormones|mesh-ancestor
24571626|NCT00811096|Tinidazole|tinidazole|mesh-list
24571670|NCT00811239|Antivenins|antivenins|mesh-list
24571671|NCT00811239|Immunologic Factors|immunologic factors|mesh-ancestor
24571916|NCT00812266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571672|NCT00811239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571674|NCT00811291|Folic Acid|folic acid|mesh-list
24571675|NCT00811291|Calcium|calcium|mesh-list
24671066|NCT01323465|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24571676|NCT00811291|Vitamins|vitamins|mesh-ancestor
24571677|NCT00811291|Micronutrients|micronutrients|mesh-ancestor
24571678|NCT00811291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571679|NCT00811291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24571680|NCT00811291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24571681|NCT00811291|Hematinics|hematinics|mesh-ancestor
24571682|NCT00811291|Vitamin B Complex|vitamin b complex|mesh-ancestor
24571683|NCT00811330|Atorvastatin|atorvastatin|mesh-list
25009230|NCT02822092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25009231|NCT02822092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25710385|NCT02285634|Adrenergic Agents|adrenergic agents|mesh-ancestor
25710386|NCT02285634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25710387|NCT02285634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24529727|NCT00627666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25009232|NCT02822092|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25009233|NCT02822092|Dopamine Agents|dopamine agents|mesh-ancestor
25009234|NCT02822092|Antidepressive Agents|antidepressive agents|mesh-ancestor
25009235|NCT02822092|Dopamine Agonists|dopamine agonists|mesh-ancestor
25009236|NCT02822092|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25009237|NCT02822092|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25009238|NCT02822092|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25009239|NCT02822092|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25009240|NCT02804074|Antihypertensive Agents|antihypertensive agents|mesh-list
25009242|NCT02717416|Coagulants|coagulants|mesh-ancestor
25009243|NCT02675946|Pembrolizumab|pembrolizumab|mesh-list
25009244|NCT02675946|Cetuximab|cetuximab|mesh-list
24792185|NCT05411744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25009245|NCT02675946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25009246|NCT02675946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009247|NCT02660827|Insulin|insulin|mesh-list
25009248|NCT02660827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25009249|NCT02660827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009250|NCT02627963|Sorafenib|sorafenib|mesh-list
25009251|NCT02627963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009253|NCT02627963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571738|NCT00811447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24571739|NCT00811447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24571740|NCT00811447|Immunologic Factors|immunologic factors|mesh-ancestor
24571741|NCT00811447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571742|NCT00811460|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24571743|NCT00811460|Incretins|incretins|mesh-ancestor
24571802|NCT00811876|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24571803|NCT00811876|Fertility Agents|fertility agents|mesh-ancestor
24571896|NCT00812123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24571897|NCT00812123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24571900|NCT00812175|Sorafenib|sorafenib|mesh-list
24571913|NCT00812266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24571914|NCT00812266|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24571915|NCT00812266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24571920|NCT00812292|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24571921|NCT00812292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24571923|NCT00812292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571924|NCT00812292|Antiviral Agents|antiviral agents|mesh-ancestor
24571925|NCT00812292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571926|NCT00812292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24572002|NCT00812578|Micronutrients|micronutrients|mesh-ancestor
24572003|NCT00812578|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24572004|NCT00812669|Cyclophosphamide|cyclophosphamide|mesh-list
24572005|NCT00812669|Rituximab|rituximab|mesh-list
24572006|NCT00812669|Fludarabine|fludarabine|mesh-list
24572007|NCT00812669|Fludarabine phosphate|fludarabine phosphate|mesh-list
24572008|NCT00812669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24572009|NCT00812669|Immunologic Factors|immunologic factors|mesh-ancestor
24572052|NCT00812825|Glucocorticoids|glucocorticoids|mesh-ancestor
24572054|NCT00812825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24572055|NCT00812825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572056|NCT00812825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24572057|NCT00812825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572058|NCT00812851|Dronabinol|dronabinol|mesh-list
24572059|NCT00812851|Hallucinogens|hallucinogens|mesh-ancestor
24572060|NCT00812851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572061|NCT00812851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24572062|NCT00812851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24572063|NCT00812851|Analgesics|analgesics|mesh-ancestor
24561046|NCT00567580|Goserelin|goserelin|mesh-list
24561047|NCT00567580|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24561048|NCT00567580|Flutamide|flutamide|mesh-list
24561049|NCT00567580|Bicalutamide|bicalutamide|mesh-list
24561050|NCT00567580|Buserelin|buserelin|mesh-list
24561051|NCT00567580|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24561052|NCT00567580|Fertility Agents|fertility agents|mesh-ancestor
24561053|NCT00567580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24572217|NCT00813722|Adrenergic Agents|adrenergic agents|mesh-ancestor
24572218|NCT00813722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24572219|NCT00813722|Sympatholytics|sympatholytics|mesh-ancestor
24572220|NCT00813722|Autonomic Agents|autonomic agents|mesh-ancestor
24572221|NCT00813722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24572222|NCT00813722|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24572224|NCT00813735|Eszopiclone|eszopiclone|mesh-list
24572225|NCT00813735|Citalopram|citalopram|mesh-list
24572226|NCT00813735|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24572288|NCT00814086|Antimitotic Agents|antimitotic agents|mesh-ancestor
24572289|NCT00814086|Mitosis Modulators|mitosis modulators|mesh-ancestor
24572290|NCT00814086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572291|NCT00814125|Tamoxifen|tamoxifen|mesh-list
24572292|NCT00814125|Anastrozole|anastrozole|mesh-list
24572348|NCT00814281|Hormone Antagonists|hormone antagonists|mesh-ancestor
24572369|NCT00814515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24572370|NCT00814515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24572371|NCT00814528|Imiquimod|imiquimod|mesh-list
24572373|NCT00814528|Immunologic Factors|immunologic factors|mesh-ancestor
24572374|NCT00814528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572375|NCT00814528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572376|NCT00814528|Interferon Inducers|interferon inducers|mesh-ancestor
24572377|NCT00814541|Dexamethasone|dexamethasone|mesh-list
24572379|NCT00814541|Bortezomib|bortezomib|mesh-list
24572485|NCT00815048|Anesthetics|anesthetics|mesh-ancestor
24572486|NCT00815048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24572488|NCT00815048|Autonomic Agents|autonomic agents|mesh-ancestor
24572489|NCT00815048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24572490|NCT00815048|Respiratory System Agents|respiratory system agents|mesh-ancestor
24572491|NCT00815048|Mydriatics|mydriatics|mesh-ancestor
24572492|NCT00815048|Parasympatholytics|parasympatholytics|mesh-ancestor
24572493|NCT00815048|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24572494|NCT00815048|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24572495|NCT00815048|Cholinergic Agents|cholinergic agents|mesh-ancestor
24572496|NCT00815048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25009341|NCT02054104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25009342|NCT02054104|Analgesics|analgesics|mesh-ancestor
24572554|NCT00815464|Antiviral Agents|antiviral agents|mesh-list
24572555|NCT00815464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24572556|NCT00815503|Ropivacaine|ropivacaine|mesh-list
24572557|NCT00815503|Anesthetics, Local|anesthetics, local|mesh-ancestor
24572558|NCT00815503|Anesthetics|anesthetics|mesh-ancestor
24572559|NCT00815503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24572560|NCT00815503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572561|NCT00815503|Sensory System Agents|sensory system agents|mesh-ancestor
24572562|NCT00815503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24572563|NCT00815542|Dinoprostone|dinoprostone|mesh-list
24572564|NCT00815542|Oxytocics|oxytocics|mesh-ancestor
24572565|NCT00815542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24572566|NCT00815542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572567|NCT00815568|Vidarabine|vidarabine|mesh-list
24572568|NCT00815568|Fludarabine|fludarabine|mesh-list
24572569|NCT00815568|Fludarabine phosphate|fludarabine phosphate|mesh-list
24572570|NCT00815568|Busulfan|busulfan|mesh-list
24572571|NCT00815568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572572|NCT00815568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24572645|NCT00816049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572646|NCT00816049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24572647|NCT00816049|Immunologic Factors|immunologic factors|mesh-ancestor
24624592|NCT01076842|Incretins|incretins|mesh-ancestor
24572648|NCT00816049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572649|NCT00816049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24572650|NCT00816049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24572651|NCT00816127|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24572653|NCT00816127|Coagulants|coagulants|mesh-ancestor
24572654|NCT00816127|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24572655|NCT00816127|Natriuretic Agents|natriuretic agents|mesh-ancestor
24572656|NCT00816127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572657|NCT00816140|Clarithromycin|clarithromycin|mesh-list
24572658|NCT00816140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24572659|NCT00816140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24572660|NCT00816140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24572661|NCT00816140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24572679|NCT00816244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24572680|NCT00816244|Antimetabolites|antimetabolites|mesh-ancestor
25009343|NCT02054104|Sensory System Agents|sensory system agents|mesh-ancestor
24572686|NCT00816283|Vorinostat|vorinostat|mesh-list
24572687|NCT00816283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572690|NCT00816283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572691|NCT00816283|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24572692|NCT00816335|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24561356|NCT00759733|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24572694|NCT00816335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572695|NCT00816413|Cyclosporine|cyclosporine|mesh-list
24572696|NCT00816413|Mycophenolic Acid|mycophenolic acid|mesh-list
24572697|NCT00816413|Pentostatin|pentostatin|mesh-list
24572698|NCT00816413|Cyclosporins|cyclosporins|mesh-list
24572699|NCT00816413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24572700|NCT00816413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572701|NCT00816413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24572702|NCT00816413|Immunologic Factors|immunologic factors|mesh-ancestor
24572703|NCT00816413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572704|NCT00816413|Antifungal Agents|antifungal agents|mesh-ancestor
24572705|NCT00816413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24792280|NCT05384951|Vitamins|vitamins|mesh-ancestor
25009367|NCT01899144|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25009368|NCT01899144|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25009369|NCT01899144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25009370|NCT01899144|Adrenergic Agents|adrenergic agents|mesh-ancestor
25009371|NCT01899144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25009372|NCT01899144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009373|NCT01899144|Sympathomimetics|sympathomimetics|mesh-ancestor
25009374|NCT01853631|Cyclophosphamide|cyclophosphamide|mesh-list
25009375|NCT01853631|Fludarabine|fludarabine|mesh-list
25009376|NCT01853631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25009377|NCT01853631|Immunologic Factors|immunologic factors|mesh-ancestor
25009378|NCT01853631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009379|NCT01853631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25009380|NCT01853631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25009381|NCT01853631|Alkylating Agents|alkylating agents|mesh-ancestor
25009382|NCT01853631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009383|NCT01853631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009384|NCT01853631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25009385|NCT01724879|Dasatinib|dasatinib|mesh-list
25009386|NCT01724879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009387|NCT01724879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25009388|NCT01724879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25009389|NCT01724879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009390|NCT01468831|Minocycline|minocycline|mesh-list
24572826|NCT00816868|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24572827|NCT00816868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24572838|NCT00816894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24572839|NCT00816894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24572840|NCT00816894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24572841|NCT00816894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24572842|NCT00816894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24572843|NCT00816894|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24572844|NCT00816894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24572850|NCT00816959|Dacarbazine|dacarbazine|mesh-list
24572854|NCT00816959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572855|NCT00816959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24572857|NCT00816959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24572858|NCT00816959|Tubulin Modulators|tubulin modulators|mesh-ancestor
24572859|NCT00816959|Antimitotic Agents|antimitotic agents|mesh-ancestor
24572860|NCT00816959|Mitosis Modulators|mitosis modulators|mesh-ancestor
24572861|NCT00817011|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24572862|NCT00817011|Mirtazapine|mirtazapine|mesh-list
24572863|NCT00817011|Trazodone|trazodone|mesh-list
24572864|NCT00817011|Bupropion|bupropion|mesh-list
24572865|NCT00817011|Fluoxetine|fluoxetine|mesh-list
24572866|NCT00817011|Paroxetine|paroxetine|mesh-list
24572867|NCT00817011|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25710388|NCT02285634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25710389|NCT02285634|Autonomic Agents|autonomic agents|mesh-ancestor
25710390|NCT02285634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25710391|NCT02285634|Respiratory System Agents|respiratory system agents|mesh-ancestor
25710392|NCT02285634|Mydriatics|mydriatics|mesh-ancestor
25710393|NCT02285634|Sympathomimetics|sympathomimetics|mesh-ancestor
24532010|NCT00637858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532011|NCT00637858|Protective Agents|protective agents|mesh-ancestor
24572868|NCT00817011|Citalopram|citalopram|mesh-list
24572869|NCT00817011|Sertraline|sertraline|mesh-list
24572870|NCT00817011|Nortriptyline|nortriptyline|mesh-list
24572872|NCT00817011|Antidepressive Agents|antidepressive agents|mesh-ancestor
24572876|NCT00817011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24572877|NCT00817011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572878|NCT00817011|Dopamine Agents|dopamine agents|mesh-ancestor
24572879|NCT00817011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24572880|NCT00817011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572881|NCT00817011|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24572945|NCT00817284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24572946|NCT00817284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24572947|NCT00817284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24572991|NCT00817466|Epinephrine|epinephrine|mesh-list
24572992|NCT00817466|Racepinephrine|racepinephrine|mesh-list
24572993|NCT00817466|Epinephryl borate|epinephryl borate|mesh-list
24572994|NCT00817466|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24572995|NCT00817466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24572996|NCT00817466|Adrenergic Agents|adrenergic agents|mesh-ancestor
24572997|NCT00817466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24573006|NCT00817466|Mydriatics|mydriatics|mesh-ancestor
24573007|NCT00817466|Sympathomimetics|sympathomimetics|mesh-ancestor
24573008|NCT00817466|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24573009|NCT00817557|Loteprednol Etabonate|loteprednol etabonate|mesh-list
24573010|NCT00817557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24573011|NCT00817583|Docetaxel|docetaxel|mesh-list
24573012|NCT00817583|Fluorouracil|fluorouracil|mesh-list
24573013|NCT00817583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24573014|NCT00817583|Tubulin Modulators|tubulin modulators|mesh-ancestor
24573015|NCT00817583|Antimitotic Agents|antimitotic agents|mesh-ancestor
24573016|NCT00817583|Mitosis Modulators|mitosis modulators|mesh-ancestor
24573017|NCT00817583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573018|NCT00817583|Antimetabolites|antimetabolites|mesh-ancestor
24573019|NCT00817583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24573024|NCT00817622|Vitamins|vitamins|mesh-ancestor
24573051|NCT00817687|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25009441|NCT00799110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009442|NCT00799110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25009443|NCT00799110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009444|NCT00799110|Interferon Inducers|interferon inducers|mesh-ancestor
25009446|NCT00697684|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25009447|NCT00697684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25009448|NCT00697684|Antimetabolites|antimetabolites|mesh-ancestor
25009449|NCT00697684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009450|NCT00697684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009451|NCT00697684|Immunologic Factors|immunologic factors|mesh-ancestor
25009452|NCT00697684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009453|NCT00697684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25009454|NCT00603954|Vidarabine|vidarabine|mesh-list
25009455|NCT00603954|Fludarabine|fludarabine|mesh-list
25009456|NCT00603954|Fludarabine phosphate|fludarabine phosphate|mesh-list
25009457|NCT00603954|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25009458|NCT00603954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009459|NCT00603954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24928615|NCT04120311|Hormones|hormones|mesh-ancestor
25009460|NCT00603954|Antimetabolites|antimetabolites|mesh-ancestor
25710394|NCT02285634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25710395|NCT02285634|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25009461|NCT00603954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009462|NCT00603954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25710396|NCT02285634|Nasal Decongestants|nasal decongestants|mesh-ancestor
25710397|NCT02285634|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25710398|NCT02285634|Protective Agents|protective agents|mesh-ancestor
25710399|NCT02285855|Metformin|metformin|mesh-list
25710400|NCT02285855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25710401|NCT02285855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710402|NCT02285920|Spironolactone|spironolactone|mesh-list
25710403|NCT02285920|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25710404|NCT02285920|Hormone Antagonists|hormone antagonists|mesh-ancestor
24532544|NCT00640276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25009463|NCT00603954|Immunologic Factors|immunologic factors|mesh-ancestor
25009475|NCT00003777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009477|NCT00003777|Protective Agents|protective agents|mesh-ancestor
24573061|NCT00817713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24573083|NCT00817765|Fosamprenavir|fosamprenavir|mesh-list
24573084|NCT00817765|Posaconazole|posaconazole|mesh-list
24573085|NCT00817765|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24573086|NCT00817765|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24573087|NCT00817765|Protease Inhibitors|protease inhibitors|mesh-ancestor
24573088|NCT00817765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573089|NCT00817765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573091|NCT00817765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24573092|NCT00817765|Antiviral Agents|antiviral agents|mesh-ancestor
24573093|NCT00817765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24573094|NCT00817765|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24671068|NCT01323465|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24573095|NCT00817765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24573096|NCT00817765|Antifungal Agents|antifungal agents|mesh-ancestor
24573097|NCT00817765|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24573098|NCT00817765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24573099|NCT00817765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24573100|NCT00817765|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24573101|NCT00817765|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24573172|NCT00818194|Antifungal Agents|antifungal agents|mesh-ancestor
24573182|NCT00818298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573183|NCT00818298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24573184|NCT00818298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24573185|NCT00818298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24573186|NCT00818298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24573187|NCT00818298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25109946|NCT03120962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24561795|NCT00762775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24573201|NCT00818415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24573202|NCT00818415|Analgesics|analgesics|mesh-ancestor
24573203|NCT00818415|Sensory System Agents|sensory system agents|mesh-ancestor
24573204|NCT00818415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24573205|NCT00818415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573206|NCT00818415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24573207|NCT00818415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24573208|NCT00818415|Gout Suppressants|gout suppressants|mesh-ancestor
24573209|NCT00818415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24573210|NCT00818415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573211|NCT00818415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573212|NCT00818584|Micafungin|micafungin|mesh-list
24573213|NCT00818584|Antifungal Agents|antifungal agents|mesh-ancestor
24573214|NCT00818584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24573215|NCT00818610|Amoxicillin|amoxicillin|mesh-list
24573216|NCT00818610|Clarithromycin|clarithromycin|mesh-list
24573217|NCT00818610|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24573229|NCT00818610|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24573230|NCT00818675|Sirolimus|sirolimus|mesh-list
24573231|NCT00818675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24573232|NCT00818675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24561813|NCT00762944|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24573268|NCT00819000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24573269|NCT00819000|Antiviral Agents|antiviral agents|mesh-ancestor
24573270|NCT00819000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24573293|NCT00819078|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24573294|NCT00819078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25777121|NCT03740659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25777122|NCT03740659|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25777123|NCT03740659|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25777124|NCT03740659|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25777125|NCT03740659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25777126|NCT03739528|Levofloxacin|levofloxacin|mesh-list
25777127|NCT03739528|Ofloxacin|ofloxacin|mesh-list
25777128|NCT03739528|Tobramycin|tobramycin|mesh-list
25777129|NCT03739528|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
24573295|NCT00819078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573297|NCT00819104|Amlodipine|amlodipine|mesh-list
24573298|NCT00819104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24573299|NCT00819104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24573300|NCT00819104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24573301|NCT00819104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573302|NCT00819104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24573303|NCT00819104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573308|NCT00819104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24573309|NCT00819104|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24573310|NCT00819104|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24573311|NCT00819104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24573312|NCT00819104|Adrenergic Agents|adrenergic agents|mesh-ancestor
24573331|NCT00819377|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24573332|NCT00819377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24573333|NCT00819377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573334|NCT00819377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573335|NCT00819377|Protective Agents|protective agents|mesh-ancestor
24573336|NCT00819377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573338|NCT00819468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24573339|NCT00819468|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24573341|NCT00819468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573342|NCT00819520|Ivermectin|ivermectin|mesh-list
24573343|NCT00819520|Malathion|malathion|mesh-list
24573344|NCT00819520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24573359|NCT00819676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24573360|NCT00819676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573361|NCT00819676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24573362|NCT00819676|Respiratory System Agents|respiratory system agents|mesh-ancestor
24573363|NCT00819676|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24573365|NCT00819676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573366|NCT00819676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24573367|NCT00819676|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24573387|NCT00819754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24573388|NCT00819754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24573389|NCT00819754|Growth Substances|growth substances|mesh-ancestor
24573412|NCT00819845|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24573413|NCT00819845|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24573414|NCT00819845|Adrenergic Agents|adrenergic agents|mesh-ancestor
24573415|NCT00819845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24443897|NCT00296127|Celecoxib|celecoxib|mesh-list
24573440|NCT00819988|Pregabalin|pregabalin|mesh-list
24573441|NCT00819988|Analgesics|analgesics|mesh-ancestor
24573442|NCT00819988|Sensory System Agents|sensory system agents|mesh-ancestor
24573443|NCT00819988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24573444|NCT00819988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573445|NCT00819988|Anticonvulsants|anticonvulsants|mesh-ancestor
24573446|NCT00819988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24573447|NCT00819988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24573459|NCT00820053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24573460|NCT00820053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573461|NCT00820053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573462|NCT00820092|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
24533081|NCT00642187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24573529|NCT00820547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24573539|NCT00820547|Antimetabolites|antimetabolites|mesh-ancestor
24573540|NCT00820547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24573541|NCT00820547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24573542|NCT00820547|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24573543|NCT00820547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24792414|NCT05223075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792441|NCT05167760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24792442|NCT05167760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24792443|NCT05167760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24792444|NCT05167760|Adrenergic Agents|adrenergic agents|mesh-ancestor
24792445|NCT05167760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24792446|NCT05167760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792447|NCT05167760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897490|NCT04425135|Apatinib|apatinib|mesh-list
24573544|NCT00820547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573545|NCT00820690|Paclitaxel|paclitaxel|mesh-list
24573546|NCT00820690|Cyclophosphamide|cyclophosphamide|mesh-list
24573547|NCT00820690|Doxorubicin|doxorubicin|mesh-list
24573548|NCT00820690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24573549|NCT00820690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24573550|NCT00820690|Tubulin Modulators|tubulin modulators|mesh-ancestor
24573565|NCT00820768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24573578|NCT00820885|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24573579|NCT00820885|Protective Agents|protective agents|mesh-ancestor
24573580|NCT00820885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573581|NCT00820911|Cyclosporine|cyclosporine|mesh-list
24573583|NCT00820911|Cyclosporins|cyclosporins|mesh-list
24573584|NCT00820911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573585|NCT00820911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629598|NCT01106547|Antiemetics|antiemetics|mesh-ancestor
24573586|NCT00820911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24573587|NCT00820911|Immunologic Factors|immunologic factors|mesh-ancestor
24573588|NCT00820911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573589|NCT00820911|Antifungal Agents|antifungal agents|mesh-ancestor
24573590|NCT00820911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24573591|NCT00820911|Dermatologic Agents|dermatologic agents|mesh-ancestor
24573592|NCT00820911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24573595|NCT00820963|Temozolomide|temozolomide|mesh-list
24671084|NCT01323465|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24671085|NCT01323465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24671086|NCT01323465|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24573645|NCT00821301|Dopamine Agents|dopamine agents|mesh-ancestor
24573646|NCT00821301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24573647|NCT00821301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573648|NCT00821353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
24573649|NCT00821392|Febuxostat|febuxostat|mesh-list
24573650|NCT00821392|Gout Suppressants|gout suppressants|mesh-ancestor
24573651|NCT00821392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24573652|NCT00821444|Ziprasidone|ziprasidone|mesh-list
24573653|NCT00821444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24573654|NCT00821444|Serotonin Agents|serotonin agents|mesh-ancestor
24573655|NCT00821444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24573682|NCT00821496|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25777130|NCT03739528|Dexamethasone|dexamethasone|mesh-list
24573683|NCT00821496|Contraceptive Agents|contraceptive agents|mesh-ancestor
24573685|NCT00821496|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25777131|NCT03739528|Dexamethasone acetate|dexamethasone acetate|mesh-list
25777132|NCT03739528|BB 1101|bb 1101|mesh-list
25777133|NCT03739528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25777134|NCT03739528|Antiemetics|antiemetics|mesh-ancestor
25777135|NCT03739528|Autonomic Agents|autonomic agents|mesh-ancestor
25777136|NCT03739528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25777137|NCT03739528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770640|NCT03555890|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24573686|NCT00821496|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24573687|NCT00821496|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24573688|NCT00821496|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24573689|NCT00821496|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24562095|NCT00764582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24562096|NCT00764582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24562097|NCT00764582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24562098|NCT00764582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24513494|NCT00582920|Zoledronic Acid|zoledronic acid|mesh-list
24513495|NCT00582920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24573726|NCT00821652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573728|NCT00821782|Levofloxacin|levofloxacin|mesh-list
24573730|NCT00821782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24573731|NCT00821782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24573732|NCT00821782|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24562123|NCT00764725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24562124|NCT00764725|Dermatologic Agents|dermatologic agents|mesh-ancestor
24562125|NCT00764725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24562126|NCT00764725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24562127|NCT00764725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24562128|NCT00764725|Immunologic Factors|immunologic factors|mesh-ancestor
24562129|NCT00764725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24562130|NCT00764725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24562131|NCT00764725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24562132|NCT00764725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24562133|NCT00764725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24562134|NCT00764725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24573733|NCT00821782|Renal Agents|renal agents|mesh-ancestor
24573734|NCT00821782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24573735|NCT00821782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24573736|NCT00821782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573737|NCT00821782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573760|NCT00821912|Antimitotic Agents|antimitotic agents|mesh-ancestor
24573761|NCT00821912|Mitosis Modulators|mitosis modulators|mesh-ancestor
24573762|NCT00821912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573763|NCT00821912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24573764|NCT00821912|Antimetabolites|antimetabolites|mesh-ancestor
24573765|NCT00822029|Alendronate|alendronate|mesh-list
24573766|NCT00822029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24629737|NCT01107522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629738|NCT01107574|Gabapentin|gabapentin|mesh-list
24573767|NCT00822029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573768|NCT00822055|Timolol|timolol|mesh-list
24573769|NCT00822055|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24573770|NCT00822055|Dorzolamide|dorzolamide|mesh-list
24573771|NCT00822055|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
24562138|NCT00764725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24562139|NCT00764816|Caseins|caseins|mesh-list
24562140|NCT00764816|Chelating Agents|chelating agents|mesh-ancestor
24562141|NCT00764816|Sequestering Agents|sequestering agents|mesh-ancestor
24562142|NCT00764816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562143|NCT00764855|Propofol|propofol|mesh-list
24562144|NCT00764855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24562145|NCT00764855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24562146|NCT00764855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573800|NCT00822081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24573801|NCT00822081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24573802|NCT00822081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25770641|NCT03555890|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25770642|NCT03555890|Histamine Antagonists|histamine antagonists|mesh-ancestor
25770643|NCT03555890|Histamine Agents|histamine agents|mesh-ancestor
25770644|NCT03555890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25770645|NCT03555890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770646|NCT03555890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573815|NCT00822133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24573816|NCT00822133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573818|NCT00822133|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24562192|NCT00764907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24562193|NCT00764907|Antimetabolites|antimetabolites|mesh-ancestor
24562194|NCT00764907|Dermatologic Agents|dermatologic agents|mesh-ancestor
24562195|NCT00764907|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24562196|NCT00764907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24573824|NCT00822211|Vildagliptin|vildagliptin|mesh-list
24562213|NCT00764972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573879|NCT00822393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573897|NCT00822419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24573898|NCT00822419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24573900|NCT00822419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24573901|NCT00822419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24573902|NCT00822419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24573904|NCT00822536|Clopidogrel|clopidogrel|mesh-list
24573905|NCT00822536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24573906|NCT00822536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25009507|NCT05214157|Anesthetics|anesthetics|mesh-ancestor
25009508|NCT05214157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25009511|NCT05214157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25009518|NCT05213988|Clofibric Acid|clofibric acid|mesh-list
25009519|NCT05213988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25009520|NCT05213988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25009521|NCT05213988|Antimetabolites|antimetabolites|mesh-ancestor
25009522|NCT05213988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573926|NCT00822549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24573927|NCT00822549|Narcotics|narcotics|mesh-ancestor
24573928|NCT00822549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24573930|NCT00822549|Analgesics|analgesics|mesh-ancestor
24573965|NCT00822744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24573966|NCT00822744|Antidepressive Agents|antidepressive agents|mesh-ancestor
24573967|NCT00822744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24573968|NCT00822783|Omalizumab|omalizumab|mesh-list
24573969|NCT00822783|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24573970|NCT00822783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24574060|NCT00823342|Antiviral Agents|antiviral agents|mesh-ancestor
24574061|NCT00823342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24574062|NCT00823342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24574069|NCT00823381|Antioxidants|antioxidants|mesh-ancestor
24574070|NCT00823381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574246|NCT00824317|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24574247|NCT00824317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574248|NCT00824317|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24574249|NCT00824317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24574250|NCT00824317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24574251|NCT00824317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574283|NCT00824811|Cyclosporins|cyclosporins|mesh-list
24574284|NCT00824811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574285|NCT00824811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574286|NCT00824811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25710405|NCT02285920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25710406|NCT02285920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574287|NCT00824811|Immunologic Factors|immunologic factors|mesh-ancestor
24574288|NCT00824811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574289|NCT00824811|Antifungal Agents|antifungal agents|mesh-ancestor
24574290|NCT00824811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24574291|NCT00824811|Dermatologic Agents|dermatologic agents|mesh-ancestor
24574292|NCT00824811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24574293|NCT00824811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24574294|NCT00824811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24574295|NCT00824811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24574296|NCT00824811|Glucocorticoids|glucocorticoids|mesh-ancestor
24574331|NCT00825045|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24574332|NCT00825045|Serotonin Agents|serotonin agents|mesh-ancestor
24574333|NCT00825045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24574349|NCT00825058|Serotonin Agents|serotonin agents|mesh-ancestor
24574366|NCT00825071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574367|NCT00825071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24574370|NCT00825071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24574371|NCT00825071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24574372|NCT00825071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24574373|NCT00825071|Antipruritics|antipruritics|mesh-ancestor
24574374|NCT00825071|Dermatologic Agents|dermatologic agents|mesh-ancestor
24574375|NCT00825071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24574376|NCT00825071|Serotonin Agents|serotonin agents|mesh-ancestor
24574377|NCT00825071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24574378|NCT00825071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574379|NCT00825071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24574380|NCT00825071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24574381|NCT00825071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24574382|NCT00825071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25009527|NCT05213676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25009529|NCT05213676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24792517|NCT05085002|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24792518|NCT05085002|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24792519|NCT05085002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574409|NCT00825149|Vincristine|vincristine|mesh-list
25009530|NCT05213676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009531|NCT05213676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25009532|NCT05213676|Respiratory System Agents|respiratory system agents|mesh-ancestor
25009533|NCT05213676|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25009534|NCT05213676|Antioxidants|antioxidants|mesh-ancestor
24574455|NCT00825201|Mitosis Modulators|mitosis modulators|mesh-ancestor
25009537|NCT05213676|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25009538|NCT05213676|Vasodilator Agents|vasodilator agents|mesh-ancestor
25009539|NCT05213676|Gasotransmitters|gasotransmitters|mesh-ancestor
25009540|NCT05213676|Protective Agents|protective agents|mesh-ancestor
25009541|NCT05213585|Ivermectin|ivermectin|mesh-list
25009542|NCT05213585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24562517|NCT00766857|Insulin|insulin|mesh-list
24562518|NCT00766857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24562519|NCT00766857|Insulin Glargine|insulin glargine|mesh-list
25009543|NCT05213585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25109947|NCT03120962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109948|NCT03120962|Antimanic Agents|antimanic agents|mesh-ancestor
25109949|NCT03120962|Antiviral Agents|antiviral agents|mesh-ancestor
25109950|NCT03120962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25109951|NCT03120962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25109952|NCT03120962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25109954|NCT03120936|Emtricitabine|emtricitabine|mesh-list
25109955|NCT03120936|Antiviral Agents|antiviral agents|mesh-ancestor
25109956|NCT03120936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25109960|NCT03120936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25109961|NCT03120936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25109962|NCT03120936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25109963|NCT03121079|Interferons|interferons|mesh-list
25710407|NCT02285920|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25710408|NCT02285920|Diuretics|diuretics|mesh-ancestor
25710409|NCT02285920|Natriuretic Agents|natriuretic agents|mesh-ancestor
25710410|NCT02285998|Vaccines|vaccines|mesh-list
25109964|NCT03121079|Interferon-alpha|interferon-alpha|mesh-list
25109965|NCT03121079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24574423|NCT00825149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574424|NCT00825149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24574425|NCT00825149|Glucocorticoids|glucocorticoids|mesh-ancestor
24574427|NCT00825149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24574428|NCT00825149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24574429|NCT00825149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24574430|NCT00825149|Tubulin Modulators|tubulin modulators|mesh-ancestor
24574431|NCT00825149|Antimitotic Agents|antimitotic agents|mesh-ancestor
24574432|NCT00825149|Mitosis Modulators|mitosis modulators|mesh-ancestor
24574453|NCT00825201|Tubulin Modulators|tubulin modulators|mesh-ancestor
24671101|NCT01323491|Cholinergic Agents|cholinergic agents|mesh-ancestor
24574454|NCT00825201|Antimitotic Agents|antimitotic agents|mesh-ancestor
24574456|NCT00825201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574457|NCT00825253|Insulin|insulin|mesh-list
24574458|NCT00825253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24574459|NCT00825253|Insulin Aspart|insulin aspart|mesh-list
24574483|NCT00825552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24630331|NCT01110941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24574486|NCT00825591|Antioxidants|antioxidants|mesh-ancestor
24574487|NCT00825591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574488|NCT00825591|Protective Agents|protective agents|mesh-ancestor
24574489|NCT00825591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574490|NCT00825591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24574491|NCT00825617|Hormones|hormones|mesh-list
24574492|NCT00825617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24574493|NCT00825617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574494|NCT00825643|Insulin Detemir|insulin detemir|mesh-list
24574495|NCT00825643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24574496|NCT00825643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574497|NCT00825656|Capsaicin|capsaicin|mesh-list
24574498|NCT00825656|Antipruritics|antipruritics|mesh-ancestor
24574499|NCT00825656|Dermatologic Agents|dermatologic agents|mesh-ancestor
24574500|NCT00825656|Sensory System Agents|sensory system agents|mesh-ancestor
24562597|NCT00767221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24562598|NCT00767221|Autonomic Agents|autonomic agents|mesh-ancestor
24562599|NCT00767221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24562600|NCT00767221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574501|NCT00825656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24574502|NCT00825656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574503|NCT00825721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24574504|NCT00825721|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24574519|NCT00825864|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24574552|NCT00826163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24574553|NCT00826163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574554|NCT00826163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25415973|NCT02980510|Vitamins|vitamins|mesh-ancestor
24574555|NCT00826163|Respiratory System Agents|respiratory system agents|mesh-ancestor
25710411|NCT02285998|Immunologic Factors|immunologic factors|mesh-ancestor
25710412|NCT02285998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710413|NCT02286726|Cytarabine|cytarabine|mesh-list
25710414|NCT02286726|Daunorubicin|daunorubicin|mesh-list
25710415|NCT02286726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25710416|NCT02286726|Antimetabolites|antimetabolites|mesh-ancestor
25710417|NCT02286726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710418|NCT02286726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710419|NCT02286726|Antiviral Agents|antiviral agents|mesh-ancestor
25710420|NCT02286726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24574556|NCT00826163|Glucocorticoids|glucocorticoids|mesh-ancestor
24574558|NCT00826163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24574560|NCT00826254|Vitamin K|vitamin k|mesh-list
24574561|NCT00826254|Micronutrients|micronutrients|mesh-ancestor
24574562|NCT00826254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574563|NCT00826254|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24574564|NCT00826254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24574565|NCT00826254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574566|NCT00826254|Hemostatics|hemostatics|mesh-ancestor
24574567|NCT00826254|Coagulants|coagulants|mesh-ancestor
24574568|NCT00826306|Sunscreening Agents|sunscreening agents|mesh-list
24574569|NCT00826306|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24574570|NCT00826306|Protective Agents|protective agents|mesh-ancestor
24574571|NCT00826306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574572|NCT00826306|Dermatologic Agents|dermatologic agents|mesh-ancestor
24574573|NCT00826358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24574574|NCT00826358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24574613|NCT00826553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24574614|NCT00826553|Adrenergic Agents|adrenergic agents|mesh-ancestor
24574615|NCT00826553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24574616|NCT00826553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574617|NCT00826553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24574618|NCT00826553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24574619|NCT00826553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24574620|NCT00826553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24574621|NCT00826553|GABA Modulators|gaba modulators|mesh-ancestor
24574622|NCT00826553|GABA Agents|gaba agents|mesh-ancestor
24574712|NCT00826969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24574713|NCT00826969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574734|NCT00827216|Erythromycin Estolate|erythromycin estolate|mesh-list
24574735|NCT00827216|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24574736|NCT00827216|Erythromycin stearate|erythromycin stearate|mesh-list
24574737|NCT00827216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24574755|NCT00827307|Hormone Antagonists|hormone antagonists|mesh-ancestor
24574756|NCT00827307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24574757|NCT00827307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574758|NCT00827307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24574759|NCT00827307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24574760|NCT00827307|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24574761|NCT00827307|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25009544|NCT05213143|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25009545|NCT05213143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25009546|NCT05213143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25009547|NCT05213143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25009548|NCT05213143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574771|NCT00827346|Purinergic Agents|purinergic agents|mesh-ancestor
24574772|NCT00827346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24630636|NCT01112852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
24630637|NCT01112852|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24671103|NCT01323491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574776|NCT00827411|Clopidogrel|clopidogrel|mesh-list
24574777|NCT00827411|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24574778|NCT00827411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25710421|NCT02286726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25710422|NCT02286726|Immunologic Factors|immunologic factors|mesh-ancestor
25710423|NCT02286726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710424|NCT02286726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25710425|NCT02286726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24574779|NCT00827411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24574780|NCT00827411|Analgesics|analgesics|mesh-ancestor
24574781|NCT00827411|Sensory System Agents|sensory system agents|mesh-ancestor
24574782|NCT00827411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24574783|NCT00827411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574784|NCT00827411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24574785|NCT00827411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24574786|NCT00827411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24574787|NCT00827411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24574788|NCT00827411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574789|NCT00827411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24574804|NCT00827450|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24574805|NCT00827450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24574806|NCT00827450|Purinergic Agents|purinergic agents|mesh-ancestor
24574807|NCT00827450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24574809|NCT00827554|Anticoagulants|anticoagulants|mesh-ancestor
24574810|NCT00827554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24574893|NCT00828373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24574912|NCT00828503|Valganciclovir|valganciclovir|mesh-list
24574913|NCT00828503|Everolimus|everolimus|mesh-list
24574914|NCT00828503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24574915|NCT00828503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24574916|NCT00828503|Immunologic Factors|immunologic factors|mesh-ancestor
24574917|NCT00828503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574918|NCT00828503|Antiviral Agents|antiviral agents|mesh-ancestor
24574919|NCT00828503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24574978|NCT00828815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24574979|NCT00828815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24574980|NCT00828815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574982|NCT00828815|Antiviral Agents|antiviral agents|mesh-ancestor
24575027|NCT00829023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24575028|NCT00829023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24575029|NCT00829023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24575030|NCT00829023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792529|NCT05077800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24792530|NCT05077800|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24792531|NCT05077800|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24792532|NCT05077800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009552|NCT05213143|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25009553|NCT05213143|Adrenergic Agents|adrenergic agents|mesh-ancestor
25009554|NCT05213143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25009555|NCT05213143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009556|NCT05213143|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25009557|NCT05213143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25009558|NCT05213143|Serotonin Agents|serotonin agents|mesh-ancestor
25009559|NCT05213143|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25009560|NCT05213143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25009561|NCT05213143|Dopamine Agents|dopamine agents|mesh-ancestor
25009562|NCT05213065|Bupivacaine|bupivacaine|mesh-list
25009563|NCT05213065|Anesthetics, Local|anesthetics, local|mesh-ancestor
25009564|NCT05213065|Anesthetics|anesthetics|mesh-ancestor
25009565|NCT05213065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25009566|NCT05213065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009567|NCT05213065|Sensory System Agents|sensory system agents|mesh-ancestor
24562855|NCT00768612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25710426|NCT02286726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25710427|NCT02286726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710428|NCT02286843|Trastuzumab|trastuzumab|mesh-list
25710429|NCT02286843|Pertuzumab|pertuzumab|mesh-list
25710430|NCT02286843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25710431|NCT02286843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710432|NCT02286895|Vaccines|vaccines|mesh-list
25710433|NCT02286895|Immunologic Factors|immunologic factors|mesh-ancestor
25710434|NCT02286895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710435|NCT02286921|Methyltestosterone|methyltestosterone|mesh-list
25710436|NCT02286921|Testosterone|testosterone|mesh-list
25009568|NCT05213065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25009569|NCT05212662|Cysteamine|cysteamine|mesh-list
25009570|NCT05212662|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
25009571|NCT05212662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009572|NCT05212636|Antidepressive Agents|antidepressive agents|mesh-list
25009573|NCT05212636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25009574|NCT05212597|Losartan|losartan|mesh-list
25009575|NCT05212597|Amlodipine|amlodipine|mesh-list
25009576|NCT05212597|Valsartan|valsartan|mesh-list
25009584|NCT05212597|Vasodilator Agents|vasodilator agents|mesh-ancestor
25009585|NCT05212597|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25009586|NCT05212597|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25009587|NCT05212597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25009588|NCT05212337|Denosumab|denosumab|mesh-list
25009590|NCT05212337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009591|NCT05212246|Imiquimod|imiquimod|mesh-list
25009592|NCT05212246|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25009593|NCT05212246|Immunologic Factors|immunologic factors|mesh-ancestor
25009594|NCT05212246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009618|NCT05211583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25009619|NCT05211583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009620|NCT05211050|Cromakalim|cromakalim|mesh-list
24575031|NCT00829023|Disinfectants|disinfectants|mesh-ancestor
24575032|NCT00829023|Dermatologic Agents|dermatologic agents|mesh-ancestor
24575033|NCT00829023|Plasma Substitutes|plasma substitutes|mesh-ancestor
24575062|NCT00829205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24575063|NCT00829205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24575064|NCT00829205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24575065|NCT00829205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575066|NCT00829205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575067|NCT00829205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24575068|NCT00829205|Alkylating Agents|alkylating agents|mesh-ancestor
24575069|NCT00829205|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24575070|NCT00829205|Protective Agents|protective agents|mesh-ancestor
24575071|NCT00829231|Sorafenib|sorafenib|mesh-list
24575072|NCT00829231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24575073|NCT00829231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24575074|NCT00829231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575075|NCT00829231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575076|NCT00829257|Fluticasone|fluticasone|mesh-list
24575077|NCT00829257|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24575078|NCT00829257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24575079|NCT00829257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24575080|NCT00829257|Autonomic Agents|autonomic agents|mesh-ancestor
24575081|NCT00829257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24575082|NCT00829257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575083|NCT00829257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25710437|NCT02286921|Testosterone undecanoate|testosterone undecanoate|mesh-list
25710438|NCT02286921|Testosterone enanthate|testosterone enanthate|mesh-list
25710439|NCT02286921|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25710440|NCT02286921|Androgens|androgens|mesh-ancestor
25710441|NCT02286921|Hormones|hormones|mesh-ancestor
25710442|NCT02286921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25710443|NCT02286921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710444|NCT02286921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25710445|NCT02286921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710446|NCT02286921|Anabolic Agents|anabolic agents|mesh-ancestor
25710447|NCT02287038|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24575084|NCT00829257|Respiratory System Agents|respiratory system agents|mesh-ancestor
24575085|NCT00829257|Dermatologic Agents|dermatologic agents|mesh-ancestor
24575086|NCT00829257|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24575087|NCT00829257|Glucocorticoids|glucocorticoids|mesh-ancestor
24575088|NCT00829257|Hormones|hormones|mesh-ancestor
24575089|NCT00829257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24575090|NCT00829257|Sympathomimetics|sympathomimetics|mesh-ancestor
24575093|NCT00829322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575113|NCT00829634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575115|NCT00829634|Autonomic Agents|autonomic agents|mesh-ancestor
24575117|NCT00829634|Dopamine Agents|dopamine agents|mesh-ancestor
24575118|NCT00829634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24575126|NCT00829647|Dasatinib|dasatinib|mesh-list
24575127|NCT00829647|Immunologic Factors|immunologic factors|mesh-ancestor
24575128|NCT00829647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575129|NCT00829647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24575130|NCT00829647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24575131|NCT00829647|Growth Substances|growth substances|mesh-ancestor
24575132|NCT00829647|Growth Inhibitors|growth inhibitors|mesh-ancestor
24575133|NCT00829647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24575134|NCT00829647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24575135|NCT00829647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575136|NCT00829647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575138|NCT00829660|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24575139|NCT00829660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25009621|NCT05211050|Sumatriptan|sumatriptan|mesh-list
25109966|NCT03121079|Antiviral Agents|antiviral agents|mesh-ancestor
24575140|NCT00829660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575141|NCT00829660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24575142|NCT00829660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575143|NCT00829699|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
24575168|NCT00829894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24575169|NCT00829894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24575170|NCT00829894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24575183|NCT00830050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24575184|NCT00830050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575185|NCT00830050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575186|NCT00830089|Levobupivacaine|levobupivacaine|mesh-list
24575187|NCT00830089|Anesthetics, Local|anesthetics, local|mesh-ancestor
24575188|NCT00830089|Anesthetics|anesthetics|mesh-ancestor
24575189|NCT00830089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24575190|NCT00830089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575191|NCT00830089|Sensory System Agents|sensory system agents|mesh-ancestor
24575192|NCT00830089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24575205|NCT00830245|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24575207|NCT00830245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24575208|NCT00830245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575209|NCT00830245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575210|NCT00830297|Isophane Insulin, Human|isophane insulin, human|mesh-list
24575211|NCT00830297|Insulin, Isophane|insulin, isophane|mesh-list
24575212|NCT00830297|Isophane insulin, beef|isophane insulin, beef|mesh-list
24575213|NCT00830297|Insulin, Long-Acting|insulin, long-acting|mesh-list
24575214|NCT00830297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24575217|NCT00830323|Amantadine|amantadine|mesh-list
24575232|NCT00830349|Risperidone|risperidone|mesh-list
24575233|NCT00830349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24575234|NCT00830349|Serotonin Agents|serotonin agents|mesh-ancestor
24575235|NCT00830349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24575236|NCT00830349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575237|NCT00830349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575238|NCT00830349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24575239|NCT00830349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24575240|NCT00830349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24575241|NCT00830349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25710448|NCT02287038|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25710449|NCT02287038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24575242|NCT00830349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24575243|NCT00830349|Dopamine Agents|dopamine agents|mesh-ancestor
24575244|NCT00830401|Doxycycline|doxycycline|mesh-list
24575245|NCT00830401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24575246|NCT00830401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24575370|NCT00830882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575382|NCT00830895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24792592|NCT04933552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24792593|NCT04933552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24792594|NCT04933552|Immunologic Factors|immunologic factors|mesh-ancestor
24792595|NCT04933552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009622|NCT05211050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25009623|NCT05211050|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25009624|NCT05211050|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25009625|NCT05211050|Serotonin Agents|serotonin agents|mesh-ancestor
25009626|NCT05211050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25009627|NCT05211050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009628|NCT05211050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009629|NCT05211050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25009630|NCT05211050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25009631|NCT05211050|Autonomic Agents|autonomic agents|mesh-ancestor
25009632|NCT05211050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25009633|NCT05211050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25009634|NCT05211050|Respiratory System Agents|respiratory system agents|mesh-ancestor
25009635|NCT05211050|Parasympatholytics|parasympatholytics|mesh-ancestor
25009636|NCT05211050|Vasodilator Agents|vasodilator agents|mesh-ancestor
25009638|NCT05211011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25009639|NCT05211011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25009640|NCT05210595|Clopidogrel|clopidogrel|mesh-list
25009642|NCT05210595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25009660|NCT05210465|Dobutamine|dobutamine|mesh-list
25009661|NCT05210465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25009662|NCT05210465|Sympathomimetics|sympathomimetics|mesh-ancestor
25009663|NCT05210465|Autonomic Agents|autonomic agents|mesh-ancestor
25009664|NCT05210465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25009665|NCT05210465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009666|NCT05210465|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25009667|NCT05210465|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25009668|NCT05210465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25009669|NCT05210465|Adrenergic Agents|adrenergic agents|mesh-ancestor
25009670|NCT05210465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25009671|NCT05210465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25009672|NCT05210465|Protective Agents|protective agents|mesh-ancestor
25009790|NCT05186454|Morphine|morphine|mesh-list
25109968|NCT03121079|Immunologic Factors|immunologic factors|mesh-ancestor
25109969|NCT03121079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25109970|NCT03120923|Triamcinolone|triamcinolone|mesh-list
25109971|NCT03120923|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24792596|NCT04927585|Vaccines|vaccines|mesh-list
24792597|NCT04927585|Immunologic Factors|immunologic factors|mesh-ancestor
24792598|NCT04927585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24792599|NCT04917055|Dexamethasone|dexamethasone|mesh-list
24792600|NCT04917055|Epinephrine|epinephrine|mesh-list
25109972|NCT03120923|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25109973|NCT03120923|Lidocaine|lidocaine|mesh-list
25109974|NCT03120923|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25109975|NCT03120923|Anesthetics, Local|anesthetics, local|mesh-ancestor
25109976|NCT03120923|Anesthetics|anesthetics|mesh-ancestor
25109977|NCT03120923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25109978|NCT03120923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575445|NCT00831636|Antimetabolites|antimetabolites|mesh-ancestor
24575446|NCT00831636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575447|NCT00831636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710450|NCT02287038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25710451|NCT02287038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710452|NCT02287038|Adrenergic Agents|adrenergic agents|mesh-ancestor
24575448|NCT00831636|Antiviral Agents|antiviral agents|mesh-ancestor
25710453|NCT02287038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25710454|NCT02287038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575449|NCT00831636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24575450|NCT00831636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24575451|NCT00831636|Immunologic Factors|immunologic factors|mesh-ancestor
24575452|NCT00831636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575454|NCT00831649|Immunologic Factors|immunologic factors|mesh-ancestor
24575455|NCT00831649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575456|NCT00831714|Rivaroxaban|rivaroxaban|mesh-list
24575457|NCT00831714|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24575458|NCT00831714|Antithrombins|antithrombins|mesh-ancestor
24575459|NCT00831714|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24575460|NCT00831714|Protease Inhibitors|protease inhibitors|mesh-ancestor
24575461|NCT00831714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575462|NCT00831714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575463|NCT00831714|Anticoagulants|anticoagulants|mesh-ancestor
24575464|NCT00831857|Bevacizumab|bevacizumab|mesh-list
24575465|NCT00831857|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
24575466|NCT00831857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24575471|NCT00831857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575472|NCT00831857|Growth Inhibitors|growth inhibitors|mesh-ancestor
24575473|NCT00831857|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24575474|NCT00831857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575476|NCT00832013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24575477|NCT00832013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24575478|NCT00832013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575479|NCT00832013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24575480|NCT00832013|Anesthetics, General|anesthetics, general|mesh-ancestor
24575506|NCT00832221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24575507|NCT00832221|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24575508|NCT00832221|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24631238|NCT01116596|Analgesics|analgesics|mesh-ancestor
24575534|NCT00832286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24575548|NCT00832364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24575549|NCT00832364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575550|NCT00832364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24575551|NCT00832364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24575552|NCT00832364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24575560|NCT00832442|Metoprolol|metoprolol|mesh-list
25710455|NCT02287350|Diclofenac|diclofenac|mesh-list
25710456|NCT02287350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25710457|NCT02287350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25710458|NCT02287350|Analgesics|analgesics|mesh-ancestor
25710459|NCT02287350|Sensory System Agents|sensory system agents|mesh-ancestor
25710460|NCT02287350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25710461|NCT02287350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710462|NCT02287350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25710463|NCT02287350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25710464|NCT02287350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25710465|NCT02287350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710466|NCT02287350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710467|NCT02287376|Diclofenac|diclofenac|mesh-list
25710468|NCT02287376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25710469|NCT02287376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25710470|NCT02287376|Analgesics|analgesics|mesh-ancestor
25710471|NCT02287376|Sensory System Agents|sensory system agents|mesh-ancestor
24575561|NCT00832442|Carvedilol|carvedilol|mesh-list
24575562|NCT00832442|Nebivolol|nebivolol|mesh-list
24575563|NCT00832442|Bisoprolol|bisoprolol|mesh-list
25710472|NCT02287376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24575565|NCT00832442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24575566|NCT00832442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24575587|NCT00832442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24575615|NCT00832689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24575617|NCT00832806|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24575623|NCT00832884|Lacosamide|lacosamide|mesh-list
24575656|NCT00833300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24575657|NCT00833300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575658|NCT00833300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24575659|NCT00833300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24575660|NCT00833300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24575661|NCT00833300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24575662|NCT00833300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24575663|NCT00833300|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24575664|NCT00833300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24575665|NCT00833300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24575666|NCT00833300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575667|NCT00833300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24575669|NCT00833300|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24575670|NCT00833300|Dopamine Agents|dopamine agents|mesh-ancestor
24575671|NCT00833300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24575672|NCT00833326|Docetaxel|docetaxel|mesh-list
24575673|NCT00833326|Antimitotic Agents|antimitotic agents|mesh-list
24575674|NCT00833326|Mitogens|mitogens|mesh-list
24575675|NCT00833326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25009673|NCT05210192|Lidocaine|lidocaine|mesh-list
25009674|NCT05210192|Anesthetics, Local|anesthetics, local|mesh-ancestor
25009675|NCT05210192|Anesthetics|anesthetics|mesh-ancestor
25009676|NCT05210192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25009677|NCT05210192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009678|NCT05210192|Sensory System Agents|sensory system agents|mesh-ancestor
25009679|NCT05210192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25009680|NCT05210192|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25009681|NCT05210192|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25009682|NCT05210192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24575683|NCT00833339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575684|NCT00833339|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24575685|NCT00833339|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24575722|NCT00833534|Immunologic Factors|immunologic factors|mesh-ancestor
24575822|NCT00834600|Amlodipine|amlodipine|mesh-list
24631583|NCT01118923|Antacids|antacids|mesh-ancestor
24575823|NCT00834600|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24575824|NCT00834600|Olmesartan|olmesartan|mesh-list
24575825|NCT00834600|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24575826|NCT00834600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24575827|NCT00834600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24575828|NCT00834600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24575829|NCT00834600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575830|NCT00834600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24575831|NCT00834600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575832|NCT00834600|Vasodilator Agents|vasodilator agents|mesh-ancestor
24575973|NCT00835965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24575974|NCT00835965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575975|NCT00835965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24575976|NCT00835965|Glucocorticoids|glucocorticoids|mesh-ancestor
24575977|NCT00835965|Hormones|hormones|mesh-ancestor
24575978|NCT00835965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24575979|NCT00835965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25710473|NCT02287376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710474|NCT02287376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25710475|NCT02287376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25710476|NCT02287376|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24575980|NCT00835965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710477|NCT02287376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710478|NCT02287376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575982|NCT00835965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575985|NCT00835965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576250|NCT00837837|Dermatologic Agents|dermatologic agents|mesh-ancestor
24576251|NCT00837837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24576252|NCT00837837|Histamine Antagonists|histamine antagonists|mesh-ancestor
24576253|NCT00837837|Histamine Agents|histamine agents|mesh-ancestor
24576254|NCT00837837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576255|NCT00837837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576256|NCT00837837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576257|NCT00837837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24576258|NCT00837850|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
24576259|NCT00837850|Vasodilator Agents|vasodilator agents|mesh-ancestor
24576260|NCT00837850|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24576261|NCT00837850|Protective Agents|protective agents|mesh-ancestor
24576262|NCT00837850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576263|NCT00837889|Diuretics|diuretics|mesh-list
24576264|NCT00837889|Natriuretic Agents|natriuretic agents|mesh-ancestor
24576265|NCT00837889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576474|NCT00838760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24576475|NCT00838760|Antiviral Agents|antiviral agents|mesh-ancestor
24576476|NCT00838760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24632030|NCT01121744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632031|NCT01121744|Antifungal Agents|antifungal agents|mesh-ancestor
24632032|NCT01121744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24632033|NCT01121744|Immunologic Factors|immunologic factors|mesh-ancestor
24576477|NCT00838838|Methyltestosterone|methyltestosterone|mesh-list
24576478|NCT00838838|Testosterone|testosterone|mesh-list
24576479|NCT00838838|Testosterone undecanoate|testosterone undecanoate|mesh-list
24576501|NCT00838968|Interferons|interferons|mesh-list
25009787|NCT05187039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25009788|NCT05186454|Dexamethasone|dexamethasone|mesh-list
25009789|NCT05186454|Midazolam|midazolam|mesh-list
24792828|NCT04605614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24792830|NCT04605614|Micronutrients|micronutrients|mesh-ancestor
24577343|NCT00843323|Dermatologic Agents|dermatologic agents|mesh-ancestor
24577344|NCT00843362|Dinoprostone|dinoprostone|mesh-list
24577345|NCT00843362|Oxytocics|oxytocics|mesh-ancestor
24577346|NCT00843362|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24577347|NCT00843362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577423|NCT00844142|Sulfasalazine|sulfasalazine|mesh-list
24577424|NCT00844142|Etanercept|etanercept|mesh-list
24577425|NCT00844142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24577426|NCT00844142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24577427|NCT00844142|Analgesics|analgesics|mesh-ancestor
24577428|NCT00844142|Sensory System Agents|sensory system agents|mesh-ancestor
24577429|NCT00844142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24577581|NCT00844740|Hormone Antagonists|hormone antagonists|mesh-ancestor
24577582|NCT00844740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24577583|NCT00844792|Vitamin D|vitamin d|mesh-list
24577584|NCT00844792|Cholecalciferol|cholecalciferol|mesh-list
24577585|NCT00844792|Vitamins|vitamins|mesh-list
24577586|NCT00844792|Vitamin E|vitamin e|mesh-list
24577587|NCT00844792|Selenium|selenium|mesh-list
24577588|NCT00844792|Lycopene|lycopene|mesh-list
24577589|NCT00844792|Micronutrients|micronutrients|mesh-ancestor
24578092|NCT00846872|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24578093|NCT00846872|Diuretics|diuretics|mesh-ancestor
24578246|NCT00847834|Natriuretic Agents|natriuretic agents|mesh-ancestor
24578247|NCT00847834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578248|NCT00847834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24578249|NCT00847834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25710479|NCT02287402|Voglibose|voglibose|mesh-list
25710480|NCT02287402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25710481|NCT02287402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710482|NCT02287402|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24578250|NCT00847834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710483|NCT02287402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710484|NCT02287402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710485|NCT02287415|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
24578425|NCT00849030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24578426|NCT00849030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24578503|NCT00849316|Insulin Aspart|insulin aspart|mesh-list
24792951|NCT04339101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24792952|NCT04339101|Alkylating Agents|alkylating agents|mesh-ancestor
25009876|NCT05107778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25009904|NCT05058872|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25009906|NCT05058872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25009907|NCT05058872|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25009908|NCT05058872|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25009909|NCT05058872|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25009910|NCT05058872|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24578761|NCT00851565|Antibodies|antibodies|mesh-list
24578762|NCT00851565|Immunologic Factors|immunologic factors|mesh-ancestor
24578767|NCT00851708|Acetylcysteine|acetylcysteine|mesh-list
24792989|NCT04305158|Anesthetics|anesthetics|mesh-ancestor
24792990|NCT04305158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24579078|NCT00853216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24579473|NCT00855270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24579475|NCT00855283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24579476|NCT00855283|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24579477|NCT00855283|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24579499|NCT00855530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579501|NCT00855608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24579502|NCT00855608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24579503|NCT00855660|Riociguat|riociguat|mesh-list
24579505|NCT00855660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579626|NCT00856596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24579627|NCT00856622|Timolol|timolol|mesh-list
24579628|NCT00856622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24579629|NCT00856622|Latanoprost|latanoprost|mesh-list
24579630|NCT00856622|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24579631|NCT00856622|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24579632|NCT00856622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24579633|NCT00856622|Adrenergic Agents|adrenergic agents|mesh-ancestor
24579634|NCT00856622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24579635|NCT00856622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579644|NCT00856687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24579649|NCT00856700|Incretins|incretins|mesh-list
24579688|NCT00857077|Antimalarials|antimalarials|mesh-ancestor
24579689|NCT00857077|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24579690|NCT00857077|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24579888|NCT00858624|Sensory System Agents|sensory system agents|mesh-ancestor
24579889|NCT00858624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24579890|NCT00858624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579891|NCT00858624|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24579939|NCT00858767|Vitamin K|vitamin k|mesh-list
24579940|NCT00858767|Vitamin MK 7|vitamin mk 7|mesh-list
24579941|NCT00858767|Caseins|caseins|mesh-list
24579942|NCT00858767|Chelating Agents|chelating agents|mesh-ancestor
24579943|NCT00858767|Sequestering Agents|sequestering agents|mesh-ancestor
25710486|NCT02287415|Warfarin|warfarin|mesh-list
25710487|NCT02287415|Anticoagulants|anticoagulants|mesh-ancestor
25710488|NCT02287415|Anticonvulsants|anticonvulsants|mesh-ancestor
25710489|NCT02287415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25710490|NCT02287415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25710491|NCT02287415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25710492|NCT02287415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710493|NCT02287467|Immunoglobulins|immunoglobulins|mesh-list
24579944|NCT00858767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579945|NCT00858767|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24579946|NCT00858767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24580091|NCT00860223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24580092|NCT00860223|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24580093|NCT00860223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415974|NCT02980510|Micronutrients|micronutrients|mesh-ancestor
24580094|NCT00860223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580095|NCT00860223|Protective Agents|protective agents|mesh-ancestor
24580096|NCT00860223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580098|NCT00860275|Ketoconazole|ketoconazole|mesh-list
24580099|NCT00860275|Antifungal Agents|antifungal agents|mesh-ancestor
24580114|NCT00860340|Hormone Antagonists|hormone antagonists|mesh-ancestor
24580115|NCT00860340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24580126|NCT00860496|Tacrolimus|tacrolimus|mesh-list
24580127|NCT00860496|Cyclosporins|cyclosporins|mesh-list
24580128|NCT00860496|Tofacitinib|tofacitinib|mesh-list
24580129|NCT00860496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24580215|NCT00861029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24580216|NCT00861029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24580217|NCT00861029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24580227|NCT00861029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24580229|NCT00861042|Anticonvulsants|anticonvulsants|mesh-ancestor
24580230|NCT00861042|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24580234|NCT00861068|Lacosamide|lacosamide|mesh-list
24580373|NCT00861523|Vitamins|vitamins|mesh-ancestor
24580374|NCT00861523|Micronutrients|micronutrients|mesh-ancestor
24580375|NCT00861523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580376|NCT00861523|Antipruritics|antipruritics|mesh-ancestor
24580377|NCT00861523|Dermatologic Agents|dermatologic agents|mesh-ancestor
24580378|NCT00861523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24580379|NCT00861523|Histamine Antagonists|histamine antagonists|mesh-ancestor
24580380|NCT00861523|Histamine Agents|histamine agents|mesh-ancestor
24580388|NCT00861523|Anesthetics|anesthetics|mesh-ancestor
24580484|NCT00861939|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24580485|NCT00861939|Antidepressive Agents|antidepressive agents|mesh-ancestor
24580487|NCT00861939|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24580488|NCT00861939|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24580489|NCT00861939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24580490|NCT00861939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580491|NCT00861939|Dopamine Agents|dopamine agents|mesh-ancestor
24793130|NCT04074460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24793131|NCT04074460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24793132|NCT04074460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24793133|NCT04074460|Anesthetics, General|anesthetics, general|mesh-ancestor
25010040|NCT04700007|Sensory System Agents|sensory system agents|mesh-ancestor
25010041|NCT04700007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25010042|NCT04700007|Antipruritics|antipruritics|mesh-ancestor
25010043|NCT04700007|Dermatologic Agents|dermatologic agents|mesh-ancestor
25010044|NCT04700007|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25010045|NCT04700007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25010046|NCT04700007|Anesthetics, Local|anesthetics, local|mesh-ancestor
25010047|NCT04700007|Anesthetics|anesthetics|mesh-ancestor
25010048|NCT04700007|Antiemetics|antiemetics|mesh-ancestor
25010049|NCT04700007|Autonomic Agents|autonomic agents|mesh-ancestor
25010050|NCT04700007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25010051|NCT04700007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25710494|NCT02287467|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25710495|NCT02287467|Antibodies|antibodies|mesh-list
25710496|NCT02287467|gamma-Globulins|gamma-globulins|mesh-list
25710497|NCT02287467|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25710498|NCT02287467|Immunologic Factors|immunologic factors|mesh-ancestor
25710499|NCT02287467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710500|NCT02287610|Prednisone|prednisone|mesh-list
25710501|NCT02287610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25710502|NCT02287610|Glucocorticoids|glucocorticoids|mesh-ancestor
25710503|NCT02287610|Hormones|hormones|mesh-ancestor
25710504|NCT02287610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25710505|NCT02287610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710506|NCT02287610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25710507|NCT02287610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010052|NCT04700007|Histamine Antagonists|histamine antagonists|mesh-ancestor
25010054|NCT04700007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25010055|NCT04700007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580971|NCT00864136|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24580972|NCT00864149|Carvedilol|carvedilol|mesh-list
24580973|NCT00864149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24580998|NCT00864188|Protective Agents|protective agents|mesh-ancestor
25010146|NCT04581148|Antibodies|antibodies|mesh-list
24581500|NCT00865384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581501|NCT00865384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581608|NCT00865540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24581609|NCT00865540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581611|NCT00865605|Halobetasol|halobetasol|mesh-list
24581612|NCT00865605|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24581613|NCT00865605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24581614|NCT00865605|Glucocorticoids|glucocorticoids|mesh-ancestor
24581747|NCT00865982|Docetaxel|docetaxel|mesh-list
24581748|NCT00865982|Capecitabine|capecitabine|mesh-list
24581749|NCT00865982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24581750|NCT00865982|Tubulin Modulators|tubulin modulators|mesh-ancestor
24581751|NCT00865982|Antimitotic Agents|antimitotic agents|mesh-ancestor
24581752|NCT00865982|Mitosis Modulators|mitosis modulators|mesh-ancestor
24581753|NCT00865982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24581754|NCT00865982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24581761|NCT00866008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24581762|NCT00866008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110073|NCT03120494|Emtricitabine|emtricitabine|mesh-list
25110074|NCT03120494|Antiviral Agents|antiviral agents|mesh-ancestor
25110075|NCT03120494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24582358|NCT00869271|Fluorouracil|fluorouracil|mesh-list
24582431|NCT00869596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24582432|NCT00869596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582434|NCT00869700|Artemether|artemether|mesh-list
24582453|NCT00869765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24582454|NCT00869765|Renal Agents|renal agents|mesh-ancestor
24582455|NCT00869765|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24582456|NCT00869765|Antitubercular Agents|antitubercular agents|mesh-ancestor
24582457|NCT00869765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24582458|NCT00869765|Antimetabolites|antimetabolites|mesh-ancestor
24582459|NCT00869765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582460|NCT00869856|Epoetin Alfa|epoetin alfa|mesh-list
24582461|NCT00869856|Hematinics|hematinics|mesh-ancestor
24582462|NCT00869869|Melatonin|melatonin|mesh-list
24582463|NCT00869869|Antioxidants|antioxidants|mesh-ancestor
24582464|NCT00869869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582465|NCT00869869|Protective Agents|protective agents|mesh-ancestor
24582469|NCT00869908|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24582470|NCT00869908|Insulin Aspart|insulin aspart|mesh-list
24582471|NCT00869908|Insulin, Long-Acting|insulin, long-acting|mesh-list
24582472|NCT00869908|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24582473|NCT00869908|Insulin Detemir|insulin detemir|mesh-list
24582474|NCT00869908|Biphasic Insulins|biphasic insulins|mesh-list
24632895|NCT01126086|Antithrombins|antithrombins|mesh-ancestor
24582504|NCT00870142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24582505|NCT00870142|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24582506|NCT00870142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24582610|NCT00870714|Docetaxel|docetaxel|mesh-list
24582611|NCT00870714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582612|NCT00870714|Tubulin Modulators|tubulin modulators|mesh-ancestor
24582724|NCT00871247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582837|NCT00872131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24582838|NCT00872131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582839|NCT00872131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24582841|NCT00872131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582842|NCT00872144|Nabiximols|nabiximols|mesh-list
25710508|NCT02287623|Bupivacaine|bupivacaine|mesh-list
25710509|NCT02287623|Anesthetics, Local|anesthetics, local|mesh-ancestor
24582843|NCT00872144|Analgesics|analgesics|mesh-ancestor
25710510|NCT02287623|Anesthetics|anesthetics|mesh-ancestor
25710511|NCT02287623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25710512|NCT02287623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710513|NCT02287623|Sensory System Agents|sensory system agents|mesh-ancestor
25710514|NCT02287623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24582844|NCT00872144|Sensory System Agents|sensory system agents|mesh-ancestor
24582845|NCT00872144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24582846|NCT00872144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582847|NCT00872209|Ciprofloxacin|ciprofloxacin|mesh-list
25010290|NCT04301934|Estradiol|estradiol|mesh-list
24582948|NCT00872651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24582949|NCT00872651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24582958|NCT00872664|Protective Agents|protective agents|mesh-ancestor
24582959|NCT00872664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531745|NCT00637078|Amlodipine|amlodipine|mesh-list
24582962|NCT00872716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24582963|NCT00872716|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24582964|NCT00872716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24583049|NCT00873262|Estradiol|estradiol|mesh-list
24583050|NCT00873262|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24583051|NCT00873262|Estrone|estrone|mesh-list
24583052|NCT00873262|Progesterone|progesterone|mesh-list
24583114|NCT00873366|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24583115|NCT00873366|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24583116|NCT00873366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24583117|NCT00873366|Antitussive Agents|antitussive agents|mesh-ancestor
24583118|NCT00873366|Respiratory System Agents|respiratory system agents|mesh-ancestor
24583119|NCT00873366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24583419|NCT00874419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24583420|NCT00874419|Immunologic Factors|immunologic factors|mesh-ancestor
24583421|NCT00874419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583422|NCT00874419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24583423|NCT00874484|Enoxaparin|enoxaparin|mesh-list
24583424|NCT00874484|Anticoagulants|anticoagulants|mesh-ancestor
24583425|NCT00874484|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24583426|NCT00874484|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24632992|NCT01126697|Ubiquinone|ubiquinone|mesh-list
24583665|NCT00876135|Adrenergic Agents|adrenergic agents|mesh-ancestor
24583666|NCT00876135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24583667|NCT00876135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583669|NCT00876226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24583670|NCT00876226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24583671|NCT00876226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24583672|NCT00876226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583673|NCT00876226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24583674|NCT00876226|Serotonin Agents|serotonin agents|mesh-ancestor
24583927|NCT00877591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583929|NCT00877591|Sensory System Agents|sensory system agents|mesh-ancestor
24583930|NCT00877591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24583931|NCT00877591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24583932|NCT00877591|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24583933|NCT00877591|Antitubercular Agents|antitubercular agents|mesh-ancestor
24633120|NCT01127295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24633121|NCT01127295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633122|NCT01127295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633123|NCT01127295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24633124|NCT01127295|Hormone Antagonists|hormone antagonists|mesh-ancestor
24633126|NCT01127295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584184|NCT00878943|Vasodilator Agents|vasodilator agents|mesh-ancestor
24584185|NCT00878943|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24584186|NCT00878943|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24633137|NCT01127360|Ranibizumab|ranibizumab|mesh-list
24793559|NCT03123913|Testosterone|testosterone|mesh-list
24793560|NCT03123913|Testosterone undecanoate|testosterone undecanoate|mesh-list
24793561|NCT03123913|Testosterone enanthate|testosterone enanthate|mesh-list
24793562|NCT03123913|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24584260|NCT00879177|Cholinergic Agents|cholinergic agents|mesh-ancestor
25710515|NCT02287779|Volixibat|volixibat|mesh-list
25710516|NCT02287779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25710517|NCT02287909|Clopidogrel|clopidogrel|mesh-list
25710518|NCT02287909|Ticagrelor|ticagrelor|mesh-list
25710519|NCT02287909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25710520|NCT02287909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24584261|NCT00879177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24584262|NCT00879177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584263|NCT00879177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584264|NCT00879242|Deferasirox|deferasirox|mesh-list
24584265|NCT00879242|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24584267|NCT00879242|Sequestering Agents|sequestering agents|mesh-ancestor
24584270|NCT00879307|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24584271|NCT00879307|Antidepressive Agents|antidepressive agents|mesh-ancestor
24584272|NCT00879307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24584286|NCT00879385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584287|NCT00879385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584288|NCT00879385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24584289|NCT00879424|Vitamin D|vitamin d|mesh-list
24584323|NCT00879892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584325|NCT00879918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24584326|NCT00879918|Autonomic Agents|autonomic agents|mesh-ancestor
24584327|NCT00879918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24584328|NCT00879918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584329|NCT00879918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24584334|NCT00879931|Methylprednisolone|methylprednisolone|mesh-list
24584335|NCT00879931|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24584348|NCT00879931|Hormones|hormones|mesh-ancestor
24584404|NCT00880282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24584405|NCT00880282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24584406|NCT00880282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24584407|NCT00880282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24584408|NCT00880282|Antifungal Agents|antifungal agents|mesh-ancestor
24584409|NCT00880282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24584410|NCT00880282|Immunologic Factors|immunologic factors|mesh-ancestor
24584411|NCT00880282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584412|NCT00880321|Dabrafenib|dabrafenib|mesh-list
24584413|NCT00880321|Midazolam|midazolam|mesh-list
24584414|NCT00880321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24584415|NCT00880321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24584416|NCT00880321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24584417|NCT00880321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633188|NCT01127555|Oxaliplatin|oxaliplatin|mesh-list
24584595|NCT00881127|Histamine Antagonists|histamine antagonists|mesh-ancestor
24584596|NCT00881127|Histamine Agents|histamine agents|mesh-ancestor
24584597|NCT00881127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24584598|NCT00881127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584599|NCT00881127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24584600|NCT00881127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24584601|NCT00881127|Autonomic Agents|autonomic agents|mesh-ancestor
24584602|NCT00881127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24584603|NCT00881127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24584604|NCT00881127|Respiratory System Agents|respiratory system agents|mesh-ancestor
24584605|NCT00881127|Nasal Decongestants|nasal decongestants|mesh-ancestor
24584606|NCT00881127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24584607|NCT00881127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24584608|NCT00881127|Sympathomimetics|sympathomimetics|mesh-ancestor
24584609|NCT00881127|Adrenergic Agents|adrenergic agents|mesh-ancestor
24584611|NCT00881140|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24584612|NCT00881140|Abortifacient Agents|abortifacient agents|mesh-ancestor
25110167|NCT05464979|Fentanyl|fentanyl|mesh-list
25710521|NCT02287909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25710522|NCT02287909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25710523|NCT02287909|Purinergic Agents|purinergic agents|mesh-ancestor
25710524|NCT02287909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25710525|NCT02287909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710526|NCT02287909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904256|NCT04357392|Hormones|hormones|mesh-ancestor
24584685|NCT00881296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24584686|NCT00881296|Antiviral Agents|antiviral agents|mesh-ancestor
24584687|NCT00881296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24584688|NCT00881296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24584936|NCT00882323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24584938|NCT00882375|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24584939|NCT00882375|Autonomic Agents|autonomic agents|mesh-ancestor
24584949|NCT00882388|Clopidogrel|clopidogrel|mesh-list
24584950|NCT00882388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24584951|NCT00882388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24584952|NCT00882388|Analgesics|analgesics|mesh-ancestor
24584953|NCT00882388|Sensory System Agents|sensory system agents|mesh-ancestor
25011060|NCT02184741|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24584954|NCT00882388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24585179|NCT00883935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24585180|NCT00883935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585181|NCT00883935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24585182|NCT00883935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24585183|NCT00883935|Antiviral Agents|antiviral agents|mesh-ancestor
24585184|NCT00883935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24585185|NCT00883935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24585186|NCT00883935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24585187|NCT00883935|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24585188|NCT00883935|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24585189|NCT00884104|Solifenacin Succinate|solifenacin succinate|mesh-list
24585191|NCT00884104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24586757|NCT00892125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24585310|NCT00884845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24585311|NCT00884845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585312|NCT00884858|Maraviroc|maraviroc|mesh-list
24585313|NCT00884858|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24585314|NCT00884858|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24585315|NCT00884858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585316|NCT00884858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24585317|NCT00884858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24585318|NCT00884858|Antiviral Agents|antiviral agents|mesh-ancestor
24585353|NCT00885066|Immunologic Factors|immunologic factors|mesh-ancestor
24585466|NCT00885690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24585467|NCT00885690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24585468|NCT00885690|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24585469|NCT00885690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24585470|NCT00885690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24585471|NCT00885690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585524|NCT00885872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24585525|NCT00885885|Panitumumab|panitumumab|mesh-list
24585526|NCT00885885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24585527|NCT00885885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585552|NCT00886028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24585553|NCT00886028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24585554|NCT00886028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24585555|NCT00886028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24585559|NCT00886106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24585560|NCT00886106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24585562|NCT00886106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585563|NCT00886106|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24585624|NCT00886314|GABA Agents|gaba agents|mesh-ancestor
24585625|NCT00886314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24585626|NCT00886314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585627|NCT00886405|Nitroglycerin|nitroglycerin|mesh-list
25710527|NCT02288156|Capsaicin|capsaicin|mesh-list
25710528|NCT02288156|Antipruritics|antipruritics|mesh-ancestor
25710529|NCT02288156|Dermatologic Agents|dermatologic agents|mesh-ancestor
25710530|NCT02288156|Sensory System Agents|sensory system agents|mesh-ancestor
25710531|NCT02288156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25710532|NCT02288156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585628|NCT00886405|Vasodilator Agents|vasodilator agents|mesh-ancestor
24585630|NCT00886457|Interferon-alpha|interferon-alpha|mesh-list
24585631|NCT00886457|Interferon alpha-2|interferon alpha-2|mesh-list
24585632|NCT00886457|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24585680|NCT00886678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24585876|NCT00887601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585877|NCT00887601|Nootropic Agents|nootropic agents|mesh-ancestor
24633745|NCT01131000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24633746|NCT01131000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633747|NCT01131000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633748|NCT01131026|Amoxicillin|amoxicillin|mesh-list
24585878|NCT00887627|Conivaptan|conivaptan|mesh-list
24585879|NCT00887627|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24585880|NCT00887627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571529|NCT00810589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25010528|NCT03854110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25010529|NCT03854110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010662|NCT03428958|Micronutrients|micronutrients|mesh-ancestor
25010663|NCT03428958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25010664|NCT03428958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25010665|NCT03428958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25010667|NCT03393611|Cytarabine|cytarabine|mesh-list
24895081|NCT05069298|Silybin|silybin|mesh-list
24895082|NCT05069298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24895083|NCT05069298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25010833|NCT02939573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25010834|NCT02939573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25010835|NCT02939573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25010836|NCT02939573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25010837|NCT02939573|Leprostatic Agents|leprostatic agents|mesh-ancestor
25010838|NCT02939573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25010839|NCT02929589|Ibuprofen|ibuprofen|mesh-list
25010840|NCT02929589|Analgesics, Opioid|analgesics, opioid|mesh-list
24586067|NCT00889057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24586068|NCT00889057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24586069|NCT00889057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586070|NCT00889096|Propranolol|propranolol|mesh-list
24586071|NCT00889096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24586072|NCT00889096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24586073|NCT00889096|Adrenergic Agents|adrenergic agents|mesh-ancestor
25011047|NCT02285504|Brexanolone|brexanolone|mesh-list
25011048|NCT02285504|Neurosteroids|neurosteroids|mesh-ancestor
25011049|NCT02285504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25011050|NCT02285504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011051|NCT02285504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011058|NCT02184741|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25011106|NCT01940094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25011107|NCT01940094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011108|NCT01940094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25011109|NCT01940094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011110|NCT01882933|Oxaliplatin|oxaliplatin|mesh-list
25011111|NCT01882933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011112|NCT01869829|Antifungal Agents|antifungal agents|mesh-list
25011113|NCT01869829|Clotrimazole|clotrimazole|mesh-list
25011114|NCT01869829|Miconazole|miconazole|mesh-list
25011115|NCT01869829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25011281|NCT00477412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25011282|NCT00477412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25011284|NCT00477412|Hormones|hormones|mesh-ancestor
25011285|NCT00477412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25011286|NCT00477412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25011287|NCT00477412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24968071|NCT03754842|Antimetabolites|antimetabolites|mesh-ancestor
24968072|NCT03754842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24968073|NCT03754842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24968074|NCT03754842|Vasodilator Agents|vasodilator agents|mesh-ancestor
24586080|NCT00889135|Droxidopa|droxidopa|mesh-list
25710533|NCT02288273|Exenatide|exenatide|mesh-list
25710534|NCT02288273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25011337|NCT05216419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25011338|NCT05216419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011340|NCT05216419|Micronutrients|micronutrients|mesh-ancestor
25011341|NCT05216419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25011342|NCT05216237|Oxaliplatin|oxaliplatin|mesh-list
25011343|NCT05216237|Apatinib|apatinib|mesh-list
25011422|NCT05189145|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25011423|NCT05189145|Hormones|hormones|mesh-list
25011424|NCT05189145|Estradiol|estradiol|mesh-list
25011425|NCT05189145|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25011426|NCT05189145|Progesterone|progesterone|mesh-list
25011427|NCT05189145|Dydrogesterone|dydrogesterone|mesh-list
25011428|NCT05189145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25011429|NCT05189145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011430|NCT05189145|Estrogens|estrogens|mesh-ancestor
25011431|NCT05189145|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25011432|NCT05189145|Contraceptive Agents|contraceptive agents|mesh-ancestor
25011433|NCT05189145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25011435|NCT05189145|Progestins|progestins|mesh-ancestor
25011475|NCT04964193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011476|NCT04964193|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25011477|NCT04964193|Estrogens|estrogens|mesh-ancestor
25011478|NCT04964193|Hormones|hormones|mesh-ancestor
25011488|NCT04958876|Sensory System Agents|sensory system agents|mesh-ancestor
25011489|NCT04958876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24514551|NCT00591526|Antimetabolites|antimetabolites|mesh-ancestor
25110284|NCT05464615|Amoxicillin|amoxicillin|mesh-list
25110300|NCT05464394|Tranexamic Acid|tranexamic acid|mesh-list
25110301|NCT05464394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25110302|NCT05464394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25110303|NCT05464394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110304|NCT05464394|Hemostatics|hemostatics|mesh-ancestor
25110305|NCT05464394|Coagulants|coagulants|mesh-ancestor
25011599|NCT04647084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25011600|NCT04647084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011603|NCT04620798|Antibodies|antibodies|mesh-list
25011604|NCT04620798|Immunologic Factors|immunologic factors|mesh-ancestor
25011605|NCT04620798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25011606|NCT04576078|Nefopam|nefopam|mesh-list
25011607|NCT04576078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24968458|NCT03751111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24968459|NCT03751059|Dexamethasone|dexamethasone|mesh-list
24968461|NCT03751059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24968462|NCT03751059|Antiemetics|antiemetics|mesh-ancestor
24968463|NCT03751059|Autonomic Agents|autonomic agents|mesh-ancestor
25011756|NCT04186494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25011757|NCT04180995|Axitinib|axitinib|mesh-list
25011758|NCT04180995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25011759|NCT04180995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25011760|NCT04180995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011761|NCT04180995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110309|NCT05464303|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25110310|NCT05464303|Immunologic Factors|immunologic factors|mesh-ancestor
25110311|NCT05464303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110312|NCT05464264|Ketamine|ketamine|mesh-list
25110313|NCT05464264|Analgesics|analgesics|mesh-ancestor
25110314|NCT05464264|Sensory System Agents|sensory system agents|mesh-ancestor
25110315|NCT05464264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25110316|NCT05464264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110317|NCT05464264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25110319|NCT05464264|Anesthetics, General|anesthetics, general|mesh-ancestor
25110345|NCT05463913|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25110346|NCT05463913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110347|NCT05463861|Lemborexant|lemborexant|mesh-list
25110348|NCT05463861|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25110349|NCT05463861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25110352|NCT05463861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25011861|NCT03424525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25011862|NCT03424525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25011863|NCT03424525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25011864|NCT03424525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25011865|NCT03424525|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25011866|NCT03424525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25012044|NCT02335060|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25012045|NCT02335060|Antiviral Agents|antiviral agents|mesh-ancestor
25012046|NCT02335060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25012048|NCT02335060|Respiratory System Agents|respiratory system agents|mesh-ancestor
25012049|NCT02335060|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25012050|NCT02335060|Antioxidants|antioxidants|mesh-ancestor
25012051|NCT02335060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012052|NCT02335060|Protective Agents|protective agents|mesh-ancestor
25012055|NCT02335060|Hallucinogens|hallucinogens|mesh-ancestor
25012056|NCT02335060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25012057|NCT02335060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25012058|NCT02335060|Analgesics|analgesics|mesh-ancestor
25012104|NCT02250326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25012105|NCT02250326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25012106|NCT02250326|Tubulin Modulators|tubulin modulators|mesh-ancestor
25012107|NCT02250326|Antimitotic Agents|antimitotic agents|mesh-ancestor
25012108|NCT02250326|Mitosis Modulators|mitosis modulators|mesh-ancestor
25012109|NCT02250326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012110|NCT02250326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25012158|NCT01856270|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25012159|NCT01856270|Antidepressive Agents|antidepressive agents|mesh-ancestor
25012160|NCT01856270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25012161|NCT01856270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25012162|NCT01856270|Analgesics|analgesics|mesh-ancestor
25012163|NCT01856270|Sensory System Agents|sensory system agents|mesh-ancestor
25012170|NCT01856270|Adrenergic Agents|adrenergic agents|mesh-ancestor
25012268|NCT00136903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012269|NCT00136903|Antifungal Agents|antifungal agents|mesh-ancestor
25012270|NCT00136903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25012271|NCT00136903|Dermatologic Agents|dermatologic agents|mesh-ancestor
25012272|NCT00136903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25012395|NCT05217069|Micronutrients|micronutrients|mesh-ancestor
25012396|NCT05217069|Hematinics|hematinics|mesh-ancestor
25012397|NCT05216822|Racecadotril|racecadotril|mesh-list
25012398|NCT05216822|Antidiarrheals|antidiarrheals|mesh-ancestor
25012399|NCT05216822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25012400|NCT05216822|Protease Inhibitors|protease inhibitors|mesh-ancestor
25012401|NCT05216822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25012402|NCT05216822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012403|NCT05215470|Nivolumab|nivolumab|mesh-list
25012404|NCT05215470|Ipilimumab|ipilimumab|mesh-list
25012503|NCT05052970|Bortezomib|bortezomib|mesh-list
25012504|NCT05052970|Mitoxantrone|mitoxantrone|mesh-list
25012505|NCT05052970|BB 1101|bb 1101|mesh-list
25012506|NCT05052970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25012507|NCT05052970|Antiemetics|antiemetics|mesh-ancestor
25012508|NCT05052970|Autonomic Agents|autonomic agents|mesh-ancestor
25012509|NCT05052970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25012510|NCT05052970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25012511|NCT05052970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25012512|NCT05052970|Glucocorticoids|glucocorticoids|mesh-ancestor
25012513|NCT05052970|Hormones|hormones|mesh-ancestor
25012515|NCT05052970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25012575|NCT04896658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25012576|NCT04896658|Glucocorticoids|glucocorticoids|mesh-ancestor
25012578|NCT04896658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25012579|NCT04896658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25012580|NCT04856319|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25012581|NCT04856319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25012582|NCT04802837|Vancomycin|vancomycin|mesh-list
25012583|NCT04802837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25012584|NCT04802837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25012585|NCT04769401|Progesterone|progesterone|mesh-list
25012586|NCT04769401|Progestins|progestins|mesh-ancestor
25012587|NCT04769401|Hormones|hormones|mesh-ancestor
25012590|NCT04742023|Insulin|insulin|mesh-list
25012605|NCT04724252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25012606|NCT04724252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25770647|NCT03555890|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25012607|NCT04724252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25012608|NCT04724252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25770648|NCT03556761|Furosemide|furosemide|mesh-list
25770649|NCT03556761|Diuretics|diuretics|mesh-ancestor
25770650|NCT03556761|Natriuretic Agents|natriuretic agents|mesh-ancestor
25770651|NCT03556761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770652|NCT03556761|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25012737|NCT04531176|Incretins|incretins|mesh-ancestor
25012738|NCT04531176|Hormones|hormones|mesh-ancestor
25012739|NCT04531176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25012740|NCT04531176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25012741|NCT04531176|Antidepressive Agents|antidepressive agents|mesh-ancestor
25012742|NCT04531176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25012743|NCT04531176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25012744|NCT04531176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25012745|NCT04531176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25012746|NCT04531176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012747|NCT04531176|Dopamine Agents|dopamine agents|mesh-ancestor
25012748|NCT04531176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24969662|NCT03741426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24969663|NCT03741426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24969664|NCT03741309|Calcium|calcium|mesh-list
24969665|NCT03741309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24969666|NCT03741309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24969667|NCT03741244|Temozolomide|temozolomide|mesh-list
24969668|NCT03741244|Apatinib|apatinib|mesh-list
24969669|NCT03741244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24969670|NCT03741244|Alkylating Agents|alkylating agents|mesh-ancestor
25012881|NCT04190056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25012882|NCT04190056|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25012883|NCT04190056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25012884|NCT04190056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25012885|NCT04186988|9-arabinofuranosylguanine|9-arabinofuranosylguanine|mesh-list
25012998|NCT03913091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25012999|NCT03906136|Adalimumab|adalimumab|mesh-list
25013000|NCT03906136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25013001|NCT03906136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25013002|NCT03889249|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25013003|NCT03889249|Tenecteplase|tenecteplase|mesh-list
25013004|NCT03889249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25013005|NCT03889249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25013006|NCT03889249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013007|NCT03858322|Paclitaxel|paclitaxel|mesh-list
25013008|NCT03858322|Cyclophosphamide|cyclophosphamide|mesh-list
25013009|NCT03858322|Carboplatin|carboplatin|mesh-list
25013039|NCT03822637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013042|NCT03822637|Expectorants|expectorants|mesh-ancestor
25013153|NCT03441555|Alvocidib|alvocidib|mesh-list
25013154|NCT03441555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013155|NCT03441555|Growth Inhibitors|growth inhibitors|mesh-ancestor
25013156|NCT03441555|Growth Substances|growth substances|mesh-ancestor
25013157|NCT03441555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013158|NCT03441555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25013159|NCT03441555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25013160|NCT03441555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574790|NCT00827411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24586233|NCT00889642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24586234|NCT00889642|Adrenergic Agents|adrenergic agents|mesh-ancestor
24586235|NCT00889642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24586236|NCT00889642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24586237|NCT00889642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24586238|NCT00889642|Autonomic Agents|autonomic agents|mesh-ancestor
24586239|NCT00889642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24586282|NCT00890110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710535|NCT02288273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710536|NCT02288273|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25710537|NCT02288273|Incretins|incretins|mesh-ancestor
25710538|NCT02288273|Hormones|hormones|mesh-ancestor
25710539|NCT02288273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25013218|NCT03346239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710540|NCT02288312|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
25710541|NCT02288312|Anticonvulsants|anticonvulsants|mesh-ancestor
25710542|NCT02288312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25710543|NCT02288312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25710544|NCT02288312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25710545|NCT02288312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013219|NCT03346239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25013220|NCT03346239|Antidepressive Agents|antidepressive agents|mesh-ancestor
25013221|NCT03346239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25110456|NCT05463367|Carbidopa|carbidopa|mesh-list
25110463|NCT05463367|Sensory System Agents|sensory system agents|mesh-ancestor
25110464|NCT05463367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25110465|NCT05463367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25110466|NCT05463367|Antipyretics|antipyretics|mesh-ancestor
25110467|NCT05463367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25110468|NCT05463367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25013277|NCT03161678|Purinergic Agents|purinergic agents|mesh-ancestor
25013278|NCT03161678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25013279|NCT03161678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013280|NCT03161678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013429|NCT02733042|Immunologic Factors|immunologic factors|mesh-ancestor
25013430|NCT02733042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013431|NCT02733042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25013432|NCT02733042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25013433|NCT02733042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25013434|NCT02733042|Growth Substances|growth substances|mesh-ancestor
25013435|NCT02733042|Growth Inhibitors|growth inhibitors|mesh-ancestor
25013436|NCT02733042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25013437|NCT02733042|Alkylating Agents|alkylating agents|mesh-ancestor
25013438|NCT02733042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013479|NCT02574286|Vitamin D|vitamin d|mesh-list
24970346|NCT03734068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24970347|NCT03734068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24621914|NCT01064726|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24621915|NCT01064726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24621916|NCT01064726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24621918|NCT01064726|Sensory System Agents|sensory system agents|mesh-ancestor
24621919|NCT01064726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24621920|NCT01064726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25710546|NCT02288325|Milnacipran|milnacipran|mesh-list
25710547|NCT02288325|Levomilnacipran|levomilnacipran|mesh-list
25710548|NCT02288325|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25710549|NCT02288325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25710550|NCT02288325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25710551|NCT02288325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710552|NCT02288325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25710553|NCT02288325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710554|NCT02288325|Antidepressive Agents|antidepressive agents|mesh-ancestor
25013580|NCT02236806|Adrenergic Agents|adrenergic agents|mesh-ancestor
25013614|NCT02061514|Anesthetics, General|anesthetics, general|mesh-ancestor
25013615|NCT02061514|Anesthetics|anesthetics|mesh-ancestor
25013616|NCT02061514|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25013630|NCT01446016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25013631|NCT01446016|Taxane|taxane|mesh-list
25013632|NCT01446016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25013633|NCT01446016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013634|NCT01446016|Tubulin Modulators|tubulin modulators|mesh-ancestor
25013635|NCT01446016|Antimitotic Agents|antimitotic agents|mesh-ancestor
25013636|NCT01446016|Mitosis Modulators|mitosis modulators|mesh-ancestor
25013662|NCT01078454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013663|NCT01078454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25013664|NCT01078454|Alkylating Agents|alkylating agents|mesh-ancestor
25013665|NCT01078454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25013666|NCT01078454|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25013667|NCT01078454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25013668|NCT01078454|Immunologic Factors|immunologic factors|mesh-ancestor
25013670|NCT00472654|Vitamins|vitamins|mesh-ancestor
25013671|NCT00472654|Micronutrients|micronutrients|mesh-ancestor
25013672|NCT00472654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25013673|NCT00472654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25013674|NCT00458536|Molgramostim|molgramostim|mesh-list
25013675|NCT00458536|Sargramostim|sargramostim|mesh-list
25110518|NCT05462470|Liver Extracts|liver extracts|mesh-list
25110519|NCT05462470|Hematinics|hematinics|mesh-ancestor
25110520|NCT05461560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25110521|NCT05461339|Ranibizumab|ranibizumab|mesh-list
25110522|NCT05461339|Antibodies|antibodies|mesh-list
25110523|NCT05461339|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25110524|NCT05461339|Immunologic Factors|immunologic factors|mesh-ancestor
25110525|NCT05461339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110526|NCT05461339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25110527|NCT05461339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25110528|NCT05461339|Growth Substances|growth substances|mesh-ancestor
25110529|NCT05461339|Growth Inhibitors|growth inhibitors|mesh-ancestor
25110530|NCT05461339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25013723|NCT05223010|Anesthetics, General|anesthetics, general|mesh-ancestor
25013787|NCT05222191|Hormone Antagonists|hormone antagonists|mesh-ancestor
25013788|NCT05222191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25013837|NCT05221645|Rituximab|rituximab|mesh-list
25013838|NCT05221645|Pembrolizumab|pembrolizumab|mesh-list
25013839|NCT05221645|Carboplatin|carboplatin|mesh-list
25013840|NCT05221645|Etoposide|etoposide|mesh-list
25013841|NCT05221645|Ifosfamide|ifosfamide|mesh-list
25013842|NCT05221645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24586314|NCT00890214|Heparin|heparin|mesh-list
24586324|NCT00890253|Mycophenolic Acid|mycophenolic acid|mesh-list
24586325|NCT00890253|Prednisone|prednisone|mesh-list
24586326|NCT00890253|Prednisolone|prednisolone|mesh-list
24586327|NCT00890253|Everolimus|everolimus|mesh-list
24586328|NCT00890253|Basiliximab|basiliximab|mesh-list
24586329|NCT00890253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24586330|NCT00890253|Glucocorticoids|glucocorticoids|mesh-ancestor
24586331|NCT00890253|Hormones|hormones|mesh-ancestor
24586332|NCT00890253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24586333|NCT00890253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586368|NCT00890383|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24586369|NCT00890383|Plasma Substitutes|plasma substitutes|mesh-ancestor
24586370|NCT00890383|Blood Substitutes|blood substitutes|mesh-ancestor
25110575|NCT05442580|Fludarabine|fludarabine|mesh-list
25013986|NCT05189028|Gemcitabine|gemcitabine|mesh-list
25013987|NCT05189028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25014032|NCT05126264|Ibuprofen|ibuprofen|mesh-list
25014033|NCT05126264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25014034|NCT05126264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24575944|NCT00835744|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25710555|NCT02288325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25710556|NCT02288325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25710557|NCT02288325|Analgesics|analgesics|mesh-ancestor
25710558|NCT02288325|Sensory System Agents|sensory system agents|mesh-ancestor
25710559|NCT02288325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25710560|NCT02288364|Lidocaine|lidocaine|mesh-list
25710561|NCT02288364|Anesthetics, Local|anesthetics, local|mesh-ancestor
25710562|NCT02288364|Anesthetics|anesthetics|mesh-ancestor
25710563|NCT02288364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25710564|NCT02288364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575945|NCT00835744|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24575946|NCT00835848|Exenatide|exenatide|mesh-list
24575947|NCT00835848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24575948|NCT00835848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110620|NCT05434663|Granisetron|granisetron|mesh-list
25110621|NCT05434663|Antiemetics|antiemetics|mesh-ancestor
25110622|NCT05434663|Autonomic Agents|autonomic agents|mesh-ancestor
25014107|NCT05049278|Adrenergic Agents|adrenergic agents|mesh-ancestor
25014156|NCT04963816|Dexamethasone acetate|dexamethasone acetate|mesh-list
25014158|NCT04963816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25014159|NCT04963816|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25014160|NCT04963816|BB 1101|bb 1101|mesh-list
25014161|NCT04963816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25014163|NCT04963816|Autonomic Agents|autonomic agents|mesh-ancestor
25014164|NCT04963816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25014165|NCT04963816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014166|NCT04963816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25014167|NCT04963816|Glucocorticoids|glucocorticoids|mesh-ancestor
25014168|NCT04963816|Hormones|hormones|mesh-ancestor
25014235|NCT04889703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25014236|NCT04889703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014237|NCT04889703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25014238|NCT04889703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25014239|NCT04889703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25014240|NCT04889703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25014241|NCT04889703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014242|NCT04887792|Acetazolamide|acetazolamide|mesh-list
25014243|NCT04887792|Anticonvulsants|anticonvulsants|mesh-ancestor
25014268|NCT04814433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25014269|NCT04814433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25014270|NCT04814433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25014353|NCT04671355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25014354|NCT04671355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25014356|NCT04671355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25014357|NCT04671355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014358|NCT04671355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25014359|NCT04671355|Respiratory System Agents|respiratory system agents|mesh-ancestor
25014360|NCT04671355|Dermatologic Agents|dermatologic agents|mesh-ancestor
25014361|NCT04671355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25014362|NCT04671355|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25014363|NCT04671355|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25014551|NCT04337827|Rituximab|rituximab|mesh-list
25014552|NCT04337827|Acalabrutinib|acalabrutinib|mesh-list
25014553|NCT04337827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25014554|NCT04337827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25014555|NCT04337827|Immunologic Factors|immunologic factors|mesh-ancestor
25014565|NCT04291521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25014575|NCT04291521|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25014576|NCT04291521|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25014577|NCT04291521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25014578|NCT04291521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014615|NCT04198766|Antibodies|antibodies|mesh-list
25014726|NCT03995017|Ramucirumab|ramucirumab|mesh-list
25014727|NCT03995017|Rucaparib|rucaparib|mesh-list
25014728|NCT03995017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25014729|NCT03995017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25014730|NCT03995017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24576764|NCT00840346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710565|NCT02288364|Sensory System Agents|sensory system agents|mesh-ancestor
25710566|NCT02288364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25710567|NCT02288364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25710568|NCT02288364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25710569|NCT02288364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25710570|NCT02288364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25710571|NCT02288364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576765|NCT00840346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576766|NCT00840385|Vidarabine|vidarabine|mesh-list
24576767|NCT00840385|Fludarabine|fludarabine|mesh-list
24576768|NCT00840385|Fludarabine phosphate|fludarabine phosphate|mesh-list
25014751|NCT03923374|Narcotics|narcotics|mesh-ancestor
25014752|NCT03923374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25014871|NCT03738852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014872|NCT03738397|Upadacitinib|upadacitinib|mesh-list
25014873|NCT03738397|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25014874|NCT03738397|Immunologic Factors|immunologic factors|mesh-ancestor
25014875|NCT03738397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25014876|NCT03738397|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25014877|NCT03738397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25014878|NCT03738397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25014879|NCT03738397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25014880|NCT03738397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25014881|NCT03705845|Tocotrienols|tocotrienols|mesh-list
25014882|NCT03705845|Vitamin E|vitamin e|mesh-list
25014883|NCT03705845|Tocopherols|tocopherols|mesh-list
25014884|NCT03705845|Antioxidants|antioxidants|mesh-ancestor
25014886|NCT03705845|Protective Agents|protective agents|mesh-ancestor
24576903|NCT00840918|Sensory System Agents|sensory system agents|mesh-ancestor
25014892|NCT03674320|Testosterone undecanoate|testosterone undecanoate|mesh-list
25014893|NCT03674320|Testosterone enanthate|testosterone enanthate|mesh-list
25014894|NCT03674320|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25014895|NCT03674320|Androgens|androgens|mesh-ancestor
25014896|NCT03674320|Hormones|hormones|mesh-ancestor
25014934|NCT03639610|Immunologic Factors|immunologic factors|mesh-ancestor
25014945|NCT03589729|Cytarabine|cytarabine|mesh-list
25015061|NCT03392441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24577160|NCT00842140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25015062|NCT03392441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015063|NCT03389243|Acetaminophen|acetaminophen|mesh-list
25015064|NCT03389243|Dipyrone|dipyrone|mesh-list
25015065|NCT03389243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25015066|NCT03389243|Analgesics|analgesics|mesh-ancestor
25015067|NCT03389243|Sensory System Agents|sensory system agents|mesh-ancestor
25015068|NCT03389243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25015069|NCT03389243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015070|NCT03389243|Antipyretics|antipyretics|mesh-ancestor
25015071|NCT03389243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25015072|NCT03389243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25015073|NCT03389243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25015074|NCT03243838|Apatinib|apatinib|mesh-list
25015075|NCT03243838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015076|NCT03243838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25015077|NCT03243838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25015078|NCT03243838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015079|NCT03221309|Analgesics, Opioid|analgesics, opioid|mesh-list
25015080|NCT03221309|Narcotics|narcotics|mesh-ancestor
25015081|NCT03221309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25015082|NCT03221309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015083|NCT03221309|Analgesics|analgesics|mesh-ancestor
25015084|NCT03221309|Sensory System Agents|sensory system agents|mesh-ancestor
25710573|NCT02288377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710574|NCT02288819|Diuretics|diuretics|mesh-list
25710575|NCT02288819|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
25710576|NCT02288819|Natriuretic Agents|natriuretic agents|mesh-ancestor
25710577|NCT02288819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710578|NCT02288819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25710579|NCT02288819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015119|NCT03126968|Adrenergic Agents|adrenergic agents|mesh-ancestor
25015120|NCT03126968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25015121|NCT03126968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015122|NCT03126968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015123|NCT03126968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25015124|NCT03126968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25015126|NCT03126968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25015150|NCT03059446|Cenicriviroc|cenicriviroc|mesh-list
25015151|NCT03059446|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24577239|NCT00842595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015152|NCT03059446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015165|NCT03039673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015166|NCT03039673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25015167|NCT03039673|Analgesics|analgesics|mesh-ancestor
25015168|NCT03039673|Sensory System Agents|sensory system agents|mesh-ancestor
25015169|NCT03039673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25015170|NCT03039673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015177|NCT03039673|Protective Agents|protective agents|mesh-ancestor
25015193|NCT02980666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24456717|NCT00332046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25015194|NCT02980666|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25015195|NCT02980666|Protective Agents|protective agents|mesh-ancestor
24971830|NCT03722173|Antifungal Agents|antifungal agents|mesh-ancestor
24971831|NCT03722173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24971832|NCT03722173|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24971833|NCT03722173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24971834|NCT03722173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24971835|NCT03722173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110703|NCT05395507|Interferon alpha-2|interferon alpha-2|mesh-list
25110704|NCT05395507|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25110705|NCT05395507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25110706|NCT05395507|Antiviral Agents|antiviral agents|mesh-ancestor
25110707|NCT05395507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25110708|NCT05395507|Immunologic Factors|immunologic factors|mesh-ancestor
25110709|NCT05395507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110757|NCT05373225|Acetic Acid|acetic acid|mesh-list
25015354|NCT02538666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015355|NCT02527200|Liraglutide|liraglutide|mesh-list
25015356|NCT02527200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25015384|NCT02516696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015385|NCT02516696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25015386|NCT02516696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25015387|NCT02511106|Osimertinib|osimertinib|mesh-list
25015388|NCT02511106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015391|NCT02511106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015393|NCT02491099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015394|NCT02491099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015395|NCT02491099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25015396|NCT02491099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25015397|NCT02476058|Diphenhydramine|diphenhydramine|mesh-list
25015399|NCT02476058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25015400|NCT02476058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25015499|NCT02245230|Respiratory System Agents|respiratory system agents|mesh-ancestor
25710580|NCT02289079|Bupivacaine|bupivacaine|mesh-list
25710581|NCT02289079|Anesthetics, Local|anesthetics, local|mesh-ancestor
25710582|NCT02289079|Anesthetics|anesthetics|mesh-ancestor
25710583|NCT02289079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25710584|NCT02289079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710585|NCT02289079|Sensory System Agents|sensory system agents|mesh-ancestor
25710586|NCT02289079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25710587|NCT02289222|Dexamethasone|dexamethasone|mesh-list
25015500|NCT02245230|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25015503|NCT02245230|Adrenergic Agents|adrenergic agents|mesh-ancestor
25015504|NCT02245230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25015505|NCT02245230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015561|NCT01747447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25015571|NCT01656434|Estrogens|estrogens|mesh-ancestor
25015589|NCT01601522|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25015590|NCT01599494|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25015591|NCT01599494|Progesterone|progesterone|mesh-list
25110760|NCT05373225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25110761|NCT05373225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25110762|NCT05373225|Immunologic Factors|immunologic factors|mesh-ancestor
25110763|NCT05373225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110764|NCT05373225|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25110765|NCT05373225|Protective Agents|protective agents|mesh-ancestor
25110766|NCT05373225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25110776|NCT05370326|Analgesics, Opioid|analgesics, opioid|mesh-list
25110777|NCT05370326|Narcotics|narcotics|mesh-ancestor
25110778|NCT05370326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25110779|NCT05370326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25110790|NCT05360576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24972397|NCT03718377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25015777|NCT00960141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015778|NCT00960141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456167|NCT00330317|Letrozole|letrozole|mesh-list
25015779|NCT00960141|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25015780|NCT00960141|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25015781|NCT00960141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015783|NCT00960141|Dermatologic Agents|dermatologic agents|mesh-ancestor
25015784|NCT00960141|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25015785|NCT00960141|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25015786|NCT00960141|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25015787|NCT00960141|Histamine Antagonists|histamine antagonists|mesh-ancestor
25015789|NCT00960141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25015790|NCT00943683|Montelukast|montelukast|mesh-list
25015791|NCT00943683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25015792|NCT00943683|Respiratory System Agents|respiratory system agents|mesh-ancestor
25015793|NCT00943683|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25015794|NCT00943683|Hormone Antagonists|hormone antagonists|mesh-ancestor
25015795|NCT00943683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015800|NCT00943397|Montelukast|montelukast|mesh-list
25015825|NCT00899379|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25015826|NCT00899379|Serotonin Agents|serotonin agents|mesh-ancestor
25015827|NCT00899379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25015828|NCT00899379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25015829|NCT00899379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015873|NCT00745108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25015874|NCT00745108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015875|NCT00745108|Hormones|hormones|mesh-ancestor
25015878|NCT00745108|Hormone Antagonists|hormone antagonists|mesh-ancestor
25015879|NCT00745108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25015880|NCT00745108|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25015881|NCT00745108|Anabolic Agents|anabolic agents|mesh-ancestor
25015882|NCT00725491|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25015883|NCT00725491|Ganirelix|ganirelix|mesh-list
25015884|NCT00725491|Luteolytic Agents|luteolytic agents|mesh-ancestor
25015885|NCT00725491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25015886|NCT00725491|Contraceptive Agents|contraceptive agents|mesh-ancestor
25015887|NCT00725491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25015888|NCT00725491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015889|NCT00725491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25015890|NCT00725491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25015891|NCT00725491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25015892|NCT00725491|Hormone Antagonists|hormone antagonists|mesh-ancestor
25015893|NCT00725491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015894|NCT00725374|Tibolone|tibolone|mesh-list
25015928|NCT00702845|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25015929|NCT00702845|Ganirelix|ganirelix|mesh-list
25015930|NCT00702845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015931|NCT00702845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015932|NCT00702845|Progestins|progestins|mesh-ancestor
25015933|NCT00702845|Hormone Antagonists|hormone antagonists|mesh-ancestor
25015934|NCT00702806|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25015935|NCT00702806|Ganirelix|ganirelix|mesh-list
25015936|NCT00702806|Hormone Antagonists|hormone antagonists|mesh-ancestor
25015937|NCT00702806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25015938|NCT00702806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25015939|NCT00702806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25015940|NCT00702624|Hormones|hormones|mesh-list
25015941|NCT00702624|Progesterone|progesterone|mesh-list
25015942|NCT00702624|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25015943|NCT00702624|Ganirelix|ganirelix|mesh-list
25016021|NCT00641771|Cholecalciferol|cholecalciferol|mesh-list
25016022|NCT00641771|Vitamin D|vitamin d|mesh-list
25016023|NCT00641771|Alendronate|alendronate|mesh-list
25016024|NCT00641771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25016025|NCT00641771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016026|NCT00641771|Vitamins|vitamins|mesh-ancestor
25016027|NCT00641771|Micronutrients|micronutrients|mesh-ancestor
25016028|NCT00641771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25016029|NCT00616967|Paclitaxel|paclitaxel|mesh-list
25016030|NCT00616967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25016165|NCT00389740|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25016208|NCT00229970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25016209|NCT00229970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016210|NCT00229970|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25016211|NCT00229970|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25016212|NCT00229970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016213|NCT00140946|Montelukast|montelukast|mesh-list
25016214|NCT00140946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016215|NCT00140946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016317|NCT00092066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25016318|NCT00092066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016320|NCT00092066|Micronutrients|micronutrients|mesh-ancestor
25016321|NCT00092066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25016322|NCT00092053|Ibandronic Acid|ibandronic acid|mesh-list
25016323|NCT00092053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25016324|NCT00092053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016325|NCT00092040|Alendronate|alendronate|mesh-list
25016326|NCT00092040|Risedronic Acid|risedronic acid|mesh-list
25016327|NCT00092040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016333|NCT00092027|Alendronate|alendronate|mesh-list
25016408|NCT05225077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016409|NCT05225077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25016417|NCT05224687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25016418|NCT05224687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25016543|NCT05137548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25016544|NCT05137548|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25016545|NCT05137548|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25110916|NCT05291325|Linaclotide|linaclotide|mesh-list
25110917|NCT05291325|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25110918|NCT05291325|Enzyme Activators|enzyme activators|mesh-ancestor
25110919|NCT05291325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25110920|NCT05291325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25016552|NCT05072704|Sufentanil|sufentanil|mesh-list
25016553|NCT05072704|Dexmedetomidine|dexmedetomidine|mesh-list
25016554|NCT05072704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25016555|NCT05072704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25016556|NCT05072704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016557|NCT05072704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25016672|NCT04808973|Lamivudine|lamivudine|mesh-list
24586671|NCT00891670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24586672|NCT00891670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24634051|NCT01131923|Vasodilator Agents|vasodilator agents|mesh-ancestor
24586673|NCT00891670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24586674|NCT00891670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24586675|NCT00891670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710588|NCT02289222|Pembrolizumab|pembrolizumab|mesh-list
25710589|NCT02289222|Pomalidomide|pomalidomide|mesh-list
25710590|NCT02289222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25710591|NCT02289222|Antiemetics|antiemetics|mesh-ancestor
25710592|NCT02289222|Autonomic Agents|autonomic agents|mesh-ancestor
25710593|NCT02289222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25710594|NCT02289222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586713|NCT00891761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24586714|NCT00891761|Antiemetics|antiemetics|mesh-ancestor
25016698|NCT04741945|Metformin|metformin|mesh-list
25016830|NCT04140162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25016831|NCT04140162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25016832|NCT04140162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25016833|NCT04140162|Glucocorticoids|glucocorticoids|mesh-ancestor
25016834|NCT04140162|Hormones|hormones|mesh-ancestor
25016835|NCT04140162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25016837|NCT04140162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25016838|NCT04140162|Immunologic Factors|immunologic factors|mesh-ancestor
25016839|NCT04140162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25016840|NCT04140162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25016841|NCT04140162|Growth Substances|growth substances|mesh-ancestor
25016842|NCT04140162|Growth Inhibitors|growth inhibitors|mesh-ancestor
25016844|NCT04104178|Clindamycin palmitate|clindamycin palmitate|mesh-list
25016845|NCT04104178|Clindamycin phosphate|clindamycin phosphate|mesh-list
25016846|NCT04104178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24973549|NCT03708718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24973550|NCT03708718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24973551|NCT03708588|Ticagrelor|ticagrelor|mesh-list
24973552|NCT03708588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25016919|NCT03837977|Irinotecan|irinotecan|mesh-list
25016920|NCT03837977|Levoleucovorin|levoleucovorin|mesh-list
24456764|NCT00332176|Ribavirin|ribavirin|mesh-list
25016921|NCT03837977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25016922|NCT03837977|Tubulin Modulators|tubulin modulators|mesh-ancestor
25016923|NCT03837977|Antimitotic Agents|antimitotic agents|mesh-ancestor
25016950|NCT03772353|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25016951|NCT03772353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25016952|NCT03772353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25016953|NCT03772353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25017390|NCT01267812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25017391|NCT01267812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25017392|NCT01267812|Immunologic Factors|immunologic factors|mesh-ancestor
25017393|NCT01267812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017394|NCT01267812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25017395|NCT01244828|Asenapine|asenapine|mesh-list
25017435|NCT01005056|Progestins|progestins|mesh-ancestor
25017550|NCT00413764|Norethindrone Acetate|norethindrone acetate|mesh-list
25017551|NCT00413764|Estradiol|estradiol|mesh-list
25017552|NCT00413764|Estrogens|estrogens|mesh-ancestor
25017553|NCT00413764|Hormones|hormones|mesh-ancestor
25017554|NCT00413764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25017555|NCT00413764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017556|NCT00413764|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25017557|NCT00413764|Contraceptive Agents|contraceptive agents|mesh-ancestor
25017561|NCT00413764|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25017609|NCT00159796|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25017696|NCT03704909|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25017697|NCT03704909|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25017698|NCT03704909|Autonomic Agents|autonomic agents|mesh-ancestor
25017699|NCT03704909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25017700|NCT03704909|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25017701|NCT03704909|Respiratory System Agents|respiratory system agents|mesh-ancestor
24580550|NCT00862264|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25017721|NCT03704753|Anesthetics, Local|anesthetics, local|mesh-ancestor
25017723|NCT03704753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25710595|NCT02289222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25710596|NCT02289222|Glucocorticoids|glucocorticoids|mesh-ancestor
25710597|NCT02289222|Hormones|hormones|mesh-ancestor
25710598|NCT02289222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25710599|NCT02289222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25017724|NCT03704753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017843|NCT03703349|Magnesium Sulfate|magnesium sulfate|mesh-list
25017844|NCT03703349|Analgesics|analgesics|mesh-ancestor
25017845|NCT03703349|Sensory System Agents|sensory system agents|mesh-ancestor
25017846|NCT03703349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25017847|NCT03703349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017848|NCT03703349|Anesthetics|anesthetics|mesh-ancestor
25017849|NCT03703349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25017850|NCT03703349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25017851|NCT03703349|Anticonvulsants|anticonvulsants|mesh-ancestor
25017852|NCT03703349|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25017853|NCT03703349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25017854|NCT03703349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017855|NCT03703349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25017963|NCT03702738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25017964|NCT03702738|Protective Agents|protective agents|mesh-ancestor
25017965|NCT03702738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25017966|NCT03702738|Antidotes|antidotes|mesh-ancestor
25018003|NCT03702491|Apatinib|apatinib|mesh-list
25018004|NCT03702491|Tegafur|tegafur|mesh-list
25018005|NCT03702491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018114|NCT03701698|Prednisolone|prednisolone|mesh-list
24974661|NCT05310331|Tubulin Modulators|tubulin modulators|mesh-ancestor
24974662|NCT05310331|Antimitotic Agents|antimitotic agents|mesh-ancestor
24974663|NCT05310331|Mitosis Modulators|mitosis modulators|mesh-ancestor
25018115|NCT03701698|Prednisolone acetate|prednisolone acetate|mesh-list
25018116|NCT03701698|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25018119|NCT03701698|Antiemetics|antiemetics|mesh-ancestor
25018150|NCT03701529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24974756|NCT05294172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24974757|NCT05294172|Immunologic Factors|immunologic factors|mesh-ancestor
24974758|NCT05294172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586859|NCT00892424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24586860|NCT00892450|Oxybutynin|oxybutynin|mesh-list
24586939|NCT00892892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24586940|NCT00892892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24586941|NCT00892892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24586945|NCT00892892|Vasodilator Agents|vasodilator agents|mesh-ancestor
25018254|NCT03700749|Cadexomer iodine|cadexomer iodine|mesh-list
25018265|NCT03700749|Blood Substitutes|blood substitutes|mesh-ancestor
25018267|NCT03700645|Antimetabolites|antimetabolites|mesh-ancestor
25018268|NCT03700645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018269|NCT03700645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018270|NCT03700645|Gout Suppressants|gout suppressants|mesh-ancestor
25018271|NCT03700645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25018272|NCT03700645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25018273|NCT03700645|Antioxidants|antioxidants|mesh-ancestor
25018274|NCT03700645|Protective Agents|protective agents|mesh-ancestor
25018302|NCT03700333|Pemetrexed|pemetrexed|mesh-list
25018463|NCT03699033|Mitosis Modulators|mitosis modulators|mesh-ancestor
25018464|NCT03699033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018466|NCT03698916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25018467|NCT03698916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25018468|NCT03698916|Analgesics|analgesics|mesh-ancestor
25018469|NCT03698916|Sensory System Agents|sensory system agents|mesh-ancestor
25018470|NCT03698916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25018471|NCT03698916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25018472|NCT03698916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25018473|NCT03698916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25018474|NCT03698916|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25018602|NCT03698474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25018603|NCT03698474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25018604|NCT03698474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25018605|NCT03698474|Tocolytic Agents|tocolytic agents|mesh-ancestor
25018606|NCT03698474|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25018607|NCT03698474|Antioxidants|antioxidants|mesh-ancestor
25018608|NCT03698474|Protective Agents|protective agents|mesh-ancestor
25018609|NCT03698474|Vitamins|vitamins|mesh-ancestor
25018610|NCT03698474|Micronutrients|micronutrients|mesh-ancestor
25018611|NCT03698474|Cathartics|cathartics|mesh-ancestor
25018612|NCT03698474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25018613|NCT03698435|Valganciclovir|valganciclovir|mesh-list
25018614|NCT03698435|Ganciclovir|ganciclovir|mesh-list
25018615|NCT03698435|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
25710600|NCT02289222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710601|NCT02289222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25710602|NCT02289222|Immunologic Factors|immunologic factors|mesh-ancestor
25710603|NCT02289222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25710604|NCT02289222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25018616|NCT03698435|Antiviral Agents|antiviral agents|mesh-ancestor
25018617|NCT03698435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25018618|NCT03698435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25018783|NCT03697044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018785|NCT03697018|Antidepressive Agents|antidepressive agents|mesh-ancestor
25018786|NCT03697018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25018787|NCT03697018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25018788|NCT03697018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25018789|NCT03697018|Antimanic Agents|antimanic agents|mesh-ancestor
25018790|NCT03697018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25018914|NCT03695744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25018917|NCT03695705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25018918|NCT03695705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25018919|NCT03695705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25018920|NCT03695705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24586948|NCT00892892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24586949|NCT00892892|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24586950|NCT00892892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24586952|NCT00892892|Adrenergic Agents|adrenergic agents|mesh-ancestor
24586953|NCT00892892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24586954|NCT00892918|Moxifloxacin|moxifloxacin|mesh-list
24586955|NCT00892918|Gatifloxacin|gatifloxacin|mesh-list
24586956|NCT00892918|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24586957|NCT00892918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24586972|NCT00892996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586973|NCT00892996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24586974|NCT00892996|Glucocorticoids|glucocorticoids|mesh-ancestor
24586976|NCT00892996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24586977|NCT00892996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24586978|NCT00892996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586979|NCT00892996|Protease Inhibitors|protease inhibitors|mesh-ancestor
24586980|NCT00892996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24586981|NCT00892996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25111315|NCT04954313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25111316|NCT04954313|Disinfectants|disinfectants|mesh-ancestor
25111317|NCT04942210|Vaccines|vaccines|mesh-list
25111318|NCT04942210|Immunologic Factors|immunologic factors|mesh-ancestor
25111319|NCT04942210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019121|NCT03693560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25019122|NCT03693560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25019123|NCT03693508|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25019125|NCT03693508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25019126|NCT03693508|Antiviral Agents|antiviral agents|mesh-ancestor
25019127|NCT03693508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25019168|NCT03693222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25019169|NCT03693222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019170|NCT03693222|Analgesics|analgesics|mesh-ancestor
25019171|NCT03693222|Sensory System Agents|sensory system agents|mesh-ancestor
25019173|NCT03693183|Ketorolac|ketorolac|mesh-list
25019250|NCT03692416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25019251|NCT03692416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710605|NCT02289222|Growth Substances|growth substances|mesh-ancestor
25710606|NCT02289222|Growth Inhibitors|growth inhibitors|mesh-ancestor
25710607|NCT02289352|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25710608|NCT02289352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25710609|NCT02289352|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25710610|NCT02289352|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25710611|NCT02289352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25019252|NCT03692416|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25019253|NCT03692416|Abortifacient Agents|abortifacient agents|mesh-ancestor
25019254|NCT03692416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25019255|NCT03692416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25019262|NCT03692416|Immunologic Factors|immunologic factors|mesh-ancestor
25019263|NCT03692416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25019264|NCT03692416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25019265|NCT03692416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25019266|NCT03692416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25019267|NCT03692416|Analgesics|analgesics|mesh-ancestor
25019268|NCT03692416|Sensory System Agents|sensory system agents|mesh-ancestor
25019269|NCT03692416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25019323|NCT03691922|Anesthetics, Local|anesthetics, local|mesh-ancestor
25019324|NCT03691922|Anesthetics|anesthetics|mesh-ancestor
25019374|NCT03691688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25019375|NCT03691688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25019376|NCT03691688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25019380|NCT03691688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25019427|NCT03691493|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25019428|NCT03691493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25019429|NCT03691467|Hyaluronic Acid|hyaluronic acid|mesh-list
25019430|NCT03691467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25019431|NCT03691467|Immunologic Factors|immunologic factors|mesh-ancestor
25019432|NCT03691467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019433|NCT03691467|Viscosupplements|viscosupplements|mesh-ancestor
25019528|NCT03690739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25019529|NCT03690739|Antimetabolites|antimetabolites|mesh-ancestor
25019530|NCT03690739|Antiviral Agents|antiviral agents|mesh-ancestor
25019531|NCT03690739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25019532|NCT03690739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25019534|NCT03690739|Immunologic Factors|immunologic factors|mesh-ancestor
25019571|NCT03690414|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25019572|NCT03690414|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25019573|NCT03690414|Cholinergic Agents|cholinergic agents|mesh-ancestor
25019686|NCT03689010|Dermatologic Agents|dermatologic agents|mesh-ancestor
25019687|NCT03688971|Ketoconazole|ketoconazole|mesh-list
25019688|NCT03688971|Antifungal Agents|antifungal agents|mesh-ancestor
24546982|NCT00701623|Heparin|heparin|mesh-list
25019689|NCT03688971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25019690|NCT03688971|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25111429|NCT04841434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25111430|NCT04841434|Immunologic Factors|immunologic factors|mesh-ancestor
25111431|NCT04841434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25111432|NCT04841434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24976312|NCT04188028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24976313|NCT04188028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24976317|NCT04154800|Itraconazole|itraconazole|mesh-list
24976318|NCT04154800|Diltiazem|diltiazem|mesh-list
24976319|NCT04154800|Antifungal Agents|antifungal agents|mesh-ancestor
25019783|NCT03687931|Dexamethasone|dexamethasone|mesh-list
25019944|NCT03686085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25019945|NCT03685630|Brivaracetam|brivaracetam|mesh-list
25019946|NCT03685630|Anticonvulsants|anticonvulsants|mesh-ancestor
25019947|NCT03685409|Metformin|metformin|mesh-list
25019948|NCT03685409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25019949|NCT03685409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020117|NCT03683277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25020118|NCT03683277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020120|NCT03683277|Glucocorticoids|glucocorticoids|mesh-ancestor
25020121|NCT03683277|Hormones|hormones|mesh-ancestor
25020290|NCT03681548|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25020357|NCT03680638|Antimetabolites|antimetabolites|mesh-ancestor
25020358|NCT03680638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020359|NCT03680638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710612|NCT02289352|Adrenergic Agents|adrenergic agents|mesh-ancestor
25710613|NCT02289352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25710614|NCT02289352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710615|NCT02289352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710616|NCT02289417|Apremilast|apremilast|mesh-list
25710617|NCT02289417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25020360|NCT03680638|Gout Suppressants|gout suppressants|mesh-ancestor
25020361|NCT03680638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25020363|NCT03680638|Antioxidants|antioxidants|mesh-ancestor
25020479|NCT03679897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25020499|NCT03679442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25020500|NCT03679442|Antidotes|antidotes|mesh-list
25020501|NCT03679442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020502|NCT03679442|Antiviral Agents|antiviral agents|mesh-ancestor
25020503|NCT03679442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25020504|NCT03679442|Expectorants|expectorants|mesh-ancestor
25020505|NCT03679442|Respiratory System Agents|respiratory system agents|mesh-ancestor
25020669|NCT03678532|Anesthetics, General|anesthetics, general|mesh-ancestor
25020671|NCT03678532|GABA Modulators|gaba modulators|mesh-ancestor
25020672|NCT03678532|GABA Agents|gaba agents|mesh-ancestor
25020673|NCT03678532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25020674|NCT03678532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25020868|NCT03676413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25020869|NCT03676413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25020870|NCT03676413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25020871|NCT03676413|Respiratory System Agents|respiratory system agents|mesh-ancestor
25020872|NCT03676413|Dermatologic Agents|dermatologic agents|mesh-ancestor
25020873|NCT03676413|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25020874|NCT03676413|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25020875|NCT03676413|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25020876|NCT03676413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25020877|NCT03676413|Adrenergic Agents|adrenergic agents|mesh-ancestor
25021251|NCT03673735|Durvalumab|durvalumab|mesh-list
25021252|NCT03673735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25021253|NCT03673735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25021254|NCT03673605|Warfarin|warfarin|mesh-list
25021255|NCT03673605|Rivaroxaban|rivaroxaban|mesh-list
25021256|NCT03673605|Anticoagulants|anticoagulants|mesh-ancestor
25021257|NCT03673605|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25021258|NCT03673605|Antithrombins|antithrombins|mesh-ancestor
25021259|NCT03673605|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25021438|NCT03671538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25111683|NCT04718805|Darunavir|darunavir|mesh-list
25111684|NCT04718805|Cobicistat|cobicistat|mesh-list
25111685|NCT04718805|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
25111686|NCT04718805|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25111687|NCT04718805|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25111688|NCT04718805|Protease Inhibitors|protease inhibitors|mesh-ancestor
24978024|NCT00381381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24978026|NCT00381381|Cholinergic Agents|cholinergic agents|mesh-ancestor
25021602|NCT03669783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25021603|NCT03669783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021604|NCT03669783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25021605|NCT03669783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25021606|NCT03669783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25021607|NCT03669783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25710618|NCT02289417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25710619|NCT02289417|Analgesics|analgesics|mesh-ancestor
25710620|NCT02289417|Sensory System Agents|sensory system agents|mesh-ancestor
25710621|NCT02289417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25710622|NCT02289417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710623|NCT02289417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25710624|NCT02289417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25710625|NCT02289417|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25710626|NCT02289417|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25710627|NCT02289417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25021608|NCT03669783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25021609|NCT03669783|Tubulin Modulators|tubulin modulators|mesh-ancestor
25021610|NCT03669783|Antimitotic Agents|antimitotic agents|mesh-ancestor
25021611|NCT03669783|Mitosis Modulators|mitosis modulators|mesh-ancestor
25021888|NCT03667313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25021889|NCT03667313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25021890|NCT03667313|Tubulin Modulators|tubulin modulators|mesh-ancestor
25021893|NCT03667313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021894|NCT03667313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25021895|NCT03667313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25021896|NCT03667313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25021928|NCT03667066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25021929|NCT03667066|Purinergic Agents|purinergic agents|mesh-ancestor
25021930|NCT03667066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25021931|NCT03667066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25021932|NCT03667066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25021933|NCT03667001|Lidocaine|lidocaine|mesh-list
25021934|NCT03667001|Anesthetics, Local|anesthetics, local|mesh-ancestor
25021935|NCT03667001|Anesthetics|anesthetics|mesh-ancestor
25022032|NCT03666390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25022033|NCT03666390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25022034|NCT03666390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022035|NCT03666390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25022036|NCT03666390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25022037|NCT03666390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25022038|NCT03666390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25022039|NCT03666390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25022041|NCT03666390|GABA Agents|gaba agents|mesh-ancestor
25022091|NCT03666195|Dermatologic Agents|dermatologic agents|mesh-ancestor
25022105|NCT03665779|Vitamins|vitamins|mesh-ancestor
25022106|NCT03665779|Micronutrients|micronutrients|mesh-ancestor
25022107|NCT03665766|Cycloserine|cycloserine|mesh-list
25022108|NCT03665766|Tacrolimus|tacrolimus|mesh-list
25022109|NCT03665766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25022110|NCT03665766|Immunologic Factors|immunologic factors|mesh-ancestor
25022111|NCT03665766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022112|NCT03665766|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25022113|NCT03665766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022114|NCT03665766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022115|NCT03665766|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25022286|NCT03664388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25022287|NCT03664388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25710628|NCT02289417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710629|NCT02289456|Paclitaxel|paclitaxel|mesh-list
25710630|NCT02289456|Carboplatin|carboplatin|mesh-list
25710631|NCT02289456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25710632|NCT02289456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710633|NCT02289456|Tubulin Modulators|tubulin modulators|mesh-ancestor
25710634|NCT02289456|Antimitotic Agents|antimitotic agents|mesh-ancestor
25022447|NCT03662568|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25022448|NCT03662568|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25111830|NCT04608474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25111832|NCT04608474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25111833|NCT04608474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25022532|NCT03662100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25022533|NCT03662100|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25022534|NCT03662100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25022535|NCT03662035|Apatinib|apatinib|mesh-list
25022536|NCT03662035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25022634|NCT03661463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25022635|NCT03661463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25022654|NCT03661385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25022655|NCT03661385|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25022656|NCT03661385|Vasodilator Agents|vasodilator agents|mesh-ancestor
25022657|NCT03661385|Gasotransmitters|gasotransmitters|mesh-ancestor
25022658|NCT03661385|Protective Agents|protective agents|mesh-ancestor
25022694|NCT03660475|Naltrexone|naltrexone|mesh-list
25022773|NCT03659435|Rivastigmine|rivastigmine|mesh-list
25022774|NCT03659435|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25022775|NCT03659435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25022776|NCT03659435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022777|NCT03659435|Cholinergic Agents|cholinergic agents|mesh-ancestor
25022778|NCT03659435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25022779|NCT03659435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24979512|NCT04057937|Apremilast|apremilast|mesh-list
25022858|NCT03658746|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25022859|NCT03658746|Amoxicillin|amoxicillin|mesh-list
25022860|NCT03658746|Metronidazole|metronidazole|mesh-list
25022861|NCT03658746|Clarithromycin|clarithromycin|mesh-list
25022974|NCT03658421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25022975|NCT03658421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25022976|NCT03658421|Narcotics|narcotics|mesh-ancestor
25022977|NCT03658408|4-Aminopyridine|4-aminopyridine|mesh-list
25022981|NCT03658330|Naltrexone|naltrexone|mesh-list
25023021|NCT03658109|Anesthetics|anesthetics|mesh-ancestor
25023022|NCT03658109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25023023|NCT03658109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023024|NCT03658109|Sensory System Agents|sensory system agents|mesh-ancestor
25023031|NCT03658057|Rocuronium|rocuronium|mesh-list
25023042|NCT03657979|Ropivacaine|ropivacaine|mesh-list
25023043|NCT03657979|Anesthetics, Local|anesthetics, local|mesh-ancestor
24587445|NCT00894998|Calcium heparin|calcium heparin|mesh-list
24587446|NCT00894998|Anticoagulants|anticoagulants|mesh-ancestor
25023423|NCT03654794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710635|NCT02289456|Mitosis Modulators|mitosis modulators|mesh-ancestor
25710636|NCT02289456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710637|NCT02289690|Carboplatin|carboplatin|mesh-list
25710638|NCT02289690|Etoposide|etoposide|mesh-list
25710639|NCT02289690|Veliparib|veliparib|mesh-list
25710640|NCT02289690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710641|NCT02289690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25710642|NCT02289690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25710643|NCT02289690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25710644|NCT02289690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25023424|NCT03654794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023425|NCT03654703|Cyclophosphamide|cyclophosphamide|mesh-list
25023426|NCT03654703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25023427|NCT03654703|Immunologic Factors|immunologic factors|mesh-ancestor
24980302|NCT05406102|Propofol|propofol|mesh-list
24980303|NCT05406102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25023660|NCT03652571|Adrenergic Agents|adrenergic agents|mesh-ancestor
25023661|NCT03652571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25023662|NCT03652571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023663|NCT03652493|Carboplatin|carboplatin|mesh-list
25023664|NCT03652493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023665|NCT03652480|Methylprednisolone|methylprednisolone|mesh-list
25023666|NCT03652480|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25023667|NCT03652480|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25023668|NCT03652480|Prednisolone|prednisolone|mesh-list
25023669|NCT03652480|Prednisolone acetate|prednisolone acetate|mesh-list
25023670|NCT03652480|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25023671|NCT03652480|Prednisolone phosphate|prednisolone phosphate|mesh-list
25023672|NCT03652480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25023751|NCT03652103|Anesthetics|anesthetics|mesh-ancestor
25023752|NCT03652103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25023753|NCT03652103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023754|NCT03652103|Sensory System Agents|sensory system agents|mesh-ancestor
25023755|NCT03652103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023756|NCT03651947|Denosumab|denosumab|mesh-list
25023757|NCT03651947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25023758|NCT03651947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023760|NCT03651934|Selenium|selenium|mesh-list
25023761|NCT03651934|Trace Elements|trace elements|mesh-ancestor
25023762|NCT03651934|Micronutrients|micronutrients|mesh-ancestor
25023763|NCT03651934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023764|NCT03651934|Antioxidants|antioxidants|mesh-ancestor
25023765|NCT03651934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023766|NCT03651934|Protective Agents|protective agents|mesh-ancestor
25023767|NCT03651882|Oxytocin|oxytocin|mesh-list
25023768|NCT03651882|Carbetocin|carbetocin|mesh-list
25023840|NCT03651219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25023854|NCT03650881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25023855|NCT03650881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25023856|NCT03650881|Analgesics|analgesics|mesh-ancestor
25023857|NCT03650881|Sensory System Agents|sensory system agents|mesh-ancestor
25023858|NCT03650881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023859|NCT03650881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023860|NCT03650881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25023861|NCT03650881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25023862|NCT03650777|Warfarin|warfarin|mesh-list
25023863|NCT03650777|Anticoagulants|anticoagulants|mesh-ancestor
25023864|NCT03650738|Paclitaxel|paclitaxel|mesh-list
25023865|NCT03650738|Carboplatin|carboplatin|mesh-list
25023866|NCT03650738|Apatinib|apatinib|mesh-list
25023867|NCT03650738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25023868|NCT03650738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023896|NCT03650361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25023897|NCT03650361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25023898|NCT03650361|Analgesics|analgesics|mesh-ancestor
25023899|NCT03650361|Sensory System Agents|sensory system agents|mesh-ancestor
25023900|NCT03650361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25023901|NCT03650361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25023902|NCT03650361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25023903|NCT03650361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25023904|NCT03650361|Dermatologic Agents|dermatologic agents|mesh-ancestor
25710645|NCT02289690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710646|NCT02289690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25710647|NCT02289833|Trastuzumab|trastuzumab|mesh-list
25710648|NCT02289833|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25710649|NCT02289833|Maytansine|maytansine|mesh-list
25023905|NCT03650348|Atezolizumab|atezolizumab|mesh-list
25023906|NCT03650348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710650|NCT02289833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25023907|NCT03650270|Phenytoin|phenytoin|mesh-list
25023908|NCT03650270|Midazolam|midazolam|mesh-list
25023909|NCT03650270|Phenobarbital|phenobarbital|mesh-list
25023937|NCT03650257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023938|NCT03650257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25023939|NCT03650023|Chitosan|chitosan|mesh-list
25023940|NCT03650023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25023941|NCT03650023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25023942|NCT03650023|Antimetabolites|antimetabolites|mesh-ancestor
25023943|NCT03650023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25023944|NCT03650023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25023945|NCT03650023|Chelating Agents|chelating agents|mesh-ancestor
25023946|NCT03650023|Sequestering Agents|sequestering agents|mesh-ancestor
25023947|NCT03650023|Hemostatics|hemostatics|mesh-ancestor
25023948|NCT03650023|Coagulants|coagulants|mesh-ancestor
25023949|NCT03649945|Docetaxel|docetaxel|mesh-list
25023950|NCT03649945|Endostar protein|endostar protein|mesh-list
25023951|NCT03649945|Nedaplatin|nedaplatin|mesh-list
25024042|NCT03649243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25024043|NCT03649230|Palonosetron|palonosetron|mesh-list
25024044|NCT03649230|Antiemetics|antiemetics|mesh-ancestor
25024045|NCT03649230|Autonomic Agents|autonomic agents|mesh-ancestor
25024046|NCT03649230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024047|NCT03649230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024048|NCT03649230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25024049|NCT03649230|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25024082|NCT03649009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024084|NCT03648996|Antimetabolites|antimetabolites|mesh-ancestor
25024085|NCT03648996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024086|NCT03648996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024087|NCT03648996|Gout Suppressants|gout suppressants|mesh-ancestor
25024088|NCT03648996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25024089|NCT03648996|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25024090|NCT03648996|Antioxidants|antioxidants|mesh-ancestor
25024091|NCT03648996|Protective Agents|protective agents|mesh-ancestor
25024092|NCT03648996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024093|NCT03648970|Pravastatin|pravastatin|mesh-list
25024125|NCT03648671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024126|NCT03648671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25024127|NCT03648671|Protective Agents|protective agents|mesh-ancestor
25024128|NCT03648671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024130|NCT03648658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25024131|NCT03648658|Analgesics|analgesics|mesh-ancestor
25024132|NCT03648658|Sensory System Agents|sensory system agents|mesh-ancestor
25024133|NCT03648658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25024134|NCT03648658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587599|NCT00895778|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25024234|NCT03647956|Carboplatin|carboplatin|mesh-list
25024235|NCT03647956|Pemetrexed|pemetrexed|mesh-list
25024236|NCT03647956|Atezolizumab|atezolizumab|mesh-list
25024237|NCT03647956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25024238|NCT03647956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25024239|NCT03647956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25024240|NCT03647956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25024292|NCT03647579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25024294|NCT03647579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25024418|NCT03646292|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25024420|NCT03646266|Bromides|bromides|mesh-list
25024466|NCT03645642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25024467|NCT03645642|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25024468|NCT03645642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25024469|NCT03645642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25710651|NCT02289833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710652|NCT02289833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25710653|NCT02289833|Tubulin Modulators|tubulin modulators|mesh-ancestor
25710654|NCT02289833|Antimitotic Agents|antimitotic agents|mesh-ancestor
25024470|NCT03645642|Adrenergic Agents|adrenergic agents|mesh-ancestor
25024471|NCT03645642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25404035|NCT03686124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25024472|NCT03645642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112212|NCT04282018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25024601|NCT03644264|Sevelamer|sevelamer|mesh-list
25024602|NCT03644264|Chelating Agents|chelating agents|mesh-ancestor
25024603|NCT03644264|Sequestering Agents|sequestering agents|mesh-ancestor
25024604|NCT03644264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25024605|NCT03644147|Acetaminophen|acetaminophen|mesh-list
25024606|NCT03644147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25024607|NCT03644147|Analgesics|analgesics|mesh-ancestor
25024608|NCT03644147|Sensory System Agents|sensory system agents|mesh-ancestor
25026025|NCT03632330|Propofol|propofol|mesh-list
25024783|NCT03642665|Progesterone|progesterone|mesh-list
25024784|NCT03642665|Estrogens|estrogens|mesh-ancestor
25024785|NCT03642665|Hormones|hormones|mesh-ancestor
25024786|NCT03642665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25024787|NCT03642665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25024788|NCT03642665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25024789|NCT03642665|Contraceptive Agents|contraceptive agents|mesh-ancestor
25024790|NCT03642665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25024791|NCT03642665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25024885|NCT03641456|Dexamethasone|dexamethasone|mesh-list
25024886|NCT03641456|Dexamethasone acetate|dexamethasone acetate|mesh-list
25024887|NCT03641456|Lenalidomide|lenalidomide|mesh-list
25024889|NCT03641456|BB 1101|bb 1101|mesh-list
25024890|NCT03641456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25024891|NCT03641456|Antiemetics|antiemetics|mesh-ancestor
25024892|NCT03641456|Autonomic Agents|autonomic agents|mesh-ancestor
25025000|NCT03640390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25025001|NCT03640390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25025002|NCT03640390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025035|NCT03640273|Histamine Antagonists|histamine antagonists|mesh-ancestor
25025037|NCT03640273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25025038|NCT03640273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025039|NCT03640273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025040|NCT03640247|Acetaminophen|acetaminophen|mesh-list
25025042|NCT03640247|Oxycodone|oxycodone|mesh-list
25025043|NCT03640247|Tramadol|tramadol|mesh-list
25025044|NCT03640247|Hydrocodone|hydrocodone|mesh-list
25025045|NCT03640247|Narcotics|narcotics|mesh-list
25025046|NCT03640247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25025162|NCT03639493|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25025163|NCT03639493|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25025164|NCT03639493|Antimetabolites|antimetabolites|mesh-ancestor
25025165|NCT03639493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025166|NCT03639493|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25025167|NCT03639493|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25710655|NCT02289833|Mitosis Modulators|mitosis modulators|mesh-ancestor
25710656|NCT02289833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710657|NCT02289898|Gemcitabine|gemcitabine|mesh-list
25710658|NCT02289898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25710659|NCT02289898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25710660|NCT02289898|Antimetabolites|antimetabolites|mesh-ancestor
25710661|NCT02289898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025168|NCT03639493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25025169|NCT03639493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25025171|NCT03639480|Valsartan|valsartan|mesh-list
25025172|NCT03639480|Atorvastatin|atorvastatin|mesh-list
25025173|NCT03639480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25025174|NCT03639480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25025175|NCT03639480|Antimetabolites|antimetabolites|mesh-ancestor
25025176|NCT03639480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025177|NCT03639480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25025178|NCT03639480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25025179|NCT03639480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25025180|NCT03639480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25025237|NCT03638960|Anesthetics|anesthetics|mesh-ancestor
25025238|NCT03638960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25025243|NCT03638869|D-methadone|d-methadone|mesh-list
25025244|NCT03638869|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25025245|NCT03638869|Narcotics|narcotics|mesh-ancestor
24587655|NCT00896155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24587656|NCT00896285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
24587659|NCT00896285|Sensory System Agents|sensory system agents|mesh-ancestor
24587660|NCT00896285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24587661|NCT00896285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587666|NCT00896285|Narcotics|narcotics|mesh-ancestor
24587704|NCT00896519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24587705|NCT00896519|Alkylating Agents|alkylating agents|mesh-ancestor
24587706|NCT00896519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587707|NCT00896519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587708|NCT00896519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24587709|NCT00896519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24587710|NCT00896519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24587711|NCT00896519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24587712|NCT00896519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24587713|NCT00896519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587714|NCT00896519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24634822|NCT01135550|Glucocorticoids|glucocorticoids|mesh-ancestor
24590204|NCT00911092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24634823|NCT01135550|Hormones|hormones|mesh-ancestor
25112341|NCT04172558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25112342|NCT04172558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25112343|NCT04172558|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25112344|NCT04172558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25112345|NCT04172558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25112346|NCT04172558|Cholinergic Agents|cholinergic agents|mesh-ancestor
25112347|NCT04172558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25112359|NCT04168866|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25112360|NCT04168866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25025377|NCT03637790|Antitubercular Agents|antitubercular agents|mesh-ancestor
25025378|NCT03637790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25025379|NCT03637790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24982179|NCT03697629|Daratumumab|daratumumab|mesh-list
24449845|NCT00317330|Isoniazid|isoniazid|mesh-list
24590331|NCT00912145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590332|NCT00912145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24590333|NCT00912145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24590334|NCT00912145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24590335|NCT00912145|GABA Modulators|gaba modulators|mesh-ancestor
25025393|NCT03637582|Anesthetics|anesthetics|mesh-ancestor
25025394|NCT03637582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25025395|NCT03637582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025396|NCT03637582|Sensory System Agents|sensory system agents|mesh-ancestor
25025403|NCT03637543|Nivolumab|nivolumab|mesh-list
25710662|NCT02289898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710663|NCT02289898|Antiviral Agents|antiviral agents|mesh-ancestor
25710664|NCT02289898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25710665|NCT02289898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710666|NCT02289898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25710667|NCT02289898|Immunologic Factors|immunologic factors|mesh-ancestor
25710668|NCT02289898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770653|NCT03556761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25770654|NCT03556761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777138|NCT03739528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25777139|NCT03739528|Glucocorticoids|glucocorticoids|mesh-ancestor
25777140|NCT03739528|Hormones|hormones|mesh-ancestor
25777141|NCT03739528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25777142|NCT03739528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25710669|NCT02289950|Farletuzumab|farletuzumab|mesh-list
25710670|NCT02289950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710671|NCT02289963|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25710672|NCT02289963|Immunologic Factors|immunologic factors|mesh-ancestor
24590521|NCT00913029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25025569|NCT03636048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24982359|NCT02913664|Losartan|losartan|mesh-list
25025617|NCT03635411|Niacin|niacin|mesh-list
25025618|NCT03635411|Nicotinic Acids|nicotinic acids|mesh-list
25025619|NCT03635411|Vitamin B Complex|vitamin b complex|mesh-ancestor
25025633|NCT03635398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25025634|NCT03635398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25025635|NCT03635398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25025636|NCT03635398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25025637|NCT03635398|Anesthetics, General|anesthetics, general|mesh-ancestor
25025638|NCT03635398|Anesthetics|anesthetics|mesh-ancestor
25025639|NCT03635398|GABA Modulators|gaba modulators|mesh-ancestor
25025640|NCT03635398|GABA Agents|gaba agents|mesh-ancestor
25025641|NCT03635398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25025643|NCT03635372|Sucralfate|sucralfate|mesh-list
25025647|NCT03635372|Antacids|antacids|mesh-ancestor
25025665|NCT03635125|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25025666|NCT03635125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25025717|NCT03634605|Tetracycline|tetracycline|mesh-list
25025718|NCT03634605|Lidocaine|lidocaine|mesh-list
25025719|NCT03634605|Anesthetics, Local|anesthetics, local|mesh-ancestor
25025720|NCT03634605|Anesthetics|anesthetics|mesh-ancestor
25025721|NCT03634605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25025722|NCT03634605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025723|NCT03634605|Sensory System Agents|sensory system agents|mesh-ancestor
25025724|NCT03634605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25025725|NCT03634605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25025726|NCT03634605|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24590636|NCT00913367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24590637|NCT00913367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24590638|NCT00913367|Immunologic Factors|immunologic factors|mesh-ancestor
25025727|NCT03634605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25025766|NCT03634332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25025767|NCT03634332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25025768|NCT03634202|Capecitabine|capecitabine|mesh-list
25025769|NCT03634202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24590677|NCT00913549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590678|NCT00913549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025770|NCT03634202|Antimetabolites|antimetabolites|mesh-ancestor
25025771|NCT03634202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025878|NCT03633175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25025879|NCT03633175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025881|NCT03632915|Phenytoin|phenytoin|mesh-list
25025882|NCT03632915|Ketamine|ketamine|mesh-list
25025883|NCT03632915|Levetiracetam|levetiracetam|mesh-list
25025884|NCT03632915|Valproic Acid|valproic acid|mesh-list
25025885|NCT03632915|Phenobarbital|phenobarbital|mesh-list
25025886|NCT03632915|Analgesics|analgesics|mesh-ancestor
25025895|NCT03632915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25025896|NCT03632915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25025897|NCT03632915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25025898|NCT03632915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025899|NCT03632915|Anticonvulsants|anticonvulsants|mesh-ancestor
25025900|NCT03632915|Nootropic Agents|nootropic agents|mesh-ancestor
25025901|NCT03632915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25025902|NCT03632915|GABA Agents|gaba agents|mesh-ancestor
25025903|NCT03632915|Antimanic Agents|antimanic agents|mesh-ancestor
25025904|NCT03632915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25025905|NCT03632915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25710673|NCT02289963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710674|NCT02289989|Hydrocortisone|hydrocortisone|mesh-list
25710675|NCT02289989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25710676|NCT02290106|Pitavastatin|pitavastatin|mesh-list
25710677|NCT02290106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25025906|NCT03632915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25710678|NCT02290106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25710679|NCT02290106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25710680|NCT02290106|Antimetabolites|antimetabolites|mesh-ancestor
25710681|NCT02290106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710682|NCT02290106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710683|NCT02290106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25025907|NCT03632915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25025908|NCT03632915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25025909|NCT03632915|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25025916|NCT03632876|Retinol palmitate|retinol palmitate|mesh-list
25025918|NCT03632876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025919|NCT03632876|Protective Agents|protective agents|mesh-ancestor
25025920|NCT03632876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25025923|NCT03632876|Vitamins|vitamins|mesh-ancestor
25025924|NCT03632876|Micronutrients|micronutrients|mesh-ancestor
25025925|NCT03632824|Tranexamic Acid|tranexamic acid|mesh-list
25025926|NCT03632824|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25025927|NCT03632824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25025928|NCT03632824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025929|NCT03632824|Hemostatics|hemostatics|mesh-ancestor
25025930|NCT03632824|Coagulants|coagulants|mesh-ancestor
25025931|NCT03632772|Solifenacin Succinate|solifenacin succinate|mesh-list
25025932|NCT03632772|Mirabegron|mirabegron|mesh-list
25025933|NCT03632772|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25025934|NCT03632772|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25025935|NCT03632772|Cholinergic Agents|cholinergic agents|mesh-ancestor
25025936|NCT03632772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25025937|NCT03632772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25025939|NCT03632772|Urological Agents|urological agents|mesh-ancestor
24590846|NCT00913965|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24590847|NCT00913965|Adrenergic Agents|adrenergic agents|mesh-ancestor
25026015|NCT03632408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24590939|NCT00914394|Nasal Decongestants|nasal decongestants|mesh-ancestor
25026016|NCT03632408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026018|NCT03632369|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25026019|NCT03632369|Anesthetics, General|anesthetics, general|mesh-ancestor
25026020|NCT03632369|Anesthetics|anesthetics|mesh-ancestor
25026021|NCT03632369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25026022|NCT03632369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026023|NCT03632330|Midazolam|midazolam|mesh-list
25026024|NCT03632330|Dexmedetomidine|dexmedetomidine|mesh-list
25026029|NCT03632330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25026030|NCT03632330|Anesthetics, General|anesthetics, general|mesh-ancestor
25026031|NCT03632330|Anesthetics|anesthetics|mesh-ancestor
25026032|NCT03632330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25026033|NCT03632330|Analgesics|analgesics|mesh-ancestor
25026034|NCT03632330|Sensory System Agents|sensory system agents|mesh-ancestor
25026035|NCT03632330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25026036|NCT03632330|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25026037|NCT03632330|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25026038|NCT03632330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25026039|NCT03632330|Adrenergic Agents|adrenergic agents|mesh-ancestor
25026040|NCT03632330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25026041|NCT03632330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026042|NCT03632330|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25026043|NCT03632330|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25026044|NCT03632330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25026045|NCT03632330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25026046|NCT03632330|GABA Modulators|gaba modulators|mesh-ancestor
25026047|NCT03632330|GABA Agents|gaba agents|mesh-ancestor
25026048|NCT03632317|Everolimus|everolimus|mesh-list
24590977|NCT00914524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24590982|NCT00914563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24590983|NCT00914563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026055|NCT03632317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25026056|NCT03632317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026058|NCT03632304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25026059|NCT03632304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710684|NCT02290444|Hormones|hormones|mesh-list
25710685|NCT02290444|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25710686|NCT02290444|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
25026060|NCT03632213|Losartan|losartan|mesh-list
25026061|NCT03632213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25026066|NCT03632161|Dexmedetomidine|dexmedetomidine|mesh-list
24591018|NCT00914667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24591019|NCT00914667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591020|NCT00914667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591021|NCT00914667|Urological Agents|urological agents|mesh-ancestor
24591022|NCT00914693|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24591023|NCT00914693|Gestodene|gestodene|mesh-list
24591024|NCT00914693|Femovan|femovan|mesh-list
24591025|NCT00914693|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25026103|NCT03631901|Anticonvulsants|anticonvulsants|mesh-ancestor
24591026|NCT00914693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25026104|NCT03631901|Antiemetics|antiemetics|mesh-ancestor
25026105|NCT03631901|Autonomic Agents|autonomic agents|mesh-ancestor
24982896|NCT00338260|Atenolol|atenolol|mesh-list
25026106|NCT03631901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25026107|NCT03631901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25026108|NCT03631901|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25026152|NCT03631823|Temozolomide|temozolomide|mesh-list
25026153|NCT03631823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25026154|NCT03631823|Alkylating Agents|alkylating agents|mesh-ancestor
25026155|NCT03631823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026156|NCT03631823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25026157|NCT03631641|Nivolumab|nivolumab|mesh-list
25026158|NCT03631641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25026159|NCT03631641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25026160|NCT03631641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25026161|NCT03631641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026163|NCT03631615|Immunologic Factors|immunologic factors|mesh-ancestor
25026164|NCT03631615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026165|NCT03631602|Antifungal Agents|antifungal agents|mesh-list
25026166|NCT03631602|Clotrimazole|clotrimazole|mesh-list
25026174|NCT03631602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25026199|NCT03631121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026228|NCT03630796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25026229|NCT03630796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026230|NCT03630614|Nicotine|nicotine|mesh-list
25026231|NCT03630614|Varenicline|varenicline|mesh-list
25026232|NCT03630614|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25026233|NCT03630614|Autonomic Agents|autonomic agents|mesh-ancestor
25026234|NCT03630614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25026235|NCT03630614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026240|NCT03630614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591263|NCT00915733|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24591264|NCT00915733|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24591266|NCT00915733|Purinergic Agents|purinergic agents|mesh-ancestor
24591267|NCT00915733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24591268|NCT00915733|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25026279|NCT03630081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25026280|NCT03630081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25026281|NCT03630081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25026282|NCT03630081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026283|NCT03630081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25026286|NCT03630042|Rituximab|rituximab|mesh-list
24591316|NCT00915837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24591317|NCT00915837|Immunologic Factors|immunologic factors|mesh-ancestor
25026336|NCT03629522|Antipruritics|antipruritics|mesh-ancestor
25026337|NCT03629522|Dermatologic Agents|dermatologic agents|mesh-ancestor
25026338|NCT03629522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25026339|NCT03629522|Serotonin Agents|serotonin agents|mesh-ancestor
25026340|NCT03629522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25026342|NCT03629522|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25026355|NCT03629418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25026356|NCT03629418|Nasal Decongestants|nasal decongestants|mesh-ancestor
25026358|NCT03629418|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25026359|NCT03629418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25026381|NCT03629262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25026382|NCT03629262|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25026383|NCT03629262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25026384|NCT03629262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25026385|NCT03629262|Adrenergic Agents|adrenergic agents|mesh-ancestor
25026386|NCT03629262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25026387|NCT03629262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026388|NCT03629262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25026390|NCT03629262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25026391|NCT03629262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25026392|NCT03629262|Anesthetics, General|anesthetics, general|mesh-ancestor
24983154|NCT02118610|Analgesics|analgesics|mesh-ancestor
25026393|NCT03629262|Anesthetics|anesthetics|mesh-ancestor
25026396|NCT03629210|Dexamethasone|dexamethasone|mesh-list
25026403|NCT03629210|Glucocorticoids|glucocorticoids|mesh-ancestor
25026404|NCT03629210|Hormones|hormones|mesh-ancestor
25026405|NCT03629210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25026406|NCT03629210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25026407|NCT03629210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25026408|NCT03629093|Anesthetics|anesthetics|mesh-list
24591461|NCT00916760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591462|NCT00916760|Antacids|antacids|mesh-ancestor
25026428|NCT03628625|Oxytocics|oxytocics|mesh-ancestor
25026429|NCT03628521|Gemcitabine|gemcitabine|mesh-list
25026430|NCT03628521|Carboplatin|carboplatin|mesh-list
25026431|NCT03628521|Pemetrexed|pemetrexed|mesh-list
25026438|NCT03628521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25026439|NCT03628521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25026440|NCT03628521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25026441|NCT03628521|Immunologic Factors|immunologic factors|mesh-ancestor
25026442|NCT03628521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026443|NCT03628521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25026444|NCT03628521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25026445|NCT03628521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25026446|NCT03628443|Mitogens|mitogens|mesh-list
25026447|NCT03628443|Mitosis Modulators|mitosis modulators|mesh-ancestor
25026449|NCT03628430|Lidocaine|lidocaine|mesh-list
24591550|NCT00917358|Interferons|interferons|mesh-list
25026525|NCT03628040|Sensory System Agents|sensory system agents|mesh-ancestor
25026526|NCT03628040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25026527|NCT03627884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25026533|NCT03627546|Sofosbuvir|sofosbuvir|mesh-list
25026534|NCT03627546|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25026535|NCT03627546|Velpatasvir|velpatasvir|mesh-list
25026536|NCT03627546|Antiviral Agents|antiviral agents|mesh-ancestor
25026626|NCT03626454|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25026627|NCT03626298|Niacinamide|niacinamide|mesh-list
25026628|NCT03626298|Niacin|niacin|mesh-list
25026629|NCT03626298|Nicotinic Acids|nicotinic acids|mesh-list
25026630|NCT03626298|Adapalene|adapalene|mesh-list
25026663|NCT03626064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25026664|NCT03626064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026665|NCT03626064|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25026666|NCT03626064|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25026667|NCT03626064|Cholinergic Agents|cholinergic agents|mesh-ancestor
25026668|NCT03626064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25026669|NCT03626064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026670|NCT03625960|Cantharidin|cantharidin|mesh-list
25026671|NCT03625960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25026672|NCT03625960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24983500|NCT05185544|Pemetrexed|pemetrexed|mesh-list
25026674|NCT03625830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25026675|NCT03625830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25026676|NCT03625830|Tubulin Modulators|tubulin modulators|mesh-ancestor
25026677|NCT03625830|Antimitotic Agents|antimitotic agents|mesh-ancestor
25710687|NCT02290444|beta-Endorphin|beta-endorphin|mesh-list
25026678|NCT03625830|Mitosis Modulators|mitosis modulators|mesh-ancestor
25026679|NCT03625830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026680|NCT03625739|Amoxicillin|amoxicillin|mesh-list
25026681|NCT03625739|Moxifloxacin|moxifloxacin|mesh-list
25026682|NCT03625739|Levofloxacin|levofloxacin|mesh-list
25026683|NCT03625739|Isoniazid|isoniazid|mesh-list
25026684|NCT03625739|Cycloserine|cycloserine|mesh-list
25026685|NCT03625739|Clavulanic Acid|clavulanic acid|mesh-list
25026686|NCT03625739|Imipenem|imipenem|mesh-list
25026687|NCT03625739|Amikacin|amikacin|mesh-list
25026688|NCT03625739|Pyrazinamide|pyrazinamide|mesh-list
25026703|NCT03625739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25026712|NCT03625739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25026714|NCT03625739|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25026715|NCT03625739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25026716|NCT03625739|Antimetabolites|antimetabolites|mesh-ancestor
25026717|NCT03625739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25026718|NCT03625739|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25026719|NCT03625739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25026720|NCT03625739|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25026721|NCT03625739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25026722|NCT03625739|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25026737|NCT03625531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25026738|NCT03625531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026740|NCT03625518|Dinoprostone|dinoprostone|mesh-list
25026741|NCT03625518|Oxytocics|oxytocics|mesh-ancestor
25026742|NCT03625518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25026743|NCT03625518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026744|NCT03625505|Venetoclax|venetoclax|mesh-list
25026745|NCT03625505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25026746|NCT03625310|Listerine|listerine|mesh-list
24983654|NCT05182957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921505|NCT04189900|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24587863|NCT00897871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587864|NCT00897884|Metformin|metformin|mesh-list
24587865|NCT00897884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24587866|NCT00897884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587867|NCT00897975|Red yeast rice|red yeast rice|mesh-list
24587868|NCT00897975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24587869|NCT00897975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24587870|NCT00897975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24587871|NCT00897975|Antimetabolites|antimetabolites|mesh-ancestor
24587872|NCT00897975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587873|NCT00897975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587875|NCT00898287|Gemcitabine|gemcitabine|mesh-list
25026836|NCT03624959|Gemfibrozil|gemfibrozil|mesh-list
25026837|NCT03624959|Ozanimod|ozanimod|mesh-list
25026838|NCT03624959|Antifungal Agents|antifungal agents|mesh-ancestor
25026839|NCT03624959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25026840|NCT03624959|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25026841|NCT03624959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25026842|NCT03624959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25026843|NCT03624959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026844|NCT03624959|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25026845|NCT03624959|Hormone Antagonists|hormone antagonists|mesh-ancestor
25026869|NCT03624595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25026870|NCT03624595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25026871|NCT03624595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25026873|NCT03624595|Sensory System Agents|sensory system agents|mesh-ancestor
25026874|NCT03624595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25026875|NCT03624595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25026876|NCT03624595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25026877|NCT03624595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25026878|NCT03624595|Adrenergic Agents|adrenergic agents|mesh-ancestor
25026879|NCT03624595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25026880|NCT03624595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026881|NCT03624322|Olanzapine|olanzapine|mesh-list
25026882|NCT03624322|Antiemetics|antiemetics|mesh-ancestor
25710688|NCT02290444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25026883|NCT03624322|Autonomic Agents|autonomic agents|mesh-ancestor
25026884|NCT03624322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25710689|NCT02290444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710690|NCT02290444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25026892|NCT03624322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25026893|NCT03624322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25026894|NCT03624322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026907|NCT03624283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25026908|NCT03624283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25026909|NCT03624283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027034|NCT03623256|Anesthetics, General|anesthetics, general|mesh-ancestor
25027035|NCT03623230|Bupivacaine|bupivacaine|mesh-list
25027036|NCT03623230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25027037|NCT03623230|Anesthetics, Local|anesthetics, local|mesh-ancestor
25027038|NCT03623230|Anesthetics|anesthetics|mesh-ancestor
25027039|NCT03623230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25027040|NCT03623230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027041|NCT03623230|Sensory System Agents|sensory system agents|mesh-ancestor
25027042|NCT03623230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25027043|NCT03623087|Gemcitabine|gemcitabine|mesh-list
25027044|NCT03623087|Dexamethasone|dexamethasone|mesh-list
25027045|NCT03623087|Etoposide|etoposide|mesh-list
25027046|NCT03623087|Ifosfamide|ifosfamide|mesh-list
25027047|NCT03623087|Asparaginase|asparaginase|mesh-list
25027048|NCT03623087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25027049|NCT03623087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25027094|NCT03622827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25027095|NCT03622827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25027792|NCT03616691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25027119|NCT03622502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027132|NCT03622489|Sensory System Agents|sensory system agents|mesh-ancestor
25027209|NCT03621904|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25027210|NCT03621904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25027211|NCT03621904|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25027212|NCT03621904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984003|NCT04905173|Amyl Nitrite|amyl nitrite|mesh-list
25027213|NCT03621904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027214|NCT03621800|Menthol|menthol|mesh-list
25027215|NCT03621800|Antipruritics|antipruritics|mesh-ancestor
25027216|NCT03621800|Dermatologic Agents|dermatologic agents|mesh-ancestor
25112655|NCT03970746|Pembrolizumab|pembrolizumab|mesh-list
24592420|NCT00921700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24592421|NCT00921700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592422|NCT00921700|Antipyretics|antipyretics|mesh-ancestor
24592423|NCT00921700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24592424|NCT00921700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24592425|NCT00921700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24592426|NCT00921700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24592427|NCT00921700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592528|NCT00922506|Adrenergic Agents|adrenergic agents|mesh-ancestor
24592530|NCT00922519|Fluorides|fluorides|mesh-list
24592531|NCT00922519|Sodium Fluoride|sodium fluoride|mesh-list
24592532|NCT00922519|Cariostatic Agents|cariostatic agents|mesh-ancestor
24592533|NCT00922519|Protective Agents|protective agents|mesh-ancestor
24592534|NCT00922519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027283|NCT03621046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25027284|NCT03621046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027285|NCT03621046|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25027286|NCT03621046|GABA Agonists|gaba agonists|mesh-ancestor
25027287|NCT03621046|GABA Agents|gaba agents|mesh-ancestor
25027342|NCT03620760|Sensory System Agents|sensory system agents|mesh-ancestor
24984233|NCT04714190|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24984234|NCT04714190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24984235|NCT04714190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984236|NCT04714190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25027418|NCT03620435|Atezolizumab|atezolizumab|mesh-list
25027419|NCT03620435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25027420|NCT03620422|Mannitol|mannitol|mesh-list
25027421|NCT03620422|Albuterol|albuterol|mesh-list
25027422|NCT03620422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25027423|NCT03620422|Autonomic Agents|autonomic agents|mesh-ancestor
25027424|NCT03620422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25415975|NCT02980510|Hematinics|hematinics|mesh-ancestor
25415976|NCT02980510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25415977|NCT02980510|Antimetabolites|antimetabolites|mesh-ancestor
25415978|NCT02980510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25415979|NCT02980510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25415980|NCT02980510|Immunologic Factors|immunologic factors|mesh-ancestor
25415981|NCT02980341|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
25415982|NCT02980341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25415983|NCT02980341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25027425|NCT03620422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027636|NCT03618264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25027637|NCT03618264|Antiemetics|antiemetics|mesh-ancestor
25027638|NCT03618264|Autonomic Agents|autonomic agents|mesh-ancestor
24593073|NCT00926835|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24593074|NCT00926835|Dopamine Agents|dopamine agents|mesh-ancestor
24593077|NCT00926835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25027675|NCT03618108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25027676|NCT03618108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25027677|NCT03618108|Antitubercular Agents|antitubercular agents|mesh-ancestor
25027679|NCT03618082|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25027680|NCT03618082|Anesthetics, General|anesthetics, general|mesh-ancestor
25027681|NCT03618082|Anesthetics|anesthetics|mesh-ancestor
25027682|NCT03618082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25027683|NCT03618082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027684|NCT03617900|Acetaminophen|acetaminophen|mesh-list
25027685|NCT03617900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25027686|NCT03617900|Analgesics|analgesics|mesh-ancestor
25027758|NCT03617289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24796124|NCT01948011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027759|NCT03617289|Anticonvulsants|anticonvulsants|mesh-ancestor
25027760|NCT03617289|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25027761|NCT03617289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25027762|NCT03617289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027763|NCT03617289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25027764|NCT03617289|Tocolytic Agents|tocolytic agents|mesh-ancestor
25027765|NCT03617289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25027766|NCT03617224|Pembrolizumab|pembrolizumab|mesh-list
25027767|NCT03617224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25027768|NCT03617224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25027769|NCT03617055|Cystatins|cystatins|mesh-list
25027770|NCT03617055|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25027780|NCT03617016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593193|NCT00927407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25027781|NCT03617016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25027782|NCT03617016|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25027783|NCT03617016|Dopamine Agents|dopamine agents|mesh-ancestor
25027784|NCT03617016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25027785|NCT03617016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25027786|NCT03616808|Hemostatics|hemostatics|mesh-list
25027787|NCT03616808|Coagulants|coagulants|mesh-ancestor
25027788|NCT03616769|Antihypertensive Agents|antihypertensive agents|mesh-list
25027789|NCT03616769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25027790|NCT03616691|Bevacizumab|bevacizumab|mesh-list
25027791|NCT03616691|Atezolizumab|atezolizumab|mesh-list
25027843|NCT03616405|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25027844|NCT03616405|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25027850|NCT03616301|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25112879|NCT03866174|Psilocybin|psilocybin|mesh-list
25027893|NCT03615950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24984836|NCT03982485|Antimitotic Agents|antimitotic agents|mesh-ancestor
24984837|NCT03982485|Mitosis Modulators|mitosis modulators|mesh-ancestor
24984838|NCT03982485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984839|NCT03982485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24984840|NCT03982485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984841|NCT03969121|Palbociclib|palbociclib|mesh-list
24984842|NCT03969121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24984843|NCT03969121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24984844|NCT03969121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24984845|NCT03969121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24984846|NCT03966339|Hormones|hormones|mesh-list
24984848|NCT03966339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25027999|NCT03614455|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-list
25028000|NCT03614455|Antifungal Agents|antifungal agents|mesh-ancestor
25028001|NCT03614455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25028002|NCT03614455|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25028003|NCT03614455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25028004|NCT03614455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25028005|NCT03614455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028006|NCT03614455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25028007|NCT03614455|Hormone Antagonists|hormone antagonists|mesh-ancestor
25028008|NCT03614455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25028009|NCT03614455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028010|NCT03614455|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25028011|NCT03614455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25028012|NCT03614455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25028013|NCT03614429|Chlorhexidine|chlorhexidine|mesh-list
25112900|NCT03798080|Insulin|insulin|mesh-list
25028078|NCT03613961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25028079|NCT03613961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028080|NCT03613857|Clopidogrel|clopidogrel|mesh-list
25028081|NCT03613857|Ticagrelor|ticagrelor|mesh-list
25028082|NCT03613857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25028083|NCT03613857|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25028084|NCT03613857|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25028085|NCT03613857|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25028264|NCT03612401|Adrenergic Agents|adrenergic agents|mesh-ancestor
25028265|NCT03612401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25028268|NCT03612401|Urological Agents|urological agents|mesh-ancestor
25028269|NCT03612349|Menthol|menthol|mesh-list
25028270|NCT03612349|Antipruritics|antipruritics|mesh-ancestor
25028410|NCT03610945|Cholinergic Agents|cholinergic agents|mesh-ancestor
25028411|NCT03610945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25028412|NCT03610945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25028413|NCT03610945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25028414|NCT03610945|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25028415|NCT03610932|Ascorbic Acid|ascorbic acid|mesh-list
25028416|NCT03610932|Vitamins|vitamins|mesh-ancestor
25028417|NCT03610932|Micronutrients|micronutrients|mesh-ancestor
25028418|NCT03610932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028455|NCT03610685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25028461|NCT03610347|Paclitaxel|paclitaxel|mesh-list
25028626|NCT03609307|Adrenergic Agents|adrenergic agents|mesh-ancestor
25028627|NCT03609307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25028628|NCT03609307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028629|NCT03609307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25028630|NCT03609307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25028631|NCT03609307|Vasodilator Agents|vasodilator agents|mesh-ancestor
25028633|NCT03609294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25028634|NCT03609294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028635|NCT03609294|Incretins|incretins|mesh-ancestor
24594343|NCT00933465|Loperamide|loperamide|mesh-list
25028655|NCT03609190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028656|NCT03609125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25028657|NCT03609125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25028658|NCT03609099|Moxifloxacin|moxifloxacin|mesh-list
25028659|NCT03609099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25028660|NCT03609099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25028661|NCT03609099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25028662|NCT03609099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25028663|NCT03609099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25028664|NCT03609099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028665|NCT03609099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028666|NCT03609086|Melatonin|melatonin|mesh-list
25028667|NCT03609086|Antioxidants|antioxidants|mesh-ancestor
25028668|NCT03609086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028669|NCT03609086|Protective Agents|protective agents|mesh-ancestor
25028670|NCT03609086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028671|NCT03609086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25028823|NCT03607643|Irinotecan|irinotecan|mesh-list
24594533|NCT00934258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594534|NCT00934323|Metformin|metformin|mesh-list
24594535|NCT00934323|Glimepiride|glimepiride|mesh-list
24594536|NCT00934323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25028824|NCT03607643|Temozolomide|temozolomide|mesh-list
25028825|NCT03607643|Bortezomib|bortezomib|mesh-list
25028826|NCT03607643|Cannabidiol|cannabidiol|mesh-list
25028827|NCT03607643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25028828|NCT03607643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25028829|NCT03607643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25028830|NCT03607643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25028831|NCT03607643|Growth Substances|growth substances|mesh-ancestor
25028879|NCT03607227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25028880|NCT03607227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028881|NCT03607227|Sensory System Agents|sensory system agents|mesh-ancestor
25028882|NCT03607227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25028883|NCT03607175|Triamcinolone|triamcinolone|mesh-list
25028884|NCT03607175|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25028885|NCT03607175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25028886|NCT03607175|Glucocorticoids|glucocorticoids|mesh-ancestor
25028887|NCT03607175|Hormones|hormones|mesh-ancestor
25028890|NCT03607175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24594638|NCT00934752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24594639|NCT00934752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24594640|NCT00934752|Tubulin Modulators|tubulin modulators|mesh-ancestor
24594641|NCT00934752|Antimitotic Agents|antimitotic agents|mesh-ancestor
25028941|NCT03606902|Anesthetics|anesthetics|mesh-ancestor
25028942|NCT03606902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25028943|NCT03606902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25028944|NCT03606902|Sensory System Agents|sensory system agents|mesh-ancestor
25028945|NCT03606902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25028946|NCT03606902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25028947|NCT03606902|Narcotics|narcotics|mesh-ancestor
25028948|NCT03606902|Analgesics|analgesics|mesh-ancestor
25028949|NCT03606902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25028950|NCT03606902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25028951|NCT03606902|Anesthetics, General|anesthetics, general|mesh-ancestor
25028952|NCT03606824|Pitavastatin|pitavastatin|mesh-list
25028953|NCT03606824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25028969|NCT03606590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25028971|NCT03606577|Lenalidomide|lenalidomide|mesh-list
25028972|NCT03606577|Daratumumab|daratumumab|mesh-list
25028973|NCT03606577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25028974|NCT03606577|Antiemetics|antiemetics|mesh-ancestor
25028975|NCT03606577|Autonomic Agents|autonomic agents|mesh-ancestor
25029035|NCT03606057|Moxifloxacin|moxifloxacin|mesh-list
25029118|NCT03605056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25029119|NCT03605056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25029120|NCT03605056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029187|NCT03604354|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25029188|NCT03604354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25029189|NCT03604354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25029190|NCT03604354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25029191|NCT03604354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25029192|NCT03604354|Narcotics|narcotics|mesh-ancestor
25029193|NCT03604354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25029194|NCT03604354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24986299|NCT01978938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24986300|NCT01978938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24587908|NCT00898534|Sensory System Agents|sensory system agents|mesh-ancestor
24587909|NCT00898534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24587910|NCT00898534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587911|NCT00898534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24587912|NCT00898534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24587914|NCT00898573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25029373|NCT03602911|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25029374|NCT03602911|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25710691|NCT02290444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710692|NCT02290613|Ambrisentan|ambrisentan|mesh-list
25710693|NCT02290613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25710694|NCT02290873|Midazolam|midazolam|mesh-list
25710695|NCT02290873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25710696|NCT02290873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25710697|NCT02290873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25710698|NCT02290873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710699|NCT02290873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25029375|NCT03602911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25029376|NCT03602898|Cyclosporine|cyclosporine|mesh-list
25029426|NCT03602690|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25029427|NCT03602690|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25029428|NCT03602690|Protease Inhibitors|protease inhibitors|mesh-ancestor
24595312|NCT00937924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25029429|NCT03602690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415984|NCT02979873|Sirolimus|sirolimus|mesh-list
25415985|NCT02979873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25415986|NCT02979873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25415987|NCT02979873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25415988|NCT02979873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24595377|NCT00938262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25029494|NCT03602469|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25029495|NCT03602469|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25029496|NCT03602469|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25029498|NCT03602430|Cholecalciferol|cholecalciferol|mesh-list
25029499|NCT03602430|Vitamins|vitamins|mesh-ancestor
25029500|NCT03602430|Micronutrients|micronutrients|mesh-ancestor
25029504|NCT03602378|Hydrocortisone|hydrocortisone|mesh-list
25029618|NCT03601871|Serotonin Agents|serotonin agents|mesh-ancestor
24595506|NCT00938990|GABA Agents|gaba agents|mesh-ancestor
25113192|NCT03377049|Diuretics|diuretics|mesh-ancestor
24595570|NCT00939588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24595571|NCT00939588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24595572|NCT00939588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030081|NCT03598634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596139|NCT00941967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596140|NCT00941967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25030122|NCT03598374|Inositol|inositol|mesh-list
25030203|NCT03597867|Indomethacin|indomethacin|mesh-list
25030204|NCT03597867|Nepafenac|nepafenac|mesh-list
25030205|NCT03597867|Bromfenac|bromfenac|mesh-list
25030206|NCT03597867|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25030207|NCT03597867|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25030208|NCT03597867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25030209|NCT03597867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25030210|NCT03597867|Analgesics|analgesics|mesh-ancestor
25030220|NCT03597867|Tocolytic Agents|tocolytic agents|mesh-ancestor
24987043|NCT04447287|ASP8062|asp8062|mesh-list
24987044|NCT04447287|Naloxone|naloxone|mesh-list
24987045|NCT04447287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24987046|NCT04447287|Narcotics|narcotics|mesh-ancestor
24987047|NCT04447287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24987049|NCT04447287|Analgesics|analgesics|mesh-ancestor
25030222|NCT03597815|Aflibercept|aflibercept|mesh-list
25030223|NCT03597815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25030224|NCT03597815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25030225|NCT03597815|Growth Substances|growth substances|mesh-ancestor
25030226|NCT03597815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030227|NCT03597815|Growth Inhibitors|growth inhibitors|mesh-ancestor
25030228|NCT03597815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25030276|NCT03597308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25030277|NCT03597308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030286|NCT03597282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25030287|NCT03597282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25030288|NCT03597282|Interferon Inducers|interferon inducers|mesh-ancestor
25030291|NCT03597087|Anesthetics|anesthetics|mesh-list
25113339|NCT02968810|Antimetabolites|antimetabolites|mesh-ancestor
25113340|NCT02968810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113341|NCT02968810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25113342|NCT02968810|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25113343|NCT02968810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25030444|NCT03595514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25030445|NCT03595514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25030446|NCT03595514|Glucocorticoids|glucocorticoids|mesh-ancestor
25030643|NCT03594188|Anesthetics|anesthetics|mesh-list
25030742|NCT03593135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25030744|NCT03593044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25030745|NCT03593044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25030746|NCT03593044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25030747|NCT03593044|Autonomic Agents|autonomic agents|mesh-ancestor
25030748|NCT03593044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25030826|NCT03592498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25030827|NCT03592498|Coccidiostats|coccidiostats|mesh-ancestor
25030828|NCT03592498|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25030829|NCT03592485|Acetaminophen|acetaminophen|mesh-list
25710700|NCT02290873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25710701|NCT02290873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25113390|NCT02888743|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25113391|NCT02888743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24987628|NCT05190341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24987629|NCT05190341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24987630|NCT05190341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25030998|NCT03591471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25030999|NCT03591471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25031000|NCT03591471|Vasodilator Agents|vasodilator agents|mesh-ancestor
25031001|NCT03591471|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25031002|NCT03591471|Protease Inhibitors|protease inhibitors|mesh-ancestor
25031003|NCT03591471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25031005|NCT03591341|Antioxidants|antioxidants|mesh-ancestor
25031006|NCT03591341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031007|NCT03591341|Protective Agents|protective agents|mesh-ancestor
25031008|NCT03591341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031193|NCT03589495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25031194|NCT03589495|Protective Agents|protective agents|mesh-ancestor
25031195|NCT03589495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031196|NCT03589495|Antidotes|antidotes|mesh-ancestor
25031197|NCT03589430|Protein C|protein c|mesh-list
25031198|NCT03589430|Antithrombins|antithrombins|mesh-list
25031199|NCT03589430|Antithrombin III|antithrombin iii|mesh-list
25031200|NCT03589430|Protein S|protein s|mesh-list
25113616|NCT02474173|Mitosis Modulators|mitosis modulators|mesh-ancestor
25031201|NCT03589430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25031202|NCT03589430|Protease Inhibitors|protease inhibitors|mesh-ancestor
25031203|NCT03589430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25031710|NCT03586154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25031711|NCT03586154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25031713|NCT03586154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25031714|NCT03586154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25031715|NCT03586154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25031767|NCT03585894|Ketorolac|ketorolac|mesh-list
25031768|NCT03585894|Sumatriptan|sumatriptan|mesh-list
25031769|NCT03585894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25031770|NCT03585894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25031771|NCT03585894|Analgesics|analgesics|mesh-ancestor
25031772|NCT03585894|Sensory System Agents|sensory system agents|mesh-ancestor
25031773|NCT03585894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25031774|NCT03585894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031775|NCT03585894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25031776|NCT03585894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25031777|NCT03585894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24598329|NCT00955318|Emetics|emetics|mesh-ancestor
25031906|NCT03585179|Coagulants|coagulants|mesh-ancestor
25031907|NCT03585179|Antioxidants|antioxidants|mesh-ancestor
25031908|NCT03585179|Protective Agents|protective agents|mesh-ancestor
25031909|NCT03585179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25031910|NCT03585179|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25031911|NCT03585140|Doxycycline|doxycycline|mesh-list
25031912|NCT03585140|Adapalene|adapalene|mesh-list
25031913|NCT03585140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25031914|NCT03585140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25031915|NCT03585140|Antimalarials|antimalarials|mesh-ancestor
25031916|NCT03585140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25031917|NCT03585140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25031918|NCT03585140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25031919|NCT03585140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25031920|NCT03585140|Analgesics|analgesics|mesh-ancestor
25031921|NCT03585140|Sensory System Agents|sensory system agents|mesh-ancestor
25031922|NCT03585140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25031924|NCT03585140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25032050|NCT03584360|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25032051|NCT03584360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25032052|NCT03584360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032053|NCT03584360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25032054|NCT03584360|Vitamins|vitamins|mesh-ancestor
25032055|NCT03584360|Micronutrients|micronutrients|mesh-ancestor
25032056|NCT03584360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25032057|NCT03584178|Budesonide|budesonide|mesh-list
25032066|NCT03584178|Hormones|hormones|mesh-ancestor
24988825|NCT00033293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25032118|NCT03583567|Ranitidine|ranitidine|mesh-list
25113626|NCT02453620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25113627|NCT02453620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113628|NCT02453620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25032384|NCT03580967|Antidepressive Agents|antidepressive agents|mesh-ancestor
25032392|NCT03580967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25032393|NCT03580967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25032438|NCT03580733|Antifungal Agents|antifungal agents|mesh-list
25032439|NCT03580733|Clotrimazole|clotrimazole|mesh-list
25032508|NCT03580239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032509|NCT03580239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25032510|NCT03580239|Immunologic Factors|immunologic factors|mesh-ancestor
24517644|NCT00608972|Growth Inhibitors|growth inhibitors|mesh-ancestor
25032511|NCT03580239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032555|NCT03579927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25032557|NCT03579927|Immunologic Factors|immunologic factors|mesh-ancestor
25032558|NCT03579927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032559|NCT03579927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25032560|NCT03579927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25032561|NCT03579927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25032562|NCT03579927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25032563|NCT03579927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25032564|NCT03579927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25113638|NCT02425891|Paclitaxel|paclitaxel|mesh-list
25113639|NCT02425891|Atezolizumab|atezolizumab|mesh-list
25113640|NCT02425891|Antibodies|antibodies|mesh-list
25113641|NCT02425891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25113642|NCT02425891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24599423|NCT04591431|Mitosis Modulators|mitosis modulators|mesh-ancestor
25113675|NCT02392429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113676|NCT02392429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599424|NCT04588948|Aflibercept|aflibercept|mesh-list
24599425|NCT04588948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25113677|NCT02392429|Antiviral Agents|antiviral agents|mesh-ancestor
25032750|NCT03578874|Capecitabine|capecitabine|mesh-list
24599728|NCT03940729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24599729|NCT03940729|Disinfectants|disinfectants|mesh-ancestor
24599735|NCT03913559|Acetaminophen|acetaminophen|mesh-list
24599736|NCT03913559|Diphenhydramine|diphenhydramine|mesh-list
25032933|NCT03576911|Micronutrients|micronutrients|mesh-ancestor
25032934|NCT03576911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25032935|NCT03576911|Vitamins|vitamins|mesh-ancestor
25032936|NCT03576820|Lidocaine|lidocaine|mesh-list
25032979|NCT03576664|Carvedilol|carvedilol|mesh-list
25113758|NCT02271919|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25113759|NCT02271919|Autonomic Agents|autonomic agents|mesh-ancestor
25113760|NCT02271919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25033210|NCT03575234|Cyclophosphamide|cyclophosphamide|mesh-list
25033211|NCT03575234|Nivolumab|nivolumab|mesh-list
25033212|NCT03575234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25033213|NCT03575234|Immunologic Factors|immunologic factors|mesh-ancestor
25033214|NCT03575234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033215|NCT03575234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25033216|NCT03575234|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25033217|NCT03575234|Alkylating Agents|alkylating agents|mesh-ancestor
25033218|NCT03575234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033219|NCT03575234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600136|NCT02465138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24600137|NCT02465138|Analgesics|analgesics|mesh-ancestor
24600138|NCT02465138|Sensory System Agents|sensory system agents|mesh-ancestor
24600139|NCT02465138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24600140|NCT02465138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600141|NCT02465138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24600142|NCT02465138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25033273|NCT03574857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033274|NCT03574857|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25033275|NCT03574857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24990091|NCT03875378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24990093|NCT03869866|Immunologic Factors|immunologic factors|mesh-ancestor
24588250|NCT00901745|Angiotensin II|angiotensin ii|mesh-list
25113796|NCT02189798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25113799|NCT02167945|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25113800|NCT02167945|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25113801|NCT02167945|Protease Inhibitors|protease inhibitors|mesh-ancestor
25113802|NCT02167945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25113803|NCT02167945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113804|NCT02167945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25113805|NCT02167945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25113806|NCT02167945|Antiviral Agents|antiviral agents|mesh-ancestor
25113807|NCT02167945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25113808|NCT02167945|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25033532|NCT03572790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033533|NCT03572790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033534|NCT03572686|Dexamethasone|dexamethasone|mesh-list
25033535|NCT03572686|Dexamethasone acetate|dexamethasone acetate|mesh-list
25033536|NCT03572686|Ropivacaine|ropivacaine|mesh-list
25033537|NCT03572686|BB 1101|bb 1101|mesh-list
25033538|NCT03572686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25033539|NCT03572686|Antiemetics|antiemetics|mesh-ancestor
25033540|NCT03572686|Autonomic Agents|autonomic agents|mesh-ancestor
25033541|NCT03572686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25033542|NCT03572686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25033543|NCT03572686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25033544|NCT03572686|Glucocorticoids|glucocorticoids|mesh-ancestor
25033545|NCT03572686|Hormones|hormones|mesh-ancestor
25033546|NCT03572686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25033547|NCT03572686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25033668|NCT03571711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25033669|NCT03571711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25033671|NCT03571594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25033672|NCT03571594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25033673|NCT03571594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25033674|NCT03571490|Ropivacaine|ropivacaine|mesh-list
25033675|NCT03571490|Anesthetics, Local|anesthetics, local|mesh-ancestor
25033676|NCT03571490|Anesthetics|anesthetics|mesh-ancestor
25033682|NCT03571438|Sunitinib|sunitinib|mesh-list
25033683|NCT03571438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600769|NCT00960479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24600770|NCT00960492|Temozolomide|temozolomide|mesh-list
25033789|NCT03571230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033790|NCT03571230|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25033791|NCT03571230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25033792|NCT03571230|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25033793|NCT03571230|Renal Agents|renal agents|mesh-ancestor
25033794|NCT03571230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25033795|NCT03571230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25033796|NCT03571230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25033797|NCT03571230|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25033798|NCT03571230|Antacids|antacids|mesh-ancestor
25033799|NCT03571230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25033800|NCT03571230|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25033801|NCT03571230|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
24608196|NCT01965704|Antipruritics|antipruritics|mesh-ancestor
25033836|NCT03570710|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25033837|NCT03570710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25033839|NCT03570710|Coagulants|coagulants|mesh-ancestor
25113899|NCT02104310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25113900|NCT02074436|Aminocaproic Acid|aminocaproic acid|mesh-list
25113901|NCT02074436|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25113902|NCT02074436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24600928|NCT00961194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24600929|NCT00961194|Anesthetics, General|anesthetics, general|mesh-ancestor
24600930|NCT00961194|Anesthetics|anesthetics|mesh-ancestor
24600931|NCT00961194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24600932|NCT00961194|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24600933|NCT00961194|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24600934|NCT00961194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25033953|NCT03569995|Antiviral Agents|antiviral agents|mesh-ancestor
25033954|NCT03569995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25033955|NCT03569696|Nivolumab|nivolumab|mesh-list
24990756|NCT00936936|Alkylating Agents|alkylating agents|mesh-ancestor
25034164|NCT03567369|Hormones|hormones|mesh-ancestor
25034165|NCT03567369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25034166|NCT03567369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25034167|NCT03567369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25034169|NCT03567369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034170|NCT03567369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034171|NCT03567343|Melatonin|melatonin|mesh-list
25034172|NCT03567343|Antioxidants|antioxidants|mesh-ancestor
25034173|NCT03567343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034174|NCT03567343|Protective Agents|protective agents|mesh-ancestor
25034175|NCT03567343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034176|NCT03567343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25034177|NCT03567304|Rilpivirine|rilpivirine|mesh-list
25034178|NCT03567304|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25034224|NCT03566394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25034225|NCT03566394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25034226|NCT03566394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034227|NCT03566394|Antimanic Agents|antimanic agents|mesh-ancestor
25034228|NCT03566329|Lidocaine|lidocaine|mesh-list
25034229|NCT03566329|Magnesium Sulfate|magnesium sulfate|mesh-list
25034230|NCT03566329|Anesthetics, Local|anesthetics, local|mesh-ancestor
24601260|NCT00963703|Rituximab|rituximab|mesh-list
24601261|NCT00963703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25113982|NCT01552434|Sirolimus|sirolimus|mesh-list
25113985|NCT01552434|Cetuximab|cetuximab|mesh-list
25034293|NCT03566225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25034299|NCT03566134|DA-8010|da-8010|mesh-list
25034301|NCT03566134|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25034302|NCT03566134|Cholinergic Agents|cholinergic agents|mesh-ancestor
25034303|NCT03566134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25034304|NCT03566134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034305|NCT03566134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034306|NCT03566134|Urological Agents|urological agents|mesh-ancestor
25034307|NCT03566069|Oxytocin|oxytocin|mesh-list
25034308|NCT03566069|Oxytocics|oxytocics|mesh-ancestor
25034309|NCT03566069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25034310|NCT03566069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034311|NCT03566030|Tenofovir|tenofovir|mesh-list
24588418|NCT00902655|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24588419|NCT00902655|Hemostatics|hemostatics|mesh-ancestor
24608197|NCT01965704|Dermatologic Agents|dermatologic agents|mesh-ancestor
24588467|NCT00902811|Amodiaquine|amodiaquine|mesh-list
25034437|NCT03564704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25034438|NCT03564704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25034439|NCT03564704|Antimetabolites|antimetabolites|mesh-ancestor
25034440|NCT03564704|Dermatologic Agents|dermatologic agents|mesh-ancestor
25034441|NCT03564704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034442|NCT03564704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25034443|NCT03564704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25034444|NCT03564704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25034445|NCT03564704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25034446|NCT03564704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25034447|NCT03564704|Antiviral Agents|antiviral agents|mesh-ancestor
25034448|NCT03564704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25034449|NCT03564704|Tubulin Modulators|tubulin modulators|mesh-ancestor
25034450|NCT03564704|Antimitotic Agents|antimitotic agents|mesh-ancestor
25034451|NCT03564704|Mitosis Modulators|mitosis modulators|mesh-ancestor
25034452|NCT03564704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25710702|NCT02290873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25710703|NCT02290873|Anesthetics, General|anesthetics, general|mesh-ancestor
25710704|NCT02290873|Anesthetics|anesthetics|mesh-ancestor
25034556|NCT03563833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25034557|NCT03563833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25034558|NCT03563794|Insulin Lispro|insulin lispro|mesh-list
25034605|NCT03563365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25034606|NCT03563365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25034608|NCT03563365|Sensory System Agents|sensory system agents|mesh-ancestor
25034609|NCT03563365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25034610|NCT03563365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25034611|NCT03563365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25034654|NCT03563170|Antimetabolites|antimetabolites|mesh-ancestor
25034655|NCT03563170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25034656|NCT03563170|Antidotes|antidotes|mesh-ancestor
25034657|NCT03563170|Protective Agents|protective agents|mesh-ancestor
25034658|NCT03563170|Vitamin B Complex|vitamin b complex|mesh-ancestor
25034660|NCT03563170|Micronutrients|micronutrients|mesh-ancestor
25034661|NCT03563170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25034662|NCT03563170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25034663|NCT03563170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034664|NCT03563144|Leucovorin|leucovorin|mesh-list
25034665|NCT03563144|Gemcitabine|gemcitabine|mesh-list
25034666|NCT03563144|Paclitaxel|paclitaxel|mesh-list
25034667|NCT03563144|Cyclophosphamide|cyclophosphamide|mesh-list
25034668|NCT03563144|Bevacizumab|bevacizumab|mesh-list
25034669|NCT03563144|Fluorouracil|fluorouracil|mesh-list
25034670|NCT03563144|Capecitabine|capecitabine|mesh-list
24991366|NCT05194852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25034671|NCT03563144|Oxaliplatin|oxaliplatin|mesh-list
25034672|NCT03563144|Avelumab|avelumab|mesh-list
25034673|NCT03563144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25034674|NCT03563144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588644|NCT00903747|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24588645|NCT00903747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24588646|NCT00903747|Serotonin Agents|serotonin agents|mesh-ancestor
24456903|NCT00332553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24588647|NCT00903747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24588649|NCT00903825|Anesthetics, Local|anesthetics, local|mesh-list
24588650|NCT00903825|Anesthetics|anesthetics|mesh-list
24588651|NCT00903825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25034745|NCT03562754|Heparin|heparin|mesh-list
25034747|NCT03562754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034749|NCT03562754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25034750|NCT03562611|Flurbiprofen|flurbiprofen|mesh-list
25034751|NCT03562611|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
25034752|NCT03562611|Nalbuphine|nalbuphine|mesh-list
25034753|NCT03562611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25034754|NCT03562611|Narcotics|narcotics|mesh-ancestor
25034755|NCT03562611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25034810|NCT03562390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034811|NCT03562390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25034812|NCT03562390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25034814|NCT03562169|Dexamethasone|dexamethasone|mesh-list
25034815|NCT03562169|Ixazomib|ixazomib|mesh-list
25034816|NCT03562169|Glycine|glycine|mesh-list
25034817|NCT03562169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25034818|NCT03562169|Antiemetics|antiemetics|mesh-ancestor
24991515|NCT05143489|Lidocaine|lidocaine|mesh-list
25034909|NCT03561402|Immunologic Factors|immunologic factors|mesh-ancestor
25034910|NCT03561298|Zanubrutinib|zanubrutinib|mesh-list
25034911|NCT03561298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25034912|NCT03561298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25034913|NCT03561298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25034914|NCT03561298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035084|NCT03559920|Propofol|propofol|mesh-list
25035085|NCT03559920|Anesthetics|anesthetics|mesh-list
25035086|NCT03559920|Sevoflurane|sevoflurane|mesh-list
25035087|NCT03559920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25035088|NCT03559920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25035089|NCT03559920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035090|NCT03559920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25035091|NCT03559920|Anesthetics, General|anesthetics, general|mesh-ancestor
25035092|NCT03559920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25035093|NCT03559920|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25035094|NCT03559803|Cisplatin|cisplatin|mesh-list
25035095|NCT03559803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25035096|NCT03559790|Tenofovir|tenofovir|mesh-list
24588653|NCT00903825|Sensory System Agents|sensory system agents|mesh-ancestor
24588654|NCT00903825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588655|NCT00903825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24588656|NCT00903825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25035147|NCT03559387|Lenograstim|lenograstim|mesh-list
25035148|NCT03559387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25035149|NCT03559387|Immunologic Factors|immunologic factors|mesh-ancestor
25035150|NCT03559387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035234|NCT03558295|Anticoagulants|anticoagulants|mesh-list
25035235|NCT03558243|Hemostatics|hemostatics|mesh-list
25035236|NCT03558243|Coagulants|coagulants|mesh-ancestor
25035237|NCT03558139|Avelumab|avelumab|mesh-list
25035238|NCT03558139|Magrolimab|magrolimab|mesh-list
25035239|NCT03558139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25035240|NCT03558139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25035241|NCT03557996|Listerine|listerine|mesh-list
25035242|NCT03557996|Fluorides|fluorides|mesh-list
24991876|NCT04796948|Leucovorin|leucovorin|mesh-list
25035243|NCT03557996|Sodium Fluoride|sodium fluoride|mesh-list
25035244|NCT03557996|Fluorides, Topical|fluorides, topical|mesh-list
25035245|NCT03557996|Cariostatic Agents|cariostatic agents|mesh-ancestor
25035269|NCT03557580|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25035270|NCT03557580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035271|NCT03557437|Amoxicillin|amoxicillin|mesh-list
24991976|NCT04690023|Anesthetics, Local|anesthetics, local|mesh-ancestor
25035353|NCT03556839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25035354|NCT03556839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25035442|NCT03555929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25035443|NCT03555617|Itraconazole|itraconazole|mesh-list
25035444|NCT03555617|Antifungal Agents|antifungal agents|mesh-ancestor
25035445|NCT03555617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25035446|NCT03555617|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25035447|NCT03555617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25035448|NCT03555617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467396|NCT00377468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25035449|NCT03555617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035450|NCT03555617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25035451|NCT03555617|Hormone Antagonists|hormone antagonists|mesh-ancestor
25035452|NCT03555617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25035453|NCT03555617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035454|NCT03555617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25035455|NCT03555526|Amoxicillin|amoxicillin|mesh-list
25035456|NCT03555526|Metronidazole|metronidazole|mesh-list
25035457|NCT03555526|Clarithromycin|clarithromycin|mesh-list
25035532|NCT03554980|Listerine|listerine|mesh-list
25035555|NCT03554915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035556|NCT03554915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25035557|NCT03554915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25035558|NCT03554915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25035559|NCT03554915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25035560|NCT03554915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25035561|NCT03554915|GABA Modulators|gaba modulators|mesh-ancestor
25035562|NCT03554915|GABA Agents|gaba agents|mesh-ancestor
25035563|NCT03554889|Nimotuzumab|nimotuzumab|mesh-list
25035564|NCT03554889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25035565|NCT03554889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25035566|NCT03554590|Insulin|insulin|mesh-list
25035700|NCT03553537|Immunologic Factors|immunologic factors|mesh-ancestor
25035701|NCT03553537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035702|NCT03553537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25035703|NCT03553537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25035704|NCT03553537|Alkylating Agents|alkylating agents|mesh-ancestor
25035705|NCT03553537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588809|NCT00904397|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24588810|NCT00904397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25710705|NCT02290873|GABA Modulators|gaba modulators|mesh-ancestor
25710706|NCT02290873|GABA Agents|gaba agents|mesh-ancestor
24588811|NCT00904397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24588812|NCT00904397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710707|NCT02290873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25710708|NCT02290873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710709|NCT02291016|Formoterol Fumarate|formoterol fumarate|mesh-list
25035724|NCT03553433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25035725|NCT03553433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25035727|NCT03553433|Sensory System Agents|sensory system agents|mesh-ancestor
25035728|NCT03553433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25035729|NCT03553433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035730|NCT03553433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25035731|NCT03553433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25035732|NCT03553433|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25035733|NCT03553433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25035773|NCT03553238|Hormones|hormones|mesh-ancestor
25035836|NCT03552770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25035837|NCT03552770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25035838|NCT03552770|Growth Substances|growth substances|mesh-ancestor
25035839|NCT03552770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25035840|NCT03552770|Growth Inhibitors|growth inhibitors|mesh-ancestor
25035841|NCT03552705|Tranexamic Acid|tranexamic acid|mesh-list
25035842|NCT03552705|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25035843|NCT03552705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25035844|NCT03552705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25035845|NCT03552705|Hemostatics|hemostatics|mesh-ancestor
25035914|NCT03552146|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25036007|NCT03551197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25036008|NCT03551197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25036009|NCT03551197|Adrenergic Agents|adrenergic agents|mesh-ancestor
25036011|NCT03551197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036013|NCT03551171|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25036015|NCT03551171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24992716|NCT03057431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25036025|NCT03551067|Sensory System Agents|sensory system agents|mesh-ancestor
25036026|NCT03551067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25036027|NCT03551067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25036028|NCT03551067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25036029|NCT03551067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25036030|NCT03551067|Adrenergic Agents|adrenergic agents|mesh-ancestor
25036031|NCT03551067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25036032|NCT03551067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036033|NCT03551067|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25036034|NCT03551067|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25036087|NCT03550534|Calcium Carbonate|calcium carbonate|mesh-list
25036089|NCT03550534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25036090|NCT03550534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036092|NCT03550534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036093|NCT03550534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25036094|NCT03550508|Antibodies|antibodies|mesh-list
25036095|NCT03550508|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25036096|NCT03550508|Immunologic Factors|immunologic factors|mesh-ancestor
25036099|NCT03549975|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25036100|NCT03549975|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25036101|NCT03549975|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25036102|NCT03549975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25036197|NCT03549663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25036198|NCT03549663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036199|NCT03549663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25036200|NCT03549663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25036201|NCT03549663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25036202|NCT03549663|Immunologic Factors|immunologic factors|mesh-ancestor
25036203|NCT03549663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25036204|NCT03549663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036205|NCT03549663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036206|NCT03549611|Acetaminophen|acetaminophen|mesh-list
25036207|NCT03549611|Celecoxib|celecoxib|mesh-list
25036208|NCT03549611|Oxycodone|oxycodone|mesh-list
25036209|NCT03549611|Gabapentin|gabapentin|mesh-list
25036311|NCT03548714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25710710|NCT02291016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25710711|NCT02291016|Autonomic Agents|autonomic agents|mesh-ancestor
25036312|NCT03548714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036313|NCT03548662|Hyaluronic Acid|hyaluronic acid|mesh-list
25036314|NCT03548662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25036315|NCT03548662|Immunologic Factors|immunologic factors|mesh-ancestor
25036316|NCT03548662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036317|NCT03548662|Viscosupplements|viscosupplements|mesh-ancestor
25036318|NCT03548662|Protective Agents|protective agents|mesh-ancestor
25036324|NCT03548493|Magnesium Sulfate|magnesium sulfate|mesh-list
25036326|NCT03548493|Propofol|propofol|mesh-list
25036327|NCT03548493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25036340|NCT03548493|Anticonvulsants|anticonvulsants|mesh-ancestor
24603989|NCT00976690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24603990|NCT00976690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24603991|NCT00976690|Analgesics|analgesics|mesh-ancestor
24992986|NCT01883804|Autonomic Agents|autonomic agents|mesh-ancestor
24992987|NCT01883804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25036500|NCT03547024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25036501|NCT03547024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24993126|NCT00925652|Dermatologic Agents|dermatologic agents|mesh-ancestor
25036503|NCT03547024|Hormones|hormones|mesh-ancestor
25036504|NCT03547024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25036505|NCT03547024|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25036532|NCT03546855|Apatinib|apatinib|mesh-list
25036544|NCT03546530|Interferons|interferons|mesh-list
25036545|NCT03546530|Resveratrol|resveratrol|mesh-list
25036546|NCT03546530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25036648|NCT03545243|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25036649|NCT03545243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036650|NCT03545243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036651|NCT03544996|Insulin|insulin|mesh-list
25036652|NCT03544996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25036653|NCT03544996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036654|NCT03544827|Atropine|atropine|mesh-list
25036655|NCT03544827|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25036656|NCT03544827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25036657|NCT03544827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25036658|NCT03544827|Autonomic Agents|autonomic agents|mesh-ancestor
25036780|NCT03543683|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25036781|NCT03543683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25036782|NCT03543683|Antipyretics|antipyretics|mesh-ancestor
25036783|NCT03543683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25036784|NCT03543683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25036785|NCT03543657|Darbepoetin alfa|darbepoetin alfa|mesh-list
25036786|NCT03543657|Hematinics|hematinics|mesh-ancestor
25036787|NCT03543436|Meropenem|meropenem|mesh-list
25036788|NCT03543436|Imipenem|imipenem|mesh-list
25036789|NCT03543436|Temocillin|temocillin|mesh-list
25036790|NCT03543436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25036791|NCT03543436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25036792|NCT03543306|Trametinib|trametinib|mesh-list
24588841|NCT00904462|Lidocaine|lidocaine|mesh-list
24588842|NCT00904462|Anesthetics, Local|anesthetics, local|mesh-ancestor
24588843|NCT00904462|Anesthetics|anesthetics|mesh-ancestor
24588844|NCT00904462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24588845|NCT00904462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588846|NCT00904462|Sensory System Agents|sensory system agents|mesh-ancestor
24608199|NCT01965704|Serotonin Agents|serotonin agents|mesh-ancestor
24588856|NCT00904475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24588857|NCT00904475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588858|NCT00904475|Sensory System Agents|sensory system agents|mesh-ancestor
24588859|NCT00904475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24588860|NCT00904475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24604570|NCT00980239|Oxaliplatin|oxaliplatin|mesh-list
25036827|NCT03542851|Pentylenetetrazole|pentylenetetrazole|mesh-list
25036828|NCT03542851|Convulsants|convulsants|mesh-ancestor
25036829|NCT03542851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25036830|NCT03542851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036831|NCT03542851|GABA Antagonists|gaba antagonists|mesh-ancestor
25036832|NCT03542851|GABA Agents|gaba agents|mesh-ancestor
25036833|NCT03542851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25036834|NCT03542851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25036835|NCT03542825|Iron|iron|mesh-list
25036836|NCT03542825|Lactoferrin|lactoferrin|mesh-list
25770656|NCT03557333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25770657|NCT03557333|Dopamine Agonists|dopamine agonists|mesh-ancestor
25770658|NCT03557333|Dopamine Agents|dopamine agents|mesh-ancestor
25770659|NCT03557333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25036848|NCT03542617|Dexamethasone|dexamethasone|mesh-list
25036849|NCT03542617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25036850|NCT03542617|Antiemetics|antiemetics|mesh-ancestor
25036851|NCT03542617|Autonomic Agents|autonomic agents|mesh-ancestor
25036852|NCT03542617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25036853|NCT03542617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25036854|NCT03542617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25036855|NCT03542617|Glucocorticoids|glucocorticoids|mesh-ancestor
25036856|NCT03542617|Hormones|hormones|mesh-ancestor
25036857|NCT03542617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25036858|NCT03542617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25037057|NCT03540979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25037058|NCT03540979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037059|NCT03540979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037060|NCT03540979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25037061|NCT03540979|Hormone Antagonists|hormone antagonists|mesh-ancestor
25037062|NCT03540979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25037063|NCT03540979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037085|NCT03540836|Cortisone|cortisone|mesh-list
25037086|NCT03540836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25037087|NCT03540810|Hydroxychloroquine|hydroxychloroquine|mesh-list
25037226|NCT03539328|Mitosis Modulators|mitosis modulators|mesh-ancestor
25037227|NCT03539328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037228|NCT03539328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25037229|NCT03539328|Antimetabolites|antimetabolites|mesh-ancestor
25037230|NCT03539328|Antiviral Agents|antiviral agents|mesh-ancestor
25037231|NCT03539328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25037232|NCT03539328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037233|NCT03539328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25037234|NCT03539328|Immunologic Factors|immunologic factors|mesh-ancestor
24456995|NCT00332904|Propranolol|propranolol|mesh-list
25037382|NCT03537768|Contraceptive Agents|contraceptive agents|mesh-ancestor
25037383|NCT03537768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25037384|NCT03537768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037385|NCT03537768|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25037386|NCT03537768|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25037569|NCT03536494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25037570|NCT03536494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037571|NCT03536494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037572|NCT03536494|Urological Agents|urological agents|mesh-ancestor
25037573|NCT03536481|Ensartinib|ensartinib|mesh-list
25037574|NCT03536481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25037575|NCT03536481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25037576|NCT03536481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037577|NCT03536481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037578|NCT03536390|Methylphenidate|methylphenidate|mesh-list
25037676|NCT03535792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037677|NCT03535792|Sensory System Agents|sensory system agents|mesh-ancestor
24994448|NCT04138277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24994450|NCT04138277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24994451|NCT04138277|Antiviral Agents|antiviral agents|mesh-ancestor
24994452|NCT04138277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24994453|NCT04138277|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24994454|NCT04138277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24994455|NCT04138277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932379|NCT04080310|Ezetimibe|ezetimibe|mesh-list
24588990|NCT00905073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25037786|NCT03535259|Sorafenib|sorafenib|mesh-list
25037794|NCT03535233|Clobetasol|clobetasol|mesh-list
25037800|NCT03535233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25037801|NCT03535233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25037802|NCT03535233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25037803|NCT03535233|Immunologic Factors|immunologic factors|mesh-ancestor
25037804|NCT03535233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25037805|NCT03535233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037806|NCT03535233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25037807|NCT03535233|Vasodilator Agents|vasodilator agents|mesh-ancestor
25037808|NCT03535220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
25037809|NCT03535220|Protease Inhibitors|protease inhibitors|mesh-list
25037857|NCT03535051|Tacrolimus|tacrolimus|mesh-list
25037858|NCT03535051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25037859|NCT03535051|Immunologic Factors|immunologic factors|mesh-ancestor
25037896|NCT03534713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25037897|NCT03534713|Tubulin Modulators|tubulin modulators|mesh-ancestor
25037898|NCT03534713|Antimitotic Agents|antimitotic agents|mesh-ancestor
25037899|NCT03534713|Mitosis Modulators|mitosis modulators|mesh-ancestor
25037900|NCT03534713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25037901|NCT03534674|Vitamin D|vitamin d|mesh-list
25037902|NCT03534674|Cholecalciferol|cholecalciferol|mesh-list
25038285|NCT05261971|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25038286|NCT05261971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25038287|NCT05261971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25038288|NCT05261971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038289|NCT05261581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25038290|NCT05261581|Analgesics|analgesics|mesh-list
25038291|NCT05261581|Sensory System Agents|sensory system agents|mesh-ancestor
25038411|NCT05175001|Anesthetics|anesthetics|mesh-ancestor
24589086|NCT00905762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24589120|NCT00905918|Micronutrients|micronutrients|mesh-ancestor
25038504|NCT05057130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25038505|NCT05057130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25038506|NCT05055713|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25038507|NCT05055713|Somatostatin|somatostatin|mesh-list
25038513|NCT05055713|Hormones|hormones|mesh-ancestor
25038608|NCT04873583|Glucocorticoids|glucocorticoids|mesh-ancestor
25038609|NCT04873583|Hormones|hormones|mesh-ancestor
25038610|NCT04873583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25038611|NCT04873583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25038612|NCT04873583|Protective Agents|protective agents|mesh-ancestor
25038613|NCT04873583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25038614|NCT04873583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25038615|NCT04831619|Deoxyglucose|deoxyglucose|mesh-list
25038616|NCT04831619|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25038617|NCT04831619|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25038618|NCT04831619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25038774|NCT04530383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25038775|NCT04528563|Ketorolac|ketorolac|mesh-list
24995480|NCT05136677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24995481|NCT05136677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24995482|NCT05136677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24995483|NCT05136677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24995484|NCT05136677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24995485|NCT05136677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24995486|NCT05136677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24995487|NCT05134363|Dexmedetomidine|dexmedetomidine|mesh-list
25039017|NCT04209296|Sensory System Agents|sensory system agents|mesh-ancestor
24995652|NCT04961593|Antifungal Agents|antifungal agents|mesh-ancestor
25039018|NCT04209296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039019|NCT04209296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039020|NCT04209296|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25114745|NCT00238420|Paclitaxel|paclitaxel|mesh-list
25114746|NCT00238420|Trastuzumab|trastuzumab|mesh-list
25114747|NCT00238420|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25114748|NCT00238420|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
25114749|NCT00238420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25114750|NCT00238420|Antibodies|antibodies|mesh-list
25114751|NCT00238420|Immunoglobulins|immunoglobulins|mesh-list
25114752|NCT00238420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25114753|NCT00238420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25114754|NCT00238420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25114755|NCT00238420|Tubulin Modulators|tubulin modulators|mesh-ancestor
25114756|NCT00238420|Antimitotic Agents|antimitotic agents|mesh-ancestor
25039246|NCT03943147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25039247|NCT03943147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25039248|NCT03943147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25039249|NCT03943147|Antitubercular Agents|antitubercular agents|mesh-ancestor
25039250|NCT03943147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25039251|NCT03943147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25039252|NCT03943147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608198|NCT01965704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25039525|NCT03786770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25039526|NCT03786770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25039527|NCT03786770|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25039528|NCT03786770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25039529|NCT03786770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996393|NCT03568708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24996394|NCT03568708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24996396|NCT03568422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24996397|NCT03568422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24996398|NCT03568422|Tubulin Modulators|tubulin modulators|mesh-ancestor
24996399|NCT03568422|Antimitotic Agents|antimitotic agents|mesh-ancestor
24996400|NCT03568422|Mitosis Modulators|mitosis modulators|mesh-ancestor
24996401|NCT03568422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24996403|NCT03566511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24996404|NCT03566511|Vasodilator Agents|vasodilator agents|mesh-ancestor
25039979|NCT03541655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25039980|NCT03541655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25039981|NCT03541655|Analgesics|analgesics|mesh-ancestor
25039982|NCT03541655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25039983|NCT03541655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25039984|NCT03541655|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25039985|NCT03541655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25039986|NCT03541655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25039987|NCT03541655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25039989|NCT03521934|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25039991|NCT03521934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25040186|NCT03320434|Prednisolone acetate|prednisolone acetate|mesh-list
25040187|NCT03320434|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25040188|NCT03320434|Methylprednisolone|methylprednisolone|mesh-list
25040189|NCT03320434|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25040190|NCT03320434|Prednisolone|prednisolone|mesh-list
25040191|NCT03320434|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25040192|NCT03320434|Prednisolone phosphate|prednisolone phosphate|mesh-list
25040193|NCT03320434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25040200|NCT03320434|Hormones|hormones|mesh-ancestor
25040219|NCT03315143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040312|NCT03187834|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25040313|NCT03187834|Renal Agents|renal agents|mesh-ancestor
25040314|NCT03187834|Antimalarials|antimalarials|mesh-ancestor
25040315|NCT03187834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25040316|NCT03187834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25040317|NCT03180684|Imiquimod|imiquimod|mesh-list
25040318|NCT03180684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24591956|NCT00919815|Prednisolone|prednisolone|mesh-list
24591957|NCT00919815|Cyclosporins|cyclosporins|mesh-list
24591958|NCT00919815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591959|NCT00919815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591960|NCT00919815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24591961|NCT00919815|Immunologic Factors|immunologic factors|mesh-ancestor
24591962|NCT00919815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591963|NCT00919815|Antifungal Agents|antifungal agents|mesh-ancestor
24591964|NCT00919815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24589178|NCT00906048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24589179|NCT00906048|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24634448|NCT01133470|Histamine Agents|histamine agents|mesh-ancestor
24634449|NCT01133483|Fexofenadine|fexofenadine|mesh-list
25040412|NCT03094416|Omeprazole|omeprazole|mesh-list
25040420|NCT03094416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25040456|NCT03062540|Antidepressive Agents|antidepressive agents|mesh-ancestor
25040457|NCT03062540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25040458|NCT03062540|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25040459|NCT03062540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040460|NCT03062540|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25040461|NCT03062540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25040462|NCT03062540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25040463|NCT03062540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25040464|NCT03060980|Empagliflozin|empagliflozin|mesh-list
25710712|NCT02291016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25040465|NCT03060980|Glimepiride|glimepiride|mesh-list
25040466|NCT03060980|Exenatide|exenatide|mesh-list
25040467|NCT03060980|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25040468|NCT03060980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25040469|NCT03060980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25040470|NCT03060980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040560|NCT03009019|Sensory System Agents|sensory system agents|mesh-ancestor
25040561|NCT03009019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25040562|NCT03009019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25040563|NCT03009019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25040565|NCT03009019|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25040566|NCT03009019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25040567|NCT03009019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25040597|NCT02997657|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24853495|NCT02268565|Sensory System Agents|sensory system agents|mesh-ancestor
24853496|NCT02268565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24853497|NCT02268565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607332|NCT04764942|Pomalidomide|pomalidomide|mesh-list
24607333|NCT04764942|Ichthammol|ichthammol|mesh-list
24607334|NCT04764942|BB 1101|bb 1101|mesh-list
24607335|NCT04764942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24607336|NCT04764942|Antiemetics|antiemetics|mesh-ancestor
24607337|NCT04764942|Autonomic Agents|autonomic agents|mesh-ancestor
24607338|NCT04764942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24607339|NCT04764942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671294|NCT01324596|Mitosis Modulators|mitosis modulators|mesh-ancestor
24671295|NCT01324596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24671296|NCT01324596|Glucocorticoids|glucocorticoids|mesh-ancestor
24481092|NCT00433277|Cyclosporine|cyclosporine|mesh-list
24671298|NCT01324596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24853545|NCT02268825|Pembrolizumab|pembrolizumab|mesh-list
24853546|NCT02268825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24853547|NCT02268825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24853548|NCT02268890|Bortezomib|bortezomib|mesh-list
24853549|NCT02268890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24853550|NCT02268903|Furosemide|furosemide|mesh-list
24853551|NCT02268903|Diuretics|diuretics|mesh-list
24853554|NCT02268903|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24853555|NCT02268903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24853556|NCT02268903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853557|NCT02268968|Lidocaine|lidocaine|mesh-list
24853558|NCT02268968|Anesthetics, Local|anesthetics, local|mesh-ancestor
24853559|NCT02268968|Anesthetics|anesthetics|mesh-ancestor
24456361|NCT00330993|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24607773|NCT03709446|Immunologic Factors|immunologic factors|mesh-ancestor
24607774|NCT03709446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607775|NCT03675139|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24607977|NCT03077698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24607978|NCT03077698|Interferon Inducers|interferon inducers|mesh-ancestor
24607979|NCT03077698|Immunologic Factors|immunologic factors|mesh-ancestor
24671327|NCT01324843|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24608010|NCT02874742|Growth Substances|growth substances|mesh-ancestor
24608011|NCT02874742|Growth Inhibitors|growth inhibitors|mesh-ancestor
24446790|NCT00305903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24608012|NCT02852655|Pembrolizumab|pembrolizumab|mesh-list
24608013|NCT02852655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24608014|NCT02852655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608015|NCT02644525|Imatinib Mesylate|imatinib mesylate|mesh-list
24608194|NCT01965704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608195|NCT01965704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24608404|NCT00992082|Anesthetics, Local|anesthetics, local|mesh-ancestor
24608405|NCT00992082|Anesthetics|anesthetics|mesh-ancestor
24608406|NCT00992082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24853637|NCT02269319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24853638|NCT02269319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24853639|NCT02269319|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24853640|NCT02269319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24853641|NCT02269319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608407|NCT00992082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24608408|NCT00992082|Adrenergic Agents|adrenergic agents|mesh-ancestor
24608409|NCT00992082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25710713|NCT02291016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608413|NCT00992082|Autonomic Agents|autonomic agents|mesh-ancestor
24608509|NCT00992355|Protease Inhibitors|protease inhibitors|mesh-ancestor
24608510|NCT00992355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608511|NCT00992355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608513|NCT00992355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24608545|NCT00992472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24608546|NCT00992472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608547|NCT00992524|Misoprostol|misoprostol|mesh-list
24608548|NCT00992524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24608549|NCT00992524|Abortifacient Agents|abortifacient agents|mesh-ancestor
24608550|NCT00992524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24608551|NCT00992524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608552|NCT00992524|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24608623|NCT00992797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608737|NCT00993343|Methotrexate|methotrexate|mesh-list
24608739|NCT00993343|Cyclosporins|cyclosporins|mesh-list
24608740|NCT00993343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24608741|NCT00993343|Abortifacient Agents|abortifacient agents|mesh-ancestor
24608742|NCT00993343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24608743|NCT00993343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608744|NCT00993343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24608745|NCT00993343|Antimetabolites|antimetabolites|mesh-ancestor
24608746|NCT00993343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482031|NCT00437684|Ribavirin|ribavirin|mesh-list
24608747|NCT00993343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608748|NCT00993343|Dermatologic Agents|dermatologic agents|mesh-ancestor
24608749|NCT00993343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608750|NCT00993343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24608751|NCT00993343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24608752|NCT00993343|Immunologic Factors|immunologic factors|mesh-ancestor
24608753|NCT00993343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24608754|NCT00993343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24608755|NCT00993343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24853678|NCT02269514|Autonomic Agents|autonomic agents|mesh-ancestor
24608813|NCT00993746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24608814|NCT00993746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24608900|NCT00994344|Darunavir|darunavir|mesh-list
24608901|NCT00994344|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24608902|NCT00994344|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24608903|NCT00994344|Protease Inhibitors|protease inhibitors|mesh-ancestor
24608904|NCT00994344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24608905|NCT00994344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608906|NCT00994344|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24608907|NCT00994344|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24608908|NCT00994344|Antiviral Agents|antiviral agents|mesh-ancestor
24608909|NCT00994344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24608910|NCT00994344|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24608911|NCT00994344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24608912|NCT00994383|Morphine|morphine|mesh-list
24608913|NCT00994383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24608914|NCT00994383|Narcotics|narcotics|mesh-ancestor
24608916|NCT00994383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608917|NCT00994383|Analgesics|analgesics|mesh-ancestor
24608918|NCT00994383|Sensory System Agents|sensory system agents|mesh-ancestor
24608919|NCT00994383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24608920|NCT00994396|Vitamin D|vitamin d|mesh-list
24608921|NCT00994396|Cholecalciferol|cholecalciferol|mesh-list
24608922|NCT00994396|Vitamins|vitamins|mesh-ancestor
24608949|NCT00994526|Protective Agents|protective agents|mesh-ancestor
24608950|NCT00994539|Morphine|morphine|mesh-list
24608951|NCT00994539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24608952|NCT00994539|Narcotics|narcotics|mesh-ancestor
24608953|NCT00994539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24608954|NCT00994539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608955|NCT00994539|Analgesics|analgesics|mesh-ancestor
24671363|NCT01325194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24608956|NCT00994539|Sensory System Agents|sensory system agents|mesh-ancestor
24608957|NCT00994539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24609058|NCT00994916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609059|NCT00994942|Morphine|morphine|mesh-list
24609060|NCT00994942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24609061|NCT00994942|Narcotics|narcotics|mesh-ancestor
24609062|NCT00994942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24609063|NCT00994942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609204|NCT00995332|Antimanic Agents|antimanic agents|mesh-ancestor
24609205|NCT00995332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24609206|NCT00995332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24609207|NCT00995332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24609208|NCT00995397|Chlorpheniramine|chlorpheniramine|mesh-list
24609209|NCT00995397|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
24609210|NCT00995397|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24609211|NCT00995397|Histamine Antagonists|histamine antagonists|mesh-ancestor
24609212|NCT00995397|Histamine Agents|histamine agents|mesh-ancestor
24609213|NCT00995397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24609215|NCT00995397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609369|NCT00996190|Respiratory System Agents|respiratory system agents|mesh-ancestor
24609370|NCT00996190|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24609371|NCT00996190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24609372|NCT00996190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24609401|NCT00996424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609402|NCT00996424|Antidotes|antidotes|mesh-ancestor
24609403|NCT00996463|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
24482963|NCT00441181|Travoprost|travoprost|mesh-list
24609404|NCT00996463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24609416|NCT00996515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24609417|NCT00996515|Antimetabolites|antimetabolites|mesh-ancestor
24609418|NCT00996567|Cetuximab|cetuximab|mesh-list
24609419|NCT00996567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24609420|NCT00996567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609421|NCT00996684|Plasminogen|plasminogen|mesh-list
24609422|NCT00996684|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24609423|NCT00996684|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24609424|NCT00996684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609425|NCT00996697|Budesonide|budesonide|mesh-list
24609426|NCT00996697|Formoterol Fumarate|formoterol fumarate|mesh-list
24609437|NCT00996697|Hormones|hormones|mesh-ancestor
24609439|NCT00996697|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24609440|NCT00996697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24609441|NCT00996697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24609442|NCT00996697|Adrenergic Agents|adrenergic agents|mesh-ancestor
24609443|NCT00996697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24609444|NCT00996697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609445|NCT00996697|Parasympatholytics|parasympatholytics|mesh-ancestor
24609548|NCT00997191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609549|NCT00997191|Growth Inhibitors|growth inhibitors|mesh-ancestor
24609550|NCT00997191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24609573|NCT00997347|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24609574|NCT00997347|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24609575|NCT00997347|Hormone Antagonists|hormone antagonists|mesh-ancestor
24609576|NCT00997347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24609577|NCT00997347|Luteolytic Agents|luteolytic agents|mesh-ancestor
24609578|NCT00997347|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24609579|NCT00997347|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24609748|NCT00997997|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24609749|NCT00997997|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24609751|NCT00998036|Cisplatin|cisplatin|mesh-list
24609752|NCT00998036|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24609753|NCT00998036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609754|NCT00998036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24609829|NCT00998439|Paclitaxel|paclitaxel|mesh-list
24609936|NCT00999180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609937|NCT00999180|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24609938|NCT00999180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24609940|NCT00999206|Immunologic Factors|immunologic factors|mesh-ancestor
24609941|NCT00999206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609942|NCT00999219|Zolpidem|zolpidem|mesh-list
24609943|NCT00999219|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24609944|NCT00999219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24609945|NCT00999219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24609946|NCT00999219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853762|NCT02270281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24853764|NCT02270281|Sensory System Agents|sensory system agents|mesh-ancestor
24610005|NCT00999440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24610006|NCT00999440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610007|NCT00999440|Analgesics|analgesics|mesh-ancestor
24610008|NCT00999440|Sensory System Agents|sensory system agents|mesh-ancestor
24610009|NCT00999440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24610010|NCT00999440|Antitussive Agents|antitussive agents|mesh-ancestor
24610011|NCT00999440|Respiratory System Agents|respiratory system agents|mesh-ancestor
24610012|NCT00999479|Ferrous fumarate|ferrous fumarate|mesh-list
24610013|NCT00999479|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24610014|NCT00999479|Norethindrone|norethindrone|mesh-list
24610015|NCT00999479|Norethindrone Acetate|norethindrone acetate|mesh-list
24610016|NCT00999479|Estradiol|estradiol|mesh-list
24610017|NCT00999479|Estrogens|estrogens|mesh-ancestor
24610018|NCT00999479|Hormones|hormones|mesh-ancestor
24610020|NCT00999479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610063|NCT00999739|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24610064|NCT00999739|Immunologic Factors|immunologic factors|mesh-ancestor
24405236|NCT00166127|Simendan|simendan|mesh-list
24456558|NCT00331708|Pyrimethamine|pyrimethamine|mesh-list
24456559|NCT00331708|Sulfadoxine|sulfadoxine|mesh-list
24610067|NCT00999752|Nebivolol|nebivolol|mesh-list
24610086|NCT00999791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24610087|NCT00999791|Growth Substances|growth substances|mesh-ancestor
24610096|NCT00999791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24610097|NCT00999791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24610098|NCT00999791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610099|NCT00999791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610194|NCT01000545|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
24610195|NCT01000545|Anticoagulants|anticoagulants|mesh-ancestor
24610196|NCT01000545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24610197|NCT01000545|Antimetabolites|antimetabolites|mesh-ancestor
24610199|NCT01000545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24610255|NCT01000831|Immunologic Factors|immunologic factors|mesh-ancestor
24610256|NCT01000831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610257|NCT01000857|Paroxetine|paroxetine|mesh-list
24610258|NCT01000857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24610279|NCT01000896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610281|NCT01001013|Pioglitazone|pioglitazone|mesh-list
24610282|NCT01001013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24610283|NCT01001013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610284|NCT01001130|Fluticasone|fluticasone|mesh-list
24610285|NCT01001130|Xhance|xhance|mesh-list
24610286|NCT01001130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24610287|NCT01001130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25710714|NCT02291016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25710715|NCT02291016|Respiratory System Agents|respiratory system agents|mesh-ancestor
25710716|NCT02291016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25710717|NCT02291016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25710718|NCT02291016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25710719|NCT02291016|Adrenergic Agents|adrenergic agents|mesh-ancestor
25710720|NCT02291016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24812565|NCT02053558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24671527|NCT01326442|Vitamin D|vitamin d|mesh-list
25710721|NCT02291016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710722|NCT02291029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24671528|NCT01326442|Vitamins|vitamins|mesh-ancestor
24671529|NCT01326442|Micronutrients|micronutrients|mesh-ancestor
24671530|NCT01326442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671552|NCT01326559|Docetaxel|docetaxel|mesh-list
24671553|NCT01326559|Cetuximab|cetuximab|mesh-list
24671554|NCT01326559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24671555|NCT01326559|Tubulin Modulators|tubulin modulators|mesh-ancestor
24671556|NCT01326559|Antimitotic Agents|antimitotic agents|mesh-ancestor
24637377|NCT01149980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24637378|NCT01149980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24671585|NCT01326611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24671587|NCT01326650|Ergocalciferols|ergocalciferols|mesh-list
24671588|NCT01326650|Cholecalciferol|cholecalciferol|mesh-list
24671589|NCT01326650|Vitamins|vitamins|mesh-list
24671590|NCT01326650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24671591|NCT01326650|Micronutrients|micronutrients|mesh-ancestor
24671592|NCT01326650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671593|NCT01326650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24671594|NCT01326650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24671595|NCT01326754|Artesunate|artesunate|mesh-list
24671596|NCT01326754|Lumefantrine|lumefantrine|mesh-list
24671597|NCT01326754|Artemether|artemether|mesh-list
24671598|NCT01326754|Piperaquine|piperaquine|mesh-list
24671599|NCT01326754|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24671600|NCT01326754|Amodiaquine|amodiaquine|mesh-list
24671601|NCT01326754|Artenimol|artenimol|mesh-list
24671602|NCT01326754|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
24671604|NCT01326754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24671605|NCT01326754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24671606|NCT01326754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24455643|NCT00328380|Rifaximin|rifaximin|mesh-list
24671618|NCT01326767|Mitosis Modulators|mitosis modulators|mesh-ancestor
24671623|NCT01326858|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24671624|NCT01326858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24671625|NCT01326858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24671626|NCT01326858|Analgesics|analgesics|mesh-ancestor
24671627|NCT01326858|Sensory System Agents|sensory system agents|mesh-ancestor
24671628|NCT01326858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24671629|NCT01326858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671630|NCT01326858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24671631|NCT01326858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24671632|NCT01326858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24671633|NCT01326858|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24671634|NCT01326858|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24671635|NCT01326858|Histamine Antagonists|histamine antagonists|mesh-ancestor
24671636|NCT01326858|Histamine Agents|histamine agents|mesh-ancestor
24671637|NCT01326858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24671638|NCT01326858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853828|NCT02270437|Autonomic Agents|autonomic agents|mesh-ancestor
24853829|NCT02270437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24853830|NCT02270437|Respiratory System Agents|respiratory system agents|mesh-ancestor
24853831|NCT02270437|Mydriatics|mydriatics|mesh-ancestor
24671774|NCT01327521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24671775|NCT01327521|Alkylating Agents|alkylating agents|mesh-ancestor
24671776|NCT01327521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24671777|NCT01327534|Clopidogrel|clopidogrel|mesh-list
24671778|NCT01327534|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24671779|NCT01327534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24671780|NCT01327534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24671781|NCT01327534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24671782|NCT01327534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25710723|NCT02291029|Immunologic Factors|immunologic factors|mesh-ancestor
25710724|NCT02291029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710725|NCT02291133|Bleomycin|bleomycin|mesh-list
25710726|NCT02291133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25710727|NCT02291133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710728|NCT02291289|Bevacizumab|bevacizumab|mesh-list
24671783|NCT01327534|Purinergic Agents|purinergic agents|mesh-ancestor
25710729|NCT02291289|Trastuzumab|trastuzumab|mesh-list
25710730|NCT02291289|Cetuximab|cetuximab|mesh-list
24671784|NCT01327534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24671785|NCT01327534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671786|NCT01327534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671788|NCT01327625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24671789|NCT01327625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24671790|NCT01327729|Interferons|interferons|mesh-list
24853868|NCT02270788|Crenolanib|crenolanib|mesh-list
24456618|NCT00331825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456619|NCT00331825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456620|NCT00331825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24456621|NCT00331825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24456622|NCT00331825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24456623|NCT00331825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24456624|NCT00331825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24456625|NCT00331825|Dopamine Agents|dopamine agents|mesh-ancestor
24456626|NCT00331825|Antiemetics|antiemetics|mesh-ancestor
24671929|NCT01328470|Cilostazol|cilostazol|mesh-list
24672029|NCT01329289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672030|NCT01329289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24672031|NCT01329289|Glucocorticoids|glucocorticoids|mesh-ancestor
24672032|NCT01329289|Hormones|hormones|mesh-ancestor
24672033|NCT01329289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24672034|NCT01329289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24672035|NCT01329289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672036|NCT01329289|Protease Inhibitors|protease inhibitors|mesh-ancestor
24672037|NCT01329289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672038|NCT01329289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672039|NCT01329367|Antioxidants|antioxidants|mesh-list
24672040|NCT01329367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672041|NCT01329367|Protective Agents|protective agents|mesh-ancestor
24672042|NCT01329367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672043|NCT01329406|Milnacipran|milnacipran|mesh-list
24672044|NCT01329406|Levomilnacipran|levomilnacipran|mesh-list
24672132|NCT01329783|Maraviroc|maraviroc|mesh-list
24672189|NCT01330524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672190|NCT01330524|Growth Inhibitors|growth inhibitors|mesh-ancestor
24672191|NCT01330524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24672205|NCT01330563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672206|NCT01330563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24672209|NCT01330615|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
24672210|NCT01330615|Anesthetics, Local|anesthetics, local|mesh-ancestor
24672235|NCT01330693|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24672236|NCT01330693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24672237|NCT01330693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24672238|NCT01330693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24672239|NCT01330693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672240|NCT01330693|Adrenergic Agents|adrenergic agents|mesh-ancestor
24456296|NCT00330824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672241|NCT01330693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24672242|NCT01330693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672243|NCT01330706|Polihexanide|polihexanide|mesh-list
24610470|NCT01002534|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24610471|NCT01002534|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24610472|NCT01002534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610473|NCT01002534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610478|NCT01002690|Analgesics|analgesics|mesh-ancestor
25710731|NCT02291289|Pertuzumab|pertuzumab|mesh-list
25710732|NCT02291289|Capecitabine|capecitabine|mesh-list
25710733|NCT02291289|Fluorouracil|fluorouracil|mesh-list
25710734|NCT02291289|Atezolizumab|atezolizumab|mesh-list
25710735|NCT02291289|Vemurafenib|vemurafenib|mesh-list
25710736|NCT02291289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25710737|NCT02291289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710738|NCT02291289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25710739|NCT02291289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25710740|NCT02291289|Growth Substances|growth substances|mesh-ancestor
25710741|NCT02291289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456670|NCT00331955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456671|NCT00331955|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24672269|NCT01331135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24672358|NCT01331707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672359|NCT01331707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24672360|NCT01331707|Immunologic Factors|immunologic factors|mesh-ancestor
24672361|NCT01331707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672363|NCT01331785|Sympathomimetics|sympathomimetics|mesh-ancestor
24672364|NCT01331785|Autonomic Agents|autonomic agents|mesh-ancestor
24672365|NCT01331785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24672366|NCT01331785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672367|NCT01331785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24672368|NCT01331785|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24672369|NCT01331785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24672370|NCT01331785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24672412|NCT01331941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672413|NCT01331941|Growth Inhibitors|growth inhibitors|mesh-ancestor
24672415|NCT01331967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24672416|NCT01331967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672417|NCT01331993|Naproxen|naproxen|mesh-list
24672418|NCT01331993|Esomeprazole|esomeprazole|mesh-list
24672419|NCT01331993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24672420|NCT01331993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24672421|NCT01331993|Analgesics|analgesics|mesh-ancestor
24672422|NCT01331993|Sensory System Agents|sensory system agents|mesh-ancestor
24672423|NCT01331993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24672424|NCT01331993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672425|NCT01331993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24672434|NCT01332097|Prednisone|prednisone|mesh-list
24853937|NCT02271126|Heparin|heparin|mesh-list
24672503|NCT01332409|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24672504|NCT01332409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24672505|NCT01332409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24672506|NCT01332409|Autonomic Agents|autonomic agents|mesh-ancestor
24672507|NCT01332409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24672508|NCT01332409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672509|NCT01332409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24672510|NCT01332409|Respiratory System Agents|respiratory system agents|mesh-ancestor
24672511|NCT01332409|Dermatologic Agents|dermatologic agents|mesh-ancestor
24672512|NCT01332409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24672572|NCT01332604|Capecitabine|capecitabine|mesh-list
24672573|NCT01332604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24672574|NCT01332604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710742|NCT02291289|Growth Inhibitors|growth inhibitors|mesh-ancestor
25710743|NCT02291289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25710744|NCT02291289|Antimetabolites|antimetabolites|mesh-ancestor
25710745|NCT02291289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710746|NCT02291289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25710747|NCT02291289|Immunologic Factors|immunologic factors|mesh-ancestor
25710749|NCT02291289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710750|NCT02291419|Aspirin|aspirin|mesh-list
24672575|NCT01332604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24672576|NCT01332604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24672578|NCT01332604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853939|NCT02271126|Anticoagulants|anticoagulants|mesh-ancestor
24853940|NCT02271126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24853941|NCT02271126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24672579|NCT01332604|Growth Inhibitors|growth inhibitors|mesh-ancestor
24672580|NCT01332604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24672581|NCT01332604|Antimetabolites|antimetabolites|mesh-ancestor
24672582|NCT01332604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672583|NCT01332617|Zoledronic Acid|zoledronic acid|mesh-list
24672584|NCT01332617|Methylprednisolone|methylprednisolone|mesh-list
24672585|NCT01332617|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24456638|NCT00331838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24672586|NCT01332617|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24672587|NCT01332617|Prednisolone|prednisolone|mesh-list
24672588|NCT01332617|Prednisolone acetate|prednisolone acetate|mesh-list
24672589|NCT01332617|Diclofenac|diclofenac|mesh-list
24672590|NCT01332617|Bortezomib|bortezomib|mesh-list
24672591|NCT01332617|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24672592|NCT01332617|Simvastatin|simvastatin|mesh-list
24672593|NCT01332617|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24672594|NCT01332617|Prednisolone phosphate|prednisolone phosphate|mesh-list
24672621|NCT01332617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24672623|NCT01332617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24672624|NCT01332734|Magnesium Sulfate|magnesium sulfate|mesh-list
24672625|NCT01332734|Analgesics|analgesics|mesh-ancestor
24672629|NCT01332734|Anesthetics|anesthetics|mesh-ancestor
24672640|NCT01332747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24672688|NCT01333124|Immunologic Factors|immunologic factors|mesh-ancestor
24672689|NCT01333124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672690|NCT01333137|Gemcitabine|gemcitabine|mesh-list
24672691|NCT01333137|Carboplatin|carboplatin|mesh-list
24672692|NCT01333137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672693|NCT01333137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24672694|NCT01333137|Antimetabolites|antimetabolites|mesh-ancestor
24672695|NCT01333137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672696|NCT01333137|Antiviral Agents|antiviral agents|mesh-ancestor
24672697|NCT01333137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24672698|NCT01333137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672699|NCT01333137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24672700|NCT01333137|Immunologic Factors|immunologic factors|mesh-ancestor
24672701|NCT01333137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672702|NCT01333150|Propranolol|propranolol|mesh-list
24672703|NCT01333150|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24672704|NCT01333150|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24672705|NCT01333150|Adrenergic Agents|adrenergic agents|mesh-ancestor
24672706|NCT01333150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24672715|NCT01333267|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
24672719|NCT01333267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24672720|NCT01333332|Capecitabine|capecitabine|mesh-list
24672721|NCT01333332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24672722|NCT01333332|Antimetabolites|antimetabolites|mesh-ancestor
24672723|NCT01333332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672724|NCT01333332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672725|NCT01333358|Alemtuzumab|alemtuzumab|mesh-list
24672726|NCT01333358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24672738|NCT01333410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24672740|NCT01333423|Doxorubicin|doxorubicin|mesh-list
24672741|NCT01333423|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24672742|NCT01333423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24672743|NCT01333423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672744|NCT01333423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24672745|NCT01333423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25710751|NCT02291419|Ticagrelor|ticagrelor|mesh-list
25710752|NCT02291419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25710753|NCT02291419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25710754|NCT02291419|Analgesics|analgesics|mesh-ancestor
25710755|NCT02291419|Sensory System Agents|sensory system agents|mesh-ancestor
25710756|NCT02291419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24672746|NCT01333423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672747|NCT01333423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672748|NCT01333423|Antiviral Agents|antiviral agents|mesh-ancestor
24672749|NCT01333423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24672758|NCT01333514|Insulin, Long-Acting|insulin, long-acting|mesh-list
24672759|NCT01333514|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24672760|NCT01333514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24853946|NCT02271165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24853947|NCT02271165|Antibodies|antibodies|mesh-list
24853948|NCT02271165|Immunologic Factors|immunologic factors|mesh-ancestor
24853949|NCT02271165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853950|NCT02271191|Nicardipine|nicardipine|mesh-list
24853951|NCT02271191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24853952|NCT02271191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24853953|NCT02271191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24853954|NCT02271191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455813|NCT00329134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24455814|NCT00329134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24672783|NCT01333774|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24672784|NCT01333774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637556|NCT01151384|Antimitotic Agents|antimitotic agents|mesh-ancestor
24672792|NCT01333800|Hormones|hormones|mesh-ancestor
24672818|NCT01333891|Oxymetazoline|oxymetazoline|mesh-list
24672819|NCT01333891|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24672820|NCT01333891|Mydriatics|mydriatics|mesh-ancestor
24672821|NCT01333891|Autonomic Agents|autonomic agents|mesh-ancestor
24672822|NCT01333891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24672823|NCT01333891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672824|NCT01333891|Sympathomimetics|sympathomimetics|mesh-ancestor
24672825|NCT01333891|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24672826|NCT01333891|Nasal Decongestants|nasal decongestants|mesh-ancestor
24672827|NCT01333891|Respiratory System Agents|respiratory system agents|mesh-ancestor
24672828|NCT01333891|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24672829|NCT01333891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24672830|NCT01333891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24672831|NCT01333891|Adrenergic Agents|adrenergic agents|mesh-ancestor
24672832|NCT01333891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24672833|NCT01333891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672834|NCT01333891|Protective Agents|protective agents|mesh-ancestor
24672835|NCT01333891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24672836|NCT01333891|Vasodilator Agents|vasodilator agents|mesh-ancestor
24672837|NCT01333891|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24672839|NCT01333917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24672911|NCT01334333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672920|NCT01334502|Prednisone|prednisone|mesh-list
24672921|NCT01334502|Cyclophosphamide|cyclophosphamide|mesh-list
24672922|NCT01334502|Rituximab|rituximab|mesh-list
24672923|NCT01334502|Doxorubicin|doxorubicin|mesh-list
24672924|NCT01334502|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24672925|NCT01334502|Vincristine|vincristine|mesh-list
24610479|NCT01002690|Sensory System Agents|sensory system agents|mesh-ancestor
24610480|NCT01002690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24610481|NCT01002690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672926|NCT01334502|Everolimus|everolimus|mesh-list
24672927|NCT01334502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24672950|NCT01334567|Tenofovir|tenofovir|mesh-list
24672951|NCT01334567|Antiviral Agents|antiviral agents|mesh-ancestor
24672952|NCT01334567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24672953|NCT01334567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24853971|NCT02271295|Anticoagulants|anticoagulants|mesh-ancestor
24853972|NCT02271295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24673196|NCT01336062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673197|NCT01336166|Vaccines|vaccines|mesh-list
24673198|NCT01336166|Immunologic Factors|immunologic factors|mesh-ancestor
25710757|NCT02291419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710758|NCT02291419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25710759|NCT02291419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25710760|NCT02291419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24673199|NCT01336166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673200|NCT01336192|Gemcitabine|gemcitabine|mesh-list
24673201|NCT01336192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24673282|NCT01336595|Micronutrients|micronutrients|mesh-ancestor
24673283|NCT01336595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673284|NCT01336595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24673285|NCT01336595|Glucocorticoids|glucocorticoids|mesh-ancestor
24673286|NCT01336595|Hormones|hormones|mesh-ancestor
24673287|NCT01336595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24673288|NCT01336621|Ezogabine|ezogabine|mesh-list
24673289|NCT01336621|Anticonvulsants|anticonvulsants|mesh-ancestor
24673290|NCT01336621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24673291|NCT01336621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673363|NCT01337401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673364|NCT01337401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673365|NCT01337427|Interferons|interferons|mesh-list
24673366|NCT01337427|Interferon-beta|interferon-beta|mesh-list
24673367|NCT01337427|Interferon beta-1a|interferon beta-1a|mesh-list
24673368|NCT01337427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673384|NCT01337440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673385|NCT01337440|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24673386|NCT01337440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24673387|NCT01337466|Fialuridine|fialuridine|mesh-list
24673388|NCT01337466|Antiviral Agents|antiviral agents|mesh-ancestor
24673424|NCT01337804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24673425|NCT01337804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24673426|NCT01337804|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24673427|NCT01337804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673428|NCT01337804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673438|NCT01338090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24673471|NCT01338311|Tocolytic Agents|tocolytic agents|mesh-ancestor
24673472|NCT01338311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24673498|NCT01338441|Erythromycin stearate|erythromycin stearate|mesh-list
24673712|NCT01339741|Cholecalciferol|cholecalciferol|mesh-list
24673799|NCT01340417|Protective Agents|protective agents|mesh-ancestor
24673800|NCT01340417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673801|NCT01340417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24673802|NCT01340456|Rifampin|rifampin|mesh-list
24673803|NCT01340456|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24673804|NCT01340456|Antitubercular Agents|antitubercular agents|mesh-ancestor
24673839|NCT01340599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673927|NCT01341184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673928|NCT01341184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673929|NCT01341184|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24673930|NCT01341184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24673931|NCT01341184|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24673932|NCT01341184|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24673933|NCT01341184|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24673934|NCT01341184|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24457977|NCT00335985|Immunoglobulins|immunoglobulins|mesh-list
24673935|NCT01341262|Zoledronic Acid|zoledronic acid|mesh-list
24673936|NCT01341262|Thalidomide|thalidomide|mesh-list
24673937|NCT01341262|Dexamethasone|dexamethasone|mesh-list
24673938|NCT01341262|Cyclophosphamide|cyclophosphamide|mesh-list
24673940|NCT01341262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24673941|NCT01341262|Immunologic Factors|immunologic factors|mesh-ancestor
24673942|NCT01341262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674010|NCT01341405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674020|NCT01341496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674021|NCT01341496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24674022|NCT01341496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24674023|NCT01341496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24674024|NCT01341496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24674025|NCT01341496|Analgesics|analgesics|mesh-ancestor
24674202|NCT01342328|Dexmedetomidine|dexmedetomidine|mesh-list
24674203|NCT01342328|Propofol|propofol|mesh-list
24674204|NCT01342328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24674205|NCT01342328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24674206|NCT01342328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674207|NCT01342328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24674208|NCT01342328|Anesthetics, General|anesthetics, general|mesh-ancestor
24674209|NCT01342328|Anesthetics|anesthetics|mesh-ancestor
24674210|NCT01342328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24674211|NCT01342328|Analgesics|analgesics|mesh-ancestor
24674212|NCT01342328|Sensory System Agents|sensory system agents|mesh-ancestor
24674213|NCT01342328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24674216|NCT01342328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24854053|NCT02271464|Growth Substances|growth substances|mesh-ancestor
24854054|NCT02271464|Growth Inhibitors|growth inhibitors|mesh-ancestor
24456772|NCT00332228|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24674400|NCT05249751|Natriuretic Agents|natriuretic agents|mesh-ancestor
24513479|NCT00582582|Vitamins|vitamins|mesh-ancestor
24674401|NCT05249751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674404|NCT05249712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24674405|NCT05249712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854055|NCT02271464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24546806|NCT00700492|Progesterone|progesterone|mesh-list
24674537|NCT05119101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24674538|NCT05119101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674540|NCT05119101|Sensory System Agents|sensory system agents|mesh-ancestor
24674541|NCT05119101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24674542|NCT05119101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674579|NCT05073250|Rituximab|rituximab|mesh-list
24674684|NCT04832087|Protective Agents|protective agents|mesh-ancestor
24674685|NCT04832087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674686|NCT04761848|Cilostazol|cilostazol|mesh-list
24674687|NCT04761848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24674688|NCT04761848|Autonomic Agents|autonomic agents|mesh-ancestor
24674689|NCT04761848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24674690|NCT04761848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674691|NCT04761848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24674692|NCT04761848|Respiratory System Agents|respiratory system agents|mesh-ancestor
24674759|NCT04541108|Paclitaxel|paclitaxel|mesh-list
24674760|NCT04541108|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24674761|NCT04541108|Carboplatin|carboplatin|mesh-list
24674762|NCT04541108|Pembrolizumab|pembrolizumab|mesh-list
24674763|NCT04541108|Fluorouracil|fluorouracil|mesh-list
24674765|NCT04541108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24674878|NCT04091022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24674879|NCT04091022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24674880|NCT04091022|Analgesics|analgesics|mesh-ancestor
24674881|NCT04091022|Sensory System Agents|sensory system agents|mesh-ancestor
24674882|NCT04091022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24674883|NCT04091022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674884|NCT04091022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24674885|NCT04091022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24674886|NCT04091022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24674887|NCT04091022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674910|NCT03951649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24674911|NCT03875690|Methylprednisolone|methylprednisolone|mesh-list
24674912|NCT03875690|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24674913|NCT03875690|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24674914|NCT03875690|Prednisolone|prednisolone|mesh-list
24674915|NCT03875690|Prednisolone acetate|prednisolone acetate|mesh-list
24674916|NCT03875690|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24674917|NCT03875690|Prednisolone phosphate|prednisolone phosphate|mesh-list
24676803|NCT01352559|Adrenergic Agents|adrenergic agents|mesh-ancestor
24674919|NCT03875690|Antiemetics|antiemetics|mesh-ancestor
24674920|NCT03875690|Autonomic Agents|autonomic agents|mesh-ancestor
25710761|NCT02291419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25710762|NCT02291419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710763|NCT02291419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25710764|NCT02291419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25710765|NCT02291419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710766|NCT02291419|Antipyretics|antipyretics|mesh-ancestor
25710767|NCT02291419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24674921|NCT03875690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24674922|NCT03875690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674923|NCT03875690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24674924|NCT03875690|Glucocorticoids|glucocorticoids|mesh-ancestor
24674925|NCT03875690|Hormones|hormones|mesh-ancestor
24674927|NCT03875690|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24674959|NCT03740958|Antithrombins|antithrombins|mesh-ancestor
24674960|NCT03740958|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24674961|NCT03740958|Protease Inhibitors|protease inhibitors|mesh-ancestor
24675036|NCT03599791|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24675037|NCT03599791|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24675038|NCT03599791|Histamine Antagonists|histamine antagonists|mesh-ancestor
24675039|NCT03599791|Histamine Agents|histamine agents|mesh-ancestor
24675141|NCT03004131|Respiratory System Agents|respiratory system agents|mesh-ancestor
24675142|NCT03004131|Dermatologic Agents|dermatologic agents|mesh-ancestor
24675143|NCT03004131|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24675144|NCT03004131|Antipruritics|antipruritics|mesh-ancestor
24675145|NCT03004131|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24675146|NCT03004131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24675147|NCT03004131|Histamine Antagonists|histamine antagonists|mesh-ancestor
24854099|NCT02271958|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24675227|NCT02681549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24675228|NCT02681549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24675229|NCT02681549|Growth Substances|growth substances|mesh-ancestor
24675230|NCT02681549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675231|NCT02681549|Growth Inhibitors|growth inhibitors|mesh-ancestor
24675233|NCT02607319|Anticoagulants|anticoagulants|mesh-ancestor
24675234|NCT02562599|Raltitrexed|raltitrexed|mesh-list
24675235|NCT02562599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24675393|NCT00423579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675394|NCT00394355|Fluticasone|fluticasone|mesh-list
24812581|NCT02053675|Vasopressins|vasopressins|mesh-list
24812582|NCT02053675|Arginine Vasopressin|arginine vasopressin|mesh-list
24812583|NCT02053675|Hemostatics|hemostatics|mesh-ancestor
24812584|NCT02053675|Coagulants|coagulants|mesh-ancestor
24812585|NCT02053675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24675664|NCT01344395|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24610734|NCT01004731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24610735|NCT01004731|Antimetabolites|antimetabolites|mesh-ancestor
24610736|NCT01004731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610737|NCT01004731|Antiviral Agents|antiviral agents|mesh-ancestor
24610738|NCT01004731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24610739|NCT01004731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610740|NCT01004731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24610741|NCT01004731|Immunologic Factors|immunologic factors|mesh-ancestor
24675917|NCT01346254|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24675918|NCT01346254|Protease Inhibitors|protease inhibitors|mesh-ancestor
24675919|NCT01346254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675920|NCT01346254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675922|NCT01346670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24675923|NCT01346670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24675924|NCT01346670|Antimetabolites|antimetabolites|mesh-ancestor
24460161|NCT00347555|Aluminum phosphate|aluminum phosphate|mesh-list
24675940|NCT01346800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24675941|NCT01346800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24675942|NCT01346800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24675944|NCT01346826|Dermatologic Agents|dermatologic agents|mesh-ancestor
24676052|NCT01347957|Vasodilator Agents|vasodilator agents|mesh-ancestor
24676053|NCT01347957|Gasotransmitters|gasotransmitters|mesh-ancestor
24676054|NCT01347957|Protective Agents|protective agents|mesh-ancestor
24676056|NCT01347983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24854116|NCT02271971|Vitamins|vitamins|mesh-ancestor
24854723|NCT02275013|Simendan|simendan|mesh-list
24676086|NCT01348009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24676087|NCT01348009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24676089|NCT01348009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610760|NCT01004900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676317|NCT01349556|Keratolytic Agents|keratolytic agents|mesh-ancestor
24676330|NCT01349738|Ciprofloxacin|ciprofloxacin|mesh-list
24676331|NCT01349738|Levofloxacin|levofloxacin|mesh-list
25710768|NCT02291419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24676332|NCT01349738|Ofloxacin|ofloxacin|mesh-list
24676333|NCT01349738|Gentamicins|gentamicins|mesh-list
24676334|NCT01349738|Cefazolin|cefazolin|mesh-list
24676335|NCT01349738|Tobramycin|tobramycin|mesh-list
24676336|NCT01349738|Ampicillin|ampicillin|mesh-list
24676337|NCT01349738|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24676338|NCT01349738|Nitrofurantoin|nitrofurantoin|mesh-list
24676339|NCT01349738|Sulbactam|sulbactam|mesh-list
24676340|NCT01349738|Trimethoprim|trimethoprim|mesh-list
24676380|NCT01349777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24676409|NCT01350024|Respiratory System Agents|respiratory system agents|mesh-ancestor
24676564|NCT01351038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24676565|NCT01351038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24676566|NCT01351038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24676567|NCT01351038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676568|NCT01351168|Levodopa|levodopa|mesh-list
24676569|NCT01351168|Zolpidem|zolpidem|mesh-list
24676570|NCT01351168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24676571|NCT01351168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24676572|NCT01351168|Dopamine Agents|dopamine agents|mesh-ancestor
24676573|NCT01351168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24676574|NCT01351168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676593|NCT01351285|Narcotics|narcotics|mesh-ancestor
24637879|NCT01153802|Norepinephrine|norepinephrine|mesh-list
24676594|NCT01351285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24676595|NCT01351285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676596|NCT01351285|Analgesics|analgesics|mesh-ancestor
24854138|NCT02272166|Propofol|propofol|mesh-list
24676782|NCT01352559|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24676783|NCT01352559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24676784|NCT01352559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24676785|NCT01352559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676794|NCT01352559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24676795|NCT01352559|Histamine Antagonists|histamine antagonists|mesh-ancestor
24676797|NCT01352559|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24676798|NCT01352559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24676799|NCT01352559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24676800|NCT01352559|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24676801|NCT01352559|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24676802|NCT01352559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24854167|NCT02272478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854168|NCT02272478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24854169|NCT02272478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854170|NCT02272478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24854171|NCT02272517|Vortioxetine|vortioxetine|mesh-list
24676867|NCT01352650|Antimetabolites|antimetabolites|mesh-ancestor
24610851|NCT01005472|Growth Substances|growth substances|mesh-ancestor
24610852|NCT01005472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610853|NCT01005472|Growth Inhibitors|growth inhibitors|mesh-ancestor
24610854|NCT01005472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24676908|NCT01353209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24676909|NCT01353209|Hormone Antagonists|hormone antagonists|mesh-ancestor
24637917|NCT01153919|Interferons|interferons|mesh-list
24676910|NCT01353209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24676911|NCT01353209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676912|NCT01353235|Prednisolone|prednisolone|mesh-list
24676913|NCT01353235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24676914|NCT01353235|Glucocorticoids|glucocorticoids|mesh-ancestor
24676915|NCT01353235|Hormones|hormones|mesh-ancestor
24676916|NCT01353235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25710769|NCT02291419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25710770|NCT02291419|Purinergic Agents|purinergic agents|mesh-ancestor
25710771|NCT02291419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25710772|NCT02291549|Mometasone Furoate|mometasone furoate|mesh-list
25710773|NCT02291549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24677053|NCT01353937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24677054|NCT01353937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24677055|NCT01353937|Antiviral Agents|antiviral agents|mesh-ancestor
25710774|NCT02291549|Dermatologic Agents|dermatologic agents|mesh-ancestor
25710775|NCT02291549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24677056|NCT01353937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24677057|NCT01353937|Anticoagulants|anticoagulants|mesh-ancestor
24677060|NCT01353937|Growth Substances|growth substances|mesh-ancestor
24447596|NCT00309192|Hormones|hormones|mesh-ancestor
24677127|NCT01354483|Prednisolone acetate|prednisolone acetate|mesh-list
24677128|NCT01354483|Lithium Carbonate|lithium carbonate|mesh-list
24677129|NCT01354483|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24677130|NCT01354483|Prednisolone phosphate|prednisolone phosphate|mesh-list
24677239|NCT01355198|Antiviral Agents|antiviral agents|mesh-ancestor
24677240|NCT01355198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24677241|NCT01355198|Expectorants|expectorants|mesh-ancestor
24677242|NCT01355198|Respiratory System Agents|respiratory system agents|mesh-ancestor
24677259|NCT01355276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24677260|NCT01355276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677476|NCT01356511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677477|NCT01356511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24677478|NCT01356511|Glucocorticoids|glucocorticoids|mesh-ancestor
24677479|NCT01356511|Hormones|hormones|mesh-ancestor
24677480|NCT01356511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24677481|NCT01356511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24677482|NCT01356511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24677483|NCT01356524|Progesterone|progesterone|mesh-list
24677540|NCT01356732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24677541|NCT01356732|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24677542|NCT01356732|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24677543|NCT01356732|Anesthetics, General|anesthetics, general|mesh-ancestor
24854252|NCT02272738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854253|NCT02272738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24854254|NCT02272738|Immunologic Factors|immunologic factors|mesh-ancestor
24854255|NCT02272738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854256|NCT02272764|Itraconazole|itraconazole|mesh-list
24675852|NCT01345851|Carboplatin|carboplatin|mesh-list
24854257|NCT02272764|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
24854258|NCT02272764|Antifungal Agents|antifungal agents|mesh-ancestor
24854259|NCT02272764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24610900|NCT01005758|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24677987|NCT01359423|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24677988|NCT01359423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24677989|NCT01359423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24854261|NCT02272764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24854262|NCT02272764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24677991|NCT01359436|Immunologic Factors|immunologic factors|mesh-ancestor
24677992|NCT01359436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677993|NCT01359462|Tolvaptan|tolvaptan|mesh-list
24677996|NCT01359462|Natriuretic Agents|natriuretic agents|mesh-ancestor
24678183|NCT01360086|Calcium|calcium|mesh-list
24678184|NCT01360086|Levoleucovorin|levoleucovorin|mesh-list
24678185|NCT01360086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24678186|NCT01360086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24678223|NCT01360372|Methylnaltrexone|methylnaltrexone|mesh-list
24678224|NCT01360372|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24678225|NCT01360372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678226|NCT01360372|Sensory System Agents|sensory system agents|mesh-ancestor
24678227|NCT01360372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24678228|NCT01360424|Teriparatide|teriparatide|mesh-list
24678242|NCT01360463|Methadone|methadone|mesh-list
24610926|NCT01005758|Hormones|hormones|mesh-ancestor
25710776|NCT02291601|Chlorhexidine|chlorhexidine|mesh-list
25710777|NCT02291601|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25710778|NCT02291601|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25710779|NCT02291601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25710780|NCT02291601|Disinfectants|disinfectants|mesh-ancestor
25710781|NCT02291601|Dermatologic Agents|dermatologic agents|mesh-ancestor
25710782|NCT02291679|Linaclotide|linaclotide|mesh-list
25710783|NCT02291679|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25710784|NCT02291679|Enzyme Activators|enzyme activators|mesh-ancestor
25710785|NCT02291679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710787|NCT02291913|Tamoxifen|tamoxifen|mesh-list
25710788|NCT02291913|Everolimus|everolimus|mesh-list
25710789|NCT02291913|Letrozole|letrozole|mesh-list
25710790|NCT02291913|Fulvestrant|fulvestrant|mesh-list
25710791|NCT02291913|Anastrozole|anastrozole|mesh-list
25710792|NCT02291913|Exemestane|exemestane|mesh-list
24678314|NCT01360827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678315|NCT01360827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24678316|NCT01360827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24678317|NCT01360827|Immunologic Factors|immunologic factors|mesh-ancestor
24678318|NCT01360827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678319|NCT01360827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24678320|NCT01361022|Brotizolam|brotizolam|mesh-list
24678321|NCT01361022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24678322|NCT01361022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24462750|NCT00357461|Ipilimumab|ipilimumab|mesh-list
24678367|NCT01361425|Autonomic Agents|autonomic agents|mesh-ancestor
24678368|NCT01361425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24678369|NCT01361425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678370|NCT01361425|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24678371|NCT01361425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24678372|NCT01361425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24678373|NCT01361425|Adrenergic Agents|adrenergic agents|mesh-ancestor
24678376|NCT01361516|Anesthetics|anesthetics|mesh-list
24678509|NCT01362400|Tubulin Modulators|tubulin modulators|mesh-ancestor
24678510|NCT01362400|Antimitotic Agents|antimitotic agents|mesh-ancestor
24678511|NCT01362400|Mitosis Modulators|mitosis modulators|mesh-ancestor
24678512|NCT01362400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678513|NCT01362426|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24678537|NCT01363037|Dapivirine|dapivirine|mesh-list
24854282|NCT02272868|Omeprazole|omeprazole|mesh-list
24854283|NCT02272868|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24854284|NCT02272868|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24854285|NCT02272868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24470911|NCT00392457|Hormones|hormones|mesh-list
24678538|NCT01363037|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24678539|NCT01363037|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24678540|NCT01363037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678541|NCT01363037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24678542|NCT01363037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24678543|NCT01363037|Antiviral Agents|antiviral agents|mesh-ancestor
24678544|NCT01363037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24462970|NCT00358228|Hormones|hormones|mesh-ancestor
24678576|NCT01363089|Adrenergic Agents|adrenergic agents|mesh-ancestor
24610977|NCT01005979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24678671|NCT01363336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678672|NCT01363336|Vasodilator Agents|vasodilator agents|mesh-ancestor
24678673|NCT01363336|Tocolytic Agents|tocolytic agents|mesh-ancestor
24678674|NCT01363336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24678676|NCT01363375|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24678677|NCT01363375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24678678|NCT01363414|Hyaluronic Acid|hyaluronic acid|mesh-list
24678679|NCT01363414|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24678680|NCT01363414|Immunologic Factors|immunologic factors|mesh-ancestor
24678681|NCT01363414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678682|NCT01363414|Viscosupplements|viscosupplements|mesh-ancestor
24678683|NCT01363414|Protective Agents|protective agents|mesh-ancestor
24678684|NCT01363531|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24678685|NCT01363531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24678686|NCT01363544|Methylphenidate|methylphenidate|mesh-list
24678842|NCT01364675|Antimetabolites|antimetabolites|mesh-ancestor
24678843|NCT01364675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678844|NCT01364675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24678845|NCT01364675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24678846|NCT01364675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24678847|NCT01364675|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24678848|NCT01364675|Protease Inhibitors|protease inhibitors|mesh-ancestor
25710793|NCT02291913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710794|NCT02291913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24678849|NCT01364675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24679062|NCT01366300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24679063|NCT01366300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679064|NCT01366300|Sensory System Agents|sensory system agents|mesh-ancestor
25710796|NCT02291913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777143|NCT03739528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24679065|NCT01366300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679066|NCT01366300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24679067|NCT01366300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24679068|NCT01366300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24679069|NCT01366300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24679070|NCT01366300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679071|NCT01366300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24679090|NCT01366326|Sensory System Agents|sensory system agents|mesh-ancestor
24679429|NCT01368445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679430|NCT01368445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679431|NCT01368445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24679432|NCT01368445|Respiratory System Agents|respiratory system agents|mesh-ancestor
24611040|NCT01006525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24611041|NCT01006525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679537|NCT01369121|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
24679538|NCT01369121|Hormones|hormones|mesh-ancestor
24679539|NCT01369121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24679540|NCT01369121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679541|NCT01369186|Morphine|morphine|mesh-list
24679542|NCT01369186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24679543|NCT01369186|Narcotics|narcotics|mesh-ancestor
24679544|NCT01369186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24679545|NCT01369186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679546|NCT01369186|Analgesics|analgesics|mesh-ancestor
24679547|NCT01369186|Sensory System Agents|sensory system agents|mesh-ancestor
24679548|NCT01369186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679549|NCT01369212|Tenofovir|tenofovir|mesh-list
24679550|NCT01369212|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24679551|NCT01369212|Antiviral Agents|antiviral agents|mesh-ancestor
24679552|NCT01369212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24679554|NCT01369212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24679566|NCT01369238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24679567|NCT01369238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24679568|NCT01369238|Gout Suppressants|gout suppressants|mesh-ancestor
24679569|NCT01369277|Nicotinic Acids|nicotinic acids|mesh-list
24679570|NCT01369277|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
24679574|NCT01369277|Vitamins|vitamins|mesh-ancestor
24854383|NCT02273492|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24854384|NCT02273505|Aspirin|aspirin|mesh-list
24854385|NCT02273505|Salicylic Acid|salicylic acid|mesh-list
24854386|NCT02273505|Salicylates|salicylates|mesh-list
24854387|NCT02273505|Dipyridamole|dipyridamole|mesh-list
24854388|NCT02273505|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
24456981|NCT00332852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24456982|NCT00332852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456983|NCT00332852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456984|NCT00332852|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24679658|NCT01369667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24679659|NCT01369693|Lobeline|lobeline|mesh-list
24679660|NCT01369693|Nicotine|nicotine|mesh-list
24679661|NCT01369693|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24679662|NCT01369693|Autonomic Agents|autonomic agents|mesh-ancestor
24679663|NCT01369693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679690|NCT01370096|Tezosentan|tezosentan|mesh-list
24679691|NCT01370096|Hemostatics|hemostatics|mesh-ancestor
24679753|NCT01370343|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
24679804|NCT01370772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24679805|NCT01370772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24679806|NCT01370811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24679807|NCT01370876|Oxaliplatin|oxaliplatin|mesh-list
24679808|NCT01370876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24679809|NCT01370889|Resveratrol|resveratrol|mesh-list
24679810|NCT01370889|Antioxidants|antioxidants|mesh-ancestor
24679811|NCT01370889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710797|NCT02291913|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25710798|NCT02291913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25710799|NCT02291913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777144|NCT03739528|Protease Inhibitors|protease inhibitors|mesh-ancestor
25777145|NCT03739528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24679817|NCT01370915|Pregabalin|pregabalin|mesh-list
24680110|NCT01373021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680111|NCT01373021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24680112|NCT01373021|Analgesics|analgesics|mesh-ancestor
24680113|NCT01373021|Sensory System Agents|sensory system agents|mesh-ancestor
24680114|NCT01373021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24680115|NCT01373021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24680116|NCT01373021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24680156|NCT01373216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680157|NCT01373216|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24680158|NCT01373216|Incretins|incretins|mesh-ancestor
24680159|NCT01373216|Hormones|hormones|mesh-ancestor
24680160|NCT01373216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24680161|NCT01373333|Amifampridine|amifampridine|mesh-list
24680162|NCT01373333|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24680163|NCT01373333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24905346|NCT04348409|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24905351|NCT04348006|Dexamethasone|dexamethasone|mesh-list
24680257|NCT01373684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24680258|NCT01373684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24457950|NCT00335920|Dexamethasone|dexamethasone|mesh-list
24680259|NCT01373684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24680270|NCT01373697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24680271|NCT01373697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680514|NCT01375244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680515|NCT01375244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680516|NCT01375244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24680517|NCT01375244|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24680518|NCT01375244|Protective Agents|protective agents|mesh-ancestor
24680519|NCT01375244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680520|NCT01375257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24680521|NCT01375257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24854534|NCT02273791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24854535|NCT02273791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24854536|NCT02273791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24854537|NCT02273791|Hormone Antagonists|hormone antagonists|mesh-ancestor
24611137|NCT01007500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24611138|NCT01007500|Glucocorticoids|glucocorticoids|mesh-ancestor
24611140|NCT01007500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24611141|NCT01007500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24611142|NCT01007500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611143|NCT01007500|Antipruritics|antipruritics|mesh-ancestor
24611144|NCT01007500|Dermatologic Agents|dermatologic agents|mesh-ancestor
24611145|NCT01007500|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24611146|NCT01007500|Serotonin Agents|serotonin agents|mesh-ancestor
24611147|NCT01007500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24611148|NCT01007500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680725|NCT01376076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680726|NCT01376076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680727|NCT01376076|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24680728|NCT01376076|Contraceptive Agents|contraceptive agents|mesh-ancestor
24680729|NCT01376076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24680730|NCT01376076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680731|NCT01376076|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24680829|NCT01376271|Paroxetine|paroxetine|mesh-list
24680830|NCT01376271|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24680831|NCT01376271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24680843|NCT01376284|Dutasteride|dutasteride|mesh-list
24680844|NCT01376284|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24680845|NCT01376284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24680870|NCT01376401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680871|NCT01376401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24680872|NCT01376401|Alkylating Agents|alkylating agents|mesh-ancestor
24680873|NCT01376401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680876|NCT01376440|Disinfectants|disinfectants|mesh-ancestor
25777729|NCT03219372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25777730|NCT03219372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25777731|NCT03219372|Antimetabolites|antimetabolites|mesh-ancestor
25777732|NCT03219372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777733|NCT03219372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25777734|NCT03219372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24611192|NCT01007773|Dexmedetomidine|dexmedetomidine|mesh-list
24611193|NCT01007773|Propofol|propofol|mesh-list
24611194|NCT01007773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24611195|NCT01007773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24611196|NCT01007773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611197|NCT01007773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24611198|NCT01007773|Anesthetics, General|anesthetics, general|mesh-ancestor
24611199|NCT01007773|Anesthetics|anesthetics|mesh-ancestor
24611200|NCT01007773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24611201|NCT01007773|Analgesics|analgesics|mesh-ancestor
24611202|NCT01007773|Sensory System Agents|sensory system agents|mesh-ancestor
24611203|NCT01007773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24611204|NCT01007773|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24611205|NCT01007773|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24611206|NCT01007773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24611207|NCT01007773|Adrenergic Agents|adrenergic agents|mesh-ancestor
24681121|NCT01378533|Antimitotic Agents|antimitotic agents|mesh-ancestor
24681122|NCT01378533|Mitosis Modulators|mitosis modulators|mesh-ancestor
24681205|NCT01378884|Autonomic Agents|autonomic agents|mesh-ancestor
24681206|NCT01378884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24681207|NCT01378884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681208|NCT01378884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24681209|NCT01378884|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24681210|NCT01378884|Dopamine Agents|dopamine agents|mesh-ancestor
24681211|NCT01378884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24854612|NCT02274142|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24854613|NCT02274142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854614|NCT02274142|Sympathomimetics|sympathomimetics|mesh-ancestor
24854615|NCT02274142|Autonomic Agents|autonomic agents|mesh-ancestor
24681394|NCT01380301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24681395|NCT01380301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681396|NCT01380301|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24681446|NCT01380483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24681447|NCT01380483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24681448|NCT01380483|Antimalarials|antimalarials|mesh-ancestor
24681449|NCT01380483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24681450|NCT01380483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24611260|NCT01008046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611262|NCT01008046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24611263|NCT01008046|Expectorants|expectorants|mesh-ancestor
24611264|NCT01008046|Respiratory System Agents|respiratory system agents|mesh-ancestor
24611265|NCT01008046|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24611266|NCT01008046|Antioxidants|antioxidants|mesh-ancestor
24611267|NCT01008046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611268|NCT01008046|Protective Agents|protective agents|mesh-ancestor
24611269|NCT01008046|Antidotes|antidotes|mesh-ancestor
24611270|NCT01008098|Citalopram|citalopram|mesh-list
24611271|NCT01008098|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24611272|NCT01008098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24681553|NCT01381185|Sensory System Agents|sensory system agents|mesh-ancestor
24681554|NCT01381185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24681555|NCT01381185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24681622|NCT01381393|Ibandronic Acid|ibandronic acid|mesh-list
24681670|NCT01381523|Sumatriptan|sumatriptan|mesh-list
24681671|NCT01381523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24466263|NCT00372788|Pemetrexed|pemetrexed|mesh-list
24681672|NCT01381523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24681673|NCT01381523|Analgesics|analgesics|mesh-ancestor
24681674|NCT01381523|Sensory System Agents|sensory system agents|mesh-ancestor
24681675|NCT01381523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24681676|NCT01381523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457267|NCT00333632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24457268|NCT00333632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24681854|NCT01382342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681855|NCT01382342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681875|NCT01382472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24681876|NCT01382472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24681878|NCT01382498|Calcium Dobesilate|calcium dobesilate|mesh-list
24681879|NCT01382498|Calcium|calcium|mesh-list
25777736|NCT03217175|Glucagon|glucagon|mesh-list
25777737|NCT03217175|Pancrelipase|pancrelipase|mesh-list
25777738|NCT03217175|Pancreatin|pancreatin|mesh-list
25777739|NCT03217175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777740|NCT03217175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25777741|NCT03217175|Hormones|hormones|mesh-ancestor
24854710|NCT02274974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854713|NCT02274974|Adrenergic Agents|adrenergic agents|mesh-ancestor
24854714|NCT02274974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24854715|NCT02274974|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24854716|NCT02274974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24854717|NCT02274974|Autonomic Agents|autonomic agents|mesh-ancestor
24854718|NCT02274974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24854719|NCT02274974|Respiratory System Agents|respiratory system agents|mesh-ancestor
24854720|NCT02274974|Mydriatics|mydriatics|mesh-ancestor
24854721|NCT02274974|Sympathomimetics|sympathomimetics|mesh-ancestor
24854722|NCT02274974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24682006|NCT01383395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24682007|NCT01383395|Antimetabolites|antimetabolites|mesh-ancestor
24682008|NCT01383395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854757|NCT02275182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24854758|NCT02275182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24854759|NCT02275182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24854760|NCT02275182|Adrenergic Agents|adrenergic agents|mesh-ancestor
24682009|NCT01383395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24682010|NCT01383395|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24682011|NCT01383395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682012|NCT01383395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24682013|NCT01383395|Autonomic Agents|autonomic agents|mesh-ancestor
24682014|NCT01383395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24682015|NCT01383395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682016|NCT01383395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24682017|NCT01383395|Respiratory System Agents|respiratory system agents|mesh-ancestor
24682018|NCT01383395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24682019|NCT01383395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24682132|NCT01384448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682133|NCT01384448|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24682134|NCT01384448|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24682135|NCT01384448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24682136|NCT01384448|Adrenergic Agents|adrenergic agents|mesh-ancestor
24682137|NCT01384448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24682176|NCT01384578|Protective Agents|protective agents|mesh-ancestor
24682177|NCT01384578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24682178|NCT01384578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682194|NCT01384682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682196|NCT01384682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24682197|NCT01384682|Antiviral Agents|antiviral agents|mesh-ancestor
24682198|NCT01384682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24682199|NCT01384682|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24682200|NCT01384695|Proflavine|proflavine|mesh-list
24854769|NCT02275247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24854770|NCT02275299|Methotrexate|methotrexate|mesh-list
24854771|NCT02275299|Leflunomide|leflunomide|mesh-list
24854772|NCT02275299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24854773|NCT02275299|Abortifacient Agents|abortifacient agents|mesh-ancestor
24854774|NCT02275299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24854775|NCT02275299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24854776|NCT02275299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24854777|NCT02275299|Antimetabolites|antimetabolites|mesh-ancestor
24854778|NCT02275299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24854779|NCT02275299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24854780|NCT02275299|Dermatologic Agents|dermatologic agents|mesh-ancestor
24854782|NCT02275299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24854783|NCT02275299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24854784|NCT02275299|Immunologic Factors|immunologic factors|mesh-ancestor
24854785|NCT02275299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24682207|NCT01384773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24682208|NCT01384773|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24682209|NCT01384773|Vitamin B Complex|vitamin b complex|mesh-ancestor
24682211|NCT01384773|Micronutrients|micronutrients|mesh-ancestor
24854807|NCT02275663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24812639|NCT02053818|Anesthetics|anesthetics|mesh-ancestor
24812640|NCT02053857|Amoxicillin|amoxicillin|mesh-list
24812641|NCT02053857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24812642|NCT02053857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24812643|NCT02053922|Misoprostol|misoprostol|mesh-list
25777754|NCT03169530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24457320|NCT00333996|Glucocorticoids|glucocorticoids|mesh-ancestor
24457321|NCT00333996|Hormones|hormones|mesh-ancestor
24457322|NCT00333996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24457323|NCT00333996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24457324|NCT00333996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24457325|NCT00334022|Enfuvirtide|enfuvirtide|mesh-list
24457329|NCT00334022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24682234|NCT01384994|Fluorouracil|fluorouracil|mesh-list
24682235|NCT01384994|Panitumumab|panitumumab|mesh-list
24682236|NCT01384994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24682237|NCT01384994|Antimetabolites|antimetabolites|mesh-ancestor
24812658|NCT02053935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812660|NCT02053935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24812661|NCT02053935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812662|NCT02053935|Protective Agents|protective agents|mesh-ancestor
24812663|NCT02053974|Spironolactone|spironolactone|mesh-list
24812664|NCT02053974|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24812665|NCT02053974|Hormone Antagonists|hormone antagonists|mesh-ancestor
24457350|NCT00334126|Antidepressive Agents|antidepressive agents|mesh-ancestor
24682333|NCT01385956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24682334|NCT01385956|Antimetabolites|antimetabolites|mesh-ancestor
24682337|NCT01385956|Antiviral Agents|antiviral agents|mesh-ancestor
24682390|NCT01386229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682391|NCT01386229|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24682392|NCT01386229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24682393|NCT01386229|Anesthetics, General|anesthetics, general|mesh-ancestor
24682394|NCT01386229|Anesthetics|anesthetics|mesh-ancestor
24682395|NCT01386229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24682396|NCT01386229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24682397|NCT01386229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24682398|NCT01386229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24682399|NCT01386229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682400|NCT01386229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24682402|NCT01386242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24682403|NCT01386242|Antiviral Agents|antiviral agents|mesh-ancestor
24611312|NCT01008566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611314|NCT01008566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611358|NCT01008917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24611359|NCT01008917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24611360|NCT01008917|Antifungal Agents|antifungal agents|mesh-ancestor
24611361|NCT01008917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24611362|NCT01008917|Immunologic Factors|immunologic factors|mesh-ancestor
24611363|NCT01008917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611365|NCT01008982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24611366|NCT01008982|Immunologic Factors|immunologic factors|mesh-ancestor
24611367|NCT01008982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611369|NCT01009021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24611370|NCT01009021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24611371|NCT01009021|Analgesics|analgesics|mesh-ancestor
24611372|NCT01009021|Sensory System Agents|sensory system agents|mesh-ancestor
24611373|NCT01009021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24611374|NCT01009021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611375|NCT01009021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24682404|NCT01386242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24682405|NCT01386255|Baclofen|baclofen|mesh-list
24682406|NCT01386255|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24682407|NCT01386255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682408|NCT01386255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24682409|NCT01386255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24682491|NCT01386580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24682492|NCT01386580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682493|NCT01386580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682494|NCT01386580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24682557|NCT01386710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24682558|NCT01386710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24682566|NCT01386736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25777755|NCT03169530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682594|NCT01386996|Hormones|hormones|mesh-ancestor
24682649|NCT01387373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24682650|NCT01387373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24682652|NCT01387399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24682653|NCT01387425|Varenicline|varenicline|mesh-list
24682654|NCT01387425|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24682655|NCT01387425|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24682656|NCT01387425|Cholinergic Agents|cholinergic agents|mesh-ancestor
24682657|NCT01387425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24682658|NCT01387425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682659|NCT01387425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682660|NCT01387568|Lidocaine|lidocaine|mesh-list
24682661|NCT01387568|Anesthetics, Local|anesthetics, local|mesh-ancestor
24682662|NCT01387568|Anesthetics|anesthetics|mesh-ancestor
24682663|NCT01387568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24682665|NCT01387568|Sensory System Agents|sensory system agents|mesh-ancestor
24682718|NCT01388075|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24682719|NCT01388075|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24639385|NCT01161277|Dopamine Agonists|dopamine agonists|mesh-ancestor
24682720|NCT01388075|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24682723|NCT01388088|Spironolactone|spironolactone|mesh-list
24682724|NCT01388088|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24682725|NCT01388088|Hormone Antagonists|hormone antagonists|mesh-ancestor
24682726|NCT01388088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24682729|NCT01388088|Diuretics|diuretics|mesh-ancestor
24682781|NCT01388517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24682782|NCT01388517|Immunologic Factors|immunologic factors|mesh-ancestor
24682783|NCT01388517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24682784|NCT01388517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682785|NCT01388517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682786|NCT01388517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24682787|NCT01388517|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24682788|NCT01388517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24682789|NCT01388517|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24682790|NCT01388517|Emollients|emollients|mesh-ancestor
24682791|NCT01388517|Dermatologic Agents|dermatologic agents|mesh-ancestor
24682792|NCT01388582|Copper|copper|mesh-list
24682793|NCT01388582|Contraceptive Agents|contraceptive agents|mesh-list
24682794|NCT01388582|Levonorgestrel|levonorgestrel|mesh-list
24682795|NCT01388582|Etonogestrel|etonogestrel|mesh-list
24682796|NCT01388582|Desogestrel|desogestrel|mesh-list
24682797|NCT01388582|Contraceptives, Oral|contraceptives, oral|mesh-list
24682798|NCT01388582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24854876|NCT02275988|Clarithromycin|clarithromycin|mesh-list
24854952|NCT02276495|Anesthetics|anesthetics|mesh-ancestor
24854953|NCT02276495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24854954|NCT02276495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682986|NCT01389427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24682987|NCT01389427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24683051|NCT01389609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24683052|NCT01389609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683053|NCT01389609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683054|NCT01389713|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24683057|NCT01389713|Zuclomiphene|zuclomiphene|mesh-list
24683058|NCT01389713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24683059|NCT01389713|Hormone Antagonists|hormone antagonists|mesh-ancestor
24683060|NCT01389713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24683061|NCT01389713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683062|NCT01389713|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24683064|NCT01389713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24683065|NCT01389713|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24683140|NCT01390311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24683141|NCT01390324|Naproxen|naproxen|mesh-list
24683142|NCT01390324|Naratriptan|naratriptan|mesh-list
24683143|NCT01390324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24683144|NCT01390324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24683145|NCT01390324|Analgesics|analgesics|mesh-ancestor
24683146|NCT01390324|Sensory System Agents|sensory system agents|mesh-ancestor
24683150|NCT01390324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24683257|NCT01390922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683258|NCT01390922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25710800|NCT02291913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683259|NCT01390922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24683260|NCT01390935|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
24683321|NCT01391221|Sensory System Agents|sensory system agents|mesh-ancestor
24683322|NCT01391221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24683323|NCT01391221|Antidepressive Agents|antidepressive agents|mesh-ancestor
24683336|NCT01391377|Vasodilator Agents|vasodilator agents|mesh-ancestor
24683337|NCT01391377|Vitamin B Complex|vitamin b complex|mesh-ancestor
24683339|NCT01391377|Micronutrients|micronutrients|mesh-ancestor
24683340|NCT01391377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683403|NCT01392014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24683404|NCT01392014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24683405|NCT01392014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24683406|NCT01392079|Alemtuzumab|alemtuzumab|mesh-list
24683489|NCT01392534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24683511|NCT01392755|Protease Inhibitors|protease inhibitors|mesh-ancestor
24683910|NCT01394679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24683911|NCT01394731|Acetaminophen|acetaminophen|mesh-list
24683928|NCT01394757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683929|NCT01394757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24683931|NCT01394757|Anesthetics, General|anesthetics, general|mesh-ancestor
24683932|NCT01394757|Anesthetics|anesthetics|mesh-ancestor
24683933|NCT01394757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24683981|NCT01394848|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24683982|NCT01394848|Purinergic Agents|purinergic agents|mesh-ancestor
24683983|NCT01394848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24683985|NCT01394887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24683986|NCT01394887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683988|NCT01394913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24683989|NCT01394913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24684162|NCT01395849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24684163|NCT01395849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684165|NCT01395849|Hormones|hormones|mesh-ancestor
24684166|NCT01395849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24684167|NCT01395849|Sympathomimetics|sympathomimetics|mesh-ancestor
24684168|NCT01395862|Fluticasone|fluticasone|mesh-list
24684169|NCT01395862|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24684170|NCT01395862|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24684171|NCT01395862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24684172|NCT01395862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24684173|NCT01395862|Autonomic Agents|autonomic agents|mesh-ancestor
24684174|NCT01395862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24684175|NCT01395862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684176|NCT01395862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24684177|NCT01395862|Respiratory System Agents|respiratory system agents|mesh-ancestor
24684178|NCT01395862|Dermatologic Agents|dermatologic agents|mesh-ancestor
24684357|NCT01397006|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24684399|NCT01397214|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24684401|NCT01397305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684402|NCT01397305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24684403|NCT01397305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684404|NCT01397305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24684405|NCT01397305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24684499|NCT05268068|Immunologic Factors|immunologic factors|mesh-ancestor
24684500|NCT05268068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684501|NCT05267977|Cephalosporins|cephalosporins|mesh-list
24684502|NCT05267977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24684503|NCT05267977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24684504|NCT05244252|Bupivacaine|bupivacaine|mesh-list
24684505|NCT05244252|Anesthetics, Local|anesthetics, local|mesh-ancestor
24684774|NCT04415333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24684775|NCT04415333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684776|NCT04415333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685040|NCT02607956|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
24685041|NCT02607956|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24685042|NCT02607956|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24685043|NCT02607956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24685103|NCT02215122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24685104|NCT02215122|Autonomic Agents|autonomic agents|mesh-ancestor
25710801|NCT02291913|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25710802|NCT02291913|Hormone Antagonists|hormone antagonists|mesh-ancestor
24685105|NCT02215122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24685106|NCT02215122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685107|NCT02215122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24685214|NCT01175356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24685215|NCT01175356|Alkylating Agents|alkylating agents|mesh-ancestor
24685216|NCT01175356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855091|NCT02277184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855093|NCT02277197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24855094|NCT02277197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855095|NCT02277223|Curcumin|curcumin|mesh-list
24457572|NCT00334685|Pregabalin|pregabalin|mesh-list
24685317|NCT05273944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24685318|NCT05273944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24685319|NCT05273944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24685320|NCT05273944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812678|NCT02054052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812687|NCT02054078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24685322|NCT05273775|Vitamin K 1|vitamin k 1|mesh-list
24685472|NCT05271539|Dexamethasone|dexamethasone|mesh-list
24685473|NCT05271539|Ranibizumab|ranibizumab|mesh-list
24685474|NCT05271539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24685475|NCT05271539|Antiemetics|antiemetics|mesh-ancestor
24685476|NCT05271539|Autonomic Agents|autonomic agents|mesh-ancestor
24685477|NCT05271539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24685478|NCT05271539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685480|NCT05271539|Glucocorticoids|glucocorticoids|mesh-ancestor
24685488|NCT05271539|Growth Inhibitors|growth inhibitors|mesh-ancestor
24685490|NCT05271448|Valsartan|valsartan|mesh-list
24685491|NCT05271448|Candesartan|candesartan|mesh-list
24685492|NCT05271448|Ramipril|ramipril|mesh-list
24685493|NCT05271448|Enalapril|enalapril|mesh-list
24685494|NCT05271448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24685653|NCT05250141|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24685654|NCT05250141|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24685655|NCT05250141|Dopamine Agents|dopamine agents|mesh-ancestor
24685656|NCT05250141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24685657|NCT05250141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685658|NCT05250141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25415989|NCT02979873|Antifungal Agents|antifungal agents|mesh-ancestor
24685659|NCT05250141|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24685660|NCT05250141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24685661|NCT05248724|Ketorolac|ketorolac|mesh-list
24685662|NCT05248724|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24685797|NCT05207280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24685798|NCT05207280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685810|NCT05173142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685811|NCT05173142|Antiviral Agents|antiviral agents|mesh-ancestor
24685812|NCT05173142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24685813|NCT05173142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24685814|NCT05173142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24685815|NCT05173142|Immunologic Factors|immunologic factors|mesh-ancestor
24685816|NCT05173142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685817|NCT05173142|Tubulin Modulators|tubulin modulators|mesh-ancestor
24685818|NCT05173142|Antimitotic Agents|antimitotic agents|mesh-ancestor
24685905|NCT05155917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24685906|NCT05155917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685909|NCT05142267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24685917|NCT05142072|Vitamin D|vitamin d|mesh-list
24686095|NCT05052528|Fludarabine|fludarabine|mesh-list
24686096|NCT05052528|Fludarabine phosphate|fludarabine phosphate|mesh-list
24686097|NCT05052528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24686098|NCT05052528|Antibodies|antibodies|mesh-list
24686111|NCT05052528|Antimetabolites|antimetabolites|mesh-ancestor
25710803|NCT02291913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24686114|NCT05051150|Epinephryl borate|epinephryl borate|mesh-list
24686115|NCT05051150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24686116|NCT05051150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24686117|NCT05051150|Adrenergic Agents|adrenergic agents|mesh-ancestor
24686118|NCT05051150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24686120|NCT05051150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812728|NCT02054299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24812729|NCT02054299|Adrenergic Agents|adrenergic agents|mesh-ancestor
24812730|NCT02054299|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24686181|NCT05007561|Sensory System Agents|sensory system agents|mesh-ancestor
24686182|NCT05007561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24686184|NCT05002738|Desogestrel|desogestrel|mesh-list
24686185|NCT05002738|Estradiol|estradiol|mesh-list
24686186|NCT05002738|Estrogens|estrogens|mesh-ancestor
24686256|NCT04961801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24686257|NCT04961801|Immunologic Factors|immunologic factors|mesh-ancestor
24686258|NCT04961801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24686259|NCT04961801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24686260|NCT04961801|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24686325|NCT04907825|Anticoagulants|anticoagulants|mesh-list
24686326|NCT04896645|Albuterol|albuterol|mesh-list
24686362|NCT04886284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24686363|NCT04886284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24686389|NCT04879823|Analgesics|analgesics|mesh-ancestor
24611640|NCT01010178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24611641|NCT01010178|Autonomic Agents|autonomic agents|mesh-ancestor
24611642|NCT01010178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24611645|NCT01010178|Respiratory System Agents|respiratory system agents|mesh-ancestor
24611646|NCT01010178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24611647|NCT01010178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611648|NCT01010178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611664|NCT01010243|Glucocorticoids|glucocorticoids|mesh-ancestor
24611666|NCT01010243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24611667|NCT01010243|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24611668|NCT01010243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611687|NCT01010295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611688|NCT01010308|Nadolol|nadolol|mesh-list
24611699|NCT01010308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24611700|NCT01010373|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
24611701|NCT01010373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24611702|NCT01010373|Immunologic Factors|immunologic factors|mesh-ancestor
24471355|NCT00394810|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
24686390|NCT04879823|Sensory System Agents|sensory system agents|mesh-ancestor
24686392|NCT04879823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24686393|NCT04879823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24686394|NCT04879823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25710804|NCT02291913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25710805|NCT02291913|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25710806|NCT02291913|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25710807|NCT02291913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25710808|NCT02291913|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25710809|NCT02292082|Cefazolin|cefazolin|mesh-list
24686395|NCT04879823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710810|NCT02292082|Dexamethasone|dexamethasone|mesh-list
25710811|NCT02292082|Methylprednisolone|methylprednisolone|mesh-list
24686447|NCT04791761|Ibuprofen|ibuprofen|mesh-list
24686448|NCT04791761|Oxycodone|oxycodone|mesh-list
24686449|NCT04791761|Analgesics, Opioid|analgesics, opioid|mesh-list
24855110|NCT02277457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24855111|NCT02277457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855112|NCT02277457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855113|NCT02277587|Hydrocortisone|hydrocortisone|mesh-list
24394560|NCT00133627|Ketotifen|ketotifen|mesh-list
24686450|NCT04791761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24686451|NCT04791761|Analgesics|analgesics|mesh-ancestor
24686452|NCT04791761|Sensory System Agents|sensory system agents|mesh-ancestor
24686453|NCT04791761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24686540|NCT04710641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24686552|NCT04706767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24686553|NCT04706767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24686554|NCT04706767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24686555|NCT04706767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24686556|NCT04706767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24686557|NCT04706767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686558|NCT04706767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24686559|NCT04706767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24686583|NCT04697719|Aspirin|aspirin|mesh-list
24686592|NCT04697719|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24686593|NCT04697719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24686594|NCT04697719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686787|NCT04579848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24686788|NCT04579848|Dermatologic Agents|dermatologic agents|mesh-ancestor
24686789|NCT04579848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24686790|NCT04579848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24686791|NCT04579848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24686792|NCT04579848|Immunologic Factors|immunologic factors|mesh-ancestor
24686793|NCT04579848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24686794|NCT04579848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24686795|NCT04579848|Hematinics|hematinics|mesh-ancestor
24686796|NCT04579848|Vitamin B Complex|vitamin b complex|mesh-ancestor
24686797|NCT04579848|Vitamins|vitamins|mesh-ancestor
24686798|NCT04579848|Micronutrients|micronutrients|mesh-ancestor
24686838|NCT04561648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24686839|NCT04561648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686867|NCT04551430|Nivolumab|nivolumab|mesh-list
24686868|NCT04551430|Ipilimumab|ipilimumab|mesh-list
24686869|NCT04551430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24686870|NCT04551430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24686871|NCT04551430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24686872|NCT04551430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855119|NCT02277587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24855120|NCT02277587|Hormones|hormones|mesh-ancestor
24855121|NCT02277587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24471840|NCT00397059|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24471841|NCT00397059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24471842|NCT00397059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24471843|NCT00397059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471844|NCT00397059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24471845|NCT00397059|Serotonin Agents|serotonin agents|mesh-ancestor
24686879|NCT04543682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24686880|NCT04543682|Vasodilator Agents|vasodilator agents|mesh-ancestor
24686881|NCT04530981|Repaglinide|repaglinide|mesh-list
24686882|NCT04530981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24686883|NCT04530981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686884|NCT04530006|Amantadine|amantadine|mesh-list
24686885|NCT04530006|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24686946|NCT04496245|Broncho-Vaxom|broncho-vaxom|mesh-list
24686947|NCT04496245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24686994|NCT04454203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24686996|NCT04433390|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24686997|NCT04433390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686998|NCT04433390|Sensory System Agents|sensory system agents|mesh-ancestor
25710812|NCT02292082|Midazolam|midazolam|mesh-list
25710813|NCT02292082|Morphine|morphine|mesh-list
25710814|NCT02292082|Bupivacaine|bupivacaine|mesh-list
25710815|NCT02292082|Propofol|propofol|mesh-list
25710816|NCT02292082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25710817|NCT02292082|Antiemetics|antiemetics|mesh-ancestor
24686999|NCT04433390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24687000|NCT04432610|Nebivolol|nebivolol|mesh-list
24687001|NCT04432610|Bisoprolol|bisoprolol|mesh-list
24687002|NCT04432610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24687003|NCT04432610|Vasodilator Agents|vasodilator agents|mesh-ancestor
24687004|NCT04432610|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24687005|NCT04432610|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24687099|NCT04389177|Mitosis Modulators|mitosis modulators|mesh-ancestor
24687100|NCT04389177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687101|NCT04389177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24687102|NCT04380831|Cyclophosphamide|cyclophosphamide|mesh-list
24687103|NCT04380831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24687140|NCT04328090|Anti-Infective Agents|anti-infective agents|mesh-list
24687141|NCT04328090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24687142|NCT04324021|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24687278|NCT04108026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24687279|NCT04108026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24687280|NCT04095104|Topiramate|topiramate|mesh-list
24687281|NCT04095104|Phentermine|phentermine|mesh-list
24687282|NCT04095104|Anticonvulsants|anticonvulsants|mesh-ancestor
24687316|NCT04057131|Icatibant|icatibant|mesh-list
24611741|NCT01010516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611743|NCT01010581|Methotrexate|methotrexate|mesh-list
24687334|NCT04055389|Protease Inhibitors|protease inhibitors|mesh-ancestor
24855145|NCT02277678|Analgesics|analgesics|mesh-ancestor
24855146|NCT02277678|Sensory System Agents|sensory system agents|mesh-ancestor
24855147|NCT02277678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24687335|NCT04055389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24687336|NCT04055389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687337|NCT04055389|Anticoagulants|anticoagulants|mesh-ancestor
24687338|NCT04054648|Antihypertensive Agents|antihypertensive agents|mesh-list
24687339|NCT04050540|Doxycycline|doxycycline|mesh-list
24687340|NCT04050540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24687341|NCT04050540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24687342|NCT04050540|Antimalarials|antimalarials|mesh-ancestor
24687343|NCT04050540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24687344|NCT04050540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24687345|NCT04044729|Cannabidiol|cannabidiol|mesh-list
24687346|NCT04044729|Anticonvulsants|anticonvulsants|mesh-ancestor
24687382|NCT04011150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24687383|NCT04011150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24687384|NCT04011150|Narcotics|narcotics|mesh-ancestor
24687385|NCT04011150|Analgesics|analgesics|mesh-ancestor
24907897|NCT04326764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907898|NCT04326790|Colchicine|colchicine|mesh-list
24907899|NCT04326790|Gout Suppressants|gout suppressants|mesh-ancestor
24472435|NCT00399165|Testosterone|testosterone|mesh-list
24687474|NCT03967925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24687475|NCT03967925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855151|NCT02277730|Phenylephrine|phenylephrine|mesh-list
24855152|NCT02277730|Oxymetazoline|oxymetazoline|mesh-list
24855153|NCT02277730|Ephedrine|ephedrine|mesh-list
24687693|NCT03778944|Sympathomimetics|sympathomimetics|mesh-ancestor
24687694|NCT03778944|Autonomic Agents|autonomic agents|mesh-ancestor
24687696|NCT03778944|Dopamine Agents|dopamine agents|mesh-ancestor
24855164|NCT02277730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24855165|NCT02277730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24855166|NCT02277730|Adrenergic Agents|adrenergic agents|mesh-ancestor
24855167|NCT02277730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24855168|NCT02277730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855169|NCT02277730|Protective Agents|protective agents|mesh-ancestor
24855170|NCT02277730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24855171|NCT02277808|Amikacin|amikacin|mesh-list
24855172|NCT02277808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24855173|NCT02277808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24687764|NCT03705338|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24687765|NCT03704285|Propofol|propofol|mesh-list
24687766|NCT03704285|Anesthetics|anesthetics|mesh-list
24687767|NCT03704285|Anesthetics, General|anesthetics, general|mesh-list
24688119|NCT03359239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688120|NCT03359239|Interferon Inducers|interferon inducers|mesh-ancestor
24688121|NCT03359239|Immunologic Factors|immunologic factors|mesh-ancestor
24688122|NCT03359239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473173|NCT00402272|Everolimus|everolimus|mesh-list
24688128|NCT03332173|Zanubrutinib|zanubrutinib|mesh-list
24688129|NCT03332173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688130|NCT03332173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24688131|NCT03332173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24688132|NCT03332173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688134|NCT03328676|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24688135|NCT03328676|Protective Agents|protective agents|mesh-ancestor
24688136|NCT03328676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688137|NCT03322293|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24688138|NCT03322293|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24688943|NCT02551991|Immunologic Factors|immunologic factors|mesh-ancestor
24688944|NCT02551991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688945|NCT02551991|Antidotes|antidotes|mesh-ancestor
24855199|NCT02277938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24855200|NCT02277938|Dopamine Agents|dopamine agents|mesh-ancestor
24855201|NCT02277938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24855202|NCT02277938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689099|NCT02299999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24689104|NCT02299999|Olaparib|olaparib|mesh-list
24689105|NCT02299999|Mitomycins|mitomycins|mesh-list
24689106|NCT02299999|Mitomycin|mitomycin|mesh-list
24689108|NCT02299999|Taxane|taxane|mesh-list
24689262|NCT01891747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24689263|NCT01891747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689264|NCT01891747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24689265|NCT01891747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24689267|NCT01891747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855216|NCT02278172|Ergocalciferols|ergocalciferols|mesh-list
24689555|NCT01107717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24689556|NCT01107717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689557|NCT01107717|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24689558|NCT01107717|Incretins|incretins|mesh-ancestor
24689559|NCT01107717|Hormones|hormones|mesh-ancestor
24689560|NCT01107717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24689561|NCT01104350|Gemcitabine|gemcitabine|mesh-list
24689562|NCT01104350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24689563|NCT01104350|Antimetabolites|antimetabolites|mesh-ancestor
24689651|NCT00785525|Immunologic Factors|immunologic factors|mesh-ancestor
24689731|NCT00430040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24689732|NCT00430040|Vasodilator Agents|vasodilator agents|mesh-ancestor
24689737|NCT00430040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689738|NCT00430040|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24855219|NCT02278172|Micronutrients|micronutrients|mesh-ancestor
24855220|NCT02278172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689899|NCT01398046|Rabeprazole|rabeprazole|mesh-list
24689900|NCT01398046|Betaine|betaine|mesh-list
24689901|NCT01398046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689933|NCT01398111|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24689934|NCT01398111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24689935|NCT01398111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24689936|NCT01398111|Adrenergic Agents|adrenergic agents|mesh-ancestor
24689937|NCT01398111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24689938|NCT01398111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641658|NCT01174849|Immunologic Factors|immunologic factors|mesh-ancestor
24689939|NCT01398111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24689940|NCT01398111|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24689941|NCT01398111|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24689942|NCT01398111|Cholinergic Agents|cholinergic agents|mesh-ancestor
24689943|NCT01398189|Clozapine|clozapine|mesh-list
24689944|NCT01398189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24689972|NCT01398267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689973|NCT01398293|Ritonavir|ritonavir|mesh-list
24690416|NCT01401491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24690432|NCT01401933|Antitubercular Agents|antitubercular agents|mesh-ancestor
24690433|NCT01401933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24690434|NCT01401933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24690435|NCT01401933|Leprostatic Agents|leprostatic agents|mesh-ancestor
24690436|NCT01401933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25710818|NCT02292082|Autonomic Agents|autonomic agents|mesh-ancestor
25710819|NCT02292082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25710820|NCT02292082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710821|NCT02292082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25710822|NCT02292082|Glucocorticoids|glucocorticoids|mesh-ancestor
25710823|NCT02292082|Hormones|hormones|mesh-ancestor
25777756|NCT03189433|Dantrolene|dantrolene|mesh-list
24690513|NCT01402193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24690703|NCT01403415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690704|NCT01403415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24690705|NCT01403415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24690706|NCT01403415|Immunologic Factors|immunologic factors|mesh-ancestor
24690707|NCT01403415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24690710|NCT01403415|Tubulin Modulators|tubulin modulators|mesh-ancestor
24855278|NCT02278588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855279|NCT02278588|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24855280|NCT02278588|Protective Agents|protective agents|mesh-ancestor
24855281|NCT02278588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690936|NCT01404468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24690937|NCT01404468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690938|NCT01404468|Sensory System Agents|sensory system agents|mesh-ancestor
24690939|NCT01404468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24690945|NCT01404507|Abciximab|abciximab|mesh-list
24691120|NCT01405144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691121|NCT01405157|Methylprednisolone|methylprednisolone|mesh-list
24691230|NCT01405586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24691231|NCT01405586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691232|NCT01405586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24641896|NCT01176409|Valacyclovir|valacyclovir|mesh-list
24691709|NCT01408810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24691711|NCT01408836|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24691712|NCT01408836|Methylprednisolone|methylprednisolone|mesh-list
24691713|NCT01408836|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24691714|NCT01408836|Prednisolone acetate|prednisolone acetate|mesh-list
24691715|NCT01408836|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24691719|NCT01408836|Hormones|hormones|mesh-ancestor
24692124|NCT01411280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24692125|NCT01411280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24692126|NCT01411280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24692127|NCT01411280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692128|NCT01411280|Dopamine Agents|dopamine agents|mesh-ancestor
24692129|NCT01411280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24692130|NCT01411410|Paclitaxel|paclitaxel|mesh-list
24612360|NCT01013532|Protective Agents|protective agents|mesh-ancestor
24692480|NCT01414569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24692481|NCT01414569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855318|NCT02278913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692482|NCT01414569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24692483|NCT01414569|Glucocorticoids|glucocorticoids|mesh-ancestor
24692484|NCT01414569|Hormones|hormones|mesh-ancestor
24692487|NCT01414569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24693002|NCT01417754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24693003|NCT01417754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693004|NCT01417754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24693006|NCT01417767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24693007|NCT01417767|Antimetabolites|antimetabolites|mesh-ancestor
24693008|NCT01417767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693009|NCT01417767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24693046|NCT01418118|Norepinephrine|norepinephrine|mesh-list
24693047|NCT01418118|Dopexamine|dopexamine|mesh-list
24693172|NCT01418599|Alfuzosin|alfuzosin|mesh-list
24693393|NCT01420250|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24693394|NCT01420250|Androgen Antagonists|androgen antagonists|mesh-list
24693395|NCT01420250|Androgens|androgens|mesh-list
24693426|NCT01420406|Vitamin A|vitamin a|mesh-list
24693427|NCT01420406|Vitamins|vitamins|mesh-ancestor
24693428|NCT01420406|Micronutrients|micronutrients|mesh-ancestor
24693429|NCT01420406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855330|NCT02278978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693431|NCT01420471|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24612257|NCT01012960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612258|NCT01012960|Sensory System Agents|sensory system agents|mesh-ancestor
24612259|NCT01012960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25777757|NCT03189433|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25777758|NCT03189433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777759|NCT03189433|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25777760|NCT03189433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25777761|NCT03172026|Maraviroc|maraviroc|mesh-list
25777762|NCT03172026|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25710824|NCT02292082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24612261|NCT01013012|Ramosetron|ramosetron|mesh-list
24612262|NCT01013012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24612263|NCT01013012|Antiemetics|antiemetics|mesh-ancestor
24612264|NCT01013012|Autonomic Agents|autonomic agents|mesh-ancestor
24612287|NCT01013155|Protease Inhibitors|protease inhibitors|mesh-ancestor
24612288|NCT01013155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612289|NCT01013155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612290|NCT01013155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24612291|NCT01013272|Lamivudine|lamivudine|mesh-list
24855333|NCT02279121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24693591|NCT01421173|Protease Inhibitors|protease inhibitors|mesh-ancestor
24693617|NCT01421368|Contraceptive Agents|contraceptive agents|mesh-list
24693618|NCT01421368|Medroxyprogesterone|medroxyprogesterone|mesh-list
24693619|NCT01421368|Contraceptives, Oral|contraceptives, oral|mesh-list
24693621|NCT01421368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24693622|NCT01421368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24693623|NCT01421368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24693624|NCT01421368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24693625|NCT01421368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693626|NCT01421368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24693627|NCT01421368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24693628|NCT01421368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24693629|NCT01421368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693726|NCT01421979|Purinergic Agents|purinergic agents|mesh-ancestor
24693727|NCT01421979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24693729|NCT01421992|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24693730|NCT01421992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24693731|NCT01421992|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24693732|NCT01421992|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24693733|NCT01421992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24693734|NCT01421992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693735|NCT01421992|Dopamine Agents|dopamine agents|mesh-ancestor
24693736|NCT01421992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24693912|NCT01422785|Clindamycin palmitate|clindamycin palmitate|mesh-list
24642817|NCT01181505|Cholinergic Agents|cholinergic agents|mesh-ancestor
24612362|NCT01013532|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24612363|NCT01013532|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24612364|NCT01013532|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24612365|NCT01013532|Antimetabolites|antimetabolites|mesh-ancestor
24612366|NCT01013532|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24612367|NCT01013532|Antioxidants|antioxidants|mesh-ancestor
24612368|NCT01013558|Remifentanil|remifentanil|mesh-list
24612369|NCT01013558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24612370|NCT01013558|Narcotics|narcotics|mesh-ancestor
24694062|NCT01423695|Tubulin Modulators|tubulin modulators|mesh-ancestor
24694063|NCT01423695|Antimitotic Agents|antimitotic agents|mesh-ancestor
24694064|NCT01423695|Mitosis Modulators|mitosis modulators|mesh-ancestor
24694065|NCT01423695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479456|NCT00426985|Ketoprofen|ketoprofen|mesh-list
24694066|NCT01423695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24694067|NCT01423708|Everolimus|everolimus|mesh-list
24694308|NCT01424891|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24695870|NCT01426087|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24695871|NCT01426087|Somatostatin|somatostatin|mesh-list
24612609|NCT01014559|Oxycodone|oxycodone|mesh-list
24612610|NCT01014559|Naloxone|naloxone|mesh-list
24612611|NCT01014559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24696105|NCT01427283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24696106|NCT01427283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24696252|NCT01428388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24696253|NCT01428388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24696254|NCT01428388|Growth Substances|growth substances|mesh-ancestor
24696373|NCT01429090|Methantheline|methantheline|mesh-list
24696716|NCT01431118|Sensory System Agents|sensory system agents|mesh-ancestor
24696854|NCT01431404|Immunologic Factors|immunologic factors|mesh-ancestor
24696855|NCT01431430|Cholecalciferol|cholecalciferol|mesh-list
24696856|NCT01431430|Vitamin D|vitamin d|mesh-list
25710825|NCT02292082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24696857|NCT01431430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24696937|NCT01431924|Fluticasone|fluticasone|mesh-list
24697328|NCT01434160|Levonorgestrel|levonorgestrel|mesh-list
25710826|NCT02292082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698722|NCT01442727|Antioxidants|antioxidants|mesh-ancestor
24698723|NCT01442727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698724|NCT01442727|Protective Agents|protective agents|mesh-ancestor
24698725|NCT01442727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698813|NCT01442987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24698814|NCT01443065|Leucovorin|leucovorin|mesh-list
24698881|NCT01443247|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24698882|NCT01443247|Immunologic Factors|immunologic factors|mesh-ancestor
24699106|NCT01444885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24699107|NCT01444885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699108|NCT01444885|Vasodilator Agents|vasodilator agents|mesh-ancestor
24699109|NCT01444976|Midazolam|midazolam|mesh-list
24699110|NCT01444976|Anesthetics|anesthetics|mesh-ancestor
24699111|NCT01444976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24699437|NCT01446679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699438|NCT01446731|Docetaxel|docetaxel|mesh-list
24699439|NCT01446731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24699440|NCT01446731|Tubulin Modulators|tubulin modulators|mesh-ancestor
24699441|NCT01446731|Antimitotic Agents|antimitotic agents|mesh-ancestor
24699442|NCT01446731|Mitosis Modulators|mitosis modulators|mesh-ancestor
24699443|NCT01446731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699444|NCT01446783|Mecasermin|mecasermin|mesh-list
24699493|NCT01447095|Epoprostenol|epoprostenol|mesh-list
24699494|NCT01447095|Tezosentan|tezosentan|mesh-list
24699495|NCT01447095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24699496|NCT01447095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24699497|NCT01447095|Vasodilator Agents|vasodilator agents|mesh-ancestor
24699498|NCT01447160|Cortisone|cortisone|mesh-list
24699499|NCT01447160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24699500|NCT01447173|Vitamin D|vitamin d|mesh-list
24699501|NCT01447173|Vitamins|vitamins|mesh-ancestor
24699502|NCT01447173|Micronutrients|micronutrients|mesh-ancestor
24699503|NCT01447173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699504|NCT01447173|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24699505|NCT01447212|Hydromorphone|hydromorphone|mesh-list
24699506|NCT01447212|Heroin|heroin|mesh-list
24699643|NCT01448291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699678|NCT01448395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699680|NCT01448395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24699681|NCT01448434|Plasma-lyte 148|plasma-lyte 148|mesh-list
24699682|NCT01448434|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24699683|NCT01448434|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24699709|NCT01448720|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24699710|NCT01448720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24699711|NCT01448720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24699726|NCT01448733|Tretinoin|tretinoin|mesh-list
24699837|NCT01449253|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24613036|NCT01016665|Anastrozole|anastrozole|mesh-list
24699838|NCT01449344|Cytarabine|cytarabine|mesh-list
24699839|NCT01449344|Dexamethasone|dexamethasone|mesh-list
24699840|NCT01449344|Dexamethasone acetate|dexamethasone acetate|mesh-list
24699841|NCT01449344|Rituximab|rituximab|mesh-list
24699842|NCT01449344|Bortezomib|bortezomib|mesh-list
24699843|NCT01449344|BB 1101|bb 1101|mesh-list
24699844|NCT01449344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24699845|NCT01449344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24699846|NCT01449344|Immunologic Factors|immunologic factors|mesh-ancestor
24699847|NCT01449344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699848|NCT01449344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24699850|NCT01449344|Antiemetics|antiemetics|mesh-ancestor
24699855|NCT01449344|Hormones|hormones|mesh-ancestor
24699856|NCT01449344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24700813|NCT01455246|Daptomycin|daptomycin|mesh-list
24699857|NCT01449344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24699858|NCT01449344|Protease Inhibitors|protease inhibitors|mesh-ancestor
24699859|NCT01449344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699860|NCT01449344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699861|NCT01449344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24699862|NCT01449344|Antimetabolites|antimetabolites|mesh-ancestor
24699969|NCT01449877|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24687491|NCT03954743|Vaccines|vaccines|mesh-list
24687492|NCT03954743|Immunologic Factors|immunologic factors|mesh-ancestor
24687493|NCT03954743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687494|NCT03947671|Acetaminophen|acetaminophen|mesh-list
24687495|NCT03947671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24687496|NCT03947671|Analgesics|analgesics|mesh-ancestor
24687497|NCT03947671|Sensory System Agents|sensory system agents|mesh-ancestor
24687498|NCT03947671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24700017|NCT01450163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24700018|NCT01450163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24700049|NCT01450241|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24700050|NCT01450241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24700051|NCT01450267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24700052|NCT01450345|Pregabalin|pregabalin|mesh-list
24700053|NCT01450345|Analgesics|analgesics|mesh-ancestor
24700054|NCT01450345|Sensory System Agents|sensory system agents|mesh-ancestor
24703110|NCT01469624|Antioxidants|antioxidants|mesh-ancestor
24700055|NCT01450345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24700056|NCT01450345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700057|NCT01450345|Anticonvulsants|anticonvulsants|mesh-ancestor
24700058|NCT01450345|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24485683|NCT00454480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24700059|NCT01450345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24700060|NCT01450345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613039|NCT01016665|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24613047|NCT01016717|Omeprazole|omeprazole|mesh-list
24613065|NCT01016821|Analgesics|analgesics|mesh-ancestor
24855423|NCT02279563|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24855424|NCT02279563|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24700107|NCT01450566|Anesthetics|anesthetics|mesh-ancestor
24700130|NCT01450774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700131|NCT01450774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24700133|NCT01450774|Hormones|hormones|mesh-ancestor
24700150|NCT01450956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24700151|NCT01450956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700152|NCT01450995|Sumatriptan|sumatriptan|mesh-list
24700153|NCT01450995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24700154|NCT01450995|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24700155|NCT01450995|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24700190|NCT01451229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24700590|NCT01453426|Immunologic Factors|immunologic factors|mesh-ancestor
24643792|NCT01187303|Ofatumumab|ofatumumab|mesh-list
24700591|NCT01453426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700676|NCT01454180|Leucovorin|leucovorin|mesh-list
24700677|NCT01454180|Gemcitabine|gemcitabine|mesh-list
24700678|NCT01454180|Capecitabine|capecitabine|mesh-list
24700679|NCT01454180|Fluorouracil|fluorouracil|mesh-list
24700680|NCT01454180|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24700681|NCT01454180|Oxaliplatin|oxaliplatin|mesh-list
24700682|NCT01454180|Folfirinox|folfirinox|mesh-list
24700683|NCT01454180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24700684|NCT01454180|Antimetabolites|antimetabolites|mesh-ancestor
24700685|NCT01454180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700686|NCT01454180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24700687|NCT01454180|Antiviral Agents|antiviral agents|mesh-ancestor
24700688|NCT01454180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24700689|NCT01454180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855427|NCT02279563|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24855428|NCT02279563|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24700719|NCT01454609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24700721|NCT01454609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24700722|NCT01454609|Sympatholytics|sympatholytics|mesh-ancestor
24700723|NCT01454609|Autonomic Agents|autonomic agents|mesh-ancestor
24700724|NCT01454609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24700725|NCT01454609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24700726|NCT01454609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24700814|NCT01455246|Ceftazidime|ceftazidime|mesh-list
24700815|NCT01455246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24700816|NCT01455246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24700817|NCT01455337|Prednisolone|prednisolone|mesh-list
24700818|NCT01455337|Pentoxifylline|pentoxifylline|mesh-list
24700819|NCT01455337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24700820|NCT01455337|Glucocorticoids|glucocorticoids|mesh-ancestor
24700821|NCT01455337|Hormones|hormones|mesh-ancestor
24700822|NCT01455337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24700823|NCT01455337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700824|NCT01455337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24700825|NCT01455337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812733|NCT02054299|Micronutrients|micronutrients|mesh-ancestor
24812734|NCT02054299|Antimalarials|antimalarials|mesh-ancestor
24701243|NCT01457859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24613231|NCT01017796|Protective Agents|protective agents|mesh-ancestor
24613232|NCT01017796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701306|NCT01458067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701307|NCT01458223|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24701308|NCT01458223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24701309|NCT01458223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24701310|NCT01458223|Antitubercular Agents|antitubercular agents|mesh-ancestor
24701311|NCT01458236|Beraprost|beraprost|mesh-list
24644018|NCT01188304|Antipyretics|antipyretics|mesh-ancestor
24701312|NCT01458236|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24701313|NCT01458236|Vasodilator Agents|vasodilator agents|mesh-ancestor
24701314|NCT01458301|Leuprolide|leuprolide|mesh-list
24701315|NCT01458301|Relugolix|relugolix|mesh-list
24701316|NCT01458301|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24701317|NCT01458301|Fertility Agents|fertility agents|mesh-ancestor
24701490|NCT01459315|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24701491|NCT01459315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701492|NCT01459315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701532|NCT01459419|Immunologic Factors|immunologic factors|mesh-ancestor
24633758|NCT01131026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24633759|NCT01131026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633760|NCT01131026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633761|NCT01131026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24633762|NCT01131026|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24633763|NCT01131026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24812735|NCT02054299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24812736|NCT02054299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24812737|NCT02054299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24812739|NCT02054299|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24527072|NCT00614757|Antidotes|antidotes|mesh-ancestor
24633825|NCT01131273|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
24633826|NCT01131273|Naloxone|naloxone|mesh-list
24633925|NCT01131728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24633926|NCT01131728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633949|NCT01131741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633950|NCT01131741|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24633951|NCT01131741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24633953|NCT01131741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24633954|NCT01131741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24633955|NCT01131741|Respiratory System Agents|respiratory system agents|mesh-ancestor
24688020|NCT03522584|Immunoglobulins|immunoglobulins|mesh-list
24688021|NCT03522584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24688022|NCT03522584|Immunoglobulin G|immunoglobulin g|mesh-list
24688023|NCT03522584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24688024|NCT03522584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688025|NCT03522584|Immunologic Factors|immunologic factors|mesh-ancestor
24641387|NCT01173107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688026|NCT03522584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634082|NCT01131975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24634083|NCT01131975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24634085|NCT01131975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24634087|NCT01131988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24634093|NCT01132027|Tacrolimus|tacrolimus|mesh-list
24634171|NCT01132222|Adrenergic Agents|adrenergic agents|mesh-ancestor
24634195|NCT01132404|Leuprolide|leuprolide|mesh-list
24634196|NCT01132404|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24634197|NCT01132404|Fertility Agents|fertility agents|mesh-ancestor
24634199|NCT01132404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634200|NCT01132404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24634201|NCT01132404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24634203|NCT01132417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24634204|NCT01132417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24634205|NCT01132417|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24634323|NCT01132781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634324|NCT01132781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634325|NCT01132781|Vasodilator Agents|vasodilator agents|mesh-ancestor
24634326|NCT01132781|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24634327|NCT01132781|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24634328|NCT01132781|Purinergic Agents|purinergic agents|mesh-ancestor
24634329|NCT01132781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24634330|NCT01132794|Dexmedetomidine|dexmedetomidine|mesh-list
24634331|NCT01132794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24634332|NCT01132794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24634334|NCT01132794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24634473|NCT01133509|Vaccines|vaccines|mesh-list
24634474|NCT01133509|Immunologic Factors|immunologic factors|mesh-ancestor
24634475|NCT01133509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634476|NCT01133548|Methyltestosterone|methyltestosterone|mesh-list
24634477|NCT01133548|Testosterone|testosterone|mesh-list
24634478|NCT01133548|Testosterone undecanoate|testosterone undecanoate|mesh-list
24634479|NCT01133548|Testosterone enanthate|testosterone enanthate|mesh-list
24634480|NCT01133548|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24634481|NCT01133548|Androgens|androgens|mesh-ancestor
24634482|NCT01133548|Hormones|hormones|mesh-ancestor
24634483|NCT01133548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24634530|NCT01133873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24634531|NCT01133873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634558|NCT01133912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24634559|NCT01133912|Immunologic Factors|immunologic factors|mesh-ancestor
24634560|NCT01133912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634561|NCT01133912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24634563|NCT01133925|Paclitaxel|paclitaxel|mesh-list
24634564|NCT01133925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24812754|NCT02054442|Cetuximab|cetuximab|mesh-list
24634625|NCT01134432|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24634626|NCT01134432|Prednisolone acetate|prednisolone acetate|mesh-list
24634628|NCT01134432|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24634797|NCT01135433|Ipragliflozin|ipragliflozin|mesh-list
24634798|NCT01135433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24634799|NCT01135433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634800|NCT01135433|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24634801|NCT01135433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634802|NCT01135446|Dapagliflozin|dapagliflozin|mesh-list
24634803|NCT01135446|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24634870|NCT01135641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24634871|NCT01135641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634873|NCT01135641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24634874|NCT01135641|Antifungal Agents|antifungal agents|mesh-ancestor
24634875|NCT01135641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24634876|NCT01135641|Dermatologic Agents|dermatologic agents|mesh-ancestor
24634877|NCT01135641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24634878|NCT01135667|Clopidogrel|clopidogrel|mesh-list
24634879|NCT01135667|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24634880|NCT01135667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24634881|NCT01135667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24634882|NCT01135667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24634883|NCT01135667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24635015|NCT01136421|Autonomic Agents|autonomic agents|mesh-ancestor
24635016|NCT01136421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24635017|NCT01136421|Respiratory System Agents|respiratory system agents|mesh-ancestor
24635018|NCT01136421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24635054|NCT01136642|Cholinergic Agents|cholinergic agents|mesh-ancestor
24635055|NCT01136642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24635086|NCT01136863|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24635088|NCT01136863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635093|NCT01136941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24635094|NCT01136941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24635096|NCT01136941|Sensory System Agents|sensory system agents|mesh-ancestor
24635097|NCT01136941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24635098|NCT01136941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635099|NCT01136941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24635100|NCT01136941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24635117|NCT01137084|Methylprednisolone|methylprednisolone|mesh-list
24635118|NCT01137084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24635119|NCT01137084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24635138|NCT01137253|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
24635334|NCT01138553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635335|NCT01138553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24635336|NCT01138553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24635337|NCT01138553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25710827|NCT02292082|Anesthetics, Local|anesthetics, local|mesh-ancestor
24635358|NCT01138605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24635359|NCT01138683|Diuretics|diuretics|mesh-list
24635360|NCT01138683|Natriuretic Agents|natriuretic agents|mesh-ancestor
24635361|NCT01138683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704647|NCT01479504|Cisplatin|cisplatin|mesh-list
24635362|NCT01138774|Thioctic Acid|thioctic acid|mesh-list
24635363|NCT01138774|Antioxidants|antioxidants|mesh-ancestor
24635364|NCT01138774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635365|NCT01138774|Protective Agents|protective agents|mesh-ancestor
24635366|NCT01138774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635367|NCT01138774|Vitamin B Complex|vitamin b complex|mesh-ancestor
24635369|NCT01138774|Micronutrients|micronutrients|mesh-ancestor
24635370|NCT01138839|Dexamethasone|dexamethasone|mesh-list
24635371|NCT01138839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24635372|NCT01138839|Antiemetics|antiemetics|mesh-ancestor
24635373|NCT01138839|Autonomic Agents|autonomic agents|mesh-ancestor
24635374|NCT01138839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24635460|NCT01139463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24635461|NCT01139463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24855441|NCT02279589|Immunologic Factors|immunologic factors|mesh-ancestor
24635462|NCT01139463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24635463|NCT01139463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24635464|NCT01139463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24635465|NCT01139463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635466|NCT01139463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24635467|NCT01139463|Serotonin Agents|serotonin agents|mesh-ancestor
24635468|NCT01139463|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24635469|NCT01139463|Dopamine Agents|dopamine agents|mesh-ancestor
24635643|NCT01140529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24635644|NCT01140529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635645|NCT01140529|Antiemetics|antiemetics|mesh-ancestor
24635646|NCT01140529|Autonomic Agents|autonomic agents|mesh-ancestor
24635647|NCT01140529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24635648|NCT01140529|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24635649|NCT01140529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24666005|NCT01316744|Ketamine|ketamine|mesh-list
24635650|NCT01140529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24635665|NCT01140620|Anesthetics|anesthetics|mesh-ancestor
24635666|NCT01140620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24635667|NCT01140620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24855447|NCT02279615|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24635739|NCT01140984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24635740|NCT01140984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24635741|NCT01140984|Protective Agents|protective agents|mesh-ancestor
24635742|NCT01140984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24635743|NCT01140984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24635744|NCT01140997|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24635745|NCT01140997|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24635746|NCT01140997|Antiviral Agents|antiviral agents|mesh-ancestor
24635748|NCT01141036|Midazolam|midazolam|mesh-list
24635749|NCT01141036|Propofol|propofol|mesh-list
24635750|NCT01141036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24635751|NCT01141036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24635752|NCT01141036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635753|NCT01141036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24635754|NCT01141036|Anesthetics, General|anesthetics, general|mesh-ancestor
24635755|NCT01141036|Anesthetics|anesthetics|mesh-ancestor
24451985|NCT00325676|Pantoprazole|pantoprazole|mesh-list
25710828|NCT02292082|Anesthetics|anesthetics|mesh-ancestor
25710829|NCT02292082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25710830|NCT02292082|Sensory System Agents|sensory system agents|mesh-ancestor
25710831|NCT02292082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25710832|NCT02292082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25710833|NCT02292082|Anesthetics, General|anesthetics, general|mesh-ancestor
24635790|NCT01141153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24635791|NCT01141153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710834|NCT02292082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25710835|NCT02292082|Narcotics|narcotics|mesh-ancestor
25710836|NCT02292082|Analgesics|analgesics|mesh-ancestor
24635792|NCT01141153|Antipyretics|antipyretics|mesh-ancestor
24635874|NCT01141465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24635875|NCT01141465|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24635876|NCT01141465|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24635877|NCT01141465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24635878|NCT01141465|Adrenergic Agents|adrenergic agents|mesh-ancestor
24635879|NCT01141465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24636085|NCT01142648|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24636086|NCT01142648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636087|NCT01142648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636088|NCT01142648|Cholinergic Agents|cholinergic agents|mesh-ancestor
24636089|NCT01142648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24636090|NCT01142648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636091|NCT01142648|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24636092|NCT01142648|Autonomic Agents|autonomic agents|mesh-ancestor
24636093|NCT01142648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24636094|NCT01142648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24636095|NCT01142648|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24636096|NCT01142648|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24636097|NCT01142700|Ribavirin|ribavirin|mesh-list
24636098|NCT01142700|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24636099|NCT01142700|Antimetabolites|antimetabolites|mesh-ancestor
24636100|NCT01142700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636101|NCT01142700|Antiviral Agents|antiviral agents|mesh-ancestor
24855454|NCT02279615|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24855455|NCT02279615|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24855457|NCT02279628|Ropivacaine|ropivacaine|mesh-list
24529432|NCT00625911|Anesthetics|anesthetics|mesh-ancestor
24636320|NCT01144728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636321|NCT01144728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24636328|NCT01144754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636329|NCT01144754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24636331|NCT01144832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24636332|NCT01144832|Histamine Antagonists|histamine antagonists|mesh-ancestor
24636333|NCT01144832|Histamine Agents|histamine agents|mesh-ancestor
24636334|NCT01144832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24636335|NCT01144832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636336|NCT01144832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636337|NCT01144910|Methacholine Chloride|methacholine chloride|mesh-list
24636338|NCT01144910|Miotics|miotics|mesh-ancestor
24636339|NCT01144910|Autonomic Agents|autonomic agents|mesh-ancestor
24636340|NCT01144910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24636539|NCT01146002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24636540|NCT01146002|Adrenergic Agents|adrenergic agents|mesh-ancestor
24636541|NCT01146002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24636542|NCT01146002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636543|NCT01146002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636544|NCT01146028|Tizanidine|tizanidine|mesh-list
24636546|NCT01146028|Sensory System Agents|sensory system agents|mesh-ancestor
24636547|NCT01146028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24636548|NCT01146028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636595|NCT01146145|Morphine|morphine|mesh-list
24636682|NCT01146925|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24636683|NCT01146925|Chelating Agents|chelating agents|mesh-ancestor
24636684|NCT01146925|Sequestering Agents|sequestering agents|mesh-ancestor
24636685|NCT01146925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636687|NCT01146977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24636688|NCT01146977|Antimetabolites|antimetabolites|mesh-ancestor
24636689|NCT01146977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636690|NCT01146977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24636691|NCT01146977|Antiviral Agents|antiviral agents|mesh-ancestor
24636700|NCT01147016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24636702|NCT01147016|Tubulin Modulators|tubulin modulators|mesh-ancestor
24636703|NCT01147016|Antimitotic Agents|antimitotic agents|mesh-ancestor
24636704|NCT01147016|Mitosis Modulators|mitosis modulators|mesh-ancestor
24636729|NCT01147133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24636730|NCT01147133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636936|NCT01148147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636938|NCT01148160|Antifungal Agents|antifungal agents|mesh-ancestor
24636939|NCT01148160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24636940|NCT01148160|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24636941|NCT01148160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24636942|NCT01148160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705488|NCT01485367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24636943|NCT01148160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636944|NCT01148160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24636946|NCT01148160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24636948|NCT01148160|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24637017|NCT01148316|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24637018|NCT01148316|Antidepressive Agents|antidepressive agents|mesh-ancestor
24637019|NCT01148316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24637020|NCT01148316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24855477|NCT02279875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24855478|NCT02279875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24637021|NCT01148316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24637022|NCT01148316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637023|NCT01148342|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
24637025|NCT01148342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637026|NCT01148342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24637027|NCT01148342|Serotonin Agents|serotonin agents|mesh-ancestor
24637028|NCT01148342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24637042|NCT01148446|Immunologic Factors|immunologic factors|mesh-ancestor
24637043|NCT01148446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637063|NCT01148446|Mitosis Modulators|mitosis modulators|mesh-ancestor
24637064|NCT01148472|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24637065|NCT01148472|Citalopram|citalopram|mesh-list
24637066|NCT01148472|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24637067|NCT01148472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24637136|NCT01148992|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24637138|NCT01148992|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24637139|NCT01148992|Adrenergic Agents|adrenergic agents|mesh-ancestor
24637160|NCT01149018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637162|NCT01149018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24637163|NCT01149109|Temozolomide|temozolomide|mesh-list
24637165|NCT01149109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24637166|NCT01149109|Alkylating Agents|alkylating agents|mesh-ancestor
24637167|NCT01149109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637168|NCT01149109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637169|NCT01149122|Gemcitabine|gemcitabine|mesh-list
24637170|NCT01149122|Oxaliplatin|oxaliplatin|mesh-list
24637171|NCT01149122|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24637177|NCT01149122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24637178|NCT01149122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637179|NCT01149122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24637180|NCT01149122|Immunologic Factors|immunologic factors|mesh-ancestor
24637181|NCT01149122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637182|NCT01149122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24637184|NCT01149174|Mitomycin|mitomycin|mesh-list
24637187|NCT01149174|Alkylating Agents|alkylating agents|mesh-ancestor
24637219|NCT01149304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24637220|NCT01149330|Adapalene|adapalene|mesh-list
24637224|NCT01149330|Sensory System Agents|sensory system agents|mesh-ancestor
24637225|NCT01149330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24637226|NCT01149330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637227|NCT01149330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24637228|NCT01149330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24637229|NCT01149330|Dermatologic Agents|dermatologic agents|mesh-ancestor
24637230|NCT01149356|Exemestane|exemestane|mesh-list
24637231|NCT01149356|Goserelin|goserelin|mesh-list
24637232|NCT01149356|R04929097|r04929097|mesh-list
24637334|NCT01149941|Sensory System Agents|sensory system agents|mesh-ancestor
24637335|NCT01149941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24637336|NCT01149941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637337|NCT01149941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24637338|NCT01149941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24637339|NCT01149941|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24637340|NCT01149941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637341|NCT01149941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637346|NCT01149954|Sensory System Agents|sensory system agents|mesh-ancestor
24637347|NCT01149954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24637348|NCT01149954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637349|NCT01149954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24706743|NCT01491503|Cetirizine|cetirizine|mesh-list
24637350|NCT01149954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24637351|NCT01149954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24637353|NCT01149954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637355|NCT01149967|Citalopram|citalopram|mesh-list
24637356|NCT01149967|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24637357|NCT01149967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24637358|NCT01149967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24637359|NCT01149967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637415|NCT01150162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24637416|NCT01150162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24637417|NCT01150162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24637418|NCT01150162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637534|NCT01151254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24637536|NCT01151254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637537|NCT01151254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24637538|NCT01151254|Anesthetics, General|anesthetics, general|mesh-ancestor
24637539|NCT01151254|Anesthetics|anesthetics|mesh-ancestor
24637584|NCT01151696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24637585|NCT01151696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637586|NCT01151696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637587|NCT01151722|Bevacizumab|bevacizumab|mesh-list
24637588|NCT01151722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24637590|NCT01151722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24637591|NCT01151722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24637592|NCT01151722|Growth Substances|growth substances|mesh-ancestor
24637593|NCT01151722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637594|NCT01151722|Growth Inhibitors|growth inhibitors|mesh-ancestor
24637595|NCT01151735|Complement C1s|complement c1s|mesh-list
24637596|NCT01151735|Immunologic Factors|immunologic factors|mesh-ancestor
24637597|NCT01151735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637598|NCT01151787|Amitriptyline|amitriptyline|mesh-list
24637599|NCT01151787|Cyclobenzaprine|cyclobenzaprine|mesh-list
24855496|NCT02279914|Abortifacient Agents|abortifacient agents|mesh-ancestor
24855497|NCT02279914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24531126|NCT00634192|Tobramycin|tobramycin|mesh-list
24637600|NCT01151787|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24637601|NCT01151787|Antidepressive Agents|antidepressive agents|mesh-ancestor
24637622|NCT01151800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637623|NCT01151800|Sensory System Agents|sensory system agents|mesh-ancestor
24637624|NCT01151800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24637727|NCT01152749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637729|NCT01152801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637730|NCT01152801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24637731|NCT01152801|Immunologic Factors|immunologic factors|mesh-ancestor
24637732|NCT01152801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637745|NCT01152866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637746|NCT01152931|Vitamins|vitamins|mesh-list
24637747|NCT01152931|Vitamin E|vitamin e|mesh-list
24637748|NCT01152931|Tocopherols|tocopherols|mesh-list
24637749|NCT01152931|Tocotrienols|tocotrienols|mesh-list
24637750|NCT01152931|alpha-Tocopherol|alpha-tocopherol|mesh-list
24637751|NCT01152931|Vitamin A|vitamin a|mesh-list
24637752|NCT01152931|Zinc|zinc|mesh-list
24637753|NCT01152931|Selenium|selenium|mesh-list
24637754|NCT01152931|Artesunate|artesunate|mesh-list
24637755|NCT01152931|Lumefantrine|lumefantrine|mesh-list
24637756|NCT01152931|Artemether|artemether|mesh-list
24637757|NCT01152931|Amodiaquine|amodiaquine|mesh-list
24637758|NCT01152931|Retinol palmitate|retinol palmitate|mesh-list
24637935|NCT01154348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637937|NCT01154361|Icatibant|icatibant|mesh-list
24637938|NCT01154361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25710837|NCT02292082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25710838|NCT02292082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25710839|NCT02292082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24638018|NCT01154504|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24638019|NCT01154504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25710840|NCT02292082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24638020|NCT01154504|Autonomic Agents|autonomic agents|mesh-ancestor
24638021|NCT01154504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24638022|NCT01154504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638023|NCT01154504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24638024|NCT01154504|Respiratory System Agents|respiratory system agents|mesh-ancestor
24638025|NCT01154504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24638026|NCT01154504|Vasodilator Agents|vasodilator agents|mesh-ancestor
24638027|NCT01154504|Protective Agents|protective agents|mesh-ancestor
24638028|NCT01154530|Chlorhexidine|chlorhexidine|mesh-list
24638029|NCT01154530|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24638030|NCT01154530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24638031|NCT01154530|Disinfectants|disinfectants|mesh-ancestor
24638048|NCT01154738|Anesthetics|anesthetics|mesh-ancestor
24855517|NCT02279953|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24855518|NCT02279953|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24855519|NCT02279966|Vortioxetine|vortioxetine|mesh-list
24457919|NCT00335673|Irbesartan|irbesartan|mesh-list
24638175|NCT01155115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638176|NCT01155115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24638177|NCT01155115|Respiratory System Agents|respiratory system agents|mesh-ancestor
24638178|NCT01155115|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24638179|NCT01155115|Antioxidants|antioxidants|mesh-ancestor
24638180|NCT01155115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638404|NCT01156389|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24638405|NCT01156389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24638406|NCT01156389|Antimalarials|antimalarials|mesh-ancestor
24638407|NCT01156389|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24638439|NCT01156688|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24638440|NCT01156688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24638441|NCT01156688|Oxytocics|oxytocics|mesh-ancestor
24638479|NCT01156883|Thioguanine|thioguanine|mesh-list
24638480|NCT01156883|Vindesine|vindesine|mesh-list
24855522|NCT02279966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24855523|NCT02279966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24855524|NCT02279966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638481|NCT01156883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24638482|NCT01156883|Immunologic Factors|immunologic factors|mesh-ancestor
24638483|NCT01156883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638484|NCT01156883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24638485|NCT01156883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24638486|NCT01156883|Alkylating Agents|alkylating agents|mesh-ancestor
24638487|NCT01156883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638488|NCT01156883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638614|NCT01157312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638643|NCT01157455|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24638644|NCT01157455|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24638645|NCT01157455|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24638646|NCT01157455|Purinergic Agents|purinergic agents|mesh-ancestor
24638647|NCT01157455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24638650|NCT01157455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24638651|NCT01157455|Protease Inhibitors|protease inhibitors|mesh-ancestor
24638652|NCT01157481|Nifedipine|nifedipine|mesh-list
24638653|NCT01157481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24638654|NCT01157481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24638655|NCT01157481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638656|NCT01157481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24638657|NCT01157481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638658|NCT01157481|Vasodilator Agents|vasodilator agents|mesh-ancestor
25710841|NCT02292082|GABA Modulators|gaba modulators|mesh-ancestor
25710842|NCT02292082|GABA Agents|gaba agents|mesh-ancestor
25710843|NCT02292082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25710844|NCT02292082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638659|NCT01157481|Tocolytic Agents|tocolytic agents|mesh-ancestor
24638660|NCT01157481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24638661|NCT01157507|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24638717|NCT01157585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24638718|NCT01157585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638719|NCT01157585|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24638720|NCT01157585|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24638721|NCT01157585|Dopamine Agents|dopamine agents|mesh-ancestor
24638772|NCT01158014|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24638800|NCT01158183|Interferon beta-1b|interferon beta-1b|mesh-list
24638801|NCT01158183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638836|NCT01158586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24638837|NCT01158586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638838|NCT01158586|Sensory System Agents|sensory system agents|mesh-ancestor
24638839|NCT01158586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24638840|NCT01158612|Hormones|hormones|mesh-list
24638841|NCT01158612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24638842|NCT01158612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638843|NCT01158729|Antithrombins|antithrombins|mesh-list
24638845|NCT01158729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24638846|NCT01158729|Protease Inhibitors|protease inhibitors|mesh-ancestor
24638847|NCT01158729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24638848|NCT01158729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638849|NCT01158729|Anticoagulants|anticoagulants|mesh-ancestor
24638850|NCT01158755|Moxifloxacin|moxifloxacin|mesh-list
24638914|NCT01159132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638916|NCT01159145|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24855704|NCT02280629|Mesalamine|mesalamine|mesh-list
24638917|NCT01159145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24638918|NCT01159145|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24638919|NCT01159145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24638920|NCT01159145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638922|NCT01159158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24638923|NCT01159158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638924|NCT01159210|Thrombin|thrombin|mesh-list
24638925|NCT01159210|Hemostatics|hemostatics|mesh-ancestor
24638926|NCT01159210|Coagulants|coagulants|mesh-ancestor
24638927|NCT01159236|Paclitaxel|paclitaxel|mesh-list
24638933|NCT01159236|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24638935|NCT01159236|Tubulin Modulators|tubulin modulators|mesh-ancestor
24638943|NCT01159236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24638944|NCT01159236|Alkylating Agents|alkylating agents|mesh-ancestor
24638981|NCT01159353|Insulin|insulin|mesh-list
24638982|NCT01159353|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24638983|NCT01159353|Insulin Aspart|insulin aspart|mesh-list
24638984|NCT01159353|Insulin glulisine|insulin glulisine|mesh-list
24638985|NCT01159353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24638986|NCT01159353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638987|NCT01159379|Ertapenem|ertapenem|mesh-list
24638988|NCT01159379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24638989|NCT01159379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24638991|NCT01159418|Carboplatin|carboplatin|mesh-list
24638992|NCT01159418|Panobinostat|panobinostat|mesh-list
24638995|NCT01159418|Tubulin Modulators|tubulin modulators|mesh-ancestor
24855537|NCT02279966|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24855538|NCT02279966|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24855539|NCT02279966|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24855540|NCT02279966|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24855542|NCT02279992|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24855543|NCT02279992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639176|NCT01160419|Micronutrients|micronutrients|mesh-ancestor
24639177|NCT01160419|Hematinics|hematinics|mesh-ancestor
24639178|NCT01160432|Methadone|methadone|mesh-list
24639179|NCT01160432|Naloxone|naloxone|mesh-list
24639198|NCT01160588|Serotonin Agents|serotonin agents|mesh-ancestor
24639199|NCT01160588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639201|NCT01160627|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24639202|NCT01160627|Antiviral Agents|antiviral agents|mesh-ancestor
24639203|NCT01160627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24639204|NCT01160627|Expectorants|expectorants|mesh-ancestor
24639376|NCT01161277|Haloperidol|haloperidol|mesh-list
24855551|NCT02280031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24855552|NCT02280031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24855553|NCT02280031|Analgesics|analgesics|mesh-ancestor
24855554|NCT02280031|Sensory System Agents|sensory system agents|mesh-ancestor
24855555|NCT02280031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24855556|NCT02280031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855557|NCT02280031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24639401|NCT01161316|Cetuximab|cetuximab|mesh-list
24639527|NCT01162720|Nasal Decongestants|nasal decongestants|mesh-ancestor
24639528|NCT01162720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24708388|NCT01501149|Etoposide|etoposide|mesh-list
24639529|NCT01162720|Respiratory System Agents|respiratory system agents|mesh-ancestor
24639530|NCT01162746|Dexamethasone|dexamethasone|mesh-list
24639531|NCT01162746|Ranibizumab|ranibizumab|mesh-list
24639532|NCT01162746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24639533|NCT01162746|Antiemetics|antiemetics|mesh-ancestor
24639534|NCT01162746|Autonomic Agents|autonomic agents|mesh-ancestor
24639535|NCT01162746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24639536|NCT01162746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855581|NCT02280070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855582|NCT02280070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24855583|NCT02280070|Antidotes|antidotes|mesh-ancestor
24855584|NCT02280070|Protective Agents|protective agents|mesh-ancestor
24855586|NCT02280070|Vitamins|vitamins|mesh-ancestor
24639844|NCT01164488|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24639845|NCT01164488|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24639846|NCT01164488|Hormone Antagonists|hormone antagonists|mesh-ancestor
24639847|NCT01164488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24639848|NCT01164488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639849|NCT01164540|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24639850|NCT01164540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24639851|NCT01164540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24639853|NCT01164540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24639854|NCT01164540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24639942|NCT01165060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855611|NCT02280148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855617|NCT02280174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855618|NCT02280174|Incretins|incretins|mesh-ancestor
24855620|NCT02280174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24855628|NCT02280239|Sensory System Agents|sensory system agents|mesh-ancestor
24855629|NCT02280239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24855630|NCT02280239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855631|NCT02280239|Antipyretics|antipyretics|mesh-ancestor
24855632|NCT02280265|Factor VIII|factor viii|mesh-list
24640019|NCT01165580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24640020|NCT01165645|Ritonavir|ritonavir|mesh-list
24640021|NCT01165645|Lopinavir|lopinavir|mesh-list
24640022|NCT01165645|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24640044|NCT01165814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24640045|NCT01165814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24640046|NCT01165814|Gout Suppressants|gout suppressants|mesh-ancestor
24640047|NCT01165814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24640048|NCT01165814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640049|NCT01165814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640050|NCT01165866|Ondansetron|ondansetron|mesh-list
24640051|NCT01165866|Metoclopramide|metoclopramide|mesh-list
24640052|NCT01165866|Antiemetics|antiemetics|mesh-ancestor
24640053|NCT01165866|Autonomic Agents|autonomic agents|mesh-ancestor
24640054|NCT01165866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24640055|NCT01165866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640056|NCT01165866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24640057|NCT01165866|Antipruritics|antipruritics|mesh-ancestor
24690832|NCT01404156|Epirubicin|epirubicin|mesh-list
24690835|NCT01404156|Tubulin Modulators|tubulin modulators|mesh-ancestor
24640190|NCT01166594|Growth Substances|growth substances|mesh-ancestor
24640191|NCT01166594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640193|NCT01166685|Everolimus|everolimus|mesh-list
24855645|NCT02280486|Hormones|hormones|mesh-ancestor
24855646|NCT02280486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24855647|NCT02280486|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24855648|NCT02280486|Protease Inhibitors|protease inhibitors|mesh-ancestor
24855649|NCT02280486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855650|NCT02280486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640209|NCT01166711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640210|NCT01166789|Lubiprostone|lubiprostone|mesh-list
24640211|NCT01166789|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24640355|NCT01167738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24640356|NCT01167738|Antimetabolites|antimetabolites|mesh-ancestor
24640423|NCT01167946|Autonomic Agents|autonomic agents|mesh-ancestor
24640424|NCT01167946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24640425|NCT01167946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640426|NCT01167946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24640454|NCT01168336|Vasodilator Agents|vasodilator agents|mesh-ancestor
24640455|NCT01168336|Histamine Agonists|histamine agonists|mesh-ancestor
24640456|NCT01168336|Histamine Agents|histamine agents|mesh-ancestor
24640457|NCT01168336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24640459|NCT01168336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640460|NCT01168375|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24640461|NCT01168375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24640462|NCT01168440|Sunitinib|sunitinib|mesh-list
24640463|NCT01168440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640464|NCT01168440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24640466|NCT01168440|Growth Substances|growth substances|mesh-ancestor
24640586|NCT01169025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24640587|NCT01169025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24640588|NCT01169025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24640589|NCT01169025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24640669|NCT01169571|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24640671|NCT01169571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24640672|NCT01169571|Adrenergic Agents|adrenergic agents|mesh-ancestor
24640822|NCT01170182|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24640823|NCT01170182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640824|NCT01170182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640826|NCT01170260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24641234|NCT01172509|Baclofen|baclofen|mesh-list
24640828|NCT01170260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24640829|NCT01170260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640830|NCT01170325|Valproic Acid|valproic acid|mesh-list
24640831|NCT01170325|Anticonvulsants|anticonvulsants|mesh-ancestor
24640832|NCT01170325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640833|NCT01170325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640834|NCT01170325|GABA Agents|gaba agents|mesh-ancestor
24640835|NCT01170325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24640836|NCT01170325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640837|NCT01170325|Antimanic Agents|antimanic agents|mesh-ancestor
24640838|NCT01170325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24640839|NCT01170325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24812801|NCT02054676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24812802|NCT02054676|Analgesics|analgesics|mesh-ancestor
24812803|NCT02054676|Sensory System Agents|sensory system agents|mesh-ancestor
24812804|NCT02054676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812805|NCT02054676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640953|NCT01170780|Glucocorticoids|glucocorticoids|mesh-ancestor
24640954|NCT01170780|Hormones|hormones|mesh-ancestor
24640955|NCT01170780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24640956|NCT01170780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24640957|NCT01170780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640958|NCT01170806|Orlistat|orlistat|mesh-list
24640959|NCT01170806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640960|NCT01170806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640961|NCT01170806|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24640962|NCT01170806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24640963|NCT01170819|Dinoprostone|dinoprostone|mesh-list
24641073|NCT01171807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24641074|NCT01171807|Antiemetics|antiemetics|mesh-ancestor
24641075|NCT01171807|Autonomic Agents|autonomic agents|mesh-ancestor
24641076|NCT01171807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24641077|NCT01171807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641078|NCT01171807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24641079|NCT01171807|Glucocorticoids|glucocorticoids|mesh-ancestor
24641080|NCT01171807|Hormones|hormones|mesh-ancestor
24641081|NCT01171807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24641082|NCT01171807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24641083|NCT01171807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641084|NCT01171833|Sevoflurane|sevoflurane|mesh-list
24641085|NCT01171833|Desflurane|desflurane|mesh-list
24641086|NCT01171833|Isoflurane|isoflurane|mesh-list
24641087|NCT01171833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24641088|NCT01171833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24641089|NCT01171833|Anesthetics, General|anesthetics, general|mesh-ancestor
24641090|NCT01171833|Anesthetics|anesthetics|mesh-ancestor
24641091|NCT01171833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24641153|NCT01172171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24641155|NCT01172223|Doxorubicin|doxorubicin|mesh-list
24641156|NCT01172223|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24641157|NCT01172223|Lapatinib|lapatinib|mesh-list
24812813|NCT02054793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24641180|NCT01172405|Ibuprofen|ibuprofen|mesh-list
24641189|NCT01172405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24641190|NCT01172405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24855721|NCT02280694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24855722|NCT02280694|Alkylating Agents|alkylating agents|mesh-ancestor
24458157|NCT00336791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641202|NCT01172431|Diuretics|diuretics|mesh-ancestor
24641203|NCT01172431|Natriuretic Agents|natriuretic agents|mesh-ancestor
24641204|NCT01172431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641223|NCT01172470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641224|NCT01172470|Antiviral Agents|antiviral agents|mesh-ancestor
24641225|NCT01172470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24641226|NCT01172470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710845|NCT02292082|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25710846|NCT02292082|Protective Agents|protective agents|mesh-ancestor
25710847|NCT02292082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25710848|NCT02292082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25710849|NCT02292719|Ritonavir|ritonavir|mesh-list
25710850|NCT02292719|Ribavirin|ribavirin|mesh-list
25710851|NCT02292719|Sofosbuvir|sofosbuvir|mesh-list
25710852|NCT02292719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25710853|NCT02292719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25710854|NCT02292719|Protease Inhibitors|protease inhibitors|mesh-ancestor
25710855|NCT02292719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710856|NCT02292719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710857|NCT02292719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25710858|NCT02292719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25710859|NCT02292719|Antiviral Agents|antiviral agents|mesh-ancestor
25710860|NCT02292719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25710861|NCT02292719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25710862|NCT02292719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25710863|NCT02292719|Antimetabolites|antimetabolites|mesh-ancestor
25710864|NCT02292771|Vasotocin|vasotocin|mesh-list
25710865|NCT02292771|Atosiban|atosiban|mesh-list
25710866|NCT02292771|Hormone Antagonists|hormone antagonists|mesh-ancestor
25710867|NCT02292771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25710868|NCT02292771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710869|NCT02292771|Tocolytic Agents|tocolytic agents|mesh-ancestor
24641227|NCT01172470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24641228|NCT01172470|Immunologic Factors|immunologic factors|mesh-ancestor
24641229|NCT01172470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641230|NCT01172470|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24641231|NCT01172470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24641232|NCT01172496|Treprostinil|treprostinil|mesh-list
24641396|NCT01173263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24641397|NCT01173263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641416|NCT01173510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24641418|NCT01173536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24641419|NCT01173536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24641420|NCT01173536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24641421|NCT01173536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24641422|NCT01173536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855734|NCT02280694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24855735|NCT02280694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24855736|NCT02280694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24855738|NCT02280694|Sensory System Agents|sensory system agents|mesh-ancestor
24855739|NCT02280694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24641423|NCT01173536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641424|NCT01173536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641426|NCT01173549|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24641427|NCT01173549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641447|NCT01173627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24641448|NCT01173627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641487|NCT01173809|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24641488|NCT01173809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24641489|NCT01173887|Mogamulizumab|mogamulizumab|mesh-list
24641490|NCT01173887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641492|NCT01173926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24641494|NCT01173926|Insulin, Long-Acting|insulin, long-acting|mesh-list
24641495|NCT01173926|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24641497|NCT01173926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855740|NCT02280694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24855741|NCT02280694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24855742|NCT02280694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24855743|NCT02280720|Tryptophan|tryptophan|mesh-list
24855745|NCT02280720|Antidepressive Agents|antidepressive agents|mesh-ancestor
24855756|NCT02280876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24855757|NCT02280876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24855758|NCT02280876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24855759|NCT02280876|Analgesics|analgesics|mesh-ancestor
24855760|NCT02280876|Sensory System Agents|sensory system agents|mesh-ancestor
24855761|NCT02280876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24855762|NCT02280876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855763|NCT02280876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24855764|NCT02280876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24855765|NCT02280876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24855771|NCT02280993|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24855772|NCT02280993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855773|NCT02280993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24855774|NCT02280993|Antiemetics|antiemetics|mesh-ancestor
24855775|NCT02280993|Autonomic Agents|autonomic agents|mesh-ancestor
24855776|NCT02280993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24855777|NCT02280993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855778|NCT02280993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24641559|NCT01174212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24641560|NCT01174212|Antitubercular Agents|antitubercular agents|mesh-ancestor
24641565|NCT01174290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24641566|NCT01174290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641648|NCT01174693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641649|NCT01174693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641651|NCT01174810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24641652|NCT01174810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641653|NCT01174810|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24641654|NCT01174810|Incretins|incretins|mesh-ancestor
24641655|NCT01174810|Hormones|hormones|mesh-ancestor
24641656|NCT01174810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24641657|NCT01174849|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24855789|NCT02281006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855791|NCT02281006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24855803|NCT02281058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24855804|NCT02281058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855805|NCT02281058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855806|NCT02281058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24855807|NCT02281058|Immunologic Factors|immunologic factors|mesh-ancestor
24641866|NCT01175772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24641867|NCT01175772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24641868|NCT01175772|Analgesics|analgesics|mesh-ancestor
24641869|NCT01175772|Sensory System Agents|sensory system agents|mesh-ancestor
24641870|NCT01175772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24641871|NCT01175772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24641898|NCT01176409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24641900|NCT01176552|Interferon alpha-2|interferon alpha-2|mesh-list
24641901|NCT01176552|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
24641902|NCT01176552|Antiviral Agents|antiviral agents|mesh-ancestor
24641903|NCT01176552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24641904|NCT01176552|Immunologic Factors|immunologic factors|mesh-ancestor
24641905|NCT01176552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641906|NCT01176552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641907|NCT01176669|Apatinib|apatinib|mesh-list
24642009|NCT01177306|Adrenergic Agents|adrenergic agents|mesh-ancestor
24642010|NCT01177306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24642011|NCT01177306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642012|NCT01177306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642021|NCT01177358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642022|NCT01177358|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24642023|NCT01177358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24642025|NCT01177371|Methylprednisolone|methylprednisolone|mesh-list
24642026|NCT01177371|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24855850|NCT02281305|Gout Suppressants|gout suppressants|mesh-ancestor
24855851|NCT02281305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24642163|NCT01178021|Chloroquine|chloroquine|mesh-list
24642164|NCT01178021|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
24642165|NCT01178021|Primaquine|primaquine|mesh-list
24642166|NCT01178021|Amebicides|amebicides|mesh-ancestor
24642167|NCT01178021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24642168|NCT01178021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24642294|NCT01178697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642295|NCT01178697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642310|NCT01178788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642311|NCT01178788|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24642312|NCT01178788|Hormone Antagonists|hormone antagonists|mesh-ancestor
24642313|NCT01178931|Dydrogesterone|dydrogesterone|mesh-list
24642314|NCT01178931|Progesterone|progesterone|mesh-list
24642315|NCT01178931|Progestins|progestins|mesh-ancestor
24642316|NCT01178931|Hormones|hormones|mesh-ancestor
24642317|NCT01178931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24642318|NCT01178931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642319|NCT01178996|Ribavirin|ribavirin|mesh-list
24642325|NCT01178996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24642376|NCT01179100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24642377|NCT01179100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24642378|NCT01179100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24642379|NCT01179100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24642380|NCT01179100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642382|NCT01179152|Formoterol Fumarate|formoterol fumarate|mesh-list
24855873|NCT02281643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24855874|NCT02281643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24855875|NCT02281643|Antimalarials|antimalarials|mesh-ancestor
24855876|NCT02281643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24855877|NCT02281643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24855878|NCT02281669|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
24855879|NCT02281669|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24855880|NCT02281669|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24855881|NCT02281669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24855882|NCT02281669|Schistosomicides|schistosomicides|mesh-ancestor
25710870|NCT02292771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24855883|NCT02281669|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24458308|NCT00337389|Immunologic Factors|immunologic factors|mesh-ancestor
24458309|NCT00337389|Antidotes|antidotes|mesh-ancestor
24642552|NCT01180075|Emtricitabine|emtricitabine|mesh-list
24642553|NCT01180075|Efavirenz|efavirenz|mesh-list
24642554|NCT01180075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24642555|NCT01180075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24642557|NCT01180075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642558|NCT01180075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855899|NCT02281708|Cisplatin|cisplatin|mesh-list
24642614|NCT01180322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24642615|NCT01180322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642616|NCT01180322|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24642617|NCT01180322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24642618|NCT01180322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24642619|NCT01180322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642620|NCT01180322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24642621|NCT01180322|Antimetabolites|antimetabolites|mesh-ancestor
24642622|NCT01180322|Antiviral Agents|antiviral agents|mesh-ancestor
24642623|NCT01180322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24642624|NCT01180322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24642625|NCT01180322|Immunologic Factors|immunologic factors|mesh-ancestor
24642626|NCT01180322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642627|NCT01180322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24642628|NCT01180322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24855902|NCT02281708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24642678|NCT01180816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24642679|NCT01180816|Alkylating Agents|alkylating agents|mesh-ancestor
24642680|NCT01180816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642681|NCT01180816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642683|NCT01180933|Vitamin B Complex|vitamin b complex|mesh-list
24642684|NCT01180933|Hematinics|hematinics|mesh-ancestor
24642685|NCT01180933|Vitamins|vitamins|mesh-ancestor
24642686|NCT01180933|Micronutrients|micronutrients|mesh-ancestor
24642687|NCT01180933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642688|NCT01180946|Vitamin D|vitamin d|mesh-list
24642722|NCT01181063|Adrenergic Agents|adrenergic agents|mesh-ancestor
24642723|NCT01181063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24642724|NCT01181063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642725|NCT01181115|Interferon beta-1a|interferon beta-1a|mesh-list
24642726|NCT01181115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24642791|NCT01181401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642794|NCT01181414|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24642795|NCT01181414|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24642796|NCT01181414|Vasodilator Agents|vasodilator agents|mesh-ancestor
24642797|NCT01181414|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24642798|NCT01181414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24642799|NCT01181414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855907|NCT02281721|Calcium Carbonate|calcium carbonate|mesh-list
24855908|NCT02281721|Antacids|antacids|mesh-ancestor
24643776|NCT01187264|Methotrexate|methotrexate|mesh-list
24855909|NCT02281721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24855911|NCT02281799|Mercaptopurine|mercaptopurine|mesh-list
24642800|NCT01181414|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24642830|NCT01181570|Sodium Citrate|sodium citrate|mesh-list
24642831|NCT01181570|Anticoagulants|anticoagulants|mesh-ancestor
24642832|NCT01181570|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24642833|NCT01181570|Chelating Agents|chelating agents|mesh-ancestor
24642866|NCT01181934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642893|NCT01182077|Midazolam|midazolam|mesh-list
24642894|NCT01182077|Peficitinib|peficitinib|mesh-list
24642895|NCT01182077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24642896|NCT01182077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24642897|NCT01182077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24642898|NCT01182077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710871|NCT02292771|Oxytocics|oxytocics|mesh-ancestor
25710872|NCT02292771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25710873|NCT02292784|Atosiban|atosiban|mesh-list
24642899|NCT01182077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24642900|NCT01182077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24643006|NCT01182974|Sensory System Agents|sensory system agents|mesh-ancestor
24643007|NCT01182974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24643008|NCT01182974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643009|NCT01182974|Antipyretics|antipyretics|mesh-ancestor
24643117|NCT01183676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24643118|NCT01183676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643119|NCT01183676|Antimanic Agents|antimanic agents|mesh-ancestor
24643120|NCT01183676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24643121|NCT01183676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24643122|NCT01183676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24643123|NCT01183767|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24643124|NCT01183767|Antioxidants|antioxidants|mesh-ancestor
24643125|NCT01183767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643126|NCT01183767|Protective Agents|protective agents|mesh-ancestor
24643158|NCT01184196|Plasma Substitutes|plasma substitutes|mesh-ancestor
24643159|NCT01184196|Blood Substitutes|blood substitutes|mesh-ancestor
24643160|NCT01184196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24643245|NCT01184664|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24855919|NCT02281799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855920|NCT02281799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24855921|NCT02281799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24855922|NCT02281799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24855923|NCT02281929|Amoxicillin|amoxicillin|mesh-list
24855924|NCT02281929|Clavulanic Acids|clavulanic acids|mesh-list
24855925|NCT02281929|Clavulanic Acid|clavulanic acid|mesh-list
24855926|NCT02281929|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24855927|NCT02281929|Prednisolone|prednisolone|mesh-list
24643365|NCT01185405|Antifungal Agents|antifungal agents|mesh-ancestor
24643366|NCT01185405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24643367|NCT01185405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24643368|NCT01185405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24643369|NCT01185405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643370|NCT01185405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643371|NCT01185405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24643372|NCT01185405|Hormone Antagonists|hormone antagonists|mesh-ancestor
24643690|NCT01186653|Autonomic Agents|autonomic agents|mesh-ancestor
24643691|NCT01186653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24643692|NCT01186653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643693|NCT01186653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24643694|NCT01186653|Respiratory System Agents|respiratory system agents|mesh-ancestor
24643725|NCT01186835|Viscosupplements|viscosupplements|mesh-ancestor
24643726|NCT01186835|Protective Agents|protective agents|mesh-ancestor
24643727|NCT01186835|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24643728|NCT01186835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24643729|NCT01186887|Celecoxib|celecoxib|mesh-list
24643774|NCT01187238|Cisplatin|cisplatin|mesh-list
24643775|NCT01187238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24855943|NCT02281968|Analgesics|analgesics|mesh-ancestor
24855944|NCT02281968|Sensory System Agents|sensory system agents|mesh-ancestor
24643869|NCT01187862|Anesthetics, General|anesthetics, general|mesh-ancestor
24643870|NCT01187862|Anesthetics|anesthetics|mesh-ancestor
24643871|NCT01187862|GABA Modulators|gaba modulators|mesh-ancestor
24643872|NCT01187862|GABA Agents|gaba agents|mesh-ancestor
24643873|NCT01187862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24643874|NCT01187862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643875|NCT01187862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24643876|NCT01187862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24643877|NCT01187862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24643878|NCT01187862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24643879|NCT01187862|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24643880|NCT01187862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24643881|NCT01187862|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24643882|NCT01187862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643883|NCT01187862|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24643884|NCT01187862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24643885|NCT01187862|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25710875|NCT02292784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24855946|NCT02281968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855947|NCT02281968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24855948|NCT02281968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24643887|NCT01187862|Purinergic Agents|purinergic agents|mesh-ancestor
24643888|NCT01187862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24643889|NCT01187862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24643890|NCT01187862|Antiviral Agents|antiviral agents|mesh-ancestor
24643891|NCT01187862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24643892|NCT01187862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24643898|NCT01187862|Sympatholytics|sympatholytics|mesh-ancestor
24643942|NCT01188005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24643944|NCT01188031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24643945|NCT01188031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24644016|NCT01188304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24644017|NCT01188304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644020|NCT01188317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24644021|NCT01188317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24644022|NCT01188317|Analgesics|analgesics|mesh-ancestor
24644023|NCT01188317|Sensory System Agents|sensory system agents|mesh-ancestor
24855958|NCT02282059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24855959|NCT02282059|Growth Inhibitors|growth inhibitors|mesh-ancestor
24855960|NCT02282059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24855961|NCT02282059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458373|NCT00337649|Epothilones|epothilones|mesh-list
24644154|NCT01189448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24644155|NCT01189448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24644156|NCT01189448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644157|NCT01189448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644158|NCT01189448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24644159|NCT01189448|Coccidiostats|coccidiostats|mesh-ancestor
24644160|NCT01189526|Ranibizumab|ranibizumab|mesh-list
24644316|NCT01190345|Bevacizumab|bevacizumab|mesh-list
24644317|NCT01190345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24644318|NCT01190345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644319|NCT01190345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24644320|NCT01190345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24644321|NCT01190345|Growth Substances|growth substances|mesh-ancestor
24644322|NCT01190345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644323|NCT01190345|Growth Inhibitors|growth inhibitors|mesh-ancestor
24644324|NCT01190358|Grape Seed Extract|grape seed extract|mesh-list
24644325|NCT01190358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24644326|NCT01190358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644327|NCT01190358|Antioxidants|antioxidants|mesh-ancestor
24644355|NCT01190462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644356|NCT01190462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24668470|NCT04918147|Antipruritics|antipruritics|mesh-ancestor
24644396|NCT01190722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24644397|NCT01190722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24644399|NCT01190722|Sensory System Agents|sensory system agents|mesh-ancestor
24644400|NCT01190722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24644448|NCT01191021|Anesthetics|anesthetics|mesh-ancestor
24644449|NCT01191021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24644451|NCT01191021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24644452|NCT01191021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24644453|NCT01191021|Anesthetics, General|anesthetics, general|mesh-ancestor
24644454|NCT01191034|Imiquimod|imiquimod|mesh-list
24644455|NCT01191034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24644456|NCT01191034|Immunologic Factors|immunologic factors|mesh-ancestor
24644457|NCT01191034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710876|NCT02292784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710877|NCT02292784|Tocolytic Agents|tocolytic agents|mesh-ancestor
25710878|NCT02292784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24644458|NCT01191034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644459|NCT01191034|Interferon Inducers|interferon inducers|mesh-ancestor
24644460|NCT01191060|Lenalidomide|lenalidomide|mesh-list
24644462|NCT01191060|Immunologic Factors|immunologic factors|mesh-ancestor
24644463|NCT01191060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644464|NCT01191060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24855970|NCT02282085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24644465|NCT01191060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24644466|NCT01191060|Growth Substances|growth substances|mesh-ancestor
24644467|NCT01191060|Growth Inhibitors|growth inhibitors|mesh-ancestor
24644590|NCT01191918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644591|NCT01191918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644592|NCT01191918|Cholinergic Agents|cholinergic agents|mesh-ancestor
24644593|NCT01191918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24644594|NCT01191918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644595|NCT01191918|Nootropic Agents|nootropic agents|mesh-ancestor
24644596|NCT01191918|Antidepressive Agents|antidepressive agents|mesh-ancestor
24644597|NCT01191918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24644598|NCT01191918|Antimanic Agents|antimanic agents|mesh-ancestor
24644599|NCT01191918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24644600|NCT01191918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24644601|NCT01191957|Cyclophosphamide|cyclophosphamide|mesh-list
24644602|NCT01191957|Busulfan|busulfan|mesh-list
24645110|NCT01195805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645174|NCT01196481|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24645176|NCT01196481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24645177|NCT01196481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645178|NCT01196481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645179|NCT01196481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24645180|NCT01196481|Antioxidants|antioxidants|mesh-ancestor
24645181|NCT01196481|Protective Agents|protective agents|mesh-ancestor
24645182|NCT01196481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24645419|NCT01198210|Anesthetics, General|anesthetics, general|mesh-ancestor
24645420|NCT01198210|Anesthetics|anesthetics|mesh-ancestor
24645782|NCT01199783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24645783|NCT01199783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24645785|NCT01199835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24645786|NCT01199835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645788|NCT01199900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24645789|NCT01199900|Glucocorticoids|glucocorticoids|mesh-ancestor
24645790|NCT01199900|Hormones|hormones|mesh-ancestor
24645792|NCT01199900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645793|NCT01199900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24645794|NCT01199900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24645795|NCT01200004|Lenalidomide|lenalidomide|mesh-list
24645796|NCT01200004|Azacitidine|azacitidine|mesh-list
24645816|NCT01200108|Budesonide|budesonide|mesh-list
24812828|NCT02054884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24812829|NCT02054884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812830|NCT02054884|Tubulin Modulators|tubulin modulators|mesh-ancestor
24812831|NCT02054884|Antimitotic Agents|antimitotic agents|mesh-ancestor
24812832|NCT02054884|Mitosis Modulators|mitosis modulators|mesh-ancestor
24812833|NCT02054884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812834|NCT02054936|Warfarin|warfarin|mesh-list
24812835|NCT02054936|Rivaroxaban|rivaroxaban|mesh-list
24812836|NCT02054936|Anticoagulants|anticoagulants|mesh-ancestor
24812844|NCT02054949|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24693669|NCT01421771|Antihypertensive Agents|antihypertensive agents|mesh-list
24645837|NCT01200186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24645838|NCT01200186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645839|NCT01200212|Bevacizumab|bevacizumab|mesh-list
24645853|NCT01200264|Analgesics|analgesics|mesh-ancestor
24645854|NCT01200264|Sensory System Agents|sensory system agents|mesh-ancestor
24645855|NCT01200264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24645856|NCT01200264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645857|NCT01200264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24645858|NCT01200264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24645886|NCT01200537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24645887|NCT01200537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24645888|NCT01200537|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24645890|NCT01200641|Melatonin|melatonin|mesh-list
24645891|NCT01200641|Analgesics|analgesics|mesh-ancestor
24645892|NCT01200641|Sensory System Agents|sensory system agents|mesh-ancestor
24645893|NCT01200641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24645894|NCT01200641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645896|NCT01200641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24645897|NCT01200641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24645898|NCT01200641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24458482|NCT00338117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812852|NCT02054949|Protective Agents|protective agents|mesh-ancestor
24812853|NCT02054949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812854|NCT02054949|Antidotes|antidotes|mesh-ancestor
24812855|NCT02054975|Vitamin D|vitamin d|mesh-list
24812856|NCT02054975|Ergocalciferols|ergocalciferols|mesh-list
24812857|NCT02054975|Cholecalciferol|cholecalciferol|mesh-list
24645962|NCT01200914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645963|NCT01201005|Hydroxocobalamin|hydroxocobalamin|mesh-list
24645964|NCT01201005|Vitamin B 12|vitamin b 12|mesh-list
24458508|NCT00338221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458509|NCT00338221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458510|NCT00338247|Capecitabine|capecitabine|mesh-list
24856018|NCT02282241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856019|NCT02282241|Protective Agents|protective agents|mesh-ancestor
24856020|NCT02282241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856021|NCT02282241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24856023|NCT02282267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24856024|NCT02282267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24856025|NCT02282267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856026|NCT02282267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856027|NCT02282280|Prilocaine|prilocaine|mesh-list
24856028|NCT02282280|Anesthetics, Local|anesthetics, local|mesh-ancestor
24856029|NCT02282280|Anesthetics|anesthetics|mesh-ancestor
24856030|NCT02282280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24645969|NCT01201005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645970|NCT01201044|Gemcitabine|gemcitabine|mesh-list
24645971|NCT01201044|Nedaplatin|nedaplatin|mesh-list
24645972|NCT01201044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24645973|NCT01201044|Antimetabolites|antimetabolites|mesh-ancestor
24645982|NCT01201070|Antithrombins|antithrombins|mesh-list
24645990|NCT01201122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24645991|NCT01201122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24645992|NCT01201122|Analgesics|analgesics|mesh-ancestor
24645993|NCT01201122|Sensory System Agents|sensory system agents|mesh-ancestor
24645994|NCT01201122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24646022|NCT01201278|Insulin Lispro|insulin lispro|mesh-list
24646023|NCT01201278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24646024|NCT01201278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646025|NCT01201499|Morphine|morphine|mesh-list
24646026|NCT01201499|Remifentanil|remifentanil|mesh-list
24646027|NCT01201499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24646028|NCT01201499|Narcotics|narcotics|mesh-ancestor
24646029|NCT01201499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24646030|NCT01201499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646032|NCT01201499|Sensory System Agents|sensory system agents|mesh-ancestor
24646033|NCT01201499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24646034|NCT01201551|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24646035|NCT01201551|Latanoprost|latanoprost|mesh-list
24646036|NCT01201551|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24646037|NCT01201551|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24646038|NCT01201551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24646039|NCT01201551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24646042|NCT01201551|Adrenergic Agents|adrenergic agents|mesh-ancestor
24646068|NCT01201694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24646069|NCT01201694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646070|NCT01201694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24646072|NCT01201694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24646073|NCT01201694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856064|NCT02282384|Antacids|antacids|mesh-ancestor
24856065|NCT02282384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24856066|NCT02282410|Factor VIII|factor viii|mesh-list
24856067|NCT02282410|Coagulants|coagulants|mesh-ancestor
25710879|NCT02293096|Metoprolol|metoprolol|mesh-list
24856075|NCT02282683|Hormones|hormones|mesh-ancestor
24856076|NCT02282683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24856139|NCT02282956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24856152|NCT02282956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24856153|NCT02282956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24856154|NCT02282956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24856155|NCT02282956|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24856156|NCT02282956|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24856157|NCT02282956|Dopamine Agents|dopamine agents|mesh-ancestor
24856158|NCT02282956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24856159|NCT02282956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856160|NCT02283060|Tenofovir|tenofovir|mesh-list
24856161|NCT02283060|Emtricitabine|emtricitabine|mesh-list
24856162|NCT02283060|Efavirenz|efavirenz|mesh-list
24856163|NCT02283060|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24856164|NCT02283060|Cobicistat|cobicistat|mesh-list
24856165|NCT02283060|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24856166|NCT02283060|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24856167|NCT02283060|Elvitegravir|elvitegravir|mesh-list
24856170|NCT02283060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24856171|NCT02283060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24856173|NCT02283060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856174|NCT02283060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24856175|NCT02283060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24646234|NCT01202487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24646235|NCT01202513|Bimatoprost|bimatoprost|mesh-list
24646237|NCT01202513|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24646238|NCT01202513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24646239|NCT01202552|Vaccines|vaccines|mesh-list
24646240|NCT01202552|Immunologic Factors|immunologic factors|mesh-ancestor
24646241|NCT01202552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646242|NCT01202734|Methylphenidate|methylphenidate|mesh-list
24646243|NCT01202734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24646244|NCT01202734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646245|NCT01202734|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24693997|NCT01423305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24693998|NCT01423305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24693999|NCT01423305|Autonomic Agents|autonomic agents|mesh-ancestor
24694000|NCT01423305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24694001|NCT01423305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694002|NCT01423305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24694003|NCT01423305|Respiratory System Agents|respiratory system agents|mesh-ancestor
24694004|NCT01423305|Glucocorticoids|glucocorticoids|mesh-ancestor
24694005|NCT01423305|Hormones|hormones|mesh-ancestor
24646246|NCT01202734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24646295|NCT01203020|Immunologic Factors|immunologic factors|mesh-ancestor
24646296|NCT01203020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646297|NCT01203020|Antiviral Agents|antiviral agents|mesh-ancestor
24646298|NCT01203020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24646299|NCT01203020|Alkylating Agents|alkylating agents|mesh-ancestor
24646300|NCT01203020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24856284|NCT02283489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24856285|NCT02283489|Tubulin Modulators|tubulin modulators|mesh-ancestor
24856286|NCT02283489|Antimitotic Agents|antimitotic agents|mesh-ancestor
24856287|NCT02283489|Mitosis Modulators|mitosis modulators|mesh-ancestor
24694154|NCT01424137|Respiratory System Agents|respiratory system agents|mesh-ancestor
24812888|NCT02055131|Aspirin|aspirin|mesh-list
24812889|NCT02055131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24812890|NCT02055131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24812891|NCT02055131|Analgesics|analgesics|mesh-ancestor
24812892|NCT02055131|Sensory System Agents|sensory system agents|mesh-ancestor
24812893|NCT02055131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812894|NCT02055131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694179|NCT01424332|Salicylic Acid|salicylic acid|mesh-list
24677986|NCT01359423|Protective Agents|protective agents|mesh-ancestor
24856309|NCT02283710|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24856310|NCT02283710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856311|NCT02283710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856312|NCT02283710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24856313|NCT02283710|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24856314|NCT02283710|Protective Agents|protective agents|mesh-ancestor
24856315|NCT02283710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856316|NCT02283710|Vasodilator Agents|vasodilator agents|mesh-ancestor
24856317|NCT02283710|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25710881|NCT02293096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25710882|NCT02293096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24856319|NCT02283775|Dexamethasone|dexamethasone|mesh-list
24856320|NCT02283775|Pomalidomide|pomalidomide|mesh-list
24856343|NCT02283801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24856344|NCT02283801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856345|NCT02283801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24856346|NCT02283801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24856347|NCT02283801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24856348|NCT02283801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24856349|NCT02283801|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24856350|NCT02283801|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24856351|NCT02283866|Desflurane|desflurane|mesh-list
24856352|NCT02283866|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24856353|NCT02283866|Anesthetics, General|anesthetics, general|mesh-ancestor
24646488|NCT01204112|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24646489|NCT01204112|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24646490|NCT01204112|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24646491|NCT01204112|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24646492|NCT01204112|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24646493|NCT01204112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24646495|NCT01204125|Iniparib|iniparib|mesh-list
24646496|NCT01204125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24646498|NCT01204125|Tubulin Modulators|tubulin modulators|mesh-ancestor
24856372|NCT02283905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24856373|NCT02283905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24856374|NCT02283905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24856375|NCT02284035|Raltegravir Potassium|raltegravir potassium|mesh-list
24856377|NCT02284035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24856379|NCT02284035|Antiviral Agents|antiviral agents|mesh-ancestor
24856398|NCT02284204|Sevoflurane|sevoflurane|mesh-list
24856399|NCT02284204|Analgesics|analgesics|mesh-ancestor
24856400|NCT02284204|Sensory System Agents|sensory system agents|mesh-ancestor
24856401|NCT02284204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24856402|NCT02284204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856403|NCT02284204|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24856404|NCT02284204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24856405|NCT02284204|Anesthetics, General|anesthetics, general|mesh-ancestor
24856406|NCT02284204|Anesthetics|anesthetics|mesh-ancestor
24694334|NCT01425099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24856410|NCT02284204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24646540|NCT01204190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646541|NCT01204190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24646542|NCT01204190|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24646544|NCT01204190|Hormones|hormones|mesh-ancestor
24646545|NCT01204190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24646547|NCT01204216|Vitamin B Complex|vitamin b complex|mesh-ancestor
24646548|NCT01204216|Vitamins|vitamins|mesh-ancestor
24646549|NCT01204216|Micronutrients|micronutrients|mesh-ancestor
24646550|NCT01204216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646551|NCT01204268|Sevoflurane|sevoflurane|mesh-list
24856456|NCT02284412|Autonomic Agents|autonomic agents|mesh-ancestor
24856457|NCT02284412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24646587|NCT01204372|Antimetabolites|antimetabolites|mesh-ancestor
24646588|NCT01204372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646589|NCT01204372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914516|NCT04254601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24914517|NCT04254601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24914518|NCT04254601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24914519|NCT04254601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24914520|NCT04254601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914528|NCT04254679|Analgesics, Opioid|analgesics, opioid|mesh-list
24914529|NCT04254679|Analgesics|analgesics|mesh-list
24646688|NCT01204723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25710883|NCT02293096|Sympatholytics|sympatholytics|mesh-ancestor
24646689|NCT01204723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24694451|NCT01425619|Lidocaine|lidocaine|mesh-list
24646893|NCT01205360|Analgesics|analgesics|mesh-ancestor
25710884|NCT02293096|Autonomic Agents|autonomic agents|mesh-ancestor
25710885|NCT02293096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25710886|NCT02293096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710887|NCT02293096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25710888|NCT02293096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25710889|NCT02293096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25710890|NCT02293096|Adrenergic Agents|adrenergic agents|mesh-ancestor
24856491|NCT02284672|Analgesics|analgesics|mesh-ancestor
24856492|NCT02284672|Sensory System Agents|sensory system agents|mesh-ancestor
24856493|NCT02284672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24856494|NCT02284672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24856495|NCT02284672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24646714|NCT01204996|Antimetabolites|antimetabolites|mesh-ancestor
24646715|NCT01204996|Antiviral Agents|antiviral agents|mesh-ancestor
24646791|NCT01205139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24646792|NCT01205178|Chloroquine|chloroquine|mesh-list
24646793|NCT01205178|Primaquine|primaquine|mesh-list
24646794|NCT01205178|Tafenoquine|tafenoquine|mesh-list
24646795|NCT01205178|Amebicides|amebicides|mesh-ancestor
24646796|NCT01205178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24646797|NCT01205178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24646798|NCT01205178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24646799|NCT01205178|Antimalarials|antimalarials|mesh-ancestor
24856496|NCT02284672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24856497|NCT02284672|Adrenergic Agents|adrenergic agents|mesh-ancestor
24856498|NCT02284672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24856499|NCT02284672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856500|NCT02284737|Sildenafil Citrate|sildenafil citrate|mesh-list
24856501|NCT02284737|Vasodilator Agents|vasodilator agents|mesh-ancestor
24856502|NCT02284737|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24856503|NCT02284737|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24856504|NCT02284737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856505|NCT02284737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856506|NCT02284737|Urological Agents|urological agents|mesh-ancestor
24856508|NCT02284984|Belimumab|belimumab|mesh-list
24856509|NCT02284984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24856510|NCT02284984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24856511|NCT02284984|Immunologic Factors|immunologic factors|mesh-ancestor
24646841|NCT01205217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24646842|NCT01205217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24646843|NCT01205217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24646844|NCT01205217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24646845|NCT01205217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646846|NCT01205217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24646848|NCT01205243|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24646849|NCT01205243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24646850|NCT01205243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646856|NCT01205256|Methadone|methadone|mesh-list
24646890|NCT01205360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24646891|NCT01205360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24646892|NCT01205360|Narcotics|narcotics|mesh-ancestor
24646902|NCT01205464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24646903|NCT01205464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24646904|NCT01205464|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24646905|NCT01205464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646906|NCT01205464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646907|NCT01205477|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24646908|NCT01205477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24646909|NCT01205516|Morphine|morphine|mesh-list
24646910|NCT01205516|Methadone|methadone|mesh-list
24646911|NCT01205516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24646912|NCT01205516|Narcotics|narcotics|mesh-ancestor
24646913|NCT01205516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24646914|NCT01205516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710891|NCT02293096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24646916|NCT01205516|Sensory System Agents|sensory system agents|mesh-ancestor
24646917|NCT01205516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24646918|NCT01205516|Antitussive Agents|antitussive agents|mesh-ancestor
24646919|NCT01205516|Respiratory System Agents|respiratory system agents|mesh-ancestor
24646920|NCT01205672|Metformin|metformin|mesh-list
25710892|NCT02293096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710893|NCT02293096|Antitussive Agents|antitussive agents|mesh-ancestor
25710894|NCT02293096|Respiratory System Agents|respiratory system agents|mesh-ancestor
25710895|NCT02293096|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24646921|NCT01205672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24646922|NCT01205672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646923|NCT01205711|Leucovorin|leucovorin|mesh-list
24856537|NCT02285374|Antiviral Agents|antiviral agents|mesh-ancestor
24856538|NCT02285374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24856539|NCT02285374|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24856540|NCT02285374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24856541|NCT02285374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856542|NCT02285374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856543|NCT02285374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24856544|NCT02285374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24856545|NCT02285374|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24856546|NCT02285374|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24646956|NCT01205880|Calcitriol|calcitriol|mesh-list
24646957|NCT01205880|Clobetasol|clobetasol|mesh-list
24646958|NCT01205880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24646959|NCT01205880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646960|NCT01205880|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24694691|NCT05379413|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24694701|NCT05379374|Bupivacaine|bupivacaine|mesh-list
24646966|NCT01205880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24646967|NCT01205880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24646968|NCT01205880|Glucocorticoids|glucocorticoids|mesh-ancestor
24646969|NCT01205880|Hormones|hormones|mesh-ancestor
24646970|NCT01205880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24646972|NCT01205932|Rivaroxaban|rivaroxaban|mesh-list
24646973|NCT01205932|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24646974|NCT01205932|Antithrombins|antithrombins|mesh-ancestor
24646975|NCT01205932|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24646976|NCT01205932|Protease Inhibitors|protease inhibitors|mesh-ancestor
24646977|NCT01205932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24647058|NCT01206036|Immunologic Factors|immunologic factors|mesh-ancestor
24647059|NCT01206036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647066|NCT01206049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647067|NCT01206049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24647068|NCT01206049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24647069|NCT01206049|Growth Substances|growth substances|mesh-ancestor
24647070|NCT01206049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647071|NCT01206049|Growth Inhibitors|growth inhibitors|mesh-ancestor
24856606|NCT02285738|Antipyretics|antipyretics|mesh-ancestor
24856607|NCT02285738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24856608|NCT02285738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24856609|NCT02285738|Antimetabolites|antimetabolites|mesh-ancestor
24856610|NCT02285738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24856611|NCT02285738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24856613|NCT02285751|Clopidogrel|clopidogrel|mesh-list
24856614|NCT02285751|Ticagrelor|ticagrelor|mesh-list
24856621|NCT02285751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856623|NCT02285751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24856624|NCT02285751|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24856625|NCT02285751|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24459066|NCT00343447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24647123|NCT01206348|Dermatologic Agents|dermatologic agents|mesh-ancestor
24647124|NCT01206348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647125|NCT01206348|Keratolytic Agents|keratolytic agents|mesh-ancestor
24647126|NCT01206530|Leucovorin|leucovorin|mesh-list
24647127|NCT01206530|Hydroxychloroquine|hydroxychloroquine|mesh-list
24647128|NCT01206530|Bevacizumab|bevacizumab|mesh-list
24856626|NCT02285751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710896|NCT02293096|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25710897|NCT02293395|Aspirin|aspirin|mesh-list
25710898|NCT02293395|Rivaroxaban|rivaroxaban|mesh-list
25710899|NCT02293395|Clopidogrel|clopidogrel|mesh-list
25710900|NCT02293395|Ticagrelor|ticagrelor|mesh-list
25710901|NCT02293395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25710902|NCT02293395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25710903|NCT02293395|Analgesics|analgesics|mesh-ancestor
25710904|NCT02293395|Sensory System Agents|sensory system agents|mesh-ancestor
24856627|NCT02285751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24856628|NCT02285751|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24856630|NCT02285751|Antipyretics|antipyretics|mesh-ancestor
24856631|NCT02285751|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24812909|NCT02055170|Hormone Antagonists|hormone antagonists|mesh-ancestor
24678254|NCT01360476|Vitamins|vitamins|mesh-ancestor
24856637|NCT02285829|Rocuronium|rocuronium|mesh-list
24856638|NCT02285829|Cisatracurium|cisatracurium|mesh-list
24856639|NCT02285829|Anticonvulsants|anticonvulsants|mesh-ancestor
24856640|NCT02285829|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24856641|NCT02285829|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24856642|NCT02285829|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24459101|NCT00343655|Atorvastatin|atorvastatin|mesh-list
24647129|NCT01206530|Fluorouracil|fluorouracil|mesh-list
24647130|NCT01206530|Oxaliplatin|oxaliplatin|mesh-list
24856652|NCT02285972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856653|NCT02285972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24856654|NCT02285972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24856661|NCT02285985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24856662|NCT02285985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856663|NCT02285985|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24856664|NCT02285985|Protease Inhibitors|protease inhibitors|mesh-ancestor
24856665|NCT02285985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856666|NCT02285985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856667|NCT02285985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24647297|NCT01207739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24647298|NCT01207739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24647299|NCT01207739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24647300|NCT01207739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647301|NCT01207739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24647302|NCT01207739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24647303|NCT01207739|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24647304|NCT01207739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24647336|NCT01208285|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24647337|NCT01208285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24647338|NCT01208285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647340|NCT01208363|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24647341|NCT01208363|Chelating Agents|chelating agents|mesh-ancestor
24647362|NCT01208454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647363|NCT01208454|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24695010|NCT04765371|Hormones|hormones|mesh-ancestor
24647368|NCT01208480|Carboplatin|carboplatin|mesh-list
24647394|NCT01208701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24647395|NCT01208701|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24647396|NCT01208701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24647397|NCT01208740|Metformin|metformin|mesh-list
24647398|NCT01208740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24647410|NCT01208766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24647411|NCT01208766|Glucocorticoids|glucocorticoids|mesh-ancestor
24647453|NCT01208935|Autonomic Agents|autonomic agents|mesh-ancestor
24647454|NCT01208935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24647455|NCT01208935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647456|NCT01208935|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24647457|NCT01208935|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24647461|NCT01209026|Fluticasone|fluticasone|mesh-list
24647463|NCT01209026|Moxifloxacin|moxifloxacin|mesh-list
24695133|NCT04425902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24695134|NCT04425902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24695135|NCT04425902|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24695136|NCT04425902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24695137|NCT04425902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24647559|NCT01209416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24647560|NCT01209429|Hormones|hormones|mesh-list
24647561|NCT01209429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24647562|NCT01209429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647563|NCT01209455|Acetaminophen|acetaminophen|mesh-list
24647564|NCT01209455|Chlorpheniramine|chlorpheniramine|mesh-list
24647565|NCT01209455|Ranitidine|ranitidine|mesh-list
24647598|NCT01209715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24647599|NCT01209715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647600|NCT01209715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24647601|NCT01209715|Respiratory System Agents|respiratory system agents|mesh-ancestor
24647602|NCT01209715|Dermatologic Agents|dermatologic agents|mesh-ancestor
24647603|NCT01209715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24647604|NCT01209715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24647605|NCT01209715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24856810|NCT02287064|Immunoglobulins|immunoglobulins|mesh-list
24856811|NCT02287064|Antibodies|antibodies|mesh-list
24856812|NCT02287064|gamma-Globulins|gamma-globulins|mesh-list
24856813|NCT02287064|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24856814|NCT02287064|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24856815|NCT02287064|Immunologic Factors|immunologic factors|mesh-ancestor
24856816|NCT02287064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856817|NCT02287129|Paclitaxel|paclitaxel|mesh-list
24856818|NCT02287129|Carboplatin|carboplatin|mesh-list
24856821|NCT02287129|Epirubicin|epirubicin|mesh-list
24647640|NCT01209845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647641|NCT01209845|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24647642|NCT01209845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24647643|NCT01209845|Anesthetics, General|anesthetics, general|mesh-ancestor
24647644|NCT01209845|Anesthetics|anesthetics|mesh-ancestor
24647645|NCT01209845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24695220|NCT04203472|Autonomic Agents|autonomic agents|mesh-ancestor
24647675|NCT01209988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647676|NCT01209988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647677|NCT01209988|Urological Agents|urological agents|mesh-ancestor
24647678|NCT01210014|Zinc Sulfate|zinc sulfate|mesh-list
24856858|NCT02287246|Bupivacaine|bupivacaine|mesh-list
24812949|NCT02055378|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24812950|NCT02055378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24812951|NCT02055378|Cholinergic Agents|cholinergic agents|mesh-ancestor
24812952|NCT02055378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24812953|NCT02055378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812954|NCT02055456|Nandrolone Decanoate|nandrolone decanoate|mesh-list
24812968|NCT02055586|Protective Agents|protective agents|mesh-ancestor
24812969|NCT02055586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812971|NCT02055586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24812972|NCT02055664|Ropivacaine|ropivacaine|mesh-list
24812973|NCT02055664|Anesthetics, Local|anesthetics, local|mesh-ancestor
24450310|NCT00318669|Antidepressive Agents|antidepressive agents|mesh-ancestor
24647888|NCT01211275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24647891|NCT01211314|Lercanidipine|lercanidipine|mesh-list
24647892|NCT01211314|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24647893|NCT01211314|Protease Inhibitors|protease inhibitors|mesh-ancestor
24647894|NCT01211314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24647895|NCT01211314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647896|NCT01211314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24647897|NCT01211314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24647898|NCT01211314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24647899|NCT01211314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24647900|NCT01211314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812976|NCT02055664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812977|NCT02055664|Sensory System Agents|sensory system agents|mesh-ancestor
24812978|NCT02055664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25710905|NCT02293395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25710906|NCT02293395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710907|NCT02293395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25710908|NCT02293395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25710909|NCT02293395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25710910|NCT02293395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24812980|NCT02055690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24812981|NCT02055690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647930|NCT01211457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647932|NCT01211470|Daptomycin|daptomycin|mesh-list
24647933|NCT01211470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24647934|NCT01211470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24647935|NCT01211496|Methamphetamine|methamphetamine|mesh-list
24647936|NCT01211496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24647939|NCT01211496|Autonomic Agents|autonomic agents|mesh-ancestor
24647946|NCT01211496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24647947|NCT01211496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24647948|NCT01211496|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24647950|NCT01211509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24647951|NCT01211509|Respiratory System Agents|respiratory system agents|mesh-ancestor
24647952|NCT01211509|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24647953|NCT01211509|Hormone Antagonists|hormone antagonists|mesh-ancestor
24647954|NCT01211509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24648369|NCT01213849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648370|NCT01213849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24648371|NCT01213849|Respiratory System Agents|respiratory system agents|mesh-ancestor
24648372|NCT01213849|Dermatologic Agents|dermatologic agents|mesh-ancestor
24648373|NCT01213849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24648375|NCT01213888|Chelating Agents|chelating agents|mesh-ancestor
24648376|NCT01213888|Sequestering Agents|sequestering agents|mesh-ancestor
24648377|NCT01213888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648378|NCT01213901|Insulin Lispro|insulin lispro|mesh-list
24459427|NCT00344617|Growth Inhibitors|growth inhibitors|mesh-ancestor
24648384|NCT01213979|Trace Elements|trace elements|mesh-ancestor
24648385|NCT01213979|Micronutrients|micronutrients|mesh-ancestor
24648386|NCT01213979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648387|NCT01213979|Hematinics|hematinics|mesh-ancestor
24648389|NCT01213992|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
24648390|NCT01213992|Ferric Compounds|ferric compounds|mesh-list
24648447|NCT01214746|Atorvastatin|atorvastatin|mesh-list
24648448|NCT01214746|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24856948|NCT02288078|Autonomic Agents|autonomic agents|mesh-ancestor
24856949|NCT02288078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24856953|NCT02288078|Hormones|hormones|mesh-ancestor
24856954|NCT02288078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24856955|NCT02288078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24856956|NCT02288078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24856957|NCT02288078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24856958|NCT02288078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24856959|NCT02288130|Ulipristal acetate|ulipristal acetate|mesh-list
24856960|NCT02288130|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24856961|NCT02288130|Contraceptive Agents|contraceptive agents|mesh-ancestor
24856962|NCT02288130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24856963|NCT02288130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24856964|NCT02288130|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24695606|NCT02767882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24695612|NCT02547662|Ixazomib|ixazomib|mesh-list
24648449|NCT01214746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24648450|NCT01214746|Antimetabolites|antimetabolites|mesh-ancestor
24648451|NCT01214746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648452|NCT01214746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24648461|NCT01214889|Immunologic Factors|immunologic factors|mesh-ancestor
24648462|NCT01214889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648463|NCT01214928|Vitamin D|vitamin d|mesh-list
24648464|NCT01214928|Cholecalciferol|cholecalciferol|mesh-list
24648465|NCT01214928|Vitamins|vitamins|mesh-ancestor
24648525|NCT01215214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24648526|NCT01215214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24648527|NCT01215214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24648528|NCT01215214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648529|NCT01215214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24648530|NCT01215214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24648656|NCT01216124|Oxaliplatin|oxaliplatin|mesh-list
24695695|NCT02124941|Acetylcysteine|acetylcysteine|mesh-list
24856989|NCT02288338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24856990|NCT02288338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24856992|NCT02288338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710911|NCT02293395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710912|NCT02293395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25710913|NCT02293395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24856993|NCT02288338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24856994|NCT02288338|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24856996|NCT02288429|Colistin|colistin|mesh-list
24856997|NCT02288429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24856998|NCT02288429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24856999|NCT02288507|Sorafenib|sorafenib|mesh-list
24857000|NCT02288507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24857002|NCT02288507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857012|NCT02288741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857013|NCT02288741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24857014|NCT02288741|Glucocorticoids|glucocorticoids|mesh-ancestor
24857015|NCT02288741|Hormones|hormones|mesh-ancestor
24857016|NCT02288741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24857017|NCT02288741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24648662|NCT01216267|Lansoprazole|lansoprazole|mesh-list
24857092|NCT02289261|Adrenergic Agents|adrenergic agents|mesh-ancestor
24857021|NCT02288741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857022|NCT02288741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24857023|NCT02288741|Alkylating Agents|alkylating agents|mesh-ancestor
24857024|NCT02288741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24857025|NCT02288741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24857026|NCT02288741|Immunologic Factors|immunologic factors|mesh-ancestor
24648745|NCT01216644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24648746|NCT01216644|Immunologic Factors|immunologic factors|mesh-ancestor
24648764|NCT01216657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24648765|NCT01216657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648766|NCT01216657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648768|NCT01216696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24648769|NCT01216696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648770|NCT01216696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24648771|NCT01216696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648773|NCT01216709|Trace Elements|trace elements|mesh-ancestor
24648774|NCT01216709|Micronutrients|micronutrients|mesh-ancestor
24648775|NCT01216709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648776|NCT01216787|R04929097|r04929097|mesh-list
24857042|NCT02288923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24857043|NCT02288923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24857044|NCT02288923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24857045|NCT02288923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24649216|NCT01219010|Siltuximab|siltuximab|mesh-list
24648778|NCT01216787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648780|NCT01216826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648781|NCT01216826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24648782|NCT01216826|Immunologic Factors|immunologic factors|mesh-ancestor
24648783|NCT01216826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857086|NCT02289261|Analgesics|analgesics|mesh-ancestor
24857087|NCT02289261|Sensory System Agents|sensory system agents|mesh-ancestor
24857088|NCT02289261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857089|NCT02289261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24857090|NCT02289261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24857091|NCT02289261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24857093|NCT02289261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24857095|NCT02289261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24857102|NCT02289274|Sensory System Agents|sensory system agents|mesh-ancestor
25710914|NCT02293395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710915|NCT02293395|Antipyretics|antipyretics|mesh-ancestor
25710916|NCT02293395|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24648792|NCT01216852|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25710917|NCT02293395|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24648794|NCT01216852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648796|NCT01216878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24648797|NCT01216878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24648798|NCT01216878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24648799|NCT01216878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24648800|NCT01216878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648801|NCT01216904|Nicotine|nicotine|mesh-list
24857103|NCT02289274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24857104|NCT02289274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857105|NCT02289274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24857106|NCT02289274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24857107|NCT02289274|Anticonvulsants|anticonvulsants|mesh-ancestor
24612560|NCT01014481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612561|NCT01014481|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24612562|NCT01014481|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24857108|NCT02289274|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24857109|NCT02289274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24857110|NCT02289274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459619|NCT00345644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24648802|NCT01216904|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24648803|NCT01216904|Autonomic Agents|autonomic agents|mesh-ancestor
24650073|NCT01223729|Micronutrients|micronutrients|mesh-ancestor
24648849|NCT01217099|Autonomic Agents|autonomic agents|mesh-ancestor
24648850|NCT01217099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24648852|NCT01217099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24648853|NCT01217099|Glucocorticoids|glucocorticoids|mesh-ancestor
24648910|NCT01217359|Interferon alpha-2|interferon alpha-2|mesh-list
24648911|NCT01217359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648912|NCT01217359|Antiviral Agents|antiviral agents|mesh-ancestor
24648913|NCT01217359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24648914|NCT01217359|Immunologic Factors|immunologic factors|mesh-ancestor
24648915|NCT01217359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648916|NCT01217398|Bevacizumab|bevacizumab|mesh-list
24648917|NCT01217398|Temozolomide|temozolomide|mesh-list
24648918|NCT01217398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24648920|NCT01217398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24648921|NCT01217398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24857128|NCT02289430|Ezetimibe|ezetimibe|mesh-list
24857129|NCT02289430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24857130|NCT02289430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24857131|NCT02289430|Antimetabolites|antimetabolites|mesh-ancestor
24857132|NCT02289430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857133|NCT02289430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24857134|NCT02289430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24857135|NCT02289430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857136|NCT02289482|Ritonavir|ritonavir|mesh-list
24857137|NCT02289482|GSK-2838232|gsk-2838232|mesh-list
24857138|NCT02289482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24857139|NCT02289482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24459671|NCT00345761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24695931|NCT01426490|Micronutrients|micronutrients|mesh-ancestor
24649004|NCT01218217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24649005|NCT01218217|Antitubercular Agents|antitubercular agents|mesh-ancestor
24649006|NCT01218217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24649008|NCT01218217|Leprostatic Agents|leprostatic agents|mesh-ancestor
24649023|NCT01218347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649024|NCT01218347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24649025|NCT01218347|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24649026|NCT01218347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24649027|NCT01218386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24695968|NCT01426802|Protease Inhibitors|protease inhibitors|mesh-ancestor
24649058|NCT01218425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24857210|NCT02289768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24857211|NCT02289768|Immunologic Factors|immunologic factors|mesh-ancestor
24649148|NCT01218711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24649206|NCT01218893|Proguanil|proguanil|mesh-list
24649207|NCT01218893|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
24649208|NCT01218893|Amebicides|amebicides|mesh-ancestor
24649209|NCT01218893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24649210|NCT01218893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24649211|NCT01218893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24649212|NCT01218893|Antimalarials|antimalarials|mesh-ancestor
24649213|NCT01218893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24649214|NCT01218893|Antimetabolites|antimetabolites|mesh-ancestor
24649215|NCT01218893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649228|NCT01219036|Autonomic Agents|autonomic agents|mesh-ancestor
24649576|NCT01220440|Dextroamphetamine|dextroamphetamine|mesh-list
24649577|NCT01220440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24649578|NCT01220440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649579|NCT01220440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24649580|NCT01220440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24649581|NCT01220440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24649583|NCT01220440|Dopamine Agents|dopamine agents|mesh-ancestor
24649609|NCT01220622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24649645|NCT01221025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857213|NCT02289768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24857214|NCT02289768|Antifungal Agents|antifungal agents|mesh-ancestor
24649646|NCT01221025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24649671|NCT01221116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24649672|NCT01221116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24649673|NCT01221116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649674|NCT01221116|Protective Agents|protective agents|mesh-ancestor
24649675|NCT01221116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649677|NCT01221129|Trace Elements|trace elements|mesh-ancestor
24649679|NCT01221129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649680|NCT01221337|Heparin|heparin|mesh-list
24649681|NCT01221337|Anticoagulants|anticoagulants|mesh-ancestor
24649682|NCT01221337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24649683|NCT01221337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24649774|NCT01221883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24649775|NCT01221883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649776|NCT01221883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24649777|NCT01221883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24696107|NCT01427322|Lapatinib|lapatinib|mesh-list
24696108|NCT01427322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24696109|NCT01427322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24696110|NCT01427322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24696111|NCT01427322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696112|NCT01427335|Calcium, Dietary|calcium, dietary|mesh-list
24696113|NCT01427335|Calcium|calcium|mesh-list
24649778|NCT01221883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24649857|NCT01222182|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24649858|NCT01222182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24649859|NCT01222182|Antimetabolites|antimetabolites|mesh-ancestor
24649860|NCT01222182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649861|NCT01222182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24649862|NCT01222182|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24649863|NCT01222182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24649866|NCT01222221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24649867|NCT01222221|Alkylating Agents|alkylating agents|mesh-ancestor
25710918|NCT02293395|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24649868|NCT01222221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649869|NCT01222221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649870|NCT01222221|Immunologic Factors|immunologic factors|mesh-ancestor
24649871|NCT01222221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649918|NCT01222650|Adrenergic Agents|adrenergic agents|mesh-ancestor
24649919|NCT01222650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24649920|NCT01222650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649950|NCT01222897|Antiviral Agents|antiviral agents|mesh-ancestor
24649951|NCT01222897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24649952|NCT01222910|Valacyclovir|valacyclovir|mesh-list
24649953|NCT01222910|Antiviral Agents|antiviral agents|mesh-ancestor
24649954|NCT01222910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24649955|NCT01222923|Risperidone|risperidone|mesh-list
24649956|NCT01222923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24649957|NCT01222923|Serotonin Agents|serotonin agents|mesh-ancestor
24649958|NCT01222923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24649959|NCT01222923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649960|NCT01222923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649961|NCT01222923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24650060|NCT01223625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24650063|NCT01223690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24650064|NCT01223690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24650065|NCT01223690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24650066|NCT01223690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24650067|NCT01223690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650068|NCT01223690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24650069|NCT01223690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24650070|NCT01223729|Acetylcarnitine|acetylcarnitine|mesh-list
24650071|NCT01223729|Vitamin B Complex|vitamin b complex|mesh-ancestor
24650262|NCT01224847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24650263|NCT01224847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650264|NCT01224847|Sensory System Agents|sensory system agents|mesh-ancestor
24650265|NCT01224847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24650266|NCT01224847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24650292|NCT01224964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24650293|NCT01224964|Respiratory System Agents|respiratory system agents|mesh-ancestor
24857220|NCT02289768|Sensory System Agents|sensory system agents|mesh-ancestor
24650349|NCT01225341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24650350|NCT01225341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24650351|NCT01225341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24650352|NCT01225341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24650353|NCT01225341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650354|NCT01225341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25710919|NCT02293395|Purinergic Agents|purinergic agents|mesh-ancestor
25710920|NCT02293395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25710921|NCT02293395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25710922|NCT02293395|Antithrombins|antithrombins|mesh-ancestor
25710923|NCT02293395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25710924|NCT02293395|Protease Inhibitors|protease inhibitors|mesh-ancestor
25710925|NCT02293395|Anticoagulants|anticoagulants|mesh-ancestor
25710926|NCT02293538|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24650765|NCT01227876|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24650766|NCT01227876|Prednisolone phosphate|prednisolone phosphate|mesh-list
24650892|NCT01228357|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24650893|NCT01228357|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24650894|NCT01228357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24650895|NCT01228357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24650896|NCT01228357|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24650897|NCT01228357|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24650898|NCT01228357|Histamine Antagonists|histamine antagonists|mesh-ancestor
24650934|NCT01228422|Immunologic Factors|immunologic factors|mesh-ancestor
24650935|NCT01228422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651233|NCT01230580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
24651234|NCT01230580|Protease Inhibitors|protease inhibitors|mesh-list
24651235|NCT01230580|Antiviral Agents|antiviral agents|mesh-ancestor
24651236|NCT01230580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24651237|NCT01230580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651238|NCT01230580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651239|NCT01230580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24651240|NCT01230580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24651242|NCT01230697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651243|NCT01230697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24651244|NCT01230697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651245|NCT01230697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651268|NCT01230983|Leucovorin|leucovorin|mesh-list
24812988|NCT02055703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651355|NCT01231165|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
24651356|NCT01231165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24651502|NCT01231828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24651503|NCT01231854|Cyclosporine|cyclosporine|mesh-list
24651504|NCT01231854|Alitretinoin|alitretinoin|mesh-list
24651505|NCT01231854|Cyclosporins|cyclosporins|mesh-list
24651506|NCT01231854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651632|NCT01232647|Vitamin K 1|vitamin k 1|mesh-list
24651633|NCT01232647|Menatetrenone|menatetrenone|mesh-list
24651634|NCT01232647|Micronutrients|micronutrients|mesh-ancestor
24651635|NCT01232647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651636|NCT01232647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24651637|NCT01232647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24651638|NCT01232647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651639|NCT01232647|Hemostatics|hemostatics|mesh-ancestor
24651640|NCT01232647|Coagulants|coagulants|mesh-ancestor
24651641|NCT01232660|Hydroxychloroquine|hydroxychloroquine|mesh-list
24651642|NCT01232660|Antimalarials|antimalarials|mesh-ancestor
24651643|NCT01232660|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24651896|NCT01234454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651897|NCT01234454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651899|NCT01234454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24651900|NCT01234454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24651901|NCT01234454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24651902|NCT01234454|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24651904|NCT01234454|Antiemetics|antiemetics|mesh-ancestor
24651905|NCT01234454|Autonomic Agents|autonomic agents|mesh-ancestor
24651930|NCT01234701|Liver Extracts|liver extracts|mesh-list
24652081|NCT01235819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24652082|NCT01235819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652083|NCT01235819|Incretins|incretins|mesh-ancestor
24652175|NCT01236859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652177|NCT01236859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24652178|NCT01236859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24652179|NCT01236859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24652180|NCT01236859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24652181|NCT01236859|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24652182|NCT01236859|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24652183|NCT01236859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24652209|NCT01237067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652210|NCT01237067|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24652305|NCT01237535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24652306|NCT01237535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652307|NCT01237730|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24652308|NCT01237730|Cefuroxime|cefuroxime|mesh-list
24652309|NCT01237730|Cefuroxime axetil|cefuroxime axetil|mesh-list
24652310|NCT01237730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24652311|NCT01237769|Vitamin D|vitamin d|mesh-list
24652312|NCT01237769|Ergocalciferols|ergocalciferols|mesh-list
24813001|NCT02055703|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24813002|NCT02055703|Antitubercular Agents|antitubercular agents|mesh-ancestor
24813003|NCT02055703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24652428|NCT01238185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24652429|NCT01238185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24652430|NCT01238185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24652431|NCT01238185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652432|NCT01238185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24652433|NCT01238185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24652434|NCT01238185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652437|NCT01238224|Vasodilator Agents|vasodilator agents|mesh-ancestor
24652438|NCT01238224|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24652439|NCT01238224|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24652440|NCT01238224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652441|NCT01238224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652444|NCT01238237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24652445|NCT01238237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652645|NCT01239498|Lidocaine|lidocaine|mesh-list
24652646|NCT01239498|Epinephrine|epinephrine|mesh-list
24652776|NCT01240096|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24652877|NCT01240824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24652878|NCT01240824|Protective Agents|protective agents|mesh-ancestor
24652897|NCT01240850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24652898|NCT01240850|Immunologic Factors|immunologic factors|mesh-ancestor
24653050|NCT01241682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24696973|NCT01432028|Diuretics|diuretics|mesh-ancestor
24696974|NCT01432028|Natriuretic Agents|natriuretic agents|mesh-ancestor
24653151|NCT01242215|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24653152|NCT01242215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653156|NCT01242228|Alogliptin|alogliptin|mesh-list
24653157|NCT01242228|Ipragliflozin|ipragliflozin|mesh-list
24813040|NCT02056223|Ibuprofen|ibuprofen|mesh-list
24653158|NCT01242228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24653185|NCT01242267|Growth Inhibitors|growth inhibitors|mesh-ancestor
24653186|NCT01242306|Acetylcholine|acetylcholine|mesh-list
24653187|NCT01242306|Vasodilator Agents|vasodilator agents|mesh-ancestor
24653188|NCT01242306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24653313|NCT01243359|Antibodies|antibodies|mesh-list
24653314|NCT01243359|Immunoglobulins|immunoglobulins|mesh-list
24653315|NCT01243359|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24653316|NCT01243359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653317|NCT01243359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24653318|NCT01243359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24653319|NCT01243359|Growth Substances|growth substances|mesh-ancestor
24653320|NCT01243359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653321|NCT01243359|Growth Inhibitors|growth inhibitors|mesh-ancestor
24653322|NCT01243359|Immunologic Factors|immunologic factors|mesh-ancestor
24653323|NCT01243359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24653324|NCT01243359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653325|NCT01243359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653580|NCT01244334|Prednisolone acetate|prednisolone acetate|mesh-list
24653608|NCT01244360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653609|NCT01244360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24653610|NCT01244399|Inositol|inositol|mesh-list
24653611|NCT01244399|Vitamin B Complex|vitamin b complex|mesh-ancestor
24653612|NCT01244399|Vitamins|vitamins|mesh-ancestor
24653613|NCT01244399|Micronutrients|micronutrients|mesh-ancestor
24670415|NCT02655016|Niraparib|niraparib|mesh-list
24653614|NCT01244399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653615|NCT01244581|Amoxicillin|amoxicillin|mesh-list
24653616|NCT01244581|Clavulanic Acid|clavulanic acid|mesh-list
24653617|NCT01244581|Clavulanic Acids|clavulanic acids|mesh-list
24653618|NCT01244581|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24653619|NCT01244581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24653620|NCT01244581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24653621|NCT01244581|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24653622|NCT01244581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653623|NCT01244581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653677|NCT01244971|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24653678|NCT01244971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653679|NCT01244971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813044|NCT02056223|Sensory System Agents|sensory system agents|mesh-ancestor
24653693|NCT01245179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653695|NCT01245205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24653697|NCT01245205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653936|NCT01246323|Anesthetics|anesthetics|mesh-ancestor
24653937|NCT01246323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24653938|NCT01246323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653939|NCT01246323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24653940|NCT01246323|Narcotics|narcotics|mesh-ancestor
24654043|NCT01247077|Micronutrients|micronutrients|mesh-ancestor
24654044|NCT01247311|Vitamin D|vitamin d|mesh-list
24654045|NCT01247311|Ergocalciferols|ergocalciferols|mesh-list
24654046|NCT01247311|Cholecalciferol|cholecalciferol|mesh-list
25710927|NCT02293538|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25710928|NCT02293863|Oseltamivir|oseltamivir|mesh-list
24654047|NCT01247311|Vitamins|vitamins|mesh-list
24654048|NCT01247311|Micronutrients|micronutrients|mesh-ancestor
24654389|NCT01249352|Antimetabolites|antimetabolites|mesh-ancestor
25710929|NCT02293863|Antiviral Agents|antiviral agents|mesh-ancestor
25710930|NCT02293863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25710931|NCT02293863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654392|NCT01249352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24654393|NCT01249352|Immunologic Factors|immunologic factors|mesh-ancestor
24654394|NCT01249352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654395|NCT01249352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24654397|NCT01249430|Etoposide|etoposide|mesh-list
24654398|NCT01249430|Mitoxantrone|mitoxantrone|mesh-list
24654432|NCT01249521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24654433|NCT01249521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24654434|NCT01249521|Growth Substances|growth substances|mesh-ancestor
24654436|NCT01249521|Growth Inhibitors|growth inhibitors|mesh-ancestor
24813049|NCT02056223|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24813050|NCT02056223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24813051|NCT02056223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813052|NCT02056223|Antipyretics|antipyretics|mesh-ancestor
24813053|NCT02056249|Norepinephrine|norepinephrine|mesh-list
24813054|NCT02056249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24654912|NCT01252056|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24654965|NCT01252524|Calcium|calcium|mesh-list
24655124|NCT01254526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24655151|NCT01254617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24655170|NCT00660673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24655206|NCT01254929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655208|NCT01254994|Antiviral Agents|antiviral agents|mesh-ancestor
24655209|NCT01254994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24655376|NCT01256151|GABA Agents|gaba agents|mesh-ancestor
24857221|NCT02289768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24655616|NCT01257412|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24655617|NCT01257412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655618|NCT01257412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24655621|NCT01257451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24655622|NCT01257451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655623|NCT01257451|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24656096|NCT01259830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656435|NCT01261689|Narcotics|narcotics|mesh-ancestor
24656500|NCT01262196|Chrysarobin|chrysarobin|mesh-list
24656501|NCT01262196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24656502|NCT01262196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24656503|NCT01262196|Analgesics|analgesics|mesh-ancestor
24656504|NCT01262196|Sensory System Agents|sensory system agents|mesh-ancestor
24656505|NCT01262196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24656506|NCT01262196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656875|NCT01264484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24656876|NCT01264484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656877|NCT01264484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656913|NCT01264640|Analgesics|analgesics|mesh-ancestor
24656914|NCT01264640|Sensory System Agents|sensory system agents|mesh-ancestor
24656915|NCT01264640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24656916|NCT01264640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656917|NCT01264640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24656918|NCT01264640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24656950|NCT01264692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24657557|NCT01268202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24657559|NCT01268202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657572|NCT01268215|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
24657573|NCT01268371|Everolimus|everolimus|mesh-list
24657574|NCT01268371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24657575|NCT01268371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24657577|NCT01268371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657578|NCT01268384|Gemcitabine|gemcitabine|mesh-list
24657579|NCT01268384|Capecitabine|capecitabine|mesh-list
24657580|NCT01268384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24657581|NCT01268384|Antimetabolites|antimetabolites|mesh-ancestor
24657583|NCT01268384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24658088|NCT01270412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24658089|NCT01270412|Immunologic Factors|immunologic factors|mesh-ancestor
24658093|NCT01270438|Leucovorin|leucovorin|mesh-list
24658098|NCT01270438|Levoleucovorin|levoleucovorin|mesh-list
24658133|NCT01270672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658135|NCT01270672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24658136|NCT01270672|Antioxidants|antioxidants|mesh-ancestor
24658137|NCT01270672|Protective Agents|protective agents|mesh-ancestor
24658138|NCT01270672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24658168|NCT01270737|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24658170|NCT01270737|Hormones|hormones|mesh-ancestor
24857234|NCT02289924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24857235|NCT02289937|Ropivacaine|ropivacaine|mesh-list
24857236|NCT02289937|Anesthetics, Local|anesthetics, local|mesh-ancestor
24658171|NCT01270737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24658172|NCT01270737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658173|NCT01270750|Bosentan|bosentan|mesh-list
24658174|NCT01270750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24658175|NCT01270750|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24658176|NCT01270750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658177|NCT01270776|Chlorhexidine|chlorhexidine|mesh-list
24658260|NCT01271088|Antidotes|antidotes|mesh-ancestor
24658261|NCT01271114|Terlipressin|terlipressin|mesh-list
24658262|NCT01271114|Norepinephrine|norepinephrine|mesh-list
24658263|NCT01271114|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24658264|NCT01271114|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24658265|NCT01271114|Adrenergic Agents|adrenergic agents|mesh-ancestor
24658266|NCT01271114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24658267|NCT01271114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658268|NCT01271114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658269|NCT01271114|Sympathomimetics|sympathomimetics|mesh-ancestor
24658270|NCT01271114|Autonomic Agents|autonomic agents|mesh-ancestor
24658351|NCT01271283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24658352|NCT01271283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24658354|NCT01271283|Growth Inhibitors|growth inhibitors|mesh-ancestor
24658355|NCT01271283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24658356|NCT01271348|Etoricoxib|etoricoxib|mesh-list
24658587|NCT01272778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24658588|NCT01272778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24658589|NCT01272778|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24658590|NCT01272778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24658591|NCT01272778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24658592|NCT01272778|GABA Modulators|gaba modulators|mesh-ancestor
24857239|NCT02289937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658597|NCT01272856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24658598|NCT01272856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658599|NCT01272856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24658767|NCT01273948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24658768|NCT01273948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24658769|NCT01273974|Vaccines|vaccines|mesh-list
24658770|NCT01273974|Immunologic Factors|immunologic factors|mesh-ancestor
24658771|NCT01273974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658772|NCT01274000|Ramosetron|ramosetron|mesh-list
24658773|NCT01274000|Antiemetics|antiemetics|mesh-ancestor
24658774|NCT01274000|Autonomic Agents|autonomic agents|mesh-ancestor
24658775|NCT01274000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658794|NCT01274039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658822|NCT01274221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24658823|NCT01274221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658828|NCT01274247|Anesthetics|anesthetics|mesh-ancestor
24658980|NCT01275014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24658981|NCT01275014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24658982|NCT01275014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24658983|NCT01275183|Raltegravir Potassium|raltegravir potassium|mesh-list
24658984|NCT01275183|Cisplatin|cisplatin|mesh-list
24658985|NCT01275183|Docetaxel|docetaxel|mesh-list
24658986|NCT01275183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659017|NCT01275274|Keratolytic Agents|keratolytic agents|mesh-ancestor
24659018|NCT01275274|Dermatologic Agents|dermatologic agents|mesh-ancestor
24659078|NCT01275547|GABA Modulators|gaba modulators|mesh-ancestor
24659084|NCT01275560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24659085|NCT01275560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24659086|NCT01275599|Buprenorphine|buprenorphine|mesh-list
24659087|NCT01275599|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
24659088|NCT01275599|Naloxone|naloxone|mesh-list
24659113|NCT01275638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24659170|NCT01275976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24659171|NCT01276015|Botulinum Toxins|botulinum toxins|mesh-list
24857245|NCT02290002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857246|NCT02290002|Hemostatics|hemostatics|mesh-ancestor
24857247|NCT02290002|Coagulants|coagulants|mesh-ancestor
24659172|NCT01276015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24659173|NCT01276015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24659244|NCT01276496|Antimitotic Agents|antimitotic agents|mesh-ancestor
24659245|NCT01276496|Mitosis Modulators|mitosis modulators|mesh-ancestor
24659246|NCT01276496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659248|NCT01276548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24455527|NCT00327691|Atorvastatin|atorvastatin|mesh-list
24612831|NCT01015482|Narcotics|narcotics|mesh-ancestor
24612832|NCT01015482|Analgesics|analgesics|mesh-ancestor
24659292|NCT01276704|Phytoestrogens|phytoestrogens|mesh-ancestor
24659293|NCT01276704|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24659294|NCT01276704|Estrogens|estrogens|mesh-ancestor
24659296|NCT01276704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24659297|NCT01276704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659298|NCT01276717|Vorinostat|vorinostat|mesh-list
24659299|NCT01276717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659300|NCT01276717|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24659301|NCT01276717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24659302|NCT01276717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659303|NCT01276730|Interferons|interferons|mesh-list
24659304|NCT01276730|Tretinoin|tretinoin|mesh-list
24659305|NCT01276730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24659306|NCT01276730|Antiviral Agents|antiviral agents|mesh-ancestor
24659353|NCT01277016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659381|NCT01277185|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24659383|NCT01277289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24659478|NCT01277913|Micronutrients|micronutrients|mesh-ancestor
24659479|NCT01277913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659480|NCT01277913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24659481|NCT01277913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24659482|NCT01278004|Ethosuximide|ethosuximide|mesh-list
24659483|NCT01278004|Anticonvulsants|anticonvulsants|mesh-ancestor
24659484|NCT01278017|Ceftriaxone|ceftriaxone|mesh-list
24659485|NCT01278017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24659486|NCT01278017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24659487|NCT01278056|Deferasirox|deferasirox|mesh-list
24659716|NCT01279434|Antioxidants|antioxidants|mesh-ancestor
24659717|NCT01279434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659718|NCT01279434|Protective Agents|protective agents|mesh-ancestor
25710932|NCT02293863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710933|NCT02293902|Folic Acid|folic acid|mesh-list
25710934|NCT02293902|Methotrexate|methotrexate|mesh-list
24659719|NCT01279499|Remifentanil|remifentanil|mesh-list
24659720|NCT01279499|Propofol|propofol|mesh-list
24659721|NCT01279499|Sevoflurane|sevoflurane|mesh-list
24659722|NCT01279499|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24659723|NCT01279499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25710935|NCT02293902|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24659725|NCT01279499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24659726|NCT01279499|Anesthetics, General|anesthetics, general|mesh-ancestor
24659727|NCT01279499|Anesthetics|anesthetics|mesh-ancestor
24455574|NCT00327808|Glucocorticoids|glucocorticoids|mesh-ancestor
24659824|NCT01279915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659825|NCT01279915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24659826|NCT01279980|Anesthetics|anesthetics|mesh-list
24659827|NCT01279980|Anesthetics, Local|anesthetics, local|mesh-list
24659828|NCT01279980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24659832|NCT01280006|Celecoxib|celecoxib|mesh-list
24659836|NCT01280006|Analgesics|analgesics|mesh-ancestor
24659837|NCT01280006|Sensory System Agents|sensory system agents|mesh-ancestor
24659859|NCT01280071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659961|NCT01281150|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24659963|NCT01281150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24659964|NCT01281150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660400|NCT01283217|Tubulin Modulators|tubulin modulators|mesh-ancestor
24660401|NCT01283217|Antimitotic Agents|antimitotic agents|mesh-ancestor
24660402|NCT01283217|Mitosis Modulators|mitosis modulators|mesh-ancestor
24660404|NCT01283256|Zonisamide|zonisamide|mesh-list
24660679|NCT01285141|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24660680|NCT01285141|Protective Agents|protective agents|mesh-ancestor
24660681|NCT01285219|Lenograstim|lenograstim|mesh-list
24660682|NCT01285219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24660683|NCT01285219|Immunologic Factors|immunologic factors|mesh-ancestor
24660684|NCT01285219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660685|NCT01285232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24660686|NCT01285232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24660688|NCT01285245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24660689|NCT01285271|Sevoflurane|sevoflurane|mesh-list
24660798|NCT01285817|Abortifacient Agents|abortifacient agents|mesh-ancestor
24660799|NCT01285817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24660800|NCT01285817|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24660802|NCT01285817|Dermatologic Agents|dermatologic agents|mesh-ancestor
24660803|NCT01285817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660804|NCT01285817|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24660805|NCT01285817|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24660806|NCT01285817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24660807|NCT01285817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24660808|NCT01285817|Analgesics|analgesics|mesh-ancestor
24660809|NCT01285817|Sensory System Agents|sensory system agents|mesh-ancestor
24660827|NCT01286090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24660849|NCT01286246|Hormones|hormones|mesh-ancestor
24660850|NCT01286246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24660851|NCT01286246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660852|NCT01286584|Varenicline|varenicline|mesh-list
24660853|NCT01286584|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24660854|NCT01286584|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24660855|NCT01286584|Cholinergic Agents|cholinergic agents|mesh-ancestor
24660856|NCT01286584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24660857|NCT01286584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660860|NCT01286688|Antifungal Agents|antifungal agents|mesh-ancestor
24660959|NCT01287338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24660960|NCT01287338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857271|NCT02290431|Hormones|hormones|mesh-ancestor
24857272|NCT02290431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24857273|NCT02290431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24857274|NCT02290431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24857275|NCT02290431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24660961|NCT01287351|Fluticasone|fluticasone|mesh-list
24660963|NCT01287351|Beclomethasone|beclomethasone|mesh-list
24660964|NCT01287351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24660965|NCT01287351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24660966|NCT01287351|Autonomic Agents|autonomic agents|mesh-ancestor
24660967|NCT01287351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24661036|NCT01287624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24661038|NCT01287624|Antiviral Agents|antiviral agents|mesh-ancestor
24661039|NCT01287624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24661040|NCT01287624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857276|NCT02290431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661068|NCT01287741|Doxorubicin|doxorubicin|mesh-list
24661147|NCT01288157|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24661148|NCT01288157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24661149|NCT01288157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24661150|NCT01288157|Immunologic Factors|immunologic factors|mesh-ancestor
24661152|NCT01288170|Tobramycin|tobramycin|mesh-list
24661223|NCT01288547|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24661224|NCT01288547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661225|NCT01288547|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24661226|NCT01288547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661227|NCT01288547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661260|NCT01288742|Simeprevir|simeprevir|mesh-list
24661323|NCT01288898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661324|NCT01288924|Parecoxib|parecoxib|mesh-list
24661325|NCT01288924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24661326|NCT01288924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24661327|NCT01288924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661328|NCT01288924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661329|NCT01288924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24661330|NCT01288924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24661331|NCT01288924|Analgesics|analgesics|mesh-ancestor
24612906|NCT01015729|Antipyretics|antipyretics|mesh-ancestor
24661662|NCT01290276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24661664|NCT01290276|Autonomic Agents|autonomic agents|mesh-ancestor
24661665|NCT01290276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24661666|NCT01290276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24661765|NCT01290900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24661824|NCT01291186|Sympathomimetics|sympathomimetics|mesh-ancestor
24661825|NCT01291186|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24661826|NCT01291199|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24661827|NCT01291199|Vasodilator Agents|vasodilator agents|mesh-ancestor
24661829|NCT01291199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24662014|NCT01291719|Insulin|insulin|mesh-list
24662015|NCT01291719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24662016|NCT01291719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662017|NCT01291823|Gefitinib|gefitinib|mesh-list
24662018|NCT01291823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662019|NCT01291823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24662020|NCT01291823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24662021|NCT01291823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662022|NCT01291927|Pancrelipase|pancrelipase|mesh-list
24662023|NCT01291927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24662024|NCT01291940|Petrolatum|petrolatum|mesh-list
24662025|NCT01291940|Emollients|emollients|mesh-ancestor
24662026|NCT01291940|Dermatologic Agents|dermatologic agents|mesh-ancestor
24662027|NCT01291979|Lidocaine|lidocaine|mesh-list
24662028|NCT01291979|Anesthetics, Local|anesthetics, local|mesh-ancestor
24662084|NCT01292356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24662085|NCT01292356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662086|NCT01292408|Hydroxychloroquine|hydroxychloroquine|mesh-list
24662087|NCT01292408|Antimalarials|antimalarials|mesh-ancestor
24662088|NCT01292408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24662089|NCT01292408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24662090|NCT01292408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24662091|NCT01292408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24662092|NCT01292408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662093|NCT01292408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24662094|NCT01292460|Timolol|timolol|mesh-list
24662095|NCT01292460|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24662118|NCT01292668|Dermatologic Agents|dermatologic agents|mesh-ancestor
24662119|NCT01292694|Losartan|losartan|mesh-list
24857291|NCT02290470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24857292|NCT02290470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24857294|NCT02290470|Autonomic Agents|autonomic agents|mesh-ancestor
24662224|NCT01293422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24662225|NCT01293422|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24662226|NCT01293422|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24662227|NCT01293422|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24662228|NCT01293422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25710936|NCT02293902|Abortifacient Agents|abortifacient agents|mesh-ancestor
24662230|NCT01293630|Carboplatin|carboplatin|mesh-list
24662231|NCT01293630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24662232|NCT01293630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662233|NCT01293630|Tubulin Modulators|tubulin modulators|mesh-ancestor
24662234|NCT01293630|Antimitotic Agents|antimitotic agents|mesh-ancestor
24662267|NCT01293734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24662317|NCT01293942|Antimetabolites|antimetabolites|mesh-ancestor
24662318|NCT01293942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662319|NCT01293942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24662320|NCT01293942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24662394|NCT01294618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662396|NCT01294618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24662417|NCT01294761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24662418|NCT01294761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24662419|NCT01294761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662420|NCT01294761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24662421|NCT01294761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24662422|NCT01294761|Protease Inhibitors|protease inhibitors|mesh-ancestor
24662423|NCT01294826|Cetuximab|cetuximab|mesh-list
24662424|NCT01294826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24662525|NCT01295151|Sensory System Agents|sensory system agents|mesh-ancestor
24455780|NCT00328939|Protease Inhibitors|protease inhibitors|mesh-ancestor
24662526|NCT01295151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24662527|NCT01295151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24662528|NCT01295151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24662529|NCT01295151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662530|NCT01295151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24662532|NCT01295177|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24662533|NCT01295177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24662534|NCT01295177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662535|NCT01295268|Emu Oil|emu oil|mesh-list
24662537|NCT01295268|Dermatologic Agents|dermatologic agents|mesh-ancestor
24662538|NCT01295294|Mefenamic Acid|mefenamic acid|mesh-list
24662539|NCT01295294|Tranexamic Acid|tranexamic acid|mesh-list
24662540|NCT01295294|Levonorgestrel|levonorgestrel|mesh-list
24662541|NCT01295294|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24662542|NCT01295294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24662543|NCT01295294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662544|NCT01295294|Hemostatics|hemostatics|mesh-ancestor
24662545|NCT01295294|Coagulants|coagulants|mesh-ancestor
24662546|NCT01295294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24662740|NCT01296503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662741|NCT01296503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24662742|NCT01296503|Immunologic Factors|immunologic factors|mesh-ancestor
24662743|NCT01296503|Leprostatic Agents|leprostatic agents|mesh-ancestor
24662744|NCT01296503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24662745|NCT01296503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24662746|NCT01296503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24662747|NCT01296503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24662748|NCT01296503|Growth Substances|growth substances|mesh-ancestor
24662749|NCT01296503|Growth Inhibitors|growth inhibitors|mesh-ancestor
24662750|NCT01296555|Letrozole|letrozole|mesh-list
24662751|NCT01296555|Fulvestrant|fulvestrant|mesh-list
24662752|NCT01296555|Midazolam|midazolam|mesh-list
24662753|NCT01296555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24662754|NCT01296555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24662915|NCT01297634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24662916|NCT01297686|Dexamethasone|dexamethasone|mesh-list
24662917|NCT01297686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24662918|NCT01297686|Antiemetics|antiemetics|mesh-ancestor
24662919|NCT01297686|Autonomic Agents|autonomic agents|mesh-ancestor
24662920|NCT01297686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24662921|NCT01297686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662922|NCT01297686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24662948|NCT01297764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24857313|NCT02290470|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25710939|NCT02293902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25710940|NCT02293902|Antimetabolites|antimetabolites|mesh-ancestor
24662950|NCT01297764|Growth Substances|growth substances|mesh-ancestor
24663272|NCT01299922|Antitubercular Agents|antitubercular agents|mesh-ancestor
24663273|NCT01299922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24663275|NCT01299948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24663276|NCT01299948|Glucocorticoids|glucocorticoids|mesh-ancestor
24663277|NCT01299948|Hormones|hormones|mesh-ancestor
24663311|NCT01300364|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24663312|NCT01300364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24663722|NCT01303497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24663723|NCT01303497|Growth Substances|growth substances|mesh-ancestor
24663724|NCT01303497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663753|NCT01303601|Antiemetics|antiemetics|mesh-ancestor
24663754|NCT01303601|Autonomic Agents|autonomic agents|mesh-ancestor
24663757|NCT01303601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24664006|NCT01304537|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24664007|NCT01304537|Protease Inhibitors|protease inhibitors|mesh-ancestor
24664008|NCT01304537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24664009|NCT01304537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664011|NCT01304563|Immunologic Factors|immunologic factors|mesh-ancestor
24664012|NCT01304563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664013|NCT01304602|Irinotecan|irinotecan|mesh-list
24664014|NCT01304602|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24664087|NCT01304901|Respiratory System Agents|respiratory system agents|mesh-ancestor
24664141|NCT01305317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24664142|NCT01305317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24664143|NCT01305369|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24664144|NCT01305369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24664145|NCT01305395|Sirolimus|sirolimus|mesh-list
24664146|NCT01305395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24664366|NCT01306370|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24664367|NCT01306370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24664368|NCT01306370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664369|NCT01306370|Coagulants|coagulants|mesh-ancestor
24664370|NCT01306409|Darbepoetin alfa|darbepoetin alfa|mesh-list
24664371|NCT01306409|Hematinics|hematinics|mesh-ancestor
24664372|NCT01306461|Timolol|timolol|mesh-list
24664373|NCT01306461|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24664374|NCT01306461|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24664410|NCT01306708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857322|NCT02290717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24857323|NCT02290717|Respiratory System Agents|respiratory system agents|mesh-ancestor
24857324|NCT02290717|Dermatologic Agents|dermatologic agents|mesh-ancestor
24857325|NCT02290717|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24857326|NCT02291055|Durvalumab|durvalumab|mesh-list
24664592|NCT01307969|Lidocaine|lidocaine|mesh-list
24664972|NCT01309607|Lapatinib|lapatinib|mesh-list
24857339|NCT02291094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24857340|NCT02291094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24664973|NCT01309607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24664974|NCT01309607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24664975|NCT01309607|Tubulin Modulators|tubulin modulators|mesh-ancestor
24664976|NCT01309607|Antimitotic Agents|antimitotic agents|mesh-ancestor
24664977|NCT01309607|Mitosis Modulators|mitosis modulators|mesh-ancestor
24664978|NCT01309607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664979|NCT01309607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24664980|NCT01309607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24664981|NCT01309620|Zinc|zinc|mesh-list
24664982|NCT01309620|Trace Elements|trace elements|mesh-ancestor
24664983|NCT01309620|Micronutrients|micronutrients|mesh-ancestor
24664984|NCT01309620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664985|NCT01309633|Gemcitabine|gemcitabine|mesh-list
24665186|NCT01310712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24665187|NCT01310712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665188|NCT01310712|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24665189|NCT01310712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25710941|NCT02293902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710942|NCT02293902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710943|NCT02293902|Dermatologic Agents|dermatologic agents|mesh-ancestor
25710944|NCT02293902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710945|NCT02293902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25710946|NCT02293902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25710947|NCT02293902|Immunologic Factors|immunologic factors|mesh-ancestor
24665190|NCT01310712|Cholinergic Agents|cholinergic agents|mesh-ancestor
24665191|NCT01310712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665192|NCT01310712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665193|NCT01310712|Urological Agents|urological agents|mesh-ancestor
24665195|NCT01310738|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24665287|NCT01311414|Vasodilator Agents|vasodilator agents|mesh-ancestor
24665288|NCT01311414|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24665289|NCT01311414|Serotonin Agents|serotonin agents|mesh-ancestor
24665290|NCT01311414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665320|NCT01311700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665321|NCT01311739|Vitamin B 12|vitamin b 12|mesh-list
24665336|NCT01311778|Analgesics|analgesics|mesh-ancestor
24665337|NCT01311778|Sensory System Agents|sensory system agents|mesh-ancestor
24665607|NCT01313611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665609|NCT01313689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665652|NCT01313845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24665654|NCT01313845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665655|NCT01313845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665656|NCT01313845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665657|NCT01313845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24857342|NCT02291094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24857343|NCT02291094|Narcotics|narcotics|mesh-ancestor
24857344|NCT02291094|Analgesics|analgesics|mesh-ancestor
24857345|NCT02291211|Cisplatin|cisplatin|mesh-list
24665671|NCT01314027|Immunologic Factors|immunologic factors|mesh-ancestor
24665672|NCT01314027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665673|NCT01314066|Bevacizumab|bevacizumab|mesh-list
24665674|NCT01314066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24665675|NCT01314066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665676|NCT01314066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24533617|NCT00644631|Sildenafil Citrate|sildenafil citrate|mesh-list
24665677|NCT01314066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24740579|NCT01689116|Moxifloxacin|moxifloxacin|mesh-list
24665679|NCT01314066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665680|NCT01314066|Growth Inhibitors|growth inhibitors|mesh-ancestor
24665681|NCT01314144|Bupivacaine|bupivacaine|mesh-list
24665856|NCT01315093|Anticoagulants|anticoagulants|mesh-ancestor
24665857|NCT01315093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24665858|NCT01315093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24665859|NCT01315093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665860|NCT01315262|Sildenafil Citrate|sildenafil citrate|mesh-list
24665878|NCT01315431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665879|NCT01315470|Lenograstim|lenograstim|mesh-list
24665880|NCT01315470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24665881|NCT01315470|Immunologic Factors|immunologic factors|mesh-ancestor
24666352|NCT01318681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24666353|NCT01318681|Autonomic Agents|autonomic agents|mesh-ancestor
24666354|NCT01318681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24666355|NCT01318681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666356|NCT01318681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24666357|NCT01318681|Respiratory System Agents|respiratory system agents|mesh-ancestor
24666358|NCT01318681|Dermatologic Agents|dermatologic agents|mesh-ancestor
24666359|NCT01318681|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24666360|NCT01318681|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24666361|NCT01318681|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24666362|NCT01318681|Histamine Antagonists|histamine antagonists|mesh-ancestor
24666363|NCT01318681|Histamine Agents|histamine agents|mesh-ancestor
24666395|NCT01319019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666396|NCT01319019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24666397|NCT01319019|Respiratory System Agents|respiratory system agents|mesh-ancestor
24666398|NCT01319019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24666399|NCT01319019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24666400|NCT01319019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25710948|NCT02293902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25710949|NCT02293902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25710950|NCT02293902|Hematinics|hematinics|mesh-ancestor
25710951|NCT02293902|Vitamin B Complex|vitamin b complex|mesh-ancestor
25710952|NCT02293902|Vitamins|vitamins|mesh-ancestor
25710953|NCT02293902|Micronutrients|micronutrients|mesh-ancestor
24666403|NCT01319019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666553|NCT01319864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24666554|NCT01319864|Antiviral Agents|antiviral agents|mesh-ancestor
24666555|NCT01319864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24666556|NCT01319903|Antibodies|antibodies|mesh-list
24666557|NCT01319903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24666558|NCT01319903|Immunologic Factors|immunologic factors|mesh-ancestor
24666559|NCT01319903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666560|NCT01319942|Sorafenib|sorafenib|mesh-list
24666561|NCT01319942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24666562|NCT01319942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24666563|NCT01319942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24666717|NCT01320579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666719|NCT01320579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24857363|NCT02291367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24666720|NCT01320579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24666721|NCT01320592|Paclitaxel|paclitaxel|mesh-list
24667022|NCT01321931|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24667114|NCT01322204|Antitussive Agents|antitussive agents|mesh-ancestor
24667115|NCT01322204|Respiratory System Agents|respiratory system agents|mesh-ancestor
24667117|NCT01322282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24667176|NCT01322867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24667177|NCT01322867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24667178|NCT01322867|GABA Modulators|gaba modulators|mesh-ancestor
24667180|NCT01322867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24667181|NCT01322867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24667186|NCT05461092|Analgesics, Opioid|analgesics, opioid|mesh-list
24667187|NCT05461092|Bupivacaine|bupivacaine|mesh-list
24667188|NCT05461092|Anesthetics, Local|anesthetics, local|mesh-ancestor
24667189|NCT05461092|Anesthetics|anesthetics|mesh-ancestor
24667190|NCT05461092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24667191|NCT05461092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667192|NCT05461092|Sensory System Agents|sensory system agents|mesh-ancestor
24667193|NCT05461092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24667194|NCT05461092|Narcotics|narcotics|mesh-ancestor
24700595|NCT01453504|Immunologic Factors|immunologic factors|mesh-ancestor
24700596|NCT01453504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700611|NCT01453582|Propolis|propolis|mesh-list
24667971|NCT05200884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24668154|NCT05069896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24668155|NCT05069896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24668157|NCT05069896|Sensory System Agents|sensory system agents|mesh-ancestor
24668158|NCT05069896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24668159|NCT05069896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24668160|NCT05069896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24668189|NCT05050305|Growth Inhibitors|growth inhibitors|mesh-ancestor
24533490|NCT00644137|Anticonvulsants|anticonvulsants|mesh-ancestor
24533491|NCT00644137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24533499|NCT00644176|Azithromycin|azithromycin|mesh-list
25404036|NCT03686124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24533513|NCT00644306|Thalidomide|thalidomide|mesh-list
24533514|NCT00644306|Prednisone|prednisone|mesh-list
24533515|NCT00644306|Melphalan|melphalan|mesh-list
24533516|NCT00644306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24533517|NCT00644306|Glucocorticoids|glucocorticoids|mesh-ancestor
24533520|NCT00644306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533523|NCT00644306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24533524|NCT00644306|Alkylating Agents|alkylating agents|mesh-ancestor
24857377|NCT02291380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24459885|NCT00346749|Adrenergic Agents|adrenergic agents|mesh-ancestor
24533574|NCT00644449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24533576|NCT00644475|Imidapril|imidapril|mesh-list
24533577|NCT00644475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24533578|NCT00644475|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24533579|NCT00644475|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24533580|NCT00644475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533582|NCT00644475|Protease Inhibitors|protease inhibitors|mesh-ancestor
24533615|NCT00644618|Immunologic Factors|immunologic factors|mesh-ancestor
24533616|NCT00644618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533735|NCT00644982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710954|NCT02293993|Guadecitabine|guadecitabine|mesh-list
25710955|NCT02293993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710956|NCT02294019|Ibuprofen|ibuprofen|mesh-list
25710957|NCT02294019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25710958|NCT02294019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25710959|NCT02294019|Analgesics|analgesics|mesh-ancestor
25710960|NCT02294019|Sensory System Agents|sensory system agents|mesh-ancestor
25710961|NCT02294019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25710962|NCT02294019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710963|NCT02294019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25710965|NCT02294019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24857388|NCT02291471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24857389|NCT02291536|Dronabinol|dronabinol|mesh-list
24857390|NCT02291536|Cannabidiol|cannabidiol|mesh-list
25710966|NCT02294019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25710967|NCT02294019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710968|NCT02294058|Interferons|interferons|mesh-list
25710969|NCT02294058|Interferon-beta|interferon-beta|mesh-list
25710970|NCT02294058|Interferon beta-1a|interferon beta-1a|mesh-list
25710971|NCT02294058|Ozanimod|ozanimod|mesh-list
25710972|NCT02294058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24533871|NCT00645320|Ziprasidone|ziprasidone|mesh-list
24533905|NCT00645398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24533906|NCT00645398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24533907|NCT00645398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24533908|NCT00645398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24533916|NCT00645424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24533917|NCT00645424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533918|NCT00645437|Levofloxacin|levofloxacin|mesh-list
24533919|NCT00645437|Ofloxacin|ofloxacin|mesh-list
24533920|NCT00645437|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24533921|NCT00645437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24533923|NCT00645437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24533924|NCT00645437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24533925|NCT00645437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24533926|NCT00645437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533927|NCT00645437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533928|NCT00645437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710973|NCT02294058|Antiviral Agents|antiviral agents|mesh-ancestor
25710974|NCT02294058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25710975|NCT02294058|Immunologic Factors|immunologic factors|mesh-ancestor
24428964|NCT00241982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24428965|NCT00241982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428973|NCT00242008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428974|NCT00242008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429097|NCT00242606|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24429103|NCT00242736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24429104|NCT00242736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24429105|NCT00242736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429132|NCT00242775|Dermatologic Agents|dermatologic agents|mesh-ancestor
24429133|NCT00242775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24429134|NCT00242775|Glucocorticoids|glucocorticoids|mesh-ancestor
24429135|NCT00242775|Hormones|hormones|mesh-ancestor
24429136|NCT00242775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24429137|NCT00242775|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24429138|NCT00242775|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24429139|NCT00242775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24429140|NCT00242775|Adrenergic Agents|adrenergic agents|mesh-ancestor
24429274|NCT00243113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429276|NCT00243178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24429277|NCT00243178|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24429278|NCT00243178|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24429279|NCT00243178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24429295|NCT00243256|Micronutrients|micronutrients|mesh-ancestor
24429296|NCT00243256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24429297|NCT00243399|Oxandrolone|oxandrolone|mesh-list
24429298|NCT00243399|Androgens|androgens|mesh-ancestor
24429300|NCT00243399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24429301|NCT00243399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429302|NCT00243399|Anabolic Agents|anabolic agents|mesh-ancestor
24429303|NCT00243464|Betamethasone|betamethasone|mesh-list
24429304|NCT00243464|Betamethasone Valerate|betamethasone valerate|mesh-list
24429305|NCT00243464|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24429306|NCT00243464|Betamethasone benzoate|betamethasone benzoate|mesh-list
24429307|NCT00243464|Calcipotriene|calcipotriene|mesh-list
24429308|NCT00243464|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24429309|NCT00243464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24429310|NCT00243464|Glucocorticoids|glucocorticoids|mesh-ancestor
24429311|NCT00243464|Hormones|hormones|mesh-ancestor
24429312|NCT00243464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24429313|NCT00243464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429314|NCT00243464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24429392|NCT00243789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429393|NCT00243789|Vasodilator Agents|vasodilator agents|mesh-ancestor
24429394|NCT00243789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24429395|NCT00243789|Antioxidants|antioxidants|mesh-ancestor
24429396|NCT00243815|Ibuprofen|ibuprofen|mesh-list
24429397|NCT00243815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24429399|NCT00243815|Analgesics|analgesics|mesh-ancestor
24429434|NCT00243945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824942|NCT02126332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25710976|NCT02294058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710977|NCT02294058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24824943|NCT02126332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24824945|NCT02126332|Antipyretics|antipyretics|mesh-ancestor
24429435|NCT00243945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429437|NCT00243984|Anticonvulsants|anticonvulsants|mesh-ancestor
24429438|NCT00243984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24429439|NCT00243984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429440|NCT00244023|Methyltestosterone|methyltestosterone|mesh-list
24429441|NCT00244023|Testosterone|testosterone|mesh-list
24429442|NCT00244023|Testosterone undecanoate|testosterone undecanoate|mesh-list
24429446|NCT00244023|Hormones|hormones|mesh-ancestor
24824952|NCT02126358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24429547|NCT00244309|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24429548|NCT00244309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24429549|NCT00244309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429550|NCT00244309|Hormone Antagonists|hormone antagonists|mesh-ancestor
24429551|NCT00244309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24429553|NCT00244348|Oxaliplatin|oxaliplatin|mesh-list
24429554|NCT00244348|Antimetabolites|antimetabolites|mesh-ancestor
24429555|NCT00244348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429556|NCT00244348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24429558|NCT00244348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24429573|NCT00244426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24429574|NCT00244426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429575|NCT00244426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24429576|NCT00244426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24429577|NCT00244426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24429578|NCT00244426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24429579|NCT00244426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24824973|NCT02126527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24824974|NCT02126527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24824975|NCT02126527|Antifungal Agents|antifungal agents|mesh-ancestor
24824976|NCT02126527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24429666|NCT00244608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24429667|NCT00244608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429669|NCT00244608|Tocolytic Agents|tocolytic agents|mesh-ancestor
24429670|NCT00244608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24429672|NCT00244738|Cathartics|cathartics|mesh-ancestor
24429673|NCT00244738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24429674|NCT00244829|Imatinib Mesylate|imatinib mesylate|mesh-list
24429675|NCT00244829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429676|NCT00244829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24429677|NCT00244829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429678|NCT00244829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429679|NCT00244907|Risedronic Acid|risedronic acid|mesh-list
24429680|NCT00244907|Genistein|genistein|mesh-list
24429681|NCT00244907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24429682|NCT00244907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24824995|NCT02126683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24824996|NCT02126683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429701|NCT00244920|Androgen Antagonists|androgen antagonists|mesh-list
24429702|NCT00244920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24429703|NCT00244920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429740|NCT00244959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429793|NCT00245089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24429794|NCT00245089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24429795|NCT00245089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24429796|NCT00245089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429797|NCT00245089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24429798|NCT00245115|Cyclophosphamide|cyclophosphamide|mesh-list
24429800|NCT00245115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24429801|NCT00245115|Immunologic Factors|immunologic factors|mesh-ancestor
24429802|NCT00245115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429803|NCT00245115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24429804|NCT00245115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24429805|NCT00245115|Alkylating Agents|alkylating agents|mesh-ancestor
24429806|NCT00245115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24429807|NCT00245115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429958|NCT00245609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24429959|NCT00245609|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24429960|NCT00245609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24429961|NCT00245609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24429962|NCT00245609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24429963|NCT00245609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24429964|NCT00245609|GABA Modulators|gaba modulators|mesh-ancestor
24429965|NCT00245609|GABA Agents|gaba agents|mesh-ancestor
24429966|NCT00245609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24429967|NCT00245661|Temazepam|temazepam|mesh-list
24429968|NCT00245661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24429971|NCT00245661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24430006|NCT00245791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24430007|NCT00245791|Renal Agents|renal agents|mesh-ancestor
24430008|NCT00245791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24430020|NCT00245908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24430022|NCT00245921|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24430023|NCT00245921|Estradiol|estradiol|mesh-list
24430034|NCT00245921|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24825000|NCT02126761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825002|NCT02126917|Hydrocodone|hydrocodone|mesh-list
24825003|NCT02126917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24825004|NCT02126917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24825005|NCT02126917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24825008|NCT02126917|Narcotics|narcotics|mesh-ancestor
24430037|NCT00245934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24430039|NCT00245934|Sensory System Agents|sensory system agents|mesh-ancestor
24430040|NCT00245934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24430041|NCT00245934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430043|NCT00245934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24430044|NCT00245934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24430045|NCT00245934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24430046|NCT00245934|Immunologic Factors|immunologic factors|mesh-ancestor
24430047|NCT00246064|Infliximab|infliximab|mesh-list
24430048|NCT00246064|Dermatologic Agents|dermatologic agents|mesh-ancestor
24430050|NCT00246064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24430063|NCT00246103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24430064|NCT00246103|Antimetabolites|antimetabolites|mesh-ancestor
24430065|NCT00246103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24430066|NCT00246103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24430067|NCT00246103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24430068|NCT00246103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24430069|NCT00246103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430070|NCT00246103|Anticonvulsants|anticonvulsants|mesh-ancestor
24430071|NCT00246103|GABA Agents|gaba agents|mesh-ancestor
24430072|NCT00246103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430073|NCT00246103|Antimanic Agents|antimanic agents|mesh-ancestor
24430076|NCT00246103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24430095|NCT00246155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430096|NCT00246155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430097|NCT00246155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24430123|NCT00246207|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24430124|NCT00246207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430126|NCT00246207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24430127|NCT00246207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24430128|NCT00246207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430129|NCT00246207|Dopamine Agents|dopamine agents|mesh-ancestor
24430130|NCT00246207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430131|NCT00246220|Methylphenidate|methylphenidate|mesh-list
24430132|NCT00246220|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24430133|NCT00246220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430134|NCT00246220|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24430152|NCT00246246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430153|NCT00246246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430154|NCT00246246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430155|NCT00246246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24430156|NCT00246246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24430157|NCT00246246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24430158|NCT00246246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24430159|NCT00246246|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24430160|NCT00246246|Dopamine Agents|dopamine agents|mesh-ancestor
24430161|NCT00246272|Risperidone|risperidone|mesh-list
24430162|NCT00246272|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24430163|NCT00246272|Serotonin Agents|serotonin agents|mesh-ancestor
24430178|NCT00246285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430179|NCT00246285|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24430180|NCT00246285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24430185|NCT00246298|Epoetin Alfa|epoetin alfa|mesh-list
24430186|NCT00246298|Hematinics|hematinics|mesh-ancestor
24430187|NCT00246363|Silymarin|silymarin|mesh-list
24430188|NCT00246363|Antioxidants|antioxidants|mesh-ancestor
24430189|NCT00246363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430190|NCT00246363|Protective Agents|protective agents|mesh-ancestor
24430191|NCT00246363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430192|NCT00246389|Cyclobenzaprine|cyclobenzaprine|mesh-list
24430193|NCT00246389|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24430194|NCT00246389|Antidepressive Agents|antidepressive agents|mesh-ancestor
24430195|NCT00246389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24430196|NCT00246389|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24430206|NCT00246402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24430208|NCT00246415|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24430209|NCT00246415|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24430210|NCT00246415|Dopamine Agents|dopamine agents|mesh-ancestor
24430211|NCT00246415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430238|NCT00246610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430239|NCT00246610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24430240|NCT00246610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24430241|NCT00246610|Antiviral Agents|antiviral agents|mesh-ancestor
24430242|NCT00246610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24430243|NCT00246623|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24430244|NCT00246623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430246|NCT00246636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24430247|NCT00246636|Antimetabolites|antimetabolites|mesh-ancestor
24430248|NCT00246636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430249|NCT00246636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24430250|NCT00246675|Furosemide|furosemide|mesh-list
24430251|NCT00246675|Diuretics|diuretics|mesh-ancestor
24430259|NCT00246701|Simvastatin|simvastatin|mesh-list
24430260|NCT00246701|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24430261|NCT00246701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24430262|NCT00246701|Antimetabolites|antimetabolites|mesh-ancestor
24430263|NCT00246701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430264|NCT00246701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24430265|NCT00246701|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24430280|NCT00246974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24430285|NCT00246974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24430286|NCT00247026|Ubiquinone|ubiquinone|mesh-list
24825031|NCT02127034|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24825032|NCT02127034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825033|NCT02127034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825034|NCT02127034|Protective Agents|protective agents|mesh-ancestor
24825035|NCT02127034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430287|NCT00247026|Coenzyme Q10|coenzyme q10|mesh-list
24430294|NCT00247026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430295|NCT00247026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24430296|NCT00247026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24430297|NCT00247026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24430298|NCT00247026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430299|NCT00247026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430300|NCT00247026|Micronutrients|micronutrients|mesh-ancestor
24430301|NCT00247026|Vitamins|vitamins|mesh-ancestor
24430302|NCT00247052|Diclofenac|diclofenac|mesh-list
24430303|NCT00247052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24430304|NCT00247052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24430305|NCT00247052|Analgesics|analgesics|mesh-ancestor
24430306|NCT00247052|Sensory System Agents|sensory system agents|mesh-ancestor
24430307|NCT00247052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24430369|NCT00247494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24430370|NCT00247494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24430371|NCT00247494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24698428|NCT01441206|Rifampin|rifampin|mesh-list
24430443|NCT00247715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24430444|NCT00247715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24430445|NCT00247715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24430446|NCT00247715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430453|NCT00247715|Antacids|antacids|mesh-ancestor
24430454|NCT00247715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24430455|NCT00247715|Immunologic Factors|immunologic factors|mesh-ancestor
24430456|NCT00247741|Lidocaine|lidocaine|mesh-list
24430457|NCT00247741|Carticaine|carticaine|mesh-list
24430458|NCT00247741|Anesthetics, Local|anesthetics, local|mesh-ancestor
24430459|NCT00247741|Anesthetics|anesthetics|mesh-ancestor
24430460|NCT00247741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24430461|NCT00247741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430462|NCT00247741|Sensory System Agents|sensory system agents|mesh-ancestor
24430463|NCT00247741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24430464|NCT00247741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24430510|NCT00248118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24430511|NCT00248118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24430512|NCT00248118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430513|NCT00248118|Dopamine Agents|dopamine agents|mesh-ancestor
24430514|NCT00248118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430515|NCT00248118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430516|NCT00248118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24430517|NCT00248118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24825050|NCT02127047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24825051|NCT02127047|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25415990|NCT02979873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24825054|NCT02127047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825057|NCT02127060|Micronutrients|micronutrients|mesh-ancestor
24825058|NCT02127060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825059|NCT02127060|Antioxidants|antioxidants|mesh-ancestor
24825060|NCT02127060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698489|NCT01441505|Midazolam|midazolam|mesh-list
24430532|NCT00248157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24430636|NCT00248482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24430637|NCT00248482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24430638|NCT00248482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24430639|NCT00248482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430640|NCT00248482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825061|NCT02127060|Protective Agents|protective agents|mesh-ancestor
24698549|NCT01441869|Incretins|incretins|mesh-ancestor
24430641|NCT00248482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24430642|NCT00248482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24430643|NCT00248716|Ferrous gluconate|ferrous gluconate|mesh-list
24430644|NCT00248716|Hematinics|hematinics|mesh-ancestor
24430645|NCT00248729|Midazolam|midazolam|mesh-list
24430646|NCT00248729|Etomidate|etomidate|mesh-list
24430713|NCT00249132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24430714|NCT00249132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24430715|NCT00249132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24430716|NCT00249132|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24430718|NCT00249145|Risperidone|risperidone|mesh-list
24430719|NCT00249145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24430720|NCT00249145|Serotonin Agents|serotonin agents|mesh-ancestor
24430721|NCT00249145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430722|NCT00249145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430723|NCT00249145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430724|NCT00249145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25710978|NCT02294058|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25710979|NCT02294058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25710980|NCT02294058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25710981|NCT02294253|Buprenorphine|buprenorphine|mesh-list
25710982|NCT02294253|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25710983|NCT02294253|Naloxone|naloxone|mesh-list
25710984|NCT02294253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24430725|NCT00249145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24430726|NCT00249145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24430746|NCT00249171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430747|NCT00249171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430748|NCT00249171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24430749|NCT00249171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24430750|NCT00249171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24430751|NCT00249171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24430752|NCT00249171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24430753|NCT00249171|Dopamine Agents|dopamine agents|mesh-ancestor
24430754|NCT00249197|Levofloxacin|levofloxacin|mesh-list
24430756|NCT00249197|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24430757|NCT00249197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24430758|NCT00249197|Renal Agents|renal agents|mesh-ancestor
24430759|NCT00249197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24825086|NCT02127320|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24825088|NCT02127320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24430853|NCT00249483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24430855|NCT00249483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24430928|NCT00249782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430929|NCT00249782|Leprostatic Agents|leprostatic agents|mesh-ancestor
24430930|NCT00249847|Paroxetine|paroxetine|mesh-list
24430931|NCT00249847|Estrogens|estrogens|mesh-list
24430933|NCT00249847|Hormones|hormones|mesh-ancestor
24430935|NCT00249847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430952|NCT00249860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24430953|NCT00249860|Antiviral Agents|antiviral agents|mesh-ancestor
24430960|NCT00249886|Citalopram|citalopram|mesh-list
24430988|NCT00249912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430989|NCT00249938|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
24430990|NCT00249938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24430991|NCT00249938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24430992|NCT00249938|Antimetabolites|antimetabolites|mesh-ancestor
24430993|NCT00249938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430994|NCT00249938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24430996|NCT00249964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24430997|NCT00249964|Carboplatin|carboplatin|mesh-list
24430998|NCT00249964|Temozolomide|temozolomide|mesh-list
24430999|NCT00249964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24431000|NCT00249964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431087|NCT00250315|Sympathomimetics|sympathomimetics|mesh-ancestor
24431088|NCT00250315|Autonomic Agents|autonomic agents|mesh-ancestor
24431089|NCT00250315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24431251|NCT00250978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24431252|NCT00250978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431253|NCT00250978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24431254|NCT00250978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24431255|NCT00250978|Growth Substances|growth substances|mesh-ancestor
24431256|NCT00250978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431257|NCT00250978|Growth Inhibitors|growth inhibitors|mesh-ancestor
24431258|NCT00250991|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24431260|NCT00250991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24431261|NCT00250991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24431262|NCT00250991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431263|NCT00250991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24431264|NCT00251017|Vancomycin|vancomycin|mesh-list
24431265|NCT00251017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24431266|NCT00251017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24431267|NCT00251030|Nelfinavir|nelfinavir|mesh-list
24431268|NCT00251030|Omeprazole|omeprazole|mesh-list
24431315|NCT00251277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24431316|NCT00251277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431317|NCT00251277|Immunologic Factors|immunologic factors|mesh-ancestor
24431318|NCT00251277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431319|NCT00251277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24431320|NCT00251355|Gemcitabine|gemcitabine|mesh-list
24431321|NCT00251355|Fluorouracil|fluorouracil|mesh-list
24431322|NCT00251355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24431323|NCT00251355|Antimetabolites|antimetabolites|mesh-ancestor
24431324|NCT00251355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431325|NCT00251355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431326|NCT00251355|Antiviral Agents|antiviral agents|mesh-ancestor
24431327|NCT00251355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24431328|NCT00251355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431329|NCT00251355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24431330|NCT00251355|Immunologic Factors|immunologic factors|mesh-ancestor
24431331|NCT00251355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431361|NCT00251472|Mitosis Modulators|mitosis modulators|mesh-ancestor
24431362|NCT00251472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431363|NCT00251485|Cetuximab|cetuximab|mesh-list
24825106|NCT02127541|Exenatide|exenatide|mesh-list
24825107|NCT02127541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24825108|NCT02127541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825109|NCT02127541|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24825110|NCT02127541|Incretins|incretins|mesh-ancestor
24825111|NCT02127541|Hormones|hormones|mesh-ancestor
24825112|NCT02127541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24431370|NCT00251511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431387|NCT00251550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431388|NCT00251550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431389|NCT00251550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24431390|NCT00251550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24431391|NCT00251602|Propranolol|propranolol|mesh-list
24431392|NCT00251602|Atropine|atropine|mesh-list
24431393|NCT00251602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24431394|NCT00251602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24431395|NCT00251602|Adrenergic Agents|adrenergic agents|mesh-ancestor
24431396|NCT00251602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431397|NCT00251602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431398|NCT00251602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431399|NCT00251602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24431400|NCT00251602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24431401|NCT00251602|Vasodilator Agents|vasodilator agents|mesh-ancestor
24431402|NCT00251602|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24431403|NCT00251602|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24431457|NCT00251784|Vasodilator Agents|vasodilator agents|mesh-ancestor
24431458|NCT00251784|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24431459|NCT00251784|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24431472|NCT00251797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431473|NCT00251797|Leprostatic Agents|leprostatic agents|mesh-ancestor
24431474|NCT00251797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25415991|NCT02979873|Immunologic Factors|immunologic factors|mesh-ancestor
24431476|NCT00251797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24431477|NCT00251797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24431478|NCT00251797|Growth Substances|growth substances|mesh-ancestor
24431479|NCT00251797|Growth Inhibitors|growth inhibitors|mesh-ancestor
24431480|NCT00251823|Eptifibatide|eptifibatide|mesh-list
24431481|NCT00251823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24431482|NCT00251849|KRM 1648|krm 1648|mesh-list
24431483|NCT00251849|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24825135|NCT02127593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24825136|NCT02127593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24825138|NCT02127593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825139|NCT02127593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825140|NCT02127593|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24431501|NCT00251914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25710986|NCT02294253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25710987|NCT02294253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25710988|NCT02294253|Analgesics|analgesics|mesh-ancestor
25710989|NCT02294253|Sensory System Agents|sensory system agents|mesh-ancestor
25710990|NCT02294253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25710991|NCT02294253|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25710992|NCT02294396|Solifenacin Succinate|solifenacin succinate|mesh-list
25710993|NCT02294396|Mirabegron|mirabegron|mesh-list
24431510|NCT00251953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24431511|NCT00251953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431513|NCT00251966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24431514|NCT00251966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24431515|NCT00251966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24431516|NCT00251966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431517|NCT00251966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431518|NCT00251992|Esomeprazole|esomeprazole|mesh-list
24431519|NCT00251992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24431527|NCT00252044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431528|NCT00252044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431529|NCT00252044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431530|NCT00252122|Ketamine|ketamine|mesh-list
24431531|NCT00252122|Analgesics|analgesics|mesh-ancestor
24431532|NCT00252122|Sensory System Agents|sensory system agents|mesh-ancestor
24431533|NCT00252122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24431534|NCT00252122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431535|NCT00252122|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24431536|NCT00252122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24431537|NCT00252122|Anesthetics, General|anesthetics, general|mesh-ancestor
24431539|NCT00252122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24431540|NCT00252122|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24431548|NCT00252226|Antidepressive Agents|antidepressive agents|mesh-ancestor
24431549|NCT00252226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24431550|NCT00252226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24431551|NCT00252226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24431552|NCT00252226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24431553|NCT00252226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431554|NCT00252278|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24431555|NCT00252278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24431556|NCT00252278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24431557|NCT00252278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24431558|NCT00252278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431559|NCT00252278|Adrenergic Agents|adrenergic agents|mesh-ancestor
24431560|NCT00252278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431561|NCT00252278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431563|NCT00252291|Miotics|miotics|mesh-ancestor
24431627|NCT00252434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431634|NCT00252603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24431635|NCT00252603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431636|NCT00252603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602203|NCT00967629|Calcium Carbonate|calcium carbonate|mesh-list
24431639|NCT00252603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431640|NCT00252603|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24431641|NCT00252603|Autonomic Agents|autonomic agents|mesh-ancestor
24431642|NCT00252603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24431643|NCT00252603|Nootropic Agents|nootropic agents|mesh-ancestor
24431644|NCT00252642|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24431645|NCT00252642|Antiviral Agents|antiviral agents|mesh-ancestor
24431646|NCT00252642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24431647|NCT00252655|Sirolimus|sirolimus|mesh-list
24431648|NCT00252655|Tacrolimus|tacrolimus|mesh-list
24431649|NCT00252655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24431650|NCT00252655|Immunologic Factors|immunologic factors|mesh-ancestor
24431651|NCT00252655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431685|NCT00252707|Gefitinib|gefitinib|mesh-list
24825145|NCT02127684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825147|NCT02127684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825148|NCT02127697|Glycopyrrolate|glycopyrrolate|mesh-list
24431694|NCT00252785|Theophylline|theophylline|mesh-list
24431695|NCT00252785|Formoterol Fumarate|formoterol fumarate|mesh-list
24431704|NCT00252785|Hormones|hormones|mesh-ancestor
24431705|NCT00252785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24431706|NCT00252785|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24431707|NCT00252785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24431708|NCT00252785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24431709|NCT00252785|Adrenergic Agents|adrenergic agents|mesh-ancestor
24431710|NCT00252785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431712|NCT00252785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24431745|NCT00252824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25710994|NCT02294396|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25710995|NCT02294396|Propiverine|propiverine|mesh-list
24431746|NCT00252824|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24431747|NCT00252824|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24431748|NCT00252824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24431749|NCT00252824|Adrenergic Agents|adrenergic agents|mesh-ancestor
24431750|NCT00252824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431751|NCT00252824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431754|NCT00252863|Budesonide|budesonide|mesh-list
24431755|NCT00252863|Theophylline|theophylline|mesh-list
24431756|NCT00252863|Albuterol|albuterol|mesh-list
24431757|NCT00252863|Terbutaline|terbutaline|mesh-list
24431966|NCT00253318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24431967|NCT00253318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24431968|NCT00253318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431969|NCT00253318|Tubulin Modulators|tubulin modulators|mesh-ancestor
24431970|NCT00253318|Antimitotic Agents|antimitotic agents|mesh-ancestor
24431989|NCT00253344|Growth Inhibitors|growth inhibitors|mesh-ancestor
24431990|NCT00253396|Heparin|heparin|mesh-list
24431991|NCT00253396|Enoxaparin|enoxaparin|mesh-list
24431992|NCT00253396|Calcium heparin|calcium heparin|mesh-list
24431993|NCT00253396|Anticoagulants|anticoagulants|mesh-ancestor
24431994|NCT00253396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24432007|NCT00253422|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24432008|NCT00253422|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24432009|NCT00253422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432010|NCT00253422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432775|NCT00256100|Fondaparinux|fondaparinux|mesh-list
24825154|NCT02127697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24825155|NCT02127697|Respiratory System Agents|respiratory system agents|mesh-ancestor
24432135|NCT00253721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24432142|NCT00253721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432144|NCT00253773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24432145|NCT00253773|Analgesics|analgesics|mesh-ancestor
24432146|NCT00253773|Sensory System Agents|sensory system agents|mesh-ancestor
24432147|NCT00253773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24432148|NCT00253773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432149|NCT00253773|Antipyretics|antipyretics|mesh-ancestor
24432150|NCT00253799|Hylan|hylan|mesh-list
24432167|NCT00253903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24432170|NCT00253929|Nitroprusside|nitroprusside|mesh-list
24432171|NCT00253929|Acetylcholine|acetylcholine|mesh-list
24432172|NCT00253929|Caffeine|caffeine|mesh-list
24432173|NCT00253929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24432174|NCT00253929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432175|NCT00253929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24432182|NCT00253929|Analgesics|analgesics|mesh-ancestor
24432226|NCT00254020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24432227|NCT00254020|Serotonin Agents|serotonin agents|mesh-ancestor
24432261|NCT00254137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24432262|NCT00254137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432263|NCT00254137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24432264|NCT00254176|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
24432265|NCT00254176|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24825157|NCT02127697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24825158|NCT02127697|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24825159|NCT02127697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24825160|NCT02127697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24825161|NCT02127697|Adrenergic Agents|adrenergic agents|mesh-ancestor
24825162|NCT02127697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24825163|NCT02127697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825164|NCT02127697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24432266|NCT00254176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24432267|NCT00254189|Levonorgestrel|levonorgestrel|mesh-list
24432268|NCT00254189|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24432269|NCT00254189|Estradiol|estradiol|mesh-list
24432270|NCT00254189|Estrogens|estrogens|mesh-ancestor
24432271|NCT00254189|Hormones|hormones|mesh-ancestor
24432272|NCT00254189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24432273|NCT00254189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432356|NCT00254553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24432357|NCT00254553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432358|NCT00254553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24432359|NCT00254553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25710996|NCT02294396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25710997|NCT02294396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25710998|NCT02294396|Cholinergic Agents|cholinergic agents|mesh-ancestor
25710999|NCT02294396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24432360|NCT00254553|Anabolic Agents|anabolic agents|mesh-ancestor
24432362|NCT00254618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24432483|NCT00254878|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24432484|NCT00254878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24432485|NCT00254878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24432486|NCT00254878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432487|NCT00254878|Dopamine Agents|dopamine agents|mesh-ancestor
24432488|NCT00254878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24432490|NCT00254917|Immunologic Factors|immunologic factors|mesh-ancestor
24432491|NCT00254917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432493|NCT00254930|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24432494|NCT00254930|Serotonin Agents|serotonin agents|mesh-ancestor
24432495|NCT00254930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24432521|NCT00255242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24432539|NCT00255255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24432543|NCT00255255|Adrenergic Agents|adrenergic agents|mesh-ancestor
24432544|NCT00255255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24432545|NCT00255255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432547|NCT00255268|Bicalutamide|bicalutamide|mesh-list
24432548|NCT00255268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24432549|NCT00255268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432550|NCT00255268|Androgen Antagonists|androgen antagonists|mesh-ancestor
24602696|NCT00970528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432651|NCT00255593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24432652|NCT00255593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432653|NCT00255593|Immunologic Factors|immunologic factors|mesh-ancestor
24432654|NCT00255593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432655|NCT00255593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24432656|NCT00255606|Prednisone|prednisone|mesh-list
24432657|NCT00255606|Docetaxel|docetaxel|mesh-list
24432658|NCT00255606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432659|NCT00255606|Tubulin Modulators|tubulin modulators|mesh-ancestor
24432660|NCT00255606|Antimitotic Agents|antimitotic agents|mesh-ancestor
24432661|NCT00255606|Mitosis Modulators|mitosis modulators|mesh-ancestor
24432662|NCT00255606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432663|NCT00255606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24432664|NCT00255606|Glucocorticoids|glucocorticoids|mesh-ancestor
24432665|NCT00255606|Hormones|hormones|mesh-ancestor
24432666|NCT00255606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24432667|NCT00255606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432668|NCT00255606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24432669|NCT00255658|Sirolimus|sirolimus|mesh-list
24432670|NCT00255658|Sorafenib|sorafenib|mesh-list
24432671|NCT00255658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432672|NCT00255658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24432673|NCT00255658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825175|NCT02127736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24432771|NCT00256009|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24432772|NCT00256009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24432777|NCT00256100|Antithrombins|antithrombins|mesh-ancestor
24432778|NCT00256100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24432779|NCT00256100|Protease Inhibitors|protease inhibitors|mesh-ancestor
24432780|NCT00256100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432781|NCT00256100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432804|NCT00256256|Incretins|incretins|mesh-ancestor
24432805|NCT00256269|Oxaliplatin|oxaliplatin|mesh-list
24432807|NCT00256269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432808|NCT00256269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24432809|NCT00256269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24432810|NCT00256269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432811|NCT00256269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432812|NCT00256321|Celecoxib|celecoxib|mesh-list
24432813|NCT00256321|Capecitabine|capecitabine|mesh-list
24432814|NCT00256321|Oxaliplatin|oxaliplatin|mesh-list
24432815|NCT00256321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24432816|NCT00256321|Antimetabolites|antimetabolites|mesh-ancestor
24432817|NCT00256321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711000|NCT02294396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432923|NCT00257023|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24432924|NCT00257023|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24432925|NCT00257023|Serotonin Agents|serotonin agents|mesh-ancestor
24432926|NCT00257023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24432927|NCT00257023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432929|NCT00257023|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24432930|NCT00257023|Dopamine Agents|dopamine agents|mesh-ancestor
24432931|NCT00257036|Levofloxacin|levofloxacin|mesh-list
24432932|NCT00257036|Ofloxacin|ofloxacin|mesh-list
24432933|NCT00257036|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24432934|NCT00257036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24432935|NCT00257036|Renal Agents|renal agents|mesh-ancestor
24432936|NCT00257036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24432938|NCT00257036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24432939|NCT00257036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432949|NCT00257049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24432950|NCT00257049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24432951|NCT00257049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24432952|NCT00257049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24432966|NCT00257062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432977|NCT00257075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24433034|NCT00257361|Cycloserine|cycloserine|mesh-list
24433035|NCT00257361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24433036|NCT00257361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24433037|NCT00257361|Renal Agents|renal agents|mesh-ancestor
24433038|NCT00257361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24433039|NCT00257361|Antitubercular Agents|antitubercular agents|mesh-ancestor
24433040|NCT00257361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24433041|NCT00257361|Antimetabolites|antimetabolites|mesh-ancestor
24433042|NCT00257361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433043|NCT00257387|Cyclosporine|cyclosporine|mesh-list
24433044|NCT00257387|Cyclosporins|cyclosporins|mesh-list
24433045|NCT00257387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433046|NCT00257387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433047|NCT00257387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24433058|NCT00257426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433059|NCT00257452|Moxifloxacin|moxifloxacin|mesh-list
24433061|NCT00257452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24433087|NCT00257530|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24433088|NCT00257530|Immunologic Factors|immunologic factors|mesh-ancestor
24433089|NCT00257530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433090|NCT00257530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433122|NCT00257621|Protease Inhibitors|protease inhibitors|mesh-ancestor
24433123|NCT00257621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24433124|NCT00257621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433125|NCT00257621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24433126|NCT00257621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24433127|NCT00257621|Antiviral Agents|antiviral agents|mesh-ancestor
24433136|NCT00257634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433137|NCT00257634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24433138|NCT00257634|Glucocorticoids|glucocorticoids|mesh-ancestor
24433139|NCT00257634|Hormones|hormones|mesh-ancestor
24433140|NCT00257634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24433141|NCT00257634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24433142|NCT00257634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433143|NCT00257699|Metronidazole|metronidazole|mesh-list
24433145|NCT00257699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24433146|NCT00257699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24433147|NCT00257699|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24549472|NCT00715377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24549473|NCT00715377|Dopamine Agents|dopamine agents|mesh-ancestor
24549474|NCT00715455|Heparin|heparin|mesh-list
24433580|NCT00259129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433581|NCT00259142|Chloroquine|chloroquine|mesh-list
24433582|NCT00259142|Pyrimethamine|pyrimethamine|mesh-list
24433583|NCT00259142|Sulfadoxine|sulfadoxine|mesh-list
24433584|NCT00259142|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24433585|NCT00259142|Amebicides|amebicides|mesh-ancestor
24433586|NCT00259142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24433587|NCT00259142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24433588|NCT00259142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24433589|NCT00259142|Antimalarials|antimalarials|mesh-ancestor
24433655|NCT00259662|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24433656|NCT00259662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24433657|NCT00259662|Antimetabolites|antimetabolites|mesh-ancestor
24433658|NCT00259662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433659|NCT00259662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24433660|NCT00259662|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24433663|NCT00259675|Carboplatin|carboplatin|mesh-list
24433664|NCT00259675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825214|NCT02127840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24825215|NCT02127840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24825216|NCT02127840|Autonomic Agents|autonomic agents|mesh-ancestor
24825217|NCT02127840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24825218|NCT02127840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24825219|NCT02127840|Respiratory System Agents|respiratory system agents|mesh-ancestor
24825220|NCT02127840|Mydriatics|mydriatics|mesh-ancestor
24433721|NCT00259779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24433722|NCT00259779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24433743|NCT00259792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24433744|NCT00259792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433746|NCT00259805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24433747|NCT00259805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24433748|NCT00259805|Immunologic Factors|immunologic factors|mesh-ancestor
24433749|NCT00259805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433750|NCT00259805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24433751|NCT00259870|Olanzapine|olanzapine|mesh-list
24433752|NCT00259870|Antiemetics|antiemetics|mesh-ancestor
24433753|NCT00259870|Autonomic Agents|autonomic agents|mesh-ancestor
24433754|NCT00259870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24433755|NCT00259870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433756|NCT00259870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24433757|NCT00259870|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24433758|NCT00259870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24433759|NCT00259870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24433760|NCT00259870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24433833|NCT00260247|Antimanic Agents|antimanic agents|mesh-ancestor
24433834|NCT00260247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24433835|NCT00260247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24433842|NCT00260247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24433843|NCT00260247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24433844|NCT00260247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433845|NCT00260247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24549552|NCT00715871|Autonomic Agents|autonomic agents|mesh-ancestor
24549553|NCT00715871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24549554|NCT00715871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433931|NCT00260793|Ropinirole|ropinirole|mesh-list
24433932|NCT00260793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24433933|NCT00260793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24433934|NCT00260793|Dopamine Agonists|dopamine agonists|mesh-ancestor
24433935|NCT00260793|Dopamine Agents|dopamine agents|mesh-ancestor
25711001|NCT02294396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711002|NCT02294396|Urological Agents|urological agents|mesh-ancestor
25711003|NCT02294396|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25711004|NCT02294396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25711005|NCT02294396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25711006|NCT02294396|Adrenergic Agents|adrenergic agents|mesh-ancestor
25711007|NCT02294396|Parasympatholytics|parasympatholytics|mesh-ancestor
25711008|NCT02294396|Autonomic Agents|autonomic agents|mesh-ancestor
24433936|NCT00260793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24433938|NCT00260793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434039|NCT00261287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24434040|NCT00261287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434041|NCT00261287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24434043|NCT00261300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24434044|NCT00261300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24434045|NCT00261300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24434046|NCT00261300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434048|NCT00261313|Darbepoetin alfa|darbepoetin alfa|mesh-list
24434154|NCT00261586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434168|NCT00261599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24434170|NCT00261599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24434171|NCT00261599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434252|NCT00261820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24434276|NCT00261872|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24434277|NCT00261872|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24434278|NCT00261872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24434279|NCT00261872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434280|NCT00261872|Dopamine Agents|dopamine agents|mesh-ancestor
24434281|NCT00261872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24434282|NCT00261911|Sibutramine|sibutramine|mesh-list
24434283|NCT00261911|Antidepressive Agents|antidepressive agents|mesh-ancestor
24434284|NCT00261911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24434285|NCT00261911|Appetite Depressants|appetite depressants|mesh-ancestor
24434286|NCT00261911|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24434287|NCT00261937|Furosemide|furosemide|mesh-list
24434288|NCT00261937|Diuretics|diuretics|mesh-ancestor
24434289|NCT00261937|Natriuretic Agents|natriuretic agents|mesh-ancestor
24434290|NCT00261937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434292|NCT00261937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24825254|NCT02127866|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24825255|NCT02127866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24825256|NCT02127866|Cholinergic Agents|cholinergic agents|mesh-ancestor
24825257|NCT02127866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24434385|NCT00262392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434386|NCT00262405|Prednisone|prednisone|mesh-list
24434387|NCT00262405|Zileuton|zileuton|mesh-list
24434388|NCT00262405|Azathioprine|azathioprine|mesh-list
24434416|NCT00262418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825290|NCT02128061|Growth Substances|growth substances|mesh-ancestor
24825291|NCT02128061|Growth Inhibitors|growth inhibitors|mesh-ancestor
24825292|NCT02128100|Leucovorin|leucovorin|mesh-list
24825293|NCT02128100|Fluorouracil|fluorouracil|mesh-list
24825294|NCT02128100|Oxaliplatin|oxaliplatin|mesh-list
24825295|NCT02128100|Irinotecan|irinotecan|mesh-list
24825296|NCT02128100|Folfirinox|folfirinox|mesh-list
24825297|NCT02128100|Antimetabolites|antimetabolites|mesh-ancestor
24825316|NCT02128178|Enoxaparin sodium|enoxaparin sodium|mesh-list
24825325|NCT02128191|Sensory System Agents|sensory system agents|mesh-ancestor
24825326|NCT02128191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24825327|NCT02128191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825328|NCT02128191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24825329|NCT02128191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24825330|NCT02128191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24825331|NCT02128191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435555|NCT00266838|Dexamethasone|dexamethasone|mesh-list
25711009|NCT02294396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25711010|NCT02294474|Insulin|insulin|mesh-list
25711011|NCT02294474|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25711012|NCT02294474|Insulin Glargine|insulin glargine|mesh-list
25711013|NCT02294474|Insulin Lispro|insulin lispro|mesh-list
25711014|NCT02294474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25711015|NCT02294474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825332|NCT02128191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825333|NCT02128204|Lidocaine|lidocaine|mesh-list
24825334|NCT02128204|Anesthetics, Local|anesthetics, local|mesh-ancestor
24825335|NCT02128204|Anesthetics|anesthetics|mesh-ancestor
24825336|NCT02128204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24825337|NCT02128204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825338|NCT02128204|Sensory System Agents|sensory system agents|mesh-ancestor
24825339|NCT02128204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24825340|NCT02128204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24434593|NCT00262886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24434595|NCT00262886|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24434596|NCT00262886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434597|NCT00262886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24434598|NCT00262886|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24434599|NCT00262886|Antitubercular Agents|antitubercular agents|mesh-ancestor
24434600|NCT00262886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24434601|NCT00262886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24434602|NCT00262977|Aspirin|aspirin|mesh-list
24825343|NCT02128204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24825344|NCT02128204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825345|NCT02128243|Leucovorin|leucovorin|mesh-list
24825346|NCT02128243|Cisplatin|cisplatin|mesh-list
24434605|NCT00262977|Analgesics|analgesics|mesh-ancestor
24825361|NCT02128243|Immunologic Factors|immunologic factors|mesh-ancestor
24825362|NCT02128243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825363|NCT02128243|Antidotes|antidotes|mesh-ancestor
24825364|NCT02128243|Protective Agents|protective agents|mesh-ancestor
24825365|NCT02128243|Vitamin B Complex|vitamin b complex|mesh-ancestor
24825366|NCT02128243|Vitamins|vitamins|mesh-ancestor
24825367|NCT02128243|Micronutrients|micronutrients|mesh-ancestor
24825368|NCT02128243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24825369|NCT02128243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24825370|NCT02128243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24825371|NCT02128243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825372|NCT02128282|Gemcitabine|gemcitabine|mesh-list
24825373|NCT02128282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825374|NCT02128282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24825375|NCT02128282|Antimetabolites|antimetabolites|mesh-ancestor
24825376|NCT02128282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825377|NCT02128282|Antiviral Agents|antiviral agents|mesh-ancestor
24825378|NCT02128282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24825379|NCT02128282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825380|NCT02128282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24825381|NCT02128282|Immunologic Factors|immunologic factors|mesh-ancestor
24825382|NCT02128282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825383|NCT02128308|Moxifloxacin|moxifloxacin|mesh-list
24825384|NCT02128308|Levofloxacin|levofloxacin|mesh-list
24434674|NCT00263185|Cholecalciferol|cholecalciferol|mesh-list
24825387|NCT02128308|Pyrazinamide|pyrazinamide|mesh-list
24825388|NCT02128308|Aminosalicylic Acid|aminosalicylic acid|mesh-list
24825389|NCT02128308|Streptomycin|streptomycin|mesh-list
24607412|NCT04665037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24825390|NCT02128308|Kanamycin|kanamycin|mesh-list
24825391|NCT02128308|Prothionamide|prothionamide|mesh-list
24825392|NCT02128308|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24825393|NCT02128308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25711016|NCT02294604|Chlorhexidine|chlorhexidine|mesh-list
25711017|NCT02294604|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25711018|NCT02294604|Povidone-Iodine|povidone-iodine|mesh-list
25711019|NCT02294604|Povidone|povidone|mesh-list
25711020|NCT02294604|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25711021|NCT02294604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25711022|NCT02294604|Disinfectants|disinfectants|mesh-ancestor
25711023|NCT02294604|Dermatologic Agents|dermatologic agents|mesh-ancestor
25711024|NCT02294604|Plasma Substitutes|plasma substitutes|mesh-ancestor
24825395|NCT02128308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24825396|NCT02128308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24825398|NCT02128308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825399|NCT02128308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825400|NCT02128308|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24825401|NCT02128308|Contraceptive Agents|contraceptive agents|mesh-ancestor
24825402|NCT02128308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24825403|NCT02128308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700847|NCT01455441|Liraglutide|liraglutide|mesh-list
24434746|NCT00263393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24434792|NCT00263484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24434793|NCT00263484|Growth Substances|growth substances|mesh-ancestor
24434794|NCT00263484|Growth Inhibitors|growth inhibitors|mesh-ancestor
24434795|NCT00263484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24825404|NCT02128308|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24825406|NCT02128308|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24825408|NCT02128308|Renal Agents|renal agents|mesh-ancestor
24434836|NCT00263978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24434837|NCT00263978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434838|NCT00263978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24434839|NCT00264069|Antipsychotic Agents|antipsychotic agents|mesh-list
24434840|NCT00264069|Antidepressive Agents|antidepressive agents|mesh-list
24434841|NCT00264069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24434843|NCT00264069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24434844|NCT00264069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434845|NCT00264082|Zoledronic Acid|zoledronic acid|mesh-list
24434846|NCT00264082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24434847|NCT00264082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434848|NCT00264108|Epoetin Alfa|epoetin alfa|mesh-list
24825414|NCT02128308|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24825416|NCT02128321|Isavuconazole|isavuconazole|mesh-list
24825417|NCT02128321|Caffeine|caffeine|mesh-list
24825418|NCT02128321|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24434859|NCT00264134|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24434929|NCT00264355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434930|NCT00264355|Antifungal Agents|antifungal agents|mesh-ancestor
24825422|NCT02128321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825423|NCT02128321|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24825425|NCT02128321|Purinergic Agents|purinergic agents|mesh-ancestor
24700978|NCT01456234|Oseltamivir|oseltamivir|mesh-list
24438587|NCT00276289|Natriuretic Agents|natriuretic agents|mesh-ancestor
24434931|NCT00264355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24434933|NCT00264355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24434934|NCT00264355|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24434935|NCT00264368|Ganciclovir|ganciclovir|mesh-list
24434936|NCT00264368|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
24434937|NCT00264368|Antiviral Agents|antiviral agents|mesh-ancestor
24434938|NCT00264368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24434939|NCT00264368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24434940|NCT00264368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24434941|NCT00264368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434942|NCT00264407|Hormones|hormones|mesh-list
24434943|NCT00264407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24434944|NCT00264407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434945|NCT00264420|Zoledronic Acid|zoledronic acid|mesh-list
24434946|NCT00264420|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24434948|NCT00264446|Eniluracil|eniluracil|mesh-list
24434950|NCT00264446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434951|NCT00264459|Immunologic Factors|immunologic factors|mesh-list
24434952|NCT00264459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434953|NCT00264472|Eniluracil|eniluracil|mesh-list
24434954|NCT00264472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825447|NCT02128425|Leucovorin|leucovorin|mesh-list
24825448|NCT02128425|Fluorouracil|fluorouracil|mesh-list
24825449|NCT02128425|Oxaliplatin|oxaliplatin|mesh-list
24825450|NCT02128425|Irinotecan|irinotecan|mesh-list
24825451|NCT02128425|Levoleucovorin|levoleucovorin|mesh-list
24825452|NCT02128425|Antimetabolites|antimetabolites|mesh-ancestor
24825453|NCT02128425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825454|NCT02128425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24825455|NCT02128425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825456|NCT02128425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24825457|NCT02128425|Immunologic Factors|immunologic factors|mesh-ancestor
24825458|NCT02128425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825459|NCT02128425|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24825460|NCT02128425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24825461|NCT02128425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825462|NCT02128425|Antidotes|antidotes|mesh-ancestor
24825464|NCT02128425|Vitamin B Complex|vitamin b complex|mesh-ancestor
24825465|NCT02128425|Vitamins|vitamins|mesh-ancestor
24435308|NCT00265928|Immunoglobulins|immunoglobulins|mesh-list
24435309|NCT00265928|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24435310|NCT00265928|Enzyme Inhibitors|enzyme inhibitors|mesh-list
24435311|NCT00265928|Immunologic Factors|immunologic factors|mesh-ancestor
24435312|NCT00265928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435313|NCT00265928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24435315|NCT00265928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24435316|NCT00265928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435317|NCT00265967|Irbesartan|irbesartan|mesh-list
24435318|NCT00265967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24435319|NCT00265967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24435320|NCT00265967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24435441|NCT00266344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24435442|NCT00266344|Analgesics|analgesics|mesh-ancestor
24825474|NCT02128451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24825475|NCT02128451|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24825476|NCT02128451|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24825477|NCT02128451|Anesthetics, General|anesthetics, general|mesh-ancestor
24825478|NCT02128451|Anesthetics|anesthetics|mesh-ancestor
24825480|NCT02128633|Fluorides|fluorides|mesh-list
24825481|NCT02128633|Sodium Fluoride|sodium fluoride|mesh-list
24825482|NCT02128633|Cariostatic Agents|cariostatic agents|mesh-ancestor
24825483|NCT02128633|Protective Agents|protective agents|mesh-ancestor
24825484|NCT02128633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701302|NCT01458067|GSK2636771|gsk2636771|mesh-list
24435443|NCT00266344|Sensory System Agents|sensory system agents|mesh-ancestor
24435467|NCT00266487|Vitamin B Complex|vitamin b complex|mesh-list
24435468|NCT00266487|Micronutrients|micronutrients|mesh-ancestor
24435469|NCT00266487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435470|NCT00266487|Hematinics|hematinics|mesh-ancestor
24435498|NCT00266578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24435499|NCT00266578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24435500|NCT00266578|Autonomic Agents|autonomic agents|mesh-ancestor
24435501|NCT00266578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24435502|NCT00266578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435503|NCT00266578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24435551|NCT00266786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24825485|NCT02128633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24825487|NCT02128646|Ketorolac|ketorolac|mesh-list
24549842|NCT00717704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549843|NCT00717730|Vitamins|vitamins|mesh-list
24549844|NCT00717730|Folic Acid|folic acid|mesh-list
24549845|NCT00717730|Hydroxocobalamin|hydroxocobalamin|mesh-list
24549846|NCT00717730|Vitamin B 12|vitamin b 12|mesh-list
24549847|NCT00717730|Vitamin B Complex|vitamin b complex|mesh-list
24825492|NCT02128646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825493|NCT02128646|Sensory System Agents|sensory system agents|mesh-ancestor
24825494|NCT02128646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24756770|NCT01735487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24756771|NCT01735487|Cholinergic Agents|cholinergic agents|mesh-ancestor
24756834|NCT01736020|Anesthetics|anesthetics|mesh-ancestor
24825495|NCT02128646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24825496|NCT02128646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24825497|NCT02128646|Analgesics|analgesics|mesh-ancestor
24435552|NCT00266786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24435553|NCT00266786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435554|NCT00266786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435556|NCT00266838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24435557|NCT00266838|Antiemetics|antiemetics|mesh-ancestor
24435558|NCT00266838|Autonomic Agents|autonomic agents|mesh-ancestor
24435559|NCT00266838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24435560|NCT00266838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435561|NCT00266838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24435562|NCT00266838|Glucocorticoids|glucocorticoids|mesh-ancestor
24435563|NCT00266838|Hormones|hormones|mesh-ancestor
24435565|NCT00266838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24435592|NCT00267215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435593|NCT00267215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24435614|NCT00267267|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
24435672|NCT00267553|Hormone Antagonists|hormone antagonists|mesh-ancestor
24435673|NCT00267553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24435674|NCT00267553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435675|NCT00267553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24435676|NCT00267553|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24435677|NCT00267553|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24435678|NCT00267553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24604583|NCT00980304|Rituximab|rituximab|mesh-list
24435724|NCT00267917|Ipratropium|ipratropium|mesh-list
24435725|NCT00267917|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24435726|NCT00267917|Autonomic Agents|autonomic agents|mesh-ancestor
24435727|NCT00267917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24435728|NCT00267917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550084|NCT00719056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24435729|NCT00267917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24435730|NCT00267917|Respiratory System Agents|respiratory system agents|mesh-ancestor
24435731|NCT00267917|Sympathomimetics|sympathomimetics|mesh-ancestor
24435732|NCT00267917|Tocolytic Agents|tocolytic agents|mesh-ancestor
24435800|NCT00268229|Imatinib Mesylate|imatinib mesylate|mesh-list
24435801|NCT00268229|Daunorubicin|daunorubicin|mesh-list
24435802|NCT00268229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24435803|NCT00268229|Antimetabolites|antimetabolites|mesh-ancestor
24435804|NCT00268229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711025|NCT02294604|Blood Substitutes|blood substitutes|mesh-ancestor
25711026|NCT02294630|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25711027|NCT02294630|Respiratory System Agents|respiratory system agents|mesh-ancestor
25711028|NCT02294734|Nemiralisib|nemiralisib|mesh-list
25711029|NCT02294734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25711030|NCT02294734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711031|NCT02294734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711032|NCT02294773|Letrozole|letrozole|mesh-list
24435805|NCT00268229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435806|NCT00268229|Antiviral Agents|antiviral agents|mesh-ancestor
24435809|NCT00268229|Immunologic Factors|immunologic factors|mesh-ancestor
24435814|NCT00268229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24435815|NCT00268229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24435817|NCT00268255|Enzyme Inhibitors|enzyme inhibitors|mesh-list
24435868|NCT00268398|Irinotecan|irinotecan|mesh-list
24435869|NCT00268398|Levoleucovorin|levoleucovorin|mesh-list
24435870|NCT00268398|Antimetabolites|antimetabolites|mesh-ancestor
24435871|NCT00268398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435872|NCT00268398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24435873|NCT00268398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435874|NCT00268398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24435875|NCT00268398|Immunologic Factors|immunologic factors|mesh-ancestor
24757656|NCT01741558|Antimetabolites|antimetabolites|mesh-ancestor
24435878|NCT00268398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24435879|NCT00268398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24550025|NCT00718757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24825541|NCT02128984|Protective Agents|protective agents|mesh-ancestor
24825542|NCT02128984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550027|NCT00718757|Autonomic Agents|autonomic agents|mesh-ancestor
24825543|NCT02129088|Esketamine|esketamine|mesh-list
24825544|NCT02129088|Antidepressive Agents|antidepressive agents|mesh-ancestor
24435931|NCT00268515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24435932|NCT00268515|Antimetabolites|antimetabolites|mesh-ancestor
24435933|NCT00268515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24435940|NCT00268528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24435941|NCT00268528|Antimetabolites|antimetabolites|mesh-ancestor
24436048|NCT00268749|Glycine Agents|glycine agents|mesh-ancestor
24436049|NCT00268749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24436050|NCT00268749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436051|NCT00268749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436052|NCT00268788|Immunoglobulins|immunoglobulins|mesh-list
24436053|NCT00268788|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24436055|NCT00268788|gamma-Globulins|gamma-globulins|mesh-list
24436056|NCT00268788|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24825545|NCT02129088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24825546|NCT02129101|Azacitidine|azacitidine|mesh-list
24825547|NCT02129101|Decitabine|decitabine|mesh-list
24825548|NCT02129101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24825549|NCT02129101|Antimetabolites|antimetabolites|mesh-ancestor
24436057|NCT00268788|Immunologic Factors|immunologic factors|mesh-ancestor
24550085|NCT00719056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24436130|NCT00269126|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24436131|NCT00269126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24436132|NCT00269126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24436133|NCT00269126|Autonomic Agents|autonomic agents|mesh-ancestor
24436134|NCT00269126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24436135|NCT00269126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711033|NCT02294773|Clomiphene|clomiphene|mesh-list
25711034|NCT02294773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711035|NCT02294773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25711036|NCT02294773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25711037|NCT02294773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711038|NCT02294773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711039|NCT02294773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25711040|NCT02294773|Hormone Antagonists|hormone antagonists|mesh-ancestor
25711041|NCT02294773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24436186|NCT00269334|Citalopram|citalopram|mesh-list
24436187|NCT00269334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24436188|NCT00269334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24436206|NCT00269386|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24436207|NCT00269386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24436209|NCT00269412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24436210|NCT00269412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24436211|NCT00269412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24436212|NCT00269542|Iron|iron|mesh-list
24436213|NCT00269542|Folic Acid|folic acid|mesh-list
24825566|NCT02129127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24825567|NCT02129127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825568|NCT02129127|Tubulin Modulators|tubulin modulators|mesh-ancestor
24825569|NCT02129127|Antimitotic Agents|antimitotic agents|mesh-ancestor
24825570|NCT02129127|Mitosis Modulators|mitosis modulators|mesh-ancestor
24825571|NCT02129127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825572|NCT02129166|Imatinib Mesylate|imatinib mesylate|mesh-list
24825573|NCT02129166|Dasatinib|dasatinib|mesh-list
24825574|NCT02129166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825575|NCT02129166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24436214|NCT00269542|Vitamin B Complex|vitamin b complex|mesh-list
24436215|NCT00269542|Trace Elements|trace elements|mesh-ancestor
24436216|NCT00269542|Micronutrients|micronutrients|mesh-ancestor
24436217|NCT00269542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436218|NCT00269542|Hematinics|hematinics|mesh-ancestor
24436219|NCT00269542|Vitamins|vitamins|mesh-ancestor
24436223|NCT00269555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436225|NCT00269555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24550152|NCT00719407|Hematinics|hematinics|mesh-ancestor
24550153|NCT00719420|Amoxicillin|amoxicillin|mesh-list
24436239|NCT00269568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24436240|NCT00269568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24436241|NCT00269568|Oxytocics|oxytocics|mesh-ancestor
24436242|NCT00269568|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24436344|NCT00269763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24436345|NCT00269763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24436346|NCT00269763|Anesthetics, General|anesthetics, general|mesh-ancestor
25711042|NCT02294773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711043|NCT02294773|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25711044|NCT02294773|Fertility Agents|fertility agents|mesh-ancestor
25711045|NCT02294773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25711046|NCT02294773|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24436347|NCT00269763|Anesthetics|anesthetics|mesh-ancestor
24550213|NCT00719693|Antimetabolites|antimetabolites|mesh-ancestor
24436348|NCT00269776|Methylphenidate|methylphenidate|mesh-list
25711047|NCT02294773|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25711048|NCT02294786|Capecitabine|capecitabine|mesh-list
25711049|NCT02294786|Lapatinib|lapatinib|mesh-list
25711050|NCT02294786|Octreotide|octreotide|mesh-list
25711051|NCT02294786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25711052|NCT02294786|Antimetabolites|antimetabolites|mesh-ancestor
24436349|NCT00269776|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24436350|NCT00269776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436351|NCT00269776|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24436352|NCT00269776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24436451|NCT00269932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24436452|NCT00269945|Epoetin Alfa|epoetin alfa|mesh-list
24436453|NCT00269945|Hematinics|hematinics|mesh-ancestor
24436454|NCT00269958|Epoetin Alfa|epoetin alfa|mesh-list
24436455|NCT00269958|Hematinics|hematinics|mesh-ancestor
24436456|NCT00269971|Epoetin Alfa|epoetin alfa|mesh-list
24436457|NCT00269971|Hematinics|hematinics|mesh-ancestor
24436458|NCT00269984|Epoetin Alfa|epoetin alfa|mesh-list
24436459|NCT00269984|Hematinics|hematinics|mesh-ancestor
24436460|NCT00269997|Epoetin Alfa|epoetin alfa|mesh-list
24436461|NCT00269997|Hematinics|hematinics|mesh-ancestor
24436462|NCT00270010|Epoetin Alfa|epoetin alfa|mesh-list
24436463|NCT00270010|Hematinics|hematinics|mesh-ancestor
24436464|NCT00270023|Epoetin Alfa|epoetin alfa|mesh-list
24436465|NCT00270023|Hematinics|hematinics|mesh-ancestor
24436466|NCT00270036|Epoetin Alfa|epoetin alfa|mesh-list
24436467|NCT00270036|Hematinics|hematinics|mesh-ancestor
24436473|NCT00270075|Hematinics|hematinics|mesh-ancestor
24825594|NCT02129231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24701956|NCT01463150|Clopidogrel|clopidogrel|mesh-list
24436569|NCT00270491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436570|NCT00270491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24436572|NCT00270517|Telithromycin|telithromycin|mesh-list
24436573|NCT00270517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24436574|NCT00270517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24436575|NCT00270530|Pyrimethamine|pyrimethamine|mesh-list
24436576|NCT00270530|Sulfadoxine|sulfadoxine|mesh-list
24436577|NCT00270530|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24437711|NCT00274274|Insulin|insulin|mesh-list
24436681|NCT00270777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24436682|NCT00270816|Interferons|interferons|mesh-list
24436683|NCT00270816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24436684|NCT00270816|Antiviral Agents|antiviral agents|mesh-ancestor
24436685|NCT00270816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24436686|NCT00270829|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
24436687|NCT00270829|Natriuretic Agents|natriuretic agents|mesh-ancestor
24436688|NCT00270829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436689|NCT00270881|Cytarabine|cytarabine|mesh-list
24436690|NCT00270881|Cyclophosphamide|cyclophosphamide|mesh-list
24436691|NCT00270881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24436692|NCT00270881|Immunologic Factors|immunologic factors|mesh-ancestor
24436693|NCT00270881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436694|NCT00270881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24436695|NCT00270881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24825595|NCT02129231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24825596|NCT02129231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24436696|NCT00270881|Alkylating Agents|alkylating agents|mesh-ancestor
24436728|NCT00271245|Selenic Acid|selenic acid|mesh-list
24436729|NCT00271245|Antioxidants|antioxidants|mesh-ancestor
24436730|NCT00271245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436731|NCT00271245|Protective Agents|protective agents|mesh-ancestor
24436732|NCT00271245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436733|NCT00271245|Trace Elements|trace elements|mesh-ancestor
24436734|NCT00271245|Micronutrients|micronutrients|mesh-ancestor
24436745|NCT00271271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24436746|NCT00271271|Immunologic Factors|immunologic factors|mesh-ancestor
24436749|NCT00271271|Tubulin Modulators|tubulin modulators|mesh-ancestor
24436755|NCT00271284|Insulin Detemir|insulin detemir|mesh-list
24436756|NCT00271284|Insulin glulisine|insulin glulisine|mesh-list
24436757|NCT00271284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24436758|NCT00271284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436759|NCT00271323|Docetaxel|docetaxel|mesh-list
24436819|NCT00271453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436820|NCT00271453|Analgesics|analgesics|mesh-ancestor
24436821|NCT00271453|Sensory System Agents|sensory system agents|mesh-ancestor
24436822|NCT00271453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24436823|NCT00271453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24436824|NCT00271453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24582209|NCT00868634|Vinorelbine|vinorelbine|mesh-list
24825614|NCT02129257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24702049|NCT01463813|Vitamins|vitamins|mesh-list
24436932|NCT00272116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436934|NCT00272116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436935|NCT00272116|Protective Agents|protective agents|mesh-ancestor
24437140|NCT00272753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24437141|NCT00272753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24437142|NCT00272753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24437143|NCT00272753|Adrenergic Agents|adrenergic agents|mesh-ancestor
24437144|NCT00272753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24437145|NCT00272753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437146|NCT00272753|Tocolytic Agents|tocolytic agents|mesh-ancestor
24437147|NCT00272753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24437148|NCT00272805|Carvedilol|carvedilol|mesh-list
24437149|NCT00272805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24437150|NCT00272805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24437151|NCT00272805|Adrenergic Agents|adrenergic agents|mesh-ancestor
24437152|NCT00272805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24437153|NCT00272805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437154|NCT00272805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437157|NCT00272805|Protective Agents|protective agents|mesh-ancestor
24437158|NCT00272805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24437202|NCT00272935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24437204|NCT00272948|Defibrotide|defibrotide|mesh-list
24437663|NCT00274092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24437664|NCT00274092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437665|NCT00274105|Telmisartan|telmisartan|mesh-list
24437666|NCT00274105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24437667|NCT00274105|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24437671|NCT00274118|Enalapril|enalapril|mesh-list
24437677|NCT00274118|Protease Inhibitors|protease inhibitors|mesh-ancestor
24437678|NCT00274118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24437679|NCT00274131|Pramipexole|pramipexole|mesh-list
24437680|NCT00274131|Antioxidants|antioxidants|mesh-ancestor
24437710|NCT00274235|Renal Agents|renal agents|mesh-ancestor
24437727|NCT00274339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438312|NCT00275457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24438326|NCT00275535|Thymoglobulin|thymoglobulin|mesh-list
24438327|NCT00275535|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24438328|NCT00275535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24438329|NCT00275535|Glucocorticoids|glucocorticoids|mesh-ancestor
25777763|NCT03172026|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25777764|NCT03172026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777765|NCT03172026|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25777766|NCT03172026|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25777767|NCT03172026|Antiviral Agents|antiviral agents|mesh-ancestor
25777768|NCT03172026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25777769|NCT03172026|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25777770|NCT03161964|Propranolol|propranolol|mesh-list
25777771|NCT03161964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25777772|NCT03161964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25777773|NCT03161964|Adrenergic Agents|adrenergic agents|mesh-ancestor
24825639|NCT02129322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825640|NCT02129322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24825641|NCT02129322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825642|NCT02129322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825643|NCT02129400|Anesthetics|anesthetics|mesh-list
24438330|NCT00275535|Hormones|hormones|mesh-ancestor
24438331|NCT00275535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24438332|NCT00275535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438333|NCT00275535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24438334|NCT00275535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438335|NCT00275535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24438336|NCT00275535|Immunologic Factors|immunologic factors|mesh-ancestor
24438347|NCT00275548|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24438348|NCT00275548|Antimetabolites|antimetabolites|mesh-ancestor
24438349|NCT00275548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438350|NCT00275548|Antiviral Agents|antiviral agents|mesh-ancestor
24438351|NCT00275548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24438352|NCT00275600|Vitamin E|vitamin e|mesh-list
24438353|NCT00275600|Vitamins|vitamins|mesh-ancestor
24438524|NCT00276081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438525|NCT00276081|Anticonvulsants|anticonvulsants|mesh-ancestor
24825657|NCT02129582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24825658|NCT02129582|Abortifacient Agents|abortifacient agents|mesh-ancestor
24825659|NCT02129582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24825660|NCT02129582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825661|NCT02129582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24825662|NCT02129582|Antimetabolites|antimetabolites|mesh-ancestor
24825663|NCT02129582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825664|NCT02129582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825665|NCT02129582|Dermatologic Agents|dermatologic agents|mesh-ancestor
24825666|NCT02129582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825667|NCT02129582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24825668|NCT02129582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24438526|NCT00276081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24438534|NCT00276081|Antimanic Agents|antimanic agents|mesh-ancestor
24438570|NCT00276198|Vitamins|vitamins|mesh-ancestor
24438571|NCT00276198|Micronutrients|micronutrients|mesh-ancestor
24438585|NCT00276289|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24438590|NCT00276315|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24438591|NCT00276315|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24438592|NCT00276315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24438627|NCT00276575|Everolimus|everolimus|mesh-list
24438628|NCT00276575|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24438629|NCT00276575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25711053|NCT02294786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711054|NCT02294786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711055|NCT02294786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25711056|NCT02294786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711057|NCT02294786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25711058|NCT02294786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25711059|NCT02295280|Diphenhydramine|diphenhydramine|mesh-list
24438630|NCT00276575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438631|NCT00276575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24438871|NCT00276835|Sensory System Agents|sensory system agents|mesh-ancestor
24438872|NCT00276835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24438873|NCT00276835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438874|NCT00276835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24438875|NCT00276835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24438876|NCT00276835|Antiviral Agents|antiviral agents|mesh-ancestor
24438877|NCT00276835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24438878|NCT00276835|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24438927|NCT00276900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24438928|NCT00276900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24438929|NCT00276900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438930|NCT00276900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24438931|NCT00276900|Serotonin Agents|serotonin agents|mesh-ancestor
24439175|NCT00277758|Antimetabolites|antimetabolites|mesh-ancestor
24439176|NCT00277758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439177|NCT00277758|Immunologic Factors|immunologic factors|mesh-ancestor
24439178|NCT00277758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439179|NCT00277758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24439180|NCT00277758|Analgesics|analgesics|mesh-ancestor
24439181|NCT00277758|Sensory System Agents|sensory system agents|mesh-ancestor
24439182|NCT00277758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24439308|NCT00278278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439309|NCT00278278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24439310|NCT00278278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24439311|NCT00278278|Abortifacient Agents|abortifacient agents|mesh-ancestor
24439312|NCT00278278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24439313|NCT00278278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24439314|NCT00278278|Antimetabolites|antimetabolites|mesh-ancestor
24439315|NCT00278278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439316|NCT00278278|Dermatologic Agents|dermatologic agents|mesh-ancestor
24439317|NCT00278278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24439318|NCT00278278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24439319|NCT00278278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24439320|NCT00278278|Immunologic Factors|immunologic factors|mesh-ancestor
24439321|NCT00278278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25711061|NCT02295280|Codeine|codeine|mesh-list
25711062|NCT02295280|Metoclopramide|metoclopramide|mesh-list
25711063|NCT02295280|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25711064|NCT02295280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25711065|NCT02295280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25711066|NCT02295280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711067|NCT02295280|Anesthetics, Local|anesthetics, local|mesh-ancestor
25711068|NCT02295280|Anesthetics|anesthetics|mesh-ancestor
24439373|NCT00278408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24439375|NCT00278408|Alkylating Agents|alkylating agents|mesh-ancestor
24439743|NCT00280215|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24439744|NCT00280215|Enzyme Inhibitors|enzyme inhibitors|mesh-list
24439745|NCT00280215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24439746|NCT00280215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24439747|NCT00280215|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24439748|NCT00280215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439749|NCT00280215|Protease Inhibitors|protease inhibitors|mesh-ancestor
24439750|NCT00280215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24439983|NCT00281125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24439984|NCT00281125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439985|NCT00281125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24439988|NCT00281190|Dimercaprol|dimercaprol|mesh-list
24440060|NCT00281593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440061|NCT00281593|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24440063|NCT00281593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24440064|NCT00281606|Ritonavir|ritonavir|mesh-list
24440065|NCT00281606|Lopinavir|lopinavir|mesh-list
24440066|NCT00281606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24440067|NCT00281606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24440068|NCT00281606|Protease Inhibitors|protease inhibitors|mesh-ancestor
24440069|NCT00281606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24440070|NCT00281606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440071|NCT00281606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24440072|NCT00281606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24440073|NCT00281606|Antiviral Agents|antiviral agents|mesh-ancestor
24440074|NCT00281606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24440075|NCT00281606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24440079|NCT00281619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440081|NCT00281619|Antitubercular Agents|antitubercular agents|mesh-ancestor
24440257|NCT00282061|Protective Agents|protective agents|mesh-ancestor
24440258|NCT00282061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440265|NCT00282126|Potassium Citrate|potassium citrate|mesh-list
24440266|NCT00282126|Diuretics|diuretics|mesh-ancestor
24440275|NCT00282139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24440298|NCT00282178|Candesartan|candesartan|mesh-list
24440299|NCT00282178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24440300|NCT00282178|Diuretics|diuretics|mesh-ancestor
24440301|NCT00282178|Natriuretic Agents|natriuretic agents|mesh-ancestor
24440302|NCT00282178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711069|NCT02295280|Sensory System Agents|sensory system agents|mesh-ancestor
25711070|NCT02295280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24440392|NCT00282932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25711071|NCT02295280|Antiemetics|antiemetics|mesh-ancestor
25711072|NCT02295280|Autonomic Agents|autonomic agents|mesh-ancestor
25711073|NCT02295280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25711074|NCT02295280|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25711075|NCT02295280|Histamine Antagonists|histamine antagonists|mesh-ancestor
25711076|NCT02295280|Histamine Agents|histamine agents|mesh-ancestor
25711077|NCT02295280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24440394|NCT00282932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24440463|NCT00283192|Antidepressive Agents|antidepressive agents|mesh-ancestor
24440464|NCT00283192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24396244|NCT00138216|Antimitotic Agents|antimitotic agents|mesh-ancestor
24440465|NCT00283192|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24440466|NCT00283192|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24440467|NCT00283192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24440469|NCT00283192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24440654|NCT00284206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440655|NCT00284206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440656|NCT00284206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24440657|NCT00284206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24440658|NCT00284206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24825743|NCT02129985|Incretins|incretins|mesh-ancestor
24825744|NCT02129985|Hormones|hormones|mesh-ancestor
24825745|NCT02129985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24825746|NCT02130154|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24440659|NCT00284206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24440660|NCT00284206|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24440661|NCT00284206|Dopamine Agents|dopamine agents|mesh-ancestor
24440662|NCT00284232|Insulin|insulin|mesh-list
24440663|NCT00284232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24440682|NCT00284271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440684|NCT00284271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24440685|NCT00284271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24440686|NCT00284271|Glucocorticoids|glucocorticoids|mesh-ancestor
24440728|NCT00284427|Antioxidants|antioxidants|mesh-ancestor
24440729|NCT00284427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440730|NCT00284427|Protective Agents|protective agents|mesh-ancestor
24440772|NCT00284765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24440773|NCT00284765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24440774|NCT00284765|Analgesics|analgesics|mesh-ancestor
24440775|NCT00284765|Sensory System Agents|sensory system agents|mesh-ancestor
24440776|NCT00284765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24440884|NCT00285155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24440886|NCT00285181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24440887|NCT00285181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24440888|NCT00285181|Antimetabolites|antimetabolites|mesh-ancestor
24440889|NCT00285181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440890|NCT00285181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24440891|NCT00285181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24440892|NCT00285181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24440893|NCT00285298|Pentoxifylline|pentoxifylline|mesh-list
24440894|NCT00285298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24440895|NCT00285298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24440896|NCT00285298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440899|NCT00285298|Protective Agents|protective agents|mesh-ancestor
24825748|NCT02130154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825750|NCT02130167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24825751|NCT02130167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24825752|NCT02130167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24825753|NCT02130167|Autonomic Agents|autonomic agents|mesh-ancestor
25711079|NCT02295280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25711080|NCT02295280|Antipruritics|antipruritics|mesh-ancestor
25711081|NCT02295280|Dermatologic Agents|dermatologic agents|mesh-ancestor
25711082|NCT02295280|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25711083|NCT02295280|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25711084|NCT02295280|Dopamine Agents|dopamine agents|mesh-ancestor
25711085|NCT02295280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25711086|NCT02295280|Narcotics|narcotics|mesh-ancestor
24825754|NCT02130167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24825755|NCT02130167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825756|NCT02130167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24825757|NCT02130167|Respiratory System Agents|respiratory system agents|mesh-ancestor
24825758|NCT02130167|Mydriatics|mydriatics|mesh-ancestor
24440922|NCT00285376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440923|NCT00285376|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24440924|NCT00285376|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24440925|NCT00285389|Dexamethasone|dexamethasone|mesh-list
24440926|NCT00285389|Cyclophosphamide|cyclophosphamide|mesh-list
24440927|NCT00285389|Melphalan|melphalan|mesh-list
24440928|NCT00285389|Chlorambucil|chlorambucil|mesh-list
24440929|NCT00285389|Rituximab|rituximab|mesh-list
24440978|NCT00285519|Adrenergic Agents|adrenergic agents|mesh-ancestor
24440979|NCT00285519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24825773|NCT02130414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825774|NCT02130414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825775|NCT02130414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24825776|NCT02130414|Immunologic Factors|immunologic factors|mesh-ancestor
24825777|NCT02130414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825778|NCT02130414|Antifungal Agents|antifungal agents|mesh-ancestor
24825779|NCT02130414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24703483|NCT01471899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703484|NCT01471899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703485|NCT01471899|Gout Suppressants|gout suppressants|mesh-ancestor
24703487|NCT01471925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24703488|NCT01471925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24703489|NCT01471925|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24703490|NCT01471925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703492|NCT01471964|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24441113|NCT00286130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441114|NCT00286130|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24441115|NCT00286130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24441116|NCT00286130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441117|NCT00286130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441118|NCT00286130|Antidotes|antidotes|mesh-ancestor
24441119|NCT00286130|Protective Agents|protective agents|mesh-ancestor
24441120|NCT00286130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441121|NCT00286130|Vitamin B Complex|vitamin b complex|mesh-ancestor
24441122|NCT00286130|Vitamins|vitamins|mesh-ancestor
24441123|NCT00286130|Micronutrients|micronutrients|mesh-ancestor
24441124|NCT00286130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24441394|NCT00287326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24441395|NCT00287326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24441396|NCT00287326|Narcotics|narcotics|mesh-ancestor
24441397|NCT00287326|Analgesics|analgesics|mesh-ancestor
24441398|NCT00287326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24441399|NCT00287326|Sympatholytics|sympatholytics|mesh-ancestor
24825789|NCT02130440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24441400|NCT00287326|Autonomic Agents|autonomic agents|mesh-ancestor
24441408|NCT00287352|Olanzapine|olanzapine|mesh-list
24441527|NCT00287781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25711087|NCT02295280|Analgesics|analgesics|mesh-ancestor
25711088|NCT02295280|Antitussive Agents|antitussive agents|mesh-ancestor
25711089|NCT02295280|Respiratory System Agents|respiratory system agents|mesh-ancestor
25711090|NCT02295553|Ketamine|ketamine|mesh-list
25711091|NCT02295553|Propofol|propofol|mesh-list
25711092|NCT02295553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25711093|NCT02295553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24441533|NCT00287794|Antioxidants|antioxidants|mesh-ancestor
24441534|NCT00287794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441535|NCT00287794|Protective Agents|protective agents|mesh-ancestor
24441536|NCT00287794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441537|NCT00287794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24441538|NCT00287794|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24441539|NCT00287794|Anticonvulsants|anticonvulsants|mesh-ancestor
24441540|NCT00287794|Antiemetics|antiemetics|mesh-ancestor
24441577|NCT00287846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441578|NCT00287846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24441579|NCT00287846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441580|NCT00287846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441582|NCT00287859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24441583|NCT00287859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24441584|NCT00287859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441585|NCT00287859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441586|NCT00287859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441587|NCT00287885|Docetaxel|docetaxel|mesh-list
24441588|NCT00287885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441589|NCT00287885|Tubulin Modulators|tubulin modulators|mesh-ancestor
24441590|NCT00287885|Antimitotic Agents|antimitotic agents|mesh-ancestor
24441591|NCT00287885|Mitosis Modulators|mitosis modulators|mesh-ancestor
24441592|NCT00287885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441593|NCT00287911|Topotecan|topotecan|mesh-list
24441594|NCT00287911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441646|NCT00287963|Topotecan|topotecan|mesh-list
24607355|NCT04761198|Nivolumab|nivolumab|mesh-list
24441702|NCT00288158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441866|NCT00288561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441867|NCT00288561|Growth Inhibitors|growth inhibitors|mesh-ancestor
24441868|NCT00288561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24441870|NCT00288652|Antidepressive Agents|antidepressive agents|mesh-ancestor
24441871|NCT00288652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24441878|NCT00288652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441880|NCT00288717|Candesartan|candesartan|mesh-list
24441881|NCT00288717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25711094|NCT02295553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711095|NCT02295553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25711096|NCT02295553|Anesthetics, General|anesthetics, general|mesh-ancestor
25711097|NCT02295553|Anesthetics|anesthetics|mesh-ancestor
25711098|NCT02295553|Analgesics|analgesics|mesh-ancestor
25711099|NCT02295553|Sensory System Agents|sensory system agents|mesh-ancestor
25711100|NCT02295553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25711101|NCT02295553|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25711102|NCT02295553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25711103|NCT02295553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25711104|NCT02295553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24442173|NCT00290173|Adrenergic Agents|adrenergic agents|mesh-ancestor
24825818|NCT02130713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24825819|NCT02130713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24825820|NCT02130713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825821|NCT02130713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825838|NCT02130804|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
24825840|NCT02130804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24825841|NCT02130804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24825842|NCT02130804|Analgesics|analgesics|mesh-ancestor
24825843|NCT02130804|Sensory System Agents|sensory system agents|mesh-ancestor
24825844|NCT02130804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24442406|NCT00290901|Sensory System Agents|sensory system agents|mesh-ancestor
24442407|NCT00290901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24442408|NCT00290901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24442409|NCT00290901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24442410|NCT00290901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24442411|NCT00290901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24442412|NCT00290901|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24442413|NCT00290901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24442414|NCT00290901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442415|NCT00290901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442416|NCT00290914|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
24442417|NCT00290914|Antidepressive Agents|antidepressive agents|mesh-ancestor
24442418|NCT00290914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24442573|NCT00291707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24442631|NCT00291850|Paclitaxel|paclitaxel|mesh-list
24442632|NCT00291850|Cisplatin|cisplatin|mesh-list
24442633|NCT00291850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24825848|NCT02130804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24825849|NCT02130804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24825850|NCT02130804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825852|NCT02130817|Dexamethasone|dexamethasone|mesh-list
24442706|NCT00292214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442707|NCT00292214|Antipyretics|antipyretics|mesh-ancestor
24442708|NCT00292253|Interferon beta-1a|interferon beta-1a|mesh-list
24442709|NCT00292253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24442713|NCT00292253|Antiviral Agents|antiviral agents|mesh-ancestor
24442714|NCT00292253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24442785|NCT00292721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24442786|NCT00292721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24442787|NCT00292721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442788|NCT00292721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442790|NCT00292734|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24442791|NCT00292734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24825853|NCT02130817|Prednisone|prednisone|mesh-list
24825854|NCT02130817|Abatacept|abatacept|mesh-list
24825855|NCT02130817|Tacrolimus|tacrolimus|mesh-list
24825856|NCT02130817|Thymoglobulin|thymoglobulin|mesh-list
24825857|NCT02130817|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24442792|NCT00292734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24442793|NCT00292734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442794|NCT00292734|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24442795|NCT00292734|GABA Agonists|gaba agonists|mesh-ancestor
24442797|NCT00292734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24442798|NCT00292734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442799|NCT00292747|Ibuprofen|ibuprofen|mesh-list
24442809|NCT00292747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24404193|NCT00162721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442810|NCT00292747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25711105|NCT02295553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711106|NCT02295774|Methylene Blue|methylene blue|mesh-list
25711107|NCT02295774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711108|NCT02295774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711109|NCT02296099|Bupivacaine|bupivacaine|mesh-list
25711110|NCT02296099|Anesthetics, Local|anesthetics, local|mesh-ancestor
25711111|NCT02296099|Anesthetics|anesthetics|mesh-ancestor
25711112|NCT02296099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25711113|NCT02296099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442812|NCT00292747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442813|NCT00292747|Parasympatholytics|parasympatholytics|mesh-ancestor
24442815|NCT00292747|Vasodilator Agents|vasodilator agents|mesh-ancestor
24442816|NCT00292747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24442817|NCT00292747|Urological Agents|urological agents|mesh-ancestor
24442818|NCT00292760|Alemtuzumab|alemtuzumab|mesh-list
24442819|NCT00292760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24825859|NCT02130817|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24825860|NCT02130817|Antibodies|antibodies|mesh-list
24825862|NCT02130817|gamma-Globulins|gamma-globulins|mesh-list
24608063|NCT02451553|Afatinib|afatinib|mesh-list
25711116|NCT02296112|Trametinib|trametinib|mesh-list
25711117|NCT02296112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711118|NCT02296112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25711119|NCT02296112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711120|NCT02296112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711121|NCT02296138|Tiotropium Bromide|tiotropium bromide|mesh-list
25711122|NCT02296138|Olodaterol|olodaterol|mesh-list
25711123|NCT02296138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25711124|NCT02296138|Autonomic Agents|autonomic agents|mesh-ancestor
25711125|NCT02296138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25711126|NCT02296138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825868|NCT02130817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442949|NCT00293345|Antiviral Agents|antiviral agents|mesh-ancestor
24442950|NCT00293345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24442951|NCT00293345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442965|NCT00293358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24442966|NCT00293358|Alkylating Agents|alkylating agents|mesh-ancestor
24825870|NCT02130817|Glucocorticoids|glucocorticoids|mesh-ancestor
24825871|NCT02130817|Hormones|hormones|mesh-ancestor
24825872|NCT02130817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24825873|NCT02130817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24825874|NCT02130817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825875|NCT02130817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711127|NCT02296138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25711128|NCT02296138|Respiratory System Agents|respiratory system agents|mesh-ancestor
25711129|NCT02296138|Parasympatholytics|parasympatholytics|mesh-ancestor
25711130|NCT02296138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25711131|NCT02296138|Cholinergic Agents|cholinergic agents|mesh-ancestor
25711132|NCT02296138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25711133|NCT02296138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443031|NCT00293475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443074|NCT00293592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24443076|NCT00293592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711141|NCT02296190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25711142|NCT02296190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24825935|NCT02130973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24825936|NCT02130973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24825937|NCT02130973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24705233|NCT01483053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25711143|NCT02296190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25711144|NCT02296190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711145|NCT02296346|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25711146|NCT02296346|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24825959|NCT02131246|Insulin Aspart|insulin aspart|mesh-list
25711147|NCT02296346|Methylprednisolone|methylprednisolone|mesh-list
24825961|NCT02131246|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24825962|NCT02131246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24825967|NCT02131298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24825968|NCT02131298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24825969|NCT02131298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443172|NCT00293839|Autonomic Agents|autonomic agents|mesh-ancestor
24443173|NCT00293839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24443174|NCT00293839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443175|NCT00293839|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24443176|NCT00293839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24443177|NCT00293839|Cholinergic Agents|cholinergic agents|mesh-ancestor
24443178|NCT00293839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24443179|NCT00293839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443180|NCT00293839|Urological Agents|urological agents|mesh-ancestor
24825992|NCT02131480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24825993|NCT02131480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711149|NCT02296346|Prednisolone acetate|prednisolone acetate|mesh-list
25711150|NCT02296346|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25711151|NCT02296346|Prednisolone phosphate|prednisolone phosphate|mesh-list
25711152|NCT02296346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25711153|NCT02296346|Glucocorticoids|glucocorticoids|mesh-ancestor
24825994|NCT02131480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711155|NCT02296346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25711156|NCT02296346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711157|NCT02296346|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25711158|NCT02296346|Protective Agents|protective agents|mesh-ancestor
25711159|NCT02296346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25711160|NCT02296346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711161|NCT02296346|Antiemetics|antiemetics|mesh-ancestor
25711162|NCT02296346|Autonomic Agents|autonomic agents|mesh-ancestor
24826074|NCT02132234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826075|NCT02132234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24826076|NCT02132234|Immunologic Factors|immunologic factors|mesh-ancestor
24826078|NCT02132260|Antifungal Agents|antifungal agents|mesh-ancestor
24826079|NCT02132260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24826080|NCT02132286|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24826081|NCT02132286|Antidepressive Agents|antidepressive agents|mesh-ancestor
24826082|NCT02132286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24826083|NCT02132286|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24826084|NCT02132286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24447919|NCT00309881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447920|NCT00309881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447921|NCT00309881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24447925|NCT00309881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25711166|NCT02296424|Immunologic Factors|immunologic factors|mesh-ancestor
25711167|NCT02296424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711168|NCT02296775|Rituximab|rituximab|mesh-list
25711169|NCT02296775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25711170|NCT02296775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711171|NCT02296775|Immunologic Factors|immunologic factors|mesh-ancestor
25711172|NCT02296775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826117|NCT02132416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826122|NCT02132416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24826126|NCT02132416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24707204|NCT01494597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24443257|NCT00294255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24443258|NCT00294255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24443259|NCT00294255|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24443260|NCT00294255|Dopamine Agents|dopamine agents|mesh-ancestor
25711173|NCT02296775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25711174|NCT02296840|Acetaminophen|acetaminophen|mesh-list
25711175|NCT02296840|Ibuprofen|ibuprofen|mesh-list
25711176|NCT02296840|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25711177|NCT02296840|Hydrocodone|hydrocodone|mesh-list
25711178|NCT02296840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24443281|NCT00294359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443284|NCT00294385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24826262|NCT02133677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826263|NCT02133677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24826277|NCT02133820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826278|NCT02133885|Minocycline|minocycline|mesh-list
24826279|NCT02133885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24826280|NCT02133885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24826281|NCT02133911|Ranolazine|ranolazine|mesh-list
24826282|NCT02133911|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24826283|NCT02133911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24826284|NCT02133911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826285|NCT02133924|Prednisone|prednisone|mesh-list
24826286|NCT02133924|Methylprednisolone|methylprednisolone|mesh-list
24826287|NCT02133924|Natalizumab|natalizumab|mesh-list
24826288|NCT02133924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24826289|NCT02133924|Glucocorticoids|glucocorticoids|mesh-ancestor
24826290|NCT02133924|Hormones|hormones|mesh-ancestor
24826304|NCT02133937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826305|NCT02133989|Ticlopidine|ticlopidine|mesh-list
25711179|NCT02296840|Analgesics|analgesics|mesh-ancestor
25711180|NCT02296840|Sensory System Agents|sensory system agents|mesh-ancestor
25711181|NCT02296840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25711182|NCT02296840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711183|NCT02296840|Antipyretics|antipyretics|mesh-ancestor
25711184|NCT02296840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25711185|NCT02296840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25711186|NCT02296840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24826318|NCT02133989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24826319|NCT02133989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826321|NCT02134002|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24826364|NCT02134093|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24826365|NCT02134093|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24826366|NCT02134093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24826367|NCT02134093|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24443342|NCT00294567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826386|NCT02134262|Immunologic Factors|immunologic factors|mesh-ancestor
24826387|NCT02134262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826388|NCT02134262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24826389|NCT02134262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24826390|NCT02134262|Alkylating Agents|alkylating agents|mesh-ancestor
24443344|NCT00294580|Maloprim|maloprim|mesh-list
24826420|NCT02134327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24826424|NCT02134327|Anesthetics|anesthetics|mesh-ancestor
24826445|NCT02134366|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24826447|NCT02134379|Clotrimazole|clotrimazole|mesh-list
24826448|NCT02134379|Miconazole|miconazole|mesh-list
24826449|NCT02134379|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24826450|NCT02134379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24826451|NCT02134379|Antifungal Agents|antifungal agents|mesh-ancestor
24826452|NCT02134379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24826453|NCT02134379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24826454|NCT02134379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826455|NCT02134379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583139|NCT00873483|Gestodene|gestodene|mesh-list
24826456|NCT02134379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24826457|NCT02134379|Hormone Antagonists|hormone antagonists|mesh-ancestor
24826458|NCT02134379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24826459|NCT02134379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826460|NCT02134379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24826461|NCT02134379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24826462|NCT02134405|Esomeprazole|esomeprazole|mesh-list
24826463|NCT02134405|Rebamipide|rebamipide|mesh-list
24826464|NCT02134405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24610493|NCT01002703|Hormones|hormones|mesh-ancestor
24443446|NCT00294944|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24443447|NCT00294944|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24443448|NCT00294944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24443501|NCT00295282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24826518|NCT02134899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24826519|NCT02134899|Immunologic Factors|immunologic factors|mesh-ancestor
24826520|NCT02134899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826521|NCT02134899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826522|NCT02134899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826523|NCT02134938|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
25711188|NCT02296840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711189|NCT02296840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711190|NCT02296840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25711191|NCT02296840|Narcotics|narcotics|mesh-ancestor
25711192|NCT02296840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25711193|NCT02296840|Antitussive Agents|antitussive agents|mesh-ancestor
25711194|NCT02296840|Respiratory System Agents|respiratory system agents|mesh-ancestor
25711195|NCT02296892|Midazolam|midazolam|mesh-list
25711196|NCT02296892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25711197|NCT02296892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24443544|NCT00295373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24443545|NCT00295373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711198|NCT02296892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25711199|NCT02296892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711200|NCT02296892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25711201|NCT02296892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25711202|NCT02296892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25711203|NCT02296892|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25711204|NCT02296892|Anesthetics, General|anesthetics, general|mesh-ancestor
25711205|NCT02296892|Anesthetics|anesthetics|mesh-ancestor
25711206|NCT02296892|GABA Modulators|gaba modulators|mesh-ancestor
25711207|NCT02296892|GABA Agents|gaba agents|mesh-ancestor
25711208|NCT02296892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25711209|NCT02296892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443577|NCT00295464|Glucocorticoids|glucocorticoids|mesh-ancestor
24826551|NCT02135055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24826552|NCT02135055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24826553|NCT02135055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24826554|NCT02135055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24826555|NCT02135055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24826556|NCT02135055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24826557|NCT02135055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25711210|NCT02296931|Magnesium Sulfate|magnesium sulfate|mesh-list
25711211|NCT02296931|Analgesics|analgesics|mesh-ancestor
25711212|NCT02296931|Sensory System Agents|sensory system agents|mesh-ancestor
25711213|NCT02296931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24826591|NCT02135263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24709617|NCT01506505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443627|NCT00295542|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24443628|NCT00295542|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24443629|NCT00295555|Doxazosin|doxazosin|mesh-list
24443630|NCT00295555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24443631|NCT00295555|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24443632|NCT00295555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24826592|NCT02135263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826594|NCT02135263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24826595|NCT02135263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24709688|NCT01506739|Donepezil|donepezil|mesh-list
25711214|NCT02296931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711215|NCT02296931|Anesthetics|anesthetics|mesh-ancestor
25711216|NCT02296931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25711217|NCT02296931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25711218|NCT02296931|Anticonvulsants|anticonvulsants|mesh-ancestor
25711219|NCT02296931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25711220|NCT02296931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25711221|NCT02296931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711223|NCT02296931|Tocolytic Agents|tocolytic agents|mesh-ancestor
24443635|NCT00295555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24443636|NCT00295555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443637|NCT00295555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443644|NCT00295594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674839|NCT04326933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24674840|NCT04326933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674841|NCT04326933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674889|NCT04091022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711224|NCT02296931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25711225|NCT02297100|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25711226|NCT02297100|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25711227|NCT02297100|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25711228|NCT02297100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25711229|NCT02297100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443659|NCT00295672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443660|NCT00295685|Antacids|antacids|mesh-list
24443661|NCT00295685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443662|NCT00295685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24443663|NCT00295698|Diethylcarbamazine|diethylcarbamazine|mesh-list
25711230|NCT02297100|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25711231|NCT02297100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25711232|NCT02297100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711233|NCT02297100|Cholinergic Agents|cholinergic agents|mesh-ancestor
25711234|NCT02297100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25711235|NCT02297516|Botulinum Toxins|botulinum toxins|mesh-list
25711236|NCT02297516|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25711237|NCT02297516|Hyaluronic Acid|hyaluronic acid|mesh-list
24826672|NCT02135627|Adrenergic Agents|adrenergic agents|mesh-ancestor
24826673|NCT02135627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24826674|NCT02135627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710145|NCT01508611|Fluorides|fluorides|mesh-list
24443719|NCT00295893|Antimitotic Agents|antimitotic agents|mesh-ancestor
24826675|NCT02135627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826676|NCT02135627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24826677|NCT02135627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24826678|NCT02135627|Autonomic Agents|autonomic agents|mesh-ancestor
24826679|NCT02135627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24826680|NCT02135627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24826681|NCT02135627|Respiratory System Agents|respiratory system agents|mesh-ancestor
24826682|NCT02135627|Mydriatics|mydriatics|mesh-ancestor
24826683|NCT02135627|Sympathomimetics|sympathomimetics|mesh-ancestor
24826684|NCT02135627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24826685|NCT02135640|Denosumab|denosumab|mesh-list
24710197|NCT01508858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24443730|NCT00295893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24443731|NCT00295893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24443736|NCT00295919|Antifungal Agents|antifungal agents|mesh-ancestor
24443737|NCT00295919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24443738|NCT00295919|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24443739|NCT00295919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24443740|NCT00295919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826702|NCT02135822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826703|NCT02135822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25711238|NCT02297516|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25711239|NCT02297516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25711240|NCT02297516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711241|NCT02297516|Cholinergic Agents|cholinergic agents|mesh-ancestor
25711242|NCT02297516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25711243|NCT02297516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711244|NCT02297516|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25711245|NCT02297516|Immunologic Factors|immunologic factors|mesh-ancestor
25711246|NCT02297516|Viscosupplements|viscosupplements|mesh-ancestor
25711247|NCT02297516|Protective Agents|protective agents|mesh-ancestor
25711248|NCT02297815|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25711249|NCT02297815|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24826706|NCT02135822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24826707|NCT02135822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24826708|NCT02135822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24826709|NCT02135822|Immunologic Factors|immunologic factors|mesh-ancestor
24443896|NCT00296062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443774|NCT00295971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711250|NCT02297815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25711251|NCT02297815|Antitubercular Agents|antitubercular agents|mesh-ancestor
25770660|NCT03557333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770661|NCT03557333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770662|NCT03557333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25770663|NCT03557333|Analgesics|analgesics|mesh-ancestor
25770664|NCT03557333|Sensory System Agents|sensory system agents|mesh-ancestor
25770665|NCT03557333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24443847|NCT00296010|Antimetabolites|antimetabolites|mesh-ancestor
24443848|NCT00296010|Dermatologic Agents|dermatologic agents|mesh-ancestor
24443849|NCT00296010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24443850|NCT00296010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24443851|NCT00296023|Methotrexate|methotrexate|mesh-list
24443852|NCT00296023|Fludarabine phosphate|fludarabine phosphate|mesh-list
24443853|NCT00296023|Fludarabine|fludarabine|mesh-list
24443856|NCT00296023|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24443857|NCT00296023|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24443863|NCT00296023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443864|NCT00296023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24443865|NCT00296023|Dermatologic Agents|dermatologic agents|mesh-ancestor
24443866|NCT00296023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443867|NCT00296023|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24443868|NCT00296023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24443869|NCT00296023|Immunologic Factors|immunologic factors|mesh-ancestor
24443870|NCT00296023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24443871|NCT00296023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24443872|NCT00296023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24443873|NCT00296023|Alkylating Agents|alkylating agents|mesh-ancestor
24454632|NCT03878524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24826769|NCT02135887|Micronutrients|micronutrients|mesh-ancestor
24826770|NCT02135887|Hematinics|hematinics|mesh-ancestor
24826771|NCT02135913|Vitamin D|vitamin d|mesh-list
24826798|NCT02136030|Amphotericin B|amphotericin b|mesh-list
24826799|NCT02136030|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24826805|NCT02136030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24826806|NCT02136030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24826807|NCT02136030|Antifungal Agents|antifungal agents|mesh-ancestor
24826808|NCT02136030|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24826809|NCT02136030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24826811|NCT02136147|Methylphenidate|methylphenidate|mesh-list
24826812|NCT02136147|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
24826813|NCT02136147|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24826814|NCT02136147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24826815|NCT02136147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826816|NCT02136147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24826817|NCT02136147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24826818|NCT02136147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24826819|NCT02136147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826820|NCT02136147|Dopamine Agents|dopamine agents|mesh-ancestor
24443991|NCT00296465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24443992|NCT00296465|Hormone Antagonists|hormone antagonists|mesh-ancestor
24443993|NCT00296465|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24443994|NCT00296465|Fertility Agents|fertility agents|mesh-ancestor
24444001|NCT00296478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24444002|NCT00296478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444003|NCT00296530|Fluticasone|fluticasone|mesh-list
24826898|NCT02136784|Hydrocodone|hydrocodone|mesh-list
24826899|NCT02136784|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24826900|NCT02136784|Narcotics|narcotics|mesh-ancestor
24826901|NCT02136784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25711252|NCT02298023|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24826902|NCT02136784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826903|NCT02136784|Analgesics|analgesics|mesh-ancestor
24826905|NCT02136784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24826906|NCT02136784|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25711253|NCT02298023|Hemostatics|hemostatics|mesh-ancestor
25711254|NCT02298023|Coagulants|coagulants|mesh-ancestor
25711255|NCT02298179|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25711256|NCT02298179|MF59 oil emulsion|mf59 oil emulsion|mesh-list
25711257|NCT02298179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25711258|NCT02298179|Immunologic Factors|immunologic factors|mesh-ancestor
25711259|NCT02298179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711260|NCT02298179|Antacids|antacids|mesh-ancestor
25770667|NCT03557658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25770668|NCT03557658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770669|NCT03558555|Acetaminophen|acetaminophen|mesh-list
25770670|NCT03558555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25770671|NCT03558555|Analgesics|analgesics|mesh-ancestor
25711261|NCT02298179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24826907|NCT02136784|Antitussive Agents|antitussive agents|mesh-ancestor
24826908|NCT02136784|Respiratory System Agents|respiratory system agents|mesh-ancestor
24826909|NCT02136823|Isradipine|isradipine|mesh-list
24826910|NCT02136823|Riluzole|riluzole|mesh-list
24826912|NCT02136823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24826913|NCT02136823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24826914|NCT02136823|Dopamine Agents|dopamine agents|mesh-ancestor
24826915|NCT02136823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24826935|NCT02136875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24826936|NCT02136875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24826937|NCT02136875|Respiratory System Agents|respiratory system agents|mesh-ancestor
24826938|NCT02136875|Dermatologic Agents|dermatologic agents|mesh-ancestor
24827082|NCT02137278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24827083|NCT02137278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827084|NCT02137278|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24446951|NCT00306735|Palonosetron|palonosetron|mesh-list
25711262|NCT02298179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25711263|NCT02298192|Liraglutide|liraglutide|mesh-list
25711264|NCT02298192|Xultophy|xultophy|mesh-list
25711265|NCT02298192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25711266|NCT02298192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711267|NCT02298192|Incretins|incretins|mesh-ancestor
25711268|NCT02298192|Hormones|hormones|mesh-ancestor
24446952|NCT00306735|Antiemetics|antiemetics|mesh-ancestor
25770672|NCT03558555|Sensory System Agents|sensory system agents|mesh-ancestor
25770673|NCT03558555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770674|NCT03558555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770675|NCT03558555|Antipyretics|antipyretics|mesh-ancestor
25770676|NCT03558997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25770677|NCT03558997|Immunologic Factors|immunologic factors|mesh-ancestor
25770678|NCT03558997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770679|NCT03559062|Ivacaftor|ivacaftor|mesh-list
25770680|NCT03559062|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25770681|NCT03559062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25770682|NCT03559062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770683|NCT03559179|Analgesics, Opioid|analgesics, opioid|mesh-list
25770684|NCT03559179|Narcotics|narcotics|mesh-ancestor
25770685|NCT03559179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25770686|NCT03559179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770687|NCT03559179|Analgesics|analgesics|mesh-ancestor
25770688|NCT03559179|Sensory System Agents|sensory system agents|mesh-ancestor
25770689|NCT03559179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770690|NCT03559530|Anti-Infective Agents|anti-infective agents|mesh-list
25770691|NCT03559530|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25770692|NCT03560245|Bryostatin 1|bryostatin 1|mesh-list
25770693|NCT03560245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25770694|NCT03560245|Immunologic Factors|immunologic factors|mesh-ancestor
25770695|NCT03560245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770696|NCT03560245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25770697|NCT03560739|Ofatumumab|ofatumumab|mesh-list
25770698|NCT03560739|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25770699|NCT03560739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827111|NCT02137421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24827113|NCT02137434|Calcium|calcium|mesh-list
24827114|NCT02137434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24827115|NCT02137434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827116|NCT02137434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24827117|NCT02137525|Fentanyl|fentanyl|mesh-list
24827152|NCT02137616|Antidepressive Agents|antidepressive agents|mesh-ancestor
24454858|NCT03451799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24454859|NCT03451799|Alkylating Agents|alkylating agents|mesh-ancestor
24827165|NCT02137668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24827166|NCT02137668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24827167|NCT02137681|Rituximab|rituximab|mesh-list
24827168|NCT02137681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24827169|NCT02137681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827170|NCT02137681|Immunologic Factors|immunologic factors|mesh-ancestor
24827172|NCT02137681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24827173|NCT02137707|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24827174|NCT02137707|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24827175|NCT02137707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827176|NCT02137707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24827177|NCT02137707|Immunologic Factors|immunologic factors|mesh-ancestor
24827178|NCT02137707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711269|NCT02298192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25711271|NCT02298868|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25711272|NCT02298868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711273|NCT02298868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24827410|NCT02138799|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24827411|NCT02138799|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24827412|NCT02138799|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24446972|NCT00306774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24827534|NCT02140073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711274|NCT02298868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25711275|NCT02298868|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25711276|NCT02298868|GABA Agonists|gaba agonists|mesh-ancestor
25711277|NCT02298868|GABA Agents|gaba agents|mesh-ancestor
24827535|NCT02140073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827536|NCT02140073|Antiemetics|antiemetics|mesh-ancestor
24827537|NCT02140073|Autonomic Agents|autonomic agents|mesh-ancestor
24827553|NCT02140242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24827557|NCT02140255|Ritonavir|ritonavir|mesh-list
24827566|NCT02140255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827567|NCT02140255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24615201|NCT01028339|Mannitol|mannitol|mesh-list
24827568|NCT02140255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24827569|NCT02140255|Antiviral Agents|antiviral agents|mesh-ancestor
24827581|NCT02140268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24827582|NCT02140268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711278|NCT02298868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24827584|NCT02140268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25711279|NCT02298868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711280|NCT02298933|Eculizumab|eculizumab|mesh-list
25711281|NCT02298933|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25711282|NCT02298933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25711283|NCT02298933|Immunologic Factors|immunologic factors|mesh-ancestor
25711284|NCT02298933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711285|NCT02298946|Cyclophosphamide|cyclophosphamide|mesh-list
25711286|NCT02298946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25711287|NCT02298946|Immunologic Factors|immunologic factors|mesh-ancestor
25711288|NCT02298946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711289|NCT02298946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25711290|NCT02298946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25711291|NCT02298946|Alkylating Agents|alkylating agents|mesh-ancestor
25711292|NCT02298946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711293|NCT02298946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827608|NCT02140437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24827609|NCT02140437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827610|NCT02140437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24827611|NCT02140437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24827612|NCT02140437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24827613|NCT02140437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711294|NCT02298946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25711295|NCT02299050|Bromocriptine|bromocriptine|mesh-list
25711296|NCT02299050|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25711297|NCT02299050|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25711298|NCT02299050|Hormone Antagonists|hormone antagonists|mesh-ancestor
25711299|NCT02299050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25711300|NCT02299050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711301|NCT02299050|Dopamine Agonists|dopamine agonists|mesh-ancestor
25711302|NCT02299050|Dopamine Agents|dopamine agents|mesh-ancestor
25711303|NCT02299050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25711304|NCT02299050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711305|NCT02299089|Octreotide|octreotide|mesh-list
25711306|NCT02299089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25711307|NCT02299089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25711308|NCT02299089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711309|NCT02299141|Nintedanib|nintedanib|mesh-list
25711310|NCT02299141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711311|NCT02299141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24827632|NCT02140450|Anticonvulsants|anticonvulsants|mesh-ancestor
24827633|NCT02140450|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24827634|NCT02140450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711312|NCT02299141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711313|NCT02299141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711315|NCT02299297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24827635|NCT02140489|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24827636|NCT02140489|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24827637|NCT02140489|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24827638|NCT02140489|Antimetabolites|antimetabolites|mesh-ancestor
24719683|NCT01563289|Ibuprofen|ibuprofen|mesh-list
25711316|NCT02299297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711317|NCT02299297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711318|NCT02299336|Aflibercept|aflibercept|mesh-list
25711319|NCT02299336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25711320|NCT02299336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25711321|NCT02299336|Growth Substances|growth substances|mesh-ancestor
25711323|NCT02299336|Growth Inhibitors|growth inhibitors|mesh-ancestor
25711324|NCT02299336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711325|NCT02299349|Epinephrine|epinephrine|mesh-list
25711326|NCT02299349|Racepinephrine|racepinephrine|mesh-list
25711327|NCT02299349|Morphine|morphine|mesh-list
25711328|NCT02299349|Bupivacaine|bupivacaine|mesh-list
25711329|NCT02299349|Epinephryl borate|epinephryl borate|mesh-list
24827674|NCT02140801|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24455027|NCT03011268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827677|NCT02140801|Purinergic Agents|purinergic agents|mesh-ancestor
24827678|NCT02140801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24827679|NCT02140801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827680|NCT02140801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827681|NCT02140814|Niacinamide|niacinamide|mesh-list
24827683|NCT02140814|Nicotinic Acids|nicotinic acids|mesh-list
24827684|NCT02140814|Vitamins|vitamins|mesh-ancestor
24827685|NCT02140814|Micronutrients|micronutrients|mesh-ancestor
24720298|NCT01567618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24684867|NCT03580473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25711330|NCT02299349|Anesthetics, Local|anesthetics, local|mesh-ancestor
25711331|NCT02299349|Anesthetics|anesthetics|mesh-ancestor
25711332|NCT02299349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25711333|NCT02299349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711334|NCT02299349|Sensory System Agents|sensory system agents|mesh-ancestor
25711335|NCT02299349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25711336|NCT02299349|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25711337|NCT02299349|Narcotics|narcotics|mesh-ancestor
25711338|NCT02299349|Analgesics|analgesics|mesh-ancestor
25711340|NCT02299349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25711341|NCT02299349|Adrenergic Agents|adrenergic agents|mesh-ancestor
24684868|NCT03580473|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25711342|NCT02299349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25711343|NCT02299349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711344|NCT02299349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25711345|NCT02299349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25711346|NCT02299349|Autonomic Agents|autonomic agents|mesh-ancestor
25711347|NCT02299349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25770700|NCT03560739|Immunologic Factors|immunologic factors|mesh-ancestor
25770701|NCT03560739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770702|NCT03562377|Vaccines|vaccines|mesh-list
25770703|NCT03562377|Immunologic Factors|immunologic factors|mesh-ancestor
25770704|NCT03562377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770705|NCT03562481|Lidocaine|lidocaine|mesh-list
25770706|NCT03562481|Epinephrine|epinephrine|mesh-list
25770707|NCT03562481|Racepinephrine|racepinephrine|mesh-list
25770708|NCT03562481|Epinephryl borate|epinephryl borate|mesh-list
25770709|NCT03562481|Anesthetics, Local|anesthetics, local|mesh-ancestor
25770710|NCT03562481|Anesthetics|anesthetics|mesh-ancestor
25770711|NCT03562481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24827737|NCT02141113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827738|NCT02141113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827739|NCT02141139|Ibuprofen|ibuprofen|mesh-list
24827740|NCT02141139|Ketorolac|ketorolac|mesh-list
24827741|NCT02141139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24827742|NCT02141139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24827743|NCT02141139|Analgesics|analgesics|mesh-ancestor
24447517|NCT00308763|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24447522|NCT00308763|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24447524|NCT00308763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24447525|NCT00308763|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24447526|NCT00308763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24447527|NCT00308763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24447528|NCT00308763|Dopamine Agents|dopamine agents|mesh-ancestor
24447529|NCT00308763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24447530|NCT00308763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24447531|NCT00308763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24447532|NCT00308776|Cholecystokinin|cholecystokinin|mesh-list
24447533|NCT00308776|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25711348|NCT02299349|Respiratory System Agents|respiratory system agents|mesh-ancestor
25711349|NCT02299349|Mydriatics|mydriatics|mesh-ancestor
25711350|NCT02299349|Sympathomimetics|sympathomimetics|mesh-ancestor
25711351|NCT02299349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24447534|NCT00308776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24827773|NCT02141347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24827774|NCT02141347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827775|NCT02141412|Dexmedetomidine|dexmedetomidine|mesh-list
24827776|NCT02141412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24827777|NCT02141412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24827778|NCT02141412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827779|NCT02141412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24827780|NCT02141412|Analgesics|analgesics|mesh-ancestor
24827781|NCT02141412|Sensory System Agents|sensory system agents|mesh-ancestor
24827782|NCT02141412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24827783|NCT02141412|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24827784|NCT02141412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24827785|NCT02141412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24827786|NCT02141412|Adrenergic Agents|adrenergic agents|mesh-ancestor
24827787|NCT02141412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24827788|NCT02141412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827789|NCT02141425|Peficitinib|peficitinib|mesh-list
24827790|NCT02141425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24686434|NCT04801641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24686435|NCT04801641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24686436|NCT04801641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24686437|NCT04801641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24686454|NCT04791761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827814|NCT02141737|Rocuronium|rocuronium|mesh-list
25711352|NCT02299375|Albuterol|albuterol|mesh-list
25711353|NCT02299375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25711354|NCT02299375|Autonomic Agents|autonomic agents|mesh-ancestor
25711355|NCT02299375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25711356|NCT02299375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827815|NCT02141737|Anesthetics, Local|anesthetics, local|mesh-ancestor
24827820|NCT02141737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24827822|NCT02141737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24827823|NCT02141737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24827824|NCT02141737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24827825|NCT02141737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827826|NCT02141737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24827827|NCT02141737|Narcotics|narcotics|mesh-ancestor
24827828|NCT02141737|Analgesics|analgesics|mesh-ancestor
24827829|NCT02141737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24827830|NCT02141737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24827831|NCT02141737|Anesthetics, General|anesthetics, general|mesh-ancestor
24827832|NCT02141737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24827833|NCT02141737|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24827834|NCT02141737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24827835|NCT02141737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24827836|NCT02141737|GABA Modulators|gaba modulators|mesh-ancestor
24827837|NCT02141737|GABA Agents|gaba agents|mesh-ancestor
24827838|NCT02141737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24827839|NCT02141737|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24827840|NCT02141737|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24827841|NCT02141737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24827842|NCT02141958|Fenretinide|fenretinide|mesh-list
24827843|NCT02141958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827856|NCT02142036|Cetuximab|cetuximab|mesh-list
24827872|NCT02142036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24827873|NCT02142036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711357|NCT02299375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25711358|NCT02299375|Respiratory System Agents|respiratory system agents|mesh-ancestor
24827874|NCT02142036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827875|NCT02142036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24827876|NCT02142036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24827877|NCT02142036|Growth Substances|growth substances|mesh-ancestor
24827878|NCT02142036|Growth Inhibitors|growth inhibitors|mesh-ancestor
24827879|NCT02142075|Daptomycin|daptomycin|mesh-list
24827880|NCT02142075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24827881|NCT02142075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24827882|NCT02142140|Methylphenidate|methylphenidate|mesh-list
24827883|NCT02142140|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
24827885|NCT02142140|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
24827887|NCT02142140|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24827888|NCT02142140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827889|NCT02142140|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24827890|NCT02142140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24827891|NCT02142140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24827892|NCT02142140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827893|NCT02142140|Dopamine Agents|dopamine agents|mesh-ancestor
24827896|NCT02142140|Adrenergic Agents|adrenergic agents|mesh-ancestor
24827923|NCT02142309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24827924|NCT02142309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24827925|NCT02142309|Immunologic Factors|immunologic factors|mesh-ancestor
24827926|NCT02142309|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24827927|NCT02142309|Protease Inhibitors|protease inhibitors|mesh-ancestor
24827931|NCT02142335|Rituximab|rituximab|mesh-list
24827935|NCT02142335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827937|NCT02142530|Belinostat|belinostat|mesh-list
24827938|NCT02142530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24827939|NCT02142530|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24827940|NCT02142530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711359|NCT02299375|Tocolytic Agents|tocolytic agents|mesh-ancestor
25711360|NCT02299375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25711361|NCT02299375|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25711362|NCT02299375|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25711363|NCT02299375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25711364|NCT02299375|Adrenergic Agents|adrenergic agents|mesh-ancestor
25711365|NCT02299375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24827941|NCT02142530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24827942|NCT02142543|Zinc Oxide|zinc oxide|mesh-list
25711366|NCT02299375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711367|NCT02299388|Liraglutide|liraglutide|mesh-list
25711368|NCT02299388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24827943|NCT02142543|Dermatologic Agents|dermatologic agents|mesh-ancestor
24827944|NCT02142543|Sunscreening Agents|sunscreening agents|mesh-ancestor
24827945|NCT02142543|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24827946|NCT02142543|Protective Agents|protective agents|mesh-ancestor
24827947|NCT02142543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24827948|NCT02142556|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24828000|NCT02142634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828017|NCT02142777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24828018|NCT02142777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828020|NCT02142790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24828029|NCT02142829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24828030|NCT02142829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828031|NCT02142829|Sensory System Agents|sensory system agents|mesh-ancestor
24828032|NCT02142829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24828034|NCT02142868|Palbociclib|palbociclib|mesh-list
24828035|NCT02142868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828036|NCT02142868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24828037|NCT02142868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24828038|NCT02142868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828039|NCT02142868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828040|NCT02142868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24828041|NCT02142868|Hormone Antagonists|hormone antagonists|mesh-ancestor
24828045|NCT02142881|Antihypertensive Agents|antihypertensive agents|mesh-list
24828117|NCT02143479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828118|NCT02143479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828120|NCT02143518|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
24828121|NCT02143518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24828122|NCT02143518|Immunologic Factors|immunologic factors|mesh-ancestor
24828123|NCT02143518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828124|NCT02143518|Antacids|antacids|mesh-ancestor
24721391|NCT01573754|Hydroxychloroquine|hydroxychloroquine|mesh-list
24447582|NCT00309088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447584|NCT00309101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24447585|NCT00309101|Immunologic Factors|immunologic factors|mesh-ancestor
24447586|NCT00309101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447587|NCT00309101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24447588|NCT00309101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24447589|NCT00309101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447590|NCT00309192|Triamcinolone|triamcinolone|mesh-list
24828125|NCT02143518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828126|NCT02143518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24828128|NCT02143531|Ondansetron|ondansetron|mesh-list
24828129|NCT02143531|Haloperidol decanoate|haloperidol decanoate|mesh-list
24828130|NCT02143531|Antiemetics|antiemetics|mesh-ancestor
24828149|NCT02143570|Darifenacin|darifenacin|mesh-list
24828150|NCT02143570|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24828151|NCT02143570|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24828152|NCT02143570|Cholinergic Agents|cholinergic agents|mesh-ancestor
24828153|NCT02143570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24828154|NCT02143570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585190|NCT00884104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24828157|NCT02143622|Cetuximab|cetuximab|mesh-list
24828166|NCT02143687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552006|NCT04254627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24828167|NCT02143765|Acarbose|acarbose|mesh-list
24828168|NCT02143765|Mitiglinide|mitiglinide|mesh-list
24828169|NCT02143765|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24828170|NCT02143765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711369|NCT02299388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711370|NCT02299388|Incretins|incretins|mesh-ancestor
25711371|NCT02299388|Hormones|hormones|mesh-ancestor
25711372|NCT02299388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25711373|NCT02300077|Fentanyl|fentanyl|mesh-list
25711374|NCT02300077|Morphine|morphine|mesh-list
24828171|NCT02143765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828172|NCT02143765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24828173|NCT02143765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828212|NCT02144194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828213|NCT02144194|Tubulin Modulators|tubulin modulators|mesh-ancestor
24828239|NCT02144246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24828240|NCT02144246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24828241|NCT02144246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24828242|NCT02144246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24447591|NCT00309192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24828243|NCT02144246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828244|NCT02144246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828245|NCT02144246|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24828246|NCT02144376|Psyllium|psyllium|mesh-list
24828247|NCT02144376|Cathartics|cathartics|mesh-ancestor
24828248|NCT02144376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24828249|NCT02144389|Praziquantel|praziquantel|mesh-list
24828304|NCT02144766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24828306|NCT02144792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24828307|NCT02144792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24828308|NCT02144792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24828312|NCT02144792|Vasodilator Agents|vasodilator agents|mesh-ancestor
24828313|NCT02144818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24828346|NCT02145091|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24828348|NCT02145104|Cilnidipine|cilnidipine|mesh-list
24828349|NCT02145104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24828350|NCT02145104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24828351|NCT02145104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24828352|NCT02145104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828353|NCT02145104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24828357|NCT02145195|Vitamin D|vitamin d|mesh-list
24828387|NCT02145520|Anesthetics|anesthetics|mesh-ancestor
24828388|NCT02145520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24828389|NCT02145520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24828390|NCT02145520|Anticonvulsants|anticonvulsants|mesh-ancestor
24828391|NCT02145520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24828392|NCT02145520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24828393|NCT02145520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828394|NCT02145520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24828395|NCT02145520|Tocolytic Agents|tocolytic agents|mesh-ancestor
24828396|NCT02145520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24585612|NCT00886314|Midazolam|midazolam|mesh-list
25711375|NCT02300077|Methadone|methadone|mesh-list
25711376|NCT02300077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25711377|NCT02300077|Narcotics|narcotics|mesh-ancestor
25711378|NCT02300077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25711379|NCT02300077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711380|NCT02300077|Analgesics|analgesics|mesh-ancestor
25711381|NCT02300077|Sensory System Agents|sensory system agents|mesh-ancestor
24585677|NCT00886574|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24828397|NCT02145546|Amiodarone|amiodarone|mesh-list
25711382|NCT02300077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24828436|NCT02145598|Immunologic Factors|immunologic factors|mesh-ancestor
24828437|NCT02145598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828438|NCT02145598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24687968|NCT03563690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24687969|NCT03563690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24687970|NCT03563690|Analgesics|analgesics|mesh-ancestor
24687971|NCT03563690|Sensory System Agents|sensory system agents|mesh-ancestor
24828439|NCT02145598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24828440|NCT02145598|Growth Substances|growth substances|mesh-ancestor
24828441|NCT02145598|Growth Inhibitors|growth inhibitors|mesh-ancestor
24828442|NCT02145598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828443|NCT02145611|Vildagliptin|vildagliptin|mesh-list
24828444|NCT02145611|Glyburide|glyburide|mesh-list
24447610|NCT00309218|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24447612|NCT00309218|Prednisolone acetate|prednisolone acetate|mesh-list
24447613|NCT00309218|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24828484|NCT02145715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448708|NCT00312650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25711383|NCT02300077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24828500|NCT02145767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24828501|NCT02145767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828502|NCT02145832|Fluconazole|fluconazole|mesh-list
24828503|NCT02145832|Micafungin|micafungin|mesh-list
24828518|NCT02145832|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24828519|NCT02145832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24828520|NCT02145884|Timolol|timolol|mesh-list
24828521|NCT02145884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24828522|NCT02145884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24828523|NCT02145884|Adrenergic Agents|adrenergic agents|mesh-ancestor
24828570|NCT02146222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828572|NCT02146261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24828573|NCT02146300|Xylometazoline|xylometazoline|mesh-list
24828574|NCT02146300|Nasal Decongestants|nasal decongestants|mesh-ancestor
24828575|NCT02146300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24828576|NCT02146300|Respiratory System Agents|respiratory system agents|mesh-ancestor
24828577|NCT02146391|Enclomiphene|enclomiphene|mesh-list
24828578|NCT02146391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24828579|NCT02146391|Hormone Antagonists|hormone antagonists|mesh-ancestor
24828580|NCT02146391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24828582|NCT02146391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24828583|NCT02146391|Fertility Agents|fertility agents|mesh-ancestor
24828584|NCT02146391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24828601|NCT02146547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24828602|NCT02146547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24828603|NCT02146547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24828604|NCT02146547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711384|NCT02300077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25711385|NCT02300077|Anesthetics, General|anesthetics, general|mesh-ancestor
25711386|NCT02300077|Anesthetics|anesthetics|mesh-ancestor
25711387|NCT02300077|Antitussive Agents|antitussive agents|mesh-ancestor
25711388|NCT02300077|Respiratory System Agents|respiratory system agents|mesh-ancestor
25711389|NCT02300103|Sofosbuvir|sofosbuvir|mesh-list
25711390|NCT02300103|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25711391|NCT02300103|Velpatasvir|velpatasvir|mesh-list
25711392|NCT02300103|Antiviral Agents|antiviral agents|mesh-ancestor
25711393|NCT02300103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25711394|NCT02300220|Ciprofloxacin|ciprofloxacin|mesh-list
25711395|NCT02300220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24828616|NCT02146638|Fentanyl|fentanyl|mesh-list
24828629|NCT02146651|Insulin|insulin|mesh-list
24828630|NCT02146651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24828631|NCT02146651|Insulin Lispro|insulin lispro|mesh-list
24828632|NCT02146651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24828633|NCT02146651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828634|NCT02146703|Gemcitabine|gemcitabine|mesh-list
24828635|NCT02146703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24828636|NCT02146703|Antimetabolites|antimetabolites|mesh-ancestor
24828637|NCT02146703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711396|NCT02300220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25711397|NCT02300220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25711398|NCT02300220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25711399|NCT02300220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711400|NCT02300220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711401|NCT02300220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711402|NCT02300220|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24447678|NCT00309374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24447679|NCT00309374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24447682|NCT00309478|Tamoxifen|tamoxifen|mesh-list
24447684|NCT00309478|Fluorouracil|fluorouracil|mesh-list
24447685|NCT00309478|Methotrexate|methotrexate|mesh-list
24447686|NCT00309478|Goserelin|goserelin|mesh-list
24554288|NCT00735280|Heparin|heparin|mesh-list
24447687|NCT00309478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24447688|NCT00309478|Immunologic Factors|immunologic factors|mesh-ancestor
24447690|NCT00309478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24828653|NCT02146911|Antidepressive Agents|antidepressive agents|mesh-ancestor
24828654|NCT02146911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24828655|NCT02146911|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24722248|NCT01579227|Vitamins|vitamins|mesh-ancestor
24447696|NCT00309478|Antimetabolites|antimetabolites|mesh-ancestor
24447697|NCT00309478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24447698|NCT00309478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24447699|NCT00309478|Abortifacient Agents|abortifacient agents|mesh-ancestor
24447700|NCT00309478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24447701|NCT00309478|Dermatologic Agents|dermatologic agents|mesh-ancestor
24828674|NCT02146937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828675|NCT02146937|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24828680|NCT02146976|Propofol|propofol|mesh-list
24828681|NCT02146976|Sevoflurane|sevoflurane|mesh-list
24828682|NCT02146976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24828683|NCT02146976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24828684|NCT02146976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828685|NCT02146976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24828686|NCT02146976|Anesthetics, General|anesthetics, general|mesh-ancestor
24828687|NCT02146976|Anesthetics|anesthetics|mesh-ancestor
24828688|NCT02146976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24828693|NCT02147015|Cholinergic Agents|cholinergic agents|mesh-list
25711403|NCT02300220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25711404|NCT02300259|Itraconazole|itraconazole|mesh-list
25711405|NCT02300259|Diltiazem|diltiazem|mesh-list
25711406|NCT02300259|Tadalafil|tadalafil|mesh-list
25711407|NCT02300259|Simvastatin|simvastatin|mesh-list
25711408|NCT02300259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25711409|NCT02300259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25711410|NCT02300259|Antimetabolites|antimetabolites|mesh-ancestor
25770712|NCT03562481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828694|NCT02147015|Muscarinic Antagonists|muscarinic antagonists|mesh-list
24828695|NCT02147015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24828696|NCT02147015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24828697|NCT02147015|Antiemetics|antiemetics|mesh-ancestor
24828698|NCT02147015|Autonomic Agents|autonomic agents|mesh-ancestor
24828699|NCT02147015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24828700|NCT02147015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828701|NCT02147015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24828702|NCT02147015|Hormones|hormones|mesh-ancestor
24828703|NCT02147015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24828704|NCT02147015|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24828705|NCT02147015|Protective Agents|protective agents|mesh-ancestor
24828706|NCT02147015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24828707|NCT02147015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828708|NCT02147015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24828709|NCT02147041|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24828710|NCT02147041|Antioxidants|antioxidants|mesh-ancestor
24828711|NCT02147041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828712|NCT02147041|Protective Agents|protective agents|mesh-ancestor
24828713|NCT02147041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828714|NCT02147041|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24828715|NCT02147041|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24828716|NCT02147041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828717|NCT02147041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24828718|NCT02147054|Rocuronium|rocuronium|mesh-list
24828719|NCT02147054|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24828720|NCT02147054|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24828721|NCT02147054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24828722|NCT02147054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24828723|NCT02147054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828724|NCT02147249|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24828725|NCT02147249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24828726|NCT02147262|Doxycycline|doxycycline|mesh-list
24828727|NCT02147262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24828728|NCT02147262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24828729|NCT02147262|Antimalarials|antimalarials|mesh-ancestor
24828730|NCT02147262|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24828731|NCT02147262|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24828732|NCT02147379|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
24828733|NCT02147379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24828734|NCT02147379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24828736|NCT02147379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828737|NCT02147379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24828738|NCT02147379|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24828739|NCT02147379|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24828740|NCT02147379|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24828741|NCT02147379|Adrenergic Agents|adrenergic agents|mesh-ancestor
25770713|NCT03562481|Sensory System Agents|sensory system agents|mesh-ancestor
25770714|NCT03562481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770715|NCT03562481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25770716|NCT03562481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25770717|NCT03562481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25770718|NCT03562481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25770719|NCT03562481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770720|NCT03562481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25770721|NCT03562481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25770722|NCT03562481|Adrenergic Agents|adrenergic agents|mesh-ancestor
25770723|NCT03562481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25770724|NCT03562481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25770725|NCT03562481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25770726|NCT03562481|Autonomic Agents|autonomic agents|mesh-ancestor
25770727|NCT03562481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25770728|NCT03562481|Respiratory System Agents|respiratory system agents|mesh-ancestor
24828744|NCT02147379|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24828745|NCT02147379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24828747|NCT02147379|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24828748|NCT02147379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24828749|NCT02147379|Dopamine Agents|dopamine agents|mesh-ancestor
24828750|NCT02147535|Methylphenidate|methylphenidate|mesh-list
24828751|NCT02147535|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24828752|NCT02147535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828753|NCT02147535|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24828754|NCT02147535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24828775|NCT02147548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828776|NCT02147574|Antidiarrheals|antidiarrheals|mesh-list
24828777|NCT02147574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24828778|NCT02147678|Remifentanil|remifentanil|mesh-list
24828784|NCT02147678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24828785|NCT02147678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24828786|NCT02147678|Anesthetics, General|anesthetics, general|mesh-ancestor
24828787|NCT02147678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24828788|NCT02147678|Narcotics|narcotics|mesh-ancestor
24828789|NCT02147678|Analgesics|analgesics|mesh-ancestor
24828790|NCT02147678|Sensory System Agents|sensory system agents|mesh-ancestor
24828792|NCT02147730|Anesthetics|anesthetics|mesh-list
24828807|NCT02147808|GABA Agents|gaba agents|mesh-ancestor
24828808|NCT02147808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24828809|NCT02147808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828810|NCT02147873|Azacitidine|azacitidine|mesh-list
24828811|NCT02147873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24828812|NCT02147873|Antimetabolites|antimetabolites|mesh-ancestor
24828813|NCT02147873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828831|NCT02147938|Immunologic Factors|immunologic factors|mesh-ancestor
24688874|NCT02619552|Autonomic Agents|autonomic agents|mesh-ancestor
24828832|NCT02147938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828833|NCT02147938|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24447722|NCT00309491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24447723|NCT00309491|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24447724|NCT00309491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24447725|NCT00309491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770729|NCT03562481|Mydriatics|mydriatics|mesh-ancestor
25770730|NCT03562481|Sympathomimetics|sympathomimetics|mesh-ancestor
25770731|NCT03562481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25770732|NCT03562988|Vitamins|vitamins|mesh-list
25770733|NCT03562988|Ascorbic Acid|ascorbic acid|mesh-list
25770734|NCT03562988|Micronutrients|micronutrients|mesh-ancestor
25770735|NCT03562988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770736|NCT03562988|Antioxidants|antioxidants|mesh-ancestor
25711411|NCT02300259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828865|NCT02147964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24828867|NCT02148016|Ofloxacin|ofloxacin|mesh-list
24828868|NCT02148016|Betamethasone|betamethasone|mesh-list
24828869|NCT02148016|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24828870|NCT02148016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24722689|NCT01582022|Bupivacaine|bupivacaine|mesh-list
25711412|NCT02300259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25711413|NCT02300259|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25711414|NCT02300259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711415|NCT02300259|Antifungal Agents|antifungal agents|mesh-ancestor
25711416|NCT02300259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25711417|NCT02300259|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25711419|NCT02300259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24828872|NCT02148016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24828873|NCT02148016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24828875|NCT02148016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24828876|NCT02148016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828877|NCT02148016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828880|NCT02148016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24828881|NCT02148016|Glucocorticoids|glucocorticoids|mesh-ancestor
24828883|NCT02148016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24689322|NCT01729754|Sensory System Agents|sensory system agents|mesh-ancestor
25711420|NCT02300259|Hormone Antagonists|hormone antagonists|mesh-ancestor
25711421|NCT02300259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25711422|NCT02300259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711423|NCT02300259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25711424|NCT02300259|Vasodilator Agents|vasodilator agents|mesh-ancestor
25711425|NCT02300259|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24828904|NCT02148120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24828905|NCT02148120|Respiratory System Agents|respiratory system agents|mesh-ancestor
24828906|NCT02148120|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24828907|NCT02148120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24828908|NCT02148120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24828909|NCT02148120|Adrenergic Agents|adrenergic agents|mesh-ancestor
24828910|NCT02148120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24828911|NCT02148120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828912|NCT02148120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24828913|NCT02148120|Glucocorticoids|glucocorticoids|mesh-ancestor
24828915|NCT02148120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24828916|NCT02148328|Vaccines|vaccines|mesh-list
24828917|NCT02148328|Immunologic Factors|immunologic factors|mesh-ancestor
24828918|NCT02148328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689364|NCT01595620|Dronabinol|dronabinol|mesh-list
24828919|NCT02148367|Epoetin Alfa|epoetin alfa|mesh-list
24828920|NCT02148367|Hematinics|hematinics|mesh-ancestor
24828921|NCT02148380|Carboplatin|carboplatin|mesh-list
24828922|NCT02148380|Pemetrexed|pemetrexed|mesh-list
24828923|NCT02148380|Gefitinib|gefitinib|mesh-list
24828924|NCT02148380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828932|NCT02148393|Progesterone|progesterone|mesh-list
24828933|NCT02148393|Estrogens|estrogens|mesh-ancestor
24828934|NCT02148393|Hormones|hormones|mesh-ancestor
24828935|NCT02148393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24828936|NCT02148393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828937|NCT02148393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24828938|NCT02148393|Progestins|progestins|mesh-ancestor
24828962|NCT02148601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24828963|NCT02148640|Infliximab|infliximab|mesh-list
25711426|NCT02300259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24828964|NCT02148640|Dermatologic Agents|dermatologic agents|mesh-ancestor
24828965|NCT02148640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25711427|NCT02300259|Urological Agents|urological agents|mesh-ancestor
25711428|NCT02300259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25711429|NCT02300259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25711430|NCT02300259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25711431|NCT02300259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25711432|NCT02300298|Docetaxel|docetaxel|mesh-list
24828966|NCT02148640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24586301|NCT00890188|Thalidomide|thalidomide|mesh-list
24722942|NCT01583621|Vitamin D|vitamin d|mesh-list
24474654|NCT00406991|Aspirin|aspirin|mesh-list
24828968|NCT02148783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24828969|NCT02148783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828970|NCT02148783|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24828971|NCT02148783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24828972|NCT02148783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24828973|NCT02148783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828974|NCT02148783|Dopamine Agents|dopamine agents|mesh-ancestor
24828975|NCT02148783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24828990|NCT02148913|Alkylating Agents|alkylating agents|mesh-ancestor
24828991|NCT02148913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24828992|NCT02148913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24828993|NCT02148913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24828994|NCT02148913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24828995|NCT02148913|Immunologic Factors|immunologic factors|mesh-ancestor
24828996|NCT02148913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24828997|NCT02148978|Saxagliptin|saxagliptin|mesh-list
24829008|NCT02149095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24829010|NCT02149212|Hemostatics|hemostatics|mesh-ancestor
24829011|NCT02149212|Coagulants|coagulants|mesh-ancestor
24829012|NCT02149225|Poly I-C|poly i-c|mesh-list
24829013|NCT02149225|Molgramostim|molgramostim|mesh-list
24829014|NCT02149225|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24829015|NCT02149225|Vaccines|vaccines|mesh-list
24829016|NCT02149225|Sargramostim|sargramostim|mesh-list
24829017|NCT02149225|Poly ICLC|poly iclc|mesh-list
24829018|NCT02149225|Immunologic Factors|immunologic factors|mesh-ancestor
24829021|NCT02149225|Interferon Inducers|interferon inducers|mesh-ancestor
24829022|NCT02149225|Laxatives|laxatives|mesh-ancestor
24829023|NCT02149225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24829024|NCT02149225|Antiviral Agents|antiviral agents|mesh-ancestor
24829025|NCT02149225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24829026|NCT02149329|Meropenem|meropenem|mesh-list
24829027|NCT02149329|Imipenem|imipenem|mesh-list
24829028|NCT02149329|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
25711433|NCT02300298|Nintedanib|nintedanib|mesh-list
25711434|NCT02300298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711435|NCT02300298|Tubulin Modulators|tubulin modulators|mesh-ancestor
25711436|NCT02300298|Antimitotic Agents|antimitotic agents|mesh-ancestor
24829029|NCT02149329|Cilastatin|cilastatin|mesh-list
25711437|NCT02300298|Mitosis Modulators|mitosis modulators|mesh-ancestor
25711438|NCT02300298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711439|NCT02300298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25711440|NCT02300298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711441|NCT02300311|Nicotinic Acids|nicotinic acids|mesh-list
25711443|NCT02300311|Nonivamide|nonivamide|mesh-list
25711444|NCT02300311|Sensory System Agents|sensory system agents|mesh-ancestor
24829037|NCT02149407|Protective Agents|protective agents|mesh-ancestor
24829038|NCT02149407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829039|NCT02149433|Prednisone|prednisone|mesh-list
24829040|NCT02149433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24829041|NCT02149433|Glucocorticoids|glucocorticoids|mesh-ancestor
24829042|NCT02149433|Hormones|hormones|mesh-ancestor
24586474|NCT00890786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24829043|NCT02149433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24829044|NCT02149433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829045|NCT02149433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24829046|NCT02149433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24829047|NCT02149459|Metformin|metformin|mesh-list
24829068|NCT02149758|Sensory System Agents|sensory system agents|mesh-ancestor
24829069|NCT02149758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24829070|NCT02149758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829071|NCT02149758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24829072|NCT02149758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24829073|NCT02149758|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24829074|NCT02149758|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24829075|NCT02149758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829076|NCT02149758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829078|NCT02149823|Oxytocics|oxytocics|mesh-ancestor
24829079|NCT02149823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24829080|NCT02149823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829081|NCT02149888|Tenofovir|tenofovir|mesh-list
24829082|NCT02149888|Emtricitabine|emtricitabine|mesh-list
24829083|NCT02149888|Antiviral Agents|antiviral agents|mesh-ancestor
24829084|NCT02149888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24829087|NCT02149888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448853|NCT00313391|Risperidone|risperidone|mesh-list
24829101|NCT02149901|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24829102|NCT02149901|Sympathomimetics|sympathomimetics|mesh-ancestor
24829103|NCT02149901|Adrenergic Agents|adrenergic agents|mesh-ancestor
24829104|NCT02149901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25711445|NCT02300311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25711446|NCT02300311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711447|NCT02300311|Antipruritics|antipruritics|mesh-ancestor
25711448|NCT02300311|Dermatologic Agents|dermatologic agents|mesh-ancestor
25711449|NCT02300311|Vitamin B Complex|vitamin b complex|mesh-ancestor
25711450|NCT02300311|Vitamins|vitamins|mesh-ancestor
25711451|NCT02300311|Micronutrients|micronutrients|mesh-ancestor
25711452|NCT02300610|Gemcitabine|gemcitabine|mesh-list
24829105|NCT02149901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829106|NCT02149914|Rabeprazole|rabeprazole|mesh-list
24829107|NCT02149914|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24829108|NCT02149914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24829109|NCT02149914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24829110|NCT02149914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829111|NCT02149914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829112|NCT02149927|Sevoflurane|sevoflurane|mesh-list
24829113|NCT02149927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24829114|NCT02149927|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24829115|NCT02149927|Anesthetics, General|anesthetics, general|mesh-ancestor
24829163|NCT02150122|Cholecalciferol|cholecalciferol|mesh-list
24829167|NCT02150122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24829168|NCT02150122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24829169|NCT02150161|Lidocaine|lidocaine|mesh-list
24829170|NCT02150161|Fentanyl|fentanyl|mesh-list
24829171|NCT02150161|Ketamine|ketamine|mesh-list
24829172|NCT02150161|Anesthetics, Local|anesthetics, local|mesh-ancestor
24829173|NCT02150161|Anesthetics|anesthetics|mesh-ancestor
24829174|NCT02150161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24829218|NCT02150447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24829219|NCT02150447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829220|NCT02150447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829221|NCT02150473|Adalimumab|adalimumab|mesh-list
24829222|NCT02150473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24829240|NCT02150707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24829241|NCT02150707|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24829242|NCT02150707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24829243|NCT02150707|Protease Inhibitors|protease inhibitors|mesh-ancestor
24829244|NCT02150707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829245|NCT02150707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829246|NCT02150720|Tranexamic Acid|tranexamic acid|mesh-list
24829247|NCT02150720|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24829248|NCT02150720|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24829249|NCT02150720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24829250|NCT02150720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829251|NCT02150720|Hemostatics|hemostatics|mesh-ancestor
24829252|NCT02150720|Coagulants|coagulants|mesh-ancestor
24829253|NCT02150928|Asparaginase|asparaginase|mesh-list
24829316|NCT02151305|Anesthetics, General|anesthetics, general|mesh-ancestor
24829317|NCT02151305|Anesthetics|anesthetics|mesh-ancestor
24829318|NCT02151305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24829319|NCT02151305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24829320|NCT02151305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24829321|NCT02151305|Narcotics|narcotics|mesh-ancestor
24829322|NCT02151305|Analgesics|analgesics|mesh-ancestor
24829323|NCT02151305|Sensory System Agents|sensory system agents|mesh-ancestor
24829324|NCT02151305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24829325|NCT02151344|Vaccines|vaccines|mesh-list
24829326|NCT02151344|Immunologic Factors|immunologic factors|mesh-ancestor
24829327|NCT02151344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829329|NCT02151604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24829330|NCT02151604|Anesthetics, General|anesthetics, general|mesh-ancestor
25711453|NCT02300610|Cisplatin|cisplatin|mesh-list
25711454|NCT02300610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711455|NCT02300610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25711456|NCT02300610|Antimetabolites|antimetabolites|mesh-ancestor
25711457|NCT02300610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711458|NCT02300610|Antiviral Agents|antiviral agents|mesh-ancestor
25711459|NCT02300610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25711460|NCT02300610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711461|NCT02300610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25711462|NCT02300610|Immunologic Factors|immunologic factors|mesh-ancestor
25711463|NCT02300610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711464|NCT02300727|Curcumin|curcumin|mesh-list
25711465|NCT02300727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25711466|NCT02300727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25711467|NCT02300727|Analgesics|analgesics|mesh-ancestor
25711468|NCT02300727|Sensory System Agents|sensory system agents|mesh-ancestor
24829335|NCT02151630|Salicylates|salicylates|mesh-list
24829336|NCT02151630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24829337|NCT02151630|Antifungal Agents|antifungal agents|mesh-ancestor
24829340|NCT02151630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24829342|NCT02151630|Analgesics|analgesics|mesh-ancestor
24447988|NCT00309998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24447989|NCT00309998|Growth Inhibitors|growth inhibitors|mesh-ancestor
24447990|NCT00309998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24447991|NCT00309998|Tubulin Modulators|tubulin modulators|mesh-ancestor
24447992|NCT00309998|Antimitotic Agents|antimitotic agents|mesh-ancestor
24447993|NCT00309998|Mitosis Modulators|mitosis modulators|mesh-ancestor
24447994|NCT00309998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447995|NCT00310011|Gemcitabine|gemcitabine|mesh-list
24447996|NCT00310011|Paclitaxel|paclitaxel|mesh-list
25711469|NCT02300727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25711470|NCT02300727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711471|NCT02300727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25711472|NCT02300727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25711473|NCT02300727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711474|NCT02300727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711475|NCT02300727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711476|NCT02301039|Pembrolizumab|pembrolizumab|mesh-list
24448141|NCT00310505|Amebicides|amebicides|mesh-ancestor
25711477|NCT02301039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25711478|NCT02301039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711479|NCT02301143|Gemcitabine|gemcitabine|mesh-list
25711480|NCT02301143|Paclitaxel|paclitaxel|mesh-list
25711481|NCT02301143|Capecitabine|capecitabine|mesh-list
25711482|NCT02301143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25711483|NCT02301143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711484|NCT02301143|Tubulin Modulators|tubulin modulators|mesh-ancestor
24829480|NCT02152553|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24829481|NCT02152553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24829482|NCT02152579|Isosorbide|isosorbide|mesh-list
24829493|NCT02152709|Immunologic Factors|immunologic factors|mesh-ancestor
24829494|NCT02152709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829495|NCT02152787|Propofol|propofol|mesh-list
24829496|NCT02152787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25711485|NCT02301143|Antimitotic Agents|antimitotic agents|mesh-ancestor
25711486|NCT02301143|Mitosis Modulators|mitosis modulators|mesh-ancestor
25711487|NCT02301143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711488|NCT02301143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25711489|NCT02301143|Antimetabolites|antimetabolites|mesh-ancestor
25711490|NCT02301143|Antiviral Agents|antiviral agents|mesh-ancestor
25711491|NCT02301143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25711492|NCT02301143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711493|NCT02301143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25711494|NCT02301143|Immunologic Factors|immunologic factors|mesh-ancestor
25711495|NCT02301143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711496|NCT02301390|Amiodarone|amiodarone|mesh-list
25711497|NCT02301390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25711498|NCT02301390|Vasodilator Agents|vasodilator agents|mesh-ancestor
25711499|NCT02301390|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24829542|NCT02152969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24829544|NCT02152969|Diuretics|diuretics|mesh-ancestor
24829545|NCT02152969|Natriuretic Agents|natriuretic agents|mesh-ancestor
24829546|NCT02152969|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24829547|NCT02153060|Dexamethasone|dexamethasone|mesh-list
24829548|NCT02153060|Dexamethasone acetate|dexamethasone acetate|mesh-list
24829550|NCT02153060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24829551|NCT02153060|Antiemetics|antiemetics|mesh-ancestor
24829552|NCT02153060|Autonomic Agents|autonomic agents|mesh-ancestor
24725453|NCT01597765|Antiviral Agents|antiviral agents|mesh-ancestor
24829553|NCT02153060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24829554|NCT02153060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829555|NCT02153060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24829556|NCT02153060|Glucocorticoids|glucocorticoids|mesh-ancestor
24829557|NCT02153060|Hormones|hormones|mesh-ancestor
24829558|NCT02153060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24829559|NCT02153060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24829560|NCT02153060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24829561|NCT02153060|Protease Inhibitors|protease inhibitors|mesh-ancestor
25711500|NCT02301390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25711501|NCT02301390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711502|NCT02301390|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25711503|NCT02301390|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25711504|NCT02301390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24829562|NCT02153060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829563|NCT02153060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829564|NCT02153125|Eplerenone|eplerenone|mesh-list
24829571|NCT02153125|Natriuretic Agents|natriuretic agents|mesh-ancestor
24829572|NCT02153125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24829573|NCT02153177|Acetaminophen|acetaminophen|mesh-list
24829574|NCT02153177|Ibuprofen|ibuprofen|mesh-list
24829575|NCT02153177|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
24829576|NCT02153177|Hydrocodone|hydrocodone|mesh-list
24448563|NCT00312260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24448564|NCT00312260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448571|NCT00312260|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24725672|NCT01598883|Antithrombins|antithrombins|mesh-list
24448607|NCT00312325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24448608|NCT00312325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448627|NCT00312481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711505|NCT02301390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711506|NCT02301390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24448628|NCT00312481|Vitamins|vitamins|mesh-ancestor
24448629|NCT00312481|Micronutrients|micronutrients|mesh-ancestor
24448630|NCT00312481|Cathartics|cathartics|mesh-ancestor
25711507|NCT02301390|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25711508|NCT02301390|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25711509|NCT02301403|Nicotine|nicotine|mesh-list
25711510|NCT02301403|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25711511|NCT02301403|Autonomic Agents|autonomic agents|mesh-ancestor
25711512|NCT02301403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24448631|NCT00312481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24448632|NCT00312481|Laxatives|laxatives|mesh-ancestor
24448633|NCT00312507|Pulmonary Surfactants|pulmonary surfactants|mesh-list
24448634|NCT00312507|Respiratory System Agents|respiratory system agents|mesh-ancestor
24448635|NCT00312520|Methylprednisolone|methylprednisolone|mesh-list
24448636|NCT00312520|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24448637|NCT00312520|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24448638|NCT00312520|Prednisolone|prednisolone|mesh-list
25711513|NCT02301403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711514|NCT02301403|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25711515|NCT02301403|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25711516|NCT02301403|Cholinergic Agents|cholinergic agents|mesh-ancestor
25711517|NCT02301403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25711518|NCT02301403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711520|NCT02301416|Phentermine|phentermine|mesh-list
25711521|NCT02301416|Anticonvulsants|anticonvulsants|mesh-ancestor
25711523|NCT02301416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711524|NCT02301416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25711525|NCT02301416|Appetite Depressants|appetite depressants|mesh-ancestor
25711526|NCT02301416|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25711527|NCT02301416|Sympathomimetics|sympathomimetics|mesh-ancestor
25711528|NCT02301416|Autonomic Agents|autonomic agents|mesh-ancestor
25711529|NCT02301416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25711530|NCT02301416|Adrenergic Agents|adrenergic agents|mesh-ancestor
25711531|NCT02301416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25711532|NCT02301416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711533|NCT02301624|Eculizumab|eculizumab|mesh-list
25711534|NCT02301624|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25711535|NCT02301624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25711536|NCT02301624|Immunologic Factors|immunologic factors|mesh-ancestor
24829690|NCT02153944|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24829691|NCT02153944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829692|NCT02153944|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24829693|NCT02153944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24829694|NCT02153944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24616288|NCT01035580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24829718|NCT02154074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24829746|NCT02154334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24829748|NCT02154334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24829749|NCT02154334|Antidepressive Agents|antidepressive agents|mesh-ancestor
24829750|NCT02154334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24829751|NCT02154334|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24829752|NCT02154334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24829753|NCT02154334|Adrenergic Agents|adrenergic agents|mesh-ancestor
24829754|NCT02154334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24829783|NCT02154438|Anesthetics, General|anesthetics, general|mesh-ancestor
24829785|NCT02154438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24829786|NCT02154438|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25711537|NCT02301624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711538|NCT02301936|Sofosbuvir|sofosbuvir|mesh-list
25711539|NCT02301936|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25711540|NCT02301936|Ledipasvir|ledipasvir|mesh-list
25711541|NCT02301936|Antiviral Agents|antiviral agents|mesh-ancestor
25711542|NCT02301936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25711543|NCT02301975|Fluticasone|fluticasone|mesh-list
25711544|NCT02301975|Xhance|xhance|mesh-list
25711545|NCT02301975|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25711546|NCT02301975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25711547|NCT02301975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25711548|NCT02301975|Autonomic Agents|autonomic agents|mesh-ancestor
25711549|NCT02301975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25711550|NCT02301975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829791|NCT02154464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24829792|NCT02154464|Analgesics|analgesics|mesh-ancestor
24829793|NCT02154464|Sensory System Agents|sensory system agents|mesh-ancestor
24829794|NCT02154464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24829795|NCT02154464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829796|NCT02154464|Antipyretics|antipyretics|mesh-ancestor
24829797|NCT02154503|Minoxidil|minoxidil|mesh-list
24829798|NCT02154503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24829799|NCT02154503|Vasodilator Agents|vasodilator agents|mesh-ancestor
24829801|NCT02154594|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24829802|NCT02154594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24829803|NCT02154594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24829804|NCT02154594|Disinfectants|disinfectants|mesh-ancestor
24448765|NCT00313079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24448771|NCT00313105|Lobeline|lobeline|mesh-list
24829886|NCT02155166|Sensory System Agents|sensory system agents|mesh-ancestor
24829887|NCT02155166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24829888|NCT02155166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24829889|NCT02155166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24448795|NCT00313131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448796|NCT00313131|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24448797|NCT00313131|Hormone Antagonists|hormone antagonists|mesh-ancestor
24448798|NCT00313131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24448799|NCT00313131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448800|NCT00313131|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24451972|NCT00325546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24829899|NCT02155166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829900|NCT02155205|Moxifloxacin|moxifloxacin|mesh-list
24829901|NCT02155205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25711551|NCT02301975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25711552|NCT02301975|Respiratory System Agents|respiratory system agents|mesh-ancestor
25711553|NCT02301975|Dermatologic Agents|dermatologic agents|mesh-ancestor
25711554|NCT02301975|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25711555|NCT02301975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25711556|NCT02301975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25711557|NCT02301975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24829902|NCT02155205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24829903|NCT02155205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24829904|NCT02155205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24829905|NCT02155205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829906|NCT02155205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829907|NCT02155205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24829908|NCT02155374|Insulin|insulin|mesh-list
24829910|NCT02155374|Insulin, Short-Acting|insulin, short-acting|mesh-list
24829911|NCT02155374|Antineoplastic Agents|antineoplastic agents|mesh-list
24829912|NCT02155374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24829913|NCT02155374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24829929|NCT02155504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24829930|NCT02155504|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24829931|NCT02155504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24829932|NCT02155504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24829933|NCT02155504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24829934|NCT02155504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24829935|NCT02155504|Hormone Antagonists|hormone antagonists|mesh-ancestor
24829939|NCT02155517|Propofol|propofol|mesh-list
24829967|NCT02155777|Contraceptive Agents|contraceptive agents|mesh-ancestor
24829968|NCT02155777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24830008|NCT02156661|Oxytocin|oxytocin|mesh-list
24448815|NCT00313157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830016|NCT02156726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830064|NCT02157181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24830065|NCT02157181|Immunologic Factors|immunologic factors|mesh-ancestor
24830066|NCT02157181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830067|NCT02157181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24830084|NCT02157311|Tenofovir|tenofovir|mesh-list
24830106|NCT02157311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24830107|NCT02157311|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24830110|NCT02157311|Protease Inhibitors|protease inhibitors|mesh-ancestor
25711558|NCT02301975|Adrenergic Agents|adrenergic agents|mesh-ancestor
25711559|NCT02301975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25711560|NCT02301975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711561|NCT02301988|Paclitaxel|paclitaxel|mesh-list
25711562|NCT02301988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25711564|NCT02301988|Tubulin Modulators|tubulin modulators|mesh-ancestor
24448850|NCT00313287|Clevudine|clevudine|mesh-list
24448878|NCT00313482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24448879|NCT00313482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830202|NCT02157792|Carboplatin|carboplatin|mesh-list
24830203|NCT02157792|Irinotecan|irinotecan|mesh-list
24830204|NCT02157792|Etoposide|etoposide|mesh-list
24830205|NCT02157792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24830206|NCT02157792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24830223|NCT02157818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830224|NCT02157818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24830225|NCT02157818|Analgesics|analgesics|mesh-ancestor
24830226|NCT02157818|Sensory System Agents|sensory system agents|mesh-ancestor
25711565|NCT02301988|Antimitotic Agents|antimitotic agents|mesh-ancestor
25711566|NCT02301988|Mitosis Modulators|mitosis modulators|mesh-ancestor
25711567|NCT02301988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711568|NCT02302092|Cefepime|cefepime|mesh-list
25711569|NCT02302092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25711570|NCT02302092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24830227|NCT02157818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24830228|NCT02157818|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24830229|NCT02157818|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24830230|NCT02157818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24830231|NCT02157818|Adrenergic Agents|adrenergic agents|mesh-ancestor
24830232|NCT02157818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24830233|NCT02157818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448888|NCT00313508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448889|NCT00313508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24830266|NCT02158117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24830267|NCT02158143|Vitamin D|vitamin d|mesh-list
24830268|NCT02158143|Cholecalciferol|cholecalciferol|mesh-list
24830269|NCT02158143|Vitamins|vitamins|mesh-ancestor
24830270|NCT02158143|Micronutrients|micronutrients|mesh-ancestor
24830271|NCT02158143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830337|NCT02158702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24830370|NCT02158910|Nootropic Agents|nootropic agents|mesh-ancestor
24830371|NCT02159027|Maraviroc|maraviroc|mesh-list
24830372|NCT02159027|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24830373|NCT02159027|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24830374|NCT02159027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830375|NCT02159027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24830376|NCT02159027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24830377|NCT02159027|Antiviral Agents|antiviral agents|mesh-ancestor
25711571|NCT02302339|Pembrolizumab|pembrolizumab|mesh-list
25711572|NCT02302339|Nivolumab|nivolumab|mesh-list
25711573|NCT02302339|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
25711574|NCT02302339|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25711575|NCT02302339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25711576|NCT02302339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711577|NCT02302339|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25711578|NCT02302339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830448|NCT02159248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24830449|NCT02159248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24830450|NCT02159248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24830451|NCT02159248|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24728582|NCT01617200|Olanzapine|olanzapine|mesh-list
24830504|NCT02159599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830505|NCT02159599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24830506|NCT02159599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24830507|NCT02159599|Antiviral Agents|antiviral agents|mesh-ancestor
24830508|NCT02159599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24830509|NCT02159599|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24830510|NCT02159599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24830511|NCT02159599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24830513|NCT02159651|Tacrolimus|tacrolimus|mesh-list
24830542|NCT02159820|Antimitotic Agents|antimitotic agents|mesh-ancestor
24830543|NCT02159820|Mitosis Modulators|mitosis modulators|mesh-ancestor
24830544|NCT02159820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830545|NCT02159820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24830546|NCT02159820|Antimetabolites|antimetabolites|mesh-ancestor
24830547|NCT02159820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830548|NCT02159911|Misoprostol|misoprostol|mesh-list
24728807|NCT01618396|GABA Agents|gaba agents|mesh-ancestor
24830564|NCT02160054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830565|NCT02160054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830567|NCT02160080|Ribavirin|ribavirin|mesh-list
24830568|NCT02160080|Interferon-alpha|interferon-alpha|mesh-list
24830569|NCT02160080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24830570|NCT02160080|Antiviral Agents|antiviral agents|mesh-ancestor
24830571|NCT02160080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25711579|NCT02302339|Immunologic Factors|immunologic factors|mesh-ancestor
25711580|NCT02302339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711581|NCT02302716|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25711582|NCT02302716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711583|NCT02302807|Paclitaxel|paclitaxel|mesh-list
25711584|NCT02302807|Docetaxel|docetaxel|mesh-list
25711585|NCT02302807|Atezolizumab|atezolizumab|mesh-list
25711586|NCT02302807|Antibodies|antibodies|mesh-list
24830618|NCT02160236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24830619|NCT02160236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24830620|NCT02160236|Analgesics|analgesics|mesh-ancestor
24830647|NCT02160301|Hormones|hormones|mesh-ancestor
24830689|NCT02160548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24830690|NCT02160548|Autonomic Agents|autonomic agents|mesh-ancestor
24830691|NCT02160548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24830692|NCT02160548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830693|NCT02160548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24830694|NCT02160548|Respiratory System Agents|respiratory system agents|mesh-ancestor
24830695|NCT02160548|Tocolytic Agents|tocolytic agents|mesh-ancestor
24830696|NCT02160548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24830702|NCT02160548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830703|NCT02160548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24830704|NCT02160548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25711587|NCT02302807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25711588|NCT02302807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711589|NCT02302807|Tubulin Modulators|tubulin modulators|mesh-ancestor
25711590|NCT02302807|Antimitotic Agents|antimitotic agents|mesh-ancestor
25711591|NCT02302807|Mitosis Modulators|mitosis modulators|mesh-ancestor
25711592|NCT02302807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711593|NCT02302807|Immunologic Factors|immunologic factors|mesh-ancestor
24830722|NCT02160587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24830723|NCT02160587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24830736|NCT02160704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24830739|NCT02160743|Atorvastatin|atorvastatin|mesh-list
24830740|NCT02160743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24830741|NCT02160743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830751|NCT02160925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830753|NCT02161055|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24830754|NCT02161055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25711598|NCT02302846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711599|NCT02302846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711600|NCT02303093|gamma-Globulins|gamma-globulins|mesh-list
25711601|NCT02303093|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25711602|NCT02303093|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25711603|NCT02303093|Immunologic Factors|immunologic factors|mesh-ancestor
25711604|NCT02303093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711605|NCT02303184|Aflibercept|aflibercept|mesh-list
25711606|NCT02303184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25711607|NCT02303184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25711608|NCT02303184|Growth Substances|growth substances|mesh-ancestor
25711609|NCT02303184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711610|NCT02303184|Growth Inhibitors|growth inhibitors|mesh-ancestor
25711611|NCT02303184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711612|NCT02303262|Gemcitabine|gemcitabine|mesh-list
25711613|NCT02303262|Mocetinostat|mocetinostat|mesh-list
24830777|NCT02161354|Narcotics|narcotics|mesh-ancestor
24830778|NCT02161354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24830779|NCT02161354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830781|NCT02161354|Sensory System Agents|sensory system agents|mesh-ancestor
24830782|NCT02161354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24830783|NCT02161354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24830784|NCT02161367|Simethicone|simethicone|mesh-list
24830785|NCT02161367|Antifoaming Agents|antifoaming agents|mesh-ancestor
24830786|NCT02161367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830810|NCT02161653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24830811|NCT02161653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24830812|NCT02161653|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24830813|NCT02161653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24830814|NCT02161653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830829|NCT02161679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24830830|NCT02161679|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24830834|NCT02161679|Immunologic Factors|immunologic factors|mesh-ancestor
24830835|NCT02161679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24830836|NCT02161692|Cyclophosphamide|cyclophosphamide|mesh-list
24830837|NCT02161692|Carboplatin|carboplatin|mesh-list
24830838|NCT02161692|Etoposide|etoposide|mesh-list
24830839|NCT02161692|Bleomycin|bleomycin|mesh-list
24830840|NCT02161692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24830841|NCT02161692|Immunologic Factors|immunologic factors|mesh-ancestor
24449044|NCT00313976|Interferon beta-1b|interferon beta-1b|mesh-list
24449045|NCT00313976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449046|NCT00313976|Antiviral Agents|antiviral agents|mesh-ancestor
24449047|NCT00313976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24830861|NCT02161822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24830862|NCT02161822|Antimetabolites|antimetabolites|mesh-ancestor
24730622|NCT01629368|Analgesics|analgesics|mesh-ancestor
24449051|NCT00314080|Antitoxins|antitoxins|mesh-list
24449052|NCT00314080|Botulinum Antitoxin|botulinum antitoxin|mesh-list
24449053|NCT00314080|Immunologic Factors|immunologic factors|mesh-ancestor
24449054|NCT00314080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449055|NCT00314158|Timolol|timolol|mesh-list
24449056|NCT00314158|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24449057|NCT00314158|Brinzolamide|brinzolamide|mesh-list
24449058|NCT00314158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24449059|NCT00314158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24449060|NCT00314158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24830877|NCT02161952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24730896|NCT01631201|Azithromycin|azithromycin|mesh-list
25711614|NCT02303262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25711615|NCT02303262|Antimetabolites|antimetabolites|mesh-ancestor
25711616|NCT02303262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711617|NCT02303262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711618|NCT02303262|Antiviral Agents|antiviral agents|mesh-ancestor
25711619|NCT02303262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25711620|NCT02303262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711621|NCT02303262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24830917|NCT02162121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24830918|NCT02162121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24830919|NCT02162121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24449074|NCT00314171|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24449075|NCT00314171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24449076|NCT00314171|Adrenergic Agents|adrenergic agents|mesh-ancestor
24449077|NCT00314171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24449078|NCT00314171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449079|NCT00314171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452355|NCT00327197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24830981|NCT02162303|Tubulin Modulators|tubulin modulators|mesh-ancestor
24830982|NCT02162303|Antimitotic Agents|antimitotic agents|mesh-ancestor
24830983|NCT02162303|Mitosis Modulators|mitosis modulators|mesh-ancestor
24830984|NCT02162303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24830985|NCT02162303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24452406|NCT00327418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24831037|NCT02162537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24831038|NCT02162537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24831039|NCT02162550|Exenatide|exenatide|mesh-list
24831040|NCT02162550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24831041|NCT02162550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696487|NCT01429701|Anesthetics|anesthetics|mesh-ancestor
24831050|NCT02162693|Viscosupplements|viscosupplements|mesh-ancestor
24463560|NCT00361413|Alefacept|alefacept|mesh-list
24831054|NCT02162784|Albuterol|albuterol|mesh-list
24831055|NCT02162784|Procaterol|procaterol|mesh-list
24831056|NCT02162784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25711622|NCT02303262|Immunologic Factors|immunologic factors|mesh-ancestor
25711623|NCT02303262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711624|NCT02303262|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25711625|NCT02303574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25711626|NCT02303977|Gemcitabine|gemcitabine|mesh-list
25711627|NCT02303977|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25711628|NCT02303977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25711629|NCT02303977|Antimetabolites|antimetabolites|mesh-ancestor
24831058|NCT02162784|Autonomic Agents|autonomic agents|mesh-ancestor
24831059|NCT02162784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24831060|NCT02162784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831061|NCT02162784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24831064|NCT02162784|Hormones|hormones|mesh-ancestor
24732616|NCT01640574|Sensory System Agents|sensory system agents|mesh-ancestor
24831067|NCT02162784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24831068|NCT02162784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24831069|NCT02162784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24831070|NCT02162784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24831071|NCT02162784|Adrenergic Agents|adrenergic agents|mesh-ancestor
24831072|NCT02162784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24831074|NCT02162784|Sympathomimetics|sympathomimetics|mesh-ancestor
24831129|NCT02163330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831131|NCT02163330|Natriuretic Agents|natriuretic agents|mesh-ancestor
24831132|NCT02163330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831133|NCT02163616|Misoprostol|misoprostol|mesh-list
24831134|NCT02163616|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24696720|NCT01431118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25711630|NCT02303977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831166|NCT02163954|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24831167|NCT02163954|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24831168|NCT02163954|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24831169|NCT02163954|Purinergic Agents|purinergic agents|mesh-ancestor
24831170|NCT02163954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24831171|NCT02163954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831172|NCT02163954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831175|NCT02163980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24831176|NCT02163980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24831177|NCT02163980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831178|NCT02163980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24831179|NCT02163980|Analgesics|analgesics|mesh-ancestor
24831180|NCT02163980|Sensory System Agents|sensory system agents|mesh-ancestor
24449134|NCT00314509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24449135|NCT00314509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24449137|NCT00314548|Alprostadil|alprostadil|mesh-list
24449138|NCT00314548|Tezosentan|tezosentan|mesh-list
24449139|NCT00314548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24449140|NCT00314548|Vasodilator Agents|vasodilator agents|mesh-ancestor
24449141|NCT00314548|Urological Agents|urological agents|mesh-ancestor
24449144|NCT00314561|Rosiglitazone|rosiglitazone|mesh-list
24449145|NCT00314561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24449146|NCT00314561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831248|NCT02164448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24831249|NCT02164448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831251|NCT02164552|Ergocalciferols|ergocalciferols|mesh-list
24831271|NCT02164578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831272|NCT02164578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25711631|NCT02303977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711632|NCT02303977|Antiviral Agents|antiviral agents|mesh-ancestor
25711633|NCT02303977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25711634|NCT02303977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711635|NCT02303977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25711636|NCT02303977|Immunologic Factors|immunologic factors|mesh-ancestor
24449148|NCT00314613|Antipsychotic Agents|antipsychotic agents|mesh-list
24449149|NCT00314613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24449151|NCT00314613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24449152|NCT00314613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449153|NCT00314613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831280|NCT02164578|Antipyretics|antipyretics|mesh-ancestor
24831281|NCT02164578|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24831282|NCT02164578|Antithrombins|antithrombins|mesh-ancestor
24831283|NCT02164578|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24449172|NCT00314626|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24831297|NCT02164734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831298|NCT02164734|Analgesics|analgesics|mesh-ancestor
24449176|NCT00314639|Modafinil|modafinil|mesh-list
25711637|NCT02303977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711638|NCT02303990|Pembrolizumab|pembrolizumab|mesh-list
24831362|NCT02165020|Hyaluronic Acid|hyaluronic acid|mesh-list
25711639|NCT02303990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24831370|NCT02165033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24831371|NCT02165033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24831372|NCT02165033|Autonomic Agents|autonomic agents|mesh-ancestor
24831373|NCT02165033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24831374|NCT02165033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831375|NCT02165033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24831376|NCT02165033|Respiratory System Agents|respiratory system agents|mesh-ancestor
24831377|NCT02165033|Glucocorticoids|glucocorticoids|mesh-ancestor
24831378|NCT02165033|Hormones|hormones|mesh-ancestor
24831379|NCT02165033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24831380|NCT02165033|Sympathomimetics|sympathomimetics|mesh-ancestor
24831414|NCT02165189|Simeprevir|simeprevir|mesh-list
24831415|NCT02165189|Antimetabolites|antimetabolites|mesh-ancestor
24831416|NCT02165189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831451|NCT02165449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24831452|NCT02165449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24831453|NCT02165449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24831454|NCT02165449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831455|NCT02165475|Loperamide|loperamide|mesh-list
24831456|NCT02165475|Antidiarrheals|antidiarrheals|mesh-list
24831457|NCT02165475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24831458|NCT02165566|Insulin|insulin|mesh-list
24831489|NCT02165930|Naltrexone|naltrexone|mesh-list
24831586|NCT02166944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24831587|NCT02166944|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24831588|NCT02166944|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24831589|NCT02166944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24831591|NCT02167061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24831592|NCT02167061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831593|NCT02167165|Digoxin|digoxin|mesh-list
24831594|NCT02167165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24831595|NCT02167165|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24831596|NCT02167165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24831597|NCT02167165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831598|NCT02167165|Protective Agents|protective agents|mesh-ancestor
24831599|NCT02167165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831600|NCT02167178|Polygeline|polygeline|mesh-list
24831669|NCT02167698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24831670|NCT02167698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24831693|NCT02168010|Immunologic Factors|immunologic factors|mesh-ancestor
24831694|NCT02168010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711640|NCT02303990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711641|NCT02304159|Ribavirin|ribavirin|mesh-list
25711642|NCT02304159|Sofosbuvir|sofosbuvir|mesh-list
25711643|NCT02304159|Antimetabolites|antimetabolites|mesh-ancestor
25711644|NCT02304159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711645|NCT02304159|Antiviral Agents|antiviral agents|mesh-ancestor
25711646|NCT02304159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25711647|NCT02304432|Cycloserine|cycloserine|mesh-list
25711648|NCT02304432|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24831695|NCT02168010|Analgesics|analgesics|mesh-ancestor
24831696|NCT02168010|Sensory System Agents|sensory system agents|mesh-ancestor
24831697|NCT02168010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24831698|NCT02168010|Anticonvulsants|anticonvulsants|mesh-ancestor
24831700|NCT02168075|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24831701|NCT02168075|Diuretics|diuretics|mesh-ancestor
24831702|NCT02168075|Natriuretic Agents|natriuretic agents|mesh-ancestor
24831703|NCT02168075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831704|NCT02168127|Methylphenidate|methylphenidate|mesh-list
24831711|NCT02168127|Dopamine Agents|dopamine agents|mesh-ancestor
24449202|NCT00314665|Growth Inhibitors|growth inhibitors|mesh-ancestor
24449203|NCT00314665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449204|NCT00314678|Paclitaxel|paclitaxel|mesh-list
24449205|NCT00314678|Topotecan|topotecan|mesh-list
24449206|NCT00314678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24449207|NCT00314678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449208|NCT00314678|Tubulin Modulators|tubulin modulators|mesh-ancestor
24449209|NCT00314678|Antimitotic Agents|antimitotic agents|mesh-ancestor
24449210|NCT00314678|Mitosis Modulators|mitosis modulators|mesh-ancestor
24831737|NCT02168543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24831758|NCT02168634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24449211|NCT00314678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449212|NCT00314678|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24449213|NCT00314678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24449214|NCT00314678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449215|NCT00314704|Dopamine|dopamine|mesh-list
24831775|NCT02168881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831777|NCT02168881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24831780|NCT02168907|Rituximab|rituximab|mesh-list
24831813|NCT02169154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24831814|NCT02169154|Analgesics|analgesics|mesh-ancestor
24831815|NCT02169154|Sensory System Agents|sensory system agents|mesh-ancestor
24831816|NCT02169154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24831817|NCT02169154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831818|NCT02169154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24831819|NCT02169154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24831829|NCT02169544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24831836|NCT02169570|Calcium, Dietary|calcium, dietary|mesh-list
24831890|NCT02169713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24831891|NCT02169713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24831892|NCT02169752|Ambrisentan|ambrisentan|mesh-list
24831893|NCT02169752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24831894|NCT02169804|Enclomiphene|enclomiphene|mesh-list
24831895|NCT02169804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24831896|NCT02169804|Hormone Antagonists|hormone antagonists|mesh-ancestor
24831897|NCT02169804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24831898|NCT02169804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24831899|NCT02169804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24831900|NCT02169804|Fertility Agents|fertility agents|mesh-ancestor
24831901|NCT02169804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25711649|NCT02304432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25711650|NCT02304432|Renal Agents|renal agents|mesh-ancestor
25711651|NCT02304432|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25711652|NCT02304432|Antitubercular Agents|antitubercular agents|mesh-ancestor
25711653|NCT02304432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25711654|NCT02304432|Antimetabolites|antimetabolites|mesh-ancestor
25711655|NCT02304432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831902|NCT02169804|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24831903|NCT02169804|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24831910|NCT02169843|Analgesics|analgesics|mesh-ancestor
24831911|NCT02169843|Sensory System Agents|sensory system agents|mesh-ancestor
24831912|NCT02169843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24831913|NCT02169843|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24831914|NCT02169843|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24831915|NCT02169843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24831916|NCT02169843|Adrenergic Agents|adrenergic agents|mesh-ancestor
24831917|NCT02169843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24831918|NCT02169843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24831973|NCT02169882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24831974|NCT02169882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24831975|NCT02169882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24831984|NCT02169882|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24831985|NCT02169882|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24831986|NCT02169882|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24831987|NCT02169882|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24831988|NCT02169882|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24831989|NCT02169882|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24831991|NCT02169973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24831992|NCT02169973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832026|NCT02170402|Factor VIII|factor viii|mesh-list
24832027|NCT02170402|Coagulants|coagulants|mesh-ancestor
24832034|NCT02170415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832035|NCT02170415|Anticonvulsants|anticonvulsants|mesh-ancestor
24832036|NCT02170415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24832037|NCT02170415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24832038|NCT02170415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832039|NCT02170415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24832092|NCT02170636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832093|NCT02170636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832094|NCT02170636|Antithrombins|antithrombins|mesh-ancestor
24832095|NCT02170636|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832096|NCT02170636|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832097|NCT02170636|Anticoagulants|anticoagulants|mesh-ancestor
24832100|NCT02170675|Antithrombins|antithrombins|mesh-ancestor
24832101|NCT02170675|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832103|NCT02170675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832105|NCT02170675|Anticoagulants|anticoagulants|mesh-ancestor
24832185|NCT02170857|Hyaluronic Acid|hyaluronic acid|mesh-list
24832186|NCT02170857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24832187|NCT02170857|Immunologic Factors|immunologic factors|mesh-ancestor
24832188|NCT02170857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832189|NCT02170857|Viscosupplements|viscosupplements|mesh-ancestor
24832190|NCT02170857|Protective Agents|protective agents|mesh-ancestor
24832191|NCT02170896|Pantoprazole|pantoprazole|mesh-list
24832192|NCT02170896|Dabigatran|dabigatran|mesh-list
25711656|NCT02304484|Evolocumab|evolocumab|mesh-list
25711657|NCT02304484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25711658|NCT02304484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25711659|NCT02304484|Antimetabolites|antimetabolites|mesh-ancestor
25711660|NCT02304484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711661|NCT02304484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25711662|NCT02304705|Sildenafil Citrate|sildenafil citrate|mesh-list
25711663|NCT02304705|Vasodilator Agents|vasodilator agents|mesh-ancestor
25711664|NCT02304705|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24832239|NCT02170974|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832240|NCT02170974|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832241|NCT02170974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832242|NCT02170974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832243|NCT02170974|Anticoagulants|anticoagulants|mesh-ancestor
24832266|NCT02171013|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832267|NCT02171013|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832268|NCT02171013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832323|NCT02171182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24832324|NCT02171182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832325|NCT02171208|Dimethyl Fumarate|dimethyl fumarate|mesh-list
24832326|NCT02171208|Dermatologic Agents|dermatologic agents|mesh-ancestor
24832327|NCT02171208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24832367|NCT02171390|Methyltestosterone|methyltestosterone|mesh-list
24832369|NCT02171390|Testosterone undecanoate|testosterone undecanoate|mesh-list
24832370|NCT02171390|Testosterone enanthate|testosterone enanthate|mesh-list
24832371|NCT02171390|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24832372|NCT02171390|Androgens|androgens|mesh-ancestor
24832373|NCT02171390|Hormones|hormones|mesh-ancestor
24832374|NCT02171390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24832375|NCT02171390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449236|NCT00314743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24449237|NCT00314743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832406|NCT02171481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832446|NCT02171533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25711665|NCT02304705|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25711666|NCT02304705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711667|NCT02304705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711668|NCT02304705|Urological Agents|urological agents|mesh-ancestor
25711669|NCT02304757|Alendronate|alendronate|mesh-list
25711670|NCT02304757|Methylene diphosphonate|methylene diphosphonate|mesh-list
25711671|NCT02304757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24832450|NCT02171546|Quinidine|quinidine|mesh-list
24832451|NCT02171546|Quinidine gluconate|quinidine gluconate|mesh-list
24832452|NCT02171546|Dabigatran|dabigatran|mesh-list
24832453|NCT02171546|Antithrombins|antithrombins|mesh-ancestor
24832454|NCT02171546|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24832455|NCT02171546|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832456|NCT02171546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832457|NCT02171546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24832459|NCT02171546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24832460|NCT02171546|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24832461|NCT02171546|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24832462|NCT02171546|Histamine Antagonists|histamine antagonists|mesh-ancestor
24590525|NCT00913055|Octreotide|octreotide|mesh-list
24832463|NCT02171546|Histamine Agents|histamine agents|mesh-ancestor
24736837|NCT01665378|Folic Acid|folic acid|mesh-list
24449320|NCT00314990|Hematinics|hematinics|mesh-ancestor
24449364|NCT00315211|Antimitotic Agents|antimitotic agents|mesh-ancestor
24449365|NCT00315211|Mitosis Modulators|mitosis modulators|mesh-ancestor
25711672|NCT02304757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711673|NCT02304926|Simvastatin|simvastatin|mesh-list
25711675|NCT02304926|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
25711676|NCT02304926|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25777774|NCT03161964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24449366|NCT00315211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449367|NCT00315211|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24449368|NCT00315211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24449385|NCT00315432|Interferons|interferons|mesh-list
24832524|NCT02171598|Protease Inhibitors|protease inhibitors|mesh-ancestor
24832525|NCT02171598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737366|NCT01668680|Celecoxib|celecoxib|mesh-list
24832527|NCT02171624|Quinidine|quinidine|mesh-list
24832528|NCT02171624|Dabigatran|dabigatran|mesh-list
24832529|NCT02171624|Antithrombins|antithrombins|mesh-ancestor
24832530|NCT02171624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24617880|NCT01045941|Antiviral Agents|antiviral agents|mesh-ancestor
24449430|NCT00315601|Azithromycin|azithromycin|mesh-list
25711677|NCT02304926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25711678|NCT02304926|Antimetabolites|antimetabolites|mesh-ancestor
25711679|NCT02304926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711680|NCT02304926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25777775|NCT03161964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777776|NCT03161964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777777|NCT03161964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25777778|NCT03161964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25777779|NCT03161964|Vasodilator Agents|vasodilator agents|mesh-ancestor
25777780|NCT03150160|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25777781|NCT03150160|Travoprost|travoprost|mesh-list
25777782|NCT03150160|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25777783|NCT03150160|Brinzolamide|brinzolamide|mesh-list
25777784|NCT03150160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25777785|NCT03150160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25711681|NCT02304926|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25711682|NCT02304926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24832659|NCT02171975|Anesthetics|anesthetics|mesh-list
24832660|NCT02171975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24832661|NCT02171975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832662|NCT02171988|Propranolol|propranolol|mesh-list
24832664|NCT02171988|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
24832665|NCT02171988|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24832666|NCT02171988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24832667|NCT02171988|Adrenergic Agents|adrenergic agents|mesh-ancestor
24832668|NCT02171988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24832669|NCT02171988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449486|NCT00315835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24832720|NCT02172131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24832721|NCT02172131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24832722|NCT02172131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24832723|NCT02172131|Respiratory System Agents|respiratory system agents|mesh-ancestor
24832724|NCT02172144|Moxifloxacin|moxifloxacin|mesh-list
24832725|NCT02172144|Olodaterol|olodaterol|mesh-list
24832726|NCT02172144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24832727|NCT02172144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24832728|NCT02172144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24832729|NCT02172144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24832730|NCT02172144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449500|NCT00315861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24449501|NCT00315861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449502|NCT00315861|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25711683|NCT02305017|Acetaminophen|acetaminophen|mesh-list
25711684|NCT02305017|Opicapone|opicapone|mesh-list
25711685|NCT02305017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25711686|NCT02305017|Analgesics|analgesics|mesh-ancestor
25711687|NCT02305017|Sensory System Agents|sensory system agents|mesh-ancestor
25711688|NCT02305017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24449503|NCT00315861|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24832762|NCT02172196|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24832763|NCT02172209|Empagliflozin|empagliflozin|mesh-list
24617984|NCT01046435|Amoxicillin|amoxicillin|mesh-list
24449516|NCT00315887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24449517|NCT00315887|Narcotics|narcotics|mesh-ancestor
24449518|NCT00315887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24449519|NCT00315887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449520|NCT00315887|Analgesics|analgesics|mesh-ancestor
24449521|NCT00315887|Sensory System Agents|sensory system agents|mesh-ancestor
24832788|NCT02172248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24739210|NCT01679795|Hormones|hormones|mesh-ancestor
25711690|NCT02305017|Antipyretics|antipyretics|mesh-ancestor
25711691|NCT02305017|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25711692|NCT02305017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711693|NCT02305017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711694|NCT02305017|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25711695|NCT02305017|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25711696|NCT02305238|Aflibercept|aflibercept|mesh-list
25711697|NCT02305238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25711698|NCT02305238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24833363|NCT02173782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24833364|NCT02173782|Respiratory System Agents|respiratory system agents|mesh-ancestor
24833365|NCT02173782|Sympathomimetics|sympathomimetics|mesh-ancestor
24833366|NCT02173782|Tocolytic Agents|tocolytic agents|mesh-ancestor
24833367|NCT02173782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24833368|NCT02173782|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24833369|NCT02173782|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24833370|NCT02173782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24833371|NCT02173782|Adrenergic Agents|adrenergic agents|mesh-ancestor
24833405|NCT02173808|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24833406|NCT02173834|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
24833407|NCT02173834|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24833408|NCT02173834|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24833409|NCT02173834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833410|NCT02173834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24833411|NCT02173834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24833412|NCT02173873|Aflibercept|aflibercept|mesh-list
24833413|NCT02173873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24833414|NCT02173873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24833415|NCT02173873|Growth Substances|growth substances|mesh-ancestor
24833416|NCT02173873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833417|NCT02173873|Growth Inhibitors|growth inhibitors|mesh-ancestor
24833418|NCT02173873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24833420|NCT02173886|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24833421|NCT02173886|Antidepressive Agents|antidepressive agents|mesh-ancestor
24833512|NCT02174172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24833513|NCT02174172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24833514|NCT02174172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833515|NCT02174172|Immunologic Factors|immunologic factors|mesh-ancestor
24833516|NCT02174211|Ranibizumab|ranibizumab|mesh-list
24833517|NCT02174211|Aflibercept|aflibercept|mesh-list
24833518|NCT02174211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24833519|NCT02174211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24833520|NCT02174211|Growth Substances|growth substances|mesh-ancestor
24833521|NCT02174211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833522|NCT02174211|Growth Inhibitors|growth inhibitors|mesh-ancestor
24833532|NCT02174250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24833533|NCT02174250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833534|NCT02174250|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24833535|NCT02174250|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24833536|NCT02174250|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24833537|NCT02174250|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24833538|NCT02174250|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24833539|NCT02174250|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24833540|NCT02174250|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
24833541|NCT02174250|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24833542|NCT02174250|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24833543|NCT02174250|Purinergic Agents|purinergic agents|mesh-ancestor
24833544|NCT02174250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24833559|NCT02174328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24833560|NCT02174328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24833564|NCT02174328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24833612|NCT02174666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833614|NCT02174666|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24833615|NCT02174666|Estrogens|estrogens|mesh-ancestor
24833617|NCT02174666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24833623|NCT02174718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24833624|NCT02174718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24833626|NCT02174757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24833627|NCT02174757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24833628|NCT02174757|Antimalarials|antimalarials|mesh-ancestor
24833632|NCT02174887|Paclitaxel|paclitaxel|mesh-list
24833714|NCT02175381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833716|NCT02175381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24833717|NCT02175381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24833718|NCT02175381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24833719|NCT02175381|Immunologic Factors|immunologic factors|mesh-ancestor
24833720|NCT02175381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833721|NCT02175394|Linagliptin|linagliptin|mesh-list
24833726|NCT02175394|Incretins|incretins|mesh-ancestor
24833732|NCT02175394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833733|NCT02175394|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24833735|NCT02175394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24833736|NCT02175394|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24833737|NCT02175394|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24833738|NCT02175394|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24833739|NCT02175394|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24833740|NCT02175394|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24833742|NCT02175394|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24833763|NCT02175446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24833823|NCT02175901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833825|NCT02175901|Antitubercular Agents|antitubercular agents|mesh-ancestor
24833826|NCT02175901|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24833827|NCT02175901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24833828|NCT02175901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24833829|NCT02175901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24833830|NCT02175901|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24833831|NCT02175901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24833832|NCT02175901|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24833833|NCT02175901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24833849|NCT02175914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833851|NCT02175927|Amoxicillin|amoxicillin|mesh-list
24833852|NCT02175927|Metronidazole|metronidazole|mesh-list
24833853|NCT02175927|Tetracycline|tetracycline|mesh-list
24833857|NCT02175927|Bismuth|bismuth|mesh-list
24833858|NCT02175927|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25711768|NCT02305849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25711769|NCT02305849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711770|NCT02305849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25711771|NCT02305849|Antimetabolites|antimetabolites|mesh-ancestor
25711772|NCT02305849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833859|NCT02175927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833860|NCT02175927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24833861|NCT02175927|Antitubercular Agents|antitubercular agents|mesh-ancestor
24833862|NCT02175927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24833863|NCT02175927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24833864|NCT02175927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24833865|NCT02175927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24833866|NCT02175927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24833867|NCT02175927|Antacids|antacids|mesh-ancestor
24833868|NCT02175927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24833869|NCT02175927|Diuretics|diuretics|mesh-ancestor
24833870|NCT02175927|Natriuretic Agents|natriuretic agents|mesh-ancestor
24833871|NCT02175927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24833872|NCT02175927|Expectorants|expectorants|mesh-ancestor
24833874|NCT02176044|Nitroprusside|nitroprusside|mesh-list
24833988|NCT02176304|Protective Agents|protective agents|mesh-ancestor
24833989|NCT02176304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24833990|NCT02176304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24833991|NCT02176369|Vinorelbine|vinorelbine|mesh-list
24833992|NCT02176369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24833993|NCT02176369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24833994|NCT02176369|Tubulin Modulators|tubulin modulators|mesh-ancestor
24833995|NCT02176369|Antimitotic Agents|antimitotic agents|mesh-ancestor
24833996|NCT02176369|Mitosis Modulators|mitosis modulators|mesh-ancestor
24592218|NCT00920868|Growth Substances|growth substances|mesh-ancestor
24833997|NCT02176369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24833998|NCT02176460|Colchicine|colchicine|mesh-list
24833999|NCT02176460|Gout Suppressants|gout suppressants|mesh-ancestor
24834000|NCT02176460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24834001|NCT02176460|Tubulin Modulators|tubulin modulators|mesh-ancestor
24834002|NCT02176460|Antimitotic Agents|antimitotic agents|mesh-ancestor
24834035|NCT02176720|Fluorides|fluorides|mesh-list
24834147|NCT02177344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24834148|NCT02177344|Autonomic Agents|autonomic agents|mesh-ancestor
24834149|NCT02177344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834224|NCT02177448|Enalaprilat|enalaprilat|mesh-list
24834230|NCT02177448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24834231|NCT02177448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24834232|NCT02177448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24834233|NCT02177461|Telmisartan|telmisartan|mesh-list
24834235|NCT02177461|Enalapril|enalapril|mesh-list
24834237|NCT02177461|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24834238|NCT02177461|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24834239|NCT02177461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834240|NCT02177461|Analgesics|analgesics|mesh-ancestor
24834241|NCT02177461|Sensory System Agents|sensory system agents|mesh-ancestor
24834242|NCT02177461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834269|NCT02177500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24834270|NCT02177500|Diuretics|diuretics|mesh-ancestor
24834271|NCT02177500|Natriuretic Agents|natriuretic agents|mesh-ancestor
24834272|NCT02177500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834273|NCT02177500|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24834274|NCT02177500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24834275|NCT02177500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834276|NCT02177500|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24834277|NCT02177500|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24834278|NCT02177539|Phenylephrine|phenylephrine|mesh-list
24834279|NCT02177539|Oxymetazoline|oxymetazoline|mesh-list
24834280|NCT02177539|Tropicamide|tropicamide|mesh-list
24834281|NCT02177539|Cyclopentolate|cyclopentolate|mesh-list
24834282|NCT02177539|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24834283|NCT02177539|Mydriatics|mydriatics|mesh-ancestor
24834284|NCT02177539|Autonomic Agents|autonomic agents|mesh-ancestor
24834369|NCT02177994|Ceftriaxone|ceftriaxone|mesh-list
24834370|NCT02177994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24834371|NCT02177994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25711773|NCT02305849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711774|NCT02305849|Dermatologic Agents|dermatologic agents|mesh-ancestor
24834372|NCT02178033|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25711775|NCT02305849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711776|NCT02305849|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25711777|NCT02305849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25711778|NCT02305849|Immunologic Factors|immunologic factors|mesh-ancestor
24834375|NCT02178124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24834376|NCT02178124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834377|NCT02178124|Cholinergic Agents|cholinergic agents|mesh-ancestor
24834378|NCT02178124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24834379|NCT02178124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834380|NCT02178124|Nootropic Agents|nootropic agents|mesh-ancestor
24834381|NCT02178137|Zinc Sulfate|zinc sulfate|mesh-list
24834382|NCT02178137|Astringents|astringents|mesh-ancestor
24834383|NCT02178137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834385|NCT02178150|Magnesium Oxide|magnesium oxide|mesh-list
24834387|NCT02178150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834388|NCT02178150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24834390|NCT02178254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24592692|NCT00923962|Incretins|incretins|mesh-ancestor
24834416|NCT02178449|Dexamethasone|dexamethasone|mesh-list
24834417|NCT02178449|Dexamethasone acetate|dexamethasone acetate|mesh-list
24834418|NCT02178449|Ropivacaine|ropivacaine|mesh-list
24834419|NCT02178449|BB 1101|bb 1101|mesh-list
24834420|NCT02178449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24744099|NCT04515147|Vaccines|vaccines|mesh-list
24834444|NCT02178488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24834445|NCT02178644|Capecitabine|capecitabine|mesh-list
24834446|NCT02178644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24834447|NCT02178644|Antimetabolites|antimetabolites|mesh-ancestor
24834448|NCT02178644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834453|NCT02178683|Immunologic Factors|immunologic factors|mesh-ancestor
24834454|NCT02178683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834455|NCT02178683|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24834456|NCT02178683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24834458|NCT02178683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24834459|NCT02178683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24834460|NCT02178683|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24834461|NCT02178683|Antitubercular Agents|antitubercular agents|mesh-ancestor
24834462|NCT02178683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24834463|NCT02178683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24834503|NCT02179255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24834504|NCT02179255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834506|NCT02179268|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24834507|NCT02179268|Citalopram|citalopram|mesh-list
24834508|NCT02179268|Reboxetine|reboxetine|mesh-list
24834509|NCT02179268|Antidepressive Agents|antidepressive agents|mesh-ancestor
24834510|NCT02179268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24834511|NCT02179268|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24834512|NCT02179268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24834513|NCT02179268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24834514|NCT02179268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834515|NCT02179268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24834516|NCT02179268|Serotonin Agents|serotonin agents|mesh-ancestor
24834517|NCT02179268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25407567|NCT03496623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25711779|NCT02305849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25711780|NCT02305849|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25711781|NCT02306694|Factor VIII|factor viii|mesh-list
25711782|NCT02306694|Coagulants|coagulants|mesh-ancestor
25711783|NCT02306759|Ketamine|ketamine|mesh-list
25711784|NCT02306759|Analgesics|analgesics|mesh-ancestor
25711785|NCT02306759|Sensory System Agents|sensory system agents|mesh-ancestor
25711786|NCT02306759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834555|NCT02179645|Analgesics|analgesics|mesh-ancestor
24834556|NCT02179645|Sensory System Agents|sensory system agents|mesh-ancestor
24834557|NCT02179645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834558|NCT02179645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834559|NCT02179645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24452309|NCT00327106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24452310|NCT00327106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452311|NCT00327106|Hemostatics|hemostatics|mesh-ancestor
24452312|NCT00327106|Coagulants|coagulants|mesh-ancestor
24834563|NCT02179645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24834564|NCT02179645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834565|NCT02179658|Vancomycin|vancomycin|mesh-list
24834566|NCT02179658|Fidaxomicin|fidaxomicin|mesh-list
24834608|NCT02179931|Dopamine Agents|dopamine agents|mesh-ancestor
24834609|NCT02179931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24834610|NCT02179931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834611|NCT02179970|Plerixafor|plerixafor|mesh-list
24834612|NCT02179970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24592940|NCT00926354|Antiviral Agents|antiviral agents|mesh-ancestor
24834613|NCT02179970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24834614|NCT02179970|Antiviral Agents|antiviral agents|mesh-ancestor
24834615|NCT02179970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24834616|NCT02179996|Vaccines|vaccines|mesh-list
24834617|NCT02179996|Immunologic Factors|immunologic factors|mesh-ancestor
24834618|NCT02179996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593014|NCT00926718|Analgesics|analgesics|mesh-ancestor
24834657|NCT02180334|Sensory System Agents|sensory system agents|mesh-ancestor
24834658|NCT02180334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834659|NCT02180334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834660|NCT02180334|Antipyretics|antipyretics|mesh-ancestor
24834710|NCT02180516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834712|NCT02180529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24834713|NCT02180529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834714|NCT02180529|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24834715|NCT02180529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24834718|NCT02180529|Dopamine Agents|dopamine agents|mesh-ancestor
24834719|NCT02180529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25711787|NCT02306759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711788|NCT02306759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25711789|NCT02306759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25711790|NCT02306759|Anesthetics, General|anesthetics, general|mesh-ancestor
25711791|NCT02306759|Anesthetics|anesthetics|mesh-ancestor
25711792|NCT02306759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25711793|NCT02306759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25711794|NCT02306759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24834720|NCT02180568|Ethiodized Oil|ethiodized oil|mesh-list
24834721|NCT02180568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24834722|NCT02180737|Dexmedetomidine|dexmedetomidine|mesh-list
24834723|NCT02180737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24834724|NCT02180737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24834725|NCT02180737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834747|NCT02180880|Analgesics|analgesics|mesh-ancestor
24834748|NCT02180880|Sensory System Agents|sensory system agents|mesh-ancestor
24834749|NCT02180880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834750|NCT02180880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834751|NCT02180880|Anticonvulsants|anticonvulsants|mesh-ancestor
24834752|NCT02180880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24834753|NCT02180880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24834756|NCT02180880|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24834757|NCT02180880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24834758|NCT02180880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24834759|NCT02180880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24834760|NCT02180880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24593162|NCT00927147|Cetuximab|cetuximab|mesh-list
24834761|NCT02180880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24834762|NCT02180880|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24834763|NCT02180880|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24834764|NCT02180997|Tamsulosin|tamsulosin|mesh-list
24834765|NCT02180997|Solifenacin Succinate|solifenacin succinate|mesh-list
24834778|NCT02181023|Bromides|bromides|mesh-list
24834791|NCT02181205|Anesthetics, Local|anesthetics, local|mesh-ancestor
24834793|NCT02181205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24834794|NCT02181205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834835|NCT02181309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24834836|NCT02181309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834838|NCT02181322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24834873|NCT02181361|Analgesics|analgesics|mesh-ancestor
24834874|NCT02181361|Sensory System Agents|sensory system agents|mesh-ancestor
24834875|NCT02181361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24834876|NCT02181361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834877|NCT02181361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24834878|NCT02181361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24834879|NCT02181361|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24834880|NCT02181361|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24834881|NCT02181361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834882|NCT02181361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24834883|NCT02181361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24834884|NCT02181361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24834885|NCT02181361|Antipyretics|antipyretics|mesh-ancestor
24834893|NCT02181478|Fludarabine|fludarabine|mesh-list
24834967|NCT02181946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24834968|NCT02181946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24834969|NCT02181946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24834970|NCT02181946|Hormone Antagonists|hormone antagonists|mesh-ancestor
24834971|NCT02181946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24834972|NCT02181946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24834973|NCT02181946|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24834974|NCT02181946|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24834975|NCT02181946|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24834976|NCT02181946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24835013|NCT02182050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24835014|NCT02182050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24835015|NCT02182050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835016|NCT02182050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835017|NCT02182063|Nintedanib|nintedanib|mesh-list
24835018|NCT02182063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24835019|NCT02182063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24835020|NCT02182063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835021|NCT02182063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711795|NCT02306759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25777786|NCT03150160|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24835289|NCT02182570|Histamine Antagonists|histamine antagonists|mesh-ancestor
24835290|NCT02182570|Histamine Agents|histamine agents|mesh-ancestor
24835329|NCT02182648|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24835330|NCT02182648|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24835331|NCT02182661|Oxitropium|oxitropium|mesh-list
24835332|NCT02182661|Parasympatholytics|parasympatholytics|mesh-ancestor
24835333|NCT02182661|Autonomic Agents|autonomic agents|mesh-ancestor
24835334|NCT02182661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835335|NCT02182661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835336|NCT02182700|Bromides|bromides|mesh-list
24835337|NCT02182700|Albuterol|albuterol|mesh-list
24835385|NCT02182739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24835386|NCT02182739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24835387|NCT02182739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835388|NCT02182739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835389|NCT02182752|Tramadol|tramadol|mesh-list
24835390|NCT02182752|Ropivacaine|ropivacaine|mesh-list
24835391|NCT02182752|Anesthetics, Local|anesthetics, local|mesh-ancestor
24835392|NCT02182752|Anesthetics|anesthetics|mesh-ancestor
24835393|NCT02182752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24835394|NCT02182752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835395|NCT02182752|Sensory System Agents|sensory system agents|mesh-ancestor
24835396|NCT02182752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835397|NCT02182752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24835398|NCT02182752|Narcotics|narcotics|mesh-ancestor
24835476|NCT02182986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835479|NCT02183012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24835480|NCT02183012|Analgesics|analgesics|mesh-ancestor
24835481|NCT02183012|Sensory System Agents|sensory system agents|mesh-ancestor
24835482|NCT02183012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835483|NCT02183012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777787|NCT03150160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25777788|NCT03150160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25777789|NCT03150160|Adrenergic Agents|adrenergic agents|mesh-ancestor
25777790|NCT03150160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25777791|NCT03150160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777792|NCT03150160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777793|NCT03150160|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24835572|NCT02183103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24835573|NCT02183103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24835575|NCT02183103|Sensory System Agents|sensory system agents|mesh-ancestor
24835600|NCT02183129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24835601|NCT02183129|Analgesics|analgesics|mesh-ancestor
24835602|NCT02183129|Sensory System Agents|sensory system agents|mesh-ancestor
24835603|NCT02183129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835604|NCT02183129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835605|NCT02183129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24835606|NCT02183129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24835607|NCT02183129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24835608|NCT02183129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835609|NCT02183129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835610|NCT02183129|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24835611|NCT02183142|Meloxicam|meloxicam|mesh-list
24835612|NCT02183142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24835613|NCT02183142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24835614|NCT02183142|Analgesics|analgesics|mesh-ancestor
24835615|NCT02183142|Sensory System Agents|sensory system agents|mesh-ancestor
24598450|NCT00956189|Aripiprazole|aripiprazole|mesh-list
24835616|NCT02183142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24835617|NCT02183142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835624|NCT02183155|Indomethacin|indomethacin|mesh-list
24835721|NCT02183298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594294|NCT00933387|Paclitaxel|paclitaxel|mesh-list
24835722|NCT02183311|Linagliptin|linagliptin|mesh-list
24835723|NCT02183311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24835724|NCT02183311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835725|NCT02183311|Incretins|incretins|mesh-ancestor
24835726|NCT02183311|Hormones|hormones|mesh-ancestor
24835727|NCT02183311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24835728|NCT02183311|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24835729|NCT02183311|Protease Inhibitors|protease inhibitors|mesh-ancestor
24835730|NCT02183311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835731|NCT02183311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835732|NCT02183324|Linagliptin|linagliptin|mesh-list
25777797|NCT03109418|Sensory System Agents|sensory system agents|mesh-ancestor
25777798|NCT03109418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25777799|NCT03109418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777800|NCT03109418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25777801|NCT03109418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25711796|NCT02306759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835874|NCT02183480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835887|NCT02183506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24835888|NCT02183506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835889|NCT02183506|Incretins|incretins|mesh-ancestor
24835890|NCT02183506|Hormones|hormones|mesh-ancestor
24835891|NCT02183506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24835892|NCT02183506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24835893|NCT02183506|Protease Inhibitors|protease inhibitors|mesh-ancestor
24835894|NCT02183506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835895|NCT02183506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835896|NCT02183532|Linagliptin|linagliptin|mesh-list
24835897|NCT02183532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24835898|NCT02183532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24835899|NCT02183532|Incretins|incretins|mesh-ancestor
24835900|NCT02183532|Hormones|hormones|mesh-ancestor
24835901|NCT02183532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24835902|NCT02183532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24835903|NCT02183532|Protease Inhibitors|protease inhibitors|mesh-ancestor
24835904|NCT02183532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24835906|NCT02183571|Metformin|metformin|mesh-list
24835915|NCT02183584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24835942|NCT02183610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835944|NCT02183623|Simvastatin|simvastatin|mesh-list
24835945|NCT02183623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24835946|NCT02183623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24835954|NCT02183623|Incretins|incretins|mesh-ancestor
24835996|NCT02183701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24835998|NCT02183701|Natriuretic Agents|natriuretic agents|mesh-ancestor
24835999|NCT02183701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836053|NCT02184052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836054|NCT02184065|Meloxicam|meloxicam|mesh-list
24836055|NCT02184065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24836056|NCT02184065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24836057|NCT02184065|Analgesics|analgesics|mesh-ancestor
24836058|NCT02184065|Sensory System Agents|sensory system agents|mesh-ancestor
24836059|NCT02184065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24836070|NCT02184078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24836071|NCT02184078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836072|NCT02184078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836073|NCT02184078|Antiviral Agents|antiviral agents|mesh-ancestor
24836074|NCT02184078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24836075|NCT02184078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24836076|NCT02184078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24863113|NCT03088059|Palbociclib|palbociclib|mesh-list
24863114|NCT03088059|Niraparib|niraparib|mesh-list
24836077|NCT02184078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24836078|NCT02184078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24836116|NCT02184247|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24836117|NCT02184247|Autonomic Agents|autonomic agents|mesh-ancestor
24836118|NCT02184247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24836119|NCT02184247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770737|NCT03562988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770738|NCT03562988|Protective Agents|protective agents|mesh-ancestor
25770739|NCT03565211|Progesterone|progesterone|mesh-list
25770740|NCT03565211|Progestins|progestins|mesh-ancestor
25770741|NCT03565211|Hormones|hormones|mesh-ancestor
25770742|NCT03565211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25770743|NCT03565211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770744|NCT03565666|Insulin|insulin|mesh-list
25770745|NCT03565666|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24836200|NCT02184351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24836201|NCT02184351|Antifungal Agents|antifungal agents|mesh-ancestor
24836202|NCT02184351|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24836203|NCT02184351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24836204|NCT02184351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836271|NCT02184858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836272|NCT02184858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24836273|NCT02184858|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25711797|NCT02306850|Pembrolizumab|pembrolizumab|mesh-list
25711798|NCT02306850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25711799|NCT02306850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711800|NCT02307318|Hemostatics|hemostatics|mesh-list
25711801|NCT02307318|Coagulants|coagulants|mesh-ancestor
25711802|NCT02307513|Apremilast|apremilast|mesh-list
25711803|NCT02307513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25711804|NCT02307513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25711805|NCT02307513|Analgesics|analgesics|mesh-ancestor
25711807|NCT02307513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24836368|NCT02185456|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25407568|NCT03493932|Nivolumab|nivolumab|mesh-list
25711808|NCT02307513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711809|NCT02307513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25711810|NCT02307513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25711811|NCT02307513|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25711812|NCT02307513|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25711813|NCT02307513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711814|NCT02307513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711815|NCT02307526|Bromides|bromides|mesh-list
25711816|NCT02307526|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
25711817|NCT02307526|Anticonvulsants|anticonvulsants|mesh-ancestor
25770746|NCT03565666|Insulin Lispro|insulin lispro|mesh-list
25770747|NCT03565666|Insulin Aspart|insulin aspart|mesh-list
25770748|NCT03565666|Pancrelipase|pancrelipase|mesh-list
25770749|NCT03565666|Pancreatin|pancreatin|mesh-list
25770750|NCT03565666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25770751|NCT03565666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770752|NCT03565666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25770753|NCT03565887|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25770754|NCT03565887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25770755|NCT03566485|Atezolizumab|atezolizumab|mesh-list
25770756|NCT03566485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25770757|NCT03566810|Metformin|metformin|mesh-list
25770758|NCT03566810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25770759|NCT03566810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770760|NCT03566979|Naproxen|naproxen|mesh-list
25770761|NCT03566979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25770762|NCT03566979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24836594|NCT02186496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836595|NCT02186496|Vasodilator Agents|vasodilator agents|mesh-ancestor
24836596|NCT02186496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24836597|NCT02186496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24836599|NCT02186535|Calcium|calcium|mesh-list
24836600|NCT02186535|Vitamins|vitamins|mesh-ancestor
24836601|NCT02186535|Micronutrients|micronutrients|mesh-ancestor
24836602|NCT02186535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836603|NCT02186535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25711828|NCT02307682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25711829|NCT02307682|Growth Substances|growth substances|mesh-ancestor
25711830|NCT02307682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711831|NCT02307682|Growth Inhibitors|growth inhibitors|mesh-ancestor
25711832|NCT02307682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711833|NCT02307916|Mitogens|mitogens|mesh-list
25711834|NCT02307916|Mitosis Modulators|mitosis modulators|mesh-ancestor
25711839|NCT02308007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25711840|NCT02308007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25711841|NCT02308007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25711842|NCT02308007|Antifungal Agents|antifungal agents|mesh-ancestor
25711844|NCT02308033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25711845|NCT02308033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24836658|NCT02186782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836689|NCT02186990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24836690|NCT02186990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836691|NCT02186990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24836692|NCT02186990|Anesthetics, General|anesthetics, general|mesh-ancestor
24836693|NCT02186990|Anesthetics|anesthetics|mesh-ancestor
24836694|NCT02187068|Dexmedetomidine|dexmedetomidine|mesh-list
24836695|NCT02187068|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24836696|NCT02187068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24836697|NCT02187068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24748612|NCT02325466|Aspirin|aspirin|mesh-list
25711851|NCT02308124|Midodrine|midodrine|mesh-list
25711852|NCT02308124|Bromides|bromides|mesh-list
25711853|NCT02308124|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
25711854|NCT02308124|Anticonvulsants|anticonvulsants|mesh-ancestor
24836852|NCT02187614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24836853|NCT02187614|Analgesics|analgesics|mesh-ancestor
24836854|NCT02187614|Sensory System Agents|sensory system agents|mesh-ancestor
24749101|NCT01741103|Protease Inhibitors|protease inhibitors|mesh-ancestor
24836863|NCT02187614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836864|NCT02187679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24836865|NCT02187679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24836866|NCT02187679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25770764|NCT03566979|Sensory System Agents|sensory system agents|mesh-ancestor
25770765|NCT03566979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770766|NCT03566979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770767|NCT03566979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25770768|NCT03566979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25770769|NCT03566979|Gout Suppressants|gout suppressants|mesh-ancestor
25770770|NCT03566979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24472687|NCT00400231|Metformin|metformin|mesh-list
24836936|NCT02188186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24836937|NCT02188186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836938|NCT02188225|Fluoxetine|fluoxetine|mesh-list
24836940|NCT02188225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24836941|NCT02188225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24749337|NCT01166113|Cyclophosphamide|cyclophosphamide|mesh-list
24452480|NCT05458674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24836952|NCT02188277|Botulinum Toxins|botulinum toxins|mesh-list
24836953|NCT02188277|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24836954|NCT02188277|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25711864|NCT02308124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25711865|NCT02308124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711866|NCT02308124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25711867|NCT02308124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711868|NCT02308124|Cholinergic Agents|cholinergic agents|mesh-ancestor
25711869|NCT02308163|Etanercept|etanercept|mesh-list
25711870|NCT02308163|Peficitinib|peficitinib|mesh-list
25711871|NCT02308163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24836982|NCT02188368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24836983|NCT02188368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24836984|NCT02188368|Glucocorticoids|glucocorticoids|mesh-ancestor
24836986|NCT02188368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24749448|NCT01093196|Antiemetics|antiemetics|mesh-ancestor
24836990|NCT02188368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24836991|NCT02188368|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24836992|NCT02188368|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24836994|NCT02188368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24836995|NCT02188368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24836996|NCT02188368|Growth Substances|growth substances|mesh-ancestor
24836997|NCT02188368|Growth Inhibitors|growth inhibitors|mesh-ancestor
24836999|NCT02188394|Anesthetics|anesthetics|mesh-list
24837000|NCT02188394|Anesthetics, Local|anesthetics, local|mesh-ancestor
25711872|NCT02308163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25711873|NCT02308163|Analgesics|analgesics|mesh-ancestor
25711874|NCT02308163|Sensory System Agents|sensory system agents|mesh-ancestor
25711875|NCT02308163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25711876|NCT02308163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711877|NCT02308163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25711878|NCT02308163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24837175|NCT02189577|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24837176|NCT02189577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24837177|NCT02189577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24837211|NCT02190305|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
24837212|NCT02190305|Immunologic Factors|immunologic factors|mesh-ancestor
24837225|NCT02190318|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24837226|NCT02190318|Diuretics|diuretics|mesh-ancestor
24837227|NCT02190318|Natriuretic Agents|natriuretic agents|mesh-ancestor
24837229|NCT02190357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24837230|NCT02190357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24837231|NCT02190357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24837232|NCT02190526|Mesalamine|mesalamine|mesh-list
24837248|NCT02190526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837249|NCT02190526|Adrenergic Agents|adrenergic agents|mesh-ancestor
24837250|NCT02190526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24837252|NCT02190695|Decitabine|decitabine|mesh-list
24837253|NCT02190695|Arsenic Trioxide|arsenic trioxide|mesh-list
24837254|NCT02190695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24837255|NCT02190695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24473082|NCT00401804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24473083|NCT00401804|Antiemetics|antiemetics|mesh-ancestor
24473084|NCT00401804|Autonomic Agents|autonomic agents|mesh-ancestor
24473085|NCT00401804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24473086|NCT00401804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837399|NCT02191189|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24837400|NCT02191202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
25777802|NCT03109418|Anesthetics, General|anesthetics, general|mesh-ancestor
25777803|NCT03109418|Anesthetics|anesthetics|mesh-ancestor
25777804|NCT03109418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25777805|NCT03109418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25777806|NCT03109418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25777807|NCT03109418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25777808|NCT03109418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777809|NCT03120676|Atezolizumab|atezolizumab|mesh-list
24837401|NCT02191202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24837403|NCT02191202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837404|NCT02191202|Antiviral Agents|antiviral agents|mesh-ancestor
24837405|NCT02191202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24837407|NCT02191215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24837408|NCT02191215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24837409|NCT02191215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837477|NCT02191423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837478|NCT02191475|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24837479|NCT02191475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24837480|NCT02191475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24837481|NCT02191475|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24837482|NCT02191475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24837528|NCT02191839|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
24837623|NCT02192411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24837624|NCT02192411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24837625|NCT02192411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837626|NCT02192424|Insulin|insulin|mesh-list
24750656|NCT01699919|Lidocaine|lidocaine|mesh-list
24837687|NCT02192723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24837688|NCT02192723|Serotonin Agents|serotonin agents|mesh-ancestor
24837689|NCT02192723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24473395|NCT00402623|Quercetin|quercetin|mesh-list
24837690|NCT02192723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837691|NCT02192723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837692|NCT02192723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24837693|NCT02192723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24837694|NCT02192723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24837695|NCT02192723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24837696|NCT02192723|Dopamine Agents|dopamine agents|mesh-ancestor
24837697|NCT02192723|Antiemetics|antiemetics|mesh-ancestor
24596518|NCT00943956|Fertility Agents|fertility agents|mesh-ancestor
24837792|NCT02193334|Mitosis Modulators|mitosis modulators|mesh-ancestor
24837793|NCT02193334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24837794|NCT02193568|Anesthetics|anesthetics|mesh-list
24837795|NCT02193568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24837796|NCT02193568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24837797|NCT02193594|Oxaliplatin|oxaliplatin|mesh-list
24837798|NCT02193594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24837799|NCT02193620|Nalbuphine|nalbuphine|mesh-list
24837800|NCT02193620|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24837801|NCT02193620|Narcotics|narcotics|mesh-ancestor
24837825|NCT02193698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24837826|NCT02193698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24837827|NCT02193698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24837828|NCT02193698|Immunologic Factors|immunologic factors|mesh-ancestor
24837829|NCT02193698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24837830|NCT02193698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24837831|NCT02193698|Growth Substances|growth substances|mesh-ancestor
24837832|NCT02193698|Growth Inhibitors|growth inhibitors|mesh-ancestor
24837833|NCT02193893|Coal Tar|coal tar|mesh-list
24837835|NCT02193893|Dermatologic Agents|dermatologic agents|mesh-ancestor
24837836|NCT02193971|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24837837|NCT02193971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24837838|NCT02194049|Etoposide|etoposide|mesh-list
24837839|NCT02194049|Etoposide phosphate|etoposide phosphate|mesh-list
24837840|NCT02194049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24837841|NCT02194049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24837842|NCT02194049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24837843|NCT02194049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24837893|NCT02194192|Ephedrine|ephedrine|mesh-list
25711888|NCT02308501|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25711889|NCT02308501|Histamine Antagonists|histamine antagonists|mesh-ancestor
25711890|NCT02308501|Histamine Agents|histamine agents|mesh-ancestor
25711891|NCT02308501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25711892|NCT02308501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473321|NCT00402545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24473324|NCT00402545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473325|NCT00402545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24838023|NCT02194829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24838024|NCT02194829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473385|NCT00402610|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24473386|NCT00402610|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24473387|NCT00402610|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24473388|NCT00402610|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24838098|NCT02195271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838099|NCT02195271|Protective Agents|protective agents|mesh-ancestor
24838100|NCT02195271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838101|NCT02195271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24473403|NCT00402636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24473404|NCT00402636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473405|NCT00402636|Antifungal Agents|antifungal agents|mesh-ancestor
24473406|NCT00402636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24473407|NCT00402636|Immunologic Factors|immunologic factors|mesh-ancestor
24838115|NCT02195336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838116|NCT02195336|Growth Inhibitors|growth inhibitors|mesh-ancestor
24838117|NCT02195375|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24838118|NCT02195375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24838119|NCT02195375|Autonomic Agents|autonomic agents|mesh-ancestor
24838122|NCT02195375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24473467|NCT00402974|Vitamins|vitamins|mesh-ancestor
24473468|NCT00402974|Micronutrients|micronutrients|mesh-ancestor
24473469|NCT00402974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473470|NCT00403000|Dutasteride|dutasteride|mesh-list
24473473|NCT00403000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24838228|NCT02196194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838229|NCT02196194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24838230|NCT02196194|Respiratory System Agents|respiratory system agents|mesh-ancestor
24838231|NCT02196194|Parasympatholytics|parasympatholytics|mesh-ancestor
24838232|NCT02196194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24838233|NCT02196194|Cholinergic Agents|cholinergic agents|mesh-ancestor
24838234|NCT02196194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25711893|NCT02308501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711894|NCT02308540|Vaccines|vaccines|mesh-list
25711895|NCT02308540|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25711896|NCT02308540|Immunologic Factors|immunologic factors|mesh-ancestor
25711897|NCT02308540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711898|NCT02308748|Moxifloxacin|moxifloxacin|mesh-list
25711899|NCT02308748|Lidocaine|lidocaine|mesh-list
25711901|NCT02308748|Dofetilide|dofetilide|mesh-list
25711902|NCT02308748|Diltiazem|diltiazem|mesh-list
25711903|NCT02308748|Anesthetics, Local|anesthetics, local|mesh-ancestor
25711904|NCT02308748|Anesthetics|anesthetics|mesh-ancestor
24838235|NCT02196194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838236|NCT02196207|Antibodies, Bispecific|antibodies, bispecific|mesh-list
24838237|NCT02196207|Immunologic Factors|immunologic factors|mesh-ancestor
24838239|NCT02196285|Vaccines|vaccines|mesh-list
24838324|NCT02197156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24838326|NCT02197156|Sensory System Agents|sensory system agents|mesh-ancestor
24838327|NCT02197156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838328|NCT02197156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838329|NCT02197156|Antipyretics|antipyretics|mesh-ancestor
24838330|NCT02197156|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24838332|NCT02197156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24838333|NCT02197156|Antitussive Agents|antitussive agents|mesh-ancestor
24838334|NCT02197156|Respiratory System Agents|respiratory system agents|mesh-ancestor
24838335|NCT02197169|Interferons|interferons|mesh-list
24838336|NCT02197169|Interferon-gamma|interferon-gamma|mesh-list
24838337|NCT02197169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24838338|NCT02197169|Antiviral Agents|antiviral agents|mesh-ancestor
24838339|NCT02197169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24838343|NCT02197182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24838344|NCT02197182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24838345|NCT02197182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24838346|NCT02197182|Trace Elements|trace elements|mesh-ancestor
24838347|NCT02197182|Micronutrients|micronutrients|mesh-ancestor
24838348|NCT02197182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838349|NCT02197260|Amoxicillin|amoxicillin|mesh-list
24838350|NCT02197260|Metronidazole|metronidazole|mesh-list
24838351|NCT02197260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24473500|NCT00403065|Dexamethasone|dexamethasone|mesh-list
24838404|NCT02197650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24838412|NCT02197702|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24838415|NCT02197741|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24838416|NCT02197741|Narcotics|narcotics|mesh-ancestor
24838417|NCT02197741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24838418|NCT02197741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838419|NCT02197741|Analgesics|analgesics|mesh-ancestor
24838420|NCT02197741|Sensory System Agents|sensory system agents|mesh-ancestor
24838421|NCT02197741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24838422|NCT02197884|Clarithromycin|clarithromycin|mesh-list
25711905|NCT02308748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25711906|NCT02308748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711907|NCT02308748|Sensory System Agents|sensory system agents|mesh-ancestor
24863687|NCT03822897|Cisplatin|cisplatin|mesh-list
25711908|NCT02308748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25711909|NCT02308748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25711910|NCT02308748|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25711911|NCT02308748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24838423|NCT02197884|Itraconazole|itraconazole|mesh-list
24838424|NCT02197884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24838425|NCT02197884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24838528|NCT02198404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24838529|NCT02198404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838531|NCT02198404|Anesthetics, General|anesthetics, general|mesh-ancestor
24838532|NCT02198404|Anesthetics|anesthetics|mesh-ancestor
24838536|NCT02198443|Ritonavir|ritonavir|mesh-list
24838537|NCT02198443|Lopinavir|lopinavir|mesh-list
24838538|NCT02198443|Tenofovir|tenofovir|mesh-list
24838539|NCT02198443|Emtricitabine|emtricitabine|mesh-list
24897692|NCT04423276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838540|NCT02198443|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24838541|NCT02198443|Cobicistat|cobicistat|mesh-list
24838542|NCT02198443|Elvitegravir|elvitegravir|mesh-list
24838543|NCT02198443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24838544|NCT02198443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24838545|NCT02198443|Protease Inhibitors|protease inhibitors|mesh-ancestor
24838546|NCT02198443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24838548|NCT02198443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24838674|NCT02199418|Tubulin Modulators|tubulin modulators|mesh-ancestor
24838675|NCT02199418|Antimitotic Agents|antimitotic agents|mesh-ancestor
24838676|NCT02199418|Mitosis Modulators|mitosis modulators|mesh-ancestor
24838677|NCT02199418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838678|NCT02199431|Itraconazole|itraconazole|mesh-list
24838679|NCT02199431|Antifungal Agents|antifungal agents|mesh-ancestor
24619119|NCT01050933|Carbon Monoxide|carbon monoxide|mesh-list
24473539|NCT00403247|Vitamin B Complex|vitamin b complex|mesh-ancestor
24473540|NCT00403247|Hematinics|hematinics|mesh-ancestor
24473541|NCT00403286|Fluticasone|fluticasone|mesh-list
24473543|NCT00403286|Formoterol Fumarate|formoterol fumarate|mesh-list
24473544|NCT00403286|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24838846|NCT02200718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838848|NCT02200757|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24838849|NCT02200757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24838850|NCT02200757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24838851|NCT02200757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24838852|NCT02200757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24838853|NCT02200822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
24838855|NCT02200822|Adrenergic Agents|adrenergic agents|mesh-ancestor
24473574|NCT00403325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473577|NCT00403338|Sirolimus|sirolimus|mesh-list
24838898|NCT02201043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24838899|NCT02201043|Leprostatic Agents|leprostatic agents|mesh-ancestor
25711912|NCT02308748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25711913|NCT02308748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711914|NCT02308748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25711915|NCT02308748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25711916|NCT02308748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25711917|NCT02308748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25711918|NCT02308748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711919|NCT02308748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24838907|NCT02201043|Antifungal Agents|antifungal agents|mesh-ancestor
24838909|NCT02201082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24838910|NCT02201082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24839121|NCT02202239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24839122|NCT02202239|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24839123|NCT02202239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24839124|NCT02202239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24839125|NCT02202239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24839126|NCT02202239|GABA Modulators|gaba modulators|mesh-ancestor
24839127|NCT02202239|GABA Agents|gaba agents|mesh-ancestor
24839128|NCT02202239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24839129|NCT02202239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839130|NCT02202239|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24839131|NCT02202239|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24839134|NCT02202304|Chlorhexidine|chlorhexidine|mesh-list
24839216|NCT02202720|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24839217|NCT02202720|Anesthetics, General|anesthetics, general|mesh-ancestor
24839218|NCT02202720|Anesthetics|anesthetics|mesh-ancestor
24839221|NCT02202889|Calcium|calcium|mesh-list
24839262|NCT02203175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24839263|NCT02203175|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24839264|NCT02203227|Turmeric extract|turmeric extract|mesh-list
24839265|NCT02203227|Antioxidants|antioxidants|mesh-ancestor
24839266|NCT02203227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839267|NCT02203227|Protective Agents|protective agents|mesh-ancestor
24839268|NCT02203227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839269|NCT02203253|Thalidomide|thalidomide|mesh-list
24839270|NCT02203253|Dexamethasone|dexamethasone|mesh-list
24839271|NCT02203253|Palonosetron|palonosetron|mesh-list
24839272|NCT02203253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24839273|NCT02203253|Antiemetics|antiemetics|mesh-ancestor
24839274|NCT02203253|Autonomic Agents|autonomic agents|mesh-ancestor
24839275|NCT02203253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24839276|NCT02203253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839277|NCT02203253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24839278|NCT02203253|Glucocorticoids|glucocorticoids|mesh-ancestor
24839394|NCT02203643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24839395|NCT02203643|Antiemetics|antiemetics|mesh-ancestor
24839396|NCT02203643|Autonomic Agents|autonomic agents|mesh-ancestor
24839397|NCT02203643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24839398|NCT02203643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24839399|NCT02203643|Glucocorticoids|glucocorticoids|mesh-ancestor
24839400|NCT02203643|Hormones|hormones|mesh-ancestor
24839402|NCT02203643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24839455|NCT02204501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24839456|NCT02204501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24839457|NCT02204501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24839458|NCT02204501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24839459|NCT02204501|Anesthetics, General|anesthetics, general|mesh-ancestor
24839460|NCT02204501|Anesthetics|anesthetics|mesh-ancestor
24839461|NCT02204501|GABA Modulators|gaba modulators|mesh-ancestor
24839483|NCT02204644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839484|NCT02204683|Aflibercept|aflibercept|mesh-list
24839485|NCT02204683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24839534|NCT02205112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24839535|NCT02205151|Amlodipine|amlodipine|mesh-list
24839536|NCT02205151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24839537|NCT02205151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24839610|NCT02205489|Antiviral Agents|antiviral agents|mesh-ancestor
24839730|NCT02205931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24839731|NCT02205931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24839732|NCT02205931|GABA Modulators|gaba modulators|mesh-ancestor
24839733|NCT02205931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24839734|NCT02205931|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24839735|NCT02205931|GABA Agonists|gaba agonists|mesh-ancestor
24839740|NCT02205996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839741|NCT02206022|Remifentanil|remifentanil|mesh-list
24839742|NCT02206022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24839743|NCT02206022|Narcotics|narcotics|mesh-ancestor
24839744|NCT02206022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24839745|NCT02206022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839746|NCT02206022|Analgesics|analgesics|mesh-ancestor
24839747|NCT02206022|Sensory System Agents|sensory system agents|mesh-ancestor
24839748|NCT02206022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24839802|NCT02206204|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24839803|NCT02206204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24839804|NCT02206204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24839805|NCT02206204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24839806|NCT02206204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24839807|NCT02206204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24839808|NCT02206204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24839899|NCT02206503|Antiemetics|antiemetics|mesh-ancestor
24839900|NCT02206503|Autonomic Agents|autonomic agents|mesh-ancestor
24839901|NCT02206503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24839902|NCT02206503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24839903|NCT02206503|Glucocorticoids|glucocorticoids|mesh-ancestor
24839904|NCT02206503|Hormones|hormones|mesh-ancestor
24839905|NCT02206503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24839906|NCT02206503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24839907|NCT02206503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24839908|NCT02206503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24839909|NCT02206503|Growth Substances|growth substances|mesh-ancestor
24839910|NCT02206503|Growth Inhibitors|growth inhibitors|mesh-ancestor
24839911|NCT02206555|Tenofovir|tenofovir|mesh-list
24839912|NCT02206555|Emtricitabine|emtricitabine|mesh-list
25404038|NCT03686124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711920|NCT02308748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25711921|NCT02308748|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25711922|NCT02308748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25711923|NCT02308748|Vasodilator Agents|vasodilator agents|mesh-ancestor
25711924|NCT02308748|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25711925|NCT02309359|Methotrexate|methotrexate|mesh-list
25711926|NCT02309359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25711927|NCT02309359|Abortifacient Agents|abortifacient agents|mesh-ancestor
25711928|NCT02309359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25711929|NCT02309359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24839913|NCT02206555|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24839914|NCT02206555|Antiviral Agents|antiviral agents|mesh-ancestor
24839915|NCT02206555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24839916|NCT02206555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24839997|NCT02206815|Sensory System Agents|sensory system agents|mesh-ancestor
24840712|NCT02211976|Cathartics|cathartics|mesh-ancestor
24839998|NCT02206815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24897693|NCT04423276|Cholinergic Agents|cholinergic agents|mesh-ancestor
24839999|NCT02206815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840000|NCT02206815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24840001|NCT02206815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24840002|NCT02206815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24840003|NCT02206815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24840004|NCT02206815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840005|NCT02206815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24840006|NCT02206815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24840007|NCT02206815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840008|NCT02206815|Antipyretics|antipyretics|mesh-ancestor
24840009|NCT02206815|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24840010|NCT02206815|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24840011|NCT02206815|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24840012|NCT02206815|Purinergic Agents|purinergic agents|mesh-ancestor
24840013|NCT02206815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24840014|NCT02206815|Anticoagulants|anticoagulants|mesh-ancestor
24840015|NCT02206854|Flurbiprofen|flurbiprofen|mesh-list
24840016|NCT02206854|Analgesics|analgesics|mesh-ancestor
24840017|NCT02206854|Sensory System Agents|sensory system agents|mesh-ancestor
24840018|NCT02206854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24840019|NCT02206854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840039|NCT02207010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840041|NCT02207335|Carboplatin|carboplatin|mesh-list
24840043|NCT02207335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24840053|NCT02207348|Liraglutide|liraglutide|mesh-list
24840063|NCT02207361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24840064|NCT02207361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24840065|NCT02207361|Tubulin Modulators|tubulin modulators|mesh-ancestor
24840066|NCT02207361|Antimitotic Agents|antimitotic agents|mesh-ancestor
24840070|NCT02207361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24840071|NCT02207361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24840080|NCT02207426|Tobramycin|tobramycin|mesh-list
24840088|NCT02207439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840089|NCT02207439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24840090|NCT02207439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24840091|NCT02207439|Antiviral Agents|antiviral agents|mesh-ancestor
24840092|NCT02207439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24840093|NCT02207452|Albuterol|albuterol|mesh-list
24840094|NCT02207452|Ipratropium|ipratropium|mesh-list
24840095|NCT02207452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24840181|NCT02208427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24840183|NCT02208492|Levetiracetam|levetiracetam|mesh-list
24840184|NCT02208492|Anticonvulsants|anticonvulsants|mesh-ancestor
24840185|NCT02208492|Nootropic Agents|nootropic agents|mesh-ancestor
24840186|NCT02208505|Dexmedetomidine|dexmedetomidine|mesh-list
24840187|NCT02208505|Remifentanil|remifentanil|mesh-list
24840188|NCT02208505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24840189|NCT02208505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24840190|NCT02208505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840191|NCT02208505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24840192|NCT02208505|Analgesics|analgesics|mesh-ancestor
24840193|NCT02208505|Sensory System Agents|sensory system agents|mesh-ancestor
25711930|NCT02309359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24840194|NCT02208505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24840195|NCT02208505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24840196|NCT02208505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25711931|NCT02309359|Antimetabolites|antimetabolites|mesh-ancestor
25770781|NCT03567382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25770782|NCT03567616|Dexamethasone|dexamethasone|mesh-list
25770783|NCT03567616|Venetoclax|venetoclax|mesh-list
25770784|NCT03567616|Pomalidomide|pomalidomide|mesh-list
25770785|NCT03567616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25770786|NCT03567616|Antiemetics|antiemetics|mesh-ancestor
25770787|NCT03567616|Autonomic Agents|autonomic agents|mesh-ancestor
25770788|NCT03567616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24840227|NCT02208596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24840275|NCT02208882|Anesthetics, General|anesthetics, general|mesh-ancestor
24840276|NCT02208882|Anesthetics|anesthetics|mesh-ancestor
24840277|NCT02208882|GABA Modulators|gaba modulators|mesh-ancestor
24840278|NCT02208882|GABA Agents|gaba agents|mesh-ancestor
24840367|NCT02209740|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24840368|NCT02209740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24840369|NCT02209740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840370|NCT02209740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840371|NCT02209740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24840390|NCT02209909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840391|NCT02209909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24840392|NCT02209909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24840393|NCT02209909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840395|NCT02209974|Fluticasone|fluticasone|mesh-list
24840396|NCT02209974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24840397|NCT02209974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24840398|NCT02209974|Autonomic Agents|autonomic agents|mesh-ancestor
24840399|NCT02209974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24840400|NCT02209974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840401|NCT02209974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24840402|NCT02209974|Respiratory System Agents|respiratory system agents|mesh-ancestor
24840403|NCT02209974|Dermatologic Agents|dermatologic agents|mesh-ancestor
24840441|NCT02210169|Vancomycin|vancomycin|mesh-list
24840491|NCT02210702|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24840492|NCT02210702|Contraceptive Agents|contraceptive agents|mesh-ancestor
24840493|NCT02210702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24840494|NCT02210702|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24840495|NCT02210702|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24840496|NCT02210702|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24840497|NCT02210702|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24840498|NCT02210715|Raltegravir Potassium|raltegravir potassium|mesh-list
24840499|NCT02210715|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24840500|NCT02210715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24840501|NCT02210715|Antiviral Agents|antiviral agents|mesh-ancestor
24840502|NCT02210715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24840503|NCT02210715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24840504|NCT02210715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24840505|NCT02210715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840537|NCT02210754|Dermatologic Agents|dermatologic agents|mesh-ancestor
24840538|NCT02210754|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24840539|NCT02210754|Protective Agents|protective agents|mesh-ancestor
24840540|NCT02210819|Rivaroxaban|rivaroxaban|mesh-list
24840541|NCT02210819|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24840542|NCT02210819|Antithrombins|antithrombins|mesh-ancestor
24840543|NCT02210819|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24840709|NCT02211950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24840710|NCT02211950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840711|NCT02211976|Bisacodyl|bisacodyl|mesh-list
24840713|NCT02211976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24840714|NCT02211976|Laxatives|laxatives|mesh-ancestor
24840715|NCT02212119|Botulinum Toxins|botulinum toxins|mesh-list
24840716|NCT02212119|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24840717|NCT02212119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24840718|NCT02212119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840719|NCT02212119|Cholinergic Agents|cholinergic agents|mesh-ancestor
24840720|NCT02212119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24840721|NCT02212119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600203|NCT01696734|Domperidone|domperidone|mesh-list
24840722|NCT02212210|Methylprednisolone|methylprednisolone|mesh-list
24840723|NCT02212210|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24840859|NCT02212821|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24840860|NCT02212821|Erythromycin stearate|erythromycin stearate|mesh-list
24842401|NCT02220868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24840888|NCT02213081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24840889|NCT02213081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840890|NCT02213081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24753437|NCT01715363|Antidotes|antidotes|mesh-ancestor
24840950|NCT02213302|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24840951|NCT02213302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24840952|NCT02213302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24840953|NCT02213302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24840954|NCT02213302|Anesthetics, General|anesthetics, general|mesh-ancestor
24840955|NCT02213302|Anesthetics|anesthetics|mesh-ancestor
24840956|NCT02213302|GABA Modulators|gaba modulators|mesh-ancestor
24840957|NCT02213302|GABA Agents|gaba agents|mesh-ancestor
24840958|NCT02213302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24840959|NCT02213302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24840964|NCT02213315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24840965|NCT02213328|Tenofovir|tenofovir|mesh-list
24840966|NCT02213328|Emtricitabine|emtricitabine|mesh-list
24840967|NCT02213328|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24840968|NCT02213328|Antiviral Agents|antiviral agents|mesh-ancestor
24840969|NCT02213328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24840970|NCT02213328|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24840971|NCT02213328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24840972|NCT02213328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24840976|NCT02213419|Ethanol|ethanol|mesh-list
24841080|NCT02213913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25711932|NCT02309359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711933|NCT02309359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25711934|NCT02309359|Dermatologic Agents|dermatologic agents|mesh-ancestor
24841081|NCT02213913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24841082|NCT02213913|Alkylating Agents|alkylating agents|mesh-ancestor
24841083|NCT02213913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841084|NCT02213913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841085|NCT02213913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24841086|NCT02213913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24841090|NCT02213913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841091|NCT02213913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24841094|NCT02213913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24841095|NCT02213913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24864669|NCT02841215|Ivermectin|ivermectin|mesh-list
24841096|NCT02213913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24841097|NCT02213913|Tubulin Modulators|tubulin modulators|mesh-ancestor
24841098|NCT02213913|Antimitotic Agents|antimitotic agents|mesh-ancestor
24841108|NCT02214004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24841109|NCT02214004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24841160|NCT02214498|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24841161|NCT02214498|Protease Inhibitors|protease inhibitors|mesh-ancestor
24841162|NCT02214498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841163|NCT02214563|Vitamin D|vitamin d|mesh-list
24841164|NCT02214563|Ergocalciferols|ergocalciferols|mesh-list
24841170|NCT02214563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24841173|NCT02214602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24841174|NCT02214602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841175|NCT02214602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24841263|NCT02215057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24841274|NCT02215096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24841275|NCT02215096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841276|NCT02215096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841278|NCT02215148|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24841279|NCT02215148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24600845|NCT00960830|Histamine Agents|histamine agents|mesh-ancestor
24841384|NCT02215538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24841385|NCT02215538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24841386|NCT02215538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841387|NCT02215538|Dopamine Agents|dopamine agents|mesh-ancestor
24841388|NCT02215538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24841389|NCT02215720|Sirolimus|sirolimus|mesh-list
24841390|NCT02215720|Cetuximab|cetuximab|mesh-list
24841391|NCT02215720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24841392|NCT02215720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841419|NCT02215798|Analgesics|analgesics|mesh-ancestor
24841518|NCT02216331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24841519|NCT02216331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841520|NCT02216331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841521|NCT02216331|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24841522|NCT02216331|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24841523|NCT02216331|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24841524|NCT02216331|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24841525|NCT02216331|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24841526|NCT02216331|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24841528|NCT02216383|Carbetocin|carbetocin|mesh-list
24841533|NCT02216383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841534|NCT02216409|Magrolimab|magrolimab|mesh-list
24841535|NCT02216409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24841536|NCT02216409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841623|NCT02217020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24841624|NCT02217020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841625|NCT02217163|Dexamethasone|dexamethasone|mesh-list
24841626|NCT02217163|Cyclophosphamide|cyclophosphamide|mesh-list
25711935|NCT02309359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711936|NCT02309359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25711937|NCT02309359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24841634|NCT02217163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841678|NCT02217514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24841679|NCT02217514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24841681|NCT02217514|Anesthetics|anesthetics|mesh-ancestor
24841737|NCT02217722|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24841738|NCT02217722|Amoxicillin|amoxicillin|mesh-list
24841739|NCT02217722|Metronidazole|metronidazole|mesh-list
24841740|NCT02217722|Doxycycline|doxycycline|mesh-list
24841741|NCT02217722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24841742|NCT02217722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24841743|NCT02217722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24841744|NCT02217722|Antimalarials|antimalarials|mesh-ancestor
24841793|NCT02218021|Narcotics|narcotics|mesh-ancestor
24841794|NCT02218021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24841795|NCT02218021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841796|NCT02218021|Analgesics|analgesics|mesh-ancestor
24841797|NCT02218021|Sensory System Agents|sensory system agents|mesh-ancestor
24841799|NCT02218034|Nicotinic Acids|nicotinic acids|mesh-list
24841820|NCT02218177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841821|NCT02218177|Growth Inhibitors|growth inhibitors|mesh-ancestor
24841822|NCT02218177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24841824|NCT02218359|Fosfomycin|fosfomycin|mesh-list
24841825|NCT02218359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24841826|NCT02218359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24841827|NCT02218359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24841828|NCT02218398|Albuterol|albuterol|mesh-list
24841829|NCT02218398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24841830|NCT02218398|Autonomic Agents|autonomic agents|mesh-ancestor
24841831|NCT02218398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24841832|NCT02218398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841833|NCT02218398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24841834|NCT02218398|Respiratory System Agents|respiratory system agents|mesh-ancestor
24841835|NCT02218398|Tocolytic Agents|tocolytic agents|mesh-ancestor
24841836|NCT02218398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24841839|NCT02218398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24841855|NCT02218645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841856|NCT02218658|Brotizolam|brotizolam|mesh-list
24841857|NCT02218658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24841858|NCT02218658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24841859|NCT02218658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841860|NCT02218671|Brotizolam|brotizolam|mesh-list
24841861|NCT02218671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24841862|NCT02218671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24841864|NCT02218684|Telmisartan|telmisartan|mesh-list
25404039|NCT03685773|Niacin|niacin|mesh-list
25711938|NCT02309359|Immunologic Factors|immunologic factors|mesh-ancestor
24841934|NCT02219100|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24841936|NCT02219152|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24841937|NCT02219152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24841938|NCT02219152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24841939|NCT02219152|Hemostatics|hemostatics|mesh-ancestor
24841940|NCT02219152|Coagulants|coagulants|mesh-ancestor
24841941|NCT02219165|Immunoglobulins|immunoglobulins|mesh-list
24841942|NCT02219165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24841943|NCT02219165|Antibodies|antibodies|mesh-list
24841944|NCT02219165|Immunologic Factors|immunologic factors|mesh-ancestor
24841945|NCT02219165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841946|NCT02219178|Dexamethasone|dexamethasone|mesh-list
24841947|NCT02219178|Lenalidomide|lenalidomide|mesh-list
24841948|NCT02219178|Bortezomib|bortezomib|mesh-list
24841949|NCT02219178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24841950|NCT02219178|Antiemetics|antiemetics|mesh-ancestor
24841951|NCT02219178|Autonomic Agents|autonomic agents|mesh-ancestor
24841952|NCT02219178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24841953|NCT02219178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24841954|NCT02219178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24841955|NCT02219178|Glucocorticoids|glucocorticoids|mesh-ancestor
24841956|NCT02219178|Hormones|hormones|mesh-ancestor
24841957|NCT02219178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24841970|NCT02219191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842011|NCT02219412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24842012|NCT02219412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24842013|NCT02219412|Analgesics|analgesics|mesh-ancestor
24842017|NCT02219412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24842018|NCT02219412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24842019|NCT02219412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24842020|NCT02219412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24842021|NCT02219412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842022|NCT02219412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24842023|NCT02219412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24842027|NCT02219412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24842028|NCT02219412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24842029|NCT02219412|Purinergic Agents|purinergic agents|mesh-ancestor
24865486|NCT02023996|Trastuzumab|trastuzumab|mesh-list
24842030|NCT02219412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24842032|NCT02219490|Antimetabolites|antimetabolites|mesh-ancestor
24842033|NCT02219490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842116|NCT02219737|Isophosphamide mustard|isophosphamide mustard|mesh-list
24842117|NCT02219737|Podophyllotoxin|podophyllotoxin|mesh-list
24842118|NCT02219737|Antibodies|antibodies|mesh-list
24842119|NCT02219737|Immunoglobulins|immunoglobulins|mesh-list
24842120|NCT02219737|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24842121|NCT02219737|Immunologic Factors|immunologic factors|mesh-ancestor
24842122|NCT02219737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842123|NCT02219737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24842124|NCT02219737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24842125|NCT02219737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24842126|NCT02219737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24842127|NCT02219737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24842128|NCT02219737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24842129|NCT02219737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842130|NCT02219737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25711939|NCT02309359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24842250|NCT02220335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711940|NCT02309359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25711941|NCT02309411|Rivaroxaban|rivaroxaban|mesh-list
25711942|NCT02309411|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25711943|NCT02309411|Antithrombins|antithrombins|mesh-ancestor
25711944|NCT02309411|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25711945|NCT02309411|Protease Inhibitors|protease inhibitors|mesh-ancestor
24842260|NCT02220348|Enzyme Activators|enzyme activators|mesh-ancestor
24842261|NCT02220348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842262|NCT02220348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24842263|NCT02220361|Dexmedetomidine|dexmedetomidine|mesh-list
24842353|NCT02220660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24842398|NCT02220868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842399|NCT02220868|Antiviral Agents|antiviral agents|mesh-ancestor
24842400|NCT02220868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24842415|NCT02221102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24842416|NCT02221102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842417|NCT02221102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24842418|NCT02221102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24842419|NCT02221102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24842435|NCT02221154|Micronutrients|micronutrients|mesh-ancestor
24842436|NCT02221154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842439|NCT02221180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24842440|NCT02221180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842441|NCT02221180|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24842443|NCT02221323|Insulin Lispro|insulin lispro|mesh-list
24842486|NCT02221453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842487|NCT02221479|Plerixafor|plerixafor|mesh-list
24842488|NCT02221479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24842489|NCT02221479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24842490|NCT02221479|Antiviral Agents|antiviral agents|mesh-ancestor
24842491|NCT02221479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24842492|NCT02221492|Plerixafor|plerixafor|mesh-list
24842493|NCT02221492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24842537|NCT02221635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24842538|NCT02221635|Serotonin Agents|serotonin agents|mesh-ancestor
24842539|NCT02221635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24842540|NCT02221635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24842546|NCT02221635|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24842547|NCT02221635|Dopamine Agents|dopamine agents|mesh-ancestor
24842548|NCT02221752|Folic Acid|folic acid|mesh-list
24842549|NCT02221752|Vitamin B Complex|vitamin b complex|mesh-list
24842550|NCT02221752|Hematinics|hematinics|mesh-ancestor
24842551|NCT02221752|Vitamins|vitamins|mesh-ancestor
25711946|NCT02309411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25711947|NCT02309411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711948|NCT02309411|Anticoagulants|anticoagulants|mesh-ancestor
25711949|NCT02309515|Lenalidomide|lenalidomide|mesh-list
25711950|NCT02309515|Vaccines|vaccines|mesh-list
25711951|NCT02309515|Immunologic Factors|immunologic factors|mesh-ancestor
25711952|NCT02309515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711953|NCT02309515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24842560|NCT02221830|Oxytocics|oxytocics|mesh-ancestor
24842561|NCT02221830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24842562|NCT02221830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842627|NCT02222428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24842642|NCT02222441|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24842643|NCT02222441|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24842644|NCT02222480|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24842645|NCT02222480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24842646|NCT02222480|Diuretics|diuretics|mesh-ancestor
24842647|NCT02222480|Natriuretic Agents|natriuretic agents|mesh-ancestor
24842648|NCT02222480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842649|NCT02222480|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24842653|NCT02222519|Rocuronium|rocuronium|mesh-list
24842735|NCT02223052|Antimetabolites|antimetabolites|mesh-ancestor
24842761|NCT02223533|Analgesics|analgesics|mesh-ancestor
24842762|NCT02223533|Sensory System Agents|sensory system agents|mesh-ancestor
24842763|NCT02223533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24842764|NCT02223598|Dexamethasone|dexamethasone|mesh-list
24842765|NCT02223598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24842766|NCT02223598|Antiemetics|antiemetics|mesh-ancestor
24842767|NCT02223598|Autonomic Agents|autonomic agents|mesh-ancestor
24842768|NCT02223598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24842769|NCT02223598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24842770|NCT02223598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24842771|NCT02223598|Glucocorticoids|glucocorticoids|mesh-ancestor
24842772|NCT02223598|Hormones|hormones|mesh-ancestor
24842773|NCT02223598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24842774|NCT02223598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24842775|NCT02223598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24842776|NCT02223611|Cisplatin|cisplatin|mesh-list
24842777|NCT02223611|Vinorelbine|vinorelbine|mesh-list
24842778|NCT02223611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24842779|NCT02223611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24842780|NCT02223611|Tubulin Modulators|tubulin modulators|mesh-ancestor
24842793|NCT02223832|Immunologic Factors|immunologic factors|mesh-ancestor
24842796|NCT02223884|Docetaxel|docetaxel|mesh-list
24842841|NCT02224105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24842842|NCT02224105|Prednisolone acetate|prednisolone acetate|mesh-list
24842843|NCT02224105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24842844|NCT02224105|Prednisolone phosphate|prednisolone phosphate|mesh-list
24842845|NCT02224105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24842846|NCT02224105|Glucocorticoids|glucocorticoids|mesh-ancestor
25711958|NCT02310568|PF-06372865|pf-06372865|mesh-list
25711959|NCT02310568|GABA Modulators|gaba modulators|mesh-ancestor
25711960|NCT02310568|GABA Agents|gaba agents|mesh-ancestor
25711961|NCT02310568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25711962|NCT02310568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843067|NCT02225418|Ropivacaine|ropivacaine|mesh-list
24843068|NCT02225418|Anesthetics, Local|anesthetics, local|mesh-ancestor
24843069|NCT02225418|Anesthetics|anesthetics|mesh-ancestor
24843070|NCT02225418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24843071|NCT02225418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843107|NCT02225652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24843108|NCT02225652|Immunologic Factors|immunologic factors|mesh-ancestor
24843109|NCT02225652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843110|NCT02225652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24843162|NCT02225886|Micronutrients|micronutrients|mesh-ancestor
24843163|NCT02225977|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24843164|NCT02225977|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24843165|NCT02225977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843166|NCT02225977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24843167|NCT02225977|Immunologic Factors|immunologic factors|mesh-ancestor
24843203|NCT02226289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24843204|NCT02226289|Growth Substances|growth substances|mesh-ancestor
24843205|NCT02226289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843206|NCT02226289|Growth Inhibitors|growth inhibitors|mesh-ancestor
24843208|NCT02226328|Midazolam|midazolam|mesh-list
24843209|NCT02226328|Propofol|propofol|mesh-list
24843210|NCT02226328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24843211|NCT02226328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24843257|NCT02226510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24866206|NCT03030222|Empagliflozin|empagliflozin|mesh-list
24843258|NCT02226510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843259|NCT02226588|Misoprostol|misoprostol|mesh-list
24843260|NCT02226588|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25711966|NCT02310581|Narcotics|narcotics|mesh-ancestor
25711967|NCT02310581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25711968|NCT02310581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25711969|NCT02310581|Analgesics|analgesics|mesh-ancestor
25711970|NCT02310581|Sensory System Agents|sensory system agents|mesh-ancestor
24843273|NCT02226601|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24843320|NCT02226926|Sensory System Agents|sensory system agents|mesh-ancestor
24843334|NCT02226978|Ritonavir|ritonavir|mesh-list
24843335|NCT02226978|Tipranavir|tipranavir|mesh-list
24843336|NCT02226978|Valacyclovir|valacyclovir|mesh-list
24843337|NCT02226978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24843338|NCT02226978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24843339|NCT02226978|Protease Inhibitors|protease inhibitors|mesh-ancestor
24843340|NCT02226978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24843342|NCT02226978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24843353|NCT02226991|Protease Inhibitors|protease inhibitors|mesh-ancestor
24843354|NCT02226991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24843355|NCT02226991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843425|NCT02227420|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24843483|NCT02227901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24843515|NCT02228005|Sertraline|sertraline|mesh-list
24843516|NCT02228005|Antidepressive Agents|antidepressive agents|mesh-ancestor
24843518|NCT02228005|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24843519|NCT02228005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24843520|NCT02228005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24843521|NCT02228005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843522|NCT02228005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24843564|NCT02228135|Glucocorticoids|glucocorticoids|mesh-ancestor
24843573|NCT02228239|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25711974|NCT02310672|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25711975|NCT02310672|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25711976|NCT02310672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711977|NCT02310672|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25711978|NCT02310750|PF-06700841|pf-06700841|mesh-list
25711979|NCT02310750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25711980|NCT02310750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404040|NCT03685773|Nicotinic Acids|nicotinic acids|mesh-list
25711981|NCT02310750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25711983|NCT02310789|Pilocarpine|pilocarpine|mesh-list
24843574|NCT02228239|Histamine Antagonists|histamine antagonists|mesh-ancestor
24843575|NCT02228239|Histamine Agents|histamine agents|mesh-ancestor
24843576|NCT02228239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24843577|NCT02228239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843578|NCT02228239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843579|NCT02228239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24843580|NCT02228239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24843590|NCT02228252|Caseins|caseins|mesh-list
24843618|NCT02228512|Rituximab|rituximab|mesh-list
24843629|NCT02228512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603608|NCT00974753|Sensory System Agents|sensory system agents|mesh-ancestor
24843631|NCT02228512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24843632|NCT02228512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24843633|NCT02228512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24843634|NCT02228512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24843635|NCT02228512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24843636|NCT02228512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24452587|NCT05458089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452589|NCT05458076|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24452590|NCT05458076|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24452591|NCT05458076|Protease Inhibitors|protease inhibitors|mesh-ancestor
24452592|NCT05458076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24452593|NCT05458076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452594|NCT05458076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24843640|NCT02228512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24843641|NCT02228512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24843642|NCT02228512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24843643|NCT02228512|Tubulin Modulators|tubulin modulators|mesh-ancestor
24843644|NCT02228512|Antimitotic Agents|antimitotic agents|mesh-ancestor
24843649|NCT02228512|Growth Inhibitors|growth inhibitors|mesh-ancestor
24843650|NCT02228616|Lactulose|lactulose|mesh-list
24843651|NCT02228616|Prucalopride|prucalopride|mesh-list
24843667|NCT02228772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24843668|NCT02228772|Immunologic Factors|immunologic factors|mesh-ancestor
24843669|NCT02228772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843670|NCT02228772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24843672|NCT02228772|Alkylating Agents|alkylating agents|mesh-ancestor
24843689|NCT02228772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24843690|NCT02228772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24843691|NCT02228772|Tubulin Modulators|tubulin modulators|mesh-ancestor
24843692|NCT02228772|Antimitotic Agents|antimitotic agents|mesh-ancestor
24843693|NCT02228772|Mitosis Modulators|mitosis modulators|mesh-ancestor
24843694|NCT02228772|Protease Inhibitors|protease inhibitors|mesh-ancestor
24843695|NCT02228850|Alprostadil|alprostadil|mesh-list
24843696|NCT02228850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24843697|NCT02228850|Vasodilator Agents|vasodilator agents|mesh-ancestor
24843698|NCT02228850|Urological Agents|urological agents|mesh-ancestor
24843699|NCT02228863|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24843700|NCT02228863|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24843744|NCT02229175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24843746|NCT02229175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843747|NCT02229175|Growth Inhibitors|growth inhibitors|mesh-ancestor
24843748|NCT02229201|Propofol|propofol|mesh-list
24843749|NCT02229201|Sevoflurane|sevoflurane|mesh-list
24843750|NCT02229201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24843751|NCT02229201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25711984|NCT02310789|Adrenergic Agents|adrenergic agents|mesh-list
25711985|NCT02310789|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25711986|NCT02310789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25711987|NCT02310789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843928|NCT02230033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24843929|NCT02230033|Antimetabolites|antimetabolites|mesh-ancestor
24843930|NCT02230033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24843931|NCT02230033|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24843932|NCT02230046|Abiraterone Acetate|abiraterone acetate|mesh-list
24843933|NCT02230046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843934|NCT02230046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24843935|NCT02230046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24843936|NCT02230046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843981|NCT02230371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24843982|NCT02230371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24843983|NCT02230371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24843984|NCT02230371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24843985|NCT02230371|Serotonin Agents|serotonin agents|mesh-ancestor
24843986|NCT02230371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24843990|NCT02230553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24843991|NCT02230553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24843992|NCT02230553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24843993|NCT02230553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24843994|NCT02230618|Insulin|insulin|mesh-list
24843995|NCT02230618|Insulin Aspart|insulin aspart|mesh-list
25711988|NCT02310789|Miotics|miotics|mesh-ancestor
24844045|NCT02230982|Nintedanib|nintedanib|mesh-list
24844046|NCT02230982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24844047|NCT02230982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24844048|NCT02230982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24844049|NCT02230982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844079|NCT02231255|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24844080|NCT02231255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24844081|NCT02231255|Dopamine Agonists|dopamine agonists|mesh-ancestor
24844082|NCT02231255|Dopamine Agents|dopamine agents|mesh-ancestor
24844083|NCT02231255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24844085|NCT02231281|Lopinavir|lopinavir|mesh-list
24844087|NCT02231281|Lamivudine|lamivudine|mesh-list
24844088|NCT02231281|Zidovudine|zidovudine|mesh-list
24844089|NCT02231281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24844090|NCT02231281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24844091|NCT02231281|Protease Inhibitors|protease inhibitors|mesh-ancestor
24844092|NCT02231281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24844093|NCT02231281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844178|NCT02231606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844179|NCT02231606|Sympathomimetics|sympathomimetics|mesh-ancestor
24844180|NCT02231606|Autonomic Agents|autonomic agents|mesh-ancestor
24844181|NCT02231606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24844185|NCT02231606|Adrenergic Agents|adrenergic agents|mesh-ancestor
24844186|NCT02231606|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24844187|NCT02231606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24844188|NCT02231606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24844189|NCT02231606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24844191|NCT02231632|Immunologic Factors|immunologic factors|mesh-ancestor
24844192|NCT02231632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844193|NCT02231658|Liraglutide|liraglutide|mesh-list
24844194|NCT02231658|Lixisenatide|lixisenatide|mesh-list
24844277|NCT02232139|Midazolam|midazolam|mesh-list
24844282|NCT02232139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24844283|NCT02232139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24844284|NCT02232139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24844285|NCT02232139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24844286|NCT02232139|Anesthetics, General|anesthetics, general|mesh-ancestor
24844287|NCT02232139|Anesthetics|anesthetics|mesh-ancestor
24844470|NCT02232789|Serotonin Agents|serotonin agents|mesh-ancestor
24844592|NCT02233387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844594|NCT02233400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24844595|NCT02233400|Analgesics|analgesics|mesh-ancestor
24844596|NCT02233400|Sensory System Agents|sensory system agents|mesh-ancestor
24844597|NCT02233400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24844598|NCT02233400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844599|NCT02233400|Antipyretics|antipyretics|mesh-ancestor
24844600|NCT02233439|Galactogogues|galactogogues|mesh-list
24844601|NCT02233439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844602|NCT02233452|Ketamine|ketamine|mesh-list
24844603|NCT02233452|Methadone|methadone|mesh-list
24844604|NCT02233452|Analgesics|analgesics|mesh-ancestor
24844605|NCT02233452|Sensory System Agents|sensory system agents|mesh-ancestor
24844606|NCT02233452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24844607|NCT02233452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25404041|NCT03685773|Niacinamide|niacinamide|mesh-list
25711994|NCT02310789|Cholinergic Agents|cholinergic agents|mesh-ancestor
25711995|NCT02310789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25711996|NCT02311361|Durvalumab|durvalumab|mesh-list
25711997|NCT02311361|Tremelimumab|tremelimumab|mesh-list
24844756|NCT02234193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844758|NCT02234193|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24844759|NCT02234193|Adrenergic Agents|adrenergic agents|mesh-ancestor
24844760|NCT02234193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24844761|NCT02234193|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24844762|NCT02234193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24844763|NCT02234193|Autonomic Agents|autonomic agents|mesh-ancestor
24844836|NCT02234843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24844837|NCT02234843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844840|NCT02234869|Interferon-beta|interferon-beta|mesh-list
24844841|NCT02234869|Interferon beta-1a|interferon beta-1a|mesh-list
24844842|NCT02234869|Interferon beta-1b|interferon beta-1b|mesh-list
24604960|NCT00982566|Navitoclax|navitoclax|mesh-list
24844857|NCT02234882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24844858|NCT02234882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24844859|NCT02234882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24844860|NCT02234882|Antiviral Agents|antiviral agents|mesh-ancestor
24844861|NCT02234882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24844862|NCT02234882|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24844864|NCT02234921|Cyclophosphamide|cyclophosphamide|mesh-list
24844896|NCT02235194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844897|NCT02235194|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24844898|NCT02235194|Chelating Agents|chelating agents|mesh-ancestor
24844899|NCT02235194|Sequestering Agents|sequestering agents|mesh-ancestor
24844900|NCT02235194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844901|NCT02235233|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
24844913|NCT02235246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24844914|NCT02235246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24844915|NCT02235246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844916|NCT02235246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24844917|NCT02235246|Tocolytic Agents|tocolytic agents|mesh-ancestor
24844918|NCT02235246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24844920|NCT02235324|Fluorouracil|fluorouracil|mesh-list
24844921|NCT02235324|Aflibercept|aflibercept|mesh-list
24844922|NCT02235324|Calcium|calcium|mesh-list
24844923|NCT02235324|Levoleucovorin|levoleucovorin|mesh-list
25712002|NCT02311881|Analgesics|analgesics|mesh-ancestor
25712003|NCT02311881|Sensory System Agents|sensory system agents|mesh-ancestor
25712004|NCT02311881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25712005|NCT02311881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712006|NCT02311881|Antipyretics|antipyretics|mesh-ancestor
25712007|NCT02311907|Paclitaxel|paclitaxel|mesh-list
24844924|NCT02235324|Endothelial Growth Factors|endothelial growth factors|mesh-list
24844925|NCT02235324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25712008|NCT02311907|Carboplatin|carboplatin|mesh-list
24844927|NCT02235324|Antimetabolites|antimetabolites|mesh-ancestor
24844928|NCT02235324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24844929|NCT02235324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24844931|NCT02235324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24844932|NCT02235324|Immunologic Factors|immunologic factors|mesh-ancestor
24844933|NCT02235324|Antidotes|antidotes|mesh-ancestor
24844934|NCT02235324|Protective Agents|protective agents|mesh-ancestor
24844959|NCT02235402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24844960|NCT02235402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24844962|NCT02235402|Natriuretic Agents|natriuretic agents|mesh-ancestor
24844963|NCT02235402|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24844992|NCT02235480|Dermatologic Agents|dermatologic agents|mesh-ancestor
24844993|NCT02235480|Keratolytic Agents|keratolytic agents|mesh-ancestor
24844994|NCT02235519|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
24844995|NCT02235519|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24844996|NCT02235519|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24845898|NCT02239913|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24844998|NCT02235532|Fluorides|fluorides|mesh-list
24844999|NCT02235532|Cariostatic Agents|cariostatic agents|mesh-ancestor
24845000|NCT02235532|Protective Agents|protective agents|mesh-ancestor
24845001|NCT02235532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845002|NCT02235558|Verapamil|verapamil|mesh-list
24845117|NCT02236169|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24845118|NCT02236169|Cholinergic Agents|cholinergic agents|mesh-ancestor
24845119|NCT02236169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845120|NCT02236169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845121|NCT02236169|Anesthetics|anesthetics|mesh-ancestor
24845122|NCT02236169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24845123|NCT02236182|Bromides|bromides|mesh-list
24845124|NCT02236182|Ipratropium|ipratropium|mesh-list
24845126|NCT02236182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24845136|NCT02236260|Lidocaine|lidocaine|mesh-list
24845263|NCT02237326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24845264|NCT02237326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24845265|NCT02237326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24845266|NCT02237326|Immunologic Factors|immunologic factors|mesh-ancestor
24845267|NCT02237326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845268|NCT02237326|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24845269|NCT02237326|Protective Agents|protective agents|mesh-ancestor
24845270|NCT02237326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24845271|NCT02237326|Hemostatics|hemostatics|mesh-ancestor
24845272|NCT02237326|Coagulants|coagulants|mesh-ancestor
24845273|NCT02237339|Allopurinol|allopurinol|mesh-list
24845274|NCT02237339|Antimetabolites|antimetabolites|mesh-ancestor
24845275|NCT02237339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845276|NCT02237339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24845284|NCT02237365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24845285|NCT02237365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24845286|NCT02237365|Analgesics|analgesics|mesh-ancestor
24845287|NCT02237365|Sensory System Agents|sensory system agents|mesh-ancestor
24845288|NCT02237365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845289|NCT02237365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845290|NCT02237365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24845291|NCT02237365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24845292|NCT02237365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24845293|NCT02237365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24845294|NCT02237365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845295|NCT02237365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24845296|NCT02237365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24845297|NCT02237365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24845298|NCT02237365|Antipyretics|antipyretics|mesh-ancestor
25712009|NCT02311907|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25712010|NCT02311907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25712011|NCT02311907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712012|NCT02311907|Tubulin Modulators|tubulin modulators|mesh-ancestor
25712013|NCT02311907|Antimitotic Agents|antimitotic agents|mesh-ancestor
25712014|NCT02311907|Mitosis Modulators|mitosis modulators|mesh-ancestor
25712015|NCT02311907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845329|NCT02237534|Calcium Carbonate|calcium carbonate|mesh-list
24845330|NCT02237534|Calcium|calcium|mesh-list
24845331|NCT02237534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24845332|NCT02237534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845333|NCT02237534|Antacids|antacids|mesh-ancestor
24845334|NCT02237534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845335|NCT02237534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24845336|NCT02237560|Camphor|camphor|mesh-list
24845337|NCT02237560|Salicylates|salicylates|mesh-list
24845338|NCT02237560|Methyl salicylate|methyl salicylate|mesh-list
24845339|NCT02237560|Menthol|menthol|mesh-list
24845340|NCT02237560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24845341|NCT02237560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24845342|NCT02237560|Antipruritics|antipruritics|mesh-ancestor
24845414|NCT02237924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845415|NCT02237924|Growth Inhibitors|growth inhibitors|mesh-ancestor
24845416|NCT02237924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24845899|NCT02239913|Sympathomimetics|sympathomimetics|mesh-ancestor
24452666|NCT05457855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24452667|NCT05457855|Respiratory System Agents|respiratory system agents|mesh-ancestor
24452668|NCT05457855|Dermatologic Agents|dermatologic agents|mesh-ancestor
24452669|NCT05457855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24845497|NCT02238158|Ipratropium|ipratropium|mesh-list
24845498|NCT02238158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24845499|NCT02238158|Autonomic Agents|autonomic agents|mesh-ancestor
24845500|NCT02238158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845501|NCT02238158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845502|NCT02238158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24845503|NCT02238158|Respiratory System Agents|respiratory system agents|mesh-ancestor
24845504|NCT02238158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24845505|NCT02238158|Cholinergic Agents|cholinergic agents|mesh-ancestor
24845506|NCT02238158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845507|NCT02238158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845508|NCT02238171|Ipratropium|ipratropium|mesh-list
24845509|NCT02238171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24845510|NCT02238171|Autonomic Agents|autonomic agents|mesh-ancestor
24845511|NCT02238171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845512|NCT02238171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845516|NCT02238171|Cholinergic Agents|cholinergic agents|mesh-ancestor
24845544|NCT02238210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24845545|NCT02238210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845546|NCT02238210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24845570|NCT02238288|Sensory System Agents|sensory system agents|mesh-ancestor
24845598|NCT02238314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
25712020|NCT02311933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712021|NCT02311933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25712022|NCT02311933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24845838|NCT02239484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845841|NCT02239523|Diphosphonates|diphosphonates|mesh-list
24845842|NCT02239523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24845843|NCT02239523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24845844|NCT02239523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24845845|NCT02239614|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24845846|NCT02239614|Aluminum sulfate|aluminum sulfate|mesh-list
24845887|NCT02239913|Sensory System Agents|sensory system agents|mesh-ancestor
24845889|NCT02239913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24845890|NCT02239913|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24845891|NCT02239913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24845892|NCT02239913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24845893|NCT02239913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845894|NCT02239913|Dopamine Agents|dopamine agents|mesh-ancestor
24845895|NCT02239913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845896|NCT02239913|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24845897|NCT02239913|Appetite Depressants|appetite depressants|mesh-ancestor
24845904|NCT02239952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24845905|NCT02239952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24845906|NCT02239952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24867738|NCT02555657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24845907|NCT02239952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845908|NCT02239952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24845913|NCT02240017|Gemcitabine|gemcitabine|mesh-list
24845916|NCT02240017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24845917|NCT02240017|Antimetabolites|antimetabolites|mesh-ancestor
24845942|NCT02240173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24845943|NCT02240173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24845944|NCT02240173|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24845960|NCT02240199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24845961|NCT02240199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24845962|NCT02240199|Analgesics|analgesics|mesh-ancestor
24845963|NCT02240199|Anticonvulsants|anticonvulsants|mesh-ancestor
24845964|NCT02240199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24845965|NCT02240199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24845966|NCT02240199|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24845967|NCT02240199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24845968|NCT02240199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24845969|NCT02240212|Paclitaxel|paclitaxel|mesh-list
24845970|NCT02240212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24845993|NCT02240459|Oxybutynin|oxybutynin|mesh-list
24845994|NCT02240459|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24845995|NCT02240459|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24845996|NCT02240459|Cholinergic Agents|cholinergic agents|mesh-ancestor
24845997|NCT02240459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24845998|NCT02240459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846001|NCT02240459|Parasympatholytics|parasympatholytics|mesh-ancestor
24846002|NCT02240459|Autonomic Agents|autonomic agents|mesh-ancestor
24846003|NCT02240459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24846004|NCT02240537|Sargramostim|sargramostim|mesh-list
24846030|NCT02240641|Protease Inhibitors|protease inhibitors|mesh-ancestor
24846031|NCT02240641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24846032|NCT02240641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24846033|NCT02240641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24846034|NCT02240719|Everolimus|everolimus|mesh-list
24846043|NCT02240888|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24846044|NCT02240888|Immunologic Factors|immunologic factors|mesh-ancestor
24846045|NCT02240888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846046|NCT02240927|Enoxaparin|enoxaparin|mesh-list
24846047|NCT02240927|Warfarin|warfarin|mesh-list
24846048|NCT02240927|Enoxaparin sodium|enoxaparin sodium|mesh-list
24846049|NCT02240927|Anticoagulants|anticoagulants|mesh-ancestor
24846050|NCT02240927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24846051|NCT02240927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24846052|NCT02240927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846053|NCT02240953|Warfarin|warfarin|mesh-list
24846054|NCT02240953|Anticoagulants|anticoagulants|mesh-ancestor
24846055|NCT02241018|Antibodies|antibodies|mesh-list
24846056|NCT02241018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24846057|NCT02241018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
24846058|NCT02241018|Immunologic Factors|immunologic factors|mesh-ancestor
24846059|NCT02241018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24846060|NCT02241018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24846061|NCT02241018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24846062|NCT02241031|Oprelvekin|oprelvekin|mesh-list
24846063|NCT02241031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24846064|NCT02241083|Dopamine|dopamine|mesh-list
25404042|NCT03685773|Diazoxide|diazoxide|mesh-list
25770789|NCT03567616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770790|NCT03567616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25770791|NCT03567616|Glucocorticoids|glucocorticoids|mesh-ancestor
24846297|NCT02242292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770793|NCT03567616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25770794|NCT03567616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25770796|NCT03567616|Immunologic Factors|immunologic factors|mesh-ancestor
25770797|NCT03567616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25770798|NCT03567616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25770799|NCT03567616|Growth Substances|growth substances|mesh-ancestor
24847038|NCT02244762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847040|NCT02244762|Sensory System Agents|sensory system agents|mesh-ancestor
24481318|NCT00434031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24632066|NCT01121822|Vaccines|vaccines|mesh-list
24847077|NCT02245022|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24847078|NCT02245126|Lidocaine|lidocaine|mesh-list
24847079|NCT02245126|Bupivacaine|bupivacaine|mesh-list
24632233|NCT01122667|Anacetrapib|anacetrapib|mesh-list
24481595|NCT00435799|Riboflavin|riboflavin|mesh-list
25712077|NCT02312739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25712078|NCT02312739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712079|NCT02312739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25712080|NCT02312739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25712081|NCT02312739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25712082|NCT02312739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712083|NCT02312739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712084|NCT02312739|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25712105|NCT02312934|Autonomic Agents|autonomic agents|mesh-ancestor
25712106|NCT02312934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25712107|NCT02312934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847518|NCT02247505|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25712108|NCT02312934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25712109|NCT02312934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25712110|NCT02312934|Cholinergic Agents|cholinergic agents|mesh-ancestor
25712111|NCT02312934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25712112|NCT02312934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712119|NCT02313675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25712120|NCT02313675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712121|NCT02313675|Antipyretics|antipyretics|mesh-ancestor
24847908|NCT05352854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24847909|NCT05352854|Pilocarpine|pilocarpine|mesh-list
24847910|NCT05352854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24847911|NCT05352854|Miotics|miotics|mesh-ancestor
24847912|NCT05352854|Autonomic Agents|autonomic agents|mesh-ancestor
24847913|NCT05352854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24847914|NCT05352854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24847915|NCT05352854|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24847916|NCT05352854|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24847960|NCT05330364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24847961|NCT05330364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24847962|NCT05330364|Immunologic Factors|immunologic factors|mesh-ancestor
24848019|NCT05248633|Autonomic Agents|autonomic agents|mesh-ancestor
24848022|NCT05248633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24848023|NCT05248633|Glucocorticoids|glucocorticoids|mesh-ancestor
24848024|NCT05248633|Hormones|hormones|mesh-ancestor
24848025|NCT05248633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24848026|NCT05248633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24636843|NCT01147588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636844|NCT01147692|Simvastatin|simvastatin|mesh-list
24636845|NCT01147692|rGLP-1 protein|rglp-1 protein|mesh-list
24636846|NCT01147692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24636847|NCT01147692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24636848|NCT01147692|Antimetabolites|antimetabolites|mesh-ancestor
25712122|NCT02313675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25712123|NCT02313675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25712124|NCT02313675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25712125|NCT02313675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25712126|NCT02313675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712127|NCT02313675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712128|NCT02313909|Aspirin|aspirin|mesh-list
25712138|NCT02313909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25712139|NCT02313909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25712140|NCT02313909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712141|NCT02313909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25712142|NCT02313909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25712143|NCT02313909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24848746|NCT03561870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487941|NCT00465907|Carboplatin|carboplatin|mesh-list
25712145|NCT02313909|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25712146|NCT02313909|Antithrombins|antithrombins|mesh-ancestor
25712147|NCT02313909|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25712148|NCT02313909|Protease Inhibitors|protease inhibitors|mesh-ancestor
25712149|NCT02313909|Anticoagulants|anticoagulants|mesh-ancestor
25712150|NCT02314104|Ropivacaine|ropivacaine|mesh-list
25712151|NCT02314104|Anesthetics, Local|anesthetics, local|mesh-ancestor
25712152|NCT02314104|Anesthetics|anesthetics|mesh-ancestor
24848826|NCT03440190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24848827|NCT03440190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24848828|NCT03440190|Dopamine Agents|dopamine agents|mesh-ancestor
24848890|NCT03289351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24848891|NCT03289351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24848892|NCT03289351|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24848906|NCT03283488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24848907|NCT03283488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24848908|NCT03283488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24848909|NCT03283488|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24848910|NCT03283488|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24848911|NCT03283488|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24848912|NCT03283488|Adrenergic Agents|adrenergic agents|mesh-ancestor
24848913|NCT03283488|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24848956|NCT03176953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24848957|NCT03176953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24848970|NCT03170882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24848972|NCT03170882|Autonomic Agents|autonomic agents|mesh-ancestor
24488343|NCT00467987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24488344|NCT00467987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488346|NCT00468091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24488347|NCT00468091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24488348|NCT00468091|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24488349|NCT00468091|Autonomic Agents|autonomic agents|mesh-ancestor
24488350|NCT00468091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24488351|NCT00468091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488352|NCT00468091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24488353|NCT00468091|Respiratory System Agents|respiratory system agents|mesh-ancestor
24849527|NCT02248896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712154|NCT02314104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712155|NCT02314104|Sensory System Agents|sensory system agents|mesh-ancestor
25712156|NCT02314104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25712157|NCT02314117|Cisplatin|cisplatin|mesh-list
25712158|NCT02314117|Fluorouracil|fluorouracil|mesh-list
25712159|NCT02314117|Capecitabine|capecitabine|mesh-list
25712160|NCT02314117|Ramucirumab|ramucirumab|mesh-list
24491787|NCT00483990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24491788|NCT00483990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491789|NCT00483990|Sensory System Agents|sensory system agents|mesh-ancestor
24444217|NCT00297011|Valacyclovir|valacyclovir|mesh-list
24444224|NCT00297011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24444240|NCT00297076|Antiviral Agents|antiviral agents|mesh-ancestor
24849917|NCT02251119|Antiviral Agents|antiviral agents|mesh-ancestor
24849918|NCT02251119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24849927|NCT02251132|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24643684|NCT01186653|Budesonide|budesonide|mesh-list
24849937|NCT02251132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24444515|NCT00298324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24444516|NCT00298324|Immunologic Factors|immunologic factors|mesh-ancestor
24444517|NCT00298324|Antifungal Agents|antifungal agents|mesh-ancestor
24444518|NCT00298324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24444519|NCT00298324|Dermatologic Agents|dermatologic agents|mesh-ancestor
24444520|NCT00298324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24444521|NCT00298324|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24444522|NCT00298324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24444523|NCT00298324|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24444524|NCT00298324|Antitubercular Agents|antitubercular agents|mesh-ancestor
24444525|NCT00298324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24444526|NCT00298350|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
25712187|NCT02314546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25712188|NCT02314546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25712189|NCT02314546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712190|NCT02314546|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25712191|NCT02314546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25712192|NCT02314546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25712193|NCT02314546|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25712194|NCT02314546|Anesthetics, General|anesthetics, general|mesh-ancestor
24492618|NCT00487032|Mydriatics|mydriatics|mesh-ancestor
24444614|NCT00298636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24444615|NCT00298636|Vasodilator Agents|vasodilator agents|mesh-ancestor
24444616|NCT00298636|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24850026|NCT02251249|Acetaminophen|acetaminophen|mesh-list
24850027|NCT02251249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24850028|NCT02251249|Analgesics|analgesics|mesh-ancestor
24850029|NCT02251249|Sensory System Agents|sensory system agents|mesh-ancestor
24850030|NCT02251249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24850031|NCT02251249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850032|NCT02251249|Antipyretics|antipyretics|mesh-ancestor
24850033|NCT02251288|Vaccines|vaccines|mesh-list
24850034|NCT02251288|Immunologic Factors|immunologic factors|mesh-ancestor
24850035|NCT02251288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850036|NCT02251431|Exenatide|exenatide|mesh-list
24850042|NCT02251431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24850043|NCT02251457|Ranolazine|ranolazine|mesh-list
24850044|NCT02251457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24850045|NCT02251457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24850046|NCT02251457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850047|NCT02251483|Immunoglobulins|immunoglobulins|mesh-list
24850049|NCT02251483|Antibodies|antibodies|mesh-list
24492742|NCT00487773|Autonomic Agents|autonomic agents|mesh-ancestor
24850078|NCT02251600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850080|NCT02251626|Coenzyme Q10|coenzyme q10|mesh-list
25712195|NCT02314546|Anesthetics|anesthetics|mesh-ancestor
25712196|NCT02314546|GABA Modulators|gaba modulators|mesh-ancestor
25712197|NCT02314546|GABA Agents|gaba agents|mesh-ancestor
25712198|NCT02314546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25712199|NCT02314546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712200|NCT02314546|Anesthetics, Local|anesthetics, local|mesh-ancestor
25712201|NCT02314546|Sensory System Agents|sensory system agents|mesh-ancestor
25712202|NCT02314546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25712203|NCT02314546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25712204|NCT02314546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25712205|NCT02314546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24850098|NCT02251769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850099|NCT02251769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24850100|NCT02251769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24850101|NCT02251769|Antiviral Agents|antiviral agents|mesh-ancestor
24850102|NCT02251769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24850103|NCT02251769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24850104|NCT02251769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24850105|NCT02251769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24850106|NCT02251769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24850107|NCT02251795|Aspirin|aspirin|mesh-list
24850108|NCT02251795|Ritonavir|ritonavir|mesh-list
24850109|NCT02251795|Darunavir|darunavir|mesh-list
24850110|NCT02251795|Tipranavir|tipranavir|mesh-list
24850112|NCT02251795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24850113|NCT02251795|Analgesics|analgesics|mesh-ancestor
24850114|NCT02251795|Sensory System Agents|sensory system agents|mesh-ancestor
24493247|NCT00490178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24493248|NCT00490178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493249|NCT00490178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24493251|NCT00490178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712206|NCT02314546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25712207|NCT02314728|Misoprostol|misoprostol|mesh-list
25712208|NCT02314728|Oxytocin|oxytocin|mesh-list
25712209|NCT02314728|Oxytocics|oxytocics|mesh-ancestor
25712210|NCT02314728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25712211|NCT02314728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712212|NCT02314728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25712213|NCT02314728|Abortifacient Agents|abortifacient agents|mesh-ancestor
24850416|NCT02252926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24850418|NCT02252926|Anticonvulsants|anticonvulsants|mesh-ancestor
24850419|NCT02252926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24850420|NCT02252926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24850421|NCT02252926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24850717|NCT02253901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24850719|NCT02253901|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24850720|NCT02253901|Antiviral Agents|antiviral agents|mesh-ancestor
24850721|NCT02253901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24850749|NCT02253927|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24850751|NCT02253940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24850752|NCT02253940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24850753|NCT02253940|Protease Inhibitors|protease inhibitors|mesh-ancestor
24850754|NCT02253940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24850756|NCT02253940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24812177|NCT02050152|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24812178|NCT02050152|Anesthetics, General|anesthetics, general|mesh-ancestor
24812179|NCT02050152|Anesthetics|anesthetics|mesh-ancestor
24812180|NCT02050152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24812181|NCT02050152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812182|NCT02050152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24812183|NCT02050152|Analgesics|analgesics|mesh-ancestor
24812184|NCT02050152|Sensory System Agents|sensory system agents|mesh-ancestor
24812185|NCT02050152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24812186|NCT02050178|Gemcitabine|gemcitabine|mesh-list
24812187|NCT02050178|Paclitaxel|paclitaxel|mesh-list
24812188|NCT02050178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24812189|NCT02050178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24812190|NCT02050178|Tubulin Modulators|tubulin modulators|mesh-ancestor
24812191|NCT02050178|Antimitotic Agents|antimitotic agents|mesh-ancestor
24850798|NCT02253966|Hormones|hormones|mesh-ancestor
24850956|NCT02254577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24850957|NCT02254577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24850958|NCT02254629|Laxatives|laxatives|mesh-list
24494902|NCT00497497|Irinotecan|irinotecan|mesh-list
24494271|NCT00494624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24494513|NCT00495378|Epoetin Alfa|epoetin alfa|mesh-list
24494514|NCT00495378|Hematinics|hematinics|mesh-ancestor
24851289|NCT02256280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851290|NCT02256280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24851291|NCT02256280|Autonomic Agents|autonomic agents|mesh-ancestor
24851292|NCT02256280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851293|NCT02256319|Dexmedetomidine|dexmedetomidine|mesh-list
24851294|NCT02256319|Propofol|propofol|mesh-list
24851295|NCT02256319|Imidazole|imidazole|mesh-list
24851296|NCT02256319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24851297|NCT02256319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24851298|NCT02256319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851299|NCT02256319|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24494874|NCT00497341|Cefuroxime|cefuroxime|mesh-list
24494875|NCT00497341|Cefuroxime axetil|cefuroxime axetil|mesh-list
24494876|NCT00497341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24851346|NCT02256722|Acipimox|acipimox|mesh-list
24851347|NCT02256722|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24851348|NCT02256722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24851349|NCT02256722|Autonomic Agents|autonomic agents|mesh-ancestor
24851350|NCT02256722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24851351|NCT02256722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851352|NCT02256722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24851353|NCT02256722|Respiratory System Agents|respiratory system agents|mesh-ancestor
24851354|NCT02256722|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24851355|NCT02256722|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24851356|NCT02256722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24851357|NCT02256722|Adrenergic Agents|adrenergic agents|mesh-ancestor
24494900|NCT00497497|Bevacizumab|bevacizumab|mesh-list
24851490|NCT02256943|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24851497|NCT02256943|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24851498|NCT02256943|Antidepressive Agents|antidepressive agents|mesh-ancestor
24812211|NCT02050529|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24812212|NCT02050529|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24812213|NCT02050529|Adrenergic Agents|adrenergic agents|mesh-ancestor
24812214|NCT02050529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25712214|NCT02314728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25712215|NCT02314728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25770809|NCT03568500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770810|NCT03568500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25770811|NCT03568500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25770812|NCT03568500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25770813|NCT03568500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25770814|NCT03568500|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25770815|NCT03568500|Dopamine Agents|dopamine agents|mesh-ancestor
25770816|NCT03568500|Antiemetics|antiemetics|mesh-ancestor
25770817|NCT03568500|Autonomic Agents|autonomic agents|mesh-ancestor
25770818|NCT03568500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770819|NCT03568500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25770820|NCT03568500|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25770821|NCT03568500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25770822|NCT03568500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25770823|NCT03568500|Antidepressive Agents|antidepressive agents|mesh-ancestor
25770824|NCT03568500|Dopamine Agonists|dopamine agonists|mesh-ancestor
25770825|NCT03568500|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25770826|NCT03568500|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25770827|NCT03568500|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25770828|NCT03568500|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25770829|NCT03569098|Botulinum Toxins|botulinum toxins|mesh-list
25770830|NCT03569098|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25770831|NCT03569098|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25770832|NCT03569098|Hemagglutinins|hemagglutinins|mesh-list
25770833|NCT03569098|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25770834|NCT03569098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25770835|NCT03569098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770836|NCT03569098|Cholinergic Agents|cholinergic agents|mesh-ancestor
25770837|NCT03569098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25770838|NCT03569098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770839|NCT03569098|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25770840|NCT03569098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770841|NCT03569098|Agglutinins|agglutinins|mesh-ancestor
25770842|NCT03569098|Immunologic Factors|immunologic factors|mesh-ancestor
25770843|NCT03569202|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25770844|NCT03569202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25770845|NCT03570476|Olaparib|olaparib|mesh-list
25770846|NCT03570476|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25770847|NCT03570476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770848|NCT03570476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812308|NCT02051387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24851810|NCT02259374|Ropivacaine|ropivacaine|mesh-list
24851811|NCT02259374|Anesthetics, Local|anesthetics, local|mesh-ancestor
24851812|NCT02259374|Anesthetics|anesthetics|mesh-ancestor
24851813|NCT02259374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24851849|NCT02259595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851850|NCT02259595|Protective Agents|protective agents|mesh-ancestor
24851851|NCT02259595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24851852|NCT02259595|Antidotes|antidotes|mesh-ancestor
24445531|NCT00301782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445533|NCT00301782|Antimitotic Agents|antimitotic agents|mesh-ancestor
24445534|NCT00301782|Mitosis Modulators|mitosis modulators|mesh-ancestor
24445535|NCT00301782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24445552|NCT00301860|Melphalan|melphalan|mesh-list
24851879|NCT02259777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24851880|NCT02259777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24851881|NCT02259777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24851882|NCT02259777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24654111|NCT01247714|Phentermine|phentermine|mesh-list
24445709|NCT00302341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24445710|NCT00302341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24445711|NCT00302341|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24445712|NCT00302341|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24445714|NCT00302341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24851884|NCT02259777|Vasodilator Agents|vasodilator agents|mesh-ancestor
24673553|NCT01338844|Inositol|inositol|mesh-list
25712216|NCT02315625|Everolimus|everolimus|mesh-list
25712217|NCT02315625|Sunitinib|sunitinib|mesh-list
25712218|NCT02315625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712219|NCT02315625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25712220|NCT02315625|Immunologic Factors|immunologic factors|mesh-ancestor
25712221|NCT02315625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712222|NCT02315625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25712223|NCT02315625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25712224|NCT02315625|Growth Substances|growth substances|mesh-ancestor
25712225|NCT02315625|Growth Inhibitors|growth inhibitors|mesh-ancestor
25712226|NCT02315625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25712227|NCT02315625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712228|NCT02315625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712229|NCT02315872|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25712230|NCT02315872|Hormones|hormones|mesh-ancestor
25712231|NCT02315872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25712233|NCT02316353|Complement C1s|complement c1s|mesh-list
25712234|NCT02316353|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
24812335|NCT02051530|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24852023|NCT02260011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24852024|NCT02260011|Respiratory System Agents|respiratory system agents|mesh-ancestor
24852025|NCT02260011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24852026|NCT02260011|Cholinergic Agents|cholinergic agents|mesh-ancestor
24852027|NCT02260011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24852029|NCT02260011|Anesthetics|anesthetics|mesh-ancestor
24852035|NCT02260024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852036|NCT02260024|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24852037|NCT02260024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24852038|NCT02260024|Dopamine Agonists|dopamine agonists|mesh-ancestor
24852039|NCT02260024|Dopamine Agents|dopamine agents|mesh-ancestor
24852040|NCT02260024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24852048|NCT02260050|Epinastine|epinastine|mesh-list
24445885|NCT00302913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24445886|NCT00302913|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24445900|NCT00303004|Urological Agents|urological agents|mesh-ancestor
24852211|NCT02261103|Pramipexole|pramipexole|mesh-list
24656364|NCT01261169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589415|NCT00907400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24589416|NCT00907400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24589417|NCT00907400|Analgesics|analgesics|mesh-ancestor
24589428|NCT00907452|Dexamethasone|dexamethasone|mesh-list
24589451|NCT00907452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24589452|NCT00907452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24589634|NCT00908271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24589690|NCT00908531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590285|NCT00911651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24590286|NCT00911651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24590316|NCT00911716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24590317|NCT00911716|Growth Substances|growth substances|mesh-ancestor
24590318|NCT00911716|Growth Inhibitors|growth inhibitors|mesh-ancestor
24590319|NCT00911716|Tubulin Modulators|tubulin modulators|mesh-ancestor
24590320|NCT00911716|Antimitotic Agents|antimitotic agents|mesh-ancestor
25712235|NCT02316353|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
25712236|NCT02316353|Immunologic Factors|immunologic factors|mesh-ancestor
25712237|NCT02316353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712238|NCT02316353|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25712239|NCT02316353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25712240|NCT02316613|Rituximab|rituximab|mesh-list
25712241|NCT02316613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25712242|NCT02316613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712243|NCT02316613|Immunologic Factors|immunologic factors|mesh-ancestor
24590611|NCT00913328|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24590612|NCT00913328|Hormone Antagonists|hormone antagonists|mesh-ancestor
24852481|NCT02262611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24590669|NCT00913497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590671|NCT00913549|Antipruritics|antipruritics|mesh-ancestor
24590672|NCT00913549|Dermatologic Agents|dermatologic agents|mesh-ancestor
24590673|NCT00913549|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24590674|NCT00913549|Histamine Antagonists|histamine antagonists|mesh-ancestor
24590675|NCT00913549|Histamine Agents|histamine agents|mesh-ancestor
24590694|NCT00913588|Serotonin Agents|serotonin agents|mesh-ancestor
24590875|NCT00914095|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24590876|NCT00914095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24590877|NCT00914095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24590878|NCT00914095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590879|NCT00914095|Dopamine Agents|dopamine agents|mesh-ancestor
24590880|NCT00914095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24590886|NCT00914121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591035|NCT00914693|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24591037|NCT00914693|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24591038|NCT00914771|Vaccines|vaccines|mesh-list
24591039|NCT00914771|Immunologic Factors|immunologic factors|mesh-ancestor
24591111|NCT00915200|Expectorants|expectorants|mesh-ancestor
24591258|NCT00915733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591259|NCT00915733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24591261|NCT00915733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852547|NCT02262741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24852548|NCT02262741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24852549|NCT02262767|Trimethobenzamide|trimethobenzamide|mesh-list
24852551|NCT02262767|Autonomic Agents|autonomic agents|mesh-ancestor
24591850|NCT00919295|Mirtazapine|mirtazapine|mesh-list
24591852|NCT00919295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24591853|NCT00919295|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24591854|NCT00919295|Histamine Antagonists|histamine antagonists|mesh-ancestor
24591862|NCT00919295|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24591863|NCT00919295|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24591864|NCT00919295|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24591865|NCT00919295|Adrenergic Agents|adrenergic agents|mesh-ancestor
24591900|NCT00919451|Dermatologic Agents|dermatologic agents|mesh-ancestor
24591901|NCT00919451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24591902|NCT00919451|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24591903|NCT00919542|Cyclosporine|cyclosporine|mesh-list
24591904|NCT00919542|Prednisolone|prednisolone|mesh-list
24591905|NCT00919542|Cyclosporins|cyclosporins|mesh-list
24591906|NCT00919542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24591907|NCT00919542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591908|NCT00919542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24591909|NCT00919542|Immunologic Factors|immunologic factors|mesh-ancestor
24591910|NCT00919542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591947|NCT00919776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24592244|NCT00921063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24592245|NCT00921063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592246|NCT00921063|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24592247|NCT00921063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24592248|NCT00921063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24592249|NCT00921063|GABA Modulators|gaba modulators|mesh-ancestor
24592250|NCT00921063|GABA Agents|gaba agents|mesh-ancestor
24592251|NCT00921063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24592346|NCT00921388|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24592347|NCT00921388|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24592348|NCT00921388|Cholinergic Agents|cholinergic agents|mesh-ancestor
25712244|NCT02316613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712245|NCT02316613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25712246|NCT02316847|Diazepam|diazepam|mesh-list
25712247|NCT02316847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25712248|NCT02316847|Anticonvulsants|anticonvulsants|mesh-ancestor
25712249|NCT02316847|Antiemetics|antiemetics|mesh-ancestor
25712250|NCT02316847|Autonomic Agents|autonomic agents|mesh-ancestor
25712251|NCT02316847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24592489|NCT00922129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24592490|NCT00922129|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24592604|NCT00923234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24592609|NCT00923234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24592610|NCT00923234|Antimetabolites|antimetabolites|mesh-ancestor
24592612|NCT00923234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592767|NCT00924755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24592768|NCT00924755|Purinergic Agents|purinergic agents|mesh-ancestor
24592769|NCT00924755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24592800|NCT00925106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24592801|NCT00925106|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24592802|NCT00925106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24592803|NCT00925106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592804|NCT00925106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24592806|NCT00925327|Vitamin B Complex|vitamin b complex|mesh-ancestor
24592807|NCT00925327|Vitamins|vitamins|mesh-ancestor
24592808|NCT00925327|Micronutrients|micronutrients|mesh-ancestor
24592812|NCT00925392|Doripenem|doripenem|mesh-list
24852633|NCT02263248|Narcotics|narcotics|mesh-ancestor
24852634|NCT02263248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24852635|NCT02263248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852636|NCT02263248|Analgesics|analgesics|mesh-ancestor
24852637|NCT02263248|Sensory System Agents|sensory system agents|mesh-ancestor
24852638|NCT02263248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658638|NCT01273402|Immunologic Factors|immunologic factors|mesh-ancestor
24658640|NCT01273441|Amoxicillin|amoxicillin|mesh-list
24852639|NCT02263248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24593039|NCT00926809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24593040|NCT00926809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24593041|NCT00926809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593042|NCT00926809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593043|NCT00926809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24593044|NCT00926809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24593045|NCT00926809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24593046|NCT00926809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24593190|NCT00927407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593191|NCT00927407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712252|NCT02316847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712253|NCT02316847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25712254|NCT02316847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25712255|NCT02316847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25712256|NCT02316847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25712257|NCT02316847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25712258|NCT02316847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25712259|NCT02316847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25712260|NCT02316847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25712261|NCT02316847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24593245|NCT00927602|PENTA|penta|mesh-list
24593348|NCT00928148|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24593375|NCT00928330|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
24852662|NCT02263495|Antimetabolites|antimetabolites|mesh-ancestor
24593379|NCT00928330|Antimitotic Agents|antimitotic agents|mesh-ancestor
24593380|NCT00928330|Mitosis Modulators|mitosis modulators|mesh-ancestor
24593381|NCT00928330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593383|NCT00928525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24852673|NCT02263677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852674|NCT02263677|Incretins|incretins|mesh-ancestor
24852675|NCT02263677|Hormones|hormones|mesh-ancestor
24852676|NCT02263677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24852677|NCT02263677|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24852678|NCT02263677|Protease Inhibitors|protease inhibitors|mesh-ancestor
24852679|NCT02263677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24852680|NCT02263677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852681|NCT02263690|Lidocaine|lidocaine|mesh-list
24852682|NCT02263690|Anesthetics, Local|anesthetics, local|mesh-ancestor
24852683|NCT02263690|Anesthetics|anesthetics|mesh-ancestor
24593608|NCT00930306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24593609|NCT00930306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593611|NCT00930306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24593612|NCT00930306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24593613|NCT00930306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24593656|NCT00930475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24593657|NCT00930475|Immunologic Factors|immunologic factors|mesh-ancestor
24593658|NCT00930475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593659|NCT00930488|Moxifloxacin|moxifloxacin|mesh-list
24593660|NCT00930488|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24593754|NCT00930839|Vitamin B Complex|vitamin b complex|mesh-ancestor
24593756|NCT00930839|Micronutrients|micronutrients|mesh-ancestor
24593757|NCT00930865|Dapagliflozin|dapagliflozin|mesh-list
24593758|NCT00930865|Bumetanide|bumetanide|mesh-list
24593759|NCT00930865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24593760|NCT00930865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852713|NCT02263976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25712262|NCT02316847|Anesthetics, General|anesthetics, general|mesh-ancestor
25712263|NCT02316847|Anesthetics|anesthetics|mesh-ancestor
25712264|NCT02316847|GABA Modulators|gaba modulators|mesh-ancestor
25712265|NCT02316847|GABA Agents|gaba agents|mesh-ancestor
24593803|NCT00931021|Cholinergic Agents|cholinergic agents|mesh-ancestor
24593804|NCT00931021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24593805|NCT00931021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593806|NCT00931073|Ketoconazole|ketoconazole|mesh-list
24593807|NCT00931073|Omeprazole|omeprazole|mesh-list
24593808|NCT00931073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24593809|NCT00931073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24593810|NCT00931073|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24852739|NCT02264002|Autonomic Agents|autonomic agents|mesh-ancestor
24852740|NCT02264002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24852741|NCT02264002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852742|NCT02264002|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24852743|NCT02264002|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24852744|NCT02264002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24852745|NCT02264002|Adrenergic Agents|adrenergic agents|mesh-ancestor
24852746|NCT02264002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24852747|NCT02264002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852751|NCT02264015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24593919|NCT00931580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24593921|NCT00931645|Dexamethasone|dexamethasone|mesh-list
24852757|NCT02264041|Itraconazole|itraconazole|mesh-list
24852758|NCT02264041|Antifungal Agents|antifungal agents|mesh-ancestor
24852759|NCT02264041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24852760|NCT02264041|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24852761|NCT02264041|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24594027|NCT00931957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24594028|NCT00931957|Immunologic Factors|immunologic factors|mesh-ancestor
24594077|NCT00932529|Olanzapine|olanzapine|mesh-list
24594078|NCT00932529|Risperidone|risperidone|mesh-list
24594079|NCT00932529|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24594080|NCT00932529|Ziprasidone|ziprasidone|mesh-list
24594081|NCT00932529|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24594082|NCT00932529|Serotonin Agents|serotonin agents|mesh-ancestor
24594151|NCT00932802|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24594152|NCT00932802|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24594153|NCT00932802|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24594155|NCT00932867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24594175|NCT00932971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24594176|NCT00932971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24594204|NCT00933179|Gestodene|gestodene|mesh-list
24594317|NCT00933439|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24594318|NCT00933439|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24594319|NCT00933439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24594320|NCT00933439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24594348|NCT00933517|Panitumumab|panitumumab|mesh-list
24665096|NCT01310166|Immunologic Factors|immunologic factors|mesh-ancestor
24665097|NCT01310166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665107|NCT01310244|Carboplatin|carboplatin|mesh-list
24665108|NCT01310244|Belinostat|belinostat|mesh-list
24594456|NCT00933998|Vitamin B Complex|vitamin b complex|mesh-ancestor
25712266|NCT02316847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25712267|NCT02316847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712268|NCT02317016|Osimertinib|osimertinib|mesh-list
25712269|NCT02317016|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25712270|NCT02317016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24594457|NCT00933998|Vitamins|vitamins|mesh-ancestor
24594458|NCT00933998|Micronutrients|micronutrients|mesh-ancestor
24594459|NCT00933998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594471|NCT00934154|Melphalan|melphalan|mesh-list
24594560|NCT00934492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24594561|NCT00934492|Renal Agents|renal agents|mesh-ancestor
24594562|NCT00934492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24594563|NCT00934492|Antimalarials|antimalarials|mesh-ancestor
24594600|NCT00934713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594602|NCT00934739|Dexamethasone|dexamethasone|mesh-list
24594604|NCT00934739|Cyclophosphamide|cyclophosphamide|mesh-list
24594605|NCT00934739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24594606|NCT00934739|Immunologic Factors|immunologic factors|mesh-ancestor
24594607|NCT00934739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594608|NCT00934739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24594609|NCT00934739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24594610|NCT00934739|Alkylating Agents|alkylating agents|mesh-ancestor
24594612|NCT00934739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24594746|NCT00935415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24594747|NCT00935415|Respiratory System Agents|respiratory system agents|mesh-ancestor
24594748|NCT00935415|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24594749|NCT00935415|Hormone Antagonists|hormone antagonists|mesh-ancestor
24594750|NCT00935415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24594751|NCT00935415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594754|NCT00935415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594756|NCT00935467|Incretins|incretins|mesh-ancestor
24594757|NCT00935467|Hormones|hormones|mesh-ancestor
24594758|NCT00935467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24594759|NCT00935467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594760|NCT00935467|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24852794|NCT02264132|Protective Agents|protective agents|mesh-ancestor
24594915|NCT00936156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24594916|NCT00936156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24594917|NCT00936156|Alkylating Agents|alkylating agents|mesh-ancestor
24594918|NCT00936156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24594919|NCT00936156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24595053|NCT00936689|Doxorubicin|doxorubicin|mesh-list
24595054|NCT00936689|Chlorotrianisene|chlorotrianisene|mesh-list
24595055|NCT00936689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24595056|NCT00936689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24595057|NCT00936689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24635901|NCT01141881|Bevacizumab|bevacizumab|mesh-list
24595058|NCT00936689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24595059|NCT00936689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595097|NCT00936793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24595098|NCT00936793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24595099|NCT00936793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24595101|NCT00936793|Hormones|hormones|mesh-ancestor
24595102|NCT00936793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24852795|NCT02264132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24852796|NCT02264132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24852797|NCT02264132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24595106|NCT00936819|Plasma-lyte 148|plasma-lyte 148|mesh-list
24635921|NCT01141894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24635922|NCT01141894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635923|NCT01141894|Sympathomimetics|sympathomimetics|mesh-ancestor
24635924|NCT01141894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24635925|NCT01141894|Nasal Decongestants|nasal decongestants|mesh-ancestor
24503053|NCT03532022|Glucocorticoids|glucocorticoids|mesh-ancestor
24595229|NCT00937300|Sensory System Agents|sensory system agents|mesh-ancestor
24595230|NCT00937300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24595232|NCT00937417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24852798|NCT02264132|Dopamine Agonists|dopamine agonists|mesh-ancestor
24852799|NCT02264132|Dopamine Agents|dopamine agents|mesh-ancestor
24852800|NCT02264132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24595233|NCT00937417|Tubulin Modulators|tubulin modulators|mesh-ancestor
24503088|NCT03315897|Epoetin Alfa|epoetin alfa|mesh-list
24503089|NCT03315897|Hematinics|hematinics|mesh-ancestor
24595513|NCT00939068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595514|NCT00939068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595516|NCT00939133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24595517|NCT00939133|Keratolytic Agents|keratolytic agents|mesh-ancestor
24595518|NCT00939133|Dermatologic Agents|dermatologic agents|mesh-ancestor
24595520|NCT00939328|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24595521|NCT00939328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24595626|NCT00939848|Cediranib|cediranib|mesh-list
24595627|NCT00939848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24595629|NCT00939848|Antimetabolites|antimetabolites|mesh-ancestor
24595881|NCT00940784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24595933|NCT00940953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24595934|NCT00940953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24595935|NCT00940953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24595936|NCT00940953|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24595937|NCT00940953|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24595938|NCT00940953|Histamine Antagonists|histamine antagonists|mesh-ancestor
24595943|NCT00941057|Dienogest|dienogest|mesh-list
24596012|NCT00941161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24596147|NCT00942006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24812427|NCT02052167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812428|NCT02052167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24812429|NCT02052167|Antimetabolites|antimetabolites|mesh-ancestor
24812430|NCT02052167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812451|NCT02052193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812454|NCT02052258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24812455|NCT02052258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661238|NCT01288573|Plerixafor|plerixafor|mesh-list
24596470|NCT00943839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596471|NCT00943930|Dronabinol|dronabinol|mesh-list
24596472|NCT00943930|Amphetamine|amphetamine|mesh-list
24596473|NCT00943930|Dextroamphetamine|dextroamphetamine|mesh-list
24596474|NCT00943930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24596475|NCT00943930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596705|NCT00944957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596706|NCT00944957|Antiviral Agents|antiviral agents|mesh-ancestor
24596707|NCT00944957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24596708|NCT00944957|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24596709|NCT00944957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24596710|NCT00944957|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24596718|NCT00944996|Citalopram|citalopram|mesh-list
24596739|NCT00945022|Anesthetics|anesthetics|mesh-list
24852853|NCT02264184|Adrenergic Agents|adrenergic agents|mesh-ancestor
24852854|NCT02264184|Urological Agents|urological agents|mesh-ancestor
24852855|NCT02264236|Vaccines|vaccines|mesh-list
24596798|NCT00945529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596799|NCT00945529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24596802|NCT00945529|Gasotransmitters|gasotransmitters|mesh-ancestor
24596956|NCT00946595|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24596957|NCT00946595|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24596958|NCT00946595|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24596959|NCT00946608|Loratadine|loratadine|mesh-list
24596960|NCT00946608|Antipruritics|antipruritics|mesh-ancestor
24596961|NCT00946608|Dermatologic Agents|dermatologic agents|mesh-ancestor
25712271|NCT02317016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25712272|NCT02317016|Antimetabolites|antimetabolites|mesh-ancestor
25712273|NCT02317016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712274|NCT02317016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25712275|NCT02317016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25712276|NCT02317016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712277|NCT02317016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712278|NCT02317016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25712279|NCT02317510|Anesthetics|anesthetics|mesh-list
25712280|NCT02317510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24596962|NCT00946608|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24599255|NCT04919369|Protective Agents|protective agents|mesh-ancestor
24596963|NCT00946608|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24596964|NCT00946608|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24597065|NCT00947063|Dermatologic Agents|dermatologic agents|mesh-ancestor
24597066|NCT00947063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24597067|NCT00947063|Histamine Antagonists|histamine antagonists|mesh-ancestor
24597068|NCT00947063|Histamine Agents|histamine agents|mesh-ancestor
24597069|NCT00947063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24597070|NCT00947063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597077|NCT00947063|Anesthetics|anesthetics|mesh-ancestor
24852882|NCT02264587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24852883|NCT02264587|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24597240|NCT00947843|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24597241|NCT00947843|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24597242|NCT00947843|Purinergic Agents|purinergic agents|mesh-ancestor
24597243|NCT00947843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24597244|NCT00947895|Methylprednisolone|methylprednisolone|mesh-list
24597245|NCT00947895|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24597246|NCT00947895|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24597449|NCT00949377|Anticonvulsants|anticonvulsants|mesh-ancestor
24597450|NCT00949377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24597451|NCT00949377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597510|NCT00949624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24597511|NCT00949624|Tubulin Modulators|tubulin modulators|mesh-ancestor
24597512|NCT00949624|Antimitotic Agents|antimitotic agents|mesh-ancestor
24597513|NCT00949624|Mitosis Modulators|mitosis modulators|mesh-ancestor
24597514|NCT00949624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597515|NCT00949624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24597516|NCT00949624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597594|NCT00950196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24597595|NCT00950196|Dopamine Agents|dopamine agents|mesh-ancestor
24597601|NCT00950196|Sensory System Agents|sensory system agents|mesh-ancestor
24852912|NCT02264743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24597708|NCT00950898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24597710|NCT00951106|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24597712|NCT00951106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24597713|NCT00951106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24597836|NCT00952029|Immunologic Factors|immunologic factors|mesh-ancestor
24597837|NCT00952029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24597838|NCT00952029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24597839|NCT00952029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24597840|NCT00952029|Antidotes|antidotes|mesh-ancestor
24597873|NCT00952432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24597874|NCT00952432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597875|NCT00952432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24597876|NCT00952432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24597878|NCT00952432|Sensory System Agents|sensory system agents|mesh-ancestor
24597879|NCT00952432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24597880|NCT00952432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24598191|NCT00954525|Vitamins|vitamins|mesh-ancestor
24598192|NCT00954525|Micronutrients|micronutrients|mesh-ancestor
24598193|NCT00954525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598194|NCT00954525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24598241|NCT00954642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24598242|NCT00954642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24598243|NCT00954642|Growth Substances|growth substances|mesh-ancestor
24598244|NCT00954642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598245|NCT00954642|Growth Inhibitors|growth inhibitors|mesh-ancestor
24598246|NCT00954785|Diclofenac|diclofenac|mesh-list
24598247|NCT00954785|Etoricoxib|etoricoxib|mesh-list
24598349|NCT00955604|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24598350|NCT00955604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24897694|NCT04423276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25712281|NCT02317510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712282|NCT02317549|Tranexamic Acid|tranexamic acid|mesh-list
25712283|NCT02317549|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24598351|NCT00955604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598352|NCT00955604|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24598487|NCT00956267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598497|NCT00956306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598498|NCT00956319|Estazolam|estazolam|mesh-list
24598499|NCT00956319|Zolpidem|zolpidem|mesh-list
24598500|NCT00956319|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24598501|NCT00956319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24598574|NCT00956748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24598575|NCT00956748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598582|NCT00956748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598583|NCT00956748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598584|NCT00956748|Antiviral Agents|antiviral agents|mesh-ancestor
24598585|NCT00956748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24598586|NCT00956748|Expectorants|expectorants|mesh-ancestor
24598587|NCT00956748|Respiratory System Agents|respiratory system agents|mesh-ancestor
24598588|NCT00956748|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24598589|NCT00956748|Antioxidants|antioxidants|mesh-ancestor
24852986|NCT02265068|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24852987|NCT02265068|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24852988|NCT02265068|Purinergic Agents|purinergic agents|mesh-ancestor
24852989|NCT02265068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24599204|NCT05003245|Growth Substances|growth substances|mesh-ancestor
24599246|NCT04919369|Retinol palmitate|retinol palmitate|mesh-list
24599248|NCT04919369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24599249|NCT04919369|Micronutrients|micronutrients|mesh-ancestor
24599250|NCT04919369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599251|NCT04919369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24599252|NCT04919369|Immunologic Factors|immunologic factors|mesh-ancestor
24599253|NCT04919369|Antioxidants|antioxidants|mesh-ancestor
24599254|NCT04919369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599794|NCT03908437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24599795|NCT03908437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599796|NCT03908437|Analgesics|analgesics|mesh-ancestor
24599797|NCT03908437|Sensory System Agents|sensory system agents|mesh-ancestor
24599798|NCT03908437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24599799|NCT03908437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24599800|NCT03891446|Bimatoprost|bimatoprost|mesh-list
24599801|NCT03891446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24599802|NCT03867383|Calcium, Dietary|calcium, dietary|mesh-list
24599918|NCT03047070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24599919|NCT03040778|Vitamin E|vitamin e|mesh-list
24599920|NCT03040778|Tocopherols|tocopherols|mesh-list
24599921|NCT03040778|Tocotrienols|tocotrienols|mesh-list
24599922|NCT03040778|alpha-Tocopherol|alpha-tocopherol|mesh-list
24599923|NCT03040778|Pentoxifylline|pentoxifylline|mesh-list
24599924|NCT03040778|Vitamins|vitamins|mesh-ancestor
24599925|NCT03040778|Micronutrients|micronutrients|mesh-ancestor
24599926|NCT03040778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24599927|NCT03040778|Antioxidants|antioxidants|mesh-ancestor
24600012|NCT02879409|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24600013|NCT02879409|Liraglutide|liraglutide|mesh-list
24600014|NCT02879409|Dapagliflozin|dapagliflozin|mesh-list
24600015|NCT02879409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25712284|NCT02317549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25712285|NCT02317549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712286|NCT02317549|Hemostatics|hemostatics|mesh-ancestor
24600016|NCT02879409|Gliclazide|gliclazide|mesh-list
24600017|NCT02879409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25712287|NCT02317549|Coagulants|coagulants|mesh-ancestor
25712288|NCT02317575|Insulin Lispro|insulin lispro|mesh-list
24600575|NCT00959439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24600718|NCT00960284|Epirubicin|epirubicin|mesh-list
24600719|NCT00960284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24600720|NCT00960284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24600721|NCT00960284|Antimetabolites|antimetabolites|mesh-ancestor
24664746|NCT01308528|Enoxaparin|enoxaparin|mesh-list
24636457|NCT01145612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24600908|NCT00961155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600909|NCT00961155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24600948|NCT00961363|Protease Inhibitors|protease inhibitors|mesh-ancestor
24601371|NCT00964106|Omeprazole|omeprazole|mesh-list
24601373|NCT00964106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24601374|NCT00964106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24601375|NCT00964106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24601376|NCT00964106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601426|NCT00964106|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24601459|NCT00964275|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24853189|NCT02266485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853190|NCT02266485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24853191|NCT02266485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24853192|NCT02266485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24853194|NCT02266511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24602251|NCT00967707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24602252|NCT00967707|Antidepressive Agents|antidepressive agents|mesh-ancestor
24602254|NCT00967772|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24602255|NCT00967772|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24602256|NCT00967772|Adrenergic Agents|adrenergic agents|mesh-ancestor
24602257|NCT00967772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24602302|NCT00968006|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24602303|NCT00968006|Protease Inhibitors|protease inhibitors|mesh-ancestor
24602331|NCT00968383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
24602567|NCT00969449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602569|NCT00969462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24602570|NCT00969462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24602571|NCT00969462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24602572|NCT00969462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24602573|NCT00969462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24602574|NCT00969462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602576|NCT00969566|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24602624|NCT00969852|Serotonin Agents|serotonin agents|mesh-ancestor
24602625|NCT00969852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602626|NCT00969904|Acetylcysteine|acetylcysteine|mesh-list
24602627|NCT00969904|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24602628|NCT00969904|Antiviral Agents|antiviral agents|mesh-ancestor
24602629|NCT00969904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24602630|NCT00969904|Expectorants|expectorants|mesh-ancestor
24602631|NCT00969904|Respiratory System Agents|respiratory system agents|mesh-ancestor
24602632|NCT00969904|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24602867|NCT00971399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24602868|NCT00971399|Serotonin Agents|serotonin agents|mesh-ancestor
24602869|NCT00971399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24602870|NCT00971399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602871|NCT00971399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24602872|NCT00971399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24602873|NCT00971399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24602874|NCT00971399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24602875|NCT00971399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24602878|NCT00971581|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24602879|NCT00971581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24602880|NCT00971581|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24602881|NCT00971581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24602882|NCT00971581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602883|NCT00971581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24602884|NCT00971581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24602885|NCT00971581|Analgesics|analgesics|mesh-ancestor
25712289|NCT02317575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25712290|NCT02317575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602886|NCT00971581|Sensory System Agents|sensory system agents|mesh-ancestor
24602903|NCT00971659|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24602905|NCT00971659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24602916|NCT00971685|Lenalidomide|lenalidomide|mesh-list
24602917|NCT00971685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24602918|NCT00971685|Antiemetics|antiemetics|mesh-ancestor
24602919|NCT00971685|Autonomic Agents|autonomic agents|mesh-ancestor
24602920|NCT00971685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24602921|NCT00971685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602922|NCT00971685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24602925|NCT00971685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24603030|NCT00972101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24603031|NCT00972101|Antimetabolites|antimetabolites|mesh-ancestor
24603032|NCT00972101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603033|NCT00972101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24603058|NCT00972140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24603059|NCT00972140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603061|NCT00972218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24603063|NCT00972257|Timolol|timolol|mesh-list
24603224|NCT00972946|Plasma Substitutes|plasma substitutes|mesh-ancestor
24603225|NCT00972946|Blood Substitutes|blood substitutes|mesh-ancestor
24603226|NCT00972985|Lorazepam|lorazepam|mesh-list
24603227|NCT00972985|Methylphenidate|methylphenidate|mesh-list
24603228|NCT00972985|Modafinil|modafinil|mesh-list
24603229|NCT00972985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24603230|NCT00972985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603231|NCT00972985|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24603232|NCT00972985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24603233|NCT00972985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24603235|NCT00972985|Dopamine Agents|dopamine agents|mesh-ancestor
24603343|NCT00973310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603411|NCT00973609|Micronutrients|micronutrients|mesh-ancestor
24603412|NCT00973687|Dexamethasone|dexamethasone|mesh-list
24603413|NCT00973687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24603414|NCT00973687|Antiemetics|antiemetics|mesh-ancestor
24603415|NCT00973687|Autonomic Agents|autonomic agents|mesh-ancestor
24603416|NCT00973687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24603417|NCT00973687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603420|NCT00973687|Hormones|hormones|mesh-ancestor
24603619|NCT00974766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603622|NCT00974792|Cyclophosphamide|cyclophosphamide|mesh-list
24603623|NCT00974792|Ifosfamide|ifosfamide|mesh-list
24603624|NCT00974792|Rituximab|rituximab|mesh-list
24603625|NCT00974792|Doxorubicin|doxorubicin|mesh-list
24603626|NCT00974792|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24603627|NCT00974792|Methotrexate|methotrexate|mesh-list
24603628|NCT00974792|Etoposide|etoposide|mesh-list
24603629|NCT00974792|Vincristine|vincristine|mesh-list
24603630|NCT00974792|Etoposide phosphate|etoposide phosphate|mesh-list
24603631|NCT00974792|Levoleucovorin|levoleucovorin|mesh-list
24603632|NCT00974792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24603633|NCT00974792|Immunologic Factors|immunologic factors|mesh-ancestor
24603634|NCT00974792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603727|NCT00975182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603728|NCT00975182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24853332|NCT02267655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24853333|NCT02267655|Respiratory System Agents|respiratory system agents|mesh-ancestor
24853334|NCT02267655|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24853336|NCT02267655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24853337|NCT02267655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24603729|NCT00975182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603730|NCT00975182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603732|NCT00975299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25712291|NCT02317744|Naltrexone|naltrexone|mesh-list
25712292|NCT02317744|Bupropion|bupropion|mesh-list
25712293|NCT02317744|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25712294|NCT02317744|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25712295|NCT02317744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712296|NCT02317744|Sensory System Agents|sensory system agents|mesh-ancestor
25712297|NCT02317744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25712298|NCT02317744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24603733|NCT00975299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603734|NCT00975299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853340|NCT02267655|Gasotransmitters|gasotransmitters|mesh-ancestor
24603855|NCT00975910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24603856|NCT00975910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603857|NCT00975910|Sensory System Agents|sensory system agents|mesh-ancestor
24603858|NCT00975910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24603859|NCT00975910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24603860|NCT00975910|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24603861|NCT00975910|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24603862|NCT00975910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24604059|NCT00977028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24604060|NCT00977028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24604061|NCT00977028|Adrenergic Agents|adrenergic agents|mesh-ancestor
24604062|NCT00977028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24604063|NCT00977028|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24604064|NCT00977028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24604065|NCT00977028|Autonomic Agents|autonomic agents|mesh-ancestor
24604066|NCT00977028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24604067|NCT00977028|Respiratory System Agents|respiratory system agents|mesh-ancestor
24604068|NCT00977028|Mydriatics|mydriatics|mesh-ancestor
24604069|NCT00977028|Sympathomimetics|sympathomimetics|mesh-ancestor
24604070|NCT00977028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24604071|NCT00977054|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24604072|NCT00977054|Interferon-alpha|interferon-alpha|mesh-list
24604073|NCT00977054|Ribavirin|ribavirin|mesh-list
24604074|NCT00977054|Interferon alpha-2|interferon alpha-2|mesh-list
24604075|NCT00977054|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
24604076|NCT00977054|Antiviral Agents|antiviral agents|mesh-ancestor
24604077|NCT00977054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24604078|NCT00977054|Immunologic Factors|immunologic factors|mesh-ancestor
24604155|NCT00977301|Serotonin Agents|serotonin agents|mesh-ancestor
24604156|NCT00977353|Citalopram|citalopram|mesh-list
24604157|NCT00977353|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24604209|NCT00977756|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24604210|NCT00977756|Antiviral Agents|antiviral agents|mesh-ancestor
24604211|NCT00977756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24604212|NCT00977756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24604213|NCT00977756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24604214|NCT00977756|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24604215|NCT00977756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24604216|NCT00977756|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24604217|NCT00977756|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24604218|NCT00977756|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24604219|NCT00977756|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24604220|NCT00977756|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24604221|NCT00977795|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24604222|NCT00977795|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24853351|NCT02267681|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24853352|NCT02267681|Narcotics|narcotics|mesh-ancestor
24853353|NCT02267681|Analgesics|analgesics|mesh-ancestor
24853354|NCT02267681|Sensory System Agents|sensory system agents|mesh-ancestor
24853355|NCT02267681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24853356|NCT02267681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24853357|NCT02267707|Gemcitabine|gemcitabine|mesh-list
24853358|NCT02267707|Paclitaxel|paclitaxel|mesh-list
24604223|NCT00977795|Dermatologic Agents|dermatologic agents|mesh-ancestor
24853359|NCT02267707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24853361|NCT02267707|Tubulin Modulators|tubulin modulators|mesh-ancestor
24853362|NCT02267707|Antimitotic Agents|antimitotic agents|mesh-ancestor
24604350|NCT00978796|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24604351|NCT00978796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24604352|NCT00978796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712299|NCT02317744|Antidepressive Agents|antidepressive agents|mesh-ancestor
24604353|NCT00978796|Incretins|incretins|mesh-ancestor
24604354|NCT00978796|Hormones|hormones|mesh-ancestor
24604355|NCT00978796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24604356|NCT00978796|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24604357|NCT00978796|Protease Inhibitors|protease inhibitors|mesh-ancestor
24604358|NCT00978796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24815176|NCT02068560|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24604359|NCT00978796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604360|NCT00978822|Clevidipine|clevidipine|mesh-list
24604398|NCT00978978|GABA Modulators|gaba modulators|mesh-ancestor
24604399|NCT00978978|GABA Agents|gaba agents|mesh-ancestor
24604410|NCT00979160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604411|NCT00979186|Hemostatics|hemostatics|mesh-list
24604437|NCT00979563|Irinotecan|irinotecan|mesh-list
24604438|NCT00979563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24604439|NCT00979563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24604440|NCT00979563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604527|NCT00979966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24604528|NCT00979966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24604559|NCT00980213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604560|NCT00980213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24604561|NCT00980213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24604562|NCT00980213|Growth Substances|growth substances|mesh-ancestor
24604563|NCT00980213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604564|NCT00980213|Growth Inhibitors|growth inhibitors|mesh-ancestor
24604565|NCT00980213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24604672|NCT00980876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24604673|NCT00980876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24604674|NCT00980876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24604675|NCT00980876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604676|NCT00980876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604677|NCT00980876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604678|NCT00980876|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24604679|NCT00980876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24604680|NCT00981006|Mitogens|mitogens|mesh-list
24853394|NCT02267980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24853395|NCT02267980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24604714|NCT00981318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24604715|NCT00981318|Antiviral Agents|antiviral agents|mesh-ancestor
24604722|NCT00981487|Ondansetron|ondansetron|mesh-list
24604808|NCT00981838|Immunologic Factors|immunologic factors|mesh-ancestor
24604809|NCT00981838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604810|NCT00981838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24604812|NCT00981851|Tiotropium Bromide|tiotropium bromide|mesh-list
24604813|NCT00981851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24604814|NCT00981851|Autonomic Agents|autonomic agents|mesh-ancestor
24604815|NCT00981851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24604816|NCT00981851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604817|NCT00981851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24604818|NCT00981851|Respiratory System Agents|respiratory system agents|mesh-ancestor
24604819|NCT00981851|Parasympatholytics|parasympatholytics|mesh-ancestor
24604820|NCT00981851|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24604821|NCT00981851|Cholinergic Agents|cholinergic agents|mesh-ancestor
24604823|NCT00981851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604825|NCT00981851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24853396|NCT02267980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24604861|NCT00981929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604862|NCT00981929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24604888|NCT00981968|Sitaxsentan|sitaxsentan|mesh-list
25712300|NCT02317744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25712301|NCT02317744|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25712302|NCT02317744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25712303|NCT02317744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25712304|NCT02317744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712305|NCT02317744|Dopamine Agents|dopamine agents|mesh-ancestor
24604889|NCT00981968|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24604890|NCT00981968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604892|NCT00982124|Zoledronic Acid|zoledronic acid|mesh-list
24604898|NCT00982215|Acetaminophen|acetaminophen|mesh-list
24604899|NCT00982215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24604900|NCT00982215|Analgesics|analgesics|mesh-ancestor
24604901|NCT00982215|Sensory System Agents|sensory system agents|mesh-ancestor
24604902|NCT00982215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24604903|NCT00982215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604906|NCT00982254|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24604907|NCT00982254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24604908|NCT00982254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604909|NCT00982332|Betamethasone|betamethasone|mesh-list
24604922|NCT00982358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604923|NCT00982436|Carboplatin|carboplatin|mesh-list
24604974|NCT00982618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604975|NCT00982618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24604976|NCT00982618|Narcotics|narcotics|mesh-ancestor
24604977|NCT00982618|Analgesics|analgesics|mesh-ancestor
24604978|NCT00982631|Sirolimus|sirolimus|mesh-list
24604979|NCT00982631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24604980|NCT00982631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24604981|NCT00982631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24853406|NCT02268019|Epinephrine|epinephrine|mesh-list
24604986|NCT00982631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604987|NCT00982722|Calcium, Dietary|calcium, dietary|mesh-list
24604988|NCT00982722|Cholecalciferol|cholecalciferol|mesh-list
24604989|NCT00982722|Vitamin D|vitamin d|mesh-list
24604990|NCT00982722|Calcium Carbonate|calcium carbonate|mesh-list
24604991|NCT00982722|Calcium|calcium|mesh-list
24604992|NCT00982722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24604993|NCT00982722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24604994|NCT00982722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24604995|NCT00982722|Vitamins|vitamins|mesh-ancestor
24604996|NCT00982722|Micronutrients|micronutrients|mesh-ancestor
24604997|NCT00982722|Antacids|antacids|mesh-ancestor
24604998|NCT00982722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604999|NCT00982722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24605000|NCT00982800|Gabapentin|gabapentin|mesh-list
24605001|NCT00982800|Analgesics|analgesics|mesh-ancestor
24605002|NCT00982800|Sensory System Agents|sensory system agents|mesh-ancestor
24605003|NCT00982800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24605004|NCT00982800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605005|NCT00982800|Anticonvulsants|anticonvulsants|mesh-ancestor
24605006|NCT00982800|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24605007|NCT00982800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24605008|NCT00982800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24605009|NCT00982800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24605042|NCT00983034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605043|NCT00983034|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24605044|NCT00983034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24605045|NCT00983034|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24605046|NCT00983034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24605047|NCT00983034|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24605048|NCT00983047|Docetaxel|docetaxel|mesh-list
24605049|NCT00983047|Nimotuzumab|nimotuzumab|mesh-list
25712306|NCT02317744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25712307|NCT02317744|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25712308|NCT02317744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25712309|NCT02317744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712310|NCT02317809|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25712311|NCT02317809|Hormones|hormones|mesh-ancestor
25712312|NCT02317809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25712313|NCT02317809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605051|NCT00983047|Tubulin Modulators|tubulin modulators|mesh-ancestor
24605052|NCT00983047|Antimitotic Agents|antimitotic agents|mesh-ancestor
24605053|NCT00983047|Mitosis Modulators|mitosis modulators|mesh-ancestor
24605054|NCT00983047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605055|NCT00983047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24605151|NCT00983424|Tubulin Modulators|tubulin modulators|mesh-ancestor
24605152|NCT00983424|Antimitotic Agents|antimitotic agents|mesh-ancestor
24605153|NCT00983424|Mitosis Modulators|mitosis modulators|mesh-ancestor
24605154|NCT00983424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605155|NCT00983424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605156|NCT00983424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24605157|NCT00983424|Immunologic Factors|immunologic factors|mesh-ancestor
24629682|NCT01107145|Mefloquine|mefloquine|mesh-list
24605158|NCT00983424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605159|NCT00983424|Antifungal Agents|antifungal agents|mesh-ancestor
24605160|NCT00983424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24605161|NCT00983424|Dermatologic Agents|dermatologic agents|mesh-ancestor
24605162|NCT00983424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24878159|NCT02097225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605163|NCT00983424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24605165|NCT00983450|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
24605166|NCT00983450|beta-Endorphin|beta-endorphin|mesh-list
24605167|NCT00983450|Hormones|hormones|mesh-ancestor
24605280|NCT00984386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24605282|NCT00984386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24605283|NCT00984386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24605284|NCT00984399|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24605285|NCT00984399|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24605286|NCT00984399|Estradiol|estradiol|mesh-list
24605287|NCT00984399|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24605288|NCT00984399|Estrogens|estrogens|mesh-ancestor
24605289|NCT00984399|Hormones|hormones|mesh-ancestor
24605292|NCT00984399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24605370|NCT00984763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605371|NCT00984763|Antacids|antacids|mesh-ancestor
24605372|NCT00984763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605373|NCT00984763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24605374|NCT00984789|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24605375|NCT00984789|Gestodene|gestodene|mesh-list
24605376|NCT00984789|Norelgestromin|norelgestromin|mesh-list
24605393|NCT00984893|Zoledronic Acid|zoledronic acid|mesh-list
24636857|NCT01147705|Allopurinol|allopurinol|mesh-list
24605395|NCT00984893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24605396|NCT00984893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605397|NCT00984932|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24605398|NCT00984932|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24605399|NCT00984932|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24605400|NCT00984932|Antimetabolites|antimetabolites|mesh-ancestor
25712314|NCT02318303|Mometasone Furoate|mometasone furoate|mesh-list
25712315|NCT02318303|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25712316|NCT02318303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25712317|NCT02318303|Dermatologic Agents|dermatologic agents|mesh-ancestor
25712318|NCT02318303|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25712319|NCT02318303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25712320|NCT02318303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25712321|NCT02318303|Analgesics|analgesics|mesh-ancestor
25712322|NCT02318303|Sensory System Agents|sensory system agents|mesh-ancestor
24605414|NCT00984971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605416|NCT00984971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24608035|NCT02557672|Thrombin|thrombin|mesh-list
24605487|NCT00985387|Solifenacin Succinate|solifenacin succinate|mesh-list
24605488|NCT00985387|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24671196|NCT01324180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24671197|NCT01324180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605489|NCT00985387|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24605490|NCT00985387|Cholinergic Agents|cholinergic agents|mesh-ancestor
24605491|NCT00985387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24812533|NCT02053298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24812534|NCT02053298|Adrenergic Agents|adrenergic agents|mesh-ancestor
24812535|NCT02053298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24812536|NCT02053298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24812537|NCT02053298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24812538|NCT02053298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24812539|NCT02053298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24812540|NCT02053298|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24812541|NCT02053298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605495|NCT00985530|Arsenic Trioxide|arsenic trioxide|mesh-list
24605496|NCT00985530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605497|NCT00985556|Capecitabine|capecitabine|mesh-list
24671199|NCT01324180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24671200|NCT01324180|Tubulin Modulators|tubulin modulators|mesh-ancestor
24671201|NCT01324180|Antimitotic Agents|antimitotic agents|mesh-ancestor
24671202|NCT01324180|Mitosis Modulators|mitosis modulators|mesh-ancestor
24671204|NCT01324245|Enalaprilat|enalaprilat|mesh-list
24671205|NCT01324245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24671206|NCT01324245|Vasodilator Agents|vasodilator agents|mesh-ancestor
24671210|NCT01324245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671212|NCT01324245|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24671213|NCT01324245|Protease Inhibitors|protease inhibitors|mesh-ancestor
24671214|NCT01324245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671215|NCT01324258|Gemcitabine|gemcitabine|mesh-list
24671216|NCT01324258|Trametinib|trametinib|mesh-list
24605532|NCT00985777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605533|NCT00985777|Protective Agents|protective agents|mesh-ancestor
24605535|NCT00985855|Cetuximab|cetuximab|mesh-list
24605536|NCT00985855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605537|NCT00985855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24605538|NCT00985855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24605539|NCT00985855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24605759|NCT00987168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605760|NCT00987207|Cyclosporine|cyclosporine|mesh-list
24605761|NCT00987207|Cyclosporins|cyclosporins|mesh-list
24605762|NCT00987207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605763|NCT00987207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605764|NCT00987207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24605791|NCT00987233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605792|NCT00987233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605793|NCT00987376|Choline|choline|mesh-list
24812555|NCT02053519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24812556|NCT02053558|Lidocaine|lidocaine|mesh-list
24812557|NCT02053558|Ropivacaine|ropivacaine|mesh-list
24812558|NCT02053558|Anesthetics, Local|anesthetics, local|mesh-ancestor
24605928|NCT00987974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605929|NCT00987974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24605930|NCT00987974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25712323|NCT02318303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24605931|NCT00987974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605932|NCT00988026|Minocycline|minocycline|mesh-list
25712324|NCT02318303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712325|NCT02318303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25712326|NCT02318303|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25712327|NCT02318303|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25712328|NCT02318303|Histamine Antagonists|histamine antagonists|mesh-ancestor
25712329|NCT02318303|Histamine Agents|histamine agents|mesh-ancestor
25712330|NCT02318303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25712331|NCT02318303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712332|NCT02318368|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25712333|NCT02318368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605933|NCT00988026|Lymecycline|lymecycline|mesh-list
24605934|NCT00988026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24605935|NCT00988026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24605936|NCT00988039|Raltegravir Potassium|raltegravir potassium|mesh-list
24605938|NCT00988039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24605939|NCT00988039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24605940|NCT00988039|Antiviral Agents|antiviral agents|mesh-ancestor
24606053|NCT00988728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24606054|NCT00988728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24606055|NCT00988728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606056|NCT00988728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24606057|NCT00988728|Serotonin Agents|serotonin agents|mesh-ancestor
24606058|NCT00988780|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24606060|NCT00988780|Maraviroc|maraviroc|mesh-list
24671234|NCT01324336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671242|NCT01324492|Everolimus|everolimus|mesh-list
24606138|NCT00989053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24606139|NCT00989053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24606140|NCT00989053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606141|NCT00989053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24606142|NCT00989053|Serotonin Agents|serotonin agents|mesh-ancestor
24606143|NCT00989053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606144|NCT00989053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24606145|NCT00989053|Antidepressive Agents|antidepressive agents|mesh-ancestor
24606199|NCT00989404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606200|NCT00989443|Cidofovir|cidofovir|mesh-list
24606201|NCT00989443|Antiviral Agents|antiviral agents|mesh-ancestor
24606202|NCT00989443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24606203|NCT00989443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606204|NCT00989443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606206|NCT00989469|Sorafenib|sorafenib|mesh-list
24606207|NCT00989469|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24606208|NCT00989469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24606209|NCT00989469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606210|NCT00989469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606211|NCT00989469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24606212|NCT00989469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24606213|NCT00989508|Perhexiline|perhexiline|mesh-list
24606214|NCT00989508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24606215|NCT00989508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24853442|NCT02268279|Solithromycin|solithromycin|mesh-list
24606243|NCT00989651|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24606245|NCT00989651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24606246|NCT00989651|Endothelial Growth Factors|endothelial growth factors|mesh-list
24606247|NCT00989651|Antibodies|antibodies|mesh-list
24606248|NCT00989651|Immunoglobulins|immunoglobulins|mesh-list
24606249|NCT00989651|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24606250|NCT00989651|Immunoglobulin G|immunoglobulin g|mesh-list
24606252|NCT00989651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24606297|NCT00989729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24606298|NCT00989729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24606299|NCT00989729|Prednisolone|prednisolone|mesh-list
24606300|NCT00989729|Prednisolone acetate|prednisolone acetate|mesh-list
24606301|NCT00989729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24606302|NCT00989729|Prednisolone phosphate|prednisolone phosphate|mesh-list
24606303|NCT00989729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24606304|NCT00989729|Antiemetics|antiemetics|mesh-ancestor
24606305|NCT00989729|Autonomic Agents|autonomic agents|mesh-ancestor
24606306|NCT00989729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24606307|NCT00989729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853444|NCT02268279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25407569|NCT03493932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25712334|NCT02318368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25712335|NCT02318368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770849|NCT03570476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25770850|NCT03570554|Acetaminophen|acetaminophen|mesh-list
25770851|NCT03570554|Celecoxib|celecoxib|mesh-list
25770852|NCT03570554|Naproxen|naproxen|mesh-list
25770853|NCT03570554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25770854|NCT03570554|Analgesics|analgesics|mesh-ancestor
25712336|NCT02318368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712337|NCT02318602|Cannabidiol|cannabidiol|mesh-list
25712338|NCT02318602|Anticonvulsants|anticonvulsants|mesh-ancestor
25712339|NCT02318667|Golimumab|golimumab|mesh-list
25712340|NCT02318667|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25712341|NCT02318667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25712342|NCT02318667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24606377|NCT00990197|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24606378|NCT00990197|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24606411|NCT00990392|Gramicidin|gramicidin|mesh-list
24606412|NCT00990392|Petrolatum|petrolatum|mesh-list
24606413|NCT00990392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24606414|NCT00990392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24606415|NCT00990392|Emollients|emollients|mesh-ancestor
24606422|NCT00990405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24606423|NCT00990405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606424|NCT00990405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606425|NCT00990405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24606503|NCT00990691|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24606504|NCT00990691|Antidepressive Agents|antidepressive agents|mesh-ancestor
24606505|NCT00990691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24606506|NCT00990691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606507|NCT00990691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606508|NCT00990691|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24606509|NCT00990691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24606510|NCT00990691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24606554|NCT00990847|Adrenergic Agents|adrenergic agents|mesh-ancestor
24606555|NCT00990847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24606556|NCT00990847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606558|NCT00990860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24606559|NCT00990860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24606625|NCT00991562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24606661|NCT00991627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24606662|NCT00991627|Adrenergic Agents|adrenergic agents|mesh-ancestor
24606663|NCT00991627|Nasal Decongestants|nasal decongestants|mesh-ancestor
24606704|NCT00991783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606708|NCT00991796|Paclitaxel|paclitaxel|mesh-list
24606709|NCT00991796|Carboplatin|carboplatin|mesh-list
24606710|NCT00991796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24606711|NCT00991796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24606712|NCT00991796|Tubulin Modulators|tubulin modulators|mesh-ancestor
24606713|NCT00991796|Antimitotic Agents|antimitotic agents|mesh-ancestor
24606714|NCT00991796|Mitosis Modulators|mitosis modulators|mesh-ancestor
24671253|NCT01324544|Sensory System Agents|sensory system agents|mesh-ancestor
24671254|NCT01324544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24671255|NCT01324544|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24671256|NCT01324583|Prednisolone|prednisolone|mesh-list
24671257|NCT01324583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24671258|NCT01324583|Glucocorticoids|glucocorticoids|mesh-ancestor
24606768|NCT05408481|Hydrocortisone|hydrocortisone|mesh-list
24606769|NCT05408481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24606814|NCT05408065|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24853489|NCT02268487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24853490|NCT02268565|Aspirin|aspirin|mesh-list
24606815|NCT05408065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24606816|NCT05408065|Glucocorticoids|glucocorticoids|mesh-ancestor
24606930|NCT05406934|Infliximab|infliximab|mesh-list
24606931|NCT05406934|Dermatologic Agents|dermatologic agents|mesh-ancestor
24606932|NCT05406934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25712343|NCT02318667|Immunologic Factors|immunologic factors|mesh-ancestor
24533470|NCT00644111|Anesthetics|anesthetics|mesh-ancestor
24450107|NCT00317785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25712344|NCT02318667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712345|NCT02318693|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25712346|NCT02318693|Glyburide|glyburide|mesh-list
25712347|NCT02318693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25712348|NCT02318693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712349|NCT02318693|Incretins|incretins|mesh-ancestor
25712350|NCT02318693|Hormones|hormones|mesh-ancestor
25770855|NCT03570554|Sensory System Agents|sensory system agents|mesh-ancestor
24533556|NCT00644371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533557|NCT00644371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24533559|NCT00644384|Keratolytic Agents|keratolytic agents|mesh-ancestor
24533560|NCT00644384|Dermatologic Agents|dermatologic agents|mesh-ancestor
24533562|NCT00644449|Levofloxacin|levofloxacin|mesh-list
24533563|NCT00644449|Ofloxacin|ofloxacin|mesh-list
24533564|NCT00644449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24458316|NCT00337493|Cyclosporine|cyclosporine|mesh-list
24458317|NCT00337493|Mycophenolic Acid|mycophenolic acid|mesh-list
24458318|NCT00337493|Tacrolimus|tacrolimus|mesh-list
24458319|NCT00337493|Cyclosporins|cyclosporins|mesh-list
24533628|NCT00644670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533629|NCT00644670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24533630|NCT00644670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24533631|NCT00644670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533632|NCT00644696|Cefixime|cefixime|mesh-list
24533633|NCT00644696|Cefpodoxime|cefpodoxime|mesh-list
25770856|NCT03570554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770857|NCT03570554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631971|NCT01121198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24533663|NCT00644748|Analgesics|analgesics|mesh-ancestor
24533681|NCT00644761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25712353|NCT02318693|Protease Inhibitors|protease inhibitors|mesh-ancestor
25712354|NCT02318693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712355|NCT02318693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712356|NCT02319031|Ribavirin|ribavirin|mesh-list
25712357|NCT02319031|Sofosbuvir|sofosbuvir|mesh-list
25712358|NCT02319031|Antimetabolites|antimetabolites|mesh-ancestor
25712359|NCT02319031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712360|NCT02319031|Antiviral Agents|antiviral agents|mesh-ancestor
25712361|NCT02319031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25712362|NCT02319044|Durvalumab|durvalumab|mesh-list
25712363|NCT02319044|Tremelimumab|tremelimumab|mesh-list
25712364|NCT02319044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25712365|NCT02319044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25712366|NCT02319044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712367|NCT02319044|Immunologic Factors|immunologic factors|mesh-ancestor
24533770|NCT00645086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24533771|NCT00645112|Azithromycin|azithromycin|mesh-list
24533772|NCT00645112|Cefdinir|cefdinir|mesh-list
24533773|NCT00645112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24533774|NCT00645112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25712368|NCT02319044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712369|NCT02319148|Itraconazole|itraconazole|mesh-list
24533775|NCT00645125|Amoxicillin|amoxicillin|mesh-list
25712371|NCT02319148|Diltiazem|diltiazem|mesh-list
25712372|NCT02319148|Antifungal Agents|antifungal agents|mesh-ancestor
24533776|NCT00645125|Cefdinir|cefdinir|mesh-list
24533777|NCT00645125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24533786|NCT00645151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533787|NCT00645151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24533789|NCT00645151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712373|NCT02319148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25712374|NCT02319148|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25712375|NCT02319148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25712376|NCT02319148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712377|NCT02319148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770859|NCT03570554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25712379|NCT02319148|Hormone Antagonists|hormone antagonists|mesh-ancestor
24498552|NCT00515268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498554|NCT00515281|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24498555|NCT00515281|Autonomic Agents|autonomic agents|mesh-ancestor
24498556|NCT00515281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24498557|NCT00515281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498558|NCT00515281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24498559|NCT00515281|Respiratory System Agents|respiratory system agents|mesh-ancestor
24498560|NCT00515281|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24498561|NCT00515281|Antioxidants|antioxidants|mesh-ancestor
24923007|NCT04174131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923009|NCT04174131|Immunologic Factors|immunologic factors|mesh-ancestor
24923010|NCT04174131|Viscosupplements|viscosupplements|mesh-ancestor
24923011|NCT04174131|Protective Agents|protective agents|mesh-ancestor
24923012|NCT04173858|Naloxegol|naloxegol|mesh-list
24923013|NCT04173858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24923014|NCT04173858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923015|NCT04173858|Sensory System Agents|sensory system agents|mesh-ancestor
24923016|NCT04173858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24923017|NCT04173988|Cyclophosphamide|cyclophosphamide|mesh-list
24923018|NCT04173988|Fludarabine|fludarabine|mesh-list
24923019|NCT04173988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25712380|NCT02319148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25712381|NCT02319148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712382|NCT02319148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25712383|NCT02319148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25770860|NCT03570554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25770861|NCT03570554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25770862|NCT03570554|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25770863|NCT03570554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25770864|NCT03570554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712384|NCT02319148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24923020|NCT04173988|Immunologic Factors|immunologic factors|mesh-ancestor
24923021|NCT04173988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923022|NCT04173988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24624169|NCT01074970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923136|NCT04172740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24923137|NCT04172740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923139|NCT04172363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24923140|NCT04172363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24923141|NCT04172311|Levetiracetam|levetiracetam|mesh-list
24923142|NCT04172311|Anticonvulsants|anticonvulsants|mesh-ancestor
24923235|NCT04171843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24923236|NCT04171388|Micronutrients|micronutrients|mesh-list
24923237|NCT04171388|Trace Elements|trace elements|mesh-list
24923238|NCT04171388|Azithromycin|azithromycin|mesh-list
24923239|NCT04171388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24923240|NCT04171388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24923246|NCT04171427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923247|NCT04171427|Antimanic Agents|antimanic agents|mesh-ancestor
24923248|NCT04171427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24923249|NCT04171427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24923250|NCT04171427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923251|NCT04171739|Itraconazole|itraconazole|mesh-list
24923253|NCT04171739|Rifampin|rifampin|mesh-list
24923254|NCT04171739|Antifungal Agents|antifungal agents|mesh-ancestor
24923271|NCT04171739|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24923344|NCT04171284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24923345|NCT04171284|Tubulin Modulators|tubulin modulators|mesh-ancestor
24923346|NCT04171284|Antimitotic Agents|antimitotic agents|mesh-ancestor
24923347|NCT04171284|Mitosis Modulators|mitosis modulators|mesh-ancestor
24923348|NCT04171284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923356|NCT04170855|Diuretics|diuretics|mesh-ancestor
24923388|NCT04170530|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24923389|NCT04170530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24923390|NCT04170530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24923392|NCT04170790|Saxagliptin|saxagliptin|mesh-list
24923406|NCT04170790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24923407|NCT04170647|Plasminogen|plasminogen|mesh-list
24923408|NCT04170647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24923409|NCT04170647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24923410|NCT04170647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923411|NCT04170439|Chromium|chromium|mesh-list
24923412|NCT04170439|Metformin|metformin|mesh-list
24923533|NCT04169763|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24923534|NCT04169763|Protease Inhibitors|protease inhibitors|mesh-ancestor
24923535|NCT04169763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24923536|NCT04169763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923580|NCT04169269|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24923582|NCT04169269|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24923583|NCT04169269|Protease Inhibitors|protease inhibitors|mesh-ancestor
24923584|NCT04169269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24923585|NCT04169269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499186|NCT00518193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24499187|NCT00518193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24499188|NCT00518232|Methylphenidate|methylphenidate|mesh-list
24499189|NCT00518232|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24499190|NCT00518232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24923586|NCT04169269|Anticoagulants|anticoagulants|mesh-ancestor
24923587|NCT04169269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24923588|NCT04169269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24923589|NCT04168879|Bupivacaine|bupivacaine|mesh-list
24923664|NCT04168099|Cefotaxime|cefotaxime|mesh-list
24923741|NCT04167280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24923742|NCT04167280|Respiratory System Agents|respiratory system agents|mesh-ancestor
24923743|NCT04167280|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24923744|NCT04167280|Cholinergic Agents|cholinergic agents|mesh-ancestor
24923745|NCT04167280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24923780|NCT04166604|Antimetabolites|antimetabolites|mesh-ancestor
24923781|NCT04166604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24923782|NCT04166604|Antiviral Agents|antiviral agents|mesh-ancestor
24624193|NCT01075113|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24624194|NCT01075126|Valproic Acid|valproic acid|mesh-list
24624195|NCT01075126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24624196|NCT01075126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25407570|NCT03493932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624197|NCT01075126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924043|NCT04164368|Growth Substances|growth substances|mesh-ancestor
24924044|NCT04164368|Growth Inhibitors|growth inhibitors|mesh-ancestor
24924045|NCT04164368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924046|NCT04164329|Anesthetics|anesthetics|mesh-list
24924401|NCT04160416|Capecitabine|capecitabine|mesh-list
24924051|NCT04164264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24924052|NCT04164264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24924053|NCT04164264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924054|NCT04164264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24924055|NCT04164264|Anesthetics, General|anesthetics, general|mesh-ancestor
24924057|NCT04163783|Zanubrutinib|zanubrutinib|mesh-list
24924058|NCT04163783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924059|NCT04163783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24499794|NCT00521157|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24924153|NCT04162535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24924154|NCT04162535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924155|NCT04162535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24924156|NCT04162535|Anesthetics, General|anesthetics, general|mesh-ancestor
24924157|NCT04162535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24924158|NCT04162535|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24924160|NCT04162522|Brexpiprazole|brexpiprazole|mesh-list
24924165|NCT04162522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24522954|NCT03012971|Narcotics|narcotics|mesh-ancestor
24522955|NCT02992522|Lenalidomide|lenalidomide|mesh-list
24624232|NCT01075477|Rituximab|rituximab|mesh-list
24499908|NCT00521482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24499909|NCT00521482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24499910|NCT00521482|Growth Substances|growth substances|mesh-ancestor
24499911|NCT00521482|Growth Inhibitors|growth inhibitors|mesh-ancestor
24499912|NCT00521521|Docetaxel|docetaxel|mesh-list
24924273|NCT04161339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924274|NCT04161339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24924275|NCT04161274|Silver Nitrate|silver nitrate|mesh-list
24924276|NCT04161274|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24924288|NCT04161404|Metformin|metformin|mesh-list
24924289|NCT04161404|Andrographolide|andrographolide|mesh-list
24924290|NCT04161404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24924291|NCT04161404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924292|NCT04161404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24924293|NCT04161404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24924294|NCT04161404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24924319|NCT04161014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924321|NCT04161053|Nitazoxanide|nitazoxanide|mesh-list
24924322|NCT04161053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24924323|NCT04161053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24924324|NCT04161053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24924325|NCT04161053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24924326|NCT04161001|Amlodipine|amlodipine|mesh-list
24924327|NCT04161001|Olmesartan|olmesartan|mesh-list
24924328|NCT04161001|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24924329|NCT04161001|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
24924330|NCT04161001|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24924331|NCT04161001|Ezetimibe|ezetimibe|mesh-list
24924346|NCT04161001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24924348|NCT04160936|Anesthetics, Local|anesthetics, local|mesh-ancestor
24924349|NCT04160936|Anesthetics|anesthetics|mesh-ancestor
24924350|NCT04160936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24924354|NCT04161027|Pregabalin|pregabalin|mesh-list
24924397|NCT04160676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924398|NCT04160676|Vitamins|vitamins|mesh-ancestor
24924399|NCT04160676|Micronutrients|micronutrients|mesh-ancestor
24924400|NCT04160676|Vitamin B Complex|vitamin b complex|mesh-ancestor
24924402|NCT04160416|Oxaliplatin|oxaliplatin|mesh-list
24924403|NCT04160416|Irinotecan|irinotecan|mesh-list
24924404|NCT04160416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25712385|NCT02319148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25712386|NCT02319148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25712387|NCT02319148|Vasodilator Agents|vasodilator agents|mesh-ancestor
24924405|NCT04160416|Antimetabolites|antimetabolites|mesh-ancestor
24924406|NCT04160416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924407|NCT04160416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924408|NCT04160416|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24924409|NCT04160416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24500064|NCT00522444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500174|NCT00523120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24500175|NCT00523120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24500176|NCT00523120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24500177|NCT00523120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396657|NCT00139620|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24500178|NCT00523120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500179|NCT00523133|Naltrexone|naltrexone|mesh-list
24500180|NCT00523133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24500181|NCT00523133|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24500182|NCT00523133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522965|NCT02992522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24522966|NCT02990338|Dexamethasone|dexamethasone|mesh-list
24522967|NCT02990338|Pomalidomide|pomalidomide|mesh-list
24522968|NCT02990338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24522969|NCT02990338|Antiemetics|antiemetics|mesh-ancestor
24522970|NCT02990338|Autonomic Agents|autonomic agents|mesh-ancestor
24522971|NCT02990338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24882310|NCT01495676|Cisplatin|cisplatin|mesh-list
24522972|NCT02990338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522974|NCT02990338|Glucocorticoids|glucocorticoids|mesh-ancestor
24522975|NCT02990338|Hormones|hormones|mesh-ancestor
24924566|NCT04158947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924567|NCT04158947|Tubulin Modulators|tubulin modulators|mesh-ancestor
24924568|NCT04158947|Antimitotic Agents|antimitotic agents|mesh-ancestor
24924569|NCT04158947|Mitosis Modulators|mitosis modulators|mesh-ancestor
24500241|NCT00523406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24500242|NCT00523406|Glucocorticoids|glucocorticoids|mesh-ancestor
24500243|NCT00523406|Hormones|hormones|mesh-ancestor
24924613|NCT04158830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924614|NCT04158830|Antipyretics|antipyretics|mesh-ancestor
24924615|NCT04158856|Trastuzumab|trastuzumab|mesh-list
24924616|NCT04158856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24924617|NCT04158856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924618|NCT04158076|Amlodipine|amlodipine|mesh-list
24924619|NCT04158076|Telmisartan|telmisartan|mesh-list
24523008|NCT02954991|Mocetinostat|mocetinostat|mesh-list
24523009|NCT02954991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24523010|NCT02954991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924631|NCT04158076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24924632|NCT04158076|Antimetabolites|antimetabolites|mesh-ancestor
24924633|NCT04158076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24924634|NCT04158076|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24924635|NCT04158076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924636|NCT04158076|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24924637|NCT04158076|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24924638|NCT04158102|Bupivacaine|bupivacaine|mesh-list
24924639|NCT04158102|Anesthetics, Local|anesthetics, local|mesh-ancestor
24924640|NCT04158102|Anesthetics|anesthetics|mesh-ancestor
25712388|NCT02319148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25712389|NCT02319304|Leucovorin|leucovorin|mesh-list
25712390|NCT02319304|Fluorouracil|fluorouracil|mesh-list
25712391|NCT02319304|Oxaliplatin|oxaliplatin|mesh-list
25712392|NCT02319304|Antimetabolites|antimetabolites|mesh-ancestor
25712393|NCT02319304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712394|NCT02319304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25712395|NCT02319304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712396|NCT02319304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24924641|NCT04158102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24924700|NCT04157699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924701|NCT04157699|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24924702|NCT04157699|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24500371|NCT00524069|Gemcitabine|gemcitabine|mesh-list
24500372|NCT00524069|Bevacizumab|bevacizumab|mesh-list
24500375|NCT00524069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24500376|NCT00524069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24500377|NCT00524069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24500378|NCT00524069|Growth Substances|growth substances|mesh-ancestor
24523064|NCT02897050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24523085|NCT02821507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24924733|NCT04157010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24924734|NCT04157010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24500404|NCT00524160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24500405|NCT00524160|Narcotics|narcotics|mesh-ancestor
24500406|NCT00524160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24500407|NCT00524160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500408|NCT00524160|Analgesics|analgesics|mesh-ancestor
24500409|NCT00524160|Sensory System Agents|sensory system agents|mesh-ancestor
24500410|NCT00524160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24924805|NCT04156451|Furosemide|furosemide|mesh-list
24924860|NCT04156035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24924861|NCT04156035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24924862|NCT04156035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24924863|NCT04156035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24924866|NCT04156152|Sodium Fluoride|sodium fluoride|mesh-list
24924867|NCT04156152|Cariostatic Agents|cariostatic agents|mesh-ancestor
24924868|NCT04156152|Protective Agents|protective agents|mesh-ancestor
24924869|NCT04156152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924870|NCT04156152|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24924871|NCT04156152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24924872|NCT04155814|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24924873|NCT04155814|Hematinics|hematinics|mesh-ancestor
24924874|NCT04155879|Colchicine|colchicine|mesh-list
24924875|NCT04155879|Gout Suppressants|gout suppressants|mesh-ancestor
24924876|NCT04155879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24924877|NCT04155879|Tubulin Modulators|tubulin modulators|mesh-ancestor
24500545|NCT00524875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500546|NCT00524875|Growth Inhibitors|growth inhibitors|mesh-ancestor
24500547|NCT00524901|Epoetin Alfa|epoetin alfa|mesh-list
24924902|NCT04155918|Protective Agents|protective agents|mesh-ancestor
24924903|NCT04155918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24924904|NCT04155697|Ethanol|ethanol|mesh-list
24523143|NCT02512497|Busulfan|busulfan|mesh-list
24500594|NCT00525200|Docetaxel|docetaxel|mesh-list
24500595|NCT00525200|Cisplatin|cisplatin|mesh-list
24500596|NCT00525200|Fluorouracil|fluorouracil|mesh-list
24500597|NCT00525200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24500598|NCT00525200|Tubulin Modulators|tubulin modulators|mesh-ancestor
24500599|NCT00525200|Antimitotic Agents|antimitotic agents|mesh-ancestor
24500607|NCT00525239|Ritonavir|ritonavir|mesh-list
24523156|NCT02512497|Alkylating Agents|alkylating agents|mesh-ancestor
24523157|NCT02512497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24523158|NCT02512497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24624273|NCT01075555|Sorafenib|sorafenib|mesh-list
24624315|NCT01075698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24624316|NCT01075698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24624317|NCT01075711|Prednisone|prednisone|mesh-list
24624318|NCT01075711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24624319|NCT01075711|Glucocorticoids|glucocorticoids|mesh-ancestor
24624320|NCT01075711|Hormones|hormones|mesh-ancestor
24624321|NCT01075711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24624322|NCT01075711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712397|NCT02319304|Immunologic Factors|immunologic factors|mesh-ancestor
25712398|NCT02319304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712399|NCT02319304|Antidotes|antidotes|mesh-ancestor
24624323|NCT01075711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24523182|NCT02403310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24523183|NCT02403310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25712400|NCT02319304|Protective Agents|protective agents|mesh-ancestor
25712401|NCT02319304|Vitamin B Complex|vitamin b complex|mesh-ancestor
25712402|NCT02319304|Vitamins|vitamins|mesh-ancestor
25712403|NCT02319304|Micronutrients|micronutrients|mesh-ancestor
24523184|NCT02403310|Immunologic Factors|immunologic factors|mesh-ancestor
24523185|NCT02403310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523186|NCT02403310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24523187|NCT02403310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24523188|NCT02403310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24523189|NCT02403310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24523202|NCT02389036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24924929|NCT04155515|Yimitasvir|yimitasvir|mesh-list
24924930|NCT04155515|Antimetabolites|antimetabolites|mesh-ancestor
24924931|NCT04155515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24924932|NCT04155515|Antiviral Agents|antiviral agents|mesh-ancestor
24924933|NCT04155515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24924934|NCT04155229|Acetaminophen|acetaminophen|mesh-list
24924935|NCT04155229|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
24924936|NCT04155229|Oxycodone|oxycodone|mesh-list
24924937|NCT04155229|Hydrocodone|hydrocodone|mesh-list
24924938|NCT04155229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24924939|NCT04155229|Analgesics|analgesics|mesh-ancestor
24924940|NCT04155229|Sensory System Agents|sensory system agents|mesh-ancestor
24924979|NCT04154813|Topiramate|topiramate|mesh-list
24924980|NCT04154813|Fluoxetine|fluoxetine|mesh-list
24924981|NCT04154813|Anticonvulsants|anticonvulsants|mesh-ancestor
24924982|NCT04154813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24924983|NCT04154813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523204|NCT02389036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24523205|NCT02389036|Antifungal Agents|antifungal agents|mesh-ancestor
24523206|NCT02389036|Ionophores|ionophores|mesh-ancestor
24523207|NCT02389036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24523241|NCT02341911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24523242|NCT02341911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24924995|NCT04154813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24924996|NCT04154982|Acetylcysteine|acetylcysteine|mesh-list
24924997|NCT04154982|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24924998|NCT04154982|Antiviral Agents|antiviral agents|mesh-ancestor
24924999|NCT04154982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24925000|NCT04154982|Expectorants|expectorants|mesh-ancestor
24882681|NCT05148377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24925001|NCT04154982|Respiratory System Agents|respiratory system agents|mesh-ancestor
24925002|NCT04154982|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24925003|NCT04154982|Antioxidants|antioxidants|mesh-ancestor
24925004|NCT04154982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535221|NCT00648804|Serotonin Agents|serotonin agents|mesh-ancestor
24535222|NCT00648804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24523337|NCT01754857|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24523338|NCT01754857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24523339|NCT01754857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24523340|NCT01754857|Immunologic Factors|immunologic factors|mesh-ancestor
24523341|NCT01754857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523342|NCT01754857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24523343|NCT01754857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24925077|NCT04154449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24925078|NCT04154449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925081|NCT04153968|Retinol acetate|retinol acetate|mesh-list
24925082|NCT04153968|Protective Agents|protective agents|mesh-ancestor
24925083|NCT04153968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925084|NCT04153968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24925085|NCT04153968|Immunologic Factors|immunologic factors|mesh-ancestor
24925107|NCT04153487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925109|NCT04153487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925110|NCT04153487|Protective Agents|protective agents|mesh-ancestor
24925121|NCT04153734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500809|NCT00525759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500810|NCT00525759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24500811|NCT00525759|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24500812|NCT00525759|Tubulin Modulators|tubulin modulators|mesh-ancestor
24925188|NCT04152759|Golimumab|golimumab|mesh-list
24925189|NCT04152759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24925190|NCT04152759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24925191|NCT04152759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24925192|NCT04152759|Immunologic Factors|immunologic factors|mesh-ancestor
24925193|NCT04152759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925202|NCT04152889|Docetaxel|docetaxel|mesh-list
24398186|NCT00143715|Vitamin K 1|vitamin k 1|mesh-list
24398187|NCT00143715|Vitamins|vitamins|mesh-ancestor
25712405|NCT02319369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25712406|NCT02319369|Antimetabolites|antimetabolites|mesh-ancestor
25712407|NCT02319369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712408|NCT02319369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712409|NCT02319369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712410|NCT02319486|Carboplatin|carboplatin|mesh-list
24398188|NCT00143715|Micronutrients|micronutrients|mesh-ancestor
25712411|NCT02319486|Etoposide|etoposide|mesh-list
24925209|NCT04152434|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
24925792|NCT04147806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24925215|NCT04152629|Methylphenidate|methylphenidate|mesh-list
24925216|NCT04152629|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
24925217|NCT04152629|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24925223|NCT04152629|Dopamine Agents|dopamine agents|mesh-ancestor
24523515|NCT05342389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24523516|NCT05342389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24523517|NCT05342389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523518|NCT05342272|Lactoferrin|lactoferrin|mesh-list
24523519|NCT05342272|Betaine|betaine|mesh-list
24523520|NCT05342272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24523525|NCT05342272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925253|NCT04152057|Mitosis Modulators|mitosis modulators|mesh-ancestor
24500942|NCT00526305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24523541|NCT05341999|Ibuprofen|ibuprofen|mesh-list
24523542|NCT05341999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24925318|NCT04151381|Autonomic Agents|autonomic agents|mesh-ancestor
24925319|NCT04151381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24925320|NCT04151381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925321|NCT04151381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24925322|NCT04151381|Respiratory System Agents|respiratory system agents|mesh-ancestor
24925323|NCT04151381|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24925432|NCT04150367|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24925433|NCT04150367|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24925439|NCT04150172|Rebamipide|rebamipide|mesh-list
24506149|NCT00544219|Vincristine|vincristine|mesh-list
24925455|NCT04149938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24925457|NCT04149938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24925458|NCT04149938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925459|NCT04150146|Rebamipide|rebamipide|mesh-list
24925490|NCT04149678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24925491|NCT04149678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24925492|NCT04149678|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24925493|NCT04149626|Midazolam|midazolam|mesh-list
24925495|NCT04149626|Remifentanil|remifentanil|mesh-list
24925559|NCT04149067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925560|NCT04149067|Incretins|incretins|mesh-ancestor
24925609|NCT04149132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24925610|NCT04149132|Antioxidants|antioxidants|mesh-ancestor
24925611|NCT04149132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925612|NCT04149132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24925613|NCT04149132|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24925614|NCT04149132|Vasodilator Agents|vasodilator agents|mesh-ancestor
24523937|NCT05338489|Hormone Antagonists|hormone antagonists|mesh-ancestor
24523938|NCT05338489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24523939|NCT05338489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523940|NCT05338489|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24523941|NCT05338489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24523942|NCT05338489|Antitubercular Agents|antitubercular agents|mesh-ancestor
24925677|NCT04148599|Anesthetics|anesthetics|mesh-ancestor
24925678|NCT04148599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24925679|NCT04148599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925680|NCT04148599|Sensory System Agents|sensory system agents|mesh-ancestor
24925681|NCT04148599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24925682|NCT04148599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24925689|NCT04148599|Analgesics|analgesics|mesh-ancestor
24925789|NCT04147806|Glucocorticoids|glucocorticoids|mesh-ancestor
24925790|NCT04147806|Hormones|hormones|mesh-ancestor
25712412|NCT02319486|Vincristine|vincristine|mesh-list
24925791|NCT04147806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24925794|NCT04147806|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24925795|NCT04147806|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24925796|NCT04147806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24925797|NCT04147806|Adrenergic Agents|adrenergic agents|mesh-ancestor
24925798|NCT04147806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24925799|NCT04147806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925800|NCT04147806|Urological Agents|urological agents|mesh-ancestor
24925802|NCT04147754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24925803|NCT04147754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925804|NCT04147754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24925805|NCT04147754|Narcotics|narcotics|mesh-ancestor
24925806|NCT04147754|Analgesics|analgesics|mesh-ancestor
24925807|NCT04147754|Sensory System Agents|sensory system agents|mesh-ancestor
24925808|NCT04147754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24925809|NCT04147845|Triamcinolone|triamcinolone|mesh-list
24925810|NCT04147845|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24925811|NCT04147845|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24925812|NCT04147845|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24925815|NCT04147845|Hormones|hormones|mesh-ancestor
24925826|NCT04147728|Growth Inhibitors|growth inhibitors|mesh-ancestor
24925827|NCT04147728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24925829|NCT04147286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24925830|NCT04147286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24925831|NCT04147286|Antimetabolites|antimetabolites|mesh-ancestor
24925832|NCT04147286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925833|NCT04147286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24925834|NCT04147286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24925835|NCT04147286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925837|NCT04147208|Entecavir|entecavir|mesh-list
24925838|NCT04147208|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24925839|NCT04147208|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24925840|NCT04147208|Protease Inhibitors|protease inhibitors|mesh-ancestor
24925841|NCT04147208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925843|NCT04147208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24925881|NCT04147260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925882|NCT04147260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24925883|NCT04147260|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24925884|NCT04147260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24925885|NCT04146883|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24925886|NCT04146883|Cephalexin|cephalexin|mesh-list
24925887|NCT04146883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24925888|NCT04146610|Antibodies|antibodies|mesh-list
24925889|NCT04146610|Immunoconjugates|immunoconjugates|mesh-list
24925907|NCT04146493|Anticoagulants|anticoagulants|mesh-ancestor
24925908|NCT04146493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24925909|NCT04146493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24925910|NCT04146493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925911|NCT04146532|Aspirin|aspirin|mesh-list
24925912|NCT04146532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24925913|NCT04146532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24925914|NCT04146532|Analgesics|analgesics|mesh-ancestor
24925915|NCT04146532|Sensory System Agents|sensory system agents|mesh-ancestor
24925916|NCT04146532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24925917|NCT04146532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925918|NCT04146532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24925919|NCT04146532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24925920|NCT04146532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24925921|NCT04146532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24925922|NCT04146532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925923|NCT04146532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24925924|NCT04146532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24925925|NCT04146532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925926|NCT04146532|Antipyretics|antipyretics|mesh-ancestor
24925927|NCT04146155|Liraglutide|liraglutide|mesh-list
24925928|NCT04146155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24925929|NCT04146155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925930|NCT04146155|Incretins|incretins|mesh-ancestor
25712413|NCT02319486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24925934|NCT04146259|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
24925935|NCT04146259|Calcium Carbonate|calcium carbonate|mesh-list
25712414|NCT02319486|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25712415|NCT02319486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24925939|NCT04146259|Antacids|antacids|mesh-ancestor
24925948|NCT04145856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925960|NCT04146116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24501702|NCT00530517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24524017|NCT05325489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24524018|NCT05325489|Respiratory System Agents|respiratory system agents|mesh-ancestor
24524019|NCT05325489|Glucocorticoids|glucocorticoids|mesh-ancestor
24524020|NCT05325489|Hormones|hormones|mesh-ancestor
24524021|NCT05325489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24524022|NCT05322031|Aripiprazole|aripiprazole|mesh-list
24524023|NCT05322031|Antidepressive Agents|antidepressive agents|mesh-ancestor
24524024|NCT05322031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24524025|NCT05322031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24524026|NCT05322031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24524044|NCT05319093|Immunologic Factors|immunologic factors|mesh-ancestor
24524045|NCT05319093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524047|NCT05314660|Cariostatic Agents|cariostatic agents|mesh-ancestor
24524048|NCT05314660|Protective Agents|protective agents|mesh-ancestor
24524049|NCT05314660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524050|NCT05307003|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24524051|NCT05307003|Trazodone|trazodone|mesh-list
24925962|NCT04145804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24925963|NCT04145804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925964|NCT04145583|Voriconazole|voriconazole|mesh-list
24925970|NCT04145583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925971|NCT04145583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24925972|NCT04145583|Hormone Antagonists|hormone antagonists|mesh-ancestor
24925973|NCT04145583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24925974|NCT04145583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925975|NCT04145583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24925976|NCT04145570|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24925977|NCT04145570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24925978|NCT04145570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24925979|NCT04145570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24925980|NCT04145570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24925982|NCT04145492|Cholecalciferol|cholecalciferol|mesh-list
24925983|NCT04145492|Calcifediol|calcifediol|mesh-list
24925984|NCT04145492|Vitamins|vitamins|mesh-list
24925985|NCT04145492|Vitamin K|vitamin k|mesh-list
24925986|NCT04145492|Vitamin K 2|vitamin k 2|mesh-list
24925987|NCT04145492|Micronutrients|micronutrients|mesh-ancestor
24925988|NCT04145492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24925989|NCT04145492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24925990|NCT04145492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24524052|NCT05307003|Antidepressive Agents|antidepressive agents|mesh-ancestor
24524053|NCT05307003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24624391|NCT01075945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24501759|NCT00530907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24524065|NCT05307003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24624393|NCT01076062|Oxytocin|oxytocin|mesh-list
24624394|NCT01076062|Oxytocics|oxytocics|mesh-ancestor
24624395|NCT01076062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24624396|NCT01076062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624399|NCT01076062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24624400|NCT01076062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24926020|NCT04145193|Immunologic Factors|immunologic factors|mesh-ancestor
24926021|NCT04145193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926022|NCT04145193|Antidotes|antidotes|mesh-ancestor
24926023|NCT04145193|Protective Agents|protective agents|mesh-ancestor
24926024|NCT04145193|Vitamin B Complex|vitamin b complex|mesh-ancestor
24926025|NCT04145193|Vitamins|vitamins|mesh-ancestor
24926026|NCT04145193|Micronutrients|micronutrients|mesh-ancestor
25712416|NCT02319486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25712417|NCT02319486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712418|NCT02319486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712419|NCT02319486|Tubulin Modulators|tubulin modulators|mesh-ancestor
25712420|NCT02319486|Antimitotic Agents|antimitotic agents|mesh-ancestor
25712421|NCT02319486|Mitosis Modulators|mitosis modulators|mesh-ancestor
25712422|NCT02319642|Certolizumab Pegol|certolizumab pegol|mesh-list
25712423|NCT02319642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25712424|NCT02319642|Immunologic Factors|immunologic factors|mesh-ancestor
24926091|NCT04144933|Sevoflurane|sevoflurane|mesh-list
24926092|NCT04144933|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24926093|NCT04144933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24926094|NCT04144933|Antiemetics|antiemetics|mesh-ancestor
24926095|NCT04144933|Autonomic Agents|autonomic agents|mesh-ancestor
24926096|NCT04144933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24926097|NCT04144933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926100|NCT04144933|Hormones|hormones|mesh-ancestor
24926149|NCT04144439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926150|NCT04144439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926152|NCT04144218|Anticonvulsants|anticonvulsants|mesh-ancestor
24926153|NCT04144218|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24926154|NCT04144218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24524077|NCT05282277|Progesterone|progesterone|mesh-list
24524078|NCT05282277|Estrogens|estrogens|mesh-ancestor
24524079|NCT05282277|Hormones|hormones|mesh-ancestor
24524080|NCT05282277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24524081|NCT05282277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524082|NCT05282277|Progestins|progestins|mesh-ancestor
24524083|NCT05282277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24926156|NCT04144218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926157|NCT04144153|Analgesics, Opioid|analgesics, opioid|mesh-list
24926158|NCT04144153|Anesthetics|anesthetics|mesh-list
24926165|NCT04144101|Etoricoxib|etoricoxib|mesh-list
24926169|NCT04144101|Analgesics|analgesics|mesh-ancestor
24926170|NCT04144101|Sensory System Agents|sensory system agents|mesh-ancestor
24926171|NCT04144101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24926172|NCT04144101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926173|NCT04144101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24926174|NCT04144101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24926175|NCT04144101|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24926176|NCT04144101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24926177|NCT04144101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24926181|NCT04143880|Hormones|hormones|mesh-ancestor
24524123|NCT05252923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524125|NCT05252923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24524126|NCT05252923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24524127|NCT05252923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24524128|NCT05252923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926320|NCT04142762|Itraconazole|itraconazole|mesh-list
24926322|NCT04142762|Midazolam|midazolam|mesh-list
24926323|NCT04142762|Esomeprazole|esomeprazole|mesh-list
24926324|NCT04142762|Levonorgestrel|levonorgestrel|mesh-list
24926325|NCT04142762|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24926326|NCT04142762|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
24926327|NCT04142762|Contraceptive Agents|contraceptive agents|mesh-list
24926328|NCT04142762|Contraceptives, Oral|contraceptives, oral|mesh-list
24926329|NCT04142762|Estradiol|estradiol|mesh-list
24624417|NCT01076322|Albuterol|albuterol|mesh-list
24624418|NCT01076322|Procaterol|procaterol|mesh-list
24624419|NCT01076322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24624420|NCT01076322|Autonomic Agents|autonomic agents|mesh-ancestor
24624421|NCT01076322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24624422|NCT01076322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624423|NCT01076322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24624424|NCT01076322|Respiratory System Agents|respiratory system agents|mesh-ancestor
24624425|NCT01076322|Tocolytic Agents|tocolytic agents|mesh-ancestor
24624426|NCT01076322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24524226|NCT05149898|Cannabidiol|cannabidiol|mesh-list
24624457|NCT01076478|Cilostazol|cilostazol|mesh-list
24624458|NCT01076478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24524260|NCT05074823|Anesthetics, General|anesthetics, general|mesh-ancestor
24926601|NCT04140058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24926602|NCT04140058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24926603|NCT04140058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24926604|NCT04140058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24926605|NCT04140188|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
24926606|NCT04140188|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24926614|NCT04140136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24926616|NCT04140136|Micronutrients|micronutrients|mesh-ancestor
24400601|NCT00150982|Dermatologic Agents|dermatologic agents|mesh-ancestor
24524445|NCT04914741|Vincristine|vincristine|mesh-list
24524446|NCT04914741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24524447|NCT04914741|Immunologic Factors|immunologic factors|mesh-ancestor
25712425|NCT02319642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524448|NCT04914741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524449|NCT04914741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24524450|NCT04914741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24524451|NCT04914741|Alkylating Agents|alkylating agents|mesh-ancestor
24524452|NCT04914741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24926630|NCT04139824|Analgesics|analgesics|mesh-ancestor
24926631|NCT04139824|Sensory System Agents|sensory system agents|mesh-ancestor
24926632|NCT04139824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24926634|NCT04139824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24926671|NCT04139629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524555|NCT04710277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24524556|NCT04703075|Rifapentine|rifapentine|mesh-list
24926718|NCT04139070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24926719|NCT04139070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926720|NCT04138901|Ropivacaine|ropivacaine|mesh-list
24926781|NCT04138836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24926787|NCT04138719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24926788|NCT04138719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24926789|NCT04138719|Tubulin Modulators|tubulin modulators|mesh-ancestor
24926790|NCT04138719|Antimitotic Agents|antimitotic agents|mesh-ancestor
24926791|NCT04138719|Mitosis Modulators|mitosis modulators|mesh-ancestor
24502615|NCT04748172|Antibodies|antibodies|mesh-list
24524557|NCT04703075|Rifampin|rifampin|mesh-list
24926847|NCT04137978|Respiratory System Agents|respiratory system agents|mesh-ancestor
24926848|NCT04138004|Lubiprostone|lubiprostone|mesh-list
24926849|NCT04138004|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24927037|NCT04136470|Nivolumab|nivolumab|mesh-list
24927038|NCT04136470|Ipilimumab|ipilimumab|mesh-list
24927039|NCT04136470|Atezolizumab|atezolizumab|mesh-list
24927040|NCT04136470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24524846|NCT04276259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524847|NCT04276259|Analgesics|analgesics|mesh-ancestor
24524848|NCT04276259|Sensory System Agents|sensory system agents|mesh-ancestor
24524849|NCT04276259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24524850|NCT04276259|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24524851|NCT04276259|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24524853|NCT04267926|Micronutrients|micronutrients|mesh-ancestor
24524854|NCT04267926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524855|NCT04243278|Aspirin|aspirin|mesh-list
24524856|NCT04243278|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24524857|NCT04243278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24524858|NCT04243278|Analgesics|analgesics|mesh-ancestor
24524859|NCT04243278|Sensory System Agents|sensory system agents|mesh-ancestor
24524860|NCT04243278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24524861|NCT04243278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927100|NCT04135833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24927101|NCT04135833|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24927102|NCT04135833|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24524864|NCT04243278|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24524865|NCT04243278|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24524866|NCT04243278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524867|NCT04243278|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24524868|NCT04243278|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24524869|NCT04243278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24524870|NCT04243278|Antipyretics|antipyretics|mesh-ancestor
24524871|NCT04243122|Aspirin|aspirin|mesh-list
24927124|NCT04135781|Mitosis Modulators|mitosis modulators|mesh-ancestor
24927125|NCT04135781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927126|NCT04135781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24927127|NCT04135781|Antimetabolites|antimetabolites|mesh-ancestor
24927128|NCT04135508|Adalimumab|adalimumab|mesh-list
24927129|NCT04135508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24927130|NCT04135508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24927146|NCT04135690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24927147|NCT04135690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927195|NCT04134611|Viscosupplements|viscosupplements|mesh-ancestor
24927196|NCT04134611|Protective Agents|protective agents|mesh-ancestor
24927198|NCT04134650|Linagliptin|linagliptin|mesh-list
24624467|NCT01076478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24624468|NCT01076478|Vasodilator Agents|vasodilator agents|mesh-ancestor
24624469|NCT01076478|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25712426|NCT02319642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24624490|NCT01076556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24624492|NCT01076556|Immunoglobulins|immunoglobulins|mesh-list
24624493|NCT01076556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24624494|NCT01076556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24624495|NCT01076556|Immunologic Factors|immunologic factors|mesh-ancestor
24624496|NCT01076556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624497|NCT01076556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24401678|NCT00153660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525218|NCT03812588|Antidepressive Agents|antidepressive agents|mesh-ancestor
24525219|NCT03812588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24525221|NCT03809988|Fulvestrant|fulvestrant|mesh-list
24525222|NCT03809988|Palbociclib|palbociclib|mesh-list
24525223|NCT03809988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525224|NCT03809988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24525225|NCT03809988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24525226|NCT03809988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525227|NCT03809988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525228|NCT03809988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24525229|NCT03809988|Hormone Antagonists|hormone antagonists|mesh-ancestor
24525230|NCT03809988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24525231|NCT03809988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927346|NCT04133974|Analgesics|analgesics|mesh-ancestor
24927394|NCT04133337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24927395|NCT04133337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927396|NCT04133337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927397|NCT04133506|Aspirin|aspirin|mesh-list
24927398|NCT04133506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24927399|NCT04133506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24927400|NCT04133506|Analgesics|analgesics|mesh-ancestor
24927401|NCT04133506|Sensory System Agents|sensory system agents|mesh-ancestor
24927440|NCT04133051|Anesthetics|anesthetics|mesh-ancestor
24927441|NCT04133051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24927442|NCT04133051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927443|NCT04133051|Sensory System Agents|sensory system agents|mesh-ancestor
24927444|NCT04133051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24927445|NCT04132583|Diclofenac|diclofenac|mesh-list
24927446|NCT04132583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24927447|NCT04132583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24927448|NCT04132583|Analgesics|analgesics|mesh-ancestor
24751631|NCT01705223|Vaccines|vaccines|mesh-list
24927450|NCT04132583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24525533|NCT03188068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24525534|NCT03188068|Glucocorticoids|glucocorticoids|mesh-ancestor
24525535|NCT03188068|Hormones|hormones|mesh-ancestor
24525536|NCT03188068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24525537|NCT03188068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24525538|NCT03181789|Interleukin-12|interleukin-12|mesh-list
24525539|NCT03181789|Vaccines|vaccines|mesh-list
24525540|NCT03181789|Immunologic Factors|immunologic factors|mesh-ancestor
24525834|NCT02684851|Coagulants|coagulants|mesh-ancestor
24525541|NCT03181789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525542|NCT03181789|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24927514|NCT04132570|Glucocorticoids|glucocorticoids|mesh-ancestor
24927515|NCT04132570|Hormones|hormones|mesh-ancestor
24927516|NCT04132570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24927517|NCT04132349|Ulipristal acetate|ulipristal acetate|mesh-list
24927518|NCT04132349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24927519|NCT04132349|Contraceptive Agents|contraceptive agents|mesh-ancestor
24927520|NCT04132349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24927521|NCT04132349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927522|NCT04132349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24525690|NCT02883400|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24525692|NCT02883400|Natriuretic Agents|natriuretic agents|mesh-ancestor
24525693|NCT02869217|Cyclophosphamide|cyclophosphamide|mesh-list
24525694|NCT02869217|Fludarabine|fludarabine|mesh-list
24525695|NCT02869217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24525696|NCT02869217|Immunologic Factors|immunologic factors|mesh-ancestor
24525700|NCT02869217|Alkylating Agents|alkylating agents|mesh-ancestor
24525701|NCT02869217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712427|NCT02319668|Chlorhexidine|chlorhexidine|mesh-list
24525702|NCT02869217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525703|NCT02869217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24525704|NCT02856594|Dexmedetomidine|dexmedetomidine|mesh-list
24525705|NCT02856594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24927581|NCT04131621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24927582|NCT04131621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927583|NCT04131621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24927584|NCT04131621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927585|NCT04131348|Botulinum Toxins|botulinum toxins|mesh-list
24927586|NCT04131348|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24927587|NCT04131348|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24927588|NCT04131348|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24927636|NCT04131309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24927637|NCT04131309|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24927638|NCT04131309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927639|NCT04131231|Aldesleukin|aldesleukin|mesh-list
24927640|NCT04131231|Methotrexate|methotrexate|mesh-list
24927641|NCT04131231|Interleukin-2|interleukin-2|mesh-list
24927642|NCT04131231|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24927643|NCT04131231|Abortifacient Agents|abortifacient agents|mesh-ancestor
24927644|NCT04131231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24927645|NCT04131231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927646|NCT04131231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24927647|NCT04131231|Antimetabolites|antimetabolites|mesh-ancestor
24927648|NCT04131231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927649|NCT04131231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927650|NCT04131231|Dermatologic Agents|dermatologic agents|mesh-ancestor
24927651|NCT04131231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24525773|NCT02757872|Vitamin D|vitamin d|mesh-list
24927711|NCT04130477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927713|NCT04130230|Neostigmine|neostigmine|mesh-list
24927714|NCT04130230|Lipotropic Agents|lipotropic agents|mesh-ancestor
24927715|NCT04130230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24927716|NCT04130230|Antimetabolites|antimetabolites|mesh-ancestor
24927717|NCT04130230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927718|NCT04130230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24751991|NCT01707537|Vaccines|vaccines|mesh-list
24927719|NCT04130230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24927720|NCT04130230|Nootropic Agents|nootropic agents|mesh-ancestor
24927721|NCT04130230|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24927722|NCT04130230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927723|NCT04130230|Cholinergic Agents|cholinergic agents|mesh-ancestor
24927724|NCT04130230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24927725|NCT04130230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927726|NCT04130230|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24927727|NCT04130230|Autonomic Agents|autonomic agents|mesh-ancestor
24525825|NCT02685709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24525826|NCT02685709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24525827|NCT02685709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525828|NCT02684851|Fibrinolytic Agents|fibrinolytic agents|mesh-list
24525829|NCT02684851|Tranexamic Acid|tranexamic acid|mesh-list
24525830|NCT02684851|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
24525831|NCT02684851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24525832|NCT02684851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525833|NCT02684851|Hemostatics|hemostatics|mesh-ancestor
24525835|NCT02653482|Dapagliflozin|dapagliflozin|mesh-list
24525836|NCT02653482|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24525837|NCT02653482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525850|NCT02619253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24525862|NCT02586207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525863|NCT02586207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24525864|NCT02571725|Olaparib|olaparib|mesh-list
24927772|NCT04129736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24525886|NCT02519777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525888|NCT02519777|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24525907|NCT02441491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24927803|NCT04129710|Growth Substances|growth substances|mesh-ancestor
24927804|NCT04129710|Growth Inhibitors|growth inhibitors|mesh-ancestor
24927806|NCT04129424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24927807|NCT04129424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927808|NCT04129255|Octreotide|octreotide|mesh-list
25712428|NCT02319668|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25712429|NCT02319668|Listerine|listerine|mesh-list
25712430|NCT02319668|Fluorides|fluorides|mesh-list
25712431|NCT02319668|Sodium Fluoride|sodium fluoride|mesh-list
25712432|NCT02319668|Cariostatic Agents|cariostatic agents|mesh-ancestor
24927809|NCT04129255|Somatostatin|somatostatin|mesh-list
24927810|NCT04129255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24927811|NCT04129255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24927812|NCT04129255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927813|NCT04129255|Hormones|hormones|mesh-ancestor
24927814|NCT04129255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24525966|NCT02265367|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24525967|NCT02265367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24525968|NCT02265367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24927830|NCT04128800|Apatinib|apatinib|mesh-list
24927831|NCT04128800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927834|NCT04128800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927835|NCT04129008|Aspirin|aspirin|mesh-list
24927836|NCT04129008|Indobufen|indobufen|mesh-list
24927837|NCT04129008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24927838|NCT04129008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24927839|NCT04129008|Analgesics|analgesics|mesh-ancestor
24927840|NCT04129008|Sensory System Agents|sensory system agents|mesh-ancestor
24927841|NCT04129008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24927842|NCT04129008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24927843|NCT04129008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24927844|NCT04129008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24927875|NCT04128462|Antimetabolites|antimetabolites|mesh-ancestor
24927876|NCT04128462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927877|NCT04128462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526372|NCT00611416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526373|NCT00611416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24526374|NCT00611416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24526375|NCT00611416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526376|NCT00611416|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24927952|NCT04127721|Antimetabolites|antimetabolites|mesh-ancestor
24927953|NCT04127721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24927954|NCT04127721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24927955|NCT04127721|Dermatologic Agents|dermatologic agents|mesh-ancestor
24927956|NCT04127721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24927957|NCT04127721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24927958|NCT04127721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24927959|NCT04127721|Immunologic Factors|immunologic factors|mesh-ancestor
24927960|NCT04127721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24927961|NCT04127721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24624586|NCT01076842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24624587|NCT01076842|Exenatide|exenatide|mesh-list
24624588|NCT01076842|Insulin Detemir|insulin detemir|mesh-list
24624589|NCT01076842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24624590|NCT01076842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526392|NCT00611494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24526393|NCT00611494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24526394|NCT00611494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526396|NCT00611507|Oxaliplatin|oxaliplatin|mesh-list
25712433|NCT02319668|Protective Agents|protective agents|mesh-ancestor
25712434|NCT02319668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712435|NCT02319668|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25712436|NCT02319668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24526397|NCT00611507|Antimetabolites|antimetabolites|mesh-ancestor
25712437|NCT02319668|Disinfectants|disinfectants|mesh-ancestor
25712438|NCT02319668|Dermatologic Agents|dermatologic agents|mesh-ancestor
25712439|NCT02319759|Ustekinumab|ustekinumab|mesh-list
25712440|NCT02319759|Dermatologic Agents|dermatologic agents|mesh-ancestor
25712441|NCT02320058|Nivolumab|nivolumab|mesh-list
25712442|NCT02320058|Ipilimumab|ipilimumab|mesh-list
25712443|NCT02320058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25712444|NCT02320058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712445|NCT02320058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25712446|NCT02320058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712447|NCT02320149|Sarecycline|sarecycline|mesh-list
24526398|NCT00611507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526399|NCT00611507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24526400|NCT00611507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526401|NCT00611507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24526402|NCT00611507|Immunologic Factors|immunologic factors|mesh-ancestor
24526425|NCT00611663|Immunologic Factors|immunologic factors|mesh-ancestor
24526426|NCT00611663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526427|NCT00611676|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24526429|NCT00611676|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24526439|NCT00611689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24928034|NCT04127019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24403419|NCT00160316|Hormones|hormones|mesh-ancestor
24403420|NCT00160316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24403421|NCT00160316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403422|NCT00160316|Progestins|progestins|mesh-ancestor
24403423|NCT00160329|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24403424|NCT00160329|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24928035|NCT04127019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24928042|NCT04127227|Oxaliplatin|oxaliplatin|mesh-list
24928043|NCT04127227|Pegaspargase|pegaspargase|mesh-list
24928044|NCT04127227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24928045|NCT04127227|Antimetabolites|antimetabolites|mesh-ancestor
24928046|NCT04127227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928047|NCT04127227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24928048|NCT04127227|Antiviral Agents|antiviral agents|mesh-ancestor
24928049|NCT04127227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24928050|NCT04127227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24928051|NCT04127227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24928052|NCT04127227|Immunologic Factors|immunologic factors|mesh-ancestor
24928054|NCT04126811|Apatinib|apatinib|mesh-list
24526526|NCT00611910|Immunologic Factors|immunologic factors|mesh-ancestor
24928093|NCT04126382|Respiratory System Agents|respiratory system agents|mesh-ancestor
24928094|NCT04126720|Vitamin E|vitamin e|mesh-list
24928095|NCT04126720|Vitamins|vitamins|mesh-ancestor
24928096|NCT04126720|Micronutrients|micronutrients|mesh-ancestor
24504064|NCT00533936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526527|NCT00611910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526528|NCT00611936|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24526550|NCT00612144|Metformin|metformin|mesh-list
24928097|NCT04126720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928098|NCT04126720|Antioxidants|antioxidants|mesh-ancestor
24928099|NCT04126720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928100|NCT04126720|Protective Agents|protective agents|mesh-ancestor
24928101|NCT04126304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24928102|NCT04126304|Azithromycin|azithromycin|mesh-list
24928103|NCT04126304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24928104|NCT04126252|Sildenafil Citrate|sildenafil citrate|mesh-list
24928106|NCT04126252|Vasodilator Agents|vasodilator agents|mesh-ancestor
24928123|NCT04125719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24928124|NCT04125719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24928125|NCT04125719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24928126|NCT04125719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928127|NCT04125706|Metronidazole|metronidazole|mesh-list
24928128|NCT04125706|Minocycline|minocycline|mesh-list
24928140|NCT04124991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24928141|NCT04124991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24928142|NCT04125121|Propofol|propofol|mesh-list
24928143|NCT04125121|Sevoflurane|sevoflurane|mesh-list
24928144|NCT04125121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24504116|NCT00534183|Dopamine Agents|dopamine agents|mesh-ancestor
24526632|NCT00612495|Immunologic Factors|immunologic factors|mesh-ancestor
24526633|NCT00612495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928205|NCT04124757|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24928206|NCT04124757|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24928207|NCT04124757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24526686|NCT00612638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24928208|NCT04124757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928214|NCT04124302|Insulin|insulin|mesh-list
24928215|NCT04124302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25712448|NCT02320149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25712449|NCT02320149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24928216|NCT04124302|Insulin Aspart|insulin aspart|mesh-list
24928217|NCT04124302|Insulin Lispro|insulin lispro|mesh-list
24526726|NCT00612950|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24526727|NCT00612950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24526728|NCT00612950|Hormones|hormones|mesh-ancestor
24526729|NCT00612950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24526730|NCT00612950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526731|NCT00612950|Incretins|incretins|mesh-ancestor
24526732|NCT00612989|Temozolomide|temozolomide|mesh-list
24526754|NCT00613067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526755|NCT00613067|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24526756|NCT00613067|Antidepressive Agents|antidepressive agents|mesh-ancestor
24526757|NCT00613067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24526758|NCT00613093|Temozolomide|temozolomide|mesh-list
24526759|NCT00613093|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
24526760|NCT00613093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24526772|NCT00613132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24526773|NCT00613132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24526774|NCT00613132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526775|NCT00613132|Antisickling Agents|antisickling agents|mesh-ancestor
24526776|NCT00613132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24526777|NCT00613145|Capecitabine|capecitabine|mesh-list
24526778|NCT00613145|Sorafenib|sorafenib|mesh-list
24928261|NCT04124094|Autonomic Agents|autonomic agents|mesh-ancestor
24928341|NCT04123392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928342|NCT04123392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24928343|NCT04123392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24928345|NCT04123392|Antimetabolites|antimetabolites|mesh-ancestor
24928373|NCT04123249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24928374|NCT04123249|Anesthetics, General|anesthetics, general|mesh-ancestor
24928375|NCT04123249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24928376|NCT04123249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24928377|NCT04122885|Oxaliplatin|oxaliplatin|mesh-list
24928378|NCT04122885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24928379|NCT04122911|Temozolomide|temozolomide|mesh-list
24928380|NCT04122911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24928384|NCT04122599|Melatonin|melatonin|mesh-list
24527017|NCT00614471|Entecavir|entecavir|mesh-list
24527018|NCT00614471|Antiviral Agents|antiviral agents|mesh-ancestor
24527019|NCT00614471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24527020|NCT00614471|Immunologic Factors|immunologic factors|mesh-ancestor
24527021|NCT00614471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527022|NCT00614536|Rabeprazole|rabeprazole|mesh-list
24527023|NCT00614536|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24527024|NCT00614536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24527143|NCT00615173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24928528|NCT04121091|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24928529|NCT04121091|Dopamine Agonists|dopamine agonists|mesh-ancestor
24928530|NCT04121091|Dopamine Agents|dopamine agents|mesh-ancestor
24928573|NCT04120831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24928574|NCT04120831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24928575|NCT04120831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24928576|NCT04120831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24527196|NCT00615446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527197|NCT00615446|Antiviral Agents|antiviral agents|mesh-ancestor
24527198|NCT00615446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24527199|NCT00615446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527200|NCT00615446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24527201|NCT00615446|Immunologic Factors|immunologic factors|mesh-ancestor
24928612|NCT04120311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527240|NCT00615602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527241|NCT00615602|Antimetabolites|antimetabolites|mesh-ancestor
24527242|NCT00615602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24527243|NCT00615615|Levetiracetam|levetiracetam|mesh-list
24928614|NCT04120311|Glucocorticoids|glucocorticoids|mesh-ancestor
24624698|NCT01077726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24624700|NCT01077752|Lidocaine|lidocaine|mesh-list
24624701|NCT01077752|Morphine|morphine|mesh-list
25712450|NCT02320149|Dermatologic Agents|dermatologic agents|mesh-ancestor
25712451|NCT02320487|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25712452|NCT02320487|Obinutuzumab|obinutuzumab|mesh-list
24624702|NCT01077752|Ropivacaine|ropivacaine|mesh-list
24624703|NCT01077752|Anesthetics, Local|anesthetics, local|mesh-ancestor
25712453|NCT02320487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24928693|NCT04119921|Lubricant Eye Drops|lubricant eye drops|mesh-list
24527639|NCT00617799|Antiviral Agents|antiviral agents|mesh-ancestor
24527640|NCT00617799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24527641|NCT00617877|Losartan|losartan|mesh-list
24527642|NCT00617877|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24527643|NCT00617877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24527644|NCT00617877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24928723|NCT04119752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527827|NCT00618423|Sensory System Agents|sensory system agents|mesh-ancestor
24928883|NCT04117893|Immunologic Factors|immunologic factors|mesh-ancestor
24928884|NCT04117893|Viscosupplements|viscosupplements|mesh-ancestor
24928885|NCT04117893|Protective Agents|protective agents|mesh-ancestor
24928886|NCT04117776|Chlorhexidine|chlorhexidine|mesh-list
24928887|NCT04117776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24928888|NCT04117776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24928897|NCT04117750|Vitamins|vitamins|mesh-ancestor
24928937|NCT04117009|Sensory System Agents|sensory system agents|mesh-ancestor
24504948|NCT00538603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504949|NCT00538655|Modafinil|modafinil|mesh-list
24504950|NCT00538655|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24504951|NCT00538655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527921|NCT00618644|Ranibizumab|ranibizumab|mesh-list
24527922|NCT00618644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24527923|NCT00618644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24527924|NCT00618644|Growth Substances|growth substances|mesh-ancestor
24527925|NCT00618644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527926|NCT00618644|Growth Inhibitors|growth inhibitors|mesh-ancestor
24527927|NCT00618644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527928|NCT00618657|Paclitaxel|paclitaxel|mesh-list
24527990|NCT00619034|Analgesics|analgesics|mesh-ancestor
24929123|NCT04115449|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24505164|NCT00540202|Artemether|artemether|mesh-list
24528124|NCT00619905|Immunologic Factors|immunologic factors|mesh-ancestor
24528125|NCT00619905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528140|NCT00619944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24528142|NCT00619944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24929154|NCT04115410|Tubulin Modulators|tubulin modulators|mesh-ancestor
24625248|NCT01081223|Immunologic Factors|immunologic factors|mesh-ancestor
24929184|NCT04115163|Paclitaxel|paclitaxel|mesh-list
24929185|NCT04115163|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24929186|NCT04115163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24929187|NCT04115163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929188|NCT04115163|Tubulin Modulators|tubulin modulators|mesh-ancestor
24929189|NCT04115163|Antimitotic Agents|antimitotic agents|mesh-ancestor
24528322|NCT00620789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24528323|NCT00620789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24528324|NCT00620789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528327|NCT00620789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929366|NCT04113993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929367|NCT04113993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24929368|NCT04113668|Diflunisal|diflunisal|mesh-list
24624719|NCT01077908|Antiviral Agents|antiviral agents|mesh-list
24624720|NCT01077908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24624721|NCT01077947|Anesthetics|anesthetics|mesh-list
24929549|NCT04111848|Analgesics|analgesics|mesh-ancestor
24929550|NCT04111848|Sensory System Agents|sensory system agents|mesh-ancestor
24929551|NCT04111848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24929552|NCT04111848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929553|NCT04111848|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24929556|NCT04111848|Anesthetics|anesthetics|mesh-ancestor
24929558|NCT04111848|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25712454|NCT02320487|Alkylating Agents|alkylating agents|mesh-ancestor
25712455|NCT02320487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712456|NCT02320487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712457|NCT02320487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25712458|NCT02320695|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25770865|NCT03570554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929559|NCT04111848|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24929560|NCT04111848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25712459|NCT02320695|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
25712461|NCT02320695|Neomycin|neomycin|mesh-list
25712462|NCT02320695|Polymyxin B|polymyxin b|mesh-list
25712463|NCT02320695|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25712464|NCT02320695|Ethanol|ethanol|mesh-list
25712465|NCT02320695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25712466|NCT02320695|Antitubercular Agents|antitubercular agents|mesh-ancestor
25712467|NCT02320695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25712468|NCT02320695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25712469|NCT02320695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712470|NCT02320695|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24929561|NCT04111848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929562|NCT04111367|Sofosbuvir|sofosbuvir|mesh-list
24929620|NCT04110808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24929621|NCT04110808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929622|NCT04111380|Paclitaxel|paclitaxel|mesh-list
24929623|NCT04111380|Cisplatin|cisplatin|mesh-list
24929624|NCT04111380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24929625|NCT04111380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929626|NCT04111380|Tubulin Modulators|tubulin modulators|mesh-ancestor
24929627|NCT04111380|Antimitotic Agents|antimitotic agents|mesh-ancestor
24929628|NCT04111380|Mitosis Modulators|mitosis modulators|mesh-ancestor
24528494|NCT00621400|Hormones|hormones|mesh-ancestor
24929755|NCT04109742|Analgesics|analgesics|mesh-ancestor
24929756|NCT04109742|Sensory System Agents|sensory system agents|mesh-ancestor
24929757|NCT04109742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24929758|NCT04109742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24929759|NCT04109742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24929760|NCT04109742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24929761|NCT04109742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929762|NCT04109742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24929763|NCT04109742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929764|NCT04109859|Methylene Blue|methylene blue|mesh-list
24929765|NCT04109859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24929766|NCT04109859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24929767|NCT04109833|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24929768|NCT04109833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24929769|NCT04109755|Pembrolizumab|pembrolizumab|mesh-list
24929770|NCT04109755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24929781|NCT04109534|Methacholine Chloride|methacholine chloride|mesh-list
24929782|NCT04109534|Miotics|miotics|mesh-ancestor
24929783|NCT04109534|Autonomic Agents|autonomic agents|mesh-ancestor
24929828|NCT04108013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24929829|NCT04108013|Tubulin Modulators|tubulin modulators|mesh-ancestor
24929830|NCT04108013|Antimitotic Agents|antimitotic agents|mesh-ancestor
24929831|NCT04108013|Mitosis Modulators|mitosis modulators|mesh-ancestor
24929833|NCT04107896|Tamsulosin|tamsulosin|mesh-list
24929999|NCT04106557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930001|NCT04106726|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24930004|NCT04106843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930005|NCT04106843|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24930049|NCT04106011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24930050|NCT04106011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24930051|NCT04106011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24930052|NCT04106011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24528608|NCT00621907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24528609|NCT00621907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528610|NCT00621907|Sensory System Agents|sensory system agents|mesh-ancestor
24528611|NCT00621907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24528613|NCT00621998|Risperidone|risperidone|mesh-list
24930184|NCT04104789|Autonomic Agents|autonomic agents|mesh-ancestor
24930185|NCT04104789|Nasal Decongestants|nasal decongestants|mesh-ancestor
24930211|NCT04103684|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24930212|NCT04103684|Prednisolone|prednisolone|mesh-list
24930213|NCT04103684|Prednisolone acetate|prednisolone acetate|mesh-list
24930214|NCT04103684|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24930215|NCT04103684|Prednisolone phosphate|prednisolone phosphate|mesh-list
24930216|NCT04103684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24930220|NCT04103684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930221|NCT04103684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24930222|NCT04103684|Glucocorticoids|glucocorticoids|mesh-ancestor
24624848|NCT01079052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930250|NCT04103398|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24930251|NCT04103398|Estrogens|estrogens|mesh-ancestor
24930252|NCT04103398|Hormones|hormones|mesh-ancestor
24930253|NCT04103398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24930254|NCT04103398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930262|NCT04102995|Pregnanolone|pregnanolone|mesh-list
24930314|NCT04102449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24930315|NCT04102449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930316|NCT04102449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24930322|NCT04102566|Ibuprofen|ibuprofen|mesh-list
24930416|NCT04101578|Bromides|bromides|mesh-list
24930417|NCT04101578|Tacrolimus|tacrolimus|mesh-list
24930418|NCT04101578|Cyclosporins|cyclosporins|mesh-list
24930419|NCT04101578|Immunosuppressive Agents|immunosuppressive agents|mesh-list
24930420|NCT04101578|Immunoglobulins|immunoglobulins|mesh-list
24930507|NCT04101136|Atorvastatin|atorvastatin|mesh-list
24930508|NCT04101136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24930509|NCT04101136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24930510|NCT04101136|Antimetabolites|antimetabolites|mesh-ancestor
24930511|NCT04101136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930512|NCT04101136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24930513|NCT04101136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24930514|NCT04101136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24930515|NCT04101019|Lidocaine|lidocaine|mesh-list
24624894|NCT01079312|Fentanyl|fentanyl|mesh-list
24930535|NCT04100772|Immunologic Factors|immunologic factors|mesh-ancestor
24930536|NCT04100772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24930538|NCT04100655|Estradiol|estradiol|mesh-list
24930539|NCT04100655|Sargramostim|sargramostim|mesh-list
24930540|NCT04100655|Estrogens|estrogens|mesh-ancestor
24930541|NCT04100655|Hormones|hormones|mesh-ancestor
24930542|NCT04100655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24930544|NCT04100655|Immunologic Factors|immunologic factors|mesh-ancestor
24930618|NCT04099771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930619|NCT04099563|Abrocitinib|abrocitinib|mesh-list
24930620|NCT04099563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24930621|NCT04099563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24930623|NCT04099732|Dabigatran|dabigatran|mesh-list
24930707|NCT04098081|Gemcitabine|gemcitabine|mesh-list
24930709|NCT04098081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24930912|NCT04095455|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24930957|NCT04095013|Sensory System Agents|sensory system agents|mesh-ancestor
24934078|NCT04064073|Metformin|metformin|mesh-list
24930966|NCT04095013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24930967|NCT04095013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24930968|NCT04095013|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24930969|NCT04095013|Narcotics|narcotics|mesh-ancestor
24930996|NCT04094909|Carboplatin|carboplatin|mesh-list
24930997|NCT04094909|Pembrolizumab|pembrolizumab|mesh-list
24930998|NCT04094909|Pemetrexed|pemetrexed|mesh-list
24930999|NCT04094909|Endostatins|endostatins|mesh-list
24931000|NCT04094909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24931015|NCT04094727|Lumefantrine|lumefantrine|mesh-list
24931046|NCT04094467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24624971|NCT01079624|Incretins|incretins|mesh-ancestor
24931054|NCT04094142|Lenalidomide|lenalidomide|mesh-list
24931122|NCT04093050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931123|NCT04092751|Ibrexafungerp|ibrexafungerp|mesh-list
24931124|NCT04092751|Antifungal Agents|antifungal agents|mesh-ancestor
24931125|NCT04092751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24931126|NCT04092725|Ibrexafungerp|ibrexafungerp|mesh-list
24931129|NCT04092868|Protamines|protamines|mesh-list
24931136|NCT04092621|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24529194|NCT00625014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24529195|NCT00625014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529196|NCT00625014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24529197|NCT00625014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24529198|NCT00625014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24529199|NCT00625014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24931197|NCT04092101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24931198|NCT04092101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712472|NCT02320695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407677|NCT00175032|Dexlansoprazole|dexlansoprazole|mesh-list
24931199|NCT04092101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24931200|NCT04092101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24931201|NCT04092101|Cholinergic Agents|cholinergic agents|mesh-ancestor
24931202|NCT04092101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24931203|NCT04092101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931207|NCT04091815|Anesthetics|anesthetics|mesh-list
24931209|NCT04091815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24624999|NCT01079754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625046|NCT01080079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24625047|NCT01080079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625048|NCT01080079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625049|NCT01080352|Ascorbic Acid|ascorbic acid|mesh-list
24625050|NCT01080352|Vitamins|vitamins|mesh-ancestor
24625051|NCT01080352|Micronutrients|micronutrients|mesh-ancestor
24625052|NCT01080352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625053|NCT01080352|Antioxidants|antioxidants|mesh-ancestor
24529338|NCT00625495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529339|NCT00625495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529341|NCT00625547|Cabergoline|cabergoline|mesh-list
24529342|NCT00625547|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24529344|NCT00625547|Dopamine Agents|dopamine agents|mesh-ancestor
24931678|NCT04086186|Anesthetics, Local|anesthetics, local|mesh-ancestor
24931680|NCT04086186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24931681|NCT04086186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931682|NCT04086186|Sensory System Agents|sensory system agents|mesh-ancestor
24931683|NCT04086186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24931684|NCT04086238|Decitabine|decitabine|mesh-list
24931685|NCT04086238|Tetrahydrouridine|tetrahydrouridine|mesh-list
24931686|NCT04086238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24931745|NCT04085744|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24931746|NCT04085744|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24931747|NCT04085744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24931748|NCT04085744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24931749|NCT04085744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24931750|NCT04085744|Dermatologic Agents|dermatologic agents|mesh-ancestor
24931751|NCT04085744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24931752|NCT04085484|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-list
24931753|NCT04085484|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24931754|NCT04085770|Alfacalcidol|alfacalcidol|mesh-list
24931755|NCT04085770|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
24931876|NCT04084977|Immunologic Factors|immunologic factors|mesh-ancestor
24931877|NCT04084977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931878|NCT04084912|Dexamethasone|dexamethasone|mesh-list
24931879|NCT04084912|Dexamethasone acetate|dexamethasone acetate|mesh-list
24931880|NCT04084912|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24931881|NCT04084912|BB 1101|bb 1101|mesh-list
24931882|NCT04084912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24529450|NCT00626015|Daclizumab|daclizumab|mesh-list
24529451|NCT00626015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24529452|NCT00626015|Alkylating Agents|alkylating agents|mesh-ancestor
24529487|NCT00626262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25712473|NCT02320721|Insulin|insulin|mesh-list
25712474|NCT02320721|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25712475|NCT02320721|Insulin Glargine|insulin glargine|mesh-list
25712476|NCT02320721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25712477|NCT02320721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712478|NCT02321098|Amorolfine|amorolfine|mesh-list
24529488|NCT00626262|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25712479|NCT02321098|Antifungal Agents|antifungal agents|mesh-ancestor
25712480|NCT02321098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25712481|NCT02321319|Hydromorphone|hydromorphone|mesh-list
25712482|NCT02321319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25712483|NCT02321319|Narcotics|narcotics|mesh-ancestor
24529489|NCT00626262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24931908|NCT04084171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24931931|NCT04083911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24931932|NCT04083807|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24931933|NCT04083807|Thrombin|thrombin|mesh-list
24931934|NCT04083807|Hemostatics|hemostatics|mesh-ancestor
24931935|NCT04083807|Coagulants|coagulants|mesh-ancestor
24931936|NCT04083833|Tetrodotoxin|tetrodotoxin|mesh-list
24931937|NCT04083833|Anesthetics, Local|anesthetics, local|mesh-ancestor
24931938|NCT04083833|Anesthetics|anesthetics|mesh-ancestor
24931939|NCT04083833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24931940|NCT04083833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24931941|NCT04083833|Sensory System Agents|sensory system agents|mesh-ancestor
24931948|NCT04083651|Bromides|bromides|mesh-list
24529519|NCT00626535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529520|NCT00626600|Oxycodone|oxycodone|mesh-list
24529521|NCT00626600|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24529522|NCT00626600|Narcotics|narcotics|mesh-ancestor
24529523|NCT00626600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24529524|NCT00626600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529525|NCT00626600|Analgesics|analgesics|mesh-ancestor
24529526|NCT00626600|Sensory System Agents|sensory system agents|mesh-ancestor
24408821|NCT00179725|Doxorubicin|doxorubicin|mesh-list
24529582|NCT00626769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24529583|NCT00626769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529584|NCT00626769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529585|NCT00626769|Phytoestrogens|phytoestrogens|mesh-ancestor
24932118|NCT04082858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24529673|NCT00627471|Insulin|insulin|mesh-list
24932464|NCT04079231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24932465|NCT04079231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24932466|NCT04079231|Growth Substances|growth substances|mesh-ancestor
24932467|NCT04079231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932468|NCT04079231|Growth Inhibitors|growth inhibitors|mesh-ancestor
24932469|NCT04079231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24932470|NCT04079374|Etanercept|etanercept|mesh-list
24932556|NCT04078399|Interferons|interferons|mesh-list
24932557|NCT04078399|Azacitidine|azacitidine|mesh-list
24932558|NCT04078399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24932559|NCT04078399|Antiviral Agents|antiviral agents|mesh-ancestor
24932560|NCT04078399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24932561|NCT04078399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24932562|NCT04078399|Antimetabolites|antimetabolites|mesh-ancestor
24932563|NCT04078399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932630|NCT04077957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24932883|NCT04075721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24932884|NCT04075721|Glucocorticoids|glucocorticoids|mesh-ancestor
24932893|NCT04075760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24932894|NCT04075760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932895|NCT04075578|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24625205|NCT01080846|Oxytocics|oxytocics|mesh-ancestor
24932896|NCT04075578|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24932897|NCT04075578|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24932898|NCT04075578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24932899|NCT04075578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24932900|NCT04075578|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24529937|NCT00628342|Esomeprazole|esomeprazole|mesh-list
24529938|NCT00628342|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24529939|NCT00628342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24529940|NCT00628342|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24529941|NCT00628342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529958|NCT00628550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25712484|NCT02321319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25712485|NCT02321319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712486|NCT02321319|Analgesics|analgesics|mesh-ancestor
25712487|NCT02321319|Sensory System Agents|sensory system agents|mesh-ancestor
25712488|NCT02321319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25712489|NCT02321748|Montelukast|montelukast|mesh-list
25712490|NCT02321748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25712491|NCT02321748|Respiratory System Agents|respiratory system agents|mesh-ancestor
25712492|NCT02321748|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25712493|NCT02321748|Hormone Antagonists|hormone antagonists|mesh-ancestor
25712494|NCT02321748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25712495|NCT02321748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507175|NCT00549120|Propranolol|propranolol|mesh-list
25712496|NCT02321748|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25712497|NCT02321748|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24529959|NCT00628550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24529960|NCT00628550|Respiratory System Agents|respiratory system agents|mesh-ancestor
24625243|NCT01081158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24625244|NCT01081158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24625245|NCT01081158|Immunologic Factors|immunologic factors|mesh-ancestor
24625246|NCT01081158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625247|NCT01081223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
24625255|NCT01081353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24625256|NCT01081353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625257|NCT01081353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24625258|NCT01081353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24625259|NCT01081353|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24625260|NCT01081353|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24625261|NCT01081353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625262|NCT01081353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24625263|NCT01081353|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24932971|NCT04074915|Chlorhexidine|chlorhexidine|mesh-list
24932972|NCT04074915|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24932973|NCT04074915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24932974|NCT04074915|Disinfectants|disinfectants|mesh-ancestor
24932975|NCT04075188|Aflibercept|aflibercept|mesh-list
24932976|NCT04075188|Verteporfin|verteporfin|mesh-list
24932977|NCT04075188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24932978|NCT04075188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24932979|NCT04075188|Growth Substances|growth substances|mesh-ancestor
24932980|NCT04075188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530043|NCT00628810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530047|NCT00628810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24530048|NCT00628810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24530049|NCT00628810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530050|NCT00628810|Antidotes|antidotes|mesh-ancestor
24530051|NCT00628810|Protective Agents|protective agents|mesh-ancestor
24530052|NCT00628810|Vitamin B Complex|vitamin b complex|mesh-ancestor
24933081|NCT04073758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24933082|NCT04073758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24933083|NCT04073758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24933084|NCT04073758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24933085|NCT04073758|Adrenergic Agents|adrenergic agents|mesh-ancestor
24933086|NCT04073758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24933087|NCT04073758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933088|NCT04073758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24933089|NCT04073758|Narcotics|narcotics|mesh-ancestor
24933091|NCT04073797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24933092|NCT04073797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24933093|NCT04073797|Antimetabolites|antimetabolites|mesh-ancestor
24530079|NCT00628953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24530080|NCT00628953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24530081|NCT00628953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24530082|NCT00628953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530083|NCT00628953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712498|NCT02321748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712499|NCT02321800|Imipenem|imipenem|mesh-list
24933136|NCT04074265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933137|NCT04074265|Sensory System Agents|sensory system agents|mesh-ancestor
24530099|NCT00629135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530100|NCT00629135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530101|NCT00629135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24530102|NCT00629135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24530103|NCT00629135|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24933138|NCT04074265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24933139|NCT04074265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24933140|NCT04074265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24933141|NCT04074265|Adrenergic Agents|adrenergic agents|mesh-ancestor
24933142|NCT04074265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24933143|NCT04074265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933144|NCT04074265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24933154|NCT04074265|Analgesics|analgesics|mesh-ancestor
24933225|NCT04072640|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24933226|NCT04072640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24933227|NCT04072640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933228|NCT04072640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509657|NCT00561496|Tenofovir|tenofovir|mesh-list
24530110|NCT00629148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24530111|NCT00629148|Tubulin Modulators|tubulin modulators|mesh-ancestor
24530112|NCT00629148|Antimitotic Agents|antimitotic agents|mesh-ancestor
24530113|NCT00629148|Mitosis Modulators|mitosis modulators|mesh-ancestor
24530114|NCT00629187|Temozolomide|temozolomide|mesh-list
24530119|NCT00629200|Interferons|interferons|mesh-list
24933245|NCT04072900|Interferon Inducers|interferon inducers|mesh-ancestor
24757699|NCT01741831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24933246|NCT04072601|Atorvastatin|atorvastatin|mesh-list
24933247|NCT04072601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24933248|NCT04072601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24530162|NCT00629278|Trastuzumab|trastuzumab|mesh-list
24530163|NCT00629278|Epirubicin|epirubicin|mesh-list
24530164|NCT00629278|Hormones|hormones|mesh-list
24530165|NCT00629278|Aromatase Inhibitors|aromatase inhibitors|mesh-list
24530166|NCT00629278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530167|NCT00629278|Tubulin Modulators|tubulin modulators|mesh-ancestor
24530168|NCT00629278|Antimitotic Agents|antimitotic agents|mesh-ancestor
24530169|NCT00629278|Mitosis Modulators|mitosis modulators|mesh-ancestor
24530170|NCT00629278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530171|NCT00629278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24530172|NCT00629278|Immunologic Factors|immunologic factors|mesh-ancestor
24530173|NCT00629278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530174|NCT00629278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24530176|NCT00629278|Alkylating Agents|alkylating agents|mesh-ancestor
24933299|NCT04072198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933300|NCT04072198|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24933303|NCT04072198|Antidotes|antidotes|mesh-ancestor
24530239|NCT00629512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24530240|NCT00629512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24530241|NCT00629512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24530242|NCT00629512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530259|NCT00629616|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24530260|NCT00629616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24530261|NCT00629616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530264|NCT00629642|Oxybutynin|oxybutynin|mesh-list
25712500|NCT02321800|Cilastatin|cilastatin|mesh-list
25712501|NCT02321800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25712502|NCT02321800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25712503|NCT02321800|Protease Inhibitors|protease inhibitors|mesh-ancestor
24933421|NCT04070755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24933422|NCT04070755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25712504|NCT02321800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712505|NCT02321800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712506|NCT02321930|Tofacitinib|tofacitinib|mesh-list
25712507|NCT02321930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25712508|NCT02321930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933424|NCT04070794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24933529|NCT04069234|Ticagrelor|ticagrelor|mesh-list
24933530|NCT04069234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24933531|NCT04069234|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24933532|NCT04069234|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24933533|NCT04069234|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24933534|NCT04069234|Purinergic Agents|purinergic agents|mesh-ancestor
24933535|NCT04069234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24933536|NCT04069234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933537|NCT04069234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933538|NCT04069169|Lidocaine|lidocaine|mesh-list
24933539|NCT04069169|Anesthetics, Local|anesthetics, local|mesh-ancestor
24530275|NCT00629681|Pregabalin|pregabalin|mesh-list
24933552|NCT04069208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24933554|NCT04069208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933555|NCT04069208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24933556|NCT04069208|Antiviral Agents|antiviral agents|mesh-ancestor
24933557|NCT04069208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24933558|NCT04069208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24933559|NCT04069208|Immunologic Factors|immunologic factors|mesh-ancestor
24933560|NCT04069208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933561|NCT04069208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24933562|NCT04069208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24933563|NCT04069208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24933564|NCT04069208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933565|NCT04069325|Febuxostat|febuxostat|mesh-list
24933566|NCT04069325|Gout Suppressants|gout suppressants|mesh-ancestor
24933567|NCT04069325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24933568|NCT04069429|Heparin|heparin|mesh-list
24933569|NCT04069429|Anticoagulants|anticoagulants|mesh-ancestor
24933570|NCT04069429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24933571|NCT04069429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24530279|NCT00629681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530280|NCT00629681|Anticonvulsants|anticonvulsants|mesh-ancestor
24530281|NCT00629681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24933592|NCT04069078|Cholinergic Agents|cholinergic agents|mesh-ancestor
24933593|NCT04069078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24933594|NCT04069078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933595|NCT04069078|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24933596|NCT04069078|Parasympatholytics|parasympatholytics|mesh-ancestor
24933597|NCT04069065|Tacrolimus|tacrolimus|mesh-list
24933598|NCT04069065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24933599|NCT04069065|Immunologic Factors|immunologic factors|mesh-ancestor
24510002|NCT00563069|Midazolam|midazolam|mesh-list
24933627|NCT04068974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24933688|NCT04068506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24933689|NCT04068506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24933690|NCT04068506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24933691|NCT04068506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24933693|NCT04068272|Bosentan|bosentan|mesh-list
24933694|NCT04068272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24933695|NCT04068272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24933696|NCT04068272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625297|NCT01081548|Antimetabolites|antimetabolites|mesh-ancestor
24933697|NCT04068207|Minocycline|minocycline|mesh-list
24933698|NCT04068207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24933699|NCT04068207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24933700|NCT04067986|Apatinib|apatinib|mesh-list
24933701|NCT04067986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24933702|NCT04067986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24933703|NCT04067986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24933705|NCT04067791|Melatonin|melatonin|mesh-list
24934079|NCT04064073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24625311|NCT01081600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24625312|NCT01081613|Bevacizumab|bevacizumab|mesh-list
24625313|NCT01081613|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
24625314|NCT01081613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24625315|NCT01081613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24625316|NCT01081613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24625317|NCT01081613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24625318|NCT01081613|Growth Substances|growth substances|mesh-ancestor
24625319|NCT01081613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625320|NCT01081613|Growth Inhibitors|growth inhibitors|mesh-ancestor
24625321|NCT01081613|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24625322|NCT01081613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625323|NCT01081639|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24625324|NCT01081639|Hormones|hormones|mesh-ancestor
24625325|NCT01081639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24625326|NCT01081639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625327|NCT01081652|Progesterone|progesterone|mesh-list
24625328|NCT01081652|Progestins|progestins|mesh-ancestor
24933810|NCT04067102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24933811|NCT04067102|Alkylating Agents|alkylating agents|mesh-ancestor
24933812|NCT04067102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24530386|NCT00630084|Interferons|interferons|mesh-list
24530387|NCT00630084|Ribavirin|ribavirin|mesh-list
24530388|NCT00630084|Interferon-alpha|interferon-alpha|mesh-list
24933886|NCT04066296|Anesthetics, Local|anesthetics, local|mesh-list
24933887|NCT04066296|Anesthetics|anesthetics|mesh-list
24933888|NCT04066296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24933889|NCT04066296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24933890|NCT04066296|Sensory System Agents|sensory system agents|mesh-ancestor
24933891|NCT04066296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24933892|NCT04066257|Metronidazole|metronidazole|mesh-list
24933893|NCT04066257|Tetracycline|tetracycline|mesh-list
24933901|NCT04066257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24530471|NCT00630500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530472|NCT00630500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530473|NCT00630500|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24530474|NCT00630500|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24530475|NCT00630513|Ampicillin|ampicillin|mesh-list
24530476|NCT00630513|Ertapenem|ertapenem|mesh-list
24530478|NCT00630513|Sultamicillin|sultamicillin|mesh-list
24934002|NCT04065581|Metformin|metformin|mesh-list
24934003|NCT04065581|Acarbose|acarbose|mesh-list
24934004|NCT04065581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24934005|NCT04065581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934009|NCT04065230|Tenofovir|tenofovir|mesh-list
24934035|NCT04065035|Protective Agents|protective agents|mesh-ancestor
24934036|NCT04065035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934037|NCT04065035|Dermatologic Agents|dermatologic agents|mesh-ancestor
24530479|NCT00630513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24530480|NCT00630513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24934081|NCT04063904|Misoprostol|misoprostol|mesh-list
24934082|NCT04063904|Mifepristone|mifepristone|mesh-list
24934083|NCT04063904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24934084|NCT04063904|Abortifacient Agents|abortifacient agents|mesh-ancestor
24934085|NCT04063904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24934086|NCT04063904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934087|NCT04063904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24934147|NCT04063449|Endostar protein|endostar protein|mesh-list
24934148|NCT04063449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24934149|NCT04063449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24934274|NCT04062201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24934275|NCT04062201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24934276|NCT04062201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934277|NCT04062201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934278|NCT04062201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24934279|NCT04062201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24934280|NCT04062201|Antitubercular Agents|antitubercular agents|mesh-ancestor
24530507|NCT00630708|Benazepril|benazepril|mesh-list
24530508|NCT00630708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24530509|NCT00630708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24530521|NCT00630851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24530522|NCT00630851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530523|NCT00630851|Nootropic Agents|nootropic agents|mesh-ancestor
25712509|NCT02321930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530524|NCT00630890|Capecitabine|capecitabine|mesh-list
24934366|NCT04062045|Sensory System Agents|sensory system agents|mesh-ancestor
24934367|NCT04062045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25712510|NCT02322047|Prazosin|prazosin|mesh-list
25712511|NCT02322047|Naltrexone|naltrexone|mesh-list
25712512|NCT02322047|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25712513|NCT02322047|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25712514|NCT02322047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934369|NCT04061798|Anticoagulants|anticoagulants|mesh-ancestor
24934370|NCT04061798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24934371|NCT04061798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24934372|NCT04061798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934373|NCT04061863|Nivolumab|nivolumab|mesh-list
24934374|NCT04061863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24934375|NCT04061863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934376|NCT04061863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24934377|NCT04061863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934378|NCT04062006|Aldesleukin|aldesleukin|mesh-list
24934379|NCT04062006|Interleukin-2|interleukin-2|mesh-list
24934380|NCT04062006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934387|NCT04062006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24934388|NCT04062006|Antiviral Agents|antiviral agents|mesh-ancestor
24934389|NCT04062006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24934413|NCT04061655|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
24934414|NCT04061655|Trace Elements|trace elements|mesh-ancestor
24934415|NCT04061655|Micronutrients|micronutrients|mesh-ancestor
24934416|NCT04061655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934417|NCT04061655|Hematinics|hematinics|mesh-ancestor
24934418|NCT04061447|Clarithromycin|clarithromycin|mesh-list
24934419|NCT04061447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24934420|NCT04061447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24934422|NCT04061447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530551|NCT00630968|Nootropic Agents|nootropic agents|mesh-ancestor
24530552|NCT00630981|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24530554|NCT00630981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24530555|NCT00630981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24530556|NCT00630981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24530557|NCT00630981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530558|NCT00630981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24530559|NCT00630981|Serotonin Agents|serotonin agents|mesh-ancestor
24530583|NCT00631085|Micronutrients|micronutrients|mesh-ancestor
24530584|NCT00631124|Drospirenone|drospirenone|mesh-list
24530864|NCT00632697|Vasodilator Agents|vasodilator agents|mesh-ancestor
24510848|NCT00565968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934439|NCT04061265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934440|NCT04061265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24934441|NCT04061265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24934442|NCT04061265|Adrenergic Agents|adrenergic agents|mesh-ancestor
24934443|NCT04061265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24934444|NCT04061265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24934445|NCT04061265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24934446|NCT04061265|Autonomic Agents|autonomic agents|mesh-ancestor
24934447|NCT04061265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24934448|NCT04061265|Respiratory System Agents|respiratory system agents|mesh-ancestor
24530631|NCT00631514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530632|NCT00631514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530633|NCT00631527|Sunitinib|sunitinib|mesh-list
24530634|NCT00631527|Leuprolide|leuprolide|mesh-list
24530635|NCT00631527|Goserelin|goserelin|mesh-list
24530636|NCT00631527|Bicalutamide|bicalutamide|mesh-list
24530637|NCT00631527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934464|NCT04061473|Hormones|hormones|mesh-ancestor
24934465|NCT04061473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24934466|NCT04061473|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24934467|NCT04061473|Protease Inhibitors|protease inhibitors|mesh-ancestor
24934468|NCT04061473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712515|NCT02322047|Sensory System Agents|sensory system agents|mesh-ancestor
25712516|NCT02322047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25712517|NCT02322047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25712518|NCT02322047|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25712519|NCT02322047|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24934469|NCT04061473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530639|NCT00631527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24530640|NCT00631527|Growth Substances|growth substances|mesh-ancestor
24530641|NCT00631527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530642|NCT00631527|Growth Inhibitors|growth inhibitors|mesh-ancestor
24530643|NCT00631527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24530644|NCT00631527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530645|NCT00631527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530646|NCT00631527|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24411524|NCT00189358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530715|NCT00631943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24530716|NCT00631943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24530717|NCT00631943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24530719|NCT00631995|Immunologic Factors|immunologic factors|mesh-ancestor
24530720|NCT00631995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530721|NCT00632073|Maleic acid|maleic acid|mesh-list
24530722|NCT00632073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24934747|NCT04059198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24934748|NCT04059198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24934749|NCT04059198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24934750|NCT04059198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24934751|NCT04059198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934786|NCT04058236|Plasma Substitutes|plasma substitutes|mesh-ancestor
24934787|NCT04058236|Blood Substitutes|blood substitutes|mesh-ancestor
24759113|NCT01749371|Vitamins|vitamins|mesh-list
24934788|NCT04058145|Plerixafor|plerixafor|mesh-list
24934789|NCT04058145|Pembrolizumab|pembrolizumab|mesh-list
24934790|NCT04058145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24934791|NCT04058145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24934792|NCT04058145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24934794|NCT04058145|Antiviral Agents|antiviral agents|mesh-ancestor
24934795|NCT04058145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24934796|NCT04058210|Ivacaftor|ivacaftor|mesh-list
24934797|NCT04058210|Elexacaftor|elexacaftor|mesh-list
24934798|NCT04058210|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24934799|NCT04058210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24934800|NCT04058210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934801|NCT04058132|Sildenafil Citrate|sildenafil citrate|mesh-list
24934802|NCT04058132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934803|NCT04058132|Vasodilator Agents|vasodilator agents|mesh-ancestor
24934804|NCT04058132|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24934805|NCT04058132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24530862|NCT00632697|Protective Agents|protective agents|mesh-ancestor
24530863|NCT00632697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530865|NCT00632697|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24530866|NCT00632697|Antioxidants|antioxidants|mesh-ancestor
24530867|NCT00632723|Gefitinib|gefitinib|mesh-list
24530872|NCT00632762|Amantadine|amantadine|mesh-list
24625387|NCT01081990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24625388|NCT01082003|Pentoxifylline|pentoxifylline|mesh-list
24625389|NCT01082003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24625390|NCT01082003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24625391|NCT01082003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24934839|NCT04057365|Nivolumab|nivolumab|mesh-list
24934858|NCT04057261|Incretins|incretins|mesh-ancestor
24934859|NCT04057261|Hormones|hormones|mesh-ancestor
25712520|NCT02322047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25712521|NCT02322047|Adrenergic Agents|adrenergic agents|mesh-ancestor
25712522|NCT02322047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25712523|NCT02322047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712524|NCT02322190|Methoxsalen|methoxsalen|mesh-list
25712525|NCT02322190|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24934860|NCT04057261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24934905|NCT04056897|Sensory System Agents|sensory system agents|mesh-ancestor
25712526|NCT02322190|Dermatologic Agents|dermatologic agents|mesh-ancestor
25712527|NCT02322216|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
24934906|NCT04056897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25712528|NCT02322216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25712529|NCT02322216|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25712530|NCT02322216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25712531|NCT02322216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24934907|NCT04056897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934908|NCT04056897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24934909|NCT04056897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24934910|NCT04056897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24934911|NCT04056897|Immunologic Factors|immunologic factors|mesh-ancestor
24934912|NCT04057014|Amoxicillin|amoxicillin|mesh-list
24934913|NCT04057014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24934914|NCT04057014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24934915|NCT04057053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24934916|NCT04057053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24934917|NCT04056975|Antibodies|antibodies|mesh-list
24934918|NCT04056975|Immunologic Factors|immunologic factors|mesh-ancestor
24934919|NCT04056975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24934920|NCT04056806|Ceftriaxone|ceftriaxone|mesh-list
24934921|NCT04056806|Terlipressin|terlipressin|mesh-list
24934922|NCT04056806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24934959|NCT04056754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24935005|NCT04056143|Anticoagulants|anticoagulants|mesh-ancestor
24935006|NCT04056143|Hemostatics|hemostatics|mesh-ancestor
24935007|NCT04056143|Coagulants|coagulants|mesh-ancestor
24935008|NCT04056169|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24935009|NCT04056169|Ezetimibe|ezetimibe|mesh-list
24935010|NCT04056169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24935011|NCT04056169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24935012|NCT04056169|Antimetabolites|antimetabolites|mesh-ancestor
24935016|NCT04056169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935017|NCT04056000|Caffeine|caffeine|mesh-list
24935018|NCT04056000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24935019|NCT04056000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935020|NCT04056000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24935021|NCT04056000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935022|NCT04056000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935023|NCT04056000|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24935024|NCT04056000|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24935025|NCT04056000|Purinergic Agents|purinergic agents|mesh-ancestor
24935026|NCT04056000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24935028|NCT04055480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24935029|NCT04055480|Insulin Aspart|insulin aspart|mesh-list
24935030|NCT04055480|Insulin, Short-Acting|insulin, short-acting|mesh-list
24935031|NCT04055480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24935033|NCT04055506|Ritonavir|ritonavir|mesh-list
24530940|NCT00633373|Cyclosporins|cyclosporins|mesh-list
24530982|NCT00633425|Immunologic Factors|immunologic factors|mesh-ancestor
24530984|NCT00633438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24625410|NCT01082146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24625411|NCT01082146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24625412|NCT01082146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24625413|NCT01082146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625414|NCT01082146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24625415|NCT01082146|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24625416|NCT01082146|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24625417|NCT01082146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24625418|NCT01082146|Adrenergic Agents|adrenergic agents|mesh-ancestor
24625419|NCT01082146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25712532|NCT02322216|Analgesics|analgesics|mesh-ancestor
25712533|NCT02322216|Sensory System Agents|sensory system agents|mesh-ancestor
25712534|NCT02322216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24625420|NCT01082146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24625421|NCT01082146|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24625422|NCT01082146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24625423|NCT01082146|Serotonin Agents|serotonin agents|mesh-ancestor
24625424|NCT01082146|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24625425|NCT01082146|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24625426|NCT01082146|Dopamine Agents|dopamine agents|mesh-ancestor
24625428|NCT01082198|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
24625429|NCT01082198|Immunologic Factors|immunologic factors|mesh-ancestor
24625430|NCT01082198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625431|NCT01082198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24625432|NCT01082224|Motexafin gadolinium|motexafin gadolinium|mesh-list
24625433|NCT01082224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24625434|NCT01082224|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24625435|NCT01082224|Dermatologic Agents|dermatologic agents|mesh-ancestor
24625437|NCT01082237|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24625438|NCT01082237|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24511474|NCT00568880|Bortezomib|bortezomib|mesh-list
24411982|NCT00190580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24625462|NCT01082250|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24625469|NCT01082263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24625470|NCT01082263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24935061|NCT04055415|Expectorants|expectorants|mesh-list
24935062|NCT04055415|Autonomic Agents|autonomic agents|mesh-ancestor
24935063|NCT04055415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24935064|NCT04055415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935065|NCT04055415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24935066|NCT04055415|Respiratory System Agents|respiratory system agents|mesh-ancestor
24935068|NCT04054960|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24530985|NCT00633438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24530986|NCT00633438|Analgesics|analgesics|mesh-ancestor
24530987|NCT00633438|Sensory System Agents|sensory system agents|mesh-ancestor
24530988|NCT00633438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24530989|NCT00633438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530990|NCT00633438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24530991|NCT00633438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24530992|NCT00633438|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24531007|NCT00633542|Immunologic Factors|immunologic factors|mesh-ancestor
24531008|NCT00633542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531009|NCT00633542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24531010|NCT00633542|Leprostatic Agents|leprostatic agents|mesh-ancestor
24531011|NCT00633542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24935073|NCT04054960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935075|NCT04055194|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24935076|NCT04055194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24935077|NCT04055194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935079|NCT04055194|Coagulants|coagulants|mesh-ancestor
24935080|NCT04055142|Cidofovir|cidofovir|mesh-list
24935081|NCT04055142|Antiviral Agents|antiviral agents|mesh-ancestor
24935082|NCT04055142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24935083|NCT04055142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935084|NCT04055142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935085|NCT04055233|Biguanides|biguanides|mesh-list
24935086|NCT04055233|Polihexanide|polihexanide|mesh-list
24935087|NCT04055233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24935088|NCT04055233|Disinfectants|disinfectants|mesh-ancestor
24935089|NCT04055233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24935090|NCT04055233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935091|NCT04054830|Diclofenac|diclofenac|mesh-list
24935092|NCT04054830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24935093|NCT04054830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25712535|NCT02322216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712536|NCT02322216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25712537|NCT02322216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25712538|NCT02322216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25712539|NCT02322216|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25712540|NCT02322216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24935094|NCT04054830|Analgesics|analgesics|mesh-ancestor
24935095|NCT04054830|Sensory System Agents|sensory system agents|mesh-ancestor
24935096|NCT04054830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24935097|NCT04054830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935098|NCT04054830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24935099|NCT04054830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24935100|NCT04054830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24935111|NCT04054531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935112|NCT04054531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935113|NCT04054531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24935114|NCT04054531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24935115|NCT04054687|Tranexamic Acid|tranexamic acid|mesh-list
24935116|NCT04054687|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24935119|NCT04054687|Hemostatics|hemostatics|mesh-ancestor
24412064|NCT00190736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412066|NCT00190762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412067|NCT00190762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412068|NCT00190762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412069|NCT00190762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24412070|NCT00190762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24935123|NCT04054635|Protective Agents|protective agents|mesh-ancestor
24935124|NCT04054635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935125|NCT04054518|Durvalumab|durvalumab|mesh-list
24935127|NCT04054518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935130|NCT04054362|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24935131|NCT04054362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24935132|NCT04054362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24935133|NCT04054362|Tubulin Modulators|tubulin modulators|mesh-ancestor
24935134|NCT04054362|Antimitotic Agents|antimitotic agents|mesh-ancestor
24935135|NCT04054362|Mitosis Modulators|mitosis modulators|mesh-ancestor
24935136|NCT04054362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935137|NCT04054362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24935138|NCT04054362|Antimetabolites|antimetabolites|mesh-ancestor
24935139|NCT04054362|Antiviral Agents|antiviral agents|mesh-ancestor
24935140|NCT04054362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24935141|NCT04054362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935159|NCT04054024|Erenumab|erenumab|mesh-list
24935165|NCT04054024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24935166|NCT04054089|Tenofovir|tenofovir|mesh-list
24935167|NCT04054089|Lamivudine|lamivudine|mesh-list
24935168|NCT04054089|Emtricitabine|emtricitabine|mesh-list
24935169|NCT04054089|Dolutegravir|dolutegravir|mesh-list
24935170|NCT04054089|Antiviral Agents|antiviral agents|mesh-ancestor
24935171|NCT04054089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24935172|NCT04054089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24935173|NCT04054089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24935174|NCT04054089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24935175|NCT04054089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24935176|NCT04054089|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24531093|NCT00633802|Risperidone|risperidone|mesh-list
24531101|NCT00633802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24935198|NCT04054115|Vasodilator Agents|vasodilator agents|mesh-ancestor
24935199|NCT04054115|Urological Agents|urological agents|mesh-ancestor
24935200|NCT04054128|Heparin|heparin|mesh-list
24935201|NCT04054128|Calcium heparin|calcium heparin|mesh-list
24935202|NCT04054128|Anticoagulants|anticoagulants|mesh-ancestor
24935203|NCT04054128|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24531140|NCT00634205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531141|NCT00634205|Antimanic Agents|antimanic agents|mesh-ancestor
24531142|NCT00634205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24531143|NCT00634205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24531144|NCT00634205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24531145|NCT00634231|Valacyclovir|valacyclovir|mesh-list
24531146|NCT00634231|Antiviral Agents|antiviral agents|mesh-ancestor
24531147|NCT00634231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24531148|NCT00634309|Candesartan|candesartan|mesh-list
24531149|NCT00634309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24531150|NCT00634309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24531151|NCT00634309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24531152|NCT00634309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531153|NCT00634348|Aripiprazole|aripiprazole|mesh-list
24531154|NCT00634348|Ziprasidone|ziprasidone|mesh-list
24531166|NCT00634348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24668516|NCT04889547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24668517|NCT04889547|Glucocorticoids|glucocorticoids|mesh-ancestor
24668519|NCT04889547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24668520|NCT04889547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24668521|NCT04889547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24668522|NCT04889547|Protease Inhibitors|protease inhibitors|mesh-ancestor
24668523|NCT04889547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24668524|NCT04889547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456308|NCT00330824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24456309|NCT00330824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24668579|NCT04837716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24668580|NCT04837716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24668581|NCT04837716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24668588|NCT04823364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511794|NCT00570934|Calcium|calcium|mesh-list
24511798|NCT00570934|Vitamins|vitamins|mesh-ancestor
24531218|NCT00634556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24668654|NCT04681677|Growth Substances|growth substances|mesh-ancestor
24668655|NCT04681677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24668656|NCT04681677|Growth Inhibitors|growth inhibitors|mesh-ancestor
24668662|NCT04650542|Paroxetine|paroxetine|mesh-list
24668663|NCT04650542|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24531264|NCT00634725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24531265|NCT00634725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24531266|NCT00634725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24531267|NCT00634725|Immunologic Factors|immunologic factors|mesh-ancestor
24531268|NCT00634725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531269|NCT00634725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24531270|NCT00634790|Alprazolam|alprazolam|mesh-list
24531271|NCT00634790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24531272|NCT00634790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24531273|NCT00634790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531274|NCT00634790|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24531275|NCT00634790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24456313|NCT00330824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24668667|NCT04650542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24531307|NCT00634985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531308|NCT00634985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531309|NCT00634998|Ascorbic Acid|ascorbic acid|mesh-list
24531310|NCT00634998|Vitamins|vitamins|mesh-ancestor
24531311|NCT00634998|Micronutrients|micronutrients|mesh-ancestor
24531312|NCT00634998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531313|NCT00634998|Antioxidants|antioxidants|mesh-ancestor
24531314|NCT00634998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24668774|NCT04609514|Autonomic Agents|autonomic agents|mesh-ancestor
24668775|NCT04609514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24668776|NCT04609514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24668777|NCT04609514|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24668778|NCT04609514|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24456319|NCT00330902|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24456321|NCT00330902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24456322|NCT00330902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25712541|NCT02322216|Histamine Antagonists|histamine antagonists|mesh-ancestor
25712543|NCT02322216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25712544|NCT02322216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456323|NCT00330902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24456324|NCT00330902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24456325|NCT00330902|Antiviral Agents|antiviral agents|mesh-ancestor
24456326|NCT00330902|Schistosomicides|schistosomicides|mesh-ancestor
24456327|NCT00330902|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24668807|NCT04591353|Sensory System Agents|sensory system agents|mesh-ancestor
24456344|NCT00330941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24456345|NCT00330941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412657|NCT00191737|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24668917|NCT04512066|Risperidone|risperidone|mesh-list
24668918|NCT04512066|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24668919|NCT04512066|Serotonin Agents|serotonin agents|mesh-ancestor
24668920|NCT04512066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24668921|NCT04512066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531381|NCT00635531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24531382|NCT00635531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531383|NCT00635531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24531384|NCT00635531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24531385|NCT00635531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24531386|NCT00635531|GABA Modulators|gaba modulators|mesh-ancestor
24531387|NCT00635531|GABA Agents|gaba agents|mesh-ancestor
24531388|NCT00635531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24531471|NCT00635986|Analgesics|analgesics|mesh-ancestor
24531472|NCT00635986|Sensory System Agents|sensory system agents|mesh-ancestor
24531473|NCT00635986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24531474|NCT00635986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24531494|NCT00636064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24531496|NCT00636064|Sensory System Agents|sensory system agents|mesh-ancestor
24531531|NCT00636298|Cetuximab|cetuximab|mesh-list
24531532|NCT00636298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24531533|NCT00636298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531534|NCT00636298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24531690|NCT00636909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24669017|NCT04332653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24669018|NCT04332653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24669019|NCT04330248|Carbamazepine|carbamazepine|mesh-list
24669020|NCT04330248|Anticonvulsants|anticonvulsants|mesh-ancestor
24669021|NCT04330248|Antimanic Agents|antimanic agents|mesh-ancestor
24669022|NCT04330248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24669023|NCT04330248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24669024|NCT04330248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24669025|NCT04330248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24669026|NCT04330248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24669027|NCT04330248|Analgesics|analgesics|mesh-ancestor
24669028|NCT04330248|Sensory System Agents|sensory system agents|mesh-ancestor
24669029|NCT04330248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24669030|NCT04330248|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24669031|NCT04330248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24669032|NCT04330248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24669033|NCT04330248|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24669034|NCT04330248|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24531691|NCT00636909|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24531693|NCT00636922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531694|NCT00636922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24531695|NCT00636922|Immunologic Factors|immunologic factors|mesh-ancestor
24531696|NCT00636922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712545|NCT02322242|Dexamethasone|dexamethasone|mesh-list
25712546|NCT02322242|Dexamethasone acetate|dexamethasone acetate|mesh-list
25712547|NCT02322242|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25712548|NCT02322242|BB 1101|bb 1101|mesh-list
25712549|NCT02322242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25712550|NCT02322242|Antiemetics|antiemetics|mesh-ancestor
25712551|NCT02322242|Autonomic Agents|autonomic agents|mesh-ancestor
25712552|NCT02322242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25712553|NCT02322242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712554|NCT02322242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24531697|NCT00636935|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24531698|NCT00636935|Clindamycin|clindamycin|mesh-list
24531699|NCT00636935|Clindamycin palmitate|clindamycin palmitate|mesh-list
24531700|NCT00636935|Clindamycin phosphate|clindamycin phosphate|mesh-list
24531701|NCT00636935|Dapsone|dapsone|mesh-list
24531702|NCT00636935|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24531703|NCT00636935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24531704|NCT00636935|Primaquine|primaquine|mesh-list
24531705|NCT00636935|Trimethoprim|trimethoprim|mesh-list
24531706|NCT00636935|Atovaquone|atovaquone|mesh-list
24456381|NCT00331058|Hormones|hormones|mesh-ancestor
24512297|NCT00574015|Acetaminophen|acetaminophen|mesh-list
24531707|NCT00636935|Pentamidine|pentamidine|mesh-list
24531708|NCT00636935|Prednisone|prednisone|mesh-list
24531709|NCT00636935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24531710|NCT00636935|Glucocorticoids|glucocorticoids|mesh-ancestor
24531711|NCT00636935|Hormones|hormones|mesh-ancestor
24531712|NCT00636935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24531713|NCT00636935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531714|NCT00636935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24531715|NCT00636935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531716|NCT00636935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24531740|NCT00637026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531742|NCT00637065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24531743|NCT00637065|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24531773|NCT00637117|Interferon-alpha|interferon-alpha|mesh-list
24531774|NCT00637117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531800|NCT00637182|Hormone Antagonists|hormone antagonists|mesh-ancestor
24531801|NCT00637182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24531802|NCT00637182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531803|NCT00637234|Oxcarbazepine|oxcarbazepine|mesh-list
24531804|NCT00637234|Anticonvulsants|anticonvulsants|mesh-ancestor
24531805|NCT00637234|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24531806|NCT00637234|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24531807|NCT00637234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24531833|NCT00637403|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24531834|NCT00637403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24531835|NCT00637403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531836|NCT00637403|Appetite Stimulants|appetite stimulants|mesh-ancestor
24531837|NCT00637403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24531839|NCT00637442|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24531957|NCT00637663|Entecavir|entecavir|mesh-list
24531960|NCT00637663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24531972|NCT00637715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531973|NCT00637715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24669271|NCT04145258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24669272|NCT04145258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24669273|NCT04145258|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24669296|NCT04116112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24669297|NCT04116112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24669300|NCT04116112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24669301|NCT04116112|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24669302|NCT04116112|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24669303|NCT04116112|Vasodilator Agents|vasodilator agents|mesh-ancestor
24669304|NCT04116112|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24669305|NCT04116112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24669306|NCT04116112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24456438|NCT00331097|Antimetabolites|antimetabolites|mesh-ancestor
24456439|NCT00331097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24456440|NCT00331097|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25712555|NCT02322242|Glucocorticoids|glucocorticoids|mesh-ancestor
25712556|NCT02322242|Hormones|hormones|mesh-ancestor
25712557|NCT02322242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25712558|NCT02322242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24512687|NCT00576173|Tramadol|tramadol|mesh-list
24532023|NCT00637871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24532071|NCT00637962|Immunologic Factors|immunologic factors|mesh-ancestor
24532072|NCT00637962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532073|NCT00637962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24532074|NCT00637962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24532075|NCT00637962|Antiviral Agents|antiviral agents|mesh-ancestor
24532076|NCT00637962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24532077|NCT00637962|Interferon Inducers|interferon inducers|mesh-ancestor
24532078|NCT00637962|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24532079|NCT00637962|Protective Agents|protective agents|mesh-ancestor
24532080|NCT00637975|Pregabalin|pregabalin|mesh-list
24413405|NCT00193726|Contraceptive Agents|contraceptive agents|mesh-ancestor
24532081|NCT00637975|Oxycodone|oxycodone|mesh-list
24532082|NCT00637975|Analgesics|analgesics|mesh-ancestor
24532083|NCT00637975|Sensory System Agents|sensory system agents|mesh-ancestor
24532084|NCT00637975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24532085|NCT00637975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532086|NCT00637975|Anticonvulsants|anticonvulsants|mesh-ancestor
24532087|NCT00637975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24532088|NCT00637975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24532089|NCT00637975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532090|NCT00637975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24532094|NCT00637975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24532095|NCT00637975|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24532096|NCT00637975|Narcotics|narcotics|mesh-ancestor
24532097|NCT00637988|Aspirin|aspirin|mesh-list
24532098|NCT00637988|Rofecoxib|rofecoxib|mesh-list
24532099|NCT00637988|Esomeprazole|esomeprazole|mesh-list
24532100|NCT00637988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24532101|NCT00637988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24532102|NCT00637988|Analgesics|analgesics|mesh-ancestor
24532132|NCT00638079|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24532133|NCT00638079|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24532134|NCT00638079|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24532135|NCT00638079|Contraceptive Agents|contraceptive agents|mesh-ancestor
24532136|NCT00638079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24532137|NCT00638079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532138|NCT00638079|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24532192|NCT00638482|Diuretics|diuretics|mesh-ancestor
24532293|NCT00639015|Adrenergic Agents|adrenergic agents|mesh-ancestor
24456462|NCT00331188|Sensory System Agents|sensory system agents|mesh-ancestor
24456463|NCT00331188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24456468|NCT00331214|Hormones|hormones|mesh-ancestor
24456469|NCT00331214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24456470|NCT00331214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456471|NCT00331240|Timolol|timolol|mesh-list
24456472|NCT00331240|Travoprost|travoprost|mesh-list
24456473|NCT00331240|Lubricant Eye Drops|lubricant eye drops|mesh-list
24669716|NCT03702725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24669717|NCT03702725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24669719|NCT03702725|Hormones|hormones|mesh-ancestor
24669720|NCT03702725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24669721|NCT03702725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24669722|NCT03702725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24669723|NCT03702725|Immunologic Factors|immunologic factors|mesh-ancestor
24669724|NCT03702725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24669725|NCT03702725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24669726|NCT03702725|Growth Substances|growth substances|mesh-ancestor
24669727|NCT03702725|Growth Inhibitors|growth inhibitors|mesh-ancestor
24669729|NCT03691376|Melphalan|melphalan|mesh-list
24669730|NCT03691376|Mechlorethamine|mechlorethamine|mesh-list
24669731|NCT03691376|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25712559|NCT02322242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712560|NCT02322242|Protease Inhibitors|protease inhibitors|mesh-ancestor
25712561|NCT02322242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712562|NCT02322242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712563|NCT02322281|Gemcitabine|gemcitabine|mesh-list
25712564|NCT02322281|Paclitaxel|paclitaxel|mesh-list
25712565|NCT02322281|Docetaxel|docetaxel|mesh-list
25712567|NCT02322281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25712568|NCT02322281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712569|NCT02322281|Tubulin Modulators|tubulin modulators|mesh-ancestor
24669732|NCT03691376|Interleukin-2|interleukin-2|mesh-list
24532531|NCT00640263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24532532|NCT00640263|Antiviral Agents|antiviral agents|mesh-ancestor
24532533|NCT00640263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24532534|NCT00640263|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24532598|NCT00640575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24532599|NCT00640575|Glucocorticoids|glucocorticoids|mesh-ancestor
24532600|NCT00640575|Hormones|hormones|mesh-ancestor
24532601|NCT00640575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24532602|NCT00640575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24669779|NCT03613181|Capecitabine|capecitabine|mesh-list
24669780|NCT03613181|Methotrexate|methotrexate|mesh-list
24669781|NCT03613181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24669782|NCT03613181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24669783|NCT03613181|Tubulin Modulators|tubulin modulators|mesh-ancestor
24669784|NCT03613181|Antimitotic Agents|antimitotic agents|mesh-ancestor
24669785|NCT03613181|Mitosis Modulators|mitosis modulators|mesh-ancestor
24669786|NCT03613181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456495|NCT00331435|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24669864|NCT03476798|Bevacizumab|bevacizumab|mesh-list
24669865|NCT03476798|Rucaparib|rucaparib|mesh-list
24669866|NCT03476798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24456499|NCT00331487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24456500|NCT00331487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456501|NCT00331500|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
24532739|NCT00640939|Analgesics|analgesics|mesh-ancestor
24532740|NCT00640939|Sensory System Agents|sensory system agents|mesh-ancestor
24532795|NCT00641095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532796|NCT00641095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24532797|NCT00641095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24532798|NCT00641095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24532799|NCT00641160|Vinorelbine|vinorelbine|mesh-list
24532800|NCT00641160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24532801|NCT00641160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24532802|NCT00641160|Tubulin Modulators|tubulin modulators|mesh-ancestor
24532803|NCT00641160|Antimitotic Agents|antimitotic agents|mesh-ancestor
24532804|NCT00641160|Mitosis Modulators|mitosis modulators|mesh-ancestor
24532806|NCT00641173|Paroxetine|paroxetine|mesh-list
24532907|NCT00641602|Lansoprazole|lansoprazole|mesh-list
24532908|NCT00641602|Dexlansoprazole|dexlansoprazole|mesh-list
24532909|NCT00641602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24532910|NCT00641602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24532911|NCT00641602|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24532912|NCT00641602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532913|NCT00641602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532955|NCT00641758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532956|NCT00641758|Antioxidants|antioxidants|mesh-ancestor
24532957|NCT00641758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532958|NCT00641758|Protective Agents|protective agents|mesh-ancestor
24532959|NCT00641758|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24532960|NCT00641810|Caffeine|caffeine|mesh-list
24532961|NCT00641810|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24532962|NCT00641810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532963|NCT00641810|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25712570|NCT02322281|Antimitotic Agents|antimitotic agents|mesh-ancestor
25712571|NCT02322281|Mitosis Modulators|mitosis modulators|mesh-ancestor
25712572|NCT02322281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712573|NCT02322281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25712574|NCT02322281|Antimetabolites|antimetabolites|mesh-ancestor
24532964|NCT00641810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532965|NCT00641810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712575|NCT02322281|Antiviral Agents|antiviral agents|mesh-ancestor
24532967|NCT00641810|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24532977|NCT00641914|Respiratory System Agents|respiratory system agents|mesh-ancestor
24532978|NCT00641914|Glucocorticoids|glucocorticoids|mesh-ancestor
24532979|NCT00641914|Hormones|hormones|mesh-ancestor
24532980|NCT00641914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24532983|NCT00641927|Antidepressive Agents|antidepressive agents|mesh-ancestor
24532984|NCT00641927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24533022|NCT00642096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24533084|NCT00642187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533085|NCT00642187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24533086|NCT00642187|Respiratory System Agents|respiratory system agents|mesh-ancestor
24533088|NCT00642187|Hormones|hormones|mesh-ancestor
24533089|NCT00642187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24533090|NCT00642226|Triamcinolone|triamcinolone|mesh-list
24533091|NCT00642226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24533092|NCT00642226|Glucocorticoids|glucocorticoids|mesh-ancestor
24456511|NCT00331500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24456512|NCT00331500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24456513|NCT00331500|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24533108|NCT00642291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24533109|NCT00642330|Ibuprofen|ibuprofen|mesh-list
24670077|NCT03300947|Psilocybin|psilocybin|mesh-list
24670078|NCT03300947|Anticonvulsants|anticonvulsants|mesh-ancestor
24670079|NCT03300947|Antiemetics|antiemetics|mesh-ancestor
24670080|NCT03300947|Autonomic Agents|autonomic agents|mesh-ancestor
24670081|NCT03300947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24670083|NCT03300947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24513534|NCT00583193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24670102|NCT03263767|Thymoglobulin|thymoglobulin|mesh-list
24670103|NCT03263767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24670104|NCT03263767|Immunologic Factors|immunologic factors|mesh-ancestor
24670105|NCT03263767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24670106|NCT03263767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24670107|NCT03263767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24670108|NCT03263767|Alkylating Agents|alkylating agents|mesh-ancestor
24670109|NCT03263767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24670110|NCT03263767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24670111|NCT03263767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24670112|NCT03263767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25712576|NCT02322281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25712577|NCT02322281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887902|NCT04511195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712578|NCT02322281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25712579|NCT02322281|Immunologic Factors|immunologic factors|mesh-ancestor
24670113|NCT03263767|Antimetabolites|antimetabolites|mesh-ancestor
24670114|NCT03251326|Propranolol|propranolol|mesh-list
25712580|NCT02322281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712581|NCT02322281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25712582|NCT02322281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25712583|NCT02322320|Lenalidomide|lenalidomide|mesh-list
25712584|NCT02322320|Immunologic Factors|immunologic factors|mesh-ancestor
25712585|NCT02322320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712586|NCT02322320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25712587|NCT02322320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25712588|NCT02322320|Growth Substances|growth substances|mesh-ancestor
25712589|NCT02322320|Growth Inhibitors|growth inhibitors|mesh-ancestor
25712590|NCT02322320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712591|NCT02322528|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25712592|NCT02322528|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25712593|NCT02322775|Benralizumab|benralizumab|mesh-list
25712594|NCT02322775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25712595|NCT02322775|Respiratory System Agents|respiratory system agents|mesh-ancestor
25712596|NCT02322788|Terbutaline|terbutaline|mesh-list
24670116|NCT03251326|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24533261|NCT00642824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24414578|NCT00198094|GABA Modulators|gaba modulators|mesh-ancestor
24533285|NCT00642863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533287|NCT00642863|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24533288|NCT00642863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24670722|NCT01998971|Bortezomib|bortezomib|mesh-list
24670723|NCT01998971|Daratumumab|daratumumab|mesh-list
24670724|NCT01998971|Pomalidomide|pomalidomide|mesh-list
25712597|NCT02322788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25712598|NCT02322788|Autonomic Agents|autonomic agents|mesh-ancestor
25712599|NCT02322788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25712600|NCT02322788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712601|NCT02322788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25712602|NCT02322788|Respiratory System Agents|respiratory system agents|mesh-ancestor
25712603|NCT02322788|Sympathomimetics|sympathomimetics|mesh-ancestor
25712604|NCT02322788|Tocolytic Agents|tocolytic agents|mesh-ancestor
25712620|NCT02322814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712621|NCT02322866|Sarecycline|sarecycline|mesh-list
25712622|NCT02322866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25770866|NCT03570554|Gout Suppressants|gout suppressants|mesh-ancestor
24456673|NCT00331981|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24456674|NCT00331981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24455504|NCT00327587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455505|NCT00327587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24455506|NCT00327587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455507|NCT00327587|Vasodilator Agents|vasodilator agents|mesh-ancestor
24455508|NCT00327587|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24455509|NCT00327587|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24453534|NCT04942340|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24453535|NCT04942340|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24453536|NCT04942340|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24453537|NCT04941144|Vaccines|vaccines|mesh-list
24455553|NCT00327769|Fulvestrant|fulvestrant|mesh-list
24455554|NCT00327769|Anastrozole|anastrozole|mesh-list
24455555|NCT00327769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24455556|NCT00327769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514751|NCT00592670|Fluoxetine|fluoxetine|mesh-list
24456675|NCT00331981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24456676|NCT00331981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456677|NCT00331981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24456678|NCT00331981|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24456679|NCT00331981|Dopamine Agents|dopamine agents|mesh-ancestor
24456680|NCT00331981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24456681|NCT00331981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456682|NCT00331981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24456683|NCT00331981|Antidepressive Agents|antidepressive agents|mesh-ancestor
24455557|NCT00327769|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24455558|NCT00327769|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24455559|NCT00327769|Hormone Antagonists|hormone antagonists|mesh-ancestor
24455560|NCT00327769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24455561|NCT00327769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455562|NCT00327769|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24455563|NCT00327769|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24455564|NCT00327769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404090|NCT00162526|Tocopherols|tocopherols|mesh-list
24455590|NCT00327925|Antibodies|antibodies|mesh-list
24455608|NCT00328107|Immunologic Factors|immunologic factors|mesh-ancestor
24455609|NCT00328107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455610|NCT00328120|Fulvestrant|fulvestrant|mesh-list
24456684|NCT00331994|Metronidazole|metronidazole|mesh-list
24456685|NCT00331994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24456686|NCT00331994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24455611|NCT00328120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24455612|NCT00328120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24455613|NCT00328120|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24455614|NCT00328120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24455615|NCT00328120|Hormone Antagonists|hormone antagonists|mesh-ancestor
24455628|NCT00328367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24455629|NCT00328367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24455670|NCT00328497|Bevacizumab|bevacizumab|mesh-list
24456687|NCT00331994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24456688|NCT00331994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24456689|NCT00332020|Enoxaparin|enoxaparin|mesh-list
24456690|NCT00332020|Rivaroxaban|rivaroxaban|mesh-list
24455671|NCT00328497|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
24455672|NCT00328497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24455673|NCT00328497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24455674|NCT00328497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24455675|NCT00328497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24455676|NCT00328497|Growth Substances|growth substances|mesh-ancestor
24455698|NCT00328718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24455699|NCT00328718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24455700|NCT00328718|Autonomic Agents|autonomic agents|mesh-ancestor
24455701|NCT00328718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24455702|NCT00328718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455703|NCT00328718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24455705|NCT00328718|Dermatologic Agents|dermatologic agents|mesh-ancestor
24455706|NCT00328718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24455707|NCT00328718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24455708|NCT00328718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24455709|NCT00328718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24455730|NCT00328809|Spironolactone|spironolactone|mesh-list
24455731|NCT00328809|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24455732|NCT00328809|Hormone Antagonists|hormone antagonists|mesh-ancestor
24456691|NCT00332020|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24416426|NCT00203099|(T,G)-A-L|(t,g)-a-l|mesh-list
24416427|NCT00203099|Antiviral Agents|antiviral agents|mesh-ancestor
25712623|NCT02322866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25712624|NCT02322866|Dermatologic Agents|dermatologic agents|mesh-ancestor
25712625|NCT02322892|Thiamine|thiamine|mesh-list
24416429|NCT00203099|Expectorants|expectorants|mesh-ancestor
25712626|NCT02322892|Vitamins|vitamins|mesh-ancestor
25712627|NCT02322892|Micronutrients|micronutrients|mesh-ancestor
25712628|NCT02322892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712629|NCT02322892|Vitamin B Complex|vitamin b complex|mesh-ancestor
25712630|NCT02323048|Methamphetamine|methamphetamine|mesh-list
24455735|NCT00328809|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24455736|NCT00328809|Diuretics|diuretics|mesh-ancestor
24455737|NCT00328809|Natriuretic Agents|natriuretic agents|mesh-ancestor
24455738|NCT00328822|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24455743|NCT00328822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24455744|NCT00328822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455746|NCT00328874|Coenzyme Q10|coenzyme q10|mesh-list
24455747|NCT00328874|Micronutrients|micronutrients|mesh-ancestor
24455748|NCT00328874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455749|NCT00328874|Vitamins|vitamins|mesh-ancestor
24455750|NCT00328900|Atropine|atropine|mesh-list
24455751|NCT00328900|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24455752|NCT00328900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24455753|NCT00328900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24455754|NCT00328900|Autonomic Agents|autonomic agents|mesh-ancestor
24455755|NCT00328900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24455756|NCT00328900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455757|NCT00328900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24455758|NCT00328900|Respiratory System Agents|respiratory system agents|mesh-ancestor
24455760|NCT00328900|Parasympatholytics|parasympatholytics|mesh-ancestor
24455789|NCT00328978|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24455790|NCT00328978|Antidepressive Agents|antidepressive agents|mesh-ancestor
24455791|NCT00328978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24455792|NCT00328978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24455793|NCT00328978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24455794|NCT00328978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24455795|NCT00328978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455796|NCT00329069|Atorvastatin|atorvastatin|mesh-list
24455797|NCT00329069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24455798|NCT00329069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24455799|NCT00329069|Antimetabolites|antimetabolites|mesh-ancestor
24456697|NCT00332020|Anticoagulants|anticoagulants|mesh-ancestor
24456698|NCT00332020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24456699|NCT00332020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24455829|NCT00329147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24455830|NCT00329147|Serotonin Agents|serotonin agents|mesh-ancestor
24455831|NCT00329147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455832|NCT00329147|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24455833|NCT00329147|Antidepressive Agents|antidepressive agents|mesh-ancestor
24455834|NCT00329147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24455836|NCT00329147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24455837|NCT00329147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24455838|NCT00329147|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24455873|NCT00329316|Progestins|progestins|mesh-ancestor
24455874|NCT00329316|Hormones|hormones|mesh-ancestor
24455875|NCT00329316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24455876|NCT00329316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455877|NCT00329329|Capecitabine|capecitabine|mesh-list
24455878|NCT00329329|Satraplatin|satraplatin|mesh-list
24455879|NCT00329329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24455880|NCT00329329|Antimetabolites|antimetabolites|mesh-ancestor
24455881|NCT00329329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515085|NCT00594373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24515086|NCT00594373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24455927|NCT00329381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455928|NCT00329394|Ketamine|ketamine|mesh-list
24455943|NCT00329446|Citalopram|citalopram|mesh-list
24456715|NCT00332046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24456716|NCT00332046|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24456004|NCT00329511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24456005|NCT00329511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25712631|NCT02323048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25712632|NCT02323048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712633|NCT02323048|Sympathomimetics|sympathomimetics|mesh-ancestor
25712634|NCT02323048|Autonomic Agents|autonomic agents|mesh-ancestor
25712635|NCT02323048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25712636|NCT02323048|Dopamine Agents|dopamine agents|mesh-ancestor
25712637|NCT02323048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25712640|NCT02323048|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25712641|NCT02323048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24456007|NCT00329511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24456092|NCT00329914|Hormones|hormones|mesh-ancestor
24456100|NCT00329940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456101|NCT00329940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24456102|NCT00329940|Hormone Antagonists|hormone antagonists|mesh-ancestor
24456103|NCT00329940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24456104|NCT00329940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456105|NCT00330018|Acyclovir|acyclovir|mesh-list
24456106|NCT00330018|Valganciclovir|valganciclovir|mesh-list
24456107|NCT00330018|Antiviral Agents|antiviral agents|mesh-ancestor
24456109|NCT00330044|Carboplatin|carboplatin|mesh-list
24456162|NCT00330304|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24456163|NCT00330304|Renal Agents|renal agents|mesh-ancestor
24456164|NCT00330304|Antimalarials|antimalarials|mesh-ancestor
24456165|NCT00330304|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24456166|NCT00330304|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24456233|NCT00330746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456234|NCT00330746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25712642|NCT02323048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25712643|NCT02323048|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25712644|NCT02323217|Isocarboxazid|isocarboxazid|mesh-list
25712645|NCT02323217|Idazoxan|idazoxan|mesh-list
25712646|NCT02323217|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25712647|NCT02323217|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25712648|NCT02323217|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25712649|NCT02323217|Adrenergic Agents|adrenergic agents|mesh-ancestor
24536444|NCT00651300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24536445|NCT00651300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536446|NCT00651300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449617|NCT00316238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24449618|NCT00316238|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24538360|NCT00659022|Oxaliplatin|oxaliplatin|mesh-list
24449620|NCT00316238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25712656|NCT02323217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770870|NCT03571516|Protective Agents|protective agents|mesh-ancestor
25770871|NCT03571516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770872|NCT03571607|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25770873|NCT03571607|Immunologic Factors|immunologic factors|mesh-ancestor
25770874|NCT03571607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770875|NCT03571724|Menthol|menthol|mesh-list
25770876|NCT03571724|Nicotine|nicotine|mesh-list
25770877|NCT03571724|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25770878|NCT03571724|Autonomic Agents|autonomic agents|mesh-ancestor
25770879|NCT03571724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25770880|NCT03571724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770881|NCT03571724|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25770882|NCT03571724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25770883|NCT03571724|Cholinergic Agents|cholinergic agents|mesh-ancestor
25770884|NCT03571724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25770885|NCT03571724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770886|NCT03571724|Antipruritics|antipruritics|mesh-ancestor
25770887|NCT03571724|Dermatologic Agents|dermatologic agents|mesh-ancestor
25770888|NCT03572478|Nivolumab|nivolumab|mesh-list
25770889|NCT03572478|Rucaparib|rucaparib|mesh-list
25770890|NCT03572478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24538269|NCT00658255|Respiratory System Agents|respiratory system agents|mesh-ancestor
24538270|NCT00658255|Glucocorticoids|glucocorticoids|mesh-ancestor
24538271|NCT00658255|Hormones|hormones|mesh-ancestor
24538272|NCT00658255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24538349|NCT00658957|Gentamicins|gentamicins|mesh-list
24538350|NCT00658957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24538351|NCT00658957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24538352|NCT00658957|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25712657|NCT02323334|Itraconazole|itraconazole|mesh-list
25712658|NCT02323334|Antifungal Agents|antifungal agents|mesh-ancestor
25712659|NCT02323334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25712660|NCT02323334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25712661|NCT02323334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25712662|NCT02323334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712663|NCT02323334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538353|NCT00658957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538354|NCT00658957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538355|NCT00658970|Tirbanibulin|tirbanibulin|mesh-list
24515746|NCT00598962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515781|NCT00599274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24515782|NCT00599287|Haloperidol|haloperidol|mesh-list
24515784|NCT00599287|Methylphenidate|methylphenidate|mesh-list
24538411|NCT00659113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24538412|NCT00659113|Antimetabolites|antimetabolites|mesh-ancestor
24538413|NCT00659113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538414|NCT00659178|Doxorubicin|doxorubicin|mesh-list
24538415|NCT00659178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24538520|NCT00659685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24538522|NCT00659685|Dermatologic Agents|dermatologic agents|mesh-ancestor
24538524|NCT00659685|Serotonin Agents|serotonin agents|mesh-ancestor
24538597|NCT00660036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538598|NCT00660036|Analgesics|analgesics|mesh-ancestor
24538599|NCT00660036|Sensory System Agents|sensory system agents|mesh-ancestor
24449671|NCT00316472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449690|NCT00316563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24449691|NCT00316563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24449692|NCT00316563|Analgesics|analgesics|mesh-ancestor
24449693|NCT00316563|Sensory System Agents|sensory system agents|mesh-ancestor
24449695|NCT00316563|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24449696|NCT00316563|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24539634|NCT00664781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539635|NCT00664781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24539636|NCT00664833|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24539637|NCT00664833|Vasodilator Agents|vasodilator agents|mesh-ancestor
24539638|NCT00664833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24539639|NCT00664833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24539640|NCT00664833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712664|NCT02323334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24539675|NCT00664963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24539676|NCT00664963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24539677|NCT00664963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24539678|NCT00664963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712665|NCT02323334|Hormone Antagonists|hormone antagonists|mesh-ancestor
25712674|NCT02324153|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24539981|NCT00666159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539982|NCT00666159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24418395|NCT00209521|Propofol|propofol|mesh-list
24544471|NCT00689169|Etoposide|etoposide|mesh-list
24544472|NCT00689169|Melphalan|melphalan|mesh-list
24544473|NCT00689169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24544474|NCT00689169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544475|NCT00689169|Immunologic Factors|immunologic factors|mesh-ancestor
24544476|NCT00689169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544477|NCT00689169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24545855|NCT00695344|Azathioprine|azathioprine|mesh-list
24546490|NCT00698724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24546491|NCT00698724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24546492|NCT00698724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24515948|NCT00600093|Analgesics|analgesics|mesh-ancestor
24546971|NCT00701532|Modafinil|modafinil|mesh-list
24546972|NCT00701532|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24546973|NCT00701532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546974|NCT00701532|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24546975|NCT00701532|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24546976|NCT00701532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24546977|NCT00701532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546978|NCT00701597|Bosentan|bosentan|mesh-list
24546979|NCT00701597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24547018|NCT00701909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24547047|NCT00702117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547049|NCT00702130|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24547050|NCT00702130|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24547051|NCT00702130|Antimetabolites|antimetabolites|mesh-ancestor
24547052|NCT00702130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547053|NCT00702130|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24547056|NCT00702156|Bisoprolol|bisoprolol|mesh-list
24547063|NCT00702156|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24547064|NCT00702156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25712675|NCT02324153|Dermatologic Agents|dermatologic agents|mesh-ancestor
25712676|NCT02324270|Diclofenac|diclofenac|mesh-list
25712677|NCT02324270|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
25712678|NCT02324270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25712679|NCT02324270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25712680|NCT02324270|Analgesics|analgesics|mesh-ancestor
25712681|NCT02324270|Sensory System Agents|sensory system agents|mesh-ancestor
24547143|NCT00702637|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24547144|NCT00702637|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24547145|NCT00702637|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24547208|NCT00702975|Mitosis Modulators|mitosis modulators|mesh-ancestor
24547883|NCT00706277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24547884|NCT00706277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547885|NCT00706277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24547886|NCT00706277|Anesthetics, General|anesthetics, general|mesh-ancestor
24547888|NCT00706277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24547892|NCT00706277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24548068|NCT00707473|Cisplatin|cisplatin|mesh-list
24548069|NCT00707473|Carboplatin|carboplatin|mesh-list
24548070|NCT00707473|Docetaxel|docetaxel|mesh-list
24548071|NCT00707473|Fluorouracil|fluorouracil|mesh-list
24548072|NCT00707473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24548803|NCT00712140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24548804|NCT00712140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24548931|NCT00712647|Carotenoids|carotenoids|mesh-list
24548932|NCT00712647|Antioxidants|antioxidants|mesh-ancestor
24548933|NCT00712647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548934|NCT00712647|Protective Agents|protective agents|mesh-ancestor
24549914|NCT00717990|Capecitabine|capecitabine|mesh-list
25712688|NCT02324270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712689|NCT02324543|Gemcitabine|gemcitabine|mesh-list
25712690|NCT02324543|Cisplatin|cisplatin|mesh-list
25712691|NCT02324543|Docetaxel|docetaxel|mesh-list
25407571|NCT03493932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25712698|NCT02324543|Antiviral Agents|antiviral agents|mesh-ancestor
25712699|NCT02324543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25712756|NCT02325518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712757|NCT02325518|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25712758|NCT02325713|Praziquantel|praziquantel|mesh-list
25712759|NCT02325713|Anthelmintics|anthelmintics|mesh-ancestor
25712760|NCT02325713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25712761|NCT02325713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25712762|NCT02325739|Spartalizumab|spartalizumab|mesh-list
25712763|NCT02325739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25712764|NCT02325739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449946|NCT00317421|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24449947|NCT00317421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24456878|NCT00332540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456879|NCT00332540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24454642|NCT03878524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24454643|NCT03878524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24454644|NCT03878524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24454645|NCT03878524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24454646|NCT03878524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24517627|NCT00608816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24517629|NCT00608816|Mydriatics|mydriatics|mesh-ancestor
24422484|NCT00222573|Purinergic Agents|purinergic agents|mesh-ancestor
24422485|NCT00222573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24454655|NCT03878524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24454656|NCT03878524|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24517642|NCT00608972|Growth Substances|growth substances|mesh-ancestor
24517643|NCT00608972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465613|NCT00370266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24465614|NCT00370266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465615|NCT00370305|Rosiglitazone|rosiglitazone|mesh-list
24465616|NCT00370305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24465617|NCT00370305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465620|NCT00370318|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24465622|NCT00370318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465623|NCT00370318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24465658|NCT00370422|Glucocorticoids|glucocorticoids|mesh-ancestor
24465660|NCT00370422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24465661|NCT00370500|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24465662|NCT00370500|Antidepressive Agents|antidepressive agents|mesh-ancestor
24465663|NCT00370500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24465664|NCT00370500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24465665|NCT00370500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24517701|NCT00609531|Citalopram|citalopram|mesh-list
25712795|NCT02326805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25712796|NCT02326805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25712797|NCT02326805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24466127|NCT00372216|Clopidogrel|clopidogrel|mesh-list
24466128|NCT00372216|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24466129|NCT00372216|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24517842|NCT00610246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517843|NCT00610246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24517844|NCT00610246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517846|NCT00610324|Chlorhexidine|chlorhexidine|mesh-list
25712798|NCT02326844|Talazoparib|talazoparib|mesh-list
24890792|NCT04480359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712799|NCT02326844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25712800|NCT02326844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712801|NCT02326844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712802|NCT02326844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712803|NCT02327013|Vortioxetine|vortioxetine|mesh-list
25712804|NCT02327013|Antidepressive Agents|antidepressive agents|mesh-ancestor
25712805|NCT02327013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25712806|NCT02327013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25712807|NCT02327013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25712808|NCT02327013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24517983|NCT00610948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24517984|NCT00610948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517985|NCT00610948|Antimetabolites|antimetabolites|mesh-ancestor
24517986|NCT00610948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517987|NCT00610948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24517988|NCT00610948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517989|NCT00610948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24517990|NCT00610948|Immunologic Factors|immunologic factors|mesh-ancestor
24517991|NCT00610948|Antidotes|antidotes|mesh-ancestor
25712809|NCT02327013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712810|NCT02327013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25712811|NCT02327013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25712812|NCT02327013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25712813|NCT02327013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712814|NCT02327013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24467127|NCT00376337|Miconazole|miconazole|mesh-list
24467390|NCT00377468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24467391|NCT00377468|Analgesics|analgesics|mesh-ancestor
24467392|NCT00377468|Sensory System Agents|sensory system agents|mesh-ancestor
24467393|NCT00377468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24467394|NCT00377468|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25712815|NCT02327013|Serotonin Agents|serotonin agents|mesh-ancestor
25712816|NCT02327013|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25712817|NCT02327013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25712818|NCT02327013|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25712819|NCT02327013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25712820|NCT02327117|Tranexamic Acid|tranexamic acid|mesh-list
25712821|NCT02327117|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25712822|NCT02327117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25712823|NCT02327117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24456905|NCT00332553|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24456906|NCT00332553|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24456907|NCT00332553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24468271|NCT00380887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24468272|NCT00380887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468273|NCT00380913|Nabilone|nabilone|mesh-list
24468297|NCT00380965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24468298|NCT00380965|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24468299|NCT00380965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24468300|NCT00380965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24468304|NCT00381017|Interferon alpha-2|interferon alpha-2|mesh-list
24468641|NCT00382499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24468642|NCT00382499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468643|NCT00382538|Mifepristone|mifepristone|mesh-list
24468644|NCT00382538|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24468645|NCT00382538|Abortifacient Agents|abortifacient agents|mesh-ancestor
24468646|NCT00382538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24468647|NCT00382538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468648|NCT00382538|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24468649|NCT00382538|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24468650|NCT00382538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24468651|NCT00382538|Contraceptive Agents|contraceptive agents|mesh-ancestor
24468654|NCT00382538|Hormone Antagonists|hormone antagonists|mesh-ancestor
24469835|NCT00387530|Valganciclovir|valganciclovir|mesh-list
24469836|NCT00387530|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
24469894|NCT00387777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24469895|NCT00387777|Narcotics|narcotics|mesh-ancestor
24469896|NCT00387777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24469897|NCT00387777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469898|NCT00387777|Sensory System Agents|sensory system agents|mesh-ancestor
24890988|NCT04477811|Vitamins|vitamins|mesh-list
24469899|NCT00387777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24469900|NCT00387777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24469901|NCT00387868|Etoposide|etoposide|mesh-list
24469903|NCT00387868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24470034|NCT00388635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24470035|NCT00388635|Glucocorticoids|glucocorticoids|mesh-ancestor
24470036|NCT00388635|Hormones|hormones|mesh-ancestor
24470037|NCT00388635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24470038|NCT00388635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470039|NCT00388635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24470040|NCT00388635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470041|NCT00388635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24470042|NCT00388635|Alkylating Agents|alkylating agents|mesh-ancestor
24470047|NCT00388661|Melatonin|melatonin|mesh-list
24470048|NCT00388661|Antioxidants|antioxidants|mesh-ancestor
24470092|NCT00388739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24470263|NCT00389415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24470560|NCT00390624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470561|NCT00390624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24470562|NCT00390624|Autonomic Agents|autonomic agents|mesh-ancestor
24470563|NCT00390624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24470564|NCT00390624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24518875|NCT04094961|Autonomic Agents|autonomic agents|mesh-ancestor
24518876|NCT04094961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24470805|NCT00392002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470868|NCT00392275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470869|NCT00392275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472010|NCT00397735|Expectorants|expectorants|mesh-ancestor
24472011|NCT00397735|Respiratory System Agents|respiratory system agents|mesh-ancestor
24472012|NCT00397735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24472013|NCT00397735|Antioxidants|antioxidants|mesh-ancestor
24472014|NCT00397735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472015|NCT00397735|Protective Agents|protective agents|mesh-ancestor
24472016|NCT00397735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472017|NCT00397735|Antidotes|antidotes|mesh-ancestor
24472589|NCT00399685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24472591|NCT00399685|Contraceptive Agents|contraceptive agents|mesh-ancestor
24476604|NCT00415844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476605|NCT00415844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476606|NCT00415844|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24477537|NCT00418925|Analgesics|analgesics|mesh-ancestor
24477538|NCT00418925|Sensory System Agents|sensory system agents|mesh-ancestor
24477539|NCT00418925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24477540|NCT00418925|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24477541|NCT00418925|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24477573|NCT00419146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477574|NCT00419146|Antioxidants|antioxidants|mesh-ancestor
24477575|NCT00419146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477576|NCT00419146|Protective Agents|protective agents|mesh-ancestor
24477577|NCT00419146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24477578|NCT00419146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24477579|NCT00419172|Rifampin|rifampin|mesh-list
24456976|NCT00332826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24456977|NCT00332826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24456978|NCT00332852|Letrozole|letrozole|mesh-list
24456979|NCT00332852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478265|NCT00421980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24478266|NCT00421980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24478268|NCT00421980|Sensory System Agents|sensory system agents|mesh-ancestor
24478269|NCT00421980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24478270|NCT00421980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478271|NCT00421980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24478272|NCT00421980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24478273|NCT00421980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24478274|NCT00421980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24478364|NCT00422565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24478365|NCT00422565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24478366|NCT00422565|Antifungal Agents|antifungal agents|mesh-ancestor
24428424|NCT00240448|Valsartan|valsartan|mesh-list
24478367|NCT00422565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24478368|NCT00422565|Immunologic Factors|immunologic factors|mesh-ancestor
24478450|NCT00422864|Antidotes|antidotes|mesh-ancestor
24478451|NCT00422864|Protective Agents|protective agents|mesh-ancestor
24478452|NCT00422864|Vitamin B Complex|vitamin b complex|mesh-ancestor
24478454|NCT00422864|Micronutrients|micronutrients|mesh-ancestor
24478455|NCT00422955|Rosiglitazone|rosiglitazone|mesh-list
24457012|NCT00332930|Interferons|interferons|mesh-list
24457013|NCT00332930|Interferon-gamma|interferon-gamma|mesh-list
24457014|NCT00332930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24457015|NCT00332930|Antiviral Agents|antiviral agents|mesh-ancestor
24457016|NCT00332930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24457018|NCT00332969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24457019|NCT00332969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24457020|NCT00332969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24457021|NCT00332995|Dapivirine|dapivirine|mesh-list
24457022|NCT00332995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24457023|NCT00332995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24457024|NCT00332995|Antiviral Agents|antiviral agents|mesh-ancestor
24457027|NCT00333008|Cyclophosphamide|cyclophosphamide|mesh-list
24457039|NCT00333008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24457040|NCT00333008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24457041|NCT00333008|Glucocorticoids|glucocorticoids|mesh-ancestor
24457042|NCT00333008|Hormones|hormones|mesh-ancestor
24457043|NCT00333008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24457044|NCT00333008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24457045|NCT00333008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24457046|NCT00333008|Tubulin Modulators|tubulin modulators|mesh-ancestor
24457047|NCT00333008|Antimitotic Agents|antimitotic agents|mesh-ancestor
24457048|NCT00333008|Mitosis Modulators|mitosis modulators|mesh-ancestor
24457049|NCT00333021|PENTA|penta|mesh-list
24457050|NCT00333021|Fondaparinux|fondaparinux|mesh-list
24457051|NCT00333021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24457052|NCT00333021|Antithrombins|antithrombins|mesh-ancestor
24457053|NCT00333021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24479156|NCT00425724|Dermatologic Agents|dermatologic agents|mesh-ancestor
24479157|NCT00425724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24479158|NCT00425724|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24457087|NCT00333086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24457088|NCT00333086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479208|NCT00426010|Caffeine|caffeine|mesh-list
24479252|NCT00426101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479254|NCT00426101|Glucocorticoids|glucocorticoids|mesh-ancestor
25712824|NCT02327117|Hemostatics|hemostatics|mesh-ancestor
25712825|NCT02327117|Coagulants|coagulants|mesh-ancestor
25712826|NCT02327169|Paclitaxel|paclitaxel|mesh-list
25712827|NCT02327169|Irinotecan|irinotecan|mesh-list
25712828|NCT02327169|Cetuximab|cetuximab|mesh-list
25712829|NCT02327169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25712830|NCT02327169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712831|NCT02327169|Tubulin Modulators|tubulin modulators|mesh-ancestor
25712832|NCT02327169|Antimitotic Agents|antimitotic agents|mesh-ancestor
24479256|NCT00426101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24479257|NCT00426101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24479258|NCT00426101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479259|NCT00426101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24479260|NCT00426101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24479338|NCT00426478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479339|NCT00426478|Vasodilator Agents|vasodilator agents|mesh-ancestor
24479340|NCT00426478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24479341|NCT00426478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24479342|NCT00426478|Diuretics|diuretics|mesh-ancestor
24479343|NCT00426478|Natriuretic Agents|natriuretic agents|mesh-ancestor
24479344|NCT00426478|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24479345|NCT00426491|Misoprostol|misoprostol|mesh-list
24479464|NCT00426985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24479465|NCT00426985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24479466|NCT00426985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479467|NCT00426985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479932|NCT00428909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24479934|NCT00428909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480143|NCT00429936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480144|NCT00429936|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24480147|NCT00429962|Ranibizumab|ranibizumab|mesh-list
24520874|NCT05288777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520875|NCT05288777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24520876|NCT05288777|Tubulin Modulators|tubulin modulators|mesh-ancestor
24520877|NCT05288777|Antimitotic Agents|antimitotic agents|mesh-ancestor
24520878|NCT05288777|Mitosis Modulators|mitosis modulators|mesh-ancestor
24480214|NCT00430118|Immunologic Factors|immunologic factors|mesh-ancestor
25712833|NCT02327169|Mitosis Modulators|mitosis modulators|mesh-ancestor
24480215|NCT00430118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712834|NCT02327169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712835|NCT02327169|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25712836|NCT02327169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24480216|NCT00430118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24480356|NCT00430794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480357|NCT00430794|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24480359|NCT00430794|Natriuretic Agents|natriuretic agents|mesh-ancestor
24480361|NCT00430807|Antimalarials|antimalarials|mesh-ancestor
24480362|NCT00430807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24480363|NCT00430807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24480364|NCT00430807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24480365|NCT00430807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480366|NCT00430807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480367|NCT00430807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24480368|NCT00430833|Candesartan|candesartan|mesh-list
24480369|NCT00430833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24480468|NCT00431119|Mycophenolic Acid|mycophenolic acid|mesh-list
24480469|NCT00431119|Azathioprine|azathioprine|mesh-list
24480470|NCT00431119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24480471|NCT00431119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480472|NCT00431119|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24480473|NCT00431119|Antitubercular Agents|antitubercular agents|mesh-ancestor
24480479|NCT00431119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24480511|NCT00431197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24405803|NCT00168467|Ramipril|ramipril|mesh-list
24480707|NCT00431704|Trastuzumab|trastuzumab|mesh-list
24480708|NCT00431704|Vinorelbine|vinorelbine|mesh-list
24480709|NCT00431704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480710|NCT00431704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24480711|NCT00431704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24480712|NCT00431704|Tubulin Modulators|tubulin modulators|mesh-ancestor
24480931|NCT00432757|Ketotifen|ketotifen|mesh-list
24480932|NCT00432757|Antipruritics|antipruritics|mesh-ancestor
24480933|NCT00432757|Dermatologic Agents|dermatologic agents|mesh-ancestor
24480934|NCT00432757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24457182|NCT00333307|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24457183|NCT00333307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457184|NCT00333307|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24457185|NCT00333307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24457186|NCT00333346|Tramadol|tramadol|mesh-list
24457187|NCT00333346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24457188|NCT00333346|Narcotics|narcotics|mesh-ancestor
24457189|NCT00333346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24457190|NCT00333346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457191|NCT00333346|Analgesics|analgesics|mesh-ancestor
24481096|NCT00433277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481099|NCT00433277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481100|NCT00433277|Antifungal Agents|antifungal agents|mesh-ancestor
24481101|NCT00433277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24457199|NCT00333372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24481183|NCT00433576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481184|NCT00433576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24481185|NCT00433615|Epoetin Alfa|epoetin alfa|mesh-list
24481186|NCT00433615|Hematinics|hematinics|mesh-ancestor
24481187|NCT00433641|Sibutramine|sibutramine|mesh-list
24481188|NCT00433641|Antidepressive Agents|antidepressive agents|mesh-ancestor
24481192|NCT00433719|Efavirenz|efavirenz|mesh-list
24481253|NCT00433927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24481254|NCT00433927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24481255|NCT00433927|Growth Substances|growth substances|mesh-ancestor
24481256|NCT00433927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481257|NCT00433927|Growth Inhibitors|growth inhibitors|mesh-ancestor
24481258|NCT00433927|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24481259|NCT00433927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24481260|NCT00433927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481261|NCT00433927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481497|NCT00435175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24481498|NCT00435175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712837|NCT02327169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481499|NCT00435279|Eszopiclone|eszopiclone|mesh-list
24481533|NCT00435305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24481733|NCT00436709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24481734|NCT00436709|Alkylating Agents|alkylating agents|mesh-ancestor
24481735|NCT00436709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24481736|NCT00436709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24481788|NCT00436787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481789|NCT00436787|Anticoagulants|anticoagulants|mesh-ancestor
24481790|NCT00436787|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24457228|NCT00333489|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24457229|NCT00333489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457230|NCT00333567|Lumiracoxib|lumiracoxib|mesh-list
24481949|NCT00437359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481950|NCT00437359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24481952|NCT00437359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24481953|NCT00437359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24481954|NCT00437359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481955|NCT00437359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24481956|NCT00437359|Hormone Antagonists|hormone antagonists|mesh-ancestor
24481957|NCT00437359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24481962|NCT00437372|Sunitinib|sunitinib|mesh-list
24426109|NCT00235053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24482027|NCT00437671|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24482030|NCT00437671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482037|NCT00437697|Dalteparin|dalteparin|mesh-list
24482038|NCT00437697|Tinzaparin|tinzaparin|mesh-list
24482039|NCT00437697|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24482040|NCT00437697|Anticoagulants|anticoagulants|mesh-ancestor
24482041|NCT00437697|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24482042|NCT00437697|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24457250|NCT00333632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457252|NCT00333632|Anesthetics, General|anesthetics, general|mesh-ancestor
24482182|NCT00438113|Autonomic Agents|autonomic agents|mesh-ancestor
24482183|NCT00438113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24482184|NCT00438113|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24482185|NCT00438113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24482186|NCT00438113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24482187|NCT00438113|Adrenergic Agents|adrenergic agents|mesh-ancestor
24482188|NCT00438113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24482189|NCT00438113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24482190|NCT00438113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24482191|NCT00438113|Urological Agents|urological agents|mesh-ancestor
24482192|NCT00438139|Dronabinol|dronabinol|mesh-list
24482193|NCT00438139|Hallucinogens|hallucinogens|mesh-ancestor
24482194|NCT00438139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482195|NCT00438139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24482256|NCT00438269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24482257|NCT00438269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24482258|NCT00438269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24482259|NCT00438269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24482260|NCT00438269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24482374|NCT00438828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24482375|NCT00438828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24482376|NCT00438828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24482378|NCT00438841|Dexamethasone|dexamethasone|mesh-list
24482379|NCT00438841|Cyclophosphamide|cyclophosphamide|mesh-list
24482380|NCT00438841|Bortezomib|bortezomib|mesh-list
24482381|NCT00438841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25712838|NCT02327169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24482382|NCT00438841|Immunologic Factors|immunologic factors|mesh-ancestor
24457294|NCT00333918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24482857|NCT00440804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24482957|NCT00441051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482958|NCT00441155|Imatinib Mesylate|imatinib mesylate|mesh-list
24482959|NCT00441155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24426703|NCT00236522|Renal Agents|renal agents|mesh-ancestor
24426704|NCT00236522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24426705|NCT00236522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24426706|NCT00236522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24426707|NCT00236522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24426708|NCT00236522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426709|NCT00236522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24457341|NCT00334048|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24457342|NCT00334048|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24457343|NCT00334048|Dopamine Agonists|dopamine agonists|mesh-ancestor
24483087|NCT00441740|Antiviral Agents|antiviral agents|mesh-ancestor
24483088|NCT00441740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24522193|NCT04112303|Sofosbuvir|sofosbuvir|mesh-list
24483178|NCT00442221|Naproxen|naproxen|mesh-list
24483259|NCT00442546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24483260|NCT00442546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483309|NCT00442741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483310|NCT00442741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483311|NCT00442741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24483312|NCT00442741|Tubulin Modulators|tubulin modulators|mesh-ancestor
24483313|NCT00442741|Antimitotic Agents|antimitotic agents|mesh-ancestor
24483314|NCT00442741|Mitosis Modulators|mitosis modulators|mesh-ancestor
24483315|NCT00442780|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
24483316|NCT00442780|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
24483317|NCT00442780|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25712839|NCT02327741|Clopidogrel|clopidogrel|mesh-list
25712840|NCT02327741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25712841|NCT02327741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25712842|NCT02327741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24483318|NCT00442780|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24483319|NCT00442780|Purinergic Agents|purinergic agents|mesh-ancestor
24483400|NCT00443235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483401|NCT00443235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24483403|NCT00443235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24483405|NCT00443235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483406|NCT00443235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24483487|NCT00443794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483488|NCT00443794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24483489|NCT00443794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24483524|NCT00443937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24483525|NCT00443937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24483526|NCT00443937|Antitubercular Agents|antitubercular agents|mesh-ancestor
24483527|NCT00443937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24484194|NCT00446953|Respiratory System Agents|respiratory system agents|mesh-ancestor
24484195|NCT00446979|UC-781|uc-781|mesh-list
24484196|NCT00446979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24484948|NCT00450853|Granisetron|granisetron|mesh-list
24485157|NCT00451776|Anesthetics|anesthetics|mesh-ancestor
24485158|NCT00451815|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
24457454|NCT00334425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24457456|NCT00334438|Rituximab|rituximab|mesh-list
24457457|NCT00334438|Bortezomib|bortezomib|mesh-list
24457458|NCT00334438|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24457459|NCT00334438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24457460|NCT00334438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24457462|NCT00334438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485700|NCT00454545|Atorvastatin|atorvastatin|mesh-list
24485701|NCT00454545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24485702|NCT00454545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24485703|NCT00454545|Antimetabolites|antimetabolites|mesh-ancestor
24891651|NCT04468139|Ascorbic Acid|ascorbic acid|mesh-list
24485704|NCT00454545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485738|NCT00454740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24485740|NCT00454740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485995|NCT00455754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485996|NCT00455806|Amoxicillin|amoxicillin|mesh-list
24485997|NCT00455806|Moxifloxacin|moxifloxacin|mesh-list
24485998|NCT00455806|Esomeprazole|esomeprazole|mesh-list
24485999|NCT00455806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24486000|NCT00455806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24486680|NCT00459407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486681|NCT00459407|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24486682|NCT00459407|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24486683|NCT00459407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712843|NCT02327741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25712844|NCT02327741|Purinergic Agents|purinergic agents|mesh-ancestor
25712845|NCT02327741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25712846|NCT02327741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712847|NCT02327741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712848|NCT02328040|Insulin|insulin|mesh-list
25712849|NCT02328040|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25712850|NCT02328040|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25712851|NCT02328040|Insulin Aspart|insulin aspart|mesh-list
24486684|NCT00459407|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24486686|NCT00459420|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24486753|NCT00459901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24486757|NCT00459901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24486758|NCT00459901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486760|NCT00459940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24486761|NCT00459940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486762|NCT00459992|Betahistine|betahistine|mesh-list
24486763|NCT00459992|Vasodilator Agents|vasodilator agents|mesh-ancestor
24486764|NCT00459992|Histamine Agonists|histamine agonists|mesh-ancestor
24486765|NCT00459992|Histamine Agents|histamine agents|mesh-ancestor
24486795|NCT00460148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486796|NCT00460174|Gemcitabine|gemcitabine|mesh-list
24486797|NCT00460174|Bevacizumab|bevacizumab|mesh-list
24486798|NCT00460174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24486799|NCT00460174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486800|NCT00460174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24487158|NCT00461825|Cyclosporins|cyclosporins|mesh-list
24487159|NCT00461825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487160|NCT00461825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487161|NCT00461825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24487162|NCT00461825|Immunologic Factors|immunologic factors|mesh-ancestor
24487163|NCT00461825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487223|NCT00462111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487224|NCT00462189|Immunotoxin HA22|immunotoxin ha22|mesh-list
24487225|NCT00462189|Immunotoxins|immunotoxins|mesh-list
24487226|NCT00462189|Immunologic Factors|immunologic factors|mesh-ancestor
24487227|NCT00462189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487228|NCT00462189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487229|NCT00462215|Vaccines|vaccines|mesh-list
24487230|NCT00462215|Immunologic Factors|immunologic factors|mesh-ancestor
24487231|NCT00462215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487232|NCT00462358|Filanesib|filanesib|mesh-list
24487233|NCT00462358|Lenograstim|lenograstim|mesh-list
24487234|NCT00462358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24487235|NCT00462358|Immunologic Factors|immunologic factors|mesh-ancestor
24487236|NCT00462358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487237|NCT00462358|Antimitotic Agents|antimitotic agents|mesh-ancestor
24487506|NCT00463541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487537|NCT00463736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24487538|NCT00463736|Anticonvulsants|anticonvulsants|mesh-ancestor
24487539|NCT00463736|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24487540|NCT00463736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24487550|NCT00463762|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24487787|NCT00465075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24487788|NCT00465075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487789|NCT00465075|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24487790|NCT00465075|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24487791|NCT00465075|Hormone Antagonists|hormone antagonists|mesh-ancestor
24487792|NCT00465075|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24487825|NCT00465244|Nootropic Agents|nootropic agents|mesh-ancestor
24487826|NCT00465244|Antiemetics|antiemetics|mesh-ancestor
24487827|NCT00465244|Autonomic Agents|autonomic agents|mesh-ancestor
24487830|NCT00465244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24487879|NCT00465439|Adrenergic Agents|adrenergic agents|mesh-ancestor
24487880|NCT00465439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24488004|NCT00466154|Antipyretics|antipyretics|mesh-ancestor
24488707|NCT00469781|Methylprednisolone|methylprednisolone|mesh-list
24488708|NCT00469781|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25712852|NCT02328040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25712853|NCT02328040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712854|NCT02328040|Incretins|incretins|mesh-ancestor
25712855|NCT02328040|Hormones|hormones|mesh-ancestor
25712856|NCT02328040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25712857|NCT02328040|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25712858|NCT02328040|Protease Inhibitors|protease inhibitors|mesh-ancestor
24488709|NCT00469781|Prednisolone|prednisolone|mesh-list
25712859|NCT02328040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712860|NCT02328040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712861|NCT02328404|Vitamin D|vitamin d|mesh-list
25712862|NCT02328404|Cholecalciferol|cholecalciferol|mesh-list
24489054|NCT00471341|Celecoxib|celecoxib|mesh-list
24489055|NCT00471341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24489092|NCT00471432|Docetaxel|docetaxel|mesh-list
24489326|NCT00472355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489328|NCT00472368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489329|NCT00472368|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24489330|NCT00472368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24489331|NCT00472368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489332|NCT00472381|Insulin|insulin|mesh-list
24489333|NCT00472381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24489334|NCT00472381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489335|NCT00472433|Alemtuzumab|alemtuzumab|mesh-list
24523428|NCT00887536|Antimitotic Agents|antimitotic agents|mesh-ancestor
24523434|NCT00867321|Bevacizumab|bevacizumab|mesh-list
24489336|NCT00472433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24489337|NCT00472433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489338|NCT00472459|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
24489339|NCT00472459|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24489340|NCT00472459|Dermatologic Agents|dermatologic agents|mesh-ancestor
24489574|NCT00474110|Sensory System Agents|sensory system agents|mesh-ancestor
24489578|NCT00474110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24489702|NCT00474890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489736|NCT00475137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24489737|NCT00475137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489738|NCT00475137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24489739|NCT00475137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490084|NCT00476268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24490085|NCT00476346|Vitamin D|vitamin d|mesh-list
24490086|NCT00476346|Calcium|calcium|mesh-list
24490087|NCT00476346|Vitamins|vitamins|mesh-ancestor
24490088|NCT00476346|Micronutrients|micronutrients|mesh-ancestor
24490089|NCT00476346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490090|NCT00476346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24490118|NCT00476437|Insulin|insulin|mesh-list
24490119|NCT00476437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24490120|NCT00476437|Insulin Aspart|insulin aspart|mesh-list
24490175|NCT00476983|Saquinavir|saquinavir|mesh-list
24490340|NCT00477776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24490341|NCT00477776|Dopamine Agents|dopamine agents|mesh-ancestor
24490493|NCT00478621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490494|NCT00478634|Irinotecan|irinotecan|mesh-list
24490495|NCT00478634|Cetuximab|cetuximab|mesh-list
24490528|NCT00478764|Hormones|hormones|mesh-ancestor
24490529|NCT00478764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24490530|NCT00478764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490531|NCT00478816|Vaccines|vaccines|mesh-list
24490532|NCT00478816|Immunologic Factors|immunologic factors|mesh-ancestor
24490533|NCT00478816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490534|NCT00478855|Piperacillin|piperacillin|mesh-list
24490535|NCT00478855|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24490536|NCT00478855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24490537|NCT00478855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24490538|NCT00478855|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24490572|NCT00478959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24490573|NCT00478959|Growth Substances|growth substances|mesh-ancestor
24490789|NCT00480142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490790|NCT00480142|Analgesics|analgesics|mesh-ancestor
24490791|NCT00480142|Sensory System Agents|sensory system agents|mesh-ancestor
24490792|NCT00480142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25712863|NCT02328404|Vitamins|vitamins|mesh-ancestor
25712864|NCT02328404|Micronutrients|micronutrients|mesh-ancestor
24490793|NCT00480181|Nabilone|nabilone|mesh-list
25712865|NCT02328404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712866|NCT02328404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25712867|NCT02328404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25712868|NCT02328755|Methotrexate|methotrexate|mesh-list
24490794|NCT00480181|Antiemetics|antiemetics|mesh-ancestor
24490795|NCT00480181|Autonomic Agents|autonomic agents|mesh-ancestor
24490796|NCT00480181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24490829|NCT00480246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490831|NCT00480246|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24490832|NCT00480246|Dopamine Agents|dopamine agents|mesh-ancestor
24490833|NCT00480246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24490835|NCT00480272|Prednisone|prednisone|mesh-list
24457528|NCT00334672|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24457529|NCT00334672|Cyclophosphamide|cyclophosphamide|mesh-list
24490920|NCT00480571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24490921|NCT00480571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24490922|NCT00480571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24490923|NCT00480571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24490924|NCT00480571|Dopamine Agents|dopamine agents|mesh-ancestor
24490925|NCT00480584|Gemcitabine|gemcitabine|mesh-list
24490926|NCT00480584|Capecitabine|capecitabine|mesh-list
24490927|NCT00480584|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24490928|NCT00480584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24491177|NCT00481481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24491178|NCT00481481|Immunologic Factors|immunologic factors|mesh-ancestor
24491179|NCT00481481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491180|NCT00481481|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24491181|NCT00481481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491182|NCT00481481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491918|NCT00484510|Protective Agents|protective agents|mesh-ancestor
24491920|NCT00484575|Sevoflurane|sevoflurane|mesh-list
24491921|NCT00484575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24491922|NCT00484575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24495398|NCT00499876|Mefloquine|mefloquine|mesh-list
24491954|NCT00484692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24491955|NCT00484731|Bupivacaine|bupivacaine|mesh-list
24491956|NCT00484731|Anesthetics, Local|anesthetics, local|mesh-ancestor
24491957|NCT00484731|Anesthetics|anesthetics|mesh-ancestor
24491961|NCT00484731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24491962|NCT00484744|Acetaminophen|acetaminophen|mesh-list
24491963|NCT00484744|Ibuprofen|ibuprofen|mesh-list
24491964|NCT00484744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24492234|NCT00485771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24492235|NCT00485771|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24492236|NCT00485771|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24492237|NCT00485771|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24492238|NCT00485771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492239|NCT00485771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492240|NCT00485771|Serotonin Agents|serotonin agents|mesh-ancestor
25712869|NCT02328755|Tacrolimus|tacrolimus|mesh-list
25712870|NCT02328755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25712871|NCT02328755|Abortifacient Agents|abortifacient agents|mesh-ancestor
25712872|NCT02328755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24492241|NCT00485771|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24492242|NCT00485771|Antidepressive Agents|antidepressive agents|mesh-ancestor
25712873|NCT02328755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712874|NCT02328755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25712875|NCT02328755|Antimetabolites|antimetabolites|mesh-ancestor
25712876|NCT02328755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492243|NCT00485771|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24492273|NCT00485810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492471|NCT00486421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24492472|NCT00486421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24492474|NCT00486421|Hormones|hormones|mesh-ancestor
24492475|NCT00486421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24492548|NCT00486694|Antiviral Agents|antiviral agents|mesh-ancestor
24492582|NCT00486798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492584|NCT00486876|Antidepressive Agents|antidepressive agents|mesh-ancestor
24492586|NCT00486980|Peramivir|peramivir|mesh-list
24428178|NCT00239863|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24428179|NCT00239863|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24492928|NCT00488605|Tubulin Modulators|tubulin modulators|mesh-ancestor
24493372|NCT00490711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24493373|NCT00490711|Antimetabolites|antimetabolites|mesh-ancestor
24494067|NCT00493610|Respiratory System Agents|respiratory system agents|mesh-ancestor
24494068|NCT00493610|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24494069|NCT00493610|Antioxidants|antioxidants|mesh-ancestor
24494070|NCT00493610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494103|NCT00493831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24494104|NCT00493831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494105|NCT00493831|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24494106|NCT00493831|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24494107|NCT00493831|Cholinergic Agents|cholinergic agents|mesh-ancestor
24494108|NCT00493831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24494109|NCT00493831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494110|NCT00493857|Nimotuzumab|nimotuzumab|mesh-list
24494151|NCT00493987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24494152|NCT00493987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494153|NCT00493987|Hormone Antagonists|hormone antagonists|mesh-ancestor
24494155|NCT00494078|Insulin, Long-Acting|insulin, long-acting|mesh-list
24494215|NCT00494377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24494216|NCT00494377|Antidepressive Agents|antidepressive agents|mesh-ancestor
24495470|NCT00500409|Vitamin D|vitamin d|mesh-list
24495471|NCT00500409|Vitamins|vitamins|mesh-ancestor
24495472|NCT00500409|Micronutrients|micronutrients|mesh-ancestor
24495475|NCT00500422|Gemcitabine|gemcitabine|mesh-list
24496296|NCT00504140|Immunologic Factors|immunologic factors|mesh-ancestor
24496297|NCT00504140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496298|NCT00504192|Gemcitabine|gemcitabine|mesh-list
24496299|NCT00504192|Oxaliplatin|oxaliplatin|mesh-list
24457587|NCT00334685|Antidepressive Agents|antidepressive agents|mesh-ancestor
24457588|NCT00334685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24457589|NCT00334685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24496300|NCT00504192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24496301|NCT00504192|Antimetabolites|antimetabolites|mesh-ancestor
24496302|NCT00504192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496303|NCT00504192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24428416|NCT00240435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428417|NCT00240435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24428418|NCT00240435|Respiratory System Agents|respiratory system agents|mesh-ancestor
24428419|NCT00240435|Parasympatholytics|parasympatholytics|mesh-ancestor
24496574|NCT00505531|Sensory System Agents|sensory system agents|mesh-ancestor
24496636|NCT00505804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24496637|NCT00505804|Adrenergic Agents|adrenergic agents|mesh-ancestor
24496638|NCT00505804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24496639|NCT00505804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712877|NCT02328755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712878|NCT02328755|Dermatologic Agents|dermatologic agents|mesh-ancestor
24499252|NCT00518466|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24499253|NCT00518466|Appetite Depressants|appetite depressants|mesh-ancestor
24499254|NCT00518466|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24499255|NCT00518466|Sympathomimetics|sympathomimetics|mesh-ancestor
24499256|NCT00518466|Autonomic Agents|autonomic agents|mesh-ancestor
24499257|NCT00518466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24499324|NCT00518947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24499325|NCT00518947|Vasodilator Agents|vasodilator agents|mesh-ancestor
24499549|NCT00520000|Mitosis Modulators|mitosis modulators|mesh-ancestor
24499550|NCT00520000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24500464|NCT00524407|Hematinics|hematinics|mesh-ancestor
24500681|NCT00525473|Azathioprine|azathioprine|mesh-list
24500682|NCT00525473|Antimetabolites|antimetabolites|mesh-ancestor
24500683|NCT00525473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24457624|NCT00334763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24457625|NCT00334763|Growth Substances|growth substances|mesh-ancestor
24457628|NCT00334789|Vitamin A|vitamin a|mesh-list
24501993|NCT00531908|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24501994|NCT00531908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24501995|NCT00531908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501996|NCT00531973|Doxorubicin|doxorubicin|mesh-list
24501997|NCT00531973|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24501998|NCT00531973|Epirubicin|epirubicin|mesh-list
24501999|NCT00531973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24502771|NCT04447716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24502902|NCT04049799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502904|NCT04049799|Sensory System Agents|sensory system agents|mesh-ancestor
24503030|NCT03571802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503171|NCT02978391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24503172|NCT02978391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503174|NCT02978391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24505793|NCT00542555|Naproxen|naproxen|mesh-list
24505794|NCT00542555|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
24505795|NCT00542555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24505796|NCT00542555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24505797|NCT00542555|Analgesics|analgesics|mesh-ancestor
24505798|NCT00542555|Sensory System Agents|sensory system agents|mesh-ancestor
24505799|NCT00542555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24505800|NCT00542555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505801|NCT00542555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24505802|NCT00542555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24505803|NCT00542555|Gout Suppressants|gout suppressants|mesh-ancestor
24506180|NCT00544232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506426|NCT00545246|Docetaxel|docetaxel|mesh-list
24506427|NCT00545246|Aflibercept|aflibercept|mesh-list
24506573|NCT00546039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712879|NCT02328755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712880|NCT02328755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24508851|NCT00557232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712881|NCT02328755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25712882|NCT02328755|Immunologic Factors|immunologic factors|mesh-ancestor
25712883|NCT02328755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25712884|NCT02328755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25712885|NCT02328755|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25712886|NCT02329223|Omalizumab|omalizumab|mesh-list
24508852|NCT00557232|Growth Inhibitors|growth inhibitors|mesh-ancestor
24508853|NCT00557427|Fluoxetine|fluoxetine|mesh-list
24508854|NCT00557427|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24509621|NCT00561132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509622|NCT00561184|Vaccines|vaccines|mesh-list
24509623|NCT00561184|Immunologic Factors|immunologic factors|mesh-ancestor
24509624|NCT00561184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509625|NCT00561197|Gossypol acetic acid|gossypol acetic acid|mesh-list
24509626|NCT00561197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24509714|NCT00561717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24509715|NCT00561756|Vaccines|vaccines|mesh-list
24509941|NCT00562835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24510502|NCT00564707|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24510503|NCT00564707|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24510504|NCT00564707|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24510538|NCT00564772|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24512823|NCT00577018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24512824|NCT00577018|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24512825|NCT00577018|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24512826|NCT00577018|Serotonin Agents|serotonin agents|mesh-ancestor
24512827|NCT00577018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24512917|NCT00577668|Melphalan|melphalan|mesh-list
24512918|NCT00577668|Bortezomib|bortezomib|mesh-list
24512919|NCT00577668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24512960|NCT00577798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513668|NCT00584493|Tremelimumab|tremelimumab|mesh-list
24514118|NCT00588003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514119|NCT00588003|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24514120|NCT00588003|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24514121|NCT00588003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24514122|NCT00588003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514123|NCT00588003|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24514319|NCT00589901|Cyclophosphamide|cyclophosphamide|mesh-list
24514320|NCT00589901|Capecitabine|capecitabine|mesh-list
24514322|NCT00589901|Immunologic Factors|immunologic factors|mesh-ancestor
24519236|NCT02790723|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24519237|NCT02790723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24519823|NCT04907370|Gemcitabine|gemcitabine|mesh-list
24519824|NCT04907370|Cisplatin|cisplatin|mesh-list
24519825|NCT04907370|Antibodies|antibodies|mesh-list
24519826|NCT04907370|Antibodies, Blocking|antibodies, blocking|mesh-list
24519827|NCT04907370|Immunologic Factors|immunologic factors|mesh-ancestor
24520583|NCT05337085|Anesthetics, General|anesthetics, general|mesh-ancestor
24527890|NCT00618527|Mycophenolic Acid|mycophenolic acid|mesh-list
24520743|NCT05333640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24520751|NCT05333640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24520752|NCT05333640|Antifungal Agents|antifungal agents|mesh-ancestor
24520753|NCT05333640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24520754|NCT05333640|Immunologic Factors|immunologic factors|mesh-ancestor
24520790|NCT05325164|Respiratory System Agents|respiratory system agents|mesh-ancestor
24520791|NCT05324059|Pregabalin|pregabalin|mesh-list
24520792|NCT05324059|Tramadol|tramadol|mesh-list
24520793|NCT05324059|Analgesics|analgesics|mesh-ancestor
24520794|NCT05324059|Sensory System Agents|sensory system agents|mesh-ancestor
24520829|NCT05319561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24520830|NCT05319561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24522888|NCT03083678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522889|NCT03083678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24522890|NCT03083678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24522891|NCT03083678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522893|NCT03071926|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24522894|NCT03071926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24523279|NCT02268175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523315|NCT02066220|Alkylating Agents|alkylating agents|mesh-ancestor
24523600|NCT05341583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524482|NCT04818229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712887|NCT02329223|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25712888|NCT02329223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25712889|NCT02329223|Respiratory System Agents|respiratory system agents|mesh-ancestor
24524483|NCT04818229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712890|NCT02329600|Triamcinolone|triamcinolone|mesh-list
25712891|NCT02329600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24524484|NCT04818229|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24524485|NCT04818229|Contraceptive Agents|contraceptive agents|mesh-ancestor
24524486|NCT04818229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24524487|NCT04818229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524488|NCT04818229|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24524489|NCT04818229|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24524490|NCT04818229|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24524492|NCT04807348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24524493|NCT04807348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524537|NCT04771741|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24524538|NCT04771741|Antidepressive Agents|antidepressive agents|mesh-ancestor
24524539|NCT04771741|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24524540|NCT04771741|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24524578|NCT04688658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24524579|NCT04688658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24524638|NCT04639986|Vinorelbine|vinorelbine|mesh-list
24431286|NCT00251082|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24524883|NCT04243122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524884|NCT04243122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24524885|NCT04243122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24457831|NCT00335348|Bortezomib|bortezomib|mesh-list
24524886|NCT04243122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24524980|NCT04141644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24524981|NCT04141644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24524982|NCT04140266|Tenofovir|tenofovir|mesh-list
24524983|NCT04140266|Emtricitabine|emtricitabine|mesh-list
24525276|NCT03709758|Daunorubicin|daunorubicin|mesh-list
24525277|NCT03709758|Venetoclax|venetoclax|mesh-list
24525278|NCT03709758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24525280|NCT03709758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525281|NCT03709758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24525282|NCT03709758|Antiviral Agents|antiviral agents|mesh-ancestor
24525283|NCT03709758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24525284|NCT03709758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24525285|NCT03709758|Immunologic Factors|immunologic factors|mesh-ancestor
24525286|NCT03709758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526271|NCT00290511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24526272|NCT00290511|Glucocorticoids|glucocorticoids|mesh-ancestor
24526273|NCT00290511|Hormones|hormones|mesh-ancestor
24526306|NCT00195091|Chelating Agents|chelating agents|mesh-ancestor
24528936|NCT00623415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526350|NCT00611286|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
24526503|NCT00611871|Propranolol|propranolol|mesh-list
24526504|NCT00611871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24526505|NCT00611871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24526506|NCT00611871|Adrenergic Agents|adrenergic agents|mesh-ancestor
24526548|NCT00612079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526549|NCT00612079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24526551|NCT00612144|Glimepiride|glimepiride|mesh-list
24526552|NCT00612144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24526553|NCT00612144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526554|NCT00612144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24526558|NCT00612157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24526559|NCT00612157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24526560|NCT00612157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526561|NCT00612183|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24526566|NCT00612261|Triamcinolone|triamcinolone|mesh-list
24527095|NCT00614965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527102|NCT00614978|Temozolomide|temozolomide|mesh-list
24527104|NCT00614978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24527105|NCT00614978|Alkylating Agents|alkylating agents|mesh-ancestor
25712892|NCT02329600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24527106|NCT00614978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527107|NCT00614978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712893|NCT02329600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24527108|NCT00614978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24527109|NCT00614978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527288|NCT00615797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24527289|NCT00615797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527290|NCT00615797|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24527291|NCT00615797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24527292|NCT00615797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24527293|NCT00615810|Efavirenz|efavirenz|mesh-list
24527294|NCT00615810|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24527297|NCT00615810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527878|NCT00618501|Antimitotic Agents|antimitotic agents|mesh-ancestor
24527879|NCT00618501|Mitosis Modulators|mitosis modulators|mesh-ancestor
24527880|NCT00618501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24527882|NCT00618501|Hormones|hormones|mesh-ancestor
24527883|NCT00618501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24527884|NCT00618501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24527885|NCT00618501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24527886|NCT00618501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24527887|NCT00618527|Interferons|interferons|mesh-list
24527888|NCT00618527|Interferon-beta|interferon-beta|mesh-list
24528010|NCT00619203|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24528011|NCT00619203|Protective Agents|protective agents|mesh-ancestor
24528056|NCT00619372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24528084|NCT00619541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24528085|NCT00619541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528087|NCT00619671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24528088|NCT00619671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528089|NCT00619671|Immunologic Factors|immunologic factors|mesh-ancestor
24528090|NCT00619671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528091|NCT00619671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24528092|NCT00619697|Insulin|insulin|mesh-list
24528258|NCT00620581|Serotonin Agents|serotonin agents|mesh-ancestor
24528449|NCT00621166|Antiviral Agents|antiviral agents|mesh-ancestor
24528450|NCT00621166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24528457|NCT00621283|Secretin|secretin|mesh-list
24528502|NCT00621400|Growth Inhibitors|growth inhibitors|mesh-ancestor
24528503|NCT00621400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24528504|NCT00621400|Alkylating Agents|alkylating agents|mesh-ancestor
24528683|NCT00622245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24528684|NCT00622245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528685|NCT00622258|Everolimus|everolimus|mesh-list
24528686|NCT00622258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528687|NCT00622258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24528688|NCT00622258|Immunologic Factors|immunologic factors|mesh-ancestor
24394224|NCT00132587|Vasodilator Agents|vasodilator agents|mesh-ancestor
24528698|NCT00622349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528699|NCT00622349|Antiviral Agents|antiviral agents|mesh-ancestor
24528700|NCT00622349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24528701|NCT00622349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528702|NCT00622349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24528703|NCT00622349|Immunologic Factors|immunologic factors|mesh-ancestor
24528704|NCT00622349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528810|NCT00623064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24528811|NCT00623064|Antimetabolites|antimetabolites|mesh-ancestor
24528812|NCT00623064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528813|NCT00623064|Antiviral Agents|antiviral agents|mesh-ancestor
24528814|NCT00623064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24528857|NCT00623155|Renal Agents|renal agents|mesh-ancestor
24529006|NCT00624143|Hormone Antagonists|hormone antagonists|mesh-ancestor
24529007|NCT00624143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24529008|NCT00624143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529009|NCT00624143|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24529010|NCT00624143|Amebicides|amebicides|mesh-ancestor
24529011|NCT00624143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24400056|NCT00149578|Antimetabolites|antimetabolites|mesh-ancestor
24529012|NCT00624143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25712894|NCT02329600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25712895|NCT02329600|Glucocorticoids|glucocorticoids|mesh-ancestor
25712896|NCT02329600|Hormones|hormones|mesh-ancestor
25770891|NCT03572478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24529013|NCT00624143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25712897|NCT02329600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25712898|NCT02329600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712899|NCT02329600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25712900|NCT02329600|Immunologic Factors|immunologic factors|mesh-ancestor
25712901|NCT02329600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712902|NCT02329600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394226|NCT00132587|Protective Agents|protective agents|mesh-ancestor
24529050|NCT00624273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24529051|NCT00624273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394227|NCT00132587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529088|NCT00624455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24529089|NCT00624455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24529116|NCT00624676|Benzoic Acid|benzoic acid|mesh-list
24529117|NCT00624676|Salicylates|salicylates|mesh-list
24529118|NCT00624676|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24529143|NCT00624754|Budesonide|budesonide|mesh-list
24529243|NCT00625170|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24529244|NCT00625170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24529245|NCT00625170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24529246|NCT00625170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529247|NCT00625170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24529259|NCT00625196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24529260|NCT00625196|Respiratory System Agents|respiratory system agents|mesh-ancestor
24529261|NCT00625196|Dermatologic Agents|dermatologic agents|mesh-ancestor
24529262|NCT00625196|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24529263|NCT00625209|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
24529265|NCT00625209|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24529266|NCT00625209|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24529267|NCT00625209|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24529455|NCT00626015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24529456|NCT00626015|Immunologic Factors|immunologic factors|mesh-ancestor
24529457|NCT00626015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529458|NCT00626054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24529460|NCT00626080|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24529462|NCT00626080|Isophane Insulin, Human|isophane insulin, human|mesh-list
24529463|NCT00626080|Insulin, Isophane|insulin, isophane|mesh-list
24529464|NCT00626080|Isophane insulin, beef|isophane insulin, beef|mesh-list
24529465|NCT00626080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24529466|NCT00626080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529467|NCT00626158|Gemcitabine|gemcitabine|mesh-list
24529468|NCT00626158|Capecitabine|capecitabine|mesh-list
24529469|NCT00626158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24529736|NCT00627666|Vitamins|vitamins|mesh-ancestor
24529990|NCT00628706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529991|NCT00628706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24529992|NCT00628706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24529993|NCT00628706|Analgesics|analgesics|mesh-ancestor
24529994|NCT00628706|Sensory System Agents|sensory system agents|mesh-ancestor
24529995|NCT00628706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24457885|NCT00335582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530294|NCT00629720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24894187|NCT04443881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24530295|NCT00629720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530317|NCT00629863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530318|NCT00629863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24530319|NCT00629863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24530320|NCT00629863|Immunologic Factors|immunologic factors|mesh-ancestor
24530321|NCT00629863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530322|NCT00629889|Pregabalin|pregabalin|mesh-list
24530323|NCT00629889|Levetiracetam|levetiracetam|mesh-list
24530324|NCT00629889|Analgesics|analgesics|mesh-ancestor
24530325|NCT00629889|Sensory System Agents|sensory system agents|mesh-ancestor
24530328|NCT00629889|Anticonvulsants|anticonvulsants|mesh-ancestor
24433012|NCT00257270|Sensory System Agents|sensory system agents|mesh-ancestor
24433013|NCT00257270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24457886|NCT00335582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25712903|NCT02329964|Neostigmine|neostigmine|mesh-list
25712904|NCT02329964|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
25712905|NCT02329964|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25712906|NCT02329964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530450|NCT00630370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530667|NCT00631618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24530461|NCT00630435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530463|NCT00630474|Nasal Decongestants|nasal decongestants|mesh-ancestor
24530482|NCT00630513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530483|NCT00630513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530668|NCT00631618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24530669|NCT00631618|Growth Substances|growth substances|mesh-ancestor
24530670|NCT00631618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530671|NCT00631618|Growth Inhibitors|growth inhibitors|mesh-ancestor
24530484|NCT00630630|Levetiracetam|levetiracetam|mesh-list
24530491|NCT00630682|Dextroamphetamine|dextroamphetamine|mesh-list
24457889|NCT00335582|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24457890|NCT00335582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24530581|NCT00631085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530614|NCT00631501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24530615|NCT00631501|Antimalarials|antimalarials|mesh-ancestor
24530616|NCT00631501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24530617|NCT00631501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24530618|NCT00631514|Acetaminophen|acetaminophen|mesh-list
24530662|NCT00631592|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24530915|NCT00633269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24530916|NCT00633269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530917|NCT00633269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530918|NCT00633269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530919|NCT00633282|Pioglitazone|pioglitazone|mesh-list
24530920|NCT00633282|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
24530921|NCT00633282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24530922|NCT00633282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530960|NCT00633386|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24457901|NCT00335621|Respiratory System Agents|respiratory system agents|mesh-ancestor
24457902|NCT00335621|Parasympatholytics|parasympatholytics|mesh-ancestor
24531125|NCT00634140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24531127|NCT00634192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24531584|NCT00636493|Glucocorticoids|glucocorticoids|mesh-ancestor
24531586|NCT00636493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24531587|NCT00636493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531588|NCT00636519|Antitoxins|antitoxins|mesh-list
24531589|NCT00636519|Botulinum Antitoxin|botulinum antitoxin|mesh-list
24531590|NCT00636519|Immunologic Factors|immunologic factors|mesh-ancestor
24531591|NCT00636519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531592|NCT00636545|Oblimersen|oblimersen|mesh-list
24531593|NCT00636545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531594|NCT00636584|Nitroprusside|nitroprusside|mesh-list
24531595|NCT00636584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24531596|NCT00636584|Vasodilator Agents|vasodilator agents|mesh-ancestor
24531597|NCT00636584|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24531598|NCT00636584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531599|NCT00636740|Zoledronic Acid|zoledronic acid|mesh-list
24531631|NCT00636870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531632|NCT00636870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531634|NCT00636883|Oxaliplatin|oxaliplatin|mesh-list
24531635|NCT00636883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24532313|NCT00639262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24532314|NCT00639262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532315|NCT00639327|Irinotecan|irinotecan|mesh-list
24532316|NCT00639327|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24532385|NCT00639743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24532386|NCT00639743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24532387|NCT00639743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532389|NCT00639756|Antimetabolites|antimetabolites|mesh-ancestor
24394231|NCT00132600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24532412|NCT00639873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457912|NCT00335647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24457913|NCT00335647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24457914|NCT00335647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24532415|NCT00639873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25712907|NCT02329964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532458|NCT00640029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24532459|NCT00640029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24532460|NCT00640029|Analgesics|analgesics|mesh-ancestor
24532461|NCT00640029|Sensory System Agents|sensory system agents|mesh-ancestor
24532462|NCT00640029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24532463|NCT00640029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532464|NCT00640029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24532465|NCT00640029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24532885|NCT00641472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24532886|NCT00641472|Autonomic Agents|autonomic agents|mesh-ancestor
24532887|NCT00641472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24532888|NCT00641472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532889|NCT00641472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24532890|NCT00641472|Respiratory System Agents|respiratory system agents|mesh-ancestor
24532891|NCT00641472|Glucocorticoids|glucocorticoids|mesh-ancestor
24532893|NCT00641472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24532894|NCT00641472|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24532895|NCT00641472|Hormone Antagonists|hormone antagonists|mesh-ancestor
24532896|NCT00641472|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24532897|NCT00641472|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24533176|NCT00642512|Serotonin Agents|serotonin agents|mesh-ancestor
24533177|NCT00642512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24394233|NCT00132613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24533205|NCT00642577|Fluorouracil|fluorouracil|mesh-list
24533206|NCT00642577|Irinotecan|irinotecan|mesh-list
24533208|NCT00642577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24401532|NCT00153127|Laxatives|laxatives|mesh-ancestor
24540856|NCT00669812|Epirubicin|epirubicin|mesh-list
25712908|NCT02329964|Cholinergic Agents|cholinergic agents|mesh-ancestor
25712909|NCT02329964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25712910|NCT02329964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712911|NCT02329964|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24458097|NCT00336531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458098|NCT00336531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458099|NCT00336531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24435177|NCT00265408|Sensory System Agents|sensory system agents|mesh-ancestor
24458109|NCT00336648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25712912|NCT02329964|Autonomic Agents|autonomic agents|mesh-ancestor
25712913|NCT02329964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25712914|NCT02330094|Gabapentin|gabapentin|mesh-list
25712915|NCT02330094|Analgesics|analgesics|mesh-ancestor
25712916|NCT02330094|Sensory System Agents|sensory system agents|mesh-ancestor
25712917|NCT02330094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25712918|NCT02330094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712919|NCT02330094|Anticonvulsants|anticonvulsants|mesh-ancestor
25712920|NCT02330094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25712921|NCT02330094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25712922|NCT02330094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25712923|NCT02330094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25712924|NCT02330094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24458193|NCT00336960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24458194|NCT00336960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24458195|NCT00336960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458196|NCT00336960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24458198|NCT00336960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458199|NCT00336960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24458201|NCT00336960|Analgesics|analgesics|mesh-ancestor
24458202|NCT00336960|Sensory System Agents|sensory system agents|mesh-ancestor
25712925|NCT02330094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25712926|NCT02330094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25712927|NCT02330094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712928|NCT02330094|Antimanic Agents|antimanic agents|mesh-ancestor
24458252|NCT00337246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458253|NCT00337259|Gemcitabine|gemcitabine|mesh-list
24458254|NCT00337259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24458255|NCT00337259|Antimetabolites|antimetabolites|mesh-ancestor
24533293|NCT00642915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533294|NCT00642915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24533295|NCT00642915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24436494|NCT00270270|Epoetin Alfa|epoetin alfa|mesh-list
24533300|NCT00642980|Clindamycin palmitate|clindamycin palmitate|mesh-list
24533307|NCT00643071|Tacrolimus|tacrolimus|mesh-list
24533308|NCT00643071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25712929|NCT02330172|Neostigmine|neostigmine|mesh-list
25712930|NCT02330172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25712931|NCT02330172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25712932|NCT02330172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712933|NCT02330172|Cholinergic Agents|cholinergic agents|mesh-ancestor
25712934|NCT02330172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25712935|NCT02330172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712936|NCT02330172|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25712937|NCT02330172|Autonomic Agents|autonomic agents|mesh-ancestor
25712938|NCT02330172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24450004|NCT00317577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24450005|NCT00317577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450006|NCT00317577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24458273|NCT00337298|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24533341|NCT00643240|Antibodies|antibodies|mesh-list
24533342|NCT00643240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25712939|NCT02330549|Cenicriviroc|cenicriviroc|mesh-list
25712940|NCT02330549|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25712941|NCT02330549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712942|NCT02330549|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25712943|NCT02330549|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25712944|NCT02330549|Antiviral Agents|antiviral agents|mesh-ancestor
24533364|NCT00643357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25712946|NCT02331095|Warfarin|warfarin|mesh-list
25712947|NCT02331095|Rivaroxaban|rivaroxaban|mesh-list
25712948|NCT02331095|Atorvastatin|atorvastatin|mesh-list
25712949|NCT02331095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25712950|NCT02331095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25712951|NCT02331095|Antimetabolites|antimetabolites|mesh-ancestor
25712952|NCT02331095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712953|NCT02331095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25712954|NCT02331095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25712955|NCT02331095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24897695|NCT04423276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533378|NCT00643409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24533379|NCT00643500|Levetiracetam|levetiracetam|mesh-list
24533380|NCT00643500|Anticonvulsants|anticonvulsants|mesh-ancestor
24533382|NCT00643539|Azithromycin|azithromycin|mesh-list
24437303|NCT00273377|Glucocorticoids|glucocorticoids|mesh-ancestor
24437304|NCT00273377|Hormones|hormones|mesh-ancestor
24437307|NCT00273377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24458275|NCT00337298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24458276|NCT00337298|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24458277|NCT00337298|Protective Agents|protective agents|mesh-ancestor
24458278|NCT00337376|Sirolimus|sirolimus|mesh-list
24458279|NCT00337376|Paclitaxel|paclitaxel|mesh-list
24458280|NCT00337376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24403675|NCT00161239|Antimetabolites|antimetabolites|mesh-ancestor
25712957|NCT02331095|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25712958|NCT02331095|Antithrombins|antithrombins|mesh-ancestor
25712959|NCT02331095|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25712960|NCT02331095|Protease Inhibitors|protease inhibitors|mesh-ancestor
25712961|NCT02331108|Propofol|propofol|mesh-list
25712962|NCT02331108|Anesthetics|anesthetics|mesh-list
25712963|NCT02331108|Sevoflurane|sevoflurane|mesh-list
24533414|NCT00643799|Sensory System Agents|sensory system agents|mesh-ancestor
24533417|NCT00643799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25712965|NCT02331108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25712966|NCT02331108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712967|NCT02331108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25712968|NCT02331108|Anesthetics, General|anesthetics, general|mesh-ancestor
25712969|NCT02331108|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25712970|NCT02331108|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25712971|NCT02331368|Pembrolizumab|pembrolizumab|mesh-list
25712972|NCT02331368|Lenalidomide|lenalidomide|mesh-list
25712973|NCT02331368|Melphalan|melphalan|mesh-list
24533422|NCT00643799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533423|NCT00643799|Gout Suppressants|gout suppressants|mesh-ancestor
24450013|NCT00317629|Nitric Oxide|nitric oxide|mesh-list
24450014|NCT00317629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24450015|NCT00317629|Autonomic Agents|autonomic agents|mesh-ancestor
24450016|NCT00317629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24450017|NCT00317629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450018|NCT00317629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24450019|NCT00317629|Respiratory System Agents|respiratory system agents|mesh-ancestor
24450020|NCT00317629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24450021|NCT00317629|Antioxidants|antioxidants|mesh-ancestor
24450022|NCT00317629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450023|NCT00317629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24450024|NCT00317629|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24437634|NCT00274066|Tocolytic Agents|tocolytic agents|mesh-ancestor
24437635|NCT00274066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24450025|NCT00317629|Vasodilator Agents|vasodilator agents|mesh-ancestor
24450026|NCT00317629|Gasotransmitters|gasotransmitters|mesh-ancestor
24450027|NCT00317629|Protective Agents|protective agents|mesh-ancestor
24450028|NCT00317629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24450029|NCT00317629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24450030|NCT00317629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24450032|NCT00317655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24450038|NCT00317655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24450039|NCT00317655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24450040|NCT00317655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24450041|NCT00317655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450042|NCT00317655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450044|NCT00317681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24450070|NCT00317746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24450071|NCT00317746|Antidepressive Agents|antidepressive agents|mesh-ancestor
24450074|NCT00317759|Fludarabine phosphate|fludarabine phosphate|mesh-list
24450075|NCT00317759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450076|NCT00317759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25712974|NCT02331368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25712975|NCT02331368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25712976|NCT02331368|Immunologic Factors|immunologic factors|mesh-ancestor
25712977|NCT02331368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712978|NCT02331368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24437887|NCT00274612|Protease Inhibitors|protease inhibitors|mesh-ancestor
24437954|NCT00274820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712979|NCT02331368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25712980|NCT02331368|Growth Substances|growth substances|mesh-ancestor
25712981|NCT02331368|Growth Inhibitors|growth inhibitors|mesh-ancestor
24533455|NCT00644085|Sensory System Agents|sensory system agents|mesh-ancestor
24533456|NCT00644085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24533457|NCT00644085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701597|NCT01459627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701598|NCT01459627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701599|NCT01459640|Hyaluronic Acid|hyaluronic acid|mesh-list
24701600|NCT01459640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24613312|NCT01018225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613313|NCT01018225|Urological Agents|urological agents|mesh-ancestor
24613315|NCT01018251|Antiviral Agents|antiviral agents|mesh-ancestor
24613316|NCT01018251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24613317|NCT01018342|Nitrofurantoin|nitrofurantoin|mesh-list
24613318|NCT01018342|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24613319|NCT01018342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24613320|NCT01018342|Renal Agents|renal agents|mesh-ancestor
24613321|NCT01018342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24613322|NCT01018368|Rifampin|rifampin|mesh-list
24613323|NCT01018368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24613324|NCT01018368|Antitubercular Agents|antitubercular agents|mesh-ancestor
24613325|NCT01018368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24613326|NCT01018368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24613327|NCT01018368|Leprostatic Agents|leprostatic agents|mesh-ancestor
24613328|NCT01018368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24613329|NCT01018368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613330|NCT01018368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613331|NCT01018368|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24613332|NCT01018368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24613338|NCT01018381|Entecavir|entecavir|mesh-list
24701615|NCT01459887|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24701616|NCT01459887|Vincristine|vincristine|mesh-list
24701617|NCT01459887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24701618|NCT01459887|Immunologic Factors|immunologic factors|mesh-ancestor
24701619|NCT01459887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701621|NCT01459887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24701622|NCT01459887|Alkylating Agents|alkylating agents|mesh-ancestor
24701623|NCT01459887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701624|NCT01459887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701625|NCT01459887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25712982|NCT02331368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25712983|NCT02331368|Alkylating Agents|alkylating agents|mesh-ancestor
25712984|NCT02331368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701626|NCT01459887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25712985|NCT02331368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25712986|NCT02331368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25712987|NCT02331680|Tolvaptan|tolvaptan|mesh-list
24701627|NCT01459887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24701628|NCT01459887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24438070|NCT00274963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24701629|NCT01459887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701630|NCT01459887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24701631|NCT01459887|Glucocorticoids|glucocorticoids|mesh-ancestor
24541896|NCT00675714|Hormone Antagonists|hormone antagonists|mesh-ancestor
24701633|NCT01459887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24701634|NCT01459887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24701635|NCT01459887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24701636|NCT01459887|Tubulin Modulators|tubulin modulators|mesh-ancestor
24701637|NCT01459887|Antimitotic Agents|antimitotic agents|mesh-ancestor
24701638|NCT01459887|Mitosis Modulators|mitosis modulators|mesh-ancestor
24701639|NCT01460030|Cinacalcet|cinacalcet|mesh-list
24701640|NCT01460030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24701641|NCT01460030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701648|NCT01460069|Incretins|incretins|mesh-ancestor
24701650|NCT01460069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24701651|NCT01460134|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24701719|NCT01460563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701720|NCT01460563|Anesthetics|anesthetics|mesh-ancestor
24487441|NCT00463073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701721|NCT01460563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24701722|NCT01460563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24701723|NCT01460563|Anticonvulsants|anticonvulsants|mesh-ancestor
24701724|NCT01460563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24897697|NCT04423185|Atezolizumab|atezolizumab|mesh-list
24701725|NCT01460563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24701726|NCT01460563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701728|NCT01460563|Tocolytic Agents|tocolytic agents|mesh-ancestor
24701753|NCT01460667|Acetaminophen|acetaminophen|mesh-list
24701754|NCT01460667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24701755|NCT01460667|Analgesics|analgesics|mesh-ancestor
24701756|NCT01460667|Sensory System Agents|sensory system agents|mesh-ancestor
24701757|NCT01460667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24701957|NCT01463150|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24701958|NCT01463150|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24701959|NCT01463150|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24701964|NCT01463150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701965|NCT01463150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701967|NCT01463163|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24701968|NCT01463163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24701969|NCT01463163|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24701970|NCT01463163|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24701971|NCT01463163|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24701972|NCT01463163|Purinergic Agents|purinergic agents|mesh-ancestor
24701973|NCT01463163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24702026|NCT01463592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702027|NCT01463592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24702029|NCT01463592|Micronutrients|micronutrients|mesh-ancestor
24702030|NCT01463605|Nimotuzumab|nimotuzumab|mesh-list
24702031|NCT01463605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24702032|NCT01463605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24702034|NCT01463735|Vitamins|vitamins|mesh-ancestor
24702224|NCT01464606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702225|NCT01464606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24702226|NCT01464606|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24702227|NCT01464606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24702228|NCT01464606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24702229|NCT01464606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24702364|NCT01465399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702365|NCT01465438|Adalimumab|adalimumab|mesh-list
24702366|NCT01465438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24702367|NCT01465438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24702368|NCT01465503|Heparin|heparin|mesh-list
24702369|NCT01465503|Calcium heparin|calcium heparin|mesh-list
24702370|NCT01465503|Hirudins|hirudins|mesh-list
25770892|NCT03572478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25770893|NCT03572478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770894|NCT03572478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24702372|NCT01465503|Anticoagulants|anticoagulants|mesh-ancestor
24702373|NCT01465503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24702385|NCT01465685|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
24702386|NCT01465685|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24702421|NCT01465893|Vitamin D|vitamin d|mesh-list
24702500|NCT01466114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24702501|NCT01466205|Dihydrexidine|dihydrexidine|mesh-list
24702502|NCT01466205|Dopamine Agonists|dopamine agonists|mesh-ancestor
24702503|NCT01466205|Dopamine Agents|dopamine agents|mesh-ancestor
24702504|NCT01466205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24702505|NCT01466205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702506|NCT01466205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702508|NCT01466231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24702775|NCT01467596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24895706|NCT03474276|Mitosis Modulators|mitosis modulators|mesh-ancestor
24702776|NCT01467596|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24702777|NCT01467596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24702778|NCT01467596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24702789|NCT01467687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702790|NCT01467687|Vasodilator Agents|vasodilator agents|mesh-ancestor
24702792|NCT01467804|Antidepressive Agents|antidepressive agents|mesh-ancestor
24702793|NCT01467804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24702794|NCT01467804|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24702795|NCT01467804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24702796|NCT01467804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24702797|NCT01467804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702800|NCT01467804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702801|NCT01467921|Oxaliplatin|oxaliplatin|mesh-list
24702802|NCT01467921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24702803|NCT01467986|Sirolimus|sirolimus|mesh-list
24702804|NCT01467986|Irinotecan|irinotecan|mesh-list
24702805|NCT01467986|Temozolomide|temozolomide|mesh-list
24702806|NCT01467986|Dasatinib|dasatinib|mesh-list
24702808|NCT01467986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24702821|NCT01467986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24702822|NCT01468025|Naproxen|naproxen|mesh-list
24702823|NCT01468025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24702824|NCT01468025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24702825|NCT01468025|Analgesics|analgesics|mesh-ancestor
24702835|NCT01468038|Trazodone|trazodone|mesh-list
24702843|NCT01468038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24702844|NCT01468038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24702845|NCT01468038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24702846|NCT01468038|Serotonin Agents|serotonin agents|mesh-ancestor
24702847|NCT01468038|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24702848|NCT01468038|Antidepressive Agents|antidepressive agents|mesh-ancestor
24702849|NCT01468051|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24702850|NCT01468051|Vaccines|vaccines|mesh-list
24702851|NCT01468051|Immunologic Factors|immunologic factors|mesh-ancestor
24702852|NCT01468051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702854|NCT01468051|Antacids|antacids|mesh-ancestor
24702910|NCT01468441|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24702911|NCT01468441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24702912|NCT01468441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703017|NCT01469338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703018|NCT01469338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24703019|NCT01469338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703020|NCT01469338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24703021|NCT01469351|Liraglutide|liraglutide|mesh-list
24703022|NCT01469351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24703023|NCT01469351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703024|NCT01469351|Incretins|incretins|mesh-ancestor
24703025|NCT01469351|Hormones|hormones|mesh-ancestor
24703109|NCT01469624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24703111|NCT01469650|Vitamin D|vitamin d|mesh-list
24703112|NCT01469650|Ergocalciferols|ergocalciferols|mesh-list
24703113|NCT01469650|Cholecalciferol|cholecalciferol|mesh-list
24703114|NCT01469650|Vitamins|vitamins|mesh-list
24703115|NCT01469650|Micronutrients|micronutrients|mesh-ancestor
24703116|NCT01469650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703117|NCT01469650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24703118|NCT01469650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25712988|NCT02331680|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24703256|NCT01470456|Immunologic Factors|immunologic factors|mesh-ancestor
24704035|NCT01476280|Palonosetron|palonosetron|mesh-list
24703257|NCT01470456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703258|NCT01470456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24703260|NCT01470495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703261|NCT01470495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24703262|NCT01470495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703263|NCT01470495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703264|NCT01470690|Omeprazole|omeprazole|mesh-list
24703265|NCT01470690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24703266|NCT01470690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24703267|NCT01470690|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24703268|NCT01470690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703269|NCT01470690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703270|NCT01470742|Capecitabine|capecitabine|mesh-list
24703271|NCT01470742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24703272|NCT01470742|Antimetabolites|antimetabolites|mesh-ancestor
24703273|NCT01470742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703274|NCT01470742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703286|NCT01470755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24703287|NCT01470755|Adrenergic Agents|adrenergic agents|mesh-ancestor
24703309|NCT01471067|Clofarabine|clofarabine|mesh-list
24703310|NCT01471067|Tacrolimus|tacrolimus|mesh-list
24703311|NCT01471067|Thymoglobulin|thymoglobulin|mesh-list
24703312|NCT01471067|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24703313|NCT01471067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24703314|NCT01471067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703315|NCT01471067|Immunologic Factors|immunologic factors|mesh-ancestor
24703316|NCT01471067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703317|NCT01471067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24703383|NCT01471470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703384|NCT01471470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24703385|NCT01471470|Antimetabolites|antimetabolites|mesh-ancestor
24703386|NCT01471535|Interferons|interferons|mesh-list
24703387|NCT01471535|Interferon-alpha|interferon-alpha|mesh-list
24703388|NCT01471535|Interferon alpha-2|interferon alpha-2|mesh-list
24703389|NCT01471535|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24703390|NCT01471535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703391|NCT01471535|Antiviral Agents|antiviral agents|mesh-ancestor
24703392|NCT01471535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24703393|NCT01471535|Immunologic Factors|immunologic factors|mesh-ancestor
24703394|NCT01471535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703395|NCT01471613|Lithium Carbonate|lithium carbonate|mesh-list
24703396|NCT01471613|Antidepressive Agents|antidepressive agents|mesh-ancestor
24703397|NCT01471613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24703398|NCT01471613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703399|NCT01471613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703400|NCT01471613|Antimanic Agents|antimanic agents|mesh-ancestor
24703401|NCT01471613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24703402|NCT01471613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24703403|NCT01471613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703447|NCT01471847|Lapatinib|lapatinib|mesh-list
24703448|NCT01471847|Dactolisib|dactolisib|mesh-list
24703449|NCT01471847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24703637|NCT01473043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24703638|NCT01473043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703639|NCT01473043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703640|NCT01473069|Ketoconazole|ketoconazole|mesh-list
24703641|NCT01473069|Antifungal Agents|antifungal agents|mesh-ancestor
24703642|NCT01473069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25712989|NCT02331680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25712990|NCT02331680|Natriuretic Agents|natriuretic agents|mesh-ancestor
25712991|NCT02331680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712992|NCT02331940|Tiotropium Bromide|tiotropium bromide|mesh-list
25712993|NCT02331940|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25712994|NCT02331940|Autonomic Agents|autonomic agents|mesh-ancestor
25712995|NCT02331940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25712996|NCT02331940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25712997|NCT02331940|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25770895|NCT03572478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703643|NCT01473069|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24703644|NCT01473069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24703645|NCT01473069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703646|NCT01473069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703647|NCT01473069|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24703648|NCT01473069|Hormone Antagonists|hormone antagonists|mesh-ancestor
24703649|NCT01473069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24703650|NCT01473069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703651|NCT01473069|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24703653|NCT01473147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24703654|NCT01473147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703701|NCT01473303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24703702|NCT01473303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24703703|NCT01473303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24703704|NCT01473303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24703706|NCT01473303|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24703707|NCT01473303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24703708|NCT01473303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24703710|NCT01473303|Protective Agents|protective agents|mesh-ancestor
24703711|NCT01473303|Vitamin B Complex|vitamin b complex|mesh-ancestor
24703713|NCT01473303|Micronutrients|micronutrients|mesh-ancestor
24703714|NCT01473316|Ketoconazole|ketoconazole|mesh-list
24703715|NCT01473316|Antifungal Agents|antifungal agents|mesh-ancestor
24703716|NCT01473316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24703717|NCT01473316|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24703718|NCT01473316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24703719|NCT01473316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613476|NCT01019278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24613477|NCT01019291|Formaldehyde|formaldehyde|mesh-list
24703792|NCT01474304|Antipyretics|antipyretics|mesh-ancestor
24703793|NCT01474330|Pomalidomide|pomalidomide|mesh-list
24703794|NCT01474330|Immunologic Factors|immunologic factors|mesh-ancestor
24703795|NCT01474330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703801|NCT01474382|Phentolamine|phentolamine|mesh-list
24703807|NCT01474382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703808|NCT01474382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24703809|NCT01474460|Vitamin K|vitamin k|mesh-list
24703810|NCT01474460|Vitamin K 1|vitamin k 1|mesh-list
24703811|NCT01474460|Vitamins|vitamins|mesh-ancestor
24703812|NCT01474460|Micronutrients|micronutrients|mesh-ancestor
24703813|NCT01474460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24703814|NCT01474460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24704025|NCT01476189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24704026|NCT01476189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704027|NCT01476189|Antipyretics|antipyretics|mesh-ancestor
24704028|NCT01476215|Acetaminophen|acetaminophen|mesh-list
24704029|NCT01476215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24704030|NCT01476215|Analgesics|analgesics|mesh-ancestor
24704031|NCT01476215|Sensory System Agents|sensory system agents|mesh-ancestor
24704032|NCT01476215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24704034|NCT01476215|Antipyretics|antipyretics|mesh-ancestor
24704037|NCT01476280|Antiemetics|antiemetics|mesh-ancestor
24704038|NCT01476280|Autonomic Agents|autonomic agents|mesh-ancestor
24704039|NCT01476280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24704101|NCT01476592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704102|NCT01476592|Protective Agents|protective agents|mesh-ancestor
24704103|NCT01476592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613508|NCT01019434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24613509|NCT01019434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24613510|NCT01019434|Antifungal Agents|antifungal agents|mesh-ancestor
24613511|NCT01019434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24613512|NCT01019434|Immunologic Factors|immunologic factors|mesh-ancestor
24613513|NCT01019434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613514|NCT01019447|Anti-Infective Agents|anti-infective agents|mesh-list
24704282|NCT01477580|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24704283|NCT01477580|Immunologic Factors|immunologic factors|mesh-ancestor
24704284|NCT01477580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704285|NCT01477580|Antacids|antacids|mesh-ancestor
24704286|NCT01477580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770896|NCT03572972|Warfarin|warfarin|mesh-list
25770897|NCT03572972|Rivaroxaban|rivaroxaban|mesh-list
25770898|NCT03572972|Dabigatran|dabigatran|mesh-list
25712998|NCT02331940|Respiratory System Agents|respiratory system agents|mesh-ancestor
24704287|NCT01477580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24704355|NCT01477931|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24704356|NCT01477931|Antidepressive Agents|antidepressive agents|mesh-ancestor
24644382|NCT01190683|Ergocalciferols|ergocalciferols|mesh-list
24704366|NCT01477931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24704367|NCT01477931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704368|NCT01477983|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
24704369|NCT01477983|Flecainide|flecainide|mesh-list
24704370|NCT01477983|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24704371|NCT01477983|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24704372|NCT01477983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24704374|NCT01478022|Ibuprofen|ibuprofen|mesh-list
24704442|NCT01478282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704443|NCT01478282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704446|NCT01478308|Prednisone|prednisone|mesh-list
24704447|NCT01478308|Docetaxel|docetaxel|mesh-list
24704448|NCT01478308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24704449|NCT01478308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897698|NCT04423185|Imatinib Mesylate|imatinib mesylate|mesh-list
24704450|NCT01478308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24704451|NCT01478308|Tubulin Modulators|tubulin modulators|mesh-ancestor
24704457|NCT01478308|Hormones|hormones|mesh-ancestor
24704490|NCT01478503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704491|NCT01478503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704492|NCT01478503|Urological Agents|urological agents|mesh-ancestor
24704493|NCT01478529|Mirabegron|mirabegron|mesh-list
24704494|NCT01478529|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24704495|NCT01478529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24704496|NCT01478529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24704497|NCT01478529|Adrenergic Agents|adrenergic agents|mesh-ancestor
24704498|NCT01478529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24704499|NCT01478529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704500|NCT01478529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704501|NCT01478529|Urological Agents|urological agents|mesh-ancestor
24704502|NCT01478568|Desipramine|desipramine|mesh-list
24704503|NCT01478568|Mirabegron|mirabegron|mesh-list
24704522|NCT01478607|Sensory System Agents|sensory system agents|mesh-ancestor
24704523|NCT01478607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24704524|NCT01478607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704525|NCT01478633|Galantamine|galantamine|mesh-list
24704526|NCT01478633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24704590|NCT01479036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24704591|NCT01479036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24704616|NCT01479192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24704617|NCT01479192|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24704618|NCT01479192|Protective Agents|protective agents|mesh-ancestor
24704619|NCT01479192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704620|NCT01479231|Dexlansoprazole|dexlansoprazole|mesh-list
24704644|NCT01479361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24704645|NCT01479361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704700|NCT01479751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24897699|NCT04423185|Palbociclib|palbociclib|mesh-list
24704701|NCT01479751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24704702|NCT01479751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24704703|NCT01479751|Tocolytic Agents|tocolytic agents|mesh-ancestor
24704704|NCT01479751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24704705|NCT01479751|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24704706|NCT01479751|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24704749|NCT01480050|Alkylating Agents|alkylating agents|mesh-ancestor
24704750|NCT01480050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704751|NCT01480050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24704752|NCT01480050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25712999|NCT02331940|Parasympatholytics|parasympatholytics|mesh-ancestor
24704753|NCT01480050|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25713000|NCT02331940|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25713001|NCT02331940|Cholinergic Agents|cholinergic agents|mesh-ancestor
25713002|NCT02331940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25713003|NCT02331940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713004|NCT02332291|Citalopram|citalopram|mesh-list
25713006|NCT02332291|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25713007|NCT02332291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25713008|NCT02332291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24704754|NCT01480050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24704755|NCT01480050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24704850|NCT01480765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24704854|NCT01480765|Anticonvulsants|anticonvulsants|mesh-ancestor
24442800|NCT00292747|Drotaverin|drotaverin|mesh-list
24704869|NCT01480778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24704870|NCT01480778|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24704871|NCT01480778|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
24704872|NCT01480778|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24704873|NCT01480778|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24704874|NCT01480791|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24704875|NCT01480791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24704876|NCT01480791|Diuretics|diuretics|mesh-ancestor
24704877|NCT01480791|Natriuretic Agents|natriuretic agents|mesh-ancestor
24704878|NCT01480791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24704942|NCT01481233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704943|NCT01481233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24704945|NCT01481259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24704946|NCT01481259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24704947|NCT01481259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24704948|NCT01481259|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24704949|NCT01481259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24704950|NCT01481311|Bromides|bromides|mesh-list
24613589|NCT01019798|Growth Inhibitors|growth inhibitors|mesh-ancestor
24705015|NCT01481701|Oxaliplatin|oxaliplatin|mesh-list
24705016|NCT01481701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705017|NCT01481714|Picosulfate sodium|picosulfate sodium|mesh-list
24705050|NCT01481844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24705051|NCT01481844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24705052|NCT01481844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24705053|NCT01481844|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24705054|NCT01481844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705055|NCT01481844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705061|NCT01481844|Antacids|antacids|mesh-ancestor
24705175|NCT01482559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24705176|NCT01482559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705177|NCT01482559|Dopamine Agents|dopamine agents|mesh-ancestor
24705186|NCT01482624|Protective Agents|protective agents|mesh-ancestor
24705188|NCT01482728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705189|NCT01482728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24705190|NCT01482728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705191|NCT01482728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705192|NCT01482754|Rituximab|rituximab|mesh-list
24705193|NCT01482754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24705194|NCT01482754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705195|NCT01482754|Immunologic Factors|immunologic factors|mesh-ancestor
24705196|NCT01482754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705216|NCT01482897|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24705217|NCT01482897|Protective Agents|protective agents|mesh-ancestor
24705218|NCT01482936|Oxycodone|oxycodone|mesh-list
24705219|NCT01482936|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24705220|NCT01482936|Narcotics|narcotics|mesh-ancestor
24705221|NCT01482936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24705247|NCT01483248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705248|NCT01483248|Antiviral Agents|antiviral agents|mesh-ancestor
24705249|NCT01483248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24705294|NCT01483781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705295|NCT01483859|Liver Extracts|liver extracts|mesh-list
24705296|NCT01483859|Hematinics|hematinics|mesh-ancestor
24705297|NCT01483911|Gontivimab|gontivimab|mesh-list
24705298|NCT01483911|Antiviral Agents|antiviral agents|mesh-ancestor
24705299|NCT01483911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24705300|NCT01484015|Cefepime|cefepime|mesh-list
24705301|NCT01484015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24705302|NCT01484015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25713009|NCT02332291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713010|NCT02332291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24705303|NCT01484080|Paclitaxel|paclitaxel|mesh-list
24705304|NCT01484080|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24705305|NCT01484080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24705306|NCT01484080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705307|NCT01484080|Tubulin Modulators|tubulin modulators|mesh-ancestor
24705308|NCT01484080|Antimitotic Agents|antimitotic agents|mesh-ancestor
24705309|NCT01484080|Mitosis Modulators|mitosis modulators|mesh-ancestor
24896176|NCT01515748|Tegafur|tegafur|mesh-list
24705310|NCT01484080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705311|NCT01484145|Terbinafine|terbinafine|mesh-list
24705312|NCT01484145|Antifungal Agents|antifungal agents|mesh-ancestor
24705313|NCT01484145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24705314|NCT01484145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24705315|NCT01484145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705316|NCT01484171|Idarubicin|idarubicin|mesh-list
24705317|NCT01484171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24705318|NCT01484171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705330|NCT01484184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705331|NCT01484184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24705332|NCT01484184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24705333|NCT01484184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24705334|NCT01484184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24613597|NCT01019850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613598|NCT01019850|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24613599|NCT01019863|Oxaliplatin|oxaliplatin|mesh-list
24613600|NCT01019863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705483|NCT01485367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24705484|NCT01485367|Analgesics|analgesics|mesh-ancestor
24705485|NCT01485367|Sensory System Agents|sensory system agents|mesh-ancestor
24705486|NCT01485367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24705487|NCT01485367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24705621|NCT01485835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24705622|NCT01485835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24705642|NCT01485939|Lidocaine|lidocaine|mesh-list
24705769|NCT01486706|Anticonvulsants|anticonvulsants|mesh-ancestor
24705770|NCT01486706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24706007|NCT01488253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24706008|NCT01488253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24706009|NCT01488253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24706010|NCT01488253|Antifungal Agents|antifungal agents|mesh-ancestor
24644486|NCT01191216|Tryptophan|tryptophan|mesh-list
24706011|NCT01488266|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24706012|NCT01488266|Milnacipran|milnacipran|mesh-list
24706013|NCT01488266|Aripiprazole|aripiprazole|mesh-list
24706014|NCT01488266|Mirtazapine|mirtazapine|mesh-list
24706053|NCT01488266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24706054|NCT01488266|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24706394|NCT01489943|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24706395|NCT01489943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24706396|NCT01489943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24706397|NCT01489943|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24706398|NCT01489943|Anesthetics, General|anesthetics, general|mesh-ancestor
24706399|NCT01489943|Anesthetics|anesthetics|mesh-ancestor
24706400|NCT01489943|GABA Modulators|gaba modulators|mesh-ancestor
24706401|NCT01489943|GABA Agents|gaba agents|mesh-ancestor
24706402|NCT01489943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24706449|NCT01490047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24706450|NCT01490047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24706451|NCT01490047|Immunologic Factors|immunologic factors|mesh-ancestor
24706452|NCT01490099|Insulin Detemir|insulin detemir|mesh-list
24706453|NCT01490099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24706454|NCT01490099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706455|NCT01490112|Insulin Aspart|insulin aspart|mesh-list
24706456|NCT01490112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24706457|NCT01490112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706458|NCT01490203|Edetic Acid|edetic acid|mesh-list
24706459|NCT01490203|Pentetic Acid|pentetic acid|mesh-list
24706569|NCT01490671|Tenofovir|tenofovir|mesh-list
24706570|NCT01490671|Antiviral Agents|antiviral agents|mesh-ancestor
24706571|NCT01490671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24706572|NCT01490671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24706573|NCT01490671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24706574|NCT01490671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24706575|NCT01490671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706576|NCT01490671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24706577|NCT01490671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24706578|NCT01490749|Carboplatin|carboplatin|mesh-list
24706579|NCT01490749|Capecitabine|capecitabine|mesh-list
24706677|NCT01491139|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24706678|NCT01491139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644543|NCT01191645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24706679|NCT01491139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706689|NCT01491191|Antiviral Agents|antiviral agents|mesh-ancestor
24706690|NCT01491191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24706691|NCT01491191|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24706692|NCT01491191|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24706693|NCT01491191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24706694|NCT01491191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24706695|NCT01491191|Hormones|hormones|mesh-ancestor
24706696|NCT01491191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24613686|NCT01020292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24613687|NCT01020292|Antiviral Agents|antiviral agents|mesh-ancestor
24613688|NCT01020292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24613690|NCT01020331|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24706736|NCT01491321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706737|NCT01491321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24706741|NCT01491438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24706742|NCT01491438|Antitubercular Agents|antitubercular agents|mesh-ancestor
24706744|NCT01491503|Montelukast|montelukast|mesh-list
24706745|NCT01491503|Levocetirizine|levocetirizine|mesh-list
24706746|NCT01491503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24706747|NCT01491503|Respiratory System Agents|respiratory system agents|mesh-ancestor
24706748|NCT01491503|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24706749|NCT01491503|Hormone Antagonists|hormone antagonists|mesh-ancestor
24706751|NCT01491503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24706855|NCT01492712|Anesthetics|anesthetics|mesh-ancestor
24706856|NCT01492725|Plasminogen|plasminogen|mesh-list
24706940|NCT01493102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24706941|NCT01493102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24706942|NCT01493102|Hemostatics|hemostatics|mesh-ancestor
24706943|NCT01493102|Coagulants|coagulants|mesh-ancestor
24706944|NCT01493102|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24706945|NCT01493102|Natriuretic Agents|natriuretic agents|mesh-ancestor
24706946|NCT01493115|Insulin|insulin|mesh-list
24706947|NCT01493115|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24706948|NCT01493115|Insulin Glargine|insulin glargine|mesh-list
24706949|NCT01493115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24706950|NCT01493115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613825|NCT01021163|Antiviral Agents|antiviral agents|mesh-ancestor
24613826|NCT01021163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24613827|NCT01021163|Expectorants|expectorants|mesh-ancestor
24613828|NCT01021163|Respiratory System Agents|respiratory system agents|mesh-ancestor
24613829|NCT01021163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24613830|NCT01021163|Antioxidants|antioxidants|mesh-ancestor
24707032|NCT01493648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707033|NCT01493648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24707034|NCT01493648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24707035|NCT01493674|Folic Acid|folic acid|mesh-list
24707036|NCT01493674|Vitamin B Complex|vitamin b complex|mesh-list
24707037|NCT01493674|Hematinics|hematinics|mesh-ancestor
24707038|NCT01493674|Vitamins|vitamins|mesh-ancestor
24707039|NCT01493674|Micronutrients|micronutrients|mesh-ancestor
24707040|NCT01493674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707169|NCT01494402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24707171|NCT01494402|Analgesics|analgesics|mesh-ancestor
24707172|NCT01494402|Sensory System Agents|sensory system agents|mesh-ancestor
24707173|NCT01494402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24707174|NCT01494402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707175|NCT01494402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24707176|NCT01494402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24707177|NCT01494402|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24707178|NCT01494402|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25713011|NCT02332291|Serotonin Agents|serotonin agents|mesh-ancestor
25713012|NCT02332291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707211|NCT01494636|Anesthetics|anesthetics|mesh-ancestor
24707371|NCT01495338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713013|NCT02332291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25713014|NCT02332291|Antidepressive Agents|antidepressive agents|mesh-ancestor
25713015|NCT02332291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25713016|NCT02332291|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24707373|NCT01495351|Veliparib|veliparib|mesh-list
24707374|NCT01495351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516089|NCT00600587|Antiviral Agents|antiviral agents|mesh-ancestor
24707375|NCT01495351|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24707376|NCT01495351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707377|NCT01495351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707378|NCT01495377|Remifentanil|remifentanil|mesh-list
24707379|NCT01495377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24707380|NCT01495377|Narcotics|narcotics|mesh-ancestor
24707381|NCT01495377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24707382|NCT01495377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707383|NCT01495377|Analgesics|analgesics|mesh-ancestor
24707384|NCT01495377|Sensory System Agents|sensory system agents|mesh-ancestor
24707385|NCT01495377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24707399|NCT01495520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24707400|NCT01495520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707401|NCT01495624|Dexamethasone|dexamethasone|mesh-list
24707402|NCT01495624|Dexamethasone acetate|dexamethasone acetate|mesh-list
24707403|NCT01495624|Ropivacaine|ropivacaine|mesh-list
24707443|NCT01495884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707444|NCT01495884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707445|NCT01495910|Abiraterone Acetate|abiraterone acetate|mesh-list
24707446|NCT01495910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24707447|NCT01495910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24707456|NCT01495949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24707457|NCT01495949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24707458|NCT01495949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707569|NCT01496690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707572|NCT01496690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24707597|NCT01496742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24707599|NCT01496911|Levocetirizine|levocetirizine|mesh-list
24707600|NCT01496911|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24707601|NCT01496911|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24707602|NCT01496911|Histamine Antagonists|histamine antagonists|mesh-ancestor
24707603|NCT01496911|Histamine Agents|histamine agents|mesh-ancestor
24707604|NCT01496911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24707607|NCT01496911|Antipruritics|antipruritics|mesh-ancestor
24707682|NCT01497327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24707697|NCT01497431|Antioxidants|antioxidants|mesh-ancestor
24707698|NCT01497431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707786|NCT01497626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24707787|NCT01497626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707788|NCT01497626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707789|NCT01497652|Rasagiline|rasagiline|mesh-list
24707790|NCT01497652|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24707791|NCT01497652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707792|NCT01497652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24707835|NCT01498016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24707836|NCT01498016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24707837|NCT01498081|Tiotropium Bromide|tiotropium bromide|mesh-list
24707838|NCT01498081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24707839|NCT01498081|Autonomic Agents|autonomic agents|mesh-ancestor
24707840|NCT01498081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24707841|NCT01498081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707842|NCT01498081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24707843|NCT01498081|Respiratory System Agents|respiratory system agents|mesh-ancestor
24613883|NCT01021488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24613884|NCT01021501|Nifedipine|nifedipine|mesh-list
24613885|NCT01021501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24707891|NCT01498796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24707892|NCT01498796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24707894|NCT01498796|Sensory System Agents|sensory system agents|mesh-ancestor
24707895|NCT01498796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24707896|NCT01498796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707897|NCT01498796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24707898|NCT01498796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24707899|NCT01498796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24707900|NCT01498796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24707902|NCT01498809|Midodrine|midodrine|mesh-list
24897700|NCT04423185|Niraparib|niraparib|mesh-list
24707930|NCT01498861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713017|NCT02332291|Dopamine Agents|dopamine agents|mesh-ancestor
25713018|NCT02332291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24707932|NCT01498861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24707933|NCT01498861|Antiviral Agents|antiviral agents|mesh-ancestor
24707934|NCT01498861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24707935|NCT01498861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24707936|NCT01498861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24707937|NCT01498861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24707938|NCT01498861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24707939|NCT01498861|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24707940|NCT01498861|Contraceptive Agents|contraceptive agents|mesh-ancestor
24707941|NCT01498861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24707942|NCT01498861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24707943|NCT01498861|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24707944|NCT01498861|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24708051|NCT01499641|Prednisolone|prednisolone|mesh-list
24708052|NCT01499641|Prednisolone acetate|prednisolone acetate|mesh-list
24708053|NCT01499641|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24708054|NCT01499641|Prednisolone phosphate|prednisolone phosphate|mesh-list
24708055|NCT01499641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24708056|NCT01499641|Antiemetics|antiemetics|mesh-ancestor
24708057|NCT01499641|Autonomic Agents|autonomic agents|mesh-ancestor
24708058|NCT01499641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24708059|NCT01499641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708115|NCT01500018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708116|NCT01500018|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24494181|NCT00494156|Antipyretics|antipyretics|mesh-ancestor
24708169|NCT01500473|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24708170|NCT01500473|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24708171|NCT01500473|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24708172|NCT01500473|Contraceptive Agents|contraceptive agents|mesh-ancestor
24708173|NCT01500473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24708177|NCT01500473|Progestins|progestins|mesh-ancestor
24613929|NCT01021696|Sensory System Agents|sensory system agents|mesh-ancestor
24613930|NCT01021696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24613931|NCT01021696|Anticonvulsants|anticonvulsants|mesh-ancestor
24613932|NCT01021696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24613933|NCT01021696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24613934|NCT01021696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613945|NCT01021735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24708190|NCT01500577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708218|NCT01500785|Vitamin B Complex|vitamin b complex|mesh-ancestor
24708219|NCT01500785|Hematinics|hematinics|mesh-ancestor
24708220|NCT01500785|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24708221|NCT01500785|Vasodilator Agents|vasodilator agents|mesh-ancestor
24708222|NCT01500785|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24708223|NCT01500785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24708224|NCT01500785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708225|NCT01500785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708226|NCT01500785|Protective Agents|protective agents|mesh-ancestor
24708227|NCT01500824|Crizotinib|crizotinib|mesh-list
24708228|NCT01500824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708229|NCT01500824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24708230|NCT01500824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708231|NCT01500824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708232|NCT01500837|Levofloxacin|levofloxacin|mesh-list
24708362|NCT01501136|Antiemetics|antiemetics|mesh-ancestor
24708363|NCT01501136|Autonomic Agents|autonomic agents|mesh-ancestor
25713019|NCT02332291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24708364|NCT01501136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713020|NCT02332291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713021|NCT02332707|Ribavirin|ribavirin|mesh-list
25713022|NCT02332707|Grazoprevir|grazoprevir|mesh-list
25713023|NCT02332707|Uprifosbuvir|uprifosbuvir|mesh-list
25713024|NCT02332707|Ruzasvir|ruzasvir|mesh-list
25713025|NCT02332707|Antimetabolites|antimetabolites|mesh-ancestor
25713026|NCT02332707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713027|NCT02332707|Antiviral Agents|antiviral agents|mesh-ancestor
25713028|NCT02332707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24708365|NCT01501136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708366|NCT01501136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24708367|NCT01501136|Glucocorticoids|glucocorticoids|mesh-ancestor
24708368|NCT01501136|Hormones|hormones|mesh-ancestor
24708369|NCT01501136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24708385|NCT01501136|Protective Agents|protective agents|mesh-ancestor
24708387|NCT01501149|Dexamethasone|dexamethasone|mesh-list
24708402|NCT01501149|Antimetabolites|antimetabolites|mesh-ancestor
24708403|NCT01501149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708404|NCT01501149|Antiviral Agents|antiviral agents|mesh-ancestor
24708405|NCT01501149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24708406|NCT01501149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708407|NCT01501149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24708408|NCT01501149|Immunologic Factors|immunologic factors|mesh-ancestor
24708409|NCT01501149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24644935|NCT01194037|Interferons|interferons|mesh-list
24708410|NCT01501149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24708424|NCT01501253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708434|NCT01501370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24708435|NCT01501370|Antiemetics|antiemetics|mesh-ancestor
24708436|NCT01501370|Autonomic Agents|autonomic agents|mesh-ancestor
24708437|NCT01501370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24708472|NCT01501396|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24708473|NCT01501396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24708474|NCT01501396|Serotonin Agents|serotonin agents|mesh-ancestor
24708518|NCT01501487|Docetaxel|docetaxel|mesh-list
24708519|NCT01501487|Trastuzumab|trastuzumab|mesh-list
24708520|NCT01501487|Pertuzumab|pertuzumab|mesh-list
24708521|NCT01501487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24708522|NCT01501487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708523|NCT01501487|Tubulin Modulators|tubulin modulators|mesh-ancestor
24708524|NCT01501487|Antimitotic Agents|antimitotic agents|mesh-ancestor
24708525|NCT01501487|Mitosis Modulators|mitosis modulators|mesh-ancestor
24708526|NCT01501487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708527|NCT01501487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24708528|NCT01501500|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24708529|NCT01501500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24708584|NCT01501747|Cephalexin|cephalexin|mesh-list
24708585|NCT01501747|Ibuprofen|ibuprofen|mesh-list
24708586|NCT01501747|Caffeine|caffeine|mesh-list
24708587|NCT01501747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24708588|NCT01501747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24708589|NCT01501747|Analgesics|analgesics|mesh-ancestor
24708590|NCT01501747|Sensory System Agents|sensory system agents|mesh-ancestor
24708591|NCT01501747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24708592|NCT01501747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708594|NCT01501747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24614019|NCT01022047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24614020|NCT01022047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614021|NCT01022047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24614022|NCT01022047|Respiratory System Agents|respiratory system agents|mesh-ancestor
24614023|NCT01022047|Glucocorticoids|glucocorticoids|mesh-ancestor
24709378|NCT01505283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24708682|NCT01502020|Immunologic Factors|immunologic factors|mesh-ancestor
24708683|NCT01502020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24708684|NCT01502020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24708759|NCT01502774|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24708760|NCT01502800|Beta-lapachone|beta-lapachone|mesh-list
24708761|NCT01502800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24708762|NCT01502800|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25713029|NCT02332720|Ribavirin|ribavirin|mesh-list
25713030|NCT02332720|Grazoprevir|grazoprevir|mesh-list
25713031|NCT02332720|Uprifosbuvir|uprifosbuvir|mesh-list
25713032|NCT02332720|Ruzasvir|ruzasvir|mesh-list
25713033|NCT02332720|Antimetabolites|antimetabolites|mesh-ancestor
25713034|NCT02332720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708763|NCT01502800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24708764|NCT01502800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24708765|NCT01502800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24708766|NCT01502800|Antiviral Agents|antiviral agents|mesh-ancestor
24708767|NCT01502878|Cefpodoxime|cefpodoxime|mesh-list
24708768|NCT01502878|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
24708769|NCT01502878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24708770|NCT01502878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24708920|NCT01503424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614028|NCT01022125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24614029|NCT01022125|Protease Inhibitors|protease inhibitors|mesh-ancestor
24614030|NCT01022125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24614031|NCT01022125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614032|NCT01022138|Cyclophosphamide|cyclophosphamide|mesh-list
24614033|NCT01022138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24614034|NCT01022138|Immunologic Factors|immunologic factors|mesh-ancestor
24614041|NCT01022138|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24614042|NCT01022151|Aminophylline|aminophylline|mesh-list
24614043|NCT01022151|Doxapram|doxapram|mesh-list
24614044|NCT01022151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24614045|NCT01022151|Autonomic Agents|autonomic agents|mesh-ancestor
24614046|NCT01022151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24614047|NCT01022151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614048|NCT01022151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24614049|NCT01022151|Respiratory System Agents|respiratory system agents|mesh-ancestor
24614050|NCT01022151|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24708931|NCT01503437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24708932|NCT01503437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24708933|NCT01503437|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24709004|NCT01503736|Sodium Citrate|sodium citrate|mesh-list
24709005|NCT01503736|Ferric Compounds|ferric compounds|mesh-list
24709006|NCT01503736|Anticoagulants|anticoagulants|mesh-ancestor
24709007|NCT01503736|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24709008|NCT01503736|Chelating Agents|chelating agents|mesh-ancestor
24709009|NCT01503736|Sequestering Agents|sequestering agents|mesh-ancestor
24709010|NCT01503736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709011|NCT01503736|Hematinics|hematinics|mesh-ancestor
24709013|NCT01503788|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24709014|NCT01503788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24709015|NCT01503788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24709023|NCT01503788|GABA Modulators|gaba modulators|mesh-ancestor
24709024|NCT01503788|GABA Agents|gaba agents|mesh-ancestor
24709178|NCT01504295|Metadoxine|metadoxine|mesh-list
24614086|NCT01022476|Raltegravir Potassium|raltegravir potassium|mesh-list
24614087|NCT01022476|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24614088|NCT01022476|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24614089|NCT01022476|Antiviral Agents|antiviral agents|mesh-ancestor
24614090|NCT01022476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24614091|NCT01022476|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24614092|NCT01022476|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24614093|NCT01022476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24614094|NCT01022476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614095|NCT01022528|Dexamethasone|dexamethasone|mesh-list
24614111|NCT01022528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614112|NCT01022541|Bevacizumab|bevacizumab|mesh-list
24614113|NCT01022541|Capecitabine|capecitabine|mesh-list
24709275|NCT01504906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709276|NCT01504906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24709277|NCT01504906|Immunologic Factors|immunologic factors|mesh-ancestor
25713035|NCT02332720|Antiviral Agents|antiviral agents|mesh-ancestor
24709278|NCT01504906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709279|NCT01504906|Antifungal Agents|antifungal agents|mesh-ancestor
24709280|NCT01504906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24709281|NCT01504906|Dermatologic Agents|dermatologic agents|mesh-ancestor
24709282|NCT01504906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24709283|NCT01504906|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24709284|NCT01504906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24709288|NCT01504906|Purinergic Agents|purinergic agents|mesh-ancestor
24709363|NCT01505231|Autonomic Agents|autonomic agents|mesh-ancestor
24614302|NCT01023399|Antimalarials|antimalarials|mesh-ancestor
24709366|NCT01505231|Hemostatics|hemostatics|mesh-ancestor
24709367|NCT01505231|Coagulants|coagulants|mesh-ancestor
24709368|NCT01505231|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24709369|NCT01505231|Natriuretic Agents|natriuretic agents|mesh-ancestor
24709371|NCT01505283|Sufentanil|sufentanil|mesh-list
24709372|NCT01505283|Anesthetics, Local|anesthetics, local|mesh-ancestor
24709373|NCT01505283|Anesthetics|anesthetics|mesh-ancestor
24709374|NCT01505283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24709375|NCT01505283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709376|NCT01505283|Sensory System Agents|sensory system agents|mesh-ancestor
24709434|NCT01505504|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24709435|NCT01505504|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24709436|NCT01505504|Serotonin Agents|serotonin agents|mesh-ancestor
24709437|NCT01505504|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24495642|NCT00501397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709439|NCT01505777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24709440|NCT01505777|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24709441|NCT01505777|Serotonin Agents|serotonin agents|mesh-ancestor
24709442|NCT01505777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24709444|NCT01505777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709445|NCT01505790|Clopidogrel|clopidogrel|mesh-list
24709446|NCT01505790|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24709447|NCT01505790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24709448|NCT01505790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24709449|NCT01505790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24709450|NCT01505790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24709451|NCT01505790|Purinergic Agents|purinergic agents|mesh-ancestor
24709452|NCT01505790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24709453|NCT01505790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709454|NCT01505790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709488|NCT01505998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709489|NCT01506011|Amlodipine|amlodipine|mesh-list
24709490|NCT01506011|Benazepril|benazepril|mesh-list
24709491|NCT01506011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24709492|NCT01506011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24709493|NCT01506011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24709494|NCT01506011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709495|NCT01506011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24709496|NCT01506011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713036|NCT02332720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25713037|NCT02332824|Candesartan|candesartan|mesh-list
25713038|NCT02332824|Candesartan cilexetil|candesartan cilexetil|mesh-list
25713039|NCT02332824|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
25713040|NCT02332824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25713041|NCT02332824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25713042|NCT02332824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25713043|NCT02332824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713044|NCT02332824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713045|NCT02332889|Decitabine|decitabine|mesh-list
25713046|NCT02332889|Poly ICLC|poly iclc|mesh-list
25713047|NCT02332889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25713048|NCT02332889|Antimetabolites|antimetabolites|mesh-ancestor
25713049|NCT02332889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713050|NCT02332889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713051|NCT02332889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713052|NCT02332889|Interferon Inducers|interferon inducers|mesh-ancestor
25713053|NCT02332889|Immunologic Factors|immunologic factors|mesh-ancestor
25713054|NCT02332889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713056|NCT02332902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713057|NCT02332902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25713058|NCT02332902|Immunologic Factors|immunologic factors|mesh-ancestor
24709497|NCT01506011|Vasodilator Agents|vasodilator agents|mesh-ancestor
24709498|NCT01506011|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24709499|NCT01506011|Protease Inhibitors|protease inhibitors|mesh-ancestor
24709500|NCT01506011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709501|NCT01506024|Tacrine|tacrine|mesh-list
24709502|NCT01506024|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24709503|NCT01506024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24709504|NCT01506024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24709532|NCT01506063|Levocetirizine|levocetirizine|mesh-list
24709677|NCT01506635|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24709678|NCT01506635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24709680|NCT01506713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24709681|NCT01506713|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24709901|NCT01507480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709902|NCT01507480|Growth Inhibitors|growth inhibitors|mesh-ancestor
24709904|NCT01507519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24709905|NCT01507519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24709906|NCT01507519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24709907|NCT01507519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24709908|NCT01507519|Antifungal Agents|antifungal agents|mesh-ancestor
24709909|NCT01507519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24709910|NCT01507519|Immunologic Factors|immunologic factors|mesh-ancestor
24709911|NCT01507519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24709918|NCT01507558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24709938|NCT01507701|Analgesics|analgesics|mesh-ancestor
24710043|NCT01508143|Abortifacient Agents|abortifacient agents|mesh-ancestor
24710044|NCT01508143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24710045|NCT01508143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710046|NCT01508143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24710047|NCT01508143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24710049|NCT01508182|Metformin|metformin|mesh-list
24710050|NCT01508182|Canagliflozin|canagliflozin|mesh-list
24710051|NCT01508182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24710052|NCT01508182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710082|NCT01508286|Ribavirin|ribavirin|mesh-list
24710138|NCT01508572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24710142|NCT01508572|Growth Substances|growth substances|mesh-ancestor
24710289|NCT01509365|Clopidogrel|clopidogrel|mesh-list
24710333|NCT01509560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710335|NCT01509599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24710336|NCT01509742|Liraglutide|liraglutide|mesh-list
24710337|NCT01509742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24710338|NCT01509742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710339|NCT01509742|Incretins|incretins|mesh-ancestor
24710341|NCT01509742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24710342|NCT01509755|Liraglutide|liraglutide|mesh-list
24710395|NCT01510132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24710396|NCT01510132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24710397|NCT01510171|Ticagrelor|ticagrelor|mesh-list
24710566|NCT01511159|Incretins|incretins|mesh-ancestor
24710567|NCT01511159|Hormones|hormones|mesh-ancestor
24710568|NCT01511159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24710569|NCT01511172|Metformin|metformin|mesh-list
24710621|NCT01511237|Antimetabolites|antimetabolites|mesh-ancestor
24710622|NCT01511237|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24710623|NCT01511237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24710625|NCT01511263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
24710626|NCT01511263|Diuretics|diuretics|mesh-list
25713059|NCT02332902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710721|NCT01511705|Antiemetics|antiemetics|mesh-ancestor
24710722|NCT01511705|Autonomic Agents|autonomic agents|mesh-ancestor
24710723|NCT01511705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24710726|NCT01511705|Antipruritics|antipruritics|mesh-ancestor
24710779|NCT01511770|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24710780|NCT01511770|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24710782|NCT01511770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710783|NCT01511770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24710784|NCT01511770|Hormone Antagonists|hormone antagonists|mesh-ancestor
24710785|NCT01511770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24710786|NCT01511770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24710787|NCT01511770|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24710788|NCT01511770|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24710906|NCT01512199|Antimitotic Agents|antimitotic agents|mesh-ancestor
24710907|NCT01512199|Mitosis Modulators|mitosis modulators|mesh-ancestor
24710908|NCT01512199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24710998|NCT01512901|Hormones|hormones|mesh-ancestor
24614296|NCT01023360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614297|NCT01023360|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24614298|NCT01023360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24614299|NCT01023360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24614301|NCT01023399|Amodiaquine|amodiaquine|mesh-list
24614303|NCT01023399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24614304|NCT01023399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24614305|NCT01023399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24614306|NCT01023399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614307|NCT01023399|Antiviral Agents|antiviral agents|mesh-ancestor
24614308|NCT01023399|Schistosomicides|schistosomicides|mesh-ancestor
24614309|NCT01023399|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24614310|NCT01023399|Anthelmintics|anthelmintics|mesh-ancestor
24614311|NCT01023425|Donepezil|donepezil|mesh-list
24614312|NCT01023425|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24614313|NCT01023425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24614314|NCT01023425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614315|NCT01023425|Cholinergic Agents|cholinergic agents|mesh-ancestor
24614316|NCT01023425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24614318|NCT01023425|Nootropic Agents|nootropic agents|mesh-ancestor
24711069|NCT01513083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24711070|NCT01513083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24711071|NCT01513083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24711072|NCT01513083|Tubulin Modulators|tubulin modulators|mesh-ancestor
24711073|NCT01513083|Antimitotic Agents|antimitotic agents|mesh-ancestor
24711165|NCT01513772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24711166|NCT01513772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24711167|NCT01513772|Adrenergic Agents|adrenergic agents|mesh-ancestor
24711168|NCT01513772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24711169|NCT01513772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711171|NCT01513785|Rabeprazole|rabeprazole|mesh-list
24711172|NCT01513785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24711173|NCT01513785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24711174|NCT01513785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24711175|NCT01513785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24711176|NCT01513785|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24711177|NCT01513785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711178|NCT01513785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711179|NCT01513811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24711180|NCT01513863|Metronidazole|metronidazole|mesh-list
24711181|NCT01513863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24711182|NCT01513863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24711183|NCT01513863|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24711184|NCT01513863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24711185|NCT01513941|Interferons|interferons|mesh-list
24711187|NCT01513941|Interferon-alpha|interferon-alpha|mesh-list
24711196|NCT01513941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711214|NCT01514110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713060|NCT02333045|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25713061|NCT02333045|Maraviroc|maraviroc|mesh-list
25713062|NCT02333045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24711215|NCT01514110|Tubulin Modulators|tubulin modulators|mesh-ancestor
24711216|NCT01514110|Antimitotic Agents|antimitotic agents|mesh-ancestor
24711217|NCT01514110|Mitosis Modulators|mitosis modulators|mesh-ancestor
24711218|NCT01514110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711219|NCT01514110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24711220|NCT01514110|Immunologic Factors|immunologic factors|mesh-ancestor
24711221|NCT01514110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711222|NCT01514123|Bevacizumab|bevacizumab|mesh-list
24711223|NCT01514123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24711302|NCT01514695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24711303|NCT01514695|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24711304|NCT01514695|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24711305|NCT01514695|Anesthetics, General|anesthetics, general|mesh-ancestor
24711306|NCT01514695|Anesthetics|anesthetics|mesh-ancestor
24711307|NCT01514695|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24711308|NCT01514695|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24711319|NCT01514721|Adrenergic Agents|adrenergic agents|mesh-ancestor
24711320|NCT01514721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24711321|NCT01514721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711322|NCT01514721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711323|NCT01514721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24711324|NCT01514721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24711325|NCT01514812|Digoxin|digoxin|mesh-list
24711326|NCT01514812|Darexaban|darexaban|mesh-list
24711327|NCT01514812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24711328|NCT01514812|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24711329|NCT01514812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711330|NCT01514812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711331|NCT01514812|Protective Agents|protective agents|mesh-ancestor
24711332|NCT01514812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711333|NCT01514812|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24711334|NCT01514812|Antithrombins|antithrombins|mesh-ancestor
24711384|NCT01514942|Micronutrients|micronutrients|mesh-ancestor
24711385|NCT01514942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711386|NCT01514942|Trace Elements|trace elements|mesh-ancestor
24711387|NCT01514968|Cyclosporine|cyclosporine|mesh-list
24711388|NCT01514968|Ritonavir|ritonavir|mesh-list
24711389|NCT01514968|Cyclosporins|cyclosporins|mesh-list
24711390|NCT01514968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711391|NCT01514968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711392|NCT01514968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24711404|NCT01514968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24711405|NCT01514968|Antiviral Agents|antiviral agents|mesh-ancestor
24614322|NCT01023464|Dermatologic Agents|dermatologic agents|mesh-ancestor
24614323|NCT01023490|Vitamin D|vitamin d|mesh-list
24614324|NCT01023490|Vitamins|vitamins|mesh-ancestor
24614325|NCT01023490|Micronutrients|micronutrients|mesh-ancestor
24614326|NCT01023490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614327|NCT01023490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24614328|NCT01023542|Everolimus|everolimus|mesh-list
24614329|NCT01023542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614332|NCT01023542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614333|NCT01023607|Atorvastatin|atorvastatin|mesh-list
24614334|NCT01023607|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24614335|NCT01023607|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24614336|NCT01023607|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24614339|NCT01023607|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24614341|NCT01023607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711462|NCT01515371|Cholinergic Agents|cholinergic agents|mesh-ancestor
24711463|NCT01515371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24711464|NCT01515397|Polygeline|polygeline|mesh-list
24711465|NCT01515397|Plasma Substitutes|plasma substitutes|mesh-ancestor
24711466|NCT01515397|Blood Substitutes|blood substitutes|mesh-ancestor
24711467|NCT01515553|Liraglutide|liraglutide|mesh-list
24711468|NCT01515553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24711469|NCT01515553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711470|NCT01515553|Incretins|incretins|mesh-ancestor
25713063|NCT02333045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25713064|NCT02333045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770899|NCT03572972|Apixaban|apixaban|mesh-list
24711471|NCT01515553|Hormones|hormones|mesh-ancestor
24711472|NCT01515553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24711473|NCT01515579|Liraglutide|liraglutide|mesh-list
25713065|NCT02333045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713066|NCT02333045|Antiviral Agents|antiviral agents|mesh-ancestor
24711476|NCT01515579|Incretins|incretins|mesh-ancestor
24711478|NCT01515579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24711479|NCT01515592|Liraglutide|liraglutide|mesh-list
24711480|NCT01515592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24711482|NCT01515592|Incretins|incretins|mesh-ancestor
24711486|NCT01515683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24711487|NCT01515683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711488|NCT01515774|Pramipexole|pramipexole|mesh-list
24711490|NCT01515774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711491|NCT01515774|Protective Agents|protective agents|mesh-ancestor
24711492|NCT01515774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711493|NCT01515774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24711494|NCT01515774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24711495|NCT01515774|Dopamine Agonists|dopamine agonists|mesh-ancestor
24711574|NCT01515839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24711575|NCT01515839|Expectorants|expectorants|mesh-ancestor
24711576|NCT01515839|Respiratory System Agents|respiratory system agents|mesh-ancestor
24711577|NCT01515839|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24711578|NCT01515839|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24711579|NCT01515839|Vasodilator Agents|vasodilator agents|mesh-ancestor
24711580|NCT01515852|Anesthetics|anesthetics|mesh-list
24711581|NCT01515852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24711582|NCT01515852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712992|NCT01523431|Vitamins|vitamins|mesh-ancestor
24711583|NCT01515917|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
24711584|NCT01515917|Nootropic Agents|nootropic agents|mesh-ancestor
24711585|NCT01515969|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24711586|NCT01515969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24711587|NCT01515969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24711588|NCT01515969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711589|NCT01515969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711614|NCT01516255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24711636|NCT01516450|Belimumab|belimumab|mesh-list
24711687|NCT01516580|Immunologic Factors|immunologic factors|mesh-ancestor
24711688|NCT01516580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24711689|NCT01516580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24711690|NCT01516580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24711691|NCT01516580|Alkylating Agents|alkylating agents|mesh-ancestor
24711692|NCT01516580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711693|NCT01516580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24711694|NCT01516580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24712044|NCT01518231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24711695|NCT01516580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24711696|NCT01516580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24711697|NCT01516580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24614378|NCT01024075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24614379|NCT01024075|Antiemetics|antiemetics|mesh-ancestor
24614380|NCT01024075|Autonomic Agents|autonomic agents|mesh-ancestor
24614420|NCT01024205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614421|NCT01024205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24614422|NCT01024205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24614423|NCT01024205|Growth Substances|growth substances|mesh-ancestor
24614424|NCT01024205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614425|NCT01024205|Growth Inhibitors|growth inhibitors|mesh-ancestor
24614426|NCT01024205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24614427|NCT01024205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24614428|NCT01024205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614429|NCT01024270|Misoprostol|misoprostol|mesh-list
24614430|NCT01024270|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25713067|NCT02333045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25713068|NCT02333045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25713069|NCT02333045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25713070|NCT02333045|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25713071|NCT02333045|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25713072|NCT02333045|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
25770900|NCT03572972|Anticoagulants|anticoagulants|mesh-ancestor
25770901|NCT03572972|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25770902|NCT03572972|Antithrombins|antithrombins|mesh-ancestor
25770903|NCT03572972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24711829|NCT01517321|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24711830|NCT01517321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24897701|NCT04423185|Vemurafenib|vemurafenib|mesh-list
24711834|NCT01517321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24711835|NCT01517321|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24711836|NCT01517321|Protease Inhibitors|protease inhibitors|mesh-ancestor
24711837|NCT01517321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24711838|NCT01517321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711953|NCT01517828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24711954|NCT01517828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24711955|NCT01517828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24711956|NCT01517828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24711957|NCT01517828|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24711958|NCT01517828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24711959|NCT01517828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24711960|NCT01517828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24711961|NCT01517828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24711962|NCT01517828|GABA Modulators|gaba modulators|mesh-ancestor
24712011|NCT01518166|Lisinopril|lisinopril|mesh-list
24712012|NCT01518166|Atorvastatin|atorvastatin|mesh-list
24712013|NCT01518166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24712014|NCT01518166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24712015|NCT01518166|Antimetabolites|antimetabolites|mesh-ancestor
24712030|NCT01518166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24712031|NCT01518166|Antifungal Agents|antifungal agents|mesh-ancestor
24712032|NCT01518166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24712033|NCT01518231|Aspirin|aspirin|mesh-list
24712034|NCT01518231|Edaravone|edaravone|mesh-list
24712035|NCT01518231|Warfarin|warfarin|mesh-list
24712036|NCT01518231|Atorvastatin|atorvastatin|mesh-list
24712037|NCT01518231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24712038|NCT01518231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24712039|NCT01518231|Analgesics|analgesics|mesh-ancestor
24712040|NCT01518231|Sensory System Agents|sensory system agents|mesh-ancestor
24712041|NCT01518231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24712042|NCT01518231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712043|NCT01518231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24712046|NCT01518231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24712047|NCT01518231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712048|NCT01518231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24712049|NCT01518231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24712131|NCT01518634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712133|NCT01518712|Canagliflozin|canagliflozin|mesh-list
24712134|NCT01518712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24712135|NCT01518712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712136|NCT01518712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24897515|NCT04425226|Pembrolizumab|pembrolizumab|mesh-list
24712137|NCT01518712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712138|NCT01518725|Vitamin D|vitamin d|mesh-list
24712139|NCT01518725|Cholecalciferol|cholecalciferol|mesh-list
24614461|NCT01024322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24614462|NCT01024322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25713073|NCT02333383|Adalimumab|adalimumab|mesh-list
25713074|NCT02333383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25713075|NCT02333383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25713076|NCT02334059|Ketamine|ketamine|mesh-list
25713077|NCT02334059|Analgesics|analgesics|mesh-ancestor
25713078|NCT02334059|Sensory System Agents|sensory system agents|mesh-ancestor
25713079|NCT02334059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713080|NCT02334059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713081|NCT02334059|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25713082|NCT02334059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25713083|NCT02334059|Anesthetics, General|anesthetics, general|mesh-ancestor
25713084|NCT02334059|Anesthetics|anesthetics|mesh-ancestor
25713085|NCT02334059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24614494|NCT01024491|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24614495|NCT01024491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24614497|NCT01024504|Bevacizumab|bevacizumab|mesh-list
24614498|NCT01024504|Capecitabine|capecitabine|mesh-list
24614499|NCT01024504|Oxaliplatin|oxaliplatin|mesh-list
24614500|NCT01024504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24614501|NCT01024504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24614502|NCT01024504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24614503|NCT01024504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24614504|NCT01024504|Growth Substances|growth substances|mesh-ancestor
24614505|NCT01024504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614506|NCT01024504|Growth Inhibitors|growth inhibitors|mesh-ancestor
24614507|NCT01024504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24614508|NCT01024504|Antimetabolites|antimetabolites|mesh-ancestor
24614509|NCT01024504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614511|NCT01024543|Oxymetazoline|oxymetazoline|mesh-list
24614512|NCT01024543|Angiotensin II|angiotensin ii|mesh-list
24614513|NCT01024543|Giapreza|giapreza|mesh-list
24614514|NCT01024543|Angiotensinogen|angiotensinogen|mesh-list
24712143|NCT01518725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24712145|NCT01518790|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24712175|NCT01518998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24712176|NCT01518998|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24712177|NCT01518998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24712178|NCT01518998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712233|NCT01519297|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24712234|NCT01519297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712235|NCT01519310|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24712236|NCT01519310|Metronidazole|metronidazole|mesh-list
24712237|NCT01519310|Ciprofloxacin|ciprofloxacin|mesh-list
24712238|NCT01519310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24712239|NCT01519310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24712240|NCT01519310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24712241|NCT01519310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24712242|NCT01519310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24712243|NCT01519310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24712244|NCT01519310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712300|NCT01519687|Antidepressive Agents|antidepressive agents|mesh-ancestor
24712301|NCT01519687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24712303|NCT01519726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24712304|NCT01519726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24712307|NCT01519726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24712339|NCT01520012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24712340|NCT01520012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712341|NCT01520025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24712342|NCT01520025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24712343|NCT01520025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713086|NCT02334059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25713087|NCT02334059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25713088|NCT02334059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25713089|NCT02334059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713090|NCT02334215|Methadone|methadone|mesh-list
25713091|NCT02334215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25713092|NCT02334215|Narcotics|narcotics|mesh-ancestor
24516813|NCT00603785|Omalizumab|omalizumab|mesh-list
24712344|NCT01520077|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
25713093|NCT02334215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24712346|NCT01520077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24897702|NCT04423185|Crizotinib|crizotinib|mesh-list
24712464|NCT01520766|Sympathomimetics|sympathomimetics|mesh-ancestor
24712465|NCT01520766|Autonomic Agents|autonomic agents|mesh-ancestor
24712466|NCT01520766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24712467|NCT01520766|Dopamine Agents|dopamine agents|mesh-ancestor
24712468|NCT01520766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24712469|NCT01520766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712470|NCT01520766|Adrenergic Agents|adrenergic agents|mesh-ancestor
24712471|NCT01520766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24712472|NCT01520766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24712567|NCT01521455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24712568|NCT01521455|Sympathomimetics|sympathomimetics|mesh-ancestor
24712570|NCT01521481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24712571|NCT01521481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712572|NCT01521520|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
24712573|NCT01521520|Hematinics|hematinics|mesh-ancestor
24712574|NCT01521520|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24712575|NCT01521520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24712576|NCT01521572|Albuterol|albuterol|mesh-list
24712577|NCT01521572|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24712578|NCT01521572|Autonomic Agents|autonomic agents|mesh-ancestor
24712579|NCT01521572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24712580|NCT01521572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712635|NCT01521962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24712636|NCT01521962|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24712637|NCT01521962|Protease Inhibitors|protease inhibitors|mesh-ancestor
24712638|NCT01521962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24712639|NCT01521962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712640|NCT01521975|Adefovir|adefovir|mesh-list
24712641|NCT01521975|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
24712642|NCT01521975|Telbivudine|telbivudine|mesh-list
24712643|NCT01521975|Antiviral Agents|antiviral agents|mesh-ancestor
24712644|NCT01521975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24712645|NCT01521975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24712646|NCT01521975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24712647|NCT01521975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24712650|NCT01522040|Analgesics|analgesics|mesh-ancestor
24712702|NCT01522378|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24712703|NCT01522534|Morphine|morphine|mesh-list
24712704|NCT01522534|Mepivacaine|mepivacaine|mesh-list
24712705|NCT01522534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24712706|NCT01522534|Narcotics|narcotics|mesh-ancestor
24712707|NCT01522534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25713094|NCT02334215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713095|NCT02334215|Analgesics|analgesics|mesh-ancestor
25713096|NCT02334215|Sensory System Agents|sensory system agents|mesh-ancestor
25713097|NCT02334215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713098|NCT02334215|Antitussive Agents|antitussive agents|mesh-ancestor
25713099|NCT02334215|Respiratory System Agents|respiratory system agents|mesh-ancestor
25713100|NCT02334384|Anti-Infective Agents|anti-infective agents|mesh-list
25713101|NCT02334384|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25713102|NCT02334423|Botulinum Toxins|botulinum toxins|mesh-list
25713103|NCT02334423|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25713104|NCT02334423|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25713105|NCT02334423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25713106|NCT02334423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24712708|NCT01522534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712710|NCT01522534|Sensory System Agents|sensory system agents|mesh-ancestor
24712719|NCT01522547|Growth Substances|growth substances|mesh-ancestor
24712720|NCT01522547|Growth Inhibitors|growth inhibitors|mesh-ancestor
24712721|NCT01522547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24712723|NCT01522612|Fluorouracil|fluorouracil|mesh-list
24712724|NCT01522612|Cetuximab|cetuximab|mesh-list
24712725|NCT01522612|Antimetabolites|antimetabolites|mesh-ancestor
24645498|NCT01198392|Cisplatin|cisplatin|mesh-list
24712813|NCT01522989|Fluorouracil|fluorouracil|mesh-list
24712814|NCT01522989|Oxaliplatin|oxaliplatin|mesh-list
24499163|NCT00518141|Aspirin|aspirin|mesh-list
24712815|NCT01522989|Palbociclib|palbociclib|mesh-list
24712838|NCT01523002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24712839|NCT01523002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712840|NCT01523002|Antimalarials|antimalarials|mesh-ancestor
24712841|NCT01523002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24712845|NCT01523002|Antiviral Agents|antiviral agents|mesh-ancestor
24712884|NCT01523067|Vasodilator Agents|vasodilator agents|mesh-ancestor
24712885|NCT01523080|Acetaminophen|acetaminophen|mesh-list
24712886|NCT01523080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24712887|NCT01523080|Analgesics|analgesics|mesh-ancestor
24712888|NCT01523080|Sensory System Agents|sensory system agents|mesh-ancestor
24712889|NCT01523080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24712890|NCT01523080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712891|NCT01523080|Antipyretics|antipyretics|mesh-ancestor
24712892|NCT01523093|Ondansetron|ondansetron|mesh-list
24712893|NCT01523093|Antiemetics|antiemetics|mesh-ancestor
24712894|NCT01523093|Autonomic Agents|autonomic agents|mesh-ancestor
24712895|NCT01523093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24712896|NCT01523093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24712897|NCT01523093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24712899|NCT01523093|Dermatologic Agents|dermatologic agents|mesh-ancestor
24712966|NCT01523379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24712968|NCT01523418|Rivaroxaban|rivaroxaban|mesh-list
24712969|NCT01523418|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24712970|NCT01523418|Antithrombins|antithrombins|mesh-ancestor
24712971|NCT01523418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24712972|NCT01523418|Protease Inhibitors|protease inhibitors|mesh-ancestor
24712973|NCT01523418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24712974|NCT01523418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712975|NCT01523418|Anticoagulants|anticoagulants|mesh-ancestor
24712976|NCT01523431|Leucovorin|leucovorin|mesh-list
24712977|NCT01523431|Fluorouracil|fluorouracil|mesh-list
24712978|NCT01523431|Irinotecan|irinotecan|mesh-list
24712979|NCT01523431|Antimetabolites|antimetabolites|mesh-ancestor
24712980|NCT01523431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24712981|NCT01523431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24713090|NCT01524081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24713091|NCT01524081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713092|NCT01524081|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24713093|NCT01524081|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24713094|NCT01524081|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24713095|NCT01524094|Leucovorin|leucovorin|mesh-list
24713096|NCT01524094|Fluorouracil|fluorouracil|mesh-list
24713097|NCT01524094|Oxaliplatin|oxaliplatin|mesh-list
24713098|NCT01524094|Levoleucovorin|levoleucovorin|mesh-list
24713099|NCT01524094|Antimetabolites|antimetabolites|mesh-ancestor
24713100|NCT01524094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713101|NCT01524094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24713129|NCT01524315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713130|NCT01524354|Anesthetics|anesthetics|mesh-list
24713138|NCT01524367|Analgesics|analgesics|mesh-ancestor
24713209|NCT01524705|Insulin Glargine|insulin glargine|mesh-list
24713247|NCT01524744|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24713248|NCT01524744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24713249|NCT01524744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713250|NCT01524757|Pantoprazole|pantoprazole|mesh-list
24713251|NCT01524757|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24713252|NCT01524757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24713253|NCT01524757|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24713255|NCT01524757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713257|NCT01524809|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24713258|NCT01524809|Insulin Aspart|insulin aspart|mesh-list
24713259|NCT01524809|Insulin, Long-Acting|insulin, long-acting|mesh-list
24713310|NCT01525290|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24713311|NCT01525290|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24713312|NCT01525290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24713313|NCT01525290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713314|NCT01525394|Moxifloxacin|moxifloxacin|mesh-list
24713315|NCT01525394|Lenvatinib|lenvatinib|mesh-list
24713316|NCT01525394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24713317|NCT01525394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24713318|NCT01525394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24713319|NCT01525394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24713320|NCT01525394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24713321|NCT01525394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713322|NCT01525394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24713383|NCT01525914|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24713476|NCT01526161|Adrenergic Agents|adrenergic agents|mesh-ancestor
24713477|NCT01526161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24713478|NCT01526161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713479|NCT01526161|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24713480|NCT01526161|Hormone Antagonists|hormone antagonists|mesh-ancestor
24713481|NCT01526161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24713482|NCT01526161|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24713483|NCT01526161|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24713484|NCT01526174|Golimumab|golimumab|mesh-list
24713485|NCT01526174|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24713486|NCT01526174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24713500|NCT01526278|Vitamins|vitamins|mesh-ancestor
24713596|NCT01526616|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24713597|NCT01526616|Diuretics|diuretics|mesh-ancestor
24713598|NCT01526616|Natriuretic Agents|natriuretic agents|mesh-ancestor
24713599|NCT01526694|Thalidomide|thalidomide|mesh-list
24713600|NCT01526694|Dexamethasone|dexamethasone|mesh-list
24713601|NCT01526694|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24713602|NCT01526694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24713603|NCT01526694|Antiemetics|antiemetics|mesh-ancestor
24713604|NCT01526694|Autonomic Agents|autonomic agents|mesh-ancestor
24713605|NCT01526694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24713606|NCT01526694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713607|NCT01526694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24713647|NCT01526850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24713649|NCT01526876|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24713650|NCT01526876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24715901|NCT01538927|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
24713651|NCT01526876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713652|NCT01526876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24713653|NCT01526876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713668|NCT01526980|Biphasic Insulins|biphasic insulins|mesh-list
24713678|NCT01527019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24713679|NCT01527019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713680|NCT01527019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24713808|NCT01527630|Insulin Aspart|insulin aspart|mesh-list
24713809|NCT01527630|Biphasic Insulins|biphasic insulins|mesh-list
24713810|NCT01527630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24713811|NCT01527630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713812|NCT01527643|Insulin Aspart|insulin aspart|mesh-list
24713813|NCT01527643|Biphasic Insulins|biphasic insulins|mesh-list
24713814|NCT01527643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24713815|NCT01527643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713918|NCT01528007|Naltrexone|naltrexone|mesh-list
24713919|NCT01528007|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24713920|NCT01528007|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24713921|NCT01528007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24713945|NCT01528176|Vitamin D|vitamin d|mesh-list
24713964|NCT01528371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24713965|NCT01528371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24713966|NCT01528501|Panobinostat|panobinostat|mesh-list
24714382|NCT01530386|Lacosamide|lacosamide|mesh-list
24714425|NCT01530542|Sensory System Agents|sensory system agents|mesh-ancestor
24714426|NCT01530542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24714427|NCT01530555|Thymoglobulin|thymoglobulin|mesh-list
24714428|NCT01530555|Immunologic Factors|immunologic factors|mesh-ancestor
25770904|NCT03572972|Protease Inhibitors|protease inhibitors|mesh-ancestor
24714429|NCT01530555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24714430|NCT01530555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24714431|NCT01530594|Lenalidomide|lenalidomide|mesh-list
24714432|NCT01530594|Bortezomib|bortezomib|mesh-list
24714441|NCT01530607|Goserelin|goserelin|mesh-list
24714703|NCT01532076|Hemostatics|hemostatics|mesh-ancestor
24714704|NCT01532076|Coagulants|coagulants|mesh-ancestor
24714705|NCT01532102|Antiviral Agents|antiviral agents|mesh-list
24714706|NCT01532102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24714707|NCT01532115|Moxifloxacin|moxifloxacin|mesh-list
24714708|NCT01532115|Opicapone|opicapone|mesh-list
24714748|NCT01532544|Tinzaparin|tinzaparin|mesh-list
24714749|NCT01532544|Dalteparin|dalteparin|mesh-list
24714750|NCT01532544|Eptifibatide|eptifibatide|mesh-list
24714751|NCT01532544|Anticoagulants|anticoagulants|mesh-ancestor
24714752|NCT01532544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24714753|NCT01532544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24714754|NCT01532544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715075|NCT01534312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24715102|NCT01534455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715103|NCT01534455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715105|NCT01534494|Hallucinogens|hallucinogens|mesh-ancestor
24715106|NCT01534494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24614795|NCT01026363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614797|NCT01026376|Decitabine|decitabine|mesh-list
24715373|NCT01536132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24715374|NCT01536132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24715375|NCT01536132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24715376|NCT01536132|Protective Agents|protective agents|mesh-ancestor
24715377|NCT01536132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715378|NCT01536158|Acetaminophen|acetaminophen|mesh-list
24715657|NCT01537861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24715658|NCT01537861|Immunologic Factors|immunologic factors|mesh-ancestor
24715659|NCT01537861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715660|NCT01537861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24715661|NCT01537861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24715667|NCT01537861|Antiemetics|antiemetics|mesh-ancestor
24715898|NCT01538901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24715899|NCT01538901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24715900|NCT01538901|Interferon Inducers|interferon inducers|mesh-ancestor
24715902|NCT01538927|Hemostatics|hemostatics|mesh-ancestor
24715903|NCT01538927|Coagulants|coagulants|mesh-ancestor
24715904|NCT01538940|Vaccines|vaccines|mesh-list
24715905|NCT01538940|Immunologic Factors|immunologic factors|mesh-ancestor
24715907|NCT01538953|Sodium Hypochlorite|sodium hypochlorite|mesh-list
24614976|NCT01027117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24614977|NCT01027117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24614978|NCT01027117|Urological Agents|urological agents|mesh-ancestor
24614979|NCT01027182|Raltegravir Potassium|raltegravir potassium|mesh-list
24614980|NCT01027182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24614981|NCT01027182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24614982|NCT01027182|Antiviral Agents|antiviral agents|mesh-ancestor
24614983|NCT01027182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24614984|NCT01027182|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24614993|NCT01027429|Penicillin G Procaine|penicillin g procaine|mesh-list
24614995|NCT01027429|Penicillin G Benzathine|penicillin g benzathine|mesh-list
24716207|NCT01540708|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24716208|NCT01540708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24716209|NCT01540708|Autonomic Agents|autonomic agents|mesh-ancestor
24615010|NCT01027481|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24615011|NCT01027481|Growth Substances|growth substances|mesh-ancestor
24615012|NCT01027481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24615013|NCT01027481|Growth Inhibitors|growth inhibitors|mesh-ancestor
24615014|NCT01027481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24716574|NCT01542450|Insulin, Isophane|insulin, isophane|mesh-list
24716575|NCT01542450|Isophane insulin, beef|isophane insulin, beef|mesh-list
24716576|NCT01542450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24716577|NCT01542450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716578|NCT01542463|Insulin Detemir|insulin detemir|mesh-list
24716579|NCT01542463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24716581|NCT01542476|Insulin Detemir|insulin detemir|mesh-list
25770905|NCT03572972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770906|NCT03572972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770907|NCT03573323|Ixekizumab|ixekizumab|mesh-list
25770908|NCT03573323|Dermatologic Agents|dermatologic agents|mesh-ancestor
25770909|NCT03573908|Linaclotide|linaclotide|mesh-list
24716910|NCT01544634|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24716911|NCT01544634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24716912|NCT01544634|Adrenergic Agents|adrenergic agents|mesh-ancestor
24716913|NCT01544634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24716914|NCT01544634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24716915|NCT01544634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24716916|NCT01544634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24716917|NCT01544634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24716918|NCT01544634|Vasodilator Agents|vasodilator agents|mesh-ancestor
24716993|NCT01544907|Paclitaxel|paclitaxel|mesh-list
24717444|NCT01548066|GABA Agents|gaba agents|mesh-ancestor
24717445|NCT01548066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24717446|NCT01548066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717447|NCT01548066|Antimanic Agents|antimanic agents|mesh-ancestor
24717519|NCT01548274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24717520|NCT01548274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24717521|NCT01548274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24717522|NCT01548274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24717523|NCT01548274|Serotonin Agents|serotonin agents|mesh-ancestor
24717934|NCT01551069|Hydroxychloroquine|hydroxychloroquine|mesh-list
24717935|NCT01551069|Antimalarials|antimalarials|mesh-ancestor
24717942|NCT01551147|Montelukast|montelukast|mesh-list
24717948|NCT01551147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24717949|NCT01551147|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24718005|NCT01551459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718006|NCT01551459|Growth Inhibitors|growth inhibitors|mesh-ancestor
24718007|NCT01551459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24718008|NCT01551459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718009|NCT01551459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24718010|NCT01551459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24718011|NCT01551459|Alkylating Agents|alkylating agents|mesh-ancestor
24718013|NCT01551485|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24718414|NCT01554852|Autonomic Agents|autonomic agents|mesh-ancestor
24718415|NCT01554852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24718416|NCT01554852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24718417|NCT01554852|Glucocorticoids|glucocorticoids|mesh-ancestor
24718419|NCT01554852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24718420|NCT01554852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24718421|NCT01554852|Protease Inhibitors|protease inhibitors|mesh-ancestor
24718422|NCT01554852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24718423|NCT01554852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24718424|NCT01554852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24718425|NCT01554852|Growth Substances|growth substances|mesh-ancestor
24718426|NCT01554852|Growth Inhibitors|growth inhibitors|mesh-ancestor
24718802|NCT01557270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24718803|NCT01557270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24718804|NCT01557270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24718805|NCT01557270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24718806|NCT01557270|Analgesics|analgesics|mesh-ancestor
24718807|NCT01557270|Sensory System Agents|sensory system agents|mesh-ancestor
24718810|NCT01557270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24615249|NCT01028508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719019|NCT01558622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24719020|NCT01558622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24719025|NCT01558713|Fentanyl|fentanyl|mesh-list
24719232|NCT01560052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24719233|NCT01560052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24719234|NCT01560052|Protective Agents|protective agents|mesh-ancestor
24719235|NCT01560052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24719236|NCT01560052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719237|NCT01560065|Folic Acid|folic acid|mesh-list
24719238|NCT01560065|Vitamin B Complex|vitamin b complex|mesh-list
24719239|NCT01560065|Inositol|inositol|mesh-list
24719240|NCT01560065|Hematinics|hematinics|mesh-ancestor
24719281|NCT01560390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719282|NCT01560390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24719283|NCT01560390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24719284|NCT01560390|Anesthetics, General|anesthetics, general|mesh-ancestor
24719285|NCT01560390|Anesthetics|anesthetics|mesh-ancestor
24719286|NCT01560390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24646071|NCT01201694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24719575|NCT01562561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24719577|NCT01562626|Flucytosine|flucytosine|mesh-list
24615274|NCT01028547|Glucocorticoids|glucocorticoids|mesh-ancestor
24615275|NCT01028547|Hormones|hormones|mesh-ancestor
24615276|NCT01028547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24615277|NCT01028547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24615278|NCT01028547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24719921|NCT01564979|Cholinergic Agents|cholinergic agents|mesh-ancestor
24719922|NCT01564979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24719923|NCT01564979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24719924|NCT01564979|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24719925|NCT01564979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24719927|NCT01565018|Dopamine Agonists|dopamine agonists|mesh-ancestor
24719928|NCT01565018|Dopamine Agents|dopamine agents|mesh-ancestor
24719929|NCT01565018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24719930|NCT01565018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24719934|NCT01565096|Vildagliptin|vildagliptin|mesh-list
24615335|NCT01028950|Darexaban|darexaban|mesh-list
24720104|NCT01566474|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24720105|NCT01566474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720106|NCT01566487|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24720107|NCT01566487|Antidepressive Agents|antidepressive agents|mesh-ancestor
24720456|NCT01568632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24720459|NCT01568645|Imatinib Mesylate|imatinib mesylate|mesh-list
24720532|NCT01569048|Sensory System Agents|sensory system agents|mesh-ancestor
24615438|NCT01029743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24615439|NCT01029743|Antithrombins|antithrombins|mesh-ancestor
24615487|NCT01030016|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24615489|NCT01030042|Oxaliplatin|oxaliplatin|mesh-list
24615490|NCT01030042|Irinotecan|irinotecan|mesh-list
24720978|NCT01571791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24721284|NCT01572961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721285|NCT01572961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24721286|NCT01572961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24721287|NCT01572961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24721288|NCT01572961|Antipyretics|antipyretics|mesh-ancestor
24508542|NCT00556127|Prednisone|prednisone|mesh-list
24721290|NCT01573013|Trace Elements|trace elements|mesh-ancestor
24721291|NCT01573013|Micronutrients|micronutrients|mesh-ancestor
24721292|NCT01573013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721293|NCT01573143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24721294|NCT01573143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24721296|NCT01573143|Antimetabolites|antimetabolites|mesh-ancestor
24721301|NCT01573286|Glucagon|glucagon|mesh-list
24721363|NCT01573663|Respiratory System Agents|respiratory system agents|mesh-ancestor
24721364|NCT01573663|Antitussive Agents|antitussive agents|mesh-ancestor
24721436|NCT01574027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24721437|NCT01574027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24721439|NCT01574092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24721440|NCT01574092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24721441|NCT01574092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24721442|NCT01574092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24721443|NCT01574092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721444|NCT01574131|Fenofibrate|fenofibrate|mesh-list
25713107|NCT02334423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713108|NCT02334423|Cholinergic Agents|cholinergic agents|mesh-ancestor
25713109|NCT02334423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24721445|NCT01574131|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24721446|NCT01574131|Antimetabolites|antimetabolites|mesh-ancestor
24721447|NCT01574131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721448|NCT01574131|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24721464|NCT01574313|Vitamins|vitamins|mesh-ancestor
24721676|NCT01576315|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24721677|NCT01576315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24721678|NCT01576315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24721679|NCT01576315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721680|NCT01576315|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24721681|NCT01576315|Hormone Antagonists|hormone antagonists|mesh-ancestor
24721682|NCT01576315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24721683|NCT01576315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721684|NCT01576315|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24721685|NCT01576354|4-Aminopyridine|4-aminopyridine|mesh-list
24721686|NCT01576354|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24721687|NCT01576354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24721688|NCT01576354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721689|NCT01576419|Celecoxib|celecoxib|mesh-list
24721690|NCT01576419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24721730|NCT01576679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24721731|NCT01576679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24721732|NCT01576692|Aldesleukin|aldesleukin|mesh-list
24721734|NCT01576692|Immunoglobulins|immunoglobulins|mesh-list
24721735|NCT01576692|Sargramostim|sargramostim|mesh-list
24721736|NCT01576692|Immunologic Factors|immunologic factors|mesh-ancestor
24721737|NCT01576692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721738|NCT01576692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24721739|NCT01576692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24721787|NCT01577017|Hormone Antagonists|hormone antagonists|mesh-ancestor
24721788|NCT01577017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24721789|NCT01577017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24721806|NCT01577121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24721807|NCT01577121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24721808|NCT01577121|Gout Suppressants|gout suppressants|mesh-ancestor
24721809|NCT01577121|Tocolytic Agents|tocolytic agents|mesh-ancestor
24721810|NCT01577121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24721811|NCT01577121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24721812|NCT01577121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722111|NCT01578564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24722112|NCT01578564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722113|NCT01578564|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24722114|NCT01578564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24722116|NCT01578603|Caseins|caseins|mesh-list
24615630|NCT01030796|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24615631|NCT01030796|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24615632|NCT01030796|Purinergic Agents|purinergic agents|mesh-ancestor
24615634|NCT01030900|Rituximab|rituximab|mesh-list
24722419|NCT01580202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722420|NCT01580202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615693|NCT01031355|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24722614|NCT01581788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24722615|NCT01581788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24722616|NCT01581814|Metformin|metformin|mesh-list
24723733|NCT01588912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24722621|NCT01581814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24722622|NCT01581814|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24722623|NCT01581814|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24722630|NCT01581853|Ritonavir|ritonavir|mesh-list
25713110|NCT02334423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713111|NCT02334423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25713112|NCT02334423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713113|NCT02334436|Botulinum Toxins|botulinum toxins|mesh-list
25713114|NCT02334436|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25713115|NCT02334436|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24722647|NCT01581866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24722654|NCT01581866|Dopamine Agents|dopamine agents|mesh-ancestor
24723052|NCT01584492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24723053|NCT01584492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723054|NCT01584492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24723055|NCT01584492|Glucocorticoids|glucocorticoids|mesh-ancestor
24723056|NCT01584492|Hormones|hormones|mesh-ancestor
24723057|NCT01584492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24723058|NCT01584492|Tocolytic Agents|tocolytic agents|mesh-ancestor
24723059|NCT01584492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24723060|NCT01584557|Tolvaptan|tolvaptan|mesh-list
24723061|NCT01584557|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24723063|NCT01584557|Natriuretic Agents|natriuretic agents|mesh-ancestor
24723112|NCT01584921|Hematinics|hematinics|mesh-ancestor
24723113|NCT01584934|Sodium Oxybate|sodium oxybate|mesh-list
24723114|NCT01584934|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24723115|NCT01584934|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24723116|NCT01584934|Anesthetics, General|anesthetics, general|mesh-ancestor
24723137|NCT01585350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723138|NCT01585350|Interferon Inducers|interferon inducers|mesh-ancestor
24723139|NCT01585402|Etidronic Acid|etidronic acid|mesh-list
24723140|NCT01585402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24723141|NCT01585402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723289|NCT01586442|Hormone Antagonists|hormone antagonists|mesh-ancestor
24723290|NCT01586442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24723291|NCT01586442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723292|NCT01586442|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24723293|NCT01586442|Diuretics|diuretics|mesh-ancestor
24723294|NCT01586442|Natriuretic Agents|natriuretic agents|mesh-ancestor
24723375|NCT01587222|Midodrine|midodrine|mesh-list
24723376|NCT01587222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24723377|NCT01587222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24723378|NCT01587222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24723379|NCT01587222|Sympathomimetics|sympathomimetics|mesh-ancestor
24723380|NCT01587222|Autonomic Agents|autonomic agents|mesh-ancestor
24723381|NCT01587222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24723382|NCT01587222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723402|NCT01587313|Diuretics|diuretics|mesh-ancestor
24723682|NCT01588795|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24723684|NCT01588795|Micronutrients|micronutrients|mesh-ancestor
24723685|NCT01588795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723686|NCT01588795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24723687|NCT01588795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24723721|NCT01588873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24723722|NCT01588873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24723723|NCT01588873|Progestins|progestins|mesh-ancestor
24723724|NCT01588873|Hormones|hormones|mesh-ancestor
24723726|NCT01588912|Tenofovir|tenofovir|mesh-list
24723727|NCT01588912|Entecavir|entecavir|mesh-list
24723731|NCT01588912|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24723732|NCT01588912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24723735|NCT01588912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24723921|NCT01589809|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24723922|NCT01589809|Vasodilator Agents|vasodilator agents|mesh-ancestor
24723923|NCT01589861|Lapatinib|lapatinib|mesh-list
24723924|NCT01589861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24723925|NCT01589861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24723969|NCT01590303|Vitamins|vitamins|mesh-ancestor
24723970|NCT01590303|Micronutrients|micronutrients|mesh-ancestor
24723971|NCT01590303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24723972|NCT01590303|Antioxidants|antioxidants|mesh-ancestor
24723973|NCT01590303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24723974|NCT01590303|Protective Agents|protective agents|mesh-ancestor
24723975|NCT01590342|Diclofenac|diclofenac|mesh-list
24723976|NCT01590342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24723977|NCT01590342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24724024|NCT01590732|Ifosfamide|ifosfamide|mesh-list
24615817|NCT01032057|Capecitabine|capecitabine|mesh-list
24724289|NCT01592162|Remifentanil|remifentanil|mesh-list
24724291|NCT01592162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24724292|NCT01592162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24724294|NCT01592162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24615885|NCT01032213|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24615887|NCT01032304|Expectorants|expectorants|mesh-ancestor
24615888|NCT01032304|Respiratory System Agents|respiratory system agents|mesh-ancestor
24615889|NCT01032434|Sertraline|sertraline|mesh-list
24615890|NCT01032434|Antidepressive Agents|antidepressive agents|mesh-ancestor
24724387|NCT01592318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24724754|NCT01594502|Dutasteride|dutasteride|mesh-list
24724755|NCT01594502|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24724756|NCT01594502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24724757|NCT01594502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724758|NCT01594502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724759|NCT01594502|Hormone Antagonists|hormone antagonists|mesh-ancestor
24647905|NCT01211327|Antiemetics|antiemetics|mesh-ancestor
24724760|NCT01594502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24724761|NCT01594502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724763|NCT01594619|Naloxegol|naloxegol|mesh-list
24724764|NCT01594619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24724765|NCT01594619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24724766|NCT01594619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24724767|NCT01594619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724830|NCT01594918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24724831|NCT01594918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724832|NCT01594918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24724834|NCT01594918|Analgesics|analgesics|mesh-ancestor
24724835|NCT01594918|Sensory System Agents|sensory system agents|mesh-ancestor
24724836|NCT01594918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24724837|NCT01594918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24724838|NCT01594918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24724839|NCT01594918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724840|NCT01594918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24724841|NCT01595009|Everolimus|everolimus|mesh-list
24615938|NCT01033084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24615939|NCT01033084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615940|NCT01033084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24512589|NCT00575835|Vitamin D|vitamin d|mesh-list
24724981|NCT01595893|Micronutrients|micronutrients|mesh-ancestor
24724982|NCT01595893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24724983|NCT01595893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24724984|NCT01595893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24724985|NCT01595958|Cyclosporine|cyclosporine|mesh-list
24724986|NCT01595958|Cyclosporins|cyclosporins|mesh-list
24724987|NCT01595958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24724989|NCT01595958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24725075|NCT01596296|Oxytocics|oxytocics|mesh-ancestor
24725076|NCT01596296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24725077|NCT01596296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725078|NCT01596387|Propofol|propofol|mesh-list
24725079|NCT01596387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24725080|NCT01596387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24725081|NCT01596387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725082|NCT01596387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24725160|NCT01596647|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24725162|NCT01596647|Purinergic Agents|purinergic agents|mesh-ancestor
24725163|NCT01596647|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24725164|NCT01596647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24725165|NCT01596647|Analgesics|analgesics|mesh-ancestor
24725166|NCT01596647|Sensory System Agents|sensory system agents|mesh-ancestor
24725251|NCT01596868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725252|NCT01596868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24725253|NCT01596868|Immunologic Factors|immunologic factors|mesh-ancestor
24725254|NCT01596868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725255|NCT01596868|Tubulin Modulators|tubulin modulators|mesh-ancestor
24725256|NCT01596868|Antimitotic Agents|antimitotic agents|mesh-ancestor
24725257|NCT01596868|Mitosis Modulators|mitosis modulators|mesh-ancestor
24725258|NCT01596894|Azithromycin|azithromycin|mesh-list
24725259|NCT01596894|Metronidazole|metronidazole|mesh-list
24725289|NCT01596998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24725290|NCT01596998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24725291|NCT01596998|Adrenergic Agents|adrenergic agents|mesh-ancestor
24725292|NCT01596998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24725293|NCT01596998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725294|NCT01596998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725295|NCT01596998|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24725297|NCT01596998|Autonomic Agents|autonomic agents|mesh-ancestor
24725377|NCT01597518|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24725378|NCT01597518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24725379|NCT01597518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725380|NCT01597518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725381|NCT01597518|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24725382|NCT01597518|Protective Agents|protective agents|mesh-ancestor
24725383|NCT01597531|Liraglutide|liraglutide|mesh-list
24725384|NCT01597531|Orlistat|orlistat|mesh-list
24725385|NCT01597531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24725386|NCT01597531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725476|NCT01597895|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24725477|NCT01597895|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24725478|NCT01597895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24725479|NCT01597895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24725480|NCT01597895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24725484|NCT01597934|Tenofovir|tenofovir|mesh-list
24725518|NCT01598012|Mefenamic Acid|mefenamic acid|mesh-list
24725519|NCT01598012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24725520|NCT01598012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24725521|NCT01598012|Analgesics|analgesics|mesh-ancestor
24725522|NCT01598012|Sensory System Agents|sensory system agents|mesh-ancestor
24648025|NCT01211847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24725523|NCT01598012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24725525|NCT01598012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24725558|NCT01598337|Analgesics|analgesics|mesh-ancestor
24725559|NCT01598337|Sensory System Agents|sensory system agents|mesh-ancestor
24725560|NCT01598337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24725561|NCT01598337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725562|NCT01598337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24725563|NCT01598337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24725564|NCT01598337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24725565|NCT01598337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24725611|NCT01598558|Immunologic Factors|immunologic factors|mesh-ancestor
24725612|NCT01598558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24725613|NCT01598558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24725614|NCT01598584|Gemcitabine|gemcitabine|mesh-list
24725615|NCT01598584|Mirtazapine|mirtazapine|mesh-list
24725616|NCT01598584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24725617|NCT01598584|Antimetabolites|antimetabolites|mesh-ancestor
24725757|NCT01599364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24725759|NCT01599377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24725760|NCT01599377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24725763|NCT01599468|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24725764|NCT01599468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24725765|NCT01599468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726165|NCT01602029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24726166|NCT01602029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726167|NCT01602029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24726168|NCT01602029|Antipruritics|antipruritics|mesh-ancestor
24726169|NCT01602029|Dermatologic Agents|dermatologic agents|mesh-ancestor
24726170|NCT01602029|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24726171|NCT01602029|Serotonin Agents|serotonin agents|mesh-ancestor
24726172|NCT01602029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24726181|NCT01602185|Memantine|memantine|mesh-list
25713116|NCT02334436|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25713117|NCT02334436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25713118|NCT02334436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713119|NCT02334436|Cholinergic Agents|cholinergic agents|mesh-ancestor
24726359|NCT01602913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24726379|NCT01603030|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24726380|NCT01603030|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24726381|NCT01603030|Prednisolone phosphate|prednisolone phosphate|mesh-list
24726382|NCT01603030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24726385|NCT01603030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24726386|NCT01603030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726387|NCT01603030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24726441|NCT01603212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24726442|NCT01603212|Antiviral Agents|antiviral agents|mesh-ancestor
24726524|NCT01603758|Ezetimibe|ezetimibe|mesh-list
24726808|NCT01606046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726809|NCT01606046|Sensory System Agents|sensory system agents|mesh-ancestor
24726810|NCT01606046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24726811|NCT01606046|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24726812|NCT01606059|Acetaminophen|acetaminophen|mesh-list
24726813|NCT01606059|Tramadol|tramadol|mesh-list
24726814|NCT01606059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24726883|NCT01606527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24726884|NCT01606527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24726886|NCT01606540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24726887|NCT01606540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24726888|NCT01606540|Analgesics|analgesics|mesh-ancestor
24726948|NCT01607034|Pramipexole|pramipexole|mesh-list
24616340|NCT01036399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616341|NCT01036399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24727258|NCT01608711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24727259|NCT01608711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24727260|NCT01608711|Immunologic Factors|immunologic factors|mesh-ancestor
24727261|NCT01608711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727262|NCT01608750|Folic Acid|folic acid|mesh-list
24727263|NCT01608750|Hematinics|hematinics|mesh-ancestor
24727264|NCT01608750|Vitamin B Complex|vitamin b complex|mesh-ancestor
24727265|NCT01608750|Vitamins|vitamins|mesh-ancestor
24727266|NCT01608750|Micronutrients|micronutrients|mesh-ancestor
24727271|NCT01608841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24727272|NCT01608841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727273|NCT01608854|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24727274|NCT01608854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24727275|NCT01608880|Nitroglycerin|nitroglycerin|mesh-list
24727276|NCT01608880|Vasodilator Agents|vasodilator agents|mesh-ancestor
24727277|NCT01608945|Hydrocortisone|hydrocortisone|mesh-list
24727278|NCT01608945|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24727279|NCT01608945|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24727282|NCT01608958|Oxytocin|oxytocin|mesh-list
24727315|NCT01609127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727316|NCT01609127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727317|NCT01609153|Olanzapine|olanzapine|mesh-list
24727318|NCT01609153|Amisulpride|amisulpride|mesh-list
24727319|NCT01609153|Antiemetics|antiemetics|mesh-ancestor
24727320|NCT01609153|Autonomic Agents|autonomic agents|mesh-ancestor
24727321|NCT01609153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24727322|NCT01609153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727421|NCT01609816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727422|NCT01609855|Scopolamine|scopolamine|mesh-list
24727429|NCT01609855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713120|NCT02334436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25713121|NCT02334436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713122|NCT02334436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25713123|NCT02334436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24727430|NCT01609855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727431|NCT01609855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24727432|NCT01609855|Mydriatics|mydriatics|mesh-ancestor
25713124|NCT02334527|Palbociclib|palbociclib|mesh-list
25713125|NCT02334527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24727433|NCT01609855|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24727434|NCT01609855|Cholinergic Agents|cholinergic agents|mesh-ancestor
24727435|NCT01609855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24727436|NCT01609855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24727437|NCT01609855|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24727438|NCT01609855|Parasympatholytics|parasympatholytics|mesh-ancestor
24727439|NCT01609881|Ketorolac|ketorolac|mesh-list
24727440|NCT01609881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24727457|NCT01609907|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24727458|NCT01609907|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24727459|NCT01609907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24727460|NCT01609907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24727469|NCT01609998|Vaccines|vaccines|mesh-list
24727470|NCT01609998|Immunologic Factors|immunologic factors|mesh-ancestor
24727471|NCT01609998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727472|NCT01610141|Warfarin|warfarin|mesh-list
24727473|NCT01610141|Anticoagulants|anticoagulants|mesh-ancestor
24616400|NCT01036893|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24616450|NCT01037387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24616451|NCT01037387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24616452|NCT01037387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24616453|NCT01037387|Respiratory System Agents|respiratory system agents|mesh-ancestor
24616455|NCT01037465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24727824|NCT01612975|Sensory System Agents|sensory system agents|mesh-ancestor
24727825|NCT01612975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24727826|NCT01612975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727827|NCT01612975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24727828|NCT01612975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24727829|NCT01612975|Gout Suppressants|gout suppressants|mesh-ancestor
24727831|NCT01612975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728359|NCT01615627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24728361|NCT01615757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24728455|NCT01616355|Sodium Hypochlorite|sodium hypochlorite|mesh-list
24728456|NCT01616355|Eusol|eusol|mesh-list
24728457|NCT01616355|Disinfectants|disinfectants|mesh-ancestor
24728458|NCT01616355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24728459|NCT01616381|Sildenafil Citrate|sildenafil citrate|mesh-list
24728460|NCT01616381|Vasodilator Agents|vasodilator agents|mesh-ancestor
24728461|NCT01616381|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24728462|NCT01616381|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24728463|NCT01616381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24728464|NCT01616381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24728465|NCT01616381|Urological Agents|urological agents|mesh-ancestor
24728482|NCT01616485|Nitroglycerin|nitroglycerin|mesh-list
24728551|NCT01616966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24728552|NCT01616966|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24733195|NCT01643889|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24616639|NCT01038388|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24729149|NCT01620112|Sympatholytics|sympatholytics|mesh-ancestor
24729150|NCT01620112|Autonomic Agents|autonomic agents|mesh-ancestor
25713126|NCT02334527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25713127|NCT02334527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713128|NCT02334527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713129|NCT02334800|Palbociclib|palbociclib|mesh-list
25713130|NCT02334800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713131|NCT02334800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25713132|NCT02334800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713133|NCT02334800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729191|NCT01620320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729193|NCT01620333|Insulin|insulin|mesh-list
24729194|NCT01620333|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24729195|NCT01620333|Insulin Aspart|insulin aspart|mesh-list
24729196|NCT01620333|Insulin, Long-Acting|insulin, long-acting|mesh-list
24729716|NCT01623440|Naltrexone|naltrexone|mesh-list
24729717|NCT01623440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24729718|NCT01623440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24729719|NCT01623440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24729720|NCT01623440|Sensory System Agents|sensory system agents|mesh-ancestor
24729721|NCT01623440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24729722|NCT01623505|Varenicline|varenicline|mesh-list
24729723|NCT01623505|Nicotine|nicotine|mesh-list
24729724|NCT01623505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24729725|NCT01623505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24729726|NCT01623505|Cholinergic Agents|cholinergic agents|mesh-ancestor
24729727|NCT01623505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24729728|NCT01623505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24729907|NCT01624493|Antiviral Agents|antiviral agents|mesh-ancestor
24729968|NCT01624805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24729969|NCT01624805|Dermatologic Agents|dermatologic agents|mesh-ancestor
24729970|NCT01624805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24729971|NCT01624805|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24729972|NCT01624805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24729973|NCT01624805|Antiemetics|antiemetics|mesh-ancestor
24729974|NCT01624805|Autonomic Agents|autonomic agents|mesh-ancestor
24729975|NCT01624805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24729978|NCT01624805|Hormones|hormones|mesh-ancestor
24730229|NCT01627145|Urological Agents|urological agents|mesh-ancestor
24730231|NCT01627158|Formoterol Fumarate|formoterol fumarate|mesh-list
24730232|NCT01627158|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24730233|NCT01627158|Charcoal|charcoal|mesh-list
24730234|NCT01627158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24730235|NCT01627158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24730272|NCT01627236|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24730274|NCT01627236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24730275|NCT01627236|Antiemetics|antiemetics|mesh-ancestor
24730276|NCT01627236|Autonomic Agents|autonomic agents|mesh-ancestor
24730277|NCT01627236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24730278|NCT01627236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730279|NCT01627236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24730280|NCT01627236|Glucocorticoids|glucocorticoids|mesh-ancestor
24730281|NCT01627236|Hormones|hormones|mesh-ancestor
24730282|NCT01627236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24730283|NCT01627236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24730511|NCT01628562|Analgesics|analgesics|mesh-ancestor
24730512|NCT01628562|Sensory System Agents|sensory system agents|mesh-ancestor
24730513|NCT01628562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24730520|NCT01628640|Interferons|interferons|mesh-list
25713134|NCT02334813|Dexamethasone|dexamethasone|mesh-list
25713135|NCT02334813|Prednisone|prednisone|mesh-list
25713136|NCT02334813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25713137|NCT02334813|Antiemetics|antiemetics|mesh-ancestor
25713138|NCT02334813|Autonomic Agents|autonomic agents|mesh-ancestor
25713139|NCT02334813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713140|NCT02334813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713141|NCT02334813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25713142|NCT02334813|Glucocorticoids|glucocorticoids|mesh-ancestor
25713143|NCT02334813|Hormones|hormones|mesh-ancestor
24616831|NCT01039363|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24731069|NCT01631994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24731070|NCT01631994|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24731071|NCT01631994|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24731142|NCT01632657|Serotonin Agents|serotonin agents|mesh-ancestor
24731143|NCT01632657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24731144|NCT01632657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731396|NCT01634438|Calcium heparin|calcium heparin|mesh-list
24731458|NCT01634789|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24731459|NCT01634789|Hormone Antagonists|hormone antagonists|mesh-ancestor
24731460|NCT01634789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24731461|NCT01634880|Panitumumab|panitumumab|mesh-list
24731462|NCT01634880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24731463|NCT01634880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24731469|NCT01634893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24731973|NCT01637259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24731974|NCT01637259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24731987|NCT01637454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24731988|NCT01637454|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24731989|NCT01637454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24731990|NCT01637454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24731991|NCT01637454|Adrenergic Agents|adrenergic agents|mesh-ancestor
24731992|NCT01637454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24731993|NCT01637454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732224|NCT01638377|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24732225|NCT01638377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24732226|NCT01638377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732227|NCT01638377|Sensory System Agents|sensory system agents|mesh-ancestor
24649463|NCT01220063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617054|NCT01040455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617055|NCT01040559|Idarubicin|idarubicin|mesh-list
24617056|NCT01040559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24617057|NCT01040559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617058|NCT01040559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24617059|NCT01040559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24617118|NCT01041092|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
24617120|NCT01041092|Hormone Antagonists|hormone antagonists|mesh-ancestor
24617122|NCT01041092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617127|NCT01041170|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24617128|NCT01041170|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
24617129|NCT01041170|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24617130|NCT01041170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24617131|NCT01041170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732538|NCT01640002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24732539|NCT01640093|Abiraterone Acetate|abiraterone acetate|mesh-list
24732540|NCT01640093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732541|NCT01640093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24617206|NCT01041625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24617207|NCT01041625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617208|NCT01041625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24617209|NCT01041625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24617210|NCT01041625|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24617211|NCT01041625|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24617212|NCT01041625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713144|NCT02334813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25713145|NCT02334813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25713146|NCT02334813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713147|NCT02335125|Psychotropic Drugs|psychotropic drugs|mesh-list
25713148|NCT02335294|Morphine|morphine|mesh-list
25713149|NCT02335294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24617213|NCT01041625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732793|NCT01641406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24732976|NCT01642745|Cholinergic Agents|cholinergic agents|mesh-ancestor
24732977|NCT01642745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24732978|NCT01642745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24732979|NCT01642771|Docetaxel|docetaxel|mesh-list
24732980|NCT01642771|Fluorouracil|fluorouracil|mesh-list
24732981|NCT01642771|Capecitabine|capecitabine|mesh-list
24732982|NCT01642771|Epirubicin|epirubicin|mesh-list
24732983|NCT01642771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24732984|NCT01642771|Tubulin Modulators|tubulin modulators|mesh-ancestor
24732985|NCT01642771|Antimitotic Agents|antimitotic agents|mesh-ancestor
24732986|NCT01642771|Mitosis Modulators|mitosis modulators|mesh-ancestor
24733196|NCT01643889|Dopamine Agents|dopamine agents|mesh-ancestor
24733197|NCT01643889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24733198|NCT01643941|Vaccines|vaccines|mesh-list
24733199|NCT01643941|Immunologic Factors|immunologic factors|mesh-ancestor
24733200|NCT01643941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733201|NCT01643980|Progesterone|progesterone|mesh-list
24733202|NCT01643980|Progestins|progestins|mesh-ancestor
24733203|NCT01643980|Hormones|hormones|mesh-ancestor
24733204|NCT01643980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24733205|NCT01643980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733238|NCT01644253|Obinutuzumab|obinutuzumab|mesh-list
24733239|NCT01644253|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24733240|NCT01644253|Idelalisib|idelalisib|mesh-list
24733241|NCT01644253|Immunoglobulin G|immunoglobulin g|mesh-list
24733242|NCT01644253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24733243|NCT01644253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733244|NCT01644253|Immunologic Factors|immunologic factors|mesh-ancestor
24733246|NCT01644253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24733359|NCT01645423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24733360|NCT01645423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733361|NCT01645423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24733362|NCT01645423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24733363|NCT01645423|Antimetabolites|antimetabolites|mesh-ancestor
24733375|NCT01645449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733376|NCT01645449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24733377|NCT01645449|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24733378|NCT01645449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24733379|NCT01645475|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
24733651|NCT01647685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24733652|NCT01647685|Glucocorticoids|glucocorticoids|mesh-ancestor
24733729|NCT01648218|Isophane Insulin, Human|isophane insulin, human|mesh-list
24733730|NCT01648218|Protamines|protamines|mesh-list
24733731|NCT01648218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24733732|NCT01648218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733733|NCT01648218|Heparin Antagonists|heparin antagonists|mesh-ancestor
24733734|NCT01648218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24733736|NCT01648231|Losartan|losartan|mesh-list
24733737|NCT01648231|Amlodipine|amlodipine|mesh-list
24733788|NCT01648595|Fentanyl|fentanyl|mesh-list
24733789|NCT01648595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24733790|NCT01648595|Narcotics|narcotics|mesh-ancestor
24733791|NCT01648595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24733792|NCT01648595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24733793|NCT01648595|Analgesics|analgesics|mesh-ancestor
24733901|NCT01649466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617454|NCT01043224|Hormones|hormones|mesh-ancestor
24617455|NCT01043224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24617456|NCT01043224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617457|NCT01043224|Dermatologic Agents|dermatologic agents|mesh-ancestor
24734797|NCT01653990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24734798|NCT01653990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24734799|NCT01653990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24734875|NCT01654497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24734876|NCT01654497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24734877|NCT01654497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24617593|NCT01044199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735125|NCT01655706|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24735126|NCT01655706|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25713150|NCT02335294|Narcotics|narcotics|mesh-ancestor
25713151|NCT02335294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25713152|NCT02335294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735127|NCT01655745|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24735128|NCT01655745|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24735178|NCT01655914|Antidotes|antidotes|mesh-ancestor
24735179|NCT01655914|Protective Agents|protective agents|mesh-ancestor
24735180|NCT01655914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24735181|NCT01655914|GABA Modulators|gaba modulators|mesh-ancestor
24735182|NCT01655914|GABA Agents|gaba agents|mesh-ancestor
24735183|NCT01655914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24735184|NCT01655914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24735185|NCT01655927|Tranexamic Acid|tranexamic acid|mesh-list
24735186|NCT01655927|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24735187|NCT01655927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24735477|NCT01657240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24735478|NCT01657240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24735480|NCT01657240|Sensory System Agents|sensory system agents|mesh-ancestor
24735481|NCT01657240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24735551|NCT01657578|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24735552|NCT01657578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24735553|NCT01657578|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24735554|NCT01657578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24735555|NCT01657578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736023|NCT01659775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24736025|NCT01659775|Dermatologic Agents|dermatologic agents|mesh-ancestor
24736026|NCT01659775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24736027|NCT01659775|Serotonin Agents|serotonin agents|mesh-ancestor
24736028|NCT01659775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24736029|NCT01659775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736030|NCT01659775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24736031|NCT01659775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24736032|NCT01659775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24736033|NCT01659775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24736034|NCT01659775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24617772|NCT01045681|Dexamethasone acetate|dexamethasone acetate|mesh-list
24617773|NCT01045681|Bortezomib|bortezomib|mesh-list
24617774|NCT01045681|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24736509|NCT01662687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736512|NCT01662687|Serotonin Agents|serotonin agents|mesh-ancestor
24736530|NCT01662804|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24736531|NCT01662804|Immunologic Factors|immunologic factors|mesh-ancestor
24736532|NCT01662804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24736535|NCT01662804|Analgesics|analgesics|mesh-ancestor
24525341|NCT03633058|Sensory System Agents|sensory system agents|mesh-ancestor
24525342|NCT03633058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24525343|NCT03633058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525344|NCT03633058|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24525345|NCT03633058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24525346|NCT03633058|Anesthetics, General|anesthetics, general|mesh-ancestor
24525347|NCT03633058|Anesthetics|anesthetics|mesh-ancestor
24736902|NCT01665586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24736903|NCT01665586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24736904|NCT01665586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24736905|NCT01665586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24736906|NCT01665586|Adrenergic Agents|adrenergic agents|mesh-ancestor
24736907|NCT01665586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24736908|NCT01665586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24736909|NCT01665638|Canagliflozin|canagliflozin|mesh-list
24736910|NCT01665638|Somatostatin|somatostatin|mesh-list
24737273|NCT01667874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24737274|NCT01667874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737341|NCT01668446|Urological Agents|urological agents|mesh-ancestor
24737342|NCT01668485|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24737343|NCT01668485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737345|NCT01668498|Erythromycin|erythromycin|mesh-list
24737346|NCT01668498|Erythromycin Estolate|erythromycin estolate|mesh-list
24737347|NCT01668498|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24737348|NCT01668498|Erythromycin stearate|erythromycin stearate|mesh-list
25713154|NCT02335294|Sensory System Agents|sensory system agents|mesh-ancestor
25713155|NCT02335294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713156|NCT02335346|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25713157|NCT02335346|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25713158|NCT02335346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25713159|NCT02335346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25713160|NCT02335346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24737349|NCT01668498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24737350|NCT01668498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24737351|NCT01668498|Antimalarials|antimalarials|mesh-ancestor
24737352|NCT01668498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24737353|NCT01668498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24737354|NCT01668498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24737355|NCT01668498|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24737356|NCT01668498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24737422|NCT01668901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24617883|NCT01045941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24617884|NCT01045941|Immunologic Factors|immunologic factors|mesh-ancestor
24617888|NCT01045954|Insulin Lispro|insulin lispro|mesh-list
24617889|NCT01045954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24617890|NCT01045954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617891|NCT01045980|Vitamin D|vitamin d|mesh-list
24737433|NCT01668927|Bismuth|bismuth|mesh-list
24737882|NCT01671410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24737883|NCT01671410|Narcotics|narcotics|mesh-ancestor
24737884|NCT01671410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24737885|NCT01671410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24737886|NCT01671410|Analgesics|analgesics|mesh-ancestor
24737887|NCT01671410|Sensory System Agents|sensory system agents|mesh-ancestor
24737888|NCT01671410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24737889|NCT01671410|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24737890|NCT01671449|Oxaliplatin|oxaliplatin|mesh-list
24737891|NCT01671449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24737892|NCT01671709|Montelukast|montelukast|mesh-list
24737893|NCT01671709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24737894|NCT01671709|Respiratory System Agents|respiratory system agents|mesh-ancestor
24737896|NCT01671709|Hormone Antagonists|hormone antagonists|mesh-ancestor
24738172|NCT01673724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24738173|NCT01673724|Hormone Antagonists|hormone antagonists|mesh-ancestor
24738174|NCT01673724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24738175|NCT01673737|Vemurafenib|vemurafenib|mesh-list
24738176|NCT01673737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24738177|NCT01673737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24738178|NCT01673737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24738179|NCT01673737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738180|NCT01673997|Metoprolol|metoprolol|mesh-list
24738181|NCT01673997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24738384|NCT01675115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738385|NCT01675115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24738386|NCT01675115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24738387|NCT01675115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24738388|NCT01675115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24738389|NCT01675115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738390|NCT01675115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24738391|NCT01675115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24738392|NCT01675115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24738393|NCT01675115|Antipyretics|antipyretics|mesh-ancestor
24738408|NCT01675219|Alkylating Agents|alkylating agents|mesh-ancestor
24738409|NCT01675219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24738594|NCT01676259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738595|NCT01676285|Metoprolol|metoprolol|mesh-list
24738596|NCT01676285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24738610|NCT01676363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25713161|NCT02335346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25713162|NCT02335346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713163|NCT02335346|Analgesics|analgesics|mesh-ancestor
25713164|NCT02335346|Sensory System Agents|sensory system agents|mesh-ancestor
25713165|NCT02335346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24738611|NCT01676363|Analgesics|analgesics|mesh-ancestor
24738612|NCT01676363|Sensory System Agents|sensory system agents|mesh-ancestor
24738613|NCT01676363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713166|NCT02335346|Antidepressive Agents|antidepressive agents|mesh-ancestor
25713167|NCT02335346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25713168|NCT02335346|Dopamine Agents|dopamine agents|mesh-ancestor
25713169|NCT02335905|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
25713170|NCT02335905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24738614|NCT01676363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738615|NCT01676363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24738616|NCT01676363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24738617|NCT01676363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24738618|NCT01676363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24738856|NCT01677923|Metformin|metformin|mesh-list
24738857|NCT01677923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24738858|NCT01677923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738859|NCT01677949|Cyclophosphamide|cyclophosphamide|mesh-list
24738860|NCT01677949|Etoposide|etoposide|mesh-list
24738861|NCT01677949|Clofarabine|clofarabine|mesh-list
24738862|NCT01677949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24738863|NCT01677949|Immunologic Factors|immunologic factors|mesh-ancestor
24738864|NCT01677949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24738865|NCT01677949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24739303|NCT01680263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739304|NCT01680263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24739305|NCT01680406|Chloroquine|chloroquine|mesh-list
24739306|NCT01680406|Lumefantrine|lumefantrine|mesh-list
24739307|NCT01680406|Artemether|artemether|mesh-list
24739308|NCT01680406|Primaquine|primaquine|mesh-list
24617995|NCT01046461|Autonomic Agents|autonomic agents|mesh-ancestor
24617996|NCT01046461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24617997|NCT01046461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24617998|NCT01046461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24617999|NCT01046461|Glucocorticoids|glucocorticoids|mesh-ancestor
24618000|NCT01046461|Hormones|hormones|mesh-ancestor
24618001|NCT01046461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24618013|NCT01046487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739318|NCT01680471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24739319|NCT01680471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24739320|NCT01680471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739321|NCT01680471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24739322|NCT01680471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24739323|NCT01680471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24739324|NCT01680471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24739325|NCT01680471|Anesthetics, General|anesthetics, general|mesh-ancestor
24739326|NCT01680471|Anesthetics|anesthetics|mesh-ancestor
24739327|NCT01680471|GABA Modulators|gaba modulators|mesh-ancestor
24739433|NCT01681537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24739434|NCT01681537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24739435|NCT01681537|Growth Substances|growth substances|mesh-ancestor
24404047|NCT00162422|Tocolytic Agents|tocolytic agents|mesh-ancestor
24739460|NCT01681667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24739461|NCT01681667|Analgesics|analgesics|mesh-ancestor
24739462|NCT01681667|Sensory System Agents|sensory system agents|mesh-ancestor
24739463|NCT01681667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24739464|NCT01681667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739465|NCT01681667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24739466|NCT01681667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24739468|NCT01681667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24739576|NCT01682499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24739577|NCT01682499|Anesthetics|anesthetics|mesh-ancestor
24739578|NCT01682499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24739579|NCT01682499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24739580|NCT01682499|Anticonvulsants|anticonvulsants|mesh-ancestor
24739581|NCT01682499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24739582|NCT01682499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24739583|NCT01682499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739584|NCT01682499|Tocolytic Agents|tocolytic agents|mesh-ancestor
24739585|NCT01682499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24739586|NCT01682564|Candesartan cilexetil|candesartan cilexetil|mesh-list
24739587|NCT01682564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24739588|NCT01682564|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24739589|NCT01682564|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24740038|NCT01685970|Cathartics|cathartics|mesh-ancestor
24739590|NCT01682564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739591|NCT01682577|Perindopril|perindopril|mesh-list
24739592|NCT01682577|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24739593|NCT01682577|Protease Inhibitors|protease inhibitors|mesh-ancestor
25713171|NCT02335905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24739594|NCT01682577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528762|NCT00622674|Cetuximab|cetuximab|mesh-list
24739654|NCT01683175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739655|NCT01683175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24739656|NCT01683175|Tubulin Modulators|tubulin modulators|mesh-ancestor
24739657|NCT01683175|Antimitotic Agents|antimitotic agents|mesh-ancestor
24739658|NCT01683175|Mitosis Modulators|mitosis modulators|mesh-ancestor
24739660|NCT01683188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24739661|NCT01683188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24739734|NCT01683747|Tranexamic Acid|tranexamic acid|mesh-list
24739735|NCT01683747|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24739736|NCT01683747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24739737|NCT01683747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739738|NCT01683747|Hemostatics|hemostatics|mesh-ancestor
24739739|NCT01683747|Coagulants|coagulants|mesh-ancestor
24739740|NCT01683760|Fluconazole|fluconazole|mesh-list
24739741|NCT01683760|Antifungal Agents|antifungal agents|mesh-ancestor
24739742|NCT01683760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24739743|NCT01683760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24739744|NCT01683760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24739745|NCT01683760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24739748|NCT01683760|Hormone Antagonists|hormone antagonists|mesh-ancestor
24739807|NCT01684306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739810|NCT01684319|Sequestering Agents|sequestering agents|mesh-ancestor
24739811|NCT01684319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739812|NCT01684371|Tea Tree Oil|tea tree oil|mesh-list
24739813|NCT01684371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24739814|NCT01684371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24739815|NCT01684371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24739816|NCT01684449|Gemcitabine|gemcitabine|mesh-list
24739817|NCT01684449|Sirolimus|sirolimus|mesh-list
24739818|NCT01684449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24739819|NCT01684449|Antimetabolites|antimetabolites|mesh-ancestor
24739820|NCT01684449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24739893|NCT01684969|Autonomic Agents|autonomic agents|mesh-ancestor
24739894|NCT01684969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24519138|NCT03408236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24739895|NCT01684969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24739896|NCT01684969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24739897|NCT01684969|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24739898|NCT01684969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24739899|NCT01684969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24618134|NCT01046942|Analgesics|analgesics|mesh-ancestor
24618135|NCT01046942|Sensory System Agents|sensory system agents|mesh-ancestor
24618136|NCT01046942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24618137|NCT01046942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618138|NCT01046942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24618139|NCT01046942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24618140|NCT01046942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24618141|NCT01046942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24618142|NCT01046942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404625|NCT00164255|Artesunate|artesunate|mesh-list
24740027|NCT01685931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740028|NCT01685931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24740029|NCT01685931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24740030|NCT01685931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24740031|NCT01685931|Serotonin Agents|serotonin agents|mesh-ancestor
25713172|NCT02335983|Dexamethasone|dexamethasone|mesh-list
25713173|NCT02335983|Lenalidomide|lenalidomide|mesh-list
25713174|NCT02335983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25713175|NCT02335983|Antiemetics|antiemetics|mesh-ancestor
25713176|NCT02335983|Autonomic Agents|autonomic agents|mesh-ancestor
24740032|NCT01685931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25713177|NCT02335983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713178|NCT02335983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713179|NCT02335983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24740033|NCT01685931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740034|NCT01685931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24740035|NCT01685931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24740036|NCT01685931|Dopamine Agents|dopamine agents|mesh-ancestor
24740037|NCT01685970|Picosulfate sodium|picosulfate sodium|mesh-list
24740246|NCT01687348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24740247|NCT01687348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740249|NCT01687348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740250|NCT01687348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24740251|NCT01687348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24740252|NCT01687348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24740253|NCT01687348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24740254|NCT01687348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740255|NCT01687374|Hormones|hormones|mesh-list
24740256|NCT01687374|Parathyroid Hormone|parathyroid hormone|mesh-list
24740257|NCT01687374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24740258|NCT01687374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740333|NCT01687868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740334|NCT01687868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24740335|NCT01687868|Analgesics|analgesics|mesh-ancestor
24740336|NCT01687868|Sensory System Agents|sensory system agents|mesh-ancestor
24740337|NCT01687868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740338|NCT01687868|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24740450|NCT01688570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24740451|NCT01688570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24740491|NCT01688648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24740492|NCT01688648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24740493|NCT01688648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24740494|NCT01688648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740495|NCT01688648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24740505|NCT01688700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24740507|NCT01688700|Tubulin Modulators|tubulin modulators|mesh-ancestor
24740508|NCT01688700|Antimitotic Agents|antimitotic agents|mesh-ancestor
24740509|NCT01688700|Mitosis Modulators|mitosis modulators|mesh-ancestor
24740510|NCT01688700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24740578|NCT01689090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24740583|NCT01689116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24740584|NCT01689116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24618228|NCT01047215|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24740700|NCT01689896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740701|NCT01689935|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24740702|NCT01689935|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24740703|NCT01689935|Dermatologic Agents|dermatologic agents|mesh-ancestor
24740705|NCT01689987|Hydroxychloroquine|hydroxychloroquine|mesh-list
24740706|NCT01689987|Dexamethasone|dexamethasone|mesh-list
24740821|NCT01690338|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24740822|NCT01690338|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24740823|NCT01690338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24740824|NCT01690338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24740825|NCT01690338|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24740826|NCT01690338|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24740827|NCT01690338|Cholinergic Agents|cholinergic agents|mesh-ancestor
24740828|NCT01690338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24740846|NCT01690403|Antitubercular Agents|antitubercular agents|mesh-ancestor
24740847|NCT01690403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24740848|NCT01690403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24740851|NCT01690468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24740852|NCT01690507|Cytarabine|cytarabine|mesh-list
24740853|NCT01690507|Decitabine|decitabine|mesh-list
24740854|NCT01690507|Aclacinomycins|aclacinomycins|mesh-list
25713180|NCT02335983|Glucocorticoids|glucocorticoids|mesh-ancestor
25713181|NCT02335983|Hormones|hormones|mesh-ancestor
25713182|NCT02335983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25713183|NCT02335983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25713184|NCT02335983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713185|NCT02335983|Immunologic Factors|immunologic factors|mesh-ancestor
25713186|NCT02335983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25713187|NCT02335983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25713188|NCT02335983|Growth Substances|growth substances|mesh-ancestor
25713189|NCT02335983|Growth Inhibitors|growth inhibitors|mesh-ancestor
25713190|NCT02336074|Raltegravir Potassium|raltegravir potassium|mesh-list
24740855|NCT01690507|Lenograstim|lenograstim|mesh-list
24740857|NCT01690507|Antimetabolites|antimetabolites|mesh-ancestor
24740885|NCT01690559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24740886|NCT01690559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24740887|NCT01690559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24741084|NCT01691677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24741086|NCT01691677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24741087|NCT01691677|Respiratory System Agents|respiratory system agents|mesh-ancestor
24741088|NCT01691742|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24741090|NCT01691742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24741091|NCT01691807|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24741092|NCT01691807|Ofatumumab|ofatumumab|mesh-list
24741093|NCT01691807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24741094|NCT01691807|Alkylating Agents|alkylating agents|mesh-ancestor
24741097|NCT01691872|Ezogabine|ezogabine|mesh-list
24406002|NCT00169000|Antimitotic Agents|antimitotic agents|mesh-ancestor
24406003|NCT00169000|Mitosis Modulators|mitosis modulators|mesh-ancestor
24406004|NCT00169000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406005|NCT00169000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24406006|NCT00169000|Antimetabolites|antimetabolites|mesh-ancestor
24741332|NCT01693419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741333|NCT01693419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24741384|NCT01693718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24741385|NCT01693718|Immunologic Factors|immunologic factors|mesh-ancestor
24741386|NCT01693718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741387|NCT01693718|Antisickling Agents|antisickling agents|mesh-ancestor
24448488|NCT00311974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24741403|NCT01693822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24406082|NCT00169091|Clozapine|clozapine|mesh-list
24406110|NCT00169130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24741448|NCT05288816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24741449|NCT05288816|Immunologic Factors|immunologic factors|mesh-ancestor
24741450|NCT05288816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741452|NCT05288738|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24741584|NCT05291455|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24741586|NCT05291338|Ethiodized Oil|ethiodized oil|mesh-list
24406221|NCT00169299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24741694|NCT05290324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24741696|NCT05290324|Anesthetics|anesthetics|mesh-ancestor
24741697|NCT05290324|GABA Modulators|gaba modulators|mesh-ancestor
24741698|NCT05290324|GABA Agents|gaba agents|mesh-ancestor
24741699|NCT05290324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24741700|NCT05290324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24741701|NCT05290207|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24741702|NCT05290207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24741708|NCT05290090|Rituximab|rituximab|mesh-list
24741709|NCT05290090|Lenalidomide|lenalidomide|mesh-list
24741710|NCT05290090|Zanubrutinib|zanubrutinib|mesh-list
24741711|NCT05290090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24741712|NCT05290090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24741713|NCT05290090|Immunologic Factors|immunologic factors|mesh-ancestor
24741738|NCT05292742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742051|NCT05293808|Sensory System Agents|sensory system agents|mesh-ancestor
24742052|NCT05293808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24742053|NCT05293808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742054|NCT05293808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24742055|NCT05293808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24742056|NCT05293808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24742057|NCT05293808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24742058|NCT05293808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742059|NCT05293808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24742060|NCT05293808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24742061|NCT05293808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24742108|NCT05293574|Norethindrone|norethindrone|mesh-list
24742109|NCT05293574|Norethindrone Acetate|norethindrone acetate|mesh-list
25713191|NCT02336074|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24742175|NCT05296564|Cyclophosphamide|cyclophosphamide|mesh-list
24742176|NCT05296564|Interleukin-2|interleukin-2|mesh-list
24742177|NCT05296564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24742178|NCT05296564|Immunologic Factors|immunologic factors|mesh-ancestor
24742179|NCT05296564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742180|NCT05296564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24742181|NCT05296564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24742182|NCT05296564|Alkylating Agents|alkylating agents|mesh-ancestor
24742183|NCT05296564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742184|NCT05296564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24742185|NCT05296564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24742313|NCT05275647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24742314|NCT05275647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742315|NCT05275647|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24742316|NCT05275647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24742317|NCT05275647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742318|NCT05275647|Cholinergic Agents|cholinergic agents|mesh-ancestor
24742319|NCT05275647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24742321|NCT05275491|Parathyroid Hormone|parathyroid hormone|mesh-list
24742322|NCT05275491|Hormones|hormones|mesh-list
24742323|NCT05275491|Mitogens|mitogens|mesh-list
24742324|NCT05275491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24742325|NCT05275491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742327|NCT05275491|Mitosis Modulators|mitosis modulators|mesh-ancestor
24742328|NCT05275491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24742426|NCT05267431|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24742527|NCT05249920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742529|NCT05245669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24742530|NCT05245669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742531|NCT05243147|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
24742532|NCT05243147|Hemostatics|hemostatics|mesh-ancestor
24742533|NCT05243147|Coagulants|coagulants|mesh-ancestor
24651743|NCT01233622|Vildagliptin|vildagliptin|mesh-list
24742786|NCT05217706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742787|NCT05217706|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24742788|NCT05217706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24742789|NCT05217706|Anesthetics, General|anesthetics, general|mesh-ancestor
24742790|NCT05217706|Anesthetics|anesthetics|mesh-ancestor
24743142|NCT04981912|Immunologic Factors|immunologic factors|mesh-ancestor
24742793|NCT05217706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24742794|NCT05217706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24742832|NCT05150756|Anesthetics, Local|anesthetics, local|mesh-ancestor
24742887|NCT05129137|Acetaminophen|acetaminophen|mesh-list
24742888|NCT05129137|Nefopam|nefopam|mesh-list
24742889|NCT05129137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24742890|NCT05129137|Analgesics|analgesics|mesh-ancestor
24742891|NCT05129137|Sensory System Agents|sensory system agents|mesh-ancestor
24742892|NCT05129137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24742893|NCT05129137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742894|NCT05129137|Antipyretics|antipyretics|mesh-ancestor
24742895|NCT05114980|Parathyroid Hormone|parathyroid hormone|mesh-list
24742896|NCT05114980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24742897|NCT05114980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24742898|NCT05111314|Edetic Acid|edetic acid|mesh-list
24743013|NCT05039476|Micronutrients|micronutrients|mesh-ancestor
24743014|NCT05039476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743018|NCT05035680|Vaccines|vaccines|mesh-list
24743021|NCT05033743|Secnidazole|secnidazole|mesh-list
25713192|NCT02336074|Vorinostat|vorinostat|mesh-list
25713193|NCT02336074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713194|NCT02336074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25713195|NCT02336074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713196|NCT02336074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713197|NCT02336074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25713198|NCT02336074|Antiviral Agents|antiviral agents|mesh-ancestor
24618403|NCT01048177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713199|NCT02336074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25713200|NCT02336074|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25713201|NCT02336074|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25713202|NCT02336165|Bevacizumab|bevacizumab|mesh-list
24618405|NCT01048177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24618406|NCT01048177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24618407|NCT01048177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24618408|NCT01048177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24618409|NCT01048177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24618410|NCT01048177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618411|NCT01048177|Anticoagulants|anticoagulants|mesh-ancestor
24618412|NCT01048177|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24618413|NCT01048177|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24618414|NCT01048190|Vaccines|vaccines|mesh-list
24618415|NCT01048190|Immunologic Factors|immunologic factors|mesh-ancestor
24618416|NCT01048190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618417|NCT01048229|Pramipexole|pramipexole|mesh-list
24618418|NCT01048229|Rasagiline|rasagiline|mesh-list
24618419|NCT01048229|Antioxidants|antioxidants|mesh-ancestor
24618420|NCT01048229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618421|NCT01048229|Protective Agents|protective agents|mesh-ancestor
24407704|NCT00175045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407705|NCT00175123|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24743359|NCT04869605|Analgesics|analgesics|mesh-ancestor
24743140|NCT04981912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24743141|NCT04981912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24743143|NCT04981912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743144|NCT04981912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24743177|NCT04973930|Serotonin Agents|serotonin agents|mesh-ancestor
24743178|NCT04973930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743245|NCT04936854|Immunologic Factors|immunologic factors|mesh-ancestor
24743246|NCT04936854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743247|NCT04936854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24743248|NCT04936854|Antiemetics|antiemetics|mesh-ancestor
24743249|NCT04936854|Autonomic Agents|autonomic agents|mesh-ancestor
24743250|NCT04936854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24743251|NCT04936854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24743252|NCT04936854|Glucocorticoids|glucocorticoids|mesh-ancestor
24743253|NCT04936854|Hormones|hormones|mesh-ancestor
24743254|NCT04936854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24743255|NCT04936854|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25713203|NCT02336165|Durvalumab|durvalumab|mesh-list
25713204|NCT02336165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25713205|NCT02336165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713206|NCT02336165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25713207|NCT02336165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24743256|NCT04936854|Protective Agents|protective agents|mesh-ancestor
24743257|NCT04936854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24407913|NCT00175838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24743260|NCT04926181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24743263|NCT04921527|Chiauranib|chiauranib|mesh-list
24743348|NCT04871425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24743349|NCT04871425|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24743350|NCT04871425|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24743351|NCT04871425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24743352|NCT04871425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743353|NCT04871425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24743355|NCT04871425|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24743356|NCT04869605|Chrysarobin|chrysarobin|mesh-list
24743357|NCT04869605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24743358|NCT04869605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24743404|NCT04838743|Incretins|incretins|mesh-ancestor
24743405|NCT04838743|Hormones|hormones|mesh-ancestor
24743406|NCT04838743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24743407|NCT04835584|Dasatinib|dasatinib|mesh-list
24743408|NCT04835584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24743409|NCT04835584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24743410|NCT04835584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24743412|NCT04834973|Pembrolizumab|pembrolizumab|mesh-list
24652132|NCT01236612|Amebicides|amebicides|mesh-ancestor
24743413|NCT04834973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24743414|NCT04834973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24743415|NCT04818034|Dapagliflozin|dapagliflozin|mesh-list
24743416|NCT04818034|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24743417|NCT04818034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743418|NCT04818034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24743603|NCT04731480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743604|NCT04731480|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25713208|NCT02336165|Growth Substances|growth substances|mesh-ancestor
25713209|NCT02336165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713210|NCT02336165|Growth Inhibitors|growth inhibitors|mesh-ancestor
25713211|NCT02336373|Hydroxyurea|hydroxyurea|mesh-list
25713212|NCT02336373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713213|NCT02336373|Antisickling Agents|antisickling agents|mesh-ancestor
25713214|NCT02336373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713215|NCT02336373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713216|NCT02336373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24743605|NCT04731480|Anesthetics, General|anesthetics, general|mesh-ancestor
25713217|NCT02336438|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
25713218|NCT02336438|Cathartics|cathartics|mesh-ancestor
25713219|NCT02336438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25713220|NCT02336451|Ceritinib|ceritinib|mesh-list
24743607|NCT04730947|Dapagliflozin|dapagliflozin|mesh-list
24743608|NCT04730947|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24743609|NCT04730947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533328|NCT00643149|Amoxicillin|amoxicillin|mesh-list
24743661|NCT04672772|Cetuximab|cetuximab|mesh-list
24743662|NCT04672772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24743663|NCT04672772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24743664|NCT04672772|Tubulin Modulators|tubulin modulators|mesh-ancestor
24743665|NCT04672772|Antimitotic Agents|antimitotic agents|mesh-ancestor
24743666|NCT04672772|Mitosis Modulators|mitosis modulators|mesh-ancestor
24743667|NCT04672772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743668|NCT04672772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24743742|NCT04640818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24743812|NCT04606797|Nicotine|nicotine|mesh-list
24743813|NCT04606797|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24743814|NCT04606797|Autonomic Agents|autonomic agents|mesh-ancestor
24743931|NCT04564885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24743932|NCT04564885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24743933|NCT04564885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24743934|NCT04564885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24743935|NCT04564885|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24743978|NCT04560972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24743979|NCT04560972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24743980|NCT04560972|Immunologic Factors|immunologic factors|mesh-ancestor
24743981|NCT04560972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618480|NCT01048515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24618481|NCT01048515|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24618482|NCT01048515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618483|NCT01048515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618484|NCT01048515|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24618485|NCT01048515|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24618486|NCT01048515|Purinergic Agents|purinergic agents|mesh-ancestor
24618487|NCT01048515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24618488|NCT01048554|Bevacizumab|bevacizumab|mesh-list
24618489|NCT01048554|Temozolomide|temozolomide|mesh-list
24653003|NCT01241175|Tocolytic Agents|tocolytic agents|mesh-ancestor
24744265|NCT04387110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745654|NCT03662685|Dermatologic Agents|dermatologic agents|mesh-ancestor
24744267|NCT04375683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24744268|NCT04375683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24744269|NCT04375683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24744340|NCT04348864|Antibodies|antibodies|mesh-list
25713221|NCT02336451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713222|NCT02336451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24744531|NCT04238546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744532|NCT04238091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24744533|NCT04238091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24744801|NCT04136262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24744802|NCT04136262|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24744803|NCT04136262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24744804|NCT04136262|Immunologic Factors|immunologic factors|mesh-ancestor
24744805|NCT04136262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24744894|NCT04084548|Lidocaine|lidocaine|mesh-list
24744895|NCT04084548|Ketamine|ketamine|mesh-list
24744896|NCT04084548|Anesthetics, Local|anesthetics, local|mesh-ancestor
24744897|NCT04084548|Anesthetics|anesthetics|mesh-ancestor
24744898|NCT04084548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24744899|NCT04084548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744900|NCT04084548|Sensory System Agents|sensory system agents|mesh-ancestor
24744901|NCT04084548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24744902|NCT04084548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24744903|NCT04084548|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24744904|NCT04084548|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24744905|NCT04084548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24744991|NCT04055818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24744992|NCT04055818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24744993|NCT04055818|Vitamin B Complex|vitamin b complex|mesh-ancestor
24744994|NCT04055818|Vitamins|vitamins|mesh-ancestor
24744995|NCT04055818|Micronutrients|micronutrients|mesh-ancestor
24744996|NCT04055818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24744997|NCT04055818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24744998|NCT04055818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24744999|NCT04055818|Vasodilator Agents|vasodilator agents|mesh-ancestor
24745114|NCT03990883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24745115|NCT03990883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745117|NCT03990883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24745118|NCT03990883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24745119|NCT03990883|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24745120|NCT03990883|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24745121|NCT03990883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24745122|NCT03990883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745123|NCT03984890|Vitamin D|vitamin d|mesh-list
24745124|NCT03984890|Cholecalciferol|cholecalciferol|mesh-list
24745125|NCT03984890|Vitamins|vitamins|mesh-ancestor
24745126|NCT03984890|Micronutrients|micronutrients|mesh-ancestor
24745127|NCT03984890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745128|NCT03984890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24904236|NCT04357535|Angiotensin II|angiotensin ii|mesh-list
24745129|NCT03984890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24745133|NCT03969446|Pembrolizumab|pembrolizumab|mesh-list
24745134|NCT03969446|Decitabine|decitabine|mesh-list
24745135|NCT03969446|Venetoclax|venetoclax|mesh-list
24745136|NCT03969446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24745137|NCT03969446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745138|NCT03969446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24745139|NCT03969446|Antimetabolites|antimetabolites|mesh-ancestor
24745140|NCT03969446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745141|NCT03969446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24745150|NCT03930615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745231|NCT03889314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24745233|NCT03884998|Nivolumab|nivolumab|mesh-list
24745234|NCT03884998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24745235|NCT03884998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745236|NCT03884998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24745237|NCT03884998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745238|NCT03873857|Venetoclax|venetoclax|mesh-list
24745239|NCT03873857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745240|NCT03870880|Risperidone|risperidone|mesh-list
24745241|NCT03870880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24745242|NCT03870880|Serotonin Agents|serotonin agents|mesh-ancestor
24745243|NCT03870880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25713223|NCT02336451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713224|NCT02336451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713225|NCT02336594|Verinurad|verinurad|mesh-list
25713226|NCT02336594|Gout Suppressants|gout suppressants|mesh-ancestor
25713227|NCT02336594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25713228|NCT02336607|Metoprolol|metoprolol|mesh-list
25713229|NCT02336607|Felodipine|felodipine|mesh-list
24745244|NCT03870880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745655|NCT03660839|Artefenomel|artefenomel|mesh-list
24745245|NCT03870880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745246|NCT03870880|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24745247|NCT03870880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24745248|NCT03870880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24745249|NCT03870880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24745250|NCT03870880|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24745251|NCT03870880|Dopamine Agents|dopamine agents|mesh-ancestor
24745252|NCT03861377|Remifentanil|remifentanil|mesh-list
24745253|NCT03861377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24745254|NCT03861377|Narcotics|narcotics|mesh-ancestor
24745255|NCT03861377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24745256|NCT03861377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745257|NCT03861377|Analgesics|analgesics|mesh-ancestor
24745258|NCT03861377|Sensory System Agents|sensory system agents|mesh-ancestor
24745259|NCT03861377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24745260|NCT03846570|Beclomethasone|beclomethasone|mesh-list
24745277|NCT03846570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24745278|NCT03844100|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
24745279|NCT03844100|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24745280|NCT03844100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24745282|NCT03838367|Carboplatin|carboplatin|mesh-list
24745283|NCT03838367|HIV Antibodies|hiv antibodies|mesh-list
24745284|NCT03838367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745285|NCT03838367|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24745286|NCT03838367|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24745288|NCT03838367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24745329|NCT03825536|Dopamine Agents|dopamine agents|mesh-ancestor
24745330|NCT03825536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24745331|NCT03825536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745344|NCT03809923|Dexmedetomidine|dexmedetomidine|mesh-list
24745345|NCT03809923|Anesthetics, Local|anesthetics, local|mesh-ancestor
24745346|NCT03809923|Anesthetics|anesthetics|mesh-ancestor
24745347|NCT03809923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24745348|NCT03809923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745349|NCT03809923|Sensory System Agents|sensory system agents|mesh-ancestor
24745350|NCT03809923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24745351|NCT03809923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24745352|NCT03809923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24745353|NCT03809923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24745354|NCT03809923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24618519|NCT01048684|Natriuretic Agents|natriuretic agents|mesh-ancestor
24409955|NCT00183924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24409956|NCT00183924|Alkylating Agents|alkylating agents|mesh-ancestor
24745392|NCT03785106|Pyridoxal|pyridoxal|mesh-list
24745393|NCT03785106|Vitamin B 6|vitamin b 6|mesh-list
24745394|NCT03785106|Vitamin B Complex|vitamin b complex|mesh-list
24745395|NCT03785106|Isoniazid|isoniazid|mesh-list
24745396|NCT03785106|Rifapentine|rifapentine|mesh-list
24745397|NCT03785106|Rifampin|rifampin|mesh-list
24745398|NCT03785106|Micronutrients|micronutrients|mesh-ancestor
24745399|NCT03785106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745547|NCT03712254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24653779|NCT01245803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24745548|NCT03712254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24745549|NCT03712254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745550|NCT03704441|Bupivacaine|bupivacaine|mesh-list
24745551|NCT03704441|Anesthetics, Local|anesthetics, local|mesh-ancestor
24745552|NCT03704441|Anesthetics|anesthetics|mesh-ancestor
24745553|NCT03704441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24745554|NCT03704441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24745555|NCT03704441|Sensory System Agents|sensory system agents|mesh-ancestor
24745556|NCT03704441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24745560|NCT03695471|Pembrolizumab|pembrolizumab|mesh-list
24745561|NCT03695471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24745562|NCT03695471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24745563|NCT03693677|Gemcitabine|gemcitabine|mesh-list
24745564|NCT03693677|Paclitaxel|paclitaxel|mesh-list
24745565|NCT03693677|Irinotecan|irinotecan|mesh-list
25713230|NCT02336607|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25713231|NCT02336607|Lisinopril|lisinopril|mesh-list
25713232|NCT02336607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25713233|NCT02336607|Diuretics|diuretics|mesh-ancestor
25713234|NCT02336607|Natriuretic Agents|natriuretic agents|mesh-ancestor
24745609|NCT03677934|Ranibizumab|ranibizumab|mesh-list
24745610|NCT03677934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24745611|NCT03677934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24745612|NCT03677934|Growth Substances|growth substances|mesh-ancestor
24745653|NCT03662685|Keratolytic Agents|keratolytic agents|mesh-ancestor
24745656|NCT03660839|Ferroquine|ferroquine|mesh-list
24745657|NCT03660839|Antimalarials|antimalarials|mesh-ancestor
24745658|NCT03660839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24745659|NCT03660839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24745660|NCT03660839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24745661|NCT03660241|Abrocitinib|abrocitinib|mesh-list
24745662|NCT03660241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24745663|NCT03660241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24745664|NCT03660241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24745665|NCT03651102|Thalidomide|thalidomide|mesh-list
24745666|NCT03651102|Hydroxyurea|hydroxyurea|mesh-list
24745667|NCT03651102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24745809|NCT03582475|Carboplatin|carboplatin|mesh-list
24745810|NCT03582475|Docetaxel|docetaxel|mesh-list
24745811|NCT03582475|Pembrolizumab|pembrolizumab|mesh-list
24745812|NCT03582475|Etoposide|etoposide|mesh-list
24745984|NCT03460379|Antidepressive Agents|antidepressive agents|mesh-ancestor
24745985|NCT03460379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24745986|NCT03460366|Enalapril|enalapril|mesh-list
24745987|NCT03460366|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24745988|NCT03460366|Protease Inhibitors|protease inhibitors|mesh-ancestor
24745989|NCT03460366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24745990|NCT03460366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746031|NCT03456700|Immunologic Factors|immunologic factors|mesh-ancestor
24746032|NCT03456700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746033|NCT03456700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24746046|NCT03435185|Lidocaine|lidocaine|mesh-list
24746233|NCT03216343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24746234|NCT03216343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24746235|NCT03216343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746236|NCT03201939|Lisinopril|lisinopril|mesh-list
24410742|NCT00187005|Antiemetics|antiemetics|mesh-ancestor
24746257|NCT05438316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24746344|NCT05437575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24746352|NCT05437497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746353|NCT05437497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24746354|NCT05437497|Anesthetics, General|anesthetics, general|mesh-ancestor
24746653|NCT04590586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24746654|NCT04590586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24746655|NCT04590586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746656|NCT04590586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24746657|NCT04590586|Immunologic Factors|immunologic factors|mesh-ancestor
24746658|NCT04590586|Leprostatic Agents|leprostatic agents|mesh-ancestor
24746659|NCT04590586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24746660|NCT04590586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24746661|NCT04590586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24746666|NCT04561557|Cyclophosphamide|cyclophosphamide|mesh-list
24618613|NCT01049347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24618614|NCT01049347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24618615|NCT01049347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24618616|NCT01049347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24618617|NCT01049347|Serotonin Agents|serotonin agents|mesh-ancestor
24618618|NCT01049347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24746686|NCT04427293|Lenvatinib|lenvatinib|mesh-list
25713235|NCT02336607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713236|NCT02336607|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25713237|NCT02336607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25713238|NCT02336607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746687|NCT04427293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24746688|NCT04427293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24746689|NCT04427293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24746690|NCT04427293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713239|NCT02336607|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25713240|NCT02336607|Sympatholytics|sympatholytics|mesh-ancestor
24746728|NCT04058743|Chromium|chromium|mesh-list
24746730|NCT04058743|Trace Elements|trace elements|mesh-ancestor
24746731|NCT04058743|Micronutrients|micronutrients|mesh-ancestor
24746732|NCT04058743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536756|NCT00652288|Insulin|insulin|mesh-list
24746752|NCT03850483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24746753|NCT03850483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24746754|NCT03850483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24746755|NCT03819296|Prednisone|prednisone|mesh-list
24746756|NCT03819296|Cortisone|cortisone|mesh-list
24746757|NCT03819296|Infliximab|infliximab|mesh-list
24746758|NCT03819296|Vedolizumab|vedolizumab|mesh-list
24746759|NCT03819296|Immunoglobulins|immunoglobulins|mesh-list
24746760|NCT03819296|Immunoglobulin G|immunoglobulin g|mesh-list
24750640|NCT01699828|Buspirone|buspirone|mesh-list
24747035|NCT02203773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24747036|NCT02203773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24747037|NCT02203773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24747038|NCT02203773|Hormone Antagonists|hormone antagonists|mesh-ancestor
24747039|NCT02203773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24747040|NCT02203773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24747041|NCT02175030|Copper|copper|mesh-list
24747042|NCT02175030|Levonorgestrel|levonorgestrel|mesh-list
24747043|NCT02175030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24618662|NCT01049438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24747650|NCT00378482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24747652|NCT00316888|Fluorouracil|fluorouracil|mesh-list
24747653|NCT00316888|Cetuximab|cetuximab|mesh-list
24747654|NCT00316888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24747694|NCT03178487|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
24747695|NCT03178487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24747696|NCT03178487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24747697|NCT03178487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24747698|NCT03178487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24747700|NCT03164889|Molgramostim|molgramostim|mesh-list
24747701|NCT03164889|Sargramostim|sargramostim|mesh-list
24748013|NCT02999633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748014|NCT02999633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24748015|NCT02999633|Analgesics|analgesics|mesh-ancestor
24748091|NCT02950766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24748092|NCT02950766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748094|NCT02943785|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24748095|NCT02943785|Antithrombins|antithrombins|mesh-ancestor
24748096|NCT02943785|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24748122|NCT02901067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24748143|NCT02886286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24748144|NCT02886286|Narcotics|narcotics|mesh-ancestor
24748145|NCT02886286|Analgesics|analgesics|mesh-ancestor
24748146|NCT02886286|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24748550|NCT02381652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24748551|NCT02381652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748657|NCT02283281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24748658|NCT02283281|Analgesics|analgesics|mesh-ancestor
24748659|NCT02283281|Sensory System Agents|sensory system agents|mesh-ancestor
24748660|NCT02283281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24748661|NCT02283281|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24748662|NCT02283281|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24748663|NCT02283281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24748664|NCT02283281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24748666|NCT02283281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24748667|NCT02251548|Cyclophosphamide|cyclophosphamide|mesh-list
24748668|NCT02251548|Rituximab|rituximab|mesh-list
24748669|NCT02251548|Fludarabine|fludarabine|mesh-list
24748670|NCT02251548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24748747|NCT02185820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24413393|NCT00193700|Androgens|androgens|mesh-ancestor
24748973|NCT01898117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24748974|NCT01898117|Cyclophosphamide|cyclophosphamide|mesh-list
24748975|NCT01898117|Carboplatin|carboplatin|mesh-list
24748976|NCT01898117|Atezolizumab|atezolizumab|mesh-list
24748977|NCT01898117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25713241|NCT02336607|Autonomic Agents|autonomic agents|mesh-ancestor
25713242|NCT02336607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713243|NCT02336607|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25713244|NCT02336607|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25713245|NCT02336607|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25713246|NCT02336607|Adrenergic Agents|adrenergic agents|mesh-ancestor
25713247|NCT02336607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24748978|NCT01898117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24748979|NCT01898117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24748980|NCT01898117|Tubulin Modulators|tubulin modulators|mesh-ancestor
24655258|NCT01255371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24748981|NCT01898117|Antimitotic Agents|antimitotic agents|mesh-ancestor
24749078|NCT01817751|Vasodilator Agents|vasodilator agents|mesh-ancestor
24749079|NCT01817751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24749080|NCT01817751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24749322|NCT01190787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24749323|NCT01190787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24749324|NCT01190787|Alkylating Agents|alkylating agents|mesh-ancestor
24749325|NCT01190787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24749326|NCT01190787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24749327|NCT01190787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24749328|NCT01190787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24749329|NCT01190787|Glucocorticoids|glucocorticoids|mesh-ancestor
24749330|NCT01190787|Hormones|hormones|mesh-ancestor
24749331|NCT01190787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24749332|NCT01190787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24749333|NCT01187433|Vaccines|vaccines|mesh-list
24749334|NCT01187433|Immunologic Factors|immunologic factors|mesh-ancestor
24749335|NCT01187433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749776|NCT00379340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24749933|NCT01695005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24749934|NCT01695005|Glucocorticoids|glucocorticoids|mesh-ancestor
24749935|NCT01695005|Hormones|hormones|mesh-ancestor
24749936|NCT01695005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24749937|NCT01695005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24749938|NCT01695005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24750005|NCT01695460|Cholecalciferol|cholecalciferol|mesh-list
24750007|NCT01695460|Micronutrients|micronutrients|mesh-ancestor
24750008|NCT01695460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750009|NCT01695460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24750010|NCT01695460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24750011|NCT01695707|Pioglitazone|pioglitazone|mesh-list
24750012|NCT01695707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24750013|NCT01695707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750014|NCT01695733|Vaccines|vaccines|mesh-list
24750015|NCT01695733|Immunologic Factors|immunologic factors|mesh-ancestor
24750016|NCT01695733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750017|NCT01695759|Epoetin Alfa|epoetin alfa|mesh-list
24750018|NCT01695759|Hematinics|hematinics|mesh-ancestor
24750065|NCT01696409|Vitamin D|vitamin d|mesh-list
24750066|NCT01696409|Ergocalciferols|ergocalciferols|mesh-list
24750067|NCT01696409|Cholecalciferol|cholecalciferol|mesh-list
24750068|NCT01696409|Vitamins|vitamins|mesh-list
24750069|NCT01696409|Micronutrients|micronutrients|mesh-ancestor
24750070|NCT01696409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750071|NCT01696409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24750072|NCT01696409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25713248|NCT02336607|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25713249|NCT02336607|Protease Inhibitors|protease inhibitors|mesh-ancestor
25713250|NCT02336607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713251|NCT02336607|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25713252|NCT02336607|Protective Agents|protective agents|mesh-ancestor
25713253|NCT02336607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24750073|NCT01696422|Vaccines|vaccines|mesh-list
25713254|NCT02336607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24750074|NCT01696422|Immunologic Factors|immunologic factors|mesh-ancestor
24750075|NCT01696422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750077|NCT01696448|Antioxidants|antioxidants|mesh-ancestor
24750078|NCT01696448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750079|NCT01696448|Protective Agents|protective agents|mesh-ancestor
24750080|NCT01696448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750148|NCT01696799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750149|NCT01696799|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24750150|NCT01696799|Hormone Antagonists|hormone antagonists|mesh-ancestor
24750151|NCT01696799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24750152|NCT01696799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750200|NCT01697059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24750201|NCT01697059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24750202|NCT01697059|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24750203|NCT01697059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750204|NCT01697059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750359|NCT01697826|Clotrimazole|clotrimazole|mesh-list
24750360|NCT01697826|Miconazole|miconazole|mesh-list
24750361|NCT01697826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24750362|NCT01697826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24750363|NCT01697826|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24750364|NCT01697826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24750365|NCT01697826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750366|NCT01697826|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24750367|NCT01697826|Antifungal Agents|antifungal agents|mesh-ancestor
24750510|NCT01699113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24750603|NCT01699594|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24750604|NCT01699594|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
24750653|NCT01699854|Sensory System Agents|sensory system agents|mesh-ancestor
24750654|NCT01699854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24750655|NCT01699854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750657|NCT01699919|Anesthetics, Local|anesthetics, local|mesh-ancestor
24750658|NCT01699919|Anesthetics|anesthetics|mesh-ancestor
24750659|NCT01699919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24750660|NCT01699919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750661|NCT01699919|Sensory System Agents|sensory system agents|mesh-ancestor
24750662|NCT01699919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24750663|NCT01699919|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24750664|NCT01699919|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24750690|NCT01700270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24750691|NCT01700270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24750692|NCT01700270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24750693|NCT01700270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750694|NCT01700270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24750695|NCT01700270|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24750696|NCT01700270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24750697|NCT01700270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24750698|NCT01700270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24750937|NCT01701232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24750938|NCT01701232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24750939|NCT01701232|Immunologic Factors|immunologic factors|mesh-ancestor
25713255|NCT02336607|Vasodilator Agents|vasodilator agents|mesh-ancestor
25713256|NCT02336737|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
25713257|NCT02336737|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25713258|NCT02336737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713259|NCT02336815|Dexamethasone|dexamethasone|mesh-list
25713260|NCT02336815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24750940|NCT01701232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750941|NCT01701232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24750942|NCT01701297|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24750943|NCT01701297|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24750944|NCT01701297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24750945|NCT01701297|Renal Agents|renal agents|mesh-ancestor
24750946|NCT01701297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24750947|NCT01701297|Antimalarials|antimalarials|mesh-ancestor
24750948|NCT01701297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24750949|NCT01701297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24750998|NCT01701479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24750999|NCT01701479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24751000|NCT01701479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24751001|NCT01701479|Antiviral Agents|antiviral agents|mesh-ancestor
24751002|NCT01701479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24751003|NCT01701479|Dermatologic Agents|dermatologic agents|mesh-ancestor
24751004|NCT01701518|Dexamethasone|dexamethasone|mesh-list
24751005|NCT01701518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24751115|NCT01702129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24751186|NCT01702701|Fluticasone|fluticasone|mesh-list
24751187|NCT01702701|Montelukast|montelukast|mesh-list
24751188|NCT01702701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24751189|NCT01702701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24751190|NCT01702701|Autonomic Agents|autonomic agents|mesh-ancestor
24751271|NCT01703130|Anesthetics, Local|anesthetics, local|mesh-ancestor
24751273|NCT01703130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24751274|NCT01703130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751277|NCT01703234|Ramipril|ramipril|mesh-list
24751344|NCT01703624|Anticonvulsants|anticonvulsants|mesh-ancestor
24619055|NCT01050595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24619056|NCT01050595|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24619057|NCT01050608|Ethanol|ethanol|mesh-list
24619074|NCT01050699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24751345|NCT01703624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24619075|NCT01050699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24751346|NCT01703624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24751347|NCT01703624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24751348|NCT01703624|Cholinergic Agents|cholinergic agents|mesh-ancestor
24751349|NCT01703624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24751412|NCT01703910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24751414|NCT01703910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24751653|NCT01705340|Trastuzumab|trastuzumab|mesh-list
24751654|NCT01705340|Lapatinib|lapatinib|mesh-list
24751655|NCT01705340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24751729|NCT01705743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24751863|NCT01706887|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24751865|NCT01706887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24751926|NCT01707251|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24751927|NCT01707251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416422|NCT00203073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24619154|NCT01051102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619155|NCT01051115|Dasatinib|dasatinib|mesh-list
24619156|NCT01051115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24619157|NCT01051115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24619158|NCT01051115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24752087|NCT01708330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752088|NCT01708369|Aspirin|aspirin|mesh-list
24752089|NCT01708369|Ethanol|ethanol|mesh-list
24752090|NCT01708369|Oseltamivir|oseltamivir|mesh-list
24752091|NCT01708369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24752092|NCT01708369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24752093|NCT01708369|Analgesics|analgesics|mesh-ancestor
24906241|NCT04341402|Analgesics|analgesics|mesh-ancestor
24752094|NCT01708369|Sensory System Agents|sensory system agents|mesh-ancestor
24416640|NCT00203632|Rosiglitazone|rosiglitazone|mesh-list
24752097|NCT01708369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24752154|NCT01708707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24752155|NCT01708707|Narcotics|narcotics|mesh-ancestor
24752156|NCT01708707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24752157|NCT01708707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752158|NCT01708707|Analgesics|analgesics|mesh-ancestor
24752159|NCT01708707|Sensory System Agents|sensory system agents|mesh-ancestor
24752161|NCT01708707|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24752162|NCT01708720|Vaccines|vaccines|mesh-list
24752163|NCT01708720|Immunologic Factors|immunologic factors|mesh-ancestor
24752165|NCT01708798|Eplerenone|eplerenone|mesh-list
24752224|NCT01709019|Vaccines|vaccines|mesh-list
24752225|NCT01709019|Immunologic Factors|immunologic factors|mesh-ancestor
24752226|NCT01709019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752227|NCT01709071|Vaccines|vaccines|mesh-list
24752228|NCT01709071|Immunologic Factors|immunologic factors|mesh-ancestor
24752230|NCT01709292|Vemurafenib|vemurafenib|mesh-list
24752325|NCT01709825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24752326|NCT01709929|Insulin Detemir|insulin detemir|mesh-list
24619170|NCT01051193|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24619171|NCT01051219|Losartan|losartan|mesh-list
24619172|NCT01051219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24619173|NCT01051219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24619174|NCT01051219|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24752350|NCT01709994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24752351|NCT01709994|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24752352|NCT01709994|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24752610|NCT01711320|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24752611|NCT01711320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24752681|NCT01711528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24752682|NCT01711528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752684|NCT01711528|Glucocorticoids|glucocorticoids|mesh-ancestor
24752698|NCT01711567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24752719|NCT01711671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24752720|NCT01711671|Immunologic Factors|immunologic factors|mesh-ancestor
24752721|NCT01711671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24752722|NCT01711671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24752723|NCT01711671|Growth Substances|growth substances|mesh-ancestor
24752724|NCT01711671|Growth Inhibitors|growth inhibitors|mesh-ancestor
24752726|NCT01711697|Carboplatin|carboplatin|mesh-list
24752727|NCT01711697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24752728|NCT01711697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24752733|NCT01711723|Darapladib|darapladib|mesh-list
24752798|NCT01712126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24752799|NCT01712126|Diuretics|diuretics|mesh-ancestor
24752800|NCT01712126|Natriuretic Agents|natriuretic agents|mesh-ancestor
24752801|NCT01712126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752802|NCT01712126|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24752808|NCT01712139|Irbesartan|irbesartan|mesh-list
24752819|NCT01712295|Salicylates|salicylates|mesh-list
24752820|NCT01712295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24752821|NCT01712295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24752822|NCT01712295|Analgesics|analgesics|mesh-ancestor
24752823|NCT01712295|Sensory System Agents|sensory system agents|mesh-ancestor
24752824|NCT01712295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24752825|NCT01712295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24752826|NCT01712295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24752827|NCT01712295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24752879|NCT01712568|Dopamine Agents|dopamine agents|mesh-ancestor
24753016|NCT01713231|Ergocalciferols|ergocalciferols|mesh-list
24753017|NCT01713231|Cholecalciferol|cholecalciferol|mesh-list
24753018|NCT01713231|Vitamins|vitamins|mesh-list
24753019|NCT01713231|Micronutrients|micronutrients|mesh-ancestor
24753020|NCT01713231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619248|NCT01051583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24619249|NCT01051583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24619250|NCT01051583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24619251|NCT01051583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24619252|NCT01051583|Growth Substances|growth substances|mesh-ancestor
24619253|NCT01051583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619254|NCT01051583|Growth Inhibitors|growth inhibitors|mesh-ancestor
24619255|NCT01051622|Technetium Tc 99m Exametazime|technetium tc 99m exametazime|mesh-list
24619256|NCT01051622|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24897703|NCT04423185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713261|NCT02336815|Antiemetics|antiemetics|mesh-ancestor
25713262|NCT02336815|Autonomic Agents|autonomic agents|mesh-ancestor
25713263|NCT02336815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713264|NCT02336815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713265|NCT02336815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25713266|NCT02336815|Glucocorticoids|glucocorticoids|mesh-ancestor
25713267|NCT02336815|Hormones|hormones|mesh-ancestor
25713268|NCT02336815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25713269|NCT02336815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25713270|NCT02336815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713271|NCT02336958|Ropivacaine|ropivacaine|mesh-list
25713272|NCT02336958|Prilocaine|prilocaine|mesh-list
24753237|NCT01714297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24753238|NCT01714297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24753239|NCT01714297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753240|NCT01714388|Remifentanil|remifentanil|mesh-list
24753241|NCT01714388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24753242|NCT01714388|Narcotics|narcotics|mesh-ancestor
24753306|NCT01714570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24753307|NCT01714570|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24753308|NCT01714570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753309|NCT01714570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753310|NCT01714596|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24753321|NCT01714765|Everolimus|everolimus|mesh-list
24753371|NCT01714908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24417980|NCT00208260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753464|NCT01715519|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24753465|NCT01715519|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24753467|NCT01715584|Sevoflurane|sevoflurane|mesh-list
24753468|NCT01715584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24753469|NCT01715584|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24753470|NCT01715584|Anesthetics, General|anesthetics, general|mesh-ancestor
24753471|NCT01715584|Anesthetics|anesthetics|mesh-ancestor
24753472|NCT01715584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24753473|NCT01715584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753546|NCT01715922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753547|NCT01715922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24753548|NCT01715922|Hormone Antagonists|hormone antagonists|mesh-ancestor
24753549|NCT01715922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24753550|NCT01715922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753551|NCT01715922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24753555|NCT01715935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24753587|NCT01716377|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24753588|NCT01716377|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24753589|NCT01716377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24753590|NCT01716377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24753673|NCT01716767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24753675|NCT01716767|Dermatologic Agents|dermatologic agents|mesh-ancestor
24753676|NCT01716858|Sulforaphane|sulforaphane|mesh-list
24753677|NCT01716858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24753678|NCT01716858|Protective Agents|protective agents|mesh-ancestor
24753890|NCT01718288|Vasodilator Agents|vasodilator agents|mesh-ancestor
24753891|NCT01718301|Ribavirin|ribavirin|mesh-list
24753892|NCT01718301|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24753893|NCT01718301|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24753894|NCT01718301|Antimetabolites|antimetabolites|mesh-ancestor
24753895|NCT01718301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24753896|NCT01718301|Antiviral Agents|antiviral agents|mesh-ancestor
24753897|NCT01718301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24753898|NCT01718314|Lidocaine|lidocaine|mesh-list
24753940|NCT01718366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713273|NCT02336958|Anesthetics, Local|anesthetics, local|mesh-ancestor
25713274|NCT02336958|Anesthetics|anesthetics|mesh-ancestor
25713275|NCT02336958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25713276|NCT02336958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713277|NCT02336958|Sensory System Agents|sensory system agents|mesh-ancestor
25713278|NCT02336958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713279|NCT02337478|Vincristine|vincristine|mesh-list
25713280|NCT02337478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24753941|NCT01718366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24753942|NCT01718366|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24753943|NCT01718366|Chelating Agents|chelating agents|mesh-ancestor
24753944|NCT01718366|Sequestering Agents|sequestering agents|mesh-ancestor
24753946|NCT01718379|Immunologic Factors|immunologic factors|mesh-ancestor
24753947|NCT01718379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754148|NCT01719302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24754150|NCT01719302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24754151|NCT01719302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24754152|NCT01719302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24754153|NCT01719302|Immunologic Factors|immunologic factors|mesh-ancestor
24754154|NCT01719302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754155|NCT01719302|Tubulin Modulators|tubulin modulators|mesh-ancestor
24754156|NCT01719302|Antimitotic Agents|antimitotic agents|mesh-ancestor
24754157|NCT01719302|Mitosis Modulators|mitosis modulators|mesh-ancestor
24754158|NCT01719419|Orlistat|orlistat|mesh-list
24619390|NCT01052298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24619391|NCT01052298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24754271|NCT01719835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24754272|NCT01719835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24754273|NCT01719835|Glucocorticoids|glucocorticoids|mesh-ancestor
24754274|NCT01719835|Hormones|hormones|mesh-ancestor
24619392|NCT01052298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24619393|NCT01052298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619413|NCT01052324|Sensory System Agents|sensory system agents|mesh-ancestor
24619414|NCT01052324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24754525|NCT01721135|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24754526|NCT01721135|Contraceptive Agents|contraceptive agents|mesh-ancestor
24754527|NCT01721135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24754528|NCT01721135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24754529|NCT01721135|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24754530|NCT01721135|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24754666|NCT01722305|Dexamethasone|dexamethasone|mesh-list
24619476|NCT01052597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619477|NCT01052623|Clonidine|clonidine|mesh-list
24619478|NCT01052623|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24619479|NCT01052623|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24619480|NCT01052623|Estradiol|estradiol|mesh-list
24619481|NCT01052623|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24619482|NCT01052623|Hormones|hormones|mesh-ancestor
24619483|NCT01052623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24619484|NCT01052623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24619485|NCT01052623|Estrogens|estrogens|mesh-ancestor
24619486|NCT01052623|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24619487|NCT01052623|Contraceptive Agents|contraceptive agents|mesh-ancestor
24754723|NCT01722513|Alprostadil|alprostadil|mesh-list
24754790|NCT01722942|Amiodarone|amiodarone|mesh-list
24755021|NCT01724372|Fluoxetine|fluoxetine|mesh-list
24755022|NCT01724372|Antidepressive Agents|antidepressive agents|mesh-list
24755023|NCT01724372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24755024|NCT01724372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24755027|NCT01724372|Dopamine Agonists|dopamine agonists|mesh-ancestor
24755080|NCT01724554|Growth Inhibitors|growth inhibitors|mesh-ancestor
24755081|NCT01724554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755082|NCT01724619|Dihydrotestosterone|dihydrotestosterone|mesh-list
24755083|NCT01724619|Androgens|androgens|mesh-ancestor
24755084|NCT01724619|Hormones|hormones|mesh-ancestor
24755085|NCT01724619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24755086|NCT01724619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755087|NCT01724658|Methyltestosterone|methyltestosterone|mesh-list
24755088|NCT01724658|Testosterone|testosterone|mesh-list
24755090|NCT01724658|Testosterone enanthate|testosterone enanthate|mesh-list
24755151|NCT01724983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24619555|NCT01052974|Sensory System Agents|sensory system agents|mesh-ancestor
24619556|NCT01052974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24619558|NCT01052987|Allopurinol|allopurinol|mesh-list
24619559|NCT01052987|Antimetabolites|antimetabolites|mesh-ancestor
24619560|NCT01052987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24619561|NCT01052987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24619562|NCT01052987|Gout Suppressants|gout suppressants|mesh-ancestor
24619563|NCT01052987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24755384|NCT01726283|Dermatologic Agents|dermatologic agents|mesh-ancestor
24755385|NCT01726400|Interferons|interferons|mesh-list
24755386|NCT01726400|Ribavirin|ribavirin|mesh-list
24755387|NCT01726400|Interferon-alpha|interferon-alpha|mesh-list
24755388|NCT01726400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755389|NCT01726400|Antiviral Agents|antiviral agents|mesh-ancestor
24755699|NCT01728363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24755700|NCT01728363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24755701|NCT01728363|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24755702|NCT01728363|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24755703|NCT01728363|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24755737|NCT01728818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24755738|NCT01728818|Antiviral Agents|antiviral agents|mesh-ancestor
24755739|NCT01728818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24755740|NCT01728818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24755741|NCT01728818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24755742|NCT01728818|Immunologic Factors|immunologic factors|mesh-ancestor
24755743|NCT01728818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24755744|NCT01728818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24755746|NCT01728909|Oxytocics|oxytocics|mesh-ancestor
24755747|NCT01728909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24619638|NCT01053325|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24619639|NCT01053325|Antimalarials|antimalarials|mesh-ancestor
24619640|NCT01053325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24619641|NCT01053325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24619642|NCT01053325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24619643|NCT01053325|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24619644|NCT01053325|Renal Agents|renal agents|mesh-ancestor
25713281|NCT02337478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713282|NCT02337478|Tubulin Modulators|tubulin modulators|mesh-ancestor
25713283|NCT02337478|Antimitotic Agents|antimitotic agents|mesh-ancestor
25713284|NCT02337478|Mitosis Modulators|mitosis modulators|mesh-ancestor
25713285|NCT02337478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713286|NCT02337491|Bevacizumab|bevacizumab|mesh-list
25713287|NCT02337491|Pembrolizumab|pembrolizumab|mesh-list
25713288|NCT02337491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25713289|NCT02337491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713290|NCT02337491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24756241|NCT01731782|Anesthetics, Local|anesthetics, local|mesh-ancestor
24756242|NCT01731782|Anesthetics|anesthetics|mesh-ancestor
24756243|NCT01731782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24756244|NCT01731782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756245|NCT01731782|Sensory System Agents|sensory system agents|mesh-ancestor
24756246|NCT01731782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24756247|NCT01731795|Dexamethasone|dexamethasone|mesh-list
24756248|NCT01731795|Dexamethasone acetate|dexamethasone acetate|mesh-list
24756711|NCT01735240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24756712|NCT01735240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24756713|NCT01735240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756714|NCT01735240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756715|NCT01735240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24756716|NCT01735240|Hormone Antagonists|hormone antagonists|mesh-ancestor
24756717|NCT01735240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24756718|NCT01735240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756719|NCT01735240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24756720|NCT01735318|Lisinopril|lisinopril|mesh-list
24756721|NCT01735318|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24756722|NCT01735318|Protease Inhibitors|protease inhibitors|mesh-ancestor
24756723|NCT01735318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756724|NCT01735318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756725|NCT01735318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24756726|NCT01735318|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24756727|NCT01735318|Protective Agents|protective agents|mesh-ancestor
24756728|NCT01735318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756729|NCT01735344|Lisinopril|lisinopril|mesh-list
24756758|NCT01735383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24756760|NCT01735383|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24756761|NCT01735383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24756762|NCT01735383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24756763|NCT01735383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24756764|NCT01735487|Nicotine|nicotine|mesh-list
24756765|NCT01735487|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24756766|NCT01735487|Autonomic Agents|autonomic agents|mesh-ancestor
24756767|NCT01735487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24756768|NCT01735487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24756769|NCT01735487|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24757085|NCT01737671|Antimetabolites|antimetabolites|mesh-ancestor
24757086|NCT01737671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757087|NCT01737671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24757088|NCT01737671|Dermatologic Agents|dermatologic agents|mesh-ancestor
24757089|NCT01737671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757090|NCT01737671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24757091|NCT01737671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24757092|NCT01737671|Immunologic Factors|immunologic factors|mesh-ancestor
24757093|NCT01737671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24757094|NCT01737671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24757095|NCT01737671|Antidotes|antidotes|mesh-ancestor
24757096|NCT01737671|Protective Agents|protective agents|mesh-ancestor
24757097|NCT01737671|Vitamin B Complex|vitamin b complex|mesh-ancestor
24757098|NCT01737671|Vitamins|vitamins|mesh-ancestor
24757099|NCT01737671|Micronutrients|micronutrients|mesh-ancestor
24757100|NCT01737918|Solifenacin Succinate|solifenacin succinate|mesh-list
24757101|NCT01737918|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24757102|NCT01737918|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24757120|NCT01738087|Xhance|xhance|mesh-list
24757359|NCT01739439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757360|NCT01739504|Anesthetics|anesthetics|mesh-list
24757361|NCT01739504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24757363|NCT01739556|Aspirin|aspirin|mesh-list
24619774|NCT01053650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24757644|NCT01741519|Adrenergic Agents|adrenergic agents|mesh-ancestor
24757677|NCT01741623|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24757698|NCT01741831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757700|NCT01741831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24757702|NCT01741831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24757703|NCT01741948|Contraceptive Agents|contraceptive agents|mesh-list
24757704|NCT01741948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24757705|NCT01741948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24757707|NCT01742247|Analgesics|analgesics|mesh-ancestor
24757774|NCT01742429|Amoxicillin|amoxicillin|mesh-list
24757789|NCT01742429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24757790|NCT01742429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757791|NCT01742429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757792|NCT01742429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24757793|NCT01742429|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24757794|NCT01742429|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24757796|NCT01742429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24757797|NCT01742429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24757798|NCT01742429|Antidiarrheals|antidiarrheals|mesh-ancestor
24757799|NCT01742533|Hormones|hormones|mesh-list
24757802|NCT01742624|Mycophenolic Acid|mycophenolic acid|mesh-list
24757846|NCT01742689|Indomethacin|indomethacin|mesh-list
24757854|NCT01742689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24757855|NCT01742689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24757856|NCT01742689|Gout Suppressants|gout suppressants|mesh-ancestor
24757857|NCT01742689|Tocolytic Agents|tocolytic agents|mesh-ancestor
24757858|NCT01742689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24757859|NCT01742689|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24663323|NCT01300377|Lidocaine|lidocaine|mesh-list
24757861|NCT01742689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757862|NCT01742689|Hemostatics|hemostatics|mesh-ancestor
24757863|NCT01742689|Coagulants|coagulants|mesh-ancestor
24757864|NCT01742689|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
24757865|NCT01742689|Natriuretic Agents|natriuretic agents|mesh-ancestor
24757866|NCT01742702|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
25713291|NCT02337491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25713292|NCT02337491|Growth Substances|growth substances|mesh-ancestor
25713293|NCT02337491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713294|NCT02337491|Growth Inhibitors|growth inhibitors|mesh-ancestor
25713295|NCT02337530|Cisplatin|cisplatin|mesh-list
25713296|NCT02337530|Carboplatin|carboplatin|mesh-list
25713297|NCT02337530|Pemetrexed|pemetrexed|mesh-list
25713298|NCT02337530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713299|NCT02337530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713300|NCT02337530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713301|NCT02337530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25713302|NCT02337530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25713304|NCT02337907|BI 409306|bi 409306|mesh-list
25713305|NCT02337907|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25713306|NCT02337907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713307|NCT02337907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713308|NCT02337907|Cholinergic Agents|cholinergic agents|mesh-ancestor
25713309|NCT02337907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25713310|NCT02337907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713311|NCT02337907|Nootropic Agents|nootropic agents|mesh-ancestor
24757892|NCT01742702|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24757893|NCT01742702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24757894|NCT01742767|Pemetrexed|pemetrexed|mesh-list
24757895|NCT01742767|Cisplatin|cisplatin|mesh-list
24757896|NCT01742767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24757897|NCT01742767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24757898|NCT01742767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24757899|NCT01742767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24757900|NCT01742767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24757901|NCT01742793|Lenalidomide|lenalidomide|mesh-list
24757902|NCT01742793|Romidepsin|romidepsin|mesh-list
24758021|NCT01743300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24758023|NCT01743300|Growth Inhibitors|growth inhibitors|mesh-ancestor
24758024|NCT01743300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24758025|NCT01743300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24758027|NCT01743326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24758028|NCT01743326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758201|NCT01744314|Indomethacin|indomethacin|mesh-list
24758202|NCT01744314|Pantoprazole|pantoprazole|mesh-list
24758203|NCT01744314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24758204|NCT01744314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24758224|NCT01744379|Gout Suppressants|gout suppressants|mesh-ancestor
24758283|NCT01744873|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24423010|NCT00224445|Ritonavir|ritonavir|mesh-list
24758284|NCT01744873|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24758285|NCT01744873|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24758286|NCT01744873|Adrenergic Agents|adrenergic agents|mesh-ancestor
24758287|NCT01744873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24758288|NCT01744873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758289|NCT01744886|Benzocaine|benzocaine|mesh-list
24758448|NCT01745770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758449|NCT01745770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24758450|NCT01745770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24758451|NCT01745809|Dimercaprol|dimercaprol|mesh-list
24758583|NCT01746875|Growth Inhibitors|growth inhibitors|mesh-ancestor
24758584|NCT01746875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758585|NCT01746875|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24758586|NCT01746875|Dermatologic Agents|dermatologic agents|mesh-ancestor
24758588|NCT01746992|Cyclophosphamide|cyclophosphamide|mesh-list
24758589|NCT01746992|Ifosfamide|ifosfamide|mesh-list
24758590|NCT01746992|Doxorubicin|doxorubicin|mesh-list
24758591|NCT01746992|Methotrexate|methotrexate|mesh-list
24758592|NCT01746992|Etoposide|etoposide|mesh-list
24758593|NCT01746992|Vincristine|vincristine|mesh-list
24758594|NCT01746992|Etoposide phosphate|etoposide phosphate|mesh-list
24758595|NCT01746992|Pirarubicin|pirarubicin|mesh-list
24758596|NCT01746992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24758702|NCT01747564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713312|NCT02337907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24758703|NCT01747564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758704|NCT01747564|Urological Agents|urological agents|mesh-ancestor
24758773|NCT01747707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758774|NCT01747707|Tubulin Modulators|tubulin modulators|mesh-ancestor
24758775|NCT01747707|Antimitotic Agents|antimitotic agents|mesh-ancestor
24758776|NCT01747707|Mitosis Modulators|mitosis modulators|mesh-ancestor
24758777|NCT01747707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758829|NCT01748253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24758830|NCT01748253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24758831|NCT01748253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24758832|NCT01748253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758834|NCT01748253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24758835|NCT01748253|Vasodilator Agents|vasodilator agents|mesh-ancestor
24758881|NCT01748370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24758882|NCT01748370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24758884|NCT01748396|Calcium Carbonate|calcium carbonate|mesh-list
24758885|NCT01748396|Calcium|calcium|mesh-list
24758886|NCT01748396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24758888|NCT01748396|Antacids|antacids|mesh-ancestor
24620050|NCT01055301|Hormones|hormones|mesh-ancestor
24620051|NCT01055301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24620052|NCT01055301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24620053|NCT01055301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24620054|NCT01055301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24620055|NCT01055301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24620065|NCT01055327|Lamotrigine|lamotrigine|mesh-list
24758987|NCT01748773|Antimetabolites|antimetabolites|mesh-ancestor
24758988|NCT01748773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24758989|NCT01748773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24758990|NCT01748773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24758992|NCT01748838|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24758993|NCT01748838|Diuretics|diuretics|mesh-ancestor
24450826|NCT00320697|Cholinergic Agents|cholinergic agents|mesh-ancestor
24450827|NCT00320697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24450828|NCT00320697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24459766|NCT00346359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713314|NCT02337933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713315|NCT02337933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25713316|NCT02337933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25713317|NCT02337933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713318|NCT02337933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25713319|NCT02337933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713320|NCT02337933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24459767|NCT00346359|Dermatologic Agents|dermatologic agents|mesh-ancestor
24459768|NCT00346359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459769|NCT00346359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24459770|NCT00346359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24459771|NCT00346359|Immunologic Factors|immunologic factors|mesh-ancestor
24424194|NCT00228254|Micronutrients|micronutrients|mesh-ancestor
25713321|NCT02337933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25713322|NCT02337933|Analgesics|analgesics|mesh-ancestor
25713323|NCT02337933|Sensory System Agents|sensory system agents|mesh-ancestor
25713324|NCT02337933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713325|NCT02337933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713326|NCT02337933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25713327|NCT02337933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24394280|NCT00132821|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24394281|NCT00132821|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24394282|NCT00132821|Cholinergic Agents|cholinergic agents|mesh-ancestor
24394319|NCT00132912|Vorapaxar|vorapaxar|mesh-list
24394953|NCT00134693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24394954|NCT00134693|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24394955|NCT00134693|Protective Agents|protective agents|mesh-ancestor
24394956|NCT00134706|Carboplatin|carboplatin|mesh-list
24394957|NCT00134706|Docetaxel|docetaxel|mesh-list
24394958|NCT00134706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24394959|NCT00134706|Tubulin Modulators|tubulin modulators|mesh-ancestor
24394960|NCT00134706|Antimitotic Agents|antimitotic agents|mesh-ancestor
24394961|NCT00134706|Mitosis Modulators|mitosis modulators|mesh-ancestor
24394983|NCT00134875|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
24394986|NCT00134875|Narcotics|narcotics|mesh-ancestor
24394987|NCT00134875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24394988|NCT00134875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394989|NCT00134875|Analgesics|analgesics|mesh-ancestor
24394990|NCT00134875|Sensory System Agents|sensory system agents|mesh-ancestor
24394991|NCT00134875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24394992|NCT00134875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24394993|NCT00134888|Buprenorphine|buprenorphine|mesh-list
24394994|NCT00134888|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
24394995|NCT00134888|Naloxone|naloxone|mesh-list
24459792|NCT00346489|Fluorouracil|fluorouracil|mesh-list
24459793|NCT00346489|Mitomycins|mitomycins|mesh-list
24459794|NCT00346489|Mitomycin|mitomycin|mesh-list
24394996|NCT00134888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24394997|NCT00134888|Narcotics|narcotics|mesh-ancestor
24394998|NCT00134888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24395000|NCT00134888|Analgesics|analgesics|mesh-ancestor
24395079|NCT00135018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24395081|NCT00135018|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24395533|NCT00136344|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24395536|NCT00136344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24395537|NCT00136344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24395538|NCT00136344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24395539|NCT00136344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395541|NCT00136344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24395813|NCT00136981|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25713328|NCT02337946|Calcium, Dietary|calcium, dietary|mesh-list
25713329|NCT02337946|Leucovorin|leucovorin|mesh-list
25713330|NCT02337946|Oxaliplatin|oxaliplatin|mesh-list
25713331|NCT02337946|Fluorouracil|fluorouracil|mesh-list
25713332|NCT02337946|Panitumumab|panitumumab|mesh-list
25713333|NCT02337946|Calcium|calcium|mesh-list
25713334|NCT02337946|Levoleucovorin|levoleucovorin|mesh-list
25713335|NCT02337946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24395814|NCT00136981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24395815|NCT00136994|Ziprasidone|ziprasidone|mesh-list
24395851|NCT00137033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24395852|NCT00137033|Analgesics|analgesics|mesh-ancestor
24459805|NCT00346489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459806|NCT00346502|Betulinic acid|betulinic acid|mesh-list
24459807|NCT00346502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24459808|NCT00346502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24459809|NCT00346502|Analgesics|analgesics|mesh-ancestor
24459810|NCT00346502|Sensory System Agents|sensory system agents|mesh-ancestor
24459811|NCT00346502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24459812|NCT00346502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459813|NCT00346502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24459820|NCT00346502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396052|NCT00137735|Analgesics|analgesics|mesh-ancestor
24396053|NCT00137735|Sensory System Agents|sensory system agents|mesh-ancestor
24396089|NCT00137787|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24396119|NCT00137826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396120|NCT00137826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24396121|NCT00137826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24396122|NCT00137826|Growth Substances|growth substances|mesh-ancestor
24396123|NCT00137826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396246|NCT00138216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24396247|NCT00138216|Alkylating Agents|alkylating agents|mesh-ancestor
24396248|NCT00138229|Aldesleukin|aldesleukin|mesh-list
24396249|NCT00138229|Cyclophosphamide|cyclophosphamide|mesh-list
24396250|NCT00138229|Fludarabine|fludarabine|mesh-list
24396501|NCT00139204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396504|NCT00139217|Autonomic Agents|autonomic agents|mesh-ancestor
24396539|NCT00139230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24396543|NCT00139243|Leucovorin|leucovorin|mesh-list
24459849|NCT00346580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24459850|NCT00346580|Antiviral Agents|antiviral agents|mesh-ancestor
24459851|NCT00346580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24398592|NCT00144911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24398593|NCT00144911|Adrenergic Agents|adrenergic agents|mesh-ancestor
24398594|NCT00144911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24398595|NCT00144911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398596|NCT00144976|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24398597|NCT00144976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24398598|NCT00144976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24398626|NCT00145106|Keratolytic Agents|keratolytic agents|mesh-ancestor
24398628|NCT00145171|Emetics|emetics|mesh-ancestor
24398629|NCT00145171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398692|NCT00145314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398722|NCT00145444|Autonomic Agents|autonomic agents|mesh-ancestor
24398723|NCT00145444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24398724|NCT00145444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398725|NCT00145444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24398726|NCT00145444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24398727|NCT00145444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24398728|NCT00145444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24398729|NCT00145444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24398730|NCT00145444|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24398731|NCT00145444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24399097|NCT00146588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399098|NCT00146588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24399329|NCT00147394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24399331|NCT00147511|Linezolid|linezolid|mesh-list
24399332|NCT00147511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24399333|NCT00147511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24399365|NCT00147602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399366|NCT00147602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24399367|NCT00147602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24399368|NCT00147602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459856|NCT00346619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24459858|NCT00346619|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25713336|NCT02337946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713337|NCT02337946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24399638|NCT00148291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399822|NCT00148720|Antimetabolites|antimetabolites|mesh-ancestor
24399823|NCT00148720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400086|NCT00149617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24400087|NCT00149617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24400088|NCT00149617|Serotonin Agents|serotonin agents|mesh-ancestor
24400089|NCT00149617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24400090|NCT00149617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400120|NCT00149877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400122|NCT00149903|Mycophenolic Acid|mycophenolic acid|mesh-list
24400295|NCT00150280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400296|NCT00150280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400297|NCT00150280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24400299|NCT00150293|Analgesics|analgesics|mesh-ancestor
24400300|NCT00150293|Sensory System Agents|sensory system agents|mesh-ancestor
24400301|NCT00150293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24400302|NCT00150293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400303|NCT00150293|Anticonvulsants|anticonvulsants|mesh-ancestor
24400304|NCT00150293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24400305|NCT00150293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24400333|NCT00150358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400834|NCT00151463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24400835|NCT00151463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400836|NCT00151463|Urological Agents|urological agents|mesh-ancestor
24400870|NCT00151528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400873|NCT00151528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24400995|NCT00151944|Mesalamine|mesalamine|mesh-list
24400996|NCT00151944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24400997|NCT00151944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24400998|NCT00151944|Analgesics|analgesics|mesh-ancestor
24400999|NCT00151944|Sensory System Agents|sensory system agents|mesh-ancestor
24401000|NCT00151944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24401001|NCT00151944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401002|NCT00151944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24401028|NCT00151983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401029|NCT00151983|Dopamine Agents|dopamine agents|mesh-ancestor
24401030|NCT00151983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24401031|NCT00152022|Amphetamine|amphetamine|mesh-list
24401032|NCT00152022|Dextroamphetamine|dextroamphetamine|mesh-list
24401033|NCT00152022|Adderall|adderall|mesh-list
24401034|NCT00152022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24401246|NCT00152581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24401247|NCT00152581|Antimetabolites|antimetabolites|mesh-ancestor
24459879|NCT00346749|Respiratory System Agents|respiratory system agents|mesh-ancestor
24459880|NCT00346749|Dermatologic Agents|dermatologic agents|mesh-ancestor
24402149|NCT00155233|Analgesics|analgesics|mesh-ancestor
24402150|NCT00155233|Sensory System Agents|sensory system agents|mesh-ancestor
24402151|NCT00155233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24402152|NCT00155246|Pentoxifylline|pentoxifylline|mesh-list
24459882|NCT00346749|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24459883|NCT00346749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24459884|NCT00346749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24402153|NCT00155246|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25713338|NCT02337946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713339|NCT02337946|Antimetabolites|antimetabolites|mesh-ancestor
25713340|NCT02337946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713341|NCT02337946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24402154|NCT00155246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402156|NCT00155246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24402444|NCT00157326|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24402445|NCT00157326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24402513|NCT00157547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24402516|NCT00157547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24402517|NCT00157547|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24402518|NCT00157547|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24402520|NCT00157586|Delapril|delapril|mesh-list
24402521|NCT00157586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24402522|NCT00157586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24459886|NCT00346749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24402553|NCT00157729|Vitamin B Complex|vitamin b complex|mesh-ancestor
24402906|NCT00158782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24402907|NCT00158821|Tenofovir|tenofovir|mesh-list
24402908|NCT00158821|Lamivudine|lamivudine|mesh-list
24402909|NCT00158821|Efavirenz|efavirenz|mesh-list
24403007|NCT00159016|Imatinib Mesylate|imatinib mesylate|mesh-list
24403008|NCT00159016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24403009|NCT00159016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24403010|NCT00159016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403011|NCT00159016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403054|NCT00159133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24403055|NCT00159133|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24403056|NCT00159133|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24403057|NCT00159133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24403058|NCT00159133|GABA Modulators|gaba modulators|mesh-ancestor
24403059|NCT00159133|GABA Agents|gaba agents|mesh-ancestor
24403060|NCT00159133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24403062|NCT00159146|Pindolol|pindolol|mesh-list
24403619|NCT00161070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24403620|NCT00161070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403751|NCT00161434|Valacyclovir|valacyclovir|mesh-list
24403986|NCT00162331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403988|NCT00162344|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24403989|NCT00162344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403990|NCT00162357|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
24403991|NCT00162357|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24403992|NCT00162357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403993|NCT00162383|Dapsone|dapsone|mesh-list
24403994|NCT00162383|Debrisoquin|debrisoquin|mesh-list
24403995|NCT00162383|Mephenytoin|mephenytoin|mesh-list
24403996|NCT00162383|Caffeine|caffeine|mesh-list
24403998|NCT00162383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404001|NCT00162383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404030|NCT00162396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24404031|NCT00162396|Adrenergic Agents|adrenergic agents|mesh-ancestor
24404032|NCT00162396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24404033|NCT00162396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24404034|NCT00162409|Folic Acid|folic acid|mesh-list
24404035|NCT00162409|Hematinics|hematinics|mesh-ancestor
24404036|NCT00162409|Vitamin B Complex|vitamin b complex|mesh-ancestor
24404037|NCT00162409|Vitamins|vitamins|mesh-ancestor
24404038|NCT00162409|Micronutrients|micronutrients|mesh-ancestor
24404039|NCT00162409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404040|NCT00162422|Albuterol|albuterol|mesh-list
24404041|NCT00162422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24404042|NCT00162422|Autonomic Agents|autonomic agents|mesh-ancestor
24404043|NCT00162422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24404044|NCT00162422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404142|NCT00162643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25713342|NCT02337946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25713343|NCT02337946|Immunologic Factors|immunologic factors|mesh-ancestor
25713344|NCT02337946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25713345|NCT02337946|Antidotes|antidotes|mesh-ancestor
25713346|NCT02337946|Protective Agents|protective agents|mesh-ancestor
25713348|NCT02337946|Vitamins|vitamins|mesh-ancestor
25713349|NCT02337946|Micronutrients|micronutrients|mesh-ancestor
24404143|NCT00162643|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24404144|NCT00162643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24759002|NCT01748929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24404146|NCT00162643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24404147|NCT00162643|Antimetabolites|antimetabolites|mesh-ancestor
24404148|NCT00162643|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24404149|NCT00162643|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24404150|NCT00162643|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24459892|NCT00346801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24459893|NCT00346801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24459894|NCT00346801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24404151|NCT00162643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24404153|NCT00162656|Cyclophosphamide|cyclophosphamide|mesh-list
24404156|NCT00162656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24404157|NCT00162656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24404158|NCT00162656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24404159|NCT00162656|Alkylating Agents|alkylating agents|mesh-ancestor
24405076|NCT00165451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24405077|NCT00165451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24405078|NCT00165451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24405080|NCT00165451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24405081|NCT00165451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24405083|NCT00165451|Sensory System Agents|sensory system agents|mesh-ancestor
24405084|NCT00165451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24405115|NCT00165490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24405117|NCT00165490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24405243|NCT00166127|Protective Agents|protective agents|mesh-ancestor
24759003|NCT01748929|Tubulin Modulators|tubulin modulators|mesh-ancestor
24406740|NCT00171106|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24406741|NCT00171106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406743|NCT00171119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24406744|NCT00171119|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24406745|NCT00171119|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24406761|NCT00171132|Autonomic Agents|autonomic agents|mesh-ancestor
24406788|NCT00171184|Urological Agents|urological agents|mesh-ancestor
24406828|NCT00171392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406829|NCT00171392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24459901|NCT00346801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24459902|NCT00346801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24406830|NCT00171392|Antitubercular Agents|antitubercular agents|mesh-ancestor
24406851|NCT00171457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406852|NCT00171457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406854|NCT00171470|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24406855|NCT00171470|Serotonin Agents|serotonin agents|mesh-ancestor
24406856|NCT00171470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24406857|NCT00171470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406858|NCT00171470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407113|NCT00171886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407114|NCT00171899|Imatinib Mesylate|imatinib mesylate|mesh-list
24407115|NCT00171899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407116|NCT00171899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25713350|NCT02338076|Petrolatum|petrolatum|mesh-list
25713351|NCT02338076|Emollients|emollients|mesh-ancestor
25713352|NCT02338076|Dermatologic Agents|dermatologic agents|mesh-ancestor
25713353|NCT02338193|Metformin|metformin|mesh-list
25713354|NCT02338193|Dapagliflozin|dapagliflozin|mesh-list
25713355|NCT02338193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25713356|NCT02338193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713357|NCT02338193|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24407149|NCT00172029|Zoledronic Acid|zoledronic acid|mesh-list
24407150|NCT00172029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24407151|NCT00172029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407152|NCT00172055|Zoledronic Acid|zoledronic acid|mesh-list
24407296|NCT00174226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407297|NCT00174226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24407298|NCT00174226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24407299|NCT00174226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24407300|NCT00174226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24407301|NCT00174226|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24407302|NCT00174226|Serotonin Agents|serotonin agents|mesh-ancestor
24407303|NCT00174239|Levodopa|levodopa|mesh-list
24407304|NCT00174239|Carbidopa|carbidopa|mesh-list
24407305|NCT00174239|Cabergoline|cabergoline|mesh-list
24407334|NCT00174317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24407336|NCT00174317|Sensory System Agents|sensory system agents|mesh-ancestor
24407337|NCT00174317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24407338|NCT00174317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407339|NCT00174317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24407340|NCT00174317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24407384|NCT00174434|Paclitaxel|paclitaxel|mesh-list
24407385|NCT00174434|Sunitinib|sunitinib|mesh-list
24407386|NCT00174434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24407387|NCT00174434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407388|NCT00174434|Tubulin Modulators|tubulin modulators|mesh-ancestor
24407389|NCT00174434|Antimitotic Agents|antimitotic agents|mesh-ancestor
24407391|NCT00174434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407392|NCT00174434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24407393|NCT00174434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24407448|NCT00174551|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24407460|NCT00174577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24407511|NCT00174642|Metformin|metformin|mesh-list
24407561|NCT00174707|Tubulin Modulators|tubulin modulators|mesh-ancestor
24407562|NCT00174707|Antimitotic Agents|antimitotic agents|mesh-ancestor
24407563|NCT00174707|Mitosis Modulators|mitosis modulators|mesh-ancestor
24407628|NCT00174876|Dopamine Agonists|dopamine agonists|mesh-ancestor
24407629|NCT00174876|Dopamine Agents|dopamine agents|mesh-ancestor
24407630|NCT00174876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24407694|NCT00175032|Gout Suppressants|gout suppressants|mesh-ancestor
24407695|NCT00175032|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24459906|NCT00346827|Apomorphine|apomorphine|mesh-list
24414488|NCT00197743|Provitamins|provitamins|mesh-ancestor
24407696|NCT00175032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24407697|NCT00175032|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24407698|NCT00175045|Lansoprazole|lansoprazole|mesh-list
24407699|NCT00175045|Dexlansoprazole|dexlansoprazole|mesh-list
24407700|NCT00175045|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24407701|NCT00175045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24407702|NCT00175045|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24407703|NCT00175045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407724|NCT00175227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407725|NCT00175227|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24407726|NCT00175227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24407727|NCT00175227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713358|NCT02338193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713359|NCT02338362|Fluticasone|fluticasone|mesh-list
25713361|NCT02338362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25713362|NCT02338362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25713363|NCT02338362|Autonomic Agents|autonomic agents|mesh-ancestor
25713364|NCT02338362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713365|NCT02338362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713367|NCT02338362|Respiratory System Agents|respiratory system agents|mesh-ancestor
24407729|NCT00175253|Alemtuzumab|alemtuzumab|mesh-list
24407730|NCT00175253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25713368|NCT02338362|Dermatologic Agents|dermatologic agents|mesh-ancestor
25713369|NCT02338362|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24407810|NCT00175617|Minoxidil|minoxidil|mesh-list
24407811|NCT00175617|Spironolactone|spironolactone|mesh-list
24407812|NCT00175617|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24407813|NCT00175617|Hormone Antagonists|hormone antagonists|mesh-ancestor
24407814|NCT00175617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24407815|NCT00175617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407816|NCT00175617|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24407817|NCT00175617|Diuretics|diuretics|mesh-ancestor
24407818|NCT00175617|Natriuretic Agents|natriuretic agents|mesh-ancestor
24407819|NCT00175617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24407820|NCT00175617|Vasodilator Agents|vasodilator agents|mesh-ancestor
24407821|NCT00175630|Bupivacaine|bupivacaine|mesh-list
24408177|NCT00176774|Chelating Agents|chelating agents|mesh-ancestor
24408178|NCT00176774|Sequestering Agents|sequestering agents|mesh-ancestor
24408223|NCT00176982|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24408224|NCT00176982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24408225|NCT00176982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24408226|NCT00176982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408227|NCT00176982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408228|NCT00176982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24408229|NCT00176995|Eflornithine|eflornithine|mesh-list
24408230|NCT00176995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408231|NCT00176995|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24408232|NCT00176995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24408233|NCT00176995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24408234|NCT00176995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24408235|NCT00176995|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
24408236|NCT00176995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408327|NCT00177372|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24408328|NCT00177372|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24408359|NCT00177528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408514|NCT00178100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24408639|NCT00178971|Buspirone|buspirone|mesh-list
24408936|NCT00180089|Autonomic Agents|autonomic agents|mesh-ancestor
24408937|NCT00180089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24408938|NCT00180089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408939|NCT00180089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24408970|NCT00180115|Immunologic Factors|immunologic factors|mesh-ancestor
24408971|NCT00180115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408973|NCT00180128|Daunorubicin|daunorubicin|mesh-list
24408974|NCT00180128|Mitoxantrone|mitoxantrone|mesh-list
24408975|NCT00180128|Idarubicin|idarubicin|mesh-list
24408976|NCT00180128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24408977|NCT00180128|Antimetabolites|antimetabolites|mesh-ancestor
24410010|NCT00184041|Daunorubicin|daunorubicin|mesh-list
24410011|NCT00184041|Asparaginase|asparaginase|mesh-list
24410012|NCT00184041|Mercaptopurine|mercaptopurine|mesh-list
24410013|NCT00184041|Thioguanine|thioguanine|mesh-list
24410014|NCT00184041|Pegaspargase|pegaspargase|mesh-list
24410015|NCT00184041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24410080|NCT00184197|Botulinum Toxins|botulinum toxins|mesh-list
24410114|NCT00184587|Angiotensin II|angiotensin ii|mesh-list
24410115|NCT00184587|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24410118|NCT00184587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410119|NCT00184587|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24410120|NCT00184613|Insulin|insulin|mesh-list
24410121|NCT00184613|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24410122|NCT00184613|Insulin Glargine|insulin glargine|mesh-list
24410161|NCT00184795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24411333|NCT00188773|Acetylcysteine|acetylcysteine|mesh-list
24411334|NCT00188773|Heparin|heparin|mesh-list
24411336|NCT00188773|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24411558|NCT00189384|Antimalarials|antimalarials|mesh-ancestor
24411559|NCT00189384|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24411560|NCT00189384|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24411561|NCT00189384|Anesthetics, Local|anesthetics, local|mesh-ancestor
24411562|NCT00189384|Anesthetics|anesthetics|mesh-ancestor
24411563|NCT00189384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24411564|NCT00189384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411565|NCT00189384|Sensory System Agents|sensory system agents|mesh-ancestor
24411566|NCT00189384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24412060|NCT00190736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412238|NCT00191022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412239|NCT00191022|Serotonin Agents|serotonin agents|mesh-ancestor
24412240|NCT00191022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412241|NCT00191022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24412242|NCT00191022|Antidepressive Agents|antidepressive agents|mesh-ancestor
24412243|NCT00191022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24412244|NCT00191022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24910234|NCT04301336|Morphine|morphine|mesh-list
24412245|NCT00191022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24412837|NCT00192569|Interferon alpha-2|interferon alpha-2|mesh-list
24412838|NCT00192569|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24412839|NCT00192569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412840|NCT00192569|Antiviral Agents|antiviral agents|mesh-ancestor
24412841|NCT00192569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24412842|NCT00192569|Antimetabolites|antimetabolites|mesh-ancestor
24412843|NCT00192569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412844|NCT00192569|Immunologic Factors|immunologic factors|mesh-ancestor
24412870|NCT00192608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412871|NCT00192608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24413592|NCT00194597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413594|NCT00194597|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24413595|NCT00194597|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24413597|NCT00194597|Urological Agents|urological agents|mesh-ancestor
24413598|NCT00194623|Botulinum Toxins|botulinum toxins|mesh-list
24413599|NCT00194623|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24413600|NCT00194623|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24414074|NCT00195871|Mitosis Modulators|mitosis modulators|mesh-ancestor
24414075|NCT00195871|Antiviral Agents|antiviral agents|mesh-ancestor
24414076|NCT00195871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24415814|NCT00201305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24415815|NCT00201305|Antimetabolites|antimetabolites|mesh-ancestor
24415816|NCT00201305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24428952|NCT00241618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416823|NCT00204191|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24416824|NCT00204191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416825|NCT00204191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416826|NCT00204230|Mycophenolic Acid|mycophenolic acid|mesh-list
24416827|NCT00204230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24416828|NCT00204230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417839|NCT00208065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24417840|NCT00208065|Respiratory System Agents|respiratory system agents|mesh-ancestor
24417870|NCT00208130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417872|NCT00208143|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24417873|NCT00208143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24417874|NCT00208143|Serotonin Agents|serotonin agents|mesh-ancestor
24417875|NCT00208143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24417876|NCT00208143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417877|NCT00208143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417930|NCT00208182|Dopamine Agents|dopamine agents|mesh-ancestor
24417932|NCT00208195|Anticonvulsants|anticonvulsants|mesh-ancestor
24420180|NCT00215345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24420480|NCT00216138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420481|NCT00216138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24420482|NCT00216138|Antimetabolites|antimetabolites|mesh-ancestor
24421048|NCT00217542|Interferons|interferons|mesh-list
24421049|NCT00217542|Interferon-alpha|interferon-alpha|mesh-list
24421050|NCT00217542|Interferon alpha-2|interferon alpha-2|mesh-list
24421051|NCT00217542|Azacitidine|azacitidine|mesh-list
24421052|NCT00217542|Amifostine|amifostine|mesh-list
24421053|NCT00217542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421054|NCT00217542|Antiviral Agents|antiviral agents|mesh-ancestor
24421055|NCT00217542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24421056|NCT00217542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24421566|NCT00219700|Ibuprofen|ibuprofen|mesh-list
25713370|NCT02338713|Calcium Carbonate|calcium carbonate|mesh-list
25713371|NCT02338713|Antacids|antacids|mesh-ancestor
25713372|NCT02338713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713373|NCT02338713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25713374|NCT02338843|Angiotensin II|angiotensin ii|mesh-list
25713375|NCT02338843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24421569|NCT00219700|Analgesics|analgesics|mesh-ancestor
24460109|NCT00347425|Olanzapine|olanzapine|mesh-list
24460110|NCT00347425|Risperidone|risperidone|mesh-list
24460111|NCT00347425|Aripiprazole|aripiprazole|mesh-list
24460112|NCT00347425|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24423130|NCT00224809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24423131|NCT00224809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24423133|NCT00224809|Sensory System Agents|sensory system agents|mesh-ancestor
24423134|NCT00224809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24423135|NCT00224809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24423137|NCT00224809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24423476|NCT00226096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24423477|NCT00226096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24423478|NCT00226096|Adrenergic Agents|adrenergic agents|mesh-ancestor
24423498|NCT00226096|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24423500|NCT00226096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24423502|NCT00226109|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24423503|NCT00226109|Hormone Antagonists|hormone antagonists|mesh-ancestor
24423505|NCT00226109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424474|NCT00229515|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24424959|NCT00231491|Botulinum Toxins|botulinum toxins|mesh-list
24424960|NCT00231491|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24424961|NCT00231491|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24424962|NCT00231491|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24424963|NCT00231491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24424964|NCT00231491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424965|NCT00231491|Cholinergic Agents|cholinergic agents|mesh-ancestor
24430505|NCT00248118|Bupropion|bupropion|mesh-list
24425294|NCT00232648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24425295|NCT00232661|Tamoxifen|tamoxifen|mesh-list
24425296|NCT00232661|Anastrozole|anastrozole|mesh-list
24425297|NCT00232661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24425298|NCT00232661|Hormone Antagonists|hormone antagonists|mesh-ancestor
24425299|NCT00232661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24425300|NCT00232661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425318|NCT00232674|Glucocorticoids|glucocorticoids|mesh-ancestor
24418077|NCT00208546|Cetuximab|cetuximab|mesh-list
24425938|NCT00234858|Verapamil|verapamil|mesh-list
24425939|NCT00234858|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24425940|NCT00234858|Trandolapril|trandolapril|mesh-list
24425941|NCT00234858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24425942|NCT00234858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24425990|NCT00234910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24425992|NCT00234923|Lopinavir|lopinavir|mesh-list
24425993|NCT00234923|Lamivudine|lamivudine|mesh-list
24425994|NCT00234923|Zidovudine|zidovudine|mesh-list
24425995|NCT00234923|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
24425996|NCT00234923|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24425997|NCT00234923|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24425998|NCT00234923|Protease Inhibitors|protease inhibitors|mesh-ancestor
24425999|NCT00234923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24426000|NCT00234923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24426001|NCT00234923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24426227|NCT00235261|Glucocorticoids|glucocorticoids|mesh-ancestor
24426257|NCT00235287|Protease Inhibitors|protease inhibitors|mesh-ancestor
24426258|NCT00235287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24426259|NCT00235300|Thymoglobulin|thymoglobulin|mesh-list
24426260|NCT00235300|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24426261|NCT00235300|Basiliximab|basiliximab|mesh-list
25713376|NCT02338973|Interferons|interferons|mesh-list
25713377|NCT02338973|Interferon-gamma|interferon-gamma|mesh-list
24426262|NCT00235300|Immunologic Factors|immunologic factors|mesh-ancestor
24426263|NCT00235300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713378|NCT02338973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713379|NCT02338973|Antiviral Agents|antiviral agents|mesh-ancestor
25713380|NCT02338973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25713381|NCT02338999|Pioglitazone|pioglitazone|mesh-list
24429241|NCT00243009|Immunologic Factors|immunologic factors|mesh-ancestor
24429242|NCT00243009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24429243|NCT00243009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24429244|NCT00243009|Antifungal Agents|antifungal agents|mesh-ancestor
24429245|NCT00243009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24429246|NCT00243009|Dermatologic Agents|dermatologic agents|mesh-ancestor
24429247|NCT00243009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24429488|NCT00244153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24429489|NCT00244153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24429491|NCT00244153|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24429526|NCT00244296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24429527|NCT00244296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24429860|NCT00245206|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24429861|NCT00245206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24429862|NCT00245206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24429863|NCT00245206|Antidepressive Agents|antidepressive agents|mesh-ancestor
24429864|NCT00245206|Dopamine Agonists|dopamine agonists|mesh-ancestor
24429865|NCT00245206|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24429866|NCT00245206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24429901|NCT00245401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24429942|NCT00245596|Vasodilator Agents|vasodilator agents|mesh-ancestor
24429943|NCT00245596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24429945|NCT00245596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430000|NCT00245739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24430002|NCT00245739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24430115|NCT00246194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430116|NCT00246194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24430117|NCT00246194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24430118|NCT00246194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24460236|NCT00347815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430119|NCT00246194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24430120|NCT00246194|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24430121|NCT00246194|Dopamine Agents|dopamine agents|mesh-ancestor
24430122|NCT00246207|Methylphenidate|methylphenidate|mesh-list
24430281|NCT00246974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430282|NCT00246974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24430283|NCT00246974|Immunologic Factors|immunologic factors|mesh-ancestor
24430363|NCT00247481|Antimitotic Agents|antimitotic agents|mesh-ancestor
24430364|NCT00247481|Mitosis Modulators|mitosis modulators|mesh-ancestor
24430385|NCT00247507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430387|NCT00247507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430388|NCT00247507|Antidotes|antidotes|mesh-ancestor
24430389|NCT00247559|Botulinum Toxins|botulinum toxins|mesh-list
24430390|NCT00247559|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24430391|NCT00247559|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24430392|NCT00247559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24430978|NCT00249899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430979|NCT00249899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24431126|NCT00250393|Purinergic Agents|purinergic agents|mesh-ancestor
24431127|NCT00250393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431128|NCT00250393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431129|NCT00250393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24431146|NCT00250562|Natriuretic Agents|natriuretic agents|mesh-ancestor
24431229|NCT00250874|Trastuzumab|trastuzumab|mesh-list
24431230|NCT00250874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431231|NCT00250874|Tubulin Modulators|tubulin modulators|mesh-ancestor
24431232|NCT00250874|Antimitotic Agents|antimitotic agents|mesh-ancestor
25713382|NCT02338999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25713383|NCT02338999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713384|NCT02339038|Sofosbuvir|sofosbuvir|mesh-list
25713385|NCT02339038|Ledipasvir|ledipasvir|mesh-list
25713386|NCT02339038|Antiviral Agents|antiviral agents|mesh-ancestor
25713388|NCT02339155|Diphenhydramine|diphenhydramine|mesh-list
25713389|NCT02339155|Promethazine|promethazine|mesh-list
25713390|NCT02339155|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24431233|NCT00250874|Mitosis Modulators|mitosis modulators|mesh-ancestor
24431234|NCT00250874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431235|NCT00250874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24431269|NCT00251030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24431270|NCT00251030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24431271|NCT00251030|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24431306|NCT00251095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431307|NCT00251186|Capecitabine|capecitabine|mesh-list
24431429|NCT00251706|Vasodilator Agents|vasodilator agents|mesh-ancestor
24431430|NCT00251706|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
24431431|NCT00251706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24431792|NCT00252863|Purinergic Agents|purinergic agents|mesh-ancestor
24431793|NCT00252863|Sympathomimetics|sympathomimetics|mesh-ancestor
24431794|NCT00252889|Doxorubicin|doxorubicin|mesh-list
24431796|NCT00252889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
24431797|NCT00252889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24431798|NCT00252889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431799|NCT00252889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24431812|NCT00253058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24431813|NCT00253058|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24431814|NCT00253058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24431815|NCT00253058|Histamine Antagonists|histamine antagonists|mesh-ancestor
24431816|NCT00253058|Histamine Agents|histamine agents|mesh-ancestor
24431817|NCT00253058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24419683|NCT00213265|Vaccines|vaccines|mesh-list
24431901|NCT00253188|Nootropic Agents|nootropic agents|mesh-ancestor
24431948|NCT00253266|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24431949|NCT00253305|Terbinafine|terbinafine|mesh-list
24431950|NCT00253305|Naftifine|naftifine|mesh-list
24431951|NCT00253305|Antifungal Agents|antifungal agents|mesh-ancestor
24431952|NCT00253305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24431953|NCT00253305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431972|NCT00253318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431973|NCT00253318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24431975|NCT00253331|Nitroglycerin|nitroglycerin|mesh-list
24431976|NCT00253331|Vasodilator Agents|vasodilator agents|mesh-ancestor
24431977|NCT00253344|Docetaxel|docetaxel|mesh-list
24431978|NCT00253344|Lenalidomide|lenalidomide|mesh-list
24431979|NCT00253344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432459|NCT00254800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24432460|NCT00254813|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24432461|NCT00254813|Antidepressive Agents|antidepressive agents|mesh-ancestor
24460276|NCT00347984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24432462|NCT00254813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24432463|NCT00254813|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24432464|NCT00254813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24432753|NCT00255918|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
24432754|NCT00255918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24432755|NCT00255918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24432756|NCT00255918|Cholinergic Agents|cholinergic agents|mesh-ancestor
24432757|NCT00255918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24432761|NCT00255996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24433955|NCT00261027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433956|NCT00261027|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24433957|NCT00261027|Hormone Antagonists|hormone antagonists|mesh-ancestor
24433958|NCT00261027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24433959|NCT00261027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434003|NCT00261170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24434066|NCT00261352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24434067|NCT00261352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434068|NCT00261352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24434069|NCT00261352|Antimetabolites|antimetabolites|mesh-ancestor
24434072|NCT00261365|Ipilimumab|ipilimumab|mesh-list
24435767|NCT00268177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24435768|NCT00268177|Autonomic Agents|autonomic agents|mesh-ancestor
24435769|NCT00268177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24435770|NCT00268177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713391|NCT02339155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25713392|NCT02339155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25713393|NCT02339155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713394|NCT02339155|Anesthetics, Local|anesthetics, local|mesh-ancestor
25713395|NCT02339155|Anesthetics|anesthetics|mesh-ancestor
25713396|NCT02339155|Sensory System Agents|sensory system agents|mesh-ancestor
25713397|NCT02339155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24435771|NCT00268177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24435772|NCT00268177|Respiratory System Agents|respiratory system agents|mesh-ancestor
24435773|NCT00268177|Dermatologic Agents|dermatologic agents|mesh-ancestor
24435774|NCT00268177|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24435807|NCT00268229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24435902|NCT00268489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24435903|NCT00268489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24435904|NCT00268489|Growth Substances|growth substances|mesh-ancestor
24435905|NCT00268489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24435906|NCT00268489|Growth Inhibitors|growth inhibitors|mesh-ancestor
24435907|NCT00268489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24435908|NCT00268489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24435909|NCT00268489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24436082|NCT00268840|Tubulin Modulators|tubulin modulators|mesh-ancestor
24436083|NCT00268840|Antimitotic Agents|antimitotic agents|mesh-ancestor
24436084|NCT00268840|Mitosis Modulators|mitosis modulators|mesh-ancestor
24436085|NCT00268879|Renzapride|renzapride|mesh-list
24436086|NCT00268879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24436087|NCT00268879|Serotonin Agents|serotonin agents|mesh-ancestor
24436088|NCT00268879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24436089|NCT00268879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436421|NCT00269867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436426|NCT00269880|Heparin|heparin|mesh-list
24436554|NCT00270478|Hydroxyurea|hydroxyurea|mesh-list
24436555|NCT00270478|Epoetin Alfa|epoetin alfa|mesh-list
24436556|NCT00270478|Hematinics|hematinics|mesh-ancestor
24436557|NCT00270478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24436558|NCT00270478|Antisickling Agents|antisickling agents|mesh-ancestor
24436559|NCT00270478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24436560|NCT00270478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436561|NCT00270478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24436877|NCT00271791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24436879|NCT00271791|Hormones|hormones|mesh-ancestor
24436880|NCT00271791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24436881|NCT00271791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438485|NCT00276055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438486|NCT00276055|Growth Inhibitors|growth inhibitors|mesh-ancestor
24438487|NCT00276055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24438488|NCT00276055|Antimetabolites|antimetabolites|mesh-ancestor
24438489|NCT00276055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438490|NCT00276055|Antiviral Agents|antiviral agents|mesh-ancestor
24438492|NCT00276055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24439604|NCT00279487|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24439605|NCT00279487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24439607|NCT00279487|Antimanic Agents|antimanic agents|mesh-ancestor
24439768|NCT00280358|Fluticasone|fluticasone|mesh-list
24439770|NCT00280358|Formoterol Fumarate|formoterol fumarate|mesh-list
24439771|NCT00280358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24439772|NCT00280358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24439773|NCT00280358|Autonomic Agents|autonomic agents|mesh-ancestor
24439774|NCT00280358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24439775|NCT00280358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439776|NCT00280358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24439777|NCT00280358|Respiratory System Agents|respiratory system agents|mesh-ancestor
24439938|NCT00280930|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24439939|NCT00280930|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24439940|NCT00280930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24439941|NCT00280930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439942|NCT00280930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24439946|NCT00280956|Natalizumab|natalizumab|mesh-list
24440550|NCT00283660|Protective Agents|protective agents|mesh-ancestor
25713398|NCT02339155|Antiemetics|antiemetics|mesh-ancestor
25713399|NCT02339155|Autonomic Agents|autonomic agents|mesh-ancestor
25713400|NCT02339155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24435298|NCT00265915|Rituximab|rituximab|mesh-list
24440559|NCT00283699|Tubulin Modulators|tubulin modulators|mesh-ancestor
24440560|NCT00283699|Antimitotic Agents|antimitotic agents|mesh-ancestor
24440561|NCT00283699|Mitosis Modulators|mitosis modulators|mesh-ancestor
24440562|NCT00283699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440563|NCT00283699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440564|NCT00283751|Insulin|insulin|mesh-list
24440565|NCT00283751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24440566|NCT00283751|Insulin Glargine|insulin glargine|mesh-list
24440567|NCT00283751|Insulin Detemir|insulin detemir|mesh-list
24440568|NCT00283751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24440573|NCT00283777|Chromium|chromium|mesh-list
24440634|NCT00283985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24440664|NCT00284232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440803|NCT00284791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24441025|NCT00285766|Selegiline|selegiline|mesh-list
24441026|NCT00285766|Antidepressive Agents|antidepressive agents|mesh-ancestor
24441027|NCT00285766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24441028|NCT00285766|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24441029|NCT00285766|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24441030|NCT00285766|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24441031|NCT00285766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441032|NCT00285766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441033|NCT00285766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24441034|NCT00285766|Protective Agents|protective agents|mesh-ancestor
24441035|NCT00285766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441036|NCT00285805|Rosiglitazone|rosiglitazone|mesh-list
24441037|NCT00285805|Amiloride|amiloride|mesh-list
24441038|NCT00285805|Furosemide|furosemide|mesh-list
24441039|NCT00285805|Diuretics|diuretics|mesh-ancestor
24441137|NCT00286208|Misoprostol|misoprostol|mesh-list
24441154|NCT00286208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24441155|NCT00286208|Luteolytic Agents|luteolytic agents|mesh-ancestor
24441156|NCT00286208|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24441157|NCT00286208|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24435615|NCT00267267|Torcetrapib|torcetrapib|mesh-list
24441369|NCT00287300|Schistosomicides|schistosomicides|mesh-ancestor
24441370|NCT00287300|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24441374|NCT00287300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441375|NCT00287300|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24441376|NCT00287300|Renal Agents|renal agents|mesh-ancestor
24441785|NCT00288353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24441786|NCT00288353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24441788|NCT00288379|Formoterol Fumarate|formoterol fumarate|mesh-list
24441789|NCT00288379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24441790|NCT00288379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24441791|NCT00288379|Autonomic Agents|autonomic agents|mesh-ancestor
24441792|NCT00288379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24441793|NCT00288379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442200|NCT00290420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24442201|NCT00290420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24442202|NCT00290420|Antimalarials|antimalarials|mesh-ancestor
24442212|NCT00290602|Prednisolone|prednisolone|mesh-list
24442214|NCT00290602|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24442451|NCT00291109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24442452|NCT00291109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713401|NCT02339155|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25713402|NCT02339155|Histamine Antagonists|histamine antagonists|mesh-ancestor
25713403|NCT02339155|Histamine Agents|histamine agents|mesh-ancestor
25713404|NCT02339155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25713405|NCT02339155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713406|NCT02339155|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25713407|NCT02339155|Antipruritics|antipruritics|mesh-ancestor
25713408|NCT02339155|Dermatologic Agents|dermatologic agents|mesh-ancestor
25713411|NCT02339246|Immunologic Factors|immunologic factors|mesh-ancestor
24460464|NCT00348452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24460466|NCT00348452|Analgesics|analgesics|mesh-ancestor
24460467|NCT00348452|Sensory System Agents|sensory system agents|mesh-ancestor
24460468|NCT00348452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24460469|NCT00348452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443310|NCT00294463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24443354|NCT00294593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443356|NCT00294593|Vitamins|vitamins|mesh-ancestor
24443357|NCT00294593|Micronutrients|micronutrients|mesh-ancestor
24443358|NCT00294593|Hematinics|hematinics|mesh-ancestor
24443359|NCT00294606|Phenylephrine|phenylephrine|mesh-list
25713412|NCT02339246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713413|NCT02339246|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25713414|NCT02339246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713415|NCT02339246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713416|NCT02339415|Edoxaban|edoxaban|mesh-list
25713417|NCT02339415|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25713418|NCT02339415|Antithrombins|antithrombins|mesh-ancestor
25713419|NCT02339415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25713420|NCT02339415|Protease Inhibitors|protease inhibitors|mesh-ancestor
25713421|NCT02339415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24460786|NCT00349518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24460788|NCT00349518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713422|NCT02339415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713423|NCT02339415|Anticoagulants|anticoagulants|mesh-ancestor
24460789|NCT00349531|Pramipexole|pramipexole|mesh-list
24460790|NCT00349531|Antioxidants|antioxidants|mesh-ancestor
24460791|NCT00349531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443567|NCT00295425|Dermatologic Agents|dermatologic agents|mesh-ancestor
24443568|NCT00295425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24443569|NCT00295425|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24443570|NCT00295425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24460876|NCT00350038|Irbesartan|irbesartan|mesh-list
24460877|NCT00350038|Ciprofibrate|ciprofibrate|mesh-list
24460879|NCT00350038|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24460880|NCT00350038|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24460881|NCT00350038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24460882|NCT00350038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24460970|NCT00350415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24460971|NCT00350415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24460992|NCT00350454|Immunologic Factors|immunologic factors|mesh-ancestor
24460993|NCT00350454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24460994|NCT00350467|Olanzapine|olanzapine|mesh-list
24460995|NCT00350467|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24460996|NCT00350467|Antiemetics|antiemetics|mesh-ancestor
24460997|NCT00350467|Autonomic Agents|autonomic agents|mesh-ancestor
24460998|NCT00350467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24440175|NCT00281931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24461145|NCT00351130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461146|NCT00351130|Vasodilator Agents|vasodilator agents|mesh-ancestor
25713424|NCT02339558|Nivolumab|nivolumab|mesh-list
25713425|NCT02339558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25713426|NCT02339558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713427|NCT02339558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25713428|NCT02339558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713429|NCT02339584|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25713430|NCT02339584|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25713431|NCT02339584|Brinzolamide|brinzolamide|mesh-list
25713432|NCT02339584|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25713433|NCT02339584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25713434|NCT02339584|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24461229|NCT00351507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461230|NCT00351507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24550863|NCT00722956|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24550864|NCT00722956|Antiviral Agents|antiviral agents|mesh-ancestor
24550865|NCT00722956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24550866|NCT00722969|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24550867|NCT00722969|Sorafenib|sorafenib|mesh-list
24550868|NCT00722969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550874|NCT00723047|Coagulants|coagulants|mesh-ancestor
24550930|NCT00723268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24550931|NCT00723268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550932|NCT00723268|Gout Suppressants|gout suppressants|mesh-ancestor
24551176|NCT00724256|Ceftibuten|ceftibuten|mesh-list
24551177|NCT00724256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24551179|NCT00724295|Ribavirin|ribavirin|mesh-list
24551184|NCT00724295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24551185|NCT00724321|Iloprost|iloprost|mesh-list
24551999|NCT04261790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552000|NCT04254627|Etanercept|etanercept|mesh-list
24552001|NCT04254627|Mifepristone|mifepristone|mesh-list
24552002|NCT04254627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24552003|NCT04254627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24552004|NCT04254627|Analgesics|analgesics|mesh-ancestor
24552005|NCT04254627|Sensory System Agents|sensory system agents|mesh-ancestor
24552262|NCT03728478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24552263|NCT03728478|Antimetabolites|antimetabolites|mesh-ancestor
24552264|NCT03728478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552265|NCT03728478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552336|NCT03504241|Glucocorticoids|glucocorticoids|mesh-ancestor
24552551|NCT02688530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552552|NCT02688530|Protease Inhibitors|protease inhibitors|mesh-ancestor
24552553|NCT02688530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24552554|NCT02688530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552563|NCT02383966|Carboplatin|carboplatin|mesh-list
24552564|NCT02383966|Fluorouracil|fluorouracil|mesh-list
24552565|NCT02383966|Cetuximab|cetuximab|mesh-list
24552566|NCT02383966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24552567|NCT02383966|Antimetabolites|antimetabolites|mesh-ancestor
24552568|NCT02383966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24552882|NCT00728013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24552884|NCT00728078|Thalidomide|thalidomide|mesh-list
24552885|NCT00728078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24552886|NCT00728078|Immunologic Factors|immunologic factors|mesh-ancestor
24552887|NCT00728078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552888|NCT00728078|Leprostatic Agents|leprostatic agents|mesh-ancestor
24911456|NCT04287803|Anesthetics|anesthetics|mesh-ancestor
24552889|NCT00728078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24552990|NCT00728715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24552991|NCT00728715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713435|NCT02339584|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25713436|NCT02339584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25713437|NCT02339584|Adrenergic Agents|adrenergic agents|mesh-ancestor
25713438|NCT02339584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25713439|NCT02339584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713440|NCT02339584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24552992|NCT00728715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24552993|NCT00728715|Respiratory System Agents|respiratory system agents|mesh-ancestor
24553015|NCT00728832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553016|NCT00728832|Analgesics|analgesics|mesh-ancestor
24553017|NCT00728832|Sensory System Agents|sensory system agents|mesh-ancestor
24553018|NCT00728832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24553019|NCT00729001|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24553020|NCT00729001|Immunologic Factors|immunologic factors|mesh-ancestor
24553021|NCT00729001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553022|NCT00729118|Lenalidomide|lenalidomide|mesh-list
24553023|NCT00729118|Vorinostat|vorinostat|mesh-list
24553024|NCT00729118|Immunologic Factors|immunologic factors|mesh-ancestor
24553025|NCT00729118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553026|NCT00729118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24553027|NCT00729118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24553028|NCT00729118|Growth Substances|growth substances|mesh-ancestor
24553240|NCT00730054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553242|NCT00730054|Sensory System Agents|sensory system agents|mesh-ancestor
24553243|NCT00730054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24553244|NCT00730054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24553245|NCT00730054|Sympatholytics|sympatholytics|mesh-ancestor
24553246|NCT00730054|Autonomic Agents|autonomic agents|mesh-ancestor
24553247|NCT00730054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24553248|NCT00730054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24553249|NCT00730054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24553250|NCT00730054|Adrenergic Agents|adrenergic agents|mesh-ancestor
24553251|NCT00730054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24553252|NCT00730054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553253|NCT00730067|Sildenafil Citrate|sildenafil citrate|mesh-list
24553254|NCT00730067|Vasodilator Agents|vasodilator agents|mesh-ancestor
24553255|NCT00730067|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24553286|NCT00730223|Nevirapine|nevirapine|mesh-list
24553287|NCT00730223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24553289|NCT00730223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553290|NCT00730223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553291|NCT00730223|Antiviral Agents|antiviral agents|mesh-ancestor
24553473|NCT00731302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553474|NCT00731302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24553475|NCT00731302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24553476|NCT00731302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24553477|NCT00731302|Antipyretics|antipyretics|mesh-ancestor
24553478|NCT00731302|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24553479|NCT00731367|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24553480|NCT00731367|Laxatives|laxatives|mesh-ancestor
24553481|NCT00731367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24553482|NCT00731380|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24553483|NCT00731380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24553484|NCT00731393|Vaccines|vaccines|mesh-list
24553485|NCT00731393|Immunologic Factors|immunologic factors|mesh-ancestor
24553486|NCT00731393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553487|NCT00731523|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
24553490|NCT00731523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24553549|NCT00731926|Antioxidants|antioxidants|mesh-ancestor
24553730|NCT00732693|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24553731|NCT00732693|Norethindrone|norethindrone|mesh-list
24553732|NCT00732693|Norethindrone Acetate|norethindrone acetate|mesh-list
24553733|NCT00732693|Estradiol|estradiol|mesh-list
25713441|NCT02339584|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25713442|NCT02339584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713443|NCT02340000|Amoxicillin|amoxicillin|mesh-list
25713444|NCT02340000|Clavulanic Acid|clavulanic acid|mesh-list
25713445|NCT02340000|Clavulanic Acids|clavulanic acids|mesh-list
24553747|NCT00732745|Docetaxel|docetaxel|mesh-list
24553748|NCT00732745|Oxaliplatin|oxaliplatin|mesh-list
24553749|NCT00732745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24553750|NCT00732745|Tubulin Modulators|tubulin modulators|mesh-ancestor
24553751|NCT00732745|Antimitotic Agents|antimitotic agents|mesh-ancestor
24553940|NCT00733473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24553941|NCT00733473|Respiratory System Agents|respiratory system agents|mesh-ancestor
24553942|NCT00733473|Glucocorticoids|glucocorticoids|mesh-ancestor
24553943|NCT00733473|Hormones|hormones|mesh-ancestor
24553944|NCT00733473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24553945|NCT00733525|Fluoxetine|fluoxetine|mesh-list
24553946|NCT00733525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24553947|NCT00733525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24553948|NCT00733525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24553949|NCT00733525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24553950|NCT00733525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24553951|NCT00733525|Serotonin Agents|serotonin agents|mesh-ancestor
24553952|NCT00733525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553968|NCT00733564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24553982|NCT00733616|Capecitabine|capecitabine|mesh-list
24554252|NCT00735124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24554253|NCT00735124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24554254|NCT00735124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24554284|NCT00735241|Vitamin B Complex|vitamin b complex|mesh-ancestor
24554285|NCT00735241|Vitamins|vitamins|mesh-ancestor
24554286|NCT00735241|Micronutrients|micronutrients|mesh-ancestor
24554287|NCT00735241|Hematinics|hematinics|mesh-ancestor
24554295|NCT00735345|Cetuximab|cetuximab|mesh-list
24554296|NCT00735345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24554297|NCT00735345|Tubulin Modulators|tubulin modulators|mesh-ancestor
24554701|NCT00737724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24554702|NCT00737724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24554703|NCT00737724|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24554704|NCT00737724|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24554705|NCT00737724|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24554706|NCT00737724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24554707|NCT00737724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24554786|NCT00738192|Dsuvia|dsuvia|mesh-list
24554811|NCT00738257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24554812|NCT00738296|Simvastatin|simvastatin|mesh-list
24554813|NCT00738296|Ezetimibe|ezetimibe|mesh-list
24554814|NCT00738296|Pravastatin|pravastatin|mesh-list
24554844|NCT00738556|Paclitaxel|paclitaxel|mesh-list
24554898|NCT00738621|Dermatologic Agents|dermatologic agents|mesh-ancestor
24554899|NCT00738621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24554900|NCT00738621|Serotonin Agents|serotonin agents|mesh-ancestor
24554901|NCT00738621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24554902|NCT00738621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24554903|NCT00738621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24554905|NCT00738621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24554906|NCT00738621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24554908|NCT00738660|Telmisartan|telmisartan|mesh-list
24555138|NCT00740168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24555139|NCT00740168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24555140|NCT00740168|Growth Substances|growth substances|mesh-ancestor
24555141|NCT00740168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555142|NCT00740168|Growth Inhibitors|growth inhibitors|mesh-ancestor
25713446|NCT02340000|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25713447|NCT02340000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25713448|NCT02340000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24555173|NCT00740363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24555174|NCT00740363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555175|NCT00740363|Incretins|incretins|mesh-ancestor
24555176|NCT00740363|Hormones|hormones|mesh-ancestor
24555177|NCT00740363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24555178|NCT00740363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24555179|NCT00740363|Protease Inhibitors|protease inhibitors|mesh-ancestor
24555180|NCT00740363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24555181|NCT00740363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555182|NCT00740389|Etravirine|etravirine|mesh-list
24555183|NCT00740389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24555184|NCT00740389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24555366|NCT00741234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24555374|NCT00741325|Antiviral Agents|antiviral agents|mesh-ancestor
24555375|NCT00741325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24555376|NCT00741351|Fentanyl|fentanyl|mesh-list
24555377|NCT00741351|Remifentanil|remifentanil|mesh-list
24555378|NCT00741351|Propofol|propofol|mesh-list
24555379|NCT00741351|Sevoflurane|sevoflurane|mesh-list
24555380|NCT00741351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24555381|NCT00741351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24555382|NCT00741351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555496|NCT00741767|Hormones|hormones|mesh-ancestor
24555497|NCT00741767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24555498|NCT00741767|Sympathomimetics|sympathomimetics|mesh-ancestor
24555501|NCT00741780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24555880|NCT00744081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555881|NCT00744081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24555883|NCT00744081|Sensory System Agents|sensory system agents|mesh-ancestor
24555991|NCT00744549|Lycopene|lycopene|mesh-list
24555992|NCT00744549|Micronutrients|micronutrients|mesh-ancestor
24555993|NCT00744549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24555994|NCT00744549|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24555995|NCT00744549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24555996|NCT00744549|Antioxidants|antioxidants|mesh-ancestor
24555997|NCT00744549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24555998|NCT00744549|Protective Agents|protective agents|mesh-ancestor
24555999|NCT00744549|Trace Elements|trace elements|mesh-ancestor
24556000|NCT00744549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24556002|NCT00744549|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24556004|NCT00744640|Gemcitabine|gemcitabine|mesh-list
24556005|NCT00744640|Capecitabine|capecitabine|mesh-list
24556006|NCT00744640|Oxaliplatin|oxaliplatin|mesh-list
24556007|NCT00744640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24556062|NCT00744809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24556063|NCT00744809|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24556064|NCT00744809|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24556065|NCT00744809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24556066|NCT00744809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24556067|NCT00744809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24556267|NCT00746681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556268|NCT00746681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24556331|NCT00747110|Mesalamine|mesalamine|mesh-list
24556332|NCT00747110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24556333|NCT00747110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24556334|NCT00747110|Autonomic Agents|autonomic agents|mesh-ancestor
24556335|NCT00747110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24556617|NCT00748423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24556618|NCT00748423|Autonomic Agents|autonomic agents|mesh-ancestor
24556631|NCT00748436|Betahistine|betahistine|mesh-list
24556632|NCT00748436|Vasodilator Agents|vasodilator agents|mesh-ancestor
24556774|NCT00749619|Calcium heparin|calcium heparin|mesh-list
24556775|NCT00749619|Citric Acid|citric acid|mesh-list
24556798|NCT00749723|Etoposide|etoposide|mesh-list
24556804|NCT00749723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24556805|NCT00749723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24556806|NCT00749723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25713449|NCT02340000|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25713450|NCT02340000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556807|NCT00749723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24556808|NCT00749723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24556809|NCT00749723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556845|NCT00749918|Vitamin D|vitamin d|mesh-list
24556860|NCT00750048|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24556861|NCT00750100|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24556862|NCT00750100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24556863|NCT00750100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24556864|NCT00750113|Telmisartan|telmisartan|mesh-list
24556865|NCT00750113|Nifedipine|nifedipine|mesh-list
24556866|NCT00750113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24556867|NCT00750113|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24556868|NCT00750113|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24462588|NCT00357045|Serotonin Agents|serotonin agents|mesh-ancestor
24556869|NCT00750113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24556870|NCT00750113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24557027|NCT00751049|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24557028|NCT00751049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24557030|NCT00751062|Latanoprost|latanoprost|mesh-list
24557031|NCT00751062|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24557036|NCT00751062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557037|NCT00751062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24557038|NCT00751062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24557039|NCT00751062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24557040|NCT00751062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24557041|NCT00751127|Timolol|timolol|mesh-list
24557042|NCT00751127|Latanoprost|latanoprost|mesh-list
24557043|NCT00751127|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24557091|NCT00751205|Vitamins|vitamins|mesh-ancestor
24557260|NCT00752037|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24557261|NCT00752037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24557262|NCT00752037|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24557263|NCT00752037|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24557264|NCT00752063|Capecitabine|capecitabine|mesh-list
24557265|NCT00752063|Oxaliplatin|oxaliplatin|mesh-list
24557266|NCT00752063|Sorafenib|sorafenib|mesh-list
24557267|NCT00752063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24557268|NCT00752063|Antimetabolites|antimetabolites|mesh-ancestor
24557311|NCT00752154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24557312|NCT00752154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24557313|NCT00752154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557314|NCT00752180|Insulin|insulin|mesh-list
24557315|NCT00752180|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24557316|NCT00752180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24557550|NCT00752934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557552|NCT00752947|Metronidazole|metronidazole|mesh-list
24557553|NCT00752947|Levofloxacin|levofloxacin|mesh-list
24557554|NCT00752947|Ofloxacin|ofloxacin|mesh-list
24557555|NCT00752947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24557585|NCT00753051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24557586|NCT00753051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24557719|NCT00753571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24557720|NCT00753571|Protective Agents|protective agents|mesh-ancestor
24557732|NCT00753727|Growth Substances|growth substances|mesh-ancestor
24557733|NCT00753727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24557734|NCT00753727|Growth Inhibitors|growth inhibitors|mesh-ancestor
24557735|NCT00753727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24557736|NCT00753727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24558182|NCT00755664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24558183|NCT00755781|Cyclosporine|cyclosporine|mesh-list
24558184|NCT00755781|Cyclosporins|cyclosporins|mesh-list
24558185|NCT00755781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24558186|NCT00755781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558187|NCT00755781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24558188|NCT00755781|Immunologic Factors|immunologic factors|mesh-ancestor
24558189|NCT00755781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713451|NCT02340000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713452|NCT02340156|Temozolomide|temozolomide|mesh-list
25713453|NCT02340156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24558195|NCT00755820|Cycloserine|cycloserine|mesh-list
25713454|NCT02340156|Alkylating Agents|alkylating agents|mesh-ancestor
24558252|NCT00755885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24558253|NCT00755898|Amantadine|amantadine|mesh-list
24558254|NCT00755898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24558255|NCT00755898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24558257|NCT00755898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24558324|NCT00756301|Lidocaine|lidocaine|mesh-list
24558630|NCT00758199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24558631|NCT00758199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24558632|NCT00758199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24558633|NCT00758199|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24558634|NCT00758199|Contraceptive Agents|contraceptive agents|mesh-ancestor
24558635|NCT00758199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24558636|NCT00758199|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24558637|NCT00758199|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24558638|NCT00758199|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24558705|NCT05435729|Levodopa|levodopa|mesh-list
24558706|NCT05435729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24558707|NCT05435729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24558708|NCT05435729|Dopamine Agents|dopamine agents|mesh-ancestor
24558712|NCT05435677|Insulin|insulin|mesh-list
24671008|NCT01323218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24559279|NCT05122221|Sensory System Agents|sensory system agents|mesh-ancestor
24559282|NCT05117554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24559283|NCT05117554|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24559284|NCT05117554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24559285|NCT05117554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24559286|NCT05117554|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24559287|NCT05117554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24559288|NCT05117554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24560431|NCT02677545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24560803|NCT01451515|Abortifacient Agents|abortifacient agents|mesh-ancestor
24561015|NCT00662792|Parasympatholytics|parasympatholytics|mesh-ancestor
24561016|NCT00662792|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24561017|NCT00662792|Cholinergic Agents|cholinergic agents|mesh-ancestor
24561018|NCT00662792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24561019|NCT00662792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561020|NCT00662792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24561021|NCT00662792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24561202|NCT00759005|Propranolol|propranolol|mesh-list
24561285|NCT00759226|Hematinics|hematinics|mesh-ancestor
24561501|NCT00760981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24561528|NCT00761241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24561529|NCT00761241|Antiviral Agents|antiviral agents|mesh-ancestor
24561530|NCT00761241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24561531|NCT00761241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24561532|NCT00761241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24561533|NCT00761241|Immunologic Factors|immunologic factors|mesh-ancestor
24561535|NCT00761241|Tubulin Modulators|tubulin modulators|mesh-ancestor
24561543|NCT00761254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24561544|NCT00761254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24561545|NCT00761254|Dopamine Agents|dopamine agents|mesh-ancestor
24561546|NCT00761254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24561547|NCT00761254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561548|NCT00761332|Teriparatide|teriparatide|mesh-list
24561768|NCT00762736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561769|NCT00762749|Diphenhydramine|diphenhydramine|mesh-list
24561770|NCT00762749|Promethazine|promethazine|mesh-list
24561771|NCT00762749|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24561772|NCT00762749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24561773|NCT00762749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24561774|NCT00762749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24561775|NCT00762749|Anesthetics, Local|anesthetics, local|mesh-ancestor
24561776|NCT00762749|Anesthetics|anesthetics|mesh-ancestor
24561828|NCT00762983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24561831|NCT00763165|Fluorides|fluorides|mesh-list
24561832|NCT00763165|Cariostatic Agents|cariostatic agents|mesh-ancestor
24562198|NCT00764907|Antiviral Agents|antiviral agents|mesh-ancestor
24562199|NCT00764907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24562200|NCT00764907|Antidotes|antidotes|mesh-ancestor
24562201|NCT00764907|Protective Agents|protective agents|mesh-ancestor
24562202|NCT00764907|Vitamin B Complex|vitamin b complex|mesh-ancestor
24562203|NCT00764907|Vitamins|vitamins|mesh-ancestor
24562204|NCT00764907|Micronutrients|micronutrients|mesh-ancestor
24562205|NCT00764907|Tubulin Modulators|tubulin modulators|mesh-ancestor
24562206|NCT00764907|Antimitotic Agents|antimitotic agents|mesh-ancestor
24562207|NCT00764907|Mitosis Modulators|mitosis modulators|mesh-ancestor
24562208|NCT00764972|Sorafenib|sorafenib|mesh-list
24562234|NCT00765154|Ritonavir|ritonavir|mesh-list
24562539|NCT00766896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24564875|NCT00778076|Hyaluronic Acid|hyaluronic acid|mesh-list
24562711|NCT00767754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24562712|NCT00767754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24562714|NCT00767754|Serotonin Agents|serotonin agents|mesh-ancestor
24562770|NCT00768157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24562771|NCT00768157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24562772|NCT00768157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24562774|NCT00768183|Morphine|morphine|mesh-list
24562775|NCT00768183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24563098|NCT00770042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24563168|NCT00770471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563169|NCT00770471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24563170|NCT00770471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24563171|NCT00770471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563173|NCT00770497|Ramipril|ramipril|mesh-list
24563174|NCT00770497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24563175|NCT00770497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563176|NCT00770497|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24563177|NCT00770497|Protease Inhibitors|protease inhibitors|mesh-ancestor
24563178|NCT00770497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24563239|NCT00770705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563240|NCT00770705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563241|NCT00770705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24563242|NCT00770705|Vasodilator Agents|vasodilator agents|mesh-ancestor
24563243|NCT00770718|Thrombin|thrombin|mesh-list
24563244|NCT00770718|Hemostatics|hemostatics|mesh-ancestor
24563245|NCT00770718|Coagulants|coagulants|mesh-ancestor
24563334|NCT00771147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563336|NCT00771199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24563337|NCT00771199|Narcotics|narcotics|mesh-ancestor
24563338|NCT00771199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24563339|NCT00771199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563340|NCT00771199|Analgesics|analgesics|mesh-ancestor
24563341|NCT00771199|Sensory System Agents|sensory system agents|mesh-ancestor
24574658|NCT00826787|Nootropic Agents|nootropic agents|mesh-ancestor
24563343|NCT00771199|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24563414|NCT00771459|Ropivacaine|ropivacaine|mesh-list
24563443|NCT00771563|Cisplatin|cisplatin|mesh-list
24563444|NCT00771563|Docetaxel|docetaxel|mesh-list
24563445|NCT00771563|Enoxaparin|enoxaparin|mesh-list
24563446|NCT00771563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24563578|NCT00772499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24563579|NCT00772499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24563580|NCT00772499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24563581|NCT00772499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24563582|NCT00772499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24563583|NCT00772499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24563584|NCT00772499|Vasodilator Agents|vasodilator agents|mesh-ancestor
24564870|NCT00778063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24564871|NCT00778063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24564872|NCT00778063|Adrenergic Agents|adrenergic agents|mesh-ancestor
25713455|NCT02340156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713456|NCT02340156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713457|NCT02340520|Theophylline|theophylline|mesh-list
25713458|NCT02340520|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24564873|NCT00778063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24564940|NCT00778193|Gout Suppressants|gout suppressants|mesh-ancestor
24564942|NCT00778232|Analgesics|analgesics|mesh-ancestor
24564943|NCT00778232|Sensory System Agents|sensory system agents|mesh-ancestor
24564944|NCT00778232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24564945|NCT00778232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24564946|NCT00778232|Anticonvulsants|anticonvulsants|mesh-ancestor
24564956|NCT00778245|Cefprozil|cefprozil|mesh-list
24565160|NCT00779051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24565161|NCT00779051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24565162|NCT00779064|Rivaroxaban|rivaroxaban|mesh-list
24565163|NCT00779064|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24565194|NCT00779220|Methotrexate|methotrexate|mesh-list
24565195|NCT00779220|Ocrelizumab|ocrelizumab|mesh-list
24565196|NCT00779220|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24565197|NCT00779220|Abortifacient Agents|abortifacient agents|mesh-ancestor
24628948|NCT01102244|Glucocorticoids|glucocorticoids|mesh-ancestor
24565198|NCT00779220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24566047|NCT00784186|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24566048|NCT00784186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24566049|NCT00784186|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24566050|NCT00784186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24566051|NCT00784186|Contraceptive Agents|contraceptive agents|mesh-ancestor
24566052|NCT00784186|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24566053|NCT00784186|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24566054|NCT00784186|Hormone Antagonists|hormone antagonists|mesh-ancestor
24566150|NCT00784498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24566151|NCT00784498|GABA Modulators|gaba modulators|mesh-ancestor
24566152|NCT00784498|GABA Agents|gaba agents|mesh-ancestor
24566153|NCT00784511|Vitamin D|vitamin d|mesh-list
24566196|NCT00784745|Autonomic Agents|autonomic agents|mesh-ancestor
24566197|NCT00784745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24566198|NCT00784745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566199|NCT00784745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24566367|NCT00785421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566368|NCT00785421|Antiviral Agents|antiviral agents|mesh-ancestor
24566369|NCT00785421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24566370|NCT00785421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24566371|NCT00785421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24566372|NCT00785421|Immunologic Factors|immunologic factors|mesh-ancestor
24566373|NCT00785421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566374|NCT00785421|Antidotes|antidotes|mesh-ancestor
24566702|NCT00787436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24566703|NCT00787436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566704|NCT00787436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24566705|NCT00787436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24566706|NCT00787436|Vasodilator Agents|vasodilator agents|mesh-ancestor
24566707|NCT00787436|Sympatholytics|sympatholytics|mesh-ancestor
24566708|NCT00787436|Autonomic Agents|autonomic agents|mesh-ancestor
24566709|NCT00787436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24566710|NCT00787462|Pregabalin|pregabalin|mesh-list
24566711|NCT00787462|Analgesics|analgesics|mesh-ancestor
24566712|NCT00787462|Sensory System Agents|sensory system agents|mesh-ancestor
24566715|NCT00787462|Anticonvulsants|anticonvulsants|mesh-ancestor
24566802|NCT00788034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24566803|NCT00788034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24566804|NCT00788034|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24566805|NCT00788034|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24566806|NCT00788034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24566807|NCT00788034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566808|NCT00788034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24566809|NCT00788034|Serotonin Agents|serotonin agents|mesh-ancestor
24566810|NCT00788034|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24566811|NCT00788034|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24566812|NCT00788034|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24566813|NCT00788034|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24566909|NCT00788515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24566913|NCT00788515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24566914|NCT00788515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24566915|NCT00788567|Mycophenolic Acid|mycophenolic acid|mesh-list
24566916|NCT00788567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24393974|NCT00131430|Hormones|hormones|mesh-ancestor
24566925|NCT00788580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24566926|NCT00788580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24566927|NCT00788580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24566928|NCT00788580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24567012|NCT00789308|Cyclosporine|cyclosporine|mesh-list
24567013|NCT00789308|Sirolimus|sirolimus|mesh-list
24567014|NCT00789308|Mycophenolic Acid|mycophenolic acid|mesh-list
24567015|NCT00789308|Etanercept|etanercept|mesh-list
24567016|NCT00789308|Heparin|heparin|mesh-list
24567017|NCT00789308|Dextrans|dextrans|mesh-list
24567018|NCT00789308|Tacrolimus|tacrolimus|mesh-list
24567019|NCT00789308|Cyclosporins|cyclosporins|mesh-list
24567020|NCT00789308|Thymoglobulin|thymoglobulin|mesh-list
24567021|NCT00789308|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24567022|NCT00789308|Basiliximab|basiliximab|mesh-list
24567023|NCT00789308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24567024|NCT00789308|Immunologic Factors|immunologic factors|mesh-ancestor
24567025|NCT00789308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567026|NCT00789308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24567027|NCT00789308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24567029|NCT00789308|Antifungal Agents|antifungal agents|mesh-ancestor
24567062|NCT00789386|GABA Modulators|gaba modulators|mesh-ancestor
24567063|NCT00789386|GABA Agents|gaba agents|mesh-ancestor
24567064|NCT00789386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24567066|NCT00789386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24567067|NCT00789386|Narcotics|narcotics|mesh-ancestor
24567139|NCT00789646|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24567140|NCT00789646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24567144|NCT00789711|Insulin|insulin|mesh-list
24567166|NCT00789945|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24567167|NCT00789945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24567168|NCT00789945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24567169|NCT00789971|Triamcinolone|triamcinolone|mesh-list
24567170|NCT00789971|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24567171|NCT00789971|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24567172|NCT00789971|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24567173|NCT00789971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24567174|NCT00789971|Glucocorticoids|glucocorticoids|mesh-ancestor
24567302|NCT00790439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24567303|NCT00790439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24567304|NCT00790439|Plasma Substitutes|plasma substitutes|mesh-ancestor
24567305|NCT00790439|Blood Substitutes|blood substitutes|mesh-ancestor
24567307|NCT00790595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24567308|NCT00790595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24567310|NCT00790595|Growth Substances|growth substances|mesh-ancestor
24567511|NCT00791401|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24567512|NCT00791401|Serotonin Agents|serotonin agents|mesh-ancestor
24567875|NCT00793273|Insulin Detemir|insulin detemir|mesh-list
24567952|NCT00793663|Anesthetics, General|anesthetics, general|mesh-ancestor
24567953|NCT00793663|Anesthetics|anesthetics|mesh-ancestor
24567954|NCT00793663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24567955|NCT00793663|Antipruritics|antipruritics|mesh-ancestor
24567956|NCT00793663|Dermatologic Agents|dermatologic agents|mesh-ancestor
24567957|NCT00793663|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24567958|NCT00793663|Serotonin Agents|serotonin agents|mesh-ancestor
24568266|NCT00795457|Interferon Inducers|interferon inducers|mesh-ancestor
24568267|NCT00795457|Laxatives|laxatives|mesh-ancestor
24568268|NCT00795457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24568446|NCT00796029|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24568448|NCT00796029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24568450|NCT00796029|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24568900|NCT00798070|Antimetabolites|antimetabolites|mesh-ancestor
24568901|NCT00798070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24568902|NCT00798070|Tubulin Modulators|tubulin modulators|mesh-ancestor
24568903|NCT00798070|Antimitotic Agents|antimitotic agents|mesh-ancestor
24569082|NCT00798980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24569084|NCT00798980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24569085|NCT00798980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569086|NCT00798980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24569087|NCT00798980|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24569088|NCT00798980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24569089|NCT00798993|Cholecalciferol|cholecalciferol|mesh-list
24569462|NCT00800592|Urological Agents|urological agents|mesh-ancestor
24569464|NCT00800709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24569465|NCT00800709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24569466|NCT00800709|Dopamine Agents|dopamine agents|mesh-ancestor
24569467|NCT00800709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24569477|NCT00800722|Antifungal Agents|antifungal agents|mesh-ancestor
24569573|NCT00801151|Vinorelbine|vinorelbine|mesh-list
24569574|NCT00801151|Vorinostat|vorinostat|mesh-list
24569575|NCT00801151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24569576|NCT00801151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24569578|NCT00801151|Antimitotic Agents|antimitotic agents|mesh-ancestor
24569579|NCT00801151|Mitosis Modulators|mitosis modulators|mesh-ancestor
24569580|NCT00801151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24569581|NCT00801151|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24569582|NCT00801151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24569625|NCT00801281|Mitosis Modulators|mitosis modulators|mesh-ancestor
24569626|NCT00801294|Nintedanib|nintedanib|mesh-list
24569627|NCT00801294|Afatinib|afatinib|mesh-list
24569967|NCT00802568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24569968|NCT00802568|Immunologic Factors|immunologic factors|mesh-ancestor
24569969|NCT00802568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24569970|NCT00802568|Alkylating Agents|alkylating agents|mesh-ancestor
24569971|NCT00802568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24569972|NCT00802568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24569973|NCT00802581|Anesthetics|anesthetics|mesh-list
24569974|NCT00802581|Anesthetics, Local|anesthetics, local|mesh-list
24569975|NCT00802581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24570530|NCT00805155|Dermatologic Agents|dermatologic agents|mesh-ancestor
24570531|NCT00805155|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24570533|NCT00805233|Ranibizumab|ranibizumab|mesh-list
24570534|NCT00805233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24570535|NCT00805233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24570575|NCT00805311|Losartan|losartan|mesh-list
24570666|NCT00805649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24570720|NCT00806169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24570722|NCT00806247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24570723|NCT00806247|Narcotics|narcotics|mesh-ancestor
24571500|NCT00810446|Rifabutin|rifabutin|mesh-list
24571501|NCT00810446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24571530|NCT00810680|Valproic Acid|valproic acid|mesh-list
24571531|NCT00810680|Anticonvulsants|anticonvulsants|mesh-ancestor
24571532|NCT00810680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571533|NCT00810680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571534|NCT00810680|GABA Agents|gaba agents|mesh-ancestor
24571535|NCT00810680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24571536|NCT00810680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571537|NCT00810680|Antimanic Agents|antimanic agents|mesh-ancestor
24571538|NCT00810680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24571539|NCT00810680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24571540|NCT00810680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24571541|NCT00810706|Exemestane|exemestane|mesh-list
24571542|NCT00810706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24571543|NCT00810706|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24571544|NCT00810706|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24571545|NCT00810706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571546|NCT00810706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571578|NCT00810862|Immunologic Factors|immunologic factors|mesh-ancestor
24571579|NCT00810862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24571580|NCT00810862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571581|NCT00810862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571583|NCT00810914|Anesthetics, Local|anesthetics, local|mesh-ancestor
24571584|NCT00810914|Anesthetics|anesthetics|mesh-ancestor
24571585|NCT00810914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24571586|NCT00810914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24571589|NCT00810940|Mannitol|mannitol|mesh-list
24571595|NCT00810953|Antifungal Agents|antifungal agents|mesh-ancestor
24571596|NCT00810953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24571597|NCT00810953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24571598|NCT00810953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24571633|NCT00811096|Alkylating Agents|alkylating agents|mesh-ancestor
24571831|NCT00811980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24571832|NCT00811980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24571833|NCT00811993|Gemcitabine|gemcitabine|mesh-list
24571834|NCT00811993|Etoposide|etoposide|mesh-list
24571835|NCT00811993|Docetaxel|docetaxel|mesh-list
24571836|NCT00811993|Bevacizumab|bevacizumab|mesh-list
24571837|NCT00811993|Carboplatin|carboplatin|mesh-list
24571838|NCT00811993|Capecitabine|capecitabine|mesh-list
24571839|NCT00811993|Trastuzumab|trastuzumab|mesh-list
24571840|NCT00811993|Irinotecan|irinotecan|mesh-list
24571841|NCT00811993|Cetuximab|cetuximab|mesh-list
24571842|NCT00811993|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24571843|NCT00811993|Temozolomide|temozolomide|mesh-list
24571844|NCT00811993|Sorafenib|sorafenib|mesh-list
24571845|NCT00811993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24571846|NCT00811993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24571847|NCT00811993|Tubulin Modulators|tubulin modulators|mesh-ancestor
24571848|NCT00811993|Antimitotic Agents|antimitotic agents|mesh-ancestor
24571849|NCT00811993|Mitosis Modulators|mitosis modulators|mesh-ancestor
24571870|NCT00812019|Vaccines|vaccines|mesh-list
24572042|NCT00812786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24572043|NCT00812786|Dermatologic Agents|dermatologic agents|mesh-ancestor
24572044|NCT00812786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24572053|NCT00812825|Hormones|hormones|mesh-ancestor
24572313|NCT00814216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24572463|NCT00815022|Sensory System Agents|sensory system agents|mesh-ancestor
24572464|NCT00815022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24572465|NCT00815022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24572466|NCT00815022|Narcotics|narcotics|mesh-ancestor
24572467|NCT00815022|Analgesics|analgesics|mesh-ancestor
24572468|NCT00815022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24572469|NCT00815022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24572470|NCT00815022|Anesthetics, General|anesthetics, general|mesh-ancestor
24572472|NCT00815048|Fentanyl|fentanyl|mesh-list
24572473|NCT00815048|Remifentanil|remifentanil|mesh-list
24572474|NCT00815048|Succinylcholine|succinylcholine|mesh-list
24572619|NCT00815893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572620|NCT00815893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24444504|NCT00298324|Prednisone|prednisone|mesh-list
24572829|NCT00816868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24572830|NCT00816868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24572831|NCT00816868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24572832|NCT00816868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24572833|NCT00816894|Olanzapine|olanzapine|mesh-list
24572932|NCT00817271|Hormones|hormones|mesh-ancestor
25407649|NCT03487016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25713459|NCT02340520|Autonomic Agents|autonomic agents|mesh-ancestor
24572933|NCT00817271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24572934|NCT00817271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24572935|NCT00817284|Bevacizumab|bevacizumab|mesh-list
24572936|NCT00817284|Irinotecan|irinotecan|mesh-list
24572937|NCT00817284|Temozolomide|temozolomide|mesh-list
24572938|NCT00817284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24573156|NCT00818155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24573157|NCT00818155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24573158|NCT00818155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573162|NCT00818155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24573425|NCT00819845|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24573426|NCT00819845|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24573427|NCT00819845|Protease Inhibitors|protease inhibitors|mesh-ancestor
24573428|NCT00819845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573430|NCT00819962|Anesthetics, Local|anesthetics, local|mesh-ancestor
24573431|NCT00819962|Anesthetics|anesthetics|mesh-ancestor
24573436|NCT00819975|Caseins|caseins|mesh-list
24573470|NCT00820118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24573471|NCT00820118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573711|NCT00821600|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24573712|NCT00821600|Serotonin Agents|serotonin agents|mesh-ancestor
24573713|NCT00821600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24573714|NCT00821600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24573715|NCT00821600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24573716|NCT00821600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24629700|NCT01107145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24573718|NCT00821600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24573719|NCT00821600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24573720|NCT00821600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24573721|NCT00821600|Dopamine Agents|dopamine agents|mesh-ancestor
24573722|NCT00821652|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
24573723|NCT00821652|Freund's Adjuvant|freund's adjuvant|mesh-list
24573724|NCT00821652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24573739|NCT00821782|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24573788|NCT00822081|Dorzolamide|dorzolamide|mesh-list
24576483|NCT00838838|Hormones|hormones|mesh-ancestor
24573789|NCT00822081|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
24573790|NCT00822081|Maleic acid|maleic acid|mesh-list
24573791|NCT00822081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24574033|NCT00823030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574034|NCT00823121|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24574036|NCT00823121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24574037|NCT00823121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574040|NCT00823186|Paclitaxel|paclitaxel|mesh-list
24574098|NCT00823602|Hormone Antagonists|hormone antagonists|mesh-ancestor
24574099|NCT00823602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24574100|NCT00823602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574101|NCT00823602|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24574102|NCT00823602|Fertility Agents|fertility agents|mesh-ancestor
24574103|NCT00823602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24574116|NCT00823849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24574117|NCT00823849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24574118|NCT00823849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574119|NCT00823849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24574120|NCT00823849|Vasodilator Agents|vasodilator agents|mesh-ancestor
24574121|NCT00823849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24574231|NCT00824239|Anesthetics|anesthetics|mesh-ancestor
24574232|NCT00824239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24574233|NCT00824239|Narcotics|narcotics|mesh-ancestor
24574234|NCT00824239|Analgesics|analgesics|mesh-ancestor
24574235|NCT00824239|Sensory System Agents|sensory system agents|mesh-ancestor
24574261|NCT00824668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24574262|NCT00824668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574263|NCT00824707|Entecavir|entecavir|mesh-list
24574264|NCT00824707|Antiviral Agents|antiviral agents|mesh-ancestor
24574265|NCT00824707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24574266|NCT00824785|Capecitabine|capecitabine|mesh-list
24574267|NCT00824785|Oxaliplatin|oxaliplatin|mesh-list
24574269|NCT00824785|Panitumumab|panitumumab|mesh-list
24630113|NCT01109615|Pemetrexed|pemetrexed|mesh-list
24574270|NCT00824785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24574271|NCT00824785|Antimetabolites|antimetabolites|mesh-ancestor
25713460|NCT02340520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24574272|NCT00824785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574273|NCT00824785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24574274|NCT00824785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24574275|NCT00824785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24574276|NCT00824785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24574277|NCT00824785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574422|NCT00825149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24574466|NCT00825422|Ropivacaine|ropivacaine|mesh-list
24574543|NCT00825942|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24574544|NCT00826046|Remestemcel-l|remestemcel-l|mesh-list
24574579|NCT00826358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24574580|NCT00826358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574581|NCT00826371|Ranibizumab|ranibizumab|mesh-list
24574582|NCT00826371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24574583|NCT00826371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24574584|NCT00826371|Growth Substances|growth substances|mesh-ancestor
24574585|NCT00826371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574586|NCT00826371|Growth Inhibitors|growth inhibitors|mesh-ancestor
24574591|NCT00826527|Cholinergic Agents|cholinergic agents|mesh-ancestor
24574592|NCT00826527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24574606|NCT00826553|Anesthetics|anesthetics|mesh-ancestor
24574607|NCT00826553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24574608|NCT00826553|Analgesics|analgesics|mesh-ancestor
24574609|NCT00826553|Sensory System Agents|sensory system agents|mesh-ancestor
24574610|NCT00826553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24574611|NCT00826553|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24574612|NCT00826553|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24574634|NCT00826566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24574635|NCT00826566|Purinergic Agents|purinergic agents|mesh-ancestor
24574636|NCT00826566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24574637|NCT00826644|Etoposide|etoposide|mesh-list
24574638|NCT00826644|Belotecan|belotecan|mesh-list
24574639|NCT00826644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24574850|NCT00827840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24574851|NCT00827840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24574852|NCT00827840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24574853|NCT00827840|Dopamine Agents|dopamine agents|mesh-ancestor
24574854|NCT00827840|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24574855|NCT00827840|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24574856|NCT00827892|Pioglitazone|pioglitazone|mesh-list
24574857|NCT00827892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24574858|NCT00827892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574859|NCT00827996|Adalimumab|adalimumab|mesh-list
24574962|NCT00828789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24574963|NCT00828789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24574964|NCT00828802|Lenalidomide|lenalidomide|mesh-list
24574965|NCT00828802|Decitabine|decitabine|mesh-list
24574966|NCT00828802|Immunologic Factors|immunologic factors|mesh-ancestor
24574977|NCT00828815|Etravirine|etravirine|mesh-list
24574986|NCT00828919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24574987|NCT00828919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24574988|NCT00828919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24574994|NCT00828958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24574995|NCT00828958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24574996|NCT00828958|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24574997|NCT00828958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24574998|NCT00828958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24574999|NCT00828958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24575000|NCT00828958|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25713461|NCT02340520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713462|NCT02340520|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25713463|NCT02340520|Respiratory System Agents|respiratory system agents|mesh-ancestor
25713464|NCT02340520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25713465|NCT02340520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713466|NCT02340520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713467|NCT02340520|Vasodilator Agents|vasodilator agents|mesh-ancestor
24575001|NCT00828958|Dopamine Agents|dopamine agents|mesh-ancestor
24575335|NCT00830843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24575336|NCT00830843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575337|NCT00830843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24575338|NCT00830843|Anesthetics, General|anesthetics, general|mesh-ancestor
24575339|NCT00830843|Anesthetics|anesthetics|mesh-ancestor
24575340|NCT00830843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24575343|NCT00830856|Stavudine|stavudine|mesh-list
24575344|NCT00830856|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
24575345|NCT00830856|Fluconazole|fluconazole|mesh-list
24575346|NCT00830856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24575347|NCT00830856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24575348|NCT00830856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575350|NCT00830856|Antiviral Agents|antiviral agents|mesh-ancestor
24575386|NCT00831103|Valacyclovir|valacyclovir|mesh-list
24575387|NCT00831103|Antiviral Agents|antiviral agents|mesh-ancestor
24575388|NCT00831103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24575389|NCT00831155|Nicotine|nicotine|mesh-list
24575390|NCT00831155|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24575391|NCT00831155|Autonomic Agents|autonomic agents|mesh-ancestor
24575428|NCT00831545|Temozolomide|temozolomide|mesh-list
24575487|NCT00832182|Insulin|insulin|mesh-list
24671109|NCT01323569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575488|NCT00832182|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24575489|NCT00832182|Insulin Aspart|insulin aspart|mesh-list
24575490|NCT00832182|Isophane Insulin, Human|isophane insulin, human|mesh-list
24575491|NCT00832182|Insulin, Isophane|insulin, isophane|mesh-list
24575492|NCT00832182|Isophane insulin, beef|isophane insulin, beef|mesh-list
24575493|NCT00832182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24575535|NCT00832286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24575536|NCT00832286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24575537|NCT00832286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575538|NCT00832286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575539|NCT00832286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24575540|NCT00832286|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24575541|NCT00832286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24575543|NCT00832364|Acitretin|acitretin|mesh-list
24575544|NCT00832364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24575545|NCT00832364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24575546|NCT00832364|Analgesics|analgesics|mesh-ancestor
24575547|NCT00832364|Sensory System Agents|sensory system agents|mesh-ancestor
24575589|NCT00832481|Metformin|metformin|mesh-list
24575590|NCT00832481|Repaglinide|repaglinide|mesh-list
24575647|NCT00833157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575648|NCT00833235|Lubricant Eye Drops|lubricant eye drops|mesh-list
24575649|NCT00833235|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24575650|NCT00833235|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24575651|NCT00833300|Haloperidol|haloperidol|mesh-list
24575652|NCT00833300|Olanzapine|olanzapine|mesh-list
24575653|NCT00833300|Haloperidol decanoate|haloperidol decanoate|mesh-list
24575654|NCT00833300|Antiemetics|antiemetics|mesh-ancestor
24575655|NCT00833300|Autonomic Agents|autonomic agents|mesh-ancestor
24575693|NCT00833339|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24575694|NCT00833339|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24575695|NCT00833378|Ritonavir|ritonavir|mesh-list
24575696|NCT00833378|Lopinavir|lopinavir|mesh-list
25713468|NCT02340520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24575697|NCT00833378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24575698|NCT00833378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25713469|NCT02340520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25713470|NCT02340520|Purinergic Agents|purinergic agents|mesh-ancestor
25713471|NCT02340520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25713472|NCT02340819|Teduglutide|teduglutide|mesh-list
25713473|NCT02340819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25713474|NCT02340819|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25713475|NCT02340819|Protective Agents|protective agents|mesh-ancestor
25713476|NCT02340819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713477|NCT02340949|Leucovorin|leucovorin|mesh-list
25713478|NCT02340949|Oxaliplatin|oxaliplatin|mesh-list
25713480|NCT02340949|Fluorouracil|fluorouracil|mesh-list
25713481|NCT02340949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713482|NCT02340949|Antidotes|antidotes|mesh-ancestor
25713483|NCT02340949|Protective Agents|protective agents|mesh-ancestor
25713484|NCT02340949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713485|NCT02340949|Vitamin B Complex|vitamin b complex|mesh-ancestor
24575699|NCT00833378|Protease Inhibitors|protease inhibitors|mesh-ancestor
24575700|NCT00833378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24575701|NCT00833378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575702|NCT00833378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24575703|NCT00833378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24575704|NCT00833378|Antiviral Agents|antiviral agents|mesh-ancestor
24575705|NCT00833378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24671111|NCT01323569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24575710|NCT00833404|Autonomic Agents|autonomic agents|mesh-ancestor
24575716|NCT00833404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24575717|NCT00833404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24575718|NCT00833534|Rituximab|rituximab|mesh-list
24575719|NCT00833534|Lenalidomide|lenalidomide|mesh-list
24575748|NCT00833807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24575749|NCT00833807|Tubulin Modulators|tubulin modulators|mesh-ancestor
24575750|NCT00833807|Antimitotic Agents|antimitotic agents|mesh-ancestor
24575803|NCT00834457|Antimetabolites|antimetabolites|mesh-ancestor
24575805|NCT00834457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24575807|NCT00834470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24575808|NCT00834470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24575809|NCT00834470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24575810|NCT00834470|Autonomic Agents|autonomic agents|mesh-ancestor
24575811|NCT00834470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24575812|NCT00834470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24575813|NCT00834470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24575958|NCT00835939|Sensory System Agents|sensory system agents|mesh-ancestor
24575959|NCT00835939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24575960|NCT00835939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24575996|NCT00836199|Vaccines|vaccines|mesh-list
24576289|NCT00837928|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24576290|NCT00837928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24576291|NCT00837928|Alkylating Agents|alkylating agents|mesh-ancestor
24576310|NCT00837941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24576311|NCT00837941|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24576312|NCT00837941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24576313|NCT00837941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576484|NCT00838838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24576485|NCT00838838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576486|NCT00838838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24576487|NCT00838838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24576488|NCT00838838|Anabolic Agents|anabolic agents|mesh-ancestor
24576490|NCT00838864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24576491|NCT00838864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24576492|NCT00838955|Sirolimus|sirolimus|mesh-list
24576493|NCT00838955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24576494|NCT00838955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24576498|NCT00838955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24576605|NCT00839371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576606|NCT00839371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576608|NCT00839397|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24576609|NCT00839397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24576610|NCT00839397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24576611|NCT00839397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24576612|NCT00839397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24576613|NCT00839397|Serotonin Agents|serotonin agents|mesh-ancestor
25407650|NCT03487016|Immunologic Factors|immunologic factors|mesh-ancestor
25713486|NCT02340949|Vitamins|vitamins|mesh-ancestor
25713487|NCT02340949|Micronutrients|micronutrients|mesh-ancestor
25713488|NCT02340949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25713489|NCT02340949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25713490|NCT02340949|Growth Substances|growth substances|mesh-ancestor
24576614|NCT00839397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24576729|NCT00840229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24576730|NCT00840229|Glucocorticoids|glucocorticoids|mesh-ancestor
24576734|NCT00840229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24576819|NCT00840580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24576820|NCT00840580|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24576821|NCT00840580|Renal Agents|renal agents|mesh-ancestor
24576822|NCT00840580|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24576824|NCT00840606|Buspirone|buspirone|mesh-list
24576872|NCT00840684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24576874|NCT00840801|Immunologic Factors|immunologic factors|mesh-ancestor
24576875|NCT00840801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577106|NCT00841945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24577107|NCT00841945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24577108|NCT00841945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24577109|NCT00841945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24577110|NCT00841945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577111|NCT00841945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577127|NCT00842114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577396|NCT00843895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577398|NCT00843908|Cholinergic Agents|cholinergic agents|mesh-ancestor
24577399|NCT00843908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24577400|NCT00843908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577401|NCT00843908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24577402|NCT00843934|Epirubicin|epirubicin|mesh-list
24577403|NCT00843934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24577404|NCT00843934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24577405|NCT00843934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24577406|NCT00843934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24577407|NCT00843934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577408|NCT00843934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24577409|NCT00844012|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24577513|NCT00844350|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24577526|NCT00844454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24577724|NCT00845689|Analgesics|analgesics|mesh-ancestor
24444664|NCT00298857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24577814|NCT00845936|Metformin|metformin|mesh-list
24578059|NCT00846703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24578060|NCT00846703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24578061|NCT00846703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24578062|NCT00846703|Immunologic Factors|immunologic factors|mesh-ancestor
24578209|NCT00847483|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24578211|NCT00847483|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24578212|NCT00847483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24578217|NCT00847639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24578218|NCT00847639|Growth Substances|growth substances|mesh-ancestor
24578279|NCT00847899|1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea|1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea|mesh-list
24578280|NCT00847899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24578281|NCT00847899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632316|NCT01123278|Testosterone|testosterone|mesh-list
24578282|NCT00847899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713491|NCT02340949|Growth Inhibitors|growth inhibitors|mesh-ancestor
25713492|NCT02340949|Antimetabolites|antimetabolites|mesh-ancestor
25713493|NCT02340949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713494|NCT02340949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25713495|NCT02340949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25713496|NCT02340949|Immunologic Factors|immunologic factors|mesh-ancestor
25713497|NCT02340962|Interferons|interferons|mesh-list
25713498|NCT02340962|Ribavirin|ribavirin|mesh-list
24578283|NCT00848068|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24578284|NCT00848068|Lubricant Eye Drops|lubricant eye drops|mesh-list
24578285|NCT00848068|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24578287|NCT00848302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24578435|NCT00849030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444666|NCT00298857|GABA Agents|gaba agents|mesh-ancestor
24578446|NCT00849082|Contraceptive Agents|contraceptive agents|mesh-ancestor
24578448|NCT00849095|Budesonide|budesonide|mesh-list
24444052|NCT00296634|Antacids|antacids|mesh-ancestor
24578659|NCT00850382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24579057|NCT00853177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579058|NCT00853190|Chlorpheniramine|chlorpheniramine|mesh-list
24579237|NCT00853983|Saracatinib|saracatinib|mesh-list
24579238|NCT00853983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24579239|NCT00853983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579240|NCT00853983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579241|NCT00854009|BLI-489|bli-489|mesh-list
24579242|NCT00854009|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24579283|NCT00854204|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24579284|NCT00854204|Protease Inhibitors|protease inhibitors|mesh-ancestor
24579285|NCT00854204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24579286|NCT00854204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579287|NCT00854204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24579288|NCT00854204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24579289|NCT00854204|Antiviral Agents|antiviral agents|mesh-ancestor
24579290|NCT00854204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24579291|NCT00854230|Naltrexone|naltrexone|mesh-list
24579292|NCT00854230|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24579293|NCT00854230|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24579294|NCT00854230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579295|NCT00854230|Sensory System Agents|sensory system agents|mesh-ancestor
24579416|NCT00854932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24579417|NCT00855049|Acetaminophen|acetaminophen|mesh-list
24579418|NCT00855049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24579419|NCT00855049|Analgesics|analgesics|mesh-ancestor
24579420|NCT00855049|Sensory System Agents|sensory system agents|mesh-ancestor
24579423|NCT00855049|Antipyretics|antipyretics|mesh-ancestor
24579479|NCT00855283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24579480|NCT00855283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24579481|NCT00855283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579538|NCT00855972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24579539|NCT00855972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24579540|NCT00855972|Sensory System Agents|sensory system agents|mesh-ancestor
24579541|NCT00855972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24579542|NCT00856037|Doxorubicin|doxorubicin|mesh-list
24579543|NCT00856037|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24579544|NCT00856037|Topotecan|topotecan|mesh-list
24579545|NCT00856037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24580343|NCT00861419|Motesanib diphosphate|motesanib diphosphate|mesh-list
24580344|NCT00861419|Imetelstat|imetelstat|mesh-list
24580349|NCT00861419|Growth Substances|growth substances|mesh-ancestor
24580394|NCT00861536|Thymoglobulin|thymoglobulin|mesh-list
24580395|NCT00861536|Immunologic Factors|immunologic factors|mesh-ancestor
24580396|NCT00861536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580397|NCT00861536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24580398|NCT00861627|Paclitaxel|paclitaxel|mesh-list
24580399|NCT00861627|Carboplatin|carboplatin|mesh-list
24580400|NCT00861627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24580401|NCT00861627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713499|NCT02340962|Interferon-alpha|interferon-alpha|mesh-list
25713500|NCT02340962|Interferon alpha-2|interferon alpha-2|mesh-list
25713501|NCT02340962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713502|NCT02340962|Antiviral Agents|antiviral agents|mesh-ancestor
24580402|NCT00861627|Tubulin Modulators|tubulin modulators|mesh-ancestor
24580521|NCT00862095|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24580522|NCT00862095|Antidepressive Agents|antidepressive agents|mesh-ancestor
24580523|NCT00862095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24580524|NCT00862095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24580525|NCT00862095|Analgesics|analgesics|mesh-ancestor
24580526|NCT00862095|Sensory System Agents|sensory system agents|mesh-ancestor
25713503|NCT02340962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25713504|NCT02340962|Antimetabolites|antimetabolites|mesh-ancestor
25713505|NCT02340962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580527|NCT00862095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24580528|NCT00862095|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24580529|NCT00862095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24580530|NCT00862095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24580531|NCT00862108|Methylphenidate|methylphenidate|mesh-list
24580532|NCT00862108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24580552|NCT00862264|Adrenergic Agents|adrenergic agents|mesh-ancestor
24580948|NCT00864058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24580975|NCT00864149|Adrenergic Agents|adrenergic agents|mesh-ancestor
24580976|NCT00864149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24580977|NCT00864149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24580978|NCT00864149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24580979|NCT00864149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24580981|NCT00864149|Protective Agents|protective agents|mesh-ancestor
24580982|NCT00864149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24580983|NCT00864149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24632702|NCT01125410|Clindamycin|clindamycin|mesh-list
24580984|NCT00864149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24581282|NCT00864825|Antioxidants|antioxidants|mesh-ancestor
24581283|NCT00864825|Protective Agents|protective agents|mesh-ancestor
24581284|NCT00864825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581435|NCT00865111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24581436|NCT00865111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24581437|NCT00865111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24581438|NCT00865111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24581440|NCT00865137|Tacrolimus|tacrolimus|mesh-list
24581441|NCT00865137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24581447|NCT00865176|Eplerenone|eplerenone|mesh-list
24595219|NCT00937300|Alkylating Agents|alkylating agents|mesh-ancestor
24582366|NCT00869271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582367|NCT00869271|Antidotes|antidotes|mesh-ancestor
24582368|NCT00869271|Protective Agents|protective agents|mesh-ancestor
24582369|NCT00869271|Vitamin B Complex|vitamin b complex|mesh-ancestor
24582370|NCT00869271|Vitamins|vitamins|mesh-ancestor
24582371|NCT00869271|Micronutrients|micronutrients|mesh-ancestor
24582494|NCT00870025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24444794|NCT00299091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24444795|NCT00299091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24582495|NCT00870025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24582498|NCT00870038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24582938|NCT00872625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24582984|NCT00872924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24582985|NCT00872924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583092|NCT00873340|Antiviral Agents|antiviral agents|mesh-ancestor
24583093|NCT00873340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24583094|NCT00873340|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24583095|NCT00873340|Immunologic Factors|immunologic factors|mesh-ancestor
24583096|NCT00873340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583121|NCT00873366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24583122|NCT00873379|Melatonin|melatonin|mesh-list
24583123|NCT00873379|Antioxidants|antioxidants|mesh-ancestor
25713506|NCT02340962|Immunologic Factors|immunologic factors|mesh-ancestor
25713507|NCT02340962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713508|NCT02340975|Durvalumab|durvalumab|mesh-list
24583124|NCT00873379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583125|NCT00873379|Protective Agents|protective agents|mesh-ancestor
24583126|NCT00873379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583128|NCT00873392|Nicotine|nicotine|mesh-list
24583370|NCT00874315|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24583371|NCT00874315|Antitubercular Agents|antitubercular agents|mesh-ancestor
24583372|NCT00874315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24583376|NCT00874328|Irinotecan|irinotecan|mesh-list
24583536|NCT00875069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24583537|NCT00875069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24583538|NCT00875082|Montelukast|montelukast|mesh-list
24583539|NCT00875082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24583540|NCT00875082|Respiratory System Agents|respiratory system agents|mesh-ancestor
24583541|NCT00875082|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24583542|NCT00875082|Hormone Antagonists|hormone antagonists|mesh-ancestor
24583761|NCT00876772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24583762|NCT00876772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24583763|NCT00876772|Serotonin Agents|serotonin agents|mesh-ancestor
24583764|NCT00876824|Amphotericin B|amphotericin b|mesh-list
24583765|NCT00876824|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24583766|NCT00876824|Amebicides|amebicides|mesh-ancestor
24583767|NCT00876824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24583768|NCT00876824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24583769|NCT00876824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24583770|NCT00876824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24583771|NCT00876824|Antifungal Agents|antifungal agents|mesh-ancestor
24633109|NCT01127269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633110|NCT01127282|Vitamins|vitamins|mesh-list
24585000|NCT00882635|Heparin|heparin|mesh-list
24585001|NCT00882635|Enoxaparin|enoxaparin|mesh-list
24585325|NCT00884884|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24585326|NCT00884884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24585327|NCT00884884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24585328|NCT00884884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585329|NCT00884884|Dopamine Agonists|dopamine agonists|mesh-ancestor
24585330|NCT00884884|Dopamine Agents|dopamine agents|mesh-ancestor
24585331|NCT00884884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24585332|NCT00884884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24585333|NCT00884884|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24585708|NCT00886873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24585739|NCT00887003|Methylprednisolone|methylprednisolone|mesh-list
24585740|NCT00887003|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24585741|NCT00887003|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24585742|NCT00887003|Prednisolone|prednisolone|mesh-list
24585743|NCT00887003|Prednisolone acetate|prednisolone acetate|mesh-list
24585744|NCT00887003|Bupivacaine|bupivacaine|mesh-list
24585745|NCT00887003|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24585746|NCT00887003|Prednisolone phosphate|prednisolone phosphate|mesh-list
24585747|NCT00887003|Anesthetics, Local|anesthetics, local|mesh-ancestor
24585748|NCT00887003|Anesthetics|anesthetics|mesh-ancestor
24585749|NCT00887003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24585750|NCT00887003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24585751|NCT00887003|Sensory System Agents|sensory system agents|mesh-ancestor
24585752|NCT00887003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24585753|NCT00887003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24585754|NCT00887003|Antiemetics|antiemetics|mesh-ancestor
24585844|NCT00887276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24585845|NCT00887276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24585846|NCT00887276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24585848|NCT00887276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24586163|NCT00889369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586164|NCT00889369|Analgesics|analgesics|mesh-ancestor
24586165|NCT00889369|Sensory System Agents|sensory system agents|mesh-ancestor
24586166|NCT00889369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24586193|NCT00889525|Dopamine Agonists|dopamine agonists|mesh-ancestor
24586875|NCT00892463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25713510|NCT02340975|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24586876|NCT00892463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25713511|NCT02340975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25713512|NCT02340975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713513|NCT02340975|Immunologic Factors|immunologic factors|mesh-ancestor
25713514|NCT02340975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713515|NCT02341144|Ropivacaine|ropivacaine|mesh-list
25713516|NCT02341144|Anesthetics, Local|anesthetics, local|mesh-ancestor
25713517|NCT02341144|Anesthetics|anesthetics|mesh-ancestor
24586877|NCT00892463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24586878|NCT00892463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586879|NCT00892476|Calcium, Dietary|calcium, dietary|mesh-list
24586881|NCT00892476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24586882|NCT00892476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24586883|NCT00892476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24587148|NCT00893594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24587149|NCT00893594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24587151|NCT00893594|Analgesics|analgesics|mesh-ancestor
24587152|NCT00893594|Sensory System Agents|sensory system agents|mesh-ancestor
24587220|NCT00893841|Dopamine Agents|dopamine agents|mesh-ancestor
24587221|NCT00893841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24587222|NCT00893854|Triamcinolone|triamcinolone|mesh-list
24587223|NCT00893854|Diclofenac|diclofenac|mesh-list
24587224|NCT00893854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24587225|NCT00893854|Glucocorticoids|glucocorticoids|mesh-ancestor
24587226|NCT00893854|Hormones|hormones|mesh-ancestor
24587227|NCT00893854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24863181|NCT02934529|Immunologic Factors|immunologic factors|mesh-ancestor
24587475|NCT00895089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24587476|NCT00895089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24587477|NCT00895089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24587478|NCT00895089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24587479|NCT00895089|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24587480|NCT00895089|Contraceptive Agents|contraceptive agents|mesh-ancestor
24587481|NCT00895089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24587482|NCT00895089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588198|NCT00901524|Antimetabolites|antimetabolites|mesh-ancestor
24588199|NCT00901524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588200|NCT00901524|Immunologic Factors|immunologic factors|mesh-ancestor
24588201|NCT00901524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588202|NCT00901537|Azacitidine|azacitidine|mesh-list
24588203|NCT00901537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588206|NCT00901537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588207|NCT00901537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588208|NCT00901550|Methotrexate|methotrexate|mesh-list
24588209|NCT00901550|Infliximab|infliximab|mesh-list
24634178|NCT01132235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24634179|NCT01132235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24588294|NCT00901849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24588295|NCT00901849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588296|NCT00901849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588616|NCT00903292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588617|NCT00903292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24588618|NCT00903292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24588619|NCT00903292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24588620|NCT00903292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24588621|NCT00903292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24588622|NCT00903656|Lapatinib|lapatinib|mesh-list
24588623|NCT00903656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24588624|NCT00903656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24588685|NCT00903942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24589437|NCT00907452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24589438|NCT00907452|Glucocorticoids|glucocorticoids|mesh-ancestor
24589439|NCT00907452|Hormones|hormones|mesh-ancestor
24589440|NCT00907452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24589441|NCT00907452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24589442|NCT00907452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24589443|NCT00907452|Immunologic Factors|immunologic factors|mesh-ancestor
24589485|NCT00907829|Anesthetics, Local|anesthetics, local|mesh-ancestor
24589486|NCT00907829|Anesthetics|anesthetics|mesh-ancestor
24590056|NCT00910442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590059|NCT00910455|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24590060|NCT00910455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590072|NCT00910598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24590073|NCT00910637|Gestodene|gestodene|mesh-list
24590074|NCT00910637|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24634779|NCT01135199|Pomalidomide|pomalidomide|mesh-list
24590075|NCT00910637|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24590076|NCT00910637|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24590077|NCT00910637|Contraceptive Agents|contraceptive agents|mesh-ancestor
24590082|NCT00910637|Progestins|progestins|mesh-ancestor
24590309|NCT00911716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24590311|NCT00911716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24590453|NCT00912574|Freund's Adjuvant|freund's adjuvant|mesh-list
24590454|NCT00912574|Immunologic Factors|immunologic factors|mesh-ancestor
24590455|NCT00912574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590456|NCT00912574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24590457|NCT00912574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24590762|NCT00913809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24590763|NCT00913809|Adrenergic Agents|adrenergic agents|mesh-ancestor
24590764|NCT00913809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24590889|NCT00914134|Levodopa|levodopa|mesh-list
24590896|NCT00914160|Diclofenac|diclofenac|mesh-list
24590897|NCT00914160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24590964|NCT00914498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24590965|NCT00914498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24590966|NCT00914498|Sensory System Agents|sensory system agents|mesh-ancestor
24590967|NCT00914498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24590969|NCT00914498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24590970|NCT00914498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24590971|NCT00914498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24590973|NCT00914524|Olmesartan|olmesartan|mesh-list
24590984|NCT00914563|Antimanic Agents|antimanic agents|mesh-ancestor
24590985|NCT00914563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24591326|NCT00915850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591327|NCT00915915|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24591377|NCT00916097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591378|NCT00916097|Tubulin Modulators|tubulin modulators|mesh-ancestor
24591379|NCT00916097|Antimitotic Agents|antimitotic agents|mesh-ancestor
24591380|NCT00916097|Mitosis Modulators|mitosis modulators|mesh-ancestor
24591381|NCT00916097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591383|NCT00916123|Docetaxel|docetaxel|mesh-list
24591384|NCT00916123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591385|NCT00916123|Tubulin Modulators|tubulin modulators|mesh-ancestor
24591600|NCT00917761|Antiviral Agents|antiviral agents|mesh-ancestor
24591601|NCT00917761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24591602|NCT00917761|Immunologic Factors|immunologic factors|mesh-ancestor
24591603|NCT00917761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24591604|NCT00917839|Lamotrigine|lamotrigine|mesh-list
24591605|NCT00917839|Anticonvulsants|anticonvulsants|mesh-ancestor
24591606|NCT00917839|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24591607|NCT00917839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24635211|NCT01137903|Amoxicillin|amoxicillin|mesh-list
24591608|NCT00917839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591722|NCT00918320|Alkylating Agents|alkylating agents|mesh-ancestor
24591723|NCT00918320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24591724|NCT00918320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24591725|NCT00918320|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24591726|NCT00918320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24591772|NCT00918554|Antimetabolites|antimetabolites|mesh-ancestor
24592016|NCT00920088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24592017|NCT00920088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24592018|NCT00920088|Protease Inhibitors|protease inhibitors|mesh-ancestor
24592019|NCT00920088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24592020|NCT00920088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24592021|NCT00920088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24592022|NCT00920088|Antiviral Agents|antiviral agents|mesh-ancestor
24592023|NCT00920088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24592024|NCT00920088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24592025|NCT00920088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24592030|NCT00920088|Analgesics|analgesics|mesh-ancestor
24592087|NCT00920153|Mitosis Modulators|mitosis modulators|mesh-ancestor
24592088|NCT00920153|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24592089|NCT00920153|Protective Agents|protective agents|mesh-ancestor
24592310|NCT00921219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24592311|NCT00921245|Darifenacin|darifenacin|mesh-list
24592381|NCT00921531|Growth Substances|growth substances|mesh-ancestor
24592382|NCT00921531|Growth Inhibitors|growth inhibitors|mesh-ancestor
24592383|NCT00921531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24592385|NCT00921570|Valsartan|valsartan|mesh-list
24635480|NCT01139671|Narcotics|narcotics|mesh-ancestor
24593076|NCT00926835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24593078|NCT00926835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24593079|NCT00926835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24593080|NCT00926835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24593081|NCT00926835|Dopamine Agonists|dopamine agonists|mesh-ancestor
24593082|NCT00926835|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24593083|NCT00926835|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24593173|NCT00927212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24593174|NCT00927212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593196|NCT00927498|Daunorubicin|daunorubicin|mesh-list
24593197|NCT00927498|Gemtuzumab|gemtuzumab|mesh-list
24593198|NCT00927498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24593199|NCT00927498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24593200|NCT00927498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24593201|NCT00927498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24593202|NCT00927498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24593203|NCT00927498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593204|NCT00927498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24593205|NCT00927498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24593206|NCT00927498|Antimetabolites|antimetabolites|mesh-ancestor
24593225|NCT00927537|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24593227|NCT00927537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24593228|NCT00927537|Diuretics|diuretics|mesh-ancestor
24593229|NCT00927537|Natriuretic Agents|natriuretic agents|mesh-ancestor
24593230|NCT00927537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593268|NCT00927732|Parasympatholytics|parasympatholytics|mesh-ancestor
24593330|NCT00927966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24593869|NCT00931281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24593870|NCT00931281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24593871|NCT00931281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24593872|NCT00931281|Antiviral Agents|antiviral agents|mesh-ancestor
24593873|NCT00931281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24593874|NCT00931281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24593875|NCT00931281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24593876|NCT00931372|Lixisenatide|lixisenatide|mesh-list
24593927|NCT00931645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24594036|NCT00931957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24595212|NCT00937300|Fludarabine phosphate|fludarabine phosphate|mesh-list
24595213|NCT00937300|Interleukin-2|interleukin-2|mesh-list
24595214|NCT00937300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24595215|NCT00937300|Immunologic Factors|immunologic factors|mesh-ancestor
24595216|NCT00937300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24595217|NCT00937300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24596091|NCT00941499|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24596092|NCT00941499|Growth Substances|growth substances|mesh-ancestor
24596093|NCT00941499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596094|NCT00941499|Growth Inhibitors|growth inhibitors|mesh-ancestor
24596095|NCT00941499|Immunologic Factors|immunologic factors|mesh-ancestor
24596096|NCT00941499|Antimetabolites|antimetabolites|mesh-ancestor
24596097|NCT00941499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596205|NCT00942344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596206|NCT00942344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24596207|NCT00942344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596208|NCT00942344|Vasodilator Agents|vasodilator agents|mesh-ancestor
24596219|NCT00942435|Anticoagulants|anticoagulants|mesh-ancestor
24596220|NCT00942487|Nebivolol|nebivolol|mesh-list
24596221|NCT00942487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24596222|NCT00942487|Vasodilator Agents|vasodilator agents|mesh-ancestor
24596223|NCT00942487|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24596224|NCT00942487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24596225|NCT00942487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24596226|NCT00942487|Adrenergic Agents|adrenergic agents|mesh-ancestor
24596401|NCT00943449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24596402|NCT00943449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596403|NCT00943449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596405|NCT00943462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24596406|NCT00943462|Alkylating Agents|alkylating agents|mesh-ancestor
24596407|NCT00943462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596408|NCT00943462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596410|NCT00943501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24596411|NCT00943501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596412|NCT00943501|Incretins|incretins|mesh-ancestor
24596413|NCT00943501|Hormones|hormones|mesh-ancestor
24596414|NCT00943501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24596415|NCT00943540|Lamivudine|lamivudine|mesh-list
24596442|NCT00943566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24596602|NCT00944424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24596604|NCT00944463|Simvastatin|simvastatin|mesh-list
24596605|NCT00944463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24596606|NCT00944463|Antimetabolites|antimetabolites|mesh-ancestor
24596607|NCT00944463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596608|NCT00944463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596609|NCT00944463|Antiviral Agents|antiviral agents|mesh-ancestor
24596610|NCT00944463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24596611|NCT00944463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596612|NCT00944463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24596692|NCT00944918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24596693|NCT00944918|Hormone Antagonists|hormone antagonists|mesh-ancestor
24596694|NCT00944918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24596695|NCT00944918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24596696|NCT00944918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24596697|NCT00944918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24596698|NCT00944918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596699|NCT00944918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24596873|NCT00946335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596874|NCT00946335|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24596875|NCT00946335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24596876|NCT00946374|Cyclosporine|cyclosporine|mesh-list
24596877|NCT00946374|Doxorubicin|doxorubicin|mesh-list
24596878|NCT00946374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24596879|NCT00946374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24596938|NCT00946595|Lopinavir|lopinavir|mesh-list
24596939|NCT00946595|Tenofovir|tenofovir|mesh-list
24597020|NCT00946790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597021|NCT00946790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25713518|NCT02341144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25713519|NCT02341144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713520|NCT02341144|Sensory System Agents|sensory system agents|mesh-ancestor
25713521|NCT02341144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24597022|NCT00946829|Telmisartan|telmisartan|mesh-list
24597023|NCT00946829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24597024|NCT00946829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24597025|NCT00946829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24597026|NCT00946829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24597079|NCT00947063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24597080|NCT00947063|Antiemetics|antiemetics|mesh-ancestor
24597081|NCT00947063|Autonomic Agents|autonomic agents|mesh-ancestor
24597363|NCT00948987|Aspirin|aspirin|mesh-list
24597364|NCT00948987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24597365|NCT00948987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24597425|NCT00949247|Growth Inhibitors|growth inhibitors|mesh-ancestor
24597426|NCT00949247|Tubulin Modulators|tubulin modulators|mesh-ancestor
24597427|NCT00949247|Antimitotic Agents|antimitotic agents|mesh-ancestor
24597985|NCT00953134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24597986|NCT00953303|Dexamethasone|dexamethasone|mesh-list
24597987|NCT00953303|Dexamethasone acetate|dexamethasone acetate|mesh-list
24597988|NCT00953303|Prednisone|prednisone|mesh-list
24597989|NCT00953303|Torsemide|torsemide|mesh-list
24597990|NCT00953303|Dobutamine|dobutamine|mesh-list
24597991|NCT00953303|Dopamine|dopamine|mesh-list
24597992|NCT00953303|Furosemide|furosemide|mesh-list
24597993|NCT00953303|Nitroglycerin|nitroglycerin|mesh-list
24598014|NCT00953303|Vasodilator Agents|vasodilator agents|mesh-ancestor
24598015|NCT00953303|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24598016|NCT00953303|Sympathomimetics|sympathomimetics|mesh-ancestor
24598369|NCT00955773|Trametinib|trametinib|mesh-list
24598370|NCT00955773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598371|NCT00955773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24598372|NCT00955773|Immunologic Factors|immunologic factors|mesh-ancestor
24598373|NCT00955773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598374|NCT00955773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24598375|NCT00955773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598376|NCT00955773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598377|NCT00955890|Dexrazoxane|dexrazoxane|mesh-list
24598378|NCT00955890|Razoxane|razoxane|mesh-list
24598379|NCT00955890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598380|NCT00955890|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24598381|NCT00955890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24598382|NCT00955890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24598383|NCT00955890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598384|NCT00955890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598385|NCT00955890|Protective Agents|protective agents|mesh-ancestor
24598386|NCT00955890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598387|NCT00955890|Antimitotic Agents|antimitotic agents|mesh-ancestor
24598388|NCT00955890|Mitosis Modulators|mitosis modulators|mesh-ancestor
24598389|NCT00956007|Cetuximab|cetuximab|mesh-list
24598390|NCT00956007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24598391|NCT00956007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24598392|NCT00956046|Vaccines|vaccines|mesh-list
24598393|NCT00956046|Immunologic Factors|immunologic factors|mesh-ancestor
24598394|NCT00956046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598395|NCT00956059|Prednisone|prednisone|mesh-list
24598396|NCT00956059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24598397|NCT00956059|Glucocorticoids|glucocorticoids|mesh-ancestor
24598426|NCT00956150|Rifaximin|rifaximin|mesh-list
24598443|NCT00956163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24598444|NCT00956163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24598445|NCT00956176|Cidofovir|cidofovir|mesh-list
24598446|NCT00956176|Antiviral Agents|antiviral agents|mesh-ancestor
24598447|NCT00956176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24598448|NCT00956176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24598610|NCT00956982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598611|NCT00957060|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25713522|NCT02341417|Cinacalcet|cinacalcet|mesh-list
25713523|NCT02341417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25713524|NCT02341417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598613|NCT00957060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24598614|NCT00957060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24598615|NCT00957060|Incretins|incretins|mesh-ancestor
24598618|NCT00957060|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24600143|NCT02465138|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24542923|NCT00680940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24542924|NCT00680940|Tubulin Modulators|tubulin modulators|mesh-ancestor
24542925|NCT00680940|Antimitotic Agents|antimitotic agents|mesh-ancestor
24863162|NCT02934529|Leucovorin|leucovorin|mesh-list
24863163|NCT02934529|Folic Acid|folic acid|mesh-list
25713528|NCT02341456|Paclitaxel|paclitaxel|mesh-list
25713529|NCT02341456|Carboplatin|carboplatin|mesh-list
25713530|NCT02341456|Adavosertib|adavosertib|mesh-list
25713531|NCT02341456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24863164|NCT02934529|Bevacizumab|bevacizumab|mesh-list
24863165|NCT02934529|Cetuximab|cetuximab|mesh-list
24863166|NCT02934529|Fluorouracil|fluorouracil|mesh-list
24863167|NCT02934529|Capecitabine|capecitabine|mesh-list
24863168|NCT02934529|Irinotecan|irinotecan|mesh-list
24863169|NCT02934529|Levoleucovorin|levoleucovorin|mesh-list
25713532|NCT02341456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713533|NCT02341456|Tubulin Modulators|tubulin modulators|mesh-ancestor
25713534|NCT02341456|Antimitotic Agents|antimitotic agents|mesh-ancestor
25770914|NCT03574818|Gemcitabine|gemcitabine|mesh-list
25770915|NCT03574818|Cisplatin|cisplatin|mesh-list
25770916|NCT03574818|Necitumumab|necitumumab|mesh-list
24813596|NCT02059590|Antifungal Agents|antifungal agents|mesh-ancestor
24813597|NCT02059590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24813598|NCT02059616|Amlodipine|amlodipine|mesh-list
24813599|NCT02059616|Candesartan|candesartan|mesh-list
24813600|NCT02059616|Candesartan cilexetil|candesartan cilexetil|mesh-list
24813601|NCT02059616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24813602|NCT02059616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24813603|NCT02059616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24813604|NCT02059616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813605|NCT02059616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24813614|NCT02059655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24813615|NCT02059655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24813616|NCT02059655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24813617|NCT02059694|Lidocaine|lidocaine|mesh-list
24543102|NCT00681941|Sevelamer|sevelamer|mesh-list
24451885|NCT00325104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24451886|NCT00325104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609248|NCT00995657|Xhance|xhance|mesh-list
24813673|NCT02059876|Paclitaxel|paclitaxel|mesh-list
24813674|NCT02059876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24813675|NCT02059876|Carboplatin|carboplatin|mesh-list
24813676|NCT02059876|Trastuzumab|trastuzumab|mesh-list
24543126|NCT00681993|Doxorubicin|doxorubicin|mesh-list
24863343|NCT05146245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25713539|NCT02341482|Antifungal Agents|antifungal agents|mesh-ancestor
25713540|NCT02341482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25713541|NCT02341482|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25713542|NCT02341482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25713543|NCT02341482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713544|NCT02341482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863449|NCT04956302|Daratumumab|daratumumab|mesh-list
24813703|NCT02059967|Tubulin Modulators|tubulin modulators|mesh-ancestor
24813704|NCT02059967|Antimitotic Agents|antimitotic agents|mesh-ancestor
24813705|NCT02059967|Mitosis Modulators|mitosis modulators|mesh-ancestor
24813706|NCT02059967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813707|NCT02060006|Meloxicam|meloxicam|mesh-list
24813711|NCT02060006|Analgesics|analgesics|mesh-ancestor
24813715|NCT02060006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24813716|NCT02060006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24813717|NCT02060006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24813718|NCT02060006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609373|NCT00996190|Adrenergic Agents|adrenergic agents|mesh-ancestor
24609374|NCT00996190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24609375|NCT00996190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609376|NCT00996190|Protective Agents|protective agents|mesh-ancestor
24543407|NCT00683514|Cisplatin|cisplatin|mesh-list
24863598|NCT04223024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543422|NCT00683670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543423|NCT00683670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543424|NCT00683670|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24543426|NCT00683735|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24863626|NCT04182997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863627|NCT04137354|Vitamins|vitamins|mesh-list
24463845|NCT00362531|Hormones|hormones|mesh-ancestor
24609389|NCT00996411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609391|NCT00996424|Acetylcysteine|acetylcysteine|mesh-list
24609392|NCT00996424|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24609393|NCT00996424|Antiviral Agents|antiviral agents|mesh-ancestor
24863665|NCT04002037|Hormones|hormones|mesh-ancestor
24863666|NCT04002037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24863679|NCT03954938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24863680|NCT03954938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24863681|NCT03954938|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24863707|NCT03734016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609394|NCT00996424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24863709|NCT03599635|Anesthetics, Local|anesthetics, local|mesh-ancestor
24863710|NCT03599635|Anesthetics|anesthetics|mesh-ancestor
24863711|NCT03599635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24863712|NCT03599635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24863713|NCT03599635|Sensory System Agents|sensory system agents|mesh-ancestor
24863714|NCT03599635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24863715|NCT03570632|Metformin|metformin|mesh-list
24863716|NCT03570632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24863717|NCT03570632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543537|NCT00684164|Natriuretic Agents|natriuretic agents|mesh-ancestor
24863791|NCT03305341|Immunologic Factors|immunologic factors|mesh-ancestor
24863792|NCT03305341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813730|NCT02060032|Atorvastatin|atorvastatin|mesh-list
24863833|NCT03277248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24863834|NCT03277248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24863835|NCT03277248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24863836|NCT03277248|Immunologic Factors|immunologic factors|mesh-ancestor
24863837|NCT03229499|Anastrozole|anastrozole|mesh-list
24863838|NCT03229499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24863839|NCT03229499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24863840|NCT03229499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24863841|NCT03229499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24863842|NCT03229499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24863843|NCT03229499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24863844|NCT03229499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24863845|NCT03229499|Hormone Antagonists|hormone antagonists|mesh-ancestor
24543715|NCT00685100|Hormones|hormones|mesh-ancestor
24863919|NCT02922985|Acetaminophen|acetaminophen|mesh-list
24863920|NCT02922985|Ketorolac|ketorolac|mesh-list
24863921|NCT02922985|Bupivacaine|bupivacaine|mesh-list
24863922|NCT02922985|Anesthetics, Local|anesthetics, local|mesh-ancestor
24863923|NCT02922985|Anesthetics|anesthetics|mesh-ancestor
24863924|NCT02922985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24863992|NCT02494258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24813842|NCT02060656|Lenalidomide|lenalidomide|mesh-list
24864024|NCT02229149|Antimetabolites|antimetabolites|mesh-ancestor
24864025|NCT02229149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24864055|NCT01388491|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24864056|NCT01388491|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24864057|NCT01388491|Desogestrel|desogestrel|mesh-list
24864070|NCT01388491|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24864071|NCT01388491|Progestins|progestins|mesh-ancestor
24864072|NCT01373151|Adalimumab|adalimumab|mesh-list
24864073|NCT01373151|Methotrexate|methotrexate|mesh-list
24864074|NCT01373151|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24864075|NCT01373151|Abortifacient Agents|abortifacient agents|mesh-ancestor
24864076|NCT01373151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24864077|NCT01373151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864078|NCT01373151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24864079|NCT01373151|Antimetabolites|antimetabolites|mesh-ancestor
24864081|NCT01373151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864106|NCT00960297|Tubulin Modulators|tubulin modulators|mesh-ancestor
24864107|NCT00960297|Antimitotic Agents|antimitotic agents|mesh-ancestor
24864108|NCT00960297|Mitosis Modulators|mitosis modulators|mesh-ancestor
24864109|NCT00960297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864110|NCT00960297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25713545|NCT02341482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25713546|NCT02341482|Hormone Antagonists|hormone antagonists|mesh-ancestor
24864111|NCT00960297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24864112|NCT00960297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24864113|NCT00960297|Growth Substances|growth substances|mesh-ancestor
24864114|NCT00960297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864115|NCT00960297|Growth Inhibitors|growth inhibitors|mesh-ancestor
24864129|NCT00756288|Dermatologic Agents|dermatologic agents|mesh-ancestor
24864130|NCT00703326|Docetaxel|docetaxel|mesh-list
24864131|NCT00703326|Ramucirumab|ramucirumab|mesh-list
24864132|NCT00703326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864133|NCT00703326|Tubulin Modulators|tubulin modulators|mesh-ancestor
24444915|NCT00299676|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24444916|NCT00299676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444918|NCT00299676|Cholinergic Agents|cholinergic agents|mesh-ancestor
24864197|NCT05147857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24864199|NCT05147753|Moxonidine|moxonidine|mesh-list
24864200|NCT05147753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24864201|NCT05147727|Fluconazole|fluconazole|mesh-list
24864202|NCT05147727|Antifungal Agents|antifungal agents|mesh-ancestor
24864203|NCT05147727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24864204|NCT05147727|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24864205|NCT05147727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24813863|NCT02060656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24813864|NCT02060656|Glucocorticoids|glucocorticoids|mesh-ancestor
24813866|NCT02060656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24544148|NCT00687622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544149|NCT00687622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24544150|NCT00687622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544151|NCT00687622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544152|NCT00687648|Prednisolone|prednisolone|mesh-list
24544153|NCT00687648|Cyclophosphamide|cyclophosphamide|mesh-list
24544154|NCT00687648|Methotrexate|methotrexate|mesh-list
24544155|NCT00687648|Letrozole|letrozole|mesh-list
24544156|NCT00687648|Anastrozole|anastrozole|mesh-list
24544161|NCT00687648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24864227|NCT05145608|Lamotrigine|lamotrigine|mesh-list
24864228|NCT05145608|Anticonvulsants|anticonvulsants|mesh-list
24864229|NCT05145608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24864230|NCT05145608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24864231|NCT05145608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445082|NCT00300313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24864232|NCT05145608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24864233|NCT05145608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445083|NCT00300339|Clopidogrel|clopidogrel|mesh-list
24864234|NCT05145608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24864235|NCT05145608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24864236|NCT05145608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24864237|NCT05145608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24864238|NCT05145608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24864239|NCT05134987|Insulin Detemir|insulin detemir|mesh-list
24864240|NCT05134987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24864241|NCT05134987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544190|NCT00687700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24864243|NCT05118308|Hematinics|hematinics|mesh-ancestor
24864244|NCT05116800|Gemcitabine|gemcitabine|mesh-list
24864245|NCT05116800|Docetaxel|docetaxel|mesh-list
24864246|NCT05116800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24864247|NCT05116800|Antimetabolites|antimetabolites|mesh-ancestor
24864248|NCT05116800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864325|NCT04939363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864326|NCT04939363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24864328|NCT04894721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24864329|NCT04894721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25713547|NCT02341482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25713548|NCT02341482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864400|NCT04715230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864401|NCT04715230|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24864402|NCT04715230|Anticonvulsants|anticonvulsants|mesh-ancestor
24864403|NCT04715230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25713549|NCT02341482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25713550|NCT02342015|Atorvastatin|atorvastatin|mesh-list
25713551|NCT02342015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25713552|NCT02342015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25713553|NCT02342015|Antimetabolites|antimetabolites|mesh-ancestor
25713554|NCT02342015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713555|NCT02342015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25713556|NCT02342015|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25713557|NCT02342015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864404|NCT04715230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24813904|NCT02060929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24813905|NCT02060955|Bevacizumab|bevacizumab|mesh-list
24813906|NCT02060955|Irinotecan|irinotecan|mesh-list
24544427|NCT00688961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24864530|NCT03589976|Immunologic Factors|immunologic factors|mesh-ancestor
24864531|NCT03589976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864549|NCT03475953|Avelumab|avelumab|mesh-list
24864550|NCT03475953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24864551|NCT03475953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24864552|NCT03475953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864553|NCT03475953|Immunologic Factors|immunologic factors|mesh-ancestor
24864555|NCT03447574|Ethanol|ethanol|mesh-list
24813929|NCT02061137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24813930|NCT02061137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24813931|NCT02061137|Immunologic Factors|immunologic factors|mesh-ancestor
24813932|NCT02061137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24813934|NCT02061267|Nicotinic Acids|nicotinic acids|mesh-list
24544453|NCT00689156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24544454|NCT00689156|Immunologic Factors|immunologic factors|mesh-ancestor
24544455|NCT00689156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544456|NCT00689156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24544457|NCT00689156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24544458|NCT00689156|Alkylating Agents|alkylating agents|mesh-ancestor
24544459|NCT00689156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544460|NCT00689156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544461|NCT00689156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24544488|NCT00689169|Antimetabolites|antimetabolites|mesh-ancestor
24544509|NCT00689208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24544510|NCT00689208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544511|NCT00689208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24544512|NCT00689208|Respiratory System Agents|respiratory system agents|mesh-ancestor
24544513|NCT00689208|Mydriatics|mydriatics|mesh-ancestor
24864607|NCT03212963|Clobetasol|clobetasol|mesh-list
24864608|NCT03212963|Halobetasol|halobetasol|mesh-list
24864609|NCT03212963|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24864610|NCT03212963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24864611|NCT03212963|Glucocorticoids|glucocorticoids|mesh-ancestor
24864660|NCT02880540|Adrenergic Agents|adrenergic agents|mesh-ancestor
24864661|NCT02880540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24864662|NCT02880540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864663|NCT02880540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24864664|NCT02880540|Narcotics|narcotics|mesh-ancestor
24864665|NCT02880540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24864666|NCT02880540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24864667|NCT02880540|Anesthetics, General|anesthetics, general|mesh-ancestor
24864668|NCT02880540|Anesthetics|anesthetics|mesh-ancestor
24864763|NCT02686346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24864765|NCT02662985|Immunologic Factors|immunologic factors|mesh-ancestor
24864766|NCT02662985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864767|NCT02536339|Trastuzumab|trastuzumab|mesh-list
24864768|NCT02536339|Pertuzumab|pertuzumab|mesh-list
24864769|NCT02536339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24864770|NCT02536339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864800|NCT01869361|Sensory System Agents|sensory system agents|mesh-ancestor
24864801|NCT01869361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24864802|NCT01869361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713558|NCT02342197|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25713559|NCT02342197|Luteolytic Agents|luteolytic agents|mesh-ancestor
25713560|NCT02342197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24864803|NCT01869361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24864804|NCT01869361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25713561|NCT02342197|Contraceptive Agents|contraceptive agents|mesh-ancestor
25713562|NCT02342197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24864805|NCT01869361|Gout Suppressants|gout suppressants|mesh-ancestor
24864806|NCT01869361|Tocolytic Agents|tocolytic agents|mesh-ancestor
24864807|NCT01869361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24864813|NCT01578967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864814|NCT01186003|Insulin Detemir|insulin detemir|mesh-list
24864815|NCT01186003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24864816|NCT01186003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864817|NCT00943618|Bupropion|bupropion|mesh-list
24864818|NCT00943618|Varenicline|varenicline|mesh-list
24544703|NCT00689845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24544704|NCT00689845|Glucocorticoids|glucocorticoids|mesh-ancestor
24544705|NCT00689845|Hormones|hormones|mesh-ancestor
24544706|NCT00689845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24544707|NCT00689845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24864867|NCT05148884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864870|NCT05148767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24864871|NCT05148767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24864872|NCT05148767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24864873|NCT05148767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864874|NCT05148715|Tacrolimus|tacrolimus|mesh-list
24864875|NCT05148715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24864876|NCT05148715|Immunologic Factors|immunologic factors|mesh-ancestor
24864877|NCT05148715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24864878|NCT05148715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24864931|NCT05145218|Paclitaxel|paclitaxel|mesh-list
24864932|NCT05145218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24864933|NCT05145218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24864934|NCT05145218|Tubulin Modulators|tubulin modulators|mesh-ancestor
24864935|NCT05145218|Antimitotic Agents|antimitotic agents|mesh-ancestor
24864936|NCT05145218|Mitosis Modulators|mitosis modulators|mesh-ancestor
24864967|NCT05100264|Protective Agents|protective agents|mesh-ancestor
24865046|NCT04883437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24865047|NCT04883437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865048|NCT04804709|Panobinostat|panobinostat|mesh-list
24865049|NCT04804709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865050|NCT04804709|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24865051|NCT04804709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544910|NCT00690885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544911|NCT00690911|Adalimumab|adalimumab|mesh-list
24865075|NCT04682288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24544997|NCT00691275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24544998|NCT00691275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24544999|NCT00691275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24865168|NCT04308837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24865169|NCT04308837|Serotonin Agents|serotonin agents|mesh-ancestor
24865170|NCT04308837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24865171|NCT04308837|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24865173|NCT04298034|Nifedipine|nifedipine|mesh-list
24865174|NCT04298034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24865175|NCT04298034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24865177|NCT04298034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24814070|NCT02062203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24814071|NCT02062203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814072|NCT02062203|Glycine Agents|glycine agents|mesh-ancestor
25713563|NCT02342197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713564|NCT02342197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25713565|NCT02342197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25713566|NCT02342197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713567|NCT02342223|Hyaluronic Acid|hyaluronic acid|mesh-list
24814073|NCT02062203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24814074|NCT02062255|Aspirin|aspirin|mesh-list
25713568|NCT02342223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24814075|NCT02062255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24814076|NCT02062255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24545079|NCT00691886|Sensory System Agents|sensory system agents|mesh-ancestor
24545087|NCT00691912|Paclitaxel|paclitaxel|mesh-list
24865229|NCT04177654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865328|NCT03529890|Nivolumab|nivolumab|mesh-list
24865329|NCT03529890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24865330|NCT03529890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24865331|NCT03529890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24545224|NCT00692510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24545225|NCT00692510|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24445876|NCT00302822|Protease Inhibitors|protease inhibitors|mesh-ancestor
24445877|NCT00302822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24865370|NCT03317795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24865371|NCT03317795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865372|NCT03317795|Hemostatics|hemostatics|mesh-ancestor
24865373|NCT03317795|Coagulants|coagulants|mesh-ancestor
24865374|NCT03317795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24865375|NCT03317795|Contraceptive Agents|contraceptive agents|mesh-ancestor
24865487|NCT02023996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24545445|NCT00693433|Sirolimus|sirolimus|mesh-list
24865549|NCT00805961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24446041|NCT00303732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446044|NCT00303745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24446045|NCT00303745|Antimetabolites|antimetabolites|mesh-ancestor
24446046|NCT00303745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865572|NCT05152420|Rivaroxaban|rivaroxaban|mesh-list
24865573|NCT05152420|Apixaban|apixaban|mesh-list
24865574|NCT05152420|Edoxaban|edoxaban|mesh-list
24865582|NCT05152355|Budesonide|budesonide|mesh-list
24865602|NCT05152264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24865603|NCT05152264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865604|NCT05152186|Disinfectants|disinfectants|mesh-list
24865605|NCT05152186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24865606|NCT05151874|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24865607|NCT05151874|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24865608|NCT05151874|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24865609|NCT05151874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24865610|NCT05151874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865611|NCT05151874|Cholinergic Agents|cholinergic agents|mesh-ancestor
24865612|NCT05151874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24865613|NCT05151874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545533|NCT00693680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24865629|NCT05151796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24865630|NCT05151796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24865631|NCT05151796|Antipyretics|antipyretics|mesh-ancestor
24865632|NCT05151679|Iron|iron|mesh-list
24546113|NCT00696748|Anabolic Agents|anabolic agents|mesh-ancestor
24865634|NCT05151679|Iron Chelating Agents|iron chelating agents|mesh-list
24865635|NCT05151679|Trace Elements|trace elements|mesh-ancestor
24865765|NCT04998981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24865766|NCT04998981|Antimetabolites|antimetabolites|mesh-ancestor
24865767|NCT04998981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24865768|NCT04998981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24865769|NCT04991350|Bevacizumab|bevacizumab|mesh-list
25713570|NCT02342223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713571|NCT02342223|Viscosupplements|viscosupplements|mesh-ancestor
25713572|NCT02342223|Protective Agents|protective agents|mesh-ancestor
25713573|NCT02342327|Menthol|menthol|mesh-list
25713574|NCT02342327|Antipruritics|antipruritics|mesh-ancestor
25713575|NCT02342327|Dermatologic Agents|dermatologic agents|mesh-ancestor
25713576|NCT02342379|Bevacizumab|bevacizumab|mesh-list
25713577|NCT02342379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25713579|NCT02342379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25713580|NCT02342379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24865770|NCT04991350|Ranibizumab|ranibizumab|mesh-list
24865789|NCT04940572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24865791|NCT04933058|Acetaminophen|acetaminophen|mesh-list
24865792|NCT04933058|Fentanyl|fentanyl|mesh-list
24865793|NCT04933058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24865794|NCT04933058|Narcotics|narcotics|mesh-ancestor
24865795|NCT04933058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24865885|NCT04597372|Urological Agents|urological agents|mesh-ancestor
24865886|NCT04574154|Anesthetics|anesthetics|mesh-list
24865913|NCT04526821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24865914|NCT04492241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24865915|NCT04445389|Vaccines|vaccines|mesh-list
24865916|NCT04445389|Immunologic Factors|immunologic factors|mesh-ancestor
24865917|NCT04445389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24865918|NCT04365088|Deflazacort|deflazacort|mesh-list
24446144|NCT00303836|Freund's Adjuvant|freund's adjuvant|mesh-list
24446145|NCT00303836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24446146|NCT00303836|Immunologic Factors|immunologic factors|mesh-ancestor
24546060|NCT00696566|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24546061|NCT00696566|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24546062|NCT00696566|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24546063|NCT00696566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24446176|NCT00303940|Carboplatin|carboplatin|mesh-list
24546087|NCT00696631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24546088|NCT00696644|Teriparatide|teriparatide|mesh-list
24546089|NCT00696644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24866099|NCT03593252|Anticoagulants|anticoagulants|mesh-ancestor
24866100|NCT03593252|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24546110|NCT00696748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546111|NCT00696748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24546112|NCT00696748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24866212|NCT02892604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24866213|NCT02892604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866214|NCT02832687|Acetaminophen|acetaminophen|mesh-list
24866215|NCT02832687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24866216|NCT02832687|Analgesics|analgesics|mesh-ancestor
24866217|NCT02832687|Sensory System Agents|sensory system agents|mesh-ancestor
24866328|NCT02021773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866330|NCT05153785|Anesthetics, Local|anesthetics, local|mesh-ancestor
24866331|NCT05153785|Anesthetics|anesthetics|mesh-ancestor
24866353|NCT05153304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24866354|NCT05153304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713581|NCT02342379|Growth Substances|growth substances|mesh-ancestor
25713582|NCT02342379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713583|NCT02342379|Growth Inhibitors|growth inhibitors|mesh-ancestor
25713584|NCT02342418|Tedizolid|tedizolid|mesh-list
25713585|NCT02342418|Tedizolid phosphate|tedizolid phosphate|mesh-list
24866355|NCT05153304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24866356|NCT05153304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866357|NCT05153200|Adalimumab|adalimumab|mesh-list
24866358|NCT05153200|Upadacitinib|upadacitinib|mesh-list
24866359|NCT05153200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24866360|NCT05153200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24546351|NCT00697866|Vaccines|vaccines|mesh-list
24546352|NCT00697866|Immunologic Factors|immunologic factors|mesh-ancestor
24546353|NCT00697866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446286|NCT00304317|Sensory System Agents|sensory system agents|mesh-ancestor
24446287|NCT00304317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24866402|NCT05152667|Progestins|progestins|mesh-list
24866403|NCT05152667|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24866404|NCT05152667|Contraceptive Agents|contraceptive agents|mesh-ancestor
24866405|NCT05152667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24866406|NCT05152667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866407|NCT05152667|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24866408|NCT05152667|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24866409|NCT05152667|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24866410|NCT05152667|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24866411|NCT05152667|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24866412|NCT05152667|Hormone Antagonists|hormone antagonists|mesh-ancestor
24866413|NCT05152667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24866414|NCT05152667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24814317|NCT02063945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24814318|NCT02063945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24814319|NCT02063945|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24814320|NCT02063945|Dopamine Agents|dopamine agents|mesh-ancestor
24814321|NCT02063945|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24814322|NCT02063945|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24814338|NCT02064036|Bicalutamide|bicalutamide|mesh-list
24814339|NCT02064036|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24814340|NCT02064036|Fertility Agents|fertility agents|mesh-ancestor
24814341|NCT02064036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24814350|NCT02064049|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
24814352|NCT02064049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24866435|NCT05118399|Bupivacaine|bupivacaine|mesh-list
24866436|NCT05118399|Anesthetics, Local|anesthetics, local|mesh-ancestor
24866437|NCT05118399|Anesthetics|anesthetics|mesh-ancestor
24866438|NCT05118399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24866439|NCT05118399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866440|NCT05118399|Sensory System Agents|sensory system agents|mesh-ancestor
24866608|NCT05258721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866609|NCT05258682|Acetylcysteine|acetylcysteine|mesh-list
24866610|NCT05258682|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24866611|NCT05258682|Antiviral Agents|antiviral agents|mesh-ancestor
24866612|NCT05258682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24866613|NCT05258682|Expectorants|expectorants|mesh-ancestor
24866614|NCT05258682|Respiratory System Agents|respiratory system agents|mesh-ancestor
24866615|NCT05258682|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24866616|NCT05258682|Antioxidants|antioxidants|mesh-ancestor
24866617|NCT05258682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866618|NCT05258682|Protective Agents|protective agents|mesh-ancestor
24866619|NCT05258682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866620|NCT05258682|Antidotes|antidotes|mesh-ancestor
24866621|NCT05258565|Plasminogen|plasminogen|mesh-list
24866622|NCT05258565|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24866623|NCT05258565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24866624|NCT05258565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24866625|NCT05258565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24866626|NCT05258474|Niacinamide|niacinamide|mesh-list
24866628|NCT05258474|Nicotinic Acids|nicotinic acids|mesh-list
24866629|NCT05258474|Vitamin B Complex|vitamin b complex|mesh-ancestor
24866630|NCT05258474|Vitamins|vitamins|mesh-ancestor
24866749|NCT05008003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24866750|NCT04990804|Analgesics, Opioid|analgesics, opioid|mesh-list
24866752|NCT04990804|Narcotics|narcotics|mesh-ancestor
24866753|NCT04990804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24866762|NCT04906278|Oxytocics|oxytocics|mesh-ancestor
24866763|NCT04906278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24866764|NCT04906278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866765|NCT04859608|Eculizumab|eculizumab|mesh-list
24866766|NCT04859608|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
24866767|NCT04859608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24866768|NCT04859608|Immunologic Factors|immunologic factors|mesh-ancestor
24866769|NCT04859608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24866770|NCT04827953|Gemcitabine|gemcitabine|mesh-list
24866771|NCT04827953|Paclitaxel|paclitaxel|mesh-list
24866926|NCT03908307|Dexamethasone|dexamethasone|mesh-list
24866927|NCT03908307|Dexamethasone acetate|dexamethasone acetate|mesh-list
24866928|NCT03908307|BB 1101|bb 1101|mesh-list
24866929|NCT03908307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24866930|NCT03908307|Antiemetics|antiemetics|mesh-ancestor
24866931|NCT03908307|Autonomic Agents|autonomic agents|mesh-ancestor
24866932|NCT03908307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24868300|NCT05156970|Carboplatin|carboplatin|mesh-list
24867014|NCT03765619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867015|NCT03765619|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24867016|NCT03765619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24867147|NCT03347123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24867148|NCT03347123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24867149|NCT03347123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24867150|NCT03347123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867151|NCT03309007|Metformin|metformin|mesh-list
24867152|NCT03309007|Calcium Carbonate|calcium carbonate|mesh-list
24867153|NCT03309007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24867154|NCT03309007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867155|NCT03309007|Antacids|antacids|mesh-ancestor
24867156|NCT03309007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867157|NCT03309007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24867158|NCT03307616|Nivolumab|nivolumab|mesh-list
24867159|NCT03307616|Ipilimumab|ipilimumab|mesh-list
24867160|NCT03307616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24867161|NCT03307616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24867162|NCT03307616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24867163|NCT03307616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867197|NCT03177460|Daratumumab|daratumumab|mesh-list
24867213|NCT03015740|Nivolumab|nivolumab|mesh-list
24867214|NCT03015740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24867215|NCT03015740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24867216|NCT03015740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24867242|NCT02553161|Citalopram|citalopram|mesh-list
24867244|NCT02553161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24867245|NCT02553161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24867246|NCT02553161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867247|NCT02553161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24867248|NCT02553161|Serotonin Agents|serotonin agents|mesh-ancestor
24867249|NCT02553161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867251|NCT02553161|Antidepressive Agents|antidepressive agents|mesh-ancestor
24867282|NCT02478788|Adrenergic Agents|adrenergic agents|mesh-ancestor
24867283|NCT02478788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24867284|NCT02478788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24867285|NCT02478788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24867286|NCT02478788|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25713586|NCT02342418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25713587|NCT02342418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25713588|NCT02342561|Anti-Infective Agents|anti-infective agents|mesh-list
25713589|NCT02342561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25713590|NCT02342639|Rifaximin|rifaximin|mesh-list
25713591|NCT02342639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25713592|NCT02342639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25713593|NCT02342639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24867287|NCT02335242|Sildenafil Citrate|sildenafil citrate|mesh-list
24867288|NCT02335242|Vasodilator Agents|vasodilator agents|mesh-ancestor
24547331|NCT00703430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24867289|NCT02335242|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24867290|NCT02335242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24867291|NCT02335242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24867308|NCT01712763|Contraceptive Agents|contraceptive agents|mesh-ancestor
24867309|NCT01712763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24867310|NCT01712763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867311|NCT01712763|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24867312|NCT01366612|Vidarabine|vidarabine|mesh-list
24867313|NCT01366612|Fludarabine|fludarabine|mesh-list
24867314|NCT01366612|Fludarabine phosphate|fludarabine phosphate|mesh-list
24689501|NCT01334606|Insulin|insulin|mesh-list
24867315|NCT01366612|Busulfan|busulfan|mesh-list
24867316|NCT01366612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24867317|NCT01366612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24867318|NCT01366612|Antimetabolites|antimetabolites|mesh-ancestor
24867319|NCT01366612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867320|NCT01366612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24867321|NCT01366612|Immunologic Factors|immunologic factors|mesh-ancestor
24547371|NCT00703638|Pemetrexed|pemetrexed|mesh-list
24547372|NCT00703638|Sorafenib|sorafenib|mesh-list
24547373|NCT00703638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547374|NCT00703638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547375|NCT00703638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867322|NCT01366612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867323|NCT01366612|Antiviral Agents|antiviral agents|mesh-ancestor
24867324|NCT01366612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24867325|NCT01366612|Alkylating Agents|alkylating agents|mesh-ancestor
24867328|NCT01126749|Gemcitabine|gemcitabine|mesh-list
24867354|NCT01064245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24867356|NCT01059448|Brodalumab|brodalumab|mesh-list
24867374|NCT00585195|Antifungal Agents|antifungal agents|mesh-ancestor
24867375|NCT00585195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24867376|NCT00585195|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24867377|NCT00585195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24867378|NCT00585195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24867379|NCT00585195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867380|NCT00585195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24547393|NCT00703703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867467|NCT04372017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24867468|NCT04372017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24867469|NCT04372017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24867470|NCT04372017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867471|NCT04372017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24867472|NCT04339049|Lidocaine|lidocaine|mesh-list
24867473|NCT04339049|Misoprostol|misoprostol|mesh-list
24867474|NCT04339049|Anesthetics, Local|anesthetics, local|mesh-ancestor
24867475|NCT04339049|Anesthetics|anesthetics|mesh-ancestor
24867476|NCT04339049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24547472|NCT00704249|Nevirapine|nevirapine|mesh-list
24446378|NCT00304616|Autonomic Agents|autonomic agents|mesh-ancestor
24867568|NCT03842696|Vorinostat|vorinostat|mesh-list
24867589|NCT03842696|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24867590|NCT03842696|Antifungal Agents|antifungal agents|mesh-ancestor
24867591|NCT03842696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24867592|NCT03842696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24867593|NCT03842696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24867648|NCT03380507|Thiamine|thiamine|mesh-list
24867691|NCT03179475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867692|NCT03179475|Analgesics|analgesics|mesh-ancestor
24867693|NCT03179475|Sensory System Agents|sensory system agents|mesh-ancestor
24867694|NCT03179475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24867695|NCT03179475|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24867696|NCT03132129|Manganese|manganese|mesh-list
24867697|NCT03132129|Calcium|calcium|mesh-list
24867702|NCT02898207|Olaparib|olaparib|mesh-list
24446477|NCT00304811|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24446478|NCT00304811|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24446479|NCT00304811|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24867705|NCT02898207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867706|NCT02898207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24867707|NCT02777372|Sertraline|sertraline|mesh-list
24867708|NCT02777372|Antidepressive Agents|antidepressive agents|mesh-ancestor
24867709|NCT02777372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24867710|NCT02777372|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24867712|NCT02777372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24867726|NCT02682901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24867731|NCT02555657|Gemcitabine|gemcitabine|mesh-list
24867732|NCT02555657|Capecitabine|capecitabine|mesh-list
24867733|NCT02555657|Pembrolizumab|pembrolizumab|mesh-list
24867734|NCT02555657|Vinorelbine|vinorelbine|mesh-list
24867735|NCT02555657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24867736|NCT02555657|Antimetabolites|antimetabolites|mesh-ancestor
24867737|NCT02555657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868881|NCT05158699|Bromfenac|bromfenac|mesh-list
24867739|NCT02555657|Antiviral Agents|antiviral agents|mesh-ancestor
24867740|NCT02555657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24867741|NCT02555657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610165|NCT01000233|Micronutrients|micronutrients|mesh-ancestor
24623244|NCT01070706|Mitosis Modulators|mitosis modulators|mesh-ancestor
24623245|NCT01070706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623246|NCT01070706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24623247|NCT01070706|Antimetabolites|antimetabolites|mesh-ancestor
24623248|NCT01070706|Antiviral Agents|antiviral agents|mesh-ancestor
25713595|NCT02342704|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25713596|NCT02342704|Immunologic Factors|immunologic factors|mesh-ancestor
25713597|NCT02342704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713598|NCT02342704|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25713599|NCT02342704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623249|NCT01070706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24623250|NCT01070706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623251|NCT01070706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24623252|NCT01070706|Immunologic Factors|immunologic factors|mesh-ancestor
24814409|NCT02064491|Tubulin Modulators|tubulin modulators|mesh-ancestor
24814410|NCT02064491|Antimitotic Agents|antimitotic agents|mesh-ancestor
24814411|NCT02064491|Mitosis Modulators|mitosis modulators|mesh-ancestor
24547783|NCT00705692|Levamisole|levamisole|mesh-list
24446497|NCT00304980|Sulfadoxine|sulfadoxine|mesh-list
24446498|NCT00304980|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24446508|NCT00304980|Renal Agents|renal agents|mesh-ancestor
24602272|NCT00967928|Everolimus|everolimus|mesh-list
24547809|NCT00705796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814445|NCT02064530|Adrenergic Agents|adrenergic agents|mesh-ancestor
24814446|NCT02064530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24814447|NCT02064530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814448|NCT02064556|Amlodipine|amlodipine|mesh-list
24814449|NCT02064556|Candesartan|candesartan|mesh-list
24814450|NCT02064556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24547828|NCT00705822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24547829|NCT00705822|Alkylating Agents|alkylating agents|mesh-ancestor
24547830|NCT00705835|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24547831|NCT00705835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24547832|NCT00705835|Immunologic Factors|immunologic factors|mesh-ancestor
24867908|NCT05051293|Estrogens|estrogens|mesh-list
24867909|NCT05051293|Androgens|androgens|mesh-ancestor
24867910|NCT05051293|Hormones|hormones|mesh-ancestor
24867911|NCT05051293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24867912|NCT05051293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24867913|NCT05005897|Vitamin B 12|vitamin b 12|mesh-list
24867914|NCT05005897|Hydroxocobalamin|hydroxocobalamin|mesh-list
24547992|NCT00707083|Antimetabolites|antimetabolites|mesh-ancestor
24547993|NCT00707083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547994|NCT00707083|Dermatologic Agents|dermatologic agents|mesh-ancestor
24547995|NCT00707083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547996|NCT00707083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24547997|NCT00707083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24547998|NCT00707083|Immunologic Factors|immunologic factors|mesh-ancestor
24867981|NCT04508621|Cyclobenzaprine|cyclobenzaprine|mesh-list
24867982|NCT04508621|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24867983|NCT04508621|Antidepressive Agents|antidepressive agents|mesh-ancestor
24867984|NCT04508621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24867985|NCT04508621|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24867990|NCT04508621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25713600|NCT02342704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24867991|NCT04454905|Apatinib|apatinib|mesh-list
24867992|NCT04454905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24867993|NCT04454905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24867994|NCT04454905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24868013|NCT04144023|Immunologic Factors|immunologic factors|mesh-ancestor
24868014|NCT04144023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868015|NCT04144023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24868016|NCT04079218|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24868017|NCT04079218|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24868019|NCT04079218|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24868020|NCT04079218|Estrogens|estrogens|mesh-ancestor
24868021|NCT04079218|Hormones|hormones|mesh-ancestor
24868022|NCT04079218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24868023|NCT04079218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868024|NCT04079218|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24868025|NCT04079218|Contraceptive Agents|contraceptive agents|mesh-ancestor
24868026|NCT04079218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24868027|NCT04079218|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24868101|NCT03774641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24868102|NCT03774641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24446591|NCT00305422|Risperidone|risperidone|mesh-list
24868184|NCT02782702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548150|NCT00707876|Hematinics|hematinics|mesh-ancestor
24868219|NCT02088632|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24868220|NCT02088632|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24868221|NCT02088632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24868222|NCT02088632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868223|NCT02088632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24868224|NCT02088632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24548186|NCT00708240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24548189|NCT00708240|Serotonin Agents|serotonin agents|mesh-ancestor
24868240|NCT01602666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24868241|NCT01602666|Alkylating Agents|alkylating agents|mesh-ancestor
24868242|NCT01602666|Keratolytic Agents|keratolytic agents|mesh-ancestor
24868243|NCT01602666|Dermatologic Agents|dermatologic agents|mesh-ancestor
24868244|NCT01602666|Tubulin Modulators|tubulin modulators|mesh-ancestor
24868245|NCT01602666|Antimitotic Agents|antimitotic agents|mesh-ancestor
24868246|NCT01602666|Mitosis Modulators|mitosis modulators|mesh-ancestor
24868279|NCT00354835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868280|NCT00354835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24868281|NCT00354835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24868282|NCT00354835|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24868283|NCT00354835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24868284|NCT00354835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24868285|NCT00354835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24868286|NCT00354835|Tubulin Modulators|tubulin modulators|mesh-ancestor
24868298|NCT05157243|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24868299|NCT05157243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24868328|NCT05156892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24868329|NCT05156788|Lenvatinib|lenvatinib|mesh-list
24868330|NCT05156788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24868331|NCT05156788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24868332|NCT05156788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24868333|NCT05156788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868334|NCT05156749|Calpastatin|calpastatin|mesh-list
24868335|NCT05156749|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
24868336|NCT05156749|Protease Inhibitors|protease inhibitors|mesh-ancestor
24868337|NCT05156749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24868457|NCT04560725|Choline|choline|mesh-list
24868520|NCT04455464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24868521|NCT04455464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868522|NCT04455464|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24868523|NCT04455464|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24868524|NCT04455464|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24868525|NCT04455464|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24868526|NCT04455464|Adrenergic Agents|adrenergic agents|mesh-ancestor
24868527|NCT04455464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24868528|NCT04455464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868529|NCT04403971|Chlorhexidine|chlorhexidine|mesh-list
24868530|NCT04403971|Listerine|listerine|mesh-list
24868531|NCT04403971|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24868532|NCT04403971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24868533|NCT04403971|Disinfectants|disinfectants|mesh-ancestor
24868534|NCT04351243|Gimsilumab|gimsilumab|mesh-list
24868535|NCT04351243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24868536|NCT04351243|Antiviral Agents|antiviral agents|mesh-ancestor
24868537|NCT04351243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24868538|NCT04351061|Acetazolamide|acetazolamide|mesh-list
24868539|NCT04351061|Anticonvulsants|anticonvulsants|mesh-ancestor
24868540|NCT04351061|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24868541|NCT04351061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24868543|NCT04351061|Diuretics|diuretics|mesh-ancestor
24548499|NCT00709969|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24548501|NCT00709969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24548502|NCT00709969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24548503|NCT00709969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24814495|NCT02064829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24814498|NCT02064829|Tubulin Modulators|tubulin modulators|mesh-ancestor
24814505|NCT02064842|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24814506|NCT02064842|Protease Inhibitors|protease inhibitors|mesh-ancestor
24814507|NCT02064842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24814509|NCT02064842|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24814553|NCT02065401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814554|NCT02065401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24814556|NCT02065414|Listerine|listerine|mesh-list
24814557|NCT02065414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24814558|NCT02065414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24814559|NCT02065414|Disinfectants|disinfectants|mesh-ancestor
24814560|NCT02065466|Paclitaxel|paclitaxel|mesh-list
24814561|NCT02065466|Bevacizumab|bevacizumab|mesh-list
24548570|NCT00710229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868582|NCT04206761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24868583|NCT04206761|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24868584|NCT04206761|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24868585|NCT04206761|Cholinergic Agents|cholinergic agents|mesh-ancestor
24868586|NCT04206761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24868587|NCT04206761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868588|NCT04206761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868590|NCT04194814|Betamethasone Valerate|betamethasone valerate|mesh-list
24868591|NCT04194814|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24868592|NCT04194814|Betamethasone benzoate|betamethasone benzoate|mesh-list
24868593|NCT04194814|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24868603|NCT04143204|Insulin|insulin|mesh-list
24868631|NCT03998293|Somatostatin|somatostatin|mesh-list
24868633|NCT03998293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24868634|NCT03998293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868635|NCT03925246|Nivolumab|nivolumab|mesh-list
24548614|NCT00710736|Fluorouracil|fluorouracil|mesh-list
24868683|NCT03518203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24868684|NCT03518203|Immunologic Factors|immunologic factors|mesh-ancestor
24868685|NCT03518203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868686|NCT03479307|Ketotifen|ketotifen|mesh-list
24868687|NCT03479307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24868688|NCT03479307|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24868689|NCT03479307|Antipruritics|antipruritics|mesh-ancestor
24868690|NCT03479307|Dermatologic Agents|dermatologic agents|mesh-ancestor
24814601|NCT02065752|Metformin|metformin|mesh-list
24868691|NCT03479307|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24868692|NCT03479307|Histamine Antagonists|histamine antagonists|mesh-ancestor
24868693|NCT03479307|Histamine Agents|histamine agents|mesh-ancestor
24868694|NCT03479307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24868695|NCT03479307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24868696|NCT03479307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868697|NCT03479307|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24868804|NCT02259517|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24868805|NCT02259517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868806|NCT02259517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24868807|NCT02259517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24868808|NCT02259517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24868822|NCT02209545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24868823|NCT02209545|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24868824|NCT02209545|Abortifacient Agents|abortifacient agents|mesh-ancestor
24868825|NCT02209545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24868826|NCT02209545|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24868827|NCT02209545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24868829|NCT02209545|Vitamin B Complex|vitamin b complex|mesh-ancestor
24446685|NCT00305669|Sargramostim|sargramostim|mesh-list
24446686|NCT00305669|Immunologic Factors|immunologic factors|mesh-ancestor
25713601|NCT02342886|Moxifloxacin|moxifloxacin|mesh-list
25713602|NCT02342886|Rifampin|rifampin|mesh-list
25713603|NCT02342886|Isoniazid|isoniazid|mesh-list
25713604|NCT02342886|Pyrazinamide|pyrazinamide|mesh-list
25713605|NCT02342886|Ethambutol|ethambutol|mesh-list
25713606|NCT02342886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25713607|NCT02342886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25713608|NCT02342886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25713609|NCT02342886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25713610|NCT02342886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713611|NCT02342886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713612|NCT02342886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713613|NCT02342886|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24446690|NCT00305708|Busulfan|busulfan|mesh-list
24446691|NCT00305708|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24814605|NCT02065752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24814606|NCT02065752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814607|NCT02065804|Bupivacaine|bupivacaine|mesh-list
24814608|NCT02065804|Anesthetics, Local|anesthetics, local|mesh-ancestor
24814609|NCT02065804|Anesthetics|anesthetics|mesh-ancestor
24814610|NCT02065804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24814615|NCT02065843|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24814616|NCT02065843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24610315|NCT01001260|Aspirin|aspirin|mesh-list
24869023|NCT05076253|Ivermectin|ivermectin|mesh-list
24869024|NCT05076253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24869025|NCT05076253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24548983|NCT00712764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869029|NCT04983498|Ondansetron|ondansetron|mesh-list
24869030|NCT04983498|Antiemetics|antiemetics|mesh-ancestor
24869037|NCT04983498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24869038|NCT04983498|Serotonin Agents|serotonin agents|mesh-ancestor
24869039|NCT04983498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24869040|NCT04983498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869042|NCT04983498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24869043|NCT04983498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24869044|NCT04983498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24869045|NCT04983498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24869051|NCT04947592|Fluconazole|fluconazole|mesh-list
24869052|NCT04947592|Antifungal Agents|antifungal agents|mesh-ancestor
24869083|NCT04831892|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24869084|NCT04831892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869085|NCT04761627|Ustekinumab|ustekinumab|mesh-list
24869086|NCT04761627|Dermatologic Agents|dermatologic agents|mesh-ancestor
24869087|NCT04761614|Calcium, Dietary|calcium, dietary|mesh-list
24869088|NCT04761614|Leucovorin|leucovorin|mesh-list
24869089|NCT04761614|Folic Acid|folic acid|mesh-list
24869090|NCT04761614|Bevacizumab|bevacizumab|mesh-list
24869091|NCT04761614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24869092|NCT04761614|Fluorouracil|fluorouracil|mesh-list
24869093|NCT04761614|Oxaliplatin|oxaliplatin|mesh-list
24549075|NCT00713271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869123|NCT04761614|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24869124|NCT04761614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24869125|NCT04761614|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24869127|NCT04748588|Antiviral Agents|antiviral agents|mesh-ancestor
25713614|NCT02342886|Antitubercular Agents|antitubercular agents|mesh-ancestor
25713615|NCT02342886|Leprostatic Agents|leprostatic agents|mesh-ancestor
24869128|NCT04748588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24869129|NCT04694248|Aspirin|aspirin|mesh-list
24869130|NCT04694248|Rivaroxaban|rivaroxaban|mesh-list
24869131|NCT04694248|Anticoagulants|anticoagulants|mesh-list
24869132|NCT04694248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24869133|NCT04694248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24869134|NCT04694248|Analgesics|analgesics|mesh-ancestor
24869135|NCT04694248|Sensory System Agents|sensory system agents|mesh-ancestor
24869136|NCT04694248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24869138|NCT04694248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24869154|NCT04650152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869155|NCT04650152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24869156|NCT04608955|Bedaquiline|bedaquiline|mesh-list
24869157|NCT04608955|Antitubercular Agents|antitubercular agents|mesh-ancestor
24869158|NCT04608955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24869159|NCT04608955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24869160|NCT04579783|Triamcinolone|triamcinolone|mesh-list
24869165|NCT04579783|Glucocorticoids|glucocorticoids|mesh-ancestor
24869172|NCT04579783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869173|NCT04559347|Bupivacaine|bupivacaine|mesh-list
24869174|NCT04559347|Ropivacaine|ropivacaine|mesh-list
24549097|NCT00713440|Prednisolone acetate|prednisolone acetate|mesh-list
24814634|NCT02065947|Ketamine|ketamine|mesh-list
24814635|NCT02065947|Bupivacaine|bupivacaine|mesh-list
24814636|NCT02065947|Propofol|propofol|mesh-list
24814637|NCT02065947|Sevoflurane|sevoflurane|mesh-list
24814638|NCT02065947|Epinephryl borate|epinephryl borate|mesh-list
25713616|NCT02342886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25713617|NCT02342886|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25713618|NCT02342886|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25713619|NCT02342886|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25713620|NCT02342886|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25713621|NCT02342886|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25713622|NCT02342886|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25713623|NCT02342886|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
24814640|NCT02065947|Anesthetics, Local|anesthetics, local|mesh-ancestor
24814641|NCT02065947|Anesthetics|anesthetics|mesh-ancestor
24869246|NCT04278404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24869247|NCT04278404|Glucocorticoids|glucocorticoids|mesh-ancestor
24869249|NCT04278404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24869250|NCT04278404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24869251|NCT04278404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24869252|NCT04278404|Protease Inhibitors|protease inhibitors|mesh-ancestor
24869253|NCT04278404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24869254|NCT04278404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869255|NCT04278404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24869256|NCT04278404|Antiviral Agents|antiviral agents|mesh-ancestor
24869257|NCT04278404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24869258|NCT04278404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24869260|NCT04278404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24869264|NCT04278404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24869265|NCT04278404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24869266|NCT04278404|Adrenergic Agents|adrenergic agents|mesh-ancestor
24869270|NCT04278404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24869271|NCT04278404|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24869272|NCT04278404|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24869273|NCT04278404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24466961|NCT00375765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466962|NCT00375765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466963|NCT00375765|Hormone Antagonists|hormone antagonists|mesh-ancestor
24466965|NCT00375765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713624|NCT02342886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25713625|NCT02342886|Antimetabolites|antimetabolites|mesh-ancestor
25713626|NCT02342886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24869274|NCT04278404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24869275|NCT04278404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25713627|NCT02343081|Temozolomide|temozolomide|mesh-list
25713628|NCT02343081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25713629|NCT02343081|Alkylating Agents|alkylating agents|mesh-ancestor
25713630|NCT02343081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549245|NCT00714090|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24549250|NCT00714090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24869290|NCT04278404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24869331|NCT04278404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24869332|NCT04278404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24869333|NCT04278404|Sympathomimetics|sympathomimetics|mesh-ancestor
24869334|NCT04278404|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24869335|NCT04278404|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24869336|NCT04278404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24869337|NCT04278404|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24869338|NCT04278404|Chelating Agents|chelating agents|mesh-ancestor
24869339|NCT04278404|Sequestering Agents|sequestering agents|mesh-ancestor
24869340|NCT04278404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24869341|NCT04278404|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24869342|NCT04278404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24869343|NCT04278404|Protective Agents|protective agents|mesh-ancestor
24869344|NCT04278404|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24869345|NCT04278404|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24869346|NCT04278404|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24869347|NCT04278404|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24869348|NCT04278404|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24869349|NCT04278404|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24869350|NCT04266379|Insulin|insulin|mesh-list
24869351|NCT04266379|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24869352|NCT04266379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24869353|NCT04266379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869354|NCT04240093|Analgesics, Opioid|analgesics, opioid|mesh-list
24869355|NCT04240093|Narcotics|narcotics|mesh-ancestor
24869356|NCT04240093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24869357|NCT04240093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869358|NCT04240093|Analgesics|analgesics|mesh-ancestor
24467041|NCT00376064|Octreotide|octreotide|mesh-list
24869374|NCT04234477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24869375|NCT04234477|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24869376|NCT04234477|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24869377|NCT04234477|Adrenergic Agents|adrenergic agents|mesh-ancestor
24869378|NCT04234477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24814686|NCT02065986|Tenofovir|tenofovir|mesh-list
24897704|NCT04423185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24869400|NCT04156698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869401|NCT04156698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25713631|NCT02343081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713632|NCT02343276|Nitroglycerin|nitroglycerin|mesh-list
25713633|NCT02343276|Vasodilator Agents|vasodilator agents|mesh-ancestor
25713634|NCT02343406|Temozolomide|temozolomide|mesh-list
25713635|NCT02343406|Lomustine|lomustine|mesh-list
25713636|NCT02343406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25713637|NCT02343406|Alkylating Agents|alkylating agents|mesh-ancestor
25713638|NCT02343406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713639|NCT02343406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713640|NCT02343458|Glycopyrrolate|glycopyrrolate|mesh-list
25713641|NCT02343458|Formoterol Fumarate|formoterol fumarate|mesh-list
25713642|NCT02343458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25713643|NCT02343458|Autonomic Agents|autonomic agents|mesh-ancestor
25713644|NCT02343458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24869402|NCT04156698|Antimetabolites|antimetabolites|mesh-ancestor
24869403|NCT04046614|Nivolumab|nivolumab|mesh-list
24869404|NCT04046614|Nintedanib|nintedanib|mesh-list
24869405|NCT04046614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24869406|NCT04046614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24869407|NCT04046614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24869408|NCT04046614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549348|NCT00714779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24869421|NCT03795233|Vancomycin|vancomycin|mesh-list
24869422|NCT03795233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24869423|NCT03795233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24869424|NCT03783091|Hydroxocobalamin|hydroxocobalamin|mesh-list
24869425|NCT03783091|Vitamin B 12|vitamin b 12|mesh-list
24869426|NCT03783091|Hematinics|hematinics|mesh-ancestor
24869427|NCT03783091|Vitamin B Complex|vitamin b complex|mesh-ancestor
24869428|NCT03783091|Vitamins|vitamins|mesh-ancestor
24869429|NCT03783091|Micronutrients|micronutrients|mesh-ancestor
24869430|NCT03783091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869437|NCT03769376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24869438|NCT03769376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24869439|NCT03769376|Antioxidants|antioxidants|mesh-ancestor
24869440|NCT03769376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869441|NCT03769376|Protective Agents|protective agents|mesh-ancestor
24869443|NCT03645863|Iron|iron|mesh-list
24869474|NCT03423355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869475|NCT03423355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24869476|NCT03423355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869477|NCT03423355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24869478|NCT03423355|Diuretics|diuretics|mesh-ancestor
24869479|NCT03423355|Natriuretic Agents|natriuretic agents|mesh-ancestor
24869480|NCT03423355|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24869495|NCT03238534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24814680|NCT02065947|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24814681|NCT02065947|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24814694|NCT02065986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610458|NCT01002157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869511|NCT03193931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24869512|NCT03193931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24869513|NCT03193931|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24869515|NCT03193931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24869516|NCT03193931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713645|NCT02343458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713646|NCT02343458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25713647|NCT02343458|Respiratory System Agents|respiratory system agents|mesh-ancestor
25713648|NCT02343458|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25713649|NCT02343458|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25713650|NCT02343458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25713651|NCT02343458|Adrenergic Agents|adrenergic agents|mesh-ancestor
25713652|NCT02343458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25713653|NCT02343458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713654|NCT02343458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24869563|NCT02840136|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24869564|NCT02840136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24869565|NCT02840136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24869567|NCT02840136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623260|NCT01070732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24623261|NCT01070732|Analgesics|analgesics|mesh-ancestor
24869685|NCT00741988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24869686|NCT00741988|Growth Inhibitors|growth inhibitors|mesh-ancestor
24869988|NCT04622553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24869989|NCT04557085|Cenobamate|cenobamate|mesh-list
24869990|NCT04557085|Anticonvulsants|anticonvulsants|mesh-ancestor
24870022|NCT04328961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24870272|NCT02621151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25713655|NCT02343458|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25713656|NCT02343458|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25713657|NCT02343458|Cholinergic Agents|cholinergic agents|mesh-ancestor
25713658|NCT02343575|Valproic Acid|valproic acid|mesh-list
25713659|NCT02343575|Haloperidol|haloperidol|mesh-list
25713660|NCT02343575|Haloperidol decanoate|haloperidol decanoate|mesh-list
25713661|NCT02343575|Antiemetics|antiemetics|mesh-ancestor
24870351|NCT01471444|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24870353|NCT01471444|Abortifacient Agents|abortifacient agents|mesh-ancestor
24814767|NCT02066649|Protective Agents|protective agents|mesh-ancestor
24814768|NCT02066649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24814769|NCT02066649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24606685|NCT00991744|Antiviral Agents|antiviral agents|mesh-ancestor
24814770|NCT02066649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24814771|NCT02066649|Vasodilator Agents|vasodilator agents|mesh-ancestor
24814772|NCT02066649|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24814773|NCT02066649|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24814774|NCT02066662|Rivaroxaban|rivaroxaban|mesh-list
24814775|NCT02066662|Phenprocoumon|phenprocoumon|mesh-list
24814776|NCT02066662|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24870425|NCT05162001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870426|NCT05161975|Vitamin K|vitamin k|mesh-list
24870427|NCT05161975|Vitamin K 2|vitamin k 2|mesh-list
24870428|NCT05161975|Vitamins|vitamins|mesh-ancestor
24870429|NCT05161975|Micronutrients|micronutrients|mesh-ancestor
24870435|NCT05161975|Coagulants|coagulants|mesh-ancestor
24870436|NCT05161572|Oxaliplatin|oxaliplatin|mesh-list
24870437|NCT05161572|Tegafur|tegafur|mesh-list
24870455|NCT05161221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870506|NCT05067270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870507|NCT05067270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24870518|NCT05063851|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24870520|NCT05046522|Analgesics|analgesics|mesh-ancestor
24870521|NCT05046522|Sensory System Agents|sensory system agents|mesh-ancestor
24870522|NCT05046522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24870523|NCT05046522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870524|NCT05046522|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24870525|NCT05046522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24870526|NCT05046522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24870527|NCT05046522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24870528|NCT05046522|Antiviral Agents|antiviral agents|mesh-ancestor
24870529|NCT05046522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24870530|NCT05046522|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24870531|NCT05046522|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24870534|NCT05046522|Hormones|hormones|mesh-ancestor
24870625|NCT04821284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24870629|NCT04821284|Vitamin B Complex|vitamin b complex|mesh-ancestor
24870631|NCT04821284|Micronutrients|micronutrients|mesh-ancestor
24870632|NCT04729621|Denosumab|denosumab|mesh-list
24870633|NCT04729621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24870634|NCT04729621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870635|NCT04648826|Azacitidine|azacitidine|mesh-list
24870636|NCT04648826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24870637|NCT04648826|Antimetabolites|antimetabolites|mesh-ancestor
24870638|NCT04648826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24870639|NCT04648826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24870640|NCT04648826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24870641|NCT04606394|Albuterol|albuterol|mesh-list
24870642|NCT04606394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24870643|NCT04606394|Autonomic Agents|autonomic agents|mesh-ancestor
24870644|NCT04606394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24870645|NCT04606394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870646|NCT04606394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24870647|NCT04606394|Respiratory System Agents|respiratory system agents|mesh-ancestor
24870648|NCT04606394|Tocolytic Agents|tocolytic agents|mesh-ancestor
24870649|NCT04606394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24870650|NCT04606394|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24870651|NCT04606394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25713662|NCT02343575|Autonomic Agents|autonomic agents|mesh-ancestor
25713663|NCT02343575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713664|NCT02343575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713665|NCT02343575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24870652|NCT04606394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24870653|NCT04606394|Adrenergic Agents|adrenergic agents|mesh-ancestor
24870654|NCT04606394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24870656|NCT04577690|Epinephrine|epinephrine|mesh-list
24870687|NCT04523922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870700|NCT04496596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24870701|NCT04447053|Belimumab|belimumab|mesh-list
24870754|NCT04017442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24870755|NCT03993314|Bupivacaine|bupivacaine|mesh-list
24870756|NCT03993314|Chloroprocaine|chloroprocaine|mesh-list
24870757|NCT03993314|Anesthetics, Local|anesthetics, local|mesh-ancestor
24870758|NCT03993314|Anesthetics|anesthetics|mesh-ancestor
24870759|NCT03993314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24870760|NCT03993314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24870761|NCT03993314|Sensory System Agents|sensory system agents|mesh-ancestor
24870762|NCT03993314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24871204|NCT04565392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24871205|NCT04565392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871206|NCT04565392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871318|NCT03765632|Alkylating Agents|alkylating agents|mesh-ancestor
24871343|NCT03548246|Abiraterone Acetate|abiraterone acetate|mesh-list
24871344|NCT03548246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24871345|NCT03548246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871346|NCT03548246|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24871367|NCT03166085|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
24871368|NCT03166085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24871369|NCT03166085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871370|NCT03166085|Tubulin Modulators|tubulin modulators|mesh-ancestor
24871437|NCT02639910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24871438|NCT02639910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871440|NCT02618980|Coagulants|coagulants|mesh-ancestor
24871441|NCT02613598|Bortezomib|bortezomib|mesh-list
24871442|NCT02613598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871443|NCT02595320|Capecitabine|capecitabine|mesh-list
24871444|NCT02595320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24871445|NCT02595320|Antimetabolites|antimetabolites|mesh-ancestor
24871535|NCT00424099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24871536|NCT00424099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871538|NCT00424099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24871539|NCT05166083|Testosterone|testosterone|mesh-list
24871540|NCT05166083|Androgens|androgens|mesh-ancestor
24871541|NCT05166083|Hormones|hormones|mesh-ancestor
24871542|NCT05166083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24871543|NCT05166083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871544|NCT05166005|Vitamin D|vitamin d|mesh-list
24871545|NCT05166005|Vitamins|vitamins|mesh-ancestor
24871547|NCT05166005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871548|NCT05166005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24871549|NCT05165914|Midazolam|midazolam|mesh-list
24871570|NCT05165615|Insulin|insulin|mesh-list
24871592|NCT05164952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24871593|NCT05164848|Afatinib|afatinib|mesh-list
24871594|NCT05164848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871595|NCT05164848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24871596|NCT05164848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24871599|NCT05164770|Zanubrutinib|zanubrutinib|mesh-list
24871600|NCT05164770|Cyclophosphamide|cyclophosphamide|mesh-list
24871602|NCT05164770|Rituximab|rituximab|mesh-list
25713666|NCT02343575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25713667|NCT02343575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25713668|NCT02343575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24693994|NCT01423305|Budesonide|budesonide|mesh-list
24871740|NCT04923295|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24871809|NCT04518124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24871810|NCT04518124|Vasodilator Agents|vasodilator agents|mesh-ancestor
24871811|NCT04511052|Carotenoids|carotenoids|mesh-list
24871812|NCT04511052|Antioxidants|antioxidants|mesh-ancestor
24871813|NCT04511052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24871814|NCT04511052|Protective Agents|protective agents|mesh-ancestor
24814905|NCT02067143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24814906|NCT02067143|Immunologic Factors|immunologic factors|mesh-ancestor
24814907|NCT02067143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814909|NCT02067182|Antithrombins|antithrombins|mesh-ancestor
24814910|NCT02067182|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24814911|NCT02067182|Protease Inhibitors|protease inhibitors|mesh-ancestor
24814912|NCT02067182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24814913|NCT02067182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24814914|NCT02067182|Anticoagulants|anticoagulants|mesh-ancestor
24610631|NCT01004224|Infigratinib|infigratinib|mesh-list
24814915|NCT02067338|Morphine|morphine|mesh-list
24814916|NCT02067338|Cellulose, Oxidized|cellulose, oxidized|mesh-list
24814917|NCT02067338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24814918|NCT02067338|Narcotics|narcotics|mesh-ancestor
24814919|NCT02067338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24814920|NCT02067338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24814921|NCT02067338|Analgesics|analgesics|mesh-ancestor
24814922|NCT02067338|Sensory System Agents|sensory system agents|mesh-ancestor
24814923|NCT02067338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24814924|NCT02067338|Hemostatics|hemostatics|mesh-ancestor
24871908|NCT03651518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871909|NCT03651518|Immunologic Factors|immunologic factors|mesh-ancestor
24871914|NCT03624517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24871915|NCT03624517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24871916|NCT03624517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24871975|NCT03353233|Sensory System Agents|sensory system agents|mesh-ancestor
24871976|NCT03353233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24871980|NCT03273322|Rivaroxaban|rivaroxaban|mesh-list
24871981|NCT03273322|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24871982|NCT03273322|Antithrombins|antithrombins|mesh-ancestor
24871983|NCT03273322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24872053|NCT05399732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24872054|NCT05399732|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24872225|NCT05398393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24872226|NCT05398393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24872227|NCT05398393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872230|NCT05398367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872231|NCT05398289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24872232|NCT05398289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24872233|NCT05398289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25713669|NCT02343575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25713670|NCT02343575|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25713671|NCT02343575|Dopamine Agents|dopamine agents|mesh-ancestor
25713672|NCT02343575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25713673|NCT02343575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872266|NCT05398055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24872271|NCT05397938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24872272|NCT05397938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872312|NCT05397236|Autonomic Agents|autonomic agents|mesh-ancestor
24872446|NCT05385705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24872447|NCT05385705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24872459|NCT05385523|Hormones|hormones|mesh-ancestor
24872490|NCT05359315|Antiviral Agents|antiviral agents|mesh-ancestor
24872491|NCT05359315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24872500|NCT05341180|Lactulose|lactulose|mesh-list
24872501|NCT05341180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24872565|NCT05313659|Anesthetics, General|anesthetics, general|mesh-ancestor
24872566|NCT05313659|Anesthetics|anesthetics|mesh-ancestor
24872567|NCT05313659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24872568|NCT05313659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24872569|NCT05313659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24872570|NCT05313659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24872612|NCT05300152|Antibodies|antibodies|mesh-list
24872613|NCT05300152|Immunoglobulins|immunoglobulins|mesh-list
24872614|NCT05300152|Immunologic Factors|immunologic factors|mesh-ancestor
24872798|NCT05440487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24872859|NCT05439772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24872860|NCT05439629|Ranibizumab|ranibizumab|mesh-list
24872861|NCT05439629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24872862|NCT05439629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24872863|NCT05439629|Growth Substances|growth substances|mesh-ancestor
24872864|NCT05439629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872865|NCT05439629|Growth Inhibitors|growth inhibitors|mesh-ancestor
24872866|NCT05439629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24872867|NCT05439577|Heparinoids|heparinoids|mesh-list
24872868|NCT05439577|Glucocorticoids|glucocorticoids|mesh-list
24815090|NCT02068170|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24815091|NCT02068170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24815092|NCT02068170|Narcotics|narcotics|mesh-ancestor
24815093|NCT02068170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24815094|NCT02068170|Analgesics|analgesics|mesh-ancestor
24815095|NCT02068170|Sensory System Agents|sensory system agents|mesh-ancestor
24815096|NCT02068170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24815097|NCT02068170|Antitussive Agents|antitussive agents|mesh-ancestor
24815098|NCT02068170|Respiratory System Agents|respiratory system agents|mesh-ancestor
24815099|NCT02068170|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25713674|NCT02343575|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25713675|NCT02343575|Anticonvulsants|anticonvulsants|mesh-ancestor
25713676|NCT02343575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713677|NCT02343575|GABA Agents|gaba agents|mesh-ancestor
25713678|NCT02343575|Antimanic Agents|antimanic agents|mesh-ancestor
25713679|NCT02343939|Cytarabine|cytarabine|mesh-list
25713680|NCT02343939|Azacitidine|azacitidine|mesh-list
25713681|NCT02343939|Decitabine|decitabine|mesh-list
25713682|NCT02343939|Daunorubicin|daunorubicin|mesh-list
25713683|NCT02343939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25713685|NCT02343939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815100|NCT02068170|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24815101|NCT02068170|Antiemetics|antiemetics|mesh-ancestor
24815103|NCT02068170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24815104|NCT02068170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24815105|NCT02068170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24815106|NCT02068170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24815107|NCT02068170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24815108|NCT02068170|Dopamine Agents|dopamine agents|mesh-ancestor
24815109|NCT02068170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24815110|NCT02068170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24815111|NCT02068170|Antimalarials|antimalarials|mesh-ancestor
24815112|NCT02068170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24815116|NCT02068196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815117|NCT02068196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24815118|NCT02068196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815120|NCT02068209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24815127|NCT02068235|Ponesimod|ponesimod|mesh-list
24872871|NCT05439577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24872872|NCT05439577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24872873|NCT05439577|Anticoagulants|anticoagulants|mesh-ancestor
24872929|NCT05439213|Respiratory System Agents|respiratory system agents|mesh-ancestor
24872931|NCT05439213|Sympathomimetics|sympathomimetics|mesh-ancestor
24872932|NCT05439213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24872933|NCT05438992|Bupivacaine|bupivacaine|mesh-list
24872934|NCT05438992|Anesthetics, Local|anesthetics, local|mesh-ancestor
24872935|NCT05438992|Anesthetics|anesthetics|mesh-ancestor
24873000|NCT05434624|Anesthetics, General|anesthetics, general|mesh-ancestor
24873001|NCT05434624|Anesthetics|anesthetics|mesh-ancestor
24873002|NCT05434624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24873003|NCT05434624|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24873004|NCT05434624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24873005|NCT05434624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24873006|NCT05434624|GABA Modulators|gaba modulators|mesh-ancestor
24873007|NCT05434624|GABA Agents|gaba agents|mesh-ancestor
24873008|NCT05434624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24873149|NCT05382715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24873191|NCT05330130|Hormones|hormones|mesh-ancestor
24873236|NCT05320380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24873237|NCT05320380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24873238|NCT05319015|Pembrolizumab|pembrolizumab|mesh-list
24873239|NCT05319015|Lenvatinib|lenvatinib|mesh-list
24873240|NCT05319015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24873241|NCT05319015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24873330|NCT05274789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24873346|NCT05263895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24873515|NCT05181124|Aceclofenac|aceclofenac|mesh-list
24873516|NCT05181124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24873517|NCT05181124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24873518|NCT05181124|Analgesics|analgesics|mesh-ancestor
24873519|NCT05181124|Sensory System Agents|sensory system agents|mesh-ancestor
25713686|NCT02343939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713687|NCT02343939|Antiviral Agents|antiviral agents|mesh-ancestor
25713688|NCT02343939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25713689|NCT02343939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24873520|NCT05181124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713690|NCT02343939|Immunologic Factors|immunologic factors|mesh-ancestor
24873521|NCT05181124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24873588|NCT05129748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24873593|NCT05129748|Sequestering Agents|sequestering agents|mesh-ancestor
24873770|NCT05030155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24873771|NCT05030155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24873772|NCT05030155|Antimetabolites|antimetabolites|mesh-ancestor
24873773|NCT05030155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24873774|NCT05025423|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24873776|NCT05025423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24873777|NCT05025423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24873805|NCT05015387|Proanthocyanidin|proanthocyanidin|mesh-list
24873807|NCT05015387|Antioxidants|antioxidants|mesh-ancestor
24873808|NCT05015387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24873819|NCT04996719|Sirolimus|sirolimus|mesh-list
24609488|NCT00996983|Ziconotide|ziconotide|mesh-list
24873820|NCT04996719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24696285|NCT01428466|Benzoyl Peroxide|benzoyl peroxide|mesh-list
24873821|NCT04996719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24873822|NCT04996719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24873823|NCT04996719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24873824|NCT04996719|Antifungal Agents|antifungal agents|mesh-ancestor
24874240|NCT04860141|Analgesics|analgesics|mesh-ancestor
24874241|NCT04860141|Sensory System Agents|sensory system agents|mesh-ancestor
24874242|NCT04860141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24874243|NCT04860141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24874244|NCT04860141|Anticonvulsants|anticonvulsants|mesh-ancestor
24874245|NCT04860141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24874246|NCT04860141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24874339|NCT04812535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24874340|NCT04812535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713691|NCT02343939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713692|NCT02343939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713693|NCT02343939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25713694|NCT02343939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25713695|NCT02343939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25713696|NCT02344004|Amikacin|amikacin|mesh-list
25713697|NCT02344004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25713698|NCT02344004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25713699|NCT02344225|Ibuprofen|ibuprofen|mesh-list
25713700|NCT02344225|Ketorolac|ketorolac|mesh-list
24874415|NCT04767594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24874416|NCT04767594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24874417|NCT04751500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24874418|NCT04751500|Metronidazole|metronidazole|mesh-list
24874638|NCT04616547|Pentetic Acid|pentetic acid|mesh-list
24874639|NCT04616547|Antidotes|antidotes|mesh-ancestor
24874640|NCT04616547|Protective Agents|protective agents|mesh-ancestor
24874641|NCT04616547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24874642|NCT04616547|Chelating Agents|chelating agents|mesh-ancestor
24874643|NCT04616547|Sequestering Agents|sequestering agents|mesh-ancestor
24874928|NCT04505774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24874929|NCT04505774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24874930|NCT04497584|Prednisone|prednisone|mesh-list
24874931|NCT04497584|Afatinib|afatinib|mesh-list
24874932|NCT04497584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24874933|NCT04497584|Glucocorticoids|glucocorticoids|mesh-ancestor
24874934|NCT04497584|Hormones|hormones|mesh-ancestor
24874935|NCT04497584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24874936|NCT04497584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24874937|NCT04497584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24874938|NCT04497584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24874939|NCT04497584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24874958|NCT04492033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24874959|NCT04492033|Tubulin Modulators|tubulin modulators|mesh-ancestor
24874960|NCT04492033|Antimitotic Agents|antimitotic agents|mesh-ancestor
24874961|NCT04492033|Mitosis Modulators|mitosis modulators|mesh-ancestor
24875208|NCT04329325|Antiemetics|antiemetics|mesh-ancestor
24875511|NCT04108897|Ivermectin|ivermectin|mesh-list
24875512|NCT04108897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24875513|NCT04108897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24875514|NCT04108897|Antimalarials|antimalarials|mesh-ancestor
24875515|NCT04108897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24875516|NCT04108897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24875848|NCT03819465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24875849|NCT03819465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24875910|NCT03813147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24875921|NCT03813147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24875922|NCT03813147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24876097|NCT03730649|Protective Agents|protective agents|mesh-ancestor
24876098|NCT03730649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24876099|NCT03730649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24876100|NCT03728881|Vaccines|vaccines|mesh-list
24876101|NCT03728881|Immunologic Factors|immunologic factors|mesh-ancestor
24876118|NCT03722680|Riluzole|riluzole|mesh-list
24876119|NCT03722680|Anticonvulsants|anticonvulsants|mesh-ancestor
24876120|NCT03722680|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24876121|NCT03722680|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24876250|NCT03646123|Dacarbazine|dacarbazine|mesh-list
24876251|NCT03646123|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24876252|NCT03646123|Vinblastine|vinblastine|mesh-list
24876253|NCT03646123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24876254|NCT03646123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24876255|NCT03646123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25713703|NCT02344225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713704|NCT02344225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25713705|NCT02344225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24876256|NCT03646123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24876257|NCT03646123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713706|NCT02344225|Analgesics|analgesics|mesh-ancestor
25713707|NCT02344225|Sensory System Agents|sensory system agents|mesh-ancestor
25713708|NCT02344225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713709|NCT02344225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713710|NCT02344225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24876258|NCT03646123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24876457|NCT03512756|Gemcitabine|gemcitabine|mesh-list
24876459|NCT03512756|Capecitabine|capecitabine|mesh-list
24876460|NCT03512756|Phenytoin|phenytoin|mesh-list
24876461|NCT03512756|Methoxsalen|methoxsalen|mesh-list
24815413|NCT02070159|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24623378|NCT01071135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24623379|NCT01071135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24623380|NCT01071135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24623381|NCT01071135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623383|NCT01071161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24623384|NCT01071161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24623385|NCT01071174|Dapivirine|dapivirine|mesh-list
24623397|NCT01071291|Niacin|niacin|mesh-list
24876846|NCT03199053|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24876848|NCT03199053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24877083|NCT02965716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24877542|NCT02568553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24877543|NCT02568553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24877544|NCT02568553|Growth Substances|growth substances|mesh-ancestor
24877545|NCT02568553|Growth Inhibitors|growth inhibitors|mesh-ancestor
24877546|NCT02568553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24877549|NCT02535325|Cisplatin|cisplatin|mesh-list
24877550|NCT02535325|Pemetrexed|pemetrexed|mesh-list
24877551|NCT02535325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24877552|NCT02535325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24878156|NCT02097225|Dabrafenib|dabrafenib|mesh-list
24878157|NCT02097225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24878158|NCT02097225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24878549|NCT01434316|Veliparib|veliparib|mesh-list
24878881|NCT00494234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24878882|NCT00494234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878883|NCT00494234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24878914|NCT00329043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24878915|NCT00329043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24878916|NCT00329043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24878917|NCT00329043|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24878918|NCT00329043|Fertility Agents|fertility agents|mesh-ancestor
24878919|NCT00329043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24878920|NCT00329043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24878981|NCT05183984|Growth Substances|growth substances|mesh-ancestor
24878982|NCT05183984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24878983|NCT05183984|Growth Inhibitors|growth inhibitors|mesh-ancestor
24879022|NCT05140954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24879023|NCT05140954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25713711|NCT02344225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25713712|NCT02344225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25713713|NCT02344225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713714|NCT02344225|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25713715|NCT02344225|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25713716|NCT02344225|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25713717|NCT02344225|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24879024|NCT05140954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24879025|NCT05140954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24879026|NCT05140954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879027|NCT05140954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24879028|NCT05140954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24815748|NCT02071888|BB 1101|bb 1101|mesh-list
24879060|NCT05082259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24879061|NCT05082259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24879062|NCT05082155|Bupivacaine|bupivacaine|mesh-list
24879063|NCT05082155|Anesthetics, Local|anesthetics, local|mesh-ancestor
24879064|NCT05082155|Anesthetics|anesthetics|mesh-ancestor
24879065|NCT05082155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24879078|NCT05062174|Mifepristone|mifepristone|mesh-list
24879079|NCT05062174|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24879476|NCT04740580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24879477|NCT04740580|Expectorants|expectorants|mesh-ancestor
24879478|NCT04740580|Respiratory System Agents|respiratory system agents|mesh-ancestor
24879479|NCT04740580|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24879480|NCT04740580|Antioxidants|antioxidants|mesh-ancestor
24879598|NCT04640376|Sensory System Agents|sensory system agents|mesh-ancestor
24879599|NCT04640376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24879600|NCT04640376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879601|NCT04640376|Antipyretics|antipyretics|mesh-ancestor
24879662|NCT04560660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879663|NCT04560660|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24879664|NCT04560660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24815883|NCT02072382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24702033|NCT01463735|Vitamin E|vitamin e|mesh-list
24879738|NCT04509596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879739|NCT04509596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24879740|NCT04509596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24879741|NCT04496219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24879742|NCT04496219|BCG Vaccine|bcg vaccine|mesh-list
24879772|NCT04439799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24879773|NCT04439799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24879774|NCT04439799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24879967|NCT04273737|Analgesics|analgesics|mesh-ancestor
24879968|NCT04273737|Sensory System Agents|sensory system agents|mesh-ancestor
24879969|NCT04273737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24879970|NCT04266795|Azacitidine|azacitidine|mesh-list
24879971|NCT04266795|Venetoclax|venetoclax|mesh-list
24879972|NCT04266795|Pevonedistat|pevonedistat|mesh-list
24879973|NCT04266795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24879974|NCT04266795|Antimetabolites|antimetabolites|mesh-ancestor
25713719|NCT02344225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24879975|NCT04266795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24879976|NCT04266795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24815896|NCT02072512|Fulvestrant|fulvestrant|mesh-list
24815897|NCT02072512|Anastrozole|anastrozole|mesh-list
24815898|NCT02072512|Goserelin|goserelin|mesh-list
24815899|NCT02072512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24815900|NCT02072512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24880185|NCT03986996|Metronidazole|metronidazole|mesh-list
24880186|NCT03986996|Doxycycline|doxycycline|mesh-list
24880363|NCT03829371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24880512|NCT03608358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24880513|NCT03608358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880514|NCT03608358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24880515|NCT03608358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880517|NCT03608358|Hormones|hormones|mesh-ancestor
24702798|NCT01467804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24880603|NCT03564093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24880604|NCT03564093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24880605|NCT03564093|Adrenergic Agents|adrenergic agents|mesh-ancestor
24880665|NCT03525002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880666|NCT03469999|Botulinum Toxins|botulinum toxins|mesh-list
24880667|NCT03469999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24880668|NCT03469999|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24880669|NCT03469999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24880670|NCT03469999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24880671|NCT03469999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24880672|NCT03469999|Cholinergic Agents|cholinergic agents|mesh-ancestor
24880673|NCT03469999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24880674|NCT03469999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24880739|NCT03418038|Antimitotic Agents|antimitotic agents|mesh-ancestor
24880740|NCT03418038|Mitosis Modulators|mitosis modulators|mesh-ancestor
24880741|NCT03398135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24881068|NCT03101475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24881069|NCT03101475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713720|NCT02344238|Riboflavin|riboflavin|mesh-list
25713721|NCT02344238|Vitamin B Complex|vitamin b complex|mesh-ancestor
25713722|NCT02344238|Vitamins|vitamins|mesh-ancestor
25713723|NCT02344238|Micronutrients|micronutrients|mesh-ancestor
25713724|NCT02344238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713725|NCT02344238|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24881076|NCT03083405|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24881077|NCT03083405|Antidepressive Agents|antidepressive agents|mesh-ancestor
24881078|NCT03083405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24881079|NCT03083405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24881080|NCT03083405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24881111|NCT03015610|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24881113|NCT03015610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24815968|NCT02072967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24881115|NCT03003962|Paclitaxel|paclitaxel|mesh-list
24881116|NCT03003962|Cisplatin|cisplatin|mesh-list
24881117|NCT03003962|Carboplatin|carboplatin|mesh-list
24881118|NCT03003962|Pemetrexed|pemetrexed|mesh-list
24881133|NCT03003962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881134|NCT03003962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24881135|NCT03003962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24881136|NCT03003962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24881137|NCT02983461|Sildenafil Citrate|sildenafil citrate|mesh-list
24881138|NCT02983461|Vasodilator Agents|vasodilator agents|mesh-ancestor
24881139|NCT02983461|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24881140|NCT02983461|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24881141|NCT02983461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881142|NCT02983461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881143|NCT02983461|Urological Agents|urological agents|mesh-ancestor
24881144|NCT02977494|Dexamethasone|dexamethasone|mesh-list
24881145|NCT02977494|Dexamethasone acetate|dexamethasone acetate|mesh-list
24881146|NCT02977494|Bortezomib|bortezomib|mesh-list
24881147|NCT02977494|Daratumumab|daratumumab|mesh-list
24881156|NCT02977494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24881157|NCT02977494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24881198|NCT02935309|Lenvatinib|lenvatinib|mesh-list
24881199|NCT02935309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24881200|NCT02935309|Antimetabolites|antimetabolites|mesh-ancestor
24881201|NCT02935309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24881202|NCT02935309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24881203|NCT02935309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24881204|NCT02935309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24881205|NCT02922725|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
24881206|NCT02922725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24881207|NCT02922725|Antidepressive Agents|antidepressive agents|mesh-ancestor
24881208|NCT02922725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24881230|NCT02921893|Immunologic Factors|immunologic factors|mesh-ancestor
24881231|NCT02921893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25713726|NCT02344238|Dermatologic Agents|dermatologic agents|mesh-ancestor
25713727|NCT02344316|Melatonin|melatonin|mesh-list
25713728|NCT02344316|Antioxidants|antioxidants|mesh-ancestor
25713729|NCT02344316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713730|NCT02344316|Protective Agents|protective agents|mesh-ancestor
25713731|NCT02344316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713732|NCT02344316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25713733|NCT02344342|Diuretics|diuretics|mesh-list
25713734|NCT02344342|Natriuretic Agents|natriuretic agents|mesh-ancestor
25713735|NCT02344342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24881233|NCT02921893|Growth Substances|growth substances|mesh-ancestor
24881234|NCT02921893|Growth Inhibitors|growth inhibitors|mesh-ancestor
24881862|NCT01004029|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24881863|NCT01004029|Hormone Antagonists|hormone antagonists|mesh-ancestor
24881972|NCT00006455|Dexamethasone|dexamethasone|mesh-list
24881997|NCT00006455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24881998|NCT00006455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24881999|NCT00006455|Glucocorticoids|glucocorticoids|mesh-ancestor
24882031|NCT00003716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24882032|NCT02983617|Obinutuzumab|obinutuzumab|mesh-list
24882033|NCT02983617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24882085|NCT02743923|Paclitaxel|paclitaxel|mesh-list
24882086|NCT02743923|Bevacizumab|bevacizumab|mesh-list
24882087|NCT02743923|Carboplatin|carboplatin|mesh-list
24882088|NCT02743923|Pemetrexed|pemetrexed|mesh-list
24882089|NCT02743923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24882090|NCT02743923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882091|NCT02743923|Tubulin Modulators|tubulin modulators|mesh-ancestor
24671799|NCT01327755|Selenium|selenium|mesh-list
24882092|NCT02743923|Antimitotic Agents|antimitotic agents|mesh-ancestor
24882129|NCT02735707|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24882130|NCT02735707|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24882131|NCT02735707|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24882133|NCT02735707|Valsartan|valsartan|mesh-list
24816114|NCT02074228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816115|NCT02074228|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24816116|NCT02074228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24816117|NCT02074228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24816118|NCT02074228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713737|NCT02344628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24816119|NCT02074228|Dopamine Agents|dopamine agents|mesh-ancestor
24816120|NCT02074228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24816121|NCT02074267|Gabapentin|gabapentin|mesh-list
24816122|NCT02074267|Analgesics|analgesics|mesh-ancestor
24882247|NCT02345850|Antimetabolites|antimetabolites|mesh-ancestor
24882313|NCT01495676|Antimetabolites|antimetabolites|mesh-ancestor
24882314|NCT01495676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882315|NCT01495676|Antiviral Agents|antiviral agents|mesh-ancestor
24882316|NCT01495676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24882317|NCT01495676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24882318|NCT01495676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24882319|NCT01495676|Immunologic Factors|immunologic factors|mesh-ancestor
24882320|NCT01495676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882359|NCT01111565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24882361|NCT01111565|Dopamine Agents|dopamine agents|mesh-ancestor
24882362|NCT01111565|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24882542|NCT05169554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24505430|NCT00541112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24882572|NCT05169021|Antihypertensive Agents|antihypertensive agents|mesh-list
24882573|NCT05169021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24882574|NCT05169021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24882575|NCT05169021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882576|NCT05169021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24882577|NCT05169021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882578|NCT05169021|Vasodilator Agents|vasodilator agents|mesh-ancestor
24882579|NCT05169021|Hematinics|hematinics|mesh-ancestor
24882641|NCT05167175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24882642|NCT05167175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882643|NCT05167175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24882644|NCT05167175|Hormone Antagonists|hormone antagonists|mesh-ancestor
24882645|NCT05167175|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24882646|NCT05167123|Calcium|calcium|mesh-list
24882690|NCT05144698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25713738|NCT02344628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25713739|NCT02345161|Budesonide|budesonide|mesh-list
25713740|NCT02345161|Albuterol|albuterol|mesh-list
24882691|NCT05144698|Immunologic Factors|immunologic factors|mesh-ancestor
25713741|NCT02345161|Formoterol Fumarate|formoterol fumarate|mesh-list
25713742|NCT02345161|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25713743|NCT02345161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25713744|NCT02345161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25713745|NCT02345161|Autonomic Agents|autonomic agents|mesh-ancestor
25713746|NCT02345161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713747|NCT02345161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713748|NCT02345161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24882692|NCT05144698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882696|NCT05111912|Incretins|incretins|mesh-ancestor
24882698|NCT05111912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24882699|NCT05111912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882701|NCT05111912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24882702|NCT05107050|Anti-Infective Agents|anti-infective agents|mesh-list
24882703|NCT05107050|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24882705|NCT05105672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882706|NCT05093517|Volagidemab|volagidemab|mesh-list
24882707|NCT05093517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24882708|NCT05093517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24882754|NCT05024188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24882755|NCT05024188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24882756|NCT05024188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672096|NCT01329640|Tubulin Modulators|tubulin modulators|mesh-ancestor
24882757|NCT05024188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24882758|NCT05024188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24882759|NCT05024188|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24882760|NCT05024188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24506150|NCT00544219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24506151|NCT00544219|Immunologic Factors|immunologic factors|mesh-ancestor
24882840|NCT04929600|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24882841|NCT04929600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24882842|NCT04929600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24882889|NCT04795557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24882894|NCT04780204|Tenofovir|tenofovir|mesh-list
24882895|NCT04780204|Antiviral Agents|antiviral agents|mesh-ancestor
24882896|NCT04780204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24882897|NCT04780204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24882898|NCT04780204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24882901|NCT04780204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24883079|NCT04588818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24883080|NCT04588818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24883082|NCT04579510|Immunologic Factors|immunologic factors|mesh-ancestor
24883083|NCT04579510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883087|NCT04539730|Bupivacaine|bupivacaine|mesh-list
24883089|NCT04539730|Anesthetics, Local|anesthetics, local|mesh-ancestor
24883090|NCT04539730|Anesthetics|anesthetics|mesh-ancestor
24816195|NCT02074891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816196|NCT02074891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24816197|NCT02074891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24816198|NCT02075034|ON 01910|on 01910|mesh-list
24816199|NCT02075034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816200|NCT02075034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24816201|NCT02075034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713749|NCT02345161|Respiratory System Agents|respiratory system agents|mesh-ancestor
24816208|NCT02075086|Growth Substances|growth substances|mesh-ancestor
24816209|NCT02075086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816210|NCT02075086|Growth Inhibitors|growth inhibitors|mesh-ancestor
24816211|NCT02075112|Genistein|genistein|mesh-list
24816212|NCT02075112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816213|NCT02075112|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24816214|NCT02075112|Protective Agents|protective agents|mesh-ancestor
24816215|NCT02075112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816216|NCT02075112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24816217|NCT02075112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816218|NCT02075112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816219|NCT02075112|Phytoestrogens|phytoestrogens|mesh-ancestor
24816220|NCT02075112|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24816221|NCT02075112|Estrogens|estrogens|mesh-ancestor
24816222|NCT02075112|Hormones|hormones|mesh-ancestor
24816223|NCT02075112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24816224|NCT02075242|Mycophenolic Acid|mycophenolic acid|mesh-list
24816225|NCT02075242|Tacrolimus|tacrolimus|mesh-list
24393522|NCT00130195|Mitosis Modulators|mitosis modulators|mesh-ancestor
24816229|NCT02075242|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24816230|NCT02075242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24816231|NCT02075242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816232|NCT02075242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24883133|NCT04452383|Sensory System Agents|sensory system agents|mesh-ancestor
24883134|NCT04452383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24883135|NCT04452383|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24883136|NCT04452383|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24883137|NCT04452383|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24883138|NCT04452383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24883139|NCT04452383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24705457|NCT01485211|Riboflavin|riboflavin|mesh-list
24883145|NCT04418401|Antibodies|antibodies|mesh-list
24883146|NCT04418401|Immunologic Factors|immunologic factors|mesh-ancestor
24883148|NCT04412018|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
24883149|NCT04412018|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24883150|NCT04412018|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24883151|NCT04401904|Dapagliflozin|dapagliflozin|mesh-list
24883152|NCT04401904|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24883153|NCT04401904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713750|NCT02345161|Glucocorticoids|glucocorticoids|mesh-ancestor
25713751|NCT02345161|Hormones|hormones|mesh-ancestor
25713752|NCT02345161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25713753|NCT02345161|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25713754|NCT02345161|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25713755|NCT02345161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25713756|NCT02345161|Adrenergic Agents|adrenergic agents|mesh-ancestor
24883217|NCT04297293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883219|NCT04297293|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24883232|NCT04249297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24883233|NCT04249297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883265|NCT04167761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883267|NCT04167761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883269|NCT04147546|Antimalarials|antimalarials|mesh-ancestor
24883270|NCT04147546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24883271|NCT04147546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24883272|NCT04147546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24816239|NCT02075268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24816240|NCT02075294|Entecavir|entecavir|mesh-list
24816241|NCT02075294|Adefovir|adefovir|mesh-list
24816242|NCT02075294|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
24816243|NCT02075294|Antiviral Agents|antiviral agents|mesh-ancestor
24816244|NCT02075294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24816245|NCT02075294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24883402|NCT03852888|7-hydroxymethotrexate|7-hydroxymethotrexate|mesh-list
24883403|NCT03852888|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24883404|NCT03852888|Abortifacient Agents|abortifacient agents|mesh-ancestor
24883405|NCT03852888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24883406|NCT03852888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883407|NCT03852888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24883408|NCT03852888|Antimetabolites|antimetabolites|mesh-ancestor
24883409|NCT03852888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883410|NCT03852888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24883411|NCT03852888|Dermatologic Agents|dermatologic agents|mesh-ancestor
24883470|NCT03804268|Miotics|miotics|mesh-ancestor
24883484|NCT05239390|Analgesics|analgesics|mesh-ancestor
24883485|NCT05239390|Sensory System Agents|sensory system agents|mesh-ancestor
24883486|NCT05239390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24883487|NCT05239390|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24883488|NCT05239390|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24883489|NCT05239390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24883521|NCT05238727|Anesthetics, Local|anesthetics, local|mesh-ancestor
24883522|NCT05238727|Anesthetics|anesthetics|mesh-ancestor
24883523|NCT05238727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24883524|NCT05238727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883525|NCT05238727|Sensory System Agents|sensory system agents|mesh-ancestor
24883539|NCT05238064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24883540|NCT05238064|Immunologic Factors|immunologic factors|mesh-ancestor
24883541|NCT05238064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883738|NCT05040282|Contraceptive Agents|contraceptive agents|mesh-ancestor
24883739|NCT05040282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24883740|NCT05040282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883741|NCT05040282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24883742|NCT05004038|BCG Vaccine|bcg vaccine|mesh-list
24883747|NCT04982172|Dermatologic Agents|dermatologic agents|mesh-ancestor
24883748|NCT04982172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24883749|NCT04982172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24883780|NCT04817410|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24883781|NCT04817410|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24883782|NCT04817410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394185|NCT00132535|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24394186|NCT00132535|Renal Agents|renal agents|mesh-ancestor
24883845|NCT04652245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24883846|NCT04652245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24883847|NCT04652245|Autonomic Agents|autonomic agents|mesh-ancestor
24883872|NCT04631536|Nebivolol|nebivolol|mesh-list
24883873|NCT04631536|Atorvastatin|atorvastatin|mesh-list
24883874|NCT04631536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24883875|NCT04631536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24883876|NCT04631536|Antimetabolites|antimetabolites|mesh-ancestor
24883894|NCT04567992|Anesthetics, Local|anesthetics, local|mesh-ancestor
24883895|NCT04567992|Anesthetics|anesthetics|mesh-ancestor
24883896|NCT04567992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24883897|NCT04567992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883898|NCT04567992|Sensory System Agents|sensory system agents|mesh-ancestor
24883899|NCT04567992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24883912|NCT04565600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883914|NCT04501211|Antiemetics|antiemetics|mesh-ancestor
24883915|NCT04501211|Autonomic Agents|autonomic agents|mesh-ancestor
24883931|NCT04409262|Remdesivir|remdesivir|mesh-list
24883932|NCT04409262|Antimetabolites|antimetabolites|mesh-ancestor
24883933|NCT04409262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883934|NCT04409262|Antiviral Agents|antiviral agents|mesh-ancestor
24883935|NCT04409262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24883936|NCT04408508|Amoxicillin|amoxicillin|mesh-list
24883937|NCT04408508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25713757|NCT02345161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25713758|NCT02345161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883984|NCT03759587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24883985|NCT03759587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24883989|NCT03730662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24883990|NCT03730662|Incretins|incretins|mesh-ancestor
24883992|NCT03730662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24816300|NCT02076191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816301|NCT02076191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816302|NCT02076191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713759|NCT02345161|Tocolytic Agents|tocolytic agents|mesh-ancestor
25713760|NCT02345161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25713761|NCT02345226|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25713762|NCT02345226|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25713763|NCT02345226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25713764|NCT02345226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713765|NCT02345226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713766|NCT02345226|Antiviral Agents|antiviral agents|mesh-ancestor
25713767|NCT02345226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25713768|NCT02345226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25713769|NCT02345226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25713770|NCT02345252|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
25713771|NCT02345252|Antiviral Agents|antiviral agents|mesh-ancestor
25713772|NCT02345252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25713773|NCT02345252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25713774|NCT02345252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25713775|NCT02345252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713776|NCT02345252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713777|NCT02345252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25713778|NCT02345252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25713779|NCT02345330|Interleukin-12|interleukin-12|mesh-list
25713780|NCT02345330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25713781|NCT02345330|Immunologic Factors|immunologic factors|mesh-ancestor
25713782|NCT02345330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713783|NCT02345330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25713784|NCT02345330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25713785|NCT02345330|Growth Substances|growth substances|mesh-ancestor
24884023|NCT03571633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884041|NCT03439085|Durvalumab|durvalumab|mesh-list
24884042|NCT03439085|Interleukin-12|interleukin-12|mesh-list
24884043|NCT03439085|Vaccines|vaccines|mesh-list
24884044|NCT03439085|Immunoglobulins|immunoglobulins|mesh-list
24884045|NCT03439085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24884046|NCT03439085|Immunoglobulin G|immunoglobulin g|mesh-list
24884051|NCT03439085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24884052|NCT03439085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24884053|NCT03439085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24884054|NCT03439085|Growth Substances|growth substances|mesh-ancestor
24884055|NCT03439085|Growth Inhibitors|growth inhibitors|mesh-ancestor
24884056|NCT03433183|Sirolimus|sirolimus|mesh-list
24505144|NCT00540098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505145|NCT00540137|Ritonavir|ritonavir|mesh-list
24637589|NCT01151722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505267|NCT00540787|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24505268|NCT00540787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24505269|NCT00540787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505270|NCT00540787|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24505271|NCT00540787|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24505272|NCT00540787|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24505297|NCT00540800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24510781|NCT00565630|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24510782|NCT00565630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24510783|NCT00565630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24510784|NCT00565630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24505298|NCT00540800|Antimetabolites|antimetabolites|mesh-ancestor
24505299|NCT00540800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24505300|NCT00540800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25713786|NCT02345330|Growth Inhibitors|growth inhibitors|mesh-ancestor
25713787|NCT02345330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713788|NCT02345486|Plasma-lyte 148|plasma-lyte 148|mesh-list
25713789|NCT02345486|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25713790|NCT02345486|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25713792|NCT02346240|Certolizumab Pegol|certolizumab pegol|mesh-list
24505301|NCT00540800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24505302|NCT00540800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505303|NCT00540826|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24505304|NCT00540826|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24505305|NCT00540826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24505306|NCT00540826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24510815|NCT00565682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505338|NCT00540956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505339|NCT00540956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505340|NCT00540956|Antiviral Agents|antiviral agents|mesh-ancestor
24505399|NCT00541086|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24505400|NCT00541086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24505401|NCT00541086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505402|NCT00541086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24505407|NCT00541086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24505408|NCT00541086|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24505409|NCT00541086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24505411|NCT00541112|Fluorouracil|fluorouracil|mesh-list
24505412|NCT00541112|Capecitabine|capecitabine|mesh-list
24505413|NCT00541112|Oxaliplatin|oxaliplatin|mesh-list
24505414|NCT00541112|Cetuximab|cetuximab|mesh-list
24505415|NCT00541112|Calcium|calcium|mesh-list
24505416|NCT00541112|Levoleucovorin|levoleucovorin|mesh-list
24505417|NCT00541112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24505418|NCT00541112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505419|NCT00541112|Antimetabolites|antimetabolites|mesh-ancestor
24505420|NCT00541112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884142|NCT02959918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884143|NCT02823847|Carbon Monoxide|carbon monoxide|mesh-list
24884144|NCT02823847|Antimetabolites|antimetabolites|mesh-ancestor
24884145|NCT02823847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884146|NCT02823847|Gasotransmitters|gasotransmitters|mesh-ancestor
24884147|NCT02823847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24884148|NCT02823847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505446|NCT00541125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505447|NCT00541125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24505448|NCT00541125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24505449|NCT00541125|Immunologic Factors|immunologic factors|mesh-ancestor
24505451|NCT00541125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24505452|NCT00541125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505461|NCT00541138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505462|NCT00541138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505560|NCT00541411|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24505562|NCT00541411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24884149|NCT02817789|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
24884150|NCT02817789|Clopidogrel|clopidogrel|mesh-list
24884151|NCT02817789|Ticagrelor|ticagrelor|mesh-list
24884152|NCT02817789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24884153|NCT02817789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24884154|NCT02817789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25713793|NCT02346240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25713794|NCT02346240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25713795|NCT02346240|Analgesics|analgesics|mesh-ancestor
25713796|NCT02346240|Sensory System Agents|sensory system agents|mesh-ancestor
25713797|NCT02346240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713798|NCT02346240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713799|NCT02346240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25713800|NCT02346240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24884155|NCT02817789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24884156|NCT02817789|Purinergic Agents|purinergic agents|mesh-ancestor
24884157|NCT02817789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24884158|NCT02817789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884159|NCT02817789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510936|NCT00566683|Anesthetics, General|anesthetics, general|mesh-ancestor
24505622|NCT00541710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505623|NCT00541710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24505624|NCT00541710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505625|NCT00541710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505626|NCT00541710|Phytoestrogens|phytoestrogens|mesh-ancestor
24505627|NCT00541710|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24505628|NCT00541710|Estrogens|estrogens|mesh-ancestor
24505630|NCT00541710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24884191|NCT02744742|Immunologic Factors|immunologic factors|mesh-ancestor
24884192|NCT02744742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884193|NCT02744742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24505749|NCT00542243|Finasteride|finasteride|mesh-list
24506442|NCT00545311|Cholinergic Agents|cholinergic agents|mesh-ancestor
24505781|NCT00542412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505782|NCT00542412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24505783|NCT00542412|Protective Agents|protective agents|mesh-ancestor
24884264|NCT02628405|Tubulin Modulators|tubulin modulators|mesh-ancestor
24884265|NCT02628405|Antimitotic Agents|antimitotic agents|mesh-ancestor
24884266|NCT02628405|Mitosis Modulators|mitosis modulators|mesh-ancestor
24505979|NCT00543634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24505980|NCT00543634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505981|NCT00543634|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24505982|NCT00543634|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24505992|NCT00543647|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24505993|NCT00543686|Fluticasone|fluticasone|mesh-list
24506301|NCT00544596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24506302|NCT00544596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24506304|NCT00544596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506305|NCT00544596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506306|NCT00544596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24506307|NCT00544596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25713801|NCT02346240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25713802|NCT02346240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25713803|NCT02346240|Immunologic Factors|immunologic factors|mesh-ancestor
25713804|NCT02346370|Docetaxel|docetaxel|mesh-list
25713805|NCT02346370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713806|NCT02346370|Tubulin Modulators|tubulin modulators|mesh-ancestor
25713807|NCT02346370|Antimitotic Agents|antimitotic agents|mesh-ancestor
25713808|NCT02346370|Mitosis Modulators|mitosis modulators|mesh-ancestor
25713809|NCT02346370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713810|NCT02346721|Sofosbuvir|sofosbuvir|mesh-list
25713811|NCT02346721|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25713812|NCT02346721|Velpatasvir|velpatasvir|mesh-list
25713813|NCT02346721|Antiviral Agents|antiviral agents|mesh-ancestor
25713814|NCT02346721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25713815|NCT02346903|Capsaicin|capsaicin|mesh-list
25713816|NCT02346903|Antipruritics|antipruritics|mesh-ancestor
25713817|NCT02346903|Dermatologic Agents|dermatologic agents|mesh-ancestor
25713818|NCT02346903|Sensory System Agents|sensory system agents|mesh-ancestor
25713819|NCT02346903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713820|NCT02346903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713821|NCT02346916|Capsaicin|capsaicin|mesh-list
24884323|NCT01889303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506378|NCT00544999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24506434|NCT00545246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24506435|NCT00545246|Growth Substances|growth substances|mesh-ancestor
24506436|NCT00545246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506437|NCT00545246|Growth Inhibitors|growth inhibitors|mesh-ancestor
24506439|NCT00545311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24506440|NCT00545311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24506441|NCT00545311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24506487|NCT00545519|Immunologic Factors|immunologic factors|mesh-ancestor
24506488|NCT00545519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506489|NCT00545519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24506490|NCT00545558|Tenofovir|tenofovir|mesh-list
24506491|NCT00545558|Emtricitabine|emtricitabine|mesh-list
24506511|NCT00545675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24506512|NCT00545675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24506513|NCT00545675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24506514|NCT00545675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24506515|NCT00545675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506516|NCT00545675|Dopamine Agonists|dopamine agonists|mesh-ancestor
24506517|NCT00545675|Dopamine Agents|dopamine agents|mesh-ancestor
24506518|NCT00545675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24506519|NCT00545675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506522|NCT00545675|Serotonin Agents|serotonin agents|mesh-ancestor
24884401|NCT00664937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884402|NCT00635882|Mometasone Furoate|mometasone furoate|mesh-list
24506541|NCT00545870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506542|NCT00545870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24506543|NCT00545870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24506625|NCT00546234|Cholinergic Agents|cholinergic agents|mesh-ancestor
24506632|NCT00546286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24506633|NCT00546286|Adrenergic Agents|adrenergic agents|mesh-ancestor
24506719|NCT00546559|Simvastatin|simvastatin|mesh-list
24506720|NCT00546559|Pravastatin|pravastatin|mesh-list
24506721|NCT00546559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24506722|NCT00546559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24506723|NCT00546559|Antimetabolites|antimetabolites|mesh-ancestor
24506789|NCT00547053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24506790|NCT00547053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24506791|NCT00547053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884442|NCT00540839|Xhance|xhance|mesh-list
24511848|NCT00571246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24511929|NCT00571714|Lipotropic Agents|lipotropic agents|mesh-ancestor
24884485|NCT00462748|Antimetabolites|antimetabolites|mesh-ancestor
24884490|NCT00446186|Montelukast|montelukast|mesh-list
24507002|NCT00548002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507003|NCT00548002|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24507004|NCT00548002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24507006|NCT00548067|Valsartan|valsartan|mesh-list
24507007|NCT00548067|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24507008|NCT00548067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24507009|NCT00548067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24507010|NCT00548067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24507012|NCT00548067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25713822|NCT02346916|Antipruritics|antipruritics|mesh-ancestor
25713823|NCT02346916|Dermatologic Agents|dermatologic agents|mesh-ancestor
24507013|NCT00548067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507014|NCT00548067|Vasodilator Agents|vasodilator agents|mesh-ancestor
24507015|NCT00548067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24507016|NCT00548067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24507085|NCT00548574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24507086|NCT00548574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507087|NCT00548574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24507090|NCT00548678|Diclofenac|diclofenac|mesh-list
24507091|NCT00548678|Ketorolac|ketorolac|mesh-list
24507092|NCT00548678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24507093|NCT00548678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24507094|NCT00548678|Analgesics|analgesics|mesh-ancestor
24507095|NCT00548678|Sensory System Agents|sensory system agents|mesh-ancestor
24507155|NCT00548964|Antimanic Agents|antimanic agents|mesh-ancestor
24507156|NCT00548964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24507157|NCT00549068|Risedronic Acid|risedronic acid|mesh-list
24507158|NCT00549068|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24507159|NCT00549068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24507160|NCT00549068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507161|NCT00549068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24507162|NCT00549068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507163|NCT00549068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24507164|NCT00549107|Simendan|simendan|mesh-list
24507165|NCT00549107|Milrinone|milrinone|mesh-list
24507166|NCT00549107|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24507167|NCT00549107|Vasodilator Agents|vasodilator agents|mesh-ancestor
24507168|NCT00549107|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24507171|NCT00549107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507172|NCT00549107|Protective Agents|protective agents|mesh-ancestor
24507173|NCT00549107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507174|NCT00549107|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24507176|NCT00549120|Albuterol|albuterol|mesh-list
24463554|NCT00361387|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24507274|NCT00549536|Calcium|calcium|mesh-list
24507340|NCT00549965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24884523|NCT00409773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24884525|NCT00409773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24884526|NCT00409773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24884527|NCT00409773|Antimetabolites|antimetabolites|mesh-ancestor
25713824|NCT02346916|Sensory System Agents|sensory system agents|mesh-ancestor
25713825|NCT02346916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713826|NCT02346916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713827|NCT02347072|Glycopyrrolate|glycopyrrolate|mesh-list
25713828|NCT02347072|Bromides|bromides|mesh-list
25713829|NCT02347072|Formoterol Fumarate|formoterol fumarate|mesh-list
25713830|NCT02347072|Tiotropium Bromide|tiotropium bromide|mesh-list
25713831|NCT02347072|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25713832|NCT02347072|Autonomic Agents|autonomic agents|mesh-ancestor
25713833|NCT02347072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713834|NCT02347072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713835|NCT02347072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25713836|NCT02347072|Respiratory System Agents|respiratory system agents|mesh-ancestor
25713837|NCT02347072|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24884528|NCT00409773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884529|NCT00409773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24884530|NCT00409773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24884531|NCT00409773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507341|NCT00549965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507342|NCT00549965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24507343|NCT00549965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507344|NCT00549965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24884560|NCT00380705|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24884561|NCT00380705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884562|NCT00276484|Atorvastatin|atorvastatin|mesh-list
24507433|NCT00550485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507434|NCT00550485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24507435|NCT00550485|Antidepressive Agents|antidepressive agents|mesh-ancestor
24507436|NCT00550485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24507437|NCT00550563|Cholecalciferol|cholecalciferol|mesh-list
24507438|NCT00550563|Vitamin D|vitamin d|mesh-list
24507439|NCT00550563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24507440|NCT00550563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507441|NCT00550563|Vitamins|vitamins|mesh-ancestor
24507442|NCT00550563|Micronutrients|micronutrients|mesh-ancestor
24507443|NCT00550563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24507466|NCT00550784|Alkylating Agents|alkylating agents|mesh-ancestor
24507467|NCT00550784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24507606|NCT00551096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507607|NCT00551096|Antiviral Agents|antiviral agents|mesh-ancestor
24507608|NCT00551096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24507609|NCT00551096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24507610|NCT00551096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24507611|NCT00551096|Immunologic Factors|immunologic factors|mesh-ancestor
24507612|NCT00551096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507613|NCT00551109|SA 4503|sa 4503|mesh-list
24507837|NCT00552656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507838|NCT00552682|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24507839|NCT00552682|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24507845|NCT00552682|Analgesics|analgesics|mesh-ancestor
24507846|NCT00552682|Sensory System Agents|sensory system agents|mesh-ancestor
24507859|NCT00552747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24507860|NCT00552799|Penicillins|penicillins|mesh-list
24507888|NCT00553072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507889|NCT00553072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24507890|NCT00553072|Tocolytic Agents|tocolytic agents|mesh-ancestor
24507891|NCT00553072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24507892|NCT00553124|Vitamin E|vitamin e|mesh-list
24507893|NCT00553124|Selenium|selenium|mesh-list
24507894|NCT00553124|Vitamins|vitamins|mesh-ancestor
24507930|NCT00553345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713838|NCT02347072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25713839|NCT02347072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25713840|NCT02347072|Adrenergic Agents|adrenergic agents|mesh-ancestor
25713841|NCT02347072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25713842|NCT02347072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713843|NCT02347072|Parasympatholytics|parasympatholytics|mesh-ancestor
25713844|NCT02347072|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25713845|NCT02347072|Cholinergic Agents|cholinergic agents|mesh-ancestor
25713846|NCT02347072|Anticonvulsants|anticonvulsants|mesh-ancestor
25713847|NCT02347072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24507932|NCT00553345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507933|NCT00553345|Protective Agents|protective agents|mesh-ancestor
24508008|NCT00553878|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24508009|NCT00553878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24508010|NCT00553878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508078|NCT00554164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508080|NCT00554164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24508081|NCT00554164|Alkylating Agents|alkylating agents|mesh-ancestor
24508082|NCT00554164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508083|NCT00554164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508084|NCT00554164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24508085|NCT00554164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24508086|NCT00554164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24508094|NCT00554164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24508095|NCT00554164|Tubulin Modulators|tubulin modulators|mesh-ancestor
24508096|NCT00554164|Antimitotic Agents|antimitotic agents|mesh-ancestor
24508097|NCT00554164|Mitosis Modulators|mitosis modulators|mesh-ancestor
24508098|NCT00554177|Mifepristone|mifepristone|mesh-list
24508099|NCT00554177|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24508100|NCT00554177|Abortifacient Agents|abortifacient agents|mesh-ancestor
24508101|NCT00554177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24508102|NCT00554177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508103|NCT00554177|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24508104|NCT00554177|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24508105|NCT00554177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24508106|NCT00554177|Contraceptive Agents|contraceptive agents|mesh-ancestor
24508107|NCT00554177|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
24508129|NCT00554242|Protective Agents|protective agents|mesh-ancestor
24508130|NCT00554242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508132|NCT00554242|Micronutrients|micronutrients|mesh-ancestor
24884633|NCT00092989|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24884634|NCT00092989|Hormone Antagonists|hormone antagonists|mesh-ancestor
24884635|NCT00092989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24884636|NCT00092989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884637|NCT00092989|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24884638|NCT00092989|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24884639|NCT00092989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884640|NCT00092144|Montelukast|montelukast|mesh-list
24884641|NCT00092144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884642|NCT00092144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508269|NCT00554710|Immunologic Factors|immunologic factors|mesh-ancestor
24512879|NCT00577200|Sufentanil|sufentanil|mesh-list
24512880|NCT00577200|Propofol|propofol|mesh-list
24508321|NCT00555087|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24508322|NCT00555087|Androgens|androgens|mesh-ancestor
24508323|NCT00555087|Hormones|hormones|mesh-ancestor
24508346|NCT00555100|Growth Inhibitors|growth inhibitors|mesh-ancestor
24508347|NCT00555139|Alprazolam|alprazolam|mesh-list
24508348|NCT00555139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24508349|NCT00555139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24508350|NCT00555139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508351|NCT00555139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24508352|NCT00555139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24508353|NCT00555139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24508372|NCT00555256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508373|NCT00555256|Growth Inhibitors|growth inhibitors|mesh-ancestor
24508381|NCT00555256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24508382|NCT00555256|Immunologic Factors|immunologic factors|mesh-ancestor
24508384|NCT00555334|Entecavir|entecavir|mesh-list
24508385|NCT00555334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25713848|NCT02347072|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25713849|NCT02347085|Glycopyrrolate|glycopyrrolate|mesh-list
25713850|NCT02347085|Formoterol Fumarate|formoterol fumarate|mesh-list
25713851|NCT02347085|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25713852|NCT02347085|Autonomic Agents|autonomic agents|mesh-ancestor
25713853|NCT02347085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713854|NCT02347085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713855|NCT02347085|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24884725|NCT03686813|Urological Agents|urological agents|mesh-ancestor
24884726|NCT03679624|Daratumumab|daratumumab|mesh-list
24884727|NCT03679624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24884728|NCT03658304|Mitomycins|mitomycins|mesh-list
24884729|NCT03658304|Mitomycin|mitomycin|mesh-list
24884730|NCT03658304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24884734|NCT03658304|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24884735|NCT03658304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24884736|NCT03642028|Suvorexant|suvorexant|mesh-list
24884737|NCT03642028|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24884738|NCT03642028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24884739|NCT03642028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24884740|NCT03642028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884741|NCT03642028|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
24884742|NCT03642028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24884743|NCT03642028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884744|NCT03636451|Lidocaine|lidocaine|mesh-list
24508493|NCT00555984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
24508494|NCT00555984|Anesthetics|anesthetics|mesh-list
24508495|NCT00555984|Sevoflurane|sevoflurane|mesh-list
24508496|NCT00555984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24508497|NCT00555984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24508498|NCT00555984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508508|NCT00556023|Tremelimumab|tremelimumab|mesh-list
24508509|NCT00556023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24508510|NCT00556023|Antimetabolites|antimetabolites|mesh-ancestor
24508511|NCT00556023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508512|NCT00556023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24884786|NCT03571334|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24884787|NCT03571334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24884788|NCT03571334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24884789|NCT03571334|Cholinergic Agents|cholinergic agents|mesh-ancestor
24884790|NCT03571334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24884808|NCT03460015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24884809|NCT03460015|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24884810|NCT03460015|Anesthetics, General|anesthetics, general|mesh-ancestor
24884811|NCT03460015|Anesthetics|anesthetics|mesh-ancestor
24508624|NCT00556270|Sensory System Agents|sensory system agents|mesh-ancestor
24508625|NCT00556270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24508626|NCT00556270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24508627|NCT00556270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24508628|NCT00556270|Anesthetics, General|anesthetics, general|mesh-ancestor
24508629|NCT00556270|Anesthetics|anesthetics|mesh-ancestor
24884816|NCT03459859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24513241|NCT00580112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24513242|NCT00580112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24884817|NCT03459859|Antimetabolites|antimetabolites|mesh-ancestor
24884818|NCT03459859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713856|NCT02347085|Respiratory System Agents|respiratory system agents|mesh-ancestor
25713857|NCT02347085|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25713858|NCT02347085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25713859|NCT02347085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25713860|NCT02347085|Adrenergic Agents|adrenergic agents|mesh-ancestor
25713861|NCT02347085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24884819|NCT03459859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24884820|NCT03459859|Antiviral Agents|antiviral agents|mesh-ancestor
24884821|NCT03459859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24472940|NCT00401206|Dexmedetomidine|dexmedetomidine|mesh-list
24472941|NCT00401206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24472942|NCT00401206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24472943|NCT00401206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472944|NCT00401206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24508794|NCT00557102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24508795|NCT00557102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24508796|NCT00557102|Antidotes|antidotes|mesh-ancestor
24508810|NCT00557180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24508811|NCT00557180|Respiratory System Agents|respiratory system agents|mesh-ancestor
24508812|NCT00557180|Parasympatholytics|parasympatholytics|mesh-ancestor
24508813|NCT00557180|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24508814|NCT00557180|Cholinergic Agents|cholinergic agents|mesh-ancestor
24508815|NCT00557180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24884876|NCT03339284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24884877|NCT03339284|Sensory System Agents|sensory system agents|mesh-ancestor
24884878|NCT03339284|Protease Inhibitors|protease inhibitors|mesh-ancestor
24884879|NCT03339284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24884880|NCT03339284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463932|NCT00362765|Metformin|metformin|mesh-list
24513342|NCT00580814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24508951|NCT00557921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24508952|NCT00557921|Analgesics|analgesics|mesh-ancestor
24508964|NCT00557921|Antipyretics|antipyretics|mesh-ancestor
24612385|NCT01013584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612386|NCT01013584|Vitamins|vitamins|mesh-ancestor
24612388|NCT01013584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24623452|NCT01071499|Sensory System Agents|sensory system agents|mesh-ancestor
24623453|NCT01071499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24623455|NCT01071525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24623456|NCT01071525|Antimetabolites|antimetabolites|mesh-ancestor
24623457|NCT01071525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24463968|NCT00362895|BB 1101|bb 1101|mesh-list
24509085|NCT00558337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24509086|NCT00558337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24509087|NCT00558337|Immunologic Factors|immunologic factors|mesh-ancestor
24509088|NCT00558337|Dopamine Agonists|dopamine agonists|mesh-ancestor
24509089|NCT00558376|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24509090|NCT00558376|Laxatives|laxatives|mesh-ancestor
24509091|NCT00558376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24509092|NCT00558454|Ferrous succinate|ferrous succinate|mesh-list
24509093|NCT00558454|Hematinics|hematinics|mesh-ancestor
24509094|NCT00558480|Vitamins|vitamins|mesh-list
24509095|NCT00558480|Vitamin A|vitamin a|mesh-list
24509099|NCT00558480|Antioxidants|antioxidants|mesh-ancestor
24509123|NCT00558662|Antifungal Agents|antifungal agents|mesh-ancestor
24509124|NCT00558662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24509125|NCT00558662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24509152|NCT00559026|Dacarbazine|dacarbazine|mesh-list
24509153|NCT00559026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24509154|NCT00559026|Alkylating Agents|alkylating agents|mesh-ancestor
24509155|NCT00559026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509156|NCT00559026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509157|NCT00559052|Pancrelipase|pancrelipase|mesh-list
24509181|NCT00559286|Telmisartan|telmisartan|mesh-list
24509182|NCT00559286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24509183|NCT00559286|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24509184|NCT00559286|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24509185|NCT00559286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509186|NCT00559312|Fluticasone|fluticasone|mesh-list
24509187|NCT00559312|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24509188|NCT00559312|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24509189|NCT00559312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24509190|NCT00559312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24509191|NCT00559312|Autonomic Agents|autonomic agents|mesh-ancestor
24509192|NCT00559312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24509193|NCT00559312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509194|NCT00559312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24623473|NCT01071655|Immunologic Factors|immunologic factors|mesh-ancestor
24884937|NCT03193333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24884938|NCT03193333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24884940|NCT03193333|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24509306|NCT00559676|Vitamins|vitamins|mesh-ancestor
24509335|NCT00559741|Cetuximab|cetuximab|mesh-list
24509336|NCT00559741|Calcium|calcium|mesh-list
24509337|NCT00559741|Levoleucovorin|levoleucovorin|mesh-list
24509338|NCT00559741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24509339|NCT00559741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509340|NCT00559741|Antimetabolites|antimetabolites|mesh-ancestor
24509341|NCT00559741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509342|NCT00559741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24509343|NCT00559741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509344|NCT00559741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24509345|NCT00559741|Immunologic Factors|immunologic factors|mesh-ancestor
24509346|NCT00559741|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24509363|NCT00559975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509364|NCT00560079|Allopurinol|allopurinol|mesh-list
24509365|NCT00560079|Dipyridamole|dipyridamole|mesh-list
24509366|NCT00560079|Antimetabolites|antimetabolites|mesh-ancestor
24884976|NCT03030235|Dapagliflozin|dapagliflozin|mesh-list
24509498|NCT00560586|Autonomic Agents|autonomic agents|mesh-ancestor
24509499|NCT00560586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24509500|NCT00560586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509501|NCT00560586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24509502|NCT00560586|Respiratory System Agents|respiratory system agents|mesh-ancestor
24509503|NCT00560586|Glucocorticoids|glucocorticoids|mesh-ancestor
24509504|NCT00560586|Hormones|hormones|mesh-ancestor
24509508|NCT00560599|Mupirocin|mupirocin|mesh-list
24885056|NCT02728752|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24885057|NCT02728752|Immunologic Factors|immunologic factors|mesh-ancestor
24885058|NCT02728752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885059|NCT02710331|Ethanol|ethanol|mesh-list
24885060|NCT02710331|Dronabinol|dronabinol|mesh-list
24509551|NCT00561054|Cetuximab|cetuximab|mesh-list
24509558|NCT00561067|Prednisolone acetate|prednisolone acetate|mesh-list
24509559|NCT00561067|Epoetin Alfa|epoetin alfa|mesh-list
24509560|NCT00561067|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24509561|NCT00561067|Prednisolone phosphate|prednisolone phosphate|mesh-list
24509562|NCT00561067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24509563|NCT00561067|Antiemetics|antiemetics|mesh-ancestor
24509564|NCT00561067|Autonomic Agents|autonomic agents|mesh-ancestor
24509565|NCT00561067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24509627|NCT00561197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24509628|NCT00561197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24509754|NCT00562055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509815|NCT00562198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713862|NCT02347085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713863|NCT02347085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25713864|NCT02347085|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24509816|NCT00562198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509817|NCT00562198|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24509831|NCT00562250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24509832|NCT00562250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509833|NCT00562250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24509834|NCT00562250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24509835|NCT00562250|Immunologic Factors|immunologic factors|mesh-ancestor
24509836|NCT00562289|Aspirin|aspirin|mesh-list
24509837|NCT00562289|Dipyridamole|dipyridamole|mesh-list
24509838|NCT00562289|Rivaroxaban|rivaroxaban|mesh-list
24509839|NCT00562289|Apixaban|apixaban|mesh-list
24509840|NCT00562289|Dabigatran|dabigatran|mesh-list
24509841|NCT00562289|Antivitamins K|antivitamins k|mesh-list
24509842|NCT00562289|Clopidogrel|clopidogrel|mesh-list
24509843|NCT00562289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24509844|NCT00562289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24509845|NCT00562289|Analgesics|analgesics|mesh-ancestor
24509846|NCT00562289|Sensory System Agents|sensory system agents|mesh-ancestor
24509847|NCT00562289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24509848|NCT00562289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885137|NCT02346630|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24885138|NCT02346630|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24885139|NCT02346630|Dopamine Agents|dopamine agents|mesh-ancestor
24885140|NCT02346630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24510027|NCT00563147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24510028|NCT00563147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24510029|NCT00563147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510030|NCT00563147|Antifungal Agents|antifungal agents|mesh-ancestor
24510031|NCT00563147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24510032|NCT00563147|Immunologic Factors|immunologic factors|mesh-ancestor
24510033|NCT00563147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510034|NCT00563160|Gemcitabine|gemcitabine|mesh-list
24510035|NCT00563160|Carboplatin|carboplatin|mesh-list
24510036|NCT00563160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24443939|NCT00296309|Tacrolimus|tacrolimus|mesh-list
24510049|NCT00563212|Antiviral Agents|antiviral agents|mesh-ancestor
24510050|NCT00563212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24510071|NCT00563303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24510072|NCT00563342|Ethanol|ethanol|mesh-list
24510148|NCT00563589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24510149|NCT00563589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24510150|NCT00563589|Antifungal Agents|antifungal agents|mesh-ancestor
24510151|NCT00563589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24510152|NCT00563589|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24510153|NCT00563589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24510154|NCT00563589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25713865|NCT02347085|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25713866|NCT02347085|Cholinergic Agents|cholinergic agents|mesh-ancestor
25713867|NCT02347098|Atorvastatin|atorvastatin|mesh-list
25713868|NCT02347098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
24510155|NCT00563589|Antitubercular Agents|antitubercular agents|mesh-ancestor
24510156|NCT00563589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24510157|NCT00563615|Tegaserod|tegaserod|mesh-list
24510158|NCT00563615|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24510159|NCT00563615|Serotonin Agents|serotonin agents|mesh-ancestor
24510160|NCT00563615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24510161|NCT00563615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510201|NCT00563862|Immunologic Factors|immunologic factors|mesh-ancestor
24510202|NCT00563862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510312|NCT00564200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24510315|NCT00564200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24510316|NCT00564200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510317|NCT00564200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24510318|NCT00564200|Glucocorticoids|glucocorticoids|mesh-ancestor
24510319|NCT00564200|Hormones|hormones|mesh-ancestor
24510320|NCT00564200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24510321|NCT00564200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24510322|NCT00564200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510323|NCT00564200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885216|NCT01481272|Antimetabolites|antimetabolites|mesh-ancestor
24887884|NCT04511000|Antimetabolites|antimetabolites|mesh-ancestor
24510364|NCT00564408|Sensory System Agents|sensory system agents|mesh-ancestor
24510366|NCT00564460|Finasteride|finasteride|mesh-list
24510367|NCT00564460|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24510368|NCT00564460|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24510369|NCT00564460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510370|NCT00564460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510433|NCT00564590|Melatonin|melatonin|mesh-list
24510434|NCT00564590|Omeprazole|omeprazole|mesh-list
24510435|NCT00564590|Antioxidants|antioxidants|mesh-ancestor
24510436|NCT00564590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510437|NCT00564590|Protective Agents|protective agents|mesh-ancestor
24510438|NCT00564590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510439|NCT00564590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24510440|NCT00564590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24510441|NCT00564590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24510442|NCT00564590|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24885267|NCT01123707|Citalopram|citalopram|mesh-list
24510472|NCT00564642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510483|NCT00564655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24510484|NCT00564655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24510485|NCT00564655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24510486|NCT00564655|Adrenergic Agents|adrenergic agents|mesh-ancestor
24510487|NCT00564655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24510488|NCT00564655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510489|NCT00564655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24510490|NCT00564655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24510491|NCT00564655|Autonomic Agents|autonomic agents|mesh-ancestor
24510505|NCT00564707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24885278|NCT01123707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24885279|NCT01123707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24510534|NCT00564772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24510535|NCT00564772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24510536|NCT00564772|Antiviral Agents|antiviral agents|mesh-ancestor
24510537|NCT00564772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24510541|NCT00564772|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24510616|NCT00565175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510617|NCT00565175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510618|NCT00565188|Adenosine|adenosine|mesh-list
24510619|NCT00565188|Analgesics|analgesics|mesh-ancestor
24510620|NCT00565188|Sensory System Agents|sensory system agents|mesh-ancestor
24510621|NCT00565188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24510622|NCT00565188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510623|NCT00565188|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24885314|NCT00725127|Antipyretics|antipyretics|mesh-ancestor
24510666|NCT00565240|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24510668|NCT00565240|Hormones|hormones|mesh-ancestor
24510669|NCT00565253|Nitric Oxide|nitric oxide|mesh-list
24510670|NCT00565253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24510671|NCT00565253|Autonomic Agents|autonomic agents|mesh-ancestor
24510672|NCT00565253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24510677|NCT00565253|Antioxidants|antioxidants|mesh-ancestor
24510754|NCT00565500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510755|NCT00565500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24510756|NCT00565500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24510758|NCT00565500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510759|NCT00565500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510760|NCT00565500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24510775|NCT00565591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24510776|NCT00565591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24510777|NCT00565591|Adrenergic Agents|adrenergic agents|mesh-ancestor
24510778|NCT00565591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24510779|NCT00565591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510794|NCT00565630|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24510795|NCT00565630|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24510921|NCT00566644|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24510922|NCT00566644|Contraceptive Agents|contraceptive agents|mesh-ancestor
24510923|NCT00566644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24510924|NCT00566644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510925|NCT00566644|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24510926|NCT00566644|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24885458|NCT05172518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510970|NCT00566800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24510971|NCT00566800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510972|NCT00566800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24510973|NCT00566800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510975|NCT00566865|Gemfibrozil|gemfibrozil|mesh-list
24816435|NCT02076893|Narcotics|narcotics|mesh-ancestor
24816436|NCT02076945|Lidocaine|lidocaine|mesh-list
24816437|NCT02076945|Bupivacaine|bupivacaine|mesh-list
24816438|NCT02076945|Anesthetics, Local|anesthetics, local|mesh-ancestor
24885500|NCT05171985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24885501|NCT05171985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24885502|NCT05171985|Adrenergic Agents|adrenergic agents|mesh-ancestor
24885503|NCT05171985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24885504|NCT05171985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885505|NCT05171946|Vaccines|vaccines|mesh-list
24885506|NCT05171946|Immunologic Factors|immunologic factors|mesh-ancestor
24885507|NCT05171946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885508|NCT05171751|Octreotide|octreotide|mesh-list
24885509|NCT05171751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24885510|NCT05171751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24885543|NCT05151588|Fluorouracil|fluorouracil|mesh-list
24885544|NCT05151588|Cisplatin|cisplatin|mesh-list
24885545|NCT05151588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511037|NCT00567099|Aripiprazole|aripiprazole|mesh-list
24511059|NCT00567177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24511061|NCT00567177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511062|NCT00567177|Antifungal Agents|antifungal agents|mesh-ancestor
24511063|NCT00567177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24511064|NCT00567177|Dermatologic Agents|dermatologic agents|mesh-ancestor
24885668|NCT04947072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885669|NCT04942158|Eugenol|eugenol|mesh-list
24885670|NCT04942158|Zinc Oxide|zinc oxide|mesh-list
24885671|NCT04942158|Dermatologic Agents|dermatologic agents|mesh-ancestor
24885679|NCT04941703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24885680|NCT04911166|Atezolizumab|atezolizumab|mesh-list
24885681|NCT04911166|Interleukin-12|interleukin-12|mesh-list
24885682|NCT04911166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885683|NCT04911166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24885684|NCT04911166|Immunologic Factors|immunologic factors|mesh-ancestor
24885685|NCT04911166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885686|NCT04911166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24885687|NCT04911166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24885688|NCT04911166|Growth Substances|growth substances|mesh-ancestor
24885689|NCT04911166|Growth Inhibitors|growth inhibitors|mesh-ancestor
24511109|NCT00567463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24511110|NCT00567463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511111|NCT00567463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24511112|NCT00567463|Respiratory System Agents|respiratory system agents|mesh-ancestor
24511113|NCT00567463|Dermatologic Agents|dermatologic agents|mesh-ancestor
24511114|NCT00567463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24511116|NCT00567528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24511117|NCT00567528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24511118|NCT00567528|Analgesics|analgesics|mesh-ancestor
24511119|NCT00567528|Sensory System Agents|sensory system agents|mesh-ancestor
24511120|NCT00567528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24885745|NCT04652206|Antimetabolites|antimetabolites|mesh-ancestor
24511173|NCT00567697|Ranibizumab|ranibizumab|mesh-list
24511174|NCT00567697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24511175|NCT00567697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24511176|NCT00567697|Growth Substances|growth substances|mesh-ancestor
24511177|NCT00567697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511178|NCT00567697|Growth Inhibitors|growth inhibitors|mesh-ancestor
24511179|NCT00567697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511180|NCT00567710|Risperidone|risperidone|mesh-list
24885765|NCT04647903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24885766|NCT04647903|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24885768|NCT04632264|Oxytocics|oxytocics|mesh-ancestor
24885830|NCT04448717|Immunologic Factors|immunologic factors|mesh-ancestor
24885831|NCT04448717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885832|NCT04436965|Cisplatin|cisplatin|mesh-list
24885833|NCT04436965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24885834|NCT04420741|Iloprost|iloprost|mesh-list
24885835|NCT04420741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24816440|NCT02076945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24816441|NCT02076945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816442|NCT02076945|Sensory System Agents|sensory system agents|mesh-ancestor
24816444|NCT02076945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24816450|NCT02077010|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25713869|NCT02347098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24816451|NCT02077010|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24816452|NCT02077010|Vasodilator Agents|vasodilator agents|mesh-ancestor
24464796|NCT00366834|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24511192|NCT00567762|Tacrolimus|tacrolimus|mesh-list
24464826|NCT00367068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24464827|NCT00367068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464828|NCT00367081|Pyrimethamine|pyrimethamine|mesh-list
24816513|NCT02077556|Everolimus|everolimus|mesh-list
24816514|NCT02077556|Tacrolimus|tacrolimus|mesh-list
24816515|NCT02077556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24816516|NCT02077556|Immunologic Factors|immunologic factors|mesh-ancestor
24816517|NCT02077556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24885875|NCT04282239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24885876|NCT04282239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24885877|NCT04282239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24885878|NCT04282239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24885879|NCT04282239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24885881|NCT04282239|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24885882|NCT04282239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24511195|NCT00567762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511197|NCT00567762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24511198|NCT00567762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511199|NCT00567775|Insulin|insulin|mesh-list
24511200|NCT00567775|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24511201|NCT00567775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24511202|NCT00567775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464868|NCT00367185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24464897|NCT00367250|Cetuximab|cetuximab|mesh-list
24464899|NCT00367250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24464900|NCT00367263|Ciclesonide|ciclesonide|mesh-list
24464901|NCT00367263|Glucocorticoids|glucocorticoids|mesh-ancestor
24464902|NCT00367263|Hormones|hormones|mesh-ancestor
24464903|NCT00367263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24464904|NCT00367263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24464905|NCT00367263|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24464906|NCT00367276|Drospirenone|drospirenone|mesh-list
24886139|NCT02997358|Alkylating Agents|alkylating agents|mesh-ancestor
24886140|NCT02963610|Pembrolizumab|pembrolizumab|mesh-list
24886157|NCT02945800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886158|NCT02945800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24886159|NCT02945800|Antimetabolites|antimetabolites|mesh-ancestor
24886160|NCT02945800|Antiviral Agents|antiviral agents|mesh-ancestor
24886161|NCT02945800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24886162|NCT02945800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886163|NCT02945800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24886164|NCT02945800|Immunologic Factors|immunologic factors|mesh-ancestor
24886165|NCT02945800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886166|NCT02903160|Prednisone|prednisone|mesh-list
24886167|NCT02903160|Carboplatin|carboplatin|mesh-list
24886168|NCT02903160|Abiraterone Acetate|abiraterone acetate|mesh-list
24886169|NCT02903160|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
24886171|NCT02903160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24511442|NCT00568737|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
24511443|NCT00568737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24511445|NCT00568750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511446|NCT00568750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24511447|NCT00568750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886203|NCT02766335|Antimitotic Agents|antimitotic agents|mesh-ancestor
24886204|NCT02766335|Mitosis Modulators|mitosis modulators|mesh-ancestor
24886205|NCT02766335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886206|NCT02766335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25713870|NCT02347098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24886207|NCT02766335|Immunologic Factors|immunologic factors|mesh-ancestor
25713871|NCT02347098|Antimetabolites|antimetabolites|mesh-ancestor
25713872|NCT02347098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713873|NCT02347098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25713874|NCT02347098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713875|NCT02347176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25713876|NCT02347176|Immunologic Factors|immunologic factors|mesh-ancestor
24511516|NCT00569296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24511517|NCT00569296|Antiviral Agents|antiviral agents|mesh-ancestor
24511518|NCT00569296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24511519|NCT00569335|Bevacizumab|bevacizumab|mesh-list
24511520|NCT00569335|Irinotecan|irinotecan|mesh-list
24511521|NCT00569335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24511522|NCT00569335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24511523|NCT00569335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24511524|NCT00569335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24511525|NCT00569335|Growth Substances|growth substances|mesh-ancestor
24464993|NCT00367497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24511602|NCT00569790|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24511603|NCT00569790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24511604|NCT00569790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24511605|NCT00569790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511607|NCT00569816|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24511631|NCT00569920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511632|NCT00569920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24511633|NCT00569920|Glucocorticoids|glucocorticoids|mesh-ancestor
24511634|NCT00569920|Hormones|hormones|mesh-ancestor
24886239|NCT02432378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24886240|NCT02432378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24886241|NCT02432378|Analgesics|analgesics|mesh-ancestor
24886242|NCT02432378|Sensory System Agents|sensory system agents|mesh-ancestor
24886243|NCT02432378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24886244|NCT02432378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24886245|NCT02432378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24511770|NCT00570856|Vitamin B Complex|vitamin b complex|mesh-ancestor
24511771|NCT00570856|Vitamins|vitamins|mesh-ancestor
24511772|NCT00570856|Micronutrients|micronutrients|mesh-ancestor
24610950|NCT01005784|Cetrorelix|cetrorelix|mesh-list
24511773|NCT00570856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511774|NCT00570882|Sunitinib|sunitinib|mesh-list
24511775|NCT00570882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24886272|NCT02090998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24886274|NCT02090998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24886275|NCT02051309|Guanfacine|guanfacine|mesh-list
24886297|NCT01595061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886298|NCT01595061|Antiviral Agents|antiviral agents|mesh-ancestor
24886299|NCT01595061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24886300|NCT01595061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24886301|NCT01595061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24886302|NCT01595061|Immunologic Factors|immunologic factors|mesh-ancestor
24511852|NCT00571246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24886493|NCT04525495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24886494|NCT04525495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886495|NCT04525495|Dopamine Agents|dopamine agents|mesh-ancestor
24886496|NCT04525495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24886569|NCT04525274|Sensory System Agents|sensory system agents|mesh-ancestor
24886570|NCT04525274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24886571|NCT04525274|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24886572|NCT04525274|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24886573|NCT04525274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24886574|NCT04525274|Adrenergic Agents|adrenergic agents|mesh-ancestor
24886575|NCT04525274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24886576|NCT04525274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816529|NCT02077556|Autonomic Agents|autonomic agents|mesh-ancestor
24816530|NCT02077556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24816550|NCT02077634|Hormone Antagonists|hormone antagonists|mesh-ancestor
24816551|NCT02077634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24816552|NCT02077712|Dexmedetomidine|dexmedetomidine|mesh-list
24816553|NCT02077712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24816554|NCT02077712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24816555|NCT02077712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816556|NCT02077712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24816557|NCT02077712|Analgesics|analgesics|mesh-ancestor
24816558|NCT02077712|Sensory System Agents|sensory system agents|mesh-ancestor
24816559|NCT02077712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24886890|NCT04522037|Narcotics|narcotics|mesh-ancestor
24886948|NCT04521751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886949|NCT04521751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24886950|NCT04521751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24886951|NCT04521751|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24886952|NCT04521751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24886953|NCT04521517|Imidacloprid|imidacloprid|mesh-list
24886954|NCT04521517|Cholinergic Agents|cholinergic agents|mesh-ancestor
24886955|NCT04521517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24886956|NCT04521517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24886984|NCT04521140|Dexamethasone|dexamethasone|mesh-list
24886985|NCT04521140|Prednisolone|prednisolone|mesh-list
24886986|NCT04521140|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24886987|NCT04521140|Methylprednisolone|methylprednisolone|mesh-list
24886988|NCT04521140|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24887098|NCT04520178|Dopamine Agents|dopamine agents|mesh-ancestor
24887099|NCT04520178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24887100|NCT04520178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887101|NCT04520178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887102|NCT04520178|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
24887103|NCT04520178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887104|NCT04520178|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24887105|NCT04520178|Antidepressive Agents|antidepressive agents|mesh-ancestor
24887106|NCT04520178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24887107|NCT04520126|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
24887108|NCT04520126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24887109|NCT04520126|Antioxidants|antioxidants|mesh-ancestor
24887110|NCT04520126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887111|NCT04520126|Protective Agents|protective agents|mesh-ancestor
24887114|NCT04520139|Acetylcysteine|acetylcysteine|mesh-list
24887446|NCT04516174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24887447|NCT04516174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24887448|NCT04516174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24887449|NCT04516174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24887451|NCT04516174|Sensory System Agents|sensory system agents|mesh-ancestor
24887452|NCT04516174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24887453|NCT04516174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24887454|NCT04516174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24887455|NCT04516174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24887456|NCT04516174|Adrenergic Agents|adrenergic agents|mesh-ancestor
24887457|NCT04516174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24887458|NCT04516174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887459|NCT04516174|Anesthetics, Local|anesthetics, local|mesh-ancestor
24887460|NCT04516174|Anesthetics|anesthetics|mesh-ancestor
24887461|NCT04516395|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24887462|NCT04516395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24887463|NCT04516395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24887482|NCT04515966|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24887483|NCT04515966|Prednisolone|prednisolone|mesh-list
24887484|NCT04515966|Prednisolone acetate|prednisolone acetate|mesh-list
24887485|NCT04515966|Lidocaine|lidocaine|mesh-list
24887486|NCT04515966|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24887616|NCT04514094|Fluorides|fluorides|mesh-list
24512526|NCT00575523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512528|NCT00575549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24512529|NCT00575549|Sympathomimetics|sympathomimetics|mesh-ancestor
24512530|NCT00575549|Autonomic Agents|autonomic agents|mesh-ancestor
24512531|NCT00575549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713877|NCT02347176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713879|NCT02347332|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25713880|NCT02347332|Abortifacient Agents|abortifacient agents|mesh-ancestor
25713881|NCT02347332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25713882|NCT02347332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713883|NCT02347332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24512532|NCT00575549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512533|NCT00575549|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24512548|NCT00575614|Prucalopride|prucalopride|mesh-list
24887684|NCT04513509|Propranolol|propranolol|mesh-list
24887685|NCT04513509|Metoprolol|metoprolol|mesh-list
24887686|NCT04513509|Digoxin|digoxin|mesh-list
24887687|NCT04513509|Atenolol|atenolol|mesh-list
24887688|NCT04513509|Verapamil|verapamil|mesh-list
24887689|NCT04513509|Nebivolol|nebivolol|mesh-list
24512565|NCT00575627|Antimetabolites|antimetabolites|mesh-ancestor
24887783|NCT04512404|Antimetabolites|antimetabolites|mesh-ancestor
24887866|NCT04511468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816635|NCT02078063|Sensory System Agents|sensory system agents|mesh-ancestor
24887867|NCT04511468|Protective Agents|protective agents|mesh-ancestor
24887868|NCT04511468|Trace Elements|trace elements|mesh-ancestor
24887869|NCT04511611|Rivaroxaban|rivaroxaban|mesh-list
24465938|NCT00371124|Mydriatics|mydriatics|mesh-ancestor
24887870|NCT04511611|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24887871|NCT04511611|Antithrombins|antithrombins|mesh-ancestor
24887872|NCT04511611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24887873|NCT04511611|Protease Inhibitors|protease inhibitors|mesh-ancestor
24887874|NCT04511611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24887875|NCT04511611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887876|NCT04511611|Anticoagulants|anticoagulants|mesh-ancestor
24887878|NCT04511299|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24887879|NCT04511299|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24887880|NCT04511299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24887881|NCT04511000|Atorvastatin|atorvastatin|mesh-list
24887882|NCT04511000|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24887883|NCT04511000|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24887885|NCT04511000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887887|NCT04511000|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24512567|NCT00575627|Immunologic Factors|immunologic factors|mesh-ancestor
24512568|NCT00575627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512569|NCT00575640|Hydralazine|hydralazine|mesh-list
24887899|NCT04511195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24887900|NCT04511195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24512607|NCT00575861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24512608|NCT00575861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512609|NCT00575861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24512610|NCT00575861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24512611|NCT00575861|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24887919|NCT04510649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24887920|NCT04510649|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24887921|NCT04510649|Antitubercular Agents|antitubercular agents|mesh-ancestor
24887922|NCT04510649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24887923|NCT04510649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24887924|NCT04510649|Leprostatic Agents|leprostatic agents|mesh-ancestor
24887925|NCT04510649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24887926|NCT04510649|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24887927|NCT04510649|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24887932|NCT04510818|Capecitabine|capecitabine|mesh-list
24816679|NCT02078336|Lorazepam|lorazepam|mesh-list
24816680|NCT02078336|Biperiden|biperiden|mesh-list
24816681|NCT02078336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24816682|NCT02078336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24816683|NCT02078336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24466035|NCT00371592|Acyclovir|acyclovir|mesh-list
24816688|NCT02078336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24816689|NCT02078336|Anesthetics, General|anesthetics, general|mesh-ancestor
24816690|NCT02078336|Anesthetics|anesthetics|mesh-ancestor
24512646|NCT00576017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24512672|NCT00576069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24512673|NCT00576069|Autonomic Agents|autonomic agents|mesh-ancestor
24512674|NCT00576069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713884|NCT02347332|Antimetabolites|antimetabolites|mesh-ancestor
25713885|NCT02347332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713886|NCT02347332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713887|NCT02347332|Dermatologic Agents|dermatologic agents|mesh-ancestor
25713888|NCT02347332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512685|NCT00576069|Sympathomimetics|sympathomimetics|mesh-ancestor
24512688|NCT00576173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24512689|NCT00576173|Analgesics|analgesics|mesh-ancestor
24512690|NCT00576173|Sensory System Agents|sensory system agents|mesh-ancestor
24512691|NCT00576173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24512692|NCT00576173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512693|NCT00576173|Antipyretics|antipyretics|mesh-ancestor
24512694|NCT00576173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24512695|NCT00576173|Narcotics|narcotics|mesh-ancestor
24512696|NCT00576173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24512698|NCT00576225|Carboplatin|carboplatin|mesh-list
24512699|NCT00576225|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
24887955|NCT04510220|Ofatumumab|ofatumumab|mesh-list
24887956|NCT04510220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24887957|NCT04510337|Magnesium Sulfate|magnesium sulfate|mesh-list
24887958|NCT04510337|Rocuronium|rocuronium|mesh-list
24887959|NCT04510337|Analgesics|analgesics|mesh-ancestor
24887960|NCT04510337|Sensory System Agents|sensory system agents|mesh-ancestor
24512722|NCT00576329|Sensory System Agents|sensory system agents|mesh-ancestor
24512723|NCT00576329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24888105|NCT04509258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24888107|NCT04509258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24888109|NCT04509258|Respiratory System Agents|respiratory system agents|mesh-ancestor
24888110|NCT04509258|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24888112|NCT04509258|Protective Agents|protective agents|mesh-ancestor
24888113|NCT04509258|Antidotes|antidotes|mesh-ancestor
24888114|NCT04509258|Vitamin B Complex|vitamin b complex|mesh-ancestor
24888115|NCT04509258|Vitamins|vitamins|mesh-ancestor
24516364|NCT00601666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888191|NCT04508400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24888192|NCT04508400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24888193|NCT04508400|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24888194|NCT04508400|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24888195|NCT04508452|Bevacizumab|bevacizumab|mesh-list
24888196|NCT04508452|Capecitabine|capecitabine|mesh-list
24888197|NCT04508452|Oxaliplatin|oxaliplatin|mesh-list
24888198|NCT04508452|Irinotecan|irinotecan|mesh-list
24888200|NCT04508452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24888287|NCT04507165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24888288|NCT04507165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512729|NCT00576329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713889|NCT02347332|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25713890|NCT02347332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25713891|NCT02347332|Immunologic Factors|immunologic factors|mesh-ancestor
25713892|NCT02347332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24888338|NCT04506125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24888339|NCT04506125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24888340|NCT04506242|Apatinib|apatinib|mesh-list
24888341|NCT04506242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713893|NCT02347332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25713894|NCT02347345|Sofosbuvir|sofosbuvir|mesh-list
24888342|NCT04506242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24888343|NCT04506242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24888344|NCT04506242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888345|NCT04505904|Oxytocin|oxytocin|mesh-list
24888346|NCT04505904|Oxytocics|oxytocics|mesh-ancestor
24888347|NCT04505904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24888348|NCT04505904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888349|NCT04505943|Isoniazid|isoniazid|mesh-list
24888374|NCT04505995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24888375|NCT04505514|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
24888376|NCT04505514|Hematinics|hematinics|mesh-ancestor
24888377|NCT04505644|Lidocaine|lidocaine|mesh-list
24888378|NCT04505644|Anesthetics, Local|anesthetics, local|mesh-ancestor
24888440|NCT04505228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24888441|NCT04505228|Autonomic Agents|autonomic agents|mesh-ancestor
24888442|NCT04505228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24888443|NCT04505228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888444|NCT04505228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24888445|NCT04505228|Respiratory System Agents|respiratory system agents|mesh-ancestor
24888446|NCT04505228|Mydriatics|mydriatics|mesh-ancestor
24888461|NCT04504851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24888462|NCT04504851|Antimetabolites|antimetabolites|mesh-ancestor
24888718|NCT04501250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24888719|NCT04501250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24888772|NCT04500743|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24888774|NCT04500743|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24888775|NCT04500743|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24888776|NCT04500743|Hormone Antagonists|hormone antagonists|mesh-ancestor
24888777|NCT04500743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24888778|NCT04500522|Isoniazid|isoniazid|mesh-list
24888779|NCT04500522|Antitubercular Agents|antitubercular agents|mesh-ancestor
24888855|NCT04500002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24888856|NCT04499742|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
24888857|NCT04499742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24888858|NCT04499742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24888860|NCT04499898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24888861|NCT04499898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24888862|NCT04499898|Adrenergic Agents|adrenergic agents|mesh-ancestor
24888863|NCT04499898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24512784|NCT00576615|Propofol|propofol|mesh-list
24512785|NCT00576615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24512786|NCT00576615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24512787|NCT00576615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512788|NCT00576615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24512828|NCT00577018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512829|NCT00577018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512831|NCT00577057|Capecitabine|capecitabine|mesh-list
24512832|NCT00577057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512833|NCT00577057|Antimetabolites|antimetabolites|mesh-ancestor
24512834|NCT00577057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512835|NCT00577057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24512836|NCT00577057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24512837|NCT00577057|Immunologic Factors|immunologic factors|mesh-ancestor
24889142|NCT04496921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889143|NCT04496921|Hemostatics|hemostatics|mesh-ancestor
24889144|NCT04496921|Coagulants|coagulants|mesh-ancestor
24889146|NCT04496882|Antiviral Agents|antiviral agents|mesh-ancestor
24889147|NCT04496882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24889204|NCT04495881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889206|NCT04495933|MF59 oil emulsion|mf59 oil emulsion|mesh-list
24889207|NCT04495933|Immunologic Factors|immunologic factors|mesh-ancestor
24889208|NCT04495933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889209|NCT04495933|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24889211|NCT04496024|Levofloxacin|levofloxacin|mesh-list
24889212|NCT04496024|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24889213|NCT04496024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24889214|NCT04496024|Renal Agents|renal agents|mesh-ancestor
24889215|NCT04496024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24889216|NCT04496024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25713895|NCT02347345|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
24889217|NCT04496024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24889218|NCT04496024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512999|NCT00578097|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24513000|NCT00578097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24513001|NCT00578097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24513011|NCT00578149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24683626|NCT01393145|Hormones|hormones|mesh-ancestor
24513012|NCT00578149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513013|NCT00578149|Tubulin Modulators|tubulin modulators|mesh-ancestor
24513014|NCT00578149|Antimitotic Agents|antimitotic agents|mesh-ancestor
24513015|NCT00578149|Mitosis Modulators|mitosis modulators|mesh-ancestor
24513016|NCT00578149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513017|NCT00578149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24513018|NCT00578149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24612837|NCT01015495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24612838|NCT01015495|Growth Substances|growth substances|mesh-ancestor
24612839|NCT01015495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612840|NCT01015495|Growth Inhibitors|growth inhibitors|mesh-ancestor
24612841|NCT01015495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513029|NCT00578266|Immunologic Factors|immunologic factors|mesh-ancestor
24513030|NCT00578266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513031|NCT00578266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24513032|NCT00578266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24513044|NCT00578370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24513045|NCT00578370|Immunologic Factors|immunologic factors|mesh-ancestor
24513046|NCT00578370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513048|NCT00578370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24513049|NCT00578370|Dermatologic Agents|dermatologic agents|mesh-ancestor
24513050|NCT00578370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24513051|NCT00578370|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24513052|NCT00578370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24513053|NCT00578370|Glucocorticoids|glucocorticoids|mesh-ancestor
24513054|NCT00578370|Hormones|hormones|mesh-ancestor
24513055|NCT00578370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24889405|NCT04493489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24889406|NCT04493489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889407|NCT04493489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889411|NCT04493528|Lidocaine|lidocaine|mesh-list
24889555|NCT04492358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24889556|NCT04492358|Tubulin Modulators|tubulin modulators|mesh-ancestor
24889557|NCT04492358|Antimitotic Agents|antimitotic agents|mesh-ancestor
24467240|NCT00376701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24467241|NCT00376701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24513129|NCT00578825|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24513130|NCT00578825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24513131|NCT00578825|Antimetabolites|antimetabolites|mesh-ancestor
24623566|NCT01072240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24623568|NCT01072318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623569|NCT01072318|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24623570|NCT01072318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24712299|NCT01519687|Tofisopam|tofisopam|mesh-list
24889803|NCT04489797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24889900|NCT04488601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24889901|NCT04488601|Antifungal Agents|antifungal agents|mesh-ancestor
24889902|NCT04488601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25713896|NCT02347345|Ledipasvir|ledipasvir|mesh-list
25713897|NCT02347345|Antiviral Agents|antiviral agents|mesh-ancestor
25713898|NCT02347345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25713899|NCT02347605|Nicotine|nicotine|mesh-list
25713900|NCT02347605|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25713901|NCT02347605|Autonomic Agents|autonomic agents|mesh-ancestor
25713902|NCT02347605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713903|NCT02347605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713904|NCT02347605|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25713905|NCT02347605|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24889903|NCT04488601|Immunologic Factors|immunologic factors|mesh-ancestor
24889904|NCT04488601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889905|NCT04488107|Letrozole|letrozole|mesh-list
24889906|NCT04488107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24889907|NCT04488107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24889908|NCT04488107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24889909|NCT04488107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889910|NCT04488107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889959|NCT04487951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24889960|NCT04487743|Liraglutide|liraglutide|mesh-list
24889961|NCT04487743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24889962|NCT04487743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24889963|NCT04487743|Incretins|incretins|mesh-ancestor
24889964|NCT04487743|Hormones|hormones|mesh-ancestor
24889965|NCT04487743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24889966|NCT04487834|Simethicone|simethicone|mesh-list
24684345|NCT01396733|Vitamins|vitamins|mesh-ancestor
24889967|NCT04487834|Antifoaming Agents|antifoaming agents|mesh-ancestor
24889969|NCT04487834|Emollients|emollients|mesh-ancestor
24889975|NCT04487587|Olaparib|olaparib|mesh-list
24889976|NCT04487587|Cediranib|cediranib|mesh-list
24889977|NCT04487587|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24889978|NCT04487587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24889979|NCT04487587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24889980|NCT04487587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24889981|NCT04487587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24889982|NCT04487236|Capecitabine|capecitabine|mesh-list
24889983|NCT04487236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24889991|NCT04487392|Estrogens|estrogens|mesh-list
24890005|NCT04487093|Immunologic Factors|immunologic factors|mesh-ancestor
24890006|NCT04487093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890007|NCT04486690|Ketamine|ketamine|mesh-list
24890008|NCT04486690|Propofol|propofol|mesh-list
24890009|NCT04486690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24890010|NCT04486690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24890011|NCT04486690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890012|NCT04486690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24890013|NCT04486690|Anesthetics, General|anesthetics, general|mesh-ancestor
24890056|NCT04486430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890057|NCT04486430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24890058|NCT04486430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24890059|NCT04486430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24890060|NCT04486430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24890061|NCT04486430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890062|NCT04486521|Siltuximab|siltuximab|mesh-list
24890090|NCT04485988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890093|NCT04485780|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24890094|NCT04485780|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24890095|NCT04485780|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24890096|NCT04485780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24513279|NCT00580424|Norethindrone Acetate|norethindrone acetate|mesh-list
24890145|NCT04485520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24890146|NCT04485520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24890147|NCT04485520|Disinfectants|disinfectants|mesh-ancestor
24890148|NCT04485429|Methylprednisolone|methylprednisolone|mesh-list
24890149|NCT04485429|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24890150|NCT04485429|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24890181|NCT04485299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24890183|NCT04485403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24890184|NCT04485403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24467656|NCT00378443|Cilazapril|cilazapril|mesh-list
24890208|NCT04485156|Rifampin|rifampin|mesh-list
24890209|NCT04485156|Isoniazid|isoniazid|mesh-list
24890210|NCT04485156|Pyrazinamide|pyrazinamide|mesh-list
24890211|NCT04485156|Ethambutol|ethambutol|mesh-list
24890212|NCT04485156|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24890213|NCT04485156|Antitubercular Agents|antitubercular agents|mesh-ancestor
24890214|NCT04485156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24890230|NCT04485065|Azacitidine|azacitidine|mesh-list
24890231|NCT04485065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24890232|NCT04485065|Antimetabolites|antimetabolites|mesh-ancestor
25713907|NCT02347605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24890233|NCT04485065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890235|NCT04485065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713908|NCT02347605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890265|NCT04484844|Sodium Fluoride|sodium fluoride|mesh-list
24890266|NCT04484844|Cariostatic Agents|cariostatic agents|mesh-ancestor
24890267|NCT04484844|Protective Agents|protective agents|mesh-ancestor
24890268|NCT04484844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890269|NCT04484844|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24890270|NCT04484844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24890271|NCT04484493|Mometasone Furoate|mometasone furoate|mesh-list
24890272|NCT04484493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24890273|NCT04484493|Dermatologic Agents|dermatologic agents|mesh-ancestor
24890274|NCT04484493|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24890275|NCT04484506|Prednisone|prednisone|mesh-list
24890276|NCT04484506|Cyclophosphamide|cyclophosphamide|mesh-list
24890277|NCT04484506|Etoposide|etoposide|mesh-list
24890278|NCT04484506|Vincristine|vincristine|mesh-list
24890279|NCT04484506|Pegaspargase|pegaspargase|mesh-list
24890280|NCT04484506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24890281|NCT04484506|Immunologic Factors|immunologic factors|mesh-ancestor
24890282|NCT04484506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890283|NCT04484506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24890284|NCT04484506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24890285|NCT04484506|Alkylating Agents|alkylating agents|mesh-ancestor
24890294|NCT04484506|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24890295|NCT04484506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24890296|NCT04484506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24890297|NCT04484506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24890298|NCT04484506|Tubulin Modulators|tubulin modulators|mesh-ancestor
24890299|NCT04484506|Antimitotic Agents|antimitotic agents|mesh-ancestor
24890300|NCT04484506|Mitosis Modulators|mitosis modulators|mesh-ancestor
24890308|NCT04484558|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24890309|NCT04484558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24890310|NCT04484558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24890311|NCT04484558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890312|NCT04484467|Menthol|menthol|mesh-list
24890313|NCT04484467|Antipruritics|antipruritics|mesh-ancestor
24890352|NCT04483830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24890353|NCT04483830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24890361|NCT04483596|Protective Agents|protective agents|mesh-ancestor
24890362|NCT04483596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467803|NCT00378781|Anticoagulants|anticoagulants|mesh-ancestor
24890442|NCT04483492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24890443|NCT04483492|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24890444|NCT04483492|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24890445|NCT04483492|Purinergic Agents|purinergic agents|mesh-ancestor
24890446|NCT04483492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24890447|NCT04483258|Sevoflurane|sevoflurane|mesh-list
24890448|NCT04483258|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24890449|NCT04483258|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24890450|NCT04483258|Anesthetics, General|anesthetics, general|mesh-ancestor
24890451|NCT04483258|Anesthetics|anesthetics|mesh-ancestor
24890452|NCT04483258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24890456|NCT04483284|Estrogens|estrogens|mesh-ancestor
24890533|NCT04482543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24890534|NCT04482543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890535|NCT04482543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24890536|NCT04482543|Antimetabolites|antimetabolites|mesh-ancestor
24890537|NCT04482543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890538|NCT04482543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24890539|NCT04482543|Dermatologic Agents|dermatologic agents|mesh-ancestor
24890540|NCT04482543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24890541|NCT04482543|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24890542|NCT04482543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24890543|NCT04482543|Immunologic Factors|immunologic factors|mesh-ancestor
24890544|NCT04482543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24890545|NCT04482543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24890672|NCT04481282|Respiratory System Agents|respiratory system agents|mesh-ancestor
24890674|NCT04481282|Tocolytic Agents|tocolytic agents|mesh-ancestor
24816844|NCT02079220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24816845|NCT02079220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24816846|NCT02079220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24890675|NCT04481282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24890676|NCT04481282|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24890677|NCT04481282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24890678|NCT04481282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24890679|NCT04481282|Adrenergic Agents|adrenergic agents|mesh-ancestor
24890680|NCT04481282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24890681|NCT04481282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890682|NCT04481282|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24890683|NCT04481282|Hormone Antagonists|hormone antagonists|mesh-ancestor
24890684|NCT04481282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24890719|NCT04480775|Triamcinolone|triamcinolone|mesh-list
24890720|NCT04480775|Bupivacaine|bupivacaine|mesh-list
24890784|NCT04480359|Analgesics|analgesics|mesh-ancestor
24890785|NCT04480359|Sensory System Agents|sensory system agents|mesh-ancestor
24890786|NCT04480359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24890787|NCT04480359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890788|NCT04480359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24890789|NCT04480359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24890790|NCT04480359|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24890799|NCT04479748|Prednisolone acetate|prednisolone acetate|mesh-list
24890800|NCT04479748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24890801|NCT04479748|Prednisolone phosphate|prednisolone phosphate|mesh-list
24890802|NCT04479748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24890803|NCT04479748|Antiemetics|antiemetics|mesh-ancestor
24890804|NCT04479748|Autonomic Agents|autonomic agents|mesh-ancestor
24890805|NCT04479748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24890806|NCT04479748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890807|NCT04479748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24890838|NCT04479891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24890841|NCT04479527|Apatinib|apatinib|mesh-list
24890842|NCT04479527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24890843|NCT04479527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24890844|NCT04479527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24890845|NCT04479527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890846|NCT04479202|Bentonite|bentonite|mesh-list
24890847|NCT04479202|Antidotes|antidotes|mesh-ancestor
24890848|NCT04479202|Protective Agents|protective agents|mesh-ancestor
24468186|NCT00380380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24890849|NCT04479202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890882|NCT04478526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513395|NCT00581035|Immunologic Factors|immunologic factors|mesh-ancestor
24513396|NCT00581035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890883|NCT04478526|Sympathomimetics|sympathomimetics|mesh-ancestor
24890884|NCT04478526|Autonomic Agents|autonomic agents|mesh-ancestor
24890885|NCT04478526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24890886|NCT04478526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24890887|NCT04478526|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24890888|NCT04478526|Serotonin Agents|serotonin agents|mesh-ancestor
24890889|NCT04478526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24890890|NCT04478526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24890891|NCT04478357|Fesoterodine|fesoterodine|mesh-list
24890892|NCT04478357|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24890893|NCT04478357|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24890894|NCT04478357|Cholinergic Agents|cholinergic agents|mesh-ancestor
24890899|NCT04478474|Ganciclovir|ganciclovir|mesh-list
24890947|NCT04478513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890949|NCT04478513|Serotonin Agents|serotonin agents|mesh-ancestor
24890950|NCT04478513|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24890951|NCT04478513|Antidepressive Agents|antidepressive agents|mesh-ancestor
24890952|NCT04478513|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24890953|NCT04478513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24890954|NCT04478513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713909|NCT02347631|Dipivefrin|dipivefrin|mesh-list
25713910|NCT02347631|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24890955|NCT04478513|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24890959|NCT04477993|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
24890983|NCT04477642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24890984|NCT04477642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24890985|NCT04477642|Immunologic Factors|immunologic factors|mesh-ancestor
24890986|NCT04477642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890987|NCT04477642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24890989|NCT04477811|Vitamin K|vitamin k|mesh-list
24890990|NCT04477811|Vitamin K 2|vitamin k 2|mesh-list
24890991|NCT04477811|Vitamin K 1|vitamin k 1|mesh-list
24890992|NCT04477811|Micronutrients|micronutrients|mesh-ancestor
24890993|NCT04477811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24890994|NCT04477811|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24890995|NCT04477811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24890996|NCT04477811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24890997|NCT04477811|Hemostatics|hemostatics|mesh-ancestor
24890998|NCT04477811|Coagulants|coagulants|mesh-ancestor
24891047|NCT04477096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891049|NCT04477096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24891050|NCT04476966|Mirabegron|mirabegron|mesh-list
24891051|NCT04476966|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24891052|NCT04476966|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24891053|NCT04476966|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24891054|NCT04476966|Adrenergic Agents|adrenergic agents|mesh-ancestor
24891055|NCT04476966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24891056|NCT04476966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891057|NCT04476966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891058|NCT04476966|Urological Agents|urological agents|mesh-ancestor
24891059|NCT04477083|Hydroxychloroquine|hydroxychloroquine|mesh-list
24891060|NCT04477083|Antimalarials|antimalarials|mesh-ancestor
24891061|NCT04477083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24891062|NCT04477083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24891063|NCT04477083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24891064|NCT04477083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24513401|NCT00581139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24513402|NCT00581139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24513403|NCT00581139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24513404|NCT00581139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24513405|NCT00581139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24891070|NCT04477018|Vitamins|vitamins|mesh-ancestor
24891071|NCT04477018|Micronutrients|micronutrients|mesh-ancestor
24891072|NCT04477018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513412|NCT00581165|Etanercept|etanercept|mesh-list
24513418|NCT00581165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513419|NCT00581165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24513420|NCT00581165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24513421|NCT00581165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24513422|NCT00581165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24513423|NCT00581165|Immunologic Factors|immunologic factors|mesh-ancestor
24513424|NCT00581217|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
24513425|NCT00581217|Laxatives|laxatives|mesh-ancestor
24513426|NCT00581217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24513427|NCT00581425|Interferons|interferons|mesh-list
24513428|NCT00581425|Interferon-alpha|interferon-alpha|mesh-list
24513429|NCT00581425|Imiquimod|imiquimod|mesh-list
24513430|NCT00581425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513431|NCT00581425|Antiviral Agents|antiviral agents|mesh-ancestor
24513432|NCT00581425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24513433|NCT00581425|Immunologic Factors|immunologic factors|mesh-ancestor
24513434|NCT00581425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513435|NCT00581425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24513436|NCT00581425|Interferon Inducers|interferon inducers|mesh-ancestor
24513437|NCT00581607|Bosentan|bosentan|mesh-list
24513438|NCT00581607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24891087|NCT04476459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891088|NCT04476121|Aspirin|aspirin|mesh-list
24891090|NCT04476121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24891129|NCT04476069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713911|NCT02347631|Adrenergic Agents|adrenergic agents|mesh-ancestor
25713912|NCT02347631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25713913|NCT02347631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713914|NCT02347631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713915|NCT02347657|Ivacaftor|ivacaftor|mesh-list
24891130|NCT04476069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816848|NCT02079220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24816849|NCT02079220|Growth Inhibitors|growth inhibitors|mesh-ancestor
24816850|NCT02079298|Fluconazole|fluconazole|mesh-list
24816851|NCT02079298|Ibuprofen|ibuprofen|mesh-list
24816852|NCT02079298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24816853|NCT02079298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24816854|NCT02079298|Analgesics|analgesics|mesh-ancestor
24816855|NCT02079298|Sensory System Agents|sensory system agents|mesh-ancestor
24816860|NCT02079298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24816862|NCT02079298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24816871|NCT02079298|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24816872|NCT02079337|Rocuronium|rocuronium|mesh-list
24816873|NCT02079337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
24816885|NCT02079506|Candesartan|candesartan|mesh-list
24816886|NCT02079506|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24816887|NCT02079506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24816888|NCT02079506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24891145|NCT04475276|Protective Agents|protective agents|mesh-ancestor
24891162|NCT04475107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24891163|NCT04475107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24891164|NCT04475107|Antiviral Agents|antiviral agents|mesh-ancestor
24891165|NCT04475107|Schistosomicides|schistosomicides|mesh-ancestor
24891166|NCT04475107|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24891167|NCT04475107|Anthelmintics|anthelmintics|mesh-ancestor
24891168|NCT04475042|Dapagliflozin|dapagliflozin|mesh-list
24891169|NCT04475042|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24891170|NCT04475042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891171|NCT04475042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24891172|NCT04475042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891173|NCT04475120|Lactoferrin|lactoferrin|mesh-list
24891174|NCT04475120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24891204|NCT04474457|Favipiravir|favipiravir|mesh-list
24891205|NCT04474457|Antiviral Agents|antiviral agents|mesh-ancestor
24891206|NCT04474457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24891207|NCT04474327|Montelukast|montelukast|mesh-list
24891208|NCT04474327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24891209|NCT04474327|Respiratory System Agents|respiratory system agents|mesh-ancestor
24891210|NCT04474327|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24891211|NCT04474327|Hormone Antagonists|hormone antagonists|mesh-ancestor
24891212|NCT04474327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24891213|NCT04474327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891214|NCT04474327|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24891215|NCT04474327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24513496|NCT00582920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513497|NCT00582985|Antibodies|antibodies|mesh-list
24513498|NCT00582985|Immunologic Factors|immunologic factors|mesh-ancestor
24891216|NCT04474327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891218|NCT04474262|Sympathomimetics|sympathomimetics|mesh-ancestor
24891219|NCT04474262|Autonomic Agents|autonomic agents|mesh-ancestor
24891229|NCT04474210|JNJ-56136379|jnj-56136379|mesh-list
24891238|NCT04474093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891239|NCT04474093|Sympathomimetics|sympathomimetics|mesh-ancestor
24891241|NCT04474093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891242|NCT04474093|Dopamine Agents|dopamine agents|mesh-ancestor
24891243|NCT04474093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24891244|NCT04474093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891245|NCT04474093|Adrenergic Agents|adrenergic agents|mesh-ancestor
24891246|NCT04474093|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24468511|NCT00381953|Immunologic Factors|immunologic factors|mesh-ancestor
24513499|NCT00582985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513500|NCT00583063|Sirolimus|sirolimus|mesh-list
24513501|NCT00583063|Sunitinib|sunitinib|mesh-list
24513502|NCT00583063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513503|NCT00583063|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24513504|NCT00583063|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24513505|NCT00583063|Growth Substances|growth substances|mesh-ancestor
24513506|NCT00583063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513507|NCT00583063|Growth Inhibitors|growth inhibitors|mesh-ancestor
25713917|NCT02347657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25713918|NCT02347657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713919|NCT02347813|Pioglitazone|pioglitazone|mesh-list
24513512|NCT00583063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24513513|NCT00583063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24513514|NCT00583063|Antifungal Agents|antifungal agents|mesh-ancestor
24513515|NCT00583063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24513516|NCT00583063|Immunologic Factors|immunologic factors|mesh-ancestor
24513517|NCT00583180|Capsaicin|capsaicin|mesh-list
24513518|NCT00583180|Antipruritics|antipruritics|mesh-ancestor
24513519|NCT00583180|Dermatologic Agents|dermatologic agents|mesh-ancestor
24513520|NCT00583180|Sensory System Agents|sensory system agents|mesh-ancestor
24513521|NCT00583180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24513522|NCT00583180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513523|NCT00583193|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24513524|NCT00583193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24891649|NCT04468464|Keratolytic Agents|keratolytic agents|mesh-ancestor
24891273|NCT04473911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24891274|NCT04473911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24891275|NCT04473911|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24891276|NCT04473911|Antitubercular Agents|antitubercular agents|mesh-ancestor
24891277|NCT04473911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24891278|NCT04473911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24891279|NCT04473911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24891280|NCT04473911|Antifungal Agents|antifungal agents|mesh-ancestor
24891281|NCT04473950|Naloxone|naloxone|mesh-list
24891282|NCT04473950|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24891283|NCT04473950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891284|NCT04473950|Sensory System Agents|sensory system agents|mesh-ancestor
24891285|NCT04473950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891286|NCT04473820|Lidocaine|lidocaine|mesh-list
24891289|NCT04473820|Anesthetics, Local|anesthetics, local|mesh-ancestor
24891290|NCT04473820|Anesthetics|anesthetics|mesh-ancestor
24513526|NCT00583193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24513527|NCT00583193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513528|NCT00583193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24513529|NCT00583193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513530|NCT00583193|Analgesics|analgesics|mesh-ancestor
24513531|NCT00583193|Sensory System Agents|sensory system agents|mesh-ancestor
24513532|NCT00583193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24513533|NCT00583193|Antidepressive Agents|antidepressive agents|mesh-ancestor
24891293|NCT04473820|Sensory System Agents|sensory system agents|mesh-ancestor
24891294|NCT04473820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891295|NCT04473820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24891296|NCT04473820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24891297|NCT04473820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24891298|NCT04473820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24891299|NCT04473820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891300|NCT04473820|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
24891301|NCT04473846|Anesthetics|anesthetics|mesh-list
24891302|NCT04473846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24891303|NCT04473846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891304|NCT04473417|Dapagliflozin|dapagliflozin|mesh-list
24891305|NCT04473417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24891306|NCT04473417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891307|NCT04473417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24713885|NCT01527890|Anesthetics|anesthetics|mesh-ancestor
24891337|NCT04473144|Urinastatin|urinastatin|mesh-list
24891338|NCT04473144|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24891366|NCT04472689|Anesthetics, Local|anesthetics, local|mesh-ancestor
24446800|NCT00306020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891408|NCT04471441|Antitubercular Agents|antitubercular agents|mesh-ancestor
24891409|NCT04471441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24891410|NCT04471441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24891411|NCT04471441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24891527|NCT04470310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891419|NCT04470908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24891420|NCT04470908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891422|NCT04470908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24891433|NCT04470479|Pilocarpine|pilocarpine|mesh-list
24891434|NCT04470479|Miotics|miotics|mesh-ancestor
24891435|NCT04470479|Autonomic Agents|autonomic agents|mesh-ancestor
24891436|NCT04470479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891650|NCT04468464|Dermatologic Agents|dermatologic agents|mesh-ancestor
24891437|NCT04470479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891438|NCT04470479|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24891439|NCT04470479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24891440|NCT04470479|Cholinergic Agents|cholinergic agents|mesh-ancestor
24891441|NCT04470479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24891443|NCT04470752|Capsaicin|capsaicin|mesh-list
24891498|NCT04470401|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24891499|NCT04470401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24513543|NCT00583258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513544|NCT00583258|Urological Agents|urological agents|mesh-ancestor
24513546|NCT00583271|Triamcinolone|triamcinolone|mesh-list
24891505|NCT04470401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891506|NCT04470076|Gemcitabine|gemcitabine|mesh-list
24891507|NCT04470076|Carboplatin|carboplatin|mesh-list
24891510|NCT04470076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24891511|NCT04470076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24891512|NCT04470076|Antimetabolites|antimetabolites|mesh-ancestor
24891513|NCT04470076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891514|NCT04470076|Antiviral Agents|antiviral agents|mesh-ancestor
24891515|NCT04470076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24891516|NCT04470076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24891517|NCT04470076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24891518|NCT04470076|Immunologic Factors|immunologic factors|mesh-ancestor
24891519|NCT04470076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891520|NCT04470076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24891521|NCT04470076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24891522|NCT04470076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24891523|NCT04470310|Pioglitazone|pioglitazone|mesh-list
24891524|NCT04470310|Glimepiride|glimepiride|mesh-list
25713920|NCT02347813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24891525|NCT04470310|Alogliptin|alogliptin|mesh-list
24891526|NCT04470310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25713921|NCT02347813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713922|NCT02348385|Amphetamine|amphetamine|mesh-list
25713923|NCT02348385|Dextroamphetamine|dextroamphetamine|mesh-list
25713924|NCT02348385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25713925|NCT02348385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713926|NCT02348385|Sympathomimetics|sympathomimetics|mesh-ancestor
25713927|NCT02348385|Autonomic Agents|autonomic agents|mesh-ancestor
25713928|NCT02348385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713929|NCT02348385|Dopamine Agents|dopamine agents|mesh-ancestor
25713930|NCT02348385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25713931|NCT02348385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713932|NCT02348385|Adrenergic Agents|adrenergic agents|mesh-ancestor
25713933|NCT02348385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24891558|NCT04469829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24891562|NCT04469829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891563|NCT04469829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24891564|NCT04469829|Dermatologic Agents|dermatologic agents|mesh-ancestor
24891565|NCT04469829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24891566|NCT04469829|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24891567|NCT04469829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24891568|NCT04469829|Immunologic Factors|immunologic factors|mesh-ancestor
24891569|NCT04469829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24891570|NCT04469829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24891571|NCT04469777|Epoetin Alfa|epoetin alfa|mesh-list
24891572|NCT04469777|Hematinics|hematinics|mesh-ancestor
24891578|NCT04469413|Acetaminophen|acetaminophen|mesh-list
24891579|NCT04469413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24891583|NCT04469413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891584|NCT04469413|Antipyretics|antipyretics|mesh-ancestor
24891585|NCT04469283|Caffeine|caffeine|mesh-list
24891586|NCT04469283|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24891587|NCT04469283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891642|NCT04468685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24891643|NCT04468685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24891644|NCT04468685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24891645|NCT04468685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24891646|NCT04468464|Salicylic Acid|salicylic acid|mesh-list
24891647|NCT04468464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24891648|NCT04468464|Antifungal Agents|antifungal agents|mesh-ancestor
24891688|NCT04468282|Anticonvulsants|anticonvulsants|mesh-ancestor
24891689|NCT04468282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24891690|NCT04468282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891691|NCT04468282|GABA Agents|gaba agents|mesh-ancestor
24891692|NCT04468282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24891749|NCT04467931|Diltiazem|diltiazem|mesh-list
24891750|NCT04467931|Bisoprolol|bisoprolol|mesh-list
24891751|NCT04467931|Perindopril|perindopril|mesh-list
24816907|NCT02079701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891752|NCT04467931|Guanfacine|guanfacine|mesh-list
24816908|NCT02079727|Celecoxib|celecoxib|mesh-list
24891753|NCT04467931|Minoxidil|minoxidil|mesh-list
24891754|NCT04467931|Prazosin|prazosin|mesh-list
24891755|NCT04467931|Doxazosin|doxazosin|mesh-list
24891756|NCT04467931|Benazepril|benazepril|mesh-list
24891757|NCT04467931|Labetalol|labetalol|mesh-list
24891758|NCT04467931|Hydralazine|hydralazine|mesh-list
24891759|NCT04467931|Captopril|captopril|mesh-list
24891760|NCT04467931|Indapamide|indapamide|mesh-list
24891764|NCT04467931|Metolazone|metolazone|mesh-list
24891765|NCT04467931|Torsemide|torsemide|mesh-list
24891766|NCT04467931|Methyldopa|methyldopa|mesh-list
24891767|NCT04467931|Fosinopril|fosinopril|mesh-list
24891768|NCT04467931|Isradipine|isradipine|mesh-list
24891769|NCT04467931|Eprosartan|eprosartan|mesh-list
24891770|NCT04467931|Pindolol|pindolol|mesh-list
24891771|NCT04467931|Moexipril|moexipril|mesh-list
24891772|NCT04467931|Betaxolol|betaxolol|mesh-list
24891773|NCT04467931|Reserpine|reserpine|mesh-list
25713934|NCT02348385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25713935|NCT02348385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25713936|NCT02348385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25713937|NCT02348489|Guadecitabine|guadecitabine|mesh-list
25713938|NCT02348489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713939|NCT02348658|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
24891774|NCT04467931|Bendroflumethiazide|bendroflumethiazide|mesh-list
24891775|NCT04467931|Chlorothiazide|chlorothiazide|mesh-list
24891777|NCT04467931|Nisoldipine|nisoldipine|mesh-list
24891778|NCT04467931|Penbutolol|penbutolol|mesh-list
24891779|NCT04467931|Nifedipine|nifedipine|mesh-list
24891780|NCT04467931|Amiloride|amiloride|mesh-list
24891781|NCT04467931|Triamterene|triamterene|mesh-list
24891782|NCT04467931|Furosemide|furosemide|mesh-list
24891783|NCT04467931|Spironolactone|spironolactone|mesh-list
24891784|NCT04467931|Bumetanide|bumetanide|mesh-list
24891785|NCT04467931|Ethacrynic Acid|ethacrynic acid|mesh-list
24891786|NCT04467931|Terazosin|terazosin|mesh-list
24891787|NCT04467931|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
24891788|NCT04467931|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24891789|NCT04467931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24891790|NCT04467931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24891791|NCT04467931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24892915|NCT04456985|Hematinics|hematinics|mesh-ancestor
24891794|NCT04467931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891796|NCT04467931|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24891797|NCT04467931|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24891799|NCT04467931|Diuretics|diuretics|mesh-ancestor
24891817|NCT04467931|Hormone Antagonists|hormone antagonists|mesh-ancestor
24891818|NCT04467931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24891819|NCT04467931|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24891821|NCT04467931|Protective Agents|protective agents|mesh-ancestor
24891822|NCT04467931|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24891823|NCT04467931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24891824|NCT04467931|Protease Inhibitors|protease inhibitors|mesh-ancestor
24891825|NCT04467931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24891826|NCT04467931|Tocolytic Agents|tocolytic agents|mesh-ancestor
24891827|NCT04467931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24891839|NCT04467931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24891840|NCT04467931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24891842|NCT04467931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24891843|NCT04467931|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24891844|NCT04467931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24891846|NCT04467983|Abaloparatide|abaloparatide|mesh-list
24891847|NCT04467983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24892352|NCT04463875|Antiviral Agents|antiviral agents|mesh-ancestor
24891848|NCT04467983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891849|NCT04467463|Levobupivacaine|levobupivacaine|mesh-list
24891854|NCT04467463|Sensory System Agents|sensory system agents|mesh-ancestor
24891855|NCT04467463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891856|NCT04467450|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24891857|NCT04467450|Botulinum Toxins|botulinum toxins|mesh-list
24891858|NCT04467450|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24891859|NCT04467450|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24891860|NCT04467450|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24891861|NCT04467450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24891862|NCT04467450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891863|NCT04467450|Cholinergic Agents|cholinergic agents|mesh-ancestor
24891864|NCT04467450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24891865|NCT04467450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24891867|NCT04467450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24891868|NCT04467450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24891869|NCT04467346|Temozolomide|temozolomide|mesh-list
24891870|NCT04467346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24891885|NCT04467125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24891886|NCT04467125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24891887|NCT04467125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891935|NCT04466670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24891936|NCT04466670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24891937|NCT04466670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24891938|NCT04466670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24891939|NCT04466670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24891940|NCT04466670|Antipyretics|antipyretics|mesh-ancestor
24891941|NCT04466670|Anticoagulants|anticoagulants|mesh-ancestor
24891942|NCT04466436|Tryptophan|tryptophan|mesh-list
24891943|NCT04466436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24891944|NCT04466436|Antidepressive Agents|antidepressive agents|mesh-ancestor
24891945|NCT04466436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24891947|NCT04466423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24891948|NCT04466046|Midazolam|midazolam|mesh-list
24891949|NCT04466046|Palonosetron|palonosetron|mesh-list
24892916|NCT04456985|Vitamin B Complex|vitamin b complex|mesh-ancestor
24891950|NCT04466046|Ramosetron|ramosetron|mesh-list
24891951|NCT04466046|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24891952|NCT04466046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24891955|NCT04466046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24891997|NCT04466176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24891998|NCT04466176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24891999|NCT04466176|Adrenergic Agents|adrenergic agents|mesh-ancestor
24892000|NCT04466176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24892001|NCT04466176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892002|NCT04466176|Glucocorticoids|glucocorticoids|mesh-ancestor
24892003|NCT04466176|Hormones|hormones|mesh-ancestor
24892004|NCT04466176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24892005|NCT04466176|Sympathomimetics|sympathomimetics|mesh-ancestor
24892006|NCT04466241|Ritonavir|ritonavir|mesh-list
24892007|NCT04466241|Lopinavir|lopinavir|mesh-list
24892008|NCT04466241|Telmisartan|telmisartan|mesh-list
24892009|NCT04466241|Atorvastatin|atorvastatin|mesh-list
24892011|NCT04466241|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24892012|NCT04466241|Antimetabolites|antimetabolites|mesh-ancestor
24892013|NCT04466241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892014|NCT04466241|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24892015|NCT04466241|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24892016|NCT04466241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24892017|NCT04466241|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24892061|NCT04465942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24892062|NCT04465942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24892063|NCT04465942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24892102|NCT04465695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24892103|NCT04465695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24714730|NCT01532297|Dialysis Solutions|dialysis solutions|mesh-list
24892104|NCT04465695|Leprostatic Agents|leprostatic agents|mesh-ancestor
24892105|NCT04465695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24892106|NCT04465851|Curcumin|curcumin|mesh-list
24892107|NCT04465851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24892108|NCT04465851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24892112|NCT04465851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892113|NCT04465851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24892114|NCT04465851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24892115|NCT04465851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24892116|NCT04465851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24892117|NCT04465851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892118|NCT04465539|Hydrocortisone|hydrocortisone|mesh-list
24892119|NCT04465539|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24892120|NCT04465539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24892121|NCT04465539|Plasma Substitutes|plasma substitutes|mesh-ancestor
24892122|NCT04465539|Blood Substitutes|blood substitutes|mesh-ancestor
24892123|NCT04465292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24892124|NCT04465292|Immunologic Factors|immunologic factors|mesh-ancestor
24892125|NCT04465292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892126|NCT04465123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24892127|NCT04465123|Spironolactone|spironolactone|mesh-list
24892128|NCT04465123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24892129|NCT04465123|Diuretics|diuretics|mesh-ancestor
24892130|NCT04465123|Natriuretic Agents|natriuretic agents|mesh-ancestor
24892131|NCT04465123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892132|NCT04465123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24892133|NCT04465123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25407651|NCT03487016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713940|NCT02348658|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25713941|NCT02348658|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24892134|NCT04465123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892136|NCT04465123|Hormone Antagonists|hormone antagonists|mesh-ancestor
24892137|NCT04465123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24892138|NCT04465123|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24892142|NCT04465357|Analgesics|analgesics|mesh-ancestor
24892165|NCT04465175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24892166|NCT04465175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24892167|NCT04465175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892168|NCT04465175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24892170|NCT04465175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24892171|NCT04465396|Teduglutide|teduglutide|mesh-list
24892196|NCT04464759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892197|NCT04464759|Antimalarials|antimalarials|mesh-ancestor
24892198|NCT04464759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24892199|NCT04464759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24892200|NCT04464759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24892201|NCT04464759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24892202|NCT04464759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24892203|NCT04464694|Ranibizumab|ranibizumab|mesh-list
24892214|NCT04464811|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24892215|NCT04464811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24892216|NCT04464811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892218|NCT04465097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24892219|NCT04465097|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24892220|NCT04465097|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24892221|NCT04465097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24892222|NCT04465097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892223|NCT04465097|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24892224|NCT04465097|Hormone Antagonists|hormone antagonists|mesh-ancestor
24892225|NCT04465097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24892226|NCT04465097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892227|NCT04465110|Grape Seed Extract|grape seed extract|mesh-list
24892228|NCT04465110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24892229|NCT04465110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24892230|NCT04465110|Antioxidants|antioxidants|mesh-ancestor
24892231|NCT04465110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892232|NCT04465110|Protective Agents|protective agents|mesh-ancestor
24892233|NCT04465110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892234|NCT04464850|Iron|iron|mesh-list
24892235|NCT04464850|Ferrous fumarate|ferrous fumarate|mesh-list
24892236|NCT04464850|Folic Acid|folic acid|mesh-list
24892237|NCT04464850|Trace Elements|trace elements|mesh-ancestor
24517950|NCT00610792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517951|NCT00610818|Mitogens|mitogens|mesh-list
24517952|NCT00610818|Mitosis Modulators|mitosis modulators|mesh-ancestor
24892240|NCT04464850|Hematinics|hematinics|mesh-ancestor
24892305|NCT04464135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24892306|NCT04464135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24892307|NCT04464135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24892308|NCT04464135|Immunologic Factors|immunologic factors|mesh-ancestor
24892309|NCT04464135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892310|NCT04464135|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24892311|NCT04464135|Protective Agents|protective agents|mesh-ancestor
24892312|NCT04464135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24892313|NCT04464005|Magnesium Sulfate|magnesium sulfate|mesh-list
24892314|NCT04464005|Analgesics|analgesics|mesh-ancestor
24892315|NCT04464005|Sensory System Agents|sensory system agents|mesh-ancestor
24892316|NCT04464005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24892317|NCT04464005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892318|NCT04464005|Anesthetics|anesthetics|mesh-ancestor
25713942|NCT02348658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713943|NCT02348723|Warfarin|warfarin|mesh-list
25713944|NCT02348723|Dabigatran|dabigatran|mesh-list
25713945|NCT02348723|Anticoagulants|anticoagulants|mesh-ancestor
25713946|NCT02348723|Antithrombins|antithrombins|mesh-ancestor
25713947|NCT02348723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25713948|NCT02348723|Protease Inhibitors|protease inhibitors|mesh-ancestor
24892350|NCT04463875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24892351|NCT04463875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24513553|NCT00583271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24513554|NCT00583271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24513555|NCT00583323|Atropine sulfate-diphenoxylate hydrochloride drug combination|atropine sulfate-diphenoxylate hydrochloride drug combination|mesh-list
24513556|NCT00583323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24469530|NCT00386230|Antiviral Agents|antiviral agents|mesh-ancestor
24469531|NCT00386230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24469532|NCT00386230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24469533|NCT00386230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24892393|NCT04463901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24892394|NCT04463901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24892395|NCT04463901|Alkylating Agents|alkylating agents|mesh-ancestor
24892396|NCT04463901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892397|NCT04463901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24892398|NCT04463901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24892412|NCT04463342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24892413|NCT04463342|Dopamine Agents|dopamine agents|mesh-ancestor
24892414|NCT04463342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24892415|NCT04463342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892416|NCT04463342|Adrenergic Agents|adrenergic agents|mesh-ancestor
24892417|NCT04463342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24892418|NCT04463342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24892419|NCT04463342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24892420|NCT04463342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24892428|NCT04463264|Nitazoxanide|nitazoxanide|mesh-list
24892443|NCT04462796|Magnesium citrate|magnesium citrate|mesh-list
24892444|NCT04462796|Cathartics|cathartics|mesh-ancestor
24892462|NCT04462822|Autonomic Agents|autonomic agents|mesh-ancestor
24892463|NCT04462822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24892464|NCT04462822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892481|NCT04462809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24892483|NCT04462809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713949|NCT02348723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713950|NCT02348723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713951|NCT02348775|Acetylcysteine|acetylcysteine|mesh-list
25713952|NCT02348775|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25713953|NCT02348775|Glycine|glycine|mesh-list
25713954|NCT02348775|Antiviral Agents|antiviral agents|mesh-ancestor
25713955|NCT02348775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25713956|NCT02348775|Expectorants|expectorants|mesh-ancestor
24892563|NCT04461925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24469709|NCT00386815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24469710|NCT00386828|Bevacizumab|bevacizumab|mesh-list
24892596|NCT04461353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24892597|NCT04461353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24892598|NCT04461353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24892599|NCT04461353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892600|NCT04461353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24892601|NCT04461418|Glucocorticoids|glucocorticoids|mesh-list
24892602|NCT04461418|Hormones|hormones|mesh-ancestor
24892917|NCT04456803|Sevelamer|sevelamer|mesh-list
24892604|NCT04461418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892605|NCT04461379|Vaccines|vaccines|mesh-list
24892606|NCT04461379|BCG Vaccine|bcg vaccine|mesh-list
24892607|NCT04461379|Immunologic Factors|immunologic factors|mesh-ancestor
24892608|NCT04461379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892609|NCT04461379|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24518256|NCT05329740|Prednisolone|prednisolone|mesh-list
24518257|NCT05329740|Prednisolone acetate|prednisolone acetate|mesh-list
24518258|NCT05329740|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24518259|NCT05329740|Prednisolone phosphate|prednisolone phosphate|mesh-list
24892620|NCT04461340|Sirolimus|sirolimus|mesh-list
24892621|NCT04461340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24892622|NCT04461340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24513558|NCT00583349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24513559|NCT00583349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513560|NCT00583349|Tubulin Modulators|tubulin modulators|mesh-ancestor
24513561|NCT00583349|Antimitotic Agents|antimitotic agents|mesh-ancestor
24513562|NCT00583349|Mitosis Modulators|mitosis modulators|mesh-ancestor
24513563|NCT00583349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513564|NCT00583427|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
24513570|NCT00583427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24513571|NCT00583427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24513572|NCT00583427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24513573|NCT00583427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469732|NCT00386867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24892657|NCT04460807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24892697|NCT04460443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24892698|NCT04460521|Acetylcysteine|acetylcysteine|mesh-list
24892699|NCT04460521|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24715332|NCT01535989|Sirolimus|sirolimus|mesh-list
24892700|NCT04460521|Antiviral Agents|antiviral agents|mesh-ancestor
24892701|NCT04460521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24892702|NCT04460521|Expectorants|expectorants|mesh-ancestor
24892703|NCT04460521|Respiratory System Agents|respiratory system agents|mesh-ancestor
24892704|NCT04460521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24892705|NCT04460521|Antioxidants|antioxidants|mesh-ancestor
24892706|NCT04460521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892793|NCT04459377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24892794|NCT04459377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892795|NCT04459377|Antidepressive Agents|antidepressive agents|mesh-ancestor
24892796|NCT04459377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24892797|NCT04459026|Ropivacaine|ropivacaine|mesh-list
24892798|NCT04459026|Anesthetics, Local|anesthetics, local|mesh-ancestor
24892799|NCT04459026|Anesthetics|anesthetics|mesh-ancestor
24469837|NCT00387530|Antiviral Agents|antiviral agents|mesh-ancestor
24513581|NCT00583869|Sensory System Agents|sensory system agents|mesh-ancestor
24513582|NCT00583869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24892856|NCT04458116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24892857|NCT04458116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24892858|NCT04458116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24892859|NCT04458116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24892860|NCT04458116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713957|NCT02348775|Respiratory System Agents|respiratory system agents|mesh-ancestor
25713958|NCT02348775|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25713959|NCT02348775|Antioxidants|antioxidants|mesh-ancestor
25713960|NCT02348775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713961|NCT02348775|Protective Agents|protective agents|mesh-ancestor
25713962|NCT02348775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713963|NCT02348775|Antidotes|antidotes|mesh-ancestor
25713964|NCT02348775|Glycine Agents|glycine agents|mesh-ancestor
24892865|NCT04457609|Azithromycin|azithromycin|mesh-list
24892866|NCT04457609|Oseltamivir|oseltamivir|mesh-list
24892869|NCT04457609|Antiviral Agents|antiviral agents|mesh-ancestor
24513596|NCT00583986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24469960|NCT00388128|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24469961|NCT00388128|Purinergic Agents|purinergic agents|mesh-ancestor
24469962|NCT00388128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24892914|NCT04456985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24892918|NCT04456803|Chelating Agents|chelating agents|mesh-ancestor
24892919|NCT04456803|Sequestering Agents|sequestering agents|mesh-ancestor
24892920|NCT04456803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892953|NCT04456712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24892954|NCT04456712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24892955|NCT04456712|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24892956|NCT04456712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24892957|NCT04456712|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24893025|NCT04455958|Ritonavir|ritonavir|mesh-list
24893026|NCT04455958|Lopinavir|lopinavir|mesh-list
24893027|NCT04455958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24893028|NCT04455958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24893036|NCT04455958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24893037|NCT04455958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24475431|NCT00410449|Vitamins|vitamins|mesh-ancestor
24817016|NCT02080182|Antidotes|antidotes|mesh-ancestor
24518859|NCT04133948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518865|NCT04117672|Antisecretory factor|antisecretory factor|mesh-list
24518871|NCT04094961|Ixazomib|ixazomib|mesh-list
24518885|NCT04094961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24518886|NCT04094961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817017|NCT02080234|Gemcitabine|gemcitabine|mesh-list
24817018|NCT02080234|Oxaliplatin|oxaliplatin|mesh-list
24817019|NCT02080234|Asparaginase|asparaginase|mesh-list
24817020|NCT02080234|Pegaspargase|pegaspargase|mesh-list
24817022|NCT02080234|Antimetabolites|antimetabolites|mesh-ancestor
24893088|NCT04454307|Narcotics|narcotics|mesh-ancestor
24893089|NCT04454307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24893319|NCT04451200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893320|NCT04451200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24893321|NCT04451200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24893322|NCT04451200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24893323|NCT04451239|Cyclosporine|cyclosporine|mesh-list
24893324|NCT04451239|Cyclosporins|cyclosporins|mesh-list
24893325|NCT04451239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893326|NCT04451239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893327|NCT04451239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24893328|NCT04451239|Immunologic Factors|immunologic factors|mesh-ancestor
24893436|NCT04449224|Etanercept|etanercept|mesh-list
24470485|NCT00390260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24893437|NCT04449224|Abatacept|abatacept|mesh-list
24893438|NCT04449224|Tofacitinib|tofacitinib|mesh-list
24893439|NCT04449224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24893440|NCT04449224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24893480|NCT04449471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893482|NCT04449185|Clarithromycin|clarithromycin|mesh-list
24893578|NCT04448028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713965|NCT02348775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25713966|NCT02348918|Bevacizumab|bevacizumab|mesh-list
25713967|NCT02348918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25713968|NCT02348918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25713969|NCT02348918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25713970|NCT02348918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25713971|NCT02348918|Growth Substances|growth substances|mesh-ancestor
25713972|NCT02348918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25713973|NCT02348918|Growth Inhibitors|growth inhibitors|mesh-ancestor
25713974|NCT02349048|Sofosbuvir|sofosbuvir|mesh-list
25713975|NCT02349048|Simeprevir|simeprevir|mesh-list
24893579|NCT04447612|Gemcitabine|gemcitabine|mesh-list
24893580|NCT04447612|Durvalumab|durvalumab|mesh-list
24893581|NCT04447612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24893582|NCT04447612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24893583|NCT04447612|Antimetabolites|antimetabolites|mesh-ancestor
24893584|NCT04447612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893585|NCT04447612|Antiviral Agents|antiviral agents|mesh-ancestor
24893586|NCT04447612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24893587|NCT04447612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893588|NCT04447612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24893589|NCT04447612|Immunologic Factors|immunologic factors|mesh-ancestor
24893591|NCT04447612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24893620|NCT04447274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24893621|NCT04447274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24893622|NCT04447274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893675|NCT04447092|Protective Agents|protective agents|mesh-ancestor
24893676|NCT04447092|Vitamin B Complex|vitamin b complex|mesh-ancestor
24893677|NCT04447092|Vitamins|vitamins|mesh-ancestor
24893678|NCT04447092|Micronutrients|micronutrients|mesh-ancestor
24893680|NCT04447378|Fondaparinux|fondaparinux|mesh-list
24893681|NCT04447378|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24893682|NCT04447378|Antithrombins|antithrombins|mesh-ancestor
24893683|NCT04447378|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24893684|NCT04447378|Protease Inhibitors|protease inhibitors|mesh-ancestor
24893767|NCT04446637|Tocolytic Agents|tocolytic agents|mesh-ancestor
24893768|NCT04446637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24893769|NCT04446637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24893773|NCT04446637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24893774|NCT04446637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24893775|NCT04446637|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24893776|NCT04446637|Cholinergic Agents|cholinergic agents|mesh-ancestor
24893777|NCT04446416|Bevacizumab|bevacizumab|mesh-list
24893778|NCT04446416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24893779|NCT04446416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24893780|NCT04446416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24893781|NCT04446416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24893782|NCT04446416|Growth Substances|growth substances|mesh-ancestor
24893783|NCT04446416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893784|NCT04446416|Growth Inhibitors|growth inhibitors|mesh-ancestor
24893785|NCT04446403|Anesthetics|anesthetics|mesh-list
24893788|NCT04446338|Antibodies|antibodies|mesh-list
24893789|NCT04446338|Immunologic Factors|immunologic factors|mesh-ancestor
24893790|NCT04446338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24893791|NCT04446364|Disinfectants|disinfectants|mesh-list
24893792|NCT04446364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24893793|NCT04445922|Anastrozole|anastrozole|mesh-list
24893794|NCT04445922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24893795|NCT04445922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24893796|NCT04445922|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24893797|NCT04445922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24893815|NCT04446234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24893816|NCT04446234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24716363|NCT01541267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24893832|NCT04446065|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24893833|NCT04446065|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24893834|NCT04446065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24893850|NCT04445948|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24893851|NCT04445948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24894030|NCT04444726|Betamethasone Valerate|betamethasone valerate|mesh-list
24894031|NCT04444726|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24894032|NCT04444726|Betamethasone benzoate|betamethasone benzoate|mesh-list
24894091|NCT04444193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24894092|NCT04444193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713976|NCT02349048|Antiviral Agents|antiviral agents|mesh-ancestor
25713977|NCT02349048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25713978|NCT02349048|Protease Inhibitors|protease inhibitors|mesh-ancestor
24894093|NCT04443920|Tranexamic Acid|tranexamic acid|mesh-list
24894094|NCT04443920|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24894095|NCT04443920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24894096|NCT04443920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894097|NCT04443920|Hemostatics|hemostatics|mesh-ancestor
24894098|NCT04443920|Coagulants|coagulants|mesh-ancestor
24894099|NCT04443946|Sufentanil|sufentanil|mesh-list
24817134|NCT02081287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24894185|NCT04443647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894186|NCT04443881|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24894190|NCT04443387|Micronutrients|micronutrients|mesh-ancestor
24894191|NCT04443387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894320|NCT04442906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24894321|NCT04442906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24894322|NCT04442906|Analgesics|analgesics|mesh-ancestor
24894323|NCT04442906|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24471462|NCT00395421|Antiviral Agents|antiviral agents|mesh-ancestor
24471463|NCT00395421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24471464|NCT00395434|Bevacizumab|bevacizumab|mesh-list
24471465|NCT00395434|Combretastatin|combretastatin|mesh-list
24471466|NCT00395434|Fosbretabulin|fosbretabulin|mesh-list
24471467|NCT00395434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24471468|NCT00395434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894342|NCT04442633|Antifungal Agents|antifungal agents|mesh-ancestor
24894343|NCT04442633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24894427|NCT04440488|Protease Inhibitors|protease inhibitors|mesh-list
24894428|NCT04440488|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
24513795|NCT00585156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24513796|NCT00585156|Analgesics|analgesics|mesh-ancestor
24513797|NCT00585156|Sensory System Agents|sensory system agents|mesh-ancestor
24513798|NCT00585156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24513799|NCT00585156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817160|NCT02081391|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24817161|NCT02081391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24817162|NCT02081391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24817163|NCT02081391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817164|NCT02081391|Adrenergic Agents|adrenergic agents|mesh-ancestor
24817165|NCT02081391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24817166|NCT02081404|Esomeprazole|esomeprazole|mesh-list
24817167|NCT02081404|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24817168|NCT02081404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24817169|NCT02081404|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24817170|NCT02081404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817171|NCT02081404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817172|NCT02081482|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24817173|NCT02081482|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24817175|NCT02081495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24817209|NCT02081885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817210|NCT02081885|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24894459|NCT04440267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24894460|NCT04440267|Immunologic Factors|immunologic factors|mesh-ancestor
24894461|NCT04440267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24894462|NCT04440267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24894463|NCT04440267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24894464|NCT04440267|Alkylating Agents|alkylating agents|mesh-ancestor
24894499|NCT04440436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24894500|NCT04440436|Alkylating Agents|alkylating agents|mesh-ancestor
24894501|NCT04440436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24894502|NCT04440436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24894503|NCT04440436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24894504|NCT04440085|Midodrine|midodrine|mesh-list
25713979|NCT02349048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25713980|NCT02349048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25713981|NCT02349061|Ustekinumab|ustekinumab|mesh-list
25713982|NCT02349061|Dermatologic Agents|dermatologic agents|mesh-ancestor
25713983|NCT02349152|Fentanyl|fentanyl|mesh-list
25713984|NCT02349152|Remifentanil|remifentanil|mesh-list
25713985|NCT02349152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24513874|NCT00585871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513875|NCT00585871|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24513876|NCT00585871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24513877|NCT00585871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24513878|NCT00585871|Adrenergic Agents|adrenergic agents|mesh-ancestor
24513879|NCT00585871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24513880|NCT00585871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513881|NCT00585871|Analgesics|analgesics|mesh-ancestor
24513882|NCT00585871|Sensory System Agents|sensory system agents|mesh-ancestor
24894505|NCT04440085|Sympathomimetics|sympathomimetics|mesh-ancestor
24513930|NCT00586430|Lorazepam|lorazepam|mesh-list
24513931|NCT00586430|Anticonvulsants|anticonvulsants|mesh-ancestor
24513932|NCT00586430|Antiemetics|antiemetics|mesh-ancestor
24513933|NCT00586430|Autonomic Agents|autonomic agents|mesh-ancestor
24513934|NCT00586430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24513935|NCT00586430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513936|NCT00586430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24513937|NCT00586430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24513938|NCT00586430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24894751|NCT05387967|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
24894756|NCT05387954|Anticoagulants|anticoagulants|mesh-list
24894794|NCT05387616|Obinutuzumab|obinutuzumab|mesh-list
24514135|NCT00588016|Hormone Antagonists|hormone antagonists|mesh-ancestor
24514136|NCT00588016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24514137|NCT00588016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514138|NCT00588016|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24817221|NCT02082054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24817241|NCT02082054|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24817242|NCT02082054|Histamine Antagonists|histamine antagonists|mesh-ancestor
24817244|NCT02082054|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24817251|NCT02082067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24817252|NCT02082067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817253|NCT02082067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24817254|NCT02082067|Narcotics|narcotics|mesh-ancestor
24817255|NCT02082067|Analgesics|analgesics|mesh-ancestor
24817256|NCT02082067|Sensory System Agents|sensory system agents|mesh-ancestor
24817265|NCT02082236|Sufentanil|sufentanil|mesh-list
24817266|NCT02082236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24817267|NCT02082236|Narcotics|narcotics|mesh-ancestor
24817268|NCT02082236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24817269|NCT02082236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817270|NCT02082236|Analgesics|analgesics|mesh-ancestor
24817271|NCT02082236|Sensory System Agents|sensory system agents|mesh-ancestor
24514326|NCT00589901|Alkylating Agents|alkylating agents|mesh-ancestor
24514368|NCT00590122|Levodopa|levodopa|mesh-list
24514369|NCT00590122|Carbidopa|carbidopa|mesh-list
24514370|NCT00590122|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24514371|NCT00590122|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24895031|NCT05214599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24895032|NCT05199714|Pramlintide|pramlintide|mesh-list
24895033|NCT05199714|Pancrelipase|pancrelipase|mesh-list
25713987|NCT02349152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25713988|NCT02349152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895034|NCT05199714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24895035|NCT05199714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24895036|NCT05199714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895047|NCT05191875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24895048|NCT05191875|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24895054|NCT05184712|Carboplatin|carboplatin|mesh-list
24514459|NCT00590694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514460|NCT00590785|Tamoxifen|tamoxifen|mesh-list
24514461|NCT00590785|Ciprofloxacin|ciprofloxacin|mesh-list
24514462|NCT00590785|Cyclophosphamide|cyclophosphamide|mesh-list
24514463|NCT00590785|Doxorubicin|doxorubicin|mesh-list
24514464|NCT00590785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24514465|NCT00590785|Immunologic Factors|immunologic factors|mesh-ancestor
24514466|NCT00590785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514467|NCT00590785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24514468|NCT00590785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24514469|NCT00590785|Alkylating Agents|alkylating agents|mesh-ancestor
24895110|NCT05014919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895111|NCT05014919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24895112|NCT05014919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24895113|NCT05014919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24895114|NCT05014919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895116|NCT05014919|Serotonin Agents|serotonin agents|mesh-ancestor
24521797|NCT04519476|Hormones|hormones|mesh-ancestor
24895118|NCT05014919|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24895119|NCT05014919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24514482|NCT00590785|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24514483|NCT00590785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24514484|NCT00590785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24514485|NCT00590785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24514493|NCT00590915|Asparaginase|asparaginase|mesh-list
24895132|NCT04955470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24895133|NCT04955470|Anesthetics, General|anesthetics, general|mesh-ancestor
24895135|NCT04955470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24895136|NCT04955470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24895137|NCT04955470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24514550|NCT00591526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24514552|NCT00591526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514553|NCT00591526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514593|NCT00591708|Sodium Citrate|sodium citrate|mesh-list
24895171|NCT04939623|Antifungal Agents|antifungal agents|mesh-ancestor
24895172|NCT04939623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24895182|NCT04903314|Cenobamate|cenobamate|mesh-list
24895183|NCT04903314|Anticonvulsants|anticonvulsants|mesh-ancestor
24895184|NCT04892940|Analgesics|analgesics|mesh-list
24895185|NCT04892940|Sensory System Agents|sensory system agents|mesh-ancestor
24895186|NCT04892940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24895187|NCT04892940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895188|NCT04879550|Antithrombins|antithrombins|mesh-list
24514601|NCT00591708|Chelating Agents|chelating agents|mesh-ancestor
24514602|NCT00591708|Sequestering Agents|sequestering agents|mesh-ancestor
24895220|NCT04729387|Paclitaxel|paclitaxel|mesh-list
24895221|NCT04729387|Doxorubicin|doxorubicin|mesh-list
25713989|NCT02349152|Analgesics|analgesics|mesh-ancestor
25713990|NCT02349152|Sensory System Agents|sensory system agents|mesh-ancestor
25713991|NCT02349152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713992|NCT02349152|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25713993|NCT02349152|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24696279|NCT01428427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25713994|NCT02349152|Anesthetics, General|anesthetics, general|mesh-ancestor
25713995|NCT02349152|Anesthetics|anesthetics|mesh-ancestor
25713996|NCT02349178|Cyclophosphamide|cyclophosphamide|mesh-list
24895222|NCT04729387|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24895223|NCT04729387|Olaparib|olaparib|mesh-list
24514636|NCT00592111|Alkylating Agents|alkylating agents|mesh-ancestor
24514637|NCT00592111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514638|NCT00592111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514639|NCT00592111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24514640|NCT00592111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24514641|NCT00592111|Glucocorticoids|glucocorticoids|mesh-ancestor
24514642|NCT00592111|Hormones|hormones|mesh-ancestor
24895225|NCT04729387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514658|NCT00592150|Fenoldopam|fenoldopam|mesh-list
24514659|NCT00592150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24514660|NCT00592150|Vasodilator Agents|vasodilator agents|mesh-ancestor
24514661|NCT00592150|Dopamine Agonists|dopamine agonists|mesh-ancestor
24514662|NCT00592150|Dopamine Agents|dopamine agents|mesh-ancestor
24514699|NCT00592332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24514700|NCT00592332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24514701|NCT00592332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514702|NCT00592332|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24514703|NCT00592332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24514704|NCT00592332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24514705|NCT00592332|GABA Modulators|gaba modulators|mesh-ancestor
24514706|NCT00592332|GABA Agents|gaba agents|mesh-ancestor
24514707|NCT00592332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24514708|NCT00592332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514709|NCT00592410|Insulin|insulin|mesh-list
24514710|NCT00592410|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24514713|NCT00592527|Insulin Detemir|insulin detemir|mesh-list
24895242|NCT04699591|Dopamine Agents|dopamine agents|mesh-ancestor
24895243|NCT04699591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24895244|NCT04699591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895245|NCT04650074|Lidocaine|lidocaine|mesh-list
24895246|NCT04650074|Ketamine|ketamine|mesh-list
24895247|NCT04650074|Anesthetics, Local|anesthetics, local|mesh-ancestor
24895248|NCT04650074|Anesthetics|anesthetics|mesh-ancestor
24895249|NCT04650074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24895250|NCT04650074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895269|NCT04647721|Viscosupplements|viscosupplements|mesh-ancestor
24895270|NCT04647721|Protective Agents|protective agents|mesh-ancestor
24514715|NCT00592527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895323|NCT04537715|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24895324|NCT04537715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24895325|NCT04537715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24895372|NCT04427241|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24895373|NCT04427241|Antiviral Agents|antiviral agents|mesh-ancestor
24895374|NCT04427241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24895375|NCT04427241|Dopamine Agents|dopamine agents|mesh-ancestor
24895376|NCT04427241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24895377|NCT04427241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895378|NCT04427241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895379|NCT04427241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24895380|NCT04427241|Analgesics|analgesics|mesh-ancestor
24895381|NCT04427241|Sensory System Agents|sensory system agents|mesh-ancestor
24895382|NCT04427241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24895383|NCT04427241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24895384|NCT04427241|Protective Agents|protective agents|mesh-ancestor
24895385|NCT04427241|Nootropic Agents|nootropic agents|mesh-ancestor
24895386|NCT04424511|Azithromycin|azithromycin|mesh-list
24895387|NCT04424511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24895388|NCT04424511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24514817|NCT00593060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24514818|NCT00593060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24514819|NCT00593060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24514820|NCT00593060|Antifungal Agents|antifungal agents|mesh-ancestor
24613456|NCT01019174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24613457|NCT01019174|Alkylating Agents|alkylating agents|mesh-ancestor
25713997|NCT02349178|Etoposide|etoposide|mesh-list
25713998|NCT02349178|Clofarabine|clofarabine|mesh-list
24696498|NCT01429714|Autonomic Agents|autonomic agents|mesh-ancestor
24696499|NCT01429714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25713999|NCT02349178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25714000|NCT02349178|Immunologic Factors|immunologic factors|mesh-ancestor
24613458|NCT01019174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613459|NCT01019174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25714001|NCT02349178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714002|NCT02349178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25714003|NCT02349178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25714004|NCT02349178|Alkylating Agents|alkylating agents|mesh-ancestor
25714005|NCT02349178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714006|NCT02349178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25714007|NCT02349178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24613460|NCT01019174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24613461|NCT01019174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24613462|NCT01019174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24623606|NCT01072734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817313|NCT02082613|Polidocanol|polidocanol|mesh-list
24817314|NCT02082613|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
24817315|NCT02082613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24895429|NCT04119180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24472449|NCT00399165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24514904|NCT00593463|Verapamil|verapamil|mesh-list
24514905|NCT00593463|Diltiazem|diltiazem|mesh-list
24514906|NCT00593463|Isradipine|isradipine|mesh-list
24514907|NCT00593463|Nifedipine|nifedipine|mesh-list
24514908|NCT00593463|Gabapentin|gabapentin|mesh-list
24514909|NCT00593463|Naloxone|naloxone|mesh-list
24514910|NCT00593463|Analgesics|analgesics|mesh-ancestor
24514931|NCT00593463|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24514953|NCT00593619|Iron|iron|mesh-list
24514978|NCT00593697|Tubulin Modulators|tubulin modulators|mesh-ancestor
24514979|NCT00593697|Antimitotic Agents|antimitotic agents|mesh-ancestor
24514980|NCT00593697|Mitosis Modulators|mitosis modulators|mesh-ancestor
24515035|NCT00594126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515036|NCT00594126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24515037|NCT00594191|Simvastatin|simvastatin|mesh-list
24515038|NCT00594191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24515039|NCT00594191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24515040|NCT00594191|Antimetabolites|antimetabolites|mesh-ancestor
24515041|NCT00594191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515042|NCT00594191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24895485|NCT04022057|Sensory System Agents|sensory system agents|mesh-ancestor
24895486|NCT04022057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24895487|NCT04020601|Ropivacaine|ropivacaine|mesh-list
24895488|NCT04020601|Anesthetics, Local|anesthetics, local|mesh-ancestor
24895548|NCT03900949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895549|NCT03900949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24895550|NCT03900949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24895551|NCT03900949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25714008|NCT02349178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25714009|NCT02349178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25714010|NCT02349178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25714011|NCT02349178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770917|NCT03574818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24895592|NCT03840967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472693|NCT00400231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895703|NCT03474276|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24895704|NCT03474276|Tubulin Modulators|tubulin modulators|mesh-ancestor
24895705|NCT03474276|Antimitotic Agents|antimitotic agents|mesh-ancestor
24515126|NCT00594737|Memantine|memantine|mesh-list
24615172|NCT01028287|Hormones|hormones|mesh-ancestor
24895733|NCT03434041|Dopamine Agents|dopamine agents|mesh-ancestor
24895734|NCT03378466|Heparin|heparin|mesh-list
24895735|NCT03378466|Calcium heparin|calcium heparin|mesh-list
24895736|NCT03378466|Anticoagulants|anticoagulants|mesh-ancestor
24895737|NCT03378466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24895738|NCT03378466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24895739|NCT03378466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895740|NCT03233243|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24895741|NCT03233243|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24696749|NCT01431326|Warfarin|warfarin|mesh-list
24895742|NCT03233243|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24895743|NCT03233243|Antimetabolites|antimetabolites|mesh-ancestor
24895744|NCT03233243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895745|NCT03233243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24895747|NCT03233243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515178|NCT00595322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24515179|NCT00595322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24515180|NCT00595322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24515181|NCT00595322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24515183|NCT00595322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515184|NCT00595322|Growth Inhibitors|growth inhibitors|mesh-ancestor
24515185|NCT00595374|Insulin|insulin|mesh-list
24515186|NCT00595374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24515187|NCT00595374|Insulin Aspart|insulin aspart|mesh-list
24515188|NCT00595374|Insulin Detemir|insulin detemir|mesh-list
25714012|NCT02349178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25714013|NCT02349178|Antimetabolites|antimetabolites|mesh-ancestor
25714014|NCT02349295|Ixekizumab|ixekizumab|mesh-list
25714015|NCT02349295|Dermatologic Agents|dermatologic agents|mesh-ancestor
25770918|NCT03574818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25770919|NCT03574818|Antimetabolites|antimetabolites|mesh-ancestor
25770920|NCT03574818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770921|NCT03574818|Antiviral Agents|antiviral agents|mesh-ancestor
25770922|NCT03574818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25770923|NCT03574818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770924|NCT03574818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25770925|NCT03574818|Immunologic Factors|immunologic factors|mesh-ancestor
25770926|NCT03574818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770927|NCT03574818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25770928|NCT03575702|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25770929|NCT03575702|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25770930|NCT03575702|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25770931|NCT03575702|Cholinergic Agents|cholinergic agents|mesh-ancestor
25770932|NCT03575702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25770933|NCT03575702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770934|NCT03575702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770935|NCT03575702|Urological Agents|urological agents|mesh-ancestor
25777146|NCT03739528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777147|NCT03739528|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25777148|NCT03739528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25777149|NCT03739528|Renal Agents|renal agents|mesh-ancestor
25777150|NCT03739528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25777151|NCT03739528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25777152|NCT03739528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25777153|NCT03739528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25777154|NCT03739528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25777155|NCT03739528|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25777156|NCT03739528|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25777157|NCT03738865|Glucagon|glucagon|mesh-list
25777158|NCT03738865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25777159|NCT03738865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25777160|NCT03738865|Hormones|hormones|mesh-ancestor
25777161|NCT03738865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25777162|NCT03738865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24895767|NCT03151057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895769|NCT03123211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24895770|NCT03123211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24895771|NCT03123211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895772|NCT03123211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24895811|NCT03022097|Respiratory System Agents|respiratory system agents|mesh-ancestor
24895812|NCT03022097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24895813|NCT03022097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24895897|NCT02871297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24895835|NCT02999854|Alkylating Agents|alkylating agents|mesh-ancestor
24515242|NCT00596050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24523729|NCT05340803|Anesthetics|anesthetics|mesh-ancestor
24515293|NCT00596154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24523810|NCT05340192|Octreotide|octreotide|mesh-list
24515298|NCT00596154|Antimetabolites|antimetabolites|mesh-ancestor
24515299|NCT00596154|Dermatologic Agents|dermatologic agents|mesh-ancestor
24515300|NCT00596154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515303|NCT00596154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24515304|NCT00596154|Tubulin Modulators|tubulin modulators|mesh-ancestor
24515305|NCT00596154|Antimitotic Agents|antimitotic agents|mesh-ancestor
24476847|NCT00416676|Mitosis Modulators|mitosis modulators|mesh-ancestor
24895888|NCT02918084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24895893|NCT02871297|Vortioxetine|vortioxetine|mesh-list
24895894|NCT02871297|Antidepressive Agents|antidepressive agents|mesh-ancestor
24895895|NCT02871297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24895896|NCT02871297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24515328|NCT00596297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25714016|NCT02349451|Adalimumab|adalimumab|mesh-list
25714017|NCT02349451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25714018|NCT02349451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25714019|NCT02349477|Gabapentin|gabapentin|mesh-list
25714020|NCT02349477|Analgesics|analgesics|mesh-ancestor
25714021|NCT02349477|Sensory System Agents|sensory system agents|mesh-ancestor
25714022|NCT02349477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25714023|NCT02349477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515329|NCT00596297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24515330|NCT00596297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24515331|NCT00596297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24515332|NCT00596297|Growth Substances|growth substances|mesh-ancestor
24515333|NCT00596297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515334|NCT00596297|Growth Inhibitors|growth inhibitors|mesh-ancestor
24515335|NCT00596336|Imiquimod|imiquimod|mesh-list
24515361|NCT00596414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24515362|NCT00596414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24515363|NCT00596414|Anesthetics, General|anesthetics, general|mesh-ancestor
24515364|NCT00596414|Anesthetics|anesthetics|mesh-ancestor
24515365|NCT00596414|GABA Modulators|gaba modulators|mesh-ancestor
24515366|NCT00596414|GABA Agents|gaba agents|mesh-ancestor
24515367|NCT00596414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24515368|NCT00596414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895944|NCT02794896|Sevoflurane|sevoflurane|mesh-list
24895945|NCT02794896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24895946|NCT02794896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24515369|NCT00596414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24515370|NCT00596414|Narcotics|narcotics|mesh-ancestor
24515371|NCT00596414|Analgesics|analgesics|mesh-ancestor
24515372|NCT00596414|Sensory System Agents|sensory system agents|mesh-ancestor
24515381|NCT00596557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24515382|NCT00596557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24515383|NCT00596557|Immunologic Factors|immunologic factors|mesh-ancestor
24515384|NCT00596557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515385|NCT00596596|Prucalopride|prucalopride|mesh-list
24515386|NCT00596596|Laxatives|laxatives|mesh-ancestor
24515387|NCT00596596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24515388|NCT00596596|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24515389|NCT00596596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24515390|NCT00596596|Serotonin Agents|serotonin agents|mesh-ancestor
24515391|NCT00596596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24515405|NCT00596648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515406|NCT00596648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895977|NCT02728531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24895978|NCT02728531|Antiviral Agents|antiviral agents|mesh-ancestor
24895979|NCT02728531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24895980|NCT02728531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24895981|NCT02728531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24895982|NCT02728531|Alkylating Agents|alkylating agents|mesh-ancestor
24895989|NCT02693184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24895991|NCT02677181|Methotrexate|methotrexate|mesh-list
24895992|NCT02677181|Thymoglobulin|thymoglobulin|mesh-list
24895993|NCT02677181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24895994|NCT02677181|Abortifacient Agents|abortifacient agents|mesh-ancestor
24473020|NCT00401596|Omalizumab|omalizumab|mesh-list
25714024|NCT02349477|Anticonvulsants|anticonvulsants|mesh-ancestor
25714025|NCT02349477|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25714026|NCT02349477|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25714027|NCT02349477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25714028|NCT02349477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25714029|NCT02349477|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25714030|NCT02349477|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25714031|NCT02349477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24895999|NCT02677181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896000|NCT02677181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24896001|NCT02677181|Dermatologic Agents|dermatologic agents|mesh-ancestor
24896002|NCT02677181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896003|NCT02677181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24896004|NCT02677181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24896005|NCT02677181|Immunologic Factors|immunologic factors|mesh-ancestor
24896006|NCT02677181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24896007|NCT02677181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24515449|NCT00597259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24515451|NCT00597389|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24515452|NCT00597389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24515453|NCT00597389|Adrenergic Agents|adrenergic agents|mesh-ancestor
24515454|NCT00597389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24515473|NCT00597597|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24473072|NCT00401765|Docetaxel|docetaxel|mesh-list
24515499|NCT00598052|Serotonin Agents|serotonin agents|mesh-ancestor
24515500|NCT00598052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515501|NCT00598052|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24515502|NCT00598052|Antidepressive Agents|antidepressive agents|mesh-ancestor
24515503|NCT00598052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24515508|NCT00598091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24896069|NCT02514655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24896070|NCT02438722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24896071|NCT02438722|Cetuximab|cetuximab|mesh-list
24896072|NCT02438722|Afatinib|afatinib|mesh-list
24896073|NCT02438722|Antibodies|antibodies|mesh-list
24896074|NCT02438722|Immunoglobulins|immunoglobulins|mesh-list
24817351|NCT02083055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817352|NCT02083055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24817353|NCT02083055|Analgesics|analgesics|mesh-ancestor
24817354|NCT02083055|Sensory System Agents|sensory system agents|mesh-ancestor
24817357|NCT02083055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24817383|NCT02083315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24817384|NCT02083328|Mannitol|mannitol|mesh-list
24817385|NCT02083328|Caffeine|caffeine|mesh-list
24817386|NCT02083328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24817387|NCT02083328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515563|NCT00598195|Anesthetics, General|anesthetics, general|mesh-ancestor
24515564|NCT00598195|Anesthetics|anesthetics|mesh-ancestor
25714032|NCT02349477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714033|NCT02349477|Antimanic Agents|antimanic agents|mesh-ancestor
25714034|NCT02349542|Bupivacaine|bupivacaine|mesh-list
25714035|NCT02349542|Anesthetics, Local|anesthetics, local|mesh-ancestor
25714036|NCT02349542|Anesthetics|anesthetics|mesh-ancestor
25714037|NCT02349542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25714038|NCT02349542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714039|NCT02349542|Sensory System Agents|sensory system agents|mesh-ancestor
25714040|NCT02349542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25714041|NCT02349633|Palbociclib|palbociclib|mesh-list
25714042|NCT02349633|Avelumab|avelumab|mesh-list
25714043|NCT02349633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25714044|NCT02349633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25714045|NCT02349633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896128|NCT02067819|Salicylic Acid|salicylic acid|mesh-list
24515582|NCT00598234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515584|NCT00598247|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
24896156|NCT01668719|Immunologic Factors|immunologic factors|mesh-ancestor
24896157|NCT01668719|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24896158|NCT01668719|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24896159|NCT01668719|Growth Substances|growth substances|mesh-ancestor
24515595|NCT00598338|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24515596|NCT00598338|Serotonin Agents|serotonin agents|mesh-ancestor
24515597|NCT00598338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24515598|NCT00598338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817453|NCT02083991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24817454|NCT02083991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817455|NCT02083991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24698579|NCT01441986|Amantadine|amantadine|mesh-list
24817456|NCT02083991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24817457|NCT02083991|Immunologic Factors|immunologic factors|mesh-ancestor
24817458|NCT02083991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24515647|NCT00598611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24515648|NCT00598611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515649|NCT00598611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515650|NCT00598611|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24896319|NCT04437836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24896320|NCT04437836|Antitubercular Agents|antitubercular agents|mesh-ancestor
24515702|NCT00598858|Cortisone|cortisone|mesh-list
24515703|NCT00598858|Docetaxel|docetaxel|mesh-list
24515704|NCT00598858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24515705|NCT00598858|Tubulin Modulators|tubulin modulators|mesh-ancestor
24515706|NCT00598858|Antimitotic Agents|antimitotic agents|mesh-ancestor
24515707|NCT00598858|Mitosis Modulators|mitosis modulators|mesh-ancestor
24515708|NCT00598858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515709|NCT00598858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24515710|NCT00598858|Glucocorticoids|glucocorticoids|mesh-ancestor
24526229|NCT00621751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25714046|NCT02349633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714047|NCT02349633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25714048|NCT02349685|Anti-Infective Agents|anti-infective agents|mesh-list
25714049|NCT02349685|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25714050|NCT02350309|Lemborexant|lemborexant|mesh-list
25714051|NCT02350309|Flurazepam|flurazepam|mesh-list
25714052|NCT02350309|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
24526230|NCT00621751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24896406|NCT04436796|Pancrelipase|pancrelipase|mesh-list
24896407|NCT04436796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24896408|NCT04436601|Lactulose|lactulose|mesh-list
24515812|NCT00599417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24896495|NCT04435587|Darunavir|darunavir|mesh-list
24896496|NCT04435587|Hydroxychloroquine|hydroxychloroquine|mesh-list
24896497|NCT04435587|Ivermectin|ivermectin|mesh-list
24896498|NCT04435587|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24473565|NCT00403312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24515833|NCT00599573|Autonomic Agents|autonomic agents|mesh-ancestor
24515834|NCT00599573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24515963|NCT00600145|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24515964|NCT00600145|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24515965|NCT00600145|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24515966|NCT00600145|Adrenergic Agents|adrenergic agents|mesh-ancestor
24515967|NCT00600145|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24896643|NCT04434248|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24896644|NCT04434248|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24896645|NCT04434248|Protease Inhibitors|protease inhibitors|mesh-ancestor
24896646|NCT04434248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896648|NCT04434248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24515979|NCT00600158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24515980|NCT00600158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24515981|NCT00600158|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24515982|NCT00600158|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25714053|NCT02350309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25714054|NCT02350309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714055|NCT02350309|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24817558|NCT02084550|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24817559|NCT02084550|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24817561|NCT02084563|Decitabine|decitabine|mesh-list
24817562|NCT02084563|Daunorubicin|daunorubicin|mesh-list
24817563|NCT02084563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24817564|NCT02084563|Antimetabolites|antimetabolites|mesh-ancestor
24817565|NCT02084563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817566|NCT02084563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24817567|NCT02084563|Antiviral Agents|antiviral agents|mesh-ancestor
24817568|NCT02084563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24817576|NCT02084576|Ketorolac|ketorolac|mesh-list
24896791|NCT04432714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698744|NCT01442870|Metformin|metformin|mesh-list
24896792|NCT04432714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24896793|NCT04432714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24896794|NCT04432714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24896795|NCT04432714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24896797|NCT04432714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896798|NCT04432714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24896800|NCT04432714|Hormones|hormones|mesh-ancestor
24896801|NCT04432714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24896802|NCT04432714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24896803|NCT04432714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24896804|NCT04432714|Tubulin Modulators|tubulin modulators|mesh-ancestor
24896805|NCT04432714|Antimitotic Agents|antimitotic agents|mesh-ancestor
24896806|NCT04432714|Mitosis Modulators|mitosis modulators|mesh-ancestor
24516178|NCT00600847|Histamine Agents|histamine agents|mesh-ancestor
24516179|NCT00600847|Antipruritics|antipruritics|mesh-ancestor
24516180|NCT00600847|Dermatologic Agents|dermatologic agents|mesh-ancestor
24516184|NCT00600873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516186|NCT00600873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516187|NCT00600873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24516188|NCT00600873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24516189|NCT00600873|Dopamine Agonists|dopamine agonists|mesh-ancestor
24516190|NCT00600873|Dopamine Agents|dopamine agents|mesh-ancestor
24516191|NCT00600873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24516192|NCT00600912|SMOFlipid|smoflipid|mesh-list
24896847|NCT04432415|Fluorides|fluorides|mesh-list
24478523|NCT00423397|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24478524|NCT00423397|Gefitinib|gefitinib|mesh-list
24478525|NCT00423397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478526|NCT00423397|Antiviral Agents|antiviral agents|mesh-ancestor
24478527|NCT00423397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24478533|NCT00423475|Goserelin|goserelin|mesh-list
25714056|NCT02350309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25714057|NCT02350309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25714058|NCT02350309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714059|NCT02350309|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24516253|NCT00601276|Cyproterone|cyproterone|mesh-list
24516254|NCT00601276|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25714060|NCT02350309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25714061|NCT02350309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25714062|NCT02350309|GABA Modulators|gaba modulators|mesh-ancestor
24516255|NCT00601276|Fertility Agents|fertility agents|mesh-ancestor
24516256|NCT00601276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24516257|NCT00601276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516280|NCT00601315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24516281|NCT00601315|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24516282|NCT00601315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24896922|NCT04432259|Hormones|hormones|mesh-ancestor
24474038|NCT00404781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24474039|NCT00404781|Autonomic Agents|autonomic agents|mesh-ancestor
24474040|NCT00404781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24474041|NCT00404781|Respiratory System Agents|respiratory system agents|mesh-ancestor
24474042|NCT00404781|Vasodilator Agents|vasodilator agents|mesh-ancestor
24516305|NCT00601432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817616|NCT02084615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24474111|NCT00404937|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
24474112|NCT00404937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24516404|NCT00601913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516405|NCT00601913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24516406|NCT00601913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24897019|NCT04430621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24897020|NCT04430621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897023|NCT04430556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24897035|NCT04430361|Antiemetics|antiemetics|mesh-ancestor
24897036|NCT04430361|Autonomic Agents|autonomic agents|mesh-ancestor
24719790|NCT01564108|Ranibizumab|ranibizumab|mesh-list
25714063|NCT02350309|GABA Agents|gaba agents|mesh-ancestor
25714064|NCT02350478|Linagliptin|linagliptin|mesh-list
25714065|NCT02350478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25714066|NCT02350478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714067|NCT02350478|Incretins|incretins|mesh-ancestor
25714068|NCT02350478|Hormones|hormones|mesh-ancestor
25770936|NCT03575806|Chlorotrianisene|chlorotrianisene|mesh-list
25770937|NCT03575806|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25770938|NCT03575806|Estrogens|estrogens|mesh-ancestor
25770939|NCT03575806|Hormones|hormones|mesh-ancestor
25770940|NCT03575806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25770941|NCT03575806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770942|NCT03575806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25770943|NCT03575806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25770944|NCT03575871|Abrocitinib|abrocitinib|mesh-list
25770945|NCT03575871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25770946|NCT03575871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770947|NCT03575871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770948|NCT03576066|Tenofovir|tenofovir|mesh-list
25770949|NCT03576066|Entecavir|entecavir|mesh-list
25770950|NCT03576066|Antiviral Agents|antiviral agents|mesh-ancestor
25770951|NCT03576066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25770952|NCT03576066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25770953|NCT03576066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25770954|NCT03576066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770955|NCT03576066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770956|NCT03576066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25770957|NCT03576066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25770958|NCT03577171|Entecavir|entecavir|mesh-list
25770959|NCT03577171|Antiviral Agents|antiviral agents|mesh-ancestor
25770960|NCT03577171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25770961|NCT03577275|Moxifloxacin|moxifloxacin|mesh-list
25770962|NCT03577275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25770963|NCT03577275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25770964|NCT03577275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25770965|NCT03577275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25770966|NCT03577275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770967|NCT03577275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770968|NCT03577275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25770969|NCT03577730|Caffeine|caffeine|mesh-list
25770970|NCT03577730|Caffeine citrate|caffeine citrate|mesh-list
25770971|NCT03577730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770972|NCT03577730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25770973|NCT03577730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897037|NCT04430361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24897038|NCT04430361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897039|NCT04430361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24897040|NCT04430361|Glucocorticoids|glucocorticoids|mesh-ancestor
24897041|NCT04430361|Hormones|hormones|mesh-ancestor
24897043|NCT04430361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24516437|NCT00602004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516438|NCT00601159|Gemcitabine|gemcitabine|mesh-list
24516481|NCT00602134|Antimetabolites|antimetabolites|mesh-ancestor
24897169|NCT04428268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24897170|NCT04428268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897171|NCT04428268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24897172|NCT04428268|Filaricides|filaricides|mesh-ancestor
24897173|NCT04428268|Antinematodal Agents|antinematodal agents|mesh-ancestor
24516546|NCT00602394|Lithium Carbonate|lithium carbonate|mesh-list
24516547|NCT00602394|Antidepressive Agents|antidepressive agents|mesh-ancestor
24516548|NCT00602394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24516549|NCT00602394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516550|NCT00602394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516552|NCT00602394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24516553|NCT00602394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24516554|NCT00602394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25770975|NCT03577730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770976|NCT03577730|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25770977|NCT03577730|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25770978|NCT03577730|Purinergic Agents|purinergic agents|mesh-ancestor
25770979|NCT03577730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25770980|NCT03578146|Rivaroxaban|rivaroxaban|mesh-list
25770981|NCT03578146|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24897197|NCT04427826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24516568|NCT00602407|Protective Agents|protective agents|mesh-ancestor
24516569|NCT00602407|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24516570|NCT00602407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24516571|NCT00602407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516573|NCT00602498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24516574|NCT00602498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24516575|NCT00602498|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24516578|NCT00602498|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24516579|NCT00602498|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24516581|NCT00602511|Bortezomib|bortezomib|mesh-list
24516582|NCT00602511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516583|NCT00602511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24516584|NCT00602511|Immunologic Factors|immunologic factors|mesh-ancestor
24516585|NCT00602511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516586|NCT00602511|Leprostatic Agents|leprostatic agents|mesh-ancestor
24516587|NCT00602511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24516588|NCT00602511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24516589|NCT00602511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24516590|NCT00602511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24516598|NCT00602524|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24516599|NCT00602524|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24516600|NCT00602524|Cholinergic Agents|cholinergic agents|mesh-ancestor
24516601|NCT00602524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24516602|NCT00602524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516603|NCT00602550|Zidovudine|zidovudine|mesh-list
24516604|NCT00602550|Antimetabolites|antimetabolites|mesh-ancestor
24516605|NCT00602550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817631|NCT02084654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24817632|NCT02084654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817633|NCT02084654|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24817634|NCT02084654|Incretins|incretins|mesh-ancestor
24817635|NCT02084654|Hormones|hormones|mesh-ancestor
24897226|NCT04427020|Chelating Agents|chelating agents|mesh-ancestor
24897227|NCT04427020|Sequestering Agents|sequestering agents|mesh-ancestor
24897228|NCT04427020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897229|NCT04426994|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
24897230|NCT04426994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474358|NCT00405769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24474359|NCT00405769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24474360|NCT00405769|Antimetabolites|antimetabolites|mesh-ancestor
24516627|NCT00602615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24516629|NCT00602615|Natriuretic Agents|natriuretic agents|mesh-ancestor
24516630|NCT00602615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516631|NCT00602615|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24516632|NCT00602615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24516633|NCT00602615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770982|NCT03578146|Antithrombins|antithrombins|mesh-ancestor
25770983|NCT03578146|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25770984|NCT03578146|Protease Inhibitors|protease inhibitors|mesh-ancestor
25770985|NCT03578146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770986|NCT03578146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770987|NCT03578146|Anticoagulants|anticoagulants|mesh-ancestor
25770988|NCT03579719|Itraconazole|itraconazole|mesh-list
25770989|NCT03579719|Antifungal Agents|antifungal agents|mesh-ancestor
25714069|NCT02350478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25714070|NCT02350478|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25714071|NCT02350478|Protease Inhibitors|protease inhibitors|mesh-ancestor
25714072|NCT02350478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25714073|NCT02350478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531625|NCT00636870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24516635|NCT00602680|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24516636|NCT00602680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516637|NCT00602680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516638|NCT00602680|Cholinergic Agents|cholinergic agents|mesh-ancestor
24516639|NCT00602680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24516651|NCT00602693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24700489|NCT01452698|Lansoprazole|lansoprazole|mesh-list
24516652|NCT00602693|Alkylating Agents|alkylating agents|mesh-ancestor
24516653|NCT00602693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516654|NCT00602693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24897233|NCT04427098|Enoxaparin sodium|enoxaparin sodium|mesh-list
24516658|NCT00602693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24516659|NCT00602693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24516660|NCT00602693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24516661|NCT00602693|Antifungal Agents|antifungal agents|mesh-ancestor
24897259|NCT04426721|Hyaluronic Acid|hyaluronic acid|mesh-list
24897260|NCT04426721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24897261|NCT04426721|Immunologic Factors|immunologic factors|mesh-ancestor
24897262|NCT04426721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516666|NCT00602693|Protective Agents|protective agents|mesh-ancestor
24516668|NCT00602706|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
24516669|NCT00602706|Sargramostim|sargramostim|mesh-list
24516670|NCT00602706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24516671|NCT00602706|Alkylating Agents|alkylating agents|mesh-ancestor
24516672|NCT00602706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516673|NCT00602706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516674|NCT00602706|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24516675|NCT00602706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24516676|NCT00602706|Immunologic Factors|immunologic factors|mesh-ancestor
24516677|NCT00602706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714074|NCT02350569|Sofosbuvir|sofosbuvir|mesh-list
25714075|NCT02350569|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25714076|NCT02350569|Ledipasvir|ledipasvir|mesh-list
24516684|NCT00602719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24516685|NCT00602719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24516691|NCT00602719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516693|NCT00602849|Antidepressive Agents|antidepressive agents|mesh-ancestor
24897287|NCT04426578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897292|NCT04426669|Cyclophosphamide|cyclophosphamide|mesh-list
24897293|NCT04426669|Fludarabine|fludarabine|mesh-list
24897294|NCT04426669|Interleukin-2|interleukin-2|mesh-list
24897295|NCT04426669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24897296|NCT04426669|Immunologic Factors|immunologic factors|mesh-ancestor
24897297|NCT04426669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897298|NCT04426669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24897299|NCT04426669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24897300|NCT04426669|Alkylating Agents|alkylating agents|mesh-ancestor
24897301|NCT04426669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516701|NCT00602849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516702|NCT00602862|Bevacizumab|bevacizumab|mesh-list
24516703|NCT00602862|Sorafenib|sorafenib|mesh-list
24516704|NCT00602862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24516705|NCT00602862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516706|NCT00602862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24516707|NCT00602862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24516708|NCT00602862|Growth Substances|growth substances|mesh-ancestor
24516709|NCT00602862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516710|NCT00602862|Growth Inhibitors|growth inhibitors|mesh-ancestor
24516711|NCT00602862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24516712|NCT00602862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24516717|NCT00602901|Analgesics|analgesics|mesh-ancestor
24516718|NCT00602901|Sensory System Agents|sensory system agents|mesh-ancestor
24516719|NCT00602901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24516720|NCT00602901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516735|NCT00603083|Ropivacaine|ropivacaine|mesh-list
24516736|NCT00603083|Anesthetics, Local|anesthetics, local|mesh-ancestor
24516737|NCT00603083|Anesthetics|anesthetics|mesh-ancestor
24516738|NCT00603083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24479574|NCT00427362|Adalimumab|adalimumab|mesh-list
24897340|NCT04425993|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25714077|NCT02350569|Antiviral Agents|antiviral agents|mesh-ancestor
25714078|NCT02350569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25714079|NCT02351037|Azacitidine|azacitidine|mesh-list
25714080|NCT02351037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25714081|NCT02351037|Antimetabolites|antimetabolites|mesh-ancestor
25714082|NCT02351037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714083|NCT02351037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25714084|NCT02351037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25714085|NCT02351115|Alprazolam|alprazolam|mesh-list
25714086|NCT02351115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25714087|NCT02351115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25714088|NCT02351115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714089|NCT02351115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25714090|NCT02351115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25714091|NCT02351115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24897341|NCT04425993|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
24897342|NCT04425993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24897343|NCT04425993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24897345|NCT04425993|Sensory System Agents|sensory system agents|mesh-ancestor
24897346|NCT04425993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24897347|NCT04425993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897348|NCT04425993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24897349|NCT04425993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24897350|NCT04425993|Gout Suppressants|gout suppressants|mesh-ancestor
24474452|NCT00406042|Autonomic Agents|autonomic agents|mesh-ancestor
24474453|NCT00406042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24474454|NCT00406042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24474455|NCT00406042|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24474456|NCT00406042|Protective Agents|protective agents|mesh-ancestor
24474457|NCT00406094|Montelukast|montelukast|mesh-list
24897396|NCT04425590|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24897397|NCT04425590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24897398|NCT04425590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897399|NCT04425590|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24897400|NCT04425590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24897427|NCT04425642|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24897441|NCT04425681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24613770|NCT01020708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24613771|NCT01020708|Antitubercular Agents|antitubercular agents|mesh-ancestor
24613772|NCT01020708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24613773|NCT01020734|Cyclosporine|cyclosporine|mesh-list
24613774|NCT01020734|Cyclophosphamide|cyclophosphamide|mesh-list
25714092|NCT02351115|GABA Modulators|gaba modulators|mesh-ancestor
25714093|NCT02351115|GABA Agents|gaba agents|mesh-ancestor
25714094|NCT02351115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25714095|NCT02351115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714096|NCT02351167|Nicotine|nicotine|mesh-list
25714097|NCT02351167|Varenicline|varenicline|mesh-list
25714098|NCT02351167|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25714099|NCT02351167|Autonomic Agents|autonomic agents|mesh-ancestor
25714100|NCT02351167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25714101|NCT02351167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714102|NCT02351167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25714103|NCT02351167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25714104|NCT02351167|Cholinergic Agents|cholinergic agents|mesh-ancestor
24613775|NCT01020734|Busulfan|busulfan|mesh-list
24613776|NCT01020734|Methotrexate|methotrexate|mesh-list
24613777|NCT01020734|Fludarabine|fludarabine|mesh-list
24613779|NCT01020734|Cyclosporins|cyclosporins|mesh-list
24817670|NCT02085005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817671|NCT02085005|Growth Inhibitors|growth inhibitors|mesh-ancestor
24817673|NCT02085018|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24817674|NCT02085018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24817675|NCT02085018|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24817676|NCT02085018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817677|NCT02085018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817678|NCT02085109|Theobromine|theobromine|mesh-list
24817679|NCT02085109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24817680|NCT02085109|Autonomic Agents|autonomic agents|mesh-ancestor
24817681|NCT02085109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24817682|NCT02085109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817683|NCT02085109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24817684|NCT02085109|Respiratory System Agents|respiratory system agents|mesh-ancestor
24817685|NCT02085109|Vasodilator Agents|vasodilator agents|mesh-ancestor
24817686|NCT02085213|Nitroglycerin|nitroglycerin|mesh-list
24817687|NCT02085213|Vasodilator Agents|vasodilator agents|mesh-ancestor
24817688|NCT02085239|Lidocaine|lidocaine|mesh-list
24817689|NCT02085239|Ropivacaine|ropivacaine|mesh-list
24817690|NCT02085239|Anesthetics, Local|anesthetics, local|mesh-ancestor
24817691|NCT02085239|Anesthetics|anesthetics|mesh-ancestor
24817692|NCT02085239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24474596|NCT00406861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474597|NCT00406861|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24474598|NCT00406861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24474599|NCT00406861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474600|NCT00406874|Folic Acid|folic acid|mesh-list
24474601|NCT00406874|Hematinics|hematinics|mesh-ancestor
24474602|NCT00406874|Vitamin B Complex|vitamin b complex|mesh-ancestor
24474603|NCT00406874|Vitamins|vitamins|mesh-ancestor
24474604|NCT00406874|Micronutrients|micronutrients|mesh-ancestor
24474605|NCT00406874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474606|NCT00406887|Difluprednate|difluprednate|mesh-list
24516788|NCT00603434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24516789|NCT00603434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516790|NCT00603434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24897518|NCT04425226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24897519|NCT04425226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24897520|NCT04425226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24897526|NCT04424901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24897527|NCT04424901|Vasodilator Agents|vasodilator agents|mesh-ancestor
24720352|NCT01567774|Atorvastatin|atorvastatin|mesh-list
24897528|NCT04424875|Melatonin|melatonin|mesh-list
24897529|NCT04424875|Antioxidants|antioxidants|mesh-ancestor
24479918|NCT00428896|Gefitinib|gefitinib|mesh-list
24474608|NCT00406887|Hormones|hormones|mesh-ancestor
24897533|NCT04424875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24897534|NCT04424420|Acetaminophen|acetaminophen|mesh-list
24897535|NCT04424420|Ibuprofen|ibuprofen|mesh-list
24897536|NCT04424420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24897537|NCT04424420|Analgesics|analgesics|mesh-ancestor
24897538|NCT04424420|Sensory System Agents|sensory system agents|mesh-ancestor
24897539|NCT04424420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24897590|NCT04423926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24897591|NCT04423926|Tubulin Modulators|tubulin modulators|mesh-ancestor
24897592|NCT04423926|Antimitotic Agents|antimitotic agents|mesh-ancestor
24897593|NCT04423926|Mitosis Modulators|mitosis modulators|mesh-ancestor
25714105|NCT02351167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24897594|NCT04423926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24897595|NCT04423926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24897596|NCT04423926|Growth Substances|growth substances|mesh-ancestor
25714106|NCT02351167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714107|NCT02351700|Ibuprofen|ibuprofen|mesh-list
25714108|NCT02351700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25714109|NCT02351700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25714110|NCT02351700|Analgesics|analgesics|mesh-ancestor
25714111|NCT02351700|Sensory System Agents|sensory system agents|mesh-ancestor
25714112|NCT02351700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25777163|NCT03738865|Incretins|incretins|mesh-ancestor
25777164|NCT03736785|Insulin|insulin|mesh-list
25777165|NCT03736785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25777166|NCT03736785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714113|NCT02351700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714114|NCT02351700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25714115|NCT02351700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25714116|NCT02351700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24897597|NCT04423926|Growth Inhibitors|growth inhibitors|mesh-ancestor
24897598|NCT04423926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24897599|NCT04423926|Glucocorticoids|glucocorticoids|mesh-ancestor
24897600|NCT04423926|Hormones|hormones|mesh-ancestor
24897601|NCT04423926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24897602|NCT04423926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24897603|NCT04424056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24897604|NCT04424056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24474713|NCT00407121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24474714|NCT00407121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474715|NCT00407121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24474716|NCT00407121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24474717|NCT00407121|Growth Substances|growth substances|mesh-ancestor
24474718|NCT00407121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474832|NCT00407589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474833|NCT00407589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474834|NCT00407641|Heparin|heparin|mesh-list
24474835|NCT00407641|Tinzaparin|tinzaparin|mesh-list
24474836|NCT00407641|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24474837|NCT00407641|Dalteparin|dalteparin|mesh-list
24817724|NCT02085317|Cholinergic Agents|cholinergic agents|mesh-ancestor
24817725|NCT02085317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24817726|NCT02085317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516810|NCT00603772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24516811|NCT00603772|Keratolytic Agents|keratolytic agents|mesh-ancestor
24516812|NCT00603772|Dermatologic Agents|dermatologic agents|mesh-ancestor
24516814|NCT00603785|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24817741|NCT02085408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817742|NCT02085408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24817743|NCT02085408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24817744|NCT02085408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24817745|NCT02085538|Palbociclib|palbociclib|mesh-list
24817746|NCT02085538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24817747|NCT02085538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24817748|NCT02085538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817749|NCT02085538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897753|NCT04422392|Tubulin Modulators|tubulin modulators|mesh-ancestor
24897754|NCT04422392|Antimitotic Agents|antimitotic agents|mesh-ancestor
24897779|NCT04422184|Respiratory System Agents|respiratory system agents|mesh-ancestor
24897780|NCT04421872|Anesthetics|anesthetics|mesh-list
24897781|NCT04421872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25714117|NCT02351700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25714118|NCT02351700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714119|NCT02351739|Pembrolizumab|pembrolizumab|mesh-list
25714120|NCT02351739|Acalabrutinib|acalabrutinib|mesh-list
25714121|NCT02351739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25714122|NCT02351739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25714123|NCT02351934|Celecoxib|celecoxib|mesh-list
25714124|NCT02351934|Furosemide|furosemide|mesh-list
25714125|NCT02351934|Gabapentin|gabapentin|mesh-list
24897782|NCT04421872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897783|NCT04421716|Ursolic acid|ursolic acid|mesh-list
24474891|NCT00407927|Histamine Antagonists|histamine antagonists|mesh-ancestor
24474892|NCT00407927|Histamine Agents|histamine agents|mesh-ancestor
24474893|NCT00407927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24424726|NCT00230503|Adefovir|adefovir|mesh-list
24897808|NCT04421911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24897809|NCT04421911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24897810|NCT04421911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24897811|NCT04421911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897812|NCT04421742|Beclomethasone|beclomethasone|mesh-list
24897813|NCT04421742|Formoterol Fumarate|formoterol fumarate|mesh-list
24897814|NCT04421742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24897815|NCT04421742|Autonomic Agents|autonomic agents|mesh-ancestor
24897816|NCT04421742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24480260|NCT00430170|Dipyridamole|dipyridamole|mesh-list
24897819|NCT04421742|Respiratory System Agents|respiratory system agents|mesh-ancestor
24897820|NCT04421742|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24897821|NCT04421742|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24897823|NCT04421742|Adrenergic Agents|adrenergic agents|mesh-ancestor
24897824|NCT04421742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24897825|NCT04421742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24897826|NCT04421742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24897830|NCT04421547|Letrozole|letrozole|mesh-list
24897831|NCT04421547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24897832|NCT04421547|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24897833|NCT04421547|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24474942|NCT00408213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24474943|NCT00408213|Antitubercular Agents|antitubercular agents|mesh-ancestor
24474944|NCT00408213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24474945|NCT00408213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24474946|NCT00408213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474947|NCT00408213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474948|NCT00408226|Pemetrexed|pemetrexed|mesh-list
24474949|NCT00408226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25714126|NCT02351934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25714127|NCT02351934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25714128|NCT02351934|Analgesics|analgesics|mesh-ancestor
25714129|NCT02351934|Sensory System Agents|sensory system agents|mesh-ancestor
25714130|NCT02351934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25714131|NCT02351934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897846|NCT04421300|Immunologic Factors|immunologic factors|mesh-ancestor
25714132|NCT02351934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24897847|NCT04421300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474968|NCT00408252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474969|NCT00408278|Mitoxantrone|mitoxantrone|mesh-list
24474970|NCT00408278|Analgesics|analgesics|mesh-ancestor
24474971|NCT00408278|Sensory System Agents|sensory system agents|mesh-ancestor
24474972|NCT00408278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24474973|NCT00408278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474974|NCT00408278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24474975|NCT00408278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24897876|NCT04420936|Benzocaine|benzocaine|mesh-list
24475013|NCT00408525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475016|NCT00408538|Anti-Infective Agents|anti-infective agents|mesh-list
24475017|NCT00408538|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24475018|NCT00408538|Antiviral Agents|antiviral agents|mesh-ancestor
24475019|NCT00408551|Leucovorin|leucovorin|mesh-list
24475020|NCT00408551|Fluorouracil|fluorouracil|mesh-list
24475021|NCT00408551|Floxuridine|floxuridine|mesh-list
24475022|NCT00408551|Oxaliplatin|oxaliplatin|mesh-list
24897902|NCT04419948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24897903|NCT04419948|Analgesics|analgesics|mesh-ancestor
24897904|NCT04419948|Sensory System Agents|sensory system agents|mesh-ancestor
24897905|NCT04419948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24897906|NCT04419948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24897907|NCT04419948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24897912|NCT04420351|Aspirin|aspirin|mesh-list
24475031|NCT00408551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24475032|NCT00408551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24516989|NCT00605137|Insulin Detemir|insulin detemir|mesh-list
24516991|NCT00605137|Insulin, Isophane|insulin, isophane|mesh-list
24475135|NCT00409201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24475136|NCT00409201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24475137|NCT00409201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24475138|NCT00409201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24475139|NCT00409201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898012|NCT04419038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898014|NCT04419038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24898030|NCT04419025|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24898031|NCT04419025|Antiviral Agents|antiviral agents|mesh-ancestor
24898032|NCT04419025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24898033|NCT04419025|Expectorants|expectorants|mesh-ancestor
24898079|NCT04418154|Epirubicin|epirubicin|mesh-list
24898080|NCT04418154|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24898081|NCT04418154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24898082|NCT04418154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898084|NCT04418154|Antimitotic Agents|antimitotic agents|mesh-ancestor
25714134|NCT02351934|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25714135|NCT02351934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25714136|NCT02351934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25714137|NCT02351934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714138|NCT02351934|Anticonvulsants|anticonvulsants|mesh-ancestor
25714139|NCT02351934|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24475210|NCT00409383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24475211|NCT00409383|Alkylating Agents|alkylating agents|mesh-ancestor
24898117|NCT04418219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24898118|NCT04418219|Antiviral Agents|antiviral agents|mesh-ancestor
24898119|NCT04418219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24898121|NCT04418128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24898122|NCT04418128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24898123|NCT04418128|Analgesics|analgesics|mesh-ancestor
24898124|NCT04418128|Sensory System Agents|sensory system agents|mesh-ancestor
24898125|NCT04418128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24898126|NCT04418128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898127|NCT04418128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24898128|NCT04418128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24898129|NCT04418128|Anticoagulants|anticoagulants|mesh-ancestor
24898130|NCT04418128|Protease Inhibitors|protease inhibitors|mesh-ancestor
24898131|NCT04418128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24898173|NCT04417452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898234|NCT04416399|Respiratory System Agents|respiratory system agents|mesh-ancestor
24898235|NCT04416399|Glucocorticoids|glucocorticoids|mesh-ancestor
24898236|NCT04416399|Hormones|hormones|mesh-ancestor
24898237|NCT04416399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24898238|NCT04416607|Menotropins|menotropins|mesh-list
24898239|NCT04416607|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24898240|NCT04416607|Fertility Agents|fertility agents|mesh-ancestor
24475326|NCT00409903|Eprosartan|eprosartan|mesh-list
24898272|NCT04416035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898273|NCT04416035|Growth Inhibitors|growth inhibitors|mesh-ancestor
24898274|NCT04415983|Metronidazole|metronidazole|mesh-list
24898275|NCT04415983|Clarithromycin|clarithromycin|mesh-list
24898280|NCT04415983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24898281|NCT04415983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24898282|NCT04415983|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24898283|NCT04415983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24898284|NCT04415983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898326|NCT04415476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898327|NCT04415476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24898328|NCT04415476|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24898329|NCT04415476|Antitubercular Agents|antitubercular agents|mesh-ancestor
24898330|NCT04415476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24898331|NCT04415476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24898332|NCT04415476|Antifungal Agents|antifungal agents|mesh-ancestor
24898333|NCT04414995|Acetaminophen|acetaminophen|mesh-list
24898334|NCT04414995|Ibuprofen|ibuprofen|mesh-list
24898335|NCT04414995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24898336|NCT04414995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24898337|NCT04414995|Analgesics|analgesics|mesh-ancestor
24898338|NCT04414995|Sensory System Agents|sensory system agents|mesh-ancestor
24517122|NCT00606099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898402|NCT04414800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898403|NCT04414800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24898404|NCT04414800|Narcotics|narcotics|mesh-ancestor
24898405|NCT04414800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24898425|NCT04414540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24898426|NCT04414540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898427|NCT04414540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24898428|NCT04414540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898429|NCT04414605|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24898430|NCT04414605|Immunologic Factors|immunologic factors|mesh-ancestor
24898431|NCT04414605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898433|NCT04414566|Cisplatin|cisplatin|mesh-list
24898434|NCT04414566|Docetaxel|docetaxel|mesh-list
24898435|NCT04414566|Fluorouracil|fluorouracil|mesh-list
24898436|NCT04414566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898437|NCT04414566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24898438|NCT04414566|Antimetabolites|antimetabolites|mesh-ancestor
24898440|NCT04414566|Antiviral Agents|antiviral agents|mesh-ancestor
24475506|NCT00410631|Antimitotic Agents|antimitotic agents|mesh-ancestor
24475507|NCT00410631|Mitosis Modulators|mitosis modulators|mesh-ancestor
24475509|NCT00410631|Dermatologic Agents|dermatologic agents|mesh-ancestor
24898478|NCT04413838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898479|NCT04413838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24898480|NCT04413838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898481|NCT04413864|Dexmedetomidine|dexmedetomidine|mesh-list
24898482|NCT04413864|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24898483|NCT04413864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24898484|NCT04413864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898485|NCT04413864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24898523|NCT04413227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898524|NCT04413227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24898525|NCT04413227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24898526|NCT04413227|Growth Substances|growth substances|mesh-ancestor
24898527|NCT04413227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898528|NCT04413227|Growth Inhibitors|growth inhibitors|mesh-ancestor
24817755|NCT02085577|Ondansetron|ondansetron|mesh-list
24475663|NCT00411034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24475664|NCT00411034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475666|NCT00411034|Sensory System Agents|sensory system agents|mesh-ancestor
24475667|NCT00411034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24475668|NCT00411047|Gefitinib|gefitinib|mesh-list
24475669|NCT00411047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517195|NCT00606450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517196|NCT00606450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24898738|NCT04411160|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24898750|NCT04411069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898751|NCT04411069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24898752|NCT04411069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24898753|NCT04411069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24898754|NCT04411069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25714140|NCT02351934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25714141|NCT02351934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24898755|NCT04411069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25714142|NCT02351934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25714143|NCT02351934|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25714144|NCT02351934|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25714145|NCT02351934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25714146|NCT02351934|Antimanic Agents|antimanic agents|mesh-ancestor
25714147|NCT02351934|Diuretics|diuretics|mesh-ancestor
24898756|NCT04411069|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24898757|NCT04411069|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24898758|NCT04411069|Dopamine Agents|dopamine agents|mesh-ancestor
24898759|NCT04411069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24898762|NCT04410874|Immunologic Factors|immunologic factors|mesh-ancestor
24898763|NCT04410874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898764|NCT04410887|Olaparib|olaparib|mesh-list
24898765|NCT04410887|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24898794|NCT04410588|Fentanyl|fentanyl|mesh-list
24898868|NCT04410211|GABA Modulators|gaba modulators|mesh-ancestor
24898869|NCT04410211|GABA Agents|gaba agents|mesh-ancestor
24898870|NCT04410211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24898871|NCT04410211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898872|NCT04410211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24898873|NCT04410211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24898874|NCT04409522|Melatonin|melatonin|mesh-list
24898875|NCT04409522|Antioxidants|antioxidants|mesh-ancestor
24898876|NCT04409522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24898877|NCT04409522|Protective Agents|protective agents|mesh-ancestor
24898878|NCT04409522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24898879|NCT04409522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24898880|NCT04409431|Epinephrine|epinephrine|mesh-list
24898881|NCT04409431|Racepinephrine|racepinephrine|mesh-list
24898882|NCT04409431|Epinephryl borate|epinephryl borate|mesh-list
24898901|NCT04409691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24898902|NCT04409691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24898903|NCT04409691|Antifungal Agents|antifungal agents|mesh-ancestor
24898904|NCT04409691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24898908|NCT04409769|Ceftobiprole|ceftobiprole|mesh-list
24517289|NCT00607074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24899018|NCT04407312|Clopidogrel|clopidogrel|mesh-list
24899020|NCT04407312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24899030|NCT04407312|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24899031|NCT04407312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24899032|NCT04407312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899033|NCT04407312|Antipyretics|antipyretics|mesh-ancestor
24899034|NCT04407312|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24899035|NCT04407312|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24899036|NCT04407312|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24899037|NCT04407312|Purinergic Agents|purinergic agents|mesh-ancestor
24899038|NCT04407312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24899052|NCT04407234|Sensory System Agents|sensory system agents|mesh-ancestor
24899053|NCT04407234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24899054|NCT04407234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817764|NCT02085577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24817765|NCT02085577|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24817766|NCT02085577|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24817767|NCT02085577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24431753|NCT00252863|Xhance|xhance|mesh-list
24517346|NCT00607542|GABA Agonists|gaba agonists|mesh-ancestor
24817768|NCT02085577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817769|NCT02085577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24817770|NCT02085577|Narcotics|narcotics|mesh-ancestor
24817771|NCT02085577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24817772|NCT02085577|Antipyretics|antipyretics|mesh-ancestor
24817773|NCT02085577|Antiemetics|antiemetics|mesh-ancestor
24817774|NCT02085577|Autonomic Agents|autonomic agents|mesh-ancestor
24817775|NCT02085577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24817776|NCT02085577|Antipruritics|antipruritics|mesh-ancestor
24817777|NCT02085577|Dermatologic Agents|dermatologic agents|mesh-ancestor
24817778|NCT02085577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24817779|NCT02085577|Serotonin Agents|serotonin agents|mesh-ancestor
24817780|NCT02085577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24817781|NCT02085577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24817782|NCT02085577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24817783|NCT02085577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24817784|NCT02085577|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24517374|NCT00607581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24517544|NCT00608673|Betamethasone benzoate|betamethasone benzoate|mesh-list
24517545|NCT00608673|Pimecrolimus|pimecrolimus|mesh-list
24517546|NCT00608673|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24517547|NCT00608673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24517548|NCT00608673|Glucocorticoids|glucocorticoids|mesh-ancestor
24517550|NCT00608673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24517551|NCT00608673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517552|NCT00608673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24517553|NCT00608673|Respiratory System Agents|respiratory system agents|mesh-ancestor
24476108|NCT00413075|Belinostat|belinostat|mesh-list
24476109|NCT00413075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25714148|NCT02351934|Natriuretic Agents|natriuretic agents|mesh-ancestor
25714149|NCT02351934|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25714150|NCT02351934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25714151|NCT02351960|Dexlansoprazole|dexlansoprazole|mesh-list
25714152|NCT02351960|Lansoprazole|lansoprazole|mesh-list
25714153|NCT02351960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25714154|NCT02351960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25714155|NCT02351960|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24476194|NCT00413426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24476195|NCT00413426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476196|NCT00413426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476197|NCT00413426|Urological Agents|urological agents|mesh-ancestor
24476199|NCT00413439|Antifungal Agents|antifungal agents|mesh-ancestor
24476200|NCT00413439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24476201|NCT00413452|Etanercept|etanercept|mesh-list
24476202|NCT00413452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24476203|NCT00413452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24476204|NCT00413452|Analgesics|analgesics|mesh-ancestor
24476206|NCT00413452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24517835|NCT00610142|Dermatologic Agents|dermatologic agents|mesh-ancestor
24899299|NCT04404946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24899300|NCT04404946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899301|NCT04404946|Sympathomimetics|sympathomimetics|mesh-ancestor
24899302|NCT04404946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24899303|NCT04404946|Nasal Decongestants|nasal decongestants|mesh-ancestor
24899340|NCT04404686|Tocolytic Agents|tocolytic agents|mesh-ancestor
24899341|NCT04404686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24899342|NCT04404686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24899343|NCT04404686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24899344|NCT04404686|Analgesics|analgesics|mesh-ancestor
24899345|NCT04404686|Sensory System Agents|sensory system agents|mesh-ancestor
24899346|NCT04404686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24899347|NCT04404686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24899348|NCT04404686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24899363|NCT04404439|Nortriptyline|nortriptyline|mesh-list
24899364|NCT04404439|Anticonvulsants|anticonvulsants|mesh-ancestor
24899365|NCT04404439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24899366|NCT04404439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899367|NCT04404439|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24899368|NCT04404439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24899369|NCT04404439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25714156|NCT02351960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25714157|NCT02351960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714158|NCT02352259|Bleomycin|bleomycin|mesh-list
25714159|NCT02352259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25714160|NCT02352259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25714161|NCT02352363|Levodopa|levodopa|mesh-list
25714162|NCT02352363|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25714163|NCT02352363|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25714164|NCT02352363|Dopamine Agents|dopamine agents|mesh-ancestor
25714165|NCT02352363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24481698|NCT00436423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899370|NCT04404439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899372|NCT04404439|Serotonin Agents|serotonin agents|mesh-ancestor
24899383|NCT04404439|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24899384|NCT04404439|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24476272|NCT00413751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24476273|NCT00413751|Adrenergic Agents|adrenergic agents|mesh-ancestor
24476274|NCT00413751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24476275|NCT00413751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476276|NCT00413751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476277|NCT00413790|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24476279|NCT00413790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24476280|NCT00413790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24899414|NCT04403724|Morphine|morphine|mesh-list
24899415|NCT04403724|Bupivacaine|bupivacaine|mesh-list
24899416|NCT04403724|Anesthetics, Local|anesthetics, local|mesh-ancestor
24476281|NCT00413790|Cholinergic Agents|cholinergic agents|mesh-ancestor
24476282|NCT00413790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24476283|NCT00413790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476284|NCT00413790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476285|NCT00413790|Urological Agents|urological agents|mesh-ancestor
24476286|NCT00413829|Ranibizumab|ranibizumab|mesh-list
24899417|NCT04403724|Anesthetics|anesthetics|mesh-ancestor
24899418|NCT04403724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24899419|NCT04403724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899423|NCT04403724|Narcotics|narcotics|mesh-ancestor
24476332|NCT00414180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476333|NCT00414180|Dopamine Agents|dopamine agents|mesh-ancestor
24476334|NCT00414180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24476335|NCT00414180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476336|NCT00414180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24476337|NCT00414180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24476338|NCT00414180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24518225|NCT05330065|Growth Inhibitors|growth inhibitors|mesh-ancestor
24518226|NCT05330000|Voriconazole|voriconazole|mesh-list
24518227|NCT05330000|Antifungal Agents|antifungal agents|mesh-ancestor
24518228|NCT05330000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24518229|NCT05330000|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24817818|NCT02085655|Immunologic Factors|immunologic factors|mesh-ancestor
24817819|NCT02085655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24817820|NCT02085655|Abortifacient Agents|abortifacient agents|mesh-ancestor
24518245|NCT05329857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518246|NCT05329844|Vildagliptin|vildagliptin|mesh-list
24518247|NCT05329844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24518248|NCT05329844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518249|NCT05329844|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24518250|NCT05329844|Protease Inhibitors|protease inhibitors|mesh-ancestor
24518251|NCT05329844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24518252|NCT05329844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24817829|NCT02085655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24817830|NCT02085655|Growth Substances|growth substances|mesh-ancestor
24817831|NCT02085655|Growth Inhibitors|growth inhibitors|mesh-ancestor
24817832|NCT02085824|Enoxaparin|enoxaparin|mesh-list
24817833|NCT02085824|Rivaroxaban|rivaroxaban|mesh-list
24817834|NCT02085824|Dabigatran|dabigatran|mesh-list
24817844|NCT02085902|Ropivacaine|ropivacaine|mesh-list
24817845|NCT02085902|Anesthetics, Local|anesthetics, local|mesh-ancestor
24899447|NCT04403347|Losartan|losartan|mesh-list
24899448|NCT04403347|Antihypertensive Agents|antihypertensive agents|mesh-list
24899449|NCT04403347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24899450|NCT04403347|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24899451|NCT04403347|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25407652|NCT03487016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25714166|NCT02352363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714167|NCT02352363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714168|NCT02352831|Capecitabine|capecitabine|mesh-list
25714169|NCT02352831|Tosedostat|tosedostat|mesh-list
25714170|NCT02352831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25714171|NCT02352831|Antimetabolites|antimetabolites|mesh-ancestor
24899452|NCT04403347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899453|NCT04403334|Moxifloxacin|moxifloxacin|mesh-list
24899454|NCT04403334|Levofloxacin|levofloxacin|mesh-list
24899455|NCT04403334|Ofloxacin|ofloxacin|mesh-list
24899456|NCT04403334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24899457|NCT04403334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24899458|NCT04403334|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24899459|NCT04403334|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24899460|NCT04403334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25415992|NCT02979873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899461|NCT04403334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899462|NCT04403334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24899463|NCT04403334|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24899464|NCT04403334|Renal Agents|renal agents|mesh-ancestor
24899465|NCT04403334|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24899489|NCT04403243|Antimitotic Agents|antimitotic agents|mesh-ancestor
24899490|NCT04403243|Mitosis Modulators|mitosis modulators|mesh-ancestor
24899491|NCT04403243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476391|NCT00414648|Antifungal Agents|antifungal agents|mesh-ancestor
24899532|NCT04402892|Lithium Carbonate|lithium carbonate|mesh-list
24899533|NCT04402892|Antidepressive Agents|antidepressive agents|mesh-ancestor
24899534|NCT04402892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24476429|NCT00415064|Lenalidomide|lenalidomide|mesh-list
24476431|NCT00415064|Antiemetics|antiemetics|mesh-ancestor
24518363|NCT05188508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24518364|NCT05176314|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24518365|NCT05176314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24518366|NCT05176314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24518367|NCT05176314|Antimetabolites|antimetabolites|mesh-ancestor
24518368|NCT05176314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518369|NCT05176314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24518370|NCT05176314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24899556|NCT04402580|Antitubercular Agents|antitubercular agents|mesh-ancestor
24899559|NCT04402580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899597|NCT04402359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24518384|NCT05132595|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24518386|NCT05132595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24518387|NCT05132595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24518388|NCT05132595|Analgesics|analgesics|mesh-ancestor
24518391|NCT05132595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518405|NCT05069935|Fludarabine|fludarabine|mesh-list
24899627|NCT04402112|Pitavastatin|pitavastatin|mesh-list
24899628|NCT04402112|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24899629|NCT04402112|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24899630|NCT04402112|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24899631|NCT04402112|Antimetabolites|antimetabolites|mesh-ancestor
24899632|NCT04402112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899633|NCT04402112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899634|NCT04402112|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25714172|NCT02352831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714173|NCT02352831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25714174|NCT02352831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25714175|NCT02352844|Everolimus|everolimus|mesh-list
25714176|NCT02352844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25714177|NCT02352844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25714178|NCT02352844|Immunologic Factors|immunologic factors|mesh-ancestor
25714179|NCT02352844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714180|NCT02352922|Bupivacaine|bupivacaine|mesh-list
24899636|NCT04401878|Anesthetics, Local|anesthetics, local|mesh-ancestor
24899637|NCT04401878|Anesthetics|anesthetics|mesh-ancestor
24899638|NCT04401878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24899639|NCT04401878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899640|NCT04401878|Sensory System Agents|sensory system agents|mesh-ancestor
24899641|NCT04401878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24476519|NCT00415376|Anticonvulsants|anticonvulsants|mesh-ancestor
24476520|NCT00415376|Nootropic Agents|nootropic agents|mesh-ancestor
24476522|NCT00415402|Cholecalciferol|cholecalciferol|mesh-list
24476523|NCT00415402|Vitamins|vitamins|mesh-ancestor
24476524|NCT00415402|Micronutrients|micronutrients|mesh-ancestor
24518414|NCT05069935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24518415|NCT05069935|Alkylating Agents|alkylating agents|mesh-ancestor
24518416|NCT05069935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518417|NCT05069935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24518418|NCT05069935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24518419|NCT05069740|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
24518420|NCT05069740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24518421|NCT05069740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24518423|NCT05069740|Sensory System Agents|sensory system agents|mesh-ancestor
24518424|NCT05069740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24518425|NCT05069740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518428|NCT05059626|Bazedoxifene|bazedoxifene|mesh-list
24518431|NCT05059626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24518455|NCT04981041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25415993|NCT02978625|Nivolumab|nivolumab|mesh-list
24518456|NCT04981041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24518457|NCT04981041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24518458|NCT04981041|Purinergic Agents|purinergic agents|mesh-ancestor
24518475|NCT04939467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24518476|NCT04939467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518477|NCT04939467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24817877|NCT02085967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24817878|NCT02085967|Antifungal Agents|antifungal agents|mesh-ancestor
24899701|NCT04401085|Immunologic Factors|immunologic factors|mesh-ancestor
24899702|NCT04401085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899706|NCT04401007|Lidocaine|lidocaine|mesh-list
24899765|NCT04400188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899790|NCT04399187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24899791|NCT04399213|Histamine|histamine|mesh-list
24899792|NCT04399213|Histamine phosphate|histamine phosphate|mesh-list
24899793|NCT04399213|Histamine Agonists|histamine agonists|mesh-ancestor
25714181|NCT02352922|Anesthetics, Local|anesthetics, local|mesh-ancestor
25714182|NCT02352922|Anesthetics|anesthetics|mesh-ancestor
25714183|NCT02352922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25714184|NCT02352922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24899794|NCT04399213|Histamine Agents|histamine agents|mesh-ancestor
25714185|NCT02352922|Sensory System Agents|sensory system agents|mesh-ancestor
25714186|NCT02352922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25714187|NCT02352974|Vitamin D|vitamin d|mesh-list
25714188|NCT02352974|Vitamins|vitamins|mesh-ancestor
25714189|NCT02352974|Micronutrients|micronutrients|mesh-ancestor
25714190|NCT02352974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714191|NCT02352974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25714192|NCT02353169|Dexmedetomidine|dexmedetomidine|mesh-list
24899795|NCT04399213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24899796|NCT04399213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899881|NCT04399148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24899882|NCT04399148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899883|NCT04399148|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24899884|NCT04399148|Cholinergic Agents|cholinergic agents|mesh-ancestor
24899885|NCT04399148|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24899886|NCT04399148|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24899887|NCT04399148|Histamine Antagonists|histamine antagonists|mesh-ancestor
24899888|NCT04399148|Histamine Agents|histamine agents|mesh-ancestor
24899889|NCT04399148|Antipruritics|antipruritics|mesh-ancestor
24899890|NCT04399148|Dermatologic Agents|dermatologic agents|mesh-ancestor
24899917|NCT04399083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24899918|NCT04399083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24899919|NCT04399083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24899920|NCT04399083|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24899921|NCT04399083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24899942|NCT04398771|Antimetabolites|antimetabolites|mesh-ancestor
24899986|NCT04398290|Protective Agents|protective agents|mesh-ancestor
24899987|NCT04398316|Lidocaine|lidocaine|mesh-list
24817905|NCT02086019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24817906|NCT02086019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24817908|NCT02086019|Sensory System Agents|sensory system agents|mesh-ancestor
24817909|NCT02086019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24817910|NCT02086019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24817911|NCT02086019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24817912|NCT02086019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24817913|NCT02086019|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24817914|NCT02086019|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24900037|NCT04397653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24900038|NCT04397653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24900040|NCT04397653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900041|NCT04397653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24900072|NCT04397913|Analgesics|analgesics|mesh-ancestor
24900073|NCT04397913|Sensory System Agents|sensory system agents|mesh-ancestor
24900074|NCT04397913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24900075|NCT04397913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900076|NCT04397913|Antipyretics|antipyretics|mesh-ancestor
24900077|NCT04397913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24900078|NCT04397913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24900079|NCT04397913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24476993|NCT00416910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476994|NCT00416923|Rituximab|rituximab|mesh-list
24641877|NCT01175954|Lacosamide|lacosamide|mesh-list
24476995|NCT00416923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24476996|NCT00416923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24900242|NCT04396223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900243|NCT04396223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24900531|NCT04393025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24900533|NCT04393025|Analgesics|analgesics|mesh-ancestor
24900534|NCT04393025|Sensory System Agents|sensory system agents|mesh-ancestor
25714193|NCT02353169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25714194|NCT02353169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25714195|NCT02353169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714196|NCT02353169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25714197|NCT02353169|Analgesics|analgesics|mesh-ancestor
25714198|NCT02353169|Sensory System Agents|sensory system agents|mesh-ancestor
25777167|NCT03734991|Ibrexafungerp|ibrexafungerp|mesh-list
25777168|NCT03734991|Antifungal Agents|antifungal agents|mesh-ancestor
25777169|NCT03734991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25777170|NCT03734601|Mycophenolic Acid|mycophenolic acid|mesh-list
25777171|NCT03734601|Tacrolimus|tacrolimus|mesh-list
25777172|NCT03734601|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25777173|NCT03734601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24900536|NCT04393025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900537|NCT04393025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24900538|NCT04393025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24900539|NCT04393025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24900540|NCT04393025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24901840|NCT04380220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900568|NCT04392427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24900569|NCT04392700|Tenofovir|tenofovir|mesh-list
24900570|NCT04392700|Entecavir|entecavir|mesh-list
24900571|NCT04392700|Antiviral Agents|antiviral agents|mesh-ancestor
24900572|NCT04392700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24518522|NCT04901689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24518523|NCT04901689|Antiviral Agents|antiviral agents|mesh-ancestor
24518524|NCT04901689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24518525|NCT04901676|Leronlimab|leronlimab|mesh-list
24518526|NCT04901676|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24518558|NCT04833140|Estradiol|estradiol|mesh-list
24900626|NCT04392713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24900628|NCT04392375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24900629|NCT04392375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24900630|NCT04392375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900631|NCT04392375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24900632|NCT04392375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818036|NCT02086656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818057|NCT02086838|Blood Substitutes|blood substitutes|mesh-ancestor
24900751|NCT04391569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900752|NCT04391569|GABA Modulators|gaba modulators|mesh-ancestor
24900753|NCT04391569|GABA Agents|gaba agents|mesh-ancestor
24900754|NCT04391478|Milrinone|milrinone|mesh-list
24900755|NCT04391478|Sildenafil Citrate|sildenafil citrate|mesh-list
24900756|NCT04391478|Vasodilator Agents|vasodilator agents|mesh-ancestor
24900757|NCT04391478|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25714200|NCT02353169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25714201|NCT02353169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25714202|NCT02353169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25714203|NCT02353169|Adrenergic Agents|adrenergic agents|mesh-ancestor
25714204|NCT02353169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25714205|NCT02353169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714206|NCT02353299|Zolpidem|zolpidem|mesh-list
25714207|NCT02353299|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24900758|NCT04391478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24900760|NCT04391478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900814|NCT04391283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24900815|NCT04391283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24900817|NCT04391283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900819|NCT04391127|Ivermectin|ivermectin|mesh-list
24900820|NCT04391127|Antimalarials|antimalarials|mesh-ancestor
24900821|NCT04391127|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24900822|NCT04391127|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24818059|NCT02086903|Ticagrelor|ticagrelor|mesh-list
24723759|NCT01589055|Nicotine|nicotine|mesh-list
24643046|NCT01183494|Irinotecan|irinotecan|mesh-list
24900890|NCT04390334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24900891|NCT04390334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24900892|NCT04390334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24900893|NCT04390334|Antiviral Agents|antiviral agents|mesh-ancestor
24900894|NCT04390334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24900895|NCT04390334|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24818080|NCT02086929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24818081|NCT02086929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24477723|NCT00419783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477724|NCT00419783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477725|NCT00419783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477726|NCT00419783|Antifungal Agents|antifungal agents|mesh-ancestor
24477727|NCT00419783|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24477728|NCT00419783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24477729|NCT00419783|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24518673|NCT04559906|Anesthetics, Local|anesthetics, local|mesh-ancestor
24518675|NCT04559906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24518676|NCT04559906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24900961|NCT04390152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24900962|NCT04390152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24900963|NCT04390152|Antimalarials|antimalarials|mesh-ancestor
24900964|NCT04390152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24900965|NCT04390152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24900966|NCT04390152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24900967|NCT04390100|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
24900968|NCT04390100|Hyaluronic Acid|hyaluronic acid|mesh-list
24901052|NCT04389320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24901053|NCT04389320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901054|NCT04389320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901055|NCT04389320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24901057|NCT04389060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24901058|NCT04389060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24901059|NCT04389060|Antioxidants|antioxidants|mesh-ancestor
24901060|NCT04389060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901061|NCT04389060|Protective Agents|protective agents|mesh-ancestor
24901062|NCT04389060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901063|NCT04389229|Aldesleukin|aldesleukin|mesh-list
24901064|NCT04389229|Cyclophosphamide|cyclophosphamide|mesh-list
24518734|NCT04432623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518735|NCT04431778|Ethosuximide|ethosuximide|mesh-list
24518736|NCT04431778|Anticonvulsants|anticonvulsants|mesh-ancestor
24518737|NCT04417049|Pentoxifylline|pentoxifylline|mesh-list
25714208|NCT02353299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25714209|NCT02353299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25714210|NCT02353299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714211|NCT02353299|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25714212|NCT02353299|GABA Agonists|gaba agonists|mesh-ancestor
25714213|NCT02353299|GABA Agents|gaba agents|mesh-ancestor
25714214|NCT02353299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25714215|NCT02353299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714216|NCT02353754|Morphine|morphine|mesh-list
25714217|NCT02353754|Bupivacaine|bupivacaine|mesh-list
24518738|NCT04417049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24518739|NCT04417049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24518740|NCT04417049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518741|NCT04417049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24901073|NCT04389229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24901074|NCT04389229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24901075|NCT04389229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24901076|NCT04389229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24901077|NCT04389229|Antiviral Agents|antiviral agents|mesh-ancestor
24901078|NCT04389229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24901108|NCT04388904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24518755|NCT04372927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24901109|NCT04388904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901110|NCT04388904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901112|NCT04388904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24901113|NCT04388904|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24901114|NCT04388904|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24901115|NCT04388904|Protease Inhibitors|protease inhibitors|mesh-ancestor
24901116|NCT04388904|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24901117|NCT04388904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24901118|NCT04388202|Citalopram|citalopram|mesh-list
24901119|NCT04388202|Sertraline|sertraline|mesh-list
24901130|NCT04388124|Bosentan|bosentan|mesh-list
24477915|NCT00420797|Mydriatics|mydriatics|mesh-ancestor
24477916|NCT00420797|Autonomic Agents|autonomic agents|mesh-ancestor
24477917|NCT00420797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24477918|NCT00420797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518756|NCT04372927|Immunoglobulin G|immunoglobulin g|mesh-list
24518757|NCT04372927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24518758|NCT04372927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24518759|NCT04372927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24518760|NCT04372927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24518761|NCT04372927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24518762|NCT04372927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518809|NCT04177953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24518810|NCT04177953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24518814|NCT04177953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24518834|NCT04151082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24518835|NCT04151082|Antiemetics|antiemetics|mesh-ancestor
24518836|NCT04151082|Autonomic Agents|autonomic agents|mesh-ancestor
24518837|NCT04151082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24518838|NCT04151082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25714218|NCT02353754|Anesthetics, Local|anesthetics, local|mesh-ancestor
25714219|NCT02353754|Anesthetics|anesthetics|mesh-ancestor
25714220|NCT02353754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25714221|NCT02353754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714222|NCT02353754|Sensory System Agents|sensory system agents|mesh-ancestor
25714223|NCT02353754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25714224|NCT02353754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25714225|NCT02353754|Narcotics|narcotics|mesh-ancestor
25714226|NCT02353754|Analgesics|analgesics|mesh-ancestor
24518839|NCT04151082|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24518840|NCT04151082|Protective Agents|protective agents|mesh-ancestor
24477940|NCT00420953|Amiodarone|amiodarone|mesh-list
24518856|NCT04133948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24518857|NCT04133948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24518858|NCT04133948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24518893|NCT04067752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24518894|NCT04054674|Salicylic Acid|salicylic acid|mesh-list
24518895|NCT04054674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24518896|NCT04054674|Antifungal Agents|antifungal agents|mesh-ancestor
24518897|NCT04054674|Keratolytic Agents|keratolytic agents|mesh-ancestor
24518898|NCT04054674|Dermatologic Agents|dermatologic agents|mesh-ancestor
24518899|NCT04052490|Salicylic Acid|salicylic acid|mesh-list
24518900|NCT04052490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24901201|NCT04387604|Ranibizumab|ranibizumab|mesh-list
24518928|NCT03889756|Midazolam|midazolam|mesh-list
24518929|NCT03889756|Ketamine|ketamine|mesh-list
24518930|NCT03889756|Analgesics|analgesics|mesh-ancestor
24519010|NCT03710772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24519011|NCT03710772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24519012|NCT03710772|Protease Inhibitors|protease inhibitors|mesh-ancestor
24519013|NCT03710772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24519014|NCT03710772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24519015|NCT03710772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24519016|NCT03710772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24519017|NCT03710772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24519018|NCT03710772|Abortifacient Agents|abortifacient agents|mesh-ancestor
24901303|NCT04386499|Vitamins|vitamins|mesh-ancestor
24901348|NCT04385719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902767|NCT04370782|Dermatologic Agents|dermatologic agents|mesh-ancestor
24818123|NCT02087007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818124|NCT02087007|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24818126|NCT02087007|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24818127|NCT02087007|Protective Agents|protective agents|mesh-ancestor
24818128|NCT02087007|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24643578|NCT01186146|Analgesics|analgesics|mesh-ancestor
24643579|NCT01186146|Sensory System Agents|sensory system agents|mesh-ancestor
24643580|NCT01186146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24818129|NCT02087007|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24818130|NCT02087007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24519059|NCT03594552|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24519060|NCT03594552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519061|NCT03594552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24519062|NCT03594552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24519063|NCT03594552|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24519064|NCT03594552|GABA Agonists|gaba agonists|mesh-ancestor
24519065|NCT03594552|GABA Agents|gaba agents|mesh-ancestor
24519066|NCT03594552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24519067|NCT03594552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714227|NCT02353780|Etanercept|etanercept|mesh-list
25714228|NCT02353780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
25714229|NCT02353780|Abatacept|abatacept|mesh-list
24519068|NCT03539952|Penicillamine|penicillamine|mesh-list
24519069|NCT03539952|Trientine|trientine|mesh-list
24519070|NCT03539952|Chelating Agents|chelating agents|mesh-ancestor
25714230|NCT02353780|Infliximab|infliximab|mesh-list
25714231|NCT02353780|Certolizumab Pegol|certolizumab pegol|mesh-list
25714232|NCT02353780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25714233|NCT02353780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25714234|NCT02353780|Analgesics|analgesics|mesh-ancestor
25714235|NCT02353780|Sensory System Agents|sensory system agents|mesh-ancestor
24519071|NCT03539952|Sequestering Agents|sequestering agents|mesh-ancestor
24519072|NCT03539952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519073|NCT03539952|Antidotes|antidotes|mesh-ancestor
24519074|NCT03539952|Protective Agents|protective agents|mesh-ancestor
24519075|NCT03539952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519078|NCT03513562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519082|NCT03441893|Nitazoxanide|nitazoxanide|mesh-list
24901423|NCT04385264|Hydroxychloroquine|hydroxychloroquine|mesh-list
24901424|NCT04385264|Mannitol|mannitol|mesh-list
24901425|NCT04385264|Antimalarials|antimalarials|mesh-ancestor
24901426|NCT04385264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24901427|NCT04385264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24901428|NCT04385264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24901429|NCT04385264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901430|NCT04385264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901431|NCT04385264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24901432|NCT04385264|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24901433|NCT04385264|Diuretics|diuretics|mesh-ancestor
24901434|NCT04385264|Natriuretic Agents|natriuretic agents|mesh-ancestor
24901435|NCT04385264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901436|NCT04385407|Ribavirin|ribavirin|mesh-list
24901476|NCT04384731|Respiratory System Agents|respiratory system agents|mesh-ancestor
24901478|NCT04384458|Ivermectin|ivermectin|mesh-list
24901479|NCT04384458|Antimalarials|antimalarials|mesh-ancestor
24901480|NCT04384458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24901481|NCT04384458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24901482|NCT04384458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24901537|NCT04383717|Levamisole|levamisole|mesh-list
24901559|NCT04383418|Sensory System Agents|sensory system agents|mesh-ancestor
24901560|NCT04383418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24901561|NCT04383418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24901562|NCT04383418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24901563|NCT04383418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24901566|NCT04383418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901567|NCT04383548|Immunoglobulins|immunoglobulins|mesh-list
24901572|NCT04383093|Tadalafil|tadalafil|mesh-list
24901573|NCT04383093|Tamsulosin|tamsulosin|mesh-list
24901574|NCT04383093|Vasodilator Agents|vasodilator agents|mesh-ancestor
24901575|NCT04383093|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24901576|NCT04383093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24901577|NCT04383093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901578|NCT04383093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901579|NCT04383093|Urological Agents|urological agents|mesh-ancestor
24901580|NCT04383093|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24901581|NCT04383093|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24901582|NCT04383093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25714236|NCT02353780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25714237|NCT02353780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714238|NCT02353780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25714239|NCT02353780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25714240|NCT02353780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25714241|NCT02353780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25714242|NCT02353780|Immunologic Factors|immunologic factors|mesh-ancestor
25714243|NCT02353780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24901588|NCT04382781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818166|NCT02087202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24818167|NCT02087202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818168|NCT02087202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24818169|NCT02087202|Anticonvulsants|anticonvulsants|mesh-ancestor
24818170|NCT02087202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24818171|NCT02087202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24818172|NCT02087202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24818173|NCT02087202|Tocolytic Agents|tocolytic agents|mesh-ancestor
24901738|NCT04382014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24901739|NCT04382014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901740|NCT04382014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24901741|NCT04381858|Immunoglobulins|immunoglobulins|mesh-list
24901742|NCT04381858|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24901744|NCT04381858|Immunologic Factors|immunologic factors|mesh-ancestor
24901745|NCT04381858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901747|NCT04381377|Anticonvulsants|anticonvulsants|mesh-ancestor
24901748|NCT04381234|Citric Acid|citric acid|mesh-list
24901749|NCT04381234|Sodium Citrate|sodium citrate|mesh-list
24901750|NCT04381234|Dialysis Solutions|dialysis solutions|mesh-list
24901751|NCT04381234|Anticoagulants|anticoagulants|mesh-ancestor
24901752|NCT04381234|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24901757|NCT04381104|Acetaminophen|acetaminophen|mesh-list
24519110|NCT03432949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519112|NCT03421288|Docetaxel|docetaxel|mesh-list
24519113|NCT03421288|Fluorouracil|fluorouracil|mesh-list
24519114|NCT03421288|Oxaliplatin|oxaliplatin|mesh-list
24519115|NCT03421288|Atezolizumab|atezolizumab|mesh-list
24519116|NCT03421288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519117|NCT03421288|Tubulin Modulators|tubulin modulators|mesh-ancestor
24519131|NCT03408236|Botulinum Toxins|botulinum toxins|mesh-list
24519132|NCT03408236|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24519133|NCT03408236|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24519134|NCT03408236|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24519135|NCT03408236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24519136|NCT03408236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519137|NCT03408236|Cholinergic Agents|cholinergic agents|mesh-ancestor
24519141|NCT03408236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24519144|NCT03245892|Nivolumab|nivolumab|mesh-list
24519145|NCT03245892|Ipilimumab|ipilimumab|mesh-list
24519146|NCT03245892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24519147|NCT03245892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519148|NCT03245892|Tubulin Modulators|tubulin modulators|mesh-ancestor
24519152|NCT03245892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24519153|NCT03245892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24519154|NCT03223597|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
24901800|NCT04380818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24901801|NCT04380818|Antimalarials|antimalarials|mesh-ancestor
24901802|NCT04380818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24901803|NCT04380818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24901804|NCT04380818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24901805|NCT04380857|Dexamethasone|dexamethasone|mesh-list
24901806|NCT04380857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24901807|NCT04380857|Antiemetics|antiemetics|mesh-ancestor
24901808|NCT04380857|Autonomic Agents|autonomic agents|mesh-ancestor
24901809|NCT04380857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24901810|NCT04380857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901811|NCT04380857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24478507|NCT00423228|Cholinergic Agents|cholinergic agents|mesh-ancestor
24478508|NCT00423228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24519156|NCT03150810|Temozolomide|temozolomide|mesh-list
25714244|NCT02353780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714245|NCT02353780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25714246|NCT02353780|Dermatologic Agents|dermatologic agents|mesh-ancestor
25714248|NCT02353806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25777174|NCT03734601|Immunologic Factors|immunologic factors|mesh-ancestor
24519157|NCT03150810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24519158|NCT03150810|Alkylating Agents|alkylating agents|mesh-ancestor
24519159|NCT03150810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519160|NCT03150810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519161|NCT03112603|Mycophenolic Acid|mycophenolic acid|mesh-list
24519162|NCT03112603|Sirolimus|sirolimus|mesh-list
24519163|NCT03112603|Rituximab|rituximab|mesh-list
24519164|NCT03112603|Methotrexate|methotrexate|mesh-list
24519165|NCT03112603|Everolimus|everolimus|mesh-list
24519166|NCT03112603|Imatinib Mesylate|imatinib mesylate|mesh-list
24519167|NCT03112603|Pentostatin|pentostatin|mesh-list
24519168|NCT03112603|Infliximab|infliximab|mesh-list
24519169|NCT03112603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24901835|NCT04380220|Factor VIII|factor viii|mesh-list
24901836|NCT04380220|Complement C3|complement c3|mesh-list
24901837|NCT04380220|Coagulants|coagulants|mesh-ancestor
24901838|NCT04380220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24901839|NCT04380220|Protease Inhibitors|protease inhibitors|mesh-ancestor
24901842|NCT04380220|Anticoagulants|anticoagulants|mesh-ancestor
24901843|NCT04380220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24478537|NCT00423501|Incretins|incretins|mesh-ancestor
24519170|NCT03112603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519171|NCT03112603|Immunologic Factors|immunologic factors|mesh-ancestor
24519172|NCT03112603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519173|NCT03112603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24519174|NCT03112603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24519175|NCT03112603|Abortifacient Agents|abortifacient agents|mesh-ancestor
24519176|NCT03112603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24519177|NCT03112603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24519178|NCT03112603|Antimetabolites|antimetabolites|mesh-ancestor
24519180|NCT03112603|Dermatologic Agents|dermatologic agents|mesh-ancestor
24901900|NCT04380298|Sympathomimetics|sympathomimetics|mesh-ancestor
24901901|NCT04380298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24901902|NCT04380298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24901903|NCT04380298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24901905|NCT04380298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24901906|NCT04380298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24901907|NCT04380298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24901908|NCT04380298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24901909|NCT04380103|Bevacizumab|bevacizumab|mesh-list
24901910|NCT04380103|Capecitabine|capecitabine|mesh-list
24901911|NCT04380103|Oxaliplatin|oxaliplatin|mesh-list
24901912|NCT04380103|Irinotecan|irinotecan|mesh-list
24901913|NCT04380103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24901914|NCT04380103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24901915|NCT04380103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24901916|NCT04380103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24901917|NCT04380103|Growth Substances|growth substances|mesh-ancestor
24901918|NCT04380103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24901919|NCT04380103|Growth Inhibitors|growth inhibitors|mesh-ancestor
24901920|NCT04380103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24478664|NCT00423865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478666|NCT00423969|Citalopram|citalopram|mesh-list
25714249|NCT02353806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25714250|NCT02353806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25777175|NCT03734601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777176|NCT03734601|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25777177|NCT03734601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777178|NCT03734601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777179|NCT03734601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25777180|NCT03734601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519216|NCT02973542|Ethosuximide|ethosuximide|mesh-list
24519217|NCT02973542|Anticonvulsants|anticonvulsants|mesh-ancestor
24519218|NCT02973386|Cisplatin|cisplatin|mesh-list
24519219|NCT02973386|Capecitabine|capecitabine|mesh-list
24519220|NCT02973386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24902014|NCT04379102|Anesthetics|anesthetics|mesh-list
25777181|NCT03734601|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25777182|NCT03734601|Antitubercular Agents|antitubercular agents|mesh-ancestor
25777183|NCT03734601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24902016|NCT04379102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24902017|NCT04379102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902018|NCT04379102|Sensory System Agents|sensory system agents|mesh-ancestor
24902019|NCT04379102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24902020|NCT04378868|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24902021|NCT04378868|Metronidazole|metronidazole|mesh-list
24902022|NCT04378868|Cefuroxime|cefuroxime|mesh-list
24902023|NCT04378868|Cefuroxime axetil|cefuroxime axetil|mesh-list
24902024|NCT04378868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24902081|NCT04377867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902082|NCT04377867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24725115|NCT01596517|Ribavirin|ribavirin|mesh-list
24902083|NCT04377789|Quercetin|quercetin|mesh-list
24902084|NCT04377789|Antioxidants|antioxidants|mesh-ancestor
24644841|NCT01193452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24902085|NCT04377789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902086|NCT04377789|Protective Agents|protective agents|mesh-ancestor
24902087|NCT04377789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902166|NCT04377048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24902167|NCT04377048|Antiviral Agents|antiviral agents|mesh-ancestor
24902168|NCT04377048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902169|NCT04377048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902170|NCT04377048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24902171|NCT04377048|Immunologic Factors|immunologic factors|mesh-ancestor
24902206|NCT04376814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24902208|NCT04376814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902209|NCT04376814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24902210|NCT04376814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24902211|NCT04376814|Antimalarials|antimalarials|mesh-ancestor
24902212|NCT04376814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24902213|NCT04376814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24902214|NCT04376814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24902215|NCT04376554|Amoxicillin|amoxicillin|mesh-list
24902216|NCT04376554|Clavulanic Acid|clavulanic acid|mesh-list
24902217|NCT04376554|Clavulanic Acids|clavulanic acids|mesh-list
24902218|NCT04376554|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
24902219|NCT04376554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24902220|NCT04376554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902221|NCT04376554|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24902222|NCT04376554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902223|NCT04376554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902224|NCT04376541|Fentanyl|fentanyl|mesh-list
24902293|NCT04374981|Respiratory System Agents|respiratory system agents|mesh-ancestor
24902295|NCT04374981|Hormone Antagonists|hormone antagonists|mesh-ancestor
24902296|NCT04374981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24902297|NCT04374981|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24902314|NCT04374929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24902315|NCT04374929|Glucocorticoids|glucocorticoids|mesh-list
24902317|NCT04374929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24902318|NCT04374929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902319|NCT04374942|Hydroxychloroquine|hydroxychloroquine|mesh-list
24902320|NCT04374942|Antimalarials|antimalarials|mesh-ancestor
24902321|NCT04374942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24902322|NCT04374942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25714251|NCT02353806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714252|NCT02353806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25714253|NCT02353806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714254|NCT02353806|Vasodilator Agents|vasodilator agents|mesh-ancestor
25714255|NCT02354092|Anesthetics|anesthetics|mesh-list
25714256|NCT02354092|Anesthetics, Local|anesthetics, local|mesh-list
25714257|NCT02354092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25714258|NCT02354092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714259|NCT02354092|Sensory System Agents|sensory system agents|mesh-ancestor
25714260|NCT02354092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24902323|NCT04374942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902324|NCT04374942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902325|NCT04374942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902326|NCT04374942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24902327|NCT04374604|Mitogens|mitogens|mesh-list
24902328|NCT04374604|Mitosis Modulators|mitosis modulators|mesh-ancestor
24902329|NCT04374604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902330|NCT04374318|Dexmedetomidine|dexmedetomidine|mesh-list
24902331|NCT04374318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24902332|NCT04374318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24902337|NCT04374318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24725358|NCT01597336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24902419|NCT04374071|Protective Agents|protective agents|mesh-ancestor
24902420|NCT04374071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24902421|NCT04374071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24902422|NCT04373824|Ivermectin|ivermectin|mesh-list
24479039|NCT00425360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479040|NCT00425360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24902423|NCT04373824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24483477|NCT00443794|Aspirin|aspirin|mesh-list
24902424|NCT04373824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902425|NCT04374006|Propolis|propolis|mesh-list
24902426|NCT04374006|Dienogest|dienogest|mesh-list
24902427|NCT04374006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902428|NCT04374006|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24902429|NCT04374006|Contraceptive Agents|contraceptive agents|mesh-ancestor
24902512|NCT04372732|Autoantibodies|autoantibodies|mesh-list
24902513|NCT04372732|Immunologic Factors|immunologic factors|mesh-ancestor
24902514|NCT04372732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902515|NCT04372589|Heparin|heparin|mesh-list
24902516|NCT04372589|Anticoagulants|anticoagulants|mesh-ancestor
24902517|NCT04372589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24902518|NCT04372589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24902519|NCT04372589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902520|NCT04372342|Remifentanil|remifentanil|mesh-list
24902521|NCT04372342|Nalbuphine|nalbuphine|mesh-list
24902522|NCT04372342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24902523|NCT04372342|Narcotics|narcotics|mesh-ancestor
24902524|NCT04372342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24902525|NCT04372342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902526|NCT04372342|Analgesics|analgesics|mesh-ancestor
24902527|NCT04372342|Sensory System Agents|sensory system agents|mesh-ancestor
24902528|NCT04372342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24902529|NCT04372264|Acetaminophen|acetaminophen|mesh-list
24902530|NCT04372264|Ibuprofen|ibuprofen|mesh-list
24902531|NCT04372264|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
24483581|NCT00444171|Insulin|insulin|mesh-list
24902539|NCT04372264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24902560|NCT04372407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24902562|NCT04371874|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24902563|NCT04371874|Captopril|captopril|mesh-list
24902564|NCT04371874|Nitrendipine|nitrendipine|mesh-list
24902565|NCT04371874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24902567|NCT04371874|Analgesics|analgesics|mesh-ancestor
24902568|NCT04371874|Sensory System Agents|sensory system agents|mesh-ancestor
24902569|NCT04371874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24902570|NCT04371874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714261|NCT02354222|Canagliflozin|canagliflozin|mesh-list
24902571|NCT04371874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25714262|NCT02354222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25714263|NCT02354222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714264|NCT02354222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25714265|NCT02354222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714266|NCT02354235|Canagliflozin|canagliflozin|mesh-list
25714267|NCT02354235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25714268|NCT02354235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902572|NCT04371874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24902573|NCT04371874|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24902574|NCT04371874|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24483681|NCT00444548|Reboxetine|reboxetine|mesh-list
24818249|NCT02087566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24818250|NCT02087566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24818251|NCT02087566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818253|NCT02087579|Risperidone|risperidone|mesh-list
24818254|NCT02087579|Aripiprazole|aripiprazole|mesh-list
24818255|NCT02087579|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24818256|NCT02087579|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24818257|NCT02087579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24818258|NCT02087579|Serotonin Agents|serotonin agents|mesh-ancestor
24818259|NCT02087579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24818260|NCT02087579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818261|NCT02087579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818262|NCT02087579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24818265|NCT02087579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24818266|NCT02087579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24818267|NCT02087579|Dopamine Agents|dopamine agents|mesh-ancestor
24818268|NCT02087579|Antiemetics|antiemetics|mesh-ancestor
24902718|NCT04371406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24902719|NCT04371406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24902720|NCT04371406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902721|NCT04371406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902722|NCT04371406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24902723|NCT04371185|Ustekinumab|ustekinumab|mesh-list
24902742|NCT04370977|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24902743|NCT04370977|Amodiaquine|amodiaquine|mesh-list
24902744|NCT04370977|Antimalarials|antimalarials|mesh-ancestor
24902745|NCT04370977|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24902746|NCT04370977|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24902747|NCT04370977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24902764|NCT04370782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24902765|NCT04370782|Astringents|astringents|mesh-ancestor
24902766|NCT04370782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24902919|NCT04368546|Growth Inhibitors|growth inhibitors|mesh-ancestor
24902920|NCT04368546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24902921|NCT04368546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902922|NCT04368546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24902924|NCT04368598|Dexamethasone|dexamethasone|mesh-list
24902925|NCT04368598|Dexamethasone acetate|dexamethasone acetate|mesh-list
24902936|NCT04368598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24902937|NCT04368598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24902938|NCT04368598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24902939|NCT04368598|Protease Inhibitors|protease inhibitors|mesh-ancestor
24902940|NCT04368598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24902942|NCT04368598|Antiviral Agents|antiviral agents|mesh-ancestor
24903024|NCT04367831|Heparin|heparin|mesh-list
24903025|NCT04367831|Calcium heparin|calcium heparin|mesh-list
24519296|NCT02448381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519297|NCT02448381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24519298|NCT02448381|Immunologic Factors|immunologic factors|mesh-ancestor
25714269|NCT02354235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25714270|NCT02354235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714271|NCT02354339|Magnesium Oxide|magnesium oxide|mesh-list
25714272|NCT02354339|Antacids|antacids|mesh-ancestor
25714273|NCT02354339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714274|NCT02354339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25714275|NCT02354352|Eplerenone|eplerenone|mesh-list
25714276|NCT02354352|Spironolactone|spironolactone|mesh-list
24519299|NCT02448381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519302|NCT02437279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24903069|NCT04367051|Diuretics|diuretics|mesh-ancestor
24903081|NCT04366609|Methylphenidate|methylphenidate|mesh-list
24903082|NCT04366609|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24903083|NCT04366609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903084|NCT04366609|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24903085|NCT04366609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24903086|NCT04366609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24903087|NCT04366609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903088|NCT04366609|Dopamine Agents|dopamine agents|mesh-ancestor
24903089|NCT04366609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24903090|NCT04366622|Riociguat|riociguat|mesh-list
24903115|NCT04366869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24903116|NCT04366869|Antifungal Agents|antifungal agents|mesh-ancestor
24903295|NCT04364945|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24903296|NCT04364945|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24903298|NCT04364945|Anesthetics|anesthetics|mesh-ancestor
24903299|NCT04364945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24903300|NCT04364945|Narcotics|narcotics|mesh-ancestor
24903302|NCT04364802|Cadexomer iodine|cadexomer iodine|mesh-list
24726297|NCT01602822|Ritonavir|ritonavir|mesh-list
24903303|NCT04364802|Povidone-Iodine|povidone-iodine|mesh-list
24903304|NCT04364802|Povidone|povidone|mesh-list
24903305|NCT04364802|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24903531|NCT04362943|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
24903532|NCT04362943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24903625|NCT04362332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903626|NCT04362332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24903627|NCT04362332|Filaricides|filaricides|mesh-ancestor
24903628|NCT04362332|Antinematodal Agents|antinematodal agents|mesh-ancestor
24903629|NCT04362332|Anthelmintics|anthelmintics|mesh-ancestor
24903630|NCT04362124|BCG Vaccine|bcg vaccine|mesh-list
24903631|NCT04362124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24903632|NCT04362124|Immunologic Factors|immunologic factors|mesh-ancestor
24903633|NCT04362124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24726639|NCT01604928|Mirabegron|mirabegron|mesh-list
24903720|NCT04361461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24903721|NCT04361461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24903722|NCT04361461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24903724|NCT04361279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24903725|NCT04361279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24903726|NCT04361279|Immunologic Factors|immunologic factors|mesh-ancestor
24903727|NCT04361279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24903728|NCT04361279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24903729|NCT04361188|Anesthetics|anesthetics|mesh-list
24903731|NCT04361188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904114|NCT04358627|Sensory System Agents|sensory system agents|mesh-ancestor
24904115|NCT04358627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24904116|NCT04358627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24904117|NCT04358627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24904118|NCT04358627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24904119|NCT04358627|Adrenergic Agents|adrenergic agents|mesh-ancestor
24904120|NCT04358627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25770990|NCT03579719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24904128|NCT04358770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25770991|NCT03579719|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25770992|NCT03579719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25770993|NCT03579719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25770994|NCT03579719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25770995|NCT03579719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25770996|NCT03579719|Hormone Antagonists|hormone antagonists|mesh-ancestor
25770997|NCT03579719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25770998|NCT03579719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714277|NCT02354352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25714278|NCT02354352|Hormone Antagonists|hormone antagonists|mesh-ancestor
25714279|NCT02354352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24904130|NCT04358770|Hormones|hormones|mesh-ancestor
24904131|NCT04358770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24904132|NCT04358770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904133|NCT04358562|Gefitinib|gefitinib|mesh-list
24904134|NCT04358562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904141|NCT04358367|Dexmedetomidine|dexmedetomidine|mesh-list
24904142|NCT04358367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24904143|NCT04358367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24904237|NCT04357535|Giapreza|giapreza|mesh-list
24904238|NCT04357535|Enzyme Inhibitors|enzyme inhibitors|mesh-list
24904239|NCT04357535|Angiotensinogen|angiotensinogen|mesh-list
24904240|NCT04357535|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24904241|NCT04357535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24904242|NCT04357535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904243|NCT04357535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24904244|NCT04357535|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24484187|NCT00446953|Betamethasone|betamethasone|mesh-list
24904245|NCT04357535|Protease Inhibitors|protease inhibitors|mesh-ancestor
24904246|NCT04357483|Thrombin|thrombin|mesh-list
24904247|NCT04357483|Hemostatics|hemostatics|mesh-ancestor
24904248|NCT04357483|Coagulants|coagulants|mesh-ancestor
24904267|NCT04357093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24904268|NCT04357093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24904410|NCT04355962|Anesthetics, General|anesthetics, general|mesh-ancestor
24904411|NCT04355962|Anesthetics|anesthetics|mesh-ancestor
24904504|NCT04355273|Calcium heparin|calcium heparin|mesh-list
24904505|NCT04355273|Anticoagulants|anticoagulants|mesh-ancestor
24904506|NCT04355273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24904507|NCT04355273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24904508|NCT04355273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904510|NCT04355429|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24904511|NCT04355429|Protease Inhibitors|protease inhibitors|mesh-ancestor
24904512|NCT04355429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904513|NCT04355429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904514|NCT04355429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24904533|NCT04355247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24904534|NCT04355247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24904596|NCT04355039|Growth Inhibitors|growth inhibitors|mesh-ancestor
24904599|NCT04354805|Autonomic Agents|autonomic agents|mesh-ancestor
24904600|NCT04354805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24904601|NCT04354805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24727560|NCT01611077|Amlodipine|amlodipine|mesh-list
24904602|NCT04354805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24904603|NCT04354805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25714280|NCT02354352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714281|NCT02354352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25714282|NCT02354352|Diuretics|diuretics|mesh-ancestor
25714283|NCT02354352|Natriuretic Agents|natriuretic agents|mesh-ancestor
25714284|NCT02354352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25714285|NCT02354378|Dexmedetomidine|dexmedetomidine|mesh-list
25714286|NCT02354378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25714287|NCT02354378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25714288|NCT02354378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714289|NCT02354378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24904604|NCT04354805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24904606|NCT04354805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24904622|NCT04354662|Antimitotic Agents|antimitotic agents|mesh-ancestor
24904623|NCT04354662|Mitosis Modulators|mitosis modulators|mesh-ancestor
24904624|NCT04354662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904625|NCT04354662|Antimetabolites|antimetabolites|mesh-ancestor
24904626|NCT04354662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24904627|NCT04354662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24904628|NCT04354662|Immunologic Factors|immunologic factors|mesh-ancestor
24904629|NCT04354662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904630|NCT04354662|Antidotes|antidotes|mesh-ancestor
24818472|NCT02088983|Lipotropic Agents|lipotropic agents|mesh-ancestor
24818473|NCT02088983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24818479|NCT02089048|Auranofin|auranofin|mesh-list
24904718|NCT04353505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24904719|NCT04353505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24904755|NCT04353362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24904803|NCT04353193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24904804|NCT04353193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24904805|NCT04352946|Hydroxychloroquine|hydroxychloroquine|mesh-list
24904806|NCT04352946|Antimalarials|antimalarials|mesh-ancestor
24904807|NCT04352946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24904808|NCT04352946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24904809|NCT04352946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24904810|NCT04352946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904811|NCT04352946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904812|NCT04352946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24904813|NCT04352933|Hydroxychloroquine|hydroxychloroquine|mesh-list
24904814|NCT04352933|Antimalarials|antimalarials|mesh-ancestor
24904815|NCT04352933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24904816|NCT04352933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24904817|NCT04352933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24904818|NCT04352933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24904819|NCT04352933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904820|NCT04352933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24904822|NCT04352855|Ceftolozane|ceftolozane|mesh-list
24904823|NCT04352855|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
24904824|NCT04352855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24904825|NCT04352855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24904847|NCT04352621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24904848|NCT04352621|Anesthetics, General|anesthetics, general|mesh-ancestor
24904849|NCT04352621|Anesthetics|anesthetics|mesh-ancestor
24904853|NCT04352621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24904854|NCT04352621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904859|NCT04352400|Sensory System Agents|sensory system agents|mesh-ancestor
24904860|NCT04352400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24904861|NCT04352400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24904864|NCT04352400|Anticoagulants|anticoagulants|mesh-ancestor
24904910|NCT04351724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24904911|NCT04351724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24904912|NCT04351724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24904913|NCT04351724|Antiviral Agents|antiviral agents|mesh-ancestor
24904914|NCT04351724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25714290|NCT02354378|Analgesics|analgesics|mesh-ancestor
25714291|NCT02354378|Sensory System Agents|sensory system agents|mesh-ancestor
24904915|NCT04351724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24904916|NCT04351724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24904917|NCT04351724|Antimalarials|antimalarials|mesh-ancestor
24904918|NCT04351724|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24818501|NCT02089178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818502|NCT02089178|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24818503|NCT02089178|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24818504|NCT02089178|Anesthetics, General|anesthetics, general|mesh-ancestor
24818505|NCT02089178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24519388|NCT01724866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24519389|NCT01724866|Alkylating Agents|alkylating agents|mesh-ancestor
24519390|NCT01724866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905111|NCT04350528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24905112|NCT04350528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905113|NCT04350528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24905114|NCT04350528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24905116|NCT04350528|GABA Agents|gaba agents|mesh-ancestor
24905117|NCT04350580|Immunoglobulins|immunoglobulins|mesh-list
24905118|NCT04350580|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24905119|NCT04350580|Antibodies|antibodies|mesh-list
24905147|NCT04350684|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24905148|NCT04350684|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24905149|NCT04350684|Antimalarials|antimalarials|mesh-ancestor
24905150|NCT04350684|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24905151|NCT04350684|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24905152|NCT04350684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24905153|NCT04350684|Immunologic Factors|immunologic factors|mesh-ancestor
24905154|NCT04350684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905155|NCT04350684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24905156|NCT04350450|Hydroxychloroquine|hydroxychloroquine|mesh-list
24905157|NCT04350450|Antimalarials|antimalarials|mesh-ancestor
24905158|NCT04350450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24905159|NCT04350450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24905160|NCT04350450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905161|NCT04350450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905162|NCT04350450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905163|NCT04350450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24905164|NCT04350671|Interferons|interferons|mesh-list
24905165|NCT04350671|Ritonavir|ritonavir|mesh-list
24905244|NCT04349228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905245|NCT04349228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484537|NCT00449137|Leucovorin|leucovorin|mesh-list
24905250|NCT04349410|Remdesivir|remdesivir|mesh-list
24905251|NCT04349410|Azithromycin|azithromycin|mesh-list
24905252|NCT04349410|Hydroxychloroquine|hydroxychloroquine|mesh-list
24905253|NCT04349410|Doxycycline|doxycycline|mesh-list
24905254|NCT04349410|Clindamycin|clindamycin|mesh-list
24623635|NCT01072942|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24905305|NCT04348786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25714292|NCT02354378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25714293|NCT02354378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25714294|NCT02354378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25714295|NCT02354378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24905306|NCT04348786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24905307|NCT04348786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905308|NCT04348786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905310|NCT04348786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25714296|NCT02354378|Adrenergic Agents|adrenergic agents|mesh-ancestor
25714297|NCT02354378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25714298|NCT02354378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714299|NCT02354508|Pasireotide|pasireotide|mesh-list
25714300|NCT02354508|Hormones|hormones|mesh-ancestor
25714301|NCT02354508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25714302|NCT02354508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714303|NCT02354534|Artesunate|artesunate|mesh-list
25714304|NCT02354534|Antimalarials|antimalarials|mesh-ancestor
25714305|NCT02354534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24481194|NCT00433719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24481195|NCT00433719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24481196|NCT00433719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481197|NCT00433719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519408|NCT01711021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24519409|NCT01711021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24519410|NCT01711021|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24519411|NCT01670877|Trastuzumab|trastuzumab|mesh-list
24519412|NCT01670877|Fulvestrant|fulvestrant|mesh-list
24905347|NCT04348409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905352|NCT04348006|Cyclophosphamide|cyclophosphamide|mesh-list
24905353|NCT04348006|Lenalidomide|lenalidomide|mesh-list
24905354|NCT04348006|Bortezomib|bortezomib|mesh-list
24905355|NCT04348006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24905356|NCT04348006|Immunologic Factors|immunologic factors|mesh-ancestor
24905358|NCT04348006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24905460|NCT04347720|Tocolytic Agents|tocolytic agents|mesh-ancestor
24484582|NCT00449319|Daunorubicin|daunorubicin|mesh-list
24905461|NCT04347720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24905462|NCT04347577|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24905463|NCT04347577|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24905464|NCT04347577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24905465|NCT04347577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24905466|NCT04347577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905541|NCT04346667|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24905542|NCT04346667|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24905543|NCT04346667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905544|NCT04346667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905545|NCT04346667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905546|NCT04346667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24905547|NCT04346667|Amebicides|amebicides|mesh-ancestor
24905548|NCT04346407|Dronabinol|dronabinol|mesh-list
24905549|NCT04346407|Hallucinogens|hallucinogens|mesh-ancestor
24905550|NCT04346407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905551|NCT04346407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24905552|NCT04346407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24481407|NCT00434382|Sevoflurane|sevoflurane|mesh-list
24905613|NCT04346030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24905614|NCT04346030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905615|NCT04346030|Sensory System Agents|sensory system agents|mesh-ancestor
24905616|NCT04346030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24905617|NCT04346030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24905618|NCT04346030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24905683|NCT04345445|Antiemetics|antiemetics|mesh-ancestor
24905684|NCT04345445|Autonomic Agents|autonomic agents|mesh-ancestor
24905697|NCT04345588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24905698|NCT04345588|Antiemetics|antiemetics|mesh-ancestor
24905699|NCT04345588|Autonomic Agents|autonomic agents|mesh-ancestor
24905700|NCT04345588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24905701|NCT04345588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905702|NCT04345588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24905707|NCT04345588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905708|NCT04345744|Chlorhexidine|chlorhexidine|mesh-list
24905709|NCT04345744|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24905710|NCT04345744|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25714306|NCT02354534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25714307|NCT02354534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25714308|NCT02354534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905711|NCT04345744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25714309|NCT02354534|Antiviral Agents|antiviral agents|mesh-ancestor
25714310|NCT02354534|Schistosomicides|schistosomicides|mesh-ancestor
25714311|NCT02354534|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25714312|NCT02354534|Anthelmintics|anthelmintics|mesh-ancestor
25714313|NCT02354599|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24905765|NCT04345094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24905766|NCT04345094|Protective Agents|protective agents|mesh-ancestor
24905767|NCT04345094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24905768|NCT04345094|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24905769|NCT04345146|Bevacizumab|bevacizumab|mesh-list
24905770|NCT04345146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24905771|NCT04345146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905772|NCT04345146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24905773|NCT04345146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24905774|NCT04345146|Growth Substances|growth substances|mesh-ancestor
24905779|NCT04345276|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24905780|NCT04345276|Protease Inhibitors|protease inhibitors|mesh-ancestor
24905781|NCT04345276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905783|NCT04345276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24905832|NCT04344483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24905833|NCT04344483|Respiratory System Agents|respiratory system agents|mesh-ancestor
24905834|NCT04344483|Mydriatics|mydriatics|mesh-ancestor
24905835|NCT04344483|Sympathomimetics|sympathomimetics|mesh-ancestor
24905836|NCT04344483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24905837|NCT04344457|Hydroxychloroquine|hydroxychloroquine|mesh-list
24905838|NCT04344457|Azithromycin|azithromycin|mesh-list
24905839|NCT04344457|Indomethacin|indomethacin|mesh-list
24905840|NCT04344457|Antimalarials|antimalarials|mesh-ancestor
24905841|NCT04344457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24905842|NCT04344457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24905843|NCT04344457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24905844|NCT04344457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905846|NCT04344457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24818578|NCT02089438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818579|NCT02089451|Insulin Aspart|insulin aspart|mesh-list
24818580|NCT02089451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24818581|NCT02089451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818582|NCT02089503|Ranibizumab|ranibizumab|mesh-list
24818583|NCT02089503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24818584|NCT02089503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24818585|NCT02089503|Growth Substances|growth substances|mesh-ancestor
24818586|NCT02089503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818587|NCT02089503|Growth Inhibitors|growth inhibitors|mesh-ancestor
24818588|NCT02089503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24818589|NCT02089529|Ibuprofen|ibuprofen|mesh-list
24818590|NCT02089529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24818591|NCT02089529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24818592|NCT02089529|Analgesics|analgesics|mesh-ancestor
24905896|NCT04344236|Blood Substitutes|blood substitutes|mesh-ancestor
24905898|NCT04344288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25714314|NCT02354599|Immunologic Factors|immunologic factors|mesh-ancestor
25714315|NCT02354599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714316|NCT02354690|Cyclophosphamide|cyclophosphamide|mesh-list
25714317|NCT02354690|Fludarabine|fludarabine|mesh-list
25714318|NCT02354690|Interleukin-2|interleukin-2|mesh-list
25714319|NCT02354690|Vemurafenib|vemurafenib|mesh-list
25714320|NCT02354690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25714321|NCT02354690|Immunologic Factors|immunologic factors|mesh-ancestor
25714322|NCT02354690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714323|NCT02354690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25714324|NCT02354690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24905899|NCT04344288|Glucocorticoids|glucocorticoids|mesh-ancestor
24905901|NCT04344288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24481614|NCT00435955|Immunologic Factors|immunologic factors|mesh-ancestor
24905979|NCT04343729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24905980|NCT04343729|Prednisolone phosphate|prednisolone phosphate|mesh-list
24905981|NCT04343729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24905982|NCT04343729|Antiemetics|antiemetics|mesh-ancestor
24905983|NCT04343729|Autonomic Agents|autonomic agents|mesh-ancestor
24905991|NCT04343729|Protective Agents|protective agents|mesh-ancestor
24905992|NCT04343729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24905993|NCT04343729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24905995|NCT04343963|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
24905996|NCT04343963|Anticonvulsants|anticonvulsants|mesh-ancestor
24905997|NCT04343963|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24905998|NCT04343963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24905999|NCT04343963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906000|NCT04343963|Cholinergic Agents|cholinergic agents|mesh-ancestor
24906001|NCT04343963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24906002|NCT04343963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906003|NCT04343651|Leronlimab|leronlimab|mesh-list
24906004|NCT04343651|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24906005|NCT04343651|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24906006|NCT04343651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906007|NCT04343651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24906008|NCT04343651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24906068|NCT04343144|Nivolumab|nivolumab|mesh-list
24906072|NCT04343144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906073|NCT04342910|Paclitaxel|paclitaxel|mesh-list
24906074|NCT04342910|Irinotecan|irinotecan|mesh-list
24906075|NCT04342910|Apatinib|apatinib|mesh-list
24906082|NCT04342910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24906083|NCT04342910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24906084|NCT04342910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906086|NCT04342676|Panitumumab|panitumumab|mesh-list
24906155|NCT04342065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24906191|NCT04342351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906192|NCT04342351|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24906193|NCT04342351|Protease Inhibitors|protease inhibitors|mesh-ancestor
24906194|NCT04342351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906195|NCT04342273|Moxifloxacin|moxifloxacin|mesh-list
24906196|NCT04342273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24906197|NCT04342273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24906198|NCT04342273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24906199|NCT04342273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24906200|NCT04342273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24906201|NCT04342273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906202|NCT04342273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24906203|NCT04342026|Endocrine Disruptors|endocrine disruptors|mesh-list
24906204|NCT04342026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906231|NCT04341857|Antibodies|antibodies|mesh-list
24906232|NCT04341857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24906233|NCT04341857|Immunologic Factors|immunologic factors|mesh-ancestor
24906234|NCT04341857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906235|NCT04341402|Antifungal Agents|antifungal agents|mesh-list
24906236|NCT04341402|Clotrimazole|clotrimazole|mesh-list
24906237|NCT04341402|Miconazole|miconazole|mesh-list
24906238|NCT04341402|Diclofenac|diclofenac|mesh-list
24906239|NCT04341402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24906240|NCT04341402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24818691|NCT02090309|Hydrocortisone|hydrocortisone|mesh-list
24818692|NCT02090309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24818693|NCT02090322|Bevacizumab|bevacizumab|mesh-list
24818694|NCT02090322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24818695|NCT02090322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24818696|NCT02090322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24906307|NCT04341727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906308|NCT04341727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24906325|NCT04341545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906326|NCT04341545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24906327|NCT04341545|Hormone Antagonists|hormone antagonists|mesh-ancestor
24906328|NCT04341545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24906329|NCT04341545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906330|NCT04341207|Azithromycin|azithromycin|mesh-list
24906331|NCT04341207|Hydroxychloroquine|hydroxychloroquine|mesh-list
24906334|NCT04341207|Antimalarials|antimalarials|mesh-ancestor
24906482|NCT04340388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24906484|NCT04340388|Protease Inhibitors|protease inhibitors|mesh-ancestor
24906485|NCT04340388|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24906486|NCT04340388|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24906487|NCT04340388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24906488|NCT04340388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24906531|NCT04339361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906532|NCT04339361|Sensory System Agents|sensory system agents|mesh-ancestor
24906533|NCT04339361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24906534|NCT04339361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24906535|NCT04339361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24906536|NCT04339361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24906620|NCT04338919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24906621|NCT04338919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24906622|NCT04338919|Analgesics|analgesics|mesh-ancestor
24906623|NCT04338919|Sensory System Agents|sensory system agents|mesh-ancestor
24906634|NCT04338919|Antipyretics|antipyretics|mesh-ancestor
24906635|NCT04338919|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24906643|NCT04338620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24906644|NCT04338620|Tubulin Modulators|tubulin modulators|mesh-ancestor
24906645|NCT04338620|Antimitotic Agents|antimitotic agents|mesh-ancestor
24906646|NCT04338620|Mitosis Modulators|mitosis modulators|mesh-ancestor
24906762|NCT04337658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24906763|NCT04337658|Antimetabolites|antimetabolites|mesh-ancestor
24906764|NCT04337658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906765|NCT04337658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24906766|NCT04337658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24906767|NCT04337658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24906768|NCT04337658|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24906769|NCT04337658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24906770|NCT04337658|Hormone Antagonists|hormone antagonists|mesh-ancestor
24906771|NCT04337658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25714325|NCT02354690|Alkylating Agents|alkylating agents|mesh-ancestor
25714326|NCT02354690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714327|NCT02354690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25714328|NCT02354690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25714329|NCT02354690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25714330|NCT02354690|Analgesics|analgesics|mesh-ancestor
25714331|NCT02354690|Sensory System Agents|sensory system agents|mesh-ancestor
25714332|NCT02354690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25714333|NCT02354690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24906772|NCT04337658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906774|NCT04337450|Dolutegravir|dolutegravir|mesh-list
24906775|NCT04337450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24519504|NCT05333159|Canagliflozin|canagliflozin|mesh-list
24519505|NCT05333159|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
24519506|NCT05333159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519507|NCT05333159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24519510|NCT05332821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24650041|NCT01223534|Antimetabolites|antimetabolites|mesh-ancestor
24519511|NCT05332821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24519512|NCT05332821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519513|NCT05332821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24519514|NCT05332821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24519516|NCT05332821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519517|NCT05332821|Growth Inhibitors|growth inhibitors|mesh-ancestor
24906800|NCT04336891|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24906802|NCT04336891|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24906803|NCT04336891|Testosterone|testosterone|mesh-list
24906831|NCT04336917|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24906832|NCT04336917|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24906833|NCT04336917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24906834|NCT04336917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906835|NCT04337099|Tempol|tempol|mesh-list
24906836|NCT04337099|TEMPO|tempo|mesh-list
24906837|NCT04337099|TEMPOL-H|tempol-h|mesh-list
24906838|NCT04337099|Antioxidants|antioxidants|mesh-ancestor
24906839|NCT04337099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906840|NCT04337099|Protective Agents|protective agents|mesh-ancestor
24482329|NCT00438737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24906863|NCT04336488|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-list
24906864|NCT04336488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24906865|NCT04336488|Glucocorticoids|glucocorticoids|mesh-ancestor
24906866|NCT04336488|Hormones|hormones|mesh-ancestor
24906918|NCT04335526|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24906919|NCT04335526|Antimetabolites|antimetabolites|mesh-ancestor
24906920|NCT04335526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24906921|NCT04335526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24906922|NCT04335383|Antibodies|antibodies|mesh-list
24906923|NCT04335383|Immunologic Factors|immunologic factors|mesh-ancestor
24906925|NCT04335123|Losartan|losartan|mesh-list
24906995|NCT04334629|Sensory System Agents|sensory system agents|mesh-ancestor
24906996|NCT04334629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24906997|NCT04334629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24906998|NCT04334629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24906999|NCT04334629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24818815|NCT02090933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24907072|NCT04333550|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24907073|NCT04333550|Chelating Agents|chelating agents|mesh-ancestor
24907074|NCT04333550|Sequestering Agents|sequestering agents|mesh-ancestor
24907075|NCT04333550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907076|NCT04333589|Favipiravir|favipiravir|mesh-list
24907077|NCT04333589|Antiviral Agents|antiviral agents|mesh-ancestor
24907078|NCT04333589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24907079|NCT04332978|Fluticasone|fluticasone|mesh-list
24907080|NCT04332978|Xhance|xhance|mesh-list
24907081|NCT04332978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24907082|NCT04332978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24907083|NCT04332978|Autonomic Agents|autonomic agents|mesh-ancestor
24482501|NCT00439283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907155|NCT04332276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907156|NCT04332276|Protective Agents|protective agents|mesh-ancestor
24907157|NCT04332289|Deuterium Oxide|deuterium oxide|mesh-list
24907158|NCT04332289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24907159|NCT04332289|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24907160|NCT04332289|Protective Agents|protective agents|mesh-ancestor
24907161|NCT04332289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907163|NCT04332042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24907164|NCT04332042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907165|NCT04332042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907167|NCT04332393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24907168|NCT04332393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907169|NCT04332094|Azithromycin|azithromycin|mesh-list
24907238|NCT04331600|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24907239|NCT04331600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24907240|NCT04331600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24907241|NCT04331600|Antimalarials|antimalarials|mesh-ancestor
24907242|NCT04331600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24519520|NCT05332730|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24519521|NCT05332730|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24907326|NCT04331197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24907327|NCT04331197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907328|NCT04331197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24907329|NCT04331197|Hormone Antagonists|hormone antagonists|mesh-ancestor
24485654|NCT00454402|Alfuzosin|alfuzosin|mesh-list
24907343|NCT04331210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907344|NCT04331210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24907345|NCT04331210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24907346|NCT04331210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24907347|NCT04331210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907348|NCT04331210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24818834|NCT02091219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24818835|NCT02091219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24818836|NCT02091297|Acetaminophen|acetaminophen|mesh-list
24818837|NCT02091297|Morphine|morphine|mesh-list
24818838|NCT02091297|Ropivacaine|ropivacaine|mesh-list
24818839|NCT02091297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24818840|NCT02091297|Narcotics|narcotics|mesh-ancestor
24818841|NCT02091297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24818842|NCT02091297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818849|NCT02091297|Antipyretics|antipyretics|mesh-ancestor
24818850|NCT02091310|Moxifloxacin|moxifloxacin|mesh-list
24818851|NCT02091310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24818868|NCT02091388|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24818869|NCT02091388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24907400|NCT04330755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24907401|NCT04330755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907402|NCT04330755|Anesthetics|anesthetics|mesh-ancestor
24907403|NCT04330755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24907404|NCT04330755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24907405|NCT04330755|Anticonvulsants|anticonvulsants|mesh-ancestor
24907406|NCT04330755|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24907407|NCT04330755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24907408|NCT04330755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907409|NCT04330755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24907410|NCT04330755|Tocolytic Agents|tocolytic agents|mesh-ancestor
24907411|NCT04330755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24907412|NCT04330755|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24907413|NCT04330755|Vasodilator Agents|vasodilator agents|mesh-ancestor
24907414|NCT04330755|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24907417|NCT04330755|Protective Agents|protective agents|mesh-ancestor
24907419|NCT04330300|Verapamil|verapamil|mesh-list
24907420|NCT04330300|Felodipine|felodipine|mesh-list
24907421|NCT04330300|Amlodipine|amlodipine|mesh-list
24519522|NCT05332730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24519523|NCT05332730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24519524|NCT05332730|Immunologic Factors|immunologic factors|mesh-ancestor
24519525|NCT05332730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519545|NCT05332496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24519546|NCT05332496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24519547|NCT05332496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519548|NCT05332496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24519549|NCT05332496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24907433|NCT04330300|Perindopril|perindopril|mesh-list
24907434|NCT04330300|Benazepril|benazepril|mesh-list
24907435|NCT04330300|Captopril|captopril|mesh-list
24907436|NCT04330300|Indapamide|indapamide|mesh-list
24907437|NCT04330300|Nicardipine|nicardipine|mesh-list
24907438|NCT04330300|Nimodipine|nimodipine|mesh-list
24907439|NCT04330300|Quinapril|quinapril|mesh-list
24907440|NCT04330300|Trandolapril|trandolapril|mesh-list
24907441|NCT04330300|Metolazone|metolazone|mesh-list
24907442|NCT04330300|Fosinopril|fosinopril|mesh-list
24907443|NCT04330300|Eprosartan|eprosartan|mesh-list
24907444|NCT04330300|Nitrendipine|nitrendipine|mesh-list
24907445|NCT04330300|Bendroflumethiazide|bendroflumethiazide|mesh-list
24907446|NCT04330300|Chlorothiazide|chlorothiazide|mesh-list
24907447|NCT04330300|Nifedipine|nifedipine|mesh-list
24907448|NCT04330300|Calcium Channel Blockers|calcium channel blockers|mesh-list
24907449|NCT04330300|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
24907450|NCT04330300|Diuretics|diuretics|mesh-list
24907451|NCT04330300|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24907452|NCT04330300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24907477|NCT04330586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907478|NCT04330586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24623665|NCT01073059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24907525|NCT04329611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907526|NCT04329611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907527|NCT04329611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24907528|NCT04329650|Methylprednisolone|methylprednisolone|mesh-list
24907529|NCT04329650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24907530|NCT04329650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24907531|NCT04329650|Prednisolone|prednisolone|mesh-list
24907532|NCT04329650|Prednisolone acetate|prednisolone acetate|mesh-list
24907533|NCT04329650|Siltuximab|siltuximab|mesh-list
24907534|NCT04329650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24907535|NCT04329650|Prednisolone phosphate|prednisolone phosphate|mesh-list
24907613|NCT04329130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24907614|NCT04329130|Growth Substances|growth substances|mesh-ancestor
24907615|NCT04329130|Growth Inhibitors|growth inhibitors|mesh-ancestor
24907616|NCT04329130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24907617|NCT04329429|Trastuzumab|trastuzumab|mesh-list
24907618|NCT04329429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24907619|NCT04329429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24907620|NCT04329091|Dexmedetomidine|dexmedetomidine|mesh-list
24907621|NCT04329091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24907624|NCT04329091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24907656|NCT04328883|Aspirin|aspirin|mesh-list
24907657|NCT04328883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24907662|NCT04328883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907663|NCT04328883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24907664|NCT04328883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24907694|NCT04328493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24907695|NCT04328493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24449976|NCT00317512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24907696|NCT04328493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24907697|NCT04328493|Antimalarials|antimalarials|mesh-ancestor
24907698|NCT04328493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24907699|NCT04328493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24907700|NCT04328493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24907701|NCT04328493|Analgesics|analgesics|mesh-ancestor
24907702|NCT04328493|Sensory System Agents|sensory system agents|mesh-ancestor
24907703|NCT04328493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24907704|NCT04328493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907705|NCT04328493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24907706|NCT04328493|Filaricides|filaricides|mesh-ancestor
24907707|NCT04328493|Antinematodal Agents|antinematodal agents|mesh-ancestor
24907708|NCT04328493|Anthelmintics|anthelmintics|mesh-ancestor
24623666|NCT01073059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24907709|NCT04328285|Ritonavir|ritonavir|mesh-list
24907710|NCT04328285|Lopinavir|lopinavir|mesh-list
24907711|NCT04328285|Hydroxychloroquine|hydroxychloroquine|mesh-list
24907712|NCT04328285|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24907713|NCT04328285|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24907714|NCT04328285|Protease Inhibitors|protease inhibitors|mesh-ancestor
24907715|NCT04328285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907716|NCT04328285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907717|NCT04328285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24482965|NCT00441207|Ascorbic Acid|ascorbic acid|mesh-list
24907759|NCT04328064|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24907760|NCT04328064|Calcium|calcium|mesh-list
24907761|NCT04328064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24907762|NCT04328064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907954|NCT04325932|Kallikreins|kallikreins|mesh-list
24907763|NCT04328064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24907786|NCT04327245|Chelating Agents|chelating agents|mesh-ancestor
24907787|NCT04327245|Sequestering Agents|sequestering agents|mesh-ancestor
24907788|NCT04327245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907789|NCT04327401|Dexamethasone|dexamethasone|mesh-list
24907790|NCT04327401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24907791|NCT04327401|Antiemetics|antiemetics|mesh-ancestor
24907792|NCT04327401|Autonomic Agents|autonomic agents|mesh-ancestor
24907793|NCT04327401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24907794|NCT04327401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714334|NCT02354690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25714335|NCT02354833|Phenylephrine|phenylephrine|mesh-list
25714336|NCT02354833|Oxymetazoline|oxymetazoline|mesh-list
25714337|NCT02354833|Norepinephrine|norepinephrine|mesh-list
25714338|NCT02354833|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25714339|NCT02354833|Mydriatics|mydriatics|mesh-ancestor
25714340|NCT02354833|Autonomic Agents|autonomic agents|mesh-ancestor
25714341|NCT02354833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25714342|NCT02354833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714343|NCT02354833|Sympathomimetics|sympathomimetics|mesh-ancestor
25714344|NCT02354833|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25714345|NCT02354833|Nasal Decongestants|nasal decongestants|mesh-ancestor
25714346|NCT02354833|Respiratory System Agents|respiratory system agents|mesh-ancestor
25714347|NCT02354833|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24907795|NCT04327401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24907796|NCT04327401|Glucocorticoids|glucocorticoids|mesh-ancestor
24907798|NCT04327401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24907799|NCT04327401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24907800|NCT04327401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24907801|NCT04327427|Aspirin|aspirin|mesh-list
24907802|NCT04327427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24907803|NCT04327427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24907804|NCT04327427|Analgesics|analgesics|mesh-ancestor
24907805|NCT04327427|Sensory System Agents|sensory system agents|mesh-ancestor
24485968|NCT00455624|Androgens|androgens|mesh-list
24907834|NCT04327011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24907835|NCT04327011|Antimetabolites|antimetabolites|mesh-ancestor
24907836|NCT04327011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615231|NCT01028482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24615237|NCT01028495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24615238|NCT01028495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24615239|NCT01028495|Antiviral Agents|antiviral agents|mesh-ancestor
24615240|NCT01028495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24615241|NCT01028495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24615242|NCT01028495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24615243|NCT01028495|Immunologic Factors|immunologic factors|mesh-ancestor
24615244|NCT01028495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623660|NCT01073059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623661|NCT01073059|GABA Agents|gaba agents|mesh-ancestor
24623662|NCT01073059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24623663|NCT01073059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623664|NCT01073059|Antimanic Agents|antimanic agents|mesh-ancestor
24623667|NCT01073059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24623668|NCT01073059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24623669|NCT01073059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24623670|NCT01073111|Sirolimus|sirolimus|mesh-list
24623671|NCT01073111|Everolimus|everolimus|mesh-list
24623672|NCT01073111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24623673|NCT01073111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24907845|NCT04326959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907847|NCT04326959|Immunologic Factors|immunologic factors|mesh-ancestor
24907848|NCT04326959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24907849|NCT04326959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907850|NCT04326985|Hyaluronic Acid|hyaluronic acid|mesh-list
24907900|NCT04326790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24907901|NCT04326790|Tubulin Modulators|tubulin modulators|mesh-ancestor
24907902|NCT04326790|Antimitotic Agents|antimitotic agents|mesh-ancestor
24907903|NCT04326790|Mitosis Modulators|mitosis modulators|mesh-ancestor
24907904|NCT04326790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24907905|NCT04326790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24907906|NCT04326803|Vaccines|vaccines|mesh-list
24907907|NCT04326803|Immunologic Factors|immunologic factors|mesh-ancestor
24907908|NCT04326803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24730846|NCT01630902|Felodipine|felodipine|mesh-list
24907951|NCT04325984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24907952|NCT04325984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24907993|NCT04325698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24907994|NCT04325698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25714348|NCT02354833|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25714349|NCT02354833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25714350|NCT02354833|Adrenergic Agents|adrenergic agents|mesh-ancestor
25714351|NCT02354833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25714352|NCT02354833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714353|NCT02354833|Protective Agents|protective agents|mesh-ancestor
24907995|NCT04325698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24652186|NCT01236911|Calcium|calcium|mesh-list
24907996|NCT04325698|Growth Substances|growth substances|mesh-ancestor
24907997|NCT04325698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24907998|NCT04325698|Growth Inhibitors|growth inhibitors|mesh-ancestor
24908000|NCT04325581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24908001|NCT04325581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908002|NCT04325581|Incretins|incretins|mesh-ancestor
24908003|NCT04325581|Hormones|hormones|mesh-ancestor
24908004|NCT04325581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24908005|NCT04325776|Zoledronic Acid|zoledronic acid|mesh-list
24908006|NCT04325776|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24908007|NCT04325776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908008|NCT04325425|Carboplatin|carboplatin|mesh-list
24908009|NCT04325425|Etoposide|etoposide|mesh-list
24908099|NCT04324476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908100|NCT04324476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24908101|NCT04324476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24908102|NCT04324476|Growth Substances|growth substances|mesh-ancestor
24908103|NCT04324476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908104|NCT04324476|Growth Inhibitors|growth inhibitors|mesh-ancestor
24908105|NCT04324476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24908106|NCT04324476|Antimetabolites|antimetabolites|mesh-ancestor
24908107|NCT04324476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908109|NCT04324476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24908110|NCT04324476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908111|NCT04324086|Calcium, Dietary|calcium, dietary|mesh-list
24908112|NCT04324086|Calcium|calcium|mesh-list
24908113|NCT04324086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24908114|NCT04324086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908154|NCT04323527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24908155|NCT04323527|Analgesics|analgesics|mesh-ancestor
24908156|NCT04323527|Sensory System Agents|sensory system agents|mesh-ancestor
24519553|NCT05332496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519554|NCT05332483|Megestrol|megestrol|mesh-list
24519555|NCT05332483|Megestrol Acetate|megestrol acetate|mesh-list
24908157|NCT04323527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24908158|NCT04323527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908159|NCT04323527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24908161|NCT04323527|Antinematodal Agents|antinematodal agents|mesh-ancestor
24908162|NCT04323527|Anthelmintics|anthelmintics|mesh-ancestor
24908163|NCT04323514|Ascorbic Acid|ascorbic acid|mesh-list
24908164|NCT04323514|Vitamins|vitamins|mesh-ancestor
24908165|NCT04323514|Micronutrients|micronutrients|mesh-ancestor
24908166|NCT04323514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908167|NCT04323514|Antioxidants|antioxidants|mesh-ancestor
24908168|NCT04323514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714354|NCT02354859|Gallium nitrate|gallium nitrate|mesh-list
24908262|NCT04322175|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24908263|NCT04322175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25714355|NCT02354859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25714356|NCT02354859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714357|NCT02354859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25714358|NCT02354976|Fenofibrate|fenofibrate|mesh-list
25714359|NCT02354976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25714360|NCT02354976|Antimetabolites|antimetabolites|mesh-ancestor
25714361|NCT02354976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714362|NCT02354976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24908264|NCT04322175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908265|NCT04322175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908266|NCT04322214|Cobicistat|cobicistat|mesh-list
24908267|NCT04322214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24908364|NCT04321278|Azithromycin|azithromycin|mesh-list
24908365|NCT04321278|Hydroxychloroquine|hydroxychloroquine|mesh-list
24908366|NCT04321278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24908367|NCT04321278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24908368|NCT04321278|Antimalarials|antimalarials|mesh-ancestor
24908369|NCT04321278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24908370|NCT04321278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24908371|NCT04321278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908372|NCT04321278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908373|NCT04321278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24908374|NCT04321070|Clindamycin|clindamycin|mesh-list
24908375|NCT04321070|Clindamycin palmitate|clindamycin palmitate|mesh-list
24908376|NCT04321070|Clindamycin phosphate|clindamycin phosphate|mesh-list
24908377|NCT04321070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24908378|NCT04321070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24908379|NCT04321070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24908380|NCT04321070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908383|NCT04321096|Protease Inhibitors|protease inhibitors|mesh-ancestor
24908384|NCT04321096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908385|NCT04321096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623682|NCT01073150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24623684|NCT01073189|Furosemide|furosemide|mesh-list
24623699|NCT01073319|Rivastigmine|rivastigmine|mesh-list
24623700|NCT01073319|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24623701|NCT01073319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623702|NCT01073319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623703|NCT01073319|Cholinergic Agents|cholinergic agents|mesh-ancestor
24818881|NCT02091401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24818882|NCT02091401|Anticonvulsants|anticonvulsants|mesh-ancestor
24818883|NCT02091401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24818884|NCT02091401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24818885|NCT02091401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24616894|NCT01039740|Mirtazapine|mirtazapine|mesh-list
24908387|NCT04321096|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24908402|NCT04320706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24908450|NCT04320277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24908451|NCT04320225|Dexamethasone|dexamethasone|mesh-list
24908452|NCT04320225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24908453|NCT04320225|Antiemetics|antiemetics|mesh-ancestor
24908454|NCT04320225|Autonomic Agents|autonomic agents|mesh-ancestor
24908455|NCT04320225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24908456|NCT04320225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908457|NCT04320225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24908458|NCT04320225|Glucocorticoids|glucocorticoids|mesh-ancestor
24908459|NCT04320225|Hormones|hormones|mesh-ancestor
24908460|NCT04320225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24908461|NCT04320225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24908462|NCT04320225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486378|NCT00457678|Verteporfin|verteporfin|mesh-list
24908465|NCT04319978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24908536|NCT04319601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24908537|NCT04319692|Acetic Acid|acetic acid|mesh-list
24908538|NCT04319692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24908539|NCT04319692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24908540|NCT04319705|Azithromycin|azithromycin|mesh-list
24908541|NCT04319705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24908542|NCT04319705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24908543|NCT04319614|Tranexamic Acid|tranexamic acid|mesh-list
24908544|NCT04319614|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24908545|NCT04319614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24908546|NCT04319614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24908547|NCT04319614|Hemostatics|hemostatics|mesh-ancestor
25714363|NCT02355028|Ranibizumab|ranibizumab|mesh-list
25714364|NCT02355028|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25714365|NCT02355028|Acrizanib|acrizanib|mesh-list
25714366|NCT02355028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25714367|NCT02355028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25714368|NCT02355028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25714369|NCT02355028|Growth Substances|growth substances|mesh-ancestor
25714370|NCT02355028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908550|NCT04319549|Eusol|eusol|mesh-list
24908681|NCT04317872|Hormones|hormones|mesh-ancestor
24908682|NCT04317872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24908683|NCT04317872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24908684|NCT04317872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24908688|NCT04317703|Metformin|metformin|mesh-list
24908836|NCT04315935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24908837|NCT04315935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24908840|NCT04315935|Anesthetics|anesthetics|mesh-ancestor
24908917|NCT04315194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24908918|NCT04315194|Analgesics|analgesics|mesh-ancestor
24908919|NCT04315194|Sensory System Agents|sensory system agents|mesh-ancestor
24908920|NCT04315194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24483831|NCT00445094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24483832|NCT00445094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519558|NCT05332483|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24908984|NCT04314193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24908985|NCT04314193|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24908986|NCT04314193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24908987|NCT04314193|Immunologic Factors|immunologic factors|mesh-ancestor
24909006|NCT04313790|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24909007|NCT04313790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909113|NCT04312698|Hypolipidemic Agents|hypolipidemic agents|mesh-list
24909114|NCT04312698|Antimetabolites|antimetabolites|mesh-ancestor
24818902|NCT02091674|Immunologic Factors|immunologic factors|mesh-ancestor
24818903|NCT02091674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24818904|NCT02091674|Viscosupplements|viscosupplements|mesh-ancestor
24818905|NCT02091674|Protective Agents|protective agents|mesh-ancestor
24818906|NCT02091817|Oxytocin|oxytocin|mesh-list
24818907|NCT02091817|Oxytocics|oxytocics|mesh-ancestor
24909379|NCT04309643|Levonorgestrel|levonorgestrel|mesh-list
24909380|NCT04309643|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24909381|NCT04309643|Contraceptive Agents|contraceptive agents|mesh-list
24909382|NCT04309643|Contraceptives, Oral|contraceptives, oral|mesh-list
24909383|NCT04309643|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
24909384|NCT04309643|Estradiol|estradiol|mesh-list
24909385|NCT04309643|Estrogens|estrogens|mesh-ancestor
24909386|NCT04309643|Hormones|hormones|mesh-ancestor
24909394|NCT04309708|Nimodipine|nimodipine|mesh-list
24909442|NCT04308551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909443|NCT04308551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24909444|NCT04308551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24909445|NCT04308551|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24909446|NCT04308551|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24909447|NCT04308551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909451|NCT04308551|Antipyretics|antipyretics|mesh-ancestor
24909453|NCT04308850|Vitamins|vitamins|mesh-ancestor
24909454|NCT04308850|Micronutrients|micronutrients|mesh-ancestor
24909455|NCT04308850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909473|NCT04308317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25714371|NCT02355028|Growth Inhibitors|growth inhibitors|mesh-ancestor
25714372|NCT02355028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25714373|NCT02355028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25714374|NCT02355028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24909474|NCT04308317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484241|NCT00447239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714375|NCT02355028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714376|NCT02355158|Clonidine|clonidine|mesh-list
25714377|NCT02355158|Analgesics|analgesics|mesh-ancestor
24484243|NCT00447304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24484244|NCT00447304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24484245|NCT00447304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24484246|NCT00447304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24909475|NCT04308317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24909478|NCT04308317|Immunologic Factors|immunologic factors|mesh-ancestor
24909493|NCT04308343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24909494|NCT04308343|Immunologic Factors|immunologic factors|mesh-ancestor
24909495|NCT04308343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24909504|NCT04308174|Durvalumab|durvalumab|mesh-list
24909506|NCT04308174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24909508|NCT04308161|Miconazole|miconazole|mesh-list
24909509|NCT04308161|Vitamins|vitamins|mesh-ancestor
24909510|NCT04308161|Micronutrients|micronutrients|mesh-ancestor
24909511|NCT04308161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909512|NCT04308161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24909513|NCT04308161|Antifungal Agents|antifungal agents|mesh-ancestor
24909514|NCT04308161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24909515|NCT04308161|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24909516|NCT04308161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24909517|NCT04308161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24909518|NCT04308161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909519|NCT04308161|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24909524|NCT04308031|Digoxin|digoxin|mesh-list
24519588|NCT05332314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24909672|NCT04306276|Contraceptive Agents|contraceptive agents|mesh-ancestor
24484391|NCT00448110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519645|NCT05331781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24909730|NCT04305587|Purinergic Agents|purinergic agents|mesh-ancestor
24909731|NCT04305587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24909732|NCT04305587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909733|NCT04305587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909734|NCT04305236|Fulvestrant|fulvestrant|mesh-list
24909735|NCT04305236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24909736|NCT04305236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24909737|NCT04305236|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24909738|NCT04305236|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24909739|NCT04305236|Hormone Antagonists|hormone antagonists|mesh-ancestor
24909740|NCT04305236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24519649|NCT05331690|Dexamethasone|dexamethasone|mesh-list
24519650|NCT05331690|Nepafenac|nepafenac|mesh-list
24519651|NCT05331690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24519652|NCT05331690|Antiemetics|antiemetics|mesh-ancestor
24519653|NCT05331690|Autonomic Agents|autonomic agents|mesh-ancestor
24909741|NCT04305236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909743|NCT04305457|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24909744|NCT04305457|Autonomic Agents|autonomic agents|mesh-ancestor
24909757|NCT04305028|Aspirin|aspirin|mesh-list
24909780|NCT04304807|Melatonin|melatonin|mesh-list
24909781|NCT04304807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24909782|NCT04304807|Antioxidants|antioxidants|mesh-ancestor
24909783|NCT04304807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24909784|NCT04304807|Protective Agents|protective agents|mesh-ancestor
24909785|NCT04304807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909786|NCT04304807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24909787|NCT04304794|Antithyroid Agents|antithyroid agents|mesh-list
24909788|NCT04304794|Hormone Antagonists|hormone antagonists|mesh-ancestor
24910232|NCT04301336|Vitamin B Complex|vitamin b complex|mesh-list
24909841|NCT04304157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909842|NCT04304157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24519662|NCT05331690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24519663|NCT05331690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24519664|NCT05331690|Analgesics|analgesics|mesh-ancestor
24909930|NCT04303988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24909931|NCT04303988|Growth Substances|growth substances|mesh-ancestor
24909932|NCT04303988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24909933|NCT04303988|Growth Inhibitors|growth inhibitors|mesh-ancestor
24909937|NCT04303819|Exenatide|exenatide|mesh-list
24909938|NCT04303819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24909940|NCT04303819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24909957|NCT04304014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24909959|NCT04303520|Fludarabine|fludarabine|mesh-list
24909960|NCT04303520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24909969|NCT04303377|Evolocumab|evolocumab|mesh-list
24909998|NCT04303598|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24909999|NCT04303026|Zoledronic Acid|zoledronic acid|mesh-list
24910000|NCT04303026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24910001|NCT04303026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910002|NCT04303130|Endostar protein|endostar protein|mesh-list
24910003|NCT04303130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24484691|NCT00449618|Aspirin|aspirin|mesh-list
24484692|NCT00449618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24484693|NCT00449618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24484694|NCT00449618|Analgesics|analgesics|mesh-ancestor
24484695|NCT00449618|Sensory System Agents|sensory system agents|mesh-ancestor
24484696|NCT00449618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24484697|NCT00449618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484698|NCT00449618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24484699|NCT00449618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24519693|NCT05315024|Imiquimod|imiquimod|mesh-list
24519694|NCT05315024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24519695|NCT05315024|Immunologic Factors|immunologic factors|mesh-ancestor
24519696|NCT05315024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714378|NCT02355158|Sensory System Agents|sensory system agents|mesh-ancestor
25714379|NCT02355158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25714380|NCT02355158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714381|NCT02355158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25714382|NCT02355158|Sympatholytics|sympatholytics|mesh-ancestor
25714383|NCT02355158|Autonomic Agents|autonomic agents|mesh-ancestor
25714384|NCT02355158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24519708|NCT05280743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519738|NCT05242874|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24910050|NCT04302441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24910051|NCT04302441|Antimetabolites|antimetabolites|mesh-ancestor
24910052|NCT04302441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910053|NCT04302441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910054|NCT04302441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24910055|NCT04302441|Tubulin Modulators|tubulin modulators|mesh-ancestor
24910058|NCT04302584|Vasopressins|vasopressins|mesh-list
24519740|NCT05242874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24910228|NCT04301349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24910229|NCT04301349|Oxytocics|oxytocics|mesh-ancestor
24910230|NCT04301336|Zinc|zinc|mesh-list
24910231|NCT04301336|Folic Acid|folic acid|mesh-list
24519769|NCT05177614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519770|NCT05159934|Nicotine|nicotine|mesh-list
24519771|NCT05159934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24910247|NCT04301336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910248|NCT04301336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24910249|NCT04301336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24910250|NCT04301336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24910251|NCT04301336|Trace Elements|trace elements|mesh-ancestor
24910252|NCT04301336|Micronutrients|micronutrients|mesh-ancestor
24910253|NCT04301336|Hematinics|hematinics|mesh-ancestor
24910254|NCT04301336|Vitamins|vitamins|mesh-ancestor
24910255|NCT04301336|Astringents|astringents|mesh-ancestor
24910256|NCT04301336|Dermatologic Agents|dermatologic agents|mesh-ancestor
24910257|NCT04301336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910258|NCT04301336|Antisickling Agents|antisickling agents|mesh-ancestor
24910259|NCT04301336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24910260|NCT04301024|Nitrous Oxide|nitrous oxide|mesh-list
24910261|NCT04301024|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24910262|NCT04301024|Anesthetics, General|anesthetics, general|mesh-ancestor
24910263|NCT04301024|Anesthetics|anesthetics|mesh-ancestor
24910304|NCT04300881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25714385|NCT02355158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25714386|NCT02355158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25714387|NCT02355158|Adrenergic Agents|adrenergic agents|mesh-ancestor
25714388|NCT02355158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25714389|NCT02355158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714390|NCT02355210|DEFB1 protein, human|defb1 protein, human|mesh-list
25714391|NCT02355210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25714392|NCT02355665|Nicotine|nicotine|mesh-list
24910305|NCT04300881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910306|NCT04300881|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24910307|NCT04300881|Diuretics|diuretics|mesh-ancestor
24910308|NCT04300881|Natriuretic Agents|natriuretic agents|mesh-ancestor
24910309|NCT04300881|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24910384|NCT04298528|Analgesics|analgesics|mesh-ancestor
24819004|NCT02092506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819005|NCT02092506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910320|NCT04300751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24910322|NCT04300751|Analgesics|analgesics|mesh-ancestor
24910364|NCT04299633|Sequestering Agents|sequestering agents|mesh-ancestor
24910365|NCT04299633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910366|NCT04299854|Dinoprostone|dinoprostone|mesh-list
24910367|NCT04299854|Oxytocics|oxytocics|mesh-ancestor
24910368|NCT04299854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24910369|NCT04299854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910370|NCT04298775|Morphine|morphine|mesh-list
24910371|NCT04298775|Anesthetics|anesthetics|mesh-list
24910372|NCT04298775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24910373|NCT04298775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910374|NCT04298775|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24910375|NCT04298775|Narcotics|narcotics|mesh-ancestor
24910376|NCT04298775|Analgesics|analgesics|mesh-ancestor
24910377|NCT04298775|Sensory System Agents|sensory system agents|mesh-ancestor
24910378|NCT04298775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24910379|NCT04298528|Dronabinol|dronabinol|mesh-list
24910380|NCT04298528|Hallucinogens|hallucinogens|mesh-ancestor
24484990|NCT00451061|Urological Agents|urological agents|mesh-ancestor
25714393|NCT02355665|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25714394|NCT02355665|Autonomic Agents|autonomic agents|mesh-ancestor
25714395|NCT02355665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25714396|NCT02355665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714397|NCT02355665|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25714398|NCT02355665|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25714399|NCT02355665|Cholinergic Agents|cholinergic agents|mesh-ancestor
25714400|NCT02355665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25714401|NCT02355665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714402|NCT02355821|Bisoprolol|bisoprolol|mesh-list
25714403|NCT02355821|Moxonidine|moxonidine|mesh-list
25714404|NCT02355821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24484991|NCT00451074|Gentamicins|gentamicins|mesh-list
24484992|NCT00451074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24484993|NCT00451074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24484994|NCT00451074|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24910381|NCT04298528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910383|NCT04298528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24910387|NCT04298528|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24910388|NCT04298528|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24487334|NCT00462696|Mitosis Modulators|mitosis modulators|mesh-ancestor
24910389|NCT04298528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24910390|NCT04298528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910396|NCT04298684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910398|NCT04298684|Hormones|hormones|mesh-ancestor
24910399|NCT04298684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24910400|NCT04298684|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24910401|NCT04298684|Protease Inhibitors|protease inhibitors|mesh-ancestor
24910402|NCT04298684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24910403|NCT04298684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910404|NCT04298372|Lenalidomide|lenalidomide|mesh-list
24910405|NCT04298372|Immunologic Factors|immunologic factors|mesh-ancestor
24910451|NCT04297215|Sequestering Agents|sequestering agents|mesh-ancestor
24910519|NCT04296422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24910520|NCT04296422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24910521|NCT04296422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24910522|NCT04296422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910523|NCT04296422|Gout Suppressants|gout suppressants|mesh-ancestor
24910524|NCT04296422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24819021|NCT02092597|Exenatide|exenatide|mesh-list
24910574|NCT04296240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24910575|NCT04296240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910576|NCT04296240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24910577|NCT04296370|Apatinib|apatinib|mesh-list
24910578|NCT04296370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910579|NCT04296370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24485222|NCT00452062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24485223|NCT00452062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485224|NCT00452062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24485225|NCT00452062|Glucocorticoids|glucocorticoids|mesh-ancestor
24485226|NCT00452062|Hormones|hormones|mesh-ancestor
24485227|NCT00452062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24485228|NCT00452062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24485229|NCT00452062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485230|NCT00452075|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24485231|NCT00452075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485232|NCT00452075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24910591|NCT04296175|Tubulin Modulators|tubulin modulators|mesh-ancestor
24910592|NCT04296175|Antimitotic Agents|antimitotic agents|mesh-ancestor
24910648|NCT04296149|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25714405|NCT02355821|Sympatholytics|sympatholytics|mesh-ancestor
25714406|NCT02355821|Autonomic Agents|autonomic agents|mesh-ancestor
25714407|NCT02355821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25714408|NCT02355821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714409|NCT02355821|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25714410|NCT02355821|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25714411|NCT02355821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25714412|NCT02355821|Adrenergic Agents|adrenergic agents|mesh-ancestor
24910649|NCT04296149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910650|NCT04295408|Ropivacaine|ropivacaine|mesh-list
24910651|NCT04295408|Anesthetics, Local|anesthetics, local|mesh-ancestor
24910652|NCT04295408|Anesthetics|anesthetics|mesh-ancestor
24910655|NCT04295408|Sensory System Agents|sensory system agents|mesh-ancestor
24910656|NCT04295408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24910658|NCT04295317|Antibodies|antibodies|mesh-list
24910659|NCT04295317|Antibodies, Blocking|antibodies, blocking|mesh-list
24910660|NCT04295317|Immunologic Factors|immunologic factors|mesh-ancestor
24910661|NCT04295317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910696|NCT04295161|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24910698|NCT04295161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910722|NCT04294836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24910723|NCT04294836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24910725|NCT04294836|Sensory System Agents|sensory system agents|mesh-ancestor
24910726|NCT04294836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24910727|NCT04294836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910728|NCT04294836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24910729|NCT04294836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24910730|NCT04294836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24733660|NCT01647828|Paclitaxel|paclitaxel|mesh-list
24910731|NCT04294836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24910732|NCT04294836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910733|NCT04294966|Dronabinol|dronabinol|mesh-list
24910734|NCT04294966|Hallucinogens|hallucinogens|mesh-ancestor
24910776|NCT04294992|Serotonin Agents|serotonin agents|mesh-ancestor
24910777|NCT04294992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24910778|NCT04294992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910779|NCT04294992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25714413|NCT02355821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25714414|NCT02355821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714415|NCT02355886|Gabapentin|gabapentin|mesh-list
25714416|NCT02355886|Analgesics|analgesics|mesh-ancestor
25714417|NCT02355886|Sensory System Agents|sensory system agents|mesh-ancestor
25714418|NCT02355886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25714419|NCT02355886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714420|NCT02355886|Anticonvulsants|anticonvulsants|mesh-ancestor
25714421|NCT02355886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25714422|NCT02355886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25714423|NCT02355886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24910781|NCT04294992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24910782|NCT04294992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24910783|NCT04294992|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24910784|NCT04294511|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
24910785|NCT04294511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910786|NCT04294511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910788|NCT04294537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24910789|NCT04294537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485448|NCT00453076|Paclitaxel|paclitaxel|mesh-list
24485449|NCT00453076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24910824|NCT04293822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24910825|NCT04293822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819144|NCT02093598|Immunologic Factors|immunologic factors|mesh-ancestor
24819145|NCT02093598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910850|NCT04293172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24910851|NCT04293172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910852|NCT04293172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910854|NCT04292990|Morphine|morphine|mesh-list
24910855|NCT04292990|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24910856|NCT04292990|Narcotics|narcotics|mesh-ancestor
24910857|NCT04292990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24485548|NCT00453635|Mitosis Modulators|mitosis modulators|mesh-ancestor
24910858|NCT04292990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910860|NCT04292990|Sensory System Agents|sensory system agents|mesh-ancestor
24910861|NCT04292990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24910862|NCT04292990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24910863|NCT04292990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24910864|NCT04292990|Anesthetics, General|anesthetics, general|mesh-ancestor
24910865|NCT04292990|Anesthetics|anesthetics|mesh-ancestor
24910866|NCT04292886|Tamoxifen|tamoxifen|mesh-list
24910867|NCT04292886|Ascorbic Acid|ascorbic acid|mesh-list
24910868|NCT04292886|Vitamins|vitamins|mesh-ancestor
24910869|NCT04292886|Micronutrients|micronutrients|mesh-ancestor
24910870|NCT04292886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910871|NCT04292886|Antioxidants|antioxidants|mesh-ancestor
24910872|NCT04292886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910873|NCT04292886|Protective Agents|protective agents|mesh-ancestor
24910874|NCT04292886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24910875|NCT04292886|Hormone Antagonists|hormone antagonists|mesh-ancestor
24487706|NCT00464594|Acarbose|acarbose|mesh-list
24910877|NCT04292886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25714424|NCT02355886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25714425|NCT02355886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25714426|NCT02355886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25714427|NCT02355886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25714428|NCT02355886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714429|NCT02355886|Antimanic Agents|antimanic agents|mesh-ancestor
25714430|NCT02355977|Minocycline|minocycline|mesh-list
25714431|NCT02355977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25714432|NCT02355977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24910879|NCT04292886|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24910880|NCT04292886|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24910881|NCT04292886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24485582|NCT00453778|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24485584|NCT00453804|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24485585|NCT00453804|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24910938|NCT04292808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910940|NCT04292691|Anesthetics, Local|anesthetics, local|mesh-ancestor
24910941|NCT04292691|Anesthetics|anesthetics|mesh-ancestor
24910942|NCT04292691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24910943|NCT04292691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24910944|NCT04292691|Sensory System Agents|sensory system agents|mesh-ancestor
25714433|NCT02356107|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
25714434|NCT02356107|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25714435|NCT02356107|Antidepressive Agents|antidepressive agents|mesh-ancestor
25714436|NCT02356107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25714437|NCT02356198|Hydromorphone|hydromorphone|mesh-list
25714438|NCT02356198|Bupivacaine|bupivacaine|mesh-list
25714439|NCT02356198|Anesthetics, Local|anesthetics, local|mesh-ancestor
25714440|NCT02356198|Anesthetics|anesthetics|mesh-ancestor
25714441|NCT02356198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25714442|NCT02356198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714443|NCT02356198|Sensory System Agents|sensory system agents|mesh-ancestor
25714444|NCT02356198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25714445|NCT02356198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25714446|NCT02356198|Narcotics|narcotics|mesh-ancestor
25714447|NCT02356198|Analgesics|analgesics|mesh-ancestor
25714448|NCT02356562|Ritonavir|ritonavir|mesh-list
24910945|NCT04292691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24910946|NCT04292769|Decitabine|decitabine|mesh-list
24910947|NCT04292769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24910948|NCT04292769|Antimetabolites|antimetabolites|mesh-ancestor
24910949|NCT04292769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910950|NCT04292769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24910951|NCT04292769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24910977|NCT04292184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24910978|NCT04292184|Antitubercular Agents|antitubercular agents|mesh-ancestor
24910979|NCT04292184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24910980|NCT04292184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24910981|NCT04292184|Chelating Agents|chelating agents|mesh-ancestor
24910982|NCT04292184|Sequestering Agents|sequestering agents|mesh-ancestor
24910983|NCT04292236|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
24910984|NCT04292236|Perilla seed oil|perilla seed oil|mesh-list
24910985|NCT04292236|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24910987|NCT04292236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911106|NCT04291066|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24911107|NCT04291066|Antioxidants|antioxidants|mesh-ancestor
24911108|NCT04291066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911109|NCT04291066|Protective Agents|protective agents|mesh-ancestor
24911173|NCT04290429|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24911174|NCT04290429|Protective Agents|protective agents|mesh-ancestor
24911175|NCT04290429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911176|NCT04290572|Isotretinoin|isotretinoin|mesh-list
24911177|NCT04290572|Dermatologic Agents|dermatologic agents|mesh-ancestor
24911178|NCT04290390|Itraconazole|itraconazole|mesh-list
24911179|NCT04290390|Rifampin|rifampin|mesh-list
24911180|NCT04290390|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24911181|NCT04290390|Estradiol|estradiol|mesh-list
24911182|NCT04290390|Estrogens|estrogens|mesh-ancestor
24911183|NCT04290390|Hormones|hormones|mesh-ancestor
24911184|NCT04290390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24911233|NCT04290013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24911234|NCT04290013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24911236|NCT04290208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24911237|NCT04290208|Analgesics|analgesics|mesh-ancestor
24911238|NCT04290208|Sensory System Agents|sensory system agents|mesh-ancestor
24911239|NCT04290208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24911240|NCT04290208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911242|NCT04290169|Botulinum Toxins|botulinum toxins|mesh-list
24911243|NCT04290169|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24911244|NCT04290169|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24911245|NCT04290169|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24911253|NCT04290104|Ampicillin|ampicillin|mesh-list
24446873|NCT00306397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24446874|NCT00306397|Immunologic Factors|immunologic factors|mesh-ancestor
24911272|NCT04290026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911273|NCT04290026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24911274|NCT04290026|Serotonin Agents|serotonin agents|mesh-ancestor
25714450|NCT02356562|Sofosbuvir|sofosbuvir|mesh-list
25714451|NCT02356562|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25714452|NCT02356562|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25714453|NCT02356562|Protease Inhibitors|protease inhibitors|mesh-ancestor
25714454|NCT02356562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25714455|NCT02356562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714456|NCT02356562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25714457|NCT02356562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25714458|NCT02356562|Antiviral Agents|antiviral agents|mesh-ancestor
25714459|NCT02356562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24911312|NCT04289974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24911313|NCT04289974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24911314|NCT04289974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911315|NCT04289883|Calcium|calcium|mesh-list
24911316|NCT04289883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24911317|NCT04289883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911318|NCT04289792|Gemcitabine|gemcitabine|mesh-list
24911319|NCT04289792|Paclitaxel|paclitaxel|mesh-list
24911323|NCT04289792|Antimitotic Agents|antimitotic agents|mesh-ancestor
24911324|NCT04289792|Mitosis Modulators|mitosis modulators|mesh-ancestor
24911325|NCT04289792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911326|NCT04289792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24911328|NCT04289792|Antiviral Agents|antiviral agents|mesh-ancestor
24911329|NCT04289792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24911330|NCT04289792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24911331|NCT04289792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24911380|NCT04288765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24911381|NCT04288765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24911382|NCT04288765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24911383|NCT04288765|Immunologic Factors|immunologic factors|mesh-ancestor
24911384|NCT04288765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24911385|NCT04288765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24911386|NCT04288765|Growth Substances|growth substances|mesh-ancestor
24911387|NCT04288765|Growth Inhibitors|growth inhibitors|mesh-ancestor
24911388|NCT04288700|Timolol|timolol|mesh-list
24911389|NCT04288700|Propranolol|propranolol|mesh-list
24911408|NCT04288349|Epinephryl borate|epinephryl borate|mesh-list
24911448|NCT04287894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24911449|NCT04287894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623713|NCT01073371|Anesthetics, Local|anesthetics, local|mesh-ancestor
24911450|NCT04287894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24911451|NCT04287894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24911452|NCT04287894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24911453|NCT04287803|Methoxyflurane|methoxyflurane|mesh-list
25714460|NCT02356562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25714461|NCT02356562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25714462|NCT02356562|Antimetabolites|antimetabolites|mesh-ancestor
25714463|NCT02356588|Sufentanil|sufentanil|mesh-list
25714464|NCT02356588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25714465|NCT02356588|Narcotics|narcotics|mesh-ancestor
25714466|NCT02356588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25714467|NCT02356588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714468|NCT02356588|Analgesics|analgesics|mesh-ancestor
24486090|NCT00456313|Fluticasone|fluticasone|mesh-list
24519879|NCT04542278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519884|NCT04500665|Colchicine|colchicine|mesh-list
24519885|NCT04500665|Gout Suppressants|gout suppressants|mesh-ancestor
24911515|NCT04287387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24911578|NCT04286503|Sensory System Agents|sensory system agents|mesh-ancestor
24911579|NCT04286503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24911580|NCT04286503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911581|NCT04286503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24911582|NCT04286503|Filaricides|filaricides|mesh-ancestor
24911583|NCT04286503|Antinematodal Agents|antinematodal agents|mesh-ancestor
24911650|NCT04285281|Sensory System Agents|sensory system agents|mesh-ancestor
24734600|NCT01652794|Gemcitabine|gemcitabine|mesh-list
24911651|NCT04285281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24911652|NCT04285281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911653|NCT04285281|Anticonvulsants|anticonvulsants|mesh-ancestor
24911654|NCT04285281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24911655|NCT04285281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24911656|NCT04285281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24911657|NCT04285281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24911658|NCT04285281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24911659|NCT04285281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24911660|NCT04285281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24911661|NCT04285281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911662|NCT04285281|Antimanic Agents|antimanic agents|mesh-ancestor
24911663|NCT04285073|Paclitaxel|paclitaxel|mesh-list
24911664|NCT04285073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24911665|NCT04285073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24911666|NCT04285073|Tubulin Modulators|tubulin modulators|mesh-ancestor
24911667|NCT04285073|Antimitotic Agents|antimitotic agents|mesh-ancestor
24911668|NCT04285073|Mitosis Modulators|mitosis modulators|mesh-ancestor
24734691|NCT01653171|Acetylcysteine|acetylcysteine|mesh-list
24911678|NCT04285268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911679|NCT04285268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24911680|NCT04285268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24911681|NCT04285320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24911682|NCT04285320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24911683|NCT04285320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24911684|NCT04285320|Antitubercular Agents|antitubercular agents|mesh-ancestor
24911685|NCT04285346|Ganaxolone|ganaxolone|mesh-list
24911686|NCT04285346|Neurosteroids|neurosteroids|mesh-ancestor
25714469|NCT02356588|Sensory System Agents|sensory system agents|mesh-ancestor
25714470|NCT02356588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25714471|NCT02356588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25714472|NCT02356588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25714473|NCT02356588|Anesthetics, General|anesthetics, general|mesh-ancestor
25714474|NCT02356588|Anesthetics|anesthetics|mesh-ancestor
25714475|NCT02357147|Cisplatin|cisplatin|mesh-list
25714476|NCT02357147|Pemetrexed|pemetrexed|mesh-list
25714477|NCT02357147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25714478|NCT02357147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25714479|NCT02357147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714480|NCT02357147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24911687|NCT04285346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24911688|NCT04285346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911689|NCT04285346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519967|NCT04333407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519968|NCT04333407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24519969|NCT04333407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24519970|NCT04333407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24519971|NCT04333407|Antipyretics|antipyretics|mesh-ancestor
24911769|NCT04284150|Dexmedetomidine|dexmedetomidine|mesh-list
24911770|NCT04284150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24911771|NCT04284150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24911772|NCT04284150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911773|NCT04284150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24911792|NCT04284059|Vitamin D|vitamin d|mesh-list
24911798|NCT04283916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24911799|NCT04283916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24911800|NCT04283916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24911801|NCT04283916|Cholinergic Agents|cholinergic agents|mesh-ancestor
24911802|NCT04283916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24911803|NCT04283916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24911804|NCT04283747|Immunoglobulins|immunoglobulins|mesh-list
24911805|NCT04283747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24911807|NCT04283747|Immunologic Factors|immunologic factors|mesh-ancestor
24911872|NCT04283435|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24911873|NCT04283435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24911874|NCT04283435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24911875|NCT04283435|Urological Agents|urological agents|mesh-ancestor
24912038|NCT04281745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714481|NCT02357147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25714482|NCT02357290|Acetylcysteine|acetylcysteine|mesh-list
25714483|NCT02357290|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25714484|NCT02357290|Antiviral Agents|antiviral agents|mesh-ancestor
25714485|NCT02357290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25714486|NCT02357290|Expectorants|expectorants|mesh-ancestor
25714487|NCT02357290|Respiratory System Agents|respiratory system agents|mesh-ancestor
25714489|NCT02357290|Antioxidants|antioxidants|mesh-ancestor
24912039|NCT04281745|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24912040|NCT04281745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24912041|NCT04281576|Capecitabine|capecitabine|mesh-list
24912101|NCT04281095|Cholinergic Agents|cholinergic agents|mesh-ancestor
24912102|NCT04281095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24912103|NCT04281095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912104|NCT04281095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24912105|NCT04281095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24912106|NCT04280874|Dinoprostone|dinoprostone|mesh-list
24912111|NCT04280588|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24912112|NCT04280588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912113|NCT04280588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24912114|NCT04280588|Immunologic Factors|immunologic factors|mesh-ancestor
24912115|NCT04280588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912116|NCT04280289|Cannabidiol|cannabidiol|mesh-list
24912117|NCT04280289|Anticonvulsants|anticonvulsants|mesh-ancestor
24912119|NCT04279938|Pembrolizumab|pembrolizumab|mesh-list
24912120|NCT04279938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24912153|NCT04279106|Chlorhexidine|chlorhexidine|mesh-list
24912154|NCT04279106|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24912156|NCT04279106|Fluorides|fluorides|mesh-list
24912157|NCT04279106|Sodium Fluoride|sodium fluoride|mesh-list
24912158|NCT04279106|Cariostatic Agents|cariostatic agents|mesh-ancestor
24819159|NCT02093728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24819160|NCT02093728|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24819161|NCT02093728|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24819162|NCT02093741|Factor VIII|factor viii|mesh-list
24819163|NCT02093741|Coagulants|coagulants|mesh-ancestor
24819164|NCT02093780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
24819166|NCT02093845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24819167|NCT02093845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24819168|NCT02093845|Immunologic Factors|immunologic factors|mesh-ancestor
24819169|NCT02093845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912229|NCT04278378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912230|NCT04278378|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24912231|NCT04278378|Dermatologic Agents|dermatologic agents|mesh-ancestor
24912233|NCT04278287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24912234|NCT04278287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24912235|NCT04278287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912236|NCT04278287|Tubulin Modulators|tubulin modulators|mesh-ancestor
25714490|NCT02357290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714491|NCT02357290|Protective Agents|protective agents|mesh-ancestor
25714492|NCT02357290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714493|NCT02357290|Antidotes|antidotes|mesh-ancestor
25714494|NCT02357342|Sirolimus|sirolimus|mesh-list
25714495|NCT02357342|Aflibercept|aflibercept|mesh-list
25714496|NCT02357342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912237|NCT04278287|Antimitotic Agents|antimitotic agents|mesh-ancestor
24912238|NCT04278287|Mitosis Modulators|mitosis modulators|mesh-ancestor
24912239|NCT04278287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912240|NCT04278248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24912241|NCT04278248|Immunologic Factors|immunologic factors|mesh-ancestor
24912242|NCT04278248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912244|NCT04278495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24912245|NCT04278495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24486891|NCT00460473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24912287|NCT04277663|Interferons|interferons|mesh-list
24912288|NCT04277663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912289|NCT04277663|Antiviral Agents|antiviral agents|mesh-ancestor
24912290|NCT04277663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24912291|NCT04277923|SMOFlipid|smoflipid|mesh-list
24912292|NCT04277923|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24912293|NCT04277923|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24912294|NCT04277923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24912295|NCT04277533|Calcium|calcium|mesh-list
24912296|NCT04277533|Bilirubin|bilirubin|mesh-list
24912297|NCT04277533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24912298|NCT04277533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912299|NCT04277533|Antioxidants|antioxidants|mesh-ancestor
24912302|NCT04277143|Daptomycin|daptomycin|mesh-list
24912365|NCT04276480|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
24912366|NCT04276480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24912367|NCT04276480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24912368|NCT04276480|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24912370|NCT04276480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912371|NCT04276428|Insulin|insulin|mesh-list
24912372|NCT04276428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24912373|NCT04276428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912374|NCT04276597|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
24912375|NCT04276597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24735400|NCT01656811|Albuterol|albuterol|mesh-list
24912376|NCT04276597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912377|NCT04276545|Midazolam|midazolam|mesh-list
24912378|NCT04276545|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24912379|NCT04276545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24912380|NCT04276545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24912381|NCT04276545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912382|NCT04276545|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25714497|NCT02357342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25714498|NCT02357342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25714499|NCT02357342|Growth Substances|growth substances|mesh-ancestor
25714500|NCT02357342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714501|NCT02357342|Growth Inhibitors|growth inhibitors|mesh-ancestor
25714502|NCT02357342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25714503|NCT02357342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25714504|NCT02357342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25714505|NCT02357342|Antifungal Agents|antifungal agents|mesh-ancestor
25714506|NCT02357342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24912384|NCT04276545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24520027|NCT04029116|Antifungal Agents|antifungal agents|mesh-ancestor
24520028|NCT04029116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24520029|NCT04029116|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24912504|NCT04274933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912505|NCT04274933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912507|NCT04275245|Antiviral Agents|antiviral agents|mesh-ancestor
24912508|NCT04275245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24912509|NCT04274920|Calcium|calcium|mesh-list
24912510|NCT04274920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24912511|NCT04274920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912512|NCT04275024|Calcipotriene|calcipotriene|mesh-list
24912513|NCT04275024|Dermatologic Agents|dermatologic agents|mesh-ancestor
24912514|NCT04274907|Pembrolizumab|pembrolizumab|mesh-list
24912515|NCT04274907|Venetoclax|venetoclax|mesh-list
24912516|NCT04274907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24912518|NCT04274608|Botulinum Toxins|botulinum toxins|mesh-list
24520041|NCT04020185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520042|NCT04019964|Nivolumab|nivolumab|mesh-list
24912542|NCT04274270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912543|NCT04274270|Growth Inhibitors|growth inhibitors|mesh-ancestor
24912544|NCT04274270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24912545|NCT04274166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24912546|NCT04274166|Immunologic Factors|immunologic factors|mesh-ancestor
24912547|NCT04274166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912548|NCT04274413|Adrenergic Agents|adrenergic agents|mesh-list
24912549|NCT04274413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24912552|NCT04274257|Rituximab|rituximab|mesh-list
24912606|NCT04273763|Expectorants|expectorants|mesh-ancestor
24912703|NCT04273100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912704|NCT04273035|Midazolam|midazolam|mesh-list
24912705|NCT04273035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24912706|NCT04273035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24912707|NCT04273035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25714507|NCT02357342|Immunologic Factors|immunologic factors|mesh-ancestor
25714508|NCT02357368|Copper|copper|mesh-list
25714509|NCT02357368|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25714510|NCT02357368|Contraceptive Agents|contraceptive agents|mesh-list
25714511|NCT02357368|Levonorgestrel|levonorgestrel|mesh-list
25714512|NCT02357368|Medroxyprogesterone|medroxyprogesterone|mesh-list
25714513|NCT02357368|Etonogestrel|etonogestrel|mesh-list
24912708|NCT04273035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912709|NCT04273035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24912710|NCT04273035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24912749|NCT04272476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24912750|NCT04272359|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24912751|NCT04272359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912752|NCT04272372|Ketoprofen|ketoprofen|mesh-list
24912753|NCT04272372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24912754|NCT04272372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24912755|NCT04272372|Analgesics|analgesics|mesh-ancestor
24912756|NCT04272372|Sensory System Agents|sensory system agents|mesh-ancestor
24912757|NCT04272372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24912758|NCT04272372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24912759|NCT04272372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24912760|NCT04272372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24520046|NCT04019964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520048|NCT04019015|Hemostatics|hemostatics|mesh-ancestor
24520049|NCT04019015|Coagulants|coagulants|mesh-ancestor
24446897|NCT00306462|Tocolytic Agents|tocolytic agents|mesh-ancestor
24446898|NCT00306462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24488898|NCT00470509|Adalimumab|adalimumab|mesh-list
24446899|NCT00306462|Vasodilator Agents|vasodilator agents|mesh-ancestor
24446900|NCT00306475|Valproic Acid|valproic acid|mesh-list
24446901|NCT00306475|Anticonvulsants|anticonvulsants|mesh-ancestor
24446902|NCT00306475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446903|NCT00306475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819206|NCT02094157|Anticoagulants|anticoagulants|mesh-ancestor
24819244|NCT02094287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819245|NCT02094287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819246|NCT02094287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24819247|NCT02094313|Atorvastatin|atorvastatin|mesh-list
24819248|NCT02094313|Anticholesteremic Agents|anticholesteremic agents|mesh-list
24819249|NCT02094313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24819250|NCT02094313|Antimetabolites|antimetabolites|mesh-ancestor
24912905|NCT04270370|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24912906|NCT04270370|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24912907|NCT04270370|Antimetabolites|antimetabolites|mesh-ancestor
24912908|NCT04270370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24912909|NCT04270370|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24912910|NCT04270370|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24912911|NCT04270370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24912912|NCT04270279|Nitroglycerin|nitroglycerin|mesh-list
24912914|NCT04270344|Valsartan|valsartan|mesh-list
24912922|NCT04270344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24912923|NCT04270344|Antimetabolites|antimetabolites|mesh-ancestor
24912928|NCT04269954|Tinzaparin|tinzaparin|mesh-list
24913055|NCT04268927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913056|NCT04268927|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24913057|NCT04268927|Hormone Antagonists|hormone antagonists|mesh-ancestor
24913113|NCT04268472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24913114|NCT04268472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24913115|NCT04268472|Antiviral Agents|antiviral agents|mesh-ancestor
24913117|NCT04268537|Antibodies|antibodies|mesh-list
24913131|NCT04268394|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24913132|NCT04268394|Abortifacient Agents|abortifacient agents|mesh-ancestor
24913133|NCT04268394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24913134|NCT04268394|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24913189|NCT04267991|Tacrolimus|tacrolimus|mesh-list
24913190|NCT04267991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24913191|NCT04267991|Immunologic Factors|immunologic factors|mesh-ancestor
24913192|NCT04267991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913193|NCT04267991|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24913194|NCT04267991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24913195|NCT04267991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913196|NCT04268069|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24913197|NCT04268069|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24913198|NCT04267653|Lactoferrin|lactoferrin|mesh-list
24819293|NCT02094599|Analgesics|analgesics|mesh-ancestor
24440025|NCT00281476|Simvastatin|simvastatin|mesh-list
24913686|NCT04262193|Suvorexant|suvorexant|mesh-list
24819294|NCT02094599|Sensory System Agents|sensory system agents|mesh-ancestor
24819295|NCT02094599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24736326|NCT01661335|Hormones|hormones|mesh-ancestor
24913230|NCT04267614|Etanercept|etanercept|mesh-list
24913232|NCT04267614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24913233|NCT04267614|Analgesics|analgesics|mesh-ancestor
24913248|NCT04267497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24913249|NCT04267497|Antifungal Agents|antifungal agents|mesh-ancestor
24913250|NCT04267549|Paclitaxel|paclitaxel|mesh-list
24913251|NCT04267549|Apatinib|apatinib|mesh-list
24913252|NCT04267549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24913253|NCT04267549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913254|NCT04267549|Tubulin Modulators|tubulin modulators|mesh-ancestor
24913255|NCT04267549|Antimitotic Agents|antimitotic agents|mesh-ancestor
24913256|NCT04267549|Mitosis Modulators|mitosis modulators|mesh-ancestor
24913257|NCT04267549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913258|NCT04267549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24913307|NCT04267146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913308|NCT04267146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24913309|NCT04267146|Alkylating Agents|alkylating agents|mesh-ancestor
24913310|NCT04266756|Selexipag|selexipag|mesh-list
24913311|NCT04266756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24913312|NCT04266509|Rifampin|rifampin|mesh-list
24520053|NCT03980769|Thiotepa|thiotepa|mesh-list
24487921|NCT00465608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487922|NCT00465608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487923|NCT00465608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24520058|NCT03980769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913345|NCT04266288|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24913349|NCT04266132|Anesthetics, Local|anesthetics, local|mesh-ancestor
24913389|NCT04265274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913390|NCT04265274|Trace Elements|trace elements|mesh-ancestor
24913391|NCT04265274|Micronutrients|micronutrients|mesh-ancestor
24913392|NCT04265274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913393|NCT04265274|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24913394|NCT04265274|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
24913395|NCT04265274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24913396|NCT04265001|Hyaluronic Acid|hyaluronic acid|mesh-list
24913397|NCT04265001|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24913398|NCT04265001|Immunologic Factors|immunologic factors|mesh-ancestor
24913406|NCT04264858|Immunologic Factors|immunologic factors|mesh-ancestor
24913407|NCT04264858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913408|NCT04264988|Tin Fluorides|tin fluorides|mesh-list
24913412|NCT04265027|Opicapone|opicapone|mesh-list
24520082|NCT03936192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520083|NCT03929627|Hydrocortisone|hydrocortisone|mesh-list
24520084|NCT03929627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24819296|NCT02094599|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24819297|NCT02094599|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24819298|NCT02094599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24819299|NCT02094599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819300|NCT02094599|Hormones|hormones|mesh-ancestor
24913478|NCT04264260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533706|NCT00644904|Ergocalciferols|ergocalciferols|mesh-list
24913479|NCT04264260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913481|NCT04264130|Lumefantrine|lumefantrine|mesh-list
24913482|NCT04264130|Artemether|artemether|mesh-list
25714514|NCT02357368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25714515|NCT02357368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714516|NCT02357368|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25714517|NCT02357368|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25714518|NCT02357368|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25714519|NCT02357368|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25714520|NCT02357368|Trace Elements|trace elements|mesh-ancestor
25714521|NCT02357368|Micronutrients|micronutrients|mesh-ancestor
25714522|NCT02357368|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25714523|NCT02357368|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25714524|NCT02357368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25714525|NCT02357368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25714526|NCT02357459|Triamcinolone|triamcinolone|mesh-list
25714527|NCT02357459|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25714528|NCT02357459|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25714529|NCT02357459|FX006|fx006|mesh-list
25714530|NCT02357459|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25714531|NCT02357459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24913483|NCT04264130|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24913485|NCT04264130|Artefenomel|artefenomel|mesh-list
24913486|NCT04264130|Ferroquine|ferroquine|mesh-list
24913487|NCT04264130|Antimalarials|antimalarials|mesh-ancestor
24913488|NCT04264130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24913489|NCT04264130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24913490|NCT04264130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24913491|NCT04264130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913492|NCT04264130|Antiviral Agents|antiviral agents|mesh-ancestor
24913493|NCT04264130|Schistosomicides|schistosomicides|mesh-ancestor
24913497|NCT04264286|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24913500|NCT04264286|Adrenergic Agents|adrenergic agents|mesh-ancestor
24913630|NCT04262765|Amlodipine|amlodipine|mesh-list
24913680|NCT04262388|Durvalumab|durvalumab|mesh-list
24913681|NCT04262388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24913682|NCT04262388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913683|NCT04262375|Durvalumab|durvalumab|mesh-list
24913684|NCT04262375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24913685|NCT04262375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913746|NCT04261270|Ritonavir|ritonavir|mesh-list
24913747|NCT04261270|Oseltamivir|oseltamivir|mesh-list
24913748|NCT04261270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24913749|NCT04261270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24913750|NCT04261270|Protease Inhibitors|protease inhibitors|mesh-ancestor
24913751|NCT04261270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819372|NCT02095054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24819373|NCT02095054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913760|NCT04261023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24913761|NCT04261023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913762|NCT04261023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913763|NCT04261023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24913764|NCT04261023|Immunologic Factors|immunologic factors|mesh-ancestor
24488345|NCT00468091|Atropine|atropine|mesh-list
24520165|NCT03638128|Denosumab|denosumab|mesh-list
24520166|NCT03638128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24520167|NCT03638128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520168|NCT03608657|Apremilast|apremilast|mesh-list
24913808|NCT04260711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24913809|NCT04260711|Dermatologic Agents|dermatologic agents|mesh-ancestor
24913810|NCT04260607|Ketamine|ketamine|mesh-list
24913811|NCT04260607|Analgesics|analgesics|mesh-ancestor
24913812|NCT04260607|Sensory System Agents|sensory system agents|mesh-ancestor
24913813|NCT04260607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24913814|NCT04260607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24913815|NCT04260607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24488402|NCT00468351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24520218|NCT03561376|Petrolatum|petrolatum|mesh-list
24520244|NCT03486314|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24520245|NCT03486314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24520252|NCT03425812|Analgesics|analgesics|mesh-ancestor
24520255|NCT03425812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520256|NCT03425812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24520257|NCT03425812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24913881|NCT04260269|Capecitabine|capecitabine|mesh-list
25714532|NCT02357459|Glucocorticoids|glucocorticoids|mesh-ancestor
24913882|NCT04260269|Tegafur|tegafur|mesh-list
24913883|NCT04260269|Antimetabolites|antimetabolites|mesh-ancestor
24913884|NCT04260269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714533|NCT02357459|Hormones|hormones|mesh-ancestor
25714534|NCT02357459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25714535|NCT02357459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714536|NCT02357459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25714537|NCT02357459|Immunologic Factors|immunologic factors|mesh-ancestor
25714538|NCT02357459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25714539|NCT02357459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714540|NCT02357576|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25714541|NCT02357576|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25714542|NCT02357576|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24913885|NCT04260269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24913886|NCT04260269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24913887|NCT04260269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24913891|NCT04260269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24913925|NCT04259476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24913926|NCT04259476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24913927|NCT04259476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24913928|NCT04259476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24913929|NCT04259476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913931|NCT04259333|Celecoxib|celecoxib|mesh-list
24913932|NCT04259333|Codeine|codeine|mesh-list
24913933|NCT04259333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24913934|NCT04259333|Analgesics|analgesics|mesh-ancestor
24913935|NCT04259333|Sensory System Agents|sensory system agents|mesh-ancestor
24913938|NCT04259333|Antipyretics|antipyretics|mesh-ancestor
24520289|NCT03085004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520290|NCT03085004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24520304|NCT02993198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24520305|NCT02993198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520306|NCT02993198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520307|NCT02993198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24520309|NCT02993198|Protective Agents|protective agents|mesh-ancestor
24520310|NCT02993198|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24520311|NCT02993198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24520313|NCT02993198|Vasodilator Agents|vasodilator agents|mesh-ancestor
24913942|NCT04259333|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24913943|NCT04259333|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24913944|NCT04259333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24913945|NCT04259333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24913946|NCT04259333|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24913951|NCT04259073|Pregabalin|pregabalin|mesh-list
24520406|NCT02339922|Glycine Agents|glycine agents|mesh-ancestor
24520407|NCT02339922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24520408|NCT02074631|Vitamin D|vitamin d|mesh-list
24520409|NCT02074631|Cholecalciferol|cholecalciferol|mesh-list
24520410|NCT02074631|Ergocalciferols|ergocalciferols|mesh-list
24520411|NCT02074631|Pamidronate|pamidronate|mesh-list
25714543|NCT02357576|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25770999|NCT03579719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25771000|NCT03579940|Lasmiditan|lasmiditan|mesh-list
24520412|NCT02074631|Calcium|calcium|mesh-list
25771001|NCT03579940|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25771002|NCT03579940|Serotonin Agents|serotonin agents|mesh-ancestor
25771003|NCT03579940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25771004|NCT03579940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771005|NCT03579940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771006|NCT03580343|Tofacitinib|tofacitinib|mesh-list
25771007|NCT03580343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25771008|NCT03580343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771009|NCT03580343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771010|NCT03581084|Acetylcysteine|acetylcysteine|mesh-list
25771011|NCT03581084|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25771012|NCT03581084|Antiviral Agents|antiviral agents|mesh-ancestor
25771013|NCT03581084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25771014|NCT03581084|Expectorants|expectorants|mesh-ancestor
25771015|NCT03581084|Respiratory System Agents|respiratory system agents|mesh-ancestor
25771016|NCT03581084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25771017|NCT03581084|Antioxidants|antioxidants|mesh-ancestor
24534571|NCT00647634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25771018|NCT03581084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771019|NCT03581084|Protective Agents|protective agents|mesh-ancestor
25771020|NCT03581084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771021|NCT03581084|Antidotes|antidotes|mesh-ancestor
25771022|NCT03582215|Salicylates|salicylates|mesh-list
25771023|NCT03582215|Avobenzone|avobenzone|mesh-list
25771024|NCT03582215|Oxybenzone|oxybenzone|mesh-list
25771025|NCT03582215|Homosalate|homosalate|mesh-list
25771026|NCT03582215|2-ethylhexyl salicylate|2-ethylhexyl salicylate|mesh-list
25771027|NCT03582215|Octylmethoxycinnamate|octylmethoxycinnamate|mesh-list
25771028|NCT03582215|Sunscreening Agents|sunscreening agents|mesh-ancestor
25771029|NCT03582215|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25771030|NCT03582215|Protective Agents|protective agents|mesh-ancestor
24520414|NCT02074631|Micronutrients|micronutrients|mesh-ancestor
24520415|NCT02074631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520416|NCT02074631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24520417|NCT02074631|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24520418|NCT02020707|Paclitaxel|paclitaxel|mesh-list
24914091|NCT04258371|Dapagliflozin|dapagliflozin|mesh-list
24488710|NCT00469781|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24488711|NCT00469781|Prednisolone phosphate|prednisolone phosphate|mesh-list
24488712|NCT00469781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24914098|NCT04258098|Streptomycin|streptomycin|mesh-list
24914165|NCT04257461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914166|NCT04257461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24914191|NCT04257656|Antimetabolites|antimetabolites|mesh-ancestor
24914192|NCT04257656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24914193|NCT04257656|Antiviral Agents|antiviral agents|mesh-ancestor
24819421|NCT02095405|Purinergic Agents|purinergic agents|mesh-ancestor
24819422|NCT02095405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24819423|NCT02095418|Mycophenolic Acid|mycophenolic acid|mesh-list
24819424|NCT02095418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24819425|NCT02095418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24819426|NCT02095418|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24819427|NCT02095418|Antitubercular Agents|antitubercular agents|mesh-ancestor
24819428|NCT02095418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24819429|NCT02095418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24819430|NCT02095418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24819431|NCT02095418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819433|NCT02095509|Anticoagulants|anticoagulants|mesh-ancestor
24819434|NCT02095509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24819435|NCT02095509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24819443|NCT02095522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714544|NCT02357706|Acetaminophen|acetaminophen|mesh-list
25714545|NCT02357706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25714546|NCT02357706|Analgesics|analgesics|mesh-ancestor
25714547|NCT02357706|Sensory System Agents|sensory system agents|mesh-ancestor
25714548|NCT02357706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25714549|NCT02357706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714550|NCT02357706|Antipyretics|antipyretics|mesh-ancestor
25714551|NCT02357758|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24819444|NCT02095522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24819452|NCT02095665|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24819453|NCT02095665|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24819454|NCT02095665|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24819455|NCT02095665|Adrenergic Agents|adrenergic agents|mesh-ancestor
24819456|NCT02095665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24819457|NCT02095665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24819458|NCT02095665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819459|NCT02095665|Urological Agents|urological agents|mesh-ancestor
24819460|NCT02095665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24819461|NCT02095665|Analgesics|analgesics|mesh-ancestor
24819462|NCT02095665|Sensory System Agents|sensory system agents|mesh-ancestor
24819463|NCT02095665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24819464|NCT02095665|Antipyretics|antipyretics|mesh-ancestor
24819465|NCT02095665|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
24819466|NCT02095665|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24914239|NCT04256473|Saruplase|saruplase|mesh-list
24914241|NCT04256473|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24914243|NCT04256343|Deuterium Oxide|deuterium oxide|mesh-list
24914276|NCT04256525|Protease Inhibitors|protease inhibitors|mesh-ancestor
24914277|NCT04256200|Dienogest|dienogest|mesh-list
24914278|NCT04256200|Contraceptive Agents|contraceptive agents|mesh-list
24914279|NCT04256200|Contraceptives, Oral|contraceptives, oral|mesh-list
24914280|NCT04256200|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
24914281|NCT04256200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24914282|NCT04256200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914283|NCT04256200|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24914284|NCT04256200|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24914285|NCT04256200|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24914286|NCT04256200|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24914287|NCT04256200|Hormone Antagonists|hormone antagonists|mesh-ancestor
24737456|NCT01669044|Propofol|propofol|mesh-list
24914938|NCT05253014|Acetaminophen|acetaminophen|mesh-list
24914616|NCT04253678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520447|NCT01657500|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24520448|NCT01657500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24819548|NCT02095938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24819549|NCT02095938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24914805|NCT04251962|Bupivacaine|bupivacaine|mesh-list
24914837|NCT04251741|Adalimumab|adalimumab|mesh-list
24914939|NCT05253014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24914940|NCT05253014|Analgesics|analgesics|mesh-ancestor
24914961|NCT05252546|Antidotes|antidotes|mesh-ancestor
24914962|NCT05252546|Protective Agents|protective agents|mesh-ancestor
24914963|NCT05252546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24819550|NCT02095938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24819557|NCT02095990|Hydroquinone|hydroquinone|mesh-list
24819587|NCT02096068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24819588|NCT02096068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24819589|NCT02096068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24819590|NCT02096068|Adrenergic Agents|adrenergic agents|mesh-ancestor
24819591|NCT02096068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24915161|NCT04538092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915162|NCT04373564|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
24915163|NCT04373564|Chelating Agents|chelating agents|mesh-ancestor
24915164|NCT04373564|Sequestering Agents|sequestering agents|mesh-ancestor
24915165|NCT04373564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915166|NCT04173312|Bupivacaine|bupivacaine|mesh-list
24520457|NCT01497509|Racepinephrine|racepinephrine|mesh-list
24520459|NCT01497509|Bupivacaine|bupivacaine|mesh-list
24915219|NCT03854019|Antitussive Agents|antitussive agents|mesh-ancestor
24915220|NCT03854019|Respiratory System Agents|respiratory system agents|mesh-ancestor
24915221|NCT03854019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24915222|NCT03854019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24915223|NCT03854019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25714552|NCT02357758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25771031|NCT03582215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771032|NCT03582215|Dermatologic Agents|dermatologic agents|mesh-ancestor
25771033|NCT03582215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25771034|NCT03582215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24915224|NCT03854019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915368|NCT03320018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24915369|NCT03320018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24915415|NCT02631941|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24915416|NCT02631941|Charcoal|charcoal|mesh-list
24915417|NCT02631941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24915420|NCT02631941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24915421|NCT02631941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915422|NCT02631941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24915423|NCT02631941|Respiratory System Agents|respiratory system agents|mesh-ancestor
24915424|NCT02631941|Glucocorticoids|glucocorticoids|mesh-ancestor
24915425|NCT02631941|Hormones|hormones|mesh-ancestor
24915428|NCT02631941|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24616084|NCT01033955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24819652|NCT02096419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24819653|NCT02096419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24915489|NCT01822288|Tibolone|tibolone|mesh-list
24915602|NCT04250142|Dopamine Agents|dopamine agents|mesh-ancestor
24915603|NCT04250142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24915604|NCT04250142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24915605|NCT04250142|Adrenergic Agents|adrenergic agents|mesh-ancestor
24915606|NCT04250142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24915607|NCT04250142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24915608|NCT04250142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24915609|NCT04250142|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24915611|NCT04250116|Clopidogrel|clopidogrel|mesh-list
24915612|NCT04250116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24915613|NCT04250116|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24915614|NCT04250116|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24915615|NCT04250116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24915616|NCT04250116|Purinergic Agents|purinergic agents|mesh-ancestor
24915669|NCT04249804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24915670|NCT04249804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520476|NCT01497509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24915820|NCT04248101|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24819669|NCT02096601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24819671|NCT02096601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24819673|NCT02096601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24915855|NCT04247815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24915856|NCT04247815|Dermatologic Agents|dermatologic agents|mesh-ancestor
24915857|NCT04247815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24915858|NCT04247815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24915859|NCT04247815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24915860|NCT04247815|Immunologic Factors|immunologic factors|mesh-ancestor
24915861|NCT04247815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24915862|NCT04247815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24915863|NCT04247373|Ropivacaine|ropivacaine|mesh-list
24915864|NCT04247373|Anesthetics, Local|anesthetics, local|mesh-ancestor
25714553|NCT02357836|Itraconazole|itraconazole|mesh-list
25714554|NCT02357836|Antifungal Agents|antifungal agents|mesh-ancestor
25714555|NCT02357836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25714556|NCT02357836|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25714557|NCT02357836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25714558|NCT02357836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25714559|NCT02357836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714560|NCT02357836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25714561|NCT02357836|Hormone Antagonists|hormone antagonists|mesh-ancestor
25771035|NCT03582215|Analgesics|analgesics|mesh-ancestor
25771036|NCT03582215|Sensory System Agents|sensory system agents|mesh-ancestor
25771037|NCT03582215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771038|NCT03582215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25771039|NCT03582215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25771040|NCT03582215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25771041|NCT03582215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777184|NCT03734601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24916240|NCT04243109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24916241|NCT04243109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24916242|NCT04243109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24916243|NCT04243109|Antiemetics|antiemetics|mesh-ancestor
24916244|NCT04243109|Autonomic Agents|autonomic agents|mesh-ancestor
24916245|NCT04243109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24916246|NCT04243109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24916247|NCT04243109|Glucocorticoids|glucocorticoids|mesh-ancestor
24916250|NCT04243109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24916291|NCT04242758|Dapagliflozin|dapagliflozin|mesh-list
24916293|NCT04242758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24916294|NCT04242758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916295|NCT04242758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24916355|NCT04241744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24916356|NCT04241744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24916357|NCT04241887|Anesthetics|anesthetics|mesh-list
24916358|NCT04241887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24916359|NCT04241887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916361|NCT04241601|Interleukin-2|interleukin-2|mesh-list
24916362|NCT04241601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24916363|NCT04241601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24916364|NCT04241601|Analgesics|analgesics|mesh-ancestor
24916365|NCT04241601|Sensory System Agents|sensory system agents|mesh-ancestor
24916366|NCT04241601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24916367|NCT04241601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916368|NCT04241601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24916452|NCT04240834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24916686|NCT04238169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24916687|NCT04238169|Growth Substances|growth substances|mesh-ancestor
24916688|NCT04238169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916689|NCT04238169|Growth Inhibitors|growth inhibitors|mesh-ancestor
24916690|NCT04238195|Moxifloxacin|moxifloxacin|mesh-list
24916698|NCT04238078|Contraceptive Agents|contraceptive agents|mesh-list
24535791|NCT00649714|Zonisamide|zonisamide|mesh-list
24916699|NCT04238078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24916700|NCT04238078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916701|NCT04237987|Cyclosporine|cyclosporine|mesh-list
24916702|NCT04237987|Aldesleukin|aldesleukin|mesh-list
24916761|NCT04237532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916784|NCT04237493|Insulin Glargine|insulin glargine|mesh-list
25714562|NCT02357836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25714563|NCT02357836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714564|NCT02357836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25714565|NCT02357901|Buprenorphine|buprenorphine|mesh-list
25714566|NCT02357901|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25714567|NCT02357901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25714568|NCT02357901|Narcotics|narcotics|mesh-ancestor
25714569|NCT02357901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25714570|NCT02357901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916786|NCT04237493|Vildagliptin|vildagliptin|mesh-list
24916787|NCT04237493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24916788|NCT04237493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916789|NCT04237493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24916790|NCT04237493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24916791|NCT04237493|Immunologic Factors|immunologic factors|mesh-ancestor
24916792|NCT04237493|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24916793|NCT04237493|Protease Inhibitors|protease inhibitors|mesh-ancestor
24916794|NCT04237493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24916795|NCT04237493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916796|NCT04237480|Vitamin D|vitamin d|mesh-list
24916797|NCT04237480|Ergocalciferols|ergocalciferols|mesh-list
24916798|NCT04237480|Cholecalciferol|cholecalciferol|mesh-list
24916799|NCT04237480|Vitamins|vitamins|mesh-list
24520494|NCT00630565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24520495|NCT00630565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24520496|NCT00630565|Alkylating Agents|alkylating agents|mesh-ancestor
24520529|NCT05337657|Letrozole|letrozole|mesh-list
24916873|NCT04236310|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24916874|NCT04236310|Hormone Antagonists|hormone antagonists|mesh-ancestor
24916875|NCT04236310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24916876|NCT04236310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916877|NCT04236219|Rasburicase|rasburicase|mesh-list
24916878|NCT04236219|Gout Suppressants|gout suppressants|mesh-ancestor
24916912|NCT04235868|Mitogens|mitogens|mesh-list
24916913|NCT04235868|Mitosis Modulators|mitosis modulators|mesh-ancestor
24916914|NCT04235868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24916915|NCT04235959|Tirzepatide|tirzepatide|mesh-list
24916916|NCT04235959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24916917|NCT04235959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24916919|NCT04235959|Hormones|hormones|mesh-ancestor
24916920|NCT04235959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24916921|NCT04235478|Triamcinolone|triamcinolone|mesh-list
24917496|NCT04229264|Protease Inhibitors|protease inhibitors|mesh-ancestor
24616258|NCT01035450|Sirolimus|sirolimus|mesh-list
24616259|NCT01035450|Everolimus|everolimus|mesh-list
24616260|NCT01035450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24917083|NCT04234048|Fenretinide|fenretinide|mesh-list
24819918|NCT02097615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24819919|NCT02097615|Disinfectants|disinfectants|mesh-ancestor
24819920|NCT02097615|Dermatologic Agents|dermatologic agents|mesh-ancestor
24917099|NCT04233294|Decitabine|decitabine|mesh-list
24491979|NCT00484809|Etanercept|etanercept|mesh-list
24520648|NCT05335460|Capecitabine|capecitabine|mesh-list
24520649|NCT05335460|Oxaliplatin|oxaliplatin|mesh-list
24520674|NCT05334316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24520675|NCT05334316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520676|NCT05334316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24917131|NCT04233359|Anesthetics|anesthetics|mesh-list
24917132|NCT04233359|Anesthetics, Local|anesthetics, local|mesh-list
24917133|NCT04233359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24917134|NCT04233359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917135|NCT04233359|Sensory System Agents|sensory system agents|mesh-ancestor
24917136|NCT04233359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24917137|NCT04233515|Anticoagulants|anticoagulants|mesh-list
24917290|NCT04231448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24917291|NCT04231448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24917292|NCT04231448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24917293|NCT04231448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24917294|NCT04231448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25714571|NCT02357901|Analgesics|analgesics|mesh-ancestor
25714572|NCT02357901|Sensory System Agents|sensory system agents|mesh-ancestor
25714573|NCT02357901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25714574|NCT02357901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25714575|NCT02357979|Fluorides|fluorides|mesh-list
25714576|NCT02357979|Cariostatic Agents|cariostatic agents|mesh-ancestor
25714577|NCT02357979|Protective Agents|protective agents|mesh-ancestor
25714578|NCT02357979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714579|NCT02358044|Ribavirin|ribavirin|mesh-list
25714580|NCT02358044|Sofosbuvir|sofosbuvir|mesh-list
25714581|NCT02358044|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
25714582|NCT02358044|Grazoprevir|grazoprevir|mesh-list
25714583|NCT02358044|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
25714584|NCT02358044|Antimetabolites|antimetabolites|mesh-ancestor
24917295|NCT04231448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24917296|NCT04231448|Glucocorticoids|glucocorticoids|mesh-ancestor
24917298|NCT04231448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24917299|NCT04231448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24917301|NCT04231448|Tubulin Modulators|tubulin modulators|mesh-ancestor
24917335|NCT04231279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917489|NCT04229264|Purinergic Agents|purinergic agents|mesh-ancestor
24917490|NCT04229264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24917491|NCT04229264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24917492|NCT04229264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917493|NCT04229264|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24917495|NCT04229264|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24917612|NCT04227704|Analgesics|analgesics|mesh-ancestor
24917613|NCT04227704|Sensory System Agents|sensory system agents|mesh-ancestor
24917614|NCT04227704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24917615|NCT04227704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917616|NCT04227704|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24917618|NCT04227704|Anesthetics, General|anesthetics, general|mesh-ancestor
24917619|NCT04227704|Anesthetics|anesthetics|mesh-ancestor
24917763|NCT04226443|Midazolam|midazolam|mesh-list
24917764|NCT04226443|Remifentanil|remifentanil|mesh-list
24917765|NCT04226443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24917766|NCT04226443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24917767|NCT04226443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24917768|NCT04226443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917769|NCT04226443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24917770|NCT04226443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24917771|NCT04226443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24917772|NCT04226443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24917773|NCT04226443|Anesthetics, General|anesthetics, general|mesh-ancestor
24917774|NCT04226443|Anesthetics|anesthetics|mesh-ancestor
24917910|NCT04225195|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24917911|NCT04225195|Protective Agents|protective agents|mesh-ancestor
24917912|NCT04225195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24917913|NCT04225195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24492769|NCT00487799|Ularitide|ularitide|mesh-list
24520803|NCT05324059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24520804|NCT05324059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25714585|NCT02358044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714586|NCT02358044|Antiviral Agents|antiviral agents|mesh-ancestor
25714587|NCT02358044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25714588|NCT02358343|Sertraline|sertraline|mesh-list
25714589|NCT02358343|Antidepressive Agents|antidepressive agents|mesh-list
25714590|NCT02358343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25714591|NCT02358343|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25714592|NCT02358343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25777185|NCT03733899|Anesthetics|anesthetics|mesh-list
25777186|NCT03733899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25777187|NCT03733899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777188|NCT03733470|Sildenafil Citrate|sildenafil citrate|mesh-list
25777189|NCT03733470|Vasodilator Agents|vasodilator agents|mesh-ancestor
25777190|NCT03733470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25777191|NCT03733470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25777192|NCT03733470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777193|NCT03733470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777194|NCT03733470|Urological Agents|urological agents|mesh-ancestor
25777195|NCT03732248|Sirolimus|sirolimus|mesh-list
25777196|NCT03732248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25777197|NCT03732248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25777198|NCT03732248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25777199|NCT03732248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24536205|NCT00650468|Hormones|hormones|mesh-ancestor
25777200|NCT03732248|Antifungal Agents|antifungal agents|mesh-ancestor
25777201|NCT03732248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25777202|NCT03732248|Immunologic Factors|immunologic factors|mesh-ancestor
25777203|NCT03732248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777204|NCT03731182|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25777205|NCT03731182|Immunologic Factors|immunologic factors|mesh-ancestor
25777206|NCT03731182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777207|NCT03730961|Furosemide|furosemide|mesh-list
25777208|NCT03730961|Diuretics|diuretics|mesh-ancestor
25714593|NCT02358343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25714594|NCT02358343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714595|NCT02358343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24520805|NCT05324059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24520819|NCT05322733|Alkylating Agents|alkylating agents|mesh-ancestor
24520820|NCT05322733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520821|NCT05322733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520822|NCT05322733|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24520823|NCT05322733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24918060|NCT04224246|Anesthetics|anesthetics|mesh-ancestor
24918061|NCT04224246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24918062|NCT04224246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918064|NCT04223973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24918136|NCT04223219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24918137|NCT04223219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24918138|NCT04223219|Tocolytic Agents|tocolytic agents|mesh-ancestor
24918139|NCT04223219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24616546|NCT01037959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616547|NCT01037959|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24616548|NCT01037959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24616550|NCT01037998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24616551|NCT01037998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24616552|NCT01037998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24616553|NCT01037998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918219|NCT04221971|Immunologic Factors|immunologic factors|mesh-ancestor
24918220|NCT04221971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918221|NCT04221971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24918222|NCT04221971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24918223|NCT04221971|Alkylating Agents|alkylating agents|mesh-ancestor
24918224|NCT04221971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918383|NCT04220281|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24918384|NCT04220281|Anesthetics, General|anesthetics, general|mesh-ancestor
24918385|NCT04220281|Anesthetics|anesthetics|mesh-ancestor
24918386|NCT04220281|Vasodilator Agents|vasodilator agents|mesh-ancestor
24741751|NCT05292677|Anesthetics|anesthetics|mesh-list
24918440|NCT04219982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918441|NCT04219982|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24918442|NCT04219982|Parasympatholytics|parasympatholytics|mesh-ancestor
24617146|NCT01041235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24617151|NCT01041313|Memantine|memantine|mesh-list
24520961|NCT05217589|beta-Endorphin|beta-endorphin|mesh-list
24520962|NCT05217589|Hormones|hormones|mesh-ancestor
24520963|NCT05217589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24520964|NCT05217589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520965|NCT05217589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24520967|NCT05210764|Ketamine|ketamine|mesh-list
24520972|NCT05210764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24520973|NCT05210764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520974|NCT05210764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24520976|NCT05210764|Anesthetics, General|anesthetics, general|mesh-ancestor
24520977|NCT05210764|Analgesics|analgesics|mesh-ancestor
25714596|NCT02358343|Serotonin Agents|serotonin agents|mesh-ancestor
25714597|NCT02358343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714598|NCT02358369|Timolol|timolol|mesh-list
25714599|NCT02358369|Bimatoprost|bimatoprost|mesh-list
25714600|NCT02358369|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25714601|NCT02358369|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25714602|NCT02358369|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25714603|NCT02358369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25714604|NCT02358369|Adrenergic Agents|adrenergic agents|mesh-ancestor
25714605|NCT02358369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24520978|NCT05210764|Sensory System Agents|sensory system agents|mesh-ancestor
24520979|NCT05210764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24520980|NCT05210764|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24521036|NCT05174832|Olaparib|olaparib|mesh-list
24521037|NCT05174832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24918639|NCT04217265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24918640|NCT04217265|Abortifacient Agents|abortifacient agents|mesh-ancestor
24918641|NCT04217265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24918642|NCT04217265|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24918643|NCT04217265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24918644|NCT04217265|Oxytocics|oxytocics|mesh-ancestor
24918646|NCT04217447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24918647|NCT04217447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24918648|NCT04217447|Analgesics|analgesics|mesh-ancestor
24918701|NCT04217148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24521081|NCT05113368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24521082|NCT05113368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918702|NCT04217148|Protease Inhibitors|protease inhibitors|mesh-ancestor
24918703|NCT04217148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918704|NCT04217148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918705|NCT04217148|Keratolytic Agents|keratolytic agents|mesh-ancestor
24918706|NCT04217148|Dermatologic Agents|dermatologic agents|mesh-ancestor
24918707|NCT04216836|Magnesium Oxide|magnesium oxide|mesh-list
24918708|NCT04216836|Antacids|antacids|mesh-ancestor
24918709|NCT04216836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918749|NCT04216706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24918750|NCT04216888|Ketamine|ketamine|mesh-list
24918751|NCT04216888|Analgesics|analgesics|mesh-ancestor
24918752|NCT04216888|Sensory System Agents|sensory system agents|mesh-ancestor
24918753|NCT04216888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24918754|NCT04216888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918755|NCT04216888|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24918756|NCT04216888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24918757|NCT04216888|Anesthetics, General|anesthetics, general|mesh-ancestor
24918835|NCT04216186|Micronutrients|micronutrients|mesh-ancestor
24918837|NCT04215965|Dialysis Solutions|dialysis solutions|mesh-list
24918838|NCT04215965|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24918839|NCT04215653|Rabeprazole|rabeprazole|mesh-list
24918844|NCT04215653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918845|NCT04215731|Leucovorin|leucovorin|mesh-list
25714606|NCT02358369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714607|NCT02358369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714608|NCT02358369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25714609|NCT02358369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25714610|NCT02358473|Docetaxel|docetaxel|mesh-list
25714611|NCT02358473|Mogamulizumab|mogamulizumab|mesh-list
25714612|NCT02358473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24918881|NCT04215614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24918882|NCT04215614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24918883|NCT04215614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918885|NCT04215588|Coagulants|coagulants|mesh-ancestor
24918886|NCT04215835|Letrozole|letrozole|mesh-list
24918887|NCT04215835|Misoprostol|misoprostol|mesh-list
24918888|NCT04215835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24918889|NCT04215835|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24918890|NCT04215835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24918891|NCT04215835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918892|NCT04215835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918893|NCT04215835|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24918894|NCT04215835|Hormone Antagonists|hormone antagonists|mesh-ancestor
24918936|NCT04215159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24918937|NCT04215159|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24918938|NCT04215159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24918939|NCT04215523|Dapagliflozin|dapagliflozin|mesh-list
24918940|NCT04215523|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
24918941|NCT04215523|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24918942|NCT04215523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24918943|NCT04215523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24918944|NCT04215523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24918945|NCT04215523|Protease Inhibitors|protease inhibitors|mesh-ancestor
24918946|NCT04215523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24918959|NCT04215237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24918960|NCT04215237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24918961|NCT04215237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24919237|NCT04213612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24919238|NCT04213612|Alkylating Agents|alkylating agents|mesh-ancestor
24919239|NCT04213612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521105|NCT05112081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521106|NCT05112081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24521107|NCT05112081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24521134|NCT05104554|Trace Elements|trace elements|mesh-list
24919252|NCT04213495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919258|NCT04213170|Growth Substances|growth substances|mesh-ancestor
25714613|NCT02358473|Tubulin Modulators|tubulin modulators|mesh-ancestor
25714614|NCT02358473|Antimitotic Agents|antimitotic agents|mesh-ancestor
25714615|NCT02358473|Mitosis Modulators|mitosis modulators|mesh-ancestor
25714616|NCT02358473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714617|NCT02358668|PAZ320|paz320|mesh-list
25714618|NCT02358668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25714619|NCT02358668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714620|NCT02358863|Leucovorin|leucovorin|mesh-list
25714621|NCT02358863|Cisplatin|cisplatin|mesh-list
25714622|NCT02358863|Docetaxel|docetaxel|mesh-list
25714623|NCT02358863|Capecitabine|capecitabine|mesh-list
25714624|NCT02358863|Oxaliplatin|oxaliplatin|mesh-list
25714626|NCT02358863|Epirubicin|epirubicin|mesh-list
25714627|NCT02358863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919316|NCT04212845|Glucocorticoids|glucocorticoids|mesh-ancestor
24919317|NCT04212845|Hormones|hormones|mesh-ancestor
24919318|NCT04212845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24919319|NCT04212845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24919320|NCT04212845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919321|NCT04212845|Anesthetics, Local|anesthetics, local|mesh-ancestor
24919322|NCT04212845|Anesthetics|anesthetics|mesh-ancestor
24919323|NCT04212845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24919324|NCT04212845|Sensory System Agents|sensory system agents|mesh-ancestor
24521213|NCT04991493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521214|NCT04991493|Analgesics|analgesics|mesh-ancestor
24919359|NCT04212403|Ofloxacin|ofloxacin|mesh-list
24919360|NCT04212403|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24919361|NCT04212403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24919362|NCT04212403|Renal Agents|renal agents|mesh-ancestor
24919363|NCT04212403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24919364|NCT04212403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24919365|NCT04212403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24919366|NCT04212403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24919408|NCT04211961|Scopolamine|scopolamine|mesh-list
24919409|NCT04211961|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24919410|NCT04211961|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24919411|NCT04211961|Antiemetics|antiemetics|mesh-ancestor
24919412|NCT04211961|Autonomic Agents|autonomic agents|mesh-ancestor
24919413|NCT04211961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24919414|NCT04211961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919415|NCT04211961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24919416|NCT04211961|Mydriatics|mydriatics|mesh-ancestor
24919417|NCT04211961|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24919418|NCT04211961|Cholinergic Agents|cholinergic agents|mesh-ancestor
24919419|NCT04211961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24494413|NCT00495118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24521215|NCT04991493|Sensory System Agents|sensory system agents|mesh-ancestor
24521216|NCT04991493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24521217|NCT04958538|Methotrexate|methotrexate|mesh-list
24521219|NCT04958538|Abortifacient Agents|abortifacient agents|mesh-ancestor
24494440|NCT00495287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494442|NCT00495287|Antiviral Agents|antiviral agents|mesh-ancestor
24919521|NCT04211103|Pembrolizumab|pembrolizumab|mesh-list
24919522|NCT04211103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24919523|NCT04211103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919525|NCT04211168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919526|NCT04211168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24919527|NCT04211168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24919528|NCT04211168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919575|NCT04209933|Bismuth|bismuth|mesh-list
24919576|NCT04209933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24919577|NCT04209933|Antacids|antacids|mesh-ancestor
24919578|NCT04209933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24919579|NCT04209933|Diuretics|diuretics|mesh-ancestor
24919580|NCT04209933|Natriuretic Agents|natriuretic agents|mesh-ancestor
24919581|NCT04209933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919582|NCT04209933|Expectorants|expectorants|mesh-ancestor
24919583|NCT04209933|Respiratory System Agents|respiratory system agents|mesh-ancestor
24618111|NCT01046838|Urological Agents|urological agents|mesh-ancestor
24618112|NCT01046864|Leucovorin|leucovorin|mesh-list
24618113|NCT01046864|Fluorouracil|fluorouracil|mesh-list
24618114|NCT01046864|Irinotecan|irinotecan|mesh-list
24618115|NCT01046864|Antimetabolites|antimetabolites|mesh-ancestor
24618125|NCT01046864|Antidotes|antidotes|mesh-ancestor
25714628|NCT02358863|Tubulin Modulators|tubulin modulators|mesh-ancestor
25714629|NCT02358863|Antimitotic Agents|antimitotic agents|mesh-ancestor
25714630|NCT02358863|Mitosis Modulators|mitosis modulators|mesh-ancestor
25714631|NCT02358863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714632|NCT02358863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25714633|NCT02358863|Antimetabolites|antimetabolites|mesh-ancestor
25714634|NCT02358863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25714635|NCT02358863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24919635|NCT04209426|Cholinergic Agents|cholinergic agents|mesh-ancestor
25714636|NCT02358863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25714638|NCT02358863|Protective Agents|protective agents|mesh-ancestor
24919681|NCT04209192|Amikacin|amikacin|mesh-list
24623802|NCT01073670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24919682|NCT04209192|Fosfomycin|fosfomycin|mesh-list
24919683|NCT04209192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24919684|NCT04209192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24919685|NCT04208841|Sulfamethazine|sulfamethazine|mesh-list
24919686|NCT04208841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24919687|NCT04208854|Vinorelbine|vinorelbine|mesh-list
24919688|NCT04208854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24919689|NCT04208854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24919726|NCT04208594|Adrenergic Agents|adrenergic agents|mesh-ancestor
24494767|NCT00497003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494768|NCT00497003|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24494769|NCT00497003|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24494770|NCT00497003|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24494771|NCT00497003|Adrenergic Agents|adrenergic agents|mesh-ancestor
24521564|NCT04655976|Tubulin Modulators|tubulin modulators|mesh-ancestor
24521565|NCT04655976|Antimitotic Agents|antimitotic agents|mesh-ancestor
24521566|NCT04655976|Mitosis Modulators|mitosis modulators|mesh-ancestor
24521567|NCT04655976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521568|NCT04647435|Tramadol|tramadol|mesh-list
24521569|NCT04647435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24919872|NCT04207684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919873|NCT04207411|Lidocaine|lidocaine|mesh-list
24919874|NCT04207411|Bupivacaine|bupivacaine|mesh-list
24919875|NCT04207411|Anesthetics, Local|anesthetics, local|mesh-ancestor
24919876|NCT04207411|Anesthetics|anesthetics|mesh-ancestor
24919877|NCT04207411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24919878|NCT04207411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24919879|NCT04207411|Sensory System Agents|sensory system agents|mesh-ancestor
24919880|NCT04207411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24919881|NCT04207411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24919882|NCT04207411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24919940|NCT04207021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24919991|NCT04205916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495108|NCT00498342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521632|NCT04629534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24521647|NCT04622904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24521648|NCT04622904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24521649|NCT04622904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24920038|NCT04205890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920039|NCT04205890|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24920040|NCT04205890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24920041|NCT04205890|Anesthetics, General|anesthetics, general|mesh-ancestor
24920042|NCT04205890|Anesthetics|anesthetics|mesh-ancestor
24920043|NCT04205890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24920044|NCT04205890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24920045|NCT04205890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24920046|NCT04205890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25714639|NCT02358863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714640|NCT02358863|Vitamin B Complex|vitamin b complex|mesh-ancestor
25714641|NCT02358863|Vitamins|vitamins|mesh-ancestor
25714642|NCT02358863|Micronutrients|micronutrients|mesh-ancestor
24920047|NCT04205890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920048|NCT04205851|Gimsilumab|gimsilumab|mesh-list
24920049|NCT04205851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24495165|NCT00498901|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24495166|NCT00498901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24618974|NCT01050374|Antinematodal Agents|antinematodal agents|mesh-ancestor
24618975|NCT01050374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24623864|NCT01073826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24623865|NCT01073826|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24521693|NCT04597333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521694|NCT04596579|Antibodies|antibodies|mesh-list
24521695|NCT04596579|Immunologic Factors|immunologic factors|mesh-ancestor
24521696|NCT04596579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521697|NCT04595565|Carboplatin|carboplatin|mesh-list
24521698|NCT04595565|Capecitabine|capecitabine|mesh-list
24521742|NCT04553536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24920076|NCT04205240|Mycophenolic Acid|mycophenolic acid|mesh-list
24920077|NCT04205240|Cyclophosphamide|cyclophosphamide|mesh-list
24920079|NCT04205240|Mechlorethamine|mechlorethamine|mesh-list
24920080|NCT04205240|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
24920081|NCT04205240|Fludarabine|fludarabine|mesh-list
24521769|NCT04533451|Pemetrexed|pemetrexed|mesh-list
24920102|NCT04205201|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25714643|NCT02358863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25714644|NCT02358863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25714645|NCT02358889|Ranibizumab|ranibizumab|mesh-list
25714646|NCT02358889|Immunoconjugates|immunoconjugates|mesh-list
25714647|NCT02358889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25714648|NCT02358889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25714649|NCT02358889|Growth Substances|growth substances|mesh-ancestor
25714650|NCT02358889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714651|NCT02358889|Growth Inhibitors|growth inhibitors|mesh-ancestor
25714652|NCT02358889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25714653|NCT02358889|Immunologic Factors|immunologic factors|mesh-ancestor
25714654|NCT02359006|Minocycline|minocycline|mesh-list
25714655|NCT02359006|Tetracycline|tetracycline|mesh-list
24920106|NCT04205201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24920107|NCT04205201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920108|NCT04205201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714656|NCT02359006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25714657|NCT02359006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25714658|NCT02359006|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25714659|NCT02359006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920112|NCT04205305|Labetalol|labetalol|mesh-list
24920120|NCT04205305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24920122|NCT04205305|Autonomic Agents|autonomic agents|mesh-ancestor
24920123|NCT04205305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24920124|NCT04205305|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24920125|NCT04205305|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24920134|NCT04205344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920135|NCT04205344|Sensory System Agents|sensory system agents|mesh-ancestor
24920136|NCT04205344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24522012|NCT04377932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522013|NCT04377932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24522014|NCT04377932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24920378|NCT04203511|Carboplatin|carboplatin|mesh-list
24920380|NCT04203511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24920403|NCT04202835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920404|NCT04202835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24920405|NCT04202835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24920407|NCT04203485|Carboplatin|carboplatin|mesh-list
24920409|NCT04203485|Apatinib|apatinib|mesh-list
24920410|NCT04203485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24920411|NCT04203485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24920412|NCT04203485|Tubulin Modulators|tubulin modulators|mesh-ancestor
24920413|NCT04203485|Antimitotic Agents|antimitotic agents|mesh-ancestor
24495650|NCT00501410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495651|NCT00501410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24495652|NCT00501410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495654|NCT00501410|Immunologic Factors|immunologic factors|mesh-ancestor
24920455|NCT04202367|Anesthetics|anesthetics|mesh-ancestor
24920456|NCT04202367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24495722|NCT00501657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495723|NCT00501696|Naltrexone|naltrexone|mesh-list
24495724|NCT00501696|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24495725|NCT00501696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24495726|NCT00501696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495727|NCT00501696|Sensory System Agents|sensory system agents|mesh-ancestor
24522177|NCT04158440|Antimitotic Agents|antimitotic agents|mesh-ancestor
24522178|NCT04158440|Mitosis Modulators|mitosis modulators|mesh-ancestor
24522179|NCT04158440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920478|NCT04202406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24920479|NCT04202406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920481|NCT04202406|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25714660|NCT02359006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714661|NCT02359058|Cisplatin|cisplatin|mesh-list
25714662|NCT02359058|Capecitabine|capecitabine|mesh-list
25714663|NCT02359058|Oxaliplatin|oxaliplatin|mesh-list
25714664|NCT02359058|Ramucirumab|ramucirumab|mesh-list
25714665|NCT02359058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25714666|NCT02359058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25714667|NCT02359058|Antimetabolites|antimetabolites|mesh-ancestor
25714668|NCT02359058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714669|NCT02359110|Gabapentin|gabapentin|mesh-list
25714670|NCT02359110|Analgesics|analgesics|mesh-ancestor
25714671|NCT02359110|Sensory System Agents|sensory system agents|mesh-ancestor
25714672|NCT02359110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25714673|NCT02359110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714674|NCT02359110|Anticonvulsants|anticonvulsants|mesh-ancestor
25714675|NCT02359110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25714676|NCT02359110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25714677|NCT02359110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24920482|NCT04202406|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24920483|NCT04202406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24920484|NCT04202406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920485|NCT04202406|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24920486|NCT04202406|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24920487|NCT04202406|Purinergic Agents|purinergic agents|mesh-ancestor
24920488|NCT04202406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24920489|NCT04202406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24920550|NCT04201769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24920648|NCT04200235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24920649|NCT04200235|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24920650|NCT04200235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24920651|NCT04200235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24920652|NCT04200235|Adrenergic Agents|adrenergic agents|mesh-ancestor
24920653|NCT04200235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24920654|NCT04200235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920655|NCT04200092|Granisetron|granisetron|mesh-list
24920656|NCT04200092|Antiemetics|antiemetics|mesh-ancestor
24920657|NCT04200092|Autonomic Agents|autonomic agents|mesh-ancestor
24920658|NCT04200092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24920659|NCT04200092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24920660|NCT04200092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24495881|NCT00502411|Doxorubicin|doxorubicin|mesh-list
24495882|NCT00502411|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24920661|NCT04200092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24522309|NCT04001621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522310|NCT03994796|Entrectinib|entrectinib|mesh-list
24522311|NCT03994796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24522312|NCT03994796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24522366|NCT03927378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24522367|NCT03927378|Anesthetics, General|anesthetics, general|mesh-ancestor
24522368|NCT03927378|Anesthetics|anesthetics|mesh-ancestor
24522369|NCT03927378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24522393|NCT03893175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24522394|NCT03893175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24620553|NCT01057511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24620554|NCT01057511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24620555|NCT01057563|Paclitaxel|paclitaxel|mesh-list
24620556|NCT01057563|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24620557|NCT01057563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24620583|NCT01057758|Simvastatin|simvastatin|mesh-list
24620803|NCT01059110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24920722|NCT04198727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24920723|NCT04198727|Antimetabolites|antimetabolites|mesh-ancestor
24920728|NCT04198571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24920806|NCT04197739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24920807|NCT04197323|Alprostadil|alprostadil|mesh-list
24920808|NCT04197323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24920809|NCT04197323|Vasodilator Agents|vasodilator agents|mesh-ancestor
25714678|NCT02359110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25714679|NCT02359110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25714680|NCT02359110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25714681|NCT02359110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24920810|NCT04197323|Urological Agents|urological agents|mesh-ancestor
24920812|NCT04197349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24920813|NCT04197349|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24920814|NCT04197349|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24920815|NCT04197349|Serotonin Agents|serotonin agents|mesh-ancestor
24920816|NCT04197349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24920817|NCT04197349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522477|NCT03753243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522483|NCT03747419|Avelumab|avelumab|mesh-list
24522484|NCT03747419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24621261|NCT01061320|Tocopherols|tocopherols|mesh-list
24920919|NCT04196608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24920920|NCT04196608|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24920921|NCT04196608|Renal Agents|renal agents|mesh-ancestor
24920922|NCT04196270|Ropivacaine|ropivacaine|mesh-list
24920923|NCT04196270|Anesthetics, Local|anesthetics, local|mesh-ancestor
24921015|NCT04195321|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24921016|NCT04195321|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24921017|NCT04195321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24921018|NCT04195321|Adrenergic Agents|adrenergic agents|mesh-ancestor
24921019|NCT04195321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24921020|NCT04195321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921023|NCT04195074|Entecavir|entecavir|mesh-list
24921024|NCT04195074|Antiviral Agents|antiviral agents|mesh-ancestor
24921025|NCT04195074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24921090|NCT04194294|Lidocaine|lidocaine|mesh-list
24921091|NCT04194294|Anesthetics, Local|anesthetics, local|mesh-ancestor
24921092|NCT04194294|Anesthetics|anesthetics|mesh-ancestor
24921093|NCT04194294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24921094|NCT04194294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921095|NCT04194294|Sensory System Agents|sensory system agents|mesh-ancestor
24921096|NCT04194294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24496396|NCT00504439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496397|NCT00504465|Dinoprostone|dinoprostone|mesh-list
24522563|NCT03651011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24522583|NCT03637062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921104|NCT04194125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921105|NCT04194086|Posaconazole|posaconazole|mesh-list
24921106|NCT04194086|Antifungal Agents|antifungal agents|mesh-ancestor
24921107|NCT04194086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24921108|NCT04194086|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25714682|NCT02359110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714683|NCT02359110|Antimanic Agents|antimanic agents|mesh-ancestor
25714684|NCT02359305|Acetaminophen|acetaminophen|mesh-list
25714685|NCT02359305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24921109|NCT04194086|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24921110|NCT04194086|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25714686|NCT02359305|Analgesics|analgesics|mesh-ancestor
25714687|NCT02359305|Sensory System Agents|sensory system agents|mesh-ancestor
25714688|NCT02359305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25714689|NCT02359305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714690|NCT02359305|Antipyretics|antipyretics|mesh-ancestor
25714691|NCT02359435|Amoxicillin|amoxicillin|mesh-list
24921111|NCT04194086|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24496419|NCT00504673|Isophane Insulin, Human|isophane insulin, human|mesh-list
24496420|NCT00504673|Insulin, Isophane|insulin, isophane|mesh-list
24496421|NCT00504673|Isophane insulin, beef|isophane insulin, beef|mesh-list
24496422|NCT00504673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24496423|NCT00504673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496473|NCT00504946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24921152|NCT04193930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24921153|NCT04193982|Vitamin E|vitamin e|mesh-list
24921154|NCT04193982|Vitamins|vitamins|mesh-ancestor
24921155|NCT04193982|Micronutrients|micronutrients|mesh-ancestor
24921156|NCT04193982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921157|NCT04193982|Antioxidants|antioxidants|mesh-ancestor
24921158|NCT04193982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921159|NCT04193982|Protective Agents|protective agents|mesh-ancestor
24921160|NCT04193852|Dienogest|dienogest|mesh-list
24921161|NCT04193852|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24921162|NCT04193852|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24921163|NCT04193852|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24921164|NCT04193852|Estradiol|estradiol|mesh-list
24921165|NCT04193852|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24921166|NCT04193852|Nandrolone|nandrolone|mesh-list
24921167|NCT04193852|Estrogens|estrogens|mesh-ancestor
24621958|NCT01064986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24621959|NCT01064986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24621960|NCT01064999|Capecitabine|capecitabine|mesh-list
24621961|NCT01064999|Oxaliplatin|oxaliplatin|mesh-list
24621962|NCT01064999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24496497|NCT00505102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24496498|NCT00505102|Immunologic Factors|immunologic factors|mesh-ancestor
24496500|NCT00505154|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24921211|NCT04193319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921212|NCT04193319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921213|NCT04193319|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24921214|NCT04193319|Hormone Antagonists|hormone antagonists|mesh-ancestor
24921215|NCT04193319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24921216|NCT04193319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921217|NCT04193319|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24921218|NCT04193319|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24921219|NCT04193566|Dapagliflozin|dapagliflozin|mesh-list
24921220|NCT04193566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25714692|NCT02359435|Metronidazole|metronidazole|mesh-list
25714693|NCT02359435|Clarithromycin|clarithromycin|mesh-list
25714694|NCT02359435|Pantoprazole|pantoprazole|mesh-list
25714695|NCT02359435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25714696|NCT02359435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25714697|NCT02359435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25714698|NCT02359435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25714699|NCT02359435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25714700|NCT02359435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921221|NCT04193566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921222|NCT04193566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24921223|NCT04193566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921388|NCT04192331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921389|NCT04192331|Tubulin Modulators|tubulin modulators|mesh-ancestor
24921390|NCT04192331|Antimitotic Agents|antimitotic agents|mesh-ancestor
24921391|NCT04192331|Mitosis Modulators|mitosis modulators|mesh-ancestor
24921392|NCT04192331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921393|NCT04191694|Ondansetron|ondansetron|mesh-list
24921394|NCT04191694|Antiemetics|antiemetics|mesh-ancestor
24921395|NCT04191694|Autonomic Agents|autonomic agents|mesh-ancestor
24921396|NCT04191694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24921397|NCT04191694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921398|NCT04191694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24921498|NCT04190173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24921499|NCT04190173|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
24921500|NCT04190173|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24921501|NCT04190173|Serotonin Agents|serotonin agents|mesh-ancestor
24921502|NCT04190173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24921503|NCT04190173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921504|NCT04190173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921506|NCT04189900|Luteolytic Agents|luteolytic agents|mesh-ancestor
24921541|NCT04189744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921542|NCT04189744|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24921543|NCT04189744|Renal Agents|renal agents|mesh-ancestor
24921544|NCT04189601|Complement System Proteins|complement system proteins|mesh-list
24921545|NCT04189601|Immunologic Factors|immunologic factors|mesh-ancestor
24921546|NCT04189601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921547|NCT04189250|Carbon Monoxide|carbon monoxide|mesh-list
24921548|NCT04189250|Antimetabolites|antimetabolites|mesh-ancestor
24921549|NCT04189250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921550|NCT04189250|Gasotransmitters|gasotransmitters|mesh-ancestor
24921551|NCT04189250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24921552|NCT04189250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921554|NCT04189484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24921555|NCT04189484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24921556|NCT04189484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24921557|NCT04189484|Antimetabolites|antimetabolites|mesh-ancestor
24522790|NCT03127592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522791|NCT03116425|Pantothenic Acid|pantothenic acid|mesh-list
24522792|NCT03116425|Vitamin B Complex|vitamin b complex|mesh-ancestor
24522793|NCT03116425|Vitamins|vitamins|mesh-ancestor
24622381|NCT01066767|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24622382|NCT01066767|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24522797|NCT03110822|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24522798|NCT03110822|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24522799|NCT03110822|Prednisolone|prednisolone|mesh-list
24622383|NCT01066767|Histamine Antagonists|histamine antagonists|mesh-ancestor
24622385|NCT01066767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24622386|NCT01066767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921677|NCT04188158|Antimetabolites|antimetabolites|mesh-ancestor
24921678|NCT04188158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921679|NCT04188158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921680|NCT04188184|Epinephrine|epinephrine|mesh-list
24921681|NCT04188184|Tranexamic Acid|tranexamic acid|mesh-list
24921682|NCT04188184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24921683|NCT04188184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24921684|NCT04188184|Adrenergic Agents|adrenergic agents|mesh-ancestor
24921685|NCT04188184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24921686|NCT04188184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921687|NCT04188184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921688|NCT04188184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24921789|NCT04187456|GABA Modulators|gaba modulators|mesh-ancestor
24921790|NCT04187456|GABA Agents|gaba agents|mesh-ancestor
24921791|NCT04187456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24921792|NCT04187456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921793|NCT04186702|Ranibizumab|ranibizumab|mesh-list
24921807|NCT04186936|Dermatologic Agents|dermatologic agents|mesh-ancestor
24921808|NCT04187014|Tranexamic Acid|tranexamic acid|mesh-list
24921809|NCT04187014|Aminocaproic Acid|aminocaproic acid|mesh-list
24921810|NCT04187014|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24921811|NCT04187014|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24921812|NCT04187014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921814|NCT04187014|Coagulants|coagulants|mesh-ancestor
24921824|NCT04186559|Pentoxifylline|pentoxifylline|mesh-list
24921900|NCT04185649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24921902|NCT04185649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24921903|NCT04185649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24921904|NCT04185649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24921905|NCT04185649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24921906|NCT04185350|Exenatide|exenatide|mesh-list
24921907|NCT04185350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24921908|NCT04185350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24921909|NCT04185350|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24921910|NCT04185350|Incretins|incretins|mesh-ancestor
24921911|NCT04185350|Hormones|hormones|mesh-ancestor
24497359|NCT00509639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24497360|NCT00509639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24497361|NCT00509639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24497362|NCT00509639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24497363|NCT00509678|Rituximab|rituximab|mesh-list
24497364|NCT00509678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24497365|NCT00509678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24497366|NCT00509678|Immunologic Factors|immunologic factors|mesh-ancestor
24522812|NCT03110822|Antiemetics|antiemetics|mesh-ancestor
24623109|NCT01070225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623110|NCT01070225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24623111|NCT01070225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24522876|NCT03103087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24522877|NCT03103087|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24522878|NCT03103087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24623550|NCT01072097|Antimetabolites|antimetabolites|mesh-ancestor
24623551|NCT01072097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24623552|NCT01072097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24623553|NCT01072097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24623554|NCT01072097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24922188|NCT04182932|Vaccines|vaccines|mesh-list
24922189|NCT04182932|Immunologic Factors|immunologic factors|mesh-ancestor
24922190|NCT04182932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922191|NCT04182737|Immunoglobulins|immunoglobulins|mesh-list
24922192|NCT04182737|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24922193|NCT04182737|Antibodies|antibodies|mesh-list
25714701|NCT02359435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714702|NCT02359435|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24922194|NCT04182737|Immunoglobulin M|immunoglobulin m|mesh-list
24922198|NCT04182568|Paclitaxel|paclitaxel|mesh-list
25714703|NCT02359435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25714704|NCT02359435|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25714705|NCT02359435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25714706|NCT02359435|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25714707|NCT02359552|Rasagiline|rasagiline|mesh-list
25777209|NCT03730961|Natriuretic Agents|natriuretic agents|mesh-ancestor
24922338|NCT04181385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24922339|NCT04181385|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24922340|NCT04181385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24922341|NCT04181385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24922342|NCT04181385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922343|NCT04181385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24922344|NCT04181385|Serotonin Agents|serotonin agents|mesh-ancestor
24922345|NCT04181385|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24922346|NCT04181385|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24922366|NCT04181489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24922613|NCT04178512|Anesthetics, General|anesthetics, general|mesh-ancestor
24922709|NCT04177173|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24922710|NCT04177173|Abortifacient Agents|abortifacient agents|mesh-ancestor
24922711|NCT04177173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24922712|NCT04177173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922713|NCT04177173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24922714|NCT04177173|Antimetabolites|antimetabolites|mesh-ancestor
24922715|NCT04177173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922716|NCT04177173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24922717|NCT04177173|Dermatologic Agents|dermatologic agents|mesh-ancestor
24922718|NCT04177173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24922719|NCT04177173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24922720|NCT04177173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24922765|NCT04177303|Metformin|metformin|mesh-list
24922766|NCT04177303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24922767|NCT04177303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522899|NCT03071926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24922768|NCT04177043|Antibodies|antibodies|mesh-list
24922848|NCT04175990|Dydrogesterone|dydrogesterone|mesh-list
24922849|NCT04175990|Progestins|progestins|mesh-ancestor
24746484|NCT05426811|Raltitrexed|raltitrexed|mesh-list
24522900|NCT03049735|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24522942|NCT03012971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24922872|NCT04176068|Calcium|calcium|mesh-list
24624141|NCT01074892|Hormones|hormones|mesh-ancestor
24636355|NCT01144923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24600659|NCT00959777|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24600660|NCT00959777|Immunologic Factors|immunologic factors|mesh-ancestor
24600661|NCT00959777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448606|NCT00312325|Hormones|hormones|mesh-ancestor
24600663|NCT00959881|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24600664|NCT00959881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24600669|NCT00959881|Nootropic Agents|nootropic agents|mesh-ancestor
24600988|NCT00961753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24600989|NCT00961753|Analgesics|analgesics|mesh-ancestor
24600990|NCT00961753|Sensory System Agents|sensory system agents|mesh-ancestor
24600991|NCT00961753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24636470|NCT01145677|Anticonvulsants|anticonvulsants|mesh-ancestor
24636489|NCT01145846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24601163|NCT00963209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25714710|NCT02359552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714711|NCT02359552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25714712|NCT02359552|Protective Agents|protective agents|mesh-ancestor
25714713|NCT02359552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714714|NCT02359851|Pembrolizumab|pembrolizumab|mesh-list
24636509|NCT01145859|Anticoagulants|anticoagulants|mesh-ancestor
25714715|NCT02359851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24601164|NCT00963209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24601166|NCT00963209|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24601171|NCT00963222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601172|NCT00963274|Bortezomib|bortezomib|mesh-list
24601173|NCT00963274|Romidepsin|romidepsin|mesh-list
24601174|NCT00963274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24601175|NCT00963274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24601176|NCT00963313|Adalimumab|adalimumab|mesh-list
24601177|NCT00963313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24601178|NCT00963313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24601179|NCT00963443|Aspirin|aspirin|mesh-list
24601180|NCT00963443|Pseudoephedrine|pseudoephedrine|mesh-list
24601181|NCT00963443|Ephedrine|ephedrine|mesh-list
24601182|NCT00963443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24601183|NCT00963443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24601184|NCT00963443|Analgesics|analgesics|mesh-ancestor
24601185|NCT00963443|Sensory System Agents|sensory system agents|mesh-ancestor
24601188|NCT00963443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24601311|NCT00963846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601312|NCT00963846|Cholinergic Agents|cholinergic agents|mesh-ancestor
24601313|NCT00963846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24601314|NCT00963846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601315|NCT00963846|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24601316|NCT00963846|Protective Agents|protective agents|mesh-ancestor
24601317|NCT00963976|Enalapril|enalapril|mesh-list
24601318|NCT00963976|Labetalol|labetalol|mesh-list
24601319|NCT00963976|Hydralazine|hydralazine|mesh-list
24601336|NCT00964015|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24601337|NCT00964015|Plasma Substitutes|plasma substitutes|mesh-ancestor
24601338|NCT00964015|Blood Substitutes|blood substitutes|mesh-ancestor
24601339|NCT00964041|Cycloserine|cycloserine|mesh-list
24601340|NCT00964041|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24601341|NCT00964041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24601342|NCT00964041|Renal Agents|renal agents|mesh-ancestor
24601347|NCT00964041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601349|NCT00964080|Fluorouracil|fluorouracil|mesh-list
24601350|NCT00964080|Oxaliplatin|oxaliplatin|mesh-list
24601351|NCT00964080|Antimetabolites|antimetabolites|mesh-ancestor
24601352|NCT00964080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601353|NCT00964080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24601354|NCT00964080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24601355|NCT00964080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24601356|NCT00964080|Immunologic Factors|immunologic factors|mesh-ancestor
24601357|NCT00964080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601378|NCT00964106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24601444|NCT00964171|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24601445|NCT00964171|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24601446|NCT00964171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24601447|NCT00964171|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24601449|NCT00964184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24601450|NCT00964184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601451|NCT00964262|Exenatide|exenatide|mesh-list
24601452|NCT00964262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24601453|NCT00964262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601531|NCT00964626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24601535|NCT00964626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601536|NCT00964639|Ropivacaine|ropivacaine|mesh-list
24601601|NCT00964808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24601602|NCT00964808|Narcotics|narcotics|mesh-ancestor
24601603|NCT00964808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24601604|NCT00964808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601605|NCT00964808|Analgesics|analgesics|mesh-ancestor
24601606|NCT00964808|Sensory System Agents|sensory system agents|mesh-ancestor
24601607|NCT00964808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25714716|NCT02359851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25714717|NCT02359877|Interferons|interferons|mesh-list
25714718|NCT02359877|Interferon-beta|interferon-beta|mesh-list
25714719|NCT02359877|Interferon beta-1a|interferon beta-1a|mesh-list
25714720|NCT02359877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25714721|NCT02359877|Antiviral Agents|antiviral agents|mesh-ancestor
25714722|NCT02359877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24601608|NCT00964808|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24601609|NCT00964834|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24601610|NCT00964834|Doxycycline|doxycycline|mesh-list
24601611|NCT00964834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
24601612|NCT00964834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24601613|NCT00964834|Antitubercular Agents|antitubercular agents|mesh-ancestor
24601614|NCT00964834|Antimalarials|antimalarials|mesh-ancestor
24601615|NCT00964834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24601616|NCT00964834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24601617|NCT00964964|Insulin|insulin|mesh-list
24601618|NCT00964964|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24601619|NCT00964964|Insulin, Long-Acting|insulin, long-acting|mesh-list
24601620|NCT00964964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24601621|NCT00964964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601623|NCT00965042|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
24601624|NCT00965042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24601625|NCT00965042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24601626|NCT00965107|Thiopental|thiopental|mesh-list
24601627|NCT00965107|Propofol|propofol|mesh-list
24601628|NCT00965107|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24601737|NCT00965809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601738|NCT00965809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24601739|NCT00965809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24601740|NCT00965809|Analgesics|analgesics|mesh-ancestor
24601741|NCT00965809|Sensory System Agents|sensory system agents|mesh-ancestor
24601742|NCT00965809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24601743|NCT00965809|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24601744|NCT00965809|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24601745|NCT00965809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24601746|NCT00965809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601747|NCT00965809|Hormones|hormones|mesh-ancestor
24601748|NCT00965809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24601749|NCT00965874|Magnesium Sulfate|magnesium sulfate|mesh-list
24636594|NCT01146145|Ketamine|ketamine|mesh-list
24601750|NCT00965874|Analgesics|analgesics|mesh-ancestor
24601764|NCT00965900|Propranolol|propranolol|mesh-list
24601815|NCT00966056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601816|NCT00966056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24601817|NCT00966056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601900|NCT00966368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24601901|NCT00966368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601910|NCT00966472|Antimetabolites|antimetabolites|mesh-ancestor
24601919|NCT00966576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601920|NCT00966576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601921|NCT00966576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24601922|NCT00966576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24601923|NCT00966576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24601924|NCT00966576|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24601925|NCT00966602|Ivacaftor|ivacaftor|mesh-list
24601926|NCT00966602|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24601927|NCT00966602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24601928|NCT00966602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24601929|NCT00966615|Dialysis Solutions|dialysis solutions|mesh-list
24601968|NCT00966771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24601969|NCT00966771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24601970|NCT00966771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24601971|NCT00966771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24601972|NCT00966771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24601973|NCT00966771|Trace Elements|trace elements|mesh-ancestor
24601974|NCT00966771|Micronutrients|micronutrients|mesh-ancestor
24601975|NCT00966836|Mycophenolic Acid|mycophenolic acid|mesh-list
24601997|NCT00966901|Cholinergic Agents|cholinergic agents|mesh-ancestor
24601998|NCT00966901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24601999|NCT00966901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602001|NCT00966966|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24602002|NCT00966966|Antimetabolites|antimetabolites|mesh-ancestor
24602263|NCT00967772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25714723|NCT02359877|Immunologic Factors|immunologic factors|mesh-ancestor
25714724|NCT02359877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602264|NCT00967772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24602266|NCT00967837|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24602267|NCT00967837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24602268|NCT00967837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602269|NCT00967850|Verteporfin|verteporfin|mesh-list
24602270|NCT00967850|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24602271|NCT00967850|Dermatologic Agents|dermatologic agents|mesh-ancestor
24602375|NCT00968578|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24602376|NCT00968578|Prednisolone|prednisolone|mesh-list
24602377|NCT00968578|Prednisolone acetate|prednisolone acetate|mesh-list
24602378|NCT00968578|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24602379|NCT00968578|Prednisolone phosphate|prednisolone phosphate|mesh-list
24602380|NCT00968578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24602381|NCT00968578|Antiemetics|antiemetics|mesh-ancestor
24602382|NCT00968578|Autonomic Agents|autonomic agents|mesh-ancestor
24602429|NCT00968760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24602430|NCT00968760|Analgesics|analgesics|mesh-ancestor
24602431|NCT00968760|Sensory System Agents|sensory system agents|mesh-ancestor
24602432|NCT00968760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24602433|NCT00968877|Cholecalciferol|cholecalciferol|mesh-list
24602435|NCT00968877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24602436|NCT00968877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602585|NCT00969566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602649|NCT00969982|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24602650|NCT00969982|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24602745|NCT00970905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24602746|NCT00970905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602747|NCT00970905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24602748|NCT00970905|Antipruritics|antipruritics|mesh-ancestor
24602749|NCT00970905|Dermatologic Agents|dermatologic agents|mesh-ancestor
24602750|NCT00970905|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24602751|NCT00970905|Serotonin Agents|serotonin agents|mesh-ancestor
24602752|NCT00970905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24602753|NCT00970905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24602754|NCT00970905|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24602755|NCT00970905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24602769|NCT00970931|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24602771|NCT00970931|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24602772|NCT00970931|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24602773|NCT00970957|Bevacizumab|bevacizumab|mesh-list
24602947|NCT00971763|Immunologic Factors|immunologic factors|mesh-ancestor
24602948|NCT00971763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24602949|NCT00971763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24602950|NCT00971763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24602951|NCT00971763|Alkylating Agents|alkylating agents|mesh-ancestor
24602968|NCT00971763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24602969|NCT00971763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24602970|NCT00971815|Dexetimide|dexetimide|mesh-list
24602971|NCT00971815|Citalopram|citalopram|mesh-list
24602973|NCT00971815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24603088|NCT00972387|Immunologic Factors|immunologic factors|mesh-ancestor
24603110|NCT00972426|Carteolol|carteolol|mesh-list
24603111|NCT00972426|Latanoprost|latanoprost|mesh-list
24603112|NCT00972426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24603113|NCT00972426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24603114|NCT00972426|Adrenergic Agents|adrenergic agents|mesh-ancestor
24603122|NCT00972426|Sympatholytics|sympatholytics|mesh-ancestor
24603124|NCT00972426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24603125|NCT00972465|Nimotuzumab|nimotuzumab|mesh-list
24603126|NCT00972465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24603127|NCT00972465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603133|NCT00972660|Prednisone|prednisone|mesh-list
24603361|NCT00973336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24603362|NCT00973336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24603363|NCT00973388|Moxifloxacin|moxifloxacin|mesh-list
24603364|NCT00973388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25714725|NCT02359877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25714726|NCT02359903|Infliximab|infliximab|mesh-list
24603365|NCT00973388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24603366|NCT00973388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25714727|NCT02359903|Dermatologic Agents|dermatologic agents|mesh-ancestor
24603367|NCT00973388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24603368|NCT00973388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603369|NCT00973388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603370|NCT00973388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603371|NCT00973401|Insulin|insulin|mesh-list
24603372|NCT00973401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24603373|NCT00973401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603488|NCT00974012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603489|NCT00974012|Antimanic Agents|antimanic agents|mesh-ancestor
24603490|NCT00974012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24603491|NCT00974012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24603492|NCT00974012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24603493|NCT00974025|Ascorbic Acid|ascorbic acid|mesh-list
24603494|NCT00974025|Vitamins|vitamins|mesh-ancestor
24603495|NCT00974025|Micronutrients|micronutrients|mesh-ancestor
24603496|NCT00974025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603497|NCT00974025|Antioxidants|antioxidants|mesh-ancestor
24603498|NCT00974025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603499|NCT00974025|Protective Agents|protective agents|mesh-ancestor
24603529|NCT00974181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603531|NCT00974272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24603532|NCT00974272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603533|NCT00974272|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24603534|NCT00974272|Incretins|incretins|mesh-ancestor
24603535|NCT00974272|Hormones|hormones|mesh-ancestor
24603536|NCT00974272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24603537|NCT00974324|Endostar protein|endostar protein|mesh-list
24603538|NCT00974324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24603539|NCT00974324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24603556|NCT00974428|Wobenzym|wobenzym|mesh-list
24603557|NCT00974428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24603558|NCT00974428|Immunologic Factors|immunologic factors|mesh-ancestor
24603559|NCT00974428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603560|NCT00974441|Valproic Acid|valproic acid|mesh-list
24603561|NCT00974441|Anticonvulsants|anticonvulsants|mesh-ancestor
24603562|NCT00974441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603564|NCT00974441|GABA Agents|gaba agents|mesh-ancestor
24603566|NCT00974441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603568|NCT00974441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24603569|NCT00974441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24603570|NCT00974441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24603571|NCT00974532|Calcium, Dietary|calcium, dietary|mesh-list
24603572|NCT00974532|Calcium|calcium|mesh-list
24603573|NCT00974532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24603574|NCT00974532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603575|NCT00974532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24603576|NCT00974584|Paclitaxel|paclitaxel|mesh-list
24603577|NCT00974584|Bevacizumab|bevacizumab|mesh-list
24603596|NCT00974740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24603597|NCT00974740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24603639|NCT00974792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24603799|NCT00975754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24603800|NCT00975754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24603801|NCT00975754|Respiratory System Agents|respiratory system agents|mesh-ancestor
24603809|NCT00975767|Antimitotic Agents|antimitotic agents|mesh-ancestor
24603810|NCT00975767|Mitosis Modulators|mitosis modulators|mesh-ancestor
24603945|NCT00976261|Hormones|hormones|mesh-ancestor
24603946|NCT00976261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24603947|NCT00976261|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24603948|NCT00976261|Protease Inhibitors|protease inhibitors|mesh-ancestor
24603949|NCT00976261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24603950|NCT00976261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24603952|NCT00976300|Cyclophosphamide|cyclophosphamide|mesh-list
24603953|NCT00976300|Cyclosporins|cyclosporins|mesh-list
24603993|NCT00976690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24604127|NCT00977288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636765|NCT01147224|Hormones|hormones|mesh-ancestor
24604129|NCT00977301|Fosamprenavir|fosamprenavir|mesh-list
24604130|NCT00977301|Olanzapine|olanzapine|mesh-list
24604131|NCT00977301|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24604132|NCT00977301|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24604133|NCT00977301|Protease Inhibitors|protease inhibitors|mesh-ancestor
24604134|NCT00977301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604236|NCT00978081|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24604237|NCT00978081|Dermatologic Agents|dermatologic agents|mesh-ancestor
24604238|NCT00978107|Flucytosine|flucytosine|mesh-list
24604239|NCT00978107|Antifungal Agents|antifungal agents|mesh-ancestor
24604240|NCT00978107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24604241|NCT00978107|Antimetabolites|antimetabolites|mesh-ancestor
24604242|NCT00978107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604243|NCT00978146|Hydroxyurea|hydroxyurea|mesh-list
24604244|NCT00978146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24604245|NCT00978146|Antisickling Agents|antisickling agents|mesh-ancestor
24604246|NCT00978146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604247|NCT00978146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604249|NCT00978159|Esomeprazole|esomeprazole|mesh-list
24604310|NCT00978393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24604311|NCT00978471|Thiotepa|thiotepa|mesh-list
24604312|NCT00978471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24604379|NCT00978913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24604473|NCT00979667|Antiviral Agents|antiviral agents|mesh-ancestor
24604474|NCT00979667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24604475|NCT00979667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604476|NCT00979667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604477|NCT00979706|Cyclosporine|cyclosporine|mesh-list
24604479|NCT00979706|Cyclosporins|cyclosporins|mesh-list
24604480|NCT00979706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604481|NCT00979706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24604495|NCT00979758|Atorvastatin|atorvastatin|mesh-list
24604581|NCT00980239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24604584|NCT00980304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24604744|NCT00981591|Vasodilator Agents|vasodilator agents|mesh-ancestor
24604745|NCT00981708|Dexamethasone|dexamethasone|mesh-list
24604746|NCT00981708|Dexamethasone acetate|dexamethasone acetate|mesh-list
24604747|NCT00981708|Cyclophosphamide|cyclophosphamide|mesh-list
24604748|NCT00981708|Lenalidomide|lenalidomide|mesh-list
24604749|NCT00981708|BB 1101|bb 1101|mesh-list
24604824|NCT00981851|Tocolytic Agents|tocolytic agents|mesh-ancestor
24604863|NCT00981929|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24604864|NCT00981929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24604865|NCT00981929|Purinergic Agents|purinergic agents|mesh-ancestor
24604866|NCT00981929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24604867|NCT00981929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24604868|NCT00981929|Narcotics|narcotics|mesh-ancestor
24604870|NCT00981929|Analgesics|analgesics|mesh-ancestor
24605076|NCT00983151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24605077|NCT00983151|Narcotics|narcotics|mesh-ancestor
24605078|NCT00983151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24605079|NCT00983151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605080|NCT00983151|Analgesics|analgesics|mesh-ancestor
24605081|NCT00983151|Sensory System Agents|sensory system agents|mesh-ancestor
24605082|NCT00983151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24605083|NCT00983164|Antioxidants|antioxidants|mesh-list
24605084|NCT00983164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605085|NCT00983164|Protective Agents|protective agents|mesh-ancestor
24605086|NCT00983164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605087|NCT00983177|Colchicine|colchicine|mesh-list
24605088|NCT00983177|Gout Suppressants|gout suppressants|mesh-ancestor
24605089|NCT00983177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24605090|NCT00983177|Tubulin Modulators|tubulin modulators|mesh-ancestor
24605091|NCT00983177|Antimitotic Agents|antimitotic agents|mesh-ancestor
24605092|NCT00983177|Mitosis Modulators|mitosis modulators|mesh-ancestor
24605093|NCT00983177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605094|NCT00983177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605095|NCT00983203|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24605121|NCT00983398|Sodium thiosulfate|sodium thiosulfate|mesh-list
24605258|NCT00984217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24605259|NCT00984217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605260|NCT00984230|Lactoferrin|lactoferrin|mesh-list
24605261|NCT00984230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24605263|NCT00984347|Oxytocics|oxytocics|mesh-ancestor
24605264|NCT00984347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24605266|NCT00984360|Naltrexone|naltrexone|mesh-list
24605306|NCT00984438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24605307|NCT00984438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24605308|NCT00984438|Growth Substances|growth substances|mesh-ancestor
24636852|NCT01147692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605315|NCT00984464|Paclitaxel|paclitaxel|mesh-list
24605362|NCT00984750|Vitamin B Complex|vitamin b complex|mesh-ancestor
24605363|NCT00984750|Vitamins|vitamins|mesh-ancestor
24605364|NCT00984750|Micronutrients|micronutrients|mesh-ancestor
24605365|NCT00984750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605449|NCT00985270|Antitubercular Agents|antitubercular agents|mesh-ancestor
24605450|NCT00985270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24605526|NCT00985777|Tocopherols|tocopherols|mesh-list
24605571|NCT00986076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605576|NCT00986115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24605577|NCT00986115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605578|NCT00986115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605579|NCT00986115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24605626|NCT00986505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24605627|NCT00986505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24605628|NCT00986505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24605629|NCT00986505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24605630|NCT00986505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24605631|NCT00986505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605632|NCT00986557|Ganciclovir|ganciclovir|mesh-list
24605633|NCT00986557|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
24605634|NCT00986557|Foscarnet|foscarnet|mesh-list
24605635|NCT00986557|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
24605636|NCT00986557|Alemtuzumab|alemtuzumab|mesh-list
24605637|NCT00986557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24605638|NCT00986557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24605639|NCT00986557|Antiviral Agents|antiviral agents|mesh-ancestor
24605640|NCT00986557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24605641|NCT00986557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24605642|NCT00986557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605643|NCT00986557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24605644|NCT00986557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24605645|NCT00986596|Vitamin D|vitamin d|mesh-list
24605646|NCT00986596|Cholecalciferol|cholecalciferol|mesh-list
24605647|NCT00986596|Vitamins|vitamins|mesh-ancestor
24605648|NCT00986596|Micronutrients|micronutrients|mesh-ancestor
24605649|NCT00986596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605666|NCT00986713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24605667|NCT00986713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24605668|NCT00986713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24605669|NCT00986713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24605723|NCT00987038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605725|NCT00987038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24605734|NCT00987103|Tacrolimus|tacrolimus|mesh-list
24605736|NCT00987103|Immunologic Factors|immunologic factors|mesh-ancestor
24605737|NCT00987103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605738|NCT00987103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24605739|NCT00987103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24605742|NCT00987116|Azathioprine|azathioprine|mesh-list
24605743|NCT00987116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24605744|NCT00987116|Glucocorticoids|glucocorticoids|mesh-ancestor
24605745|NCT00987116|Hormones|hormones|mesh-ancestor
24605746|NCT00987116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24605747|NCT00987116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24605780|NCT00987233|Triamcinolone|triamcinolone|mesh-list
24605882|NCT00987779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24605883|NCT00987779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24605885|NCT00987779|Antimanic Agents|antimanic agents|mesh-ancestor
24606078|NCT00988806|Simendan|simendan|mesh-list
24606079|NCT00988806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24606080|NCT00988806|Vasodilator Agents|vasodilator agents|mesh-ancestor
24606081|NCT00988806|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24606082|NCT00988806|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24606083|NCT00988806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606084|NCT00988806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606085|NCT00988806|Protective Agents|protective agents|mesh-ancestor
24606086|NCT00988806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606088|NCT00988845|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24606089|NCT00988845|Protective Agents|protective agents|mesh-ancestor
24606092|NCT00988897|Leucovorin|leucovorin|mesh-list
24606103|NCT00988897|Antimetabolites|antimetabolites|mesh-ancestor
24606107|NCT00988897|Immunologic Factors|immunologic factors|mesh-ancestor
24606108|NCT00988897|Antidotes|antidotes|mesh-ancestor
24606109|NCT00988897|Protective Agents|protective agents|mesh-ancestor
24606110|NCT00988897|Vitamin B Complex|vitamin b complex|mesh-ancestor
24606112|NCT00988897|Micronutrients|micronutrients|mesh-ancestor
24606113|NCT00988910|Contraceptive Agents|contraceptive agents|mesh-list
24606114|NCT00988910|Contraceptives, Oral|contraceptives, oral|mesh-list
24606337|NCT00990028|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24606338|NCT00990028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606339|NCT00990054|Plerixafor|plerixafor|mesh-list
24606340|NCT00990054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24606341|NCT00990054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24606342|NCT00990054|Antiviral Agents|antiviral agents|mesh-ancestor
24606343|NCT00990054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24606344|NCT00990067|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24606345|NCT00990067|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
24606346|NCT00990067|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24606650|NCT00991627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24606651|NCT00991627|Respiratory System Agents|respiratory system agents|mesh-ancestor
24606652|NCT00991627|Mydriatics|mydriatics|mesh-ancestor
24606680|NCT00991744|Prednisolone phosphate|prednisolone phosphate|mesh-list
24606681|NCT00991744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24606682|NCT00991744|Antimetabolites|antimetabolites|mesh-ancestor
24606683|NCT00991744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606684|NCT00991744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24606686|NCT00991744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24606687|NCT00991744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24606688|NCT00991744|Immunologic Factors|immunologic factors|mesh-ancestor
24606689|NCT00991744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606690|NCT00991744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24606691|NCT00991744|Glucocorticoids|glucocorticoids|mesh-ancestor
24606692|NCT00991744|Hormones|hormones|mesh-ancestor
24606693|NCT00991744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24606694|NCT00991744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24606715|NCT00991796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606716|NCT00991822|Timolol|timolol|mesh-list
24606717|NCT00991822|Dorzolamide|dorzolamide|mesh-list
24606718|NCT00991822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24606719|NCT00991822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24606720|NCT00991822|Adrenergic Agents|adrenergic agents|mesh-ancestor
24606721|NCT00991822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24606722|NCT00991822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606723|NCT00991822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502236|NCT05317676|Hormones|hormones|mesh-ancestor
24606724|NCT00991822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24606725|NCT00991822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24671251|NCT01324544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671252|NCT01324544|Analgesics|analgesics|mesh-ancestor
24606776|NCT05408221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25714728|NCT02359903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25714729|NCT02359903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25714730|NCT02360098|Anesthetics|anesthetics|mesh-list
25714731|NCT02360098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25714732|NCT02360098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714733|NCT02360124|Fluorides|fluorides|mesh-list
25714734|NCT02360124|Cariostatic Agents|cariostatic agents|mesh-ancestor
25714735|NCT02360124|Protective Agents|protective agents|mesh-ancestor
25714736|NCT02360124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24606777|NCT05408221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24606778|NCT05408221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24606779|NCT05408208|Triamcinolone|triamcinolone|mesh-list
24606780|NCT05408208|Methotrexate|methotrexate|mesh-list
24606781|NCT05408208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24606782|NCT05408208|Abortifacient Agents|abortifacient agents|mesh-ancestor
24607237|NCT04946006|Oxytocics|oxytocics|mesh-ancestor
24607238|NCT04946006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24607239|NCT04946006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607240|NCT04941443|Ibuprofen|ibuprofen|mesh-list
24607241|NCT04941443|Methadone|methadone|mesh-list
24607242|NCT04941443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24607243|NCT04941443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24607244|NCT04941443|Analgesics|analgesics|mesh-ancestor
24607285|NCT04849455|Morphine|morphine|mesh-list
24607498|NCT04469842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24607499|NCT04469842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607503|NCT04469842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24607504|NCT04469842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607505|NCT04469842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24607690|NCT03979352|Pancrelipase|pancrelipase|mesh-list
24607691|NCT03979352|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24607692|NCT03979352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24607693|NCT03979352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24607694|NCT03979352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24607695|NCT03979352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24607696|NCT03978091|Ceftazidime|ceftazidime|mesh-list
24607697|NCT03978091|Avibactam|avibactam|mesh-list
24607698|NCT03978091|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
24607699|NCT03978091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24607704|NCT03971409|Doxorubicin|doxorubicin|mesh-list
24607856|NCT03331484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24607857|NCT03331484|Anticoagulants|anticoagulants|mesh-ancestor
24607858|NCT03322267|Cisplatin|cisplatin|mesh-list
24607859|NCT03322267|Pembrolizumab|pembrolizumab|mesh-list
24607860|NCT03322267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24607861|NCT03322267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24607866|NCT03275818|Paclitaxel|paclitaxel|mesh-list
24608347|NCT00991978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24608348|NCT00991978|Growth Substances|growth substances|mesh-ancestor
24608349|NCT00991978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608350|NCT00991978|Growth Inhibitors|growth inhibitors|mesh-ancestor
25714737|NCT02360215|Memantine|memantine|mesh-list
25714738|NCT02360215|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25714739|NCT02360215|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25714740|NCT02360215|Dopamine Agents|dopamine agents|mesh-ancestor
25714741|NCT02360215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25714742|NCT02360215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714743|NCT02360215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714744|NCT02360215|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25714745|NCT02360215|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25714746|NCT02360319|Aripiprazole|aripiprazole|mesh-list
24608351|NCT00991978|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24608352|NCT00991978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714747|NCT02360319|Antipsychotic Agents|antipsychotic agents|mesh-list
24608353|NCT00992004|Turmeric extract|turmeric extract|mesh-list
24608354|NCT00992004|Antioxidants|antioxidants|mesh-ancestor
24608355|NCT00992004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608356|NCT00992004|Protective Agents|protective agents|mesh-ancestor
24671348|NCT01325051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24671349|NCT01325051|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24671350|NCT01325051|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24671351|NCT01325051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671352|NCT01325051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671354|NCT01325168|Oxytocics|oxytocics|mesh-ancestor
24671355|NCT01325168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24671356|NCT01325168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671357|NCT01325194|Cytarabine|cytarabine|mesh-list
24671358|NCT01325194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24671359|NCT01325194|Antimetabolites|antimetabolites|mesh-ancestor
24671360|NCT01325194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671361|NCT01325194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24608877|NCT00994149|Vasodilator Agents|vasodilator agents|mesh-ancestor
24608878|NCT00994253|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24608879|NCT00994253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24608881|NCT00994253|Natriuretic Agents|natriuretic agents|mesh-ancestor
24608882|NCT00994253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24608883|NCT00994253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24608884|NCT00994253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24609299|NCT00995995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24608885|NCT00994253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24608886|NCT00994305|Acetylcysteine|acetylcysteine|mesh-list
24608887|NCT00994305|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24608888|NCT00994305|Antiviral Agents|antiviral agents|mesh-ancestor
24609099|NCT00994981|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24609100|NCT00994981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24609101|NCT00994981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609102|NCT00994981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24609103|NCT00994981|Tocolytic Agents|tocolytic agents|mesh-ancestor
24609104|NCT00994981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24609105|NCT00994994|Tranylcypromine|tranylcypromine|mesh-list
24609106|NCT00994994|Tranexamic Acid|tranexamic acid|mesh-list
24609107|NCT00994994|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
24609108|NCT00994994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25714748|NCT02360319|Antidepressive Agents|antidepressive agents|mesh-ancestor
25714749|NCT02360319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25714750|NCT02360319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25714751|NCT02360319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25714752|NCT02360319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714753|NCT02360319|Dopamine Agonists|dopamine agonists|mesh-ancestor
25714754|NCT02360319|Dopamine Agents|dopamine agents|mesh-ancestor
24609110|NCT00994994|Hemostatics|hemostatics|mesh-ancestor
24637212|NCT01149304|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24637213|NCT01149304|Protective Agents|protective agents|mesh-ancestor
24637214|NCT01149304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637215|NCT01149304|Vasodilator Agents|vasodilator agents|mesh-ancestor
24671370|NCT01325220|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24671371|NCT01325220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24671372|NCT01325220|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24671373|NCT01325220|GABA Agonists|gaba agonists|mesh-ancestor
24671374|NCT01325220|GABA Agents|gaba agents|mesh-ancestor
24671375|NCT01325220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24609122|NCT00995033|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24609123|NCT00995033|Cholinergic Agents|cholinergic agents|mesh-ancestor
24609124|NCT00995033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24609125|NCT00995033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609126|NCT00995033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609127|NCT00995046|Factor VIII|factor viii|mesh-list
24609128|NCT00995046|Coagulants|coagulants|mesh-ancestor
24609129|NCT00995059|Sirolimus|sirolimus|mesh-list
24609131|NCT00995059|Melphalan|melphalan|mesh-list
24609132|NCT00995059|Tacrolimus|tacrolimus|mesh-list
24609133|NCT00995059|Thymoglobulin|thymoglobulin|mesh-list
24609134|NCT00995059|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24609135|NCT00995059|Immunoglobulins|immunoglobulins|mesh-list
24609136|NCT00995059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24609137|NCT00995059|Immunologic Factors|immunologic factors|mesh-ancestor
24609145|NCT00995059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24609146|NCT00995059|Antifungal Agents|antifungal agents|mesh-ancestor
24609147|NCT00995059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24609148|NCT00995059|Alkylating Agents|alkylating agents|mesh-ancestor
24609149|NCT00995059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24609182|NCT00995306|Dermatologic Agents|dermatologic agents|mesh-ancestor
24609183|NCT00995306|Sensory System Agents|sensory system agents|mesh-ancestor
24609186|NCT00995332|Cytarabine|cytarabine|mesh-list
24609187|NCT00995332|Tretinoin|tretinoin|mesh-list
24609188|NCT00995332|Valproic Acid|valproic acid|mesh-list
24609189|NCT00995332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24609190|NCT00995332|Antimetabolites|antimetabolites|mesh-ancestor
24609191|NCT00995332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609192|NCT00995332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609193|NCT00995332|Antiviral Agents|antiviral agents|mesh-ancestor
24609194|NCT00995332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24609233|NCT00995618|Sensory System Agents|sensory system agents|mesh-ancestor
24609234|NCT00995618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24609235|NCT00995618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609236|NCT00995618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24609237|NCT00995618|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24609238|NCT00995618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24609239|NCT00995618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609240|NCT00995618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24609241|NCT00995618|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24609242|NCT00995618|Histamine Antagonists|histamine antagonists|mesh-ancestor
24609297|NCT00995917|Coagulants|coagulants|mesh-ancestor
24609298|NCT00995995|Rosiglitazone|rosiglitazone|mesh-list
24609324|NCT00996060|Valproic Acid|valproic acid|mesh-list
24609325|NCT00996060|Anticonvulsants|anticonvulsants|mesh-ancestor
24609326|NCT00996060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609327|NCT00996060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609328|NCT00996060|GABA Agents|gaba agents|mesh-ancestor
24609341|NCT00996151|Testosterone|testosterone|mesh-list
24609342|NCT00996151|Androgens|androgens|mesh-ancestor
24609343|NCT00996151|Hormones|hormones|mesh-ancestor
24609346|NCT00996177|Fentanyl|fentanyl|mesh-list
24609405|NCT00996463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24609406|NCT00996463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24609407|NCT00996463|Schistosomicides|schistosomicides|mesh-ancestor
24609408|NCT00996463|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24609409|NCT00996463|Anthelmintics|anthelmintics|mesh-ancestor
24609410|NCT00996515|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24609473|NCT00996879|Midazolam|midazolam|mesh-list
24609474|NCT00996879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24609475|NCT00996879|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24609476|NCT00996879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24609477|NCT00996879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609478|NCT00996879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24609479|NCT00996879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24609480|NCT00996879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24609561|NCT00997347|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24609562|NCT00997347|Abortifacient Agents|abortifacient agents|mesh-ancestor
24609563|NCT00997347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24609564|NCT00997347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609565|NCT00997347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24609566|NCT00997347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24609611|NCT00997477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609613|NCT00997542|Antimetabolites|antimetabolites|mesh-ancestor
24609614|NCT00997542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609615|NCT00997542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609616|NCT00997542|Gout Suppressants|gout suppressants|mesh-ancestor
24609617|NCT00997542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24609618|NCT00997542|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24609619|NCT00997542|Antioxidants|antioxidants|mesh-ancestor
24609620|NCT00997542|Protective Agents|protective agents|mesh-ancestor
24609621|NCT00997542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609622|NCT00997581|Apremilast|apremilast|mesh-list
24609623|NCT00997581|Indomethacin|indomethacin|mesh-list
24609624|NCT00997581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24609662|NCT00997711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609664|NCT00997711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24609665|NCT00997711|Immunologic Factors|immunologic factors|mesh-ancestor
24609666|NCT00997711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609667|NCT00997750|Lornoxicam|lornoxicam|mesh-list
24609668|NCT00997750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25714755|NCT02360319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24671377|NCT01325259|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24671380|NCT01325298|Riboflavin|riboflavin|mesh-list
24609722|NCT00997919|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24609723|NCT00997919|Immunologic Factors|immunologic factors|mesh-ancestor
24609724|NCT00997919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609726|NCT00997958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24609727|NCT00997958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609732|NCT00997958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609781|NCT00998075|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24609799|NCT00998166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24609800|NCT00998166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609848|NCT00998556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609849|NCT00998556|Dopamine Agonists|dopamine agonists|mesh-ancestor
24609850|NCT00998556|Dopamine Agents|dopamine agents|mesh-ancestor
24609851|NCT00998556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24609852|NCT00998556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609854|NCT00998608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24609855|NCT00998608|Serotonin Agents|serotonin agents|mesh-ancestor
24609856|NCT00998608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24609857|NCT00998608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24609858|NCT00998608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609859|NCT00998608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24609860|NCT00998608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24609861|NCT00998608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24609862|NCT00998608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24609863|NCT00998608|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24609864|NCT00998608|Dopamine Agents|dopamine agents|mesh-ancestor
24609865|NCT00998634|Lithium Carbonate|lithium carbonate|mesh-list
24609966|NCT00999258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24609967|NCT00999258|Antifungal Agents|antifungal agents|mesh-ancestor
24609968|NCT00999258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24609969|NCT00999258|Immunologic Factors|immunologic factors|mesh-ancestor
24609970|NCT00999258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609971|NCT00999271|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
24609974|NCT00999271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24609975|NCT00999271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24609976|NCT00999271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24609978|NCT00999297|Antipruritics|antipruritics|mesh-ancestor
24609979|NCT00999297|Dermatologic Agents|dermatologic agents|mesh-ancestor
24609980|NCT00999297|Sensory System Agents|sensory system agents|mesh-ancestor
25714756|NCT02360319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714757|NCT02360319|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25714758|NCT02360319|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25714759|NCT02360319|Serotonin Agents|serotonin agents|mesh-ancestor
25714760|NCT02360319|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25714761|NCT02360319|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25714762|NCT02360319|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25714763|NCT02360319|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25714764|NCT02360397|Ranolazine|ranolazine|mesh-list
25714765|NCT02360397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24671418|NCT01325610|Cholecalciferol|cholecalciferol|mesh-list
24671419|NCT01325610|Vitamin D|vitamin d|mesh-list
24671420|NCT01325610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24671421|NCT01325610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671422|NCT01325610|Vitamins|vitamins|mesh-ancestor
24671423|NCT01325610|Micronutrients|micronutrients|mesh-ancestor
24671424|NCT01325610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24671425|NCT01325779|Heparin|heparin|mesh-list
24671426|NCT01325779|Enoxaparin|enoxaparin|mesh-list
24671427|NCT01325779|Anticoagulants|anticoagulants|mesh-ancestor
24610135|NCT00999973|Mitomycins|mitomycins|mesh-list
24610174|NCT01000441|Etanercept|etanercept|mesh-list
24610175|NCT01000441|Rituximab|rituximab|mesh-list
24610176|NCT01000441|Abatacept|abatacept|mesh-list
24610177|NCT01000441|Infliximab|infliximab|mesh-list
24610178|NCT01000441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24610179|NCT01000441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610180|NCT01000441|Immunologic Factors|immunologic factors|mesh-ancestor
24610181|NCT01000441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610207|NCT01000597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24610208|NCT01000597|Autonomic Agents|autonomic agents|mesh-ancestor
24610209|NCT01000597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24610210|NCT01000597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610211|NCT01000597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24610312|NCT01001247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24610313|NCT01001247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24610314|NCT01001247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24671454|NCT01325935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671457|NCT01325987|Cholecalciferol|cholecalciferol|mesh-list
24671458|NCT01325987|Vitamins|vitamins|mesh-list
24671459|NCT01325987|Micronutrients|micronutrients|mesh-ancestor
24671643|NCT01326871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24671644|NCT01326871|Antimetabolites|antimetabolites|mesh-ancestor
24671645|NCT01326871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671646|NCT01326871|Antiviral Agents|antiviral agents|mesh-ancestor
24671647|NCT01326871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24671648|NCT01326871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671649|NCT01326871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24671650|NCT01326871|Immunologic Factors|immunologic factors|mesh-ancestor
24503253|NCT02384850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24671651|NCT01326871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671664|NCT01327066|Droxidopa|droxidopa|mesh-list
24671749|NCT01327469|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
24671750|NCT01327469|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
24671751|NCT01327469|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24671752|NCT01327469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24671753|NCT01327469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671754|NCT01327521|Gemcitabine|gemcitabine|mesh-list
24671755|NCT01327521|Cisplatin|cisplatin|mesh-list
24671756|NCT01327521|Doxorubicin|doxorubicin|mesh-list
24671757|NCT01327521|Fluorouracil|fluorouracil|mesh-list
24671791|NCT01327729|Interferon-alpha|interferon-alpha|mesh-list
24671792|NCT01327729|Interferon alpha-2|interferon alpha-2|mesh-list
24671793|NCT01327729|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24671794|NCT01327729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24671795|NCT01327729|Antiviral Agents|antiviral agents|mesh-ancestor
24671796|NCT01327729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24671797|NCT01327729|Immunologic Factors|immunologic factors|mesh-ancestor
24671798|NCT01327729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671800|NCT01327755|Antioxidants|antioxidants|mesh-ancestor
24610373|NCT01001637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610374|NCT01001676|Paclitaxel|paclitaxel|mesh-list
24610375|NCT01001676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24610376|NCT01001676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610377|NCT01001676|Tubulin Modulators|tubulin modulators|mesh-ancestor
24610378|NCT01001676|Antimitotic Agents|antimitotic agents|mesh-ancestor
24610379|NCT01001676|Mitosis Modulators|mitosis modulators|mesh-ancestor
24610380|NCT01001676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610381|NCT01001754|Ribavirin|ribavirin|mesh-list
24610382|NCT01001754|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24610383|NCT01001754|Antimetabolites|antimetabolites|mesh-ancestor
24540012|NCT00666302|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24610384|NCT01001754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610385|NCT01001754|Antiviral Agents|antiviral agents|mesh-ancestor
24610386|NCT01001754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24610387|NCT01001780|Cyclophosphamide|cyclophosphamide|mesh-list
24610388|NCT01001780|Rituximab|rituximab|mesh-list
24671813|NCT01327859|Nootropic Agents|nootropic agents|mesh-ancestor
25714766|NCT02360397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24671815|NCT01328015|Cholinergic Antagonists|cholinergic antagonists|mesh-list
24671816|NCT01328015|Parasympatholytics|parasympatholytics|mesh-ancestor
24671818|NCT01328015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24671819|NCT01328015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24671820|NCT01328015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24671821|NCT01328015|Cholinergic Agents|cholinergic agents|mesh-ancestor
24671822|NCT01328015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24671823|NCT01328015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671824|NCT01328015|Urological Agents|urological agents|mesh-ancestor
24671826|NCT01328106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24671827|NCT01328106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24671828|NCT01328106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671829|NCT01328106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24671830|NCT01328145|Aspirin|aspirin|mesh-list
24671831|NCT01328145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24671832|NCT01328145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24671833|NCT01328145|Analgesics|analgesics|mesh-ancestor
24671834|NCT01328145|Sensory System Agents|sensory system agents|mesh-ancestor
24671835|NCT01328145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24671837|NCT01328145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24671853|NCT01328171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24671854|NCT01328171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24671914|NCT01328392|Lansoprazole|lansoprazole|mesh-list
24672067|NCT01329614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24672068|NCT01329614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672069|NCT01329627|Paclitaxel|paclitaxel|mesh-list
24672070|NCT01329627|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24672071|NCT01329627|Cyclophosphamide|cyclophosphamide|mesh-list
24672072|NCT01329627|Doxorubicin|doxorubicin|mesh-list
24672073|NCT01329627|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24672074|NCT01329627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24672075|NCT01329627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672076|NCT01329627|Tubulin Modulators|tubulin modulators|mesh-ancestor
24672077|NCT01329627|Antimitotic Agents|antimitotic agents|mesh-ancestor
24672078|NCT01329627|Mitosis Modulators|mitosis modulators|mesh-ancestor
24672079|NCT01329627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672092|NCT01329640|Cyclophosphamide|cyclophosphamide|mesh-list
24672093|NCT01329640|Trastuzumab|trastuzumab|mesh-list
24672094|NCT01329640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24672095|NCT01329640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672098|NCT01329640|Mitosis Modulators|mitosis modulators|mesh-ancestor
24672099|NCT01329640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672100|NCT01329640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24672101|NCT01329640|Immunologic Factors|immunologic factors|mesh-ancestor
24672114|NCT01329666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24672142|NCT01329796|Anesthetics, Local|anesthetics, local|mesh-ancestor
24672143|NCT01329796|Anesthetics|anesthetics|mesh-ancestor
24672144|NCT01329796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24672145|NCT01329796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672146|NCT01329796|Sensory System Agents|sensory system agents|mesh-ancestor
24672148|NCT01329796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25714767|NCT02360397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714768|NCT02360475|Vaccines|vaccines|mesh-list
25714769|NCT02360475|Immunologic Factors|immunologic factors|mesh-ancestor
25714770|NCT02360475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714771|NCT02360631|Varenicline|varenicline|mesh-list
25714772|NCT02360631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24672152|NCT01329796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672153|NCT01329809|Molgramostim|molgramostim|mesh-list
24672154|NCT01329809|Sargramostim|sargramostim|mesh-list
24672156|NCT01329809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672157|NCT01329809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672158|NCT01329887|Ketanserin|ketanserin|mesh-list
24672159|NCT01329887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24672160|NCT01329887|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24672161|NCT01329887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24672171|NCT01330472|Alprazolam|alprazolam|mesh-list
24672192|NCT01330524|Glucocorticoids|glucocorticoids|mesh-ancestor
24672193|NCT01330524|Hormones|hormones|mesh-ancestor
24672194|NCT01330524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24672195|NCT01330563|Ketoconazole|ketoconazole|mesh-list
24672196|NCT01330563|Antifungal Agents|antifungal agents|mesh-ancestor
24672200|NCT01330563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637502|NCT01150786|Protective Agents|protective agents|mesh-ancestor
24637503|NCT01150786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610449|NCT01002092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610451|NCT01002157|Vitamin K 2|vitamin k 2|mesh-list
24672279|NCT01331382|Resveratrol|resveratrol|mesh-list
24672280|NCT01331382|Antioxidants|antioxidants|mesh-ancestor
24672281|NCT01331382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672282|NCT01331382|Protective Agents|protective agents|mesh-ancestor
24672283|NCT01331382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672284|NCT01331382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672285|NCT01331382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24672287|NCT01331421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672288|NCT01331421|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24672289|NCT01331421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24672290|NCT01331421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672291|NCT01331421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672292|NCT01331421|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24672293|NCT01331421|Hormone Antagonists|hormone antagonists|mesh-ancestor
24672294|NCT01331421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24672295|NCT01331421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672296|NCT01331434|Exemestane|exemestane|mesh-list
24672297|NCT01331434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672298|NCT01331434|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24672299|NCT01331434|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24672441|NCT01332097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24456526|NCT00331513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24456527|NCT00331513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24456529|NCT00331526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24456530|NCT00331526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24456531|NCT00331526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24456532|NCT00331526|Antiviral Agents|antiviral agents|mesh-ancestor
24456533|NCT00331526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24672479|NCT01332370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24672480|NCT01332370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672481|NCT01332370|Incretins|incretins|mesh-ancestor
24672482|NCT01332370|Hormones|hormones|mesh-ancestor
24672946|NCT01334502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24672484|NCT01332370|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24672485|NCT01332370|Protease Inhibitors|protease inhibitors|mesh-ancestor
24672486|NCT01332370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672487|NCT01332370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672488|NCT01332383|Naratriptan|naratriptan|mesh-list
25714773|NCT02360631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24672489|NCT01332383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24672490|NCT01332383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24672491|NCT01332383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24672708|NCT01333150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672709|NCT01333150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24672710|NCT01333150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24672711|NCT01333150|Vasodilator Agents|vasodilator agents|mesh-ancestor
24672712|NCT01333267|Hormones|hormones|mesh-list
24672713|NCT01333267|Testosterone Congeners|testosterone congeners|mesh-list
24637553|NCT01151384|Docetaxel|docetaxel|mesh-list
24672714|NCT01333267|Parathyroid Hormone|parathyroid hormone|mesh-list
24672716|NCT01333267|Anabolic Agents|anabolic agents|mesh-list
24672750|NCT01333423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24672751|NCT01333449|Decitabine|decitabine|mesh-list
24672752|NCT01333449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24672753|NCT01333449|Antimetabolites|antimetabolites|mesh-ancestor
24672754|NCT01333449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24672755|NCT01333449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24672939|NCT01334502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24672940|NCT01334502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24672941|NCT01334502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24672942|NCT01334502|Glucocorticoids|glucocorticoids|mesh-ancestor
24672944|NCT01334502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24672945|NCT01334502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24672947|NCT01334502|Tubulin Modulators|tubulin modulators|mesh-ancestor
24672948|NCT01334502|Antimitotic Agents|antimitotic agents|mesh-ancestor
24672949|NCT01334502|Mitosis Modulators|mitosis modulators|mesh-ancestor
24672978|NCT01334632|Narcotics|narcotics|mesh-ancestor
24672979|NCT01334632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24672980|NCT01334632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24672981|NCT01334632|Analgesics|analgesics|mesh-ancestor
24673000|NCT01334684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24673001|NCT01334684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673002|NCT01334762|Letrozole|letrozole|mesh-list
24673003|NCT01334762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673004|NCT01334762|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24673005|NCT01334762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24673006|NCT01334762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673008|NCT01334762|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25714774|NCT02360631|Cholinergic Agents|cholinergic agents|mesh-ancestor
25714775|NCT02360631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25714776|NCT02360631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714777|NCT02360631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714778|NCT02360774|Canagliflozin|canagliflozin|mesh-list
25714779|NCT02360774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25777210|NCT03730961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777211|NCT03730961|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25777212|NCT03730961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25777213|NCT03730961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777214|NCT03730116|Bisoprolol|bisoprolol|mesh-list
25777215|NCT03730116|Perindopril|perindopril|mesh-list
25777216|NCT03730116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25777217|NCT03730116|Sympatholytics|sympatholytics|mesh-ancestor
25714780|NCT02360774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714781|NCT02360774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24673022|NCT01334892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673023|NCT01334892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24673024|NCT01334892|Immunologic Factors|immunologic factors|mesh-ancestor
24673025|NCT01334892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673026|NCT01334892|Antifungal Agents|antifungal agents|mesh-ancestor
24673027|NCT01334892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673028|NCT01334892|Dermatologic Agents|dermatologic agents|mesh-ancestor
24673029|NCT01334892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24673030|NCT01334892|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24673033|NCT01334905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24673100|NCT01335334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24673101|NCT01335334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24673102|NCT01335334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24673103|NCT01335334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673123|NCT01335373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24673124|NCT01335373|Antifungal Agents|antifungal agents|mesh-ancestor
24673125|NCT01335373|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24673126|NCT01335373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24673127|NCT01335373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673128|NCT01335373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673129|NCT01335373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24673130|NCT01335373|Hormone Antagonists|hormone antagonists|mesh-ancestor
24673131|NCT01335373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24673132|NCT01335373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673133|NCT01335373|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24673134|NCT01335373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24673136|NCT01335386|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
24673137|NCT01335386|Protective Agents|protective agents|mesh-ancestor
24673138|NCT01335386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673139|NCT01335516|Terlipressin|terlipressin|mesh-list
24673140|NCT01335516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24673141|NCT01335516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24673142|NCT01335529|Interferons|interferons|mesh-list
24673143|NCT01335529|Ribavirin|ribavirin|mesh-list
24673178|NCT01335763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24673208|NCT01336192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24673209|NCT01336192|Immunologic Factors|immunologic factors|mesh-ancestor
24673210|NCT01336192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673211|NCT01336218|Rifampin|rifampin|mesh-list
24673212|NCT01336218|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24673213|NCT01336218|Antitubercular Agents|antitubercular agents|mesh-ancestor
24673214|NCT01336218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24673255|NCT01336543|Cisplatin|cisplatin|mesh-list
24673256|NCT01336543|Etoposide|etoposide|mesh-list
24673257|NCT01336543|Pemetrexed|pemetrexed|mesh-list
24673258|NCT01336543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673259|NCT01336543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24673379|NCT01337440|Hormones|hormones|mesh-ancestor
25714782|NCT02360774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714783|NCT02360995|Triclosan|triclosan|mesh-list
25714784|NCT02360995|Cetylpyridinium|cetylpyridinium|mesh-list
25714785|NCT02360995|Fluorides|fluorides|mesh-list
25714786|NCT02360995|Tin Fluorides|tin fluorides|mesh-list
25714787|NCT02360995|Cariostatic Agents|cariostatic agents|mesh-ancestor
25714788|NCT02360995|Protective Agents|protective agents|mesh-ancestor
25777218|NCT03730116|Autonomic Agents|autonomic agents|mesh-ancestor
25777219|NCT03730116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25777220|NCT03730116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777221|NCT03730116|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25777222|NCT03730116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25777223|NCT03730116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25777224|NCT03730116|Adrenergic Agents|adrenergic agents|mesh-ancestor
25777225|NCT03730116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25777226|NCT03730116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777227|NCT03730116|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24673380|NCT01337440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24673381|NCT01337440|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24673382|NCT01337440|Protease Inhibitors|protease inhibitors|mesh-ancestor
24673383|NCT01337440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673412|NCT01337583|Antiviral Agents|antiviral agents|mesh-ancestor
24673413|NCT01337583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673414|NCT01337765|Dactolisib|dactolisib|mesh-list
24673415|NCT01337765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24673416|NCT01337791|Telbivudine|telbivudine|mesh-list
24673417|NCT01337791|Antiviral Agents|antiviral agents|mesh-ancestor
24673418|NCT01337791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673419|NCT01337791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24673420|NCT01337791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673421|NCT01337791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673422|NCT01337804|Omeprazole|omeprazole|mesh-list
24673423|NCT01337804|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
24673473|NCT01338311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24673474|NCT01338311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24673475|NCT01338311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24673476|NCT01338311|Adrenergic Agents|adrenergic agents|mesh-ancestor
24673477|NCT01338311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24673478|NCT01338311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673479|NCT01338324|Simvastatin|simvastatin|mesh-list
24673480|NCT01338324|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24673481|NCT01338324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24673482|NCT01338324|Antimetabolites|antimetabolites|mesh-ancestor
24673483|NCT01338324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673484|NCT01338324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24673485|NCT01338324|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24673486|NCT01338324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673487|NCT01338337|Azacitidine|azacitidine|mesh-list
24673488|NCT01338337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24673675|NCT01339624|Anesthetics|anesthetics|mesh-ancestor
24673676|NCT01339624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24673677|NCT01339624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24673678|NCT01339624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24673679|NCT01339624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24673680|NCT01339624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24673681|NCT01339624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673682|NCT01339624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673683|NCT01339663|Aldesleukin|aldesleukin|mesh-list
24673684|NCT01339663|Cyclophosphamide|cyclophosphamide|mesh-list
24673685|NCT01339663|Interleukin-2|interleukin-2|mesh-list
24673686|NCT01339663|Vaccines|vaccines|mesh-list
24673687|NCT01339663|Immunologic Factors|immunologic factors|mesh-ancestor
24673688|NCT01339663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673689|NCT01339663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24673690|NCT01339663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24673718|NCT01339754|Trabectedin|trabectedin|mesh-list
24673723|NCT01339819|Dabigatran|dabigatran|mesh-list
25714789|NCT02360995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714790|NCT02360995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24673781|NCT01340248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24673782|NCT01340248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24673783|NCT01340248|Antioxidants|antioxidants|mesh-ancestor
24673808|NCT01340456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24673809|NCT01340456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24673810|NCT01340456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24673811|NCT01340456|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24673812|NCT01340456|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24673813|NCT01340456|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24673814|NCT01340456|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24673815|NCT01340456|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24673816|NCT01340456|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24673817|NCT01340521|Clomiphene|clomiphene|mesh-list
24673818|NCT01340521|Enclomiphene|enclomiphene|mesh-list
24673819|NCT01340521|Zuclomiphene|zuclomiphene|mesh-list
24673820|NCT01340521|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24673821|NCT01340521|Hormone Antagonists|hormone antagonists|mesh-ancestor
24673822|NCT01340521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24673925|NCT01341184|Leprostatic Agents|leprostatic agents|mesh-ancestor
24673949|NCT01341262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24673950|NCT01341262|Antiemetics|antiemetics|mesh-ancestor
24673951|NCT01341262|Autonomic Agents|autonomic agents|mesh-ancestor
24673952|NCT01341262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24673953|NCT01341262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24673954|NCT01341262|Glucocorticoids|glucocorticoids|mesh-ancestor
24673955|NCT01341262|Hormones|hormones|mesh-ancestor
24673956|NCT01341262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24673957|NCT01341262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24673958|NCT01341262|Leprostatic Agents|leprostatic agents|mesh-ancestor
24673959|NCT01341262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24673960|NCT01341262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24673961|NCT01341262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24673963|NCT01341262|Growth Substances|growth substances|mesh-ancestor
24674189|NCT01342289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24674190|NCT01342289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24674191|NCT01342289|Alkylating Agents|alkylating agents|mesh-ancestor
24674192|NCT01342289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714791|NCT02360995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25714792|NCT02360995|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25714793|NCT02360995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25714794|NCT02360995|Antimetabolites|antimetabolites|mesh-ancestor
25714795|NCT02360995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714796|NCT02360995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25714797|NCT02361476|Clonidine|clonidine|mesh-list
25714798|NCT02361476|Analgesics|analgesics|mesh-ancestor
25714799|NCT02361476|Sensory System Agents|sensory system agents|mesh-ancestor
25714800|NCT02361476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25714801|NCT02361476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714802|NCT02361476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25714803|NCT02361476|Sympatholytics|sympatholytics|mesh-ancestor
25714804|NCT02361476|Autonomic Agents|autonomic agents|mesh-ancestor
25714805|NCT02361476|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25714806|NCT02361476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24674193|NCT01342289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24674195|NCT01342289|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25714807|NCT02361476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25714808|NCT02361476|Adrenergic Agents|adrenergic agents|mesh-ancestor
24674196|NCT01342289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674197|NCT01342289|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25714809|NCT02361476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25714810|NCT02361476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714811|NCT02362048|Pembrolizumab|pembrolizumab|mesh-list
25714812|NCT02362048|Acalabrutinib|acalabrutinib|mesh-list
25714813|NCT02362048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24674198|NCT01342289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24674221|NCT01342562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24674222|NCT01342562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674223|NCT01342601|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24674224|NCT01342601|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24674225|NCT01342614|Metformin|metformin|mesh-list
24674226|NCT01342614|Fosinopril|fosinopril|mesh-list
24674227|NCT01342614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24637685|NCT01152593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24674228|NCT01342614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674229|NCT01342614|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24610542|NCT01003002|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24610543|NCT01003002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24610545|NCT01003002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24610546|NCT01003002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610548|NCT01003054|Cyclophosphamide|cyclophosphamide|mesh-list
24674443|NCT05220319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24674445|NCT05220319|Autonomic Agents|autonomic agents|mesh-ancestor
24674446|NCT05220319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24674447|NCT05220319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674448|NCT05220319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24674449|NCT05220319|Glucocorticoids|glucocorticoids|mesh-ancestor
24674451|NCT05220319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24674452|NCT05220319|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24674526|NCT05124691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24674527|NCT05124691|Anthelmintics|anthelmintics|mesh-ancestor
24674544|NCT05119101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24674545|NCT05119101|Anticonvulsants|anticonvulsants|mesh-ancestor
24674546|NCT05119101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24674547|NCT05119101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24674548|NCT05119101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24674549|NCT05119101|Tocolytic Agents|tocolytic agents|mesh-ancestor
24674550|NCT05119101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24674561|NCT05109455|Proanthocyanidin|proanthocyanidin|mesh-list
24674562|NCT05109455|Procyanidin|procyanidin|mesh-list
24674563|NCT05109455|Antioxidants|antioxidants|mesh-ancestor
24674564|NCT05109455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674565|NCT05109455|Protective Agents|protective agents|mesh-ancestor
24674566|NCT05109455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674567|NCT05109455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24674568|NCT05109455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24674569|NCT05109455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24674615|NCT05027919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674616|NCT05027919|Analgesics|analgesics|mesh-ancestor
24674617|NCT05027919|Sensory System Agents|sensory system agents|mesh-ancestor
24674618|NCT05027919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24674620|NCT05027919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24674621|NCT05027919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24674622|NCT05027919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24674623|NCT05027919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24674624|NCT05027919|Adrenergic Agents|adrenergic agents|mesh-ancestor
25714814|NCT02362048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25714815|NCT02362269|Vitamin D|vitamin d|mesh-list
25714816|NCT02362269|Vitamins|vitamins|mesh-ancestor
24674625|NCT05027919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24674626|NCT05027919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674627|NCT05027919|Sympatholytics|sympatholytics|mesh-ancestor
24674628|NCT05027919|Autonomic Agents|autonomic agents|mesh-ancestor
24674629|NCT05027048|Calcium|calcium|mesh-list
24674630|NCT05027048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24674632|NCT04999228|Mesalamine|mesalamine|mesh-list
24610613|NCT01003847|Antimetabolites|antimetabolites|mesh-ancestor
24610632|NCT01004224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24674644|NCT04983407|Gemcitabine|gemcitabine|mesh-list
24674645|NCT04983407|Paclitaxel|paclitaxel|mesh-list
24674646|NCT04983407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24674647|NCT04983407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24674709|NCT04757571|Serotonin Agents|serotonin agents|mesh-ancestor
24674710|NCT04757571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674711|NCT04757571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24674733|NCT04721132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24610633|NCT01004237|Valsartan|valsartan|mesh-list
24610634|NCT01004237|Pravastatin|pravastatin|mesh-list
24610635|NCT01004237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24610636|NCT01004237|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24610637|NCT01004237|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24610638|NCT01004237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610639|NCT01004237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24610640|NCT01004237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24610641|NCT01004237|Antimetabolites|antimetabolites|mesh-ancestor
24610647|NCT01004315|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24610648|NCT01004315|Cholinergic Agents|cholinergic agents|mesh-ancestor
24674795|NCT04409964|Anesthetics|anesthetics|mesh-ancestor
24674890|NCT04091022|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24674891|NCT04091022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24674892|NCT04091022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24674893|NCT04091022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24674894|NCT04091022|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
25714817|NCT02362269|Micronutrients|micronutrients|mesh-ancestor
25714818|NCT02362269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714819|NCT02362269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25714820|NCT02362321|Dexamethasone|dexamethasone|mesh-list
25714821|NCT02362321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25714822|NCT02362321|Antiemetics|antiemetics|mesh-ancestor
25714823|NCT02362321|Autonomic Agents|autonomic agents|mesh-ancestor
25714824|NCT02362321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25714825|NCT02362321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714826|NCT02362321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25714827|NCT02362321|Glucocorticoids|glucocorticoids|mesh-ancestor
24674895|NCT03951649|Acetaminophen|acetaminophen|mesh-list
24674896|NCT03951649|Caffeine|caffeine|mesh-list
24674897|NCT03951649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24674898|NCT03951649|Analgesics|analgesics|mesh-ancestor
24674899|NCT03951649|Sensory System Agents|sensory system agents|mesh-ancestor
24674900|NCT03951649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24674901|NCT03951649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24674902|NCT03951649|Antipyretics|antipyretics|mesh-ancestor
24674903|NCT03951649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24674904|NCT03951649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24674905|NCT03951649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674906|NCT03951649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24674907|NCT03951649|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24674908|NCT03951649|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24674909|NCT03951649|Purinergic Agents|purinergic agents|mesh-ancestor
24674938|NCT03809013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24674939|NCT03795428|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
24674940|NCT03795428|Vasodilator Agents|vasodilator agents|mesh-ancestor
24674941|NCT03785249|Pembrolizumab|pembrolizumab|mesh-list
24674942|NCT03785249|Cetuximab|cetuximab|mesh-list
24674944|NCT03785249|Adagrasib|adagrasib|mesh-list
24674947|NCT03785249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24674948|NCT03785249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24674949|NCT03785249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675001|NCT03635749|Analgesics|analgesics|mesh-ancestor
24675002|NCT03635749|Sensory System Agents|sensory system agents|mesh-ancestor
24675003|NCT03635749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24675004|NCT03635749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675005|NCT03635749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24675006|NCT03635749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24675007|NCT03635749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24675008|NCT03635749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24675009|NCT03635749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675010|NCT03635749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24675063|NCT03363035|Enoxaparin|enoxaparin|mesh-list
24675064|NCT03363035|Rivaroxaban|rivaroxaban|mesh-list
24675065|NCT03363035|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24675066|NCT03363035|Antithrombins|antithrombins|mesh-ancestor
24675067|NCT03363035|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24675068|NCT03363035|Protease Inhibitors|protease inhibitors|mesh-ancestor
24675069|NCT03363035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675071|NCT03363035|Anticoagulants|anticoagulants|mesh-ancestor
24675102|NCT03143816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675103|NCT03133988|Margetuximab|margetuximab|mesh-list
24675104|NCT03133988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24675105|NCT03122847|Methylprednisolone|methylprednisolone|mesh-list
24675106|NCT03122847|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24675162|NCT02903823|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24675163|NCT02903823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675164|NCT02903823|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24675165|NCT02903823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25714828|NCT02362321|Hormones|hormones|mesh-ancestor
25714829|NCT02362321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25714830|NCT02362321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24675166|NCT02903823|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24675167|NCT02903823|GABA Agonists|gaba agonists|mesh-ancestor
25714831|NCT02362321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25714832|NCT02362373|Levonorgestrel|levonorgestrel|mesh-list
24675168|NCT02903823|GABA Agents|gaba agents|mesh-ancestor
24675169|NCT02903823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24675170|NCT02903823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675171|NCT02869009|Aspirin|aspirin|mesh-list
24675172|NCT02869009|Clopidogrel|clopidogrel|mesh-list
24675173|NCT02869009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24675174|NCT02869009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24675175|NCT02869009|Analgesics|analgesics|mesh-ancestor
24675176|NCT02869009|Sensory System Agents|sensory system agents|mesh-ancestor
24675177|NCT02869009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24675178|NCT02869009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675179|NCT02869009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24675180|NCT02869009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24675181|NCT02869009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24675182|NCT02869009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24675184|NCT02869009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24675357|NCT00496834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675360|NCT00496834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675361|NCT00496834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24675369|NCT00496834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24675370|NCT00496834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24675406|NCT00394355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24675407|NCT00394355|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24675408|NCT00394355|Hormone Antagonists|hormone antagonists|mesh-ancestor
24675409|NCT00394355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24675410|NCT00394355|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24675413|NCT00359216|Mometasone Furoate|mometasone furoate|mesh-list
24675457|NCT01343225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24675458|NCT01343225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24675459|NCT01343225|Antiviral Agents|antiviral agents|mesh-ancestor
24675460|NCT01343225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24675461|NCT01343225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24675462|NCT01343225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24675503|NCT01343498|Dactolisib|dactolisib|mesh-list
24675504|NCT01343498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24675505|NCT01343628|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24675506|NCT01343628|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24675507|NCT01343628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24675508|NCT01343628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24675558|NCT01344083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24675560|NCT01344083|Analgesics|analgesics|mesh-ancestor
24675561|NCT01344083|Sensory System Agents|sensory system agents|mesh-ancestor
24675562|NCT01344083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24675563|NCT01344083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637789|NCT01153191|Gentamicins|gentamicins|mesh-list
24675564|NCT01344083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24675565|NCT01344083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24675566|NCT01344083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24675567|NCT01344083|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24675568|NCT01344083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24675569|NCT01344083|Histamine Antagonists|histamine antagonists|mesh-ancestor
24675570|NCT01344083|Histamine Agents|histamine agents|mesh-ancestor
25714833|NCT02362373|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25714834|NCT02362373|Contraceptive Agents|contraceptive agents|mesh-ancestor
25714835|NCT02362373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25714836|NCT02362373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714837|NCT02362373|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25714838|NCT02362373|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25714839|NCT02362373|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25714840|NCT02362412|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25714841|NCT02362412|Antidepressive Agents|antidepressive agents|mesh-ancestor
24675571|NCT01344083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24675572|NCT01344083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675573|NCT01344174|Lamivudine|lamivudine|mesh-list
24675574|NCT01344174|Dexamethasone|dexamethasone|mesh-list
24675575|NCT01344174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24675576|NCT01344174|Antiemetics|antiemetics|mesh-ancestor
24675608|NCT01344213|Pregabalin|pregabalin|mesh-list
24675609|NCT01344213|Analgesics|analgesics|mesh-ancestor
24675610|NCT01344213|Sensory System Agents|sensory system agents|mesh-ancestor
24675611|NCT01344213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24675680|NCT01344473|Caseins|caseins|mesh-list
24610721|NCT01004601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610722|NCT01004601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24610723|NCT01004601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24610724|NCT01004601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24610725|NCT01004692|Salicylic Acid|salicylic acid|mesh-list
24610726|NCT01004692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24610727|NCT01004692|Antifungal Agents|antifungal agents|mesh-ancestor
24610728|NCT01004692|Keratolytic Agents|keratolytic agents|mesh-ancestor
24610729|NCT01004692|Dermatologic Agents|dermatologic agents|mesh-ancestor
24610730|NCT01004731|Gemcitabine|gemcitabine|mesh-list
24610731|NCT01004731|Carboplatin|carboplatin|mesh-list
24610732|NCT01004731|Cetuximab|cetuximab|mesh-list
24610733|NCT01004731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24610750|NCT01004809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24610751|NCT01004809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610752|NCT01004900|Timolol|timolol|mesh-list
24610753|NCT01004900|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24610754|NCT01004900|Travoprost|travoprost|mesh-list
24610755|NCT01004900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24610756|NCT01004900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24610757|NCT01004900|Adrenergic Agents|adrenergic agents|mesh-ancestor
24610758|NCT01004900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24610759|NCT01004900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675703|NCT01344564|Leuprolide|leuprolide|mesh-list
24675733|NCT01344681|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24675734|NCT01344681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675735|NCT01344681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675736|NCT01344681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24675737|NCT01344681|Hormone Antagonists|hormone antagonists|mesh-ancestor
24675748|NCT01344720|Sensory System Agents|sensory system agents|mesh-ancestor
24675786|NCT01345279|Antimitotic Agents|antimitotic agents|mesh-ancestor
24675787|NCT01345279|Mitosis Modulators|mitosis modulators|mesh-ancestor
24675788|NCT01345279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675789|NCT01345279|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24675790|NCT01345279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24675791|NCT01345279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675792|NCT01345357|Gemcitabine|gemcitabine|mesh-list
24675793|NCT01345357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24675794|NCT01345357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24675795|NCT01345357|Antimetabolites|antimetabolites|mesh-ancestor
24675796|NCT01345357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675797|NCT01345357|Antiviral Agents|antiviral agents|mesh-ancestor
24675826|NCT01345643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24675827|NCT01345643|Analgesics|analgesics|mesh-ancestor
24675828|NCT01345643|Sensory System Agents|sensory system agents|mesh-ancestor
24675829|NCT01345643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24675830|NCT01345643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675831|NCT01345643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24675832|NCT01345643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24675834|NCT01345708|Rituximab|rituximab|mesh-list
24675835|NCT01345708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24675840|NCT01345708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24675841|NCT01345708|Glucocorticoids|glucocorticoids|mesh-ancestor
24675849|NCT01345734|Hormones|hormones|mesh-ancestor
24675873|NCT01345864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24675874|NCT01345864|Mydriatics|mydriatics|mesh-ancestor
24675890|NCT01346007|Vaccines|vaccines|mesh-list
24675891|NCT01346007|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24675925|NCT01346670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675926|NCT01346670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24675927|NCT01346670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24540331|NCT00667433|Antiviral Agents|antiviral agents|mesh-ancestor
24675931|NCT01346800|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24675932|NCT01346800|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24675934|NCT01346800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24675935|NCT01346800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675936|NCT01346800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24675937|NCT01346800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24675938|NCT01346800|Antiviral Agents|antiviral agents|mesh-ancestor
24675939|NCT01346800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24675943|NCT01346826|Infliximab|infliximab|mesh-list
24675981|NCT01347268|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24675983|NCT01347268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24675984|NCT01347268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24675986|NCT01347294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24675987|NCT01347294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24675988|NCT01347424|Paclitaxel|paclitaxel|mesh-list
24675989|NCT01347424|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24675990|NCT01347424|Carboplatin|carboplatin|mesh-list
24675991|NCT01347424|Endostatins|endostatins|mesh-list
24675992|NCT01347424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24675993|NCT01347424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24675994|NCT01347424|Tubulin Modulators|tubulin modulators|mesh-ancestor
24675995|NCT01347424|Antimitotic Agents|antimitotic agents|mesh-ancestor
24675996|NCT01347424|Mitosis Modulators|mitosis modulators|mesh-ancestor
24675997|NCT01347424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24675998|NCT01347424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24675999|NCT01347424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24676000|NCT01347424|Growth Substances|growth substances|mesh-ancestor
24676001|NCT01347424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676034|NCT01347944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676035|NCT01347944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24676036|NCT01347944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24676037|NCT01347944|Growth Substances|growth substances|mesh-ancestor
24676038|NCT01347944|Growth Inhibitors|growth inhibitors|mesh-ancestor
24676039|NCT01347944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25714842|NCT02362412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25714843|NCT02362412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25714844|NCT02362412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25714845|NCT02362412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25714846|NCT02362412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714847|NCT02362425|Acetylcysteine|acetylcysteine|mesh-list
24676040|NCT01347957|Nitric Oxide|nitric oxide|mesh-list
25714848|NCT02362425|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25714849|NCT02362425|Antiviral Agents|antiviral agents|mesh-ancestor
25714850|NCT02362425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24610766|NCT01005095|Vitamin D|vitamin d|mesh-list
24676182|NCT01348984|Analgesics|analgesics|mesh-ancestor
24676183|NCT01348984|Sensory System Agents|sensory system agents|mesh-ancestor
24676184|NCT01348984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24676185|NCT01348984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24676236|NCT01349205|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24676237|NCT01349205|Protective Agents|protective agents|mesh-ancestor
24676238|NCT01349205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24676240|NCT01349205|Sensory System Agents|sensory system agents|mesh-ancestor
24676285|NCT01349348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676286|NCT01349387|Metformin|metformin|mesh-list
24676287|NCT01349387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24676435|NCT01350063|Antiviral Agents|antiviral agents|mesh-ancestor
24676436|NCT01350063|Disinfectants|disinfectants|mesh-ancestor
24676437|NCT01350089|Ethanol|ethanol|mesh-list
24676438|NCT01350089|Caffeine|caffeine|mesh-list
24676439|NCT01350089|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24676440|NCT01350089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24676441|NCT01350089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24676442|NCT01350089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676443|NCT01350089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24676444|NCT01350089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24676445|NCT01350089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676446|NCT01350089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676447|NCT01350089|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24676448|NCT01350089|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24676449|NCT01350089|Purinergic Agents|purinergic agents|mesh-ancestor
24676450|NCT01350089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24676451|NCT01350154|Sildenafil Citrate|sildenafil citrate|mesh-list
24676452|NCT01350154|Vasodilator Agents|vasodilator agents|mesh-ancestor
24676453|NCT01350154|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24676454|NCT01350154|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24676455|NCT01350154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676456|NCT01350154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676473|NCT01350596|Sensory System Agents|sensory system agents|mesh-ancestor
24610807|NCT01005238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24610808|NCT01005238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24610809|NCT01005238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24610810|NCT01005303|Vitamin D|vitamin d|mesh-list
24610811|NCT01005303|Cholecalciferol|cholecalciferol|mesh-list
24610812|NCT01005303|Vitamins|vitamins|mesh-ancestor
24610813|NCT01005303|Micronutrients|micronutrients|mesh-ancestor
24610814|NCT01005303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24610815|NCT01005303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24610820|NCT01005381|Calcium|calcium|mesh-list
24610821|NCT01005381|Vitamins|vitamins|mesh-ancestor
24610822|NCT01005381|Micronutrients|micronutrients|mesh-ancestor
24677678|NCT01357798|Cholinergic Agents|cholinergic agents|mesh-ancestor
24610823|NCT01005381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676521|NCT01350817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24676522|NCT01350817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676524|NCT01350856|Antimalarials|antimalarials|mesh-ancestor
24676525|NCT01350856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24676526|NCT01350856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24676527|NCT01350856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24676528|NCT01350856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24676529|NCT01350856|Antiviral Agents|antiviral agents|mesh-ancestor
25777228|NCT03730116|Protease Inhibitors|protease inhibitors|mesh-ancestor
25777229|NCT03730116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676530|NCT01350856|Schistosomicides|schistosomicides|mesh-ancestor
24676531|NCT01350856|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24676532|NCT01350856|Anthelmintics|anthelmintics|mesh-ancestor
24676639|NCT01351519|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24676640|NCT01351519|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24676641|NCT01351519|Dermatologic Agents|dermatologic agents|mesh-ancestor
24676643|NCT01351597|Oxaliplatin|oxaliplatin|mesh-list
24676644|NCT01351597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24676645|NCT01351597|Tubulin Modulators|tubulin modulators|mesh-ancestor
24676646|NCT01351597|Antimitotic Agents|antimitotic agents|mesh-ancestor
24676647|NCT01351597|Mitosis Modulators|mitosis modulators|mesh-ancestor
24676649|NCT01351636|Arotinolol|arotinolol|mesh-list
24676698|NCT01352130|Serotonin Agents|serotonin agents|mesh-ancestor
24676699|NCT01352130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24676700|NCT01352130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676701|NCT01352130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24676702|NCT01352130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24676703|NCT01352130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24676704|NCT01352130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24676705|NCT01352130|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24676706|NCT01352143|Thrombin|thrombin|mesh-list
24676707|NCT01352143|Hemostatics|hemostatics|mesh-ancestor
24676708|NCT01352143|Coagulants|coagulants|mesh-ancestor
24676709|NCT01352234|Aspirin|aspirin|mesh-list
24676710|NCT01352234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24676711|NCT01352234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24676712|NCT01352234|Analgesics|analgesics|mesh-ancestor
24676713|NCT01352234|Sensory System Agents|sensory system agents|mesh-ancestor
24676714|NCT01352234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24676715|NCT01352234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676716|NCT01352234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24676717|NCT01352234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24676718|NCT01352234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24676737|NCT01352338|Prednisone|prednisone|mesh-list
24676863|NCT01352611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24676864|NCT01352650|Plerixafor|plerixafor|mesh-list
24676891|NCT01352728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24610862|NCT01005537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24610863|NCT01005537|Alkylating Agents|alkylating agents|mesh-ancestor
24461243|NCT00351585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24676892|NCT01352988|Dimethyl Fumarate|dimethyl fumarate|mesh-list
24676893|NCT01352988|Dermatologic Agents|dermatologic agents|mesh-ancestor
24676896|NCT01352988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24676897|NCT01353170|Dialysis Solutions|dialysis solutions|mesh-list
24676898|NCT01353170|Calcium|calcium|mesh-list
24677079|NCT01354301|Tacrolimus|tacrolimus|mesh-list
24677080|NCT01354301|Thymoglobulin|thymoglobulin|mesh-list
24677081|NCT01354301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25714851|NCT02362425|Expectorants|expectorants|mesh-ancestor
25714852|NCT02362425|Respiratory System Agents|respiratory system agents|mesh-ancestor
24677082|NCT01354301|Immunologic Factors|immunologic factors|mesh-ancestor
25714853|NCT02362425|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25714854|NCT02362425|Antioxidants|antioxidants|mesh-ancestor
25777810|NCT03120676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25777231|NCT03726996|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24677083|NCT01354301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677119|NCT01354470|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24677120|NCT01354470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24677121|NCT01354470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24677122|NCT01354470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677123|NCT01354483|Methylprednisolone|methylprednisolone|mesh-list
24677124|NCT01354483|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24677125|NCT01354483|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24677126|NCT01354483|Prednisolone|prednisolone|mesh-list
24677184|NCT01354613|Autonomic Agents|autonomic agents|mesh-ancestor
24677192|NCT01354665|Interferons|interferons|mesh-list
24677446|NCT01356368|Mitosis Modulators|mitosis modulators|mesh-ancestor
24677447|NCT01356368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677448|NCT01356381|Vildagliptin|vildagliptin|mesh-list
24677449|NCT01356381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24677450|NCT01356381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677451|NCT01356381|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24677452|NCT01356381|Protease Inhibitors|protease inhibitors|mesh-ancestor
24461833|NCT00354081|Vitamins|vitamins|mesh-list
24677453|NCT01356381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24677454|NCT01356381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677455|NCT01356433|Vitamins|vitamins|mesh-list
24677456|NCT01356433|Ascorbic Acid|ascorbic acid|mesh-list
24677457|NCT01356433|Micronutrients|micronutrients|mesh-ancestor
24677459|NCT01356433|Antioxidants|antioxidants|mesh-ancestor
24677502|NCT01356680|Cyclophosphamide|cyclophosphamide|mesh-list
24677503|NCT01356680|Dacarbazine|dacarbazine|mesh-list
24677632|NCT01357252|Protease Inhibitors|protease inhibitors|mesh-ancestor
24677633|NCT01357252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24677656|NCT01357603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24677657|NCT01357603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677658|NCT01357681|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24677659|NCT01357681|Antioxidants|antioxidants|mesh-ancestor
24677661|NCT01357681|Protective Agents|protective agents|mesh-ancestor
24677662|NCT01357681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677663|NCT01357681|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24677664|NCT01357681|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24677665|NCT01357681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24677666|NCT01357681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24677667|NCT01357694|Psychotropic Drugs|psychotropic drugs|mesh-list
24677668|NCT01357759|Gimsilumab|gimsilumab|mesh-list
24677669|NCT01357759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24677670|NCT01357759|Antiviral Agents|antiviral agents|mesh-ancestor
24677671|NCT01357759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24677672|NCT01357798|Botulinum Toxins|botulinum toxins|mesh-list
24677673|NCT01357798|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24677674|NCT01357798|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24677675|NCT01357798|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25714855|NCT02362425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714856|NCT02362425|Protective Agents|protective agents|mesh-ancestor
24677676|NCT01357798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24677677|NCT01357798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24677703|NCT01357902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25714857|NCT02362425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714858|NCT02362425|Antidotes|antidotes|mesh-ancestor
25714859|NCT02363270|Ketamine|ketamine|mesh-list
25714860|NCT02363270|Analgesics|analgesics|mesh-ancestor
25714861|NCT02363270|Sensory System Agents|sensory system agents|mesh-ancestor
25777232|NCT03726996|Antidepressive Agents|antidepressive agents|mesh-ancestor
25777233|NCT03726996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25777234|NCT03726996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777235|NCT03726996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777236|NCT03726996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24677707|NCT01357967|Antidepressive Agents|antidepressive agents|mesh-ancestor
24677708|NCT01357967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24677709|NCT01357967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24677759|NCT01358253|Vincristine|vincristine|mesh-list
24677760|NCT01358253|Asparaginase|asparaginase|mesh-list
24677761|NCT01358253|Mercaptopurine|mercaptopurine|mesh-list
24677762|NCT01358253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24677763|NCT01358253|Immunologic Factors|immunologic factors|mesh-ancestor
24677764|NCT01358253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24677765|NCT01358253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24677766|NCT01358253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24677767|NCT01358253|Alkylating Agents|alkylating agents|mesh-ancestor
24677768|NCT01358253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678133|NCT01359930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24678134|NCT01359930|Antidepressive Agents|antidepressive agents|mesh-ancestor
24678135|NCT01359930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24678136|NCT01359930|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24678137|NCT01359930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24678169|NCT01360060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678171|NCT01360060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24678172|NCT01360060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24678174|NCT01360060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24678175|NCT01360060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24678176|NCT01360060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678177|NCT01360060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24678178|NCT01360060|Tocolytic Agents|tocolytic agents|mesh-ancestor
24678231|NCT01360424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24678232|NCT01360437|Ticagrelor|ticagrelor|mesh-list
24678237|NCT01360437|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24610937|NCT01005758|Antimetabolites|antimetabolites|mesh-ancestor
24610938|NCT01005758|Dermatologic Agents|dermatologic agents|mesh-ancestor
25714862|NCT02363270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25714863|NCT02363270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714864|NCT02363270|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25714865|NCT02363270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25714866|NCT02363270|Anesthetics, General|anesthetics, general|mesh-ancestor
25714867|NCT02363270|Anesthetics|anesthetics|mesh-ancestor
25714868|NCT02363270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25714869|NCT02363270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25714870|NCT02363270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25714871|NCT02363270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24610939|NCT01005758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24610940|NCT01005758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24610941|NCT01005758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24610942|NCT01005758|Antiviral Agents|antiviral agents|mesh-ancestor
24610943|NCT01005758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24610944|NCT01005758|Tubulin Modulators|tubulin modulators|mesh-ancestor
24610945|NCT01005758|Antimitotic Agents|antimitotic agents|mesh-ancestor
24610946|NCT01005758|Mitosis Modulators|mitosis modulators|mesh-ancestor
24610947|NCT01005758|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24610948|NCT01005758|Protective Agents|protective agents|mesh-ancestor
24610949|NCT01005758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24610951|NCT01005784|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24610952|NCT01005784|Fertility Agents|fertility agents|mesh-ancestor
24678292|NCT01360788|Ipratropium|ipratropium|mesh-list
24678311|NCT01360827|Cetuximab|cetuximab|mesh-list
24678466|NCT01362153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678467|NCT01362218|Aspirin|aspirin|mesh-list
24678468|NCT01362218|Ramipril|ramipril|mesh-list
24678469|NCT01362218|Simvastatin|simvastatin|mesh-list
24678470|NCT01362218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24678471|NCT01362218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24678472|NCT01362218|Antimetabolites|antimetabolites|mesh-ancestor
24678473|NCT01362218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24678474|NCT01362218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24678475|NCT01362218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24638171|NCT01155115|Nitric Oxide|nitric oxide|mesh-list
24678478|NCT01362218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24678484|NCT01362218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24678485|NCT01362218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24678486|NCT01362218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24678487|NCT01362218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24678488|NCT01362218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24678899|NCT01364974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678900|NCT01364987|Mycophenolic Acid|mycophenolic acid|mesh-list
24678938|NCT01365260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24678939|NCT01365260|Viscosupplements|viscosupplements|mesh-ancestor
24678940|NCT01365260|Protective Agents|protective agents|mesh-ancestor
24678941|NCT01365312|Ethanol|ethanol|mesh-list
24678942|NCT01365312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24678943|NCT01365312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24611023|NCT01006499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611024|NCT01006499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611026|NCT01006499|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24679000|NCT01365923|Sensory System Agents|sensory system agents|mesh-ancestor
24679001|NCT01365923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679002|NCT01365923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24679012|NCT01365936|Fertility Agents|fertility agents|mesh-ancestor
24679013|NCT01365936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24679014|NCT01365936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679015|NCT01366001|Buprenorphine|buprenorphine|mesh-list
24679016|NCT01366001|ALKS-33|alks-33|mesh-list
24463499|NCT00361244|Irinotecan|irinotecan|mesh-list
24679017|NCT01366001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24679018|NCT01366001|Narcotics|narcotics|mesh-ancestor
25714872|NCT02363270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714873|NCT02363283|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
24679019|NCT01366001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25714874|NCT02363283|Immunoconjugates|immunoconjugates|mesh-list
25714875|NCT02363283|Immunotoxins|immunotoxins|mesh-list
25714876|NCT02363283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25714877|NCT02363283|Immunologic Factors|immunologic factors|mesh-ancestor
25714878|NCT02363283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714879|NCT02363283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25714880|NCT02363283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25714881|NCT02363478|Buspirone|buspirone|mesh-list
24679020|NCT01366001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679021|NCT01366001|Analgesics|analgesics|mesh-ancestor
24679022|NCT01366001|Sensory System Agents|sensory system agents|mesh-ancestor
24679023|NCT01366001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679198|NCT01367431|Growth Substances|growth substances|mesh-ancestor
24679199|NCT01367431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679200|NCT01367431|Growth Inhibitors|growth inhibitors|mesh-ancestor
24679201|NCT01367483|Methylnaltrexone|methylnaltrexone|mesh-list
24679202|NCT01367483|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24679203|NCT01367483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679204|NCT01367483|Sensory System Agents|sensory system agents|mesh-ancestor
24679205|NCT01367483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679207|NCT01367496|Methylnaltrexone|methylnaltrexone|mesh-list
24679208|NCT01367496|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24679209|NCT01367496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679210|NCT01367496|Sensory System Agents|sensory system agents|mesh-ancestor
24679211|NCT01367496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24679212|NCT01367496|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24679213|NCT01367509|Methylnaltrexone|methylnaltrexone|mesh-list
24679214|NCT01367509|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24679215|NCT01367509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679243|NCT01367548|Methylnaltrexone|methylnaltrexone|mesh-list
24679244|NCT01367548|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24679245|NCT01367548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679471|NCT01368783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24679472|NCT01368783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24679490|NCT01368848|Antimitotic Agents|antimitotic agents|mesh-ancestor
24679491|NCT01368848|Mitosis Modulators|mitosis modulators|mesh-ancestor
24679493|NCT01368887|Niacinamide|niacinamide|mesh-list
24679494|NCT01368887|Niacin|niacin|mesh-list
24679495|NCT01368887|Nicotinic Acids|nicotinic acids|mesh-list
24679496|NCT01368887|Calcipotriene|calcipotriene|mesh-list
24679498|NCT01368887|Vitamins|vitamins|mesh-ancestor
24679684|NCT01370031|Antidotes|antidotes|mesh-ancestor
24679685|NCT01370031|Protective Agents|protective agents|mesh-ancestor
24679686|NCT01370031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24679687|NCT01370096|Epoprostenol|epoprostenol|mesh-list
24680030|NCT01372670|Histamine Agents|histamine agents|mesh-ancestor
24680031|NCT01372670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24680032|NCT01372670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680033|NCT01372670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680034|NCT01372761|CKD732|ckd732|mesh-list
24680035|NCT01372761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24680036|NCT01372761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24680037|NCT01372761|Growth Substances|growth substances|mesh-ancestor
24680038|NCT01372761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680041|NCT01372826|Naloxegol|naloxegol|mesh-list
24680137|NCT01373138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24680138|NCT01373138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680139|NCT01373138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680140|NCT01373138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24680180|NCT01373372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680182|NCT01373398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680184|NCT01373411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24680185|NCT01373411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24680186|NCT01373411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24680187|NCT01373411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24680188|NCT01373411|Purinergic Agents|purinergic agents|mesh-ancestor
24680442|NCT01374750|Sirolimus|sirolimus|mesh-list
24680443|NCT01374750|Tacrolimus|tacrolimus|mesh-list
24680444|NCT01374750|Cyclosporins|cyclosporins|mesh-list
24680445|NCT01374750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24680446|NCT01374750|Immunologic Factors|immunologic factors|mesh-ancestor
24680447|NCT01374750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680448|NCT01374750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24680449|NCT01374750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680450|NCT01374750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680451|NCT01374750|Antifungal Agents|antifungal agents|mesh-ancestor
24680452|NCT01374750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25714882|NCT02363478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24680453|NCT01374750|Dermatologic Agents|dermatologic agents|mesh-ancestor
24680454|NCT01374750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24680455|NCT01374750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24680458|NCT01374763|Oxycodone|oxycodone|mesh-list
24680491|NCT01374841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680616|NCT01375556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24680709|NCT01375985|Antiviral Agents|antiviral agents|mesh-ancestor
24680710|NCT01375985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24680711|NCT01376011|Quercetin|quercetin|mesh-list
24680712|NCT01376011|Antioxidants|antioxidants|mesh-ancestor
24680716|NCT01376076|Moxifloxacin|moxifloxacin|mesh-list
24680741|NCT01376076|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24680742|NCT01376076|Dopamine Agents|dopamine agents|mesh-ancestor
24680748|NCT01376128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24680749|NCT01376128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24680750|NCT01376128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680751|NCT01376128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24680753|NCT01376128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680754|NCT01376128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24680755|NCT01376128|Antidepressive Agents|antidepressive agents|mesh-ancestor
24680756|NCT01376128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24680757|NCT01376128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24680760|NCT01376141|Sumatriptan|sumatriptan|mesh-list
24680793|NCT01376193|Serotonin Agents|serotonin agents|mesh-ancestor
24680794|NCT01376193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24611160|NCT01007539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24680795|NCT01376193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680796|NCT01376193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24680797|NCT01376206|Fluticasone|fluticasone|mesh-list
24680982|NCT01377324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24680983|NCT01377324|Contraceptive Agents|contraceptive agents|mesh-ancestor
24465532|NCT00369993|Dermatologic Agents|dermatologic agents|mesh-ancestor
24680986|NCT01377376|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24680987|NCT01377376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24680988|NCT01377376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24680989|NCT01377376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24680990|NCT01377376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24680991|NCT01377415|Bupivacaine|bupivacaine|mesh-list
24680992|NCT01377415|Anesthetics, Local|anesthetics, local|mesh-ancestor
24680993|NCT01377415|Anesthetics|anesthetics|mesh-ancestor
24681115|NCT01378533|Cyclophosphamide|cyclophosphamide|mesh-list
24681116|NCT01378533|Carboplatin|carboplatin|mesh-list
24681118|NCT01378533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24681119|NCT01378533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24681162|NCT01378715|Antimetabolites|antimetabolites|mesh-ancestor
24681163|NCT01378715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681164|NCT01378715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24541867|NCT00675714|Metoprolol|metoprolol|mesh-list
24681165|NCT01378715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24681166|NCT01378715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681167|NCT01378741|Dexmedetomidine|dexmedetomidine|mesh-list
24681168|NCT01378741|Propofol|propofol|mesh-list
24681423|NCT01380431|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24466067|NCT00371735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24681424|NCT01380431|Protease Inhibitors|protease inhibitors|mesh-ancestor
24681425|NCT01380431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24681466|NCT01380522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24681468|NCT01380548|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24681469|NCT01380548|Trace Elements|trace elements|mesh-ancestor
24681470|NCT01380548|Micronutrients|micronutrients|mesh-ancestor
24681472|NCT01380548|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24681538|NCT01381055|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24681591|NCT01381354|Niacin|niacin|mesh-list
24682096|NCT01384240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24682097|NCT01384253|Trastuzumab|trastuzumab|mesh-list
24682098|NCT01384253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24682099|NCT01384253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24682100|NCT01384058|Simvastatin|simvastatin|mesh-list
24682102|NCT01384058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24682103|NCT01384058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24682104|NCT01384058|Antimetabolites|antimetabolites|mesh-ancestor
24682105|NCT01384058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682109|NCT01384279|Metformin|metformin|mesh-list
25714883|NCT02363478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25714884|NCT02363478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24682138|NCT01384448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682139|NCT01384448|Protective Agents|protective agents|mesh-ancestor
24682186|NCT01384643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682187|NCT01384643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24682188|NCT01384643|Anesthetics, General|anesthetics, general|mesh-ancestor
24682420|NCT01386294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24682421|NCT01386294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24682422|NCT01386294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682423|NCT01386294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682424|NCT01386294|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24682425|NCT01386294|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24682426|NCT01386333|Oxytocin|oxytocin|mesh-list
24682427|NCT01386333|Oxytocics|oxytocics|mesh-ancestor
24682428|NCT01386333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24682429|NCT01386333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682430|NCT01386346|Capecitabine|capecitabine|mesh-list
24682465|NCT01386567|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24682466|NCT01386567|Anticoagulants|anticoagulants|mesh-ancestor
24682469|NCT01386567|Sequestering Agents|sequestering agents|mesh-ancestor
24682470|NCT01386567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682471|NCT01386567|Androgens|androgens|mesh-ancestor
24682472|NCT01386567|Hormones|hormones|mesh-ancestor
24682473|NCT01386567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24682474|NCT01386567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24682535|NCT01386658|Icatibant|icatibant|mesh-list
24682582|NCT01386879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682584|NCT01386996|Formoterol Fumarate|formoterol fumarate|mesh-list
24682585|NCT01386996|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24682628|NCT01387204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682629|NCT01387204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682631|NCT01387243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24682632|NCT01387243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682633|NCT01387243|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24682634|NCT01387243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24682637|NCT01387295|Trastuzumab|trastuzumab|mesh-list
24682638|NCT01387295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24682639|NCT01387295|Antimetabolites|antimetabolites|mesh-ancestor
24682640|NCT01387295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24682750|NCT01388270|Anticoagulants|anticoagulants|mesh-ancestor
24611398|NCT01009190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611400|NCT01009437|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24611401|NCT01009437|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24611402|NCT01009437|Protease Inhibitors|protease inhibitors|mesh-ancestor
24611403|NCT01009437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611404|NCT01009437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683068|NCT01389713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24683069|NCT01389713|Contraceptive Agents|contraceptive agents|mesh-ancestor
24683070|NCT01389713|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24683071|NCT01389713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24683072|NCT01389713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24683073|NCT01389778|Metformin|metformin|mesh-list
24683074|NCT01389778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24683075|NCT01389778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683076|NCT01389791|Magnesium Sulfate|magnesium sulfate|mesh-list
24683077|NCT01389791|Rocuronium|rocuronium|mesh-list
24683078|NCT01389791|Analgesics|analgesics|mesh-ancestor
24683079|NCT01389791|Sensory System Agents|sensory system agents|mesh-ancestor
24683080|NCT01389791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24683081|NCT01389791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683082|NCT01389791|Anesthetics|anesthetics|mesh-ancestor
24683083|NCT01389791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24683084|NCT01389791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24683193|NCT01390571|Olaparib|olaparib|mesh-list
24639611|NCT01163201|Fludarabine|fludarabine|mesh-list
24683194|NCT01390571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24683195|NCT01390571|Alkylating Agents|alkylating agents|mesh-ancestor
24683196|NCT01390571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683197|NCT01390571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24683198|NCT01390571|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24683199|NCT01390571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25714885|NCT02363478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683200|NCT01390623|Ceftriaxone|ceftriaxone|mesh-list
24683201|NCT01390623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24683555|NCT01392833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24683556|NCT01392833|Glucocorticoids|glucocorticoids|mesh-ancestor
24683623|NCT01393145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24683624|NCT01393145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683625|NCT01393145|Glucocorticoids|glucocorticoids|mesh-ancestor
24683627|NCT01393145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24683628|NCT01393145|Sympathomimetics|sympathomimetics|mesh-ancestor
24683629|NCT01393184|Nimotuzumab|nimotuzumab|mesh-list
24683630|NCT01393184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24683645|NCT01393288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24683646|NCT01393288|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24683647|NCT01393288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24683648|NCT01393288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24683649|NCT01393288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24683650|NCT01393288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24683727|NCT01393769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24683728|NCT01393769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24683729|NCT01393769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24683730|NCT01393769|Immunologic Factors|immunologic factors|mesh-ancestor
24683731|NCT01393769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24683792|NCT01394133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24611490|NCT01009801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24611491|NCT01009801|Immunologic Factors|immunologic factors|mesh-ancestor
24611492|NCT01009801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611493|NCT01009853|Codeine|codeine|mesh-list
24611495|NCT01009853|Narcotics|narcotics|mesh-ancestor
24611496|NCT01009853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24611497|NCT01009853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611498|NCT01009853|Analgesics|analgesics|mesh-ancestor
25714886|NCT02363478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25714887|NCT02363478|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25714888|NCT02363478|Serotonin Agents|serotonin agents|mesh-ancestor
25714889|NCT02363478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25714890|NCT02363478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714891|NCT02363621|Ranibizumab|ranibizumab|mesh-list
25714892|NCT02363621|Aflibercept|aflibercept|mesh-list
25714893|NCT02363621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25714894|NCT02363621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25714895|NCT02363621|Growth Substances|growth substances|mesh-ancestor
25714896|NCT02363621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714897|NCT02363621|Growth Inhibitors|growth inhibitors|mesh-ancestor
25714898|NCT02363621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611500|NCT01009853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24611501|NCT01009853|Antitussive Agents|antitussive agents|mesh-ancestor
24611502|NCT01009853|Respiratory System Agents|respiratory system agents|mesh-ancestor
24684143|NCT01395732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24684144|NCT01395732|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24684145|NCT01395732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24684146|NCT01395849|Fluticasone|fluticasone|mesh-list
24684147|NCT01395849|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24684148|NCT01395849|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24684149|NCT01395849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24684150|NCT01395849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24684151|NCT01395849|Autonomic Agents|autonomic agents|mesh-ancestor
24684152|NCT01395849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24684286|NCT01396655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24684287|NCT01396655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24684290|NCT01396668|Gemcitabine|gemcitabine|mesh-list
24684311|NCT01396681|Immunologic Factors|immunologic factors|mesh-ancestor
24684314|NCT01396707|Oxaliplatin|oxaliplatin|mesh-list
24684331|NCT01396720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24684343|NCT01396733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684376|NCT01397097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24684377|NCT01397097|Contraceptive Agents|contraceptive agents|mesh-ancestor
24684378|NCT01397097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24684379|NCT01397097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24684380|NCT01397097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24685052|NCT02499666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24685053|NCT02499666|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24685054|NCT02499666|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24685055|NCT02499666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24685056|NCT02499666|Purinergic Agents|purinergic agents|mesh-ancestor
24685057|NCT02499666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24685058|NCT02499666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685059|NCT02499666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24685235|NCT00703222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24685775|NCT05209841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24685790|NCT05207280|Terlipressin|terlipressin|mesh-list
24685791|NCT05207280|Norepinephrine|norepinephrine|mesh-list
24685792|NCT05207280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24685822|NCT05168735|Sensory System Agents|sensory system agents|mesh-ancestor
24685928|NCT05138029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24685929|NCT05138029|Antiemetics|antiemetics|mesh-ancestor
24685930|NCT05138029|Autonomic Agents|autonomic agents|mesh-ancestor
24685931|NCT05138029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24686107|NCT05052528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686108|NCT05052528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24686109|NCT05052528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24686110|NCT05052528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24686112|NCT05051150|Epinephrine|epinephrine|mesh-list
24686177|NCT05007561|Naltrexone|naltrexone|mesh-list
24686178|NCT05007561|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24686216|NCT04997759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24686217|NCT04991948|Pembrolizumab|pembrolizumab|mesh-list
24686218|NCT04991948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24686219|NCT04991948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24686284|NCT04918823|Cyclosporins|cyclosporins|mesh-list
24686285|NCT04918823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24611673|NCT01010243|Growth Inhibitors|growth inhibitors|mesh-ancestor
24611674|NCT01010243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24611675|NCT01010243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24611676|NCT01010243|Alkylating Agents|alkylating agents|mesh-ancestor
24611677|NCT01010243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611678|NCT01010295|Doxycycline|doxycycline|mesh-list
25714899|NCT02363738|Infliximab|infliximab|mesh-list
25714900|NCT02363738|Dermatologic Agents|dermatologic agents|mesh-ancestor
24611679|NCT01010295|Tetracycline|tetracycline|mesh-list
24686455|NCT04791761|Antipyretics|antipyretics|mesh-ancestor
24686456|NCT04791761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24686457|NCT04791761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24686458|NCT04791761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24686459|NCT04791761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24686460|NCT04791761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543889|NCT00685854|Ranibizumab|ranibizumab|mesh-list
24686461|NCT04791761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686462|NCT04791761|Narcotics|narcotics|mesh-ancestor
24686518|NCT04760691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24686519|NCT04760691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24686772|NCT04583501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24686773|NCT04583501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24686958|NCT04481412|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24686959|NCT04481412|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24686960|NCT04481412|Histamine Antagonists|histamine antagonists|mesh-ancestor
24686962|NCT04481412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24686963|NCT04481412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24686964|NCT04481412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24687105|NCT04380831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687106|NCT04380831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24687112|NCT04368091|Sirolimus|sirolimus|mesh-list
24687246|NCT04186663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687247|NCT04167462|BMS-986165|bms-986165|mesh-list
24687248|NCT04167462|Dermatologic Agents|dermatologic agents|mesh-ancestor
24687249|NCT04167462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24687250|NCT04167462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24687251|NCT04167462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24687252|NCT04164849|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24687253|NCT04164849|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24687256|NCT04164199|Pemetrexed|pemetrexed|mesh-list
24687553|NCT03897439|Varenicline|varenicline|mesh-list
24687554|NCT03897439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24687555|NCT03897439|Autonomic Agents|autonomic agents|mesh-ancestor
24687556|NCT03897439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24687557|NCT03897439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24687558|NCT03897439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24687559|NCT03897439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24687646|NCT03858621|Anesthetics, General|anesthetics, general|mesh-ancestor
24687647|NCT03858621|Anesthetics|anesthetics|mesh-ancestor
24687648|NCT03845270|Docetaxel|docetaxel|mesh-list
24687649|NCT03845270|Trastuzumab|trastuzumab|mesh-list
24687650|NCT03845270|Pertuzumab|pertuzumab|mesh-list
24687740|NCT03758170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24687741|NCT03758170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24687742|NCT03758170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611765|NCT01010646|Interferon alpha-2|interferon alpha-2|mesh-list
24611767|NCT01010646|Antimetabolites|antimetabolites|mesh-ancestor
24611768|NCT01010646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611769|NCT01010646|Antiviral Agents|antiviral agents|mesh-ancestor
24611770|NCT01010646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24611771|NCT01010646|Immunologic Factors|immunologic factors|mesh-ancestor
24688054|NCT03489018|Immunologic Factors|immunologic factors|mesh-ancestor
24688055|NCT03489018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688062|NCT03439124|Cephalosporins|cephalosporins|mesh-list
24688063|NCT03439124|Ceftobiprole|ceftobiprole|mesh-list
25714901|NCT02363738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25714902|NCT02363738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24688064|NCT03439124|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
25714903|NCT02363803|Lidocaine|lidocaine|mesh-list
25714904|NCT02363803|Anesthetics, Local|anesthetics, local|mesh-ancestor
25714905|NCT02363803|Anesthetics|anesthetics|mesh-ancestor
25714906|NCT02363803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25777811|NCT03109873|Metformin|metformin|mesh-list
25777812|NCT03109873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25777813|NCT03109873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777814|NCT03113071|Decitabine|decitabine|mesh-list
25777815|NCT03113071|Digoxin|digoxin|mesh-list
25777816|NCT03113071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25777817|NCT03113071|Antimetabolites|antimetabolites|mesh-ancestor
25777818|NCT03113071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688065|NCT03439124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24688066|NCT03439124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24688067|NCT03436368|Anesthetics|anesthetics|mesh-list
24688251|NCT03215940|Hallucinogens|hallucinogens|mesh-ancestor
24688252|NCT03215940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688253|NCT03215940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24611789|NCT01010698|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24611790|NCT01010698|Histamine Antagonists|histamine antagonists|mesh-ancestor
24611791|NCT01010698|Histamine Agents|histamine agents|mesh-ancestor
24611792|NCT01010698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24611810|NCT01010945|Gemcitabine|gemcitabine|mesh-list
24641425|NCT01173549|Canagliflozin|canagliflozin|mesh-list
24688502|NCT03012672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24688504|NCT03012672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688505|NCT03012672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688506|NCT03012672|Antiviral Agents|antiviral agents|mesh-ancestor
24688543|NCT03011775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24688544|NCT03011775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24688685|NCT02740699|Atorvastatin|atorvastatin|mesh-list
24688546|NCT03011775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24688547|NCT03011775|Antipyretics|antipyretics|mesh-ancestor
24688548|NCT03011775|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24688549|NCT03011775|Protease Inhibitors|protease inhibitors|mesh-ancestor
24688550|NCT03011775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24688551|NCT03011775|Sympatholytics|sympatholytics|mesh-ancestor
24688552|NCT03011775|Autonomic Agents|autonomic agents|mesh-ancestor
24688553|NCT03011775|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24688554|NCT03011775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24688555|NCT03011775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24688556|NCT03011775|Adrenergic Agents|adrenergic agents|mesh-ancestor
24688557|NCT03011775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24688558|NCT03011775|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24688559|NCT03011775|Diuretics|diuretics|mesh-ancestor
24688560|NCT03011775|Natriuretic Agents|natriuretic agents|mesh-ancestor
24688561|NCT03011775|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24688562|NCT02998047|Lintuzumab|lintuzumab|mesh-list
24688563|NCT02998047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24688564|NCT02998047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688565|NCT02964559|Pembrolizumab|pembrolizumab|mesh-list
24688566|NCT02964559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24688567|NCT02964559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24688568|NCT02960997|Sirolimus|sirolimus|mesh-list
24688569|NCT02960997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24688570|NCT02960997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24688571|NCT02960997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24688582|NCT02924480|Lidocaine|lidocaine|mesh-list
25714907|NCT02363803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714908|NCT02363803|Sensory System Agents|sensory system agents|mesh-ancestor
25714909|NCT02363803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25714910|NCT02363803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25714911|NCT02363803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25714912|NCT02363803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25714913|NCT02363803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25714914|NCT02363803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688657|NCT02810457|Mitosis Modulators|mitosis modulators|mesh-ancestor
24688658|NCT02810457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688659|NCT02810457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24688680|NCT02745535|Sofosbuvir|sofosbuvir|mesh-list
24688681|NCT02745535|Velpatasvir|velpatasvir|mesh-list
24688682|NCT02745535|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
24688683|NCT02745535|Antiviral Agents|antiviral agents|mesh-ancestor
24688684|NCT02745535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24688686|NCT02740699|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24688687|NCT02740699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24688688|NCT02740699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24688689|NCT02740699|Antimetabolites|antimetabolites|mesh-ancestor
24688704|NCT02723331|Gemcitabine|gemcitabine|mesh-list
24688705|NCT02723331|Paclitaxel|paclitaxel|mesh-list
24688706|NCT02723331|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24688708|NCT02723331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641496|NCT01173926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24688786|NCT02666794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24688787|NCT02666794|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24688788|NCT02666794|Narcotics|narcotics|mesh-ancestor
24688789|NCT02666794|Analgesics|analgesics|mesh-ancestor
24688790|NCT02666794|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24688811|NCT02636569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24688812|NCT02636569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24688813|NCT02636569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24688814|NCT02636569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24688815|NCT02636569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24688816|NCT02636569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24688817|NCT02636569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688818|NCT02636322|Prednisone|prednisone|mesh-list
24688819|NCT02636322|Cortisone|cortisone|mesh-list
24688820|NCT02636322|Cyclophosphamide|cyclophosphamide|mesh-list
24688821|NCT02636322|Rituximab|rituximab|mesh-list
24473967|NCT00404586|Fluticasone|fluticasone|mesh-list
24688822|NCT02636322|Doxorubicin|doxorubicin|mesh-list
24688823|NCT02636322|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24688824|NCT02636322|Etoposide|etoposide|mesh-list
24688825|NCT02636322|Vincristine|vincristine|mesh-list
24688826|NCT02636322|Lenalidomide|lenalidomide|mesh-list
24688827|NCT02636322|Etoposide phosphate|etoposide phosphate|mesh-list
24688828|NCT02636322|Podophyllotoxin|podophyllotoxin|mesh-list
24688917|NCT02575963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24688918|NCT02575963|Antimetabolites|antimetabolites|mesh-ancestor
24688919|NCT02575963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24688926|NCT02575963|Diuretics|diuretics|mesh-ancestor
24688981|NCT02500849|Busulfan|busulfan|mesh-list
24688982|NCT02500849|Alkylating Agents|alkylating agents|mesh-ancestor
24689057|NCT02427581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689058|NCT02427581|Laxatives|laxatives|mesh-ancestor
25714915|NCT02363946|Diphenhydramine|diphenhydramine|mesh-list
25714916|NCT02363946|Promethazine|promethazine|mesh-list
25714917|NCT02363946|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25714918|NCT02363946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25714919|NCT02363946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25714920|NCT02363946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714921|NCT02363946|Anesthetics, Local|anesthetics, local|mesh-ancestor
25714922|NCT02363946|Anesthetics|anesthetics|mesh-ancestor
24689059|NCT02427581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24689060|NCT02427581|Antiviral Agents|antiviral agents|mesh-ancestor
24689061|NCT02427581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24689062|NCT02423525|Afatinib|afatinib|mesh-list
24689063|NCT02423525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689064|NCT02423525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24689065|NCT02423525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689066|NCT02423525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689067|NCT02369653|Apixaban|apixaban|mesh-list
24689175|NCT02293109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24689204|NCT02293109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24689205|NCT02270034|Crizotinib|crizotinib|mesh-list
24689206|NCT02270034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689207|NCT02270034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24689208|NCT02270034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689209|NCT02270034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689210|NCT02195986|Estradiol|estradiol|mesh-list
24689211|NCT02195986|Estrogens|estrogens|mesh-ancestor
24689212|NCT02195986|Hormones|hormones|mesh-ancestor
24689213|NCT02195986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24689214|NCT02195986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689215|NCT02183883|Afatinib|afatinib|mesh-list
24689216|NCT02183883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24611888|NCT01011127|Antimetabolites|antimetabolites|mesh-ancestor
24611889|NCT01011127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611890|NCT01011127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24611891|NCT01011127|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24689240|NCT01982448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689241|NCT01951469|Pemetrexed|pemetrexed|mesh-list
24689242|NCT01951469|Gefitinib|gefitinib|mesh-list
24689243|NCT01951469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689244|NCT01951469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689245|NCT01951469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689246|NCT01951469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24689247|NCT01951469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24689277|NCT01879228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24689278|NCT01879228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689279|NCT01879228|Incretins|incretins|mesh-ancestor
24689280|NCT01879228|Hormones|hormones|mesh-ancestor
24689281|NCT01879228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24689282|NCT01879228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24689283|NCT01879228|Protease Inhibitors|protease inhibitors|mesh-ancestor
24689284|NCT01879228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24689286|NCT01829958|Prednisone|prednisone|mesh-list
24689287|NCT01829958|Rituximab|rituximab|mesh-list
24689323|NCT01729754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24689324|NCT01729754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689325|NCT01729754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24689326|NCT01729754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24689327|NCT01729754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24689328|NCT01729754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24689329|NCT01729754|Immunologic Factors|immunologic factors|mesh-ancestor
24689365|NCT01595620|Capsaicin|capsaicin|mesh-list
25714923|NCT02363946|Sensory System Agents|sensory system agents|mesh-ancestor
25714924|NCT02363946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24689470|NCT01464268|Dermatologic Agents|dermatologic agents|mesh-ancestor
24689472|NCT01464268|Plasma Substitutes|plasma substitutes|mesh-ancestor
24689473|NCT01464268|Blood Substitutes|blood substitutes|mesh-ancestor
24689474|NCT01433965|Lenalidomide|lenalidomide|mesh-list
24689476|NCT01433965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24689477|NCT01433965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24689478|NCT01433965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24689479|NCT01433965|Growth Substances|growth substances|mesh-ancestor
24689480|NCT01433965|Growth Inhibitors|growth inhibitors|mesh-ancestor
24689481|NCT01433965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24689483|NCT01360593|Capecitabine|capecitabine|mesh-list
24689484|NCT01360593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24689485|NCT01360593|Antimetabolites|antimetabolites|mesh-ancestor
24689486|NCT01360593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689576|NCT01085097|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24689577|NCT01085097|Prednisolone|prednisolone|mesh-list
24689578|NCT01085097|Prednisolone acetate|prednisolone acetate|mesh-list
24689579|NCT01085097|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24689580|NCT01085097|Prednisolone phosphate|prednisolone phosphate|mesh-list
24689581|NCT01085097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24689698|NCT00500071|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24689699|NCT00500071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24689700|NCT00500071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24689701|NCT00500071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24689703|NCT00500071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24689704|NCT00447122|Gemcitabine|gemcitabine|mesh-list
24689706|NCT00447122|Lapatinib|lapatinib|mesh-list
24689800|NCT00290251|Contraceptive Agents|contraceptive agents|mesh-ancestor
24689801|NCT00290251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24690036|NCT01398592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690039|NCT01398618|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24690057|NCT01398657|Androgens|androgens|mesh-list
24611932|NCT01011257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24611933|NCT01011257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611935|NCT01011348|Coenzyme Q10|coenzyme q10|mesh-list
24611936|NCT01011348|Micronutrients|micronutrients|mesh-ancestor
24611937|NCT01011348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24611938|NCT01011348|Vitamins|vitamins|mesh-ancestor
24611939|NCT01011374|Ranibizumab|ranibizumab|mesh-list
24611940|NCT01011374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24690128|NCT01399463|Mitosis Modulators|mitosis modulators|mesh-ancestor
24690129|NCT01399463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690130|NCT01399515|Valproic Acid|valproic acid|mesh-list
24690131|NCT01399515|Anticonvulsants|anticonvulsants|mesh-ancestor
24690132|NCT01399515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24690133|NCT01399515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690134|NCT01399515|GABA Agents|gaba agents|mesh-ancestor
24690135|NCT01399515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24690136|NCT01399515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690137|NCT01399515|Antimanic Agents|antimanic agents|mesh-ancestor
24690138|NCT01399515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24690212|NCT01400256|Valsartan|valsartan|mesh-list
24690329|NCT01400867|Clindamycin|clindamycin|mesh-list
24690330|NCT01400867|Clindamycin palmitate|clindamycin palmitate|mesh-list
25714925|NCT02363946|Antiemetics|antiemetics|mesh-ancestor
25714926|NCT02363946|Autonomic Agents|autonomic agents|mesh-ancestor
24690331|NCT01400867|Clindamycin phosphate|clindamycin phosphate|mesh-list
24690332|NCT01400867|Cefazolin|cefazolin|mesh-list
24690333|NCT01400867|Linezolid|linezolid|mesh-list
24690334|NCT01400867|Cephalexin|cephalexin|mesh-list
25714927|NCT02363946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25714928|NCT02363946|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25714929|NCT02363946|Histamine Antagonists|histamine antagonists|mesh-ancestor
25714930|NCT02363946|Histamine Agents|histamine agents|mesh-ancestor
25714931|NCT02363946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24690335|NCT01400867|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
24690336|NCT01400867|Aztreonam|aztreonam|mesh-list
24690342|NCT01400945|Pantoprazole|pantoprazole|mesh-list
24475586|NCT00410852|Insulin|insulin|mesh-list
24690382|NCT01401192|Gemcitabine|gemcitabine|mesh-list
24690388|NCT01401192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690389|NCT01401192|Antiviral Agents|antiviral agents|mesh-ancestor
24690390|NCT01401192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24690521|NCT01402271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24690522|NCT01402271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24690523|NCT01402271|Tubulin Modulators|tubulin modulators|mesh-ancestor
24690524|NCT01402271|Antimitotic Agents|antimitotic agents|mesh-ancestor
24690525|NCT01402271|Mitosis Modulators|mitosis modulators|mesh-ancestor
24690526|NCT01402271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24690527|NCT01402297|Acetovanillone|acetovanillone|mesh-list
24690528|NCT01402297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24475713|NCT00411203|Tamoxifen|tamoxifen|mesh-list
24690529|NCT01402297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24690712|NCT01403415|Mitosis Modulators|mitosis modulators|mesh-ancestor
24690713|NCT01403415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24690714|NCT01403415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24690715|NCT01403415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24690716|NCT01403415|Antifungal Agents|antifungal agents|mesh-ancestor
24690717|NCT01403415|Protease Inhibitors|protease inhibitors|mesh-ancestor
24690719|NCT01403415|Sensory System Agents|sensory system agents|mesh-ancestor
24690720|NCT01403415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24690721|NCT01403415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24690907|NCT01404377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24690908|NCT01404377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690909|NCT01404377|Sensory System Agents|sensory system agents|mesh-ancestor
24690910|NCT01404377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24690912|NCT01404442|Ketamine|ketamine|mesh-list
24690913|NCT01404442|Analgesics|analgesics|mesh-ancestor
24690914|NCT01404442|Sensory System Agents|sensory system agents|mesh-ancestor
24690915|NCT01404442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24690916|NCT01404442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24690917|NCT01404442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24612024|NCT01011660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24612025|NCT01011660|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24612026|NCT01011660|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24691189|NCT01405352|Vitamins|vitamins|mesh-ancestor
24691190|NCT01405352|Micronutrients|micronutrients|mesh-ancestor
24691191|NCT01405352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691192|NCT01405365|Metronidazole|metronidazole|mesh-list
24691193|NCT01405365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24691194|NCT01405365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24691329|NCT01406158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691330|NCT01406158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777237|NCT03726996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25777238|NCT03726996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25777239|NCT03726996|Adrenergic Agents|adrenergic agents|mesh-ancestor
25777240|NCT03726996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25777241|NCT03726996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777242|NCT03725085|Guaifenesin|guaifenesin|mesh-list
25777243|NCT03725085|Expectorants|expectorants|mesh-ancestor
25777244|NCT03725085|Respiratory System Agents|respiratory system agents|mesh-ancestor
25777245|NCT03724981|Dulaglutide|dulaglutide|mesh-list
25777246|NCT03724981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25777247|NCT03724981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691359|NCT01406262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24691360|NCT01406262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24691362|NCT01406262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691363|NCT01406262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24691364|NCT01406262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24691366|NCT01406262|Hormones|hormones|mesh-ancestor
24691726|NCT01408836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24691727|NCT01408836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24691728|NCT01408836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24691729|NCT01408836|Protective Agents|protective agents|mesh-ancestor
24691730|NCT01408849|Omeprazole|omeprazole|mesh-list
24691731|NCT01408849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24691732|NCT01408849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24691733|NCT01408849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24691734|NCT01408849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24691735|NCT01408849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24691737|NCT01408927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24691816|NCT01409174|Alkylating Agents|alkylating agents|mesh-ancestor
24691817|NCT01409174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612117|NCT01011998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24477083|NCT00417157|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24691818|NCT01409174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24691819|NCT01409174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24691828|NCT01409187|Interferons|interferons|mesh-list
24692108|NCT01411202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24692109|NCT01411254|Betamethasone|betamethasone|mesh-list
24692110|NCT01411254|Betamethasone Valerate|betamethasone valerate|mesh-list
24692111|NCT01411254|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24692112|NCT01411254|Betamethasone benzoate|betamethasone benzoate|mesh-list
24692113|NCT01411254|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24692114|NCT01411254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24692115|NCT01411254|Glucocorticoids|glucocorticoids|mesh-ancestor
24692116|NCT01411254|Hormones|hormones|mesh-ancestor
24692117|NCT01411254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24692118|NCT01411254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24692119|NCT01411254|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24692120|NCT01411254|Respiratory System Agents|respiratory system agents|mesh-ancestor
24692121|NCT01411280|Methylphenidate|methylphenidate|mesh-list
24692122|NCT01411280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24692180|NCT01411930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25777248|NCT03724968|Nivolumab|nivolumab|mesh-list
24692181|NCT01411930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24692182|NCT01411930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692183|NCT01411930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24692185|NCT01411930|Antidepressive Agents|antidepressive agents|mesh-ancestor
24692186|NCT01411930|Dopamine Agonists|dopamine agonists|mesh-ancestor
24692187|NCT01411930|Dopamine Agents|dopamine agents|mesh-ancestor
24692188|NCT01411930|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24692189|NCT01411930|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24692190|NCT01411930|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24692191|NCT01411930|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24692192|NCT01411930|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24692193|NCT01411930|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24692195|NCT01411969|Oxymetazoline|oxymetazoline|mesh-list
24692196|NCT01411969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24692197|NCT01411969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24692198|NCT01411969|Adrenergic Agents|adrenergic agents|mesh-ancestor
24692204|NCT01411969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24692205|NCT01411969|Nasal Decongestants|nasal decongestants|mesh-ancestor
24692206|NCT01411969|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24692207|NCT01411969|Respiratory System Agents|respiratory system agents|mesh-ancestor
24692208|NCT01411969|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24692209|NCT01411969|Mydriatics|mydriatics|mesh-ancestor
24692210|NCT01411969|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24612123|NCT01012063|Epoetin Alfa|epoetin alfa|mesh-list
24612149|NCT01012193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24612150|NCT01012193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24612151|NCT01012193|Respiratory System Agents|respiratory system agents|mesh-ancestor
24612152|NCT01012193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24612153|NCT01012193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24692332|NCT01413022|Oxaliplatin|oxaliplatin|mesh-list
24692333|NCT01413022|Irinotecan|irinotecan|mesh-list
24692334|NCT01413022|Antimetabolites|antimetabolites|mesh-ancestor
24642301|NCT01178710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24692335|NCT01413022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24692336|NCT01413022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24692337|NCT01413022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692519|NCT01414881|Mipomersen|mipomersen|mesh-list
24692848|NCT01416883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24692850|NCT01416909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24692852|NCT01416948|Galantamine|galantamine|mesh-list
24692853|NCT01416948|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24692854|NCT01416948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547140|NCT00702637|Modafinil|modafinil|mesh-list
24692855|NCT01416948|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24693143|NCT01418534|Isosorbide|isosorbide|mesh-list
24693144|NCT01418534|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
24693145|NCT01418534|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25777249|NCT03724968|Ipilimumab|ipilimumab|mesh-list
25777250|NCT03724968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25777251|NCT03724968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25777252|NCT03724968|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25777253|NCT03724968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777254|NCT03724877|Cholinergic Agents|cholinergic agents|mesh-list
25777255|NCT03724877|Muscarinic Antagonists|muscarinic antagonists|mesh-list
25777256|NCT03724877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25777257|NCT03724877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693467|NCT01420575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24693468|NCT01420575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24693469|NCT01420575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693471|NCT01420575|Serotonin Agents|serotonin agents|mesh-ancestor
24612265|NCT01013012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24612266|NCT01013012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612267|NCT01013012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24612268|NCT01013012|Glucocorticoids|glucocorticoids|mesh-ancestor
24612270|NCT01013012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24612271|NCT01013012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24612272|NCT01013012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612273|NCT01013012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24612274|NCT01013012|Serotonin Agents|serotonin agents|mesh-ancestor
24612275|NCT01013012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24612277|NCT01013103|Atorvastatin|atorvastatin|mesh-list
24693609|NCT01421264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24693610|NCT01421264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24693611|NCT01421264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24693612|NCT01421264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24693613|NCT01421264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24693614|NCT01421264|Antimanic Agents|antimanic agents|mesh-ancestor
24693615|NCT01421368|Tenofovir|tenofovir|mesh-list
24693616|NCT01421368|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24612337|NCT01013532|Cilostazol|cilostazol|mesh-list
24612338|NCT01013532|Probucol|probucol|mesh-list
24612339|NCT01013532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24694251|NCT01424709|Irinotecan|irinotecan|mesh-list
24694252|NCT01424709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24694277|NCT01424826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24694779|NCT05308979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24694780|NCT05308979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694784|NCT05308979|Cholinergic Agents|cholinergic agents|mesh-ancestor
24694859|NCT05113615|Bromides|bromides|mesh-list
24694861|NCT05113615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24694862|NCT05113615|Autonomic Agents|autonomic agents|mesh-ancestor
24694863|NCT05113615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24694864|NCT05113615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24694865|NCT05113615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24694872|NCT05113615|Anticonvulsants|anticonvulsants|mesh-ancestor
24694928|NCT05089916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24694955|NCT05007652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24694956|NCT05007652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24694957|NCT05007652|Antiviral Agents|antiviral agents|mesh-ancestor
24694958|NCT05007652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25777258|NCT03724877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777259|NCT03724877|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25777260|NCT03723980|Propolis|propolis|mesh-list
25777261|NCT03723980|Calcium|calcium|mesh-list
25777262|NCT03723980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25777263|NCT03723980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777264|NCT03723980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25777265|NCT03723447|Dexamethasone|dexamethasone|mesh-list
25777266|NCT03723447|Epinephrine|epinephrine|mesh-list
25777267|NCT03723447|Bupivacaine|bupivacaine|mesh-list
24695108|NCT04510051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695112|NCT04425902|Metoprolol|metoprolol|mesh-list
24695125|NCT04425902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24695126|NCT04425902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24695127|NCT04425902|Anesthetics, General|anesthetics, general|mesh-ancestor
24695128|NCT04425902|Anesthetics|anesthetics|mesh-ancestor
24695129|NCT04425902|GABA Modulators|gaba modulators|mesh-ancestor
24695270|NCT03996265|Bupropion|bupropion|mesh-list
24695271|NCT03996265|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24695272|NCT03996265|Antidepressive Agents|antidepressive agents|mesh-ancestor
24695273|NCT03996265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24695321|NCT03809767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24695322|NCT03809767|Immunologic Factors|immunologic factors|mesh-ancestor
24695323|NCT03809767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695324|NCT03771612|Naproxen|naproxen|mesh-list
24695325|NCT03771612|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24695326|NCT03771612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24695327|NCT03771612|Analgesics|analgesics|mesh-ancestor
24695328|NCT03771612|Sensory System Agents|sensory system agents|mesh-ancestor
24695329|NCT03771612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24695330|NCT03771612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612516|NCT01014247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24612517|NCT01014247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612518|NCT01014247|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24612519|NCT01014247|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24612520|NCT01014247|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24612521|NCT01014260|Doxycycline|doxycycline|mesh-list
24612522|NCT01014260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24612523|NCT01014260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24612524|NCT01014260|Antimalarials|antimalarials|mesh-ancestor
24612525|NCT01014260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24612526|NCT01014260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24695381|NCT03713424|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24695424|NCT03596424|Adrenergic Agents|adrenergic agents|mesh-ancestor
24695425|NCT03596424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24695430|NCT03596424|Anesthetics|anesthetics|mesh-ancestor
24695487|NCT03417154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24695488|NCT03417154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24695489|NCT03417154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24695490|NCT03417154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24695492|NCT03375203|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24695529|NCT03158389|Atezolizumab|atezolizumab|mesh-list
24695530|NCT03158389|Palbociclib|palbociclib|mesh-list
24695531|NCT03158389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24695532|NCT03158389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24695533|NCT03158389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24695543|NCT03142035|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25777268|NCT03723447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25777269|NCT03723447|Antiemetics|antiemetics|mesh-ancestor
25777270|NCT03723447|Autonomic Agents|autonomic agents|mesh-ancestor
25777271|NCT03723447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25777272|NCT03723447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777273|NCT03723447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25777274|NCT03723447|Glucocorticoids|glucocorticoids|mesh-ancestor
25777275|NCT03723447|Hormones|hormones|mesh-ancestor
24695566|NCT02926833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24695624|NCT02547662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24695625|NCT02547662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24695626|NCT02547662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24695627|NCT02547662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695628|NCT02547662|Protease Inhibitors|protease inhibitors|mesh-ancestor
24695629|NCT02547662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24695630|NCT02547662|Immunologic Factors|immunologic factors|mesh-ancestor
24695631|NCT02547662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24695632|NCT02547662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24695677|NCT02246257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695678|NCT02246257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24695679|NCT02246257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24695680|NCT02246257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24695681|NCT02246257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24695682|NCT02246257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24695683|NCT02246257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24695684|NCT02246257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24695685|NCT02197221|Bortezomib|bortezomib|mesh-list
24695686|NCT02197221|Melphalan|melphalan|mesh-list
24695687|NCT02197221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24695727|NCT01949714|Epinephrine|epinephrine|mesh-list
24612565|NCT01014481|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24612567|NCT01014481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24612568|NCT01014481|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24612570|NCT01014507|Contraceptive Agents|contraceptive agents|mesh-list
24612571|NCT01014507|Contraceptives, Oral|contraceptives, oral|mesh-list
24612572|NCT01014507|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24612573|NCT01014507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612574|NCT01014507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24612575|NCT01014507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24695945|NCT01426633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24695946|NCT01426633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24695947|NCT01426633|Antiviral Agents|antiviral agents|mesh-ancestor
24695948|NCT01426633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25714932|NCT02363946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714933|NCT02363946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25714934|NCT02363946|Antipruritics|antipruritics|mesh-ancestor
25714935|NCT02363946|Dermatologic Agents|dermatologic agents|mesh-ancestor
25714936|NCT02364037|Contraceptive Agents|contraceptive agents|mesh-list
25714937|NCT02364037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25714938|NCT02364037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714939|NCT02364076|Pembrolizumab|pembrolizumab|mesh-list
24695949|NCT01426633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24695950|NCT01426633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24695951|NCT01426633|Immunologic Factors|immunologic factors|mesh-ancestor
24695952|NCT01426633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695953|NCT01426633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24695954|NCT01426633|Alkylating Agents|alkylating agents|mesh-ancestor
24695955|NCT01426646|Cisplatin|cisplatin|mesh-list
24695956|NCT01426646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24695957|NCT01426737|Vildagliptin|vildagliptin|mesh-list
24695958|NCT01426737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24695959|NCT01426737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24695960|NCT01426737|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24695961|NCT01426737|Protease Inhibitors|protease inhibitors|mesh-ancestor
24695962|NCT01426737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24695981|NCT01426880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24695982|NCT01426880|Tubulin Modulators|tubulin modulators|mesh-ancestor
24695983|NCT01426880|Antimitotic Agents|antimitotic agents|mesh-ancestor
24695984|NCT01426880|Mitosis Modulators|mitosis modulators|mesh-ancestor
24695987|NCT01426880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24695988|NCT01426906|Rifampin|rifampin|mesh-list
24695989|NCT01426906|Ketoconazole|ketoconazole|mesh-list
24695990|NCT01426906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24695991|NCT01426906|Antitubercular Agents|antitubercular agents|mesh-ancestor
24695992|NCT01426906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24695993|NCT01426906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24695994|NCT01426906|Leprostatic Agents|leprostatic agents|mesh-ancestor
24695995|NCT01426906|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24695996|NCT01426906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24696028|NCT01426971|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24696029|NCT01426971|Purinergic Agents|purinergic agents|mesh-ancestor
24696030|NCT01426971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24696031|NCT01426984|Methylphenidate|methylphenidate|mesh-list
24696032|NCT01426984|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24696033|NCT01426984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696034|NCT01426984|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24696035|NCT01426984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24696036|NCT01426984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24696037|NCT01426984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696038|NCT01426984|Dopamine Agents|dopamine agents|mesh-ancestor
24696039|NCT01426984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24696040|NCT01427114|Prednisolone|prednisolone|mesh-list
24696041|NCT01427114|Cyclophosphamide|cyclophosphamide|mesh-list
24696043|NCT01427114|Vincristine|vincristine|mesh-list
24696044|NCT01427114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24696045|NCT01427114|Immunologic Factors|immunologic factors|mesh-ancestor
24696046|NCT01427114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696047|NCT01427114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24696048|NCT01427114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24696049|NCT01427114|Alkylating Agents|alkylating agents|mesh-ancestor
25714940|NCT02364076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25714941|NCT02364076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25714942|NCT02364336|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25714943|NCT02364336|Antiviral Agents|antiviral agents|mesh-ancestor
25714944|NCT02364336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25714945|NCT02364947|Nalmefene|nalmefene|mesh-list
25714946|NCT02364947|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25714947|NCT02364947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696054|NCT01427114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24481575|NCT00435747|Analgesics|analgesics|mesh-ancestor
24612596|NCT01014520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24612597|NCT01014520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24612598|NCT01014520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24612599|NCT01014520|Adrenergic Agents|adrenergic agents|mesh-ancestor
24612612|NCT01014559|Narcotics|narcotics|mesh-ancestor
24612613|NCT01014559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24612640|NCT01014650|Glycine|glycine|mesh-list
24612641|NCT01014650|Glycine Agents|glycine agents|mesh-ancestor
24612642|NCT01014650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24612643|NCT01014650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612654|NCT01014832|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24612655|NCT01014832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24612656|NCT01014832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612657|NCT01014845|Vaccines|vaccines|mesh-list
24612658|NCT01014845|Immunologic Factors|immunologic factors|mesh-ancestor
24612659|NCT01014845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612660|NCT01014858|Donepezil|donepezil|mesh-list
24612661|NCT01014858|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24696059|NCT01427114|Glucocorticoids|glucocorticoids|mesh-ancestor
24696060|NCT01427114|Hormones|hormones|mesh-ancestor
24696061|NCT01427114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24696217|NCT01428180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24696218|NCT01428180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24696220|NCT01428180|Sensory System Agents|sensory system agents|mesh-ancestor
24696221|NCT01428180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24696222|NCT01428180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696223|NCT01428180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24696224|NCT01428180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24696278|NCT01428427|Antiviral Agents|antiviral agents|mesh-ancestor
24696280|NCT01428427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24696281|NCT01428427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24696282|NCT01428427|Immunologic Factors|immunologic factors|mesh-ancestor
24696283|NCT01428427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481804|NCT00436826|Interferons|interferons|mesh-list
24696284|NCT01428427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24696286|NCT01428466|Dermatologic Agents|dermatologic agents|mesh-ancestor
24696287|NCT01428492|Dexamethasone|dexamethasone|mesh-list
25714949|NCT02364947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25714950|NCT02364999|Paclitaxel|paclitaxel|mesh-list
25714951|NCT02364999|Bevacizumab|bevacizumab|mesh-list
25714952|NCT02364999|Carboplatin|carboplatin|mesh-list
25714953|NCT02364999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25714954|NCT02364999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25714955|NCT02364999|Tubulin Modulators|tubulin modulators|mesh-ancestor
25714956|NCT02364999|Antimitotic Agents|antimitotic agents|mesh-ancestor
24696289|NCT01428492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24696290|NCT01428492|Antiemetics|antiemetics|mesh-ancestor
24696291|NCT01428492|Autonomic Agents|autonomic agents|mesh-ancestor
24696309|NCT01428518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24696310|NCT01428518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24696311|NCT01428518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24696313|NCT01428531|Fondaparinux|fondaparinux|mesh-list
24696314|NCT01428531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24696315|NCT01428531|Antithrombins|antithrombins|mesh-ancestor
24696316|NCT01428531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24696362|NCT01429025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24696363|NCT01429025|Immunologic Factors|immunologic factors|mesh-ancestor
24696365|NCT01429025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24696475|NCT01429701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696476|NCT01429701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24696477|NCT01429701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24696478|NCT01429701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24696479|NCT01429701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24696480|NCT01429701|Respiratory System Agents|respiratory system agents|mesh-ancestor
24696481|NCT01429701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24696482|NCT01429701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24696483|NCT01429701|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24696484|NCT01429701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24696485|NCT01429701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696486|NCT01429701|Anesthetics, Local|anesthetics, local|mesh-ancestor
24696488|NCT01429701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24696496|NCT01429714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696497|NCT01429714|Sympathomimetics|sympathomimetics|mesh-ancestor
24696561|NCT01430013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24696562|NCT01430013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24696563|NCT01430013|Growth Substances|growth substances|mesh-ancestor
24696564|NCT01430013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24696565|NCT01430013|Growth Inhibitors|growth inhibitors|mesh-ancestor
24696566|NCT01430013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24696567|NCT01430052|Gemcitabine|gemcitabine|mesh-list
24696568|NCT01430052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24696569|NCT01430052|Antimetabolites|antimetabolites|mesh-ancestor
24696570|NCT01430052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24696571|NCT01430052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24696572|NCT01430052|Antiviral Agents|antiviral agents|mesh-ancestor
24696573|NCT01430052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24696574|NCT01430052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612662|NCT01014858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612664|NCT01014858|Cholinergic Agents|cholinergic agents|mesh-ancestor
24696634|NCT01430351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24696635|NCT01430351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24696636|NCT01430351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24696747|NCT01431326|Clozapine|clozapine|mesh-list
24696748|NCT01431326|Molindone|molindone|mesh-list
24696999|NCT01432080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24697052|NCT01432496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24697053|NCT01432496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697054|NCT01432496|Sensory System Agents|sensory system agents|mesh-ancestor
24697055|NCT01432496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24697056|NCT01432522|Epinephrine|epinephrine|mesh-list
24697057|NCT01432522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24697058|NCT01432522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24697059|NCT01432522|Adrenergic Agents|adrenergic agents|mesh-ancestor
24697060|NCT01432522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24697061|NCT01432522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697062|NCT01432522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697063|NCT01432522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24697064|NCT01432522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24697065|NCT01432522|Autonomic Agents|autonomic agents|mesh-ancestor
24697066|NCT01432522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24697072|NCT01432587|Diflunisal|diflunisal|mesh-list
24697089|NCT01432665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697090|NCT01432665|Vasodilator Agents|vasodilator agents|mesh-ancestor
25714957|NCT02364999|Mitosis Modulators|mitosis modulators|mesh-ancestor
25714958|NCT02364999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714959|NCT02364999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25714960|NCT02364999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25714961|NCT02364999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25714962|NCT02364999|Growth Substances|growth substances|mesh-ancestor
25714963|NCT02364999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714964|NCT02364999|Growth Inhibitors|growth inhibitors|mesh-ancestor
24697093|NCT01432665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24697094|NCT01432665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697146|NCT01432977|Dermatologic Agents|dermatologic agents|mesh-ancestor
24697147|NCT01432977|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24697149|NCT01432977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24697150|NCT01432977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697151|NCT01432977|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24697152|NCT01432977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24697154|NCT01432977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24697194|NCT01433614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697195|NCT01433614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24697196|NCT01433614|Antimetabolites|antimetabolites|mesh-ancestor
24697419|NCT01434459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697420|NCT01434459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697421|NCT01434459|Antiviral Agents|antiviral agents|mesh-ancestor
24612765|NCT01015339|Tubulin Modulators|tubulin modulators|mesh-ancestor
24612766|NCT01015339|Antimitotic Agents|antimitotic agents|mesh-ancestor
24612767|NCT01015339|Mitosis Modulators|mitosis modulators|mesh-ancestor
24612768|NCT01015339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612769|NCT01015339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24612770|NCT01015339|Antimetabolites|antimetabolites|mesh-ancestor
24697571|NCT01435499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697572|NCT01435499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24697573|NCT01435499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24697574|NCT01435499|Alkylating Agents|alkylating agents|mesh-ancestor
24697683|NCT01436513|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24697684|NCT01436513|Estrogens|estrogens|mesh-ancestor
24697686|NCT01436513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24697717|NCT01436838|Interferon-beta|interferon-beta|mesh-list
24697718|NCT01436838|Interferon beta-1b|interferon beta-1b|mesh-list
24697719|NCT01436838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24697720|NCT01436838|Antiviral Agents|antiviral agents|mesh-ancestor
24697721|NCT01436838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24697722|NCT01436838|Immunologic Factors|immunologic factors|mesh-ancestor
24697723|NCT01436838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697724|NCT01436838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24697906|NCT01437813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697907|NCT01437813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24697908|NCT01437813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24697909|NCT01437813|Immunologic Factors|immunologic factors|mesh-ancestor
24697911|NCT01437826|Antioxidants|antioxidants|mesh-list
24697912|NCT01437826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697913|NCT01437826|Protective Agents|protective agents|mesh-ancestor
24697914|NCT01437826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697991|NCT01438320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24697993|NCT01438320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24697994|NCT01438359|Furosemide|furosemide|mesh-list
24697995|NCT01438359|Diuretics|diuretics|mesh-ancestor
24697996|NCT01438359|Natriuretic Agents|natriuretic agents|mesh-ancestor
25714965|NCT02365285|Heparin|heparin|mesh-list
25714966|NCT02365285|Galantamine|galantamine|mesh-list
25714967|NCT02365285|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25714968|NCT02365285|Anticoagulants|anticoagulants|mesh-ancestor
25714969|NCT02365285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25714970|NCT02365285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25714971|NCT02365285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714972|NCT02365285|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
24698255|NCT01440114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24698256|NCT01440114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24698257|NCT01440114|Anesthetics, General|anesthetics, general|mesh-ancestor
24698260|NCT01440127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24698261|NCT01440127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698262|NCT01440140|Insulin|insulin|mesh-list
24698263|NCT01440140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24612814|NCT01015482|Midazolam|midazolam|mesh-list
24612817|NCT01015482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24612818|NCT01015482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24612819|NCT01015482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612820|NCT01015482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24698347|NCT01440673|Antiemetics|antiemetics|mesh-ancestor
24698348|NCT01440673|Autonomic Agents|autonomic agents|mesh-ancestor
24698461|NCT01441284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24698462|NCT01441284|Dopamine Agonists|dopamine agonists|mesh-ancestor
24698463|NCT01441284|Dopamine Agents|dopamine agents|mesh-ancestor
24698464|NCT01441284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24698465|NCT01441297|Nintedanib|nintedanib|mesh-list
24698466|NCT01441297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24698467|NCT01441297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24698468|NCT01441297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698469|NCT01441297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698470|NCT01441388|Bevacizumab|bevacizumab|mesh-list
24698471|NCT01441388|Sunitinib|sunitinib|mesh-list
24698472|NCT01441388|Sorafenib|sorafenib|mesh-list
24698473|NCT01441388|Axitinib|axitinib|mesh-list
24698516|NCT01441531|Anticonvulsants|anticonvulsants|mesh-ancestor
24698517|NCT01441531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24698518|NCT01441531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24698519|NCT01441531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24698520|NCT01441531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24698521|NCT01441531|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24698522|NCT01441531|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24698532|NCT01441557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698533|NCT01441700|Anesthetics|anesthetics|mesh-list
24698534|NCT01441700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24698581|NCT01441986|Antitussive Agents|antitussive agents|mesh-ancestor
24698594|NCT01441986|Analgesics|analgesics|mesh-ancestor
24698595|NCT01441986|Sensory System Agents|sensory system agents|mesh-ancestor
24550148|NCT00719381|Pioglitazone|pioglitazone|mesh-list
24698596|NCT01441986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24698598|NCT01442025|Dermatologic Agents|dermatologic agents|mesh-ancestor
24698599|NCT01442025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24698600|NCT01442025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24698601|NCT01442168|Atovaquone|atovaquone|mesh-list
24698602|NCT01442168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24698603|NCT01442168|Antimalarials|antimalarials|mesh-ancestor
24698604|NCT01442168|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24698605|NCT01442168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25714973|NCT02365285|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24698606|NCT01442168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24698607|NCT01442168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24698608|NCT01442272|Calcifediol|calcifediol|mesh-list
24698609|NCT01442272|Vitamins|vitamins|mesh-ancestor
25714974|NCT02365285|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25714975|NCT02365285|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25714976|NCT02365285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25714977|NCT02365285|Cholinergic Agents|cholinergic agents|mesh-ancestor
25714978|NCT02365285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25714979|NCT02365285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25714980|NCT02365285|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24612851|NCT01015547|Antimetabolites|antimetabolites|mesh-ancestor
24612852|NCT01015547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612853|NCT01015547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612854|NCT01015547|Dermatologic Agents|dermatologic agents|mesh-ancestor
24612855|NCT01015547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612858|NCT01015547|Immunologic Factors|immunologic factors|mesh-ancestor
24612869|NCT01015547|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24612870|NCT01015547|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24612871|NCT01015651|Remifentanil|remifentanil|mesh-list
24612872|NCT01015651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24612873|NCT01015651|Narcotics|narcotics|mesh-ancestor
24612874|NCT01015651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24612875|NCT01015651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612876|NCT01015651|Analgesics|analgesics|mesh-ancestor
24612877|NCT01015651|Sensory System Agents|sensory system agents|mesh-ancestor
24612878|NCT01015651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24612879|NCT01015664|Sirolimus|sirolimus|mesh-list
24612880|NCT01015664|Cetuximab|cetuximab|mesh-list
24612881|NCT01015664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612882|NCT01015664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24612884|NCT01015664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24612885|NCT01015664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24612886|NCT01015664|Antifungal Agents|antifungal agents|mesh-ancestor
24698740|NCT01442818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24698741|NCT01442818|Analgesics|analgesics|mesh-ancestor
24698742|NCT01442818|Sensory System Agents|sensory system agents|mesh-ancestor
24698743|NCT01442818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24612915|NCT01015794|Autonomic Agents|autonomic agents|mesh-ancestor
24612916|NCT01015794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24612917|NCT01015794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24612918|NCT01015794|Adrenergic Agents|adrenergic agents|mesh-ancestor
24612919|NCT01015794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24612920|NCT01015794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612921|NCT01015794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24612922|NCT01015794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24612923|NCT01015794|Respiratory System Agents|respiratory system agents|mesh-ancestor
24612924|NCT01015794|Nasal Decongestants|nasal decongestants|mesh-ancestor
24612925|NCT01015937|Losartan|losartan|mesh-list
24612926|NCT01015937|Enalapril|enalapril|mesh-list
24612927|NCT01015937|Angiotensin II|angiotensin ii|mesh-list
24612928|NCT01015937|Giapreza|giapreza|mesh-list
24612929|NCT01015937|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
24612951|NCT01016041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24612952|NCT01016041|Tubulin Modulators|tubulin modulators|mesh-ancestor
24612953|NCT01016041|Antimitotic Agents|antimitotic agents|mesh-ancestor
24612954|NCT01016041|Mitosis Modulators|mitosis modulators|mesh-ancestor
24612955|NCT01016041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699139|NCT01445210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24699140|NCT01445210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699141|NCT01445210|Sensory System Agents|sensory system agents|mesh-ancestor
24699142|NCT01445210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24699143|NCT01445223|Ritonavir|ritonavir|mesh-list
24699144|NCT01445223|Lopinavir|lopinavir|mesh-list
24699145|NCT01445223|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24699163|NCT01445223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24699164|NCT01445223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24699165|NCT01445236|Cyclosporine|cyclosporine|mesh-list
24699166|NCT01445236|Tacrolimus|tacrolimus|mesh-list
24699167|NCT01445236|Cyclosporins|cyclosporins|mesh-list
24699168|NCT01445236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24699169|NCT01445236|Immunologic Factors|immunologic factors|mesh-ancestor
24699170|NCT01445236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699171|NCT01445236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25714981|NCT02365285|Autonomic Agents|autonomic agents|mesh-ancestor
24699206|NCT01445405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24612966|NCT01016054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24612967|NCT01016054|Antiviral Agents|antiviral agents|mesh-ancestor
24612968|NCT01016054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24612969|NCT01016054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24612970|NCT01016054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24612971|NCT01016054|Immunologic Factors|immunologic factors|mesh-ancestor
24612972|NCT01016054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612973|NCT01016054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24612974|NCT01016054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24612975|NCT01016054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24612976|NCT01016093|Zoledronic Acid|zoledronic acid|mesh-list
24612977|NCT01016093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24612983|NCT01016145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24612984|NCT01016158|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24699671|NCT01448330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24699673|NCT01448330|Purinergic Agents|purinergic agents|mesh-ancestor
24699674|NCT01448330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24699675|NCT01448395|Avibactam|avibactam|mesh-list
24699676|NCT01448395|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24612998|NCT01016223|Respiratory System Agents|respiratory system agents|mesh-ancestor
24612999|NCT01016249|Epinephrine|epinephrine|mesh-list
24613000|NCT01016249|Racepinephrine|racepinephrine|mesh-list
24613001|NCT01016249|Epinephryl borate|epinephryl borate|mesh-list
24613002|NCT01016249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24613003|NCT01016249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24613004|NCT01016249|Adrenergic Agents|adrenergic agents|mesh-ancestor
24613005|NCT01016249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24613006|NCT01016249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613007|NCT01016249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613008|NCT01016249|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24613009|NCT01016249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24613010|NCT01016249|Autonomic Agents|autonomic agents|mesh-ancestor
24699815|NCT01449188|Autonomic Agents|autonomic agents|mesh-ancestor
24699881|NCT01449435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699882|NCT01449448|Triamcinolone|triamcinolone|mesh-list
24699884|NCT01449448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24699885|NCT01449448|Glucocorticoids|glucocorticoids|mesh-ancestor
24699886|NCT01449448|Hormones|hormones|mesh-ancestor
24699887|NCT01449448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24699888|NCT01449448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24699889|NCT01449448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24699890|NCT01449448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24699891|NCT01449448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24699892|NCT01449448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24699893|NCT01449448|Analgesics|analgesics|mesh-ancestor
24699917|NCT01449578|Dopamine Agonists|dopamine agonists|mesh-ancestor
24700019|NCT01450163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24700020|NCT01450163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24700021|NCT01450163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24700022|NCT01450176|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
24700023|NCT01450176|Bepotastine besilate|bepotastine besilate|mesh-list
24700024|NCT01450176|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24700025|NCT01450176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25714982|NCT02365285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25714983|NCT02365285|Nootropic Agents|nootropic agents|mesh-ancestor
25714984|NCT02365519|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25714985|NCT02365519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25714986|NCT02365558|Omeprazole|omeprazole|mesh-list
25714987|NCT02365558|Evacetrapib|evacetrapib|mesh-list
25714988|NCT02365558|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25714989|NCT02365558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25714990|NCT02365558|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25714991|NCT02365558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700026|NCT01450176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24700168|NCT01451060|Adrenergic Agents|adrenergic agents|mesh-ancestor
24700169|NCT01451060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24643745|NCT01187108|Antiviral Agents|antiviral agents|mesh-ancestor
24700170|NCT01451060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700180|NCT01451229|Adrenergic Agents|adrenergic agents|mesh-ancestor
24700181|NCT01451229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24700182|NCT01451229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700183|NCT01451229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700184|NCT01451229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24700252|NCT01451580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24700253|NCT01451580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24700254|NCT01451580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24700256|NCT01451593|Anticonvulsants|anticonvulsants|mesh-ancestor
24700257|NCT01451593|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24700258|NCT01451593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24700259|NCT01451593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24700286|NCT01451710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24700287|NCT01451710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24700288|NCT01451710|Antiemetics|antiemetics|mesh-ancestor
24700289|NCT01451710|Autonomic Agents|autonomic agents|mesh-ancestor
24700290|NCT01451710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24700291|NCT01451710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24700292|NCT01451710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24700293|NCT01451710|Protective Agents|protective agents|mesh-ancestor
24700294|NCT01451788|Thrombin|thrombin|mesh-list
24700295|NCT01451788|Hemostatics|hemostatics|mesh-ancestor
24700337|NCT01451879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700339|NCT01451879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24700461|NCT01452607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700462|NCT01452607|Protective Agents|protective agents|mesh-ancestor
24700463|NCT01452607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24700464|NCT01452607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700465|NCT01452607|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24700466|NCT01452633|Bupivacaine|bupivacaine|mesh-list
24486084|NCT00456248|Ribavirin|ribavirin|mesh-list
24700467|NCT01452633|Anesthetics, Local|anesthetics, local|mesh-ancestor
24700483|NCT01452685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24700484|NCT01452685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24700485|NCT01452685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24700486|NCT01452685|Androgen Antagonists|androgen antagonists|mesh-ancestor
24700492|NCT01452698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24700493|NCT01452698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24700494|NCT01452698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25714992|NCT02365558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25714993|NCT02365558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25714994|NCT02365558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25714995|NCT02365558|Antimetabolites|antimetabolites|mesh-ancestor
25714996|NCT02365558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25714997|NCT02365584|Lanreotide|lanreotide|mesh-list
25714998|NCT02365584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25714999|NCT02365870|Rotigotine|rotigotine|mesh-list
25715000|NCT02365870|Dopamine Agonists|dopamine agonists|mesh-ancestor
25715002|NCT02365870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24700495|NCT01452698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700496|NCT01452711|Lansoprazole|lansoprazole|mesh-list
24700497|NCT01452711|Dexlansoprazole|dexlansoprazole|mesh-list
24700498|NCT01452711|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24700499|NCT01452711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24613106|NCT01017107|Anticoagulants|anticoagulants|mesh-ancestor
24613107|NCT01017107|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24613108|NCT01017107|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24613109|NCT01017107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613110|NCT01017107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24613111|NCT01017133|Deoxyglucose|deoxyglucose|mesh-list
24613112|NCT01017133|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
24613113|NCT01017133|Fluorides|fluorides|mesh-list
24613114|NCT01017133|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24613119|NCT01017133|Antimetabolites|antimetabolites|mesh-ancestor
24700513|NCT01452737|Laxatives|laxatives|mesh-ancestor
24700514|NCT01452750|Lansoprazole|lansoprazole|mesh-list
24700515|NCT01452750|Dexlansoprazole|dexlansoprazole|mesh-list
24700529|NCT01452828|Tedizolid|tedizolid|mesh-list
24700649|NCT01453920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24700650|NCT01453933|Raltegravir Potassium|raltegravir potassium|mesh-list
24700651|NCT01453933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24700652|NCT01453933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24700653|NCT01453933|Antiviral Agents|antiviral agents|mesh-ancestor
24700654|NCT01453933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24700655|NCT01453933|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24700656|NCT01453933|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24700657|NCT01453933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700658|NCT01453933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700659|NCT01453959|Fludrocortisone|fludrocortisone|mesh-list
24700660|NCT01453959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24700661|NCT01454011|Methyltestosterone|methyltestosterone|mesh-list
24700856|NCT01455506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24700857|NCT01455506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24700858|NCT01455506|Antimetabolites|antimetabolites|mesh-ancestor
24700860|NCT01455506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24700871|NCT01455532|Iniparib|iniparib|mesh-list
24700872|NCT01455532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24700873|NCT01455532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24700874|NCT01455532|Antimetabolites|antimetabolites|mesh-ancestor
24700875|NCT01455532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700876|NCT01455532|Antiviral Agents|antiviral agents|mesh-ancestor
24700877|NCT01455532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24700878|NCT01455532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24700879|NCT01455532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24700880|NCT01455532|Immunologic Factors|immunologic factors|mesh-ancestor
24700914|NCT01455831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700915|NCT01455883|Glimepiride|glimepiride|mesh-list
24700916|NCT01455883|Exenatide|exenatide|mesh-list
25715003|NCT02365870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715004|NCT02365870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715005|NCT02365961|Clonidine|clonidine|mesh-list
25715006|NCT02365961|Epinephrine|epinephrine|mesh-list
25715007|NCT02365961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25715008|NCT02365961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25715009|NCT02365961|Adrenergic Agents|adrenergic agents|mesh-ancestor
25715010|NCT02365961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25715011|NCT02365961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613203|NCT01017679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24613204|NCT01017744|Anesthetics|anesthetics|mesh-list
24613205|NCT01017744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24613206|NCT01017744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24613207|NCT01017770|Artesunate|artesunate|mesh-list
24613208|NCT01017770|Lumefantrine|lumefantrine|mesh-list
24613209|NCT01017770|Artemether|artemether|mesh-list
24700952|NCT01455935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24700953|NCT01455974|Dialysis Solutions|dialysis solutions|mesh-list
24701061|NCT01456546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24701062|NCT01456546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701063|NCT01456546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701065|NCT01456546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24701066|NCT01456546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24701067|NCT01456546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24701068|NCT01456546|Antimetabolites|antimetabolites|mesh-ancestor
24701069|NCT01456585|Gemcitabine|gemcitabine|mesh-list
24701080|NCT01456611|Diclofenac|diclofenac|mesh-list
24701134|NCT01457131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24701135|NCT01457131|Immunologic Factors|immunologic factors|mesh-ancestor
24701136|NCT01457131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701137|NCT01457131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24701138|NCT01457131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24701139|NCT01457131|Alkylating Agents|alkylating agents|mesh-ancestor
24701140|NCT01457131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701141|NCT01457131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701142|NCT01457131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24701144|NCT01457261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24701145|NCT01457261|Autonomic Agents|autonomic agents|mesh-ancestor
24701218|NCT01457716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24701219|NCT01457716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701220|NCT01457716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24701221|NCT01457716|Respiratory System Agents|respiratory system agents|mesh-ancestor
24701222|NCT01457716|Glucocorticoids|glucocorticoids|mesh-ancestor
24701273|NCT01458015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701274|NCT01458015|Analgesics|analgesics|mesh-ancestor
24701275|NCT01458015|Sensory System Agents|sensory system agents|mesh-ancestor
24701276|NCT01458015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24701277|NCT01458015|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24701278|NCT01458015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24701279|NCT01458015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24701280|NCT01458015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701282|NCT01458015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24701283|NCT01458041|Iloprost|iloprost|mesh-list
24701285|NCT01458041|Vasodilator Agents|vasodilator agents|mesh-ancestor
24701330|NCT01458431|Sensory System Agents|sensory system agents|mesh-ancestor
24701331|NCT01458431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24701332|NCT01458470|Memantine|memantine|mesh-list
24701333|NCT01458470|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24701334|NCT01458470|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24701335|NCT01458470|Dopamine Agents|dopamine agents|mesh-ancestor
24701336|NCT01458470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24701337|NCT01458470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701338|NCT01458470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701339|NCT01458470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24701342|NCT01458548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24701343|NCT01458548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24701344|NCT01458548|Immunologic Factors|immunologic factors|mesh-ancestor
24701345|NCT01458548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701346|NCT01458548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24701432|NCT01458977|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24701433|NCT01458977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24701434|NCT01458977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701435|NCT01458977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701436|NCT01458977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24701437|NCT01458977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24701438|NCT01459081|Zanamivir|zanamivir|mesh-list
24701439|NCT01459081|Antiviral Agents|antiviral agents|mesh-ancestor
24701440|NCT01459081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24701441|NCT01459081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24701442|NCT01459081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701443|NCT01459133|Insulin|insulin|mesh-list
24701581|NCT01459601|Cabergoline|cabergoline|mesh-list
24701582|NCT01459601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24701583|NCT01459601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24701584|NCT01459601|Dopamine Agonists|dopamine agonists|mesh-ancestor
24701585|NCT01459601|Dopamine Agents|dopamine agents|mesh-ancestor
24701586|NCT01459601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24701587|NCT01459601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24701588|NCT01459601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24701589|NCT01459627|Ticagrelor|ticagrelor|mesh-list
24633928|NCT01131728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24633929|NCT01131728|Gout Suppressants|gout suppressants|mesh-ancestor
24633930|NCT01131728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24633931|NCT01131728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24633932|NCT01131728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633933|NCT01131728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24634046|NCT01131923|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24634047|NCT01131923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24443330|NCT00294502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634050|NCT01131923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634272|NCT01132677|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24634273|NCT01132677|Prednisolone phosphate|prednisolone phosphate|mesh-list
24634274|NCT01132677|Hylan|hylan|mesh-list
24634410|NCT01133444|Finasteride|finasteride|mesh-list
24634411|NCT01133444|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24634412|NCT01133444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24634413|NCT01133444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24634432|NCT01133470|Autonomic Agents|autonomic agents|mesh-ancestor
24634433|NCT01133470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24634434|NCT01133470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24634457|NCT01133483|Respiratory System Agents|respiratory system agents|mesh-ancestor
24634458|NCT01133483|Nasal Decongestants|nasal decongestants|mesh-ancestor
24634459|NCT01133483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24634460|NCT01133483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24634462|NCT01133483|Adrenergic Agents|adrenergic agents|mesh-ancestor
24634463|NCT01133483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24634464|NCT01133483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634465|NCT01133483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24634586|NCT01134224|Insulin|insulin|mesh-list
24634865|NCT01135641|Cyclosporins|cyclosporins|mesh-list
24634866|NCT01135641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24634913|NCT01135758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24634917|NCT01135927|Insulin|insulin|mesh-list
24635047|NCT01136642|Nicotine|nicotine|mesh-list
24635048|NCT01136642|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24635049|NCT01136642|Autonomic Agents|autonomic agents|mesh-ancestor
24635050|NCT01136642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24635051|NCT01136642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635053|NCT01136642|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24635056|NCT01136642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635057|NCT01136759|Tenofovir|tenofovir|mesh-list
24635083|NCT01136863|Felodipine|felodipine|mesh-list
25715012|NCT02365961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715013|NCT02365961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25715014|NCT02365961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25715015|NCT02365961|Autonomic Agents|autonomic agents|mesh-ancestor
25715016|NCT02365961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25715017|NCT02365961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25715018|NCT02365961|Respiratory System Agents|respiratory system agents|mesh-ancestor
25715019|NCT02365961|Mydriatics|mydriatics|mesh-ancestor
25715020|NCT02365961|Sympathomimetics|sympathomimetics|mesh-ancestor
25715021|NCT02365961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25715022|NCT02365961|Analgesics|analgesics|mesh-ancestor
25715023|NCT02365961|Sensory System Agents|sensory system agents|mesh-ancestor
25715024|NCT02365961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25715025|NCT02365961|Sympatholytics|sympatholytics|mesh-ancestor
24635114|NCT01137019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24635115|NCT01137019|Immunologic Factors|immunologic factors|mesh-ancestor
24635116|NCT01137019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635151|NCT01137383|Interferons|interferons|mesh-list
24635152|NCT01137383|Ribavirin|ribavirin|mesh-list
24635153|NCT01137383|Interferon-alpha|interferon-alpha|mesh-list
24635154|NCT01137383|Interferon alpha-2|interferon alpha-2|mesh-list
24635155|NCT01137383|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24635156|NCT01137383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24635157|NCT01137383|Antiviral Agents|antiviral agents|mesh-ancestor
24635158|NCT01137383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24635159|NCT01137383|Antimetabolites|antimetabolites|mesh-ancestor
24635160|NCT01137383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635161|NCT01137383|Immunologic Factors|immunologic factors|mesh-ancestor
24635162|NCT01137383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635163|NCT01137591|Acetaminophen|acetaminophen|mesh-list
24635164|NCT01137591|Acetylcysteine|acetylcysteine|mesh-list
24635302|NCT01138137|Protective Agents|protective agents|mesh-ancestor
24635303|NCT01138137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635304|NCT01138137|Antidotes|antidotes|mesh-ancestor
24635306|NCT01138384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24635307|NCT01138384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24635308|NCT01138384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635309|NCT01138384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635310|NCT01138397|Vaccines|vaccines|mesh-list
24635311|NCT01138397|Immunologic Factors|immunologic factors|mesh-ancestor
24635312|NCT01138397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635313|NCT01138423|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24635314|NCT01138423|Moxonidine|moxonidine|mesh-list
24635315|NCT01138423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24635316|NCT01138423|Diuretics|diuretics|mesh-ancestor
24635317|NCT01138423|Natriuretic Agents|natriuretic agents|mesh-ancestor
24635318|NCT01138423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24635319|NCT01138423|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24635320|NCT01138423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24635322|NCT01138449|Vitamin A|vitamin a|mesh-list
24635443|NCT01139203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24635444|NCT01139372|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24635445|NCT01139372|Lubricant Eye Drops|lubricant eye drops|mesh-list
24635446|NCT01139372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24635448|NCT01139437|Immunologic Factors|immunologic factors|mesh-ancestor
24635450|NCT01139463|Haloperidol|haloperidol|mesh-list
24635571|NCT01140399|Diuretics|diuretics|mesh-ancestor
24635590|NCT01140412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24635591|NCT01140412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24635593|NCT01140412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24635594|NCT01140412|Antiviral Agents|antiviral agents|mesh-ancestor
24635597|NCT01140412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24635849|NCT01141452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24635850|NCT01141452|Respiratory System Agents|respiratory system agents|mesh-ancestor
24635851|NCT01141452|Dermatologic Agents|dermatologic agents|mesh-ancestor
24635852|NCT01141452|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24635854|NCT01141452|Hormones|hormones|mesh-ancestor
24635855|NCT01141452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24635856|NCT01141465|Fluticasone|fluticasone|mesh-list
25715026|NCT02365961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25715027|NCT02366091|Methotrexate|methotrexate|mesh-list
25715028|NCT02366091|Colchicine|colchicine|mesh-list
25715029|NCT02366091|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25715030|NCT02366091|Abortifacient Agents|abortifacient agents|mesh-ancestor
25715031|NCT02366091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24636183|NCT01143662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24636184|NCT01143805|Tofacitinib|tofacitinib|mesh-list
24636185|NCT01143805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24636186|NCT01143805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636187|NCT01143805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636189|NCT01143831|Vitamin K|vitamin k|mesh-list
24636190|NCT01143831|Vitamin K 2|vitamin k 2|mesh-list
24636191|NCT01143831|Menatetrenone|menatetrenone|mesh-list
24636192|NCT01143831|Micronutrients|micronutrients|mesh-ancestor
24636193|NCT01143831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636194|NCT01143831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24636195|NCT01143831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24636196|NCT01143831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636287|NCT01144533|Immunologic Factors|immunologic factors|mesh-ancestor
24636288|NCT01144533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636290|NCT01144533|Protective Agents|protective agents|mesh-ancestor
25715032|NCT02366091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715033|NCT02366091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25715034|NCT02366091|Antimetabolites|antimetabolites|mesh-ancestor
25715035|NCT02366091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715036|NCT02366091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25715037|NCT02366091|Dermatologic Agents|dermatologic agents|mesh-ancestor
25715038|NCT02366091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25715039|NCT02366091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24636566|NCT01146041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636567|NCT01146041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24636569|NCT01146067|Rivastigmine|rivastigmine|mesh-list
24636570|NCT01146067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24636571|NCT01146067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24636572|NCT01146067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636573|NCT01146067|Cholinergic Agents|cholinergic agents|mesh-ancestor
24636574|NCT01146067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24636652|NCT01146535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24636654|NCT01146548|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24636718|NCT01147029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24636763|NCT01147224|Ciclesonide|ciclesonide|mesh-list
24636764|NCT01147224|Glucocorticoids|glucocorticoids|mesh-ancestor
24636766|NCT01147224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24636767|NCT01147224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636768|NCT01147224|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24636769|NCT01147276|Vildagliptin|vildagliptin|mesh-list
24636770|NCT01147276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24636771|NCT01147276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24636772|NCT01147276|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24636773|NCT01147276|Protease Inhibitors|protease inhibitors|mesh-ancestor
24636774|NCT01147276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637511|NCT01150955|Resveratrol|resveratrol|mesh-list
24637512|NCT01150955|Antioxidants|antioxidants|mesh-ancestor
24637513|NCT01150955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637514|NCT01150955|Protective Agents|protective agents|mesh-ancestor
24637515|NCT01150955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637544|NCT01151267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637545|NCT01151306|Simvastatin|simvastatin|mesh-list
24637546|NCT01151306|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24637547|NCT01151306|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24637568|NCT01151397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24637569|NCT01151592|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24637571|NCT01151605|Insulin|insulin|mesh-list
24637572|NCT01151605|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24637573|NCT01151605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24637574|NCT01151605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637575|NCT01151670|Pioglitazone|pioglitazone|mesh-list
24637576|NCT01151670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24637578|NCT01151696|Hydroxyzine|hydroxyzine|mesh-list
24637743|NCT01152866|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
24637744|NCT01152866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24637793|NCT01153191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637794|NCT01153191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637797|NCT01153204|Sodium Citrate|sodium citrate|mesh-list
24637926|NCT01153919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24637927|NCT01153919|Immunologic Factors|immunologic factors|mesh-ancestor
24637928|NCT01153919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24637929|NCT01154114|Darapladib|darapladib|mesh-list
24637930|NCT01154114|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
24637931|NCT01154114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24637933|NCT01154348|Metformin|metformin|mesh-list
24637984|NCT01154426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24637986|NCT01154439|Etoposide|etoposide|mesh-list
24637988|NCT01154439|Idarubicin|idarubicin|mesh-list
24637989|NCT01154439|Etoposide phosphate|etoposide phosphate|mesh-list
24637991|NCT01154439|Ifosfamide|ifosfamide|mesh-list
24637992|NCT01154439|Carboplatin|carboplatin|mesh-list
24637993|NCT01154439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24637994|NCT01154439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24637995|NCT01154439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24637996|NCT01154439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24637997|NCT01154439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24638240|NCT01155505|Growth Inhibitors|growth inhibitors|mesh-ancestor
24638241|NCT01155505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638242|NCT01155635|Carvedilol|carvedilol|mesh-list
24638243|NCT01155635|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24638244|NCT01155635|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24638285|NCT01155895|Amlodipine|amlodipine|mesh-list
24638302|NCT01155908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638306|NCT01155908|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24638307|NCT01155908|Protease Inhibitors|protease inhibitors|mesh-ancestor
24638308|NCT01155908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24638309|NCT01155921|Risperidone|risperidone|mesh-list
24638310|NCT01155921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24638311|NCT01155921|Serotonin Agents|serotonin agents|mesh-ancestor
24638312|NCT01155921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24638313|NCT01155921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638333|NCT01155947|Anastrozole|anastrozole|mesh-list
24638426|NCT01156636|Urological Agents|urological agents|mesh-ancestor
24638427|NCT01156649|Acetaminophen|acetaminophen|mesh-list
24638428|NCT01156649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24638429|NCT01156649|Analgesics|analgesics|mesh-ancestor
24638430|NCT01156649|Sensory System Agents|sensory system agents|mesh-ancestor
24638431|NCT01156649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24638432|NCT01156649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638433|NCT01156649|Antipyretics|antipyretics|mesh-ancestor
24638434|NCT01156688|Misoprostol|misoprostol|mesh-list
24638435|NCT01156688|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24638436|NCT01156688|Abortifacient Agents|abortifacient agents|mesh-ancestor
24638437|NCT01156688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24638509|NCT01156883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24638510|NCT01156883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24638640|NCT01157455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638641|NCT01157455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24638642|NCT01157455|Immunologic Factors|immunologic factors|mesh-ancestor
24638662|NCT01157507|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24638663|NCT01157507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24638664|NCT01157507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24638665|NCT01157507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638666|NCT01157507|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24638667|NCT01157507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24638668|NCT01157507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638669|NCT01157507|Cholinergic Agents|cholinergic agents|mesh-ancestor
24638670|NCT01157507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24638671|NCT01157546|Lidocaine|lidocaine|mesh-list
24638672|NCT01157546|Anesthetics, Local|anesthetics, local|mesh-ancestor
24638673|NCT01157546|Anesthetics|anesthetics|mesh-ancestor
24638674|NCT01157546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24638675|NCT01157546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638676|NCT01157546|Sensory System Agents|sensory system agents|mesh-ancestor
24638677|NCT01157546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771042|NCT03582215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771043|NCT03582553|Naringenin|naringenin|mesh-list
25771044|NCT03582553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25771045|NCT03582553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25771046|NCT03582553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25771047|NCT03582553|Hormone Antagonists|hormone antagonists|mesh-ancestor
25771048|NCT03582553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25771049|NCT03582553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771050|NCT03583372|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25771051|NCT03583372|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25771052|NCT03583372|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24638726|NCT01157754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638727|NCT01157754|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24638728|NCT01157754|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24638731|NCT01157819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24638735|NCT01157819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24638736|NCT01157819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24638737|NCT01157819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24638828|NCT01158560|Vitamins|vitamins|mesh-ancestor
24638829|NCT01158560|Micronutrients|micronutrients|mesh-ancestor
24638830|NCT01158560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638831|NCT01158560|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24638832|NCT01158560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24638833|NCT01158586|Levobupivacaine|levobupivacaine|mesh-list
24638834|NCT01158586|Anesthetics, Local|anesthetics, local|mesh-ancestor
24638835|NCT01158586|Anesthetics|anesthetics|mesh-ancestor
24638877|NCT01158859|Sensory System Agents|sensory system agents|mesh-ancestor
24638878|NCT01158859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24638879|NCT01158859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24638880|NCT01158859|Anticonvulsants|anticonvulsants|mesh-ancestor
24638881|NCT01158859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24639053|NCT01159821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639054|NCT01159821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24639055|NCT01159821|Antidepressive Agents|antidepressive agents|mesh-ancestor
24639056|NCT01159821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24639057|NCT01159821|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24639058|NCT01159821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24639059|NCT01159821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24639060|NCT01159847|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24639105|NCT01160276|Dermatologic Agents|dermatologic agents|mesh-ancestor
24639106|NCT01160276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24639107|NCT01160276|Gout Suppressants|gout suppressants|mesh-ancestor
24639567|NCT01162902|Bisoprolol|bisoprolol|mesh-list
24639568|NCT01162902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24639569|NCT01162902|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24639570|NCT01162902|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24639571|NCT01162902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715040|NCT02366091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25715041|NCT02366091|Immunologic Factors|immunologic factors|mesh-ancestor
25715042|NCT02366091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25715043|NCT02366091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25715044|NCT02366091|Gout Suppressants|gout suppressants|mesh-ancestor
25715045|NCT02366091|Tubulin Modulators|tubulin modulators|mesh-ancestor
25715046|NCT02366091|Antimitotic Agents|antimitotic agents|mesh-ancestor
25715047|NCT02366091|Mitosis Modulators|mitosis modulators|mesh-ancestor
25771053|NCT03583372|Cholinergic Agents|cholinergic agents|mesh-ancestor
25771054|NCT03583372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25771055|NCT03583372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771056|NCT03583372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771057|NCT03583372|Urological Agents|urological agents|mesh-ancestor
25771058|NCT03583385|Metformin|metformin|mesh-list
25771059|NCT03583385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25771060|NCT03583385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771061|NCT03585504|Contraceptive Agents|contraceptive agents|mesh-list
25771062|NCT03585504|Etonogestrel|etonogestrel|mesh-list
25771063|NCT03585504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25771064|NCT03585504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771065|NCT03585504|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25771066|NCT03585504|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25771067|NCT03585712|Norgestrel|norgestrel|mesh-list
24639575|NCT01162902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639778|NCT01164176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639779|NCT01164176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24639780|NCT01164176|Immunologic Factors|immunologic factors|mesh-ancestor
24639781|NCT01164176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24639782|NCT01164189|Bevacizumab|bevacizumab|mesh-list
24639783|NCT01164189|Temozolomide|temozolomide|mesh-list
24639784|NCT01164189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24639785|NCT01164189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24639786|NCT01164189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24639924|NCT01164826|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24639925|NCT01164826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24639927|NCT01164826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640329|NCT01167725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24640330|NCT01167725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24640331|NCT01167725|Growth Substances|growth substances|mesh-ancestor
24640332|NCT01167725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640333|NCT01167725|Growth Inhibitors|growth inhibitors|mesh-ancestor
24640446|NCT01168063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24640447|NCT01168063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24640448|NCT01168063|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24640449|NCT01168063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640450|NCT01168063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640451|NCT01168063|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24640452|NCT01168063|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24640453|NCT01168336|Betahistine|betahistine|mesh-list
24640472|NCT01168492|Ketamine|ketamine|mesh-list
24640473|NCT01168492|Analgesics|analgesics|mesh-ancestor
24640474|NCT01168492|Sensory System Agents|sensory system agents|mesh-ancestor
24640475|NCT01168492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24640483|NCT01168492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24640493|NCT01168531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24640494|NCT01168531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640495|NCT01168531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24640496|NCT01168531|Glucocorticoids|glucocorticoids|mesh-ancestor
24640497|NCT01168531|Hormones|hormones|mesh-ancestor
24640654|NCT01169415|Protease Inhibitors|protease inhibitors|mesh-ancestor
24640655|NCT01169415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640656|NCT01169415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640658|NCT01169506|Trace Elements|trace elements|mesh-ancestor
24640659|NCT01169506|Micronutrients|micronutrients|mesh-ancestor
24640660|NCT01169506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640661|NCT01169571|Dexmedetomidine|dexmedetomidine|mesh-list
24640721|NCT01169792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24640722|NCT01169792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640754|NCT01169857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640756|NCT01169870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24640757|NCT01169870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640758|NCT01169870|Tubulin Modulators|tubulin modulators|mesh-ancestor
24640759|NCT01169870|Antimitotic Agents|antimitotic agents|mesh-ancestor
25715048|NCT02366130|Denosumab|denosumab|mesh-list
25715049|NCT02366130|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25715050|NCT02366130|Hormones|hormones|mesh-list
25715051|NCT02366130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25715052|NCT02366130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715053|NCT02366130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25715054|NCT02366130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24640761|NCT01169870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640762|NCT01169909|Ranibizumab|ranibizumab|mesh-list
24640763|NCT01169909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24640764|NCT01169909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24640774|NCT01169935|Dextrans|dextrans|mesh-list
24640817|NCT01170169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640840|NCT01170325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24640842|NCT01170338|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24640843|NCT01170338|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24640844|NCT01170338|Cholinergic Agents|cholinergic agents|mesh-ancestor
24640845|NCT01170338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24640846|NCT01170338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640847|NCT01170338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640848|NCT01170351|Cyclosporine|cyclosporine|mesh-list
24640849|NCT01170351|Cyclosporins|cyclosporins|mesh-list
24640850|NCT01170351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24640851|NCT01170351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640852|NCT01170351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24640854|NCT01170351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24640855|NCT01170351|Antifungal Agents|antifungal agents|mesh-ancestor
24640856|NCT01170351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24640857|NCT01170351|Dermatologic Agents|dermatologic agents|mesh-ancestor
24640858|NCT01170351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24640859|NCT01170351|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24640861|NCT01170429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24640862|NCT01170429|Autonomic Agents|autonomic agents|mesh-ancestor
24640863|NCT01170429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24640874|NCT01170442|Vitamin D|vitamin d|mesh-list
24640905|NCT01170585|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24640906|NCT01170585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24640907|NCT01170585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24640908|NCT01170585|Antimetabolites|antimetabolites|mesh-ancestor
24640909|NCT01170585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24640910|NCT01170585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24640911|NCT01170585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24641095|NCT01171859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24641096|NCT01171859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24641097|NCT01171859|Antimalarials|antimalarials|mesh-ancestor
24641098|NCT01171859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24641099|NCT01171859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24641100|NCT01171859|Antiviral Agents|antiviral agents|mesh-ancestor
24641101|NCT01171859|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24641102|NCT01171859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24641128|NCT01172002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24641129|NCT01172002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641130|NCT01172002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24641131|NCT01172002|Immunologic Factors|immunologic factors|mesh-ancestor
25715055|NCT02366143|Paclitaxel|paclitaxel|mesh-list
25715056|NCT02366143|Bevacizumab|bevacizumab|mesh-list
25715057|NCT02366143|Carboplatin|carboplatin|mesh-list
25715058|NCT02366143|Atezolizumab|atezolizumab|mesh-list
25715059|NCT02366143|Antibodies|antibodies|mesh-list
25715060|NCT02366143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25715061|NCT02366143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25715062|NCT02366143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25715063|NCT02366143|Tubulin Modulators|tubulin modulators|mesh-ancestor
25715064|NCT02366143|Antimitotic Agents|antimitotic agents|mesh-ancestor
25715065|NCT02366143|Mitosis Modulators|mitosis modulators|mesh-ancestor
25715066|NCT02366143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641132|NCT01172002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641133|NCT01172002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24641134|NCT01172002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641213|NCT01172444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24641214|NCT01172444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641215|NCT01172444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24641216|NCT01172444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24641217|NCT01172470|Gemcitabine|gemcitabine|mesh-list
24641218|NCT01172470|Carboplatin|carboplatin|mesh-list
24641219|NCT01172470|Pemetrexed|pemetrexed|mesh-list
24641220|NCT01172470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24641221|NCT01172470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24641222|NCT01172470|Antimetabolites|antimetabolites|mesh-ancestor
24641259|NCT01172626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24641261|NCT01172652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24641262|NCT01172652|Serotonin Agents|serotonin agents|mesh-ancestor
24641263|NCT01172652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24641264|NCT01172652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641265|NCT01172652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641413|NCT01173510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24641451|NCT01173627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24641452|NCT01173627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24641453|NCT01173627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24641454|NCT01173627|Anesthetics, General|anesthetics, general|mesh-ancestor
24641456|NCT01173640|Midazolam|midazolam|mesh-list
24641457|NCT01173640|Resveratrol|resveratrol|mesh-list
24641458|NCT01173640|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24641517|NCT01174017|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24641518|NCT01174017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24641519|NCT01174017|Trace Elements|trace elements|mesh-ancestor
24641520|NCT01174017|Micronutrients|micronutrients|mesh-ancestor
24641521|NCT01174017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641522|NCT01174056|Pioglitazone|pioglitazone|mesh-list
24641523|NCT01174056|Zileuton|zileuton|mesh-list
24641524|NCT01174056|Hydroxyurea|hydroxyurea|mesh-list
24641525|NCT01174056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24641526|NCT01174056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641601|NCT01174420|Mitomycin|mitomycin|mesh-list
24641836|NCT01175746|Narcotics|narcotics|mesh-ancestor
24641837|NCT01175746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24641838|NCT01175746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24641839|NCT01175746|Analgesics|analgesics|mesh-ancestor
24641872|NCT01175772|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24641873|NCT01175772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24641874|NCT01175772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24641875|NCT01175772|Alkylating Agents|alkylating agents|mesh-ancestor
24641876|NCT01175772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25715067|NCT02366143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25715068|NCT02366143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25715069|NCT02366143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25715070|NCT02366143|Growth Substances|growth substances|mesh-ancestor
25715071|NCT02366143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715072|NCT02366143|Growth Inhibitors|growth inhibitors|mesh-ancestor
25715074|NCT02366195|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25715075|NCT02366195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24641879|NCT01175954|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24641880|NCT01175954|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24641881|NCT01175954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24641882|NCT01175954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24641885|NCT01176175|Hormones|hormones|mesh-ancestor
24641980|NCT01176903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24642090|NCT01177514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642092|NCT01177566|Pimecrolimus|pimecrolimus|mesh-list
24454726|NCT03769311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24454727|NCT03768089|Ivacaftor|ivacaftor|mesh-list
24642093|NCT01177566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24642094|NCT01177566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24642095|NCT01177566|Analgesics|analgesics|mesh-ancestor
24642096|NCT01177566|Sensory System Agents|sensory system agents|mesh-ancestor
24642097|NCT01177566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24642098|NCT01177566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642099|NCT01177566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24642100|NCT01177566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24642101|NCT01177566|Dermatologic Agents|dermatologic agents|mesh-ancestor
24642102|NCT01177566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24642357|NCT01179009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24642361|NCT01179009|GABA Modulators|gaba modulators|mesh-ancestor
24642532|NCT01179971|Evening primrose oil|evening primrose oil|mesh-list
24642533|NCT01179971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24642534|NCT01179971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24642535|NCT01179971|Analgesics|analgesics|mesh-ancestor
24642536|NCT01179971|Sensory System Agents|sensory system agents|mesh-ancestor
24642537|NCT01179971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24642538|NCT01179971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642539|NCT01179971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24642540|NCT01179971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24642541|NCT01179971|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24642566|NCT01180075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24642567|NCT01180075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24642568|NCT01180075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24642569|NCT01180075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24642570|NCT01180075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24642571|NCT01180075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24642572|NCT01180153|Oxaliplatin|oxaliplatin|mesh-list
24642573|NCT01180153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642574|NCT01180166|Nimotuzumab|nimotuzumab|mesh-list
24642814|NCT01181505|Tolterodine Tartrate|tolterodine tartrate|mesh-list
24642815|NCT01181505|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24642867|NCT01181934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24642869|NCT01181934|Cholinergic Agents|cholinergic agents|mesh-ancestor
24642870|NCT01181934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24642873|NCT01181960|Paliperidone Palmitate|paliperidone palmitate|mesh-list
24642889|NCT01181999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24642890|NCT01181999|Immunologic Factors|immunologic factors|mesh-ancestor
24642891|NCT01181999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642892|NCT01181999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24642913|NCT01182129|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24642914|NCT01182129|Autonomic Agents|autonomic agents|mesh-ancestor
24642915|NCT01182129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24642916|NCT01182129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24642917|NCT01182129|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24642918|NCT01182129|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24642919|NCT01182129|Cholinergic Agents|cholinergic agents|mesh-ancestor
24642920|NCT01182129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24642921|NCT01182129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24642922|NCT01182142|Capecitabine|capecitabine|mesh-list
24642923|NCT01182142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24643031|NCT01183364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643033|NCT01183442|Ergocalciferols|ergocalciferols|mesh-list
24643034|NCT01183442|Cholecalciferol|cholecalciferol|mesh-list
24643035|NCT01183442|Vitamins|vitamins|mesh-list
25715076|NCT02366195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25715077|NCT02366468|Ranibizumab|ranibizumab|mesh-list
25715078|NCT02366468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25715079|NCT02366468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24643037|NCT01183442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643038|NCT01183442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24643039|NCT01183442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24643040|NCT01183455|Protease Inhibitors|protease inhibitors|mesh-list
24643478|NCT01185847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24643084|NCT01183663|Bevacizumab|bevacizumab|mesh-list
24643085|NCT01183663|Lenalidomide|lenalidomide|mesh-list
24643086|NCT01183663|Fluorouracil|fluorouracil|mesh-list
24643087|NCT01183663|Oxaliplatin|oxaliplatin|mesh-list
24643088|NCT01183663|Sorafenib|sorafenib|mesh-list
24643089|NCT01183663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24643090|NCT01183663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24643113|NCT01183676|Anticonvulsants|anticonvulsants|mesh-ancestor
24643114|NCT01183676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643127|NCT01183767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643128|NCT01183767|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
24643129|NCT01183767|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24643130|NCT01183767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24643131|NCT01183767|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24643133|NCT01183806|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24643134|NCT01183806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643135|NCT01183806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643136|NCT01183806|Cholinergic Agents|cholinergic agents|mesh-ancestor
24643192|NCT01184404|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24643193|NCT01184404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643210|NCT01184482|Cetuximab|cetuximab|mesh-list
24643216|NCT01184482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643218|NCT01184495|Hematinics|hematinics|mesh-ancestor
24643219|NCT01184560|Orlistat|orlistat|mesh-list
24643220|NCT01184560|Sibutramine|sibutramine|mesh-list
24643221|NCT01184560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643222|NCT01184560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643223|NCT01184560|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24643224|NCT01184560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24643225|NCT01184560|Antidepressive Agents|antidepressive agents|mesh-ancestor
24643226|NCT01184560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24643318|NCT01185184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643319|NCT01185197|Mycophenolic Acid|mycophenolic acid|mesh-list
24643320|NCT01185197|Prednisolone|prednisolone|mesh-list
24643321|NCT01185197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24643322|NCT01185197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24643323|NCT01185197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24643324|NCT01185197|Antitubercular Agents|antitubercular agents|mesh-ancestor
24643325|NCT01185197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24643326|NCT01185197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24643327|NCT01185197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643328|NCT01185197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643329|NCT01185197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24643330|NCT01185197|Glucocorticoids|glucocorticoids|mesh-ancestor
24643332|NCT01185197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24643333|NCT01185197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643345|NCT01185236|Ezetimibe|ezetimibe|mesh-list
25715080|NCT02366468|Growth Substances|growth substances|mesh-ancestor
25715081|NCT02366468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715082|NCT02366468|Growth Inhibitors|growth inhibitors|mesh-ancestor
25715083|NCT02366468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25715084|NCT02366663|Cytarabine|cytarabine|mesh-list
25715085|NCT02366663|Rituximab|rituximab|mesh-list
25715086|NCT02366663|Etoposide|etoposide|mesh-list
25715087|NCT02366663|Melphalan|melphalan|mesh-list
25715088|NCT02366663|Carmustine|carmustine|mesh-list
25715092|NCT02366663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643470|NCT01185808|Cholecalciferol|cholecalciferol|mesh-list
24643471|NCT01185808|Vitamins|vitamins|mesh-list
24643472|NCT01185808|Micronutrients|micronutrients|mesh-ancestor
24643473|NCT01185808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643474|NCT01185808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24643475|NCT01185808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24643476|NCT01185847|Gemcitabine|gemcitabine|mesh-list
24643477|NCT01185847|Pemetrexed|pemetrexed|mesh-list
24643479|NCT01185847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24643481|NCT01185847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643503|NCT01185860|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24643504|NCT01185860|Antimetabolites|antimetabolites|mesh-ancestor
24643505|NCT01185873|Ritonavir|ritonavir|mesh-list
24643506|NCT01185873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24643507|NCT01185873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24410377|NCT00185172|Olmesartan|olmesartan|mesh-list
24643513|NCT01185873|Antiviral Agents|antiviral agents|mesh-ancestor
24643514|NCT01185873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24643515|NCT01185873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24643516|NCT01185873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24643517|NCT01185925|Sildenafil Citrate|sildenafil citrate|mesh-list
24643518|NCT01185925|Vasodilator Agents|vasodilator agents|mesh-ancestor
24643519|NCT01185925|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24643520|NCT01185925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24643521|NCT01185925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643522|NCT01185925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643523|NCT01185925|Urological Agents|urological agents|mesh-ancestor
24643524|NCT01185938|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24643525|NCT01185938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24643526|NCT01185938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24643527|NCT01185938|Antimetabolites|antimetabolites|mesh-ancestor
24643528|NCT01185938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643529|NCT01185938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24643530|NCT01185938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24643544|NCT01185977|Antidepressive Agents|antidepressive agents|mesh-ancestor
24643545|NCT01185977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24643546|NCT01185977|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24643563|NCT01186094|Antifungal Agents|antifungal agents|mesh-ancestor
24643564|NCT01186094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24643565|NCT01186094|Immunologic Factors|immunologic factors|mesh-ancestor
24643566|NCT01186094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643567|NCT01186120|Umirolimus|umirolimus|mesh-list
24643568|NCT01186120|Everolimus|everolimus|mesh-list
24643569|NCT01186120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24643570|NCT01186120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24643573|NCT01186120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24643575|NCT01186146|Clopidogrel|clopidogrel|mesh-list
24643576|NCT01186146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25715093|NCT02366663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25715094|NCT02366663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25715095|NCT02366663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25715096|NCT02366663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24643581|NCT01186146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643626|NCT01186289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643627|NCT01186289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24643628|NCT01186289|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24643629|NCT01186289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24643630|NCT01186445|Morphine|morphine|mesh-list
24643632|NCT01186445|Narcotics|narcotics|mesh-ancestor
24643633|NCT01186445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24643634|NCT01186445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643635|NCT01186445|Analgesics|analgesics|mesh-ancestor
24643638|NCT01186471|Nicotine|nicotine|mesh-list
24643655|NCT01186549|Ephedrine|ephedrine|mesh-list
24643656|NCT01186549|Pseudoephedrine|pseudoephedrine|mesh-list
24643657|NCT01186549|Anesthetics, Local|anesthetics, local|mesh-ancestor
24643658|NCT01186549|Anesthetics|anesthetics|mesh-ancestor
24643659|NCT01186549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24643660|NCT01186549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643661|NCT01186549|Sensory System Agents|sensory system agents|mesh-ancestor
24643662|NCT01186549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24643911|NCT01187888|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24643912|NCT01187888|Protective Agents|protective agents|mesh-ancestor
24643913|NCT01187888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24643914|NCT01187992|Atorvastatin|atorvastatin|mesh-list
24643915|NCT01187992|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24643916|NCT01187992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24643917|NCT01187992|Antimetabolites|antimetabolites|mesh-ancestor
24643918|NCT01187992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24643919|NCT01187992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24643981|NCT01188265|Valproic Acid|valproic acid|mesh-list
24643982|NCT01188265|Dextromethorphan|dextromethorphan|mesh-list
24643984|NCT01188265|Respiratory System Agents|respiratory system agents|mesh-ancestor
24643985|NCT01188265|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24643986|NCT01188265|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24643987|NCT01188265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24643989|NCT01188265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644036|NCT01188408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644037|NCT01188707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24644039|NCT01188707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644040|NCT01188707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24644041|NCT01188707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644042|NCT01188707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644043|NCT01188707|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24644044|NCT01188733|Octreotide|octreotide|mesh-list
24644045|NCT01188733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24644046|NCT01188733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25715098|NCT02366663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715099|NCT02366663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25715100|NCT02366663|Antimetabolites|antimetabolites|mesh-ancestor
25715101|NCT02366663|Antiviral Agents|antiviral agents|mesh-ancestor
25715102|NCT02366663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25715103|NCT02366663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24644050|NCT01188759|Antifungal Agents|antifungal agents|mesh-ancestor
24644112|NCT01189019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644113|NCT01189097|Dextromethorphan|dextromethorphan|mesh-list
24644114|NCT01189097|Antitussive Agents|antitussive agents|mesh-ancestor
24644115|NCT01189097|Respiratory System Agents|respiratory system agents|mesh-ancestor
24644121|NCT01189214|Memantine|memantine|mesh-list
24644138|NCT01189253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644139|NCT01189253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24644140|NCT01189253|Alkylating Agents|alkylating agents|mesh-ancestor
24644141|NCT01189318|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24644142|NCT01189318|Antidepressive Agents|antidepressive agents|mesh-ancestor
24644143|NCT01189318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24644144|NCT01189318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24644309|NCT01190293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24644311|NCT01190293|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24644388|NCT01190683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644389|NCT01190683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24644390|NCT01190683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24644394|NCT01190722|Diclofenac|diclofenac|mesh-list
24644431|NCT01190761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644432|NCT01190761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644433|NCT01190761|Cholinergic Agents|cholinergic agents|mesh-ancestor
24644434|NCT01190761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24644435|NCT01190761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644436|NCT01190761|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24644437|NCT01190761|Autonomic Agents|autonomic agents|mesh-ancestor
24644438|NCT01190761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24644439|NCT01190761|Nootropic Agents|nootropic agents|mesh-ancestor
24644440|NCT01190982|Paclitaxel|paclitaxel|mesh-list
24644441|NCT01190982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24644442|NCT01190982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644492|NCT01191216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24644494|NCT01191216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24644495|NCT01191424|Formoterol Fumarate|formoterol fumarate|mesh-list
24644496|NCT01191424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24644497|NCT01191424|Autonomic Agents|autonomic agents|mesh-ancestor
24644498|NCT01191424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24644499|NCT01191424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644500|NCT01191424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24644503|NCT01191424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24644628|NCT01192165|Trametinib|trametinib|mesh-list
24644629|NCT01192165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24644630|NCT01192165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644631|NCT01192165|Tubulin Modulators|tubulin modulators|mesh-ancestor
24644632|NCT01192165|Antimitotic Agents|antimitotic agents|mesh-ancestor
24644633|NCT01192165|Mitosis Modulators|mitosis modulators|mesh-ancestor
24644634|NCT01192165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644637|NCT01192165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25715104|NCT02366663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25715105|NCT02366663|Alkylating Agents|alkylating agents|mesh-ancestor
25715106|NCT02366663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25715107|NCT02366689|Triclosan|triclosan|mesh-list
25715108|NCT02366689|Cetylpyridinium|cetylpyridinium|mesh-list
25715109|NCT02366689|Fluorides|fluorides|mesh-list
25715110|NCT02366689|Tin Fluorides|tin fluorides|mesh-list
25715111|NCT02366689|Cariostatic Agents|cariostatic agents|mesh-ancestor
25715112|NCT02366689|Protective Agents|protective agents|mesh-ancestor
25715113|NCT02366689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644676|NCT01192490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24644678|NCT01192490|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24644679|NCT01192490|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24644680|NCT01192490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24644681|NCT01192490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644682|NCT01192503|Rasagiline|rasagiline|mesh-list
24644683|NCT01192503|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24644684|NCT01192503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24644685|NCT01192503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644687|NCT01192503|Protective Agents|protective agents|mesh-ancestor
24644721|NCT01192724|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24644722|NCT01192724|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24644723|NCT01192724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24644724|NCT01192724|Purinergic Agents|purinergic agents|mesh-ancestor
24644725|NCT01192724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24644726|NCT01192724|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24644727|NCT01192724|Autonomic Agents|autonomic agents|mesh-ancestor
24644728|NCT01192724|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24644729|NCT01192724|Respiratory System Agents|respiratory system agents|mesh-ancestor
24644730|NCT01192724|Vasodilator Agents|vasodilator agents|mesh-ancestor
25715114|NCT02366689|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25715115|NCT02366689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25715116|NCT02366689|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25715117|NCT02366689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25715118|NCT02366689|Antimetabolites|antimetabolites|mesh-ancestor
25715119|NCT02366689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715120|NCT02366689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25715121|NCT02366767|Insulin|insulin|mesh-list
25715122|NCT02366767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25715123|NCT02366767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715124|NCT02366871|Enoxaparin|enoxaparin|mesh-list
25715125|NCT02366871|Apixaban|apixaban|mesh-list
25715126|NCT02366871|Anticoagulants|anticoagulants|mesh-ancestor
24644733|NCT01192724|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24644749|NCT01192802|Antimitotic Agents|antimitotic agents|mesh-ancestor
24644750|NCT01192802|Mitosis Modulators|mitosis modulators|mesh-ancestor
24644751|NCT01192802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644752|NCT01192802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24644755|NCT01192854|Antiviral Agents|antiviral agents|mesh-ancestor
24644796|NCT01193166|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24644797|NCT01193166|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24644799|NCT01193192|Micronutrients|micronutrients|mesh-ancestor
24644800|NCT01193192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644801|NCT01193270|Vitamin E|vitamin e|mesh-list
24644802|NCT01193270|Vitamins|vitamins|mesh-ancestor
24644803|NCT01193270|Micronutrients|micronutrients|mesh-ancestor
24644805|NCT01193270|Antioxidants|antioxidants|mesh-ancestor
24644820|NCT01193387|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24644832|NCT01193400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24644833|NCT01193400|Immunologic Factors|immunologic factors|mesh-ancestor
24644834|NCT01193400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644835|NCT01193452|Leucovorin|leucovorin|mesh-list
24644836|NCT01193452|Fluorouracil|fluorouracil|mesh-list
24644837|NCT01193452|Levoleucovorin|levoleucovorin|mesh-list
24644838|NCT01193452|Antimetabolites|antimetabolites|mesh-ancestor
24644839|NCT01193452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644840|NCT01193452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24644844|NCT01193452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644846|NCT01193452|Protective Agents|protective agents|mesh-ancestor
24644847|NCT01193452|Vitamin B Complex|vitamin b complex|mesh-ancestor
24644848|NCT01193452|Vitamins|vitamins|mesh-ancestor
24644849|NCT01193452|Micronutrients|micronutrients|mesh-ancestor
24644850|NCT01193465|Anesthetics|anesthetics|mesh-list
24644851|NCT01193465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24644912|NCT01193816|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24644913|NCT01193816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24644914|NCT01193816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24644915|NCT01193816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644916|NCT01193816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24644917|NCT01193816|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24644918|NCT01193816|Dopamine Agents|dopamine agents|mesh-ancestor
24644919|NCT01193816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24644920|NCT01193816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644922|NCT01193855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24644944|NCT01194115|Metronidazole|metronidazole|mesh-list
24644955|NCT01194232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24644957|NCT01194284|Mifamurtide|mifamurtide|mesh-list
24644958|NCT01194284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24644959|NCT01194284|Immunologic Factors|immunologic factors|mesh-ancestor
24644960|NCT01194284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24644961|NCT01194336|Huperzine A|huperzine a|mesh-list
24645099|NCT01195727|Protease Inhibitors|protease inhibitors|mesh-ancestor
24645100|NCT01195727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25715128|NCT02366871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25715129|NCT02366871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715130|NCT02366871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25715131|NCT02366871|Antithrombins|antithrombins|mesh-ancestor
25715132|NCT02366871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24645105|NCT01195805|Amiloride|amiloride|mesh-list
25715133|NCT02366871|Protease Inhibitors|protease inhibitors|mesh-ancestor
25715134|NCT02366871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24645113|NCT01195805|Natriuretic Agents|natriuretic agents|mesh-ancestor
24645114|NCT01195805|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
24645115|NCT01195805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24645116|NCT01195805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24645261|NCT01197014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645262|NCT01197014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24645263|NCT01197014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645264|NCT01197014|Vasodilator Agents|vasodilator agents|mesh-ancestor
24645265|NCT01197014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24645266|NCT01197014|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24645267|NCT01197014|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24645268|NCT01197040|Mycophenolic Acid|mycophenolic acid|mesh-list
24645270|NCT01197040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24645364|NCT01198106|Scopolamine|scopolamine|mesh-list
24645365|NCT01198106|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
24645366|NCT01198106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24645367|NCT01198106|Antiemetics|antiemetics|mesh-ancestor
24645368|NCT01198106|Autonomic Agents|autonomic agents|mesh-ancestor
24645369|NCT01198106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24645397|NCT01198210|Dexamethasone|dexamethasone|mesh-list
24645437|NCT01198236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24645438|NCT01198236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645439|NCT01198236|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24645440|NCT01198236|Hormone Antagonists|hormone antagonists|mesh-ancestor
24645441|NCT01198236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24645442|NCT01198236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645443|NCT01198236|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24645445|NCT01198249|Amlodipine|amlodipine|mesh-list
24645446|NCT01198249|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24645447|NCT01198249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24645448|NCT01198249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24645449|NCT01198249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24645453|NCT01198249|Vasodilator Agents|vasodilator agents|mesh-ancestor
24645469|NCT01198340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25715135|NCT02367131|Empagliflozin|empagliflozin|mesh-list
25715136|NCT02367131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25715137|NCT02367131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715138|NCT02367131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25715139|NCT02367131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715140|NCT02367352|Paclitaxel|paclitaxel|mesh-list
25715141|NCT02367352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25715142|NCT02367352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25715143|NCT02367352|Tubulin Modulators|tubulin modulators|mesh-ancestor
24645470|NCT01198353|Ziprasidone|ziprasidone|mesh-list
24645471|NCT01198353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24645472|NCT01198353|Serotonin Agents|serotonin agents|mesh-ancestor
24645577|NCT01198665|Glucocorticoids|glucocorticoids|mesh-ancestor
24645579|NCT01198665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24645580|NCT01198665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24645581|NCT01198782|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24645593|NCT01198821|Immunologic Factors|immunologic factors|mesh-ancestor
24645594|NCT01198821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645595|NCT01198860|Ascorbic Acid|ascorbic acid|mesh-list
24645597|NCT01198860|Antiviral Agents|antiviral agents|mesh-ancestor
24645598|NCT01198860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24645599|NCT01198860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24645600|NCT01198860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24645601|NCT01198860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24645602|NCT01198860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645603|NCT01198860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24645604|NCT01198860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24645605|NCT01198860|Antioxidants|antioxidants|mesh-ancestor
24645607|NCT01198860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645608|NCT01198860|Vitamins|vitamins|mesh-ancestor
24645609|NCT01198860|Micronutrients|micronutrients|mesh-ancestor
25715144|NCT02367352|Antimitotic Agents|antimitotic agents|mesh-ancestor
25715145|NCT02367352|Mitosis Modulators|mitosis modulators|mesh-ancestor
25715146|NCT02367352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715147|NCT02367599|Vitamin D|vitamin d|mesh-list
25715148|NCT02367599|Vitamins|vitamins|mesh-ancestor
25715149|NCT02367599|Micronutrients|micronutrients|mesh-ancestor
25715150|NCT02367599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715151|NCT02367599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25715152|NCT02367781|Paclitaxel|paclitaxel|mesh-list
25715153|NCT02367781|Carboplatin|carboplatin|mesh-list
25715154|NCT02367781|Pemetrexed|pemetrexed|mesh-list
25715155|NCT02367781|Atezolizumab|atezolizumab|mesh-list
25715156|NCT02367781|Antibodies|antibodies|mesh-list
24645610|NCT01198912|Doxycycline|doxycycline|mesh-list
24645611|NCT01198912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24645612|NCT01198912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24645657|NCT01199276|Anesthetics, General|anesthetics, general|mesh-ancestor
24645676|NCT01199328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24645678|NCT01199328|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24645679|NCT01199328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24645680|NCT01199328|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24645681|NCT01199341|Warfarin|warfarin|mesh-list
24645682|NCT01199341|Anticoagulants|anticoagulants|mesh-ancestor
24645707|NCT01199432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645710|NCT01199432|Alkylating Agents|alkylating agents|mesh-ancestor
24645711|NCT01199432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24645712|NCT01199432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24645713|NCT01199432|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24645715|NCT01199432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24645716|NCT01199432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24645717|NCT01199432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24645718|NCT01199432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24645719|NCT01199432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24645720|NCT01199445|Vitamin A|vitamin a|mesh-list
24645721|NCT01199445|Vitamins|vitamins|mesh-ancestor
24645722|NCT01199445|Micronutrients|micronutrients|mesh-ancestor
24645723|NCT01199445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645724|NCT01199458|Alfentanil|alfentanil|mesh-list
24645725|NCT01199458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24645753|NCT01199523|Urological Agents|urological agents|mesh-ancestor
24645754|NCT01199562|Valganciclovir|valganciclovir|mesh-list
24645755|NCT01199562|Ganciclovir|ganciclovir|mesh-list
24645756|NCT01199562|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
24645883|NCT01200537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24645884|NCT01200537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24645885|NCT01200537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24645901|NCT01200641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24645902|NCT01200641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24645903|NCT01200641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646095|NCT01202058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24646096|NCT01202058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24646097|NCT01202058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24646098|NCT01202058|Antifungal Agents|antifungal agents|mesh-ancestor
24646100|NCT01202084|Xhance|xhance|mesh-list
24646101|NCT01202084|Formoterol Fumarate|formoterol fumarate|mesh-list
24646102|NCT01202084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24646103|NCT01202084|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24646105|NCT01202084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24646106|NCT01202084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646107|NCT01202084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24646148|NCT01202149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24646149|NCT01202149|Dermatologic Agents|dermatologic agents|mesh-ancestor
24646150|NCT01202149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24646151|NCT01202149|Immunologic Factors|immunologic factors|mesh-ancestor
24646152|NCT01202149|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24646153|NCT01202149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646154|NCT01202149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646155|NCT01202240|Ketoconazole|ketoconazole|mesh-list
24646156|NCT01202240|Tofacitinib|tofacitinib|mesh-list
24646157|NCT01202240|Antifungal Agents|antifungal agents|mesh-ancestor
24646158|NCT01202240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24646159|NCT01202240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
24646160|NCT01202240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24646227|NCT01202487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24646228|NCT01202487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24646229|NCT01202487|Autonomic Agents|autonomic agents|mesh-ancestor
24646230|NCT01202487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24646365|NCT01203358|Beractant|beractant|mesh-list
24646366|NCT01203358|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
24647349|NCT01208441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646369|NCT01203371|Tamsulosin|tamsulosin|mesh-list
25715157|NCT02367781|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25715158|NCT02367781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25715159|NCT02367781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25715160|NCT02367781|Tubulin Modulators|tubulin modulators|mesh-ancestor
25715161|NCT02367781|Antimitotic Agents|antimitotic agents|mesh-ancestor
25715162|NCT02367781|Mitosis Modulators|mitosis modulators|mesh-ancestor
25715163|NCT02367781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646512|NCT01204138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24646513|NCT01204138|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24646514|NCT01204138|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24646515|NCT01204138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646516|NCT01204138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24646554|NCT01204268|Anesthetics, General|anesthetics, general|mesh-ancestor
24646556|NCT01204268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24646557|NCT01204268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24646559|NCT01204307|Docetaxel|docetaxel|mesh-list
24646560|NCT01204307|Pemetrexed|pemetrexed|mesh-list
24646561|NCT01204307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24646638|NCT01204437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24646639|NCT01204450|Sirolimus|sirolimus|mesh-list
24646640|NCT01204450|Valproic Acid|valproic acid|mesh-list
24646641|NCT01204450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24646642|NCT01204450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24646643|NCT01204450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24646644|NCT01204450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24646645|NCT01204450|Antifungal Agents|antifungal agents|mesh-ancestor
24646646|NCT01204450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24646937|NCT01205711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24646938|NCT01205711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24646939|NCT01205711|Antidotes|antidotes|mesh-ancestor
24646940|NCT01205711|Protective Agents|protective agents|mesh-ancestor
24646941|NCT01205711|Vitamin B Complex|vitamin b complex|mesh-ancestor
24646942|NCT01205711|Vitamins|vitamins|mesh-ancestor
24646943|NCT01205711|Micronutrients|micronutrients|mesh-ancestor
24646944|NCT01205724|Factor VIII|factor viii|mesh-list
24646945|NCT01205724|Coagulants|coagulants|mesh-ancestor
24646946|NCT01205737|Rituximab|rituximab|mesh-list
24646947|NCT01205737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24646948|NCT01205737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24646980|NCT01205932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24647045|NCT01206010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647047|NCT01206036|Docetaxel|docetaxel|mesh-list
24647083|NCT01206075|Antiviral Agents|antiviral agents|mesh-ancestor
24647084|NCT01206075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24647086|NCT01206153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24647087|NCT01206153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647088|NCT01206205|Lenalidomide|lenalidomide|mesh-list
24647089|NCT01206205|Bortezomib|bortezomib|mesh-list
24647283|NCT01207310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647284|NCT01207622|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24647285|NCT01207622|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24647286|NCT01207622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24647305|NCT01207739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24647308|NCT01207921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647309|NCT01207921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24647310|NCT01207921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24647311|NCT01207921|Growth Substances|growth substances|mesh-ancestor
24647312|NCT01207921|Growth Inhibitors|growth inhibitors|mesh-ancestor
24647313|NCT01207921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647314|NCT01207947|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24647315|NCT01207947|Vasodilator Agents|vasodilator agents|mesh-ancestor
24647316|NCT01207947|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24647317|NCT01207947|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25415994|NCT02978625|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
24647328|NCT01208090|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24647329|NCT01208090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647330|NCT01208090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24647332|NCT01208090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647333|NCT01208194|Immunologic Factors|immunologic factors|mesh-list
25715164|NCT02367781|Immunologic Factors|immunologic factors|mesh-ancestor
25715165|NCT02367781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715166|NCT02367781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24647334|NCT01208194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647335|NCT01208285|Ivacaftor|ivacaftor|mesh-list
25715167|NCT02367781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24647428|NCT01208818|Cyclophosphamide|cyclophosphamide|mesh-list
24647446|NCT01208818|Hormones|hormones|mesh-ancestor
24647447|NCT01208818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24647495|NCT01209065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24647496|NCT01209065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24647497|NCT01209065|Antiviral Agents|antiviral agents|mesh-ancestor
24647498|NCT01209065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24647499|NCT01209065|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24647500|NCT01209065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24647501|NCT01209065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24647502|NCT01209065|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
24647503|NCT01209130|Rituximab|rituximab|mesh-list
24647504|NCT01209130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24647505|NCT01209130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24647506|NCT01209130|Immunologic Factors|immunologic factors|mesh-ancestor
24647513|NCT01209208|Autonomic Agents|autonomic agents|mesh-ancestor
24647840|NCT01211080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647841|NCT01211080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24647860|NCT01211158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647862|NCT01211171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24647863|NCT01211171|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24647864|NCT01211171|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24647865|NCT01211171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647866|NCT01211210|Fluorouracil|fluorouracil|mesh-list
24647881|NCT01211275|Cisplatin|cisplatin|mesh-list
24647957|NCT01211509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24647958|NCT01211509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24647959|NCT01211561|Selenium|selenium|mesh-list
24647960|NCT01211561|Antioxidants|antioxidants|mesh-ancestor
24647961|NCT01211561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648002|NCT01211808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648003|NCT01211808|Vasodilator Agents|vasodilator agents|mesh-ancestor
24648004|NCT01211821|Metoprolol|metoprolol|mesh-list
24648005|NCT01211821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24648006|NCT01211821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24648007|NCT01211821|Sympatholytics|sympatholytics|mesh-ancestor
24648008|NCT01211821|Autonomic Agents|autonomic agents|mesh-ancestor
24648009|NCT01211821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24648010|NCT01211821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648011|NCT01211821|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24648012|NCT01211821|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24648013|NCT01211821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24648014|NCT01211821|Adrenergic Agents|adrenergic agents|mesh-ancestor
24648015|NCT01211821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24648051|NCT01211925|Sensory System Agents|sensory system agents|mesh-ancestor
24648052|NCT01211925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24648054|NCT01211925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24648200|NCT01212965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648201|NCT01212965|Trace Elements|trace elements|mesh-ancestor
24648202|NCT01212965|Micronutrients|micronutrients|mesh-ancestor
24648203|NCT01213017|Certolizumab Pegol|certolizumab pegol|mesh-list
24648204|NCT01213017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24648205|NCT01213017|Immunologic Factors|immunologic factors|mesh-ancestor
24648206|NCT01213017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648207|NCT01213017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24648209|NCT01213095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24648210|NCT01213095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648211|NCT01213095|Immunologic Factors|immunologic factors|mesh-ancestor
24648212|NCT01213095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648213|NCT01213095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24648214|NCT01213121|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24648215|NCT01213121|Antidepressive Agents|antidepressive agents|mesh-ancestor
24648216|NCT01213121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24648217|NCT01213121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24648218|NCT01213121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24648219|NCT01213121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25715168|NCT02367781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25715169|NCT02367833|Contraceptive Agents|contraceptive agents|mesh-list
25715170|NCT02367833|NuvaRing|nuvaring|mesh-list
25715171|NCT02367833|Contraceptives, Oral|contraceptives, oral|mesh-list
25715172|NCT02367833|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
25715173|NCT02367833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25715174|NCT02367833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648220|NCT01213121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648222|NCT01213147|Enclomiphene|enclomiphene|mesh-list
24648265|NCT01213355|Parasympatholytics|parasympatholytics|mesh-ancestor
24648313|NCT01213498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24648314|NCT01213498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648315|NCT01213550|Chlorhexidine|chlorhexidine|mesh-list
24648316|NCT01213550|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24648317|NCT01213550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24648318|NCT01213550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24648359|NCT01213719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648360|NCT01213719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24648361|NCT01213784|Hypoglycemic Agents|hypoglycemic agents|mesh-list
24648409|NCT01214291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24648410|NCT01214291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648411|NCT01214291|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24648594|NCT01215708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648595|NCT01215708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648596|NCT01215708|Urological Agents|urological agents|mesh-ancestor
24648597|NCT01215799|Bafetinib|bafetinib|mesh-list
24648598|NCT01215799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24648599|NCT01215799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648600|NCT01215799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648601|NCT01215890|Risedronic Acid|risedronic acid|mesh-list
24648602|NCT01215890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24648603|NCT01215890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24648604|NCT01215890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648605|NCT01215890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24648606|NCT01215890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648607|NCT01215890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24648630|NCT01216085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648632|NCT01216111|Docetaxel|docetaxel|mesh-list
24648633|NCT01216111|Cyclophosphamide|cyclophosphamide|mesh-list
24648634|NCT01216111|Fluorouracil|fluorouracil|mesh-list
24648635|NCT01216111|Epirubicin|epirubicin|mesh-list
24648636|NCT01216111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24648637|NCT01216111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648638|NCT01216111|Tubulin Modulators|tubulin modulators|mesh-ancestor
24648639|NCT01216111|Antimitotic Agents|antimitotic agents|mesh-ancestor
24648640|NCT01216111|Mitosis Modulators|mitosis modulators|mesh-ancestor
24648641|NCT01216111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648642|NCT01216111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24648643|NCT01216111|Immunologic Factors|immunologic factors|mesh-ancestor
24648644|NCT01216111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648645|NCT01216111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24648706|NCT01216449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24648707|NCT01216449|Serotonin Agents|serotonin agents|mesh-ancestor
24648708|NCT01216449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648709|NCT01216449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24648710|NCT01216449|Antidepressive Agents|antidepressive agents|mesh-ancestor
24648711|NCT01216449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24648712|NCT01216488|Lidocaine|lidocaine|mesh-list
24648713|NCT01216488|Anesthetics, Local|anesthetics, local|mesh-ancestor
24648714|NCT01216488|Anesthetics|anesthetics|mesh-ancestor
24648820|NCT01216956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715175|NCT02367833|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25715176|NCT02367833|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25715177|NCT02367859|Trametinib|trametinib|mesh-list
25715178|NCT02367859|Dabrafenib|dabrafenib|mesh-list
25715179|NCT02367859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25715180|NCT02367859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25715181|NCT02367859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648821|NCT01216956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24648822|NCT01216956|Vasodilator Agents|vasodilator agents|mesh-ancestor
24648824|NCT01217034|Chlorotrianisene|chlorotrianisene|mesh-list
24648825|NCT01217034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648826|NCT01217034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24648827|NCT01217034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24648828|NCT01217034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24648829|NCT01217034|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
24648830|NCT01217034|Estrogens|estrogens|mesh-ancestor
24648831|NCT01217034|Hormones|hormones|mesh-ancestor
24648833|NCT01217034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648855|NCT01217099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24648856|NCT01217099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24648858|NCT01217099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24648884|NCT01217138|Mydriatics|mydriatics|mesh-ancestor
24648885|NCT01217138|Sympathomimetics|sympathomimetics|mesh-ancestor
24648886|NCT01217138|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24648888|NCT01217177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24648889|NCT01217177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24648890|NCT01217177|Immunologic Factors|immunologic factors|mesh-ancestor
24648891|NCT01217177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24648892|NCT01217203|Lenalidomide|lenalidomide|mesh-list
24648950|NCT01217632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24648957|NCT01217697|Prednisone|prednisone|mesh-list
24648997|NCT01218022|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24648998|NCT01218022|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24649009|NCT01218217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24649010|NCT01218217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24649011|NCT01218217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649012|NCT01218217|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24649013|NCT01218217|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24649014|NCT01218217|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
24649015|NCT01218217|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24649016|NCT01218217|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24649017|NCT01218217|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24649018|NCT01218321|Anticonvulsants|anticonvulsants|mesh-list
24649019|NCT01218347|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24649020|NCT01218347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24649021|NCT01218347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24649022|NCT01218347|Antimetabolites|antimetabolites|mesh-ancestor
24649067|NCT01218529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649069|NCT01218568|Lactulose|lactulose|mesh-list
24649070|NCT01218568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25715182|NCT02367859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715183|NCT02367872|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
25715184|NCT02367872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25715185|NCT02367872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715186|NCT02368093|Dextromethorphan|dextromethorphan|mesh-list
25715187|NCT02368093|Antitussive Agents|antitussive agents|mesh-ancestor
25715188|NCT02368093|Respiratory System Agents|respiratory system agents|mesh-ancestor
25715189|NCT02368093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25715190|NCT02368093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25771068|NCT03585712|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24649071|NCT01218568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24649085|NCT01218607|Bosentan|bosentan|mesh-list
24649086|NCT01218607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24649087|NCT01218607|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
24649088|NCT01218607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649089|NCT01218620|Tolbutamide|tolbutamide|mesh-list
24649090|NCT01218620|Rifampin|rifampin|mesh-list
24649170|NCT01218737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24649171|NCT01218737|Methylprednisolone|methylprednisolone|mesh-list
24649246|NCT01219062|Analgesics|analgesics|mesh-ancestor
24649247|NCT01219088|Morphine|morphine|mesh-list
24649249|NCT01219088|Anesthetics, Local|anesthetics, local|mesh-ancestor
24649250|NCT01219088|Anesthetics|anesthetics|mesh-ancestor
24649251|NCT01219088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24649252|NCT01219088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649253|NCT01219088|Sensory System Agents|sensory system agents|mesh-ancestor
24649254|NCT01219088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24649336|NCT01219556|Olmesartan|olmesartan|mesh-list
24649363|NCT01219686|Pindolol|pindolol|mesh-list
24649366|NCT01219686|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24649367|NCT01219686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24649368|NCT01219686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24649369|NCT01219686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649370|NCT01219686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24649371|NCT01219686|Serotonin Agents|serotonin agents|mesh-ancestor
24649372|NCT01219686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649373|NCT01219686|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24649374|NCT01219686|Antidepressive Agents|antidepressive agents|mesh-ancestor
24649391|NCT01219699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24649392|NCT01219699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649393|NCT01219699|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24649394|NCT01219699|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24649395|NCT01219699|Hormone Antagonists|hormone antagonists|mesh-ancestor
24649397|NCT01219699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649443|NCT01219907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649444|NCT01219907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649445|NCT01219907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24649448|NCT01219920|Antidotes|antidotes|mesh-ancestor
24649449|NCT01219920|Protective Agents|protective agents|mesh-ancestor
24649450|NCT01219920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649451|NCT01219920|Vitamin B Complex|vitamin b complex|mesh-ancestor
24649452|NCT01219920|Vitamins|vitamins|mesh-ancestor
24649453|NCT01219920|Micronutrients|micronutrients|mesh-ancestor
24649454|NCT01219920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649498|NCT01220154|Growth Substances|growth substances|mesh-ancestor
24649499|NCT01220154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649500|NCT01220154|Growth Inhibitors|growth inhibitors|mesh-ancestor
24649501|NCT01220219|Pregabalin|pregabalin|mesh-list
24649502|NCT01220219|Analgesics|analgesics|mesh-ancestor
24649517|NCT01220232|Dideoxynucleosides|dideoxynucleosides|mesh-list
24649518|NCT01220232|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24649519|NCT01220232|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24649520|NCT01220232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24649521|NCT01220232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715191|NCT02368093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25715192|NCT02368093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715193|NCT02368093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715194|NCT02368314|Enoxaparin|enoxaparin|mesh-list
25715195|NCT02368314|Enoxaparin sodium|enoxaparin sodium|mesh-list
25715196|NCT02368314|Anticoagulants|anticoagulants|mesh-ancestor
25715197|NCT02368314|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25715198|NCT02368314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25771069|NCT03585712|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25771070|NCT03585712|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25771071|NCT03585712|Contraceptive Agents|contraceptive agents|mesh-ancestor
25771072|NCT03585712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25771073|NCT03585712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771074|NCT03585712|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25771075|NCT03585712|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24649639|NCT01221025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649640|NCT01221025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24649641|NCT01221025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24649642|NCT01221025|Analgesics|analgesics|mesh-ancestor
24649643|NCT01221025|Sensory System Agents|sensory system agents|mesh-ancestor
24649644|NCT01221025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24649647|NCT01221025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24649649|NCT01221103|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24649651|NCT01221103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24649652|NCT01221103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24649653|NCT01221103|Antiemetics|antiemetics|mesh-ancestor
24649654|NCT01221103|Autonomic Agents|autonomic agents|mesh-ancestor
24649655|NCT01221103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24649656|NCT01221103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649657|NCT01221103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24649658|NCT01221103|Glucocorticoids|glucocorticoids|mesh-ancestor
24649659|NCT01221103|Hormones|hormones|mesh-ancestor
24649660|NCT01221103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24649661|NCT01221103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24649745|NCT01221792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24649746|NCT01221792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24649747|NCT01221792|Vasodilator Agents|vasodilator agents|mesh-ancestor
24649748|NCT01221792|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24649749|NCT01221792|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24649751|NCT01221831|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24649752|NCT01221831|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24649753|NCT01221831|Estradiol|estradiol|mesh-list
24649754|NCT01221831|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24649755|NCT01221831|Estrogens|estrogens|mesh-ancestor
24649818|NCT01222013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649819|NCT01222026|Vitamin D|vitamin d|mesh-list
24649820|NCT01222026|Strontium ranelate|strontium ranelate|mesh-list
24649821|NCT01222026|Vitamins|vitamins|mesh-ancestor
24649826|NCT01222052|Docetaxel|docetaxel|mesh-list
24649828|NCT01222052|Epirubicin|epirubicin|mesh-list
24649829|NCT01222052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24649830|NCT01222052|Immunologic Factors|immunologic factors|mesh-ancestor
24649831|NCT01222052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649832|NCT01222052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24649833|NCT01222052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24649834|NCT01222052|Alkylating Agents|alkylating agents|mesh-ancestor
24649835|NCT01222052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649836|NCT01222052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649837|NCT01222052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24649838|NCT01222052|Tubulin Modulators|tubulin modulators|mesh-ancestor
24649839|NCT01222052|Antimitotic Agents|antimitotic agents|mesh-ancestor
24649840|NCT01222052|Mitosis Modulators|mitosis modulators|mesh-ancestor
24649841|NCT01222052|Antimetabolites|antimetabolites|mesh-ancestor
24649842|NCT01222052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24649843|NCT01222052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24649844|NCT01222052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25715199|NCT02368314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24649887|NCT01222442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24649888|NCT01222442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24649890|NCT01222442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24650009|NCT01223131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24650010|NCT01223131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650012|NCT01223326|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24650013|NCT01223326|Antiviral Agents|antiviral agents|mesh-ancestor
24650014|NCT01223326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24650016|NCT01223326|Respiratory System Agents|respiratory system agents|mesh-ancestor
24650017|NCT01223326|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24650018|NCT01223326|Antioxidants|antioxidants|mesh-ancestor
24650019|NCT01223326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650020|NCT01223326|Protective Agents|protective agents|mesh-ancestor
24650021|NCT01223326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650022|NCT01223326|Antidotes|antidotes|mesh-ancestor
24650023|NCT01223339|Ertugliflozin|ertugliflozin|mesh-list
24650024|NCT01223339|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24650025|NCT01223339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650042|NCT01223534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650044|NCT01223560|Insulin Aspart|insulin aspart|mesh-list
24650045|NCT01223560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24650046|NCT01223560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650047|NCT01223612|Ranibizumab|ranibizumab|mesh-list
24650048|NCT01223612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24650049|NCT01223612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24650226|NCT01224652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650227|NCT01224652|Tubulin Modulators|tubulin modulators|mesh-ancestor
24650228|NCT01224652|Antimitotic Agents|antimitotic agents|mesh-ancestor
24650229|NCT01224652|Mitosis Modulators|mitosis modulators|mesh-ancestor
24650230|NCT01224652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650231|NCT01224652|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24650232|NCT01224652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24650233|NCT01224652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24650235|NCT01224717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24650236|NCT01224717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650237|NCT01224717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24650239|NCT01224756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24650240|NCT01224756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24650241|NCT01224756|Analgesics|analgesics|mesh-ancestor
24650242|NCT01224756|Sensory System Agents|sensory system agents|mesh-ancestor
24650243|NCT01224756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24650363|NCT01225406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24650364|NCT01225406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24650365|NCT01225406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650366|NCT01225406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24650367|NCT01225406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24650406|NCT01225705|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24650407|NCT01225705|Raltegravir Potassium|raltegravir potassium|mesh-list
24650408|NCT01225705|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24650409|NCT01225705|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24650410|NCT01225705|Protease Inhibitors|protease inhibitors|mesh-ancestor
24650411|NCT01225705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24650412|NCT01225705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650413|NCT01225705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24650414|NCT01225705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24650415|NCT01225705|Antiviral Agents|antiviral agents|mesh-ancestor
24650416|NCT01225705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24650419|NCT01225705|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24650469|NCT01225874|Antimitotic Agents|antimitotic agents|mesh-ancestor
24650470|NCT01225874|Mitosis Modulators|mitosis modulators|mesh-ancestor
24650471|NCT01225874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24650472|NCT01225874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24650473|NCT01225874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25715200|NCT02368431|Zonisamide|zonisamide|mesh-list
25715201|NCT02368431|Anticonvulsants|anticonvulsants|mesh-ancestor
25715202|NCT02368431|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25715203|NCT02368431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25715204|NCT02368431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771076|NCT03586544|Albuterol|albuterol|mesh-list
24650474|NCT01225913|Fluticasone|fluticasone|mesh-list
24650475|NCT01225913|Xhance|xhance|mesh-list
24650476|NCT01225913|Budesonide|budesonide|mesh-list
24650477|NCT01225913|Formoterol Fumarate|formoterol fumarate|mesh-list
24650478|NCT01225913|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24650479|NCT01225913|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24650480|NCT01225913|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24650481|NCT01225913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24650482|NCT01225913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24650488|NCT01225913|Dermatologic Agents|dermatologic agents|mesh-ancestor
24650553|NCT01226355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24650554|NCT01226355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650555|NCT01226355|Antifungal Agents|antifungal agents|mesh-ancestor
24650557|NCT01226355|Immunologic Factors|immunologic factors|mesh-ancestor
24650561|NCT01226446|Micronutrients|micronutrients|mesh-ancestor
24650562|NCT01226446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650563|NCT01226446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24650564|NCT01226602|Ticagrelor|ticagrelor|mesh-list
24650565|NCT01226602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24650566|NCT01226602|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24650568|NCT01226602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24650607|NCT01226849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650608|NCT01226849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24650673|NCT01227408|Cyclophosphamide|cyclophosphamide|mesh-list
24650674|NCT01227408|Doxorubicin|doxorubicin|mesh-list
24650675|NCT01227408|Capecitabine|capecitabine|mesh-list
24650676|NCT01227408|Methotrexate|methotrexate|mesh-list
24650677|NCT01227408|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
24650678|NCT01227408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24650679|NCT01227408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650680|NCT01227408|Tubulin Modulators|tubulin modulators|mesh-ancestor
24650681|NCT01227408|Antimitotic Agents|antimitotic agents|mesh-ancestor
24650682|NCT01227408|Mitosis Modulators|mitosis modulators|mesh-ancestor
24650683|NCT01227408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650684|NCT01227408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24650685|NCT01227408|Immunologic Factors|immunologic factors|mesh-ancestor
24650686|NCT01227408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650687|NCT01227408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24650688|NCT01227408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24650689|NCT01227408|Alkylating Agents|alkylating agents|mesh-ancestor
24650690|NCT01227408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24650691|NCT01227408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24650692|NCT01227408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24650711|NCT01227590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24650712|NCT01227590|Antiviral Agents|antiviral agents|mesh-ancestor
24650715|NCT01227590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24650717|NCT01227603|Candesartan cilexetil|candesartan cilexetil|mesh-list
24650721|NCT01227603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24650722|NCT01227603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650723|NCT01227603|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24650724|NCT01227603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24650725|NCT01227603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24650726|NCT01227603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650728|NCT01227603|Tocolytic Agents|tocolytic agents|mesh-ancestor
24650729|NCT01227603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24650730|NCT01227720|Nicotine|nicotine|mesh-list
24650731|NCT01227720|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25771077|NCT03586544|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25771078|NCT03586544|Autonomic Agents|autonomic agents|mesh-ancestor
25771079|NCT03586544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771080|NCT03586544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771081|NCT03586544|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25771082|NCT03586544|Respiratory System Agents|respiratory system agents|mesh-ancestor
25771083|NCT03586544|Tocolytic Agents|tocolytic agents|mesh-ancestor
25771084|NCT03586544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25771085|NCT03586544|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25771086|NCT03586544|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25771087|NCT03586544|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24650733|NCT01227720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24650734|NCT01227720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24650735|NCT01227720|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24650801|NCT01228045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24650806|NCT01228136|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24650807|NCT01228136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24650808|NCT01228136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650810|NCT01228136|Coagulants|coagulants|mesh-ancestor
24650812|NCT01228214|Amiloride|amiloride|mesh-list
24650813|NCT01228214|Clopidogrel|clopidogrel|mesh-list
24650815|NCT01228214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24650838|NCT01228214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24650839|NCT01228214|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
24650840|NCT01228214|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24650841|NCT01228227|Atorvastatin|atorvastatin|mesh-list
24650842|NCT01228227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24650843|NCT01228227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24650844|NCT01228227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24650845|NCT01228227|Antimetabolites|antimetabolites|mesh-ancestor
24650846|NCT01228227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24650847|NCT01228227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24650848|NCT01228227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24650901|NCT01228357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24650902|NCT01228357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24650903|NCT01228357|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
24650904|NCT01228357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24650905|NCT01228357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24651024|NCT01228994|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24651025|NCT01228994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24651026|NCT01228994|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24651027|NCT01228994|GABA Agonists|gaba agonists|mesh-ancestor
24651028|NCT01228994|GABA Agents|gaba agents|mesh-ancestor
24651313|NCT01230983|Micronutrients|micronutrients|mesh-ancestor
24651314|NCT01230983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24651315|NCT01230983|Tubulin Modulators|tubulin modulators|mesh-ancestor
24651316|NCT01230983|Antimitotic Agents|antimitotic agents|mesh-ancestor
24651318|NCT01230983|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24651320|NCT01230996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651321|NCT01231074|Metformin|metformin|mesh-list
24651322|NCT01231074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24651323|NCT01231074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651422|NCT01231542|Rifampin|rifampin|mesh-list
24651423|NCT01231542|Rifabutin|rifabutin|mesh-list
24651424|NCT01231542|Dolutegravir|dolutegravir|mesh-list
24651425|NCT01231542|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24651426|NCT01231542|Antitubercular Agents|antitubercular agents|mesh-ancestor
24651427|NCT01231542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24651428|NCT01231542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24651429|NCT01231542|Leprostatic Agents|leprostatic agents|mesh-ancestor
24651430|NCT01231542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24651431|NCT01231542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651432|NCT01231542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651433|NCT01231542|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25771089|NCT03586544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25771090|NCT03586544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771091|NCT03586726|Rifampin|rifampin|mesh-list
25771092|NCT03586726|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25771093|NCT03586726|Antitubercular Agents|antitubercular agents|mesh-ancestor
25771094|NCT03586726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25715206|NCT02368431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715207|NCT02368457|Tocopherols|tocopherols|mesh-list
25715208|NCT02368457|Vitamin E|vitamin e|mesh-list
25715209|NCT02368457|Tocotrienols|tocotrienols|mesh-list
24651434|NCT01231542|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24651466|NCT01231685|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24651570|NCT01232075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24651571|NCT01232075|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24651572|NCT01232075|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24651573|NCT01232140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24651574|NCT01232140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24651575|NCT01232244|Glucagon|glucagon|mesh-list
24651576|NCT01232244|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24651577|NCT01232244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24651578|NCT01232244|Hormones|hormones|mesh-ancestor
24651661|NCT01232803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24651804|NCT01233934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24651805|NCT01233934|Antipruritics|antipruritics|mesh-ancestor
24651806|NCT01233934|Dermatologic Agents|dermatologic agents|mesh-ancestor
24651807|NCT01233934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24651809|NCT01233947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24651810|NCT01233947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651811|NCT01233947|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24651812|NCT01233947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24651879|NCT01234324|Capecitabine|capecitabine|mesh-list
24651880|NCT01234324|Epirubicin|epirubicin|mesh-list
24651881|NCT01234324|Panitumumab|panitumumab|mesh-list
24651882|NCT01234324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24651883|NCT01234324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24651884|NCT01234324|Antimetabolites|antimetabolites|mesh-ancestor
24651885|NCT01234324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24651886|NCT01234324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24651887|NCT01234324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24651888|NCT01234324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24651889|NCT01234324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24651891|NCT01234454|Olanzapine|olanzapine|mesh-list
24652102|NCT01236482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652104|NCT01236495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24652105|NCT01236495|Narcotics|narcotics|mesh-ancestor
24652137|NCT01236612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24652138|NCT01236612|Antimetabolites|antimetabolites|mesh-ancestor
24652139|NCT01236612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652141|NCT01236651|Meperidine|meperidine|mesh-list
25715210|NCT02368457|alpha-Tocopherol|alpha-tocopherol|mesh-list
25715211|NCT02368457|Pentoxifylline|pentoxifylline|mesh-list
25715212|NCT02368457|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25715213|NCT02368457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25715214|NCT02368457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715215|NCT02368457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24652279|NCT01237444|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24652280|NCT01237444|Protease Inhibitors|protease inhibitors|mesh-ancestor
24652281|NCT01237444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652282|NCT01237444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652283|NCT01237444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24652284|NCT01237444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24652285|NCT01237444|Antiviral Agents|antiviral agents|mesh-ancestor
24652286|NCT01237444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24652287|NCT01237444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24652288|NCT01237444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24652289|NCT01237457|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
24652290|NCT01237457|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24652291|NCT01237457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652292|NCT01237483|Cetuximab|cetuximab|mesh-list
24652542|NCT01238926|Hydroxocobalamin|hydroxocobalamin|mesh-list
24652543|NCT01238926|Vitamin B 12|vitamin b 12|mesh-list
24652544|NCT01238926|Vitamin B 6|vitamin b 6|mesh-list
24652545|NCT01238926|Pyridoxal|pyridoxal|mesh-list
24652546|NCT01238926|Pyridoxine|pyridoxine|mesh-list
24652547|NCT01238926|Vitamin B Complex|vitamin b complex|mesh-list
24652548|NCT01238926|Micronutrients|micronutrients|mesh-ancestor
24652549|NCT01238926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652550|NCT01238926|Hematinics|hematinics|mesh-ancestor
24652551|NCT01238952|Carboplatin|carboplatin|mesh-list
24652552|NCT01238952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652553|NCT01238965|Calcium, Dietary|calcium, dietary|mesh-list
24652555|NCT01238965|Fluorouracil|fluorouracil|mesh-list
24652759|NCT01239953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24652760|NCT01240096|Mirtazapine|mirtazapine|mesh-list
24652765|NCT01240096|Histamine Agents|histamine agents|mesh-ancestor
24652985|NCT01241162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24652986|NCT01241162|Antimetabolites|antimetabolites|mesh-ancestor
24652987|NCT01241162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24652988|NCT01241162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24652989|NCT01241162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24652990|NCT01241175|Magnesium Sulfate|magnesium sulfate|mesh-list
24652991|NCT01241175|Analgesics|analgesics|mesh-ancestor
24652992|NCT01241175|Sensory System Agents|sensory system agents|mesh-ancestor
25715216|NCT02368457|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24653181|NCT01242267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24653182|NCT01242267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24653183|NCT01242267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24653205|NCT01242332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25715217|NCT02368457|Protective Agents|protective agents|mesh-ancestor
25715218|NCT02368457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715219|NCT02368457|Vasodilator Agents|vasodilator agents|mesh-ancestor
25715220|NCT02368457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25715221|NCT02368457|Antioxidants|antioxidants|mesh-ancestor
25715222|NCT02368457|Vitamins|vitamins|mesh-ancestor
25715223|NCT02368457|Micronutrients|micronutrients|mesh-ancestor
25715224|NCT02369068|Triamcinolone|triamcinolone|mesh-list
24653207|NCT01242384|Silicon|silicon|mesh-list
24653208|NCT01242384|Trace Elements|trace elements|mesh-ancestor
24653209|NCT01242384|Micronutrients|micronutrients|mesh-ancestor
24653210|NCT01242384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653211|NCT01242410|Silicon|silicon|mesh-list
24653212|NCT01242410|Trace Elements|trace elements|mesh-ancestor
24653213|NCT01242410|Micronutrients|micronutrients|mesh-ancestor
24653278|NCT01243060|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24653279|NCT01243060|GABA Agonists|gaba agonists|mesh-ancestor
24653280|NCT01243060|GABA Agents|gaba agents|mesh-ancestor
24653285|NCT01243086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24653286|NCT01243086|Antiemetics|antiemetics|mesh-ancestor
24653287|NCT01243086|Autonomic Agents|autonomic agents|mesh-ancestor
24653288|NCT01243086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24653289|NCT01243086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653357|NCT01243632|Antiviral Agents|antiviral agents|mesh-ancestor
24653358|NCT01243632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24653359|NCT01243632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653360|NCT01243632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24653361|NCT01243632|Immunologic Factors|immunologic factors|mesh-ancestor
24653362|NCT01243632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24653399|NCT01243736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653400|NCT01243736|Antifoaming Agents|antifoaming agents|mesh-ancestor
24653401|NCT01243736|Emollients|emollients|mesh-ancestor
24653692|NCT01245179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24653694|NCT01245205|Lapatinib|lapatinib|mesh-list
24653717|NCT01245452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24653718|NCT01245452|Antimetabolites|antimetabolites|mesh-ancestor
24653719|NCT01245452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24653944|NCT01246323|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24653950|NCT01246362|Analgesics|analgesics|mesh-ancestor
24653958|NCT01246362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25715225|NCT02369068|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25715226|NCT02369068|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25715227|NCT02369068|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25715228|NCT02369068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25715229|NCT02369068|Glucocorticoids|glucocorticoids|mesh-ancestor
25715230|NCT02369068|Hormones|hormones|mesh-ancestor
25715231|NCT02369068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25715232|NCT02369068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715233|NCT02369068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25715234|NCT02369068|Immunologic Factors|immunologic factors|mesh-ancestor
24654162|NCT01247961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24654163|NCT01247961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654164|NCT01247961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24654165|NCT01247961|Glucocorticoids|glucocorticoids|mesh-ancestor
24654166|NCT01247961|Hormones|hormones|mesh-ancestor
24654167|NCT01247961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24654168|NCT01247961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24654169|NCT01247961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654170|NCT01247961|Protease Inhibitors|protease inhibitors|mesh-ancestor
24654356|NCT01248923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24654357|NCT01248923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24654359|NCT01248923|Protease Inhibitors|protease inhibitors|mesh-ancestor
24654360|NCT01248923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654361|NCT01248923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654362|NCT01248923|Antimitotic Agents|antimitotic agents|mesh-ancestor
24654423|NCT01249443|Antimitotic Agents|antimitotic agents|mesh-ancestor
24654424|NCT01249443|Mitosis Modulators|mitosis modulators|mesh-ancestor
24654425|NCT01249443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654426|NCT01249443|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24654427|NCT01249443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24654428|NCT01249521|Bevacizumab|bevacizumab|mesh-list
24654429|NCT01249521|Trebananib|trebananib|mesh-list
24654653|NCT01250743|Antioxidants|antioxidants|mesh-ancestor
24654654|NCT01250743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24654655|NCT01250743|Protective Agents|protective agents|mesh-ancestor
24654656|NCT01250808|Dexamethasone|dexamethasone|mesh-list
24654658|NCT01250808|Melphalan|melphalan|mesh-list
24654659|NCT01250808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24654660|NCT01250808|Antiemetics|antiemetics|mesh-ancestor
24654661|NCT01250808|Autonomic Agents|autonomic agents|mesh-ancestor
25715235|NCT02369068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715236|NCT02369068|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25715237|NCT02369068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25715238|NCT02369068|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25715239|NCT02369068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25715240|NCT02369068|Cholinergic Agents|cholinergic agents|mesh-ancestor
25715241|NCT02369068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24654978|NCT01252758|Albuterol|albuterol|mesh-list
24654979|NCT01252758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24654980|NCT01252758|Autonomic Agents|autonomic agents|mesh-ancestor
24654981|NCT01252758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24654982|NCT01252758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24654983|NCT01252758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24654984|NCT01252758|Respiratory System Agents|respiratory system agents|mesh-ancestor
24654985|NCT01252758|Tocolytic Agents|tocolytic agents|mesh-ancestor
24655096|NCT01254461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24655097|NCT01254461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24655098|NCT00701207|Nicotine|nicotine|mesh-list
24655099|NCT00701207|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24655100|NCT00701207|Autonomic Agents|autonomic agents|mesh-ancestor
24655101|NCT00701207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24655102|NCT00701207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655103|NCT00701207|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24655104|NCT00701207|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24655105|NCT00701207|Cholinergic Agents|cholinergic agents|mesh-ancestor
24655106|NCT00701207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24655107|NCT00701207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655108|NCT01254513|Prednisone|prednisone|mesh-list
24655109|NCT01254513|Docetaxel|docetaxel|mesh-list
24655125|NCT01254526|Tubulin Modulators|tubulin modulators|mesh-ancestor
24655126|NCT01254526|Antimitotic Agents|antimitotic agents|mesh-ancestor
24655259|NCT01255371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24655260|NCT01255371|Antiviral Agents|antiviral agents|mesh-ancestor
24655261|NCT01255371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24655262|NCT01255371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24655304|NCT01255644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24655305|NCT01255774|Ranibizumab|ranibizumab|mesh-list
24655306|NCT01255774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24655307|NCT01255774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24655308|NCT01255774|Growth Substances|growth substances|mesh-ancestor
24655506|NCT01257035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655508|NCT01257048|Formoterol Fumarate|formoterol fumarate|mesh-list
24655509|NCT01257048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24655510|NCT01257048|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24655511|NCT01257048|Autonomic Agents|autonomic agents|mesh-ancestor
24655513|NCT01257048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655514|NCT01257048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24655515|NCT01257048|Respiratory System Agents|respiratory system agents|mesh-ancestor
24655518|NCT01257048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24655519|NCT01257048|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24655637|NCT01257490|Bupropion|bupropion|mesh-list
24655638|NCT01257490|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24655639|NCT01257490|Antidepressive Agents|antidepressive agents|mesh-ancestor
24655673|NCT01257529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24655674|NCT01257529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24655675|NCT01257529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24655676|NCT01257529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24655868|NCT01258491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24655938|NCT01258764|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24655939|NCT01258764|Protective Agents|protective agents|mesh-ancestor
24655941|NCT01258777|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24655942|NCT01258777|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
24655943|NCT01258777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24655944|NCT01258777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24655945|NCT01258777|Immunologic Factors|immunologic factors|mesh-ancestor
24655946|NCT01258777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656176|NCT01260285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24656177|NCT01260285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656178|NCT01260285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656179|NCT01260285|Urological Agents|urological agents|mesh-ancestor
25715242|NCT02369159|Oseltamivir|oseltamivir|mesh-list
25715243|NCT02369159|Peramivir|peramivir|mesh-list
25715244|NCT02369159|Antiviral Agents|antiviral agents|mesh-ancestor
25715245|NCT02369159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25715246|NCT02369159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25715247|NCT02369159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715248|NCT02369172|Bupropion|bupropion|mesh-list
25715250|NCT02369172|Antidepressive Agents|antidepressive agents|mesh-ancestor
24656181|NCT01260376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24656182|NCT01260376|Antimetabolites|antimetabolites|mesh-ancestor
24656183|NCT01260376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656184|NCT01260376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24656186|NCT01260415|Panitumumab|panitumumab|mesh-list
24656187|NCT01260415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24656188|NCT01260415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24656189|NCT01260506|Bevacizumab|bevacizumab|mesh-list
24656220|NCT01260610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656221|NCT01260610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656222|NCT01260610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24656223|NCT01260610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24656224|NCT01260623|Prednisone|prednisone|mesh-list
24656225|NCT01260623|Prednisolone|prednisolone|mesh-list
24656226|NCT01260623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24656227|NCT01260623|Glucocorticoids|glucocorticoids|mesh-ancestor
24656228|NCT01260623|Hormones|hormones|mesh-ancestor
24656229|NCT01260623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24656233|NCT01260675|Buprenorphine|buprenorphine|mesh-list
24656292|NCT01260857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656293|NCT01260857|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24656294|NCT01260857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24656295|NCT01260857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656296|NCT01260974|Caspofungin|caspofungin|mesh-list
24656297|NCT01260974|Antifungal Agents|antifungal agents|mesh-ancestor
24656298|NCT01260974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24656299|NCT01260974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656300|NCT01260974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656301|NCT01261065|Carvedilol|carvedilol|mesh-list
24656302|NCT01261065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24656303|NCT01261065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24656304|NCT01261065|Adrenergic Agents|adrenergic agents|mesh-ancestor
24656305|NCT01261065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24656319|NCT01261078|Epinephryl borate|epinephryl borate|mesh-list
24656320|NCT01261078|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24656321|NCT01261078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24656322|NCT01261078|Adrenergic Agents|adrenergic agents|mesh-ancestor
24656323|NCT01261078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24656520|NCT01262274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656521|NCT01262274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24656522|NCT01262274|Antimetabolites|antimetabolites|mesh-ancestor
24656793|NCT01264237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24656794|NCT01264237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656795|NCT01264237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24656796|NCT01264237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24656797|NCT01264237|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24656798|NCT01264237|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24656799|NCT01264237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656800|NCT01264237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24656801|NCT01264289|Finasteride|finasteride|mesh-list
24656802|NCT01264289|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25715252|NCT02369172|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25715253|NCT02369172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25715254|NCT02369172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25715255|NCT02369172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715256|NCT02369172|Dopamine Agents|dopamine agents|mesh-ancestor
25715257|NCT02369172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25715258|NCT02369172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656804|NCT01264289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24656882|NCT01264536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24656883|NCT01264575|Epinephrine|epinephrine|mesh-list
24656884|NCT01264575|Racepinephrine|racepinephrine|mesh-list
24656885|NCT01264575|Bupivacaine|bupivacaine|mesh-list
24656886|NCT01264575|Epinephryl borate|epinephryl borate|mesh-list
24656887|NCT01264575|Anesthetics, Local|anesthetics, local|mesh-ancestor
24656888|NCT01264575|Anesthetics|anesthetics|mesh-ancestor
24656889|NCT01264575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24656890|NCT01264575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24656891|NCT01264575|Sensory System Agents|sensory system agents|mesh-ancestor
24656892|NCT01264575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24656893|NCT01264575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24656894|NCT01264575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24656944|NCT01264653|Mydriatics|mydriatics|mesh-ancestor
24656968|NCT01264783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24656969|NCT01264783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24656970|NCT01264783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24656971|NCT01264822|Rabeprazole|rabeprazole|mesh-list
24656972|NCT01264822|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24656973|NCT01264822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24656974|NCT01264822|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24656975|NCT01264822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24657226|NCT01266213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24657228|NCT01266252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24657229|NCT01266252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24657230|NCT01266252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657231|NCT01266252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24657232|NCT01266252|Analgesics|analgesics|mesh-ancestor
24657233|NCT01266252|Sensory System Agents|sensory system agents|mesh-ancestor
24657234|NCT01266252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24657352|NCT01266811|Siltuximab|siltuximab|mesh-list
24657353|NCT01266811|BB 1101|bb 1101|mesh-list
24657354|NCT01266811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24657355|NCT01266811|Antiemetics|antiemetics|mesh-ancestor
24657356|NCT01266811|Autonomic Agents|autonomic agents|mesh-ancestor
24657357|NCT01266811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24657358|NCT01266811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24657360|NCT01266811|Glucocorticoids|glucocorticoids|mesh-ancestor
24657422|NCT01267305|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24657423|NCT01267305|Antithrombins|antithrombins|mesh-ancestor
24657616|NCT01268670|Oxycodone|oxycodone|mesh-list
24657617|NCT01268670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24657618|NCT01268670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24657619|NCT01268670|Analgesics|analgesics|mesh-ancestor
24657620|NCT01268670|Sensory System Agents|sensory system agents|mesh-ancestor
24657621|NCT01268670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24657755|NCT01269151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24658235|NCT01270997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24658236|NCT01270997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24658237|NCT01270997|Analgesics|analgesics|mesh-ancestor
24658238|NCT01270997|Sensory System Agents|sensory system agents|mesh-ancestor
24658239|NCT01270997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658240|NCT01270997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658241|NCT01270997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24658242|NCT01270997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24658436|NCT01271569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658438|NCT01271582|Irinotecan|irinotecan|mesh-list
24658439|NCT01271582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24658440|NCT01271582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24658441|NCT01271582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24658442|NCT01271582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658443|NCT01271582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24658444|NCT01271582|Antidotes|antidotes|mesh-ancestor
24658581|NCT01272778|Anticonvulsants|anticonvulsants|mesh-ancestor
24658582|NCT01272778|Antiemetics|antiemetics|mesh-ancestor
25715259|NCT02369172|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25715260|NCT02369172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24658583|NCT01272778|Autonomic Agents|autonomic agents|mesh-ancestor
25715261|NCT02369172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25715262|NCT02369211|Acetaminophen|acetaminophen|mesh-list
24658617|NCT01273233|Vaccines|vaccines|mesh-list
24658618|NCT01273233|Immunologic Factors|immunologic factors|mesh-ancestor
24658619|NCT01273233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658620|NCT01273246|Vaccines|vaccines|mesh-list
24658621|NCT01273246|Immunologic Factors|immunologic factors|mesh-ancestor
24658622|NCT01273246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658623|NCT01273298|Bisoprolol|bisoprolol|mesh-list
24658624|NCT01273298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24658625|NCT01273298|Sympatholytics|sympatholytics|mesh-ancestor
24658626|NCT01273298|Autonomic Agents|autonomic agents|mesh-ancestor
24658627|NCT01273298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24658628|NCT01273298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658630|NCT01273298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24658759|NCT01273831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24658776|NCT01274000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24658777|NCT01274000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24658778|NCT01274000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24658779|NCT01274000|Serotonin Agents|serotonin agents|mesh-ancestor
24658780|NCT01274000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24658781|NCT01274000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658783|NCT01274026|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24658784|NCT01274026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24658785|NCT01274026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24658916|NCT01274624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24658917|NCT01274624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24658918|NCT01274624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24658919|NCT01274624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24658920|NCT01274624|Growth Substances|growth substances|mesh-ancestor
24658922|NCT01274624|Growth Inhibitors|growth inhibitors|mesh-ancestor
24658923|NCT01274624|Antimetabolites|antimetabolites|mesh-ancestor
24658924|NCT01274624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658925|NCT01274624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24448649|NCT00312520|Hormones|hormones|mesh-ancestor
24658953|NCT01274780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24658955|NCT01274793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24658956|NCT01274793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24658958|NCT01274793|Serotonin Agents|serotonin agents|mesh-ancestor
24659179|NCT01276015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659180|NCT01276015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24659181|NCT01276015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24659183|NCT01276067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24659184|NCT01276067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24659186|NCT01276067|Cholinergic Agents|cholinergic agents|mesh-ancestor
24659187|NCT01276067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24659327|NCT01276834|Immunologic Factors|immunologic factors|mesh-ancestor
24659328|NCT01276834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659329|NCT01276886|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24659330|NCT01276886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24659331|NCT01276912|Insulin Glargine|insulin glargine|mesh-list
24659332|NCT01276912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24659415|NCT01277627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24659416|NCT01277627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24659417|NCT01277627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659418|NCT01277627|Antiviral Agents|antiviral agents|mesh-ancestor
24659419|NCT01277627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24659420|NCT01277627|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24659421|NCT01277627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24659423|NCT01277627|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24659658|NCT01279213|Serotonin Agents|serotonin agents|mesh-ancestor
24659659|NCT01279213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24659660|NCT01279213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24659661|NCT01279213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24659662|NCT01279213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24659663|NCT01279213|Dopamine Agents|dopamine agents|mesh-ancestor
25715263|NCT02369211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25715264|NCT02369211|Analgesics|analgesics|mesh-ancestor
24659665|NCT01279213|GABA Agents|gaba agents|mesh-ancestor
24659666|NCT01279252|Metronidazole|metronidazole|mesh-list
24659667|NCT01279252|Clarithromycin|clarithromycin|mesh-list
24659668|NCT01279252|Ciprofloxacin|ciprofloxacin|mesh-list
24659742|NCT01279551|Lidocaine|lidocaine|mesh-list
24659943|NCT01281111|Analgesics|analgesics|mesh-ancestor
24659944|NCT01281111|Sensory System Agents|sensory system agents|mesh-ancestor
24659945|NCT01281111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24659946|NCT01281111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24659947|NCT01281111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24659989|NCT01281514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24659990|NCT01281514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24659991|NCT01281514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24659992|NCT01281514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660068|NCT01281696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24660069|NCT01281696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24660146|NCT01281813|Antiviral Agents|antiviral agents|mesh-ancestor
24660147|NCT01281813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24660148|NCT01281813|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24660292|NCT01282619|Protective Agents|protective agents|mesh-ancestor
24660296|NCT01282632|Serotonin Agents|serotonin agents|mesh-ancestor
24660313|NCT01282697|Sirolimus|sirolimus|mesh-list
24660314|NCT01282697|Irinotecan|irinotecan|mesh-list
24660315|NCT01282697|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24660316|NCT01282697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24660317|NCT01282697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24660318|NCT01282697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660321|NCT01282697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24660322|NCT01282697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24660323|NCT01282697|Antifungal Agents|antifungal agents|mesh-ancestor
24660324|NCT01282697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24660470|NCT01283776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660472|NCT01283776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24660474|NCT01283789|Lapatinib|lapatinib|mesh-list
24660475|NCT01283789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24660543|NCT01284309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24660544|NCT01284309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660545|NCT01284309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660546|NCT01284309|Urological Agents|urological agents|mesh-ancestor
24660547|NCT01284413|Gemcitabine|gemcitabine|mesh-list
24660548|NCT01284413|Cisplatin|cisplatin|mesh-list
24660672|NCT01285141|Immunologic Factors|immunologic factors|mesh-ancestor
24660673|NCT01285141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660694|NCT01285271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24660695|NCT01285271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24660696|NCT01285375|Curcumin|curcumin|mesh-list
24660697|NCT01285375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24660698|NCT01285375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25715265|NCT02369211|Sensory System Agents|sensory system agents|mesh-ancestor
24660699|NCT01285375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24660701|NCT01285375|Sensory System Agents|sensory system agents|mesh-ancestor
25715266|NCT02369211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25715267|NCT02369211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715268|NCT02369211|Antipyretics|antipyretics|mesh-ancestor
25715269|NCT02369341|Vaccines|vaccines|mesh-list
25715270|NCT02369341|Immunologic Factors|immunologic factors|mesh-ancestor
25715271|NCT02369341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715272|NCT02369510|Epinephrine|epinephrine|mesh-list
25715273|NCT02369510|Racepinephrine|racepinephrine|mesh-list
24660702|NCT01285375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24660704|NCT01285375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24660710|NCT01285388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24660743|NCT01285505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24660744|NCT01285505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660745|NCT01285544|Atorvastatin|atorvastatin|mesh-list
24660746|NCT01285544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24660747|NCT01285544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24660748|NCT01285544|Antimetabolites|antimetabolites|mesh-ancestor
24660749|NCT01285544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24660750|NCT01285544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24660751|NCT01285544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24660752|NCT01285544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24661155|NCT01288261|Paclitaxel|paclitaxel|mesh-list
24661156|NCT01288261|Bavituximab|bavituximab|mesh-list
24661157|NCT01288261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24661158|NCT01288261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661159|NCT01288261|Tubulin Modulators|tubulin modulators|mesh-ancestor
24661160|NCT01288261|Antimitotic Agents|antimitotic agents|mesh-ancestor
24661161|NCT01288261|Mitosis Modulators|mitosis modulators|mesh-ancestor
24661162|NCT01288261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455657|NCT00328432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24661163|NCT01288261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24661165|NCT01288326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24661235|NCT01288547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24661236|NCT01288547|Respiratory System Agents|respiratory system agents|mesh-ancestor
24661424|NCT01289327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24661426|NCT01289483|Propofol|propofol|mesh-list
24661427|NCT01289483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24661428|NCT01289483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24661429|NCT01289483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661430|NCT01289483|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24661456|NCT01289561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24661457|NCT01289561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24661458|NCT01289561|Purinergic Agents|purinergic agents|mesh-ancestor
24661497|NCT01289756|Zuclomiphene|zuclomiphene|mesh-list
24661498|NCT01289756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24661499|NCT01289756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24661500|NCT01289756|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24661516|NCT01289756|Hormone Antagonists|hormone antagonists|mesh-ancestor
24661696|NCT01290380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661698|NCT01290406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24661699|NCT01290419|Vaccines|vaccines|mesh-list
24661700|NCT01290419|Immunologic Factors|immunologic factors|mesh-ancestor
24661701|NCT01290419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661702|NCT01290432|Folic Acid|folic acid|mesh-list
24661703|NCT01290432|Melatonin|melatonin|mesh-list
24661704|NCT01290432|Antioxidants|antioxidants|mesh-ancestor
24661705|NCT01290432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661706|NCT01290432|Protective Agents|protective agents|mesh-ancestor
25715274|NCT02369510|Epinephryl borate|epinephryl borate|mesh-list
24661707|NCT01290432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24661708|NCT01290432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24661854|NCT01291316|Urological Agents|urological agents|mesh-ancestor
25715275|NCT02369510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25715276|NCT02369510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25715277|NCT02369510|Adrenergic Agents|adrenergic agents|mesh-ancestor
25715278|NCT02369510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25715279|NCT02369510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24661855|NCT01291316|Anticonvulsants|anticonvulsants|mesh-ancestor
24661856|NCT01291316|GABA Modulators|gaba modulators|mesh-ancestor
24661857|NCT01291316|GABA Agents|gaba agents|mesh-ancestor
24661858|NCT01291316|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24661863|NCT01291316|GABA Agonists|gaba agonists|mesh-ancestor
24661916|NCT01291511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24662183|NCT01293149|Autonomic Agents|autonomic agents|mesh-ancestor
24662184|NCT01293149|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24662185|NCT01293149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24662186|NCT01293149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24662187|NCT01293149|Adrenergic Agents|adrenergic agents|mesh-ancestor
24662188|NCT01293149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24662189|NCT01293149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662190|NCT01293162|Folic Acid|folic acid|mesh-list
24662191|NCT01293162|Policosanol|policosanol|mesh-list
24662192|NCT01293162|Hematinics|hematinics|mesh-ancestor
24662193|NCT01293162|Vitamin B Complex|vitamin b complex|mesh-ancestor
24662194|NCT01293162|Vitamins|vitamins|mesh-ancestor
24662195|NCT01293162|Micronutrients|micronutrients|mesh-ancestor
24662196|NCT01293162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662197|NCT01293162|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24662252|NCT01293643|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24662339|NCT01294072|Analgesics|analgesics|mesh-ancestor
24662340|NCT01294072|Sensory System Agents|sensory system agents|mesh-ancestor
24662341|NCT01294072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24662342|NCT01294072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662382|NCT01294605|Edetic Acid|edetic acid|mesh-list
24662383|NCT01294605|Pentetic Acid|pentetic acid|mesh-list
24662384|NCT01294605|Antidotes|antidotes|mesh-ancestor
24662385|NCT01294605|Protective Agents|protective agents|mesh-ancestor
24662386|NCT01294605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662387|NCT01294605|Chelating Agents|chelating agents|mesh-ancestor
24662388|NCT01294605|Sequestering Agents|sequestering agents|mesh-ancestor
24662494|NCT01295099|Antimetabolites|antimetabolites|mesh-ancestor
24662495|NCT01295099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662496|NCT01295099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24662515|NCT01295151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662547|NCT01295294|Contraceptive Agents|contraceptive agents|mesh-ancestor
24662548|NCT01295294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24662549|NCT01295294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662550|NCT01295294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24662551|NCT01295294|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24662552|NCT01295294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24662553|NCT01295294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24662554|NCT01295294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24662642|NCT01295866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662643|NCT01295866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24662644|NCT01295866|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24662645|NCT01295866|Vasodilator Agents|vasodilator agents|mesh-ancestor
24662646|NCT01295866|Gasotransmitters|gasotransmitters|mesh-ancestor
24662647|NCT01295866|Protective Agents|protective agents|mesh-ancestor
24662650|NCT01295892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24662651|NCT01295892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662652|NCT01295918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24662653|NCT01295918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24662655|NCT01296074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24662686|NCT01296269|Vasopressins|vasopressins|mesh-list
24662758|NCT01296555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24662759|NCT01296555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25715280|NCT02369510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715281|NCT02369510|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25715282|NCT02369510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25715283|NCT02369510|Autonomic Agents|autonomic agents|mesh-ancestor
25715284|NCT02369510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25715285|NCT02369510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25715286|NCT02369510|Respiratory System Agents|respiratory system agents|mesh-ancestor
25715287|NCT02369510|Mydriatics|mydriatics|mesh-ancestor
24662761|NCT01296555|Anesthetics, General|anesthetics, general|mesh-ancestor
24662762|NCT01296555|Anesthetics|anesthetics|mesh-ancestor
24662763|NCT01296555|GABA Modulators|gaba modulators|mesh-ancestor
24662764|NCT01296555|GABA Agents|gaba agents|mesh-ancestor
24662765|NCT01296555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24662766|NCT01296555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662767|NCT01296555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24662769|NCT01296555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24662841|NCT01297101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24662842|NCT01297166|Calcitriol|calcitriol|mesh-list
24662843|NCT01297166|Calcipotriene|calcipotriene|mesh-list
24662844|NCT01297166|Dermatologic Agents|dermatologic agents|mesh-ancestor
24662937|NCT01297764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24662938|NCT01297764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24662939|NCT01297764|Glucocorticoids|glucocorticoids|mesh-ancestor
24662940|NCT01297764|Hormones|hormones|mesh-ancestor
24662941|NCT01297764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24662942|NCT01297764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24662943|NCT01297764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24663007|NCT01297907|Miotics|miotics|mesh-ancestor
24663008|NCT01297907|Autonomic Agents|autonomic agents|mesh-ancestor
24663382|NCT01300793|Immunologic Factors|immunologic factors|mesh-ancestor
24663383|NCT01300793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663384|NCT01300793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24663385|NCT01300793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24663386|NCT01300793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24663444|NCT01301313|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24663445|NCT01301313|Vasodilator Agents|vasodilator agents|mesh-ancestor
24663446|NCT01301313|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24663447|NCT01301313|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24663448|NCT01301313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24663449|NCT01301313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24663450|NCT01301313|Protective Agents|protective agents|mesh-ancestor
24663451|NCT01301313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663701|NCT01303250|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24663702|NCT01303250|Plasma Substitutes|plasma substitutes|mesh-ancestor
24663703|NCT01303250|Blood Substitutes|blood substitutes|mesh-ancestor
24663705|NCT01303471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24663707|NCT01303471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24663708|NCT01303471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24663709|NCT01303471|Analgesics|analgesics|mesh-ancestor
24663871|NCT01303926|Carboplatin|carboplatin|mesh-list
24664180|NCT01305707|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24664181|NCT01305707|Antipsychotic Agents|antipsychotic agents|mesh-list
24664182|NCT01305707|Lithium Carbonate|lithium carbonate|mesh-list
24664183|NCT01305707|Mirtazapine|mirtazapine|mesh-list
24664184|NCT01305707|Citalopram|citalopram|mesh-list
24664185|NCT01305707|Sertraline|sertraline|mesh-list
24664242|NCT01305707|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
24664243|NCT01305707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24664244|NCT01305707|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24664245|NCT01305707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24664246|NCT01305707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24664247|NCT01305707|Anesthetics, General|anesthetics, general|mesh-ancestor
24664248|NCT01305707|Anesthetics|anesthetics|mesh-ancestor
25715288|NCT02369510|Sympathomimetics|sympathomimetics|mesh-ancestor
25715289|NCT02369510|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25715290|NCT02369835|Sodium Hypochlorite|sodium hypochlorite|mesh-list
25715291|NCT02369835|Eusol|eusol|mesh-list
25715292|NCT02369835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25715293|NCT02369835|Disinfectants|disinfectants|mesh-ancestor
25715294|NCT02369835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25715295|NCT02369874|Durvalumab|durvalumab|mesh-list
25715296|NCT02369874|Tremelimumab|tremelimumab|mesh-list
25715297|NCT02369874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25715298|NCT02369874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24664322|NCT01306097|Dermatologic Agents|dermatologic agents|mesh-ancestor
24664323|NCT01306123|Vitamin B 12|vitamin b 12|mesh-list
24664533|NCT01307488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24664534|NCT01307488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24664535|NCT01307488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24664536|NCT01307488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24664537|NCT01307527|Riboflavin|riboflavin|mesh-list
24664538|NCT01307527|Vitamin B Complex|vitamin b complex|mesh-ancestor
24664539|NCT01307527|Vitamins|vitamins|mesh-ancestor
24664540|NCT01307527|Micronutrients|micronutrients|mesh-ancestor
24664541|NCT01307527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24664542|NCT01307527|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24665215|NCT01310842|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24665216|NCT01310842|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24665217|NCT01310842|Cholinergic Agents|cholinergic agents|mesh-ancestor
24665218|NCT01310842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24665219|NCT01310842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665221|NCT01310985|Cetuximab|cetuximab|mesh-list
24665544|NCT01313377|Immunologic Factors|immunologic factors|mesh-ancestor
24665545|NCT01313377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24665547|NCT01313390|Everolimus|everolimus|mesh-list
24665548|NCT01313390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24665549|NCT01313390|Tubulin Modulators|tubulin modulators|mesh-ancestor
24665550|NCT01313390|Antimitotic Agents|antimitotic agents|mesh-ancestor
24665551|NCT01313390|Mitosis Modulators|mitosis modulators|mesh-ancestor
24665552|NCT01313390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24665553|NCT01313390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24665554|NCT01313390|Immunologic Factors|immunologic factors|mesh-ancestor
25715299|NCT02369874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25715300|NCT02369874|Immunologic Factors|immunologic factors|mesh-ancestor
25715301|NCT02369874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715302|NCT02369900|Esmolol|esmolol|mesh-list
25715303|NCT02369900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25715304|NCT02369900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25715305|NCT02369900|Adrenergic Agents|adrenergic agents|mesh-ancestor
25715306|NCT02369900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25715307|NCT02369900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715308|NCT02369900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715309|NCT02369900|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25715310|NCT02370095|Treprostinil|treprostinil|mesh-list
24456077|NCT00329810|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24666260|NCT01318187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24666261|NCT01318187|Analgesics|analgesics|mesh-ancestor
24666262|NCT01318187|Sensory System Agents|sensory system agents|mesh-ancestor
24666263|NCT01318187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24666264|NCT01318187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24666265|NCT01318187|Antipyretics|antipyretics|mesh-ancestor
24666266|NCT01318265|Ketoconazole|ketoconazole|mesh-list
24666666|NCT01320397|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24666774|NCT01320982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24666775|NCT01320982|Antioxidants|antioxidants|mesh-ancestor
24666776|NCT01320982|Protective Agents|protective agents|mesh-ancestor
24666777|NCT01320982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24666778|NCT01320982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24667068|NCT01322139|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24667069|NCT01322139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24667070|NCT01322139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24667832|NCT05275907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24667833|NCT05275907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24667834|NCT05275907|Vasodilator Agents|vasodilator agents|mesh-ancestor
24667835|NCT05275907|Diuretics|diuretics|mesh-ancestor
24667836|NCT05275907|Natriuretic Agents|natriuretic agents|mesh-ancestor
24667837|NCT05275907|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24533529|NCT00644306|Leprostatic Agents|leprostatic agents|mesh-ancestor
24533636|NCT00644696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24533637|NCT00644696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24533795|NCT00645190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24533822|NCT00645242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533823|NCT00645242|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24533825|NCT00645242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24533956|NCT00645554|Galantamine|galantamine|mesh-list
24533957|NCT00645554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24533958|NCT00645554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24533959|NCT00645554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534174|NCT00646321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24534175|NCT00646321|Autonomic Agents|autonomic agents|mesh-ancestor
25715311|NCT02370095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25715312|NCT02370095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25715313|NCT02370498|Paclitaxel|paclitaxel|mesh-list
25715314|NCT02370498|Pembrolizumab|pembrolizumab|mesh-list
25715315|NCT02370498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25715316|NCT02370498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25715317|NCT02370498|Tubulin Modulators|tubulin modulators|mesh-ancestor
25715318|NCT02370498|Antimitotic Agents|antimitotic agents|mesh-ancestor
24534480|NCT00647140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534481|NCT00647140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534482|NCT00647140|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24534483|NCT00647140|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24534485|NCT00647166|Antimetabolites|antimetabolites|mesh-ancestor
24534486|NCT00647166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534487|NCT00647166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24534562|NCT00647621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24534563|NCT00647621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24534564|NCT00647621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24534565|NCT00647621|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24534566|NCT00647621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24534568|NCT00647634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24534569|NCT00647634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24534570|NCT00647634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24534924|NCT00648297|Bendroflumethiazide|bendroflumethiazide|mesh-list
24534925|NCT00648297|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25715319|NCT02370498|Mitosis Modulators|mitosis modulators|mesh-ancestor
25715320|NCT02370498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715321|NCT02370498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25715322|NCT02370615|Itraconazole|itraconazole|mesh-list
25715324|NCT02370615|Midazolam|midazolam|mesh-list
25715325|NCT02370615|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
25715326|NCT02370615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25715327|NCT02370615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25715328|NCT02370615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25715329|NCT02370615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715330|NCT02370615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25715331|NCT02370615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25715332|NCT02370615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25715333|NCT02370615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25715334|NCT02370615|Anesthetics, General|anesthetics, general|mesh-ancestor
25715335|NCT02370615|Anesthetics|anesthetics|mesh-ancestor
25715337|NCT02370615|GABA Agents|gaba agents|mesh-ancestor
25715338|NCT02370615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24534964|NCT00648336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24534965|NCT00648336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24534966|NCT00648336|Immunologic Factors|immunologic factors|mesh-ancestor
24535042|NCT00648440|Adrenergic Agents|adrenergic agents|mesh-ancestor
24535043|NCT00648440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535170|NCT00648713|Terbinafine|terbinafine|mesh-list
24535171|NCT00648713|Antifungal Agents|antifungal agents|mesh-ancestor
24535172|NCT00648713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24535173|NCT00648713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535174|NCT00648713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535175|NCT00648726|Azithromycin|azithromycin|mesh-list
24535176|NCT00648726|Erythromycin|erythromycin|mesh-list
24535177|NCT00648726|Erythromycin Estolate|erythromycin estolate|mesh-list
24535178|NCT00648726|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24535181|NCT00648726|Cefuroxime axetil|cefuroxime axetil|mesh-list
24535182|NCT00648726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24535188|NCT00648765|Anagrelide|anagrelide|mesh-list
24535250|NCT00648843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535251|NCT00648843|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24535252|NCT00648843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24535253|NCT00648843|Cholinergic Agents|cholinergic agents|mesh-ancestor
24535257|NCT00648856|Sertraline|sertraline|mesh-list
24535258|NCT00648856|Antidepressive Agents|antidepressive agents|mesh-ancestor
25715339|NCT02370615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715340|NCT02370615|Antifungal Agents|antifungal agents|mesh-ancestor
25715341|NCT02370615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25715342|NCT02370615|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25715343|NCT02370615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25715344|NCT02370615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535434|NCT00649129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24535435|NCT00649129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535436|NCT00649129|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24535437|NCT00649129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24535438|NCT00649129|Cholinergic Agents|cholinergic agents|mesh-ancestor
24535439|NCT00649129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24535440|NCT00649129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535441|NCT00649129|Urological Agents|urological agents|mesh-ancestor
24535443|NCT00649155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24535444|NCT00649155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24535445|NCT00649155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24535446|NCT00649155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24535447|NCT00649155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24535456|NCT00649168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24535457|NCT00649168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535458|NCT00649168|Dopamine Agonists|dopamine agonists|mesh-ancestor
24535490|NCT00649233|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24535491|NCT00649233|Sympatholytics|sympatholytics|mesh-ancestor
24535492|NCT00649233|Autonomic Agents|autonomic agents|mesh-ancestor
24535493|NCT00649233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24536141|NCT00650403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24535494|NCT00649233|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24535495|NCT00649233|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24535497|NCT00649233|Adrenergic Agents|adrenergic agents|mesh-ancestor
24535533|NCT00649311|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24535534|NCT00649311|Hormone Antagonists|hormone antagonists|mesh-ancestor
24535535|NCT00649311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25715345|NCT02370615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25715346|NCT02370615|Hormone Antagonists|hormone antagonists|mesh-ancestor
25715347|NCT02370615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25715348|NCT02370615|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25715349|NCT02370615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25715350|NCT02370615|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25715351|NCT02370615|Protective Agents|protective agents|mesh-ancestor
25715352|NCT02370693|Mycophenolic Acid|mycophenolic acid|mesh-list
25715353|NCT02370693|Bortezomib|bortezomib|mesh-list
25715354|NCT02370693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25715355|NCT02370693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25715356|NCT02370693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25715357|NCT02370693|Antitubercular Agents|antitubercular agents|mesh-ancestor
24535793|NCT00649714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24535794|NCT00649714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24535795|NCT00649714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24535796|NCT00649714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24535797|NCT00649714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24535887|NCT00649896|Estrogens|estrogens|mesh-ancestor
24535937|NCT00650026|Adalimumab|adalimumab|mesh-list
24535970|NCT00650117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25715358|NCT02370693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25715359|NCT02370693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25715360|NCT02370693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25715361|NCT02370693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715362|NCT02370784|Atorvastatin|atorvastatin|mesh-list
25715363|NCT02370784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24536055|NCT00650247|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24536057|NCT00650247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24536098|NCT00650351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24536099|NCT00650351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24536100|NCT00650351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24536120|NCT00650377|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
24536121|NCT00650377|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24536122|NCT00650377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536123|NCT00650377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536124|NCT00650377|Hormone Antagonists|hormone antagonists|mesh-ancestor
24536125|NCT00650377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24536126|NCT00650377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536127|NCT00650377|Urological Agents|urological agents|mesh-ancestor
24536129|NCT00650390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24536142|NCT00650403|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24536143|NCT00650403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24536144|NCT00650403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536145|NCT00650416|Carvedilol|carvedilol|mesh-list
24536146|NCT00650416|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24536147|NCT00650416|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24536148|NCT00650416|Adrenergic Agents|adrenergic agents|mesh-ancestor
24536149|NCT00650416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24536150|NCT00650416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451209|NCT00322595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451210|NCT00322660|Epinephrine|epinephrine|mesh-list
24451211|NCT00322660|Racepinephrine|racepinephrine|mesh-list
24451212|NCT00322660|Epinephryl borate|epinephryl borate|mesh-list
24536168|NCT00650429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24536169|NCT00650429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24536170|NCT00650429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24536171|NCT00650429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24536172|NCT00650429|Dopamine Agents|dopamine agents|mesh-ancestor
24536179|NCT00650442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24536180|NCT00650442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536185|NCT00650455|Naproxen|naproxen|mesh-list
24536203|NCT00650468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24536204|NCT00650468|Glucocorticoids|glucocorticoids|mesh-ancestor
25715364|NCT02370784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25715365|NCT02370784|Antimetabolites|antimetabolites|mesh-ancestor
25715366|NCT02370784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715367|NCT02370784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25715368|NCT02370784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25715369|NCT02370784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536391|NCT00651066|Antitubercular Agents|antitubercular agents|mesh-ancestor
24536392|NCT00651105|Vildagliptin|vildagliptin|mesh-list
24536393|NCT00651105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24536394|NCT00651105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536395|NCT00651105|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24536396|NCT00651105|Protease Inhibitors|protease inhibitors|mesh-ancestor
24536397|NCT00651105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24536398|NCT00651105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536531|NCT00651586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24536532|NCT00651599|Drospirenone|drospirenone|mesh-list
24536534|NCT00651599|Estrogens|estrogens|mesh-ancestor
24536535|NCT00651599|Hormones|hormones|mesh-ancestor
24536536|NCT00651599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24536537|NCT00651599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536676|NCT00652002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24536677|NCT00652041|Thalidomide|thalidomide|mesh-list
24536678|NCT00652041|Bortezomib|bortezomib|mesh-list
24536679|NCT00652041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24536680|NCT00652041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24536681|NCT00652041|Immunologic Factors|immunologic factors|mesh-ancestor
24536682|NCT00652041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24536701|NCT00652106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24446347|NCT00304499|Urological Agents|urological agents|mesh-ancestor
24446348|NCT00304538|Glucagon|glucagon|mesh-list
24446349|NCT00304538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24446350|NCT00304538|Hormones|hormones|mesh-ancestor
24446351|NCT00304538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24446352|NCT00304538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446353|NCT00304551|Ribavirin|ribavirin|mesh-list
24446354|NCT00304551|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24446355|NCT00304551|Interferon-alpha|interferon-alpha|mesh-list
24536900|NCT00652821|Analgesics|analgesics|mesh-ancestor
24536947|NCT00652925|Sensory System Agents|sensory system agents|mesh-ancestor
24536948|NCT00652925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24537019|NCT00653302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24537020|NCT00653302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537021|NCT00653315|Tramadol|tramadol|mesh-list
24537022|NCT00653315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24537023|NCT00653315|Narcotics|narcotics|mesh-ancestor
24537024|NCT00653315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24537025|NCT00653315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537026|NCT00653315|Analgesics|analgesics|mesh-ancestor
24537027|NCT00653315|Sensory System Agents|sensory system agents|mesh-ancestor
24537028|NCT00653315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24537031|NCT00653341|Insulin Glargine|insulin glargine|mesh-list
25715370|NCT02371187|Dapagliflozin|dapagliflozin|mesh-list
25715371|NCT02371187|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24537100|NCT00653458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25715372|NCT02371187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537114|NCT00653510|Insulin|insulin|mesh-list
24537146|NCT00653614|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24537147|NCT00653614|Hormone Antagonists|hormone antagonists|mesh-ancestor
24537148|NCT00653614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24537149|NCT00653614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537150|NCT00653614|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24537151|NCT00653614|Diuretics|diuretics|mesh-ancestor
25715373|NCT02371187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25715374|NCT02371187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715375|NCT02371252|Alendronate|alendronate|mesh-list
25715376|NCT02371252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25715377|NCT02371252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715378|NCT02371616|Listerine|listerine|mesh-list
25715379|NCT02371616|Calcium|calcium|mesh-list
25715380|NCT02371616|Fluorides|fluorides|mesh-list
24537199|NCT00653926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24537201|NCT00653926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24537202|NCT00653926|Respiratory System Agents|respiratory system agents|mesh-ancestor
24537236|NCT00654043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537238|NCT00654056|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24537239|NCT00654056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24537454|NCT00654602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537455|NCT00654602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24537456|NCT00654602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24537457|NCT00654602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24537458|NCT00654667|Resveratrol|resveratrol|mesh-list
24537459|NCT00654667|Antioxidants|antioxidants|mesh-ancestor
24537460|NCT00654667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537523|NCT00655109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537525|NCT00655109|Respiratory System Agents|respiratory system agents|mesh-ancestor
24537526|NCT00655109|Dermatologic Agents|dermatologic agents|mesh-ancestor
24537527|NCT00655109|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24537528|NCT00655109|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24537529|NCT00655109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24537530|NCT00655109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24537531|NCT00655109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24537532|NCT00655109|Analgesics|analgesics|mesh-ancestor
24537533|NCT00655109|Sensory System Agents|sensory system agents|mesh-ancestor
24537534|NCT00655109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24537536|NCT00655109|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24537574|NCT00655200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537576|NCT00655252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24537581|NCT00655265|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24537582|NCT00655265|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24537583|NCT00655265|Antimetabolites|antimetabolites|mesh-ancestor
24537585|NCT00655265|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24537685|NCT00655785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537686|NCT00655798|Antioxidants|antioxidants|mesh-list
24537687|NCT00655798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537688|NCT00655798|Protective Agents|protective agents|mesh-ancestor
24537689|NCT00655798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537748|NCT00656110|Prednisolone phosphate|prednisolone phosphate|mesh-list
24537749|NCT00656110|Anesthetics, Local|anesthetics, local|mesh-ancestor
24537750|NCT00656110|Anesthetics|anesthetics|mesh-ancestor
24537751|NCT00656110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24537752|NCT00656110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537753|NCT00656110|Sensory System Agents|sensory system agents|mesh-ancestor
24537795|NCT00656214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24537797|NCT00656214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24537798|NCT00656214|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24537799|NCT00656214|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24537800|NCT00656214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24537801|NCT00656240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24537802|NCT00656240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24537803|NCT00656266|Mycophenolic Acid|mycophenolic acid|mesh-list
24537804|NCT00656266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24537805|NCT00656266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24537806|NCT00656266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24537807|NCT00656266|Antitubercular Agents|antitubercular agents|mesh-ancestor
25715381|NCT02371616|Sodium Fluoride|sodium fluoride|mesh-list
25715382|NCT02371616|Fluorophosphate|fluorophosphate|mesh-list
25715383|NCT02371616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25715384|NCT02371616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715385|NCT02371616|Cariostatic Agents|cariostatic agents|mesh-ancestor
25715386|NCT02371616|Protective Agents|protective agents|mesh-ancestor
25715387|NCT02371616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25715388|NCT02371616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25715389|NCT02371629|Glycopyrrolate|glycopyrrolate|mesh-list
25715390|NCT02371629|Bromides|bromides|mesh-list
25715391|NCT02371629|Albuterol|albuterol|mesh-list
25715392|NCT02371629|Anticonvulsants|anticonvulsants|mesh-ancestor
25715393|NCT02371629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25715394|NCT02371629|Autonomic Agents|autonomic agents|mesh-ancestor
25715395|NCT02371629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24538093|NCT00657449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538152|NCT00657748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24538153|NCT00657748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24538154|NCT00657748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538155|NCT00657748|Antifungal Agents|antifungal agents|mesh-ancestor
24538156|NCT00657748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24538157|NCT00657761|Enfuvirtide|enfuvirtide|mesh-list
24538158|NCT00657761|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24538159|NCT00657761|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24538160|NCT00657761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451250|NCT00322803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24451251|NCT00322803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451253|NCT00322907|Quinine|quinine|mesh-list
24538241|NCT00657982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24538242|NCT00657982|Immunologic Factors|immunologic factors|mesh-ancestor
24538243|NCT00657982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538244|NCT00657995|Pancrelipase|pancrelipase|mesh-list
24538245|NCT00657995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24538246|NCT00658099|Insulin|insulin|mesh-list
24538247|NCT00658099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24538248|NCT00658099|Insulin Detemir|insulin detemir|mesh-list
24538249|NCT00658099|Isophane Insulin, Human|isophane insulin, human|mesh-list
24538250|NCT00658099|Insulin, Isophane|insulin, isophane|mesh-list
24538251|NCT00658099|Isophane insulin, beef|isophane insulin, beef|mesh-list
24538252|NCT00658099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24538261|NCT00658255|Budesonide|budesonide|mesh-list
24538342|NCT00658931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538343|NCT00658931|Analgesics|analgesics|mesh-ancestor
24538344|NCT00658931|Sensory System Agents|sensory system agents|mesh-ancestor
24538345|NCT00658931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24538346|NCT00658931|Antidepressive Agents|antidepressive agents|mesh-ancestor
24538347|NCT00658931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24538348|NCT00658931|Dopamine Agents|dopamine agents|mesh-ancestor
24538372|NCT00659048|Glucocorticoids|glucocorticoids|mesh-ancestor
24538373|NCT00659048|Hormones|hormones|mesh-ancestor
24538374|NCT00659048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24538375|NCT00659048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538376|NCT00659048|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24538377|NCT00659074|Ondansetron|ondansetron|mesh-list
24538378|NCT00659074|Antiemetics|antiemetics|mesh-ancestor
24538379|NCT00659074|Autonomic Agents|autonomic agents|mesh-ancestor
24538382|NCT00659074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24538449|NCT00659399|Protease Inhibitors|protease inhibitors|mesh-ancestor
24538450|NCT00659399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538451|NCT00659399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538452|NCT00659399|Anticoagulants|anticoagulants|mesh-ancestor
24538453|NCT00659399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24538454|NCT00659399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25715396|NCT02371629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715397|NCT02371629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25715398|NCT02371629|Respiratory System Agents|respiratory system agents|mesh-ancestor
25715399|NCT02371629|Tocolytic Agents|tocolytic agents|mesh-ancestor
25715400|NCT02371629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25715401|NCT02371629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25715402|NCT02371629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25715403|NCT02371629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25715404|NCT02371629|Adrenergic Agents|adrenergic agents|mesh-ancestor
25715405|NCT02371629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24538535|NCT00659750|Glucocorticoids|glucocorticoids|mesh-ancestor
24538689|NCT00660335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538690|NCT00660374|Isophane Insulin, Human|isophane insulin, human|mesh-list
24538691|NCT00660374|Insulin, Isophane|insulin, isophane|mesh-list
24538692|NCT00660374|Isophane insulin, beef|isophane insulin, beef|mesh-list
24538693|NCT00660374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24538694|NCT00660374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538695|NCT00660426|Gemcitabine|gemcitabine|mesh-list
24538696|NCT00660426|Capecitabine|capecitabine|mesh-list
24538697|NCT00660426|Oxaliplatin|oxaliplatin|mesh-list
24538760|NCT00660751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24538761|NCT00660751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538762|NCT00660751|Analgesics|analgesics|mesh-ancestor
24538763|NCT00660751|Sensory System Agents|sensory system agents|mesh-ancestor
24538797|NCT00660855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538799|NCT00660855|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24538805|NCT00660855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24538806|NCT00660855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25715406|NCT02371629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715407|NCT02371629|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25715408|NCT02371629|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25715409|NCT02371629|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25715410|NCT02371629|Cholinergic Agents|cholinergic agents|mesh-ancestor
25715411|NCT02371746|Travoprost|travoprost|mesh-list
24538926|NCT00661206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538927|NCT00661206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24538929|NCT00661219|Vasodilator Agents|vasodilator agents|mesh-ancestor
24538930|NCT00661219|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24538931|NCT00661219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24538932|NCT00661219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538933|NCT00661219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24538934|NCT00661219|Urological Agents|urological agents|mesh-ancestor
24538935|NCT00661297|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24538936|NCT00661297|Vasodilator Agents|vasodilator agents|mesh-ancestor
24538937|NCT00661297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24451432|NCT00323778|Hyaluronic Acid|hyaluronic acid|mesh-list
24451433|NCT00323778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24451442|NCT00323791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451443|NCT00323791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451445|NCT00323791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24451446|NCT00323791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451451|NCT00323804|Ribavirin|ribavirin|mesh-list
24538959|NCT00661349|Nevirapine|nevirapine|mesh-list
24538960|NCT00661349|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24538961|NCT00661349|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25715412|NCT02371746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25715413|NCT02371759|Anesthetics|anesthetics|mesh-list
25715414|NCT02371759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25715415|NCT02371759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715416|NCT02371850|Nicotine|nicotine|mesh-list
25715417|NCT02371850|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25715418|NCT02371850|Autonomic Agents|autonomic agents|mesh-ancestor
25715419|NCT02371850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25715420|NCT02371850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715421|NCT02371850|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24538962|NCT00661349|Protease Inhibitors|protease inhibitors|mesh-ancestor
24538963|NCT00661349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24538965|NCT00661349|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24539001|NCT00661635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24539002|NCT00661635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24539003|NCT00661648|Pancrelipase|pancrelipase|mesh-list
24539004|NCT00661648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24539005|NCT00661700|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24539006|NCT00661700|Vasodilator Agents|vasodilator agents|mesh-ancestor
24539007|NCT00661700|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24539008|NCT00661700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24539009|NCT00661700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539010|NCT00661700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539011|NCT00661700|Urological Agents|urological agents|mesh-ancestor
24539012|NCT00661739|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24539013|NCT00661739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24539014|NCT00661739|Alkylating Agents|alkylating agents|mesh-ancestor
24539015|NCT00661739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539017|NCT00661765|Varenicline|varenicline|mesh-list
25715422|NCT02371850|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25715423|NCT02371850|Cholinergic Agents|cholinergic agents|mesh-ancestor
25715424|NCT02371850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25715425|NCT02371850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715426|NCT02371980|Vortioxetine|vortioxetine|mesh-list
25715427|NCT02371980|Antidepressive Agents|antidepressive agents|mesh-ancestor
25715428|NCT02371980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24539038|NCT00661973|Budesonide|budesonide|mesh-list
24539060|NCT00662220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539061|NCT00662233|Cyclophosphamide|cyclophosphamide|mesh-list
24539062|NCT00662233|Ifosfamide|ifosfamide|mesh-list
24539063|NCT00662233|Doxorubicin|doxorubicin|mesh-list
24539064|NCT00662233|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24539065|NCT00662233|Etoposide|etoposide|mesh-list
24539066|NCT00662233|Vincristine|vincristine|mesh-list
24539067|NCT00662233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24539088|NCT00662337|Promethazine|promethazine|mesh-list
24539089|NCT00662337|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24539090|NCT00662337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24539091|NCT00662337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25715429|NCT02371980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25715430|NCT02371980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25715431|NCT02371980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25715432|NCT02371980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715433|NCT02371980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25715434|NCT02371980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25715435|NCT02371980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25715436|NCT02371980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715437|NCT02371980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25715438|NCT02371980|Serotonin Agents|serotonin agents|mesh-ancestor
25715439|NCT02371980|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24539092|NCT00662337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539093|NCT00662337|Anesthetics, Local|anesthetics, local|mesh-ancestor
24539097|NCT00662337|Antiemetics|antiemetics|mesh-ancestor
24539111|NCT00662441|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24539112|NCT00662441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539113|NCT00662441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539114|NCT00662441|Urological Agents|urological agents|mesh-ancestor
24539115|NCT00662454|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
24539116|NCT00662454|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
24539117|NCT00662454|Levonorgestrel|levonorgestrel|mesh-list
24539118|NCT00662454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24539119|NCT00662454|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
24539121|NCT00662454|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24539122|NCT00662454|Estrogens|estrogens|mesh-ancestor
24539123|NCT00662454|Hormones|hormones|mesh-ancestor
24539124|NCT00662454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24539125|NCT00662454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539126|NCT00662454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24539127|NCT00662454|Contraceptive Agents|contraceptive agents|mesh-ancestor
24539128|NCT00662454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24539129|NCT00662454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24443664|NCT00295698|Filaricides|filaricides|mesh-ancestor
24443665|NCT00295698|Antinematodal Agents|antinematodal agents|mesh-ancestor
24443666|NCT00295698|Anthelmintics|anthelmintics|mesh-ancestor
24443667|NCT00295698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24443668|NCT00295698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24443669|NCT00295698|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24443670|NCT00295698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25715440|NCT02371980|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25715441|NCT02371980|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25715442|NCT02371980|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25715443|NCT02372006|Afatinib|afatinib|mesh-list
25715444|NCT02372006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25715445|NCT02372006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25715446|NCT02372006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25715447|NCT02372006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715449|NCT02372253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25715450|NCT02372253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24443671|NCT00295698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24443672|NCT00295776|Lamotrigine|lamotrigine|mesh-list
24539202|NCT00662779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24539203|NCT00662779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539204|NCT00662805|Fluticasone|fluticasone|mesh-list
24539210|NCT00662805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24539230|NCT00662883|Ketamine|ketamine|mesh-list
25715451|NCT02372253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25715452|NCT02372253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715453|NCT02372253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25715454|NCT02372253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715455|NCT02372253|Vasodilator Agents|vasodilator agents|mesh-ancestor
25715456|NCT02372383|Azithromycin|azithromycin|mesh-list
25715457|NCT02372383|Rifampin|rifampin|mesh-list
25715458|NCT02372383|Ethambutol|ethambutol|mesh-list
25715459|NCT02372383|Pancrelipase|pancrelipase|mesh-list
25715460|NCT02372383|Pancreatin|pancreatin|mesh-list
25715461|NCT02372383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25715462|NCT02372383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25715463|NCT02372383|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24443718|NCT00295893|Tubulin Modulators|tubulin modulators|mesh-ancestor
25715464|NCT02372383|Antitubercular Agents|antitubercular agents|mesh-ancestor
25715465|NCT02372383|Leprostatic Agents|leprostatic agents|mesh-ancestor
25715466|NCT02372383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25715467|NCT02372383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25715468|NCT02372383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715469|NCT02372383|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25715470|NCT02372383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25715472|NCT02372383|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25715473|NCT02372383|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25715474|NCT02372383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25715475|NCT02372383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25715476|NCT02372799|Fluoxetine|fluoxetine|mesh-list
25715477|NCT02372799|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
24539497|NCT00664053|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24539498|NCT00664053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24539499|NCT00664053|Immunologic Factors|immunologic factors|mesh-ancestor
24539550|NCT00664313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539552|NCT00664417|Immunologic Factors|immunologic factors|mesh-ancestor
24539553|NCT00664417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539554|NCT00664469|Atorvastatin|atorvastatin|mesh-list
24539555|NCT00664469|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24539556|NCT00664469|Simvastatin|simvastatin|mesh-list
24539557|NCT00664469|Ezetimibe|ezetimibe|mesh-list
24539558|NCT00664469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24539609|NCT00664690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24539610|NCT00664690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24539611|NCT00664690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24539612|NCT00664690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539613|NCT00664690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715478|NCT02372799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25715479|NCT02372799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25715480|NCT02372799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25715481|NCT02372799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715482|NCT02372799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25715483|NCT02372799|Serotonin Agents|serotonin agents|mesh-ancestor
25715484|NCT02372799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715485|NCT02372799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25715486|NCT02372799|Antidepressive Agents|antidepressive agents|mesh-ancestor
25715487|NCT02372799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25715488|NCT02372799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25715489|NCT02372799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25715490|NCT02372799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25715491|NCT02372799|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25715492|NCT02372799|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25715493|NCT02373098|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25715494|NCT02373098|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
24539614|NCT00664703|Methylphenidate|methylphenidate|mesh-list
24539615|NCT00664703|Lobeline|lobeline|mesh-list
24539616|NCT00664703|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24539617|NCT00664703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539618|NCT00664703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24539619|NCT00664703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24539641|NCT00664833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539720|NCT00665327|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24539721|NCT00665327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24539725|NCT00665327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539726|NCT00665327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715495|NCT02373098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715496|NCT02373098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25771095|NCT03586726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25771096|NCT03586726|Leprostatic Agents|leprostatic agents|mesh-ancestor
25771097|NCT03586726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24539727|NCT00665327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24539728|NCT00665327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24539729|NCT00665327|Contraceptive Agents|contraceptive agents|mesh-ancestor
24539736|NCT00665327|Renal Agents|renal agents|mesh-ancestor
24438373|NCT00275652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24539751|NCT00665418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24539752|NCT00665418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539753|NCT00665496|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24539754|NCT00665496|Vasodilator Agents|vasodilator agents|mesh-ancestor
24539755|NCT00665496|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24539756|NCT00665496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24539757|NCT00665496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539758|NCT00665496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539759|NCT00665496|Urological Agents|urological agents|mesh-ancestor
24539760|NCT00665522|Fentanyl|fentanyl|mesh-list
24539761|NCT00665522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24539762|NCT00665522|Narcotics|narcotics|mesh-ancestor
25715497|NCT02373098|Immunologic Factors|immunologic factors|mesh-ancestor
25715498|NCT02373098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715499|NCT02373124|N-Methylaspartate|n-methylaspartate|mesh-list
25715500|NCT02373124|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
25715501|NCT02373124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25715502|NCT02373124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25715503|NCT02373124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715504|NCT02373124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715505|NCT02373137|Ofloxacin|ofloxacin|mesh-list
25715506|NCT02373137|Prednisolone|prednisolone|mesh-list
25715507|NCT02373137|Phenylephrine|phenylephrine|mesh-list
25715508|NCT02373137|Oxymetazoline|oxymetazoline|mesh-list
25715509|NCT02373137|Tropicamide|tropicamide|mesh-list
25715510|NCT02373137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25715511|NCT02373137|Glucocorticoids|glucocorticoids|mesh-ancestor
25715512|NCT02373137|Hormones|hormones|mesh-ancestor
25771098|NCT03586726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771099|NCT03586726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771100|NCT03586726|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25771101|NCT03586726|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25771102|NCT03586726|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25771103|NCT03586726|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25771104|NCT03586726|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25771105|NCT03586726|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25771106|NCT03587207|Vaccines|vaccines|mesh-list
25771107|NCT03587207|Immunologic Factors|immunologic factors|mesh-ancestor
25771108|NCT03587207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771109|NCT03587428|Zinc|zinc|mesh-list
25771110|NCT03587428|Trace Elements|trace elements|mesh-ancestor
25771111|NCT03587428|Micronutrients|micronutrients|mesh-ancestor
25771112|NCT03587428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771113|NCT03588572|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25771114|NCT03588572|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25771115|NCT03588572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25771116|NCT03588572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25771117|NCT03588572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771118|NCT03588572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25771119|NCT03588572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771120|NCT03588572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25771121|NCT03588572|Antidepressive Agents|antidepressive agents|mesh-ancestor
25771122|NCT03588572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25771123|NCT03588806|Oxycodone|oxycodone|mesh-list
25771124|NCT03588806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24539763|NCT00665522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24539764|NCT00665522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539765|NCT00665522|Analgesics|analgesics|mesh-ancestor
24539773|NCT00665600|Albuterol|albuterol|mesh-list
24539777|NCT00665600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24539778|NCT00665600|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24539779|NCT00665600|Respiratory System Agents|respiratory system agents|mesh-ancestor
24539780|NCT00665600|Tocolytic Agents|tocolytic agents|mesh-ancestor
24539781|NCT00665600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24539782|NCT00665600|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24539783|NCT00665600|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24539784|NCT00665600|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24539785|NCT00665600|Adrenergic Agents|adrenergic agents|mesh-ancestor
24539786|NCT00665600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24539860|NCT00665834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539868|NCT00665873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539869|NCT00665873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539871|NCT00665951|Ritonavir|ritonavir|mesh-list
24539908|NCT00665990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24539909|NCT00665990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24539910|NCT00665990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24539911|NCT00665990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24539912|NCT00665990|Growth Substances|growth substances|mesh-ancestor
24539913|NCT00665990|Growth Inhibitors|growth inhibitors|mesh-ancestor
24539914|NCT00665990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24539915|NCT00665990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771125|NCT03588806|Narcotics|narcotics|mesh-ancestor
25771126|NCT03588806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25771127|NCT03588806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771128|NCT03588806|Analgesics|analgesics|mesh-ancestor
25771129|NCT03588806|Sensory System Agents|sensory system agents|mesh-ancestor
25771130|NCT03588806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771131|NCT03588910|Acetaminophen|acetaminophen|mesh-list
25771132|NCT03588910|Ibuprofen|ibuprofen|mesh-list
25771133|NCT03588910|Oxycodone|oxycodone|mesh-list
24539916|NCT00666042|Moxifloxacin|moxifloxacin|mesh-list
24539917|NCT00666042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24539918|NCT00666042|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24539919|NCT00666042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24539920|NCT00666042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24539924|NCT00666042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24539925|NCT00666042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24539926|NCT00666042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24539962|NCT00666055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24539963|NCT00666055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24539964|NCT00666055|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24539966|NCT00666055|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24539967|NCT00666055|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25715513|NCT02373137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25715514|NCT02373137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715515|NCT02373137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25715516|NCT02373137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25715517|NCT02373137|Autonomic Agents|autonomic agents|mesh-ancestor
25715518|NCT02373137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25715519|NCT02373137|Protective Agents|protective agents|mesh-ancestor
25715520|NCT02373137|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25715521|NCT02373137|Mydriatics|mydriatics|mesh-ancestor
24539968|NCT00666055|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
24540003|NCT00666185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24540004|NCT00666185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540005|NCT00666185|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24540006|NCT00666185|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24540008|NCT00666302|Tacrolimus|tacrolimus|mesh-list
24540009|NCT00666302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24540010|NCT00666302|Immunologic Factors|immunologic factors|mesh-ancestor
24540011|NCT00666302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540015|NCT00666302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24540016|NCT00666302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24540017|NCT00666302|Analgesics|analgesics|mesh-ancestor
24540018|NCT00666302|Sensory System Agents|sensory system agents|mesh-ancestor
25715522|NCT02373137|Sympathomimetics|sympathomimetics|mesh-ancestor
25715523|NCT02373137|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25715524|NCT02373137|Nasal Decongestants|nasal decongestants|mesh-ancestor
25715525|NCT02373137|Respiratory System Agents|respiratory system agents|mesh-ancestor
25715526|NCT02373137|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25715527|NCT02373137|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25715528|NCT02373137|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25715529|NCT02373137|Adrenergic Agents|adrenergic agents|mesh-ancestor
25715530|NCT02373137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25715531|NCT02373137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715532|NCT02373137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24540019|NCT00666302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24540020|NCT00666302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24540021|NCT00666302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24540022|NCT00666302|Dermatologic Agents|dermatologic agents|mesh-ancestor
24540023|NCT00666341|Immunologic Factors|immunologic factors|mesh-list
24540024|NCT00666341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540026|NCT00666354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24540027|NCT00666354|Abortifacient Agents|abortifacient agents|mesh-ancestor
24540028|NCT00666354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24540029|NCT00666354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540030|NCT00666354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24540031|NCT00666354|Antimetabolites|antimetabolites|mesh-ancestor
24540032|NCT00666354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540033|NCT00666354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24540034|NCT00666354|Dermatologic Agents|dermatologic agents|mesh-ancestor
24540035|NCT00666354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540036|NCT00666354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24540037|NCT00666354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24540038|NCT00666354|Immunologic Factors|immunologic factors|mesh-ancestor
24540052|NCT00666393|Anesthetics|anesthetics|mesh-ancestor
24540053|NCT00666484|Prednisolone|prednisolone|mesh-list
24540054|NCT00666484|Cyclophosphamide|cyclophosphamide|mesh-list
24540055|NCT00666484|Doxorubicin|doxorubicin|mesh-list
24540056|NCT00666484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24540057|NCT00666484|Etoposide|etoposide|mesh-list
24540058|NCT00666484|Vincristine|vincristine|mesh-list
24540059|NCT00666484|Procarbazine|procarbazine|mesh-list
25715533|NCT02373137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25715534|NCT02373137|Cholinergic Agents|cholinergic agents|mesh-ancestor
25715535|NCT02373137|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25715536|NCT02373137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25715537|NCT02373137|Renal Agents|renal agents|mesh-ancestor
25715538|NCT02373137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25715539|NCT02373137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25715540|NCT02373137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25715541|NCT02373137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25715542|NCT02373137|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25715543|NCT02373137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25715544|NCT02373202|Sulfasalazine|sulfasalazine|mesh-list
25715545|NCT02373202|Mizoribine|mizoribine|mesh-list
25715546|NCT02373202|Bucillamine|bucillamine|mesh-list
24540060|NCT00666484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24540061|NCT00666484|Immunologic Factors|immunologic factors|mesh-ancestor
24540062|NCT00666484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540063|NCT00666484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24540064|NCT00666484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24540065|NCT00666484|Alkylating Agents|alkylating agents|mesh-ancestor
24540066|NCT00666484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540073|NCT00666484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24540074|NCT00666484|Tubulin Modulators|tubulin modulators|mesh-ancestor
24540075|NCT00666484|Antimitotic Agents|antimitotic agents|mesh-ancestor
24540076|NCT00666484|Mitosis Modulators|mitosis modulators|mesh-ancestor
24540077|NCT00666484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24540085|NCT00666575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24540126|NCT00666692|Tubulin Modulators|tubulin modulators|mesh-ancestor
24540127|NCT00666692|Antimitotic Agents|antimitotic agents|mesh-ancestor
24540134|NCT00666692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540135|NCT00666692|Growth Inhibitors|growth inhibitors|mesh-ancestor
24540136|NCT00666692|Immunologic Factors|immunologic factors|mesh-ancestor
24540137|NCT00666770|Gabapentin|gabapentin|mesh-list
24540138|NCT00666770|Analgesics|analgesics|mesh-ancestor
24540139|NCT00666770|Sensory System Agents|sensory system agents|mesh-ancestor
24540140|NCT00666770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24540141|NCT00666770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540142|NCT00666770|Anticonvulsants|anticonvulsants|mesh-ancestor
24540143|NCT00666770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24540144|NCT00666770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25715547|NCT02373202|Tacrolimus|tacrolimus|mesh-list
25715548|NCT02373202|Leflunomide|leflunomide|mesh-list
25715549|NCT02373202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25715550|NCT02373202|Immunologic Factors|immunologic factors|mesh-ancestor
25715551|NCT02373202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715552|NCT02373202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25715553|NCT02373202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25715554|NCT02373202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444931|NCT00299754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24540146|NCT00666770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24540174|NCT00666796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24540175|NCT00666796|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24540176|NCT00666796|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24540177|NCT00666796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24540185|NCT00666809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24540187|NCT00666809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540188|NCT00666809|Urological Agents|urological agents|mesh-ancestor
24540189|NCT00666887|Minocycline|minocycline|mesh-list
24540190|NCT00666887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24540191|NCT00666887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24540192|NCT00666939|Gabapentin|gabapentin|mesh-list
24540193|NCT00666939|Analgesics|analgesics|mesh-ancestor
24540194|NCT00666939|Sensory System Agents|sensory system agents|mesh-ancestor
24540195|NCT00666939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24540196|NCT00666939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540197|NCT00666939|Anticonvulsants|anticonvulsants|mesh-ancestor
24540198|NCT00666939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24444958|NCT00299858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24444959|NCT00299871|Lixisenatide|lixisenatide|mesh-list
24444960|NCT00299871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24444961|NCT00299871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444962|NCT00299884|Atorvastatin|atorvastatin|mesh-list
24540208|NCT00666991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24540209|NCT00666991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24540210|NCT00666991|Tubulin Modulators|tubulin modulators|mesh-ancestor
24540211|NCT00666991|Antimitotic Agents|antimitotic agents|mesh-ancestor
24540212|NCT00666991|Mitosis Modulators|mitosis modulators|mesh-ancestor
24540213|NCT00666991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540214|NCT00667043|Fentanyl|fentanyl|mesh-list
24443763|NCT00295945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24443764|NCT00295945|Anesthetics, General|anesthetics, general|mesh-ancestor
24443765|NCT00295958|Freund's Adjuvant|freund's adjuvant|mesh-list
24443766|NCT00295958|Immunotoxins|immunotoxins|mesh-list
24443767|NCT00295958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24445012|NCT00300014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24445013|NCT00300014|Glucocorticoids|glucocorticoids|mesh-ancestor
25715555|NCT02373202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25715556|NCT02373202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25715557|NCT02373202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25715558|NCT02373202|Analgesics|analgesics|mesh-ancestor
25715559|NCT02373202|Sensory System Agents|sensory system agents|mesh-ancestor
25715560|NCT02373202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25715561|NCT02373202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25715562|NCT02373202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24540240|NCT00667056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540241|NCT00667056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24540242|NCT00667056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540243|NCT00667056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540244|NCT00667069|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24540245|NCT00667069|Luteolytic Agents|luteolytic agents|mesh-ancestor
24540246|NCT00667069|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24540247|NCT00667069|Contraceptive Agents|contraceptive agents|mesh-ancestor
24540248|NCT00667069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24540249|NCT00667069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540250|NCT00667069|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24445103|NCT00300378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24393265|NCT00129337|Bavituximab|bavituximab|mesh-list
24393267|NCT00129337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445136|NCT00300508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25407653|NCT03487016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25715563|NCT02373202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25715564|NCT02373202|Antioxidants|antioxidants|mesh-ancestor
25715565|NCT02373202|Protective Agents|protective agents|mesh-ancestor
25715566|NCT02373202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25715567|NCT02373202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25715568|NCT02373202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25715569|NCT02373202|Antimalarials|antimalarials|mesh-ancestor
25715570|NCT02373202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25715571|NCT02373202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25715572|NCT02373371|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
24540296|NCT00667160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24540297|NCT00667160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24540298|NCT00667160|Dermatologic Agents|dermatologic agents|mesh-ancestor
24540299|NCT00667199|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
24445159|NCT00300586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24445178|NCT00300729|Analgesics|analgesics|mesh-ancestor
24445179|NCT00300729|Sensory System Agents|sensory system agents|mesh-ancestor
24445180|NCT00300729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24445181|NCT00300729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445182|NCT00300729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24445183|NCT00300729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24445184|NCT00300729|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24445185|NCT00300729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24445186|NCT00300729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25715573|NCT02373371|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25715574|NCT02373371|Dermatologic Agents|dermatologic agents|mesh-ancestor
25715575|NCT02373813|Folic Acid|folic acid|mesh-list
25715576|NCT02373813|Etanercept|etanercept|mesh-list
25715577|NCT02373813|Methotrexate|methotrexate|mesh-list
25715578|NCT02373813|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24445188|NCT00300768|Ivermectin|ivermectin|mesh-list
25715579|NCT02373813|Abortifacient Agents|abortifacient agents|mesh-ancestor
24540321|NCT00667407|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24444112|NCT00296751|Meperidine|meperidine|mesh-list
24445252|NCT00300950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24445253|NCT00300950|Antimetabolites|antimetabolites|mesh-ancestor
24445254|NCT00300950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445255|NCT00300950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445256|NCT00300950|Antiviral Agents|antiviral agents|mesh-ancestor
24540354|NCT00667485|Growth Substances|growth substances|mesh-ancestor
24540355|NCT00667485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24540356|NCT00667485|Growth Inhibitors|growth inhibitors|mesh-ancestor
24540357|NCT00667485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24540358|NCT00667485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24540359|NCT00667485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24540360|NCT00667485|Antifungal Agents|antifungal agents|mesh-ancestor
24540361|NCT00667485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24445367|NCT00301405|Leprostatic Agents|leprostatic agents|mesh-ancestor
24444067|NCT00296686|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24540738|NCT00669435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540739|NCT00669435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24540779|NCT00669643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24540780|NCT00669643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25715580|NCT02373813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25715581|NCT02373813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715582|NCT02373813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25715583|NCT02373813|Antimetabolites|antimetabolites|mesh-ancestor
25715584|NCT02373813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715585|NCT02373813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25715586|NCT02373813|Dermatologic Agents|dermatologic agents|mesh-ancestor
24540820|NCT00669721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24540822|NCT00669721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24540830|NCT00669773|Antimitotic Agents|antimitotic agents|mesh-ancestor
24540831|NCT00669773|Mitosis Modulators|mitosis modulators|mesh-ancestor
24540837|NCT00669786|Menotropins|menotropins|mesh-list
24540857|NCT00669812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24540858|NCT00669812|Immunologic Factors|immunologic factors|mesh-ancestor
24445894|NCT00303004|Sildenafil Citrate|sildenafil citrate|mesh-list
24540868|NCT00669812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24540869|NCT00669812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24540871|NCT00669812|Abortifacient Agents|abortifacient agents|mesh-ancestor
24541036|NCT00670566|Natriuretic Agents|natriuretic agents|mesh-ancestor
24541037|NCT00670566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715587|NCT02373813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24541038|NCT00670566|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25715588|NCT02373813|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25715589|NCT02373813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25715590|NCT02373813|Immunologic Factors|immunologic factors|mesh-ancestor
25715591|NCT02373813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25715592|NCT02373813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25715593|NCT02373813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25715594|NCT02373813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25715595|NCT02373813|Analgesics|analgesics|mesh-ancestor
25715596|NCT02373813|Sensory System Agents|sensory system agents|mesh-ancestor
25715597|NCT02373813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25715598|NCT02373813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25715599|NCT02373813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24541073|NCT00670722|Insulin Aspart|insulin aspart|mesh-list
24541097|NCT00670787|Natriuretic Agents|natriuretic agents|mesh-ancestor
24541103|NCT00670813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541104|NCT00670813|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24541108|NCT00670878|Gemcitabine|gemcitabine|mesh-list
24541207|NCT00671424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24541228|NCT00671593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541229|NCT00671593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24541230|NCT00671593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24541231|NCT00671593|Disinfectants|disinfectants|mesh-ancestor
24541232|NCT00671593|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
24446958|NCT00306735|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24541362|NCT00672399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24541399|NCT00672568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24541433|NCT00672763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24541434|NCT00672763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24541436|NCT00672776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24541437|NCT00672776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24541438|NCT00672776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25715600|NCT02373813|Hematinics|hematinics|mesh-ancestor
25715601|NCT02373813|Vitamin B Complex|vitamin b complex|mesh-ancestor
25715602|NCT02373813|Vitamins|vitamins|mesh-ancestor
25715603|NCT02373813|Micronutrients|micronutrients|mesh-ancestor
25771134|NCT03588910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25771135|NCT03588910|Analgesics|analgesics|mesh-ancestor
25771136|NCT03588910|Sensory System Agents|sensory system agents|mesh-ancestor
25771137|NCT03588910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771138|NCT03588910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771139|NCT03588910|Antipyretics|antipyretics|mesh-ancestor
25771140|NCT03588910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25771141|NCT03588910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25771142|NCT03588910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24541597|NCT00674050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24541598|NCT00674050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24541600|NCT00674063|Dermatologic Agents|dermatologic agents|mesh-ancestor
24541861|NCT00675714|Nandrolone Decanoate|nandrolone decanoate|mesh-list
24541862|NCT00675714|Itraconazole|itraconazole|mesh-list
24541863|NCT00675714|Fluconazole|fluconazole|mesh-list
24541864|NCT00675714|Ketoconazole|ketoconazole|mesh-list
24541865|NCT00675714|Methyltestosterone|methyltestosterone|mesh-list
24541866|NCT00675714|Propranolol|propranolol|mesh-list
24541868|NCT00675714|Hormones|hormones|mesh-list
24541869|NCT00675714|Testosterone|testosterone|mesh-list
24541870|NCT00675714|Testosterone undecanoate|testosterone undecanoate|mesh-list
24541897|NCT00675714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24541898|NCT00675714|Sympatholytics|sympatholytics|mesh-ancestor
24541899|NCT00675714|Autonomic Agents|autonomic agents|mesh-ancestor
24541900|NCT00675714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24393488|NCT00130195|Imatinib Mesylate|imatinib mesylate|mesh-list
24541901|NCT00675714|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24542275|NCT00678145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542276|NCT00678145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24542277|NCT00678145|Narcotics|narcotics|mesh-ancestor
24542278|NCT00678145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24542279|NCT00678145|Analgesics|analgesics|mesh-ancestor
24542402|NCT00678509|Immunologic Factors|immunologic factors|mesh-ancestor
24542403|NCT00678509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715604|NCT02374060|Dexamethasone|dexamethasone|mesh-list
25715605|NCT02374060|Triamcinolone|triamcinolone|mesh-list
25715606|NCT02374060|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25715607|NCT02374060|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24542955|NCT00681174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542956|NCT00681174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24542957|NCT00681174|Anesthetics, General|anesthetics, general|mesh-ancestor
24542958|NCT00681174|Anesthetics|anesthetics|mesh-ancestor
24542959|NCT00681174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24542960|NCT00681174|Narcotics|narcotics|mesh-ancestor
24542961|NCT00681174|Analgesics|analgesics|mesh-ancestor
24542962|NCT00681174|Sensory System Agents|sensory system agents|mesh-ancestor
24542963|NCT00681174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24542964|NCT00681174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24542965|NCT00681174|Antipyretics|antipyretics|mesh-ancestor
24542967|NCT00681213|Tacrolimus|tacrolimus|mesh-list
24542968|NCT00681213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24542969|NCT00681213|Immunologic Factors|immunologic factors|mesh-ancestor
24542970|NCT00681213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24542971|NCT00681213|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24542972|NCT00681213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543025|NCT00681720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543237|NCT00682578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543238|NCT00682630|Artesunate|artesunate|mesh-list
24543239|NCT00682630|Pyronaridine|pyronaridine|mesh-list
24543240|NCT00682630|Antimalarials|antimalarials|mesh-ancestor
24543241|NCT00682630|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24543242|NCT00682630|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24543243|NCT00682630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24543244|NCT00682630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543265|NCT00682760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24543281|NCT00683059|Paclitaxel|paclitaxel|mesh-list
24543282|NCT00683059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24543283|NCT00683059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543284|NCT00683059|Tubulin Modulators|tubulin modulators|mesh-ancestor
24543285|NCT00683059|Antimitotic Agents|antimitotic agents|mesh-ancestor
24543286|NCT00683059|Mitosis Modulators|mitosis modulators|mesh-ancestor
25715608|NCT02374060|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25715609|NCT02374060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25715610|NCT02374060|Antiemetics|antiemetics|mesh-ancestor
25715611|NCT02374060|Autonomic Agents|autonomic agents|mesh-ancestor
25715612|NCT02374060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25715613|NCT02374060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543290|NCT00683111|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24543291|NCT00683111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24543292|NCT00683111|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24543293|NCT00683111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24543294|NCT00683111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446519|NCT00304993|Vitamin B Complex|vitamin b complex|mesh-ancestor
24446521|NCT00304993|Micronutrients|micronutrients|mesh-ancestor
24543361|NCT00683306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24543530|NCT00684112|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24543531|NCT00684112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24543532|NCT00684112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543533|NCT00684112|Antimanic Agents|antimanic agents|mesh-ancestor
24543585|NCT00684372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24543586|NCT00684372|Immunologic Factors|immunologic factors|mesh-ancestor
24543587|NCT00684372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543590|NCT00684385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24543592|NCT00684385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543593|NCT00684450|Protamines|protamines|mesh-list
24543594|NCT00684450|Heparin Antagonists|heparin antagonists|mesh-ancestor
24543596|NCT00684450|Coagulants|coagulants|mesh-ancestor
24543817|NCT00685568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393698|NCT00130767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24543818|NCT00685594|Vitamin D|vitamin d|mesh-list
24543819|NCT00685594|Cholecalciferol|cholecalciferol|mesh-list
24543820|NCT00685594|Vitamins|vitamins|mesh-ancestor
24543821|NCT00685594|Micronutrients|micronutrients|mesh-ancestor
24543822|NCT00685594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446973|NCT00306774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24446974|NCT00306800|Aminolevulinic Acid|aminolevulinic acid|mesh-list
24447004|NCT00306878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24447005|NCT00306969|Bexarotene|bexarotene|mesh-list
24447006|NCT00306969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24447007|NCT00307008|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24447008|NCT00307008|Immunologic Factors|immunologic factors|mesh-ancestor
24447009|NCT00307008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24543998|NCT00686361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24544000|NCT00686361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544003|NCT00686361|Nootropic Agents|nootropic agents|mesh-ancestor
24544055|NCT00686621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24544056|NCT00686621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24544057|NCT00686816|Sucrose polyester|sucrose polyester|mesh-list
24544058|NCT00686816|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24544059|NCT00686816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24544060|NCT00686816|Antimetabolites|antimetabolites|mesh-ancestor
24446666|NCT00305591|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
24446667|NCT00305591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24446668|NCT00305591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24446669|NCT00305591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446670|NCT00305591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446671|NCT00305617|Antineoplastic Agents|antineoplastic agents|mesh-list
24544249|NCT00688194|Letrozole|letrozole|mesh-list
24544250|NCT00688194|Fulvestrant|fulvestrant|mesh-list
24544251|NCT00688194|Lapatinib|lapatinib|mesh-list
24544252|NCT00688194|Anastrozole|anastrozole|mesh-list
24544253|NCT00688194|Exemestane|exemestane|mesh-list
24544383|NCT00688857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24544384|NCT00688857|Nootropic Agents|nootropic agents|mesh-ancestor
24544385|NCT00688857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24544386|NCT00688857|Vasodilator Agents|vasodilator agents|mesh-ancestor
24544387|NCT00688883|Fludarabine|fludarabine|mesh-list
24544388|NCT00688883|Fludarabine phosphate|fludarabine phosphate|mesh-list
24544389|NCT00688883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544406|NCT00688922|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24544407|NCT00688922|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24544408|NCT00688922|Antimetabolites|antimetabolites|mesh-ancestor
24544436|NCT00688961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544438|NCT00688987|Hydrocortisone|hydrocortisone|mesh-list
24544439|NCT00688987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24544440|NCT00689000|Tosedostat|tosedostat|mesh-list
24544441|NCT00689000|Glycine|glycine|mesh-list
24544442|NCT00689000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544482|NCT00689169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544483|NCT00689169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24544484|NCT00689169|Alkylating Agents|alkylating agents|mesh-ancestor
24544485|NCT00689169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24544486|NCT00689169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25715614|NCT02374060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25715615|NCT02374060|Glucocorticoids|glucocorticoids|mesh-ancestor
25715616|NCT02374060|Hormones|hormones|mesh-ancestor
25715617|NCT02374060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25715618|NCT02374060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25715619|NCT02374060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25715620|NCT02374060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25715621|NCT02374060|Immunologic Factors|immunologic factors|mesh-ancestor
24544693|NCT00689845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24544694|NCT00689845|Alkylating Agents|alkylating agents|mesh-ancestor
24393839|NCT00131053|Methotrexate|methotrexate|mesh-list
24393843|NCT00131053|Pirarubicin|pirarubicin|mesh-list
24393844|NCT00131053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24544695|NCT00689845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24544696|NCT00689845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24544697|NCT00689845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24544698|NCT00689845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24544699|NCT00689845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24544700|NCT00689845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24544701|NCT00689845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24544702|NCT00689845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24544917|NCT00690937|Sequestering Agents|sequestering agents|mesh-ancestor
24544979|NCT00691262|Immunologic Factors|immunologic factors|mesh-ancestor
24544980|NCT00691262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545001|NCT00691379|Paclitaxel|paclitaxel|mesh-list
24545065|NCT00691795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24545066|NCT00691795|Adrenergic Agents|adrenergic agents|mesh-ancestor
24446648|NCT00305513|Purinergic Agents|purinergic agents|mesh-ancestor
24545346|NCT00693108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25715622|NCT02374060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25715623|NCT02374060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545585|NCT00693862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545600|NCT00693979|Mitosis Modulators|mitosis modulators|mesh-ancestor
24545601|NCT00693979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545603|NCT00694005|Paclitaxel|paclitaxel|mesh-list
24545604|NCT00694005|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24545605|NCT00694005|Everolimus|everolimus|mesh-list
24545669|NCT00694317|Zaleplon|zaleplon|mesh-list
24545670|NCT00694317|Anticonvulsants|anticonvulsants|mesh-ancestor
24545671|NCT00694317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24545672|NCT00694317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24545673|NCT00694317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24545674|NCT00694317|GABA Modulators|gaba modulators|mesh-ancestor
24545675|NCT00694317|GABA Agents|gaba agents|mesh-ancestor
24545676|NCT00694317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24545677|NCT00694317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24545678|NCT00694343|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
24545708|NCT00694590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24545709|NCT00694590|Antiviral Agents|antiviral agents|mesh-ancestor
24545710|NCT00694590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24545711|NCT00694629|Rifampin|rifampin|mesh-list
24545712|NCT00694629|Rifapentine|rifapentine|mesh-list
24545713|NCT00694629|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24545749|NCT00694733|Testosterone enanthate|testosterone enanthate|mesh-list
24545750|NCT00694733|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25715624|NCT02374099|Azacitidine|azacitidine|mesh-list
25715625|NCT02374099|Fulvestrant|fulvestrant|mesh-list
24546107|NCT00696748|Androgens|androgens|mesh-ancestor
24546108|NCT00696748|Hormones|hormones|mesh-ancestor
25407654|NCT03486873|Pembrolizumab|pembrolizumab|mesh-list
25715626|NCT02374099|Cc-486|cc-486|mesh-list
25715627|NCT02374099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25715628|NCT02374099|Antimetabolites|antimetabolites|mesh-ancestor
25715629|NCT02374099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546109|NCT00696748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24546114|NCT00696826|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24546115|NCT00696826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24546144|NCT00696969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24546145|NCT00696969|Antifungal Agents|antifungal agents|mesh-ancestor
24546146|NCT00696969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24546147|NCT00696969|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
24546148|NCT00696969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24546149|NCT00696982|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24546151|NCT00696982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24546152|NCT00696982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546153|NCT00696982|Incretins|incretins|mesh-ancestor
24546198|NCT00697060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546199|NCT00697086|Dronedarone|dronedarone|mesh-list
24446743|NCT00305812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24446744|NCT00305812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446746|NCT00305812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24446752|NCT00305812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446753|NCT00305812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24447448|NCT00308503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24447449|NCT00308503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447450|NCT00308503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24447451|NCT00308503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24447452|NCT00308503|Serotonin Agents|serotonin agents|mesh-ancestor
24447453|NCT00308503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25715630|NCT02374099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25715631|NCT02374099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25715632|NCT02374099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25715633|NCT02374099|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25715634|NCT02374099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25715635|NCT02374099|Hormone Antagonists|hormone antagonists|mesh-ancestor
25715636|NCT02374099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25715637|NCT02374099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715638|NCT02374164|Febuxostat|febuxostat|mesh-list
25715639|NCT02374164|Gout Suppressants|gout suppressants|mesh-ancestor
24546380|NCT00697892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24546450|NCT00698464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24546458|NCT00698607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546459|NCT00698607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24546460|NCT00698607|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24546461|NCT00698607|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24546464|NCT00698607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24546465|NCT00698607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546466|NCT00698607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24546526|NCT00698945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546531|NCT00699023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24546532|NCT00699023|Antimetabolites|antimetabolites|mesh-ancestor
24546533|NCT00699023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24546534|NCT00699023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24546535|NCT00699023|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24546536|NCT00699023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24546537|NCT00699036|Metformin|metformin|mesh-list
24546538|NCT00699036|Rosiglitazone|rosiglitazone|mesh-list
24546539|NCT00699036|Losartan|losartan|mesh-list
24546540|NCT00699036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24546541|NCT00699036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24546542|NCT00699036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24546543|NCT00699036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24546749|NCT00700024|Hormones|hormones|mesh-ancestor
24546802|NCT00700466|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24546803|NCT00700466|Adrenergic Agents|adrenergic agents|mesh-ancestor
24546804|NCT00700466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24546836|NCT00700687|Aspirin|aspirin|mesh-list
24546837|NCT00700687|Celecoxib|celecoxib|mesh-list
24546838|NCT00700687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24546841|NCT00700687|Sensory System Agents|sensory system agents|mesh-ancestor
24546851|NCT00700687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24546853|NCT00700687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24546952|NCT00701337|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
24546953|NCT00701337|Estrogens|estrogens|mesh-ancestor
24546954|NCT00701337|Hormones|hormones|mesh-ancestor
24546955|NCT00701337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24546958|NCT00701337|Contraceptive Agents|contraceptive agents|mesh-ancestor
24547035|NCT00702091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24547036|NCT00702091|Protease Inhibitors|protease inhibitors|mesh-ancestor
24547037|NCT00702091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547080|NCT00702260|Protease Inhibitors|protease inhibitors|mesh-ancestor
24547081|NCT00702260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25715640|NCT02374164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25715641|NCT02374398|Tranexamic Acid|tranexamic acid|mesh-list
25715642|NCT02374398|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25715643|NCT02374398|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25715644|NCT02374398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715645|NCT02374398|Hemostatics|hemostatics|mesh-ancestor
24547082|NCT00702260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547083|NCT00702260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24547084|NCT00702416|Acetaminophen|acetaminophen|mesh-list
24547085|NCT00702416|Fentanyl|fentanyl|mesh-list
24393964|NCT00131404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24547086|NCT00702416|Morphine|morphine|mesh-list
24547087|NCT00702416|Analgesics, Opioid|analgesics, opioid|mesh-list
24547088|NCT00702416|Narcotics|narcotics|mesh-list
24547089|NCT00702416|Analgesics|analgesics|mesh-list
24547090|NCT00702416|Anesthetics|anesthetics|mesh-list
24547091|NCT00702416|Ropivacaine|ropivacaine|mesh-list
24547092|NCT00702416|Anesthetics, Local|anesthetics, local|mesh-list
24547093|NCT00702416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24547094|NCT00702416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547095|NCT00702416|Sensory System Agents|sensory system agents|mesh-ancestor
24547107|NCT00702442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547108|NCT00702442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24547109|NCT00702442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24547110|NCT00702442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24547111|NCT00702442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24547191|NCT00702936|Telmisartan|telmisartan|mesh-list
24547192|NCT00702936|Ramipril|ramipril|mesh-list
24547193|NCT00702936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24547194|NCT00702936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24547195|NCT00702936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24547196|NCT00702936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547197|NCT00702936|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24547198|NCT00702936|Protease Inhibitors|protease inhibitors|mesh-ancestor
24547199|NCT00702936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547200|NCT00702975|Paclitaxel|paclitaxel|mesh-list
24547201|NCT00702975|Bevacizumab|bevacizumab|mesh-list
24547246|NCT00703170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24547247|NCT00703170|Immunologic Factors|immunologic factors|mesh-ancestor
24547248|NCT00703170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547249|NCT00703196|Folic Acid|folic acid|mesh-list
24547256|NCT00703235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24547317|NCT00703365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24547319|NCT00703378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547320|NCT00703378|Tubulin Modulators|tubulin modulators|mesh-ancestor
24547321|NCT00703378|Antimitotic Agents|antimitotic agents|mesh-ancestor
24547322|NCT00703378|Mitosis Modulators|mitosis modulators|mesh-ancestor
24547323|NCT00703378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547324|NCT00703430|Memantine|memantine|mesh-list
24547325|NCT00703430|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24547326|NCT00703430|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24547327|NCT00703430|Dopamine Agents|dopamine agents|mesh-ancestor
24547328|NCT00703430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24547410|NCT00703755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547411|NCT00703755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24547412|NCT00703755|Antimetabolites|antimetabolites|mesh-ancestor
24547413|NCT00703755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547414|NCT00703755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24547415|NCT00703807|Everolimus|everolimus|mesh-list
24547416|NCT00703807|Topotecan|topotecan|mesh-list
24547417|NCT00703807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547498|NCT00704301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24547499|NCT00704301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24547500|NCT00704301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547501|NCT00704301|Cholinergic Agents|cholinergic agents|mesh-ancestor
24547502|NCT00704301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24547503|NCT00704301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547504|NCT00704301|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25715647|NCT02374957|Cilostazol|cilostazol|mesh-list
24547505|NCT00704301|Protective Agents|protective agents|mesh-ancestor
24547507|NCT00704314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24547508|NCT00704314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24547509|NCT00704314|Antimetabolites|antimetabolites|mesh-ancestor
24547625|NCT00704925|Amifampridine|amifampridine|mesh-list
24547652|NCT00704990|Vitamin B Complex|vitamin b complex|mesh-list
24547698|NCT00705315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24547699|NCT00705315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24547722|NCT00705419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24547724|NCT00705419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547777|NCT00705588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24547778|NCT00705588|Urological Agents|urological agents|mesh-ancestor
25715648|NCT02374957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25715649|NCT02374957|Autonomic Agents|autonomic agents|mesh-ancestor
25715650|NCT02374957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25715651|NCT02374957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715652|NCT02374957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25715653|NCT02374957|Respiratory System Agents|respiratory system agents|mesh-ancestor
25715654|NCT02374957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25715655|NCT02374957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25715656|NCT02374957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715657|NCT02374957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25715658|NCT02374957|Vasodilator Agents|vasodilator agents|mesh-ancestor
25715659|NCT02374957|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25715660|NCT02374957|Protective Agents|protective agents|mesh-ancestor
25715661|NCT02374957|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25715662|NCT02374957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24547786|NCT00705692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547787|NCT00705692|Antinematodal Agents|antinematodal agents|mesh-ancestor
24547788|NCT00705692|Anthelmintics|anthelmintics|mesh-ancestor
24547789|NCT00705692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24547872|NCT00706225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24547873|NCT00706225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24547874|NCT00706225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24547875|NCT00706225|Hormone Antagonists|hormone antagonists|mesh-ancestor
24548022|NCT00707252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24548023|NCT00707252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24548024|NCT00707252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548027|NCT00707278|Oxaliplatin|oxaliplatin|mesh-list
24548119|NCT00707772|Antimetabolites|antimetabolites|mesh-ancestor
24548120|NCT00707772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548121|NCT00707772|Antiviral Agents|antiviral agents|mesh-ancestor
24548122|NCT00707772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24548123|NCT00707772|Immunologic Factors|immunologic factors|mesh-ancestor
25715663|NCT02374957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25715664|NCT02375724|Bromides|bromides|mesh-list
25715665|NCT02375724|Anticonvulsants|anticonvulsants|mesh-ancestor
25715666|NCT02375971|Ranibizumab|ranibizumab|mesh-list
25715667|NCT02375971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25715668|NCT02375971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25715669|NCT02375971|Growth Substances|growth substances|mesh-ancestor
24548274|NCT00708656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24548275|NCT00708656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548276|NCT00708656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24548278|NCT00708747|Immunoglobulins|immunoglobulins|mesh-list
24548279|NCT00708747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24548281|NCT00708747|Immunologic Factors|immunologic factors|mesh-ancestor
24548282|NCT00708747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548311|NCT00708903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24548312|NCT00708903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548313|NCT00708903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548314|NCT00708903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24548315|NCT00709007|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24548316|NCT00709007|Antiviral Agents|antiviral agents|mesh-ancestor
24548317|NCT00709007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24548318|NCT00709046|Pantoprazole|pantoprazole|mesh-list
24548319|NCT00709046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24550147|NCT00719290|Protective Agents|protective agents|mesh-ancestor
24548398|NCT00709332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24548399|NCT00709332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24548401|NCT00709332|Vitamin B Complex|vitamin b complex|mesh-ancestor
24548402|NCT00709332|Vitamins|vitamins|mesh-ancestor
24548442|NCT00709488|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24548458|NCT00709553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715670|NCT02375971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715671|NCT02375971|Growth Inhibitors|growth inhibitors|mesh-ancestor
25715672|NCT02375971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25715673|NCT02376010|Warfarin|warfarin|mesh-list
25715674|NCT02376010|Rivaroxaban|rivaroxaban|mesh-list
25715675|NCT02376010|Anticoagulants|anticoagulants|mesh-ancestor
25715676|NCT02376010|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25715677|NCT02376010|Antithrombins|antithrombins|mesh-ancestor
25715678|NCT02376010|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25715679|NCT02376010|Protease Inhibitors|protease inhibitors|mesh-ancestor
25715680|NCT02376010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25715681|NCT02376010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548460|NCT00709644|Ethinyl Estradiol|ethinyl estradiol|mesh-list
24548592|NCT00710359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548700|NCT00711789|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24548701|NCT00711789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24548702|NCT00711789|Protease Inhibitors|protease inhibitors|mesh-ancestor
24548838|NCT00712439|Sensory System Agents|sensory system agents|mesh-ancestor
24548839|NCT00712439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24548840|NCT00712439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24548841|NCT00712439|Anticonvulsants|anticonvulsants|mesh-ancestor
24548842|NCT00712439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24548844|NCT00712439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24548845|NCT00712439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24548852|NCT00712452|Vinblastine|vinblastine|mesh-list
24548869|NCT00712465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24548870|NCT00712465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24548871|NCT00712465|Protective Agents|protective agents|mesh-ancestor
24548888|NCT00712504|Tubulin Modulators|tubulin modulators|mesh-ancestor
24548889|NCT00712504|Antimitotic Agents|antimitotic agents|mesh-ancestor
24447666|NCT00309361|Adrenergic Agents|adrenergic agents|mesh-ancestor
24447670|NCT00309361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24447671|NCT00309374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24447672|NCT00309374|Simvastatin|simvastatin|mesh-list
24548984|NCT00712764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24548985|NCT00712764|Vasodilator Agents|vasodilator agents|mesh-ancestor
24548986|NCT00712764|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
24549074|NCT00713271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549076|NCT00713336|Moxifloxacin|moxifloxacin|mesh-list
24549077|NCT00713336|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24549134|NCT00713622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24549135|NCT00713622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24549136|NCT00713622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24549137|NCT00713674|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24549138|NCT00713674|Mupirocin|mupirocin|mesh-list
24549143|NCT00713687|Gemcitabine|gemcitabine|mesh-list
24549259|NCT00714103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549269|NCT00714181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24549270|NCT00714181|Alkylating Agents|alkylating agents|mesh-ancestor
24549271|NCT00714181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549272|NCT00714181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549273|NCT00714181|Antimalarials|antimalarials|mesh-ancestor
24549274|NCT00714181|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24549275|NCT00714181|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24549276|NCT00714181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25715682|NCT02376166|Metformin|metformin|mesh-list
25715683|NCT02376166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25715684|NCT02376166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715685|NCT02376257|Cycloserine|cycloserine|mesh-list
25715686|NCT02376257|Modafinil|modafinil|mesh-list
25715687|NCT02376257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25715688|NCT02376257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715689|NCT02376257|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25715690|NCT02376257|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25715691|NCT02376257|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24549623|NCT00716248|Protective Agents|protective agents|mesh-ancestor
24447793|NCT00309569|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24447794|NCT00309569|Abortifacient Agents|abortifacient agents|mesh-ancestor
24550146|NCT00719290|Viscosupplements|viscosupplements|mesh-ancestor
24447795|NCT00309569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24549821|NCT00717652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549823|NCT00717652|Dermatologic Agents|dermatologic agents|mesh-ancestor
24549824|NCT00717678|Mycophenolic Acid|mycophenolic acid|mesh-list
24549826|NCT00717678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24549827|NCT00717678|Immunologic Factors|immunologic factors|mesh-ancestor
24549871|NCT00717808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24549872|NCT00717808|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25715692|NCT02376257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715693|NCT02376257|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25715694|NCT02376257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25715695|NCT02376257|Renal Agents|renal agents|mesh-ancestor
25715696|NCT02376257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24549909|NCT00717951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24549910|NCT00717951|Tubulin Modulators|tubulin modulators|mesh-ancestor
24549915|NCT00717990|Irinotecan|irinotecan|mesh-list
24549916|NCT00717990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24549917|NCT00717990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24549918|NCT00717990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24549919|NCT00717990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24549920|NCT00717990|Growth Substances|growth substances|mesh-ancestor
24549921|NCT00717990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24549922|NCT00717990|Growth Inhibitors|growth inhibitors|mesh-ancestor
24550028|NCT00718757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24550134|NCT00719173|Autonomic Agents|autonomic agents|mesh-ancestor
24550135|NCT00719173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24550136|NCT00719173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24550137|NCT00719173|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24550138|NCT00719173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24550139|NCT00719199|Cetuximab|cetuximab|mesh-list
24550140|NCT00719199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24550141|NCT00719199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24550142|NCT00719290|Hyaluronic Acid|hyaluronic acid|mesh-list
24550143|NCT00719290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24550144|NCT00719290|Immunologic Factors|immunologic factors|mesh-ancestor
24550145|NCT00719290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24550350|NCT00720408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24550351|NCT00720408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24550352|NCT00720421|Lorazepam|lorazepam|mesh-list
24550353|NCT00720421|Anticonvulsants|anticonvulsants|mesh-ancestor
24550354|NCT00720421|Antiemetics|antiemetics|mesh-ancestor
24550355|NCT00720421|Autonomic Agents|autonomic agents|mesh-ancestor
24550356|NCT00720421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25715697|NCT02376257|Antitubercular Agents|antitubercular agents|mesh-ancestor
25715698|NCT02376257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25715699|NCT02376257|Antimetabolites|antimetabolites|mesh-ancestor
25715700|NCT02376283|Clopidogrel|clopidogrel|mesh-list
25715701|NCT02376283|Ticagrelor|ticagrelor|mesh-list
25715702|NCT02376283|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25715703|NCT02376283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25715704|NCT02376283|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24550380|NCT00720447|Antimetabolites|antimetabolites|mesh-ancestor
24550381|NCT00720447|Antiviral Agents|antiviral agents|mesh-ancestor
24550382|NCT00720447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24550383|NCT00720447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24550384|NCT00720447|Immunologic Factors|immunologic factors|mesh-ancestor
24550427|NCT00720538|Growth Substances|growth substances|mesh-ancestor
24550428|NCT00720538|Growth Inhibitors|growth inhibitors|mesh-ancestor
24447873|NCT00309725|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25715705|NCT02376283|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25715706|NCT02376283|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25715707|NCT02376283|Purinergic Agents|purinergic agents|mesh-ancestor
25715708|NCT02376283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25715709|NCT02376283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715710|NCT02376283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715711|NCT02377752|Doxorubicin|doxorubicin|mesh-list
25715712|NCT02377752|Olaratumab|olaratumab|mesh-list
24448267|NCT00310921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24448269|NCT00310934|Buprenorphine|buprenorphine|mesh-list
25715831|NCT02379637|Antioxidants|antioxidants|mesh-ancestor
25715832|NCT02379637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715833|NCT02379637|Protective Agents|protective agents|mesh-ancestor
25715834|NCT02379637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715835|NCT02379637|Antidotes|antidotes|mesh-ancestor
25715836|NCT02379858|Alvimopan|alvimopan|mesh-list
25715837|NCT02379858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25715838|NCT02380248|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25715839|NCT02380248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25715840|NCT02380287|Antibodies|antibodies|mesh-list
25715841|NCT02380287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25715896|NCT02383043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24394160|NCT00132418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24394161|NCT00132418|Immunologic Factors|immunologic factors|mesh-ancestor
24394162|NCT00132431|Cinacalcet|cinacalcet|mesh-list
24394163|NCT00132431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25715897|NCT02383043|Anesthetics, Local|anesthetics, local|mesh-ancestor
25715899|NCT02383043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25715900|NCT02383043|Sensory System Agents|sensory system agents|mesh-ancestor
25715901|NCT02383043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25771150|NCT03589885|Immunologic Factors|immunologic factors|mesh-ancestor
25771151|NCT03589885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771152|NCT03591068|Fluticasone|fluticasone|mesh-list
25771153|NCT03591068|Xhance|xhance|mesh-list
25771154|NCT03591068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25771155|NCT03591068|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25771156|NCT03591068|Autonomic Agents|autonomic agents|mesh-ancestor
25771157|NCT03591068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771158|NCT03591068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771159|NCT03591068|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25771160|NCT03591068|Respiratory System Agents|respiratory system agents|mesh-ancestor
25771161|NCT03591068|Dermatologic Agents|dermatologic agents|mesh-ancestor
25771162|NCT03591068|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25771163|NCT03591146|Ropivacaine|ropivacaine|mesh-list
25771164|NCT03591146|Anesthetics, Local|anesthetics, local|mesh-ancestor
25771165|NCT03591146|Anesthetics|anesthetics|mesh-ancestor
25771166|NCT03591146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25771167|NCT03591146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771168|NCT03591146|Sensory System Agents|sensory system agents|mesh-ancestor
25771184|NCT03592121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25771185|NCT03592121|Adrenergic Agents|adrenergic agents|mesh-ancestor
25771186|NCT03592121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25715933|NCT02383940|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25715935|NCT02383940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715951|NCT02384070|Sensory System Agents|sensory system agents|mesh-ancestor
25715952|NCT02384070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25715953|NCT02384070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25715954|NCT02384070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25715956|NCT02384070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25715957|NCT02384070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25715958|NCT02384070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448865|NCT00313456|Satraplatin|satraplatin|mesh-list
24448866|NCT00313456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448867|NCT00313482|Prednisone|prednisone|mesh-list
24448868|NCT00313482|Docetaxel|docetaxel|mesh-list
24448869|NCT00313482|Sargramostim|sargramostim|mesh-list
24448870|NCT00313482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448871|NCT00313482|Tubulin Modulators|tubulin modulators|mesh-ancestor
24448872|NCT00313482|Antimitotic Agents|antimitotic agents|mesh-ancestor
24448873|NCT00313482|Mitosis Modulators|mitosis modulators|mesh-ancestor
24448874|NCT00313482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448875|NCT00313482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24448876|NCT00313482|Glucocorticoids|glucocorticoids|mesh-ancestor
25715962|NCT02384070|Antipyretics|antipyretics|mesh-ancestor
25715963|NCT02384070|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25715964|NCT02384070|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25715965|NCT02384070|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25715966|NCT02384070|Purinergic Agents|purinergic agents|mesh-ancestor
25715967|NCT02384070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25715988|NCT02384395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24455214|NCT02329080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24455215|NCT02329080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25715990|NCT02384395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25715991|NCT02384395|Antiviral Agents|antiviral agents|mesh-ancestor
25715992|NCT02384395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25715993|NCT02384395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25715994|NCT02384395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25715995|NCT02384395|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
24393214|NCT00129168|Daunorubicin|daunorubicin|mesh-list
24451898|NCT00325169|Autonomic Agents|autonomic agents|mesh-ancestor
24451899|NCT00325169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24451900|NCT00325169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451901|NCT00325169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24451902|NCT00325169|Respiratory System Agents|respiratory system agents|mesh-ancestor
24451903|NCT00325169|Parasympatholytics|parasympatholytics|mesh-ancestor
24451904|NCT00325169|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25716011|NCT02385240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25716012|NCT02385240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25716013|NCT02385240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25716014|NCT02385240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25716015|NCT02385240|Adrenergic Agents|adrenergic agents|mesh-ancestor
24451909|NCT00325169|Hormones|hormones|mesh-ancestor
24451910|NCT00325169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24451911|NCT00325169|Sympathomimetics|sympathomimetics|mesh-ancestor
24451912|NCT00325182|Levetiracetam|levetiracetam|mesh-list
24451913|NCT00325182|Anticonvulsants|anticonvulsants|mesh-ancestor
24393266|NCT00129337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24393269|NCT00129363|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24393270|NCT00129363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24393271|NCT00129363|Adrenergic Agents|adrenergic agents|mesh-ancestor
24393272|NCT00129363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24393273|NCT00129363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393274|NCT00129363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393292|NCT00129506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393293|NCT00129506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393294|NCT00129506|Dermatologic Agents|dermatologic agents|mesh-ancestor
24393295|NCT00129506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24393296|NCT00129506|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24393297|NCT00129506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24393298|NCT00129506|Immunologic Factors|immunologic factors|mesh-ancestor
24393299|NCT00129506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24393300|NCT00129506|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24393301|NCT00129506|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25716017|NCT02385240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716018|NCT02385240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716019|NCT02385669|Ipilimumab|ipilimumab|mesh-list
25716020|NCT02385669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25716021|NCT02385669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716022|NCT02385669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25716023|NCT02385669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393452|NCT00130065|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24393454|NCT00130091|Clonidine|clonidine|mesh-list
24393467|NCT00130091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393469|NCT00130143|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24393489|NCT00130195|Daunorubicin|daunorubicin|mesh-list
25716024|NCT02385708|Chlorhexidine|chlorhexidine|mesh-list
25716025|NCT02385708|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25716026|NCT02385708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25716027|NCT02385708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25716028|NCT02385708|Disinfectants|disinfectants|mesh-ancestor
25716029|NCT02385708|Dermatologic Agents|dermatologic agents|mesh-ancestor
25716030|NCT02385799|Sertraline|sertraline|mesh-list
25716031|NCT02385799|Antidepressive Agents|antidepressive agents|mesh-ancestor
25716032|NCT02385799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24393784|NCT00131027|Methotrexate|methotrexate|mesh-list
24393817|NCT00131027|Dermatologic Agents|dermatologic agents|mesh-ancestor
24393818|NCT00131027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24393850|NCT00131053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393851|NCT00131053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393869|NCT00131053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24393870|NCT00131053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24393871|NCT00131053|Antiviral Agents|antiviral agents|mesh-ancestor
24393872|NCT00131053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24393873|NCT00131053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24393874|NCT00131053|Tubulin Modulators|tubulin modulators|mesh-ancestor
24393875|NCT00131053|Antimitotic Agents|antimitotic agents|mesh-ancestor
24393876|NCT00131053|Mitosis Modulators|mitosis modulators|mesh-ancestor
24393877|NCT00131118|Zoledronic Acid|zoledronic acid|mesh-list
24393878|NCT00131118|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24393879|NCT00131118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24393880|NCT00131144|Octreotide|octreotide|mesh-list
24393912|NCT00131261|Hormones|hormones|mesh-ancestor
24393916|NCT00131261|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24393917|NCT00131261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24393918|NCT00131261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24393919|NCT00131274|Imatinib Mesylate|imatinib mesylate|mesh-list
24393920|NCT00131274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24393921|NCT00131274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24393922|NCT00131274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24393923|NCT00131274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716034|NCT02385799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25716035|NCT02385799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25716036|NCT02385799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716037|NCT02385799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25716038|NCT02385799|Serotonin Agents|serotonin agents|mesh-ancestor
25716039|NCT02385799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716040|NCT02386098|Ritonavir|ritonavir|mesh-list
25716041|NCT02386098|Atazanavir Sulfate|atazanavir sulfate|mesh-list
25716042|NCT02386098|Tenofovir|tenofovir|mesh-list
25716043|NCT02386098|Dolutegravir|dolutegravir|mesh-list
25716044|NCT02386098|BMS-955176|bms-955176|mesh-list
25716045|NCT02386098|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25716046|NCT02386098|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25716047|NCT02386098|Protease Inhibitors|protease inhibitors|mesh-ancestor
25716048|NCT02386098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24452087|NCT00325962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24452088|NCT00325962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24452089|NCT00325962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455234|NCT02244125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24455235|NCT02244125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24455236|NCT02244125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24455237|NCT02244125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24455239|NCT02244125|Autonomic Agents|autonomic agents|mesh-ancestor
24455240|NCT02244125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24455241|NCT02244125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25777825|NCT03110900|Lorazepam|lorazepam|mesh-list
25777826|NCT03110900|Haloperidol|haloperidol|mesh-list
25777827|NCT03110900|Haloperidol decanoate|haloperidol decanoate|mesh-list
25777828|NCT03110900|Loxapine|loxapine|mesh-list
25777829|NCT03110900|Antiemetics|antiemetics|mesh-ancestor
25777830|NCT03110900|Autonomic Agents|autonomic agents|mesh-ancestor
25777831|NCT03110900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25777832|NCT03110900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777833|NCT03110900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25777834|NCT03110900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25777835|NCT03110900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25777836|NCT03110900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25777837|NCT03110900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25777838|NCT03110900|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25777839|NCT03110900|Dopamine Agents|dopamine agents|mesh-ancestor
25777840|NCT03110900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25777841|NCT03110900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777842|NCT03110900|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25777843|NCT03110900|Anticonvulsants|anticonvulsants|mesh-ancestor
25777844|NCT03110900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25777845|NCT03110900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25777846|NCT03110900|GABA Modulators|gaba modulators|mesh-ancestor
25777847|NCT03110900|GABA Agents|gaba agents|mesh-ancestor
25777848|NCT03078270|Botulinum Toxins|botulinum toxins|mesh-list
25777849|NCT03078270|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25777850|NCT03078270|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25777851|NCT03078270|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25777852|NCT03078270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25777853|NCT03078270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777854|NCT03078270|Cholinergic Agents|cholinergic agents|mesh-ancestor
25777855|NCT03078270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25777856|NCT03078270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777857|NCT03078270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25777858|NCT03078270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25777859|NCT03065933|Clonidine|clonidine|mesh-list
25777860|NCT03065933|Analgesics|analgesics|mesh-ancestor
25777861|NCT03065933|Sensory System Agents|sensory system agents|mesh-ancestor
25777862|NCT03065933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25716091|NCT02387372|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24463132|NCT00358969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24463133|NCT00358969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452272|NCT00326820|Zoledronic Acid|zoledronic acid|mesh-list
24452273|NCT00326820|Ibandronic Acid|ibandronic acid|mesh-list
24452274|NCT00326820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24452275|NCT00326820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452295|NCT00327080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24452296|NCT00327080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24452297|NCT00327080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24452299|NCT00327093|Cetuximab|cetuximab|mesh-list
25716100|NCT02387554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25716101|NCT02387554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25716102|NCT02387554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716103|NCT02387554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25716104|NCT02387554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716105|NCT02387554|Vasodilator Agents|vasodilator agents|mesh-ancestor
25716106|NCT02387554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25716107|NCT02387554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25716108|NCT02387554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25716109|NCT02387554|Diuretics|diuretics|mesh-ancestor
25716110|NCT02387554|Natriuretic Agents|natriuretic agents|mesh-ancestor
25716111|NCT02387554|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25716131|NCT02387762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716146|NCT02387957|Ranibizumab|ranibizumab|mesh-list
25716147|NCT02387957|Aflibercept|aflibercept|mesh-list
24463859|NCT00362544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24463861|NCT00362570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24463862|NCT00362570|Alkylating Agents|alkylating agents|mesh-ancestor
24463863|NCT00362570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716201|NCT02388321|Narcotics|narcotics|mesh-ancestor
25716202|NCT02388321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25716203|NCT02388724|Lansoprazole|lansoprazole|mesh-list
25716204|NCT02388724|Dexlansoprazole|dexlansoprazole|mesh-list
25716205|NCT02388724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25716206|NCT02388724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25716207|NCT02388724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25716208|NCT02388724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24463864|NCT00362570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24463866|NCT00362583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25716209|NCT02388724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716215|NCT02388737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25716216|NCT02388737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716217|NCT02388997|Omalizumab|omalizumab|mesh-list
25716218|NCT02388997|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25716219|NCT02388997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24464497|NCT00365183|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24464498|NCT00365183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24464547|NCT00365313|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24464569|NCT00365339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24464570|NCT00365339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25716306|NCT02389829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25716307|NCT02389829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25716308|NCT02389829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25716309|NCT02389829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25716310|NCT02389829|Dopamine Agents|dopamine agents|mesh-ancestor
24464747|NCT00366470|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24464748|NCT00366652|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24464749|NCT00366652|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
24464750|NCT00366652|Desipramine|desipramine|mesh-list
24464751|NCT00366652|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24464752|NCT00366652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24464840|NCT00367081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24464841|NCT00367081|Coccidiostats|coccidiostats|mesh-ancestor
24464842|NCT00367094|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24464844|NCT00367094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24464845|NCT00367094|Diuretics|diuretics|mesh-ancestor
24464859|NCT00367120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24464860|NCT00367120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25716311|NCT02389959|Bevacizumab|bevacizumab|mesh-list
25716312|NCT02389959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25716313|NCT02389959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716314|NCT02389959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25716315|NCT02389959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25716316|NCT02389959|Growth Substances|growth substances|mesh-ancestor
25716317|NCT02389959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716341|NCT02390219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716343|NCT02391337|Bisoprolol|bisoprolol|mesh-list
25716344|NCT02391337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25716345|NCT02391337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24465430|NCT00369551|Tubulin Modulators|tubulin modulators|mesh-ancestor
24465483|NCT00369837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24465484|NCT00369837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465485|NCT00369863|Triamcinolone|triamcinolone|mesh-list
24465518|NCT00369954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24465519|NCT00369954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25716346|NCT02391337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25716347|NCT02391337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716348|NCT02391337|Protective Agents|protective agents|mesh-ancestor
25716349|NCT02391337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716350|NCT02391337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25716351|NCT02391337|Sympatholytics|sympatholytics|mesh-ancestor
25716352|NCT02391337|Autonomic Agents|autonomic agents|mesh-ancestor
25716353|NCT02391337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24465521|NCT00369954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465548|NCT00370019|Contraceptive Agents|contraceptive agents|mesh-ancestor
24465636|NCT00370370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24465637|NCT00370370|Growth Substances|growth substances|mesh-ancestor
24465639|NCT00370370|Growth Inhibitors|growth inhibitors|mesh-ancestor
24465654|NCT00370422|Growth Substances|growth substances|mesh-ancestor
24465656|NCT00370422|Growth Inhibitors|growth inhibitors|mesh-ancestor
24465669|NCT00370539|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24465670|NCT00370539|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24465672|NCT00370539|Verteporfin|verteporfin|mesh-list
24465673|NCT00370539|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24465674|NCT00370539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24465675|NCT00370539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465676|NCT00370539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24465677|NCT00370539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24465678|NCT00370539|Growth Substances|growth substances|mesh-ancestor
24465679|NCT00370539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465684|NCT00370539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24465685|NCT00370539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24465689|NCT00370539|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24465711|NCT00370591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24465712|NCT00370591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24465714|NCT00370617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24465715|NCT00370617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465716|NCT00370630|Triamcinolone|triamcinolone|mesh-list
24465717|NCT00370630|Bevacizumab|bevacizumab|mesh-list
24465718|NCT00370630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24465719|NCT00370630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24465720|NCT00370630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24465721|NCT00370630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24465722|NCT00370630|Growth Substances|growth substances|mesh-ancestor
24465763|NCT00370669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25716354|NCT02391337|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25716355|NCT02391337|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25716356|NCT02391337|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25716357|NCT02391337|Adrenergic Agents|adrenergic agents|mesh-ancestor
25716358|NCT02391337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25716359|NCT02391545|Rituximab|rituximab|mesh-list
25716360|NCT02391545|Obinutuzumab|obinutuzumab|mesh-list
25716361|NCT02391545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25716362|NCT02391545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716363|NCT02391545|Immunologic Factors|immunologic factors|mesh-ancestor
24465783|NCT00370721|Growth Substances|growth substances|mesh-ancestor
24465784|NCT00370721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24465785|NCT00370721|Growth Inhibitors|growth inhibitors|mesh-ancestor
24465786|NCT00370734|Botulinum Toxins|botulinum toxins|mesh-list
24465787|NCT00370734|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24465959|NCT00371319|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24465960|NCT00371319|Antitubercular Agents|antitubercular agents|mesh-ancestor
24465985|NCT00371501|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24465986|NCT00371501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24465987|NCT00371501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24465989|NCT00371501|Sensory System Agents|sensory system agents|mesh-ancestor
24465992|NCT00371501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24466012|NCT00371527|Respiratory System Agents|respiratory system agents|mesh-ancestor
24466013|NCT00371527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24466014|NCT00371527|Cholinergic Agents|cholinergic agents|mesh-ancestor
24453548|NCT04935177|Antibodies|antibodies|mesh-list
24466198|NCT00372476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466201|NCT00372476|Tubulin Modulators|tubulin modulators|mesh-ancestor
24466207|NCT00372515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466208|NCT00372515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466209|NCT00372541|Ceftriaxone|ceftriaxone|mesh-list
24466210|NCT00372541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24466211|NCT00372541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24466212|NCT00372632|Pyrimethamine|pyrimethamine|mesh-list
24466213|NCT00372632|Sulfadoxine|sulfadoxine|mesh-list
24466214|NCT00372632|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24466215|NCT00372632|Antimalarials|antimalarials|mesh-ancestor
24466216|NCT00372632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24466217|NCT00372632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24466218|NCT00372632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24466219|NCT00372632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24466220|NCT00372632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466221|NCT00372632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466222|NCT00372632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24466223|NCT00372632|Renal Agents|renal agents|mesh-ancestor
24466224|NCT00372645|Folic Acid|folic acid|mesh-list
25716364|NCT02391545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716365|NCT02391545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25771187|NCT03592121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771188|NCT03592121|Protective Agents|protective agents|mesh-ancestor
25771189|NCT03593538|Metformin|metformin|mesh-list
25771190|NCT03593538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25771191|NCT03593538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771192|NCT03593902|Methylprednisolone|methylprednisolone|mesh-list
25771193|NCT03593902|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25771194|NCT03593902|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24466408|NCT00373464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466410|NCT00373503|Dronabinol|dronabinol|mesh-list
24466411|NCT00373503|Hallucinogens|hallucinogens|mesh-ancestor
24466412|NCT00373503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415759|NCT00200603|Calcium|calcium|mesh-list
24466463|NCT00373594|Fludarabine|fludarabine|mesh-list
24466464|NCT00373594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24466465|NCT00373594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466466|NCT00373594|Immunologic Factors|immunologic factors|mesh-ancestor
24466467|NCT00373594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466468|NCT00373594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24466471|NCT00373607|Mefloquine|mefloquine|mesh-list
24466472|NCT00373607|Antimalarials|antimalarials|mesh-ancestor
24466473|NCT00373607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24466474|NCT00373607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24466475|NCT00373607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24466476|NCT00373607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466477|NCT00373607|Antiviral Agents|antiviral agents|mesh-ancestor
24466478|NCT00373607|Schistosomicides|schistosomicides|mesh-ancestor
24466480|NCT00373607|Anthelmintics|anthelmintics|mesh-ancestor
24466481|NCT00373620|Paclitaxel|paclitaxel|mesh-list
24466482|NCT00373620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24466483|NCT00373620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466484|NCT00373620|Tubulin Modulators|tubulin modulators|mesh-ancestor
24466485|NCT00373620|Antimitotic Agents|antimitotic agents|mesh-ancestor
24466487|NCT00373620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466490|NCT00373646|Immunologic Factors|immunologic factors|mesh-ancestor
24466491|NCT00373646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466492|NCT00373646|Leprostatic Agents|leprostatic agents|mesh-ancestor
24466493|NCT00373646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24466494|NCT00373646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24466495|NCT00373646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24466496|NCT00373646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24466497|NCT00373646|Growth Substances|growth substances|mesh-ancestor
24466498|NCT00373646|Growth Inhibitors|growth inhibitors|mesh-ancestor
25716367|NCT02391714|Povidone-Iodine|povidone-iodine|mesh-list
24466499|NCT00373646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716368|NCT02391714|Nitrous Oxide|nitrous oxide|mesh-list
25716369|NCT02391714|Povidone|povidone|mesh-list
25716370|NCT02391714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25716371|NCT02391714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25716372|NCT02391714|Disinfectants|disinfectants|mesh-ancestor
25716373|NCT02391714|Plasma Substitutes|plasma substitutes|mesh-ancestor
25716374|NCT02391714|Blood Substitutes|blood substitutes|mesh-ancestor
24466501|NCT00373659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24466520|NCT00373789|Botulinum Toxins|botulinum toxins|mesh-list
24466521|NCT00373789|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24466522|NCT00373789|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24463040|NCT00358384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24463041|NCT00358384|Glucocorticoids|glucocorticoids|mesh-ancestor
24466523|NCT00373789|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24466524|NCT00373789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24466525|NCT00373789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466526|NCT00373789|Cholinergic Agents|cholinergic agents|mesh-ancestor
24466527|NCT00373789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24466528|NCT00373789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466550|NCT00373815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466551|NCT00373815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24466552|NCT00373815|Immunologic Factors|immunologic factors|mesh-ancestor
24466553|NCT00373815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466554|NCT00373893|Lidocaine|lidocaine|mesh-list
24466555|NCT00373893|Anesthetics, Local|anesthetics, local|mesh-ancestor
24466556|NCT00373893|Anesthetics|anesthetics|mesh-ancestor
24466557|NCT00373893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24466558|NCT00373893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466559|NCT00373893|Sensory System Agents|sensory system agents|mesh-ancestor
24466560|NCT00373893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24466561|NCT00373893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24466562|NCT00373893|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24466577|NCT00373919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466580|NCT00374023|Micronutrients|micronutrients|mesh-ancestor
24466585|NCT00374075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466587|NCT00374075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24466588|NCT00374075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466589|NCT00374075|Antimanic Agents|antimanic agents|mesh-ancestor
24466590|NCT00374075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25716375|NCT02391714|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25716376|NCT02391714|Anesthetics, General|anesthetics, general|mesh-ancestor
25716377|NCT02391714|Anesthetics|anesthetics|mesh-ancestor
25716378|NCT02391714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25716379|NCT02391714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716380|NCT02391714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25716381|NCT02391714|Analgesics|analgesics|mesh-ancestor
25716382|NCT02391714|Sensory System Agents|sensory system agents|mesh-ancestor
25716383|NCT02391714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24466596|NCT00374101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24466597|NCT00374101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24466598|NCT00374101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24466599|NCT00374101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466601|NCT00374192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24466602|NCT00374192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24466603|NCT00374192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466604|NCT00374205|Artesunate|artesunate|mesh-list
24466605|NCT00374205|Lumefantrine|lumefantrine|mesh-list
24466606|NCT00374205|Artemether|artemether|mesh-list
24466607|NCT00374205|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24466608|NCT00374205|Amodiaquine|amodiaquine|mesh-list
24466609|NCT00374205|Antimalarials|antimalarials|mesh-ancestor
24466610|NCT00374205|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24466611|NCT00374205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24466612|NCT00374205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24466613|NCT00374205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466614|NCT00374205|Antiviral Agents|antiviral agents|mesh-ancestor
24466639|NCT00374387|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24466640|NCT00374387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466642|NCT00374426|Antidepressive Agents|antidepressive agents|mesh-ancestor
24466643|NCT00374426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24466644|NCT00374426|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24466645|NCT00374426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24466646|NCT00374426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24466647|NCT00374426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466695|NCT00374621|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
24466697|NCT00374621|Natriuretic Agents|natriuretic agents|mesh-ancestor
24466698|NCT00374621|Vasodilator Agents|vasodilator agents|mesh-ancestor
24466699|NCT00374621|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24466700|NCT00374621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466701|NCT00374647|Mycophenolic Acid|mycophenolic acid|mesh-list
24466703|NCT00374647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24466704|NCT00374647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466705|NCT00374647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24466706|NCT00374647|Antitubercular Agents|antitubercular agents|mesh-ancestor
24466707|NCT00374647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24466708|NCT00374647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24466710|NCT00374647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24466711|NCT00374647|Antifungal Agents|antifungal agents|mesh-ancestor
24466712|NCT00374647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24466713|NCT00374647|Immunologic Factors|immunologic factors|mesh-ancestor
24466714|NCT00374647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466715|NCT00374686|Valganciclovir|valganciclovir|mesh-list
24466716|NCT00374686|Antiviral Agents|antiviral agents|mesh-ancestor
24466745|NCT00374777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24466746|NCT00374777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24466747|NCT00374777|GABA Modulators|gaba modulators|mesh-ancestor
24466748|NCT00374855|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25716384|NCT02391961|4-Aminopyridine|4-aminopyridine|mesh-list
25716385|NCT02391961|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25716386|NCT02391961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25716387|NCT02391961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716388|NCT02392104|Warfarin|warfarin|mesh-list
25716389|NCT02392104|Anticoagulants|anticoagulants|mesh-ancestor
25716390|NCT02392208|Telavancin|telavancin|mesh-list
25716391|NCT02392208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25716392|NCT02392208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25716393|NCT02392234|Ivacaftor|ivacaftor|mesh-list
25407655|NCT03486873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25716394|NCT02392234|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25716395|NCT02392234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25716396|NCT02392234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716398|NCT02392286|Methylprednisolone|methylprednisolone|mesh-list
25716399|NCT02392286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25716400|NCT02392286|Glucocorticoids|glucocorticoids|mesh-ancestor
25716401|NCT02392286|Hormones|hormones|mesh-ancestor
25716402|NCT02392286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25716403|NCT02392286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466981|NCT00375843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24466982|NCT00375843|Serotonin Agents|serotonin agents|mesh-ancestor
24466983|NCT00375843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467083|NCT00376155|Amodiaquine|amodiaquine|mesh-list
24467084|NCT00376155|Antimalarials|antimalarials|mesh-ancestor
24467085|NCT00376155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24467086|NCT00376155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24467087|NCT00376155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24467088|NCT00376155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24467089|NCT00376155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467090|NCT00376155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716413|NCT02392507|Carboplatin|carboplatin|mesh-list
25716414|NCT02392507|Necitumumab|necitumumab|mesh-list
25716415|NCT02392507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25716416|NCT02392507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716417|NCT02392507|Tubulin Modulators|tubulin modulators|mesh-ancestor
25716418|NCT02392507|Antimitotic Agents|antimitotic agents|mesh-ancestor
25716419|NCT02392507|Mitosis Modulators|mitosis modulators|mesh-ancestor
25771196|NCT03593902|Prednisolone acetate|prednisolone acetate|mesh-list
25771197|NCT03593902|Cyclophosphamide|cyclophosphamide|mesh-list
25771198|NCT03593902|Rituximab|rituximab|mesh-list
25771199|NCT03593902|Fludarabine|fludarabine|mesh-list
25771200|NCT03593902|Thymoglobulin|thymoglobulin|mesh-list
25771201|NCT03593902|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25771202|NCT03593902|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25771203|NCT03593902|Prednisolone phosphate|prednisolone phosphate|mesh-list
25771204|NCT03593902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25771205|NCT03593902|Immunologic Factors|immunologic factors|mesh-ancestor
25771206|NCT03593902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771207|NCT03593902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25771208|NCT03593902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25771209|NCT03593902|Alkylating Agents|alkylating agents|mesh-ancestor
25771210|NCT03593902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771211|NCT03593902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25771212|NCT03593902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25771213|NCT03593902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25771214|NCT03593902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25771215|NCT03593902|Antiemetics|antiemetics|mesh-ancestor
25771216|NCT03593902|Autonomic Agents|autonomic agents|mesh-ancestor
24467152|NCT00376376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24467154|NCT00376428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24467155|NCT00376428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24467156|NCT00376428|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24467165|NCT00376480|Fludarabine|fludarabine|mesh-list
24467169|NCT00376480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467170|NCT00376480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24467171|NCT00376480|Antimetabolites|antimetabolites|mesh-ancestor
24467172|NCT00376480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467173|NCT00376480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24467175|NCT00376480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467176|NCT00376480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24467178|NCT00376480|Autonomic Agents|autonomic agents|mesh-ancestor
24467179|NCT00376480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24467180|NCT00376480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24467181|NCT00376480|Glucocorticoids|glucocorticoids|mesh-ancestor
24467220|NCT00376519|Antitubercular Agents|antitubercular agents|mesh-ancestor
24467225|NCT00376584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467226|NCT00376584|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24467227|NCT00376584|Vasodilator Agents|vasodilator agents|mesh-ancestor
25716422|NCT02392559|Evolocumab|evolocumab|mesh-list
25716423|NCT02392559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25716424|NCT02392559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25716425|NCT02392559|Antimetabolites|antimetabolites|mesh-ancestor
25716426|NCT02392559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716427|NCT02392559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25716428|NCT02392611|Fulvestrant|fulvestrant|mesh-list
25716429|NCT02392611|Exemestane|exemestane|mesh-list
25716430|NCT02392611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24467378|NCT00377442|Simvastatin|simvastatin|mesh-list
24467427|NCT00377559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24467428|NCT00377559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24467482|NCT00377910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24467483|NCT00377910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24467484|NCT00377910|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24467485|NCT00377910|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24467486|NCT00377910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24467487|NCT00377910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467488|NCT00377910|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
24467489|NCT00377910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24467490|NCT00377923|Progesterone|progesterone|mesh-list
24467491|NCT00377923|Progestins|progestins|mesh-ancestor
24467493|NCT00377923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24467494|NCT00377923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467495|NCT00377936|Gemcitabine|gemcitabine|mesh-list
24467496|NCT00377936|Paclitaxel|paclitaxel|mesh-list
24467497|NCT00377936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24467498|NCT00377936|Antimetabolites|antimetabolites|mesh-ancestor
24467499|NCT00377936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467500|NCT00377936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467501|NCT00377936|Antiviral Agents|antiviral agents|mesh-ancestor
24467502|NCT00377936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24467503|NCT00377936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467504|NCT00377936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24467505|NCT00377936|Immunologic Factors|immunologic factors|mesh-ancestor
24467506|NCT00377936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467511|NCT00377975|Pioglitazone|pioglitazone|mesh-list
24467536|NCT00377988|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24467557|NCT00378066|Growth Inhibitors|growth inhibitors|mesh-ancestor
24467558|NCT00378066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24467559|NCT00378066|Antimetabolites|antimetabolites|mesh-ancestor
24467560|NCT00378066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716459|NCT02393339|Antipyretics|antipyretics|mesh-ancestor
25716460|NCT02393378|Folic Acid|folic acid|mesh-list
25716461|NCT02393378|Adalimumab|adalimumab|mesh-list
25716462|NCT02393378|Methotrexate|methotrexate|mesh-list
24467561|NCT00378092|Risperidone|risperidone|mesh-list
24467562|NCT00378092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25716463|NCT02393378|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25716464|NCT02393378|Abortifacient Agents|abortifacient agents|mesh-ancestor
25716465|NCT02393378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24467598|NCT00378183|Risperidone|risperidone|mesh-list
24467599|NCT00378183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24467600|NCT00378183|Serotonin Agents|serotonin agents|mesh-ancestor
24467601|NCT00378183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24467602|NCT00378183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467603|NCT00378183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24467624|NCT00378313|Paclitaxel|paclitaxel|mesh-list
24467625|NCT00378313|Epirubicin|epirubicin|mesh-list
24467626|NCT00378313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24467627|NCT00378313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467628|NCT00378313|Tubulin Modulators|tubulin modulators|mesh-ancestor
24467629|NCT00378313|Antimitotic Agents|antimitotic agents|mesh-ancestor
24467630|NCT00378313|Mitosis Modulators|mitosis modulators|mesh-ancestor
24467631|NCT00378313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467632|NCT00378313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24467633|NCT00378313|Antimetabolites|antimetabolites|mesh-ancestor
24467634|NCT00378313|Antiviral Agents|antiviral agents|mesh-ancestor
24467635|NCT00378313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24467636|NCT00378313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467637|NCT00378313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24467645|NCT00378404|Docetaxel|docetaxel|mesh-list
24467667|NCT00378443|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24467668|NCT00378443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24467669|NCT00378443|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24467670|NCT00378443|Protease Inhibitors|protease inhibitors|mesh-ancestor
24467683|NCT00378456|Trace Elements|trace elements|mesh-ancestor
24467684|NCT00378456|Antidotes|antidotes|mesh-ancestor
24467690|NCT00378456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467691|NCT00378495|Miltefosine|miltefosine|mesh-list
24467692|NCT00378495|Antifungal Agents|antifungal agents|mesh-ancestor
24467693|NCT00378495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25716470|NCT02393378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716471|NCT02393378|Dermatologic Agents|dermatologic agents|mesh-ancestor
25716472|NCT02393378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24467739|NCT00378625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24467740|NCT00378625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24467741|NCT00378625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24467742|NCT00378625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467743|NCT00378625|Antiviral Agents|antiviral agents|mesh-ancestor
24467744|NCT00378625|Schistosomicides|schistosomicides|mesh-ancestor
24467745|NCT00378625|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24467746|NCT00378625|Anthelmintics|anthelmintics|mesh-ancestor
24467747|NCT00378638|Bevacizumab|bevacizumab|mesh-list
24467748|NCT00378638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24467749|NCT00378638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24467750|NCT00378638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24467804|NCT00378781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24467805|NCT00378781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24467806|NCT00378781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417197|NCT00205764|Melphalan|melphalan|mesh-list
24467807|NCT00378781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24467808|NCT00378781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24467809|NCT00378820|Caseins|caseins|mesh-list
24467810|NCT00378820|Chelating Agents|chelating agents|mesh-ancestor
24467811|NCT00378820|Sequestering Agents|sequestering agents|mesh-ancestor
24467813|NCT00378833|Niacin|niacin|mesh-list
25716473|NCT02393378|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25716474|NCT02393378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25716475|NCT02393378|Immunologic Factors|immunologic factors|mesh-ancestor
25716476|NCT02393378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25716477|NCT02393378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25716478|NCT02393378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25716479|NCT02393378|Hematinics|hematinics|mesh-ancestor
25716480|NCT02393378|Vitamin B Complex|vitamin b complex|mesh-ancestor
25716481|NCT02393378|Vitamins|vitamins|mesh-ancestor
25716482|NCT02393378|Micronutrients|micronutrients|mesh-ancestor
25716483|NCT02393547|Varenicline|varenicline|mesh-list
25716484|NCT02393547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24467996|NCT00379431|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24467997|NCT00379431|Protective Agents|protective agents|mesh-ancestor
24467998|NCT00379431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24467999|NCT00379457|Dactinomycin|dactinomycin|mesh-list
24468000|NCT00379457|Cyclophosphamide|cyclophosphamide|mesh-list
24468001|NCT00379457|Ifosfamide|ifosfamide|mesh-list
24468002|NCT00379457|Carboplatin|carboplatin|mesh-list
24468003|NCT00379457|Doxorubicin|doxorubicin|mesh-list
24468004|NCT00379457|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24468025|NCT00379457|Mitosis Modulators|mitosis modulators|mesh-ancestor
24468029|NCT00379457|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24468085|NCT00379730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24468086|NCT00379730|Glucocorticoids|glucocorticoids|mesh-ancestor
24468087|NCT00379730|Hormones|hormones|mesh-ancestor
24468088|NCT00379730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24468089|NCT00379730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468090|NCT00379730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24468091|NCT00379730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468092|NCT00379756|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
24468093|NCT00379756|Vasodilator Agents|vasodilator agents|mesh-ancestor
24468094|NCT00379756|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24468095|NCT00379756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24468096|NCT00379756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25716488|NCT02393547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716489|NCT02393547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716490|NCT02393677|Dexmedetomidine|dexmedetomidine|mesh-list
24468097|NCT00379756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716491|NCT02393677|Ropivacaine|ropivacaine|mesh-list
24468148|NCT00380146|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24468149|NCT00380146|Renal Agents|renal agents|mesh-ancestor
24468151|NCT00380224|Antiemetics|antiemetics|mesh-ancestor
24468152|NCT00380224|Autonomic Agents|autonomic agents|mesh-ancestor
24468178|NCT00380354|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
24468179|NCT00380354|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
24468180|NCT00380354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24417561|NCT00206778|Lamotrigine|lamotrigine|mesh-list
24468193|NCT00380406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24468194|NCT00380406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468195|NCT00380406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24468196|NCT00380406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468197|NCT00380445|Vildagliptin|vildagliptin|mesh-list
24468198|NCT00380445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24468218|NCT00380484|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24468219|NCT00380484|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24468220|NCT00380484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468222|NCT00380575|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24468223|NCT00380575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468224|NCT00380575|Natriuretic Agents|natriuretic agents|mesh-ancestor
24468225|NCT00380575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468226|NCT00380614|Lamivudine|lamivudine|mesh-list
24468227|NCT00380614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24468228|NCT00380614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24468229|NCT00380614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24468237|NCT00380640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24468238|NCT00380640|Renal Agents|renal agents|mesh-ancestor
24468239|NCT00380640|Antimalarials|antimalarials|mesh-ancestor
24468240|NCT00380640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24468241|NCT00380640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24468242|NCT00380640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24468243|NCT00380640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24468244|NCT00380640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468245|NCT00380640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24468246|NCT00380640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24468247|NCT00380640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24468248|NCT00380770|Lamivudine|lamivudine|mesh-list
24468249|NCT00380770|Stavudine|stavudine|mesh-list
24468250|NCT00380770|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
24468292|NCT00380965|Nabilone|nabilone|mesh-list
24468322|NCT00381030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24468325|NCT00381030|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24468326|NCT00381030|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24468327|NCT00381134|Losartan|losartan|mesh-list
24468328|NCT00381134|Spironolactone|spironolactone|mesh-list
24468329|NCT00381134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24468330|NCT00381134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24463304|NCT00359879|Incretins|incretins|mesh-ancestor
24468331|NCT00381134|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24468332|NCT00381134|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24468333|NCT00381134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468334|NCT00381134|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24468335|NCT00381134|Hormone Antagonists|hormone antagonists|mesh-ancestor
24468336|NCT00381134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24468337|NCT00381134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468418|NCT00381511|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24468420|NCT00381511|Dalteparin|dalteparin|mesh-list
24468421|NCT00381511|Anticoagulants|anticoagulants|mesh-ancestor
24468422|NCT00381511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24468724|NCT00382980|Antacids|antacids|mesh-ancestor
24468737|NCT00383032|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
24468738|NCT00383032|Hormone Antagonists|hormone antagonists|mesh-ancestor
24468739|NCT00383032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24468740|NCT00383032|Luteolytic Agents|luteolytic agents|mesh-ancestor
24468741|NCT00383032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24468742|NCT00383032|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
24468757|NCT00383136|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24468758|NCT00383136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24468779|NCT00383370|Growth Inhibitors|growth inhibitors|mesh-ancestor
24468780|NCT00383370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468781|NCT00383396|Cyclosporine|cyclosporine|mesh-list
24468782|NCT00383396|Cyclosporins|cyclosporins|mesh-list
24468787|NCT00383396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468788|NCT00383396|Antifungal Agents|antifungal agents|mesh-ancestor
24468789|NCT00383396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24468790|NCT00383396|Dermatologic Agents|dermatologic agents|mesh-ancestor
24468791|NCT00383396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24468792|NCT00383396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24468793|NCT00383474|Bortezomib|bortezomib|mesh-list
24468794|NCT00383474|Tipifarnib|tipifarnib|mesh-list
24468796|NCT00383487|Calcitriol|calcitriol|mesh-list
24468803|NCT00383487|Sensory System Agents|sensory system agents|mesh-ancestor
24468804|NCT00383487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24468805|NCT00383487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468806|NCT00383487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24468807|NCT00383487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24468808|NCT00383487|Gout Suppressants|gout suppressants|mesh-ancestor
24468809|NCT00383487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24468810|NCT00383487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24468811|NCT00383487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468812|NCT00383487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24468813|NCT00383487|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24468814|NCT00383487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24468815|NCT00383487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24468865|NCT00383799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24468866|NCT00383799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24468867|NCT00383799|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24468868|NCT00383799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24468869|NCT00383799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24468870|NCT00383799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24468872|NCT00383812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24468873|NCT00383812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468874|NCT00383812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24468875|NCT00383812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24468881|NCT00383851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24468882|NCT00383851|Alkylating Agents|alkylating agents|mesh-ancestor
24468883|NCT00383851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468901|NCT00383877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24468902|NCT00383877|Insulin Detemir|insulin detemir|mesh-list
24468903|NCT00383877|Isophane Insulin, Human|isophane insulin, human|mesh-list
24468904|NCT00383877|Insulin, Isophane|insulin, isophane|mesh-list
24468935|NCT00383929|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24468936|NCT00383929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24468938|NCT00383929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24468951|NCT00384020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24468952|NCT00384020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468953|NCT00384020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24468954|NCT00384020|Serotonin Agents|serotonin agents|mesh-ancestor
24468955|NCT00384020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468956|NCT00384020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24468957|NCT00384020|Antidepressive Agents|antidepressive agents|mesh-ancestor
24468965|NCT00384046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24468966|NCT00384046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468968|NCT00384072|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24468969|NCT00384072|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24468970|NCT00384072|Hormone Antagonists|hormone antagonists|mesh-ancestor
24468971|NCT00384072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24468972|NCT00384072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468973|NCT00384072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24468975|NCT00384124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24468976|NCT00384124|Immunologic Factors|immunologic factors|mesh-ancestor
24468977|NCT00384124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468978|NCT00384124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24468979|NCT00384124|Interferon Inducers|interferon inducers|mesh-ancestor
24468980|NCT00384137|Tacrolimus|tacrolimus|mesh-list
25716492|NCT02393677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25716493|NCT02393677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25716494|NCT02393677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716495|NCT02393677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25716496|NCT02393677|Analgesics|analgesics|mesh-ancestor
25716497|NCT02393677|Sensory System Agents|sensory system agents|mesh-ancestor
25716498|NCT02393677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25716499|NCT02393677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25716500|NCT02393677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25716501|NCT02393677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24468981|NCT00384137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24468982|NCT00384137|Immunologic Factors|immunologic factors|mesh-ancestor
24468983|NCT00384137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24468984|NCT00384137|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24468985|NCT00384137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24468986|NCT00384137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24468987|NCT00384202|Tacrolimus|tacrolimus|mesh-list
24469009|NCT00384280|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24469011|NCT00384280|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24469012|NCT00384306|Prednisolone|prednisolone|mesh-list
24469013|NCT00384306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24469014|NCT00384306|Glucocorticoids|glucocorticoids|mesh-ancestor
24469015|NCT00384306|Hormones|hormones|mesh-ancestor
24469016|NCT00384306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24469017|NCT00384306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469018|NCT00384306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24469025|NCT00384371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469026|NCT00384371|Cholinergic Agents|cholinergic agents|mesh-ancestor
24469027|NCT00384371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24469028|NCT00384371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469029|NCT00384371|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24469030|NCT00384371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24469031|NCT00384384|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
24469032|NCT00384384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24469034|NCT00384410|Antiemetics|antiemetics|mesh-ancestor
24469035|NCT00384410|Autonomic Agents|autonomic agents|mesh-ancestor
24469038|NCT00384410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24469086|NCT00384566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24469087|NCT00384566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24469116|NCT00384592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24469117|NCT00384592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24469118|NCT00384592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469119|NCT00384605|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
24469197|NCT00384878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469198|NCT00384878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25716502|NCT02393677|Adrenergic Agents|adrenergic agents|mesh-ancestor
25716503|NCT02393677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25716504|NCT02393677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716505|NCT02393677|Anesthetics, Local|anesthetics, local|mesh-ancestor
25716506|NCT02393677|Anesthetics|anesthetics|mesh-ancestor
25716507|NCT02393755|Capecitabine|capecitabine|mesh-list
25716508|NCT02393755|Nintedanib|nintedanib|mesh-list
25716509|NCT02393755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24469256|NCT00385125|Rituximab|rituximab|mesh-list
24469257|NCT00385125|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
24469258|NCT00385125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24469388|NCT00385606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24469389|NCT00385606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24469390|NCT00385606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24469392|NCT00385606|Sensory System Agents|sensory system agents|mesh-ancestor
24469393|NCT00385606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24469394|NCT00385606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24469395|NCT00385606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24469397|NCT00385632|Antiviral Agents|antiviral agents|mesh-ancestor
24469398|NCT00385632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24469399|NCT00385645|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24469446|NCT00385931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24469447|NCT00385931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24469448|NCT00385931|Antimetabolites|antimetabolites|mesh-ancestor
24469449|NCT00385931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24469450|NCT00385931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24469451|NCT00385931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24469648|NCT00386659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24469649|NCT00386659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24469650|NCT00386659|Antiviral Agents|antiviral agents|mesh-ancestor
24469651|NCT00386659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24469652|NCT00386659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24469653|NCT00386659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24469733|NCT00386867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469734|NCT00386867|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24469735|NCT00386867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24469736|NCT00386867|Oxytocics|oxytocics|mesh-ancestor
24469737|NCT00386958|Povidone-Iodine|povidone-iodine|mesh-list
24469739|NCT00386958|Plasma Substitutes|plasma substitutes|mesh-ancestor
24469740|NCT00386958|Blood Substitutes|blood substitutes|mesh-ancestor
24469741|NCT00386958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24469742|NCT00386958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24469913|NCT00387920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24469914|NCT00387920|Growth Inhibitors|growth inhibitors|mesh-ancestor
24470006|NCT00388388|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24470007|NCT00388388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24470009|NCT00388401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24470010|NCT00388427|Cetuximab|cetuximab|mesh-list
24470011|NCT00388427|Dasatinib|dasatinib|mesh-list
24470012|NCT00388427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24470013|NCT00388427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470164|NCT00389038|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
24470165|NCT00389038|Antidepressive Agents|antidepressive agents|mesh-ancestor
24470166|NCT00389038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24470167|NCT00389038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24470168|NCT00389038|Analgesics|analgesics|mesh-ancestor
24470169|NCT00389038|Sensory System Agents|sensory system agents|mesh-ancestor
24470170|NCT00389038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24470171|NCT00389038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470172|NCT00389038|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24470204|NCT00389129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24470205|NCT00389129|Antipyretics|antipyretics|mesh-ancestor
24470206|NCT00389233|Ascorbic Acid|ascorbic acid|mesh-list
24470207|NCT00389233|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
24470208|NCT00389233|Antioxidants|antioxidants|mesh-ancestor
24470209|NCT00389233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470210|NCT00389233|Protective Agents|protective agents|mesh-ancestor
24470211|NCT00389233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470212|NCT00389233|Vitamins|vitamins|mesh-ancestor
24470288|NCT00389506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24470289|NCT00389506|Immunologic Factors|immunologic factors|mesh-ancestor
24470290|NCT00389506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470291|NCT00389506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24470292|NCT00389506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24470293|NCT00389506|Alkylating Agents|alkylating agents|mesh-ancestor
24470294|NCT00389506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470295|NCT00389506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470296|NCT00389506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24470297|NCT00389506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24470298|NCT00389506|Antimetabolites|antimetabolites|mesh-ancestor
24470300|NCT00389558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24470301|NCT00389558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24470422|NCT00390091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470424|NCT00390130|Immunologic Factors|immunologic factors|mesh-ancestor
25716510|NCT02393755|Antimetabolites|antimetabolites|mesh-ancestor
25716511|NCT02393755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716512|NCT02393755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716513|NCT02393755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24470500|NCT00390260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24470501|NCT00390260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24470502|NCT00390260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24470503|NCT00390273|Metformin|metformin|mesh-list
24470504|NCT00390273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24470505|NCT00390273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470506|NCT00390312|Morphine|morphine|mesh-list
24470507|NCT00390312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24470508|NCT00390312|Narcotics|narcotics|mesh-ancestor
24470511|NCT00390312|Analgesics|analgesics|mesh-ancestor
24470532|NCT00390403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24470533|NCT00390403|Immunologic Factors|immunologic factors|mesh-ancestor
24470534|NCT00390403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470535|NCT00390403|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24470536|NCT00390403|Protective Agents|protective agents|mesh-ancestor
24470537|NCT00390403|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24470538|NCT00390403|Contraceptive Agents|contraceptive agents|mesh-ancestor
24470539|NCT00390403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24470540|NCT00390403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24470541|NCT00390403|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24470542|NCT00390403|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
24470543|NCT00390403|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
24470574|NCT00390676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24420135|NCT00215241|Dopamine Agents|dopamine agents|mesh-ancestor
24470576|NCT00390728|Insulin Glargine|insulin glargine|mesh-list
24470625|NCT00390793|Tubulin Modulators|tubulin modulators|mesh-ancestor
24470626|NCT00390793|Antimitotic Agents|antimitotic agents|mesh-ancestor
24470627|NCT00390793|Mitosis Modulators|mitosis modulators|mesh-ancestor
24470628|NCT00390793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24470629|NCT00390793|Protease Inhibitors|protease inhibitors|mesh-ancestor
24470630|NCT00390832|Epoetin Alfa|epoetin alfa|mesh-list
24470631|NCT00390832|Hematinics|hematinics|mesh-ancestor
24470632|NCT00390871|Fentanyl|fentanyl|mesh-list
24470633|NCT00390871|Dexmedetomidine|dexmedetomidine|mesh-list
24470634|NCT00390871|Propofol|propofol|mesh-list
24470635|NCT00390871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24470668|NCT00390923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470669|NCT00390923|Antidepressive Agents|antidepressive agents|mesh-ancestor
24470670|NCT00390923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24463553|NCT00361387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470671|NCT00390923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24470672|NCT00390923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24470673|NCT00390923|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24470674|NCT00390923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24470677|NCT00390975|Tegaserod|tegaserod|mesh-list
24470816|NCT00392080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24470855|NCT00392262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24470856|NCT00392262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470857|NCT00392262|Vasodilator Agents|vasodilator agents|mesh-ancestor
24470858|NCT00392262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24470859|NCT00392262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24470860|NCT00392275|Ciprofloxacin|ciprofloxacin|mesh-list
25716514|NCT02393755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25716515|NCT02394340|Luliconazole|luliconazole|mesh-list
25716516|NCT02394340|Omeprazole|omeprazole|mesh-list
25716517|NCT02394340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24470861|NCT00392275|Levofloxacin|levofloxacin|mesh-list
24470862|NCT00392275|Ofloxacin|ofloxacin|mesh-list
24470863|NCT00392275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24470864|NCT00392275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25716518|NCT02394340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25716519|NCT02394340|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24470865|NCT00392275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24470866|NCT00392275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24470867|NCT00392275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24470883|NCT00392340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24470884|NCT00392340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24470885|NCT00392340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24470886|NCT00392340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24470887|NCT00392340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24470888|NCT00392340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24470889|NCT00392340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24470890|NCT00392340|Tubulin Modulators|tubulin modulators|mesh-ancestor
24470891|NCT00392340|Antimitotic Agents|antimitotic agents|mesh-ancestor
24470892|NCT00392340|Mitosis Modulators|mitosis modulators|mesh-ancestor
24470894|NCT00392418|Micronutrients|micronutrients|mesh-list
24470906|NCT00392431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24470937|NCT00392522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24470939|NCT00392522|Sensory System Agents|sensory system agents|mesh-ancestor
24470988|NCT00392886|Immunologic Factors|immunologic factors|mesh-ancestor
24470989|NCT00392886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24470995|NCT00392886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24470996|NCT00392886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24470997|NCT00392886|Abortifacient Agents|abortifacient agents|mesh-ancestor
24470999|NCT00392886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24471007|NCT00392886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24471008|NCT00392886|Tubulin Modulators|tubulin modulators|mesh-ancestor
24471009|NCT00392886|Antimitotic Agents|antimitotic agents|mesh-ancestor
24471010|NCT00392886|Mitosis Modulators|mitosis modulators|mesh-ancestor
24471011|NCT00392899|Tegafur|tegafur|mesh-list
24471012|NCT00392899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24471013|NCT00392899|Antimetabolites|antimetabolites|mesh-ancestor
24471014|NCT00392899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471015|NCT00392899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24471016|NCT00392912|Methyltestosterone|methyltestosterone|mesh-list
24471017|NCT00392912|Testosterone|testosterone|mesh-list
24471028|NCT00392938|Docetaxel|docetaxel|mesh-list
24471029|NCT00392938|Androgen Antagonists|androgen antagonists|mesh-list
24471030|NCT00392938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24471082|NCT00393263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24471083|NCT00393263|Immunologic Factors|immunologic factors|mesh-ancestor
24471084|NCT00393263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24471085|NCT00393263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24471086|NCT00393263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471087|NCT00393289|Calcium|calcium|mesh-list
24471088|NCT00393289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24471089|NCT00393289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471090|NCT00393315|Paclitaxel|paclitaxel|mesh-list
24471091|NCT00393315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24471092|NCT00393315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24471093|NCT00393315|Tubulin Modulators|tubulin modulators|mesh-ancestor
24471094|NCT00393315|Antimitotic Agents|antimitotic agents|mesh-ancestor
24471095|NCT00393315|Mitosis Modulators|mitosis modulators|mesh-ancestor
24471096|NCT00393315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471097|NCT00393328|Ritonavir|ritonavir|mesh-list
24471098|NCT00393328|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24471111|NCT00393328|Antidepressive Agents|antidepressive agents|mesh-ancestor
24471112|NCT00393328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24471113|NCT00393328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24471114|NCT00393328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24471115|NCT00393328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24471116|NCT00393328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471117|NCT00393328|Dopamine Agonists|dopamine agonists|mesh-ancestor
25716520|NCT02394340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25716521|NCT02394340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716522|NCT02394340|Antifungal Agents|antifungal agents|mesh-ancestor
25716523|NCT02394340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25716524|NCT02394457|Cosyntropin|cosyntropin|mesh-list
25716525|NCT02394457|Hormones|hormones|mesh-ancestor
25716526|NCT02394457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24471180|NCT00393679|Artenimol|artenimol|mesh-list
24471181|NCT00393679|Dapsone|dapsone|mesh-list
24471182|NCT00393679|Chlorproguanil|chlorproguanil|mesh-list
24471183|NCT00393679|Antimalarials|antimalarials|mesh-ancestor
24471189|NCT00393679|Schistosomicides|schistosomicides|mesh-ancestor
24471190|NCT00393679|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24471191|NCT00393679|Anthelmintics|anthelmintics|mesh-ancestor
24471192|NCT00393679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24471194|NCT00393679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471195|NCT00393679|Leprostatic Agents|leprostatic agents|mesh-ancestor
24471196|NCT00393679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24471209|NCT00393744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24471210|NCT00393770|Acetylcarnitine|acetylcarnitine|mesh-list
24471211|NCT00393770|Vitamin B Complex|vitamin b complex|mesh-ancestor
24471212|NCT00393770|Vitamins|vitamins|mesh-ancestor
24471213|NCT00393770|Micronutrients|micronutrients|mesh-ancestor
24471231|NCT00394056|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24471232|NCT00394056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24471233|NCT00394056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24471234|NCT00394056|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24471261|NCT00394368|Xhance|xhance|mesh-list
25716528|NCT02394730|Vorapaxar|vorapaxar|mesh-list
25716529|NCT02394730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25716530|NCT02394951|Pregabalin|pregabalin|mesh-list
25716531|NCT02394951|Analgesics|analgesics|mesh-ancestor
25716532|NCT02394951|Sensory System Agents|sensory system agents|mesh-ancestor
24471262|NCT00394368|Beclomethasone|beclomethasone|mesh-list
24471263|NCT00394368|Formoterol Fumarate|formoterol fumarate|mesh-list
24471264|NCT00394368|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24471265|NCT00394368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24471269|NCT00394368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471270|NCT00394368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25716533|NCT02394951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25716534|NCT02394951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716535|NCT02394951|Anticonvulsants|anticonvulsants|mesh-ancestor
25716536|NCT02394951|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25716537|NCT02394951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25716538|NCT02394951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471302|NCT00394459|Anesthetics|anesthetics|mesh-list
24471303|NCT00394459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24471304|NCT00394459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471305|NCT00394485|Tiotropium Bromide|tiotropium bromide|mesh-list
24471306|NCT00394485|Procaterol|procaterol|mesh-list
24471307|NCT00394485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24471308|NCT00394485|Autonomic Agents|autonomic agents|mesh-ancestor
24471309|NCT00394485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24471310|NCT00394485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471311|NCT00394485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24471312|NCT00394485|Respiratory System Agents|respiratory system agents|mesh-ancestor
24471313|NCT00394485|Parasympatholytics|parasympatholytics|mesh-ancestor
24471314|NCT00394485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24471315|NCT00394485|Cholinergic Agents|cholinergic agents|mesh-ancestor
24471316|NCT00394485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24471357|NCT00394810|Tubulin Modulators|tubulin modulators|mesh-ancestor
24471368|NCT00394992|Oxaliplatin|oxaliplatin|mesh-list
24471433|NCT00395252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471436|NCT00395252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24471437|NCT00395252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25716540|NCT02394951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25716541|NCT02394951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25716542|NCT02394951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25716543|NCT02394951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25716544|NCT02395055|Adalimumab|adalimumab|mesh-list
25716545|NCT02395055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25716546|NCT02395055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25716547|NCT02395081|Vitamin D|vitamin d|mesh-list
25716548|NCT02395081|Ergocalciferols|ergocalciferols|mesh-list
25716549|NCT02395081|Cholecalciferol|cholecalciferol|mesh-list
24471604|NCT00396214|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24471605|NCT00396214|Antidepressive Agents|antidepressive agents|mesh-ancestor
24471606|NCT00396214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24471607|NCT00396214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24471608|NCT00396214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25716551|NCT02395081|Micronutrients|micronutrients|mesh-ancestor
25716552|NCT02395081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716553|NCT02395081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25716554|NCT02395081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25716555|NCT02395172|Docetaxel|docetaxel|mesh-list
25716556|NCT02395172|Avelumab|avelumab|mesh-list
25716557|NCT02395172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24471745|NCT00396721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24471746|NCT00396721|Protease Inhibitors|protease inhibitors|mesh-ancestor
24471749|NCT00396734|Anticonvulsants|anticonvulsants|mesh-ancestor
24471750|NCT00396734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24471751|NCT00396734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24471752|NCT00396734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24471753|NCT00396734|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24471754|NCT00396734|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25716566|NCT02395627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25716567|NCT02395627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24471894|NCT00397384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
24471928|NCT00397501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24471929|NCT00397501|Dermatologic Agents|dermatologic agents|mesh-ancestor
24471930|NCT00397501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25716571|NCT02395627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716572|NCT02395627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25716573|NCT02395627|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25716574|NCT02395627|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25716575|NCT02395627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24472059|NCT00397826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472060|NCT00397826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24472062|NCT00397826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25716582|NCT02395653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25716583|NCT02395653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716585|NCT02395653|Sensory System Agents|sensory system agents|mesh-ancestor
25716586|NCT02395653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25716587|NCT02395653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25716588|NCT02395653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24472212|NCT00398554|Doxorubicin|doxorubicin|mesh-list
24472214|NCT00398554|Etoposide|etoposide|mesh-list
24472215|NCT00398554|Vincristine|vincristine|mesh-list
24472216|NCT00398554|Vinblastine|vinblastine|mesh-list
24472217|NCT00398554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24472222|NCT00398554|Alkylating Agents|alkylating agents|mesh-ancestor
24472223|NCT00398554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716597|NCT02396147|Androgen Antagonists|androgen antagonists|mesh-ancestor
25716598|NCT02396147|Hormone Antagonists|hormone antagonists|mesh-ancestor
25716599|NCT02396147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24472233|NCT00398554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24472234|NCT00398554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24472235|NCT00398554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24472237|NCT00398554|Antimitotic Agents|antimitotic agents|mesh-ancestor
24472238|NCT00398554|Mitosis Modulators|mitosis modulators|mesh-ancestor
24472239|NCT00398580|Methyltestosterone|methyltestosterone|mesh-list
24472261|NCT00398658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24472262|NCT00398658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24472263|NCT00398658|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24472264|NCT00398658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25716601|NCT02396316|Aflibercept|aflibercept|mesh-list
25716602|NCT02396316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24472270|NCT00398684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472271|NCT00398684|Antiviral Agents|antiviral agents|mesh-ancestor
24472272|NCT00398684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24472273|NCT00398684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24472274|NCT00398684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25716603|NCT02396316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25716604|NCT02396316|Growth Substances|growth substances|mesh-ancestor
25716605|NCT02396316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716606|NCT02396316|Growth Inhibitors|growth inhibitors|mesh-ancestor
25716607|NCT02396316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716608|NCT02396511|Bevacizumab|bevacizumab|mesh-list
24472315|NCT00398827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24472316|NCT00398827|Adrenergic Agents|adrenergic agents|mesh-ancestor
24472317|NCT00398827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24472318|NCT00398827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472322|NCT00398853|Micronutrients|micronutrients|mesh-ancestor
24472323|NCT00398853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472324|NCT00398853|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24472325|NCT00398853|Chelating Agents|chelating agents|mesh-ancestor
24472326|NCT00398853|Sequestering Agents|sequestering agents|mesh-ancestor
24472327|NCT00398853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24472328|NCT00398892|Thioctic Acid|thioctic acid|mesh-list
24472329|NCT00398892|Antioxidants|antioxidants|mesh-ancestor
24422007|NCT00220896|Cholinergic Agents|cholinergic agents|mesh-ancestor
24472345|NCT00398905|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24472346|NCT00398905|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25716609|NCT02396511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25716610|NCT02396511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716611|NCT02396511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25716612|NCT02396511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25716613|NCT02396511|Growth Substances|growth substances|mesh-ancestor
25716614|NCT02396511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716615|NCT02396511|Growth Inhibitors|growth inhibitors|mesh-ancestor
24472585|NCT00399685|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24472626|NCT00399750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24472627|NCT00399750|Growth Substances|growth substances|mesh-ancestor
24472628|NCT00399750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472629|NCT00399750|Growth Inhibitors|growth inhibitors|mesh-ancestor
24472630|NCT00399867|Simvastatin|simvastatin|mesh-list
24472667|NCT00400088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24472668|NCT00400088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24472669|NCT00400088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24472671|NCT00400088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24472672|NCT00400088|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24472686|NCT00400114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24472688|NCT00400231|Fenofibrate|fenofibrate|mesh-list
24472689|NCT00400231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24472690|NCT00400231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472691|NCT00400231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24472692|NCT00400231|Antimetabolites|antimetabolites|mesh-ancestor
25716630|NCT02396537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25716631|NCT02396537|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25716632|NCT02396537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25716633|NCT02396537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25716634|NCT02396537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25716635|NCT02396537|Anesthetics, General|anesthetics, general|mesh-ancestor
25716636|NCT02396537|GABA Modulators|gaba modulators|mesh-ancestor
25716637|NCT02396537|GABA Agents|gaba agents|mesh-ancestor
25716638|NCT02396537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25716639|NCT02396732|Aspirin|aspirin|mesh-list
25716640|NCT02396732|Enoxaparin|enoxaparin|mesh-list
25716641|NCT02396732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25716642|NCT02396732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25716643|NCT02396732|Analgesics|analgesics|mesh-ancestor
24472844|NCT00400777|Valsartan|valsartan|mesh-list
24472845|NCT00400777|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24472846|NCT00400777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24472847|NCT00400777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24472848|NCT00400777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24472861|NCT00400790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24472862|NCT00400790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24472863|NCT00400790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24472864|NCT00400790|Anesthetics, General|anesthetics, general|mesh-ancestor
24472865|NCT00400790|Anesthetics|anesthetics|mesh-ancestor
24472866|NCT00400790|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24472867|NCT00400816|Temozolomide|temozolomide|mesh-list
24472868|NCT00400816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24472869|NCT00400816|Alkylating Agents|alkylating agents|mesh-ancestor
24472870|NCT00400816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473310|NCT00402532|Immunologic Factors|immunologic factors|mesh-ancestor
24473311|NCT00402532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473313|NCT00402545|Fluorouracil|fluorouracil|mesh-list
24473314|NCT00402545|Cetuximab|cetuximab|mesh-list
24473315|NCT00402545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473316|NCT00402545|Tubulin Modulators|tubulin modulators|mesh-ancestor
24444774|NCT00299065|Sensory System Agents|sensory system agents|mesh-ancestor
24444775|NCT00299065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24444776|NCT00299065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473336|NCT00402558|Abortifacient Agents|abortifacient agents|mesh-ancestor
24473337|NCT00402558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24473338|NCT00402558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473339|NCT00402558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24473341|NCT00402558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473342|NCT00402558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24473343|NCT00402558|Dermatologic Agents|dermatologic agents|mesh-ancestor
24473344|NCT00402558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473345|NCT00402558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24473346|NCT00402558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24473347|NCT00402558|Immunologic Factors|immunologic factors|mesh-ancestor
24473348|NCT00402558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24473349|NCT00402558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24473350|NCT00402558|Antiviral Agents|antiviral agents|mesh-ancestor
24473351|NCT00402558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24473461|NCT00402974|Vitamin MK 7|vitamin mk 7|mesh-list
24473724|NCT00403962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24473725|NCT00403962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24473774|NCT00404183|Sensory System Agents|sensory system agents|mesh-ancestor
24473775|NCT00404183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24473776|NCT00404183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473777|NCT00404183|Antipyretics|antipyretics|mesh-ancestor
24473778|NCT00404183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24473779|NCT00404183|Narcotics|narcotics|mesh-ancestor
24473780|NCT00404183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24473781|NCT00404183|Antitussive Agents|antitussive agents|mesh-ancestor
25716664|NCT02396953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716665|NCT02396953|Hormones|hormones|mesh-ancestor
25716666|NCT02396953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25716667|NCT02396953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716668|NCT02397265|Insulin|insulin|mesh-list
25716669|NCT02397265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25716670|NCT02397265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716671|NCT02397291|Inositol|inositol|mesh-list
24473840|NCT00404326|Valproic Acid|valproic acid|mesh-list
24473841|NCT00404326|Anticonvulsants|anticonvulsants|mesh-ancestor
24473842|NCT00404326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473843|NCT00404326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473844|NCT00404326|GABA Agents|gaba agents|mesh-ancestor
24473860|NCT00404378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473923|NCT00404482|Cyclosporins|cyclosporins|mesh-list
24473924|NCT00404482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24473925|NCT00404482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473926|NCT00404482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24473927|NCT00404482|Immunologic Factors|immunologic factors|mesh-ancestor
24473938|NCT00404508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24473939|NCT00404508|GABA Agents|gaba agents|mesh-ancestor
24473940|NCT00404508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24473941|NCT00404508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24473942|NCT00404508|Antimanic Agents|antimanic agents|mesh-ancestor
24473943|NCT00404508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24473944|NCT00404508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24473945|NCT00404508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24474017|NCT00404781|Clopidogrel|clopidogrel|mesh-list
25716672|NCT02397291|Vitamin B Complex|vitamin b complex|mesh-ancestor
25716673|NCT02397291|Vitamins|vitamins|mesh-ancestor
25716674|NCT02397291|Micronutrients|micronutrients|mesh-ancestor
25716675|NCT02397291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716676|NCT02397408|Choline|choline|mesh-list
25716677|NCT02397408|Lipotropic Agents|lipotropic agents|mesh-ancestor
25716678|NCT02397408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25716679|NCT02397408|Antimetabolites|antimetabolites|mesh-ancestor
25716680|NCT02397408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474019|NCT00404781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24474020|NCT00404781|Analgesics|analgesics|mesh-ancestor
24474021|NCT00404781|Sensory System Agents|sensory system agents|mesh-ancestor
24474022|NCT00404781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24474023|NCT00404781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474024|NCT00404781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24474081|NCT00404833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24474082|NCT00404833|Methylprednisolone|methylprednisolone|mesh-list
24446343|NCT00304499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24446344|NCT00304499|Cholinergic Agents|cholinergic agents|mesh-ancestor
24446388|NCT00304616|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24474162|NCT00405158|Penicillins|penicillins|mesh-list
24474163|NCT00405158|Floxacillin|floxacillin|mesh-list
24474164|NCT00405158|Cefadroxil|cefadroxil|mesh-list
24474165|NCT00405158|Oxytocin|oxytocin|mesh-list
24474166|NCT00405158|Oxytocics|oxytocics|mesh-ancestor
24423943|NCT00227461|Nootropic Agents|nootropic agents|mesh-ancestor
24446409|NCT00304655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24446410|NCT00304655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24446411|NCT00304655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24446420|NCT00304655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24474207|NCT00405249|Dexelvucitabine|dexelvucitabine|mesh-list
24474208|NCT00405249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24474209|NCT00405249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24474210|NCT00405249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474211|NCT00405249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474212|NCT00405249|Antiviral Agents|antiviral agents|mesh-ancestor
24474213|NCT00405249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24474214|NCT00405249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24474215|NCT00405249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24474216|NCT00405262|Ketorolac|ketorolac|mesh-list
24474217|NCT00405262|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
24446516|NCT00304993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446518|NCT00304993|Vasodilator Agents|vasodilator agents|mesh-ancestor
24446537|NCT00305292|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24446538|NCT00305292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446539|NCT00305292|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24446540|NCT00305292|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24446541|NCT00305292|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24446542|NCT00305292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446544|NCT00305331|Antiemetics|antiemetics|mesh-ancestor
24446545|NCT00305331|Autonomic Agents|autonomic agents|mesh-ancestor
24446546|NCT00305331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24446560|NCT00305370|Dopamine Agonists|dopamine agonists|mesh-ancestor
24446561|NCT00305370|Dopamine Agents|dopamine agents|mesh-ancestor
24446562|NCT00305370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24446563|NCT00305370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446564|NCT00305370|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24446565|NCT00305370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24446566|NCT00305370|Serotonin Agents|serotonin agents|mesh-ancestor
24446567|NCT00305370|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24446568|NCT00305370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24446573|NCT00305383|Antiviral Agents|antiviral agents|mesh-ancestor
24446574|NCT00305383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446575|NCT00305396|Sirolimus|sirolimus|mesh-list
24446576|NCT00305396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24446577|NCT00305396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446589|NCT00305409|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24446590|NCT00305409|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24474401|NCT00405925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474444|NCT00406042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24474446|NCT00406042|Hormones|hormones|mesh-ancestor
24474447|NCT00406042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24474448|NCT00406042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474449|NCT00406042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25716682|NCT02397408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25716683|NCT02397408|Nootropic Agents|nootropic agents|mesh-ancestor
25716684|NCT02397694|Dolutegravir|dolutegravir|mesh-list
25716685|NCT02397694|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25716686|NCT02397694|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25716687|NCT02397694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771217|NCT03593902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24474458|NCT00406094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24474727|NCT00407186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24474728|NCT00407186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24474776|NCT00407290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474777|NCT00407290|Cholinergic Agents|cholinergic agents|mesh-ancestor
24474778|NCT00407290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24474779|NCT00407290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474780|NCT00407290|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24474781|NCT00407290|Autonomic Agents|autonomic agents|mesh-ancestor
24474782|NCT00407290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24474784|NCT00407342|Dermatologic Agents|dermatologic agents|mesh-ancestor
24474785|NCT00407342|Immunologic Factors|immunologic factors|mesh-ancestor
24474786|NCT00407342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24474787|NCT00407394|Amoxicillin|amoxicillin|mesh-list
25716688|NCT02397694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716689|NCT02397694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25716690|NCT02397694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25716691|NCT02397694|Antiviral Agents|antiviral agents|mesh-ancestor
25716692|NCT02397694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25716693|NCT02397837|Pramipexole|pramipexole|mesh-list
25716694|NCT02397837|Antioxidants|antioxidants|mesh-ancestor
25716695|NCT02397837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716696|NCT02397837|Protective Agents|protective agents|mesh-ancestor
25716697|NCT02397837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716698|NCT02397837|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25716699|NCT02397837|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25716700|NCT02397837|Dopamine Agonists|dopamine agonists|mesh-ancestor
25716702|NCT02397837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25716703|NCT02397889|Midazolam|midazolam|mesh-list
25716704|NCT02397889|Ketamine|ketamine|mesh-list
25716705|NCT02397889|Analgesics|analgesics|mesh-ancestor
25716706|NCT02397889|Sensory System Agents|sensory system agents|mesh-ancestor
24474902|NCT00408031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24474903|NCT00408031|Antimetabolites|antimetabolites|mesh-ancestor
24474904|NCT00408031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24474928|NCT00408187|Cyclosporins|cyclosporins|mesh-list
24474929|NCT00408187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24474930|NCT00408187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475081|NCT00408785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24475082|NCT00408798|Botulinum Toxins|botulinum toxins|mesh-list
24475083|NCT00408798|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24475084|NCT00408798|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24475085|NCT00408798|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24475097|NCT00408915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24475098|NCT00408915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24475099|NCT00408915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24475100|NCT00408915|Serotonin Agents|serotonin agents|mesh-ancestor
24475101|NCT00408915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24475102|NCT00408915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475103|NCT00408915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475104|NCT00408915|Dopamine Agonists|dopamine agonists|mesh-ancestor
24475105|NCT00408915|Dopamine Agents|dopamine agents|mesh-ancestor
24446626|NCT00305487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24475163|NCT00409253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475164|NCT00409253|Vasodilator Agents|vasodilator agents|mesh-ancestor
24475165|NCT00409253|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24475166|NCT00409253|Serotonin Agents|serotonin agents|mesh-ancestor
24446703|NCT00305734|Bortezomib|bortezomib|mesh-list
24475282|NCT00409721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24475283|NCT00409721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475294|NCT00409760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475295|NCT00409760|Vasodilator Agents|vasodilator agents|mesh-ancestor
24475296|NCT00409760|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24475297|NCT00409760|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24475298|NCT00409851|Amlodipine|amlodipine|mesh-list
24475299|NCT00409851|Valsartan|valsartan|mesh-list
24475300|NCT00409851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24475328|NCT00409903|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
24464026|NCT00363025|Idarubicin|idarubicin|mesh-list
24475329|NCT00409903|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24475330|NCT00409903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475331|NCT00409942|Torsemide|torsemide|mesh-list
24475332|NCT00409942|Furosemide|furosemide|mesh-list
24475333|NCT00409942|Diuretics|diuretics|mesh-ancestor
24475334|NCT00409942|Natriuretic Agents|natriuretic agents|mesh-ancestor
24475335|NCT00409942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475336|NCT00409942|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24475337|NCT00409942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24446706|NCT00305734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475382|NCT00410254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475423|NCT00410449|Tocopherols|tocopherols|mesh-list
24475424|NCT00410449|Vitamin E|vitamin e|mesh-list
24475425|NCT00410449|Tocotrienols|tocotrienols|mesh-list
24475426|NCT00410449|alpha-Tocopherol|alpha-tocopherol|mesh-list
24475427|NCT00410449|Antioxidants|antioxidants|mesh-ancestor
24475430|NCT00410449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475432|NCT00410449|Micronutrients|micronutrients|mesh-ancestor
24475433|NCT00410462|Doxorubicin|doxorubicin|mesh-list
24475434|NCT00410462|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24475435|NCT00410462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24475436|NCT00410462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24475437|NCT00410462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24475438|NCT00410462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24475439|NCT00410462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24475441|NCT00410527|Meropenem|meropenem|mesh-list
24475474|NCT00410592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25716707|NCT02397889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25716708|NCT02397889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716709|NCT02397889|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25716710|NCT02397889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25716711|NCT02397889|Anesthetics, General|anesthetics, general|mesh-ancestor
25716712|NCT02397889|Anesthetics|anesthetics|mesh-ancestor
25716713|NCT02397889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25716714|NCT02397889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25716715|NCT02397889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24475571|NCT00410774|Antimetabolites|antimetabolites|mesh-ancestor
24475572|NCT00410774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475573|NCT00410774|Antiviral Agents|antiviral agents|mesh-ancestor
24475574|NCT00410774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24475681|NCT00411125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24475682|NCT00411125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475756|NCT00411320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24475758|NCT00411320|Autonomic Agents|autonomic agents|mesh-ancestor
24475759|NCT00411320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24475760|NCT00411320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475761|NCT00411320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24475762|NCT00411320|Glucocorticoids|glucocorticoids|mesh-ancestor
24475763|NCT00411320|Hormones|hormones|mesh-ancestor
24475764|NCT00411320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24475765|NCT00411320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24475766|NCT00411320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24475918|NCT00412022|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24475919|NCT00412022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24475920|NCT00412022|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25716716|NCT02397889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25716717|NCT02397889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716718|NCT02397889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25716719|NCT02397889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25716720|NCT02397889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25716721|NCT02397889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25716722|NCT02397889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25716723|NCT02397889|GABA Modulators|gaba modulators|mesh-ancestor
25716724|NCT02397889|GABA Agents|gaba agents|mesh-ancestor
25716725|NCT02397954|Ranibizumab|ranibizumab|mesh-list
24475921|NCT00412022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24475922|NCT00412022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24475923|NCT00412022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475924|NCT00412022|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24475925|NCT00412022|Hormone Antagonists|hormone antagonists|mesh-ancestor
24475926|NCT00412022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24475927|NCT00412022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475928|NCT00412022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24475929|NCT00412022|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24475930|NCT00412022|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24475931|NCT00412022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24475941|NCT00412035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24475942|NCT00412035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24475943|NCT00412035|Cholinergic Agents|cholinergic agents|mesh-ancestor
24475944|NCT00412035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24475945|NCT00412035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475953|NCT00412100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475983|NCT00412204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24475984|NCT00412204|Autonomic Agents|autonomic agents|mesh-ancestor
24475985|NCT00412204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24475986|NCT00412204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475987|NCT00412204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24475988|NCT00412204|Respiratory System Agents|respiratory system agents|mesh-ancestor
24475989|NCT00412204|Parasympatholytics|parasympatholytics|mesh-ancestor
24475991|NCT00412204|Cholinergic Agents|cholinergic agents|mesh-ancestor
24475992|NCT00412204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24476001|NCT00412334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24476002|NCT00412334|Immunologic Factors|immunologic factors|mesh-ancestor
24476003|NCT00412334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476005|NCT00412334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716727|NCT02397954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25716728|NCT02397954|Growth Substances|growth substances|mesh-ancestor
25716729|NCT02397954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716730|NCT02397954|Growth Inhibitors|growth inhibitors|mesh-ancestor
25716731|NCT02397954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716732|NCT02398188|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25716733|NCT02398188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25716734|NCT02398188|Autonomic Agents|autonomic agents|mesh-ancestor
24476073|NCT00412763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476075|NCT00412763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476076|NCT00412789|Epothilone B|epothilone b|mesh-list
24476077|NCT00412789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476078|NCT00412789|Tubulin Modulators|tubulin modulators|mesh-ancestor
24476079|NCT00412789|Antimitotic Agents|antimitotic agents|mesh-ancestor
24476080|NCT00412789|Mitosis Modulators|mitosis modulators|mesh-ancestor
24446715|NCT00305747|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24446716|NCT00305747|Protective Agents|protective agents|mesh-ancestor
24446717|NCT00305747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716735|NCT02398188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25716736|NCT02398188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716737|NCT02398188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25716738|NCT02398188|Respiratory System Agents|respiratory system agents|mesh-ancestor
25716739|NCT02398188|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25716740|NCT02398188|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25716741|NCT02398188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25716742|NCT02398188|Adrenergic Agents|adrenergic agents|mesh-ancestor
25716743|NCT02398188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25716744|NCT02398188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716745|NCT02399085|Lenalidomide|lenalidomide|mesh-list
25716746|NCT02399085|Immunologic Factors|immunologic factors|mesh-ancestor
25716747|NCT02399085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476110|NCT00413075|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24476231|NCT00413608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476234|NCT00413686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24476235|NCT00413686|Antimetabolites|antimetabolites|mesh-ancestor
24476236|NCT00413686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476237|NCT00413686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476238|NCT00413686|Antiviral Agents|antiviral agents|mesh-ancestor
24476344|NCT00414323|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24476345|NCT00414323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24476346|NCT00414323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24476347|NCT00414323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476379|NCT00414531|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24476380|NCT00414531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24476382|NCT00414531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476383|NCT00414531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24476466|NCT00415103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24476514|NCT00415324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476515|NCT00415350|Azithromycin|azithromycin|mesh-list
24476516|NCT00415350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24476517|NCT00415350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24476518|NCT00415376|Levetiracetam|levetiracetam|mesh-list
24476532|NCT00415584|Hormone Antagonists|hormone antagonists|mesh-ancestor
24476533|NCT00415584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24476534|NCT00415701|Hydrocortisone|hydrocortisone|mesh-list
24476535|NCT00415701|Propofol|propofol|mesh-list
24476545|NCT00415701|Hormones|hormones|mesh-ancestor
24476582|NCT00415831|Entacapone|entacapone|mesh-list
24476583|NCT00415831|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
24476584|NCT00415831|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24476585|NCT00415831|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24426529|NCT00236249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24476586|NCT00415831|Dopamine Agents|dopamine agents|mesh-ancestor
24476587|NCT00415831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24476588|NCT00415831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476589|NCT00415831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476591|NCT00415831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476592|NCT00415831|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
24476593|NCT00415831|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24476594|NCT00415831|Immunologic Factors|immunologic factors|mesh-ancestor
24476595|NCT00415831|Dopamine Agonists|dopamine agonists|mesh-ancestor
24476636|NCT00415935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24476637|NCT00415935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476638|NCT00415935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24476640|NCT00415935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476641|NCT00415935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24476642|NCT00415935|Dermatologic Agents|dermatologic agents|mesh-ancestor
24476643|NCT00415935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476644|NCT00415935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24476661|NCT00416039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24476662|NCT00416039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24476663|NCT00416039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24476664|NCT00416039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24476665|NCT00416039|Anesthetics, General|anesthetics, general|mesh-ancestor
24476667|NCT00416039|GABA Modulators|gaba modulators|mesh-ancestor
24476668|NCT00416039|GABA Agents|gaba agents|mesh-ancestor
24476669|NCT00416039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24476670|NCT00416039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476671|NCT00416130|Vorinostat|vorinostat|mesh-list
24476674|NCT00416130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24476736|NCT00416377|Antimitotic Agents|antimitotic agents|mesh-ancestor
24476737|NCT00416377|Mitosis Modulators|mitosis modulators|mesh-ancestor
24476738|NCT00416377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24476849|NCT00416728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24476850|NCT00416728|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24476851|NCT00416728|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24476852|NCT00416728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476854|NCT00416767|Fluorouracil|fluorouracil|mesh-list
24476855|NCT00416767|Irinotecan|irinotecan|mesh-list
24476856|NCT00416767|Calcium|calcium|mesh-list
24476857|NCT00416767|Levoleucovorin|levoleucovorin|mesh-list
24476858|NCT00416767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24476859|NCT00416767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476860|NCT00416767|Antimetabolites|antimetabolites|mesh-ancestor
24476861|NCT00416767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24476862|NCT00416767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24476904|NCT00416819|Protective Agents|protective agents|mesh-ancestor
24476905|NCT00416819|Vitamin B Complex|vitamin b complex|mesh-ancestor
24476907|NCT00416819|Micronutrients|micronutrients|mesh-ancestor
24476966|NCT00416897|Antiemetics|antiemetics|mesh-ancestor
24476967|NCT00416897|Autonomic Agents|autonomic agents|mesh-ancestor
24464202|NCT00363753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24464203|NCT00363753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24464204|NCT00363753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24476969|NCT00416897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24476970|NCT00416897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24476971|NCT00416897|Glucocorticoids|glucocorticoids|mesh-ancestor
24476972|NCT00416897|Hormones|hormones|mesh-ancestor
25716748|NCT02399085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25716749|NCT02399085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25716750|NCT02399085|Growth Substances|growth substances|mesh-ancestor
25716751|NCT02399085|Growth Inhibitors|growth inhibitors|mesh-ancestor
25716752|NCT02399085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716753|NCT02399163|Fluorides|fluorides|mesh-list
25716754|NCT02399163|Cariostatic Agents|cariostatic agents|mesh-ancestor
25716755|NCT02399163|Protective Agents|protective agents|mesh-ancestor
25716756|NCT02399163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716757|NCT02399345|Ritonavir|ritonavir|mesh-list
25716758|NCT02399345|Ribavirin|ribavirin|mesh-list
24476973|NCT00416897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24478359|NCT00422565|Tubulin Modulators|tubulin modulators|mesh-ancestor
24476982|NCT00416910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24476983|NCT00416910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24476984|NCT00416910|Alkylating Agents|alkylating agents|mesh-ancestor
24477000|NCT00416962|Oseltamivir|oseltamivir|mesh-list
24477016|NCT00417014|Vinblastine|vinblastine|mesh-list
24477017|NCT00417014|Procarbazine|procarbazine|mesh-list
24477018|NCT00417014|Chlorambucil|chlorambucil|mesh-list
24477019|NCT00417014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24477020|NCT00417014|Glucocorticoids|glucocorticoids|mesh-ancestor
24477022|NCT00417014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24477023|NCT00417014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477024|NCT00417014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24477025|NCT00417014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477027|NCT00417014|Tubulin Modulators|tubulin modulators|mesh-ancestor
24477028|NCT00417014|Antimitotic Agents|antimitotic agents|mesh-ancestor
24477029|NCT00417014|Mitosis Modulators|mitosis modulators|mesh-ancestor
24477030|NCT00417014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477031|NCT00417014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24477032|NCT00417014|Alkylating Agents|alkylating agents|mesh-ancestor
24477063|NCT00417066|Contraceptive Agents|contraceptive agents|mesh-ancestor
24477064|NCT00417066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24477065|NCT00417066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477066|NCT00417066|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24477067|NCT00417066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24477068|NCT00417066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477069|NCT00417066|Hormone Antagonists|hormone antagonists|mesh-ancestor
24477098|NCT00417183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477099|NCT00417183|Hormone Antagonists|hormone antagonists|mesh-ancestor
24477105|NCT00417222|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24477106|NCT00417222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477107|NCT00417235|Chlorhexidine|chlorhexidine|mesh-list
24477108|NCT00417235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24477109|NCT00417235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24477143|NCT00417443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24477145|NCT00417443|Autonomic Agents|autonomic agents|mesh-ancestor
24477146|NCT00417443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24477147|NCT00417443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24477148|NCT00417443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24477149|NCT00417443|Adrenergic Agents|adrenergic agents|mesh-ancestor
24477157|NCT00417677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477158|NCT00417677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24477159|NCT00417677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24477160|NCT00417677|Growth Substances|growth substances|mesh-ancestor
24477184|NCT00417729|Acarbose|acarbose|mesh-list
24477208|NCT00417807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477209|NCT00417833|Bevacizumab|bevacizumab|mesh-list
24477210|NCT00417833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24477225|NCT00417898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24477226|NCT00417898|Analgesics|analgesics|mesh-ancestor
25716759|NCT02399345|Sofosbuvir|sofosbuvir|mesh-list
25716760|NCT02399345|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25716761|NCT02399345|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25716762|NCT02399345|Protease Inhibitors|protease inhibitors|mesh-ancestor
25716763|NCT02399345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25716764|NCT02399345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716765|NCT02399345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25716766|NCT02399345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24477228|NCT00417898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24477229|NCT00417898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477230|NCT00417898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24477231|NCT00417898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24477232|NCT00417898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24477233|NCT00417898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24477235|NCT00417898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24477263|NCT00418067|Antimitotic Agents|antimitotic agents|mesh-ancestor
24477264|NCT00418067|Mitosis Modulators|mitosis modulators|mesh-ancestor
24477265|NCT00418067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477266|NCT00418067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24477267|NCT00418067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24477268|NCT00418067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24477269|NCT00418067|Antifungal Agents|antifungal agents|mesh-ancestor
24477270|NCT00418067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24477271|NCT00418067|Immunologic Factors|immunologic factors|mesh-ancestor
24477272|NCT00418067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477273|NCT00418080|Bicalutamide|bicalutamide|mesh-list
24477274|NCT00418080|Androgen Antagonists|androgen antagonists|mesh-ancestor
24477275|NCT00418080|Hormone Antagonists|hormone antagonists|mesh-ancestor
24477342|NCT00418353|Dexamethasone|dexamethasone|mesh-list
24477343|NCT00418353|Betamethasone|betamethasone|mesh-list
24477344|NCT00418353|Betamethasone Valerate|betamethasone valerate|mesh-list
24477345|NCT00418353|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24477348|NCT00418353|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
24477349|NCT00418353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24431085|NCT00250315|Dobutamine|dobutamine|mesh-list
24477416|NCT00418509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24477417|NCT00418509|Dermatologic Agents|dermatologic agents|mesh-ancestor
24477418|NCT00418509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24477419|NCT00418535|Cisplatin|cisplatin|mesh-list
24477420|NCT00418535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477421|NCT00418548|Etanercept|etanercept|mesh-list
24477422|NCT00418548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24477423|NCT00418548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24477424|NCT00418548|Analgesics|analgesics|mesh-ancestor
24477425|NCT00418548|Sensory System Agents|sensory system agents|mesh-ancestor
24477429|NCT00418548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24477503|NCT00418860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24477504|NCT00418860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477505|NCT00418860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24477506|NCT00418860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24477507|NCT00418860|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24477508|NCT00418860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25716767|NCT02399345|Antiviral Agents|antiviral agents|mesh-ancestor
25716768|NCT02399345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25716769|NCT02399345|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25716770|NCT02399345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25716771|NCT02399345|Antimetabolites|antimetabolites|mesh-ancestor
25716772|NCT02399475|Hormones|hormones|mesh-list
25716773|NCT02399475|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
25716774|NCT02399475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24477584|NCT00419172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24477585|NCT00419172|Leprostatic Agents|leprostatic agents|mesh-ancestor
24477587|NCT00419172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477634|NCT00419536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477635|NCT00419549|Valdecoxib|valdecoxib|mesh-list
24477636|NCT00419549|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24477638|NCT00419549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477640|NCT00419549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24477642|NCT00419549|Analgesics|analgesics|mesh-ancestor
24477643|NCT00419549|Sensory System Agents|sensory system agents|mesh-ancestor
24477644|NCT00419549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24477645|NCT00419549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477646|NCT00419549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24477647|NCT00419549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24477648|NCT00419601|Fentanyl|fentanyl|mesh-list
24477649|NCT00419601|Remifentanil|remifentanil|mesh-list
24477655|NCT00419601|Sensory System Agents|sensory system agents|mesh-ancestor
24477714|NCT00419731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24477715|NCT00419731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477716|NCT00419783|Moxifloxacin|moxifloxacin|mesh-list
24477717|NCT00419783|Ketoconazole|ketoconazole|mesh-list
24477718|NCT00419783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24477719|NCT00419783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24477745|NCT00419796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24477747|NCT00419835|Enalapril|enalapril|mesh-list
24477748|NCT00419835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24477749|NCT00419835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24477750|NCT00419835|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24477751|NCT00419835|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24477752|NCT00419835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477753|NCT00419835|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24478360|NCT00422565|Antimitotic Agents|antimitotic agents|mesh-ancestor
24477903|NCT00420667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24477904|NCT00420667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477905|NCT00420693|Sevoflurane|sevoflurane|mesh-list
24477906|NCT00420693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24477955|NCT00421018|Respiratory System Agents|respiratory system agents|mesh-ancestor
24477969|NCT00421083|Tadalafil|tadalafil|mesh-list
24477972|NCT00421083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24477974|NCT00421083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477975|NCT00421083|Urological Agents|urological agents|mesh-ancestor
24477977|NCT00421096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24477978|NCT00421096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24477979|NCT00421096|Antimetabolites|antimetabolites|mesh-ancestor
24477980|NCT00421096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477981|NCT00421096|Antiviral Agents|antiviral agents|mesh-ancestor
24477982|NCT00421096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24477983|NCT00421096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24477984|NCT00421096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24477985|NCT00421096|Immunologic Factors|immunologic factors|mesh-ancestor
24477986|NCT00421096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477987|NCT00421109|Levocetirizine|levocetirizine|mesh-list
24477993|NCT00421109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24477994|NCT00421109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24477995|NCT00421122|Budesonide|budesonide|mesh-list
24477996|NCT00421122|Terbutaline|terbutaline|mesh-list
24478062|NCT00421421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24478063|NCT00421421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478064|NCT00421421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478065|NCT00421421|Hormone Antagonists|hormone antagonists|mesh-ancestor
24478066|NCT00421421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24478074|NCT00421434|Antiviral Agents|antiviral agents|mesh-ancestor
24478075|NCT00421434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24478076|NCT00421434|Immunologic Factors|immunologic factors|mesh-ancestor
25716775|NCT02399475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716776|NCT02399917|Azacitidine|azacitidine|mesh-list
25716777|NCT02399917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25716778|NCT02399917|Antimetabolites|antimetabolites|mesh-ancestor
25716779|NCT02399917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716780|NCT02399917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716781|NCT02399917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478149|NCT00421694|Androgen Antagonists|androgen antagonists|mesh-ancestor
24478150|NCT00421694|Hormone Antagonists|hormone antagonists|mesh-ancestor
24478154|NCT00421720|Sufentanil|sufentanil|mesh-list
24478206|NCT00421863|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24478207|NCT00421863|Analgesics|analgesics|mesh-ancestor
24478208|NCT00421863|Sensory System Agents|sensory system agents|mesh-ancestor
24478209|NCT00421863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24478210|NCT00421863|Sympatholytics|sympatholytics|mesh-ancestor
24478211|NCT00421863|Autonomic Agents|autonomic agents|mesh-ancestor
24478227|NCT00421915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24478228|NCT00421915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24478229|NCT00421915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24478230|NCT00421915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24478353|NCT00422526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24478354|NCT00422526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478355|NCT00422565|Sirolimus|sirolimus|mesh-list
24478356|NCT00422565|Paclitaxel|paclitaxel|mesh-list
24478357|NCT00422565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24478358|NCT00422565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24478388|NCT00422604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24478389|NCT00422604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478390|NCT00422604|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24478601|NCT00423696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24478602|NCT00423696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24478603|NCT00423696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478605|NCT00423696|Protective Agents|protective agents|mesh-ancestor
24478606|NCT00423696|Vitamin B Complex|vitamin b complex|mesh-ancestor
24478607|NCT00423696|Vitamins|vitamins|mesh-ancestor
24478608|NCT00423696|Micronutrients|micronutrients|mesh-ancestor
24478609|NCT00423709|Fludarabine|fludarabine|mesh-list
24478645|NCT00423826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478646|NCT00423826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24478647|NCT00423826|Immunologic Factors|immunologic factors|mesh-ancestor
24478648|NCT00423826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478649|NCT00423826|Antiviral Agents|antiviral agents|mesh-ancestor
24478652|NCT00423826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478653|NCT00423826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25716782|NCT02400333|Ticagrelor|ticagrelor|mesh-list
24478739|NCT00424203|Alkylating Agents|alkylating agents|mesh-ancestor
24478741|NCT00424203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716783|NCT02400333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25716784|NCT02400333|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25716785|NCT02400333|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25716786|NCT02400333|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25716787|NCT02400333|Purinergic Agents|purinergic agents|mesh-ancestor
25716788|NCT02400333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25716789|NCT02400333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771218|NCT03593902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25771219|NCT03593902|Glucocorticoids|glucocorticoids|mesh-ancestor
25771220|NCT03593902|Hormones|hormones|mesh-ancestor
25771221|NCT03593902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25771222|NCT03593902|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25771223|NCT03593902|Protective Agents|protective agents|mesh-ancestor
24478770|NCT00424281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24478783|NCT00424437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478785|NCT00424580|Desloratadine|desloratadine|mesh-list
24478786|NCT00424580|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24478787|NCT00424580|Respiratory System Agents|respiratory system agents|mesh-ancestor
24478788|NCT00424580|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24478789|NCT00424580|Hormone Antagonists|hormone antagonists|mesh-ancestor
24478790|NCT00424580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24478836|NCT00424801|Amiloride|amiloride|mesh-list
24478837|NCT00424801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24478838|NCT00424801|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24478948|NCT00425074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24478949|NCT00425074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24478950|NCT00425074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24478951|NCT00425074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24478952|NCT00425074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24478953|NCT00425074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24478954|NCT00425074|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24478955|NCT00425074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24478956|NCT00425074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24478958|NCT00425126|Epoetin Alfa|epoetin alfa|mesh-list
24478959|NCT00425126|Hematinics|hematinics|mesh-ancestor
24478960|NCT00425152|Leucovorin|leucovorin|mesh-list
24478961|NCT00425152|Levamisole|levamisole|mesh-list
24478962|NCT00425152|Fluorouracil|fluorouracil|mesh-list
24478963|NCT00425152|Calcium|calcium|mesh-list
24479066|NCT00425451|Sensory System Agents|sensory system agents|mesh-ancestor
24479067|NCT00425451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24479068|NCT00425451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479069|NCT00425451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24479086|NCT00425516|Cyclophosphamide|cyclophosphamide|mesh-list
24479088|NCT00425516|Fluorouracil|fluorouracil|mesh-list
24479089|NCT00425516|Epirubicin|epirubicin|mesh-list
24479090|NCT00425516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24479091|NCT00425516|Immunologic Factors|immunologic factors|mesh-ancestor
24479092|NCT00425516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479093|NCT00425516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24479094|NCT00425516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24479095|NCT00425516|Alkylating Agents|alkylating agents|mesh-ancestor
24479096|NCT00425516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479097|NCT00425516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479098|NCT00425516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24479099|NCT00425516|Tubulin Modulators|tubulin modulators|mesh-ancestor
25716790|NCT02400333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771224|NCT03593902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25771225|NCT03594045|Apixaban|apixaban|mesh-list
25771226|NCT03594045|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25771227|NCT03594045|Antithrombins|antithrombins|mesh-ancestor
25771228|NCT03594045|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25771229|NCT03594045|Protease Inhibitors|protease inhibitors|mesh-ancestor
25771230|NCT03594045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771231|NCT03594045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771232|NCT03594045|Anticoagulants|anticoagulants|mesh-ancestor
25771233|NCT03595449|Lidocaine|lidocaine|mesh-list
25771234|NCT03595449|Anesthetics, Local|anesthetics, local|mesh-ancestor
25771235|NCT03595449|Anesthetics|anesthetics|mesh-ancestor
25771236|NCT03595449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25771237|NCT03595449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771238|NCT03595449|Sensory System Agents|sensory system agents|mesh-ancestor
25771239|NCT03595449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771240|NCT03595449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25771241|NCT03595449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24479100|NCT00425516|Antimitotic Agents|antimitotic agents|mesh-ancestor
24479159|NCT00425724|Antiemetics|antiemetics|mesh-ancestor
24479160|NCT00425724|Autonomic Agents|autonomic agents|mesh-ancestor
24479162|NCT00425724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24479186|NCT00425906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479229|NCT00426023|Dermatologic Agents|dermatologic agents|mesh-ancestor
24479230|NCT00426023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24479231|NCT00426023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24479232|NCT00426023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24479233|NCT00426023|Antipruritics|antipruritics|mesh-ancestor
24479234|NCT00426023|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24479235|NCT00426023|Histamine Antagonists|histamine antagonists|mesh-ancestor
24479236|NCT00426023|Histamine Agents|histamine agents|mesh-ancestor
24479237|NCT00426023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24479288|NCT00426296|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24479289|NCT00426296|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24479290|NCT00426296|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24479291|NCT00426296|Protease Inhibitors|protease inhibitors|mesh-ancestor
24479292|NCT00426296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479293|NCT00426296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479294|NCT00426296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24479295|NCT00426296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24479311|NCT00426348|Protective Agents|protective agents|mesh-ancestor
24479312|NCT00426348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479313|NCT00426413|Pioglitazone|pioglitazone|mesh-list
24479314|NCT00426413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24479315|NCT00426413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479316|NCT00426439|Chloroquine|chloroquine|mesh-list
24479317|NCT00426439|Lumefantrine|lumefantrine|mesh-list
24479318|NCT00426439|Artemether|artemether|mesh-list
24479319|NCT00426439|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24479320|NCT00426439|Amebicides|amebicides|mesh-ancestor
24479321|NCT00426439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24479322|NCT00426439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24479323|NCT00426439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24479324|NCT00426439|Antimalarials|antimalarials|mesh-ancestor
24479325|NCT00426439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24479326|NCT00426452|Vatalanib|vatalanib|mesh-list
24479327|NCT00426452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24479328|NCT00426452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479329|NCT00426452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479330|NCT00426478|Amlodipine|amlodipine|mesh-list
24479331|NCT00426478|Valsartan|valsartan|mesh-list
24479359|NCT00426543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24479360|NCT00426543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479361|NCT00426543|Immunologic Factors|immunologic factors|mesh-ancestor
24479373|NCT00426595|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24479374|NCT00426595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479375|NCT00426595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479376|NCT00426608|Alprazolam|alprazolam|mesh-list
24479377|NCT00426608|Metyrapone|metyrapone|mesh-list
24479378|NCT00426608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24479379|NCT00426608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24479396|NCT00426621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479397|NCT00426621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24479398|NCT00426621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24479399|NCT00426621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24479400|NCT00426621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24479401|NCT00426621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479402|NCT00426647|Buprenorphine|buprenorphine|mesh-list
24479403|NCT00426647|Tramadol|tramadol|mesh-list
24479404|NCT00426647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24479416|NCT00426712|Immunologic Factors|immunologic factors|mesh-ancestor
24479417|NCT00426712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716791|NCT02400346|Brexpiprazole|brexpiprazole|mesh-list
25716792|NCT02400346|Serotonin Agents|serotonin agents|mesh-ancestor
24479418|NCT00426777|Risedronic Acid|risedronic acid|mesh-list
24479419|NCT00426777|Etidronic Acid|etidronic acid|mesh-list
24479420|NCT00426777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24479421|NCT00426777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24479422|NCT00426777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479423|NCT00426777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24479424|NCT00426777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479425|NCT00426777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24479426|NCT00426829|Bevacizumab|bevacizumab|mesh-list
24479427|NCT00426829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24479428|NCT00426829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479429|NCT00426829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24479430|NCT00426829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24479431|NCT00426829|Growth Substances|growth substances|mesh-ancestor
24479432|NCT00426829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479433|NCT00426829|Growth Inhibitors|growth inhibitors|mesh-ancestor
24479434|NCT00426920|Insulin|insulin|mesh-list
24479435|NCT00426920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24479436|NCT00426920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479437|NCT00426933|Vancomycin|vancomycin|mesh-list
24479503|NCT00427128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24479504|NCT00427128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479505|NCT00427128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24479514|NCT00427167|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24479515|NCT00427167|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24479516|NCT00427167|Immunologic Factors|immunologic factors|mesh-ancestor
24479517|NCT00427167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479555|NCT00427271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24479557|NCT00427271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24479564|NCT00427310|Antimetabolites|antimetabolites|mesh-ancestor
24479565|NCT00427310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479566|NCT00427310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24479567|NCT00427310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479568|NCT00427310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24479569|NCT00427310|Immunologic Factors|immunologic factors|mesh-ancestor
24479570|NCT00427310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479571|NCT00427310|Anticoagulants|anticoagulants|mesh-ancestor
24479572|NCT00427310|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24479573|NCT00427310|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24479575|NCT00427362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24479576|NCT00427362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24479577|NCT00427388|Methylprednisolone|methylprednisolone|mesh-list
24479578|NCT00427388|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25716793|NCT02400346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25716794|NCT02400346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716795|NCT02400346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716796|NCT02400346|Dopamine Agonists|dopamine agonists|mesh-ancestor
25716797|NCT02400346|Dopamine Agents|dopamine agents|mesh-ancestor
25716798|NCT02400437|Dexamethasone|dexamethasone|mesh-list
25716799|NCT02400437|Rituximab|rituximab|mesh-list
25716800|NCT02400437|Ixazomib|ixazomib|mesh-list
24479584|NCT00427388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24479585|NCT00427388|Antiemetics|antiemetics|mesh-ancestor
24479586|NCT00427388|Autonomic Agents|autonomic agents|mesh-ancestor
24479587|NCT00427388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24479927|NCT00428909|Sensory System Agents|sensory system agents|mesh-ancestor
24479612|NCT00427466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24479613|NCT00427492|Magnesium Oxide|magnesium oxide|mesh-list
24479614|NCT00427492|Antacids|antacids|mesh-ancestor
24479615|NCT00427492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479616|NCT00427492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24479617|NCT00427505|Deferasirox|deferasirox|mesh-list
24479618|NCT00427505|Iron Chelating Agents|iron chelating agents|mesh-ancestor
24479619|NCT00427505|Chelating Agents|chelating agents|mesh-ancestor
24479620|NCT00427505|Sequestering Agents|sequestering agents|mesh-ancestor
24479621|NCT00427505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479770|NCT00428311|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24479771|NCT00428311|Contraceptive Agents|contraceptive agents|mesh-ancestor
24479772|NCT00428311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24479819|NCT00428480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479820|NCT00428480|Adrenergic Agents|adrenergic agents|mesh-ancestor
24479821|NCT00428480|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24479822|NCT00428480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24479823|NCT00428480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24479837|NCT00428545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24479839|NCT00428545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24479840|NCT00428545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24479841|NCT00428545|Growth Substances|growth substances|mesh-ancestor
24479842|NCT00428545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479843|NCT00428545|Growth Inhibitors|growth inhibitors|mesh-ancestor
25716801|NCT02400437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25716802|NCT02400437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716803|NCT02400437|Immunologic Factors|immunologic factors|mesh-ancestor
25716804|NCT02400437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716805|NCT02400437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25716806|NCT02400437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25716807|NCT02400437|Antiemetics|antiemetics|mesh-ancestor
25716808|NCT02400437|Autonomic Agents|autonomic agents|mesh-ancestor
25716809|NCT02400437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24479845|NCT00428558|Daunorubicin|daunorubicin|mesh-list
24479883|NCT00428727|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24479884|NCT00428727|Vasodilator Agents|vasodilator agents|mesh-ancestor
24479885|NCT00428727|Gasotransmitters|gasotransmitters|mesh-ancestor
24479886|NCT00428727|Protective Agents|protective agents|mesh-ancestor
24479887|NCT00428766|Farletuzumab|farletuzumab|mesh-list
24479888|NCT00428766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24479889|NCT00428818|Doxycycline|doxycycline|mesh-list
24479890|NCT00428818|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24479891|NCT00428818|Trimethoprim|trimethoprim|mesh-list
24479892|NCT00428818|Sulfamethoxazole|sulfamethoxazole|mesh-list
24479893|NCT00428818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24479894|NCT00428818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24479924|NCT00428909|Imatinib Mesylate|imatinib mesylate|mesh-list
24479925|NCT00428909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24479926|NCT00428909|Analgesics|analgesics|mesh-ancestor
24479941|NCT00429091|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24479942|NCT00429091|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24479943|NCT00429091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24479944|NCT00429091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24479945|NCT00429091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24479946|NCT00429091|Adrenergic Agents|adrenergic agents|mesh-ancestor
24479947|NCT00429091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24479948|NCT00429091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479949|NCT00429208|Nicotine|nicotine|mesh-list
24479950|NCT00429208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24479951|NCT00429208|Autonomic Agents|autonomic agents|mesh-ancestor
24479952|NCT00429208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24479995|NCT00429468|Sensory System Agents|sensory system agents|mesh-ancestor
24479996|NCT00429468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24479997|NCT00429468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24479998|NCT00429468|Antipyretics|antipyretics|mesh-ancestor
24479999|NCT00429468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24480000|NCT00429468|Narcotics|narcotics|mesh-ancestor
24480001|NCT00429468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24480002|NCT00429468|Antitussive Agents|antitussive agents|mesh-ancestor
24480003|NCT00429468|Respiratory System Agents|respiratory system agents|mesh-ancestor
24480004|NCT00429468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24480005|NCT00429468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24480006|NCT00429468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24480012|NCT00429520|Protective Agents|protective agents|mesh-ancestor
24480013|NCT00429533|Dapsone|dapsone|mesh-list
24480014|NCT00429533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24480065|NCT00429754|Antiemetics|antiemetics|mesh-ancestor
24480066|NCT00429754|Autonomic Agents|autonomic agents|mesh-ancestor
24480067|NCT00429754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24480068|NCT00429754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480069|NCT00429754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25716810|NCT02400437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24480070|NCT00429754|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24480071|NCT00429754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24480072|NCT00429754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480073|NCT00429780|Aluminum sulfate|aluminum sulfate|mesh-list
25716811|NCT02400437|Glucocorticoids|glucocorticoids|mesh-ancestor
25716812|NCT02400437|Hormones|hormones|mesh-ancestor
25716813|NCT02400437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25716814|NCT02400437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25716815|NCT02400437|Protease Inhibitors|protease inhibitors|mesh-ancestor
25716816|NCT02400437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25716817|NCT02400437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716818|NCT02400580|Acetaminophen|acetaminophen|mesh-list
24480074|NCT00429780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24480075|NCT00429780|Immunologic Factors|immunologic factors|mesh-ancestor
24480076|NCT00429780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480077|NCT00429806|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24480078|NCT00429806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24480085|NCT00429832|Autonomic Agents|autonomic agents|mesh-ancestor
24480086|NCT00429832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24480087|NCT00429832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480088|NCT00429832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24480109|NCT00429871|Docetaxel|docetaxel|mesh-list
24480140|NCT00429897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24480235|NCT00430118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24480237|NCT00430118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24480247|NCT00430118|Antimitotic Agents|antimitotic agents|mesh-ancestor
24480248|NCT00430118|Mitosis Modulators|mitosis modulators|mesh-ancestor
24480249|NCT00430144|Belotecan|belotecan|mesh-list
24480250|NCT00430144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24480251|NCT00430144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24480277|NCT00430196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480278|NCT00430196|Anticonvulsants|anticonvulsants|mesh-ancestor
24480279|NCT00430196|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24480280|NCT00430196|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24480281|NCT00430196|Parasympatholytics|parasympatholytics|mesh-ancestor
24480282|NCT00430196|Autonomic Agents|autonomic agents|mesh-ancestor
24480355|NCT00430794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24480370|NCT00430833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24480371|NCT00430833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24480372|NCT00430833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480373|NCT00430846|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24480374|NCT00430846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24480375|NCT00430846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480376|NCT00430885|Immunoglobulins|immunoglobulins|mesh-list
24480377|NCT00430885|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
24480378|NCT00430885|gamma-Globulins|gamma-globulins|mesh-list
24480379|NCT00430885|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
24480380|NCT00430885|Immunologic Factors|immunologic factors|mesh-ancestor
24480381|NCT00430885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480382|NCT00430898|Basiliximab|basiliximab|mesh-list
24480383|NCT00430898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24480384|NCT00430898|Immunologic Factors|immunologic factors|mesh-ancestor
24480385|NCT00430898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480386|NCT00430924|Eplerenone|eplerenone|mesh-list
24480387|NCT00430924|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24480406|NCT00431028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24480407|NCT00431028|Glucocorticoids|glucocorticoids|mesh-ancestor
24480408|NCT00431028|Hormones|hormones|mesh-ancestor
24480409|NCT00431028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24480419|NCT00431028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24480420|NCT00431054|Docetaxel|docetaxel|mesh-list
24480421|NCT00431054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480422|NCT00431054|Tubulin Modulators|tubulin modulators|mesh-ancestor
24480423|NCT00431054|Antimitotic Agents|antimitotic agents|mesh-ancestor
24480424|NCT00431054|Mitosis Modulators|mitosis modulators|mesh-ancestor
24480425|NCT00431054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480626|NCT00431418|Vasodilator Agents|vasodilator agents|mesh-ancestor
24480627|NCT00431418|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24480628|NCT00431418|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25716819|NCT02400580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25716820|NCT02400580|Analgesics|analgesics|mesh-ancestor
25716821|NCT02400580|Sensory System Agents|sensory system agents|mesh-ancestor
25716822|NCT02400580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25716823|NCT02400580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716824|NCT02400580|Antipyretics|antipyretics|mesh-ancestor
25716825|NCT02400749|Apremilast|apremilast|mesh-list
24480783|NCT00432120|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24480796|NCT00432198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24480797|NCT00432198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24480798|NCT00432198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480799|NCT00432198|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
24480800|NCT00432198|GABA Agonists|gaba agonists|mesh-ancestor
24480801|NCT00432198|GABA Agents|gaba agents|mesh-ancestor
24480802|NCT00432198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24480803|NCT00432198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480805|NCT00432302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480806|NCT00432315|Docetaxel|docetaxel|mesh-list
24480807|NCT00432315|Cisplatin|cisplatin|mesh-list
24480808|NCT00432315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24480809|NCT00432315|Tubulin Modulators|tubulin modulators|mesh-ancestor
24480810|NCT00432315|Antimitotic Agents|antimitotic agents|mesh-ancestor
24480811|NCT00432315|Mitosis Modulators|mitosis modulators|mesh-ancestor
24480819|NCT00432354|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24480820|NCT00432354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24480861|NCT00432406|Analgesics|analgesics|mesh-ancestor
24480862|NCT00432406|Sensory System Agents|sensory system agents|mesh-ancestor
24480863|NCT00432406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24480864|NCT00432406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480868|NCT00432432|Infliximab|infliximab|mesh-list
24480938|NCT00432757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480941|NCT00432796|Dalteparin|dalteparin|mesh-list
24480942|NCT00432796|Tinzaparin|tinzaparin|mesh-list
24480943|NCT00432796|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24480944|NCT00432796|Anticoagulants|anticoagulants|mesh-ancestor
24480945|NCT00432796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24480946|NCT00432796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24480947|NCT00432796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480949|NCT00432861|Pancreatin|pancreatin|mesh-list
24480971|NCT00433043|Autonomic Agents|autonomic agents|mesh-ancestor
24480972|NCT00433043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24480973|NCT00433043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480974|NCT00433043|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24480975|NCT00433043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24480976|NCT00433043|Adrenergic Agents|adrenergic agents|mesh-ancestor
24480977|NCT00433043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24480978|NCT00433043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24480979|NCT00433043|Antioxidants|antioxidants|mesh-ancestor
24480980|NCT00433043|Protective Agents|protective agents|mesh-ancestor
24480981|NCT00433043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24480982|NCT00433043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24480983|NCT00433043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24480984|NCT00433043|Vasodilator Agents|vasodilator agents|mesh-ancestor
24480985|NCT00433043|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24480986|NCT00433043|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25716826|NCT02400749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25716827|NCT02400749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25716828|NCT02400749|Analgesics|analgesics|mesh-ancestor
25716829|NCT02400749|Sensory System Agents|sensory system agents|mesh-ancestor
25716830|NCT02400749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25716831|NCT02400749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24480994|NCT00433069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24480998|NCT00433069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481078|NCT00433225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24481079|NCT00433225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24481080|NCT00433225|Analgesics|analgesics|mesh-ancestor
24481081|NCT00433225|Sensory System Agents|sensory system agents|mesh-ancestor
24481082|NCT00433225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24481083|NCT00433225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24481084|NCT00433225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481114|NCT00433342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24481115|NCT00433342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24481116|NCT00433368|N-Methylaspartate|n-methylaspartate|mesh-list
24481117|NCT00433368|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
24481118|NCT00433368|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24481119|NCT00433368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24481121|NCT00433368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481122|NCT00433407|Trastuzumab|trastuzumab|mesh-list
24481123|NCT00433407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24481124|NCT00433407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481222|NCT00433732|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24481223|NCT00433732|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24481224|NCT00433732|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24481225|NCT00433732|Serotonin Agents|serotonin agents|mesh-ancestor
24481226|NCT00433732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24481227|NCT00433784|Clopidogrel|clopidogrel|mesh-list
24481228|NCT00433784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24481281|NCT00433953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24481282|NCT00433953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24481283|NCT00433953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481284|NCT00433953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481285|NCT00433979|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25716832|NCT02400749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25716833|NCT02400749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25716834|NCT02400749|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25716835|NCT02400749|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25716836|NCT02400749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25716837|NCT02400749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481286|NCT00433979|Antiviral Agents|antiviral agents|mesh-ancestor
24481287|NCT00433979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24481288|NCT00434005|Acetylcysteine|acetylcysteine|mesh-list
24481289|NCT00434005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24481290|NCT00434005|Antiviral Agents|antiviral agents|mesh-ancestor
24481291|NCT00434005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24481338|NCT00434083|Analgesics|analgesics|mesh-ancestor
24481339|NCT00434083|Sensory System Agents|sensory system agents|mesh-ancestor
24481340|NCT00434083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24481341|NCT00434083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481342|NCT00434083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24481344|NCT00434083|Gout Suppressants|gout suppressants|mesh-ancestor
24481345|NCT00434083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24481365|NCT00434135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24481366|NCT00434135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481422|NCT00434382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24481423|NCT00434382|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24481425|NCT00434447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24481426|NCT00434447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481427|NCT00434629|Tositumomab I-131|tositumomab i-131|mesh-list
24481428|NCT00434629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24481487|NCT00435058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481503|NCT00435279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24481504|NCT00435279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481506|NCT00435279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481507|NCT00435279|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24481508|NCT00435279|Antidepressive Agents|antidepressive agents|mesh-ancestor
24481509|NCT00435279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24481510|NCT00435279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24481511|NCT00435279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24481513|NCT00435292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24481671|NCT00436293|Mitosis Modulators|mitosis modulators|mesh-ancestor
24481672|NCT00436293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481673|NCT00436306|Contraceptive Agents|contraceptive agents|mesh-list
24481674|NCT00436306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24481675|NCT00436306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481771|NCT00436761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24481772|NCT00436761|Glucocorticoids|glucocorticoids|mesh-ancestor
25716838|NCT02401048|Durvalumab|durvalumab|mesh-list
25716839|NCT02401048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25716840|NCT02401048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716841|NCT02401230|Tenofovir|tenofovir|mesh-list
25716842|NCT02401230|Emtricitabine|emtricitabine|mesh-list
24481773|NCT00436761|Hormones|hormones|mesh-ancestor
24481774|NCT00436761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24481775|NCT00436761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24481779|NCT00436761|Alkylating Agents|alkylating agents|mesh-ancestor
24481780|NCT00436761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24481781|NCT00436787|PENTA|penta|mesh-list
24481882|NCT00437177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24481883|NCT00437177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24481901|NCT00437229|Glucocorticoids|glucocorticoids|mesh-ancestor
24481902|NCT00437229|Hormones|hormones|mesh-ancestor
24481903|NCT00437229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24481935|NCT00437307|Topotecan|topotecan|mesh-list
24481936|NCT00437307|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24481937|NCT00437307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24481938|NCT00437307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481978|NCT00437385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24481979|NCT00437385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24481980|NCT00437385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24481981|NCT00437450|Epoetin Alfa|epoetin alfa|mesh-list
24481982|NCT00437450|Hematinics|hematinics|mesh-ancestor
24481983|NCT00437463|Ramipril|ramipril|mesh-list
24481984|NCT00437463|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24481985|NCT00437463|Protease Inhibitors|protease inhibitors|mesh-ancestor
24481986|NCT00437463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24481987|NCT00437463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482086|NCT00437892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482087|NCT00437892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24482088|NCT00437892|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24482089|NCT00437892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24482091|NCT00437918|Nateglinide|nateglinide|mesh-list
24482092|NCT00437918|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
24482093|NCT00437918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24482094|NCT00437918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482095|NCT00437918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24482096|NCT00437918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482097|NCT00437957|Temozolomide|temozolomide|mesh-list
24482098|NCT00437957|Valproic Acid|valproic acid|mesh-list
24482099|NCT00437957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24482100|NCT00437957|Alkylating Agents|alkylating agents|mesh-ancestor
24482101|NCT00437957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482102|NCT00437957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24482103|NCT00437957|Anticonvulsants|anticonvulsants|mesh-ancestor
24482104|NCT00437957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24482147|NCT00438048|Cholinergic Agents|cholinergic agents|mesh-ancestor
24482234|NCT00438217|Luteolytic Agents|luteolytic agents|mesh-ancestor
24482269|NCT00438321|Goserelin|goserelin|mesh-list
24482276|NCT00438321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24482303|NCT00438477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482306|NCT00438568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24482307|NCT00438568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482308|NCT00438581|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24482309|NCT00438581|Immunologic Factors|immunologic factors|mesh-ancestor
24482310|NCT00438581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482311|NCT00438607|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
24482312|NCT00438607|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
24482313|NCT00438607|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24482344|NCT00438776|Olanzapine|olanzapine|mesh-list
24482410|NCT00438906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482412|NCT00438945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24482413|NCT00438945|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
24482414|NCT00438945|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24482415|NCT00438945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482417|NCT00438958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24482418|NCT00438958|Immunologic Factors|immunologic factors|mesh-ancestor
24482419|NCT00438958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482420|NCT00438984|Aldesleukin|aldesleukin|mesh-list
24482421|NCT00438984|Cyclophosphamide|cyclophosphamide|mesh-list
24482422|NCT00438984|Interleukin-2|interleukin-2|mesh-list
24482423|NCT00438984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24482424|NCT00438984|Immunologic Factors|immunologic factors|mesh-ancestor
24482425|NCT00438984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482426|NCT00438984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24482441|NCT00439049|Modafinil|modafinil|mesh-list
24482442|NCT00439049|Amphetamine|amphetamine|mesh-list
24482443|NCT00439049|Dextroamphetamine|dextroamphetamine|mesh-list
24482444|NCT00439049|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24482445|NCT00439049|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24482564|NCT00439699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482565|NCT00439699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482566|NCT00439699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24482567|NCT00439699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24482568|NCT00439712|Levocetirizine|levocetirizine|mesh-list
24482569|NCT00439712|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24482570|NCT00439712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24482571|NCT00439712|Histamine Antagonists|histamine antagonists|mesh-ancestor
24482572|NCT00439712|Histamine Agents|histamine agents|mesh-ancestor
24482573|NCT00439712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24482574|NCT00439712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482575|NCT00439712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482576|NCT00439751|Goserelin|goserelin|mesh-list
24482600|NCT00439972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24482601|NCT00439972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24482602|NCT00439972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24482603|NCT00439972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24482604|NCT00439972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24482605|NCT00439972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482606|NCT00439972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24482607|NCT00439972|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24482610|NCT00440024|Tazarotene|tazarotene|mesh-list
24482624|NCT00440102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24482625|NCT00440102|Anesthetics, General|anesthetics, general|mesh-ancestor
24482626|NCT00440102|Anesthetics|anesthetics|mesh-ancestor
24482646|NCT00440128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24482647|NCT00440141|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24482648|NCT00440141|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24482649|NCT00440141|Latanoprost|latanoprost|mesh-list
24482650|NCT00440141|Brinzolamide|brinzolamide|mesh-list
24482651|NCT00440141|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24482652|NCT00440141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24482653|NCT00440141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24482654|NCT00440141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24482737|NCT00440349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24482738|NCT00440349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24482739|NCT00440349|Hormone Antagonists|hormone antagonists|mesh-ancestor
24482756|NCT00440427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24482757|NCT00440427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24482758|NCT00440427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482759|NCT00440427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24482760|NCT00440427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482761|NCT00440427|Antidepressive Agents|antidepressive agents|mesh-ancestor
24482762|NCT00440427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24482763|NCT00440440|Testosterone|testosterone|mesh-list
24482764|NCT00440440|Androgens|androgens|mesh-ancestor
24482765|NCT00440440|Hormones|hormones|mesh-ancestor
24482766|NCT00440440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24482767|NCT00440440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482768|NCT00440479|Bortezomib|bortezomib|mesh-list
24482769|NCT00440479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24482770|NCT00440609|Ranibizumab|ranibizumab|mesh-list
24482771|NCT00440609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24482772|NCT00440609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24482777|NCT00440622|Gemcitabine|gemcitabine|mesh-list
24482810|NCT00440687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24482811|NCT00440687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482812|NCT00440687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24482881|NCT00440843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482883|NCT00440843|Serotonin Agents|serotonin agents|mesh-ancestor
24482884|NCT00440869|Acetylcysteine|acetylcysteine|mesh-list
25771242|NCT03595449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25771243|NCT03595449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25771244|NCT03595449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771245|NCT03595579|Bupropion|bupropion|mesh-list
25771246|NCT03595579|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25771247|NCT03595579|Antidepressive Agents|antidepressive agents|mesh-ancestor
25771248|NCT03595579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24482886|NCT00440869|Antiviral Agents|antiviral agents|mesh-ancestor
24482887|NCT00440869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24482888|NCT00440869|Expectorants|expectorants|mesh-ancestor
24482889|NCT00440869|Respiratory System Agents|respiratory system agents|mesh-ancestor
24482890|NCT00440869|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24482891|NCT00440869|Antioxidants|antioxidants|mesh-ancestor
24482892|NCT00440869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24482896|NCT00440895|Abciximab|abciximab|mesh-list
24482922|NCT00440960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24482923|NCT00440960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24482933|NCT00440973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24482934|NCT00440973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24482935|NCT00440973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24482936|NCT00440973|Growth Substances|growth substances|mesh-ancestor
24482937|NCT00440973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24482938|NCT00440973|Growth Inhibitors|growth inhibitors|mesh-ancestor
24482939|NCT00440973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24482940|NCT00440973|Analgesics|analgesics|mesh-ancestor
24482941|NCT00440973|Sensory System Agents|sensory system agents|mesh-ancestor
24482942|NCT00440973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24483003|NCT00441298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24483005|NCT00441415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24483006|NCT00441415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24483007|NCT00441415|Analgesics|analgesics|mesh-ancestor
24483008|NCT00441415|Sensory System Agents|sensory system agents|mesh-ancestor
24483009|NCT00441415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24483010|NCT00441415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483011|NCT00441415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24483012|NCT00441415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24483013|NCT00441415|Dermatologic Agents|dermatologic agents|mesh-ancestor
24483027|NCT00441519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24483028|NCT00441519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24483029|NCT00441519|Analgesics|analgesics|mesh-ancestor
24483030|NCT00441519|Sensory System Agents|sensory system agents|mesh-ancestor
24483031|NCT00441519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24483032|NCT00441519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716843|NCT02401230|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25716844|NCT02401230|Antiviral Agents|antiviral agents|mesh-ancestor
25716845|NCT02401230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25716846|NCT02401230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25716847|NCT02401230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25716848|NCT02401230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25716849|NCT02401230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716850|NCT02401230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25716851|NCT02401230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24483033|NCT00441519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24483034|NCT00441519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24483035|NCT00441519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24483036|NCT00441519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24483037|NCT00441519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483038|NCT00441519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24483039|NCT00441519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24483040|NCT00441519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483041|NCT00441519|Antipyretics|antipyretics|mesh-ancestor
24483042|NCT00441519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24483043|NCT00441519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24483044|NCT00441519|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24483053|NCT00441532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24483054|NCT00441532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24483055|NCT00441532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24483056|NCT00441532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483058|NCT00441597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24483061|NCT00441597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483062|NCT00441597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24483063|NCT00441597|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24483064|NCT00441597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483065|NCT00441649|Methylphenidate|methylphenidate|mesh-list
24433616|NCT00259220|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
24483066|NCT00441649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24483067|NCT00441649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483068|NCT00441649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24483069|NCT00441649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24483070|NCT00441649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24483071|NCT00441649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483072|NCT00441649|Dopamine Agents|dopamine agents|mesh-ancestor
24483073|NCT00441649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24483197|NCT00442234|Monteplase|monteplase|mesh-list
24483198|NCT00442234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24483199|NCT00442234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24483241|NCT00442481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24483242|NCT00442481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24483243|NCT00442481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483244|NCT00442481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24483245|NCT00442481|Serotonin Agents|serotonin agents|mesh-ancestor
24483246|NCT00442481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483247|NCT00442481|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24483248|NCT00442481|Antidepressive Agents|antidepressive agents|mesh-ancestor
24483249|NCT00442481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24483250|NCT00442494|Hydrocortisone|hydrocortisone|mesh-list
24483262|NCT00442546|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24483263|NCT00442546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24483295|NCT00442676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24483296|NCT00442676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483297|NCT00442676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24483298|NCT00442676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24483299|NCT00442676|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24483300|NCT00442676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24483301|NCT00442676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483302|NCT00442676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483303|NCT00442741|Epothilone B|epothilone b|mesh-list
24483304|NCT00442741|Epothilones|epothilones|mesh-list
24483305|NCT00442741|Omeprazole|omeprazole|mesh-list
24483306|NCT00442741|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24483307|NCT00442741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24483342|NCT00443105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24483343|NCT00443105|Immunologic Factors|immunologic factors|mesh-ancestor
24483344|NCT00443105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483345|NCT00443105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24483346|NCT00443105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24483347|NCT00443105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483348|NCT00443144|Hormones|hormones|mesh-list
24483349|NCT00443144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24483350|NCT00443144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483351|NCT00443170|Rosiglitazone|rosiglitazone|mesh-list
24483987|NCT00446043|Analgesics|analgesics|mesh-ancestor
24483411|NCT00443235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24483412|NCT00443235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24483413|NCT00443235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24483476|NCT00443716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483553|NCT00443963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24483554|NCT00443963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483556|NCT00444015|Dasatinib|dasatinib|mesh-list
24483570|NCT00444093|Loperamide|loperamide|mesh-list
24483571|NCT00444093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24483572|NCT00444132|Clopidogrel|clopidogrel|mesh-list
24483573|NCT00444132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24483574|NCT00444132|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24483575|NCT00444132|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24483576|NCT00444132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24483666|NCT00444470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24483667|NCT00444470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483669|NCT00444470|Coagulants|coagulants|mesh-ancestor
24483670|NCT00444522|Alprazolam|alprazolam|mesh-list
24483671|NCT00444522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24483672|NCT00444522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25716852|NCT02401256|Efavirenz|efavirenz|mesh-list
25716853|NCT02401256|Bupropion|bupropion|mesh-list
25716854|NCT02401256|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25716855|NCT02401256|Montelukast|montelukast|mesh-list
25716856|NCT02401256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25716857|NCT02401256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25716858|NCT02401256|Antimetabolites|antimetabolites|mesh-ancestor
25716859|NCT02401256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483673|NCT00444522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483674|NCT00444522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24483675|NCT00444522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24483676|NCT00444522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24483677|NCT00444522|GABA Modulators|gaba modulators|mesh-ancestor
24483678|NCT00444522|GABA Agents|gaba agents|mesh-ancestor
24483679|NCT00444522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24483713|NCT00444639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483714|NCT00444639|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24483715|NCT00444639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24483716|NCT00444639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24483718|NCT00444652|Anticoagulants|anticoagulants|mesh-ancestor
24483719|NCT00444652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24483721|NCT00444652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24483758|NCT00444834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483760|NCT00444834|Antioxidants|antioxidants|mesh-ancestor
24483761|NCT00444834|Protective Agents|protective agents|mesh-ancestor
24483762|NCT00444834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24483763|NCT00444834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24483774|NCT00444886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24483790|NCT00445055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24483791|NCT00445055|Antiemetics|antiemetics|mesh-ancestor
24483792|NCT00445055|Autonomic Agents|autonomic agents|mesh-ancestor
24483793|NCT00445055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24483988|NCT00446043|Sensory System Agents|sensory system agents|mesh-ancestor
24483989|NCT00446043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24483990|NCT00446043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24483992|NCT00446043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24484093|NCT00446524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484094|NCT00446524|Vasodilator Agents|vasodilator agents|mesh-ancestor
24484095|NCT00446524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24484096|NCT00446524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24484097|NCT00446537|Methylphenidate|methylphenidate|mesh-list
24484140|NCT00446784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484141|NCT00446784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24484142|NCT00446784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24484143|NCT00446784|Immunologic Factors|immunologic factors|mesh-ancestor
24484144|NCT00446784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24484145|NCT00446784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24484146|NCT00446810|Benphothiamine|benphothiamine|mesh-list
24484147|NCT00446810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24484148|NCT00446810|Immunologic Factors|immunologic factors|mesh-ancestor
24484149|NCT00446810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484150|NCT00446810|Chelating Agents|chelating agents|mesh-ancestor
24484151|NCT00446810|Sequestering Agents|sequestering agents|mesh-ancestor
24484152|NCT00446810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484165|NCT00446862|Enzyme Inhibitors|enzyme inhibitors|mesh-list
24484166|NCT00446862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24484167|NCT00446862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24484168|NCT00446862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24484169|NCT00446862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484170|NCT00446862|Protease Inhibitors|protease inhibitors|mesh-ancestor
24484172|NCT00446901|Antioxidants|antioxidants|mesh-ancestor
24484173|NCT00446901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484174|NCT00446901|Protective Agents|protective agents|mesh-ancestor
24484178|NCT00446940|Atorvastatin|atorvastatin|mesh-list
24484179|NCT00446940|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24484180|NCT00446940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24484181|NCT00446940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24484182|NCT00446940|Antimetabolites|antimetabolites|mesh-ancestor
24484183|NCT00446940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484184|NCT00446940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24484185|NCT00446940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24484186|NCT00446940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484189|NCT00446953|Glucocorticoids|glucocorticoids|mesh-ancestor
24484210|NCT00447031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484211|NCT00447031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24484212|NCT00447031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24484213|NCT00447031|Growth Substances|growth substances|mesh-ancestor
24484214|NCT00447031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484215|NCT00447031|Growth Inhibitors|growth inhibitors|mesh-ancestor
24484216|NCT00447031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24484217|NCT00447031|Glucocorticoids|glucocorticoids|mesh-ancestor
24484219|NCT00447031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24484220|NCT00447031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24484223|NCT00447031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484224|NCT00447070|Atazanavir Sulfate|atazanavir sulfate|mesh-list
24484225|NCT00447070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24484226|NCT00447070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24484236|NCT00447213|Insulin Glargine|insulin glargine|mesh-list
24484247|NCT00447304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484248|NCT00447304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484249|NCT00447304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484251|NCT00447356|Interferon-alpha|interferon-alpha|mesh-list
24484252|NCT00447356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484253|NCT00447356|Antiviral Agents|antiviral agents|mesh-ancestor
24484254|NCT00447356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24484255|NCT00447356|Immunologic Factors|immunologic factors|mesh-ancestor
24484256|NCT00447356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484272|NCT00447369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484273|NCT00447369|GABA Agents|gaba agents|mesh-ancestor
24484274|NCT00447369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24484275|NCT00447369|Antimanic Agents|antimanic agents|mesh-ancestor
24484276|NCT00447473|Ketoconazole|ketoconazole|mesh-list
24484277|NCT00447473|Mitoxantrone|mitoxantrone|mesh-list
24484278|NCT00447473|Analgesics|analgesics|mesh-ancestor
24484279|NCT00447473|Sensory System Agents|sensory system agents|mesh-ancestor
24484293|NCT00447473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24484294|NCT00447473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24484405|NCT00448149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484407|NCT00448214|Anticoagulants|anticoagulants|mesh-ancestor
24484408|NCT00448240|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24484409|NCT00448240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484410|NCT00448240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24484411|NCT00448240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484412|NCT00448240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484413|NCT00448253|Immunoglobulins|immunoglobulins|mesh-list
24484414|NCT00448253|Immunologic Factors|immunologic factors|mesh-ancestor
24484415|NCT00448253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484559|NCT00449202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24484560|NCT00449202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484562|NCT00449254|Oleoyl-estrone|oleoyl-estrone|mesh-list
24484563|NCT00449254|Estrone|estrone|mesh-list
24484564|NCT00449254|Estrogens|estrogens|mesh-ancestor
24484565|NCT00449254|Hormones|hormones|mesh-ancestor
24484566|NCT00449254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24484567|NCT00449254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484568|NCT00449254|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24484569|NCT00449280|Sirolimus|sirolimus|mesh-list
24484570|NCT00449280|Sorafenib|sorafenib|mesh-list
24484646|NCT00449501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24484647|NCT00449501|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24484648|NCT00449501|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24484649|NCT00449501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24484650|NCT00449501|Adrenergic Agents|adrenergic agents|mesh-ancestor
24484652|NCT00449501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484653|NCT00449514|Tamoxifen|tamoxifen|mesh-list
24484654|NCT00449514|Clomiphene|clomiphene|mesh-list
24484655|NCT00449514|Enclomiphene|enclomiphene|mesh-list
24484656|NCT00449514|Zuclomiphene|zuclomiphene|mesh-list
24484657|NCT00449514|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24484658|NCT00449514|Hormone Antagonists|hormone antagonists|mesh-ancestor
24484659|NCT00449514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24484660|NCT00449514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24466913|NCT00375583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24466914|NCT00375596|Ketotifen|ketotifen|mesh-list
24484661|NCT00449514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24484662|NCT00449514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484663|NCT00449514|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24484669|NCT00449527|Budesonide|budesonide|mesh-list
24484680|NCT00449527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24484681|NCT00449527|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24484682|NCT00449527|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24484683|NCT00449527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24484684|NCT00449527|Adrenergic Agents|adrenergic agents|mesh-ancestor
24484685|NCT00449527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24484686|NCT00449527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484687|NCT00449553|Metformin|metformin|mesh-list
24484688|NCT00449553|Pioglitazone|pioglitazone|mesh-list
24484689|NCT00449553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24484723|NCT00449657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484724|NCT00449683|Terazosin|terazosin|mesh-list
25716860|NCT02401256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25716861|NCT02401256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24484725|NCT00449683|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24484726|NCT00449683|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24484727|NCT00449683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24484728|NCT00449683|Adrenergic Agents|adrenergic agents|mesh-ancestor
24484729|NCT00449683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24484730|NCT00449683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484732|NCT00449683|Urological Agents|urological agents|mesh-ancestor
24484733|NCT00449722|Mesalamine|mesalamine|mesh-list
24484734|NCT00449722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24484735|NCT00449722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24484736|NCT00449722|Analgesics|analgesics|mesh-ancestor
24484737|NCT00449722|Sensory System Agents|sensory system agents|mesh-ancestor
24484738|NCT00449722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24484739|NCT00449722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484740|NCT00449722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24484756|NCT00449800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24484758|NCT00449813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24484759|NCT00449813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24484760|NCT00449813|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24484761|NCT00449813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24484762|NCT00449813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24484764|NCT00449839|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24484765|NCT00449839|Insulin Aspart|insulin aspart|mesh-list
24484766|NCT00449839|Insulin, Long-Acting|insulin, long-acting|mesh-list
24484767|NCT00449839|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
24484977|NCT00450957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24484978|NCT00450957|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24484979|NCT00450957|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24484980|NCT00450957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24484981|NCT00451061|Tamsulosin|tamsulosin|mesh-list
24484982|NCT00451061|Alfuzosin|alfuzosin|mesh-list
24484983|NCT00451061|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24485143|NCT00451763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24485144|NCT00451763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485145|NCT00451763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24485146|NCT00451763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24485147|NCT00451763|Growth Substances|growth substances|mesh-ancestor
24485148|NCT00451763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485149|NCT00451763|Growth Inhibitors|growth inhibitors|mesh-ancestor
24466986|NCT00375843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24485150|NCT00451776|Propofol|propofol|mesh-list
24485151|NCT00451776|Etomidate|etomidate|mesh-list
24485152|NCT00451776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24485153|NCT00451776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24485197|NCT00451971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485198|NCT00451984|Interleukin-2|interleukin-2|mesh-list
24485199|NCT00451984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485200|NCT00451984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24485201|NCT00451984|Analgesics|analgesics|mesh-ancestor
24485202|NCT00451984|Sensory System Agents|sensory system agents|mesh-ancestor
24485203|NCT00451984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24485204|NCT00451984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485205|NCT00451997|Cytarabine|cytarabine|mesh-list
24485206|NCT00451997|Imatinib Mesylate|imatinib mesylate|mesh-list
24485207|NCT00451997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24485208|NCT00451997|Antimetabolites|antimetabolites|mesh-ancestor
24485209|NCT00451997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485210|NCT00451997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485211|NCT00451997|Antiviral Agents|antiviral agents|mesh-ancestor
24485367|NCT00452725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485369|NCT00452829|Vitamin B Complex|vitamin b complex|mesh-list
24485370|NCT00452829|Inositol|inositol|mesh-list
24485371|NCT00452829|Hematinics|hematinics|mesh-ancestor
25716862|NCT02401256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25716863|NCT02401256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24485372|NCT00452829|Vitamins|vitamins|mesh-ancestor
24485373|NCT00452829|Micronutrients|micronutrients|mesh-ancestor
24485374|NCT00452829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485375|NCT00452855|Remifentanil|remifentanil|mesh-list
24485376|NCT00452855|Sevoflurane|sevoflurane|mesh-list
24485377|NCT00452855|Anesthetics|anesthetics|mesh-ancestor
24485383|NCT00452855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24485384|NCT00452855|Narcotics|narcotics|mesh-ancestor
24485385|NCT00452855|Analgesics|analgesics|mesh-ancestor
24485389|NCT00452881|Oxaliplatin|oxaliplatin|mesh-list
24485390|NCT00452881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485391|NCT00452881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24485462|NCT00453115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24485463|NCT00453115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24485465|NCT00453115|Immunologic Factors|immunologic factors|mesh-ancestor
24485492|NCT00453232|Bleomycin|bleomycin|mesh-list
24485558|NCT00453648|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24485559|NCT00453648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485560|NCT00453648|Vitamins|vitamins|mesh-ancestor
24485561|NCT00453648|Micronutrients|micronutrients|mesh-ancestor
24485562|NCT00453765|Montelukast|montelukast|mesh-list
24485563|NCT00453765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24485608|NCT00453908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485609|NCT00453908|Urological Agents|urological agents|mesh-ancestor
24485610|NCT00453960|Norethindrone|norethindrone|mesh-list
24485611|NCT00453960|Norethindrone Acetate|norethindrone acetate|mesh-list
24485613|NCT00453960|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24485627|NCT00454259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24485628|NCT00454259|Narcotics|narcotics|mesh-ancestor
24485631|NCT00454259|Analgesics|analgesics|mesh-ancestor
24485644|NCT00454350|Micronutrients|micronutrients|mesh-ancestor
24485645|NCT00454350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485646|NCT00454350|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24485647|NCT00454389|Ranibizumab|ranibizumab|mesh-list
24485648|NCT00454389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24485649|NCT00454389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24485650|NCT00454389|Growth Substances|growth substances|mesh-ancestor
24485651|NCT00454389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485652|NCT00454389|Growth Inhibitors|growth inhibitors|mesh-ancestor
24485653|NCT00454389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485655|NCT00454402|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24485656|NCT00454402|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24485657|NCT00454402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24485662|NCT00454402|Urological Agents|urological agents|mesh-ancestor
24485663|NCT00454480|Cytarabine|cytarabine|mesh-list
24485664|NCT00454480|Fludarabine|fludarabine|mesh-list
24485665|NCT00454480|Fludarabine phosphate|fludarabine phosphate|mesh-list
24485666|NCT00454480|Azacitidine|azacitidine|mesh-list
24485667|NCT00454480|Melphalan|melphalan|mesh-list
24485668|NCT00454480|Busulfan|busulfan|mesh-list
24485669|NCT00454480|Daunorubicin|daunorubicin|mesh-list
24485670|NCT00454480|Alemtuzumab|alemtuzumab|mesh-list
24485671|NCT00454480|Clofarabine|clofarabine|mesh-list
24485719|NCT00454662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485720|NCT00454662|Vasodilator Agents|vasodilator agents|mesh-ancestor
24485721|NCT00454662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24485722|NCT00454662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24485723|NCT00454701|Alefacept|alefacept|mesh-list
24485724|NCT00454701|Dermatologic Agents|dermatologic agents|mesh-ancestor
24485725|NCT00454701|Immunologic Factors|immunologic factors|mesh-ancestor
24485726|NCT00454701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485727|NCT00454714|Sildenafil Citrate|sildenafil citrate|mesh-list
24485728|NCT00454714|Vasodilator Agents|vasodilator agents|mesh-ancestor
24485729|NCT00454714|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24485730|NCT00454714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24485756|NCT00454883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485758|NCT00454883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24485759|NCT00454883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24485831|NCT00455234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24485832|NCT00455234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24485833|NCT00455234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24485834|NCT00455234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24485835|NCT00455234|Dopamine Agents|dopamine agents|mesh-ancestor
24485836|NCT00455234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24485837|NCT00455234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485838|NCT00455234|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24485839|NCT00455234|Antipruritics|antipruritics|mesh-ancestor
24485840|NCT00455234|Dermatologic Agents|dermatologic agents|mesh-ancestor
24485841|NCT00455234|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24485842|NCT00455234|Histamine Antagonists|histamine antagonists|mesh-ancestor
24485843|NCT00455234|Histamine Agents|histamine agents|mesh-ancestor
24485844|NCT00455234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24485845|NCT00455234|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24485846|NCT00455234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24485847|NCT00455234|Anesthetics, Local|anesthetics, local|mesh-ancestor
24485848|NCT00455234|Anesthetics|anesthetics|mesh-ancestor
24485849|NCT00455234|Sensory System Agents|sensory system agents|mesh-ancestor
24485850|NCT00455286|Methylprednisolone|methylprednisolone|mesh-list
24485851|NCT00455286|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24485852|NCT00455286|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24485853|NCT00455286|Prednisolone|prednisolone|mesh-list
24485854|NCT00455286|Prednisolone acetate|prednisolone acetate|mesh-list
24485855|NCT00455286|Methotrexate|methotrexate|mesh-list
24485856|NCT00455286|Temozolomide|temozolomide|mesh-list
24485857|NCT00455286|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24485869|NCT00455286|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24485870|NCT00455286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24485871|NCT00455286|Immunologic Factors|immunologic factors|mesh-ancestor
24485872|NCT00455286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24485873|NCT00455286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24485874|NCT00455286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24485875|NCT00455286|Alkylating Agents|alkylating agents|mesh-ancestor
24485876|NCT00455286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24485877|NCT00455286|Antiemetics|antiemetics|mesh-ancestor
24485878|NCT00455286|Autonomic Agents|autonomic agents|mesh-ancestor
24485879|NCT00455286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24485880|NCT00455286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24485881|NCT00455286|Glucocorticoids|glucocorticoids|mesh-ancestor
24485883|NCT00455286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24485884|NCT00455286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24485885|NCT00455286|Protective Agents|protective agents|mesh-ancestor
24485887|NCT00455351|Vorinostat|vorinostat|mesh-list
24485888|NCT00455351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485892|NCT00455364|Voriconazole|voriconazole|mesh-list
24485898|NCT00455364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485899|NCT00455364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24485900|NCT00455364|Hormone Antagonists|hormone antagonists|mesh-ancestor
24485901|NCT00455364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24485904|NCT00455390|Psychotropic Drugs|psychotropic drugs|mesh-list
24485927|NCT00455442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716864|NCT02401256|Antidepressive Agents|antidepressive agents|mesh-ancestor
25716865|NCT02401256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25716866|NCT02401256|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25716867|NCT02401256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25716868|NCT02401256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25716869|NCT02401256|Dopamine Agents|dopamine agents|mesh-ancestor
25716870|NCT02401256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25716871|NCT02401256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485929|NCT00455442|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24485930|NCT00455442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24485940|NCT00455507|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
24485941|NCT00455507|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24485943|NCT00455507|Purinergic Agents|purinergic agents|mesh-ancestor
24485944|NCT00455507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24485945|NCT00455507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485946|NCT00455507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485947|NCT00455572|Vinorelbine|vinorelbine|mesh-list
24485948|NCT00455572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24485950|NCT00455572|Tubulin Modulators|tubulin modulators|mesh-ancestor
24485962|NCT00455585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24485963|NCT00455585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24485964|NCT00455585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24485965|NCT00455585|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24485966|NCT00455585|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24485969|NCT00455624|Hormones|hormones|mesh-ancestor
24485970|NCT00455624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24485971|NCT00455624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485972|NCT00455637|Botulinum Toxins|botulinum toxins|mesh-list
24485973|NCT00455637|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24485974|NCT00455637|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24485975|NCT00455637|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24485976|NCT00455637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24485977|NCT00455637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24485978|NCT00455637|Cholinergic Agents|cholinergic agents|mesh-ancestor
24485979|NCT00455637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24485980|NCT00455637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24485981|NCT00455637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24485982|NCT00455637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24485983|NCT00455715|Sildenafil Citrate|sildenafil citrate|mesh-list
24485984|NCT00455715|Vasodilator Agents|vasodilator agents|mesh-ancestor
24485985|NCT00455715|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24485986|NCT00455715|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24485987|NCT00455715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486007|NCT00455806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24486026|NCT00455871|Growth Substances|growth substances|mesh-ancestor
24486029|NCT00455871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486030|NCT00455871|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24486087|NCT00456248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486088|NCT00456248|Antiviral Agents|antiviral agents|mesh-ancestor
24486089|NCT00456248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24486091|NCT00456313|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24486092|NCT00456313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24486093|NCT00456313|Autonomic Agents|autonomic agents|mesh-ancestor
24486094|NCT00456313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24486139|NCT00456560|Fluvoxamine|fluvoxamine|mesh-list
24486140|NCT00456560|Paroxetine|paroxetine|mesh-list
24486141|NCT00456560|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24486142|NCT00456560|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24486143|NCT00456560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24486144|NCT00456560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486188|NCT00456820|Bupropion|bupropion|mesh-list
24486275|NCT00456976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486276|NCT00456976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486277|NCT00456976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24486308|NCT00457106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24486309|NCT00457106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24486310|NCT00457106|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24486311|NCT00457106|Dopamine Agents|dopamine agents|mesh-ancestor
24486312|NCT00457106|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24486313|NCT00457106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24486334|NCT00457223|Coagulants|coagulants|mesh-ancestor
24486335|NCT00457340|Atorvastatin|atorvastatin|mesh-list
24486336|NCT00457340|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24486337|NCT00457340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24486338|NCT00457340|Antimetabolites|antimetabolites|mesh-ancestor
24486339|NCT00457340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486340|NCT00457340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24486341|NCT00457340|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24486342|NCT00457340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486344|NCT00457405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24486345|NCT00457405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486346|NCT00457405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486349|NCT00457470|Rucaparib|rucaparib|mesh-list
24486367|NCT00457509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486369|NCT00457652|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24486370|NCT00457652|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24486371|NCT00457652|Antimetabolites|antimetabolites|mesh-ancestor
24486372|NCT00457652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486373|NCT00457652|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24486374|NCT00457652|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24486375|NCT00457652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486376|NCT00457678|Dexamethasone|dexamethasone|mesh-list
24486377|NCT00457678|Ranibizumab|ranibizumab|mesh-list
24486489|NCT00458250|Cyclosporins|cyclosporins|mesh-list
24486490|NCT00458250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24486491|NCT00458250|Immunologic Factors|immunologic factors|mesh-ancestor
24486492|NCT00458250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486493|NCT00458250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24486494|NCT00458250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24486495|NCT00458250|Alkylating Agents|alkylating agents|mesh-ancestor
24486496|NCT00458250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486497|NCT00458250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24437410|NCT00273559|Prednisone|prednisone|mesh-list
24486498|NCT00458250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24486499|NCT00458250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24486500|NCT00458250|Abortifacient Agents|abortifacient agents|mesh-ancestor
24486501|NCT00458250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24486502|NCT00458250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24486536|NCT00458315|Immunologic Factors|immunologic factors|mesh-ancestor
24486538|NCT00458328|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24486539|NCT00458328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486621|NCT00458731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486622|NCT00458731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486623|NCT00458731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24486624|NCT00458809|Oxaliplatin|oxaliplatin|mesh-list
24486625|NCT00458809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486626|NCT00458900|Moxifloxacin|moxifloxacin|mesh-list
25716872|NCT02401256|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25716873|NCT02401256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25716874|NCT02401256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25716875|NCT02401256|Respiratory System Agents|respiratory system agents|mesh-ancestor
25716876|NCT02401256|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25716877|NCT02401256|Hormone Antagonists|hormone antagonists|mesh-ancestor
25716878|NCT02401256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25716879|NCT02401256|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25716880|NCT02401256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25716881|NCT02401256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25716882|NCT02401256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25716883|NCT02401256|Antiviral Agents|antiviral agents|mesh-ancestor
25716884|NCT02401256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24486627|NCT00458900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24486721|NCT00459615|Anthelmintics|anthelmintics|mesh-ancestor
24486722|NCT00459654|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
24486723|NCT00459654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486725|NCT00459719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24486726|NCT00459719|Immunologic Factors|immunologic factors|mesh-ancestor
24486727|NCT00459719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486728|NCT00459719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24486729|NCT00459719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486730|NCT00459719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486731|NCT00459771|Candesartan|candesartan|mesh-list
24486732|NCT00459771|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24486733|NCT00459771|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24486734|NCT00459771|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24486735|NCT00459771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486736|NCT00459836|Gemcitabine|gemcitabine|mesh-list
24486737|NCT00459836|Docetaxel|docetaxel|mesh-list
24486738|NCT00459836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24486739|NCT00459836|Antimetabolites|antimetabolites|mesh-ancestor
24486740|NCT00459836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486741|NCT00459836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24486742|NCT00459836|Antiviral Agents|antiviral agents|mesh-ancestor
24486743|NCT00459836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24486744|NCT00459836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24486745|NCT00459836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24486746|NCT00459836|Immunologic Factors|immunologic factors|mesh-ancestor
24486747|NCT00459836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486751|NCT00459901|Capecitabine|capecitabine|mesh-list
24486752|NCT00459901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24486766|NCT00459992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24486777|NCT00460083|Sensory System Agents|sensory system agents|mesh-ancestor
24486778|NCT00460083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24486779|NCT00460083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486781|NCT00460083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24486782|NCT00460083|Dermatologic Agents|dermatologic agents|mesh-ancestor
24487911|NCT00465543|Protective Agents|protective agents|mesh-ancestor
24486832|NCT00460252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486833|NCT00460304|Pramlintide|pramlintide|mesh-list
24486834|NCT00460304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24486835|NCT00460304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24486836|NCT00460369|Artesunate|artesunate|mesh-list
24486837|NCT00460369|Lumefantrine|lumefantrine|mesh-list
24486838|NCT00460369|Artemether|artemether|mesh-list
24486839|NCT00460369|Pyrimethamine|pyrimethamine|mesh-list
24486840|NCT00460369|Sulfadoxine|sulfadoxine|mesh-list
24486841|NCT00460369|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24486842|NCT00460369|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24486843|NCT00460369|Amodiaquine|amodiaquine|mesh-list
24486844|NCT00460369|Antimalarials|antimalarials|mesh-ancestor
24486845|NCT00460369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24486846|NCT00460369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24486847|NCT00460369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446886|NCT00306462|Sensory System Agents|sensory system agents|mesh-ancestor
24446887|NCT00306462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24446888|NCT00306462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446889|NCT00306462|Anesthetics|anesthetics|mesh-ancestor
25716885|NCT02401256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25716886|NCT02401256|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25716887|NCT02401256|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25716888|NCT02401256|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25716889|NCT02401464|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
24446890|NCT00306462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24486908|NCT00460512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24486909|NCT00460512|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24486910|NCT00460512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24486911|NCT00460512|Serotonin Agents|serotonin agents|mesh-ancestor
24486912|NCT00460512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24486913|NCT00460512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24486914|NCT00460512|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24486915|NCT00460512|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24487070|NCT00461422|Hormone Antagonists|hormone antagonists|mesh-ancestor
24487110|NCT00461643|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
24487111|NCT00461643|Chelating Agents|chelating agents|mesh-ancestor
24487112|NCT00461643|Sequestering Agents|sequestering agents|mesh-ancestor
24487113|NCT00461643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487114|NCT00461643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24487115|NCT00461643|Hormone Antagonists|hormone antagonists|mesh-ancestor
24487116|NCT00461643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24487117|NCT00461643|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24487118|NCT00461643|Fertility Agents|fertility agents|mesh-ancestor
24487119|NCT00461643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24487120|NCT00461643|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24487121|NCT00461643|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24487153|NCT00461799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24487154|NCT00461799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24487155|NCT00461825|Cyclosporine|cyclosporine|mesh-list
24487156|NCT00461825|Mycophenolic Acid|mycophenolic acid|mesh-list
24487157|NCT00461825|Azathioprine|azathioprine|mesh-list
24487179|NCT00461890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487180|NCT00461890|Sensory System Agents|sensory system agents|mesh-ancestor
24487181|NCT00461890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24487182|NCT00461903|Perindopril|perindopril|mesh-list
24487183|NCT00461903|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24487184|NCT00461903|Protease Inhibitors|protease inhibitors|mesh-ancestor
24487185|NCT00461903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487186|NCT00461903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487187|NCT00461903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24487188|NCT00461916|Triptorelin Pamoate|triptorelin pamoate|mesh-list
24487189|NCT00461916|Buserelin|buserelin|mesh-list
24487241|NCT00462371|Insulin|insulin|mesh-list
24487251|NCT00462397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487252|NCT00462475|Hormones|hormones|mesh-list
24487253|NCT00462475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24487254|NCT00462475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487255|NCT00462540|Bromides|bromides|mesh-list
24487256|NCT00462540|Albuterol|albuterol|mesh-list
25771249|NCT03595579|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24487257|NCT00462540|Formoterol Fumarate|formoterol fumarate|mesh-list
24487258|NCT00462540|Ipratropium|ipratropium|mesh-list
24487259|NCT00462540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24487269|NCT00462540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24487270|NCT00462540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487271|NCT00462540|Anticonvulsants|anticonvulsants|mesh-ancestor
24487272|NCT00462540|Tocolytic Agents|tocolytic agents|mesh-ancestor
24487273|NCT00462540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24487274|NCT00462540|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24487275|NCT00462540|Cholinergic Agents|cholinergic agents|mesh-ancestor
24487280|NCT00462553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487281|NCT00462553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487282|NCT00462553|Antiviral Agents|antiviral agents|mesh-ancestor
24487283|NCT00462553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24487284|NCT00462553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487285|NCT00462553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24487286|NCT00462553|Immunologic Factors|immunologic factors|mesh-ancestor
24487287|NCT00462553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487288|NCT00462553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24487289|NCT00462553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24487290|NCT00462553|Growth Substances|growth substances|mesh-ancestor
24487291|NCT00462553|Growth Inhibitors|growth inhibitors|mesh-ancestor
24487292|NCT00462553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24487293|NCT00462592|Budesonide|budesonide|mesh-list
24487294|NCT00462592|Montelukast|montelukast|mesh-list
24487295|NCT00462592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24487296|NCT00462592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24487314|NCT00462618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24487315|NCT00462618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24487345|NCT00462787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24487347|NCT00462787|Autonomic Agents|autonomic agents|mesh-ancestor
24487348|NCT00462787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24487349|NCT00462787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487350|NCT00462787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24487351|NCT00462787|Glucocorticoids|glucocorticoids|mesh-ancestor
24487352|NCT00462787|Hormones|hormones|mesh-ancestor
24487365|NCT00462787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24438452|NCT00276003|Antiviral Agents|antiviral agents|mesh-ancestor
24487366|NCT00462787|Alkylating Agents|alkylating agents|mesh-ancestor
24487367|NCT00462787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24487368|NCT00462787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24487369|NCT00462787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24487370|NCT00462787|Antimetabolites|antimetabolites|mesh-ancestor
24487371|NCT00462813|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
24487449|NCT00463086|Antimetabolites|antimetabolites|mesh-ancestor
24487450|NCT00463086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487475|NCT00463268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487476|NCT00463268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24487477|NCT00463268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24487478|NCT00463320|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24487480|NCT00463359|Imiquimod|imiquimod|mesh-list
24487496|NCT00463515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24487497|NCT00463515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771250|NCT03595579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25771251|NCT03595579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25771252|NCT03595579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771253|NCT03595579|Dopamine Agents|dopamine agents|mesh-ancestor
25771254|NCT03595579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25771255|NCT03595579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771256|NCT03595579|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25771257|NCT03595579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25771258|NCT03595579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487507|NCT00463541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487508|NCT00463541|Urological Agents|urological agents|mesh-ancestor
24487570|NCT00463879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487571|NCT00463879|Cholinergic Agents|cholinergic agents|mesh-ancestor
24487572|NCT00463879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24487573|NCT00463879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487574|NCT00463879|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24487575|NCT00463879|Autonomic Agents|autonomic agents|mesh-ancestor
24487576|NCT00463879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24487577|NCT00463879|Nootropic Agents|nootropic agents|mesh-ancestor
24487578|NCT00463918|Varenicline|varenicline|mesh-list
24487579|NCT00463918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24487580|NCT00463918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24487581|NCT00463918|Cholinergic Agents|cholinergic agents|mesh-ancestor
24487582|NCT00463918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24487583|NCT00463918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487584|NCT00463918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487585|NCT00463957|Sildenafil Citrate|sildenafil citrate|mesh-list
24487586|NCT00463957|Tadalafil|tadalafil|mesh-list
24487587|NCT00463957|Vasodilator Agents|vasodilator agents|mesh-ancestor
24487588|NCT00463957|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24487589|NCT00463957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24487590|NCT00463957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24487591|NCT00463957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487592|NCT00463957|Urological Agents|urological agents|mesh-ancestor
24487594|NCT00463983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24487595|NCT00463983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24487597|NCT00464035|Calcium|calcium|mesh-list
24487636|NCT00464256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487637|NCT00464295|Capecitabine|capecitabine|mesh-list
24487638|NCT00464295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24487639|NCT00464295|Antimetabolites|antimetabolites|mesh-ancestor
24487640|NCT00464295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487641|NCT00464295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487642|NCT00464321|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
24487643|NCT00464321|Immunologic Factors|immunologic factors|mesh-ancestor
24487644|NCT00464321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487645|NCT00464347|Triamcinolone|triamcinolone|mesh-list
24487646|NCT00464347|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
24487647|NCT00464347|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
24487648|NCT00464347|Bevacizumab|bevacizumab|mesh-list
24487649|NCT00464347|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
24487650|NCT00464347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24487683|NCT00464451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24487684|NCT00464451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24487685|NCT00464451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487686|NCT00464451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24487687|NCT00464451|Analgesics|analgesics|mesh-ancestor
25716890|NCT02401464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25716891|NCT02401464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25716892|NCT02401464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716893|NCT02401529|Acetaminophen|acetaminophen|mesh-list
25716894|NCT02401529|Dexamethasone|dexamethasone|mesh-list
25716895|NCT02401529|Prednisolone|prednisolone|mesh-list
25716896|NCT02401529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25716897|NCT02401529|Antiemetics|antiemetics|mesh-ancestor
25716898|NCT02401529|Autonomic Agents|autonomic agents|mesh-ancestor
25716899|NCT02401529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24487688|NCT00464451|Sensory System Agents|sensory system agents|mesh-ancestor
25716900|NCT02401529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716901|NCT02401529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25716902|NCT02401529|Glucocorticoids|glucocorticoids|mesh-ancestor
24487689|NCT00464451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24487690|NCT00464451|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24487691|NCT00464451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24487692|NCT00464451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24487693|NCT00464451|Adrenergic Agents|adrenergic agents|mesh-ancestor
24487694|NCT00464451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24487695|NCT00464451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487697|NCT00464503|Pravastatin|pravastatin|mesh-list
24487707|NCT00464594|Gliclazide|gliclazide|mesh-list
24487708|NCT00464594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24487709|NCT00464594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487712|NCT00464594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487713|NCT00464763|Dexmedetomidine|dexmedetomidine|mesh-list
24487718|NCT00464763|Analgesics|analgesics|mesh-ancestor
24487725|NCT00464763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24487726|NCT00464763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487727|NCT00464789|Bazedoxifene|bazedoxifene|mesh-list
24487728|NCT00464789|Estrogens|estrogens|mesh-list
24487729|NCT00464789|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
24487730|NCT00464789|Hormones|hormones|mesh-ancestor
24487731|NCT00464789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24487732|NCT00464789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487859|NCT00465296|Rosiglitazone|rosiglitazone|mesh-list
24487860|NCT00465296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24487904|NCT00465543|Sensory System Agents|sensory system agents|mesh-ancestor
24487905|NCT00465543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24487906|NCT00465543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24487907|NCT00465543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24487910|NCT00465543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487926|NCT00465621|Latanoprost|latanoprost|mesh-list
24487936|NCT00465673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24487943|NCT00465907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24487944|NCT00465907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24487945|NCT00465907|Tubulin Modulators|tubulin modulators|mesh-ancestor
24487946|NCT00465907|Antimitotic Agents|antimitotic agents|mesh-ancestor
24487947|NCT00465907|Mitosis Modulators|mitosis modulators|mesh-ancestor
24487949|NCT00465907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24487974|NCT00466128|Indomethacin|indomethacin|mesh-list
24487975|NCT00466128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24487976|NCT00466128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24487977|NCT00466128|Analgesics|analgesics|mesh-ancestor
24487984|NCT00466128|Tocolytic Agents|tocolytic agents|mesh-ancestor
24488037|NCT00466258|Antiviral Agents|antiviral agents|mesh-ancestor
24488038|NCT00466258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24488063|NCT00466466|Everolimus|everolimus|mesh-list
24488064|NCT00466466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488065|NCT00466466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24488066|NCT00466466|Immunologic Factors|immunologic factors|mesh-ancestor
24488067|NCT00466466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488068|NCT00466479|Brimonidine Tartrate|brimonidine tartrate|mesh-list
24488069|NCT00466479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24488070|NCT00466479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24488071|NCT00466479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25716903|NCT02401529|Hormones|hormones|mesh-ancestor
25716904|NCT02401529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25716905|NCT02401529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25716906|NCT02401529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716907|NCT02401529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25716908|NCT02401529|Analgesics|analgesics|mesh-ancestor
24488072|NCT00466479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24488150|NCT00466843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488151|NCT00466843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24488152|NCT00466843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488153|NCT00466843|Immunologic Factors|immunologic factors|mesh-ancestor
24488175|NCT00466986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24488177|NCT00466999|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24488178|NCT00466999|Abortifacient Agents|abortifacient agents|mesh-ancestor
24488179|NCT00466999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24488198|NCT00467116|Gemcitabine|gemcitabine|mesh-list
24488199|NCT00467116|Cetuximab|cetuximab|mesh-list
24488200|NCT00467116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24488201|NCT00467116|Antimetabolites|antimetabolites|mesh-ancestor
24488229|NCT00467194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24488239|NCT00467207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488240|NCT00467207|Cholinergic Agents|cholinergic agents|mesh-ancestor
24488241|NCT00467207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24488463|NCT00468754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24488464|NCT00468754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488465|NCT00468871|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
24488466|NCT00468871|Immunosuppressive Agents|immunosuppressive agents|mesh-list
24488467|NCT00468871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24488468|NCT00468871|Glucocorticoids|glucocorticoids|mesh-ancestor
24488469|NCT00468871|Hormones|hormones|mesh-ancestor
24488470|NCT00468871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24488471|NCT00468871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488472|NCT00468871|Immunologic Factors|immunologic factors|mesh-ancestor
24488473|NCT00468923|Candesartan|candesartan|mesh-list
24488474|NCT00468923|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24488475|NCT00468923|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24488476|NCT00468923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24488477|NCT00468923|Antimetabolites|antimetabolites|mesh-ancestor
24488478|NCT00468923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488479|NCT00468923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24488481|NCT00468923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488716|NCT00469781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24488717|NCT00469781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24488718|NCT00469781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24488719|NCT00469781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24488720|NCT00469781|Antiemetics|antiemetics|mesh-ancestor
24488723|NCT00469781|Glucocorticoids|glucocorticoids|mesh-ancestor
24488724|NCT00469781|Hormones|hormones|mesh-ancestor
24488755|NCT00469924|Purinergic Agents|purinergic agents|mesh-ancestor
24488756|NCT00469924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24488758|NCT00469937|Antidepressive Agents|antidepressive agents|mesh-ancestor
24488759|NCT00469937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25716909|NCT02401529|Sensory System Agents|sensory system agents|mesh-ancestor
25716910|NCT02401529|Antipyretics|antipyretics|mesh-ancestor
24488760|NCT00469937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488761|NCT00469937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488762|NCT00469937|Antimanic Agents|antimanic agents|mesh-ancestor
24488763|NCT00469937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24488766|NCT00469976|Gemcitabine|gemcitabine|mesh-list
24488896|NCT00470483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24488897|NCT00470483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24488899|NCT00470509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24488900|NCT00470509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24488902|NCT00470522|Methotrexate|methotrexate|mesh-list
24492302|NCT00485862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24488907|NCT00470522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24488962|NCT00470743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24488963|NCT00470743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24488964|NCT00470743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24488966|NCT00470743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24488967|NCT00470743|Gout Suppressants|gout suppressants|mesh-ancestor
24488968|NCT00470743|Tocolytic Agents|tocolytic agents|mesh-ancestor
24488970|NCT00470821|Melatonin|melatonin|mesh-list
24489036|NCT00471094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489037|NCT00471159|Docetaxel|docetaxel|mesh-list
24489038|NCT00471159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489039|NCT00471159|Tubulin Modulators|tubulin modulators|mesh-ancestor
24489040|NCT00471159|Antimitotic Agents|antimitotic agents|mesh-ancestor
24489041|NCT00471159|Mitosis Modulators|mitosis modulators|mesh-ancestor
24489042|NCT00471159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489043|NCT00471185|Acyline|acyline|mesh-list
24489066|NCT00471341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489067|NCT00471393|Diclofenac|diclofenac|mesh-list
24489068|NCT00471393|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
24489069|NCT00471393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24489070|NCT00471393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24489107|NCT00471484|Oxaliplatin|oxaliplatin|mesh-list
24489108|NCT00471484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24489109|NCT00471484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489110|NCT00471484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24489111|NCT00471484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24489112|NCT00471484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24468213|NCT00380484|Glucocorticoids|glucocorticoids|mesh-ancestor
24468214|NCT00380484|Hormones|hormones|mesh-ancestor
24468216|NCT00380484|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24489113|NCT00471484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489314|NCT00472225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24489315|NCT00472329|Fludarabine|fludarabine|mesh-list
24489316|NCT00472329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489317|NCT00472355|Apomorphine|apomorphine|mesh-list
25716911|NCT02401542|Docetaxel|docetaxel|mesh-list
25716912|NCT02401542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716913|NCT02401542|Tubulin Modulators|tubulin modulators|mesh-ancestor
25716914|NCT02401542|Antimitotic Agents|antimitotic agents|mesh-ancestor
25716915|NCT02401542|Mitosis Modulators|mitosis modulators|mesh-ancestor
25716916|NCT02401542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716917|NCT02402062|Sunitinib|sunitinib|mesh-list
25716918|NCT02402062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716919|NCT02402062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25716920|NCT02402062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25716921|NCT02402062|Growth Substances|growth substances|mesh-ancestor
25716922|NCT02402062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716923|NCT02402062|Growth Inhibitors|growth inhibitors|mesh-ancestor
24489319|NCT00472355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489320|NCT00472355|Autonomic Agents|autonomic agents|mesh-ancestor
24489321|NCT00472355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24489344|NCT00472472|Tubulin Modulators|tubulin modulators|mesh-ancestor
24489345|NCT00472472|Antimitotic Agents|antimitotic agents|mesh-ancestor
24489346|NCT00472472|Mitosis Modulators|mitosis modulators|mesh-ancestor
24489347|NCT00472472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489382|NCT00472927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489383|NCT00472953|Insulin|insulin|mesh-list
24489384|NCT00472953|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24489385|NCT00472953|Insulin Aspart|insulin aspart|mesh-list
24489386|NCT00472953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24489442|NCT00473239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24489479|NCT00473551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489480|NCT00473551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24489481|NCT00473551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24489546|NCT00473980|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24489547|NCT00473980|Gout Suppressants|gout suppressants|mesh-ancestor
24489548|NCT00473980|Tocolytic Agents|tocolytic agents|mesh-ancestor
24489549|NCT00473980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24489550|NCT00474006|Daunorubicin|daunorubicin|mesh-list
24489551|NCT00474006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24489552|NCT00474006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24489553|NCT00474006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24489554|NCT00474006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24489555|NCT00474006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24489556|NCT00474006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489557|NCT00474019|Esomeprazole|esomeprazole|mesh-list
24489558|NCT00474019|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24489837|NCT00475553|Estrogens|estrogens|mesh-ancestor
24489838|NCT00475553|Hormones|hormones|mesh-ancestor
24489839|NCT00475553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24489840|NCT00475553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489842|NCT00475553|Contraceptive Agents|contraceptive agents|mesh-ancestor
24489853|NCT00475566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489859|NCT00475696|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24489860|NCT00475696|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24489861|NCT00475696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24489862|NCT00475696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24489863|NCT00475696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24489864|NCT00475696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24489865|NCT00475696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24489866|NCT00475696|Analgesics|analgesics|mesh-ancestor
24490071|NCT00476268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24490072|NCT00476268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490073|NCT00476268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24490074|NCT00476268|Respiratory System Agents|respiratory system agents|mesh-ancestor
24490142|NCT00476619|Epoetin Alfa|epoetin alfa|mesh-list
24490143|NCT00476619|Hematinics|hematinics|mesh-ancestor
24490144|NCT00476710|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
24490145|NCT00476710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24490146|NCT00476710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24468338|NCT00381134|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24468339|NCT00381134|Diuretics|diuretics|mesh-ancestor
24468340|NCT00381134|Natriuretic Agents|natriuretic agents|mesh-ancestor
24468341|NCT00381147|Clarithromycin|clarithromycin|mesh-list
24490147|NCT00476710|Antimetabolites|antimetabolites|mesh-ancestor
24490148|NCT00476710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490150|NCT00476853|Nevirapine|nevirapine|mesh-list
24490247|NCT00477126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24490252|NCT00477217|Zoledronic Acid|zoledronic acid|mesh-list
24490253|NCT00477217|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24490254|NCT00477217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490256|NCT00477282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24490257|NCT00477282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24490261|NCT00477373|Valproic Acid|valproic acid|mesh-list
24490265|NCT00477373|GABA Agents|gaba agents|mesh-ancestor
24490266|NCT00477373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25716924|NCT02402062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25716925|NCT02402062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25716926|NCT02402062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716927|NCT02402907|Chlorhexidine|chlorhexidine|mesh-list
25716928|NCT02402907|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25716929|NCT02402907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24490267|NCT00477373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490268|NCT00477373|Antimanic Agents|antimanic agents|mesh-ancestor
24490269|NCT00477373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24490270|NCT00477373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24490271|NCT00477373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24490272|NCT00477503|Pentetic Acid|pentetic acid|mesh-list
24490273|NCT00477503|Gallium citrate|gallium citrate|mesh-list
24490274|NCT00477503|Chelating Agents|chelating agents|mesh-ancestor
24490275|NCT00477503|Sequestering Agents|sequestering agents|mesh-ancestor
24490276|NCT00477503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24490543|NCT00478907|Propofol|propofol|mesh-list
24490544|NCT00478907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24490545|NCT00478907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24490546|NCT00478907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24490549|NCT00478907|Anesthetics|anesthetics|mesh-ancestor
24490650|NCT00479479|Hydroxocobalamin|hydroxocobalamin|mesh-list
24490652|NCT00479479|Micronutrients|micronutrients|mesh-ancestor
24490655|NCT00479479|Hematinics|hematinics|mesh-ancestor
24490671|NCT00479661|Sensory System Agents|sensory system agents|mesh-ancestor
24490672|NCT00479661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24490673|NCT00479661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24490674|NCT00479661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24490675|NCT00479661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24490676|NCT00479661|Adrenergic Agents|adrenergic agents|mesh-ancestor
24490677|NCT00479661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24491206|NCT00481572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24491208|NCT00481624|Ferric gluconate|ferric gluconate|mesh-list
24491209|NCT00481624|Hematinics|hematinics|mesh-ancestor
24491210|NCT00481663|Metformin|metformin|mesh-list
24491211|NCT00481663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24491212|NCT00481663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24491213|NCT00481663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491214|NCT00481663|Incretins|incretins|mesh-ancestor
24491215|NCT00481663|Hormones|hormones|mesh-ancestor
24491216|NCT00481663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24491261|NCT00481819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491269|NCT00481819|Antiemetics|antiemetics|mesh-ancestor
24491285|NCT00481923|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24491286|NCT00481923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24491287|NCT00481923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491289|NCT00481923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24491290|NCT00481923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491291|NCT00481962|Tigecycline|tigecycline|mesh-list
24491292|NCT00481962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24491293|NCT00481962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24491297|NCT00481975|Rimonabant|rimonabant|mesh-list
24491412|NCT00482313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24491413|NCT00482313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491414|NCT00482313|Dopamine Agents|dopamine agents|mesh-ancestor
24491415|NCT00482313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24491416|NCT00482378|Zoledronic Acid|zoledronic acid|mesh-list
24491471|NCT00482690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24491472|NCT00482690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491481|NCT00482716|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24491482|NCT00482716|Iron-Dextran Complex|iron-dextran complex|mesh-list
24491483|NCT00482716|Trace Elements|trace elements|mesh-ancestor
24491484|NCT00482716|Micronutrients|micronutrients|mesh-ancestor
25716930|NCT02402907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25716931|NCT02402907|Disinfectants|disinfectants|mesh-ancestor
25716932|NCT02402907|Dermatologic Agents|dermatologic agents|mesh-ancestor
25716933|NCT02402933|Glucagon|glucagon|mesh-list
25716934|NCT02402933|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25716935|NCT02402933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25716936|NCT02402933|Hormones|hormones|mesh-ancestor
25716937|NCT02402933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24491485|NCT00482716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491486|NCT00482716|Hematinics|hematinics|mesh-ancestor
24491487|NCT00482716|Anticoagulants|anticoagulants|mesh-ancestor
24491488|NCT00482716|Plasma Substitutes|plasma substitutes|mesh-ancestor
24491489|NCT00482716|Blood Substitutes|blood substitutes|mesh-ancestor
24491490|NCT00482755|Sunitinib|sunitinib|mesh-list
24491491|NCT00482755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491492|NCT00482755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24491584|NCT00483067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491585|NCT00483067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24491587|NCT00483093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24491588|NCT00483106|Methylphenidate|methylphenidate|mesh-list
24491589|NCT00483106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24491590|NCT00483106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491591|NCT00483106|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24491592|NCT00483106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24491593|NCT00483106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24491594|NCT00483106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491595|NCT00483106|Dopamine Agents|dopamine agents|mesh-ancestor
24491596|NCT00483106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24491597|NCT00483132|Interferons|interferons|mesh-list
24491598|NCT00483132|Interferon-alpha|interferon-alpha|mesh-list
24491599|NCT00483132|Interferon alpha-2|interferon alpha-2|mesh-list
24491663|NCT00483392|Rosiglitazone|rosiglitazone|mesh-list
24491664|NCT00483392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24491666|NCT00483431|Vitamin MK 7|vitamin mk 7|mesh-list
24491692|NCT00483730|Actovegin|actovegin|mesh-list
24491693|NCT00483730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24491694|NCT00483730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24491695|NCT00483730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24491696|NCT00483730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24491697|NCT00483730|Antioxidants|antioxidants|mesh-ancestor
24491698|NCT00483730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24491699|NCT00483730|Protective Agents|protective agents|mesh-ancestor
24491700|NCT00483730|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24491701|NCT00483743|Budesonide|budesonide|mesh-list
24491702|NCT00483743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24491707|NCT00483743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24491708|NCT00483743|Respiratory System Agents|respiratory system agents|mesh-ancestor
24491709|NCT00483743|Glucocorticoids|glucocorticoids|mesh-ancestor
24492301|NCT00485862|Antidepressive Agents|antidepressive agents|mesh-ancestor
24491836|NCT00484133|Dobutamine|dobutamine|mesh-list
24491908|NCT00484484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24491912|NCT00484510|Ascorbic Acid|ascorbic acid|mesh-list
24491995|NCT00484822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25716938|NCT02402933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716939|NCT02402933|Incretins|incretins|mesh-ancestor
24492145|NCT00485498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492146|NCT00485498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24492147|NCT00485498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24492148|NCT00485498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24492156|NCT00485498|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24492157|NCT00485498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24492158|NCT00485498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24468744|NCT00383045|Buprenorphine|buprenorphine|mesh-list
24468745|NCT00383045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24468746|NCT00383045|Narcotics|narcotics|mesh-ancestor
24492160|NCT00485511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24492161|NCT00485511|Antisickling Agents|antisickling agents|mesh-ancestor
24492162|NCT00485511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492163|NCT00485511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492191|NCT00485667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24492192|NCT00485667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24492193|NCT00485667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24492194|NCT00485667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24492195|NCT00485667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492196|NCT00485667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492197|NCT00485667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24492232|NCT00485771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24492233|NCT00485771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24492244|NCT00485771|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24492300|NCT00485862|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24492303|NCT00485862|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24492304|NCT00485862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24492305|NCT00485862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24492569|NCT00486785|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24492574|NCT00486785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492575|NCT00486785|Urological Agents|urological agents|mesh-ancestor
24492576|NCT00486798|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24492577|NCT00486798|Antidepressive Agents|antidepressive agents|mesh-ancestor
24492578|NCT00486798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24492579|NCT00486798|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24492580|NCT00486798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24492581|NCT00486798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24492583|NCT00486876|Tofisopam|tofisopam|mesh-list
24492711|NCT00487591|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24492712|NCT00487591|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24492713|NCT00487591|Antimetabolites|antimetabolites|mesh-ancestor
24492714|NCT00487591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492715|NCT00487591|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24492716|NCT00487591|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24492717|NCT00487591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24492718|NCT00487682|Valacyclovir|valacyclovir|mesh-list
24492719|NCT00487682|Antiviral Agents|antiviral agents|mesh-ancestor
24492720|NCT00487682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24492721|NCT00487734|Methyltestosterone|methyltestosterone|mesh-list
24492722|NCT00487734|Testosterone|testosterone|mesh-list
24492723|NCT00487734|Testosterone undecanoate|testosterone undecanoate|mesh-list
24492726|NCT00487734|Androgens|androgens|mesh-ancestor
24492818|NCT00488176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24492819|NCT00488176|Respiratory System Agents|respiratory system agents|mesh-ancestor
24492820|NCT00488176|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24492821|NCT00488176|Hormone Antagonists|hormone antagonists|mesh-ancestor
24492847|NCT00488215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24492848|NCT00488215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492905|NCT00488605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24492906|NCT00488605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24492907|NCT00488605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24492908|NCT00488605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24492909|NCT00488605|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24492910|NCT00488605|Abortifacient Agents|abortifacient agents|mesh-ancestor
24492911|NCT00488605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24492912|NCT00488605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24492913|NCT00488605|Antimetabolites|antimetabolites|mesh-ancestor
25716940|NCT02403271|Durvalumab|durvalumab|mesh-list
25716941|NCT02403271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25716942|NCT02403271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25716943|NCT02403635|Midazolam|midazolam|mesh-list
25716944|NCT02403635|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24492914|NCT00488605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24492917|NCT00488605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24492918|NCT00488605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24493041|NCT00489164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24493042|NCT00489164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493043|NCT00489164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24493044|NCT00489164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493045|NCT00489164|Antifungal Agents|antifungal agents|mesh-ancestor
24493046|NCT00489164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24493047|NCT00489164|Immunologic Factors|immunologic factors|mesh-ancestor
24493053|NCT00489229|Ramipril|ramipril|mesh-list
24493193|NCT00489944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24493194|NCT00489944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24493195|NCT00489944|Growth Substances|growth substances|mesh-ancestor
24493197|NCT00489944|Growth Inhibitors|growth inhibitors|mesh-ancestor
24493208|NCT00489983|Pemetrexed|pemetrexed|mesh-list
24493209|NCT00489983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24493210|NCT00489983|Antimetabolites|antimetabolites|mesh-ancestor
24493211|NCT00489983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493212|NCT00489983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493213|NCT00489983|Antiviral Agents|antiviral agents|mesh-ancestor
24493214|NCT00489983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493215|NCT00489983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493252|NCT00490178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24493253|NCT00490204|Cetirizine|cetirizine|mesh-list
24493260|NCT00490204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493261|NCT00490204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493263|NCT00490243|Formoterol Fumarate|formoterol fumarate|mesh-list
24493264|NCT00490243|Montelukast|montelukast|mesh-list
24493265|NCT00490243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24493266|NCT00490243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24493267|NCT00490243|Autonomic Agents|autonomic agents|mesh-ancestor
24493268|NCT00490243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24493269|NCT00490243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493270|NCT00490243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24493271|NCT00490243|Respiratory System Agents|respiratory system agents|mesh-ancestor
24493272|NCT00490243|Glucocorticoids|glucocorticoids|mesh-ancestor
24493273|NCT00490243|Hormones|hormones|mesh-ancestor
24493274|NCT00490243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24493275|NCT00490243|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24493276|NCT00490243|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24493277|NCT00490243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24493278|NCT00490243|Adrenergic Agents|adrenergic agents|mesh-ancestor
24493279|NCT00490243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24493280|NCT00490243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493281|NCT00490243|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
24493282|NCT00490243|Hormone Antagonists|hormone antagonists|mesh-ancestor
24493294|NCT00490308|Contraceptive Agents|contraceptive agents|mesh-ancestor
24493295|NCT00490308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24493342|NCT00490633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24493343|NCT00490633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493402|NCT00490854|Protamines|protamines|mesh-list
24493403|NCT00490854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24493446|NCT00490958|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24493447|NCT00490958|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24493448|NCT00490958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493449|NCT00490997|Ketamine|ketamine|mesh-list
24493450|NCT00490997|Propofol|propofol|mesh-list
24493451|NCT00490997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24493452|NCT00490997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24493453|NCT00490997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493483|NCT00491114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493484|NCT00491114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493485|NCT00491114|Antiviral Agents|antiviral agents|mesh-ancestor
24493486|NCT00491114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24493575|NCT00491478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24493576|NCT00491478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493577|NCT00491478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24493578|NCT00491478|Serotonin Agents|serotonin agents|mesh-ancestor
24493579|NCT00491478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493580|NCT00491517|Sirolimus|sirolimus|mesh-list
24493637|NCT00491855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24493638|NCT00491855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24493639|NCT00491855|Tubulin Modulators|tubulin modulators|mesh-ancestor
24493640|NCT00491855|Antimitotic Agents|antimitotic agents|mesh-ancestor
24493641|NCT00491855|Mitosis Modulators|mitosis modulators|mesh-ancestor
24493660|NCT00491920|Micronutrients|micronutrients|mesh-ancestor
24493661|NCT00491920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493675|NCT00491946|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24493677|NCT00491946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24493678|NCT00491985|Vaccines|vaccines|mesh-list
24493679|NCT00491985|Immunologic Factors|immunologic factors|mesh-ancestor
24493680|NCT00491985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493681|NCT00491998|Entacapone|entacapone|mesh-list
24493682|NCT00491998|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24493683|NCT00491998|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24493685|NCT00491998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493733|NCT00492219|Histamine Antagonists|histamine antagonists|mesh-ancestor
24493734|NCT00492219|Histamine Agents|histamine agents|mesh-ancestor
24493735|NCT00492219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24493736|NCT00492219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493737|NCT00492219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493738|NCT00492219|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24493739|NCT00492219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24493740|NCT00492219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24493773|NCT00492414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24493774|NCT00492414|Serotonin Agents|serotonin agents|mesh-ancestor
24493775|NCT00492414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493776|NCT00492414|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24493930|NCT00493116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24493932|NCT00493116|Autonomic Agents|autonomic agents|mesh-ancestor
24493935|NCT00493116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24493947|NCT00493129|Analgesics|analgesics|mesh-ancestor
24493948|NCT00493129|Sensory System Agents|sensory system agents|mesh-ancestor
24493949|NCT00493129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24493950|NCT00493129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493951|NCT00493194|Cyclosporine|cyclosporine|mesh-list
24493952|NCT00493194|Sirolimus|sirolimus|mesh-list
24443030|NCT00293475|Antimetabolites|antimetabolites|mesh-ancestor
24493953|NCT00493194|Cyclosporins|cyclosporins|mesh-list
24493954|NCT00493194|Daclizumab|daclizumab|mesh-list
24493956|NCT00493194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24493957|NCT00493194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24493958|NCT00493194|Immunologic Factors|immunologic factors|mesh-ancestor
24493959|NCT00493194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24493960|NCT00493194|Antifungal Agents|antifungal agents|mesh-ancestor
24493987|NCT00493233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24493988|NCT00493233|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24493989|NCT00493233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24493990|NCT00493233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24494037|NCT00493480|Propranolol|propranolol|mesh-list
24494038|NCT00493480|Carvedilol|carvedilol|mesh-list
24494039|NCT00493480|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24494134|NCT00493870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24494135|NCT00493870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24494136|NCT00493987|Methyltestosterone|methyltestosterone|mesh-list
24494137|NCT00493987|Testosterone|testosterone|mesh-list
24494138|NCT00493987|Testosterone undecanoate|testosterone undecanoate|mesh-list
24494139|NCT00493987|Testosterone enanthate|testosterone enanthate|mesh-list
24494140|NCT00493987|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25716945|NCT02403635|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25716946|NCT02403635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24494141|NCT00493987|Dutasteride|dutasteride|mesh-list
24494142|NCT00493987|Androgens|androgens|mesh-ancestor
24494143|NCT00493987|Hormones|hormones|mesh-ancestor
24494213|NCT00494377|Analgesics|analgesics|mesh-ancestor
24494465|NCT00495326|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24494466|NCT00495326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24494467|NCT00495326|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24494468|NCT00495326|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24494469|NCT00495326|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24494578|NCT00495872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24494581|NCT00495872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24494582|NCT00495872|Antimanic Agents|antimanic agents|mesh-ancestor
24494613|NCT00496093|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24494614|NCT00496093|Immunologic Factors|immunologic factors|mesh-ancestor
24494799|NCT00497107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24494800|NCT00497107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24494801|NCT00497107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24494802|NCT00497107|Antidotes|antidotes|mesh-ancestor
24494803|NCT00497107|Protective Agents|protective agents|mesh-ancestor
24494804|NCT00497107|Vitamin B Complex|vitamin b complex|mesh-ancestor
24494805|NCT00497107|Vitamins|vitamins|mesh-ancestor
24494806|NCT00497107|Micronutrients|micronutrients|mesh-ancestor
24494807|NCT00497120|Acetazolamide|acetazolamide|mesh-list
24494808|NCT00497120|Anticonvulsants|anticonvulsants|mesh-ancestor
24494809|NCT00497120|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
24494810|NCT00497120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24494932|NCT00497523|Hormones|hormones|mesh-ancestor
24495407|NCT00500006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24495408|NCT00500006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495409|NCT00500006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495410|NCT00500058|Rituximab|rituximab|mesh-list
24495411|NCT00500058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24495412|NCT00500058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495413|NCT00500058|Immunologic Factors|immunologic factors|mesh-ancestor
24495414|NCT00500058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495415|NCT00500058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24495416|NCT00500123|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
24495417|NCT00500123|Protein C Inhibitor|protein c inhibitor|mesh-list
24495418|NCT00500123|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24495419|NCT00500123|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24495420|NCT00500123|Protease Inhibitors|protease inhibitors|mesh-ancestor
24495421|NCT00500123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24495422|NCT00500123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495423|NCT00500188|Imatinib Mesylate|imatinib mesylate|mesh-list
24495538|NCT00500864|Anesthetics|anesthetics|mesh-ancestor
24495539|NCT00500864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24495540|NCT00500864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24495542|NCT00500864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24495543|NCT00500864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24495824|NCT00502099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24495825|NCT00502112|Lenalidomide|lenalidomide|mesh-list
24495827|NCT00502112|Immunologic Factors|immunologic factors|mesh-ancestor
24495828|NCT00502112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716947|NCT02403635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716948|NCT02403635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25716949|NCT02403635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25716950|NCT02403635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25716951|NCT02403635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25716952|NCT02403635|Anesthetics, General|anesthetics, general|mesh-ancestor
25716953|NCT02403635|Anesthetics|anesthetics|mesh-ancestor
24495829|NCT00502112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24495883|NCT00502411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24495884|NCT00502411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24495885|NCT00502411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24495886|NCT00502411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24495887|NCT00502411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498769|NCT00516191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24495888|NCT00502411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24495890|NCT00502437|Antiemetics|antiemetics|mesh-ancestor
24495891|NCT00502437|Autonomic Agents|autonomic agents|mesh-ancestor
24495892|NCT00502437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24495937|NCT00502567|Vitamins|vitamins|mesh-ancestor
24495938|NCT00502567|Micronutrients|micronutrients|mesh-ancestor
24495939|NCT00502567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24495940|NCT00502567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24495941|NCT00502567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24495943|NCT00502658|Vitamins|vitamins|mesh-list
24496109|NCT00503503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24496110|NCT00503503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496130|NCT00503542|Metronidazole|metronidazole|mesh-list
24496240|NCT00503971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496241|NCT00503971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24496242|NCT00503971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24496243|NCT00503971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496244|NCT00503971|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
24496349|NCT00504400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496350|NCT00504400|Growth Inhibitors|growth inhibitors|mesh-ancestor
24496351|NCT00504400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24496353|NCT00504413|Midazolam|midazolam|mesh-list
24496354|NCT00504413|Methadone|methadone|mesh-list
24496355|NCT00504413|Bupropion|bupropion|mesh-list
24496356|NCT00504413|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24496357|NCT00504413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24496449|NCT00504933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24496450|NCT00504933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24496451|NCT00504946|Cholecalciferol|cholecalciferol|mesh-list
24496453|NCT00504946|Prednisone|prednisone|mesh-list
24496454|NCT00504946|Budesonide|budesonide|mesh-list
24496455|NCT00504946|Montelukast|montelukast|mesh-list
24496456|NCT00504946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24496457|NCT00504946|Glucocorticoids|glucocorticoids|mesh-ancestor
24497367|NCT00509678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497368|NCT00509678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24497369|NCT00509743|Diclofenac|diclofenac|mesh-list
24497372|NCT00509743|Analgesics|analgesics|mesh-ancestor
24497407|NCT00509990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24497408|NCT00509990|Dermatologic Agents|dermatologic agents|mesh-ancestor
24497409|NCT00509990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24497410|NCT00509990|Immunologic Factors|immunologic factors|mesh-ancestor
24497411|NCT00509990|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24497412|NCT00509990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497418|NCT00510003|Sensory System Agents|sensory system agents|mesh-ancestor
24497419|NCT00510003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24497420|NCT00510003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497421|NCT00510003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24497422|NCT00510003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24497423|NCT00510003|Dermatologic Agents|dermatologic agents|mesh-ancestor
24497424|NCT00510003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24497425|NCT00510003|Immunologic Factors|immunologic factors|mesh-ancestor
24497426|NCT00510003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24497427|NCT00510003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24497492|NCT00510263|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
24497547|NCT00510406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497739|NCT00511654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24497740|NCT00511654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24497741|NCT00511654|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24497817|NCT00511966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24497818|NCT00511979|Insulin|insulin|mesh-list
24497819|NCT00511979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25716954|NCT02403635|GABA Modulators|gaba modulators|mesh-ancestor
25716955|NCT02403635|GABA Agents|gaba agents|mesh-ancestor
25716956|NCT02403635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24497820|NCT00511979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24497821|NCT00511979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498120|NCT00513266|Bevacizumab|bevacizumab|mesh-list
24498121|NCT00513266|Cetuximab|cetuximab|mesh-list
24498122|NCT00513266|Fluorouracil|fluorouracil|mesh-list
24498123|NCT00513266|Oxaliplatin|oxaliplatin|mesh-list
24498124|NCT00513266|Irinotecan|irinotecan|mesh-list
24498125|NCT00513266|Calcium|calcium|mesh-list
24498126|NCT00513266|Levoleucovorin|levoleucovorin|mesh-list
24498131|NCT00513266|Growth Substances|growth substances|mesh-ancestor
24498482|NCT00514982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24498717|NCT00516100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24498718|NCT00516100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24498770|NCT00516191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24498771|NCT00516191|Immunologic Factors|immunologic factors|mesh-ancestor
24498772|NCT00516191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24498773|NCT00516243|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
24498774|NCT00516243|Antioxidants|antioxidants|mesh-ancestor
24498775|NCT00516243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24498776|NCT00516243|Protective Agents|protective agents|mesh-ancestor
24498977|NCT00516971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24498978|NCT00516971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499021|NCT00517322|Ramipril|ramipril|mesh-list
24499028|NCT00517322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24499029|NCT00517322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24499030|NCT00517387|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24499031|NCT00517387|Antidepressive Agents|antidepressive agents|mesh-ancestor
24499032|NCT00517387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24499033|NCT00517387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24499034|NCT00517387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24499045|NCT00517491|Lanreotide|lanreotide|mesh-list
24499110|NCT00517764|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24499355|NCT00519116|Sirolimus|sirolimus|mesh-list
24499969|NCT00521859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24499970|NCT00521859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24499971|NCT00521859|Immunologic Factors|immunologic factors|mesh-ancestor
24499972|NCT00521859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24499973|NCT00521859|Antiviral Agents|antiviral agents|mesh-ancestor
24499975|NCT00521950|Mercaptopurine|mercaptopurine|mesh-list
24500820|NCT00525759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24500821|NCT00525759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24500824|NCT00525772|Hormones|hormones|mesh-ancestor
24500825|NCT00525772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24500826|NCT00525772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24500827|NCT00525772|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24500828|NCT00525889|Sirolimus|sirolimus|mesh-list
24500829|NCT00525889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24501219|NCT00527501|Travoprost|travoprost|mesh-list
24501258|NCT00527683|GABA Agents|gaba agents|mesh-ancestor
24501259|NCT00527683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24501260|NCT00527683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501261|NCT00527761|Cisplatin|cisplatin|mesh-list
24501262|NCT00527761|Docetaxel|docetaxel|mesh-list
24501263|NCT00527761|Temozolomide|temozolomide|mesh-list
24501264|NCT00527761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501265|NCT00527761|Tubulin Modulators|tubulin modulators|mesh-ancestor
24501267|NCT00527761|Mitosis Modulators|mitosis modulators|mesh-ancestor
24501268|NCT00527761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501269|NCT00527761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24501270|NCT00527761|Alkylating Agents|alkylating agents|mesh-ancestor
24501272|NCT00527800|Artemether|artemether|mesh-list
24501273|NCT00527800|Piperaquine|piperaquine|mesh-list
24501274|NCT00527800|Trimethoprim|trimethoprim|mesh-list
24501275|NCT00527800|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24501276|NCT00527800|Artenimol|artenimol|mesh-list
24501277|NCT00527800|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24501278|NCT00527800|Sulfamethoxazole|sulfamethoxazole|mesh-list
24501279|NCT00527800|Antimalarials|antimalarials|mesh-ancestor
24501526|NCT00529269|Mycophenolic Acid|mycophenolic acid|mesh-list
24501527|NCT00529269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24501826|NCT00531271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501827|NCT00531271|Tubulin Modulators|tubulin modulators|mesh-ancestor
24501828|NCT00531271|Antimitotic Agents|antimitotic agents|mesh-ancestor
24501829|NCT00531271|Mitosis Modulators|mitosis modulators|mesh-ancestor
24501830|NCT00531271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501865|NCT00531349|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24501866|NCT00531362|Aspirin|aspirin|mesh-list
24501867|NCT00531362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24501868|NCT00531362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24501869|NCT00531362|Analgesics|analgesics|mesh-ancestor
24501870|NCT00531362|Sensory System Agents|sensory system agents|mesh-ancestor
24501871|NCT00531362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24501872|NCT00531362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501873|NCT00531362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24501874|NCT00531362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24501875|NCT00531362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24501876|NCT00531362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24501877|NCT00531362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24501878|NCT00531362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24501879|NCT00531362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24501880|NCT00531362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24501929|NCT00531596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24501930|NCT00531635|Mycophenolic Acid|mycophenolic acid|mesh-list
24501931|NCT00531635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24501932|NCT00531635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24501933|NCT00531635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24501934|NCT00531635|Antitubercular Agents|antitubercular agents|mesh-ancestor
24501948|NCT00531687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24502024|NCT00531999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716957|NCT02403635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716958|NCT02403830|Morphine|morphine|mesh-list
25716959|NCT02403830|Methylnaltrexone|methylnaltrexone|mesh-list
25716960|NCT02403830|Ticagrelor|ticagrelor|mesh-list
25716961|NCT02403830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25716962|NCT02403830|Narcotics|narcotics|mesh-ancestor
25716963|NCT02403830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25716964|NCT02403830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502025|NCT00531999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25716965|NCT02403830|Analgesics|analgesics|mesh-ancestor
24502026|NCT00531999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24502027|NCT00531999|Antiviral Agents|antiviral agents|mesh-ancestor
24502028|NCT00531999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24502029|NCT00531999|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24502063|NCT05319899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24502064|NCT05319899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502065|NCT05319899|Lipotropic Agents|lipotropic agents|mesh-ancestor
24502066|NCT05319899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24502067|NCT05319899|Antimetabolites|antimetabolites|mesh-ancestor
24502068|NCT05319899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24502069|NCT05319899|Nootropic Agents|nootropic agents|mesh-ancestor
24502188|NCT05318248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24502189|NCT05318248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502190|NCT05318248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24502231|NCT05317676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24502232|NCT05317676|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24502233|NCT05317676|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
24502234|NCT05317676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24502235|NCT05317676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502237|NCT05317676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24502238|NCT05317611|Ondansetron|ondansetron|mesh-list
24502239|NCT05317611|Bupivacaine|bupivacaine|mesh-list
24502240|NCT05317611|Anesthetics, Local|anesthetics, local|mesh-ancestor
24502241|NCT05317611|Anesthetics|anesthetics|mesh-ancestor
24502242|NCT05317611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24502243|NCT05317611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502244|NCT05317611|Sensory System Agents|sensory system agents|mesh-ancestor
24502245|NCT05317611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24502246|NCT05317611|Antiemetics|antiemetics|mesh-ancestor
24502247|NCT05317611|Autonomic Agents|autonomic agents|mesh-ancestor
24502248|NCT05317611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24502257|NCT05317611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24502325|NCT05273671|Nalbuphine|nalbuphine|mesh-list
24502326|NCT05273671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24502327|NCT05273671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24502328|NCT05273671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502329|NCT05273671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24502330|NCT05273671|Analgesics|analgesics|mesh-ancestor
24502331|NCT05273671|Sensory System Agents|sensory system agents|mesh-ancestor
24502332|NCT05273671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24502340|NCT05273671|Narcotics|narcotics|mesh-ancestor
24502371|NCT05220722|Pembrolizumab|pembrolizumab|mesh-list
24502372|NCT05220722|Nivolumab|nivolumab|mesh-list
24502373|NCT05220722|Ipilimumab|ipilimumab|mesh-list
24502702|NCT04630886|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24502921|NCT04033419|Dopamine Agents|dopamine agents|mesh-ancestor
24502922|NCT04033419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24502923|NCT04033419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24502924|NCT04033419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24502925|NCT04033419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24502926|NCT04033419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24502928|NCT04020172|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24502929|NCT04020172|Sympathomimetics|sympathomimetics|mesh-ancestor
24502970|NCT03950817|Anesthetics, General|anesthetics, general|mesh-ancestor
24502971|NCT03950817|Anesthetics|anesthetics|mesh-ancestor
24502972|NCT03950817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25716966|NCT02403830|Sensory System Agents|sensory system agents|mesh-ancestor
25716967|NCT02403830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25716968|NCT02403830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25716969|NCT02403830|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25716970|NCT02403830|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25716971|NCT02403830|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25716972|NCT02403830|Purinergic Agents|purinergic agents|mesh-ancestor
24503093|NCT03288545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503094|NCT03288545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24503095|NCT03288545|Antimetabolites|antimetabolites|mesh-ancestor
24503096|NCT03288545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503097|NCT03288545|Antiviral Agents|antiviral agents|mesh-ancestor
24503098|NCT03288545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24503099|NCT03288545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503217|NCT02665143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24503219|NCT02665143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503220|NCT02550470|Sevoflurane|sevoflurane|mesh-list
24471193|NCT00393679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503221|NCT02550470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24503222|NCT02550470|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24503223|NCT02550470|Anesthetics, General|anesthetics, general|mesh-ancestor
24503310|NCT02274779|Leuprolide|leuprolide|mesh-list
24503322|NCT02143830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24503323|NCT02143830|Immunologic Factors|immunologic factors|mesh-ancestor
24503324|NCT02143830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503325|NCT02143830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24503326|NCT02143830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24503327|NCT02143830|Alkylating Agents|alkylating agents|mesh-ancestor
24503328|NCT02143830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503329|NCT02143830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503330|NCT02143830|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24503331|NCT02143830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25716973|NCT02403830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25716974|NCT02403830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716975|NCT02403830|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25716976|NCT02403895|Paclitaxel|paclitaxel|mesh-list
25716977|NCT02403895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25716978|NCT02403895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503555|NCT00532246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24503556|NCT00532246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503557|NCT00532246|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24503558|NCT00532246|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24503559|NCT00532246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24503561|NCT00532272|Goserelin|goserelin|mesh-list
24503562|NCT00532272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24503649|NCT00532519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24503650|NCT00532519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503661|NCT00532532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24503662|NCT00532545|Teriparatide|teriparatide|mesh-list
24503663|NCT00532545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24503664|NCT00532545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503777|NCT00532857|Tubulin Modulators|tubulin modulators|mesh-ancestor
24503778|NCT00532857|Antimitotic Agents|antimitotic agents|mesh-ancestor
24503779|NCT00532857|Mitosis Modulators|mitosis modulators|mesh-ancestor
24503790|NCT00532909|Bevacizumab|bevacizumab|mesh-list
24503796|NCT00532909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24503798|NCT00532909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503799|NCT00532909|Growth Inhibitors|growth inhibitors|mesh-ancestor
24503800|NCT00532909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24503801|NCT00532909|Antimetabolites|antimetabolites|mesh-ancestor
24503817|NCT00532961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24503818|NCT00532961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24503819|NCT00532961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24503820|NCT00533026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24503822|NCT00533026|Anticoagulants|anticoagulants|mesh-ancestor
24503823|NCT00533026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25716979|NCT02403895|Tubulin Modulators|tubulin modulators|mesh-ancestor
25716980|NCT02403895|Antimitotic Agents|antimitotic agents|mesh-ancestor
25716981|NCT02403895|Mitosis Modulators|mitosis modulators|mesh-ancestor
25716982|NCT02403895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716983|NCT02404025|Thymoglobulin|thymoglobulin|mesh-list
25716984|NCT02404025|Immunologic Factors|immunologic factors|mesh-ancestor
25716985|NCT02404025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716986|NCT02404025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25716987|NCT02404103|Flunisolide|flunisolide|mesh-list
25716988|NCT02404103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25716989|NCT02404103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24503824|NCT00533026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24503825|NCT00533026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24503826|NCT00533026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503827|NCT00533026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24503828|NCT00533026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503864|NCT00533247|Sensory System Agents|sensory system agents|mesh-ancestor
24503865|NCT00533247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24503866|NCT00533247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24503867|NCT00533247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24503868|NCT00533247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24503869|NCT00533247|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24503870|NCT00533247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24503871|NCT00533247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503872|NCT00533247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503873|NCT00533299|Hydralazine|hydralazine|mesh-list
24503874|NCT00533299|Valproic Acid|valproic acid|mesh-list
24503875|NCT00533299|Anticonvulsants|anticonvulsants|mesh-ancestor
24503876|NCT00533299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24503877|NCT00533299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503940|NCT00533468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24503941|NCT00533468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24503942|NCT00533468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24503943|NCT00533468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24503998|NCT00533637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24503999|NCT00533637|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
24504000|NCT00533637|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24504001|NCT00533637|Histamine Antagonists|histamine antagonists|mesh-ancestor
24504002|NCT00533637|Histamine Agents|histamine agents|mesh-ancestor
24504041|NCT00533923|Cyclosporins|cyclosporins|mesh-list
24504042|NCT00533923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24504043|NCT00533923|Immunologic Factors|immunologic factors|mesh-ancestor
24504044|NCT00533923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504045|NCT00533923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24504046|NCT00533923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24504047|NCT00533923|Alkylating Agents|alkylating agents|mesh-ancestor
24504270|NCT00534807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504271|NCT00534807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504278|NCT00534846|Toremifene|toremifene|mesh-list
24504314|NCT00535158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25716990|NCT02404103|Respiratory System Agents|respiratory system agents|mesh-ancestor
25716991|NCT02404168|Lamotrigine|lamotrigine|mesh-list
25716992|NCT02404168|Anticonvulsants|anticonvulsants|mesh-list
25716993|NCT02404168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25716994|NCT02404168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25716995|NCT02404168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25716996|NCT02404168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25716997|NCT02404168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25716998|NCT02404168|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25716999|NCT02404168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25771259|NCT03596723|Prednisolone|prednisolone|mesh-list
25771260|NCT03596723|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25771261|NCT03596723|Methylprednisolone|methylprednisolone|mesh-list
25771262|NCT03596723|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25771263|NCT03596723|Prednisolone acetate|prednisolone acetate|mesh-list
25771264|NCT03596723|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25771265|NCT03596723|Prednisolone phosphate|prednisolone phosphate|mesh-list
25771266|NCT03596723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25771267|NCT03596723|Glucocorticoids|glucocorticoids|mesh-ancestor
25771268|NCT03596723|Hormones|hormones|mesh-ancestor
25771269|NCT03596723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25771270|NCT03596723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771271|NCT03596723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25771272|NCT03596723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25771273|NCT03596723|Antiemetics|antiemetics|mesh-ancestor
25771274|NCT03596723|Autonomic Agents|autonomic agents|mesh-ancestor
25771275|NCT03596723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771276|NCT03596723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25771277|NCT03596723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24504436|NCT00536237|Antimetabolites|antimetabolites|mesh-ancestor
24504437|NCT00536237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24504450|NCT00536393|Doxorubicin|doxorubicin|mesh-list
24504451|NCT00536393|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24504452|NCT00536393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24504453|NCT00536393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504454|NCT00536393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24504455|NCT00536393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24504456|NCT00536393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504457|NCT00536393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504458|NCT00536419|Methylphenidate|methylphenidate|mesh-list
24504459|NCT00536419|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24504460|NCT00536419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504461|NCT00536419|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24504462|NCT00536419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24504465|NCT00536419|Dopamine Agents|dopamine agents|mesh-ancestor
24504472|NCT00536640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24504510|NCT00536692|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
24504511|NCT00536692|Autonomic Agents|autonomic agents|mesh-ancestor
24504512|NCT00536692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24504513|NCT00536692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24504568|NCT00536887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24504569|NCT00536887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24504570|NCT00536887|Antimetabolites|antimetabolites|mesh-ancestor
24504571|NCT00536887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504572|NCT00536887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24504573|NCT00536887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24504574|NCT00536887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504575|NCT00537121|Leucovorin|leucovorin|mesh-list
24504578|NCT00537121|Vorinostat|vorinostat|mesh-list
24504631|NCT00537472|Sensory System Agents|sensory system agents|mesh-ancestor
24504632|NCT00537472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24504636|NCT00537537|Telbivudine|telbivudine|mesh-list
24504637|NCT00537537|Antiviral Agents|antiviral agents|mesh-ancestor
24504638|NCT00537537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24504639|NCT00537537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24504640|NCT00537537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504747|NCT00537966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24504748|NCT00537966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24504749|NCT00537966|Antiviral Agents|antiviral agents|mesh-ancestor
24504750|NCT00537966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24504751|NCT00537966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24504823|NCT00538265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504824|NCT00538265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24504825|NCT00538265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504826|NCT00538265|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24504827|NCT00538265|Antitubercular Agents|antitubercular agents|mesh-ancestor
24504828|NCT00538265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24504830|NCT00538317|Tirofiban|tirofiban|mesh-list
24504845|NCT00538382|Artesunate|artesunate|mesh-list
24504846|NCT00538382|Antimalarials|antimalarials|mesh-ancestor
24504847|NCT00538382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24504848|NCT00538382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24504849|NCT00538382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24504850|NCT00538382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504851|NCT00538382|Antiviral Agents|antiviral agents|mesh-ancestor
24504852|NCT00538382|Schistosomicides|schistosomicides|mesh-ancestor
24504856|NCT00538395|Doxorubicin|doxorubicin|mesh-list
24504857|NCT00538395|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24504858|NCT00538395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24504927|NCT00538538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504929|NCT00538564|Vasodilator Agents|vasodilator agents|mesh-ancestor
24504930|NCT00538564|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24504931|NCT00538564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24504932|NCT00538564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24504933|NCT00538564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504934|NCT00538564|Urological Agents|urological agents|mesh-ancestor
24504935|NCT00538603|Paclitaxel|paclitaxel|mesh-list
24504936|NCT00538603|Carboplatin|carboplatin|mesh-list
24504937|NCT00538603|Doxorubicin|doxorubicin|mesh-list
24504938|NCT00538603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24504939|NCT00538603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24504940|NCT00538603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24504941|NCT00538603|Tubulin Modulators|tubulin modulators|mesh-ancestor
24504942|NCT00538603|Antimitotic Agents|antimitotic agents|mesh-ancestor
24504943|NCT00538603|Mitosis Modulators|mitosis modulators|mesh-ancestor
24504944|NCT00538603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24504945|NCT00538603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24504946|NCT00538603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24504947|NCT00538603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24504952|NCT00538655|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24504956|NCT00538694|Daptomycin|daptomycin|mesh-list
24505072|NCT00539565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505073|NCT00539565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24505074|NCT00539565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505076|NCT00539630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759035|NCT01749098|Sensory System Agents|sensory system agents|mesh-ancestor
24759036|NCT01749098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24759037|NCT01749098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759038|NCT01749098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24759039|NCT01749098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24759092|NCT01749228|Sensory System Agents|sensory system agents|mesh-ancestor
24759093|NCT01749228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24759094|NCT01749228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759095|NCT01749228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24759096|NCT01749228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24664407|NCT01306708|Analgesics|analgesics|mesh-ancestor
24759097|NCT01749228|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24759098|NCT01749228|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24759099|NCT01749228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24759100|NCT01749228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759101|NCT01749241|Loteprednol Etabonate|loteprednol etabonate|mesh-list
24759102|NCT01749241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24759103|NCT01749319|Baclofen|baclofen|mesh-list
24759104|NCT01749319|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
24759105|NCT01749319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759106|NCT01749319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24759107|NCT01749319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24759108|NCT01749319|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24759109|NCT01749319|GABA Agonists|gaba agonists|mesh-ancestor
24759110|NCT01749319|GABA Agents|gaba agents|mesh-ancestor
24759111|NCT01749319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24759112|NCT01749319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759114|NCT01749371|Vitamin E|vitamin e|mesh-list
24759115|NCT01749371|Tocopherols|tocopherols|mesh-list
24759131|NCT01749384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24759132|NCT01749384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24759133|NCT01749384|Growth Substances|growth substances|mesh-ancestor
24759134|NCT01749384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759135|NCT01749384|Growth Inhibitors|growth inhibitors|mesh-ancestor
24759136|NCT01749384|Immunologic Factors|immunologic factors|mesh-ancestor
24759137|NCT01749397|Fluorouracil|fluorouracil|mesh-list
24759138|NCT01749397|Floxuridine|floxuridine|mesh-list
24759139|NCT01749397|Veliparib|veliparib|mesh-list
24759140|NCT01749397|Deoxyuridine|deoxyuridine|mesh-list
24759141|NCT01749397|Antimetabolites|antimetabolites|mesh-ancestor
24759142|NCT01749397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24664427|NCT01306721|Nasal Decongestants|nasal decongestants|mesh-ancestor
24759143|NCT01749397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24759144|NCT01749397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759145|NCT01749397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24759146|NCT01749397|Immunologic Factors|immunologic factors|mesh-ancestor
24759147|NCT01749397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759331|NCT01750645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759332|NCT01750645|Cholinergic Agents|cholinergic agents|mesh-ancestor
24759333|NCT01750645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24759334|NCT01750645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759335|NCT01750723|Acetazolamide|acetazolamide|mesh-list
24759336|NCT01750723|Anticonvulsants|anticonvulsants|mesh-ancestor
24759375|NCT01750983|Lenalidomide|lenalidomide|mesh-list
24759377|NCT01750983|Immunologic Factors|immunologic factors|mesh-ancestor
24759379|NCT01750983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24759547|NCT01752322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24759548|NCT01752322|Sensory System Agents|sensory system agents|mesh-ancestor
24759549|NCT01752322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24759550|NCT01752322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24759551|NCT01752322|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24471931|NCT00397501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24471932|NCT00397501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24471933|NCT00397501|Immunologic Factors|immunologic factors|mesh-ancestor
24759552|NCT01752322|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24759553|NCT01752322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24759554|NCT01752322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24759555|NCT01752517|Vinorelbine|vinorelbine|mesh-list
24759557|NCT01752517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24759558|NCT01752517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24759559|NCT01752517|Tubulin Modulators|tubulin modulators|mesh-ancestor
24759560|NCT01752517|Antimitotic Agents|antimitotic agents|mesh-ancestor
24759561|NCT01752517|Mitosis Modulators|mitosis modulators|mesh-ancestor
24460629|NCT00349089|Antimitotic Agents|antimitotic agents|mesh-ancestor
24460630|NCT00349089|Mitosis Modulators|mitosis modulators|mesh-ancestor
24460631|NCT00349115|Thalidomide|thalidomide|mesh-list
24460632|NCT00349115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24461521|NCT00352521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24461523|NCT00352521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24461524|NCT00352521|Growth Inhibitors|growth inhibitors|mesh-ancestor
24461525|NCT00352521|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24461526|NCT00352521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24461527|NCT00352521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461528|NCT00352521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461529|NCT00352599|Lovastatin|lovastatin|mesh-list
24461530|NCT00352599|L 647318|l 647318|mesh-list
24461531|NCT00352599|Dihydromevinolin|dihydromevinolin|mesh-list
24461533|NCT00352599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24461534|NCT00352599|Antimetabolites|antimetabolites|mesh-ancestor
24461535|NCT00352599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24461536|NCT00352599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24461538|NCT00352599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24461560|NCT00352651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24461561|NCT00352651|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24461562|NCT00352651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24461563|NCT00352651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25717000|NCT02404168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25717001|NCT02404168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25717002|NCT02404168|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25717003|NCT02404220|Dexamethasone|dexamethasone|mesh-list
25717004|NCT02404220|Vincristine|vincristine|mesh-list
25717005|NCT02404220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25717006|NCT02404220|Antiemetics|antiemetics|mesh-ancestor
25717007|NCT02404220|Autonomic Agents|autonomic agents|mesh-ancestor
25717008|NCT02404220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24461564|NCT00352651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25717009|NCT02404220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717010|NCT02404220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24461566|NCT00352677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24462164|NCT00355277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24462165|NCT00355277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462166|NCT00355277|Adrenergic Agents|adrenergic agents|mesh-ancestor
24462167|NCT00355277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24462169|NCT00355290|Vitamins|vitamins|mesh-ancestor
24462170|NCT00355290|Micronutrients|micronutrients|mesh-ancestor
24462171|NCT00355290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462172|NCT00355290|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24462173|NCT00355290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24462174|NCT00355290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462175|NCT00355290|Hemostatics|hemostatics|mesh-ancestor
24462205|NCT00355524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24462206|NCT00355524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462207|NCT00355524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24462208|NCT00355524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24462209|NCT00355524|Antiviral Agents|antiviral agents|mesh-ancestor
24462353|NCT00355862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462354|NCT00355862|Antifungal Agents|antifungal agents|mesh-ancestor
24462355|NCT00355862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24462356|NCT00355862|Dermatologic Agents|dermatologic agents|mesh-ancestor
24462392|NCT00355966|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24462393|NCT00355966|Abortifacient Agents|abortifacient agents|mesh-ancestor
24471969|NCT00397657|Vitamins|vitamins|mesh-ancestor
24462394|NCT00355966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24462395|NCT00355966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462415|NCT00356070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462416|NCT00356070|Adrenergic Agents|adrenergic agents|mesh-ancestor
24462417|NCT00356070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24462418|NCT00356070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462420|NCT00356083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24462421|NCT00356083|Narcotics|narcotics|mesh-ancestor
24462422|NCT00356083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24462423|NCT00356083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24434374|NCT00262327|Endostatins|endostatins|mesh-list
24462427|NCT00356083|Antitussive Agents|antitussive agents|mesh-ancestor
24462429|NCT00356096|Pramipexole|pramipexole|mesh-list
24462430|NCT00356096|Antioxidants|antioxidants|mesh-ancestor
24462431|NCT00356096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462572|NCT00357019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24462573|NCT00357019|Respiratory System Agents|respiratory system agents|mesh-ancestor
24462574|NCT00357019|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24462575|NCT00357019|Histamine Antagonists|histamine antagonists|mesh-ancestor
24462576|NCT00357019|Histamine Agents|histamine agents|mesh-ancestor
24462577|NCT00357019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24462578|NCT00357019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24462579|NCT00357019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24462580|NCT00357019|Protective Agents|protective agents|mesh-ancestor
24462581|NCT00357019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24462583|NCT00357045|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24462787|NCT00357604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24462788|NCT00357604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24462789|NCT00357604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24462792|NCT00357604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24462793|NCT00357604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24462796|NCT00357604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24462797|NCT00357604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24462798|NCT00357604|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24462799|NCT00357604|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24462800|NCT00357604|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24462801|NCT00357604|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
24462802|NCT00357604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24628898|NCT01101802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24628937|NCT01102101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628939|NCT01102101|Sensory System Agents|sensory system agents|mesh-ancestor
24628940|NCT01102101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24628941|NCT01102114|Vaccines|vaccines|mesh-list
25717011|NCT02404220|Glucocorticoids|glucocorticoids|mesh-ancestor
25717012|NCT02404220|Hormones|hormones|mesh-ancestor
25771278|NCT03596723|Protective Agents|protective agents|mesh-ancestor
25771279|NCT03597009|Nivolumab|nivolumab|mesh-list
24628942|NCT01102114|Immunologic Factors|immunologic factors|mesh-ancestor
24628943|NCT01102114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24628944|NCT01102244|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
24628945|NCT01102244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24462828|NCT00357630|Immunologic Factors|immunologic factors|mesh-ancestor
24628949|NCT01102244|Hormones|hormones|mesh-ancestor
24628999|NCT01102478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24629000|NCT01102478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24629001|NCT01102478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24629002|NCT01102478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24629003|NCT01102478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629004|NCT01102478|Diuretics|diuretics|mesh-ancestor
24629005|NCT01102478|Natriuretic Agents|natriuretic agents|mesh-ancestor
24629006|NCT01102478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629007|NCT01102478|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24629008|NCT01102478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24629043|NCT01102686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629045|NCT01102699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24629046|NCT01102699|Immunologic Factors|immunologic factors|mesh-ancestor
24629048|NCT01102946|Ranibizumab|ranibizumab|mesh-list
24629158|NCT01103401|Protease Inhibitors|protease inhibitors|mesh-ancestor
24629194|NCT01103583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24629228|NCT01103739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629229|NCT01103739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24629230|NCT01103739|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24629231|NCT01103739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24629232|NCT01103791|Docetaxel|docetaxel|mesh-list
24629233|NCT01103791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629234|NCT01103791|Tubulin Modulators|tubulin modulators|mesh-ancestor
24629235|NCT01103791|Antimitotic Agents|antimitotic agents|mesh-ancestor
24629236|NCT01103791|Mitosis Modulators|mitosis modulators|mesh-ancestor
24629241|NCT01103817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629242|NCT01103817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24629287|NCT01104259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24629288|NCT01104259|Tubulin Modulators|tubulin modulators|mesh-ancestor
24629289|NCT01104259|Antimitotic Agents|antimitotic agents|mesh-ancestor
24629290|NCT01104259|Mitosis Modulators|mitosis modulators|mesh-ancestor
24629301|NCT01104298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24629302|NCT01104298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24629303|NCT01104298|Alkylating Agents|alkylating agents|mesh-ancestor
24629406|NCT01105013|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24629407|NCT01105013|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24629408|NCT01105208|Cephalexin|cephalexin|mesh-list
24629409|NCT01105208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24629410|NCT01105208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24629411|NCT01105234|Vitamin D|vitamin d|mesh-list
24629471|NCT01105390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24629472|NCT01105390|Immunologic Factors|immunologic factors|mesh-ancestor
24629473|NCT01105390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629474|NCT01105481|Amisulpride|amisulpride|mesh-list
24629475|NCT01105481|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24629476|NCT01105481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24665106|NCT01310244|Paclitaxel|paclitaxel|mesh-list
24629683|NCT01107145|Antimalarials|antimalarials|mesh-ancestor
24629684|NCT01107145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24629685|NCT01107145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24629686|NCT01107145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24629687|NCT01107145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629688|NCT01107145|Antiviral Agents|antiviral agents|mesh-ancestor
24629689|NCT01107145|Schistosomicides|schistosomicides|mesh-ancestor
24629690|NCT01107145|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24629691|NCT01107145|Anthelmintics|anthelmintics|mesh-ancestor
24629692|NCT01107145|Amebicides|amebicides|mesh-ancestor
24629693|NCT01107145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24629694|NCT01107145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24629695|NCT01107145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24629696|NCT01107145|Analgesics|analgesics|mesh-ancestor
24629697|NCT01107145|Sensory System Agents|sensory system agents|mesh-ancestor
24629698|NCT01107145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24629721|NCT01107431|Trace Elements|trace elements|mesh-ancestor
24629722|NCT01107431|Micronutrients|micronutrients|mesh-ancestor
24629724|NCT01107470|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24629725|NCT01107470|Hormones|hormones|mesh-ancestor
24629726|NCT01107470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24629727|NCT01107470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629728|NCT01107509|Everolimus|everolimus|mesh-list
24629729|NCT01107509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629773|NCT01107808|Vitamin D|vitamin d|mesh-list
24629839|NCT01108107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24629955|NCT01108874|Autonomic Agents|autonomic agents|mesh-ancestor
24629956|NCT01108874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24629957|NCT01108874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24629958|NCT01108874|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24629959|NCT01108874|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
24629960|NCT01108874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24629965|NCT01108900|Sildenafil Citrate|sildenafil citrate|mesh-list
24630029|NCT01109043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630030|NCT01109043|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24630047|NCT01109134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24630048|NCT01109134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24630049|NCT01109134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630050|NCT01109134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24630051|NCT01109160|Azithromycin|azithromycin|mesh-list
24630053|NCT01109160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24630054|NCT01109212|Bindarit|bindarit|mesh-list
24630055|NCT01109212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24630056|NCT01109212|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24630057|NCT01109212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24630058|NCT01109212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630060|NCT01109264|Chlorambucil|chlorambucil|mesh-list
24630164|NCT01109784|Clopidogrel|clopidogrel|mesh-list
24630165|NCT01109784|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
24630166|NCT01109784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24630167|NCT01109784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24630168|NCT01109784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
24630169|NCT01109784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24630170|NCT01109784|Purinergic Agents|purinergic agents|mesh-ancestor
24630171|NCT01109784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24630172|NCT01109784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630174|NCT01109823|Levofloxacin|levofloxacin|mesh-list
24630411|NCT01111591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24630413|NCT01111591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630414|NCT01111630|Epoetin Alfa|epoetin alfa|mesh-list
24630451|NCT01111734|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24630452|NCT01111734|Antioxidants|antioxidants|mesh-ancestor
24630453|NCT01111734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630454|NCT01111734|Protective Agents|protective agents|mesh-ancestor
24630455|NCT01111734|Antidotes|antidotes|mesh-ancestor
24630456|NCT01111747|Mitogens|mitogens|mesh-list
24630457|NCT01111747|Mitosis Modulators|mitosis modulators|mesh-ancestor
24630458|NCT01111747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630459|NCT01111864|Micronutrients|micronutrients|mesh-list
24630460|NCT01111864|Trace Elements|trace elements|mesh-list
24630461|NCT01111864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630462|NCT01111890|Timolol|timolol|mesh-list
24630463|NCT01111890|Dorzolamide|dorzolamide|mesh-list
24630464|NCT01111890|Brinzolamide|brinzolamide|mesh-list
24630465|NCT01111890|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24630531|NCT01112137|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24630532|NCT01112137|Purinergic Agents|purinergic agents|mesh-ancestor
24630533|NCT01112137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24630534|NCT01112137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630535|NCT01112137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630537|NCT01112215|Azathioprine|azathioprine|mesh-list
24630538|NCT01112215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24630539|NCT01112215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24630544|NCT01112215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24630638|NCT01112852|Somatostatin|somatostatin|mesh-list
24630639|NCT01112852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24630640|NCT01112852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24630641|NCT01112852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630642|NCT01112852|Hormones|hormones|mesh-ancestor
24630643|NCT01112852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24630644|NCT01112852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630645|NCT01112878|Clonidine|clonidine|mesh-list
24630646|NCT01112878|Gabapentin|gabapentin|mesh-list
24630647|NCT01112878|Analgesics|analgesics|mesh-ancestor
24630648|NCT01112878|Sensory System Agents|sensory system agents|mesh-ancestor
24630817|NCT01114048|Bortezomib|bortezomib|mesh-list
24630818|NCT01114048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24630920|NCT01115049|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24630921|NCT01115049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24630925|NCT01115062|Anesthetics, Local|anesthetics, local|mesh-ancestor
24630926|NCT01115062|Anesthetics|anesthetics|mesh-ancestor
24630927|NCT01115062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24630928|NCT01115062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24630929|NCT01115062|Sensory System Agents|sensory system agents|mesh-ancestor
24630937|NCT01115127|Melatonin|melatonin|mesh-list
24630938|NCT01115127|Antioxidants|antioxidants|mesh-ancestor
24630967|NCT01115322|Dermatologic Agents|dermatologic agents|mesh-ancestor
24630968|NCT01115322|Keratolytic Agents|keratolytic agents|mesh-ancestor
24630969|NCT01115322|Vitamin B Complex|vitamin b complex|mesh-ancestor
24631047|NCT01115959|Anticonvulsants|anticonvulsants|mesh-ancestor
24631048|NCT01115959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631049|NCT01115959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631050|NCT01115959|GABA Agents|gaba agents|mesh-ancestor
24631051|NCT01115959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24631052|NCT01115959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631053|NCT01115959|Antimanic Agents|antimanic agents|mesh-ancestor
24631054|NCT01115959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24631055|NCT01115959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24631056|NCT01115959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24631057|NCT01115972|Valsartan|valsartan|mesh-list
24631058|NCT01115972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24631059|NCT01115972|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24631060|NCT01115972|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24631061|NCT01115972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631062|NCT01115985|Atorvastatin|atorvastatin|mesh-list
24631063|NCT01115985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24631112|NCT01116154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631113|NCT01116154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631115|NCT01116167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24631116|NCT01116167|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24631117|NCT01116167|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24631118|NCT01116167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631128|NCT01116180|Angiotensinogen|angiotensinogen|mesh-list
24631212|NCT01116531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24631213|NCT01116531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24631215|NCT01116531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24631216|NCT01116531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24631217|NCT01116531|Antidepressive Agents|antidepressive agents|mesh-ancestor
24631218|NCT01116531|Dopamine Agents|dopamine agents|mesh-ancestor
24631219|NCT01116531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24631220|NCT01116531|Narcotics|narcotics|mesh-ancestor
24631222|NCT01116583|Analgesics|analgesics|mesh-ancestor
24631223|NCT01116583|Sensory System Agents|sensory system agents|mesh-ancestor
24631296|NCT01116713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24631298|NCT01116791|Cisplatin|cisplatin|mesh-list
24631299|NCT01116791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24631300|NCT01116817|Ritonavir|ritonavir|mesh-list
24631301|NCT01116817|Lopinavir|lopinavir|mesh-list
24631527|NCT01118702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24631528|NCT01118702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631529|NCT01118702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24631530|NCT01118702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24631563|NCT01118884|Antipruritics|antipruritics|mesh-ancestor
24631564|NCT01118884|Dermatologic Agents|dermatologic agents|mesh-ancestor
24631565|NCT01118884|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
24631566|NCT01118884|Histamine Antagonists|histamine antagonists|mesh-ancestor
24631567|NCT01118884|Histamine Agents|histamine agents|mesh-ancestor
24631568|NCT01118884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24631569|NCT01118884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631570|NCT01118884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631571|NCT01118884|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24631787|NCT01120158|Growth Substances|growth substances|mesh-ancestor
24631788|NCT01120158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631789|NCT01120158|Growth Inhibitors|growth inhibitors|mesh-ancestor
24631790|NCT01120171|Cyclophosphamide|cyclophosphamide|mesh-list
24631791|NCT01120171|Doxorubicin|doxorubicin|mesh-list
24631792|NCT01120171|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24631793|NCT01120171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24631794|NCT01120171|Immunologic Factors|immunologic factors|mesh-ancestor
24631795|NCT01120171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631796|NCT01120171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24631894|NCT01120795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631895|NCT01120795|Immunologic Factors|immunologic factors|mesh-ancestor
24631896|NCT01120795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24631897|NCT01120821|Imatinib Mesylate|imatinib mesylate|mesh-list
24631898|NCT01120821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24631899|NCT01120821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24631900|NCT01120821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24631901|NCT01120821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24631902|NCT01120912|Insulin|insulin|mesh-list
24631903|NCT01120912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24631949|NCT01121120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24631950|NCT01121120|Vasodilator Agents|vasodilator agents|mesh-ancestor
24631951|NCT01121133|Rifampin|rifampin|mesh-list
24631952|NCT01121133|Navitoclax|navitoclax|mesh-list
24631953|NCT01121133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24631954|NCT01121133|Antitubercular Agents|antitubercular agents|mesh-ancestor
24631955|NCT01121133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24631956|NCT01121133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24631957|NCT01121133|Leprostatic Agents|leprostatic agents|mesh-ancestor
24631968|NCT01121198|Ipragliflozin|ipragliflozin|mesh-list
24632016|NCT01121705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24632017|NCT01121705|Antimetabolites|antimetabolites|mesh-ancestor
24632018|NCT01121705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632019|NCT01121705|Immunologic Factors|immunologic factors|mesh-ancestor
24632020|NCT01121705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451783|NCT00324792|Insulin|insulin|mesh-list
24632035|NCT01121770|PENTA|penta|mesh-list
24632036|NCT01121770|Fondaparinux|fondaparinux|mesh-list
24632037|NCT01121770|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
24632038|NCT01121770|Antithrombins|antithrombins|mesh-ancestor
24632039|NCT01121770|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24632040|NCT01121770|Protease Inhibitors|protease inhibitors|mesh-ancestor
24632041|NCT01121770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632042|NCT01121770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632083|NCT01121848|Immunologic Factors|immunologic factors|mesh-ancestor
24632084|NCT01121848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632085|NCT01121848|Antidotes|antidotes|mesh-ancestor
24632086|NCT01121848|Protective Agents|protective agents|mesh-ancestor
24632087|NCT01121848|Vitamin B Complex|vitamin b complex|mesh-ancestor
24632088|NCT01121848|Vitamins|vitamins|mesh-ancestor
24632089|NCT01121848|Micronutrients|micronutrients|mesh-ancestor
24632090|NCT01122004|Pregabalin|pregabalin|mesh-list
24632091|NCT01122004|Analgesics|analgesics|mesh-ancestor
24632104|NCT01122056|Interferons|interferons|mesh-list
24632160|NCT01122368|Micafungin|micafungin|mesh-list
24632161|NCT01122368|Antifungal Agents|antifungal agents|mesh-ancestor
24632162|NCT01122368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24632163|NCT01122407|Trimethaphan|trimethaphan|mesh-list
24632164|NCT01122407|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
24632166|NCT01122407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24632199|NCT01122602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632200|NCT01122602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24632202|NCT01122602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24632203|NCT01122602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24632204|NCT01122602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24632205|NCT01122602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24632206|NCT01122602|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24632228|NCT01122641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632229|NCT01122641|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24632230|NCT01122641|Protease Inhibitors|protease inhibitors|mesh-ancestor
24632231|NCT01122641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24632643|NCT01124877|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24632644|NCT01124877|Dopamine Agents|dopamine agents|mesh-ancestor
24632645|NCT01125020|Gemcitabine|gemcitabine|mesh-list
24632646|NCT01125020|Doxorubicin|doxorubicin|mesh-list
24632647|NCT01125020|Oxaliplatin|oxaliplatin|mesh-list
24632652|NCT01125020|Antiviral Agents|antiviral agents|mesh-ancestor
24632653|NCT01125020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24632711|NCT01125410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24632712|NCT01125423|Milnacipran|milnacipran|mesh-list
24632713|NCT01125423|Levomilnacipran|levomilnacipran|mesh-list
24632714|NCT01125423|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24632715|NCT01125423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24632716|NCT01125423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24632830|NCT01125787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24632832|NCT01125787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24632833|NCT01125891|Gemcitabine|gemcitabine|mesh-list
24632834|NCT01125891|ON 01910|on 01910|mesh-list
24632835|NCT01125891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24632836|NCT01125891|Antimetabolites|antimetabolites|mesh-ancestor
24633140|NCT01127360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24633141|NCT01127360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24633142|NCT01127360|Growth Substances|growth substances|mesh-ancestor
24633203|NCT01127568|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24633204|NCT01127568|Adrenergic Agents|adrenergic agents|mesh-ancestor
24633205|NCT01127568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24633206|NCT01127568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633207|NCT01127568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633532|NCT01129856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24633533|NCT01129856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24633534|NCT01129856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24633561|NCT01129934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633562|NCT01129934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24633563|NCT01129934|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24633564|NCT01129934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24633565|NCT01129934|Anesthetics, Local|anesthetics, local|mesh-ancestor
24633566|NCT01129934|Anesthetics|anesthetics|mesh-ancestor
24633567|NCT01129934|Antiemetics|antiemetics|mesh-ancestor
24633568|NCT01129934|Autonomic Agents|autonomic agents|mesh-ancestor
24633569|NCT01129934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24633570|NCT01130025|Tinzaparin|tinzaparin|mesh-list
24633571|NCT01130025|Warfarin|warfarin|mesh-list
24633572|NCT01130025|Anticoagulants|anticoagulants|mesh-ancestor
24633573|NCT01130025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24633574|NCT01130025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24633575|NCT01130025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633681|NCT01130688|Hormone Antagonists|hormone antagonists|mesh-ancestor
24633711|NCT01130909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24633712|NCT01130909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24633713|NCT01130909|Anesthetics, General|anesthetics, general|mesh-ancestor
24633715|NCT01130909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24633716|NCT01130909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24633717|NCT01130909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24633718|NCT01130909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24633719|NCT01130909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24633720|NCT01130922|Moxifloxacin|moxifloxacin|mesh-list
24633721|NCT01130922|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
24394723|NCT00134030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24394741|NCT00134069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24394742|NCT00134069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24394743|NCT00134069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24394744|NCT00134069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394745|NCT00134069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394746|NCT00134069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24394748|NCT00134095|Tegafur|tegafur|mesh-list
24394749|NCT00134095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24394750|NCT00134095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24394751|NCT00134095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394752|NCT00134095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394753|NCT00134095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24394754|NCT00134095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24395112|NCT00135122|Hormones|hormones|mesh-ancestor
24395113|NCT00135122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24395114|NCT00135122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395115|NCT00135122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24395116|NCT00135122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24395117|NCT00135122|Antiemetics|antiemetics|mesh-ancestor
24395118|NCT00135122|Autonomic Agents|autonomic agents|mesh-ancestor
24395119|NCT00135122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24395121|NCT00135122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24395122|NCT00135122|Protective Agents|protective agents|mesh-ancestor
24395123|NCT00135135|Carboplatin|carboplatin|mesh-list
24395124|NCT00135135|Doxorubicin|doxorubicin|mesh-list
24395125|NCT00135135|Irinotecan|irinotecan|mesh-list
24395126|NCT00135135|Etoposide|etoposide|mesh-list
24395127|NCT00135135|Melphalan|melphalan|mesh-list
24395179|NCT00135408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
24395204|NCT00135434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24395205|NCT00135473|Insulin|insulin|mesh-list
24395206|NCT00135473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24395207|NCT00135473|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
24395208|NCT00135473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24395209|NCT00135473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395210|NCT00135473|Plasma Substitutes|plasma substitutes|mesh-ancestor
24395211|NCT00135473|Blood Substitutes|blood substitutes|mesh-ancestor
24395212|NCT00135499|Prednisone|prednisone|mesh-list
24422048|NCT00221156|Acarbose|acarbose|mesh-list
24395213|NCT00135499|Cyclophosphamide|cyclophosphamide|mesh-list
24395214|NCT00135499|Rituximab|rituximab|mesh-list
24395215|NCT00135499|Doxorubicin|doxorubicin|mesh-list
24395216|NCT00135499|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24395217|NCT00135499|Vincristine|vincristine|mesh-list
24395218|NCT00135499|Bleomycin|bleomycin|mesh-list
24395219|NCT00135499|Vindesine|vindesine|mesh-list
24395220|NCT00135499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24395221|NCT00135499|Immunologic Factors|immunologic factors|mesh-ancestor
24395222|NCT00135499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395223|NCT00135499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24395224|NCT00135499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24395225|NCT00135499|Alkylating Agents|alkylating agents|mesh-ancestor
24395226|NCT00135499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395227|NCT00135499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24395228|NCT00135499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24395229|NCT00135499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24395287|NCT00135668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395288|NCT00135681|Nedocromil|nedocromil|mesh-list
24395289|NCT00135681|Budesonide|budesonide|mesh-list
25717013|NCT02404220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25717014|NCT02404220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24395421|NCT00135954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395422|NCT00135954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24395472|NCT00136058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24395473|NCT00136058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395474|NCT00136058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24395475|NCT00136058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24395476|NCT00136058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395477|NCT00136058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24395893|NCT00137098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24395894|NCT00137098|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24395896|NCT00137098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24395897|NCT00137098|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24396012|NCT00137566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24396013|NCT00137566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396014|NCT00137566|Antipyretics|antipyretics|mesh-ancestor
24396063|NCT00137735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24396064|NCT00137735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396065|NCT00137735|Antimanic Agents|antimanic agents|mesh-ancestor
24396067|NCT00137761|Gefitinib|gefitinib|mesh-list
24396068|NCT00137761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396069|NCT00137761|Tubulin Modulators|tubulin modulators|mesh-ancestor
24396070|NCT00137761|Antimitotic Agents|antimitotic agents|mesh-ancestor
24396071|NCT00137761|Mitosis Modulators|mitosis modulators|mesh-ancestor
24396072|NCT00137761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396073|NCT00137761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24396074|NCT00137761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396075|NCT00137774|Bevacizumab|bevacizumab|mesh-list
24396213|NCT00138177|Leucovorin|leucovorin|mesh-list
24396272|NCT00138242|Mitosis Modulators|mitosis modulators|mesh-ancestor
24396273|NCT00138242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396274|NCT00138359|Niclosamide|niclosamide|mesh-list
24396275|NCT00138359|Anticestodal Agents|anticestodal agents|mesh-ancestor
24396276|NCT00138359|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24396277|NCT00138359|Anthelmintics|anthelmintics|mesh-ancestor
24396278|NCT00138359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24396279|NCT00138359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24396280|NCT00138359|Antinematodal Agents|antinematodal agents|mesh-ancestor
24396281|NCT00138411|Ciprofloxacin|ciprofloxacin|mesh-list
24396282|NCT00138411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24396283|NCT00138411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24396284|NCT00138411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24396285|NCT00138411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24396286|NCT00138411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396287|NCT00138411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396288|NCT00138411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396291|NCT00138515|Vildagliptin|vildagliptin|mesh-list
24396324|NCT00138580|Protease Inhibitors|protease inhibitors|mesh-ancestor
24396325|NCT00138580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396326|NCT00138580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396327|NCT00138593|Vildagliptin|vildagliptin|mesh-list
24396335|NCT00138606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24396336|NCT00138606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396337|NCT00138606|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24396338|NCT00138606|Protease Inhibitors|protease inhibitors|mesh-ancestor
24396339|NCT00138606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396340|NCT00138606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396341|NCT00138619|Vildagliptin|vildagliptin|mesh-list
24396342|NCT00138619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24396343|NCT00138619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396344|NCT00138619|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
24396345|NCT00138619|Protease Inhibitors|protease inhibitors|mesh-ancestor
24396346|NCT00138619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396347|NCT00138619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396348|NCT00138632|Vatalanib|vatalanib|mesh-list
24396349|NCT00138632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24396350|NCT00138632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396351|NCT00138632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396352|NCT00138710|Letrozole|letrozole|mesh-list
24396355|NCT00138710|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24396356|NCT00138710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396357|NCT00138710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396358|NCT00138710|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24396359|NCT00138710|Hormone Antagonists|hormone antagonists|mesh-ancestor
24396360|NCT00138710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24396361|NCT00138710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396367|NCT00138801|Doxycycline|doxycycline|mesh-list
24396373|NCT00138801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24396379|NCT00138866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396380|NCT00138866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24396382|NCT00138944|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24396383|NCT00138944|Hormone Antagonists|hormone antagonists|mesh-ancestor
24396384|NCT00138944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24396385|NCT00138944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396386|NCT00138944|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24396387|NCT00138944|Diuretics|diuretics|mesh-ancestor
24396388|NCT00138944|Natriuretic Agents|natriuretic agents|mesh-ancestor
24396389|NCT00138944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24396479|NCT00139074|GABA Agents|gaba agents|mesh-ancestor
24396480|NCT00139074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24396481|NCT00139074|Antimanic Agents|antimanic agents|mesh-ancestor
24396482|NCT00139100|Anti-Infective Agents|anti-infective agents|mesh-list
24396483|NCT00139100|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24396484|NCT00139152|Omalizumab|omalizumab|mesh-list
24396485|NCT00139152|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
24396486|NCT00139152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24396487|NCT00139152|Respiratory System Agents|respiratory system agents|mesh-ancestor
24396488|NCT00139165|Budesonide|budesonide|mesh-list
24396489|NCT00139165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24396490|NCT00139165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24396491|NCT00139165|Autonomic Agents|autonomic agents|mesh-ancestor
24396492|NCT00139165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24396511|NCT00139217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396512|NCT00139217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24396513|NCT00139217|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24396514|NCT00139217|Vasodilator Agents|vasodilator agents|mesh-ancestor
24396515|NCT00139217|Gasotransmitters|gasotransmitters|mesh-ancestor
24396516|NCT00139217|Protective Agents|protective agents|mesh-ancestor
24396517|NCT00139230|Leucovorin|leucovorin|mesh-list
24396590|NCT00139282|Growth Substances|growth substances|mesh-ancestor
24396591|NCT00139282|Growth Inhibitors|growth inhibitors|mesh-ancestor
24396593|NCT00139360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24396594|NCT00139360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396656|NCT00139581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396658|NCT00139620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24396659|NCT00139620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24396660|NCT00139620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24396723|NCT00139750|Cholinergic Agents|cholinergic agents|mesh-ancestor
24396724|NCT00139750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25415995|NCT02978625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24396725|NCT00139750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396726|NCT00139750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24396730|NCT00139815|Anticoagulants|anticoagulants|mesh-ancestor
24396731|NCT00139815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24396732|NCT00139815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24396733|NCT00139815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24396987|NCT00140517|Renal Agents|renal agents|mesh-ancestor
24396994|NCT00140530|Mitosis Modulators|mitosis modulators|mesh-ancestor
24396995|NCT00140530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397052|NCT00140647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397053|NCT00140647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24397054|NCT00140660|Rituximab|rituximab|mesh-list
24397055|NCT00140660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24397056|NCT00140660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24397057|NCT00140660|Immunologic Factors|immunologic factors|mesh-ancestor
24397058|NCT00140660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397059|NCT00140660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24397060|NCT00140712|Ropinirole|ropinirole|mesh-list
25717016|NCT02404220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25717017|NCT02404220|Tubulin Modulators|tubulin modulators|mesh-ancestor
25717018|NCT02404220|Antimitotic Agents|antimitotic agents|mesh-ancestor
24397061|NCT00140712|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24397062|NCT00140712|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24397063|NCT00140712|Dopamine Agonists|dopamine agonists|mesh-ancestor
24397065|NCT00140712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24397066|NCT00140712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397067|NCT00140712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397078|NCT00140725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24397128|NCT00140868|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24397129|NCT00140868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24397135|NCT00140894|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24397136|NCT00140894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24397179|NCT00140998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397180|NCT00140998|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24397207|NCT00141089|Tegaserod|tegaserod|mesh-list
24397210|NCT00141089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24397211|NCT00141089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397212|NCT00141089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24397213|NCT00141141|Atorvastatin|atorvastatin|mesh-list
24397214|NCT00141141|Simvastatin|simvastatin|mesh-list
24397215|NCT00141141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24397216|NCT00141141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24397217|NCT00141141|Antimetabolites|antimetabolites|mesh-ancestor
24397218|NCT00141141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24397219|NCT00141141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24397220|NCT00141141|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24397221|NCT00141141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24397222|NCT00141154|Celecoxib|celecoxib|mesh-list
24397223|NCT00141154|Loxoprofen|loxoprofen|mesh-list
24397692|NCT00142337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24397693|NCT00142350|Fluorouracil|fluorouracil|mesh-list
24398058|NCT00143338|Insulin|insulin|mesh-list
24398059|NCT00143338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24398061|NCT00143351|Ziprasidone|ziprasidone|mesh-list
24398205|NCT00143741|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24398206|NCT00143741|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24398208|NCT00143741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398209|NCT00143741|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24398210|NCT00143741|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24398211|NCT00143741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398212|NCT00143780|Vaccines|vaccines|mesh-list
24398213|NCT00143780|Immunologic Factors|immunologic factors|mesh-ancestor
24398214|NCT00143780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398215|NCT00143806|Cyclosporine|cyclosporine|mesh-list
24398220|NCT00143806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24398221|NCT00143806|Immunologic Factors|immunologic factors|mesh-ancestor
24398222|NCT00143806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24398223|NCT00143806|Antifungal Agents|antifungal agents|mesh-ancestor
24398267|NCT00144053|Paclitaxel|paclitaxel|mesh-list
24398268|NCT00144053|Vindesine|vindesine|mesh-list
24398269|NCT00144053|Carboplatin|carboplatin|mesh-list
24398270|NCT00144053|Irinotecan|irinotecan|mesh-list
24398565|NCT00144846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398607|NCT00144989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398608|NCT00144989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398609|NCT00144989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24398610|NCT00144989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24398611|NCT00145002|Lenograstim|lenograstim|mesh-list
24398612|NCT00145002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24398615|NCT00145028|Carboplatin|carboplatin|mesh-list
24398784|NCT00145639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24398785|NCT00145639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24398786|NCT00145639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24398787|NCT00145639|Alkylating Agents|alkylating agents|mesh-ancestor
24398788|NCT00145652|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24398790|NCT00145665|Telbivudine|telbivudine|mesh-list
24399150|NCT00146718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24399151|NCT00146718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24399152|NCT00146718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24399153|NCT00146718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24399154|NCT00146718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25717019|NCT02404220|Mitosis Modulators|mitosis modulators|mesh-ancestor
25717020|NCT02404220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717021|NCT02404311|MF59 oil emulsion|mf59 oil emulsion|mesh-list
24399155|NCT00146718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399156|NCT00146718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24399157|NCT00146718|Renal Agents|renal agents|mesh-ancestor
24399158|NCT00146731|Artesunate|artesunate|mesh-list
24399159|NCT00146731|Amodiaquine|amodiaquine|mesh-list
24399160|NCT00146731|Dapsone|dapsone|mesh-list
24399161|NCT00146731|Chlorproguanil|chlorproguanil|mesh-list
24399209|NCT00146913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24399210|NCT00146913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399211|NCT00146926|Lidocaine|lidocaine|mesh-list
24399212|NCT00146926|Ephedrine|ephedrine|mesh-list
24399213|NCT00146926|Ketamine|ketamine|mesh-list
24399214|NCT00146926|Anesthetics, Local|anesthetics, local|mesh-ancestor
24399268|NCT00147303|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24399270|NCT00147303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24399271|NCT00147303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399304|NCT00147355|Dopamine Agents|dopamine agents|mesh-ancestor
24399305|NCT00147355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24399306|NCT00147355|Narcotics|narcotics|mesh-ancestor
24399307|NCT00147355|Antitussive Agents|antitussive agents|mesh-ancestor
24399308|NCT00147355|Respiratory System Agents|respiratory system agents|mesh-ancestor
24399309|NCT00147381|Alemtuzumab|alemtuzumab|mesh-list
24399310|NCT00147381|Tacrolimus|tacrolimus|mesh-list
24399319|NCT00147394|Risperidone|risperidone|mesh-list
24399356|NCT00147589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399358|NCT00147589|Diuretics|diuretics|mesh-ancestor
24399359|NCT00147589|Natriuretic Agents|natriuretic agents|mesh-ancestor
24399360|NCT00147589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24399361|NCT00147602|Atorvastatin|atorvastatin|mesh-list
24399362|NCT00147602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24399363|NCT00147602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24399364|NCT00147602|Antimetabolites|antimetabolites|mesh-ancestor
24399373|NCT00147615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399374|NCT00147615|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24399376|NCT00147615|Natriuretic Agents|natriuretic agents|mesh-ancestor
24399377|NCT00147615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24399469|NCT00147875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24399470|NCT00147875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24399471|NCT00147875|Antiviral Agents|antiviral agents|mesh-ancestor
24401123|NCT00152191|Immunologic Factors|immunologic factors|mesh-ancestor
24399472|NCT00147875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24399473|NCT00147875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24399474|NCT00147875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24399475|NCT00147875|Immunologic Factors|immunologic factors|mesh-ancestor
24399476|NCT00147875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399477|NCT00147875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24399478|NCT00147875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24399502|NCT00147914|Amoxicillin|amoxicillin|mesh-list
24399873|NCT00148824|Immunologic Factors|immunologic factors|mesh-ancestor
24399874|NCT00148824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24399876|NCT00148837|Ribavirin|ribavirin|mesh-list
24399877|NCT00148837|Interferon-alpha|interferon-alpha|mesh-list
24399936|NCT00149084|Clarithromycin|clarithromycin|mesh-list
24399937|NCT00149084|Lansoprazole|lansoprazole|mesh-list
24400234|NCT00150111|Antithyroid Agents|antithyroid agents|mesh-ancestor
24400235|NCT00150111|Hormone Antagonists|hormone antagonists|mesh-ancestor
24400236|NCT00150111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24400237|NCT00150124|Methimazole|methimazole|mesh-list
24400238|NCT00150124|Antithyroid Agents|antithyroid agents|mesh-ancestor
24400239|NCT00150124|Hormone Antagonists|hormone antagonists|mesh-ancestor
24400240|NCT00150124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24400313|NCT00150306|Antidepressive Agents|antidepressive agents|mesh-ancestor
24400314|NCT00150306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24400315|NCT00150306|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24400316|NCT00150306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24400317|NCT00150306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24400318|NCT00150306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400319|NCT00150306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24400322|NCT00150332|Linezolid|linezolid|mesh-list
24400396|NCT00150449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24400397|NCT00150449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24400400|NCT00150449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25717022|NCT02404311|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24400548|NCT00150839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717023|NCT02404311|Immunologic Factors|immunologic factors|mesh-ancestor
25717024|NCT02404311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717025|NCT02404493|Decanoic acid|decanoic acid|mesh-list
24400634|NCT00151034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400635|NCT00151034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24400637|NCT00151047|Capecitabine|capecitabine|mesh-list
24400685|NCT00151112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24400686|NCT00151112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400687|NCT00151125|Oprelvekin|oprelvekin|mesh-list
24400688|NCT00151125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24400689|NCT00151138|Atenolol|atenolol|mesh-list
24400690|NCT00151138|Lisinopril|lisinopril|mesh-list
24400691|NCT00151138|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24400692|NCT00151138|Protease Inhibitors|protease inhibitors|mesh-ancestor
24400693|NCT00151138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400694|NCT00151138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24400695|NCT00151138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24400696|NCT00151138|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
24400697|NCT00151138|Protective Agents|protective agents|mesh-ancestor
24400698|NCT00151138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400699|NCT00151138|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24400713|NCT00151203|Autonomic Agents|autonomic agents|mesh-ancestor
24400714|NCT00151203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24400715|NCT00151203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400716|NCT00151203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24400776|NCT00151294|Dexetimide|dexetimide|mesh-list
24400918|NCT00151619|Vasodilator Agents|vasodilator agents|mesh-ancestor
24400919|NCT00151632|Mycophenolic Acid|mycophenolic acid|mesh-list
24400921|NCT00151632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24400922|NCT00151632|Immunologic Factors|immunologic factors|mesh-ancestor
24400923|NCT00151632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24400924|NCT00151632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24400925|NCT00151632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24400933|NCT00151684|Diazoxide|diazoxide|mesh-list
24401020|NCT00151970|Dopamine Agents|dopamine agents|mesh-ancestor
24401021|NCT00151970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24401022|NCT00151983|Methylphenidate|methylphenidate|mesh-list
24401023|NCT00151983|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24401024|NCT00151983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401025|NCT00151983|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24401048|NCT00152035|Dextroamphetamine|dextroamphetamine|mesh-list
24401122|NCT00152191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24401133|NCT00152191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24401134|NCT00152191|Abortifacient Agents|abortifacient agents|mesh-ancestor
24401135|NCT00152191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24401136|NCT00152191|Dermatologic Agents|dermatologic agents|mesh-ancestor
24401137|NCT00152191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24401138|NCT00152191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24401139|NCT00152191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24401140|NCT00152204|Pyrimethamine|pyrimethamine|mesh-list
24401348|NCT00152724|Vasodilator Agents|vasodilator agents|mesh-ancestor
24401349|NCT00152724|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
24401350|NCT00152724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24401367|NCT00152802|Immunologic Factors|immunologic factors|mesh-ancestor
24401368|NCT00152802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24401369|NCT00152815|Vitamin E|vitamin e|mesh-list
24401582|NCT00153283|Anticonvulsants|anticonvulsants|mesh-ancestor
24401583|NCT00153283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24401584|NCT00153283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24401585|NCT00153283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24401586|NCT00153283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24401587|NCT00153283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24401588|NCT00153283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24401589|NCT00153283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24401590|NCT00153283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24401591|NCT00153283|Antimanic Agents|antimanic agents|mesh-ancestor
24401592|NCT00153296|Carbamazepine|carbamazepine|mesh-list
25717026|NCT02404493|Antifungal Agents|antifungal agents|mesh-ancestor
24401600|NCT00153296|Analgesics|analgesics|mesh-ancestor
24402482|NCT00157508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24402623|NCT00158028|Dopamine Agents|dopamine agents|mesh-ancestor
24402924|NCT00158821|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24402928|NCT00158834|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24402929|NCT00158834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24402930|NCT00158834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24402931|NCT00158834|Autonomic Agents|autonomic agents|mesh-ancestor
24402932|NCT00158834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24403385|NCT00160160|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
24403386|NCT00160160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24403425|NCT00160329|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24403426|NCT00160329|Protease Inhibitors|protease inhibitors|mesh-ancestor
24403427|NCT00160329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403428|NCT00160329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403429|NCT00160329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24403430|NCT00160329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24403431|NCT00160329|Antiviral Agents|antiviral agents|mesh-ancestor
24403432|NCT00160329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24403524|NCT00160745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403526|NCT00160849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24403527|NCT00160849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24403528|NCT00160849|Protease Inhibitors|protease inhibitors|mesh-ancestor
24403529|NCT00160849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403530|NCT00160849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403531|NCT00160849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24403532|NCT00160849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24403533|NCT00160849|Antiviral Agents|antiviral agents|mesh-ancestor
24403534|NCT00160849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24403537|NCT00160875|Irinotecan|irinotecan|mesh-list
24403601|NCT00161031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24403602|NCT00161031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24403603|NCT00161031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24403604|NCT00161031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403605|NCT00161031|Adrenergic Agents|adrenergic agents|mesh-ancestor
24403606|NCT00161031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24403607|NCT00161031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24403608|NCT00161070|Aspirin|aspirin|mesh-list
24403645|NCT00161200|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24403646|NCT00161200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403726|NCT00161330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24403727|NCT00161330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24403728|NCT00161330|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
24403729|NCT00161356|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
24403769|NCT00161447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24403770|NCT00161447|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
24403771|NCT00161447|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
24403772|NCT00161447|Hormone Antagonists|hormone antagonists|mesh-ancestor
24403773|NCT00161486|Methyltestosterone|methyltestosterone|mesh-list
24403775|NCT00161486|Testosterone undecanoate|testosterone undecanoate|mesh-list
24403776|NCT00161486|Testosterone enanthate|testosterone enanthate|mesh-list
24403777|NCT00161486|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
24403778|NCT00161486|Acyline|acyline|mesh-list
24403779|NCT00161486|Androgens|androgens|mesh-ancestor
24403780|NCT00161486|Hormones|hormones|mesh-ancestor
24404964|NCT00165204|Hormone Antagonists|hormone antagonists|mesh-ancestor
24404965|NCT00165204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24404966|NCT00165204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405432|NCT00166842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24405433|NCT00166842|Antifungal Agents|antifungal agents|mesh-ancestor
24405434|NCT00166842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24405435|NCT00166842|Dermatologic Agents|dermatologic agents|mesh-ancestor
24405436|NCT00166842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24405475|NCT00167232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24405565|NCT00167674|Antimetabolites|antimetabolites|mesh-ancestor
24405608|NCT00167739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24405613|NCT00167739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24405614|NCT00167739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24405616|NCT00167739|Sensory System Agents|sensory system agents|mesh-ancestor
24405618|NCT00167765|Anticoagulants|anticoagulants|mesh-ancestor
24405619|NCT00167765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24405620|NCT00167791|Rituximab|rituximab|mesh-list
24405621|NCT00167791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24406098|NCT00169091|Serotonin Agents|serotonin agents|mesh-ancestor
24406099|NCT00169091|GABA Antagonists|gaba antagonists|mesh-ancestor
24406100|NCT00169091|GABA Agents|gaba agents|mesh-ancestor
24406101|NCT00169130|Cyclophosphamide|cyclophosphamide|mesh-list
24406102|NCT00169130|Doxorubicin|doxorubicin|mesh-list
24406103|NCT00169130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24406104|NCT00169130|Immunologic Factors|immunologic factors|mesh-ancestor
24406105|NCT00169130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406106|NCT00169130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24406107|NCT00169130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24406108|NCT00169130|Alkylating Agents|alkylating agents|mesh-ancestor
24406156|NCT00169182|Nicotinic Acids|nicotinic acids|mesh-list
24406157|NCT00169182|Niacin|niacin|mesh-list
24406158|NCT00169182|Docetaxel|docetaxel|mesh-list
24406159|NCT00169182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406240|NCT00169520|Docetaxel|docetaxel|mesh-list
24406265|NCT00169546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24406266|NCT00169546|Adrenergic Agents|adrenergic agents|mesh-ancestor
24406267|NCT00169546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24406569|NCT00170781|Analgesics|analgesics|mesh-ancestor
24406570|NCT00170781|Sensory System Agents|sensory system agents|mesh-ancestor
24406571|NCT00170781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24406572|NCT00170781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406573|NCT00170781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24406574|NCT00170781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24406575|NCT00170794|Everolimus|everolimus|mesh-list
24406576|NCT00170794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406577|NCT00170794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24406578|NCT00170794|Immunologic Factors|immunologic factors|mesh-ancestor
24406579|NCT00170794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406607|NCT00170872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24406608|NCT00170885|Everolimus|everolimus|mesh-list
24406609|NCT00170885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24406809|NCT00171366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24406881|NCT00171509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24406882|NCT00171509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24406883|NCT00171509|Immunologic Factors|immunologic factors|mesh-ancestor
24406884|NCT00171509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24406974|NCT00171652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451688|NCT00324506|Antitubercular Agents|antitubercular agents|mesh-ancestor
24451689|NCT00324506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24451690|NCT00324506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24451691|NCT00324506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24407169|NCT00172172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407232|NCT00173862|Ifosfamide|ifosfamide|mesh-list
24407234|NCT00173862|Antimetabolites|antimetabolites|mesh-ancestor
24407235|NCT00173862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24407236|NCT00173862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24407331|NCT00174317|Celecoxib|celecoxib|mesh-list
24472812|NCT00400621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407522|NCT00174655|Immunologic Factors|immunologic factors|mesh-ancestor
24407523|NCT00174655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24407524|NCT00174655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24407525|NCT00174655|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24407526|NCT00174655|Alkylating Agents|alkylating agents|mesh-ancestor
24407946|NCT00175981|Sildenafil Citrate|sildenafil citrate|mesh-list
24408010|NCT00176241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24408011|NCT00176241|Immunologic Factors|immunologic factors|mesh-ancestor
24408012|NCT00176241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408030|NCT00176280|Hormones|hormones|mesh-ancestor
24408140|NCT00176670|Anesthetics, General|anesthetics, general|mesh-ancestor
24408142|NCT00176670|GABA Modulators|gaba modulators|mesh-ancestor
24408525|NCT00178100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24408526|NCT00178100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408528|NCT00178113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24408529|NCT00178113|Antioxidants|antioxidants|mesh-ancestor
24408530|NCT00178113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408567|NCT00178698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24408568|NCT00178763|Gemcitabine|gemcitabine|mesh-list
24408569|NCT00178763|Interferons|interferons|mesh-list
24408570|NCT00178763|Interferon-alpha|interferon-alpha|mesh-list
24408571|NCT00178763|Cisplatin|cisplatin|mesh-list
24408572|NCT00178763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24408573|NCT00178763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24408574|NCT00178763|Antimetabolites|antimetabolites|mesh-ancestor
24408575|NCT00178763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408607|NCT00178828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408693|NCT00179114|Baclofen|baclofen|mesh-list
24408876|NCT00179816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408878|NCT00179816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24408918|NCT00180050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24408919|NCT00180063|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
24408920|NCT00180063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24408921|NCT00180063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24408922|NCT00180076|Budesonide|budesonide|mesh-list
24408923|NCT00180076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24408924|NCT00180076|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24409002|NCT00180141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24409003|NCT00180141|Immunologic Factors|immunologic factors|mesh-ancestor
24409004|NCT00180141|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24409005|NCT00180141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24409006|NCT00180141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409008|NCT00180310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24409009|NCT00180310|Everolimus|everolimus|mesh-list
24409041|NCT00180791|Melphalan|melphalan|mesh-list
24409042|NCT00180791|Thiotepa|thiotepa|mesh-list
24409043|NCT00180791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409044|NCT00180791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24409538|NCT00182429|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24409539|NCT00182429|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24409540|NCT00182429|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25717029|NCT02404610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
25717030|NCT02404610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25717031|NCT02404610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409541|NCT00182429|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
24409542|NCT00182429|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
24409623|NCT00182611|Tegafur|tegafur|mesh-list
24409624|NCT00182611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24409625|NCT00182611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24409626|NCT00182611|Antimetabolites|antimetabolites|mesh-ancestor
24409627|NCT00182611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409628|NCT00182650|Aldesleukin|aldesleukin|mesh-list
24409629|NCT00182650|Rituximab|rituximab|mesh-list
24409630|NCT00182650|Fludarabine|fludarabine|mesh-list
24409631|NCT00182650|Fludarabine phosphate|fludarabine phosphate|mesh-list
24409632|NCT00182650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24409638|NCT00182650|Antimetabolites|antimetabolites|mesh-ancestor
24409689|NCT00182715|Antimetabolites|antimetabolites|mesh-ancestor
24409690|NCT00182715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409693|NCT00182715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24409694|NCT00182715|Immunologic Factors|immunologic factors|mesh-ancestor
24409696|NCT00182715|Protective Agents|protective agents|mesh-ancestor
24409788|NCT00183222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24409789|NCT00183222|Antipruritics|antipruritics|mesh-ancestor
24409810|NCT00183235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24409811|NCT00183235|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24409812|NCT00183235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24409814|NCT00183235|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24409815|NCT00183235|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24409816|NCT00183235|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24409817|NCT00183235|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24409819|NCT00183404|Antiemetics|antiemetics|mesh-ancestor
24409820|NCT00183404|Autonomic Agents|autonomic agents|mesh-ancestor
24409821|NCT00183404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24409822|NCT00183404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24409824|NCT00183404|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24410043|NCT00184041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24410044|NCT00184041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24410045|NCT00184041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24410046|NCT00184041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24410047|NCT00184067|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
24410048|NCT00184067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24410049|NCT00184067|Immunologic Factors|immunologic factors|mesh-ancestor
24410050|NCT00184067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410051|NCT00184106|Paroxetine|paroxetine|mesh-list
24410052|NCT00184106|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24410053|NCT00184106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24410127|NCT00184626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24410128|NCT00184626|Metformin|metformin|mesh-list
24410129|NCT00184626|Insulin Glargine|insulin glargine|mesh-list
24410130|NCT00184626|Insulin Aspart|insulin aspart|mesh-list
24410131|NCT00184626|Biphasic Insulins|biphasic insulins|mesh-list
24410132|NCT00184626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24410133|NCT00184626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410134|NCT00184639|Insulin Detemir|insulin detemir|mesh-list
24410135|NCT00184639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24410136|NCT00184639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410137|NCT00184665|Insulin|insulin|mesh-list
24410138|NCT00184665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24410139|NCT00184665|Insulin Aspart|insulin aspart|mesh-list
24410166|NCT00184821|Annexin A5|annexin a5|mesh-list
24410205|NCT00184886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24410231|NCT00184899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410232|NCT00184912|Caffeine|caffeine|mesh-list
24410233|NCT00184912|Annexin A5|annexin a5|mesh-list
24410234|NCT00184912|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24410235|NCT00184912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410236|NCT00184912|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24410237|NCT00184912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24410238|NCT00184912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410239|NCT00184912|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24410240|NCT00184912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24410241|NCT00184912|Purinergic Agents|purinergic agents|mesh-ancestor
24410252|NCT00184938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24410253|NCT00184938|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
24410254|NCT00184938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24410255|NCT00184938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410278|NCT00184977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24410279|NCT00184977|Expectorants|expectorants|mesh-ancestor
24410280|NCT00184977|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24410281|NCT00184977|Antioxidants|antioxidants|mesh-ancestor
24410282|NCT00184977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410283|NCT00184977|Protective Agents|protective agents|mesh-ancestor
24410284|NCT00184977|Antidotes|antidotes|mesh-ancestor
24410285|NCT00184990|Pimagedine|pimagedine|mesh-list
24410286|NCT00184990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24410287|NCT00184990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410288|NCT00185003|Tolbutamide|tolbutamide|mesh-list
24410289|NCT00185003|Potassium Channel Blockers|potassium channel blockers|mesh-list
24410290|NCT00185003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410291|NCT00185003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24410292|NCT00185003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410293|NCT00185003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24410295|NCT00185055|Olmesartan|olmesartan|mesh-list
24410296|NCT00185055|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24410298|NCT00185055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24410299|NCT00185055|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24410300|NCT00185055|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24410301|NCT00185055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410311|NCT00185068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410312|NCT00185068|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24410313|NCT00185068|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24410355|NCT00185120|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24410357|NCT00185120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24410358|NCT00185133|Amlodipine|amlodipine|mesh-list
24410359|NCT00185133|Olmesartan|olmesartan|mesh-list
24410360|NCT00185133|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24410363|NCT00185133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24410364|NCT00185133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410365|NCT00185133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24410370|NCT00185159|Olmesartan|olmesartan|mesh-list
24410376|NCT00185172|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
24410378|NCT00185172|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24410379|NCT00185172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24410380|NCT00185172|Diuretics|diuretics|mesh-ancestor
24410381|NCT00185172|Natriuretic Agents|natriuretic agents|mesh-ancestor
24410382|NCT00185172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410383|NCT00185172|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
24410384|NCT00185172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24410388|NCT00185185|Atenolol|atenolol|mesh-list
24410390|NCT00185185|Olmesartan|olmesartan|mesh-list
24410391|NCT00185185|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
24410392|NCT00185185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24410394|NCT00185185|Natriuretic Agents|natriuretic agents|mesh-ancestor
24410395|NCT00185185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410438|NCT00185250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24410439|NCT00185250|Immunologic Factors|immunologic factors|mesh-ancestor
24410440|NCT00185250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410441|NCT00185250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24410443|NCT00185302|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
24410444|NCT00185302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24410445|NCT00185302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24410446|NCT00185302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410448|NCT00185315|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24410449|NCT00185315|Vasodilator Agents|vasodilator agents|mesh-ancestor
24410450|NCT00185328|Estradiol|estradiol|mesh-list
24410496|NCT00185510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24410497|NCT00185562|Adalimumab|adalimumab|mesh-list
24410498|NCT00185562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24410499|NCT00185562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24410500|NCT00185575|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24410501|NCT00185575|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24410530|NCT00185861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24410531|NCT00185887|Terbutaline|terbutaline|mesh-list
24410532|NCT00185887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24410533|NCT00185887|Autonomic Agents|autonomic agents|mesh-ancestor
24410534|NCT00185887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24410535|NCT00185887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410536|NCT00185887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24410537|NCT00185887|Respiratory System Agents|respiratory system agents|mesh-ancestor
24410538|NCT00185887|Sympathomimetics|sympathomimetics|mesh-ancestor
24410539|NCT00185887|Tocolytic Agents|tocolytic agents|mesh-ancestor
24410540|NCT00185887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24410541|NCT00185887|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24410608|NCT00186706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410610|NCT00186706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410612|NCT00186706|Micronutrients|micronutrients|mesh-ancestor
24410613|NCT00186745|Tinzaparin|tinzaparin|mesh-list
24410614|NCT00186745|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
24410616|NCT00186745|Anticoagulants|anticoagulants|mesh-ancestor
24410617|NCT00186745|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24410618|NCT00186745|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24410619|NCT00186745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451883|NCT00325104|Parathyroid Hormone|parathyroid hormone|mesh-list
24410623|NCT00186797|Immunologic Factors|immunologic factors|mesh-ancestor
24410624|NCT00186797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717032|NCT02404610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25717033|NCT02404610|Anesthetics, General|anesthetics, general|mesh-ancestor
25717034|NCT02404610|Anesthetics|anesthetics|mesh-ancestor
25717035|NCT02404805|Dolutegravir|dolutegravir|mesh-list
25717036|NCT02404805|Simeprevir|simeprevir|mesh-list
25717037|NCT02404805|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25717038|NCT02404805|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25717039|NCT02404805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25717040|NCT02404805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717041|NCT02404805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25717042|NCT02404805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24410625|NCT00186797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24410626|NCT00186797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24410627|NCT00186797|Alkylating Agents|alkylating agents|mesh-ancestor
24410631|NCT00186810|Cyclophosphamide|cyclophosphamide|mesh-list
24410635|NCT00186810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410636|NCT00186810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24410637|NCT00186810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24410638|NCT00186810|Alkylating Agents|alkylating agents|mesh-ancestor
24410639|NCT00186810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410640|NCT00186810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24410641|NCT00186810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24410643|NCT00186823|Immunologic Factors|immunologic factors|mesh-ancestor
24410644|NCT00186823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24410700|NCT00186966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24410701|NCT00186966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24410702|NCT00186979|Cefixime|cefixime|mesh-list
24410703|NCT00186979|Cefpodoxime|cefpodoxime|mesh-list
24410704|NCT00186979|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
24410705|NCT00186979|Irinotecan|irinotecan|mesh-list
24410706|NCT00186979|Vincristine|vincristine|mesh-list
24410707|NCT00186979|Gefitinib|gefitinib|mesh-list
24410708|NCT00186979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24410709|NCT00186979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24410710|NCT00186979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24410712|NCT00186979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24410767|NCT00187005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24410769|NCT00187031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24410770|NCT00187031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24410771|NCT00187031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24410772|NCT00187031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410773|NCT00187031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24410774|NCT00187057|Cytarabine|cytarabine|mesh-list
24410867|NCT00187070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24410868|NCT00187070|Tubulin Modulators|tubulin modulators|mesh-ancestor
24410869|NCT00187070|Antimitotic Agents|antimitotic agents|mesh-ancestor
24410873|NCT00187070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24410874|NCT00187070|Antimalarials|antimalarials|mesh-ancestor
24411773|NCT00189995|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24410875|NCT00187070|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24410876|NCT00187070|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24410878|NCT00187083|Methotrexate|methotrexate|mesh-list
24410918|NCT00187083|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24410919|NCT00187083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24410921|NCT00187122|Dexamethasone|dexamethasone|mesh-list
24410922|NCT00187122|Prednisone|prednisone|mesh-list
24410923|NCT00187122|Cyclophosphamide|cyclophosphamide|mesh-list
24410924|NCT00187122|Methotrexate|methotrexate|mesh-list
24410925|NCT00187122|Etoposide|etoposide|mesh-list
24410926|NCT00187122|Vincristine|vincristine|mesh-list
24410927|NCT00187122|Asparaginase|asparaginase|mesh-list
24410928|NCT00187122|Mercaptopurine|mercaptopurine|mesh-list
24410929|NCT00187122|Daunorubicin|daunorubicin|mesh-list
24410930|NCT00187122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24410936|NCT00187122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24410938|NCT00187122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24410939|NCT00187122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24410940|NCT00187122|Antiemetics|antiemetics|mesh-ancestor
24410972|NCT00187161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24410973|NCT00187161|Immunologic Factors|immunologic factors|mesh-ancestor
25717043|NCT02404805|Antiviral Agents|antiviral agents|mesh-ancestor
25717044|NCT02404805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25717045|NCT02404805|Protease Inhibitors|protease inhibitors|mesh-ancestor
25717046|NCT02405780|Adalimumab|adalimumab|mesh-list
25717047|NCT02405780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25717048|NCT02405780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25717049|NCT02406248|Ticagrelor|ticagrelor|mesh-list
24411131|NCT00187941|Mycophenolic Acid|mycophenolic acid|mesh-list
24411132|NCT00187941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24411133|NCT00187941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411134|NCT00187941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24411135|NCT00187941|Antitubercular Agents|antitubercular agents|mesh-ancestor
24411136|NCT00187941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24411137|NCT00187941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24411138|NCT00187941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411294|NCT00188630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411296|NCT00188630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411357|NCT00188812|Cholinergic Agents|cholinergic agents|mesh-ancestor
24411405|NCT00188942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24411407|NCT00188942|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24411408|NCT00188942|Antidepressive Agents|antidepressive agents|mesh-ancestor
24411409|NCT00188942|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24411410|NCT00188942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24411411|NCT00188942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411412|NCT00188955|Sirolimus|sirolimus|mesh-list
24411413|NCT00188955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24411414|NCT00188955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24411415|NCT00188955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24411416|NCT00188955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411421|NCT00188994|Insulin|insulin|mesh-list
24411467|NCT00189072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24411468|NCT00189072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24411469|NCT00189072|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24411470|NCT00189072|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24411471|NCT00189072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24411472|NCT00189072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411528|NCT00189358|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24411541|NCT00189371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411542|NCT00189371|Hematinics|hematinics|mesh-ancestor
24411543|NCT00189384|Gentamicins|gentamicins|mesh-list
24411544|NCT00189384|Ceftriaxone|ceftriaxone|mesh-list
24411545|NCT00189384|Penicillins|penicillins|mesh-list
24411772|NCT00189995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24411546|NCT00189384|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
24411547|NCT00189384|Penicillin G Procaine|penicillin g procaine|mesh-list
24411550|NCT00189384|Procaine|procaine|mesh-list
24411584|NCT00189410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411586|NCT00189501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24411587|NCT00189501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411588|NCT00189501|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
24411589|NCT00189501|Hormone Antagonists|hormone antagonists|mesh-ancestor
24411590|NCT00189501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24411591|NCT00189514|Pramlintide|pramlintide|mesh-list
24411592|NCT00189514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24411594|NCT00189553|Paclitaxel|paclitaxel|mesh-list
24411616|NCT00189566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411617|NCT00189566|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24411618|NCT00189566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24411619|NCT00189566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411620|NCT00189579|Trastuzumab|trastuzumab|mesh-list
25717050|NCT02406248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25717051|NCT02406248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25717052|NCT02406248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25717053|NCT02406248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25717054|NCT02406248|Purinergic Agents|purinergic agents|mesh-ancestor
24411621|NCT00189579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24411635|NCT00189618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411636|NCT00189618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24411637|NCT00189618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24411638|NCT00189618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411639|NCT00189618|Antipyretics|antipyretics|mesh-ancestor
24411640|NCT00189618|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
24411646|NCT00189644|Fluorouracil|fluorouracil|mesh-list
24411657|NCT00189644|Antimetabolites|antimetabolites|mesh-ancestor
24411658|NCT00189644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24411659|NCT00189644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24411660|NCT00189644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24411661|NCT00189644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24411662|NCT00189644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411664|NCT00189657|Fluorouracil|fluorouracil|mesh-list
24411665|NCT00189657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24411666|NCT00189657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24411667|NCT00189657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411668|NCT00189657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411687|NCT00189709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411688|NCT00189709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24411689|NCT00189709|Hormone Antagonists|hormone antagonists|mesh-ancestor
24411690|NCT00189709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24411691|NCT00189709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411692|NCT00189709|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24411693|NCT00189709|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24411695|NCT00189722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24411696|NCT00189722|Immunologic Factors|immunologic factors|mesh-ancestor
24411697|NCT00189722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411719|NCT00189787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24411720|NCT00189787|Immunologic Factors|immunologic factors|mesh-ancestor
24411744|NCT00189839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24411745|NCT00189839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411756|NCT00189878|Dermatologic Agents|dermatologic agents|mesh-ancestor
24411757|NCT00189878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24411758|NCT00189878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24411759|NCT00189878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24411765|NCT00189995|Haloperidol|haloperidol|mesh-list
24411766|NCT00189995|Haloperidol decanoate|haloperidol decanoate|mesh-list
24411767|NCT00189995|Clozapine|clozapine|mesh-list
24411768|NCT00189995|Antiemetics|antiemetics|mesh-ancestor
24411769|NCT00189995|Autonomic Agents|autonomic agents|mesh-ancestor
24411770|NCT00189995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24411771|NCT00189995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411774|NCT00189995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24411775|NCT00189995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24411776|NCT00189995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24411777|NCT00189995|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24411778|NCT00189995|Dopamine Agents|dopamine agents|mesh-ancestor
24411779|NCT00189995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24411780|NCT00189995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411781|NCT00189995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24411782|NCT00189995|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24411783|NCT00189995|Serotonin Agents|serotonin agents|mesh-ancestor
24411958|NCT00190554|Cisplatin|cisplatin|mesh-list
24411960|NCT00190554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24411961|NCT00190554|Antimetabolites|antimetabolites|mesh-ancestor
24411962|NCT00190554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411963|NCT00190554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24411965|NCT00190554|Immunologic Factors|immunologic factors|mesh-ancestor
24411966|NCT00190554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411967|NCT00190567|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24411968|NCT00190567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24411969|NCT00190567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24411972|NCT00190567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24411983|NCT00190580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24411984|NCT00190580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24411985|NCT00190593|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25717055|NCT02406248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25717056|NCT02406248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717057|NCT02406248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24411986|NCT00190593|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24411987|NCT00190593|Hormone Antagonists|hormone antagonists|mesh-ancestor
24411988|NCT00190593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24412022|NCT00190632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412024|NCT00190632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412028|NCT00190632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24412029|NCT00190632|Antidepressive Agents|antidepressive agents|mesh-ancestor
24412087|NCT00190814|Sensory System Agents|sensory system agents|mesh-ancestor
24412088|NCT00190814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24412092|NCT00190827|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24412093|NCT00190827|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24412094|NCT00190827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412095|NCT00190827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412096|NCT00190827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412097|NCT00190827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412164|NCT00190892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24412165|NCT00190892|Analgesics|analgesics|mesh-ancestor
24412166|NCT00190892|Sensory System Agents|sensory system agents|mesh-ancestor
24412167|NCT00190892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24412168|NCT00190892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24412169|NCT00190892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24412170|NCT00190905|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24412171|NCT00190905|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24412172|NCT00190905|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412173|NCT00190905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412174|NCT00190905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412175|NCT00190905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412176|NCT00190905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412177|NCT00190905|Analgesics|analgesics|mesh-ancestor
24412178|NCT00190905|Sensory System Agents|sensory system agents|mesh-ancestor
24412179|NCT00190905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24412254|NCT00191035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412256|NCT00191048|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24412257|NCT00191048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412258|NCT00191048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412259|NCT00191048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412260|NCT00191048|Adrenergic Agents|adrenergic agents|mesh-ancestor
24412261|NCT00191048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412262|NCT00191048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412263|NCT00191061|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24412264|NCT00191061|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24412265|NCT00191061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412266|NCT00191061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412267|NCT00191061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412291|NCT00191126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24412292|NCT00191126|Antimetabolites|antimetabolites|mesh-ancestor
24412293|NCT00191126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412300|NCT00191178|Insulin|insulin|mesh-list
24412324|NCT00191230|Carboplatin|carboplatin|mesh-list
24412328|NCT00191230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412400|NCT00191373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24412410|NCT00191399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24412437|NCT00191425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412438|NCT00191425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24412439|NCT00191425|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24412440|NCT00191425|Hormone Antagonists|hormone antagonists|mesh-ancestor
24412441|NCT00191425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24412447|NCT00191438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25717059|NCT02406261|Donepezil|donepezil|mesh-list
25717060|NCT02406261|Simvastatin|simvastatin|mesh-list
25717061|NCT02406261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25717062|NCT02406261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25717063|NCT02406261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25717064|NCT02406261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717065|NCT02406261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25717066|NCT02406261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24412448|NCT00191438|Antimetabolites|antimetabolites|mesh-ancestor
24412449|NCT00191438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412450|NCT00191438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412451|NCT00191438|Antiviral Agents|antiviral agents|mesh-ancestor
24412452|NCT00191438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24412453|NCT00191438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412454|NCT00191438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24412455|NCT00191438|Immunologic Factors|immunologic factors|mesh-ancestor
24412550|NCT00191581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412551|NCT00191594|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24412556|NCT00191594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412632|NCT00191685|Sensory System Agents|sensory system agents|mesh-ancestor
24412633|NCT00191685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24412634|NCT00191685|Antidepressive Agents|antidepressive agents|mesh-ancestor
24412635|NCT00191685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24412637|NCT00191698|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
24412638|NCT00191698|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24412662|NCT00191737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412667|NCT00191750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412676|NCT00191763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24412677|NCT00191763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412678|NCT00191763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24412679|NCT00191763|Immunologic Factors|immunologic factors|mesh-ancestor
24412680|NCT00191763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412681|NCT00191802|Teriparatide|teriparatide|mesh-list
24412682|NCT00191802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24412683|NCT00191802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412704|NCT00191841|Antimetabolites|antimetabolites|mesh-ancestor
24412705|NCT00191841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412741|NCT00191932|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24412742|NCT00191932|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24412743|NCT00191932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24412744|NCT00191932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24412745|NCT00191932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412746|NCT00191932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24412747|NCT00191932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412748|NCT00191932|Analgesics|analgesics|mesh-ancestor
24412749|NCT00191932|Sensory System Agents|sensory system agents|mesh-ancestor
24412750|NCT00191932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24412751|NCT00191932|Antidepressive Agents|antidepressive agents|mesh-ancestor
24412752|NCT00191932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24412768|NCT00191997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24412769|NCT00191997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412770|NCT00191997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24412771|NCT00191997|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24412772|NCT00191997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24412821|NCT00192101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24412822|NCT00192101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24412823|NCT00192101|Antimetabolites|antimetabolites|mesh-ancestor
24412824|NCT00192101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24412825|NCT00192101|Antiviral Agents|antiviral agents|mesh-ancestor
24412826|NCT00192101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24412827|NCT00192101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412828|NCT00192101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24412829|NCT00192101|Immunologic Factors|immunologic factors|mesh-ancestor
24412830|NCT00192101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24412831|NCT00192413|Vaccines|vaccines|mesh-list
24412832|NCT00192413|Immunologic Factors|immunologic factors|mesh-ancestor
24412869|NCT00192608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24412893|NCT00192621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24412894|NCT00192621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25717067|NCT02406261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25717068|NCT02406261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25717069|NCT02406261|Anesthetics, General|anesthetics, general|mesh-ancestor
25717070|NCT02406261|Anesthetics|anesthetics|mesh-ancestor
25717071|NCT02406261|GABA Modulators|gaba modulators|mesh-ancestor
25717072|NCT02406261|GABA Agents|gaba agents|mesh-ancestor
25717073|NCT02406261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25717074|NCT02406261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717076|NCT02406261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25717077|NCT02406261|Antimetabolites|antimetabolites|mesh-ancestor
24412895|NCT00192634|Tenofovir|tenofovir|mesh-list
24412896|NCT00192634|Lamivudine|lamivudine|mesh-list
24412897|NCT00192634|Emtricitabine|emtricitabine|mesh-list
24412898|NCT00192634|Abacavir|abacavir|mesh-list
24412947|NCT00192673|Pegaspargase|pegaspargase|mesh-list
24413076|NCT00193089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413077|NCT00193089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24413136|NCT00193154|Growth Inhibitors|growth inhibitors|mesh-ancestor
24413137|NCT00193154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24413138|NCT00193154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413139|NCT00193154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413141|NCT00193167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24413142|NCT00193167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24413143|NCT00193167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413144|NCT00193167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413145|NCT00193167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413147|NCT00193193|Carboplatin|carboplatin|mesh-list
24413148|NCT00193193|Estramustine|estramustine|mesh-list
24413149|NCT00193193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24413150|NCT00193193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413151|NCT00193193|Tubulin Modulators|tubulin modulators|mesh-ancestor
24413152|NCT00193193|Antimitotic Agents|antimitotic agents|mesh-ancestor
24413153|NCT00193193|Mitosis Modulators|mitosis modulators|mesh-ancestor
24413165|NCT00193245|Docetaxel|docetaxel|mesh-list
24413206|NCT00193297|Tubulin Modulators|tubulin modulators|mesh-ancestor
24413207|NCT00193297|Antimitotic Agents|antimitotic agents|mesh-ancestor
24413217|NCT00193310|Tubulin Modulators|tubulin modulators|mesh-ancestor
24413218|NCT00193310|Antimitotic Agents|antimitotic agents|mesh-ancestor
24413219|NCT00193310|Mitosis Modulators|mitosis modulators|mesh-ancestor
24413220|NCT00193310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413222|NCT00193323|Docetaxel|docetaxel|mesh-list
24413233|NCT00193323|Tubulin Modulators|tubulin modulators|mesh-ancestor
24413234|NCT00193323|Antimitotic Agents|antimitotic agents|mesh-ancestor
24413235|NCT00193323|Mitosis Modulators|mitosis modulators|mesh-ancestor
24413277|NCT00193401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413278|NCT00193401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413279|NCT00193401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413281|NCT00193440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24413282|NCT00193440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413283|NCT00193440|Immunologic Factors|immunologic factors|mesh-ancestor
24413284|NCT00193440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413285|NCT00193440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24413286|NCT00193466|Rituximab|rituximab|mesh-list
24413325|NCT00193544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24413326|NCT00193544|Immunologic Factors|immunologic factors|mesh-ancestor
24413327|NCT00193544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413328|NCT00193544|Leprostatic Agents|leprostatic agents|mesh-ancestor
24413407|NCT00193726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24413408|NCT00193726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24413409|NCT00193726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24413410|NCT00193739|Paclitaxel|paclitaxel|mesh-list
24413411|NCT00193739|Carboplatin|carboplatin|mesh-list
24413434|NCT00193869|Glucocorticoids|glucocorticoids|mesh-ancestor
24413435|NCT00193869|Hormones|hormones|mesh-ancestor
24413436|NCT00193869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24413437|NCT00193869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25717078|NCT02406261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25717079|NCT02406261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25717080|NCT02406261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25717081|NCT02406261|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24413438|NCT00193869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413439|NCT00193882|Cisplatin|cisplatin|mesh-list
24413440|NCT00193882|Fluorouracil|fluorouracil|mesh-list
24413441|NCT00193882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413442|NCT00193882|Antimetabolites|antimetabolites|mesh-ancestor
24413461|NCT00193921|Immunologic Factors|immunologic factors|mesh-ancestor
24413462|NCT00193921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413463|NCT00193921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24413464|NCT00193921|Tubulin Modulators|tubulin modulators|mesh-ancestor
24413465|NCT00193921|Antimitotic Agents|antimitotic agents|mesh-ancestor
24413466|NCT00193921|Mitosis Modulators|mitosis modulators|mesh-ancestor
24413467|NCT00193973|Methotrexate|methotrexate|mesh-list
24413481|NCT00193973|Immunologic Factors|immunologic factors|mesh-ancestor
24413492|NCT00194038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24413493|NCT00194038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413504|NCT00194038|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24413506|NCT00194064|Antiemetics|antiemetics|mesh-ancestor
24413507|NCT00194064|Autonomic Agents|autonomic agents|mesh-ancestor
24413508|NCT00194064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24413509|NCT00194064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413510|NCT00194064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24413511|NCT00194064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24413538|NCT00194272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413539|NCT00194272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24413540|NCT00194272|Antimetabolites|antimetabolites|mesh-ancestor
24413541|NCT00194272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413542|NCT00194272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24413543|NCT00194272|Dermatologic Agents|dermatologic agents|mesh-ancestor
24413544|NCT00194272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413545|NCT00194272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24413546|NCT00194272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24413547|NCT00194272|Immunologic Factors|immunologic factors|mesh-ancestor
24413548|NCT00194272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24413550|NCT00194324|Miconazole|miconazole|mesh-list
24413615|NCT00194649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24413662|NCT00194818|Mesalamine|mesalamine|mesh-list
24413758|NCT00195104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413759|NCT00195156|Valproic Acid|valproic acid|mesh-list
24413760|NCT00195156|Anticonvulsants|anticonvulsants|mesh-ancestor
24413761|NCT00195156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413762|NCT00195156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24413763|NCT00195156|GABA Agents|gaba agents|mesh-ancestor
24413764|NCT00195156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24413765|NCT00195156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413766|NCT00195156|Antimanic Agents|antimanic agents|mesh-ancestor
24413767|NCT00195156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24413777|NCT00195195|Immunologic Factors|immunologic factors|mesh-ancestor
24413778|NCT00195195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24413779|NCT00195208|Pantoprazole|pantoprazole|mesh-list
24413780|NCT00195208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24413783|NCT00195208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24413913|NCT00195598|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
24413914|NCT00195598|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24413915|NCT00195598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24413916|NCT00195598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24414152|NCT00196391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24414154|NCT00196417|Heparin|heparin|mesh-list
24414155|NCT00196417|Certoparin|certoparin|mesh-list
24414156|NCT00196417|Anticoagulants|anticoagulants|mesh-ancestor
24414157|NCT00196417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24414158|NCT00196417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24414160|NCT00196469|Heparin|heparin|mesh-list
24414193|NCT00196586|Sensory System Agents|sensory system agents|mesh-ancestor
24414194|NCT00196586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25717082|NCT02406261|Cholinergic Agents|cholinergic agents|mesh-ancestor
25717083|NCT02406261|Nootropic Agents|nootropic agents|mesh-ancestor
25717084|NCT02406443|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24414195|NCT00196599|Emtricitabine|emtricitabine|mesh-list
24414196|NCT00196599|Efavirenz|efavirenz|mesh-list
24414197|NCT00196599|Didanosine|didanosine|mesh-list
24414198|NCT00196599|Antiviral Agents|antiviral agents|mesh-ancestor
24414199|NCT00196599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25717085|NCT02406443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25717086|NCT02406443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717087|NCT02406443|Incretins|incretins|mesh-ancestor
25717088|NCT02406443|Hormones|hormones|mesh-ancestor
25717089|NCT02406443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24414200|NCT00196599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24414201|NCT00196599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24414205|NCT00196599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24414206|NCT00196599|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
24414209|NCT00196599|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
24414223|NCT00196612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24414259|NCT00196664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414260|NCT00196664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24414261|NCT00196664|Serotonin Agents|serotonin agents|mesh-ancestor
24414264|NCT00196664|Antidepressive Agents|antidepressive agents|mesh-ancestor
24414281|NCT00196703|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24414282|NCT00196703|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24414283|NCT00196703|Dopamine Agents|dopamine agents|mesh-ancestor
24414284|NCT00196703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24414954|NCT00199004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24414285|NCT00196703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414286|NCT00196703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414287|NCT00196703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24414288|NCT00196703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24414291|NCT00196755|Calcium acetate|calcium acetate|mesh-list
24414292|NCT00196755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24414293|NCT00196755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414301|NCT00196820|Antimetabolites|antimetabolites|mesh-ancestor
24414302|NCT00196820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414303|NCT00196820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24414304|NCT00196846|Goserelin|goserelin|mesh-list
24414305|NCT00196846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24414306|NCT00196846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24414346|NCT00197080|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24414347|NCT00197080|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24414348|NCT00197080|Dopamine Agonists|dopamine agonists|mesh-ancestor
24414349|NCT00197080|Dopamine Agents|dopamine agents|mesh-ancestor
24414350|NCT00197080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24414352|NCT00197080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414357|NCT00197197|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24414358|NCT00197197|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24414359|NCT00197197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414360|NCT00197197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24414361|NCT00197197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24414362|NCT00197197|Antiviral Agents|antiviral agents|mesh-ancestor
24414364|NCT00197249|Vaccines|vaccines|mesh-list
24414482|NCT00197743|Vitamins|vitamins|mesh-ancestor
24414539|NCT00197912|Sensory System Agents|sensory system agents|mesh-ancestor
24414540|NCT00197912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24414541|NCT00197912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24414542|NCT00197912|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24414543|NCT00197912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24414544|NCT00197912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24414546|NCT00198055|Antidepressive Agents|antidepressive agents|mesh-ancestor
24414547|NCT00198055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24414548|NCT00198055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24414549|NCT00198055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24414550|NCT00198055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24414551|NCT00198055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414552|NCT00198055|Dopamine Agonists|dopamine agonists|mesh-ancestor
24414553|NCT00198055|Dopamine Agents|dopamine agents|mesh-ancestor
24414612|NCT00198198|Dopamine Agonists|dopamine agonists|mesh-ancestor
24414613|NCT00198198|Dopamine Agents|dopamine agents|mesh-ancestor
24414621|NCT00198198|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24414622|NCT00198198|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24414623|NCT00198237|Docetaxel|docetaxel|mesh-list
24414624|NCT00198237|Capecitabine|capecitabine|mesh-list
24414684|NCT00198393|Immunologic Factors|immunologic factors|mesh-ancestor
24414685|NCT00198393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24414686|NCT00198393|Tubulin Modulators|tubulin modulators|mesh-ancestor
24414687|NCT00198393|Antimitotic Agents|antimitotic agents|mesh-ancestor
24414688|NCT00198393|Mitosis Modulators|mitosis modulators|mesh-ancestor
24414689|NCT00198393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25717090|NCT02406443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25717091|NCT02406443|Protease Inhibitors|protease inhibitors|mesh-ancestor
24414690|NCT00198432|Paclitaxel|paclitaxel|mesh-list
24414836|NCT00198978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24414837|NCT00198978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24414838|NCT00198978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24414950|NCT00199004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24414951|NCT00199004|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24414952|NCT00199004|Abortifacient Agents|abortifacient agents|mesh-ancestor
24414953|NCT00199004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24415268|NCT00199147|Antimetabolites|antimetabolites|mesh-ancestor
24415270|NCT00199147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24415284|NCT00199160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415285|NCT00199186|Cytarabine|cytarabine|mesh-list
24415286|NCT00199186|Dexamethasone|dexamethasone|mesh-list
24415287|NCT00199186|Dexamethasone acetate|dexamethasone acetate|mesh-list
24415288|NCT00199186|Cyclophosphamide|cyclophosphamide|mesh-list
24415289|NCT00199186|Methotrexate|methotrexate|mesh-list
24415290|NCT00199186|Vincristine|vincristine|mesh-list
24415291|NCT00199186|Imatinib Mesylate|imatinib mesylate|mesh-list
24415292|NCT00199186|Idarubicin|idarubicin|mesh-list
24415293|NCT00199186|BB 1101|bb 1101|mesh-list
24415297|NCT00199186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24415665|NCT00200473|Nebivolol|nebivolol|mesh-list
24415667|NCT00200473|Vasodilator Agents|vasodilator agents|mesh-ancestor
24415668|NCT00200473|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
24415669|NCT00200473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24415670|NCT00200473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24415671|NCT00200473|Adrenergic Agents|adrenergic agents|mesh-ancestor
24415722|NCT00200551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415750|NCT00200590|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24415751|NCT00200590|Narcotics|narcotics|mesh-ancestor
24415752|NCT00200590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24415753|NCT00200590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415754|NCT00200590|Analgesics|analgesics|mesh-ancestor
24415755|NCT00200590|Sensory System Agents|sensory system agents|mesh-ancestor
24415756|NCT00200590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24415888|NCT00201396|Mitomycin|mitomycin|mesh-list
24415889|NCT00201396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24415890|NCT00201396|Antimetabolites|antimetabolites|mesh-ancestor
24415891|NCT00201396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24415892|NCT00201396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24415893|NCT00201396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24415894|NCT00201396|Immunologic Factors|immunologic factors|mesh-ancestor
24415895|NCT00201396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415896|NCT00201396|Antidotes|antidotes|mesh-ancestor
24415897|NCT00201396|Protective Agents|protective agents|mesh-ancestor
24415898|NCT00201396|Vitamin B Complex|vitamin b complex|mesh-ancestor
24415899|NCT00201396|Vitamins|vitamins|mesh-ancestor
24415900|NCT00201396|Micronutrients|micronutrients|mesh-ancestor
24415972|NCT00201695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24415973|NCT00201695|Antiemetics|antiemetics|mesh-ancestor
24415974|NCT00201695|Autonomic Agents|autonomic agents|mesh-ancestor
24415994|NCT00201708|Doxorubicin|doxorubicin|mesh-list
24415995|NCT00201708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24415996|NCT00201708|Immunologic Factors|immunologic factors|mesh-ancestor
24415997|NCT00201708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24415998|NCT00201708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24416004|NCT00201708|Tubulin Modulators|tubulin modulators|mesh-ancestor
24416005|NCT00201708|Antimitotic Agents|antimitotic agents|mesh-ancestor
24416015|NCT00201721|Immunologic Factors|immunologic factors|mesh-ancestor
24416016|NCT00201721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416039|NCT00201799|Infliximab|infliximab|mesh-list
24416127|NCT00202020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24416128|NCT00202020|Respiratory System Agents|respiratory system agents|mesh-ancestor
24416129|NCT00202020|Vasodilator Agents|vasodilator agents|mesh-ancestor
24416130|NCT00202020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24416131|NCT00202020|Protective Agents|protective agents|mesh-ancestor
24417398|NCT00206414|Gefitinib|gefitinib|mesh-list
24416132|NCT00202020|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
24416347|NCT00202800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24416348|NCT00202800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24416349|NCT00202813|Anti-Infective Agents|anti-infective agents|mesh-list
24416350|NCT00202813|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
24416352|NCT00202852|Dermatologic Agents|dermatologic agents|mesh-ancestor
24416396|NCT00203034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416397|NCT00203034|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24416398|NCT00203034|Protective Agents|protective agents|mesh-ancestor
24416399|NCT00203034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416400|NCT00203060|Rasagiline|rasagiline|mesh-list
24416401|NCT00203060|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24416402|NCT00203060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416470|NCT00203138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416471|NCT00203138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24416472|NCT00203138|Protective Agents|protective agents|mesh-ancestor
24416473|NCT00203138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416475|NCT00203164|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
24416476|NCT00203164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24416481|NCT00203177|Rasagiline|rasagiline|mesh-list
24416506|NCT00203281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24416507|NCT00203281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24416508|NCT00203281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24416509|NCT00203281|Antitubercular Agents|antitubercular agents|mesh-ancestor
24416510|NCT00203281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24416719|NCT00203801|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
24416720|NCT00203801|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24416721|NCT00203801|Antimalarials|antimalarials|mesh-ancestor
24416722|NCT00203801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24416723|NCT00203801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24416724|NCT00203801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24416878|NCT00204347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24416879|NCT00204347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24416880|NCT00204347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24416886|NCT00204386|Topiramate|topiramate|mesh-list
24417288|NCT00206154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24417289|NCT00206154|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24417290|NCT00206154|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24417357|NCT00206219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24417358|NCT00206219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24417359|NCT00206232|Spironolactone|spironolactone|mesh-list
24417360|NCT00206232|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
24417361|NCT00206232|Hormone Antagonists|hormone antagonists|mesh-ancestor
24417362|NCT00206232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24417363|NCT00206232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417386|NCT00206388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24417387|NCT00206388|Immunologic Factors|immunologic factors|mesh-ancestor
24417388|NCT00206388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24417389|NCT00206388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24417390|NCT00206388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24417391|NCT00206388|Alkylating Agents|alkylating agents|mesh-ancestor
24417392|NCT00206388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24417393|NCT00206388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24417394|NCT00206388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24417395|NCT00206401|Insulin Glargine|insulin glargine|mesh-list
24417396|NCT00206401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24417472|NCT00206557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24418155|NCT00208741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418157|NCT00208793|Vitamin D|vitamin d|mesh-list
24418158|NCT00208793|Ergocalciferols|ergocalciferols|mesh-list
24418159|NCT00208793|Cholecalciferol|cholecalciferol|mesh-list
24418160|NCT00208793|Vitamins|vitamins|mesh-list
24418161|NCT00208793|Calcium|calcium|mesh-list
24418206|NCT00208897|Antidepressive Agents|antidepressive agents|mesh-ancestor
24418207|NCT00208897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24418208|NCT00208897|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24418263|NCT00209118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24418264|NCT00209118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24418266|NCT00209144|Insulin|insulin|mesh-list
24418267|NCT00209144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24418269|NCT00209209|Interferons|interferons|mesh-list
24418465|NCT00209664|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24418466|NCT00209664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25717092|NCT02406443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25717093|NCT02406443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717094|NCT02406586|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
25717095|NCT02406586|Carvedilol|carvedilol|mesh-list
25717096|NCT02406586|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25717097|NCT02406586|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25717098|NCT02406586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24418467|NCT00209664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24418532|NCT00209742|Levoleucovorin|levoleucovorin|mesh-list
24418533|NCT00209742|Antidotes|antidotes|mesh-ancestor
24418534|NCT00209742|Protective Agents|protective agents|mesh-ancestor
24418535|NCT00209742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418536|NCT00209742|Vitamin B Complex|vitamin b complex|mesh-ancestor
24418569|NCT00209794|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
24418570|NCT00209794|Antimalarials|antimalarials|mesh-ancestor
24418571|NCT00209794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24418572|NCT00209794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24418573|NCT00209794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24418574|NCT00209794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24418575|NCT00209794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24418576|NCT00209794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24418577|NCT00209794|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24418579|NCT00209807|Citalopram|citalopram|mesh-list
24418635|NCT00209859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24418646|NCT00209859|Hormones|hormones|mesh-ancestor
24418678|NCT00209885|Lidocaine|lidocaine|mesh-list
24418710|NCT00209885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24418711|NCT00209885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24418712|NCT00209885|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24418713|NCT00209885|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24418728|NCT00209937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24418729|NCT00209937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418730|NCT00209937|Anticonvulsants|anticonvulsants|mesh-ancestor
24418731|NCT00209937|GABA Agonists|gaba agonists|mesh-ancestor
24418732|NCT00209937|GABA Agents|gaba agents|mesh-ancestor
24418733|NCT00209937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24418797|NCT00210158|Sensory System Agents|sensory system agents|mesh-ancestor
24418798|NCT00210158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24418800|NCT00210210|Analgesics|analgesics|mesh-ancestor
24418801|NCT00210210|Sensory System Agents|sensory system agents|mesh-ancestor
24418803|NCT00210210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24418804|NCT00210210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24418805|NCT00210210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24418806|NCT00210210|Anesthetics, General|anesthetics, general|mesh-ancestor
24418807|NCT00210210|Anesthetics|anesthetics|mesh-ancestor
24418808|NCT00210210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24418809|NCT00210210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24418857|NCT00210379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24419123|NCT00211302|Serotonin Agents|serotonin agents|mesh-ancestor
24419124|NCT00211302|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
24419125|NCT00211302|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24419126|NCT00211302|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24419127|NCT00211302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24419128|NCT00211315|Anecortave|anecortave|mesh-list
24419129|NCT00211315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24419130|NCT00211315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24419131|NCT00211315|Growth Substances|growth substances|mesh-ancestor
24419132|NCT00211315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419177|NCT00211380|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24419178|NCT00211393|Ketoconazole|ketoconazole|mesh-list
24419179|NCT00211393|Antifungal Agents|antifungal agents|mesh-ancestor
24419285|NCT00211614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24419286|NCT00211653|Acetylcysteine|acetylcysteine|mesh-list
24419287|NCT00211653|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24419288|NCT00211653|Antiviral Agents|antiviral agents|mesh-ancestor
24419289|NCT00211653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24419680|NCT00213252|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
24513069|NCT00578526|Sunitinib|sunitinib|mesh-list
24419681|NCT00213252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25717099|NCT02406586|Adrenergic Agents|adrenergic agents|mesh-ancestor
24419682|NCT00213252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407656|NCT03486873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25717100|NCT02406586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25717101|NCT02406586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717102|NCT02406586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717103|NCT02406586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25717104|NCT02406586|Antioxidants|antioxidants|mesh-ancestor
25717105|NCT02406586|Protective Agents|protective agents|mesh-ancestor
25717106|NCT02406586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25717107|NCT02406586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24419684|NCT00213265|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24419685|NCT00213265|Immunologic Factors|immunologic factors|mesh-ancestor
24419686|NCT00213265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419687|NCT00213278|Vinblastine|vinblastine|mesh-list
24419688|NCT00213278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24419730|NCT00213564|Infliximab|infliximab|mesh-list
24419775|NCT00213694|Analgesics|analgesics|mesh-ancestor
24419776|NCT00213694|Sensory System Agents|sensory system agents|mesh-ancestor
24419777|NCT00213694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24419778|NCT00213694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24419779|NCT00213694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24419780|NCT00213694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24419781|NCT00213694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24419782|NCT00213694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24419783|NCT00213694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24419784|NCT00213759|Lenograstim|lenograstim|mesh-list
24419785|NCT00213759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24419786|NCT00213759|Immunologic Factors|immunologic factors|mesh-ancestor
24419872|NCT00214318|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
24419873|NCT00214318|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24419874|NCT00214318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24419875|NCT00214318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24419876|NCT00214318|Respiratory System Agents|respiratory system agents|mesh-ancestor
24420129|NCT00215241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420130|NCT00215241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24420131|NCT00215241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24420132|NCT00215241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24420133|NCT00215241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24420134|NCT00215241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24420143|NCT00215254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24420144|NCT00215254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24420145|NCT00215254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24420239|NCT00215410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24420297|NCT00215501|Antimetabolites|antimetabolites|mesh-ancestor
24420298|NCT00215501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420299|NCT00215501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24475861|NCT00411866|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24420300|NCT00215501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24420301|NCT00215501|Immunologic Factors|immunologic factors|mesh-ancestor
24420302|NCT00215501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420303|NCT00215501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24420304|NCT00215501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24420370|NCT00215774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24420371|NCT00215774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420372|NCT00215800|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
24420459|NCT00216073|Trastuzumab|trastuzumab|mesh-list
24420460|NCT00216073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24420461|NCT00216073|Antimetabolites|antimetabolites|mesh-ancestor
24420462|NCT00216073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420463|NCT00216073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420464|NCT00216073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24420465|NCT00216112|Docetaxel|docetaxel|mesh-list
24420466|NCT00216112|Imatinib Mesylate|imatinib mesylate|mesh-list
24420467|NCT00216112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24420484|NCT00216151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24420485|NCT00216151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420487|NCT00216164|Rituximab|rituximab|mesh-list
24420488|NCT00216164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24420570|NCT00216346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25717108|NCT02406586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25717109|NCT02406586|Vasodilator Agents|vasodilator agents|mesh-ancestor
25717110|NCT02406586|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25717111|NCT02406586|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25717112|NCT02406586|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25717113|NCT02406586|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
24420571|NCT00216346|Antifungal Agents|antifungal agents|mesh-ancestor
24420572|NCT00216359|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
24420574|NCT00216359|Antiviral Agents|antiviral agents|mesh-ancestor
24420575|NCT00216359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24420576|NCT00216359|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24420577|NCT00216359|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24420578|NCT00216359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420673|NCT00216554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24420674|NCT00216554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420676|NCT00216554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24420677|NCT00216554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24420678|NCT00216554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24420679|NCT00216554|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24420680|NCT00216554|Dopamine Agents|dopamine agents|mesh-ancestor
24420837|NCT00216879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24420890|NCT00217178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420891|NCT00217178|Hematinics|hematinics|mesh-ancestor
24420892|NCT00217178|Vitamin B Complex|vitamin b complex|mesh-ancestor
24420893|NCT00217191|Ibuprofen|ibuprofen|mesh-list
24420894|NCT00217191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24420895|NCT00217191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24420910|NCT00217243|Anesthetics|anesthetics|mesh-ancestor
24420911|NCT00217243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24420912|NCT00217243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24420913|NCT00217243|Sensory System Agents|sensory system agents|mesh-ancestor
24420914|NCT00217243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24420953|NCT00217373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24420954|NCT00217373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24420955|NCT00217373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24421020|NCT00217503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24421021|NCT00217503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24421612|NCT00219765|Cytarabine|cytarabine|mesh-list
24421614|NCT00219765|Daunorubicin|daunorubicin|mesh-list
24421615|NCT00219765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24421616|NCT00219765|Antimetabolites|antimetabolites|mesh-ancestor
24421637|NCT00219778|Contraceptive Agents|contraceptive agents|mesh-ancestor
24421874|NCT00220350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24421875|NCT00220350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24475946|NCT00412035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24421876|NCT00220350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24421877|NCT00220350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24421879|NCT00220454|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24421880|NCT00220454|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
24422261|NCT00221845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24422264|NCT00221871|Sensory System Agents|sensory system agents|mesh-ancestor
24422265|NCT00221871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25407657|NCT03485677|Eliglustat|eliglustat|mesh-list
25717114|NCT02406586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25717115|NCT02406586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25717116|NCT02406586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25717117|NCT02406586|Analgesics|analgesics|mesh-ancestor
25717118|NCT02406586|Sensory System Agents|sensory system agents|mesh-ancestor
25717119|NCT02406586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25717120|NCT02406586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25717121|NCT02406586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25717122|NCT02406742|Obinutuzumab|obinutuzumab|mesh-list
25717123|NCT02406742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24422266|NCT00221871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24422267|NCT00221871|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24422268|NCT00221871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24422269|NCT00221871|Anesthetics, General|anesthetics, general|mesh-ancestor
24422953|NCT00224302|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24428914|NCT00241501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24422954|NCT00224302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24422955|NCT00224302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24422956|NCT00224302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423027|NCT00224458|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
24423028|NCT00224458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24423458|NCT00226096|Clonidine|clonidine|mesh-list
24423479|NCT00226096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24423480|NCT00226096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24423481|NCT00226096|Analgesics|analgesics|mesh-ancestor
24423482|NCT00226096|Sensory System Agents|sensory system agents|mesh-ancestor
24423483|NCT00226096|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
24423709|NCT00226668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24423711|NCT00226694|Citalopram|citalopram|mesh-list
24424333|NCT00228878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24424334|NCT00228878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424456|NCT00229476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24424457|NCT00229476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24424458|NCT00229476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24424780|NCT00230763|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24424781|NCT00230763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24424782|NCT00230776|Pregabalin|pregabalin|mesh-list
24424783|NCT00230776|Analgesics|analgesics|mesh-ancestor
24424784|NCT00230776|Sensory System Agents|sensory system agents|mesh-ancestor
24424785|NCT00230776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24424813|NCT00230958|Interferons|interferons|mesh-list
24424904|NCT00231244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24424905|NCT00231244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24424906|NCT00231244|Antifungal Agents|antifungal agents|mesh-ancestor
24424907|NCT00231244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24424908|NCT00231244|Immunologic Factors|immunologic factors|mesh-ancestor
24424909|NCT00231244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24424910|NCT00231322|Praziquantel|praziquantel|mesh-list
24424911|NCT00231322|Anthelmintics|anthelmintics|mesh-ancestor
24424912|NCT00231322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24424913|NCT00231322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24424914|NCT00231335|Citalopram|citalopram|mesh-list
24424915|NCT00231335|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25717124|NCT02406742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25717125|NCT02406885|Apixaban|apixaban|mesh-list
25717126|NCT02406885|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25717127|NCT02406885|Antithrombins|antithrombins|mesh-ancestor
25717128|NCT02406885|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25717129|NCT02406885|Protease Inhibitors|protease inhibitors|mesh-ancestor
25717130|NCT02406885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25717131|NCT02406885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717132|NCT02406885|Anticoagulants|anticoagulants|mesh-ancestor
25717133|NCT02407223|Ustekinumab|ustekinumab|mesh-list
25717134|NCT02407223|Dermatologic Agents|dermatologic agents|mesh-ancestor
25717136|NCT02407704|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25717137|NCT02407704|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25717138|NCT02407704|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24424983|NCT00231556|Anticonvulsants|anticonvulsants|mesh-ancestor
24424984|NCT00231556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24425130|NCT00232063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24425156|NCT00232102|Tegaserod|tegaserod|mesh-list
24425157|NCT00232102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24425158|NCT00232102|Serotonin Agents|serotonin agents|mesh-ancestor
24425159|NCT00232102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24425266|NCT00232531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425268|NCT00232531|Vasodilator Agents|vasodilator agents|mesh-ancestor
24425360|NCT00232817|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24425361|NCT00232817|Autonomic Agents|autonomic agents|mesh-ancestor
24425362|NCT00232817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24425363|NCT00232817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425364|NCT00232817|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
24425365|NCT00232817|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24425366|NCT00232817|Cholinergic Agents|cholinergic agents|mesh-ancestor
24425367|NCT00232817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24425368|NCT00232817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425369|NCT00232856|Sirolimus|sirolimus|mesh-list
24425370|NCT00232856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24425457|NCT00233051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425458|NCT00233051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24425459|NCT00233051|Respiratory System Agents|respiratory system agents|mesh-ancestor
24432415|NCT00254748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24425746|NCT00234195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24425754|NCT00234299|Aspirin|aspirin|mesh-list
24425783|NCT00234377|Antidepressive Agents|antidepressive agents|mesh-ancestor
24425784|NCT00234377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24425785|NCT00234377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24425786|NCT00234377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24425787|NCT00234377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24425788|NCT00234377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425808|NCT00234403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24425809|NCT00234403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24425810|NCT00234403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24425811|NCT00234403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24425812|NCT00234416|Gemcitabine|gemcitabine|mesh-list
24425814|NCT00234416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24425859|NCT00234507|Cholinergic Agents|cholinergic agents|mesh-ancestor
24425860|NCT00234507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24426716|NCT00236535|Analgesics|analgesics|mesh-ancestor
24426717|NCT00236535|Sensory System Agents|sensory system agents|mesh-ancestor
24426718|NCT00236535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24426719|NCT00236535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24426720|NCT00236535|Antipyretics|antipyretics|mesh-ancestor
24426721|NCT00236535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24427637|NCT00238641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24427865|NCT00239109|Dopamine Agents|dopamine agents|mesh-ancestor
24427866|NCT00239161|Levofloxacin|levofloxacin|mesh-list
24427867|NCT00239161|Ofloxacin|ofloxacin|mesh-list
24427868|NCT00239161|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24427869|NCT00239161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24427870|NCT00239161|Renal Agents|renal agents|mesh-ancestor
24427871|NCT00239161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24427872|NCT00239161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24427873|NCT00239161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24427874|NCT00239161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24427879|NCT00239174|Surinabant|surinabant|mesh-list
24427956|NCT00239382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24427957|NCT00239382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24428346|NCT00240266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24428347|NCT00240266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428348|NCT00240279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
24428349|NCT00240279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25717139|NCT02407704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25717140|NCT02407704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717141|NCT02407704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25717142|NCT02407704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428464|NCT00240552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24428465|NCT00240552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24428466|NCT00240552|Antiviral Agents|antiviral agents|mesh-ancestor
24428467|NCT00240552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24428468|NCT00240604|Rosiglitazone|rosiglitazone|mesh-list
24428469|NCT00240604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24428470|NCT00240604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24428471|NCT00240617|Naproxen|naproxen|mesh-list
24428472|NCT00240617|Sumatriptan|sumatriptan|mesh-list
24428473|NCT00240617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24428474|NCT00240617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24428486|NCT00240617|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24428487|NCT00240617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24428823|NCT00241254|Immunologic Factors|immunologic factors|mesh-ancestor
24428825|NCT00241254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24428838|NCT00241254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24428839|NCT00241254|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24428840|NCT00241254|Protective Agents|protective agents|mesh-ancestor
24428909|NCT00241488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24428911|NCT00241501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24428912|NCT00241501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24428913|NCT00241501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24430199|NCT00246389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24430200|NCT00246389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24430201|NCT00246389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24430203|NCT00246402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24430204|NCT00246402|Antimetabolites|antimetabolites|mesh-ancestor
24430205|NCT00246402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430207|NCT00246415|Memantine|memantine|mesh-list
24430252|NCT00246675|Natriuretic Agents|natriuretic agents|mesh-ancestor
24430253|NCT00246675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24430254|NCT00246675|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24430255|NCT00246675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24430256|NCT00246675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430257|NCT00246688|Sagopilone|sagopilone|mesh-list
24430258|NCT00246688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24430325|NCT00247130|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24430326|NCT00247130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430327|NCT00247130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24430328|NCT00247130|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24430329|NCT00247130|Histamine Antagonists|histamine antagonists|mesh-ancestor
24430415|NCT00247650|Letrozole|letrozole|mesh-list
24430674|NCT00248963|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24430675|NCT00248989|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24430676|NCT00248989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24430677|NCT00248989|Immunologic Factors|immunologic factors|mesh-ancestor
24430790|NCT00249223|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24430791|NCT00249223|Dopamine Agents|dopamine agents|mesh-ancestor
24430792|NCT00249236|Risperidone|risperidone|mesh-list
24430946|NCT00249847|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24430947|NCT00249847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24430949|NCT00249860|Ribavirin|ribavirin|mesh-list
24430950|NCT00249860|Interferon-beta|interferon-beta|mesh-list
24430951|NCT00249860|Interferon beta-1a|interferon beta-1a|mesh-list
24431030|NCT00250068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24431031|NCT00250068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24431032|NCT00250068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431033|NCT00250068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431034|NCT00250081|Botulinum Toxins|botulinum toxins|mesh-list
24437981|NCT00274833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24431036|NCT00250081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24431384|NCT00251524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24431386|NCT00251550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24431432|NCT00251706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24431433|NCT00251706|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24431434|NCT00251706|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24431832|NCT00253110|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25717143|NCT02407704|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25717144|NCT02407704|Antidepressive Agents|antidepressive agents|mesh-ancestor
24431892|NCT00253188|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24432151|NCT00253799|Viscosupplements|viscosupplements|mesh-ancestor
24432152|NCT00253799|Protective Agents|protective agents|mesh-ancestor
24432153|NCT00253799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432154|NCT00253851|Heparin|heparin|mesh-list
24432155|NCT00253851|Calcium heparin|calcium heparin|mesh-list
24432156|NCT00253851|Anticoagulants|anticoagulants|mesh-ancestor
24432157|NCT00253851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24432158|NCT00253851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24432159|NCT00253851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432160|NCT00253903|SR 46349B|sr 46349b|mesh-list
24432161|NCT00253903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24432162|NCT00253903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24432163|NCT00253903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432164|NCT00253903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
24432165|NCT00253903|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24432166|NCT00253903|Serotonin Agents|serotonin agents|mesh-ancestor
24432232|NCT00254033|Methylphenidate|methylphenidate|mesh-list
24432233|NCT00254033|Dextroamphetamine|dextroamphetamine|mesh-list
24432234|NCT00254033|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24432235|NCT00254033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432416|NCT00254748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24432417|NCT00254748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24432419|NCT00254774|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24432420|NCT00254774|Antidepressive Agents|antidepressive agents|mesh-ancestor
24432421|NCT00254774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24432682|NCT00255710|Mycophenolic Acid|mycophenolic acid|mesh-list
24432866|NCT00256542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432885|NCT00256737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24432889|NCT00256828|Lamivudine|lamivudine|mesh-list
24432953|NCT00257049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24432954|NCT00257049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24432955|NCT00257049|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
24432956|NCT00257049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24432957|NCT00257062|Levofloxacin|levofloxacin|mesh-list
24432958|NCT00257062|Ofloxacin|ofloxacin|mesh-list
24432959|NCT00257062|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24432960|NCT00257062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24432961|NCT00257062|Renal Agents|renal agents|mesh-ancestor
24432962|NCT00257062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24432963|NCT00257062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24433455|NCT00258388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24433456|NCT00258388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24433457|NCT00258388|Glucocorticoids|glucocorticoids|mesh-ancestor
24433458|NCT00258388|Hormones|hormones|mesh-ancestor
24433459|NCT00258388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24433460|NCT00258388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24433462|NCT00258479|Modafinil|modafinil|mesh-list
24433507|NCT00258622|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24433508|NCT00258622|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24433509|NCT00258622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24435059|NCT00264953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435060|NCT00264953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24435061|NCT00264953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24435062|NCT00264953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24435074|NCT00265018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24435075|NCT00265018|Bleomycin|bleomycin|mesh-list
24435076|NCT00265018|Vinblastine|vinblastine|mesh-list
24435077|NCT00265018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24435078|NCT00265018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435079|NCT00265018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24435723|NCT00267917|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
24435818|NCT00268255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24435819|NCT00268255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24436006|NCT00268671|Docetaxel|docetaxel|mesh-list
25717145|NCT02407704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25717146|NCT02407704|Anticonvulsants|anticonvulsants|mesh-ancestor
25717147|NCT02407704|Antiemetics|antiemetics|mesh-ancestor
25717148|NCT02407704|Autonomic Agents|autonomic agents|mesh-ancestor
25717149|NCT02407704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25717150|NCT02407704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25717151|NCT02407704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25717152|NCT02407704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25717153|NCT02407704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25717154|NCT02407704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24436007|NCT00268671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24436008|NCT00268671|Tubulin Modulators|tubulin modulators|mesh-ancestor
24436009|NCT00268671|Antimitotic Agents|antimitotic agents|mesh-ancestor
25717155|NCT02407704|GABA Modulators|gaba modulators|mesh-ancestor
25717156|NCT02407704|GABA Agents|gaba agents|mesh-ancestor
24436203|NCT00269386|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24436204|NCT00269386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24436205|NCT00269386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436208|NCT00269412|Rifaximin|rifaximin|mesh-list
24436286|NCT00269620|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
24436287|NCT00269620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24436288|NCT00269620|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24436289|NCT00269620|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24436290|NCT00269620|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
24436291|NCT00269672|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
24436593|NCT00270543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24436594|NCT00270543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24436595|NCT00270543|Immunologic Factors|immunologic factors|mesh-ancestor
24436596|NCT00270543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436612|NCT00270556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24436614|NCT00270556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24436615|NCT00270569|Cisplatin|cisplatin|mesh-list
24436617|NCT00270582|Gemcitabine|gemcitabine|mesh-list
24436644|NCT00270751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24436645|NCT00270751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24436652|NCT00270777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24436653|NCT00270777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24436654|NCT00270777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24436655|NCT00270777|Adrenergic Agents|adrenergic agents|mesh-ancestor
24436656|NCT00270777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24436870|NCT00271713|Vitamins|vitamins|mesh-list
24436871|NCT00271713|Calcium|calcium|mesh-list
24436872|NCT00271713|Micronutrients|micronutrients|mesh-ancestor
24436873|NCT00271713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436874|NCT00271713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24436875|NCT00271713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24436876|NCT00271791|Prednisone|prednisone|mesh-list
24436878|NCT00271791|Glucocorticoids|glucocorticoids|mesh-ancestor
24436902|NCT00272025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24436903|NCT00272025|Serotonin Agents|serotonin agents|mesh-ancestor
24436904|NCT00272025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24436905|NCT00272025|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24436906|NCT00272025|Antidepressive Agents|antidepressive agents|mesh-ancestor
24436907|NCT00272025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24436908|NCT00272051|Xaliproden|xaliproden|mesh-list
24436909|NCT00272051|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24436923|NCT00272077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24437018|NCT00272454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24437019|NCT00272467|Omeprazole|omeprazole|mesh-list
24437020|NCT00272467|Rebamipide|rebamipide|mesh-list
24437090|NCT00272636|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24437091|NCT00272636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24437092|NCT00272675|Chlorhexidine|chlorhexidine|mesh-list
24437093|NCT00272675|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
24437094|NCT00272675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
24437095|NCT00272675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24437096|NCT00272675|Disinfectants|disinfectants|mesh-ancestor
24437097|NCT00272675|Dermatologic Agents|dermatologic agents|mesh-ancestor
24437098|NCT00272688|Levodopa|levodopa|mesh-list
24437099|NCT00272688|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24437100|NCT00272688|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24437101|NCT00272688|Dopamine Agents|dopamine agents|mesh-ancestor
25717157|NCT02408016|Aldesleukin|aldesleukin|mesh-list
25717158|NCT02408016|Cyclophosphamide|cyclophosphamide|mesh-list
25717159|NCT02408016|Interleukin-2|interleukin-2|mesh-list
25717160|NCT02408016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24437102|NCT00272688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24437105|NCT00272701|Esomeprazole|esomeprazole|mesh-list
24437320|NCT00273429|Dorzolamide|dorzolamide|mesh-list
24437321|NCT00273429|Latanoprost|latanoprost|mesh-list
24437322|NCT00273429|Maleic acid|maleic acid|mesh-list
24437372|NCT00273481|Dorzolamide|dorzolamide|mesh-list
24437373|NCT00273481|Latanoprost|latanoprost|mesh-list
24437374|NCT00273481|Maleic acid|maleic acid|mesh-list
24437375|NCT00273481|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24437376|NCT00273481|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24437377|NCT00273481|Adrenergic Agents|adrenergic agents|mesh-ancestor
24437378|NCT00273481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24437379|NCT00273481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437380|NCT00273481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437381|NCT00273481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24437382|NCT00273481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24437383|NCT00273481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24437384|NCT00273481|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24437525|NCT00273962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24437526|NCT00273962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24437527|NCT00273962|Adrenergic Agents|adrenergic agents|mesh-ancestor
24437528|NCT00273962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24437561|NCT00274001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437562|NCT00274001|Antiviral Agents|antiviral agents|mesh-ancestor
24437563|NCT00274001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24437564|NCT00274001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24437682|NCT00274131|Protective Agents|protective agents|mesh-ancestor
24437683|NCT00274131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24437684|NCT00274131|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24437685|NCT00274131|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24437686|NCT00274131|Dopamine Agonists|dopamine agonists|mesh-ancestor
24437687|NCT00274131|Dopamine Agents|dopamine agents|mesh-ancestor
24437689|NCT00274144|Telmisartan|telmisartan|mesh-list
24437929|NCT00274807|Cytarabine|cytarabine|mesh-list
24437964|NCT00274820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24437965|NCT00274820|Antioxidants|antioxidants|mesh-ancestor
24437966|NCT00274820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437967|NCT00274820|Protective Agents|protective agents|mesh-ancestor
24437968|NCT00274820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24437969|NCT00274820|Immunologic Factors|immunologic factors|mesh-ancestor
24437980|NCT00274833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24437982|NCT00274833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24437983|NCT00274833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24438033|NCT00274898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24438034|NCT00274898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438035|NCT00274911|Vincristine|vincristine|mesh-list
24438105|NCT00275015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24438106|NCT00275015|Antiemetics|antiemetics|mesh-ancestor
24438107|NCT00275015|Autonomic Agents|autonomic agents|mesh-ancestor
24438108|NCT00275015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24438109|NCT00275015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24438110|NCT00275015|Glucocorticoids|glucocorticoids|mesh-ancestor
24438112|NCT00275015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24438113|NCT00275015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24438114|NCT00275015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24438115|NCT00275015|Antimetabolites|antimetabolites|mesh-ancestor
24438122|NCT00275041|Irinotecan|irinotecan|mesh-list
24438197|NCT00275106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24438198|NCT00275106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25717161|NCT02408016|Immunologic Factors|immunologic factors|mesh-ancestor
25717162|NCT02408016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717163|NCT02408016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25717164|NCT02408016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25717165|NCT02408016|Alkylating Agents|alkylating agents|mesh-ancestor
25717166|NCT02408016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717167|NCT02408016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25717168|NCT02408016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24438201|NCT00275106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24438264|NCT00275236|Dopamine Agonists|dopamine agonists|mesh-ancestor
24438265|NCT00275236|Dopamine Agents|dopamine agents|mesh-ancestor
24438266|NCT00275236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24438267|NCT00275236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438268|NCT00275236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438269|NCT00275249|Levorphanol|levorphanol|mesh-list
24438282|NCT00275405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438283|NCT00275405|Protective Agents|protective agents|mesh-ancestor
24438284|NCT00275405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438285|NCT00275405|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24438286|NCT00275405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438462|NCT00276003|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24438463|NCT00276003|Antioxidants|antioxidants|mesh-ancestor
24438464|NCT00276003|Protective Agents|protective agents|mesh-ancestor
24438466|NCT00276029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24438467|NCT00276029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24438468|NCT00276029|Analgesics|analgesics|mesh-ancestor
24438469|NCT00276029|Sensory System Agents|sensory system agents|mesh-ancestor
24438470|NCT00276029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24438471|NCT00276029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438472|NCT00276029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24438473|NCT00276029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24438474|NCT00276029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24438475|NCT00276029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24438501|NCT00276068|Anesthetics|anesthetics|mesh-ancestor
24438502|NCT00276068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24438503|NCT00276068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438513|NCT00276068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24438594|NCT00276315|Cholinergic Agents|cholinergic agents|mesh-ancestor
24438607|NCT00276497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24438608|NCT00276497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24438609|NCT00276523|Interferons|interferons|mesh-list
24438636|NCT00276575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24438637|NCT00276575|Immunologic Factors|immunologic factors|mesh-ancestor
24438638|NCT00276575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24438639|NCT00276575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438640|NCT00276575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438688|NCT00276640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438689|NCT00276640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24438690|NCT00276640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24438691|NCT00276640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24438692|NCT00276640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24438693|NCT00276640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438694|NCT00276640|Tubulin Modulators|tubulin modulators|mesh-ancestor
24438695|NCT00276640|Antimitotic Agents|antimitotic agents|mesh-ancestor
24438696|NCT00276640|Mitosis Modulators|mitosis modulators|mesh-ancestor
24438697|NCT00276666|Vincristine|vincristine|mesh-list
24438698|NCT00276666|Lomustine|lomustine|mesh-list
24438699|NCT00276666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24438700|NCT00276666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24438701|NCT00276666|Tubulin Modulators|tubulin modulators|mesh-ancestor
24438702|NCT00276666|Antimitotic Agents|antimitotic agents|mesh-ancestor
24438703|NCT00276666|Mitosis Modulators|mitosis modulators|mesh-ancestor
24438704|NCT00276666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24438705|NCT00276666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24438706|NCT00276666|Alkylating Agents|alkylating agents|mesh-ancestor
25407658|NCT03485677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25717169|NCT02408016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25717170|NCT02408016|Analgesics|analgesics|mesh-ancestor
25717171|NCT02408016|Sensory System Agents|sensory system agents|mesh-ancestor
25717172|NCT02408016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25717173|NCT02408016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25717174|NCT02408016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25717175|NCT02408016|Antiviral Agents|antiviral agents|mesh-ancestor
25717176|NCT02408016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25717177|NCT02408120|Insulin|insulin|mesh-list
24438971|NCT00277017|Interferons|interferons|mesh-list
24439005|NCT00277069|Antimitotic Agents|antimitotic agents|mesh-ancestor
24439006|NCT00277069|Mitosis Modulators|mitosis modulators|mesh-ancestor
24439156|NCT00277693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439157|NCT00277693|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
24439158|NCT00277693|Diuretics|diuretics|mesh-ancestor
24439159|NCT00277693|Natriuretic Agents|natriuretic agents|mesh-ancestor
24439161|NCT00277706|Calcium|calcium|mesh-list
24439162|NCT00277706|Vitamins|vitamins|mesh-ancestor
24439188|NCT00277862|Antimetabolites|antimetabolites|mesh-ancestor
24439420|NCT00278421|Antimitotic Agents|antimitotic agents|mesh-ancestor
24439468|NCT00278928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24439469|NCT00278941|Quetiapine Fumarate|quetiapine fumarate|mesh-list
24439470|NCT00278941|Antidepressive Agents|antidepressive agents|mesh-ancestor
24439471|NCT00278941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24439472|NCT00278941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24439545|NCT00279266|Vitamin B Complex|vitamin b complex|mesh-ancestor
24439547|NCT00279266|Micronutrients|micronutrients|mesh-ancestor
24439548|NCT00279266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439549|NCT00279344|Fentanyl|fentanyl|mesh-list
24439575|NCT00279448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439576|NCT00279448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24439578|NCT00279448|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
24439579|NCT00279448|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
24439580|NCT00279448|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24439581|NCT00279448|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24439585|NCT00279461|Vitamin D|vitamin d|mesh-list
24439721|NCT00280046|Insulin Aspart|insulin aspart|mesh-list
24439722|NCT00280046|Biphasic Insulins|biphasic insulins|mesh-list
24439723|NCT00280046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24439915|NCT00280878|Rituximab|rituximab|mesh-list
24439724|NCT00280046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439726|NCT00280098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24439727|NCT00280098|Tubulin Modulators|tubulin modulators|mesh-ancestor
24439728|NCT00280098|Antimitotic Agents|antimitotic agents|mesh-ancestor
24439732|NCT00280176|Bortezomib|bortezomib|mesh-list
24439751|NCT00280215|Protective Agents|protective agents|mesh-ancestor
24439752|NCT00280215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439753|NCT00280267|Testosterone|testosterone|mesh-list
24439754|NCT00280267|Androgens|androgens|mesh-ancestor
24439755|NCT00280267|Hormones|hormones|mesh-ancestor
24439758|NCT00280280|Baclofen|baclofen|mesh-list
24439763|NCT00280280|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24439769|NCT00280358|Xhance|xhance|mesh-list
25717178|NCT02408120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25717179|NCT02408120|Insulin Glargine|insulin glargine|mesh-list
25717180|NCT02408120|Insulin Aspart|insulin aspart|mesh-list
25717181|NCT02408120|Insulin, Long-Acting|insulin, long-acting|mesh-list
25717182|NCT02408120|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25717183|NCT02408120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25717184|NCT02408120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717185|NCT02408445|Methyltestosterone|methyltestosterone|mesh-list
24439830|NCT00280501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24439831|NCT00280501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24439832|NCT00280501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24439833|NCT00280501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439834|NCT00280501|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24439835|NCT00280501|Dopamine Agents|dopamine agents|mesh-ancestor
24439862|NCT00280553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24439863|NCT00280553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439864|NCT00280553|Sensory System Agents|sensory system agents|mesh-ancestor
24439865|NCT00280553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24439878|NCT00280644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24439879|NCT00280644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439880|NCT00280644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24439881|NCT00280644|Immunologic Factors|immunologic factors|mesh-ancestor
24439882|NCT00280644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439883|NCT00280696|Levetiracetam|levetiracetam|mesh-list
24439884|NCT00280696|Anticonvulsants|anticonvulsants|mesh-ancestor
24439885|NCT00280696|Nootropic Agents|nootropic agents|mesh-ancestor
24439906|NCT00280787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24439907|NCT00280839|Topiramate|topiramate|mesh-list
24439908|NCT00280839|Anticonvulsants|anticonvulsants|mesh-ancestor
24439909|NCT00280839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24439910|NCT00280839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439911|NCT00280865|Pioglitazone|pioglitazone|mesh-list
24439912|NCT00280865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24439913|NCT00280865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439914|NCT00280878|Gemcitabine|gemcitabine|mesh-list
24439924|NCT00280878|Antimetabolites|antimetabolites|mesh-ancestor
24439925|NCT00280878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24439926|NCT00280878|Antiviral Agents|antiviral agents|mesh-ancestor
24439927|NCT00280878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24439961|NCT00280969|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24439962|NCT00280969|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24439963|NCT00280969|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24439964|NCT00280969|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24439965|NCT00280969|Protease Inhibitors|protease inhibitors|mesh-ancestor
24440154|NCT00281905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24440155|NCT00281905|Antimetabolites|antimetabolites|mesh-ancestor
24440156|NCT00281905|Dermatologic Agents|dermatologic agents|mesh-ancestor
24440174|NCT00281931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440176|NCT00281931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24440179|NCT00281931|Antimetabolites|antimetabolites|mesh-ancestor
25717186|NCT02408445|Testosterone|testosterone|mesh-list
25717187|NCT02408445|Testosterone undecanoate|testosterone undecanoate|mesh-list
25717188|NCT02408445|Testosterone enanthate|testosterone enanthate|mesh-list
25717189|NCT02408445|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25717190|NCT02408445|Androgens|androgens|mesh-ancestor
25717191|NCT02408445|Hormones|hormones|mesh-ancestor
25717192|NCT02408445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25717193|NCT02408445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717194|NCT02408445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24440345|NCT00282451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440347|NCT00282503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
24440350|NCT00282503|Prednisolone acetate|prednisolone acetate|mesh-list
24440352|NCT00282503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
24440353|NCT00282503|Prednisolone phosphate|prednisolone phosphate|mesh-list
24440354|NCT00282503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24440355|NCT00282503|Antiemetics|antiemetics|mesh-ancestor
24440356|NCT00282503|Autonomic Agents|autonomic agents|mesh-ancestor
24440357|NCT00282503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24440358|NCT00282503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440359|NCT00282503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24440360|NCT00282503|Glucocorticoids|glucocorticoids|mesh-ancestor
24440362|NCT00282503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24440363|NCT00282503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24440364|NCT00282503|Protective Agents|protective agents|mesh-ancestor
24440369|NCT00282594|Insulin|insulin|mesh-list
24440640|NCT00284024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24440641|NCT00284024|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24440642|NCT00284024|Dopamine Agents|dopamine agents|mesh-ancestor
24440643|NCT00284024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24440644|NCT00284024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440645|NCT00284193|Thrombin|thrombin|mesh-list
24440646|NCT00284193|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
24440647|NCT00284193|Factor VIII|factor viii|mesh-list
24440648|NCT00284193|Hemostatics|hemostatics|mesh-ancestor
24440649|NCT00284193|Coagulants|coagulants|mesh-ancestor
24440650|NCT00284206|Risperidone|risperidone|mesh-list
24440687|NCT00284271|Hormones|hormones|mesh-ancestor
24440688|NCT00284271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24440689|NCT00284271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24440690|NCT00284271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24440721|NCT00284336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24440722|NCT00284336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24440723|NCT00284336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24440724|NCT00284427|Ascorbic Acid|ascorbic acid|mesh-list
24440725|NCT00284427|Vitamins|vitamins|mesh-ancestor
24440726|NCT00284427|Micronutrients|micronutrients|mesh-ancestor
24440727|NCT00284427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440731|NCT00284505|Thalidomide|thalidomide|mesh-list
24440732|NCT00284505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24440733|NCT00284505|Immunologic Factors|immunologic factors|mesh-ancestor
24440734|NCT00284505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440817|NCT00284921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24440820|NCT00284947|Methylprednisolone|methylprednisolone|mesh-list
24440821|NCT00284947|Basiliximab|basiliximab|mesh-list
24440822|NCT00284947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24440823|NCT00284947|Glucocorticoids|glucocorticoids|mesh-ancestor
24440824|NCT00284947|Hormones|hormones|mesh-ancestor
24440930|NCT00285389|Vincristine|vincristine|mesh-list
24440931|NCT00285389|Doxorubicin|doxorubicin|mesh-list
24440932|NCT00285389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24440933|NCT00285389|Immunologic Factors|immunologic factors|mesh-ancestor
24440934|NCT00285389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24440935|NCT00285389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24440936|NCT00285389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24440937|NCT00285389|Alkylating Agents|alkylating agents|mesh-ancestor
24440943|NCT00285389|Antiemetics|antiemetics|mesh-ancestor
24440961|NCT00285415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24440962|NCT00285415|Tubulin Modulators|tubulin modulators|mesh-ancestor
24440963|NCT00285415|Antimitotic Agents|antimitotic agents|mesh-ancestor
24440964|NCT00285415|Mitosis Modulators|mitosis modulators|mesh-ancestor
25717195|NCT02408445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25717196|NCT02408445|Anabolic Agents|anabolic agents|mesh-ancestor
25717197|NCT02408523|Lacosamide|lacosamide|mesh-list
25717198|NCT02408523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25717199|NCT02408523|Anticonvulsants|anticonvulsants|mesh-ancestor
24440965|NCT00285415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441065|NCT00285896|Glucagon|glucagon|mesh-list
25717200|NCT02408523|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25717201|NCT02408523|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24441066|NCT00285896|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
24441067|NCT00285896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24441068|NCT00285896|Hormones|hormones|mesh-ancestor
24441069|NCT00285896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24441144|NCT00286208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24441146|NCT00286208|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
24441190|NCT00286351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441191|NCT00286351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24441192|NCT00286351|Hormone Antagonists|hormone antagonists|mesh-ancestor
24441268|NCT00286871|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24441269|NCT00286871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24441270|NCT00286871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441273|NCT00286923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24441274|NCT00286923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441275|NCT00286936|Zolpidem|zolpidem|mesh-list
24441276|NCT00286936|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
24441277|NCT00286936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24441311|NCT00287157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441490|NCT00287560|Anesthetics|anesthetics|mesh-ancestor
24441500|NCT00287677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441501|NCT00287742|Risperidone|risperidone|mesh-list
24441502|NCT00287742|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24441503|NCT00287742|Serotonin Agents|serotonin agents|mesh-ancestor
24441504|NCT00287742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24441505|NCT00287742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441506|NCT00287742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441507|NCT00287742|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24441508|NCT00287742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24441541|NCT00287794|Autonomic Agents|autonomic agents|mesh-ancestor
24441542|NCT00287794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24441598|NCT00287911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24441599|NCT00287924|Methotrexate|methotrexate|mesh-list
24441814|NCT00288431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24441815|NCT00288431|Antifungal Agents|antifungal agents|mesh-ancestor
24441817|NCT00288431|Immunologic Factors|immunologic factors|mesh-ancestor
24441818|NCT00288431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24441819|NCT00288444|Docetaxel|docetaxel|mesh-list
24441820|NCT00288444|Lonafarnib|lonafarnib|mesh-list
24441821|NCT00288444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442337|NCT00290719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24442338|NCT00290719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24442339|NCT00290719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24442341|NCT00290719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442342|NCT00290719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24442344|NCT00290758|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
24442526|NCT00291382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24442527|NCT00291382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24442528|NCT00291382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24477839|NCT00420537|Cyclosporine|cyclosporine|mesh-list
24442635|NCT00291850|Tubulin Modulators|tubulin modulators|mesh-ancestor
24442636|NCT00291850|Antimitotic Agents|antimitotic agents|mesh-ancestor
24442637|NCT00291850|Mitosis Modulators|mitosis modulators|mesh-ancestor
24442638|NCT00291850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24442639|NCT00291863|Simvastatin|simvastatin|mesh-list
24442640|NCT00291863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24442641|NCT00291863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24442642|NCT00291863|Antimetabolites|antimetabolites|mesh-ancestor
24442685|NCT00292123|Narcotics|narcotics|mesh-ancestor
25717202|NCT02408523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25717203|NCT02408523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717204|NCT02408965|Methylergonovine|methylergonovine|mesh-list
25717205|NCT02408965|Oxytocics|oxytocics|mesh-ancestor
25717206|NCT02408965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25717207|NCT02408965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717208|NCT02409680|Aspirin|aspirin|mesh-list
25717209|NCT02409680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25717210|NCT02409680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25717211|NCT02409680|Analgesics|analgesics|mesh-ancestor
25717212|NCT02409680|Sensory System Agents|sensory system agents|mesh-ancestor
25717213|NCT02409680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25717214|NCT02409680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717215|NCT02409680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24442716|NCT00292266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24442717|NCT00292266|Immunologic Factors|immunologic factors|mesh-ancestor
24442727|NCT00292344|Loperamide|loperamide|mesh-list
24442898|NCT00293150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24442900|NCT00293163|Viscosupplements|viscosupplements|mesh-ancestor
24442941|NCT00293332|Antimitotic Agents|antimitotic agents|mesh-ancestor
24443007|NCT00293436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24443008|NCT00293436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24443009|NCT00293436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24443015|NCT00293475|Carboplatin|carboplatin|mesh-list
25717216|NCT02409680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25717217|NCT02409680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25717218|NCT02409680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25717219|NCT02409680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717220|NCT02409680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25407735|NCT03480438|Blinatumomab|blinatumomab|mesh-list
25717221|NCT02409680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25717222|NCT02409680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443109|NCT00293657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717223|NCT02409680|Antipyretics|antipyretics|mesh-ancestor
25771280|NCT03597009|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25771281|NCT03597009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25771282|NCT03597009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25771283|NCT03597009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25771284|NCT03597009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771285|NCT03597022|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
25771286|NCT03597022|Immunoglobulins|immunoglobulins|mesh-list
25771287|NCT03597022|Immunoglobulin G|immunoglobulin g|mesh-list
25771288|NCT03597022|Immunologic Factors|immunologic factors|mesh-ancestor
25771289|NCT03597022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771290|NCT03597022|Anticoagulants|anticoagulants|mesh-ancestor
24443183|NCT00293891|Immunologic Factors|immunologic factors|mesh-ancestor
24443193|NCT00293917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24443198|NCT00293930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519990|NCT04290546|Ipilimumab|ipilimumab|mesh-list
25717224|NCT02409732|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25717225|NCT02409732|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25717226|NCT02409732|Dermatologic Agents|dermatologic agents|mesh-ancestor
25717227|NCT02410200|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25717228|NCT02410200|Dermatologic Agents|dermatologic agents|mesh-ancestor
24477965|NCT00421044|Tubulin Modulators|tubulin modulators|mesh-ancestor
25717229|NCT02410200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25717230|NCT02410200|Immunologic Factors|immunologic factors|mesh-ancestor
25717231|NCT02410200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717232|NCT02410278|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25717233|NCT02410278|Montelukast|montelukast|mesh-list
25717234|NCT02410278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25717235|NCT02410278|Respiratory System Agents|respiratory system agents|mesh-ancestor
25771291|NCT03597022|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25717236|NCT02410278|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25717237|NCT02410278|Hormone Antagonists|hormone antagonists|mesh-ancestor
25717238|NCT02410278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25717239|NCT02410278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717240|NCT02410278|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25717241|NCT02410278|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25771292|NCT03597022|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25771293|NCT03597022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771294|NCT03597022|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25771295|NCT03597022|Protease Inhibitors|protease inhibitors|mesh-ancestor
25771296|NCT03597022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771297|NCT03597022|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25771298|NCT03597022|Antithrombins|antithrombins|mesh-ancestor
25717242|NCT02410278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717243|NCT02410278|Dermatologic Agents|dermatologic agents|mesh-ancestor
25717244|NCT02410278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25717245|NCT02410278|Immunologic Factors|immunologic factors|mesh-ancestor
25717246|NCT02410382|Dexamethasone|dexamethasone|mesh-list
25717247|NCT02410382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25717248|NCT02410382|Antiemetics|antiemetics|mesh-ancestor
25717249|NCT02410382|Autonomic Agents|autonomic agents|mesh-ancestor
25717250|NCT02410382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25717251|NCT02410382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717252|NCT02410382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25717253|NCT02410382|Glucocorticoids|glucocorticoids|mesh-ancestor
25717254|NCT02410382|Hormones|hormones|mesh-ancestor
25717255|NCT02410382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25717256|NCT02410382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25717257|NCT02410382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25717258|NCT02410707|Nitrous Oxide|nitrous oxide|mesh-list
25717259|NCT02410707|Propofol|propofol|mesh-list
25717260|NCT02410707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24443319|NCT00294463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24443320|NCT00294463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24443321|NCT00294463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24443576|NCT00295464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25717261|NCT02410707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25717262|NCT02410707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717263|NCT02410707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25717265|NCT02410707|Anesthetics|anesthetics|mesh-ancestor
25717266|NCT02410707|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25717267|NCT02410707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25717268|NCT02410707|Analgesics|analgesics|mesh-ancestor
25717269|NCT02410707|Sensory System Agents|sensory system agents|mesh-ancestor
24443785|NCT00295984|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24443786|NCT00295984|Autonomic Agents|autonomic agents|mesh-ancestor
24443787|NCT00295984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24443973|NCT00296387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717270|NCT02410707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25717271|NCT02410772|Moxifloxacin|moxifloxacin|mesh-list
25717272|NCT02410772|Rifapentine|rifapentine|mesh-list
25717274|NCT02410772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25717275|NCT02410772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25717276|NCT02410772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24447242|NCT00307671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24447243|NCT00307671|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24447244|NCT00307671|Antitubercular Agents|antitubercular agents|mesh-ancestor
24447245|NCT00307671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24447246|NCT00307671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24447247|NCT00307671|Antiemetics|antiemetics|mesh-ancestor
24447248|NCT00307671|Autonomic Agents|autonomic agents|mesh-ancestor
25717277|NCT02410772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25717278|NCT02410772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25717279|NCT02410772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717280|NCT02410772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25717281|NCT02410772|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25717282|NCT02410772|Antitubercular Agents|antitubercular agents|mesh-ancestor
25717283|NCT02410772|Leprostatic Agents|leprostatic agents|mesh-ancestor
25717284|NCT02410772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25717285|NCT02410772|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25717286|NCT02410772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25717287|NCT02410772|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25717288|NCT02410772|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25717289|NCT02410772|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25717290|NCT02410772|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25717291|NCT02411201|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
25717292|NCT02411201|Chelating Agents|chelating agents|mesh-ancestor
25717293|NCT02411201|Sequestering Agents|sequestering agents|mesh-ancestor
25717294|NCT02411201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717295|NCT02411292|Enoxaparin|enoxaparin|mesh-list
25717297|NCT02411292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24447410|NCT00308425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24447411|NCT00308425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24447412|NCT00308425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24447429|NCT00308451|Chelating Agents|chelating agents|mesh-ancestor
24447496|NCT00308607|Bevacizumab|bevacizumab|mesh-list
24447513|NCT00308763|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24447514|NCT00308763|Autonomic Agents|autonomic agents|mesh-ancestor
24447515|NCT00308763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25717298|NCT02411292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25717299|NCT02411292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717300|NCT02411578|Glucagon|glucagon|mesh-list
25717301|NCT02411578|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25717302|NCT02411578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25717303|NCT02411578|Hormones|hormones|mesh-ancestor
25771299|NCT03597139|Cyclosporine|cyclosporine|mesh-list
25771300|NCT03597139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25771301|NCT03597139|Cyclosporins|cyclosporins|mesh-list
25771302|NCT03597139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771303|NCT03597139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771304|NCT03597139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25771305|NCT03597139|Immunologic Factors|immunologic factors|mesh-ancestor
25771306|NCT03597139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771307|NCT03597139|Antifungal Agents|antifungal agents|mesh-ancestor
25771308|NCT03597139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25771309|NCT03597139|Dermatologic Agents|dermatologic agents|mesh-ancestor
25771310|NCT03597139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25771311|NCT03597139|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25771312|NCT03597139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25771313|NCT03597347|Molgramostim|molgramostim|mesh-list
25771314|NCT03597347|Sargramostim|sargramostim|mesh-list
25771315|NCT03597347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25771316|NCT03597347|Immunologic Factors|immunologic factors|mesh-ancestor
25771317|NCT03597347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771318|NCT03597529|Melatonin|melatonin|mesh-list
25717304|NCT02411578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25717305|NCT02411578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717306|NCT02411578|Incretins|incretins|mesh-ancestor
25717307|NCT02411591|Necitumumab|necitumumab|mesh-list
25717308|NCT02411591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25717309|NCT02411591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25717310|NCT02411916|Misoprostol|misoprostol|mesh-list
25717311|NCT02411916|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25717312|NCT02411916|Abortifacient Agents|abortifacient agents|mesh-ancestor
25717313|NCT02411916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25717314|NCT02411916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717315|NCT02411916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25717316|NCT02411916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25717317|NCT02411916|Oxytocics|oxytocics|mesh-ancestor
25717318|NCT02411929|Ertugliflozin|ertugliflozin|mesh-list
25717319|NCT02411929|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25717320|NCT02411929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717321|NCT02411929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25717322|NCT02411929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717324|NCT02412111|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25717325|NCT02412111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25717326|NCT02412111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717327|NCT02412371|Paclitaxel|paclitaxel|mesh-list
25717328|NCT02412371|Carboplatin|carboplatin|mesh-list
25717329|NCT02412371|Veliparib|veliparib|mesh-list
25717330|NCT02412371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25717331|NCT02412371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448142|NCT00310505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24448095|NCT00310297|Insulin glulisine|insulin glulisine|mesh-list
24448096|NCT00310297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24448100|NCT00310323|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24448101|NCT00310323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448102|NCT00310323|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24448103|NCT00310323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448104|NCT00310323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24448105|NCT00310323|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24448106|NCT00310323|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24448107|NCT00310323|Purinergic Agents|purinergic agents|mesh-ancestor
24448108|NCT00310323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24448109|NCT00310323|Antitussive Agents|antitussive agents|mesh-ancestor
24448110|NCT00310323|Respiratory System Agents|respiratory system agents|mesh-ancestor
24448111|NCT00310323|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24448112|NCT00310323|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24448114|NCT00310336|Ribavirin|ribavirin|mesh-list
24448115|NCT00310336|Interferon-alpha|interferon-alpha|mesh-list
24448116|NCT00310336|Interferon alpha-2|interferon alpha-2|mesh-list
24448117|NCT00310336|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24448118|NCT00310336|Betaine|betaine|mesh-list
24448119|NCT00310336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24448120|NCT00310336|Antiviral Agents|antiviral agents|mesh-ancestor
24448121|NCT00310336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24448149|NCT00310518|Beta-lapachone|beta-lapachone|mesh-list
25717332|NCT02412371|Tubulin Modulators|tubulin modulators|mesh-ancestor
25717333|NCT02412371|Antimitotic Agents|antimitotic agents|mesh-ancestor
25717334|NCT02412371|Mitosis Modulators|mitosis modulators|mesh-ancestor
25717335|NCT02412371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717336|NCT02412371|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25717337|NCT02412371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25717338|NCT02412436|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
24448184|NCT00310596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24448227|NCT00310778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24448230|NCT00310778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24448231|NCT00310778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771319|NCT03597529|Antioxidants|antioxidants|mesh-ancestor
25771320|NCT03597529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771321|NCT03597529|Protective Agents|protective agents|mesh-ancestor
25771322|NCT03597529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717339|NCT02412436|Medroxyprogesterone|medroxyprogesterone|mesh-list
25717340|NCT02412436|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25717341|NCT02412436|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25717342|NCT02412436|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25717343|NCT02412436|Contraceptive Agents|contraceptive agents|mesh-ancestor
25717344|NCT02412436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25717345|NCT02412436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717346|NCT02412436|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25771323|NCT03597529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25771324|NCT03599089|Acetaminophen|acetaminophen|mesh-list
25771325|NCT03599089|Ketorolac|ketorolac|mesh-list
25771326|NCT03599089|Oxycodone|oxycodone|mesh-list
25771327|NCT03599089|Bupivacaine|bupivacaine|mesh-list
25771328|NCT03599089|Anesthetics, Local|anesthetics, local|mesh-ancestor
25771329|NCT03599089|Anesthetics|anesthetics|mesh-ancestor
25771330|NCT03599089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25771331|NCT03599089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771332|NCT03599089|Sensory System Agents|sensory system agents|mesh-ancestor
25771333|NCT03599089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771334|NCT03599089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25771335|NCT03599089|Analgesics|analgesics|mesh-ancestor
25771336|NCT03599089|Antipyretics|antipyretics|mesh-ancestor
25771337|NCT03599089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25771338|NCT03599089|Narcotics|narcotics|mesh-ancestor
25771339|NCT03599089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25771340|NCT03599089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25771341|NCT03599089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25771342|NCT03599089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25771343|NCT03599089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771344|NCT03599089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771345|NCT03599193|Nicotinic Acids|nicotinic acids|mesh-list
25771346|NCT03599193|Tazarotene|tazarotene|mesh-list
25771347|NCT03599193|Dermatologic Agents|dermatologic agents|mesh-ancestor
24448585|NCT00312273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24448586|NCT00312273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448587|NCT00312273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24448588|NCT00312273|Respiratory System Agents|respiratory system agents|mesh-ancestor
25717347|NCT02412436|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25717348|NCT02412436|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25717349|NCT02412436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25717350|NCT02412436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25717351|NCT02412631|Varenicline|varenicline|mesh-list
25717352|NCT02412631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25717353|NCT02412631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25717354|NCT02412631|Cholinergic Agents|cholinergic agents|mesh-ancestor
25717355|NCT02412631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25717356|NCT02412631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717357|NCT02412631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717358|NCT02412644|Apremilast|apremilast|mesh-list
25717359|NCT02412644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25717360|NCT02412644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25717361|NCT02412644|Analgesics|analgesics|mesh-ancestor
25717362|NCT02412644|Sensory System Agents|sensory system agents|mesh-ancestor
25717363|NCT02412644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25717364|NCT02412644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717365|NCT02412644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25717366|NCT02412644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24448682|NCT00312598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24448683|NCT00312598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448685|NCT00312598|Dopamine Agents|dopamine agents|mesh-ancestor
24448742|NCT00312988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448763|NCT00313053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717367|NCT02412644|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25717368|NCT02412644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25717369|NCT02412644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25717370|NCT02412644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717371|NCT02412657|Dexamethasone|dexamethasone|mesh-list
25717372|NCT02412657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25717373|NCT02412657|Antiemetics|antiemetics|mesh-ancestor
25717374|NCT02412657|Autonomic Agents|autonomic agents|mesh-ancestor
25717375|NCT02412657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25717376|NCT02412657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448829|NCT00313157|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
24448831|NCT00313183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24448832|NCT00313183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448833|NCT00313235|Cyclophosphamide|cyclophosphamide|mesh-list
24448835|NCT00313235|Immunologic Factors|immunologic factors|mesh-ancestor
25717377|NCT02412657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25717378|NCT02412657|Glucocorticoids|glucocorticoids|mesh-ancestor
25717379|NCT02412657|Hormones|hormones|mesh-ancestor
25717380|NCT02412657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25717381|NCT02412657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25717382|NCT02412657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25717383|NCT02412722|Paclitaxel|paclitaxel|mesh-list
24448906|NCT00313534|Protective Agents|protective agents|mesh-ancestor
24448907|NCT00313534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448908|NCT00313534|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
24448909|NCT00313534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24448925|NCT00313547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24448926|NCT00313547|Vasodilator Agents|vasodilator agents|mesh-ancestor
24448927|NCT00313547|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24448928|NCT00313547|Protease Inhibitors|protease inhibitors|mesh-ancestor
24448929|NCT00313547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771348|NCT03599193|Keratolytic Agents|keratolytic agents|mesh-ancestor
25771349|NCT03599193|Vitamin B Complex|vitamin b complex|mesh-ancestor
25771350|NCT03599193|Vitamins|vitamins|mesh-ancestor
25771351|NCT03599193|Micronutrients|micronutrients|mesh-ancestor
25771352|NCT03599193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771353|NCT03599362|Nivolumab|nivolumab|mesh-list
25771354|NCT03599362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25771355|NCT03599362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25771356|NCT03599362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25717384|NCT02412722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25717385|NCT02412722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25717386|NCT02412722|Tubulin Modulators|tubulin modulators|mesh-ancestor
25717387|NCT02412722|Antimitotic Agents|antimitotic agents|mesh-ancestor
25717388|NCT02412722|Mitosis Modulators|mitosis modulators|mesh-ancestor
25717389|NCT02412722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717390|NCT02412761|Amlodipine|amlodipine|mesh-list
25717391|NCT02412761|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25717392|NCT02412761|Lisinopril|lisinopril|mesh-list
25717393|NCT02412761|Calcium Channel Blockers|calcium channel blockers|mesh-list
25717394|NCT02412761|Diuretics|diuretics|mesh-list
25717395|NCT02412761|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
25717396|NCT02412761|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25717397|NCT02412761|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25717398|NCT02412761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25717399|NCT02412761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717400|NCT02412761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25717401|NCT02412761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25717402|NCT02412761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717403|NCT02412761|Vasodilator Agents|vasodilator agents|mesh-ancestor
25717404|NCT02412761|Natriuretic Agents|natriuretic agents|mesh-ancestor
25717405|NCT02412761|Protease Inhibitors|protease inhibitors|mesh-ancestor
25717406|NCT02412761|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25717407|NCT02412761|Protective Agents|protective agents|mesh-ancestor
25717408|NCT02412982|Enoxaparin|enoxaparin|mesh-list
25717409|NCT02412982|Enoxaparin sodium|enoxaparin sodium|mesh-list
25717410|NCT02412982|Anticoagulants|anticoagulants|mesh-ancestor
25717411|NCT02412982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25717412|NCT02412982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25717413|NCT02412982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717414|NCT02413034|Vancomycin|vancomycin|mesh-list
25717415|NCT02413034|Cefazolin|cefazolin|mesh-list
25717416|NCT02413034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25717417|NCT02413034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25717418|NCT02413203|Celecoxib|celecoxib|mesh-list
25717419|NCT02413203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25717420|NCT02413203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25717421|NCT02413203|Analgesics|analgesics|mesh-ancestor
25717422|NCT02413203|Sensory System Agents|sensory system agents|mesh-ancestor
25717423|NCT02413203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25717424|NCT02413203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717425|NCT02413203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24449066|NCT00314158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25717426|NCT02413203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25717427|NCT02413203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25717428|NCT02413203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25717429|NCT02413203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25717430|NCT02413203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717431|NCT02413320|Paclitaxel|paclitaxel|mesh-list
25717432|NCT02413320|Docetaxel|docetaxel|mesh-list
25717433|NCT02413320|Cyclophosphamide|cyclophosphamide|mesh-list
25717434|NCT02413320|Carboplatin|carboplatin|mesh-list
25717435|NCT02413320|Doxorubicin|doxorubicin|mesh-list
25717436|NCT02413320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25717437|NCT02413320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25717438|NCT02413320|Tubulin Modulators|tubulin modulators|mesh-ancestor
25717439|NCT02413320|Antimitotic Agents|antimitotic agents|mesh-ancestor
25717440|NCT02413320|Mitosis Modulators|mitosis modulators|mesh-ancestor
25717441|NCT02413320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717442|NCT02413320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25717443|NCT02413320|Immunologic Factors|immunologic factors|mesh-ancestor
25717444|NCT02413320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717445|NCT02413320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25717446|NCT02413320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25717447|NCT02413320|Alkylating Agents|alkylating agents|mesh-ancestor
25717448|NCT02413320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25717449|NCT02413320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25717450|NCT02413320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25717451|NCT02413320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25717452|NCT02413320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25717453|NCT02413333|Contact Lens Solutions|contact lens solutions|mesh-list
24449238|NCT00314743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24449279|NCT00314860|Dopamine Agonists|dopamine agonists|mesh-ancestor
24449280|NCT00314860|Dopamine Agents|dopamine agents|mesh-ancestor
25717454|NCT02413333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25717455|NCT02413333|Disinfectants|disinfectants|mesh-ancestor
25717456|NCT02413333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25717457|NCT02413346|Sarecycline|sarecycline|mesh-list
25717458|NCT02413346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25717459|NCT02413346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25717460|NCT02413346|Dermatologic Agents|dermatologic agents|mesh-ancestor
25717461|NCT02413398|Dapagliflozin|dapagliflozin|mesh-list
25717462|NCT02413398|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25717463|NCT02413398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717464|NCT02413398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24449285|NCT00314873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449291|NCT00314912|GABA Agonists|gaba agonists|mesh-ancestor
24449292|NCT00314912|GABA Agents|gaba agents|mesh-ancestor
24449293|NCT00314912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24449294|NCT00314912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449295|NCT00314912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449296|NCT00314977|Cyclophosphamide|cyclophosphamide|mesh-list
24449297|NCT00314977|Docetaxel|docetaxel|mesh-list
24449298|NCT00314977|Doxorubicin|doxorubicin|mesh-list
24449299|NCT00314977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24449300|NCT00314977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25717465|NCT02413398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717466|NCT02413489|Daratumumab|daratumumab|mesh-list
25717467|NCT02413489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25717468|NCT02413593|Sofosbuvir|sofosbuvir|mesh-list
25717469|NCT02413593|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25717470|NCT02413593|Ledipasvir|ledipasvir|mesh-list
25717471|NCT02413593|Antiviral Agents|antiviral agents|mesh-ancestor
25717472|NCT02413593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25717473|NCT02413918|Iloperidone|iloperidone|mesh-list
24449459|NCT00315744|Xhance|xhance|mesh-list
25717475|NCT02413918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25717476|NCT02413918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25717477|NCT02413918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717478|NCT02413918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25717479|NCT02414204|Sildenafil Citrate|sildenafil citrate|mesh-list
25717480|NCT02414204|Vasodilator Agents|vasodilator agents|mesh-ancestor
25717481|NCT02414204|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25771362|NCT03600376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771363|NCT03600428|Vaccines|vaccines|mesh-list
25771364|NCT03600428|Immunologic Factors|immunologic factors|mesh-ancestor
25771365|NCT03600428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777276|NCT03723447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25777277|NCT03723447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25777278|NCT03723447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25777279|NCT03723447|Anesthetics, Local|anesthetics, local|mesh-ancestor
25777280|NCT03723447|Anesthetics|anesthetics|mesh-ancestor
25777281|NCT03723447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25777282|NCT03723447|Sensory System Agents|sensory system agents|mesh-ancestor
25777283|NCT03723447|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25777284|NCT03723447|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25777285|NCT03723447|Adrenergic Agents|adrenergic agents|mesh-ancestor
25777286|NCT03723447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25777287|NCT03723447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777288|NCT03723447|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25777289|NCT03723447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25777290|NCT03723447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25777291|NCT03723447|Respiratory System Agents|respiratory system agents|mesh-ancestor
25777292|NCT03723447|Mydriatics|mydriatics|mesh-ancestor
25777293|NCT03723447|Sympathomimetics|sympathomimetics|mesh-ancestor
25777294|NCT03723447|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25777295|NCT03718143|Adavosertib|adavosertib|mesh-list
25777296|NCT03718143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777297|NCT03718143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777298|NCT03709576|Azacitidine|azacitidine|mesh-list
25777299|NCT03709576|Pevonedistat|pevonedistat|mesh-list
25777300|NCT03709576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25777301|NCT03709576|Antimetabolites|antimetabolites|mesh-ancestor
25777302|NCT03709576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777303|NCT03709576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25777304|NCT03709576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777305|NCT03701295|Azacitidine|azacitidine|mesh-list
25777306|NCT03701295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25777307|NCT03701295|Antimetabolites|antimetabolites|mesh-ancestor
24444227|NCT00297050|Antiviral Agents|antiviral agents|mesh-ancestor
24444228|NCT00297050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24444229|NCT00297050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444230|NCT00297050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444231|NCT00297063|Rosiglitazone|rosiglitazone|mesh-list
24444232|NCT00297063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24444233|NCT00297063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444235|NCT00297076|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
24444236|NCT00297076|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
24444263|NCT00297219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24444264|NCT00297219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24444265|NCT00297284|Modafinil|modafinil|mesh-list
24444266|NCT00297284|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24444267|NCT00297284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444268|NCT00297284|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
24444269|NCT00297284|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24444270|NCT00297284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24444271|NCT00297284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444272|NCT00297323|Topiramate|topiramate|mesh-list
24444273|NCT00297323|Anticonvulsants|anticonvulsants|mesh-ancestor
24444274|NCT00297323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24444275|NCT00297323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444276|NCT00297336|Topiramate|topiramate|mesh-list
24444277|NCT00297336|Anticonvulsants|anticonvulsants|mesh-ancestor
24444278|NCT00297336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24444280|NCT00297349|Topiramate|topiramate|mesh-list
24444308|NCT00297388|Serotonin Agents|serotonin agents|mesh-ancestor
25717819|NCT02419469|Abortifacient Agents|abortifacient agents|mesh-ancestor
25717820|NCT02419469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25717821|NCT02419469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25717822|NCT02419469|Antimetabolites|antimetabolites|mesh-ancestor
25717823|NCT02419469|Dermatologic Agents|dermatologic agents|mesh-ancestor
25717824|NCT02419469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25717825|NCT02419469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25717826|NCT02419469|Antiviral Agents|antiviral agents|mesh-ancestor
24444309|NCT00297388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25717827|NCT02419469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25717828|NCT02419469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25717829|NCT02419469|Tubulin Modulators|tubulin modulators|mesh-ancestor
25717830|NCT02419469|Antimitotic Agents|antimitotic agents|mesh-ancestor
24444375|NCT00297674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
24444380|NCT00297739|Risperidone|risperidone|mesh-list
24444381|NCT00297739|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
24444382|NCT00297739|Serotonin Agents|serotonin agents|mesh-ancestor
24444527|NCT00298350|Integrase Inhibitors|integrase inhibitors|mesh-list
24444528|NCT00298350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24444529|NCT00298350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444530|NCT00298350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24444531|NCT00298350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24444552|NCT00298415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444553|NCT00298415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24444554|NCT00298454|Furosemide|furosemide|mesh-list
24444555|NCT00298454|Diuretics|diuretics|mesh-ancestor
24444556|NCT00298454|Natriuretic Agents|natriuretic agents|mesh-ancestor
24444557|NCT00298454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444558|NCT00298454|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24444559|NCT00298454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24444560|NCT00298454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444563|NCT00298506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24444564|NCT00298506|Immunologic Factors|immunologic factors|mesh-ancestor
24444565|NCT00298506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444566|NCT00298506|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25717831|NCT02419469|Mitosis Modulators|mitosis modulators|mesh-ancestor
25717832|NCT02419469|Protease Inhibitors|protease inhibitors|mesh-ancestor
25717833|NCT02419508|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25717834|NCT02419508|Bimatoprost|bimatoprost|mesh-list
25717835|NCT02419508|Travoprost|travoprost|mesh-list
25717836|NCT02419508|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25717837|NCT02419508|Latanoprost|latanoprost|mesh-list
25717838|NCT02419508|Ophthalmic Solutions|ophthalmic solutions|mesh-list
24451035|NCT00321516|Antidepressive Agents|antidepressive agents|mesh-ancestor
24444573|NCT00298506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24444574|NCT00298506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24444577|NCT00298545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24444578|NCT00298545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24444579|NCT00298545|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24444580|NCT00298545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25717840|NCT02419508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25717841|NCT02419508|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25717842|NCT02419508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25717843|NCT02419508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25717844|NCT02419508|Adrenergic Agents|adrenergic agents|mesh-ancestor
25717845|NCT02419508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25717846|NCT02419508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717847|NCT02419508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717848|NCT02419508|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25717849|NCT02419508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25717850|NCT02419547|Fentanyl|fentanyl|mesh-list
25717851|NCT02419547|Midazolam|midazolam|mesh-list
25717852|NCT02419547|Propofol|propofol|mesh-list
25717853|NCT02419547|Sevoflurane|sevoflurane|mesh-list
25717854|NCT02419547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25717855|NCT02419547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25717856|NCT02419547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717857|NCT02419547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25717858|NCT02419547|Anesthetics, General|anesthetics, general|mesh-ancestor
24444581|NCT00298545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444582|NCT00298545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24444583|NCT00298545|Vitamins|vitamins|mesh-ancestor
25717859|NCT02419547|Anesthetics|anesthetics|mesh-ancestor
25717860|NCT02419547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25717861|NCT02419547|Narcotics|narcotics|mesh-ancestor
25717862|NCT02419547|Analgesics|analgesics|mesh-ancestor
25717863|NCT02419547|Sensory System Agents|sensory system agents|mesh-ancestor
25717864|NCT02419547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25717865|NCT02419547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25717866|NCT02419547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25717867|NCT02419547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25717868|NCT02419547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25717869|NCT02419547|GABA Modulators|gaba modulators|mesh-ancestor
25717870|NCT02419547|GABA Agents|gaba agents|mesh-ancestor
25717871|NCT02419547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25717872|NCT02419547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717873|NCT02419547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25717874|NCT02419547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25717875|NCT02419612|Dapagliflozin|dapagliflozin|mesh-list
25717876|NCT02419612|Glimepiride|glimepiride|mesh-list
25717877|NCT02419612|Saxagliptin|saxagliptin|mesh-list
24479930|NCT00428909|Antipyretics|antipyretics|mesh-ancestor
25717878|NCT02419612|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25717879|NCT02419612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717880|NCT02419612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24444593|NCT00298571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24444594|NCT00298571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
24444595|NCT00298571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24444596|NCT00298571|Adrenergic Agents|adrenergic agents|mesh-ancestor
24444597|NCT00298571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24444598|NCT00298571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407737|NCT03480334|Nivolumab|nivolumab|mesh-list
25717881|NCT02419612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717882|NCT02419612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25717883|NCT02419612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25717884|NCT02419612|Immunologic Factors|immunologic factors|mesh-ancestor
25717885|NCT02419612|Incretins|incretins|mesh-ancestor
25717886|NCT02419612|Hormones|hormones|mesh-ancestor
25717887|NCT02419612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25717888|NCT02419612|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25717889|NCT02419612|Protease Inhibitors|protease inhibitors|mesh-ancestor
25717890|NCT02419612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25717891|NCT02419755|Cytarabine|cytarabine|mesh-list
25717892|NCT02419755|Dexamethasone|dexamethasone|mesh-list
25717893|NCT02419755|Hydrocortisone|hydrocortisone|mesh-list
25717894|NCT02419755|Doxorubicin|doxorubicin|mesh-list
25717895|NCT02419755|Methotrexate|methotrexate|mesh-list
25717896|NCT02419755|Bortezomib|bortezomib|mesh-list
25717897|NCT02419755|Asparaginase|asparaginase|mesh-list
25717898|NCT02419755|Mitoxantrone|mitoxantrone|mesh-list
25717899|NCT02419755|Mercaptopurine|mercaptopurine|mesh-list
25717900|NCT02419755|Vorinostat|vorinostat|mesh-list
25717901|NCT02419755|Pegaspargase|pegaspargase|mesh-list
25717902|NCT02419755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25717903|NCT02419755|Antiemetics|antiemetics|mesh-ancestor
25717904|NCT02419755|Autonomic Agents|autonomic agents|mesh-ancestor
25717905|NCT02419755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25717906|NCT02419755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717907|NCT02419755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25717908|NCT02419755|Glucocorticoids|glucocorticoids|mesh-ancestor
25717909|NCT02419755|Hormones|hormones|mesh-ancestor
25717910|NCT02419755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25717911|NCT02419755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25717912|NCT02419755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25717913|NCT02419755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25717914|NCT02419755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24444860|NCT00299390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24444861|NCT00299455|Amoxicillin|amoxicillin|mesh-list
25717915|NCT02419755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25717916|NCT02419755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25717917|NCT02419755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717918|NCT02419755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25717919|NCT02419755|Abortifacient Agents|abortifacient agents|mesh-ancestor
25717920|NCT02419755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25717921|NCT02419755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25717922|NCT02419755|Antimetabolites|antimetabolites|mesh-ancestor
25717923|NCT02419755|Dermatologic Agents|dermatologic agents|mesh-ancestor
25717924|NCT02419755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25717925|NCT02419755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25717926|NCT02419755|Immunologic Factors|immunologic factors|mesh-ancestor
25717927|NCT02419755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25717928|NCT02419755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25717929|NCT02419755|Antiviral Agents|antiviral agents|mesh-ancestor
25717930|NCT02419755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24444894|NCT00299611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24444896|NCT00299611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24444954|NCT00299858|Vasodilator Agents|vasodilator agents|mesh-ancestor
24444955|NCT00299858|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24444956|NCT00299858|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
24444957|NCT00299858|Purinergic Agents|purinergic agents|mesh-ancestor
24445036|NCT00300118|Autonomic Agents|autonomic agents|mesh-ancestor
24445039|NCT00300118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24445040|NCT00300118|Respiratory System Agents|respiratory system agents|mesh-ancestor
24445042|NCT00300118|Hormones|hormones|mesh-ancestor
24445046|NCT00300118|Analgesics|analgesics|mesh-ancestor
24445047|NCT00300118|Sensory System Agents|sensory system agents|mesh-ancestor
24445048|NCT00300118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24445050|NCT00300131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25717931|NCT02419755|Analgesics|analgesics|mesh-ancestor
25717932|NCT02419755|Sensory System Agents|sensory system agents|mesh-ancestor
25717933|NCT02419755|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25717934|NCT02420015|Bupropion|bupropion|mesh-list
25717935|NCT02420015|Nicotine|nicotine|mesh-list
25717936|NCT02420015|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25717937|NCT02420015|Autonomic Agents|autonomic agents|mesh-ancestor
25717938|NCT02420015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24445102|NCT00300378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445104|NCT00300378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445506|NCT00301665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24445509|NCT00301730|Trastuzumab|trastuzumab|mesh-list
24445510|NCT00301730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24445511|NCT00301730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24445512|NCT00301730|Tubulin Modulators|tubulin modulators|mesh-ancestor
24445513|NCT00301730|Antimitotic Agents|antimitotic agents|mesh-ancestor
24445521|NCT00301782|Carboplatin|carboplatin|mesh-list
24445673|NCT00301990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24445674|NCT00301990|Antiviral Agents|antiviral agents|mesh-ancestor
24445675|NCT00301990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24445676|NCT00302224|Ketoconazole|ketoconazole|mesh-list
24445677|NCT00302224|Antifungal Agents|antifungal agents|mesh-ancestor
24445678|NCT00302224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24445692|NCT00302289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445693|NCT00302289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445694|NCT00302289|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
24445720|NCT00302354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24445721|NCT00302354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24445723|NCT00302354|Dopamine Agents|dopamine agents|mesh-ancestor
24445749|NCT00302406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445750|NCT00302406|Dopamine Agents|dopamine agents|mesh-ancestor
24445751|NCT00302406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24445752|NCT00302419|Streptokinase|streptokinase|mesh-list
24445753|NCT00302419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24445772|NCT00302523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24445774|NCT00302536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24445775|NCT00302536|Immunologic Factors|immunologic factors|mesh-ancestor
24445776|NCT00302536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445777|NCT00302536|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24445778|NCT00302536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24445780|NCT00302549|Tacrolimus|tacrolimus|mesh-list
24445827|NCT00302692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24445828|NCT00302692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25717939|NCT02420015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717940|NCT02420015|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25717941|NCT02420015|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25717942|NCT02420015|Cholinergic Agents|cholinergic agents|mesh-ancestor
25717943|NCT02420015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25717944|NCT02420015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717945|NCT02420015|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25717946|NCT02420015|Antidepressive Agents|antidepressive agents|mesh-ancestor
25717947|NCT02420015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25717948|NCT02420015|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25717949|NCT02420015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24445829|NCT00302692|Sympatholytics|sympatholytics|mesh-ancestor
24445830|NCT00302692|Autonomic Agents|autonomic agents|mesh-ancestor
24445831|NCT00302692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24445909|NCT00303017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24445910|NCT00303017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24445911|NCT00303017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24445912|NCT00303017|Gout Suppressants|gout suppressants|mesh-ancestor
24445913|NCT00303017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24445914|NCT00303017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446075|NCT00303771|Calcium|calcium|mesh-list
24446076|NCT00303771|Levoleucovorin|levoleucovorin|mesh-list
25717950|NCT02420015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25717951|NCT02420015|Dopamine Agents|dopamine agents|mesh-ancestor
25717952|NCT02420015|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25717953|NCT02420015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25717954|NCT02420015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25717955|NCT02420041|Triamcinolone|triamcinolone|mesh-list
25717956|NCT02420041|Lidocaine|lidocaine|mesh-list
25717957|NCT02420041|Anesthetics, Local|anesthetics, local|mesh-ancestor
24446077|NCT00303771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24446078|NCT00303771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446079|NCT00303771|Antimetabolites|antimetabolites|mesh-ancestor
24446080|NCT00303771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446081|NCT00303771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24446082|NCT00303771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446106|NCT00303797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446107|NCT00303810|Cyclophosphamide|cyclophosphamide|mesh-list
24446108|NCT00303810|Thiotepa|thiotepa|mesh-list
24446109|NCT00303810|Lomustine|lomustine|mesh-list
24446110|NCT00303810|Carboplatin|carboplatin|mesh-list
24446111|NCT00303810|Methotrexate|methotrexate|mesh-list
24446112|NCT00303810|Etoposide|etoposide|mesh-list
24446113|NCT00303810|Vincristine|vincristine|mesh-list
24446114|NCT00303810|Etoposide phosphate|etoposide phosphate|mesh-list
24446115|NCT00303810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24446116|NCT00303810|Immunologic Factors|immunologic factors|mesh-ancestor
24446118|NCT00303810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24446147|NCT00303836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446148|NCT00303836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24446149|NCT00303836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24446150|NCT00303836|Alkylating Agents|alkylating agents|mesh-ancestor
24446151|NCT00303836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446207|NCT00304018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446208|NCT00304018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24446209|NCT00304018|Immunologic Factors|immunologic factors|mesh-ancestor
25717959|NCT02420041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24446233|NCT00304200|Alkylating Agents|alkylating agents|mesh-ancestor
24446234|NCT00304200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446235|NCT00304200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24446236|NCT00304200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24446243|NCT00304213|Testosterone|testosterone|mesh-list
24446279|NCT00304291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24446280|NCT00304291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446337|NCT00304499|Oxybutynin|oxybutynin|mesh-list
24446338|NCT00304499|Parasympatholytics|parasympatholytics|mesh-ancestor
24446373|NCT00304616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24446377|NCT00304616|Antiemetics|antiemetics|mesh-ancestor
24446402|NCT00304642|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25717960|NCT02420041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717961|NCT02420041|Sensory System Agents|sensory system agents|mesh-ancestor
25717962|NCT02420041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25717963|NCT02420041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25717964|NCT02420041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25717965|NCT02420041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25717966|NCT02420041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25717967|NCT02420041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446428|NCT00304668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446429|NCT00304681|Methylphenidate|methylphenidate|mesh-list
24446430|NCT00304681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
24446431|NCT00304681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446432|NCT00304681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
24446433|NCT00304681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24446434|NCT00304681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24446435|NCT00304681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446436|NCT00304681|Dopamine Agents|dopamine agents|mesh-ancestor
24446437|NCT00304681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24446438|NCT00304720|Tacrolimus|tacrolimus|mesh-list
24446439|NCT00304720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24446440|NCT00304720|Immunologic Factors|immunologic factors|mesh-ancestor
24446441|NCT00304720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24446442|NCT00304720|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24446458|NCT00304772|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
24446459|NCT00304785|Latanoprost|latanoprost|mesh-list
24446460|NCT00304785|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24446461|NCT00304785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24446462|NCT00304811|Vancomycin|vancomycin|mesh-list
24446463|NCT00304811|Rifampin|rifampin|mesh-list
24446464|NCT00304811|Gentamicins|gentamicins|mesh-list
24446465|NCT00304811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24446466|NCT00304811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24446467|NCT00304811|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
24446468|NCT00304811|Antitubercular Agents|antitubercular agents|mesh-ancestor
24446469|NCT00304811|Leprostatic Agents|leprostatic agents|mesh-ancestor
24446470|NCT00304811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24446471|NCT00304811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24446472|NCT00304811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24446488|NCT00304850|Anesthetics|anesthetics|mesh-ancestor
24446602|NCT00305422|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25717968|NCT02420041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25717969|NCT02420041|Glucocorticoids|glucocorticoids|mesh-ancestor
25717970|NCT02420041|Hormones|hormones|mesh-ancestor
25717971|NCT02420041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25717972|NCT02420210|Dexamethasone|dexamethasone|mesh-list
25717973|NCT02420210|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25717974|NCT02420210|Obinutuzumab|obinutuzumab|mesh-list
24446712|NCT00305734|Immunologic Factors|immunologic factors|mesh-ancestor
25717975|NCT02420210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25717976|NCT02420210|Antiemetics|antiemetics|mesh-ancestor
25717977|NCT02420210|Autonomic Agents|autonomic agents|mesh-ancestor
25717978|NCT02420210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25717979|NCT02420210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717980|NCT02420210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25717981|NCT02420210|Glucocorticoids|glucocorticoids|mesh-ancestor
25717983|NCT02420210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25717984|NCT02420210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25717986|NCT02420210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25717987|NCT02420210|Alkylating Agents|alkylating agents|mesh-ancestor
25717988|NCT02420210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717989|NCT02420210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25717990|NCT02420223|Propranolol|propranolol|mesh-list
25717992|NCT02420223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25717993|NCT02420223|Adrenergic Agents|adrenergic agents|mesh-ancestor
25717994|NCT02420223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25717995|NCT02420223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25717996|NCT02420223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25717997|NCT02420223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25717998|NCT02420223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25717999|NCT02420223|Vasodilator Agents|vasodilator agents|mesh-ancestor
25718000|NCT02420262|Insulin|insulin|mesh-list
25718001|NCT02420262|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25718002|NCT02420262|Insulin Glargine|insulin glargine|mesh-list
25718004|NCT02420262|Liraglutide|liraglutide|mesh-list
25718005|NCT02420262|Xultophy|xultophy|mesh-list
25718006|NCT02420262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25718007|NCT02420262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718008|NCT02420262|Incretins|incretins|mesh-ancestor
25718009|NCT02420262|Hormones|hormones|mesh-ancestor
25718010|NCT02420262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25718011|NCT02420327|Galantamine|galantamine|mesh-list
25718012|NCT02420327|Nicotine|nicotine|mesh-list
25718013|NCT02420327|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25718014|NCT02420327|Autonomic Agents|autonomic agents|mesh-ancestor
25718015|NCT02420327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25718016|NCT02420327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718017|NCT02420327|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25407812|NCT03475186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718018|NCT02420327|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25718019|NCT02420327|Cholinergic Agents|cholinergic agents|mesh-ancestor
25718020|NCT02420327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25718021|NCT02420327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718022|NCT02420327|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25718023|NCT02420327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718024|NCT02420327|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25718025|NCT02420327|Nootropic Agents|nootropic agents|mesh-ancestor
25718026|NCT02420873|Maytansine|maytansine|mesh-list
25718027|NCT02420873|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
25718028|NCT02420873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25718029|NCT02420873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25718030|NCT02420873|Tubulin Modulators|tubulin modulators|mesh-ancestor
25718032|NCT02420873|Mitosis Modulators|mitosis modulators|mesh-ancestor
25718033|NCT02420873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718034|NCT02420873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25718035|NCT02420951|Bupivacaine|bupivacaine|mesh-list
25718036|NCT02420951|Anesthetics, Local|anesthetics, local|mesh-ancestor
25718037|NCT02420951|Anesthetics|anesthetics|mesh-ancestor
25718038|NCT02420951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25718039|NCT02420951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718040|NCT02420951|Sensory System Agents|sensory system agents|mesh-ancestor
25718041|NCT02420951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25718042|NCT02421120|Tazobactam|tazobactam|mesh-list
25718043|NCT02421120|Ceftolozane|ceftolozane|mesh-list
25718044|NCT02421120|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
25718045|NCT02421120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25718046|NCT02421120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25718047|NCT02421120|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25718048|NCT02421120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718049|NCT02421120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718050|NCT02421120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
24451777|NCT00324779|Rituximab|rituximab|mesh-list
25718051|NCT02421120|Renal Agents|renal agents|mesh-ancestor
25718052|NCT02421211|Sofosbuvir|sofosbuvir|mesh-list
25718053|NCT02421211|Ledipasvir|ledipasvir|mesh-list
25718054|NCT02421211|Simeprevir|simeprevir|mesh-list
25718055|NCT02421211|Antiviral Agents|antiviral agents|mesh-ancestor
25718056|NCT02421211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25718057|NCT02421211|Protease Inhibitors|protease inhibitors|mesh-ancestor
25718058|NCT02421211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718059|NCT02421211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718060|NCT02421354|Nivolumab|nivolumab|mesh-list
24505264|NCT00540787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24505324|NCT00540930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505325|NCT00540930|Growth Inhibitors|growth inhibitors|mesh-ancestor
24505326|NCT00540930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505328|NCT00540943|Cetuximab|cetuximab|mesh-list
24505329|NCT00540943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24505330|NCT00540943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24505331|NCT00540943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505333|NCT00540943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505352|NCT00541008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24505354|NCT00541008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505355|NCT00541021|Gemcitabine|gemcitabine|mesh-list
24505356|NCT00541021|Sorafenib|sorafenib|mesh-list
24505357|NCT00541021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24505358|NCT00541021|Antimetabolites|antimetabolites|mesh-ancestor
24505359|NCT00541021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505360|NCT00541021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505361|NCT00541021|Antiviral Agents|antiviral agents|mesh-ancestor
24505362|NCT00541021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24505363|NCT00541021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24505364|NCT00541021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24505365|NCT00541021|Immunologic Factors|immunologic factors|mesh-ancestor
24505379|NCT00541047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24505380|NCT00541073|Vitamin B 12|vitamin b 12|mesh-list
24505381|NCT00541073|Hydroxocobalamin|hydroxocobalamin|mesh-list
24505382|NCT00541073|Pemetrexed|pemetrexed|mesh-list
24505383|NCT00541073|Vitamins|vitamins|mesh-ancestor
24505384|NCT00541073|Micronutrients|micronutrients|mesh-ancestor
24505385|NCT00541073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505386|NCT00541073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24505433|NCT00541125|Fluorouracil|fluorouracil|mesh-list
24505434|NCT00541125|Irinotecan|irinotecan|mesh-list
24505435|NCT00541125|Calcium|calcium|mesh-list
24505454|NCT00541125|Protective Agents|protective agents|mesh-ancestor
24505455|NCT00541125|Vitamin B Complex|vitamin b complex|mesh-ancestor
24505456|NCT00541125|Vitamins|vitamins|mesh-ancestor
24505457|NCT00541125|Micronutrients|micronutrients|mesh-ancestor
24505458|NCT00541138|Tamoxifen|tamoxifen|mesh-list
24505459|NCT00541138|Carboplatin|carboplatin|mesh-list
24505460|NCT00541138|Topotecan|topotecan|mesh-list
24505504|NCT00541216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24505554|NCT00541411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505555|NCT00541411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24505556|NCT00541411|Alkylating Agents|alkylating agents|mesh-ancestor
24505557|NCT00541411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24505558|NCT00541411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24505559|NCT00541411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24505563|NCT00541463|Nelfinavir|nelfinavir|mesh-list
24505592|NCT00541554|Aripiprazole|aripiprazole|mesh-list
25718061|NCT02421354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25718062|NCT02421354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25718063|NCT02421354|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25718064|NCT02421354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505594|NCT00541554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24505595|NCT00541554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24505596|NCT00541554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24505597|NCT00541554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25718065|NCT02421419|Dexamethasone|dexamethasone|mesh-list
25718066|NCT02421419|Dexamethasone acetate|dexamethasone acetate|mesh-list
25718067|NCT02421419|Lidocaine|lidocaine|mesh-list
25718068|NCT02421419|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
24505598|NCT00541554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505599|NCT00541554|Dopamine Agonists|dopamine agonists|mesh-ancestor
24505600|NCT00541554|Dopamine Agents|dopamine agents|mesh-ancestor
24505663|NCT00541853|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24505664|NCT00541853|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24505665|NCT00541853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24505666|NCT00541853|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24505667|NCT00541853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24505668|NCT00541853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24505669|NCT00541853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24505670|NCT00541905|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
24505671|NCT00541905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24505762|NCT00542295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24505987|NCT00543634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24505988|NCT00543647|Fenofibrate|fenofibrate|mesh-list
24505989|NCT00543647|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24505990|NCT00543647|Antimetabolites|antimetabolites|mesh-ancestor
24505991|NCT00543647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506088|NCT00544037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24506089|NCT00544037|Immunologic Factors|immunologic factors|mesh-ancestor
24506090|NCT00544037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506096|NCT00544063|Irinotecan|irinotecan|mesh-list
24506152|NCT00544219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506153|NCT00544219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24506157|NCT00544219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506158|NCT00544219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24506159|NCT00544219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24506234|NCT00544362|Antimetabolites|antimetabolites|mesh-ancestor
24506285|NCT00544570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24506286|NCT00544570|Alkylating Agents|alkylating agents|mesh-ancestor
24506287|NCT00544570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506288|NCT00544570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24506289|NCT00544570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24506290|NCT00544570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24506291|NCT00544570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24506292|NCT00544570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24506293|NCT00544570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506295|NCT00544596|Etoposide|etoposide|mesh-list
24506296|NCT00544596|Etoposide phosphate|etoposide phosphate|mesh-list
24506297|NCT00544596|Retinol acetate|retinol acetate|mesh-list
24506298|NCT00544596|Gossypol acetic acid|gossypol acetic acid|mesh-list
25718069|NCT02421419|BB 1101|bb 1101|mesh-list
25404046|NCT03685773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25718070|NCT02421419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25718071|NCT02421419|Antiemetics|antiemetics|mesh-ancestor
25718072|NCT02421419|Autonomic Agents|autonomic agents|mesh-ancestor
25718073|NCT02421419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25718074|NCT02421419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718075|NCT02421419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25718076|NCT02421419|Glucocorticoids|glucocorticoids|mesh-ancestor
25718077|NCT02421419|Hormones|hormones|mesh-ancestor
24506413|NCT00545142|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24506415|NCT00545142|Anticonvulsants|anticonvulsants|mesh-ancestor
24506416|NCT00545142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24506417|NCT00545142|GABA Agents|gaba agents|mesh-ancestor
24506418|NCT00545142|Antimanic Agents|antimanic agents|mesh-ancestor
24506454|NCT00545389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24506455|NCT00545467|Aripiprazole|aripiprazole|mesh-list
24506456|NCT00545467|Antidepressive Agents|antidepressive agents|mesh-ancestor
24506530|NCT00545675|Antimanic Agents|antimanic agents|mesh-ancestor
24506538|NCT00545870|Bevacizumab|bevacizumab|mesh-list
24506609|NCT00546143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24506610|NCT00546143|Respiratory System Agents|respiratory system agents|mesh-ancestor
24506611|NCT00546143|Immunologic Factors|immunologic factors|mesh-ancestor
24506612|NCT00546143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506613|NCT00546169|Thrombin|thrombin|mesh-list
24506614|NCT00546169|Hemostatics|hemostatics|mesh-ancestor
24506615|NCT00546169|Coagulants|coagulants|mesh-ancestor
24506616|NCT00546234|Tiotropium Bromide|tiotropium bromide|mesh-list
24506617|NCT00546234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24506618|NCT00546234|Autonomic Agents|autonomic agents|mesh-ancestor
24506619|NCT00546234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24506620|NCT00546234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24506621|NCT00546234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24506622|NCT00546234|Respiratory System Agents|respiratory system agents|mesh-ancestor
24506623|NCT00546234|Parasympatholytics|parasympatholytics|mesh-ancestor
24506624|NCT00546234|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24506647|NCT00546325|Hormones|hormones|mesh-ancestor
24506683|NCT00546507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506684|NCT00546520|Ciclesonide|ciclesonide|mesh-list
24506685|NCT00546520|Glucocorticoids|glucocorticoids|mesh-ancestor
24506686|NCT00546520|Hormones|hormones|mesh-ancestor
25777863|NCT03065933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777864|NCT03065933|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25777865|NCT03065933|Sympatholytics|sympatholytics|mesh-ancestor
25777866|NCT03065933|Autonomic Agents|autonomic agents|mesh-ancestor
25777867|NCT03065933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25777868|NCT03065933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25777869|NCT03065933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25777870|NCT03065933|Adrenergic Agents|adrenergic agents|mesh-ancestor
24506827|NCT00547183|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24506829|NCT00547183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24506830|NCT00547183|Urological Agents|urological agents|mesh-ancestor
24507041|NCT00548379|Vitamins|vitamins|mesh-ancestor
24507042|NCT00548379|Micronutrients|micronutrients|mesh-ancestor
24507043|NCT00548379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507044|NCT00548379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24507053|NCT00548483|Hormones|hormones|mesh-ancestor
24507054|NCT00548483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24507266|NCT00549471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24507267|NCT00549471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507268|NCT00549471|Cholinergic Agents|cholinergic agents|mesh-ancestor
24507269|NCT00549471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24507455|NCT00550784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24507456|NCT00550784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507457|NCT00550784|Tubulin Modulators|tubulin modulators|mesh-ancestor
24507461|NCT00550784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24507462|NCT00550784|Immunologic Factors|immunologic factors|mesh-ancestor
24507463|NCT00550784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507464|NCT00550784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24507465|NCT00550784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24507507|NCT00550992|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
24507509|NCT00550992|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
24507510|NCT00550992|Cyclophosphamide|cyclophosphamide|mesh-list
24507511|NCT00550992|Melphalan|melphalan|mesh-list
24507512|NCT00550992|Busulfan|busulfan|mesh-list
24507513|NCT00550992|Methotrexate|methotrexate|mesh-list
24507515|NCT00550992|Vincristine|vincristine|mesh-list
24507516|NCT00550992|Daunorubicin|daunorubicin|mesh-list
24507517|NCT00550992|Asparaginase|asparaginase|mesh-list
24507518|NCT00550992|Mitoxantrone|mitoxantrone|mesh-list
24507519|NCT00550992|Mercaptopurine|mercaptopurine|mesh-list
24507520|NCT00550992|Pegaspargase|pegaspargase|mesh-list
24507521|NCT00550992|Thioguanine|thioguanine|mesh-list
24507522|NCT00550992|Cyclosporins|cyclosporins|mesh-list
24507523|NCT00550992|Antilymphocyte Serum|antilymphocyte serum|mesh-list
24507524|NCT00550992|Levoleucovorin|levoleucovorin|mesh-list
24507525|NCT00550992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24507526|NCT00550992|Immunologic Factors|immunologic factors|mesh-ancestor
24507527|NCT00550992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507528|NCT00550992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24507529|NCT00550992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24507530|NCT00550992|Alkylating Agents|alkylating agents|mesh-ancestor
24507531|NCT00550992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507683|NCT00551317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507685|NCT00551343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24507686|NCT00551343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507687|NCT00551343|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
24507688|NCT00551343|Incretins|incretins|mesh-ancestor
24507689|NCT00551343|Hormones|hormones|mesh-ancestor
24507690|NCT00551343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24507691|NCT00551356|Insulin Lispro|insulin lispro|mesh-list
24507711|NCT00551564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507712|NCT00551577|Carboplatin|carboplatin|mesh-list
24507713|NCT00551577|Docetaxel|docetaxel|mesh-list
24507714|NCT00551577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24507715|NCT00551577|Tubulin Modulators|tubulin modulators|mesh-ancestor
24507716|NCT00551577|Antimitotic Agents|antimitotic agents|mesh-ancestor
24507717|NCT00551577|Mitosis Modulators|mitosis modulators|mesh-ancestor
24507718|NCT00551577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24507719|NCT00551590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
24507720|NCT00551590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24507721|NCT00551590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507722|NCT00551590|Incretins|incretins|mesh-ancestor
24507763|NCT00551889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24507764|NCT00551889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24507765|NCT00551889|Analgesics|analgesics|mesh-ancestor
24507766|NCT00551889|Sensory System Agents|sensory system agents|mesh-ancestor
24507921|NCT00553189|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24507923|NCT00553293|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
24507924|NCT00553293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24507925|NCT00553293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24507926|NCT00553345|Vitamin E|vitamin e|mesh-list
24507927|NCT00553345|Selenium|selenium|mesh-list
24507928|NCT00553345|Vitamins|vitamins|mesh-ancestor
24508254|NCT00554710|Glucocorticoids|glucocorticoids|mesh-ancestor
24508255|NCT00554710|Hormones|hormones|mesh-ancestor
24508256|NCT00554710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24508257|NCT00554710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
24508258|NCT00554710|Protective Agents|protective agents|mesh-ancestor
24508261|NCT00554710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24508308|NCT00555022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508309|NCT00555022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24508310|NCT00555022|Respiratory System Agents|respiratory system agents|mesh-ancestor
24508311|NCT00555022|Parasympatholytics|parasympatholytics|mesh-ancestor
24508312|NCT00555022|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24508313|NCT00555022|Cholinergic Agents|cholinergic agents|mesh-ancestor
24508315|NCT00555022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508501|NCT00555984|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
24508502|NCT00555984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24508503|NCT00555984|Narcotics|narcotics|mesh-ancestor
24508504|NCT00555984|Analgesics|analgesics|mesh-ancestor
24508505|NCT00555984|Sensory System Agents|sensory system agents|mesh-ancestor
24508506|NCT00555984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24508507|NCT00556023|Gemcitabine|gemcitabine|mesh-list
24508582|NCT00556127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24508583|NCT00556127|Analgesics|analgesics|mesh-ancestor
24508673|NCT00556387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24508674|NCT00556387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508675|NCT00556413|Leucovorin|leucovorin|mesh-list
24508693|NCT00556413|Antidotes|antidotes|mesh-ancestor
24508694|NCT00556413|Protective Agents|protective agents|mesh-ancestor
24508695|NCT00556413|Vitamin B Complex|vitamin b complex|mesh-ancestor
24508696|NCT00556413|Vitamins|vitamins|mesh-ancestor
24508925|NCT00557739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24508926|NCT00557739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508928|NCT00557739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24508929|NCT00557739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508930|NCT00557791|Ranibizumab|ranibizumab|mesh-list
24508931|NCT00557791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24508932|NCT00557791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24508933|NCT00557791|Growth Substances|growth substances|mesh-ancestor
24508934|NCT00557791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508935|NCT00557791|Growth Inhibitors|growth inhibitors|mesh-ancestor
24508936|NCT00557791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24508937|NCT00557817|Darbepoetin alfa|darbepoetin alfa|mesh-list
24508938|NCT00557817|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
24508939|NCT00557817|Hematinics|hematinics|mesh-ancestor
24508940|NCT00557843|Bupivacaine|bupivacaine|mesh-list
24508941|NCT00557843|Anesthetics, Local|anesthetics, local|mesh-ancestor
24508942|NCT00557843|Anesthetics|anesthetics|mesh-ancestor
24508943|NCT00557843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24508944|NCT00557843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24508947|NCT00557921|Aspirin|aspirin|mesh-list
24508991|NCT00557960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24508992|NCT00557960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24508993|NCT00557960|Adrenergic Agents|adrenergic agents|mesh-ancestor
24508994|NCT00557960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24508995|NCT00557960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509109|NCT00558506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24509111|NCT00558506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24509239|NCT00559455|Immunologic Factors|immunologic factors|mesh-ancestor
24509240|NCT00559455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509241|NCT00559455|Antidotes|antidotes|mesh-ancestor
24509358|NCT00559858|Vitamins|vitamins|mesh-ancestor
24509359|NCT00559858|Micronutrients|micronutrients|mesh-ancestor
24509778|NCT00562068|Antimitotic Agents|antimitotic agents|mesh-ancestor
25718078|NCT02421419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25718079|NCT02421419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25718080|NCT02421419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25718081|NCT02421419|Anesthetics, Local|anesthetics, local|mesh-ancestor
25718082|NCT02421419|Anesthetics|anesthetics|mesh-ancestor
25718083|NCT02421419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25718084|NCT02421419|Sensory System Agents|sensory system agents|mesh-ancestor
25718085|NCT02421419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25718086|NCT02421419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24509919|NCT00562692|Natriuretic Agents|natriuretic agents|mesh-ancestor
24509920|NCT00562692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509921|NCT00562705|Hormones|hormones|mesh-list
24509922|NCT00562705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24509923|NCT00562705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24509924|NCT00562770|Valacyclovir|valacyclovir|mesh-list
24509925|NCT00562770|Valganciclovir|valganciclovir|mesh-list
24509926|NCT00562770|Antiviral Agents|antiviral agents|mesh-ancestor
24509927|NCT00562770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24509928|NCT00562809|Irbesartan|irbesartan|mesh-list
24510126|NCT00563485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510183|NCT00563823|Vatalanib|vatalanib|mesh-list
24510184|NCT00563823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24510185|NCT00563823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510186|NCT00563823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510187|NCT00563836|Catumaxomab|catumaxomab|mesh-list
24510188|NCT00563836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24510650|NCT00565240|Desogestrel|desogestrel|mesh-list
24510651|NCT00565240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24510652|NCT00565240|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24510653|NCT00565240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24510654|NCT00565240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510667|NCT00565240|Progestins|progestins|mesh-ancestor
24510707|NCT00565383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510708|NCT00565383|Analgesics|analgesics|mesh-ancestor
24510709|NCT00565383|Sensory System Agents|sensory system agents|mesh-ancestor
24510710|NCT00565383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24482806|NCT00440687|Fluticasone|fluticasone|mesh-list
24510711|NCT00565383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24510712|NCT00565383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24510713|NCT00565383|Anesthetics, General|anesthetics, general|mesh-ancestor
24510714|NCT00565383|Anesthetics|anesthetics|mesh-ancestor
24510715|NCT00565396|Losartan|losartan|mesh-list
24510716|NCT00565396|Fosinopril|fosinopril|mesh-list
24510717|NCT00565396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24510718|NCT00565396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24510719|NCT00565396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
24510720|NCT00565396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
24510721|NCT00565396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510722|NCT00565396|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
24510785|NCT00565630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24510786|NCT00565630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510787|NCT00565630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510838|NCT00565955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24510839|NCT00565955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510889|NCT00566267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24510891|NCT00566332|Chlorambucil|chlorambucil|mesh-list
24510892|NCT00566332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25718087|NCT02421419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25718088|NCT02421419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25718089|NCT02421419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718090|NCT02421419|Protease Inhibitors|protease inhibitors|mesh-ancestor
25718091|NCT02421419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718092|NCT02421510|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
24510893|NCT00566332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512290|NCT00573963|Ropivacaine|ropivacaine|mesh-list
24510894|NCT00566332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24510895|NCT00566332|Alkylating Agents|alkylating agents|mesh-ancestor
24510897|NCT00566371|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
24510898|NCT00566371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24510899|NCT00566371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24510900|NCT00566371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24510901|NCT00566371|Adrenergic Agents|adrenergic agents|mesh-ancestor
24510902|NCT00566371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24510903|NCT00566371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510904|NCT00566384|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
24510905|NCT00566384|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
24510906|NCT00566384|Immunologic Factors|immunologic factors|mesh-ancestor
24510907|NCT00566384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24510938|NCT00566683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24510939|NCT00566683|Narcotics|narcotics|mesh-ancestor
24510940|NCT00566683|Analgesics|analgesics|mesh-ancestor
24510941|NCT00566683|Sensory System Agents|sensory system agents|mesh-ancestor
24510942|NCT00566683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24510943|NCT00566683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24510944|NCT00566683|Anticonvulsants|anticonvulsants|mesh-ancestor
24510952|NCT00566683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24510953|NCT00566683|GABA Modulators|gaba modulators|mesh-ancestor
24510954|NCT00566683|GABA Agents|gaba agents|mesh-ancestor
24510955|NCT00566683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24510968|NCT00566761|Hormones|hormones|mesh-ancestor
24511224|NCT00567866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24511225|NCT00567866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24511267|NCT00568048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24511268|NCT00568048|Growth Inhibitors|growth inhibitors|mesh-ancestor
24511269|NCT00568048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24511270|NCT00568048|Alkylating Agents|alkylating agents|mesh-ancestor
24511271|NCT00568048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24511272|NCT00568074|Repaglinide|repaglinide|mesh-list
24511273|NCT00568074|Acarbose|acarbose|mesh-list
24511385|NCT00568503|Autonomic Agents|autonomic agents|mesh-ancestor
24482946|NCT00441051|Diclofenac|diclofenac|mesh-list
24511415|NCT00568672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24511416|NCT00568672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24511613|NCT00569881|Moxifloxacin|moxifloxacin|mesh-list
25718093|NCT02421510|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25718094|NCT02421510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718095|NCT02421510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25718096|NCT02421510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718097|NCT02421588|Doxorubicin|doxorubicin|mesh-list
25718098|NCT02421588|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25718099|NCT02421588|Topotecan|topotecan|mesh-list
25718100|NCT02421588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25718101|NCT02421588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25718102|NCT02421588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25718103|NCT02421588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24511948|NCT00571740|Growth Inhibitors|growth inhibitors|mesh-ancestor
24511956|NCT00571740|Protective Agents|protective agents|mesh-ancestor
24511957|NCT00571740|Vitamin B Complex|vitamin b complex|mesh-ancestor
24512127|NCT00573001|Nevirapine|nevirapine|mesh-list
24512129|NCT00573001|Efavirenz|efavirenz|mesh-list
24512154|NCT00573326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25718104|NCT02421588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718105|NCT02421588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718106|NCT02421588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25718107|NCT02421887|Antioxidants|antioxidants|mesh-list
25718108|NCT02421887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718109|NCT02421887|Protective Agents|protective agents|mesh-ancestor
25718110|NCT02421887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512156|NCT00573326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512157|NCT00573378|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24512158|NCT00573378|Antiviral Agents|antiviral agents|mesh-ancestor
24512159|NCT00573378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24512160|NCT00573404|Sunitinib|sunitinib|mesh-list
24512288|NCT00573950|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24512289|NCT00573950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512291|NCT00573963|Anesthetics, Local|anesthetics, local|mesh-ancestor
25718111|NCT02422186|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25718112|NCT02422186|Citalopram|citalopram|mesh-list
25718113|NCT02422186|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25718114|NCT02422186|Sertraline|sertraline|mesh-list
25718115|NCT02422186|Antidepressive Agents|antidepressive agents|mesh-list
25718116|NCT02422186|Esketamine|esketamine|mesh-list
24512292|NCT00573963|Anesthetics|anesthetics|mesh-ancestor
24512293|NCT00573963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25718117|NCT02422186|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24512331|NCT00574093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512332|NCT00574093|Growth Inhibitors|growth inhibitors|mesh-ancestor
24512333|NCT00574093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512334|NCT00574093|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
24512335|NCT00574093|Dermatologic Agents|dermatologic agents|mesh-ancestor
24512336|NCT00574353|Misonidazole|misonidazole|mesh-list
24512337|NCT00574353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512338|NCT00574353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24512384|NCT00574639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24512385|NCT00574639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512386|NCT00574652|Aldesleukin|aldesleukin|mesh-list
24512387|NCT00574652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512388|NCT00574652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24512389|NCT00574652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24512390|NCT00574652|Antiviral Agents|antiviral agents|mesh-ancestor
24512472|NCT00575406|Rituximab|rituximab|mesh-list
24512473|NCT00575406|Doxorubicin|doxorubicin|mesh-list
24512474|NCT00575406|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24512475|NCT00575406|Vincristine|vincristine|mesh-list
24512476|NCT00575406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24512478|NCT00575406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24512479|NCT00575406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24512534|NCT00575549|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24512535|NCT00575549|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24512536|NCT00575549|Adrenergic Agents|adrenergic agents|mesh-ancestor
24512541|NCT00575601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24512542|NCT00575601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24512543|NCT00575601|Antimetabolites|antimetabolites|mesh-ancestor
24512544|NCT00575601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512545|NCT00575601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24512546|NCT00575601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24512547|NCT00575601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24512582|NCT00575796|Vinblastine|vinblastine|mesh-list
24512583|NCT00575796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24512584|NCT00575796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24512585|NCT00575796|Tubulin Modulators|tubulin modulators|mesh-ancestor
24512586|NCT00575796|Antimitotic Agents|antimitotic agents|mesh-ancestor
24512587|NCT00575796|Mitosis Modulators|mitosis modulators|mesh-ancestor
24512588|NCT00575796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24512590|NCT00575835|Ergocalciferols|ergocalciferols|mesh-list
24512591|NCT00575835|Cholecalciferol|cholecalciferol|mesh-list
24512659|NCT00576069|Prednisone|prednisone|mesh-list
24512660|NCT00576069|Budesonide|budesonide|mesh-list
24512661|NCT00576069|Formoterol Fumarate|formoterol fumarate|mesh-list
24512662|NCT00576069|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
24512663|NCT00576069|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
24512664|NCT00576069|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24512665|NCT00576069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24512667|NCT00576069|Hormones|hormones|mesh-ancestor
24512697|NCT00576225|Paclitaxel|paclitaxel|mesh-list
25718118|NCT02422186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25718119|NCT02422186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25718120|NCT02422186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718121|NCT02422186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25718122|NCT02422186|Serotonin Agents|serotonin agents|mesh-ancestor
25718123|NCT02422186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718124|NCT02422186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25718125|NCT02422186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25718126|NCT02422186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25718127|NCT02422186|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24512706|NCT00576238|Betamethasone|betamethasone|mesh-list
24513035|NCT00578266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513036|NCT00578266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24513037|NCT00578266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24513039|NCT00578370|Betamethasone|betamethasone|mesh-list
24513040|NCT00578370|Calcipotriene|calcipotriene|mesh-list
24513041|NCT00578370|Cyclosporins|cyclosporins|mesh-list
24513042|NCT00578370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24513043|NCT00578370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513058|NCT00578435|Cyclophosphamide|cyclophosphamide|mesh-list
24513060|NCT00578435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24513061|NCT00578435|Immunologic Factors|immunologic factors|mesh-ancestor
24513062|NCT00578435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513063|NCT00578435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24513064|NCT00578435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24513065|NCT00578435|Alkylating Agents|alkylating agents|mesh-ancestor
24513066|NCT00578435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513067|NCT00578435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513068|NCT00578435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24513070|NCT00578526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513071|NCT00578526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24513698|NCT00584571|Autonomic Agents|autonomic agents|mesh-ancestor
24513072|NCT00578526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24513073|NCT00578526|Growth Substances|growth substances|mesh-ancestor
24513074|NCT00578526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513102|NCT00578760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24513103|NCT00578760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24513105|NCT00578760|Sensory System Agents|sensory system agents|mesh-ancestor
24513106|NCT00578760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24513107|NCT00578760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513108|NCT00578760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24513109|NCT00578760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24513110|NCT00578760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24513111|NCT00578760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25718128|NCT02422186|Analgesics|analgesics|mesh-ancestor
25718129|NCT02422186|Sensory System Agents|sensory system agents|mesh-ancestor
25718130|NCT02422186|Dopamine Agents|dopamine agents|mesh-ancestor
25718131|NCT02422264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25718132|NCT02422264|Immunologic Factors|immunologic factors|mesh-ancestor
25718133|NCT02422264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718134|NCT02422290|Ketamine|ketamine|mesh-list
24394213|NCT00132561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513181|NCT00579644|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24513182|NCT00579644|Abortifacient Agents|abortifacient agents|mesh-ancestor
24513183|NCT00579644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24513184|NCT00579644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513185|NCT00579644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24513186|NCT00579644|Antimetabolites|antimetabolites|mesh-ancestor
24513243|NCT00580112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24513244|NCT00580112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24513245|NCT00580112|Alkylating Agents|alkylating agents|mesh-ancestor
24513246|NCT00580112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513247|NCT00580190|Alprazolam|alprazolam|mesh-list
24513248|NCT00580190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24513249|NCT00580190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24513333|NCT00580619|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
24513334|NCT00580619|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
24513335|NCT00580619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24513336|NCT00580619|Cholinergic Agents|cholinergic agents|mesh-ancestor
24513337|NCT00580619|Vasodilator Agents|vasodilator agents|mesh-ancestor
24513343|NCT00580814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24513344|NCT00580814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24513346|NCT00580814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24513347|NCT00580827|Disulfiram|disulfiram|mesh-list
24513348|NCT00580827|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
24513377|NCT00580931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24513378|NCT00580931|Vasodilator Agents|vasodilator agents|mesh-ancestor
24513379|NCT00581009|Lithium Carbonate|lithium carbonate|mesh-list
24513380|NCT00581009|Sertraline|sertraline|mesh-list
24513691|NCT00584571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24513692|NCT00584571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24513693|NCT00584571|Antidepressive Agents|antidepressive agents|mesh-ancestor
24513694|NCT00584571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24513695|NCT00584571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
24513696|NCT00584571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24513697|NCT00584571|Parasympatholytics|parasympatholytics|mesh-ancestor
24513700|NCT00584571|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24513702|NCT00584571|Cholinergic Agents|cholinergic agents|mesh-ancestor
24514013|NCT00587249|Aluminum Hydroxide|aluminum hydroxide|mesh-list
24514236|NCT00589238|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24514237|NCT00589238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24514238|NCT00589238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514239|NCT00589238|Tubulin Modulators|tubulin modulators|mesh-ancestor
24514352|NCT00589992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24514380|NCT00590122|Immunologic Factors|immunologic factors|mesh-ancestor
24514381|NCT00590122|Dopamine Agonists|dopamine agonists|mesh-ancestor
24514382|NCT00590174|Aspirin|aspirin|mesh-list
24514383|NCT00590174|Clopidogrel|clopidogrel|mesh-list
24514384|NCT00590174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24514385|NCT00590174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24514386|NCT00590174|Analgesics|analgesics|mesh-ancestor
24514387|NCT00590174|Sensory System Agents|sensory system agents|mesh-ancestor
24514388|NCT00590174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24514430|NCT00590447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514431|NCT00590447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25718135|NCT02422290|Analgesics|analgesics|mesh-ancestor
25718136|NCT02422290|Sensory System Agents|sensory system agents|mesh-ancestor
25718137|NCT02422290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25718138|NCT02422290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514432|NCT00590603|Ascorbic Acid|ascorbic acid|mesh-list
24514433|NCT00590603|Bortezomib|bortezomib|mesh-list
24514434|NCT00590603|Arsenic Trioxide|arsenic trioxide|mesh-list
24514435|NCT00590603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514436|NCT00590603|Antioxidants|antioxidants|mesh-ancestor
25718139|NCT02422290|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25718140|NCT02422290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25718141|NCT02422290|Anesthetics, General|anesthetics, general|mesh-ancestor
25718142|NCT02422290|Anesthetics|anesthetics|mesh-ancestor
25718143|NCT02422290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25718144|NCT02422290|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
24514437|NCT00590603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514438|NCT00590603|Protective Agents|protective agents|mesh-ancestor
24514499|NCT00590928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24514500|NCT00590928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24514501|NCT00590928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24514502|NCT00590928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514503|NCT00590928|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24514504|NCT00590928|Histamine Antagonists|histamine antagonists|mesh-ancestor
24514525|NCT00591201|Infliximab|infliximab|mesh-list
24514619|NCT00591994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514620|NCT00591994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514621|NCT00592111|Prednisone|prednisone|mesh-list
24514622|NCT00592111|Cyclophosphamide|cyclophosphamide|mesh-list
24514623|NCT00592111|Etoposide|etoposide|mesh-list
24514624|NCT00592111|Vincristine|vincristine|mesh-list
24514663|NCT00592150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24514664|NCT00592150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514809|NCT00593008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24514851|NCT00593151|Interferons|interferons|mesh-list
24514852|NCT00593151|Interferon-alpha|interferon-alpha|mesh-list
24514853|NCT00593151|Interferon alpha-2|interferon alpha-2|mesh-list
24514854|NCT00593151|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
24514855|NCT00593151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24514856|NCT00593151|Antiviral Agents|antiviral agents|mesh-ancestor
24514857|NCT00593151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24514858|NCT00593151|Immunologic Factors|immunologic factors|mesh-ancestor
24514860|NCT00593164|Magnesium Sulfate|magnesium sulfate|mesh-list
24514943|NCT00593502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24514944|NCT00593502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24514945|NCT00593580|Cholecalciferol|cholecalciferol|mesh-list
24514946|NCT00593580|Vitamin D|vitamin d|mesh-list
24514947|NCT00593580|Alendronate|alendronate|mesh-list
24514948|NCT00593580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24515025|NCT00593996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515101|NCT00594542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24515102|NCT00594542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24515103|NCT00594542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515105|NCT00594555|Imatinib Mesylate|imatinib mesylate|mesh-list
24515106|NCT00594555|Cladribine|cladribine|mesh-list
24515107|NCT00594555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24515108|NCT00594555|Antimetabolites|antimetabolites|mesh-ancestor
24515109|NCT00594555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515110|NCT00594555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24515111|NCT00594555|Antiviral Agents|antiviral agents|mesh-ancestor
24515112|NCT00594555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24515113|NCT00594555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25404047|NCT03685773|Vasodilator Agents|vasodilator agents|mesh-ancestor
24515174|NCT00595140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24515176|NCT00595140|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24515177|NCT00595322|Bevacizumab|bevacizumab|mesh-list
24515207|NCT00595543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515208|NCT00595569|Insulin|insulin|mesh-list
24515209|NCT00595569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24515210|NCT00595569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515213|NCT00595972|Endostar protein|endostar protein|mesh-list
24515214|NCT00595972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24515215|NCT00595972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24515223|NCT00595985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515269|NCT00596115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24515270|NCT00596115|Dopamine Agonists|dopamine agonists|mesh-ancestor
24515271|NCT00596115|Dopamine Agents|dopamine agents|mesh-ancestor
24515294|NCT00596154|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24515295|NCT00596154|Abortifacient Agents|abortifacient agents|mesh-ancestor
24515296|NCT00596154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25718145|NCT02422290|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25718146|NCT02422290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25718147|NCT02422290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718148|NCT02422940|4-Aminopyridine|4-aminopyridine|mesh-list
25718149|NCT02422940|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25718150|NCT02422940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25718151|NCT02422940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718152|NCT02423291|Brentuximab Vedotin|brentuximab vedotin|mesh-list
24515306|NCT00596154|Mitosis Modulators|mitosis modulators|mesh-ancestor
24515307|NCT00596154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24515309|NCT00596206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515310|NCT00596206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515311|NCT00596206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24515312|NCT00596206|Immunologic Factors|immunologic factors|mesh-ancestor
24515313|NCT00596206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515349|NCT00596375|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24515429|NCT00597064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24515430|NCT00597181|Mitomycins|mitomycins|mesh-list
24515431|NCT00597181|Mitomycin|mitomycin|mesh-list
24515432|NCT00597181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24515433|NCT00597181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24515434|NCT00597181|Alkylating Agents|alkylating agents|mesh-ancestor
24515435|NCT00597181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24515436|NCT00597181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24515437|NCT00597181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515438|NCT00597233|Insulin|insulin|mesh-list
24515439|NCT00597233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
24515440|NCT00597233|Insulin Aspart|insulin aspart|mesh-list
24515533|NCT00598169|Bortezomib|bortezomib|mesh-list
24515534|NCT00598169|Ifosfamide|ifosfamide|mesh-list
24515535|NCT00598169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24515536|NCT00598169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24515539|NCT00598169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24515540|NCT00598169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24515599|NCT00598338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515600|NCT00598377|Cosyntropin|cosyntropin|mesh-list
24515602|NCT00598377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24515603|NCT00598377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24515604|NCT00598403|Ciprofloxacin|ciprofloxacin|mesh-list
24515605|NCT00598403|Cefditoren|cefditoren|mesh-list
24515606|NCT00598403|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
24515607|NCT00598403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24515608|NCT00598403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24515609|NCT00598403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24515610|NCT00598403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24515611|NCT00598403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24515713|NCT00598858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718153|NCT02423291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24515862|NCT00599716|Viscosupplements|viscosupplements|mesh-ancestor
24515863|NCT00599716|Protective Agents|protective agents|mesh-ancestor
24515865|NCT00599807|Cholecalciferol|cholecalciferol|mesh-list
24515867|NCT00599807|Micronutrients|micronutrients|mesh-ancestor
24515868|NCT00599807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516153|NCT00600691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516235|NCT00601198|Antidotes|antidotes|mesh-ancestor
24516236|NCT00601198|Protective Agents|protective agents|mesh-ancestor
24516237|NCT00601198|Vitamin B Complex|vitamin b complex|mesh-ancestor
25718154|NCT02423291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25718155|NCT02423343|Nivolumab|nivolumab|mesh-list
25718156|NCT02423343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25718157|NCT02423343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25718158|NCT02423343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25718159|NCT02423343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718160|NCT02423980|Glucagon|glucagon|mesh-list
25718161|NCT02423980|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25718162|NCT02423980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25718164|NCT02423980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24516382|NCT00601874|Autonomic Agents|autonomic agents|mesh-ancestor
24516383|NCT00601874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24516384|NCT00601874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516385|NCT00601874|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
24516386|NCT00601874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24516387|NCT00601874|Cholinergic Agents|cholinergic agents|mesh-ancestor
24516388|NCT00601874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24516389|NCT00601874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516390|NCT00601887|Meloxicam|meloxicam|mesh-list
24516494|NCT00602173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516496|NCT00602173|Respiratory System Agents|respiratory system agents|mesh-ancestor
24516497|NCT00602173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24516517|NCT00602251|Antifungal Agents|antifungal agents|mesh-ancestor
24516520|NCT00602251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516522|NCT00602303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24516523|NCT00602303|Diuretics|diuretics|mesh-ancestor
24516541|NCT00602381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24516542|NCT00602381|Antimanic Agents|antimanic agents|mesh-ancestor
24516543|NCT00602381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25718165|NCT02423980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718166|NCT02423980|Incretins|incretins|mesh-ancestor
25718167|NCT02424097|Listerine|listerine|mesh-list
25718168|NCT02424097|Fluorides|fluorides|mesh-list
25718169|NCT02424097|Sodium Fluoride|sodium fluoride|mesh-list
25718170|NCT02424097|Fluorides, Topical|fluorides, topical|mesh-list
25718171|NCT02424097|Cariostatic Agents|cariostatic agents|mesh-ancestor
24516557|NCT00602407|Autonomic Agents|autonomic agents|mesh-ancestor
24516558|NCT00602407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24516559|NCT00602407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24516560|NCT00602407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25718172|NCT02424097|Protective Agents|protective agents|mesh-ancestor
25718173|NCT02424097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718174|NCT02424097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25718175|NCT02424097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25718176|NCT02424344|Formoterol Fumarate|formoterol fumarate|mesh-list
25718177|NCT02424344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25718178|NCT02424344|Autonomic Agents|autonomic agents|mesh-ancestor
25718179|NCT02424344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25718180|NCT02424344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718181|NCT02424344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25718182|NCT02424344|Respiratory System Agents|respiratory system agents|mesh-ancestor
25718183|NCT02424344|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24516831|NCT00604006|Spironolactone|spironolactone|mesh-list
24516833|NCT00604006|Hormone Antagonists|hormone antagonists|mesh-ancestor
24516966|NCT00605020|Insulin Detemir|insulin detemir|mesh-list
24516967|NCT00605020|Biphasic Insulins|biphasic insulins|mesh-list
24516968|NCT00605020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24516969|NCT00605020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517145|NCT00606203|Antidepressive Agents|antidepressive agents|mesh-ancestor
24517146|NCT00606203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24517162|NCT00606333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24517163|NCT00606333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24517164|NCT00606333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517171|NCT00606333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24517172|NCT00606333|Antifungal Agents|antifungal agents|mesh-ancestor
24517173|NCT00606333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24517174|NCT00606333|Immunologic Factors|immunologic factors|mesh-ancestor
24517175|NCT00606333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517176|NCT00606411|Topiramate|topiramate|mesh-list
24517177|NCT00606411|Anticonvulsants|anticonvulsants|mesh-ancestor
24517178|NCT00606411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24517280|NCT00607074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24517281|NCT00607074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24517282|NCT00607074|Anticestodal Agents|anticestodal agents|mesh-ancestor
24517283|NCT00607074|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
24517284|NCT00607074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24517285|NCT00607074|Tubulin Modulators|tubulin modulators|mesh-ancestor
24517301|NCT00607152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718184|NCT02424344|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25718185|NCT02424344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25718186|NCT02424344|Adrenergic Agents|adrenergic agents|mesh-ancestor
25718187|NCT02424344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25718188|NCT02424344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718189|NCT02424357|Povidone-Iodine|povidone-iodine|mesh-list
25718190|NCT02424357|Povidone|povidone|mesh-list
25718191|NCT02424357|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25718192|NCT02424357|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25718193|NCT02424357|Plasma Substitutes|plasma substitutes|mesh-ancestor
25718194|NCT02424357|Blood Substitutes|blood substitutes|mesh-ancestor
25718195|NCT02424357|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25718196|NCT02424357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25718198|NCT02424578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25718199|NCT02424578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24517303|NCT00607178|Immunologic Factors|immunologic factors|mesh-ancestor
24517304|NCT00607178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517307|NCT00607217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517308|NCT00607282|Udenafil|udenafil|mesh-list
24517309|NCT00607282|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24517310|NCT00607282|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
24517311|NCT00607282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517312|NCT00607282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517313|NCT00607438|Paclitaxel|paclitaxel|mesh-list
24517314|NCT00607438|Sorafenib|sorafenib|mesh-list
24517315|NCT00607438|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
24517316|NCT00607438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24517317|NCT00607438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517318|NCT00607438|Tubulin Modulators|tubulin modulators|mesh-ancestor
24517319|NCT00607438|Antimitotic Agents|antimitotic agents|mesh-ancestor
24517320|NCT00607438|Mitosis Modulators|mitosis modulators|mesh-ancestor
24517321|NCT00607438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517322|NCT00607438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24517323|NCT00607438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517324|NCT00607503|Terbutaline|terbutaline|mesh-list
24517325|NCT00607503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24517401|NCT00607711|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24517402|NCT00607711|Alkylating Agents|alkylating agents|mesh-ancestor
24517403|NCT00607711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517404|NCT00607711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517405|NCT00607737|Insulin Detemir|insulin detemir|mesh-list
24517406|NCT00607737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24517409|NCT00607750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24517410|NCT00607750|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
25718200|NCT02424578|Analgesics|analgesics|mesh-ancestor
25718201|NCT02424578|Sensory System Agents|sensory system agents|mesh-ancestor
25718202|NCT02424578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25718203|NCT02424578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718204|NCT02424578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25718205|NCT02424578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25718206|NCT02424578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24517411|NCT00607750|Autonomic Agents|autonomic agents|mesh-ancestor
24517412|NCT00607750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24517418|NCT00607750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517420|NCT00607763|Antifungal Agents|antifungal agents|mesh-ancestor
24517421|NCT00607763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24517422|NCT00607932|Indole-3-carbinol|indole-3-carbinol|mesh-list
24517424|NCT00607932|Protective Agents|protective agents|mesh-ancestor
24517425|NCT00607932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517426|NCT00607932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24517427|NCT00607945|Rosiglitazone|rosiglitazone|mesh-list
24517428|NCT00607945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24517429|NCT00607945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517430|NCT00607958|Ritonavir|ritonavir|mesh-list
24517431|NCT00607958|Tipranavir|tipranavir|mesh-list
24517432|NCT00607958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
24517433|NCT00607958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24517434|NCT00607958|Protease Inhibitors|protease inhibitors|mesh-ancestor
24517449|NCT00607984|Melphalan|melphalan|mesh-list
24517536|NCT00608595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24517537|NCT00608595|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
24517538|NCT00608595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
24517539|NCT00608595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517540|NCT00608595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517541|NCT00608673|Betamethasone|betamethasone|mesh-list
24517542|NCT00608673|Betamethasone Valerate|betamethasone valerate|mesh-list
24517543|NCT00608673|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
24517556|NCT00608673|Analgesics|analgesics|mesh-ancestor
24517557|NCT00608673|Sensory System Agents|sensory system agents|mesh-ancestor
24517558|NCT00608673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24517559|NCT00608673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24517560|NCT00608673|Dermatologic Agents|dermatologic agents|mesh-ancestor
24517561|NCT00608673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24517562|NCT00608673|Immunologic Factors|immunologic factors|mesh-ancestor
24517563|NCT00608673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24517564|NCT00608673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517565|NCT00608673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517566|NCT00608699|Niacin|niacin|mesh-list
24517708|NCT00609531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517709|NCT00609531|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24517710|NCT00609531|Antidepressive Agents|antidepressive agents|mesh-ancestor
24517711|NCT00609531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24517713|NCT00609544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24517714|NCT00609557|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
24517715|NCT00609557|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
24517716|NCT00609557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24517717|NCT00609557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24517718|NCT00609557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517719|NCT00609557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24517720|NCT00609557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517721|NCT00609557|Analgesics|analgesics|mesh-ancestor
25718207|NCT02424578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718208|NCT02424578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718209|NCT02424591|Ketamine|ketamine|mesh-list
25718210|NCT02424591|Analgesics|analgesics|mesh-ancestor
25718211|NCT02424591|Sensory System Agents|sensory system agents|mesh-ancestor
25718212|NCT02424591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25718213|NCT02424591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718214|NCT02424591|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25718215|NCT02424591|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25718216|NCT02424591|Anesthetics, General|anesthetics, general|mesh-ancestor
25718217|NCT02424591|Anesthetics|anesthetics|mesh-ancestor
25718218|NCT02424591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25718219|NCT02424591|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25718220|NCT02424591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
24517804|NCT00610077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24517805|NCT00610077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517806|NCT00610077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24517807|NCT00610077|Hormone Antagonists|hormone antagonists|mesh-ancestor
24517808|NCT00610077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24517809|NCT00610077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517810|NCT00610077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24517811|NCT00610077|Fertility Agents|fertility agents|mesh-ancestor
24517812|NCT00610077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24517956|NCT00610870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24517957|NCT00610870|Antimetabolites|antimetabolites|mesh-ancestor
24517958|NCT00610870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24517959|NCT00610870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25718221|NCT02424591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25718222|NCT02424591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718223|NCT02424630|Ropivacaine|ropivacaine|mesh-list
25718224|NCT02424630|Anesthetics, Local|anesthetics, local|mesh-ancestor
24517960|NCT00610870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24517961|NCT00610870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517967|NCT00610909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24517968|NCT00610909|Serotonin Agents|serotonin agents|mesh-ancestor
24517969|NCT00610909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24517970|NCT00610909|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
24517971|NCT00610909|Antidepressive Agents|antidepressive agents|mesh-ancestor
24517972|NCT00610909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24517973|NCT00610909|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
24517974|NCT00610909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24517992|NCT00610948|Protective Agents|protective agents|mesh-ancestor
24518010|NCT00611039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24518111|NCT05331183|Ivacaftor|ivacaftor|mesh-list
24518112|NCT05331183|Elexacaftor|elexacaftor|mesh-list
24518113|NCT05331183|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
24518137|NCT05331131|Analgesics|analgesics|mesh-ancestor
24518138|NCT05331131|Sensory System Agents|sensory system agents|mesh-ancestor
24518139|NCT05331131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24518140|NCT05331131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518141|NCT05331131|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
24518170|NCT05330377|Cytarabine|cytarabine|mesh-list
25718225|NCT02424630|Anesthetics|anesthetics|mesh-ancestor
25718226|NCT02424630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25718227|NCT02424630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718228|NCT02424630|Sensory System Agents|sensory system agents|mesh-ancestor
25718229|NCT02424630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25718230|NCT02424734|Ampicillin|ampicillin|mesh-list
25718231|NCT02424734|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
25718232|NCT02424734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24518215|NCT05330078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518216|NCT05330078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24518217|NCT05330078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24518218|NCT05330065|Bevacizumab|bevacizumab|mesh-list
24518219|NCT05330065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24518220|NCT05330065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24518221|NCT05330065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24518222|NCT05330065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24518260|NCT05329740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24518261|NCT05329740|Antiemetics|antiemetics|mesh-ancestor
24518262|NCT05329740|Autonomic Agents|autonomic agents|mesh-ancestor
24518263|NCT05329740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24518264|NCT05329740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518295|NCT05321199|Tranexamic Acid|tranexamic acid|mesh-list
24518296|NCT05321199|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24518297|NCT05321199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24518298|NCT05321199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24518309|NCT05320731|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24518310|NCT05320731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24518311|NCT05320731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24518313|NCT05310253|Fludrocortisone|fludrocortisone|mesh-list
24518545|NCT04871412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518546|NCT04871412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24518547|NCT04871412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24518548|NCT04871412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24518549|NCT04871412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24518550|NCT04871412|Analgesics|analgesics|mesh-ancestor
24518551|NCT04871412|Sensory System Agents|sensory system agents|mesh-ancestor
24518615|NCT04666740|Pembrolizumab|pembrolizumab|mesh-list
24518616|NCT04666740|Olaparib|olaparib|mesh-list
24518948|NCT03889756|GABA Modulators|gaba modulators|mesh-ancestor
24518949|NCT03889756|GABA Agents|gaba agents|mesh-ancestor
24518950|NCT03851627|Methyltestosterone|methyltestosterone|mesh-list
24518954|NCT03851627|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25718233|NCT02424734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25718234|NCT02424799|GSK2646264|gsk2646264|mesh-list
25718235|NCT02424799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25718236|NCT02424799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718237|NCT02424799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718238|NCT02424968|Cyclosporine|cyclosporine|mesh-list
25718239|NCT02424968|Mycophenolic Acid|mycophenolic acid|mesh-list
25718240|NCT02424968|Cyclosporins|cyclosporins|mesh-list
25718241|NCT02424968|Thymoglobulin|thymoglobulin|mesh-list
25718242|NCT02424968|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25718243|NCT02424968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24518955|NCT03851627|Androgens|androgens|mesh-ancestor
24518957|NCT03851627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24518958|NCT03851627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24518959|NCT03851627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24518960|NCT03851627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519043|NCT03690089|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24519044|NCT03690089|Cholinergic Agents|cholinergic agents|mesh-ancestor
24519045|NCT03690089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24519118|NCT03421288|Antimitotic Agents|antimitotic agents|mesh-ancestor
24519119|NCT03421288|Mitosis Modulators|mitosis modulators|mesh-ancestor
24519120|NCT03421288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519121|NCT03421288|Antimetabolites|antimetabolites|mesh-ancestor
24519122|NCT03421288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24519123|NCT03421288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24519124|NCT03421288|Immunologic Factors|immunologic factors|mesh-ancestor
24519125|NCT03421288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24519126|NCT03421288|Antidotes|antidotes|mesh-ancestor
24519127|NCT03421288|Protective Agents|protective agents|mesh-ancestor
24519128|NCT03421288|Vitamin B Complex|vitamin b complex|mesh-ancestor
24519129|NCT03421288|Vitamins|vitamins|mesh-ancestor
24519130|NCT03421288|Micronutrients|micronutrients|mesh-ancestor
24519202|NCT03007329|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24519207|NCT03007329|Incretins|incretins|mesh-ancestor
24519285|NCT02543255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24519286|NCT02543255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519287|NCT02543255|Hormone Antagonists|hormone antagonists|mesh-ancestor
24519288|NCT02543255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24519289|NCT02448381|Hypericin|hypericin|mesh-list
24519290|NCT02448381|Antidepressive Agents|antidepressive agents|mesh-ancestor
24519291|NCT02448381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24519292|NCT02448381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519293|NCT02448381|Antiviral Agents|antiviral agents|mesh-ancestor
24519300|NCT02437279|Nivolumab|nivolumab|mesh-list
24519366|NCT01791920|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24519367|NCT01791920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24519369|NCT01791920|Cholinergic Agents|cholinergic agents|mesh-ancestor
24519633|NCT05332028|Anesthetics, General|anesthetics, general|mesh-ancestor
24519634|NCT05332028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24519635|NCT05332028|Narcotics|narcotics|mesh-ancestor
24519636|NCT05332028|Analgesics|analgesics|mesh-ancestor
24519637|NCT05332028|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24519639|NCT05331781|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24519640|NCT05331781|Narcotics|narcotics|mesh-ancestor
24519641|NCT05331781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24519709|NCT05280743|Analgesics|analgesics|mesh-ancestor
24519710|NCT05280743|Sensory System Agents|sensory system agents|mesh-ancestor
24519711|NCT05280743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24519712|NCT05263453|Vemurafenib|vemurafenib|mesh-list
24519713|NCT05263453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24519714|NCT05263453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24519715|NCT05263453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24519716|NCT05263453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24519717|NCT05242874|Dexamethasone|dexamethasone|mesh-list
24519718|NCT05242874|Olanzapine|olanzapine|mesh-list
24520068|NCT03980769|Alkylating Agents|alkylating agents|mesh-ancestor
24520069|NCT03980769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24520070|NCT03936192|Meloxicam|meloxicam|mesh-list
24520072|NCT03936192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24520124|NCT03879577|Trastuzumab|trastuzumab|mesh-list
24520125|NCT03879577|Letrozole|letrozole|mesh-list
24520126|NCT03879577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520127|NCT03879577|Tubulin Modulators|tubulin modulators|mesh-ancestor
24520128|NCT03879577|Antimitotic Agents|antimitotic agents|mesh-ancestor
24520129|NCT03879577|Mitosis Modulators|mitosis modulators|mesh-ancestor
24520130|NCT03879577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24520131|NCT03879577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24520132|NCT03879577|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
24520133|NCT03879577|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
24520134|NCT03879577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24520191|NCT03576885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25777871|NCT03065933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24520192|NCT03576885|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
24520193|NCT03576885|Vasodilator Agents|vasodilator agents|mesh-ancestor
24520195|NCT03576885|Protective Agents|protective agents|mesh-ancestor
24520196|NCT03573648|Palbociclib|palbociclib|mesh-list
24520281|NCT03085004|Gemcitabine|gemcitabine|mesh-list
24520282|NCT03085004|Ethanol|ethanol|mesh-list
24520283|NCT03085004|Paclitaxel|paclitaxel|mesh-list
24520284|NCT03085004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24520285|NCT03085004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24520286|NCT03085004|Tubulin Modulators|tubulin modulators|mesh-ancestor
24520287|NCT03085004|Antimitotic Agents|antimitotic agents|mesh-ancestor
24520288|NCT03085004|Mitosis Modulators|mitosis modulators|mesh-ancestor
24520308|NCT02993198|Antioxidants|antioxidants|mesh-ancestor
24520360|NCT02771249|Vitamin B Complex|vitamin b complex|mesh-ancestor
24520362|NCT02771249|Micronutrients|micronutrients|mesh-ancestor
24520363|NCT02771249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520558|NCT05337254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520560|NCT05337254|Analgesics|analgesics|mesh-ancestor
24520561|NCT05337254|Sensory System Agents|sensory system agents|mesh-ancestor
24520562|NCT05337254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24520563|NCT05337085|Midazolam|midazolam|mesh-list
24520568|NCT05337085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24520569|NCT05337085|Analgesics|analgesics|mesh-ancestor
24520586|NCT05337085|GABA Agents|gaba agents|mesh-ancestor
24520734|NCT05333744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520735|NCT05333744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24520737|NCT05333731|Oxytocin|oxytocin|mesh-list
24520738|NCT05333731|Oxytocics|oxytocics|mesh-ancestor
24520739|NCT05333731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24520741|NCT05333640|Sirolimus|sirolimus|mesh-list
24520755|NCT05333640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520756|NCT05333419|Latanoprost|latanoprost|mesh-list
24520757|NCT05333419|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
24520758|NCT05333419|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
24520759|NCT05327647|Bicalutamide|bicalutamide|mesh-list
24520760|NCT05327647|Androgen Antagonists|androgen antagonists|mesh-list
24520761|NCT05327647|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
24520762|NCT05327647|Hormone Antagonists|hormone antagonists|mesh-ancestor
24520806|NCT05324059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
24520808|NCT05323708|Denosumab|denosumab|mesh-list
24520809|NCT05323708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
24520810|NCT05323708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520811|NCT05322733|Cyclophosphamide|cyclophosphamide|mesh-list
24520812|NCT05322733|Fludarabine|fludarabine|mesh-list
24520813|NCT05322733|Obinutuzumab|obinutuzumab|mesh-list
24520814|NCT05322733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24520815|NCT05322733|Immunologic Factors|immunologic factors|mesh-ancestor
24520816|NCT05322733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24520817|NCT05322733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24520818|NCT05322733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24520852|NCT05304663|Lomustine|lomustine|mesh-list
24444660|NCT00298779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24520880|NCT05258747|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
24521029|NCT05199662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521031|NCT05199194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24521032|NCT05199194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24521033|NCT05199194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521034|NCT05174832|Paclitaxel|paclitaxel|mesh-list
24521035|NCT05174832|Pembrolizumab|pembrolizumab|mesh-list
24521063|NCT05122208|Famotidine|famotidine|mesh-list
24521064|NCT05122208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24521065|NCT05122208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25777872|NCT03065933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521066|NCT05122208|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24521067|NCT05122208|Histamine Antagonists|histamine antagonists|mesh-ancestor
25777873|NCT03070002|Denosumab|denosumab|mesh-list
25777874|NCT03070002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25777875|NCT03070002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777876|NCT03050398|Letrozole|letrozole|mesh-list
25777877|NCT03050398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25777878|NCT03050398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25718246|NCT02424968|Immunologic Factors|immunologic factors|mesh-ancestor
25718247|NCT02424968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521068|NCT05122208|Histamine Agents|histamine agents|mesh-ancestor
24521069|NCT05122208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24521070|NCT05122208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521071|NCT05122208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521072|NCT05116826|Nitazoxanide|nitazoxanide|mesh-list
24521190|NCT05018520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24521191|NCT05018520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24521192|NCT05018520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24521274|NCT04907279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24521281|NCT04907279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521282|NCT04907279|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
24521283|NCT04907279|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
24521352|NCT04848597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521353|NCT04848597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521354|NCT04848597|Immunologic Factors|immunologic factors|mesh-ancestor
24521397|NCT04791059|Dexmedetomidine|dexmedetomidine|mesh-list
24521398|NCT04791059|Ketamine|ketamine|mesh-list
24521399|NCT04791059|Esketamine|esketamine|mesh-list
24521400|NCT04791059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24521516|NCT04745728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24521537|NCT04692467|Amlodipine|amlodipine|mesh-list
24521538|NCT04692467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24521539|NCT04692467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24521540|NCT04692467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24521541|NCT04692467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521542|NCT04692467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24521543|NCT04692467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521544|NCT04692467|Vasodilator Agents|vasodilator agents|mesh-ancestor
24521546|NCT04690322|BAX 855|bax 855|mesh-list
24521547|NCT04690322|Antibodies, Bispecific|antibodies, bispecific|mesh-list
24521548|NCT04690322|Coagulants|coagulants|mesh-ancestor
24521551|NCT04661930|Fenofibrate|fenofibrate|mesh-list
24521570|NCT04647435|Narcotics|narcotics|mesh-ancestor
24521571|NCT04647435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24521572|NCT04647435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521574|NCT04647435|Sensory System Agents|sensory system agents|mesh-ancestor
24521575|NCT04647435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24521757|NCT04547140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521758|NCT04547140|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
24521759|NCT04547140|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
24521760|NCT04533997|Furosemide|furosemide|mesh-list
24521761|NCT04533997|Diuretics|diuretics|mesh-ancestor
24521762|NCT04533997|Natriuretic Agents|natriuretic agents|mesh-ancestor
24521763|NCT04533997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521764|NCT04533997|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
24486488|NCT00458250|Alemtuzumab|alemtuzumab|mesh-list
24521765|NCT04533997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24521766|NCT04533997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521767|NCT04533451|Carboplatin|carboplatin|mesh-list
24521768|NCT04533451|Pembrolizumab|pembrolizumab|mesh-list
24521785|NCT04519476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24521786|NCT04519476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24521787|NCT04519476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24521788|NCT04519476|Growth Substances|growth substances|mesh-ancestor
24521789|NCT04519476|Growth Inhibitors|growth inhibitors|mesh-ancestor
24521790|NCT04519476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25718248|NCT02424968|Antifungal Agents|antifungal agents|mesh-ancestor
25718249|NCT02424968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25718250|NCT02424968|Dermatologic Agents|dermatologic agents|mesh-ancestor
24521827|NCT04480190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521828|NCT04480190|Antiviral Agents|antiviral agents|mesh-ancestor
24521903|NCT04451772|Upadacitinib|upadacitinib|mesh-list
24521904|NCT04451772|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
24521905|NCT04451772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24521906|NCT04451772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24521907|NCT04451772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24521908|NCT04451772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24521910|NCT04432935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24521911|NCT04425538|Infliximab|infliximab|mesh-list
24521912|NCT04425538|Dermatologic Agents|dermatologic agents|mesh-ancestor
24521913|NCT04425538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24522052|NCT04340882|Mitosis Modulators|mitosis modulators|mesh-ancestor
24522053|NCT04340882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522068|NCT04329832|Azithromycin|azithromycin|mesh-list
24522069|NCT04329832|Hydroxychloroquine|hydroxychloroquine|mesh-list
24522070|NCT04329832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24522071|NCT04329832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24522074|NCT04329832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24522075|NCT04329832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24522076|NCT04329832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522077|NCT04329832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24522271|NCT04032964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24522272|NCT04032964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522273|NCT04032964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24522274|NCT04032964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
24522276|NCT04032964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522278|NCT04020913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24522332|NCT03961165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24522333|NCT03961165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522334|NCT03961165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
24522335|NCT03961165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
24522336|NCT03961165|Cholinergic Agents|cholinergic agents|mesh-ancestor
24522450|NCT03805594|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24522451|NCT03805594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522452|NCT03803761|Fulvestrant|fulvestrant|mesh-list
24522453|NCT03803761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24522454|NCT03803761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522455|NCT03803761|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
24522456|NCT03803761|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24522457|NCT03803761|Hormone Antagonists|hormone antagonists|mesh-ancestor
24522459|NCT03803761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522533|NCT03669614|Gallium citrate|gallium citrate|mesh-list
25404048|NCT03685773|Vitamin B Complex|vitamin b complex|mesh-ancestor
25718251|NCT02424968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25718252|NCT02424968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25718253|NCT02424968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25718254|NCT02424968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25718255|NCT02424968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25718256|NCT02424968|Antitubercular Agents|antitubercular agents|mesh-ancestor
25718257|NCT02424968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25718258|NCT02425098|Vaccines|vaccines|mesh-list
24522534|NCT03669614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522535|NCT03669614|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
24522536|NCT03667482|Cetuximab|cetuximab|mesh-list
24522537|NCT03667482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24522538|NCT03667482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522825|NCT03106987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24522826|NCT03106987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24522827|NCT03105843|Methacholine Chloride|methacholine chloride|mesh-list
24522828|NCT03105843|Miotics|miotics|mesh-ancestor
24522829|NCT03105843|Autonomic Agents|autonomic agents|mesh-ancestor
24522830|NCT03105843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24522831|NCT03105843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24522832|NCT03105843|Parasympathomimetics|parasympathomimetics|mesh-ancestor
24522833|NCT03105843|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
24523109|NCT02588248|Parasympatholytics|parasympatholytics|mesh-ancestor
24523111|NCT02584309|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
24523112|NCT02584309|Dexrazoxane|dexrazoxane|mesh-list
24523114|NCT02584309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24523115|NCT02584309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24523126|NCT02512926|Etoposide|etoposide|mesh-list
24523733|NCT05340803|Anticonvulsants|anticonvulsants|mesh-ancestor
24523135|NCT02512926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24523136|NCT02512926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24523159|NCT02512497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24523161|NCT02451358|Immunologic Factors|immunologic factors|mesh-ancestor
24523162|NCT02451358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523236|NCT02341911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24523237|NCT02341911|Antimetabolites|antimetabolites|mesh-ancestor
24523238|NCT02341911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523239|NCT02341911|Antiviral Agents|antiviral agents|mesh-ancestor
24523240|NCT02341911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24523302|NCT02178709|Vitamin B Complex|vitamin b complex|mesh-ancestor
24523332|NCT01855867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523333|NCT01855867|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24523374|NCT01661400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24523375|NCT01661400|Alkylating Agents|alkylating agents|mesh-ancestor
24523376|NCT01661400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523377|NCT01661400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24523392|NCT01503606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523393|NCT01503606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24523394|NCT01503606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24523396|NCT01293682|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
24523397|NCT01293682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523398|NCT01293682|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
24523399|NCT01293682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24523402|NCT01293682|Vitamins|vitamins|mesh-ancestor
24523579|NCT05341817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24523580|NCT05341817|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
24523581|NCT05341817|Hormone Antagonists|hormone antagonists|mesh-ancestor
24523583|NCT05341817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523603|NCT05341401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24523604|NCT05341401|Glucocorticoids|glucocorticoids|mesh-ancestor
24523605|NCT05341401|Hormones|hormones|mesh-ancestor
24523606|NCT05341401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24523607|NCT05341401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24523608|NCT05341401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24523609|NCT05341401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24523610|NCT05341401|Autonomic Agents|autonomic agents|mesh-ancestor
24523611|NCT05341401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24523688|NCT05341076|Oxytocin|oxytocin|mesh-list
24523689|NCT05341076|Oxytocics|oxytocics|mesh-ancestor
24523690|NCT05341076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24523692|NCT05340985|Vitamin D|vitamin d|mesh-list
24523730|NCT05340803|GABA Modulators|gaba modulators|mesh-ancestor
24523731|NCT05340803|GABA Agents|gaba agents|mesh-ancestor
24523732|NCT05340803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24523842|NCT05339646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24523843|NCT05339646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25404049|NCT03685773|Vitamins|vitamins|mesh-ancestor
24523999|NCT05338190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524000|NCT05338190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24524001|NCT05338190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24524069|NCT05293041|Hemostatics|hemostatics|mesh-ancestor
24524070|NCT05293041|Coagulants|coagulants|mesh-ancestor
24524071|NCT05293041|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
24524286|NCT05050500|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24524287|NCT05050500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24524288|NCT05050500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24524296|NCT05049525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24524301|NCT05049525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24524302|NCT05049525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524303|NCT05049525|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24526993|NCT00614159|Analgesics|analgesics|mesh-ancestor
24524401|NCT04973891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524402|NCT04973891|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
24524610|NCT04658654|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
24524611|NCT04658654|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25718259|NCT02425098|Immunologic Factors|immunologic factors|mesh-ancestor
25718260|NCT02425098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718261|NCT02425111|Vedolizumab|vedolizumab|mesh-list
25718262|NCT02425111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25718263|NCT02425449|Succinylcholine|succinylcholine|mesh-list
25718264|NCT02425449|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
25718265|NCT02425449|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25718266|NCT02425449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24524614|NCT04657562|Tacrolimus|tacrolimus|mesh-list
24524899|NCT04234217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24524900|NCT04234217|Vasodilator Agents|vasodilator agents|mesh-ancestor
24524901|NCT04234217|Vitamin B Complex|vitamin b complex|mesh-ancestor
24524902|NCT04234217|Vitamins|vitamins|mesh-ancestor
24524903|NCT04234217|Micronutrients|micronutrients|mesh-ancestor
24524904|NCT04234217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524905|NCT04230252|Acetaminophen|acetaminophen|mesh-list
24524906|NCT04230252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24524907|NCT04230252|Analgesics|analgesics|mesh-ancestor
24524908|NCT04230252|Sensory System Agents|sensory system agents|mesh-ancestor
24524909|NCT04230252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24524910|NCT04230252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24524911|NCT04230252|Antipyretics|antipyretics|mesh-ancestor
24524912|NCT04230031|Daratumumab|daratumumab|mesh-list
24524989|NCT04140266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24524993|NCT04140266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24525121|NCT03933904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24525122|NCT03933904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24525171|NCT03854929|Azithromycin|azithromycin|mesh-list
24525172|NCT03854929|Ciprofloxacin|ciprofloxacin|mesh-list
24525173|NCT03854929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24525174|NCT03854929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24525175|NCT03854929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
24525252|NCT03737253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24525326|NCT03655691|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24525327|NCT03655691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24525328|NCT03655691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525329|NCT03655691|Cholinergic Agents|cholinergic agents|mesh-ancestor
24525330|NCT03655691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24525331|NCT03655691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525332|NCT03655691|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24525423|NCT03405090|Autonomic Agents|autonomic agents|mesh-ancestor
24525424|NCT03405090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24525425|NCT03405090|Respiratory System Agents|respiratory system agents|mesh-ancestor
24525723|NCT02823574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525737|NCT02799134|Ascorbic Acid|ascorbic acid|mesh-list
24525739|NCT02799134|Vitamins|vitamins|mesh-ancestor
24525740|NCT02799134|Micronutrients|micronutrients|mesh-ancestor
24525741|NCT02799134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525806|NCT02719392|Respiratory System Agents|respiratory system agents|mesh-ancestor
24525807|NCT02719392|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24525808|NCT02719392|Antioxidants|antioxidants|mesh-ancestor
24525809|NCT02719392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24525810|NCT02719392|Protective Agents|protective agents|mesh-ancestor
24525811|NCT02719392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24525812|NCT02719392|Antidotes|antidotes|mesh-ancestor
24444836|NCT00299247|Renal Agents|renal agents|mesh-ancestor
24525813|NCT02719392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24525814|NCT02697448|Propofol|propofol|mesh-list
24525815|NCT02697448|Sevoflurane|sevoflurane|mesh-list
24525816|NCT02697448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
24525817|NCT02697448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24525818|NCT02697448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718267|NCT02425449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25718268|NCT02425449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718269|NCT02426086|Niacinamide|niacinamide|mesh-list
25718270|NCT02426086|Imetelstat|imetelstat|mesh-list
25718271|NCT02426086|Motesanib diphosphate|motesanib diphosphate|mesh-list
25718272|NCT02426086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718273|NCT02426086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718274|NCT02426086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25718275|NCT02426086|Vitamin B Complex|vitamin b complex|mesh-ancestor
25718276|NCT02426086|Vitamins|vitamins|mesh-ancestor
25718277|NCT02426086|Micronutrients|micronutrients|mesh-ancestor
25718278|NCT02426086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771366|NCT03602339|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
24525819|NCT02697448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24525838|NCT02653482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24525839|NCT02653482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529726|NCT00627666|Dermatologic Agents|dermatologic agents|mesh-ancestor
24525841|NCT02644369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24525843|NCT02632409|Nivolumab|nivolumab|mesh-list
24525845|NCT02632409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526036|NCT01999569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24526037|NCT01999569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526038|NCT01959464|Progesterone|progesterone|mesh-list
24526039|NCT01959464|Progestins|progestins|mesh-ancestor
24526040|NCT01959464|Hormones|hormones|mesh-ancestor
24526041|NCT01959464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24526042|NCT01959464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526043|NCT01921166|Leuprolide|leuprolide|mesh-list
24526044|NCT01921166|Clomiphene|clomiphene|mesh-list
24526231|NCT00621751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526232|NCT00621751|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
24526233|NCT00621751|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
24526234|NCT00605215|Interferons|interferons|mesh-list
24526302|NCT00248703|Antimitotic Agents|antimitotic agents|mesh-ancestor
24526303|NCT00248703|Mitosis Modulators|mitosis modulators|mesh-ancestor
24526305|NCT00195091|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
24526318|NCT00005780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24526320|NCT00611143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24526321|NCT00611143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24526322|NCT00611143|Antimetabolites|antimetabolites|mesh-ancestor
24526323|NCT00611143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526324|NCT00611143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24526326|NCT00611143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24526555|NCT00612144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24526556|NCT00612144|Immunologic Factors|immunologic factors|mesh-ancestor
24526598|NCT00612274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24526672|NCT00612612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526673|NCT00612612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24526761|NCT00613093|Alkylating Agents|alkylating agents|mesh-ancestor
24526762|NCT00613093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24526763|NCT00613093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24526765|NCT00613132|Everolimus|everolimus|mesh-list
24526988|NCT00614159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24526990|NCT00614159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
24526991|NCT00614159|Anesthetics, General|anesthetics, general|mesh-ancestor
24526992|NCT00614159|Anesthetics|anesthetics|mesh-ancestor
25771367|NCT03602339|Chelating Agents|chelating agents|mesh-ancestor
25771368|NCT03602339|Sequestering Agents|sequestering agents|mesh-ancestor
25771369|NCT03602339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771370|NCT03604341|Dronabinol|dronabinol|mesh-list
25771371|NCT03604341|Hallucinogens|hallucinogens|mesh-ancestor
25771372|NCT03604341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718279|NCT02426541|Dapagliflozin|dapagliflozin|mesh-list
25718280|NCT02426541|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25718281|NCT02426541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24527006|NCT00614328|Sensory System Agents|sensory system agents|mesh-ancestor
24527009|NCT00614328|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24527062|NCT00614757|N-monoacetylcystine|n-monoacetylcystine|mesh-list
24527063|NCT00614757|Antiviral Agents|antiviral agents|mesh-ancestor
24527064|NCT00614757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24527065|NCT00614757|Expectorants|expectorants|mesh-ancestor
24527066|NCT00614757|Respiratory System Agents|respiratory system agents|mesh-ancestor
24527068|NCT00614757|Antioxidants|antioxidants|mesh-ancestor
24527185|NCT00615368|Epoetin Alfa|epoetin alfa|mesh-list
24527394|NCT00616382|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24527396|NCT00616382|Vasodilator Agents|vasodilator agents|mesh-ancestor
24527397|NCT00616382|Free Radical Scavengers|free radical scavengers|mesh-ancestor
24527398|NCT00616382|Antioxidants|antioxidants|mesh-ancestor
24527399|NCT00616408|Octreotide|octreotide|mesh-list
24527400|NCT00616408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24527468|NCT00616785|Etoposide|etoposide|mesh-list
24527476|NCT00616850|Lidocaine|lidocaine|mesh-list
24527477|NCT00616850|Anesthetics, Local|anesthetics, local|mesh-ancestor
24527478|NCT00616850|Anesthetics|anesthetics|mesh-ancestor
24527479|NCT00616850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24527480|NCT00616850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527481|NCT00616850|Sensory System Agents|sensory system agents|mesh-ancestor
24527566|NCT00617370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24527568|NCT00617448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24527569|NCT00617448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527571|NCT00617474|Hematinics|hematinics|mesh-ancestor
24527572|NCT00617500|Hormones|hormones|mesh-list
24527573|NCT00617500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24527633|NCT00617760|Immunologic Factors|immunologic factors|mesh-ancestor
24527634|NCT00617760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24527635|NCT00617799|Aldesleukin|aldesleukin|mesh-list
24527636|NCT00617799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24527637|NCT00617799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24527638|NCT00617799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24527954|NCT00618696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528047|NCT00619333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528062|NCT00619398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528063|NCT00619398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528064|NCT00619424|Pemetrexed|pemetrexed|mesh-list
24528065|NCT00619424|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
24528066|NCT00619424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528067|NCT00619424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528068|NCT00619424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718282|NCT02426541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25718283|NCT02426541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718284|NCT02426918|Vancomycin|vancomycin|mesh-list
25718285|NCT02426918|Linezolid|linezolid|mesh-list
25718286|NCT02426918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24528069|NCT00619424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24528070|NCT00619424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24528133|NCT00619944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24528134|NCT00619944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528135|NCT00619944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24528136|NCT00619944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24528137|NCT00619944|Antiviral Agents|antiviral agents|mesh-ancestor
24528138|NCT00619944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24528139|NCT00619944|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24528141|NCT00619944|Antimalarials|antimalarials|mesh-ancestor
24528248|NCT00620490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24528249|NCT00620490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528250|NCT00620490|Sensory System Agents|sensory system agents|mesh-ancestor
24528251|NCT00620490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24528294|NCT00620646|Antipyretics|antipyretics|mesh-ancestor
24528451|NCT00621166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
24528452|NCT00621166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24528453|NCT00621218|Tretinoin|tretinoin|mesh-list
24528454|NCT00621218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24528740|NCT00622570|Anesthetics|anesthetics|mesh-ancestor
24528850|NCT00623155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24528851|NCT00623155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24528852|NCT00623155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24528981|NCT00624039|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
24528982|NCT00624039|Cholinergic Agents|cholinergic agents|mesh-ancestor
24528983|NCT00624039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24528984|NCT00624039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24528985|NCT00624078|Antivenins|antivenins|mesh-list
24528986|NCT00624078|Immunologic Factors|immunologic factors|mesh-ancestor
24528987|NCT00624078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24528989|NCT00624130|Dacuronium|dacuronium|mesh-list
24528994|NCT00624130|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24529040|NCT00624208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24529041|NCT00624208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24529042|NCT00624208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24529043|NCT00624208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
24529044|NCT00624208|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
24529045|NCT00624208|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
24529046|NCT00624208|Dopamine Agents|dopamine agents|mesh-ancestor
24529047|NCT00624273|Sildenafil Citrate|sildenafil citrate|mesh-list
24529048|NCT00624273|Vasodilator Agents|vasodilator agents|mesh-ancestor
24529049|NCT00624273|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24529107|NCT00624663|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
24529108|NCT00624663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529109|NCT00624663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529110|NCT00624663|Cholinergic Agents|cholinergic agents|mesh-ancestor
24529313|NCT00625430|Vidarabine|vidarabine|mesh-list
24529314|NCT00625430|Fludarabine|fludarabine|mesh-list
24529315|NCT00625430|Fludarabine phosphate|fludarabine phosphate|mesh-list
24529316|NCT00625430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24529317|NCT00625430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24529318|NCT00625430|Antimetabolites|antimetabolites|mesh-ancestor
24529321|NCT00625430|Immunologic Factors|immunologic factors|mesh-ancestor
24529384|NCT00625859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24529385|NCT00625859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24529386|NCT00625859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24529387|NCT00625859|Dopamine Agents|dopamine agents|mesh-ancestor
24529388|NCT00625859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24529389|NCT00625859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718287|NCT02426918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25718288|NCT02426918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25718289|NCT02426918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718290|NCT02426918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718291|NCT02427646|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25718292|NCT02427646|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25718293|NCT02427646|Botulinum Toxins|botulinum toxins|mesh-list
25718294|NCT02427646|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24529495|NCT00626288|Sensory System Agents|sensory system agents|mesh-ancestor
24529496|NCT00626288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24529497|NCT00626288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529498|NCT00626288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24529499|NCT00626288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24529500|NCT00626483|Basiliximab|basiliximab|mesh-list
24529501|NCT00626483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24529502|NCT00626483|Immunologic Factors|immunologic factors|mesh-ancestor
24529503|NCT00626483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529546|NCT00626613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24529549|NCT00626665|Vasodilator Agents|vasodilator agents|mesh-ancestor
24529550|NCT00626665|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
24529552|NCT00626665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24529630|NCT00627081|Narcotics|narcotics|mesh-ancestor
24529631|NCT00627081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24529632|NCT00627081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24529633|NCT00627081|Analgesics|analgesics|mesh-ancestor
24529636|NCT00627133|Levetiracetam|levetiracetam|mesh-list
24529728|NCT00627666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24529729|NCT00627666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24529730|NCT00627666|Immunologic Factors|immunologic factors|mesh-ancestor
24530237|NCT00629473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530238|NCT00629512|Esomeprazole|esomeprazole|mesh-list
24530299|NCT00629811|Mitosis Modulators|mitosis modulators|mesh-ancestor
24488208|NCT00467116|Immunologic Factors|immunologic factors|mesh-ancestor
24530300|NCT00629811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530301|NCT00629824|Interferons|interferons|mesh-list
24530303|NCT00629824|Interferon-alpha|interferon-alpha|mesh-list
24530304|NCT00629824|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
24530305|NCT00629824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530306|NCT00629824|Antiviral Agents|antiviral agents|mesh-ancestor
24530307|NCT00629824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24530308|NCT00629824|Antimetabolites|antimetabolites|mesh-ancestor
24530309|NCT00629824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530310|NCT00629824|Immunologic Factors|immunologic factors|mesh-ancestor
24530400|NCT00630097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530405|NCT00630110|Docetaxel|docetaxel|mesh-list
24530692|NCT00631722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24530693|NCT00631722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530701|NCT00631813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24530703|NCT00631813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530706|NCT00631943|Sensory System Agents|sensory system agents|mesh-ancestor
24530707|NCT00631943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24530708|NCT00631943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530709|NCT00631943|Anticonvulsants|anticonvulsants|mesh-ancestor
24530710|NCT00631943|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
24530711|NCT00631943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24530712|NCT00631943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530747|NCT00632255|Imatinib Mesylate|imatinib mesylate|mesh-list
24530748|NCT00632255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24530749|NCT00632255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24530846|NCT00632645|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
24530847|NCT00632645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24530848|NCT00632645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24530850|NCT00632645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24530896|NCT00632866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
24530897|NCT00632866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
24530898|NCT00632866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24530899|NCT00632866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530900|NCT00632866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24530901|NCT00632866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24530903|NCT00633035|Famotidine|famotidine|mesh-list
24530904|NCT00633035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24530905|NCT00633035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24530906|NCT00633035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24530907|NCT00633035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24530909|NCT00633035|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
24530924|NCT00633347|Cetrorelix|cetrorelix|mesh-list
24530925|NCT00633347|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
24530926|NCT00633347|Hormones|hormones|mesh-ancestor
24530927|NCT00633347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24530928|NCT00633347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24530929|NCT00633347|Fertility Agents, Female|fertility agents, female|mesh-ancestor
24531052|NCT00633685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24531366|NCT00635401|Varenicline|varenicline|mesh-list
24531407|NCT00635726|Doxorubicin|doxorubicin|mesh-list
24531408|NCT00635726|Methotrexate|methotrexate|mesh-list
24531409|NCT00635726|Vinblastine|vinblastine|mesh-list
24531410|NCT00635726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531411|NCT00635726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
24531412|NCT00635726|Antimetabolites|antimetabolites|mesh-ancestor
24531413|NCT00635726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531414|NCT00635726|Antiviral Agents|antiviral agents|mesh-ancestor
24531415|NCT00635726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24531416|NCT00635726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24531417|NCT00635726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24531644|NCT00636883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531645|NCT00636896|Olanzapine|olanzapine|mesh-list
24531646|NCT00636896|Modafinil|modafinil|mesh-list
24531647|NCT00636896|Antiemetics|antiemetics|mesh-ancestor
24531648|NCT00636896|Autonomic Agents|autonomic agents|mesh-ancestor
24531649|NCT00636896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24531650|NCT00636896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531651|NCT00636896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24531652|NCT00636896|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24531653|NCT00636896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24531654|NCT00636896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24531655|NCT00636896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24531657|NCT00636896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
24531658|NCT00636896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24531659|NCT00636896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24531726|NCT00636935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
24531727|NCT00636935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
24531728|NCT00636935|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
24531729|NCT00636935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
24531730|NCT00636935|Leprostatic Agents|leprostatic agents|mesh-ancestor
24531731|NCT00636935|Antifungal Agents|antifungal agents|mesh-ancestor
24531732|NCT00636935|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
24531733|NCT00636974|Anesthetics|anesthetics|mesh-list
24531734|NCT00636974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24531735|NCT00636974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531736|NCT00637026|Gefitinib|gefitinib|mesh-list
24531737|NCT00637026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531738|NCT00637026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
24531739|NCT00637026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24531775|NCT00637117|Antiviral Agents|antiviral agents|mesh-ancestor
24531776|NCT00637117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24531777|NCT00637117|Immunologic Factors|immunologic factors|mesh-ancestor
24531778|NCT00637117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24531819|NCT00637325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24531821|NCT00637390|Alemtuzumab|alemtuzumab|mesh-list
24531822|NCT00637390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24531823|NCT00637390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24531895|NCT00637481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24531896|NCT00637533|Botulinum Toxins|botulinum toxins|mesh-list
24531897|NCT00637533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24531999|NCT00637845|Esomeprazole|esomeprazole|mesh-list
24532000|NCT00637845|Lansoprazole|lansoprazole|mesh-list
24532001|NCT00637845|Dexlansoprazole|dexlansoprazole|mesh-list
24532002|NCT00637845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
24532003|NCT00637845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24532004|NCT00637845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
24532005|NCT00637845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24532006|NCT00637845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532008|NCT00637858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24532009|NCT00637858|Antioxidants|antioxidants|mesh-ancestor
24532012|NCT00637858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532013|NCT00637858|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
24532109|NCT00637988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
24532119|NCT00638066|Botulinum Toxins|botulinum toxins|mesh-list
24532120|NCT00638066|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
24532121|NCT00638066|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
24532122|NCT00638066|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
24532123|NCT00638066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24532124|NCT00638066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532125|NCT00638066|Cholinergic Agents|cholinergic agents|mesh-ancestor
24532126|NCT00638066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24532127|NCT00638066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532128|NCT00638066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
24532164|NCT00638248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532165|NCT00638300|Dialysis Solutions|dialysis solutions|mesh-list
24532166|NCT00638300|Calcium|calcium|mesh-list
24532237|NCT00638729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
24532238|NCT00638729|Sympatholytics|sympatholytics|mesh-ancestor
24532536|NCT00640263|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
24532537|NCT00640263|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24532538|NCT00640276|Pitavastatin|pitavastatin|mesh-list
24532539|NCT00640276|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
24532540|NCT00640276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24532541|NCT00640276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
24532542|NCT00640276|Antimetabolites|antimetabolites|mesh-ancestor
24532543|NCT00640276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532545|NCT00640276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24532546|NCT00640367|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
24532547|NCT00640367|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
24532614|NCT00640627|Celecoxib|celecoxib|mesh-list
24532671|NCT00640796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532673|NCT00640796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24532674|NCT00640796|Alkylating Agents|alkylating agents|mesh-ancestor
24532675|NCT00640796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24532676|NCT00640796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25718295|NCT02427646|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25718296|NCT02427646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25718297|NCT02427646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771373|NCT03604341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24532677|NCT00640796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
24532678|NCT00640796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24532680|NCT00640796|Sensory System Agents|sensory system agents|mesh-ancestor
24532681|NCT00640796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24532682|NCT00640796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
24532683|NCT00640796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24532684|NCT00640796|Antiviral Agents|antiviral agents|mesh-ancestor
24532685|NCT00640796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24532686|NCT00640809|Ibuprofen|ibuprofen|mesh-list
24532809|NCT00641173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24532871|NCT00641446|Budesonide|budesonide|mesh-list
24532872|NCT00641446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24532873|NCT00641446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24532874|NCT00641446|Autonomic Agents|autonomic agents|mesh-ancestor
24532880|NCT00641446|Hormones|hormones|mesh-ancestor
24532946|NCT00641693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24532947|NCT00641693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24532948|NCT00641693|Respiratory System Agents|respiratory system agents|mesh-ancestor
24532949|NCT00641693|Glucocorticoids|glucocorticoids|mesh-ancestor
24532952|NCT00641758|Pycnogenols|pycnogenols|mesh-list
24533023|NCT00642096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24533024|NCT00642096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24533025|NCT00642096|Sympatholytics|sympatholytics|mesh-ancestor
24533026|NCT00642096|Autonomic Agents|autonomic agents|mesh-ancestor
24533027|NCT00642096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24533028|NCT00642096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
24533029|NCT00642096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
24533030|NCT00642096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
24533031|NCT00642096|Adrenergic Agents|adrenergic agents|mesh-ancestor
24533032|NCT00642096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24533034|NCT00642122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24533035|NCT00642122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24533036|NCT00642122|Autonomic Agents|autonomic agents|mesh-ancestor
24533037|NCT00642122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24533042|NCT00642122|Hormones|hormones|mesh-ancestor
25404050|NCT03685773|Micronutrients|micronutrients|mesh-ancestor
25718298|NCT02427646|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25718299|NCT02427646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25718300|NCT02427646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718301|NCT02427646|Cholinergic Agents|cholinergic agents|mesh-ancestor
25718302|NCT02427646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25771374|NCT03604341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25771375|NCT03604341|Analgesics|analgesics|mesh-ancestor
25771376|NCT03604341|Sensory System Agents|sensory system agents|mesh-ancestor
25771377|NCT03604341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771378|NCT03604341|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25771379|NCT03604341|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25771380|NCT03604341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25771381|NCT03604341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771382|NCT03604341|Hormones|hormones|mesh-ancestor
24533080|NCT00642187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24533082|NCT00642187|Autonomic Agents|autonomic agents|mesh-ancestor
24533083|NCT00642187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24533087|NCT00642187|Glucocorticoids|glucocorticoids|mesh-ancestor
24533282|NCT00642863|Micronutrients|micronutrients|mesh-ancestor
24533283|NCT00642863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24533284|NCT00642863|Antioxidants|antioxidants|mesh-ancestor
25718306|NCT02427802|Gentamicins|gentamicins|mesh-list
25718307|NCT02427802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25718308|NCT02427802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25718309|NCT02427802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25718314|NCT02427841|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25718315|NCT02427841|Fluorouracil|fluorouracil|mesh-list
24491221|NCT00481689|Ciprofloxacin|ciprofloxacin|mesh-list
25718316|NCT02427841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25718317|NCT02427841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25718319|NCT02427841|Antimitotic Agents|antimitotic agents|mesh-ancestor
25718320|NCT02427841|Mitosis Modulators|mitosis modulators|mesh-ancestor
25718321|NCT02427841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718322|NCT02427841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25718323|NCT02427841|Antimetabolites|antimetabolites|mesh-ancestor
25718324|NCT02427841|Antiviral Agents|antiviral agents|mesh-ancestor
25718325|NCT02427841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25718333|NCT02428296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
24449821|NCT00317135|Immunologic Factors|immunologic factors|mesh-ancestor
24449822|NCT00317135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449824|NCT00317187|Immunologic Factors|immunologic factors|mesh-ancestor
24449825|NCT00317187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449826|NCT00317200|Paclitaxel|paclitaxel|mesh-list
24449827|NCT00317200|Bevacizumab|bevacizumab|mesh-list
24449828|NCT00317200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
24449829|NCT00317200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24449830|NCT00317200|Tubulin Modulators|tubulin modulators|mesh-ancestor
24449831|NCT00317200|Antimitotic Agents|antimitotic agents|mesh-ancestor
24449832|NCT00317200|Mitosis Modulators|mitosis modulators|mesh-ancestor
24449833|NCT00317200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24449834|NCT00317200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24449835|NCT00317200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24449836|NCT00317200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24449837|NCT00317200|Growth Substances|growth substances|mesh-ancestor
25718349|NCT02428478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25718350|NCT02428478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718355|NCT02428608|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25718356|NCT02428608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25777881|NCT03050398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777882|NCT03050398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25777883|NCT03050398|Hormone Antagonists|hormone antagonists|mesh-ancestor
25777884|NCT03050398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25777885|NCT03050398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777886|NCT03042780|Folfirinox|folfirinox|mesh-list
25777887|NCT03042780|Lenograstim|lenograstim|mesh-list
25777888|NCT03042780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25777889|NCT03042780|Immunologic Factors|immunologic factors|mesh-ancestor
25777890|NCT03042780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777891|NCT03042780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25777892|NCT03029832|Atezolizumab|atezolizumab|mesh-list
25777893|NCT03029832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25718358|NCT02428608|Cholinergic Agents|cholinergic agents|mesh-ancestor
25718359|NCT02428608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25718361|NCT02428699|Liver Extracts|liver extracts|mesh-list
25718362|NCT02428699|Hematinics|hematinics|mesh-ancestor
25718363|NCT02428699|Vitamins|vitamins|mesh-ancestor
25718364|NCT02428699|Micronutrients|micronutrients|mesh-ancestor
25718365|NCT02428699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718376|NCT02429258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718378|NCT02429427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25718379|NCT02429427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25718380|NCT02429427|Analgesics|analgesics|mesh-ancestor
25718381|NCT02429427|Sensory System Agents|sensory system agents|mesh-ancestor
25718382|NCT02429427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25718383|NCT02429427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718384|NCT02429427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25718385|NCT02429427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25718386|NCT02429427|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25718387|NCT02429427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25718388|NCT02429427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718389|NCT02429427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718390|NCT02429869|Everolimus|everolimus|mesh-list
25718391|NCT02429869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25718392|NCT02429869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25718393|NCT02429869|Immunologic Factors|immunologic factors|mesh-ancestor
25718394|NCT02429869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718395|NCT02429934|Abatacept|abatacept|mesh-list
25718396|NCT02429934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25718397|NCT02429934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718398|NCT02429934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25718399|NCT02429934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25718400|NCT02429934|Immunologic Factors|immunologic factors|mesh-ancestor
25718401|NCT02429934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718402|NCT02429934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25718403|NCT02430090|Fentanyl|fentanyl|mesh-list
25718404|NCT02430090|Sufentanil|sufentanil|mesh-list
25718405|NCT02430090|Levobupivacaine|levobupivacaine|mesh-list
25718406|NCT02430090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25718407|NCT02430090|Narcotics|narcotics|mesh-ancestor
25718408|NCT02430090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25718409|NCT02430090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718410|NCT02430090|Analgesics|analgesics|mesh-ancestor
25718411|NCT02430090|Sensory System Agents|sensory system agents|mesh-ancestor
25718412|NCT02430090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25718413|NCT02430090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25718414|NCT02430090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25718415|NCT02430090|Anesthetics, General|anesthetics, general|mesh-ancestor
25718416|NCT02430090|Anesthetics|anesthetics|mesh-ancestor
25718417|NCT02430090|Anesthetics, Local|anesthetics, local|mesh-ancestor
25718418|NCT02430311|Paclitaxel|paclitaxel|mesh-list
25718419|NCT02430311|Olaparib|olaparib|mesh-list
25718420|NCT02430311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25718421|NCT02430311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25718422|NCT02430311|Tubulin Modulators|tubulin modulators|mesh-ancestor
24449977|NCT00317512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24449978|NCT00317512|Analgesics|analgesics|mesh-ancestor
24449979|NCT00317512|Sensory System Agents|sensory system agents|mesh-ancestor
25718423|NCT02430311|Antimitotic Agents|antimitotic agents|mesh-ancestor
25718424|NCT02430311|Mitosis Modulators|mitosis modulators|mesh-ancestor
25718425|NCT02430311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718426|NCT02430311|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25718427|NCT02430311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718428|NCT02430389|Remifentanil|remifentanil|mesh-list
24449980|NCT00317512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24449981|NCT00317512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449982|NCT00317512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24449983|NCT00317512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24449984|NCT00317512|Blood Substitutes|blood substitutes|mesh-ancestor
24449988|NCT00317538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24449989|NCT00317538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24449990|NCT00317538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24449991|NCT00317538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24449992|NCT00317538|Analgesics|analgesics|mesh-ancestor
24449993|NCT00317538|Sensory System Agents|sensory system agents|mesh-ancestor
24449994|NCT00317538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24449995|NCT00317538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24449996|NCT00317538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24449997|NCT00317538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24449998|NCT00317538|Immunologic Factors|immunologic factors|mesh-ancestor
24449999|NCT00317577|Timolol|timolol|mesh-list
25718429|NCT02430389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25718430|NCT02430389|Narcotics|narcotics|mesh-ancestor
25718431|NCT02430389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25718432|NCT02430389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450081|NCT00317759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718434|NCT02430389|Sensory System Agents|sensory system agents|mesh-ancestor
25718435|NCT02430389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25718436|NCT02430818|Ketamine|ketamine|mesh-list
25718437|NCT02430818|Morphine|morphine|mesh-list
25718438|NCT02430818|Analgesics|analgesics|mesh-ancestor
25718439|NCT02430818|Sensory System Agents|sensory system agents|mesh-ancestor
25718440|NCT02430818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25718441|NCT02430818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777895|NCT03031340|Analgesics|analgesics|mesh-ancestor
25777896|NCT03031340|Sensory System Agents|sensory system agents|mesh-ancestor
25777897|NCT03031340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25777898|NCT03031340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777899|NCT03031340|Anticonvulsants|anticonvulsants|mesh-ancestor
25777900|NCT03031340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25777901|NCT03031340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25718450|NCT02430818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718451|NCT02430818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25718452|NCT02430818|Narcotics|narcotics|mesh-ancestor
25718454|NCT02431260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25718455|NCT02431468|Bryostatin 1|bryostatin 1|mesh-list
25718456|NCT02431468|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25718457|NCT02431468|Immunologic Factors|immunologic factors|mesh-ancestor
25718458|NCT02431468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450143|NCT00317850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450144|NCT00317850|Anticonvulsants|anticonvulsants|mesh-ancestor
24450145|NCT00317850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
24450146|NCT00317850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24450147|NCT00317850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25718459|NCT02431468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25718460|NCT02431533|Calcium|calcium|mesh-list
25718461|NCT02431533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25718462|NCT02431533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718463|NCT02431559|Doxorubicin|doxorubicin|mesh-list
25718464|NCT02431559|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25718465|NCT02431559|Durvalumab|durvalumab|mesh-list
25718466|NCT02431559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25718467|NCT02431559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25718468|NCT02431559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25718469|NCT02431559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25718470|NCT02431559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718471|NCT02431559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718472|NCT02431559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25718473|NCT02431572|Vaccines|vaccines|mesh-list
25718474|NCT02431572|Immunologic Factors|immunologic factors|mesh-ancestor
25718475|NCT02431572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718476|NCT02431598|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
25718477|NCT02431598|Chelating Agents|chelating agents|mesh-ancestor
25718478|NCT02431598|Sequestering Agents|sequestering agents|mesh-ancestor
25718479|NCT02431598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718480|NCT02431637|Piperaquine|piperaquine|mesh-list
25718481|NCT02431637|Antimalarials|antimalarials|mesh-ancestor
25718482|NCT02431637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25718483|NCT02431637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25718484|NCT02431637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25718485|NCT02431650|Primaquine|primaquine|mesh-list
25718486|NCT02431650|Antimalarials|antimalarials|mesh-ancestor
25718487|NCT02431650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25718488|NCT02431650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25718489|NCT02431650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25718490|NCT02431676|Metformin|metformin|mesh-list
25718496|NCT02431754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25718497|NCT02431754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718498|NCT02431754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718499|NCT02431754|Urological Agents|urological agents|mesh-ancestor
25718500|NCT02431806|Milnacipran|milnacipran|mesh-list
25718501|NCT02431806|Fluoxetine|fluoxetine|mesh-list
25718502|NCT02431806|Levomilnacipran|levomilnacipran|mesh-list
25718503|NCT02431806|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25718504|NCT02431806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25718505|NCT02431806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25718506|NCT02431806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718507|NCT02431806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25718508|NCT02431806|Serotonin Agents|serotonin agents|mesh-ancestor
25718509|NCT02431806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718510|NCT02431806|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25718511|NCT02431806|Antidepressive Agents|antidepressive agents|mesh-ancestor
25718512|NCT02431806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25718513|NCT02431806|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25718514|NCT02431806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25718515|NCT02431806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718516|NCT02431806|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25718517|NCT02431806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25718518|NCT02431806|Analgesics|analgesics|mesh-ancestor
25718519|NCT02431806|Sensory System Agents|sensory system agents|mesh-ancestor
25718520|NCT02431806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25718521|NCT02432040|Atorvastatin|atorvastatin|mesh-list
25718522|NCT02432040|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
24493254|NCT00490204|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25718527|NCT02432040|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25718529|NCT02432287|Metformin|metformin|mesh-list
25718530|NCT02432287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25718532|NCT02432456|Acetaminophen|acetaminophen|mesh-list
25718533|NCT02432456|Ibuprofen|ibuprofen|mesh-list
25718534|NCT02432456|Ketamine|ketamine|mesh-list
25718535|NCT02432456|Narcotics|narcotics|mesh-list
25718536|NCT02432456|Methocarbamol|methocarbamol|mesh-list
25718537|NCT02432456|Pantoprazole|pantoprazole|mesh-list
25718538|NCT02432456|Analgesics|analgesics|mesh-ancestor
25718539|NCT02432456|Sensory System Agents|sensory system agents|mesh-ancestor
25718540|NCT02432456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25718541|NCT02432456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718542|NCT02432456|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25718543|NCT02432456|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25718544|NCT02432456|Anesthetics, General|anesthetics, general|mesh-ancestor
25718545|NCT02432456|Anesthetics|anesthetics|mesh-ancestor
25718546|NCT02432456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25718547|NCT02432456|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25718548|NCT02432456|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25718549|NCT02432456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25718550|NCT02432456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404051|NCT03685773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718551|NCT02432456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25718552|NCT02432456|Antipyretics|antipyretics|mesh-ancestor
25718553|NCT02432456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25718554|NCT02432456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25718555|NCT02432456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25718556|NCT02432456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25718557|NCT02432456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718558|NCT02432456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25718559|NCT02432456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25718560|NCT02432456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25718561|NCT02432456|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25718562|NCT02432456|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25718563|NCT02432703|JNJ-42165279|jnj-42165279|mesh-list
25718564|NCT02432703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718565|NCT02432703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718566|NCT02432716|Insulin|insulin|mesh-list
25718567|NCT02432716|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25718568|NCT02432716|Insulin glulisine|insulin glulisine|mesh-list
25718569|NCT02432716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25718570|NCT02432716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718572|NCT02433483|Hydrocortisone|hydrocortisone|mesh-list
25718573|NCT02433483|Methotrexate|methotrexate|mesh-list
25718574|NCT02433483|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25718575|NCT02433483|Abortifacient Agents|abortifacient agents|mesh-ancestor
25718576|NCT02433483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25718577|NCT02433483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718578|NCT02433483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25718579|NCT02433483|Antimetabolites|antimetabolites|mesh-ancestor
25718580|NCT02433483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718582|NCT02433483|Dermatologic Agents|dermatologic agents|mesh-ancestor
25718583|NCT02433483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718584|NCT02433483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25718585|NCT02433483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25718586|NCT02433483|Immunologic Factors|immunologic factors|mesh-ancestor
25718587|NCT02433483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25718588|NCT02433483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25718589|NCT02433483|Antiviral Agents|antiviral agents|mesh-ancestor
25718590|NCT02433483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25718591|NCT02433483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25718593|NCT02433678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25718594|NCT02433678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718595|NCT02433678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25718596|NCT02433678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718597|NCT02433834|Glycopyrrolate|glycopyrrolate|mesh-list
25718598|NCT02433834|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25718599|NCT02433834|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25718600|NCT02433834|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25718601|NCT02433834|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25718602|NCT02433834|Cholinergic Agents|cholinergic agents|mesh-ancestor
25718603|NCT02433834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25718604|NCT02433834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718605|NCT02433834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718606|NCT02433834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25718607|NCT02433834|Autonomic Agents|autonomic agents|mesh-ancestor
25718608|NCT02433834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25718609|NCT02433834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25718610|NCT02433834|Respiratory System Agents|respiratory system agents|mesh-ancestor
25718611|NCT02433834|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25718612|NCT02433834|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25718613|NCT02433834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25718614|NCT02433834|Adrenergic Agents|adrenergic agents|mesh-ancestor
25718615|NCT02434328|Aflibercept|aflibercept|mesh-list
25718616|NCT02434328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25718617|NCT02434328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25718618|NCT02434328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25718619|NCT02434328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25718620|NCT02434328|Growth Substances|growth substances|mesh-ancestor
25718621|NCT02434328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718622|NCT02434328|Growth Inhibitors|growth inhibitors|mesh-ancestor
25718623|NCT02434328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25718624|NCT02434497|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25718625|NCT02434497|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25718629|NCT02434497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25718630|NCT02434497|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25718631|NCT02434497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718632|NCT02434523|Amitriptyline|amitriptyline|mesh-list
25718633|NCT02434523|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25718634|NCT02434523|Antidepressive Agents|antidepressive agents|mesh-ancestor
25718635|NCT02434523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24450416|NCT00319007|Sulindac|sulindac|mesh-list
24450417|NCT00319007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24450418|NCT00319007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24450419|NCT00319007|Analgesics|analgesics|mesh-ancestor
24450420|NCT00319007|Sensory System Agents|sensory system agents|mesh-ancestor
24450421|NCT00319007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24450422|NCT00319007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450423|NCT00319007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24450424|NCT00319007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24450425|NCT00319007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450426|NCT00319007|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25718636|NCT02434523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25718637|NCT02434523|Analgesics|analgesics|mesh-ancestor
25718638|NCT02434523|Sensory System Agents|sensory system agents|mesh-ancestor
25718639|NCT02434523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25718640|NCT02434523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718641|NCT02434523|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25718642|NCT02434523|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25718643|NCT02434523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25718644|NCT02434523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718645|NCT02434523|Adrenergic Agents|adrenergic agents|mesh-ancestor
25718646|NCT02434523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25718648|NCT02434770|Immunologic Factors|immunologic factors|mesh-ancestor
25718649|NCT02434770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718650|NCT02434939|Ketamine|ketamine|mesh-list
25718651|NCT02434939|Morphine|morphine|mesh-list
25718652|NCT02434939|Analgesics|analgesics|mesh-ancestor
25718653|NCT02434939|Sensory System Agents|sensory system agents|mesh-ancestor
25718654|NCT02434939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25718655|NCT02434939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718656|NCT02434939|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25718657|NCT02434939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25718658|NCT02434939|Anesthetics, General|anesthetics, general|mesh-ancestor
25718660|NCT02434939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25718661|NCT02434939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25718665|NCT02434939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25718666|NCT02434939|Narcotics|narcotics|mesh-ancestor
25718667|NCT02435069|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25718668|NCT02435069|Glycerol|glycerol|mesh-list
25718669|NCT02435069|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25718670|NCT02435069|Protective Agents|protective agents|mesh-ancestor
25718671|NCT02435069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718672|NCT02435147|Denosumab|denosumab|mesh-list
25718673|NCT02435147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25718674|NCT02435147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718675|NCT02435277|Metformin|metformin|mesh-list
25718676|NCT02435277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25718677|NCT02435277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718678|NCT02435680|Gemcitabine|gemcitabine|mesh-list
25718679|NCT02435680|Carboplatin|carboplatin|mesh-list
25718680|NCT02435680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25718681|NCT02435680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25404052|NCT03685773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25718683|NCT02435680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718684|NCT02435680|Antiviral Agents|antiviral agents|mesh-ancestor
25718685|NCT02435680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25718686|NCT02435680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718689|NCT02435680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718690|NCT02435836|Aripiprazole|aripiprazole|mesh-list
25718691|NCT02435836|Antidepressive Agents|antidepressive agents|mesh-ancestor
25718692|NCT02435836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25718693|NCT02435836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25718694|NCT02435836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25718695|NCT02435836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25718696|NCT02435836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718697|NCT02435836|Dopamine Agonists|dopamine agonists|mesh-ancestor
25718698|NCT02435836|Dopamine Agents|dopamine agents|mesh-ancestor
25718699|NCT02435836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25718700|NCT02435836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718701|NCT02435836|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25718702|NCT02435836|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25718703|NCT02435836|Serotonin Agents|serotonin agents|mesh-ancestor
25718704|NCT02435836|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25718705|NCT02435836|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25718706|NCT02435836|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25718707|NCT02435836|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25718708|NCT02435901|Cyclosporine|cyclosporine|mesh-list
25718709|NCT02435901|Mycophenolic Acid|mycophenolic acid|mesh-list
25718710|NCT02435901|Fludarabine|fludarabine|mesh-list
25718711|NCT02435901|Melphalan|melphalan|mesh-list
25718712|NCT02435901|Alemtuzumab|alemtuzumab|mesh-list
25718713|NCT02435901|Tacrolimus|tacrolimus|mesh-list
24450470|NCT00319267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450472|NCT00319293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24450473|NCT00319293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450475|NCT00319306|Formoterol Fumarate|formoterol fumarate|mesh-list
24450476|NCT00319306|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
24450477|NCT00319306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24450478|NCT00319306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25718714|NCT02435901|Cyclosporins|cyclosporins|mesh-list
25718715|NCT02435901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25718716|NCT02435901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450479|NCT00319306|Autonomic Agents|autonomic agents|mesh-ancestor
24450480|NCT00319306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24450482|NCT00319306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24450483|NCT00319306|Respiratory System Agents|respiratory system agents|mesh-ancestor
24450485|NCT00319306|Hormones|hormones|mesh-ancestor
25718717|NCT02435901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25718718|NCT02435901|Immunologic Factors|immunologic factors|mesh-ancestor
25718719|NCT02435901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718720|NCT02435901|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25718721|NCT02435901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718722|NCT02435901|Antifungal Agents|antifungal agents|mesh-ancestor
25718723|NCT02435901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25718724|NCT02435901|Dermatologic Agents|dermatologic agents|mesh-ancestor
25718725|NCT02435901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25718726|NCT02435901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25718727|NCT02435901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25718728|NCT02435901|Antitubercular Agents|antitubercular agents|mesh-ancestor
25718729|NCT02435901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25718730|NCT02435901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25718731|NCT02435901|Alkylating Agents|alkylating agents|mesh-ancestor
25718732|NCT02435901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25718733|NCT02435901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25718734|NCT02435914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25718735|NCT02435914|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25718736|NCT02435992|Ozanimod|ozanimod|mesh-list
25718737|NCT02435992|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25718738|NCT02435992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718739|NCT02435992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25718740|NCT02435992|Immunologic Factors|immunologic factors|mesh-ancestor
25718741|NCT02435992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718742|NCT02436031|Desipramine|desipramine|mesh-list
25718743|NCT02436031|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25718744|NCT02436031|Antidepressive Agents|antidepressive agents|mesh-ancestor
25718745|NCT02436031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25718746|NCT02436031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718747|NCT02436031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718748|NCT02436031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25718749|NCT02436031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25718750|NCT02436031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25718751|NCT02436031|Adrenergic Agents|adrenergic agents|mesh-ancestor
25718752|NCT02436031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25718753|NCT02436031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718755|NCT02436135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25718756|NCT02436135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718757|NCT02436135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771383|NCT03604341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25771385|NCT03605212|Gout Suppressants|gout suppressants|mesh-ancestor
25771386|NCT03605212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25771387|NCT03605914|Acetaminophen|acetaminophen|mesh-list
25771388|NCT03605914|Diclofenac|diclofenac|mesh-list
25771389|NCT03605914|Hydrocodone|hydrocodone|mesh-list
25771390|NCT03605914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25771391|NCT03605914|Analgesics|analgesics|mesh-ancestor
25771392|NCT03605914|Sensory System Agents|sensory system agents|mesh-ancestor
25771393|NCT03605914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771394|NCT03605914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771395|NCT03605914|Antipyretics|antipyretics|mesh-ancestor
25771396|NCT03605914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25718758|NCT02436239|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
25718759|NCT02436239|Antidepressive Agents|antidepressive agents|mesh-ancestor
25718760|NCT02436239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25718761|NCT02436239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25718762|NCT02436239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25718763|NCT02436239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25718764|NCT02436239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404053|NCT03685331|Olaparib|olaparib|mesh-list
25718765|NCT02436239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25718766|NCT02436239|Serotonin Agents|serotonin agents|mesh-ancestor
25718767|NCT02436239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718768|NCT02436239|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25718769|NCT02436239|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25718770|NCT02436577|Ticagrelor|ticagrelor|mesh-list
25718771|NCT02436577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25718772|NCT02436577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25718773|NCT02436577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25718774|NCT02436577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25718775|NCT02436577|Purinergic Agents|purinergic agents|mesh-ancestor
25718776|NCT02436577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25718777|NCT02436577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25404054|NCT03685331|Fulvestrant|fulvestrant|mesh-list
25718778|NCT02436577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718779|NCT02436668|Gemcitabine|gemcitabine|mesh-list
25718780|NCT02436668|Paclitaxel|paclitaxel|mesh-list
25718781|NCT02436668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25718782|NCT02436668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25718783|NCT02436668|Tubulin Modulators|tubulin modulators|mesh-ancestor
25718784|NCT02436668|Antimitotic Agents|antimitotic agents|mesh-ancestor
25718785|NCT02436668|Mitosis Modulators|mitosis modulators|mesh-ancestor
25718786|NCT02436668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718787|NCT02436668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25718788|NCT02436668|Antimetabolites|antimetabolites|mesh-ancestor
25718789|NCT02436668|Antiviral Agents|antiviral agents|mesh-ancestor
25718790|NCT02436668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25718791|NCT02436668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718792|NCT02436668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25718793|NCT02436668|Immunologic Factors|immunologic factors|mesh-ancestor
25718794|NCT02436668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718795|NCT02436759|Phenylephrine|phenylephrine|mesh-list
25718796|NCT02436759|Oxymetazoline|oxymetazoline|mesh-list
25718797|NCT02436759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25718798|NCT02436759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25718799|NCT02436759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25718800|NCT02436759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25718801|NCT02436759|Adrenergic Agents|adrenergic agents|mesh-ancestor
25718802|NCT02436759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25718803|NCT02436759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718804|NCT02436759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718805|NCT02436759|Sympathomimetics|sympathomimetics|mesh-ancestor
25718806|NCT02436759|Autonomic Agents|autonomic agents|mesh-ancestor
25718807|NCT02436759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25718808|NCT02436759|Nasal Decongestants|nasal decongestants|mesh-ancestor
25718809|NCT02436759|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25718810|NCT02436759|Respiratory System Agents|respiratory system agents|mesh-ancestor
25718811|NCT02436759|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25718813|NCT02436759|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25718814|NCT02436759|Protective Agents|protective agents|mesh-ancestor
25718815|NCT02436889|Mirabegron|mirabegron|mesh-list
25718816|NCT02436889|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25718817|NCT02436889|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25718818|NCT02436889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25718819|NCT02436889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24450490|NCT00319306|Adrenergic Agents|adrenergic agents|mesh-ancestor
25718820|NCT02436889|Adrenergic Agents|adrenergic agents|mesh-ancestor
25718821|NCT02436889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25718822|NCT02436889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718823|NCT02436889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718824|NCT02436889|Urological Agents|urological agents|mesh-ancestor
25718825|NCT02436889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25718826|NCT02436889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25718827|NCT02436889|Cholinergic Agents|cholinergic agents|mesh-ancestor
25718828|NCT02437084|Atorvastatin|atorvastatin|mesh-list
25718829|NCT02437084|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25718830|NCT02437084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25718831|NCT02437084|Antimetabolites|antimetabolites|mesh-ancestor
25718832|NCT02437084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718833|NCT02437084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25718834|NCT02437084|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25718835|NCT02437084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718836|NCT02437162|Golimumab|golimumab|mesh-list
25718837|NCT02437162|Ustekinumab|ustekinumab|mesh-list
25718838|NCT02437162|Dermatologic Agents|dermatologic agents|mesh-ancestor
25718839|NCT02437162|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25718840|NCT02437162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25718841|NCT02437162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25718842|NCT02437162|Immunologic Factors|immunologic factors|mesh-ancestor
25718843|NCT02437162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718844|NCT02437253|Adalimumab|adalimumab|mesh-list
25718845|NCT02437253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25718846|NCT02437253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25718847|NCT02437344|Naltrexone|naltrexone|mesh-list
25718848|NCT02437344|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25718849|NCT02437344|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25718850|NCT02437344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718851|NCT02437344|Sensory System Agents|sensory system agents|mesh-ancestor
25718852|NCT02437344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25718853|NCT02437383|Propranolol|propranolol|mesh-list
25718856|NCT02437383|Adrenergic Agents|adrenergic agents|mesh-ancestor
25718857|NCT02437383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25718858|NCT02437383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718859|NCT02437383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718860|NCT02437383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25718861|NCT02437383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25718862|NCT02437383|Vasodilator Agents|vasodilator agents|mesh-ancestor
25718863|NCT02437669|Hydromorphone|hydromorphone|mesh-list
25718864|NCT02437669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25718865|NCT02437669|Narcotics|narcotics|mesh-ancestor
25718866|NCT02437669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25718867|NCT02437669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718868|NCT02437669|Analgesics|analgesics|mesh-ancestor
25718869|NCT02437669|Sensory System Agents|sensory system agents|mesh-ancestor
25718870|NCT02437669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25718871|NCT02438137|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25718872|NCT02438137|Dermatologic Agents|dermatologic agents|mesh-ancestor
25718873|NCT02438137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25718874|NCT02438137|Immunologic Factors|immunologic factors|mesh-ancestor
25718875|NCT02438137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718876|NCT02438371|Indomethacin|indomethacin|mesh-list
25718877|NCT02438371|Nifedipine|nifedipine|mesh-list
25718878|NCT02438371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25718879|NCT02438371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25718880|NCT02438371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718881|NCT02438371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25718882|NCT02438371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718883|NCT02438371|Vasodilator Agents|vasodilator agents|mesh-ancestor
25718884|NCT02438371|Tocolytic Agents|tocolytic agents|mesh-ancestor
25718885|NCT02438371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25718886|NCT02438371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25718887|NCT02438371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25718888|NCT02438371|Analgesics|analgesics|mesh-ancestor
25718889|NCT02438371|Sensory System Agents|sensory system agents|mesh-ancestor
25718890|NCT02438371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25718891|NCT02438371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25718892|NCT02438371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25718893|NCT02438371|Gout Suppressants|gout suppressants|mesh-ancestor
25718894|NCT02438371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25718895|NCT02438371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718896|NCT02438540|Metformin|metformin|mesh-list
25718897|NCT02438540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25718898|NCT02438540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718899|NCT02438787|Golimumab|golimumab|mesh-list
25718900|NCT02438787|Ustekinumab|ustekinumab|mesh-list
25718901|NCT02438787|Dermatologic Agents|dermatologic agents|mesh-ancestor
25718902|NCT02438787|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25718903|NCT02438787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25718904|NCT02438787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25718905|NCT02438787|Immunologic Factors|immunologic factors|mesh-ancestor
25718906|NCT02438787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718907|NCT02438813|Deoxycholic Acid|deoxycholic acid|mesh-list
25718908|NCT02438813|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25718909|NCT02438813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25718910|NCT02439138|Idelalisib|idelalisib|mesh-list
25718911|NCT02439138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25718912|NCT02439138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718913|NCT02439138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718914|NCT02439164|Midazolam|midazolam|mesh-list
25718915|NCT02439164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25718916|NCT02439164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25718917|NCT02439164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25718918|NCT02439164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718919|NCT02439164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25718920|NCT02439164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25718921|NCT02439164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25718922|NCT02439164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25718923|NCT02439164|Anesthetics, General|anesthetics, general|mesh-ancestor
25718925|NCT02439164|GABA Modulators|gaba modulators|mesh-ancestor
25718926|NCT02439164|GABA Agents|gaba agents|mesh-ancestor
25718927|NCT02439164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25718928|NCT02439164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718929|NCT02439281|Clonidine|clonidine|mesh-list
25718930|NCT02439281|Ropivacaine|ropivacaine|mesh-list
25718931|NCT02439281|Anesthetics, Local|anesthetics, local|mesh-ancestor
25718932|NCT02439281|Anesthetics|anesthetics|mesh-ancestor
25718933|NCT02439281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25718934|NCT02439281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718935|NCT02439281|Sensory System Agents|sensory system agents|mesh-ancestor
25718936|NCT02439281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25718937|NCT02439281|Analgesics|analgesics|mesh-ancestor
25718938|NCT02439281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25718939|NCT02439281|Sympatholytics|sympatholytics|mesh-ancestor
25718940|NCT02439281|Autonomic Agents|autonomic agents|mesh-ancestor
25718941|NCT02439281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25718942|NCT02439281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25718943|NCT02439281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25718944|NCT02439281|Adrenergic Agents|adrenergic agents|mesh-ancestor
25718945|NCT02439281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25718946|NCT02439281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718948|NCT02439320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25718949|NCT02439320|Serotonin Agents|serotonin agents|mesh-ancestor
25718950|NCT02439320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25718951|NCT02439320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718952|NCT02439320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718953|NCT02439879|Thioctic Acid|thioctic acid|mesh-list
25718954|NCT02439879|Antioxidants|antioxidants|mesh-ancestor
25718955|NCT02439879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718956|NCT02439879|Protective Agents|protective agents|mesh-ancestor
25718957|NCT02439879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718958|NCT02439879|Vitamin B Complex|vitamin b complex|mesh-ancestor
24450552|NCT00319566|Contraceptive Agents|contraceptive agents|mesh-ancestor
24450553|NCT00319566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25718959|NCT02439879|Vitamins|vitamins|mesh-ancestor
25718960|NCT02439879|Micronutrients|micronutrients|mesh-ancestor
25718961|NCT02440178|Micafungin|micafungin|mesh-list
25718962|NCT02440178|Antifungal Agents|antifungal agents|mesh-ancestor
25718963|NCT02440178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25718964|NCT02440204|Remifentanil|remifentanil|mesh-list
25718965|NCT02440204|Sevoflurane|sevoflurane|mesh-list
25718966|NCT02440204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25718967|NCT02440204|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25718968|NCT02440204|Anesthetics, General|anesthetics, general|mesh-ancestor
25718969|NCT02440204|Anesthetics|anesthetics|mesh-ancestor
25718970|NCT02440204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25718971|NCT02440204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718972|NCT02440204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25718973|NCT02440204|Narcotics|narcotics|mesh-ancestor
25718974|NCT02440204|Analgesics|analgesics|mesh-ancestor
25718975|NCT02440204|Sensory System Agents|sensory system agents|mesh-ancestor
25718976|NCT02440204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25718977|NCT02440308|Bombesin|bombesin|mesh-list
25718978|NCT02440308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718979|NCT02440308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25718980|NCT02440308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718982|NCT02440568|Idarubicin|idarubicin|mesh-list
25718983|NCT02440568|Homoharringtonine|homoharringtonine|mesh-list
25718984|NCT02440568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25718985|NCT02440568|Antimetabolites|antimetabolites|mesh-ancestor
25718986|NCT02440568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25718987|NCT02440568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25718988|NCT02440568|Antiviral Agents|antiviral agents|mesh-ancestor
25718989|NCT02440568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25718990|NCT02440568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25718991|NCT02440568|Immunologic Factors|immunologic factors|mesh-ancestor
25718992|NCT02440568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25718993|NCT02440568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25718994|NCT02440568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25718995|NCT02440568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25718996|NCT02440568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25718997|NCT02440568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25718998|NCT02440568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25718999|NCT02440789|Sirolimus|sirolimus|mesh-list
25719000|NCT02440789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25719001|NCT02440789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25719002|NCT02440789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25719003|NCT02440789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719004|NCT02440789|Antifungal Agents|antifungal agents|mesh-ancestor
25719005|NCT02440789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25719006|NCT02440789|Immunologic Factors|immunologic factors|mesh-ancestor
25719007|NCT02440789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719008|NCT02441062|Edotreotide|edotreotide|mesh-list
25719009|NCT02441062|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25771397|NCT03605914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25719010|NCT02441062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719011|NCT02441114|Fluticasone|fluticasone|mesh-list
25719012|NCT02441114|Tiotropium Bromide|tiotropium bromide|mesh-list
25719013|NCT02441114|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25719014|NCT02441114|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25719015|NCT02441114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25719016|NCT02441114|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25719017|NCT02441114|Autonomic Agents|autonomic agents|mesh-ancestor
25719018|NCT02441114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771398|NCT03605914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25771399|NCT03605914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25771400|NCT03605914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771401|NCT03605914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771402|NCT03605914|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25771403|NCT03605914|Narcotics|narcotics|mesh-ancestor
25771404|NCT03605914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25771405|NCT03605914|Antitussive Agents|antitussive agents|mesh-ancestor
25719019|NCT02441114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719020|NCT02441114|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25719021|NCT02441114|Respiratory System Agents|respiratory system agents|mesh-ancestor
25719022|NCT02441114|Dermatologic Agents|dermatologic agents|mesh-ancestor
25719023|NCT02441114|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25719024|NCT02441114|Parasympatholytics|parasympatholytics|mesh-ancestor
25719025|NCT02441114|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25719026|NCT02441114|Cholinergic Agents|cholinergic agents|mesh-ancestor
25719027|NCT02441114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25771406|NCT03605914|Respiratory System Agents|respiratory system agents|mesh-ancestor
25771407|NCT03606460|Ocrelizumab|ocrelizumab|mesh-list
25771408|NCT03606460|Immunologic Factors|immunologic factors|mesh-ancestor
25771409|NCT03606460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771410|NCT03607539|Pemetrexed|pemetrexed|mesh-list
25771411|NCT03607539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25771412|NCT03607539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771413|NCT03607539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771414|NCT03607539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25771415|NCT03607539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25771416|NCT03608488|Vitamin D|vitamin d|mesh-list
25771417|NCT03608488|Vitamins|vitamins|mesh-ancestor
25771418|NCT03608488|Micronutrients|micronutrients|mesh-ancestor
25771419|NCT03608488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771420|NCT03608488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25771421|NCT03608774|Azithromycin|azithromycin|mesh-list
25771422|NCT03608774|Doxycycline|doxycycline|mesh-list
25771423|NCT03608774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25771424|NCT03608774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25771425|NCT03608774|Antimalarials|antimalarials|mesh-ancestor
25771426|NCT03608774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25771427|NCT03608774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25771428|NCT03608839|Dexamethasone|dexamethasone|mesh-list
25771429|NCT03608839|Dexamethasone acetate|dexamethasone acetate|mesh-list
25771430|NCT03608839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25771431|NCT03608839|BB 1101|bb 1101|mesh-list
25771432|NCT03608839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25771433|NCT03608839|Antiemetics|antiemetics|mesh-ancestor
25771434|NCT03608839|Autonomic Agents|autonomic agents|mesh-ancestor
25771435|NCT03608839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771436|NCT03608839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771437|NCT03608839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25771438|NCT03608839|Glucocorticoids|glucocorticoids|mesh-ancestor
25771439|NCT03608839|Hormones|hormones|mesh-ancestor
25771440|NCT03608839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25771441|NCT03608839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25771442|NCT03608839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25771443|NCT03608839|Protease Inhibitors|protease inhibitors|mesh-ancestor
25771444|NCT03608839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771445|NCT03608839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771446|NCT03610399|Primaquine|primaquine|mesh-list
25771447|NCT03610399|Antimalarials|antimalarials|mesh-ancestor
25771448|NCT03610399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25771449|NCT03610399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25771450|NCT03610399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25771451|NCT03610464|Amphetamine|amphetamine|mesh-list
25771452|NCT03610464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25771453|NCT03610464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771454|NCT03610464|Sympathomimetics|sympathomimetics|mesh-ancestor
25771455|NCT03610464|Autonomic Agents|autonomic agents|mesh-ancestor
25771456|NCT03610464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771457|NCT03610464|Dopamine Agents|dopamine agents|mesh-ancestor
25771458|NCT03610464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25771459|NCT03610464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771460|NCT03610464|Adrenergic Agents|adrenergic agents|mesh-ancestor
25771461|NCT03610464|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25771462|NCT03610464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25719028|NCT02441114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719029|NCT02441114|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25719030|NCT02441114|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25719031|NCT02441114|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25719032|NCT02441114|Adrenergic Agents|adrenergic agents|mesh-ancestor
25719033|NCT02441114|Glucocorticoids|glucocorticoids|mesh-ancestor
25719034|NCT02441114|Hormones|hormones|mesh-ancestor
25719035|NCT02441114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25719037|NCT02441309|Ifosfamide|ifosfamide|mesh-list
25719038|NCT02441309|Mifamurtide|mifamurtide|mesh-list
25719039|NCT02441309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25719040|NCT02441309|Alkylating Agents|alkylating agents|mesh-ancestor
25719041|NCT02441309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719042|NCT02441309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719043|NCT02441309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25719044|NCT02441309|Immunologic Factors|immunologic factors|mesh-ancestor
25719045|NCT02441309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719046|NCT02441946|Anastrozole|anastrozole|mesh-list
25719047|NCT02441946|Loperamide|loperamide|mesh-list
25719048|NCT02441946|Antidiarrheals|antidiarrheals|mesh-list
25719049|NCT02441946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25719050|NCT02441946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719051|NCT02441946|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25719052|NCT02441946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25719053|NCT02441946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25719054|NCT02441946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719055|NCT02441946|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25719056|NCT02441946|Hormone Antagonists|hormone antagonists|mesh-ancestor
25719057|NCT02441946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25719058|NCT02441946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719059|NCT02441946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25719060|NCT02442271|Ritonavir|ritonavir|mesh-list
25719061|NCT02442271|Ribavirin|ribavirin|mesh-list
25719062|NCT02442271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25719063|NCT02442271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25719064|NCT02442271|Protease Inhibitors|protease inhibitors|mesh-ancestor
25719065|NCT02442271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25719066|NCT02442271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719067|NCT02442271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25719068|NCT02442271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
24450656|NCT00319878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24450660|NCT00319917|Tacrolimus|tacrolimus|mesh-list
25719069|NCT02442271|Antiviral Agents|antiviral agents|mesh-ancestor
25719070|NCT02442271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25719071|NCT02442271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25719072|NCT02442271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25719073|NCT02442271|Antimetabolites|antimetabolites|mesh-ancestor
25719074|NCT02442284|Ritonavir|ritonavir|mesh-list
25719075|NCT02442284|Ribavirin|ribavirin|mesh-list
25719076|NCT02442284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25719077|NCT02442284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25719078|NCT02442284|Protease Inhibitors|protease inhibitors|mesh-ancestor
25719079|NCT02442284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450669|NCT00320021|Vitamins|vitamins|mesh-ancestor
24450670|NCT00320021|Micronutrients|micronutrients|mesh-ancestor
24450671|NCT00320021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450672|NCT00320034|Albuterol|albuterol|mesh-list
24450673|NCT00320034|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24450674|NCT00320034|Autonomic Agents|autonomic agents|mesh-ancestor
24450675|NCT00320034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24450676|NCT00320034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719080|NCT02442284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719081|NCT02442284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25719082|NCT02442284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25719083|NCT02442284|Antiviral Agents|antiviral agents|mesh-ancestor
25719084|NCT02442284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25719085|NCT02442284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25719086|NCT02442284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25719087|NCT02442284|Antimetabolites|antimetabolites|mesh-ancestor
24450677|NCT00320034|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24450678|NCT00320034|Respiratory System Agents|respiratory system agents|mesh-ancestor
24450679|NCT00320034|Tocolytic Agents|tocolytic agents|mesh-ancestor
24450680|NCT00320034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24450681|NCT00320034|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
24450682|NCT00320034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24450691|NCT00320047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24450692|NCT00320047|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
24450693|NCT00320047|GABA Agonists|gaba agonists|mesh-ancestor
24450694|NCT00320047|GABA Agents|gaba agents|mesh-ancestor
24450695|NCT00320047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24450696|NCT00320047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719088|NCT02442310|Deferiprone|deferiprone|mesh-list
25719089|NCT02442310|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25719090|NCT02442310|Chelating Agents|chelating agents|mesh-ancestor
25719091|NCT02442310|Sequestering Agents|sequestering agents|mesh-ancestor
25719092|NCT02442310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719093|NCT02442700|Pitavastatin|pitavastatin|mesh-list
25719094|NCT02442700|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25719095|NCT02442700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25719096|NCT02442700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25719097|NCT02442700|Antimetabolites|antimetabolites|mesh-ancestor
25719098|NCT02442700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719099|NCT02442700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25719100|NCT02442700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25719101|NCT02443103|Guanabenz|guanabenz|mesh-list
25719102|NCT02443103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25719103|NCT02443103|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25719104|NCT02443103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25719105|NCT02443103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25719106|NCT02443103|Adrenergic Agents|adrenergic agents|mesh-ancestor
25719107|NCT02443103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25719108|NCT02443103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771463|NCT03610464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25771464|NCT03610464|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25771465|NCT03610633|Oxytocin|oxytocin|mesh-list
25771466|NCT03610633|Oxytocics|oxytocics|mesh-ancestor
25771467|NCT03610633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25771468|NCT03610633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719109|NCT02443103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719110|NCT02443155|Liraglutide|liraglutide|mesh-list
25719111|NCT02443155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25719112|NCT02443155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719113|NCT02443155|Incretins|incretins|mesh-ancestor
25719114|NCT02443155|Hormones|hormones|mesh-ancestor
25771469|NCT03613649|Moxifloxacin|moxifloxacin|mesh-list
25771470|NCT03613649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25771471|NCT03613649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25771472|NCT03613649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25771473|NCT03613649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25771474|NCT03613649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771475|NCT03613649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771476|NCT03613649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25771477|NCT03614975|Vaccines|vaccines|mesh-list
25771478|NCT03614975|Immunologic Factors|immunologic factors|mesh-ancestor
25771479|NCT03614975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771480|NCT03615404|Molgramostim|molgramostim|mesh-list
25771481|NCT03615404|Sargramostim|sargramostim|mesh-list
25771482|NCT03615404|Immunologic Factors|immunologic factors|mesh-ancestor
25771483|NCT03615404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771484|NCT03615404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25771485|NCT03615534|Niacin|niacin|mesh-list
25771486|NCT03615534|Fenofibrate|fenofibrate|mesh-list
25771487|NCT03615534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25771488|NCT03615534|Antimetabolites|antimetabolites|mesh-ancestor
25771489|NCT03615534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771490|NCT03615534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25771491|NCT03615534|Vasodilator Agents|vasodilator agents|mesh-ancestor
25771492|NCT03615534|Vitamin B Complex|vitamin b complex|mesh-ancestor
25771493|NCT03615534|Vitamins|vitamins|mesh-ancestor
25771494|NCT03615534|Micronutrients|micronutrients|mesh-ancestor
25771495|NCT03615534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771496|NCT03615807|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25771497|NCT03615807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25771498|NCT03615924|Ticagrelor|ticagrelor|mesh-list
25771499|NCT03615924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25771500|NCT03615924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25771501|NCT03615924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25771502|NCT03615924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25771503|NCT03615924|Purinergic Agents|purinergic agents|mesh-ancestor
25771504|NCT03615924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25771505|NCT03615924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771506|NCT03615924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771507|NCT03616977|Insulin Lispro|insulin lispro|mesh-list
25771508|NCT03616977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25771509|NCT03616977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771510|NCT03617861|Secretin|secretin|mesh-list
25771511|NCT03617861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25771512|NCT03617861|Hormones|hormones|mesh-ancestor
25771513|NCT03617861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25771514|NCT03617861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771515|NCT03617913|Cisplatin|cisplatin|mesh-list
25771516|NCT03617913|Fluorouracil|fluorouracil|mesh-list
25771517|NCT03617913|Mitomycins|mitomycins|mesh-list
25771518|NCT03617913|Mitomycin|mitomycin|mesh-list
25771519|NCT03617913|Avelumab|avelumab|mesh-list
25771520|NCT03617913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25771521|NCT03617913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25771522|NCT03617913|Antimetabolites|antimetabolites|mesh-ancestor
25719115|NCT02443155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25719116|NCT02443337|Necitumumab|necitumumab|mesh-list
25719117|NCT02443337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25719118|NCT02443337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719119|NCT02443402|Insulin|insulin|mesh-list
25719120|NCT02443402|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25719121|NCT02443402|Insulin Glargine|insulin glargine|mesh-list
25719122|NCT02443402|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25719123|NCT02443402|Insulin Aspart|insulin aspart|mesh-list
25719124|NCT02443402|Insulin Lispro|insulin lispro|mesh-list
25719125|NCT02443402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25719126|NCT02443402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719127|NCT02443402|Incretins|incretins|mesh-ancestor
25719128|NCT02443402|Hormones|hormones|mesh-ancestor
25719129|NCT02443402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25719130|NCT02443402|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25719131|NCT02443402|Protease Inhibitors|protease inhibitors|mesh-ancestor
25719132|NCT02443402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25719133|NCT02443402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719134|NCT02443883|Ramucirumab|ramucirumab|mesh-list
25719135|NCT02443883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719136|NCT02444143|Tacrolimus|tacrolimus|mesh-list
25719137|NCT02444143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24450733|NCT00320294|Irinotecan|irinotecan|mesh-list
24450734|NCT00320294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450735|NCT00320294|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24450741|NCT00320307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24450742|NCT00320307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25719138|NCT02444143|Immunologic Factors|immunologic factors|mesh-ancestor
25719139|NCT02444143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719140|NCT02444143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25719141|NCT02444143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25719142|NCT02444143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719143|NCT02444234|Tedizolid|tedizolid|mesh-list
25719144|NCT02444234|Oxazolidinones|oxazolidinones|mesh-list
24450789|NCT00320580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
24450790|NCT00320580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
24450791|NCT00320580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
24450794|NCT00320619|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
24450795|NCT00320619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25719145|NCT02444234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25719146|NCT02444234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25719147|NCT02444234|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25719148|NCT02444234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25719149|NCT02444234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719150|NCT02444533|Bupivacaine|bupivacaine|mesh-list
25719151|NCT02444533|Anesthetics, Local|anesthetics, local|mesh-ancestor
25719152|NCT02444533|Anesthetics|anesthetics|mesh-ancestor
25719153|NCT02444533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25719154|NCT02444533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719155|NCT02444533|Sensory System Agents|sensory system agents|mesh-ancestor
25719156|NCT02444533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719158|NCT02444793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719159|NCT02444936|Vaccines|vaccines|mesh-list
25719160|NCT02444936|Immunologic Factors|immunologic factors|mesh-ancestor
25719161|NCT02444936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719162|NCT02444988|Plasma-lyte 148|plasma-lyte 148|mesh-list
24450816|NCT00320658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450817|NCT00320658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
24450820|NCT00320697|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
24450821|NCT00320697|Autonomic Agents|autonomic agents|mesh-ancestor
24450822|NCT00320697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24450823|NCT00320697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450839|NCT00320723|Bupropion|bupropion|mesh-list
25719163|NCT02444988|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25719164|NCT02444988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25719166|NCT02445326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25719167|NCT02445326|Antiemetics|antiemetics|mesh-ancestor
25719168|NCT02445326|Autonomic Agents|autonomic agents|mesh-ancestor
25719169|NCT02445326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719170|NCT02445326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719171|NCT02445326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25719172|NCT02445326|Glucocorticoids|glucocorticoids|mesh-ancestor
25719173|NCT02445326|Hormones|hormones|mesh-ancestor
25719174|NCT02445326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25719175|NCT02445326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25719176|NCT02445326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719177|NCT02445586|Docetaxel|docetaxel|mesh-list
25719178|NCT02445586|Trastuzumab|trastuzumab|mesh-list
25719179|NCT02445586|Pertuzumab|pertuzumab|mesh-list
25719180|NCT02445586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719181|NCT02445586|Tubulin Modulators|tubulin modulators|mesh-ancestor
25719182|NCT02445586|Antimitotic Agents|antimitotic agents|mesh-ancestor
25719183|NCT02445586|Mitosis Modulators|mitosis modulators|mesh-ancestor
25719184|NCT02445586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719185|NCT02445586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25719187|NCT02445807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25719188|NCT02445807|Glucocorticoids|glucocorticoids|mesh-ancestor
25719189|NCT02445807|Hormones|hormones|mesh-ancestor
25719190|NCT02445807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24503939|NCT00533468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25719191|NCT02445807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719192|NCT02445859|Cefuroxime|cefuroxime|mesh-list
25719193|NCT02445859|Cefuroxime axetil|cefuroxime axetil|mesh-list
25719194|NCT02445859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25719195|NCT02445859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25719196|NCT02446015|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25719197|NCT02446015|Lubricant Eye Drops|lubricant eye drops|mesh-list
25719198|NCT02446015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25719199|NCT02446171|Naloxegol|naloxegol|mesh-list
25719200|NCT02446171|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25719201|NCT02446171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450881|NCT00320814|Growth Substances|growth substances|mesh-ancestor
25719202|NCT02446171|Sensory System Agents|sensory system agents|mesh-ancestor
24450870|NCT00320736|Nootropic Agents|nootropic agents|mesh-ancestor
24450871|NCT00320775|Aflibercept|aflibercept|mesh-list
24450872|NCT00320775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24450873|NCT00320775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24450874|NCT00320775|Growth Substances|growth substances|mesh-ancestor
24450875|NCT00320775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450876|NCT00320775|Growth Inhibitors|growth inhibitors|mesh-ancestor
24450877|NCT00320775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24450878|NCT00320814|Aflibercept|aflibercept|mesh-list
24450879|NCT00320814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25719203|NCT02446171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719204|NCT02446418|Fluticasone|fluticasone|mesh-list
25719205|NCT02446418|Xhance|xhance|mesh-list
25719206|NCT02446418|Budesonide|budesonide|mesh-list
25719207|NCT02446418|Formoterol Fumarate|formoterol fumarate|mesh-list
25719208|NCT02446418|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25719209|NCT02446418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25719210|NCT02446418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25719211|NCT02446418|Autonomic Agents|autonomic agents|mesh-ancestor
25719212|NCT02446418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719213|NCT02446418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719214|NCT02446418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
24450880|NCT00320814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25719215|NCT02446418|Respiratory System Agents|respiratory system agents|mesh-ancestor
25719216|NCT02446418|Dermatologic Agents|dermatologic agents|mesh-ancestor
25719217|NCT02446418|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25719218|NCT02446418|Glucocorticoids|glucocorticoids|mesh-ancestor
25719219|NCT02446418|Hormones|hormones|mesh-ancestor
25719220|NCT02446418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25719226|NCT02446418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719227|NCT02446483|Rabeprazole|rabeprazole|mesh-list
25719229|NCT02446483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25719230|NCT02446483|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25719231|NCT02446483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25719232|NCT02446483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719233|NCT02446496|Cefadroxil|cefadroxil|mesh-list
25719234|NCT02446496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25719235|NCT02446496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25719238|NCT02446717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719239|NCT02446717|Antiviral Agents|antiviral agents|mesh-ancestor
25719240|NCT02446717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25719241|NCT02446886|Hormones|hormones|mesh-list
25719242|NCT02446886|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25719243|NCT02446886|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
25719244|NCT02446886|beta-Endorphin|beta-endorphin|mesh-list
24394297|NCT00132860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24394298|NCT00132886|Tolvaptan|tolvaptan|mesh-list
24394299|NCT00132886|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
24394300|NCT00132886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394301|NCT00132886|Natriuretic Agents|natriuretic agents|mesh-ancestor
24394302|NCT00132886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394303|NCT00132899|Methotrexate|methotrexate|mesh-list
24394304|NCT00132899|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
24394305|NCT00132899|Abortifacient Agents|abortifacient agents|mesh-ancestor
24394389|NCT00133224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24394390|NCT00133224|Tubulin Modulators|tubulin modulators|mesh-ancestor
24394391|NCT00133224|Antimitotic Agents|antimitotic agents|mesh-ancestor
24394392|NCT00133224|Mitosis Modulators|mitosis modulators|mesh-ancestor
24394393|NCT00133224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394394|NCT00133224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24394396|NCT00133224|Hormones|hormones|mesh-ancestor
24394397|NCT00133224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24394398|NCT00133224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394399|NCT00133224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24394400|NCT00133237|Sirolimus|sirolimus|mesh-list
24394401|NCT00133237|Paclitaxel|paclitaxel|mesh-list
24394482|NCT00133367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394483|NCT00133367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24394484|NCT00133367|Immunologic Factors|immunologic factors|mesh-ancestor
24394485|NCT00133367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24394486|NCT00133367|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24394487|NCT00133367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394488|NCT00133367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
24394489|NCT00133367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24394490|NCT00133367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25719245|NCT02446886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25719246|NCT02446886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719247|NCT02446886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25719248|NCT02446886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719249|NCT02447003|Pembrolizumab|pembrolizumab|mesh-list
25719250|NCT02447003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25719251|NCT02447003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719252|NCT02447029|Lidocaine|lidocaine|mesh-list
24394491|NCT00133367|Antifungal Agents|antifungal agents|mesh-ancestor
24394492|NCT00133367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
24394493|NCT00133367|Alkylating Agents|alkylating agents|mesh-ancestor
24394498|NCT00133380|Antimetabolites|antimetabolites|mesh-ancestor
24394499|NCT00133380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24394500|NCT00133380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
24394502|NCT00133380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24394548|NCT00133458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24394549|NCT00133523|Vaccines|vaccines|mesh-list
24394551|NCT00133523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24455278|NCT01972217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719253|NCT02447029|Anesthetics, Local|anesthetics, local|mesh-ancestor
25719254|NCT02447029|Anesthetics|anesthetics|mesh-ancestor
25719255|NCT02447029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25719256|NCT02447029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719257|NCT02447029|Sensory System Agents|sensory system agents|mesh-ancestor
25719258|NCT02447029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719259|NCT02447029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25719260|NCT02447029|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25719261|NCT02447029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25719262|NCT02447029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25719263|NCT02447029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719264|NCT02447172|Gentamicins|gentamicins|mesh-list
25719265|NCT02447172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25719266|NCT02447172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25719267|NCT02447172|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25719268|NCT02447172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25719269|NCT02447172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719270|NCT02447250|Albuterol|albuterol|mesh-list
25719271|NCT02447250|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25719272|NCT02447250|Autonomic Agents|autonomic agents|mesh-ancestor
25719273|NCT02447250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719274|NCT02447250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719275|NCT02447250|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25719276|NCT02447250|Respiratory System Agents|respiratory system agents|mesh-ancestor
25719277|NCT02447250|Tocolytic Agents|tocolytic agents|mesh-ancestor
25719278|NCT02447250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25719279|NCT02447250|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25719280|NCT02447250|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25719281|NCT02447250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25719282|NCT02447250|Adrenergic Agents|adrenergic agents|mesh-ancestor
25719283|NCT02447250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25719284|NCT02447250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719285|NCT02447328|Fulvestrant|fulvestrant|mesh-list
25719286|NCT02447328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25719287|NCT02447328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719288|NCT02447328|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25719289|NCT02447328|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25719290|NCT02447328|Hormone Antagonists|hormone antagonists|mesh-ancestor
25719291|NCT02447328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25719292|NCT02447328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719293|NCT02447432|Vaccines|vaccines|mesh-list
25719294|NCT02447432|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25719295|NCT02447432|Immunologic Factors|immunologic factors|mesh-ancestor
25719296|NCT02447432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719297|NCT02447848|Sufentanil|sufentanil|mesh-list
25719298|NCT02447848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25719299|NCT02447848|Narcotics|narcotics|mesh-ancestor
25719300|NCT02447848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25719301|NCT02447848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719302|NCT02447848|Analgesics|analgesics|mesh-ancestor
25719303|NCT02447848|Sensory System Agents|sensory system agents|mesh-ancestor
25719304|NCT02447848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719305|NCT02447848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25719306|NCT02447848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25719307|NCT02447848|Anesthetics, General|anesthetics, general|mesh-ancestor
25719308|NCT02447848|Anesthetics|anesthetics|mesh-ancestor
25719309|NCT02447991|Rizatriptan|rizatriptan|mesh-list
25719310|NCT02447991|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25719312|NCT02447991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25719313|NCT02447991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719314|NCT02447991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719315|NCT02448043|Bimatoprost|bimatoprost|mesh-list
25719316|NCT02448043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25719317|NCT02448303|Pembrolizumab|pembrolizumab|mesh-list
25719318|NCT02448303|Acalabrutinib|acalabrutinib|mesh-list
25719319|NCT02448303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25719320|NCT02448303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719321|NCT02448368|Verinurad|verinurad|mesh-list
25719322|NCT02448368|Gout Suppressants|gout suppressants|mesh-ancestor
25719323|NCT02448368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25719324|NCT02448446|Ranibizumab|ranibizumab|mesh-list
25719325|NCT02448446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25719326|NCT02448446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25719327|NCT02448446|Growth Substances|growth substances|mesh-ancestor
25719328|NCT02448446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719329|NCT02448446|Growth Inhibitors|growth inhibitors|mesh-ancestor
25719330|NCT02448446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719331|NCT02448537|Gemcitabine|gemcitabine|mesh-list
25719332|NCT02448537|Doxorubicin|doxorubicin|mesh-list
25719333|NCT02448537|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25719334|NCT02448537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25407738|NCT03480334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25719335|NCT02448537|Antimetabolites|antimetabolites|mesh-ancestor
25719336|NCT02448537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719337|NCT02448537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719338|NCT02448537|Antiviral Agents|antiviral agents|mesh-ancestor
25719339|NCT02448537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25719340|NCT02448537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25719341|NCT02448537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25719342|NCT02448537|Immunologic Factors|immunologic factors|mesh-ancestor
25719343|NCT02448537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719344|NCT02448537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25719345|NCT02448537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25719346|NCT02448537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25719347|NCT02448654|Tolcapone|tolcapone|mesh-list
25719348|NCT02448654|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25719349|NCT02448654|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25719350|NCT02448654|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
25719351|NCT02448654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25719352|NCT02448654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719353|NCT02448810|Fluorouracil|fluorouracil|mesh-list
25719354|NCT02448810|Panitumumab|panitumumab|mesh-list
25719355|NCT02448810|Antimetabolites|antimetabolites|mesh-ancestor
25719356|NCT02448810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719357|NCT02448810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25719358|NCT02448810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719359|NCT02448810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25719360|NCT02448810|Immunologic Factors|immunologic factors|mesh-ancestor
25719361|NCT02448810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719362|NCT02448810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25719363|NCT02448862|Fentanyl|fentanyl|mesh-list
25719364|NCT02448862|Analgesics|analgesics|mesh-list
25719365|NCT02448862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25719366|NCT02448862|Narcotics|narcotics|mesh-ancestor
25719367|NCT02448862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25719368|NCT02448862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719369|NCT02448862|Sensory System Agents|sensory system agents|mesh-ancestor
25719370|NCT02448862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719371|NCT02448862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25719372|NCT02448862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25719373|NCT02448862|Anesthetics, General|anesthetics, general|mesh-ancestor
25719374|NCT02448862|Anesthetics|anesthetics|mesh-ancestor
25719375|NCT02448914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25719376|NCT02448914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25719377|NCT02448914|Immunologic Factors|immunologic factors|mesh-ancestor
25719378|NCT02448914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719379|NCT02448914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25719380|NCT02448914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25719382|NCT02448914|Dopamine Agents|dopamine agents|mesh-ancestor
25719383|NCT02448914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25719384|NCT02448914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719385|NCT02449044|Tolvaptan|tolvaptan|mesh-list
25719386|NCT02449044|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25719387|NCT02449044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719388|NCT02449044|Natriuretic Agents|natriuretic agents|mesh-ancestor
25719389|NCT02449044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719390|NCT02449889|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25719391|NCT02449889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25719392|NCT02449889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719393|NCT02449902|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25719394|NCT02449902|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25719395|NCT02449902|Estradiol|estradiol|mesh-list
25719396|NCT02449902|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25719397|NCT02449902|Estrogens|estrogens|mesh-ancestor
25719398|NCT02449902|Hormones|hormones|mesh-ancestor
25719399|NCT02449902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25719400|NCT02449902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719401|NCT02449902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25719402|NCT02449902|Contraceptive Agents|contraceptive agents|mesh-ancestor
25719403|NCT02449902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25719404|NCT02449902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25719405|NCT02449915|Bupivacaine|bupivacaine|mesh-list
25719406|NCT02449915|Anesthetics, Local|anesthetics, local|mesh-ancestor
25719407|NCT02449915|Anesthetics|anesthetics|mesh-ancestor
25719408|NCT02449915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25719409|NCT02449915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719410|NCT02449915|Sensory System Agents|sensory system agents|mesh-ancestor
25719411|NCT02449915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719412|NCT02450487|Piroxicam|piroxicam|mesh-list
25719413|NCT02450487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25719414|NCT02450487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25719415|NCT02450487|Analgesics|analgesics|mesh-ancestor
25719416|NCT02450487|Sensory System Agents|sensory system agents|mesh-ancestor
25719417|NCT02450487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719418|NCT02450487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719419|NCT02450487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25719420|NCT02450487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25719421|NCT02450487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25719422|NCT02450487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25719423|NCT02450487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719424|NCT02450526|Botulinum Toxins|botulinum toxins|mesh-list
25719425|NCT02450526|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25719426|NCT02450526|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25719427|NCT02450526|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25719428|NCT02450526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25719429|NCT02450526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719430|NCT02450526|Cholinergic Agents|cholinergic agents|mesh-ancestor
25719431|NCT02450526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25719432|NCT02450526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719433|NCT02450526|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25719434|NCT02450526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719435|NCT02450539|Docetaxel|docetaxel|mesh-list
25719436|NCT02450539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719437|NCT02450539|Tubulin Modulators|tubulin modulators|mesh-ancestor
25719438|NCT02450539|Antimitotic Agents|antimitotic agents|mesh-ancestor
25719439|NCT02450539|Mitosis Modulators|mitosis modulators|mesh-ancestor
25719440|NCT02450539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719441|NCT02450552|Ezogabine|ezogabine|mesh-list
25719442|NCT02450552|Anticonvulsants|anticonvulsants|mesh-ancestor
25719443|NCT02450552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25719444|NCT02450552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719445|NCT02450578|Atovaquone|atovaquone|mesh-list
25719446|NCT02450578|Proguanil|proguanil|mesh-list
25719447|NCT02450578|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
25719448|NCT02450578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25719449|NCT02450578|Antimalarials|antimalarials|mesh-ancestor
25719450|NCT02450578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25719451|NCT02450578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25719452|NCT02450578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25719453|NCT02450578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719454|NCT02450578|Antimetabolites|antimetabolites|mesh-ancestor
25719455|NCT02450903|Ceritinib|ceritinib|mesh-list
25719456|NCT02450903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719457|NCT02450903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25719458|NCT02450903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25719459|NCT02450903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719460|NCT02451137|Insulin|insulin|mesh-list
25719461|NCT02451137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25719462|NCT02451137|Insulin Glargine|insulin glargine|mesh-list
25719463|NCT02451137|Insulin Detemir|insulin detemir|mesh-list
25719464|NCT02451137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25719465|NCT02451137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719466|NCT02451150|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25719467|NCT02451150|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25719468|NCT02451150|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25719469|NCT02451150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719470|NCT02451202|Rocuronium|rocuronium|mesh-list
25719471|NCT02451202|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25719472|NCT02451202|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25719473|NCT02451202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25719474|NCT02451202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719475|NCT02451202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719476|NCT02451488|Sargramostim|sargramostim|mesh-list
25719477|NCT02451488|Immunologic Factors|immunologic factors|mesh-ancestor
25719478|NCT02451488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719479|NCT02451696|Everolimus|everolimus|mesh-list
25719480|NCT02451696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719481|NCT02451696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25719482|NCT02451696|Immunologic Factors|immunologic factors|mesh-ancestor
25719483|NCT02451696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719484|NCT02451917|Insulin|insulin|mesh-list
25719485|NCT02451917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25719487|NCT02451917|Insulin, Isophane|insulin, isophane|mesh-list
25719488|NCT02451917|Isophane Insulin, Human|isophane insulin, human|mesh-list
25719489|NCT02451917|Isophane insulin, beef|isophane insulin, beef|mesh-list
25719490|NCT02451917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25719491|NCT02451917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719492|NCT02451930|Pembrolizumab|pembrolizumab|mesh-list
25719493|NCT02451930|Necitumumab|necitumumab|mesh-list
25719494|NCT02451930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25719495|NCT02451930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719496|NCT02452034|Posaconazole|posaconazole|mesh-list
25719497|NCT02452034|Antifungal Agents|antifungal agents|mesh-ancestor
25719498|NCT02452034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25719499|NCT02452034|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25719500|NCT02452034|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25719501|NCT02452034|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25719502|NCT02452034|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25719503|NCT02452034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25719504|NCT02452034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25719505|NCT02452034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719506|NCT02452034|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25719507|NCT02452034|Hormone Antagonists|hormone antagonists|mesh-ancestor
25719508|NCT02452034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25719509|NCT02452034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719511|NCT02452047|Relebactam|relebactam|mesh-list
25719512|NCT02452047|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
25719513|NCT02452047|Cilastatin|cilastatin|mesh-list
25719514|NCT02452047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25719515|NCT02452047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25719516|NCT02452047|Protease Inhibitors|protease inhibitors|mesh-ancestor
25719517|NCT02452047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25719518|NCT02452047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719519|NCT02452047|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25719520|NCT02452060|Ketamine|ketamine|mesh-list
25719521|NCT02452060|Analgesics|analgesics|mesh-ancestor
25719522|NCT02452060|Sensory System Agents|sensory system agents|mesh-ancestor
25719523|NCT02452060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719524|NCT02452060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719525|NCT02452060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25719526|NCT02452060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25719527|NCT02452060|Anesthetics, General|anesthetics, general|mesh-ancestor
25719528|NCT02452060|Anesthetics|anesthetics|mesh-ancestor
25719529|NCT02452060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25719530|NCT02452060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25719531|NCT02452060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25719532|NCT02452060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25719533|NCT02452060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719534|NCT02452190|Reslizumab|reslizumab|mesh-list
25719535|NCT02452190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25719536|NCT02452190|Respiratory System Agents|respiratory system agents|mesh-ancestor
25719537|NCT02452320|Acetaminophen|acetaminophen|mesh-list
25719538|NCT02452320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25719539|NCT02452320|Analgesics|analgesics|mesh-ancestor
25719540|NCT02452320|Sensory System Agents|sensory system agents|mesh-ancestor
25719541|NCT02452320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719542|NCT02452320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719543|NCT02452320|Antipyretics|antipyretics|mesh-ancestor
25719544|NCT02452346|Tosedostat|tosedostat|mesh-list
25719545|NCT02452346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25719546|NCT02452346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719547|NCT02452424|Pembrolizumab|pembrolizumab|mesh-list
25719548|NCT02452424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25719549|NCT02452424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719550|NCT02452463|Durvalumab|durvalumab|mesh-list
25719551|NCT02452463|Nintedanib|nintedanib|mesh-list
25719552|NCT02452463|Immunoglobulins|immunoglobulins|mesh-list
25719553|NCT02452463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25719554|NCT02452463|Immunoglobulin G|immunoglobulin g|mesh-list
25719555|NCT02452463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25719556|NCT02452463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719557|NCT02452463|Immunologic Factors|immunologic factors|mesh-ancestor
25719558|NCT02452463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719559|NCT02452463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25719560|NCT02452463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25719561|NCT02452463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771523|NCT03617913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771524|NCT03617913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25771525|NCT03617913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25771526|NCT03617913|Immunologic Factors|immunologic factors|mesh-ancestor
25771527|NCT03617913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771528|NCT03617913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25771529|NCT03617913|Alkylating Agents|alkylating agents|mesh-ancestor
25771530|NCT03617913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25771531|NCT03617913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771532|NCT03617913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25771533|NCT03618628|Carbon Fiber|carbon fiber|mesh-list
25771534|NCT03618628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25771535|NCT03618628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25771536|NCT03618823|Acetaminophen|acetaminophen|mesh-list
25771537|NCT03618823|Ibuprofen|ibuprofen|mesh-list
25771538|NCT03618823|Oxycodone|oxycodone|mesh-list
25771539|NCT03618823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25771540|NCT03618823|Analgesics|analgesics|mesh-ancestor
25771541|NCT03618823|Sensory System Agents|sensory system agents|mesh-ancestor
25771542|NCT03618823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771543|NCT03618823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771544|NCT03618823|Antipyretics|antipyretics|mesh-ancestor
25771545|NCT03618823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25771546|NCT03618823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25771547|NCT03618823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25771548|NCT03618823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25771549|NCT03618823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771550|NCT03618823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771551|NCT03618823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25771552|NCT03618823|Narcotics|narcotics|mesh-ancestor
25771553|NCT03618823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25771554|NCT03619837|Sofosbuvir|sofosbuvir|mesh-list
25771555|NCT03619837|Velpatasvir|velpatasvir|mesh-list
25771556|NCT03619837|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25771557|NCT03619837|Antiviral Agents|antiviral agents|mesh-ancestor
25771558|NCT03619837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25771559|NCT03620162|Vaccines|vaccines|mesh-list
25771560|NCT03620162|Immunologic Factors|immunologic factors|mesh-ancestor
25771561|NCT03620162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771562|NCT03620708|Nicotine|nicotine|mesh-list
25771563|NCT03620708|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25771564|NCT03620708|Autonomic Agents|autonomic agents|mesh-ancestor
25771565|NCT03620708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771566|NCT03620708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771567|NCT03620708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25771568|NCT03620708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25771569|NCT03620708|Cholinergic Agents|cholinergic agents|mesh-ancestor
25771570|NCT03620708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25771571|NCT03620708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771572|NCT03620890|Protamines|protamines|mesh-list
25771573|NCT03620890|Heparin Antagonists|heparin antagonists|mesh-ancestor
25719562|NCT02452476|Poractant alfa|poractant alfa|mesh-list
25719563|NCT02452476|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
25719564|NCT02452476|Respiratory System Agents|respiratory system agents|mesh-ancestor
25719565|NCT02452528|Diphenhydramine|diphenhydramine|mesh-list
25719566|NCT02452528|Promethazine|promethazine|mesh-list
25719567|NCT02452528|Tenofovir|tenofovir|mesh-list
25719568|NCT02452528|Entecavir|entecavir|mesh-list
25719569|NCT02452528|Antiviral Agents|antiviral agents|mesh-ancestor
25719570|NCT02452528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25719571|NCT02452528|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25719572|NCT02452528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25719574|NCT02452528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719575|NCT02452528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25719576|NCT02452528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25719577|NCT02452528|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25719578|NCT02452528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25719579|NCT02452528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25719580|NCT02452528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719581|NCT02452528|Anesthetics, Local|anesthetics, local|mesh-ancestor
25719582|NCT02452528|Anesthetics|anesthetics|mesh-ancestor
25719583|NCT02452528|Sensory System Agents|sensory system agents|mesh-ancestor
25719584|NCT02452528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719585|NCT02452528|Antiemetics|antiemetics|mesh-ancestor
25719586|NCT02452528|Autonomic Agents|autonomic agents|mesh-ancestor
25719587|NCT02452528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25719588|NCT02452528|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25719589|NCT02452528|Histamine Antagonists|histamine antagonists|mesh-ancestor
25719591|NCT02452528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25719592|NCT02452528|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25719593|NCT02452528|Antipruritics|antipruritics|mesh-ancestor
25719594|NCT02452528|Dermatologic Agents|dermatologic agents|mesh-ancestor
25719595|NCT02452762|Vitamin D|vitamin d|mesh-list
25719596|NCT02452762|Cholecalciferol|cholecalciferol|mesh-list
25719597|NCT02452762|Vitamins|vitamins|mesh-ancestor
25719598|NCT02452762|Micronutrients|micronutrients|mesh-ancestor
25719599|NCT02452762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719600|NCT02452762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25719601|NCT02452762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25719602|NCT02452866|Secnidazole|secnidazole|mesh-list
25719603|NCT02452866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25719604|NCT02452866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25719605|NCT02452866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25719606|NCT02452931|Leuprolide|leuprolide|mesh-list
25719607|NCT02452931|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25719608|NCT02452931|Fertility Agents|fertility agents|mesh-ancestor
25719609|NCT02452931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25719610|NCT02452931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719611|NCT02452931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25719612|NCT02452931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719613|NCT02453191|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25719614|NCT02453191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25719615|NCT02453191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719617|NCT02453321|Anesthetics, Local|anesthetics, local|mesh-ancestor
25719618|NCT02453321|Anesthetics|anesthetics|mesh-ancestor
25719619|NCT02453321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25719620|NCT02453321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719621|NCT02453321|Sensory System Agents|sensory system agents|mesh-ancestor
25719622|NCT02453321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719623|NCT02453360|Bupivacaine|bupivacaine|mesh-list
25719624|NCT02453360|Anesthetics, Local|anesthetics, local|mesh-ancestor
25719625|NCT02453360|Anesthetics|anesthetics|mesh-ancestor
25719626|NCT02453360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25719627|NCT02453360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719628|NCT02453360|Sensory System Agents|sensory system agents|mesh-ancestor
25719629|NCT02453360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719630|NCT02453555|Empagliflozin|empagliflozin|mesh-list
25719631|NCT02453555|Linagliptin|linagliptin|mesh-list
25719632|NCT02453555|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25719633|NCT02453555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719634|NCT02453555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25719635|NCT02453555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719636|NCT02453555|Incretins|incretins|mesh-ancestor
25719637|NCT02453555|Hormones|hormones|mesh-ancestor
25719638|NCT02453555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25719639|NCT02453555|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25719640|NCT02453555|Protease Inhibitors|protease inhibitors|mesh-ancestor
25719641|NCT02453555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24450923|NCT00320983|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25719642|NCT02453581|Artefenomel|artefenomel|mesh-list
25719643|NCT02453581|Antimalarials|antimalarials|mesh-ancestor
25719644|NCT02453581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25719645|NCT02453581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25719646|NCT02453581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25719647|NCT02453672|Bevacizumab|bevacizumab|mesh-list
25719648|NCT02453672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25719649|NCT02453672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719650|NCT02453672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25719651|NCT02453672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25719652|NCT02453672|Growth Substances|growth substances|mesh-ancestor
25719653|NCT02453672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450952|NCT00321113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24450953|NCT00321126|Zinc|zinc|mesh-list
24450954|NCT00321126|Trace Elements|trace elements|mesh-ancestor
24450957|NCT00321165|Taurolidine|taurolidine|mesh-list
25719654|NCT02453672|Growth Inhibitors|growth inhibitors|mesh-ancestor
25719655|NCT02453685|Insulin|insulin|mesh-list
25719656|NCT02453685|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25719657|NCT02453685|Insulin Glargine|insulin glargine|mesh-list
25719658|NCT02453685|Insulin Aspart|insulin aspart|mesh-list
25719659|NCT02453685|Insulin, Long-Acting|insulin, long-acting|mesh-list
25719660|NCT02453685|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25719661|NCT02453685|Biphasic Insulins|biphasic insulins|mesh-list
25719662|NCT02453685|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
25719663|NCT02453685|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25719664|NCT02453685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719665|NCT02453711|Liraglutide|liraglutide|mesh-list
25719666|NCT02453711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25719667|NCT02453711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719668|NCT02453711|Incretins|incretins|mesh-ancestor
25719669|NCT02453711|Hormones|hormones|mesh-ancestor
25719670|NCT02453711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25719671|NCT02453750|Bronchodilator Agents|bronchodilator agents|mesh-list
25719672|NCT02453750|Autonomic Agents|autonomic agents|mesh-ancestor
25719673|NCT02453750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719674|NCT02453750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719675|NCT02453750|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25719676|NCT02453750|Respiratory System Agents|respiratory system agents|mesh-ancestor
25719677|NCT02453841|Phenylephrine|phenylephrine|mesh-list
25719678|NCT02453841|Oxymetazoline|oxymetazoline|mesh-list
25719679|NCT02453841|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25719680|NCT02453841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25719681|NCT02453841|Adrenergic Agents|adrenergic agents|mesh-ancestor
25719682|NCT02453841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25719683|NCT02453841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24630924|NCT01115062|Lidocaine|lidocaine|mesh-list
25719684|NCT02453841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719685|NCT02453841|Sympathomimetics|sympathomimetics|mesh-ancestor
25719686|NCT02453841|Autonomic Agents|autonomic agents|mesh-ancestor
25719687|NCT02453841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719688|NCT02453841|Nasal Decongestants|nasal decongestants|mesh-ancestor
25719689|NCT02453841|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25719690|NCT02453841|Respiratory System Agents|respiratory system agents|mesh-ancestor
25719691|NCT02453841|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25719692|NCT02453841|Mydriatics|mydriatics|mesh-ancestor
25719693|NCT02453841|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25719694|NCT02453841|Protective Agents|protective agents|mesh-ancestor
25719695|NCT02454179|Pembrolizumab|pembrolizumab|mesh-list
25719696|NCT02454179|Acalabrutinib|acalabrutinib|mesh-list
25719697|NCT02454179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25719698|NCT02454179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719699|NCT02454283|Vanoxerine|vanoxerine|mesh-list
25719700|NCT02454283|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25719701|NCT02454283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25719702|NCT02454283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25719703|NCT02454283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719704|NCT02454283|Dopamine Agents|dopamine agents|mesh-ancestor
25719705|NCT02454283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25719706|NCT02454283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719707|NCT02454296|Lidocaine|lidocaine|mesh-list
25719708|NCT02454296|Anesthetics, Local|anesthetics, local|mesh-ancestor
25719709|NCT02454296|Anesthetics|anesthetics|mesh-ancestor
25719710|NCT02454296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25719711|NCT02454296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719712|NCT02454296|Sensory System Agents|sensory system agents|mesh-ancestor
25719713|NCT02454296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719715|NCT02454296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25719716|NCT02454296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25719717|NCT02454296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25719718|NCT02454296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719719|NCT02454478|Everolimus|everolimus|mesh-list
25719720|NCT02454478|Lenvatinib|lenvatinib|mesh-list
25719721|NCT02454478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719722|NCT02454478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25719723|NCT02454478|Immunologic Factors|immunologic factors|mesh-ancestor
25719724|NCT02454478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719725|NCT02454478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25719726|NCT02454478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25719727|NCT02454478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719728|NCT02454608|Verapamil|verapamil|mesh-list
25719729|NCT02454608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24450982|NCT00321230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24450983|NCT00321230|Protective Agents|protective agents|mesh-ancestor
24450984|NCT00321230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24450985|NCT00321230|Vitamins|vitamins|mesh-ancestor
24450995|NCT00321347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24450996|NCT00321347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
24450997|NCT00321347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
24450998|NCT00321347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
24450999|NCT00321347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24451001|NCT00321360|Propofol|propofol|mesh-list
24451027|NCT00321490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
24451028|NCT00321490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451029|NCT00321490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24451031|NCT00321490|Sensory System Agents|sensory system agents|mesh-ancestor
24451032|NCT00321490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719730|NCT02454608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25719731|NCT02454608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25719732|NCT02454608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719733|NCT02454608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25719734|NCT02454608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719735|NCT02454608|Vasodilator Agents|vasodilator agents|mesh-ancestor
25719736|NCT02455050|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25719737|NCT02455050|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25719738|NCT02455050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25719739|NCT02455050|Laxatives|laxatives|mesh-ancestor
24631814|NCT01120327|Amlodipine|amlodipine|mesh-list
25719740|NCT02455050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25719741|NCT02455076|Exenatide|exenatide|mesh-list
25719742|NCT02455076|Insulin, Short-Acting|insulin, short-acting|mesh-list
25719743|NCT02455076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25719744|NCT02455076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719745|NCT02455076|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25719746|NCT02455076|Incretins|incretins|mesh-ancestor
25719747|NCT02455076|Hormones|hormones|mesh-ancestor
25719748|NCT02455076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25719749|NCT02455167|Ribavirin|ribavirin|mesh-list
25719750|NCT02455167|Sofosbuvir|sofosbuvir|mesh-list
25719751|NCT02455167|Antimetabolites|antimetabolites|mesh-ancestor
25719752|NCT02455167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719753|NCT02455167|Antiviral Agents|antiviral agents|mesh-ancestor
25719754|NCT02455167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25719755|NCT02455336|Fenofibrate|fenofibrate|mesh-list
25719756|NCT02455336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25719757|NCT02455336|Antimetabolites|antimetabolites|mesh-ancestor
25719758|NCT02455336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719759|NCT02455336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25719760|NCT02455453|Estradiol|estradiol|mesh-list
25719761|NCT02455453|Estrogens|estrogens|mesh-ancestor
25719762|NCT02455453|Hormones|hormones|mesh-ancestor
25719763|NCT02455453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25719764|NCT02455453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719766|NCT02455518|Ibuprofen|ibuprofen|mesh-list
25719767|NCT02455518|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25719768|NCT02455518|Oxycodone|oxycodone|mesh-list
25719769|NCT02455518|Hydrocodone|hydrocodone|mesh-list
25719770|NCT02455518|Codeine|codeine|mesh-list
25719771|NCT02455518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25719772|NCT02455518|Analgesics|analgesics|mesh-ancestor
25719773|NCT02455518|Sensory System Agents|sensory system agents|mesh-ancestor
25719774|NCT02455518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719775|NCT02455518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719776|NCT02455518|Antipyretics|antipyretics|mesh-ancestor
25719777|NCT02455518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25719778|NCT02455518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25719779|NCT02455518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25719780|NCT02455518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25719781|NCT02455518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25719782|NCT02455518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719783|NCT02455518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25719784|NCT02455518|Narcotics|narcotics|mesh-ancestor
25719785|NCT02455518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25719786|NCT02455518|Antitussive Agents|antitussive agents|mesh-ancestor
25719787|NCT02455518|Respiratory System Agents|respiratory system agents|mesh-ancestor
25719788|NCT02456662|Ondansetron|ondansetron|mesh-list
25719789|NCT02456662|Antiemetics|antiemetics|mesh-ancestor
25719790|NCT02456662|Autonomic Agents|autonomic agents|mesh-ancestor
25719791|NCT02456662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719792|NCT02456662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719793|NCT02456662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25719794|NCT02456662|Antipruritics|antipruritics|mesh-ancestor
25719795|NCT02456662|Dermatologic Agents|dermatologic agents|mesh-ancestor
25719796|NCT02456662|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25719797|NCT02456662|Serotonin Agents|serotonin agents|mesh-ancestor
25719798|NCT02456662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25719799|NCT02456662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719801|NCT02456662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25719802|NCT02456662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25719803|NCT02456662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25719804|NCT02456662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25719805|NCT02456896|Oxcarbazepine|oxcarbazepine|mesh-list
25719806|NCT02456896|Anticonvulsants|anticonvulsants|mesh-ancestor
25719807|NCT02456896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25719808|NCT02456896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25719809|NCT02456896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25719810|NCT02456896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719811|NCT02456896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25719812|NCT02456896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25719813|NCT02456909|Morphine|morphine|mesh-list
25719814|NCT02456909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25719815|NCT02456909|Narcotics|narcotics|mesh-ancestor
25719816|NCT02456909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24451036|NCT00321516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
24451037|NCT00321516|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
24451038|NCT00321516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24451039|NCT00321516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24451040|NCT00321516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719817|NCT02456909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719818|NCT02456909|Analgesics|analgesics|mesh-ancestor
25719819|NCT02456909|Sensory System Agents|sensory system agents|mesh-ancestor
25719820|NCT02456909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719821|NCT02457195|Granisetron|granisetron|mesh-list
25719822|NCT02457195|Antiemetics|antiemetics|mesh-ancestor
25719823|NCT02457195|Autonomic Agents|autonomic agents|mesh-ancestor
25719824|NCT02457195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719825|NCT02457195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719826|NCT02457195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25719827|NCT02457195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25719828|NCT02457195|Serotonin Agents|serotonin agents|mesh-ancestor
25719829|NCT02457195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25719830|NCT02457195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719831|NCT02457247|Calcium Carbonate|calcium carbonate|mesh-list
25719832|NCT02457247|Antacids|antacids|mesh-ancestor
25719833|NCT02457247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719834|NCT02457247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25719835|NCT02457325|Carticaine|carticaine|mesh-list
25719836|NCT02457325|Anesthetics, Local|anesthetics, local|mesh-ancestor
25719837|NCT02457325|Anesthetics|anesthetics|mesh-ancestor
25719838|NCT02457325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25719839|NCT02457325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719840|NCT02457325|Sensory System Agents|sensory system agents|mesh-ancestor
25719841|NCT02457325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719843|NCT02457520|Dermatologic Agents|dermatologic agents|mesh-ancestor
25719844|NCT02457546|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25719845|NCT02457546|Hemostatics|hemostatics|mesh-ancestor
25719846|NCT02457546|Coagulants|coagulants|mesh-ancestor
25719847|NCT02457611|Sofosbuvir|sofosbuvir|mesh-list
25719848|NCT02457611|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25719849|NCT02457611|Ledipasvir|ledipasvir|mesh-list
25719850|NCT02457611|Antiviral Agents|antiviral agents|mesh-ancestor
25719851|NCT02457611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25719852|NCT02457793|Ravoxertinib|ravoxertinib|mesh-list
25719853|NCT02457793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719854|NCT02457793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25719855|NCT02457793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451071|NCT00321750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
24451072|NCT00321750|Analgesics|analgesics|mesh-ancestor
24451073|NCT00321750|Sensory System Agents|sensory system agents|mesh-ancestor
24451074|NCT00321750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24451075|NCT00321750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451076|NCT00321750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
24451077|NCT00321750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
24451078|NCT00321750|Dermatologic Agents|dermatologic agents|mesh-ancestor
24451079|NCT00321750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24451080|NCT00321750|Immunologic Factors|immunologic factors|mesh-ancestor
24451081|NCT00321750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
24451082|NCT00321750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451083|NCT00321750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451115|NCT00322062|Vitamins|vitamins|mesh-ancestor
25719856|NCT02457793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719857|NCT02458235|Azacitidine|azacitidine|mesh-list
25719858|NCT02458235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25719859|NCT02458235|Antimetabolites|antimetabolites|mesh-ancestor
25719860|NCT02458235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719861|NCT02458235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719862|NCT02458235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25719863|NCT02458287|Bococizumab|bococizumab|mesh-list
25719864|NCT02458287|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25719865|NCT02458287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25719866|NCT02458287|Antimetabolites|antimetabolites|mesh-ancestor
25719867|NCT02458287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719868|NCT02458287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25719869|NCT02458469|Buspirone|buspirone|mesh-list
25719870|NCT02458469|Trazodone|trazodone|mesh-list
25719871|NCT02458469|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25719872|NCT02458469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25719873|NCT02458469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25719874|NCT02458469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719875|NCT02458469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25719876|NCT02458469|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25719877|NCT02458469|Serotonin Agents|serotonin agents|mesh-ancestor
25719878|NCT02458469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25719879|NCT02458469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719880|NCT02458469|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25719881|NCT02458469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25719882|NCT02458469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25719883|NCT02458469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25719884|NCT02458469|Antidepressive Agents|antidepressive agents|mesh-ancestor
25719885|NCT02458638|Atezolizumab|atezolizumab|mesh-list
25719886|NCT02458638|Antibodies|antibodies|mesh-list
25719887|NCT02458638|Immunologic Factors|immunologic factors|mesh-ancestor
25719888|NCT02458638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719889|NCT02458638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719891|NCT02458690|Norepinephrine|norepinephrine|mesh-list
25719892|NCT02458690|Antidepressive Agents|antidepressive agents|mesh-list
25719893|NCT02458690|Serotonin|serotonin|mesh-list
25719894|NCT02458690|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25719895|NCT02458690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-list
25719896|NCT02458690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25719897|NCT02458690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25719898|NCT02458690|Adrenergic Agents|adrenergic agents|mesh-ancestor
25719899|NCT02458690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25719900|NCT02458690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719901|NCT02458690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719902|NCT02458690|Sympathomimetics|sympathomimetics|mesh-ancestor
25719903|NCT02458690|Autonomic Agents|autonomic agents|mesh-ancestor
25719904|NCT02458690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719905|NCT02458690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25719906|NCT02458690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25719907|NCT02458690|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25719908|NCT02458690|Dopamine Agents|dopamine agents|mesh-ancestor
25719909|NCT02458690|Protective Agents|protective agents|mesh-ancestor
25719910|NCT02458690|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25719911|NCT02458690|Serotonin Agents|serotonin agents|mesh-ancestor
25719912|NCT02458690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25719913|NCT02458690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25719914|NCT02458768|Menotropins|menotropins|mesh-list
25719915|NCT02458768|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25719916|NCT02458768|Fertility Agents|fertility agents|mesh-ancestor
25719917|NCT02458768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25719918|NCT02458768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719919|NCT02459275|Metoclopramide|metoclopramide|mesh-list
25719920|NCT02459275|Antiemetics|antiemetics|mesh-ancestor
25719921|NCT02459275|Autonomic Agents|autonomic agents|mesh-ancestor
25719922|NCT02459275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719923|NCT02459275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719924|NCT02459275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25719925|NCT02459275|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25719926|NCT02459275|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25719927|NCT02459275|Dopamine Agents|dopamine agents|mesh-ancestor
25719928|NCT02459275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25719929|NCT02459275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719930|NCT02459418|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25719931|NCT02459418|Hormones|hormones|mesh-ancestor
24395298|NCT00135681|Hormones|hormones|mesh-ancestor
25719932|NCT02459418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25719933|NCT02459418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719934|NCT02459665|Metronidazole|metronidazole|mesh-list
25719935|NCT02459665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25719936|NCT02459665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25719937|NCT02459665|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25719938|NCT02459665|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25719939|NCT02459899|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25719940|NCT02459899|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25719941|NCT02459899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719942|NCT02459899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25719943|NCT02459899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719944|NCT02459964|Fentanyl|fentanyl|mesh-list
25719945|NCT02459964|Hydromorphone|hydromorphone|mesh-list
25719946|NCT02459964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25719947|NCT02459964|Narcotics|narcotics|mesh-ancestor
25719948|NCT02459964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25719949|NCT02459964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719950|NCT02459964|Analgesics|analgesics|mesh-ancestor
25719951|NCT02459964|Sensory System Agents|sensory system agents|mesh-ancestor
25719952|NCT02459964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25719953|NCT02459964|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25719954|NCT02459964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25719955|NCT02459964|Anesthetics, General|anesthetics, general|mesh-ancestor
25719956|NCT02459964|Anesthetics|anesthetics|mesh-ancestor
25719957|NCT02460380|Vitamin D|vitamin d|mesh-list
25719958|NCT02460380|Cholecalciferol|cholecalciferol|mesh-list
25719959|NCT02460380|Vitamins|vitamins|mesh-ancestor
25719960|NCT02460380|Micronutrients|micronutrients|mesh-ancestor
25719961|NCT02460380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719962|NCT02460380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25719963|NCT02460380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25719964|NCT02460978|Dapagliflozin|dapagliflozin|mesh-list
24451218|NCT00322660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451219|NCT00322660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24451220|NCT00322660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25719965|NCT02460978|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25719966|NCT02460978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719967|NCT02460978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25719968|NCT02460978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719969|NCT02460991|Sorafenib|sorafenib|mesh-list
25719970|NCT02460991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719971|NCT02460991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25719972|NCT02460991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25719973|NCT02460991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719974|NCT02461134|Ponesimod|ponesimod|mesh-list
25719975|NCT02461134|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25719976|NCT02461134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719977|NCT02461134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25719978|NCT02461134|Immunologic Factors|immunologic factors|mesh-ancestor
25719979|NCT02461134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719980|NCT02461160|Midazolam|midazolam|mesh-list
25719981|NCT02461160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25719982|NCT02461160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25719983|NCT02461160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25719984|NCT02461160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25719985|NCT02461160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25719986|NCT02461160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25719987|NCT02461160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25719988|NCT02461160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25719989|NCT02461160|Anesthetics, General|anesthetics, general|mesh-ancestor
25719991|NCT02461160|GABA Modulators|gaba modulators|mesh-ancestor
25719992|NCT02461160|GABA Agents|gaba agents|mesh-ancestor
25719993|NCT02461160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25719994|NCT02461160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25719995|NCT02461290|Rituximab|rituximab|mesh-list
25719996|NCT02461290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25719997|NCT02461290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25719998|NCT02461290|Immunologic Factors|immunologic factors|mesh-ancestor
25719999|NCT02461290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720000|NCT02461290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25720001|NCT02461589|Liraglutide|liraglutide|mesh-list
25720002|NCT02461589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25720003|NCT02461589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720004|NCT02461589|Incretins|incretins|mesh-ancestor
25771574|NCT03620890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771575|NCT03620890|Coagulants|coagulants|mesh-ancestor
25720005|NCT02461589|Hormones|hormones|mesh-ancestor
25720006|NCT02461589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25771576|NCT03621085|Ketamine|ketamine|mesh-list
25771577|NCT03621085|Analgesics|analgesics|mesh-ancestor
25771578|NCT03621085|Sensory System Agents|sensory system agents|mesh-ancestor
25771579|NCT03621085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771580|NCT03621085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771581|NCT03621085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25771582|NCT03621085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25771583|NCT03621085|Anesthetics, General|anesthetics, general|mesh-ancestor
25771584|NCT03621085|Anesthetics|anesthetics|mesh-ancestor
25771585|NCT03621085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25771586|NCT03621085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25771587|NCT03621085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25771588|NCT03621085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25771589|NCT03621085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771590|NCT03622619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25771591|NCT03622619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25771592|NCT03622619|Lubricant Eye Drops|lubricant eye drops|mesh-list
25771593|NCT03622619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25771594|NCT03622619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25771595|NCT03624946|Immunoglobulins|immunoglobulins|mesh-list
25771596|NCT03624946|Antibodies|antibodies|mesh-list
25771597|NCT03624946|gamma-Globulins|gamma-globulins|mesh-list
25771598|NCT03624946|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25771599|NCT03624946|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25771600|NCT03624946|Immunoglobulin G|immunoglobulin g|mesh-list
25771601|NCT03624946|Immunologic Factors|immunologic factors|mesh-ancestor
25771602|NCT03624946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771603|NCT03626415|Abrocitinib|abrocitinib|mesh-list
25771604|NCT03626415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25771605|NCT03626415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771606|NCT03626415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771607|NCT03626714|Tacrolimus|tacrolimus|mesh-list
25771608|NCT03626714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25771609|NCT03626714|Immunologic Factors|immunologic factors|mesh-ancestor
25771610|NCT03626714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771611|NCT03626714|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25771612|NCT03626714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771613|NCT03626714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777308|NCT03701295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777309|NCT03701295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25777310|NCT03701295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777311|NCT03694821|Methylprednisolone|methylprednisolone|mesh-list
25777312|NCT03694821|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25720007|NCT02461693|Caffeine|caffeine|mesh-list
25720008|NCT02461693|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25720009|NCT02461693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720010|NCT02461693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25720011|NCT02461693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720012|NCT02461693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720013|NCT02461693|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25720014|NCT02461693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25720015|NCT02461693|Purinergic Agents|purinergic agents|mesh-ancestor
25720016|NCT02461693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25720017|NCT02461745|Ribavirin|ribavirin|mesh-list
25720018|NCT02461745|Ritonavir|ritonavir|mesh-list
25720019|NCT02461745|Antimetabolites|antimetabolites|mesh-ancestor
25720020|NCT02461745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720021|NCT02461745|Antiviral Agents|antiviral agents|mesh-ancestor
25720022|NCT02461745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25720023|NCT02461745|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25720024|NCT02461745|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25720025|NCT02461745|Protease Inhibitors|protease inhibitors|mesh-ancestor
25720026|NCT02461745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720027|NCT02461745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25720028|NCT02461745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25720029|NCT02461745|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25720030|NCT02461745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25720032|NCT02461758|Immunologic Factors|immunologic factors|mesh-ancestor
25720033|NCT02461758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720034|NCT02462148|Dexamethasone|dexamethasone|mesh-list
25720035|NCT02462148|Dexamethasone acetate|dexamethasone acetate|mesh-list
25720036|NCT02462148|Epinephrine|epinephrine|mesh-list
25720037|NCT02462148|Bupivacaine|bupivacaine|mesh-list
25720039|NCT02462148|BB 1101|bb 1101|mesh-list
25720040|NCT02462148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25720041|NCT02462148|Antiemetics|antiemetics|mesh-ancestor
25720042|NCT02462148|Autonomic Agents|autonomic agents|mesh-ancestor
25720043|NCT02462148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25720044|NCT02462148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720045|NCT02462148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25720046|NCT02462148|Glucocorticoids|glucocorticoids|mesh-ancestor
25720047|NCT02462148|Hormones|hormones|mesh-ancestor
25720048|NCT02462148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25720049|NCT02462148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25720050|NCT02462148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25720051|NCT02462148|Protease Inhibitors|protease inhibitors|mesh-ancestor
25720052|NCT02462148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720053|NCT02462148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720054|NCT02462148|Anesthetics, Local|anesthetics, local|mesh-ancestor
25720055|NCT02462148|Anesthetics|anesthetics|mesh-ancestor
25720056|NCT02462148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25720057|NCT02462148|Sensory System Agents|sensory system agents|mesh-ancestor
25720058|NCT02462148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25720059|NCT02462148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25720060|NCT02462148|Adrenergic Agents|adrenergic agents|mesh-ancestor
25720061|NCT02462148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25720062|NCT02462148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25720063|NCT02462148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25720064|NCT02462148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25720065|NCT02462148|Respiratory System Agents|respiratory system agents|mesh-ancestor
25720066|NCT02462148|Mydriatics|mydriatics|mesh-ancestor
25720067|NCT02462148|Sympathomimetics|sympathomimetics|mesh-ancestor
25720068|NCT02462148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25720069|NCT02462382|Ropivacaine|ropivacaine|mesh-list
25720070|NCT02462382|Anesthetics, Local|anesthetics, local|mesh-ancestor
25720071|NCT02462382|Anesthetics|anesthetics|mesh-ancestor
24451300|NCT00323011|Immunologic Factors|immunologic factors|mesh-ancestor
24451301|NCT00323011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
24451328|NCT00323206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
24451329|NCT00323206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
24451330|NCT00323206|Growth Substances|growth substances|mesh-ancestor
24451331|NCT00323206|Growth Inhibitors|growth inhibitors|mesh-ancestor
24451332|NCT00323206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451333|NCT00323219|Moxifloxacin|moxifloxacin|mesh-list
24451334|NCT00323219|Cefazolin|cefazolin|mesh-list
25720072|NCT02462382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25720073|NCT02462382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720074|NCT02462382|Sensory System Agents|sensory system agents|mesh-ancestor
25720075|NCT02462382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25720076|NCT02462473|Olanzapine|olanzapine|mesh-list
25720077|NCT02462473|Risperidone|risperidone|mesh-list
25720078|NCT02462473|Aripiprazole|aripiprazole|mesh-list
25720079|NCT02462473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25720080|NCT02462473|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25720081|NCT02462473|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25720082|NCT02462473|Serotonin Agents|serotonin agents|mesh-ancestor
25720083|NCT02462473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25720084|NCT02462473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720085|NCT02462473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720086|NCT02462473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25720087|NCT02462473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25720088|NCT02462473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25720089|NCT02462473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25720090|NCT02462473|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25720092|NCT02462473|Antiemetics|antiemetics|mesh-ancestor
25720093|NCT02462473|Autonomic Agents|autonomic agents|mesh-ancestor
25720094|NCT02462473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25720095|NCT02462473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25720096|NCT02462473|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25720097|NCT02462473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25720098|NCT02462473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25720099|NCT02462473|Antidepressive Agents|antidepressive agents|mesh-ancestor
25720100|NCT02462473|Dopamine Agonists|dopamine agonists|mesh-ancestor
25720101|NCT02462473|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25720102|NCT02462473|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25720103|NCT02462473|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25720104|NCT02462473|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25720105|NCT02462486|Ranibizumab|ranibizumab|mesh-list
25720106|NCT02462486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25720107|NCT02462486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25720108|NCT02462486|Growth Substances|growth substances|mesh-ancestor
25720109|NCT02462486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720110|NCT02462486|Growth Inhibitors|growth inhibitors|mesh-ancestor
25720111|NCT02462486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25720112|NCT02462720|Polidocanol|polidocanol|mesh-list
25720113|NCT02462720|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25720114|NCT02462720|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25720115|NCT02462928|Ranibizumab|ranibizumab|mesh-list
25720116|NCT02462928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25720117|NCT02462928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25720118|NCT02462928|Growth Substances|growth substances|mesh-ancestor
25720119|NCT02462928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720120|NCT02462928|Growth Inhibitors|growth inhibitors|mesh-ancestor
25720121|NCT02462928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25720123|NCT02463097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25720124|NCT02463097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720125|NCT02463331|Chloroquine|chloroquine|mesh-list
25720126|NCT02463331|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
25720128|NCT02463331|Azathioprine|azathioprine|mesh-list
25720129|NCT02463331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25720130|NCT02463331|Glucocorticoids|glucocorticoids|mesh-ancestor
25720131|NCT02463331|Hormones|hormones|mesh-ancestor
25720132|NCT02463331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25720133|NCT02463331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720134|NCT02463331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
24451379|NCT00323505|Interferon alpha-2|interferon alpha-2|mesh-list
24451380|NCT00323505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24451381|NCT00323505|Antiviral Agents|antiviral agents|mesh-ancestor
24451382|NCT00323505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25720135|NCT02463331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25720136|NCT02463331|Amebicides|amebicides|mesh-ancestor
25720137|NCT02463331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25720138|NCT02463331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25720139|NCT02463331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
24451384|NCT00323505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451386|NCT00323544|Lamivudine|lamivudine|mesh-list
24451387|NCT00323544|Zidovudine|zidovudine|mesh-list
24451388|NCT00323544|Emtricitabine|emtricitabine|mesh-list
24451389|NCT00323544|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
24451393|NCT00323544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
24451394|NCT00323544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24451395|NCT00323544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720140|NCT02463331|Antimalarials|antimalarials|mesh-ancestor
25720141|NCT02463331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25720142|NCT02463331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25720143|NCT02463331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25720144|NCT02463331|Analgesics|analgesics|mesh-ancestor
25720145|NCT02463331|Sensory System Agents|sensory system agents|mesh-ancestor
25720146|NCT02463331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25720147|NCT02463331|Filaricides|filaricides|mesh-ancestor
25720148|NCT02463331|Antinematodal Agents|antinematodal agents|mesh-ancestor
25720149|NCT02463331|Anthelmintics|anthelmintics|mesh-ancestor
25720151|NCT02463331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451470|NCT00323843|Isoproterenol|isoproterenol|mesh-list
24451471|NCT00323843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
24451472|NCT00323843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
24451473|NCT00323843|Adrenergic Agents|adrenergic agents|mesh-ancestor
24451474|NCT00323843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24451475|NCT00323843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
24451476|NCT00323843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24451477|NCT00323843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
24451478|NCT00323843|Autonomic Agents|autonomic agents|mesh-ancestor
25720152|NCT02463331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25720153|NCT02463331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25720154|NCT02463331|Immunologic Factors|immunologic factors|mesh-ancestor
25720155|NCT02463357|Metformin|metformin|mesh-list
25720156|NCT02463357|Nifedipine|nifedipine|mesh-list
25720157|NCT02463357|Methazolamide|methazolamide|mesh-list
25720158|NCT02463357|Quercetin|quercetin|mesh-list
24451479|NCT00323843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
24451480|NCT00323843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25720159|NCT02463357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25720160|NCT02463357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720161|NCT02463357|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25720162|NCT02463357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25720163|NCT02463357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720164|NCT02463357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25720165|NCT02463357|Vasodilator Agents|vasodilator agents|mesh-ancestor
25720166|NCT02463357|Tocolytic Agents|tocolytic agents|mesh-ancestor
25720167|NCT02463357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25720168|NCT02463357|Antioxidants|antioxidants|mesh-ancestor
25720169|NCT02463357|Protective Agents|protective agents|mesh-ancestor
25720170|NCT02463357|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25720171|NCT02463357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720172|NCT02463357|Diuretics|diuretics|mesh-ancestor
25720173|NCT02463357|Natriuretic Agents|natriuretic agents|mesh-ancestor
25720174|NCT02463409|Theophylline|theophylline|mesh-list
25720175|NCT02463409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25720176|NCT02463409|Autonomic Agents|autonomic agents|mesh-ancestor
25720177|NCT02463409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25720178|NCT02463409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720179|NCT02463409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25720240|NCT02464176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25720241|NCT02464176|Sensory System Agents|sensory system agents|mesh-ancestor
25720242|NCT02464176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25720243|NCT02464176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25720244|NCT02464176|Adrenergic Agents|adrenergic agents|mesh-ancestor
25720245|NCT02464176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25720246|NCT02464176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25720247|NCT02464176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25720248|NCT02464176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25720249|NCT02464176|Respiratory System Agents|respiratory system agents|mesh-ancestor
25720250|NCT02464176|Mydriatics|mydriatics|mesh-ancestor
25720267|NCT02464657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25720298|NCT02465489|Deferiprone|deferiprone|mesh-list
25720299|NCT02465489|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25720323|NCT02465632|Dermatologic Agents|dermatologic agents|mesh-ancestor
25720324|NCT02465866|Promethazine|promethazine|mesh-list
25720325|NCT02465866|Antipruritics|antipruritics|mesh-ancestor
25720326|NCT02465866|Dermatologic Agents|dermatologic agents|mesh-ancestor
25720327|NCT02465866|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25720328|NCT02465866|Histamine Antagonists|histamine antagonists|mesh-ancestor
25720329|NCT02465866|Histamine Agents|histamine agents|mesh-ancestor
25720330|NCT02465866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25720331|NCT02465866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720332|NCT02465866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720333|NCT02465866|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25720334|NCT02466386|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25720335|NCT02466386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25720336|NCT02466386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720337|NCT02466386|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25720338|NCT02466386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25720339|NCT02466386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25720340|NCT02466386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720341|NCT02466386|Dopamine Agents|dopamine agents|mesh-ancestor
25720342|NCT02466386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25720343|NCT02466399|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25720344|NCT02466399|Latanoprost|latanoprost|mesh-list
25720345|NCT02466399|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25720346|NCT02466958|Milnacipran|milnacipran|mesh-list
25720347|NCT02466958|Levomilnacipran|levomilnacipran|mesh-list
25720348|NCT02466958|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25720349|NCT02466958|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25720350|NCT02466958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25720351|NCT02466958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720352|NCT02466958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25720353|NCT02466958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720354|NCT02466958|Antidepressive Agents|antidepressive agents|mesh-ancestor
25720355|NCT02466958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25720356|NCT02466958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25720357|NCT02466958|Analgesics|analgesics|mesh-ancestor
25720358|NCT02466958|Sensory System Agents|sensory system agents|mesh-ancestor
25720359|NCT02466958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25720360|NCT02467504|Folic Acid|folic acid|mesh-list
25720361|NCT02467504|Loxoprofen|loxoprofen|mesh-list
25720362|NCT02467504|Hematinics|hematinics|mesh-ancestor
25720364|NCT02467504|Vitamins|vitamins|mesh-ancestor
25720365|NCT02467504|Micronutrients|micronutrients|mesh-ancestor
25720366|NCT02467504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720367|NCT02467504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25720368|NCT02467504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25720369|NCT02467504|Analgesics|analgesics|mesh-ancestor
25720370|NCT02467504|Sensory System Agents|sensory system agents|mesh-ancestor
25720371|NCT02467504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25720372|NCT02467504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25720374|NCT02467621|Pantoprazole|pantoprazole|mesh-list
25720375|NCT02467621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25720376|NCT02467621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25720377|NCT02467621|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25720378|NCT02467621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720379|NCT02467621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720380|NCT02468557|Paclitaxel|paclitaxel|mesh-list
25720381|NCT02468557|Idelalisib|idelalisib|mesh-list
25720382|NCT02468557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25720383|NCT02468557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25720384|NCT02468557|Tubulin Modulators|tubulin modulators|mesh-ancestor
25720385|NCT02468557|Antimitotic Agents|antimitotic agents|mesh-ancestor
25720386|NCT02468557|Mitosis Modulators|mitosis modulators|mesh-ancestor
25720387|NCT02468557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720388|NCT02468557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720389|NCT02468648|Sofosbuvir|sofosbuvir|mesh-list
25720390|NCT02468648|Velpatasvir|velpatasvir|mesh-list
25720391|NCT02468648|Antiviral Agents|antiviral agents|mesh-ancestor
25720392|NCT02468648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25720393|NCT02468700|Dexamethasone|dexamethasone|mesh-list
25720394|NCT02468700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25720395|NCT02468700|Antiemetics|antiemetics|mesh-ancestor
25720396|NCT02468700|Autonomic Agents|autonomic agents|mesh-ancestor
25720397|NCT02468700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25720398|NCT02468700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720399|NCT02468700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25720400|NCT02468700|Glucocorticoids|glucocorticoids|mesh-ancestor
25720401|NCT02468700|Hormones|hormones|mesh-ancestor
25720402|NCT02468700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25720403|NCT02468700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25720404|NCT02468700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25720405|NCT02468830|Mirabegron|mirabegron|mesh-list
25720406|NCT02468830|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25720407|NCT02468830|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25720408|NCT02468830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25720409|NCT02468830|Adrenergic Agents|adrenergic agents|mesh-ancestor
25720410|NCT02468830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25720411|NCT02468830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720412|NCT02468830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720413|NCT02468830|Urological Agents|urological agents|mesh-ancestor
25720414|NCT02469077|Morphine|morphine|mesh-list
25720415|NCT02469077|Naloxone|naloxone|mesh-list
25720416|NCT02469077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25720417|NCT02469077|Narcotics|narcotics|mesh-ancestor
25720418|NCT02469077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25720419|NCT02469077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720421|NCT02469077|Sensory System Agents|sensory system agents|mesh-ancestor
25720422|NCT02469077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25720423|NCT02469077|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25720424|NCT02469090|Apomorphine|apomorphine|mesh-list
25720425|NCT02469090|Emetics|emetics|mesh-ancestor
25720426|NCT02469090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720427|NCT02469090|Autonomic Agents|autonomic agents|mesh-ancestor
25720428|NCT02469090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25720429|NCT02469090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25720430|NCT02469090|Dopamine Agonists|dopamine agonists|mesh-ancestor
25720431|NCT02469090|Dopamine Agents|dopamine agents|mesh-ancestor
25720432|NCT02469090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25720433|NCT02469090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720434|NCT02469116|Carboplatin|carboplatin|mesh-list
25720435|NCT02469116|Docetaxel|docetaxel|mesh-list
25720436|NCT02469116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25720437|NCT02469116|Tubulin Modulators|tubulin modulators|mesh-ancestor
25720438|NCT02469116|Antimitotic Agents|antimitotic agents|mesh-ancestor
25720439|NCT02469116|Mitosis Modulators|mitosis modulators|mesh-ancestor
25720440|NCT02469116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720441|NCT02469246|Lamivudine|lamivudine|mesh-list
25720442|NCT02469246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25720443|NCT02469246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25720444|NCT02469246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720445|NCT02469246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720446|NCT02469246|Antiviral Agents|antiviral agents|mesh-ancestor
25720447|NCT02469246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25720448|NCT02469246|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25720449|NCT02469246|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25720450|NCT02469298|Oseltamivir|oseltamivir|mesh-list
25720451|NCT02469298|Antiviral Agents|antiviral agents|mesh-ancestor
25720452|NCT02469298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25720453|NCT02469298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720454|NCT02469298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720455|NCT02469597|Furosemide|furosemide|mesh-list
25720456|NCT02469597|Diuretics|diuretics|mesh-ancestor
25720457|NCT02469597|Natriuretic Agents|natriuretic agents|mesh-ancestor
25720458|NCT02469597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720459|NCT02469597|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25720460|NCT02469597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25720461|NCT02469597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720462|NCT02469610|Bupivacaine|bupivacaine|mesh-list
25720463|NCT02469610|Anesthetics, Local|anesthetics, local|mesh-ancestor
25720464|NCT02469610|Anesthetics|anesthetics|mesh-ancestor
25771614|NCT03627195|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25771615|NCT03627195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25771616|NCT03627195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25720465|NCT02469610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25720466|NCT02469610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720467|NCT02469610|Sensory System Agents|sensory system agents|mesh-ancestor
25720468|NCT02469610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25720470|NCT02469701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25720471|NCT02469701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25720472|NCT02469701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25771617|NCT03627195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25771618|NCT03627195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771619|NCT03627195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25771620|NCT03627195|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25771621|NCT03627195|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25771622|NCT03627195|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25771623|NCT03627195|Adrenergic Agents|adrenergic agents|mesh-ancestor
25771624|NCT03627195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25771625|NCT03627195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771626|NCT03627195|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25771627|NCT03627195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25771628|NCT03627195|Serotonin Agents|serotonin agents|mesh-ancestor
25771629|NCT03627195|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25771630|NCT03627195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25771631|NCT03627195|Dopamine Agents|dopamine agents|mesh-ancestor
25771632|NCT03627767|Abrocitinib|abrocitinib|mesh-list
25771633|NCT03627767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25771634|NCT03627767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771635|NCT03627767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771636|NCT03628417|Bleomycin|bleomycin|mesh-list
25771637|NCT03628417|Calcium|calcium|mesh-list
25771638|NCT03628417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25771639|NCT03628417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771640|NCT03628417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25771641|NCT03628417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25771642|NCT03628924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25771643|NCT03628924|Immunologic Factors|immunologic factors|mesh-ancestor
25771644|NCT03628924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771645|NCT03629054|Metformin|metformin|mesh-list
25771646|NCT03629054|Empagliflozin|empagliflozin|mesh-list
25771647|NCT03629054|Linagliptin|linagliptin|mesh-list
25771648|NCT03629054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25771649|NCT03629054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771650|NCT03629054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25771651|NCT03629054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771652|NCT03629054|Incretins|incretins|mesh-ancestor
25771653|NCT03629054|Hormones|hormones|mesh-ancestor
25771654|NCT03629054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25771655|NCT03629054|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25771656|NCT03629054|Protease Inhibitors|protease inhibitors|mesh-ancestor
25771657|NCT03629054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771658|NCT03629184|Oseltamivir|oseltamivir|mesh-list
25771659|NCT03629184|Baloxavir|baloxavir|mesh-list
25771660|NCT03629184|Antiviral Agents|antiviral agents|mesh-ancestor
25771661|NCT03629184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25771662|NCT03629184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771663|NCT03629184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771664|NCT03629249|Indoleacetic Acids|indoleacetic acids|mesh-list
25771665|NCT03629249|Plant Growth Regulators|plant growth regulators|mesh-ancestor
25771666|NCT03629249|Growth Substances|growth substances|mesh-ancestor
25771667|NCT03629249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771668|NCT03629925|Gemcitabine|gemcitabine|mesh-list
25771669|NCT03629925|Cisplatin|cisplatin|mesh-list
25771670|NCT03629925|Carboplatin|carboplatin|mesh-list
25720473|NCT02469701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771671|NCT03629925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25771672|NCT03629925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25771673|NCT03629925|Antimetabolites|antimetabolites|mesh-ancestor
25771674|NCT03629925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771675|NCT03629925|Antiviral Agents|antiviral agents|mesh-ancestor
25771676|NCT03629925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25771677|NCT03629925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771678|NCT03629925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25720474|NCT02469961|Dexmedetomidine|dexmedetomidine|mesh-list
25720475|NCT02469961|Propofol|propofol|mesh-list
25720476|NCT02469961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25720477|NCT02469961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25720478|NCT02469961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720479|NCT02469961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25720480|NCT02469961|Anesthetics, General|anesthetics, general|mesh-ancestor
25720481|NCT02469961|Anesthetics|anesthetics|mesh-ancestor
25720482|NCT02469961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25720483|NCT02469961|Analgesics|analgesics|mesh-ancestor
25720484|NCT02469961|Sensory System Agents|sensory system agents|mesh-ancestor
25720485|NCT02469961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25720486|NCT02469961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25720487|NCT02469961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25720489|NCT02469961|Adrenergic Agents|adrenergic agents|mesh-ancestor
25720490|NCT02469961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25720491|NCT02469961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720492|NCT02470234|Methylphenidate|methylphenidate|mesh-list
25720493|NCT02470234|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25720494|NCT02470234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720495|NCT02470234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25720496|NCT02470234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25720497|NCT02470234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25720498|NCT02470234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720500|NCT02470234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25720501|NCT02470390|Fentanyl|fentanyl|mesh-list
25720502|NCT02470390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25720503|NCT02470390|Narcotics|narcotics|mesh-ancestor
25720504|NCT02470390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25720505|NCT02470390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720506|NCT02470390|Analgesics|analgesics|mesh-ancestor
25720507|NCT02470390|Sensory System Agents|sensory system agents|mesh-ancestor
25771679|NCT03629925|Immunologic Factors|immunologic factors|mesh-ancestor
25771680|NCT03629925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771681|NCT03630198|Lidocaine|lidocaine|mesh-list
25771682|NCT03630198|Anesthetics, Local|anesthetics, local|mesh-ancestor
25771683|NCT03630198|Anesthetics|anesthetics|mesh-ancestor
25771684|NCT03630198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25771685|NCT03630198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771686|NCT03630198|Sensory System Agents|sensory system agents|mesh-ancestor
25720508|NCT02470390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25720509|NCT02470390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25720510|NCT02470390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25720511|NCT02470390|Anesthetics, General|anesthetics, general|mesh-ancestor
25720513|NCT02470403|Licogliflozin|licogliflozin|mesh-list
25720514|NCT02470403|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25720515|NCT02470403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720516|NCT02470403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25720517|NCT02470403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720518|NCT02470429|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25720520|NCT02470429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25720521|NCT02470741|Letrozole|letrozole|mesh-list
25720522|NCT02470741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25720523|NCT02470741|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25720524|NCT02470741|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25720525|NCT02470741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720526|NCT02470741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720527|NCT02470741|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25720528|NCT02470741|Hormone Antagonists|hormone antagonists|mesh-ancestor
25771687|NCT03630198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771688|NCT03630198|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25771689|NCT03630198|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25771690|NCT03630198|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25771691|NCT03630198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25771692|NCT03630198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771693|NCT03631355|Tranexamic Acid|tranexamic acid|mesh-list
25771694|NCT03631355|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25771695|NCT03631355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25771696|NCT03631355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771697|NCT03631355|Hemostatics|hemostatics|mesh-ancestor
25771698|NCT03631355|Coagulants|coagulants|mesh-ancestor
25771699|NCT03631433|Acetaminophen|acetaminophen|mesh-list
25771700|NCT03631433|Ibuprofen|ibuprofen|mesh-list
25771701|NCT03631433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25771702|NCT03631433|Analgesics|analgesics|mesh-ancestor
25771703|NCT03631433|Sensory System Agents|sensory system agents|mesh-ancestor
25771704|NCT03631433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771705|NCT03631433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771706|NCT03631433|Antipyretics|antipyretics|mesh-ancestor
25771707|NCT03631433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25771708|NCT03631433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25771709|NCT03631433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25771710|NCT03631433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25771711|NCT03631433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771712|NCT03631433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771713|NCT03632083|Contact Lens Solutions|contact lens solutions|mesh-list
25771714|NCT03632083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25771715|NCT03632083|Disinfectants|disinfectants|mesh-ancestor
25771716|NCT03632083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25771717|NCT03632109|Gentamicins|gentamicins|mesh-list
25771718|NCT03632109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25771719|NCT03632109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25771720|NCT03632109|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25771721|NCT03632109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771722|NCT03632109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771723|NCT03633331|Letrozole|letrozole|mesh-list
25771724|NCT03633331|Fulvestrant|fulvestrant|mesh-list
25771725|NCT03633331|Palbociclib|palbociclib|mesh-list
25771726|NCT03633331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25771727|NCT03633331|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25771728|NCT03633331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25771729|NCT03633331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771730|NCT03633331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771731|NCT03633331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25771732|NCT03633331|Hormone Antagonists|hormone antagonists|mesh-ancestor
25771733|NCT03633331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25771734|NCT03633331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771735|NCT03633331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25771736|NCT03633331|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25771737|NCT03633331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25771738|NCT03633344|Silicon|silicon|mesh-list
25771739|NCT03633344|Trace Elements|trace elements|mesh-ancestor
25771740|NCT03633344|Micronutrients|micronutrients|mesh-ancestor
25771741|NCT03633344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771742|NCT03633448|Phenylpropanolamine|phenylpropanolamine|mesh-list
25771743|NCT03633448|Guaifenesin|guaifenesin|mesh-list
25777313|NCT03694821|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25720529|NCT02470741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25720530|NCT02470741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720531|NCT02471014|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25720532|NCT02471014|Immunologic Factors|immunologic factors|mesh-ancestor
25720533|NCT02471014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720534|NCT02471183|Selexipag|selexipag|mesh-list
25720535|NCT02471183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25720536|NCT02471404|Dapagliflozin|dapagliflozin|mesh-list
25720537|NCT02471404|Glimepiride|glimepiride|mesh-list
25720538|NCT02471404|Saxagliptin|saxagliptin|mesh-list
25720539|NCT02471404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25777314|NCT03694821|Prednisolone|prednisolone|mesh-list
25777315|NCT03694821|Prednisolone acetate|prednisolone acetate|mesh-list
25777316|NCT03694821|Ketorolac|ketorolac|mesh-list
25777317|NCT03694821|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25777318|NCT03694821|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25777319|NCT03694821|Prednisolone phosphate|prednisolone phosphate|mesh-list
25777320|NCT03694821|Hylan|hylan|mesh-list
25777321|NCT03694821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25777322|NCT03694821|Antiemetics|antiemetics|mesh-ancestor
25777323|NCT03694821|Autonomic Agents|autonomic agents|mesh-ancestor
25777324|NCT03694821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25777325|NCT03694821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777326|NCT03694821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25777327|NCT03694821|Glucocorticoids|glucocorticoids|mesh-ancestor
25777328|NCT03694821|Hormones|hormones|mesh-ancestor
25777329|NCT03694821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25777330|NCT03694821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25777331|NCT03694821|Protective Agents|protective agents|mesh-ancestor
25777332|NCT03694821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25777333|NCT03694821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25777334|NCT03694821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25777335|NCT03694821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25777336|NCT03694821|Analgesics|analgesics|mesh-ancestor
25777337|NCT03694821|Sensory System Agents|sensory system agents|mesh-ancestor
25777338|NCT03694821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25777339|NCT03694821|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25777340|NCT03694821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777341|NCT03694821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777342|NCT03694821|Viscosupplements|viscosupplements|mesh-ancestor
25777343|NCT03682367|Gabapentin|gabapentin|mesh-list
25777344|NCT03682367|Analgesics|analgesics|mesh-ancestor
25777345|NCT03682367|Sensory System Agents|sensory system agents|mesh-ancestor
25777346|NCT03682367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25777347|NCT03682367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777348|NCT03682367|Anticonvulsants|anticonvulsants|mesh-ancestor
25777349|NCT03682367|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25777350|NCT03682367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25777351|NCT03682367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25777352|NCT03682367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25777353|NCT03682367|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25777354|NCT03682367|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25777355|NCT03682367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25777356|NCT03682367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777357|NCT03682367|Antimanic Agents|antimanic agents|mesh-ancestor
25777358|NCT03680911|Acetylcysteine|acetylcysteine|mesh-list
25777359|NCT03680911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25777360|NCT03680911|Antiviral Agents|antiviral agents|mesh-ancestor
25777361|NCT03680911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25720540|NCT02471404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720541|NCT02471404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25720542|NCT02471404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720543|NCT02471404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25720544|NCT02471404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25720545|NCT02471404|Immunologic Factors|immunologic factors|mesh-ancestor
25720546|NCT02471404|Incretins|incretins|mesh-ancestor
25720547|NCT02471404|Hormones|hormones|mesh-ancestor
25771744|NCT03633448|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
25771745|NCT03633448|Expectorants|expectorants|mesh-ancestor
25771746|NCT03633448|Respiratory System Agents|respiratory system agents|mesh-ancestor
25771747|NCT03633448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25771748|NCT03633448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25771749|NCT03633448|Adrenergic Agents|adrenergic agents|mesh-ancestor
25771750|NCT03633448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25771751|NCT03633448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771752|NCT03633448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771753|NCT03633448|Appetite Depressants|appetite depressants|mesh-ancestor
25720548|NCT02471404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25720549|NCT02471404|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25720550|NCT02471404|Protease Inhibitors|protease inhibitors|mesh-ancestor
25720551|NCT02471404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720552|NCT02471521|Rocuronium|rocuronium|mesh-list
25720553|NCT02471521|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25720554|NCT02471521|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25720555|NCT02471521|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25720556|NCT02471521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25720557|NCT02471521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720558|NCT02471651|Dexamethasone|dexamethasone|mesh-list
25720559|NCT02471651|Ranibizumab|ranibizumab|mesh-list
25720560|NCT02471651|Aflibercept|aflibercept|mesh-list
25720561|NCT02471651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25720562|NCT02471651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25720563|NCT02471651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25720564|NCT02471651|Growth Substances|growth substances|mesh-ancestor
25720565|NCT02471651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720566|NCT02471651|Growth Inhibitors|growth inhibitors|mesh-ancestor
25720567|NCT02471651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25720569|NCT02471651|Autonomic Agents|autonomic agents|mesh-ancestor
25720570|NCT02471651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25720571|NCT02471651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25720572|NCT02471651|Glucocorticoids|glucocorticoids|mesh-ancestor
25720573|NCT02471651|Hormones|hormones|mesh-ancestor
25720574|NCT02471651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25720575|NCT02471651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25720576|NCT02472145|Decitabine|decitabine|mesh-list
25720577|NCT02472145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25720578|NCT02472145|Antimetabolites|antimetabolites|mesh-ancestor
25720579|NCT02472145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720580|NCT02472145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25720581|NCT02472145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720582|NCT02472223|Povidone-Iodine|povidone-iodine|mesh-list
25720583|NCT02472223|Povidone|povidone|mesh-list
25720584|NCT02472223|Lubricant Eye Drops|lubricant eye drops|mesh-list
25720585|NCT02472223|Plasma Substitutes|plasma substitutes|mesh-ancestor
25720586|NCT02472223|Blood Substitutes|blood substitutes|mesh-ancestor
25720587|NCT02472223|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25720588|NCT02472223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25720589|NCT02472223|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25720590|NCT02472223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25720591|NCT02472314|Bupivacaine|bupivacaine|mesh-list
25720592|NCT02472314|Anesthetics, Local|anesthetics, local|mesh-ancestor
25720593|NCT02472314|Anesthetics|anesthetics|mesh-ancestor
25720594|NCT02472314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25720595|NCT02472314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720596|NCT02472314|Sensory System Agents|sensory system agents|mesh-ancestor
25720597|NCT02472314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25720598|NCT02472353|Metformin|metformin|mesh-list
25720599|NCT02472353|Doxorubicin|doxorubicin|mesh-list
25720600|NCT02472353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25720601|NCT02472353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720602|NCT02472353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25720603|NCT02472353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25720604|NCT02472353|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25720605|NCT02472353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25720606|NCT02472353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720607|NCT02472353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720608|NCT02472366|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
25720609|NCT02472366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25720610|NCT02472366|Glucocorticoids|glucocorticoids|mesh-ancestor
25720611|NCT02472366|Hormones|hormones|mesh-ancestor
25720612|NCT02472366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25720613|NCT02472366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720614|NCT02472522|Dexmedetomidine|dexmedetomidine|mesh-list
25720615|NCT02472522|Ropivacaine|ropivacaine|mesh-list
25720616|NCT02472522|Adrenergic Agonists|adrenergic agonists|mesh-list
25720617|NCT02472522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25720618|NCT02472522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25720619|NCT02472522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720620|NCT02472522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25720622|NCT02472522|Sensory System Agents|sensory system agents|mesh-ancestor
25720623|NCT02472522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771754|NCT03633448|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25771755|NCT03633448|Sympathomimetics|sympathomimetics|mesh-ancestor
25771756|NCT03633448|Autonomic Agents|autonomic agents|mesh-ancestor
25771757|NCT03633448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771758|NCT03633448|Nasal Decongestants|nasal decongestants|mesh-ancestor
25771759|NCT03633448|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25771761|NCT03633487|Expectorants|expectorants|mesh-ancestor
25771762|NCT03633487|Respiratory System Agents|respiratory system agents|mesh-ancestor
25771763|NCT03633526|Ivacaftor|ivacaftor|mesh-list
25771764|NCT03633526|VX-659|vx-659|mesh-list
25720624|NCT02472522|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25720625|NCT02472522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25720626|NCT02472522|Adrenergic Agents|adrenergic agents|mesh-ancestor
25720627|NCT02472522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25720628|NCT02472522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720629|NCT02472522|Anesthetics, Local|anesthetics, local|mesh-ancestor
25720631|NCT02472652|Aripiprazole|aripiprazole|mesh-list
25720632|NCT02472652|Antidepressive Agents|antidepressive agents|mesh-ancestor
25720633|NCT02472652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25720634|NCT02472652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25720635|NCT02472652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25720636|NCT02472652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25771765|NCT03633526|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25771766|NCT03633526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25771767|NCT03633526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771768|NCT03634800|Nivolumab|nivolumab|mesh-list
25771769|NCT03634800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25720637|NCT02472652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720638|NCT02472652|Dopamine Agonists|dopamine agonists|mesh-ancestor
25720639|NCT02472652|Dopamine Agents|dopamine agents|mesh-ancestor
25720640|NCT02472652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25771770|NCT03634800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25771771|NCT03634800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25771772|NCT03634800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771773|NCT03635957|Folic Acid|folic acid|mesh-list
25771774|NCT03635957|Methotrexate|methotrexate|mesh-list
25771775|NCT03635957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25771776|NCT03635957|Abortifacient Agents|abortifacient agents|mesh-ancestor
25771777|NCT03635957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25771778|NCT03635957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771779|NCT03635957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25771780|NCT03635957|Antimetabolites|antimetabolites|mesh-ancestor
25771781|NCT03635957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771782|NCT03635957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25771783|NCT03635957|Dermatologic Agents|dermatologic agents|mesh-ancestor
25771784|NCT03635957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771785|NCT03635957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25771786|NCT03635957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25771787|NCT03635957|Immunologic Factors|immunologic factors|mesh-ancestor
25771788|NCT03635957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25771789|NCT03635957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25771790|NCT03635957|Hematinics|hematinics|mesh-ancestor
25771791|NCT03635957|Vitamin B Complex|vitamin b complex|mesh-ancestor
25771792|NCT03635957|Vitamins|vitamins|mesh-ancestor
25771793|NCT03635957|Micronutrients|micronutrients|mesh-ancestor
25771794|NCT03636061|Varenicline|varenicline|mesh-list
25771795|NCT03636061|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25771796|NCT03636061|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25771797|NCT03636061|Cholinergic Agents|cholinergic agents|mesh-ancestor
25771798|NCT03636061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25771799|NCT03636061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771800|NCT03636061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771801|NCT03638622|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25771802|NCT03638622|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25771803|NCT03638622|Dermatologic Agents|dermatologic agents|mesh-ancestor
25771804|NCT03638635|Bupivacaine|bupivacaine|mesh-list
25771805|NCT03638635|Anesthetics, Local|anesthetics, local|mesh-ancestor
25771806|NCT03638635|Anesthetics|anesthetics|mesh-ancestor
25771807|NCT03638635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25771808|NCT03638635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771809|NCT03638635|Sensory System Agents|sensory system agents|mesh-ancestor
25771810|NCT03638635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771811|NCT03638908|Fluoxetine|fluoxetine|mesh-list
25771812|NCT03638908|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25771813|NCT03638908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25771814|NCT03638908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25771815|NCT03638908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771816|NCT03638908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25771817|NCT03638908|Serotonin Agents|serotonin agents|mesh-ancestor
25771818|NCT03638908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771819|NCT03638908|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25771820|NCT03638908|Antidepressive Agents|antidepressive agents|mesh-ancestor
25771821|NCT03638908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25771822|NCT03638908|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25771823|NCT03638908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25771824|NCT03638908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25771825|NCT03639675|Aflibercept|aflibercept|mesh-list
25771826|NCT03639675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25720641|NCT02472652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720642|NCT02472652|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25720643|NCT02472652|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25720644|NCT02472652|Serotonin Agents|serotonin agents|mesh-ancestor
25720645|NCT02472652|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25720646|NCT02472652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25720647|NCT02472652|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25720648|NCT02472652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25720649|NCT02472756|Rituximab|rituximab|mesh-list
25720650|NCT02472756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25720651|NCT02472756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25720652|NCT02472756|Immunologic Factors|immunologic factors|mesh-ancestor
25720653|NCT02472756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720654|NCT02472756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25720655|NCT02472847|Dronabinol|dronabinol|mesh-list
25720656|NCT02472847|Hallucinogens|hallucinogens|mesh-ancestor
25720657|NCT02472847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720658|NCT02472847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25720659|NCT02472847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25720660|NCT02472847|Analgesics|analgesics|mesh-ancestor
25720661|NCT02472847|Sensory System Agents|sensory system agents|mesh-ancestor
25720662|NCT02472847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25720663|NCT02472847|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
24410620|NCT00186797|Cyclophosphamide|cyclophosphamide|mesh-list
24410621|NCT00186797|Fludarabine|fludarabine|mesh-list
24410622|NCT00186797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25720664|NCT02472847|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25720665|NCT02472847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25720666|NCT02472847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720667|NCT02472847|Hormones|hormones|mesh-ancestor
25720668|NCT02472847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25720669|NCT02472886|Sofosbuvir|sofosbuvir|mesh-list
25720670|NCT02472886|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25720671|NCT02472886|Ledipasvir|ledipasvir|mesh-list
25720672|NCT02472886|Antiviral Agents|antiviral agents|mesh-ancestor
25720673|NCT02472886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25720674|NCT02472977|Nivolumab|nivolumab|mesh-list
25720675|NCT02472977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25777362|NCT03680911|Expectorants|expectorants|mesh-ancestor
25720676|NCT02472977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25720677|NCT02472977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25720678|NCT02472977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720679|NCT02473250|Fluoxetine|fluoxetine|mesh-list
25720680|NCT02473250|Citalopram|citalopram|mesh-list
25720681|NCT02473250|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25720682|NCT02473250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25777363|NCT03680911|Respiratory System Agents|respiratory system agents|mesh-ancestor
25777364|NCT03680911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25777365|NCT03680911|Antioxidants|antioxidants|mesh-ancestor
25777366|NCT03680911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777367|NCT03680911|Protective Agents|protective agents|mesh-ancestor
25777368|NCT03680911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777369|NCT03680911|Antidotes|antidotes|mesh-ancestor
25777370|NCT03656692|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
25777371|NCT03656692|Hormones|hormones|mesh-ancestor
25777372|NCT03656692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25777373|NCT03656692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777374|NCT03643159|Aripiprazole|aripiprazole|mesh-list
25777375|NCT03643159|Antipsychotic Agents|antipsychotic agents|mesh-list
25777376|NCT03643159|Antidepressive Agents|antidepressive agents|mesh-ancestor
25777377|NCT03643159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25777378|NCT03643159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25777379|NCT03643159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25777380|NCT03643159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777381|NCT03643159|Dopamine Agonists|dopamine agonists|mesh-ancestor
25777382|NCT03643159|Dopamine Agents|dopamine agents|mesh-ancestor
25777383|NCT03643159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25777384|NCT03643159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777385|NCT03643159|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25777386|NCT03643159|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25777387|NCT03643159|Serotonin Agents|serotonin agents|mesh-ancestor
25777388|NCT03643159|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25777389|NCT03643159|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25777390|NCT03643159|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25777391|NCT03643159|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25777392|NCT03630120|Sorafenib|sorafenib|mesh-list
25777393|NCT03630120|Lenvatinib|lenvatinib|mesh-list
25777394|NCT03630120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25777395|NCT03630120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25777396|NCT03630120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777397|NCT03630120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777398|NCT03615144|Fludarabine|fludarabine|mesh-list
25777399|NCT03615144|Melphalan|melphalan|mesh-list
25777400|NCT03615144|Thiotepa|thiotepa|mesh-list
25777401|NCT03615144|Clofarabine|clofarabine|mesh-list
25777402|NCT03615144|Thymoglobulin|thymoglobulin|mesh-list
25777403|NCT03615144|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25777404|NCT03615144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25777405|NCT03615144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25777406|NCT03615144|Antimetabolites|antimetabolites|mesh-ancestor
25777407|NCT03615144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777408|NCT03615144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25777409|NCT03615144|Immunologic Factors|immunologic factors|mesh-ancestor
25777410|NCT03615144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777411|NCT03615144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25777412|NCT03615144|Alkylating Agents|alkylating agents|mesh-ancestor
25777413|NCT03615144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25777414|NCT03598140|Sildenafil Citrate|sildenafil citrate|mesh-list
25777415|NCT03598140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777416|NCT03598140|Vasodilator Agents|vasodilator agents|mesh-ancestor
25777417|NCT03598140|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25777418|NCT03598140|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25720683|NCT02473250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25720684|NCT02473250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720685|NCT02473250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25720686|NCT02473250|Serotonin Agents|serotonin agents|mesh-ancestor
25720687|NCT02473250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720688|NCT02473250|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25720689|NCT02473250|Antidepressive Agents|antidepressive agents|mesh-ancestor
25720690|NCT02473250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25720691|NCT02473250|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25720692|NCT02473250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25720693|NCT02473250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720694|NCT02473367|Raltegravir Potassium|raltegravir potassium|mesh-list
25720695|NCT02473367|Antacids|antacids|mesh-list
25720696|NCT02473367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25720697|NCT02473367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25720698|NCT02473367|Antiviral Agents|antiviral agents|mesh-ancestor
25777420|NCT03598140|Urological Agents|urological agents|mesh-ancestor
25777421|NCT03591458|Amitriptyline|amitriptyline|mesh-list
25777422|NCT03591458|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25777423|NCT03591458|Antidepressive Agents|antidepressive agents|mesh-ancestor
25777424|NCT03591458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25777425|NCT03591458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25777426|NCT03591458|Analgesics|analgesics|mesh-ancestor
25777427|NCT03591458|Sensory System Agents|sensory system agents|mesh-ancestor
25720699|NCT02473367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25720700|NCT02473367|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25720701|NCT02473367|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25720702|NCT02473367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720703|NCT02473367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720704|NCT02473367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25720705|NCT02473640|Ceftriaxone|ceftriaxone|mesh-list
25720706|NCT02473640|Esomeprazole|esomeprazole|mesh-list
25720707|NCT02473640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25720708|NCT02473640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25720709|NCT02473640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25720710|NCT02473640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720711|NCT02473640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720712|NCT02473640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25720713|NCT02473640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25720714|NCT02473783|Sertraline|sertraline|mesh-list
25720715|NCT02473783|Antidepressive Agents|antidepressive agents|mesh-ancestor
25720716|NCT02473783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25720717|NCT02473783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25720718|NCT02473783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25720719|NCT02473783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25720720|NCT02473783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720721|NCT02473783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25720722|NCT02473783|Serotonin Agents|serotonin agents|mesh-ancestor
25720723|NCT02473783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720724|NCT02473913|Silymarin|silymarin|mesh-list
25720725|NCT02473913|Antioxidants|antioxidants|mesh-ancestor
25720726|NCT02473913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720727|NCT02473913|Protective Agents|protective agents|mesh-ancestor
25720728|NCT02473913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720729|NCT02474199|Acetaminophen|acetaminophen|mesh-list
25720730|NCT02474199|Diphenhydramine|diphenhydramine|mesh-list
25720731|NCT02474199|Promethazine|promethazine|mesh-list
25720732|NCT02474199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25720733|NCT02474199|Analgesics|analgesics|mesh-ancestor
25720734|NCT02474199|Sensory System Agents|sensory system agents|mesh-ancestor
25720735|NCT02474199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25720736|NCT02474199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720737|NCT02474199|Antipyretics|antipyretics|mesh-ancestor
25720738|NCT02474199|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25720739|NCT02474199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25720740|NCT02474199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25720741|NCT02474199|Anesthetics, Local|anesthetics, local|mesh-ancestor
25720742|NCT02474199|Anesthetics|anesthetics|mesh-ancestor
25720743|NCT02474199|Antiemetics|antiemetics|mesh-ancestor
25720744|NCT02474199|Autonomic Agents|autonomic agents|mesh-ancestor
25720745|NCT02474199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25720746|NCT02474199|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25720747|NCT02474199|Histamine Antagonists|histamine antagonists|mesh-ancestor
25720748|NCT02474199|Histamine Agents|histamine agents|mesh-ancestor
25720749|NCT02474199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25720750|NCT02474199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720751|NCT02474199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25720752|NCT02474199|Antipruritics|antipruritics|mesh-ancestor
25720753|NCT02474199|Dermatologic Agents|dermatologic agents|mesh-ancestor
25720754|NCT02474355|Osimertinib|osimertinib|mesh-list
25720755|NCT02474355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25720756|NCT02474355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25720757|NCT02474355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720758|NCT02474355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720760|NCT02474407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25720761|NCT02474407|Anticonvulsants|anticonvulsants|mesh-ancestor
25720762|NCT02474407|Antiemetics|antiemetics|mesh-ancestor
25720763|NCT02474407|Autonomic Agents|autonomic agents|mesh-ancestor
25720764|NCT02474407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25720765|NCT02474407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720766|NCT02474407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25720767|NCT02474407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25720768|NCT02474407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25720769|NCT02474407|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25720770|NCT02474407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25720771|NCT02474407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25720772|NCT02474407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25720773|NCT02474407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25720774|NCT02474407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25720775|NCT02474407|Anesthetics, General|anesthetics, general|mesh-ancestor
25720776|NCT02474407|Anesthetics|anesthetics|mesh-ancestor
25720777|NCT02474407|GABA Modulators|gaba modulators|mesh-ancestor
25720778|NCT02474407|GABA Agents|gaba agents|mesh-ancestor
25720779|NCT02474407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25720780|NCT02474407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720781|NCT02475070|Dapagliflozin|dapagliflozin|mesh-list
25720782|NCT02475070|Vildagliptin|vildagliptin|mesh-list
25720783|NCT02475070|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25720784|NCT02475070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720785|NCT02475070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25720786|NCT02475070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720787|NCT02475070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25720788|NCT02475070|Protease Inhibitors|protease inhibitors|mesh-ancestor
25720789|NCT02475070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720790|NCT02475265|Levonorgestrel|levonorgestrel|mesh-list
25720791|NCT02475265|Estradiol|estradiol|mesh-list
25720792|NCT02475265|Estrogens|estrogens|mesh-ancestor
25720793|NCT02475265|Hormones|hormones|mesh-ancestor
25720794|NCT02475265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25720795|NCT02475265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720796|NCT02475265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25720797|NCT02475265|Contraceptive Agents|contraceptive agents|mesh-ancestor
25720798|NCT02475265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25720799|NCT02475265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25720800|NCT02475265|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25720801|NCT02475265|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25720802|NCT02475369|Pancrelipase|pancrelipase|mesh-list
25720803|NCT02475369|Pancreatin|pancreatin|mesh-list
25720804|NCT02475369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25720805|NCT02475564|Resveratrol|resveratrol|mesh-list
25720806|NCT02475564|Antioxidants|antioxidants|mesh-ancestor
25720807|NCT02475564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720808|NCT02475564|Protective Agents|protective agents|mesh-ancestor
25720809|NCT02475564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720810|NCT02475564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720811|NCT02475564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25720812|NCT02475629|Ibalizumab|ibalizumab|mesh-list
25720813|NCT02475629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25720814|NCT02475629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25720815|NCT02475629|Antiviral Agents|antiviral agents|mesh-ancestor
25720816|NCT02475629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25407739|NCT03480334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25720817|NCT02475733|Metronidazole|metronidazole|mesh-list
25720818|NCT02475733|Meropenem|meropenem|mesh-list
25720819|NCT02475733|Ceftazidime|ceftazidime|mesh-list
25720820|NCT02475733|Avibactam|avibactam|mesh-list
25720821|NCT02475733|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
25720822|NCT02475733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25720823|NCT02475733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25720824|NCT02475733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25720825|NCT02475733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25720826|NCT02475733|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25720827|NCT02475733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720828|NCT02475733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720829|NCT02475837|Vorapaxar|vorapaxar|mesh-list
25720830|NCT02475837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25720831|NCT02476175|Mirabegron|mirabegron|mesh-list
25720832|NCT02476175|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25720833|NCT02476175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25720834|NCT02476175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25720835|NCT02476175|Adrenergic Agents|adrenergic agents|mesh-ancestor
25720836|NCT02476175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25720837|NCT02476175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720838|NCT02476175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720839|NCT02476175|Urological Agents|urological agents|mesh-ancestor
25720841|NCT02476422|Diclofenac|diclofenac|mesh-list
25720842|NCT02476422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25720843|NCT02476422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25720844|NCT02476422|Analgesics|analgesics|mesh-ancestor
25720845|NCT02476422|Sensory System Agents|sensory system agents|mesh-ancestor
25720846|NCT02476422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25720847|NCT02476422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720848|NCT02476422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25720849|NCT02476422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25720850|NCT02476422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25720851|NCT02476422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720852|NCT02476422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720853|NCT02476617|Ritonavir|ritonavir|mesh-list
25720854|NCT02476617|Ribavirin|ribavirin|mesh-list
25720855|NCT02476617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25720856|NCT02476617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25720857|NCT02476617|Protease Inhibitors|protease inhibitors|mesh-ancestor
25720858|NCT02476617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720859|NCT02476617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720860|NCT02476617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25720861|NCT02476617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25720862|NCT02476617|Antiviral Agents|antiviral agents|mesh-ancestor
25720863|NCT02476617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25720864|NCT02476617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25720865|NCT02476617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25720866|NCT02476617|Antimetabolites|antimetabolites|mesh-ancestor
25720867|NCT02477215|Dexamethasone|dexamethasone|mesh-list
25720868|NCT02477215|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25720869|NCT02477215|Ixazomib|ixazomib|mesh-list
25720870|NCT02477215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25720871|NCT02477215|Antiemetics|antiemetics|mesh-ancestor
25720872|NCT02477215|Autonomic Agents|autonomic agents|mesh-ancestor
25407740|NCT03480334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25720873|NCT02477215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25720874|NCT02477215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720875|NCT02477215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25720876|NCT02477215|Glucocorticoids|glucocorticoids|mesh-ancestor
25720877|NCT02477215|Hormones|hormones|mesh-ancestor
25720878|NCT02477215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25720879|NCT02477215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25720880|NCT02477215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25720881|NCT02477215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25720882|NCT02477215|Alkylating Agents|alkylating agents|mesh-ancestor
25720883|NCT02477215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720884|NCT02477215|Protease Inhibitors|protease inhibitors|mesh-ancestor
25720885|NCT02477215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720886|NCT02477332|Omalizumab|omalizumab|mesh-list
25720887|NCT02477332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25720888|NCT02477332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25720889|NCT02477332|Respiratory System Agents|respiratory system agents|mesh-ancestor
25720890|NCT02477423|Gentamicins|gentamicins|mesh-list
25720891|NCT02477423|Ampicillin|ampicillin|mesh-list
25720893|NCT02477423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25720894|NCT02477423|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25720895|NCT02477423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720896|NCT02477423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720897|NCT02477527|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25720898|NCT02477527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25720899|NCT02477527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25720900|NCT02477527|Antiviral Agents|antiviral agents|mesh-ancestor
25720901|NCT02477527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25720902|NCT02477839|Lacosamide|lacosamide|mesh-list
25720903|NCT02477839|Anticonvulsants|anticonvulsants|mesh-ancestor
25720904|NCT02477839|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25720905|NCT02477839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25771827|NCT03639675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25771828|NCT03639675|Growth Substances|growth substances|mesh-ancestor
25771829|NCT03639675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720906|NCT02477839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25720907|NCT02477839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771830|NCT03639675|Growth Inhibitors|growth inhibitors|mesh-ancestor
25771831|NCT03639675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25771832|NCT03639766|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25771833|NCT03639766|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25771834|NCT03639766|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25771835|NCT03639766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25771836|NCT03639766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771837|NCT03639766|Cholinergic Agents|cholinergic agents|mesh-ancestor
25771838|NCT03639766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25771839|NCT03639766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771840|NCT03639766|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25771841|NCT03639766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771842|NCT03639779|Sodium thiosulfate|sodium thiosulfate|mesh-list
25771843|NCT03639779|Antidotes|antidotes|mesh-ancestor
25771844|NCT03639779|Protective Agents|protective agents|mesh-ancestor
25771845|NCT03639779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771846|NCT03639779|Antioxidants|antioxidants|mesh-ancestor
25771847|NCT03639779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771848|NCT03639779|Antitubercular Agents|antitubercular agents|mesh-ancestor
25771849|NCT03639779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25771850|NCT03639779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25771851|NCT03639779|Chelating Agents|chelating agents|mesh-ancestor
25771852|NCT03639779|Sequestering Agents|sequestering agents|mesh-ancestor
25771853|NCT03640507|Chlorhexidine|chlorhexidine|mesh-list
25771854|NCT03640507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25771855|NCT03640507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25771856|NCT03640507|Disinfectants|disinfectants|mesh-ancestor
25771857|NCT03641508|Dexamethasone|dexamethasone|mesh-list
25771858|NCT03641508|Triamcinolone|triamcinolone|mesh-list
25771859|NCT03641508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25771860|NCT03641508|Antiemetics|antiemetics|mesh-ancestor
25771861|NCT03641508|Autonomic Agents|autonomic agents|mesh-ancestor
25771862|NCT03641508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771863|NCT03641508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771864|NCT03641508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25771865|NCT03641508|Glucocorticoids|glucocorticoids|mesh-ancestor
25771866|NCT03641508|Hormones|hormones|mesh-ancestor
25771867|NCT03641508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25771868|NCT03641508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25771869|NCT03641508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25771870|NCT03642262|Guaifenesin|guaifenesin|mesh-list
25771871|NCT03642262|Expectorants|expectorants|mesh-ancestor
25771872|NCT03642262|Respiratory System Agents|respiratory system agents|mesh-ancestor
25771873|NCT03642457|Bupivacaine|bupivacaine|mesh-list
25771874|NCT03642457|Anesthetics, Local|anesthetics, local|mesh-ancestor
25771875|NCT03642457|Anesthetics|anesthetics|mesh-ancestor
25771876|NCT03642457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25771877|NCT03642457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771878|NCT03642457|Sensory System Agents|sensory system agents|mesh-ancestor
25771879|NCT03642457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771880|NCT03642717|Empagliflozin|empagliflozin|mesh-list
25771881|NCT03642717|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25771882|NCT03642717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771883|NCT03642717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25771884|NCT03642717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771885|NCT03642873|Phenylpropanolamine|phenylpropanolamine|mesh-list
25771886|NCT03642873|Hydrocodone|hydrocodone|mesh-list
25771887|NCT03642873|Guaifenesin|guaifenesin|mesh-list
25771888|NCT03642873|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
25771889|NCT03642873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25771890|NCT03642873|Narcotics|narcotics|mesh-ancestor
25771891|NCT03642873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25771892|NCT03642873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771893|NCT03642873|Analgesics|analgesics|mesh-ancestor
25720908|NCT02478164|Ponatinib|ponatinib|mesh-list
25720909|NCT02478164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25720910|NCT02478164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25720911|NCT02478164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720912|NCT02478164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720913|NCT02478372|Bupivacaine|bupivacaine|mesh-list
25720914|NCT02478372|Ropivacaine|ropivacaine|mesh-list
25720915|NCT02478372|Levobupivacaine|levobupivacaine|mesh-list
25720916|NCT02478372|Anesthetics, Local|anesthetics, local|mesh-ancestor
25720917|NCT02478372|Anesthetics|anesthetics|mesh-ancestor
25720918|NCT02478372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25720919|NCT02478372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720920|NCT02478372|Sensory System Agents|sensory system agents|mesh-ancestor
25720921|NCT02478372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25720922|NCT02478398|Mometasone Furoate|mometasone furoate|mesh-list
25720923|NCT02478398|Loratadine|loratadine|mesh-list
25720924|NCT02478398|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25720925|NCT02478398|Epinephrine|epinephrine|mesh-list
25720926|NCT02478398|Albuterol|albuterol|mesh-list
25720927|NCT02478398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25720928|NCT02478398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25720929|NCT02478398|Adrenergic Agents|adrenergic agents|mesh-ancestor
25720930|NCT02478398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25720931|NCT02478398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720932|NCT02478398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720933|NCT02478398|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25720934|NCT02478398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25720935|NCT02478398|Autonomic Agents|autonomic agents|mesh-ancestor
25720936|NCT02478398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25720937|NCT02478398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25720938|NCT02478398|Respiratory System Agents|respiratory system agents|mesh-ancestor
25720939|NCT02478398|Mydriatics|mydriatics|mesh-ancestor
25720940|NCT02478398|Sympathomimetics|sympathomimetics|mesh-ancestor
25720941|NCT02478398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25720943|NCT02478398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25720944|NCT02478398|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25720945|NCT02478398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25720946|NCT02478398|Dermatologic Agents|dermatologic agents|mesh-ancestor
25720947|NCT02478398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25720948|NCT02478398|Antipruritics|antipruritics|mesh-ancestor
25720949|NCT02478398|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25720950|NCT02478398|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25720951|NCT02478398|Histamine Antagonists|histamine antagonists|mesh-ancestor
25407817|NCT03474770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720952|NCT02478398|Histamine Agents|histamine agents|mesh-ancestor
25720953|NCT02478398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25720954|NCT02478398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25720955|NCT02478398|Analgesics|analgesics|mesh-ancestor
25720956|NCT02478398|Sensory System Agents|sensory system agents|mesh-ancestor
25720957|NCT02478398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25720958|NCT02478463|Cabotegravir|cabotegravir|mesh-list
25720959|NCT02478463|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25720960|NCT02478463|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25720961|NCT02478463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25720962|NCT02478463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720963|NCT02478463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25720964|NCT02478463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25720965|NCT02478463|Antiviral Agents|antiviral agents|mesh-ancestor
25720966|NCT02478463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25720968|NCT02478489|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25720969|NCT02478489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25720970|NCT02478489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720971|NCT02478489|Sensory System Agents|sensory system agents|mesh-ancestor
25720972|NCT02478489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25720973|NCT02478580|Modafinil|modafinil|mesh-list
25720974|NCT02478580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25720975|NCT02478580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720976|NCT02478580|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25720977|NCT02478580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25720978|NCT02478580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25720979|NCT02478580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720980|NCT02479412|Albuterol|albuterol|mesh-list
25720981|NCT02479412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25720982|NCT02479412|Autonomic Agents|autonomic agents|mesh-ancestor
25720983|NCT02479412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25720984|NCT02479412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25720985|NCT02479412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25720986|NCT02479412|Respiratory System Agents|respiratory system agents|mesh-ancestor
25720987|NCT02479412|Tocolytic Agents|tocolytic agents|mesh-ancestor
25720988|NCT02479412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25407895|NCT03471260|Ivosidenib|ivosidenib|mesh-list
25720989|NCT02479412|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25720990|NCT02479412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25720991|NCT02479412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25720992|NCT02479412|Adrenergic Agents|adrenergic agents|mesh-ancestor
25720993|NCT02479412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25720994|NCT02479412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25720995|NCT02479880|Tenofovir|tenofovir|mesh-list
25720996|NCT02479880|Antiviral Agents|antiviral agents|mesh-ancestor
25720997|NCT02479880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25720998|NCT02479880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25720999|NCT02479880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25721000|NCT02479880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25721001|NCT02479880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721002|NCT02479880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25721003|NCT02479880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25721004|NCT02480010|Pertuzumab|pertuzumab|mesh-list
25721005|NCT02480010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25721006|NCT02480010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25721007|NCT02480114|Acetaminophen|acetaminophen|mesh-list
25721008|NCT02480114|Ibuprofen|ibuprofen|mesh-list
25721009|NCT02480114|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25721011|NCT02480114|Oxycodone|oxycodone|mesh-list
25721012|NCT02480114|Hydrocodone|hydrocodone|mesh-list
25721013|NCT02480114|Gabapentin|gabapentin|mesh-list
25721014|NCT02480114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25721015|NCT02480114|Narcotics|narcotics|mesh-ancestor
25721016|NCT02480114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25721017|NCT02480114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721018|NCT02480114|Analgesics|analgesics|mesh-ancestor
25721019|NCT02480114|Sensory System Agents|sensory system agents|mesh-ancestor
25721020|NCT02480114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721021|NCT02480114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25721022|NCT02480114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25721023|NCT02480114|Anesthetics, General|anesthetics, general|mesh-ancestor
25721024|NCT02480114|Anesthetics|anesthetics|mesh-ancestor
25721025|NCT02480114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25721026|NCT02480114|Antipyretics|antipyretics|mesh-ancestor
25721027|NCT02480114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25721028|NCT02480114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25721029|NCT02480114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25721030|NCT02480114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25721031|NCT02480114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25721032|NCT02480114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721033|NCT02480114|Anticonvulsants|anticonvulsants|mesh-ancestor
25721034|NCT02480114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25721035|NCT02480114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25721036|NCT02480114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25721037|NCT02480114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25721038|NCT02480114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25721039|NCT02480114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25721041|NCT02480114|Antitussive Agents|antitussive agents|mesh-ancestor
25721042|NCT02480114|Respiratory System Agents|respiratory system agents|mesh-ancestor
25721043|NCT02480153|Adalimumab|adalimumab|mesh-list
25721044|NCT02480153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25721045|NCT02480153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25721046|NCT02480166|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25721048|NCT02480166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25721049|NCT02480621|Bupivacaine|bupivacaine|mesh-list
25721050|NCT02480621|Anesthetics, Local|anesthetics, local|mesh-ancestor
25721051|NCT02480621|Anesthetics|anesthetics|mesh-ancestor
25721052|NCT02480621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25721053|NCT02480621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721054|NCT02480621|Sensory System Agents|sensory system agents|mesh-ancestor
25721055|NCT02480621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721056|NCT02480712|Sofosbuvir|sofosbuvir|mesh-list
25721057|NCT02480712|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25721058|NCT02480712|Velpatasvir|velpatasvir|mesh-list
25721059|NCT02480712|Antiviral Agents|antiviral agents|mesh-ancestor
25721060|NCT02480712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25721061|NCT02480764|Valsartan|valsartan|mesh-list
25721062|NCT02480764|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25721063|NCT02480764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25721064|NCT02480764|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25721065|NCT02480764|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25721066|NCT02480764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721067|NCT02480998|Vaccines|vaccines|mesh-list
25721068|NCT02480998|Immunologic Factors|immunologic factors|mesh-ancestor
25721069|NCT02480998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721070|NCT02481219|Erythromycin|erythromycin|mesh-list
25721071|NCT02481219|Erythromycin Estolate|erythromycin estolate|mesh-list
25721072|NCT02481219|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25721073|NCT02481219|Erythromycin stearate|erythromycin stearate|mesh-list
25721074|NCT02481219|Metoclopramide|metoclopramide|mesh-list
25721075|NCT02481219|Bisacodyl|bisacodyl|mesh-list
25721076|NCT02481219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25721077|NCT02481219|Antiemetics|antiemetics|mesh-ancestor
25721078|NCT02481219|Autonomic Agents|autonomic agents|mesh-ancestor
25721079|NCT02481219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721080|NCT02481219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721081|NCT02481219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25721082|NCT02481219|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25721083|NCT02481219|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25721084|NCT02481219|Dopamine Agents|dopamine agents|mesh-ancestor
25721085|NCT02481219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25721086|NCT02481219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721087|NCT02481219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25721088|NCT02481219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25721089|NCT02481219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25721090|NCT02481219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25721091|NCT02481219|Cathartics|cathartics|mesh-ancestor
25721092|NCT02481219|Laxatives|laxatives|mesh-ancestor
25721093|NCT02481258|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
25721094|NCT02481258|Enzyme Activators|enzyme activators|mesh-ancestor
25721095|NCT02481258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721096|NCT02481297|Rituximab|rituximab|mesh-list
25721097|NCT02481297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25721098|NCT02481297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25721099|NCT02481297|Immunologic Factors|immunologic factors|mesh-ancestor
25721100|NCT02481297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721101|NCT02481297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25721102|NCT02481375|Iron|iron|mesh-list
25721103|NCT02481375|Trace Elements|trace elements|mesh-list
25721104|NCT02481375|Micronutrients|micronutrients|mesh-list
25721105|NCT02481375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721106|NCT02481505|Chloroprocaine|chloroprocaine|mesh-list
25721107|NCT02481505|Anesthetics, Local|anesthetics, local|mesh-ancestor
25721108|NCT02481505|Anesthetics|anesthetics|mesh-ancestor
25721109|NCT02481505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25721110|NCT02481505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721111|NCT02481505|Sensory System Agents|sensory system agents|mesh-ancestor
25721112|NCT02481505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721113|NCT02481934|Lenalidomide|lenalidomide|mesh-list
25721114|NCT02481934|Bortezomib|bortezomib|mesh-list
25721116|NCT02481934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721117|NCT02481934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25721118|NCT02481934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25721119|NCT02481934|Growth Substances|growth substances|mesh-ancestor
25721120|NCT02481934|Growth Inhibitors|growth inhibitors|mesh-ancestor
25721121|NCT02481934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25721122|NCT02481947|Laxatives|laxatives|mesh-list
25721123|NCT02481947|Lubiprostone|lubiprostone|mesh-list
25721124|NCT02481947|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25721125|NCT02481947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25721126|NCT02481947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721128|NCT02482129|Dexamethasone|dexamethasone|mesh-list
25721129|NCT02482129|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25721130|NCT02482129|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25721131|NCT02482129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25721133|NCT02482129|Autonomic Agents|autonomic agents|mesh-ancestor
25721134|NCT02482129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721135|NCT02482129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721136|NCT02482129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25721137|NCT02482129|Glucocorticoids|glucocorticoids|mesh-ancestor
25721138|NCT02482129|Hormones|hormones|mesh-ancestor
25721139|NCT02482129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25721140|NCT02482129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25721141|NCT02482129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25721142|NCT02482298|Ticagrelor|ticagrelor|mesh-list
25721143|NCT02482298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25721144|NCT02482298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25721145|NCT02482298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25721146|NCT02482298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25721147|NCT02482298|Purinergic Agents|purinergic agents|mesh-ancestor
25721148|NCT02482298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25721149|NCT02482298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721150|NCT02482298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721151|NCT02482428|Imiquimod|imiquimod|mesh-list
25721152|NCT02482428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25721153|NCT02482428|Immunologic Factors|immunologic factors|mesh-ancestor
25721154|NCT02482428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721155|NCT02482428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25721156|NCT02482428|Interferon Inducers|interferon inducers|mesh-ancestor
25721157|NCT02482675|Caseins|caseins|mesh-list
25721158|NCT02482675|Chelating Agents|chelating agents|mesh-ancestor
25721159|NCT02482675|Sequestering Agents|sequestering agents|mesh-ancestor
25721160|NCT02482675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721162|NCT02483000|Cytarabine|cytarabine|mesh-list
25721163|NCT02483000|Etoposide|etoposide|mesh-list
25721164|NCT02483000|Podophyllotoxin|podophyllotoxin|mesh-list
25721165|NCT02483000|Etoposide phosphate|etoposide phosphate|mesh-list
25721166|NCT02483000|Melphalan|melphalan|mesh-list
25721167|NCT02483000|Mechlorethamine|mechlorethamine|mesh-list
25721168|NCT02483000|Carmustine|carmustine|mesh-list
25721169|NCT02483000|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25721170|NCT02483000|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
25721171|NCT02483000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25721172|NCT02483000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25721173|NCT02483000|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25721174|NCT02483000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25721175|NCT02483000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25721176|NCT02483000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721177|NCT02483000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25721178|NCT02483000|Antimetabolites|antimetabolites|mesh-ancestor
25721179|NCT02483000|Antiviral Agents|antiviral agents|mesh-ancestor
25721180|NCT02483000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25721181|NCT02483000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25721182|NCT02483000|Immunologic Factors|immunologic factors|mesh-ancestor
25721183|NCT02483000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721184|NCT02483000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25721185|NCT02483000|Alkylating Agents|alkylating agents|mesh-ancestor
25721186|NCT02483000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25721187|NCT02483000|Chelating Agents|chelating agents|mesh-ancestor
25721188|NCT02483000|Sequestering Agents|sequestering agents|mesh-ancestor
25721189|NCT02483000|Keratolytic Agents|keratolytic agents|mesh-ancestor
25721190|NCT02483000|Dermatologic Agents|dermatologic agents|mesh-ancestor
25721191|NCT02483000|Tubulin Modulators|tubulin modulators|mesh-ancestor
25721192|NCT02483000|Antimitotic Agents|antimitotic agents|mesh-ancestor
25721193|NCT02483000|Mitosis Modulators|mitosis modulators|mesh-ancestor
25721194|NCT02483000|Vitamin B Complex|vitamin b complex|mesh-ancestor
25721196|NCT02483000|Micronutrients|micronutrients|mesh-ancestor
25721197|NCT02483611|Lidocaine|lidocaine|mesh-list
25721199|NCT02483611|Cisatracurium|cisatracurium|mesh-list
25721200|NCT02483611|Anesthetics, Local|anesthetics, local|mesh-ancestor
25721201|NCT02483611|Anesthetics|anesthetics|mesh-ancestor
25721202|NCT02483611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25721203|NCT02483611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721204|NCT02483611|Sensory System Agents|sensory system agents|mesh-ancestor
25721205|NCT02483611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721206|NCT02483611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25721207|NCT02483611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25721208|NCT02483611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25721209|NCT02483611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25721210|NCT02483611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721211|NCT02483611|Analgesics|analgesics|mesh-ancestor
25721212|NCT02483611|Anticonvulsants|anticonvulsants|mesh-ancestor
25721213|NCT02483611|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25721214|NCT02483611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25721215|NCT02483611|Tocolytic Agents|tocolytic agents|mesh-ancestor
25721216|NCT02483611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25721217|NCT02483611|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25721218|NCT02483611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25721219|NCT02483975|Albuterol|albuterol|mesh-list
25721220|NCT02483975|Montelukast|montelukast|mesh-list
25721221|NCT02483975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25721222|NCT02483975|Respiratory System Agents|respiratory system agents|mesh-ancestor
25721224|NCT02483975|Hormone Antagonists|hormone antagonists|mesh-ancestor
25721225|NCT02483975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25721226|NCT02483975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721227|NCT02483975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25721228|NCT02483975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25721229|NCT02483975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721230|NCT02483975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25721231|NCT02483975|Autonomic Agents|autonomic agents|mesh-ancestor
25721232|NCT02483975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721233|NCT02483975|Tocolytic Agents|tocolytic agents|mesh-ancestor
25721234|NCT02483975|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25721235|NCT02483975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25721236|NCT02483975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25721238|NCT02483975|Adrenergic Agents|adrenergic agents|mesh-ancestor
25721239|NCT02483975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25721240|NCT02484222|Fentanyl|fentanyl|mesh-list
25721241|NCT02484222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25721242|NCT02484222|Narcotics|narcotics|mesh-ancestor
25721243|NCT02484222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25721244|NCT02484222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721245|NCT02484222|Analgesics|analgesics|mesh-ancestor
25721246|NCT02484222|Sensory System Agents|sensory system agents|mesh-ancestor
25721247|NCT02484222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721248|NCT02484222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25721249|NCT02484222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25721250|NCT02484222|Anesthetics, General|anesthetics, general|mesh-ancestor
25721251|NCT02484222|Anesthetics|anesthetics|mesh-ancestor
25721252|NCT02484651|Rocuronium|rocuronium|mesh-list
25721253|NCT02484651|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25721254|NCT02484651|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25721255|NCT02484651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25721256|NCT02484651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721257|NCT02484651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721258|NCT02484690|Ranibizumab|ranibizumab|mesh-list
25721259|NCT02484690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25721260|NCT02484690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25721261|NCT02484690|Growth Substances|growth substances|mesh-ancestor
25721262|NCT02484690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721263|NCT02484690|Growth Inhibitors|growth inhibitors|mesh-ancestor
25721264|NCT02484690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25721265|NCT02484859|Metoprolol|metoprolol|mesh-list
25721266|NCT02484859|Remifentanil|remifentanil|mesh-list
25721267|NCT02484859|Tramadol|tramadol|mesh-list
25721268|NCT02484859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25721269|NCT02484859|Narcotics|narcotics|mesh-ancestor
25721270|NCT02484859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25721271|NCT02484859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721272|NCT02484859|Analgesics|analgesics|mesh-ancestor
25721273|NCT02484859|Sensory System Agents|sensory system agents|mesh-ancestor
25721274|NCT02484859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721275|NCT02484859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25721276|NCT02484859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25721277|NCT02484859|Sympatholytics|sympatholytics|mesh-ancestor
25721278|NCT02484859|Autonomic Agents|autonomic agents|mesh-ancestor
25721279|NCT02484859|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25721280|NCT02484859|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25721281|NCT02484859|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25721282|NCT02484859|Adrenergic Agents|adrenergic agents|mesh-ancestor
25721283|NCT02484859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25721284|NCT02484859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721285|NCT02484911|Dexamethasone|dexamethasone|mesh-list
25721286|NCT02484911|Olanzapine|olanzapine|mesh-list
25721287|NCT02484911|Aprepitant|aprepitant|mesh-list
25721288|NCT02484911|Palonosetron|palonosetron|mesh-list
25721289|NCT02484911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25721290|NCT02484911|Antiemetics|antiemetics|mesh-ancestor
25721291|NCT02484911|Autonomic Agents|autonomic agents|mesh-ancestor
25721292|NCT02484911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721293|NCT02484911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721294|NCT02484911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25721295|NCT02484911|Glucocorticoids|glucocorticoids|mesh-ancestor
25721297|NCT02484911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25721298|NCT02484911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25721299|NCT02484911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25721300|NCT02484911|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25721301|NCT02484911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25721302|NCT02484911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25721303|NCT02484911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25721304|NCT02484911|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25721305|NCT02484911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25721306|NCT02484911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25721307|NCT02484911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721308|NCT02484911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25721309|NCT02484911|Serotonin Agents|serotonin agents|mesh-ancestor
25721310|NCT02484911|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
24418210|NCT00208897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25721311|NCT02484911|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25721312|NCT02484911|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25721313|NCT02485158|Dronabinol|dronabinol|mesh-list
25721314|NCT02485158|Amphetamine|amphetamine|mesh-list
25721315|NCT02485158|Dextroamphetamine|dextroamphetamine|mesh-list
25721316|NCT02485158|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25721317|NCT02485158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721318|NCT02485158|Sympathomimetics|sympathomimetics|mesh-ancestor
25721319|NCT02485158|Autonomic Agents|autonomic agents|mesh-ancestor
25721320|NCT02485158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721321|NCT02485158|Dopamine Agents|dopamine agents|mesh-ancestor
25721322|NCT02485158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25721323|NCT02485158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721324|NCT02485158|Adrenergic Agents|adrenergic agents|mesh-ancestor
25721325|NCT02485158|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25721326|NCT02485158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25721327|NCT02485158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25721328|NCT02485158|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25721329|NCT02485158|Hallucinogens|hallucinogens|mesh-ancestor
25721330|NCT02485158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25721331|NCT02485158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25721332|NCT02485158|Analgesics|analgesics|mesh-ancestor
25721333|NCT02485158|Sensory System Agents|sensory system agents|mesh-ancestor
25721334|NCT02485158|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25721335|NCT02485158|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25721336|NCT02485158|Hormones|hormones|mesh-ancestor
25721337|NCT02485158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25721338|NCT02485353|Cytarabine|cytarabine|mesh-list
25721339|NCT02485353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25721340|NCT02485353|Antimetabolites|antimetabolites|mesh-ancestor
25721341|NCT02485353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721342|NCT02485353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25721343|NCT02485353|Antiviral Agents|antiviral agents|mesh-ancestor
25721344|NCT02485353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25721345|NCT02485353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25721346|NCT02485353|Immunologic Factors|immunologic factors|mesh-ancestor
25721347|NCT02485353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721348|NCT02485834|Docetaxel|docetaxel|mesh-list
25721349|NCT02485834|Capecitabine|capecitabine|mesh-list
25721350|NCT02485834|Irinotecan|irinotecan|mesh-list
25721351|NCT02485834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25721352|NCT02485834|Tubulin Modulators|tubulin modulators|mesh-ancestor
25721353|NCT02485834|Antimitotic Agents|antimitotic agents|mesh-ancestor
25721354|NCT02485834|Mitosis Modulators|mitosis modulators|mesh-ancestor
25721355|NCT02485834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721356|NCT02485834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25721357|NCT02485834|Antimetabolites|antimetabolites|mesh-ancestor
25721358|NCT02485834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25721359|NCT02485834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25721360|NCT02485834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25721361|NCT02486016|Fentanyl|fentanyl|mesh-list
25721362|NCT02486016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25721363|NCT02486016|Narcotics|narcotics|mesh-ancestor
25721364|NCT02486016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25721365|NCT02486016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721366|NCT02486016|Analgesics|analgesics|mesh-ancestor
25721367|NCT02486016|Sensory System Agents|sensory system agents|mesh-ancestor
25721368|NCT02486016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721369|NCT02486016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25721370|NCT02486016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25721371|NCT02486016|Anesthetics, General|anesthetics, general|mesh-ancestor
25721372|NCT02486016|Anesthetics|anesthetics|mesh-ancestor
25721373|NCT02486211|Amantadine|amantadine|mesh-list
25721374|NCT02486211|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25721375|NCT02486211|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25721376|NCT02486211|Antiviral Agents|antiviral agents|mesh-ancestor
25721377|NCT02486211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25721378|NCT02486211|Dopamine Agents|dopamine agents|mesh-ancestor
25721379|NCT02486211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24419029|NCT00210847|Antipyretics|antipyretics|mesh-ancestor
25721380|NCT02486211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721381|NCT02486211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721383|NCT02486211|Analgesics|analgesics|mesh-ancestor
25721384|NCT02486211|Sensory System Agents|sensory system agents|mesh-ancestor
25721385|NCT02486211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721386|NCT02486302|Etanercept|etanercept|mesh-list
25721387|NCT02486302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25721388|NCT02486302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25721389|NCT02486302|Analgesics|analgesics|mesh-ancestor
25721390|NCT02486302|Sensory System Agents|sensory system agents|mesh-ancestor
25721391|NCT02486302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721392|NCT02486302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721393|NCT02486302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25721395|NCT02486302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25721396|NCT02486302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25721397|NCT02486302|Immunologic Factors|immunologic factors|mesh-ancestor
25721398|NCT02486328|Midazolam|midazolam|mesh-list
25721399|NCT02486328|Meperidine|meperidine|mesh-list
25721400|NCT02486328|Remifentanil|remifentanil|mesh-list
25721401|NCT02486328|Propofol|propofol|mesh-list
25721402|NCT02486328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25721403|NCT02486328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25721404|NCT02486328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721405|NCT02486328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25721406|NCT02486328|Anesthetics, General|anesthetics, general|mesh-ancestor
25721407|NCT02486328|Anesthetics|anesthetics|mesh-ancestor
25721408|NCT02486328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25721409|NCT02486328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25721410|NCT02486328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25721411|NCT02486328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25721412|NCT02486328|GABA Modulators|gaba modulators|mesh-ancestor
25721413|NCT02486328|GABA Agents|gaba agents|mesh-ancestor
25721414|NCT02486328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25721415|NCT02486328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721416|NCT02486328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25721417|NCT02486328|Narcotics|narcotics|mesh-ancestor
25721418|NCT02486328|Analgesics|analgesics|mesh-ancestor
25721419|NCT02486328|Sensory System Agents|sensory system agents|mesh-ancestor
25721420|NCT02486328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721421|NCT02486406|Ritonavir|ritonavir|mesh-list
25721422|NCT02486406|Ribavirin|ribavirin|mesh-list
25721423|NCT02486406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25721424|NCT02486406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25721425|NCT02486406|Protease Inhibitors|protease inhibitors|mesh-ancestor
25721426|NCT02486406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25721427|NCT02486406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721428|NCT02486406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25721429|NCT02486406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25721430|NCT02486406|Antiviral Agents|antiviral agents|mesh-ancestor
25721431|NCT02486406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25721432|NCT02486406|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25721433|NCT02486406|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25721434|NCT02486406|Antimetabolites|antimetabolites|mesh-ancestor
25721435|NCT02486627|Levofloxacin|levofloxacin|mesh-list
25721436|NCT02486627|Ofloxacin|ofloxacin|mesh-list
25721437|NCT02486627|Meropenem|meropenem|mesh-list
25721438|NCT02486627|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25721439|NCT02486627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25721440|NCT02486627|Renal Agents|renal agents|mesh-ancestor
25721441|NCT02486627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25721442|NCT02486627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25721443|NCT02486627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25721444|NCT02486627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25721445|NCT02486627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721446|NCT02486627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25721447|NCT02486627|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25721448|NCT02486627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25721449|NCT02486653|Tamsulosin|tamsulosin|mesh-list
25721450|NCT02486653|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25721451|NCT02486653|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25721452|NCT02486653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25721453|NCT02486653|Adrenergic Agents|adrenergic agents|mesh-ancestor
25721454|NCT02486653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25721455|NCT02486653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721456|NCT02486653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721457|NCT02486653|Urological Agents|urological agents|mesh-ancestor
25721458|NCT02486757|Estradiol|estradiol|mesh-list
25721459|NCT02486757|Progesterone|progesterone|mesh-list
25721460|NCT02486757|Estrogens|estrogens|mesh-ancestor
25721461|NCT02486757|Hormones|hormones|mesh-ancestor
25721462|NCT02486757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25721463|NCT02486757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721464|NCT02486757|Progestins|progestins|mesh-ancestor
25721465|NCT02486796|Ubiquinone|ubiquinone|mesh-list
25721466|NCT02486796|Coenzyme Q10|coenzyme q10|mesh-list
25721467|NCT02486796|Melatonin|melatonin|mesh-list
25721468|NCT02486796|Antioxidants|antioxidants|mesh-ancestor
25721469|NCT02486796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721470|NCT02486796|Protective Agents|protective agents|mesh-ancestor
25721471|NCT02486796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721472|NCT02486796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25721473|NCT02486796|Micronutrients|micronutrients|mesh-ancestor
25721474|NCT02486796|Vitamins|vitamins|mesh-ancestor
25721475|NCT02486952|Prednisone|prednisone|mesh-list
25721476|NCT02486952|Cyclophosphamide|cyclophosphamide|mesh-list
25721477|NCT02486952|Rituximab|rituximab|mesh-list
25721478|NCT02486952|Vincristine|vincristine|mesh-list
25721479|NCT02486952|Doxorubicin|doxorubicin|mesh-list
25721480|NCT02486952|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25721481|NCT02486952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25721482|NCT02486952|Immunologic Factors|immunologic factors|mesh-ancestor
25721483|NCT02486952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721484|NCT02486952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25721485|NCT02486952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25721486|NCT02486952|Alkylating Agents|alkylating agents|mesh-ancestor
25721487|NCT02486952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721488|NCT02486952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25721489|NCT02486952|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25721490|NCT02486952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25721491|NCT02486952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25721492|NCT02486952|Glucocorticoids|glucocorticoids|mesh-ancestor
25721493|NCT02486952|Hormones|hormones|mesh-ancestor
25721494|NCT02486952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25721495|NCT02486952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25721496|NCT02486952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25721497|NCT02486952|Tubulin Modulators|tubulin modulators|mesh-ancestor
25721498|NCT02486952|Antimitotic Agents|antimitotic agents|mesh-ancestor
25721499|NCT02486952|Mitosis Modulators|mitosis modulators|mesh-ancestor
25721500|NCT02486952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25721501|NCT02486952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25721502|NCT02486952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25721503|NCT02486952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25721504|NCT02487030|Sofosbuvir|sofosbuvir|mesh-list
25721505|NCT02487030|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25721506|NCT02487030|Ledipasvir|ledipasvir|mesh-list
25721507|NCT02487030|Antiviral Agents|antiviral agents|mesh-ancestor
25721508|NCT02487030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25721509|NCT02487199|Ritonavir|ritonavir|mesh-list
25721510|NCT02487199|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25721511|NCT02487199|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
24420682|NCT00216567|Anticonvulsants|anticonvulsants|mesh-ancestor
25721512|NCT02487199|Protease Inhibitors|protease inhibitors|mesh-ancestor
25721514|NCT02487199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721515|NCT02487199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25721516|NCT02487199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25721517|NCT02487199|Antiviral Agents|antiviral agents|mesh-ancestor
25721518|NCT02487199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25721519|NCT02487199|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25721520|NCT02487199|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25721521|NCT02487225|Pentoxifylline|pentoxifylline|mesh-list
25721522|NCT02487225|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25721523|NCT02487225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25721524|NCT02487225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721525|NCT02487225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25721526|NCT02487225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25721527|NCT02487225|Protective Agents|protective agents|mesh-ancestor
25721528|NCT02487225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721529|NCT02487225|Vasodilator Agents|vasodilator agents|mesh-ancestor
25721530|NCT02487225|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25721531|NCT02487225|Antioxidants|antioxidants|mesh-ancestor
25721532|NCT02487303|Acetaminophen|acetaminophen|mesh-list
25721533|NCT02487303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25721534|NCT02487303|Analgesics|analgesics|mesh-ancestor
25721535|NCT02487303|Sensory System Agents|sensory system agents|mesh-ancestor
25721536|NCT02487303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721537|NCT02487303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721538|NCT02487303|Antipyretics|antipyretics|mesh-ancestor
25721539|NCT02487446|Glycopyrrolate|glycopyrrolate|mesh-list
25721540|NCT02487446|Bromides|bromides|mesh-list
25721541|NCT02487446|Anticonvulsants|anticonvulsants|mesh-ancestor
25721542|NCT02487446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721543|NCT02487446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25721544|NCT02487446|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25721545|NCT02487446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25721546|NCT02487446|Cholinergic Agents|cholinergic agents|mesh-ancestor
25721547|NCT02487446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25721548|NCT02487446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721550|NCT02487485|Ketamine|ketamine|mesh-list
25721551|NCT02487485|Analgesics|analgesics|mesh-ancestor
25721552|NCT02487485|Sensory System Agents|sensory system agents|mesh-ancestor
25721553|NCT02487485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721554|NCT02487485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721555|NCT02487485|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25721556|NCT02487485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25721557|NCT02487485|Anesthetics, General|anesthetics, general|mesh-ancestor
25721558|NCT02487485|Anesthetics|anesthetics|mesh-ancestor
25721559|NCT02487485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25721560|NCT02487485|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25721561|NCT02487485|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25721562|NCT02487485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25721563|NCT02487485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721564|NCT02487485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25721565|NCT02487485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25721566|NCT02487485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25721567|NCT02487485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25721569|NCT02487485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25721570|NCT02487485|Immunologic Factors|immunologic factors|mesh-ancestor
25771894|NCT03642873|Sensory System Agents|sensory system agents|mesh-ancestor
25771895|NCT03642873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771896|NCT03642873|Antitussive Agents|antitussive agents|mesh-ancestor
25771897|NCT03642873|Respiratory System Agents|respiratory system agents|mesh-ancestor
25771898|NCT03642873|Expectorants|expectorants|mesh-ancestor
25771899|NCT03642873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25771900|NCT03642873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25771901|NCT03642873|Adrenergic Agents|adrenergic agents|mesh-ancestor
25771902|NCT03642873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25771903|NCT03642873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771904|NCT03642873|Appetite Depressants|appetite depressants|mesh-ancestor
25771905|NCT03642873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25771906|NCT03642873|Sympathomimetics|sympathomimetics|mesh-ancestor
25771907|NCT03642873|Autonomic Agents|autonomic agents|mesh-ancestor
25771908|NCT03642873|Nasal Decongestants|nasal decongestants|mesh-ancestor
25771909|NCT03642873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25771910|NCT03643575|Phenylpropanolamine|phenylpropanolamine|mesh-list
25771911|NCT03643575|Guaifenesin|guaifenesin|mesh-list
25771912|NCT03643575|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
25771913|NCT03643575|Expectorants|expectorants|mesh-ancestor
25771914|NCT03643575|Respiratory System Agents|respiratory system agents|mesh-ancestor
25771915|NCT03643575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25771916|NCT03643575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25771917|NCT03643575|Adrenergic Agents|adrenergic agents|mesh-ancestor
25771918|NCT03643575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25771919|NCT03643575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771920|NCT03643575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771921|NCT03643575|Appetite Depressants|appetite depressants|mesh-ancestor
25771922|NCT03643575|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25771923|NCT03643575|Sympathomimetics|sympathomimetics|mesh-ancestor
25771924|NCT03643575|Autonomic Agents|autonomic agents|mesh-ancestor
25771925|NCT03643575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771926|NCT03643575|Nasal Decongestants|nasal decongestants|mesh-ancestor
25771927|NCT03643575|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25771928|NCT03643952|Daptomycin|daptomycin|mesh-list
25771929|NCT03643952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25771930|NCT03643952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25771931|NCT03644095|Phenylpropanolamine|phenylpropanolamine|mesh-list
25771932|NCT03644095|Guaifenesin|guaifenesin|mesh-list
25771933|NCT03644095|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
25771934|NCT03644095|Expectorants|expectorants|mesh-ancestor
25771935|NCT03644095|Respiratory System Agents|respiratory system agents|mesh-ancestor
25771936|NCT03644095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25771937|NCT03644095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25771938|NCT03644095|Adrenergic Agents|adrenergic agents|mesh-ancestor
25771939|NCT03644095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25771940|NCT03644095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771941|NCT03644095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771942|NCT03644095|Appetite Depressants|appetite depressants|mesh-ancestor
25771943|NCT03644095|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25771944|NCT03644095|Sympathomimetics|sympathomimetics|mesh-ancestor
25771945|NCT03644095|Autonomic Agents|autonomic agents|mesh-ancestor
25771946|NCT03644095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771947|NCT03644095|Nasal Decongestants|nasal decongestants|mesh-ancestor
25771948|NCT03644095|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25771949|NCT03644108|Guaifenesin|guaifenesin|mesh-list
25771950|NCT03644108|Expectorants|expectorants|mesh-ancestor
25771951|NCT03644108|Respiratory System Agents|respiratory system agents|mesh-ancestor
25771952|NCT03644212|Vitamin D|vitamin d|mesh-list
25771953|NCT03644212|Cholecalciferol|cholecalciferol|mesh-list
25771954|NCT03644212|Vitamins|vitamins|mesh-list
25771955|NCT03644212|Micronutrients|micronutrients|mesh-ancestor
25771956|NCT03644212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771957|NCT03644212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25771958|NCT03644212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25721571|NCT02487498|Glycopyrrolate|glycopyrrolate|mesh-list
25721572|NCT02487498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25721573|NCT02487498|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25721574|NCT02487498|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25721575|NCT02487498|Cholinergic Agents|cholinergic agents|mesh-ancestor
25721576|NCT02487498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25721577|NCT02487498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721578|NCT02487498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721579|NCT02487563|Decitabine|decitabine|mesh-list
25721580|NCT02487563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25721581|NCT02487563|Antimetabolites|antimetabolites|mesh-ancestor
25407896|NCT03471260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25721582|NCT02487563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721583|NCT02487563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25721584|NCT02487563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25721585|NCT02488070|Edetic Acid|edetic acid|mesh-list
25721586|NCT02488070|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25721587|NCT02488070|Chelating Agents|chelating agents|mesh-ancestor
25721589|NCT02488070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721590|NCT02488070|Anticoagulants|anticoagulants|mesh-ancestor
25721591|NCT02488070|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25721592|NCT02488070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25721593|NCT02488330|Bevacizumab|bevacizumab|mesh-list
25721594|NCT02488330|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25721595|NCT02488330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25721596|NCT02488330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25721597|NCT02488330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25721598|NCT02488330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25721599|NCT02488330|Growth Substances|growth substances|mesh-ancestor
25721600|NCT02488330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721601|NCT02488330|Growth Inhibitors|growth inhibitors|mesh-ancestor
25721602|NCT02488330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25721603|NCT02488330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25721604|NCT02488330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407897|NCT03471260|Antimetabolites|antimetabolites|mesh-ancestor
25721606|NCT02488980|Tafenoquine|tafenoquine|mesh-list
25721607|NCT02488980|Antimalarials|antimalarials|mesh-ancestor
25721608|NCT02488980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25721609|NCT02488980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25721610|NCT02488980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25721611|NCT02489227|Adalimumab|adalimumab|mesh-list
25721612|NCT02489227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25721613|NCT02489227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25721614|NCT02489357|Pembrolizumab|pembrolizumab|mesh-list
25721615|NCT02489357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25721616|NCT02489357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25721617|NCT02489500|Bortezomib|bortezomib|mesh-list
25721618|NCT02489500|Melphalan|melphalan|mesh-list
25721619|NCT02489500|Lenograstim|lenograstim|mesh-list
25771959|NCT03647709|Analgesics, Opioid|analgesics, opioid|mesh-list
25771960|NCT03647709|Narcotics|narcotics|mesh-ancestor
25771961|NCT03647709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25771962|NCT03647709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771963|NCT03647709|Analgesics|analgesics|mesh-ancestor
25771964|NCT03647709|Sensory System Agents|sensory system agents|mesh-ancestor
25771965|NCT03647709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721620|NCT02489500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25721621|NCT02489500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25721622|NCT02489500|Alkylating Agents|alkylating agents|mesh-ancestor
25721623|NCT02489500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721624|NCT02489500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25721625|NCT02489500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25721626|NCT02489500|Immunologic Factors|immunologic factors|mesh-ancestor
25721627|NCT02489500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721628|NCT02489500|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25721630|NCT02489630|Analgesics|analgesics|mesh-list
25721631|NCT02489630|Sensory System Agents|sensory system agents|mesh-ancestor
25721632|NCT02489630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721633|NCT02489630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721634|NCT02489630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25721635|NCT02489630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25721636|NCT02489630|Anesthetics, General|anesthetics, general|mesh-ancestor
25721637|NCT02489630|Anesthetics|anesthetics|mesh-ancestor
25721638|NCT02489630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25721639|NCT02489630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25721640|NCT02489630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25721641|NCT02489630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25721642|NCT02489630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721643|NCT02489734|Sevoflurane|sevoflurane|mesh-list
25721644|NCT02489734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25721645|NCT02489734|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25771966|NCT03649750|Guaifenesin|guaifenesin|mesh-list
25771967|NCT03649750|Expectorants|expectorants|mesh-ancestor
25771968|NCT03649750|Respiratory System Agents|respiratory system agents|mesh-ancestor
25771970|NCT03650387|Anesthetics, Local|anesthetics, local|mesh-ancestor
25721646|NCT02489734|Anesthetics, General|anesthetics, general|mesh-ancestor
25721647|NCT02489734|Anesthetics|anesthetics|mesh-ancestor
25721648|NCT02489734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25721649|NCT02489734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721650|NCT02489968|Empagliflozin|empagliflozin|mesh-list
25721651|NCT02489968|Linagliptin|linagliptin|mesh-list
25721652|NCT02489968|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25771971|NCT03650387|Anesthetics|anesthetics|mesh-ancestor
25771972|NCT03650387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25771973|NCT03650387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771974|NCT03650387|Sensory System Agents|sensory system agents|mesh-ancestor
25771975|NCT03650387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771976|NCT03650387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25771977|NCT03650387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25771978|NCT03650387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25771979|NCT03650387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25771980|NCT03650387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771981|NCT03652610|Vaccines|vaccines|mesh-list
25771982|NCT03652610|Immunologic Factors|immunologic factors|mesh-ancestor
25771983|NCT03652610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771984|NCT03652818|Acetaminophen|acetaminophen|mesh-list
25771985|NCT03652818|Pregabalin|pregabalin|mesh-list
25771986|NCT03652818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25771987|NCT03652818|Analgesics|analgesics|mesh-ancestor
25771988|NCT03652818|Sensory System Agents|sensory system agents|mesh-ancestor
25771989|NCT03652818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25771990|NCT03652818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25771991|NCT03652818|Antipyretics|antipyretics|mesh-ancestor
25771992|NCT03652818|Anticonvulsants|anticonvulsants|mesh-ancestor
25771993|NCT03652818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25771994|NCT03652818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25771995|NCT03652818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25771996|NCT03652818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25771997|NCT03652818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25771998|NCT03652818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25771999|NCT03652818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25772000|NCT03652818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25772001|NCT03653416|Bupivacaine|bupivacaine|mesh-list
25772002|NCT03653416|Anesthetics, Local|anesthetics, local|mesh-ancestor
25772003|NCT03653416|Anesthetics|anesthetics|mesh-ancestor
25772004|NCT03653416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25772005|NCT03653416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772006|NCT03653416|Sensory System Agents|sensory system agents|mesh-ancestor
25772007|NCT03653416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772008|NCT03653429|Tranexamic Acid|tranexamic acid|mesh-list
25772009|NCT03653429|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25772010|NCT03653429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25772011|NCT03653429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772012|NCT03653429|Hemostatics|hemostatics|mesh-ancestor
25772013|NCT03653429|Coagulants|coagulants|mesh-ancestor
25772014|NCT03654326|Naproxen|naproxen|mesh-list
25772015|NCT03654326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25772016|NCT03654326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25772017|NCT03654326|Analgesics|analgesics|mesh-ancestor
25772018|NCT03654326|Sensory System Agents|sensory system agents|mesh-ancestor
25772019|NCT03654326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772020|NCT03654326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772021|NCT03654326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25772022|NCT03654326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25772023|NCT03654326|Gout Suppressants|gout suppressants|mesh-ancestor
25772024|NCT03654326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25772025|NCT03654326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25721653|NCT02489968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721654|NCT02489968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25721655|NCT02489968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721656|NCT02489968|Incretins|incretins|mesh-ancestor
25721657|NCT02489968|Hormones|hormones|mesh-ancestor
25721658|NCT02489968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25721659|NCT02489968|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25721660|NCT02489968|Protease Inhibitors|protease inhibitors|mesh-ancestor
25721661|NCT02489968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25721662|NCT02489981|Tiotropium Bromide|tiotropium bromide|mesh-list
25721663|NCT02489981|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25721664|NCT02489981|Autonomic Agents|autonomic agents|mesh-ancestor
25721665|NCT02489981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721666|NCT02489981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721667|NCT02489981|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25721668|NCT02489981|Respiratory System Agents|respiratory system agents|mesh-ancestor
25721669|NCT02489981|Parasympatholytics|parasympatholytics|mesh-ancestor
25721670|NCT02489981|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25721671|NCT02489981|Cholinergic Agents|cholinergic agents|mesh-ancestor
25721672|NCT02489981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25721673|NCT02489981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721674|NCT02490293|Cephalosporins|cephalosporins|mesh-list
25721675|NCT02490293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25721676|NCT02490293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25721677|NCT02490475|Docetaxel|docetaxel|mesh-list
25721678|NCT02490475|Pertuzumab|pertuzumab|mesh-list
25721679|NCT02490475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25721680|NCT02490475|Tubulin Modulators|tubulin modulators|mesh-ancestor
25721681|NCT02490475|Antimitotic Agents|antimitotic agents|mesh-ancestor
25721682|NCT02490475|Mitosis Modulators|mitosis modulators|mesh-ancestor
25721683|NCT02490475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721684|NCT02490475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25721685|NCT02490631|Chlorhexidine|chlorhexidine|mesh-list
25721686|NCT02490631|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25721687|NCT02490631|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25721688|NCT02490631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25721689|NCT02490631|Disinfectants|disinfectants|mesh-ancestor
25721690|NCT02490631|Dermatologic Agents|dermatologic agents|mesh-ancestor
25721691|NCT02490670|Cephalexin|cephalexin|mesh-list
25721692|NCT02490670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25721693|NCT02490670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25721694|NCT02490878|Bevacizumab|bevacizumab|mesh-list
25721695|NCT02490878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25721696|NCT02490878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25721697|NCT02490878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25721698|NCT02490878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25721699|NCT02490878|Growth Substances|growth substances|mesh-ancestor
25721700|NCT02490878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721701|NCT02490878|Growth Inhibitors|growth inhibitors|mesh-ancestor
25721702|NCT02491437|Progesterone|progesterone|mesh-list
25721703|NCT02491437|Dydrogesterone|dydrogesterone|mesh-list
25721704|NCT02491437|Progestins|progestins|mesh-ancestor
25721705|NCT02491437|Hormones|hormones|mesh-ancestor
25721706|NCT02491437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25721707|NCT02491437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721708|NCT02491463|Vaccines|vaccines|mesh-list
25721709|NCT02491463|Immunologic Factors|immunologic factors|mesh-ancestor
25721710|NCT02491463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721711|NCT02491684|Interferons|interferons|mesh-list
25721712|NCT02491684|Interferon-beta|interferon-beta|mesh-list
25721713|NCT02491684|Interferon beta-1a|interferon beta-1a|mesh-list
25721714|NCT02491684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25721715|NCT02491684|Antiviral Agents|antiviral agents|mesh-ancestor
25721716|NCT02491684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25721717|NCT02491684|Immunologic Factors|immunologic factors|mesh-ancestor
25721718|NCT02491684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721719|NCT02491684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25721720|NCT02491788|Suvorexant|suvorexant|mesh-list
25777428|NCT03591458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721721|NCT02491788|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25721722|NCT02491788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25721723|NCT02491788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25721724|NCT02491788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721725|NCT02491788|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25721726|NCT02491788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25721727|NCT02491788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721728|NCT02491892|Pertuzumab|pertuzumab|mesh-list
25721729|NCT02491892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25721730|NCT02491892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25721731|NCT02491944|Osimertinib|osimertinib|mesh-list
25721732|NCT02491944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25721733|NCT02491944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25721734|NCT02491944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777429|NCT03591458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777430|NCT03591458|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25777431|NCT03591458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25777432|NCT03591458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25777433|NCT03591458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777434|NCT03591458|Adrenergic Agents|adrenergic agents|mesh-ancestor
25777435|NCT03591458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25777436|NCT03590743|Apixaban|apixaban|mesh-list
25777437|NCT03590743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25777438|NCT03590743|Antithrombins|antithrombins|mesh-ancestor
25777439|NCT03590743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25777440|NCT03590743|Protease Inhibitors|protease inhibitors|mesh-ancestor
25777441|NCT03590743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777442|NCT03590743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777443|NCT03590743|Anticoagulants|anticoagulants|mesh-ancestor
25777444|NCT03580382|Trametinib|trametinib|mesh-list
25777445|NCT03580382|Antibodies|antibodies|mesh-list
25777446|NCT03580382|Immunologic Factors|immunologic factors|mesh-ancestor
25777447|NCT03580382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777448|NCT03580382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25777449|NCT03580382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25777450|NCT03580382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25777451|NCT03580382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777452|NCT03565328|Niacinamide|niacinamide|mesh-list
25777453|NCT03565328|Niacin|niacin|mesh-list
25777454|NCT03565328|Nicotinic Acids|nicotinic acids|mesh-list
25777455|NCT03565328|Vitamin B Complex|vitamin b complex|mesh-ancestor
25777456|NCT03565328|Vitamins|vitamins|mesh-ancestor
25777457|NCT03565328|Micronutrients|micronutrients|mesh-ancestor
25777458|NCT03565328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777459|NCT03565328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25777460|NCT03565328|Antimetabolites|antimetabolites|mesh-ancestor
25777461|NCT03565328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777462|NCT03565328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25777463|NCT03565328|Vasodilator Agents|vasodilator agents|mesh-ancestor
25777464|NCT03543358|Immunoconjugates|immunoconjugates|mesh-list
25777465|NCT03543358|Immunologic Factors|immunologic factors|mesh-ancestor
25777466|NCT03543358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777467|NCT03538015|Carvedilol|carvedilol|mesh-list
25777468|NCT03538015|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25777469|NCT03538015|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25777470|NCT03538015|Adrenergic Agents|adrenergic agents|mesh-ancestor
25777471|NCT03538015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25777472|NCT03538015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25777473|NCT03538015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25777474|NCT03538015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25777475|NCT03538015|Antioxidants|antioxidants|mesh-ancestor
25777476|NCT03538015|Protective Agents|protective agents|mesh-ancestor
25777477|NCT03538015|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25777478|NCT03538015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25777479|NCT03538015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25777480|NCT03538015|Vasodilator Agents|vasodilator agents|mesh-ancestor
25777481|NCT03538015|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25777482|NCT03538015|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25777483|NCT03509207|Vorinostat|vorinostat|mesh-list
25777484|NCT03509207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25777485|NCT03509207|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25777486|NCT03509207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25721735|NCT02491944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721736|NCT02492451|Progesterone|progesterone|mesh-list
25721737|NCT02492451|Progestins|progestins|mesh-ancestor
25721738|NCT02492451|Hormones|hormones|mesh-ancestor
25721739|NCT02492451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25721740|NCT02492451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721741|NCT02492750|Dexamethasone|dexamethasone|mesh-list
25721742|NCT02492750|Dexamethasone acetate|dexamethasone acetate|mesh-list
25721743|NCT02492750|Lenalidomide|lenalidomide|mesh-list
25721744|NCT02492750|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25721745|NCT02492750|Ichthammol|ichthammol|mesh-list
25721746|NCT02492750|BB 1101|bb 1101|mesh-list
25721747|NCT02492750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25721748|NCT02492750|Antiemetics|antiemetics|mesh-ancestor
25721749|NCT02492750|Autonomic Agents|autonomic agents|mesh-ancestor
25721750|NCT02492750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721751|NCT02492750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721752|NCT02492750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25721753|NCT02492750|Glucocorticoids|glucocorticoids|mesh-ancestor
25721754|NCT02492750|Hormones|hormones|mesh-ancestor
25721755|NCT02492750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25721756|NCT02492750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25721757|NCT02492750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25721758|NCT02492750|Immunologic Factors|immunologic factors|mesh-ancestor
25721759|NCT02492750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25721760|NCT02492750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25721761|NCT02492750|Growth Substances|growth substances|mesh-ancestor
25721762|NCT02492750|Growth Inhibitors|growth inhibitors|mesh-ancestor
25721763|NCT02492750|Protease Inhibitors|protease inhibitors|mesh-ancestor
25721764|NCT02492750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25721765|NCT02492750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721766|NCT02492750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25721767|NCT02492750|Dermatologic Agents|dermatologic agents|mesh-ancestor
25721768|NCT02492763|Metformin|metformin|mesh-list
25721769|NCT02492763|Liraglutide|liraglutide|mesh-list
25721770|NCT02492763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25721771|NCT02492763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721772|NCT02492763|Incretins|incretins|mesh-ancestor
25721773|NCT02492763|Hormones|hormones|mesh-ancestor
25721774|NCT02492763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25721775|NCT02492802|Posaconazole|posaconazole|mesh-list
25721776|NCT02492802|Antifungal Agents|antifungal agents|mesh-ancestor
25721777|NCT02492802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25721778|NCT02492802|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25721779|NCT02492802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25721780|NCT02492802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25721781|NCT02492802|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25721782|NCT02492802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25721783|NCT02492802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25721784|NCT02492802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721785|NCT02492802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25721786|NCT02492802|Hormone Antagonists|hormone antagonists|mesh-ancestor
25721787|NCT02492802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25721788|NCT02492802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721789|NCT02492841|Calcium, Dietary|calcium, dietary|mesh-list
25721790|NCT02492841|Calcium|calcium|mesh-list
25721791|NCT02492841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25721792|NCT02492841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721793|NCT02492841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25721794|NCT02492984|Factor VIII|factor viii|mesh-list
25721795|NCT02492984|Coagulants|coagulants|mesh-ancestor
25721796|NCT02492997|Glycerol|glycerol|mesh-list
25721797|NCT02492997|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25721798|NCT02492997|Protective Agents|protective agents|mesh-ancestor
25721799|NCT02492997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721800|NCT02493257|Ethanol|ethanol|mesh-list
25721801|NCT02493257|Capsaicin|capsaicin|mesh-list
25721802|NCT02493257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25721803|NCT02493257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25721804|NCT02493257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25721805|NCT02493257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721806|NCT02493257|Antipruritics|antipruritics|mesh-ancestor
25721807|NCT02493257|Dermatologic Agents|dermatologic agents|mesh-ancestor
25721808|NCT02493257|Sensory System Agents|sensory system agents|mesh-ancestor
25721809|NCT02493257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721810|NCT02493361|Pembrolizumab|pembrolizumab|mesh-list
25721811|NCT02493361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25721812|NCT02493361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25721813|NCT02493452|Plecanatide|plecanatide|mesh-list
25721814|NCT02493452|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25721815|NCT02493452|Enzyme Activators|enzyme activators|mesh-ancestor
25721816|NCT02493452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721817|NCT02493452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25721818|NCT02493517|Lanreotide|lanreotide|mesh-list
25721819|NCT02493517|Somatostatin|somatostatin|mesh-list
25721820|NCT02493517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25721821|NCT02493517|Hormones|hormones|mesh-ancestor
25721822|NCT02493517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25721823|NCT02493517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721825|NCT02493712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25721826|NCT02493712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25721827|NCT02493712|Analgesics|analgesics|mesh-ancestor
25721828|NCT02493712|Sensory System Agents|sensory system agents|mesh-ancestor
25721829|NCT02493712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721830|NCT02493712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721831|NCT02493712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25721832|NCT02493712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25721833|NCT02493764|Tazobactam|tazobactam|mesh-list
25721834|NCT02493764|Linezolid|linezolid|mesh-list
25721835|NCT02493764|Piperacillin|piperacillin|mesh-list
25721836|NCT02493764|Imipenem|imipenem|mesh-list
25721837|NCT02493764|Relebactam|relebactam|mesh-list
25721838|NCT02493764|Cilastatin|cilastatin|mesh-list
25721839|NCT02493764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25721840|NCT02493764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25721841|NCT02493764|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25721842|NCT02493764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25721843|NCT02493764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721844|NCT02493764|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25721845|NCT02493764|Protease Inhibitors|protease inhibitors|mesh-ancestor
25721846|NCT02493777|Methylphenidate|methylphenidate|mesh-list
25721847|NCT02493777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25721848|NCT02493777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721849|NCT02493777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25721850|NCT02493777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25721851|NCT02493777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25721852|NCT02493777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721853|NCT02493777|Dopamine Agents|dopamine agents|mesh-ancestor
25721854|NCT02493777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25721855|NCT02493855|Ritonavir|ritonavir|mesh-list
25721856|NCT02493855|Ribavirin|ribavirin|mesh-list
25721857|NCT02493855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25721858|NCT02493855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25721859|NCT02493855|Protease Inhibitors|protease inhibitors|mesh-ancestor
25721860|NCT02493855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25721861|NCT02493855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721862|NCT02493855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25721863|NCT02493855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25721864|NCT02493855|Antiviral Agents|antiviral agents|mesh-ancestor
25721865|NCT02493855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25721866|NCT02493855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25721867|NCT02493855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25721868|NCT02493855|Antimetabolites|antimetabolites|mesh-ancestor
25721869|NCT02493868|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25721870|NCT02493868|Citalopram|citalopram|mesh-list
25721871|NCT02493868|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25721872|NCT02493868|Sertraline|sertraline|mesh-list
25721873|NCT02493868|Antidepressive Agents|antidepressive agents|mesh-list
25721874|NCT02493868|Esketamine|esketamine|mesh-list
25721875|NCT02493868|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25721876|NCT02493868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25721877|NCT02493868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25721878|NCT02493868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721879|NCT02493868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25721880|NCT02493868|Serotonin Agents|serotonin agents|mesh-ancestor
25721881|NCT02493868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721882|NCT02493868|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25721883|NCT02493868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25721884|NCT02493868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721885|NCT02493868|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25721886|NCT02493868|Analgesics|analgesics|mesh-ancestor
25721887|NCT02493868|Sensory System Agents|sensory system agents|mesh-ancestor
25721888|NCT02493868|Dopamine Agents|dopamine agents|mesh-ancestor
25721889|NCT02494102|Modafinil|modafinil|mesh-list
25721890|NCT02494102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25721891|NCT02494102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721892|NCT02494102|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25721893|NCT02494102|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25721894|NCT02494102|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25721895|NCT02494102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721896|NCT02494180|Fentanyl|fentanyl|mesh-list
25407972|NCT03467373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25721897|NCT02494180|Midazolam|midazolam|mesh-list
25721898|NCT02494180|Diazepam|diazepam|mesh-list
25721899|NCT02494180|Meperidine|meperidine|mesh-list
25721900|NCT02494180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25721901|NCT02494180|Narcotics|narcotics|mesh-ancestor
25721902|NCT02494180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25721903|NCT02494180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721904|NCT02494180|Analgesics|analgesics|mesh-ancestor
25721905|NCT02494180|Sensory System Agents|sensory system agents|mesh-ancestor
25721907|NCT02494180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25721908|NCT02494180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25721909|NCT02494180|Anesthetics, General|anesthetics, general|mesh-ancestor
25721910|NCT02494180|Anesthetics|anesthetics|mesh-ancestor
25721911|NCT02494180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25721912|NCT02494180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25721913|NCT02494180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25721914|NCT02494180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25721915|NCT02494180|GABA Modulators|gaba modulators|mesh-ancestor
25721916|NCT02494180|GABA Agents|gaba agents|mesh-ancestor
25721917|NCT02494180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25721918|NCT02494180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721919|NCT02494180|Anticonvulsants|anticonvulsants|mesh-ancestor
25721920|NCT02494180|Antiemetics|antiemetics|mesh-ancestor
25721921|NCT02494180|Autonomic Agents|autonomic agents|mesh-ancestor
25721922|NCT02494180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25721923|NCT02494180|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25721925|NCT02494336|Ropivacaine|ropivacaine|mesh-list
25721926|NCT02494336|Anesthetics, Local|anesthetics, local|mesh-ancestor
25721927|NCT02494336|Anesthetics|anesthetics|mesh-ancestor
25721928|NCT02494336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25721929|NCT02494336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721930|NCT02494336|Sensory System Agents|sensory system agents|mesh-ancestor
25721931|NCT02494336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721932|NCT02494596|Capecitabine|capecitabine|mesh-list
25721933|NCT02494596|Pertuzumab|pertuzumab|mesh-list
25721934|NCT02494596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25721935|NCT02494596|Antimetabolites|antimetabolites|mesh-ancestor
25721936|NCT02494596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721937|NCT02494596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25721938|NCT02494596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25721939|NCT02494713|Ketoconazole|ketoconazole|mesh-list
25721940|NCT02494713|Docetaxel|docetaxel|mesh-list
25721941|NCT02494713|Doxorubicin|doxorubicin|mesh-list
25721942|NCT02494713|Estramustine|estramustine|mesh-list
25721943|NCT02494713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25721944|NCT02494713|Tubulin Modulators|tubulin modulators|mesh-ancestor
25721945|NCT02494713|Antimitotic Agents|antimitotic agents|mesh-ancestor
25721946|NCT02494713|Mitosis Modulators|mitosis modulators|mesh-ancestor
25721947|NCT02494713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721948|NCT02494713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25721949|NCT02494713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25721950|NCT02494713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25721951|NCT02494713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25721952|NCT02494713|Antifungal Agents|antifungal agents|mesh-ancestor
25721953|NCT02494713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25721954|NCT02494713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25721955|NCT02494713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25721956|NCT02494713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25721957|NCT02494713|Hormone Antagonists|hormone antagonists|mesh-ancestor
25721958|NCT02494713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25721959|NCT02494713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721960|NCT02494713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25721961|NCT02494713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25721962|NCT02494713|Alkylating Agents|alkylating agents|mesh-ancestor
25721963|NCT02494713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25721964|NCT02495038|Rocuronium|rocuronium|mesh-list
25721965|NCT02495038|Atracurium|atracurium|mesh-list
25721966|NCT02495038|Cisatracurium|cisatracurium|mesh-list
25721967|NCT02495038|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25721968|NCT02495038|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25721969|NCT02495038|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25721970|NCT02495038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721971|NCT02495038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
24439861|NCT00280553|Anesthetics|anesthetics|mesh-ancestor
25721972|NCT02495038|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
25721973|NCT02495038|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25721974|NCT02495038|Cholinergic Agents|cholinergic agents|mesh-ancestor
25721975|NCT02495038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25721976|NCT02495038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721977|NCT02495103|Metformin|metformin|mesh-list
25721978|NCT02495103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25721979|NCT02495103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721981|NCT02495168|Formoterol Fumarate|formoterol fumarate|mesh-list
25721982|NCT02495168|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25721983|NCT02495168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25721984|NCT02495168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25721985|NCT02495168|Autonomic Agents|autonomic agents|mesh-ancestor
25721986|NCT02495168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25721987|NCT02495168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25721988|NCT02495168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25721989|NCT02495168|Respiratory System Agents|respiratory system agents|mesh-ancestor
25721990|NCT02495168|Glucocorticoids|glucocorticoids|mesh-ancestor
25721991|NCT02495168|Hormones|hormones|mesh-ancestor
25721992|NCT02495168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25721993|NCT02495168|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25721994|NCT02495168|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25721995|NCT02495168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25721996|NCT02495168|Adrenergic Agents|adrenergic agents|mesh-ancestor
25721997|NCT02495168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25721998|NCT02495168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25721999|NCT02495233|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25722000|NCT02495233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722001|NCT02495233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25722002|NCT02495233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722003|NCT02495233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722004|NCT02495389|Mirabegron|mirabegron|mesh-list
25722005|NCT02495389|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25722006|NCT02495389|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25722007|NCT02495389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25722008|NCT02495389|Adrenergic Agents|adrenergic agents|mesh-ancestor
25722009|NCT02495389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25722010|NCT02495389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722011|NCT02495389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722012|NCT02495389|Urological Agents|urological agents|mesh-ancestor
25722013|NCT02495454|Obinutuzumab|obinutuzumab|mesh-list
25722014|NCT02495454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25722015|NCT02495454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722016|NCT02495467|Nitroglycerin|nitroglycerin|mesh-list
25722017|NCT02495467|Vasodilator Agents|vasodilator agents|mesh-ancestor
25722018|NCT02495779|Tenofovir|tenofovir|mesh-list
25722019|NCT02495779|Emtricitabine|emtricitabine|mesh-list
25722020|NCT02495779|Antiviral Agents|antiviral agents|mesh-ancestor
25722021|NCT02495779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25722022|NCT02495779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25722023|NCT02495779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25722025|NCT02495779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722026|NCT02495779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25722027|NCT02495779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25722028|NCT02495831|Diclofenac|diclofenac|mesh-list
25722029|NCT02495831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25722030|NCT02495831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25722031|NCT02495831|Analgesics|analgesics|mesh-ancestor
25722032|NCT02495831|Sensory System Agents|sensory system agents|mesh-ancestor
25722033|NCT02495831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25722034|NCT02495831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722035|NCT02495831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25722036|NCT02495831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25722037|NCT02495831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25722038|NCT02495831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722039|NCT02495831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722040|NCT02495857|Hyaluronic Acid|hyaluronic acid|mesh-list
25722041|NCT02495857|Viscosupplements|viscosupplements|mesh-list
25722042|NCT02495857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25722043|NCT02495857|Immunologic Factors|immunologic factors|mesh-ancestor
25722044|NCT02495857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722045|NCT02495857|Protective Agents|protective agents|mesh-ancestor
25722046|NCT02495883|Ethanol|ethanol|mesh-list
25722047|NCT02495883|Propranolol|propranolol|mesh-list
25722048|NCT02495883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25722049|NCT02495883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25722051|NCT02495883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25722052|NCT02495883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722053|NCT02495883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722054|NCT02495883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25722055|NCT02495883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25722056|NCT02495883|Vasodilator Agents|vasodilator agents|mesh-ancestor
25722057|NCT02495883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25722058|NCT02495883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25722059|NCT02495883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25772026|NCT03654326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772027|NCT03654417|Lidocaine|lidocaine|mesh-list
25772028|NCT03654417|Anesthetics, Local|anesthetics, local|mesh-ancestor
25722061|NCT02495948|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25772029|NCT03654417|Anesthetics|anesthetics|mesh-ancestor
25772030|NCT03654417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25722062|NCT02495948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25722063|NCT02495948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25722064|NCT02496000|Insulin|insulin|mesh-list
25722065|NCT02496000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25722066|NCT02496000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772031|NCT03654417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772032|NCT03654417|Sensory System Agents|sensory system agents|mesh-ancestor
25772033|NCT03654417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772034|NCT03654417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25772035|NCT03654417|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25772036|NCT03654417|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25772037|NCT03654417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25772038|NCT03654417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772039|NCT03655080|Paclitaxel|paclitaxel|mesh-list
25772040|NCT03655080|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25772041|NCT03655080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25772042|NCT03655080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25772043|NCT03655080|Tubulin Modulators|tubulin modulators|mesh-ancestor
25772044|NCT03655080|Antimitotic Agents|antimitotic agents|mesh-ancestor
25772045|NCT03655080|Mitosis Modulators|mitosis modulators|mesh-ancestor
25772046|NCT03655080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772047|NCT03655301|Metformin|metformin|mesh-list
25772048|NCT03655301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25772049|NCT03655301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772050|NCT03655444|Nivolumab|nivolumab|mesh-list
25772051|NCT03655444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25772052|NCT03655444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25772053|NCT03655444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25772054|NCT03655444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772055|NCT03657095|Beraprost|beraprost|mesh-list
25772056|NCT03657095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25772057|NCT03657095|Vasodilator Agents|vasodilator agents|mesh-ancestor
25772058|NCT03657407|Glycerol|glycerol|mesh-list
25772059|NCT03657407|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25772060|NCT03657407|Protective Agents|protective agents|mesh-ancestor
25772061|NCT03657407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772062|NCT03658876|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25772063|NCT03658876|Hematinics|hematinics|mesh-ancestor
25772064|NCT03661346|Labetalol|labetalol|mesh-list
25772065|NCT03661346|Esmolol|esmolol|mesh-list
25772066|NCT03661346|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25772067|NCT03661346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25772068|NCT03661346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25772069|NCT03661346|Adrenergic Agents|adrenergic agents|mesh-ancestor
25772070|NCT03661346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25722067|NCT02496221|rGLP-1 protein|rglp-1 protein|mesh-list
25722068|NCT02496221|Incretins|incretins|mesh-ancestor
25722069|NCT02496221|Hormones|hormones|mesh-ancestor
25722070|NCT02496221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25722071|NCT02496221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722072|NCT02497001|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25722073|NCT02497001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25722074|NCT02497001|Respiratory System Agents|respiratory system agents|mesh-ancestor
25722076|NCT02497040|Levobupivacaine|levobupivacaine|mesh-list
25722077|NCT02497040|Anesthetics, Local|anesthetics, local|mesh-ancestor
25722078|NCT02497040|Anesthetics|anesthetics|mesh-ancestor
25722079|NCT02497040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25722080|NCT02497040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722081|NCT02497040|Sensory System Agents|sensory system agents|mesh-ancestor
25722082|NCT02497040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25722083|NCT02497287|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25722084|NCT02497287|Citalopram|citalopram|mesh-list
25722085|NCT02497287|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25722086|NCT02497287|Sertraline|sertraline|mesh-list
25722087|NCT02497287|Antidepressive Agents|antidepressive agents|mesh-list
25722088|NCT02497287|Esketamine|esketamine|mesh-list
25722089|NCT02497287|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25722090|NCT02497287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25722091|NCT02497287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25722092|NCT02497287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722093|NCT02497287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25722094|NCT02497287|Serotonin Agents|serotonin agents|mesh-ancestor
25722095|NCT02497287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722096|NCT02497287|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25722097|NCT02497287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25722098|NCT02497287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25722099|NCT02497287|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25722100|NCT02497287|Analgesics|analgesics|mesh-ancestor
25722101|NCT02497287|Sensory System Agents|sensory system agents|mesh-ancestor
25722102|NCT02497287|Dopamine Agents|dopamine agents|mesh-ancestor
25722103|NCT02497391|Evacetrapib|evacetrapib|mesh-list
25722104|NCT02497391|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25722105|NCT02497391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25722106|NCT02497391|Antimetabolites|antimetabolites|mesh-ancestor
25722107|NCT02497391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722109|NCT02497404|Fludarabine|fludarabine|mesh-list
25722110|NCT02497404|Azacitidine|azacitidine|mesh-list
25722111|NCT02497404|Melphalan|melphalan|mesh-list
25722112|NCT02497404|Alemtuzumab|alemtuzumab|mesh-list
25722113|NCT02497404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722114|NCT02497404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25722116|NCT02497404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722117|NCT02497404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25722118|NCT02497404|Immunologic Factors|immunologic factors|mesh-ancestor
25722119|NCT02497404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722120|NCT02497404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722121|NCT02497404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25722122|NCT02497404|Alkylating Agents|alkylating agents|mesh-ancestor
25722123|NCT02497404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25722124|NCT02497404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25722125|NCT02497469|Adalimumab|adalimumab|mesh-list
25722126|NCT02497469|Vedolizumab|vedolizumab|mesh-list
25722127|NCT02497469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25722128|NCT02497469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25722129|NCT02497469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25722130|NCT02497781|Ceftazidime|ceftazidime|mesh-list
25722131|NCT02497781|Cefepime|cefepime|mesh-list
25722132|NCT02497781|Avibactam|avibactam|mesh-list
25722133|NCT02497781|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
25722134|NCT02497781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25722135|NCT02497781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25722136|NCT02497781|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25722137|NCT02497781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722138|NCT02497781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722139|NCT02497976|Certolizumab Pegol|certolizumab pegol|mesh-list
25722140|NCT02497976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
24442899|NCT00293163|Hylan|hylan|mesh-list
25722141|NCT02497976|Immunologic Factors|immunologic factors|mesh-ancestor
25722143|NCT02497976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25722144|NCT02498236|Oxytocin|oxytocin|mesh-list
25722145|NCT02498236|Oxytocics|oxytocics|mesh-ancestor
25722146|NCT02498236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25722147|NCT02498236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722148|NCT02498418|Rifaximin|rifaximin|mesh-list
25722149|NCT02498418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25722150|NCT02498418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25722151|NCT02498418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25722152|NCT02498483|Acetaminophen|acetaminophen|mesh-list
25722153|NCT02498483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25722155|NCT02498483|Sensory System Agents|sensory system agents|mesh-ancestor
25722156|NCT02498483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25722157|NCT02498483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722158|NCT02498483|Antipyretics|antipyretics|mesh-ancestor
25722159|NCT02498522|Metformin|metformin|mesh-list
25722160|NCT02498522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25722161|NCT02498522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722162|NCT02498652|Allopurinol|allopurinol|mesh-list
25722163|NCT02498652|Verinurad|verinurad|mesh-list
25722164|NCT02498652|Antimetabolites|antimetabolites|mesh-ancestor
25722165|NCT02498652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722166|NCT02498652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722167|NCT02498652|Gout Suppressants|gout suppressants|mesh-ancestor
25722168|NCT02498652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25722169|NCT02498652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25722170|NCT02498652|Antioxidants|antioxidants|mesh-ancestor
25722171|NCT02498652|Protective Agents|protective agents|mesh-ancestor
25722172|NCT02498652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722174|NCT02498769|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25722175|NCT02498769|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25722176|NCT02498769|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25722177|NCT02498769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25722178|NCT02498769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722179|NCT02498769|Cholinergic Agents|cholinergic agents|mesh-ancestor
25722180|NCT02498769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25722181|NCT02498769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722182|NCT02498769|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25722183|NCT02498769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25722184|NCT02499029|Acetylcysteine|acetylcysteine|mesh-list
25722185|NCT02499029|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25722186|NCT02499029|Antiviral Agents|antiviral agents|mesh-ancestor
25722187|NCT02499029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25722188|NCT02499029|Expectorants|expectorants|mesh-ancestor
25722189|NCT02499029|Respiratory System Agents|respiratory system agents|mesh-ancestor
25722190|NCT02499029|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25722191|NCT02499029|Antioxidants|antioxidants|mesh-ancestor
25722192|NCT02499029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722193|NCT02499029|Protective Agents|protective agents|mesh-ancestor
25722194|NCT02499029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722195|NCT02499029|Antidotes|antidotes|mesh-ancestor
25722196|NCT02499081|Ixazomib|ixazomib|mesh-list
25722197|NCT02499081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722198|NCT02499081|Protease Inhibitors|protease inhibitors|mesh-ancestor
25722199|NCT02499081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722200|NCT02499081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722201|NCT02499159|Bupivacaine|bupivacaine|mesh-list
25722202|NCT02499159|Anesthetics, Local|anesthetics, local|mesh-ancestor
25722203|NCT02499159|Anesthetics|anesthetics|mesh-ancestor
25722204|NCT02499159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25722205|NCT02499159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722206|NCT02499159|Sensory System Agents|sensory system agents|mesh-ancestor
25722207|NCT02499159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25722208|NCT02499497|Androgens|androgens|mesh-list
25722209|NCT02499497|Hormones|hormones|mesh-ancestor
25722210|NCT02499497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25722211|NCT02499497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722212|NCT02499575|Bupivacaine|bupivacaine|mesh-list
25722213|NCT02499575|Ropivacaine|ropivacaine|mesh-list
25722214|NCT02499575|Anesthetics, Local|anesthetics, local|mesh-ancestor
25722215|NCT02499575|Anesthetics|anesthetics|mesh-ancestor
25722216|NCT02499575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25722217|NCT02499575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722219|NCT02499575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25722220|NCT02499770|Carboplatin|carboplatin|mesh-list
25722221|NCT02499770|Etoposide|etoposide|mesh-list
25722222|NCT02499770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722223|NCT02499770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25722224|NCT02499770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25722225|NCT02499770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25722226|NCT02499770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722227|NCT02499770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722228|NCT02499783|Adalimumab|adalimumab|mesh-list
25722229|NCT02499783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25722230|NCT02499783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25722231|NCT02500602|Doxazosin|doxazosin|mesh-list
25722232|NCT02500602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25722233|NCT02500602|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25722234|NCT02500602|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25722235|NCT02500602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25722236|NCT02500602|Adrenergic Agents|adrenergic agents|mesh-ancestor
25722237|NCT02500602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25722238|NCT02500602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722239|NCT02500602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722240|NCT02500628|Metformin|metformin|mesh-list
25722241|NCT02500628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25722242|NCT02500628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722243|NCT02500641|Naproxen|naproxen|mesh-list
25722244|NCT02500641|Colchicine|colchicine|mesh-list
25722245|NCT02500641|Allopurinol|allopurinol|mesh-list
25722246|NCT02500641|Febuxostat|febuxostat|mesh-list
25722247|NCT02500641|Omeprazole|omeprazole|mesh-list
25722248|NCT02500641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25722249|NCT02500641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25722250|NCT02500641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25722251|NCT02500641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722252|NCT02500641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722253|NCT02500641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25722254|NCT02500641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25722255|NCT02500641|Analgesics|analgesics|mesh-ancestor
25722256|NCT02500641|Sensory System Agents|sensory system agents|mesh-ancestor
25722257|NCT02500641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25722258|NCT02500641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722259|NCT02500641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25722260|NCT02500641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25722261|NCT02500641|Gout Suppressants|gout suppressants|mesh-ancestor
25722262|NCT02500641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25722263|NCT02500641|Tubulin Modulators|tubulin modulators|mesh-ancestor
25722264|NCT02500641|Antimitotic Agents|antimitotic agents|mesh-ancestor
25722265|NCT02500641|Mitosis Modulators|mitosis modulators|mesh-ancestor
25722266|NCT02500641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722267|NCT02500641|Antimetabolites|antimetabolites|mesh-ancestor
25722268|NCT02500641|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25722269|NCT02500641|Antioxidants|antioxidants|mesh-ancestor
25722270|NCT02500641|Protective Agents|protective agents|mesh-ancestor
25722271|NCT02500706|Insulin|insulin|mesh-list
25722272|NCT02500706|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25722273|NCT02500706|Insulin Aspart|insulin aspart|mesh-list
25722274|NCT02500706|Insulin, Long-Acting|insulin, long-acting|mesh-list
25722275|NCT02500706|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25722276|NCT02500706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25722277|NCT02500706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722278|NCT02500732|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25722279|NCT02500732|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25722280|NCT02500732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25722281|NCT02500732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25722282|NCT02500732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722283|NCT02500732|Adrenergic Agents|adrenergic agents|mesh-ancestor
25722284|NCT02500732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25722285|NCT02500732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722286|NCT02500758|Chloroxylenol|chloroxylenol|mesh-list
25722287|NCT02500758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25722288|NCT02500758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25722289|NCT02500758|Disinfectants|disinfectants|mesh-ancestor
25722290|NCT02500758|Schistosomicides|schistosomicides|mesh-ancestor
25722291|NCT02500758|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25722292|NCT02500758|Anthelmintics|anthelmintics|mesh-ancestor
25722293|NCT02500758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25722294|NCT02500836|Cocaine|cocaine|mesh-list
25722295|NCT02500836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25722296|NCT02500836|Anesthetics, Local|anesthetics, local|mesh-ancestor
25722297|NCT02500836|Anesthetics|anesthetics|mesh-ancestor
25722298|NCT02500836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25722299|NCT02500836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722300|NCT02500836|Sensory System Agents|sensory system agents|mesh-ancestor
25722301|NCT02500836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25722302|NCT02500836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25722303|NCT02500836|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25722304|NCT02500836|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25722305|NCT02500836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25722306|NCT02500836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722307|NCT02500836|Dopamine Agents|dopamine agents|mesh-ancestor
25722308|NCT02500836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25722309|NCT02500979|Insulin|insulin|mesh-list
25722310|NCT02500979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25722311|NCT02500979|Insulin Lispro|insulin lispro|mesh-list
25722313|NCT02500979|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
25722314|NCT02500979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25722315|NCT02500979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722316|NCT02500979|Appetite Depressants|appetite depressants|mesh-ancestor
25722317|NCT02500979|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25722318|NCT02500979|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
25722319|NCT02500979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722320|NCT02501135|Bupivacaine|bupivacaine|mesh-list
25722321|NCT02501135|Ropivacaine|ropivacaine|mesh-list
25722322|NCT02501135|Anesthetics, Local|anesthetics, local|mesh-ancestor
25722323|NCT02501135|Anesthetics|anesthetics|mesh-ancestor
25722324|NCT02501135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25722325|NCT02501135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722326|NCT02501135|Sensory System Agents|sensory system agents|mesh-ancestor
25722327|NCT02501135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25722328|NCT02501161|Insulin|insulin|mesh-list
25722329|NCT02501161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25722330|NCT02501161|Insulin Glargine|insulin glargine|mesh-list
25722331|NCT02501161|Liraglutide|liraglutide|mesh-list
25722332|NCT02501161|Xultophy|xultophy|mesh-list
25722333|NCT02501161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25722334|NCT02501161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722335|NCT02501161|Incretins|incretins|mesh-ancestor
25722336|NCT02501161|Hormones|hormones|mesh-ancestor
25722337|NCT02501161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25722338|NCT02501265|Nicotine|nicotine|mesh-list
25722339|NCT02501265|Varenicline|varenicline|mesh-list
25722340|NCT02501265|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25722341|NCT02501265|Autonomic Agents|autonomic agents|mesh-ancestor
25722342|NCT02501265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25722343|NCT02501265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722344|NCT02501265|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25722345|NCT02501265|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25722346|NCT02501265|Cholinergic Agents|cholinergic agents|mesh-ancestor
25722347|NCT02501265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25722348|NCT02501265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722349|NCT02501473|Rituximab|rituximab|mesh-list
25722350|NCT02501473|Pembrolizumab|pembrolizumab|mesh-list
25722351|NCT02501473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25722352|NCT02501473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722353|NCT02501473|Immunologic Factors|immunologic factors|mesh-ancestor
25722354|NCT02501473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722355|NCT02501473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25722356|NCT02501629|Reslizumab|reslizumab|mesh-list
25722357|NCT02501629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25722358|NCT02501629|Respiratory System Agents|respiratory system agents|mesh-ancestor
25722359|NCT02501811|Plasma-lyte 148|plasma-lyte 148|mesh-list
25722360|NCT02501811|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25722361|NCT02501811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25722362|NCT02501902|Paclitaxel|paclitaxel|mesh-list
25722363|NCT02501902|Palbociclib|palbociclib|mesh-list
25722364|NCT02501902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25722365|NCT02501902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722366|NCT02501902|Tubulin Modulators|tubulin modulators|mesh-ancestor
25722367|NCT02501902|Antimitotic Agents|antimitotic agents|mesh-ancestor
25722368|NCT02501902|Mitosis Modulators|mitosis modulators|mesh-ancestor
25722369|NCT02501902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722370|NCT02501902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25722371|NCT02501902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722373|NCT02501928|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25722374|NCT02501928|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25722375|NCT02501928|Cholinergic Agents|cholinergic agents|mesh-ancestor
25722376|NCT02501928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25722377|NCT02501928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722378|NCT02501928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722380|NCT02502149|Factor VIII|factor viii|mesh-list
25722381|NCT02502149|Coagulants|coagulants|mesh-ancestor
25722382|NCT02502487|Ropivacaine|ropivacaine|mesh-list
25722383|NCT02502487|Tetracaine|tetracaine|mesh-list
25722384|NCT02502487|Anesthetics, Local|anesthetics, local|mesh-ancestor
25722385|NCT02502487|Anesthetics|anesthetics|mesh-ancestor
25722386|NCT02502487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25722387|NCT02502487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722388|NCT02502487|Sensory System Agents|sensory system agents|mesh-ancestor
25722389|NCT02502487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25722391|NCT02502734|Xhance|xhance|mesh-list
25722392|NCT02502734|Albuterol|albuterol|mesh-list
25722393|NCT02502734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25722394|NCT02502734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25722395|NCT02502734|Autonomic Agents|autonomic agents|mesh-ancestor
25722396|NCT02502734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25722397|NCT02502734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722398|NCT02502734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25722399|NCT02502734|Respiratory System Agents|respiratory system agents|mesh-ancestor
25722400|NCT02502734|Dermatologic Agents|dermatologic agents|mesh-ancestor
25722401|NCT02502734|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25722402|NCT02502734|Tocolytic Agents|tocolytic agents|mesh-ancestor
25722403|NCT02502734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25722404|NCT02502734|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25722405|NCT02502734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25722406|NCT02502734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25722407|NCT02502734|Adrenergic Agents|adrenergic agents|mesh-ancestor
25722408|NCT02502734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25407973|NCT03467373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25722409|NCT02502734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722411|NCT02502864|Docetaxel|docetaxel|mesh-list
25722412|NCT02502864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25722413|NCT02502864|Immunologic Factors|immunologic factors|mesh-ancestor
25722414|NCT02502864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722415|NCT02502864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25722416|NCT02502864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25722417|NCT02502864|Alkylating Agents|alkylating agents|mesh-ancestor
25722418|NCT02502864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722419|NCT02502864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722420|NCT02502864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25722421|NCT02502864|Tubulin Modulators|tubulin modulators|mesh-ancestor
25722422|NCT02502864|Antimitotic Agents|antimitotic agents|mesh-ancestor
25722423|NCT02502864|Mitosis Modulators|mitosis modulators|mesh-ancestor
25722425|NCT02503085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25722426|NCT02503085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25407974|NCT03467373|Tubulin Modulators|tubulin modulators|mesh-ancestor
25722427|NCT02503085|Analgesics|analgesics|mesh-ancestor
25722428|NCT02503085|Sensory System Agents|sensory system agents|mesh-ancestor
25722429|NCT02503085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25722430|NCT02503085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722431|NCT02503085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25722432|NCT02503085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25722433|NCT02503085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25722434|NCT02503085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722435|NCT02503085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722436|NCT02503501|Insulin glulisine|insulin glulisine|mesh-list
25722437|NCT02503501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25722438|NCT02503501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722439|NCT02503540|Aflibercept|aflibercept|mesh-list
25333268|NCT05472896|Epirubicin|epirubicin|mesh-list
25333269|NCT05472896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25333270|NCT05472896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25333271|NCT05472896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25333272|NCT05472896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25333273|NCT05472896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25333274|NCT05472896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722440|NCT02503540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25722441|NCT02503540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25722442|NCT02503540|Growth Substances|growth substances|mesh-ancestor
25722443|NCT02503540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722444|NCT02503540|Growth Inhibitors|growth inhibitors|mesh-ancestor
25722445|NCT02503540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722446|NCT02503735|Sofosbuvir|sofosbuvir|mesh-list
25722447|NCT02503735|Ledipasvir|ledipasvir|mesh-list
25333343|NCT05472675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25333344|NCT05472675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25333345|NCT05472675|Cholinergic Agents|cholinergic agents|mesh-ancestor
25333346|NCT05472675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25333347|NCT05472623|Nivolumab|nivolumab|mesh-list
25333348|NCT05472623|Adagrasib|adagrasib|mesh-list
25333349|NCT05472623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25333350|NCT05472623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25333351|NCT05472623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25333352|NCT05472623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25333385|NCT05472220|Carboplatin|carboplatin|mesh-list
25333386|NCT05472220|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
25722448|NCT02503735|Antiviral Agents|antiviral agents|mesh-ancestor
25722449|NCT02503735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25722450|NCT02503865|Orlistat|orlistat|mesh-list
25722451|NCT02503865|Diltiazem|diltiazem|mesh-list
25722452|NCT02503865|Atorvastatin|atorvastatin|mesh-list
25722453|NCT02503865|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25722454|NCT02503865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25722455|NCT02503865|Antimetabolites|antimetabolites|mesh-ancestor
25722456|NCT02503865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722457|NCT02503865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25722458|NCT02503865|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25722459|NCT02503865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722460|NCT02503865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25333420|NCT05471700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25333421|NCT05471700|Antimetabolites|antimetabolites|mesh-ancestor
25333422|NCT05471700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25333423|NCT05471700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25333424|NCT05471700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25333425|NCT05471687|Adenosine|adenosine|mesh-list
25333426|NCT05471687|Analgesics|analgesics|mesh-ancestor
25333427|NCT05471687|Sensory System Agents|sensory system agents|mesh-ancestor
25333428|NCT05471687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25333430|NCT05471687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25407975|NCT03467373|Antimitotic Agents|antimitotic agents|mesh-ancestor
25722461|NCT02503865|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25722462|NCT02503865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25722463|NCT02503865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25722464|NCT02503865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722465|NCT02503865|Vasodilator Agents|vasodilator agents|mesh-ancestor
25722466|NCT02503865|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25722467|NCT02503982|Valganciclovir|valganciclovir|mesh-list
25722468|NCT02503982|Antiviral Agents|antiviral agents|mesh-ancestor
25722469|NCT02503982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25722470|NCT02504216|Rivaroxaban|rivaroxaban|mesh-list
25333504|NCT05466318|Gemcitabine|gemcitabine|mesh-list
25333505|NCT05466318|Cytarabine|cytarabine|mesh-list
25333506|NCT05466318|Etoposide|etoposide|mesh-list
25333507|NCT05466318|Melphalan|melphalan|mesh-list
25333508|NCT05466318|Busulfan|busulfan|mesh-list
25333509|NCT05466318|Carmustine|carmustine|mesh-list
25333510|NCT05466318|Cladribine|cladribine|mesh-list
25333511|NCT05466318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25333512|NCT05466318|Antimetabolites|antimetabolites|mesh-ancestor
25333513|NCT05466318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25333514|NCT05466318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25333515|NCT05466318|Antiviral Agents|antiviral agents|mesh-ancestor
25333516|NCT05466318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25333517|NCT05466318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25333518|NCT05466318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25333519|NCT05466318|Immunologic Factors|immunologic factors|mesh-ancestor
25333520|NCT05466318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333521|NCT05466318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25333525|NCT05466318|Alkylating Agents|alkylating agents|mesh-ancestor
25722471|NCT02504216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25722472|NCT02504216|Antithrombins|antithrombins|mesh-ancestor
25722473|NCT02504216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25722474|NCT02504216|Protease Inhibitors|protease inhibitors|mesh-ancestor
25722475|NCT02504216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722476|NCT02504216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722477|NCT02504216|Anticoagulants|anticoagulants|mesh-ancestor
25722478|NCT02504268|Methotrexate|methotrexate|mesh-list
25722479|NCT02504268|Abatacept|abatacept|mesh-list
25722480|NCT02504268|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25722481|NCT02504268|Abortifacient Agents|abortifacient agents|mesh-ancestor
25722482|NCT02504268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25722483|NCT02504268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722484|NCT02504268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25722485|NCT02504268|Antimetabolites|antimetabolites|mesh-ancestor
25722486|NCT02504268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722487|NCT02504268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25333589|NCT05427474|Propranolol|propranolol|mesh-list
25333590|NCT05427474|Gabapentin|gabapentin|mesh-list
25333591|NCT05427474|Analgesics|analgesics|mesh-ancestor
25333592|NCT05427474|Sensory System Agents|sensory system agents|mesh-ancestor
25333593|NCT05427474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25333594|NCT05427474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333595|NCT05427474|Anticonvulsants|anticonvulsants|mesh-ancestor
25333596|NCT05427474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25333597|NCT05427474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25333598|NCT05427474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25333599|NCT05427474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25333600|NCT05427474|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25333601|NCT05427474|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25333602|NCT05427474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25333603|NCT05427474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25333604|NCT05427474|Antimanic Agents|antimanic agents|mesh-ancestor
25722488|NCT02504268|Dermatologic Agents|dermatologic agents|mesh-ancestor
25722489|NCT02504268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722490|NCT02504268|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25722491|NCT02504268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25722492|NCT02504268|Immunologic Factors|immunologic factors|mesh-ancestor
25722493|NCT02504268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25722494|NCT02504268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25722495|NCT02504268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25722496|NCT02504294|Epoetin Alfa|epoetin alfa|mesh-list
25722497|NCT02504294|Hematinics|hematinics|mesh-ancestor
25722498|NCT02504320|Febuxostat|febuxostat|mesh-list
25722499|NCT02504320|Gout Suppressants|gout suppressants|mesh-ancestor
25722500|NCT02504320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25722501|NCT02504541|Methyltestosterone|methyltestosterone|mesh-list
25722502|NCT02504541|Testosterone|testosterone|mesh-list
25722503|NCT02504541|Testosterone undecanoate|testosterone undecanoate|mesh-list
25722504|NCT02504541|Testosterone enanthate|testosterone enanthate|mesh-list
25333694|NCT05387642|Pramoxine|pramoxine|mesh-list
25333695|NCT05387642|Anesthetics, Local|anesthetics, local|mesh-ancestor
25333696|NCT05387642|Anesthetics|anesthetics|mesh-ancestor
25333697|NCT05387642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25333698|NCT05387642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333699|NCT05387642|Sensory System Agents|sensory system agents|mesh-ancestor
25333700|NCT05387642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25333701|NCT05382312|Bedaquiline|bedaquiline|mesh-list
25333702|NCT05382312|GSK656|gsk656|mesh-list
25333703|NCT05382312|Antitubercular Agents|antitubercular agents|mesh-ancestor
25333704|NCT05382312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25333705|NCT05382312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25722505|NCT02504541|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25722506|NCT02504541|Androgens|androgens|mesh-ancestor
25722507|NCT02504541|Hormones|hormones|mesh-ancestor
25722508|NCT02504541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25722509|NCT02504541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722510|NCT02504541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25722511|NCT02504541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722512|NCT02504541|Anabolic Agents|anabolic agents|mesh-ancestor
25722513|NCT02504554|Vancomycin|vancomycin|mesh-list
25722514|NCT02504554|Omeprazole|omeprazole|mesh-list
25722515|NCT02504554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25722516|NCT02504554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25333741|NCT05345002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25333742|NCT05345002|Keratolytic Agents|keratolytic agents|mesh-ancestor
25333743|NCT05345002|Dermatologic Agents|dermatologic agents|mesh-ancestor
25333766|NCT05328388|Lycopene|lycopene|mesh-list
25333767|NCT05328388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25333768|NCT05328388|Antioxidants|antioxidants|mesh-ancestor
25333769|NCT05328388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25333770|NCT05328388|Protective Agents|protective agents|mesh-ancestor
25333771|NCT05328388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333772|NCT05328388|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25333773|NCT05328388|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25333774|NCT05328388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25333788|NCT05309902|Moxifloxacin|moxifloxacin|mesh-list
25333789|NCT05309902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25333790|NCT05309902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25333793|NCT05309902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722517|NCT02504554|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25722518|NCT02504554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25722519|NCT02504554|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25722520|NCT02504554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722521|NCT02504554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722522|NCT02504671|Folic Acid|folic acid|mesh-list
25722523|NCT02504671|Hematinics|hematinics|mesh-ancestor
25722524|NCT02504671|Vitamin B Complex|vitamin b complex|mesh-ancestor
25722525|NCT02504671|Vitamins|vitamins|mesh-ancestor
25722526|NCT02504671|Micronutrients|micronutrients|mesh-ancestor
25722527|NCT02504671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722528|NCT02504723|Carvedilol|carvedilol|mesh-list
25722529|NCT02504723|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25722530|NCT02504723|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25722531|NCT02504723|Adrenergic Agents|adrenergic agents|mesh-ancestor
25722532|NCT02504723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25333815|NCT05291390|Antimalarials|antimalarials|mesh-ancestor
25333816|NCT05291390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25333817|NCT05291390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25333818|NCT05291390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25722533|NCT02504723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722534|NCT02504723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722535|NCT02504723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25722536|NCT02504723|Antioxidants|antioxidants|mesh-ancestor
25722537|NCT02504723|Protective Agents|protective agents|mesh-ancestor
25722538|NCT02504723|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25722539|NCT02504723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25722540|NCT02504723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25722541|NCT02504723|Vasodilator Agents|vasodilator agents|mesh-ancestor
25333886|NCT05281614|Etanercept|etanercept|mesh-list
25333887|NCT05281614|Vedolizumab|vedolizumab|mesh-list
25333888|NCT05281614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25333889|NCT05281614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25333890|NCT05281614|Analgesics|analgesics|mesh-ancestor
25333891|NCT05281614|Sensory System Agents|sensory system agents|mesh-ancestor
25333892|NCT05281614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25333893|NCT05281614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333911|NCT05269849|Sirolimus|sirolimus|mesh-list
25722542|NCT02504723|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25722543|NCT02504723|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25722544|NCT02504775|Acetaminophen|acetaminophen|mesh-list
25722545|NCT02504775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25722546|NCT02504775|Analgesics|analgesics|mesh-ancestor
25722547|NCT02504775|Sensory System Agents|sensory system agents|mesh-ancestor
25722548|NCT02504775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25722549|NCT02504775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333964|NCT05227612|Psilocybin|psilocybin|mesh-list
25333965|NCT05227612|Hallucinogens|hallucinogens|mesh-ancestor
25333966|NCT05227612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333967|NCT05227612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25333983|NCT05226455|Azacitidine|azacitidine|mesh-list
25333984|NCT05226455|Venetoclax|venetoclax|mesh-list
25333985|NCT05226455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25333986|NCT05226455|Antimetabolites|antimetabolites|mesh-ancestor
25333987|NCT05226455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722550|NCT02504775|Antipyretics|antipyretics|mesh-ancestor
25722551|NCT02504827|Ceftazidime|ceftazidime|mesh-list
25722552|NCT02504827|Avibactam|avibactam|mesh-list
25722553|NCT02504827|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
25722554|NCT02504827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25722555|NCT02504827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25722556|NCT02504827|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25722557|NCT02504827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25334033|NCT05188339|Citric Acid|citric acid|mesh-list
25334034|NCT05188339|Sodium Citrate|sodium citrate|mesh-list
25334035|NCT05188339|Anticoagulants|anticoagulants|mesh-ancestor
25334036|NCT05188339|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25334037|NCT05188339|Chelating Agents|chelating agents|mesh-ancestor
25334038|NCT05188339|Sequestering Agents|sequestering agents|mesh-ancestor
25334039|NCT05188339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25334040|NCT05188339|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25334041|NCT05188339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25334052|NCT05183646|Proxigermanium|proxigermanium|mesh-list
25722558|NCT02504827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772071|NCT03661346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772072|NCT03661346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772073|NCT03661346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25772074|NCT03661346|Sympathomimetics|sympathomimetics|mesh-ancestor
25772075|NCT03661346|Autonomic Agents|autonomic agents|mesh-ancestor
25772076|NCT03661346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772077|NCT03661346|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25334110|NCT05139472|Empagliflozin|empagliflozin|mesh-list
25334111|NCT05139472|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25334112|NCT05139472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25334113|NCT05139472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25334114|NCT05139472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25334115|NCT05130892|Tranilast|tranilast|mesh-list
25334116|NCT05130892|Colchicine|colchicine|mesh-list
25334117|NCT05130892|Gout Suppressants|gout suppressants|mesh-ancestor
25334118|NCT05130892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25722559|NCT02504892|Everolimus|everolimus|mesh-list
25722560|NCT02504892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722561|NCT02504892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25722562|NCT02504892|Immunologic Factors|immunologic factors|mesh-ancestor
25722563|NCT02504892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722564|NCT02504931|Sertraline|sertraline|mesh-list
25722565|NCT02504931|Antidepressive Agents|antidepressive agents|mesh-ancestor
25722566|NCT02504931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25722567|NCT02504931|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25722568|NCT02504931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25334180|NCT05062031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25334181|NCT05062031|Respiratory System Agents|respiratory system agents|mesh-ancestor
25334182|NCT05062031|Mydriatics|mydriatics|mesh-ancestor
25334183|NCT05062031|Parasympatholytics|parasympatholytics|mesh-ancestor
25334184|NCT05062031|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25334185|NCT05062031|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25334186|NCT05062031|Cholinergic Agents|cholinergic agents|mesh-ancestor
25334187|NCT05062031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25334188|NCT05062031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25334189|NCT05062031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25334207|NCT05035862|Interferons|interferons|mesh-list
25334208|NCT05035862|Interferon-gamma|interferon-gamma|mesh-list
25334209|NCT05035862|Prednisone|prednisone|mesh-list
25334210|NCT05035862|Albuterol|albuterol|mesh-list
25334211|NCT05035862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25334212|NCT05035862|Glucocorticoids|glucocorticoids|mesh-ancestor
25334213|NCT05035862|Hormones|hormones|mesh-ancestor
25334214|NCT05035862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25334215|NCT05035862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25334216|NCT05035862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25334217|NCT05035862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25334218|NCT05035862|Antiviral Agents|antiviral agents|mesh-ancestor
25334219|NCT05035862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25334220|NCT05035862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25334221|NCT05035862|Autonomic Agents|autonomic agents|mesh-ancestor
25722569|NCT02504931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25722570|NCT02504931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722571|NCT02504931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25722572|NCT02504931|Serotonin Agents|serotonin agents|mesh-ancestor
25722573|NCT02504931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722574|NCT02505269|Doxorubicin|doxorubicin|mesh-list
25722575|NCT02505269|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25722576|NCT02505269|Dacarbazine|dacarbazine|mesh-list
25722577|NCT02505269|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25722578|NCT02505269|Imidazole|imidazole|mesh-list
25722579|NCT02505269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25722580|NCT02505269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722581|NCT02505269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25722582|NCT02505269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25722583|NCT02505269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722584|NCT02505269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722585|NCT02505269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25722586|NCT02505269|Alkylating Agents|alkylating agents|mesh-ancestor
25722587|NCT02505269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25722588|NCT02505334|Liraglutide|liraglutide|mesh-list
25722589|NCT02505334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25722590|NCT02505334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722591|NCT02505334|Incretins|incretins|mesh-ancestor
25722592|NCT02505334|Hormones|hormones|mesh-ancestor
25334258|NCT05013632|Remdesivir|remdesivir|mesh-list
25334259|NCT05013632|Antibodies|antibodies|mesh-list
25334260|NCT05013632|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25334261|NCT05013632|Immunologic Factors|immunologic factors|mesh-ancestor
25334262|NCT05013632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25334263|NCT05013632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25334264|NCT05013632|Antimetabolites|antimetabolites|mesh-ancestor
25334265|NCT05013632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722593|NCT02505334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25722594|NCT02505542|Certolizumab Pegol|certolizumab pegol|mesh-list
25722595|NCT02505542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25722596|NCT02505542|Immunologic Factors|immunologic factors|mesh-ancestor
25722597|NCT02505542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722598|NCT02505542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25722599|NCT02505945|Omeprazole|omeprazole|mesh-list
25722600|NCT02505945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25722601|NCT02505945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25334348|NCT04988035|Antimetabolites|antimetabolites|mesh-ancestor
25334349|NCT04988035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25334350|NCT04988035|Antiviral Agents|antiviral agents|mesh-ancestor
25334351|NCT04988035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25334366|NCT04970901|Gemcitabine|gemcitabine|mesh-list
25334367|NCT04970901|Lenalidomide|lenalidomide|mesh-list
25334368|NCT04970901|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
25334369|NCT04970901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25334370|NCT04970901|Antimetabolites|antimetabolites|mesh-ancestor
25334371|NCT04970901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722602|NCT02505945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25722603|NCT02505945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722604|NCT02505945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722605|NCT02506114|Ipilimumab|ipilimumab|mesh-list
25722606|NCT02506114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25722607|NCT02506114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722608|NCT02506114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25722609|NCT02506114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722610|NCT02506257|Biguanides|biguanides|mesh-list
25722611|NCT02506257|Polihexanide|polihexanide|mesh-list
25334441|NCT04907682|Ribavirin|ribavirin|mesh-list
25334442|NCT04907682|Favipiravir|favipiravir|mesh-list
25334443|NCT04907682|Antimetabolites|antimetabolites|mesh-ancestor
25334444|NCT04907682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25334445|NCT04907682|Antiviral Agents|antiviral agents|mesh-ancestor
25334446|NCT04907682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25334480|NCT04889716|Obinutuzumab|obinutuzumab|mesh-list
25334481|NCT04889716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25334482|NCT04889716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722612|NCT02506257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25722613|NCT02506257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722614|NCT02506257|Disinfectants|disinfectants|mesh-ancestor
25722615|NCT02506257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25722616|NCT02506634|Esomeprazole|esomeprazole|mesh-list
25722617|NCT02506634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25722618|NCT02506634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25722619|NCT02506634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25722620|NCT02506634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25334491|NCT04848857|Colchicine|colchicine|mesh-list
25334492|NCT04848857|Gout Suppressants|gout suppressants|mesh-ancestor
25334493|NCT04848857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25334494|NCT04848857|Tubulin Modulators|tubulin modulators|mesh-ancestor
25334495|NCT04848857|Antimitotic Agents|antimitotic agents|mesh-ancestor
25334496|NCT04848857|Mitosis Modulators|mitosis modulators|mesh-ancestor
25334497|NCT04848857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25334498|NCT04848857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25334499|NCT04847466|Pembrolizumab|pembrolizumab|mesh-list
25334500|NCT04847466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25334501|NCT04847466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25334562|NCT04762771|Colchicine|colchicine|mesh-list
25334563|NCT04762771|Gout Suppressants|gout suppressants|mesh-ancestor
25334564|NCT04762771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25334565|NCT04762771|Tubulin Modulators|tubulin modulators|mesh-ancestor
25722621|NCT02506634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722622|NCT02506660|Dexamethasone|dexamethasone|mesh-list
25722623|NCT02506660|Dexamethasone acetate|dexamethasone acetate|mesh-list
25722624|NCT02506660|Bupivacaine|bupivacaine|mesh-list
25722625|NCT02506660|BB 1101|bb 1101|mesh-list
25722626|NCT02506660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25722627|NCT02506660|Antiemetics|antiemetics|mesh-ancestor
25722628|NCT02506660|Autonomic Agents|autonomic agents|mesh-ancestor
25722629|NCT02506660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25722630|NCT02506660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722631|NCT02506660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25722632|NCT02506660|Glucocorticoids|glucocorticoids|mesh-ancestor
25722633|NCT02506660|Hormones|hormones|mesh-ancestor
25722634|NCT02506660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25334566|NCT04762771|Antimitotic Agents|antimitotic agents|mesh-ancestor
25334567|NCT04762771|Mitosis Modulators|mitosis modulators|mesh-ancestor
25334568|NCT04762771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25334569|NCT04762771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25334570|NCT04754737|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25334571|NCT04754737|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25334572|NCT04754737|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25334573|NCT04754737|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25334574|NCT04754737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25722635|NCT02506660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25722636|NCT02506660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722637|NCT02506660|Protease Inhibitors|protease inhibitors|mesh-ancestor
25722638|NCT02506660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722639|NCT02506660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722640|NCT02506660|Anesthetics, Local|anesthetics, local|mesh-ancestor
25722641|NCT02506660|Anesthetics|anesthetics|mesh-ancestor
25722642|NCT02506660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25334662|NCT04628988|Prednisone|prednisone|mesh-list
25334663|NCT04628988|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
25334664|NCT04628988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25334665|NCT04628988|Glucocorticoids|glucocorticoids|mesh-ancestor
25334666|NCT04628988|Hormones|hormones|mesh-ancestor
25334667|NCT04628988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25334668|NCT04628988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25334669|NCT04628988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25334670|NCT04628988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25334671|NCT04628988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25334672|NCT04628988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25334685|NCT04618016|Vitamins|vitamins|mesh-list
25334686|NCT04618016|Vitamin E|vitamin e|mesh-list
25334687|NCT04618016|Tocopherols|tocopherols|mesh-list
25334688|NCT04618016|Tocotrienols|tocotrienols|mesh-list
25334689|NCT04618016|alpha-Tocopherol|alpha-tocopherol|mesh-list
25334690|NCT04618016|Micronutrients|micronutrients|mesh-ancestor
25334691|NCT04618016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25334692|NCT04618016|Antioxidants|antioxidants|mesh-ancestor
25334693|NCT04618016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25334694|NCT04618016|Protective Agents|protective agents|mesh-ancestor
25722643|NCT02506660|Sensory System Agents|sensory system agents|mesh-ancestor
25722644|NCT02506673|Midazolam|midazolam|mesh-list
25722645|NCT02506673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25722646|NCT02506673|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25722647|NCT02506673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25722648|NCT02506673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722649|NCT02506673|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25722650|NCT02506673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25722651|NCT02506673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25722652|NCT02506673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25722653|NCT02506673|Anesthetics, General|anesthetics, general|mesh-ancestor
25722654|NCT02506673|Anesthetics|anesthetics|mesh-ancestor
25722655|NCT02506673|GABA Modulators|gaba modulators|mesh-ancestor
25722656|NCT02506673|GABA Agents|gaba agents|mesh-ancestor
25722657|NCT02506673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25722658|NCT02506673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722659|NCT02506816|Olaparib|olaparib|mesh-list
25722660|NCT02506816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25722661|NCT02506816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722662|NCT02506816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25334721|NCT04583969|Antimetabolites|antimetabolites|mesh-ancestor
25334722|NCT04583969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25334723|NCT04583969|Antiviral Agents|antiviral agents|mesh-ancestor
25334724|NCT04583969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25334725|NCT04583956|Remdesivir|remdesivir|mesh-list
25334726|NCT04583956|Antimetabolites|antimetabolites|mesh-ancestor
25334727|NCT04583956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25334728|NCT04583956|Antiviral Agents|antiviral agents|mesh-ancestor
25334729|NCT04583956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25334761|NCT04550442|Azacitidine|azacitidine|mesh-list
25334762|NCT04550442|Venetoclax|venetoclax|mesh-list
25334763|NCT04550442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25334764|NCT04550442|Antimetabolites|antimetabolites|mesh-ancestor
25334765|NCT04550442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25334766|NCT04550442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25334767|NCT04550442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25334775|NCT04502264|Botulinum Toxins|botulinum toxins|mesh-list
25334776|NCT04502264|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25334777|NCT04502264|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25334778|NCT04502264|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25334779|NCT04502264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25334781|NCT04502264|Cholinergic Agents|cholinergic agents|mesh-ancestor
25407976|NCT03467373|Mitosis Modulators|mitosis modulators|mesh-ancestor
25722663|NCT02506816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722664|NCT02506868|Darbepoetin alfa|darbepoetin alfa|mesh-list
25722665|NCT02506868|Hematinics|hematinics|mesh-ancestor
25722666|NCT02506881|Darbepoetin alfa|darbepoetin alfa|mesh-list
25722667|NCT02506881|Hematinics|hematinics|mesh-ancestor
25722668|NCT02507011|Carvedilol|carvedilol|mesh-list
25722669|NCT02507011|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25722670|NCT02507011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25722671|NCT02507011|Adrenergic Agents|adrenergic agents|mesh-ancestor
25722672|NCT02507011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25722673|NCT02507011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722674|NCT02507011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722675|NCT02507011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25722676|NCT02507011|Antioxidants|antioxidants|mesh-ancestor
25722677|NCT02507011|Protective Agents|protective agents|mesh-ancestor
25722678|NCT02507011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25722679|NCT02507011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25722680|NCT02507011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25722681|NCT02507011|Vasodilator Agents|vasodilator agents|mesh-ancestor
25722682|NCT02507011|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25722683|NCT02507011|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25722684|NCT02507219|Ibuprofen|ibuprofen|mesh-list
25334815|NCT04481035|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25334816|NCT04481035|Antiviral Agents|antiviral agents|mesh-ancestor
25334817|NCT04481035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25334818|NCT04481035|Expectorants|expectorants|mesh-ancestor
25334819|NCT04481035|Respiratory System Agents|respiratory system agents|mesh-ancestor
25334820|NCT04481035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25334821|NCT04481035|Antioxidants|antioxidants|mesh-ancestor
25334822|NCT04481035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25334823|NCT04481035|Protective Agents|protective agents|mesh-ancestor
25334824|NCT04481035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25334825|NCT04481035|Antidotes|antidotes|mesh-ancestor
25722685|NCT02507219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25722686|NCT02507219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25722687|NCT02507219|Analgesics|analgesics|mesh-ancestor
25722688|NCT02507219|Sensory System Agents|sensory system agents|mesh-ancestor
25722689|NCT02507219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25722690|NCT02507219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722691|NCT02507219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25722692|NCT02507219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25722693|NCT02507219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25722694|NCT02507219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722695|NCT02507219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25334869|NCT04429022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25334870|NCT04429022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25334871|NCT04429022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25334872|NCT04429022|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25334873|NCT04429022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25334874|NCT04429022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25334875|NCT04429022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25334876|NCT04429022|Anticonvulsants|anticonvulsants|mesh-ancestor
25334877|NCT04429022|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25334878|NCT04429022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25334879|NCT04429022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25334880|NCT04429022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25334881|NCT04429022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25334882|NCT04429022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25334883|NCT04429022|Antimanic Agents|antimanic agents|mesh-ancestor
25334894|NCT04389411|Montelukast|montelukast|mesh-list
25334895|NCT04389411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25334896|NCT04389411|Respiratory System Agents|respiratory system agents|mesh-ancestor
25722696|NCT02507375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25722697|NCT02507375|Pertuzumab|pertuzumab|mesh-list
25722698|NCT02507375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722699|NCT02507375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25722700|NCT02507375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722701|NCT02507375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722702|NCT02507375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25722703|NCT02508077|Calcium, Dietary|calcium, dietary|mesh-list
25722704|NCT02508077|Leucovorin|leucovorin|mesh-list
25722705|NCT02508077|Folic Acid|folic acid|mesh-list
25722706|NCT02508077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25722707|NCT02508077|Panitumumab|panitumumab|mesh-list
25722708|NCT02508077|Fluorouracil|fluorouracil|mesh-list
25722709|NCT02508077|Irinotecan|irinotecan|mesh-list
25722710|NCT02508077|Camptothecin|camptothecin|mesh-list
25722711|NCT02508077|Antibodies|antibodies|mesh-list
25722712|NCT02508077|Immunoglobulins|immunoglobulins|mesh-list
25722713|NCT02508077|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25722714|NCT02508077|Calcium|calcium|mesh-list
25722715|NCT02508077|Levoleucovorin|levoleucovorin|mesh-list
25722716|NCT02508077|Immunologic Factors|immunologic factors|mesh-ancestor
25334964|NCT04313244|Vaccines|vaccines|mesh-list
25334965|NCT04313244|Immunologic Factors|immunologic factors|mesh-ancestor
25334966|NCT04313244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722717|NCT02508077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722718|NCT02508077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722719|NCT02508077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25722720|NCT02508077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25722721|NCT02508077|Antimetabolites|antimetabolites|mesh-ancestor
25722722|NCT02508077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722723|NCT02508077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25722724|NCT02508077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25335052|NCT04153435|Calcium|calcium|mesh-list
25335053|NCT04153435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25335054|NCT04153435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25335066|NCT04113382|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25335067|NCT04113382|Laxatives|laxatives|mesh-ancestor
25335068|NCT04113382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25335089|NCT04091126|Dexamethasone|dexamethasone|mesh-list
25335090|NCT04091126|Lenalidomide|lenalidomide|mesh-list
25335091|NCT04091126|Bortezomib|bortezomib|mesh-list
25335092|NCT04091126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25335093|NCT04091126|Antiemetics|antiemetics|mesh-ancestor
25335094|NCT04091126|Autonomic Agents|autonomic agents|mesh-ancestor
25335095|NCT04091126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25335096|NCT04091126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722725|NCT02508077|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25722726|NCT02508077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25722727|NCT02508077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722728|NCT02508077|Antidotes|antidotes|mesh-ancestor
25722729|NCT02508077|Protective Agents|protective agents|mesh-ancestor
25722730|NCT02508077|Vitamin B Complex|vitamin b complex|mesh-ancestor
25722731|NCT02508077|Vitamins|vitamins|mesh-ancestor
25722732|NCT02508077|Micronutrients|micronutrients|mesh-ancestor
25722733|NCT02508077|Hematinics|hematinics|mesh-ancestor
25722734|NCT02508077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25722735|NCT02508103|Oxytocin|oxytocin|mesh-list
25722736|NCT02508103|Oxytocics|oxytocics|mesh-ancestor
25722737|NCT02508103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25722738|NCT02508103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25335097|NCT04091126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25335098|NCT04091126|Glucocorticoids|glucocorticoids|mesh-ancestor
25335099|NCT04091126|Hormones|hormones|mesh-ancestor
25335100|NCT04091126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25335101|NCT04091126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25335102|NCT04091126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25335103|NCT04091126|Immunologic Factors|immunologic factors|mesh-ancestor
25335113|NCT04085458|Factor VIII|factor viii|mesh-list
25722739|NCT02508207|Ivacaftor|ivacaftor|mesh-list
25722740|NCT02508207|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25722741|NCT02508207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25722742|NCT02508207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722743|NCT02508259|Suramin|suramin|mesh-list
25722744|NCT02508259|Antinematodal Agents|antinematodal agents|mesh-ancestor
25722745|NCT02508259|Anthelmintics|anthelmintics|mesh-ancestor
25722746|NCT02508259|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25335174|NCT03962114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25335175|NCT03962114|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25335176|NCT03962114|Vasodilator Agents|vasodilator agents|mesh-ancestor
25335184|NCT03938389|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25335185|NCT03938389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25335186|NCT03938389|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25335187|NCT03938389|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25335188|NCT03938389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25335203|NCT03901001|Sirolimus|sirolimus|mesh-list
25722747|NCT02508259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25722748|NCT02508259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722749|NCT02508259|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25722750|NCT02508259|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25722751|NCT02508389|Cisplatin|cisplatin|mesh-list
25722752|NCT02508389|Avasopasem manganese|avasopasem manganese|mesh-list
25722753|NCT02508389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722754|NCT02508389|Antioxidants|antioxidants|mesh-ancestor
25722755|NCT02508389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722756|NCT02508389|Protective Agents|protective agents|mesh-ancestor
25722757|NCT02508389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722758|NCT02508428|Methyclothiazide|methyclothiazide|mesh-list
25335253|NCT03843853|Bevacizumab|bevacizumab|mesh-list
25335254|NCT03843853|Pemetrexed|pemetrexed|mesh-list
25335255|NCT03843853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25335256|NCT03843853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25335257|NCT03843853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25335258|NCT03843853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25335259|NCT03843853|Growth Substances|growth substances|mesh-ancestor
25335260|NCT03843853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25335261|NCT03843853|Growth Inhibitors|growth inhibitors|mesh-ancestor
25335262|NCT03843853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25335263|NCT03843853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25335264|NCT03843853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25335265|NCT03843853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25335266|NCT03819517|Resveratrol|resveratrol|mesh-list
25335267|NCT03819517|Antioxidants|antioxidants|mesh-ancestor
25335268|NCT03819517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25335269|NCT03819517|Protective Agents|protective agents|mesh-ancestor
25335270|NCT03819517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722759|NCT02508428|Diuretics|diuretics|mesh-ancestor
25722760|NCT02508428|Natriuretic Agents|natriuretic agents|mesh-ancestor
25722761|NCT02508428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722762|NCT02508428|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25722763|NCT02508428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25722764|NCT02508428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722765|NCT02508636|Leuprolide|leuprolide|mesh-list
25722766|NCT02508636|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25722767|NCT02508636|Fertility Agents|fertility agents|mesh-ancestor
25722768|NCT02508636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25722769|NCT02508636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722770|NCT02508636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25722771|NCT02508636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722772|NCT02508935|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25722773|NCT02508935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25722774|NCT02508935|Narcotics|narcotics|mesh-ancestor
25722775|NCT02508935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25335324|NCT03794388|Dermatologic Agents|dermatologic agents|mesh-ancestor
25335337|NCT03788967|Ertapenem|ertapenem|mesh-list
25335338|NCT03788967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25335339|NCT03788967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25335374|NCT03770260|Ixazomib|ixazomib|mesh-list
25335375|NCT03770260|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25335376|NCT03770260|Pevonedistat|pevonedistat|mesh-list
25335377|NCT03770260|Glycine|glycine|mesh-list
25335378|NCT03770260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25335379|NCT03770260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25335380|NCT03770260|Protease Inhibitors|protease inhibitors|mesh-ancestor
25335381|NCT03770260|Glycine Agents|glycine agents|mesh-ancestor
25335382|NCT03770260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25335383|NCT03770260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25335398|NCT03721172|Apremilast|apremilast|mesh-list
25335399|NCT03721172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25335400|NCT03721172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25722776|NCT02508935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722777|NCT02508935|Analgesics|analgesics|mesh-ancestor
25722778|NCT02508935|Sensory System Agents|sensory system agents|mesh-ancestor
25722779|NCT02508935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25722780|NCT02508935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25722781|NCT02508935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25722782|NCT02508935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25722783|NCT02508935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25722784|NCT02509026|Etanercept|etanercept|mesh-list
25722785|NCT02509026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25722786|NCT02509026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25722787|NCT02509026|Analgesics|analgesics|mesh-ancestor
25722788|NCT02509026|Sensory System Agents|sensory system agents|mesh-ancestor
25722789|NCT02509026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25722790|NCT02509026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722791|NCT02509026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25335401|NCT03721172|Analgesics|analgesics|mesh-ancestor
25335402|NCT03721172|Sensory System Agents|sensory system agents|mesh-ancestor
25335403|NCT03721172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25335404|NCT03721172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25335405|NCT03721172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25335406|NCT03721172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25335407|NCT03721172|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25335408|NCT03721172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25335409|NCT03721172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25335410|NCT03721172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25335411|NCT03714958|Trametinib|trametinib|mesh-list
25335412|NCT03714958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25335413|NCT03714958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25335414|NCT03714958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722792|NCT02509026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25722793|NCT02509026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25722794|NCT02509026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25722795|NCT02509026|Immunologic Factors|immunologic factors|mesh-ancestor
25722796|NCT02509065|Pancrelipase|pancrelipase|mesh-list
25722797|NCT02509065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25722798|NCT02509078|Cisatracurium|cisatracurium|mesh-list
25722799|NCT02509078|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25722800|NCT02509078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25722801|NCT02509078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25722802|NCT02509078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722803|NCT02509481|Ivermectin|ivermectin|mesh-list
25722804|NCT02509481|Albendazole|albendazole|mesh-list
25722805|NCT02509481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25722806|NCT02509481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25335506|NCT03548428|Atezolizumab|atezolizumab|mesh-list
25335507|NCT03548428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25335512|NCT03535298|Interferons|interferons|mesh-list
25335513|NCT03535298|Interferon-beta|interferon-beta|mesh-list
25335514|NCT03535298|Teriflunomide|teriflunomide|mesh-list
25335515|NCT03535298|Alemtuzumab|alemtuzumab|mesh-list
25335516|NCT03535298|Ofatumumab|ofatumumab|mesh-list
25335517|NCT03535298|Cladribine|cladribine|mesh-list
25335518|NCT03535298|Glatiramer Acetate|glatiramer acetate|mesh-list
25335519|NCT03535298|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25335520|NCT03535298|Ocrelizumab|ocrelizumab|mesh-list
25335521|NCT03535298|Natalizumab|natalizumab|mesh-list
25722807|NCT02509481|Anthelmintics|anthelmintics|mesh-ancestor
25722808|NCT02509481|Anticestodal Agents|anticestodal agents|mesh-ancestor
25722809|NCT02509481|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25722810|NCT02509481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25722811|NCT02509481|Tubulin Modulators|tubulin modulators|mesh-ancestor
25722812|NCT02509481|Antimitotic Agents|antimitotic agents|mesh-ancestor
25722813|NCT02509481|Mitosis Modulators|mitosis modulators|mesh-ancestor
25722814|NCT02509481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722815|NCT02509481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722816|NCT02509624|Selonsertib|selonsertib|mesh-list
25335569|NCT03516604|Citalopram|citalopram|mesh-list
25722817|NCT02509624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25722818|NCT02509624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722819|NCT02509624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722820|NCT02509767|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25722821|NCT02509767|Medroxyprogesterone|medroxyprogesterone|mesh-list
25722822|NCT02509767|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25722823|NCT02509767|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25722824|NCT02509767|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25335636|NCT03511118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25335637|NCT03511118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25335638|NCT03511118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25335639|NCT03511118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25722825|NCT02509767|Contraceptive Agents|contraceptive agents|mesh-ancestor
25722826|NCT02509767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25722827|NCT02509767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722828|NCT02509767|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25722829|NCT02509767|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25722830|NCT02509767|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25722831|NCT02509767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25722832|NCT02509767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722833|NCT02510001|Crizotinib|crizotinib|mesh-list
25335718|NCT03457701|Trace Elements|trace elements|mesh-ancestor
25335719|NCT03457701|Micronutrients|micronutrients|mesh-ancestor
25335720|NCT03457701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25335742|NCT03421353|Gemcitabine|gemcitabine|mesh-list
25335743|NCT03421353|Paclitaxel|paclitaxel|mesh-list
25335744|NCT03421353|Carboplatin|carboplatin|mesh-list
25335745|NCT03421353|Durvalumab|durvalumab|mesh-list
25335746|NCT03421353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25335747|NCT03421353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722834|NCT02510001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722835|NCT02510001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25722836|NCT02510001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722837|NCT02510001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722838|NCT02510014|Buprenorphine|buprenorphine|mesh-list
25722839|NCT02510014|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25722840|NCT02510014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25722841|NCT02510014|Narcotics|narcotics|mesh-ancestor
25335789|NCT03386942|Farletuzumab|farletuzumab|mesh-list
25335790|NCT03386942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25335824|NCT03370133|Ustekinumab|ustekinumab|mesh-list
25335825|NCT03370133|Dermatologic Agents|dermatologic agents|mesh-ancestor
25335826|NCT03358706|Vitamin K|vitamin k|mesh-list
25335827|NCT03358706|Midazolam|midazolam|mesh-list
25335828|NCT03358706|Dextromethorphan|dextromethorphan|mesh-list
25335829|NCT03358706|Caffeine|caffeine|mesh-list
25335830|NCT03358706|Ustekinumab|ustekinumab|mesh-list
25335831|NCT03358706|Omeprazole|omeprazole|mesh-list
25335832|NCT03358706|Warfarin|warfarin|mesh-list
25335833|NCT03358706|Vitamins|vitamins|mesh-ancestor
25335834|NCT03358706|Micronutrients|micronutrients|mesh-ancestor
25335835|NCT03358706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25335836|NCT03358706|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25335837|NCT03358706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25335838|NCT03358706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25335839|NCT03358706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25335840|NCT03358706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25335841|NCT03358706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25335842|NCT03358706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25335843|NCT03358706|Anesthetics, General|anesthetics, general|mesh-ancestor
25335844|NCT03358706|Anesthetics|anesthetics|mesh-ancestor
25335845|NCT03358706|GABA Modulators|gaba modulators|mesh-ancestor
25335846|NCT03358706|GABA Agents|gaba agents|mesh-ancestor
25335847|NCT03358706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25335848|NCT03358706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722842|NCT02510014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25722843|NCT02510014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722844|NCT02510014|Analgesics|analgesics|mesh-ancestor
25722845|NCT02510014|Sensory System Agents|sensory system agents|mesh-ancestor
25722846|NCT02510014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25722847|NCT02510014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25722848|NCT02510144|Chlorhexidine|chlorhexidine|mesh-list
25722849|NCT02510144|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25722850|NCT02510144|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25722851|NCT02510144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25722852|NCT02510144|Disinfectants|disinfectants|mesh-ancestor
25722853|NCT02510144|Dermatologic Agents|dermatologic agents|mesh-ancestor
25722854|NCT02510794|Ranibizumab|ranibizumab|mesh-list
25722855|NCT02510794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25722856|NCT02510794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25722857|NCT02510794|Growth Substances|growth substances|mesh-ancestor
25722858|NCT02510794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722859|NCT02510794|Growth Inhibitors|growth inhibitors|mesh-ancestor
25722860|NCT02510794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722861|NCT02511184|Pembrolizumab|pembrolizumab|mesh-list
25722862|NCT02511184|Crizotinib|crizotinib|mesh-list
25722863|NCT02511184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25722864|NCT02511184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722865|NCT02511184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25335862|NCT03358706|Hemostatics|hemostatics|mesh-ancestor
25335863|NCT03358706|Coagulants|coagulants|mesh-ancestor
25335864|NCT03358706|Antitussive Agents|antitussive agents|mesh-ancestor
25335865|NCT03358706|Respiratory System Agents|respiratory system agents|mesh-ancestor
25335866|NCT03358706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25335867|NCT03358706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25335876|NCT03283878|Cefazolin|cefazolin|mesh-list
25335877|NCT03283878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25722866|NCT02511184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722867|NCT02511184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722868|NCT02511236|Nicotine|nicotine|mesh-list
25722869|NCT02511236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25722870|NCT02511236|Autonomic Agents|autonomic agents|mesh-ancestor
25722871|NCT02511236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25722872|NCT02511236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722873|NCT02511236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25335940|NCT03082209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25335941|NCT03082209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25335942|NCT03082209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25335943|NCT03082209|Growth Substances|growth substances|mesh-ancestor
25335944|NCT03082209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25335945|NCT03082209|Growth Inhibitors|growth inhibitors|mesh-ancestor
25335957|NCT03016533|Lamivudine|lamivudine|mesh-list
25335958|NCT03016533|Dolutegravir|dolutegravir|mesh-list
25335959|NCT03016533|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25335960|NCT03016533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25335961|NCT03016533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25335962|NCT03016533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722874|NCT02511236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25722875|NCT02511236|Cholinergic Agents|cholinergic agents|mesh-ancestor
25722876|NCT02511236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25722877|NCT02511236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722878|NCT02511379|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25722879|NCT02511379|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25722880|NCT02511431|Ritonavir|ritonavir|mesh-list
25722881|NCT02511431|Lonafarnib|lonafarnib|mesh-list
25722882|NCT02511431|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25722883|NCT02511431|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25722884|NCT02511431|Protease Inhibitors|protease inhibitors|mesh-ancestor
25722885|NCT02511431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722886|NCT02511431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336039|NCT02885974|Celecoxib|celecoxib|mesh-list
25336040|NCT02885974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25336041|NCT02885974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25336042|NCT02885974|Antimetabolites|antimetabolites|mesh-ancestor
25336043|NCT02885974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336044|NCT02885974|Antiviral Agents|antiviral agents|mesh-ancestor
25336045|NCT02885974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25336046|NCT02885974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25336047|NCT02885974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25336048|NCT02885974|Immunologic Factors|immunologic factors|mesh-ancestor
25336049|NCT02885974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336050|NCT02885974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
24447488|NCT00308594|Glucocorticoids|glucocorticoids|mesh-ancestor
25336051|NCT02885974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25336052|NCT02885974|Analgesics|analgesics|mesh-ancestor
25336053|NCT02885974|Sensory System Agents|sensory system agents|mesh-ancestor
25336054|NCT02885974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25336055|NCT02885974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25336056|NCT02885974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25336057|NCT02885974|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25722887|NCT02511431|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25722888|NCT02511431|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25722889|NCT02511431|Antiviral Agents|antiviral agents|mesh-ancestor
25722890|NCT02511431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25722891|NCT02511431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25722892|NCT02511431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25722893|NCT02511535|Vaccines|vaccines|mesh-list
25722894|NCT02511535|Immunologic Factors|immunologic factors|mesh-ancestor
25722895|NCT02511535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722896|NCT02511561|Ciprofloxacin|ciprofloxacin|mesh-list
25722897|NCT02511561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25722898|NCT02511561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25722899|NCT02511561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25722900|NCT02511561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25722901|NCT02511561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722902|NCT02511561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722903|NCT02511561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722904|NCT02511561|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25722905|NCT02511561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25722906|NCT02512042|Brinzolamide|brinzolamide|mesh-list
25336093|NCT02848820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25336094|NCT02848820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25336095|NCT02848820|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25336096|NCT02848820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25336097|NCT02848820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336098|NCT02848820|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25336121|NCT02835079|Tamoxifen|tamoxifen|mesh-list
25336122|NCT02835079|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25336123|NCT02835079|Hormone Antagonists|hormone antagonists|mesh-ancestor
25336124|NCT02835079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25336125|NCT02835079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336126|NCT02835079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25336127|NCT02835079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25336128|NCT02835079|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25336129|NCT02835079|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25336130|NCT02835079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25336153|NCT02819518|Gemcitabine|gemcitabine|mesh-list
25336154|NCT02819518|Paclitaxel|paclitaxel|mesh-list
25336155|NCT02819518|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25722907|NCT02512042|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25722908|NCT02512042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25722909|NCT02512042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722910|NCT02512302|Glycopyrrolate|glycopyrrolate|mesh-list
25722911|NCT02512302|Bromides|bromides|mesh-list
25722912|NCT02512302|Charcoal|charcoal|mesh-list
25722913|NCT02512302|Anticonvulsants|anticonvulsants|mesh-ancestor
25722914|NCT02512302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25722915|NCT02512302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25722916|NCT02512302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25722917|NCT02512302|Cholinergic Agents|cholinergic agents|mesh-ancestor
25722918|NCT02512302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25722919|NCT02512302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722920|NCT02512302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722921|NCT02512302|Antidotes|antidotes|mesh-ancestor
25722922|NCT02512302|Protective Agents|protective agents|mesh-ancestor
25722923|NCT02512575|Prednisolone|prednisolone|mesh-list
25722924|NCT02512575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25722925|NCT02512575|Glucocorticoids|glucocorticoids|mesh-ancestor
25722926|NCT02512575|Hormones|hormones|mesh-ancestor
25336168|NCT02819518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25336169|NCT02819518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25336170|NCT02819518|Immunologic Factors|immunologic factors|mesh-ancestor
25336171|NCT02819518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336172|NCT02819518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25336174|NCT02790515|Cyclophosphamide|cyclophosphamide|mesh-list
25336175|NCT02790515|Melphalan|melphalan|mesh-list
25336176|NCT02790515|Mechlorethamine|mechlorethamine|mesh-list
25336177|NCT02790515|Thiotepa|thiotepa|mesh-list
25336178|NCT02790515|Rituximab|rituximab|mesh-list
25336179|NCT02790515|Fludarabine|fludarabine|mesh-list
25722927|NCT02512575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25722928|NCT02512575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722929|NCT02512575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25722930|NCT02512575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722931|NCT02512679|Cyclophosphamide|cyclophosphamide|mesh-list
25722932|NCT02512679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25722933|NCT02512679|Immunologic Factors|immunologic factors|mesh-ancestor
25722934|NCT02512679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722935|NCT02512679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25336244|NCT02613507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25336245|NCT02613507|Tubulin Modulators|tubulin modulators|mesh-ancestor
25336246|NCT02613507|Antimitotic Agents|antimitotic agents|mesh-ancestor
25336247|NCT02613507|Mitosis Modulators|mitosis modulators|mesh-ancestor
25336248|NCT02613507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336249|NCT02613507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25336250|NCT02613507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25336256|NCT02586857|Acalabrutinib|acalabrutinib|mesh-list
25336257|NCT02586857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25336258|NCT02579499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
25336259|NCT02579499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25336260|NCT02579499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25336261|NCT02579499|Antimetabolites|antimetabolites|mesh-ancestor
25336262|NCT02579499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336263|NCT02579499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25336264|NCT02579499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25336265|NCT02572791|Chlorhexidine|chlorhexidine|mesh-list
25336266|NCT02572791|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25336268|NCT02572791|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25336269|NCT02572791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25336270|NCT02572791|Disinfectants|disinfectants|mesh-ancestor
25336271|NCT02572791|Dermatologic Agents|dermatologic agents|mesh-ancestor
25336279|NCT02531906|Oxycodone|oxycodone|mesh-list
25722936|NCT02512679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25722937|NCT02512679|Alkylating Agents|alkylating agents|mesh-ancestor
25722938|NCT02512679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722939|NCT02512679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25722940|NCT02512679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25722941|NCT02512783|Lidocaine|lidocaine|mesh-list
25722942|NCT02512783|Propofol|propofol|mesh-list
25722943|NCT02512783|Anesthetics, Local|anesthetics, local|mesh-ancestor
25722944|NCT02512783|Anesthetics|anesthetics|mesh-ancestor
25722945|NCT02512783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25722946|NCT02512783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722947|NCT02512783|Sensory System Agents|sensory system agents|mesh-ancestor
25722948|NCT02512783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25722949|NCT02512783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25722950|NCT02512783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25722951|NCT02512783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25722952|NCT02512783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25722953|NCT02512783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722954|NCT02512783|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25722955|NCT02512783|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25722956|NCT02512783|Anesthetics, General|anesthetics, general|mesh-ancestor
25722957|NCT02512809|Dexmedetomidine|dexmedetomidine|mesh-list
25722958|NCT02512809|Isoflurane|isoflurane|mesh-list
25336360|NCT02460042|Paclitaxel|paclitaxel|mesh-list
25336361|NCT02460042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25336362|NCT02460042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25336363|NCT02460042|Tubulin Modulators|tubulin modulators|mesh-ancestor
25336364|NCT02460042|Antimitotic Agents|antimitotic agents|mesh-ancestor
25336365|NCT02460042|Mitosis Modulators|mitosis modulators|mesh-ancestor
25336366|NCT02460042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336367|NCT02414724|Gemcitabine|gemcitabine|mesh-list
25336368|NCT02414724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25336369|NCT02414724|Antimetabolites|antimetabolites|mesh-ancestor
25336370|NCT02414724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336371|NCT02414724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25336372|NCT02414724|Antiviral Agents|antiviral agents|mesh-ancestor
25336373|NCT02414724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25336374|NCT02414724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25336375|NCT02414724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25336376|NCT02414724|Immunologic Factors|immunologic factors|mesh-ancestor
25336377|NCT02414724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336378|NCT02413138|Hormones|hormones|mesh-list
25336379|NCT02413138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25336380|NCT02413138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336381|NCT02412228|Dexamethasone|dexamethasone|mesh-list
25336382|NCT02412228|Cyclophosphamide|cyclophosphamide|mesh-list
25336383|NCT02412228|Ixazomib|ixazomib|mesh-list
25336384|NCT02412228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25336385|NCT02412228|Immunologic Factors|immunologic factors|mesh-ancestor
25336386|NCT02412228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336387|NCT02412228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25336388|NCT02412228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25336389|NCT02412228|Alkylating Agents|alkylating agents|mesh-ancestor
25336390|NCT02412228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336391|NCT02412228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25336392|NCT02412228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25336393|NCT02412228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25407977|NCT03466411|Ustekinumab|ustekinumab|mesh-list
25722959|NCT02512809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25722960|NCT02512809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25722961|NCT02512809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722962|NCT02512809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25722963|NCT02512809|Analgesics|analgesics|mesh-ancestor
25722964|NCT02512809|Sensory System Agents|sensory system agents|mesh-ancestor
25722965|NCT02512809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25722966|NCT02512809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25722967|NCT02512809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25722968|NCT02512809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25722969|NCT02512809|Adrenergic Agents|adrenergic agents|mesh-ancestor
25722970|NCT02512809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25722971|NCT02512809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25722972|NCT02512809|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25722973|NCT02512809|Anesthetics, General|anesthetics, general|mesh-ancestor
25722974|NCT02512809|Anesthetics|anesthetics|mesh-ancestor
25722975|NCT02512861|Bupivacaine|bupivacaine|mesh-list
25722976|NCT02512861|Anesthetics, Local|anesthetics, local|mesh-ancestor
25722977|NCT02512861|Anesthetics|anesthetics|mesh-ancestor
25722978|NCT02512861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25722979|NCT02512861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722980|NCT02512861|Sensory System Agents|sensory system agents|mesh-ancestor
25722981|NCT02512861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25722982|NCT02513095|Dantrolene|dantrolene|mesh-list
25722983|NCT02513095|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25722984|NCT02513095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25722985|NCT02513095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25722986|NCT02513095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25722987|NCT02513160|Beclomethasone|beclomethasone|mesh-list
25722988|NCT02513160|Albuterol|albuterol|mesh-list
25722989|NCT02513160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25722990|NCT02513160|Autonomic Agents|autonomic agents|mesh-ancestor
25722991|NCT02513160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25722992|NCT02513160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336399|NCT02412228|Hormones|hormones|mesh-ancestor
25336400|NCT02412228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25336401|NCT02412228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25336402|NCT02412228|Protease Inhibitors|protease inhibitors|mesh-ancestor
25336403|NCT02412228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25336404|NCT02339506|Cosyntropin|cosyntropin|mesh-list
25336405|NCT02339506|Hormones|hormones|mesh-ancestor
25336406|NCT02339506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25336407|NCT02339506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336416|NCT02227940|Gemcitabine|gemcitabine|mesh-list
25336417|NCT02227940|Paclitaxel|paclitaxel|mesh-list
25336418|NCT02227940|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25336419|NCT02227940|Cisplatin|cisplatin|mesh-list
25336420|NCT02227940|Ceritinib|ceritinib|mesh-list
25336421|NCT02227940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25336422|NCT02227940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25336423|NCT02227940|Tubulin Modulators|tubulin modulators|mesh-ancestor
25336424|NCT02227940|Antimitotic Agents|antimitotic agents|mesh-ancestor
25336425|NCT02227940|Mitosis Modulators|mitosis modulators|mesh-ancestor
25336426|NCT02227940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336427|NCT02227940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25336428|NCT02227940|Antimetabolites|antimetabolites|mesh-ancestor
25336429|NCT02227940|Antiviral Agents|antiviral agents|mesh-ancestor
25336430|NCT02227940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25336431|NCT02227940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25336432|NCT02227940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25722993|NCT02513160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25722994|NCT02513160|Respiratory System Agents|respiratory system agents|mesh-ancestor
25722995|NCT02513160|Tocolytic Agents|tocolytic agents|mesh-ancestor
25722996|NCT02513160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25722997|NCT02513160|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25722998|NCT02513160|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25722999|NCT02513160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25723000|NCT02513160|Adrenergic Agents|adrenergic agents|mesh-ancestor
25723001|NCT02513160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25723002|NCT02513160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723003|NCT02513160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25723004|NCT02513160|Glucocorticoids|glucocorticoids|mesh-ancestor
25723005|NCT02513160|Hormones|hormones|mesh-ancestor
25723006|NCT02513160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25723007|NCT02513212|Fluorides|fluorides|mesh-list
25723008|NCT02513212|Tin Fluorides|tin fluorides|mesh-list
25723009|NCT02513212|Cariostatic Agents|cariostatic agents|mesh-ancestor
25723010|NCT02513212|Protective Agents|protective agents|mesh-ancestor
25723011|NCT02513212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723012|NCT02513446|Itraconazole|itraconazole|mesh-list
25723013|NCT02513446|Antifungal Agents|antifungal agents|mesh-ancestor
25723014|NCT02513446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25723015|NCT02513446|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25723016|NCT02513446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25723017|NCT02513446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25336475|NCT02143466|Durvalumab|durvalumab|mesh-list
25336476|NCT02143466|Osimertinib|osimertinib|mesh-list
25336477|NCT02143466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25336478|NCT02143466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25336479|NCT02143466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25336480|NCT02143466|Immunologic Factors|immunologic factors|mesh-ancestor
25336481|NCT02143466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336482|NCT02143466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25336483|NCT02143466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25336484|NCT02143466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336485|NCT02072486|Sorafenib|sorafenib|mesh-list
25336486|NCT02072486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25723018|NCT02513446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723019|NCT02513446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25723020|NCT02513446|Hormone Antagonists|hormone antagonists|mesh-ancestor
25723021|NCT02513446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25723022|NCT02513446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723023|NCT02513446|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25723024|NCT02513459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25723025|NCT02513459|Immunologic Factors|immunologic factors|mesh-ancestor
25723026|NCT02513459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723027|NCT02513498|Ixazomib|ixazomib|mesh-list
25723028|NCT02513498|Glycine|glycine|mesh-list
25336577|NCT01565941|Insulin|insulin|mesh-list
25336578|NCT01565941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25336579|NCT01565941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25336580|NCT01565941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723029|NCT02513498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723030|NCT02513498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25723031|NCT02513498|Protease Inhibitors|protease inhibitors|mesh-ancestor
25723032|NCT02513498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25723033|NCT02513498|Glycine Agents|glycine agents|mesh-ancestor
25723034|NCT02513498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25723035|NCT02513498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336698|NCT01014598|Cisplatin|cisplatin|mesh-list
25336699|NCT01014598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25336700|NCT00988364|Simvastatin|simvastatin|mesh-list
25336701|NCT00988364|Ezetimibe|ezetimibe|mesh-list
25336702|NCT00988364|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
25336703|NCT00988364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25723036|NCT02513550|Ixekizumab|ixekizumab|mesh-list
25723037|NCT02513550|Dermatologic Agents|dermatologic agents|mesh-ancestor
25723038|NCT02513719|Everolimus|everolimus|mesh-list
25723039|NCT02513719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25723040|NCT02513719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25723041|NCT02513719|Immunologic Factors|immunologic factors|mesh-ancestor
25723042|NCT02513719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723043|NCT02513771|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25723044|NCT02513771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25723045|NCT02513771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336704|NCT00988364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25336705|NCT00988364|Antimetabolites|antimetabolites|mesh-ancestor
25336706|NCT00988364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336707|NCT00988364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25336708|NCT00988364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25336709|NCT00988364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25336727|NCT00676715|Interferons|interferons|mesh-list
25336728|NCT00676715|Interferon-beta|interferon-beta|mesh-list
25336729|NCT00676715|Ocrelizumab|ocrelizumab|mesh-list
25407978|NCT03466411|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25723046|NCT02513771|Incretins|incretins|mesh-ancestor
25723047|NCT02513771|Hormones|hormones|mesh-ancestor
25723048|NCT02513771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25723049|NCT02513771|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25723050|NCT02513771|Protease Inhibitors|protease inhibitors|mesh-ancestor
25723051|NCT02513771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25723052|NCT02513771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723053|NCT02513823|Vitamin D|vitamin d|mesh-list
25723054|NCT02513823|Cholecalciferol|cholecalciferol|mesh-list
25336781|NCT05475041|Liver Extracts|liver extracts|mesh-list
25336782|NCT05475041|Hematinics|hematinics|mesh-ancestor
25336783|NCT05474950|Minocycline|minocycline|mesh-list
25336784|NCT05474950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25336785|NCT05474950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25336786|NCT05474937|Midazolam|midazolam|mesh-list
25336787|NCT05474937|Ketamine|ketamine|mesh-list
25336788|NCT05474937|Propofol|propofol|mesh-list
25336789|NCT05474937|Sevoflurane|sevoflurane|mesh-list
25336790|NCT05474937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25336791|NCT05474937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25336792|NCT05474937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336793|NCT05474937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25336794|NCT05474937|Anesthetics, General|anesthetics, general|mesh-ancestor
25336795|NCT05474937|Anesthetics|anesthetics|mesh-ancestor
25336796|NCT05474937|Analgesics|analgesics|mesh-ancestor
25336797|NCT05474937|Sensory System Agents|sensory system agents|mesh-ancestor
25723055|NCT02513823|Vitamins|vitamins|mesh-ancestor
25723056|NCT02513823|Micronutrients|micronutrients|mesh-ancestor
25723057|NCT02513823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723058|NCT02513823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25723059|NCT02513823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25723060|NCT02513940|Ibutilide|ibutilide|mesh-list
25723061|NCT02513940|Testosterone|testosterone|mesh-list
25723062|NCT02513940|Progesterone|progesterone|mesh-list
25723063|NCT02513940|Androgens|androgens|mesh-ancestor
25723064|NCT02513940|Hormones|hormones|mesh-ancestor
25723065|NCT02513940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25723066|NCT02513940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723067|NCT02513940|Progestins|progestins|mesh-ancestor
25723068|NCT02513940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25723069|NCT02514044|Adderall|adderall|mesh-list
25723070|NCT02514044|Dextroamphetamine|dextroamphetamine|mesh-list
25336932|NCT05474053|Ticagrelor|ticagrelor|mesh-list
25336933|NCT05474053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25336934|NCT05474053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25336935|NCT05474053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25336936|NCT05474053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25336937|NCT05474053|Purinergic Agents|purinergic agents|mesh-ancestor
25336938|NCT05474053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25336939|NCT05474053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336940|NCT05474053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336941|NCT05474040|Morphine|morphine|mesh-list
25336942|NCT05474040|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25336943|NCT05474040|Narcotics|narcotics|mesh-ancestor
25336944|NCT05474040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25336946|NCT05474040|Analgesics|analgesics|mesh-ancestor
25723071|NCT02514044|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25723072|NCT02514044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723073|NCT02514044|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25723074|NCT02514044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25723075|NCT02514044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25723076|NCT02514044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723077|NCT02514044|Dopamine Agents|dopamine agents|mesh-ancestor
25723078|NCT02514044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25723079|NCT02514122|Ketamine|ketamine|mesh-list
25723080|NCT02514122|Analgesics|analgesics|mesh-ancestor
25723081|NCT02514122|Sensory System Agents|sensory system agents|mesh-ancestor
25723082|NCT02514122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723083|NCT02514122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25337007|NCT05473741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25337008|NCT05473741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25337009|NCT05473741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25337010|NCT05473741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25337047|NCT05468892|Trifluridine|trifluridine|mesh-list
25337048|NCT05468892|Panitumumab|panitumumab|mesh-list
25337049|NCT05468892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25337050|NCT05468892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25337051|NCT05468892|Antimetabolites|antimetabolites|mesh-ancestor
25337052|NCT05468892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25337053|NCT05468892|Antiviral Agents|antiviral agents|mesh-ancestor
25337054|NCT05468892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25337058|NCT05467748|Pembrolizumab|pembrolizumab|mesh-list
25337059|NCT05467748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25337060|NCT05467748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25337061|NCT05467033|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25407979|NCT03466411|Dermatologic Agents|dermatologic agents|mesh-ancestor
25723084|NCT02514122|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25723085|NCT02514122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25723086|NCT02514122|Anesthetics, General|anesthetics, general|mesh-ancestor
25723087|NCT02514122|Anesthetics|anesthetics|mesh-ancestor
25723088|NCT02514122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25723089|NCT02514122|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25723090|NCT02514122|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25723091|NCT02514122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25723092|NCT02514122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772078|NCT03661346|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25772079|NCT03661541|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
25772080|NCT03661541|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25772081|NCT03661541|Immunologic Factors|immunologic factors|mesh-ancestor
25772082|NCT03661541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772083|NCT03661983|Aripiprazole|aripiprazole|mesh-list
25772084|NCT03661983|Antidepressive Agents|antidepressive agents|mesh-ancestor
25337084|NCT05463133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25337085|NCT05463133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25337086|NCT05463133|Antifungal Agents|antifungal agents|mesh-ancestor
25337087|NCT05463133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25337088|NCT05459844|Octreotide|octreotide|mesh-list
25337089|NCT05459844|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25337090|NCT05459844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25337091|NCT05459844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25337092|NCT05459844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25337093|NCT05459844|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25337095|NCT05458726|Paclitaxel|paclitaxel|mesh-list
25723093|NCT02514174|Afatinib|afatinib|mesh-list
25723094|NCT02514174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25723095|NCT02514174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25723096|NCT02514174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25723097|NCT02514174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723098|NCT02514473|Ivacaftor|ivacaftor|mesh-list
25723099|NCT02514473|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25723100|NCT02514473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25723101|NCT02514473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723102|NCT02514551|Paclitaxel|paclitaxel|mesh-list
25337207|NCT05399628|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25337208|NCT05399628|Respiratory System Agents|respiratory system agents|mesh-ancestor
25407980|NCT03466411|Immunologic Factors|immunologic factors|mesh-ancestor
25723103|NCT02514551|Ramucirumab|ramucirumab|mesh-list
25723104|NCT02514551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25723105|NCT02514551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25723106|NCT02514551|Tubulin Modulators|tubulin modulators|mesh-ancestor
25723107|NCT02514551|Antimitotic Agents|antimitotic agents|mesh-ancestor
25723108|NCT02514551|Mitosis Modulators|mitosis modulators|mesh-ancestor
25723109|NCT02514551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723110|NCT02514772|Rituximab|rituximab|mesh-list
25337265|NCT05388175|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25337266|NCT05388175|Respiratory System Agents|respiratory system agents|mesh-ancestor
25337459|NCT05304273|Oxytocics|oxytocics|mesh-ancestor
25723111|NCT02514772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25723112|NCT02514772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25723113|NCT02514772|Immunologic Factors|immunologic factors|mesh-ancestor
25723114|NCT02514772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723115|NCT02514772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25723116|NCT02515045|Moxifloxacin|moxifloxacin|mesh-list
25723117|NCT02515045|Prednisolone|prednisolone|mesh-list
25723118|NCT02515045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25337355|NCT05350215|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25337356|NCT05350215|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25337357|NCT05350215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25337358|NCT05350215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25337359|NCT05350215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25337360|NCT05350215|Adrenergic Agents|adrenergic agents|mesh-ancestor
25337361|NCT05350215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25337362|NCT05350215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25337363|NCT05347459|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25337364|NCT05347459|Dapagliflozin|dapagliflozin|mesh-list
25337365|NCT05347459|Empagliflozin|empagliflozin|mesh-list
25337366|NCT05347459|Linagliptin|linagliptin|mesh-list
25337367|NCT05347459|Vildagliptin|vildagliptin|mesh-list
25337368|NCT05347459|Saxagliptin|saxagliptin|mesh-list
25337369|NCT05347459|Canagliflozin|canagliflozin|mesh-list
25723119|NCT02515045|Methylprednisolone|methylprednisolone|mesh-list
25723120|NCT02515045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25723121|NCT02515045|Prednisolone acetate|prednisolone acetate|mesh-list
25723122|NCT02515045|Nepafenac|nepafenac|mesh-list
25723123|NCT02515045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25723124|NCT02515045|Prednisolone phosphate|prednisolone phosphate|mesh-list
25723125|NCT02515045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25723126|NCT02515045|Glucocorticoids|glucocorticoids|mesh-ancestor
25723127|NCT02515045|Hormones|hormones|mesh-ancestor
25723128|NCT02515045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25723129|NCT02515045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723130|NCT02515045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25723131|NCT02515045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25723132|NCT02515045|Antiemetics|antiemetics|mesh-ancestor
25723133|NCT02515045|Autonomic Agents|autonomic agents|mesh-ancestor
25772085|NCT03661983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25337384|NCT05346445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25337385|NCT05346445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25337386|NCT05346445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25337387|NCT05346445|Serotonin Agents|serotonin agents|mesh-ancestor
25337388|NCT05346445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25337389|NCT05346445|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25337390|NCT05346445|Antidepressive Agents|antidepressive agents|mesh-ancestor
25337404|NCT05331144|Losartan|losartan|mesh-list
25723134|NCT02515045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723135|NCT02515045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25723136|NCT02515045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25723137|NCT02515045|Protective Agents|protective agents|mesh-ancestor
25723138|NCT02515045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25723139|NCT02515045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25723140|NCT02515045|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25723141|NCT02515045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25337460|NCT05304273|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25337461|NCT05304273|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25337462|NCT05304273|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25337463|NCT05304273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25337464|NCT05304273|Contraceptive Agents|contraceptive agents|mesh-ancestor
25337465|NCT05304273|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25337466|NCT05304273|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25337467|NCT05304273|Luteolytic Agents|luteolytic agents|mesh-ancestor
25723142|NCT02515045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25723143|NCT02515045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723144|NCT02515045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25723145|NCT02515045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25723146|NCT02515045|Analgesics|analgesics|mesh-ancestor
25723147|NCT02515045|Sensory System Agents|sensory system agents|mesh-ancestor
25723148|NCT02515045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25723149|NCT02515279|Ribavirin|ribavirin|mesh-list
25723150|NCT02515279|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25337637|NCT05225363|Cyclophosphamide|cyclophosphamide|mesh-list
25337638|NCT05225363|Fludarabine|fludarabine|mesh-list
25337639|NCT05225363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25337640|NCT05225363|Immunologic Factors|immunologic factors|mesh-ancestor
25337641|NCT05225363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25337642|NCT05225363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25337643|NCT05225363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25337644|NCT05225363|Alkylating Agents|alkylating agents|mesh-ancestor
25337645|NCT05225363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25337646|NCT05225363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25337647|NCT05225363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25337648|NCT05205759|Bamlanivimab|bamlanivimab|mesh-list
25337649|NCT05205759|Antiviral Agents|antiviral agents|mesh-ancestor
25337650|NCT05205759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25337651|NCT05195177|Anesthetics|anesthetics|mesh-list
25337652|NCT05195177|Anesthetics, Local|anesthetics, local|mesh-list
25337653|NCT05195177|Histamine|histamine|mesh-list
25337654|NCT05195177|Histamine Antagonists|histamine antagonists|mesh-list
25337655|NCT05195177|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25723151|NCT02515279|Antimetabolites|antimetabolites|mesh-ancestor
25723152|NCT02515279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723153|NCT02515279|Antiviral Agents|antiviral agents|mesh-ancestor
25723154|NCT02515279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25723155|NCT02515305|Clindamycin|clindamycin|mesh-list
25723156|NCT02515305|Clindamycin palmitate|clindamycin palmitate|mesh-list
25723157|NCT02515305|Clindamycin phosphate|clindamycin phosphate|mesh-list
25723158|NCT02515305|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25723159|NCT02515305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25723160|NCT02515305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25723161|NCT02515305|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25723162|NCT02515305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25723163|NCT02515305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723164|NCT02515305|Dermatologic Agents|dermatologic agents|mesh-ancestor
25723165|NCT02515630|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
25723166|NCT02515630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25723167|NCT02515630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25337696|NCT05184842|Venetoclax|venetoclax|mesh-list
25337697|NCT05184842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25337698|NCT05184842|Antimetabolites|antimetabolites|mesh-ancestor
25337699|NCT05184842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25337700|NCT05184842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25337701|NCT05184842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25337718|NCT05170919|Olanzapine|olanzapine|mesh-list
25337719|NCT05170919|Mirtazapine|mirtazapine|mesh-list
25337720|NCT05170919|Antiemetics|antiemetics|mesh-ancestor
25337721|NCT05170919|Autonomic Agents|autonomic agents|mesh-ancestor
25337760|NCT05168813|Vaccines|vaccines|mesh-list
25723168|NCT02515630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723169|NCT02515890|Midazolam|midazolam|mesh-list
25723170|NCT02515890|Dexmedetomidine|dexmedetomidine|mesh-list
25723171|NCT02515890|Ketamine|ketamine|mesh-list
25723172|NCT02515890|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25723173|NCT02515890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25723174|NCT02515890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723175|NCT02515890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25723176|NCT02515890|Analgesics|analgesics|mesh-ancestor
25723177|NCT02515890|Sensory System Agents|sensory system agents|mesh-ancestor
25772086|NCT03661983|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25772087|NCT03661983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25772088|NCT03661983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25772089|NCT03661983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772090|NCT03661983|Dopamine Agonists|dopamine agonists|mesh-ancestor
25772091|NCT03661983|Dopamine Agents|dopamine agents|mesh-ancestor
25772092|NCT03661983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25772093|NCT03661983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772094|NCT03661983|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25772095|NCT03661983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25772096|NCT03661983|Serotonin Agents|serotonin agents|mesh-ancestor
25772097|NCT03661983|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25772098|NCT03661983|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25772099|NCT03661983|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25772100|NCT03661983|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25772101|NCT03662334|Insulin, Short-Acting|insulin, short-acting|mesh-list
25772102|NCT03662334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25772103|NCT03662334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772104|NCT03662789|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25772105|NCT03662789|Hematinics|hematinics|mesh-ancestor
25772106|NCT03663101|Lidocaine|lidocaine|mesh-list
25772107|NCT03663101|Botulinum Toxins|botulinum toxins|mesh-list
25772108|NCT03663101|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25772109|NCT03663101|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25772110|NCT03663101|Anesthetics, Local|anesthetics, local|mesh-ancestor
25772111|NCT03663101|Anesthetics|anesthetics|mesh-ancestor
25772112|NCT03663101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25772113|NCT03663101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772114|NCT03663101|Sensory System Agents|sensory system agents|mesh-ancestor
25772115|NCT03663101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772116|NCT03663101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25772117|NCT03663101|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25772118|NCT03663101|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25772119|NCT03663101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25772120|NCT03663101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772121|NCT03663101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25772122|NCT03663101|Cholinergic Agents|cholinergic agents|mesh-ancestor
25772123|NCT03663101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25772124|NCT03663101|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25772125|NCT03663283|Bupivacaine|bupivacaine|mesh-list
25772126|NCT03663283|Anesthetics, Local|anesthetics, local|mesh-ancestor
25772127|NCT03663283|Anesthetics|anesthetics|mesh-ancestor
25772128|NCT03663283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25772129|NCT03663283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772130|NCT03663283|Sensory System Agents|sensory system agents|mesh-ancestor
25772131|NCT03663283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772132|NCT03663582|Teduglutide|teduglutide|mesh-list
25772133|NCT03663582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25772134|NCT03663582|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25772135|NCT03663582|Protective Agents|protective agents|mesh-ancestor
25337765|NCT05168683|Antioxidants|antioxidants|mesh-ancestor
25337766|NCT05168683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25337767|NCT05168683|Protective Agents|protective agents|mesh-ancestor
25337768|NCT05168683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25337769|NCT05168683|Gout Suppressants|gout suppressants|mesh-ancestor
25337770|NCT05168683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25337802|NCT05151263|Salicylates|salicylates|mesh-list
25337803|NCT05151263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25337804|NCT05151263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25337805|NCT05151263|Analgesics|analgesics|mesh-ancestor
25337806|NCT05151263|Sensory System Agents|sensory system agents|mesh-ancestor
25337807|NCT05151263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25337808|NCT05151263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25337809|NCT05151263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25337810|NCT05151263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25337811|NCT05151263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25337812|NCT05151263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25337813|NCT05151263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723178|NCT02515890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723179|NCT02515890|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25723180|NCT02515890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25723181|NCT02515890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25723182|NCT02515890|Adrenergic Agents|adrenergic agents|mesh-ancestor
25723183|NCT02515890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25723184|NCT02515890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723185|NCT02515890|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25723186|NCT02515890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25723187|NCT02515890|Anesthetics, General|anesthetics, general|mesh-ancestor
25723188|NCT02515890|Anesthetics|anesthetics|mesh-ancestor
25723189|NCT02515890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25723190|NCT02515890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25723191|NCT02515890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25723192|NCT02515890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25723193|NCT02515890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25723194|NCT02515890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25723195|NCT02515890|GABA Modulators|gaba modulators|mesh-ancestor
25723196|NCT02515890|GABA Agents|gaba agents|mesh-ancestor
25337850|NCT05079360|Everolimus|everolimus|mesh-list
25337851|NCT05079360|Exemestane|exemestane|mesh-list
25337852|NCT05079360|Estrogens|estrogens|mesh-list
25337853|NCT05079360|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
25337854|NCT05079360|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-list
25337855|NCT05079360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25337856|NCT05079360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25337857|NCT05079360|Immunologic Factors|immunologic factors|mesh-ancestor
25337858|NCT05079360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25337859|NCT05079360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25723197|NCT02516098|Scopolamine|scopolamine|mesh-list
25723198|NCT02516098|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25723199|NCT02516098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25723200|NCT02516098|Antiemetics|antiemetics|mesh-ancestor
25723201|NCT02516098|Autonomic Agents|autonomic agents|mesh-ancestor
25723202|NCT02516098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723203|NCT02516098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723204|NCT02516098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25723205|NCT02516098|Mydriatics|mydriatics|mesh-ancestor
25723206|NCT02516098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25337922|NCT05046314|Vincristine|vincristine|mesh-list
25337923|NCT05046314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25337924|NCT05046314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25337925|NCT05046314|Tubulin Modulators|tubulin modulators|mesh-ancestor
25337926|NCT05046314|Antimitotic Agents|antimitotic agents|mesh-ancestor
25337927|NCT05046314|Mitosis Modulators|mitosis modulators|mesh-ancestor
25337928|NCT05046314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25337929|NCT05040568|Vidarabine|vidarabine|mesh-list
25337930|NCT05040568|Cyclophosphamide|cyclophosphamide|mesh-list
25337931|NCT05040568|Fludarabine|fludarabine|mesh-list
25337932|NCT05040568|Fludarabine phosphate|fludarabine phosphate|mesh-list
25337933|NCT05040568|Cetuximab|cetuximab|mesh-list
25337934|NCT05040568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25337935|NCT05040568|Immunologic Factors|immunologic factors|mesh-ancestor
25337937|NCT05040568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25723207|NCT02516098|Cholinergic Agents|cholinergic agents|mesh-ancestor
25723208|NCT02516098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25723209|NCT02516098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723210|NCT02516098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25723211|NCT02516098|Parasympatholytics|parasympatholytics|mesh-ancestor
25723212|NCT02516150|Ethanol|ethanol|mesh-list
25723213|NCT02516150|Glucagon|glucagon|mesh-list
25723214|NCT02516150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25723215|NCT02516150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25723216|NCT02516150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25723217|NCT02516150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723218|NCT02516150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25723219|NCT02516150|Hormones|hormones|mesh-ancestor
25772136|NCT03663582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772137|NCT03664544|Edaravone|edaravone|mesh-list
25772138|NCT03664544|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25772139|NCT03664544|Antioxidants|antioxidants|mesh-ancestor
25772140|NCT03664544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772141|NCT03664544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25772142|NCT03664544|Protective Agents|protective agents|mesh-ancestor
25772143|NCT03664544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772144|NCT03665155|Daratumumab|daratumumab|mesh-list
25772145|NCT03665155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25772146|NCT03666663|Lidocaine|lidocaine|mesh-list
25772147|NCT03666663|Bupivacaine|bupivacaine|mesh-list
25772148|NCT03666663|Ropivacaine|ropivacaine|mesh-list
25772149|NCT03666663|Anesthetics, Local|anesthetics, local|mesh-ancestor
25772150|NCT03666663|Anesthetics|anesthetics|mesh-ancestor
25772151|NCT03666663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25772152|NCT03666663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772153|NCT03666663|Sensory System Agents|sensory system agents|mesh-ancestor
25772154|NCT03666663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772155|NCT03666663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25772156|NCT03666663|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25772157|NCT03666663|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25772158|NCT03666663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25772159|NCT03666663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772160|NCT03667053|Glucagon|glucagon|mesh-list
25772161|NCT03667053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25772162|NCT03667053|Hormones|hormones|mesh-ancestor
25772163|NCT03667053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25772164|NCT03667053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772165|NCT03667547|Raltegravir Potassium|raltegravir potassium|mesh-list
25772166|NCT03667547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25772167|NCT03667547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25772168|NCT03667547|Antiviral Agents|antiviral agents|mesh-ancestor
25772169|NCT03667547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25772170|NCT03667547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25772171|NCT03667547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25772172|NCT03667547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25772173|NCT03667547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25338011|NCT04995653|Vancomycin|vancomycin|mesh-list
25338012|NCT04995653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25338013|NCT04995653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25338025|NCT04990128|Triamcinolone|triamcinolone|mesh-list
25338026|NCT04990128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25338027|NCT04990128|Glucocorticoids|glucocorticoids|mesh-ancestor
25338028|NCT04990128|Hormones|hormones|mesh-ancestor
25338029|NCT04990128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25338030|NCT04990128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25338031|NCT04983901|Vancomycin|vancomycin|mesh-list
25338032|NCT04983901|Meropenem|meropenem|mesh-list
25338033|NCT04983901|Tazobactam|tazobactam|mesh-list
25338034|NCT04983901|Linezolid|linezolid|mesh-list
25338035|NCT04983901|Piperacillin|piperacillin|mesh-list
25338036|NCT04983901|Daptomycin|daptomycin|mesh-list
25338037|NCT04983901|Imipenem|imipenem|mesh-list
25338038|NCT04983901|Cefepime|cefepime|mesh-list
25338039|NCT04983901|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25338040|NCT04983901|Relebactam|relebactam|mesh-list
25338041|NCT04983901|Cilastatin|cilastatin|mesh-list
25338042|NCT04983901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25338043|NCT04983901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25338044|NCT04983901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25723220|NCT02516150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25723221|NCT02516202|Estradiol|estradiol|mesh-list
25723222|NCT02516202|Estrogens|estrogens|mesh-ancestor
25723223|NCT02516202|Hormones|hormones|mesh-ancestor
25723224|NCT02516202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25723225|NCT02516202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723226|NCT02516306|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25723227|NCT02516306|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25723228|NCT02516332|Citalopram|citalopram|mesh-list
25723229|NCT02516332|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25723230|NCT02516332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25723231|NCT02516332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25723232|NCT02516332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723233|NCT02516332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25723234|NCT02516332|Serotonin Agents|serotonin agents|mesh-ancestor
25723235|NCT02516332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723236|NCT02516332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25723237|NCT02516332|Antidepressive Agents|antidepressive agents|mesh-ancestor
25723238|NCT02516332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25338068|NCT04976036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25338069|NCT04976036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25338070|NCT04976036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25338079|NCT04948333|Niacinamide|niacinamide|mesh-list
25338080|NCT04948333|Vitamin B Complex|vitamin b complex|mesh-ancestor
25338081|NCT04948333|Vitamins|vitamins|mesh-ancestor
25338082|NCT04948333|Micronutrients|micronutrients|mesh-ancestor
25338083|NCT04948333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723239|NCT02516410|Ivacaftor|ivacaftor|mesh-list
25723240|NCT02516410|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25723241|NCT02516410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25723242|NCT02516410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723243|NCT02516592|Fluticasone|fluticasone|mesh-list
25723244|NCT02516592|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
25723245|NCT02516592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25723246|NCT02516592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25338159|NCT04928664|Bupivacaine|bupivacaine|mesh-list
25338160|NCT04928664|Anesthetics, Local|anesthetics, local|mesh-ancestor
25338161|NCT04928664|Anesthetics|anesthetics|mesh-ancestor
25338162|NCT04928664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25338163|NCT04928664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25338164|NCT04928664|Sensory System Agents|sensory system agents|mesh-ancestor
25338165|NCT04928664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25338166|NCT04926324|Niraparib|niraparib|mesh-list
25338167|NCT04926324|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25338168|NCT04926324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25338169|NCT04926324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25338170|NCT04926324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25338194|NCT04890106|Bimatoprost|bimatoprost|mesh-list
25338195|NCT04890106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25407981|NCT03466411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723247|NCT02516592|Autonomic Agents|autonomic agents|mesh-ancestor
25723248|NCT02516592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723249|NCT02516592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723250|NCT02516592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25723251|NCT02516592|Respiratory System Agents|respiratory system agents|mesh-ancestor
25723252|NCT02516592|Dermatologic Agents|dermatologic agents|mesh-ancestor
25723253|NCT02516592|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25723254|NCT02516592|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25723255|NCT02516592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25723256|NCT02516592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25723257|NCT02516592|Adrenergic Agents|adrenergic agents|mesh-ancestor
25723258|NCT02516592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25723259|NCT02516592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723260|NCT02517021|Dexamethasone|dexamethasone|mesh-list
25338223|NCT04870359|Prednisolone|prednisolone|mesh-list
25338224|NCT04870359|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25338225|NCT04870359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25338226|NCT04870359|Glucocorticoids|glucocorticoids|mesh-ancestor
25338227|NCT04870359|Hormones|hormones|mesh-ancestor
25338228|NCT04870359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25338229|NCT04870359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25338230|NCT04870359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25338231|NCT04870359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25338232|NCT04870359|Immunologic Factors|immunologic factors|mesh-ancestor
25338249|NCT04825223|Vaccines|vaccines|mesh-list
25338250|NCT04825223|Immunologic Factors|immunologic factors|mesh-ancestor
25338251|NCT04825223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25338255|NCT04790032|Cangrelor|cangrelor|mesh-list
25338256|NCT04790032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25338257|NCT04790032|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25338258|NCT04790032|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25723261|NCT02517021|Palonosetron|palonosetron|mesh-list
25723262|NCT02517021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25723263|NCT02517021|Antiemetics|antiemetics|mesh-ancestor
25723264|NCT02517021|Autonomic Agents|autonomic agents|mesh-ancestor
25723265|NCT02517021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723266|NCT02517021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723267|NCT02517021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25723268|NCT02517021|Glucocorticoids|glucocorticoids|mesh-ancestor
25723269|NCT02517021|Hormones|hormones|mesh-ancestor
25723270|NCT02517021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25723271|NCT02517021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25723272|NCT02517021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25723273|NCT02517021|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25723274|NCT02517021|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25723275|NCT02517021|Serotonin Agents|serotonin agents|mesh-ancestor
25723276|NCT02517021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25772174|NCT03668613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25338292|NCT04773366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25338293|NCT04773366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25338294|NCT04773366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25338295|NCT04773366|Antimetabolites|antimetabolites|mesh-ancestor
25338296|NCT04773366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25338297|NCT04773366|Antiviral Agents|antiviral agents|mesh-ancestor
25338298|NCT04773366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25338299|NCT04773366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25338300|NCT04773366|Immunologic Factors|immunologic factors|mesh-ancestor
25338301|NCT04773366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25338302|NCT04773366|Tubulin Modulators|tubulin modulators|mesh-ancestor
25338303|NCT04773366|Antimitotic Agents|antimitotic agents|mesh-ancestor
25338304|NCT04773366|Mitosis Modulators|mitosis modulators|mesh-ancestor
25338305|NCT04773366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25338306|NCT04773366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25723277|NCT02517021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723278|NCT02517463|Ulipristal acetate|ulipristal acetate|mesh-list
25723279|NCT02517463|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25723280|NCT02517463|Contraceptive Agents|contraceptive agents|mesh-ancestor
25723281|NCT02517463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25723282|NCT02517463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723283|NCT02517463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25723284|NCT02517515|Ritonavir|ritonavir|mesh-list
25723285|NCT02517515|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25723286|NCT02517515|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25723287|NCT02517515|Protease Inhibitors|protease inhibitors|mesh-ancestor
25723288|NCT02517515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25723289|NCT02517515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723290|NCT02517515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25723291|NCT02517515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25723292|NCT02517515|Antiviral Agents|antiviral agents|mesh-ancestor
25338369|NCT04759274|Natriuretic Agents|natriuretic agents|mesh-ancestor
25338370|NCT04759274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25338385|NCT04748224|Dexmedetomidine|dexmedetomidine|mesh-list
25338386|NCT04748224|Bupivacaine|bupivacaine|mesh-list
25338387|NCT04748224|Anesthetics, Local|anesthetics, local|mesh-ancestor
25338388|NCT04748224|Anesthetics|anesthetics|mesh-ancestor
25338389|NCT04748224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25338390|NCT04748224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25338391|NCT04748224|Sensory System Agents|sensory system agents|mesh-ancestor
25338392|NCT04748224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25338393|NCT04748224|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25338394|NCT04748224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25338395|NCT04748224|Analgesics|analgesics|mesh-ancestor
25338396|NCT04748224|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25723293|NCT02517515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25723294|NCT02517515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25723295|NCT02517515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25723296|NCT02517528|Ritonavir|ritonavir|mesh-list
25723297|NCT02517528|Ribavirin|ribavirin|mesh-list
25723298|NCT02517528|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25723299|NCT02517528|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25723300|NCT02517528|Protease Inhibitors|protease inhibitors|mesh-ancestor
25723301|NCT02517528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25723302|NCT02517528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723303|NCT02517528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25723304|NCT02517528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25723305|NCT02517528|Antiviral Agents|antiviral agents|mesh-ancestor
25723306|NCT02517528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25338445|NCT04736602|Luteolytic Agents|luteolytic agents|mesh-ancestor
25338446|NCT04736602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25338447|NCT04736602|Contraceptive Agents|contraceptive agents|mesh-ancestor
25338448|NCT04736602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25338449|NCT04736602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25338450|NCT04736602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25338451|NCT04736602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25338452|NCT04736602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25338469|NCT04716413|Dsuvia|dsuvia|mesh-list
25723307|NCT02517528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25723308|NCT02517528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25723309|NCT02517528|Antimetabolites|antimetabolites|mesh-ancestor
25723310|NCT02517580|Vitamin K|vitamin k|mesh-list
25723311|NCT02517580|Vitamin K 2|vitamin k 2|mesh-list
25723312|NCT02517580|Vitamins|vitamins|mesh-ancestor
25723313|NCT02517580|Micronutrients|micronutrients|mesh-ancestor
25723314|NCT02517580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723315|NCT02517580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25723316|NCT02517580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25407982|NCT03466294|Azacitidine|azacitidine|mesh-list
25338645|NCT04589611|Hyaluronic Acid|hyaluronic acid|mesh-list
25338646|NCT04589611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25338647|NCT04589611|Immunologic Factors|immunologic factors|mesh-ancestor
25338648|NCT04589611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25338649|NCT04589611|Viscosupplements|viscosupplements|mesh-ancestor
25338650|NCT04589611|Protective Agents|protective agents|mesh-ancestor
25338651|NCT04589611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25338652|NCT04589611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25338653|NCT04589611|GABA Modulators|gaba modulators|mesh-ancestor
25338654|NCT04589611|GABA Agents|gaba agents|mesh-ancestor
25338655|NCT04589611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25338656|NCT04589611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25338657|NCT04589208|Ketamine|ketamine|mesh-list
25338658|NCT04589208|Analgesics|analgesics|mesh-ancestor
25338659|NCT04589208|Sensory System Agents|sensory system agents|mesh-ancestor
25338660|NCT04589208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723317|NCT02517580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723318|NCT02517580|Hemostatics|hemostatics|mesh-ancestor
25723319|NCT02517580|Coagulants|coagulants|mesh-ancestor
25723320|NCT02517866|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
25723321|NCT02517866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25723322|NCT02517866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25723323|NCT02517866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723324|NCT02517905|Bupivacaine|bupivacaine|mesh-list
25723325|NCT02517905|Anesthetics, Local|anesthetics, local|mesh-ancestor
25723326|NCT02517905|Anesthetics|anesthetics|mesh-ancestor
25723327|NCT02517905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25723328|NCT02517905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723329|NCT02517905|Sensory System Agents|sensory system agents|mesh-ancestor
25723330|NCT02517905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723331|NCT02517996|Lidocaine|lidocaine|mesh-list
25723332|NCT02517996|Anesthetics, Local|anesthetics, local|mesh-ancestor
25407983|NCT03466294|Venetoclax|venetoclax|mesh-list
25338691|NCT04573920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25338692|NCT04573920|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25338693|NCT04573920|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25338694|NCT04573920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25338695|NCT04570397|Ravulizumab|ravulizumab|mesh-list
25338696|NCT04570397|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25338697|NCT04570397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25338698|NCT04570397|Immunologic Factors|immunologic factors|mesh-ancestor
25338699|NCT04570397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25338700|NCT04562597|Acetylcysteine|acetylcysteine|mesh-list
25338701|NCT04562597|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25338702|NCT04562597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25338703|NCT04562597|Antiviral Agents|antiviral agents|mesh-ancestor
25338704|NCT04562597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25338705|NCT04562597|Expectorants|expectorants|mesh-ancestor
25338708|NCT04562597|Antioxidants|antioxidants|mesh-ancestor
25723333|NCT02517996|Anesthetics|anesthetics|mesh-ancestor
25723334|NCT02517996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25723335|NCT02517996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723336|NCT02517996|Sensory System Agents|sensory system agents|mesh-ancestor
25723337|NCT02517996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723338|NCT02517996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25723339|NCT02517996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25723340|NCT02517996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25723341|NCT02517996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25723342|NCT02517996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723343|NCT02518113|Dexamethasone|dexamethasone|mesh-list
25723344|NCT02518113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25723345|NCT02518113|Antiemetics|antiemetics|mesh-ancestor
25723346|NCT02518113|Autonomic Agents|autonomic agents|mesh-ancestor
25723347|NCT02518113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723348|NCT02518113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25338773|NCT04478292|Cisplatin|cisplatin|mesh-list
25338774|NCT04478292|Carboplatin|carboplatin|mesh-list
25338775|NCT04478292|Doxorubicin|doxorubicin|mesh-list
25338776|NCT04478292|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25338777|NCT04478292|Fluorouracil|fluorouracil|mesh-list
25338778|NCT04478292|Irinotecan|irinotecan|mesh-list
25338779|NCT04478292|Vincristine|vincristine|mesh-list
25338780|NCT04478292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25338781|NCT04478292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25338782|NCT04478292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25338783|NCT04478292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25338784|NCT04478292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25723349|NCT02518113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25723350|NCT02518113|Glucocorticoids|glucocorticoids|mesh-ancestor
25723351|NCT02518113|Hormones|hormones|mesh-ancestor
25723352|NCT02518113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25723353|NCT02518113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25723354|NCT02518113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25723355|NCT02518191|Goserelin|goserelin|mesh-list
25723356|NCT02518191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25723357|NCT02518191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25723358|NCT02518464|Ticagrelor|ticagrelor|mesh-list
25723359|NCT02518464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25338848|NCT04434560|Nivolumab|nivolumab|mesh-list
25338849|NCT04434560|Ipilimumab|ipilimumab|mesh-list
25338850|NCT04434560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25338851|NCT04434560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25338852|NCT04434560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25338853|NCT04434560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25338876|NCT04428086|Metformin|metformin|mesh-list
25338877|NCT04428086|Apatinib|apatinib|mesh-list
25338878|NCT04428086|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25338879|NCT04428086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25338880|NCT04428086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25338881|NCT04428086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25338882|NCT04428086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25338883|NCT04428086|Antimetabolites|antimetabolites|mesh-ancestor
25723360|NCT02518464|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25723361|NCT02518464|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25723362|NCT02518464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25723363|NCT02518464|Purinergic Agents|purinergic agents|mesh-ancestor
25723364|NCT02518464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25723365|NCT02518464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723366|NCT02518464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723367|NCT02518971|Tamsulosin|tamsulosin|mesh-list
25723368|NCT02518971|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25723369|NCT02518971|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25723370|NCT02518971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25723371|NCT02518971|Adrenergic Agents|adrenergic agents|mesh-ancestor
25338900|NCT04426409|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25338901|NCT04426409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25338910|NCT04416386|Ascorbic Acid|ascorbic acid|mesh-list
25338911|NCT04416386|Vitamins|vitamins|mesh-ancestor
25338912|NCT04416386|Micronutrients|micronutrients|mesh-ancestor
25338913|NCT04416386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25338914|NCT04416386|Antioxidants|antioxidants|mesh-ancestor
25338916|NCT04416386|Protective Agents|protective agents|mesh-ancestor
25723372|NCT02518971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25723373|NCT02518971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723374|NCT02518971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723375|NCT02518971|Urological Agents|urological agents|mesh-ancestor
25723376|NCT02519023|Acetaminophen|acetaminophen|mesh-list
25723377|NCT02519023|Ibuprofen|ibuprofen|mesh-list
25723378|NCT02519023|Epinephrine|epinephrine|mesh-list
25723379|NCT02519023|Oxycodone|oxycodone|mesh-list
25338977|NCT04373603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25338978|NCT04373603|Viscosupplements|viscosupplements|mesh-ancestor
25338979|NCT04373603|Protective Agents|protective agents|mesh-ancestor
25338994|NCT04355858|Paclitaxel|paclitaxel|mesh-list
25338995|NCT04355858|Capecitabine|capecitabine|mesh-list
25338996|NCT04355858|Everolimus|everolimus|mesh-list
25338997|NCT04355858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25338998|NCT04355858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25338999|NCT04355858|Tubulin Modulators|tubulin modulators|mesh-ancestor
25339000|NCT04355858|Antimitotic Agents|antimitotic agents|mesh-ancestor
25339001|NCT04355858|Mitosis Modulators|mitosis modulators|mesh-ancestor
25339002|NCT04355858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25339003|NCT04355858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25339004|NCT04355858|Antimetabolites|antimetabolites|mesh-ancestor
25723380|NCT02519023|Bupivacaine|bupivacaine|mesh-list
25723381|NCT02519023|Anesthetics, Local|anesthetics, local|mesh-ancestor
25723382|NCT02519023|Anesthetics|anesthetics|mesh-ancestor
25723383|NCT02519023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25723384|NCT02519023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723385|NCT02519023|Sensory System Agents|sensory system agents|mesh-ancestor
25723386|NCT02519023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723387|NCT02519023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25723388|NCT02519023|Analgesics|analgesics|mesh-ancestor
25723389|NCT02519023|Antipyretics|antipyretics|mesh-ancestor
25723390|NCT02519023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25723391|NCT02519023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25723392|NCT02519023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25723393|NCT02519023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25339056|NCT04334863|Tyrphostins|tyrphostins|mesh-list
25339057|NCT04334863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25339058|NCT04334863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25339059|NCT04334863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25339060|NCT04333706|Capecitabine|capecitabine|mesh-list
25339061|NCT04333706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25339062|NCT04333706|Antimetabolites|antimetabolites|mesh-ancestor
25339063|NCT04333706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25339064|NCT04333706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25339071|NCT04331002|Triamcinolone|triamcinolone|mesh-list
25723394|NCT02519023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25723395|NCT02519023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723396|NCT02519023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25723397|NCT02519023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25723398|NCT02519023|Adrenergic Agents|adrenergic agents|mesh-ancestor
25723399|NCT02519023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25723400|NCT02519023|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25723401|NCT02519023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25723402|NCT02519023|Autonomic Agents|autonomic agents|mesh-ancestor
25723403|NCT02519023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25339128|NCT04277975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25339129|NCT04277975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25339130|NCT04277975|Analgesics|analgesics|mesh-ancestor
25339131|NCT04277975|Sensory System Agents|sensory system agents|mesh-ancestor
25339132|NCT04277975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25339168|NCT04233190|Budesonide|budesonide|mesh-list
25339169|NCT04233190|Formoterol Fumarate|formoterol fumarate|mesh-list
25339170|NCT04233190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25339171|NCT04233190|Autonomic Agents|autonomic agents|mesh-ancestor
25339172|NCT04233190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25339173|NCT04233190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25339174|NCT04233190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25339175|NCT04233190|Respiratory System Agents|respiratory system agents|mesh-ancestor
25339176|NCT04233190|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25339177|NCT04233190|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25339178|NCT04233190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25339179|NCT04233190|Adrenergic Agents|adrenergic agents|mesh-ancestor
25339180|NCT04233190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25339181|NCT04233190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25339182|NCT04233190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25339183|NCT04233190|Glucocorticoids|glucocorticoids|mesh-ancestor
25339184|NCT04233190|Hormones|hormones|mesh-ancestor
25339185|NCT04233190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25339188|NCT04231539|Nicotine|nicotine|mesh-list
25339189|NCT04231539|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25723404|NCT02519023|Respiratory System Agents|respiratory system agents|mesh-ancestor
25723405|NCT02519023|Mydriatics|mydriatics|mesh-ancestor
25723406|NCT02519023|Sympathomimetics|sympathomimetics|mesh-ancestor
25723407|NCT02519023|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25723408|NCT02519023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25723409|NCT02519023|Narcotics|narcotics|mesh-ancestor
25723410|NCT02519231|Naproxen|naproxen|mesh-list
25723411|NCT02519231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25723412|NCT02519231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25723413|NCT02519231|Analgesics|analgesics|mesh-ancestor
25723414|NCT02519231|Sensory System Agents|sensory system agents|mesh-ancestor
25723415|NCT02519231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723416|NCT02519231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723417|NCT02519231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25723418|NCT02519231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25723419|NCT02519231|Gout Suppressants|gout suppressants|mesh-ancestor
25723420|NCT02519231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25723421|NCT02519231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25723422|NCT02519231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723423|NCT02519387|Buprenorphine|buprenorphine|mesh-list
25723424|NCT02519387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25723425|NCT02519387|Narcotics|narcotics|mesh-ancestor
25723426|NCT02519387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25723427|NCT02519387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723428|NCT02519387|Analgesics|analgesics|mesh-ancestor
25723429|NCT02519387|Sensory System Agents|sensory system agents|mesh-ancestor
25339205|NCT04225221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25339206|NCT04225221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25339207|NCT04225221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25339208|NCT04225221|Progestins|progestins|mesh-ancestor
25339209|NCT04225221|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25339210|NCT04225221|Fertility Agents|fertility agents|mesh-ancestor
25339211|NCT04225221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25723430|NCT02519387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723431|NCT02519387|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25723432|NCT02519595|Ketamine|ketamine|mesh-list
25723433|NCT02519595|Analgesics|analgesics|mesh-ancestor
25723434|NCT02519595|Sensory System Agents|sensory system agents|mesh-ancestor
25723435|NCT02519595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723436|NCT02519595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723437|NCT02519595|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25339303|NCT04134325|Pembrolizumab|pembrolizumab|mesh-list
25339304|NCT04134325|Nivolumab|nivolumab|mesh-list
25339305|NCT04134325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25339306|NCT04134325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25339307|NCT04134325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25339308|NCT04134325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25339339|NCT04089072|Phenylephrine|phenylephrine|mesh-list
25339340|NCT04089072|Oxymetazoline|oxymetazoline|mesh-list
25339341|NCT04089072|Methylene Blue|methylene blue|mesh-list
25339343|NCT04089072|Mydriatics|mydriatics|mesh-ancestor
25723438|NCT02519595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25723439|NCT02519595|Anesthetics, General|anesthetics, general|mesh-ancestor
25723440|NCT02519595|Anesthetics|anesthetics|mesh-ancestor
25723441|NCT02519595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25723442|NCT02519595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25723443|NCT02519595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25723444|NCT02519595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25723445|NCT02519595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723446|NCT02519842|Dexamethasone|dexamethasone|mesh-list
25339355|NCT04089072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25339356|NCT04089072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25339357|NCT04089072|Protective Agents|protective agents|mesh-ancestor
25339358|NCT04089072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25339391|NCT04074096|Pembrolizumab|pembrolizumab|mesh-list
25339392|NCT04074096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25339393|NCT04074096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25339396|NCT04062695|Tofacitinib|tofacitinib|mesh-list
25339397|NCT04062695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25339398|NCT04062695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25339399|NCT04062695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25339403|NCT04053140|Penicillins|penicillins|mesh-list
25339404|NCT04053140|Penicillin G|penicillin g|mesh-list
25339405|NCT04053140|Penicillin G Benzathine|penicillin g benzathine|mesh-list
25339406|NCT04053140|Penicillin G Procaine|penicillin g procaine|mesh-list
25339407|NCT04053140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25339408|NCT04053140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25723447|NCT02519842|Ondansetron|ondansetron|mesh-list
25723448|NCT02519842|Fosaprepitant|fosaprepitant|mesh-list
25723449|NCT02519842|Aprepitant|aprepitant|mesh-list
25723450|NCT02519842|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
25723451|NCT02519842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25723452|NCT02519842|Antiemetics|antiemetics|mesh-ancestor
25723453|NCT02519842|Autonomic Agents|autonomic agents|mesh-ancestor
25723454|NCT02519842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723455|NCT02519842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723456|NCT02519842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25723457|NCT02519842|Glucocorticoids|glucocorticoids|mesh-ancestor
25723458|NCT02519842|Hormones|hormones|mesh-ancestor
25723459|NCT02519842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25723460|NCT02519842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25723461|NCT02519842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25723462|NCT02519842|Antipruritics|antipruritics|mesh-ancestor
25723463|NCT02519842|Dermatologic Agents|dermatologic agents|mesh-ancestor
25723464|NCT02519842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25339441|NCT04023266|Acetylcysteine|acetylcysteine|mesh-list
25339442|NCT04023266|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25339443|NCT04023266|Antiviral Agents|antiviral agents|mesh-ancestor
25339444|NCT04023266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25339445|NCT04023266|Expectorants|expectorants|mesh-ancestor
25339446|NCT04023266|Respiratory System Agents|respiratory system agents|mesh-ancestor
25339447|NCT04023266|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25339448|NCT04023266|Antioxidants|antioxidants|mesh-ancestor
25723465|NCT02519842|Serotonin Agents|serotonin agents|mesh-ancestor
25723466|NCT02519842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25723467|NCT02519842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723468|NCT02519842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25723469|NCT02519842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25723470|NCT02519842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25723471|NCT02519842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25339510|NCT03952091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25339511|NCT03952091|Glucocorticoids|glucocorticoids|mesh-ancestor
25339512|NCT03952091|Hormones|hormones|mesh-ancestor
25339513|NCT03952091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25339514|NCT03952091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25339515|NCT03952091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25339516|NCT03952091|Protease Inhibitors|protease inhibitors|mesh-ancestor
25339517|NCT03952091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25339518|NCT03952091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25339519|NCT03952091|Immunologic Factors|immunologic factors|mesh-ancestor
25723472|NCT02519842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25723473|NCT02519842|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25723474|NCT02520388|Methylphenidate|methylphenidate|mesh-list
25723475|NCT02520388|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25723476|NCT02520388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723477|NCT02520388|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25723478|NCT02520388|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25723479|NCT02520388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25723480|NCT02520388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25339595|NCT03882307|Sofosbuvir|sofosbuvir|mesh-list
25339596|NCT03882307|Antiviral Agents|antiviral agents|mesh-ancestor
25339597|NCT03882307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25339598|NCT03880396|Cisplatin|cisplatin|mesh-list
25339599|NCT03880396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25339606|NCT03863288|Oxytocin|oxytocin|mesh-list
25339607|NCT03863288|Oxytocics|oxytocics|mesh-ancestor
25339608|NCT03863288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25339609|NCT03863288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25339657|NCT03810794|Donepezil|donepezil|mesh-list
25339659|NCT03810794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25723481|NCT02520388|Dopamine Agents|dopamine agents|mesh-ancestor
25723482|NCT02520388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25723483|NCT02520518|Dapagliflozin|dapagliflozin|mesh-list
25723484|NCT02520518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25723485|NCT02520518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723486|NCT02520518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25723487|NCT02520518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723488|NCT02521870|Pembrolizumab|pembrolizumab|mesh-list
25723489|NCT02521870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25339662|NCT03810794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25339663|NCT03810794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25339664|NCT03810794|Nootropic Agents|nootropic agents|mesh-ancestor
25339712|NCT03785925|Nivolumab|nivolumab|mesh-list
25339713|NCT03785925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25339714|NCT03785925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25339715|NCT03785925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25339716|NCT03785925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723490|NCT02521870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25723491|NCT02522104|Hydroxyurea|hydroxyurea|mesh-list
25723492|NCT02522104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25723493|NCT02522104|Antisickling Agents|antisickling agents|mesh-ancestor
25723494|NCT02522104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25723495|NCT02522104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723496|NCT02522104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25723497|NCT02522299|Nemiralisib|nemiralisib|mesh-list
25339762|NCT03737110|Rilonacept|rilonacept|mesh-list
25339763|NCT03737110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25339794|NCT03708315|Dexmedetomidine|dexmedetomidine|mesh-list
25339795|NCT03708315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25339796|NCT03708315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25339797|NCT03708315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25339798|NCT03708315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25339799|NCT03708315|Analgesics|analgesics|mesh-ancestor
25339800|NCT03708315|Sensory System Agents|sensory system agents|mesh-ancestor
25723498|NCT02522299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25723499|NCT02522299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25723500|NCT02522299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723501|NCT02522325|Cocaine|cocaine|mesh-list
25723502|NCT02522325|Phendimetrazine|phendimetrazine|mesh-list
25723503|NCT02522325|Anesthetics, Local|anesthetics, local|mesh-ancestor
25723504|NCT02522325|Anesthetics|anesthetics|mesh-ancestor
25723505|NCT02522325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25723506|NCT02522325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25339837|NCT03660488|Penicillins|penicillins|mesh-list
25339838|NCT03660488|Cefixime|cefixime|mesh-list
25339839|NCT03660488|Penicillin G|penicillin g|mesh-list
25339840|NCT03660488|Penicillin G Benzathine|penicillin g benzathine|mesh-list
25339841|NCT03660488|Penicillin G Procaine|penicillin g procaine|mesh-list
25339842|NCT03660488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25339843|NCT03660488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25339847|NCT03649477|Carbetocin|carbetocin|mesh-list
25339848|NCT03649477|Oxytocin|oxytocin|mesh-list
25339849|NCT03649477|Oxytocics|oxytocics|mesh-ancestor
25339850|NCT03649477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25339851|NCT03649477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25339862|NCT03631706|Pembrolizumab|pembrolizumab|mesh-list
25339863|NCT03631706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25339864|NCT03631706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25339865|NCT03615482|Vaccines|vaccines|mesh-list
25339866|NCT03615482|Immunologic Factors|immunologic factors|mesh-ancestor
25339867|NCT03615482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723507|NCT02522325|Sensory System Agents|sensory system agents|mesh-ancestor
25723508|NCT02522325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723509|NCT02522325|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25723510|NCT02522325|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25723511|NCT02522325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25723512|NCT02522325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25723513|NCT02522325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723514|NCT02522325|Dopamine Agents|dopamine agents|mesh-ancestor
25723515|NCT02522325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25723516|NCT02522325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25723517|NCT02522377|Midazolam|midazolam|mesh-list
25723518|NCT02522377|Ketamine|ketamine|mesh-list
25723519|NCT02522377|Analgesics|analgesics|mesh-ancestor
25723520|NCT02522377|Sensory System Agents|sensory system agents|mesh-ancestor
25723521|NCT02522377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723522|NCT02522377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25339911|NCT03572933|Pregnanolone|pregnanolone|mesh-list
25339912|NCT03572933|Ganaxolone|ganaxolone|mesh-list
25339913|NCT03572933|Neurosteroids|neurosteroids|mesh-ancestor
25339914|NCT03572933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25339915|NCT03572933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25339916|NCT03572933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25339917|NCT03572933|GABA Modulators|gaba modulators|mesh-ancestor
25339918|NCT03572933|GABA Agents|gaba agents|mesh-ancestor
25339919|NCT03572933|Anesthetics|anesthetics|mesh-ancestor
25339920|NCT03572933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25339921|NCT03544606|Pyridoxine|pyridoxine|mesh-list
25339922|NCT03544606|Isosorbide|isosorbide|mesh-list
25339923|NCT03544606|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
25339924|NCT03544606|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
25339925|NCT03544606|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25339926|NCT03544606|Diuretics|diuretics|mesh-ancestor
25723523|NCT02522377|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25723524|NCT02522377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25723525|NCT02522377|Anesthetics, General|anesthetics, general|mesh-ancestor
25723526|NCT02522377|Anesthetics|anesthetics|mesh-ancestor
25723527|NCT02522377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25723528|NCT02522377|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25723529|NCT02522377|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25723530|NCT02522377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25723531|NCT02522377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723532|NCT02522377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25723533|NCT02522377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25723534|NCT02522377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25723535|NCT02522377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25723536|NCT02522377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25339994|NCT03464084|Melatonin|melatonin|mesh-list
25339995|NCT03464084|Antioxidants|antioxidants|mesh-ancestor
25339996|NCT03464084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25339997|NCT03464084|Protective Agents|protective agents|mesh-ancestor
25339998|NCT03464084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25339999|NCT03464084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25340003|NCT03397953|Vinorelbine|vinorelbine|mesh-list
25340004|NCT03397953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25723537|NCT02522377|GABA Modulators|gaba modulators|mesh-ancestor
25723538|NCT02522377|GABA Agents|gaba agents|mesh-ancestor
25723539|NCT02522767|Mesalamine|mesalamine|mesh-list
25723540|NCT02522767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25723541|NCT02522767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25723542|NCT02522767|Analgesics|analgesics|mesh-ancestor
25723543|NCT02522767|Sensory System Agents|sensory system agents|mesh-ancestor
25723544|NCT02522767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772175|NCT03668613|Immunologic Factors|immunologic factors|mesh-ancestor
25772176|NCT03668613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772177|NCT03669081|Ketorolac|ketorolac|mesh-list
25772178|NCT03669081|Pregabalin|pregabalin|mesh-list
25772179|NCT03669081|Analgesics|analgesics|mesh-ancestor
25772180|NCT03669081|Sensory System Agents|sensory system agents|mesh-ancestor
25772181|NCT03669081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772182|NCT03669081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772183|NCT03669081|Anticonvulsants|anticonvulsants|mesh-ancestor
25772184|NCT03669081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25772185|NCT03669081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25772186|NCT03669081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772187|NCT03669081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25772188|NCT03669081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25772189|NCT03669081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25772190|NCT03669081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25772191|NCT03669081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25772192|NCT03669081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25772193|NCT03669081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25772194|NCT03669081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25772195|NCT03669081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25772196|NCT03669081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25772197|NCT03669081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25772198|NCT03669861|Abatacept|abatacept|mesh-list
25772199|NCT03669861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25772200|NCT03669861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772201|NCT03669861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25772202|NCT03669861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25772203|NCT03669861|Immunologic Factors|immunologic factors|mesh-ancestor
25772204|NCT03669861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772205|NCT03669861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25772206|NCT03670030|Sirolimus|sirolimus|mesh-list
25772207|NCT03670030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25772208|NCT03670030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25772209|NCT03670030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25772210|NCT03670030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25772211|NCT03670030|Antifungal Agents|antifungal agents|mesh-ancestor
25772212|NCT03670030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25772213|NCT03670030|Immunologic Factors|immunologic factors|mesh-ancestor
25772214|NCT03670030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772215|NCT03670160|Clonidine|clonidine|mesh-list
25772216|NCT03670160|Phenobarbital|phenobarbital|mesh-list
25772217|NCT03670160|Analgesics|analgesics|mesh-ancestor
25772218|NCT03670160|Sensory System Agents|sensory system agents|mesh-ancestor
25772219|NCT03670160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772220|NCT03670160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772221|NCT03670160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25772222|NCT03670160|Sympatholytics|sympatholytics|mesh-ancestor
25772223|NCT03670160|Autonomic Agents|autonomic agents|mesh-ancestor
25772224|NCT03670160|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25772225|NCT03670160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25772226|NCT03670160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25772227|NCT03670160|Adrenergic Agents|adrenergic agents|mesh-ancestor
25772228|NCT03670160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25723545|NCT02522767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723546|NCT02522767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25723547|NCT02522767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25723548|NCT02522780|Mesalamine|mesalamine|mesh-list
25723549|NCT02522780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25723550|NCT02522780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25723551|NCT02522780|Analgesics|analgesics|mesh-ancestor
25723552|NCT02522780|Sensory System Agents|sensory system agents|mesh-ancestor
25340050|NCT03390010|Oxytocics|oxytocics|mesh-ancestor
25340190|NCT03199963|Tamoxifen|tamoxifen|mesh-list
25340191|NCT03199963|Afimoxifene|afimoxifene|mesh-list
25340192|NCT03199963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25340193|NCT03199963|Hormone Antagonists|hormone antagonists|mesh-ancestor
25340194|NCT03199963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25340195|NCT03199963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25340196|NCT03199963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25340197|NCT03199963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25340198|NCT03199963|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25340199|NCT03199963|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25340200|NCT03199963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25723553|NCT02522780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723554|NCT02522780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723555|NCT02522780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25723556|NCT02522780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25723557|NCT02523196|Cholic Acids|cholic acids|mesh-list
25723558|NCT02523196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25723559|NCT02523235|Ropivacaine|ropivacaine|mesh-list
25723560|NCT02523235|Anesthetics, Local|anesthetics, local|mesh-ancestor
25723561|NCT02523235|Anesthetics|anesthetics|mesh-ancestor
25723562|NCT02523235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25723563|NCT02523235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723564|NCT02523235|Sensory System Agents|sensory system agents|mesh-ancestor
25340228|NCT03173066|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25340229|NCT03173066|Hematinics|hematinics|mesh-ancestor
25340230|NCT03173066|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25340231|NCT03173066|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25340232|NCT03132636|Cemiplimab|cemiplimab|mesh-list
25340233|NCT03132636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25340234|NCT03132636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25340258|NCT03085680|Curcumin|curcumin|mesh-list
25340259|NCT03085680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25340260|NCT03085680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25340261|NCT03085680|Analgesics|analgesics|mesh-ancestor
25340262|NCT03085680|Sensory System Agents|sensory system agents|mesh-ancestor
25340263|NCT03085680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25340264|NCT03085680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25340265|NCT03085680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25340266|NCT03085680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25340267|NCT03085680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25340268|NCT03085680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25340269|NCT03085680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25340272|NCT03065218|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
25340273|NCT03065218|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25340274|NCT03065218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25340275|NCT03059992|Ibrexafungerp|ibrexafungerp|mesh-list
25340276|NCT03059992|Antifungal Agents|antifungal agents|mesh-ancestor
25723565|NCT02523235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772229|NCT03670160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772230|NCT03670160|Anticonvulsants|anticonvulsants|mesh-ancestor
25772231|NCT03670160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25772232|NCT03670160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25772233|NCT03670160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25772234|NCT03670160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25772235|NCT03670160|GABA Modulators|gaba modulators|mesh-ancestor
25772236|NCT03670160|GABA Agents|gaba agents|mesh-ancestor
25772237|NCT03670160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25772238|NCT03670160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25772239|NCT03670160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25772240|NCT03670641|Insulin Glargine|insulin glargine|mesh-list
25772241|NCT03670641|Insulin Lispro|insulin lispro|mesh-list
25772242|NCT03670641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25772243|NCT03670641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772244|NCT03672006|Heparin|heparin|mesh-list
25772245|NCT03672006|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25772246|NCT03672006|Anticoagulants|anticoagulants|mesh-ancestor
25772247|NCT03672006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25772248|NCT03672006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25772249|NCT03672006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772250|NCT03672097|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25340277|NCT03059992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25340283|NCT03032107|Pembrolizumab|pembrolizumab|mesh-list
25340284|NCT03032107|Trastuzumab|trastuzumab|mesh-list
25340285|NCT03032107|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25340286|NCT03032107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25340287|NCT03032107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25340288|NCT03032107|Tubulin Modulators|tubulin modulators|mesh-ancestor
25340289|NCT03032107|Antimitotic Agents|antimitotic agents|mesh-ancestor
25340290|NCT03032107|Mitosis Modulators|mitosis modulators|mesh-ancestor
25340291|NCT03032107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25340303|NCT03029598|Carboplatin|carboplatin|mesh-list
25340304|NCT03029598|Pembrolizumab|pembrolizumab|mesh-list
25340305|NCT03029598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25340306|NCT03029598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25340334|NCT02970448|Temozolomide|temozolomide|mesh-list
25340335|NCT02970448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25723566|NCT02523599|Bupivacaine|bupivacaine|mesh-list
25723567|NCT02523599|Anesthetics, Local|anesthetics, local|mesh-ancestor
25723568|NCT02523599|Anesthetics|anesthetics|mesh-ancestor
25723569|NCT02523599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25723570|NCT02523599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723571|NCT02523599|Sensory System Agents|sensory system agents|mesh-ancestor
25723572|NCT02523599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723574|NCT02524054|Diuretics|diuretics|mesh-ancestor
25723575|NCT02524054|Natriuretic Agents|natriuretic agents|mesh-ancestor
25723576|NCT02524054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723577|NCT02524054|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25723578|NCT02524054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25723579|NCT02524054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723580|NCT02524106|Bococizumab|bococizumab|mesh-list
25340362|NCT02946788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25340363|NCT02946788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25340388|NCT02904954|Durvalumab|durvalumab|mesh-list
25340389|NCT02904954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25340390|NCT02904954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25340391|NCT02904954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25340392|NCT02904954|Immunologic Factors|immunologic factors|mesh-ancestor
25340393|NCT02904954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723581|NCT02524106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25723582|NCT02524106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25723583|NCT02524106|Antimetabolites|antimetabolites|mesh-ancestor
25723584|NCT02524106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723585|NCT02524106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25723586|NCT02524145|Isoproterenol|isoproterenol|mesh-list
25723587|NCT02524145|Glycopyrrolate|glycopyrrolate|mesh-list
25723588|NCT02524145|Dexmedetomidine|dexmedetomidine|mesh-list
25723589|NCT02524145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25340600|NCT02705859|Trastuzumab|trastuzumab|mesh-list
25340601|NCT02705859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25340602|NCT02705859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25340603|NCT02642640|Melatonin|melatonin|mesh-list
25340604|NCT02642640|Antioxidants|antioxidants|mesh-ancestor
25340605|NCT02642640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25340606|NCT02642640|Protective Agents|protective agents|mesh-ancestor
25340607|NCT02642640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723590|NCT02524145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25723591|NCT02524145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723592|NCT02524145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25723593|NCT02524145|Analgesics|analgesics|mesh-ancestor
25723594|NCT02524145|Sensory System Agents|sensory system agents|mesh-ancestor
25723595|NCT02524145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723596|NCT02524145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25340675|NCT02555111|Rivaroxaban|rivaroxaban|mesh-list
25340676|NCT02555111|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25340677|NCT02555111|Antithrombins|antithrombins|mesh-ancestor
25340678|NCT02555111|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25340679|NCT02555111|Protease Inhibitors|protease inhibitors|mesh-ancestor
25340680|NCT02555111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25340681|NCT02555111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25340682|NCT02555111|Anticoagulants|anticoagulants|mesh-ancestor
25340683|NCT02554812|Avelumab|avelumab|mesh-list
25340684|NCT02554812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25340685|NCT02554812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25340692|NCT02521415|Acetaminophen|acetaminophen|mesh-list
25340693|NCT02521415|Ibuprofen|ibuprofen|mesh-list
25340694|NCT02521415|Fentanyl|fentanyl|mesh-list
25340695|NCT02521415|Ketamine|ketamine|mesh-list
25723597|NCT02524145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25723598|NCT02524145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25723599|NCT02524145|Adrenergic Agents|adrenergic agents|mesh-ancestor
25723600|NCT02524145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25723601|NCT02524145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723602|NCT02524145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25723603|NCT02524145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25723604|NCT02524145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25723605|NCT02524145|Cholinergic Agents|cholinergic agents|mesh-ancestor
25723606|NCT02524145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25723607|NCT02524145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25723608|NCT02524145|Autonomic Agents|autonomic agents|mesh-ancestor
25723609|NCT02524145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25340760|NCT02494882|Dasatinib|dasatinib|mesh-list
25340761|NCT02494882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25340762|NCT02494882|Antiemetics|antiemetics|mesh-ancestor
25340763|NCT02494882|Autonomic Agents|autonomic agents|mesh-ancestor
25340764|NCT02494882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25340765|NCT02494882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25340766|NCT02494882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25340767|NCT02494882|Glucocorticoids|glucocorticoids|mesh-ancestor
25723610|NCT02524145|Respiratory System Agents|respiratory system agents|mesh-ancestor
25723611|NCT02524145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25723612|NCT02524145|Sympathomimetics|sympathomimetics|mesh-ancestor
25723613|NCT02524145|Protective Agents|protective agents|mesh-ancestor
25723614|NCT02524561|Estradiol|estradiol|mesh-list
25723615|NCT02524561|Progesterone|progesterone|mesh-list
25723616|NCT02524561|Estrogens|estrogens|mesh-ancestor
25723617|NCT02524561|Hormones|hormones|mesh-ancestor
25723618|NCT02524561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25340880|NCT02367105|Testosterone|testosterone|mesh-list
25340881|NCT02367105|Androgens|androgens|mesh-ancestor
25340882|NCT02367105|Hormones|hormones|mesh-ancestor
25340883|NCT02367105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25340884|NCT02367105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723619|NCT02524561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723620|NCT02524561|Progestins|progestins|mesh-ancestor
25723621|NCT02524665|Salicylic Acid|salicylic acid|mesh-list
25723622|NCT02524665|Salicylates|salicylates|mesh-list
25723623|NCT02524665|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25723624|NCT02524665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25723625|NCT02524665|Antifungal Agents|antifungal agents|mesh-ancestor
25723626|NCT02524665|Keratolytic Agents|keratolytic agents|mesh-ancestor
25723627|NCT02524665|Dermatologic Agents|dermatologic agents|mesh-ancestor
25340936|NCT02282020|Olaparib|olaparib|mesh-list
25340937|NCT02282020|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25340938|NCT02282020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25340939|NCT02282020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25340940|NCT02282020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25340951|NCT02243631|Probenecid|probenecid|mesh-list
25340952|NCT02243631|Uricosuric Agents|uricosuric agents|mesh-ancestor
25340953|NCT02243631|Gout Suppressants|gout suppressants|mesh-ancestor
25340954|NCT02243631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25340955|NCT02243631|Renal Agents|renal agents|mesh-ancestor
25340972|NCT02213926|Acalabrutinib|acalabrutinib|mesh-list
25340973|NCT02213926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25340974|NCT02197039|Esomeprazole|esomeprazole|mesh-list
25340975|NCT02197039|Pantoprazole|pantoprazole|mesh-list
25340976|NCT02197039|Hemostatics|hemostatics|mesh-list
25340977|NCT02197039|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25340978|NCT02197039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25340979|NCT02197039|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25723628|NCT02524665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25723629|NCT02524665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25723630|NCT02524665|Analgesics|analgesics|mesh-ancestor
25723631|NCT02524665|Sensory System Agents|sensory system agents|mesh-ancestor
25723632|NCT02524665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723633|NCT02524665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723634|NCT02524665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25723635|NCT02524665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25723636|NCT02524665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25723637|NCT02524665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25723638|NCT02524665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723639|NCT02524769|Estrogens|estrogens|mesh-list
25723640|NCT02524769|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25723641|NCT02524769|Hormones|hormones|mesh-ancestor
25723642|NCT02524769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25723643|NCT02524769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25340980|NCT02197039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25340981|NCT02197039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25340982|NCT02197039|Coagulants|coagulants|mesh-ancestor
25723644|NCT02524847|Methoxsalen|methoxsalen|mesh-list
25723645|NCT02524847|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25723646|NCT02524847|Dermatologic Agents|dermatologic agents|mesh-ancestor
25723647|NCT02525133|Bupivacaine|bupivacaine|mesh-list
25723648|NCT02525133|Anesthetics, Local|anesthetics, local|mesh-ancestor
25723649|NCT02525133|Anesthetics|anesthetics|mesh-ancestor
25723650|NCT02525133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25723651|NCT02525133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723652|NCT02525133|Sensory System Agents|sensory system agents|mesh-ancestor
25341058|NCT02153229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25341059|NCT02153229|Dermatologic Agents|dermatologic agents|mesh-ancestor
25341060|NCT02153229|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25341084|NCT02078141|Deoxyglucose|deoxyglucose|mesh-list
25341085|NCT02078141|Antimetabolites|antimetabolites|mesh-ancestor
25341086|NCT02078141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25341087|NCT02078141|Antiviral Agents|antiviral agents|mesh-ancestor
25341089|NCT02066181|Sorafenib|sorafenib|mesh-list
25723653|NCT02525133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723654|NCT02525471|RNS60|rns60|mesh-list
25723655|NCT02525471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25723656|NCT02525471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25723657|NCT02525471|Analgesics|analgesics|mesh-ancestor
25723658|NCT02525471|Sensory System Agents|sensory system agents|mesh-ancestor
25723659|NCT02525471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723660|NCT02525471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25341133|NCT02041533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25341134|NCT02041533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25341135|NCT02041533|Immunologic Factors|immunologic factors|mesh-ancestor
25341136|NCT02041533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25341137|NCT02041533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25341138|NCT02041533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25341139|NCT02041533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25341140|NCT02041533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25341141|NCT02037048|Leucovorin|leucovorin|mesh-list
25341142|NCT02037048|Paclitaxel|paclitaxel|mesh-list
25341143|NCT02037048|Carboplatin|carboplatin|mesh-list
25341144|NCT02037048|Fluorouracil|fluorouracil|mesh-list
25341145|NCT02037048|Oxaliplatin|oxaliplatin|mesh-list
25341146|NCT02037048|Calcium|calcium|mesh-list
25341147|NCT02037048|Levoleucovorin|levoleucovorin|mesh-list
25341148|NCT02037048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25341149|NCT02037048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25341150|NCT02037048|Tubulin Modulators|tubulin modulators|mesh-ancestor
25341151|NCT02037048|Antimitotic Agents|antimitotic agents|mesh-ancestor
25341152|NCT02037048|Mitosis Modulators|mitosis modulators|mesh-ancestor
25341153|NCT02037048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25341154|NCT02037048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25723661|NCT02525471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25723662|NCT02525471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25723663|NCT02525471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25723664|NCT02525523|Alicaforsen|alicaforsen|mesh-list
25723665|NCT02525523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25723666|NCT02525523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25723667|NCT02525523|Immunologic Factors|immunologic factors|mesh-ancestor
25723668|NCT02525523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723669|NCT02525536|Trebananib|trebananib|mesh-list
25723670|NCT02525536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25723671|NCT02525536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25723672|NCT02525536|Growth Substances|growth substances|mesh-ancestor
25723673|NCT02525536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723674|NCT02525536|Growth Inhibitors|growth inhibitors|mesh-ancestor
25723675|NCT02525536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25723676|NCT02525549|Adapalene|adapalene|mesh-list
25723677|NCT02525549|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25723678|NCT02525549|Dermatologic Agents|dermatologic agents|mesh-ancestor
25723679|NCT02525549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25723680|NCT02525549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25723681|NCT02525549|Analgesics|analgesics|mesh-ancestor
25723682|NCT02525549|Sensory System Agents|sensory system agents|mesh-ancestor
25723683|NCT02525549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25341300|NCT01852890|Ascorbic Acid|ascorbic acid|mesh-list
25341301|NCT01852890|Gemcitabine|gemcitabine|mesh-list
25341302|NCT01852890|Vitamins|vitamins|mesh-ancestor
25341303|NCT01852890|Micronutrients|micronutrients|mesh-ancestor
25341304|NCT01852890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25341305|NCT01852890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25341306|NCT01852890|Antimetabolites|antimetabolites|mesh-ancestor
25341307|NCT01852890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25341308|NCT01852890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25341309|NCT01852890|Antiviral Agents|antiviral agents|mesh-ancestor
25341310|NCT01852890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25341311|NCT01852890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25341312|NCT01852890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25723684|NCT02525549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723685|NCT02525549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25723686|NCT02525549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25723687|NCT02525653|Gemcitabine|gemcitabine|mesh-list
25723688|NCT02525653|Paclitaxel|paclitaxel|mesh-list
25723689|NCT02525653|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25723690|NCT02525653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25723691|NCT02525653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25723692|NCT02525653|Tubulin Modulators|tubulin modulators|mesh-ancestor
25723693|NCT02525653|Antimitotic Agents|antimitotic agents|mesh-ancestor
25723694|NCT02525653|Mitosis Modulators|mitosis modulators|mesh-ancestor
25723695|NCT02525653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25341395|NCT01757418|Immunoglobulins|immunoglobulins|mesh-list
25341396|NCT01757418|Antibodies|antibodies|mesh-list
25341397|NCT01757418|gamma-Globulins|gamma-globulins|mesh-list
25341398|NCT01757418|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25341399|NCT01757418|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25341400|NCT01757418|Immunologic Factors|immunologic factors|mesh-ancestor
25341401|NCT01757418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25341402|NCT01752491|Ascorbic Acid|ascorbic acid|mesh-list
25341403|NCT01752491|Temozolomide|temozolomide|mesh-list
25341404|NCT01752491|Vitamins|vitamins|mesh-ancestor
25341413|NCT01730638|Histamine|histamine|mesh-list
25723696|NCT02525653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25723697|NCT02525653|Antimetabolites|antimetabolites|mesh-ancestor
25723698|NCT02525653|Antiviral Agents|antiviral agents|mesh-ancestor
25723699|NCT02525653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25723700|NCT02525653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25723701|NCT02525653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25723702|NCT02525653|Immunologic Factors|immunologic factors|mesh-ancestor
25723703|NCT02525653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723704|NCT02525718|Dexamethasone|dexamethasone|mesh-list
25723705|NCT02525718|Epinephrine|epinephrine|mesh-list
25341524|NCT01467466|Acetylcysteine|acetylcysteine|mesh-list
25341525|NCT01467466|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25341526|NCT01467466|Antiviral Agents|antiviral agents|mesh-ancestor
25341527|NCT01467466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25341528|NCT01467466|Expectorants|expectorants|mesh-ancestor
25341529|NCT01467466|Respiratory System Agents|respiratory system agents|mesh-ancestor
25341530|NCT01467466|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25341531|NCT01467466|Antioxidants|antioxidants|mesh-ancestor
25341532|NCT01467466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25341533|NCT01467466|Protective Agents|protective agents|mesh-ancestor
25341535|NCT01467466|Antidotes|antidotes|mesh-ancestor
25723706|NCT02525718|Bupivacaine|bupivacaine|mesh-list
25723707|NCT02525718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25723708|NCT02525718|Antiemetics|antiemetics|mesh-ancestor
25723709|NCT02525718|Autonomic Agents|autonomic agents|mesh-ancestor
25723710|NCT02525718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723711|NCT02525718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723712|NCT02525718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25723713|NCT02525718|Glucocorticoids|glucocorticoids|mesh-ancestor
25723714|NCT02525718|Hormones|hormones|mesh-ancestor
25723715|NCT02525718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25341634|NCT01318317|Rituximab|rituximab|mesh-list
25341635|NCT01318317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25341636|NCT01318317|Antibodies|antibodies|mesh-list
25341637|NCT01318317|Immunoglobulins|immunoglobulins|mesh-list
25341638|NCT01318317|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25341639|NCT01318317|Lenograstim|lenograstim|mesh-list
25341640|NCT01318317|Immunologic Factors|immunologic factors|mesh-ancestor
25341641|NCT01318317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25341642|NCT01318317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25723716|NCT02525718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25723717|NCT02525718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25723718|NCT02525718|Anesthetics, Local|anesthetics, local|mesh-ancestor
25723719|NCT02525718|Anesthetics|anesthetics|mesh-ancestor
25723720|NCT02525718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25723721|NCT02525718|Sensory System Agents|sensory system agents|mesh-ancestor
25723722|NCT02525718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25723723|NCT02525718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25723724|NCT02525718|Adrenergic Agents|adrenergic agents|mesh-ancestor
25341956|NCT01121224|Clopidogrel|clopidogrel|mesh-list
25341957|NCT01121224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25341958|NCT01121224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25341959|NCT01121224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25341960|NCT01121224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25341961|NCT01121224|Purinergic Agents|purinergic agents|mesh-ancestor
25341962|NCT01121224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25723725|NCT02525718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25723726|NCT02525718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723727|NCT02525718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25723728|NCT02525718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25723729|NCT02525718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25723730|NCT02525718|Respiratory System Agents|respiratory system agents|mesh-ancestor
25723731|NCT02525718|Mydriatics|mydriatics|mesh-ancestor
25723732|NCT02525718|Sympathomimetics|sympathomimetics|mesh-ancestor
25342001|NCT01062425|Temozolomide|temozolomide|mesh-list
25342003|NCT01062425|Maleic acid|maleic acid|mesh-list
25342004|NCT01062425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25342005|NCT01062425|Alkylating Agents|alkylating agents|mesh-ancestor
25342006|NCT01062425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25342007|NCT01062425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25342008|NCT01062425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25342009|NCT01062425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25723733|NCT02525718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25723734|NCT02525744|Insulin Lispro|insulin lispro|mesh-list
25723735|NCT02525744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25723736|NCT02525744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723737|NCT02525861|Protease Inhibitors|protease inhibitors|mesh-list
25723738|NCT02525861|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25723739|NCT02525861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25723740|NCT02525861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25342330|NCT00664040|Aspirin|aspirin|mesh-list
25342331|NCT00664040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25342332|NCT00664040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25342333|NCT00664040|Analgesics|analgesics|mesh-ancestor
25342334|NCT00664040|Sensory System Agents|sensory system agents|mesh-ancestor
25342335|NCT00664040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25342336|NCT00664040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25342337|NCT00664040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25342338|NCT00664040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25342339|NCT00664040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25342340|NCT00664040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25342341|NCT00664040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25342342|NCT00664040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25342343|NCT00664040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25342344|NCT00664040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25342345|NCT00664040|Antipyretics|antipyretics|mesh-ancestor
25723741|NCT02525861|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25723742|NCT02525861|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25723743|NCT02525874|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25723744|NCT02525874|Dermatologic Agents|dermatologic agents|mesh-ancestor
25723745|NCT02525874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25723746|NCT02525874|Immunologic Factors|immunologic factors|mesh-ancestor
25723747|NCT02525874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723748|NCT02526212|Buprenorphine|buprenorphine|mesh-list
25723749|NCT02526212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25723750|NCT02526212|Narcotics|narcotics|mesh-ancestor
25723751|NCT02526212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25723752|NCT02526212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723753|NCT02526212|Analgesics|analgesics|mesh-ancestor
25723754|NCT02526212|Sensory System Agents|sensory system agents|mesh-ancestor
25723755|NCT02526212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723756|NCT02526212|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25723757|NCT02526550|Vaccines|vaccines|mesh-list
25723758|NCT02526550|Immunologic Factors|immunologic factors|mesh-ancestor
25342455|NCT00559182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25342456|NCT00559182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25342457|NCT00559182|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25342458|NCT00559182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25342459|NCT00559182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25342460|NCT00476190|Cytarabine|cytarabine|mesh-list
25342461|NCT00476190|Dexamethasone|dexamethasone|mesh-list
25342462|NCT00476190|Hydrocortisone|hydrocortisone|mesh-list
25342463|NCT00476190|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25342464|NCT00476190|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25342465|NCT00476190|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25342466|NCT00476190|Cyclophosphamide|cyclophosphamide|mesh-list
25342467|NCT00476190|Doxorubicin|doxorubicin|mesh-list
25342468|NCT00476190|Methotrexate|methotrexate|mesh-list
25342469|NCT00476190|Etoposide|etoposide|mesh-list
25342470|NCT00476190|Vincristine|vincristine|mesh-list
25342471|NCT00476190|Asparaginase|asparaginase|mesh-list
25342472|NCT00476190|Pegaspargase|pegaspargase|mesh-list
25342473|NCT00476190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25342474|NCT00476190|Immunologic Factors|immunologic factors|mesh-ancestor
25342475|NCT00476190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25342483|NCT00476190|Antiemetics|antiemetics|mesh-ancestor
25723759|NCT02526550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723760|NCT02526667|Chlorhexidine|chlorhexidine|mesh-list
25723761|NCT02526667|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25723762|NCT02526667|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25723763|NCT02526667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25723764|NCT02526667|Disinfectants|disinfectants|mesh-ancestor
25723765|NCT02526667|Dermatologic Agents|dermatologic agents|mesh-ancestor
25723766|NCT02527265|Insulin|insulin|mesh-list
25723767|NCT02527265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25723768|NCT02527265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723769|NCT02527421|Betamethasone|betamethasone|mesh-list
25723770|NCT02527421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25723771|NCT02527421|Glucocorticoids|glucocorticoids|mesh-ancestor
25723772|NCT02527421|Hormones|hormones|mesh-ancestor
25723773|NCT02527421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25723774|NCT02527421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723775|NCT02527421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25723776|NCT02527421|Respiratory System Agents|respiratory system agents|mesh-ancestor
25723777|NCT02527512|Povidone-Iodine|povidone-iodine|mesh-list
25723778|NCT02527512|Povidone|povidone|mesh-list
25723779|NCT02527512|Plasma Substitutes|plasma substitutes|mesh-ancestor
25342610|NCT00381641|Sunitinib|sunitinib|mesh-list
25723780|NCT02527512|Blood Substitutes|blood substitutes|mesh-ancestor
25723781|NCT02527512|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25723782|NCT02527512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25723783|NCT02528188|Tanezumab|tanezumab|mesh-list
25723784|NCT02528188|Analgesics|analgesics|mesh-ancestor
25723785|NCT02528188|Sensory System Agents|sensory system agents|mesh-ancestor
25723786|NCT02528188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723787|NCT02528188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723788|NCT02528214|Prednisone|prednisone|mesh-list
25723789|NCT02528214|Prednisolone|prednisolone|mesh-list
25723790|NCT02528214|Albuterol|albuterol|mesh-list
25723791|NCT02528214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25342611|NCT00381641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25342612|NCT00381641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25342613|NCT00381641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25342614|NCT00381641|Growth Substances|growth substances|mesh-ancestor
25342615|NCT00381641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25342616|NCT00381641|Growth Inhibitors|growth inhibitors|mesh-ancestor
25342617|NCT00381641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25342618|NCT00381641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25342619|NCT00381641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723792|NCT02528214|Glucocorticoids|glucocorticoids|mesh-ancestor
25723793|NCT02528214|Hormones|hormones|mesh-ancestor
25723794|NCT02528214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25723795|NCT02528214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723796|NCT02528214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25723797|NCT02528214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25723798|NCT02528214|Autonomic Agents|autonomic agents|mesh-ancestor
25723799|NCT02528214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723800|NCT02528214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25723801|NCT02528214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25342707|NCT05558956|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25342708|NCT05558956|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25342709|NCT05558956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25342713|NCT05558761|Pentoxifylline|pentoxifylline|mesh-list
25342714|NCT05558761|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25342715|NCT05558761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25342716|NCT05558761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25342717|NCT05558761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25342718|NCT05558761|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25342719|NCT05558761|Protective Agents|protective agents|mesh-ancestor
25342720|NCT05558761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25342721|NCT05558761|Vasodilator Agents|vasodilator agents|mesh-ancestor
25342722|NCT05558761|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25342723|NCT05558761|Antioxidants|antioxidants|mesh-ancestor
25723802|NCT02528214|Respiratory System Agents|respiratory system agents|mesh-ancestor
25723803|NCT02528214|Tocolytic Agents|tocolytic agents|mesh-ancestor
25723804|NCT02528214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25723805|NCT02528214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25723806|NCT02528214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25723807|NCT02528214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25723808|NCT02528214|Adrenergic Agents|adrenergic agents|mesh-ancestor
25723809|NCT02528214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25723810|NCT02528214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723811|NCT02528253|Tramadol|tramadol|mesh-list
25723812|NCT02528253|Tanezumab|tanezumab|mesh-list
25723813|NCT02528253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25723814|NCT02528253|Narcotics|narcotics|mesh-ancestor
25723815|NCT02528253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25723816|NCT02528253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723817|NCT02528253|Analgesics|analgesics|mesh-ancestor
25723818|NCT02528253|Sensory System Agents|sensory system agents|mesh-ancestor
25343833|NCT05552196|Ponesimod|ponesimod|mesh-list
25343913|NCT05551858|Proglumide|proglumide|mesh-list
25723820|NCT02528357|Pembrolizumab|pembrolizumab|mesh-list
25723821|NCT02528357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25723822|NCT02528357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25723823|NCT02528409|Vortioxetine|vortioxetine|mesh-list
25723824|NCT02528409|Antidepressive Agents|antidepressive agents|mesh-ancestor
25723825|NCT02528409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25723826|NCT02528409|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25723827|NCT02528409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25723828|NCT02528409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25723829|NCT02528409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723830|NCT02528409|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25723831|NCT02528409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25723832|NCT02528409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25723833|NCT02528409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344738|NCT05546398|Antimetabolites|antimetabolites|mesh-ancestor
25723834|NCT02528409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25723835|NCT02528409|Serotonin Agents|serotonin agents|mesh-ancestor
25723836|NCT02528409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25723837|NCT02528409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25723838|NCT02528409|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25723839|NCT02528409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25723840|NCT02529072|Nivolumab|nivolumab|mesh-list
25723841|NCT02529072|Vaccines|vaccines|mesh-list
25723842|NCT02529072|Immunologic Factors|immunologic factors|mesh-ancestor
25723843|NCT02529072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723844|NCT02529072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25723845|NCT02529072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25723846|NCT02529072|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25723847|NCT02529072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723848|NCT02529995|Osimertinib|osimertinib|mesh-list
25723849|NCT02529995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25723850|NCT02529995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25723851|NCT02529995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25723852|NCT02529995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723853|NCT02530125|Pidilizumab|pidilizumab|mesh-list
25723854|NCT02530125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25723855|NCT02530125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25723857|NCT02530151|Morphine|morphine|mesh-list
25723858|NCT02530151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25345376|NCT05541757|Heparin|heparin|mesh-list
25345416|NCT05541471|Anesthetics|anesthetics|mesh-ancestor
25723859|NCT02530151|Narcotics|narcotics|mesh-ancestor
25723860|NCT02530151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25723861|NCT02530151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723862|NCT02530151|Analgesics|analgesics|mesh-ancestor
25723863|NCT02530151|Sensory System Agents|sensory system agents|mesh-ancestor
25723864|NCT02530151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723865|NCT02530151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25723866|NCT02530151|Sympatholytics|sympatholytics|mesh-ancestor
25345838|NCT05538052|Lidocaine|lidocaine|mesh-list
25345898|NCT05537584|Bupropion|bupropion|mesh-list
25723867|NCT02530151|Autonomic Agents|autonomic agents|mesh-ancestor
25723868|NCT02530151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25723869|NCT02530151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25723870|NCT02530151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25723871|NCT02530151|Adrenergic Agents|adrenergic agents|mesh-ancestor
25723872|NCT02530151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25723873|NCT02530151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346637|NCT05532618|Anesthetics|anesthetics|mesh-ancestor
25723874|NCT02530242|Carbon Monoxide|carbon monoxide|mesh-list
25723875|NCT02530242|Antimetabolites|antimetabolites|mesh-ancestor
25723876|NCT02530242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723877|NCT02530242|Gasotransmitters|gasotransmitters|mesh-ancestor
25723878|NCT02530242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25723879|NCT02530242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723880|NCT02530281|Glycopyrrolate|glycopyrrolate|mesh-list
25723881|NCT02530281|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25347391|NCT05527340|Hormones|hormones|mesh-ancestor
25723882|NCT02530281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25723883|NCT02530281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25723884|NCT02530281|Cholinergic Agents|cholinergic agents|mesh-ancestor
25723885|NCT02530281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25723886|NCT02530281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723887|NCT02530281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723888|NCT02530294|Glycopyrrolate|glycopyrrolate|mesh-list
25723889|NCT02530294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25723890|NCT02530294|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25723891|NCT02530294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25723892|NCT02530294|Cholinergic Agents|cholinergic agents|mesh-ancestor
25723893|NCT02530294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25348222|NCT05520073|Ascorbic Acid|ascorbic acid|mesh-list
25772251|NCT03672097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25772252|NCT03673670|Tiotropium Bromide|tiotropium bromide|mesh-list
25772253|NCT03673670|Olodaterol|olodaterol|mesh-list
25772254|NCT03673670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25772255|NCT03673670|Autonomic Agents|autonomic agents|mesh-ancestor
25772256|NCT03673670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772257|NCT03673670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772258|NCT03673670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25772259|NCT03673670|Respiratory System Agents|respiratory system agents|mesh-ancestor
25772260|NCT03673670|Parasympatholytics|parasympatholytics|mesh-ancestor
25772261|NCT03673670|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25772262|NCT03673670|Cholinergic Agents|cholinergic agents|mesh-ancestor
25348442|NCT05518877|Anesthetics|anesthetics|mesh-ancestor
25772263|NCT03673670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25772264|NCT03673670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772265|NCT03674177|Vaccines|vaccines|mesh-list
25772266|NCT03674177|Immunologic Factors|immunologic factors|mesh-ancestor
25772267|NCT03674177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772268|NCT03674970|Nicotine|nicotine|mesh-list
25772269|NCT03674970|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25772270|NCT03674970|Autonomic Agents|autonomic agents|mesh-ancestor
25772271|NCT03674970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772272|NCT03674970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772273|NCT03674970|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25772274|NCT03674970|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25772275|NCT03674970|Cholinergic Agents|cholinergic agents|mesh-ancestor
25772276|NCT03674970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25772277|NCT03674970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772278|NCT03675451|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25772279|NCT03675451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25772280|NCT03675451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772282|NCT03675581|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25772283|NCT03675581|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
25772284|NCT03675581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25772285|NCT03675581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25772286|NCT03675581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25772287|NCT03675581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772288|NCT03675581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25772289|NCT03675581|Contraceptive Agents|contraceptive agents|mesh-ancestor
25772290|NCT03675581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25772291|NCT03675581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772292|NCT03675581|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25772293|NCT03675581|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25772294|NCT03675581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25772295|NCT03675581|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25772296|NCT03675581|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25772297|NCT03675581|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
25772298|NCT03675581|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25772299|NCT03675581|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25772300|NCT03676725|Lidocaine|lidocaine|mesh-list
25772301|NCT03676725|Anesthetics, Local|anesthetics, local|mesh-ancestor
25772302|NCT03676725|Anesthetics|anesthetics|mesh-ancestor
25772303|NCT03676725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25772304|NCT03676725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25772305|NCT03676725|Sensory System Agents|sensory system agents|mesh-ancestor
25772306|NCT03676725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772307|NCT03676725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25772308|NCT03676725|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25772309|NCT03676725|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25772310|NCT03676725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25772311|NCT03676725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25772312|NCT03677401|Serlopitant|serlopitant|mesh-list
25772313|NCT03677401|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25772314|NCT03677401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25349727|NCT05510141|Nitrous Oxide|nitrous oxide|mesh-list
25350108|NCT05507697|Vitamins|vitamins|mesh-ancestor
25350198|NCT05507398|Metformin|metformin|mesh-list
25350408|NCT05505630|GABA Agents|gaba agents|mesh-ancestor
25350485|NCT05505279|Nicotine|nicotine|mesh-list
25351158|NCT05500742|Selenium|selenium|mesh-list
25351311|NCT05499832|Tenecteplase|tenecteplase|mesh-list
25723894|NCT02530294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723895|NCT02530294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723896|NCT02530476|Sorafenib|sorafenib|mesh-list
25723897|NCT02530476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25723898|NCT02530476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25723899|NCT02530476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25723900|NCT02530476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723901|NCT02530528|Chlorhexidine|chlorhexidine|mesh-list
25723902|NCT02530528|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25723903|NCT02530528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25723904|NCT02530528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25723905|NCT02530528|Disinfectants|disinfectants|mesh-ancestor
25723906|NCT02530528|Dermatologic Agents|dermatologic agents|mesh-ancestor
25723907|NCT02530541|Chlorhexidine|chlorhexidine|mesh-list
25723908|NCT02530541|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25723909|NCT02530541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25723910|NCT02530541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25723911|NCT02530541|Disinfectants|disinfectants|mesh-ancestor
25723912|NCT02530541|Dermatologic Agents|dermatologic agents|mesh-ancestor
25351466|NCT05498389|Osimertinib|osimertinib|mesh-list
25723913|NCT02530554|Chlorhexidine|chlorhexidine|mesh-list
25723914|NCT02530554|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25723915|NCT02530554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25723916|NCT02530554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25723917|NCT02530554|Disinfectants|disinfectants|mesh-ancestor
25723918|NCT02530554|Dermatologic Agents|dermatologic agents|mesh-ancestor
25723919|NCT02531035|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
25351537|NCT05498181|Valsartan|valsartan|mesh-list
25723920|NCT02531035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25723921|NCT02531035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723922|NCT02531035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25723923|NCT02531035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723924|NCT02531113|Ozanimod|ozanimod|mesh-list
25723925|NCT02531113|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25351912|NCT05495464|Rituximab|rituximab|mesh-list
25352374|NCT05492968|Mydriatics|mydriatics|mesh-ancestor
25352930|NCT05488899|Iodine|iodine|mesh-list
25353009|NCT05488678|Ceftibuten|ceftibuten|mesh-list
25723926|NCT02531113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723927|NCT02531113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25723928|NCT02531113|Immunologic Factors|immunologic factors|mesh-ancestor
25723929|NCT02531113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723930|NCT02531321|Levonorgestrel|levonorgestrel|mesh-list
25723931|NCT02531321|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25723932|NCT02531321|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25723933|NCT02531321|Estradiol|estradiol|mesh-list
25723934|NCT02531321|Estrogens|estrogens|mesh-ancestor
25723935|NCT02531321|Hormones|hormones|mesh-ancestor
25723936|NCT02531321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25723937|NCT02531321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723938|NCT02531321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25723939|NCT02531321|Contraceptive Agents|contraceptive agents|mesh-ancestor
25723940|NCT02531321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25354339|NCT05479214|Metformin|metformin|mesh-list
25354798|NCT05476679|Celecoxib|celecoxib|mesh-list
25723941|NCT02531321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25723942|NCT02531321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25723943|NCT02531321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25723944|NCT02531321|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25723945|NCT02531321|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25723946|NCT02531373|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25723947|NCT02531373|Immunologic Factors|immunologic factors|mesh-ancestor
25723948|NCT02531373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723949|NCT02531438|Moxifloxacin|moxifloxacin|mesh-list
25354874|NCT05476094|Antimetabolites|antimetabolites|mesh-ancestor
25723950|NCT02531438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25723951|NCT02531438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25723952|NCT02531438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25723953|NCT02531438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25723954|NCT02531438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25723955|NCT02531438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723956|NCT02531438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25723957|NCT02531633|Prednisone|prednisone|mesh-list
25723958|NCT02531633|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25723959|NCT02531633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25723961|NCT02531633|Hormones|hormones|mesh-ancestor
25723962|NCT02531633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25723963|NCT02531633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723964|NCT02531633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25723965|NCT02531633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25723966|NCT02531633|Immunologic Factors|immunologic factors|mesh-ancestor
25723967|NCT02531698|Vaccines|vaccines|mesh-list
25355102|NCT05473195|Isoniazid|isoniazid|mesh-list
25723968|NCT02531698|Immunologic Factors|immunologic factors|mesh-ancestor
25723969|NCT02531698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723970|NCT02531971|Fentanyl|fentanyl|mesh-list
25723971|NCT02531971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25723972|NCT02531971|Narcotics|narcotics|mesh-ancestor
25723973|NCT02531971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25723974|NCT02531971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723975|NCT02531971|Analgesics|analgesics|mesh-ancestor
25355403|NCT05467462|Oxytocin|oxytocin|mesh-list
25355693|NCT05459571|Hormones|hormones|mesh-ancestor
25356369|NCT05441930|Renal Agents|renal agents|mesh-ancestor
25723976|NCT02531971|Sensory System Agents|sensory system agents|mesh-ancestor
25723977|NCT02531971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25723978|NCT02531971|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25723979|NCT02531971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25723980|NCT02531971|Anesthetics, General|anesthetics, general|mesh-ancestor
25723981|NCT02531971|Anesthetics|anesthetics|mesh-ancestor
25723982|NCT02532010|Cytarabine|cytarabine|mesh-list
25723983|NCT02532010|Decitabine|decitabine|mesh-list
25723984|NCT02532010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25723985|NCT02532010|Antimetabolites|antimetabolites|mesh-ancestor
25723986|NCT02532010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723987|NCT02532010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25723988|NCT02532010|Antiviral Agents|antiviral agents|mesh-ancestor
25358033|NCT05400122|Antimetabolites|antimetabolites|mesh-ancestor
25723989|NCT02532010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25723990|NCT02532010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25723991|NCT02532010|Immunologic Factors|immunologic factors|mesh-ancestor
25723992|NCT02532010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25723993|NCT02532010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25723994|NCT02532283|Oseltamivir|oseltamivir|mesh-list
25723995|NCT02532283|Antiviral Agents|antiviral agents|mesh-ancestor
25723996|NCT02532283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25723997|NCT02532283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25723998|NCT02532283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25723999|NCT02532374|Nicotine|nicotine|mesh-list
25358121|NCT05396014|Analgesics|analgesics|mesh-ancestor
25358788|NCT05378945|Varenicline|varenicline|mesh-list
25724000|NCT02532374|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25724001|NCT02532374|Autonomic Agents|autonomic agents|mesh-ancestor
25724002|NCT02532374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25724003|NCT02532374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724004|NCT02532374|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25724005|NCT02532374|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25724006|NCT02532374|Cholinergic Agents|cholinergic agents|mesh-ancestor
25724007|NCT02532374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25724008|NCT02532374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25407984|NCT03466294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25359097|NCT05371093|Hormones|hormones|mesh-ancestor
25724009|NCT02532647|Midazolam|midazolam|mesh-list
25724010|NCT02532647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25724011|NCT02532647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25724012|NCT02532647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25724013|NCT02532647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724014|NCT02532647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25724015|NCT02532647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25724016|NCT02532647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25407985|NCT03466294|Antimetabolites|antimetabolites|mesh-ancestor
25359765|NCT05357690|Bupivacaine|bupivacaine|mesh-list
25408059|NCT03461003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25361367|NCT05313529|Metformin|metformin|mesh-list
25408060|NCT03461003|Protective Agents|protective agents|mesh-ancestor
25408061|NCT03460522|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25362040|NCT05299073|Denosumab|denosumab|mesh-list
25724017|NCT02532647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25724018|NCT02532647|Anesthetics, General|anesthetics, general|mesh-ancestor
25724019|NCT02532647|Anesthetics|anesthetics|mesh-ancestor
25724020|NCT02532647|GABA Modulators|gaba modulators|mesh-ancestor
25724021|NCT02532647|GABA Agents|gaba agents|mesh-ancestor
25724022|NCT02532647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25724023|NCT02532647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724024|NCT02532855|Metformin|metformin|mesh-list
25724025|NCT02532855|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25724026|NCT02532855|Dapagliflozin|dapagliflozin|mesh-list
25724027|NCT02532855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25724028|NCT02532855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724029|NCT02532855|Incretins|incretins|mesh-ancestor
25724030|NCT02532855|Hormones|hormones|mesh-ancestor
25724031|NCT02532855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25363396|NCT05262751|Nintedanib|nintedanib|mesh-list
25363469|NCT05260359|Ethanol|ethanol|mesh-list
25724032|NCT02532855|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25724033|NCT02532855|Protease Inhibitors|protease inhibitors|mesh-ancestor
25724034|NCT02532855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25724035|NCT02532855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724036|NCT02532855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25724037|NCT02532998|Fludrocortisone|fludrocortisone|mesh-list
25724038|NCT02532998|Eplerenone|eplerenone|mesh-list
25724039|NCT02532998|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25724040|NCT02532998|Hormone Antagonists|hormone antagonists|mesh-ancestor
25724041|NCT02532998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25724042|NCT02532998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724043|NCT02532998|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25724044|NCT02532998|Diuretics|diuretics|mesh-ancestor
25724045|NCT02532998|Natriuretic Agents|natriuretic agents|mesh-ancestor
25724046|NCT02532998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25364156|NCT05247125|Melatonin|melatonin|mesh-list
25364243|NCT05245786|Copper|copper|mesh-list
25408062|NCT03460522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25364767|NCT05228951|Letrozole|letrozole|mesh-list
25724047|NCT02532998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25724048|NCT02533375|Adalimumab|adalimumab|mesh-list
25724049|NCT02533375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25724050|NCT02533375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25724051|NCT02533401|Cyclophosphamide|cyclophosphamide|mesh-list
25724052|NCT02533401|Rituximab|rituximab|mesh-list
25724053|NCT02533401|Fludarabine|fludarabine|mesh-list
25724054|NCT02533401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25724055|NCT02533401|Immunologic Factors|immunologic factors|mesh-ancestor
25364852|NCT05226663|Fluorides|fluorides|mesh-list
25724056|NCT02533401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724057|NCT02533401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25724058|NCT02533401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25724059|NCT02533401|Alkylating Agents|alkylating agents|mesh-ancestor
25724060|NCT02533401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724061|NCT02533401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25724062|NCT02533401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25724063|NCT02533401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25365069|NCT05217446|Cetuximab|cetuximab|mesh-list
25724065|NCT02533427|Norgestimate|norgestimate|mesh-list
25724066|NCT02533427|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25724067|NCT02533427|Estradiol|estradiol|mesh-list
25724068|NCT02533427|Estrogens|estrogens|mesh-ancestor
25724069|NCT02533427|Hormones|hormones|mesh-ancestor
25724070|NCT02533427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25724071|NCT02533427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366050|NCT05181605|Folfirinox|folfirinox|mesh-list
25408063|NCT03460522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367563|NCT05136898|Mitomycins|mitomycins|mesh-list
25724072|NCT02533427|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25724073|NCT02533427|Contraceptive Agents|contraceptive agents|mesh-ancestor
25724074|NCT02533427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25724075|NCT02533427|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25724076|NCT02533427|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25724077|NCT02533427|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25724078|NCT02533427|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25367638|NCT05133518|GABA Agents|gaba agents|mesh-ancestor
25408064|NCT03460522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25367714|NCT05127395|Acyclovir|acyclovir|mesh-list
25724079|NCT02533427|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25724080|NCT02533453|Exenatide|exenatide|mesh-list
25724081|NCT02533453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25724082|NCT02533453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724083|NCT02533453|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25724084|NCT02533453|Incretins|incretins|mesh-ancestor
25724085|NCT02533453|Hormones|hormones|mesh-ancestor
25724086|NCT02533453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25724087|NCT02533466|Listerine|listerine|mesh-list
25724088|NCT02533466|Fluorides|fluorides|mesh-list
25724089|NCT02533466|Sodium Fluoride|sodium fluoride|mesh-list
25367936|NCT05115630|Tacrolimus|tacrolimus|mesh-list
25408066|NCT03459222|Ipilimumab|ipilimumab|mesh-list
25368762|NCT05090033|Ofatumumab|ofatumumab|mesh-list
25724090|NCT02533466|Cariostatic Agents|cariostatic agents|mesh-ancestor
25724091|NCT02533466|Protective Agents|protective agents|mesh-ancestor
25724092|NCT02533466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724093|NCT02533466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25724094|NCT02533466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25724095|NCT02533505|Budesonide|budesonide|mesh-list
25724096|NCT02533505|Formoterol Fumarate|formoterol fumarate|mesh-list
25724097|NCT02533505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25724098|NCT02533505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25724099|NCT02533505|Autonomic Agents|autonomic agents|mesh-ancestor
25724100|NCT02533505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25724101|NCT02533505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724102|NCT02533505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25724103|NCT02533505|Respiratory System Agents|respiratory system agents|mesh-ancestor
25724104|NCT02533505|Glucocorticoids|glucocorticoids|mesh-ancestor
25724105|NCT02533505|Hormones|hormones|mesh-ancestor
25724106|NCT02533505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25724107|NCT02533505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25724108|NCT02533505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25724109|NCT02533505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25724110|NCT02533505|Adrenergic Agents|adrenergic agents|mesh-ancestor
25724111|NCT02533505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25724112|NCT02533505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724113|NCT02533570|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25724114|NCT02533570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25368839|NCT05085574|Celecoxib|celecoxib|mesh-list
25724115|NCT02533570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25724116|NCT02533570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25724117|NCT02533570|Immunologic Factors|immunologic factors|mesh-ancestor
25724118|NCT02533570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724119|NCT02533674|Gemcitabine|gemcitabine|mesh-list
25724120|NCT02533674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25724121|NCT02533674|Antimetabolites|antimetabolites|mesh-ancestor
25724122|NCT02533674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368912|NCT05084404|Guanabenz|guanabenz|mesh-list
25724123|NCT02533674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25724124|NCT02533674|Antiviral Agents|antiviral agents|mesh-ancestor
25724125|NCT02533674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25724126|NCT02533674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25724127|NCT02533674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25724128|NCT02533674|Immunologic Factors|immunologic factors|mesh-ancestor
25724129|NCT02533674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724130|NCT02533934|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
25724131|NCT02533934|Antiviral Agents|antiviral agents|mesh-ancestor
25724132|NCT02533934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25724133|NCT02534129|Petrolatum|petrolatum|mesh-list
25724134|NCT02534129|Emollients|emollients|mesh-ancestor
25369072|NCT05078463|Anesthetics|anesthetics|mesh-ancestor
25724135|NCT02534129|Dermatologic Agents|dermatologic agents|mesh-ancestor
25724136|NCT02534324|Antihypertensive Agents|antihypertensive agents|mesh-list
25724137|NCT02534883|Misoprostol|misoprostol|mesh-list
25724138|NCT02534883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25724139|NCT02534883|Abortifacient Agents|abortifacient agents|mesh-ancestor
25724140|NCT02534883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25724141|NCT02534883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724142|NCT02534883|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25724143|NCT02534883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25369516|NCT05062083|11C-PS13|11c-ps13|mesh-list
25724144|NCT02534883|Oxytocics|oxytocics|mesh-ancestor
25724145|NCT02534935|Vaccines|vaccines|mesh-list
25724146|NCT02534935|Immunologic Factors|immunologic factors|mesh-ancestor
25724147|NCT02534935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724148|NCT02535000|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25724149|NCT02535000|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25724150|NCT02535000|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25724151|NCT02535000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25415996|NCT02978625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25724152|NCT02535000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724153|NCT02535000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25724154|NCT02535000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724155|NCT02535000|Analgesics|analgesics|mesh-ancestor
25370359|NCT05036577|Antimetabolites|antimetabolites|mesh-ancestor
25724156|NCT02535000|Sensory System Agents|sensory system agents|mesh-ancestor
25724157|NCT02535000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25724158|NCT02535000|Antidepressive Agents|antidepressive agents|mesh-ancestor
25724159|NCT02535000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25724160|NCT02535000|Dopamine Agents|dopamine agents|mesh-ancestor
25724161|NCT02535416|Diphenhydramine|diphenhydramine|mesh-list
25724162|NCT02535416|Promethazine|promethazine|mesh-list
25724163|NCT02535416|Cetirizine|cetirizine|mesh-list
25724164|NCT02535416|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25724165|NCT02535416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25371116|NCT05009862|Aspirin|aspirin|mesh-list
25724166|NCT02535416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25724167|NCT02535416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724168|NCT02535416|Anesthetics, Local|anesthetics, local|mesh-ancestor
25724169|NCT02535416|Anesthetics|anesthetics|mesh-ancestor
25724170|NCT02535416|Sensory System Agents|sensory system agents|mesh-ancestor
25724171|NCT02535416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25724172|NCT02535416|Antiemetics|antiemetics|mesh-ancestor
25724173|NCT02535416|Autonomic Agents|autonomic agents|mesh-ancestor
25724174|NCT02535416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25724175|NCT02535416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25724176|NCT02535416|Histamine Antagonists|histamine antagonists|mesh-ancestor
25724177|NCT02535416|Histamine Agents|histamine agents|mesh-ancestor
25724178|NCT02535416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25724179|NCT02535416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724180|NCT02535416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25724181|NCT02535416|Antipruritics|antipruritics|mesh-ancestor
25724182|NCT02535416|Dermatologic Agents|dermatologic agents|mesh-ancestor
25372416|NCT04970407|Botulinum Toxins|botulinum toxins|mesh-list
25724183|NCT02535416|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25724184|NCT02535611|Memantine|memantine|mesh-list
25724185|NCT02535611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25724186|NCT02535611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25724187|NCT02535611|Dopamine Agents|dopamine agents|mesh-ancestor
25724188|NCT02535611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25724189|NCT02535611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724190|NCT02535611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724191|NCT02535611|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25408068|NCT03459222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25373543|NCT04933617|Prednisone|prednisone|mesh-list
25333235|NCT05473273|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25333236|NCT05473273|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25333237|NCT05473273|Estradiol|estradiol|mesh-list
25333238|NCT05473273|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25333239|NCT05473273|Progesterone|progesterone|mesh-list
25333240|NCT05473273|Estrogens|estrogens|mesh-ancestor
25333241|NCT05473273|Hormones|hormones|mesh-ancestor
25333242|NCT05473273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25333243|NCT05473273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333244|NCT05473273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25333245|NCT05473273|Contraceptive Agents|contraceptive agents|mesh-ancestor
25333246|NCT05473273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25333247|NCT05473273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25333248|NCT05473273|Progestins|progestins|mesh-ancestor
25333249|NCT05473234|Amoxicillin|amoxicillin|mesh-list
25333250|NCT05473234|Azithromycin|azithromycin|mesh-list
25333251|NCT05473234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25333252|NCT05473234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25333263|NCT05472948|Capecitabine|capecitabine|mesh-list
25333264|NCT05472948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25333265|NCT05472948|Antimetabolites|antimetabolites|mesh-ancestor
25333266|NCT05472948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25333267|NCT05472948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25333275|NCT05472792|Tamoxifen|tamoxifen|mesh-list
25333276|NCT05472792|Toremifene|toremifene|mesh-list
25333277|NCT05472792|Letrozole|letrozole|mesh-list
25333278|NCT05472792|Fulvestrant|fulvestrant|mesh-list
25333279|NCT05472792|Anastrozole|anastrozole|mesh-list
25333280|NCT05472792|Exemestane|exemestane|mesh-list
25333281|NCT05472792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25333282|NCT05472792|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25333283|NCT05472792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25333284|NCT05472792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25333285|NCT05472792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25333286|NCT05472792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25333287|NCT05472792|Hormone Antagonists|hormone antagonists|mesh-ancestor
25333288|NCT05472792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25333289|NCT05472792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333290|NCT05472792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25333291|NCT05472792|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25333292|NCT05472792|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25333293|NCT05472792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25333294|NCT05472792|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25333295|NCT05472779|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25333296|NCT05472779|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25333297|NCT05472779|Estradiol|estradiol|mesh-list
25333298|NCT05472779|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25333299|NCT05472779|Estrogens|estrogens|mesh-ancestor
25333300|NCT05472779|Hormones|hormones|mesh-ancestor
25333301|NCT05472779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25333302|NCT05472779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333303|NCT05472779|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25333304|NCT05472779|Contraceptive Agents|contraceptive agents|mesh-ancestor
25333305|NCT05472779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25333306|NCT05472779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25333314|NCT05472753|Selenium|selenium|mesh-list
25333315|NCT05472753|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
25333316|NCT05472753|Curcumin|curcumin|mesh-list
25333317|NCT05472753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25333318|NCT05472753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25333319|NCT05472753|Analgesics|analgesics|mesh-ancestor
25333320|NCT05472753|Sensory System Agents|sensory system agents|mesh-ancestor
25333321|NCT05472753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25333322|NCT05472753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333323|NCT05472753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25333324|NCT05472753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25333325|NCT05472753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25333326|NCT05472753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25333327|NCT05472753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25333328|NCT05472753|Antioxidants|antioxidants|mesh-ancestor
25333329|NCT05472753|Protective Agents|protective agents|mesh-ancestor
25333330|NCT05472753|Trace Elements|trace elements|mesh-ancestor
25333331|NCT05472753|Micronutrients|micronutrients|mesh-ancestor
25333332|NCT05472753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25333333|NCT05472753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25333334|NCT05472675|Bupivacaine|bupivacaine|mesh-list
25333335|NCT05472675|Botulinum Toxins|botulinum toxins|mesh-list
25333336|NCT05472675|Anesthetics, Local|anesthetics, local|mesh-ancestor
25333337|NCT05472675|Anesthetics|anesthetics|mesh-ancestor
25333338|NCT05472675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25333339|NCT05472675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333340|NCT05472675|Sensory System Agents|sensory system agents|mesh-ancestor
25333341|NCT05472675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25333342|NCT05472675|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25333387|NCT05472220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25333388|NCT05472220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25333389|NCT05472220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25333390|NCT05471986|Tropicamide|tropicamide|mesh-list
25333391|NCT05471986|Mydriatics|mydriatics|mesh-list
25333392|NCT05471986|Autonomic Agents|autonomic agents|mesh-ancestor
25333393|NCT05471986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25333394|NCT05471986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333395|NCT05471986|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25333396|NCT05471986|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25333397|NCT05471986|Cholinergic Agents|cholinergic agents|mesh-ancestor
25333398|NCT05471986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25333399|NCT05471986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25333418|NCT05471700|Azacitidine|azacitidine|mesh-list
25333419|NCT05471700|Venetoclax|venetoclax|mesh-list
25333429|NCT05471687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333431|NCT05471687|Vasodilator Agents|vasodilator agents|mesh-ancestor
25333432|NCT05471687|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25333433|NCT05471687|Purinergic Agonists|purinergic agonists|mesh-ancestor
25333434|NCT05471687|Purinergic Agents|purinergic agents|mesh-ancestor
25333435|NCT05471687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25333436|NCT05471687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25333437|NCT05471674|Nivolumab|nivolumab|mesh-list
25333438|NCT05471674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25333439|NCT05471674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25333440|NCT05471674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25333441|NCT05471674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25333447|NCT05471648|Pertuzumab|pertuzumab|mesh-list
25333448|NCT05471648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25333449|NCT05471648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25333450|NCT05471609|Levodopa|levodopa|mesh-list
25333451|NCT05471609|Carbidopa|carbidopa|mesh-list
25333452|NCT05471609|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25333453|NCT05471609|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25333454|NCT05471609|Dopamine Agents|dopamine agents|mesh-ancestor
25333455|NCT05471609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25333456|NCT05471609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25333457|NCT05471609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333458|NCT05471609|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25333459|NCT05471609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25333473|NCT05471531|Vaccines|vaccines|mesh-list
25333474|NCT05471531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25333475|NCT05471531|Immunologic Factors|immunologic factors|mesh-ancestor
25333476|NCT05471531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333487|NCT05469243|Hallucinogens|hallucinogens|mesh-list
25333488|NCT05469243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333489|NCT05469243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25333522|NCT05466318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25333523|NCT05466318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25333524|NCT05466318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25333526|NCT05466318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25333545|NCT05461820|Methimazole|methimazole|mesh-list
25333546|NCT05461820|Antithyroid Agents|antithyroid agents|mesh-ancestor
25333547|NCT05461820|Hormone Antagonists|hormone antagonists|mesh-ancestor
25333548|NCT05461820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25333549|NCT05461820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333555|NCT05453253|Vaccines|vaccines|mesh-list
25333556|NCT05453253|Immunologic Factors|immunologic factors|mesh-ancestor
25333557|NCT05453253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333558|NCT05445791|Metformin|metformin|mesh-list
25333559|NCT05445791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25333560|NCT05445791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333605|NCT05427474|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25333606|NCT05427474|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25333607|NCT05427474|Adrenergic Agents|adrenergic agents|mesh-ancestor
25333608|NCT05427474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25333609|NCT05427474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25333610|NCT05427474|Vasodilator Agents|vasodilator agents|mesh-ancestor
25333638|NCT05405595|Pembrolizumab|pembrolizumab|mesh-list
25333639|NCT05405595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25333640|NCT05405595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25333791|NCT05309902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25333792|NCT05309902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25333794|NCT05309902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25333795|NCT05309902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25333894|NCT05281614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25333895|NCT05281614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25333896|NCT05281614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25333897|NCT05281614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25333898|NCT05281614|Immunologic Factors|immunologic factors|mesh-ancestor
25333912|NCT05269849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25333913|NCT05269849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25333914|NCT05269849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25333915|NCT05269849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25333916|NCT05269849|Antifungal Agents|antifungal agents|mesh-ancestor
25333917|NCT05269849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25333918|NCT05269849|Immunologic Factors|immunologic factors|mesh-ancestor
25333919|NCT05269849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25333932|NCT05248620|Amoxicillin|amoxicillin|mesh-list
25333933|NCT05248620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25333934|NCT05248620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25333935|NCT05240131|Atezolizumab|atezolizumab|mesh-list
25333936|NCT05240131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25333988|NCT05226455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25333989|NCT05226455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25334015|NCT05199051|Cytarabine|cytarabine|mesh-list
25334016|NCT05199051|Gemtuzumab|gemtuzumab|mesh-list
25334017|NCT05199051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25334018|NCT05199051|Antimetabolites|antimetabolites|mesh-ancestor
25334019|NCT05199051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25334020|NCT05199051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25334021|NCT05199051|Antiviral Agents|antiviral agents|mesh-ancestor
25334625|NCT04661514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25334022|NCT05199051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25334023|NCT05199051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25334024|NCT05199051|Immunologic Factors|immunologic factors|mesh-ancestor
25334025|NCT05199051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25334026|NCT05199051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25334053|NCT05183646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25334054|NCT05183646|Interferon Inducers|interferon inducers|mesh-ancestor
25334055|NCT05183646|Immunologic Factors|immunologic factors|mesh-ancestor
25334056|NCT05183646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25334119|NCT05130892|Tubulin Modulators|tubulin modulators|mesh-ancestor
25334120|NCT05130892|Antimitotic Agents|antimitotic agents|mesh-ancestor
25334121|NCT05130892|Mitosis Modulators|mitosis modulators|mesh-ancestor
25334122|NCT05130892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25334123|NCT05130892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25334124|NCT05130892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25334125|NCT05130892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25334126|NCT05130892|Analgesics|analgesics|mesh-ancestor
25334127|NCT05130892|Sensory System Agents|sensory system agents|mesh-ancestor
25334128|NCT05130892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25334129|NCT05130892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25334130|NCT05130892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25334131|NCT05130892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25334132|NCT05130892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25334133|NCT05130892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25334134|NCT05130892|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25334135|NCT05130892|Histamine Antagonists|histamine antagonists|mesh-ancestor
25334136|NCT05130892|Histamine Agents|histamine agents|mesh-ancestor
25334137|NCT05130892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25334138|NCT05130892|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25334139|NCT05130892|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25334172|NCT05062031|Atropine|atropine|mesh-list
25334173|NCT05062031|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25334174|NCT05062031|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25334175|NCT05062031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25334176|NCT05062031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25334177|NCT05062031|Autonomic Agents|autonomic agents|mesh-ancestor
25334178|NCT05062031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25334179|NCT05062031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25334222|NCT05035862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25334223|NCT05035862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25334224|NCT05035862|Respiratory System Agents|respiratory system agents|mesh-ancestor
25334225|NCT05035862|Tocolytic Agents|tocolytic agents|mesh-ancestor
25334226|NCT05035862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25334227|NCT05035862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25334228|NCT05035862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25334229|NCT05035862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25334230|NCT05035862|Adrenergic Agents|adrenergic agents|mesh-ancestor
25334231|NCT05035862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25334232|NCT05035862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25334372|NCT04970901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25334373|NCT04970901|Antiviral Agents|antiviral agents|mesh-ancestor
25334374|NCT04970901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25334375|NCT04970901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25334376|NCT04970901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25334377|NCT04970901|Immunologic Factors|immunologic factors|mesh-ancestor
25334378|NCT04970901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25334379|NCT04970901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25334380|NCT04970901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25334381|NCT04970901|Growth Substances|growth substances|mesh-ancestor
25334382|NCT04970901|Growth Inhibitors|growth inhibitors|mesh-ancestor
25334383|NCT04970901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25334575|NCT04754737|Antitubercular Agents|antitubercular agents|mesh-ancestor
25334576|NCT04754737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25334577|NCT04754737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25334578|NCT04754737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25334579|NCT04754737|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25334580|NCT04754737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25334581|NCT04754737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25334582|NCT04754737|Cholinergic Agents|cholinergic agents|mesh-ancestor
25334583|NCT04754737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25334622|NCT04661514|Psilocybin|psilocybin|mesh-list
25334623|NCT04661514|Hallucinogens|hallucinogens|mesh-ancestor
25334624|NCT04661514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25334695|NCT04599478|Naltrexone|naltrexone|mesh-list
25334696|NCT04599478|Bupropion|bupropion|mesh-list
25334697|NCT04599478|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25334698|NCT04599478|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25334699|NCT04599478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25334700|NCT04599478|Sensory System Agents|sensory system agents|mesh-ancestor
25334701|NCT04599478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25334702|NCT04599478|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25334703|NCT04599478|Antidepressive Agents|antidepressive agents|mesh-ancestor
25334704|NCT04599478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25334705|NCT04599478|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25334706|NCT04599478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25334707|NCT04599478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25334708|NCT04599478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25334709|NCT04599478|Dopamine Agents|dopamine agents|mesh-ancestor
25334710|NCT04599478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25334711|NCT04599478|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25334712|NCT04599478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25334713|NCT04599478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25334780|NCT04502264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25334782|NCT04502264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25334783|NCT04502264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25334784|NCT04502264|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25334785|NCT04502264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25334826|NCT04462952|Adavosertib|adavosertib|mesh-list
25334827|NCT04462952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25334828|NCT04462952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25334841|NCT04433767|Nicotine|nicotine|mesh-list
25334842|NCT04433767|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25334843|NCT04433767|Autonomic Agents|autonomic agents|mesh-ancestor
25334844|NCT04433767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25334845|NCT04433767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25334846|NCT04433767|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25334847|NCT04433767|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25334848|NCT04433767|Cholinergic Agents|cholinergic agents|mesh-ancestor
25334849|NCT04433767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25334850|NCT04433767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25334851|NCT04429022|Acetaminophen|acetaminophen|mesh-list
25334852|NCT04429022|Celecoxib|celecoxib|mesh-list
25334853|NCT04429022|Ketorolac|ketorolac|mesh-list
25334854|NCT04429022|Oxycodone|oxycodone|mesh-list
25334855|NCT04429022|Gabapentin|gabapentin|mesh-list
25334856|NCT04429022|Hydromorphone|hydromorphone|mesh-list
25334857|NCT04429022|Ropivacaine|ropivacaine|mesh-list
25334858|NCT04429022|Anesthetics, Local|anesthetics, local|mesh-list
25334859|NCT04429022|Anesthetics|anesthetics|mesh-list
25334860|NCT04429022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25334861|NCT04429022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25334862|NCT04429022|Sensory System Agents|sensory system agents|mesh-ancestor
25334863|NCT04429022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25334864|NCT04429022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25334865|NCT04429022|Analgesics|analgesics|mesh-ancestor
25334866|NCT04429022|Antipyretics|antipyretics|mesh-ancestor
25334867|NCT04429022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25334868|NCT04429022|Narcotics|narcotics|mesh-ancestor
25334897|NCT04389411|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25334898|NCT04389411|Hormone Antagonists|hormone antagonists|mesh-ancestor
25334899|NCT04389411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25334900|NCT04389411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25334901|NCT04389411|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25334902|NCT04389411|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25334903|NCT04389411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25334904|NCT04383691|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
25334905|NCT04383691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25334906|NCT04383691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25334907|NCT04383691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25334908|NCT04383691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25334909|NCT04383691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25334910|NCT04383691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25334911|NCT04383691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25334912|NCT04383691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25334913|NCT04383691|Adrenergic Agents|adrenergic agents|mesh-ancestor
25334914|NCT04383691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25334915|NCT04383691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25334916|NCT04383691|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25334917|NCT04383691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25334918|NCT04383691|Serotonin Agents|serotonin agents|mesh-ancestor
25334919|NCT04383691|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25334920|NCT04383691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25334921|NCT04383691|Dopamine Agents|dopamine agents|mesh-ancestor
25335104|NCT04091126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25335105|NCT04091126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25335106|NCT04091126|Growth Substances|growth substances|mesh-ancestor
25335107|NCT04091126|Growth Inhibitors|growth inhibitors|mesh-ancestor
25335120|NCT04067492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25335121|NCT04067492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25335122|NCT04067492|Analgesics|analgesics|mesh-ancestor
25335123|NCT04067492|Sensory System Agents|sensory system agents|mesh-ancestor
25335124|NCT04067492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25335125|NCT04067492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25335126|NCT04067492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25335127|NCT04067492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25335128|NCT04067492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25335129|NCT04067492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25335130|NCT04067492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25335140|NCT04026776|Allopurinol|allopurinol|mesh-list
25335141|NCT04026776|Antimetabolites|antimetabolites|mesh-ancestor
25335142|NCT04026776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25335143|NCT04026776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25335144|NCT04026776|Gout Suppressants|gout suppressants|mesh-ancestor
25335145|NCT04026776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25335146|NCT04026776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25335147|NCT04026776|Antioxidants|antioxidants|mesh-ancestor
25335148|NCT04026776|Protective Agents|protective agents|mesh-ancestor
25335149|NCT04026776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25335150|NCT04023019|Thrombin|thrombin|mesh-list
25335151|NCT04023019|Hemostatics|hemostatics|mesh-ancestor
25335152|NCT04023019|Coagulants|coagulants|mesh-ancestor
25335153|NCT04008706|Acalabrutinib|acalabrutinib|mesh-list
25335154|NCT04008706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25335155|NCT03982810|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25335156|NCT03982810|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25335157|NCT03982810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25335158|NCT03982810|Antitubercular Agents|antitubercular agents|mesh-ancestor
25335159|NCT03972280|Antibodies|antibodies|mesh-list
25335160|NCT03972280|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25335161|NCT03972280|Lenograstim|lenograstim|mesh-list
25335162|NCT03972280|Immunologic Factors|immunologic factors|mesh-ancestor
25335163|NCT03972280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25335164|NCT03972280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25335165|NCT03962114|Niacinamide|niacinamide|mesh-list
25335166|NCT03962114|Niacin|niacin|mesh-list
25335167|NCT03962114|Nicotinic Acids|nicotinic acids|mesh-list
25335168|NCT03962114|Vitamins|vitamins|mesh-ancestor
25335169|NCT03962114|Micronutrients|micronutrients|mesh-ancestor
25335170|NCT03962114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25335171|NCT03962114|Vitamin B Complex|vitamin b complex|mesh-ancestor
25335172|NCT03962114|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25335173|NCT03962114|Antimetabolites|antimetabolites|mesh-ancestor
25335204|NCT03901001|Oseltamivir|oseltamivir|mesh-list
25335205|NCT03901001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25335206|NCT03901001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25335207|NCT03901001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25335208|NCT03901001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374003|NCT04919226|Leucovorin|leucovorin|mesh-list
25335209|NCT03901001|Antifungal Agents|antifungal agents|mesh-ancestor
25335210|NCT03901001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25335211|NCT03901001|Immunologic Factors|immunologic factors|mesh-ancestor
25335212|NCT03901001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25335213|NCT03901001|Antiviral Agents|antiviral agents|mesh-ancestor
25335214|NCT03901001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25335215|NCT03901001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25335216|NCT03900988|Acetylcysteine|acetylcysteine|mesh-list
25335217|NCT03900988|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25335218|NCT03900988|Antiviral Agents|antiviral agents|mesh-ancestor
25335219|NCT03900988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25335220|NCT03900988|Expectorants|expectorants|mesh-ancestor
25335221|NCT03900988|Respiratory System Agents|respiratory system agents|mesh-ancestor
25335222|NCT03900988|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25335223|NCT03900988|Antioxidants|antioxidants|mesh-ancestor
25335224|NCT03900988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25335225|NCT03900988|Protective Agents|protective agents|mesh-ancestor
25335226|NCT03900988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25335227|NCT03900988|Antidotes|antidotes|mesh-ancestor
25335236|NCT03871153|Paclitaxel|paclitaxel|mesh-list
25335237|NCT03871153|Carboplatin|carboplatin|mesh-list
25335238|NCT03871153|Durvalumab|durvalumab|mesh-list
25335239|NCT03871153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25335240|NCT03871153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25335241|NCT03871153|Tubulin Modulators|tubulin modulators|mesh-ancestor
25335242|NCT03871153|Antimitotic Agents|antimitotic agents|mesh-ancestor
25335243|NCT03871153|Mitosis Modulators|mitosis modulators|mesh-ancestor
25335244|NCT03871153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25335245|NCT03871153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25335271|NCT03819517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25335272|NCT03819517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25335300|NCT03801902|Durvalumab|durvalumab|mesh-list
25335301|NCT03801902|Immunoglobulins|immunoglobulins|mesh-list
25335302|NCT03801902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25335303|NCT03801902|Immunoglobulin G|immunoglobulin g|mesh-list
25335304|NCT03801902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25335305|NCT03801902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25335306|NCT03801902|Immunologic Factors|immunologic factors|mesh-ancestor
25335307|NCT03801902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25335308|NCT03794388|Pregabalin|pregabalin|mesh-list
25335309|NCT03794388|Capsaicin|capsaicin|mesh-list
25335310|NCT03794388|Analgesics|analgesics|mesh-ancestor
25335311|NCT03794388|Sensory System Agents|sensory system agents|mesh-ancestor
25335312|NCT03794388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25335313|NCT03794388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25335314|NCT03794388|Anticonvulsants|anticonvulsants|mesh-ancestor
25335315|NCT03794388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25335316|NCT03794388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25335317|NCT03794388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25335318|NCT03794388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25335319|NCT03794388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25335320|NCT03794388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25335321|NCT03794388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25335322|NCT03794388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25335323|NCT03794388|Antipruritics|antipruritics|mesh-ancestor
25335415|NCT03714958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25335416|NCT03687957|Temozolomide|temozolomide|mesh-list
25335417|NCT03687957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25335418|NCT03687957|Alkylating Agents|alkylating agents|mesh-ancestor
25335419|NCT03687957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25335420|NCT03687957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25335421|NCT03684694|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
25335422|NCT03684694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25335423|NCT03684694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25335424|NCT03674853|Gamma-oryzanol|gamma-oryzanol|mesh-list
25335425|NCT03674853|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25335426|NCT03674853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25335427|NCT03674853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25335428|NCT03674853|Antimetabolites|antimetabolites|mesh-ancestor
25335429|NCT03674853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25335430|NCT03674853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25335452|NCT03596918|Vincristine|vincristine|mesh-list
25335453|NCT03596918|Bleomycin|bleomycin|mesh-list
25335454|NCT03596918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25335455|NCT03596918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25335456|NCT03596918|Tubulin Modulators|tubulin modulators|mesh-ancestor
25335457|NCT03596918|Antimitotic Agents|antimitotic agents|mesh-ancestor
25335458|NCT03596918|Mitosis Modulators|mitosis modulators|mesh-ancestor
25335459|NCT03596918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25335460|NCT03596918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25335522|NCT03535298|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25335523|NCT03535298|(T,G)-A-L|(t,g)-a-l|mesh-list
25335524|NCT03535298|Ozanimod|ozanimod|mesh-list
25335525|NCT03535298|Ponesimod|ponesimod|mesh-list
25335526|NCT03535298|Siponimod|siponimod|mesh-list
25335527|NCT03535298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25335528|NCT03535298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25335529|NCT03535298|Immunologic Factors|immunologic factors|mesh-ancestor
25335530|NCT03535298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25335531|NCT03535298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25335532|NCT03535298|Antiviral Agents|antiviral agents|mesh-ancestor
25335533|NCT03535298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25335534|NCT03535298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25335535|NCT03535298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25335536|NCT03535298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25335537|NCT03535298|Dermatologic Agents|dermatologic agents|mesh-ancestor
25335538|NCT03535298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25335539|NCT03535298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25335540|NCT03535298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25335541|NCT03535298|Analgesics|analgesics|mesh-ancestor
25335542|NCT03535298|Sensory System Agents|sensory system agents|mesh-ancestor
25335543|NCT03535298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25335544|NCT03535298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25335545|NCT03526185|Nivolumab|nivolumab|mesh-list
25335546|NCT03526185|Ipilimumab|ipilimumab|mesh-list
25335547|NCT03526185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25335548|NCT03526185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25335549|NCT03526185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25335550|NCT03526185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25335551|NCT03519971|Paclitaxel|paclitaxel|mesh-list
25335552|NCT03519971|Etoposide|etoposide|mesh-list
25335553|NCT03519971|Cisplatin|cisplatin|mesh-list
25335554|NCT03519971|Carboplatin|carboplatin|mesh-list
25335555|NCT03519971|Pemetrexed|pemetrexed|mesh-list
25335556|NCT03519971|Durvalumab|durvalumab|mesh-list
25335557|NCT03519971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25335558|NCT03519971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25335559|NCT03519971|Tubulin Modulators|tubulin modulators|mesh-ancestor
25335560|NCT03519971|Antimitotic Agents|antimitotic agents|mesh-ancestor
25335561|NCT03519971|Mitosis Modulators|mitosis modulators|mesh-ancestor
25335562|NCT03519971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25335563|NCT03519971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25335564|NCT03519971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25335565|NCT03519971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25335566|NCT03519971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25335567|NCT03519971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25335568|NCT03519971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25335570|NCT03516604|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25335571|NCT03516604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25335572|NCT03516604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25335573|NCT03516604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25335574|NCT03516604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25335575|NCT03516604|Serotonin Agents|serotonin agents|mesh-ancestor
25335576|NCT03516604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25335577|NCT03516604|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25335578|NCT03516604|Antidepressive Agents|antidepressive agents|mesh-ancestor
25335579|NCT03516604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25335580|NCT03514069|Temozolomide|temozolomide|mesh-list
25335581|NCT03514069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25335582|NCT03514069|Alkylating Agents|alkylating agents|mesh-ancestor
25335583|NCT03514069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25335584|NCT03514069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25335585|NCT03511118|Metformin|metformin|mesh-list
25335586|NCT03511118|Topiramate|topiramate|mesh-list
25335587|NCT03511118|Azithromycin|azithromycin|mesh-list
25335588|NCT03511118|Doxycycline|doxycycline|mesh-list
25335589|NCT03511118|Ciprofloxacin|ciprofloxacin|mesh-list
25335590|NCT03511118|Levofloxacin|levofloxacin|mesh-list
25335591|NCT03511118|Clindamycin|clindamycin|mesh-list
25335592|NCT03511118|Valganciclovir|valganciclovir|mesh-list
25335593|NCT03511118|Remdesivir|remdesivir|mesh-list
25335594|NCT03511118|Hydroxyurea|hydroxyurea|mesh-list
25335595|NCT03511118|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25335596|NCT03511118|Verapamil|verapamil|mesh-list
25335597|NCT03511118|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25335598|NCT03511118|Labetalol|labetalol|mesh-list
25335599|NCT03511118|Nifedipine|nifedipine|mesh-list
25335600|NCT03511118|Furosemide|furosemide|mesh-list
25335601|NCT03511118|Sumatriptan|sumatriptan|mesh-list
25335602|NCT03511118|Oxycodone|oxycodone|mesh-list
25335603|NCT03511118|Gabapentin|gabapentin|mesh-list
25335604|NCT03511118|Ondansetron|ondansetron|mesh-list
25335605|NCT03511118|Trazodone|trazodone|mesh-list
25335606|NCT03511118|Fluvoxamine|fluvoxamine|mesh-list
25335607|NCT03511118|Cyclobenzaprine|cyclobenzaprine|mesh-list
25335608|NCT03511118|Methylphenidate|methylphenidate|mesh-list
25335609|NCT03511118|Citalopram|citalopram|mesh-list
25335610|NCT03511118|Sertraline|sertraline|mesh-list
25335611|NCT03511118|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25335612|NCT03511118|Tranexamic Acid|tranexamic acid|mesh-list
25335613|NCT03511118|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25335614|NCT03511118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25335615|NCT03511118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25335616|NCT03511118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25335617|NCT03511118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25335618|NCT03511118|Antimetabolites|antimetabolites|mesh-ancestor
25335619|NCT03511118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25335620|NCT03511118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25335621|NCT03511118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25335622|NCT03511118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25335623|NCT03511118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25335624|NCT03511118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25335625|NCT03511118|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25335626|NCT03511118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25335627|NCT03511118|Hemostatics|hemostatics|mesh-ancestor
25335628|NCT03511118|Coagulants|coagulants|mesh-ancestor
25335629|NCT03511118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25335630|NCT03511118|Narcotics|narcotics|mesh-ancestor
25335631|NCT03511118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25335632|NCT03511118|Analgesics|analgesics|mesh-ancestor
25335633|NCT03511118|Sensory System Agents|sensory system agents|mesh-ancestor
25335634|NCT03511118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25335635|NCT03511118|Anticonvulsants|anticonvulsants|mesh-ancestor
25335640|NCT03511118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25335641|NCT03511118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25335642|NCT03511118|Antimanic Agents|antimanic agents|mesh-ancestor
25335643|NCT03511118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25335644|NCT03511118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25335645|NCT03511118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25335646|NCT03511118|Serotonin Agents|serotonin agents|mesh-ancestor
25335647|NCT03511118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25335648|NCT03511118|Antidepressive Agents|antidepressive agents|mesh-ancestor
25335649|NCT03511118|Autonomic Agents|autonomic agents|mesh-ancestor
25335650|NCT03511118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25335651|NCT03511118|Diuretics|diuretics|mesh-ancestor
25335652|NCT03511118|Natriuretic Agents|natriuretic agents|mesh-ancestor
25335653|NCT03511118|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25335654|NCT03511118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25335655|NCT03511118|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25335656|NCT03511118|Dopamine Agents|dopamine agents|mesh-ancestor
25335657|NCT03511118|Antiemetics|antiemetics|mesh-ancestor
25335658|NCT03511118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25335659|NCT03511118|Antipruritics|antipruritics|mesh-ancestor
25335660|NCT03511118|Dermatologic Agents|dermatologic agents|mesh-ancestor
25335661|NCT03511118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25335662|NCT03511118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25335663|NCT03511118|Antimalarials|antimalarials|mesh-ancestor
25335664|NCT03511118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25335665|NCT03511118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25335666|NCT03511118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25335667|NCT03511118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25335668|NCT03511118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25335669|NCT03511118|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25335670|NCT03511118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25335671|NCT03511118|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25335672|NCT03511118|Renal Agents|renal agents|mesh-ancestor
25335673|NCT03511118|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25335674|NCT03511118|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25408069|NCT03459222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25335675|NCT03511118|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25335676|NCT03511118|Antisickling Agents|antisickling agents|mesh-ancestor
25335677|NCT03511118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25335678|NCT03511118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25335679|NCT03511118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25335680|NCT03511118|Vasodilator Agents|vasodilator agents|mesh-ancestor
25335681|NCT03511118|Tocolytic Agents|tocolytic agents|mesh-ancestor
25335682|NCT03511118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25335683|NCT03511118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25335684|NCT03511118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25335685|NCT03511118|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25335686|NCT03511118|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25335687|NCT03511118|Antiviral Agents|antiviral agents|mesh-ancestor
25335688|NCT03511118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25335689|NCT03511118|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25335690|NCT03511118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25335691|NCT03511118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25335692|NCT03511118|Adrenergic Agents|adrenergic agents|mesh-ancestor
25335693|NCT03511118|Sympathomimetics|sympathomimetics|mesh-ancestor
25335694|NCT03511118|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25335695|NCT03511118|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25335696|NCT03511118|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25335697|NCT03511118|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25335698|NCT03511118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25335699|NCT03497689|Treprostinil|treprostinil|mesh-list
25335700|NCT03497689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25335701|NCT03484923|Spartalizumab|spartalizumab|mesh-list
25335702|NCT03484923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25335703|NCT03484923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25335704|NCT03484923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25335748|NCT03421353|Tubulin Modulators|tubulin modulators|mesh-ancestor
25335749|NCT03421353|Antimitotic Agents|antimitotic agents|mesh-ancestor
25335750|NCT03421353|Mitosis Modulators|mitosis modulators|mesh-ancestor
25335751|NCT03421353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25335752|NCT03421353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25335753|NCT03421353|Antimetabolites|antimetabolites|mesh-ancestor
25335754|NCT03421353|Antiviral Agents|antiviral agents|mesh-ancestor
25335755|NCT03421353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25335756|NCT03421353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25335757|NCT03421353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25335758|NCT03421353|Immunologic Factors|immunologic factors|mesh-ancestor
25335759|NCT03421353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25335760|NCT03421353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25335761|NCT03402503|Montelukast|montelukast|mesh-list
25335762|NCT03402503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25335763|NCT03402503|Respiratory System Agents|respiratory system agents|mesh-ancestor
25335764|NCT03402503|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25335765|NCT03402503|Hormone Antagonists|hormone antagonists|mesh-ancestor
25335766|NCT03402503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25335767|NCT03402503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25335768|NCT03402503|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25335769|NCT03402503|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25335770|NCT03402503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25335849|NCT03358706|Anticoagulants|anticoagulants|mesh-ancestor
25335850|NCT03358706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25335851|NCT03358706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25335852|NCT03358706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25335853|NCT03358706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25335854|NCT03358706|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25335855|NCT03358706|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25335856|NCT03358706|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25335857|NCT03358706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25335858|NCT03358706|Purinergic Agents|purinergic agents|mesh-ancestor
25335859|NCT03358706|Dermatologic Agents|dermatologic agents|mesh-ancestor
25335860|NCT03358706|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25335861|NCT03358706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25335878|NCT03283878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25335879|NCT03267121|Apatinib|apatinib|mesh-list
25335880|NCT03267121|Tegafur|tegafur|mesh-list
25335881|NCT03267121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25335882|NCT03267121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25335883|NCT03267121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25335884|NCT03267121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25335885|NCT03267121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25335886|NCT03267121|Antimetabolites|antimetabolites|mesh-ancestor
25335905|NCT03236857|Venetoclax|venetoclax|mesh-list
25335906|NCT03236857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25335926|NCT03103971|Cyclophosphamide|cyclophosphamide|mesh-list
25335927|NCT03103971|Fludarabine|fludarabine|mesh-list
25335928|NCT03103971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25335929|NCT03103971|Immunologic Factors|immunologic factors|mesh-ancestor
25335930|NCT03103971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25335931|NCT03103971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25335932|NCT03103971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25335933|NCT03103971|Alkylating Agents|alkylating agents|mesh-ancestor
25335934|NCT03103971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25335935|NCT03103971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25335936|NCT03103971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25335937|NCT03082209|Bevacizumab|bevacizumab|mesh-list
25335938|NCT03082209|Venetoclax|venetoclax|mesh-list
25335939|NCT03082209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25335963|NCT03016533|Antiviral Agents|antiviral agents|mesh-ancestor
25335964|NCT03016533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25335965|NCT03016533|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25335966|NCT03016533|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25335967|NCT03016533|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25335968|NCT03016533|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25335978|NCT02977156|Ipilimumab|ipilimumab|mesh-list
25335979|NCT02977156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25335980|NCT02977156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25335981|NCT02977156|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25335982|NCT02977156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25335998|NCT02922764|Carboplatin|carboplatin|mesh-list
25335999|NCT02922764|Docetaxel|docetaxel|mesh-list
25336000|NCT02922764|Pembrolizumab|pembrolizumab|mesh-list
25336001|NCT02922764|Nivolumab|nivolumab|mesh-list
25336002|NCT02922764|Pemetrexed|pemetrexed|mesh-list
25336003|NCT02922764|Ipilimumab|ipilimumab|mesh-list
25336004|NCT02922764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25336005|NCT02922764|Tubulin Modulators|tubulin modulators|mesh-ancestor
25336006|NCT02922764|Antimitotic Agents|antimitotic agents|mesh-ancestor
25336007|NCT02922764|Mitosis Modulators|mitosis modulators|mesh-ancestor
25336008|NCT02922764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336009|NCT02922764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25336010|NCT02922764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25336011|NCT02922764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25336012|NCT02922764|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25336013|NCT02922764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25336058|NCT02885974|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25336059|NCT02866643|Contraceptive Agents|contraceptive agents|mesh-list
25336060|NCT02866643|Etonogestrel|etonogestrel|mesh-list
25336061|NCT02866643|Desogestrel|desogestrel|mesh-list
25336062|NCT02866643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25336063|NCT02866643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336064|NCT02866643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25336065|NCT02866643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25336066|NCT02866643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25336067|NCT02866643|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25336068|NCT02866643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25336069|NCT02866643|Progestins|progestins|mesh-ancestor
25336070|NCT02866643|Hormones|hormones|mesh-ancestor
25336071|NCT02866643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25336088|NCT02848820|Amoxicillin|amoxicillin|mesh-list
25336089|NCT02848820|Gentamicins|gentamicins|mesh-list
25336090|NCT02848820|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25336091|NCT02848820|Clavulanic Acids|clavulanic acids|mesh-list
25336092|NCT02848820|Clavulanic Acid|clavulanic acid|mesh-list
25336156|NCT02819518|Carboplatin|carboplatin|mesh-list
25336157|NCT02819518|Pembrolizumab|pembrolizumab|mesh-list
25336158|NCT02819518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25336159|NCT02819518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25336160|NCT02819518|Tubulin Modulators|tubulin modulators|mesh-ancestor
25336161|NCT02819518|Antimitotic Agents|antimitotic agents|mesh-ancestor
25336162|NCT02819518|Mitosis Modulators|mitosis modulators|mesh-ancestor
25336163|NCT02819518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336164|NCT02819518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25336165|NCT02819518|Antimetabolites|antimetabolites|mesh-ancestor
25336166|NCT02819518|Antiviral Agents|antiviral agents|mesh-ancestor
25336167|NCT02819518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25336180|NCT02790515|Blinatumomab|blinatumomab|mesh-list
25336181|NCT02790515|Tacrolimus|tacrolimus|mesh-list
25336182|NCT02790515|Thymoglobulin|thymoglobulin|mesh-list
25336183|NCT02790515|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25336184|NCT02790515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25336185|NCT02790515|Immunologic Factors|immunologic factors|mesh-ancestor
25336186|NCT02790515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336187|NCT02790515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25336188|NCT02790515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25336189|NCT02790515|Alkylating Agents|alkylating agents|mesh-ancestor
25336190|NCT02790515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336191|NCT02790515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25336192|NCT02790515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25336193|NCT02790515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25336194|NCT02790515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25336195|NCT02790515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25336196|NCT02790515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25336197|NCT02790515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25336198|NCT02790515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25336199|NCT02790515|Antifungal Agents|antifungal agents|mesh-ancestor
25336210|NCT02730923|Anastrozole|anastrozole|mesh-list
25336211|NCT02730923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25336212|NCT02730923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25336213|NCT02730923|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25336214|NCT02730923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25336215|NCT02730923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25336216|NCT02730923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336217|NCT02730923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25336218|NCT02730923|Hormone Antagonists|hormone antagonists|mesh-ancestor
25336219|NCT02730923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25336220|NCT02730923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336221|NCT02715609|Copper|copper|mesh-list
25336222|NCT02715609|Temozolomide|temozolomide|mesh-list
25336223|NCT02715609|Disulfiram|disulfiram|mesh-list
25336224|NCT02715609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25336225|NCT02715609|Alkylating Agents|alkylating agents|mesh-ancestor
25336226|NCT02715609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336227|NCT02715609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25336228|NCT02715609|Trace Elements|trace elements|mesh-ancestor
25336229|NCT02715609|Micronutrients|micronutrients|mesh-ancestor
25336230|NCT02715609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336231|NCT02715609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25336232|NCT02715609|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
25336233|NCT02715609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25336234|NCT02678052|Vedolizumab|vedolizumab|mesh-list
25336235|NCT02678052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25336242|NCT02613507|Docetaxel|docetaxel|mesh-list
25336243|NCT02613507|Nivolumab|nivolumab|mesh-list
25336272|NCT02572791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25336273|NCT02572791|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25336274|NCT02572791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25336275|NCT02572791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336280|NCT02531906|Methadone|methadone|mesh-list
25336281|NCT02531906|Gabapentin|gabapentin|mesh-list
25336282|NCT02531906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25336283|NCT02531906|Narcotics|narcotics|mesh-ancestor
25336284|NCT02531906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25336285|NCT02531906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336286|NCT02531906|Analgesics|analgesics|mesh-ancestor
25336287|NCT02531906|Sensory System Agents|sensory system agents|mesh-ancestor
25336288|NCT02531906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25336289|NCT02531906|Anticonvulsants|anticonvulsants|mesh-ancestor
25336290|NCT02531906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25336291|NCT02531906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25336292|NCT02531906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25336293|NCT02531906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25336294|NCT02531906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25336295|NCT02531906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25336296|NCT02531906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336297|NCT02531906|Antimanic Agents|antimanic agents|mesh-ancestor
25336298|NCT02531906|Antitussive Agents|antitussive agents|mesh-ancestor
25336299|NCT02531906|Respiratory System Agents|respiratory system agents|mesh-ancestor
25336394|NCT02412228|Antiemetics|antiemetics|mesh-ancestor
25336395|NCT02412228|Autonomic Agents|autonomic agents|mesh-ancestor
25336396|NCT02412228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25336489|NCT02072486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336536|NCT01828710|Inositol|inositol|mesh-list
25336537|NCT01828710|Hematinics|hematinics|mesh-ancestor
25336538|NCT01828710|Vitamin B Complex|vitamin b complex|mesh-ancestor
25336539|NCT01828710|Vitamins|vitamins|mesh-ancestor
25336540|NCT01828710|Micronutrients|micronutrients|mesh-ancestor
25336541|NCT01828710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336730|NCT00676715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25336731|NCT00676715|Antiviral Agents|antiviral agents|mesh-ancestor
25336732|NCT00676715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25336733|NCT00676715|Immunologic Factors|immunologic factors|mesh-ancestor
25336734|NCT00676715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336735|NCT00443599|Insulin|insulin|mesh-list
25336736|NCT00443599|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25336737|NCT00443599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25336738|NCT00443599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336739|NCT00347412|Paclitaxel|paclitaxel|mesh-list
25336740|NCT00347412|Carboplatin|carboplatin|mesh-list
25336741|NCT00347412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25336742|NCT00347412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25336743|NCT00347412|Tubulin Modulators|tubulin modulators|mesh-ancestor
25336744|NCT00347412|Antimitotic Agents|antimitotic agents|mesh-ancestor
25336745|NCT00347412|Mitosis Modulators|mitosis modulators|mesh-ancestor
25336746|NCT00347412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336747|NCT00076310|Cisplatin|cisplatin|mesh-list
25336748|NCT00076310|Docetaxel|docetaxel|mesh-list
25336749|NCT00076310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25336750|NCT00076310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25336751|NCT00076310|Tubulin Modulators|tubulin modulators|mesh-ancestor
25336752|NCT00076310|Antimitotic Agents|antimitotic agents|mesh-ancestor
25336753|NCT00076310|Mitosis Modulators|mitosis modulators|mesh-ancestor
25336754|NCT00076310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336755|NCT00076310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25336756|NCT00076310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25336773|NCT05475210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25336774|NCT05475210|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
25336775|NCT05475210|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25336776|NCT05475210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336779|NCT05475054|Liver Extracts|liver extracts|mesh-list
25336780|NCT05475054|Hematinics|hematinics|mesh-ancestor
25336798|NCT05474937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25336799|NCT05474937|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25336800|NCT05474937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25336801|NCT05474937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25336802|NCT05474937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25336803|NCT05474937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336804|NCT05474937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25336805|NCT05474937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25336806|NCT05474937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25336807|NCT05474937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25336808|NCT05474937|GABA Modulators|gaba modulators|mesh-ancestor
25336809|NCT05474937|GABA Agents|gaba agents|mesh-ancestor
25336810|NCT05474937|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25336811|NCT05474937|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25336812|NCT05474924|Prednisolone|prednisolone|mesh-list
25374531|NCT04904549|Vaccines|vaccines|mesh-list
25336813|NCT05474924|Budesonide|budesonide|mesh-list
25336814|NCT05474924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25336815|NCT05474924|Glucocorticoids|glucocorticoids|mesh-ancestor
25336816|NCT05474924|Hormones|hormones|mesh-ancestor
25336817|NCT05474924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25336818|NCT05474924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336819|NCT05474924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25336820|NCT05474924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25336821|NCT05474924|Autonomic Agents|autonomic agents|mesh-ancestor
25336822|NCT05474924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25336823|NCT05474924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25336824|NCT05474924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25336825|NCT05474924|Respiratory System Agents|respiratory system agents|mesh-ancestor
25336854|NCT05474781|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25336855|NCT05474781|Antiviral Agents|antiviral agents|mesh-ancestor
25336856|NCT05474781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25336857|NCT05474729|Minocycline|minocycline|mesh-list
25336858|NCT05474729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25336859|NCT05474729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25336860|NCT05474716|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25336861|NCT05474716|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25336862|NCT05474716|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25336863|NCT05474716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25336864|NCT05474716|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25336865|NCT05474716|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25336866|NCT05474716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25336867|NCT05474716|Adrenergic Agents|adrenergic agents|mesh-ancestor
25336868|NCT05474716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25336869|NCT05474716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336870|NCT05474716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336871|NCT05474690|Cyclophosphamide|cyclophosphamide|mesh-list
25336872|NCT05474690|Carboplatin|carboplatin|mesh-list
25336873|NCT05474690|Docetaxel|docetaxel|mesh-list
25336874|NCT05474690|Trastuzumab|trastuzumab|mesh-list
25336875|NCT05474690|Epirubicin|epirubicin|mesh-list
25336876|NCT05474690|Pertuzumab|pertuzumab|mesh-list
25336877|NCT05474690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25336878|NCT05474690|Immunologic Factors|immunologic factors|mesh-ancestor
25336879|NCT05474690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336880|NCT05474690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25336881|NCT05474690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25336882|NCT05474690|Alkylating Agents|alkylating agents|mesh-ancestor
25336883|NCT05474690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336884|NCT05474690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25336885|NCT05474690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25336886|NCT05474690|Tubulin Modulators|tubulin modulators|mesh-ancestor
25336887|NCT05474690|Antimitotic Agents|antimitotic agents|mesh-ancestor
25336888|NCT05474690|Mitosis Modulators|mitosis modulators|mesh-ancestor
25336889|NCT05474690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25336890|NCT05474690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25336891|NCT05474690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25336892|NCT05474690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25336893|NCT05474690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25336894|NCT05474664|Camostat|camostat|mesh-list
25336895|NCT05474664|Protease Inhibitors|protease inhibitors|mesh-ancestor
25336896|NCT05474664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25336897|NCT05474664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336898|NCT05474664|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25336899|NCT05474664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25336900|NCT05474560|Allopurinol|allopurinol|mesh-list
25336901|NCT05474560|Febuxostat|febuxostat|mesh-list
25336902|NCT05474560|Antimetabolites|antimetabolites|mesh-ancestor
25336903|NCT05474560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336904|NCT05474560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25336905|NCT05474560|Gout Suppressants|gout suppressants|mesh-ancestor
25336906|NCT05474560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25336907|NCT05474560|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25336908|NCT05474560|Antioxidants|antioxidants|mesh-ancestor
25336909|NCT05474560|Protective Agents|protective agents|mesh-ancestor
25336910|NCT05474560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336911|NCT05474183|Dexmedetomidine|dexmedetomidine|mesh-list
25336912|NCT05474183|Ketamine|ketamine|mesh-list
25336913|NCT05474183|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25336914|NCT05474183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25724192|NCT02535611|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25336915|NCT05474183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336916|NCT05474183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25336918|NCT05474183|Sensory System Agents|sensory system agents|mesh-ancestor
25336919|NCT05474183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25336920|NCT05474183|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25336921|NCT05474183|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25336922|NCT05474183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25336923|NCT05474183|Adrenergic Agents|adrenergic agents|mesh-ancestor
25336924|NCT05474183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25336925|NCT05474183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336926|NCT05474183|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25336927|NCT05474183|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25336928|NCT05474183|Anesthetics, General|anesthetics, general|mesh-ancestor
25336929|NCT05474183|Anesthetics|anesthetics|mesh-ancestor
25336930|NCT05474183|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25336931|NCT05474183|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25336945|NCT05474040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336947|NCT05474040|Sensory System Agents|sensory system agents|mesh-ancestor
25336948|NCT05474040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25336956|NCT05474001|Fentanyl|fentanyl|mesh-list
25336957|NCT05474001|Bupivacaine|bupivacaine|mesh-list
25336958|NCT05474001|Anesthetics, Local|anesthetics, local|mesh-ancestor
25336959|NCT05474001|Anesthetics|anesthetics|mesh-ancestor
25336960|NCT05474001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25336961|NCT05474001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336962|NCT05474001|Sensory System Agents|sensory system agents|mesh-ancestor
25336963|NCT05474001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25336964|NCT05474001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25336965|NCT05474001|Narcotics|narcotics|mesh-ancestor
25336966|NCT05474001|Analgesics|analgesics|mesh-ancestor
25336967|NCT05474001|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25336968|NCT05474001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25336969|NCT05474001|Anesthetics, General|anesthetics, general|mesh-ancestor
25336977|NCT05473858|Phentolamine|phentolamine|mesh-list
25336978|NCT05473858|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25336979|NCT05473858|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25336980|NCT05473858|Adrenergic Agents|adrenergic agents|mesh-ancestor
25336981|NCT05473858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25336982|NCT05473858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336983|NCT05473858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336984|NCT05473858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25336985|NCT05473819|Anesthetics|anesthetics|mesh-list
25336986|NCT05473819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25336987|NCT05473819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336988|NCT05473806|Pioglitazone|pioglitazone|mesh-list
25336989|NCT05473806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25336990|NCT05473806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25336991|NCT05473741|Risperidone|risperidone|mesh-list
25336992|NCT05473741|Aripiprazole|aripiprazole|mesh-list
25336993|NCT05473741|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25336994|NCT05473741|Antipsychotic Agents|antipsychotic agents|mesh-list
25336995|NCT05473741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25336996|NCT05473741|Serotonin Agents|serotonin agents|mesh-ancestor
25336997|NCT05473741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25336998|NCT05473741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25336999|NCT05473741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25337000|NCT05473741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25337001|NCT05473741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25337002|NCT05473741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25337003|NCT05473741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25337004|NCT05473741|Dopamine Agents|dopamine agents|mesh-ancestor
25337005|NCT05473741|Antidepressive Agents|antidepressive agents|mesh-ancestor
25337006|NCT05473741|Dopamine Agonists|dopamine agonists|mesh-ancestor
25337062|NCT05467033|Hemostatics|hemostatics|mesh-ancestor
25337063|NCT05467033|Coagulants|coagulants|mesh-ancestor
25337064|NCT05467033|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25337065|NCT05467033|Natriuretic Agents|natriuretic agents|mesh-ancestor
25337066|NCT05467033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25337070|NCT05463133|Sirolimus|sirolimus|mesh-list
25337071|NCT05463133|Cyclophosphamide|cyclophosphamide|mesh-list
25337072|NCT05463133|Busulfan|busulfan|mesh-list
25337073|NCT05463133|Alemtuzumab|alemtuzumab|mesh-list
25337074|NCT05463133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25337075|NCT05463133|Immunologic Factors|immunologic factors|mesh-ancestor
25337076|NCT05463133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25337077|NCT05463133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25337078|NCT05463133|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25337079|NCT05463133|Alkylating Agents|alkylating agents|mesh-ancestor
25337080|NCT05463133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25337081|NCT05463133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25337082|NCT05463133|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25337083|NCT05463133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25337094|NCT05459844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25337096|NCT05458726|Carboplatin|carboplatin|mesh-list
25337097|NCT05458726|Pemetrexed|pemetrexed|mesh-list
25337098|NCT05458726|Osimertinib|osimertinib|mesh-list
25337099|NCT05458726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25337100|NCT05458726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25337101|NCT05458726|Tubulin Modulators|tubulin modulators|mesh-ancestor
25337102|NCT05458726|Antimitotic Agents|antimitotic agents|mesh-ancestor
25337103|NCT05458726|Mitosis Modulators|mitosis modulators|mesh-ancestor
25337104|NCT05458726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25337105|NCT05458726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25337106|NCT05458726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25337107|NCT05458726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25337108|NCT05458726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25337109|NCT05455294|Decitabine|decitabine|mesh-list
25337110|NCT05455294|Venetoclax|venetoclax|mesh-list
25337112|NCT05455294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25337113|NCT05455294|Antimetabolites|antimetabolites|mesh-ancestor
25337114|NCT05455294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25337115|NCT05455294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25337116|NCT05455294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25337117|NCT05442567|Vedolizumab|vedolizumab|mesh-list
25337118|NCT05442567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25337370|NCT05347459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25337371|NCT05347459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25337372|NCT05347459|Incretins|incretins|mesh-ancestor
25337373|NCT05347459|Hormones|hormones|mesh-ancestor
25337374|NCT05347459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25337375|NCT05347459|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25337376|NCT05347459|Protease Inhibitors|protease inhibitors|mesh-ancestor
25337377|NCT05347459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25337378|NCT05347459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25337379|NCT05347459|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25337380|NCT05346445|Fluoxetine|fluoxetine|mesh-list
25337381|NCT05346445|Citalopram|citalopram|mesh-list
25337382|NCT05346445|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25337383|NCT05346445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25337391|NCT05346445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25337392|NCT05346445|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25337393|NCT05346445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25337394|NCT05346445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25337405|NCT05331144|Amlodipine|amlodipine|mesh-list
25337406|NCT05331144|Calcium Channel Blockers|calcium channel blockers|mesh-list
25337407|NCT05331144|Angiotensin II|angiotensin ii|mesh-list
25337408|NCT05331144|Giapreza|giapreza|mesh-list
25337409|NCT05331144|Calcium|calcium|mesh-list
25337410|NCT05331144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
25337411|NCT05331144|Angiotensinogen|angiotensinogen|mesh-list
25337412|NCT05331144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25337413|NCT05331144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25337414|NCT05331144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25337415|NCT05331144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25337416|NCT05331144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25337417|NCT05331144|Vasodilator Agents|vasodilator agents|mesh-ancestor
25337418|NCT05331144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25337419|NCT05331144|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25337420|NCT05331144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25337421|NCT05331144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25337422|NCT05331144|Protease Inhibitors|protease inhibitors|mesh-ancestor
25337423|NCT05331144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25337424|NCT05313243|Pembrolizumab|pembrolizumab|mesh-list
25337425|NCT05313243|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25337426|NCT05313243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25337427|NCT05313243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25337442|NCT05304273|Letrozole|letrozole|mesh-list
25337443|NCT05304273|Misoprostol|misoprostol|mesh-list
25337444|NCT05304273|Mifepristone|mifepristone|mesh-list
25724193|NCT02535715|Insulin|insulin|mesh-list
25337445|NCT05304273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25337446|NCT05304273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25337447|NCT05304273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25337448|NCT05304273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25337449|NCT05304273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25337450|NCT05304273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25337451|NCT05304273|Hormone Antagonists|hormone antagonists|mesh-ancestor
25337452|NCT05304273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25337453|NCT05304273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25337454|NCT05304273|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25337455|NCT05304273|Abortifacient Agents|abortifacient agents|mesh-ancestor
25337456|NCT05304273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25337457|NCT05304273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25337458|NCT05304273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25337468|NCT05304273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25337469|NCT05304273|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25337656|NCT05195177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25337657|NCT05195177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25337658|NCT05195177|Sensory System Agents|sensory system agents|mesh-ancestor
25337659|NCT05195177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25337660|NCT05195177|Histamine Agonists|histamine agonists|mesh-ancestor
25337661|NCT05195177|Histamine Agents|histamine agents|mesh-ancestor
25337662|NCT05195177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25337663|NCT05195177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25337664|NCT05191706|Dexamethasone|dexamethasone|mesh-list
25337665|NCT05191706|Prednisolone|prednisolone|mesh-list
25337666|NCT05191706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25337667|NCT05191706|Methylprednisolone|methylprednisolone|mesh-list
25337668|NCT05191706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25337669|NCT05191706|Prednisolone acetate|prednisolone acetate|mesh-list
25337670|NCT05191706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25337671|NCT05191706|Prednisolone phosphate|prednisolone phosphate|mesh-list
25337672|NCT05191706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25337673|NCT05191706|Antiemetics|antiemetics|mesh-ancestor
25337674|NCT05191706|Autonomic Agents|autonomic agents|mesh-ancestor
25337675|NCT05191706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25337676|NCT05191706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25337677|NCT05191706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25337678|NCT05191706|Glucocorticoids|glucocorticoids|mesh-ancestor
25337679|NCT05191706|Hormones|hormones|mesh-ancestor
25337680|NCT05191706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25337681|NCT05191706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25337682|NCT05191706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25337683|NCT05191706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25337684|NCT05191706|Protective Agents|protective agents|mesh-ancestor
25337685|NCT05187377|Hormones|hormones|mesh-list
25337686|NCT05187377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25337687|NCT05187377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25337764|NCT05168683|Uric Acid|uric acid|mesh-list
25337722|NCT05170919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25337723|NCT05170919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25337724|NCT05170919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25337725|NCT05170919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25337726|NCT05170919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25337727|NCT05170919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25337728|NCT05170919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25337729|NCT05170919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25337730|NCT05170919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25337731|NCT05170919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25337732|NCT05170919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25337733|NCT05170919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25337734|NCT05170919|Serotonin Agents|serotonin agents|mesh-ancestor
25337735|NCT05170919|Antidepressive Agents|antidepressive agents|mesh-ancestor
25337736|NCT05170919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25337737|NCT05170919|Histamine Antagonists|histamine antagonists|mesh-ancestor
25337738|NCT05170919|Histamine Agents|histamine agents|mesh-ancestor
25337739|NCT05170919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25337740|NCT05170919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25337741|NCT05170919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25337742|NCT05170919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25337743|NCT05170919|Adrenergic Agents|adrenergic agents|mesh-ancestor
25337744|NCT05170919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25374827|NCT04895358|Paclitaxel|paclitaxel|mesh-list
25337745|NCT05170919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25337746|NCT05170919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25337761|NCT05168813|Immunologic Factors|immunologic factors|mesh-ancestor
25337762|NCT05168813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25337763|NCT05168683|Rasburicase|rasburicase|mesh-list
25337814|NCT05151263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25337815|NCT05151263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25337816|NCT05151263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25337817|NCT05151263|Antipyretics|antipyretics|mesh-ancestor
25337824|NCT05137847|Denileukin diftitox|denileukin diftitox|mesh-list
25337825|NCT05137847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25337860|NCT05079360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25337861|NCT05079360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25337862|NCT05079360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25337863|NCT05079360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25337864|NCT05079360|Hormone Antagonists|hormone antagonists|mesh-ancestor
25337865|NCT05079360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25337866|NCT05079360|Hormones|hormones|mesh-ancestor
25337881|NCT05054179|Ropivacaine|ropivacaine|mesh-list
25337882|NCT05054179|Anesthetics, Local|anesthetics, local|mesh-ancestor
25337883|NCT05054179|Anesthetics|anesthetics|mesh-ancestor
25337884|NCT05054179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25339269|NCT04174352|Tamoxifen|tamoxifen|mesh-list
25337885|NCT05054179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25337886|NCT05054179|Sensory System Agents|sensory system agents|mesh-ancestor
25337887|NCT05054179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25337936|NCT05040568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25337938|NCT05040568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25337939|NCT05040568|Alkylating Agents|alkylating agents|mesh-ancestor
25337940|NCT05040568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25337941|NCT05040568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25337942|NCT05040568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25337943|NCT05040568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25337944|NCT05040568|Antimetabolites|antimetabolites|mesh-ancestor
25337945|NCT05040568|Antiviral Agents|antiviral agents|mesh-ancestor
25337946|NCT05040568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25337947|NCT05040568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25338045|NCT04983901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25338046|NCT04983901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25338047|NCT04983901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25338048|NCT04983901|Protease Inhibitors|protease inhibitors|mesh-ancestor
25338051|NCT04976868|Pimecrolimus|pimecrolimus|mesh-list
25338052|NCT04976868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25338053|NCT04976868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25338054|NCT04976868|Analgesics|analgesics|mesh-ancestor
25338055|NCT04976868|Sensory System Agents|sensory system agents|mesh-ancestor
25338056|NCT04976868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25338057|NCT04976868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25338058|NCT04976868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25338059|NCT04976868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25338060|NCT04976868|Dermatologic Agents|dermatologic agents|mesh-ancestor
25338061|NCT04976868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25338062|NCT04976868|Immunologic Factors|immunologic factors|mesh-ancestor
25338063|NCT04976868|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25338064|NCT04976868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25338065|NCT04976868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25338066|NCT04976036|Nintedanib|nintedanib|mesh-list
25338067|NCT04976036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25338196|NCT04890106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25338197|NCT04890106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25338259|NCT04790032|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25338260|NCT04790032|Purinergic Agents|purinergic agents|mesh-ancestor
25338261|NCT04790032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25338262|NCT04790032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25338263|NCT04790032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25338264|NCT04789057|Atorvastatin|atorvastatin|mesh-list
25338265|NCT04789057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25338266|NCT04789057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25338267|NCT04789057|Antimetabolites|antimetabolites|mesh-ancestor
25338268|NCT04789057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25338269|NCT04789057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25724194|NCT02535715|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25724195|NCT02535715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25338270|NCT04789057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25338271|NCT04789057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25338273|NCT04776148|Pembrolizumab|pembrolizumab|mesh-list
25338274|NCT04776148|Lenvatinib|lenvatinib|mesh-list
25338275|NCT04776148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25338276|NCT04776148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25338277|NCT04776148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25338278|NCT04776148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25338279|NCT04776148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25338280|NCT04776148|Antimetabolites|antimetabolites|mesh-ancestor
25338281|NCT04776148|Antiviral Agents|antiviral agents|mesh-ancestor
25338282|NCT04776148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25338283|NCT04773366|Cytarabine|cytarabine|mesh-list
25338284|NCT04773366|Prednisone|prednisone|mesh-list
25338285|NCT04773366|Vincristine|vincristine|mesh-list
25338286|NCT04773366|Mercaptopurine|mercaptopurine|mesh-list
25338287|NCT04773366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25338288|NCT04773366|Glucocorticoids|glucocorticoids|mesh-ancestor
25338289|NCT04773366|Hormones|hormones|mesh-ancestor
25338290|NCT04773366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25338291|NCT04773366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25338397|NCT04748224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25338398|NCT04748224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25338399|NCT04748224|Adrenergic Agents|adrenergic agents|mesh-ancestor
25338400|NCT04748224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25338401|NCT04748224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25338444|NCT04736602|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25338453|NCT04733963|Bevacizumab|bevacizumab|mesh-list
25338454|NCT04733963|Capecitabine|capecitabine|mesh-list
25338455|NCT04733963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25338456|NCT04733963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25338457|NCT04733963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25338458|NCT04733963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25338459|NCT04733963|Growth Substances|growth substances|mesh-ancestor
25338460|NCT04733963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25338461|NCT04733963|Growth Inhibitors|growth inhibitors|mesh-ancestor
25338462|NCT04733963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25338463|NCT04733963|Antimetabolites|antimetabolites|mesh-ancestor
25338464|NCT04733963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25338470|NCT04716413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25338471|NCT04716413|Narcotics|narcotics|mesh-ancestor
25338472|NCT04716413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25338473|NCT04716413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25338474|NCT04716413|Analgesics|analgesics|mesh-ancestor
25338475|NCT04716413|Sensory System Agents|sensory system agents|mesh-ancestor
25338476|NCT04716413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25338661|NCT04589208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25338662|NCT04589208|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25338663|NCT04589208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25338664|NCT04589208|Anesthetics, General|anesthetics, general|mesh-ancestor
25338665|NCT04589208|Anesthetics|anesthetics|mesh-ancestor
25338666|NCT04589208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25338667|NCT04589208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25338668|NCT04589208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25338669|NCT04589208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25338670|NCT04589208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25338706|NCT04562597|Respiratory System Agents|respiratory system agents|mesh-ancestor
25338707|NCT04562597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25338709|NCT04562597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25338710|NCT04562597|Protective Agents|protective agents|mesh-ancestor
25338711|NCT04562597|Antidotes|antidotes|mesh-ancestor
25338716|NCT04531098|Vaccines|vaccines|mesh-list
25338717|NCT04531098|Immunologic Factors|immunologic factors|mesh-ancestor
25338718|NCT04531098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25338719|NCT04526795|Cytarabine|cytarabine|mesh-list
25338720|NCT04526795|Fludarabine|fludarabine|mesh-list
25338721|NCT04526795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25338722|NCT04526795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25338723|NCT04526795|Antimetabolites|antimetabolites|mesh-ancestor
25338724|NCT04526795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25338725|NCT04526795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25338726|NCT04526795|Immunologic Factors|immunologic factors|mesh-ancestor
25338727|NCT04526795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25338791|NCT04478292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25338792|NCT04478292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25338793|NCT04478292|Tubulin Modulators|tubulin modulators|mesh-ancestor
25338794|NCT04478292|Antimitotic Agents|antimitotic agents|mesh-ancestor
25338795|NCT04478292|Mitosis Modulators|mitosis modulators|mesh-ancestor
25338796|NCT04478292|Antidotes|antidotes|mesh-ancestor
25338797|NCT04478292|Protective Agents|protective agents|mesh-ancestor
25338798|NCT04478292|Antioxidants|antioxidants|mesh-ancestor
25338799|NCT04478292|Antitubercular Agents|antitubercular agents|mesh-ancestor
25338800|NCT04478292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25338801|NCT04478292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25338802|NCT04478292|Chelating Agents|chelating agents|mesh-ancestor
25338803|NCT04478292|Sequestering Agents|sequestering agents|mesh-ancestor
25339127|NCT04277975|Narcotics|narcotics|mesh-ancestor
25338884|NCT04428086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25338885|NCT04428086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25338886|NCT04428086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25338887|NCT04428086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25338888|NCT04428086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25338889|NCT04428086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25338890|NCT04426409|Ofloxacin|ofloxacin|mesh-list
25338891|NCT04426409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25338892|NCT04426409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25338893|NCT04426409|Renal Agents|renal agents|mesh-ancestor
25338894|NCT04426409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25338895|NCT04426409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25338896|NCT04426409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25338897|NCT04426409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25338898|NCT04426409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25338899|NCT04426409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25338915|NCT04416386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25338956|NCT04374461|Acetylcysteine|acetylcysteine|mesh-list
25338957|NCT04374461|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25338958|NCT04374461|Antiviral Agents|antiviral agents|mesh-ancestor
25338959|NCT04374461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25338960|NCT04374461|Expectorants|expectorants|mesh-ancestor
25338961|NCT04374461|Respiratory System Agents|respiratory system agents|mesh-ancestor
25338962|NCT04374461|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25338963|NCT04374461|Antioxidants|antioxidants|mesh-ancestor
25338964|NCT04374461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25338965|NCT04374461|Protective Agents|protective agents|mesh-ancestor
25338966|NCT04374461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25338967|NCT04374461|Antidotes|antidotes|mesh-ancestor
25338968|NCT04373603|Tranexamic Acid|tranexamic acid|mesh-list
25338969|NCT04373603|Hyaluronic Acid|hyaluronic acid|mesh-list
25338970|NCT04373603|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25338971|NCT04373603|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25338972|NCT04373603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25338973|NCT04373603|Hemostatics|hemostatics|mesh-ancestor
25338974|NCT04373603|Coagulants|coagulants|mesh-ancestor
25338975|NCT04373603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25338976|NCT04373603|Immunologic Factors|immunologic factors|mesh-ancestor
25339005|NCT04355858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25339006|NCT04355858|Immunologic Factors|immunologic factors|mesh-ancestor
25339007|NCT04355858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25339008|NCT04353817|Ivacaftor|ivacaftor|mesh-list
25339009|NCT04353817|Elexacaftor|elexacaftor|mesh-list
25339010|NCT04353817|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25339011|NCT04353817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25339012|NCT04353817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25339029|NCT04339062|Sirolimus|sirolimus|mesh-list
25339030|NCT04339062|Prednisone|prednisone|mesh-list
25339031|NCT04339062|Everolimus|everolimus|mesh-list
25339032|NCT04339062|Cemiplimab|cemiplimab|mesh-list
25339033|NCT04339062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25339034|NCT04339062|Glucocorticoids|glucocorticoids|mesh-ancestor
25339035|NCT04339062|Hormones|hormones|mesh-ancestor
25339036|NCT04339062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25339037|NCT04339062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25339038|NCT04339062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25339039|NCT04339062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25339040|NCT04339062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25339041|NCT04339062|Immunologic Factors|immunologic factors|mesh-ancestor
25339042|NCT04339062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25339043|NCT04339062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25339044|NCT04339062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25339045|NCT04339062|Antifungal Agents|antifungal agents|mesh-ancestor
25339046|NCT04339062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25339072|NCT04331002|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25339073|NCT04331002|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25339074|NCT04331002|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25339075|NCT04331002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25339076|NCT04331002|Glucocorticoids|glucocorticoids|mesh-ancestor
25339077|NCT04331002|Hormones|hormones|mesh-ancestor
25339250|NCT04195256|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25339078|NCT04331002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25339079|NCT04331002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25339080|NCT04331002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25339081|NCT04331002|Immunologic Factors|immunologic factors|mesh-ancestor
25339082|NCT04331002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25339083|NCT04331002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25339085|NCT04313634|Quercetin|quercetin|mesh-list
25339086|NCT04313634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25339087|NCT04313634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25339088|NCT04313634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25339089|NCT04313634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25339090|NCT04313634|Antioxidants|antioxidants|mesh-ancestor
25339091|NCT04313634|Protective Agents|protective agents|mesh-ancestor
25339092|NCT04313634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25339107|NCT04278755|Drospirenone|drospirenone|mesh-list
25339108|NCT04278755|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25339109|NCT04278755|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
25339110|NCT04278755|Estradiol|estradiol|mesh-list
25339111|NCT04278755|Estrogens|estrogens|mesh-ancestor
25339112|NCT04278755|Hormones|hormones|mesh-ancestor
25339113|NCT04278755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25339114|NCT04278755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25339115|NCT04278755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25339116|NCT04278755|Contraceptive Agents|contraceptive agents|mesh-ancestor
25339117|NCT04278755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25339118|NCT04278755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25339119|NCT04278755|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25339120|NCT04278755|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25339121|NCT04278755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25339122|NCT04278755|Hormone Antagonists|hormone antagonists|mesh-ancestor
25339123|NCT04278755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25339124|NCT04278755|Diuretics|diuretics|mesh-ancestor
25339125|NCT04278755|Natriuretic Agents|natriuretic agents|mesh-ancestor
25339126|NCT04277975|Analgesics, Opioid|analgesics, opioid|mesh-list
25339190|NCT04231539|Autonomic Agents|autonomic agents|mesh-ancestor
25339191|NCT04231539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25339192|NCT04231539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25339193|NCT04231539|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25339194|NCT04231539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25339195|NCT04231539|Cholinergic Agents|cholinergic agents|mesh-ancestor
25339196|NCT04231539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25339197|NCT04231539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25339198|NCT04228042|Infigratinib|infigratinib|mesh-list
25339199|NCT04228042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25339200|NCT04225221|Leuprolide|leuprolide|mesh-list
25339201|NCT04225221|Estradiol|estradiol|mesh-list
25339202|NCT04225221|Progesterone|progesterone|mesh-list
25339203|NCT04225221|Estrogens|estrogens|mesh-ancestor
25339204|NCT04225221|Hormones|hormones|mesh-ancestor
25339212|NCT04225221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25339221|NCT04208178|Trastuzumab|trastuzumab|mesh-list
25339222|NCT04208178|Pertuzumab|pertuzumab|mesh-list
25339223|NCT04208178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25339224|NCT04208178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25339230|NCT04195256|Dexmedetomidine|dexmedetomidine|mesh-list
25339231|NCT04195256|Ketamine|ketamine|mesh-list
25339232|NCT04195256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25339233|NCT04195256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25339234|NCT04195256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25339235|NCT04195256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25339236|NCT04195256|Analgesics|analgesics|mesh-ancestor
25339237|NCT04195256|Sensory System Agents|sensory system agents|mesh-ancestor
25339238|NCT04195256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25339239|NCT04195256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25339240|NCT04195256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25339241|NCT04195256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25339242|NCT04195256|Adrenergic Agents|adrenergic agents|mesh-ancestor
25339243|NCT04195256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25339244|NCT04195256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25339245|NCT04195256|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25339246|NCT04195256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25339247|NCT04195256|Anesthetics, General|anesthetics, general|mesh-ancestor
25339248|NCT04195256|Anesthetics|anesthetics|mesh-ancestor
25339249|NCT04195256|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25339270|NCT04174352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25339271|NCT04174352|Hormone Antagonists|hormone antagonists|mesh-ancestor
25339272|NCT04174352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25339273|NCT04174352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25339274|NCT04174352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25339275|NCT04174352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25339276|NCT04174352|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25339277|NCT04174352|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25339278|NCT04174352|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25339342|NCT04089072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25339344|NCT04089072|Autonomic Agents|autonomic agents|mesh-ancestor
25339345|NCT04089072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25339346|NCT04089072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25339347|NCT04089072|Sympathomimetics|sympathomimetics|mesh-ancestor
25339348|NCT04089072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25339349|NCT04089072|Nasal Decongestants|nasal decongestants|mesh-ancestor
25339350|NCT04089072|Respiratory System Agents|respiratory system agents|mesh-ancestor
25339351|NCT04089072|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25339352|NCT04089072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25339353|NCT04089072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25339354|NCT04089072|Adrenergic Agents|adrenergic agents|mesh-ancestor
25339661|NCT03810794|Cholinergic Agents|cholinergic agents|mesh-ancestor
25339449|NCT04023266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25339450|NCT04023266|Protective Agents|protective agents|mesh-ancestor
25339451|NCT04023266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25339452|NCT04023266|Antidotes|antidotes|mesh-ancestor
25339453|NCT03995628|Dexamethasone|dexamethasone|mesh-list
25339454|NCT03995628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25339455|NCT03995628|Antiemetics|antiemetics|mesh-ancestor
25339456|NCT03995628|Autonomic Agents|autonomic agents|mesh-ancestor
25339457|NCT03995628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25339458|NCT03995628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25339459|NCT03995628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25339460|NCT03995628|Glucocorticoids|glucocorticoids|mesh-ancestor
25339461|NCT03995628|Hormones|hormones|mesh-ancestor
25339462|NCT03995628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25339463|NCT03995628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25339464|NCT03995628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25339465|NCT03980184|Guanfacine|guanfacine|mesh-list
25339466|NCT03980184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25339467|NCT03980184|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25339468|NCT03980184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25339469|NCT03980184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25339470|NCT03980184|Adrenergic Agents|adrenergic agents|mesh-ancestor
25339471|NCT03980184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25339472|NCT03980184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25339473|NCT03980184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25339474|NCT03975829|Trametinib|trametinib|mesh-list
25339475|NCT03975829|Dabrafenib|dabrafenib|mesh-list
25339476|NCT03975829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25339477|NCT03975829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25339478|NCT03975829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25339479|NCT03975829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25339485|NCT03971643|Vilobelimab|vilobelimab|mesh-list
25339486|NCT03971643|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25339487|NCT03971643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25339488|NCT03971643|Immunologic Factors|immunologic factors|mesh-ancestor
25339489|NCT03971643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25339501|NCT03952091|Dexamethasone|dexamethasone|mesh-list
25339502|NCT03952091|Dexamethasone acetate|dexamethasone acetate|mesh-list
25339503|NCT03952091|Lenalidomide|lenalidomide|mesh-list
25339504|NCT03952091|BB 1101|bb 1101|mesh-list
25339505|NCT03952091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25339506|NCT03952091|Antiemetics|antiemetics|mesh-ancestor
25339507|NCT03952091|Autonomic Agents|autonomic agents|mesh-ancestor
25339508|NCT03952091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25339509|NCT03952091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25339520|NCT03952091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25339521|NCT03952091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25339522|NCT03952091|Growth Substances|growth substances|mesh-ancestor
25339523|NCT03952091|Growth Inhibitors|growth inhibitors|mesh-ancestor
25339535|NCT03913832|Sirolimus|sirolimus|mesh-list
25339536|NCT03913832|Paclitaxel|paclitaxel|mesh-list
25339537|NCT03913832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25339538|NCT03913832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25339544|NCT03913832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25339545|NCT03913832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25339547|NCT03913832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25339548|NCT03913832|Immunologic Factors|immunologic factors|mesh-ancestor
25339549|NCT03913832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25339561|NCT03908736|Picolinic acid|picolinic acid|mesh-list
25339562|NCT03908736|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25339563|NCT03908736|Chelating Agents|chelating agents|mesh-ancestor
25339564|NCT03908736|Sequestering Agents|sequestering agents|mesh-ancestor
25339565|NCT03908736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25339658|NCT03810794|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25339660|NCT03810794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25339801|NCT03708315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25339802|NCT03708315|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25339803|NCT03708315|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25339804|NCT03708315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25339805|NCT03708315|Adrenergic Agents|adrenergic agents|mesh-ancestor
25339806|NCT03708315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25339807|NCT03708315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25339927|NCT03544606|Natriuretic Agents|natriuretic agents|mesh-ancestor
25339928|NCT03544606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25339929|NCT03544606|Vasodilator Agents|vasodilator agents|mesh-ancestor
25339930|NCT03544606|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25339931|NCT03544606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25339932|NCT03544606|Vitamin B Complex|vitamin b complex|mesh-ancestor
25339933|NCT03544606|Vitamins|vitamins|mesh-ancestor
25339934|NCT03544606|Micronutrients|micronutrients|mesh-ancestor
25339951|NCT03502330|Nivolumab|nivolumab|mesh-list
25339952|NCT03502330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25339953|NCT03502330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25339954|NCT03502330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25339955|NCT03502330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25340005|NCT03397953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25340006|NCT03397953|Tubulin Modulators|tubulin modulators|mesh-ancestor
25340007|NCT03397953|Antimitotic Agents|antimitotic agents|mesh-ancestor
25340008|NCT03397953|Mitosis Modulators|mitosis modulators|mesh-ancestor
25340009|NCT03397953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25340010|NCT03395639|Heparin|heparin|mesh-list
25340011|NCT03395639|Enoxaparin|enoxaparin|mesh-list
25340012|NCT03395639|Warfarin|warfarin|mesh-list
25340013|NCT03395639|Edoxaban|edoxaban|mesh-list
25340014|NCT03395639|Anticoagulants|anticoagulants|mesh-ancestor
25340015|NCT03395639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25340016|NCT03395639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25340017|NCT03395639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25340018|NCT03395639|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25340019|NCT03395639|Antithrombins|antithrombins|mesh-ancestor
25340020|NCT03395639|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25340021|NCT03395639|Protease Inhibitors|protease inhibitors|mesh-ancestor
25340022|NCT03395639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25340041|NCT03390010|Misoprostol|misoprostol|mesh-list
25340045|NCT03390010|Abortifacient Agents|abortifacient agents|mesh-ancestor
25340046|NCT03390010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25340047|NCT03390010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25340048|NCT03390010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25340049|NCT03390010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25340065|NCT03381274|Osimertinib|osimertinib|mesh-list
25340066|NCT03381274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25340067|NCT03381274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25340068|NCT03381274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25340069|NCT03381274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25340078|NCT03334682|Doxycycline|doxycycline|mesh-list
25340079|NCT03334682|Spironolactone|spironolactone|mesh-list
25340080|NCT03334682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25340081|NCT03334682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25340082|NCT03334682|Antimalarials|antimalarials|mesh-ancestor
25340083|NCT03334682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25340084|NCT03334682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25340085|NCT03334682|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25340086|NCT03334682|Hormone Antagonists|hormone antagonists|mesh-ancestor
25340087|NCT03334682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25340088|NCT03334682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25340089|NCT03334682|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25340090|NCT03334682|Diuretics|diuretics|mesh-ancestor
25340091|NCT03334682|Natriuretic Agents|natriuretic agents|mesh-ancestor
25340336|NCT02970448|Alkylating Agents|alkylating agents|mesh-ancestor
25340337|NCT02970448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25340338|NCT02970448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25340339|NCT02961374|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25340340|NCT02961374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25340341|NCT02961374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25340342|NCT02961374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25340343|NCT02961374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25340608|NCT02642640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25340638|NCT02587247|Immunologic Factors|immunologic factors|mesh-ancestor
25340639|NCT02587247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25340640|NCT02575339|Sorafenib|sorafenib|mesh-list
25340641|NCT02575339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25340642|NCT02575339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25340643|NCT02575339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25340644|NCT02575339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25340696|NCT02521415|Analgesics|analgesics|mesh-list
25340697|NCT02521415|Sensory System Agents|sensory system agents|mesh-ancestor
25340698|NCT02521415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25340699|NCT02521415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25340700|NCT02521415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25340701|NCT02521415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25340702|NCT02521415|Anesthetics, General|anesthetics, general|mesh-ancestor
25340703|NCT02521415|Anesthetics|anesthetics|mesh-ancestor
25340704|NCT02521415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25340705|NCT02521415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25340706|NCT02521415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25340707|NCT02521415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25340708|NCT02521415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25340709|NCT02521415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25340710|NCT02521415|Narcotics|narcotics|mesh-ancestor
25340711|NCT02521415|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25340712|NCT02521415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25340713|NCT02521415|Antipyretics|antipyretics|mesh-ancestor
25340714|NCT02521415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25340715|NCT02521415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25340716|NCT02521415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25340717|NCT02521415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25340718|NCT02521415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25340768|NCT02494882|Hormones|hormones|mesh-ancestor
25340769|NCT02494882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25340770|NCT02494882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25340771|NCT02494882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25340772|NCT02494882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25340773|NCT02494882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25340774|NCT02494882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25341088|NCT02078141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25341090|NCT02066181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25341091|NCT02066181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25341092|NCT02066181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25341093|NCT02066181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25341118|NCT02041533|Gemcitabine|gemcitabine|mesh-list
25341119|NCT02041533|Paclitaxel|paclitaxel|mesh-list
25341120|NCT02041533|Carboplatin|carboplatin|mesh-list
25341121|NCT02041533|Nivolumab|nivolumab|mesh-list
25341122|NCT02041533|Pemetrexed|pemetrexed|mesh-list
25341123|NCT02041533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25341124|NCT02041533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25341125|NCT02041533|Tubulin Modulators|tubulin modulators|mesh-ancestor
25341126|NCT02041533|Antimitotic Agents|antimitotic agents|mesh-ancestor
25341127|NCT02041533|Mitosis Modulators|mitosis modulators|mesh-ancestor
25341128|NCT02041533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25341129|NCT02041533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25341130|NCT02041533|Antimetabolites|antimetabolites|mesh-ancestor
25341131|NCT02041533|Antiviral Agents|antiviral agents|mesh-ancestor
25341132|NCT02041533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25341155|NCT02037048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25341156|NCT02037048|Antimetabolites|antimetabolites|mesh-ancestor
25341157|NCT02037048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25341158|NCT02037048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25341159|NCT02037048|Immunologic Factors|immunologic factors|mesh-ancestor
25341160|NCT02037048|Antidotes|antidotes|mesh-ancestor
25341161|NCT02037048|Protective Agents|protective agents|mesh-ancestor
25341162|NCT02037048|Vitamin B Complex|vitamin b complex|mesh-ancestor
25341163|NCT02037048|Vitamins|vitamins|mesh-ancestor
25341164|NCT02037048|Micronutrients|micronutrients|mesh-ancestor
25341170|NCT01964560|Lacosamide|lacosamide|mesh-list
25341171|NCT01964560|Anticonvulsants|anticonvulsants|mesh-ancestor
25341172|NCT01964560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25341173|NCT01964560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25341174|NCT01964560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25341175|NCT01964560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25341176|NCT01963728|Insulin|insulin|mesh-list
25341177|NCT01963728|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25341178|NCT01963728|Insulin Glargine|insulin glargine|mesh-list
25341179|NCT01963728|Insulin, Isophane|insulin, isophane|mesh-list
25341180|NCT01963728|Isophane Insulin, Human|isophane insulin, human|mesh-list
25341181|NCT01963728|Isophane insulin, beef|isophane insulin, beef|mesh-list
25341182|NCT01963728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25341183|NCT01963728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25341313|NCT01852890|Immunologic Factors|immunologic factors|mesh-ancestor
25341314|NCT01852890|Antioxidants|antioxidants|mesh-ancestor
25341315|NCT01852890|Protective Agents|protective agents|mesh-ancestor
25341405|NCT01752491|Micronutrients|micronutrients|mesh-ancestor
25341406|NCT01752491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25341407|NCT01752491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25341408|NCT01752491|Alkylating Agents|alkylating agents|mesh-ancestor
25341409|NCT01752491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25341410|NCT01752491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25341411|NCT01752491|Antioxidants|antioxidants|mesh-ancestor
25341412|NCT01752491|Protective Agents|protective agents|mesh-ancestor
25341414|NCT01730638|Glycine|glycine|mesh-list
25341415|NCT01730638|Histamine Agonists|histamine agonists|mesh-ancestor
25341416|NCT01730638|Histamine Agents|histamine agents|mesh-ancestor
25341417|NCT01730638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25341418|NCT01730638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25341419|NCT01730638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25341420|NCT01730638|Glycine Agents|glycine agents|mesh-ancestor
25341534|NCT01467466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25341536|NCT01463072|Paclitaxel|paclitaxel|mesh-list
25341537|NCT01463072|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25341538|NCT01463072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25341539|NCT01463072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25341540|NCT01463072|Tubulin Modulators|tubulin modulators|mesh-ancestor
25341541|NCT01463072|Antimitotic Agents|antimitotic agents|mesh-ancestor
25341542|NCT01463072|Mitosis Modulators|mitosis modulators|mesh-ancestor
25341543|NCT01463072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25341643|NCT01318317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25341644|NCT01318317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25341645|NCT01318317|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25341646|NCT01318317|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25341647|NCT01318317|Antiviral Agents|antiviral agents|mesh-ancestor
25341648|NCT01318317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25341963|NCT01121224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25341964|NCT01121224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25342476|NCT00476190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25342477|NCT00476190|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25342478|NCT00476190|Alkylating Agents|alkylating agents|mesh-ancestor
25342479|NCT00476190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25342480|NCT00476190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25342481|NCT00476190|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25342482|NCT00476190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25342484|NCT00476190|Autonomic Agents|autonomic agents|mesh-ancestor
25342485|NCT00476190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25342486|NCT00476190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25342487|NCT00476190|Glucocorticoids|glucocorticoids|mesh-ancestor
25342488|NCT00476190|Hormones|hormones|mesh-ancestor
25342489|NCT00476190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25342490|NCT00476190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25342491|NCT00476190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25342492|NCT00476190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25342493|NCT00476190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25342494|NCT00476190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25342495|NCT00476190|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25342496|NCT00476190|Abortifacient Agents|abortifacient agents|mesh-ancestor
25342497|NCT00476190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25342498|NCT00476190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25342499|NCT00476190|Antimetabolites|antimetabolites|mesh-ancestor
25342500|NCT00476190|Dermatologic Agents|dermatologic agents|mesh-ancestor
25342501|NCT00476190|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25342502|NCT00476190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25342503|NCT00476190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25342504|NCT00476190|Antiviral Agents|antiviral agents|mesh-ancestor
25342505|NCT00476190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25342506|NCT00476190|Tubulin Modulators|tubulin modulators|mesh-ancestor
25342507|NCT00476190|Antimitotic Agents|antimitotic agents|mesh-ancestor
25342508|NCT00476190|Mitosis Modulators|mitosis modulators|mesh-ancestor
25342724|NCT05558449|Midazolam|midazolam|mesh-list
25342725|NCT05558449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25342726|NCT05558449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25342727|NCT05558449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25342728|NCT05558449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25342729|NCT05558449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25342730|NCT05558449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25342731|NCT05558449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25342732|NCT05558449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25342733|NCT05558449|Anesthetics, General|anesthetics, general|mesh-ancestor
25342734|NCT05558449|Anesthetics|anesthetics|mesh-ancestor
25342735|NCT05558449|GABA Modulators|gaba modulators|mesh-ancestor
25342736|NCT05558449|GABA Agents|gaba agents|mesh-ancestor
25342737|NCT05558449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25342738|NCT05558449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25342739|NCT05558410|Acetaminophen|acetaminophen|mesh-list
25342740|NCT05558410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25342741|NCT05558410|Analgesics|analgesics|mesh-ancestor
25342742|NCT05558410|Sensory System Agents|sensory system agents|mesh-ancestor
25342743|NCT05558410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25342744|NCT05558410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25342745|NCT05558410|Antipyretics|antipyretics|mesh-ancestor
25342746|NCT05558397|Morphine|morphine|mesh-list
25342747|NCT05558397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25342748|NCT05558397|Narcotics|narcotics|mesh-ancestor
25342749|NCT05558397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25342750|NCT05558397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25342751|NCT05558397|Analgesics|analgesics|mesh-ancestor
25342752|NCT05558397|Sensory System Agents|sensory system agents|mesh-ancestor
25342753|NCT05558397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25342754|NCT05558319|Dexamethasone|dexamethasone|mesh-list
25342755|NCT05558319|Lenalidomide|lenalidomide|mesh-list
25342756|NCT05558319|Bortezomib|bortezomib|mesh-list
25342757|NCT05558319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25342758|NCT05558319|Antiemetics|antiemetics|mesh-ancestor
25342759|NCT05558319|Autonomic Agents|autonomic agents|mesh-ancestor
25342760|NCT05558319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25342766|NCT05558319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25342767|NCT05558319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25342768|NCT05558319|Immunologic Factors|immunologic factors|mesh-ancestor
25342769|NCT05558319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25342770|NCT05558319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25342771|NCT05558319|Growth Substances|growth substances|mesh-ancestor
25342772|NCT05558319|Growth Inhibitors|growth inhibitors|mesh-ancestor
25342773|NCT05558280|Dinutuximab|dinutuximab|mesh-list
25342774|NCT05558280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25342775|NCT05558176|Sildenafil Citrate|sildenafil citrate|mesh-list
25342776|NCT05558176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25342777|NCT05558176|Vasodilator Agents|vasodilator agents|mesh-ancestor
25342778|NCT05558176|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25342779|NCT05558176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25342780|NCT05558176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25342781|NCT05558176|Urological Agents|urological agents|mesh-ancestor
25342782|NCT05558150|Aceclofenac|aceclofenac|mesh-list
25342783|NCT05558150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25342784|NCT05558150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25342785|NCT05558150|Analgesics|analgesics|mesh-ancestor
25342786|NCT05558150|Sensory System Agents|sensory system agents|mesh-ancestor
25342787|NCT05558150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25342788|NCT05558150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25342789|NCT05558150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25342790|NCT05558150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25342797|NCT05558124|Cytarabine|cytarabine|mesh-list
25342798|NCT05558124|Daunorubicin|daunorubicin|mesh-list
25342799|NCT05558124|Gemtuzumab|gemtuzumab|mesh-list
25342800|NCT05558124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25342801|NCT05558124|Antimetabolites|antimetabolites|mesh-ancestor
25342802|NCT05558124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25342803|NCT05558124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25342804|NCT05558124|Antiviral Agents|antiviral agents|mesh-ancestor
25342805|NCT05558124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25342806|NCT05558124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25342807|NCT05558124|Immunologic Factors|immunologic factors|mesh-ancestor
25342808|NCT05558124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25342809|NCT05558124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25342810|NCT05558124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25342811|NCT05558124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25342812|NCT05558124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25342813|NCT05558124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25342814|NCT05558098|Dapagliflozin|dapagliflozin|mesh-list
25342815|NCT05558098|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25342816|NCT05558098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25342817|NCT05558098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25342818|NCT05558098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25342819|NCT05558007|Tadalafil|tadalafil|mesh-list
25342820|NCT05558007|Vasodilator Agents|vasodilator agents|mesh-ancestor
25342821|NCT05558007|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25342822|NCT05558007|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25342823|NCT05558007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25342824|NCT05558007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25342825|NCT05558007|Urological Agents|urological agents|mesh-ancestor
25342826|NCT05557903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25342827|NCT05557903|Alemtuzumab|alemtuzumab|mesh-list
25342828|NCT05557903|Antibodies|antibodies|mesh-list
25342829|NCT05557903|Immunoglobulins|immunoglobulins|mesh-list
25342830|NCT05557903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25342831|NCT05557903|Immunologic Factors|immunologic factors|mesh-ancestor
25342832|NCT05557903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25342833|NCT05557903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25342834|NCT05557877|Aspirin|aspirin|mesh-list
25342835|NCT05557877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25342836|NCT05557877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25342837|NCT05557877|Analgesics|analgesics|mesh-ancestor
25342838|NCT05557877|Sensory System Agents|sensory system agents|mesh-ancestor
25342839|NCT05557877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25343069|NCT05556083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25342840|NCT05557877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25342841|NCT05557877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25342842|NCT05557877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25342843|NCT05557877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25342844|NCT05557877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25342845|NCT05557877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25342846|NCT05557877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25342847|NCT05557877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25342848|NCT05557877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25342849|NCT05557877|Antipyretics|antipyretics|mesh-ancestor
25342850|NCT05557851|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
25342851|NCT05557851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25342852|NCT05557851|Alkylating Agents|alkylating agents|mesh-ancestor
25342853|NCT05557851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25342854|NCT05557851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25342855|NCT05557838|Durvalumab|durvalumab|mesh-list
25342856|NCT05557838|Tremelimumab|tremelimumab|mesh-list
25342857|NCT05557838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25342858|NCT05557838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25342859|NCT05557812|Eugenol|eugenol|mesh-list
25342860|NCT05557812|Zinc Oxide|zinc oxide|mesh-list
25342861|NCT05557812|Ferric Compounds|ferric compounds|mesh-list
25342862|NCT05557812|Dermatologic Agents|dermatologic agents|mesh-ancestor
25342863|NCT05557812|Sunscreening Agents|sunscreening agents|mesh-ancestor
25342864|NCT05557812|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25342865|NCT05557812|Protective Agents|protective agents|mesh-ancestor
25342866|NCT05557812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25342867|NCT05557812|Hematinics|hematinics|mesh-ancestor
25342868|NCT05557812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25342869|NCT05557721|Lidocaine|lidocaine|mesh-list
25342870|NCT05557721|Anesthetics, Local|anesthetics, local|mesh-ancestor
25342871|NCT05557721|Anesthetics|anesthetics|mesh-ancestor
25342872|NCT05557721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25342873|NCT05557721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25342874|NCT05557721|Sensory System Agents|sensory system agents|mesh-ancestor
25342875|NCT05557721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25342876|NCT05557721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25342877|NCT05557721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25342878|NCT05557721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25342879|NCT05557721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25342880|NCT05557721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25342881|NCT05557695|Acalabrutinib|acalabrutinib|mesh-list
25342882|NCT05557695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25342883|NCT05557643|Psilocybin|psilocybin|mesh-list
25342884|NCT05557643|Hallucinogens|hallucinogens|mesh-ancestor
25342885|NCT05557643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25342886|NCT05557643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25342887|NCT05557604|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25342888|NCT05557604|Luteolytic Agents|luteolytic agents|mesh-ancestor
25342889|NCT05557604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25342890|NCT05557604|Contraceptive Agents|contraceptive agents|mesh-ancestor
25342891|NCT05557604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25342892|NCT05557604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25342893|NCT05557604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25342894|NCT05557604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25342895|NCT05557604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25342896|NCT05557591|Cemiplimab|cemiplimab|mesh-list
25342897|NCT05557591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25342898|NCT05557591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25342899|NCT05557578|Gemcitabine|gemcitabine|mesh-list
25342900|NCT05557578|Oxaliplatin|oxaliplatin|mesh-list
25342901|NCT05557578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25342902|NCT05557578|Antimetabolites|antimetabolites|mesh-ancestor
25342903|NCT05557578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25342904|NCT05557578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25342905|NCT05557578|Antiviral Agents|antiviral agents|mesh-ancestor
25342906|NCT05557578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25342907|NCT05557578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25342908|NCT05557578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25342909|NCT05557578|Immunologic Factors|immunologic factors|mesh-ancestor
25342910|NCT05557578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25342911|NCT05557344|Acetaminophen|acetaminophen|mesh-list
25342912|NCT05557344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25342913|NCT05557344|Analgesics|analgesics|mesh-ancestor
25342914|NCT05557344|Sensory System Agents|sensory system agents|mesh-ancestor
25342915|NCT05557344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25342916|NCT05557344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25342917|NCT05557344|Antipyretics|antipyretics|mesh-ancestor
25342918|NCT05557253|Anesthetics|anesthetics|mesh-list
25342919|NCT05557253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25342920|NCT05557253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25342921|NCT05557240|Poly I-C|poly i-c|mesh-list
25342922|NCT05557240|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25342923|NCT05557240|Vaccines|vaccines|mesh-list
25342924|NCT05557240|Poly ICLC|poly iclc|mesh-list
25342925|NCT05557240|Immunologic Factors|immunologic factors|mesh-ancestor
25342926|NCT05557240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25342927|NCT05557240|Interferon Inducers|interferon inducers|mesh-ancestor
25342928|NCT05557240|Laxatives|laxatives|mesh-ancestor
25342929|NCT05557240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25342930|NCT05557240|Antiviral Agents|antiviral agents|mesh-ancestor
25342931|NCT05557240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25342932|NCT05557149|Cocaine|cocaine|mesh-list
25342933|NCT05557149|Anesthetics, Local|anesthetics, local|mesh-ancestor
25342934|NCT05557149|Anesthetics|anesthetics|mesh-ancestor
25342935|NCT05557149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25342936|NCT05557149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25342937|NCT05557149|Sensory System Agents|sensory system agents|mesh-ancestor
25342938|NCT05557149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25342939|NCT05557149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25342940|NCT05557149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25342941|NCT05557149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25342942|NCT05557149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25342943|NCT05557149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25342944|NCT05557149|Dopamine Agents|dopamine agents|mesh-ancestor
25342945|NCT05557149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25342947|NCT05557136|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25342948|NCT05557136|Anesthetics, General|anesthetics, general|mesh-ancestor
25342949|NCT05557136|Anesthetics|anesthetics|mesh-ancestor
25342950|NCT05557136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25342951|NCT05557136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25342952|NCT05557110|Blinatumomab|blinatumomab|mesh-list
25342953|NCT05557110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25342954|NCT05556889|Iodine|iodine|mesh-list
25342955|NCT05556889|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25342956|NCT05556889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25342957|NCT05556889|Trace Elements|trace elements|mesh-ancestor
25342958|NCT05556889|Micronutrients|micronutrients|mesh-ancestor
25342959|NCT05556889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25342960|NCT05556746|Rifampin|rifampin|mesh-list
25342961|NCT05556746|Clofazimine|clofazimine|mesh-list
25342962|NCT05556746|Isoniazid|isoniazid|mesh-list
25342963|NCT05556746|Pyrazinamide|pyrazinamide|mesh-list
25342964|NCT05556746|Ethambutol|ethambutol|mesh-list
25342965|NCT05556746|Bedaquiline|bedaquiline|mesh-list
25342966|NCT05556746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25342967|NCT05556746|Antitubercular Agents|antitubercular agents|mesh-ancestor
25342968|NCT05556746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25342969|NCT05556746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25342970|NCT05556746|Leprostatic Agents|leprostatic agents|mesh-ancestor
25342971|NCT05556746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25342972|NCT05556746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25342973|NCT05556746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25342974|NCT05556746|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25342975|NCT05556746|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25342976|NCT05556746|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25342977|NCT05556746|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25342978|NCT05556746|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25342979|NCT05556746|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25342980|NCT05556746|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25342981|NCT05556746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25342982|NCT05556746|Antimetabolites|antimetabolites|mesh-ancestor
25342983|NCT05556746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25342984|NCT05556746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25342985|NCT05556720|Vaccines|vaccines|mesh-list
25342986|NCT05556720|Immunologic Factors|immunologic factors|mesh-ancestor
25342994|NCT05556681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25342995|NCT05556681|Immunologic Factors|immunologic factors|mesh-ancestor
25342996|NCT05556681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25342997|NCT05556616|Lenalidomide|lenalidomide|mesh-list
25342998|NCT05556616|Pomalidomide|pomalidomide|mesh-list
25342999|NCT05556616|Bortezomib|bortezomib|mesh-list
25343005|NCT05556616|Growth Substances|growth substances|mesh-ancestor
25343006|NCT05556616|Growth Inhibitors|growth inhibitors|mesh-ancestor
25343007|NCT05556616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25343008|NCT05556512|Tirzepatide|tirzepatide|mesh-list
25343009|NCT05556512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25343010|NCT05556512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343011|NCT05556512|Incretins|incretins|mesh-ancestor
25343012|NCT05556512|Hormones|hormones|mesh-ancestor
25343013|NCT05556512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25343014|NCT05556473|Tryptophan|tryptophan|mesh-list
25343015|NCT05556473|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25343016|NCT05556473|Antidepressive Agents|antidepressive agents|mesh-ancestor
25343017|NCT05556473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25343018|NCT05556408|Propofol|propofol|mesh-list
25343019|NCT05556408|Succinylcholine|succinylcholine|mesh-list
25343020|NCT05556408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25343021|NCT05556408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25343022|NCT05556408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343023|NCT05556408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25343024|NCT05556408|Anesthetics, General|anesthetics, general|mesh-ancestor
25343025|NCT05556408|Anesthetics|anesthetics|mesh-ancestor
25343026|NCT05556408|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
25343027|NCT05556408|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25343028|NCT05556408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25343029|NCT05556408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25343042|NCT05556200|Apatinib|apatinib|mesh-list
25343043|NCT05556200|Antibodies|antibodies|mesh-list
25343044|NCT05556200|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25343045|NCT05556200|Immunologic Factors|immunologic factors|mesh-ancestor
25343046|NCT05556200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343047|NCT05556200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25343048|NCT05556200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25343049|NCT05556200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25343050|NCT05556200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343051|NCT05556122|Betamethasone|betamethasone|mesh-list
25343052|NCT05556122|Ropivacaine|ropivacaine|mesh-list
25343053|NCT05556122|Anesthetics, Local|anesthetics, local|mesh-ancestor
25343054|NCT05556122|Anesthetics|anesthetics|mesh-ancestor
25343055|NCT05556122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25343056|NCT05556122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343057|NCT05556122|Sensory System Agents|sensory system agents|mesh-ancestor
25343058|NCT05556122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25343059|NCT05556122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25343060|NCT05556122|Glucocorticoids|glucocorticoids|mesh-ancestor
25343061|NCT05556122|Hormones|hormones|mesh-ancestor
25343062|NCT05556122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25343063|NCT05556122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25343064|NCT05556122|Respiratory System Agents|respiratory system agents|mesh-ancestor
25343065|NCT05556083|Sildenafil Citrate|sildenafil citrate|mesh-list
25343066|NCT05556083|Vasodilator Agents|vasodilator agents|mesh-ancestor
25343067|NCT05556083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25343068|NCT05556083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25343070|NCT05556083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343071|NCT05556083|Urological Agents|urological agents|mesh-ancestor
25343072|NCT05556044|Empagliflozin|empagliflozin|mesh-list
25343073|NCT05556044|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25343094|NCT05555888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343095|NCT05555888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25343096|NCT05555862|Artesunate|artesunate|mesh-list
25343097|NCT05555862|Artenimol|artenimol|mesh-list
25343098|NCT05555862|Artemisinins|artemisinins|mesh-list
25343099|NCT05555862|Artemisinin|artemisinin|mesh-list
25343100|NCT05555862|Antimalarials|antimalarials|mesh-ancestor
25343101|NCT05555862|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25343102|NCT05555862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25343103|NCT05555862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25343104|NCT05555862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25343105|NCT05555862|Antiviral Agents|antiviral agents|mesh-ancestor
25343106|NCT05555862|Schistosomicides|schistosomicides|mesh-ancestor
25343107|NCT05555862|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25343108|NCT05555862|Anthelmintics|anthelmintics|mesh-ancestor
25343109|NCT05555823|Repaglinide|repaglinide|mesh-list
25343110|NCT05555823|Celecoxib|celecoxib|mesh-list
25343111|NCT05555823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25343112|NCT05555823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25343113|NCT05555823|Analgesics|analgesics|mesh-ancestor
25343114|NCT05555823|Sensory System Agents|sensory system agents|mesh-ancestor
25343115|NCT05555823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25343116|NCT05555823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343117|NCT05555823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25343118|NCT05555823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25343119|NCT05555823|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25343120|NCT05555823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25343121|NCT05555823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25343122|NCT05555823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343123|NCT05555823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25343124|NCT05555797|Betamethasone|betamethasone|mesh-list
25343125|NCT05555797|Betamethasone Valerate|betamethasone valerate|mesh-list
25343126|NCT05555797|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25343127|NCT05555797|Betamethasone benzoate|betamethasone benzoate|mesh-list
25343128|NCT05555797|Tazarotene|tazarotene|mesh-list
25343129|NCT05555797|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25343130|NCT05555797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25343131|NCT05555797|Glucocorticoids|glucocorticoids|mesh-ancestor
25343132|NCT05555797|Hormones|hormones|mesh-ancestor
25343133|NCT05555797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25343134|NCT05555797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343135|NCT05555797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25343136|NCT05555797|Respiratory System Agents|respiratory system agents|mesh-ancestor
25343137|NCT05555797|Dermatologic Agents|dermatologic agents|mesh-ancestor
25343138|NCT05555797|Keratolytic Agents|keratolytic agents|mesh-ancestor
25343139|NCT05555732|Cisplatin|cisplatin|mesh-list
25343140|NCT05555732|Carboplatin|carboplatin|mesh-list
25343141|NCT05555732|Pembrolizumab|pembrolizumab|mesh-list
25343142|NCT05555732|Pemetrexed|pemetrexed|mesh-list
25343143|NCT05555732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25343144|NCT05555732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25343145|NCT05555732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25343146|NCT05555732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343147|NCT05555732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25343148|NCT05555732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25343167|NCT05555641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25343168|NCT05555641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25343169|NCT05555641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343170|NCT05555641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25343171|NCT05555641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25343172|NCT05555641|Analgesics|analgesics|mesh-ancestor
25343173|NCT05555641|Sensory System Agents|sensory system agents|mesh-ancestor
25343174|NCT05555641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25343175|NCT05555641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343176|NCT05555641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25343177|NCT05555641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25343178|NCT05555641|Protease Inhibitors|protease inhibitors|mesh-ancestor
25343179|NCT05555641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25343180|NCT05555641|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25343181|NCT05555641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25343182|NCT05555641|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25343183|NCT05555641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25343184|NCT05555641|Immunologic Factors|immunologic factors|mesh-ancestor
25343185|NCT05555628|Salicylic Acid|salicylic acid|mesh-list
25343186|NCT05555628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25343187|NCT05555628|Antifungal Agents|antifungal agents|mesh-ancestor
25343188|NCT05555628|Keratolytic Agents|keratolytic agents|mesh-ancestor
25343189|NCT05555628|Dermatologic Agents|dermatologic agents|mesh-ancestor
25343190|NCT05555615|Pimavanserin|pimavanserin|mesh-list
25343191|NCT05555615|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25343192|NCT05555615|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25343193|NCT05555615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25343194|NCT05555615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25343195|NCT05555615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25343196|NCT05555615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343197|NCT05555615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25343198|NCT05555615|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25343199|NCT05555615|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25343200|NCT05555615|Serotonin Agents|serotonin agents|mesh-ancestor
25343201|NCT05555615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25343202|NCT05555615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343203|NCT05555576|Ascorbic Acid|ascorbic acid|mesh-list
25343204|NCT05555576|Vitamins|vitamins|mesh-ancestor
25343205|NCT05555576|Micronutrients|micronutrients|mesh-ancestor
25343206|NCT05555576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343207|NCT05555576|Antioxidants|antioxidants|mesh-ancestor
25343208|NCT05555576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343209|NCT05555576|Protective Agents|protective agents|mesh-ancestor
25343223|NCT05555316|Lenvatinib|lenvatinib|mesh-list
25343224|NCT05555316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25343225|NCT05555316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25343226|NCT05555316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25343227|NCT05555316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343228|NCT05555303|Amikacin|amikacin|mesh-list
25343229|NCT05555303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25343230|NCT05555303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25343231|NCT05555251|Trastuzumab|trastuzumab|mesh-list
25343232|NCT05555251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25343233|NCT05555251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25343234|NCT05555147|Ropivacaine|ropivacaine|mesh-list
25343235|NCT05555147|Anesthetics, Local|anesthetics, local|mesh-ancestor
25343236|NCT05555147|Anesthetics|anesthetics|mesh-ancestor
25343237|NCT05555147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25343238|NCT05555147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343239|NCT05555147|Sensory System Agents|sensory system agents|mesh-ancestor
25343240|NCT05555147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25343241|NCT05555121|Progesterone|progesterone|mesh-list
25343242|NCT05555121|Progestins|progestins|mesh-ancestor
25343243|NCT05555121|Hormones|hormones|mesh-ancestor
25343244|NCT05555121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25343245|NCT05555121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343246|NCT05555069|Menthol|menthol|mesh-list
25343247|NCT05555069|Antipruritics|antipruritics|mesh-ancestor
25343248|NCT05555069|Dermatologic Agents|dermatologic agents|mesh-ancestor
25343249|NCT05554978|Landiolol|landiolol|mesh-list
25343250|NCT05554978|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25343251|NCT05554978|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25343252|NCT05554978|Adrenergic Agents|adrenergic agents|mesh-ancestor
25343253|NCT05554978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25343254|NCT05554978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343255|NCT05554978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343256|NCT05554978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25343257|NCT05554965|Propofol|propofol|mesh-list
25343258|NCT05554965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25343259|NCT05554965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25343260|NCT05554965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343261|NCT05554965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25343262|NCT05554965|Anesthetics, General|anesthetics, general|mesh-ancestor
25343263|NCT05554965|Anesthetics|anesthetics|mesh-ancestor
25343264|NCT05554939|Vidarabine|vidarabine|mesh-list
25343265|NCT05554939|Cyclophosphamide|cyclophosphamide|mesh-list
25343266|NCT05554939|Fludarabine|fludarabine|mesh-list
25343267|NCT05554939|Fludarabine phosphate|fludarabine phosphate|mesh-list
25343268|NCT05554939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25343269|NCT05554939|Immunologic Factors|immunologic factors|mesh-ancestor
25343270|NCT05554939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343271|NCT05554939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25343272|NCT05554939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25343273|NCT05554939|Alkylating Agents|alkylating agents|mesh-ancestor
25343274|NCT05554939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343275|NCT05554939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25343276|NCT05554939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25343277|NCT05554939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25343279|NCT05554939|Antiviral Agents|antiviral agents|mesh-ancestor
25343280|NCT05554939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25343281|NCT05554848|Magnesium Sulfate|magnesium sulfate|mesh-list
25343282|NCT05554848|Dexmedetomidine|dexmedetomidine|mesh-list
25343283|NCT05554848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25343284|NCT05554848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25343285|NCT05554848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343286|NCT05554848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25343287|NCT05554848|Analgesics|analgesics|mesh-ancestor
25343288|NCT05554848|Sensory System Agents|sensory system agents|mesh-ancestor
25343289|NCT05554848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25343290|NCT05554848|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25343291|NCT05554848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25343292|NCT05554848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25343293|NCT05554848|Adrenergic Agents|adrenergic agents|mesh-ancestor
25415997|NCT02978625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25343294|NCT05554848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25416020|NCT02975882|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25343295|NCT05554848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343296|NCT05554848|Anesthetics|anesthetics|mesh-ancestor
25343297|NCT05554848|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25343298|NCT05554848|Anticonvulsants|anticonvulsants|mesh-ancestor
25343299|NCT05554848|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25343300|NCT05554848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25343301|NCT05554848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25343302|NCT05554848|Tocolytic Agents|tocolytic agents|mesh-ancestor
25343303|NCT05554848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25343304|NCT05554822|Aspirin|aspirin|mesh-list
25343305|NCT05554822|Clopidogrel|clopidogrel|mesh-list
25343306|NCT05554822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25343307|NCT05554822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25343308|NCT05554822|Analgesics|analgesics|mesh-ancestor
25343309|NCT05554822|Sensory System Agents|sensory system agents|mesh-ancestor
25343310|NCT05554822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25343311|NCT05554822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343312|NCT05554822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25343313|NCT05554822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25343314|NCT05554822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25343315|NCT05554822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25343316|NCT05554822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343317|NCT05554822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25343318|NCT05554822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25343319|NCT05554822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25343320|NCT05554822|Antipyretics|antipyretics|mesh-ancestor
25343321|NCT05554822|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25343322|NCT05554822|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25343323|NCT05554822|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25343324|NCT05554822|Purinergic Agents|purinergic agents|mesh-ancestor
25343325|NCT05554822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25343326|NCT05554731|Hemostatics|hemostatics|mesh-list
25343327|NCT05554731|Coagulants|coagulants|mesh-ancestor
25343328|NCT05554679|Metformin|metformin|mesh-list
25343329|NCT05554679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25343330|NCT05554679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343331|NCT05554627|Aripiprazole|aripiprazole|mesh-list
25343332|NCT05554627|Esketamine|esketamine|mesh-list
25343333|NCT05554627|Antidepressive Agents|antidepressive agents|mesh-ancestor
25343334|NCT05554627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25343335|NCT05554627|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25343336|NCT05554627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25343337|NCT05554627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25343338|NCT05554627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343339|NCT05554627|Dopamine Agonists|dopamine agonists|mesh-ancestor
25343340|NCT05554627|Dopamine Agents|dopamine agents|mesh-ancestor
25343341|NCT05554627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25343342|NCT05554627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343343|NCT05554627|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25343344|NCT05554627|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25343345|NCT05554627|Serotonin Agents|serotonin agents|mesh-ancestor
25343346|NCT05554627|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25343347|NCT05554627|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25343348|NCT05554627|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25343349|NCT05554627|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25343436|NCT05554276|Immunologic Factors|immunologic factors|mesh-ancestor
25343437|NCT05554276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343438|NCT05554237|Ceftibuten|ceftibuten|mesh-list
25343439|NCT05554237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25343440|NCT05554237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25343441|NCT05554224|Liver Extracts|liver extracts|mesh-list
25343442|NCT05554224|Hematinics|hematinics|mesh-ancestor
25343443|NCT05554211|Tranexamic Acid|tranexamic acid|mesh-list
25343444|NCT05554211|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25343445|NCT05554211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25343446|NCT05554211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343447|NCT05554211|Hemostatics|hemostatics|mesh-ancestor
25343448|NCT05554211|Coagulants|coagulants|mesh-ancestor
25343449|NCT05554185|Aspirin|aspirin|mesh-list
25343677|NCT05553184|Vasodilator Agents|vasodilator agents|mesh-ancestor
25343450|NCT05554185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25343451|NCT05554185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25343452|NCT05554185|Analgesics|analgesics|mesh-ancestor
25343453|NCT05554185|Sensory System Agents|sensory system agents|mesh-ancestor
25343454|NCT05554185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25343455|NCT05554185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343456|NCT05554185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25343457|NCT05554185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25343458|NCT05554185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25343459|NCT05554185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25343460|NCT05554185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343461|NCT05554185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25343462|NCT05554185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25343463|NCT05554185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25343465|NCT05554133|Proflavine|proflavine|mesh-list
25343466|NCT05554133|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25343467|NCT05554133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25343468|NCT05554094|Psilocybin|psilocybin|mesh-list
25343469|NCT05554094|Hallucinogens|hallucinogens|mesh-ancestor
25343470|NCT05554094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343471|NCT05554094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25343472|NCT05554055|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25343473|NCT05554055|Dalteparin|dalteparin|mesh-list
25343474|NCT05554055|Anticoagulants|anticoagulants|mesh-ancestor
25343475|NCT05554055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25343476|NCT05554055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25343477|NCT05554055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343478|NCT05554003|Temozolomide|temozolomide|mesh-list
25343479|NCT05554003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25343480|NCT05554003|Alkylating Agents|alkylating agents|mesh-ancestor
25343481|NCT05554003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343482|NCT05554003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25343483|NCT05553938|Empagliflozin|empagliflozin|mesh-list
25343484|NCT05553938|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25343485|NCT05553938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343486|NCT05553938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25343487|NCT05553938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343488|NCT05553834|Cemiplimab|cemiplimab|mesh-list
25343489|NCT05553834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25343490|NCT05553834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25343491|NCT05553808|Docetaxel|docetaxel|mesh-list
25343492|NCT05553808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25343493|NCT05553808|Tubulin Modulators|tubulin modulators|mesh-ancestor
25343494|NCT05553808|Antimitotic Agents|antimitotic agents|mesh-ancestor
25343495|NCT05553808|Mitosis Modulators|mitosis modulators|mesh-ancestor
25343496|NCT05553808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343497|NCT05553743|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25343498|NCT05553743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25343499|NCT05553717|Carvedilol|carvedilol|mesh-list
25343500|NCT05553717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25343501|NCT05553717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25343502|NCT05553717|Adrenergic Agents|adrenergic agents|mesh-ancestor
25343503|NCT05553717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25343504|NCT05553717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343505|NCT05553717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343506|NCT05553717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25343507|NCT05553717|Antioxidants|antioxidants|mesh-ancestor
25343508|NCT05553717|Protective Agents|protective agents|mesh-ancestor
25343509|NCT05553717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25343510|NCT05553717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25343511|NCT05553717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25343512|NCT05553717|Vasodilator Agents|vasodilator agents|mesh-ancestor
25343513|NCT05553717|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25343514|NCT05553717|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25343515|NCT05553704|Metformin|metformin|mesh-list
25343516|NCT05553704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25343517|NCT05553704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343518|NCT05553691|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
25343519|NCT05553691|Hallucinogens|hallucinogens|mesh-ancestor
25343520|NCT05553691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343521|NCT05553691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25343522|NCT05553691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25343523|NCT05553691|Serotonin Agents|serotonin agents|mesh-ancestor
25343524|NCT05553691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25343525|NCT05553691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343526|NCT05553691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25343527|NCT05553678|Midazolam|midazolam|mesh-list
25343528|NCT05553678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25343529|NCT05553678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25343530|NCT05553678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25343531|NCT05553678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343532|NCT05553678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25343533|NCT05553678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25343534|NCT05553678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25343535|NCT05553678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25343536|NCT05553678|Anesthetics, General|anesthetics, general|mesh-ancestor
25343537|NCT05553678|Anesthetics|anesthetics|mesh-ancestor
25343538|NCT05553678|GABA Modulators|gaba modulators|mesh-ancestor
25343539|NCT05553678|GABA Agents|gaba agents|mesh-ancestor
25343540|NCT05553678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25343541|NCT05553678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343542|NCT05553665|Lidocaine|lidocaine|mesh-list
25343543|NCT05553665|Fentanyl|fentanyl|mesh-list
25343544|NCT05553665|Midazolam|midazolam|mesh-list
25343545|NCT05553665|Complement System Proteins|complement system proteins|mesh-list
25343546|NCT05553665|Complement C4|complement c4|mesh-list
25343547|NCT05553665|Anesthetics, Local|anesthetics, local|mesh-ancestor
25343548|NCT05553665|Anesthetics|anesthetics|mesh-ancestor
25343549|NCT05553665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25343550|NCT05553665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343551|NCT05553665|Sensory System Agents|sensory system agents|mesh-ancestor
25343552|NCT05553665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25343553|NCT05553665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25343554|NCT05553665|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25343555|NCT05553665|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25343556|NCT05553665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25343557|NCT05553665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343558|NCT05553665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25343559|NCT05553665|Narcotics|narcotics|mesh-ancestor
25343560|NCT05553665|Analgesics|analgesics|mesh-ancestor
25343561|NCT05553665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25343562|NCT05553665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25343563|NCT05553665|Anesthetics, General|anesthetics, general|mesh-ancestor
25343564|NCT05553665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25343565|NCT05553665|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25343566|NCT05553665|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25343567|NCT05553665|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25343568|NCT05553665|GABA Modulators|gaba modulators|mesh-ancestor
25343569|NCT05553665|GABA Agents|gaba agents|mesh-ancestor
25343570|NCT05553665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25343571|NCT05553665|Immunologic Factors|immunologic factors|mesh-ancestor
25343572|NCT05553613|Clopidogrel|clopidogrel|mesh-list
25343573|NCT05553613|Ticagrelor|ticagrelor|mesh-list
25343574|NCT05553613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25343575|NCT05553613|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25343576|NCT05553613|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25343577|NCT05553613|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25343578|NCT05553613|Purinergic Agents|purinergic agents|mesh-ancestor
25343579|NCT05553613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25343580|NCT05553613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343581|NCT05553613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343582|NCT05553522|Capecitabine|capecitabine|mesh-list
25343583|NCT05553522|Trastuzumab|trastuzumab|mesh-list
25343584|NCT05553522|Tucatinib|tucatinib|mesh-list
25343585|NCT05553522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25343588|NCT05553522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25343589|NCT05553522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25343590|NCT05553522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25343591|NCT05553522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25343592|NCT05553496|Cyclosporine|cyclosporine|mesh-list
25343593|NCT05553496|Dexamethasone|dexamethasone|mesh-list
25343594|NCT05553496|Dexamethasone acetate|dexamethasone acetate|mesh-list
25343595|NCT05553496|Cyclophosphamide|cyclophosphamide|mesh-list
25343596|NCT05553496|Rituximab|rituximab|mesh-list
25343597|NCT05553496|Tacrolimus|tacrolimus|mesh-list
25343598|NCT05553496|Cyclosporins|cyclosporins|mesh-list
25343599|NCT05553496|BB 1101|bb 1101|mesh-list
25343600|NCT05553496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25343601|NCT05553496|Immunologic Factors|immunologic factors|mesh-ancestor
25343602|NCT05553496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343603|NCT05553496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25343604|NCT05553496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25343605|NCT05553496|Alkylating Agents|alkylating agents|mesh-ancestor
25343606|NCT05553496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343607|NCT05553496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25343608|NCT05553496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25343609|NCT05553496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25343610|NCT05553496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25343611|NCT05553496|Antiemetics|antiemetics|mesh-ancestor
25343612|NCT05553496|Autonomic Agents|autonomic agents|mesh-ancestor
25343613|NCT05553496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25343614|NCT05553496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25343615|NCT05553496|Glucocorticoids|glucocorticoids|mesh-ancestor
25343616|NCT05553496|Hormones|hormones|mesh-ancestor
25343617|NCT05553496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25343618|NCT05553496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25343619|NCT05553496|Protease Inhibitors|protease inhibitors|mesh-ancestor
25343620|NCT05553496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25343621|NCT05553496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25343622|NCT05553496|Antifungal Agents|antifungal agents|mesh-ancestor
25343623|NCT05553496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25343624|NCT05553496|Dermatologic Agents|dermatologic agents|mesh-ancestor
25343625|NCT05553405|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25343626|NCT05553405|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25343627|NCT05553405|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25343628|NCT05553405|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25343632|NCT05553366|Acetaminophen|acetaminophen|mesh-list
25343633|NCT05553366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25343634|NCT05553366|Analgesics|analgesics|mesh-ancestor
25343635|NCT05553366|Sensory System Agents|sensory system agents|mesh-ancestor
25343636|NCT05553366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25343637|NCT05553366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343638|NCT05553366|Antipyretics|antipyretics|mesh-ancestor
25343639|NCT05553314|Carvedilol|carvedilol|mesh-list
25343640|NCT05553314|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25343641|NCT05553314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25343642|NCT05553314|Adrenergic Agents|adrenergic agents|mesh-ancestor
25343643|NCT05553314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25343644|NCT05553314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343645|NCT05553314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343646|NCT05553314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25343647|NCT05553314|Antioxidants|antioxidants|mesh-ancestor
25343648|NCT05553314|Protective Agents|protective agents|mesh-ancestor
25343649|NCT05553314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25343650|NCT05553314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25343651|NCT05553314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25343652|NCT05553314|Vasodilator Agents|vasodilator agents|mesh-ancestor
25343653|NCT05553314|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25343654|NCT05553314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25343655|NCT05553301|Vaccines|vaccines|mesh-list
25343656|NCT05553301|Immunologic Factors|immunologic factors|mesh-ancestor
25343657|NCT05553301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343658|NCT05553184|Niacin|niacin|mesh-list
25343659|NCT05553184|Nicotinic Acids|nicotinic acids|mesh-list
25343660|NCT05553184|Niacinamide|niacinamide|mesh-list
25343661|NCT05553184|Formoterol Fumarate|formoterol fumarate|mesh-list
25343662|NCT05553184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25376344|NCT04844814|Hormones|hormones|mesh-ancestor
25343663|NCT05553184|Autonomic Agents|autonomic agents|mesh-ancestor
25343664|NCT05553184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25343665|NCT05553184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343666|NCT05553184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25343667|NCT05553184|Respiratory System Agents|respiratory system agents|mesh-ancestor
25343668|NCT05553184|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25343669|NCT05553184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25343670|NCT05553184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25343671|NCT05553184|Adrenergic Agents|adrenergic agents|mesh-ancestor
25343672|NCT05553184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25343673|NCT05553184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343674|NCT05553184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25343675|NCT05553184|Antimetabolites|antimetabolites|mesh-ancestor
25343676|NCT05553184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25343678|NCT05553184|Vitamin B Complex|vitamin b complex|mesh-ancestor
25343679|NCT05553184|Vitamins|vitamins|mesh-ancestor
25343680|NCT05553184|Micronutrients|micronutrients|mesh-ancestor
25343681|NCT05553145|Antibodies|antibodies|mesh-list
25343682|NCT05553145|Autoantibodies|autoantibodies|mesh-list
25343683|NCT05553145|Immunologic Factors|immunologic factors|mesh-ancestor
25343762|NCT05552443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25343684|NCT05553145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343685|NCT05553132|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25343686|NCT05553132|Hemostatics|hemostatics|mesh-ancestor
25343687|NCT05553132|Coagulants|coagulants|mesh-ancestor
25343688|NCT05553093|Insulin|insulin|mesh-list
25343689|NCT05553093|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25343690|NCT05553093|Insulin Glargine|insulin glargine|mesh-list
25343691|NCT05553093|Tirzepatide|tirzepatide|mesh-list
25343692|NCT05553093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25343693|NCT05553093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343694|NCT05553093|Incretins|incretins|mesh-ancestor
25343695|NCT05553093|Hormones|hormones|mesh-ancestor
25343696|NCT05553093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25343697|NCT05553067|Antibodies|antibodies|mesh-list
25343698|NCT05553067|Immunologic Factors|immunologic factors|mesh-ancestor
25343699|NCT05553067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343700|NCT05552976|Dexamethasone|dexamethasone|mesh-list
25343701|NCT05552976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25343702|NCT05552976|Antiemetics|antiemetics|mesh-ancestor
25343703|NCT05552976|Autonomic Agents|autonomic agents|mesh-ancestor
25343704|NCT05552976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25343705|NCT05552976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343706|NCT05552976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25343707|NCT05552976|Glucocorticoids|glucocorticoids|mesh-ancestor
25343708|NCT05552976|Hormones|hormones|mesh-ancestor
25343709|NCT05552976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25343710|NCT05552976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25343711|NCT05552976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25343712|NCT05552950|Antiviral Agents|antiviral agents|mesh-list
25343713|NCT05552950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25343714|NCT05552937|Lenalidomide|lenalidomide|mesh-list
25343715|NCT05552937|Immunologic Factors|immunologic factors|mesh-ancestor
25343716|NCT05552937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343717|NCT05552937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25343718|NCT05552937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25343719|NCT05552937|Growth Substances|growth substances|mesh-ancestor
25343720|NCT05552937|Growth Inhibitors|growth inhibitors|mesh-ancestor
25343721|NCT05552937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25343722|NCT05552859|Insulin|insulin|mesh-list
25343723|NCT05552859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25343724|NCT05552859|Insulin Glargine|insulin glargine|mesh-list
25343725|NCT05552859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25343726|NCT05552859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343727|NCT05552807|Paclitaxel|paclitaxel|mesh-list
25343728|NCT05552807|Docetaxel|docetaxel|mesh-list
25343729|NCT05552807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25343730|NCT05552807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25343731|NCT05552807|Tubulin Modulators|tubulin modulators|mesh-ancestor
25343732|NCT05552807|Antimitotic Agents|antimitotic agents|mesh-ancestor
25343733|NCT05552807|Mitosis Modulators|mitosis modulators|mesh-ancestor
25343734|NCT05552807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343735|NCT05552729|Vitamin D|vitamin d|mesh-list
25343736|NCT05552729|Ergocalciferols|ergocalciferols|mesh-list
25343737|NCT05552729|Cholecalciferol|cholecalciferol|mesh-list
25343738|NCT05552729|Vitamins|vitamins|mesh-list
25343739|NCT05552729|Micronutrients|micronutrients|mesh-ancestor
25724196|NCT02535715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343740|NCT05552729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343741|NCT05552729|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25343742|NCT05552729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25343743|NCT05552651|Paclitaxel|paclitaxel|mesh-list
25343744|NCT05552651|Carboplatin|carboplatin|mesh-list
25343745|NCT05552651|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25343746|NCT05552651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25343747|NCT05552651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25343748|NCT05552651|Tubulin Modulators|tubulin modulators|mesh-ancestor
25343749|NCT05552651|Antimitotic Agents|antimitotic agents|mesh-ancestor
25343750|NCT05552651|Mitosis Modulators|mitosis modulators|mesh-ancestor
25343751|NCT05552651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343752|NCT05552586|Melatonin|melatonin|mesh-list
25343753|NCT05552586|Antioxidants|antioxidants|mesh-ancestor
25343754|NCT05552586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343755|NCT05552586|Protective Agents|protective agents|mesh-ancestor
25343756|NCT05552586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343757|NCT05552586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25343758|NCT05552508|Benralizumab|benralizumab|mesh-list
25343759|NCT05552508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25343760|NCT05552508|Respiratory System Agents|respiratory system agents|mesh-ancestor
25343761|NCT05552443|Hydromorphone|hydromorphone|mesh-list
25343763|NCT05552443|Narcotics|narcotics|mesh-ancestor
25343764|NCT05552443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25343765|NCT05552443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343766|NCT05552443|Analgesics|analgesics|mesh-ancestor
25343767|NCT05552443|Sensory System Agents|sensory system agents|mesh-ancestor
25343768|NCT05552443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25343769|NCT05552404|Aminophylline|aminophylline|mesh-list
25343770|NCT05552404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25343771|NCT05552404|Autonomic Agents|autonomic agents|mesh-ancestor
25343772|NCT05552404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25343773|NCT05552404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343774|NCT05552404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25343775|NCT05552404|Respiratory System Agents|respiratory system agents|mesh-ancestor
25343776|NCT05552404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25343777|NCT05552404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25343778|NCT05552404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25343779|NCT05552404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343780|NCT05552404|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25343781|NCT05552404|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25343782|NCT05552404|Purinergic Agents|purinergic agents|mesh-ancestor
25343783|NCT05552404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25343784|NCT05552404|Protective Agents|protective agents|mesh-ancestor
25343785|NCT05552391|Dexmedetomidine|dexmedetomidine|mesh-list
25343786|NCT05552391|Ketamine|ketamine|mesh-list
25343787|NCT05552391|Bupivacaine|bupivacaine|mesh-list
25343788|NCT05552391|Anesthetics, Local|anesthetics, local|mesh-ancestor
25343789|NCT05552391|Anesthetics|anesthetics|mesh-ancestor
25343790|NCT05552391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25343791|NCT05552391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343792|NCT05552391|Sensory System Agents|sensory system agents|mesh-ancestor
25343793|NCT05552391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25343794|NCT05552391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25343795|NCT05552391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25343796|NCT05552391|Analgesics|analgesics|mesh-ancestor
25343797|NCT05552391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25343798|NCT05552391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25343799|NCT05552391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25343800|NCT05552391|Adrenergic Agents|adrenergic agents|mesh-ancestor
25343801|NCT05552391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25343802|NCT05552391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343803|NCT05552391|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25343804|NCT05552391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25343805|NCT05552391|Anesthetics, General|anesthetics, general|mesh-ancestor
25343806|NCT05552391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25343807|NCT05552391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25343808|NCT05552300|Antihypertensive Agents|antihypertensive agents|mesh-list
25343809|NCT05552287|Infliximab|infliximab|mesh-list
25343810|NCT05552287|Dermatologic Agents|dermatologic agents|mesh-ancestor
25343811|NCT05552287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25343812|NCT05552287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25343813|NCT05552222|Dexamethasone|dexamethasone|mesh-list
25343814|NCT05552222|Lenalidomide|lenalidomide|mesh-list
25343815|NCT05552222|Daratumumab|daratumumab|mesh-list
25343816|NCT05552222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25343817|NCT05552222|Antiemetics|antiemetics|mesh-ancestor
25343818|NCT05552222|Autonomic Agents|autonomic agents|mesh-ancestor
25343819|NCT05552222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25343820|NCT05552222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343821|NCT05552222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25343822|NCT05552222|Glucocorticoids|glucocorticoids|mesh-ancestor
25343823|NCT05552222|Hormones|hormones|mesh-ancestor
25343824|NCT05552222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25343825|NCT05552222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25343826|NCT05552222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25343827|NCT05552222|Immunologic Factors|immunologic factors|mesh-ancestor
25343828|NCT05552222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25343829|NCT05552222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25343830|NCT05552222|Growth Substances|growth substances|mesh-ancestor
25343831|NCT05552222|Growth Inhibitors|growth inhibitors|mesh-ancestor
25343832|NCT05552196|Carbamazepine|carbamazepine|mesh-list
25343834|NCT05552196|Anticonvulsants|anticonvulsants|mesh-ancestor
25343835|NCT05552196|Antimanic Agents|antimanic agents|mesh-ancestor
25343836|NCT05552196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25343837|NCT05552196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25343838|NCT05552196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343839|NCT05552196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25343846|NCT05552196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343848|NCT05552196|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25343849|NCT05552196|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25343850|NCT05552196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25343851|NCT05552196|Immunologic Factors|immunologic factors|mesh-ancestor
25343852|NCT05552157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25343853|NCT05552157|Immunologic Factors|immunologic factors|mesh-ancestor
25343854|NCT05552157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343862|NCT05551949|Estradiol|estradiol|mesh-list
25343863|NCT05551949|Estrogens|estrogens|mesh-ancestor
25343864|NCT05551949|Hormones|hormones|mesh-ancestor
25343865|NCT05551949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25343866|NCT05551949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343867|NCT05551936|Rituximab|rituximab|mesh-list
25343868|NCT05551936|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25343869|NCT05551936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25343870|NCT05551936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25343871|NCT05551936|Immunologic Factors|immunologic factors|mesh-ancestor
25343872|NCT05551936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343873|NCT05551936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25343874|NCT05551936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25343875|NCT05551936|Alkylating Agents|alkylating agents|mesh-ancestor
25343876|NCT05551936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343877|NCT05551910|Remifentanil|remifentanil|mesh-list
25343878|NCT05551910|Propofol|propofol|mesh-list
25343879|NCT05551910|Esketamine|esketamine|mesh-list
25343880|NCT05551910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25343881|NCT05551910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25343882|NCT05551910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343883|NCT05551910|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25343884|NCT05551910|Anesthetics, General|anesthetics, general|mesh-ancestor
25343885|NCT05551910|Anesthetics|anesthetics|mesh-ancestor
25343886|NCT05551910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25343887|NCT05551910|Narcotics|narcotics|mesh-ancestor
25343888|NCT05551910|Analgesics|analgesics|mesh-ancestor
25343889|NCT05551910|Sensory System Agents|sensory system agents|mesh-ancestor
25343890|NCT05551910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25343891|NCT05551910|Antidepressive Agents|antidepressive agents|mesh-ancestor
25343892|NCT05551910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25343893|NCT05551897|Itraconazole|itraconazole|mesh-list
25343894|NCT05551897|Antifungal Agents|antifungal agents|mesh-ancestor
25343895|NCT05551897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25343896|NCT05551897|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25343897|NCT05551897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25343898|NCT05551897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25343899|NCT05551897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343900|NCT05551897|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25343901|NCT05551897|Hormone Antagonists|hormone antagonists|mesh-ancestor
25343902|NCT05551897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25343903|NCT05551897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343904|NCT05551897|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25343905|NCT05551871|Simvastatin|simvastatin|mesh-list
25343906|NCT05551871|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25343907|NCT05551871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25343908|NCT05551871|Antimetabolites|antimetabolites|mesh-ancestor
25343909|NCT05551871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343910|NCT05551871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25343911|NCT05551871|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25343912|NCT05551871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25343914|NCT05551858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25343915|NCT05551858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25343916|NCT05551767|Cisplatin|cisplatin|mesh-list
25343917|NCT05551767|Pembrolizumab|pembrolizumab|mesh-list
25343918|NCT05551767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25343919|NCT05551767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25343920|NCT05551689|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25343921|NCT05551689|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25343922|NCT05551689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343923|NCT05551689|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25343924|NCT05551689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25343925|NCT05551689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25343926|NCT05551689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343927|NCT05551689|Dopamine Agents|dopamine agents|mesh-ancestor
25343928|NCT05551689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25343929|NCT05551624|Acetylcysteine|acetylcysteine|mesh-list
25343930|NCT05551624|Atorvastatin|atorvastatin|mesh-list
25343931|NCT05551624|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25343932|NCT05551624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25343933|NCT05551624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25343934|NCT05551624|Antimetabolites|antimetabolites|mesh-ancestor
25343935|NCT05551624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343936|NCT05551624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25343937|NCT05551624|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25343938|NCT05551624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25343939|NCT05551624|Antiviral Agents|antiviral agents|mesh-ancestor
25343940|NCT05551624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25343941|NCT05551624|Expectorants|expectorants|mesh-ancestor
25343942|NCT05551624|Respiratory System Agents|respiratory system agents|mesh-ancestor
25343943|NCT05551624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25343944|NCT05551624|Antioxidants|antioxidants|mesh-ancestor
25343945|NCT05551624|Protective Agents|protective agents|mesh-ancestor
25343946|NCT05551624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343947|NCT05551624|Antidotes|antidotes|mesh-ancestor
25343948|NCT05551598|Mitoxantrone|mitoxantrone|mesh-list
25343949|NCT05551598|Analgesics|analgesics|mesh-ancestor
25343950|NCT05551598|Sensory System Agents|sensory system agents|mesh-ancestor
25343951|NCT05551598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25343952|NCT05551598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343953|NCT05551598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25343954|NCT05551598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25343955|NCT05551598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25343956|NCT05551598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25343957|NCT05551598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343958|NCT05551299|Photosensitizing Agents|photosensitizing agents|mesh-list
25343959|NCT05551299|Dermatologic Agents|dermatologic agents|mesh-ancestor
25343960|NCT05551247|Endostatins|endostatins|mesh-list
25343961|NCT05551247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25343962|NCT05551247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25343963|NCT05551247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25343964|NCT05551247|Growth Substances|growth substances|mesh-ancestor
25343965|NCT05551247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343966|NCT05551247|Growth Inhibitors|growth inhibitors|mesh-ancestor
25343967|NCT05551221|Tamsulosin|tamsulosin|mesh-list
25343968|NCT05551221|Silodosin|silodosin|mesh-list
25343969|NCT05551221|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25343970|NCT05551221|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25343971|NCT05551221|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25343972|NCT05551221|Adrenergic Agents|adrenergic agents|mesh-ancestor
25343973|NCT05551221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25343974|NCT05551221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343975|NCT05551221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343976|NCT05551221|Urological Agents|urological agents|mesh-ancestor
25343977|NCT05551208|Bevacizumab|bevacizumab|mesh-list
25343978|NCT05551208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25343979|NCT05551208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25343980|NCT05551208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25343981|NCT05551208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25343982|NCT05551208|Growth Substances|growth substances|mesh-ancestor
25343983|NCT05551208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343984|NCT05551208|Growth Inhibitors|growth inhibitors|mesh-ancestor
25343985|NCT05551182|Nicergoline|nicergoline|mesh-list
25343986|NCT05551182|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25343987|NCT05551182|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25343988|NCT05551182|Adrenergic Agents|adrenergic agents|mesh-ancestor
25343989|NCT05551182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25343990|NCT05551182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343991|NCT05551182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25343992|NCT05551182|Vasodilator Agents|vasodilator agents|mesh-ancestor
25343993|NCT05551182|Nootropic Agents|nootropic agents|mesh-ancestor
25343994|NCT05551104|Labetalol|labetalol|mesh-list
25343995|NCT05551104|Nifedipine|nifedipine|mesh-list
25343996|NCT05551104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25343997|NCT05551104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25343998|NCT05551104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25343999|NCT05551104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25344000|NCT05551104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344001|NCT05551104|Vasodilator Agents|vasodilator agents|mesh-ancestor
25344002|NCT05551104|Tocolytic Agents|tocolytic agents|mesh-ancestor
25344003|NCT05551104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25344004|NCT05551104|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25344005|NCT05551104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25344006|NCT05551104|Adrenergic Agents|adrenergic agents|mesh-ancestor
25344007|NCT05551104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25344008|NCT05551104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25344009|NCT05551104|Sympathomimetics|sympathomimetics|mesh-ancestor
25344010|NCT05551104|Autonomic Agents|autonomic agents|mesh-ancestor
25344011|NCT05551104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25344012|NCT05551104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25344013|NCT05551104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25344014|NCT05550909|Artesunate|artesunate|mesh-list
25344015|NCT05550909|Lumefantrine|lumefantrine|mesh-list
25344016|NCT05550909|Artemether|artemether|mesh-list
25344017|NCT05550909|Primaquine|primaquine|mesh-list
25344018|NCT05550909|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25344019|NCT05550909|Amodiaquine|amodiaquine|mesh-list
25344020|NCT05550909|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
25344021|NCT05550909|Antimalarials|antimalarials|mesh-ancestor
25344022|NCT05550909|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25344023|NCT05550909|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25344024|NCT05550909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25344025|NCT05550909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25344026|NCT05550909|Antiviral Agents|antiviral agents|mesh-ancestor
25344027|NCT05550909|Schistosomicides|schistosomicides|mesh-ancestor
25344028|NCT05550909|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25344029|NCT05550909|Anthelmintics|anthelmintics|mesh-ancestor
25344030|NCT05550870|Fenugreek seed meal|fenugreek seed meal|mesh-list
25344031|NCT05550870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25344032|NCT05550870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344033|NCT05550714|Anesthetics|anesthetics|mesh-list
25344034|NCT05550714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25344035|NCT05550714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344036|NCT05550662|Xenon|xenon|mesh-list
25344037|NCT05550662|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25344038|NCT05550662|Anesthetics, General|anesthetics, general|mesh-ancestor
25344039|NCT05550662|Anesthetics|anesthetics|mesh-ancestor
25344040|NCT05550662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25344041|NCT05550662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344042|NCT05550636|Midazolam|midazolam|mesh-list
25344043|NCT05550636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25344044|NCT05550636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25344045|NCT05550636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25344046|NCT05550636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344047|NCT05550636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25344048|NCT05550636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25344049|NCT05550636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25344050|NCT05550636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25344051|NCT05550636|Anesthetics, General|anesthetics, general|mesh-ancestor
25344052|NCT05550636|Anesthetics|anesthetics|mesh-ancestor
25344053|NCT05550636|GABA Modulators|gaba modulators|mesh-ancestor
25344054|NCT05550636|GABA Agents|gaba agents|mesh-ancestor
25344055|NCT05550636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25724197|NCT02535806|Cytarabine|cytarabine|mesh-list
25344056|NCT05550636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344057|NCT05550597|Fentanyl|fentanyl|mesh-list
25344058|NCT05550597|Bupivacaine|bupivacaine|mesh-list
25344059|NCT05550597|Anesthetics, Local|anesthetics, local|mesh-ancestor
25344060|NCT05550597|Anesthetics|anesthetics|mesh-ancestor
25344061|NCT05550597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25344062|NCT05550597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344063|NCT05550597|Sensory System Agents|sensory system agents|mesh-ancestor
25344064|NCT05550597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25344065|NCT05550597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25344066|NCT05550597|Narcotics|narcotics|mesh-ancestor
25344067|NCT05550597|Analgesics|analgesics|mesh-ancestor
25344068|NCT05550597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25344069|NCT05550597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25344070|NCT05550597|Anesthetics, General|anesthetics, general|mesh-ancestor
25344072|NCT05550532|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25344073|NCT05550532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344074|NCT05550532|Sensory System Agents|sensory system agents|mesh-ancestor
25344075|NCT05550532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25344076|NCT05550519|Tenofovir|tenofovir|mesh-list
25344077|NCT05550519|Entecavir|entecavir|mesh-list
25344078|NCT05550519|Antiviral Agents|antiviral agents|mesh-ancestor
25344079|NCT05550519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25344080|NCT05550519|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25344081|NCT05550519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25344082|NCT05550519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344083|NCT05550519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344084|NCT05550519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25344085|NCT05550519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25344086|NCT05550506|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25344087|NCT05550506|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25344088|NCT05550506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25344089|NCT05550506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25344090|NCT05550506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344091|NCT05550506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25344092|NCT05550506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344093|NCT05550506|Analgesics|analgesics|mesh-ancestor
25344094|NCT05550506|Sensory System Agents|sensory system agents|mesh-ancestor
25344095|NCT05550506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25344096|NCT05550506|Antidepressive Agents|antidepressive agents|mesh-ancestor
25344097|NCT05550506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25344098|NCT05550506|Dopamine Agents|dopamine agents|mesh-ancestor
25344099|NCT05550441|Dapagliflozin|dapagliflozin|mesh-list
25344100|NCT05550441|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25344101|NCT05550441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344102|NCT05550441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25344103|NCT05550441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344104|NCT05550415|Simvastatin|simvastatin|mesh-list
25344105|NCT05550415|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25344106|NCT05550415|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25344107|NCT05550415|Antimetabolites|antimetabolites|mesh-ancestor
25344108|NCT05550415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344109|NCT05550415|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25344110|NCT05550415|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25344111|NCT05550415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344112|NCT05550402|Bromides|bromides|mesh-list
25344113|NCT05550402|Albuterol|albuterol|mesh-list
25344114|NCT05550402|Ipratropium|ipratropium|mesh-list
25344115|NCT05550402|Anticonvulsants|anticonvulsants|mesh-ancestor
25344116|NCT05550402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25344117|NCT05550402|Autonomic Agents|autonomic agents|mesh-ancestor
25344118|NCT05550402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25344119|NCT05550402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344120|NCT05550402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25344121|NCT05550402|Respiratory System Agents|respiratory system agents|mesh-ancestor
25344122|NCT05550402|Tocolytic Agents|tocolytic agents|mesh-ancestor
25344123|NCT05550402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25344124|NCT05550402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25344125|NCT05550402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25344126|NCT05550402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25344127|NCT05550402|Adrenergic Agents|adrenergic agents|mesh-ancestor
25344128|NCT05550402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25344129|NCT05550402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344130|NCT05550402|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25344144|NCT05550246|Autonomic Agents|autonomic agents|mesh-ancestor
25344145|NCT05550246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25344146|NCT05550246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25344147|NCT05550246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25344148|NCT05550246|Cholinergic Agents|cholinergic agents|mesh-ancestor
25344149|NCT05550246|Urological Agents|urological agents|mesh-ancestor
25344150|NCT05550207|Meloxicam|meloxicam|mesh-list
25344151|NCT05550207|Rizatriptan|rizatriptan|mesh-list
25344152|NCT05550207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25344153|NCT05550207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25344154|NCT05550207|Analgesics|analgesics|mesh-ancestor
25344155|NCT05550207|Sensory System Agents|sensory system agents|mesh-ancestor
25344156|NCT05550207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25344157|NCT05550207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344158|NCT05550207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25344159|NCT05550207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25344160|NCT05550207|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25344161|NCT05550207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25344162|NCT05550207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344163|NCT05550207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344164|NCT05550207|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25344165|NCT05550207|Serotonin Agents|serotonin agents|mesh-ancestor
25344166|NCT05550207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25344167|NCT05550194|Valacyclovir|valacyclovir|mesh-list
25344168|NCT05550194|Antiviral Agents|antiviral agents|mesh-ancestor
25344169|NCT05550194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25344170|NCT05550142|Vaccines|vaccines|mesh-list
25344171|NCT05550142|Immunologic Factors|immunologic factors|mesh-ancestor
25344172|NCT05550142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344173|NCT05550129|Metformin|metformin|mesh-list
25344174|NCT05550129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25344175|NCT05550129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344176|NCT05550064|Contraceptive Agents|contraceptive agents|mesh-list
25344177|NCT05550064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25344178|NCT05550064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344179|NCT05550025|Apatinib|apatinib|mesh-list
25344180|NCT05550025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25344181|NCT05550025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25344182|NCT05550025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344183|NCT05550025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344184|NCT05549973|Dexamethasone|dexamethasone|mesh-list
25344185|NCT05549973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25344186|NCT05549973|Antiemetics|antiemetics|mesh-ancestor
25344187|NCT05549973|Autonomic Agents|autonomic agents|mesh-ancestor
25344188|NCT05549973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25344189|NCT05549973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344190|NCT05549973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25344191|NCT05549973|Glucocorticoids|glucocorticoids|mesh-ancestor
25344192|NCT05549973|Hormones|hormones|mesh-ancestor
25344193|NCT05549973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25344194|NCT05549973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25344195|NCT05549973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25344218|NCT05549752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25344219|NCT05549752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25344220|NCT05549752|Vasodilator Agents|vasodilator agents|mesh-ancestor
25344221|NCT05549752|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25344222|NCT05549752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25344223|NCT05549752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344224|NCT05549752|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25344225|NCT05549752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25344226|NCT05549752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25344227|NCT05549752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344228|NCT05549752|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25344229|NCT05549752|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25344230|NCT05549752|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25344231|NCT05549752|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25344233|NCT05549726|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25344234|NCT05549726|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25344235|NCT05549726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344236|NCT05549726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344237|NCT05549726|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25344238|NCT05549726|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25344239|NCT05549726|Antiviral Agents|antiviral agents|mesh-ancestor
25344240|NCT05549726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25344241|NCT05549661|Onvansertib|onvansertib|mesh-list
25344242|NCT05549661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25344243|NCT05549661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344244|NCT05549661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344245|NCT05549583|Metformin|metformin|mesh-list
25344246|NCT05549583|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25344247|NCT05549583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25344248|NCT05549583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344249|NCT05549583|Incretins|incretins|mesh-ancestor
25344250|NCT05549583|Hormones|hormones|mesh-ancestor
25344251|NCT05549583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25344252|NCT05549583|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25344253|NCT05549583|Protease Inhibitors|protease inhibitors|mesh-ancestor
25344254|NCT05549583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344255|NCT05549583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344256|NCT05549570|Metformin|metformin|mesh-list
25344257|NCT05549570|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25344258|NCT05549570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25344259|NCT05549570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344260|NCT05549570|Incretins|incretins|mesh-ancestor
25344261|NCT05549570|Hormones|hormones|mesh-ancestor
25344262|NCT05549570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25344263|NCT05549570|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25344264|NCT05549570|Protease Inhibitors|protease inhibitors|mesh-ancestor
25344265|NCT05549570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344266|NCT05549570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344267|NCT05549531|Itraconazole|itraconazole|mesh-list
25344268|NCT05549531|Antifungal Agents|antifungal agents|mesh-ancestor
25344269|NCT05549531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25344270|NCT05549531|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25344271|NCT05549531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25344272|NCT05549531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344273|NCT05549531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344274|NCT05549531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25344275|NCT05549531|Hormone Antagonists|hormone antagonists|mesh-ancestor
25344276|NCT05549531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25344277|NCT05549531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344278|NCT05549531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25344279|NCT05549505|Anastrozole|anastrozole|mesh-list
25344280|NCT05549505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25344281|NCT05549505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25344282|NCT05549505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25344283|NCT05549505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25344284|NCT05549505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344285|NCT05549505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344286|NCT05549505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25344287|NCT05549505|Hormone Antagonists|hormone antagonists|mesh-ancestor
25344364|NCT05549167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344288|NCT05549505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25344289|NCT05549505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344290|NCT05549492|Buprenorphine|buprenorphine|mesh-list
25344291|NCT05549492|Ropivacaine|ropivacaine|mesh-list
25344292|NCT05549492|Anesthetics, Local|anesthetics, local|mesh-ancestor
25344293|NCT05549492|Anesthetics|anesthetics|mesh-ancestor
25344294|NCT05549492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25344295|NCT05549492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344296|NCT05549492|Sensory System Agents|sensory system agents|mesh-ancestor
25344297|NCT05549492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25344298|NCT05549492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25344299|NCT05549492|Narcotics|narcotics|mesh-ancestor
25344300|NCT05549492|Analgesics|analgesics|mesh-ancestor
25344301|NCT05549492|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25344302|NCT05549466|Gemcitabine|gemcitabine|mesh-list
25344303|NCT05549466|Capecitabine|capecitabine|mesh-list
25344304|NCT05549466|Docetaxel|docetaxel|mesh-list
25344305|NCT05549466|Apatinib|apatinib|mesh-list
25344306|NCT05549466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25344307|NCT05549466|Antimetabolites|antimetabolites|mesh-ancestor
25344308|NCT05549466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344309|NCT05549466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25344310|NCT05549466|Antiviral Agents|antiviral agents|mesh-ancestor
25344311|NCT05549466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25344312|NCT05549466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344313|NCT05549466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25344314|NCT05549466|Immunologic Factors|immunologic factors|mesh-ancestor
25344315|NCT05549466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344316|NCT05549466|Tubulin Modulators|tubulin modulators|mesh-ancestor
25344317|NCT05549466|Antimitotic Agents|antimitotic agents|mesh-ancestor
25344318|NCT05549466|Mitosis Modulators|mitosis modulators|mesh-ancestor
25344319|NCT05549466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25344320|NCT05549336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25344321|NCT05549336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344322|NCT05549336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25344323|NCT05549297|Pembrolizumab|pembrolizumab|mesh-list
25344324|NCT05549297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25344325|NCT05549297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25344326|NCT05549284|Rituximab|rituximab|mesh-list
25344327|NCT05549284|Methotrexate|methotrexate|mesh-list
25344328|NCT05549284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25344329|NCT05549284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25344330|NCT05549284|Immunologic Factors|immunologic factors|mesh-ancestor
25344331|NCT05549284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344332|NCT05549284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25344333|NCT05549284|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25344334|NCT05549284|Abortifacient Agents|abortifacient agents|mesh-ancestor
25344335|NCT05549284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25344336|NCT05549284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25344337|NCT05549284|Antimetabolites|antimetabolites|mesh-ancestor
25344338|NCT05549284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344339|NCT05549284|Dermatologic Agents|dermatologic agents|mesh-ancestor
25344340|NCT05549284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344341|NCT05549284|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25344342|NCT05549284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25344343|NCT05549284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25344344|NCT05549206|Vaccines|vaccines|mesh-list
25344345|NCT05549206|Immunologic Factors|immunologic factors|mesh-ancestor
25344346|NCT05549206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344347|NCT05549180|Emtricitabine|emtricitabine|mesh-list
25344348|NCT05549180|Antiviral Agents|antiviral agents|mesh-ancestor
25344349|NCT05549180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25344350|NCT05549180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25344351|NCT05549180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25724198|NCT02535806|Dexamethasone|dexamethasone|mesh-list
25724199|NCT02535806|Hydrocortisone|hydrocortisone|mesh-list
25344352|NCT05549180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344353|NCT05549180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344354|NCT05549180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25344355|NCT05549180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25344356|NCT05549167|Sirolimus|sirolimus|mesh-list
25344357|NCT05549167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25344358|NCT05549167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25344359|NCT05549167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25344360|NCT05549167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25344361|NCT05549167|Antifungal Agents|antifungal agents|mesh-ancestor
25344362|NCT05549167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25344363|NCT05549167|Immunologic Factors|immunologic factors|mesh-ancestor
25344366|NCT05549154|Ergocalciferols|ergocalciferols|mesh-list
25344367|NCT05549154|Cholecalciferol|cholecalciferol|mesh-list
25344368|NCT05549154|Vitamins|vitamins|mesh-list
25344369|NCT05549154|Micronutrients|micronutrients|mesh-ancestor
25344370|NCT05549154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344371|NCT05549154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25344372|NCT05549154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25344373|NCT05549115|Amoxicillin|amoxicillin|mesh-list
25344374|NCT05549115|Clarithromycin|clarithromycin|mesh-list
25344375|NCT05549115|Fluoroquinolones|fluoroquinolones|mesh-list
25344376|NCT05549115|Bismuth|bismuth|mesh-list
25344377|NCT05549115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25344378|NCT05549115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25344379|NCT05549115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25344380|NCT05549115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344381|NCT05549115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344382|NCT05549115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25344383|NCT05549115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25344384|NCT05549115|Antacids|antacids|mesh-ancestor
25344385|NCT05549115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25344386|NCT05549115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25344387|NCT05549024|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25344388|NCT05549024|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25344389|NCT05549024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344390|NCT05548998|Anesthetics|anesthetics|mesh-list
25344391|NCT05548998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25344392|NCT05548998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344393|NCT05548985|Midodrine|midodrine|mesh-list
25344394|NCT05548985|Metoclopramide|metoclopramide|mesh-list
25344395|NCT05548985|Antiemetics|antiemetics|mesh-ancestor
25344396|NCT05548985|Autonomic Agents|autonomic agents|mesh-ancestor
25344397|NCT05548985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25344398|NCT05548985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344399|NCT05548985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25344400|NCT05548985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25344401|NCT05548985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25344402|NCT05548985|Dopamine Agents|dopamine agents|mesh-ancestor
25344403|NCT05548985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25344404|NCT05548985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344405|NCT05548985|Sympathomimetics|sympathomimetics|mesh-ancestor
25344406|NCT05548985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25344407|NCT05548985|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25344408|NCT05548985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25344409|NCT05548985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25344410|NCT05548985|Adrenergic Agents|adrenergic agents|mesh-ancestor
25344411|NCT05548660|Analgesics|analgesics|mesh-list
25344412|NCT05548660|Sensory System Agents|sensory system agents|mesh-ancestor
25344413|NCT05548660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25344414|NCT05548660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344415|NCT05548582|Acetaminophen|acetaminophen|mesh-list
25344416|NCT05548582|Ibuprofen|ibuprofen|mesh-list
25344417|NCT05548582|Oxycodone|oxycodone|mesh-list
25344418|NCT05548582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25344419|NCT05548582|Analgesics|analgesics|mesh-ancestor
25344420|NCT05548582|Sensory System Agents|sensory system agents|mesh-ancestor
25344421|NCT05548582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25344422|NCT05548582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344423|NCT05548582|Antipyretics|antipyretics|mesh-ancestor
25344424|NCT05548582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25344425|NCT05548582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25344426|NCT05548582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25344427|NCT05548582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25344428|NCT05548582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344429|NCT05548582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344430|NCT05548582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25344432|NCT05548582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25344433|NCT05548465|Sufentanil|sufentanil|mesh-list
25344434|NCT05548465|Remifentanil|remifentanil|mesh-list
25344435|NCT05548465|Dsuvia|dsuvia|mesh-list
25344436|NCT05548465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25344437|NCT05548465|Narcotics|narcotics|mesh-ancestor
25344438|NCT05548465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25344439|NCT05548465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344440|NCT05548465|Analgesics|analgesics|mesh-ancestor
25344441|NCT05548465|Sensory System Agents|sensory system agents|mesh-ancestor
25344519|NCT05547750|Micronutrients|micronutrients|mesh-ancestor
25344442|NCT05548465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25344443|NCT05548465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25344444|NCT05548465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25344445|NCT05548465|Anesthetics, General|anesthetics, general|mesh-ancestor
25344447|NCT05548426|Linezolid|linezolid|mesh-list
25344448|NCT05548426|Penicillins|penicillins|mesh-list
25344449|NCT05548426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25344450|NCT05548426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25344451|NCT05548426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25344452|NCT05548426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344453|NCT05548426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344454|NCT05548361|Chlorhexidine|chlorhexidine|mesh-list
25344455|NCT05548361|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25344456|NCT05548361|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25344457|NCT05548361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25344458|NCT05548361|Disinfectants|disinfectants|mesh-ancestor
25344459|NCT05548361|Dermatologic Agents|dermatologic agents|mesh-ancestor
25344460|NCT05548348|Aflutinib|aflutinib|mesh-list
25344461|NCT05548348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25344462|NCT05548348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344463|NCT05548348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344464|NCT05548296|Gemcitabine|gemcitabine|mesh-list
25344465|NCT05548296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25344466|NCT05548296|Antimetabolites|antimetabolites|mesh-ancestor
25344467|NCT05548296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344468|NCT05548296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25344469|NCT05548296|Antiviral Agents|antiviral agents|mesh-ancestor
25344470|NCT05548296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25344471|NCT05548296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344472|NCT05548296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25344473|NCT05548296|Immunologic Factors|immunologic factors|mesh-ancestor
25344474|NCT05548296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344475|NCT05548283|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25344476|NCT05548283|Lactams|lactams|mesh-list
25344477|NCT05548283|beta-Lactams|beta-lactams|mesh-list
25344478|NCT05548283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25344479|NCT05548270|Scopolamine|scopolamine|mesh-list
25344480|NCT05548270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25344481|NCT05548270|Antiemetics|antiemetics|mesh-ancestor
25344482|NCT05548270|Autonomic Agents|autonomic agents|mesh-ancestor
25344483|NCT05548270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25344484|NCT05548270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344485|NCT05548270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25344486|NCT05548270|Mydriatics|mydriatics|mesh-ancestor
25344487|NCT05548270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25344488|NCT05548270|Cholinergic Agents|cholinergic agents|mesh-ancestor
25344489|NCT05548270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25344490|NCT05548270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344491|NCT05548270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25344492|NCT05548075|Psilocybin|psilocybin|mesh-list
25344493|NCT05548075|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
25344494|NCT05548075|Hallucinogens|hallucinogens|mesh-ancestor
25344495|NCT05548075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344496|NCT05548075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25344497|NCT05548075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25344498|NCT05548075|Serotonin Agents|serotonin agents|mesh-ancestor
25344499|NCT05548075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25344500|NCT05548075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344501|NCT05548075|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25344502|NCT05548062|Hydroxyurea|hydroxyurea|mesh-list
25344503|NCT05548062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25344504|NCT05548062|Antisickling Agents|antisickling agents|mesh-ancestor
25344505|NCT05548062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344506|NCT05548062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344507|NCT05548062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25344508|NCT05547789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25344509|NCT05547789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25344510|NCT05547789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25344512|NCT05547789|Sensory System Agents|sensory system agents|mesh-ancestor
25344513|NCT05547789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25344514|NCT05547789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344515|NCT05547789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25344516|NCT05547750|Vitamin K|vitamin k|mesh-list
25344517|NCT05547750|Vitamin K 2|vitamin k 2|mesh-list
25344518|NCT05547750|Vitamins|vitamins|mesh-ancestor
25344520|NCT05547750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344521|NCT05547750|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25344522|NCT05547750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25344523|NCT05547750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344524|NCT05547750|Hemostatics|hemostatics|mesh-ancestor
25344525|NCT05547750|Coagulants|coagulants|mesh-ancestor
25344526|NCT05547685|Methylene Blue|methylene blue|mesh-list
25344527|NCT05547685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344528|NCT05547685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344529|NCT05547659|Acetaminophen|acetaminophen|mesh-list
25344530|NCT05547659|Celecoxib|celecoxib|mesh-list
25344531|NCT05547659|Pregabalin|pregabalin|mesh-list
25344532|NCT05547659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25344533|NCT05547659|Analgesics|analgesics|mesh-ancestor
25344534|NCT05547659|Sensory System Agents|sensory system agents|mesh-ancestor
25344535|NCT05547659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25344536|NCT05547659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344537|NCT05547659|Antipyretics|antipyretics|mesh-ancestor
25344538|NCT05547659|Anticonvulsants|anticonvulsants|mesh-ancestor
25344539|NCT05547659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25344540|NCT05547659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25344541|NCT05547659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344542|NCT05547659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25344543|NCT05547659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25344544|NCT05547659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25344545|NCT05547659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25344546|NCT05547659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25344547|NCT05547659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25344548|NCT05547659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25344549|NCT05547659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25344550|NCT05547659|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25344551|NCT05547659|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25344552|NCT05547659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344553|NCT05547542|Carfentanil|carfentanil|mesh-list
25344554|NCT05547542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25344555|NCT05547542|Narcotics|narcotics|mesh-ancestor
25344556|NCT05547542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25344557|NCT05547542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344558|NCT05547542|Analgesics|analgesics|mesh-ancestor
25344559|NCT05547542|Sensory System Agents|sensory system agents|mesh-ancestor
25344560|NCT05547542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25344561|NCT05547516|Gemcitabine|gemcitabine|mesh-list
25344562|NCT05547516|Epirubicin|epirubicin|mesh-list
25344563|NCT05547516|Mitomycins|mitomycins|mesh-list
25344564|NCT05547516|Mitomycin|mitomycin|mesh-list
25344565|NCT05547516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25344566|NCT05547516|Antimetabolites|antimetabolites|mesh-ancestor
25344567|NCT05547516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344568|NCT05547516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25344569|NCT05547516|Antiviral Agents|antiviral agents|mesh-ancestor
25344570|NCT05547516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25344571|NCT05547516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344572|NCT05547516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25344573|NCT05547516|Immunologic Factors|immunologic factors|mesh-ancestor
25344574|NCT05547516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344575|NCT05547516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25344576|NCT05547516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25344577|NCT05547516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25344578|NCT05547516|Alkylating Agents|alkylating agents|mesh-ancestor
25344579|NCT05547516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25344580|NCT05547399|Zanubrutinib|zanubrutinib|mesh-list
25344581|NCT05547399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25344582|NCT05547399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25344583|NCT05547399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25724200|NCT02535806|Methotrexate|methotrexate|mesh-list
25344584|NCT05547399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344586|NCT05547386|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25344587|NCT05547386|Chelating Agents|chelating agents|mesh-ancestor
25344588|NCT05547386|Sequestering Agents|sequestering agents|mesh-ancestor
25344589|NCT05547386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344590|NCT05547386|Anticoagulants|anticoagulants|mesh-ancestor
25344591|NCT05547386|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25344592|NCT05547386|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25344593|NCT05547321|Pembrolizumab|pembrolizumab|mesh-list
25344594|NCT05547321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25344595|NCT05547321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25344596|NCT05547256|Vaccines|vaccines|mesh-list
25344597|NCT05547256|Immunologic Factors|immunologic factors|mesh-ancestor
25344598|NCT05547256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344599|NCT05547243|Vaccines|vaccines|mesh-list
25344600|NCT05547243|Immunologic Factors|immunologic factors|mesh-ancestor
25344601|NCT05547243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344602|NCT05547100|Olanzapine|olanzapine|mesh-list
25344603|NCT05547100|Antiemetics|antiemetics|mesh-ancestor
25344604|NCT05547100|Autonomic Agents|autonomic agents|mesh-ancestor
25344605|NCT05547100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25344606|NCT05547100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344607|NCT05547100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25344608|NCT05547100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25344609|NCT05547100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25344610|NCT05547100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25344611|NCT05547100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25344612|NCT05547100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25344613|NCT05547100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25344614|NCT05547100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25344615|NCT05547100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344616|NCT05547100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25344617|NCT05547100|Serotonin Agents|serotonin agents|mesh-ancestor
25344618|NCT05546957|Aspirin|aspirin|mesh-list
25344619|NCT05546957|Rivaroxaban|rivaroxaban|mesh-list
25344620|NCT05546957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25344621|NCT05546957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25344622|NCT05546957|Analgesics|analgesics|mesh-ancestor
25344623|NCT05546957|Sensory System Agents|sensory system agents|mesh-ancestor
25344624|NCT05546957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25344625|NCT05546957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344626|NCT05546957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25344627|NCT05546957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25344628|NCT05546957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25344629|NCT05546957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25344630|NCT05546957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344631|NCT05546957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25344632|NCT05546957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25344633|NCT05546957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344634|NCT05546957|Antipyretics|antipyretics|mesh-ancestor
25344635|NCT05546957|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25344636|NCT05546957|Antithrombins|antithrombins|mesh-ancestor
25344637|NCT05546957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25344638|NCT05546957|Protease Inhibitors|protease inhibitors|mesh-ancestor
25344639|NCT05546957|Anticoagulants|anticoagulants|mesh-ancestor
25344640|NCT05546879|Bevacizumab|bevacizumab|mesh-list
25344641|NCT05546879|Atezolizumab|atezolizumab|mesh-list
25344642|NCT05546879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25344643|NCT05546879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25344644|NCT05546879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25344645|NCT05546879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25344646|NCT05546879|Growth Substances|growth substances|mesh-ancestor
25344647|NCT05546879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344648|NCT05546879|Growth Inhibitors|growth inhibitors|mesh-ancestor
25344649|NCT05546866|Osimertinib|osimertinib|mesh-list
25344650|NCT05546866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25344651|NCT05546866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25344652|NCT05546866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344653|NCT05546866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344654|NCT05546853|Leucovorin|leucovorin|mesh-list
25344655|NCT05546853|Oxaliplatin|oxaliplatin|mesh-list
25344656|NCT05546853|Irinotecan|irinotecan|mesh-list
25344657|NCT05546853|Calcium|calcium|mesh-list
25344658|NCT05546853|Levoleucovorin|levoleucovorin|mesh-list
25344659|NCT05546853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25344660|NCT05546853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344673|NCT05546762|Plasma Substitutes|plasma substitutes|mesh-ancestor
25344674|NCT05546762|Blood Substitutes|blood substitutes|mesh-ancestor
25344675|NCT05546762|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25344676|NCT05546762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25344677|NCT05546710|Anesthetics|anesthetics|mesh-list
25344678|NCT05546710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25344679|NCT05546710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344680|NCT05546658|Psilocybin|psilocybin|mesh-list
25344681|NCT05546658|Hallucinogens|hallucinogens|mesh-ancestor
25344682|NCT05546658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344683|NCT05546658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25344696|NCT05546554|Suvorexant|suvorexant|mesh-list
25344697|NCT05546554|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25344698|NCT05546554|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25344699|NCT05546554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25344700|NCT05546554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344701|NCT05546554|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25344702|NCT05546554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25344703|NCT05546554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344704|NCT05546515|Suvorexant|suvorexant|mesh-list
25344705|NCT05546515|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-list
25344706|NCT05546515|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25344707|NCT05546515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25344708|NCT05546515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25344709|NCT05546515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344710|NCT05546515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25344711|NCT05546515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344712|NCT05546411|Leucovorin|leucovorin|mesh-list
25344713|NCT05546411|Fluorouracil|fluorouracil|mesh-list
25344714|NCT05546411|Oxaliplatin|oxaliplatin|mesh-list
25344715|NCT05546411|Irinotecan|irinotecan|mesh-list
25344716|NCT05546411|Camptothecin|camptothecin|mesh-list
25344717|NCT05546411|Levoleucovorin|levoleucovorin|mesh-list
25344718|NCT05546411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344719|NCT05546411|Antimetabolites|antimetabolites|mesh-ancestor
25344720|NCT05546411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344721|NCT05546411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25344722|NCT05546411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25344723|NCT05546411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25344724|NCT05546411|Immunologic Factors|immunologic factors|mesh-ancestor
25344725|NCT05546411|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25344726|NCT05546411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25344727|NCT05546411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344728|NCT05546411|Antidotes|antidotes|mesh-ancestor
25344729|NCT05546411|Protective Agents|protective agents|mesh-ancestor
25344730|NCT05546411|Vitamin B Complex|vitamin b complex|mesh-ancestor
25344731|NCT05546411|Vitamins|vitamins|mesh-ancestor
25344732|NCT05546411|Micronutrients|micronutrients|mesh-ancestor
25344733|NCT05546411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25344734|NCT05546398|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
25344735|NCT05546398|Ezetimibe|ezetimibe|mesh-list
25344736|NCT05546398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25344737|NCT05546398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25344739|NCT05546398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344740|NCT05546398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25344741|NCT05546398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344742|NCT05546398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25344743|NCT05546398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344744|NCT05546359|Dexamethasone|dexamethasone|mesh-list
25344745|NCT05546359|Ondansetron|ondansetron|mesh-list
25344746|NCT05546359|Amisulpride|amisulpride|mesh-list
25344747|NCT05546359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25344748|NCT05546359|Antiemetics|antiemetics|mesh-ancestor
25344749|NCT05546359|Autonomic Agents|autonomic agents|mesh-ancestor
25344750|NCT05546359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25344751|NCT05546359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344752|NCT05546359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25344753|NCT05546359|Glucocorticoids|glucocorticoids|mesh-ancestor
25344754|NCT05546359|Hormones|hormones|mesh-ancestor
25344755|NCT05546359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25344756|NCT05546359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25344757|NCT05546359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25344758|NCT05546359|Antipruritics|antipruritics|mesh-ancestor
25344759|NCT05546359|Dermatologic Agents|dermatologic agents|mesh-ancestor
25344760|NCT05546359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25344761|NCT05546359|Serotonin Agents|serotonin agents|mesh-ancestor
25344762|NCT05546359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25344763|NCT05546359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344764|NCT05546359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25344765|NCT05546359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25344766|NCT05546359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25344767|NCT05546359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25344768|NCT05546359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25344769|NCT05546359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25344770|NCT05546359|Dopamine Agents|dopamine agents|mesh-ancestor
25344771|NCT05546359|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25344772|NCT05546359|Antidepressive Agents|antidepressive agents|mesh-ancestor
25344773|NCT05546320|Aspirin|aspirin|mesh-list
25344774|NCT05546320|Metoprolol|metoprolol|mesh-list
25344775|NCT05546320|Rivaroxaban|rivaroxaban|mesh-list
25344776|NCT05546320|Clopidogrel|clopidogrel|mesh-list
25344777|NCT05546320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25344778|NCT05546320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25344779|NCT05546320|Analgesics|analgesics|mesh-ancestor
25344780|NCT05546320|Sensory System Agents|sensory system agents|mesh-ancestor
25344781|NCT05546320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25344782|NCT05546320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344783|NCT05546320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25344784|NCT05546320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25344785|NCT05546320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25344786|NCT05546320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25344787|NCT05546320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344788|NCT05546320|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25344789|NCT05546320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25344790|NCT05546320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344791|NCT05546320|Antipyretics|antipyretics|mesh-ancestor
25344792|NCT05546320|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25344793|NCT05546320|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25344794|NCT05546320|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25344795|NCT05546320|Purinergic Agents|purinergic agents|mesh-ancestor
25344796|NCT05546320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25344797|NCT05546320|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25344798|NCT05546320|Antithrombins|antithrombins|mesh-ancestor
25344799|NCT05546320|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25344800|NCT05546320|Protease Inhibitors|protease inhibitors|mesh-ancestor
25344801|NCT05546320|Anticoagulants|anticoagulants|mesh-ancestor
25344802|NCT05546320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25344803|NCT05546320|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25344804|NCT05546320|Sympatholytics|sympatholytics|mesh-ancestor
25344805|NCT05546320|Autonomic Agents|autonomic agents|mesh-ancestor
25344806|NCT05546320|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25344807|NCT05546320|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25344808|NCT05546320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25344809|NCT05546320|Adrenergic Agents|adrenergic agents|mesh-ancestor
25344810|NCT05546242|Dolutegravir|dolutegravir|mesh-list
25344811|NCT05546242|Cabotegravir|cabotegravir|mesh-list
25344812|NCT05546242|Rilpivirine|rilpivirine|mesh-list
25344813|NCT05546242|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25344814|NCT05546242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25344815|NCT05546242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25344816|NCT05546242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344817|NCT05546242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344818|NCT05546242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25344819|NCT05546242|Antiviral Agents|antiviral agents|mesh-ancestor
25344820|NCT05546242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25344821|NCT05546242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25344822|NCT05546242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25344823|NCT05546060|Dexamethasone|dexamethasone|mesh-list
25344824|NCT05546060|Etoposide|etoposide|mesh-list
25344825|NCT05546060|Venetoclax|venetoclax|mesh-list
25344826|NCT05546060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25344827|NCT05546060|Antiemetics|antiemetics|mesh-ancestor
25344828|NCT05546060|Autonomic Agents|autonomic agents|mesh-ancestor
25344829|NCT05546060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25344830|NCT05546060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344831|NCT05546060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25344833|NCT05546060|Hormones|hormones|mesh-ancestor
25344834|NCT05546060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25344835|NCT05546060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25344836|NCT05546060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25344837|NCT05546060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25344838|NCT05546060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25344839|NCT05546060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25344840|NCT05546060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344841|NCT05546060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344842|NCT05546047|Tacrolimus|tacrolimus|mesh-list
25344843|NCT05546047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25344844|NCT05546047|Immunologic Factors|immunologic factors|mesh-ancestor
25344845|NCT05546047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344846|NCT05546047|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25344847|NCT05546047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344848|NCT05546047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344849|NCT05545969|Pembrolizumab|pembrolizumab|mesh-list
25344850|NCT05545969|Lenvatinib|lenvatinib|mesh-list
25344851|NCT05545969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25344852|NCT05545969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25344853|NCT05545969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25344854|NCT05545969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344855|NCT05545969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344856|NCT05545891|Aripiprazole|aripiprazole|mesh-list
25344857|NCT05545891|Antidepressive Agents|antidepressive agents|mesh-ancestor
25344858|NCT05545891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25344859|NCT05545891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25344860|NCT05545891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25344861|NCT05545891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25344862|NCT05545891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344863|NCT05545891|Dopamine Agonists|dopamine agonists|mesh-ancestor
25344864|NCT05545891|Dopamine Agents|dopamine agents|mesh-ancestor
25344865|NCT05545891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25344866|NCT05545891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344867|NCT05545891|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25344868|NCT05545891|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25344869|NCT05545891|Serotonin Agents|serotonin agents|mesh-ancestor
25344870|NCT05545891|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25344871|NCT05545891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25344872|NCT05545891|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25344873|NCT05545891|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25344874|NCT05545800|Insulin|insulin|mesh-list
25344875|NCT05545800|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25344876|NCT05545800|Metformin|metformin|mesh-list
25344877|NCT05545800|Insulin Glargine|insulin glargine|mesh-list
25344878|NCT05545800|Empagliflozin|empagliflozin|mesh-list
25344879|NCT05545800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25344880|NCT05545800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344881|NCT05545800|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25344882|NCT05545800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344883|NCT05545735|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25344884|NCT05545735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25344885|NCT05545670|Allopurinol|allopurinol|mesh-list
25344886|NCT05545670|Antimetabolites|antimetabolites|mesh-ancestor
25345413|NCT05541471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25344887|NCT05545670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344888|NCT05545670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344889|NCT05545670|Gout Suppressants|gout suppressants|mesh-ancestor
25344890|NCT05545670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25344891|NCT05545670|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25344892|NCT05545670|Antioxidants|antioxidants|mesh-ancestor
25344893|NCT05545670|Protective Agents|protective agents|mesh-ancestor
25344894|NCT05545670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344895|NCT05545618|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25344896|NCT05545618|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25344897|NCT05545618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344898|NCT05545592|Estrogens|estrogens|mesh-list
25344899|NCT05545592|Hormones|hormones|mesh-ancestor
25344900|NCT05545592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25344901|NCT05545592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344902|NCT05545527|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25344903|NCT05545527|Ferric Compounds|ferric compounds|mesh-list
25344904|NCT05545527|Hematinics|hematinics|mesh-ancestor
25344905|NCT05545475|Heparin|heparin|mesh-list
25344906|NCT05545475|Enoxaparin|enoxaparin|mesh-list
25344907|NCT05545475|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25344908|NCT05545475|Tinzaparin|tinzaparin|mesh-list
25344909|NCT05545475|Dalteparin|dalteparin|mesh-list
25344910|NCT05545475|Nadroparin|nadroparin|mesh-list
25344911|NCT05545475|Warfarin|warfarin|mesh-list
25344912|NCT05545475|Anticoagulants|anticoagulants|mesh-ancestor
25344913|NCT05545475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25344914|NCT05545475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25344915|NCT05545475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344916|NCT05545462|Doxycycline|doxycycline|mesh-list
25344917|NCT05545462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25344918|NCT05545462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25344919|NCT05545462|Antimalarials|antimalarials|mesh-ancestor
25344920|NCT05545462|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25344921|NCT05545462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25344922|NCT05545436|Capecitabine|capecitabine|mesh-list
25344923|NCT05545436|Oxaliplatin|oxaliplatin|mesh-list
25344924|NCT05545436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25344925|NCT05545436|Antimetabolites|antimetabolites|mesh-ancestor
25344926|NCT05545436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344927|NCT05545436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25344928|NCT05545397|Propofol|propofol|mesh-list
25344929|NCT05545397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25344930|NCT05545397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25344931|NCT05545397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344932|NCT05545397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25344933|NCT05545397|Anesthetics, General|anesthetics, general|mesh-ancestor
25344934|NCT05545397|Anesthetics|anesthetics|mesh-ancestor
25344935|NCT05545384|Rituximab|rituximab|mesh-list
25344936|NCT05545384|Azathioprine|azathioprine|mesh-list
25344937|NCT05545384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25344938|NCT05545384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25344939|NCT05545384|Immunologic Factors|immunologic factors|mesh-ancestor
25344940|NCT05545384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344941|NCT05545384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25344942|NCT05545384|Antimetabolites|antimetabolites|mesh-ancestor
25344943|NCT05545384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344944|NCT05545384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25344945|NCT05545384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25344946|NCT05545319|Ritonavir|ritonavir|mesh-list
25344947|NCT05545319|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25344948|NCT05545319|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25344949|NCT05545319|Protease Inhibitors|protease inhibitors|mesh-ancestor
25344950|NCT05545319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344951|NCT05545319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344952|NCT05545319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25344953|NCT05545319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25344954|NCT05545319|Antiviral Agents|antiviral agents|mesh-ancestor
25344955|NCT05545319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25344956|NCT05545319|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25344957|NCT05545319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25344958|NCT05545280|Neostigmine|neostigmine|mesh-list
25344959|NCT05545280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25344960|NCT05545280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25344961|NCT05545280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344962|NCT05545280|Cholinergic Agents|cholinergic agents|mesh-ancestor
25344963|NCT05545280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25344964|NCT05545280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344965|NCT05545280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25344966|NCT05545280|Autonomic Agents|autonomic agents|mesh-ancestor
25344967|NCT05545280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25344968|NCT05545137|Fosfomycin|fosfomycin|mesh-list
25344969|NCT05545137|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
25344970|NCT05545137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25344971|NCT05545137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25344972|NCT05545137|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25344973|NCT05545137|Renal Agents|renal agents|mesh-ancestor
25344974|NCT05545072|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25344975|NCT05545072|Immunologic Factors|immunologic factors|mesh-ancestor
25344976|NCT05545072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344977|NCT05545059|Amlodipine|amlodipine|mesh-list
25344978|NCT05545059|Valsartan|valsartan|mesh-list
25344979|NCT05545059|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25344980|NCT05545059|Spironolactone|spironolactone|mesh-list
25344981|NCT05545059|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25344982|NCT05545059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25344983|NCT05545059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25344984|NCT05545059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25344985|NCT05545059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25344986|NCT05545059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25344987|NCT05545059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25344988|NCT05545059|Vasodilator Agents|vasodilator agents|mesh-ancestor
25344989|NCT05545059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25344990|NCT05545059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25344991|NCT05545059|Diuretics|diuretics|mesh-ancestor
25344992|NCT05545059|Natriuretic Agents|natriuretic agents|mesh-ancestor
25344993|NCT05545059|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25344994|NCT05545059|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25344995|NCT05545059|Hormone Antagonists|hormone antagonists|mesh-ancestor
25344996|NCT05545059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25344997|NCT05545059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25344998|NCT05545020|Chromium|chromium|mesh-list
25344999|NCT05545020|Trace Elements|trace elements|mesh-ancestor
25345000|NCT05545020|Micronutrients|micronutrients|mesh-ancestor
25345001|NCT05545020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345002|NCT05544968|Antibodies|antibodies|mesh-list
25345003|NCT05544968|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25345004|NCT05544968|Immunologic Factors|immunologic factors|mesh-ancestor
25345005|NCT05544968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345006|NCT05544812|Cetuximab|cetuximab|mesh-list
25345007|NCT05544812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25345008|NCT05544812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345009|NCT05544786|Ritonavir|ritonavir|mesh-list
25345010|NCT05544786|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25345011|NCT05544786|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25345012|NCT05544786|Protease Inhibitors|protease inhibitors|mesh-ancestor
25345013|NCT05544786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25345014|NCT05544786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345015|NCT05544786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25345016|NCT05544786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25345017|NCT05544786|Antiviral Agents|antiviral agents|mesh-ancestor
25345018|NCT05544786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25345019|NCT05544786|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25345020|NCT05544786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25345021|NCT05544734|Acetaminophen|acetaminophen|mesh-list
25345022|NCT05544734|Ibuprofen|ibuprofen|mesh-list
25345023|NCT05544734|Hydrocodone|hydrocodone|mesh-list
25345024|NCT05544734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25345025|NCT05544734|Analgesics|analgesics|mesh-ancestor
25345026|NCT05544734|Sensory System Agents|sensory system agents|mesh-ancestor
25345027|NCT05544734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25345028|NCT05544734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345029|NCT05544734|Antipyretics|antipyretics|mesh-ancestor
25345030|NCT05544734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25345031|NCT05544734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25345032|NCT05544734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25345033|NCT05544734|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25345034|NCT05544734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25345035|NCT05544734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345036|NCT05544734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25345037|NCT05544734|Narcotics|narcotics|mesh-ancestor
25345490|NCT05541016|Antimitotic Agents|antimitotic agents|mesh-ancestor
25345038|NCT05544734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25345039|NCT05544734|Antitussive Agents|antitussive agents|mesh-ancestor
25345040|NCT05544734|Respiratory System Agents|respiratory system agents|mesh-ancestor
25345041|NCT05544721|Ropivacaine|ropivacaine|mesh-list
25345042|NCT05544721|Anesthetics, Local|anesthetics, local|mesh-ancestor
25345043|NCT05544721|Anesthetics|anesthetics|mesh-ancestor
25345044|NCT05544721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25345045|NCT05544721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345046|NCT05544721|Sensory System Agents|sensory system agents|mesh-ancestor
25345047|NCT05544721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25345048|NCT05544695|Hyaluronic Acid|hyaluronic acid|mesh-list
25345049|NCT05544695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25345050|NCT05544695|Immunologic Factors|immunologic factors|mesh-ancestor
25345051|NCT05544695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345052|NCT05544695|Viscosupplements|viscosupplements|mesh-ancestor
25345053|NCT05544695|Protective Agents|protective agents|mesh-ancestor
25345054|NCT05544656|Tolperisone|tolperisone|mesh-list
25345055|NCT05544656|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25345056|NCT05544656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345057|NCT05544656|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25345058|NCT05544656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25345059|NCT05544565|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25345060|NCT05544565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25345061|NCT05544292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25345062|NCT05544253|Mitomycins|mitomycins|mesh-list
25345063|NCT05544253|Mitomycin|mitomycin|mesh-list
25345064|NCT05544253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25345065|NCT05544253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345066|NCT05544253|Alkylating Agents|alkylating agents|mesh-ancestor
25345067|NCT05544253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345068|NCT05544253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25345069|NCT05544253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25345070|NCT05544136|Carboplatin|carboplatin|mesh-list
25345071|NCT05544136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345072|NCT05544071|Sertraline|sertraline|mesh-list
25345073|NCT05544071|Antidepressive Agents|antidepressive agents|mesh-ancestor
25345074|NCT05544071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25345075|NCT05544071|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25345076|NCT05544071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25345077|NCT05544071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25345078|NCT05544071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345079|NCT05544071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25345080|NCT05544071|Serotonin Agents|serotonin agents|mesh-ancestor
25345081|NCT05544071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345082|NCT05544045|Calcium Carbonate|calcium carbonate|mesh-list
25345083|NCT05544045|Antacids|antacids|mesh-ancestor
25345084|NCT05544045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345085|NCT05544045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25345086|NCT05543954|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25345087|NCT05543954|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25345088|NCT05543954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345089|NCT05543941|Povidone-Iodine|povidone-iodine|mesh-list
25345090|NCT05543941|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25345091|NCT05543941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25345092|NCT05543850|Pancrelipase|pancrelipase|mesh-list
25345093|NCT05543850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25345094|NCT05543837|Capsaicin|capsaicin|mesh-list
25345095|NCT05543837|Antipruritics|antipruritics|mesh-ancestor
25345096|NCT05543837|Dermatologic Agents|dermatologic agents|mesh-ancestor
25345097|NCT05543837|Sensory System Agents|sensory system agents|mesh-ancestor
25345098|NCT05543837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25345099|NCT05543837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345100|NCT05543824|Levobupivacaine|levobupivacaine|mesh-list
25345101|NCT05543824|Anesthetics, Local|anesthetics, local|mesh-ancestor
25345102|NCT05543824|Anesthetics|anesthetics|mesh-ancestor
25345103|NCT05543824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25345104|NCT05543824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345105|NCT05543824|Sensory System Agents|sensory system agents|mesh-ancestor
25345106|NCT05543824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25345107|NCT05543785|Ketorolac|ketorolac|mesh-list
25345108|NCT05543785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25345109|NCT05543785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25345110|NCT05543785|Analgesics|analgesics|mesh-ancestor
25345111|NCT05543785|Sensory System Agents|sensory system agents|mesh-ancestor
25345112|NCT05543785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25345113|NCT05543785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345114|NCT05543785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25345115|NCT05543785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25345116|NCT05543785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25345117|NCT05543785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25345118|NCT05543785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345119|NCT05543746|Brexanolone|brexanolone|mesh-list
25345120|NCT05543746|Neurosteroids|neurosteroids|mesh-ancestor
25345121|NCT05543746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25345122|NCT05543746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345123|NCT05543746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345124|NCT05543746|GABA Modulators|gaba modulators|mesh-ancestor
25345125|NCT05543746|GABA Agents|gaba agents|mesh-ancestor
25345126|NCT05543694|Bupivacaine|bupivacaine|mesh-list
25345130|NCT05543694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345131|NCT05543694|Sensory System Agents|sensory system agents|mesh-ancestor
25345132|NCT05543694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25345136|NCT05543629|Paclitaxel|paclitaxel|mesh-list
25345137|NCT05543629|Docetaxel|docetaxel|mesh-list
25345138|NCT05543629|Carboplatin|carboplatin|mesh-list
25345139|NCT05543629|Nivolumab|nivolumab|mesh-list
25345140|NCT05543629|Taxane|taxane|mesh-list
25345141|NCT05543629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25345142|NCT05543629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345143|NCT05543629|Tubulin Modulators|tubulin modulators|mesh-ancestor
25345144|NCT05543629|Antimitotic Agents|antimitotic agents|mesh-ancestor
25345145|NCT05543629|Mitosis Modulators|mitosis modulators|mesh-ancestor
25345146|NCT05543629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345147|NCT05543629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25345148|NCT05543629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25345149|NCT05543603|Chlorhexidine|chlorhexidine|mesh-list
25345150|NCT05543603|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25345151|NCT05543603|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25345152|NCT05543603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25345153|NCT05543603|Disinfectants|disinfectants|mesh-ancestor
25345154|NCT05543603|Dermatologic Agents|dermatologic agents|mesh-ancestor
25345155|NCT05543434|Hyaluronic Acid|hyaluronic acid|mesh-list
25345156|NCT05543434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25345157|NCT05543434|Immunologic Factors|immunologic factors|mesh-ancestor
25345158|NCT05543434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345159|NCT05543434|Viscosupplements|viscosupplements|mesh-ancestor
25345160|NCT05543434|Protective Agents|protective agents|mesh-ancestor
25345161|NCT05543330|Cisplatin|cisplatin|mesh-list
25345162|NCT05543330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345163|NCT05543317|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25345164|NCT05543317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25345165|NCT05543317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345166|NCT05543278|Amiodarone|amiodarone|mesh-list
25345167|NCT05543278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25345168|NCT05543278|Vasodilator Agents|vasodilator agents|mesh-ancestor
25345169|NCT05543278|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
25345170|NCT05543278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25345171|NCT05543278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345172|NCT05543278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25345173|NCT05543278|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25345174|NCT05543278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25345175|NCT05543278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25345176|NCT05543278|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25345177|NCT05543278|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25345178|NCT05543278|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25345179|NCT05543122|Fluconazole|fluconazole|mesh-list
25345180|NCT05543122|Methotrexate|methotrexate|mesh-list
25345181|NCT05543122|Atenolol|atenolol|mesh-list
25345182|NCT05543122|Lamotrigine|lamotrigine|mesh-list
25345183|NCT05543122|Lacosamide|lacosamide|mesh-list
25345184|NCT05543122|Levetiracetam|levetiracetam|mesh-list
25345185|NCT05543122|Brivaracetam|brivaracetam|mesh-list
25345186|NCT05543122|Citalopram|citalopram|mesh-list
25345187|NCT05543122|Bupropion|bupropion|mesh-list
25345188|NCT05543122|Ezetimibe|ezetimibe|mesh-list
25345189|NCT05543122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25345190|NCT05543122|Abortifacient Agents|abortifacient agents|mesh-ancestor
25345191|NCT05543122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25345192|NCT05543122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345193|NCT05543122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25345194|NCT05543122|Antimetabolites|antimetabolites|mesh-ancestor
25345195|NCT05543122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345196|NCT05543122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345197|NCT05543122|Dermatologic Agents|dermatologic agents|mesh-ancestor
25345219|NCT05543122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25345220|NCT05543122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25345221|NCT05543122|Anticonvulsants|anticonvulsants|mesh-ancestor
25345222|NCT05543122|Nootropic Agents|nootropic agents|mesh-ancestor
25345223|NCT05543122|Antifungal Agents|antifungal agents|mesh-ancestor
25345224|NCT05543122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25345225|NCT05543122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25345226|NCT05543122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25345227|NCT05543122|Hormone Antagonists|hormone antagonists|mesh-ancestor
25345228|NCT05543122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25345229|NCT05543122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25345230|NCT05543122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25345231|NCT05543122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25345232|NCT05543122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25345233|NCT05543122|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25345234|NCT05543122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25345235|NCT05543122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25345236|NCT05543122|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25345237|NCT05543122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25345238|NCT05543122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25345239|NCT05543122|Sympatholytics|sympatholytics|mesh-ancestor
25345240|NCT05543122|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25345241|NCT05543122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25345242|NCT05543122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25345243|NCT05543122|Adrenergic Agents|adrenergic agents|mesh-ancestor
25345244|NCT05543122|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25345268|NCT05542849|Acarbose|acarbose|mesh-list
25345269|NCT05542849|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25345270|NCT05542849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25345271|NCT05542849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345272|NCT05542849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25345273|NCT05542849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345274|NCT05542667|Fluorides|fluorides|mesh-list
25345275|NCT05542667|Fluorides, Topical|fluorides, topical|mesh-list
25345276|NCT05542667|Cariostatic Agents|cariostatic agents|mesh-ancestor
25345277|NCT05542667|Protective Agents|protective agents|mesh-ancestor
25345278|NCT05542667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345279|NCT05542615|Pirfenidone|pirfenidone|mesh-list
25345280|NCT05542615|Analgesics|analgesics|mesh-ancestor
25345281|NCT05542615|Sensory System Agents|sensory system agents|mesh-ancestor
25345282|NCT05542615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25345283|NCT05542615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345284|NCT05542615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25345285|NCT05542615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25345286|NCT05542615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25345287|NCT05542615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25345288|NCT05542615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345289|NCT05542589|Phenytoin|phenytoin|mesh-list
25345290|NCT05542589|Anticonvulsants|anticonvulsants|mesh-ancestor
25345291|NCT05542589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25345292|NCT05542589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25345293|NCT05542589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25345294|NCT05542589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345295|NCT05542589|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25345296|NCT05542589|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25345297|NCT05542446|Colistin|colistin|mesh-list
25345298|NCT05542446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25345299|NCT05542446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25345300|NCT05542433|Chiauranib|chiauranib|mesh-list
25345301|NCT05542433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345302|NCT05542433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25345303|NCT05542433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25345304|NCT05542433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345305|NCT05542407|Atezolizumab|atezolizumab|mesh-list
25345306|NCT05542407|TIC10 compound|tic10 compound|mesh-list
25345307|NCT05542407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345308|NCT05542394|Curcumin|curcumin|mesh-list
25345309|NCT05542394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25345310|NCT05542394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25345311|NCT05542394|Analgesics|analgesics|mesh-ancestor
25345312|NCT05542394|Sensory System Agents|sensory system agents|mesh-ancestor
25345313|NCT05542394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25345314|NCT05542394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345315|NCT05542394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25345316|NCT05542394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25345317|NCT05542394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345318|NCT05542394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25345319|NCT05542394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345320|NCT05542381|Loteprednol Etabonate|loteprednol etabonate|mesh-list
25345321|NCT05542381|Nepafenac|nepafenac|mesh-list
25345322|NCT05542381|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25345323|NCT05542381|Lubricant Eye Drops|lubricant eye drops|mesh-list
25345324|NCT05542381|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25345325|NCT05542381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25345326|NCT05542381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25345327|NCT05542381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25345328|NCT05542381|Analgesics|analgesics|mesh-ancestor
25345329|NCT05542381|Sensory System Agents|sensory system agents|mesh-ancestor
25345330|NCT05542381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25345331|NCT05542381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345332|NCT05542381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25345333|NCT05542381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25345334|NCT05542264|Olanzapine|olanzapine|mesh-list
25345335|NCT05542264|Risperidone|risperidone|mesh-list
25345336|NCT05542264|Aripiprazole|aripiprazole|mesh-list
25345337|NCT05542264|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25345338|NCT05542264|Antipsychotic Agents|antipsychotic agents|mesh-list
25345339|NCT05542264|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25345340|NCT05542264|Serotonin Agents|serotonin agents|mesh-ancestor
25345341|NCT05542264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25345342|NCT05542264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345343|NCT05542264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345344|NCT05542264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25345345|NCT05542264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25345346|NCT05542264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25345347|NCT05542264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25345348|NCT05542264|Dopamine Agents|dopamine agents|mesh-ancestor
25345349|NCT05542264|Antiemetics|antiemetics|mesh-ancestor
25345350|NCT05542264|Autonomic Agents|autonomic agents|mesh-ancestor
25345351|NCT05542264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25345352|NCT05542264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25345582|NCT05540275|Growth Substances|growth substances|mesh-ancestor
25345353|NCT05542264|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25345354|NCT05542264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25345355|NCT05542264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25345356|NCT05542264|Antidepressive Agents|antidepressive agents|mesh-ancestor
25345357|NCT05542264|Dopamine Agonists|dopamine agonists|mesh-ancestor
25345358|NCT05542264|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25345359|NCT05542264|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25345360|NCT05542264|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25345361|NCT05542264|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25345362|NCT05542147|Fenofibrate|fenofibrate|mesh-list
25345363|NCT05542147|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25345364|NCT05542147|Antimetabolites|antimetabolites|mesh-ancestor
25345365|NCT05542147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345366|NCT05542147|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25345367|NCT05542134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25345368|NCT05542095|Simvastatin|simvastatin|mesh-list
25345369|NCT05542095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25345370|NCT05542095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25345371|NCT05542095|Antimetabolites|antimetabolites|mesh-ancestor
25345372|NCT05542095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345373|NCT05542095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25345374|NCT05542095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25345375|NCT05542095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25345377|NCT05541757|Anticoagulants|anticoagulants|mesh-ancestor
25345378|NCT05541757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25345379|NCT05541757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25345380|NCT05541757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345381|NCT05541640|Lidocaine|lidocaine|mesh-list
25345382|NCT05541640|Anesthetics, Local|anesthetics, local|mesh-ancestor
25345383|NCT05541640|Anesthetics|anesthetics|mesh-ancestor
25345384|NCT05541640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25345385|NCT05541640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345386|NCT05541640|Sensory System Agents|sensory system agents|mesh-ancestor
25345387|NCT05541640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25345388|NCT05541640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25345389|NCT05541640|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25345390|NCT05541640|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25345391|NCT05541640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25345392|NCT05541640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345393|NCT05541497|Varenicline|varenicline|mesh-list
25345394|NCT05541497|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25345395|NCT05541497|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25345396|NCT05541497|Cholinergic Agents|cholinergic agents|mesh-ancestor
25345397|NCT05541497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25345398|NCT05541497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345399|NCT05541497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345400|NCT05541484|Dapagliflozin|dapagliflozin|mesh-list
25345401|NCT05541484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25345402|NCT05541484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345403|NCT05541484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25345404|NCT05541484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345405|NCT05541471|Digoxin|digoxin|mesh-list
25345406|NCT05541471|Midazolam|midazolam|mesh-list
25345407|NCT05541471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25345408|NCT05541471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25345409|NCT05541471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25345410|NCT05541471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345411|NCT05541471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25345412|NCT05541471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25345414|NCT05541471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25345415|NCT05541471|Anesthetics, General|anesthetics, general|mesh-ancestor
25345417|NCT05541471|GABA Modulators|gaba modulators|mesh-ancestor
25345418|NCT05541471|GABA Agents|gaba agents|mesh-ancestor
25345419|NCT05541471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25345420|NCT05541471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345421|NCT05541471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25345422|NCT05541471|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25345423|NCT05541471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25345424|NCT05541471|Protective Agents|protective agents|mesh-ancestor
25345425|NCT05541445|Pembrolizumab|pembrolizumab|mesh-list
25345426|NCT05541445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25345427|NCT05541445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345428|NCT05541419|Budesonide|budesonide|mesh-list
25345429|NCT05541419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25345430|NCT05541419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25345431|NCT05541419|Autonomic Agents|autonomic agents|mesh-ancestor
25345432|NCT05541419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25345433|NCT05541419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345434|NCT05541419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25345435|NCT05541419|Respiratory System Agents|respiratory system agents|mesh-ancestor
25345436|NCT05541419|Glucocorticoids|glucocorticoids|mesh-ancestor
25345437|NCT05541419|Hormones|hormones|mesh-ancestor
25345438|NCT05541419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25345439|NCT05541276|Melatonin|melatonin|mesh-list
25345440|NCT05541276|Antioxidants|antioxidants|mesh-ancestor
25345441|NCT05541276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345442|NCT05541276|Protective Agents|protective agents|mesh-ancestor
25345443|NCT05541276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345444|NCT05541276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25345445|NCT05541185|Naproxen|naproxen|mesh-list
25345446|NCT05541185|Lidocaine|lidocaine|mesh-list
25345447|NCT05541185|Anesthetics, Local|anesthetics, local|mesh-ancestor
25345448|NCT05541185|Anesthetics|anesthetics|mesh-ancestor
25345449|NCT05541185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25345450|NCT05541185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345451|NCT05541185|Sensory System Agents|sensory system agents|mesh-ancestor
25345452|NCT05541185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25345453|NCT05541185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25345454|NCT05541185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25345455|NCT05541185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25345456|NCT05541185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25345457|NCT05541185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345458|NCT05541185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25345459|NCT05541185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25345460|NCT05541185|Analgesics|analgesics|mesh-ancestor
25345461|NCT05541185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25345462|NCT05541185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25345463|NCT05541185|Gout Suppressants|gout suppressants|mesh-ancestor
25345464|NCT05541185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25345465|NCT05541185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25345466|NCT05541172|Methyltestosterone|methyltestosterone|mesh-list
25345467|NCT05541172|Testosterone|testosterone|mesh-list
25345468|NCT05541172|Testosterone undecanoate|testosterone undecanoate|mesh-list
25345469|NCT05541172|Testosterone enanthate|testosterone enanthate|mesh-list
25345470|NCT05541172|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25345471|NCT05541172|Androgens|androgens|mesh-ancestor
25345472|NCT05541172|Hormones|hormones|mesh-ancestor
25345473|NCT05541172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25345474|NCT05541172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345475|NCT05541172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25345476|NCT05541172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345477|NCT05541172|Anabolic Agents|anabolic agents|mesh-ancestor
25345478|NCT05541107|Amphotericin B|amphotericin b|mesh-list
25345479|NCT05541107|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25345480|NCT05541107|Amebicides|amebicides|mesh-ancestor
25345481|NCT05541107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25345482|NCT05541107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25345483|NCT05541107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25345484|NCT05541107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25345485|NCT05541107|Antifungal Agents|antifungal agents|mesh-ancestor
25345486|NCT05541016|Cisplatin|cisplatin|mesh-list
25345487|NCT05541016|Docetaxel|docetaxel|mesh-list
25345488|NCT05541016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345489|NCT05541016|Tubulin Modulators|tubulin modulators|mesh-ancestor
25345491|NCT05541016|Mitosis Modulators|mitosis modulators|mesh-ancestor
25345492|NCT05541016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345493|NCT05540977|Donepezil|donepezil|mesh-list
25345494|NCT05540977|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25345495|NCT05540977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25345496|NCT05540977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345497|NCT05540977|Cholinergic Agents|cholinergic agents|mesh-ancestor
25345498|NCT05540977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25345499|NCT05540977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345500|NCT05540977|Nootropic Agents|nootropic agents|mesh-ancestor
25345501|NCT05540964|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25345502|NCT05540964|Antiviral Agents|antiviral agents|mesh-ancestor
25345503|NCT05540964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25345504|NCT05540951|Bevacizumab|bevacizumab|mesh-list
25345812|NCT05538247|Indomethacin|indomethacin|mesh-list
25345505|NCT05540951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25345506|NCT05540951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345507|NCT05540951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25345508|NCT05540951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25345509|NCT05540951|Growth Substances|growth substances|mesh-ancestor
25345510|NCT05540951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345511|NCT05540951|Growth Inhibitors|growth inhibitors|mesh-ancestor
25345512|NCT05540834|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25345514|NCT05540834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25345515|NCT05540834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25345516|NCT05540834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345517|NCT05540743|Adalimumab|adalimumab|mesh-list
25345518|NCT05540743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25345519|NCT05540743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25345520|NCT05540600|Digoxin|digoxin|mesh-list
25345521|NCT05540600|Bisoprolol|bisoprolol|mesh-list
25345522|NCT05540600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25345523|NCT05540600|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25345524|NCT05540600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25345525|NCT05540600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345526|NCT05540600|Protective Agents|protective agents|mesh-ancestor
25345527|NCT05540600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345528|NCT05540600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25345529|NCT05540600|Sympatholytics|sympatholytics|mesh-ancestor
25345530|NCT05540600|Autonomic Agents|autonomic agents|mesh-ancestor
25345531|NCT05540600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25345532|NCT05540600|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25345533|NCT05540600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25345534|NCT05540600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25345535|NCT05540600|Adrenergic Agents|adrenergic agents|mesh-ancestor
25345536|NCT05540600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25345537|NCT05540587|Warfarin|warfarin|mesh-list
25345538|NCT05540587|Edoxaban|edoxaban|mesh-list
25345539|NCT05540587|Anticoagulants|anticoagulants|mesh-ancestor
25345540|NCT05540587|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25345541|NCT05540587|Antithrombins|antithrombins|mesh-ancestor
25345542|NCT05540587|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25345543|NCT05540587|Protease Inhibitors|protease inhibitors|mesh-ancestor
25345544|NCT05540587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25345545|NCT05540587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345546|NCT05540574|Zolpidem|zolpidem|mesh-list
25345547|NCT05540574|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25345548|NCT05540574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25345549|NCT05540574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25345550|NCT05540574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345551|NCT05540574|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25345552|NCT05540574|GABA Agonists|gaba agonists|mesh-ancestor
25345553|NCT05540574|GABA Agents|gaba agents|mesh-ancestor
25345554|NCT05540574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25345555|NCT05540574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345556|NCT05540522|Vaccines|vaccines|mesh-list
25345557|NCT05540522|Immunologic Factors|immunologic factors|mesh-ancestor
25345558|NCT05540522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345559|NCT05540470|Chloroquine|chloroquine|mesh-list
25345560|NCT05540470|Primaquine|primaquine|mesh-list
25345561|NCT05540470|Tafenoquine|tafenoquine|mesh-list
25345562|NCT05540470|Amebicides|amebicides|mesh-ancestor
25345563|NCT05540470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25345564|NCT05540470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25345565|NCT05540470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25345566|NCT05540470|Antimalarials|antimalarials|mesh-ancestor
25345567|NCT05540470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25345568|NCT05540431|Charcoal|charcoal|mesh-list
25345569|NCT05540431|Antidotes|antidotes|mesh-ancestor
25345570|NCT05540431|Protective Agents|protective agents|mesh-ancestor
25345571|NCT05540431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345572|NCT05540288|Nalmefene|nalmefene|mesh-list
25345573|NCT05540288|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25345574|NCT05540288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345575|NCT05540288|Sensory System Agents|sensory system agents|mesh-ancestor
25345576|NCT05540288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25345577|NCT05540275|Bevacizumab|bevacizumab|mesh-list
25345578|NCT05540275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25345579|NCT05540275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345580|NCT05540275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25345581|NCT05540275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25345583|NCT05540275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345584|NCT05540275|Growth Inhibitors|growth inhibitors|mesh-ancestor
25345585|NCT05540262|Edaravone|edaravone|mesh-list
25345586|NCT05540262|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25345587|NCT05540262|Antioxidants|antioxidants|mesh-ancestor
25345588|NCT05540262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345589|NCT05540262|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25345590|NCT05540262|Protective Agents|protective agents|mesh-ancestor
25345591|NCT05540262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345592|NCT05540223|Sirolimus|sirolimus|mesh-list
25345593|NCT05540223|Everolimus|everolimus|mesh-list
25345594|NCT05540223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345595|NCT05540223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25345596|NCT05540223|Immunologic Factors|immunologic factors|mesh-ancestor
25345597|NCT05540223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345598|NCT05540223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25345599|NCT05540223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25345600|NCT05540223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25345601|NCT05540223|Antifungal Agents|antifungal agents|mesh-ancestor
25345602|NCT05540184|Allopurinol|allopurinol|mesh-list
25345603|NCT05540184|Trimetazidine|trimetazidine|mesh-list
25345604|NCT05540184|Antimetabolites|antimetabolites|mesh-ancestor
25345605|NCT05540184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345606|NCT05540184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25345607|NCT05540184|Gout Suppressants|gout suppressants|mesh-ancestor
25345608|NCT05540184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25345609|NCT05540184|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25345610|NCT05540184|Antioxidants|antioxidants|mesh-ancestor
25345611|NCT05540184|Protective Agents|protective agents|mesh-ancestor
25345612|NCT05540184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345613|NCT05540184|Vasodilator Agents|vasodilator agents|mesh-ancestor
25345614|NCT05540145|Paclitaxel|paclitaxel|mesh-list
25345615|NCT05540145|Antibodies|antibodies|mesh-list
25345616|NCT05540145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25345617|NCT05540145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345618|NCT05540145|Tubulin Modulators|tubulin modulators|mesh-ancestor
25345619|NCT05540145|Antimitotic Agents|antimitotic agents|mesh-ancestor
25345620|NCT05540145|Mitosis Modulators|mitosis modulators|mesh-ancestor
25345621|NCT05540145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345622|NCT05540145|Immunologic Factors|immunologic factors|mesh-ancestor
25345623|NCT05540145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345624|NCT05539989|Vaccines|vaccines|mesh-list
25345625|NCT05539989|BCG Vaccine|bcg vaccine|mesh-list
25345626|NCT05539989|Immunologic Factors|immunologic factors|mesh-ancestor
25345627|NCT05539989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345628|NCT05539989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25345629|NCT05539963|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25345630|NCT05539963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25345631|NCT05539924|Vitamin B 12|vitamin b 12|mesh-list
25345632|NCT05539924|Pregabalin|pregabalin|mesh-list
25345633|NCT05539924|Gabapentin|gabapentin|mesh-list
25345634|NCT05539924|Vitamins|vitamins|mesh-ancestor
25345635|NCT05539924|Micronutrients|micronutrients|mesh-ancestor
25345636|NCT05539924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345637|NCT05539924|Analgesics|analgesics|mesh-ancestor
25345638|NCT05539924|Sensory System Agents|sensory system agents|mesh-ancestor
25345639|NCT05539924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25345640|NCT05539924|Anticonvulsants|anticonvulsants|mesh-ancestor
25345641|NCT05539924|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25345642|NCT05539924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25345643|NCT05539924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345644|NCT05539924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25345645|NCT05539924|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25345646|NCT05539924|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25345647|NCT05539924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25345648|NCT05539924|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25345649|NCT05539924|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25345650|NCT05539924|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25345651|NCT05539924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25345652|NCT05539924|Antimanic Agents|antimanic agents|mesh-ancestor
25345653|NCT05539924|Vitamin B Complex|vitamin b complex|mesh-ancestor
25345654|NCT05539911|Fentanyl|fentanyl|mesh-list
25345655|NCT05539911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25345656|NCT05539911|Narcotics|narcotics|mesh-ancestor
25345657|NCT05539911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25345658|NCT05539911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345659|NCT05539911|Analgesics|analgesics|mesh-ancestor
25345660|NCT05539911|Sensory System Agents|sensory system agents|mesh-ancestor
25345675|NCT05539729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25345677|NCT05539521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25345678|NCT05539521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25345679|NCT05539521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345680|NCT05539521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25345681|NCT05539521|Anesthetics, General|anesthetics, general|mesh-ancestor
25345682|NCT05539521|Anesthetics|anesthetics|mesh-ancestor
25345683|NCT05539391|Rocuronium|rocuronium|mesh-list
25345684|NCT05539391|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25345685|NCT05539391|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25345686|NCT05539391|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25345687|NCT05539391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25345688|NCT05539391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345689|NCT05539365|Pembrolizumab|pembrolizumab|mesh-list
25345690|NCT05539365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25345691|NCT05539365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345692|NCT05539118|Interferons|interferons|mesh-list
25345693|NCT05539118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345694|NCT05539118|Antiviral Agents|antiviral agents|mesh-ancestor
25345695|NCT05539118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25345696|NCT05539053|Acetylcysteine|acetylcysteine|mesh-list
25345697|NCT05539053|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25345698|NCT05539053|Antiviral Agents|antiviral agents|mesh-ancestor
25345699|NCT05539053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25345700|NCT05539053|Expectorants|expectorants|mesh-ancestor
25345701|NCT05539053|Respiratory System Agents|respiratory system agents|mesh-ancestor
25345702|NCT05539053|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25345703|NCT05539053|Antioxidants|antioxidants|mesh-ancestor
25345704|NCT05539053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345705|NCT05539053|Protective Agents|protective agents|mesh-ancestor
25345706|NCT05539053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345707|NCT05539053|Antidotes|antidotes|mesh-ancestor
25345708|NCT05539027|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25345709|NCT05539027|N-Methylaspartate|n-methylaspartate|mesh-list
25345710|NCT05539027|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
25345711|NCT05539027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25345712|NCT05539027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25345713|NCT05539027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345714|NCT05539027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345715|NCT05538988|Cemiplimab|cemiplimab|mesh-list
25345716|NCT05538988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25345717|NCT05538988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345733|NCT05538897|Megestrol|megestrol|mesh-list
25345734|NCT05538897|Megestrol Acetate|megestrol acetate|mesh-list
25345735|NCT05538897|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25345736|NCT05538897|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25346266|NCT05535569|Tubulin Modulators|tubulin modulators|mesh-ancestor
25345737|NCT05538897|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25345738|NCT05538897|Contraceptive Agents|contraceptive agents|mesh-ancestor
25345739|NCT05538897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25345740|NCT05538897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345741|NCT05538897|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25345742|NCT05538897|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25345743|NCT05538897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25345744|NCT05538897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345745|NCT05538897|Appetite Stimulants|appetite stimulants|mesh-ancestor
25345746|NCT05538897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25345747|NCT05538819|Glimepiride|glimepiride|mesh-list
25345748|NCT05538819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25345749|NCT05538819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25345750|NCT05538819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345751|NCT05538819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25345752|NCT05538819|Immunologic Factors|immunologic factors|mesh-ancestor
25345753|NCT05538767|Albendazole|albendazole|mesh-list
25345754|NCT05538767|Emodepside|emodepside|mesh-list
25345755|NCT05538767|Anthelmintics|anthelmintics|mesh-ancestor
25345756|NCT05538767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25345757|NCT05538767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25345758|NCT05538767|Anticestodal Agents|anticestodal agents|mesh-ancestor
25345759|NCT05538767|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25345760|NCT05538767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25345761|NCT05538767|Tubulin Modulators|tubulin modulators|mesh-ancestor
25345762|NCT05538767|Antimitotic Agents|antimitotic agents|mesh-ancestor
25345763|NCT05538767|Mitosis Modulators|mitosis modulators|mesh-ancestor
25345764|NCT05538767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345765|NCT05538767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345766|NCT05538702|Menthol|menthol|mesh-list
25345767|NCT05538702|Antipruritics|antipruritics|mesh-ancestor
25345768|NCT05538702|Dermatologic Agents|dermatologic agents|mesh-ancestor
25345769|NCT05538663|Gemcitabine|gemcitabine|mesh-list
25345770|NCT05538663|Docetaxel|docetaxel|mesh-list
25345771|NCT05538663|BCG Vaccine|bcg vaccine|mesh-list
25345772|NCT05538663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25345773|NCT05538663|Antimetabolites|antimetabolites|mesh-ancestor
25345774|NCT05538663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345775|NCT05538663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345776|NCT05538663|Antiviral Agents|antiviral agents|mesh-ancestor
25345777|NCT05538663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25345778|NCT05538663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25345779|NCT05538663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25345780|NCT05538663|Immunologic Factors|immunologic factors|mesh-ancestor
25345781|NCT05538663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345782|NCT05538663|Tubulin Modulators|tubulin modulators|mesh-ancestor
25345783|NCT05538663|Antimitotic Agents|antimitotic agents|mesh-ancestor
25345784|NCT05538663|Mitosis Modulators|mitosis modulators|mesh-ancestor
25345785|NCT05538663|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25345786|NCT05538507|Memantine|memantine|mesh-list
25345787|NCT05538507|Donepezil|donepezil|mesh-list
25345788|NCT05538507|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25345789|NCT05538507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25345790|NCT05538507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345791|NCT05538507|Cholinergic Agents|cholinergic agents|mesh-ancestor
25345792|NCT05538507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25345793|NCT05538507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345794|NCT05538507|Nootropic Agents|nootropic agents|mesh-ancestor
25345795|NCT05538507|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25345796|NCT05538507|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25345797|NCT05538507|Dopamine Agents|dopamine agents|mesh-ancestor
25345798|NCT05538507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25345799|NCT05538507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25345800|NCT05538312|Itraconazole|itraconazole|mesh-list
25345801|NCT05538312|Antifungal Agents|antifungal agents|mesh-ancestor
25345802|NCT05538312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25345803|NCT05538312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25345804|NCT05538312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25345805|NCT05538312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25345806|NCT05538312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345807|NCT05538312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25345808|NCT05538312|Hormone Antagonists|hormone antagonists|mesh-ancestor
25345809|NCT05538312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25345810|NCT05538312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345811|NCT05538312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25345813|NCT05538247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25345814|NCT05538247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25345816|NCT05538247|Sensory System Agents|sensory system agents|mesh-ancestor
25345817|NCT05538247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25345818|NCT05538247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345819|NCT05538247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25345820|NCT05538247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25345821|NCT05538247|Gout Suppressants|gout suppressants|mesh-ancestor
25345822|NCT05538247|Tocolytic Agents|tocolytic agents|mesh-ancestor
25345823|NCT05538247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25345824|NCT05538247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25345825|NCT05538247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25345826|NCT05538247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345827|NCT05538208|Mycophenolic Acid|mycophenolic acid|mesh-list
25345828|NCT05538208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25345829|NCT05538208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345830|NCT05538208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25345831|NCT05538208|Antitubercular Agents|antitubercular agents|mesh-ancestor
25345832|NCT05538208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25345833|NCT05538208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25345834|NCT05538208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25345835|NCT05538208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345836|NCT05538091|Atezolizumab|atezolizumab|mesh-list
25378477|NCT04766450|Expectorants|expectorants|mesh-ancestor
25345837|NCT05538091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345839|NCT05538052|Tramadol|tramadol|mesh-list
25345840|NCT05538052|Anesthetics, Local|anesthetics, local|mesh-ancestor
25345841|NCT05538052|Anesthetics|anesthetics|mesh-ancestor
25345842|NCT05538052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25345843|NCT05538052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345844|NCT05538052|Sensory System Agents|sensory system agents|mesh-ancestor
25345845|NCT05538052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25345846|NCT05538052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25345847|NCT05538052|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25345848|NCT05538052|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25345849|NCT05538052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25345850|NCT05538052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345851|NCT05538052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25345852|NCT05538052|Narcotics|narcotics|mesh-ancestor
25345853|NCT05538052|Analgesics|analgesics|mesh-ancestor
25345854|NCT05538026|Mesalamine|mesalamine|mesh-list
25345855|NCT05538026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25345856|NCT05538026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25345857|NCT05538026|Analgesics|analgesics|mesh-ancestor
25345858|NCT05538026|Sensory System Agents|sensory system agents|mesh-ancestor
25345859|NCT05538026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25345860|NCT05538026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345861|NCT05538026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25345862|NCT05538026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25345863|NCT05537948|Pitavastatin|pitavastatin|mesh-list
25345864|NCT05537948|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25345865|NCT05537948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25345866|NCT05537948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25345867|NCT05537948|Antimetabolites|antimetabolites|mesh-ancestor
25345868|NCT05537948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345869|NCT05537948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25345870|NCT05537948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25345871|NCT05537935|Naltrexone|naltrexone|mesh-list
25345872|NCT05537935|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25345873|NCT05537935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25345874|NCT05537935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345875|NCT05537935|Sensory System Agents|sensory system agents|mesh-ancestor
25345876|NCT05537935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25345877|NCT05537883|Bupivacaine|bupivacaine|mesh-list
25345878|NCT05537883|Anesthetics, Local|anesthetics, local|mesh-ancestor
25345879|NCT05537883|Anesthetics|anesthetics|mesh-ancestor
25345880|NCT05537883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25345881|NCT05537883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345882|NCT05537883|Sensory System Agents|sensory system agents|mesh-ancestor
25345883|NCT05537883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25345884|NCT05537766|Cyclophosphamide|cyclophosphamide|mesh-list
25345885|NCT05537766|Fludarabine|fludarabine|mesh-list
25345886|NCT05537766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25345887|NCT05537766|Immunologic Factors|immunologic factors|mesh-ancestor
25345888|NCT05537766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345889|NCT05537766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25345890|NCT05537766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25345891|NCT05537766|Alkylating Agents|alkylating agents|mesh-ancestor
25345892|NCT05537766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345893|NCT05537766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345894|NCT05537766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25345895|NCT05537740|Pembrolizumab|pembrolizumab|mesh-list
25345896|NCT05537740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25345897|NCT05537740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345899|NCT05537584|Sertraline|sertraline|mesh-list
25345900|NCT05537584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25345901|NCT05537584|Antidepressive Agents|antidepressive agents|mesh-ancestor
25345902|NCT05537584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25345903|NCT05537584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25345904|NCT05537584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25345905|NCT05537584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25345906|NCT05537584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345907|NCT05537584|Dopamine Agents|dopamine agents|mesh-ancestor
25345908|NCT05537584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25345909|NCT05537584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345910|NCT05537584|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25724201|NCT02535806|Vincristine|vincristine|mesh-list
25345911|NCT05537584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25345912|NCT05537584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25345913|NCT05537584|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25345914|NCT05537584|Serotonin Agents|serotonin agents|mesh-ancestor
25345915|NCT05537558|Antidepressive Agents|antidepressive agents|mesh-list
25345916|NCT05537558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25345917|NCT05537402|Bevacizumab|bevacizumab|mesh-list
25345918|NCT05537402|Atezolizumab|atezolizumab|mesh-list
25345919|NCT05537402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25345920|NCT05537402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345921|NCT05537402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25345922|NCT05537402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25345923|NCT05537402|Growth Substances|growth substances|mesh-ancestor
25345924|NCT05537402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345925|NCT05537402|Growth Inhibitors|growth inhibitors|mesh-ancestor
24452983|NCT05378113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
24452984|NCT05378113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25345926|NCT05537272|Ascorbic Acid|ascorbic acid|mesh-list
25345928|NCT05537272|Tamsulosin|tamsulosin|mesh-list
25345929|NCT05537272|Vitamins|vitamins|mesh-ancestor
25345930|NCT05537272|Micronutrients|micronutrients|mesh-ancestor
25345931|NCT05537272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345932|NCT05537272|Antioxidants|antioxidants|mesh-ancestor
25345933|NCT05537272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345934|NCT05537272|Protective Agents|protective agents|mesh-ancestor
25345935|NCT05537272|Vasodilator Agents|vasodilator agents|mesh-ancestor
25345936|NCT05537272|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25345937|NCT05537272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25345938|NCT05537272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25345939|NCT05537272|Urological Agents|urological agents|mesh-ancestor
25345940|NCT05537272|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25345941|NCT05537272|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25345942|NCT05537272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25345943|NCT05537272|Adrenergic Agents|adrenergic agents|mesh-ancestor
25345944|NCT05537272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25345945|NCT05537220|Acetylcysteine|acetylcysteine|mesh-list
25345946|NCT05537220|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25345947|NCT05537220|Antiviral Agents|antiviral agents|mesh-ancestor
25345948|NCT05537220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25345949|NCT05537220|Expectorants|expectorants|mesh-ancestor
25345950|NCT05537220|Respiratory System Agents|respiratory system agents|mesh-ancestor
25345951|NCT05537220|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25345952|NCT05537220|Antioxidants|antioxidants|mesh-ancestor
25345953|NCT05537220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345954|NCT05537220|Protective Agents|protective agents|mesh-ancestor
25345955|NCT05537220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345956|NCT05537220|Antidotes|antidotes|mesh-ancestor
25345957|NCT05537194|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
25345958|NCT05537194|Calcium|calcium|mesh-list
25345959|NCT05537194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25345960|NCT05537194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345961|NCT05537194|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25345962|NCT05537194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25346267|NCT05535569|Antimitotic Agents|antimitotic agents|mesh-ancestor
25345963|NCT05537194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345965|NCT05537090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25345966|NCT05537090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25345967|NCT05537090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25345968|NCT05537090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345969|NCT05537090|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25345970|NCT05537090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25345971|NCT05537090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25345972|NCT05537090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25345973|NCT05537090|Anesthetics, General|anesthetics, general|mesh-ancestor
25345974|NCT05537090|Anesthetics|anesthetics|mesh-ancestor
25345975|NCT05537090|GABA Modulators|gaba modulators|mesh-ancestor
25345976|NCT05537090|GABA Agents|gaba agents|mesh-ancestor
25345977|NCT05537090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25345978|NCT05537090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345979|NCT05536882|Adapalene|adapalene|mesh-list
25345980|NCT05536882|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25345981|NCT05536882|Dermatologic Agents|dermatologic agents|mesh-ancestor
25345982|NCT05536882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25345983|NCT05536882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25345984|NCT05536882|Analgesics|analgesics|mesh-ancestor
25345985|NCT05536882|Sensory System Agents|sensory system agents|mesh-ancestor
25345986|NCT05536882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25345987|NCT05536882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345988|NCT05536882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25345989|NCT05536882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25345990|NCT05536856|Fluorouracil|fluorouracil|mesh-list
25345991|NCT05536856|Antimetabolites|antimetabolites|mesh-ancestor
25345992|NCT05536856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25345993|NCT05536856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25345994|NCT05536856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25345995|NCT05536856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25345996|NCT05536856|Immunologic Factors|immunologic factors|mesh-ancestor
25345997|NCT05536856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25345998|NCT05536804|Tirzepatide|tirzepatide|mesh-list
25345999|NCT05536804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
24453016|NCT05360264|Decitabine|decitabine|mesh-list
25346000|NCT05536804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346001|NCT05536804|Incretins|incretins|mesh-ancestor
25346002|NCT05536804|Hormones|hormones|mesh-ancestor
25346003|NCT05536804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25346004|NCT05536791|Dabigatran|dabigatran|mesh-list
25346005|NCT05536791|Antithrombins|antithrombins|mesh-ancestor
25346006|NCT05536791|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25346007|NCT05536791|Protease Inhibitors|protease inhibitors|mesh-ancestor
25346008|NCT05536791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25346009|NCT05536791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346010|NCT05536791|Anticoagulants|anticoagulants|mesh-ancestor
25346011|NCT05536661|Lubricant Eye Drops|lubricant eye drops|mesh-list
25346012|NCT05536661|Hyaluronic Acid|hyaluronic acid|mesh-list
25346013|NCT05536661|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25346014|NCT05536661|Immunologic Factors|immunologic factors|mesh-ancestor
25346015|NCT05536661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346016|NCT05536661|Viscosupplements|viscosupplements|mesh-ancestor
25346017|NCT05536661|Protective Agents|protective agents|mesh-ancestor
25346018|NCT05536661|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25346019|NCT05536661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25346020|NCT05536596|Hydroxocobalamin|hydroxocobalamin|mesh-list
25346021|NCT05536596|Vitamin B 12|vitamin b 12|mesh-list
25346022|NCT05536596|Melatonin|melatonin|mesh-list
25346023|NCT05536596|Antioxidants|antioxidants|mesh-ancestor
25346249|NCT05535738|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25346024|NCT05536596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346025|NCT05536596|Protective Agents|protective agents|mesh-ancestor
25346026|NCT05536596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346027|NCT05536596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25346028|NCT05536596|Hematinics|hematinics|mesh-ancestor
25346029|NCT05536596|Vitamin B Complex|vitamin b complex|mesh-ancestor
25346030|NCT05536596|Vitamins|vitamins|mesh-ancestor
25346031|NCT05536596|Micronutrients|micronutrients|mesh-ancestor
25346032|NCT05536570|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25346033|NCT05536570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25346034|NCT05536570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25346035|NCT05536570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346036|NCT05536570|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25346037|NCT05536570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25346038|NCT05536570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346039|NCT05536570|Cholinergic Agents|cholinergic agents|mesh-ancestor
25346040|NCT05536570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25346041|NCT05536414|Citalopram|citalopram|mesh-list
25346042|NCT05536414|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25346043|NCT05536414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25346044|NCT05536414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25346045|NCT05536414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346046|NCT05536414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25346047|NCT05536414|Serotonin Agents|serotonin agents|mesh-ancestor
25346048|NCT05536414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346049|NCT05536414|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25346050|NCT05536414|Antidepressive Agents|antidepressive agents|mesh-ancestor
25346051|NCT05536414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25346052|NCT05536362|Clonidine|clonidine|mesh-list
25346053|NCT05536362|Ketamine|ketamine|mesh-list
25346054|NCT05536362|Propofol|propofol|mesh-list
25346055|NCT05536362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25346056|NCT05536362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25346057|NCT05536362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346058|NCT05536362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25346059|NCT05536362|Anesthetics, General|anesthetics, general|mesh-ancestor
25346060|NCT05536362|Anesthetics|anesthetics|mesh-ancestor
25346061|NCT05536362|Analgesics|analgesics|mesh-ancestor
25346094|NCT05536284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25346095|NCT05536284|Sympatholytics|sympatholytics|mesh-ancestor
25346096|NCT05536284|Autonomic Agents|autonomic agents|mesh-ancestor
25346097|NCT05536284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25346098|NCT05536284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346099|NCT05536284|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25346100|NCT05536284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25346101|NCT05536284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25346102|NCT05536284|Adrenergic Agents|adrenergic agents|mesh-ancestor
25346103|NCT05536284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25346104|NCT05536284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346105|NCT05536271|Bisoprolol|bisoprolol|mesh-list
25346106|NCT05536271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25346107|NCT05536271|Sympatholytics|sympatholytics|mesh-ancestor
25346108|NCT05536271|Autonomic Agents|autonomic agents|mesh-ancestor
25346109|NCT05536271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25346110|NCT05536271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346111|NCT05536271|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25346112|NCT05536271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25346113|NCT05536271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25346114|NCT05536271|Adrenergic Agents|adrenergic agents|mesh-ancestor
25346115|NCT05536271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25346116|NCT05536271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346117|NCT05536219|Antibodies|antibodies|mesh-list
25346118|NCT05536219|Immunologic Factors|immunologic factors|mesh-ancestor
25346119|NCT05536219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346120|NCT05536193|Metformin|metformin|mesh-list
25346121|NCT05536193|Salicylic Acid|salicylic acid|mesh-list
25346122|NCT05536193|Salicylates|salicylates|mesh-list
25346123|NCT05536193|Mitogens|mitogens|mesh-list
25346124|NCT05536193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25346125|NCT05536193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346126|NCT05536193|Mitosis Modulators|mitosis modulators|mesh-ancestor
25346127|NCT05536193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346128|NCT05536193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25346129|NCT05536193|Antifungal Agents|antifungal agents|mesh-ancestor
25346130|NCT05536193|Keratolytic Agents|keratolytic agents|mesh-ancestor
25346131|NCT05536193|Dermatologic Agents|dermatologic agents|mesh-ancestor
25346132|NCT05536193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25346133|NCT05536193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25346134|NCT05536193|Analgesics|analgesics|mesh-ancestor
25346135|NCT05536193|Sensory System Agents|sensory system agents|mesh-ancestor
25346136|NCT05536193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25346137|NCT05536193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25346138|NCT05536193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25346139|NCT05536193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25346140|NCT05536193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25346142|NCT05536154|Etoposide|etoposide|mesh-list
25346143|NCT05536154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25346144|NCT05536154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346145|NCT05536154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25346146|NCT05536154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25346147|NCT05536154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25346148|NCT05536154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346149|NCT05536154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25346150|NCT05536154|Antimetabolites|antimetabolites|mesh-ancestor
25346151|NCT05536154|Antiviral Agents|antiviral agents|mesh-ancestor
25346152|NCT05536154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25346153|NCT05536154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25346154|NCT05536154|Immunologic Factors|immunologic factors|mesh-ancestor
25346155|NCT05536154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346156|NCT05536128|Olaparib|olaparib|mesh-list
25346157|NCT05536128|Fulvestrant|fulvestrant|mesh-list
25346158|NCT05536128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25346159|NCT05536128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25346160|NCT05536128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346161|NCT05536128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346162|NCT05536128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25346163|NCT05536128|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25346164|NCT05536128|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25346165|NCT05536128|Hormone Antagonists|hormone antagonists|mesh-ancestor
25346166|NCT05536128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25346167|NCT05536128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346168|NCT05536102|Doxorubicin|doxorubicin|mesh-list
25346169|NCT05536102|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25346170|NCT05536102|Capecitabine|capecitabine|mesh-list
25346171|NCT05536102|Oxaliplatin|oxaliplatin|mesh-list
25346172|NCT05536102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25346250|NCT05535738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25346173|NCT05536102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
24453069|NCT05309629|Etoposide|etoposide|mesh-list
25346174|NCT05536102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25346175|NCT05536102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25346176|NCT05536102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25346177|NCT05536102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346178|NCT05536102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25346179|NCT05536102|Antimetabolites|antimetabolites|mesh-ancestor
25346180|NCT05536037|Metformin|metformin|mesh-list
25346181|NCT05536037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25346182|NCT05536037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346183|NCT05536011|Sodium Oxybate|sodium oxybate|mesh-list
25346184|NCT05536011|Methylphenidate|methylphenidate|mesh-list
25346185|NCT05536011|Modafinil|modafinil|mesh-list
25346186|NCT05536011|Amphetamine|amphetamine|mesh-list
25346187|NCT05536011|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25346188|NCT05536011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346189|NCT05536011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25346190|NCT05536011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25346191|NCT05536011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25346192|NCT05536011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346193|NCT05536011|Dopamine Agents|dopamine agents|mesh-ancestor
25346194|NCT05536011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25346195|NCT05536011|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
25346196|NCT05536011|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25346197|NCT05536011|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25346198|NCT05536011|Sympathomimetics|sympathomimetics|mesh-ancestor
25346199|NCT05536011|Autonomic Agents|autonomic agents|mesh-ancestor
25346200|NCT05536011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25346201|NCT05536011|Adrenergic Agents|adrenergic agents|mesh-ancestor
25346202|NCT05536011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25346203|NCT05536011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25346204|NCT05536011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25346205|NCT05536011|Anesthetics, General|anesthetics, general|mesh-ancestor
25346206|NCT05536011|Anesthetics|anesthetics|mesh-ancestor
25346207|NCT05536011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25346208|NCT05535998|Chlorotrianisene|chlorotrianisene|mesh-list
25346209|NCT05535998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25346210|NCT05535998|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25346211|NCT05535998|Estrogens|estrogens|mesh-ancestor
25346212|NCT05535998|Hormones|hormones|mesh-ancestor
25346213|NCT05535998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25346214|NCT05535998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346215|NCT05535998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25346216|NCT05535998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346217|NCT05535998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346218|NCT05535764|Interferons|interferons|mesh-list
25346219|NCT05535764|Interferon-alpha|interferon-alpha|mesh-list
25346220|NCT05535764|Interferon alpha-2|interferon alpha-2|mesh-list
25346221|NCT05535764|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25346222|NCT05535764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346223|NCT05535764|Antiviral Agents|antiviral agents|mesh-ancestor
25346224|NCT05535764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25346225|NCT05535764|Immunologic Factors|immunologic factors|mesh-ancestor
25346226|NCT05535764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346227|NCT05535738|Fluticasone|fluticasone|mesh-list
25346228|NCT05535738|Xhance|xhance|mesh-list
25346229|NCT05535738|Adalimumab|adalimumab|mesh-list
25346230|NCT05535738|Triamcinolone|triamcinolone|mesh-list
25346231|NCT05535738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25346232|NCT05535738|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25346233|NCT05535738|Betamethasone|betamethasone|mesh-list
25346234|NCT05535738|Betamethasone Valerate|betamethasone valerate|mesh-list
25346235|NCT05535738|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25346236|NCT05535738|Betamethasone benzoate|betamethasone benzoate|mesh-list
25346237|NCT05535738|Ustekinumab|ustekinumab|mesh-list
25346238|NCT05535738|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25346239|NCT05535738|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
25346240|NCT05535738|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25346241|NCT05535738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25346242|NCT05535738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25346243|NCT05535738|Autonomic Agents|autonomic agents|mesh-ancestor
25346244|NCT05535738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25346245|NCT05535738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346246|NCT05535738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25346247|NCT05535738|Respiratory System Agents|respiratory system agents|mesh-ancestor
25346248|NCT05535738|Dermatologic Agents|dermatologic agents|mesh-ancestor
25346251|NCT05535738|Glucocorticoids|glucocorticoids|mesh-ancestor
25346252|NCT05535738|Hormones|hormones|mesh-ancestor
25346253|NCT05535738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25346254|NCT05535738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25346255|NCT05535738|Immunologic Factors|immunologic factors|mesh-ancestor
25346256|NCT05535738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25346257|NCT05535738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346258|NCT05535738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25346259|NCT05535725|Vancomycin|vancomycin|mesh-list
25346260|NCT05535725|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25346261|NCT05535725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25346262|NCT05535569|Paclitaxel|paclitaxel|mesh-list
25346263|NCT05535569|Nivolumab|nivolumab|mesh-list
25346264|NCT05535569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25346265|NCT05535569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346268|NCT05535569|Mitosis Modulators|mitosis modulators|mesh-ancestor
25346269|NCT05535569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346270|NCT05535569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25346271|NCT05535569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25346273|NCT05535517|Dermatologic Agents|dermatologic agents|mesh-ancestor
25346274|NCT05535413|Capecitabine|capecitabine|mesh-list
25346275|NCT05535413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25346276|NCT05535413|Antimetabolites|antimetabolites|mesh-ancestor
25346277|NCT05535413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346278|NCT05535413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346279|NCT05535322|Insulin|insulin|mesh-list
25346280|NCT05535322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25346281|NCT05535322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346282|NCT05535309|Sulbactam|sulbactam|mesh-list
25346283|NCT05535309|Cefoperazone|cefoperazone|mesh-list
25346284|NCT05535309|Sulperazone|sulperazone|mesh-list
25346285|NCT05535309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25346286|NCT05535309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25346287|NCT05535309|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25346288|NCT05535309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25346289|NCT05535309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346290|NCT05535309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25346291|NCT05535309|Renal Agents|renal agents|mesh-ancestor
25346292|NCT05535231|Curcumin|curcumin|mesh-list
25346293|NCT05535231|Turmeric extract|turmeric extract|mesh-list
25346294|NCT05535231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25346295|NCT05535231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25346296|NCT05535231|Analgesics|analgesics|mesh-ancestor
25346297|NCT05535231|Sensory System Agents|sensory system agents|mesh-ancestor
25346298|NCT05535231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25346299|NCT05535231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346300|NCT05535231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25346301|NCT05535231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25346302|NCT05535231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346303|NCT05535231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25346304|NCT05535231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346305|NCT05535231|Antioxidants|antioxidants|mesh-ancestor
25346306|NCT05535231|Protective Agents|protective agents|mesh-ancestor
25346307|NCT05535218|Pembrolizumab|pembrolizumab|mesh-list
25346308|NCT05535218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25346309|NCT05535218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346310|NCT05535166|Cyclophosphamide|cyclophosphamide|mesh-list
25346311|NCT05535166|Cisplatin|cisplatin|mesh-list
25346312|NCT05535166|Carboplatin|carboplatin|mesh-list
25346313|NCT05535166|Methotrexate|methotrexate|mesh-list
25346314|NCT05535166|Etoposide|etoposide|mesh-list
25346315|NCT05535166|Vincristine|vincristine|mesh-list
25346316|NCT05535166|Topotecan|topotecan|mesh-list
25346317|NCT05535166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25346318|NCT05535166|Immunologic Factors|immunologic factors|mesh-ancestor
25346319|NCT05535166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346320|NCT05535166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25346321|NCT05535166|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25346322|NCT05535166|Alkylating Agents|alkylating agents|mesh-ancestor
25346323|NCT05535166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346324|NCT05535166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346325|NCT05535166|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25346326|NCT05535166|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25346327|NCT05535166|Abortifacient Agents|abortifacient agents|mesh-ancestor
25346328|NCT05535166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25346329|NCT05535166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25346330|NCT05535166|Antimetabolites|antimetabolites|mesh-ancestor
25346331|NCT05535166|Dermatologic Agents|dermatologic agents|mesh-ancestor
25346332|NCT05535166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25346333|NCT05535166|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25346334|NCT05535166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25346335|NCT05535166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25346336|NCT05535166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25346337|NCT05535166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25346338|NCT05535166|Tubulin Modulators|tubulin modulators|mesh-ancestor
25346339|NCT05535166|Antimitotic Agents|antimitotic agents|mesh-ancestor
25346340|NCT05535166|Mitosis Modulators|mitosis modulators|mesh-ancestor
25346341|NCT05535166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25346342|NCT05535075|Vancomycin|vancomycin|mesh-list
25346343|NCT05535075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25346344|NCT05535075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25346345|NCT05535036|Dexamethasone|dexamethasone|mesh-list
25346346|NCT05535036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25346347|NCT05535036|Antiemetics|antiemetics|mesh-ancestor
25346348|NCT05535036|Autonomic Agents|autonomic agents|mesh-ancestor
25346349|NCT05535036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25346350|NCT05535036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346351|NCT05535036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25346352|NCT05535036|Glucocorticoids|glucocorticoids|mesh-ancestor
25346353|NCT05535036|Hormones|hormones|mesh-ancestor
25346354|NCT05535036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25346355|NCT05535036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25346356|NCT05535036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346357|NCT05535023|Cemiplimab|cemiplimab|mesh-list
25346358|NCT05535023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25346359|NCT05535023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346360|NCT05534802|Urinastatin|urinastatin|mesh-list
25346361|NCT05534802|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25346362|NCT05534802|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25346363|NCT05534802|Protease Inhibitors|protease inhibitors|mesh-ancestor
25346364|NCT05534802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25346365|NCT05534802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346366|NCT05534750|Linezolid|linezolid|mesh-list
25346367|NCT05534750|Tedizolid|tedizolid|mesh-list
25346368|NCT05534750|Tedizolid phosphate|tedizolid phosphate|mesh-list
25346369|NCT05534750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25346370|NCT05534750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25346371|NCT05534750|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25346372|NCT05534750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25346373|NCT05534750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346374|NCT05534685|Budesonide|budesonide|mesh-list
25346375|NCT05534685|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25346376|NCT05534685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25346377|NCT05534685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25346378|NCT05534685|Autonomic Agents|autonomic agents|mesh-ancestor
25346379|NCT05534685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25346380|NCT05534685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346381|NCT05534685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25346382|NCT05534685|Respiratory System Agents|respiratory system agents|mesh-ancestor
25346383|NCT05534685|Glucocorticoids|glucocorticoids|mesh-ancestor
25346384|NCT05534685|Hormones|hormones|mesh-ancestor
25346385|NCT05534685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25346386|NCT05534672|Sirolimus|sirolimus|mesh-list
25346387|NCT05534672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25346388|NCT05534672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25346389|NCT05534672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25346390|NCT05534672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346391|NCT05534672|Antifungal Agents|antifungal agents|mesh-ancestor
25346392|NCT05534672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25346393|NCT05534672|Immunologic Factors|immunologic factors|mesh-ancestor
25346394|NCT05534672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346395|NCT05534620|Fludarabine|fludarabine|mesh-list
25346396|NCT05534620|Treosulfan|treosulfan|mesh-list
25346397|NCT05534620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346398|NCT05534620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346399|NCT05534620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25346400|NCT05534620|Alkylating Agents|alkylating agents|mesh-ancestor
25346401|NCT05534529|Rezafungin|rezafungin|mesh-list
25346402|NCT05534529|Antifungal Agents|antifungal agents|mesh-ancestor
25346403|NCT05534529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25346404|NCT05534334|Hydrocortisone|hydrocortisone|mesh-list
25346405|NCT05534334|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25346406|NCT05534334|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25346407|NCT05534334|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25346408|NCT05534334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25346409|NCT05534243|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
25346410|NCT05534243|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25346411|NCT05534243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25346412|NCT05534243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346413|NCT05534230|Dexmedetomidine|dexmedetomidine|mesh-list
25346414|NCT05534230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25346415|NCT05534230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25346416|NCT05534230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25346417|NCT05534230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346418|NCT05534230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25346419|NCT05534230|Analgesics|analgesics|mesh-ancestor
25346429|NCT05533983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25346430|NCT05533983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346431|NCT05533983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25346432|NCT05533983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346434|NCT05533892|Cell Wall Skeleton|cell wall skeleton|mesh-list
25346435|NCT05533892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346436|NCT05533892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25346437|NCT05533892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25346438|NCT05533892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346439|NCT05533892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25346440|NCT05533892|Immunologic Factors|immunologic factors|mesh-ancestor
25346441|NCT05533892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346442|NCT05533775|Rituximab|rituximab|mesh-list
25346443|NCT05533775|Obinutuzumab|obinutuzumab|mesh-list
25346444|NCT05533775|Carboplatin|carboplatin|mesh-list
25346445|NCT05533775|Etoposide|etoposide|mesh-list
25346446|NCT05533775|Ifosfamide|ifosfamide|mesh-list
25346447|NCT05533775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25346448|NCT05533775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346449|NCT05533775|Immunologic Factors|immunologic factors|mesh-ancestor
25346450|NCT05533775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346451|NCT05533775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25346452|NCT05533775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25346453|NCT05533775|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25346454|NCT05533775|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25346455|NCT05533775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25346456|NCT05533775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346457|NCT05533775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25346458|NCT05533775|Alkylating Agents|alkylating agents|mesh-ancestor
25346459|NCT05533697|Pembrolizumab|pembrolizumab|mesh-list
25346460|NCT05533697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25346461|NCT05533697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346462|NCT05533684|Gabapentin|gabapentin|mesh-list
25346463|NCT05533684|Analgesics|analgesics|mesh-ancestor
25346464|NCT05533684|Sensory System Agents|sensory system agents|mesh-ancestor
25346465|NCT05533684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25346466|NCT05533684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346467|NCT05533684|Anticonvulsants|anticonvulsants|mesh-ancestor
25346468|NCT05533684|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25346469|NCT05533684|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25346470|NCT05533684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25346471|NCT05533684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25346472|NCT05533684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25346473|NCT05533684|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25346474|NCT05533684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25346475|NCT05533684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346476|NCT05533684|Antimanic Agents|antimanic agents|mesh-ancestor
25346477|NCT05533619|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
25346478|NCT05533619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25346479|NCT05533619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346480|NCT05533606|Lactams|lactams|mesh-list
25346481|NCT05533606|beta-Lactams|beta-lactams|mesh-list
25346482|NCT05533606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25346483|NCT05533606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25346547|NCT05533372|Immunologic Factors|immunologic factors|mesh-ancestor
25346548|NCT05533372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25346549|NCT05533372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25346550|NCT05533281|Dexamethasone|dexamethasone|mesh-list
25346551|NCT05533281|Metoclopramide|metoclopramide|mesh-list
25346552|NCT05533281|Tropisetron|tropisetron|mesh-list
25346553|NCT05533281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25346554|NCT05533281|Antiemetics|antiemetics|mesh-ancestor
25346555|NCT05533281|Autonomic Agents|autonomic agents|mesh-ancestor
25346556|NCT05533281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25346557|NCT05533281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346558|NCT05533281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25346559|NCT05533281|Glucocorticoids|glucocorticoids|mesh-ancestor
25346560|NCT05533281|Hormones|hormones|mesh-ancestor
25346561|NCT05533281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25346562|NCT05533281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25346563|NCT05533281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346564|NCT05533281|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25346565|NCT05533281|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25346566|NCT05533281|Dopamine Agents|dopamine agents|mesh-ancestor
25346567|NCT05533281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25346568|NCT05533281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346569|NCT05533281|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25346570|NCT05533281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25346571|NCT05533281|Serotonin Agents|serotonin agents|mesh-ancestor
25346572|NCT05533255|Z 350|z 350|mesh-list
25346573|NCT05533255|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25346574|NCT05533255|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25346575|NCT05533255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25346576|NCT05533255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346577|NCT05533255|Hormone Antagonists|hormone antagonists|mesh-ancestor
25346578|NCT05533255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25346579|NCT05533255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346580|NCT05533242|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
25346581|NCT05533242|Immunologic Factors|immunologic factors|mesh-ancestor
25346582|NCT05533242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346583|NCT05533229|Fentanyl|fentanyl|mesh-list
25346584|NCT05533229|Morphine|morphine|mesh-list
25346585|NCT05533229|Bupivacaine|bupivacaine|mesh-list
25346586|NCT05533229|Anesthetics, Local|anesthetics, local|mesh-ancestor
25346587|NCT05533229|Anesthetics|anesthetics|mesh-ancestor
25346588|NCT05533229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25346589|NCT05533229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346596|NCT05533229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25346597|NCT05533229|Anesthetics, General|anesthetics, general|mesh-ancestor
25346605|NCT05533125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25346606|NCT05533125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346607|NCT05533125|Immunologic Factors|immunologic factors|mesh-ancestor
25346608|NCT05533125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346609|NCT05533125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25346610|NCT05533073|Etoricoxib|etoricoxib|mesh-list
25346611|NCT05533073|Tramadol|tramadol|mesh-list
25346612|NCT05533073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25346613|NCT05533073|Narcotics|narcotics|mesh-ancestor
25346614|NCT05533073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25346615|NCT05533073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346616|NCT05533073|Analgesics|analgesics|mesh-ancestor
25346617|NCT05533073|Sensory System Agents|sensory system agents|mesh-ancestor
25346618|NCT05533073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25346619|NCT05533073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25346620|NCT05533073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25346621|NCT05533073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25346622|NCT05533073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25346623|NCT05533073|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25346624|NCT05533073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25346625|NCT05533073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25346626|NCT05533073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346627|NCT05532878|Apixaban|apixaban|mesh-list
25346628|NCT05532878|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25346629|NCT05532878|Antithrombins|antithrombins|mesh-ancestor
25346630|NCT05532878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25346631|NCT05532878|Protease Inhibitors|protease inhibitors|mesh-ancestor
25346632|NCT05532878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25346633|NCT05532878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346634|NCT05532878|Anticoagulants|anticoagulants|mesh-ancestor
25346635|NCT05532618|Levobupivacaine|levobupivacaine|mesh-list
25346636|NCT05532618|Anesthetics, Local|anesthetics, local|mesh-ancestor
25346638|NCT05532618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25346639|NCT05532618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346640|NCT05532618|Sensory System Agents|sensory system agents|mesh-ancestor
25346641|NCT05532618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25346642|NCT05532501|Oxytocin|oxytocin|mesh-list
25346643|NCT05532501|Oxytocics|oxytocics|mesh-ancestor
25346644|NCT05532501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25346645|NCT05532501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346646|NCT05532358|Midazolam|midazolam|mesh-list
25346647|NCT05532358|Fluvoxamine|fluvoxamine|mesh-list
25346648|NCT05532358|Caffeine|caffeine|mesh-list
25346649|NCT05532358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25346650|NCT05532358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25346651|NCT05532358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25346652|NCT05532358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346653|NCT05532358|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25346654|NCT05532358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25346655|NCT05532358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25346656|NCT05532358|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25346657|NCT05532358|Anesthetics, General|anesthetics, general|mesh-ancestor
25346658|NCT05532358|Anesthetics|anesthetics|mesh-ancestor
25346659|NCT05532358|GABA Modulators|gaba modulators|mesh-ancestor
25346660|NCT05532358|GABA Agents|gaba agents|mesh-ancestor
25346661|NCT05532358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25346662|NCT05532358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346663|NCT05532358|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25346664|NCT05532358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25346665|NCT05532358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25346666|NCT05532358|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25346667|NCT05532358|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25346668|NCT05532358|Purinergic Agents|purinergic agents|mesh-ancestor
25346669|NCT05532358|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25346670|NCT05532358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25346671|NCT05532358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25346672|NCT05532358|Serotonin Agents|serotonin agents|mesh-ancestor
25346673|NCT05532358|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25346674|NCT05532358|Antidepressive Agents|antidepressive agents|mesh-ancestor
25346675|NCT05532358|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25346676|NCT05532358|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25346677|NCT05532358|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25346678|NCT05532332|Fluoxetine|fluoxetine|mesh-list
25346679|NCT05532332|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25346680|NCT05532332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25346681|NCT05532332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25346682|NCT05532332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346683|NCT05532332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25346684|NCT05532332|Serotonin Agents|serotonin agents|mesh-ancestor
25346685|NCT05532332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346686|NCT05532332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25346687|NCT05532332|Antidepressive Agents|antidepressive agents|mesh-ancestor
25346688|NCT05532332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25346689|NCT05532332|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25346690|NCT05532332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25346691|NCT05532332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25346692|NCT05532319|Lenvatinib|lenvatinib|mesh-list
25346693|NCT05532319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346694|NCT05532319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25346695|NCT05532319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25346696|NCT05532319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346697|NCT05532306|Ribavirin|ribavirin|mesh-list
25346698|NCT05532306|Antimetabolites|antimetabolites|mesh-ancestor
25346699|NCT05532306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346700|NCT05532306|Antiviral Agents|antiviral agents|mesh-ancestor
25346701|NCT05532306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25346702|NCT05532280|Etoricoxib|etoricoxib|mesh-list
25346703|NCT05532280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25346704|NCT05532280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25346705|NCT05532280|Analgesics|analgesics|mesh-ancestor
25346706|NCT05532280|Sensory System Agents|sensory system agents|mesh-ancestor
25346707|NCT05532280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25346708|NCT05532280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346709|NCT05532280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25346710|NCT05532280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25346711|NCT05532280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25346712|NCT05532280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25346713|NCT05532280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25346714|NCT05532280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346715|NCT05532267|Ciprofloxacin|ciprofloxacin|mesh-list
25346716|NCT05532267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25346717|NCT05532267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25346718|NCT05532267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25346719|NCT05532267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25346720|NCT05532267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25346721|NCT05532267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346722|NCT05532267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346723|NCT05532267|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25346724|NCT05532267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25346725|NCT05532254|Aripiprazole|aripiprazole|mesh-list
25346726|NCT05532254|Antidepressive Agents|antidepressive agents|mesh-ancestor
25346727|NCT05532254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25346728|NCT05532254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25346729|NCT05532254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25346730|NCT05532254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25346731|NCT05532254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346732|NCT05532254|Dopamine Agonists|dopamine agonists|mesh-ancestor
25346733|NCT05532254|Dopamine Agents|dopamine agents|mesh-ancestor
25346734|NCT05532254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25346735|NCT05532254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346736|NCT05532254|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25346737|NCT05532254|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25346738|NCT05532254|Serotonin Agents|serotonin agents|mesh-ancestor
25346739|NCT05532254|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25346740|NCT05532254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25346741|NCT05532254|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25346742|NCT05532254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25346743|NCT05532241|Chlorhexidine|chlorhexidine|mesh-list
25346744|NCT05532241|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25346745|NCT05532241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25346746|NCT05532241|Disinfectants|disinfectants|mesh-ancestor
25346747|NCT05532215|Misoprostol|misoprostol|mesh-list
25346748|NCT05532215|Oxytocin|oxytocin|mesh-list
25346749|NCT05532215|Oxytocics|oxytocics|mesh-ancestor
25346750|NCT05532215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25346751|NCT05532215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346752|NCT05532215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25346753|NCT05532215|Abortifacient Agents|abortifacient agents|mesh-ancestor
25346754|NCT05532215|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25346755|NCT05532215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25346756|NCT05532163|Natalizumab|natalizumab|mesh-list
25346757|NCT05532163|Immunologic Factors|immunologic factors|mesh-ancestor
25346758|NCT05532163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346759|NCT05532111|Cyclophosphamide|cyclophosphamide|mesh-list
25346760|NCT05532111|Rituximab|rituximab|mesh-list
25346761|NCT05532111|Tacrolimus|tacrolimus|mesh-list
25346762|NCT05532111|Glucocorticoids|glucocorticoids|mesh-list
25346763|NCT05532111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25346764|NCT05532111|Immunologic Factors|immunologic factors|mesh-ancestor
25346765|NCT05532111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346766|NCT05532111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25346767|NCT05532111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25346768|NCT05532111|Alkylating Agents|alkylating agents|mesh-ancestor
25346769|NCT05532111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346770|NCT05532111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346771|NCT05532111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25346772|NCT05532111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25346773|NCT05532111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25346774|NCT05532111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25346775|NCT05532111|Hormones|hormones|mesh-ancestor
25346776|NCT05532111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25346777|NCT05532085|Analgesics|analgesics|mesh-list
25346778|NCT05532085|Anesthetics|anesthetics|mesh-list
25346779|NCT05532085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25346780|NCT05532085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346781|NCT05532085|Sensory System Agents|sensory system agents|mesh-ancestor
25346782|NCT05532085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25346783|NCT05532072|Sirolimus|sirolimus|mesh-list
25346784|NCT05532072|Methylprednisolone|methylprednisolone|mesh-list
25346785|NCT05532072|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25346786|NCT05532072|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25346787|NCT05532072|Prednisolone|prednisolone|mesh-list
25346788|NCT05532072|Prednisolone acetate|prednisolone acetate|mesh-list
25346789|NCT05532072|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25346790|NCT05532072|Prednisolone phosphate|prednisolone phosphate|mesh-list
25346791|NCT05532072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25346792|NCT05532072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25346793|NCT05532072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25346794|NCT05532072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346795|NCT05532072|Antifungal Agents|antifungal agents|mesh-ancestor
25346796|NCT05532072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25346797|NCT05532072|Immunologic Factors|immunologic factors|mesh-ancestor
25346798|NCT05532072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346799|NCT05532072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25346800|NCT05532072|Antiemetics|antiemetics|mesh-ancestor
25346801|NCT05532072|Autonomic Agents|autonomic agents|mesh-ancestor
25346802|NCT05532072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25346803|NCT05532072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25346804|NCT05532072|Glucocorticoids|glucocorticoids|mesh-ancestor
25346805|NCT05532072|Hormones|hormones|mesh-ancestor
25346806|NCT05532072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25346807|NCT05532072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25346808|NCT05532072|Protective Agents|protective agents|mesh-ancestor
25346809|NCT05532072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25346810|NCT05532059|Gemcitabine|gemcitabine|mesh-list
25346811|NCT05532059|Cisplatin|cisplatin|mesh-list
25346812|NCT05532059|Lenvatinib|lenvatinib|mesh-list
25346813|NCT05532059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346814|NCT05532059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25346815|NCT05532059|Antimetabolites|antimetabolites|mesh-ancestor
25346816|NCT05532059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346817|NCT05532059|Antiviral Agents|antiviral agents|mesh-ancestor
25346818|NCT05532059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25346819|NCT05532059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25346820|NCT05532059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25346821|NCT05532059|Immunologic Factors|immunologic factors|mesh-ancestor
25346822|NCT05532059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346823|NCT05532059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25346824|NCT05532020|Diazoxide|diazoxide|mesh-list
25346825|NCT05532020|Choline|choline|mesh-list
25346826|NCT05532020|Lipotropic Agents|lipotropic agents|mesh-ancestor
25346827|NCT05532020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25346828|NCT05532020|Antimetabolites|antimetabolites|mesh-ancestor
25346829|NCT05532020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346830|NCT05532020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25346831|NCT05532020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25346832|NCT05532020|Nootropic Agents|nootropic agents|mesh-ancestor
25346833|NCT05532020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25346834|NCT05532020|Vasodilator Agents|vasodilator agents|mesh-ancestor
25346835|NCT05531994|Montelukast|montelukast|mesh-list
25346836|NCT05531994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25346837|NCT05531994|Respiratory System Agents|respiratory system agents|mesh-ancestor
25346838|NCT05531994|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25346839|NCT05531994|Hormone Antagonists|hormone antagonists|mesh-ancestor
25346840|NCT05531994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25346841|NCT05531994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346842|NCT05531994|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25346843|NCT05531994|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25346844|NCT05531994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346845|NCT05531955|Pirfenidone|pirfenidone|mesh-list
25346846|NCT05531955|Analgesics|analgesics|mesh-ancestor
25346847|NCT05531955|Sensory System Agents|sensory system agents|mesh-ancestor
25346848|NCT05531955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25346849|NCT05531955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346850|NCT05531955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25346851|NCT05531955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25346852|NCT05531955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25346853|NCT05531955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25346854|NCT05531955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346855|NCT05531942|Aspirin|aspirin|mesh-list
25346856|NCT05531942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25346857|NCT05531942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25346858|NCT05531942|Analgesics|analgesics|mesh-ancestor
25346859|NCT05531942|Sensory System Agents|sensory system agents|mesh-ancestor
25346860|NCT05531942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25346861|NCT05531942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346862|NCT05531942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25346863|NCT05531942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25346864|NCT05531942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25346865|NCT05531942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25346866|NCT05531942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346867|NCT05531942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25346868|NCT05531942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25346869|NCT05531942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25346870|NCT05531942|Antipyretics|antipyretics|mesh-ancestor
25346871|NCT05531890|Betamethasone|betamethasone|mesh-list
25346872|NCT05531890|Betamethasone Valerate|betamethasone valerate|mesh-list
25346873|NCT05531890|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25346874|NCT05531890|Betamethasone benzoate|betamethasone benzoate|mesh-list
25346875|NCT05531890|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25346876|NCT05531890|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25346877|NCT05531890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25346878|NCT05531890|Glucocorticoids|glucocorticoids|mesh-ancestor
25346879|NCT05531890|Hormones|hormones|mesh-ancestor
25346880|NCT05531890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25346881|NCT05531890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346882|NCT05531890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25346883|NCT05531890|Respiratory System Agents|respiratory system agents|mesh-ancestor
25346884|NCT05531708|Cyclophosphamide|cyclophosphamide|mesh-list
25346885|NCT05531708|Fludarabine|fludarabine|mesh-list
25346886|NCT05531708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25346887|NCT05531708|Immunologic Factors|immunologic factors|mesh-ancestor
25379476|NCT04736706|Pembrolizumab|pembrolizumab|mesh-list
25346888|NCT05531708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346889|NCT05531708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25346890|NCT05531708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25346891|NCT05531708|Alkylating Agents|alkylating agents|mesh-ancestor
25346892|NCT05531708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346893|NCT05531708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346894|NCT05531708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25346895|NCT05531591|Aripiprazole|aripiprazole|mesh-list
25346896|NCT05531591|Lithium Carbonate|lithium carbonate|mesh-list
25346897|NCT05531591|Bupropion|bupropion|mesh-list
25346898|NCT05531591|Nortriptyline|nortriptyline|mesh-list
25346899|NCT05531591|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25346900|NCT05531591|Antidepressive Agents|antidepressive agents|mesh-ancestor
25346901|NCT05531591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25346902|NCT05531591|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25346903|NCT05531591|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25346904|NCT05531591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25346905|NCT05531591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346906|NCT05531591|Dopamine Agents|dopamine agents|mesh-ancestor
25346907|NCT05531591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25346908|NCT05531591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346909|NCT05531591|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25346910|NCT05531591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25346911|NCT05531591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25346912|NCT05531591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25346913|NCT05531591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25346914|NCT05531591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25346915|NCT05531591|Dopamine Agonists|dopamine agonists|mesh-ancestor
25346916|NCT05531591|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25346917|NCT05531591|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25346918|NCT05531591|Serotonin Agents|serotonin agents|mesh-ancestor
25346919|NCT05531591|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25346920|NCT05531591|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25346921|NCT05531591|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25346922|NCT05531591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25346923|NCT05531591|Antimanic Agents|antimanic agents|mesh-ancestor
25346924|NCT05531591|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25346925|NCT05531591|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25346926|NCT05531591|Adrenergic Agents|adrenergic agents|mesh-ancestor
25346927|NCT05531435|Anesthetics|anesthetics|mesh-list
25346928|NCT05531435|Anesthetics, Local|anesthetics, local|mesh-list
25346929|NCT05531435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25346930|NCT05531435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346931|NCT05531435|Sensory System Agents|sensory system agents|mesh-ancestor
25346932|NCT05531435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25346933|NCT05531422|Fentanyl|fentanyl|mesh-list
25346934|NCT05531422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25346935|NCT05531422|Narcotics|narcotics|mesh-ancestor
25346936|NCT05531422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25346937|NCT05531422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346938|NCT05531422|Analgesics|analgesics|mesh-ancestor
25346939|NCT05531422|Sensory System Agents|sensory system agents|mesh-ancestor
25346940|NCT05531422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25346941|NCT05531422|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25346942|NCT05531422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25346943|NCT05531422|Anesthetics, General|anesthetics, general|mesh-ancestor
25346944|NCT05531422|Anesthetics|anesthetics|mesh-ancestor
25346946|NCT05531383|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25346947|NCT05531383|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25346948|NCT05531383|Dopamine Agents|dopamine agents|mesh-ancestor
25346949|NCT05531383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25346950|NCT05531383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346951|NCT05531383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346952|NCT05531383|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25346953|NCT05531383|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25346954|NCT05531344|Tamsulosin|tamsulosin|mesh-list
25346955|NCT05531344|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25346956|NCT05531344|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25346957|NCT05531344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25346958|NCT05531344|Adrenergic Agents|adrenergic agents|mesh-ancestor
25346959|NCT05531344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25724202|NCT02535806|Bortezomib|bortezomib|mesh-list
25724203|NCT02535806|Mitoxantrone|mitoxantrone|mesh-list
25346960|NCT05531344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346962|NCT05531344|Urological Agents|urological agents|mesh-ancestor
25346963|NCT05531266|Glucocorticoids|glucocorticoids|mesh-list
25346964|NCT05531266|Hormones|hormones|mesh-ancestor
25346965|NCT05531266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25346966|NCT05531266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346967|NCT05531123|Gemcitabine|gemcitabine|mesh-list
25346968|NCT05531123|Cisplatin|cisplatin|mesh-list
25346969|NCT05531123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346970|NCT05531123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25346971|NCT05531123|Antimetabolites|antimetabolites|mesh-ancestor
25346972|NCT05531123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25346973|NCT05531123|Antiviral Agents|antiviral agents|mesh-ancestor
25346974|NCT05531123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25346975|NCT05531123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25346976|NCT05531123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25346977|NCT05531123|Immunologic Factors|immunologic factors|mesh-ancestor
25346978|NCT05531123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346979|NCT05531058|Vaccines|vaccines|mesh-list
25346980|NCT05531058|Immunologic Factors|immunologic factors|mesh-ancestor
25346981|NCT05531058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346982|NCT05530954|Calcium|calcium|mesh-list
25346983|NCT05530954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25346984|NCT05530954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346985|NCT05530811|Dexamethasone|dexamethasone|mesh-list
25346986|NCT05530811|Bupivacaine|bupivacaine|mesh-list
25346987|NCT05530811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25346988|NCT05530811|Antiemetics|antiemetics|mesh-ancestor
25346989|NCT05530811|Autonomic Agents|autonomic agents|mesh-ancestor
25346990|NCT05530811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25346991|NCT05530811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25346992|NCT05530811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25346993|NCT05530811|Glucocorticoids|glucocorticoids|mesh-ancestor
25346994|NCT05530811|Hormones|hormones|mesh-ancestor
25346995|NCT05530811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25346996|NCT05530811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25346997|NCT05530811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25346998|NCT05530811|Anesthetics, Local|anesthetics, local|mesh-ancestor
25346999|NCT05530811|Anesthetics|anesthetics|mesh-ancestor
25347000|NCT05530811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25347001|NCT05530811|Sensory System Agents|sensory system agents|mesh-ancestor
25347002|NCT05530785|Bevacizumab|bevacizumab|mesh-list
25347003|NCT05530785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25347004|NCT05530785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347005|NCT05530785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25347006|NCT05530785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25347007|NCT05530785|Growth Substances|growth substances|mesh-ancestor
25347008|NCT05530785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347009|NCT05530785|Growth Inhibitors|growth inhibitors|mesh-ancestor
25347010|NCT05530707|Niacinamide|niacinamide|mesh-list
25347011|NCT05530707|Niacin|niacin|mesh-list
25347012|NCT05530707|Nicotinic Acids|nicotinic acids|mesh-list
25347013|NCT05530707|Vitamin B Complex|vitamin b complex|mesh-ancestor
25347014|NCT05530707|Vitamins|vitamins|mesh-ancestor
25347015|NCT05530707|Micronutrients|micronutrients|mesh-ancestor
25347016|NCT05530707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347017|NCT05530707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25347018|NCT05530707|Antimetabolites|antimetabolites|mesh-ancestor
25347019|NCT05530707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347020|NCT05530707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25347021|NCT05530707|Vasodilator Agents|vasodilator agents|mesh-ancestor
25347023|NCT05530655|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25347024|NCT05530655|Protease Inhibitors|protease inhibitors|mesh-ancestor
25347025|NCT05530655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347026|NCT05530655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347027|NCT05530655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25347028|NCT05530655|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25347029|NCT05530655|Protective Agents|protective agents|mesh-ancestor
25347030|NCT05530655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347031|NCT05530551|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25347032|NCT05530551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25347033|NCT05530421|Dexamethasone|dexamethasone|mesh-list
25347034|NCT05530421|Venetoclax|venetoclax|mesh-list
25724204|NCT02535806|Pegaspargase|pegaspargase|mesh-list
25347035|NCT05530421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25347036|NCT05530421|Antiemetics|antiemetics|mesh-ancestor
25347037|NCT05530421|Autonomic Agents|autonomic agents|mesh-ancestor
25347038|NCT05530421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25347039|NCT05530421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347040|NCT05530421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25347041|NCT05530421|Glucocorticoids|glucocorticoids|mesh-ancestor
25347042|NCT05530421|Hormones|hormones|mesh-ancestor
25347043|NCT05530421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25347044|NCT05530421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25347045|NCT05530421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347046|NCT05530395|Testosterone|testosterone|mesh-list
25347047|NCT05530395|Androgens|androgens|mesh-ancestor
25347048|NCT05530395|Hormones|hormones|mesh-ancestor
25347049|NCT05530395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25347050|NCT05530395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347051|NCT05530356|Dextrans|dextrans|mesh-list
25347052|NCT05530356|Anticoagulants|anticoagulants|mesh-ancestor
25347053|NCT05530356|Plasma Substitutes|plasma substitutes|mesh-ancestor
25347054|NCT05530356|Blood Substitutes|blood substitutes|mesh-ancestor
25347055|NCT05530278|Midazolam|midazolam|mesh-list
25347056|NCT05530278|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25347057|NCT05530278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25347058|NCT05530278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25347059|NCT05530278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347060|NCT05530278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25347061|NCT05530278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25347062|NCT05530278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25347063|NCT05530278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25347064|NCT05530278|Anesthetics, General|anesthetics, general|mesh-ancestor
25347065|NCT05530278|Anesthetics|anesthetics|mesh-ancestor
25347066|NCT05530278|GABA Modulators|gaba modulators|mesh-ancestor
25347067|NCT05530278|GABA Agents|gaba agents|mesh-ancestor
25347068|NCT05530278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25347069|NCT05530278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347070|NCT05530252|Minocycline|minocycline|mesh-list
25347071|NCT05530252|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25347072|NCT05530252|Anti-Infective Agents|anti-infective agents|mesh-list
25347073|NCT05530200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25347074|NCT05530200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347075|NCT05530200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347076|NCT05530174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25347077|NCT05530174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25347078|NCT05530122|Adalimumab|adalimumab|mesh-list
25347079|NCT05530122|Golimumab|golimumab|mesh-list
25347080|NCT05530122|Infliximab|infliximab|mesh-list
25347081|NCT05530122|Ustekinumab|ustekinumab|mesh-list
25347082|NCT05530122|Vedolizumab|vedolizumab|mesh-list
25347083|NCT05530122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25347084|NCT05530122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25347085|NCT05530122|Dermatologic Agents|dermatologic agents|mesh-ancestor
25347086|NCT05530122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25347087|NCT05530122|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25347088|NCT05530122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25347089|NCT05530122|Immunologic Factors|immunologic factors|mesh-ancestor
25347090|NCT05530122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347091|NCT05529940|Folfirinox|folfirinox|mesh-list
25347092|NCT05529940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347093|NCT05529927|Dextroamphetamine|dextroamphetamine|mesh-list
25347094|NCT05529927|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25347095|NCT05529927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347096|NCT05529927|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25347097|NCT05529927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25347098|NCT05529927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25347099|NCT05529927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347100|NCT05529927|Dopamine Agents|dopamine agents|mesh-ancestor
25347101|NCT05529927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25347102|NCT05529888|Isotretinoin|isotretinoin|mesh-list
25347103|NCT05529888|Dermatologic Agents|dermatologic agents|mesh-ancestor
25347104|NCT05529875|Propofol|propofol|mesh-list
25347105|NCT05529875|Sevoflurane|sevoflurane|mesh-list
25347106|NCT05529875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25347107|NCT05529875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25347108|NCT05529875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347109|NCT05529875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25347110|NCT05529875|Anesthetics, General|anesthetics, general|mesh-ancestor
25347111|NCT05529875|Anesthetics|anesthetics|mesh-ancestor
25347112|NCT05529875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25347113|NCT05529875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25347114|NCT05529784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25347115|NCT05529784|Immunologic Factors|immunologic factors|mesh-ancestor
25347116|NCT05529784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347118|NCT05529667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25347119|NCT05529667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347120|NCT05529667|Tubulin Modulators|tubulin modulators|mesh-ancestor
25347121|NCT05529667|Antimitotic Agents|antimitotic agents|mesh-ancestor
25347122|NCT05529667|Mitosis Modulators|mitosis modulators|mesh-ancestor
25347123|NCT05529667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347124|NCT05529355|Tegafur|tegafur|mesh-list
25347125|NCT05529355|Endostar protein|endostar protein|mesh-list
25347126|NCT05529355|Endostatins|endostatins|mesh-list
25347127|NCT05529355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25347128|NCT05529355|Antimetabolites|antimetabolites|mesh-ancestor
25347129|NCT05529355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347130|NCT05529355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347131|NCT05529355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25347132|NCT05529355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25347133|NCT05529355|Growth Substances|growth substances|mesh-ancestor
25347134|NCT05529355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347135|NCT05529355|Growth Inhibitors|growth inhibitors|mesh-ancestor
25347136|NCT05529290|Acetaminophen|acetaminophen|mesh-list
25347137|NCT05529290|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
25347138|NCT05529290|Ketoprofen|ketoprofen|mesh-list
25347139|NCT05529290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25347140|NCT05529290|Analgesics|analgesics|mesh-ancestor
25347141|NCT05529290|Sensory System Agents|sensory system agents|mesh-ancestor
25347142|NCT05529290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25347143|NCT05529290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347144|NCT05529290|Antipyretics|antipyretics|mesh-ancestor
25347145|NCT05529290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25347146|NCT05529290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25347147|NCT05529290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25347148|NCT05529290|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25347149|NCT05529290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347150|NCT05529290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347151|NCT05529251|Carboplatin|carboplatin|mesh-list
25347152|NCT05529251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347153|NCT05529173|Povidone-Iodine|povidone-iodine|mesh-list
25347154|NCT05529173|Povidone|povidone|mesh-list
25347155|NCT05529173|Plasma Substitutes|plasma substitutes|mesh-ancestor
25347156|NCT05529173|Blood Substitutes|blood substitutes|mesh-ancestor
25347157|NCT05529173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25347158|NCT05529173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25347159|NCT05529147|Antihypertensive Agents|antihypertensive agents|mesh-list
25347160|NCT05529095|Apomorphine|apomorphine|mesh-list
25347161|NCT05529095|Emetics|emetics|mesh-ancestor
25347162|NCT05529095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347163|NCT05529095|Autonomic Agents|autonomic agents|mesh-ancestor
25347164|NCT05529095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25347165|NCT05529095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25347166|NCT05529095|Dopamine Agonists|dopamine agonists|mesh-ancestor
25347167|NCT05529095|Dopamine Agents|dopamine agents|mesh-ancestor
25347168|NCT05529095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25347169|NCT05529095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347170|NCT05529082|Analgesics, Opioid|analgesics, opioid|mesh-list
25347171|NCT05529082|Narcotics|narcotics|mesh-ancestor
25347172|NCT05529082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25347173|NCT05529082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347174|NCT05529082|Analgesics|analgesics|mesh-ancestor
25347175|NCT05529082|Sensory System Agents|sensory system agents|mesh-ancestor
25347176|NCT05529082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25347177|NCT05529069|Venetoclax|venetoclax|mesh-list
25347178|NCT05529069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347179|NCT05529056|Atropine|atropine|mesh-list
25347180|NCT05529056|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25347181|NCT05529056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25347182|NCT05529056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25347183|NCT05529056|Autonomic Agents|autonomic agents|mesh-ancestor
25347184|NCT05529056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25347185|NCT05529056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347186|NCT05529056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25347187|NCT05529056|Respiratory System Agents|respiratory system agents|mesh-ancestor
25347195|NCT05528952|Bevacizumab|bevacizumab|mesh-list
25347196|NCT05528952|Atezolizumab|atezolizumab|mesh-list
25347197|NCT05528952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25347198|NCT05528952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347199|NCT05528952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25347200|NCT05528952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25347201|NCT05528952|Growth Substances|growth substances|mesh-ancestor
25347202|NCT05528952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347203|NCT05528952|Growth Inhibitors|growth inhibitors|mesh-ancestor
25347204|NCT05528913|Benralizumab|benralizumab|mesh-list
25347205|NCT05528913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25347206|NCT05528913|Respiratory System Agents|respiratory system agents|mesh-ancestor
25347207|NCT05528887|Cyclophosphamide|cyclophosphamide|mesh-list
25347208|NCT05528887|Fludarabine|fludarabine|mesh-list
25347209|NCT05528887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25347210|NCT05528887|Immunologic Factors|immunologic factors|mesh-ancestor
25347211|NCT05528887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347212|NCT05528887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25347213|NCT05528887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25347214|NCT05528887|Alkylating Agents|alkylating agents|mesh-ancestor
25347215|NCT05528887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347216|NCT05528887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347217|NCT05528887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25347226|NCT05528718|Midazolam|midazolam|mesh-list
25347227|NCT05528718|Nitrous Oxide|nitrous oxide|mesh-list
25347228|NCT05528718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25347229|NCT05528718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25347230|NCT05528718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25347231|NCT05528718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347232|NCT05528718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25347233|NCT05528718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25347234|NCT05528718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25347235|NCT05528718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25347236|NCT05528718|Anesthetics, General|anesthetics, general|mesh-ancestor
25347237|NCT05528718|Anesthetics|anesthetics|mesh-ancestor
25347238|NCT05528718|GABA Modulators|gaba modulators|mesh-ancestor
25347239|NCT05528718|GABA Agents|gaba agents|mesh-ancestor
25347240|NCT05528718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25347241|NCT05528718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347242|NCT05528718|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25347243|NCT05528718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25347244|NCT05528718|Analgesics|analgesics|mesh-ancestor
25347245|NCT05528718|Sensory System Agents|sensory system agents|mesh-ancestor
25347246|NCT05528718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25347247|NCT05528653|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25347248|NCT05528653|Antiviral Agents|antiviral agents|mesh-ancestor
25347249|NCT05528653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25347250|NCT05528653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25347251|NCT05528653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25347252|NCT05528653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347253|NCT05528653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347254|NCT05528653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25347255|NCT05528653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25347256|NCT05528588|Furosemide|furosemide|mesh-list
25347257|NCT05528588|Diuretics|diuretics|mesh-ancestor
25347258|NCT05528588|Natriuretic Agents|natriuretic agents|mesh-ancestor
25347259|NCT05528588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347260|NCT05528588|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25347261|NCT05528588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25347262|NCT05528588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347263|NCT05528510|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25347264|NCT05528510|Immunologic Factors|immunologic factors|mesh-ancestor
25347265|NCT05528510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347266|NCT05528458|Osimertinib|osimertinib|mesh-list
25347267|NCT05528458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347268|NCT05528458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25347269|NCT05528458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347270|NCT05528458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347271|NCT05528419|Valsartan|valsartan|mesh-list
25415998|NCT02978625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25415999|NCT02978534|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25416000|NCT02978534|Antidepressive Agents|antidepressive agents|mesh-ancestor
25416001|NCT02978534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25416002|NCT02978534|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25416003|NCT02978534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25416004|NCT02978534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25347272|NCT05528419|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25347273|NCT05528419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25347274|NCT05528419|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25347275|NCT05528419|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25347276|NCT05528419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347277|NCT05528198|Montelukast|montelukast|mesh-list
25347278|NCT05528198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25347279|NCT05528198|Respiratory System Agents|respiratory system agents|mesh-ancestor
25347280|NCT05528198|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25347281|NCT05528198|Hormone Antagonists|hormone antagonists|mesh-ancestor
25347282|NCT05528198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25347283|NCT05528198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347284|NCT05528198|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25347285|NCT05528198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25347286|NCT05528198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347287|NCT05528146|Psyllium|psyllium|mesh-list
25347288|NCT05528146|Cathartics|cathartics|mesh-ancestor
25347289|NCT05528146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25347290|NCT05527912|Rituximab|rituximab|mesh-list
25347291|NCT05527912|Zanubrutinib|zanubrutinib|mesh-list
25347292|NCT05527912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25347293|NCT05527912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347294|NCT05527912|Immunologic Factors|immunologic factors|mesh-ancestor
25347295|NCT05527912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347296|NCT05527912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25347297|NCT05527912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25347298|NCT05527912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347299|NCT05527912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347300|NCT05527834|Ceftibuten|ceftibuten|mesh-list
25347301|NCT05527834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25347302|NCT05527834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25347303|NCT05527808|Carboplatin|carboplatin|mesh-list
25347304|NCT05527808|Pemetrexed|pemetrexed|mesh-list
25347305|NCT05527808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347306|NCT05527808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347307|NCT05527808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347308|NCT05527808|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25347309|NCT05527808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25347310|NCT05527795|Oxymetazoline|oxymetazoline|mesh-list
25347311|NCT05527795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25347312|NCT05527795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25347313|NCT05527795|Adrenergic Agents|adrenergic agents|mesh-ancestor
25347314|NCT05527795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25347315|NCT05527795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347316|NCT05527795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347317|NCT05527795|Sympathomimetics|sympathomimetics|mesh-ancestor
25347318|NCT05527795|Autonomic Agents|autonomic agents|mesh-ancestor
25347319|NCT05527795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25347320|NCT05527795|Nasal Decongestants|nasal decongestants|mesh-ancestor
25347323|NCT05527704|Albuterol|albuterol|mesh-list
25347324|NCT05527704|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25347325|NCT05527704|Autonomic Agents|autonomic agents|mesh-ancestor
25347326|NCT05527704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25347327|NCT05527704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347328|NCT05527704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25347329|NCT05527704|Respiratory System Agents|respiratory system agents|mesh-ancestor
25347330|NCT05527704|Tocolytic Agents|tocolytic agents|mesh-ancestor
25347331|NCT05527704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25347332|NCT05527704|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25347333|NCT05527704|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25347334|NCT05527704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25347335|NCT05527704|Adrenergic Agents|adrenergic agents|mesh-ancestor
25347336|NCT05527704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25408070|NCT03459222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25347337|NCT05527704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347338|NCT05527548|Alendronate|alendronate|mesh-list
25347339|NCT05527548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25347340|NCT05527548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347341|NCT05527483|Listerine|listerine|mesh-list
25347342|NCT05527483|Fluorides|fluorides|mesh-list
25347343|NCT05527483|Sodium Fluoride|sodium fluoride|mesh-list
25347344|NCT05527483|Cariostatic Agents|cariostatic agents|mesh-ancestor
25347345|NCT05527483|Protective Agents|protective agents|mesh-ancestor
25347346|NCT05527483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347347|NCT05527483|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25347348|NCT05527483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25347349|NCT05527470|Gemcitabine|gemcitabine|mesh-list
25347350|NCT05527470|Cisplatin|cisplatin|mesh-list
25347351|NCT05527470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347352|NCT05527470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25347353|NCT05527470|Antimetabolites|antimetabolites|mesh-ancestor
25347354|NCT05527470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347355|NCT05527470|Antiviral Agents|antiviral agents|mesh-ancestor
25347356|NCT05527470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25347357|NCT05527470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347358|NCT05527470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25347359|NCT05527470|Immunologic Factors|immunologic factors|mesh-ancestor
25347360|NCT05527470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347361|NCT05527444|Thalidomide|thalidomide|mesh-list
25347362|NCT05527444|Adalimumab|adalimumab|mesh-list
25347363|NCT05527444|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25347364|NCT05527444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25347365|NCT05527444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25347366|NCT05527444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25347367|NCT05527444|Immunologic Factors|immunologic factors|mesh-ancestor
25347368|NCT05527444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347369|NCT05527444|Leprostatic Agents|leprostatic agents|mesh-ancestor
25347370|NCT05527444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25347371|NCT05527444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25347372|NCT05527444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25347373|NCT05527444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25347374|NCT05527444|Growth Substances|growth substances|mesh-ancestor
25347375|NCT05527444|Growth Inhibitors|growth inhibitors|mesh-ancestor
25347376|NCT05527444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347377|NCT05527418|Dasatinib|dasatinib|mesh-list
25347378|NCT05527418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347379|NCT05527418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25347380|NCT05527418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347458|NCT05526911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25347381|NCT05527418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347382|NCT05527340|Dexamethasone|dexamethasone|mesh-list
25347383|NCT05527340|Daratumumab|daratumumab|mesh-list
25347384|NCT05527340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25347385|NCT05527340|Antiemetics|antiemetics|mesh-ancestor
25347386|NCT05527340|Autonomic Agents|autonomic agents|mesh-ancestor
25347387|NCT05527340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25347388|NCT05527340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347389|NCT05527340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25347390|NCT05527340|Glucocorticoids|glucocorticoids|mesh-ancestor
25347392|NCT05527340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25347393|NCT05527340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25347394|NCT05527340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347429|NCT05527106|Antioxidants|antioxidants|mesh-ancestor
25347430|NCT05527106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347431|NCT05527106|Protective Agents|protective agents|mesh-ancestor
25347432|NCT05527106|Nootropic Agents|nootropic agents|mesh-ancestor
25347433|NCT05527054|Diuretics|diuretics|mesh-list
25347434|NCT05527054|Natriuretic Agents|natriuretic agents|mesh-ancestor
25347435|NCT05527054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347436|NCT05526989|Niraparib|niraparib|mesh-list
25347437|NCT05526989|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25347438|NCT05526989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347439|NCT05526989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347440|NCT05526989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347441|NCT05526924|Fluorouracil|fluorouracil|mesh-list
25347442|NCT05526924|Hydroxyurea|hydroxyurea|mesh-list
25347443|NCT05526924|Antimetabolites|antimetabolites|mesh-ancestor
25347444|NCT05526924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408149|NCT03456843|Mitosis Modulators|mitosis modulators|mesh-ancestor
25347445|NCT05526924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25347446|NCT05526924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347447|NCT05526924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25347448|NCT05526924|Immunologic Factors|immunologic factors|mesh-ancestor
25347449|NCT05526924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347450|NCT05526924|Antisickling Agents|antisickling agents|mesh-ancestor
25347451|NCT05526924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347452|NCT05526924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25347453|NCT05526911|Tenofovir|tenofovir|mesh-list
25347454|NCT05526911|Lamivudine|lamivudine|mesh-list
25347455|NCT05526911|Dolutegravir|dolutegravir|mesh-list
25347456|NCT05526911|Digoxin|digoxin|mesh-list
25347457|NCT05526911|Midazolam|midazolam|mesh-list
25347459|NCT05526911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25347460|NCT05526911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25347461|NCT05526911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347462|NCT05526911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25347463|NCT05526911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25347464|NCT05526911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25347465|NCT05526911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25347466|NCT05526911|Anesthetics, General|anesthetics, general|mesh-ancestor
25347467|NCT05526911|Anesthetics|anesthetics|mesh-ancestor
25347468|NCT05526911|GABA Modulators|gaba modulators|mesh-ancestor
25347469|NCT05526911|GABA Agents|gaba agents|mesh-ancestor
25347470|NCT05526911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25347471|NCT05526911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347472|NCT05526911|Antiviral Agents|antiviral agents|mesh-ancestor
25347473|NCT05526911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25347474|NCT05526911|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25347475|NCT05526911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25347476|NCT05526911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347477|NCT05526911|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25347478|NCT05526911|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25347479|NCT05526911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25347480|NCT05526911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25347481|NCT05526911|Protective Agents|protective agents|mesh-ancestor
25347482|NCT05526911|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25347483|NCT05526911|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25347484|NCT05526898|Triamcinolone|triamcinolone|mesh-list
25347485|NCT05526898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25347486|NCT05526898|Glucocorticoids|glucocorticoids|mesh-ancestor
25347487|NCT05526898|Hormones|hormones|mesh-ancestor
25347488|NCT05526898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25347489|NCT05526898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347490|NCT05526820|Vaccines|vaccines|mesh-list
25347491|NCT05526820|Immunologic Factors|immunologic factors|mesh-ancestor
25347492|NCT05526820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347493|NCT05526807|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25347494|NCT05526807|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25347495|NCT05526807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25347496|NCT05526794|Analgesics|analgesics|mesh-list
25347497|NCT05526794|Sensory System Agents|sensory system agents|mesh-ancestor
25347498|NCT05526794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25347499|NCT05526794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347500|NCT05526755|Osimertinib|osimertinib|mesh-list
25347501|NCT05526755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347502|NCT05526755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25347503|NCT05526755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347504|NCT05526755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347505|NCT05526703|Antihypertensive Agents|antihypertensive agents|mesh-list
25347506|NCT05526690|Metformin|metformin|mesh-list
25347507|NCT05526690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25347508|NCT05526690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347509|NCT05526586|Ethanol|ethanol|mesh-list
25347510|NCT05526586|Listerine|listerine|mesh-list
25347511|NCT05526586|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
25347512|NCT05526586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25347513|NCT05526586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25347514|NCT05526586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347515|NCT05526469|Bupivacaine|bupivacaine|mesh-list
25347516|NCT05526469|Anesthetics, Local|anesthetics, local|mesh-ancestor
25347517|NCT05526469|Anesthetics|anesthetics|mesh-ancestor
25347518|NCT05526469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25347519|NCT05526469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347520|NCT05526469|Sensory System Agents|sensory system agents|mesh-ancestor
25347521|NCT05526469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25347522|NCT05526443|Antineoplastic Agents|antineoplastic agents|mesh-list
25347523|NCT05526430|Harmine|harmine|mesh-list
25347524|NCT05526430|Hallucinogens|hallucinogens|mesh-ancestor
25347525|NCT05526430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347526|NCT05526430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25347527|NCT05526430|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25347528|NCT05526430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347529|NCT05526430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347530|NCT05526417|Coal Tar|coal tar|mesh-list
25347531|NCT05526417|Keratolytic Agents|keratolytic agents|mesh-ancestor
25347532|NCT05526417|Dermatologic Agents|dermatologic agents|mesh-ancestor
25347533|NCT05526157|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25347534|NCT05526157|Glucagon|glucagon|mesh-list
25347535|NCT05526157|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25347536|NCT05526157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25347537|NCT05526157|Hormones|hormones|mesh-ancestor
25347538|NCT05526157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25347539|NCT05526157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347540|NCT05526157|Incretins|incretins|mesh-ancestor
25347541|NCT05526157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347542|NCT05526157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25347543|NCT05526118|Tenofovir|tenofovir|mesh-list
25347544|NCT05526118|Emtricitabine|emtricitabine|mesh-list
25347545|NCT05526118|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25347546|NCT05526118|Antiviral Agents|antiviral agents|mesh-ancestor
25347547|NCT05526118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25347548|NCT05526118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25347549|NCT05526118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25347550|NCT05526118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347626|NCT05525416|Norepinephrine|norepinephrine|mesh-list
25347551|NCT05526118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347552|NCT05526118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25347553|NCT05526118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25347554|NCT05525910|Ritonavir|ritonavir|mesh-list
25347555|NCT05525910|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25347556|NCT05525910|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25347557|NCT05525910|Protease Inhibitors|protease inhibitors|mesh-ancestor
25347558|NCT05525910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347559|NCT05525910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347560|NCT05525910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25347561|NCT05525910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25347562|NCT05525910|Antiviral Agents|antiviral agents|mesh-ancestor
25347563|NCT05525910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25347564|NCT05525910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25347565|NCT05525910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25347566|NCT05525858|Bevacizumab|bevacizumab|mesh-list
25347567|NCT05525858|Trastuzumab|trastuzumab|mesh-list
25347568|NCT05525858|Pertuzumab|pertuzumab|mesh-list
25347569|NCT05525858|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25347570|NCT05525858|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25347571|NCT05525858|Atezolizumab|atezolizumab|mesh-list
25347572|NCT05525858|Vemurafenib|vemurafenib|mesh-list
25347573|NCT05525858|Maytansine|maytansine|mesh-list
25347574|NCT05525858|Entrectinib|entrectinib|mesh-list
25347575|NCT05525858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25347576|NCT05525858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347577|NCT05525858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25347578|NCT05525858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25347579|NCT05525858|Growth Substances|growth substances|mesh-ancestor
25347580|NCT05525858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347581|NCT05525858|Growth Inhibitors|growth inhibitors|mesh-ancestor
25347582|NCT05525858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25347583|NCT05525858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347584|NCT05525858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347585|NCT05525858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25347586|NCT05525858|Tubulin Modulators|tubulin modulators|mesh-ancestor
25347587|NCT05525858|Antimitotic Agents|antimitotic agents|mesh-ancestor
25347588|NCT05525858|Mitosis Modulators|mitosis modulators|mesh-ancestor
25347589|NCT05525767|Bevacizumab|bevacizumab|mesh-list
25347590|NCT05525767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25347591|NCT05525767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347592|NCT05525767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25347593|NCT05525767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25347594|NCT05525767|Growth Substances|growth substances|mesh-ancestor
25347595|NCT05525767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347596|NCT05525767|Growth Inhibitors|growth inhibitors|mesh-ancestor
25347597|NCT05525611|Cabergoline|cabergoline|mesh-list
25347598|NCT05525611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25347599|NCT05525611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25347600|NCT05525611|Dopamine Agonists|dopamine agonists|mesh-ancestor
25347601|NCT05525611|Dopamine Agents|dopamine agents|mesh-ancestor
25347602|NCT05525611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25347603|NCT05525611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347604|NCT05525611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347606|NCT05525546|Immunologic Factors|immunologic factors|mesh-ancestor
25347607|NCT05525546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347608|NCT05525481|Tamoxifen|tamoxifen|mesh-list
25347609|NCT05525481|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25347610|NCT05525481|Hormone Antagonists|hormone antagonists|mesh-ancestor
25347611|NCT05525481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25347612|NCT05525481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347613|NCT05525481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25347614|NCT05525481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347615|NCT05525481|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25347616|NCT05525481|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25347617|NCT05525481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25347618|NCT05525455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25347619|NCT05525455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347620|NCT05525455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347621|NCT05525416|Propranolol|propranolol|mesh-list
25347622|NCT05525416|Nitroprusside|nitroprusside|mesh-list
25347623|NCT05525416|Phentolamine|phentolamine|mesh-list
25347624|NCT05525416|Phenylephrine|phenylephrine|mesh-list
25347625|NCT05525416|Oxymetazoline|oxymetazoline|mesh-list
25347627|NCT05525416|Synephrine|synephrine|mesh-list
25347628|NCT05525416|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25347629|NCT05525416|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25347630|NCT05525416|Adrenergic Agents|adrenergic agents|mesh-ancestor
25347631|NCT05525416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25347632|NCT05525416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347633|NCT05525416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347634|NCT05525416|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25347635|NCT05525416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25347636|NCT05525416|Vasodilator Agents|vasodilator agents|mesh-ancestor
25347637|NCT05525416|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25347638|NCT05525416|Mydriatics|mydriatics|mesh-ancestor
25347639|NCT05525416|Autonomic Agents|autonomic agents|mesh-ancestor
25347640|NCT05525416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25347641|NCT05525416|Sympathomimetics|sympathomimetics|mesh-ancestor
25347642|NCT05525416|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25347643|NCT05525416|Nasal Decongestants|nasal decongestants|mesh-ancestor
25347644|NCT05525416|Respiratory System Agents|respiratory system agents|mesh-ancestor
25347645|NCT05525416|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25347646|NCT05525416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25347647|NCT05525416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25347648|NCT05525416|Protective Agents|protective agents|mesh-ancestor
25347649|NCT05525416|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
25347650|NCT05525416|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25347651|NCT05525351|Dexmedetomidine|dexmedetomidine|mesh-list
25347652|NCT05525351|Alfentanil|alfentanil|mesh-list
25347653|NCT05525351|Propofol|propofol|mesh-list
25347654|NCT05525351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25347655|NCT05525351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25347656|NCT05525351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347657|NCT05525351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25347658|NCT05525351|Anesthetics, General|anesthetics, general|mesh-ancestor
25347659|NCT05525351|Anesthetics|anesthetics|mesh-ancestor
25347660|NCT05525351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25347661|NCT05525351|Analgesics|analgesics|mesh-ancestor
25347662|NCT05525351|Sensory System Agents|sensory system agents|mesh-ancestor
25347663|NCT05525351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25347664|NCT05525351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25347665|NCT05525351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25347666|NCT05525351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25347667|NCT05525351|Adrenergic Agents|adrenergic agents|mesh-ancestor
25347668|NCT05525351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25416005|NCT02978534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347669|NCT05525351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347670|NCT05525351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25347671|NCT05525351|Narcotics|narcotics|mesh-ancestor
25347672|NCT05525325|Anesthetics|anesthetics|mesh-list
25347673|NCT05525325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25380230|NCT04701008|Anesthetics|anesthetics|mesh-ancestor
25347674|NCT05525325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347675|NCT05525273|Trametinib|trametinib|mesh-list
25347676|NCT05525273|Dabrafenib|dabrafenib|mesh-list
25347677|NCT05525273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347678|NCT05525273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25347679|NCT05525273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347680|NCT05525273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347681|NCT05525247|Gemcitabine|gemcitabine|mesh-list
25347682|NCT05525247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25347683|NCT05525247|Antimetabolites|antimetabolites|mesh-ancestor
25347684|NCT05525247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347685|NCT05525247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347686|NCT05525247|Antiviral Agents|antiviral agents|mesh-ancestor
25347687|NCT05525247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25347688|NCT05525247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347689|NCT05525247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25347690|NCT05525247|Immunologic Factors|immunologic factors|mesh-ancestor
25347691|NCT05525247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347692|NCT05525234|Thalidomide|thalidomide|mesh-list
25347693|NCT05525234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25347694|NCT05525234|Immunologic Factors|immunologic factors|mesh-ancestor
25347695|NCT05525234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347696|NCT05525234|Leprostatic Agents|leprostatic agents|mesh-ancestor
25347697|NCT05525234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25347698|NCT05525234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25347699|NCT05525234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25347700|NCT05525234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25347701|NCT05525234|Growth Substances|growth substances|mesh-ancestor
25347702|NCT05525234|Growth Inhibitors|growth inhibitors|mesh-ancestor
25347703|NCT05525234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347704|NCT05525156|Aspirin|aspirin|mesh-list
25347705|NCT05525156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25347706|NCT05525156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25347707|NCT05525156|Analgesics|analgesics|mesh-ancestor
25347708|NCT05525156|Sensory System Agents|sensory system agents|mesh-ancestor
25347709|NCT05525156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25347710|NCT05525156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347711|NCT05525156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25347712|NCT05525156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25347713|NCT05525156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25347714|NCT05525156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25347715|NCT05525156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347716|NCT05525156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25347717|NCT05525156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25347718|NCT05525156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347719|NCT05525156|Antipyretics|antipyretics|mesh-ancestor
25347720|NCT05525078|Nicotine|nicotine|mesh-list
25347721|NCT05525078|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25347722|NCT05525078|Autonomic Agents|autonomic agents|mesh-ancestor
25347723|NCT05525078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25347724|NCT05525078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347725|NCT05525078|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25347726|NCT05525078|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25347727|NCT05525078|Cholinergic Agents|cholinergic agents|mesh-ancestor
25347728|NCT05525078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25347729|NCT05525078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347730|NCT05525065|Glucocorticoids|glucocorticoids|mesh-list
25347731|NCT05525065|Hormones|hormones|mesh-ancestor
25347732|NCT05525065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25347733|NCT05525065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347734|NCT05525013|Simvastatin|simvastatin|mesh-list
25347735|NCT05525013|Calcium|calcium|mesh-list
25347736|NCT05525013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25347737|NCT05525013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347738|NCT05525013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25347739|NCT05525013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25347740|NCT05525013|Antimetabolites|antimetabolites|mesh-ancestor
25347741|NCT05525013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347742|NCT05525013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25347743|NCT05525013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25347744|NCT05525013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347745|NCT05524974|Paclitaxel|paclitaxel|mesh-list
25347746|NCT05524974|Oxaliplatin|oxaliplatin|mesh-list
25724205|NCT02535806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25347747|NCT05524974|Apatinib|apatinib|mesh-list
25347748|NCT05524974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25347749|NCT05524974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347750|NCT05524974|Tubulin Modulators|tubulin modulators|mesh-ancestor
25347751|NCT05524974|Antimitotic Agents|antimitotic agents|mesh-ancestor
25347752|NCT05524974|Mitosis Modulators|mitosis modulators|mesh-ancestor
25347753|NCT05524974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347754|NCT05524974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25347755|NCT05524974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347756|NCT05524935|Pembrolizumab|pembrolizumab|mesh-list
25347757|NCT05524935|Olaparib|olaparib|mesh-list
25347758|NCT05524935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25347759|NCT05524935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347760|NCT05524935|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25347761|NCT05524935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347762|NCT05524935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347763|NCT05524857|Decitabine|decitabine|mesh-list
25347764|NCT05524857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25347765|NCT05524857|Antimetabolites|antimetabolites|mesh-ancestor
25347766|NCT05524857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347767|NCT05524857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347768|NCT05524857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347769|NCT05524714|Xanthohumol|xanthohumol|mesh-list
25347770|NCT05524714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347771|NCT05524714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25347772|NCT05524714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25347773|NCT05524714|Growth Substances|growth substances|mesh-ancestor
25347774|NCT05524714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347775|NCT05524714|Growth Inhibitors|growth inhibitors|mesh-ancestor
25347776|NCT05524584|Fulvestrant|fulvestrant|mesh-list
25347777|NCT05524584|Anastrozole|anastrozole|mesh-list
25347778|NCT05524584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25347779|NCT05524584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347780|NCT05524584|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25347781|NCT05524584|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25347782|NCT05524584|Hormone Antagonists|hormone antagonists|mesh-ancestor
25347783|NCT05524584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25347784|NCT05524584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347785|NCT05524584|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25347786|NCT05524584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25347787|NCT05524584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347788|NCT05524584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347789|NCT05524519|Antidepressive Agents|antidepressive agents|mesh-list
25347790|NCT05524519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25347791|NCT05524259|Folic Acid|folic acid|mesh-list
25347792|NCT05524259|Vitamin B Complex|vitamin b complex|mesh-list
25347793|NCT05524259|Inositol|inositol|mesh-list
25347794|NCT05524259|Hematinics|hematinics|mesh-ancestor
25347795|NCT05524259|Vitamins|vitamins|mesh-ancestor
25347796|NCT05524259|Micronutrients|micronutrients|mesh-ancestor
25347797|NCT05524259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347798|NCT05524246|Pravastatin|pravastatin|mesh-list
25347799|NCT05524246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25347800|NCT05524246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25347801|NCT05524246|Antimetabolites|antimetabolites|mesh-ancestor
25347802|NCT05524246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347803|NCT05524246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25347804|NCT05524246|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25347805|NCT05524246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347806|NCT05524168|Gemcitabine|gemcitabine|mesh-list
25347807|NCT05524168|Cisplatin|cisplatin|mesh-list
25347808|NCT05524168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347809|NCT05524168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25347810|NCT05524168|Antimetabolites|antimetabolites|mesh-ancestor
25347811|NCT05524168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347812|NCT05524168|Antiviral Agents|antiviral agents|mesh-ancestor
25347813|NCT05524168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25347814|NCT05524168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347815|NCT05524168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25347816|NCT05524168|Immunologic Factors|immunologic factors|mesh-ancestor
25347817|NCT05524168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347818|NCT05524077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
25347819|NCT05524038|Dexamethasone|dexamethasone|mesh-list
25347820|NCT05524038|Dexamethasone acetate|dexamethasone acetate|mesh-list
25347821|NCT05524038|Bupivacaine|bupivacaine|mesh-list
25347822|NCT05524038|BB 1101|bb 1101|mesh-list
25347823|NCT05524038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25347824|NCT05524038|Antiemetics|antiemetics|mesh-ancestor
25347825|NCT05524038|Autonomic Agents|autonomic agents|mesh-ancestor
25347826|NCT05524038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25347827|NCT05524038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347828|NCT05524038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25347829|NCT05524038|Glucocorticoids|glucocorticoids|mesh-ancestor
25347830|NCT05524038|Hormones|hormones|mesh-ancestor
25347831|NCT05524038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25347832|NCT05524038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25347833|NCT05524038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347834|NCT05524038|Protease Inhibitors|protease inhibitors|mesh-ancestor
25347835|NCT05524038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347836|NCT05524038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347837|NCT05524038|Anesthetics, Local|anesthetics, local|mesh-ancestor
25347838|NCT05524038|Anesthetics|anesthetics|mesh-ancestor
25347839|NCT05524038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25347840|NCT05524038|Sensory System Agents|sensory system agents|mesh-ancestor
25347841|NCT05523986|Vitamin D|vitamin d|mesh-list
25347842|NCT05523986|Vitamins|vitamins|mesh-ancestor
25347843|NCT05523986|Micronutrients|micronutrients|mesh-ancestor
25347844|NCT05523986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347845|NCT05523986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25347846|NCT05523934|Capsaicin|capsaicin|mesh-list
25347847|NCT05523934|Antipruritics|antipruritics|mesh-ancestor
25347848|NCT05523934|Dermatologic Agents|dermatologic agents|mesh-ancestor
25347849|NCT05523934|Sensory System Agents|sensory system agents|mesh-ancestor
25347850|NCT05523934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25347851|NCT05523934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347852|NCT05523895|Pimavanserin|pimavanserin|mesh-list
25347853|NCT05523895|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25347854|NCT05523895|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25347855|NCT05523895|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25347856|NCT05523895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25347857|NCT05523895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25347858|NCT05523895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347859|NCT05523895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25347860|NCT05523895|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25347861|NCT05523895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25347862|NCT05523895|Serotonin Agents|serotonin agents|mesh-ancestor
25347863|NCT05523895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25347864|NCT05523895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347865|NCT05523869|Topotecan|topotecan|mesh-list
25347866|NCT05523869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25347867|NCT05523869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25347868|NCT05523869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347869|NCT05523869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347870|NCT05523869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347871|NCT05523661|Dasatinib|dasatinib|mesh-list
25347872|NCT05523661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347873|NCT05523661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25347874|NCT05523661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347875|NCT05523661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347876|NCT05523609|Vitamin D|vitamin d|mesh-list
25347877|NCT05523609|Vitamins|vitamins|mesh-ancestor
25347878|NCT05523609|Micronutrients|micronutrients|mesh-ancestor
25347879|NCT05523609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347880|NCT05523609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25347881|NCT05523596|Benzonidazole|benzonidazole|mesh-list
25347882|NCT05523596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25347883|NCT05523596|Immunologic Factors|immunologic factors|mesh-ancestor
25347884|NCT05523596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347885|NCT05523596|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25347886|NCT05523596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25347887|NCT05523596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25347888|NCT05523596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25347889|NCT05523440|Bevacizumab|bevacizumab|mesh-list
25347890|NCT05523440|Niraparib|niraparib|mesh-list
25347891|NCT05523440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25347892|NCT05523440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347893|NCT05523440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25347894|NCT05523440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25347895|NCT05523440|Growth Substances|growth substances|mesh-ancestor
25347896|NCT05523440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347897|NCT05523440|Growth Inhibitors|growth inhibitors|mesh-ancestor
25724206|NCT02535806|Antiemetics|antiemetics|mesh-ancestor
25347898|NCT05523440|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25347899|NCT05523440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347900|NCT05523440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347901|NCT05523401|Psilocybin|psilocybin|mesh-list
25347902|NCT05523401|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25347903|NCT05523401|2-(4-bromo-2,5-dimethoxyphenyl)ethylamine|2-(4-bromo-2,5-dimethoxyphenyl)ethylamine|mesh-list
25347904|NCT05523401|Hallucinogens|hallucinogens|mesh-ancestor
25347905|NCT05523401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347906|NCT05523401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25347907|NCT05523401|Serotonin Agents|serotonin agents|mesh-ancestor
25347908|NCT05523401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25347909|NCT05523401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347910|NCT05523401|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25347911|NCT05523401|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25347912|NCT05523401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25347913|NCT05523401|Adrenergic Agents|adrenergic agents|mesh-ancestor
25347914|NCT05523401|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25347915|NCT05523401|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25347916|NCT05523401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25347917|NCT05523401|Serotonin 5-HT2 Receptor Agonists|serotonin 5-ht2 receptor agonists|mesh-ancestor
25347918|NCT05523401|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25347919|NCT05523323|Pembrolizumab|pembrolizumab|mesh-list
25347920|NCT05523323|Lenvatinib|lenvatinib|mesh-list
25347921|NCT05523323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25347922|NCT05523323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347923|NCT05523323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25347924|NCT05523323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347925|NCT05523323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347926|NCT05523102|Acetaminophen|acetaminophen|mesh-list
25347927|NCT05523102|Ketorolac|ketorolac|mesh-list
25347935|NCT05523102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25347936|NCT05523102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25347937|NCT05523102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25347938|NCT05523102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347939|NCT05523102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347940|NCT05523037|Sevoflurane|sevoflurane|mesh-list
25347941|NCT05523037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25347942|NCT05523037|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25347943|NCT05523037|Anesthetics, General|anesthetics, general|mesh-ancestor
25347944|NCT05523037|Anesthetics|anesthetics|mesh-ancestor
25347945|NCT05523037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25347946|NCT05523037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347947|NCT05522998|Propofol|propofol|mesh-list
25347948|NCT05522998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25347949|NCT05522998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25347950|NCT05522998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347951|NCT05522998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25347952|NCT05522998|Anesthetics, General|anesthetics, general|mesh-ancestor
25347953|NCT05522998|Anesthetics|anesthetics|mesh-ancestor
25347954|NCT05522894|Paclitaxel|paclitaxel|mesh-list
25347955|NCT05522894|Cisplatin|cisplatin|mesh-list
25347956|NCT05522894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25347957|NCT05522894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347958|NCT05522894|Tubulin Modulators|tubulin modulators|mesh-ancestor
25347959|NCT05522894|Antimitotic Agents|antimitotic agents|mesh-ancestor
25347960|NCT05522894|Mitosis Modulators|mitosis modulators|mesh-ancestor
25347961|NCT05522894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347962|NCT05522816|Tirbanibulin|tirbanibulin|mesh-list
25347963|NCT05522816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347964|NCT05522816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347972|NCT05522660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25347973|NCT05522660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347974|NCT05522660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347975|NCT05522582|Methotrexate|methotrexate|mesh-list
25347976|NCT05522582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25347977|NCT05522582|Antibodies|antibodies|mesh-list
25347978|NCT05522582|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25347979|NCT05522582|Immunologic Factors|immunologic factors|mesh-ancestor
25347980|NCT05522582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25347981|NCT05522582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25347982|NCT05522582|Abortifacient Agents|abortifacient agents|mesh-ancestor
25347983|NCT05522582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25380534|NCT04685135|Docetaxel|docetaxel|mesh-list
25347984|NCT05522582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25347985|NCT05522582|Antimetabolites|antimetabolites|mesh-ancestor
25347986|NCT05522582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347987|NCT05522582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347988|NCT05522582|Dermatologic Agents|dermatologic agents|mesh-ancestor
25347989|NCT05522582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347990|NCT05522582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25347991|NCT05522582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25347992|NCT05522582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25347993|NCT05522582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25347994|NCT05522491|Olaparib|olaparib|mesh-list
25347995|NCT05522491|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25347996|NCT05522491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25347997|NCT05522491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25347998|NCT05522491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25347999|NCT05522465|Dexamethasone|dexamethasone|mesh-list
25348000|NCT05522465|Prednisone|prednisone|mesh-list
25348001|NCT05522465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25348002|NCT05522465|Antiemetics|antiemetics|mesh-ancestor
25348003|NCT05522465|Autonomic Agents|autonomic agents|mesh-ancestor
25348004|NCT05522465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25348005|NCT05522465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348006|NCT05522465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25348007|NCT05522465|Glucocorticoids|glucocorticoids|mesh-ancestor
25348008|NCT05522465|Hormones|hormones|mesh-ancestor
25348009|NCT05522465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25348010|NCT05522465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25348011|NCT05522465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348012|NCT05522361|Risdiplam|risdiplam|mesh-list
25348013|NCT05522361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25348014|NCT05522361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25348015|NCT05522361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348016|NCT05522270|Mitogens|mitogens|mesh-list
25348017|NCT05522270|Mitosis Modulators|mitosis modulators|mesh-ancestor
25348018|NCT05522270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348019|NCT05522231|Everolimus|everolimus|mesh-list
25348020|NCT05522231|Axitinib|axitinib|mesh-list
25348021|NCT05522231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348022|NCT05522231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25348023|NCT05522231|Immunologic Factors|immunologic factors|mesh-ancestor
25348024|NCT05522231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348025|NCT05522231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25348026|NCT05522231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348027|NCT05522231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348028|NCT05522192|Venetoclax|venetoclax|mesh-list
25348029|NCT05522192|Mitoxantrone|mitoxantrone|mesh-list
25348030|NCT05522192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348031|NCT05522192|Analgesics|analgesics|mesh-ancestor
25348032|NCT05522192|Sensory System Agents|sensory system agents|mesh-ancestor
25348033|NCT05522192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25348034|NCT05522192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348035|NCT05522192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25348036|NCT05522192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25348037|NCT05522192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348038|NCT05522192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348039|NCT05522036|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
25348040|NCT05522036|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25348041|NCT05522036|Dermatologic Agents|dermatologic agents|mesh-ancestor
25348042|NCT05521997|Cisplatin|cisplatin|mesh-list
25348043|NCT05521997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348044|NCT05521984|Dapagliflozin|dapagliflozin|mesh-list
25348045|NCT05521984|Carmustine|carmustine|mesh-list
25348046|NCT05521984|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25348047|NCT05521984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348048|NCT05521984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25348049|NCT05521984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348050|NCT05521984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25348051|NCT05521984|Alkylating Agents|alkylating agents|mesh-ancestor
25348052|NCT05521984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348053|NCT05521880|Oritavancin|oritavancin|mesh-list
25348054|NCT05521880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25348055|NCT05521880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25348056|NCT05521828|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25724207|NCT02535806|Autonomic Agents|autonomic agents|mesh-ancestor
25348057|NCT05521828|Dydrogesterone|dydrogesterone|mesh-list
25348058|NCT05521828|Hormones|hormones|mesh-ancestor
25348059|NCT05521828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25348060|NCT05521828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348061|NCT05521828|Progestins|progestins|mesh-ancestor
25348062|NCT05521763|Vaccines|vaccines|mesh-list
25348063|NCT05521763|Immunologic Factors|immunologic factors|mesh-ancestor
25348064|NCT05521763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348065|NCT05521633|Metformin|metformin|mesh-list
25348066|NCT05521633|Pioglitazone|pioglitazone|mesh-list
25348067|NCT05521633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25348068|NCT05521633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348069|NCT05521386|Caffeine|caffeine|mesh-list
25348070|NCT05521386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25348071|NCT05521386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348072|NCT05521386|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25348073|NCT05521386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348074|NCT05521386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348075|NCT05521386|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25348076|NCT05521386|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25348077|NCT05521386|Purinergic Agents|purinergic agents|mesh-ancestor
25348078|NCT05521386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25348079|NCT05521347|Caffeine|caffeine|mesh-list
25348080|NCT05521347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25348081|NCT05521347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348082|NCT05521347|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25348083|NCT05521347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348084|NCT05521347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348085|NCT05521347|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25348086|NCT05521347|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25348087|NCT05521347|Purinergic Agents|purinergic agents|mesh-ancestor
25348088|NCT05521347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25348089|NCT05521152|Norepinephrine|norepinephrine|mesh-list
25348090|NCT05521152|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25348091|NCT05521152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25348092|NCT05521152|Adrenergic Agents|adrenergic agents|mesh-ancestor
25348093|NCT05521152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25348094|NCT05521152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348095|NCT05521152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348096|NCT05521152|Sympathomimetics|sympathomimetics|mesh-ancestor
25348097|NCT05521152|Autonomic Agents|autonomic agents|mesh-ancestor
25348098|NCT05521152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25348099|NCT05521152|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25348100|NCT05521087|Cytarabine|cytarabine|mesh-list
25348101|NCT05521087|Dexamethasone|dexamethasone|mesh-list
25348102|NCT05521087|Fludarabine|fludarabine|mesh-list
25348103|NCT05521087|Vincristine|vincristine|mesh-list
25348104|NCT05521087|Pegaspargase|pegaspargase|mesh-list
25348105|NCT05521087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25348106|NCT05521087|Antiemetics|antiemetics|mesh-ancestor
25348107|NCT05521087|Autonomic Agents|autonomic agents|mesh-ancestor
25348108|NCT05521087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25348109|NCT05521087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348110|NCT05521087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25348111|NCT05521087|Glucocorticoids|glucocorticoids|mesh-ancestor
25348112|NCT05521087|Hormones|hormones|mesh-ancestor
25348113|NCT05521087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25348114|NCT05521087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25348115|NCT05521087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348116|NCT05521087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25348117|NCT05521087|Antimetabolites|antimetabolites|mesh-ancestor
25348118|NCT05521087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348119|NCT05521087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25348120|NCT05521087|Immunologic Factors|immunologic factors|mesh-ancestor
25348121|NCT05521087|Antiviral Agents|antiviral agents|mesh-ancestor
25348122|NCT05521087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25348123|NCT05521087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25348124|NCT05521087|Tubulin Modulators|tubulin modulators|mesh-ancestor
25348125|NCT05521087|Antimitotic Agents|antimitotic agents|mesh-ancestor
25348126|NCT05521087|Mitosis Modulators|mitosis modulators|mesh-ancestor
25348127|NCT05521048|Doxycycline|doxycycline|mesh-list
25348128|NCT05521048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25348129|NCT05521048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25348130|NCT05521048|Antimalarials|antimalarials|mesh-ancestor
25348131|NCT05521048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25348132|NCT05521048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25348133|NCT05520944|Chlorpheniramine|chlorpheniramine|mesh-list
25348134|NCT05520944|Antipruritics|antipruritics|mesh-ancestor
25348135|NCT05520944|Dermatologic Agents|dermatologic agents|mesh-ancestor
25348136|NCT05520944|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25348137|NCT05520944|Histamine Antagonists|histamine antagonists|mesh-ancestor
25348138|NCT05520944|Histamine Agents|histamine agents|mesh-ancestor
25348139|NCT05520944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25348140|NCT05520944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348141|NCT05520944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348142|NCT05520944|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25348143|NCT05520892|Immunoglobulins|immunoglobulins|mesh-list
25348144|NCT05520892|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25348145|NCT05520892|Antibodies|antibodies|mesh-list
25348146|NCT05520892|gamma-Globulins|gamma-globulins|mesh-list
25348147|NCT05520892|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25348148|NCT05520892|Immunologic Factors|immunologic factors|mesh-ancestor
25348149|NCT05520892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348150|NCT05520853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25348151|NCT05520853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348152|NCT05520853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348153|NCT05520814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25348154|NCT05520814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348155|NCT05520814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348156|NCT05520749|Luspatercept|luspatercept|mesh-list
25348157|NCT05520749|Hematinics|hematinics|mesh-ancestor
25348158|NCT05520723|Loperamide|loperamide|mesh-list
25348159|NCT05520723|Antidiarrheals|antidiarrheals|mesh-list
25348160|NCT05520723|Lenograstim|lenograstim|mesh-list
25348161|NCT05520723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25348162|NCT05520723|Immunologic Factors|immunologic factors|mesh-ancestor
25348163|NCT05520723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348164|NCT05520723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25348165|NCT05520658|Fluorouracil|fluorouracil|mesh-list
25348166|NCT05520658|Digoxin|digoxin|mesh-list
25348167|NCT05520658|Furosemide|furosemide|mesh-list
25348168|NCT05520658|Antimetabolites|antimetabolites|mesh-ancestor
25348169|NCT05520658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348170|NCT05520658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25348171|NCT05520658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348172|NCT05520658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25348173|NCT05520658|Immunologic Factors|immunologic factors|mesh-ancestor
25348174|NCT05520658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348175|NCT05520658|Diuretics|diuretics|mesh-ancestor
25348176|NCT05520658|Natriuretic Agents|natriuretic agents|mesh-ancestor
25348177|NCT05520658|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25348178|NCT05520658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25348179|NCT05520658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25348180|NCT05520658|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25348181|NCT05520658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348182|NCT05520658|Protective Agents|protective agents|mesh-ancestor
25348183|NCT05520645|Propofol|propofol|mesh-list
25348184|NCT05520645|Etomidate|etomidate|mesh-list
25348185|NCT05520645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25348186|NCT05520645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25348187|NCT05520645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348188|NCT05520645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25348189|NCT05520645|Anesthetics, General|anesthetics, general|mesh-ancestor
25348190|NCT05520645|Anesthetics|anesthetics|mesh-ancestor
25348191|NCT05520619|Paclitaxel|paclitaxel|mesh-list
25348192|NCT05520619|Cisplatin|cisplatin|mesh-list
25348193|NCT05520619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25348194|NCT05520619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348195|NCT05520619|Tubulin Modulators|tubulin modulators|mesh-ancestor
25348196|NCT05520619|Antimitotic Agents|antimitotic agents|mesh-ancestor
25348197|NCT05520619|Mitosis Modulators|mitosis modulators|mesh-ancestor
25348198|NCT05520619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348199|NCT05520567|Azacitidine|azacitidine|mesh-list
25348200|NCT05520567|Venetoclax|venetoclax|mesh-list
25348201|NCT05520567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25348202|NCT05520567|Antimetabolites|antimetabolites|mesh-ancestor
25348203|NCT05520567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348204|NCT05520567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348205|NCT05520567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348206|NCT05520177|Ranibizumab|ranibizumab|mesh-list
25348207|NCT05520177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25348213|NCT05520138|Abiraterone Acetate|abiraterone acetate|mesh-list
25348214|NCT05520138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348215|NCT05520138|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25348216|NCT05520138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348217|NCT05520138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348218|NCT05520138|Hormone Antagonists|hormone antagonists|mesh-ancestor
25348219|NCT05520138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25348220|NCT05520138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348221|NCT05520138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25348223|NCT05520073|Vitamins|vitamins|mesh-ancestor
25348224|NCT05520073|Micronutrients|micronutrients|mesh-ancestor
25348225|NCT05520073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348226|NCT05520073|Antioxidants|antioxidants|mesh-ancestor
25348227|NCT05520073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348228|NCT05520073|Protective Agents|protective agents|mesh-ancestor
25348229|NCT05520021|Magnesium Sulfate|magnesium sulfate|mesh-list
25348230|NCT05520021|Nifedipine|nifedipine|mesh-list
25348231|NCT05520021|Analgesics|analgesics|mesh-ancestor
25348232|NCT05520021|Sensory System Agents|sensory system agents|mesh-ancestor
25348233|NCT05520021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25348234|NCT05520021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348235|NCT05520021|Anesthetics|anesthetics|mesh-ancestor
25348236|NCT05520021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25348237|NCT05520021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25348238|NCT05520021|Anticonvulsants|anticonvulsants|mesh-ancestor
25348239|NCT05520021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25348240|NCT05520021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25348241|NCT05520021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348242|NCT05520021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25348243|NCT05520021|Tocolytic Agents|tocolytic agents|mesh-ancestor
25348244|NCT05520021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25348245|NCT05520021|Vasodilator Agents|vasodilator agents|mesh-ancestor
25348251|NCT05519839|Vaccines|vaccines|mesh-list
25348252|NCT05519839|Immunologic Factors|immunologic factors|mesh-ancestor
25348253|NCT05519839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348254|NCT05519813|Metformin|metformin|mesh-list
25348255|NCT05519813|Pioglitazone|pioglitazone|mesh-list
25348256|NCT05519813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25348257|NCT05519813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348258|NCT05519683|Citalopram|citalopram|mesh-list
25348259|NCT05519683|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25348260|NCT05519683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25348261|NCT05519683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25348262|NCT05519683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348263|NCT05519683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25348264|NCT05519683|Serotonin Agents|serotonin agents|mesh-ancestor
25348265|NCT05519683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348266|NCT05519683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25348267|NCT05519683|Antidepressive Agents|antidepressive agents|mesh-ancestor
25348268|NCT05519683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25348269|NCT05519670|Niraparib|niraparib|mesh-list
25348270|NCT05519670|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25348271|NCT05519670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348272|NCT05519670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348273|NCT05519670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348274|NCT05519592|Ropivacaine|ropivacaine|mesh-list
25348275|NCT05519592|Anesthetics, Local|anesthetics, local|mesh-ancestor
25348276|NCT05519592|Anesthetics|anesthetics|mesh-ancestor
25348277|NCT05519592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25348278|NCT05519592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348279|NCT05519592|Sensory System Agents|sensory system agents|mesh-ancestor
25348280|NCT05519592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25348281|NCT05519579|Methotrexate|methotrexate|mesh-list
25348282|NCT05519579|Blinatumomab|blinatumomab|mesh-list
25348283|NCT05519579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25348284|NCT05519579|Abortifacient Agents|abortifacient agents|mesh-ancestor
25348285|NCT05519579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25348286|NCT05519579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348287|NCT05519579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25348288|NCT05519579|Antimetabolites|antimetabolites|mesh-ancestor
25348289|NCT05519579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348290|NCT05519579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348291|NCT05519579|Dermatologic Agents|dermatologic agents|mesh-ancestor
25348292|NCT05519579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348293|NCT05519579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25348294|NCT05519579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25348295|NCT05519579|Immunologic Factors|immunologic factors|mesh-ancestor
25348296|NCT05519579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25348297|NCT05519579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25348299|NCT05519514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25348300|NCT05519514|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25348301|NCT05519514|Autonomic Agents|autonomic agents|mesh-ancestor
25348302|NCT05519514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25348303|NCT05519514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348304|NCT05519514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25348305|NCT05519514|Respiratory System Agents|respiratory system agents|mesh-ancestor
25348307|NCT05519514|Hormones|hormones|mesh-ancestor
25348308|NCT05519514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25348309|NCT05519410|Lenvatinib|lenvatinib|mesh-list
25348310|NCT05519410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348311|NCT05519410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25348312|NCT05519410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348313|NCT05519410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348314|NCT05519384|Cyclophosphamide|cyclophosphamide|mesh-list
25348315|NCT05519384|Fludarabine|fludarabine|mesh-list
25348316|NCT05519384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25348317|NCT05519384|Immunologic Factors|immunologic factors|mesh-ancestor
25348318|NCT05519384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348319|NCT05519384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25348320|NCT05519384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25348321|NCT05519384|Alkylating Agents|alkylating agents|mesh-ancestor
25348322|NCT05519384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348323|NCT05519384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348324|NCT05519384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25348325|NCT05519371|Propofol|propofol|mesh-list
25348326|NCT05519371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25348327|NCT05519371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25348328|NCT05519371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348329|NCT05519371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25348330|NCT05519371|Anesthetics, General|anesthetics, general|mesh-ancestor
25348331|NCT05519371|Anesthetics|anesthetics|mesh-ancestor
25348332|NCT05519254|Lactoferrin|lactoferrin|mesh-list
25348333|NCT05519254|Muramidase|muramidase|mesh-list
25348334|NCT05519254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25348335|NCT05519241|Paclitaxel|paclitaxel|mesh-list
25348336|NCT05519241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25348337|NCT05519241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348338|NCT05519241|Tubulin Modulators|tubulin modulators|mesh-ancestor
25348339|NCT05519241|Antimitotic Agents|antimitotic agents|mesh-ancestor
25348340|NCT05519241|Mitosis Modulators|mitosis modulators|mesh-ancestor
25348341|NCT05519241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348342|NCT05519202|Oxaliplatin|oxaliplatin|mesh-list
25348343|NCT05519202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348344|NCT05519189|Ropivacaine|ropivacaine|mesh-list
25348345|NCT05519189|Anesthetics, Local|anesthetics, local|mesh-ancestor
25348346|NCT05519189|Anesthetics|anesthetics|mesh-ancestor
25348347|NCT05519189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25348348|NCT05519189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348349|NCT05519189|Sensory System Agents|sensory system agents|mesh-ancestor
25348350|NCT05519189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25348351|NCT05519111|Dronabinol|dronabinol|mesh-list
25348352|NCT05519111|Hallucinogens|hallucinogens|mesh-ancestor
25348353|NCT05519111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348354|NCT05519111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25348355|NCT05519111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25348356|NCT05519111|Analgesics|analgesics|mesh-ancestor
25348357|NCT05519111|Sensory System Agents|sensory system agents|mesh-ancestor
25348358|NCT05519111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25348359|NCT05519111|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25348360|NCT05519111|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25348361|NCT05519111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25348362|NCT05519111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348363|NCT05519111|Hormones|hormones|mesh-ancestor
25348364|NCT05519111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25348365|NCT05519085|Dexamethasone|dexamethasone|mesh-list
25348366|NCT05519085|Bortezomib|bortezomib|mesh-list
25348367|NCT05519085|Pomalidomide|pomalidomide|mesh-list
25348368|NCT05519085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25348369|NCT05519085|Antiemetics|antiemetics|mesh-ancestor
25348370|NCT05519085|Autonomic Agents|autonomic agents|mesh-ancestor
25348371|NCT05519085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25348372|NCT05519085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348373|NCT05519085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25348374|NCT05519085|Glucocorticoids|glucocorticoids|mesh-ancestor
25348375|NCT05519085|Hormones|hormones|mesh-ancestor
25348376|NCT05519085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25348377|NCT05519085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25348378|NCT05519085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348379|NCT05519085|Immunologic Factors|immunologic factors|mesh-ancestor
25348380|NCT05519085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25348381|NCT05519085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25348382|NCT05519085|Growth Substances|growth substances|mesh-ancestor
25348383|NCT05519085|Growth Inhibitors|growth inhibitors|mesh-ancestor
25348384|NCT05519072|Ciprofloxacin|ciprofloxacin|mesh-list
25348385|NCT05519072|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25348386|NCT05519072|Cephalexin|cephalexin|mesh-list
25348387|NCT05519072|Fosfomycin|fosfomycin|mesh-list
25348388|NCT05519072|Nitrofurantoin|nitrofurantoin|mesh-list
25348389|NCT05519072|Trimethoprim|trimethoprim|mesh-list
25348390|NCT05519072|Sulfamethoxazole|sulfamethoxazole|mesh-list
25348391|NCT05519072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25348392|NCT05519072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25348393|NCT05519072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25348394|NCT05519072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25348395|NCT05519072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348396|NCT05519072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348397|NCT05519072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348398|NCT05519072|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25348399|NCT05519072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25348400|NCT05519072|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25348401|NCT05519072|Renal Agents|renal agents|mesh-ancestor
25348402|NCT05519072|Antimalarials|antimalarials|mesh-ancestor
25348403|NCT05519072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25348404|NCT05519072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25348405|NCT05519072|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25348406|NCT05519072|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25348407|NCT05519072|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25348408|NCT05519072|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25348409|NCT05519059|Paclitaxel|paclitaxel|mesh-list
25348410|NCT05519059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25348411|NCT05519059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348412|NCT05519059|Tubulin Modulators|tubulin modulators|mesh-ancestor
25348413|NCT05519059|Antimitotic Agents|antimitotic agents|mesh-ancestor
25348414|NCT05519059|Mitosis Modulators|mitosis modulators|mesh-ancestor
25348415|NCT05519059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348416|NCT05518994|Bevacizumab|bevacizumab|mesh-list
25348417|NCT05518994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25348418|NCT05518994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348419|NCT05518994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25348420|NCT05518994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25348421|NCT05518994|Growth Substances|growth substances|mesh-ancestor
25348422|NCT05518994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348423|NCT05518994|Growth Inhibitors|growth inhibitors|mesh-ancestor
25348424|NCT05518929|Propofol|propofol|mesh-list
25348425|NCT05518929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25348426|NCT05518929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25348427|NCT05518929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348428|NCT05518929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25348429|NCT05518929|Anesthetics, General|anesthetics, general|mesh-ancestor
25348430|NCT05518929|Anesthetics|anesthetics|mesh-ancestor
25348431|NCT05518903|FAPI-46|fapi-46|mesh-list
25348432|NCT05518903|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25348433|NCT05518903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348435|NCT05518877|Analgesics|analgesics|mesh-ancestor
25348436|NCT05518877|Sensory System Agents|sensory system agents|mesh-ancestor
25348511|NCT05518513|Anesthetics, Local|anesthetics, local|mesh-ancestor
25348437|NCT05518877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25348438|NCT05518877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348439|NCT05518877|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25348440|NCT05518877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25348441|NCT05518877|Anesthetics, General|anesthetics, general|mesh-ancestor
25348443|NCT05518877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25348444|NCT05518877|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25348445|NCT05518877|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25348446|NCT05518877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25348447|NCT05518877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348448|NCT05518812|Carboprost tromethamine|carboprost tromethamine|mesh-list
25348449|NCT05518812|Carboprost|carboprost|mesh-list
25348450|NCT05518812|Oxytocics|oxytocics|mesh-ancestor
25348451|NCT05518812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25348452|NCT05518812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348453|NCT05518812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25348454|NCT05518812|Abortifacient Agents|abortifacient agents|mesh-ancestor
25348455|NCT05518799|Midazolam|midazolam|mesh-list
25348456|NCT05518799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25348457|NCT05518799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25348458|NCT05518799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25348459|NCT05518799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348460|NCT05518799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25348461|NCT05518799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25348462|NCT05518799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25348463|NCT05518799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25348464|NCT05518799|Anesthetics, General|anesthetics, general|mesh-ancestor
25348465|NCT05518799|Anesthetics|anesthetics|mesh-ancestor
25348466|NCT05518799|GABA Modulators|gaba modulators|mesh-ancestor
25348467|NCT05518799|GABA Agents|gaba agents|mesh-ancestor
25348468|NCT05518799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25348469|NCT05518799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348470|NCT05518734|Itraconazole|itraconazole|mesh-list
25348471|NCT05518734|Midazolam|midazolam|mesh-list
25348472|NCT05518734|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25348473|NCT05518734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25348474|NCT05518734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25348475|NCT05518734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348476|NCT05518734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25348477|NCT05518734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25348478|NCT05518734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25348479|NCT05518734|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25348480|NCT05518734|Anesthetics, General|anesthetics, general|mesh-ancestor
25348481|NCT05518734|Anesthetics|anesthetics|mesh-ancestor
25348482|NCT05518734|GABA Modulators|gaba modulators|mesh-ancestor
25348483|NCT05518734|GABA Agents|gaba agents|mesh-ancestor
25348484|NCT05518734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25348485|NCT05518734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348486|NCT05518734|Antifungal Agents|antifungal agents|mesh-ancestor
25348487|NCT05518734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25348488|NCT05518734|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25348489|NCT05518734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25348490|NCT05518734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348491|NCT05518734|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25348492|NCT05518734|Hormone Antagonists|hormone antagonists|mesh-ancestor
25348493|NCT05518734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25348494|NCT05518734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25348495|NCT05518695|Antibodies, Blocking|antibodies, blocking|mesh-list
25348496|NCT05518695|Immunologic Factors|immunologic factors|mesh-ancestor
25348497|NCT05518695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348498|NCT05518578|Huperzine A|huperzine a|mesh-list
25348499|NCT05518578|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25348500|NCT05518578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348501|NCT05518578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348502|NCT05518578|Cholinergic Agents|cholinergic agents|mesh-ancestor
25348503|NCT05518578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25348504|NCT05518578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348505|NCT05518578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25348506|NCT05518578|Protective Agents|protective agents|mesh-ancestor
25348507|NCT05518526|Annamycin|annamycin|mesh-list
25348508|NCT05518526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25348509|NCT05518526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348510|NCT05518513|Bupivacaine|bupivacaine|mesh-list
25348512|NCT05518513|Anesthetics|anesthetics|mesh-ancestor
25348513|NCT05518513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25348514|NCT05518513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348515|NCT05518513|Sensory System Agents|sensory system agents|mesh-ancestor
25348516|NCT05518513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25348517|NCT05518500|Vaccines|vaccines|mesh-list
25348518|NCT05518500|Immunologic Factors|immunologic factors|mesh-ancestor
25348519|NCT05518500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348520|NCT05518409|Donepezil|donepezil|mesh-list
25348521|NCT05518409|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25348522|NCT05518409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348523|NCT05518409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348524|NCT05518409|Cholinergic Agents|cholinergic agents|mesh-ancestor
25348525|NCT05518409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25348526|NCT05518409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348527|NCT05518409|Nootropic Agents|nootropic agents|mesh-ancestor
25348528|NCT05518383|Cytarabine|cytarabine|mesh-list
25348529|NCT05518383|Dexamethasone|dexamethasone|mesh-list
25348530|NCT05518383|Dexamethasone acetate|dexamethasone acetate|mesh-list
25348531|NCT05518383|Cyclophosphamide|cyclophosphamide|mesh-list
25348532|NCT05518383|Melphalan|melphalan|mesh-list
25348533|NCT05518383|Ifosfamide|ifosfamide|mesh-list
25348534|NCT05518383|Isophosphamide mustard|isophosphamide mustard|mesh-list
25348535|NCT05518383|Doxorubicin|doxorubicin|mesh-list
25348536|NCT05518383|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25348537|NCT05518383|Methotrexate|methotrexate|mesh-list
25348538|NCT05518383|Etoposide|etoposide|mesh-list
25348539|NCT05518383|Etoposide phosphate|etoposide phosphate|mesh-list
25348540|NCT05518383|Vincristine|vincristine|mesh-list
25348541|NCT05518383|Idarubicin|idarubicin|mesh-list
25348542|NCT05518383|Carboplatin|carboplatin|mesh-list
25348543|NCT05518383|BB 1101|bb 1101|mesh-list
25348544|NCT05518383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25348545|NCT05518383|Immunologic Factors|immunologic factors|mesh-ancestor
25348546|NCT05518383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348547|NCT05518383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25348548|NCT05518383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25348549|NCT05518383|Alkylating Agents|alkylating agents|mesh-ancestor
25348550|NCT05518383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348551|NCT05518383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348552|NCT05518383|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25348553|NCT05518383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25348554|NCT05518383|Antiemetics|antiemetics|mesh-ancestor
25348555|NCT05518383|Autonomic Agents|autonomic agents|mesh-ancestor
25348556|NCT05518383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25348557|NCT05518383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25348558|NCT05518383|Glucocorticoids|glucocorticoids|mesh-ancestor
25348559|NCT05518383|Hormones|hormones|mesh-ancestor
25348560|NCT05518383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25348561|NCT05518383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25348562|NCT05518383|Protease Inhibitors|protease inhibitors|mesh-ancestor
25348563|NCT05518383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348564|NCT05518383|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25348565|NCT05518383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25348566|NCT05518383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25348567|NCT05518383|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25348568|NCT05518383|Abortifacient Agents|abortifacient agents|mesh-ancestor
25348569|NCT05518383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25348570|NCT05518383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25348571|NCT05518383|Antimetabolites|antimetabolites|mesh-ancestor
25348572|NCT05518383|Dermatologic Agents|dermatologic agents|mesh-ancestor
25348573|NCT05518383|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25348574|NCT05518383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25348575|NCT05518383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25348576|NCT05518383|Antiviral Agents|antiviral agents|mesh-ancestor
25348577|NCT05518383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25348578|NCT05518383|Tubulin Modulators|tubulin modulators|mesh-ancestor
25348579|NCT05518383|Antimitotic Agents|antimitotic agents|mesh-ancestor
25348580|NCT05518383|Mitosis Modulators|mitosis modulators|mesh-ancestor
25348581|NCT05518279|Tranexamic Acid|tranexamic acid|mesh-list
25348582|NCT05518279|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25348583|NCT05518279|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25348584|NCT05518279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348585|NCT05518279|Hemostatics|hemostatics|mesh-ancestor
25348586|NCT05518279|Coagulants|coagulants|mesh-ancestor
25348588|NCT05518149|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25348589|NCT05518149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348590|NCT05518149|Sensory System Agents|sensory system agents|mesh-ancestor
25348591|NCT05518149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25348592|NCT05518110|Hydroxychloroquine|hydroxychloroquine|mesh-list
25348593|NCT05518110|Trametinib|trametinib|mesh-list
25348594|NCT05518110|Antimalarials|antimalarials|mesh-ancestor
25348595|NCT05518110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25348596|NCT05518110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25348597|NCT05518110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25348598|NCT05518110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348599|NCT05518110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348600|NCT05518110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25348601|NCT05518110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348602|NCT05518110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25348603|NCT05518032|Pembrolizumab|pembrolizumab|mesh-list
25348604|NCT05518032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25348605|NCT05518032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348606|NCT05517928|Omeprazole|omeprazole|mesh-list
25348607|NCT05517928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25348608|NCT05517928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25348609|NCT05517928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25348610|NCT05517928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348611|NCT05517928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348612|NCT05517746|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25348613|NCT05517668|Acetylcysteine|acetylcysteine|mesh-list
25348614|NCT05517668|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25348615|NCT05517668|Fomepizole|fomepizole|mesh-list
25348616|NCT05517668|Antiviral Agents|antiviral agents|mesh-ancestor
25348617|NCT05517668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25348618|NCT05517668|Expectorants|expectorants|mesh-ancestor
25348619|NCT05517668|Respiratory System Agents|respiratory system agents|mesh-ancestor
25348620|NCT05517668|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25348621|NCT05517668|Antioxidants|antioxidants|mesh-ancestor
25348622|NCT05517668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348623|NCT05517668|Protective Agents|protective agents|mesh-ancestor
25348624|NCT05517668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348625|NCT05517668|Antidotes|antidotes|mesh-ancestor
25348626|NCT05517668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348627|NCT05517642|Vaccines|vaccines|mesh-list
25348628|NCT05517642|Immunologic Factors|immunologic factors|mesh-ancestor
25348629|NCT05517642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348630|NCT05517590|Tranexamic Acid|tranexamic acid|mesh-list
25348631|NCT05517590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25348632|NCT05517590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25348633|NCT05517590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348634|NCT05517590|Hemostatics|hemostatics|mesh-ancestor
25348635|NCT05517590|Coagulants|coagulants|mesh-ancestor
25348636|NCT05517538|Botulinum Toxins|botulinum toxins|mesh-list
25348637|NCT05517538|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25348638|NCT05517538|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25348639|NCT05517538|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25348640|NCT05517538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25348641|NCT05517538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348642|NCT05517538|Cholinergic Agents|cholinergic agents|mesh-ancestor
25348643|NCT05517538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25348644|NCT05517538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348645|NCT05517538|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25348646|NCT05517538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25348647|NCT05517499|Dexamethasone|dexamethasone|mesh-list
25348648|NCT05517499|Dexamethasone acetate|dexamethasone acetate|mesh-list
25348649|NCT05517499|BB 1101|bb 1101|mesh-list
25348650|NCT05517499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25348651|NCT05517499|Antiemetics|antiemetics|mesh-ancestor
25348652|NCT05517499|Autonomic Agents|autonomic agents|mesh-ancestor
25348653|NCT05517499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25348654|NCT05517499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348655|NCT05517499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25348656|NCT05517499|Glucocorticoids|glucocorticoids|mesh-ancestor
25348657|NCT05517499|Hormones|hormones|mesh-ancestor
25348658|NCT05517499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25348659|NCT05517499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25348660|NCT05517499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348661|NCT05517499|Protease Inhibitors|protease inhibitors|mesh-ancestor
25348662|NCT05517499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348665|NCT05517486|Anesthetics, Local|anesthetics, local|mesh-ancestor
25348666|NCT05517486|Anesthetics|anesthetics|mesh-ancestor
25348667|NCT05517486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25348668|NCT05517486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348669|NCT05517486|Sensory System Agents|sensory system agents|mesh-ancestor
25348670|NCT05517486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25348671|NCT05517330|Afatinib|afatinib|mesh-list
25348672|NCT05517330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348673|NCT05517330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25348674|NCT05517330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348675|NCT05517330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348676|NCT05517291|Paclitaxel|paclitaxel|mesh-list
25348677|NCT05517291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25348678|NCT05517291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348679|NCT05517291|Tubulin Modulators|tubulin modulators|mesh-ancestor
25348680|NCT05517291|Antimitotic Agents|antimitotic agents|mesh-ancestor
25348681|NCT05517291|Mitosis Modulators|mitosis modulators|mesh-ancestor
25348682|NCT05517291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348685|NCT05517265|Acalabrutinib|acalabrutinib|mesh-list
25348686|NCT05517265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348687|NCT05517239|Gemcitabine|gemcitabine|mesh-list
25348688|NCT05517239|Oxaliplatin|oxaliplatin|mesh-list
25348689|NCT05517239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25348690|NCT05517239|Antimetabolites|antimetabolites|mesh-ancestor
25348691|NCT05517239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348692|NCT05517239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348693|NCT05517239|Antiviral Agents|antiviral agents|mesh-ancestor
25348694|NCT05517239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25348695|NCT05517239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348696|NCT05517239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25348697|NCT05517239|Immunologic Factors|immunologic factors|mesh-ancestor
25348698|NCT05517239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348699|NCT05517213|Cyclophosphamide|cyclophosphamide|mesh-list
25348701|NCT05517213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25348702|NCT05517213|Immunologic Factors|immunologic factors|mesh-ancestor
25348703|NCT05517213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348704|NCT05517213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25348705|NCT05517213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25348706|NCT05517213|Alkylating Agents|alkylating agents|mesh-ancestor
25348707|NCT05517213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348708|NCT05517213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348709|NCT05517213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25348710|NCT05517213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25348711|NCT05517213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25348712|NCT05517213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25348713|NCT05517213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348714|NCT05517174|Vaccines|vaccines|mesh-list
25348715|NCT05517174|Immunologic Factors|immunologic factors|mesh-ancestor
25348716|NCT05517174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348717|NCT05517122|Niacinamide|niacinamide|mesh-list
25348718|NCT05517122|Niacin|niacin|mesh-list
25348719|NCT05517122|Nicotinic Acids|nicotinic acids|mesh-list
25348720|NCT05517122|Vitamin B Complex|vitamin b complex|mesh-ancestor
25348721|NCT05517122|Vitamins|vitamins|mesh-ancestor
25348722|NCT05517122|Micronutrients|micronutrients|mesh-ancestor
25348723|NCT05517122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348724|NCT05517122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25348725|NCT05517122|Antimetabolites|antimetabolites|mesh-ancestor
25348726|NCT05517122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348727|NCT05517122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25348728|NCT05517122|Vasodilator Agents|vasodilator agents|mesh-ancestor
25348729|NCT05516966|Dulaglutide|dulaglutide|mesh-list
25348730|NCT05516966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25348731|NCT05516966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348732|NCT05516953|Gabapentin|gabapentin|mesh-list
25348733|NCT05516953|Ondansetron|ondansetron|mesh-list
25348734|NCT05516953|Baclofen|baclofen|mesh-list
25348735|NCT05516953|Analgesics|analgesics|mesh-ancestor
25348736|NCT05516953|Sensory System Agents|sensory system agents|mesh-ancestor
25348737|NCT05516953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25348738|NCT05516953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348739|NCT05516953|Anticonvulsants|anticonvulsants|mesh-ancestor
25348747|NCT05516953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348749|NCT05516953|Antiemetics|antiemetics|mesh-ancestor
25348750|NCT05516953|Autonomic Agents|autonomic agents|mesh-ancestor
25348751|NCT05516953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25348752|NCT05516953|Antipruritics|antipruritics|mesh-ancestor
25348753|NCT05516953|Dermatologic Agents|dermatologic agents|mesh-ancestor
25348754|NCT05516953|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25348755|NCT05516953|Serotonin Agents|serotonin agents|mesh-ancestor
25348756|NCT05516953|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25348757|NCT05516953|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25348758|NCT05516953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25348759|NCT05516953|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25348760|NCT05516953|GABA Agonists|gaba agonists|mesh-ancestor
25348761|NCT05516953|GABA Agents|gaba agents|mesh-ancestor
25348762|NCT05516862|Camphor|camphor|mesh-list
25348763|NCT05516862|Salicylates|salicylates|mesh-list
25348764|NCT05516862|Methyl salicylate|methyl salicylate|mesh-list
25348765|NCT05516862|Menthol|menthol|mesh-list
25348766|NCT05516862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25348767|NCT05516862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25348768|NCT05516862|Antipruritics|antipruritics|mesh-ancestor
25348769|NCT05516862|Dermatologic Agents|dermatologic agents|mesh-ancestor
25348770|NCT05516862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25348771|NCT05516862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25348772|NCT05516862|Analgesics|analgesics|mesh-ancestor
25348773|NCT05516862|Sensory System Agents|sensory system agents|mesh-ancestor
25348774|NCT05516862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25348775|NCT05516862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348776|NCT05516862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25348777|NCT05516862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25348778|NCT05516862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25348779|NCT05516862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348780|NCT05516862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348781|NCT05516849|Oxandrolone|oxandrolone|mesh-list
25348782|NCT05516849|Androgens|androgens|mesh-ancestor
25348783|NCT05516849|Hormones|hormones|mesh-ancestor
25348784|NCT05516849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25348785|NCT05516849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348786|NCT05516849|Anabolic Agents|anabolic agents|mesh-ancestor
25348787|NCT05516784|Clopidogrel|clopidogrel|mesh-list
25348788|NCT05516784|Ticagrelor|ticagrelor|mesh-list
25348789|NCT05516784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25348790|NCT05516784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25348791|NCT05516784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25348792|NCT05516784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25348793|NCT05516784|Purinergic Agents|purinergic agents|mesh-ancestor
25348794|NCT05516784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25348795|NCT05516784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348796|NCT05516784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348797|NCT05516745|Respiratory System Agents|respiratory system agents|mesh-list
25348798|NCT05516654|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25348799|NCT05516654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25348809|NCT05516589|Paclitaxel|paclitaxel|mesh-list
25348810|NCT05516589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25348811|NCT05516589|Cisplatin|cisplatin|mesh-list
25348812|NCT05516589|Afatinib|afatinib|mesh-list
25348813|NCT05516589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25348814|NCT05516589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348815|NCT05516589|Tubulin Modulators|tubulin modulators|mesh-ancestor
25348816|NCT05516589|Antimitotic Agents|antimitotic agents|mesh-ancestor
25348817|NCT05516589|Mitosis Modulators|mitosis modulators|mesh-ancestor
25348818|NCT05516589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348819|NCT05516589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25348820|NCT05516589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348821|NCT05516498|Dapagliflozin|dapagliflozin|mesh-list
25348822|NCT05516498|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25348823|NCT05516498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348824|NCT05516498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25348825|NCT05516498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348826|NCT05516446|Chromium|chromium|mesh-list
25348827|NCT05516446|Paclitaxel|paclitaxel|mesh-list
25348828|NCT05516446|Everolimus|everolimus|mesh-list
25348829|NCT05516446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25348830|NCT05516446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348831|NCT05516446|Tubulin Modulators|tubulin modulators|mesh-ancestor
25348832|NCT05516446|Antimitotic Agents|antimitotic agents|mesh-ancestor
25348833|NCT05516446|Mitosis Modulators|mitosis modulators|mesh-ancestor
25348834|NCT05516446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348835|NCT05516446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25348836|NCT05516446|Immunologic Factors|immunologic factors|mesh-ancestor
25348837|NCT05516446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348838|NCT05516446|Trace Elements|trace elements|mesh-ancestor
25348839|NCT05516446|Micronutrients|micronutrients|mesh-ancestor
25348840|NCT05516303|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25348841|NCT05516303|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25348842|NCT05516303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348843|NCT05516303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25348844|NCT05516303|Immunologic Factors|immunologic factors|mesh-ancestor
25348845|NCT05516303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348847|NCT05516251|Anticonvulsants|anticonvulsants|mesh-ancestor
25348848|NCT05516251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25348849|NCT05516251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348850|NCT05515978|Metformin|metformin|mesh-list
25348851|NCT05515978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25348852|NCT05515978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348853|NCT05515939|Insulin|insulin|mesh-list
25348854|NCT05515939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25348855|NCT05515939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348856|NCT05515874|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25348857|NCT05515874|Hematinics|hematinics|mesh-ancestor
25348858|NCT05515874|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25348859|NCT05515874|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25348860|NCT05515822|Oxycodone|oxycodone|mesh-list
25348861|NCT05515822|Dezocine|dezocine|mesh-list
25348862|NCT05515822|Esketamine|esketamine|mesh-list
25348863|NCT05515822|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25348864|NCT05515822|Narcotics|narcotics|mesh-ancestor
25348865|NCT05515822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25348866|NCT05515822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348867|NCT05515822|Analgesics|analgesics|mesh-ancestor
25348868|NCT05515822|Sensory System Agents|sensory system agents|mesh-ancestor
25348869|NCT05515822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25348870|NCT05515822|Antidepressive Agents|antidepressive agents|mesh-ancestor
25348871|NCT05515822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25348872|NCT05515796|Trastuzumab|trastuzumab|mesh-list
25348873|NCT05515796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25348874|NCT05515796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348875|NCT05515770|Cabotegravir|cabotegravir|mesh-list
25348876|NCT05515770|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25348877|NCT05515770|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25348878|NCT05515770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348879|NCT05515770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348880|NCT05515770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25348881|NCT05515770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25348882|NCT05515770|Antiviral Agents|antiviral agents|mesh-ancestor
25348883|NCT05515770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25348884|NCT05515731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25348885|NCT05515731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25348886|NCT05515627|Atezolizumab|atezolizumab|mesh-list
25348887|NCT05515627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348888|NCT05515601|Mirikizumab|mirikizumab|mesh-list
25348889|NCT05515601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25348890|NCT05515601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25348891|NCT05515601|Analgesics|analgesics|mesh-ancestor
25348892|NCT05515601|Sensory System Agents|sensory system agents|mesh-ancestor
25348893|NCT05515601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25348894|NCT05515601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348896|NCT05515601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25348897|NCT05515601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25348898|NCT05515601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25348899|NCT05515575|Niraparib|niraparib|mesh-list
25348900|NCT05515575|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25348901|NCT05515575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348902|NCT05515575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348903|NCT05515575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348904|NCT05515471|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25348905|NCT05515471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25348906|NCT05515354|Nicotine|nicotine|mesh-list
25348907|NCT05515354|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25348908|NCT05515354|Autonomic Agents|autonomic agents|mesh-ancestor
25348909|NCT05515354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25348910|NCT05515354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348911|NCT05515354|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25348912|NCT05515354|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25348913|NCT05515354|Cholinergic Agents|cholinergic agents|mesh-ancestor
25348914|NCT05515354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25348993|NCT05514990|Hormones|hormones|mesh-ancestor
25348915|NCT05515354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348916|NCT05515315|Paclitaxel|paclitaxel|mesh-list
25348917|NCT05515315|Nedaplatin|nedaplatin|mesh-list
25348918|NCT05515315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25348919|NCT05515315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348920|NCT05515315|Tubulin Modulators|tubulin modulators|mesh-ancestor
25348921|NCT05515315|Antimitotic Agents|antimitotic agents|mesh-ancestor
25348922|NCT05515315|Mitosis Modulators|mitosis modulators|mesh-ancestor
25348923|NCT05515315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348924|NCT05515185|Cyclophosphamide|cyclophosphamide|mesh-list
25348925|NCT05515185|Fludarabine|fludarabine|mesh-list
25348926|NCT05515185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25348927|NCT05515185|Immunologic Factors|immunologic factors|mesh-ancestor
25348928|NCT05515185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348929|NCT05515185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25348930|NCT05515185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25348931|NCT05515185|Alkylating Agents|alkylating agents|mesh-ancestor
25348932|NCT05515185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348933|NCT05515185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348934|NCT05515185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25348935|NCT05515120|Aspirin|aspirin|mesh-list
25348936|NCT05515120|Vitamin K|vitamin k|mesh-list
25348937|NCT05515120|Rivaroxaban|rivaroxaban|mesh-list
25348938|NCT05515120|Acenocoumarol|acenocoumarol|mesh-list
25348939|NCT05515120|Vitamins|vitamins|mesh-ancestor
25348940|NCT05515120|Micronutrients|micronutrients|mesh-ancestor
25348941|NCT05515120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348942|NCT05515120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25348943|NCT05515120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25348944|NCT05515120|Analgesics|analgesics|mesh-ancestor
25348945|NCT05515120|Sensory System Agents|sensory system agents|mesh-ancestor
25348946|NCT05515120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25348947|NCT05515120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25348948|NCT05515120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25348949|NCT05515120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25348950|NCT05515120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25348951|NCT05515120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348952|NCT05515120|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25348953|NCT05515120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25348954|NCT05515120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348955|NCT05515120|Antipyretics|antipyretics|mesh-ancestor
25348956|NCT05515120|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25348957|NCT05515120|Antithrombins|antithrombins|mesh-ancestor
25348958|NCT05515120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25348959|NCT05515120|Protease Inhibitors|protease inhibitors|mesh-ancestor
25348960|NCT05515120|Anticoagulants|anticoagulants|mesh-ancestor
25348961|NCT05515120|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25348962|NCT05515120|Hemostatics|hemostatics|mesh-ancestor
25348963|NCT05515120|Coagulants|coagulants|mesh-ancestor
25348964|NCT05515029|Cyclophosphamide|cyclophosphamide|mesh-list
25348965|NCT05515029|Abatacept|abatacept|mesh-list
25348966|NCT05515029|Vedolizumab|vedolizumab|mesh-list
25348967|NCT05515029|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
25348968|NCT05515029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25348969|NCT05515029|Immunologic Factors|immunologic factors|mesh-ancestor
25348970|NCT05515029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348971|NCT05515029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25348972|NCT05515029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25348973|NCT05515029|Alkylating Agents|alkylating agents|mesh-ancestor
25348974|NCT05515029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25348975|NCT05515029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348976|NCT05515029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25348977|NCT05515029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25348978|NCT05515029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25348979|NCT05515029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348981|NCT05514990|Dexamethasone acetate|dexamethasone acetate|mesh-list
25348982|NCT05514990|Pembrolizumab|pembrolizumab|mesh-list
25348983|NCT05514990|Bortezomib|bortezomib|mesh-list
25348984|NCT05514990|Ichthammol|ichthammol|mesh-list
25348985|NCT05514990|BB 1101|bb 1101|mesh-list
25348986|NCT05514990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25348987|NCT05514990|Antiemetics|antiemetics|mesh-ancestor
25348988|NCT05514990|Autonomic Agents|autonomic agents|mesh-ancestor
25348989|NCT05514990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25348990|NCT05514990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25348991|NCT05514990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25348992|NCT05514990|Glucocorticoids|glucocorticoids|mesh-ancestor
25348994|NCT05514990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25348995|NCT05514990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25348996|NCT05514990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25348997|NCT05514990|Protease Inhibitors|protease inhibitors|mesh-ancestor
25348998|NCT05514990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25348999|NCT05514990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349000|NCT05514990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25349001|NCT05514990|Dermatologic Agents|dermatologic agents|mesh-ancestor
25349002|NCT05514925|Bevacizumab|bevacizumab|mesh-list
25349003|NCT05514925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25349004|NCT05514925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349005|NCT05514925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25349006|NCT05514925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25349007|NCT05514925|Growth Substances|growth substances|mesh-ancestor
25349008|NCT05514925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349009|NCT05514925|Growth Inhibitors|growth inhibitors|mesh-ancestor
25349010|NCT05514912|Gemcitabine|gemcitabine|mesh-list
25349012|NCT05514912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25349013|NCT05514912|Cisplatin|cisplatin|mesh-list
25349014|NCT05514912|Infigratinib|infigratinib|mesh-list
25349015|NCT05514912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25349016|NCT05514912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349017|NCT05514912|Tubulin Modulators|tubulin modulators|mesh-ancestor
25349018|NCT05514912|Antimitotic Agents|antimitotic agents|mesh-ancestor
25349019|NCT05514912|Mitosis Modulators|mitosis modulators|mesh-ancestor
25349020|NCT05514912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349021|NCT05514912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25349022|NCT05514912|Antimetabolites|antimetabolites|mesh-ancestor
25349023|NCT05514912|Antiviral Agents|antiviral agents|mesh-ancestor
25349024|NCT05514912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25349025|NCT05514912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25349026|NCT05514912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25349027|NCT05514912|Immunologic Factors|immunologic factors|mesh-ancestor
25349028|NCT05514912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349029|NCT05514899|Dronabinol|dronabinol|mesh-list
25349030|NCT05514899|Cannabidiol|cannabidiol|mesh-list
25349031|NCT05514899|Anticonvulsants|anticonvulsants|mesh-ancestor
25349032|NCT05514899|Hallucinogens|hallucinogens|mesh-ancestor
25349033|NCT05514899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349034|NCT05514899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25349035|NCT05514899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25349036|NCT05514899|Analgesics|analgesics|mesh-ancestor
25349037|NCT05514899|Sensory System Agents|sensory system agents|mesh-ancestor
25349038|NCT05514899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349039|NCT05514899|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25349040|NCT05514899|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25349041|NCT05514899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25349042|NCT05514899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349043|NCT05514899|Hormones|hormones|mesh-ancestor
25349044|NCT05514899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25349045|NCT05514860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
25349046|NCT05514847|Aspirin|aspirin|mesh-list
25349049|NCT05514847|Analgesics|analgesics|mesh-ancestor
25349050|NCT05514847|Sensory System Agents|sensory system agents|mesh-ancestor
25349051|NCT05514847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349052|NCT05514847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349053|NCT05514847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25349054|NCT05514847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25349055|NCT05514847|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25349056|NCT05514847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25349057|NCT05514847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349058|NCT05514847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25349059|NCT05514847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25349060|NCT05514847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25349061|NCT05514847|Antipyretics|antipyretics|mesh-ancestor
25349062|NCT05514782|Sunscreening Agents|sunscreening agents|mesh-list
25349063|NCT05514782|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25349064|NCT05514782|Protective Agents|protective agents|mesh-ancestor
25349065|NCT05514782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349066|NCT05514782|Dermatologic Agents|dermatologic agents|mesh-ancestor
25349067|NCT05514652|Analgesics, Opioid|analgesics, opioid|mesh-list
25349068|NCT05514652|Anesthetics|anesthetics|mesh-list
25349069|NCT05514652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25349070|NCT05514652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349071|NCT05514652|Narcotics|narcotics|mesh-ancestor
25349072|NCT05514652|Analgesics|analgesics|mesh-ancestor
25349073|NCT05514652|Sensory System Agents|sensory system agents|mesh-ancestor
25349074|NCT05514652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349075|NCT05514535|Insulin Glargine|insulin glargine|mesh-list
25349076|NCT05514535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25349077|NCT05514535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349078|NCT05514509|Cabotegravir|cabotegravir|mesh-list
25349079|NCT05514509|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25349080|NCT05514509|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25349081|NCT05514509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25349082|NCT05514509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349083|NCT05514509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25349084|NCT05514509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25349085|NCT05514509|Antiviral Agents|antiviral agents|mesh-ancestor
25349086|NCT05514509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25349087|NCT05514483|Ondansetron|ondansetron|mesh-list
25349088|NCT05514483|Antiemetics|antiemetics|mesh-ancestor
25349089|NCT05514483|Autonomic Agents|autonomic agents|mesh-ancestor
25349090|NCT05514483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349091|NCT05514483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349092|NCT05514483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25349093|NCT05514483|Antipruritics|antipruritics|mesh-ancestor
25349094|NCT05514483|Dermatologic Agents|dermatologic agents|mesh-ancestor
25349095|NCT05514483|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25349096|NCT05514483|Serotonin Agents|serotonin agents|mesh-ancestor
25349097|NCT05514483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25349098|NCT05514483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349099|NCT05514483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25349100|NCT05514483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25349101|NCT05514483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25349102|NCT05514483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25349103|NCT05514483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25349107|NCT05514405|Propofol|propofol|mesh-list
25349108|NCT05514405|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25349109|NCT05514405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25349110|NCT05514405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349111|NCT05514405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25349112|NCT05514405|Anesthetics, General|anesthetics, general|mesh-ancestor
25349113|NCT05514405|Anesthetics|anesthetics|mesh-ancestor
25349114|NCT05514275|Capecitabine|capecitabine|mesh-list
25349115|NCT05514275|Endostatins|endostatins|mesh-list
25349116|NCT05514275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25349117|NCT05514275|Antimetabolites|antimetabolites|mesh-ancestor
25349118|NCT05514275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349119|NCT05514275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349120|NCT05514275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25349121|NCT05514275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25349122|NCT05514275|Growth Substances|growth substances|mesh-ancestor
25349123|NCT05514275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349124|NCT05514275|Growth Inhibitors|growth inhibitors|mesh-ancestor
25349125|NCT05514197|Ascorbic Acid|ascorbic acid|mesh-list
25349126|NCT05514197|Antioxidants|antioxidants|mesh-ancestor
25349127|NCT05514197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349128|NCT05514197|Protective Agents|protective agents|mesh-ancestor
25349129|NCT05514197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349130|NCT05514197|Vitamins|vitamins|mesh-ancestor
25349131|NCT05514197|Micronutrients|micronutrients|mesh-ancestor
25349132|NCT05514132|Durvalumab|durvalumab|mesh-list
25349133|NCT05514132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25349134|NCT05514132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25349135|NCT05514132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349136|NCT05514132|Immunologic Factors|immunologic factors|mesh-ancestor
25349137|NCT05514132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349138|NCT05514119|Fenofibrate|fenofibrate|mesh-list
25349139|NCT05514119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25349140|NCT05514119|Antimetabolites|antimetabolites|mesh-ancestor
25349141|NCT05514119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349142|NCT05514119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25349143|NCT05514106|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
25349293|NCT05513391|Immunologic Factors|immunologic factors|mesh-ancestor
25349144|NCT05514106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349145|NCT05514106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25349146|NCT05514106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349147|NCT05514106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25349148|NCT05514080|Insulin|insulin|mesh-list
25349149|NCT05514080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25349150|NCT05514080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349151|NCT05514054|Tamoxifen|tamoxifen|mesh-list
25349152|NCT05514054|Letrozole|letrozole|mesh-list
25349153|NCT05514054|Anastrozole|anastrozole|mesh-list
25349154|NCT05514054|Exemestane|exemestane|mesh-list
25349155|NCT05514054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349156|NCT05514054|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25349157|NCT05514054|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25349158|NCT05514054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25349159|NCT05514054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349160|NCT05514054|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25349161|NCT05514054|Hormone Antagonists|hormone antagonists|mesh-ancestor
25349162|NCT05514054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25349163|NCT05514054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349164|NCT05514054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25349165|NCT05514054|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25349166|NCT05514054|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25349167|NCT05514054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25349168|NCT05514041|Varenicline|varenicline|mesh-list
25349169|NCT05514041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25349170|NCT05514041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25349171|NCT05514041|Cholinergic Agents|cholinergic agents|mesh-ancestor
25349172|NCT05514041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25349173|NCT05514041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349174|NCT05514041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349175|NCT05514015|Cyclophosphamide|cyclophosphamide|mesh-list
25349176|NCT05514015|Rituximab|rituximab|mesh-list
25349177|NCT05514015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25349178|NCT05514015|Immunologic Factors|immunologic factors|mesh-ancestor
25349179|NCT05514015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349180|NCT05514015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25349181|NCT05514015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25349182|NCT05514015|Alkylating Agents|alkylating agents|mesh-ancestor
25349183|NCT05514015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349184|NCT05514015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349185|NCT05514015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25349186|NCT05514015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25349187|NCT05513976|Febuxostat|febuxostat|mesh-list
25349188|NCT05513976|Gout Suppressants|gout suppressants|mesh-ancestor
25349189|NCT05513976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25349190|NCT05513937|Amlodipine|amlodipine|mesh-list
25349191|NCT05513937|Nebivolol|nebivolol|mesh-list
25349192|NCT05513937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25349193|NCT05513937|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25349194|NCT05513937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25724208|NCT02535806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349195|NCT05513937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349196|NCT05513937|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25349197|NCT05513937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349199|NCT05513937|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25349200|NCT05513937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25349201|NCT05513937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25349202|NCT05513937|Adrenergic Agents|adrenergic agents|mesh-ancestor
25349203|NCT05513937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25349204|NCT05513924|Fluorouracil|fluorouracil|mesh-list
25349205|NCT05513924|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25349206|NCT05513924|Latanoprost|latanoprost|mesh-list
25349207|NCT05513924|Antimetabolites|antimetabolites|mesh-ancestor
25349208|NCT05513924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349209|NCT05513924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25349210|NCT05513924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349211|NCT05513924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25349212|NCT05513924|Immunologic Factors|immunologic factors|mesh-ancestor
25349213|NCT05513924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349214|NCT05513924|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25349215|NCT05513872|Nicotine|nicotine|mesh-list
25349216|NCT05513872|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25349217|NCT05513872|Autonomic Agents|autonomic agents|mesh-ancestor
25349442|NCT05512364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25349218|NCT05513872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349219|NCT05513872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349220|NCT05513872|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25349221|NCT05513872|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25349222|NCT05513872|Cholinergic Agents|cholinergic agents|mesh-ancestor
25349223|NCT05513872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25349224|NCT05513872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349225|NCT05513807|Niacinamide|niacinamide|mesh-list
25349226|NCT05513807|Niacin|niacin|mesh-list
25349227|NCT05513807|Nicotinic Acids|nicotinic acids|mesh-list
25349228|NCT05513807|Vitamin B Complex|vitamin b complex|mesh-ancestor
25349229|NCT05513807|Vitamins|vitamins|mesh-ancestor
25349230|NCT05513807|Micronutrients|micronutrients|mesh-ancestor
25349231|NCT05513807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349232|NCT05513807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25349233|NCT05513807|Antimetabolites|antimetabolites|mesh-ancestor
25349234|NCT05513807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349235|NCT05513807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25349236|NCT05513807|Vasodilator Agents|vasodilator agents|mesh-ancestor
25349237|NCT05513768|Protein C|protein c|mesh-list
25349238|NCT05513768|Anticoagulants|anticoagulants|mesh-ancestor
25349239|NCT05513768|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25349240|NCT05513768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25349241|NCT05513768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349242|NCT05513729|Pioglitazone|pioglitazone|mesh-list
25349243|NCT05513729|Canagliflozin|canagliflozin|mesh-list
25349244|NCT05513729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25349245|NCT05513729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349246|NCT05513729|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25349247|NCT05513729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349248|NCT05513664|Osimertinib|osimertinib|mesh-list
25349249|NCT05513664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349250|NCT05513664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25349251|NCT05513664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25349252|NCT05513664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349253|NCT05513625|Pritelivir|pritelivir|mesh-list
25349254|NCT05513625|Antiviral Agents|antiviral agents|mesh-ancestor
25349255|NCT05513625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25349256|NCT05513625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25349257|NCT05513625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349258|NCT05513612|Cyclophosphamide|cyclophosphamide|mesh-list
25349259|NCT05513612|Fludarabine|fludarabine|mesh-list
25349260|NCT05513612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25349261|NCT05513612|Immunologic Factors|immunologic factors|mesh-ancestor
25349262|NCT05513612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349263|NCT05513612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25349264|NCT05513612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25349265|NCT05513612|Alkylating Agents|alkylating agents|mesh-ancestor
25349266|NCT05513612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349267|NCT05513612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349274|NCT05513560|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25349275|NCT05513560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25349276|NCT05513560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349277|NCT05513560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25349278|NCT05513560|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25349279|NCT05513560|Protective Agents|protective agents|mesh-ancestor
25349280|NCT05513560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349281|NCT05513560|Vasodilator Agents|vasodilator agents|mesh-ancestor
25349282|NCT05513560|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25349284|NCT05513560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25349285|NCT05513560|Autonomic Agents|autonomic agents|mesh-ancestor
25349286|NCT05513560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349287|NCT05513560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25349288|NCT05513560|Respiratory System Agents|respiratory system agents|mesh-ancestor
25349289|NCT05513469|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25349290|NCT05513469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25349291|NCT05513469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349292|NCT05513391|Vaccines|vaccines|mesh-list
25349294|NCT05513391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349295|NCT05513365|Goserelin|goserelin|mesh-list
25349296|NCT05513365|Bicalutamide|bicalutamide|mesh-list
25349297|NCT05513365|Dutasteride|dutasteride|mesh-list
25349298|NCT05513365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25349299|NCT05513365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349300|NCT05513365|Androgen Antagonists|androgen antagonists|mesh-ancestor
25349301|NCT05513365|Hormone Antagonists|hormone antagonists|mesh-ancestor
25349302|NCT05513365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25349303|NCT05513365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349304|NCT05513365|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25349305|NCT05513365|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25349306|NCT05513365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25349307|NCT05513365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349308|NCT05513209|Anesthetics|anesthetics|mesh-list
25349309|NCT05513209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25349310|NCT05513209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349311|NCT05513131|Azacitidine|azacitidine|mesh-list
25349312|NCT05513131|Venetoclax|venetoclax|mesh-list
25349313|NCT05513131|Homoharringtonine|homoharringtonine|mesh-list
25349314|NCT05513131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25349315|NCT05513131|Antimetabolites|antimetabolites|mesh-ancestor
25349316|NCT05513131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349317|NCT05513131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349318|NCT05513131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25349319|NCT05513131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25349320|NCT05513131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25349321|NCT05513027|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25349322|NCT05513027|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25349323|NCT05513027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349324|NCT05512962|Triamcinolone|triamcinolone|mesh-list
25349325|NCT05512962|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25349326|NCT05512962|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25349327|NCT05512962|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25349328|NCT05512962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25349329|NCT05512962|Glucocorticoids|glucocorticoids|mesh-ancestor
25349330|NCT05512962|Hormones|hormones|mesh-ancestor
25349331|NCT05512962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25349332|NCT05512962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349333|NCT05512962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25349334|NCT05512962|Immunologic Factors|immunologic factors|mesh-ancestor
25349335|NCT05512962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25349336|NCT05512962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349337|NCT05512910|Minocycline|minocycline|mesh-list
25349338|NCT05512910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25349339|NCT05512910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25349340|NCT05512819|Vaccines|vaccines|mesh-list
25349341|NCT05512819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25349342|NCT05512819|Immunologic Factors|immunologic factors|mesh-ancestor
25349343|NCT05512819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349345|NCT05512780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349346|NCT05512780|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25349347|NCT05512780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25349348|NCT05512780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25349648|NCT05510856|Analgesics|analgesics|mesh-ancestor
25349349|NCT05512780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349350|NCT05512780|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25349351|NCT05512780|Hormone Antagonists|hormone antagonists|mesh-ancestor
25349352|NCT05512780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25349353|NCT05512780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349354|NCT05512767|Capecitabine|capecitabine|mesh-list
25349355|NCT05512767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25349356|NCT05512767|Antimetabolites|antimetabolites|mesh-ancestor
25349357|NCT05512767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349358|NCT05512767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349359|NCT05512754|Ibuprofen|ibuprofen|mesh-list
25349360|NCT05512754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25349361|NCT05512754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25349362|NCT05512754|Analgesics|analgesics|mesh-ancestor
25349363|NCT05512754|Sensory System Agents|sensory system agents|mesh-ancestor
25349364|NCT05512754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349365|NCT05512754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349366|NCT05512754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25349367|NCT05512754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25349368|NCT05512754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25349369|NCT05512754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25349370|NCT05512754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349371|NCT05512728|Midazolam|midazolam|mesh-list
25349372|NCT05512728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25349373|NCT05512728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25349374|NCT05512728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25349375|NCT05512728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349376|NCT05512728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25349377|NCT05512728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25349378|NCT05512728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25349379|NCT05512728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25349380|NCT05512728|Anesthetics, General|anesthetics, general|mesh-ancestor
25349381|NCT05512728|Anesthetics|anesthetics|mesh-ancestor
25349382|NCT05512728|GABA Modulators|gaba modulators|mesh-ancestor
25349383|NCT05512728|GABA Agents|gaba agents|mesh-ancestor
25349384|NCT05512728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25349385|NCT05512728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349386|NCT05512702|Heparin|heparin|mesh-list
25349387|NCT05512702|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25349388|NCT05512702|Plasminogen|plasminogen|mesh-list
25349389|NCT05512702|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25349390|NCT05512702|Tinzaparin|tinzaparin|mesh-list
25349391|NCT05512702|Dalteparin|dalteparin|mesh-list
25349392|NCT05512702|Anticoagulants|anticoagulants|mesh-ancestor
25349393|NCT05512702|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25349394|NCT05512702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25349395|NCT05512702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349396|NCT05512546|Aspirin|aspirin|mesh-list
25349397|NCT05512546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25349398|NCT05512546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25349399|NCT05512546|Analgesics|analgesics|mesh-ancestor
25349400|NCT05512546|Sensory System Agents|sensory system agents|mesh-ancestor
25349401|NCT05512546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349402|NCT05512546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349403|NCT05512546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25349404|NCT05512546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25349405|NCT05512546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25349406|NCT05512546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25349407|NCT05512546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349408|NCT05512546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25349409|NCT05512546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25349410|NCT05512546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25349411|NCT05512546|Antipyretics|antipyretics|mesh-ancestor
25349412|NCT05512520|Capecitabine|capecitabine|mesh-list
25349413|NCT05512520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25349414|NCT05512520|Antimetabolites|antimetabolites|mesh-ancestor
25349415|NCT05512520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349416|NCT05512520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349417|NCT05512481|Temozolomide|temozolomide|mesh-list
25349418|NCT05512481|Apatinib|apatinib|mesh-list
25349419|NCT05512481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25349420|NCT05512481|Alkylating Agents|alkylating agents|mesh-ancestor
25349421|NCT05512481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349422|NCT05512481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349423|NCT05512481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25349424|NCT05512481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25349425|NCT05512416|Letrozole|letrozole|mesh-list
25349426|NCT05512416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349427|NCT05512416|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25349428|NCT05512416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25349429|NCT05512416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25349430|NCT05512416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349431|NCT05512416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25349432|NCT05512416|Hormone Antagonists|hormone antagonists|mesh-ancestor
25349433|NCT05512416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25349434|NCT05512416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349435|NCT05512364|Tamoxifen|tamoxifen|mesh-list
25349436|NCT05512364|Letrozole|letrozole|mesh-list
25349437|NCT05512364|Anastrozole|anastrozole|mesh-list
25349438|NCT05512364|Exemestane|exemestane|mesh-list
25349439|NCT05512364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349440|NCT05512364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25349441|NCT05512364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25349443|NCT05512364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349444|NCT05512364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25349445|NCT05512364|Hormone Antagonists|hormone antagonists|mesh-ancestor
25349446|NCT05512364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25349447|NCT05512364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349448|NCT05512364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25349449|NCT05512364|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25349450|NCT05512364|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25349451|NCT05512364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25349452|NCT05512351|Bevacizumab|bevacizumab|mesh-list
25349453|NCT05512351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25349454|NCT05512351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349455|NCT05512351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25349456|NCT05512351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25349457|NCT05512351|Growth Substances|growth substances|mesh-ancestor
25349458|NCT05512351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349459|NCT05512351|Growth Inhibitors|growth inhibitors|mesh-ancestor
25349460|NCT05512325|Bevacizumab|bevacizumab|mesh-list
25349461|NCT05512325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25349462|NCT05512325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349463|NCT05512325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25349464|NCT05512325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25349465|NCT05512325|Growth Substances|growth substances|mesh-ancestor
25349466|NCT05512325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349467|NCT05512325|Growth Inhibitors|growth inhibitors|mesh-ancestor
25349468|NCT05512130|Empagliflozin|empagliflozin|mesh-list
25349469|NCT05512130|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25349470|NCT05512130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349471|NCT05512130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25349472|NCT05512130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349473|NCT05512039|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25349474|NCT05512039|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25349475|NCT05512039|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25349476|NCT05512039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349477|NCT05512039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349478|NCT05512039|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25349479|NCT05512039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25349480|NCT05512039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349481|NCT05512039|Cholinergic Agents|cholinergic agents|mesh-ancestor
25349482|NCT05512039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25349483|NCT05512013|Ibuprofen|ibuprofen|mesh-list
25349484|NCT05512013|Celecoxib|celecoxib|mesh-list
25349485|NCT05512013|Flurbiprofen|flurbiprofen|mesh-list
25349486|NCT05512013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25349487|NCT05512013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25349489|NCT05512013|Sensory System Agents|sensory system agents|mesh-ancestor
25349490|NCT05512013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349491|NCT05512013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349492|NCT05512013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25349493|NCT05512013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25349494|NCT05512013|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25349495|NCT05512013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25349496|NCT05512013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349497|NCT05512013|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25349498|NCT05511948|Hydroquinone|hydroquinone|mesh-list
25349499|NCT05511948|Antioxidants|antioxidants|mesh-ancestor
25349500|NCT05511948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349501|NCT05511948|Protective Agents|protective agents|mesh-ancestor
25349502|NCT05511948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349503|NCT05511948|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25349504|NCT05511909|Lofexidine|lofexidine|mesh-list
25349505|NCT05511909|Buspirone|buspirone|mesh-list
25349506|NCT05511909|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25349507|NCT05511909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25349508|NCT05511909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25349509|NCT05511909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349510|NCT05511909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25349511|NCT05511909|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25349512|NCT05511909|Serotonin Agents|serotonin agents|mesh-ancestor
25349513|NCT05511909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25349514|NCT05511909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349515|NCT05511909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25349516|NCT05511909|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25349517|NCT05511909|Sensory System Agents|sensory system agents|mesh-ancestor
25349518|NCT05511909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349519|NCT05511909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25349520|NCT05511909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25349521|NCT05511909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25349522|NCT05511909|Adrenergic Agents|adrenergic agents|mesh-ancestor
25349524|NCT05511870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25349525|NCT05511870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25349526|NCT05511870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349527|NCT05511870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25349528|NCT05511870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349529|NCT05511831|Ketotifen|ketotifen|mesh-list
25349530|NCT05511831|Antipruritics|antipruritics|mesh-ancestor
25349531|NCT05511831|Dermatologic Agents|dermatologic agents|mesh-ancestor
25349532|NCT05511831|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25349533|NCT05511831|Histamine Antagonists|histamine antagonists|mesh-ancestor
25349534|NCT05511831|Histamine Agents|histamine agents|mesh-ancestor
25349535|NCT05511831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25349536|NCT05511831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349537|NCT05511831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349538|NCT05511831|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25349539|NCT05511779|Brincidofovir|brincidofovir|mesh-list
25349540|NCT05511779|Antiviral Agents|antiviral agents|mesh-ancestor
25349541|NCT05511779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25349542|NCT05511766|Allopurinol|allopurinol|mesh-list
25349543|NCT05511766|Simvastatin|simvastatin|mesh-list
25349544|NCT05511766|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25349545|NCT05511766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25349546|NCT05511766|Antimetabolites|antimetabolites|mesh-ancestor
25349547|NCT05511766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349548|NCT05511766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25349549|NCT05511766|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25349550|NCT05511766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25349551|NCT05511766|Gout Suppressants|gout suppressants|mesh-ancestor
25349552|NCT05511766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25349553|NCT05511766|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25349554|NCT05511766|Antioxidants|antioxidants|mesh-ancestor
25349555|NCT05511766|Protective Agents|protective agents|mesh-ancestor
25349556|NCT05511766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349557|NCT05511610|Sevoflurane|sevoflurane|mesh-list
25349558|NCT05511610|Desflurane|desflurane|mesh-list
25349559|NCT05511610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25349560|NCT05511610|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25349561|NCT05511610|Anesthetics, General|anesthetics, general|mesh-ancestor
25349562|NCT05511610|Anesthetics|anesthetics|mesh-ancestor
25349563|NCT05511610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25349564|NCT05511610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349566|NCT05511441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25349567|NCT05511441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25349568|NCT05511441|Analgesics|analgesics|mesh-ancestor
25349569|NCT05511441|Sensory System Agents|sensory system agents|mesh-ancestor
25349570|NCT05511441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349571|NCT05511441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349572|NCT05511441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25349573|NCT05511441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25349574|NCT05511441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25349575|NCT05511441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25349576|NCT05511441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349577|NCT05511441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25349578|NCT05511441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25349579|NCT05511441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25349580|NCT05511441|Antipyretics|antipyretics|mesh-ancestor
25349581|NCT05511428|Daratumumab|daratumumab|mesh-list
25349582|NCT05511428|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25349583|NCT05511428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349584|NCT05511428|Immunologic Factors|immunologic factors|mesh-ancestor
25349585|NCT05511428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349586|NCT05511415|Dexmedetomidine|dexmedetomidine|mesh-list
25349587|NCT05511415|Oxytocin|oxytocin|mesh-list
25349588|NCT05511415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25349589|NCT05511415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25349590|NCT05511415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349591|NCT05511415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25349593|NCT05511415|Sensory System Agents|sensory system agents|mesh-ancestor
25349594|NCT05511415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349595|NCT05511415|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25349596|NCT05511415|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25349597|NCT05511415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25349598|NCT05511415|Adrenergic Agents|adrenergic agents|mesh-ancestor
25349599|NCT05511415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25349600|NCT05511415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349601|NCT05511415|Oxytocics|oxytocics|mesh-ancestor
25349602|NCT05511415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25349603|NCT05511337|Citric Acid|citric acid|mesh-list
25349604|NCT05511337|Sodium Citrate|sodium citrate|mesh-list
25349605|NCT05511337|Anticoagulants|anticoagulants|mesh-ancestor
25349606|NCT05511337|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25349607|NCT05511337|Chelating Agents|chelating agents|mesh-ancestor
25349608|NCT05511337|Sequestering Agents|sequestering agents|mesh-ancestor
25349609|NCT05511337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349610|NCT05511246|Ethanol|ethanol|mesh-list
25349611|NCT05511246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25349612|NCT05511246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25349613|NCT05511246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25349614|NCT05511246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349615|NCT05511038|Aflibercept|aflibercept|mesh-list
25349616|NCT05511038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25349617|NCT05511038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25349618|NCT05511038|Growth Substances|growth substances|mesh-ancestor
25349619|NCT05511038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349620|NCT05511038|Growth Inhibitors|growth inhibitors|mesh-ancestor
25349621|NCT05511038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349622|NCT05511025|Acetaminophen|acetaminophen|mesh-list
25349623|NCT05511025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25349624|NCT05511025|Analgesics|analgesics|mesh-ancestor
25349625|NCT05511025|Sensory System Agents|sensory system agents|mesh-ancestor
25349626|NCT05511025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349627|NCT05511025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349628|NCT05511025|Antipyretics|antipyretics|mesh-ancestor
25349629|NCT05510986|Fentanyl|fentanyl|mesh-list
25349630|NCT05510986|Oxycodone|oxycodone|mesh-list
25349631|NCT05510986|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25349632|NCT05510986|Narcotics|narcotics|mesh-ancestor
25349633|NCT05510986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25349634|NCT05510986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349635|NCT05510986|Analgesics|analgesics|mesh-ancestor
25349636|NCT05510986|Sensory System Agents|sensory system agents|mesh-ancestor
25349637|NCT05510986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349638|NCT05510986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25349639|NCT05510986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25349640|NCT05510986|Anesthetics, General|anesthetics, general|mesh-ancestor
25349641|NCT05510986|Anesthetics|anesthetics|mesh-ancestor
25349642|NCT05510895|Cetuximab|cetuximab|mesh-list
25349643|NCT05510895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25349644|NCT05510895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349645|NCT05510856|Lacosamide|lacosamide|mesh-list
25349646|NCT05510856|Gabapentin|gabapentin|mesh-list
25349647|NCT05510856|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25349649|NCT05510856|Sensory System Agents|sensory system agents|mesh-ancestor
25349650|NCT05510856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349651|NCT05510856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349652|NCT05510856|Anticonvulsants|anticonvulsants|mesh-ancestor
25349653|NCT05510856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25349654|NCT05510856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25349655|NCT05510856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25349656|NCT05510856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25349657|NCT05510856|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25349658|NCT05510856|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25349659|NCT05510856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25349660|NCT05510856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349661|NCT05510856|Antimanic Agents|antimanic agents|mesh-ancestor
25349662|NCT05510856|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25349663|NCT05510856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25349664|NCT05510856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25349665|NCT05510856|Antidepressive Agents|antidepressive agents|mesh-ancestor
25349666|NCT05510856|Dopamine Agents|dopamine agents|mesh-ancestor
25349667|NCT05510856|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25349668|NCT05510856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25349669|NCT05510778|Charcoal|charcoal|mesh-list
25349670|NCT05510778|Antidotes|antidotes|mesh-ancestor
25349671|NCT05510778|Protective Agents|protective agents|mesh-ancestor
25349672|NCT05510778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349673|NCT05510544|Plerixafor|plerixafor|mesh-list
25349674|NCT05510544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25349675|NCT05510544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25349676|NCT05510544|Antiviral Agents|antiviral agents|mesh-ancestor
25349677|NCT05510544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25349678|NCT05510505|Antibodies|antibodies|mesh-list
25349679|NCT05510505|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25349680|NCT05510505|Immunologic Factors|immunologic factors|mesh-ancestor
25349681|NCT05510505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349682|NCT05510427|Bevacizumab|bevacizumab|mesh-list
25349683|NCT05510427|Atezolizumab|atezolizumab|mesh-list
25349684|NCT05510427|Infigratinib|infigratinib|mesh-list
25349685|NCT05510427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25349686|NCT05510427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349687|NCT05510427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25349688|NCT05510427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25349689|NCT05510427|Growth Substances|growth substances|mesh-ancestor
25349690|NCT05510427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349691|NCT05510427|Growth Inhibitors|growth inhibitors|mesh-ancestor
25349692|NCT05510323|Prednisolone|prednisolone|mesh-list
25349693|NCT05510323|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25349694|NCT05510323|Methylprednisolone|methylprednisolone|mesh-list
25349695|NCT05510323|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25349696|NCT05510323|Prednisolone acetate|prednisolone acetate|mesh-list
25349697|NCT05510323|Cyclophosphamide|cyclophosphamide|mesh-list
25349698|NCT05510323|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25349699|NCT05510323|Prednisolone phosphate|prednisolone phosphate|mesh-list
25349700|NCT05510323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25349701|NCT05510323|Immunologic Factors|immunologic factors|mesh-ancestor
25349702|NCT05510323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349703|NCT05510323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25349704|NCT05510323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25349705|NCT05510323|Alkylating Agents|alkylating agents|mesh-ancestor
25349706|NCT05510323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349707|NCT05510323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349708|NCT05510323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25349709|NCT05510323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25349710|NCT05510323|Glucocorticoids|glucocorticoids|mesh-ancestor
25349711|NCT05510323|Hormones|hormones|mesh-ancestor
25349712|NCT05510323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25349713|NCT05510323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25349714|NCT05510323|Antiemetics|antiemetics|mesh-ancestor
25349715|NCT05510323|Autonomic Agents|autonomic agents|mesh-ancestor
25349716|NCT05510323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349717|NCT05510323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25349718|NCT05510323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25349719|NCT05510323|Protective Agents|protective agents|mesh-ancestor
25349720|NCT05510310|Oxytocin|oxytocin|mesh-list
25349721|NCT05510310|Oxytocics|oxytocics|mesh-ancestor
25349722|NCT05510310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25349723|NCT05510310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349724|NCT05510219|Obinutuzumab|obinutuzumab|mesh-list
25349725|NCT05510219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25349726|NCT05510219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349728|NCT05510141|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25349729|NCT05510141|Anesthetics, General|anesthetics, general|mesh-ancestor
25349730|NCT05510141|Anesthetics|anesthetics|mesh-ancestor
25349731|NCT05510141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25349732|NCT05510141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349733|NCT05510141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25349734|NCT05510141|Analgesics|analgesics|mesh-ancestor
25349735|NCT05510141|Sensory System Agents|sensory system agents|mesh-ancestor
25349736|NCT05510141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349737|NCT05510115|Empagliflozin|empagliflozin|mesh-list
25349738|NCT05510115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25349739|NCT05510115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349740|NCT05510115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25349741|NCT05510115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349742|NCT05510089|Cytarabine|cytarabine|mesh-list
25349743|NCT05510089|Etoposide|etoposide|mesh-list
25349744|NCT05510089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25349745|NCT05510089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349746|NCT05510089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25349747|NCT05510089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25349748|NCT05510089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25349749|NCT05510089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349750|NCT05510089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25349751|NCT05510089|Antimetabolites|antimetabolites|mesh-ancestor
25349752|NCT05510089|Antiviral Agents|antiviral agents|mesh-ancestor
25349753|NCT05510089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25349754|NCT05510089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25349755|NCT05510089|Immunologic Factors|immunologic factors|mesh-ancestor
25349756|NCT05510089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349757|NCT05510063|Adalimumab|adalimumab|mesh-list
25349758|NCT05510063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25349759|NCT05510063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25349760|NCT05509946|Celecoxib|celecoxib|mesh-list
25349761|NCT05509946|Pregabalin|pregabalin|mesh-list
25349762|NCT05509946|Analgesics|analgesics|mesh-ancestor
25349763|NCT05509946|Sensory System Agents|sensory system agents|mesh-ancestor
25349764|NCT05509946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349765|NCT05509946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349766|NCT05509946|Anticonvulsants|anticonvulsants|mesh-ancestor
25349767|NCT05509946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25349768|NCT05509946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25349769|NCT05509946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349770|NCT05509946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25349771|NCT05509946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25349772|NCT05509946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25349773|NCT05509946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25349774|NCT05509946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25349775|NCT05509946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25349776|NCT05509946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25349777|NCT05509946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25349778|NCT05509946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25349779|NCT05509946|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25349780|NCT05509946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25349781|NCT05509946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25349782|NCT05509933|Budesonide|budesonide|mesh-list
25349783|NCT05509933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25349784|NCT05509933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25349785|NCT05509933|Autonomic Agents|autonomic agents|mesh-ancestor
25349786|NCT05509933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349787|NCT05509933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349788|NCT05509933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25349789|NCT05509933|Respiratory System Agents|respiratory system agents|mesh-ancestor
25349790|NCT05509933|Glucocorticoids|glucocorticoids|mesh-ancestor
25349791|NCT05509933|Hormones|hormones|mesh-ancestor
25349792|NCT05509933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25349793|NCT05509816|Midazolam|midazolam|mesh-list
25349794|NCT05509816|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25349795|NCT05509816|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25349796|NCT05509816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25349797|NCT05509816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349798|NCT05509816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25349799|NCT05509816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25349800|NCT05509816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25349801|NCT05509816|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25349802|NCT05509816|Anesthetics, General|anesthetics, general|mesh-ancestor
25349803|NCT05509816|Anesthetics|anesthetics|mesh-ancestor
25349804|NCT05509816|GABA Modulators|gaba modulators|mesh-ancestor
25349805|NCT05509816|GABA Agents|gaba agents|mesh-ancestor
25349806|NCT05509816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25349807|NCT05509816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349808|NCT05509777|Mirikizumab|mirikizumab|mesh-list
25349809|NCT05509777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25349810|NCT05509777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25349811|NCT05509777|Analgesics|analgesics|mesh-ancestor
25349812|NCT05509777|Sensory System Agents|sensory system agents|mesh-ancestor
25349813|NCT05509777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349814|NCT05509777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349815|NCT05509777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25349816|NCT05509777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25349817|NCT05509777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25349818|NCT05509777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25349819|NCT05509699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25349820|NCT05509699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349821|NCT05509699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349822|NCT05509647|Heparin|heparin|mesh-list
25349823|NCT05509647|Calcium heparin|calcium heparin|mesh-list
25349824|NCT05509647|Anticoagulants|anticoagulants|mesh-ancestor
25349825|NCT05509647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25349826|NCT05509647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25349827|NCT05509647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349828|NCT05509634|Dexamethasone|dexamethasone|mesh-list
25349829|NCT05509634|Dexamethasone acetate|dexamethasone acetate|mesh-list
25349830|NCT05509634|Palonosetron|palonosetron|mesh-list
25349831|NCT05509634|Fosaprepitant|fosaprepitant|mesh-list
25349832|NCT05509634|Aprepitant|aprepitant|mesh-list
25349833|NCT05509634|BB 1101|bb 1101|mesh-list
25349834|NCT05509634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25349835|NCT05509634|Antiemetics|antiemetics|mesh-ancestor
25349836|NCT05509634|Autonomic Agents|autonomic agents|mesh-ancestor
25349837|NCT05509634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349838|NCT05509634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349839|NCT05509634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25349840|NCT05509634|Glucocorticoids|glucocorticoids|mesh-ancestor
25349841|NCT05509634|Hormones|hormones|mesh-ancestor
25349842|NCT05509634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25349843|NCT05509634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25349844|NCT05509634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349845|NCT05509634|Protease Inhibitors|protease inhibitors|mesh-ancestor
25349846|NCT05509634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25349847|NCT05509634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349848|NCT05509634|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25349849|NCT05509634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25349850|NCT05509634|Serotonin Agents|serotonin agents|mesh-ancestor
25349851|NCT05509634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25349852|NCT05509634|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25349853|NCT05509569|Icatibant|icatibant|mesh-list
25349854|NCT05509569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25349855|NCT05509569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25349856|NCT05509569|Analgesics|analgesics|mesh-ancestor
25349857|NCT05509569|Sensory System Agents|sensory system agents|mesh-ancestor
25349858|NCT05509569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349859|NCT05509569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349860|NCT05509569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25349861|NCT05509569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25349862|NCT05509569|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
25349863|NCT05509569|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
25349864|NCT05509569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349865|NCT05509569|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25349866|NCT05509569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25349867|NCT05509569|Immunologic Factors|immunologic factors|mesh-ancestor
25349869|NCT05509478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25349870|NCT05509478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349871|NCT05509478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25349872|NCT05509478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25349873|NCT05509478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349874|NCT05509374|Dexamethasone|dexamethasone|mesh-list
25349875|NCT05509374|Pomalidomide|pomalidomide|mesh-list
25349876|NCT05509374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25349877|NCT05509374|Antiemetics|antiemetics|mesh-ancestor
25349878|NCT05509374|Autonomic Agents|autonomic agents|mesh-ancestor
25349879|NCT05509374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349880|NCT05509374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349881|NCT05509374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25349882|NCT05509374|Glucocorticoids|glucocorticoids|mesh-ancestor
25349883|NCT05509374|Hormones|hormones|mesh-ancestor
25349884|NCT05509374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25349885|NCT05509374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25349886|NCT05509374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349887|NCT05509374|Immunologic Factors|immunologic factors|mesh-ancestor
25349888|NCT05509374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25349889|NCT05509374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25349890|NCT05509374|Growth Substances|growth substances|mesh-ancestor
25349891|NCT05509374|Growth Inhibitors|growth inhibitors|mesh-ancestor
25349892|NCT05509257|Naltrexone|naltrexone|mesh-list
25349893|NCT05509257|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25349894|NCT05509257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25349895|NCT05509257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349896|NCT05509257|Sensory System Agents|sensory system agents|mesh-ancestor
25349897|NCT05509257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349898|NCT05509244|Acetaminophen|acetaminophen|mesh-list
25349899|NCT05509244|Ibuprofen|ibuprofen|mesh-list
25349900|NCT05509244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25349901|NCT05509244|Analgesics|analgesics|mesh-ancestor
25349902|NCT05509244|Sensory System Agents|sensory system agents|mesh-ancestor
25349903|NCT05509244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349904|NCT05509244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349905|NCT05509244|Antipyretics|antipyretics|mesh-ancestor
25349906|NCT05509244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25349907|NCT05509244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25349908|NCT05509244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25349909|NCT05509244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25349910|NCT05509244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25349911|NCT05509244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349912|NCT05509153|Acetylcysteine|acetylcysteine|mesh-list
25349913|NCT05509153|Antiviral Agents|antiviral agents|mesh-ancestor
25349914|NCT05509153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25349915|NCT05509153|Expectorants|expectorants|mesh-ancestor
25349916|NCT05509153|Respiratory System Agents|respiratory system agents|mesh-ancestor
25349917|NCT05509153|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25349918|NCT05509153|Antioxidants|antioxidants|mesh-ancestor
25349919|NCT05509153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349920|NCT05509153|Protective Agents|protective agents|mesh-ancestor
25349921|NCT05509153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349922|NCT05508867|Gemcitabine|gemcitabine|mesh-list
25349923|NCT05508867|Pembrolizumab|pembrolizumab|mesh-list
25349924|NCT05508867|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25349925|NCT05508867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25349926|NCT05508867|Antimetabolites|antimetabolites|mesh-ancestor
25349927|NCT05508867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349928|NCT05508867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349929|NCT05508867|Antiviral Agents|antiviral agents|mesh-ancestor
25349930|NCT05508867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25349931|NCT05508867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25349932|NCT05508867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25349933|NCT05508867|Immunologic Factors|immunologic factors|mesh-ancestor
25349934|NCT05508867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349935|NCT05508867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25349936|NCT05508867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25349937|NCT05508867|Alkylating Agents|alkylating agents|mesh-ancestor
25349938|NCT05508815|Methotrexate|methotrexate|mesh-list
25349939|NCT05508815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25349940|NCT05508815|Abortifacient Agents|abortifacient agents|mesh-ancestor
25349941|NCT05508815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25349942|NCT05508815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349943|NCT05508815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25349944|NCT05508815|Antimetabolites|antimetabolites|mesh-ancestor
25349945|NCT05508815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349946|NCT05508815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349947|NCT05508815|Dermatologic Agents|dermatologic agents|mesh-ancestor
25349948|NCT05508815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25349949|NCT05508815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25349950|NCT05508815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25349951|NCT05508815|Immunologic Factors|immunologic factors|mesh-ancestor
25349952|NCT05508815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25349953|NCT05508815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25349954|NCT05508776|Moxifloxacin|moxifloxacin|mesh-list
25349955|NCT05508776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25349956|NCT05508776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25349957|NCT05508776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25349958|NCT05508776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25349959|NCT05508776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25349960|NCT05508776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349961|NCT05508776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349962|NCT05508737|Trifluridine|trifluridine|mesh-list
25349963|NCT05508737|Pembrolizumab|pembrolizumab|mesh-list
25349964|NCT05508737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25349965|NCT05508737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349966|NCT05508737|Antimetabolites|antimetabolites|mesh-ancestor
25349967|NCT05508737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25349968|NCT05508737|Antiviral Agents|antiviral agents|mesh-ancestor
25349969|NCT05508737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25349970|NCT05508633|Mebeverine|mebeverine|mesh-list
25349971|NCT05508633|Alverine|alverine|mesh-list
25349972|NCT05508633|Parasympatholytics|parasympatholytics|mesh-ancestor
25349973|NCT05508633|Autonomic Agents|autonomic agents|mesh-ancestor
25349974|NCT05508633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349975|NCT05508633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349976|NCT05508633|Anticonvulsants|anticonvulsants|mesh-ancestor
25349977|NCT05508620|Sirolimus|sirolimus|mesh-list
25349978|NCT05508620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25349979|NCT05508620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25349980|NCT05508620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25349981|NCT05508620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25349982|NCT05508620|Antifungal Agents|antifungal agents|mesh-ancestor
25349983|NCT05508620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25349984|NCT05508620|Immunologic Factors|immunologic factors|mesh-ancestor
25349985|NCT05508620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349986|NCT05508594|Sufentanil|sufentanil|mesh-list
25349987|NCT05508594|Ketamine|ketamine|mesh-list
25349988|NCT05508594|Analgesics|analgesics|mesh-ancestor
25349989|NCT05508594|Sensory System Agents|sensory system agents|mesh-ancestor
25349990|NCT05508594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25349991|NCT05508594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25349992|NCT05508594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25349993|NCT05508594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25349994|NCT05508594|Anesthetics, General|anesthetics, general|mesh-ancestor
25349995|NCT05508594|Anesthetics|anesthetics|mesh-ancestor
25349996|NCT05508594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25349997|NCT05508594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25349998|NCT05508594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25349999|NCT05508594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25350000|NCT05508594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350001|NCT05508594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25350002|NCT05508594|Narcotics|narcotics|mesh-ancestor
25350003|NCT05508594|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25350004|NCT05508516|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25350005|NCT05508516|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25350006|NCT05508516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25350007|NCT05508516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25350008|NCT05508516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350009|NCT05508516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25350010|NCT05508516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350011|NCT05508516|Analgesics|analgesics|mesh-ancestor
25350012|NCT05508516|Sensory System Agents|sensory system agents|mesh-ancestor
25350013|NCT05508516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25350014|NCT05508516|Antidepressive Agents|antidepressive agents|mesh-ancestor
25350015|NCT05508516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25350016|NCT05508516|Dopamine Agents|dopamine agents|mesh-ancestor
25350017|NCT05508178|Vaccines|vaccines|mesh-list
25350018|NCT05508178|Immunologic Factors|immunologic factors|mesh-ancestor
25350019|NCT05508178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350020|NCT05508152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25350021|NCT05508152|Amoxicillin|amoxicillin|mesh-list
25350022|NCT05508152|Clavulanic Acid|clavulanic acid|mesh-list
25350023|NCT05508152|Clavulanic Acids|clavulanic acids|mesh-list
25350250|NCT05506943|Tubulin Modulators|tubulin modulators|mesh-ancestor
25350024|NCT05508152|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25350025|NCT05508152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25350026|NCT05508152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25350027|NCT05508152|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25350028|NCT05508152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25350029|NCT05508152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350030|NCT05508100|Pembrolizumab|pembrolizumab|mesh-list
25350031|NCT05508100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25350032|NCT05508100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350033|NCT05508074|Riluzole|riluzole|mesh-list
25350034|NCT05508074|Anticonvulsants|anticonvulsants|mesh-ancestor
25350035|NCT05508074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25350036|NCT05508074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25350037|NCT05508074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25350038|NCT05508074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350039|NCT05508074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350040|NCT05508074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25350041|NCT05508074|Protective Agents|protective agents|mesh-ancestor
25350042|NCT05508061|Insulin|insulin|mesh-list
25350043|NCT05508061|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25350044|NCT05508061|Insulin Lispro|insulin lispro|mesh-list
25350045|NCT05508061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25350046|NCT05508061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350047|NCT05508035|Valsartan|valsartan|mesh-list
25350048|NCT05508035|Ramipril|ramipril|mesh-list
25350049|NCT05508035|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25350050|NCT05508035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25350051|NCT05508035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25350052|NCT05508035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25350053|NCT05508035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350054|NCT05508035|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25350055|NCT05508035|Protease Inhibitors|protease inhibitors|mesh-ancestor
25350056|NCT05508035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25350057|NCT05508009|Cyclophosphamide|cyclophosphamide|mesh-list
25350058|NCT05508009|Melphalan|melphalan|mesh-list
25350059|NCT05508009|Rituximab|rituximab|mesh-list
25350060|NCT05508009|Fludarabine|fludarabine|mesh-list
25350061|NCT05508009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25350062|NCT05508009|Immunologic Factors|immunologic factors|mesh-ancestor
25350063|NCT05508009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350064|NCT05508009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25350065|NCT05508009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25350066|NCT05508009|Alkylating Agents|alkylating agents|mesh-ancestor
25350067|NCT05508009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350068|NCT05508009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350069|NCT05508009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25350070|NCT05508009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25350071|NCT05507983|Tranexamic Acid|tranexamic acid|mesh-list
25350072|NCT05507983|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25350073|NCT05507983|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25350074|NCT05507983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350075|NCT05507983|Hemostatics|hemostatics|mesh-ancestor
25350076|NCT05507983|Coagulants|coagulants|mesh-ancestor
25350077|NCT05507957|Chlorhexidine|chlorhexidine|mesh-list
25350078|NCT05507957|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25350079|NCT05507957|Ethanol|ethanol|mesh-list
25350080|NCT05507957|Povidone-Iodine|povidone-iodine|mesh-list
25350081|NCT05507957|Disinfectants|disinfectants|mesh-list
25350082|NCT05507957|Povidone|povidone|mesh-list
25350083|NCT05507957|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25350084|NCT05507957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25350085|NCT05507957|Dermatologic Agents|dermatologic agents|mesh-ancestor
25350086|NCT05507957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25350087|NCT05507957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350088|NCT05507957|Plasma Substitutes|plasma substitutes|mesh-ancestor
25350089|NCT05507957|Blood Substitutes|blood substitutes|mesh-ancestor
25350090|NCT05507892|Canagliflozin|canagliflozin|mesh-list
25350091|NCT05507892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25350092|NCT05507892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350093|NCT05507892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25350094|NCT05507892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350095|NCT05507775|Digoxin|digoxin|mesh-list
25350096|NCT05507775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25350097|NCT05507775|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25350098|NCT05507775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25350099|NCT05507775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350100|NCT05507775|Protective Agents|protective agents|mesh-ancestor
25350101|NCT05507775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350102|NCT05507697|Thioctic Acid|thioctic acid|mesh-list
25350103|NCT05507697|Antioxidants|antioxidants|mesh-ancestor
25350104|NCT05507697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350105|NCT05507697|Protective Agents|protective agents|mesh-ancestor
25350106|NCT05507697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350107|NCT05507697|Vitamin B Complex|vitamin b complex|mesh-ancestor
25350109|NCT05507697|Micronutrients|micronutrients|mesh-ancestor
25350110|NCT05507671|BCG Vaccine|bcg vaccine|mesh-list
25350111|NCT05507671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25350112|NCT05507671|Immunologic Factors|immunologic factors|mesh-ancestor
25350113|NCT05507671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350114|NCT05507658|Capecitabine|capecitabine|mesh-list
25350115|NCT05507658|Oxaliplatin|oxaliplatin|mesh-list
25350116|NCT05507658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25350117|NCT05507658|Antimetabolites|antimetabolites|mesh-ancestor
25350118|NCT05507658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350119|NCT05507658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350120|NCT05507645|Aspirin|aspirin|mesh-list
25350121|NCT05507645|Saruplase|saruplase|mesh-list
25350122|NCT05507645|Anticoagulants|anticoagulants|mesh-list
25350123|NCT05507645|Clopidogrel|clopidogrel|mesh-list
25350124|NCT05507645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25350125|NCT05507645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25350126|NCT05507645|Analgesics|analgesics|mesh-ancestor
25350127|NCT05507645|Sensory System Agents|sensory system agents|mesh-ancestor
25350128|NCT05507645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25350129|NCT05507645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350130|NCT05507645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25350131|NCT05507645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25350132|NCT05507645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25350133|NCT05507645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25350134|NCT05507645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350135|NCT05507645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25350136|NCT05507645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25350137|NCT05507645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25350138|NCT05507645|Antipyretics|antipyretics|mesh-ancestor
25350139|NCT05507645|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25350140|NCT05507645|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25350141|NCT05507645|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25350142|NCT05507645|Purinergic Agents|purinergic agents|mesh-ancestor
25350143|NCT05507645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25350144|NCT05507606|Bevacizumab|bevacizumab|mesh-list
25350145|NCT05507606|Carboplatin|carboplatin|mesh-list
25350146|NCT05507606|Pemetrexed|pemetrexed|mesh-list
25350147|NCT05507606|Osimertinib|osimertinib|mesh-list
25350148|NCT05507606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25350149|NCT05507606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350150|NCT05507606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25350151|NCT05507606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25350152|NCT05507606|Growth Substances|growth substances|mesh-ancestor
25350153|NCT05507606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350154|NCT05507606|Growth Inhibitors|growth inhibitors|mesh-ancestor
25350155|NCT05507606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25350156|NCT05507606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350157|NCT05507606|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25350158|NCT05507606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25350159|NCT05507606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25350160|NCT05507580|Upadacitinib|upadacitinib|mesh-list
25350161|NCT05507580|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25350162|NCT05507580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25350163|NCT05507580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25350164|NCT05507580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350165|NCT05507580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25350166|NCT05507554|Analgesics|analgesics|mesh-list
25350167|NCT05507554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
25350168|NCT05507554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350169|NCT05507554|Sensory System Agents|sensory system agents|mesh-ancestor
25350170|NCT05507554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25350171|NCT05507541|Pembrolizumab|pembrolizumab|mesh-list
25350172|NCT05507541|Immunoglobulin G|immunoglobulin g|mesh-list
25350173|NCT05507541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25350174|NCT05507541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350175|NCT05507541|Immunologic Factors|immunologic factors|mesh-ancestor
25350176|NCT05507541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350177|NCT05507476|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
25350178|NCT05507476|Epinephrine|epinephrine|mesh-list
25350179|NCT05507476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25350180|NCT05507476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25350181|NCT05507476|Adrenergic Agents|adrenergic agents|mesh-ancestor
25350182|NCT05507476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25350183|NCT05507476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350184|NCT05507476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350185|NCT05507476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25350186|NCT05507476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25350187|NCT05507476|Autonomic Agents|autonomic agents|mesh-ancestor
25350188|NCT05507476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25350189|NCT05507476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25350190|NCT05507476|Respiratory System Agents|respiratory system agents|mesh-ancestor
25350191|NCT05507476|Mydriatics|mydriatics|mesh-ancestor
25350192|NCT05507476|Sympathomimetics|sympathomimetics|mesh-ancestor
25350193|NCT05507476|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25350194|NCT05507476|Hemostatics|hemostatics|mesh-ancestor
25350195|NCT05507476|Coagulants|coagulants|mesh-ancestor
25350196|NCT05507476|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25350197|NCT05507476|Natriuretic Agents|natriuretic agents|mesh-ancestor
25350199|NCT05507398|Atorvastatin|atorvastatin|mesh-list
25350200|NCT05507398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25350201|NCT05507398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350202|NCT05507398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25350203|NCT05507398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25350204|NCT05507398|Antimetabolites|antimetabolites|mesh-ancestor
25350205|NCT05507398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350206|NCT05507398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25350207|NCT05507398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25350208|NCT05507398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25350209|NCT05507372|Pimozide|pimozide|mesh-list
25350210|NCT05507372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25350211|NCT05507372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25350212|NCT05507372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25350213|NCT05507372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350214|NCT05507372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25350215|NCT05507372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25350216|NCT05507372|Dopamine Agents|dopamine agents|mesh-ancestor
25350217|NCT05507372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25350218|NCT05507372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350219|NCT05507372|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25350220|NCT05507359|Benzocaine|benzocaine|mesh-list
25350221|NCT05507359|Anesthetics, Local|anesthetics, local|mesh-ancestor
25350222|NCT05507359|Anesthetics|anesthetics|mesh-ancestor
25350223|NCT05507359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25350224|NCT05507359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350225|NCT05507359|Sensory System Agents|sensory system agents|mesh-ancestor
25350226|NCT05507359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25350227|NCT05507229|Vaccines|vaccines|mesh-list
25350228|NCT05507229|Immunologic Factors|immunologic factors|mesh-ancestor
25350229|NCT05507229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350230|NCT05507112|Capecitabine|capecitabine|mesh-list
25350231|NCT05507112|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25350232|NCT05507112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25350233|NCT05507112|Antimetabolites|antimetabolites|mesh-ancestor
25350234|NCT05507112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350235|NCT05507112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350236|NCT05507086|Anti-Infective Agents|anti-infective agents|mesh-list
25350237|NCT05507086|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25350238|NCT05506982|Psilocybin|psilocybin|mesh-list
25350239|NCT05506982|Hallucinogens|hallucinogens|mesh-ancestor
25350240|NCT05506982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350241|NCT05506982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25350242|NCT05506969|Vaccines|vaccines|mesh-list
25350243|NCT05506969|1018 oligonucleotide|1018 oligonucleotide|mesh-list
25350244|NCT05506969|Immunologic Factors|immunologic factors|mesh-ancestor
25350245|NCT05506969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350246|NCT05506969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25350247|NCT05506943|Paclitaxel|paclitaxel|mesh-list
25350248|NCT05506943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25350249|NCT05506943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350251|NCT05506943|Antimitotic Agents|antimitotic agents|mesh-ancestor
25350252|NCT05506943|Mitosis Modulators|mitosis modulators|mesh-ancestor
25350253|NCT05506943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350254|NCT05506930|Morphine|morphine|mesh-list
25350255|NCT05506930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25350256|NCT05506930|Narcotics|narcotics|mesh-ancestor
25350257|NCT05506930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25350258|NCT05506930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350259|NCT05506930|Analgesics|analgesics|mesh-ancestor
25350260|NCT05506930|Sensory System Agents|sensory system agents|mesh-ancestor
25350261|NCT05506930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25350262|NCT05506865|Tiotropium Bromide|tiotropium bromide|mesh-list
25350263|NCT05506865|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25350264|NCT05506865|Autonomic Agents|autonomic agents|mesh-ancestor
25350265|NCT05506865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25350266|NCT05506865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350267|NCT05506865|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25350268|NCT05506865|Respiratory System Agents|respiratory system agents|mesh-ancestor
25350269|NCT05506865|Parasympatholytics|parasympatholytics|mesh-ancestor
25350270|NCT05506865|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25350271|NCT05506865|Cholinergic Agents|cholinergic agents|mesh-ancestor
25350272|NCT05506865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25350273|NCT05506865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350274|NCT05506787|Esketamine|esketamine|mesh-list
25350275|NCT05506787|Antidepressive Agents|antidepressive agents|mesh-ancestor
25350276|NCT05506787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25350277|NCT05506592|Dermatologic Agents|dermatologic agents|mesh-list
25350278|NCT05506566|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25350279|NCT05506566|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25350280|NCT05506566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350281|NCT05506501|Anesthetics|anesthetics|mesh-list
25350282|NCT05506501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25350283|NCT05506501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350284|NCT05506488|Dasatinib|dasatinib|mesh-list
25350285|NCT05506488|Quercetin|quercetin|mesh-list
25350286|NCT05506488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350287|NCT05506488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25350288|NCT05506488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25350289|NCT05506488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350290|NCT05506488|Antioxidants|antioxidants|mesh-ancestor
25350291|NCT05506488|Protective Agents|protective agents|mesh-ancestor
25350292|NCT05506488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350293|NCT05506462|Ketamine|ketamine|mesh-list
25350294|NCT05506462|Analgesics|analgesics|mesh-ancestor
25350295|NCT05506462|Sensory System Agents|sensory system agents|mesh-ancestor
25350296|NCT05506462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25350297|NCT05506462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350298|NCT05506462|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25350299|NCT05506462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25350300|NCT05506462|Anesthetics, General|anesthetics, general|mesh-ancestor
25350301|NCT05506462|Anesthetics|anesthetics|mesh-ancestor
25350302|NCT05506462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25350303|NCT05506462|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25350304|NCT05506462|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25350305|NCT05506462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25350306|NCT05506462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350307|NCT05506410|Cytarabine|cytarabine|mesh-list
25350308|NCT05506410|Prednisone|prednisone|mesh-list
25350309|NCT05506410|Rituximab|rituximab|mesh-list
25350310|NCT05506410|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25350311|NCT05506410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25350312|NCT05506410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350313|NCT05506410|Immunologic Factors|immunologic factors|mesh-ancestor
25350314|NCT05506410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350315|NCT05506410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25350316|NCT05506410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25350317|NCT05506410|Glucocorticoids|glucocorticoids|mesh-ancestor
25350318|NCT05506410|Hormones|hormones|mesh-ancestor
25350319|NCT05506410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25350320|NCT05506410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25350321|NCT05506410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25350322|NCT05506410|Antimetabolites|antimetabolites|mesh-ancestor
25350323|NCT05506410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350324|NCT05506410|Antiviral Agents|antiviral agents|mesh-ancestor
25350325|NCT05506410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25350326|NCT05506410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25350327|NCT05506410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25350328|NCT05506410|Alkylating Agents|alkylating agents|mesh-ancestor
25350329|NCT05506332|Venetoclax|venetoclax|mesh-list
25350330|NCT05506332|Mercaptopurine|mercaptopurine|mesh-list
25350331|NCT05506332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350332|NCT05506332|Antimetabolites|antimetabolites|mesh-ancestor
25350333|NCT05506332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350334|NCT05506332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25350335|NCT05506332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25350336|NCT05506332|Immunologic Factors|immunologic factors|mesh-ancestor
25350337|NCT05506332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350338|NCT05506332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25350339|NCT05506332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25350340|NCT05506319|Vasopressins|vasopressins|mesh-list
25350341|NCT05506319|Arginine Vasopressin|arginine vasopressin|mesh-list
25350342|NCT05506319|Norepinephrine|norepinephrine|mesh-list
25350343|NCT05506319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25350344|NCT05506319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25350345|NCT05506319|Adrenergic Agents|adrenergic agents|mesh-ancestor
25350346|NCT05506319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25350347|NCT05506319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350348|NCT05506319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350349|NCT05506319|Sympathomimetics|sympathomimetics|mesh-ancestor
25350350|NCT05506319|Autonomic Agents|autonomic agents|mesh-ancestor
25350351|NCT05506319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25350352|NCT05506319|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25350354|NCT05506319|Coagulants|coagulants|mesh-ancestor
25350355|NCT05506319|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25350356|NCT05506319|Natriuretic Agents|natriuretic agents|mesh-ancestor
25350357|NCT05506137|Pilocarpine|pilocarpine|mesh-list
25350358|NCT05506137|Miotics|miotics|mesh-ancestor
25350359|NCT05506137|Autonomic Agents|autonomic agents|mesh-ancestor
25350360|NCT05506137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25350361|NCT05506137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350362|NCT05506137|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25350363|NCT05506137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25350364|NCT05506137|Cholinergic Agents|cholinergic agents|mesh-ancestor
25350365|NCT05506137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25350366|NCT05506137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350367|NCT05506046|Nicotine|nicotine|mesh-list
25350368|NCT05506046|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25350369|NCT05506046|Autonomic Agents|autonomic agents|mesh-ancestor
25350370|NCT05506046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25350371|NCT05506046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350372|NCT05506046|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25350373|NCT05506046|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25350374|NCT05506046|Cholinergic Agents|cholinergic agents|mesh-ancestor
25350375|NCT05506046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25350376|NCT05506046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350377|NCT05505994|Dapagliflozin|dapagliflozin|mesh-list
25350378|NCT05505994|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25350379|NCT05505994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350380|NCT05505994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25350381|NCT05505994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350382|NCT05505825|Chiauranib|chiauranib|mesh-list
25350383|NCT05505825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350384|NCT05505825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25350385|NCT05505825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25350386|NCT05505825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350387|NCT05505630|Midazolam|midazolam|mesh-list
25350388|NCT05505630|Ketamine|ketamine|mesh-list
25350389|NCT05505630|Analgesics|analgesics|mesh-ancestor
25350390|NCT05505630|Sensory System Agents|sensory system agents|mesh-ancestor
25350391|NCT05505630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25350392|NCT05505630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350393|NCT05505630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25350394|NCT05505630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25350395|NCT05505630|Anesthetics, General|anesthetics, general|mesh-ancestor
25350396|NCT05505630|Anesthetics|anesthetics|mesh-ancestor
25350397|NCT05505630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25350398|NCT05505630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25350399|NCT05505630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25350400|NCT05505630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25350401|NCT05505630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350402|NCT05505630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25350403|NCT05505630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25350404|NCT05505630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25350405|NCT05505630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25350406|NCT05505630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25350407|NCT05505630|GABA Modulators|gaba modulators|mesh-ancestor
25350409|NCT05505617|Nitric Oxide|nitric oxide|mesh-list
25350410|NCT05505617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25350411|NCT05505617|Autonomic Agents|autonomic agents|mesh-ancestor
25350412|NCT05505617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25350413|NCT05505617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350414|NCT05505617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25350415|NCT05505617|Respiratory System Agents|respiratory system agents|mesh-ancestor
25350416|NCT05505617|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25350417|NCT05505617|Antioxidants|antioxidants|mesh-ancestor
25350418|NCT05505617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350419|NCT05505617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25350420|NCT05505617|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25350421|NCT05505617|Vasodilator Agents|vasodilator agents|mesh-ancestor
25350422|NCT05505617|Gasotransmitters|gasotransmitters|mesh-ancestor
25350423|NCT05505617|Protective Agents|protective agents|mesh-ancestor
25350424|NCT05505591|Cangrelor|cangrelor|mesh-list
25350425|NCT05505591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25350426|NCT05505591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25350427|NCT05505591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25350428|NCT05505591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25350429|NCT05505591|Purinergic Agents|purinergic agents|mesh-ancestor
25350430|NCT05505591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25350431|NCT05505591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350432|NCT05505591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350433|NCT05505552|Vitamin K|vitamin k|mesh-list
25350434|NCT05505552|Vitamin K 1|vitamin k 1|mesh-list
25350435|NCT05505552|Vitamins|vitamins|mesh-ancestor
25350436|NCT05505552|Micronutrients|micronutrients|mesh-ancestor
25350437|NCT05505552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350438|NCT05505552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25350439|NCT05505552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25350440|NCT05505552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350441|NCT05505552|Hemostatics|hemostatics|mesh-ancestor
25350442|NCT05505552|Coagulants|coagulants|mesh-ancestor
25350443|NCT05505539|Fluorouracil|fluorouracil|mesh-list
25350444|NCT05505539|Antimetabolites|antimetabolites|mesh-ancestor
25350445|NCT05505539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350446|NCT05505539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25350447|NCT05505539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350448|NCT05505539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25350449|NCT05505539|Immunologic Factors|immunologic factors|mesh-ancestor
25350450|NCT05505539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350451|NCT05505461|Antibodies|antibodies|mesh-list
25350452|NCT05505461|Immunologic Factors|immunologic factors|mesh-ancestor
25350453|NCT05505461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350454|NCT05505435|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25350455|NCT05505435|Medroxyprogesterone|medroxyprogesterone|mesh-list
25350456|NCT05505435|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25350457|NCT05505435|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25350458|NCT05505435|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25350459|NCT05505435|Contraceptive Agents|contraceptive agents|mesh-ancestor
25350460|NCT05505435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25350461|NCT05505435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350462|NCT05505435|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25350463|NCT05505435|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25350464|NCT05505435|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25350465|NCT05505435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25350466|NCT05505435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350467|NCT05505409|Pirfenidone|pirfenidone|mesh-list
25350468|NCT05505409|Glucocorticoids|glucocorticoids|mesh-list
25350469|NCT05505409|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25350471|NCT05505409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25350472|NCT05505409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350473|NCT05505409|Analgesics|analgesics|mesh-ancestor
25350474|NCT05505409|Sensory System Agents|sensory system agents|mesh-ancestor
25350475|NCT05505409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25350476|NCT05505409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25350477|NCT05505409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25350478|NCT05505409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25350479|NCT05505409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25350480|NCT05505409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350481|NCT05505409|Immunologic Factors|immunologic factors|mesh-ancestor
25350482|NCT05505292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25350483|NCT05505292|Lifitegrast|lifitegrast|mesh-list
25350484|NCT05505292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25350486|NCT05505279|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25350487|NCT05505279|Autonomic Agents|autonomic agents|mesh-ancestor
25350488|NCT05505279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25350489|NCT05505279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350490|NCT05505279|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25350491|NCT05505279|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25350492|NCT05505279|Cholinergic Agents|cholinergic agents|mesh-ancestor
25350493|NCT05505279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25350494|NCT05505279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350495|NCT05505253|Alfacalcidol|alfacalcidol|mesh-list
25350496|NCT05505253|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
25350802|NCT05503667|Bevacizumab|bevacizumab|mesh-list
25350497|NCT05505253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25350498|NCT05505253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350499|NCT05505253|Vitamins|vitamins|mesh-ancestor
25350500|NCT05505253|Micronutrients|micronutrients|mesh-ancestor
25350501|NCT05505214|Mometasone Furoate|mometasone furoate|mesh-list
25350502|NCT05505214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25350503|NCT05505214|Dermatologic Agents|dermatologic agents|mesh-ancestor
25350504|NCT05505214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25350505|NCT05505123|Propofol|propofol|mesh-list
25350506|NCT05505123|Sevoflurane|sevoflurane|mesh-list
25350507|NCT05505123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25350508|NCT05505123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25350509|NCT05505123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350510|NCT05505123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25350511|NCT05505123|Anesthetics, General|anesthetics, general|mesh-ancestor
25350512|NCT05505123|Anesthetics|anesthetics|mesh-ancestor
25350513|NCT05505123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25350514|NCT05505123|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25350515|NCT05505006|Folic Acid|folic acid|mesh-list
25350516|NCT05505006|Vitamin B 12|vitamin b 12|mesh-list
25350517|NCT05505006|Hematinics|hematinics|mesh-ancestor
25350518|NCT05505006|Vitamin B Complex|vitamin b complex|mesh-ancestor
25350519|NCT05505006|Vitamins|vitamins|mesh-ancestor
25350520|NCT05505006|Micronutrients|micronutrients|mesh-ancestor
25350521|NCT05505006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350522|NCT05504967|Dexamethasone|dexamethasone|mesh-list
25350523|NCT05504967|Ropivacaine|ropivacaine|mesh-list
25350524|NCT05504967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25350525|NCT05504967|Antiemetics|antiemetics|mesh-ancestor
25350526|NCT05504967|Autonomic Agents|autonomic agents|mesh-ancestor
25350527|NCT05504967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25350528|NCT05504967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350529|NCT05504967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25350530|NCT05504967|Glucocorticoids|glucocorticoids|mesh-ancestor
25350531|NCT05504967|Hormones|hormones|mesh-ancestor
25350532|NCT05504967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25350533|NCT05504967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25350534|NCT05504967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350535|NCT05504967|Anesthetics, Local|anesthetics, local|mesh-ancestor
25350536|NCT05504967|Anesthetics|anesthetics|mesh-ancestor
25350537|NCT05504967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25350538|NCT05504967|Sensory System Agents|sensory system agents|mesh-ancestor
25350539|NCT05504876|Midazolam|midazolam|mesh-list
25350540|NCT05504876|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25350541|NCT05504876|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25350542|NCT05504876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25350543|NCT05504876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350544|NCT05504876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25350545|NCT05504876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25350546|NCT05504876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25350547|NCT05504876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25350548|NCT05504876|Anesthetics, General|anesthetics, general|mesh-ancestor
25350549|NCT05504876|Anesthetics|anesthetics|mesh-ancestor
25350550|NCT05504876|GABA Modulators|gaba modulators|mesh-ancestor
25350551|NCT05504876|GABA Agents|gaba agents|mesh-ancestor
25350552|NCT05504876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25350553|NCT05504876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350554|NCT05504863|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
25350555|NCT05504863|Ferric Compounds|ferric compounds|mesh-list
25350556|NCT05504863|Hematinics|hematinics|mesh-ancestor
25350557|NCT05504720|Pembrolizumab|pembrolizumab|mesh-list
25350558|NCT05504720|Trastuzumab|trastuzumab|mesh-list
25350559|NCT05504720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25350560|NCT05504720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350561|NCT05504694|Ofatumumab|ofatumumab|mesh-list
25350562|NCT05504694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350563|NCT05504642|Nivolumab|nivolumab|mesh-list
25350564|NCT05504642|Ipilimumab|ipilimumab|mesh-list
25350565|NCT05504642|Immunologic Factors|immunologic factors|mesh-list
25350566|NCT05504642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25350567|NCT05504642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350568|NCT05504642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25350569|NCT05504642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350570|NCT05504642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350571|NCT05504603|Rituximab|rituximab|mesh-list
25350572|NCT05504603|Zanubrutinib|zanubrutinib|mesh-list
25350573|NCT05504603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25350574|NCT05504603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350575|NCT05504603|Immunologic Factors|immunologic factors|mesh-ancestor
25350576|NCT05504603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350577|NCT05504603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25350578|NCT05504603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25350579|NCT05504603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25350580|NCT05504603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350582|NCT05504577|Tranexamic Acid|tranexamic acid|mesh-list
25350583|NCT05504577|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25350584|NCT05504577|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25350585|NCT05504577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350586|NCT05504577|Hemostatics|hemostatics|mesh-ancestor
25350587|NCT05504577|Coagulants|coagulants|mesh-ancestor
25350588|NCT05504577|Antidepressive Agents|antidepressive agents|mesh-ancestor
25350589|NCT05504577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25350590|NCT05504577|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25350591|NCT05504577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25350592|NCT05504577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25350593|NCT05504577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25350594|NCT05504577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25350595|NCT05504577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350596|NCT05504486|Brexpiprazole|brexpiprazole|mesh-list
25350597|NCT05504486|Serotonin Agents|serotonin agents|mesh-ancestor
25350598|NCT05504486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25350599|NCT05504486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350600|NCT05504486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350601|NCT05504486|Dopamine Agonists|dopamine agonists|mesh-ancestor
25350602|NCT05504486|Dopamine Agents|dopamine agents|mesh-ancestor
25350603|NCT05504382|Naproxen|naproxen|mesh-list
25350604|NCT05504382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25350605|NCT05504382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25350606|NCT05504382|Analgesics|analgesics|mesh-ancestor
25350607|NCT05504382|Sensory System Agents|sensory system agents|mesh-ancestor
25350608|NCT05504382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25350609|NCT05504382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350610|NCT05504382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25350611|NCT05504382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25350612|NCT05504382|Gout Suppressants|gout suppressants|mesh-ancestor
25350613|NCT05504382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25350614|NCT05504382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25350615|NCT05504382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350616|NCT05504330|Aspirin|aspirin|mesh-list
25350617|NCT05504330|Clopidogrel|clopidogrel|mesh-list
25350618|NCT05504330|Atorvastatin|atorvastatin|mesh-list
25350619|NCT05504330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25350620|NCT05504330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25350621|NCT05504330|Analgesics|analgesics|mesh-ancestor
25350622|NCT05504330|Sensory System Agents|sensory system agents|mesh-ancestor
25350623|NCT05504330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25350624|NCT05504330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350625|NCT05504330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25350626|NCT05504330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25350627|NCT05504330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25350628|NCT05504330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25350629|NCT05504330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350630|NCT05504330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25350631|NCT05504330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25350632|NCT05504330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25350633|NCT05504330|Antipyretics|antipyretics|mesh-ancestor
25350634|NCT05504330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25350635|NCT05504330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25350636|NCT05504330|Antimetabolites|antimetabolites|mesh-ancestor
25350637|NCT05504330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25350638|NCT05504330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25350639|NCT05504330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25350640|NCT05504330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25350641|NCT05504330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25350642|NCT05504330|Purinergic Agents|purinergic agents|mesh-ancestor
25350643|NCT05504330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25350644|NCT05504291|Carboplatin|carboplatin|mesh-list
25350646|NCT05504291|Vincristine|vincristine|mesh-list
25350647|NCT05504291|Etoposide phosphate|etoposide phosphate|mesh-list
25350648|NCT05504291|Melphalan|melphalan|mesh-list
25350649|NCT05504291|Mechlorethamine|mechlorethamine|mesh-list
25350650|NCT05504291|Podophyllotoxin|podophyllotoxin|mesh-list
25350651|NCT05504291|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25350652|NCT05504291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350653|NCT05504291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350654|NCT05504291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25350655|NCT05504291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25350656|NCT05504291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25350657|NCT05504291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25350658|NCT05504291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350659|NCT05504291|Tubulin Modulators|tubulin modulators|mesh-ancestor
25350660|NCT05504291|Antimitotic Agents|antimitotic agents|mesh-ancestor
25350661|NCT05504291|Mitosis Modulators|mitosis modulators|mesh-ancestor
25350662|NCT05504291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25350663|NCT05504291|Alkylating Agents|alkylating agents|mesh-ancestor
25350664|NCT05504291|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25350665|NCT05504291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25350666|NCT05504291|Immunologic Factors|immunologic factors|mesh-ancestor
25350667|NCT05504291|Keratolytic Agents|keratolytic agents|mesh-ancestor
25350668|NCT05504291|Dermatologic Agents|dermatologic agents|mesh-ancestor
25350669|NCT05504278|Carboplatin|carboplatin|mesh-list
25350670|NCT05504278|Pemetrexed|pemetrexed|mesh-list
25350671|NCT05504278|Cetuximab|cetuximab|mesh-list
25350672|NCT05504278|Cisplatin|cisplatin|mesh-list
25350673|NCT05504278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350674|NCT05504278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25350675|NCT05504278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350676|NCT05504278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25350677|NCT05504278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25350678|NCT05504278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25350679|NCT05504265|Flurbiprofen|flurbiprofen|mesh-list
25350680|NCT05504265|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
25350681|NCT05504265|Analgesics|analgesics|mesh-ancestor
25350682|NCT05504265|Sensory System Agents|sensory system agents|mesh-ancestor
25350683|NCT05504265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25350684|NCT05504265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350685|NCT05504265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25350686|NCT05504265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25350687|NCT05504265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25350688|NCT05504265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25350689|NCT05504265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25350690|NCT05504265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25350691|NCT05504265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350692|NCT05504252|Fluorouracil|fluorouracil|mesh-list
25350693|NCT05504252|Oxaliplatin|oxaliplatin|mesh-list
25350694|NCT05504252|Nivolumab|nivolumab|mesh-list
25350695|NCT05504252|Antimetabolites|antimetabolites|mesh-ancestor
25350696|NCT05504252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350697|NCT05504252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25350698|NCT05504252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350699|NCT05504252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25350700|NCT05504252|Immunologic Factors|immunologic factors|mesh-ancestor
25350701|NCT05504252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350702|NCT05504252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25350703|NCT05504252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25350704|NCT05504213|Fulvestrant|fulvestrant|mesh-list
25350705|NCT05504213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25350706|NCT05504213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350707|NCT05504213|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25350708|NCT05504213|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25350709|NCT05504213|Hormone Antagonists|hormone antagonists|mesh-ancestor
25350710|NCT05504213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25350711|NCT05504213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350712|NCT05504083|Benzbromarone|benzbromarone|mesh-list
25350713|NCT05504083|Uricosuric Agents|uricosuric agents|mesh-ancestor
25350714|NCT05504083|Gout Suppressants|gout suppressants|mesh-ancestor
25350715|NCT05504083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25350716|NCT05504083|Renal Agents|renal agents|mesh-ancestor
25350717|NCT05504057|Amantadine|amantadine|mesh-list
25350718|NCT05504057|Histamine Antagonists|histamine antagonists|mesh-list
25350719|NCT05504057|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25350720|NCT05504057|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25350721|NCT05504057|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25350722|NCT05504057|Antiviral Agents|antiviral agents|mesh-ancestor
25350723|NCT05504057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25350724|NCT05504057|Dopamine Agents|dopamine agents|mesh-ancestor
25350725|NCT05504057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25350744|NCT05503901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25350745|NCT05503901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350746|NCT05503901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350747|NCT05503901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25350748|NCT05503901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25350749|NCT05503875|Adalimumab|adalimumab|mesh-list
25350750|NCT05503875|Methotrexate|methotrexate|mesh-list
25350751|NCT05503875|Ixekizumab|ixekizumab|mesh-list
25350752|NCT05503875|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
25350753|NCT05503875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25350754|NCT05503875|Abortifacient Agents|abortifacient agents|mesh-ancestor
25350755|NCT05503875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25350756|NCT05503875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350757|NCT05503875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25350758|NCT05503875|Antimetabolites|antimetabolites|mesh-ancestor
25416006|NCT02978404|Nivolumab|nivolumab|mesh-list
25350759|NCT05503875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350760|NCT05503875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350761|NCT05503875|Dermatologic Agents|dermatologic agents|mesh-ancestor
25350762|NCT05503875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25350763|NCT05503875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25350764|NCT05503875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25350765|NCT05503875|Immunologic Factors|immunologic factors|mesh-ancestor
25350766|NCT05503875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25350767|NCT05503875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25350768|NCT05503875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25350769|NCT05503875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25350779|NCT05503706|Selenium|selenium|mesh-list
25350780|NCT05503706|Salicylic Acid|salicylic acid|mesh-list
25350781|NCT05503706|Salicylates|salicylates|mesh-list
25350782|NCT05503706|Selenium disulfide|selenium disulfide|mesh-list
25350783|NCT05503706|Antioxidants|antioxidants|mesh-ancestor
25350784|NCT05503706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350785|NCT05503706|Protective Agents|protective agents|mesh-ancestor
25350786|NCT05503706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350787|NCT05503706|Trace Elements|trace elements|mesh-ancestor
25350788|NCT05503706|Micronutrients|micronutrients|mesh-ancestor
25350789|NCT05503706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25350790|NCT05503706|Antifungal Agents|antifungal agents|mesh-ancestor
25350791|NCT05503706|Keratolytic Agents|keratolytic agents|mesh-ancestor
25350792|NCT05503706|Dermatologic Agents|dermatologic agents|mesh-ancestor
25350793|NCT05503706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25350794|NCT05503706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25350795|NCT05503706|Analgesics|analgesics|mesh-ancestor
25350796|NCT05503706|Sensory System Agents|sensory system agents|mesh-ancestor
25350797|NCT05503706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25350798|NCT05503706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25350799|NCT05503706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25350800|NCT05503706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25350801|NCT05503706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25350803|NCT05503667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25350804|NCT05503667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350805|NCT05503667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25350806|NCT05503667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25350807|NCT05503667|Growth Substances|growth substances|mesh-ancestor
25350808|NCT05503667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350809|NCT05503667|Growth Inhibitors|growth inhibitors|mesh-ancestor
25350810|NCT05503511|Bumetanide|bumetanide|mesh-list
25350811|NCT05503511|Diuretics|diuretics|mesh-ancestor
25350812|NCT05503511|Natriuretic Agents|natriuretic agents|mesh-ancestor
25350813|NCT05503511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350814|NCT05503511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25350815|NCT05503511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25350816|NCT05503511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350817|NCT05503355|Venetoclax|venetoclax|mesh-list
25350818|NCT05503355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350819|NCT05503225|Colchicine|colchicine|mesh-list
25350820|NCT05503225|Gout Suppressants|gout suppressants|mesh-ancestor
25350821|NCT05503225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25350822|NCT05503225|Tubulin Modulators|tubulin modulators|mesh-ancestor
25350823|NCT05503225|Antimitotic Agents|antimitotic agents|mesh-ancestor
25350824|NCT05503225|Mitosis Modulators|mitosis modulators|mesh-ancestor
25350825|NCT05503225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350826|NCT05503225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350827|NCT05503147|Nabiximols|nabiximols|mesh-list
25350828|NCT05503147|Analgesics|analgesics|mesh-ancestor
25350829|NCT05503147|Sensory System Agents|sensory system agents|mesh-ancestor
25350830|NCT05503147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25350831|NCT05503147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350832|NCT05503043|Lidocaine|lidocaine|mesh-list
25350833|NCT05503043|Anesthetics, Local|anesthetics, local|mesh-ancestor
25350834|NCT05503043|Anesthetics|anesthetics|mesh-ancestor
25350835|NCT05503043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25350836|NCT05503043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350837|NCT05503043|Sensory System Agents|sensory system agents|mesh-ancestor
25350838|NCT05503043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25350839|NCT05503043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25350840|NCT05503043|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25350841|NCT05503043|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25350842|NCT05503043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25350843|NCT05503043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350844|NCT05503030|Nintedanib|nintedanib|mesh-list
25350845|NCT05503030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350846|NCT05503030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25350847|NCT05503030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25350848|NCT05503030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350849|NCT05502991|Bevacizumab|bevacizumab|mesh-list
25350850|NCT05502991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25350851|NCT05502991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350852|NCT05502991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25350853|NCT05502991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25350854|NCT05502991|Growth Substances|growth substances|mesh-ancestor
25350855|NCT05502991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350856|NCT05502991|Growth Inhibitors|growth inhibitors|mesh-ancestor
25350857|NCT05502952|Pentoxifylline|pentoxifylline|mesh-list
25350858|NCT05502952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25350859|NCT05502952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25350860|NCT05502952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350861|NCT05502952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25350862|NCT05502952|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25350863|NCT05502952|Protective Agents|protective agents|mesh-ancestor
25350864|NCT05502952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350865|NCT05502952|Vasodilator Agents|vasodilator agents|mesh-ancestor
25350866|NCT05502952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25350867|NCT05502952|Antioxidants|antioxidants|mesh-ancestor
25350868|NCT05502913|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25350869|NCT05502913|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25350870|NCT05502913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25350871|NCT05502913|Antitubercular Agents|antitubercular agents|mesh-ancestor
25350872|NCT05502900|Melatonin|melatonin|mesh-list
25350873|NCT05502900|Antioxidants|antioxidants|mesh-ancestor
25350874|NCT05502900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350875|NCT05502900|Protective Agents|protective agents|mesh-ancestor
25350876|NCT05502900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350877|NCT05502900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25350878|NCT05502731|Adalimumab|adalimumab|mesh-list
25350879|NCT05502731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25350880|NCT05502731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25350881|NCT05502705|Lidocaine|lidocaine|mesh-list
25350882|NCT05502705|Anesthetics, Local|anesthetics, local|mesh-ancestor
25350883|NCT05502705|Anesthetics|anesthetics|mesh-ancestor
25350884|NCT05502705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25350885|NCT05502705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350886|NCT05502705|Sensory System Agents|sensory system agents|mesh-ancestor
25350887|NCT05502705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25350888|NCT05502705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25350889|NCT05502705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25350890|NCT05502705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25350891|NCT05502705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25350892|NCT05502705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350893|NCT05502458|Propofol|propofol|mesh-list
25350894|NCT05502458|Desflurane|desflurane|mesh-list
25350895|NCT05502458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25350896|NCT05502458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25350897|NCT05502458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350898|NCT05502458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25350899|NCT05502458|Anesthetics, General|anesthetics, general|mesh-ancestor
25350900|NCT05502458|Anesthetics|anesthetics|mesh-ancestor
25350901|NCT05502458|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25350902|NCT05502380|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25350903|NCT05502380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25350904|NCT05502315|Nivolumab|nivolumab|mesh-list
25350905|NCT05502315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25350906|NCT05502315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350907|NCT05502315|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25350908|NCT05502315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350909|NCT05502250|Gemcitabine|gemcitabine|mesh-list
25350910|NCT05502250|Cisplatin|cisplatin|mesh-list
25350911|NCT05502250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350912|NCT05502250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25350913|NCT05502250|Antimetabolites|antimetabolites|mesh-ancestor
25350914|NCT05502250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350915|NCT05502250|Antiviral Agents|antiviral agents|mesh-ancestor
25350916|NCT05502250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25350917|NCT05502250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25350918|NCT05502250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25350919|NCT05502250|Immunologic Factors|immunologic factors|mesh-ancestor
25350920|NCT05502250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350921|NCT05502237|Paclitaxel|paclitaxel|mesh-list
25350922|NCT05502237|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25350923|NCT05502237|Cisplatin|cisplatin|mesh-list
25350924|NCT05502237|Carboplatin|carboplatin|mesh-list
25350925|NCT05502237|Pembrolizumab|pembrolizumab|mesh-list
25350926|NCT05502237|Pemetrexed|pemetrexed|mesh-list
25350927|NCT05502237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25350928|NCT05502237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350929|NCT05502237|Tubulin Modulators|tubulin modulators|mesh-ancestor
25350930|NCT05502237|Antimitotic Agents|antimitotic agents|mesh-ancestor
25350931|NCT05502237|Mitosis Modulators|mitosis modulators|mesh-ancestor
25350932|NCT05502237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350933|NCT05502237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25350934|NCT05502237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25350935|NCT05502237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25350936|NCT05502237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25350937|NCT05502211|Lidocaine|lidocaine|mesh-list
25350938|NCT05502211|Fentanyl|fentanyl|mesh-list
25350939|NCT05502211|Anesthetics, Local|anesthetics, local|mesh-ancestor
25350940|NCT05502211|Anesthetics|anesthetics|mesh-ancestor
25350941|NCT05502211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25350942|NCT05502211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350943|NCT05502211|Sensory System Agents|sensory system agents|mesh-ancestor
25350944|NCT05502211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25350945|NCT05502211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25350946|NCT05502211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25350947|NCT05502211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25350948|NCT05502211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25350949|NCT05502211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350950|NCT05502211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25350953|NCT05502211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25350954|NCT05502211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25350955|NCT05502211|Anesthetics, General|anesthetics, general|mesh-ancestor
25350956|NCT05502146|Norepinephrine|norepinephrine|mesh-list
25350957|NCT05502146|Bupivacaine|bupivacaine|mesh-list
25350958|NCT05502146|Anesthetics, Local|anesthetics, local|mesh-ancestor
25350959|NCT05502146|Anesthetics|anesthetics|mesh-ancestor
25350960|NCT05502146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25350961|NCT05502146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350962|NCT05502146|Sensory System Agents|sensory system agents|mesh-ancestor
25350963|NCT05502146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25350964|NCT05502146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25350965|NCT05502146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25350966|NCT05502146|Adrenergic Agents|adrenergic agents|mesh-ancestor
25350967|NCT05502146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25350968|NCT05502146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350969|NCT05502146|Sympathomimetics|sympathomimetics|mesh-ancestor
25350970|NCT05502146|Autonomic Agents|autonomic agents|mesh-ancestor
25350971|NCT05502146|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25350972|NCT05502081|Favipiravir|favipiravir|mesh-list
25350973|NCT05502081|Remdesivir|remdesivir|mesh-list
25350974|NCT05502081|Antiviral Agents|antiviral agents|mesh-ancestor
25350975|NCT05502081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25350976|NCT05502081|Antimetabolites|antimetabolites|mesh-ancestor
25350977|NCT05502081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350978|NCT05502068|Vitamin D|vitamin d|mesh-list
25350979|NCT05502068|Vitamins|vitamins|mesh-ancestor
25350980|NCT05502068|Micronutrients|micronutrients|mesh-ancestor
25350981|NCT05502068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350982|NCT05502068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25350983|NCT05501886|Fulvestrant|fulvestrant|mesh-list
25350984|NCT05501886|Palbociclib|palbociclib|mesh-list
25350985|NCT05501886|Gedatolisib|gedatolisib|mesh-list
25350986|NCT05501886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25350987|NCT05501886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25350988|NCT05501886|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25350989|NCT05501886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25350990|NCT05501886|Hormone Antagonists|hormone antagonists|mesh-ancestor
25350991|NCT05501886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25350992|NCT05501886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25350993|NCT05501886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25350994|NCT05501886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25350995|NCT05501886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25350996|NCT05501860|Carticaine|carticaine|mesh-list
25350997|NCT05501860|Anesthetics, Local|anesthetics, local|mesh-ancestor
25350998|NCT05501860|Anesthetics|anesthetics|mesh-ancestor
25350999|NCT05501860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25351000|NCT05501860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351001|NCT05501860|Sensory System Agents|sensory system agents|mesh-ancestor
25351002|NCT05501860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25351003|NCT05501821|Pembrolizumab|pembrolizumab|mesh-list
25351004|NCT05501821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25351005|NCT05501821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351006|NCT05501769|Everolimus|everolimus|mesh-list
25351007|NCT05501769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351008|NCT05501769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25351009|NCT05501769|Immunologic Factors|immunologic factors|mesh-ancestor
25351010|NCT05501769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351011|NCT05501756|Alemtuzumab|alemtuzumab|mesh-list
25351012|NCT05501756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25351013|NCT05501756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351014|NCT05501704|Tamoxifen|tamoxifen|mesh-list
25351015|NCT05501704|Anastrozole|anastrozole|mesh-list
25351016|NCT05501704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25351017|NCT05501704|Hormone Antagonists|hormone antagonists|mesh-ancestor
25351018|NCT05501704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25351019|NCT05501704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351020|NCT05501704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25351021|NCT05501704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351022|NCT05501704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25351023|NCT05501704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25351024|NCT05501704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25351025|NCT05501704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25351026|NCT05501704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25351027|NCT05501704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351028|NCT05501704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351029|NCT05501678|Diphenhydramine|diphenhydramine|mesh-list
25351030|NCT05501678|Promethazine|promethazine|mesh-list
25351031|NCT05501678|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25351032|NCT05501678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25351033|NCT05501678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25351034|NCT05501678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351035|NCT05501678|Anesthetics, Local|anesthetics, local|mesh-ancestor
25351036|NCT05501678|Anesthetics|anesthetics|mesh-ancestor
25351037|NCT05501678|Sensory System Agents|sensory system agents|mesh-ancestor
25351038|NCT05501678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25351039|NCT05501678|Antiemetics|antiemetics|mesh-ancestor
25351040|NCT05501678|Autonomic Agents|autonomic agents|mesh-ancestor
25351041|NCT05501678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25351042|NCT05501678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25351043|NCT05501678|Histamine Antagonists|histamine antagonists|mesh-ancestor
25351044|NCT05501678|Histamine Agents|histamine agents|mesh-ancestor
25351045|NCT05501678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25351046|NCT05501678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351047|NCT05501678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25351048|NCT05501678|Antipruritics|antipruritics|mesh-ancestor
25351049|NCT05501678|Dermatologic Agents|dermatologic agents|mesh-ancestor
25351050|NCT05501665|Deoxyglucose|deoxyglucose|mesh-list
25351051|NCT05501665|Paclitaxel|paclitaxel|mesh-list
25351052|NCT05501665|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25351053|NCT05501665|Carboplatin|carboplatin|mesh-list
25351054|NCT05501665|Pembrolizumab|pembrolizumab|mesh-list
25351055|NCT05501665|Pemetrexed|pemetrexed|mesh-list
25351056|NCT05501665|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25351057|NCT05501665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25351058|NCT05501665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351059|NCT05501665|Tubulin Modulators|tubulin modulators|mesh-ancestor
25351060|NCT05501665|Antimitotic Agents|antimitotic agents|mesh-ancestor
25351061|NCT05501665|Mitosis Modulators|mitosis modulators|mesh-ancestor
25351062|NCT05501665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351063|NCT05501665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25351064|NCT05501665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351065|NCT05501665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25351066|NCT05501665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25351067|NCT05501665|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25351068|NCT05501665|Antimetabolites|antimetabolites|mesh-ancestor
25351069|NCT05501665|Antiviral Agents|antiviral agents|mesh-ancestor
25351070|NCT05501665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25351071|NCT05501639|Tiotropium Bromide|tiotropium bromide|mesh-list
25351072|NCT05501639|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25351073|NCT05501639|Autonomic Agents|autonomic agents|mesh-ancestor
25351074|NCT05501639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25351075|NCT05501639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351076|NCT05501639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25351077|NCT05501639|Respiratory System Agents|respiratory system agents|mesh-ancestor
25351078|NCT05501639|Parasympatholytics|parasympatholytics|mesh-ancestor
25351079|NCT05501639|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25351080|NCT05501639|Cholinergic Agents|cholinergic agents|mesh-ancestor
25351081|NCT05501639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25351082|NCT05501639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351083|NCT05501600|Lidocaine|lidocaine|mesh-list
25351084|NCT05501600|Anesthetics, Local|anesthetics, local|mesh-ancestor
25351085|NCT05501600|Anesthetics|anesthetics|mesh-ancestor
25351086|NCT05501600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25351087|NCT05501600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351088|NCT05501600|Sensory System Agents|sensory system agents|mesh-ancestor
25351089|NCT05501600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25351090|NCT05501600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25351091|NCT05501600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25351092|NCT05501600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25351093|NCT05501600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25351094|NCT05501600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351095|NCT05501574|Tacrolimus|tacrolimus|mesh-list
25351096|NCT05501574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25351097|NCT05501574|Immunologic Factors|immunologic factors|mesh-ancestor
25351098|NCT05501574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351099|NCT05501574|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25351100|NCT05501574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351101|NCT05501574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351102|NCT05501548|Ascorbic Acid|ascorbic acid|mesh-list
25351103|NCT05501548|Olaparib|olaparib|mesh-list
25351104|NCT05501548|Vitamins|vitamins|mesh-ancestor
25351105|NCT05501548|Micronutrients|micronutrients|mesh-ancestor
25351106|NCT05501548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351107|NCT05501548|Antioxidants|antioxidants|mesh-ancestor
25351108|NCT05501548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351109|NCT05501548|Protective Agents|protective agents|mesh-ancestor
25351110|NCT05501548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25351111|NCT05501548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351112|NCT05501548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351113|NCT05501483|Pioglitazone|pioglitazone|mesh-list
25351114|NCT05501483|Empagliflozin|empagliflozin|mesh-list
25351115|NCT05501483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25351116|NCT05501483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351117|NCT05501483|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25351118|NCT05501483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351119|NCT05501340|Molgramostim|molgramostim|mesh-list
25351120|NCT05501340|Sargramostim|sargramostim|mesh-list
25351121|NCT05501340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351122|NCT05501340|Immunologic Factors|immunologic factors|mesh-ancestor
25351123|NCT05501340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351124|NCT05501288|Pholcodine|pholcodine|mesh-list
25351125|NCT05501288|Analgesics|analgesics|mesh-ancestor
25351126|NCT05501288|Sensory System Agents|sensory system agents|mesh-ancestor
25351127|NCT05501288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25351128|NCT05501288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351129|NCT05501288|Antitussive Agents|antitussive agents|mesh-ancestor
25351130|NCT05501288|Respiratory System Agents|respiratory system agents|mesh-ancestor
25351131|NCT05501158|Tamoxifen|tamoxifen|mesh-list
25351132|NCT05501158|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25351133|NCT05501158|Hormone Antagonists|hormone antagonists|mesh-ancestor
25351134|NCT05501158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25351135|NCT05501158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351136|NCT05501158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25351137|NCT05501158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351138|NCT05501158|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25351139|NCT05501158|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25351140|NCT05501158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25351141|NCT05501080|Spironolactone|spironolactone|mesh-list
25351142|NCT05501080|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25351143|NCT05501080|Hormone Antagonists|hormone antagonists|mesh-ancestor
25351144|NCT05501080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25351145|NCT05501080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351146|NCT05501080|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25351147|NCT05501080|Diuretics|diuretics|mesh-ancestor
25351148|NCT05501080|Natriuretic Agents|natriuretic agents|mesh-ancestor
25351149|NCT05501054|Nivolumab|nivolumab|mesh-list
25351150|NCT05501054|Ipilimumab|ipilimumab|mesh-list
25351151|NCT05501054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25351152|NCT05501054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351153|NCT05501054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25351154|NCT05501054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351155|NCT05500937|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
25351156|NCT05500937|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25351157|NCT05500937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25351159|NCT05500742|Ubiquinone|ubiquinone|mesh-list
25351160|NCT05500742|Coenzyme Q10|coenzyme q10|mesh-list
25351161|NCT05500742|Resveratrol|resveratrol|mesh-list
25351162|NCT05500742|Antioxidants|antioxidants|mesh-ancestor
25351163|NCT05500742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351164|NCT05500742|Protective Agents|protective agents|mesh-ancestor
25351165|NCT05500742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351166|NCT05500742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351167|NCT05500742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25351168|NCT05500742|Trace Elements|trace elements|mesh-ancestor
25351169|NCT05500742|Micronutrients|micronutrients|mesh-ancestor
25351170|NCT05500742|Vitamins|vitamins|mesh-ancestor
25351171|NCT05500703|Dexmedetomidine|dexmedetomidine|mesh-list
25351172|NCT05500703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25351173|NCT05500703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25351174|NCT05500703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351175|NCT05500703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25351176|NCT05500703|Analgesics|analgesics|mesh-ancestor
25351177|NCT05500703|Sensory System Agents|sensory system agents|mesh-ancestor
25351178|NCT05500703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25351179|NCT05500703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25351180|NCT05500703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25351181|NCT05500703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25351182|NCT05500703|Adrenergic Agents|adrenergic agents|mesh-ancestor
25351183|NCT05500703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25351184|NCT05500703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351185|NCT05500690|Folic Acid|folic acid|mesh-list
25351186|NCT05500690|Hematinics|hematinics|mesh-ancestor
25351187|NCT05500690|Vitamin B Complex|vitamin b complex|mesh-ancestor
25351188|NCT05500690|Vitamins|vitamins|mesh-ancestor
25351189|NCT05500690|Micronutrients|micronutrients|mesh-ancestor
25351190|NCT05500690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351191|NCT05500677|Lidocaine|lidocaine|mesh-list
25351192|NCT05500677|Fentanyl|fentanyl|mesh-list
25351193|NCT05500677|Tramadol|tramadol|mesh-list
25351194|NCT05500677|Anesthetics, Local|anesthetics, local|mesh-ancestor
25351195|NCT05500677|Anesthetics|anesthetics|mesh-ancestor
25351196|NCT05500677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25351197|NCT05500677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351198|NCT05500677|Sensory System Agents|sensory system agents|mesh-ancestor
25351199|NCT05500677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25351200|NCT05500677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25351201|NCT05500677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25351202|NCT05500677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25351203|NCT05500677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25351204|NCT05500677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351205|NCT05500677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25351206|NCT05500677|Narcotics|narcotics|mesh-ancestor
25351207|NCT05500677|Analgesics|analgesics|mesh-ancestor
25351208|NCT05500677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25351209|NCT05500677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25351210|NCT05500677|Anesthetics, General|anesthetics, general|mesh-ancestor
25351211|NCT05500599|Fentanyl|fentanyl|mesh-list
25351212|NCT05500599|Midazolam|midazolam|mesh-list
25351213|NCT05500599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25351214|NCT05500599|Narcotics|narcotics|mesh-ancestor
25351215|NCT05500599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25351216|NCT05500599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351217|NCT05500599|Analgesics|analgesics|mesh-ancestor
25351218|NCT05500599|Sensory System Agents|sensory system agents|mesh-ancestor
25351219|NCT05500599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25351220|NCT05500599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25351221|NCT05500599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25351222|NCT05500599|Anesthetics, General|anesthetics, general|mesh-ancestor
25351223|NCT05500599|Anesthetics|anesthetics|mesh-ancestor
25351224|NCT05500599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25351225|NCT05500599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25351226|NCT05500599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25351227|NCT05500599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25351228|NCT05500599|GABA Modulators|gaba modulators|mesh-ancestor
25351229|NCT05500599|GABA Agents|gaba agents|mesh-ancestor
25351230|NCT05500599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25351231|NCT05500599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351232|NCT05500586|Glucagon|glucagon|mesh-list
25351233|NCT05500586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25351234|NCT05500586|Hormones|hormones|mesh-ancestor
25351235|NCT05500586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25351236|NCT05500586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351237|NCT05500508|Eflornithine|eflornithine|mesh-list
25351238|NCT05500508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351239|NCT05500508|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25351240|NCT05500508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25351241|NCT05500508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25351242|NCT05500508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25351243|NCT05500508|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
25351244|NCT05500508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351245|NCT05500508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351246|NCT05500443|Vitamin K|vitamin k|mesh-list
25351247|NCT05500443|Vitamin K 2|vitamin k 2|mesh-list
25351248|NCT05500443|Vitamin MK 7|vitamin mk 7|mesh-list
25351249|NCT05500443|Vitamins|vitamins|mesh-ancestor
25351250|NCT05500443|Micronutrients|micronutrients|mesh-ancestor
25351251|NCT05500443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351252|NCT05500443|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25351253|NCT05500443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25351254|NCT05500443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351256|NCT05500443|Coagulants|coagulants|mesh-ancestor
25351257|NCT05500326|Ivermectin|ivermectin|mesh-list
25351258|NCT05500326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25351259|NCT05500326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25351260|NCT05500261|Dexmedetomidine|dexmedetomidine|mesh-list
25351261|NCT05500261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25351262|NCT05500261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25351263|NCT05500261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351264|NCT05500261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25351265|NCT05500261|Analgesics|analgesics|mesh-ancestor
25351266|NCT05500261|Sensory System Agents|sensory system agents|mesh-ancestor
25351267|NCT05500261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25351268|NCT05500261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25351269|NCT05500261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25351270|NCT05500261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25351271|NCT05500261|Adrenergic Agents|adrenergic agents|mesh-ancestor
25351272|NCT05500261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25351273|NCT05500261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351274|NCT05500170|Niacinamide|niacinamide|mesh-list
25351275|NCT05500170|Niacin|niacin|mesh-list
25351276|NCT05500170|Nicotinic Acids|nicotinic acids|mesh-list
25351277|NCT05500170|Vitamins|vitamins|mesh-ancestor
25351278|NCT05500170|Micronutrients|micronutrients|mesh-ancestor
25351279|NCT05500170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351280|NCT05500170|Vitamin B Complex|vitamin b complex|mesh-ancestor
25351281|NCT05500170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25351282|NCT05500170|Antimetabolites|antimetabolites|mesh-ancestor
25351283|NCT05500170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351284|NCT05500170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25351285|NCT05500170|Vasodilator Agents|vasodilator agents|mesh-ancestor
25351286|NCT05500092|Gemcitabine|gemcitabine|mesh-list
25351287|NCT05500092|Cisplatin|cisplatin|mesh-list
25351288|NCT05500092|Docetaxel|docetaxel|mesh-list
25351289|NCT05500092|Nivolumab|nivolumab|mesh-list
25351290|NCT05500092|Pemetrexed|pemetrexed|mesh-list
25351291|NCT05500092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351292|NCT05500092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25351293|NCT05500092|Antimetabolites|antimetabolites|mesh-ancestor
25351294|NCT05500092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351295|NCT05500092|Antiviral Agents|antiviral agents|mesh-ancestor
25351296|NCT05500092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25351297|NCT05500092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351298|NCT05500092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25351299|NCT05500092|Immunologic Factors|immunologic factors|mesh-ancestor
25351300|NCT05500092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351301|NCT05500092|Tubulin Modulators|tubulin modulators|mesh-ancestor
25351302|NCT05500092|Antimitotic Agents|antimitotic agents|mesh-ancestor
25351303|NCT05500092|Mitosis Modulators|mitosis modulators|mesh-ancestor
25351304|NCT05500092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25351305|NCT05500092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25351306|NCT05500092|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25351307|NCT05500092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25351308|NCT05499897|Anesthetics|anesthetics|mesh-list
25351309|NCT05499897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25351310|NCT05499897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351312|NCT05499832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25351313|NCT05499832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25351314|NCT05499832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351315|NCT05499689|Bupivacaine|bupivacaine|mesh-list
25351316|NCT05499689|Anesthetics, Local|anesthetics, local|mesh-ancestor
25351317|NCT05499689|Anesthetics|anesthetics|mesh-ancestor
25351318|NCT05499689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25351319|NCT05499689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351320|NCT05499689|Sensory System Agents|sensory system agents|mesh-ancestor
25351321|NCT05499689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25351322|NCT05499598|Vitamin A|vitamin a|mesh-list
25351323|NCT05499598|Vitamins|vitamins|mesh-ancestor
25351324|NCT05499598|Micronutrients|micronutrients|mesh-ancestor
25351325|NCT05499598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351326|NCT05499572|Minocycline|minocycline|mesh-list
25351327|NCT05499572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25351328|NCT05499572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25351329|NCT05499481|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25351330|NCT05499481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25351331|NCT05499390|Pembrolizumab|pembrolizumab|mesh-list
25351332|NCT05499390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25351334|NCT05499234|Acetaminophen|acetaminophen|mesh-list
25351335|NCT05499234|Meperidine|meperidine|mesh-list
25351336|NCT05499234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25351337|NCT05499234|Analgesics|analgesics|mesh-ancestor
25351338|NCT05499234|Sensory System Agents|sensory system agents|mesh-ancestor
25351339|NCT05499234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25351340|NCT05499234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351341|NCT05499234|Antipyretics|antipyretics|mesh-ancestor
25351342|NCT05499234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25351343|NCT05499234|Narcotics|narcotics|mesh-ancestor
25351344|NCT05499234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25351345|NCT05499234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25351346|NCT05499117|Fluoxetine|fluoxetine|mesh-list
25351347|NCT05499117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25351348|NCT05499117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25351349|NCT05499117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25351350|NCT05499117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351351|NCT05499117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25351352|NCT05499117|Serotonin Agents|serotonin agents|mesh-ancestor
25351353|NCT05499117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351354|NCT05499117|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25351355|NCT05499117|Antidepressive Agents|antidepressive agents|mesh-ancestor
25351356|NCT05499117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25351357|NCT05499117|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25351358|NCT05499117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25351359|NCT05499117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351360|NCT05499065|Cetuximab|cetuximab|mesh-list
25351361|NCT05499065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25351362|NCT05499065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351363|NCT05499052|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25351364|NCT05499052|Hormones|hormones|mesh-ancestor
25351365|NCT05499052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25351366|NCT05499052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351367|NCT05499026|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
25351368|NCT05499026|Cathartics|cathartics|mesh-ancestor
25351369|NCT05499026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25351370|NCT05498896|Paclitaxel|paclitaxel|mesh-list
25351371|NCT05498896|Cyclophosphamide|cyclophosphamide|mesh-list
25351372|NCT05498896|Doxorubicin|doxorubicin|mesh-list
25351373|NCT05498896|Atezolizumab|atezolizumab|mesh-list
25351374|NCT05498896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25351375|NCT05498896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351376|NCT05498896|Tubulin Modulators|tubulin modulators|mesh-ancestor
25351377|NCT05498896|Antimitotic Agents|antimitotic agents|mesh-ancestor
25351378|NCT05498896|Mitosis Modulators|mitosis modulators|mesh-ancestor
25351379|NCT05498896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351380|NCT05498896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25351381|NCT05498896|Immunologic Factors|immunologic factors|mesh-ancestor
25351382|NCT05498896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351383|NCT05498896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25351384|NCT05498896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25351385|NCT05498896|Alkylating Agents|alkylating agents|mesh-ancestor
25351386|NCT05498896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25351387|NCT05498896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25351388|NCT05498896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25351389|NCT05498896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25351390|NCT05498896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351391|NCT05498857|Ephedrine|ephedrine|mesh-list
25351392|NCT05498857|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25351393|NCT05498857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351394|NCT05498857|Sympathomimetics|sympathomimetics|mesh-ancestor
25351395|NCT05498857|Autonomic Agents|autonomic agents|mesh-ancestor
25351396|NCT05498857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25351397|NCT05498857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25351398|NCT05498857|Adrenergic Agents|adrenergic agents|mesh-ancestor
25351399|NCT05498857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25351400|NCT05498857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351401|NCT05498792|Nivolumab|nivolumab|mesh-list
25351402|NCT05498792|Ipilimumab|ipilimumab|mesh-list
25351403|NCT05498792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25351404|NCT05498792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351405|NCT05498792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25351406|NCT05498792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351407|NCT05498766|Oxaliplatin|oxaliplatin|mesh-list
25351408|NCT05498766|Tegafur|tegafur|mesh-list
25351409|NCT05498766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351410|NCT05498766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25351411|NCT05498766|Antimetabolites|antimetabolites|mesh-ancestor
25351412|NCT05498766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351413|NCT05498714|Lactulose|lactulose|mesh-list
25351414|NCT05498714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25351415|NCT05498675|Valsartan|valsartan|mesh-list
25351416|NCT05498675|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25351417|NCT05498675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25351418|NCT05498675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25351419|NCT05498675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25351420|NCT05498675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351421|NCT05498636|Prednisone|prednisone|mesh-list
25351422|NCT05498636|Etoposide|etoposide|mesh-list
25351423|NCT05498636|Lenalidomide|lenalidomide|mesh-list
25351424|NCT05498636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25351425|NCT05498636|Glucocorticoids|glucocorticoids|mesh-ancestor
25351426|NCT05498636|Hormones|hormones|mesh-ancestor
25351427|NCT05498636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25351428|NCT05498636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351429|NCT05498636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25351430|NCT05498636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351431|NCT05498636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25351432|NCT05498636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25351433|NCT05498636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25351434|NCT05498636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351435|NCT05498636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351436|NCT05498636|Immunologic Factors|immunologic factors|mesh-ancestor
25351437|NCT05498636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25351438|NCT05498636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25351439|NCT05498636|Growth Substances|growth substances|mesh-ancestor
25351440|NCT05498636|Growth Inhibitors|growth inhibitors|mesh-ancestor
25351441|NCT05498480|Nivolumab|nivolumab|mesh-list
25351442|NCT05498480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25351443|NCT05498480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351444|NCT05498480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25351445|NCT05498480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351446|NCT05498467|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25351447|NCT05498467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25351448|NCT05498441|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25351449|NCT05498441|Antidepressive Agents|antidepressive agents|mesh-ancestor
25351450|NCT05498441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25351451|NCT05498441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25351452|NCT05498441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25351453|NCT05498441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25351454|NCT05498441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351455|NCT05498428|Carboplatin|carboplatin|mesh-list
25351456|NCT05498428|Pemetrexed|pemetrexed|mesh-list
25351457|NCT05498428|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
25351458|NCT05498428|Lazertinib|lazertinib|mesh-list
25351459|NCT05498428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351460|NCT05498428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351461|NCT05498428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351462|NCT05498428|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25351463|NCT05498428|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25351464|NCT05498428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25351465|NCT05498428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25351467|NCT05498389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351468|NCT05498389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25351469|NCT05498389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351470|NCT05498389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351471|NCT05498337|Calcium|calcium|mesh-list
25351472|NCT05498337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25351473|NCT05498337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351474|NCT05498272|Olaparib|olaparib|mesh-list
25351475|NCT05498272|Leuprolide|leuprolide|mesh-list
25351476|NCT05498272|Goserelin|goserelin|mesh-list
25351477|NCT05498272|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25724209|NCT02535806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351478|NCT05498272|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25351479|NCT05498272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351480|NCT05498272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351481|NCT05498272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351482|NCT05498272|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25351483|NCT05498272|Fertility Agents|fertility agents|mesh-ancestor
25351484|NCT05498272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25351485|NCT05498272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351486|NCT05498272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25351487|NCT05498272|Luteolytic Agents|luteolytic agents|mesh-ancestor
25351488|NCT05498272|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25351489|NCT05498272|Contraceptive Agents|contraceptive agents|mesh-ancestor
25351490|NCT05498272|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25351491|NCT05498259|Rituximab|rituximab|mesh-list
25351492|NCT05498259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25351493|NCT05498259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351494|NCT05498259|Immunologic Factors|immunologic factors|mesh-ancestor
25351495|NCT05498259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351496|NCT05498259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25351497|NCT05498233|Pyridoxine|pyridoxine|mesh-list
25351498|NCT05498233|Doxylamine|doxylamine|mesh-list
25351499|NCT05498233|Vitamin B Complex|vitamin b complex|mesh-ancestor
25351500|NCT05498233|Vitamins|vitamins|mesh-ancestor
25351501|NCT05498233|Micronutrients|micronutrients|mesh-ancestor
25351502|NCT05498233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351503|NCT05498233|Antiemetics|antiemetics|mesh-ancestor
25351504|NCT05498233|Autonomic Agents|autonomic agents|mesh-ancestor
25351505|NCT05498233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25351506|NCT05498233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25351507|NCT05498233|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25351508|NCT05498233|Histamine Antagonists|histamine antagonists|mesh-ancestor
25351509|NCT05498233|Histamine Agents|histamine agents|mesh-ancestor
25351510|NCT05498233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25351511|NCT05498233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351512|NCT05498220|Gemcitabine|gemcitabine|mesh-list
25351513|NCT05498220|Dexamethasone|dexamethasone|mesh-list
25351514|NCT05498220|Rituximab|rituximab|mesh-list
25351515|NCT05498220|Cisplatin|cisplatin|mesh-list
25351516|NCT05498220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25351517|NCT05498220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351518|NCT05498220|Immunologic Factors|immunologic factors|mesh-ancestor
25351519|NCT05498220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351520|NCT05498220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25351521|NCT05498220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25351522|NCT05498220|Antiemetics|antiemetics|mesh-ancestor
25351523|NCT05498220|Autonomic Agents|autonomic agents|mesh-ancestor
25351524|NCT05498220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25351525|NCT05498220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25351526|NCT05498220|Glucocorticoids|glucocorticoids|mesh-ancestor
25351527|NCT05498220|Hormones|hormones|mesh-ancestor
25351528|NCT05498220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25351529|NCT05498220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25351530|NCT05498220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25351531|NCT05498220|Antimetabolites|antimetabolites|mesh-ancestor
25351532|NCT05498220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351533|NCT05498220|Antiviral Agents|antiviral agents|mesh-ancestor
25351534|NCT05498220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25351535|NCT05498220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351536|NCT05498220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25351538|NCT05498181|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25351539|NCT05498181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25351540|NCT05498181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25351541|NCT05498181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25351542|NCT05498181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351543|NCT05498155|Durvalumab|durvalumab|mesh-list
25351544|NCT05498155|Olaparib|olaparib|mesh-list
25351545|NCT05498155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25351546|NCT05498155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351547|NCT05498155|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25351548|NCT05498155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351549|NCT05498155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351550|NCT05498129|Micronutrients|micronutrients|mesh-list
25351551|NCT05498129|Trace Elements|trace elements|mesh-list
25384091|NCT04555577|Temozolomide|temozolomide|mesh-list
25351552|NCT05498129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351553|NCT05498116|Montelukast|montelukast|mesh-list
25351554|NCT05498116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25351555|NCT05498116|Respiratory System Agents|respiratory system agents|mesh-ancestor
25351556|NCT05498116|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25351557|NCT05498116|Hormone Antagonists|hormone antagonists|mesh-ancestor
25351558|NCT05498116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25351559|NCT05498116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351560|NCT05498116|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25351561|NCT05498116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25351562|NCT05498116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351563|NCT05498103|Methazolamide|methazolamide|mesh-list
25351564|NCT05498103|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25351565|NCT05498103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351566|NCT05498103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351567|NCT05498103|Diuretics|diuretics|mesh-ancestor
25351568|NCT05498103|Natriuretic Agents|natriuretic agents|mesh-ancestor
25351569|NCT05498103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351570|NCT05498090|Fenofibrate|fenofibrate|mesh-list
25351571|NCT05498090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25351572|NCT05498090|Antimetabolites|antimetabolites|mesh-ancestor
25351573|NCT05498090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351574|NCT05498090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25351575|NCT05498064|Ensartinib|ensartinib|mesh-list
25351576|NCT05498064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351577|NCT05498064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25351578|NCT05498064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351579|NCT05498064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351580|NCT05498025|Charcoal|charcoal|mesh-list
25351581|NCT05498025|Antidotes|antidotes|mesh-ancestor
25351582|NCT05498025|Protective Agents|protective agents|mesh-ancestor
25351583|NCT05498025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351584|NCT05498012|Cannabidiol|cannabidiol|mesh-list
25351585|NCT05498012|Anticonvulsants|anticonvulsants|mesh-ancestor
25351586|NCT05497934|Glycerol|glycerol|mesh-list
25351587|NCT05497934|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25351588|NCT05497934|Protective Agents|protective agents|mesh-ancestor
25351589|NCT05497934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351590|NCT05497843|Chiauranib|chiauranib|mesh-list
25351591|NCT05497843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351592|NCT05497843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25351593|NCT05497843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351594|NCT05497843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351595|NCT05497804|Dexamethasone|dexamethasone|mesh-list
25351596|NCT05497804|Dexamethasone acetate|dexamethasone acetate|mesh-list
25351597|NCT05497804|Lenalidomide|lenalidomide|mesh-list
25351598|NCT05497804|Daratumumab|daratumumab|mesh-list
25351599|NCT05497804|Ichthammol|ichthammol|mesh-list
25351600|NCT05497804|BB 1101|bb 1101|mesh-list
25351601|NCT05497804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25351602|NCT05497804|Antiemetics|antiemetics|mesh-ancestor
25351603|NCT05497804|Autonomic Agents|autonomic agents|mesh-ancestor
25351604|NCT05497804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25351605|NCT05497804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351606|NCT05497804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25351607|NCT05497804|Glucocorticoids|glucocorticoids|mesh-ancestor
25351608|NCT05497804|Hormones|hormones|mesh-ancestor
25351609|NCT05497804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25351610|NCT05497804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25351611|NCT05497804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351612|NCT05497804|Protease Inhibitors|protease inhibitors|mesh-ancestor
25351613|NCT05497804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351614|NCT05497804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351615|NCT05497804|Immunologic Factors|immunologic factors|mesh-ancestor
25351616|NCT05497804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25351617|NCT05497804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25351618|NCT05497804|Growth Substances|growth substances|mesh-ancestor
25351619|NCT05497804|Growth Inhibitors|growth inhibitors|mesh-ancestor
25351620|NCT05497804|Dermatologic Agents|dermatologic agents|mesh-ancestor
25351621|NCT05497778|Gemcitabine|gemcitabine|mesh-list
25351622|NCT05497778|Paclitaxel|paclitaxel|mesh-list
25351623|NCT05497778|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25351624|NCT05497778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25351625|NCT05497778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25724210|NCT02535806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25351626|NCT05497778|Tubulin Modulators|tubulin modulators|mesh-ancestor
25351627|NCT05497778|Antimitotic Agents|antimitotic agents|mesh-ancestor
25351628|NCT05497778|Mitosis Modulators|mitosis modulators|mesh-ancestor
25351629|NCT05497778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351630|NCT05497778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25351631|NCT05497778|Antimetabolites|antimetabolites|mesh-ancestor
25351632|NCT05497778|Antiviral Agents|antiviral agents|mesh-ancestor
25351708|NCT05497492|Sufentanil|sufentanil|mesh-list
25351633|NCT05497778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25351634|NCT05497778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351635|NCT05497778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25351636|NCT05497778|Immunologic Factors|immunologic factors|mesh-ancestor
25351637|NCT05497778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351638|NCT05497765|Silybin|silybin|mesh-list
25351639|NCT05497765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25351640|NCT05497765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351641|NCT05497765|Protective Agents|protective agents|mesh-ancestor
25351642|NCT05497765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351643|NCT05497726|Bevacizumab|bevacizumab|mesh-list
25351644|NCT05497726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25351645|NCT05497726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351646|NCT05497726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25351647|NCT05497726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25351648|NCT05497726|Growth Substances|growth substances|mesh-ancestor
25351649|NCT05497726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351650|NCT05497726|Growth Inhibitors|growth inhibitors|mesh-ancestor
25351651|NCT05497700|Norepinephrine|norepinephrine|mesh-list
25351652|NCT05497700|Ephedrine|ephedrine|mesh-list
25351653|NCT05497700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25351654|NCT05497700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25351655|NCT05497700|Adrenergic Agents|adrenergic agents|mesh-ancestor
25351656|NCT05497700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25351657|NCT05497700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351658|NCT05497700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351659|NCT05497700|Sympathomimetics|sympathomimetics|mesh-ancestor
25351660|NCT05497700|Autonomic Agents|autonomic agents|mesh-ancestor
25351661|NCT05497700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25351662|NCT05497700|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25351663|NCT05497700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25351664|NCT05497674|Rifampin|rifampin|mesh-list
25351665|NCT05497674|Probenecid|probenecid|mesh-list
25351666|NCT05497674|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25351667|NCT05497674|Antitubercular Agents|antitubercular agents|mesh-ancestor
25351668|NCT05497674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25351669|NCT05497674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25351670|NCT05497674|Leprostatic Agents|leprostatic agents|mesh-ancestor
25351671|NCT05497674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25351672|NCT05497674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351673|NCT05497674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351674|NCT05497674|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25351675|NCT05497674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25351676|NCT05497674|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25351677|NCT05497674|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25351678|NCT05497674|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25351679|NCT05497674|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25351680|NCT05497674|Uricosuric Agents|uricosuric agents|mesh-ancestor
25351681|NCT05497674|Gout Suppressants|gout suppressants|mesh-ancestor
25351682|NCT05497674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25351683|NCT05497674|Renal Agents|renal agents|mesh-ancestor
25351684|NCT05497596|Vitamin D|vitamin d|mesh-list
25351685|NCT05497596|Vitamins|vitamins|mesh-ancestor
25351686|NCT05497596|Micronutrients|micronutrients|mesh-ancestor
25351687|NCT05497596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351688|NCT05497596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25351689|NCT05497570|Tenoxicam|tenoxicam|mesh-list
25351690|NCT05497570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25351691|NCT05497570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25351692|NCT05497570|Analgesics|analgesics|mesh-ancestor
25351693|NCT05497570|Sensory System Agents|sensory system agents|mesh-ancestor
25351694|NCT05497570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25351695|NCT05497570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351696|NCT05497570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25351697|NCT05497570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25351698|NCT05497570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25351699|NCT05497570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351700|NCT05497570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351701|NCT05497557|Omeprazole|omeprazole|mesh-list
25351702|NCT05497557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25351703|NCT05497557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25351704|NCT05497557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25351705|NCT05497557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351706|NCT05497557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351707|NCT05497492|Lidocaine|lidocaine|mesh-list
25351709|NCT05497492|Propofol|propofol|mesh-list
25351710|NCT05497492|Esketamine|esketamine|mesh-list
25351711|NCT05497492|Anesthetics, Local|anesthetics, local|mesh-ancestor
25351712|NCT05497492|Anesthetics|anesthetics|mesh-ancestor
25351713|NCT05497492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25351714|NCT05497492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351715|NCT05497492|Sensory System Agents|sensory system agents|mesh-ancestor
25351716|NCT05497492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25351717|NCT05497492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25351718|NCT05497492|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25351719|NCT05497492|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25351720|NCT05497492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25351721|NCT05497492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351722|NCT05497492|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25351723|NCT05497492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25351724|NCT05497492|Anesthetics, General|anesthetics, general|mesh-ancestor
25351725|NCT05497492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25351726|NCT05497492|Narcotics|narcotics|mesh-ancestor
25351727|NCT05497492|Analgesics|analgesics|mesh-ancestor
25351728|NCT05497492|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25351729|NCT05497492|Antidepressive Agents|antidepressive agents|mesh-ancestor
25351730|NCT05497492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25351731|NCT05497453|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25351732|NCT05497453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351733|NCT05497453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351734|NCT05497323|Adapalene|adapalene|mesh-list
25351735|NCT05497323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25351736|NCT05497323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25351737|NCT05497323|Analgesics|analgesics|mesh-ancestor
25351738|NCT05497323|Sensory System Agents|sensory system agents|mesh-ancestor
25351739|NCT05497323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25351740|NCT05497323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351741|NCT05497323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25351742|NCT05497323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25351743|NCT05497323|Dermatologic Agents|dermatologic agents|mesh-ancestor
25351744|NCT05497310|Tretinoin|tretinoin|mesh-list
25351745|NCT05497310|Arsenic Trioxide|arsenic trioxide|mesh-list
25351746|NCT05497310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351747|NCT05497310|Keratolytic Agents|keratolytic agents|mesh-ancestor
25351748|NCT05497310|Dermatologic Agents|dermatologic agents|mesh-ancestor
25351749|NCT05497232|Pancrelipase|pancrelipase|mesh-list
25351750|NCT05497232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25351751|NCT05497206|Metronidazole|metronidazole|mesh-list
25351752|NCT05497206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25351753|NCT05497206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25351754|NCT05497206|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25351755|NCT05497206|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25351756|NCT05497102|Lenalidomide|lenalidomide|mesh-list
25351757|NCT05497102|Immunologic Factors|immunologic factors|mesh-ancestor
25351758|NCT05497102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351759|NCT05497102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25351760|NCT05497102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25351761|NCT05497102|Growth Substances|growth substances|mesh-ancestor
25351762|NCT05497102|Growth Inhibitors|growth inhibitors|mesh-ancestor
25351763|NCT05497102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351764|NCT05497063|Pyrimethamine|pyrimethamine|mesh-list
25351765|NCT05497063|Sulfadoxine|sulfadoxine|mesh-list
25351766|NCT05497063|Antimalarials|antimalarials|mesh-ancestor
25351767|NCT05497063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25351768|NCT05497063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25351769|NCT05497063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25351770|NCT05497063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25351771|NCT05497063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351772|NCT05497063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351773|NCT05497063|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25351774|NCT05497063|Renal Agents|renal agents|mesh-ancestor
25351775|NCT05496894|Mitoxantrone|mitoxantrone|mesh-list
25351776|NCT05496894|Analgesics|analgesics|mesh-ancestor
25351777|NCT05496894|Sensory System Agents|sensory system agents|mesh-ancestor
25351778|NCT05496894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25351779|NCT05496894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351780|NCT05496894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351781|NCT05496894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25351782|NCT05496894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25351783|NCT05496894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351784|NCT05496894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351785|NCT05496764|Dexamethasone|dexamethasone|mesh-list
25351786|NCT05496764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25351787|NCT05496764|Antiemetics|antiemetics|mesh-ancestor
25351788|NCT05496764|Autonomic Agents|autonomic agents|mesh-ancestor
25351789|NCT05496764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25351790|NCT05496764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351791|NCT05496764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25351792|NCT05496764|Glucocorticoids|glucocorticoids|mesh-ancestor
25351793|NCT05496764|Hormones|hormones|mesh-ancestor
25351794|NCT05496764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25351795|NCT05496764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25351796|NCT05496764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351797|NCT05496725|Micafungin|micafungin|mesh-list
25351798|NCT05496725|Antifungal Agents|antifungal agents|mesh-ancestor
25351799|NCT05496725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25351800|NCT05496530|Triamcinolone|triamcinolone|mesh-list
25351801|NCT05496530|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25351802|NCT05496530|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25351803|NCT05496530|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25351804|NCT05496530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25351805|NCT05496530|Glucocorticoids|glucocorticoids|mesh-ancestor
25351806|NCT05496530|Hormones|hormones|mesh-ancestor
25351807|NCT05496530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
24446032|NCT00303615|Hormones|hormones|mesh-ancestor
25351808|NCT05496530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351809|NCT05496530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25351810|NCT05496530|Immunologic Factors|immunologic factors|mesh-ancestor
25351811|NCT05496530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351812|NCT05496530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351813|NCT05496335|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25351814|NCT05496335|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25351815|NCT05496335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25351816|NCT05496335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351817|NCT05496335|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25351818|NCT05496335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25351819|NCT05496335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351820|NCT05496335|Cholinergic Agents|cholinergic agents|mesh-ancestor
25351821|NCT05496335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25351822|NCT05496192|Nivolumab|nivolumab|mesh-list
25351823|NCT05496192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25351824|NCT05496192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351825|NCT05496192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25351826|NCT05496192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351827|NCT05496179|Metoclopramide|metoclopramide|mesh-list
25351828|NCT05496179|Prucalopride|prucalopride|mesh-list
25351829|NCT05496179|Antiemetics|antiemetics|mesh-ancestor
25351830|NCT05496179|Autonomic Agents|autonomic agents|mesh-ancestor
25351831|NCT05496179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25351832|NCT05496179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351833|NCT05496179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25351910|NCT05495464|Vidarabine|vidarabine|mesh-list
25351834|NCT05496179|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25351835|NCT05496179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25351836|NCT05496179|Dopamine Agents|dopamine agents|mesh-ancestor
25351837|NCT05496179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25351838|NCT05496179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351839|NCT05496179|Laxatives|laxatives|mesh-ancestor
25351840|NCT05496179|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
25351841|NCT05496179|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25351842|NCT05496179|Serotonin Agents|serotonin agents|mesh-ancestor
25351843|NCT05496075|Orlistat|orlistat|mesh-list
25351844|NCT05496075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351845|NCT05496075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351846|NCT05496075|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25351847|NCT05496075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25351848|NCT05496036|Pembrolizumab|pembrolizumab|mesh-list
25351849|NCT05496036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25351850|NCT05496036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351851|NCT05495958|Vitamin D|vitamin d|mesh-list
25351852|NCT05495958|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25351853|NCT05495958|Vitamins|vitamins|mesh-ancestor
25351854|NCT05495958|Micronutrients|micronutrients|mesh-ancestor
25351855|NCT05495958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351856|NCT05495958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25351857|NCT05495958|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25351858|NCT05495945|Propofol|propofol|mesh-list
25351859|NCT05495945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25351860|NCT05495945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25351861|NCT05495945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351862|NCT05495945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25351863|NCT05495945|Anesthetics, General|anesthetics, general|mesh-ancestor
25351864|NCT05495945|Anesthetics|anesthetics|mesh-ancestor
25351865|NCT05495893|Mycophenolic Acid|mycophenolic acid|mesh-list
25351866|NCT05495893|Cyclophosphamide|cyclophosphamide|mesh-list
25351867|NCT05495893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25351868|NCT05495893|Immunologic Factors|immunologic factors|mesh-ancestor
25351869|NCT05495893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351870|NCT05495893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25351871|NCT05495893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25351872|NCT05495893|Alkylating Agents|alkylating agents|mesh-ancestor
25351873|NCT05495893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351874|NCT05495893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351875|NCT05495893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25351876|NCT05495893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25351877|NCT05495893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25351878|NCT05495893|Antitubercular Agents|antitubercular agents|mesh-ancestor
25351879|NCT05495893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25351880|NCT05495893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25351881|NCT05495893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351882|NCT05495750|Bupivacaine|bupivacaine|mesh-list
25351883|NCT05495750|Anesthetics, Local|anesthetics, local|mesh-ancestor
25351884|NCT05495750|Anesthetics|anesthetics|mesh-ancestor
25351885|NCT05495750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25351886|NCT05495750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351887|NCT05495750|Sensory System Agents|sensory system agents|mesh-ancestor
25351888|NCT05495750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25351889|NCT05495620|Dexamethasone|dexamethasone|mesh-list
25351890|NCT05495620|Lenalidomide|lenalidomide|mesh-list
25351891|NCT05495620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25351892|NCT05495620|Antiemetics|antiemetics|mesh-ancestor
25351893|NCT05495620|Autonomic Agents|autonomic agents|mesh-ancestor
25351894|NCT05495620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25351895|NCT05495620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351896|NCT05495620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25351897|NCT05495620|Glucocorticoids|glucocorticoids|mesh-ancestor
25351898|NCT05495620|Hormones|hormones|mesh-ancestor
25351899|NCT05495620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25351900|NCT05495620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25351901|NCT05495620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351902|NCT05495620|Immunologic Factors|immunologic factors|mesh-ancestor
25351903|NCT05495620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25351904|NCT05495620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25351905|NCT05495620|Growth Substances|growth substances|mesh-ancestor
25351906|NCT05495620|Growth Inhibitors|growth inhibitors|mesh-ancestor
25351907|NCT05495568|Adalimumab|adalimumab|mesh-list
25351908|NCT05495568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25351909|NCT05495568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25351911|NCT05495464|Cyclophosphamide|cyclophosphamide|mesh-list
25351913|NCT05495464|Fludarabine|fludarabine|mesh-list
25351914|NCT05495464|Fludarabine phosphate|fludarabine phosphate|mesh-list
25351915|NCT05495464|Acalabrutinib|acalabrutinib|mesh-list
25351916|NCT05495464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25351917|NCT05495464|Immunologic Factors|immunologic factors|mesh-ancestor
25351918|NCT05495464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351919|NCT05495464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25351920|NCT05495464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25351921|NCT05495464|Alkylating Agents|alkylating agents|mesh-ancestor
25351922|NCT05495464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351923|NCT05495464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351924|NCT05495464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25351925|NCT05495464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25351926|NCT05495464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25351927|NCT05495464|Antimetabolites|antimetabolites|mesh-ancestor
25351928|NCT05495464|Antiviral Agents|antiviral agents|mesh-ancestor
25351929|NCT05495464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25351930|NCT05495321|Aldesleukin|aldesleukin|mesh-list
25351931|NCT05495321|Interleukin-2|interleukin-2|mesh-list
25351932|NCT05495321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351933|NCT05495321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25351934|NCT05495321|Analgesics|analgesics|mesh-ancestor
25351935|NCT05495321|Sensory System Agents|sensory system agents|mesh-ancestor
25351936|NCT05495321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25351937|NCT05495321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351938|NCT05495321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25351939|NCT05495321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25351940|NCT05495321|Antiviral Agents|antiviral agents|mesh-ancestor
25351941|NCT05495321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25351942|NCT05495269|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25351943|NCT05495269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25351944|NCT05495204|Ibalizumab|ibalizumab|mesh-list
25351945|NCT05495204|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25351946|NCT05495204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25351947|NCT05495204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25351948|NCT05495204|Antiviral Agents|antiviral agents|mesh-ancestor
25351949|NCT05495204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25351950|NCT05495204|Immunologic Factors|immunologic factors|mesh-ancestor
25351951|NCT05495204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351952|NCT05495100|Azacitidine|azacitidine|mesh-list
25351953|NCT05495100|Mitoxantrone|mitoxantrone|mesh-list
25351954|NCT05495100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25351955|NCT05495100|Antimetabolites|antimetabolites|mesh-ancestor
25351956|NCT05495100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351957|NCT05495100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351958|NCT05495100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351959|NCT05495100|Analgesics|analgesics|mesh-ancestor
25351960|NCT05495100|Sensory System Agents|sensory system agents|mesh-ancestor
25351961|NCT05495100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25351962|NCT05495100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351963|NCT05495100|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25351964|NCT05495100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25351965|NCT05495061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25351966|NCT05495061|Latanoprost|latanoprost|mesh-list
25351967|NCT05495061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25351968|NCT05495035|Dexamethasone|dexamethasone|mesh-list
25351969|NCT05495035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25351970|NCT05495035|Antiemetics|antiemetics|mesh-ancestor
25351971|NCT05495035|Autonomic Agents|autonomic agents|mesh-ancestor
25351972|NCT05495035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25351973|NCT05495035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351974|NCT05495035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25351975|NCT05495035|Glucocorticoids|glucocorticoids|mesh-ancestor
25351976|NCT05495035|Hormones|hormones|mesh-ancestor
25351977|NCT05495035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25351978|NCT05495035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25351979|NCT05495035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351980|NCT05494866|Cobicistat|cobicistat|mesh-list
25351981|NCT05494866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25351982|NCT05494866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25351983|NCT05494866|Antiviral Agents|antiviral agents|mesh-ancestor
25351984|NCT05494866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25351985|NCT05494866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25351986|NCT05494866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25351987|NCT05494866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25351988|NCT05494866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351989|NCT05494775|Mitogens|mitogens|mesh-list
25351990|NCT05494775|Endothelial Growth Factors|endothelial growth factors|mesh-list
25351991|NCT05494775|Mitosis Modulators|mitosis modulators|mesh-ancestor
25351992|NCT05494775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25351993|NCT05494775|Growth Substances|growth substances|mesh-ancestor
25351994|NCT05494775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25351995|NCT05494710|Bleomycin|bleomycin|mesh-list
25351996|NCT05494710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25351997|NCT05494710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25351998|NCT05494697|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
25351999|NCT05494697|Antiviral Agents|antiviral agents|mesh-ancestor
25352000|NCT05494697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25352001|NCT05494645|Bupivacaine|bupivacaine|mesh-list
25352002|NCT05494645|Anesthetics, Local|anesthetics, local|mesh-ancestor
25352003|NCT05494645|Anesthetics|anesthetics|mesh-ancestor
25352004|NCT05494645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25352005|NCT05494645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352006|NCT05494645|Sensory System Agents|sensory system agents|mesh-ancestor
25352007|NCT05494645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25352008|NCT05494619|Immunoglobulins|immunoglobulins|mesh-list
25352009|NCT05494619|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25352010|NCT05494619|Antibodies|antibodies|mesh-list
25352011|NCT05494619|gamma-Globulins|gamma-globulins|mesh-list
25352012|NCT05494619|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25352013|NCT05494619|Immunologic Factors|immunologic factors|mesh-ancestor
25352014|NCT05494619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352015|NCT05494593|Rituximab|rituximab|mesh-list
25352016|NCT05494593|Methotrexate|methotrexate|mesh-list
25352017|NCT05494593|Immunoglobulins|immunoglobulins|mesh-list
25352018|NCT05494593|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25352019|NCT05494593|Antibodies|antibodies|mesh-list
25352020|NCT05494593|gamma-Globulins|gamma-globulins|mesh-list
25352021|NCT05494593|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25352022|NCT05494593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25352023|NCT05494593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352024|NCT05494593|Immunologic Factors|immunologic factors|mesh-ancestor
25352025|NCT05494593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352026|NCT05494593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25352027|NCT05494593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25352028|NCT05494593|Abortifacient Agents|abortifacient agents|mesh-ancestor
25352029|NCT05494593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25352030|NCT05494593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25352031|NCT05494593|Antimetabolites|antimetabolites|mesh-ancestor
25352032|NCT05494593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352033|NCT05494593|Dermatologic Agents|dermatologic agents|mesh-ancestor
25352034|NCT05494593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352035|NCT05494593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25352036|NCT05494593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25352037|NCT05494593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25352038|NCT05494580|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25352039|NCT05494580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352040|NCT05494580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352041|NCT05494580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352042|NCT05494567|Tadalafil|tadalafil|mesh-list
25352043|NCT05494567|Tamsulosin|tamsulosin|mesh-list
25352044|NCT05494567|Solifenacin Succinate|solifenacin succinate|mesh-list
25352045|NCT05494567|Vasodilator Agents|vasodilator agents|mesh-ancestor
25352046|NCT05494567|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25352047|NCT05494567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25352048|NCT05494567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352049|NCT05494567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352050|NCT05494567|Urological Agents|urological agents|mesh-ancestor
25352051|NCT05494567|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25352052|NCT05494567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25352053|NCT05494567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25352054|NCT05494567|Adrenergic Agents|adrenergic agents|mesh-ancestor
25352055|NCT05494567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25352056|NCT05494567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352057|NCT05494567|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25352058|NCT05494567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25352059|NCT05494567|Cholinergic Agents|cholinergic agents|mesh-ancestor
25352060|NCT05494528|Entecavir|entecavir|mesh-list
25352061|NCT05494528|Antiviral Agents|antiviral agents|mesh-ancestor
25352062|NCT05494528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25352063|NCT05494437|Gabapentin|gabapentin|mesh-list
25352064|NCT05494437|Nabilone|nabilone|mesh-list
25352065|NCT05494437|Analgesics|analgesics|mesh-ancestor
25352066|NCT05494437|Sensory System Agents|sensory system agents|mesh-ancestor
25352067|NCT05494437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25352068|NCT05494437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352069|NCT05494437|Anticonvulsants|anticonvulsants|mesh-ancestor
25352070|NCT05494437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25352071|NCT05494437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25352072|NCT05494437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25352073|NCT05494437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25352074|NCT05494437|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25352075|NCT05494437|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25352076|NCT05494437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25352077|NCT05494437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352078|NCT05494437|Antimanic Agents|antimanic agents|mesh-ancestor
25352079|NCT05494437|Antiemetics|antiemetics|mesh-ancestor
25352080|NCT05494437|Autonomic Agents|autonomic agents|mesh-ancestor
25352081|NCT05494437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25352082|NCT05494411|Mitomycins|mitomycins|mesh-list
25352083|NCT05494411|Mitomycin|mitomycin|mesh-list
25352084|NCT05494411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25352085|NCT05494411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352086|NCT05494411|Alkylating Agents|alkylating agents|mesh-ancestor
25352087|NCT05494411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352088|NCT05494411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25352089|NCT05494411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352090|NCT05494398|Acetylcysteine|acetylcysteine|mesh-list
25352091|NCT05494398|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25352093|NCT05494398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25352094|NCT05494398|Expectorants|expectorants|mesh-ancestor
25352095|NCT05494398|Respiratory System Agents|respiratory system agents|mesh-ancestor
25352096|NCT05494398|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25352097|NCT05494398|Antioxidants|antioxidants|mesh-ancestor
25352098|NCT05494398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352099|NCT05494398|Protective Agents|protective agents|mesh-ancestor
25352100|NCT05494398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352101|NCT05494398|Antidotes|antidotes|mesh-ancestor
25352102|NCT05494385|Gabapentin|gabapentin|mesh-list
25352103|NCT05494385|Analgesics|analgesics|mesh-ancestor
25352104|NCT05494385|Sensory System Agents|sensory system agents|mesh-ancestor
25352105|NCT05494385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25352106|NCT05494385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352107|NCT05494385|Anticonvulsants|anticonvulsants|mesh-ancestor
25352108|NCT05494385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25352109|NCT05494385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25352110|NCT05494385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25352111|NCT05494385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25352112|NCT05494385|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25352113|NCT05494385|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25352114|NCT05494385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25352115|NCT05494385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352116|NCT05494385|Antimanic Agents|antimanic agents|mesh-ancestor
25352117|NCT05494307|Terbutaline|terbutaline|mesh-list
25352118|NCT05494307|Danazol|danazol|mesh-list
25352119|NCT05494307|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25352120|NCT05494307|Autonomic Agents|autonomic agents|mesh-ancestor
25352121|NCT05494307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25352122|NCT05494307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352123|NCT05494307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25352124|NCT05494307|Respiratory System Agents|respiratory system agents|mesh-ancestor
25352125|NCT05494307|Sympathomimetics|sympathomimetics|mesh-ancestor
25352126|NCT05494307|Tocolytic Agents|tocolytic agents|mesh-ancestor
25352127|NCT05494307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25352128|NCT05494307|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25352129|NCT05494307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25352130|NCT05494307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25352131|NCT05494307|Adrenergic Agents|adrenergic agents|mesh-ancestor
25352132|NCT05494307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25352133|NCT05494307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352134|NCT05494307|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25352135|NCT05494307|Hormone Antagonists|hormone antagonists|mesh-ancestor
25352136|NCT05494307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25352137|NCT05494281|Anesthetics|anesthetics|mesh-list
25352138|NCT05494281|Anesthetics, Local|anesthetics, local|mesh-list
25352215|NCT05493709|Fertility Agents|fertility agents|mesh-ancestor
25352139|NCT05494281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25352140|NCT05494281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352141|NCT05494281|Sensory System Agents|sensory system agents|mesh-ancestor
25352142|NCT05494281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25352143|NCT05494190|Cisplatin|cisplatin|mesh-list
25352144|NCT05494190|Docetaxel|docetaxel|mesh-list
25352145|NCT05494190|Capecitabine|capecitabine|mesh-list
25352146|NCT05494190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352147|NCT05494190|Tubulin Modulators|tubulin modulators|mesh-ancestor
25352148|NCT05494190|Antimitotic Agents|antimitotic agents|mesh-ancestor
25352149|NCT05494190|Mitosis Modulators|mitosis modulators|mesh-ancestor
25352150|NCT05494190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352151|NCT05494190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25352152|NCT05494190|Antimetabolites|antimetabolites|mesh-ancestor
25352153|NCT05494125|Ropivacaine|ropivacaine|mesh-list
25352154|NCT05494125|Anesthetics, Local|anesthetics, local|mesh-ancestor
25352155|NCT05494125|Anesthetics|anesthetics|mesh-ancestor
25352156|NCT05494125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25352157|NCT05494125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352158|NCT05494125|Sensory System Agents|sensory system agents|mesh-ancestor
25352159|NCT05494125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25352160|NCT05494060|Capecitabine|capecitabine|mesh-list
25352161|NCT05494060|Oxaliplatin|oxaliplatin|mesh-list
25352162|NCT05494060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25352163|NCT05494060|Antimetabolites|antimetabolites|mesh-ancestor
25352164|NCT05494060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352165|NCT05494060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352166|NCT05494047|Vaccines|vaccines|mesh-list
25352167|NCT05494047|Immunologic Factors|immunologic factors|mesh-ancestor
25352168|NCT05494047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352169|NCT05493995|Gemcitabine|gemcitabine|mesh-list
25352170|NCT05493995|Paclitaxel|paclitaxel|mesh-list
25352171|NCT05493995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25352172|NCT05493995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352173|NCT05493995|Tubulin Modulators|tubulin modulators|mesh-ancestor
25352174|NCT05493995|Antimitotic Agents|antimitotic agents|mesh-ancestor
25352175|NCT05493995|Mitosis Modulators|mitosis modulators|mesh-ancestor
25352176|NCT05493995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352177|NCT05493995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25352178|NCT05493995|Antimetabolites|antimetabolites|mesh-ancestor
25352179|NCT05493995|Antiviral Agents|antiviral agents|mesh-ancestor
25352180|NCT05493995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25352181|NCT05493995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352182|NCT05493995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25352183|NCT05493995|Immunologic Factors|immunologic factors|mesh-ancestor
25352184|NCT05493995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352185|NCT05493969|Lamivudine|lamivudine|mesh-list
25352186|NCT05493969|Dolutegravir|dolutegravir|mesh-list
25352187|NCT05493969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25352188|NCT05493969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25352189|NCT05493969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352190|NCT05493969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352191|NCT05493969|Antiviral Agents|antiviral agents|mesh-ancestor
25352192|NCT05493969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25352193|NCT05493969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25352194|NCT05493969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25352195|NCT05493969|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25352196|NCT05493969|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25352197|NCT05493761|Denosumab|denosumab|mesh-list
25352198|NCT05493761|Alendronate|alendronate|mesh-list
25352199|NCT05493761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25352200|NCT05493761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352201|NCT05493735|Lidocaine|lidocaine|mesh-list
25352202|NCT05493735|Anesthetics, Local|anesthetics, local|mesh-ancestor
25352203|NCT05493735|Anesthetics|anesthetics|mesh-ancestor
25352204|NCT05493735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25352205|NCT05493735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352206|NCT05493735|Sensory System Agents|sensory system agents|mesh-ancestor
25352207|NCT05493735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25352208|NCT05493735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25352209|NCT05493735|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25352210|NCT05493735|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25352211|NCT05493735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25352212|NCT05493735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352213|NCT05493709|Leuprolide|leuprolide|mesh-list
25352214|NCT05493709|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25352216|NCT05493709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25352217|NCT05493709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352218|NCT05493709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25352219|NCT05493709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352220|NCT05493657|Aspirin|aspirin|mesh-list
25352221|NCT05493657|Clopidogrel|clopidogrel|mesh-list
25352222|NCT05493657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25352223|NCT05493657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25352224|NCT05493657|Analgesics|analgesics|mesh-ancestor
25352225|NCT05493657|Sensory System Agents|sensory system agents|mesh-ancestor
25352226|NCT05493657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25352227|NCT05493657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352228|NCT05493657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25352229|NCT05493657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25352230|NCT05493657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25352231|NCT05493657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25352232|NCT05493657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352233|NCT05493657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25352234|NCT05493657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25352235|NCT05493657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352237|NCT05493657|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25352238|NCT05493657|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25352239|NCT05493657|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25352240|NCT05493657|Purinergic Agents|purinergic agents|mesh-ancestor
25352241|NCT05493657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25352242|NCT05493618|Dexamethasone|dexamethasone|mesh-list
25352243|NCT05493618|Pembrolizumab|pembrolizumab|mesh-list
25352244|NCT05493618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25352245|NCT05493618|Antiemetics|antiemetics|mesh-ancestor
25352246|NCT05493618|Autonomic Agents|autonomic agents|mesh-ancestor
25352247|NCT05493618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25352248|NCT05493618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352249|NCT05493618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25352250|NCT05493618|Glucocorticoids|glucocorticoids|mesh-ancestor
25352251|NCT05493618|Hormones|hormones|mesh-ancestor
25352252|NCT05493618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25352253|NCT05493618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25352254|NCT05493618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352255|NCT05493618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25352256|NCT05493566|Aldesleukin|aldesleukin|mesh-list
25352257|NCT05493566|Pembrolizumab|pembrolizumab|mesh-list
25352258|NCT05493566|Interleukin-2|interleukin-2|mesh-list
25352259|NCT05493566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25352260|NCT05493566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352261|NCT05493566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25352262|NCT05493566|Analgesics|analgesics|mesh-ancestor
25352263|NCT05493566|Sensory System Agents|sensory system agents|mesh-ancestor
25352264|NCT05493566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25352265|NCT05493566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352266|NCT05493566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25352267|NCT05493566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25352268|NCT05493566|Antiviral Agents|antiviral agents|mesh-ancestor
25352269|NCT05493566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25352270|NCT05493540|Ibuprofen|ibuprofen|mesh-list
25352271|NCT05493540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25352272|NCT05493540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25352273|NCT05493540|Analgesics|analgesics|mesh-ancestor
25352274|NCT05493540|Sensory System Agents|sensory system agents|mesh-ancestor
25352275|NCT05493540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25352276|NCT05493540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352277|NCT05493540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25352278|NCT05493540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25352279|NCT05493540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25352280|NCT05493540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352281|NCT05493540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352282|NCT05493501|Osimertinib|osimertinib|mesh-list
25352283|NCT05493501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352284|NCT05493501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25352285|NCT05493501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352286|NCT05493501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352287|NCT05493475|Fentanyl|fentanyl|mesh-list
25352288|NCT05493475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25352289|NCT05493475|Narcotics|narcotics|mesh-ancestor
25352290|NCT05493475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25352291|NCT05493475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352292|NCT05493475|Analgesics|analgesics|mesh-ancestor
25352293|NCT05493475|Sensory System Agents|sensory system agents|mesh-ancestor
25352294|NCT05493475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25352295|NCT05493475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25352296|NCT05493475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25352297|NCT05493475|Anesthetics, General|anesthetics, general|mesh-ancestor
25352298|NCT05493475|Anesthetics|anesthetics|mesh-ancestor
25352299|NCT05493371|Empagliflozin|empagliflozin|mesh-list
25352300|NCT05493371|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25352301|NCT05493371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352302|NCT05493371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25352303|NCT05493371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352304|NCT05493332|Leucovorin|leucovorin|mesh-list
25352305|NCT05493332|Fluorouracil|fluorouracil|mesh-list
25352306|NCT05493332|Oxaliplatin|oxaliplatin|mesh-list
25352307|NCT05493332|Antimetabolites|antimetabolites|mesh-ancestor
25352308|NCT05493332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352309|NCT05493332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25352310|NCT05493332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352311|NCT05493332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25352312|NCT05493332|Immunologic Factors|immunologic factors|mesh-ancestor
25352313|NCT05493332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352314|NCT05493332|Antidotes|antidotes|mesh-ancestor
25352315|NCT05493332|Protective Agents|protective agents|mesh-ancestor
25352316|NCT05493332|Vitamin B Complex|vitamin b complex|mesh-ancestor
25352319|NCT05493267|Zoledronic Acid|zoledronic acid|mesh-list
25352320|NCT05493267|Interleukin-2|interleukin-2|mesh-list
25352321|NCT05493267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352322|NCT05493267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25352323|NCT05493267|Analgesics|analgesics|mesh-ancestor
25352324|NCT05493267|Sensory System Agents|sensory system agents|mesh-ancestor
25352325|NCT05493267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25352326|NCT05493267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352327|NCT05493267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25352328|NCT05493228|Dexmedetomidine|dexmedetomidine|mesh-list
25352329|NCT05493228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25352330|NCT05493228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25352331|NCT05493228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352332|NCT05493228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25352333|NCT05493228|Analgesics|analgesics|mesh-ancestor
25352334|NCT05493228|Sensory System Agents|sensory system agents|mesh-ancestor
25352335|NCT05493228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25352336|NCT05493228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25352337|NCT05493228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25352338|NCT05493228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25352339|NCT05493228|Adrenergic Agents|adrenergic agents|mesh-ancestor
25352340|NCT05493228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25352341|NCT05493228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352342|NCT05493215|Imatinib Mesylate|imatinib mesylate|mesh-list
25352343|NCT05493215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352344|NCT05493215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25352345|NCT05493215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352346|NCT05493215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352347|NCT05493163|Fibrinolytic Agents|fibrinolytic agents|mesh-list
25352348|NCT05493163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25352349|NCT05493163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352352|NCT05492994|Carbon Monoxide|carbon monoxide|mesh-list
25352353|NCT05492994|Antimetabolites|antimetabolites|mesh-ancestor
25352354|NCT05492994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352355|NCT05492994|Gasotransmitters|gasotransmitters|mesh-ancestor
25352356|NCT05492994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25352357|NCT05492994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352358|NCT05492968|Phenylephrine|phenylephrine|mesh-list
25352359|NCT05492968|Epinephrine|epinephrine|mesh-list
25352360|NCT05492968|Oxymetazoline|oxymetazoline|mesh-list
25352361|NCT05492968|Norepinephrine|norepinephrine|mesh-list
25352362|NCT05492968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25352363|NCT05492968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25352364|NCT05492968|Adrenergic Agents|adrenergic agents|mesh-ancestor
25352365|NCT05492968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25352517|NCT05491785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25352366|NCT05492968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352367|NCT05492968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352368|NCT05492968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25352369|NCT05492968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25352370|NCT05492968|Autonomic Agents|autonomic agents|mesh-ancestor
25352371|NCT05492968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25352372|NCT05492968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25352373|NCT05492968|Respiratory System Agents|respiratory system agents|mesh-ancestor
25352375|NCT05492968|Sympathomimetics|sympathomimetics|mesh-ancestor
25352376|NCT05492968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25352377|NCT05492968|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25352378|NCT05492968|Nasal Decongestants|nasal decongestants|mesh-ancestor
25352379|NCT05492968|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25352380|NCT05492968|Protective Agents|protective agents|mesh-ancestor
25352381|NCT05492851|Hylan|hylan|mesh-list
25352382|NCT05492851|Viscosupplements|viscosupplements|mesh-ancestor
25352383|NCT05492851|Protective Agents|protective agents|mesh-ancestor
25352384|NCT05492851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352385|NCT05492812|Melatonin|melatonin|mesh-list
25352386|NCT05492812|Chloral Hydrate|chloral hydrate|mesh-list
25352387|NCT05492812|Hydroxyzine|hydroxyzine|mesh-list
25352388|NCT05492812|Antioxidants|antioxidants|mesh-ancestor
25384923|NCT04532528|Anticoagulants|anticoagulants|mesh-ancestor
25352389|NCT05492812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352390|NCT05492812|Protective Agents|protective agents|mesh-ancestor
25352391|NCT05492812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352544|NCT05491694|Mitosis Modulators|mitosis modulators|mesh-ancestor
25352392|NCT05492812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25352393|NCT05492812|Antipruritics|antipruritics|mesh-ancestor
25352394|NCT05492812|Dermatologic Agents|dermatologic agents|mesh-ancestor
25352395|NCT05492812|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25352396|NCT05492812|Histamine Antagonists|histamine antagonists|mesh-ancestor
25352397|NCT05492812|Histamine Agents|histamine agents|mesh-ancestor
25352398|NCT05492812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25352399|NCT05492812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25352400|NCT05492682|Cyclophosphamide|cyclophosphamide|mesh-list
25352401|NCT05492682|Pembrolizumab|pembrolizumab|mesh-list
25352402|NCT05492682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25352403|NCT05492682|Immunologic Factors|immunologic factors|mesh-ancestor
25352404|NCT05492682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352405|NCT05492682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25352406|NCT05492682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25352407|NCT05492682|Alkylating Agents|alkylating agents|mesh-ancestor
25352408|NCT05492682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352409|NCT05492682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352410|NCT05492682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25352411|NCT05492682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25352412|NCT05492669|Lidocaine|lidocaine|mesh-list
25352413|NCT05492669|Anesthetics, Local|anesthetics, local|mesh-ancestor
25352414|NCT05492669|Anesthetics|anesthetics|mesh-ancestor
25352415|NCT05492669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25352416|NCT05492669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352417|NCT05492669|Sensory System Agents|sensory system agents|mesh-ancestor
25352418|NCT05492669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25352419|NCT05492669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25352420|NCT05492669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25352421|NCT05492669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25352422|NCT05492669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25352423|NCT05492669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352424|NCT05492591|Valacyclovir|valacyclovir|mesh-list
25352425|NCT05492591|Antiviral Agents|antiviral agents|mesh-ancestor
25352426|NCT05492591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25352427|NCT05492565|Tenofovir|tenofovir|mesh-list
25352428|NCT05492565|Emtricitabine|emtricitabine|mesh-list
25352429|NCT05492565|Antiviral Agents|antiviral agents|mesh-ancestor
25352430|NCT05492565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25352431|NCT05492565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25352432|NCT05492565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25352433|NCT05492565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352434|NCT05492565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352435|NCT05492565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25352436|NCT05492565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25352437|NCT05492487|Megestrol Acetate|megestrol acetate|mesh-list
25352438|NCT05492487|Levonorgestrel|levonorgestrel|mesh-list
25352439|NCT05492487|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25352440|NCT05492487|Contraceptive Agents|contraceptive agents|mesh-ancestor
25352441|NCT05492487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25352442|NCT05492487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352443|NCT05492487|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25352444|NCT05492487|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25352445|NCT05492487|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25352446|NCT05492487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25352447|NCT05492487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352448|NCT05492487|Appetite Stimulants|appetite stimulants|mesh-ancestor
25352449|NCT05492487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25352450|NCT05492318|Clarithromycin|clarithromycin|mesh-list
25352451|NCT05492318|Midazolam|midazolam|mesh-list
25352452|NCT05492318|Dabigatran|dabigatran|mesh-list
25352453|NCT05492318|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
25352454|NCT05492318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25352455|NCT05492318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25352456|NCT05492318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25352457|NCT05492318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352458|NCT05492318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25352459|NCT05492318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25724211|NCT02535806|Glucocorticoids|glucocorticoids|mesh-ancestor
25724212|NCT02535806|Hormones|hormones|mesh-ancestor
25352460|NCT05492318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25352461|NCT05492318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25352462|NCT05492318|Anesthetics, General|anesthetics, general|mesh-ancestor
25352463|NCT05492318|Anesthetics|anesthetics|mesh-ancestor
25352464|NCT05492318|GABA Modulators|gaba modulators|mesh-ancestor
25352465|NCT05492318|GABA Agents|gaba agents|mesh-ancestor
25352466|NCT05492318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25352620|NCT05491304|Autonomic Agents|autonomic agents|mesh-ancestor
25352467|NCT05492318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352468|NCT05492318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25352469|NCT05492318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25352470|NCT05492318|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25352471|NCT05492318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352472|NCT05492318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25352473|NCT05492318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25352474|NCT05492318|Antithrombins|antithrombins|mesh-ancestor
25352475|NCT05492318|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25352476|NCT05492318|Protease Inhibitors|protease inhibitors|mesh-ancestor
25352477|NCT05492318|Anticoagulants|anticoagulants|mesh-ancestor
25352478|NCT05492318|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25352479|NCT05492123|Cisplatin|cisplatin|mesh-list
25352480|NCT05492123|Nivolumab|nivolumab|mesh-list
25352481|NCT05492123|Ipilimumab|ipilimumab|mesh-list
25352482|NCT05492123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352483|NCT05492123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25352484|NCT05492123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25352485|NCT05492123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352486|NCT05492019|Doxycycline|doxycycline|mesh-list
25352487|NCT05492019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25352488|NCT05492019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25352489|NCT05492019|Antimalarials|antimalarials|mesh-ancestor
25352490|NCT05492019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25352491|NCT05492019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25352492|NCT05491928|Tempol|tempol|mesh-list
25352493|NCT05491928|Antioxidants|antioxidants|mesh-ancestor
25352494|NCT05491928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352495|NCT05491928|Protective Agents|protective agents|mesh-ancestor
25352496|NCT05491928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352497|NCT05491928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25352498|NCT05491928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352499|NCT05491928|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25352500|NCT05491928|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25352501|NCT05491902|Flutemetamol|flutemetamol|mesh-list
25352502|NCT05491902|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25352503|NCT05491902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352504|NCT05491811|Bevacizumab|bevacizumab|mesh-list
25352505|NCT05491811|Ensartinib|ensartinib|mesh-list
25352506|NCT05491811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25352507|NCT05491811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352508|NCT05491811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25352509|NCT05491811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25352510|NCT05491811|Growth Substances|growth substances|mesh-ancestor
25352511|NCT05491811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352512|NCT05491811|Growth Inhibitors|growth inhibitors|mesh-ancestor
25352513|NCT05491811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25352514|NCT05491811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352515|NCT05491811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352516|NCT05491785|Oxycodone|oxycodone|mesh-list
25352518|NCT05491785|Narcotics|narcotics|mesh-ancestor
25352519|NCT05491785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25352520|NCT05491785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352521|NCT05491785|Analgesics|analgesics|mesh-ancestor
25352522|NCT05491785|Sensory System Agents|sensory system agents|mesh-ancestor
25352523|NCT05491785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25352524|NCT05491720|Risperidone|risperidone|mesh-list
25352525|NCT05491720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25352526|NCT05491720|Serotonin Agents|serotonin agents|mesh-ancestor
25352527|NCT05491720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25352528|NCT05491720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352529|NCT05491720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352530|NCT05491720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25352531|NCT05491720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25352532|NCT05491720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25352533|NCT05491720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25352534|NCT05491720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25352535|NCT05491720|Dopamine Agents|dopamine agents|mesh-ancestor
25352536|NCT05491694|Paclitaxel|paclitaxel|mesh-list
25352537|NCT05491694|Cyclophosphamide|cyclophosphamide|mesh-list
25352538|NCT05491694|Carboplatin|carboplatin|mesh-list
25352539|NCT05491694|Epirubicin|epirubicin|mesh-list
25352540|NCT05491694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25352541|NCT05491694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352542|NCT05491694|Tubulin Modulators|tubulin modulators|mesh-ancestor
25352543|NCT05491694|Antimitotic Agents|antimitotic agents|mesh-ancestor
25352545|NCT05491694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352546|NCT05491694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25352547|NCT05491694|Immunologic Factors|immunologic factors|mesh-ancestor
25352548|NCT05491694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352549|NCT05491694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25352550|NCT05491694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25352551|NCT05491694|Alkylating Agents|alkylating agents|mesh-ancestor
25352552|NCT05491694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25352553|NCT05491694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25352554|NCT05491694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25352555|NCT05491694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25352556|NCT05491694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352557|NCT05491616|Nivolumab|nivolumab|mesh-list
25352558|NCT05491616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25352559|NCT05491616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352560|NCT05491616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25352561|NCT05491616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352562|NCT05491512|Cisplatin|cisplatin|mesh-list
25352563|NCT05491512|Carboplatin|carboplatin|mesh-list
25352564|NCT05491512|Fluorouracil|fluorouracil|mesh-list
25352565|NCT05491512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352566|NCT05491512|Antimetabolites|antimetabolites|mesh-ancestor
25352567|NCT05491512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352568|NCT05491512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25352569|NCT05491512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25352570|NCT05491512|Immunologic Factors|immunologic factors|mesh-ancestor
25352571|NCT05491512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352572|NCT05491460|Rivaroxaban|rivaroxaban|mesh-list
25352573|NCT05491460|Apixaban|apixaban|mesh-list
25352574|NCT05491460|Edoxaban|edoxaban|mesh-list
25352575|NCT05491460|Dabigatran|dabigatran|mesh-list
25352576|NCT05491460|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25352577|NCT05491460|Antithrombins|antithrombins|mesh-ancestor
25352578|NCT05491460|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25352579|NCT05491460|Protease Inhibitors|protease inhibitors|mesh-ancestor
25352580|NCT05491460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352581|NCT05491460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352582|NCT05491460|Anticoagulants|anticoagulants|mesh-ancestor
25352583|NCT05491356|Plasminogen|plasminogen|mesh-list
25352584|NCT05491356|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25352585|NCT05491356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25352586|NCT05491356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25352587|NCT05491356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352588|NCT05491343|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25352589|NCT05491343|Medroxyprogesterone|medroxyprogesterone|mesh-list
25352590|NCT05491343|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25352591|NCT05491343|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25352592|NCT05491343|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25352593|NCT05491343|Contraceptive Agents|contraceptive agents|mesh-ancestor
25352594|NCT05491343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25352595|NCT05491343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352596|NCT05491343|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25352597|NCT05491343|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25352598|NCT05491343|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25352599|NCT05491343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25352600|NCT05491343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352601|NCT05491330|Ritonavir|ritonavir|mesh-list
25352602|NCT05491330|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25352603|NCT05491330|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25352604|NCT05491330|Protease Inhibitors|protease inhibitors|mesh-ancestor
25352605|NCT05491330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352606|NCT05491330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352607|NCT05491330|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25352608|NCT05491330|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25352609|NCT05491330|Antiviral Agents|antiviral agents|mesh-ancestor
25352610|NCT05491330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25352611|NCT05491330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25352612|NCT05491330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25352613|NCT05491317|Pembrolizumab|pembrolizumab|mesh-list
25352614|NCT05491317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25352615|NCT05491317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352616|NCT05491304|Dexamethasone|dexamethasone|mesh-list
25352617|NCT05491304|Etoposide|etoposide|mesh-list
25352618|NCT05491304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25352619|NCT05491304|Antiemetics|antiemetics|mesh-ancestor
25352621|NCT05491304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25352622|NCT05491304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352623|NCT05491304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25352624|NCT05491304|Glucocorticoids|glucocorticoids|mesh-ancestor
25352625|NCT05491304|Hormones|hormones|mesh-ancestor
25352626|NCT05491304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25352627|NCT05491304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25352628|NCT05491304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352629|NCT05491304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25352630|NCT05491304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25352631|NCT05491304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25352632|NCT05491304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352633|NCT05491304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352634|NCT05491278|Remifentanil|remifentanil|mesh-list
25352635|NCT05491278|Propofol|propofol|mesh-list
25352636|NCT05491278|Fospropofol|fospropofol|mesh-list
25352637|NCT05491278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25352638|NCT05491278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25352639|NCT05491278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352640|NCT05491278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25352641|NCT05491278|Anesthetics, General|anesthetics, general|mesh-ancestor
25352642|NCT05491278|Anesthetics|anesthetics|mesh-ancestor
25352643|NCT05491278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25352644|NCT05491278|Narcotics|narcotics|mesh-ancestor
25352645|NCT05491278|Analgesics|analgesics|mesh-ancestor
25352646|NCT05491278|Sensory System Agents|sensory system agents|mesh-ancestor
25352647|NCT05491278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25352648|NCT05491226|Pembrolizumab|pembrolizumab|mesh-list
25352649|NCT05491226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25352650|NCT05491226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352651|NCT05491200|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
25352652|NCT05491200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25352653|NCT05491187|Fentanyl|fentanyl|mesh-list
25352654|NCT05491187|Bupivacaine|bupivacaine|mesh-list
25352655|NCT05491187|Anesthetics, Local|anesthetics, local|mesh-ancestor
25352656|NCT05491187|Anesthetics|anesthetics|mesh-ancestor
25352657|NCT05491187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25352658|NCT05491187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352659|NCT05491187|Sensory System Agents|sensory system agents|mesh-ancestor
25352660|NCT05491187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25352661|NCT05491187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25352662|NCT05491187|Narcotics|narcotics|mesh-ancestor
25352663|NCT05491187|Analgesics|analgesics|mesh-ancestor
25352664|NCT05491187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25352665|NCT05491187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25352666|NCT05491187|Anesthetics, General|anesthetics, general|mesh-ancestor
25352667|NCT05491083|Pembrolizumab|pembrolizumab|mesh-list
25352668|NCT05491083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25352669|NCT05491083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352670|NCT05490953|Pentoxifylline|pentoxifylline|mesh-list
25352671|NCT05490953|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25352672|NCT05490953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352673|NCT05490953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352674|NCT05490953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25352675|NCT05490953|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25352676|NCT05490953|Protective Agents|protective agents|mesh-ancestor
25352677|NCT05490953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352678|NCT05490953|Vasodilator Agents|vasodilator agents|mesh-ancestor
25352679|NCT05490953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25352680|NCT05490953|Antioxidants|antioxidants|mesh-ancestor
25352681|NCT05490940|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25352682|NCT05490940|Hemostatics|hemostatics|mesh-ancestor
25352683|NCT05490940|Coagulants|coagulants|mesh-ancestor
25352684|NCT05490888|Terlipressin|terlipressin|mesh-list
25352685|NCT05490888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25352686|NCT05490888|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25352687|NCT05490836|Interferon-alpha|interferon-alpha|mesh-list
25352688|NCT05490836|Interferon alpha-2|interferon alpha-2|mesh-list
25352689|NCT05490836|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
25352690|NCT05490836|Antiviral Agents|antiviral agents|mesh-ancestor
25352691|NCT05490836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25352692|NCT05490836|Immunologic Factors|immunologic factors|mesh-ancestor
25352693|NCT05490836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352694|NCT05490836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352695|NCT05490719|Cisplatin|cisplatin|mesh-list
25352696|NCT05490719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352697|NCT05490680|Sildenafil Citrate|sildenafil citrate|mesh-list
25352698|NCT05490680|Vasodilator Agents|vasodilator agents|mesh-ancestor
25352699|NCT05490680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25352700|NCT05490680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25352701|NCT05490680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352702|NCT05490680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352703|NCT05490680|Urological Agents|urological agents|mesh-ancestor
25352704|NCT05490511|Cannabidiol|cannabidiol|mesh-list
25352705|NCT05490511|Tacrolimus|tacrolimus|mesh-list
25352706|NCT05490511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25352707|NCT05490511|Immunologic Factors|immunologic factors|mesh-ancestor
25352708|NCT05490511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352709|NCT05490511|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25352710|NCT05490511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352711|NCT05490511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352712|NCT05490511|Anticonvulsants|anticonvulsants|mesh-ancestor
25352713|NCT05490485|Cisplatin|cisplatin|mesh-list
25352714|NCT05490485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352715|NCT05490407|Carboplatin|carboplatin|mesh-list
25352716|NCT05490407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352717|NCT05490381|Ethiodized Oil|ethiodized oil|mesh-list
25352718|NCT05490381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352719|NCT05490342|Antibodies|antibodies|mesh-list
25352720|NCT05490342|Myeloma Proteins|myeloma proteins|mesh-list
25352721|NCT05490342|Paraproteins|paraproteins|mesh-list
25352722|NCT05490342|Immunologic Factors|immunologic factors|mesh-ancestor
25352723|NCT05490342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352724|NCT05490160|Tranexamic Acid|tranexamic acid|mesh-list
25352725|NCT05490160|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25352726|NCT05490160|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25352727|NCT05490160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352728|NCT05490160|Hemostatics|hemostatics|mesh-ancestor
25352729|NCT05490160|Coagulants|coagulants|mesh-ancestor
25352730|NCT05490134|Naloxone|naloxone|mesh-list
25352731|NCT05490134|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25352732|NCT05490134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352733|NCT05490134|Sensory System Agents|sensory system agents|mesh-ancestor
25352734|NCT05490134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25352735|NCT05490095|Everolimus|everolimus|mesh-list
25352736|NCT05490095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352737|NCT05490095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25352738|NCT05490095|Immunologic Factors|immunologic factors|mesh-ancestor
25352739|NCT05490095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352740|NCT05490082|Solifenacin Succinate|solifenacin succinate|mesh-list
25352741|NCT05490082|Mirabegron|mirabegron|mesh-list
25352742|NCT05490082|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25352743|NCT05490082|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25352744|NCT05490082|Cholinergic Agents|cholinergic agents|mesh-ancestor
25352745|NCT05490082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25352746|NCT05490082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352747|NCT05490082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352748|NCT05490082|Urological Agents|urological agents|mesh-ancestor
25352749|NCT05490082|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25352750|NCT05490082|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25352751|NCT05490082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25352752|NCT05490082|Adrenergic Agents|adrenergic agents|mesh-ancestor
25352754|NCT05489952|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25352755|NCT05489952|Trace Elements|trace elements|mesh-ancestor
25352756|NCT05489952|Micronutrients|micronutrients|mesh-ancestor
25352757|NCT05489952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352758|NCT05489952|Hematinics|hematinics|mesh-ancestor
25352759|NCT05489939|Salicylates|salicylates|mesh-list
25352760|NCT05489939|Methyl salicylate|methyl salicylate|mesh-list
25352761|NCT05489939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25352762|NCT05489939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25352763|NCT05489939|Analgesics|analgesics|mesh-ancestor
25352764|NCT05489939|Sensory System Agents|sensory system agents|mesh-ancestor
25352765|NCT05489939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25352766|NCT05489939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352767|NCT05489939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25352768|NCT05489939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25352769|NCT05489939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25352770|NCT05489939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352771|NCT05489939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352772|NCT05489900|Dexmedetomidine|dexmedetomidine|mesh-list
25352773|NCT05489900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25352774|NCT05489900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25352929|NCT05488925|Protective Agents|protective agents|mesh-ancestor
25352775|NCT05489900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352776|NCT05489900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25352777|NCT05489900|Analgesics|analgesics|mesh-ancestor
25352778|NCT05489900|Sensory System Agents|sensory system agents|mesh-ancestor
25352779|NCT05489900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25352780|NCT05489900|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25352781|NCT05489900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25352782|NCT05489900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25352783|NCT05489900|Adrenergic Agents|adrenergic agents|mesh-ancestor
25352784|NCT05489900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25352785|NCT05489900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352786|NCT05489887|Ceritinib|ceritinib|mesh-list
25352787|NCT05489887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352788|NCT05489887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25352789|NCT05489887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352790|NCT05489887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352791|NCT05489848|Paclitaxel|paclitaxel|mesh-list
25352792|NCT05489848|Cisplatin|cisplatin|mesh-list
25352793|NCT05489848|Carboplatin|carboplatin|mesh-list
25352794|NCT05489848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25352795|NCT05489848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352796|NCT05489848|Tubulin Modulators|tubulin modulators|mesh-ancestor
25352797|NCT05489848|Antimitotic Agents|antimitotic agents|mesh-ancestor
25352798|NCT05489848|Mitosis Modulators|mitosis modulators|mesh-ancestor
25352799|NCT05489848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352800|NCT05489796|Ketorolac|ketorolac|mesh-list
25352801|NCT05489796|Fentanyl|fentanyl|mesh-list
25352802|NCT05489796|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25352803|NCT05489796|Narcotics|narcotics|mesh-ancestor
25352804|NCT05489796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25352805|NCT05489796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352806|NCT05489796|Analgesics|analgesics|mesh-ancestor
25352807|NCT05489796|Sensory System Agents|sensory system agents|mesh-ancestor
25352808|NCT05489796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25352809|NCT05489796|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25352810|NCT05489796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25352811|NCT05489796|Anesthetics, General|anesthetics, general|mesh-ancestor
25352812|NCT05489796|Anesthetics|anesthetics|mesh-ancestor
25352813|NCT05489796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25352814|NCT05489796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25352815|NCT05489796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25352816|NCT05489796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25352817|NCT05489796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25352818|NCT05489796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352819|NCT05489796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352820|NCT05489731|Osimertinib|osimertinib|mesh-list
25352821|NCT05489731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352822|NCT05489731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25352823|NCT05489731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352824|NCT05489731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352825|NCT05489692|Leucovorin|leucovorin|mesh-list
25352826|NCT05489692|Fluorouracil|fluorouracil|mesh-list
25352827|NCT05489692|Oxaliplatin|oxaliplatin|mesh-list
25352828|NCT05489692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25352829|NCT05489692|Antimetabolites|antimetabolites|mesh-ancestor
25352830|NCT05489692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352831|NCT05489692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25352832|NCT05489692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352833|NCT05489692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25352834|NCT05489692|Immunologic Factors|immunologic factors|mesh-ancestor
25352835|NCT05489692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352836|NCT05489692|Antidotes|antidotes|mesh-ancestor
25352837|NCT05489692|Protective Agents|protective agents|mesh-ancestor
25352838|NCT05489692|Vitamin B Complex|vitamin b complex|mesh-ancestor
25352839|NCT05489692|Vitamins|vitamins|mesh-ancestor
25352840|NCT05489692|Micronutrients|micronutrients|mesh-ancestor
25352841|NCT05489666|Vitamin D|vitamin d|mesh-list
25352842|NCT05489666|Cholecalciferol|cholecalciferol|mesh-list
25352843|NCT05489666|Vitamins|vitamins|mesh-ancestor
25352844|NCT05489666|Micronutrients|micronutrients|mesh-ancestor
25352845|NCT05489666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352846|NCT05489666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25352847|NCT05489666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25352848|NCT05489601|Oxycodone|oxycodone|mesh-list
25352849|NCT05489601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25352850|NCT05489601|Narcotics|narcotics|mesh-ancestor
25352931|NCT05488899|Cadexomer iodine|cadexomer iodine|mesh-list
25352851|NCT05489601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25352852|NCT05489601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352853|NCT05489601|Analgesics|analgesics|mesh-ancestor
25352854|NCT05489601|Sensory System Agents|sensory system agents|mesh-ancestor
25352855|NCT05489601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25352856|NCT05489406|Dolutegravir|dolutegravir|mesh-list
25352857|NCT05489406|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25352858|NCT05489406|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25352859|NCT05489406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352860|NCT05489406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352861|NCT05489406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25352862|NCT05489406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25352863|NCT05489406|Antiviral Agents|antiviral agents|mesh-ancestor
25352864|NCT05489406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25352865|NCT05489211|Leucovorin|leucovorin|mesh-list
25352866|NCT05489211|Bevacizumab|bevacizumab|mesh-list
25352867|NCT05489211|Nivolumab|nivolumab|mesh-list
25352868|NCT05489211|Durvalumab|durvalumab|mesh-list
25352869|NCT05489211|Carboplatin|carboplatin|mesh-list
25352870|NCT05489211|Fluorouracil|fluorouracil|mesh-list
25352871|NCT05489211|Capecitabine|capecitabine|mesh-list
25352872|NCT05489211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25352873|NCT05489211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352874|NCT05489211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25352875|NCT05489211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25352876|NCT05489211|Growth Substances|growth substances|mesh-ancestor
25352877|NCT05489211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352878|NCT05489211|Growth Inhibitors|growth inhibitors|mesh-ancestor
25352879|NCT05489211|Antimetabolites|antimetabolites|mesh-ancestor
25352880|NCT05489211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352881|NCT05489211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25352882|NCT05489211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25352883|NCT05489211|Immunologic Factors|immunologic factors|mesh-ancestor
25352884|NCT05489211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25352885|NCT05489211|Antidotes|antidotes|mesh-ancestor
25352886|NCT05489211|Protective Agents|protective agents|mesh-ancestor
25352887|NCT05489211|Vitamin B Complex|vitamin b complex|mesh-ancestor
25352888|NCT05489211|Vitamins|vitamins|mesh-ancestor
25352889|NCT05489211|Micronutrients|micronutrients|mesh-ancestor
25352890|NCT05489185|Tranexamic Acid|tranexamic acid|mesh-list
25352891|NCT05489185|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25352892|NCT05489185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25352893|NCT05489185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352894|NCT05489185|Hemostatics|hemostatics|mesh-ancestor
25352895|NCT05489185|Coagulants|coagulants|mesh-ancestor
25352896|NCT05488990|Calcitriol|calcitriol|mesh-list
25352897|NCT05488990|Calcipotriene|calcipotriene|mesh-list
25352898|NCT05488990|Dermatologic Agents|dermatologic agents|mesh-ancestor
25352899|NCT05488990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25352900|NCT05488990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352901|NCT05488990|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25352902|NCT05488990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25352903|NCT05488990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352904|NCT05488990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25352905|NCT05488990|Vitamins|vitamins|mesh-ancestor
25352906|NCT05488990|Micronutrients|micronutrients|mesh-ancestor
25352907|NCT05488990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25352908|NCT05488925|Vitamin E|vitamin e|mesh-list
25352909|NCT05488925|Diclofenac|diclofenac|mesh-list
25352910|NCT05488925|Piroxicam|piroxicam|mesh-list
25352911|NCT05488925|Tramadol|tramadol|mesh-list
25352912|NCT05488925|Vitamins|vitamins|mesh-ancestor
25352913|NCT05488925|Micronutrients|micronutrients|mesh-ancestor
25352914|NCT05488925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352915|NCT05488925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25352916|NCT05488925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25352917|NCT05488925|Analgesics|analgesics|mesh-ancestor
25352918|NCT05488925|Sensory System Agents|sensory system agents|mesh-ancestor
25352919|NCT05488925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25352920|NCT05488925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25352921|NCT05488925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25352922|NCT05488925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25352923|NCT05488925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352924|NCT05488925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352925|NCT05488925|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25352927|NCT05488925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25352928|NCT05488925|Antioxidants|antioxidants|mesh-ancestor
25352932|NCT05488899|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25352933|NCT05488899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25352934|NCT05488899|Trace Elements|trace elements|mesh-ancestor
25352935|NCT05488899|Micronutrients|micronutrients|mesh-ancestor
25352936|NCT05488899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352937|NCT05488860|Triamcinolone|triamcinolone|mesh-list
25352938|NCT05488860|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25352939|NCT05488860|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25352940|NCT05488860|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25352941|NCT05488860|Photosensitizing Agents|photosensitizing agents|mesh-list
25352942|NCT05488860|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25352943|NCT05488860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25352944|NCT05488860|Glucocorticoids|glucocorticoids|mesh-ancestor
25352945|NCT05488860|Hormones|hormones|mesh-ancestor
25352946|NCT05488860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25352947|NCT05488860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352948|NCT05488860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25352949|NCT05488860|Immunologic Factors|immunologic factors|mesh-ancestor
25352950|NCT05488860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352951|NCT05488860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352952|NCT05488860|Dermatologic Agents|dermatologic agents|mesh-ancestor
25352953|NCT05488847|Acetaminophen|acetaminophen|mesh-list
25352954|NCT05488847|Dexamethasone|dexamethasone|mesh-list
25352955|NCT05488847|Ibuprofen|ibuprofen|mesh-list
25352956|NCT05488847|Celecoxib|celecoxib|mesh-list
25352957|NCT05488847|Ketorolac|ketorolac|mesh-list
25352958|NCT05488847|Pregabalin|pregabalin|mesh-list
25352959|NCT05488847|Epinephrine|epinephrine|mesh-list
25352960|NCT05488847|Oxycodone|oxycodone|mesh-list
25352961|NCT05488847|Tramadol|tramadol|mesh-list
25352962|NCT05488847|Tizanidine|tizanidine|mesh-list
25352963|NCT05488847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25352964|NCT05488847|Antiemetics|antiemetics|mesh-ancestor
25352965|NCT05488847|Autonomic Agents|autonomic agents|mesh-ancestor
25352966|NCT05488847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25352967|NCT05488847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25352968|NCT05488847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25352969|NCT05488847|Glucocorticoids|glucocorticoids|mesh-ancestor
25352970|NCT05488847|Hormones|hormones|mesh-ancestor
25352971|NCT05488847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25352972|NCT05488847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25352973|NCT05488847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25352974|NCT05488847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25352975|NCT05488847|Analgesics|analgesics|mesh-ancestor
25352976|NCT05488847|Sensory System Agents|sensory system agents|mesh-ancestor
25352977|NCT05488847|Antipyretics|antipyretics|mesh-ancestor
25352978|NCT05488847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25352979|NCT05488847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25352980|NCT05488847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25352981|NCT05488847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25352982|NCT05488847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25352983|NCT05488847|Anticonvulsants|anticonvulsants|mesh-ancestor
25352984|NCT05488847|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25352985|NCT05488847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25352986|NCT05488847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25352987|NCT05488847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25352988|NCT05488847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25352989|NCT05488847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25352990|NCT05488847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25352991|NCT05488847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25352992|NCT05488847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25352993|NCT05488847|Adrenergic Agents|adrenergic agents|mesh-ancestor
25352994|NCT05488847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25352995|NCT05488847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25352996|NCT05488847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25352997|NCT05488847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25352998|NCT05488847|Respiratory System Agents|respiratory system agents|mesh-ancestor
25352999|NCT05488847|Mydriatics|mydriatics|mesh-ancestor
25353000|NCT05488847|Sympathomimetics|sympathomimetics|mesh-ancestor
25353001|NCT05488847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25353002|NCT05488847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25353003|NCT05488847|Narcotics|narcotics|mesh-ancestor
25353004|NCT05488847|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25353005|NCT05488847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25353006|NCT05488847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25353007|NCT05488847|Parasympatholytics|parasympatholytics|mesh-ancestor
25353008|NCT05488847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25353310|NCT05487235|Omeprazole|omeprazole|mesh-list
25353010|NCT05488678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25353011|NCT05488678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25353012|NCT05488613|Midostaurin|midostaurin|mesh-list
25353013|NCT05488613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353014|NCT05488613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25353015|NCT05488613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353016|NCT05488613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353017|NCT05488522|Bevacizumab|bevacizumab|mesh-list
25353018|NCT05488522|Atezolizumab|atezolizumab|mesh-list
25353019|NCT05488522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25353020|NCT05488522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353021|NCT05488522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25353022|NCT05488522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25353023|NCT05488522|Growth Substances|growth substances|mesh-ancestor
25353024|NCT05488522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353025|NCT05488522|Growth Inhibitors|growth inhibitors|mesh-ancestor
25353026|NCT05488457|Oxytocin|oxytocin|mesh-list
25353027|NCT05488457|Oxytocics|oxytocics|mesh-ancestor
25353028|NCT05488457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25353029|NCT05488457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353030|NCT05488431|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
25353031|NCT05488431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25353032|NCT05488431|Antimetabolites|antimetabolites|mesh-ancestor
25353033|NCT05488431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353034|NCT05488431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25353035|NCT05488431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353036|NCT05488431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25353037|NCT05488431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353038|NCT05488405|Mesalamine|mesalamine|mesh-list
25353039|NCT05488405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25353040|NCT05488405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25353041|NCT05488405|Analgesics|analgesics|mesh-ancestor
25353042|NCT05488405|Sensory System Agents|sensory system agents|mesh-ancestor
25353043|NCT05488405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25353044|NCT05488405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353045|NCT05488405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25353046|NCT05488405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25353047|NCT05488366|Pembrolizumab|pembrolizumab|mesh-list
25353048|NCT05488366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25353049|NCT05488366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353050|NCT05488340|Calcium Carbonate|calcium carbonate|mesh-list
25353051|NCT05488340|Calcium|calcium|mesh-list
25353052|NCT05488340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25353053|NCT05488340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353054|NCT05488340|Antacids|antacids|mesh-ancestor
25353129|NCT05487807|Nicotine|nicotine|mesh-list
25353055|NCT05488340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353056|NCT05488340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25353057|NCT05488327|Lenalidomide|lenalidomide|mesh-list
25353058|NCT05488327|Immunologic Factors|immunologic factors|mesh-ancestor
25353059|NCT05488327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353060|NCT05488327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25353061|NCT05488327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25353062|NCT05488327|Growth Substances|growth substances|mesh-ancestor
25353063|NCT05488327|Growth Inhibitors|growth inhibitors|mesh-ancestor
25353064|NCT05488327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353065|NCT05488314|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
25353066|NCT05488314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25353067|NCT05488314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353068|NCT05488171|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25353069|NCT05488171|Hallucinogens|hallucinogens|mesh-ancestor
25353070|NCT05488171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353071|NCT05488171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25353072|NCT05488171|Serotonin Agents|serotonin agents|mesh-ancestor
25353073|NCT05488171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25353074|NCT05488171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353075|NCT05488171|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25353076|NCT05488171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25353077|NCT05488171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25353078|NCT05488171|Adrenergic Agents|adrenergic agents|mesh-ancestor
25353079|NCT05488106|Riboflavin|riboflavin|mesh-list
25353080|NCT05488106|Vitamin B Complex|vitamin b complex|mesh-ancestor
25353081|NCT05488106|Vitamins|vitamins|mesh-ancestor
25353082|NCT05488106|Micronutrients|micronutrients|mesh-ancestor
25353083|NCT05488106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353084|NCT05488106|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25353085|NCT05488106|Dermatologic Agents|dermatologic agents|mesh-ancestor
25353086|NCT05488067|Atorvastatin|atorvastatin|mesh-list
25353087|NCT05488067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25353088|NCT05488067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25353089|NCT05488067|Antimetabolites|antimetabolites|mesh-ancestor
25353090|NCT05488067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353091|NCT05488067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25353092|NCT05488067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25353093|NCT05488067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353094|NCT05487963|Tofacitinib|tofacitinib|mesh-list
25353095|NCT05487963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353096|NCT05487963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25353097|NCT05487963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353098|NCT05487950|Rivaroxaban|rivaroxaban|mesh-list
25353099|NCT05487950|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25353100|NCT05487950|Antithrombins|antithrombins|mesh-ancestor
25353101|NCT05487950|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25353102|NCT05487950|Protease Inhibitors|protease inhibitors|mesh-ancestor
25353103|NCT05487950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353104|NCT05487950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353105|NCT05487950|Anticoagulants|anticoagulants|mesh-ancestor
25353106|NCT05487885|Ketamine|ketamine|mesh-list
25353107|NCT05487885|Analgesics|analgesics|mesh-ancestor
25353108|NCT05487885|Sensory System Agents|sensory system agents|mesh-ancestor
25353109|NCT05487885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25353110|NCT05487885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353111|NCT05487885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25353112|NCT05487885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25353113|NCT05487885|Anesthetics, General|anesthetics, general|mesh-ancestor
25353114|NCT05487885|Anesthetics|anesthetics|mesh-ancestor
25353115|NCT05487885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25353116|NCT05487885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25353117|NCT05487885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25353118|NCT05487885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25353119|NCT05487885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353120|NCT05487859|Acarbose|acarbose|mesh-list
25353121|NCT05487859|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25353122|NCT05487859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353123|NCT05487859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353124|NCT05487859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25353125|NCT05487859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353126|NCT05487833|Insulin|insulin|mesh-list
25353127|NCT05487833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25353128|NCT05487833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353130|NCT05487807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25353131|NCT05487807|Autonomic Agents|autonomic agents|mesh-ancestor
25353132|NCT05487807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25353133|NCT05487807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353134|NCT05487807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25353135|NCT05487807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25353136|NCT05487807|Cholinergic Agents|cholinergic agents|mesh-ancestor
25353137|NCT05487807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25353138|NCT05487807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353139|NCT05487794|Methyltestosterone|methyltestosterone|mesh-list
25353140|NCT05487794|Testosterone|testosterone|mesh-list
25353141|NCT05487794|Testosterone undecanoate|testosterone undecanoate|mesh-list
25353142|NCT05487794|Testosterone enanthate|testosterone enanthate|mesh-list
25353143|NCT05487794|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25353144|NCT05487794|Androgens|androgens|mesh-ancestor
25353145|NCT05487794|Hormones|hormones|mesh-ancestor
25353146|NCT05487794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25353147|NCT05487794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353148|NCT05487794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25353149|NCT05487794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353150|NCT05487794|Anabolic Agents|anabolic agents|mesh-ancestor
25353151|NCT05487755|Tadalafil|tadalafil|mesh-list
25353152|NCT05487755|Pentoxifylline|pentoxifylline|mesh-list
25353153|NCT05487755|Vasodilator Agents|vasodilator agents|mesh-ancestor
25353154|NCT05487755|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25353155|NCT05487755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25353156|NCT05487755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353157|NCT05487755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353158|NCT05487755|Urological Agents|urological agents|mesh-ancestor
25353159|NCT05487755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25353160|NCT05487755|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25353161|NCT05487755|Protective Agents|protective agents|mesh-ancestor
25353162|NCT05487755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353163|NCT05487755|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25353164|NCT05487755|Antioxidants|antioxidants|mesh-ancestor
25353165|NCT05487742|Dexmedetomidine|dexmedetomidine|mesh-list
25353166|NCT05487742|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25353167|NCT05487742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25353168|NCT05487742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353169|NCT05487742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25353170|NCT05487742|Analgesics|analgesics|mesh-ancestor
25353171|NCT05487742|Sensory System Agents|sensory system agents|mesh-ancestor
25353172|NCT05487742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25353173|NCT05487742|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25353174|NCT05487742|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25353175|NCT05487742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25353176|NCT05487742|Adrenergic Agents|adrenergic agents|mesh-ancestor
25353177|NCT05487742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25353178|NCT05487742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353180|NCT05487599|Prednisone|prednisone|mesh-list
25353181|NCT05487599|Methylprednisolone|methylprednisolone|mesh-list
25353182|NCT05487599|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25353183|NCT05487599|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25353184|NCT05487599|Prednisolone|prednisolone|mesh-list
25353185|NCT05487599|Prednisolone acetate|prednisolone acetate|mesh-list
25353186|NCT05487599|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25353187|NCT05487599|Prednisolone phosphate|prednisolone phosphate|mesh-list
25353188|NCT05487599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25353189|NCT05487599|Glucocorticoids|glucocorticoids|mesh-ancestor
25353190|NCT05487599|Hormones|hormones|mesh-ancestor
25353191|NCT05487599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25353192|NCT05487599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353193|NCT05487599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25353194|NCT05487599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353195|NCT05487599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25353196|NCT05487599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25353197|NCT05487599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25353198|NCT05487599|Antifungal Agents|antifungal agents|mesh-ancestor
25353199|NCT05487599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25353200|NCT05487599|Immunologic Factors|immunologic factors|mesh-ancestor
25353201|NCT05487599|Antiemetics|antiemetics|mesh-ancestor
25353202|NCT05487599|Autonomic Agents|autonomic agents|mesh-ancestor
25353203|NCT05487599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25353204|NCT05487599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25353205|NCT05487599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25353206|NCT05487599|Protective Agents|protective agents|mesh-ancestor
25353207|NCT05487586|Ceftazidime|ceftazidime|mesh-list
25353208|NCT05487586|Avibactam|avibactam|mesh-list
25353209|NCT05487586|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
25353210|NCT05487586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25353211|NCT05487586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25353212|NCT05487586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25353213|NCT05487586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353214|NCT05487586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353215|NCT05487521|Methylprednisolone|methylprednisolone|mesh-list
25353216|NCT05487521|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25353217|NCT05487521|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25353218|NCT05487521|Prednisolone|prednisolone|mesh-list
25353219|NCT05487521|Prednisolone acetate|prednisolone acetate|mesh-list
25353220|NCT05487521|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25353221|NCT05487521|Prednisolone phosphate|prednisolone phosphate|mesh-list
25353222|NCT05487521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25353223|NCT05487521|Antiemetics|antiemetics|mesh-ancestor
25353224|NCT05487521|Autonomic Agents|autonomic agents|mesh-ancestor
25353225|NCT05487521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25353226|NCT05487521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353227|NCT05487521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25353228|NCT05487521|Glucocorticoids|glucocorticoids|mesh-ancestor
25353229|NCT05487521|Hormones|hormones|mesh-ancestor
25353230|NCT05487521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25353231|NCT05487521|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25353232|NCT05487521|Protective Agents|protective agents|mesh-ancestor
25353233|NCT05487521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25353234|NCT05487521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353235|NCT05487508|Dexamethasone|dexamethasone|mesh-list
25353236|NCT05487508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25353237|NCT05487508|Antiemetics|antiemetics|mesh-ancestor
25353238|NCT05487508|Autonomic Agents|autonomic agents|mesh-ancestor
25353239|NCT05487508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25353240|NCT05487508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353241|NCT05487508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25353242|NCT05487508|Glucocorticoids|glucocorticoids|mesh-ancestor
25353243|NCT05487508|Hormones|hormones|mesh-ancestor
25353244|NCT05487508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25353245|NCT05487508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25353246|NCT05487508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353247|NCT05487469|Thymalfasin|thymalfasin|mesh-list
25353248|NCT05487469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25353249|NCT05487469|Immunologic Factors|immunologic factors|mesh-ancestor
25353250|NCT05487469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353251|NCT05487456|Menthol|menthol|mesh-list
25353252|NCT05487456|Nicotine|nicotine|mesh-list
25353253|NCT05487456|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25353254|NCT05487456|Autonomic Agents|autonomic agents|mesh-ancestor
25353255|NCT05487456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25353256|NCT05487456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353257|NCT05487456|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25353258|NCT05487456|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25353259|NCT05487456|Cholinergic Agents|cholinergic agents|mesh-ancestor
25353260|NCT05487456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25353261|NCT05487456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353262|NCT05487456|Antipruritics|antipruritics|mesh-ancestor
25353263|NCT05487456|Dermatologic Agents|dermatologic agents|mesh-ancestor
25353264|NCT05487443|Gemcitabine|gemcitabine|mesh-list
25353265|NCT05487443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25353266|NCT05487443|Antimetabolites|antimetabolites|mesh-ancestor
25353267|NCT05487443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353268|NCT05487443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353269|NCT05487443|Antiviral Agents|antiviral agents|mesh-ancestor
25353270|NCT05487443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25353271|NCT05487443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353272|NCT05487443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25353273|NCT05487443|Immunologic Factors|immunologic factors|mesh-ancestor
25353274|NCT05487443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353275|NCT05487417|Minocycline|minocycline|mesh-list
25353276|NCT05487417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25353277|NCT05487417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25353278|NCT05487391|Paclitaxel|paclitaxel|mesh-list
25353279|NCT05487391|Vinorelbine|vinorelbine|mesh-list
25353280|NCT05487391|Cisplatin|cisplatin|mesh-list
25353281|NCT05487391|Carboplatin|carboplatin|mesh-list
25353282|NCT05487391|Pemetrexed|pemetrexed|mesh-list
25353283|NCT05487391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25353284|NCT05487391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353285|NCT05487391|Tubulin Modulators|tubulin modulators|mesh-ancestor
25353286|NCT05487391|Antimitotic Agents|antimitotic agents|mesh-ancestor
25353287|NCT05487391|Mitosis Modulators|mitosis modulators|mesh-ancestor
25353288|NCT05487391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353289|NCT05487391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353290|NCT05487391|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25353291|NCT05487391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25353292|NCT05487300|Levodopa|levodopa|mesh-list
25353293|NCT05487300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25353294|NCT05487300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25353295|NCT05487300|Dopamine Agents|dopamine agents|mesh-ancestor
25353296|NCT05487300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25353297|NCT05487300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353298|NCT05487300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353299|NCT05487261|Valsartan|valsartan|mesh-list
25353300|NCT05487261|Enalapril|enalapril|mesh-list
25353301|NCT05487261|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25353302|NCT05487261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25353303|NCT05487261|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25353304|NCT05487261|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25353305|NCT05487261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353306|NCT05487261|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25353307|NCT05487261|Protease Inhibitors|protease inhibitors|mesh-ancestor
25353308|NCT05487261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353311|NCT05487235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353312|NCT05487235|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25353313|NCT05487235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25353314|NCT05487235|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25353315|NCT05487235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353316|NCT05487235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353318|NCT05487196|Fentanyl|fentanyl|mesh-list
25353319|NCT05487196|Dexmedetomidine|dexmedetomidine|mesh-list
25353320|NCT05487196|Ropivacaine|ropivacaine|mesh-list
25353321|NCT05487196|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25353322|NCT05487196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25353323|NCT05487196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353324|NCT05487196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25353325|NCT05487196|Analgesics|analgesics|mesh-ancestor
25353326|NCT05487196|Sensory System Agents|sensory system agents|mesh-ancestor
25353327|NCT05487196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25353328|NCT05487196|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25353329|NCT05487196|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25353330|NCT05487196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25353331|NCT05487196|Adrenergic Agents|adrenergic agents|mesh-ancestor
25353332|NCT05487196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25353333|NCT05487196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353334|NCT05487196|Anesthetics, Local|anesthetics, local|mesh-ancestor
25353335|NCT05487196|Anesthetics|anesthetics|mesh-ancestor
25353336|NCT05487196|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25353337|NCT05487196|Narcotics|narcotics|mesh-ancestor
25353338|NCT05487196|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25353339|NCT05487196|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25353340|NCT05487196|Anesthetics, General|anesthetics, general|mesh-ancestor
25353341|NCT05487196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25353342|NCT05487196|Sympatholytics|sympatholytics|mesh-ancestor
25353343|NCT05487196|Autonomic Agents|autonomic agents|mesh-ancestor
25353344|NCT05487092|Letrozole|letrozole|mesh-list
25353345|NCT05487092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353346|NCT05487092|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25353347|NCT05487092|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25353348|NCT05487092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353349|NCT05487092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353350|NCT05487092|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25353351|NCT05487092|Hormone Antagonists|hormone antagonists|mesh-ancestor
25353352|NCT05487092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25353353|NCT05487092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353354|NCT05487040|Ritonavir|ritonavir|mesh-list
25353355|NCT05487040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25353356|NCT05487040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25353357|NCT05487040|Protease Inhibitors|protease inhibitors|mesh-ancestor
25353358|NCT05487040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353359|NCT05487040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353360|NCT05487040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25353361|NCT05487040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25353362|NCT05487040|Antiviral Agents|antiviral agents|mesh-ancestor
25353363|NCT05487040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25353364|NCT05487040|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25353365|NCT05487040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25353366|NCT05487001|Dexamethasone|dexamethasone|mesh-list
25353367|NCT05487001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25353368|NCT05487001|Antiemetics|antiemetics|mesh-ancestor
25353369|NCT05487001|Autonomic Agents|autonomic agents|mesh-ancestor
25353370|NCT05487001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25353371|NCT05487001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353372|NCT05487001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25353373|NCT05487001|Glucocorticoids|glucocorticoids|mesh-ancestor
25353374|NCT05487001|Hormones|hormones|mesh-ancestor
25353375|NCT05487001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25353376|NCT05487001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25353377|NCT05487001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353378|NCT05486988|Antineoplastic Agents|antineoplastic agents|mesh-list
25353379|NCT05486949|Itraconazole|itraconazole|mesh-list
25353380|NCT05486949|Carbamazepine|carbamazepine|mesh-list
25353381|NCT05486949|Antifungal Agents|antifungal agents|mesh-ancestor
25353382|NCT05486949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25353383|NCT05486949|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25353384|NCT05486949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25353385|NCT05486949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353386|NCT05486949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353387|NCT05486949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25353388|NCT05486949|Hormone Antagonists|hormone antagonists|mesh-ancestor
25353389|NCT05486949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25353390|NCT05486949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353391|NCT05486949|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25353392|NCT05486949|Anticonvulsants|anticonvulsants|mesh-ancestor
25353393|NCT05486949|Antimanic Agents|antimanic agents|mesh-ancestor
25353394|NCT05486949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25353395|NCT05486949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25353396|NCT05486949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25353397|NCT05486949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25353398|NCT05486949|Analgesics|analgesics|mesh-ancestor
25353399|NCT05486949|Sensory System Agents|sensory system agents|mesh-ancestor
25353400|NCT05486949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25353401|NCT05486949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25353402|NCT05486949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25353403|NCT05486949|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25353404|NCT05486949|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25353406|NCT05486884|Anesthetics, Local|anesthetics, local|mesh-ancestor
25353407|NCT05486884|Anesthetics|anesthetics|mesh-ancestor
25353408|NCT05486884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25353409|NCT05486884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353410|NCT05486884|Sensory System Agents|sensory system agents|mesh-ancestor
25353411|NCT05486884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25353412|NCT05486819|Propofol|propofol|mesh-list
25353413|NCT05486819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25353414|NCT05486819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25353415|NCT05486819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353416|NCT05486819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25353417|NCT05486819|Anesthetics, General|anesthetics, general|mesh-ancestor
25353418|NCT05486819|Anesthetics|anesthetics|mesh-ancestor
25353419|NCT05486650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25353420|NCT05486650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353421|NCT05486650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353422|NCT05486481|Dexamethasone|dexamethasone|mesh-list
25353423|NCT05486481|Venetoclax|venetoclax|mesh-list
25353424|NCT05486481|Daratumumab|daratumumab|mesh-list
25353425|NCT05486481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25353426|NCT05486481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25353427|NCT05486481|Antiemetics|antiemetics|mesh-ancestor
25353428|NCT05486481|Autonomic Agents|autonomic agents|mesh-ancestor
25353429|NCT05486481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25353430|NCT05486481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353431|NCT05486481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25353432|NCT05486481|Glucocorticoids|glucocorticoids|mesh-ancestor
25353433|NCT05486481|Hormones|hormones|mesh-ancestor
25353434|NCT05486481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25353435|NCT05486481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25353436|NCT05486481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353437|NCT05486481|Immunologic Factors|immunologic factors|mesh-ancestor
25353438|NCT05486416|Propofol|propofol|mesh-list
25353439|NCT05486416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25353440|NCT05486416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25353441|NCT05486416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353442|NCT05486416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25353443|NCT05486416|Anesthetics, General|anesthetics, general|mesh-ancestor
25353444|NCT05486416|Anesthetics|anesthetics|mesh-ancestor
25353445|NCT05486182|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
25353446|NCT05486182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353447|NCT05486104|Hemay005|hemay005|mesh-list
25353448|NCT05486104|Dermatologic Agents|dermatologic agents|mesh-ancestor
25353449|NCT05486104|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25353450|NCT05486104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25353451|NCT05486104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353452|NCT05486104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353453|NCT05486026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25353454|NCT05486026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
25353455|NCT05486026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25353456|NCT05486026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25353457|NCT05486026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25353458|NCT05486026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25353459|NCT05486026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353460|NCT05486026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25353461|NCT05486026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353462|NCT05486026|Analgesics|analgesics|mesh-ancestor
25353463|NCT05486026|Sensory System Agents|sensory system agents|mesh-ancestor
25353464|NCT05486026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25353465|NCT05486026|Antidepressive Agents|antidepressive agents|mesh-ancestor
25353466|NCT05486026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25353467|NCT05486026|Dopamine Agents|dopamine agents|mesh-ancestor
25353468|NCT05486026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25353469|NCT05486026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25353470|NCT05485896|Pembrolizumab|pembrolizumab|mesh-list
25353471|NCT05485896|Lenvatinib|lenvatinib|mesh-list
25353472|NCT05485896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25353473|NCT05485896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353474|NCT05485896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25353475|NCT05485896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353476|NCT05485896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353477|NCT05485883|Lenvatinib|lenvatinib|mesh-list
25353478|NCT05485883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353479|NCT05485883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25353480|NCT05485883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353481|NCT05485883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353482|NCT05485831|Cannabidiol|cannabidiol|mesh-list
25353483|NCT05485831|Anticonvulsants|anticonvulsants|mesh-ancestor
25353484|NCT05485805|Naproxen|naproxen|mesh-list
25353485|NCT05485805|Caffeine|caffeine|mesh-list
25353486|NCT05485805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25353487|NCT05485805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353488|NCT05485805|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25353489|NCT05485805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353490|NCT05485805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353491|NCT05485805|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25353492|NCT05485805|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25353493|NCT05485805|Purinergic Agents|purinergic agents|mesh-ancestor
25353494|NCT05485805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25353495|NCT05485805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25353496|NCT05485805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25353497|NCT05485805|Analgesics|analgesics|mesh-ancestor
25353498|NCT05485805|Sensory System Agents|sensory system agents|mesh-ancestor
25353499|NCT05485805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25353500|NCT05485805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25353501|NCT05485805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25353502|NCT05485805|Gout Suppressants|gout suppressants|mesh-ancestor
25353503|NCT05485805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25353504|NCT05485792|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25353505|NCT05485792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25353506|NCT05485792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353507|NCT05485766|Paclitaxel|paclitaxel|mesh-list
25353508|NCT05485766|Carboplatin|carboplatin|mesh-list
25353509|NCT05485766|Pembrolizumab|pembrolizumab|mesh-list
25353510|NCT05485766|Olaparib|olaparib|mesh-list
25353511|NCT05485766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25353512|NCT05485766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353513|NCT05485766|Tubulin Modulators|tubulin modulators|mesh-ancestor
25353514|NCT05485766|Antimitotic Agents|antimitotic agents|mesh-ancestor
25353515|NCT05485766|Mitosis Modulators|mitosis modulators|mesh-ancestor
25353516|NCT05485766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353517|NCT05485766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
24508314|NCT00555022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25353518|NCT05485766|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25353519|NCT05485766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353520|NCT05485662|Listerine|listerine|mesh-list
25353521|NCT05485662|Fluorides|fluorides|mesh-list
25353522|NCT05485662|Sodium Fluoride|sodium fluoride|mesh-list
25353523|NCT05485662|Cariostatic Agents|cariostatic agents|mesh-ancestor
25353524|NCT05485662|Protective Agents|protective agents|mesh-ancestor
25353525|NCT05485662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353526|NCT05485662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25353527|NCT05485662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25353529|NCT05485571|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25353530|NCT05485571|Abortifacient Agents|abortifacient agents|mesh-ancestor
25353531|NCT05485571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25353532|NCT05485571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353533|NCT05485571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25353534|NCT05485571|Antimetabolites|antimetabolites|mesh-ancestor
25353535|NCT05485571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353536|NCT05485571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353537|NCT05485571|Dermatologic Agents|dermatologic agents|mesh-ancestor
25353538|NCT05485571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353539|NCT05485571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25353540|NCT05485571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25353541|NCT05485571|Immunologic Factors|immunologic factors|mesh-ancestor
25353542|NCT05485571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25353543|NCT05485571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25353544|NCT05485558|Acetylcysteine|acetylcysteine|mesh-list
25353545|NCT05485558|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25353546|NCT05485558|Antiviral Agents|antiviral agents|mesh-ancestor
25353547|NCT05485558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25353548|NCT05485558|Expectorants|expectorants|mesh-ancestor
25353549|NCT05485558|Respiratory System Agents|respiratory system agents|mesh-ancestor
25353550|NCT05485558|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25353551|NCT05485558|Antioxidants|antioxidants|mesh-ancestor
25353552|NCT05485558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353553|NCT05485558|Protective Agents|protective agents|mesh-ancestor
25353554|NCT05485558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353555|NCT05485558|Antidotes|antidotes|mesh-ancestor
25353556|NCT05485519|Midazolam|midazolam|mesh-list
25353557|NCT05485519|Dexmedetomidine|dexmedetomidine|mesh-list
25353558|NCT05485519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25353559|NCT05485519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25353560|NCT05485519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353561|NCT05485519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25353562|NCT05485519|Analgesics|analgesics|mesh-ancestor
25353563|NCT05485519|Sensory System Agents|sensory system agents|mesh-ancestor
25353564|NCT05485519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25353565|NCT05485519|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25353566|NCT05485519|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25353567|NCT05485519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25353568|NCT05485519|Adrenergic Agents|adrenergic agents|mesh-ancestor
25353569|NCT05485519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25353570|NCT05485519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353571|NCT05485519|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25353572|NCT05485519|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25353573|NCT05485519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25353574|NCT05485519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25353575|NCT05485519|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25353576|NCT05485519|Anesthetics, General|anesthetics, general|mesh-ancestor
25353577|NCT05485519|Anesthetics|anesthetics|mesh-ancestor
25353578|NCT05485519|GABA Modulators|gaba modulators|mesh-ancestor
25353579|NCT05485519|GABA Agents|gaba agents|mesh-ancestor
25353580|NCT05485480|Analgesics, Opioid|analgesics, opioid|mesh-list
25353581|NCT05485480|Narcotics|narcotics|mesh-ancestor
25353582|NCT05485480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25353583|NCT05485480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353584|NCT05485480|Analgesics|analgesics|mesh-ancestor
25353585|NCT05485480|Sensory System Agents|sensory system agents|mesh-ancestor
24509104|NCT00558493|Clevudine|clevudine|mesh-list
25353586|NCT05485480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25353587|NCT05485272|Fluorides|fluorides|mesh-list
25353588|NCT05485272|Cariostatic Agents|cariostatic agents|mesh-ancestor
25353589|NCT05485272|Protective Agents|protective agents|mesh-ancestor
25353590|NCT05485272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353591|NCT05485259|Thioctic Acid|thioctic acid|mesh-list
25353592|NCT05485259|Antioxidants|antioxidants|mesh-ancestor
25353593|NCT05485259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353594|NCT05485259|Protective Agents|protective agents|mesh-ancestor
25353595|NCT05485259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353596|NCT05485259|Vitamin B Complex|vitamin b complex|mesh-ancestor
25353597|NCT05485259|Vitamins|vitamins|mesh-ancestor
25353598|NCT05485259|Micronutrients|micronutrients|mesh-ancestor
25353599|NCT05485207|Botulinum Toxins|botulinum toxins|mesh-list
25353600|NCT05485207|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25353601|NCT05485207|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25353602|NCT05485207|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25353603|NCT05485207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25353604|NCT05485207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353605|NCT05485207|Cholinergic Agents|cholinergic agents|mesh-ancestor
25353606|NCT05485207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25353607|NCT05485207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353608|NCT05485207|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25353609|NCT05485207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25353610|NCT05485155|Protease Inhibitors|protease inhibitors|mesh-list
25353611|NCT05485155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353612|NCT05485155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353613|NCT05485103|Glycerol|glycerol|mesh-list
25353614|NCT05485103|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25353615|NCT05485103|Protective Agents|protective agents|mesh-ancestor
25353616|NCT05485103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353617|NCT05485064|Fentanyl|fentanyl|mesh-list
25353618|NCT05485064|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25353619|NCT05485064|Narcotics|narcotics|mesh-ancestor
25353620|NCT05485064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25353621|NCT05485064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353622|NCT05485064|Analgesics|analgesics|mesh-ancestor
25353623|NCT05485064|Sensory System Agents|sensory system agents|mesh-ancestor
25353624|NCT05485064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25353625|NCT05485064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25353626|NCT05485064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25353627|NCT05485064|Anesthetics, General|anesthetics, general|mesh-ancestor
25353628|NCT05485064|Anesthetics|anesthetics|mesh-ancestor
25353629|NCT05485051|Chlorhexidine|chlorhexidine|mesh-list
25353630|NCT05485051|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25353631|NCT05485051|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25353632|NCT05485051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25353633|NCT05485051|Disinfectants|disinfectants|mesh-ancestor
25353634|NCT05485051|Dermatologic Agents|dermatologic agents|mesh-ancestor
25353635|NCT05485012|Analgesics, Opioid|analgesics, opioid|mesh-list
25353636|NCT05485012|Narcotics|narcotics|mesh-ancestor
25353637|NCT05485012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25353638|NCT05485012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353639|NCT05485012|Analgesics|analgesics|mesh-ancestor
25353640|NCT05485012|Sensory System Agents|sensory system agents|mesh-ancestor
25353641|NCT05485012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25353642|NCT05484817|Hormones|hormones|mesh-list
25353643|NCT05484817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25353644|NCT05484817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353645|NCT05484687|Anesthetics|anesthetics|mesh-list
25353646|NCT05484687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25353647|NCT05484687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353648|NCT05484648|Dexamethasone|dexamethasone|mesh-list
25353649|NCT05484648|Dexmedetomidine|dexmedetomidine|mesh-list
25353650|NCT05484648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25353651|NCT05484648|Antiemetics|antiemetics|mesh-ancestor
25353652|NCT05484648|Autonomic Agents|autonomic agents|mesh-ancestor
25353653|NCT05484648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25353654|NCT05484648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353655|NCT05484648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25353656|NCT05484648|Glucocorticoids|glucocorticoids|mesh-ancestor
25353657|NCT05484648|Hormones|hormones|mesh-ancestor
25353658|NCT05484648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25353659|NCT05484648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25353660|NCT05484648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353661|NCT05484648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25353662|NCT05484648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25353663|NCT05484648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25353664|NCT05484648|Analgesics|analgesics|mesh-ancestor
25353665|NCT05484648|Sensory System Agents|sensory system agents|mesh-ancestor
25353666|NCT05484648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25353667|NCT05484648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25353668|NCT05484648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25353669|NCT05484648|Adrenergic Agents|adrenergic agents|mesh-ancestor
25353670|NCT05484648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25353671|NCT05484648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353672|NCT05484622|Pembrolizumab|pembrolizumab|mesh-list
25353673|NCT05484622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25353674|NCT05484622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353675|NCT05484583|Cisplatin|cisplatin|mesh-list
25353676|NCT05484583|Carboplatin|carboplatin|mesh-list
25353677|NCT05484583|Etoposide|etoposide|mesh-list
25353678|NCT05484583|Durvalumab|durvalumab|mesh-list
25353679|NCT05484583|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25353680|NCT05484583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353681|NCT05484583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25353682|NCT05484583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25353683|NCT05484583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25353684|NCT05484583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353685|NCT05484583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353686|NCT05484583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25353687|NCT05484583|Immunologic Factors|immunologic factors|mesh-ancestor
25353688|NCT05484583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353689|NCT05484557|Enoxaparin|enoxaparin|mesh-list
25353690|NCT05484557|Enoxaparin sodium|enoxaparin sodium|mesh-list
25353691|NCT05484557|Apixaban|apixaban|mesh-list
25353692|NCT05484557|Anticoagulants|anticoagulants|mesh-ancestor
25353693|NCT05484557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25353694|NCT05484557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25353695|NCT05484557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353696|NCT05484557|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25353697|NCT05484557|Antithrombins|antithrombins|mesh-ancestor
25353698|NCT05484557|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25353699|NCT05484557|Protease Inhibitors|protease inhibitors|mesh-ancestor
25353700|NCT05484557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353701|NCT05484505|Nicotine|nicotine|mesh-list
25353702|NCT05484505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25353703|NCT05484505|Autonomic Agents|autonomic agents|mesh-ancestor
25353704|NCT05484505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25353705|NCT05484505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353706|NCT05484505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25353707|NCT05484505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25353708|NCT05484505|Cholinergic Agents|cholinergic agents|mesh-ancestor
25353709|NCT05484505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25353710|NCT05484505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353711|NCT05484492|Calcium|calcium|mesh-list
25353712|NCT05484492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25353713|NCT05484492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353714|NCT05484466|Entecavir|entecavir|mesh-list
25353715|NCT05484466|Antiviral Agents|antiviral agents|mesh-ancestor
25353716|NCT05484466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25353717|NCT05484401|Ibuprofen|ibuprofen|mesh-list
25353718|NCT05484401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25353719|NCT05484401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25353720|NCT05484401|Analgesics|analgesics|mesh-ancestor
25353721|NCT05484401|Sensory System Agents|sensory system agents|mesh-ancestor
25353722|NCT05484401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25353723|NCT05484401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353724|NCT05484401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25353725|NCT05484401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25353726|NCT05484401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25353727|NCT05484401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353728|NCT05484401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353729|NCT05484375|Capecitabine|capecitabine|mesh-list
25353730|NCT05484375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25353731|NCT05484375|Antimetabolites|antimetabolites|mesh-ancestor
25353732|NCT05484375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353733|NCT05484375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353734|NCT05484349|Clonidine|clonidine|mesh-list
25353735|NCT05484349|Tizanidine|tizanidine|mesh-list
25353736|NCT05484349|Analgesics|analgesics|mesh-ancestor
25353737|NCT05484349|Sensory System Agents|sensory system agents|mesh-ancestor
25353738|NCT05484349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25353739|NCT05484349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353740|NCT05484349|Anticonvulsants|anticonvulsants|mesh-ancestor
25353741|NCT05484349|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25353742|NCT05484349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25353743|NCT05484349|Parasympatholytics|parasympatholytics|mesh-ancestor
25353744|NCT05484349|Autonomic Agents|autonomic agents|mesh-ancestor
25772315|NCT03677401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353745|NCT05484349|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25353746|NCT05484349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25353747|NCT05484349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25353748|NCT05484349|Adrenergic Agents|adrenergic agents|mesh-ancestor
25353749|NCT05484349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25353750|NCT05484349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353751|NCT05484349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25353752|NCT05484349|Sympatholytics|sympatholytics|mesh-ancestor
25353753|NCT05484284|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25353754|NCT05484284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25353756|NCT05484193|Progestins|progestins|mesh-ancestor
25353757|NCT05484193|Hormones|hormones|mesh-ancestor
25353758|NCT05484193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25353759|NCT05484193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353760|NCT05484167|Methyltestosterone|methyltestosterone|mesh-list
25353761|NCT05484167|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25353767|NCT05484167|Anabolic Agents|anabolic agents|mesh-ancestor
25353768|NCT05484167|Hormones|hormones|mesh-ancestor
25353769|NCT05484167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25353770|NCT05484167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353771|NCT05484167|Androgens|androgens|mesh-ancestor
25353772|NCT05484154|Protein C|protein c|mesh-list
25353773|NCT05484154|Anticoagulants|anticoagulants|mesh-ancestor
25353774|NCT05484154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25353775|NCT05484154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25353776|NCT05484154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353777|NCT05484024|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25353778|NCT05484024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353779|NCT05484024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353780|NCT05483933|Doxorubicin|doxorubicin|mesh-list
25353781|NCT05483933|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25353782|NCT05483933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25353783|NCT05483933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353784|NCT05483933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25353785|NCT05483933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25353786|NCT05483933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353787|NCT05483933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353788|NCT05483894|Atorvastatin|atorvastatin|mesh-list
25353789|NCT05483894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25353790|NCT05483894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25353791|NCT05483894|Antimetabolites|antimetabolites|mesh-ancestor
25353792|NCT05483894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353793|NCT05483894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25353794|NCT05483894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25353795|NCT05483894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353796|NCT05483647|Anesthetics|anesthetics|mesh-list
25353797|NCT05483647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25353798|NCT05483647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353799|NCT05483634|Estrogens|estrogens|mesh-list
25353800|NCT05483634|Hormones|hormones|mesh-ancestor
25353801|NCT05483634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25353802|NCT05483634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353809|NCT05483465|Niacinamide|niacinamide|mesh-list
25353810|NCT05483465|Niacin|niacin|mesh-list
25353811|NCT05483465|Nicotinic Acids|nicotinic acids|mesh-list
25353812|NCT05483465|Vitamin B Complex|vitamin b complex|mesh-ancestor
25353813|NCT05483465|Vitamins|vitamins|mesh-ancestor
25353814|NCT05483465|Micronutrients|micronutrients|mesh-ancestor
25353815|NCT05483465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353816|NCT05483465|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25353817|NCT05483465|Antimetabolites|antimetabolites|mesh-ancestor
24510896|NCT00566371|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25353818|NCT05483465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353819|NCT05483465|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25353820|NCT05483465|Vasodilator Agents|vasodilator agents|mesh-ancestor
25353821|NCT05483439|Cyclophosphamide|cyclophosphamide|mesh-list
25353822|NCT05483439|Carboplatin|carboplatin|mesh-list
25353823|NCT05483439|Docetaxel|docetaxel|mesh-list
25353824|NCT05483439|Trastuzumab|trastuzumab|mesh-list
25353825|NCT05483439|Epirubicin|epirubicin|mesh-list
25353826|NCT05483439|Pertuzumab|pertuzumab|mesh-list
25353827|NCT05483439|Antibodies|antibodies|mesh-list
25353828|NCT05483439|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25353829|NCT05483439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25353830|NCT05483439|Immunologic Factors|immunologic factors|mesh-ancestor
25353831|NCT05483439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353832|NCT05483439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25353833|NCT05483439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25353834|NCT05483439|Alkylating Agents|alkylating agents|mesh-ancestor
25353835|NCT05483439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353836|NCT05483439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353837|NCT05483439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25353838|NCT05483439|Tubulin Modulators|tubulin modulators|mesh-ancestor
25353839|NCT05483439|Antimitotic Agents|antimitotic agents|mesh-ancestor
25353840|NCT05483439|Mitosis Modulators|mitosis modulators|mesh-ancestor
25353841|NCT05483439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25353842|NCT05483439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25353843|NCT05483439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25353844|NCT05483439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25353845|NCT05483439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353846|NCT05483400|Atezolizumab|atezolizumab|mesh-list
25353847|NCT05483400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353848|NCT05483062|Fluorides|fluorides|mesh-list
25353849|NCT05483062|Tin Fluorides|tin fluorides|mesh-list
25353850|NCT05483062|Cariostatic Agents|cariostatic agents|mesh-ancestor
25353851|NCT05483062|Protective Agents|protective agents|mesh-ancestor
25353852|NCT05483062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353853|NCT05483010|Atorvastatin|atorvastatin|mesh-list
25353854|NCT05483010|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25353855|NCT05483010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25353856|NCT05483010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25353857|NCT05483010|Antimetabolites|antimetabolites|mesh-ancestor
25353858|NCT05483010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353859|NCT05483010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25353860|NCT05483010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25353861|NCT05483010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353862|NCT05482789|Exenatide|exenatide|mesh-list
25353863|NCT05482789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25353864|NCT05482789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353865|NCT05482789|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25353866|NCT05482789|Incretins|incretins|mesh-ancestor
25353867|NCT05482789|Hormones|hormones|mesh-ancestor
25353868|NCT05482789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25353869|NCT05482763|Itraconazole|itraconazole|mesh-list
25353870|NCT05482763|Terbinafine|terbinafine|mesh-list
25353871|NCT05482763|Ciclopirox|ciclopirox|mesh-list
25353872|NCT05482763|Amorolfine|amorolfine|mesh-list
25353873|NCT05482763|Antifungal Agents|antifungal agents|mesh-ancestor
25353874|NCT05482763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25353875|NCT05482763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25353876|NCT05482763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25353877|NCT05482763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353878|NCT05482763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353879|NCT05482763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25353880|NCT05482763|Hormone Antagonists|hormone antagonists|mesh-ancestor
25353881|NCT05482763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25353882|NCT05482763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353883|NCT05482763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25353884|NCT05482542|Cyclophosphamide|cyclophosphamide|mesh-list
25353885|NCT05482542|Rituximab|rituximab|mesh-list
25353886|NCT05482542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25353887|NCT05482542|Immunologic Factors|immunologic factors|mesh-ancestor
25353888|NCT05482542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353889|NCT05482542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25353890|NCT05482542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25353891|NCT05482542|Alkylating Agents|alkylating agents|mesh-ancestor
25353892|NCT05482542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353893|NCT05482542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353894|NCT05482542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25353895|NCT05482542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25353896|NCT05482516|Bevacizumab|bevacizumab|mesh-list
25353897|NCT05482516|Atezolizumab|atezolizumab|mesh-list
25353898|NCT05482516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25353899|NCT05482516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353900|NCT05482516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25353901|NCT05482516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25353902|NCT05482516|Growth Substances|growth substances|mesh-ancestor
25353903|NCT05482516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353904|NCT05482516|Growth Inhibitors|growth inhibitors|mesh-ancestor
25353905|NCT05482464|Caseins|caseins|mesh-list
25353906|NCT05482464|Chelating Agents|chelating agents|mesh-ancestor
25353907|NCT05482464|Sequestering Agents|sequestering agents|mesh-ancestor
25353908|NCT05482464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353909|NCT05482451|Nivolumab|nivolumab|mesh-list
25353910|NCT05482451|Tretinoin|tretinoin|mesh-list
25353911|NCT05482451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25353912|NCT05482451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353913|NCT05482451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25353914|NCT05482451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353915|NCT05482451|Keratolytic Agents|keratolytic agents|mesh-ancestor
25353916|NCT05482451|Dermatologic Agents|dermatologic agents|mesh-ancestor
25353918|NCT05482373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25353919|NCT05482373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25353920|NCT05482373|Vasodilator Agents|vasodilator agents|mesh-ancestor
25353921|NCT05482334|Molgramostim|molgramostim|mesh-list
25353922|NCT05482334|Sargramostim|sargramostim|mesh-list
25353923|NCT05482334|Immunologic Factors|immunologic factors|mesh-ancestor
25353924|NCT05482334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353925|NCT05482334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353926|NCT05482295|Vaccines|vaccines|mesh-list
25353927|NCT05482295|Immunologic Factors|immunologic factors|mesh-ancestor
25353928|NCT05482295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353929|NCT05482282|Vaccines|vaccines|mesh-list
25353930|NCT05482282|Immunologic Factors|immunologic factors|mesh-ancestor
25353931|NCT05482282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353932|NCT05482256|Listerine|listerine|mesh-list
25353933|NCT05482256|Sodium Fluoride|sodium fluoride|mesh-list
25353934|NCT05482256|Cariostatic Agents|cariostatic agents|mesh-ancestor
25353935|NCT05482256|Protective Agents|protective agents|mesh-ancestor
25353936|NCT05482256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353937|NCT05482256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25353938|NCT05482256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25353939|NCT05482113|Bupivacaine|bupivacaine|mesh-list
25353940|NCT05482113|Anesthetics, Local|anesthetics, local|mesh-ancestor
25353941|NCT05482113|Anesthetics|anesthetics|mesh-ancestor
25353942|NCT05482113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25353943|NCT05482113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353944|NCT05482113|Sensory System Agents|sensory system agents|mesh-ancestor
25353945|NCT05482113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25353946|NCT05482074|Olaparib|olaparib|mesh-list
25353947|NCT05482074|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25353948|NCT05482074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25353949|NCT05482074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353950|NCT05482074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353951|NCT05481970|Dexamethasone|dexamethasone|mesh-list
25353952|NCT05481970|Lidocaine|lidocaine|mesh-list
25353953|NCT05481970|Fentanyl|fentanyl|mesh-list
25353954|NCT05481970|Dexmedetomidine|dexmedetomidine|mesh-list
25353955|NCT05481970|Ketamine|ketamine|mesh-list
25353956|NCT05481970|Propofol|propofol|mesh-list
25353957|NCT05481970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25353958|NCT05481970|Antiemetics|antiemetics|mesh-ancestor
25353959|NCT05481970|Autonomic Agents|autonomic agents|mesh-ancestor
25353960|NCT05481970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25353961|NCT05481970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25353962|NCT05481970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25353963|NCT05481970|Glucocorticoids|glucocorticoids|mesh-ancestor
25353964|NCT05481970|Hormones|hormones|mesh-ancestor
25353965|NCT05481970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25353966|NCT05481970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25353967|NCT05481970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25353968|NCT05481970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25353969|NCT05481970|Anesthetics, Local|anesthetics, local|mesh-ancestor
25353970|NCT05481970|Anesthetics|anesthetics|mesh-ancestor
25353971|NCT05481970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25353972|NCT05481970|Sensory System Agents|sensory system agents|mesh-ancestor
25353973|NCT05481970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25353974|NCT05481970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25353975|NCT05481970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25353976|NCT05481970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25353977|NCT05481970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25353978|NCT05481970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25353979|NCT05481970|Anesthetics, General|anesthetics, general|mesh-ancestor
25353980|NCT05481970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25353981|NCT05481970|Analgesics|analgesics|mesh-ancestor
25353982|NCT05481970|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25353983|NCT05481970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25353984|NCT05481970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25353985|NCT05481970|Adrenergic Agents|adrenergic agents|mesh-ancestor
25353986|NCT05481970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25353987|NCT05481970|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25353988|NCT05481970|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25353989|NCT05481970|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25353991|NCT05481970|Narcotics|narcotics|mesh-ancestor
25353992|NCT05481970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25353993|NCT05481957|Vortioxetine|vortioxetine|mesh-list
25353994|NCT05481957|Antidepressive Agents|antidepressive agents|mesh-ancestor
25353995|NCT05481957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25353996|NCT05481957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25353997|NCT05481957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25353998|NCT05481957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25353999|NCT05481957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354000|NCT05481957|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25354001|NCT05481957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25354002|NCT05481957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25354003|NCT05481957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354004|NCT05481957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25354005|NCT05481957|Serotonin Agents|serotonin agents|mesh-ancestor
25354006|NCT05481957|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25354007|NCT05481957|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25354008|NCT05481957|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25354009|NCT05481957|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25354010|NCT05481736|Psilocybin|psilocybin|mesh-list
25354011|NCT05481736|Hallucinogens|hallucinogens|mesh-ancestor
25354012|NCT05481736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354013|NCT05481736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25354014|NCT05481723|Norepinephrine|norepinephrine|mesh-list
25354015|NCT05481723|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25354016|NCT05481723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25354017|NCT05481723|Adrenergic Agents|adrenergic agents|mesh-ancestor
25354018|NCT05481723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25354019|NCT05481723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354020|NCT05481723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354021|NCT05481723|Sympathomimetics|sympathomimetics|mesh-ancestor
25354022|NCT05481723|Autonomic Agents|autonomic agents|mesh-ancestor
25354023|NCT05481723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25354024|NCT05481723|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25354025|NCT05481684|Progesterone|progesterone|mesh-list
25354026|NCT05481684|Progestins|progestins|mesh-ancestor
25354027|NCT05481684|Hormones|hormones|mesh-ancestor
25354028|NCT05481684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25354029|NCT05481684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354030|NCT05481645|Paclitaxel|paclitaxel|mesh-list
25354031|NCT05481645|Carboplatin|carboplatin|mesh-list
25354032|NCT05481645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25354033|NCT05481645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354034|NCT05481645|Tubulin Modulators|tubulin modulators|mesh-ancestor
25354035|NCT05481645|Antimitotic Agents|antimitotic agents|mesh-ancestor
25354036|NCT05481645|Mitosis Modulators|mitosis modulators|mesh-ancestor
25354037|NCT05481645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354038|NCT05481619|Vedolizumab|vedolizumab|mesh-list
25354039|NCT05481619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25354040|NCT05481528|Moxifloxacin|moxifloxacin|mesh-list
25354041|NCT05481528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25354042|NCT05481528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25354043|NCT05481528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25354044|NCT05481528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25354045|NCT05481528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25354046|NCT05481528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354047|NCT05481528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354048|NCT05481489|Atropine|atropine|mesh-list
25354049|NCT05481489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25354050|NCT05481489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25354051|NCT05481489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25354052|NCT05481489|Autonomic Agents|autonomic agents|mesh-ancestor
25354053|NCT05481489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25354054|NCT05481489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354055|NCT05481489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25354056|NCT05481489|Respiratory System Agents|respiratory system agents|mesh-ancestor
25354057|NCT05481489|Mydriatics|mydriatics|mesh-ancestor
25354058|NCT05481489|Parasympatholytics|parasympatholytics|mesh-ancestor
25354059|NCT05481489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25354060|NCT05481489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25354061|NCT05481489|Cholinergic Agents|cholinergic agents|mesh-ancestor
25354062|NCT05481489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25354063|NCT05481489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354064|NCT05481437|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25354065|NCT05481437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25354066|NCT05481437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354067|NCT05481281|Dexmedetomidine|dexmedetomidine|mesh-list
25354068|NCT05481281|Ketamine|ketamine|mesh-list
25354069|NCT05481281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25354070|NCT05481281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25354071|NCT05481281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354072|NCT05481281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25354073|NCT05481281|Analgesics|analgesics|mesh-ancestor
25354074|NCT05481281|Sensory System Agents|sensory system agents|mesh-ancestor
25354075|NCT05481281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25354076|NCT05481281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25354077|NCT05481281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25354078|NCT05481281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25354079|NCT05481281|Adrenergic Agents|adrenergic agents|mesh-ancestor
25354080|NCT05481281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25354081|NCT05481281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354082|NCT05481281|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25354083|NCT05481281|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25354084|NCT05481281|Anesthetics, General|anesthetics, general|mesh-ancestor
25354085|NCT05481281|Anesthetics|anesthetics|mesh-ancestor
25354086|NCT05481281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25354087|NCT05481281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25354088|NCT05481112|Buprenorphine|buprenorphine|mesh-list
25354089|NCT05481112|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25354090|NCT05481112|Narcotics|narcotics|mesh-ancestor
25354091|NCT05481112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25354092|NCT05481112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354093|NCT05481112|Analgesics|analgesics|mesh-ancestor
25354094|NCT05481112|Sensory System Agents|sensory system agents|mesh-ancestor
25354095|NCT05481112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25354096|NCT05481112|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25354097|NCT05480878|Nitazoxanide|nitazoxanide|mesh-list
25354098|NCT05480878|Citalopram|citalopram|mesh-list
25354099|NCT05480878|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25354100|NCT05480878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25354101|NCT05480878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25354102|NCT05480878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354103|NCT05480878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25354104|NCT05480878|Serotonin Agents|serotonin agents|mesh-ancestor
25354105|NCT05480878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354106|NCT05480878|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25354107|NCT05480878|Antidepressive Agents|antidepressive agents|mesh-ancestor
25354108|NCT05480878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25354109|NCT05480878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25354110|NCT05480878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25354111|NCT05480800|Vaccines|vaccines|mesh-list
25354112|NCT05480800|Immunologic Factors|immunologic factors|mesh-ancestor
25354113|NCT05480800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354114|NCT05480631|Mitogens|mitogens|mesh-list
25354115|NCT05480631|Mitosis Modulators|mitosis modulators|mesh-ancestor
25354116|NCT05480631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354117|NCT05480566|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
25354118|NCT05480566|Autonomic Agents|autonomic agents|mesh-ancestor
25354119|NCT05480566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25354120|NCT05480566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354121|NCT05480566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25354122|NCT05480566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25354123|NCT05480566|Respiratory System Agents|respiratory system agents|mesh-ancestor
25354124|NCT05480488|Midazolam|midazolam|mesh-list
25354125|NCT05480488|Warfarin|warfarin|mesh-list
25354126|NCT05480488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25354127|NCT05480488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25354128|NCT05480488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25354129|NCT05480488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354130|NCT05480488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25354131|NCT05480488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25354132|NCT05480488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25354133|NCT05480488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25354134|NCT05480488|Anesthetics, General|anesthetics, general|mesh-ancestor
25354135|NCT05480488|Anesthetics|anesthetics|mesh-ancestor
25354136|NCT05480488|GABA Modulators|gaba modulators|mesh-ancestor
25354137|NCT05480488|GABA Agents|gaba agents|mesh-ancestor
25354138|NCT05480488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25354216|NCT05480150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25354139|NCT05480488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354140|NCT05480488|Anticoagulants|anticoagulants|mesh-ancestor
25354141|NCT05480475|Dabigatran|dabigatran|mesh-list
25354142|NCT05480475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25354143|NCT05480475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25354144|NCT05480475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25354145|NCT05480475|Antimetabolites|antimetabolites|mesh-ancestor
25354146|NCT05480475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354147|NCT05480475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25354148|NCT05480475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25354149|NCT05480475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25354150|NCT05480475|Antithrombins|antithrombins|mesh-ancestor
25354151|NCT05480475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25354152|NCT05480475|Protease Inhibitors|protease inhibitors|mesh-ancestor
25354153|NCT05480475|Anticoagulants|anticoagulants|mesh-ancestor
25354154|NCT05480384|Nivolumab|nivolumab|mesh-list
25354155|NCT05480384|Trastuzumab|trastuzumab|mesh-list
25354156|NCT05480384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25354157|NCT05480384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354158|NCT05480384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25354159|NCT05480384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354160|NCT05480306|Bevacizumab|bevacizumab|mesh-list
25354161|NCT05480306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25354162|NCT05480306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354163|NCT05480306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25354164|NCT05480306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25354165|NCT05480306|Growth Substances|growth substances|mesh-ancestor
25354166|NCT05480306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354167|NCT05480306|Growth Inhibitors|growth inhibitors|mesh-ancestor
25354168|NCT05480293|Ranibizumab|ranibizumab|mesh-list
25354169|NCT05480293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25354170|NCT05480293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25354171|NCT05480293|Growth Substances|growth substances|mesh-ancestor
25354172|NCT05480293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354173|NCT05480293|Growth Inhibitors|growth inhibitors|mesh-ancestor
25354174|NCT05480293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354175|NCT05480280|Leucovorin|leucovorin|mesh-list
25354176|NCT05480280|Fluorouracil|fluorouracil|mesh-list
25354177|NCT05480280|Oxaliplatin|oxaliplatin|mesh-list
25354178|NCT05480280|Calcium|calcium|mesh-list
25354179|NCT05480280|Levoleucovorin|levoleucovorin|mesh-list
25354180|NCT05480280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25354181|NCT05480280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354182|NCT05480280|Antimetabolites|antimetabolites|mesh-ancestor
25354183|NCT05480280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354184|NCT05480280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25354185|NCT05480280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354186|NCT05480280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25354187|NCT05480280|Immunologic Factors|immunologic factors|mesh-ancestor
25354189|NCT05480280|Protective Agents|protective agents|mesh-ancestor
25354190|NCT05480280|Vitamin B Complex|vitamin b complex|mesh-ancestor
25354191|NCT05480280|Vitamins|vitamins|mesh-ancestor
25354192|NCT05480280|Micronutrients|micronutrients|mesh-ancestor
25354193|NCT05480150|Dexetimide|dexetimide|mesh-list
25354194|NCT05480150|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25354195|NCT05480150|Citalopram|citalopram|mesh-list
25354196|NCT05480150|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25354197|NCT05480150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25354198|NCT05480150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25354199|NCT05480150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354200|NCT05480150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25354201|NCT05480150|Serotonin Agents|serotonin agents|mesh-ancestor
25354202|NCT05480150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354203|NCT05480150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25354204|NCT05480150|Antidepressive Agents|antidepressive agents|mesh-ancestor
25354205|NCT05480150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25354206|NCT05480150|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25354207|NCT05480150|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25354208|NCT05480150|Parasympatholytics|parasympatholytics|mesh-ancestor
25354209|NCT05480150|Autonomic Agents|autonomic agents|mesh-ancestor
25354210|NCT05480150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25354211|NCT05480150|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25354212|NCT05480150|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25354213|NCT05480150|Cholinergic Agents|cholinergic agents|mesh-ancestor
25354214|NCT05480150|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25354215|NCT05480150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25354218|NCT05480111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25354219|NCT05480111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354220|NCT05480098|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25354221|NCT05480098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25354222|NCT05480098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25354223|NCT05480098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25354224|NCT05480098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25354225|NCT05480098|Adrenergic Agents|adrenergic agents|mesh-ancestor
25354226|NCT05480098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25354227|NCT05480098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354228|NCT05480098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354229|NCT05480072|Palmidrol|palmidrol|mesh-list
25354230|NCT05480072|Analgesics|analgesics|mesh-ancestor
25354231|NCT05480072|Sensory System Agents|sensory system agents|mesh-ancestor
25354232|NCT05480072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25354233|NCT05480072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354234|NCT05480072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25354235|NCT05480072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25354236|NCT05480072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25354237|NCT05480072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25354238|NCT05480072|Antiviral Agents|antiviral agents|mesh-ancestor
25354239|NCT05480072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25354240|NCT05480072|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25354241|NCT05480072|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25354242|NCT05480072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25354243|NCT05480072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354244|NCT05480072|Hormones|hormones|mesh-ancestor
25354245|NCT05480072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25354246|NCT05480046|Risperidone|risperidone|mesh-list
25354247|NCT05480046|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25354248|NCT05480046|Serotonin Agents|serotonin agents|mesh-ancestor
25354249|NCT05480046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
24513352|NCT00580905|Adenosine|adenosine|mesh-list
25354250|NCT05480046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354251|NCT05480046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354252|NCT05480046|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25354253|NCT05480046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25354254|NCT05480046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25354255|NCT05480046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25354256|NCT05480046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25354257|NCT05480046|Dopamine Agents|dopamine agents|mesh-ancestor
25354258|NCT05480007|Metformin|metformin|mesh-list
25354259|NCT05480007|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25354260|NCT05480007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25354261|NCT05480007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354262|NCT05480007|Incretins|incretins|mesh-ancestor
25354263|NCT05480007|Hormones|hormones|mesh-ancestor
25354264|NCT05480007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25354265|NCT05480007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25354266|NCT05480007|Protease Inhibitors|protease inhibitors|mesh-ancestor
25354267|NCT05480007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25354268|NCT05480007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354269|NCT05479916|Caseins|caseins|mesh-list
25354270|NCT05479916|Chelating Agents|chelating agents|mesh-ancestor
25354271|NCT05479916|Sequestering Agents|sequestering agents|mesh-ancestor
25354272|NCT05479916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354273|NCT05479812|Pembrolizumab|pembrolizumab|mesh-list
25354274|NCT05479812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25354275|NCT05479812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354276|NCT05479747|Analgesics|analgesics|mesh-list
25354277|NCT05479747|Sensory System Agents|sensory system agents|mesh-ancestor
25354278|NCT05479747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25354279|NCT05479747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354280|NCT05479591|Xultophy|xultophy|mesh-list
25354281|NCT05479591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25354282|NCT05479591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354283|NCT05479591|Incretins|incretins|mesh-ancestor
25354284|NCT05479591|Hormones|hormones|mesh-ancestor
25386819|NCT04464980|Analgesics|analgesics|mesh-ancestor
25354285|NCT05479591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25354286|NCT05479578|Dexamethasone|dexamethasone|mesh-list
25354287|NCT05479578|Dexamethasone acetate|dexamethasone acetate|mesh-list
25354288|NCT05479578|Cyclophosphamide|cyclophosphamide|mesh-list
25354289|NCT05479578|Ichthammol|ichthammol|mesh-list
25354290|NCT05479578|BB 1101|bb 1101|mesh-list
25354291|NCT05479578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25354292|NCT05479578|Immunologic Factors|immunologic factors|mesh-ancestor
25354293|NCT05479578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354294|NCT05479578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25354295|NCT05479578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25354296|NCT05479578|Alkylating Agents|alkylating agents|mesh-ancestor
25354297|NCT05479578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354298|NCT05479578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354299|NCT05479578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25354300|NCT05479578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25354301|NCT05479578|Antiemetics|antiemetics|mesh-ancestor
25354302|NCT05479578|Autonomic Agents|autonomic agents|mesh-ancestor
25354303|NCT05479578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25354304|NCT05479578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25354305|NCT05479578|Glucocorticoids|glucocorticoids|mesh-ancestor
25354306|NCT05479578|Hormones|hormones|mesh-ancestor
25354307|NCT05479578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25354308|NCT05479578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25354309|NCT05479578|Protease Inhibitors|protease inhibitors|mesh-ancestor
25354310|NCT05479578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25354311|NCT05479578|Dermatologic Agents|dermatologic agents|mesh-ancestor
25354312|NCT05479487|Apatinib|apatinib|mesh-list
25354313|NCT05479487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354314|NCT05479487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25354315|NCT05479487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25354316|NCT05479487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354317|NCT05479448|Prednisone|prednisone|mesh-list
25354318|NCT05479448|Hormones|hormones|mesh-list
25354319|NCT05479448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25354320|NCT05479448|Glucocorticoids|glucocorticoids|mesh-ancestor
25354321|NCT05479448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25354322|NCT05479448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354323|NCT05479448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25354324|NCT05479448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354325|NCT05479370|Vaccines|vaccines|mesh-list
25354326|NCT05479370|Immunologic Factors|immunologic factors|mesh-ancestor
25354327|NCT05479370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354328|NCT05479357|Oxytocin|oxytocin|mesh-list
25354329|NCT05479357|Carbetocin|carbetocin|mesh-list
25354330|NCT05479357|Oxytocics|oxytocics|mesh-ancestor
25354331|NCT05479357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25354332|NCT05479357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354333|NCT05479240|Capecitabine|capecitabine|mesh-list
25354334|NCT05479240|Oxaliplatin|oxaliplatin|mesh-list
25354335|NCT05479240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25354336|NCT05479240|Antimetabolites|antimetabolites|mesh-ancestor
25354337|NCT05479240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354338|NCT05479240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354340|NCT05479214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25354341|NCT05479214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354342|NCT05479175|Ibuprofen|ibuprofen|mesh-list
25354343|NCT05479175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25354344|NCT05479175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25354345|NCT05479175|Analgesics|analgesics|mesh-ancestor
25354346|NCT05479175|Sensory System Agents|sensory system agents|mesh-ancestor
25354347|NCT05479175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25354348|NCT05479175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354349|NCT05479175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25354350|NCT05479175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25354351|NCT05479175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25354352|NCT05479175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25354353|NCT05479175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354354|NCT05479123|Timolol|timolol|mesh-list
25354355|NCT05479123|Propranolol|propranolol|mesh-list
25354356|NCT05479123|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25354357|NCT05479123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25354358|NCT05479123|Adrenergic Agents|adrenergic agents|mesh-ancestor
25772316|NCT03677401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354359|NCT05479123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25354360|NCT05479123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354361|NCT05479123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354362|NCT05479123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25354363|NCT05479123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25354364|NCT05479123|Vasodilator Agents|vasodilator agents|mesh-ancestor
25354365|NCT05479097|Antihypertensive Agents|antihypertensive agents|mesh-list
25354367|NCT05479045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25354368|NCT05479045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354369|NCT05479045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25354370|NCT05479045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354371|NCT05479032|Amantadine|amantadine|mesh-list
25354372|NCT05479032|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25354373|NCT05479032|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25354374|NCT05479032|Antiviral Agents|antiviral agents|mesh-ancestor
25354375|NCT05479032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25354376|NCT05479032|Dopamine Agents|dopamine agents|mesh-ancestor
25354377|NCT05479032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25354378|NCT05479032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354379|NCT05479032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354380|NCT05479032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25354381|NCT05479032|Analgesics|analgesics|mesh-ancestor
25354382|NCT05479032|Sensory System Agents|sensory system agents|mesh-ancestor
25354383|NCT05479032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25354384|NCT05478993|Dexamethasone|dexamethasone|mesh-list
25354385|NCT05478993|Pomalidomide|pomalidomide|mesh-list
25354386|NCT05478993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25354387|NCT05478993|Antiemetics|antiemetics|mesh-ancestor
25354388|NCT05478993|Autonomic Agents|autonomic agents|mesh-ancestor
25354389|NCT05478993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25354390|NCT05478993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354391|NCT05478993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25354392|NCT05478993|Glucocorticoids|glucocorticoids|mesh-ancestor
25354393|NCT05478993|Hormones|hormones|mesh-ancestor
25354394|NCT05478993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25354395|NCT05478993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25354396|NCT05478993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354397|NCT05478993|Immunologic Factors|immunologic factors|mesh-ancestor
25354398|NCT05478993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25354399|NCT05478993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25354400|NCT05478993|Growth Substances|growth substances|mesh-ancestor
25354401|NCT05478993|Growth Inhibitors|growth inhibitors|mesh-ancestor
25354402|NCT05478954|Pyrimethamine|pyrimethamine|mesh-list
25354403|NCT05478954|Sulfadoxine|sulfadoxine|mesh-list
25354404|NCT05478954|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25354405|NCT05478954|Amodiaquine|amodiaquine|mesh-list
25354406|NCT05478954|Antimalarials|antimalarials|mesh-ancestor
25354407|NCT05478954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25354408|NCT05478954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25354409|NCT05478954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25354410|NCT05478954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25354411|NCT05478954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25354412|NCT05478954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354413|NCT05478954|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25354414|NCT05478954|Renal Agents|renal agents|mesh-ancestor
25354415|NCT05478863|Caffeine|caffeine|mesh-list
25354416|NCT05478863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25354417|NCT05478863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354418|NCT05478863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25354419|NCT05478863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25354420|NCT05478863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354421|NCT05478863|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25354422|NCT05478863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25354423|NCT05478863|Purinergic Agents|purinergic agents|mesh-ancestor
25354424|NCT05478863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25354425|NCT05478850|Anesthetics|anesthetics|mesh-list
25354426|NCT05478850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25354427|NCT05478850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354428|NCT05478837|Cyclophosphamide|cyclophosphamide|mesh-list
25354429|NCT05478837|Fludarabine|fludarabine|mesh-list
25354430|NCT05478837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25354431|NCT05478837|Immunologic Factors|immunologic factors|mesh-ancestor
25354432|NCT05478837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354433|NCT05478837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25354434|NCT05478837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25354435|NCT05478837|Alkylating Agents|alkylating agents|mesh-ancestor
25354436|NCT05478837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354437|NCT05478837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354438|NCT05478837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25354440|NCT05478785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354441|NCT05478772|Fluconazole|fluconazole|mesh-list
25354442|NCT05478772|Antifungal Agents|antifungal agents|mesh-ancestor
25354443|NCT05478772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25354444|NCT05478772|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25354445|NCT05478772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25354446|NCT05478772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25354447|NCT05478772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354448|NCT05478772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25354449|NCT05478772|Hormone Antagonists|hormone antagonists|mesh-ancestor
25354450|NCT05478772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25354451|NCT05478772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354452|NCT05478772|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25354453|NCT05478772|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25354454|NCT05478720|Diazooxonorleucine|diazooxonorleucine|mesh-list
25354455|NCT05478720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25354456|NCT05478720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354457|NCT05478720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25354458|NCT05478720|Antimetabolites|antimetabolites|mesh-ancestor
25354459|NCT05478720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354460|NCT05478707|Dulaglutide|dulaglutide|mesh-list
25354461|NCT05478707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25354462|NCT05478707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354463|NCT05478551|Botulinum Toxins|botulinum toxins|mesh-list
25354464|NCT05478551|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25354465|NCT05478551|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25354466|NCT05478551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25354467|NCT05478551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354468|NCT05478551|Cholinergic Agents|cholinergic agents|mesh-ancestor
25354469|NCT05478551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25354470|NCT05478551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354471|NCT05478499|BMS-986165|bms-986165|mesh-list
25354472|NCT05478499|Dermatologic Agents|dermatologic agents|mesh-ancestor
25354473|NCT05478499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25354474|NCT05478499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25354475|NCT05478499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354476|NCT05478382|Pregabalin|pregabalin|mesh-list
25354477|NCT05478382|Analgesics|analgesics|mesh-ancestor
25354478|NCT05478382|Sensory System Agents|sensory system agents|mesh-ancestor
25354479|NCT05478382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25354480|NCT05478382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354481|NCT05478382|Anticonvulsants|anticonvulsants|mesh-ancestor
25354482|NCT05478382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25354483|NCT05478382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25354484|NCT05478382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354485|NCT05478382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25354486|NCT05478382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25354487|NCT05478382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25354488|NCT05478382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25354489|NCT05478382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25354490|NCT05478356|Atropine|atropine|mesh-list
25354491|NCT05478356|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25354492|NCT05478356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25354493|NCT05478356|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25354494|NCT05478356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25354495|NCT05478356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25354496|NCT05478356|Autonomic Agents|autonomic agents|mesh-ancestor
25354497|NCT05478356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25354498|NCT05478356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354499|NCT05478356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25354500|NCT05478356|Respiratory System Agents|respiratory system agents|mesh-ancestor
25354501|NCT05478356|Mydriatics|mydriatics|mesh-ancestor
25354502|NCT05478356|Parasympatholytics|parasympatholytics|mesh-ancestor
25354503|NCT05478356|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25354504|NCT05478356|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25354505|NCT05478356|Cholinergic Agents|cholinergic agents|mesh-ancestor
25354506|NCT05478356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25354507|NCT05478356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354508|NCT05478330|Flutamide|flutamide|mesh-list
25354509|NCT05478330|Androgen Antagonists|androgen antagonists|mesh-ancestor
25354510|NCT05478330|Hormone Antagonists|hormone antagonists|mesh-ancestor
25354511|NCT05478330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25354512|NCT05478330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354513|NCT05478330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25354514|NCT05478330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354515|NCT05478291|Vitamin D|vitamin d|mesh-list
25354516|NCT05478291|Vitamins|vitamins|mesh-ancestor
25354517|NCT05478291|Micronutrients|micronutrients|mesh-ancestor
25354518|NCT05478291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354519|NCT05478291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25354520|NCT05478278|Moxifloxacin|moxifloxacin|mesh-list
25354521|NCT05478278|Psilocybin|psilocybin|mesh-list
25354522|NCT05478278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25354523|NCT05478278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25354524|NCT05478278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25354525|NCT05478278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25354526|NCT05478278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25354527|NCT05478278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354528|NCT05478278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354529|NCT05478278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354530|NCT05478278|Hallucinogens|hallucinogens|mesh-ancestor
25354531|NCT05478278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25354532|NCT05478174|Propofol|propofol|mesh-list
25354533|NCT05478174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25354534|NCT05478174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25354535|NCT05478174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354536|NCT05478174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25354537|NCT05478174|Anesthetics, General|anesthetics, general|mesh-ancestor
25354538|NCT05478174|Anesthetics|anesthetics|mesh-ancestor
25354539|NCT05478161|Fexofenadine|fexofenadine|mesh-list
25354540|NCT05478161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25354541|NCT05478161|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25354542|NCT05478161|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25354543|NCT05478161|Histamine Antagonists|histamine antagonists|mesh-ancestor
25354544|NCT05478161|Histamine Agents|histamine agents|mesh-ancestor
25354545|NCT05478161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25354546|NCT05478161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354547|NCT05478161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354548|NCT05478083|Leuprolide|leuprolide|mesh-list
25354549|NCT05478083|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25354550|NCT05478083|Fertility Agents|fertility agents|mesh-ancestor
25354551|NCT05478083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25354552|NCT05478083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354553|NCT05478083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25354554|NCT05478083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354555|NCT05478044|Ascorbic Acid|ascorbic acid|mesh-list
25354556|NCT05478044|Vitamins|vitamins|mesh-ancestor
25354557|NCT05478044|Micronutrients|micronutrients|mesh-ancestor
25354558|NCT05478044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354559|NCT05478044|Antioxidants|antioxidants|mesh-ancestor
25354560|NCT05478044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354561|NCT05478044|Protective Agents|protective agents|mesh-ancestor
25354562|NCT05477953|Nifurtimox|nifurtimox|mesh-list
25354563|NCT05477953|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25354564|NCT05477953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25354565|NCT05477953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25354566|NCT05477953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25354567|NCT05477875|Acetaminophen|acetaminophen|mesh-list
25354568|NCT05477875|Codeine|codeine|mesh-list
25354569|NCT05477875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25354570|NCT05477875|Analgesics|analgesics|mesh-ancestor
25354571|NCT05477875|Sensory System Agents|sensory system agents|mesh-ancestor
25354572|NCT05477875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25354573|NCT05477875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354574|NCT05477875|Antipyretics|antipyretics|mesh-ancestor
25354575|NCT05477875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25354576|NCT05477875|Narcotics|narcotics|mesh-ancestor
25354577|NCT05477875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25354578|NCT05477875|Antitussive Agents|antitussive agents|mesh-ancestor
25354579|NCT05477875|Respiratory System Agents|respiratory system agents|mesh-ancestor
25354580|NCT05477823|Androgens|androgens|mesh-list
25354581|NCT05477823|Hormones|hormones|mesh-ancestor
25408304|NCT03450343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25354582|NCT05477823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25354583|NCT05477823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354584|NCT05477797|Lenalidomide|lenalidomide|mesh-list
25354585|NCT05477797|Ixazomib|ixazomib|mesh-list
25354586|NCT05477797|Immunologic Factors|immunologic factors|mesh-ancestor
25354587|NCT05477797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354588|NCT05477797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25354589|NCT05477797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25354590|NCT05477797|Growth Substances|growth substances|mesh-ancestor
25354591|NCT05477797|Growth Inhibitors|growth inhibitors|mesh-ancestor
25354592|NCT05477797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354593|NCT05477797|Protease Inhibitors|protease inhibitors|mesh-ancestor
25354594|NCT05477797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25354595|NCT05477797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354596|NCT05477615|Carboplatin|carboplatin|mesh-list
25354598|NCT05477615|Lazertinib|lazertinib|mesh-list
25354599|NCT05477615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354600|NCT05477615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25354601|NCT05477615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354602|NCT05477615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25354603|NCT05477615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25354604|NCT05477615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25354605|NCT05477589|Cyclophosphamide|cyclophosphamide|mesh-list
25354606|NCT05477589|Melphalan|melphalan|mesh-list
25354607|NCT05477589|Busulfan|busulfan|mesh-list
25354608|NCT05477589|Fludarabine|fludarabine|mesh-list
25354609|NCT05477589|Clofarabine|clofarabine|mesh-list
25354610|NCT05477589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25354611|NCT05477589|Immunologic Factors|immunologic factors|mesh-ancestor
25354612|NCT05477589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354613|NCT05477589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25354614|NCT05477589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25354615|NCT05477589|Alkylating Agents|alkylating agents|mesh-ancestor
25354616|NCT05477589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354617|NCT05477589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354618|NCT05477589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25354619|NCT05477589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25354620|NCT05477589|Antimetabolites|antimetabolites|mesh-ancestor
25354621|NCT05477576|Everolimus|everolimus|mesh-list
25354622|NCT05477576|Sunitinib|sunitinib|mesh-list
25354623|NCT05477576|Octreotide|octreotide|mesh-list
25354624|NCT05477576|Lanreotide|lanreotide|mesh-list
25354625|NCT05477576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354626|NCT05477576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25354627|NCT05477576|Immunologic Factors|immunologic factors|mesh-ancestor
25354628|NCT05477576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354629|NCT05477576|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25354630|NCT05477576|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25354631|NCT05477576|Growth Substances|growth substances|mesh-ancestor
25354632|NCT05477576|Growth Inhibitors|growth inhibitors|mesh-ancestor
25354633|NCT05477576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25354634|NCT05477576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25354635|NCT05477576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354636|NCT05477576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25354637|NCT05477576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25354638|NCT05477485|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25354639|NCT05477485|Antiviral Agents|antiviral agents|mesh-ancestor
25354640|NCT05477485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25354641|NCT05477459|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
25354642|NCT05477459|Hallucinogens|hallucinogens|mesh-ancestor
25354643|NCT05477459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354644|NCT05477459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25354645|NCT05477459|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25354646|NCT05477459|Serotonin Agents|serotonin agents|mesh-ancestor
25354647|NCT05477459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25354648|NCT05477459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354649|NCT05477459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25354650|NCT05477108|Budesonide|budesonide|mesh-list
25354651|NCT05477108|Formoterol Fumarate|formoterol fumarate|mesh-list
25354652|NCT05477108|Charcoal|charcoal|mesh-list
25354653|NCT05477108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25354654|NCT05477108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25354655|NCT05477108|Autonomic Agents|autonomic agents|mesh-ancestor
25354656|NCT05477108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25354657|NCT05477108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354658|NCT05477108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25354659|NCT05477108|Respiratory System Agents|respiratory system agents|mesh-ancestor
25354660|NCT05477108|Glucocorticoids|glucocorticoids|mesh-ancestor
25354661|NCT05477108|Hormones|hormones|mesh-ancestor
25354662|NCT05477108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25354663|NCT05477108|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25354664|NCT05477108|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25354665|NCT05477108|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25354666|NCT05477108|Adrenergic Agents|adrenergic agents|mesh-ancestor
25354667|NCT05477108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25354668|NCT05477108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354669|NCT05477108|Antidotes|antidotes|mesh-ancestor
25354670|NCT05477108|Protective Agents|protective agents|mesh-ancestor
25354671|NCT05477017|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25354672|NCT05477017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354673|NCT05477017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25354674|NCT05477017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354675|NCT05477004|Ketamine|ketamine|mesh-list
25354676|NCT05477004|Analgesics|analgesics|mesh-ancestor
25354677|NCT05477004|Sensory System Agents|sensory system agents|mesh-ancestor
25354678|NCT05477004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25354679|NCT05477004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354680|NCT05477004|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25354681|NCT05477004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25354682|NCT05477004|Anesthetics, General|anesthetics, general|mesh-ancestor
25354683|NCT05477004|Anesthetics|anesthetics|mesh-ancestor
25354684|NCT05477004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25354685|NCT05477004|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25354686|NCT05477004|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25354687|NCT05477004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25354688|NCT05477004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354689|NCT05476991|Aspirin|aspirin|mesh-list
25354690|NCT05476991|Colchicine|colchicine|mesh-list
25354691|NCT05476991|Ticagrelor|ticagrelor|mesh-list
25354692|NCT05476991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25354693|NCT05476991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25354694|NCT05476991|Analgesics|analgesics|mesh-ancestor
25354695|NCT05476991|Sensory System Agents|sensory system agents|mesh-ancestor
25354696|NCT05476991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25354697|NCT05476991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354698|NCT05476991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25354699|NCT05476991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25354700|NCT05476991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25354701|NCT05476991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25354702|NCT05476991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354703|NCT05476991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25354704|NCT05476991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25354705|NCT05476991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25354706|NCT05476991|Antipyretics|antipyretics|mesh-ancestor
25354707|NCT05476991|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25354708|NCT05476991|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25354709|NCT05476991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25354710|NCT05476991|Purinergic Agents|purinergic agents|mesh-ancestor
25354711|NCT05476991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25354712|NCT05476991|Gout Suppressants|gout suppressants|mesh-ancestor
25354713|NCT05476991|Tubulin Modulators|tubulin modulators|mesh-ancestor
25354714|NCT05476991|Antimitotic Agents|antimitotic agents|mesh-ancestor
25354715|NCT05476991|Mitosis Modulators|mitosis modulators|mesh-ancestor
25354716|NCT05476991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354717|NCT05476952|Rocuronium|rocuronium|mesh-list
25354718|NCT05476952|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25354719|NCT05476952|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25354720|NCT05476952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25354721|NCT05476952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25354722|NCT05476952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354723|NCT05476939|Everolimus|everolimus|mesh-list
25354724|NCT05476939|TIC10 compound|tic10 compound|mesh-list
25354725|NCT05476939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354726|NCT05476939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25354727|NCT05476939|Immunologic Factors|immunologic factors|mesh-ancestor
25354728|NCT05476939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354729|NCT05476926|Ranibizumab|ranibizumab|mesh-list
25354730|NCT05476926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25354731|NCT05476926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25354732|NCT05476926|Growth Substances|growth substances|mesh-ancestor
25354733|NCT05476926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354734|NCT05476926|Growth Inhibitors|growth inhibitors|mesh-ancestor
25354735|NCT05476926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354736|NCT05476822|Antibodies|antibodies|mesh-list
25354737|NCT05476822|Immunologic Factors|immunologic factors|mesh-ancestor
25354738|NCT05476822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354739|NCT05476796|Trifluridine|trifluridine|mesh-list
25354740|NCT05476796|Oxaliplatin|oxaliplatin|mesh-list
25354741|NCT05476796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354742|NCT05476796|Antimetabolites|antimetabolites|mesh-ancestor
25354743|NCT05476796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354744|NCT05476796|Antiviral Agents|antiviral agents|mesh-ancestor
25354745|NCT05476796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25354746|NCT05476770|Cytarabine|cytarabine|mesh-list
25354747|NCT05476770|Dexamethasone|dexamethasone|mesh-list
25354748|NCT05476770|Hydrocortisone|hydrocortisone|mesh-list
25354749|NCT05476770|Methotrexate|methotrexate|mesh-list
25354750|NCT05476770|Fludarabine|fludarabine|mesh-list
25354751|NCT05476770|Vincristine|vincristine|mesh-list
25354752|NCT05476770|Azacitidine|azacitidine|mesh-list
25354753|NCT05476770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25354754|NCT05476770|Antiemetics|antiemetics|mesh-ancestor
25354755|NCT05476770|Autonomic Agents|autonomic agents|mesh-ancestor
25354756|NCT05476770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25354757|NCT05476770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354758|NCT05476770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25354759|NCT05476770|Glucocorticoids|glucocorticoids|mesh-ancestor
25354760|NCT05476770|Hormones|hormones|mesh-ancestor
25354761|NCT05476770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25354762|NCT05476770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25354763|NCT05476770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354764|NCT05476770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25354765|NCT05476770|Abortifacient Agents|abortifacient agents|mesh-ancestor
25354766|NCT05476770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25354767|NCT05476770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25354768|NCT05476770|Antimetabolites|antimetabolites|mesh-ancestor
25354769|NCT05476770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354770|NCT05476770|Dermatologic Agents|dermatologic agents|mesh-ancestor
25354771|NCT05476770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25354772|NCT05476770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25354773|NCT05476770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25354774|NCT05476770|Immunologic Factors|immunologic factors|mesh-ancestor
25354775|NCT05476770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25354776|NCT05476770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25354777|NCT05476770|Antiviral Agents|antiviral agents|mesh-ancestor
25354778|NCT05476770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25354779|NCT05476770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25354780|NCT05476770|Tubulin Modulators|tubulin modulators|mesh-ancestor
25354781|NCT05476770|Antimitotic Agents|antimitotic agents|mesh-ancestor
25354782|NCT05476770|Mitosis Modulators|mitosis modulators|mesh-ancestor
25354783|NCT05476731|Antifungal Agents|antifungal agents|mesh-list
25354784|NCT05476731|Clotrimazole|clotrimazole|mesh-list
25354785|NCT05476731|Miconazole|miconazole|mesh-list
25354786|NCT05476731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25354787|NCT05476731|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25354788|NCT05476731|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25354789|NCT05476731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25354790|NCT05476731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25354791|NCT05476731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354792|NCT05476731|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25354793|NCT05476731|Hormone Antagonists|hormone antagonists|mesh-ancestor
25354794|NCT05476731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25354795|NCT05476731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354796|NCT05476731|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25354797|NCT05476731|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25354799|NCT05476679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25354800|NCT05476679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25354801|NCT05476679|Analgesics|analgesics|mesh-ancestor
25354802|NCT05476679|Sensory System Agents|sensory system agents|mesh-ancestor
25354803|NCT05476679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25354804|NCT05476679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354805|NCT05476679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25354806|NCT05476679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25387351|NCT04443088|Pembrolizumab|pembrolizumab|mesh-list
25354807|NCT05476679|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25354808|NCT05476679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25354809|NCT05476679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25354810|NCT05476679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354811|NCT05476432|Leucovorin|leucovorin|mesh-list
25354812|NCT05476432|Fluorouracil|fluorouracil|mesh-list
25354813|NCT05476432|Oxaliplatin|oxaliplatin|mesh-list
25354814|NCT05476432|Antimetabolites|antimetabolites|mesh-ancestor
25354815|NCT05476432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354816|NCT05476432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25354817|NCT05476432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354818|NCT05476432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25354819|NCT05476432|Immunologic Factors|immunologic factors|mesh-ancestor
25354820|NCT05476432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354821|NCT05476432|Antidotes|antidotes|mesh-ancestor
25354822|NCT05476432|Protective Agents|protective agents|mesh-ancestor
25354823|NCT05476432|Vitamin B Complex|vitamin b complex|mesh-ancestor
25354824|NCT05476432|Vitamins|vitamins|mesh-ancestor
25354825|NCT05476432|Micronutrients|micronutrients|mesh-ancestor
25354826|NCT05476380|Paclitaxel|paclitaxel|mesh-list
25354827|NCT05476380|Cisplatin|cisplatin|mesh-list
25354828|NCT05476380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25354829|NCT05476380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354830|NCT05476380|Tubulin Modulators|tubulin modulators|mesh-ancestor
25354831|NCT05476380|Antimitotic Agents|antimitotic agents|mesh-ancestor
25354832|NCT05476380|Mitosis Modulators|mitosis modulators|mesh-ancestor
25354833|NCT05476380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354834|NCT05476354|Amlodipine|amlodipine|mesh-list
25354835|NCT05476354|Irbesartan|irbesartan|mesh-list
25354836|NCT05476354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25354837|NCT05476354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25354838|NCT05476354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25354839|NCT05476354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354840|NCT05476354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25354841|NCT05476354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354842|NCT05476354|Vasodilator Agents|vasodilator agents|mesh-ancestor
25354843|NCT05476354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25354844|NCT05476354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25354845|NCT05476341|Bevacizumab|bevacizumab|mesh-list
25354846|NCT05476341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25354847|NCT05476341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354848|NCT05476341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25354849|NCT05476341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25354850|NCT05476341|Growth Substances|growth substances|mesh-ancestor
25354851|NCT05476341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354852|NCT05476341|Growth Inhibitors|growth inhibitors|mesh-ancestor
25354853|NCT05476198|Anesthetics|anesthetics|mesh-list
25354854|NCT05476198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25354855|NCT05476198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354856|NCT05476172|Dienogest|dienogest|mesh-list
25354857|NCT05476172|Norethindrone|norethindrone|mesh-list
25354858|NCT05476172|Norethindrone Acetate|norethindrone acetate|mesh-list
25354859|NCT05476172|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25354860|NCT05476172|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25354861|NCT05476172|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25354862|NCT05476172|Contraceptive Agents|contraceptive agents|mesh-ancestor
25354863|NCT05476172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25354864|NCT05476172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354865|NCT05476172|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25354866|NCT05476172|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25354867|NCT05476172|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25354868|NCT05476172|Hormone Antagonists|hormone antagonists|mesh-ancestor
25354869|NCT05476172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25354870|NCT05476172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25354871|NCT05476172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354872|NCT05476094|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
25354873|NCT05476094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25354875|NCT05476094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354876|NCT05476094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25354877|NCT05476081|Aspirin|aspirin|mesh-list
25354878|NCT05476081|Clopidogrel|clopidogrel|mesh-list
25354879|NCT05476081|Ticagrelor|ticagrelor|mesh-list
25408305|NCT03450343|Antimetabolites|antimetabolites|mesh-ancestor
25772317|NCT03678870|Analgesics, Opioid|analgesics, opioid|mesh-list
25354880|NCT05476081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25354881|NCT05476081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25354882|NCT05476081|Analgesics|analgesics|mesh-ancestor
25354883|NCT05476081|Sensory System Agents|sensory system agents|mesh-ancestor
25354884|NCT05476081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25354885|NCT05476081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354886|NCT05476081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25354887|NCT05476081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25354888|NCT05476081|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25354889|NCT05476081|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25354890|NCT05476081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354891|NCT05476081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25354892|NCT05476081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25354893|NCT05476081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25354894|NCT05476081|Antipyretics|antipyretics|mesh-ancestor
25354895|NCT05476081|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25354896|NCT05476081|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25354897|NCT05476081|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25354898|NCT05476081|Purinergic Agents|purinergic agents|mesh-ancestor
25354899|NCT05476081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25354900|NCT05476042|Epoetin Alfa|epoetin alfa|mesh-list
25354901|NCT05476042|Hematinics|hematinics|mesh-ancestor
25354902|NCT05476003|Midazolam|midazolam|mesh-list
25354903|NCT05476003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25354904|NCT05476003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25354905|NCT05476003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25354906|NCT05476003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354907|NCT05476003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25354908|NCT05476003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25354909|NCT05476003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25354910|NCT05476003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25354911|NCT05476003|Anesthetics, General|anesthetics, general|mesh-ancestor
25354912|NCT05476003|Anesthetics|anesthetics|mesh-ancestor
25354913|NCT05476003|GABA Modulators|gaba modulators|mesh-ancestor
25354914|NCT05476003|GABA Agents|gaba agents|mesh-ancestor
25354915|NCT05476003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25354916|NCT05476003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354917|NCT05475886|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
25354918|NCT05475886|Plasma Substitutes|plasma substitutes|mesh-ancestor
25354919|NCT05475886|Blood Substitutes|blood substitutes|mesh-ancestor
25354920|NCT05475873|Ondansetron|ondansetron|mesh-list
25354921|NCT05475873|Antiemetics|antiemetics|mesh-ancestor
25354922|NCT05475873|Autonomic Agents|autonomic agents|mesh-ancestor
25354923|NCT05475873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25354924|NCT05475873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354925|NCT05475873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25354926|NCT05475873|Antipruritics|antipruritics|mesh-ancestor
25354927|NCT05475873|Dermatologic Agents|dermatologic agents|mesh-ancestor
25354928|NCT05475873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25354929|NCT05475873|Serotonin Agents|serotonin agents|mesh-ancestor
25354930|NCT05475873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25354931|NCT05475873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354932|NCT05475873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25354933|NCT05475873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25354934|NCT05475873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25354935|NCT05475873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25354936|NCT05475873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25354937|NCT05475717|Alprostadil|alprostadil|mesh-list
25354938|NCT05475717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25354939|NCT05475717|Vasodilator Agents|vasodilator agents|mesh-ancestor
25354940|NCT05475717|Urological Agents|urological agents|mesh-ancestor
25354941|NCT05475678|Carboplatin|carboplatin|mesh-list
25354942|NCT05475678|Docetaxel|docetaxel|mesh-list
25354943|NCT05475678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354944|NCT05475678|Tubulin Modulators|tubulin modulators|mesh-ancestor
25354945|NCT05475678|Antimitotic Agents|antimitotic agents|mesh-ancestor
25354946|NCT05475678|Mitosis Modulators|mitosis modulators|mesh-ancestor
25354947|NCT05475678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354948|NCT05475665|Amlodipine|amlodipine|mesh-list
25354949|NCT05475665|Irbesartan|irbesartan|mesh-list
25354950|NCT05475665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25354951|NCT05475665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25354952|NCT05475665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25354953|NCT05475665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354954|NCT05475665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25772318|NCT03678870|Narcotics|narcotics|mesh-ancestor
25354955|NCT05475665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354956|NCT05475665|Vasodilator Agents|vasodilator agents|mesh-ancestor
25354957|NCT05475665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25354958|NCT05475665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25354959|NCT05475639|Diclofenac|diclofenac|mesh-list
25354960|NCT05475639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25354961|NCT05475639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25354962|NCT05475639|Analgesics|analgesics|mesh-ancestor
25354963|NCT05475639|Sensory System Agents|sensory system agents|mesh-ancestor
25354964|NCT05475639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25354965|NCT05475639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354966|NCT05475639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25354967|NCT05475639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25354968|NCT05475639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25354969|NCT05475639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25354970|NCT05475639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354972|NCT05475613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25354973|NCT05475613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25354974|NCT05475613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25354975|NCT05475613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25354976|NCT05475613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354977|NCT05475561|Bupivacaine|bupivacaine|mesh-list
25354978|NCT05475561|Anesthetics, Local|anesthetics, local|mesh-ancestor
25354979|NCT05475561|Anesthetics|anesthetics|mesh-ancestor
25354980|NCT05475561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25354981|NCT05475561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354982|NCT05475561|Sensory System Agents|sensory system agents|mesh-ancestor
25354983|NCT05475561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25354984|NCT05475522|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25354985|NCT05475522|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25354986|NCT05475522|Dermatologic Agents|dermatologic agents|mesh-ancestor
25354987|NCT05475483|Bevantolol|bevantolol|mesh-list
25354988|NCT05475483|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25354989|NCT05475483|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25354990|NCT05475483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25354991|NCT05475483|Adrenergic Agents|adrenergic agents|mesh-ancestor
25354992|NCT05475483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25354993|NCT05475483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25354994|NCT05475483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25354995|NCT05475444|Ciprofloxacin|ciprofloxacin|mesh-list
25354996|NCT05475444|Chitosan|chitosan|mesh-list
25354997|NCT05475444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25354998|NCT05475444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25354999|NCT05475444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25355000|NCT05475444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25355001|NCT05475444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355002|NCT05475444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355003|NCT05475444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355004|NCT05475444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25355005|NCT05475444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25355006|NCT05475444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25355007|NCT05475444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25355008|NCT05475444|Antimetabolites|antimetabolites|mesh-ancestor
25355009|NCT05475444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25355010|NCT05475444|Chelating Agents|chelating agents|mesh-ancestor
25355011|NCT05475444|Sequestering Agents|sequestering agents|mesh-ancestor
25355012|NCT05475444|Hemostatics|hemostatics|mesh-ancestor
25355013|NCT05475444|Coagulants|coagulants|mesh-ancestor
25355014|NCT05475431|Bismuth|bismuth|mesh-list
25355015|NCT05475431|Antacids|antacids|mesh-ancestor
25355016|NCT05475431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355017|NCT05475431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25355018|NCT05475379|Vaccines|vaccines|mesh-list
25355019|NCT05475379|Immunologic Factors|immunologic factors|mesh-ancestor
25355020|NCT05475379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355021|NCT05475223|Carbon Monoxide|carbon monoxide|mesh-list
25355022|NCT05475223|Antimetabolites|antimetabolites|mesh-ancestor
25355023|NCT05475223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355024|NCT05475223|Gasotransmitters|gasotransmitters|mesh-ancestor
25355025|NCT05475223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25355026|NCT05475223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355027|NCT05475080|Anticoagulants|anticoagulants|mesh-list
25355028|NCT05475080|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25355029|NCT05474898|Magnesium Sulfate|magnesium sulfate|mesh-list
25355036|NCT05474898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25355037|NCT05474898|Anticonvulsants|anticonvulsants|mesh-ancestor
25355038|NCT05474898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25355039|NCT05474898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25355040|NCT05474898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355041|NCT05474898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25355042|NCT05474898|Tocolytic Agents|tocolytic agents|mesh-ancestor
25355043|NCT05474898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25355044|NCT05474846|Melatonin|melatonin|mesh-list
25355045|NCT05474846|Methylphenidate|methylphenidate|mesh-list
25355046|NCT05474846|Antioxidants|antioxidants|mesh-ancestor
25355047|NCT05474846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355048|NCT05474846|Protective Agents|protective agents|mesh-ancestor
25355049|NCT05474846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355050|NCT05474846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25355051|NCT05474846|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25355052|NCT05474846|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25355053|NCT05474846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25355054|NCT05474846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25355055|NCT05474846|Dopamine Agents|dopamine agents|mesh-ancestor
25355056|NCT05474846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25355057|NCT05474027|Antihypertensive Agents|antihypertensive agents|mesh-list
25355058|NCT05474027|Tranexamic Acid|tranexamic acid|mesh-list
25355059|NCT05474027|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25355060|NCT05474027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25355061|NCT05474027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355062|NCT05474027|Hemostatics|hemostatics|mesh-ancestor
25355063|NCT05474027|Coagulants|coagulants|mesh-ancestor
25355064|NCT05473910|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
25355065|NCT05473910|Antioxidants|antioxidants|mesh-ancestor
25355066|NCT05473910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355067|NCT05473910|Protective Agents|protective agents|mesh-ancestor
25355068|NCT05473910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355069|NCT05473910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25355070|NCT05473910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355071|NCT05473715|Aflibercept|aflibercept|mesh-list
25355072|NCT05473715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25355073|NCT05473715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25355074|NCT05473715|Growth Substances|growth substances|mesh-ancestor
25355075|NCT05473715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355076|NCT05473715|Growth Inhibitors|growth inhibitors|mesh-ancestor
25355077|NCT05473715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355078|NCT05473585|Nicotine|nicotine|mesh-list
25355079|NCT05473585|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25355080|NCT05473585|Autonomic Agents|autonomic agents|mesh-ancestor
25355081|NCT05473585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25355082|NCT05473585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355083|NCT05473585|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25355084|NCT05473585|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25355085|NCT05473585|Cholinergic Agents|cholinergic agents|mesh-ancestor
25355086|NCT05473585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25355087|NCT05473585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355094|NCT05473364|Acetazolamide|acetazolamide|mesh-list
25355095|NCT05473364|Anticonvulsants|anticonvulsants|mesh-ancestor
25355096|NCT05473364|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25355097|NCT05473364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355098|NCT05473364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355099|NCT05473364|Diuretics|diuretics|mesh-ancestor
25355100|NCT05473364|Natriuretic Agents|natriuretic agents|mesh-ancestor
25355101|NCT05473364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355103|NCT05473195|Ethionamide|ethionamide|mesh-list
25355104|NCT05473195|Antitubercular Agents|antitubercular agents|mesh-ancestor
25355105|NCT05473195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25355106|NCT05473195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25355107|NCT05473195|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25355108|NCT05473195|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25355109|NCT05473195|Antimetabolites|antimetabolites|mesh-ancestor
25355110|NCT05473195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355111|NCT05473195|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25355112|NCT05472766|Anticoagulants|anticoagulants|mesh-list
25355113|NCT05472766|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
25355114|NCT05472766|Antithrombins|antithrombins|mesh-ancestor
25355115|NCT05472766|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25355116|NCT05472766|Protease Inhibitors|protease inhibitors|mesh-ancestor
25355117|NCT05472766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355118|NCT05472766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355120|NCT05472506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25355121|NCT05472506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355122|NCT05472506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25355123|NCT05472506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355124|NCT05472337|Colchicine|colchicine|mesh-list
25355125|NCT05472337|Gout Suppressants|gout suppressants|mesh-ancestor
25355126|NCT05472337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25355127|NCT05472337|Tubulin Modulators|tubulin modulators|mesh-ancestor
25355128|NCT05472337|Antimitotic Agents|antimitotic agents|mesh-ancestor
25355129|NCT05472337|Mitosis Modulators|mitosis modulators|mesh-ancestor
25355130|NCT05472337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355131|NCT05472337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355132|NCT05472259|Leucovorin|leucovorin|mesh-list
25355133|NCT05472259|Fluorouracil|fluorouracil|mesh-list
25355134|NCT05472259|Oxaliplatin|oxaliplatin|mesh-list
25355135|NCT05472259|Irinotecan|irinotecan|mesh-list
25355136|NCT05472259|Antimetabolites|antimetabolites|mesh-ancestor
25355137|NCT05472259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355138|NCT05472259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25355139|NCT05472259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355140|NCT05472259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25355141|NCT05472259|Immunologic Factors|immunologic factors|mesh-ancestor
25355142|NCT05472259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355143|NCT05472259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25355144|NCT05472259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25355145|NCT05472259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355146|NCT05472259|Antidotes|antidotes|mesh-ancestor
25355147|NCT05472259|Protective Agents|protective agents|mesh-ancestor
25355148|NCT05472259|Vitamin B Complex|vitamin b complex|mesh-ancestor
25355149|NCT05472259|Vitamins|vitamins|mesh-ancestor
25355150|NCT05472259|Micronutrients|micronutrients|mesh-ancestor
25355151|NCT05471947|Glycolic acid|glycolic acid|mesh-list
25355152|NCT05471947|Keratolytic Agents|keratolytic agents|mesh-ancestor
25355153|NCT05471947|Dermatologic Agents|dermatologic agents|mesh-ancestor
25355154|NCT05471830|Apixaban|apixaban|mesh-list
25355155|NCT05471830|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25355156|NCT05471830|Antithrombins|antithrombins|mesh-ancestor
25355157|NCT05471830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25355158|NCT05471830|Protease Inhibitors|protease inhibitors|mesh-ancestor
25355159|NCT05471830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355160|NCT05471830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355161|NCT05471830|Anticoagulants|anticoagulants|mesh-ancestor
25355162|NCT05471817|Dabigatran|dabigatran|mesh-list
25355163|NCT05471817|Antithrombins|antithrombins|mesh-ancestor
25355164|NCT05471817|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25355165|NCT05471817|Protease Inhibitors|protease inhibitors|mesh-ancestor
25355166|NCT05471817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355167|NCT05471817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355168|NCT05471817|Anticoagulants|anticoagulants|mesh-ancestor
25355169|NCT05471661|PENTA|penta|mesh-list
25355170|NCT05471661|Anticoagulants|anticoagulants|mesh-ancestor
25355171|NCT05471661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25355172|NCT05471661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25355173|NCT05471661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355174|NCT05471544|Pyrimethamine|pyrimethamine|mesh-list
25355175|NCT05471544|Sulfadoxine|sulfadoxine|mesh-list
25355176|NCT05471544|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25355177|NCT05471544|Amodiaquine|amodiaquine|mesh-list
25355178|NCT05471544|Antimalarials|antimalarials|mesh-ancestor
25355179|NCT05471544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25355180|NCT05471544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25355181|NCT05471544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25355182|NCT05471544|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25355183|NCT05471544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355184|NCT05471544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355185|NCT05471544|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25355187|NCT05471076|Complement C4b|complement c4b|mesh-list
25355188|NCT05471076|Immunologic Factors|immunologic factors|mesh-ancestor
25355189|NCT05471076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355190|NCT05470985|Ozanimod|ozanimod|mesh-list
25355191|NCT05470985|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25355192|NCT05470985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355193|NCT05470985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25355194|NCT05470985|Immunologic Factors|immunologic factors|mesh-ancestor
25355195|NCT05470985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355205|NCT05470868|Respiratory System Agents|respiratory system agents|mesh-ancestor
25355206|NCT05470699|Fluorides|fluorides|mesh-list
25355207|NCT05470699|Cariostatic Agents|cariostatic agents|mesh-ancestor
25355208|NCT05470699|Protective Agents|protective agents|mesh-ancestor
25355209|NCT05470699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355210|NCT05470673|Metronidazole|metronidazole|mesh-list
25355211|NCT05470673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25355212|NCT05470673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25355213|NCT05470673|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25355214|NCT05470673|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25355215|NCT05470517|Ceftriaxone|ceftriaxone|mesh-list
25355216|NCT05470517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25355217|NCT05470517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25355228|NCT05470400|Vaccines|vaccines|mesh-list
25355229|NCT05470400|Immunologic Factors|immunologic factors|mesh-ancestor
25355230|NCT05470400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355231|NCT05470283|Vidarabine|vidarabine|mesh-list
25355232|NCT05470283|Cyclophosphamide|cyclophosphamide|mesh-list
25355233|NCT05470283|Fludarabine|fludarabine|mesh-list
25355234|NCT05470283|Fludarabine phosphate|fludarabine phosphate|mesh-list
25355235|NCT05470283|Furosemide|furosemide|mesh-list
25355236|NCT05470283|Acetazolamide|acetazolamide|mesh-list
25355237|NCT05470283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25355238|NCT05470283|Immunologic Factors|immunologic factors|mesh-ancestor
25355239|NCT05470283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355240|NCT05470283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25355241|NCT05470283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25355242|NCT05470283|Alkylating Agents|alkylating agents|mesh-ancestor
25355243|NCT05470283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355244|NCT05470283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355245|NCT05470283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25355246|NCT05470283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25355247|NCT05470283|Antimetabolites|antimetabolites|mesh-ancestor
25355248|NCT05470283|Antiviral Agents|antiviral agents|mesh-ancestor
25355249|NCT05470283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25355250|NCT05470283|Diuretics|diuretics|mesh-ancestor
25355251|NCT05470283|Natriuretic Agents|natriuretic agents|mesh-ancestor
25355252|NCT05470283|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25355253|NCT05470283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25355254|NCT05470283|Anticonvulsants|anticonvulsants|mesh-ancestor
25355255|NCT05470283|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25355256|NCT05470283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355257|NCT05470075|Tramadol|tramadol|mesh-list
25355258|NCT05470075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25355259|NCT05470075|Narcotics|narcotics|mesh-ancestor
25355260|NCT05470075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25355261|NCT05470075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355262|NCT05470075|Analgesics|analgesics|mesh-ancestor
25355263|NCT05470075|Sensory System Agents|sensory system agents|mesh-ancestor
25355264|NCT05470075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25355265|NCT05469893|Dexamethasone|dexamethasone|mesh-list
25355266|NCT05469893|Lenalidomide|lenalidomide|mesh-list
25355267|NCT05469893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25355268|NCT05469893|Antiemetics|antiemetics|mesh-ancestor
25355269|NCT05469893|Autonomic Agents|autonomic agents|mesh-ancestor
25355270|NCT05469893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25355271|NCT05469893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355272|NCT05469893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25355273|NCT05469893|Glucocorticoids|glucocorticoids|mesh-ancestor
25355274|NCT05469893|Hormones|hormones|mesh-ancestor
25355275|NCT05469893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25355276|NCT05469893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25355280|NCT05469893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25355281|NCT05469893|Growth Substances|growth substances|mesh-ancestor
25355282|NCT05469893|Growth Inhibitors|growth inhibitors|mesh-ancestor
25355283|NCT05469737|Azacitidine|azacitidine|mesh-list
25355284|NCT05469737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25355285|NCT05469737|Antimetabolites|antimetabolites|mesh-ancestor
25355286|NCT05469737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355287|NCT05469737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355288|NCT05469737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355289|NCT05469685|Amoxicillin|amoxicillin|mesh-list
25355290|NCT05469685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25355291|NCT05469685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25355292|NCT05469178|Carboplatin|carboplatin|mesh-list
25355293|NCT05469178|Pembrolizumab|pembrolizumab|mesh-list
25355294|NCT05469178|Pemetrexed|pemetrexed|mesh-list
25355295|NCT05469178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355296|NCT05469178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25355297|NCT05469178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355298|NCT05469178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355299|NCT05469178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25355300|NCT05469178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25355301|NCT05469126|Clarithromycin|clarithromycin|mesh-list
25355302|NCT05469126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25355303|NCT05469126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25355304|NCT05469126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25355305|NCT05469126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355306|NCT05469126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355307|NCT05469126|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25355308|NCT05469126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25355309|NCT05468957|Hemostatics|hemostatics|mesh-list
25355310|NCT05468957|Coagulants|coagulants|mesh-ancestor
25355311|NCT05468697|Palbociclib|palbociclib|mesh-list
25355312|NCT05468697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355313|NCT05468697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25355314|NCT05468697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355315|NCT05468697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355316|NCT05468671|Remifentanil|remifentanil|mesh-list
25355317|NCT05468671|Oxycodone|oxycodone|mesh-list
25355318|NCT05468671|Propofol|propofol|mesh-list
25355319|NCT05468671|Rocuronium|rocuronium|mesh-list
25355320|NCT05468671|Flumazenil|flumazenil|mesh-list
25355321|NCT05468671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25355322|NCT05468671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25355323|NCT05468671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355324|NCT05468671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25355325|NCT05468671|Anesthetics, General|anesthetics, general|mesh-ancestor
25355326|NCT05468671|Anesthetics|anesthetics|mesh-ancestor
25355327|NCT05468671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25355328|NCT05468671|Narcotics|narcotics|mesh-ancestor
25355329|NCT05468671|Analgesics|analgesics|mesh-ancestor
25355330|NCT05468671|Sensory System Agents|sensory system agents|mesh-ancestor
25355331|NCT05468671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25355332|NCT05468671|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25355333|NCT05468671|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25355334|NCT05468671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25355335|NCT05468671|Antidotes|antidotes|mesh-ancestor
25355336|NCT05468671|Protective Agents|protective agents|mesh-ancestor
25355337|NCT05468671|GABA Modulators|gaba modulators|mesh-ancestor
25355338|NCT05468671|GABA Agents|gaba agents|mesh-ancestor
25355339|NCT05468671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25355340|NCT05468671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355344|NCT05468554|Metformin|metformin|mesh-list
25355345|NCT05468554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25355346|NCT05468554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355347|NCT05468359|Cyclophosphamide|cyclophosphamide|mesh-list
25355348|NCT05468359|Bevacizumab|bevacizumab|mesh-list
25355349|NCT05468359|Sorafenib|sorafenib|mesh-list
25355350|NCT05468359|Atezolizumab|atezolizumab|mesh-list
25355426|NCT05466734|Autonomic Agents|autonomic agents|mesh-ancestor
25355351|NCT05468359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25355352|NCT05468359|Immunologic Factors|immunologic factors|mesh-ancestor
25355353|NCT05468359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25387884|NCT04423029|Nivolumab|nivolumab|mesh-list
25355354|NCT05468359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25355355|NCT05468359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25355356|NCT05468359|Alkylating Agents|alkylating agents|mesh-ancestor
25355357|NCT05468359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355358|NCT05468359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355359|NCT05468359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25355360|NCT05468359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25355361|NCT05468359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25355362|NCT05468359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25355363|NCT05468359|Growth Substances|growth substances|mesh-ancestor
25355364|NCT05468359|Growth Inhibitors|growth inhibitors|mesh-ancestor
25355365|NCT05468359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25355366|NCT05468359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355367|NCT05468320|Prednisone|prednisone|mesh-list
25355368|NCT05468320|Prednisolone|prednisolone|mesh-list
25355369|NCT05468320|Antibodies|antibodies|mesh-list
25355370|NCT05468320|Immunologic Factors|immunologic factors|mesh-ancestor
25355371|NCT05468320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355372|NCT05468320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355373|NCT05468320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25355374|NCT05468320|Glucocorticoids|glucocorticoids|mesh-ancestor
25355375|NCT05468320|Hormones|hormones|mesh-ancestor
25355376|NCT05468320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25355377|NCT05468320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25355378|NCT05468138|Antibodies|antibodies|mesh-list
25355379|NCT05468138|Immunologic Factors|immunologic factors|mesh-ancestor
25355380|NCT05468138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355381|NCT05467891|Letrozole|letrozole|mesh-list
25355382|NCT05467891|Fulvestrant|fulvestrant|mesh-list
25355383|NCT05467891|Anastrozole|anastrozole|mesh-list
25355384|NCT05467891|Exemestane|exemestane|mesh-list
25355385|NCT05467891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355386|NCT05467891|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25355387|NCT05467891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25355388|NCT05467891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
24517904|NCT00610545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25355389|NCT05467891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355390|NCT05467891|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25355391|NCT05467891|Hormone Antagonists|hormone antagonists|mesh-ancestor
25355688|NCT05459571|Antiemetics|antiemetics|mesh-ancestor
25355392|NCT05467891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25355393|NCT05467891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355394|NCT05467891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25355395|NCT05467891|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25355396|NCT05467475|Esomeprazole|esomeprazole|mesh-list
25355397|NCT05467475|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25355398|NCT05467475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25355399|NCT05467475|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25355400|NCT05467475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355401|NCT05467475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355402|NCT05467462|Tranexamic Acid|tranexamic acid|mesh-list
25355404|NCT05467462|Carbetocin|carbetocin|mesh-list
25355405|NCT05467462|Oxytocics|oxytocics|mesh-ancestor
25355406|NCT05467462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25355407|NCT05467462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355408|NCT05467462|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25355409|NCT05467462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25355410|NCT05467462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355411|NCT05467462|Hemostatics|hemostatics|mesh-ancestor
25355412|NCT05467462|Coagulants|coagulants|mesh-ancestor
25355413|NCT05467176|Relugolix|relugolix|mesh-list
25355414|NCT05467176|Androgen Antagonists|androgen antagonists|mesh-ancestor
25355415|NCT05467176|Hormone Antagonists|hormone antagonists|mesh-ancestor
25355416|NCT05467176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25355417|NCT05467176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355418|NCT05466747|Protease Inhibitors|protease inhibitors|mesh-list
25355419|NCT05466747|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25355420|NCT05466747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355421|NCT05466747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355422|NCT05466747|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25355423|NCT05466747|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25355424|NCT05466734|Cilostazol|cilostazol|mesh-list
25355425|NCT05466734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25355427|NCT05466734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25772319|NCT03678870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25355428|NCT05466734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355429|NCT05466734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25355430|NCT05466734|Respiratory System Agents|respiratory system agents|mesh-ancestor
25355431|NCT05466734|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25355432|NCT05466734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25355433|NCT05466734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355434|NCT05466734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25355435|NCT05466734|Vasodilator Agents|vasodilator agents|mesh-ancestor
25355436|NCT05466734|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25355437|NCT05466734|Protective Agents|protective agents|mesh-ancestor
25355438|NCT05466734|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25355439|NCT05466734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25355440|NCT05466734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355441|NCT05466500|Dexamethasone|dexamethasone|mesh-list
25355442|NCT05466500|Dexamethasone acetate|dexamethasone acetate|mesh-list
25355443|NCT05466500|Bupivacaine|bupivacaine|mesh-list
25355444|NCT05466500|BB 1101|bb 1101|mesh-list
25355445|NCT05466500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25355446|NCT05466500|Antiemetics|antiemetics|mesh-ancestor
25355447|NCT05466500|Autonomic Agents|autonomic agents|mesh-ancestor
25355448|NCT05466500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25355449|NCT05466500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355450|NCT05466500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25355451|NCT05466500|Glucocorticoids|glucocorticoids|mesh-ancestor
25355452|NCT05466500|Hormones|hormones|mesh-ancestor
25355453|NCT05466500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25355454|NCT05466500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25355455|NCT05466500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355456|NCT05466500|Protease Inhibitors|protease inhibitors|mesh-ancestor
25355457|NCT05466500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355458|NCT05466500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355459|NCT05466500|Anesthetics, Local|anesthetics, local|mesh-ancestor
25355460|NCT05466500|Anesthetics|anesthetics|mesh-ancestor
25355461|NCT05466500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25355462|NCT05466500|Sensory System Agents|sensory system agents|mesh-ancestor
25355463|NCT05466474|Dacarbazine|dacarbazine|mesh-list
25355464|NCT05466474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25355465|NCT05466474|Alkylating Agents|alkylating agents|mesh-ancestor
25355466|NCT05466474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355467|NCT05466474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355468|NCT05466175|Prednisone|prednisone|mesh-list
25355469|NCT05466175|Vincristine|vincristine|mesh-list
25355470|NCT05466175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25355471|NCT05466175|Glucocorticoids|glucocorticoids|mesh-ancestor
25355472|NCT05466175|Hormones|hormones|mesh-ancestor
25355473|NCT05466175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25355474|NCT05466175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355475|NCT05466175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25355476|NCT05466175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355477|NCT05466175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25355478|NCT05466175|Tubulin Modulators|tubulin modulators|mesh-ancestor
25355479|NCT05466175|Antimitotic Agents|antimitotic agents|mesh-ancestor
25355480|NCT05466175|Mitosis Modulators|mitosis modulators|mesh-ancestor
25355481|NCT05466175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355482|NCT05465954|Pembrolizumab|pembrolizumab|mesh-list
25355483|NCT05465954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25355484|NCT05465954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355485|NCT05465941|Irinotecan|irinotecan|mesh-list
25355486|NCT05465941|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25355487|NCT05465941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25355488|NCT05465941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355489|NCT05465941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355490|NCT05465941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355491|NCT05465317|Empagliflozin|empagliflozin|mesh-list
25355492|NCT05465317|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25355493|NCT05465317|Glucagon|glucagon|mesh-list
25355494|NCT05465317|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25355495|NCT05465317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355496|NCT05465317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25355497|NCT05465317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355498|NCT05465317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25355499|NCT05465317|Hormones|hormones|mesh-ancestor
25355571|NCT05463848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355503|NCT05465226|Narcotics|narcotics|mesh-ancestor
25388046|NCT04412707|Melphalan|melphalan|mesh-list
25355504|NCT05465226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25355505|NCT05465226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355506|NCT05465226|Analgesics|analgesics|mesh-ancestor
25355507|NCT05465226|Sensory System Agents|sensory system agents|mesh-ancestor
25355508|NCT05465226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25355509|NCT05465174|Nivolumab|nivolumab|mesh-list
25355510|NCT05465174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25355511|NCT05465174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355512|NCT05465174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25355513|NCT05465174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355514|NCT05464810|Letrozole|letrozole|mesh-list
25355515|NCT05464810|Simvastatin|simvastatin|mesh-list
25355516|NCT05464810|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25355517|NCT05464810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25355518|NCT05464810|Antimetabolites|antimetabolites|mesh-ancestor
25355519|NCT05464810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355520|NCT05464810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25355521|NCT05464810|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25355522|NCT05464810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355523|NCT05464810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355524|NCT05464810|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25355525|NCT05464810|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25355526|NCT05464810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25355527|NCT05464810|Hormone Antagonists|hormone antagonists|mesh-ancestor
25355528|NCT05464810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25355529|NCT05464810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355530|NCT05464719|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
25355531|NCT05464719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25355532|NCT05464719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355533|NCT05464628|Atorvastatin|atorvastatin|mesh-list
25355534|NCT05464628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25355535|NCT05464628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25355536|NCT05464628|Antimetabolites|antimetabolites|mesh-ancestor
25355537|NCT05464628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355538|NCT05464628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25355539|NCT05464628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25355540|NCT05464628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355544|NCT05464173|Fulvestrant|fulvestrant|mesh-list
25355545|NCT05464173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25355546|NCT05464173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355547|NCT05464173|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25355548|NCT05464173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25355549|NCT05464173|Hormone Antagonists|hormone antagonists|mesh-ancestor
25355550|NCT05464173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25355551|NCT05464173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355552|NCT05463965|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25355553|NCT05463965|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25355554|NCT05463965|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25355555|NCT05463965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25355556|NCT05463965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355557|NCT05463965|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25355558|NCT05463965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25355559|NCT05463965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355560|NCT05463965|Cholinergic Agents|cholinergic agents|mesh-ancestor
25355561|NCT05463965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25355562|NCT05463848|Pembrolizumab|pembrolizumab|mesh-list
25355563|NCT05463848|Temozolomide|temozolomide|mesh-list
25355564|NCT05463848|Olaparib|olaparib|mesh-list
25355565|NCT05463848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25355566|NCT05463848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355567|NCT05463848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25355568|NCT05463848|Alkylating Agents|alkylating agents|mesh-ancestor
25355569|NCT05463848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355570|NCT05463848|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25355572|NCT05463744|Insulin|insulin|mesh-list
25355573|NCT05463744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25355574|NCT05463744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355575|NCT05463341|Fentanyl|fentanyl|mesh-list
25355576|NCT05463341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25355577|NCT05463341|Narcotics|narcotics|mesh-ancestor
25724213|NCT02535806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25388129|NCT04410653|Afatinib|afatinib|mesh-list
25355578|NCT05463341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25355579|NCT05463341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355580|NCT05463341|Analgesics|analgesics|mesh-ancestor
25355581|NCT05463341|Sensory System Agents|sensory system agents|mesh-ancestor
25355582|NCT05463341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25355583|NCT05463341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25355584|NCT05463341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25355585|NCT05463341|Anesthetics, General|anesthetics, general|mesh-ancestor
25355586|NCT05463341|Anesthetics|anesthetics|mesh-ancestor
25355587|NCT05463094|Metformin|metformin|mesh-list
25355588|NCT05463094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25355589|NCT05463094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355590|NCT05462756|Insulin|insulin|mesh-list
25355591|NCT05462756|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25355592|NCT05462756|Insulin Glargine|insulin glargine|mesh-list
25355593|NCT05462756|Insulin Lispro|insulin lispro|mesh-list
25355594|NCT05462756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25355595|NCT05462756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355596|NCT05462730|Methylprednisolone|methylprednisolone|mesh-list
25355597|NCT05462730|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25355598|NCT05462730|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25355599|NCT05462730|Prednisolone|prednisolone|mesh-list
25355600|NCT05462730|Prednisolone acetate|prednisolone acetate|mesh-list
25355601|NCT05462730|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25355602|NCT05462730|Prednisolone phosphate|prednisolone phosphate|mesh-list
25355603|NCT05462730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25355604|NCT05462730|Antiemetics|antiemetics|mesh-ancestor
24519719|NCT05242874|Fosaprepitant|fosaprepitant|mesh-list
25355605|NCT05462730|Autonomic Agents|autonomic agents|mesh-ancestor
25355606|NCT05462730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25355607|NCT05462730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355608|NCT05462730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25355609|NCT05462730|Glucocorticoids|glucocorticoids|mesh-ancestor
25355610|NCT05462730|Hormones|hormones|mesh-ancestor
25355611|NCT05462730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25355612|NCT05462730|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25355613|NCT05462730|Protective Agents|protective agents|mesh-ancestor
25355614|NCT05462730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25355615|NCT05462730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355616|NCT05461807|Rivaroxaban|rivaroxaban|mesh-list
25355617|NCT05461807|Apixaban|apixaban|mesh-list
25355618|NCT05461807|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25355619|NCT05461807|Antithrombins|antithrombins|mesh-ancestor
25355620|NCT05461807|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25355621|NCT05461807|Protease Inhibitors|protease inhibitors|mesh-ancestor
25355622|NCT05461807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355623|NCT05461807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355624|NCT05461807|Anticoagulants|anticoagulants|mesh-ancestor
25355625|NCT05461794|Docetaxel|docetaxel|mesh-list
25355626|NCT05461794|Irinotecan|irinotecan|mesh-list
25355627|NCT05461794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355628|NCT05461794|Tubulin Modulators|tubulin modulators|mesh-ancestor
25355629|NCT05461794|Antimitotic Agents|antimitotic agents|mesh-ancestor
25355630|NCT05461794|Mitosis Modulators|mitosis modulators|mesh-ancestor
25355631|NCT05461794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355632|NCT05461794|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25355633|NCT05461794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25355634|NCT05461794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355635|NCT05461573|Drospirenone|drospirenone|mesh-list
25355636|NCT05461573|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25355637|NCT05461573|Hormone Antagonists|hormone antagonists|mesh-ancestor
25355638|NCT05461573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25355639|NCT05461573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355640|NCT05461573|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25355641|NCT05461573|Diuretics|diuretics|mesh-ancestor
25355642|NCT05461573|Natriuretic Agents|natriuretic agents|mesh-ancestor
25355643|NCT05461456|Fexofenadine|fexofenadine|mesh-list
25355644|NCT05461456|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25355645|NCT05461456|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25355646|NCT05461456|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25355647|NCT05461456|Histamine Antagonists|histamine antagonists|mesh-ancestor
25355648|NCT05461456|Histamine Agents|histamine agents|mesh-ancestor
25355649|NCT05461456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25355650|NCT05461456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355651|NCT05461456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355652|NCT05460871|Pregabalin|pregabalin|mesh-list
25724214|NCT02535806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25355653|NCT05460871|Analgesics|analgesics|mesh-ancestor
25355654|NCT05460871|Sensory System Agents|sensory system agents|mesh-ancestor
25355655|NCT05460871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25355656|NCT05460871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355657|NCT05460871|Anticonvulsants|anticonvulsants|mesh-ancestor
25355658|NCT05460871|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25355659|NCT05460871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25355660|NCT05460871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355661|NCT05460871|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25355662|NCT05460871|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25355663|NCT05460871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25355664|NCT05460871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25355665|NCT05460871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25355666|NCT05460455|Antibodies|antibodies|mesh-list
25355667|NCT05460455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25355668|NCT05460455|Immunologic Factors|immunologic factors|mesh-ancestor
25355669|NCT05460455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355670|NCT05459701|Dapagliflozin|dapagliflozin|mesh-list
25355671|NCT05459701|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25355672|NCT05459701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355673|NCT05459701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25355674|NCT05459701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355675|NCT05459571|Dexamethasone|dexamethasone|mesh-list
25355676|NCT05459571|Cyclophosphamide|cyclophosphamide|mesh-list
25355677|NCT05459571|Fludarabine|fludarabine|mesh-list
25355678|NCT05459571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25355679|NCT05459571|Immunologic Factors|immunologic factors|mesh-ancestor
25355680|NCT05459571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355681|NCT05459571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25355682|NCT05459571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25355683|NCT05459571|Alkylating Agents|alkylating agents|mesh-ancestor
25355684|NCT05459571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355685|NCT05459571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355686|NCT05459571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25355687|NCT05459571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25355689|NCT05459571|Autonomic Agents|autonomic agents|mesh-ancestor
25355690|NCT05459571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25355691|NCT05459571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25355692|NCT05459571|Glucocorticoids|glucocorticoids|mesh-ancestor
25355694|NCT05459571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25355695|NCT05459571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25355696|NCT05459402|Methadone|methadone|mesh-list
25355697|NCT05459402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25355698|NCT05459402|Narcotics|narcotics|mesh-ancestor
25355699|NCT05459402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25355700|NCT05459402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355701|NCT05459402|Analgesics|analgesics|mesh-ancestor
25355702|NCT05459402|Sensory System Agents|sensory system agents|mesh-ancestor
25355703|NCT05459402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25355704|NCT05459402|Antitussive Agents|antitussive agents|mesh-ancestor
25355705|NCT05459402|Respiratory System Agents|respiratory system agents|mesh-ancestor
25355706|NCT05459389|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25355707|NCT05459389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25355708|NCT05459298|Vitamin D|vitamin d|mesh-list
25355709|NCT05459298|Cholecalciferol|cholecalciferol|mesh-list
25355710|NCT05459298|Vitamins|vitamins|mesh-ancestor
25355711|NCT05459298|Micronutrients|micronutrients|mesh-ancestor
25355712|NCT05459298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355713|NCT05459298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25355714|NCT05459298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25355715|NCT05459285|Dulaglutide|dulaglutide|mesh-list
25355716|NCT05459285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25355717|NCT05459285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355718|NCT05459194|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
25355719|NCT05459194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25355720|NCT05459194|Autonomic Agents|autonomic agents|mesh-ancestor
25355721|NCT05459194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25355722|NCT05459194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355723|NCT05459194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25355724|NCT05459194|Respiratory System Agents|respiratory system agents|mesh-ancestor
25355725|NCT05459194|Glucocorticoids|glucocorticoids|mesh-ancestor
25355726|NCT05459194|Hormones|hormones|mesh-ancestor
25724215|NCT02535806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355727|NCT05459194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25355728|NCT05459194|Sympathomimetics|sympathomimetics|mesh-ancestor
25355729|NCT05459129|Paclitaxel|paclitaxel|mesh-list
25355730|NCT05459129|Carboplatin|carboplatin|mesh-list
25355731|NCT05459129|Atezolizumab|atezolizumab|mesh-list
25355732|NCT05459129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25355733|NCT05459129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355734|NCT05459129|Tubulin Modulators|tubulin modulators|mesh-ancestor
25355735|NCT05459129|Antimitotic Agents|antimitotic agents|mesh-ancestor
25355736|NCT05459129|Mitosis Modulators|mitosis modulators|mesh-ancestor
25355737|NCT05459129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355738|NCT05458856|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25355739|NCT05458856|Luteolytic Agents|luteolytic agents|mesh-ancestor
25355740|NCT05458856|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25355741|NCT05458856|Contraceptive Agents|contraceptive agents|mesh-ancestor
25355742|NCT05458856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25355743|NCT05458856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355744|NCT05458856|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25355745|NCT05458856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25355746|NCT05458856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355747|NCT05458609|Naltrexone|naltrexone|mesh-list
25355748|NCT05458609|Lemborexant|lemborexant|mesh-list
25355749|NCT05458609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25355750|NCT05458609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25355751|NCT05458609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355752|NCT05458609|Sensory System Agents|sensory system agents|mesh-ancestor
25355753|NCT05458609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25355754|NCT05458609|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25355755|NCT05458609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25355756|NCT05458609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355757|NCT05458609|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25355758|NCT05458609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25355759|NCT05458609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25355760|NCT05458453|Esketamine|esketamine|mesh-list
25355761|NCT05458453|Antidepressive Agents|antidepressive agents|mesh-ancestor
25355762|NCT05458453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25355763|NCT05458232|Tadalafil|tadalafil|mesh-list
25355764|NCT05458232|Vasodilator Agents|vasodilator agents|mesh-ancestor
25355765|NCT05458232|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25355766|NCT05458232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25355767|NCT05458232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355768|NCT05458232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355769|NCT05458232|Urological Agents|urological agents|mesh-ancestor
25355770|NCT05458102|Voriconazole|voriconazole|mesh-list
25355771|NCT05458102|Cobicistat|cobicistat|mesh-list
25355772|NCT05458102|Rifabutin|rifabutin|mesh-list
25355773|NCT05458102|Vesatolimod|vesatolimod|mesh-list
25355774|NCT05458102|Antifungal Agents|antifungal agents|mesh-ancestor
25355775|NCT05458102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25355776|NCT05458102|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25355777|NCT05458102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25355778|NCT05458102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355779|NCT05458102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355780|NCT05458102|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25355781|NCT05458102|Hormone Antagonists|hormone antagonists|mesh-ancestor
25355782|NCT05458102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25355783|NCT05458102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355784|NCT05458102|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25355785|NCT05458102|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25355786|NCT05458102|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25355787|NCT05458102|Antiviral Agents|antiviral agents|mesh-ancestor
25355788|NCT05458102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25355789|NCT05458102|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25355790|NCT05458102|Antitubercular Agents|antitubercular agents|mesh-ancestor
25355791|NCT05458024|Vitamin D|vitamin d|mesh-list
25355792|NCT05458024|Ergocalciferols|ergocalciferols|mesh-list
25355793|NCT05458024|Cholecalciferol|cholecalciferol|mesh-list
25355794|NCT05458024|Vitamins|vitamins|mesh-list
25355795|NCT05458024|Micronutrients|micronutrients|mesh-ancestor
25355796|NCT05458024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355797|NCT05458024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25355798|NCT05458024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25355799|NCT05457933|Dapagliflozin|dapagliflozin|mesh-list
25355800|NCT05457933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25355801|NCT05457933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355802|NCT05457933|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25355803|NCT05457933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355804|NCT05457868|Albuterol|albuterol|mesh-list
25355805|NCT05457868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25355806|NCT05457868|Autonomic Agents|autonomic agents|mesh-ancestor
25355807|NCT05457868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25355808|NCT05457868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355809|NCT05457868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25355810|NCT05457868|Respiratory System Agents|respiratory system agents|mesh-ancestor
25355811|NCT05457868|Tocolytic Agents|tocolytic agents|mesh-ancestor
25355812|NCT05457868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25355813|NCT05457868|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25355814|NCT05457868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25355815|NCT05457868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25355816|NCT05457868|Adrenergic Agents|adrenergic agents|mesh-ancestor
25355817|NCT05457868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25355818|NCT05457868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355819|NCT05457582|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
25355820|NCT05457582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25355821|NCT05457582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25355822|NCT05457582|Antimetabolites|antimetabolites|mesh-ancestor
25355823|NCT05457582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355824|NCT05457582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355825|NCT05457582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25355826|NCT05457556|Mycophenolic Acid|mycophenolic acid|mesh-list
25355827|NCT05457556|Cyclophosphamide|cyclophosphamide|mesh-list
25355828|NCT05457556|Melphalan|melphalan|mesh-list
25355829|NCT05457556|Busulfan|busulfan|mesh-list
25355830|NCT05457556|Mechlorethamine|mechlorethamine|mesh-list
25355831|NCT05457556|Thiotepa|thiotepa|mesh-list
25355832|NCT05457556|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25355833|NCT05457556|Rituximab|rituximab|mesh-list
25355834|NCT05457556|Methotrexate|methotrexate|mesh-list
25355835|NCT05457556|Fludarabine|fludarabine|mesh-list
25355836|NCT05457556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25355837|NCT05457556|Tacrolimus|tacrolimus|mesh-list
25355838|NCT05457556|Thymoglobulin|thymoglobulin|mesh-list
25355839|NCT05457556|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25355840|NCT05457556|Antibodies|antibodies|mesh-list
25355841|NCT05457556|Immunoglobulins|immunoglobulins|mesh-list
25355842|NCT05457556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25355843|NCT05457556|gamma-Globulins|gamma-globulins|mesh-list
25355844|NCT05457556|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25355845|NCT05457556|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25355846|NCT05457556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25355847|NCT05457556|Immunologic Factors|immunologic factors|mesh-ancestor
25355848|NCT05457556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355849|NCT05457556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25355850|NCT05457556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25355851|NCT05457556|Alkylating Agents|alkylating agents|mesh-ancestor
25355852|NCT05457556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355853|NCT05457556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355854|NCT05457556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25355855|NCT05457556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25355856|NCT05457556|Abortifacient Agents|abortifacient agents|mesh-ancestor
25355857|NCT05457556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25355858|NCT05457556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25355859|NCT05457556|Antimetabolites|antimetabolites|mesh-ancestor
25355860|NCT05457556|Dermatologic Agents|dermatologic agents|mesh-ancestor
25355861|NCT05457556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355862|NCT05457556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25355863|NCT05457556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25355864|NCT05457556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25355865|NCT05457556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25355866|NCT05457556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25355867|NCT05457556|Antitubercular Agents|antitubercular agents|mesh-ancestor
25355868|NCT05457556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25355869|NCT05457556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25355870|NCT05457257|Prednisone|prednisone|mesh-list
25355871|NCT05457257|Olaparib|olaparib|mesh-list
25355872|NCT05457257|Abiraterone Acetate|abiraterone acetate|mesh-list
25355873|NCT05457257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25355874|NCT05457257|Glucocorticoids|glucocorticoids|mesh-ancestor
25355875|NCT05457257|Hormones|hormones|mesh-ancestor
25355876|NCT05457257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25355877|NCT05457257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355878|NCT05457257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25355879|NCT05457257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355880|NCT05457257|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25355881|NCT05457257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355882|NCT05457257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355883|NCT05457257|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25355884|NCT05457257|Hormone Antagonists|hormone antagonists|mesh-ancestor
25355885|NCT05457257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25355886|NCT05456334|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
25355887|NCT05456334|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25355888|NCT05456334|Dermatologic Agents|dermatologic agents|mesh-ancestor
25355889|NCT05456256|Carboplatin|carboplatin|mesh-list
25355890|NCT05456256|Pemetrexed|pemetrexed|mesh-list
25355891|NCT05456256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355892|NCT05456256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355893|NCT05456256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355894|NCT05456256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25355895|NCT05456256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25355896|NCT05456165|Ipilimumab|ipilimumab|mesh-list
25355897|NCT05456165|Atezolizumab|atezolizumab|mesh-list
25355898|NCT05456165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25355899|NCT05456165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355900|NCT05456165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25355901|NCT05456165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355902|NCT05455931|Mogamulizumab|mogamulizumab|mesh-list
25355903|NCT05455931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355904|NCT05455879|Pulmonary Surfactants|pulmonary surfactants|mesh-list
25355905|NCT05455879|Respiratory System Agents|respiratory system agents|mesh-ancestor
25355906|NCT05455684|Aticaprant|aticaprant|mesh-list
25355907|NCT05455684|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25355908|NCT05455684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355909|NCT05455684|Sensory System Agents|sensory system agents|mesh-ancestor
25355910|NCT05455684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25355911|NCT05455658|Vaccines|vaccines|mesh-list
25355912|NCT05455658|Sargramostim|sargramostim|mesh-list
25355913|NCT05455658|Immunologic Factors|immunologic factors|mesh-ancestor
25355914|NCT05455658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355915|NCT05455320|Dexamethasone|dexamethasone|mesh-list
25355916|NCT05455320|Daratumumab|daratumumab|mesh-list
25355917|NCT05455320|Pomalidomide|pomalidomide|mesh-list
25355918|NCT05455320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25355919|NCT05455320|Antiemetics|antiemetics|mesh-ancestor
25355920|NCT05455320|Autonomic Agents|autonomic agents|mesh-ancestor
25355921|NCT05455320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25355922|NCT05455320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355923|NCT05455320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25355924|NCT05455320|Glucocorticoids|glucocorticoids|mesh-ancestor
25355925|NCT05455320|Hormones|hormones|mesh-ancestor
25355926|NCT05455320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25355927|NCT05455320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25355928|NCT05455320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355929|NCT05455320|Immunologic Factors|immunologic factors|mesh-ancestor
25355930|NCT05455320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25355931|NCT05455320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25355932|NCT05455320|Growth Substances|growth substances|mesh-ancestor
25355933|NCT05455320|Growth Inhibitors|growth inhibitors|mesh-ancestor
25355934|NCT05455047|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25355935|NCT05455047|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25355936|NCT05455047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355937|NCT05454891|Insulin|insulin|mesh-list
25355938|NCT05454891|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25355939|NCT05454891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25355940|NCT05454891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355941|NCT05454358|Letrozole|letrozole|mesh-list
25355942|NCT05454358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355943|NCT05454358|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25355944|NCT05454358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25355945|NCT05454358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355946|NCT05454358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355947|NCT05454358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25355948|NCT05454358|Hormone Antagonists|hormone antagonists|mesh-ancestor
25355949|NCT05454358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25355950|NCT05454358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355951|NCT05453955|Propofol|propofol|mesh-list
25355963|NCT05453903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355964|NCT05453903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355966|NCT05453825|Irinotecan|irinotecan|mesh-list
25355967|NCT05453825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25355968|NCT05453825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25355969|NCT05453825|Tubulin Modulators|tubulin modulators|mesh-ancestor
25355970|NCT05453825|Antimitotic Agents|antimitotic agents|mesh-ancestor
25355971|NCT05453825|Mitosis Modulators|mitosis modulators|mesh-ancestor
25355972|NCT05453825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25355973|NCT05453825|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25355974|NCT05453825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25355975|NCT05453825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25355976|NCT05453799|Antibodies|antibodies|mesh-list
25355977|NCT05453799|Immunoglobulins|immunoglobulins|mesh-list
25355978|NCT05453799|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25355979|NCT05453799|Immunologic Factors|immunologic factors|mesh-ancestor
25355980|NCT05453799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355981|NCT05453487|Vaccines|vaccines|mesh-list
25355982|NCT05453487|Immunologic Factors|immunologic factors|mesh-ancestor
25355983|NCT05453487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25355997|NCT05452174|Mirtazapine|mirtazapine|mesh-list
25355998|NCT05452174|Antidepressive Agents|antidepressive agents|mesh-ancestor
25355999|NCT05452174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25356000|NCT05452174|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25356001|NCT05452174|Histamine Antagonists|histamine antagonists|mesh-ancestor
25356002|NCT05452174|Histamine Agents|histamine agents|mesh-ancestor
25356003|NCT05452174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25356004|NCT05452174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356005|NCT05452174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356006|NCT05452174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25356007|NCT05452174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25356008|NCT05452174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25356009|NCT05452174|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25356010|NCT05452174|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25356011|NCT05452174|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25356012|NCT05452174|Adrenergic Agents|adrenergic agents|mesh-ancestor
25356013|NCT05452174|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25356014|NCT05452174|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25356015|NCT05452174|Serotonin Agents|serotonin agents|mesh-ancestor
25356016|NCT05452174|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25356017|NCT05452070|Lidocaine|lidocaine|mesh-list
25356018|NCT05452070|Anesthetics, Local|anesthetics, local|mesh-ancestor
25356019|NCT05452070|Anesthetics|anesthetics|mesh-ancestor
25356020|NCT05452070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25356021|NCT05452070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356022|NCT05452070|Sensory System Agents|sensory system agents|mesh-ancestor
25356023|NCT05452070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25356024|NCT05452070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25356025|NCT05452070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25356026|NCT05452070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25356027|NCT05452070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25356028|NCT05452070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356029|NCT05451940|Hydroxyurea|hydroxyurea|mesh-list
25356030|NCT05451940|Epoetin Alfa|epoetin alfa|mesh-list
25356031|NCT05451940|Hematinics|hematinics|mesh-list
25356032|NCT05451940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356033|NCT05451940|Antisickling Agents|antisickling agents|mesh-ancestor
25356034|NCT05451940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25356035|NCT05451940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356036|NCT05451940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25356037|NCT05451849|Cyclophosphamide|cyclophosphamide|mesh-list
25356038|NCT05451849|Fludarabine|fludarabine|mesh-list
25356039|NCT05451849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25356040|NCT05451849|Immunologic Factors|immunologic factors|mesh-ancestor
25356041|NCT05451849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356042|NCT05451849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25356043|NCT05451849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25356044|NCT05451849|Alkylating Agents|alkylating agents|mesh-ancestor
25356045|NCT05451849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356046|NCT05451849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356047|NCT05451849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25356048|NCT05451615|Abatacept|abatacept|mesh-list
25356049|NCT05451615|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
25356050|NCT05451615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25356051|NCT05451615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356052|NCT05451615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356053|NCT05451615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25356054|NCT05451615|Immunologic Factors|immunologic factors|mesh-ancestor
25356055|NCT05451615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356056|NCT05451615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25356057|NCT05451615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25356058|NCT05451615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25356060|NCT05451095|Analgesics|analgesics|mesh-ancestor
25356061|NCT05451095|Sensory System Agents|sensory system agents|mesh-ancestor
25356062|NCT05451095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25356063|NCT05451095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356064|NCT05451095|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25356065|NCT05451095|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25356066|NCT05451095|Anesthetics, General|anesthetics, general|mesh-ancestor
25356067|NCT05451095|Anesthetics|anesthetics|mesh-ancestor
25356068|NCT05451095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25356069|NCT05451095|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25356070|NCT05451095|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25356071|NCT05451095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25356072|NCT05451095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356073|NCT05450965|Onvansertib|onvansertib|mesh-list
25356074|NCT05450965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25356075|NCT05450965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25356076|NCT05450965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356077|NCT05450822|Lamotrigine|lamotrigine|mesh-list
25356078|NCT05450822|Levetiracetam|levetiracetam|mesh-list
25356079|NCT05450822|Anticonvulsants|anticonvulsants|mesh-list
25356080|NCT05450822|Nootropic Agents|nootropic agents|mesh-ancestor
25356081|NCT05450822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25356082|NCT05450822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25356083|NCT05450822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356084|NCT05450822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25356085|NCT05450822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356086|NCT05450822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25356087|NCT05450822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25356088|NCT05450822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25356089|NCT05450822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25356090|NCT05450822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25356091|NCT05450562|Cemiplimab|cemiplimab|mesh-list
25356092|NCT05450562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25356093|NCT05450562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356094|NCT05449392|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
25356095|NCT05449392|Petrolatum|petrolatum|mesh-list
25356096|NCT05449392|Emollients|emollients|mesh-ancestor
25356097|NCT05449392|Dermatologic Agents|dermatologic agents|mesh-ancestor
25356098|NCT05449392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25356099|NCT05449392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25356100|NCT05449392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25356101|NCT05448677|Bevacizumab|bevacizumab|mesh-list
25356102|NCT05448677|Atezolizumab|atezolizumab|mesh-list
25356103|NCT05448677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25356104|NCT05448677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356105|NCT05448677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25356106|NCT05448677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25356107|NCT05448677|Growth Substances|growth substances|mesh-ancestor
25356108|NCT05448677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356109|NCT05448677|Growth Inhibitors|growth inhibitors|mesh-ancestor
25356110|NCT05448456|Tranexamic Acid|tranexamic acid|mesh-list
25356111|NCT05448456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25356112|NCT05448456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25356113|NCT05448456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356114|NCT05448456|Hemostatics|hemostatics|mesh-ancestor
25356115|NCT05448456|Coagulants|coagulants|mesh-ancestor
25356117|NCT05448378|Vitamin B Complex|vitamin b complex|mesh-ancestor
25356118|NCT05448378|Vitamins|vitamins|mesh-ancestor
25356119|NCT05448378|Micronutrients|micronutrients|mesh-ancestor
25356120|NCT05448378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356121|NCT05447910|Letrozole|letrozole|mesh-list
25356122|NCT05447910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356123|NCT05447910|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25356124|NCT05447910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25356125|NCT05447910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25356126|NCT05447910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356127|NCT05447910|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25356128|NCT05447910|Hormone Antagonists|hormone antagonists|mesh-ancestor
25356129|NCT05447910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25356130|NCT05447910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356131|NCT05447507|Dexmedetomidine|dexmedetomidine|mesh-list
25356132|NCT05447507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25356133|NCT05447507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25356134|NCT05447507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356135|NCT05447507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25356136|NCT05447507|Analgesics|analgesics|mesh-ancestor
25356137|NCT05447507|Sensory System Agents|sensory system agents|mesh-ancestor
25356138|NCT05447507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25356139|NCT05447507|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25356140|NCT05447507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25356141|NCT05447507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25356142|NCT05447507|Adrenergic Agents|adrenergic agents|mesh-ancestor
25356143|NCT05447507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25356144|NCT05447507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356145|NCT05447286|Oxycodone|oxycodone|mesh-list
25356146|NCT05447286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25356147|NCT05447286|Narcotics|narcotics|mesh-ancestor
25356148|NCT05447286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25356149|NCT05447286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356150|NCT05447286|Analgesics|analgesics|mesh-ancestor
25356151|NCT05447286|Sensory System Agents|sensory system agents|mesh-ancestor
25356152|NCT05447286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25356153|NCT05447065|Vitamin D|vitamin d|mesh-list
25356154|NCT05447065|Vitamins|vitamins|mesh-ancestor
25356155|NCT05447065|Micronutrients|micronutrients|mesh-ancestor
25356156|NCT05447065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356157|NCT05447065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25356158|NCT05446870|Paclitaxel|paclitaxel|mesh-list
25356159|NCT05446870|Docetaxel|docetaxel|mesh-list
25356160|NCT05446870|Bevacizumab|bevacizumab|mesh-list
25356161|NCT05446870|Carboplatin|carboplatin|mesh-list
25356162|NCT05446870|Pembrolizumab|pembrolizumab|mesh-list
25356163|NCT05446870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25356164|NCT05446870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356165|NCT05446870|Tubulin Modulators|tubulin modulators|mesh-ancestor
25356166|NCT05446870|Antimitotic Agents|antimitotic agents|mesh-ancestor
25356167|NCT05446870|Mitosis Modulators|mitosis modulators|mesh-ancestor
25356168|NCT05446870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356169|NCT05446870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25356170|NCT05446870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25356171|NCT05446870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25356172|NCT05446870|Growth Substances|growth substances|mesh-ancestor
25356173|NCT05446870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356174|NCT05446870|Growth Inhibitors|growth inhibitors|mesh-ancestor
25356175|NCT05446571|Valacyclovir|valacyclovir|mesh-list
25356176|NCT05446571|Letermovir|letermovir|mesh-list
25356177|NCT05446571|Antiviral Agents|antiviral agents|mesh-ancestor
25356181|NCT05446571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356187|NCT05446142|Rabeprazole|rabeprazole|mesh-list
25356188|NCT05446142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25356189|NCT05446142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25356190|NCT05446142|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25356191|NCT05446142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25356192|NCT05446142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356193|NCT05446129|Pembrolizumab|pembrolizumab|mesh-list
25356194|NCT05446129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25356195|NCT05446129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356196|NCT05445921|Mepivacaine|mepivacaine|mesh-list
25356197|NCT05445921|Anesthetics, Local|anesthetics, local|mesh-ancestor
25356198|NCT05445921|Anesthetics|anesthetics|mesh-ancestor
25356199|NCT05445921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25356200|NCT05445921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356201|NCT05445921|Sensory System Agents|sensory system agents|mesh-ancestor
25356202|NCT05445921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25356203|NCT05445856|Fentanyl|fentanyl|mesh-list
25356204|NCT05445856|Methadone|methadone|mesh-list
25356205|NCT05445856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25356206|NCT05445856|Narcotics|narcotics|mesh-ancestor
25356207|NCT05445856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25356208|NCT05445856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356209|NCT05445856|Analgesics|analgesics|mesh-ancestor
25356210|NCT05445856|Sensory System Agents|sensory system agents|mesh-ancestor
25356211|NCT05445856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25356212|NCT05445856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25356213|NCT05445856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25356214|NCT05445856|Anesthetics, General|anesthetics, general|mesh-ancestor
25356215|NCT05445856|Anesthetics|anesthetics|mesh-ancestor
25356216|NCT05445856|Antitussive Agents|antitussive agents|mesh-ancestor
25356217|NCT05445856|Respiratory System Agents|respiratory system agents|mesh-ancestor
25356218|NCT05445804|Cannabidiol|cannabidiol|mesh-list
25356219|NCT05445804|Anticonvulsants|anticonvulsants|mesh-ancestor
25356220|NCT05445778|Bevacizumab|bevacizumab|mesh-list
25356221|NCT05445778|Maytansine|maytansine|mesh-list
25356222|NCT05445778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25356223|NCT05445778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356224|NCT05445778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25356225|NCT05445778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25356226|NCT05445778|Growth Substances|growth substances|mesh-ancestor
25356227|NCT05445778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356228|NCT05445778|Growth Inhibitors|growth inhibitors|mesh-ancestor
25356229|NCT05445778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25356230|NCT05445778|Tubulin Modulators|tubulin modulators|mesh-ancestor
25356231|NCT05445778|Antimitotic Agents|antimitotic agents|mesh-ancestor
25356232|NCT05445778|Mitosis Modulators|mitosis modulators|mesh-ancestor
25356233|NCT05445778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356234|NCT05445609|Nivolumab|nivolumab|mesh-list
25356235|NCT05445609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25356236|NCT05445609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356237|NCT05445609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25356238|NCT05445609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356239|NCT05445362|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25356240|NCT05445362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25356241|NCT05445232|Midazolam|midazolam|mesh-list
25356242|NCT05445232|Caffeine|caffeine|mesh-list
25356243|NCT05445232|Warfarin|warfarin|mesh-list
25356244|NCT05445232|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25356245|NCT05445232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25356246|NCT05445232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25356247|NCT05445232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356248|NCT05445232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25356249|NCT05445232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25356250|NCT05445232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25356251|NCT05445232|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25356252|NCT05445232|Anesthetics, General|anesthetics, general|mesh-ancestor
25356253|NCT05445232|Anesthetics|anesthetics|mesh-ancestor
25356254|NCT05445232|GABA Modulators|gaba modulators|mesh-ancestor
25356255|NCT05445232|GABA Agents|gaba agents|mesh-ancestor
25356256|NCT05445232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25356257|NCT05445232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356258|NCT05445232|Anticoagulants|anticoagulants|mesh-ancestor
25356259|NCT05445232|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25356260|NCT05445232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25356261|NCT05445232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25356262|NCT05445232|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25356263|NCT05445232|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25356264|NCT05445232|Purinergic Agents|purinergic agents|mesh-ancestor
25356265|NCT05445128|Plerixafor|plerixafor|mesh-list
25356266|NCT05445128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25356267|NCT05445128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25356268|NCT05445128|Antiviral Agents|antiviral agents|mesh-ancestor
25356269|NCT05445128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25356270|NCT05444699|Prednisolone|prednisolone|mesh-list
25356271|NCT05444699|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25356272|NCT05444699|Methylprednisolone|methylprednisolone|mesh-list
25356273|NCT05444699|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25356274|NCT05444699|Prednisolone acetate|prednisolone acetate|mesh-list
25356275|NCT05444699|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25356276|NCT05444699|Prednisolone phosphate|prednisolone phosphate|mesh-list
25356277|NCT05444699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25356278|NCT05444699|Glucocorticoids|glucocorticoids|mesh-ancestor
25356279|NCT05444699|Hormones|hormones|mesh-ancestor
25356280|NCT05444699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25356281|NCT05444699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356282|NCT05444699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25356283|NCT05444699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356284|NCT05444699|Antiemetics|antiemetics|mesh-ancestor
25356285|NCT05444699|Autonomic Agents|autonomic agents|mesh-ancestor
25356286|NCT05444699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25356287|NCT05444699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25356288|NCT05444699|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25356289|NCT05444699|Protective Agents|protective agents|mesh-ancestor
25356290|NCT05444569|Liraglutide|liraglutide|mesh-list
25356291|NCT05444569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25356292|NCT05444569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356293|NCT05444569|Incretins|incretins|mesh-ancestor
25356294|NCT05444569|Hormones|hormones|mesh-ancestor
25356295|NCT05444569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25356296|NCT05444530|Ipilimumab|ipilimumab|mesh-list
25356297|NCT05444530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25356298|NCT05444530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356299|NCT05444530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25356300|NCT05444530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356301|NCT05444153|Empagliflozin|empagliflozin|mesh-list
25356302|NCT05444153|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25356303|NCT05444153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356304|NCT05444153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25356305|NCT05444153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356306|NCT05444036|Ketamine|ketamine|mesh-list
25356307|NCT05444036|Analgesics|analgesics|mesh-ancestor
25356308|NCT05444036|Sensory System Agents|sensory system agents|mesh-ancestor
25356309|NCT05444036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25356310|NCT05444036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356311|NCT05444036|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25356312|NCT05444036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25356313|NCT05444036|Anesthetics, General|anesthetics, general|mesh-ancestor
25356314|NCT05444036|Anesthetics|anesthetics|mesh-ancestor
25356315|NCT05444036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25356316|NCT05444036|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25356317|NCT05444036|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25356318|NCT05444036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25356319|NCT05444036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356320|NCT05443555|Gabapentin|gabapentin|mesh-list
25356321|NCT05443555|Analgesics|analgesics|mesh-ancestor
25356322|NCT05443555|Sensory System Agents|sensory system agents|mesh-ancestor
25356323|NCT05443555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25356324|NCT05443555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356325|NCT05443555|Anticonvulsants|anticonvulsants|mesh-ancestor
25356326|NCT05443555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25356327|NCT05443555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25356557|NCT05438160|Coal Tar|coal tar|mesh-list
25356338|NCT05442554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25356339|NCT05442554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356351|NCT05442216|Azacitidine|azacitidine|mesh-list
25356352|NCT05442216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25356353|NCT05442216|Antimetabolites|antimetabolites|mesh-ancestor
25356354|NCT05442216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356355|NCT05442216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356356|NCT05442216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25356357|NCT05442060|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25356358|NCT05442060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356359|NCT05442060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25356360|NCT05442060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25356361|NCT05442060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356362|NCT05442034|Mitogens|mitogens|mesh-list
25356363|NCT05442034|Mitosis Modulators|mitosis modulators|mesh-ancestor
25356364|NCT05442034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356365|NCT05441930|Levofloxacin|levofloxacin|mesh-list
25356366|NCT05441930|Ofloxacin|ofloxacin|mesh-list
25356367|NCT05441930|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25356368|NCT05441930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25356370|NCT05441930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25356371|NCT05441930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25356372|NCT05441930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25356373|NCT05441930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25356374|NCT05441930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356375|NCT05441930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356376|NCT05441930|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25356377|NCT05441930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25356378|NCT05441605|Chlorhexidine|chlorhexidine|mesh-list
25356379|NCT05441605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25356380|NCT05441605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25356381|NCT05441605|Disinfectants|disinfectants|mesh-ancestor
25356382|NCT05441592|Tranexamic Acid|tranexamic acid|mesh-list
25356383|NCT05441592|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25356384|NCT05441592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25356385|NCT05441592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356386|NCT05441592|Hemostatics|hemostatics|mesh-ancestor
25356387|NCT05441592|Coagulants|coagulants|mesh-ancestor
25356388|NCT05441527|Muramidase|muramidase|mesh-list
25356389|NCT05441527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25356390|NCT05441280|Pimavanserin|pimavanserin|mesh-list
25356391|NCT05441280|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25356392|NCT05441280|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25356393|NCT05441280|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25356394|NCT05441280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25356395|NCT05441280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25356396|NCT05441280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356397|NCT05441280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25356398|NCT05441280|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25356399|NCT05441280|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25356400|NCT05441280|Serotonin Agents|serotonin agents|mesh-ancestor
25356401|NCT05441280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25356402|NCT05441280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356403|NCT05440916|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25356404|NCT05440916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356405|NCT05440916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356406|NCT05440786|Irinotecan|irinotecan|mesh-list
25356407|NCT05440786|Temozolomide|temozolomide|mesh-list
25356408|NCT05440786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25356409|NCT05440786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25356410|NCT05440786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25356411|NCT05440786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356412|NCT05440786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356413|NCT05440786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25356414|NCT05440786|Alkylating Agents|alkylating agents|mesh-ancestor
25356415|NCT05440734|Melatonin|melatonin|mesh-list
25356416|NCT05440734|Antioxidants|antioxidants|mesh-ancestor
25356417|NCT05440734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356418|NCT05440734|Protective Agents|protective agents|mesh-ancestor
25356419|NCT05440734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356420|NCT05440734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25356421|NCT05440708|Bevacizumab|bevacizumab|mesh-list
25356422|NCT05440708|Pembrolizumab|pembrolizumab|mesh-list
25356423|NCT05440708|Atezolizumab|atezolizumab|mesh-list
25356424|NCT05440708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25356425|NCT05440708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356426|NCT05440708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25356427|NCT05440708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25356428|NCT05440708|Growth Substances|growth substances|mesh-ancestor
25356429|NCT05440708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356430|NCT05440708|Growth Inhibitors|growth inhibitors|mesh-ancestor
25356431|NCT05440201|Enoxaparin|enoxaparin|mesh-list
25356432|NCT05440201|Anticoagulants|anticoagulants|mesh-list
25356433|NCT05440201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25356434|NCT05440201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25356435|NCT05440201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356436|NCT05439902|Tamsulosin|tamsulosin|mesh-list
25356437|NCT05439902|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25356438|NCT05439902|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25356439|NCT05439902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25356440|NCT05439902|Adrenergic Agents|adrenergic agents|mesh-ancestor
25356441|NCT05439902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25356442|NCT05439902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356443|NCT05439902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356444|NCT05439902|Urological Agents|urological agents|mesh-ancestor
25356446|NCT05439876|Antioxidants|antioxidants|mesh-ancestor
25356447|NCT05439876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356448|NCT05439876|Protective Agents|protective agents|mesh-ancestor
25356449|NCT05439876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356450|NCT05439876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25356451|NCT05439694|Tranexamic Acid|tranexamic acid|mesh-list
25356452|NCT05439694|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25356453|NCT05439694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25356466|NCT05439460|Epinephrine|epinephrine|mesh-list
25356467|NCT05439460|Racepinephrine|racepinephrine|mesh-list
25356468|NCT05439460|Oxymetazoline|oxymetazoline|mesh-list
25356469|NCT05439460|Epinephryl borate|epinephryl borate|mesh-list
25356470|NCT05439460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25356471|NCT05439460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25356472|NCT05439460|Adrenergic Agents|adrenergic agents|mesh-ancestor
25356473|NCT05439460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25356474|NCT05439460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356475|NCT05439460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356476|NCT05439460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25356477|NCT05439460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25356478|NCT05439460|Autonomic Agents|autonomic agents|mesh-ancestor
25356479|NCT05439460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25356480|NCT05439460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25356481|NCT05439460|Respiratory System Agents|respiratory system agents|mesh-ancestor
25356482|NCT05439460|Mydriatics|mydriatics|mesh-ancestor
25356483|NCT05439460|Sympathomimetics|sympathomimetics|mesh-ancestor
25356484|NCT05439460|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25356485|NCT05439460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25356486|NCT05439460|Nasal Decongestants|nasal decongestants|mesh-ancestor
25356487|NCT05439460|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25356488|NCT05439460|Protective Agents|protective agents|mesh-ancestor
25356489|NCT05439460|Hemostatics|hemostatics|mesh-ancestor
25356490|NCT05439460|Coagulants|coagulants|mesh-ancestor
25356491|NCT05439460|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
25356492|NCT05439460|Natriuretic Agents|natriuretic agents|mesh-ancestor
25356493|NCT05439356|Colchicine|colchicine|mesh-list
25356494|NCT05439356|Gout Suppressants|gout suppressants|mesh-ancestor
25356495|NCT05439356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25356496|NCT05439356|Tubulin Modulators|tubulin modulators|mesh-ancestor
25356497|NCT05439356|Antimitotic Agents|antimitotic agents|mesh-ancestor
25356498|NCT05439356|Mitosis Modulators|mitosis modulators|mesh-ancestor
25356499|NCT05439356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356500|NCT05439356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356501|NCT05438888|Warfarin|warfarin|mesh-list
25356502|NCT05438888|Apixaban|apixaban|mesh-list
25356503|NCT05438888|Anticoagulants|anticoagulants|mesh-ancestor
25356504|NCT05438888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25356505|NCT05438888|Antithrombins|antithrombins|mesh-ancestor
25356506|NCT05438888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25356507|NCT05438888|Protease Inhibitors|protease inhibitors|mesh-ancestor
25356508|NCT05438888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25356509|NCT05438888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356510|NCT05438602|Ritonavir|ritonavir|mesh-list
25356511|NCT05438602|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25356512|NCT05438602|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25356513|NCT05438602|Protease Inhibitors|protease inhibitors|mesh-ancestor
25356514|NCT05438602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25356515|NCT05438602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356516|NCT05438602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25356517|NCT05438602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25356518|NCT05438602|Antiviral Agents|antiviral agents|mesh-ancestor
25356519|NCT05438602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25356520|NCT05438602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25356521|NCT05438602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25356522|NCT05438303|Celecoxib|celecoxib|mesh-list
25356523|NCT05438303|Midazolam|midazolam|mesh-list
25356524|NCT05438303|Omeprazole|omeprazole|mesh-list
25356525|NCT05438303|Dabigatran|dabigatran|mesh-list
25356526|NCT05438303|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25356527|NCT05438303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25356528|NCT05438303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25356529|NCT05438303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356530|NCT05438303|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25356531|NCT05438303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25356532|NCT05438303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25356533|NCT05438303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25356534|NCT05438303|Anesthetics, General|anesthetics, general|mesh-ancestor
25356535|NCT05438303|Anesthetics|anesthetics|mesh-ancestor
25356536|NCT05438303|GABA Modulators|gaba modulators|mesh-ancestor
25356537|NCT05438303|GABA Agents|gaba agents|mesh-ancestor
25356538|NCT05438303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25356539|NCT05438303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356540|NCT05438303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25356541|NCT05438303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25356542|NCT05438303|Analgesics|analgesics|mesh-ancestor
25356543|NCT05438303|Sensory System Agents|sensory system agents|mesh-ancestor
25356544|NCT05438303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25356545|NCT05438303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25356546|NCT05438303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25356547|NCT05438303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25356548|NCT05438303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25356549|NCT05438303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25356550|NCT05438303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25356551|NCT05438303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25356552|NCT05438303|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25356553|NCT05438303|Antithrombins|antithrombins|mesh-ancestor
25356554|NCT05438303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25356555|NCT05438303|Protease Inhibitors|protease inhibitors|mesh-ancestor
25356556|NCT05438303|Anticoagulants|anticoagulants|mesh-ancestor
25356558|NCT05438160|Keratolytic Agents|keratolytic agents|mesh-ancestor
25356559|NCT05438160|Dermatologic Agents|dermatologic agents|mesh-ancestor
25356560|NCT05438043|Dexamethasone|dexamethasone|mesh-list
25356561|NCT05438043|Lenalidomide|lenalidomide|mesh-list
25356562|NCT05438043|Daratumumab|daratumumab|mesh-list
25356563|NCT05438043|Pomalidomide|pomalidomide|mesh-list
25356564|NCT05438043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25356565|NCT05438043|Antiemetics|antiemetics|mesh-ancestor
25356566|NCT05438043|Autonomic Agents|autonomic agents|mesh-ancestor
25356567|NCT05438043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25356568|NCT05438043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356569|NCT05438043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25356570|NCT05438043|Glucocorticoids|glucocorticoids|mesh-ancestor
25356571|NCT05438043|Hormones|hormones|mesh-ancestor
25356572|NCT05438043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25356573|NCT05438043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25356574|NCT05438043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356575|NCT05438043|Immunologic Factors|immunologic factors|mesh-ancestor
25356576|NCT05438043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25356577|NCT05438043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25356578|NCT05438043|Growth Substances|growth substances|mesh-ancestor
25356579|NCT05438043|Growth Inhibitors|growth inhibitors|mesh-ancestor
25356580|NCT05437887|Fucoidan|fucoidan|mesh-list
25356581|NCT05437887|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25356582|NCT05437887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25356583|NCT05437887|Anticoagulants|anticoagulants|mesh-ancestor
25356584|NCT05437887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356585|NCT05436886|Gabapentin|gabapentin|mesh-list
25356586|NCT05436886|Analgesics|analgesics|mesh-ancestor
25356587|NCT05436886|Sensory System Agents|sensory system agents|mesh-ancestor
25356588|NCT05436886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25356589|NCT05436886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356590|NCT05436886|Anticonvulsants|anticonvulsants|mesh-ancestor
25356591|NCT05436886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25356592|NCT05436886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25356593|NCT05436886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25356594|NCT05436886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25356595|NCT05436886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25356596|NCT05436886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25356597|NCT05436886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25356598|NCT05436886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356599|NCT05436886|Antimanic Agents|antimanic agents|mesh-ancestor
25356600|NCT05436769|Clarithromycin|clarithromycin|mesh-list
25356601|NCT05436769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25356602|NCT05436769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25356603|NCT05436769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25356604|NCT05436769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25356605|NCT05436769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356606|NCT05436769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25356607|NCT05436769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25356608|NCT05436652|Prednisolone|prednisolone|mesh-list
25356609|NCT05436652|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25356610|NCT05436652|Methylprednisolone|methylprednisolone|mesh-list
25356611|NCT05436652|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25356612|NCT05436652|Prednisolone acetate|prednisolone acetate|mesh-list
25356613|NCT05436652|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25356614|NCT05436652|Prednisolone phosphate|prednisolone phosphate|mesh-list
25356615|NCT05436652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25356616|NCT05436652|Glucocorticoids|glucocorticoids|mesh-ancestor
25356617|NCT05436652|Hormones|hormones|mesh-ancestor
25356618|NCT05436652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25356619|NCT05436652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356620|NCT05436652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25356621|NCT05436652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356622|NCT05436652|Antiemetics|antiemetics|mesh-ancestor
25356623|NCT05436652|Autonomic Agents|autonomic agents|mesh-ancestor
25356624|NCT05436652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25356625|NCT05436652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25356626|NCT05436652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25356627|NCT05436652|Protective Agents|protective agents|mesh-ancestor
25356628|NCT05436535|Triamcinolone|triamcinolone|mesh-list
25356629|NCT05436535|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25356630|NCT05436535|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25356631|NCT05436535|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25356632|NCT05436535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25356633|NCT05436535|Glucocorticoids|glucocorticoids|mesh-ancestor
25356634|NCT05436535|Hormones|hormones|mesh-ancestor
25356667|NCT05435911|Protective Agents|protective agents|mesh-ancestor
25356669|NCT05435911|GABA Agents|gaba agents|mesh-ancestor
25356670|NCT05435911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25356895|NCT05429268|Immunologic Factors|immunologic factors|mesh-ancestor
25356671|NCT05435911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356672|NCT05435846|Trametinib|trametinib|mesh-list
25356673|NCT05435846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356674|NCT05435846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25356675|NCT05435846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25356676|NCT05435846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356677|NCT05435768|Denosumab|denosumab|mesh-list
25356678|NCT05435768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25356679|NCT05435768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356680|NCT05435573|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
25356681|NCT05435573|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25356682|NCT05435573|Plasma Substitutes|plasma substitutes|mesh-ancestor
25356683|NCT05435573|Blood Substitutes|blood substitutes|mesh-ancestor
25356684|NCT05435547|Dexamethasone|dexamethasone|mesh-list
25356685|NCT05435547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25356686|NCT05435547|Antiemetics|antiemetics|mesh-ancestor
25356687|NCT05435547|Autonomic Agents|autonomic agents|mesh-ancestor
25356688|NCT05435547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25356689|NCT05435547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356690|NCT05435547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25356691|NCT05435547|Glucocorticoids|glucocorticoids|mesh-ancestor
25356692|NCT05435547|Hormones|hormones|mesh-ancestor
25356693|NCT05435547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25356694|NCT05435547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25356695|NCT05435547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356696|NCT05435313|Oxaliplatin|oxaliplatin|mesh-list
25356697|NCT05435313|Irinotecan|irinotecan|mesh-list
25356698|NCT05435313|Raltitrexed|raltitrexed|mesh-list
25356699|NCT05435313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356700|NCT05435313|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25356701|NCT05435313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25356702|NCT05435313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25356703|NCT05435313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356704|NCT05435313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25356705|NCT05435313|Antimetabolites|antimetabolites|mesh-ancestor
25356706|NCT05435313|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25356707|NCT05435222|Psychotropic Drugs|psychotropic drugs|mesh-list
25356708|NCT05435053|Nivolumab|nivolumab|mesh-list
25356709|NCT05435053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25356710|NCT05435053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356711|NCT05435053|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25356712|NCT05435053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356713|NCT05435014|Ethiodized Oil|ethiodized oil|mesh-list
25356714|NCT05435014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356715|NCT05434351|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
25356716|NCT05434351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25356717|NCT05434351|Immunologic Factors|immunologic factors|mesh-ancestor
25356718|NCT05434351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356719|NCT05434039|Diclofenac|diclofenac|mesh-list
25356720|NCT05434039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25356721|NCT05434039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25356722|NCT05434039|Analgesics|analgesics|mesh-ancestor
25356723|NCT05434039|Sensory System Agents|sensory system agents|mesh-ancestor
25356724|NCT05434039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25356725|NCT05434039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356726|NCT05434039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25356727|NCT05434039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25356728|NCT05434039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25356729|NCT05434039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25356730|NCT05434039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356731|NCT05433675|Macitentan|macitentan|mesh-list
25356732|NCT05433675|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25356733|NCT05433675|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25356734|NCT05433675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356735|NCT05433675|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25356736|NCT05433584|Tirzepatide|tirzepatide|mesh-list
25356737|NCT05433584|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25356738|NCT05433584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356739|NCT05433584|Incretins|incretins|mesh-ancestor
25356740|NCT05433584|Hormones|hormones|mesh-ancestor
25356741|NCT05433584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25356742|NCT05432947|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25356743|NCT05432947|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25356820|NCT05430009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25356744|NCT05432947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356745|NCT05432466|Celiprolol|celiprolol|mesh-list
25356746|NCT05432466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25356747|NCT05432466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25356748|NCT05432466|Sympathomimetics|sympathomimetics|mesh-ancestor
25356749|NCT05432466|Autonomic Agents|autonomic agents|mesh-ancestor
25356750|NCT05432466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25356751|NCT05432466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356752|NCT05432466|Vasodilator Agents|vasodilator agents|mesh-ancestor
25356753|NCT05432466|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25356754|NCT05432466|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25356755|NCT05432466|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25356756|NCT05432466|Adrenergic Agents|adrenergic agents|mesh-ancestor
25356757|NCT05432466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25356758|NCT05432466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356759|NCT05431777|Avelumab|avelumab|mesh-list
25356760|NCT05431777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25356761|NCT05431777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356762|NCT05431725|Vaccines|vaccines|mesh-list
25356763|NCT05431725|Immunologic Factors|immunologic factors|mesh-ancestor
24532239|NCT00638729|Autonomic Agents|autonomic agents|mesh-ancestor
25356764|NCT05431725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356765|NCT05431582|Bevacizumab|bevacizumab|mesh-list
25356766|NCT05431582|Pembrolizumab|pembrolizumab|mesh-list
25356767|NCT05431582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25356768|NCT05431582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356769|NCT05431582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25356770|NCT05431582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25356771|NCT05431582|Growth Substances|growth substances|mesh-ancestor
25356772|NCT05431582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356773|NCT05431582|Growth Inhibitors|growth inhibitors|mesh-ancestor
25356774|NCT05431543|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25356775|NCT05431543|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25356776|NCT05431543|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25356777|NCT05431543|Aceclidine|aceclidine|mesh-list
25356778|NCT05431543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25356779|NCT05431543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25356780|NCT05431543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25356781|NCT05431543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25356782|NCT05431543|Adrenergic Agents|adrenergic agents|mesh-ancestor
25356783|NCT05431543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25356784|NCT05431543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356785|NCT05431543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356786|NCT05431543|Miotics|miotics|mesh-ancestor
25356787|NCT05431543|Autonomic Agents|autonomic agents|mesh-ancestor
25356788|NCT05431543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25356789|NCT05431543|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25356790|NCT05431348|Hydrocortisone|hydrocortisone|mesh-list
25356791|NCT05431348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25356792|NCT05431270|Antibodies|antibodies|mesh-list
25356793|NCT05431270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25356794|NCT05431270|Immunologic Factors|immunologic factors|mesh-ancestor
25356795|NCT05431270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356796|NCT05430698|Antibodies|antibodies|mesh-list
25356797|NCT05430698|Immunologic Factors|immunologic factors|mesh-ancestor
25356798|NCT05430698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356799|NCT05430308|Chlorhexidine|chlorhexidine|mesh-list
25356800|NCT05430308|Povidone-Iodine|povidone-iodine|mesh-list
25356801|NCT05430308|Povidone|povidone|mesh-list
25356802|NCT05430308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25356803|NCT05430308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25356804|NCT05430308|Disinfectants|disinfectants|mesh-ancestor
25356805|NCT05430308|Plasma Substitutes|plasma substitutes|mesh-ancestor
25356806|NCT05430308|Blood Substitutes|blood substitutes|mesh-ancestor
25356807|NCT05430243|Empagliflozin|empagliflozin|mesh-list
25356808|NCT05430243|Diuretics|diuretics|mesh-list
25356809|NCT05430243|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25356810|NCT05430243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356811|NCT05430243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25356812|NCT05430243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356813|NCT05430243|Natriuretic Agents|natriuretic agents|mesh-ancestor
25356814|NCT05430074|Calpastatin|calpastatin|mesh-list
25356815|NCT05430074|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25356816|NCT05430074|Protease Inhibitors|protease inhibitors|mesh-ancestor
25356817|NCT05430074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25356818|NCT05430074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356819|NCT05430009|Pembrolizumab|pembrolizumab|mesh-list
25356821|NCT05430009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356822|NCT05429970|Etodolac|etodolac|mesh-list
25356823|NCT05429970|Propofol|propofol|mesh-list
25356824|NCT05429970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25356825|NCT05429970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25356826|NCT05429970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356827|NCT05429970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25356828|NCT05429970|Anesthetics, General|anesthetics, general|mesh-ancestor
25356829|NCT05429970|Anesthetics|anesthetics|mesh-ancestor
25356830|NCT05429970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25356831|NCT05429970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25356832|NCT05429970|Analgesics|analgesics|mesh-ancestor
25356833|NCT05429970|Sensory System Agents|sensory system agents|mesh-ancestor
25356834|NCT05429970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25356835|NCT05429970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25356836|NCT05429970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25356837|NCT05429970|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25356838|NCT05429970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25356839|NCT05429970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25356840|NCT05429970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356841|NCT05429762|Maytansine|maytansine|mesh-list
25356842|NCT05429762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25356843|NCT05429762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356844|NCT05429762|Tubulin Modulators|tubulin modulators|mesh-ancestor
25356845|NCT05429762|Antimitotic Agents|antimitotic agents|mesh-ancestor
25356846|NCT05429762|Mitosis Modulators|mitosis modulators|mesh-ancestor
25356847|NCT05429762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356848|NCT05429697|Pembrolizumab|pembrolizumab|mesh-list
25356849|NCT05429697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25356850|NCT05429697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356851|NCT05429593|Dapagliflozin|dapagliflozin|mesh-list
25356852|NCT05429593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25356853|NCT05429593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356854|NCT05429593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25356855|NCT05429593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356856|NCT05429502|Temozolomide|temozolomide|mesh-list
25356857|NCT05429502|Topotecan|topotecan|mesh-list
25356858|NCT05429502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25356859|NCT05429502|Alkylating Agents|alkylating agents|mesh-ancestor
25356860|NCT05429502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356861|NCT05429502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356862|NCT05429502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25356863|NCT05429502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25356864|NCT05429502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25356865|NCT05429476|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25356866|NCT05429476|Plasminogen|plasminogen|mesh-list
25356867|NCT05429476|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25356868|NCT05429476|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25356869|NCT05429476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356870|NCT05429450|Triamcinolone|triamcinolone|mesh-list
25356871|NCT05429450|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25356872|NCT05429450|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25356873|NCT05429450|Methotrexate|methotrexate|mesh-list
25356874|NCT05429450|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25356875|NCT05429450|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25356876|NCT05429450|Abortifacient Agents|abortifacient agents|mesh-ancestor
25356877|NCT05429450|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25356878|NCT05429450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356879|NCT05429450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25356880|NCT05429450|Antimetabolites|antimetabolites|mesh-ancestor
25356881|NCT05429450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356882|NCT05429450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356883|NCT05429450|Dermatologic Agents|dermatologic agents|mesh-ancestor
25356884|NCT05429450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25356885|NCT05429450|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25356886|NCT05429450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25356887|NCT05429450|Immunologic Factors|immunologic factors|mesh-ancestor
25356888|NCT05429450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25356889|NCT05429450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25356890|NCT05429450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25356891|NCT05429450|Glucocorticoids|glucocorticoids|mesh-ancestor
25356892|NCT05429450|Hormones|hormones|mesh-ancestor
25356893|NCT05429450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25356894|NCT05429268|Lenalidomide|lenalidomide|mesh-list
25356896|NCT05429268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356897|NCT05429268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25356898|NCT05429268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25356899|NCT05429268|Growth Substances|growth substances|mesh-ancestor
25356900|NCT05429268|Growth Inhibitors|growth inhibitors|mesh-ancestor
25356901|NCT05429268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356902|NCT05428215|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25356903|NCT05428215|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25356904|NCT05428215|Estradiol|estradiol|mesh-list
25356905|NCT05428215|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25356906|NCT05428215|Estrogens|estrogens|mesh-ancestor
25356907|NCT05428215|Hormones|hormones|mesh-ancestor
25356908|NCT05428215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25356909|NCT05428215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356910|NCT05428215|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25356911|NCT05428215|Contraceptive Agents|contraceptive agents|mesh-ancestor
25356912|NCT05428215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25356913|NCT05428215|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25356914|NCT05428150|Pirfenidone|pirfenidone|mesh-list
25356915|NCT05428150|Analgesics|analgesics|mesh-ancestor
25356916|NCT05428150|Sensory System Agents|sensory system agents|mesh-ancestor
25356917|NCT05428150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25356918|NCT05428150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356919|NCT05428150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25356920|NCT05428150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25356921|NCT05428150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25356922|NCT05428150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25356923|NCT05428150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356924|NCT05428007|Nivolumab|nivolumab|mesh-list
25356925|NCT05428007|Ipilimumab|ipilimumab|mesh-list
25356926|NCT05428007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25356927|NCT05428007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25356928|NCT05428007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25356929|NCT05428007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356930|NCT05427981|Buprenorphine|buprenorphine|mesh-list
25356931|NCT05427981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25356932|NCT05427981|Narcotics|narcotics|mesh-ancestor
25356933|NCT05427981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25356934|NCT05427981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356937|NCT05427981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25356939|NCT05427786|Nicorandil|nicorandil|mesh-list
25356940|NCT05427786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25356941|NCT05427786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25356942|NCT05427786|Vasodilator Agents|vasodilator agents|mesh-ancestor
25356943|NCT05427786|Vitamin B Complex|vitamin b complex|mesh-ancestor
25356944|NCT05427786|Vitamins|vitamins|mesh-ancestor
25356945|NCT05427786|Micronutrients|micronutrients|mesh-ancestor
25356946|NCT05427786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356947|NCT05427565|Caffeine|caffeine|mesh-list
25356948|NCT05427565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25356949|NCT05427565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356950|NCT05427565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25356951|NCT05427565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25356952|NCT05427565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356953|NCT05427565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25356954|NCT05427565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25356955|NCT05427565|Purinergic Agents|purinergic agents|mesh-ancestor
25356956|NCT05427565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25356957|NCT05427162|Epoprostenol|epoprostenol|mesh-list
25356958|NCT05427162|Tezosentan|tezosentan|mesh-list
25356959|NCT05427162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25356960|NCT05427162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25356961|NCT05427162|Vasodilator Agents|vasodilator agents|mesh-ancestor
25356962|NCT05427149|Magnesium Sulfate|magnesium sulfate|mesh-list
25356963|NCT05427149|Analgesics|analgesics|mesh-ancestor
25356964|NCT05427149|Sensory System Agents|sensory system agents|mesh-ancestor
25356965|NCT05427149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25356966|NCT05427149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356967|NCT05427149|Anesthetics|anesthetics|mesh-ancestor
25356968|NCT05427149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25356969|NCT05427149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25356970|NCT05427149|Anticonvulsants|anticonvulsants|mesh-ancestor
25356971|NCT05427149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25356972|NCT05427149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25356973|NCT05427149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356974|NCT05427149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25356975|NCT05427149|Tocolytic Agents|tocolytic agents|mesh-ancestor
25356976|NCT05427149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25356977|NCT05426434|Pyrimethamine|pyrimethamine|mesh-list
25356978|NCT05426434|Piperaquine|piperaquine|mesh-list
25356979|NCT05426434|Sulfadoxine|sulfadoxine|mesh-list
25356980|NCT05426434|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25356981|NCT05426434|Artenimol|artenimol|mesh-list
25356982|NCT05426434|Antimalarials|antimalarials|mesh-ancestor
25356983|NCT05426434|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25356984|NCT05426434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25356985|NCT05426434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25356986|NCT05426434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25356987|NCT05426434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25356988|NCT05426434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356989|NCT05426434|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25356990|NCT05426434|Renal Agents|renal agents|mesh-ancestor
25356991|NCT05426304|S 20098|s 20098|mesh-list
25356992|NCT05426304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25356993|NCT05426304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25356994|NCT05426304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25356995|NCT05426031|Protamines|protamines|mesh-list
25356996|NCT05426031|Heparin Antagonists|heparin antagonists|mesh-ancestor
25356997|NCT05426031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25356998|NCT05426031|Coagulants|coagulants|mesh-ancestor
25356999|NCT05425979|Bupivacaine|bupivacaine|mesh-list
25357000|NCT05425979|Mepivacaine|mepivacaine|mesh-list
25357001|NCT05425979|Anesthetics, Local|anesthetics, local|mesh-ancestor
25357002|NCT05425979|Anesthetics|anesthetics|mesh-ancestor
25357003|NCT05425979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25357004|NCT05425979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357005|NCT05425979|Sensory System Agents|sensory system agents|mesh-ancestor
25357006|NCT05425979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25357007|NCT05425940|Atezolizumab|atezolizumab|mesh-list
25357008|NCT05425940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357032|NCT05424835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357034|NCT05424757|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
25357035|NCT05424757|Laxatives|laxatives|mesh-ancestor
25357036|NCT05424757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25357037|NCT05423951|Sufentanil|sufentanil|mesh-list
25357038|NCT05423951|Propofol|propofol|mesh-list
25357039|NCT05423951|Rocuronium|rocuronium|mesh-list
25357040|NCT05423951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25357041|NCT05423951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25357042|NCT05423951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357043|NCT05423951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25357044|NCT05423951|Anesthetics, General|anesthetics, general|mesh-ancestor
25357045|NCT05423951|Anesthetics|anesthetics|mesh-ancestor
25357046|NCT05423951|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25357047|NCT05423951|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25357048|NCT05423951|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25357049|NCT05423951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25357050|NCT05423951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25357051|NCT05423951|Narcotics|narcotics|mesh-ancestor
25357052|NCT05423951|Analgesics|analgesics|mesh-ancestor
25357053|NCT05423951|Sensory System Agents|sensory system agents|mesh-ancestor
25357054|NCT05423951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25357055|NCT05423249|Ascorbic Acid|ascorbic acid|mesh-list
25357056|NCT05423249|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
25357057|NCT05423249|Antioxidants|antioxidants|mesh-ancestor
25357058|NCT05423249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357059|NCT05423249|Protective Agents|protective agents|mesh-ancestor
25357060|NCT05423249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357062|NCT05423249|Micronutrients|micronutrients|mesh-ancestor
25357063|NCT05423249|Antidiarrheals|antidiarrheals|mesh-ancestor
25357064|NCT05423249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25357065|NCT05423106|Tenofovir|tenofovir|mesh-list
25357066|NCT05423106|Entecavir|entecavir|mesh-list
25357067|NCT05423106|Antiviral Agents|antiviral agents|mesh-ancestor
25357068|NCT05423106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25357069|NCT05423106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25357070|NCT05423106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25357071|NCT05423106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25357072|NCT05423106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357073|NCT05423106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25357074|NCT05423106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25357075|NCT05422794|Paclitaxel|paclitaxel|mesh-list
25357076|NCT05422794|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25357077|NCT05422794|Pembrolizumab|pembrolizumab|mesh-list
25357078|NCT05422794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25357079|NCT05422794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357080|NCT05422794|Tubulin Modulators|tubulin modulators|mesh-ancestor
25357081|NCT05422794|Antimitotic Agents|antimitotic agents|mesh-ancestor
25357082|NCT05422794|Mitosis Modulators|mitosis modulators|mesh-ancestor
25357083|NCT05422794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357084|NCT05422794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25357085|NCT05422521|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25357086|NCT05422521|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25357087|NCT05422521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357088|NCT05422365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25357089|NCT05422365|Immunoglobulins|immunoglobulins|mesh-list
25357090|NCT05422365|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25357091|NCT05422365|Antibodies|antibodies|mesh-list
25357092|NCT05422365|gamma-Globulins|gamma-globulins|mesh-list
25357093|NCT05422365|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25357094|NCT05422365|Immunologic Factors|immunologic factors|mesh-ancestor
25357095|NCT05422365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357096|NCT05422092|Pioglitazone|pioglitazone|mesh-list
25357097|NCT05422092|Canagliflozin|canagliflozin|mesh-list
25357098|NCT05422092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25357099|NCT05422092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357100|NCT05422092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25357101|NCT05422092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357102|NCT05422066|Prednisone|prednisone|mesh-list
25357103|NCT05422066|Cyclophosphamide|cyclophosphamide|mesh-list
25357104|NCT05422066|Rituximab|rituximab|mesh-list
25357105|NCT05422066|Doxorubicin|doxorubicin|mesh-list
25357106|NCT05422066|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25357107|NCT05422066|Vincristine|vincristine|mesh-list
25357108|NCT05422066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25357109|NCT05422066|Immunologic Factors|immunologic factors|mesh-ancestor
25357110|NCT05422066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357111|NCT05422066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25357112|NCT05422066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25357113|NCT05422066|Alkylating Agents|alkylating agents|mesh-ancestor
25357114|NCT05422066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357115|NCT05422066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357116|NCT05422066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25357117|NCT05422066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25357118|NCT05422066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25357119|NCT05422066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25357120|NCT05422066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25357121|NCT05422066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25357122|NCT05422066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25357124|NCT05422066|Hormones|hormones|mesh-ancestor
25357352|NCT05415709|Tubulin Modulators|tubulin modulators|mesh-ancestor
25357125|NCT05422066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25357126|NCT05422066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25357127|NCT05422066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25357128|NCT05422066|Tubulin Modulators|tubulin modulators|mesh-ancestor
25357129|NCT05422066|Antimitotic Agents|antimitotic agents|mesh-ancestor
25357130|NCT05422066|Mitosis Modulators|mitosis modulators|mesh-ancestor
25357131|NCT05422053|Insulin|insulin|mesh-list
25357132|NCT05422053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25357133|NCT05422053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357134|NCT05422027|Dexamethasone|dexamethasone|mesh-list
25357135|NCT05422027|Dexamethasone acetate|dexamethasone acetate|mesh-list
25357136|NCT05422027|Lenalidomide|lenalidomide|mesh-list
25357137|NCT05422027|Bortezomib|bortezomib|mesh-list
25357138|NCT05422027|BB 1101|bb 1101|mesh-list
25357139|NCT05422027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25357140|NCT05422027|Antiemetics|antiemetics|mesh-ancestor
25357141|NCT05422027|Autonomic Agents|autonomic agents|mesh-ancestor
25357142|NCT05422027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25357143|NCT05422027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357144|NCT05422027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25357145|NCT05422027|Glucocorticoids|glucocorticoids|mesh-ancestor
25357146|NCT05422027|Hormones|hormones|mesh-ancestor
25357147|NCT05422027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25357148|NCT05422027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25357149|NCT05422027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357150|NCT05422027|Protease Inhibitors|protease inhibitors|mesh-ancestor
25357151|NCT05422027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25357152|NCT05422027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357153|NCT05422027|Immunologic Factors|immunologic factors|mesh-ancestor
25357154|NCT05422027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25357155|NCT05422027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25357156|NCT05422027|Growth Substances|growth substances|mesh-ancestor
25357157|NCT05422027|Growth Inhibitors|growth inhibitors|mesh-ancestor
25357158|NCT05421819|Calcium, Dietary|calcium, dietary|mesh-list
25357159|NCT05421819|Vitamin D|vitamin d|mesh-list
25357160|NCT05421819|Ergocalciferols|ergocalciferols|mesh-list
25357161|NCT05421819|Cholecalciferol|cholecalciferol|mesh-list
25357162|NCT05421819|Vitamins|vitamins|mesh-list
25357163|NCT05421819|Calcium|calcium|mesh-list
25357164|NCT05421819|Micronutrients|micronutrients|mesh-ancestor
25357190|NCT05419427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25357191|NCT05419427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357195|NCT05419011|Vaccines|vaccines|mesh-list
25357196|NCT05419011|Immunologic Factors|immunologic factors|mesh-ancestor
25357197|NCT05419011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357198|NCT05418868|Cabotegravir|cabotegravir|mesh-list
25357199|NCT05418868|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25357200|NCT05418868|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25357201|NCT05418868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25357202|NCT05418868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357203|NCT05418868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25357204|NCT05418868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25357205|NCT05418868|Antiviral Agents|antiviral agents|mesh-ancestor
25357206|NCT05418868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25357223|NCT05418582|Carbamazepine|carbamazepine|mesh-list
25357224|NCT05418582|Anticonvulsants|anticonvulsants|mesh-ancestor
25357225|NCT05418582|Antimanic Agents|antimanic agents|mesh-ancestor
25357226|NCT05418582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25357227|NCT05418582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25357228|NCT05418582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357229|NCT05418582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25357230|NCT05418582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25357231|NCT05418582|Analgesics|analgesics|mesh-ancestor
25357232|NCT05418582|Sensory System Agents|sensory system agents|mesh-ancestor
25357233|NCT05418582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25357234|NCT05418582|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25357235|NCT05418582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25357236|NCT05418582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357237|NCT05418582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25357238|NCT05418582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25357240|NCT05418049|Baclofen|baclofen|mesh-list
25357241|NCT05418049|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25357242|NCT05418049|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25357243|NCT05418049|Dopamine Agents|dopamine agents|mesh-ancestor
25389636|NCT04330729|Aspirin|aspirin|mesh-list
25357244|NCT05418049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25357245|NCT05418049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357246|NCT05418049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357247|NCT05418049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25357248|NCT05418049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25357249|NCT05418049|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25357250|NCT05418049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25357251|NCT05418049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25357252|NCT05418049|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
25357253|NCT05418049|GABA Agonists|gaba agonists|mesh-ancestor
25357254|NCT05418049|GABA Agents|gaba agents|mesh-ancestor
25357255|NCT05417971|Fludarabine|fludarabine|mesh-list
25357256|NCT05417971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357257|NCT05417776|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
25357258|NCT05417776|Chelating Agents|chelating agents|mesh-ancestor
25357259|NCT05417776|Sequestering Agents|sequestering agents|mesh-ancestor
25357260|NCT05417776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357261|NCT05417594|Temozolomide|temozolomide|mesh-list
25357262|NCT05417594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25357263|NCT05417594|Alkylating Agents|alkylating agents|mesh-ancestor
25357264|NCT05417594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357265|NCT05417594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357266|NCT05417386|Leucovorin|leucovorin|mesh-list
25357267|NCT05417386|Fluorouracil|fluorouracil|mesh-list
25357268|NCT05417386|Capecitabine|capecitabine|mesh-list
25357269|NCT05417386|Oxaliplatin|oxaliplatin|mesh-list
25357270|NCT05417386|Irinotecan|irinotecan|mesh-list
25357271|NCT05417386|Camptothecin|camptothecin|mesh-list
25357272|NCT05417386|Folfirinox|folfirinox|mesh-list
25357273|NCT05417386|Levoleucovorin|levoleucovorin|mesh-list
25357274|NCT05417386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357275|NCT05417386|Antimetabolites|antimetabolites|mesh-ancestor
25357353|NCT05415709|Antimitotic Agents|antimitotic agents|mesh-ancestor
25357276|NCT05417386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357277|NCT05417386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25357278|NCT05417386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357279|NCT05417386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25357280|NCT05417386|Immunologic Factors|immunologic factors|mesh-ancestor
25357281|NCT05417386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25357282|NCT05417386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25357283|NCT05417386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25357284|NCT05417386|Antidotes|antidotes|mesh-ancestor
25357285|NCT05417386|Protective Agents|protective agents|mesh-ancestor
25357286|NCT05417386|Vitamin B Complex|vitamin b complex|mesh-ancestor
25357287|NCT05417386|Vitamins|vitamins|mesh-ancestor
25357288|NCT05417386|Micronutrients|micronutrients|mesh-ancestor
25357289|NCT05417386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25357290|NCT05417100|Methadone|methadone|mesh-list
25357291|NCT05417100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25357292|NCT05417100|Narcotics|narcotics|mesh-ancestor
25357293|NCT05417100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25357294|NCT05417100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357295|NCT05417100|Analgesics|analgesics|mesh-ancestor
25357296|NCT05417100|Sensory System Agents|sensory system agents|mesh-ancestor
25357297|NCT05417100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25357298|NCT05417100|Antitussive Agents|antitussive agents|mesh-ancestor
25357299|NCT05417100|Respiratory System Agents|respiratory system agents|mesh-ancestor
25357300|NCT05416476|Anisodine|anisodine|mesh-list
25357301|NCT05416476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25357302|NCT05416476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25357303|NCT05416476|Analgesics|analgesics|mesh-ancestor
25357304|NCT05416476|Sensory System Agents|sensory system agents|mesh-ancestor
25357305|NCT05416476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25357306|NCT05416476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357307|NCT05416476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25357308|NCT05416476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25357309|NCT05416476|Parasympatholytics|parasympatholytics|mesh-ancestor
25357310|NCT05416476|Autonomic Agents|autonomic agents|mesh-ancestor
25357311|NCT05416333|Azelaic acid|azelaic acid|mesh-list
25357312|NCT05416333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357313|NCT05416333|Dermatologic Agents|dermatologic agents|mesh-ancestor
25357314|NCT05416320|Calcipotriene|calcipotriene|mesh-list
25357315|NCT05416320|Dermatologic Agents|dermatologic agents|mesh-ancestor
25724216|NCT02535806|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25357316|NCT05416229|Psilocybin|psilocybin|mesh-list
25357317|NCT05416229|Hallucinogens|hallucinogens|mesh-ancestor
25389716|NCT04329065|Paclitaxel|paclitaxel|mesh-list
25357318|NCT05416229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357319|NCT05416229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25357320|NCT05416125|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
25357321|NCT05416125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25357322|NCT05416125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357323|NCT05416125|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25357324|NCT05416125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25357325|NCT05416125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25357326|NCT05416125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357327|NCT05416125|Dopamine Agents|dopamine agents|mesh-ancestor
25357328|NCT05416125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25357329|NCT05416021|Dapivirine|dapivirine|mesh-list
25357330|NCT05416021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25357331|NCT05416021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25357332|NCT05416021|Antiviral Agents|antiviral agents|mesh-ancestor
25357333|NCT05416021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25357334|NCT05415865|Lidocaine|lidocaine|mesh-list
25357335|NCT05415865|Anesthetics, Local|anesthetics, local|mesh-ancestor
25357336|NCT05415865|Anesthetics|anesthetics|mesh-ancestor
25357337|NCT05415865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25357338|NCT05415865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357339|NCT05415865|Sensory System Agents|sensory system agents|mesh-ancestor
25357340|NCT05415865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25357341|NCT05415865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25357342|NCT05415865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25357343|NCT05415865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25357344|NCT05415865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25357345|NCT05415865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357346|NCT05415709|Paclitaxel|paclitaxel|mesh-list
25357347|NCT05415709|Cisplatin|cisplatin|mesh-list
25357348|NCT05415709|Carboplatin|carboplatin|mesh-list
25357349|NCT05415709|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25357350|NCT05415709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25357351|NCT05415709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357354|NCT05415709|Mitosis Modulators|mitosis modulators|mesh-ancestor
25357355|NCT05415709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357356|NCT05415657|Denosumab|denosumab|mesh-list
25357357|NCT05415657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25357358|NCT05415657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357359|NCT05415644|Metformin|metformin|mesh-list
25357360|NCT05415644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25357361|NCT05415644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357362|NCT05415462|Vaccines|vaccines|mesh-list
25357363|NCT05415462|Immunologic Factors|immunologic factors|mesh-ancestor
25357364|NCT05415462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357365|NCT05415215|Trastuzumab|trastuzumab|mesh-list
25357366|NCT05415215|Pertuzumab|pertuzumab|mesh-list
25357367|NCT05415215|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25357368|NCT05415215|Maytansine|maytansine|mesh-list
25357369|NCT05415215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25357370|NCT05415215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357371|NCT05415215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25357372|NCT05415215|Tubulin Modulators|tubulin modulators|mesh-ancestor
25357373|NCT05415215|Antimitotic Agents|antimitotic agents|mesh-ancestor
25357374|NCT05415215|Mitosis Modulators|mitosis modulators|mesh-ancestor
25357375|NCT05415215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357376|NCT05414877|Phenylephrine|phenylephrine|mesh-list
25357377|NCT05414877|Oxymetazoline|oxymetazoline|mesh-list
25357378|NCT05414877|Norepinephrine|norepinephrine|mesh-list
25357379|NCT05414877|Ephedrine|ephedrine|mesh-list
25357380|NCT05414877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25357381|NCT05414877|Mydriatics|mydriatics|mesh-ancestor
25357382|NCT05414877|Autonomic Agents|autonomic agents|mesh-ancestor
25357383|NCT05414877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25357384|NCT05414877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357385|NCT05414877|Sympathomimetics|sympathomimetics|mesh-ancestor
25357386|NCT05414877|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25357387|NCT05414877|Nasal Decongestants|nasal decongestants|mesh-ancestor
25357388|NCT05414877|Respiratory System Agents|respiratory system agents|mesh-ancestor
25357389|NCT05414877|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25357390|NCT05414877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25357391|NCT05414877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25357392|NCT05414877|Adrenergic Agents|adrenergic agents|mesh-ancestor
25357393|NCT05414877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25724217|NCT02535806|Abortifacient Agents|abortifacient agents|mesh-ancestor
25357394|NCT05414877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357395|NCT05414877|Protective Agents|protective agents|mesh-ancestor
25357396|NCT05414877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25357397|NCT05414838|Vitamin D|vitamin d|mesh-list
25357398|NCT05414838|Curcumin|curcumin|mesh-list
25357399|NCT05414838|Vitamins|vitamins|mesh-ancestor
25357400|NCT05414838|Micronutrients|micronutrients|mesh-ancestor
25357401|NCT05414838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357402|NCT05414838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25357403|NCT05414838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25357404|NCT05414838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25357405|NCT05414838|Analgesics|analgesics|mesh-ancestor
25357406|NCT05414838|Sensory System Agents|sensory system agents|mesh-ancestor
25357407|NCT05414838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25357408|NCT05414838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25357409|NCT05414838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25357410|NCT05414838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357411|NCT05414838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25357412|NCT05414838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357413|NCT05414500|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25357414|NCT05414500|Mogamulizumab|mogamulizumab|mesh-list
25357415|NCT05414500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25357416|NCT05414500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357417|NCT05414422|Ketamine|ketamine|mesh-list
25357418|NCT05414422|Analgesics|analgesics|mesh-ancestor
25357419|NCT05414422|Sensory System Agents|sensory system agents|mesh-ancestor
25357420|NCT05414422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25357421|NCT05414422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357422|NCT05414422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25357423|NCT05414422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25357424|NCT05414422|Anesthetics, General|anesthetics, general|mesh-ancestor
25357425|NCT05414422|Anesthetics|anesthetics|mesh-ancestor
25357426|NCT05414422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25357427|NCT05414422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25357428|NCT05414422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25357429|NCT05414422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25357430|NCT05414422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357431|NCT05414409|Metformin|metformin|mesh-list
25357432|NCT05414409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25357433|NCT05414409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357434|NCT05414331|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25357435|NCT05414331|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25357436|NCT05414331|Adrenergic Agents|adrenergic agents|mesh-ancestor
25357437|NCT05414331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25357438|NCT05414331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357439|NCT05414331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357440|NCT05414214|Anesthetics|anesthetics|mesh-list
25357441|NCT05414214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25357442|NCT05414214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357443|NCT05414201|Adalimumab|adalimumab|mesh-list
25357444|NCT05414201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25357445|NCT05414201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25357446|NCT05414084|Phenol|phenol|mesh-list
25357447|NCT05414084|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25357448|NCT05414084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25357449|NCT05414084|Disinfectants|disinfectants|mesh-ancestor
25357450|NCT05414084|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25357451|NCT05414084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25357452|NCT05414006|Ketamine|ketamine|mesh-list
25357453|NCT05414006|Esketamine|esketamine|mesh-list
25357454|NCT05414006|Analgesics|analgesics|mesh-ancestor
25357455|NCT05414006|Sensory System Agents|sensory system agents|mesh-ancestor
25357456|NCT05414006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25357457|NCT05414006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357458|NCT05414006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25357459|NCT05414006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25357460|NCT05414006|Anesthetics, General|anesthetics, general|mesh-ancestor
25357461|NCT05414006|Anesthetics|anesthetics|mesh-ancestor
25357462|NCT05414006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25357463|NCT05414006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25357464|NCT05414006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25357465|NCT05414006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25357466|NCT05414006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357479|NCT05413980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357480|NCT05413980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25357482|NCT05413980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25357483|NCT05413980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357484|NCT05413980|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25357485|NCT05413980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25357486|NCT05413980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25357487|NCT05413811|Fluorouracil|fluorouracil|mesh-list
25357488|NCT05413811|Antimetabolites|antimetabolites|mesh-ancestor
25357489|NCT05413811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357490|NCT05413811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25357491|NCT05413811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357492|NCT05413811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25357493|NCT05413811|Immunologic Factors|immunologic factors|mesh-ancestor
25357494|NCT05413811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357509|NCT05413122|Nicotine|nicotine|mesh-list
25357510|NCT05413122|Varenicline|varenicline|mesh-list
25357511|NCT05413122|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25357512|NCT05413122|Autonomic Agents|autonomic agents|mesh-ancestor
25357513|NCT05413122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25357514|NCT05413122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357515|NCT05413122|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25357516|NCT05413122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25357517|NCT05413122|Cholinergic Agents|cholinergic agents|mesh-ancestor
25357518|NCT05413122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25357519|NCT05413122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357520|NCT05413018|Azacitidine|azacitidine|mesh-list
25357521|NCT05413018|Cc-486|cc-486|mesh-list
25357522|NCT05413018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25357523|NCT05413018|Antimetabolites|antimetabolites|mesh-ancestor
25357524|NCT05413018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357525|NCT05413018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357526|NCT05413018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25357527|NCT05412875|Nicotine|nicotine|mesh-list
25357528|NCT05412875|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25357529|NCT05412875|Autonomic Agents|autonomic agents|mesh-ancestor
25357530|NCT05412875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25357531|NCT05412875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357532|NCT05412875|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25357533|NCT05412875|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25357534|NCT05412875|Cholinergic Agents|cholinergic agents|mesh-ancestor
25357535|NCT05412875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25357536|NCT05412875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357537|NCT05412758|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
25357538|NCT05412758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357539|NCT05412082|Leucovorin|leucovorin|mesh-list
25357540|NCT05412082|Fluorouracil|fluorouracil|mesh-list
25357541|NCT05412082|Capecitabine|capecitabine|mesh-list
25357543|NCT05412082|Antimetabolites|antimetabolites|mesh-ancestor
25357544|NCT05412082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357545|NCT05412082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25357546|NCT05412082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357547|NCT05412082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25357548|NCT05412082|Immunologic Factors|immunologic factors|mesh-ancestor
25357549|NCT05412082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357550|NCT05412082|Antidotes|antidotes|mesh-ancestor
25357551|NCT05412082|Protective Agents|protective agents|mesh-ancestor
25357552|NCT05412082|Vitamin B Complex|vitamin b complex|mesh-ancestor
25357553|NCT05412082|Vitamins|vitamins|mesh-ancestor
25357554|NCT05412082|Micronutrients|micronutrients|mesh-ancestor
25357555|NCT05412030|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25357560|NCT05412004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357562|NCT05412004|Hormones|hormones|mesh-ancestor
25357563|NCT05412004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25357564|NCT05411965|Pioglitazone|pioglitazone|mesh-list
25357565|NCT05411965|Dapagliflozin|dapagliflozin|mesh-list
25357566|NCT05411965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25357567|NCT05411965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357568|NCT05411965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25357569|NCT05411965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357570|NCT05411575|Plerixafor|plerixafor|mesh-list
25357571|NCT05411575|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25357572|NCT05411575|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25357573|NCT05411575|Antiviral Agents|antiviral agents|mesh-ancestor
25357574|NCT05411575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25357575|NCT05411484|Doxycycline|doxycycline|mesh-list
25357576|NCT05411484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25357577|NCT05411484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25357578|NCT05411484|Antimalarials|antimalarials|mesh-ancestor
25357579|NCT05411484|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25357580|NCT05411484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25357581|NCT05411159|Analgesics, Opioid|analgesics, opioid|mesh-list
25357582|NCT05411159|Anesthetics|anesthetics|mesh-list
25357583|NCT05411159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25357584|NCT05411159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357585|NCT05411159|Narcotics|narcotics|mesh-ancestor
25357586|NCT05411159|Analgesics|analgesics|mesh-ancestor
25357587|NCT05411159|Sensory System Agents|sensory system agents|mesh-ancestor
25357588|NCT05411159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25357589|NCT05411107|Iloprost|iloprost|mesh-list
25357590|NCT05411107|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25357591|NCT05411107|Vasodilator Agents|vasodilator agents|mesh-ancestor
25357592|NCT05411094|Durvalumab|durvalumab|mesh-list
25357593|NCT05411094|Olaparib|olaparib|mesh-list
25357594|NCT05411094|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25357595|NCT05411094|Immunoglobulins|immunoglobulins|mesh-list
25357596|NCT05411094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25357597|NCT05411094|Immunoglobulin G|immunoglobulin g|mesh-list
25357598|NCT05411094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25357599|NCT05411094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357600|NCT05411094|Immunologic Factors|immunologic factors|mesh-ancestor
25357601|NCT05411094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357602|NCT05411094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25357603|NCT05411094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357609|NCT05410860|Etripamil|etripamil|mesh-list
25357610|NCT05410860|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25357611|NCT05410860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25357612|NCT05410860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357613|NCT05410860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25357614|NCT05410860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357615|NCT05410821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25357616|NCT05410821|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
25357617|NCT05410821|Chelating Agents|chelating agents|mesh-ancestor
25357618|NCT05410821|Sequestering Agents|sequestering agents|mesh-ancestor
25357622|NCT05410301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25357623|NCT05410301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357624|NCT05410301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25357625|NCT05410301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25357626|NCT05410301|Growth Substances|growth substances|mesh-ancestor
25357627|NCT05410301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357628|NCT05410301|Growth Inhibitors|growth inhibitors|mesh-ancestor
25357629|NCT05410301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25357630|NCT05410301|Alkylating Agents|alkylating agents|mesh-ancestor
25357631|NCT05410301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357633|NCT05409066|Lenalidomide|lenalidomide|mesh-list
25357634|NCT05409066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25357635|NCT05409066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357636|NCT05409066|Immunologic Factors|immunologic factors|mesh-ancestor
25357637|NCT05409066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357638|NCT05409066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25357639|NCT05409066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25357640|NCT05409066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25357641|NCT05409066|Growth Substances|growth substances|mesh-ancestor
25357642|NCT05409066|Growth Inhibitors|growth inhibitors|mesh-ancestor
25357647|NCT05408585|Anesthetics|anesthetics|mesh-list
25357648|NCT05408585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25357649|NCT05408585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357650|NCT05408559|Sulforaphane|sulforaphane|mesh-list
25357651|NCT05408559|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25357652|NCT05408559|Protective Agents|protective agents|mesh-ancestor
25357653|NCT05408559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357654|NCT05408559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357655|NCT05408429|Vaccines|vaccines|mesh-list
25357656|NCT05408429|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25357657|NCT05408429|Immunologic Factors|immunologic factors|mesh-ancestor
25357658|NCT05408429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357659|NCT05408403|Anesthetics|anesthetics|mesh-list
25357660|NCT05408403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25357661|NCT05408403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357662|NCT05408026|Dexamethasone|dexamethasone|mesh-list
25357663|NCT05408026|Bortezomib|bortezomib|mesh-list
25357664|NCT05408026|Daratumumab|daratumumab|mesh-list
25357665|NCT05408026|Pomalidomide|pomalidomide|mesh-list
25357666|NCT05408026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25357667|NCT05408026|Antiemetics|antiemetics|mesh-ancestor
25357668|NCT05408026|Autonomic Agents|autonomic agents|mesh-ancestor
25357669|NCT05408026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25357670|NCT05408026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357671|NCT05408026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25357672|NCT05408026|Glucocorticoids|glucocorticoids|mesh-ancestor
25357673|NCT05408026|Hormones|hormones|mesh-ancestor
25357674|NCT05408026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25357675|NCT05408026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25357676|NCT05408026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357677|NCT05408026|Immunologic Factors|immunologic factors|mesh-ancestor
25357678|NCT05408026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25357679|NCT05408026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25357680|NCT05408026|Growth Substances|growth substances|mesh-ancestor
25357681|NCT05408026|Growth Inhibitors|growth inhibitors|mesh-ancestor
25357682|NCT05407675|Nivolumab|nivolumab|mesh-list
25357683|NCT05407675|Ipilimumab|ipilimumab|mesh-list
25357684|NCT05407675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25357685|NCT05407675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357686|NCT05407675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25357687|NCT05407675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357688|NCT05407662|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
25357689|NCT05407662|Mineralocorticoids|mineralocorticoids|mesh-list
25357690|NCT05407662|Hormone Antagonists|hormone antagonists|mesh-ancestor
25357691|NCT05407662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25357692|NCT05407662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357767|NCT05406401|Alkylating Agents|alkylating agents|mesh-ancestor
25357693|NCT05407662|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25357695|NCT05407662|Natriuretic Agents|natriuretic agents|mesh-ancestor
25357696|NCT05407662|Hormones|hormones|mesh-ancestor
25357697|NCT05407194|Ascorbic Acid|ascorbic acid|mesh-list
25357698|NCT05407194|Vitamins|vitamins|mesh-ancestor
25357699|NCT05407194|Micronutrients|micronutrients|mesh-ancestor
25357700|NCT05407194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357701|NCT05407194|Antioxidants|antioxidants|mesh-ancestor
25357702|NCT05407194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357703|NCT05407194|Protective Agents|protective agents|mesh-ancestor
25357704|NCT05406999|Prednisolone|prednisolone|mesh-list
25357705|NCT05406999|Abiraterone Acetate|abiraterone acetate|mesh-list
25357706|NCT05406999|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25357707|NCT05406999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25357708|NCT05406999|Glucocorticoids|glucocorticoids|mesh-ancestor
25357709|NCT05406999|Hormones|hormones|mesh-ancestor
25357710|NCT05406999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25357711|NCT05406999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357712|NCT05406999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25357713|NCT05406999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357715|NCT05406999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25357716|NCT05406999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357717|NCT05406999|Hormone Antagonists|hormone antagonists|mesh-ancestor
25357718|NCT05406999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25357719|NCT05406726|Palmidrol|palmidrol|mesh-list
25357720|NCT05406726|Analgesics|analgesics|mesh-ancestor
25357721|NCT05406726|Sensory System Agents|sensory system agents|mesh-ancestor
25357722|NCT05406726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25357723|NCT05406726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357724|NCT05406726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25357725|NCT05406726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25357726|NCT05406726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25357727|NCT05406726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25357728|NCT05406726|Antiviral Agents|antiviral agents|mesh-ancestor
25357729|NCT05406726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25357804|NCT05405166|Autonomic Agents|autonomic agents|mesh-ancestor
25357730|NCT05406726|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25357731|NCT05406726|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25357732|NCT05406726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25357733|NCT05406726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357734|NCT05406726|Hormones|hormones|mesh-ancestor
25357735|NCT05406726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25357736|NCT05406713|Pembrolizumab|pembrolizumab|mesh-list
25357737|NCT05406713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25357738|NCT05406713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357739|NCT05406700|Niraparib|niraparib|mesh-list
25357740|NCT05406700|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25357741|NCT05406700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25357742|NCT05406700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357743|NCT05406700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357744|NCT05406583|Dolutegravir|dolutegravir|mesh-list
25357745|NCT05406583|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25357746|NCT05406583|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25357747|NCT05406583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25357748|NCT05406583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357749|NCT05406583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25357750|NCT05406583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25357751|NCT05406583|Antiviral Agents|antiviral agents|mesh-ancestor
25357752|NCT05406583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25357753|NCT05406479|Bedaquiline|bedaquiline|mesh-list
25357754|NCT05406479|Antitubercular Agents|antitubercular agents|mesh-ancestor
25357755|NCT05406479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25357756|NCT05406479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25357757|NCT05406401|Prednisone|prednisone|mesh-list
25357758|NCT05406401|Prednisolone|prednisolone|mesh-list
25357759|NCT05406401|Cyclophosphamide|cyclophosphamide|mesh-list
25357760|NCT05406401|Rituximab|rituximab|mesh-list
25357761|NCT05406401|Doxorubicin|doxorubicin|mesh-list
25357762|NCT05406401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25357763|NCT05406401|Immunologic Factors|immunologic factors|mesh-ancestor
25357764|NCT05406401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357765|NCT05406401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25357766|NCT05406401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25357768|NCT05406401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357769|NCT05406401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357770|NCT05406401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25357771|NCT05406401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25357772|NCT05406401|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25357773|NCT05406401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25357774|NCT05406401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25357775|NCT05406401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25357776|NCT05406401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25357777|NCT05406401|Glucocorticoids|glucocorticoids|mesh-ancestor
25357778|NCT05406401|Hormones|hormones|mesh-ancestor
25357779|NCT05406401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25357780|NCT05406401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25357781|NCT05405725|Denosumab|denosumab|mesh-list
25357782|NCT05405725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25357783|NCT05405725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357784|NCT05405309|Olaparib|olaparib|mesh-list
25357785|NCT05405309|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25357786|NCT05405309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25357787|NCT05405309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357788|NCT05405309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357789|NCT05405244|Bromocriptine|bromocriptine|mesh-list
25357790|NCT05405244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357791|NCT05405244|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25357792|NCT05405244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25357793|NCT05405244|Hormone Antagonists|hormone antagonists|mesh-ancestor
25357794|NCT05405244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25357795|NCT05405244|Dopamine Agonists|dopamine agonists|mesh-ancestor
25357796|NCT05405244|Dopamine Agents|dopamine agents|mesh-ancestor
25357797|NCT05405244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25357798|NCT05405244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357799|NCT05405166|Dexamethasone|dexamethasone|mesh-list
25357800|NCT05405166|Pomalidomide|pomalidomide|mesh-list
25357801|NCT05405166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25357802|NCT05405166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25357803|NCT05405166|Antiemetics|antiemetics|mesh-ancestor
25357805|NCT05405166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25357806|NCT05405166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357807|NCT05405166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25357808|NCT05405166|Glucocorticoids|glucocorticoids|mesh-ancestor
25357809|NCT05405166|Hormones|hormones|mesh-ancestor
25357810|NCT05405166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25357811|NCT05405166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25357812|NCT05405166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357813|NCT05405166|Immunologic Factors|immunologic factors|mesh-ancestor
25357814|NCT05405166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25357815|NCT05405166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25357816|NCT05405166|Growth Substances|growth substances|mesh-ancestor
25357817|NCT05405166|Growth Inhibitors|growth inhibitors|mesh-ancestor
25357818|NCT05405114|Decitabine|decitabine|mesh-list
25357819|NCT05405114|Hydroxyurea|hydroxyurea|mesh-list
25357820|NCT05405114|Tetrahydrouridine|tetrahydrouridine|mesh-list
25357821|NCT05405114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25357822|NCT05405114|Antimetabolites|antimetabolites|mesh-ancestor
25357823|NCT05405114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357824|NCT05405114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357825|NCT05405114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25357826|NCT05405114|Antisickling Agents|antisickling agents|mesh-ancestor
25357827|NCT05405114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25357828|NCT05404945|Doxorubicin|doxorubicin|mesh-list
25357829|NCT05404945|Pembrolizumab|pembrolizumab|mesh-list
25357830|NCT05404945|Dacarbazine|dacarbazine|mesh-list
25357831|NCT05404945|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25357832|NCT05404945|Vinblastine|vinblastine|mesh-list
25357833|NCT05404945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25357834|NCT05404945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357835|NCT05404945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25357836|NCT05404945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25357837|NCT05404945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25357838|NCT05404945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357839|NCT05404945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25357840|NCT05404945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25357841|NCT05404945|Alkylating Agents|alkylating agents|mesh-ancestor
25358139|NCT05395117|Anesthetics|anesthetics|mesh-ancestor
25357842|NCT05404945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25357843|NCT05404945|Tubulin Modulators|tubulin modulators|mesh-ancestor
25357844|NCT05404945|Antimitotic Agents|antimitotic agents|mesh-ancestor
25357845|NCT05404945|Mitosis Modulators|mitosis modulators|mesh-ancestor
25357847|NCT05404906|Venetoclax|venetoclax|mesh-list
25357848|NCT05404906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25357849|NCT05404906|Antimetabolites|antimetabolites|mesh-ancestor
25357850|NCT05404906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357851|NCT05404906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357852|NCT05404906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25357853|NCT05403762|Protective Agents|protective agents|mesh-list
25357854|NCT05403762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357855|NCT05403502|Insulin|insulin|mesh-list
25357856|NCT05403502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25357857|NCT05403502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357858|NCT05403476|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25357859|NCT05403476|Hormones|hormones|mesh-ancestor
25357860|NCT05403476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25357861|NCT05403476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357862|NCT05403385|Carboplatin|carboplatin|mesh-list
25357863|NCT05403385|Pemetrexed|pemetrexed|mesh-list
25357864|NCT05403385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357865|NCT05403385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25357866|NCT05403385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357867|NCT05403385|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25357868|NCT05403385|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25357869|NCT05402826|Vitamin E|vitamin e|mesh-list
25357870|NCT05402826|Vitamins|vitamins|mesh-ancestor
25357871|NCT05402826|Micronutrients|micronutrients|mesh-ancestor
25357872|NCT05402826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357873|NCT05402826|Antioxidants|antioxidants|mesh-ancestor
25357874|NCT05402826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357875|NCT05402826|Protective Agents|protective agents|mesh-ancestor
25357876|NCT05402397|Losartan|losartan|mesh-list
25357877|NCT05402397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25357878|NCT05402397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25357879|NCT05402397|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25357880|NCT05402397|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25357881|NCT05402397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357882|NCT05402293|Lidocaine|lidocaine|mesh-list
25357883|NCT05402293|Anesthetics, Local|anesthetics, local|mesh-ancestor
25357884|NCT05402293|Anesthetics|anesthetics|mesh-ancestor
25357885|NCT05402293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25357886|NCT05402293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357887|NCT05402293|Sensory System Agents|sensory system agents|mesh-ancestor
25357888|NCT05402293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25357889|NCT05402293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25357890|NCT05402293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25357891|NCT05402293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25357892|NCT05402293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25357893|NCT05402293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357894|NCT05402111|Olanzapine|olanzapine|mesh-list
25357895|NCT05402111|Risperidone|risperidone|mesh-list
25357896|NCT05402111|Aripiprazole|aripiprazole|mesh-list
25357897|NCT05402111|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25357898|NCT05402111|Antipsychotic Agents|antipsychotic agents|mesh-list
25357899|NCT05402111|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25357900|NCT05402111|Serotonin Agents|serotonin agents|mesh-ancestor
25357901|NCT05402111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25357902|NCT05402111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357903|NCT05402111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357904|NCT05402111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25357905|NCT05402111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25357906|NCT05402111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25357907|NCT05402111|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25357908|NCT05402111|Dopamine Agents|dopamine agents|mesh-ancestor
25357909|NCT05402111|Antiemetics|antiemetics|mesh-ancestor
25357910|NCT05402111|Autonomic Agents|autonomic agents|mesh-ancestor
25357911|NCT05402111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25357912|NCT05402111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25357913|NCT05402111|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25357914|NCT05402111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25357915|NCT05402111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25357916|NCT05402111|Antidepressive Agents|antidepressive agents|mesh-ancestor
25357917|NCT05402111|Dopamine Agonists|dopamine agonists|mesh-ancestor
25357918|NCT05402111|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25357919|NCT05402111|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25357920|NCT05402111|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25357921|NCT05402111|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25357922|NCT05402020|Tiotropium Bromide|tiotropium bromide|mesh-list
25357923|NCT05402020|Olodaterol|olodaterol|mesh-list
25357924|NCT05402020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25357925|NCT05402020|Autonomic Agents|autonomic agents|mesh-ancestor
25357926|NCT05402020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25357927|NCT05402020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357928|NCT05402020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25357929|NCT05402020|Respiratory System Agents|respiratory system agents|mesh-ancestor
25357930|NCT05402020|Parasympatholytics|parasympatholytics|mesh-ancestor
25357931|NCT05402020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25357932|NCT05402020|Cholinergic Agents|cholinergic agents|mesh-ancestor
25357933|NCT05402020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25357934|NCT05402020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357935|NCT05401916|Acetaminophen|acetaminophen|mesh-list
25357936|NCT05401916|Ibuprofen|ibuprofen|mesh-list
25357938|NCT05401916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25357939|NCT05401916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25357940|NCT05401916|Analgesics|analgesics|mesh-ancestor
25357941|NCT05401916|Sensory System Agents|sensory system agents|mesh-ancestor
25357942|NCT05401916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25357943|NCT05401916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357944|NCT05401916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25357945|NCT05401916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25357946|NCT05401916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25357947|NCT05401916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25357948|NCT05401916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357949|NCT05401916|Antipyretics|antipyretics|mesh-ancestor
25357950|NCT05401916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25357951|NCT05401916|Narcotics|narcotics|mesh-ancestor
25357952|NCT05401916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25357953|NCT05401357|Bimatoprost|bimatoprost|mesh-list
25357954|NCT05401357|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25357955|NCT05401357|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25357956|NCT05401357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25357957|NCT05401279|Gemcitabine|gemcitabine|mesh-list
25357958|NCT05401279|Cisplatin|cisplatin|mesh-list
25357959|NCT05401279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357960|NCT05401279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25357961|NCT05401279|Antimetabolites|antimetabolites|mesh-ancestor
25357962|NCT05401279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357963|NCT05401279|Antiviral Agents|antiviral agents|mesh-ancestor
25357964|NCT05401279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25357965|NCT05401279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25357966|NCT05401279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25357967|NCT05401279|Immunologic Factors|immunologic factors|mesh-ancestor
25357968|NCT05401279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357969|NCT05401227|Ketamine|ketamine|mesh-list
25357970|NCT05401227|Analgesics|analgesics|mesh-ancestor
25357971|NCT05401227|Sensory System Agents|sensory system agents|mesh-ancestor
25357972|NCT05401227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25357973|NCT05401227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357974|NCT05401227|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25357975|NCT05401227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25357976|NCT05401227|Anesthetics, General|anesthetics, general|mesh-ancestor
25357977|NCT05401227|Anesthetics|anesthetics|mesh-ancestor
25357978|NCT05401227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25357979|NCT05401227|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25357980|NCT05401227|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25357981|NCT05401227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25357982|NCT05401227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357983|NCT05401214|Prednisone|prednisone|mesh-list
25357984|NCT05401214|Prednisolone|prednisolone|mesh-list
25357985|NCT05401214|Abiraterone Acetate|abiraterone acetate|mesh-list
25357986|NCT05401214|Niraparib|niraparib|mesh-list
25357987|NCT05401214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25357988|NCT05401214|Glucocorticoids|glucocorticoids|mesh-ancestor
25357989|NCT05401214|Hormones|hormones|mesh-ancestor
25357990|NCT05401214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25358140|NCT05395117|GABA Modulators|gaba modulators|mesh-ancestor
25357991|NCT05401214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25357992|NCT05401214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25357993|NCT05401214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25357994|NCT05401214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25357995|NCT05401214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25357996|NCT05401214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25357997|NCT05401214|Hormone Antagonists|hormone antagonists|mesh-ancestor
25357998|NCT05401214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25357999|NCT05401214|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25358000|NCT05400863|Metformin|metformin|mesh-list
25358001|NCT05400863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25358002|NCT05400863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358003|NCT05400369|Moxifloxacin|moxifloxacin|mesh-list
25358004|NCT05400369|Sitafloxacin|sitafloxacin|mesh-list
25358005|NCT05400369|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25358006|NCT05400369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25358007|NCT05400369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25358008|NCT05400369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25724218|NCT02535806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25358009|NCT05400369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25358010|NCT05400369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358011|NCT05400369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358012|NCT05400369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358013|NCT05400369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25358014|NCT05400369|Contraceptive Agents|contraceptive agents|mesh-ancestor
25358015|NCT05400369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25358016|NCT05400369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358017|NCT05400369|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25358018|NCT05400369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25358019|NCT05400369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25358020|NCT05400122|Cyclophosphamide|cyclophosphamide|mesh-list
25358021|NCT05400122|Fludarabine|fludarabine|mesh-list
25358022|NCT05400122|Fludarabine phosphate|fludarabine phosphate|mesh-list
25358023|NCT05400122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25358024|NCT05400122|Immunologic Factors|immunologic factors|mesh-ancestor
25358025|NCT05400122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358026|NCT05400122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25358027|NCT05400122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25358028|NCT05400122|Alkylating Agents|alkylating agents|mesh-ancestor
25358029|NCT05400122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358030|NCT05400122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358031|NCT05400122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25358032|NCT05400122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25358034|NCT05399641|Ibrexafungerp|ibrexafungerp|mesh-list
25358035|NCT05399641|Antifungal Agents|antifungal agents|mesh-ancestor
25358036|NCT05399641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25358037|NCT05399602|Anesthetics|anesthetics|mesh-list
25358038|NCT05399602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25358039|NCT05399602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358041|NCT05399498|Hallucinogens|hallucinogens|mesh-ancestor
25358042|NCT05399498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358043|NCT05399498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25358044|NCT05399329|Palbociclib|palbociclib|mesh-list
25358045|NCT05399329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358046|NCT05399329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25358047|NCT05399329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358048|NCT05399329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358049|NCT05399277|Rivaroxaban|rivaroxaban|mesh-list
25358050|NCT05399277|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25358051|NCT05399277|Antithrombins|antithrombins|mesh-ancestor
25358052|NCT05399277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25358053|NCT05399277|Protease Inhibitors|protease inhibitors|mesh-ancestor
25358054|NCT05399277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358055|NCT05399277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358056|NCT05399277|Anticoagulants|anticoagulants|mesh-ancestor
25358057|NCT05398874|Acetaminophen|acetaminophen|mesh-list
25358058|NCT05398874|Diclofenac|diclofenac|mesh-list
25358059|NCT05398874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25358060|NCT05398874|Analgesics|analgesics|mesh-ancestor
25358061|NCT05398874|Sensory System Agents|sensory system agents|mesh-ancestor
25358062|NCT05398874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25358063|NCT05398874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358064|NCT05398874|Antipyretics|antipyretics|mesh-ancestor
25358065|NCT05398874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25358066|NCT05398874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25358067|NCT05398874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25358068|NCT05398874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25358069|NCT05398874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358070|NCT05398874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358071|NCT05398705|Cepharanthine|cepharanthine|mesh-list
25358072|NCT05398705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25358073|NCT05398705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25358074|NCT05398705|Analgesics|analgesics|mesh-ancestor
25358075|NCT05398705|Sensory System Agents|sensory system agents|mesh-ancestor
25358076|NCT05398705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25358077|NCT05398705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358078|NCT05398705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25358079|NCT05398705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25358080|NCT05398705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25358081|NCT05398705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358082|NCT05398705|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25358083|NCT05398705|Protective Agents|protective agents|mesh-ancestor
25358085|NCT05398484|Hallucinogens|hallucinogens|mesh-ancestor
25358086|NCT05398484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358087|NCT05398484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25358088|NCT05397964|Calcium|calcium|mesh-list
25358089|NCT05397964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25358090|NCT05397964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358091|NCT05397886|Propofol|propofol|mesh-list
25358092|NCT05397886|Flumazenil|flumazenil|mesh-list
25358093|NCT05397886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25358094|NCT05397886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25358095|NCT05397886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358096|NCT05397886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25358097|NCT05397886|Anesthetics, General|anesthetics, general|mesh-ancestor
25358098|NCT05397886|Anesthetics|anesthetics|mesh-ancestor
25358099|NCT05397886|Antidotes|antidotes|mesh-ancestor
25358100|NCT05397886|Protective Agents|protective agents|mesh-ancestor
25358101|NCT05397886|GABA Modulators|gaba modulators|mesh-ancestor
25358102|NCT05397886|GABA Agents|gaba agents|mesh-ancestor
25358103|NCT05397886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25358104|NCT05397886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358105|NCT05397639|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
25358106|NCT05397639|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25358107|NCT05397639|Serotonin Agents|serotonin agents|mesh-ancestor
25358108|NCT05397639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25358109|NCT05397639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358110|NCT05397639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358111|NCT05396833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25358112|NCT05396833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358113|NCT05396833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358114|NCT05396014|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25358115|NCT05396014|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25358116|NCT05396014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25358117|NCT05396014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25358118|NCT05396014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358119|NCT05396014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25358120|NCT05396014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358122|NCT05396014|Sensory System Agents|sensory system agents|mesh-ancestor
25358123|NCT05396014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25358124|NCT05396014|Antidepressive Agents|antidepressive agents|mesh-ancestor
25358125|NCT05396014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25358126|NCT05396014|Dopamine Agents|dopamine agents|mesh-ancestor
25358127|NCT05395117|Digoxin|digoxin|mesh-list
25358128|NCT05395117|Midazolam|midazolam|mesh-list
25358129|NCT05395117|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25358130|NCT05395117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25358131|NCT05395117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25358132|NCT05395117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25358133|NCT05395117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358134|NCT05395117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25358135|NCT05395117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25358136|NCT05395117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25358137|NCT05395117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25358138|NCT05395117|Anesthetics, General|anesthetics, general|mesh-ancestor
25358144|NCT05395117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25358145|NCT05395117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25358146|NCT05395117|Antimetabolites|antimetabolites|mesh-ancestor
25358147|NCT05395117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25358148|NCT05395117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25358149|NCT05395117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358150|NCT05395117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25358151|NCT05395117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25358152|NCT05395117|Protective Agents|protective agents|mesh-ancestor
25358153|NCT05395104|Midazolam|midazolam|mesh-list
25358154|NCT05395104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25358155|NCT05395104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25358156|NCT05395104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25358157|NCT05395104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358158|NCT05395104|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25358159|NCT05395104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25358160|NCT05395104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25358161|NCT05395104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25358162|NCT05395104|Anesthetics, General|anesthetics, general|mesh-ancestor
25358163|NCT05395104|Anesthetics|anesthetics|mesh-ancestor
25358164|NCT05395104|GABA Modulators|gaba modulators|mesh-ancestor
25358165|NCT05395104|GABA Agents|gaba agents|mesh-ancestor
25358166|NCT05395104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25358167|NCT05395104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358168|NCT05395091|Denosumab|denosumab|mesh-list
25358169|NCT05395091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25358170|NCT05395091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358171|NCT05395065|Listerine|listerine|mesh-list
25358172|NCT05395065|Fluorides|fluorides|mesh-list
25358173|NCT05395065|Sodium Fluoride|sodium fluoride|mesh-list
25358174|NCT05395065|Fluorides, Topical|fluorides, topical|mesh-list
25358175|NCT05395065|Cariostatic Agents|cariostatic agents|mesh-ancestor
25358176|NCT05395065|Protective Agents|protective agents|mesh-ancestor
25358177|NCT05395065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358178|NCT05395065|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25358179|NCT05395065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25358180|NCT05394350|Pembrolizumab|pembrolizumab|mesh-list
25358181|NCT05394350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25358182|NCT05394350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358183|NCT05394298|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25358184|NCT05394298|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25358185|NCT05394298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25358186|NCT05394298|Antitubercular Agents|antitubercular agents|mesh-ancestor
25358187|NCT05393245|Tiotropium Bromide|tiotropium bromide|mesh-list
25358188|NCT05393245|Olodaterol|olodaterol|mesh-list
25358189|NCT05393245|Cholinergic Agents|cholinergic agents|mesh-list
25358190|NCT05393245|Muscarinic Antagonists|muscarinic antagonists|mesh-list
25358191|NCT05393245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25358192|NCT05393245|Autonomic Agents|autonomic agents|mesh-ancestor
25358193|NCT05393245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25358194|NCT05393245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358195|NCT05393245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25358196|NCT05393245|Respiratory System Agents|respiratory system agents|mesh-ancestor
25358197|NCT05393245|Parasympatholytics|parasympatholytics|mesh-ancestor
25358198|NCT05393245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25358199|NCT05393245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25358200|NCT05393245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358204|NCT05392959|Dapagliflozin|dapagliflozin|mesh-list
25358205|NCT05392959|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25358206|NCT05392959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358207|NCT05392959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25358208|NCT05392959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358209|NCT05392946|Dexamethasone|dexamethasone|mesh-list
25358210|NCT05392946|Dexamethasone acetate|dexamethasone acetate|mesh-list
25358211|NCT05392946|Bortezomib|bortezomib|mesh-list
25358212|NCT05392946|Daratumumab|daratumumab|mesh-list
25358213|NCT05392946|Ichthammol|ichthammol|mesh-list
25358214|NCT05392946|BB 1101|bb 1101|mesh-list
25358215|NCT05392946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25358216|NCT05392946|Antiemetics|antiemetics|mesh-ancestor
25358217|NCT05392946|Autonomic Agents|autonomic agents|mesh-ancestor
25358218|NCT05392946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25358219|NCT05392946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358220|NCT05392946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25358221|NCT05392946|Glucocorticoids|glucocorticoids|mesh-ancestor
25358222|NCT05392946|Hormones|hormones|mesh-ancestor
25358223|NCT05392946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25358224|NCT05392946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25358225|NCT05392946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358226|NCT05392946|Protease Inhibitors|protease inhibitors|mesh-ancestor
25358227|NCT05392946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358228|NCT05392946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358229|NCT05392946|Dermatologic Agents|dermatologic agents|mesh-ancestor
25358230|NCT05392764|Empagliflozin|empagliflozin|mesh-list
25358231|NCT05392764|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25358232|NCT05392764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358233|NCT05392764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25358234|NCT05392764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358235|NCT05392608|Fulvestrant|fulvestrant|mesh-list
25358236|NCT05392608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25358237|NCT05392608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358238|NCT05392608|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25358239|NCT05392608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25358240|NCT05392608|Hormone Antagonists|hormone antagonists|mesh-ancestor
25358241|NCT05392608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25358242|NCT05392608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358243|NCT05392530|Macitentan|macitentan|mesh-list
25358244|NCT05392530|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25358245|NCT05392530|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25358246|NCT05392530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358247|NCT05392530|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25358248|NCT05392205|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25358249|NCT05392205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25358250|NCT05392205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358251|NCT05392127|Vitamin K|vitamin k|mesh-list
25358252|NCT05392127|Vitamin K 1|vitamin k 1|mesh-list
25358253|NCT05392127|Repaglinide|repaglinide|mesh-list
25358254|NCT05392127|Midazolam|midazolam|mesh-list
25358255|NCT05392127|Omeprazole|omeprazole|mesh-list
25358256|NCT05392127|Warfarin|warfarin|mesh-list
25358257|NCT05392127|Vitamins|vitamins|mesh-ancestor
25358258|NCT05392127|Micronutrients|micronutrients|mesh-ancestor
25358259|NCT05392127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358260|NCT05392127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25358261|NCT05392127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25358262|NCT05392127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25358263|NCT05392127|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25358264|NCT05392127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25358265|NCT05392127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25358266|NCT05392127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25358267|NCT05392127|Anesthetics, General|anesthetics, general|mesh-ancestor
25358268|NCT05392127|Anesthetics|anesthetics|mesh-ancestor
25358269|NCT05392127|GABA Modulators|gaba modulators|mesh-ancestor
25358270|NCT05392127|GABA Agents|gaba agents|mesh-ancestor
25358271|NCT05392127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25358272|NCT05392127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358273|NCT05392127|Anticoagulants|anticoagulants|mesh-ancestor
25358274|NCT05392127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25358275|NCT05392127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25358276|NCT05392127|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25358277|NCT05392127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358278|NCT05392127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25358279|NCT05392127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25358280|NCT05392127|Hemostatics|hemostatics|mesh-ancestor
25358281|NCT05392127|Coagulants|coagulants|mesh-ancestor
25358282|NCT05392127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25358283|NCT05391828|Cimetidine|cimetidine|mesh-list
25358284|NCT05391828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25358285|NCT05391828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25358286|NCT05391828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25358287|NCT05391828|Histamine Antagonists|histamine antagonists|mesh-ancestor
25358288|NCT05391828|Histamine Agents|histamine agents|mesh-ancestor
25358289|NCT05391828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25358290|NCT05391828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358291|NCT05391828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358292|NCT05391828|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25358318|NCT05389852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358319|NCT05389852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25358320|NCT05389852|Analgesics|analgesics|mesh-ancestor
25358321|NCT05389852|Sensory System Agents|sensory system agents|mesh-ancestor
25358322|NCT05389852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25358323|NCT05389852|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25358324|NCT05389852|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25358325|NCT05389852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25358326|NCT05389852|Adrenergic Agents|adrenergic agents|mesh-ancestor
25358327|NCT05389852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25358328|NCT05389852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358329|NCT05389462|Gemcitabine|gemcitabine|mesh-list
25358330|NCT05389462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25358331|NCT05389462|Antimetabolites|antimetabolites|mesh-ancestor
25358332|NCT05389462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358333|NCT05389462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358334|NCT05389462|Antiviral Agents|antiviral agents|mesh-ancestor
25358335|NCT05389462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25358336|NCT05389462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358337|NCT05389462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25358338|NCT05389462|Immunologic Factors|immunologic factors|mesh-ancestor
25358339|NCT05389462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358381|NCT05388929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25358382|NCT05388929|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25358383|NCT05388929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25358384|NCT05388474|Ibalizumab|ibalizumab|mesh-list
25358385|NCT05388474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25358386|NCT05388474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25358387|NCT05388474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25358388|NCT05388474|Antiviral Agents|antiviral agents|mesh-ancestor
25358389|NCT05388474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25358390|NCT05388474|Immunologic Factors|immunologic factors|mesh-ancestor
25358391|NCT05388474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358392|NCT05387759|Moxifloxacin|moxifloxacin|mesh-list
25358393|NCT05387759|Aticaprant|aticaprant|mesh-list
25358394|NCT05387759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25358395|NCT05387759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25358396|NCT05387759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25358397|NCT05387759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25358398|NCT05387759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358399|NCT05387759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358400|NCT05387759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358401|NCT05387759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358402|NCT05387759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25358403|NCT05387759|Sensory System Agents|sensory system agents|mesh-ancestor
25358404|NCT05387759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25358405|NCT05387577|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25358406|NCT05387577|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25358407|NCT05387577|Estradiol|estradiol|mesh-list
25358408|NCT05387577|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25358409|NCT05387577|Estrogens|estrogens|mesh-ancestor
25358410|NCT05387577|Hormones|hormones|mesh-ancestor
25358411|NCT05387577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25358412|NCT05387577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358413|NCT05387577|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25358414|NCT05387577|Contraceptive Agents|contraceptive agents|mesh-ancestor
25358415|NCT05387577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25358416|NCT05387577|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25358417|NCT05387343|Vaccines|vaccines|mesh-list
25358418|NCT05387343|Immunologic Factors|immunologic factors|mesh-ancestor
25358419|NCT05387343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358420|NCT05386472|Ritonavir|ritonavir|mesh-list
25358421|NCT05386472|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25358422|NCT05386472|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25358423|NCT05386472|Protease Inhibitors|protease inhibitors|mesh-ancestor
25358424|NCT05386472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358425|NCT05386472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358426|NCT05386472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25358427|NCT05386472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25358428|NCT05386472|Antiviral Agents|antiviral agents|mesh-ancestor
25358429|NCT05386472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25358430|NCT05386472|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25358431|NCT05386472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25358432|NCT05386095|Bupivacaine|bupivacaine|mesh-list
25358433|NCT05386095|Anesthetics, Local|anesthetics, local|mesh-ancestor
25358434|NCT05386095|Anesthetics|anesthetics|mesh-ancestor
25358435|NCT05386095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25358436|NCT05386095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358437|NCT05386095|Sensory System Agents|sensory system agents|mesh-ancestor
25358438|NCT05386095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25358439|NCT05385432|Mycophenolic Acid|mycophenolic acid|mesh-list
25358440|NCT05385432|Tacrolimus|tacrolimus|mesh-list
25358441|NCT05385432|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25358442|NCT05385432|Basiliximab|basiliximab|mesh-list
25358443|NCT05385432|Immunosuppressive Agents|immunosuppressive agents|mesh-list
25358444|NCT05385432|Thymoglobulin|thymoglobulin|mesh-list
25358445|NCT05385432|Immunologic Factors|immunologic factors|mesh-ancestor
25358446|NCT05385432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358447|NCT05385432|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25358448|NCT05385432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358449|NCT05385432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358450|NCT05385432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25358451|NCT05385432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358452|NCT05385432|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25358453|NCT05385432|Antitubercular Agents|antitubercular agents|mesh-ancestor
25358454|NCT05385432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25358455|NCT05385432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25358456|NCT05385367|Anesthetics|anesthetics|mesh-list
25358457|NCT05385367|Anesthetics, General|anesthetics, general|mesh-list
25358458|NCT05385367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25358459|NCT05385367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358461|NCT05384938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25358462|NCT05384938|Respiratory System Agents|respiratory system agents|mesh-ancestor
25358463|NCT05384847|Hormones|hormones|mesh-list
25358464|NCT05384847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25358465|NCT05384847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358466|NCT05384756|Sirolimus|sirolimus|mesh-list
25358467|NCT05384756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25358468|NCT05384756|Alemtuzumab|alemtuzumab|mesh-list
25358469|NCT05384756|Antibodies|antibodies|mesh-list
25358470|NCT05384756|Immunoglobulins|immunoglobulins|mesh-list
25358471|NCT05384756|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25358472|NCT05384756|Immunologic Factors|immunologic factors|mesh-ancestor
25358473|NCT05384756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358474|NCT05384756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358475|NCT05384756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25358476|NCT05384756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25358477|NCT05384756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25358478|NCT05384756|Antifungal Agents|antifungal agents|mesh-ancestor
25358479|NCT05384756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25358480|NCT05384665|Sufentanil|sufentanil|mesh-list
25358481|NCT05384665|Remifentanil|remifentanil|mesh-list
25358482|NCT05384665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25358483|NCT05384665|Narcotics|narcotics|mesh-ancestor
25358484|NCT05384665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25358485|NCT05384665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358486|NCT05384665|Analgesics|analgesics|mesh-ancestor
25358487|NCT05384665|Sensory System Agents|sensory system agents|mesh-ancestor
25358488|NCT05384665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25358489|NCT05384665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25358490|NCT05384665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25358491|NCT05384665|Anesthetics, General|anesthetics, general|mesh-ancestor
25358492|NCT05384665|Anesthetics|anesthetics|mesh-ancestor
25358493|NCT05384119|Palbociclib|palbociclib|mesh-list
25358494|NCT05384119|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25358495|NCT05384119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358496|NCT05384119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25358497|NCT05384119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358498|NCT05384119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358499|NCT05384119|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25358500|NCT05384119|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25358501|NCT05384119|Hormone Antagonists|hormone antagonists|mesh-ancestor
25358502|NCT05384119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25358503|NCT05384119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358504|NCT05384015|Carboplatin|carboplatin|mesh-list
25358505|NCT05384015|Pembrolizumab|pembrolizumab|mesh-list
25358506|NCT05384015|Etoposide|etoposide|mesh-list
25358507|NCT05384015|Etoposide phosphate|etoposide phosphate|mesh-list
25358508|NCT05384015|Lenvatinib|lenvatinib|mesh-list
25358509|NCT05384015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358510|NCT05384015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25358511|NCT05384015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25358512|NCT05384015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25358513|NCT05384015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25358514|NCT05384015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358515|NCT05384015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358516|NCT05384015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25358517|NCT05383742|Rifampin|rifampin|mesh-list
25358518|NCT05383742|Isoniazid|isoniazid|mesh-list
25358519|NCT05383742|Linezolid|linezolid|mesh-list
25358520|NCT05383742|Pyrazinamide|pyrazinamide|mesh-list
25358521|NCT05383742|Ethambutol|ethambutol|mesh-list
25358522|NCT05383742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25358523|NCT05383742|Antitubercular Agents|antitubercular agents|mesh-ancestor
25358524|NCT05383742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25358525|NCT05383742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25358526|NCT05383742|Leprostatic Agents|leprostatic agents|mesh-ancestor
25358527|NCT05383742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25358528|NCT05383742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358529|NCT05383742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358530|NCT05383742|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25358531|NCT05383742|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25358532|NCT05383742|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25358533|NCT05383742|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25358534|NCT05383742|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25358535|NCT05383742|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25358536|NCT05383742|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25358537|NCT05383742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25358538|NCT05383742|Antimetabolites|antimetabolites|mesh-ancestor
25358539|NCT05383742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25358540|NCT05383742|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25358541|NCT05383612|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25358542|NCT05383612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25358543|NCT05383456|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25358544|NCT05383456|Antiviral Agents|antiviral agents|mesh-ancestor
25358545|NCT05383456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25358547|NCT05383352|Folic Acid|folic acid|mesh-list
25358548|NCT05383352|Fluorouracil|fluorouracil|mesh-list
25358549|NCT05383352|Irinotecan|irinotecan|mesh-list
25358550|NCT05383352|Camptothecin|camptothecin|mesh-list
25358551|NCT05383352|Levoleucovorin|levoleucovorin|mesh-list
25358552|NCT05383352|Antimetabolites|antimetabolites|mesh-ancestor
25358553|NCT05383352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358554|NCT05383352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25358555|NCT05383352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358556|NCT05383352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25358557|NCT05383352|Immunologic Factors|immunologic factors|mesh-ancestor
25358558|NCT05383352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358559|NCT05383352|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25358560|NCT05383352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25358561|NCT05383352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358562|NCT05383352|Antidotes|antidotes|mesh-ancestor
25358563|NCT05383352|Protective Agents|protective agents|mesh-ancestor
25358564|NCT05383352|Vitamin B Complex|vitamin b complex|mesh-ancestor
25358565|NCT05383352|Vitamins|vitamins|mesh-ancestor
25358566|NCT05383352|Micronutrients|micronutrients|mesh-ancestor
25358567|NCT05383352|Hematinics|hematinics|mesh-ancestor
25358568|NCT05383352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25358569|NCT05383001|Durvalumab|durvalumab|mesh-list
25358570|NCT05383001|Tremelimumab|tremelimumab|mesh-list
25358571|NCT05383001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25358572|NCT05383001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358573|NCT05382650|Immunoglobulins|immunoglobulins|mesh-list
25358574|NCT05382650|Antibodies|antibodies|mesh-list
25358575|NCT05382650|gamma-Globulins|gamma-globulins|mesh-list
25358576|NCT05382650|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25358577|NCT05382650|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25358578|NCT05382650|Immunologic Factors|immunologic factors|mesh-ancestor
25358579|NCT05382650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358580|NCT05382494|Mometasone Furoate|mometasone furoate|mesh-list
25358581|NCT05382494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25358582|NCT05382494|Dermatologic Agents|dermatologic agents|mesh-ancestor
25358583|NCT05382494|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25358584|NCT05382442|Leucovorin|leucovorin|mesh-list
25358585|NCT05382442|Bevacizumab|bevacizumab|mesh-list
25358586|NCT05382442|Fluorouracil|fluorouracil|mesh-list
25358587|NCT05382442|Capecitabine|capecitabine|mesh-list
25358588|NCT05382442|Oxaliplatin|oxaliplatin|mesh-list
25358589|NCT05382442|Irinotecan|irinotecan|mesh-list
25358590|NCT05382442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25358591|NCT05382442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358592|NCT05382442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25358593|NCT05382442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25358594|NCT05382442|Growth Substances|growth substances|mesh-ancestor
25358595|NCT05382442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358596|NCT05382442|Growth Inhibitors|growth inhibitors|mesh-ancestor
25358597|NCT05382442|Antimetabolites|antimetabolites|mesh-ancestor
25359052|NCT05371886|Analgesics|analgesics|mesh-ancestor
25358615|NCT05382325|Pembrolizumab|pembrolizumab|mesh-list
25358616|NCT05382325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25358617|NCT05382325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358636|NCT05382286|Gemcitabine|gemcitabine|mesh-list
25358637|NCT05382286|Paclitaxel|paclitaxel|mesh-list
25358638|NCT05382286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25358639|NCT05382286|Carboplatin|carboplatin|mesh-list
25358640|NCT05382286|Pembrolizumab|pembrolizumab|mesh-list
25358641|NCT05382286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25358642|NCT05382286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358643|NCT05382286|Tubulin Modulators|tubulin modulators|mesh-ancestor
25358644|NCT05382286|Antimitotic Agents|antimitotic agents|mesh-ancestor
25358645|NCT05382286|Mitosis Modulators|mitosis modulators|mesh-ancestor
25358646|NCT05382286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358647|NCT05382286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25358648|NCT05382286|Antimetabolites|antimetabolites|mesh-ancestor
25358649|NCT05382286|Antiviral Agents|antiviral agents|mesh-ancestor
25358650|NCT05382286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25358651|NCT05382286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358652|NCT05382286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25358653|NCT05382286|Immunologic Factors|immunologic factors|mesh-ancestor
25358654|NCT05382286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358655|NCT05382286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25358656|NCT05382208|Doxycycline|doxycycline|mesh-list
25358657|NCT05382208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25358658|NCT05382208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25358659|NCT05382208|Antimalarials|antimalarials|mesh-ancestor
25358660|NCT05382208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25358661|NCT05382208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25358662|NCT05382104|Maribavir|maribavir|mesh-list
25358663|NCT05382104|Antiviral Agents|antiviral agents|mesh-ancestor
25358664|NCT05382104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25358665|NCT05382091|Naltrexone|naltrexone|mesh-list
25358666|NCT05382091|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25358667|NCT05382091|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25358668|NCT05382091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358669|NCT05382091|Sensory System Agents|sensory system agents|mesh-ancestor
25358670|NCT05382091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25358671|NCT05381974|Psilocybin|psilocybin|mesh-list
25358672|NCT05381974|Hallucinogens|hallucinogens|mesh-ancestor
25358673|NCT05381974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358674|NCT05381974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25358675|NCT05381948|Aflibercept|aflibercept|mesh-list
25358676|NCT05381948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25358677|NCT05381948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25358678|NCT05381948|Growth Substances|growth substances|mesh-ancestor
25358679|NCT05381948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358680|NCT05381948|Growth Inhibitors|growth inhibitors|mesh-ancestor
25358681|NCT05381948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358682|NCT05381909|Paclitaxel|paclitaxel|mesh-list
25358683|NCT05381909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25358684|NCT05381909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358685|NCT05381909|Tubulin Modulators|tubulin modulators|mesh-ancestor
25358686|NCT05381909|Antimitotic Agents|antimitotic agents|mesh-ancestor
25358687|NCT05381909|Mitosis Modulators|mitosis modulators|mesh-ancestor
25358688|NCT05381909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358689|NCT05381753|Sunitinib|sunitinib|mesh-list
25358690|NCT05381753|Imatinib Mesylate|imatinib mesylate|mesh-list
25358691|NCT05381753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358692|NCT05381753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25358693|NCT05381753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25358694|NCT05381753|Growth Substances|growth substances|mesh-ancestor
25358695|NCT05381753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358696|NCT05381753|Growth Inhibitors|growth inhibitors|mesh-ancestor
25358697|NCT05381753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25358698|NCT05381753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358699|NCT05381753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358700|NCT05381597|Fluorouracil|fluorouracil|mesh-list
25358701|NCT05381597|Calcipotriene|calcipotriene|mesh-list
25358702|NCT05381597|Antimetabolites|antimetabolites|mesh-ancestor
25358703|NCT05381597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358704|NCT05381597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25358705|NCT05381597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358706|NCT05381597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25358707|NCT05381597|Immunologic Factors|immunologic factors|mesh-ancestor
25358708|NCT05381597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358709|NCT05381597|Dermatologic Agents|dermatologic agents|mesh-ancestor
25358710|NCT05381350|Vaccines|vaccines|mesh-list
25358711|NCT05381350|Immunologic Factors|immunologic factors|mesh-ancestor
25358712|NCT05381350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358713|NCT05380947|Rabeprazole|rabeprazole|mesh-list
25358714|NCT05380947|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25358715|NCT05380947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25358716|NCT05380947|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25358717|NCT05380947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358718|NCT05380947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358719|NCT05380635|Hypericin|hypericin|mesh-list
25358720|NCT05380635|Antidepressive Agents|antidepressive agents|mesh-ancestor
25358721|NCT05380635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25358722|NCT05380635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358723|NCT05380635|Antiviral Agents|antiviral agents|mesh-ancestor
25358724|NCT05380635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25358726|NCT05380635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358727|NCT05380635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25358728|NCT05380635|Immunologic Factors|immunologic factors|mesh-ancestor
25358729|NCT05380635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358730|NCT05380024|Ensartinib|ensartinib|mesh-list
25358731|NCT05380024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358732|NCT05380024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25358733|NCT05380024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358734|NCT05380024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358735|NCT05379686|Glucagon|glucagon|mesh-list
25358736|NCT05379686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25358737|NCT05379686|Hormones|hormones|mesh-ancestor
25358738|NCT05379686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25358739|NCT05379686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358740|NCT05379634|Glucocorticoids|glucocorticoids|mesh-list
25358741|NCT05379634|Hormones|hormones|mesh-ancestor
25358742|NCT05379634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25358743|NCT05379634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358744|NCT05379595|Leucovorin|leucovorin|mesh-list
25358745|NCT05379595|Fluorouracil|fluorouracil|mesh-list
25358746|NCT05379595|Oxaliplatin|oxaliplatin|mesh-list
25358747|NCT05379595|Irinotecan|irinotecan|mesh-list
25358748|NCT05379595|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
25358749|NCT05379595|Antimetabolites|antimetabolites|mesh-ancestor
25358750|NCT05379595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360410|NCT05340465|Iron|iron|mesh-list
25358751|NCT05379595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25358752|NCT05379595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358753|NCT05379595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25358754|NCT05379595|Immunologic Factors|immunologic factors|mesh-ancestor
25358755|NCT05379595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358756|NCT05379595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25358757|NCT05379595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25358758|NCT05379595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358759|NCT05379595|Antidotes|antidotes|mesh-ancestor
25358760|NCT05379595|Protective Agents|protective agents|mesh-ancestor
25358761|NCT05379595|Vitamin B Complex|vitamin b complex|mesh-ancestor
25358762|NCT05379595|Vitamins|vitamins|mesh-ancestor
25358763|NCT05379595|Micronutrients|micronutrients|mesh-ancestor
25358764|NCT05379595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25358765|NCT05379491|Linaclotide|linaclotide|mesh-list
25358766|NCT05379491|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
25358767|NCT05379491|Enzyme Activators|enzyme activators|mesh-ancestor
25358768|NCT05379491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358769|NCT05379491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25358770|NCT05379179|Fentanyl|fentanyl|mesh-list
25358771|NCT05379179|Ketamine|ketamine|mesh-list
25358772|NCT05379179|Analgesics|analgesics|mesh-ancestor
25358773|NCT05379179|Sensory System Agents|sensory system agents|mesh-ancestor
25358774|NCT05379179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25358775|NCT05379179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358776|NCT05379179|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25358777|NCT05379179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25358778|NCT05379179|Anesthetics, General|anesthetics, general|mesh-ancestor
25358779|NCT05379179|Anesthetics|anesthetics|mesh-ancestor
25358780|NCT05379179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25358781|NCT05379179|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25358782|NCT05379179|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25358783|NCT05379179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25358784|NCT05379179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358785|NCT05379179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25358786|NCT05379179|Narcotics|narcotics|mesh-ancestor
25358787|NCT05379179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25358789|NCT05378945|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25358790|NCT05378945|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25358791|NCT05378945|Cholinergic Agents|cholinergic agents|mesh-ancestor
25358792|NCT05378945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25358793|NCT05378945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358794|NCT05378945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358795|NCT05378906|Darunavir|darunavir|mesh-list
25358796|NCT05378906|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25358797|NCT05378906|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25358798|NCT05378906|Protease Inhibitors|protease inhibitors|mesh-ancestor
25358799|NCT05378906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358800|NCT05378906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358801|NCT05378906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25358802|NCT05378906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25358803|NCT05378906|Antiviral Agents|antiviral agents|mesh-ancestor
25358804|NCT05378906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25358805|NCT05378750|Diuretics|diuretics|mesh-list
25358806|NCT05378750|Natriuretic Agents|natriuretic agents|mesh-ancestor
25358807|NCT05378750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358808|NCT05378737|Exatecan|exatecan|mesh-list
25358809|NCT05378737|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25358810|NCT05378737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25358811|NCT05378737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358812|NCT05378737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358813|NCT05378737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358814|NCT05378464|Trastuzumab|trastuzumab|mesh-list
25358815|NCT05378464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25358816|NCT05378464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358817|NCT05378399|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25358818|NCT05378399|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25358819|NCT05378399|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25358820|NCT05378399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25358821|NCT05378399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358822|NCT05378399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358823|NCT05378399|Antiviral Agents|antiviral agents|mesh-ancestor
25358824|NCT05378399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25358825|NCT05378399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25358826|NCT05378399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25358828|NCT05378100|Ketamine|ketamine|mesh-list
25358829|NCT05378100|Analgesics|analgesics|mesh-ancestor
25358830|NCT05378100|Sensory System Agents|sensory system agents|mesh-ancestor
25358831|NCT05378100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25358832|NCT05378100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358833|NCT05378100|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25358834|NCT05378100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25358835|NCT05378100|Anesthetics, General|anesthetics, general|mesh-ancestor
25358836|NCT05378100|Anesthetics|anesthetics|mesh-ancestor
25358837|NCT05378100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25358838|NCT05378100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25358839|NCT05378100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25358840|NCT05378100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25358841|NCT05378100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358842|NCT05378100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25358843|NCT05378100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25358844|NCT05378100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25358845|NCT05378100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25358846|NCT05378100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25358847|NCT05378100|GABA Modulators|gaba modulators|mesh-ancestor
25358848|NCT05378100|GABA Agents|gaba agents|mesh-ancestor
25358849|NCT05377905|Doxorubicin|doxorubicin|mesh-list
25358850|NCT05377905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25358851|NCT05377905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25358852|NCT05377905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358853|NCT05377905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25358854|NCT05377905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25358855|NCT05377905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358856|NCT05377905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358857|NCT05377255|Naloxone|naloxone|mesh-list
25358858|NCT05377255|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25358859|NCT05377255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358860|NCT05377255|Sensory System Agents|sensory system agents|mesh-ancestor
25358861|NCT05377255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25358862|NCT05377242|Curcumin|curcumin|mesh-list
25358863|NCT05377242|Resveratrol|resveratrol|mesh-list
25358864|NCT05377242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25358865|NCT05377242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25358866|NCT05377242|Analgesics|analgesics|mesh-ancestor
25358867|NCT05377242|Sensory System Agents|sensory system agents|mesh-ancestor
25358868|NCT05377242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25358869|NCT05377242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358870|NCT05377242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25358871|NCT05377242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25358872|NCT05377242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358873|NCT05377242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408382|NCT03447379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25358874|NCT05377242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358876|NCT05377242|Protective Agents|protective agents|mesh-ancestor
25358877|NCT05377242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25358878|NCT05377034|Bevacizumab|bevacizumab|mesh-list
25358879|NCT05377034|Atezolizumab|atezolizumab|mesh-list
25358880|NCT05377034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25358881|NCT05377034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358882|NCT05377034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25358883|NCT05377034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25358884|NCT05377034|Growth Substances|growth substances|mesh-ancestor
25358885|NCT05377034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358886|NCT05377034|Growth Inhibitors|growth inhibitors|mesh-ancestor
25358887|NCT05376878|Copper|copper|mesh-list
25358888|NCT05376878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25358889|NCT05376878|Trastuzumab|trastuzumab|mesh-list
25358890|NCT05376878|Camptothecin|camptothecin|mesh-list
25358891|NCT05376878|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
25358892|NCT05376878|Antibodies|antibodies|mesh-list
25358893|NCT05376878|Immunoglobulins|immunoglobulins|mesh-list
25358894|NCT05376878|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25358895|NCT05376878|Immunoconjugates|immunoconjugates|mesh-list
25358896|NCT05376878|Immunologic Factors|immunologic factors|mesh-ancestor
25358897|NCT05376878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358898|NCT05376878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358899|NCT05376878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358900|NCT05376878|Trace Elements|trace elements|mesh-ancestor
25358901|NCT05376878|Micronutrients|micronutrients|mesh-ancestor
25358913|NCT05376553|Docetaxel|docetaxel|mesh-list
25358914|NCT05376553|Cemiplimab|cemiplimab|mesh-list
25358915|NCT05376553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358916|NCT05376553|Tubulin Modulators|tubulin modulators|mesh-ancestor
25358917|NCT05376553|Antimitotic Agents|antimitotic agents|mesh-ancestor
25358918|NCT05376553|Mitosis Modulators|mitosis modulators|mesh-ancestor
25358919|NCT05376553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358920|NCT05376553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25358921|NCT05376319|Rituximab|rituximab|mesh-list
25358922|NCT05376319|Obinutuzumab|obinutuzumab|mesh-list
25358923|NCT05376319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25358924|NCT05376319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358925|NCT05376319|Immunologic Factors|immunologic factors|mesh-ancestor
25358926|NCT05376319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358927|NCT05376319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25358928|NCT05375994|Adagrasib|adagrasib|mesh-list
25358929|NCT05375994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358930|NCT05375942|Infliximab|infliximab|mesh-list
25358931|NCT05375942|Dermatologic Agents|dermatologic agents|mesh-ancestor
25358932|NCT05375942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25358933|NCT05375942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25358934|NCT05375929|Abrocitinib|abrocitinib|mesh-list
25358935|NCT05375929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25358936|NCT05375929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359089|NCT05371093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25358937|NCT05375929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358938|NCT05375903|Imiquimod|imiquimod|mesh-list
25358939|NCT05375903|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25358940|NCT05375903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25358941|NCT05375903|Immunologic Factors|immunologic factors|mesh-ancestor
25358942|NCT05375903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358943|NCT05375903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25358944|NCT05375903|Interferon Inducers|interferon inducers|mesh-ancestor
25358945|NCT05374525|Cabotegravir|cabotegravir|mesh-list
25358946|NCT05374525|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25358947|NCT05374525|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25358948|NCT05374525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358949|NCT05374525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358950|NCT05374525|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25358951|NCT05374525|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25358952|NCT05374525|Antiviral Agents|antiviral agents|mesh-ancestor
25358953|NCT05374525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25358966|NCT05372939|Adalimumab|adalimumab|mesh-list
25358967|NCT05372939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25358968|NCT05372939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25358986|NCT05372393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25358987|NCT05372393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25358989|NCT05372367|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25358990|NCT05372367|Antitubercular Agents|antitubercular agents|mesh-ancestor
25358991|NCT05372367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25358992|NCT05372367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25358993|NCT05372367|Leprostatic Agents|leprostatic agents|mesh-ancestor
25358994|NCT05372367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25358995|NCT05372367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25358996|NCT05372367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25358997|NCT05372367|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25358998|NCT05372367|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25358999|NCT05372367|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25359000|NCT05372367|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25359001|NCT05372367|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25359002|NCT05372367|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25359004|NCT05372354|Trametinib|trametinib|mesh-list
25359005|NCT05372354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25359006|NCT05372354|Antiemetics|antiemetics|mesh-ancestor
25359007|NCT05372354|Autonomic Agents|autonomic agents|mesh-ancestor
25359008|NCT05372354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25359009|NCT05372354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359010|NCT05372354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25359011|NCT05372354|Glucocorticoids|glucocorticoids|mesh-ancestor
25359012|NCT05372354|Hormones|hormones|mesh-ancestor
25359013|NCT05372354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25359014|NCT05372354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25359015|NCT05372354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359016|NCT05372354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25359017|NCT05372354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359018|NCT05372354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359019|NCT05372315|Dexamethasone|dexamethasone|mesh-list
25359020|NCT05372315|Dexamethasone acetate|dexamethasone acetate|mesh-list
25359021|NCT05372315|BB 1101|bb 1101|mesh-list
25359022|NCT05372315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25359023|NCT05372315|Antiemetics|antiemetics|mesh-ancestor
25359024|NCT05372315|Autonomic Agents|autonomic agents|mesh-ancestor
25359025|NCT05372315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25359026|NCT05372315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359027|NCT05372315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25359028|NCT05372315|Glucocorticoids|glucocorticoids|mesh-ancestor
25359029|NCT05372315|Hormones|hormones|mesh-ancestor
25359030|NCT05372315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25359031|NCT05372315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25359032|NCT05372315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359033|NCT05372315|Protease Inhibitors|protease inhibitors|mesh-ancestor
25359034|NCT05372315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359035|NCT05372315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359036|NCT05371925|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
25359037|NCT05371925|Anticoagulants|anticoagulants|mesh-ancestor
25359038|NCT05371925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25359039|NCT05371925|Antimetabolites|antimetabolites|mesh-ancestor
25359040|NCT05371925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359041|NCT05371925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25359042|NCT05371925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25359043|NCT05371925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25359044|NCT05371925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25359045|NCT05371925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359046|NCT05371886|Midazolam|midazolam|mesh-list
25359047|NCT05371886|Morphine|morphine|mesh-list
25359048|NCT05371886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25359049|NCT05371886|Narcotics|narcotics|mesh-ancestor
25359050|NCT05371886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25359051|NCT05371886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359061|NCT05371886|Anesthetics, General|anesthetics, general|mesh-ancestor
25359062|NCT05371886|Anesthetics|anesthetics|mesh-ancestor
25359063|NCT05371886|GABA Modulators|gaba modulators|mesh-ancestor
25359064|NCT05371886|GABA Agents|gaba agents|mesh-ancestor
25359065|NCT05371886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25359066|NCT05371886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359067|NCT05371132|Deferoxamine|deferoxamine|mesh-list
25359068|NCT05371132|Siderophores|siderophores|mesh-ancestor
25359069|NCT05371132|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25359070|NCT05371132|Chelating Agents|chelating agents|mesh-ancestor
25359071|NCT05371132|Sequestering Agents|sequestering agents|mesh-ancestor
25359072|NCT05371132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359074|NCT05371093|Cyclophosphamide|cyclophosphamide|mesh-list
25359075|NCT05371093|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25359077|NCT05371093|Doxorubicin|doxorubicin|mesh-list
25359078|NCT05371093|Fludarabine|fludarabine|mesh-list
25359079|NCT05371093|Vincristine|vincristine|mesh-list
25359080|NCT05371093|Lenalidomide|lenalidomide|mesh-list
25359081|NCT05371093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25359082|NCT05371093|Immunologic Factors|immunologic factors|mesh-ancestor
25359083|NCT05371093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359084|NCT05371093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25359085|NCT05371093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25359086|NCT05371093|Alkylating Agents|alkylating agents|mesh-ancestor
25359087|NCT05371093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359088|NCT05371093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359090|NCT05371093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25359091|NCT05371093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25359092|NCT05371093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25359093|NCT05371093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25359094|NCT05371093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359095|NCT05371093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25359096|NCT05371093|Glucocorticoids|glucocorticoids|mesh-ancestor
25359098|NCT05371093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25359099|NCT05371093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25359100|NCT05371093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25359101|NCT05371093|Tubulin Modulators|tubulin modulators|mesh-ancestor
25359102|NCT05371093|Antimitotic Agents|antimitotic agents|mesh-ancestor
25359103|NCT05371093|Mitosis Modulators|mitosis modulators|mesh-ancestor
25359104|NCT05371093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25359105|NCT05371093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25359106|NCT05371093|Growth Substances|growth substances|mesh-ancestor
25359107|NCT05371093|Growth Inhibitors|growth inhibitors|mesh-ancestor
25359117|NCT05371015|Ropivacaine|ropivacaine|mesh-list
25359118|NCT05371015|Anesthetics, Local|anesthetics, local|mesh-ancestor
25359119|NCT05371015|Anesthetics|anesthetics|mesh-ancestor
25359120|NCT05371015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25359121|NCT05371015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359122|NCT05371015|Sensory System Agents|sensory system agents|mesh-ancestor
25359123|NCT05371015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25359124|NCT05370911|Psilocybin|psilocybin|mesh-list
25359125|NCT05370911|Hallucinogens|hallucinogens|mesh-ancestor
25359126|NCT05370911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359127|NCT05370911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25359128|NCT05370885|Vancomycin|vancomycin|mesh-list
25359129|NCT05370885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25359130|NCT05370885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25359131|NCT05370495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25359132|NCT05370495|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25359133|NCT05370417|Fluorides|fluorides|mesh-list
25359134|NCT05370417|Cariostatic Agents|cariostatic agents|mesh-ancestor
25359135|NCT05370417|Protective Agents|protective agents|mesh-ancestor
25359136|NCT05370417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359137|NCT05369832|Ozanimod|ozanimod|mesh-list
25359138|NCT05369832|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25359139|NCT05369832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359140|NCT05369832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25359141|NCT05369832|Immunologic Factors|immunologic factors|mesh-ancestor
25359142|NCT05369832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359143|NCT05369793|Thioctic Acid|thioctic acid|mesh-list
25359144|NCT05369793|Antioxidants|antioxidants|mesh-ancestor
25359145|NCT05369793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359146|NCT05369793|Protective Agents|protective agents|mesh-ancestor
25359147|NCT05369793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359148|NCT05369793|Vitamin B Complex|vitamin b complex|mesh-ancestor
25359149|NCT05369793|Vitamins|vitamins|mesh-ancestor
25359150|NCT05369793|Micronutrients|micronutrients|mesh-ancestor
25359151|NCT05369533|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25359152|NCT05369533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25359153|NCT05369533|Immunologic Factors|immunologic factors|mesh-ancestor
25359154|NCT05369533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359155|NCT05369533|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25359156|NCT05369533|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25359157|NCT05369533|Dopamine Agonists|dopamine agonists|mesh-ancestor
25359158|NCT05369533|Dopamine Agents|dopamine agents|mesh-ancestor
25359159|NCT05369533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25359160|NCT05369533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359172|NCT05368415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359173|NCT05368415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359174|NCT05368415|Sympathomimetics|sympathomimetics|mesh-ancestor
25359175|NCT05368415|Autonomic Agents|autonomic agents|mesh-ancestor
25359176|NCT05368415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25359177|NCT05368415|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25359179|NCT05368376|Labetalol|labetalol|mesh-list
25359180|NCT05368376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25359181|NCT05368376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25359182|NCT05368376|Sympatholytics|sympatholytics|mesh-ancestor
25359183|NCT05368376|Autonomic Agents|autonomic agents|mesh-ancestor
25359184|NCT05368376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25359185|NCT05368376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359186|NCT05368376|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25359187|NCT05368376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25359188|NCT05368376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25359189|NCT05368376|Adrenergic Agents|adrenergic agents|mesh-ancestor
25359190|NCT05368376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25359191|NCT05368376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359192|NCT05368376|Sympathomimetics|sympathomimetics|mesh-ancestor
25359193|NCT05368376|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25359194|NCT05368376|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25359195|NCT05368090|Epinephrine|epinephrine|mesh-list
25359196|NCT05368090|Racepinephrine|racepinephrine|mesh-list
25359197|NCT05368090|Epinephryl borate|epinephryl borate|mesh-list
25359198|NCT05368090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25359199|NCT05368090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25359200|NCT05368090|Adrenergic Agents|adrenergic agents|mesh-ancestor
25359201|NCT05368090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25359202|NCT05368090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359203|NCT05368090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359204|NCT05368090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25359205|NCT05368090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25359206|NCT05368090|Autonomic Agents|autonomic agents|mesh-ancestor
25359207|NCT05368090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25359208|NCT05368090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25359209|NCT05368090|Respiratory System Agents|respiratory system agents|mesh-ancestor
25359210|NCT05368090|Mydriatics|mydriatics|mesh-ancestor
25359211|NCT05368090|Sympathomimetics|sympathomimetics|mesh-ancestor
25359212|NCT05368090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25359213|NCT05368012|Dexamethasone|dexamethasone|mesh-list
25359214|NCT05368012|Bupivacaine|bupivacaine|mesh-list
25359215|NCT05368012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25359216|NCT05368012|Antiemetics|antiemetics|mesh-ancestor
25359217|NCT05368012|Autonomic Agents|autonomic agents|mesh-ancestor
25359218|NCT05368012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25359219|NCT05368012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359220|NCT05368012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25359221|NCT05368012|Glucocorticoids|glucocorticoids|mesh-ancestor
25359222|NCT05368012|Hormones|hormones|mesh-ancestor
25359223|NCT05368012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25359224|NCT05368012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25359225|NCT05368012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359226|NCT05368012|Anesthetics, Local|anesthetics, local|mesh-ancestor
25359227|NCT05368012|Anesthetics|anesthetics|mesh-ancestor
25359228|NCT05368012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25359229|NCT05368012|Sensory System Agents|sensory system agents|mesh-ancestor
25359230|NCT05367492|Varenicline|varenicline|mesh-list
25359231|NCT05367492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25359232|NCT05367492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25359233|NCT05367492|Cholinergic Agents|cholinergic agents|mesh-ancestor
25359234|NCT05367492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25359235|NCT05367492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359236|NCT05367492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359244|NCT05367440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359245|NCT05367440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25359247|NCT05367401|Magrolimab|magrolimab|mesh-list
25359248|NCT05367401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25359249|NCT05367401|Antimetabolites|antimetabolites|mesh-ancestor
25359250|NCT05367401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359251|NCT05367401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359252|NCT05367401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359253|NCT05367401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25359254|NCT05367271|Dexamethasone|dexamethasone|mesh-list
25359255|NCT05367271|Cortisone|cortisone|mesh-list
25359256|NCT05367271|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25359257|NCT05367271|Botulinum Toxins|botulinum toxins|mesh-list
25359258|NCT05367271|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25359259|NCT05367271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25359260|NCT05367271|Antiemetics|antiemetics|mesh-ancestor
25359261|NCT05367271|Autonomic Agents|autonomic agents|mesh-ancestor
25359262|NCT05367271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25359263|NCT05367271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359264|NCT05367271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25359265|NCT05367271|Glucocorticoids|glucocorticoids|mesh-ancestor
25359266|NCT05367271|Hormones|hormones|mesh-ancestor
25359267|NCT05367271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25359268|NCT05367271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25359269|NCT05367271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359270|NCT05367271|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25359271|NCT05367271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25359272|NCT05367271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359273|NCT05367271|Cholinergic Agents|cholinergic agents|mesh-ancestor
25359274|NCT05367271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25359275|NCT05367271|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25359276|NCT05366933|Folic Acid|folic acid|mesh-list
25359277|NCT05366933|Vitamin B Complex|vitamin b complex|mesh-list
25359278|NCT05366933|Vitamins|vitamins|mesh-ancestor
25359279|NCT05366933|Micronutrients|micronutrients|mesh-ancestor
25359280|NCT05366933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359281|NCT05366933|Hematinics|hematinics|mesh-ancestor
25359302|NCT05366764|Autonomic Agents|autonomic agents|mesh-ancestor
25359303|NCT05366764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25359304|NCT05366764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359305|NCT05366764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25359306|NCT05366764|Respiratory System Agents|respiratory system agents|mesh-ancestor
25359307|NCT05366764|Tocolytic Agents|tocolytic agents|mesh-ancestor
25359308|NCT05366764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25359309|NCT05366764|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25359310|NCT05366764|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25359311|NCT05366764|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25359312|NCT05366764|Adrenergic Agents|adrenergic agents|mesh-ancestor
25359313|NCT05366764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25359391|NCT05364424|Carboplatin|carboplatin|mesh-list
25359314|NCT05366764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359315|NCT05366725|Avelumab|avelumab|mesh-list
25359316|NCT05366725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25359317|NCT05366725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359326|NCT05365451|Metformin|metformin|mesh-list
25359327|NCT05365451|Probenecid|probenecid|mesh-list
25359328|NCT05365451|Furosemide|furosemide|mesh-list
25359329|NCT05365451|Cimetidine|cimetidine|mesh-list
25359330|NCT05365451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25359335|NCT05365451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25359336|NCT05365451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359337|NCT05365451|Uricosuric Agents|uricosuric agents|mesh-ancestor
25359338|NCT05365451|Gout Suppressants|gout suppressants|mesh-ancestor
25359339|NCT05365451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25359340|NCT05365451|Renal Agents|renal agents|mesh-ancestor
25359341|NCT05365451|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25359342|NCT05365451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25359343|NCT05365451|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25359344|NCT05365451|Histamine Antagonists|histamine antagonists|mesh-ancestor
25359345|NCT05365451|Histamine Agents|histamine agents|mesh-ancestor
25359346|NCT05365451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25359347|NCT05365451|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25359348|NCT05365451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25359349|NCT05365451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359350|NCT05365035|Cytarabine|cytarabine|mesh-list
25359351|NCT05365035|Azacitidine|azacitidine|mesh-list
25359352|NCT05365035|Venetoclax|venetoclax|mesh-list
25359353|NCT05365035|Cladribine|cladribine|mesh-list
25359354|NCT05365035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25359355|NCT05365035|Antimetabolites|antimetabolites|mesh-ancestor
25359356|NCT05365035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359357|NCT05365035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359358|NCT05365035|Antiviral Agents|antiviral agents|mesh-ancestor
25359359|NCT05365035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25359360|NCT05365035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25359361|NCT05365035|Immunologic Factors|immunologic factors|mesh-ancestor
25359362|NCT05365035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359363|NCT05365035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359369|NCT05364762|Cyclophosphamide|cyclophosphamide|mesh-list
25359370|NCT05364762|Tacrolimus|tacrolimus|mesh-list
25359371|NCT05364762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25359372|NCT05364762|Immunologic Factors|immunologic factors|mesh-ancestor
25359373|NCT05364762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359374|NCT05364762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25359375|NCT05364762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25359376|NCT05364762|Alkylating Agents|alkylating agents|mesh-ancestor
25359377|NCT05364762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359378|NCT05364762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359379|NCT05364762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25359380|NCT05364762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25359381|NCT05364762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359382|NCT05364645|Carboplatin|carboplatin|mesh-list
25359383|NCT05364645|Pemetrexed|pemetrexed|mesh-list
25359384|NCT05364645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359385|NCT05364645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359386|NCT05364645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359387|NCT05364645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25359388|NCT05364645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25359389|NCT05364424|Rituximab|rituximab|mesh-list
25359390|NCT05364424|Obinutuzumab|obinutuzumab|mesh-list
25359392|NCT05364424|Etoposide|etoposide|mesh-list
25359393|NCT05364424|Ifosfamide|ifosfamide|mesh-list
25359394|NCT05364424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25359395|NCT05364424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359396|NCT05364424|Immunologic Factors|immunologic factors|mesh-ancestor
25359397|NCT05364424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359398|NCT05364424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25359399|NCT05364424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25359400|NCT05364424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25359401|NCT05364424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25359402|NCT05364424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359403|NCT05364424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359404|NCT05364424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25359405|NCT05364424|Alkylating Agents|alkylating agents|mesh-ancestor
25359406|NCT05364190|Canagliflozin|canagliflozin|mesh-list
25359407|NCT05364190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25359408|NCT05364190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359409|NCT05364190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25359410|NCT05364190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359411|NCT05364099|Triamcinolone|triamcinolone|mesh-list
25359412|NCT05364099|Lidocaine|lidocaine|mesh-list
25359413|NCT05364099|Anesthetics, Local|anesthetics, local|mesh-ancestor
25359414|NCT05364099|Anesthetics|anesthetics|mesh-ancestor
25359415|NCT05364099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25359416|NCT05364099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359417|NCT05364099|Sensory System Agents|sensory system agents|mesh-ancestor
25359418|NCT05364099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25359419|NCT05364099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25359420|NCT05364099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25359421|NCT05364099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25359422|NCT05364099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25359423|NCT05364099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359424|NCT05364099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25359425|NCT05364099|Glucocorticoids|glucocorticoids|mesh-ancestor
25359426|NCT05364099|Hormones|hormones|mesh-ancestor
25359427|NCT05364099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25359428|NCT05364073|Aflutinib|aflutinib|mesh-list
25359429|NCT05364073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25359430|NCT05364073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359431|NCT05364073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359432|NCT05364008|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
25359433|NCT05364008|Antioxidants|antioxidants|mesh-ancestor
25359434|NCT05364008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359435|NCT05364008|Protective Agents|protective agents|mesh-ancestor
25359436|NCT05364008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359437|NCT05364008|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25359438|NCT05364008|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25359439|NCT05364008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359440|NCT05364008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25359441|NCT05363670|Albuterol|albuterol|mesh-list
25359442|NCT05363670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25359443|NCT05363670|Autonomic Agents|autonomic agents|mesh-ancestor
25359444|NCT05363670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25359445|NCT05363670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359446|NCT05363670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25359447|NCT05363670|Respiratory System Agents|respiratory system agents|mesh-ancestor
25359448|NCT05363670|Tocolytic Agents|tocolytic agents|mesh-ancestor
25359449|NCT05363670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25359450|NCT05363670|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25359451|NCT05363670|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25359452|NCT05363670|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25359453|NCT05363670|Adrenergic Agents|adrenergic agents|mesh-ancestor
25359454|NCT05363670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25359455|NCT05363670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359456|NCT05363631|Selenium|selenium|mesh-list
25359457|NCT05363631|Pembrolizumab|pembrolizumab|mesh-list
25359458|NCT05363631|Axitinib|axitinib|mesh-list
25359459|NCT05363631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25359460|NCT05363631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359461|NCT05363631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25359462|NCT05363631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359463|NCT05363631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359464|NCT05363631|Antioxidants|antioxidants|mesh-ancestor
25359465|NCT05363631|Protective Agents|protective agents|mesh-ancestor
25359466|NCT05363631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359467|NCT05363631|Trace Elements|trace elements|mesh-ancestor
25359468|NCT05363631|Micronutrients|micronutrients|mesh-ancestor
25359469|NCT05363592|Metformin|metformin|mesh-list
25359470|NCT05363592|Alogliptin|alogliptin|mesh-list
25359471|NCT05363592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25359472|NCT05363592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359473|NCT05363592|Incretins|incretins|mesh-ancestor
25359474|NCT05363592|Hormones|hormones|mesh-ancestor
25359475|NCT05363592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25359476|NCT05363592|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25359477|NCT05363592|Protease Inhibitors|protease inhibitors|mesh-ancestor
25359478|NCT05363592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359479|NCT05363592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359480|NCT05363384|Metformin|metformin|mesh-list
25359481|NCT05363384|Alogliptin|alogliptin|mesh-list
25359482|NCT05363384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25359483|NCT05363384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359484|NCT05363384|Incretins|incretins|mesh-ancestor
25359485|NCT05363384|Hormones|hormones|mesh-ancestor
25359486|NCT05363384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25359487|NCT05363384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25359488|NCT05363384|Protease Inhibitors|protease inhibitors|mesh-ancestor
25359489|NCT05363384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359490|NCT05363384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359491|NCT05363319|Cemiplimab|cemiplimab|mesh-list
25359492|NCT05363319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25359493|NCT05363319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359494|NCT05363267|Curcumin|curcumin|mesh-list
25359495|NCT05363267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25359496|NCT05363267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25359497|NCT05363267|Analgesics|analgesics|mesh-ancestor
25359498|NCT05363267|Sensory System Agents|sensory system agents|mesh-ancestor
25359499|NCT05363267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25359500|NCT05363267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359501|NCT05363267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25359502|NCT05363267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25359503|NCT05363267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359504|NCT05363267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359505|NCT05363267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359506|NCT05363111|Daratumumab|daratumumab|mesh-list
25359507|NCT05363111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25359508|NCT05363111|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
25359509|NCT05363111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359510|NCT05363111|Immunologic Factors|immunologic factors|mesh-ancestor
25359511|NCT05363111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359512|NCT05363111|Chelating Agents|chelating agents|mesh-ancestor
25359513|NCT05363111|Sequestering Agents|sequestering agents|mesh-ancestor
25359514|NCT05363111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359516|NCT05362916|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25359517|NCT05362916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359518|NCT05362916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359519|NCT05362916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359520|NCT05362916|Antiviral Agents|antiviral agents|mesh-ancestor
25359521|NCT05362916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25359522|NCT05362760|Fulvestrant|fulvestrant|mesh-list
25359523|NCT05362760|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25359524|NCT05362760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25359525|NCT05362760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359526|NCT05362760|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25359527|NCT05362760|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25359528|NCT05362760|Hormone Antagonists|hormone antagonists|mesh-ancestor
25359529|NCT05362760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25359530|NCT05362760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359531|NCT05362760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25359532|NCT05362760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359533|NCT05362760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359534|NCT05362487|Bromides|bromides|mesh-list
25359535|NCT05362487|Tiotropium Bromide|tiotropium bromide|mesh-list
25359536|NCT05362487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25359537|NCT05362487|Autonomic Agents|autonomic agents|mesh-ancestor
25359538|NCT05362487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25359539|NCT05362487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359540|NCT05362487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25359541|NCT05362487|Respiratory System Agents|respiratory system agents|mesh-ancestor
25359542|NCT05362487|Parasympatholytics|parasympatholytics|mesh-ancestor
25359543|NCT05362487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25359544|NCT05362487|Cholinergic Agents|cholinergic agents|mesh-ancestor
25359545|NCT05362487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25359546|NCT05362487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359547|NCT05362487|Anticonvulsants|anticonvulsants|mesh-ancestor
25359548|NCT05362474|Montelukast|montelukast|mesh-list
25359549|NCT05362474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25359550|NCT05362474|Respiratory System Agents|respiratory system agents|mesh-ancestor
25359551|NCT05362474|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25359552|NCT05362474|Hormone Antagonists|hormone antagonists|mesh-ancestor
25359553|NCT05362474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25359554|NCT05362474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359555|NCT05362474|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25359556|NCT05362474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25359557|NCT05362474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359558|NCT05362409|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25359559|NCT05362409|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25359560|NCT05362409|Dermatologic Agents|dermatologic agents|mesh-ancestor
25359561|NCT05362292|Mirabegron|mirabegron|mesh-list
25359562|NCT05362292|Tolterodine Tartrate|tolterodine tartrate|mesh-list
25359563|NCT05362292|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25359564|NCT05362292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25359565|NCT05362292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25359566|NCT05362292|Adrenergic Agents|adrenergic agents|mesh-ancestor
25359567|NCT05362292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25359568|NCT05362292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359569|NCT05362292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359570|NCT05362292|Urological Agents|urological agents|mesh-ancestor
25359571|NCT05362292|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25359572|NCT05362292|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25359573|NCT05362292|Cholinergic Agents|cholinergic agents|mesh-ancestor
25359574|NCT05362058|Insulin|insulin|mesh-list
25359575|NCT05362058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25359576|NCT05362058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359577|NCT05361993|Aripiprazole|aripiprazole|mesh-list
25359578|NCT05361993|Antidepressive Agents|antidepressive agents|mesh-ancestor
25359579|NCT05361993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25359580|NCT05361993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25359581|NCT05361993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25359582|NCT05361993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25359583|NCT05361993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359584|NCT05361993|Dopamine Agonists|dopamine agonists|mesh-ancestor
25359585|NCT05361993|Dopamine Agents|dopamine agents|mesh-ancestor
25359586|NCT05361993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25359587|NCT05361993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359588|NCT05361993|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25359589|NCT05361993|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25359590|NCT05361993|Serotonin Agents|serotonin agents|mesh-ancestor
25359591|NCT05361993|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25359592|NCT05361993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25359593|NCT05361993|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25359594|NCT05361993|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25359596|NCT05361941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25359597|NCT05361941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25359598|NCT05361720|Nivolumab|nivolumab|mesh-list
25359599|NCT05361720|Ipilimumab|ipilimumab|mesh-list
25359600|NCT05361720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25359601|NCT05361720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359602|NCT05361720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25359603|NCT05361720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359604|NCT05361642|Lidocaine|lidocaine|mesh-list
25359605|NCT05361642|Dexmedetomidine|dexmedetomidine|mesh-list
25359606|NCT05361642|Bupivacaine|bupivacaine|mesh-list
25359607|NCT05361642|Anesthetics, Local|anesthetics, local|mesh-ancestor
25359608|NCT05361642|Anesthetics|anesthetics|mesh-ancestor
25359609|NCT05361642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25359610|NCT05361642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359611|NCT05361642|Sensory System Agents|sensory system agents|mesh-ancestor
25359612|NCT05361642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25359613|NCT05361642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25359614|NCT05361642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25359615|NCT05361642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25359616|NCT05361642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25359617|NCT05361642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359618|NCT05361642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25359619|NCT05361642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25359620|NCT05361642|Analgesics|analgesics|mesh-ancestor
25359621|NCT05361642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25359622|NCT05361642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25359623|NCT05361642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25359624|NCT05361642|Adrenergic Agents|adrenergic agents|mesh-ancestor
25359625|NCT05361642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25359626|NCT05361447|Diazepam|diazepam|mesh-list
25359627|NCT05361447|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25359628|NCT05361447|Anticonvulsants|anticonvulsants|mesh-ancestor
25359629|NCT05361447|Antiemetics|antiemetics|mesh-ancestor
25359630|NCT05361447|Autonomic Agents|autonomic agents|mesh-ancestor
25359631|NCT05361447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25359632|NCT05361447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359633|NCT05361447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25359634|NCT05361447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25359635|NCT05361447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25359636|NCT05361447|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25359637|NCT05361447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25359638|NCT05361447|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25359639|NCT05361447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25359640|NCT05361447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25359641|NCT05361447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25359642|NCT05361447|Anesthetics, General|anesthetics, general|mesh-ancestor
25359643|NCT05361447|Anesthetics|anesthetics|mesh-ancestor
25359644|NCT05361447|GABA Modulators|gaba modulators|mesh-ancestor
25359645|NCT05361447|GABA Agents|gaba agents|mesh-ancestor
25359646|NCT05361447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25359647|NCT05361447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359648|NCT05361395|Carboplatin|carboplatin|mesh-list
25359649|NCT05361395|Etoposide|etoposide|mesh-list
25359650|NCT05361395|Atezolizumab|atezolizumab|mesh-list
25359651|NCT05361395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359652|NCT05361395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25359653|NCT05361395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25359654|NCT05361395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25359655|NCT05361395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359656|NCT05361395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359657|NCT05361382|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
25359658|NCT05361382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359659|NCT05360966|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25359660|NCT05360966|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25359662|NCT05360732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359663|NCT05360277|Capecitabine|capecitabine|mesh-list
25359664|NCT05360277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25359665|NCT05360277|Antimetabolites|antimetabolites|mesh-ancestor
25359666|NCT05360277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359667|NCT05360277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359668|NCT05359861|Bevacizumab|bevacizumab|mesh-list
25359669|NCT05359861|Atezolizumab|atezolizumab|mesh-list
25359670|NCT05359861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25359671|NCT05359861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359672|NCT05359861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25359673|NCT05359861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25359674|NCT05359861|Growth Substances|growth substances|mesh-ancestor
25359675|NCT05359861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359676|NCT05359861|Growth Inhibitors|growth inhibitors|mesh-ancestor
25359677|NCT05359653|Clemastine|clemastine|mesh-list
25359678|NCT05359653|Antipruritics|antipruritics|mesh-ancestor
25359679|NCT05359653|Dermatologic Agents|dermatologic agents|mesh-ancestor
25359680|NCT05359653|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25359681|NCT05359653|Histamine Antagonists|histamine antagonists|mesh-ancestor
25359682|NCT05359653|Histamine Agents|histamine agents|mesh-ancestor
25359683|NCT05359653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25359684|NCT05359653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359685|NCT05359653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359686|NCT05359653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25359687|NCT05359211|Cyclophosphamide|cyclophosphamide|mesh-list
25359688|NCT05359211|Fludarabine|fludarabine|mesh-list
25359689|NCT05359211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25359690|NCT05359211|Immunologic Factors|immunologic factors|mesh-ancestor
25359691|NCT05359211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359692|NCT05359211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25359693|NCT05359211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25359694|NCT05359211|Alkylating Agents|alkylating agents|mesh-ancestor
25359695|NCT05359211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359696|NCT05359211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359697|NCT05359211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25359698|NCT05359055|Itraconazole|itraconazole|mesh-list
25359699|NCT05359055|Rifampin|rifampin|mesh-list
25359700|NCT05359055|Antifungal Agents|antifungal agents|mesh-ancestor
25359701|NCT05359055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25359702|NCT05359055|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25359703|NCT05359055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25359704|NCT05359055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359705|NCT05359055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359706|NCT05359055|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25359707|NCT05359055|Hormone Antagonists|hormone antagonists|mesh-ancestor
25359708|NCT05359055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25359709|NCT05359055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359710|NCT05359055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25359711|NCT05359055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25359712|NCT05359055|Antitubercular Agents|antitubercular agents|mesh-ancestor
25359713|NCT05359055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25359714|NCT05359055|Leprostatic Agents|leprostatic agents|mesh-ancestor
25359715|NCT05359055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25359716|NCT05359055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25359717|NCT05359055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25359718|NCT05359055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25359719|NCT05359055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25359720|NCT05359055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25359721|NCT05359055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25359722|NCT05358938|Pembrolizumab|pembrolizumab|mesh-list
25359723|NCT05358938|Ipilimumab|ipilimumab|mesh-list
25359724|NCT05358938|Avelumab|avelumab|mesh-list
25359725|NCT05358938|Cemiplimab|cemiplimab|mesh-list
25359726|NCT05358938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25359733|NCT05358834|Protective Agents|protective agents|mesh-ancestor
25359734|NCT05358834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359735|NCT05358834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25359736|NCT05358535|Propofol|propofol|mesh-list
25359737|NCT05358535|Etomidate|etomidate|mesh-list
25359738|NCT05358535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25359739|NCT05358535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25359740|NCT05358535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359741|NCT05358535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25359742|NCT05358535|Anesthetics, General|anesthetics, general|mesh-ancestor
25359743|NCT05358535|Anesthetics|anesthetics|mesh-ancestor
25359744|NCT05358522|Analgesics, Opioid|analgesics, opioid|mesh-list
25359745|NCT05358522|Narcotics|narcotics|mesh-ancestor
25359746|NCT05358522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25359747|NCT05358522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359748|NCT05358522|Analgesics|analgesics|mesh-ancestor
25359749|NCT05358522|Sensory System Agents|sensory system agents|mesh-ancestor
25359750|NCT05358522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25359751|NCT05358249|Cetuximab|cetuximab|mesh-list
25359752|NCT05358249|Trametinib|trametinib|mesh-list
25359753|NCT05358249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25359754|NCT05358249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359755|NCT05358249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25359756|NCT05358249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359757|NCT05358249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359766|NCT05357690|Anesthetics, Local|anesthetics, local|mesh-ancestor
25359767|NCT05357690|Anesthetics|anesthetics|mesh-ancestor
25359768|NCT05357690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25359769|NCT05357690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359770|NCT05357690|Sensory System Agents|sensory system agents|mesh-ancestor
25359771|NCT05357690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25359772|NCT05357612|Pimavanserin|pimavanserin|mesh-list
25359773|NCT05357612|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25359774|NCT05357612|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25359775|NCT05357612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25359776|NCT05357612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25359777|NCT05357612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25359778|NCT05357612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359779|NCT05357612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25359780|NCT05357612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25359781|NCT05357612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25359782|NCT05357612|Serotonin Agents|serotonin agents|mesh-ancestor
25359783|NCT05357612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25359784|NCT05357612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359785|NCT05357417|Bevacizumab|bevacizumab|mesh-list
25359786|NCT05357417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25359787|NCT05357417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359788|NCT05357417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25359789|NCT05357417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25359790|NCT05357417|Growth Substances|growth substances|mesh-ancestor
25359791|NCT05357417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359792|NCT05357417|Growth Inhibitors|growth inhibitors|mesh-ancestor
25359793|NCT05356897|Trifluridine|trifluridine|mesh-list
25359794|NCT05356897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25359796|NCT05356897|Tucatinib|tucatinib|mesh-list
25359797|NCT05356897|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
25359798|NCT05356897|Antibodies|antibodies|mesh-list
25359799|NCT05356897|Immunoglobulins|immunoglobulins|mesh-list
25359800|NCT05356897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25359801|NCT05356897|Immunologic Factors|immunologic factors|mesh-ancestor
25359802|NCT05356897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359803|NCT05356897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359804|NCT05356897|Antimetabolites|antimetabolites|mesh-ancestor
25359805|NCT05356897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359806|NCT05356897|Antiviral Agents|antiviral agents|mesh-ancestor
25359807|NCT05356897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25359808|NCT05356897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25359809|NCT05356897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359810|NCT05356741|Pembrolizumab|pembrolizumab|mesh-list
25359811|NCT05356741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25359812|NCT05356741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359813|NCT05355974|Norepinephrine|norepinephrine|mesh-list
25359814|NCT05355974|Plasma-lyte 148|plasma-lyte 148|mesh-list
25359815|NCT05355974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25359816|NCT05355974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25359817|NCT05355974|Adrenergic Agents|adrenergic agents|mesh-ancestor
25359818|NCT05355974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25359819|NCT05355974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359820|NCT05355974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359821|NCT05355974|Sympathomimetics|sympathomimetics|mesh-ancestor
25359822|NCT05355974|Autonomic Agents|autonomic agents|mesh-ancestor
25359823|NCT05355974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25359824|NCT05355974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25359825|NCT05355974|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25359826|NCT05355974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25359827|NCT05355935|Moxifloxacin|moxifloxacin|mesh-list
25359828|NCT05355935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25359829|NCT05355935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25359830|NCT05355935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25359831|NCT05355935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25359832|NCT05355935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359833|NCT05355935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359834|NCT05355935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359835|NCT05355857|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25359836|NCT05355857|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25359837|NCT05355857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359838|NCT05355701|Cetuximab|cetuximab|mesh-list
25359839|NCT05355701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25359840|NCT05355701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359841|NCT05355350|Meropenem|meropenem|mesh-list
25359842|NCT05355350|Tazobactam|tazobactam|mesh-list
25359843|NCT05355350|Piperacillin|piperacillin|mesh-list
25359844|NCT05355350|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
25359845|NCT05355350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25359846|NCT05355350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25359847|NCT05355350|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25359848|NCT05355350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359849|NCT05355350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359850|NCT05354999|Caffeine|caffeine|mesh-list
25359851|NCT05354999|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25359852|NCT05354999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359853|NCT05354999|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25359854|NCT05354999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359855|NCT05354999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359856|NCT05354999|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25359857|NCT05354999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25359858|NCT05354999|Purinergic Agents|purinergic agents|mesh-ancestor
25359859|NCT05354999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25359860|NCT05354778|Hydrocortisone|hydrocortisone|mesh-list
25359861|NCT05354778|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25359862|NCT05354778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25359863|NCT05354453|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
25359864|NCT05354453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359865|NCT05354453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359866|NCT05354453|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25359867|NCT05354453|Protective Agents|protective agents|mesh-ancestor
25359872|NCT05354102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359873|NCT05354102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25359874|NCT05354102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359875|NCT05353933|Pantoprazole|pantoprazole|mesh-list
25359876|NCT05353933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25359877|NCT05353933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25359878|NCT05353933|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25359879|NCT05353933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359880|NCT05353933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359881|NCT05353439|Pembrolizumab|pembrolizumab|mesh-list
25359883|NCT05353439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25359884|NCT05353439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359885|NCT05353439|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25359886|NCT05353439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25359887|NCT05353439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359888|NCT05353439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359889|NCT05353348|Epoetin Alfa|epoetin alfa|mesh-list
25359890|NCT05353348|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
25359891|NCT05353348|Hematinics|hematinics|mesh-ancestor
25359892|NCT05353257|Cisplatin|cisplatin|mesh-list
25359893|NCT05353257|Carboplatin|carboplatin|mesh-list
25359894|NCT05353257|Etoposide|etoposide|mesh-list
25359895|NCT05353257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359896|NCT05353257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25359897|NCT05353257|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25359898|NCT05353257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25359899|NCT05353257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359900|NCT05353257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359901|NCT05352828|Nivolumab|nivolumab|mesh-list
25359902|NCT05352828|Fludarabine|fludarabine|mesh-list
25359903|NCT05352828|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25359904|NCT05352828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25359905|NCT05352828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359906|NCT05352828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25359907|NCT05352828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359908|NCT05352828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25359909|NCT05352828|Alkylating Agents|alkylating agents|mesh-ancestor
25359910|NCT05352685|Propofol|propofol|mesh-list
25359911|NCT05352685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25359912|NCT05352685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25359913|NCT05352685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359914|NCT05352685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25359915|NCT05352685|Anesthetics, General|anesthetics, general|mesh-ancestor
25359916|NCT05352685|Anesthetics|anesthetics|mesh-ancestor
25359921|NCT05352516|Denosumab|denosumab|mesh-list
25359922|NCT05352516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25359923|NCT05352516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359924|NCT05351944|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25359925|NCT05351944|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25359926|NCT05351944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25359927|NCT05351944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25359928|NCT05351944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359929|NCT05351944|Adrenergic Agents|adrenergic agents|mesh-ancestor
25359930|NCT05351944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25359931|NCT05351944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359932|NCT05351801|Dronabinol|dronabinol|mesh-list
25359933|NCT05351801|Nabiximols|nabiximols|mesh-list
25359934|NCT05351801|Hallucinogens|hallucinogens|mesh-ancestor
25359935|NCT05351801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359936|NCT05351801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25359937|NCT05351801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25359938|NCT05351801|Analgesics|analgesics|mesh-ancestor
25359939|NCT05351801|Sensory System Agents|sensory system agents|mesh-ancestor
25359940|NCT05351801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25359941|NCT05351801|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25359942|NCT05351801|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25392156|NCT04221477|Hormones|hormones|mesh-ancestor
25359943|NCT05351801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25359944|NCT05351801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359945|NCT05351801|Hormones|hormones|mesh-ancestor
25359946|NCT05351801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25359947|NCT05351593|Lenalidomide|lenalidomide|mesh-list
25359948|NCT05351593|Immunologic Factors|immunologic factors|mesh-ancestor
25359949|NCT05351593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25359950|NCT05351593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25359969|NCT05351346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25359970|NCT05351346|Alkylating Agents|alkylating agents|mesh-ancestor
25359971|NCT05351346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25359972|NCT05351346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25359973|NCT05351346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25359974|NCT05351346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25359975|NCT05351346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25359976|NCT05351346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25359977|NCT05351346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25359978|NCT05351346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25359979|NCT05351346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25359980|NCT05351346|Glucocorticoids|glucocorticoids|mesh-ancestor
25359982|NCT05351346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25359983|NCT05351346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25359984|NCT05351346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25359985|NCT05351346|Tubulin Modulators|tubulin modulators|mesh-ancestor
25359986|NCT05351346|Antimitotic Agents|antimitotic agents|mesh-ancestor
25359987|NCT05351346|Mitosis Modulators|mitosis modulators|mesh-ancestor
25359988|NCT05351346|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25359989|NCT05351346|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25359990|NCT05351346|Growth Substances|growth substances|mesh-ancestor
25359991|NCT05351346|Growth Inhibitors|growth inhibitors|mesh-ancestor
25359992|NCT05351346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25359993|NCT05351346|Antimetabolites|antimetabolites|mesh-ancestor
25360012|NCT05350202|Empagliflozin|empagliflozin|mesh-list
25360013|NCT05350202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25360014|NCT05350202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360015|NCT05350202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25360016|NCT05350202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360017|NCT05350124|Vitamins|vitamins|mesh-list
25360018|NCT05350124|Ascorbic Acid|ascorbic acid|mesh-list
25360019|NCT05350124|Vitamin E|vitamin e|mesh-list
25360020|NCT05350124|Tocopherols|tocopherols|mesh-list
25360021|NCT05350124|Micronutrients|micronutrients|mesh-ancestor
25360022|NCT05350124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360023|NCT05350124|Antioxidants|antioxidants|mesh-ancestor
25360024|NCT05350124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360025|NCT05350124|Protective Agents|protective agents|mesh-ancestor
25360026|NCT05350085|Midazolam|midazolam|mesh-list
25360027|NCT05350085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25360028|NCT05350085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25360029|NCT05350085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25360030|NCT05350085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360031|NCT05350085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25360032|NCT05350085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25360033|NCT05350085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25360034|NCT05350085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25360035|NCT05350085|Anesthetics, General|anesthetics, general|mesh-ancestor
25360036|NCT05350085|Anesthetics|anesthetics|mesh-ancestor
25360037|NCT05350085|GABA Modulators|gaba modulators|mesh-ancestor
25360038|NCT05350085|GABA Agents|gaba agents|mesh-ancestor
25360039|NCT05350085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25360040|NCT05350085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360041|NCT05349890|Pembrolizumab|pembrolizumab|mesh-list
25360042|NCT05349890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25360043|NCT05349890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360044|NCT05349435|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25360045|NCT05349435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360046|NCT05348824|Sodium Hypochlorite|sodium hypochlorite|mesh-list
25360047|NCT05348824|Eusol|eusol|mesh-list
25360048|NCT05348824|Disinfectants|disinfectants|mesh-ancestor
25360049|NCT05348824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25360050|NCT05348577|Docetaxel|docetaxel|mesh-list
25360051|NCT05348577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360052|NCT05348577|Tubulin Modulators|tubulin modulators|mesh-ancestor
25724219|NCT02535806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25392244|NCT04220021|Metformin|metformin|mesh-list
25360053|NCT05348577|Antimitotic Agents|antimitotic agents|mesh-ancestor
25360054|NCT05348577|Mitosis Modulators|mitosis modulators|mesh-ancestor
25360055|NCT05348577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360056|NCT05347979|Dabigatran|dabigatran|mesh-list
25360057|NCT05347979|Antithrombins|antithrombins|mesh-ancestor
25360058|NCT05347979|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25360059|NCT05347979|Protease Inhibitors|protease inhibitors|mesh-ancestor
25360060|NCT05347979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25360061|NCT05347979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360062|NCT05347979|Anticoagulants|anticoagulants|mesh-ancestor
25360063|NCT05347485|Cyclophosphamide|cyclophosphamide|mesh-list
25360064|NCT05347485|Fludarabine|fludarabine|mesh-list
25360065|NCT05347485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25360066|NCT05347485|Immunologic Factors|immunologic factors|mesh-ancestor
25360067|NCT05347485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360068|NCT05347485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25360069|NCT05347485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25360070|NCT05347485|Alkylating Agents|alkylating agents|mesh-ancestor
25360071|NCT05347485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360072|NCT05347485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360073|NCT05347485|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25360074|NCT05347238|Dopamine|dopamine|mesh-list
25360075|NCT05347238|Norepinephrine|norepinephrine|mesh-list
25360076|NCT05347238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25360077|NCT05347238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25360078|NCT05347238|Adrenergic Agents|adrenergic agents|mesh-ancestor
25360079|NCT05347238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25360080|NCT05347238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360081|NCT05347238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360082|NCT05347238|Sympathomimetics|sympathomimetics|mesh-ancestor
25360083|NCT05347238|Autonomic Agents|autonomic agents|mesh-ancestor
25360084|NCT05347238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25360085|NCT05347238|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25360086|NCT05347238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25360087|NCT05347238|Dopamine Agents|dopamine agents|mesh-ancestor
25360088|NCT05347238|Protective Agents|protective agents|mesh-ancestor
25360089|NCT05347212|Nivolumab|nivolumab|mesh-list
25360090|NCT05347212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25360091|NCT05347212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360092|NCT05347212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25360093|NCT05347212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360094|NCT05347173|Dexmedetomidine|dexmedetomidine|mesh-list
25360095|NCT05347173|Nalbuphine|nalbuphine|mesh-list
25360096|NCT05347173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25360097|NCT05347173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25360098|NCT05347173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360099|NCT05347173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25360100|NCT05347173|Analgesics|analgesics|mesh-ancestor
25360101|NCT05347173|Sensory System Agents|sensory system agents|mesh-ancestor
25360102|NCT05347173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25360103|NCT05347173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25360104|NCT05347173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25360105|NCT05347173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25360106|NCT05347173|Adrenergic Agents|adrenergic agents|mesh-ancestor
25360107|NCT05347173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25360108|NCT05347173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360109|NCT05347173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25360110|NCT05347173|Narcotics|narcotics|mesh-ancestor
25360111|NCT05347069|Aspirin|aspirin|mesh-list
25360112|NCT05347069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25360113|NCT05347069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25360114|NCT05347069|Analgesics|analgesics|mesh-ancestor
25360115|NCT05347069|Sensory System Agents|sensory system agents|mesh-ancestor
25360116|NCT05347069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25360117|NCT05347069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360118|NCT05347069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25360119|NCT05347069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25360120|NCT05347069|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25360121|NCT05347069|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25360122|NCT05347069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360123|NCT05347069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25360124|NCT05347069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25360125|NCT05347069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25724220|NCT02535806|Antimetabolites|antimetabolites|mesh-ancestor
25360126|NCT05347069|Antipyretics|antipyretics|mesh-ancestor
25360127|NCT05347004|BI 425809|bi 425809|mesh-list
25360128|NCT05347004|Nootropic Agents|nootropic agents|mesh-ancestor
25360129|NCT05346731|Dexamethasone|dexamethasone|mesh-list
25360130|NCT05346731|Ondansetron|ondansetron|mesh-list
25360131|NCT05346731|Olanzapine|olanzapine|mesh-list
25360132|NCT05346731|Aprepitant|aprepitant|mesh-list
25360133|NCT05346731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25360134|NCT05346731|Antiemetics|antiemetics|mesh-ancestor
25360135|NCT05346731|Autonomic Agents|autonomic agents|mesh-ancestor
25360136|NCT05346731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25360137|NCT05346731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360138|NCT05346731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25360139|NCT05346731|Glucocorticoids|glucocorticoids|mesh-ancestor
25360140|NCT05346731|Hormones|hormones|mesh-ancestor
25360141|NCT05346731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25360142|NCT05346731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25360143|NCT05346731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360144|NCT05346731|Antipruritics|antipruritics|mesh-ancestor
25360145|NCT05346731|Dermatologic Agents|dermatologic agents|mesh-ancestor
25360146|NCT05346731|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25360147|NCT05346731|Serotonin Agents|serotonin agents|mesh-ancestor
25360148|NCT05346731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25360149|NCT05346731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360150|NCT05346731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25360151|NCT05346731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25360152|NCT05346731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25360153|NCT05346731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25360154|NCT05346731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25360155|NCT05346731|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25360156|NCT05346731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25360157|NCT05346731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25360158|NCT05346731|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25360159|NCT05346666|Midazolam|midazolam|mesh-list
25360160|NCT05346666|Phenobarbital|phenobarbital|mesh-list
25360161|NCT05346666|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25360162|NCT05346666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25360163|NCT05346666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25360164|NCT05346666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360165|NCT05346666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25360166|NCT05346666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25360167|NCT05346666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25360168|NCT05346666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25360169|NCT05346666|Anesthetics, General|anesthetics, general|mesh-ancestor
25360170|NCT05346666|Anesthetics|anesthetics|mesh-ancestor
25360171|NCT05346666|GABA Modulators|gaba modulators|mesh-ancestor
25360172|NCT05346666|GABA Agents|gaba agents|mesh-ancestor
25360173|NCT05346666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25360174|NCT05346666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360175|NCT05346666|Anticonvulsants|anticonvulsants|mesh-ancestor
25360176|NCT05346666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25360177|NCT05346666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25360178|NCT05346666|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25360179|NCT05346666|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25360180|NCT05346666|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25360181|NCT05346588|Propofol|propofol|mesh-list
25360182|NCT05346588|Anesthetics|anesthetics|mesh-list
25360183|NCT05346588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25360184|NCT05346588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25360185|NCT05346588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360186|NCT05346588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25360187|NCT05346588|Anesthetics, General|anesthetics, general|mesh-ancestor
25360188|NCT05346484|Pembrolizumab|pembrolizumab|mesh-list
25360189|NCT05346484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25360190|NCT05346484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360191|NCT05346393|Terlipressin|terlipressin|mesh-list
25360192|NCT05346393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25360193|NCT05346393|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25360194|NCT05346354|Ravulizumab|ravulizumab|mesh-list
25360195|NCT05346354|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25360196|NCT05346354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25360197|NCT05346354|Immunologic Factors|immunologic factors|mesh-ancestor
25360198|NCT05346354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360199|NCT05345990|Immunoglobulins|immunoglobulins|mesh-list
25360200|NCT05345990|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25360201|NCT05345990|Antibodies|antibodies|mesh-list
25360202|NCT05345990|Immunologic Factors|immunologic factors|mesh-ancestor
25360207|NCT05345782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25360208|NCT05345782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360209|NCT05345782|Sensory System Agents|sensory system agents|mesh-ancestor
25360210|NCT05345782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25360215|NCT05345509|Donepezil|donepezil|mesh-list
25360216|NCT05345509|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25360217|NCT05345509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25360218|NCT05345509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360219|NCT05345509|Cholinergic Agents|cholinergic agents|mesh-ancestor
25360220|NCT05345509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25360221|NCT05345509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360222|NCT05345509|Nootropic Agents|nootropic agents|mesh-ancestor
25360223|NCT05345457|Amoxicillin|amoxicillin|mesh-list
25360224|NCT05345457|Azithromycin|azithromycin|mesh-list
25360225|NCT05345457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25360226|NCT05345457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25360227|NCT05345171|Prednisolone|prednisolone|mesh-list
25360228|NCT05345171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25360229|NCT05345171|Glucocorticoids|glucocorticoids|mesh-ancestor
25360230|NCT05345171|Hormones|hormones|mesh-ancestor
25360231|NCT05345171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25360232|NCT05345171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360233|NCT05345171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25360234|NCT05345171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360235|NCT05344625|Ketamine|ketamine|mesh-list
25360236|NCT05344625|Analgesics|analgesics|mesh-ancestor
25360237|NCT05344625|Sensory System Agents|sensory system agents|mesh-ancestor
25360238|NCT05344625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25360239|NCT05344625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360240|NCT05344625|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25360241|NCT05344625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25360242|NCT05344625|Anesthetics, General|anesthetics, general|mesh-ancestor
25360243|NCT05344625|Anesthetics|anesthetics|mesh-ancestor
25360244|NCT05344625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25360245|NCT05344625|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25360246|NCT05344625|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25360247|NCT05344625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25360248|NCT05344625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360249|NCT05344469|Interferons|interferons|mesh-list
25360250|NCT05344469|Interferon-beta|interferon-beta|mesh-list
25360251|NCT05344469|Ofatumumab|ofatumumab|mesh-list
25360252|NCT05344469|Glatiramer Acetate|glatiramer acetate|mesh-list
25360253|NCT05344469|(T,G)-A-L|(t,g)-a-l|mesh-list
25360254|NCT05344469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360255|NCT05344469|Antiviral Agents|antiviral agents|mesh-ancestor
25360256|NCT05344469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25360257|NCT05344469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25360258|NCT05344469|Immunologic Factors|immunologic factors|mesh-ancestor
25360259|NCT05344469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360260|NCT05344469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25360261|NCT05344469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25360262|NCT05344417|Iodine|iodine|mesh-list
25360263|NCT05344417|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25360264|NCT05344417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25360265|NCT05344417|Trace Elements|trace elements|mesh-ancestor
25360266|NCT05344417|Micronutrients|micronutrients|mesh-ancestor
25360267|NCT05344417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360268|NCT05344404|Niacinamide|niacinamide|mesh-list
25360269|NCT05344404|Niacin|niacin|mesh-list
25360270|NCT05344404|Nicotinic Acids|nicotinic acids|mesh-list
25360271|NCT05344404|Vitamin B Complex|vitamin b complex|mesh-ancestor
25360272|NCT05344404|Vitamins|vitamins|mesh-ancestor
25360273|NCT05344404|Micronutrients|micronutrients|mesh-ancestor
25360274|NCT05344404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360275|NCT05344404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25360276|NCT05344404|Antimetabolites|antimetabolites|mesh-ancestor
25360277|NCT05344404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360278|NCT05344404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25360279|NCT05344404|Vasodilator Agents|vasodilator agents|mesh-ancestor
25360280|NCT05344209|Sargramostim|sargramostim|mesh-list
25360281|NCT05344209|Immunologic Factors|immunologic factors|mesh-ancestor
25360282|NCT05344209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360283|NCT05343455|Doxycycline|doxycycline|mesh-list
25360284|NCT05343455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25360285|NCT05343455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25360286|NCT05343455|Antimalarials|antimalarials|mesh-ancestor
25360287|NCT05343455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25360288|NCT05343455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25360289|NCT05342662|Methamphetamine|methamphetamine|mesh-list
25360290|NCT05342662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25360291|NCT05342662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360292|NCT05342662|Sympathomimetics|sympathomimetics|mesh-ancestor
25360293|NCT05342662|Autonomic Agents|autonomic agents|mesh-ancestor
25360294|NCT05342662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25360295|NCT05342662|Dopamine Agents|dopamine agents|mesh-ancestor
25360296|NCT05342662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25360297|NCT05342662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360298|NCT05342662|Adrenergic Agents|adrenergic agents|mesh-ancestor
25360299|NCT05342662|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25360300|NCT05342662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25360301|NCT05342662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25360302|NCT05342662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25360303|NCT05342636|Paclitaxel|paclitaxel|mesh-list
25360304|NCT05342636|Pembrolizumab|pembrolizumab|mesh-list
25360305|NCT05342636|Irinotecan|irinotecan|mesh-list
25360306|NCT05342636|Lenvatinib|lenvatinib|mesh-list
25360307|NCT05342636|Immunoglobulins|immunoglobulins|mesh-list
25360308|NCT05342636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25360309|NCT05342636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360310|NCT05342636|Tubulin Modulators|tubulin modulators|mesh-ancestor
25360311|NCT05342636|Antimitotic Agents|antimitotic agents|mesh-ancestor
25360312|NCT05342636|Mitosis Modulators|mitosis modulators|mesh-ancestor
25360313|NCT05342636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360314|NCT05342636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25360315|NCT05342636|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25360316|NCT05342636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25360317|NCT05342636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25360318|NCT05342636|Immunologic Factors|immunologic factors|mesh-ancestor
25360319|NCT05342636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360320|NCT05342636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25360321|NCT05342519|Sirolimus|sirolimus|mesh-list
25360322|NCT05342519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25360323|NCT05342519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25360324|NCT05342519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25360325|NCT05342519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360326|NCT05342519|Antifungal Agents|antifungal agents|mesh-ancestor
25360327|NCT05342519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25360328|NCT05342519|Immunologic Factors|immunologic factors|mesh-ancestor
25360329|NCT05342519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360330|NCT05342194|Gemcitabine|gemcitabine|mesh-list
25360331|NCT05342194|Cisplatin|cisplatin|mesh-list
25360332|NCT05342194|Oxaliplatin|oxaliplatin|mesh-list
25360333|NCT05342194|Lenvatinib|lenvatinib|mesh-list
25360334|NCT05342194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360335|NCT05342194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25360336|NCT05342194|Antimetabolites|antimetabolites|mesh-ancestor
25360337|NCT05342194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360338|NCT05342194|Antiviral Agents|antiviral agents|mesh-ancestor
25360339|NCT05342194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25360340|NCT05342194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25360341|NCT05342194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25360342|NCT05342194|Immunologic Factors|immunologic factors|mesh-ancestor
25360343|NCT05342194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360344|NCT05342194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25360345|NCT05341609|Ritonavir|ritonavir|mesh-list
25360346|NCT05341609|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25360347|NCT05341609|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25360348|NCT05341609|Protease Inhibitors|protease inhibitors|mesh-ancestor
25360349|NCT05341609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25360350|NCT05341609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360351|NCT05341609|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25360352|NCT05341609|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25360353|NCT05341609|Antiviral Agents|antiviral agents|mesh-ancestor
25360354|NCT05341609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25360355|NCT05341609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25360356|NCT05341609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25360357|NCT05341349|Pembrolizumab|pembrolizumab|mesh-list
25360359|NCT05341349|Ipilimumab|ipilimumab|mesh-list
25360360|NCT05341349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25360361|NCT05341349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360362|NCT05341349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25360363|NCT05341349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360364|NCT05341154|Dexmedetomidine|dexmedetomidine|mesh-list
25360365|NCT05341154|Ketamine|ketamine|mesh-list
25360366|NCT05341154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25360367|NCT05341154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25360368|NCT05341154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360369|NCT05341154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25360370|NCT05341154|Analgesics|analgesics|mesh-ancestor
25360371|NCT05341154|Sensory System Agents|sensory system agents|mesh-ancestor
25360372|NCT05341154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25360373|NCT05341154|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25360374|NCT05341154|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25360375|NCT05341154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25360376|NCT05341154|Adrenergic Agents|adrenergic agents|mesh-ancestor
25360377|NCT05341154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25360378|NCT05341154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360379|NCT05341154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25360380|NCT05341154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25360381|NCT05341154|Anesthetics, General|anesthetics, general|mesh-ancestor
25360382|NCT05341154|Anesthetics|anesthetics|mesh-ancestor
25360383|NCT05341154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25360384|NCT05341154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25360385|NCT05341115|Leuprolide|leuprolide|mesh-list
25360386|NCT05341115|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25360387|NCT05341115|Fertility Agents|fertility agents|mesh-ancestor
25360388|NCT05341115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25360389|NCT05341115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360390|NCT05341115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25360391|NCT05341115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360392|NCT05340764|Infliximab|infliximab|mesh-list
25360393|NCT05340764|Dermatologic Agents|dermatologic agents|mesh-ancestor
25360394|NCT05340764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25360395|NCT05340764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25360396|NCT05340582|Acetaminophen|acetaminophen|mesh-list
25360397|NCT05340582|Ibuprofen|ibuprofen|mesh-list
25360398|NCT05340582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25360399|NCT05340582|Analgesics|analgesics|mesh-ancestor
25360400|NCT05340582|Sensory System Agents|sensory system agents|mesh-ancestor
25360401|NCT05340582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25360402|NCT05340582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360403|NCT05340582|Antipyretics|antipyretics|mesh-ancestor
25360404|NCT05340582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25360405|NCT05340582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25360406|NCT05340582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25360407|NCT05340582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25360408|NCT05340582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25360409|NCT05340582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360411|NCT05340465|Dextrans|dextrans|mesh-list
25360412|NCT05340465|Darbepoetin alfa|darbepoetin alfa|mesh-list
25360413|NCT05340465|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25360414|NCT05340465|Iron-Dextran Complex|iron-dextran complex|mesh-list
25360415|NCT05340465|Trace Elements|trace elements|mesh-ancestor
25360416|NCT05340465|Micronutrients|micronutrients|mesh-ancestor
25360417|NCT05340465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360418|NCT05340465|Hematinics|hematinics|mesh-ancestor
25360419|NCT05340465|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25360420|NCT05340465|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25360421|NCT05340465|Anticoagulants|anticoagulants|mesh-ancestor
25360422|NCT05340465|Plasma Substitutes|plasma substitutes|mesh-ancestor
25360423|NCT05340465|Blood Substitutes|blood substitutes|mesh-ancestor
25360424|NCT05340010|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25360425|NCT05340010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25360426|NCT05340010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360427|NCT05339529|Glycine|glycine|mesh-list
25360428|NCT05339529|Thymalfasin|thymalfasin|mesh-list
25360429|NCT05339529|Glycine Agents|glycine agents|mesh-ancestor
25360430|NCT05339529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25360431|NCT05339529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360432|NCT05339529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360433|NCT05339529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25360434|NCT05339529|Immunologic Factors|immunologic factors|mesh-ancestor
25360435|NCT05339386|Xenon|xenon|mesh-list
25360436|NCT05339386|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25360437|NCT05339386|Anesthetics, General|anesthetics, general|mesh-ancestor
25360438|NCT05339386|Anesthetics|anesthetics|mesh-ancestor
25360439|NCT05339386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25360440|NCT05339386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360441|NCT05339295|Levofloxacin|levofloxacin|mesh-list
25360442|NCT05339295|Ofloxacin|ofloxacin|mesh-list
25360443|NCT05339295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25360444|NCT05339295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25360445|NCT05339295|Renal Agents|renal agents|mesh-ancestor
25360597|NCT05334654|Antithrombins|antithrombins|mesh-ancestor
25360446|NCT05339295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25360447|NCT05339295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25360448|NCT05339295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25360449|NCT05339295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25360450|NCT05339295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360451|NCT05339295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360452|NCT05339295|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25360453|NCT05339295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25360454|NCT05339256|Buprenorphine|buprenorphine|mesh-list
25360455|NCT05339256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25360456|NCT05339256|Narcotics|narcotics|mesh-ancestor
25360457|NCT05339256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25360458|NCT05339256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360459|NCT05339256|Analgesics|analgesics|mesh-ancestor
25360460|NCT05339256|Sensory System Agents|sensory system agents|mesh-ancestor
25360461|NCT05339256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25360462|NCT05339256|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25360463|NCT05339074|Ketamine|ketamine|mesh-list
25360464|NCT05339074|Analgesics|analgesics|mesh-ancestor
25360465|NCT05339074|Sensory System Agents|sensory system agents|mesh-ancestor
25360466|NCT05339074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25360467|NCT05339074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360468|NCT05339074|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25360469|NCT05339074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25360470|NCT05339074|Anesthetics, General|anesthetics, general|mesh-ancestor
25360471|NCT05339074|Anesthetics|anesthetics|mesh-ancestor
25360472|NCT05339074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25360473|NCT05339074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25360474|NCT05339074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25360475|NCT05339074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25360476|NCT05339074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360477|NCT05339022|Coal Tar|coal tar|mesh-list
25360478|NCT05339022|Keratolytic Agents|keratolytic agents|mesh-ancestor
25360479|NCT05339022|Dermatologic Agents|dermatologic agents|mesh-ancestor
25360480|NCT05338970|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
25360481|NCT05338970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25360482|NCT05338970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360483|NCT05338775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25360484|NCT05338775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360485|NCT05338775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360497|NCT05338450|Dermatologic Agents|dermatologic agents|mesh-ancestor
25360498|NCT05338450|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25360499|NCT05338450|Histamine Antagonists|histamine antagonists|mesh-ancestor
25360500|NCT05338450|Histamine Agents|histamine agents|mesh-ancestor
25360501|NCT05338450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25360502|NCT05338450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360503|NCT05338450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360504|NCT05338450|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25360505|NCT05338086|Vitamin D|vitamin d|mesh-list
25360506|NCT05338086|Denosumab|denosumab|mesh-list
25360507|NCT05338086|Calcium|calcium|mesh-list
25360508|NCT05338086|Vitamins|vitamins|mesh-ancestor
25360509|NCT05338086|Micronutrients|micronutrients|mesh-ancestor
25360510|NCT05338086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360511|NCT05338086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25360512|NCT05338086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25360513|NCT05338021|Vancomycin|vancomycin|mesh-list
25360514|NCT05338021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25360515|NCT05338021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25360516|NCT05338008|Vancomycin|vancomycin|mesh-list
25360517|NCT05338008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25360518|NCT05338008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25360519|NCT05337566|Azithromycin|azithromycin|mesh-list
25360520|NCT05337566|Cefuroxime|cefuroxime|mesh-list
25360521|NCT05337566|Cefuroxime axetil|cefuroxime axetil|mesh-list
25360522|NCT05337566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25360523|NCT05337566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25360535|NCT05336812|Venetoclax|venetoclax|mesh-list
25360536|NCT05336812|Obinutuzumab|obinutuzumab|mesh-list
25360537|NCT05336812|Acalabrutinib|acalabrutinib|mesh-list
25360538|NCT05336812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360539|NCT05336812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25360540|NCT05335993|Niraparib|niraparib|mesh-list
25360541|NCT05335993|Oregovomab|oregovomab|mesh-list
25360542|NCT05335993|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25360543|NCT05335993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25360544|NCT05335993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360545|NCT05335993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360546|NCT05335993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25360547|NCT05335941|Pemetrexed|pemetrexed|mesh-list
25360548|NCT05335941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360549|NCT05335941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25360550|NCT05335941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360551|NCT05335941|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25360552|NCT05335941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25360553|NCT05335928|Abatacept|abatacept|mesh-list
25360554|NCT05335928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25360555|NCT05335928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360556|NCT05335928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360557|NCT05335928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25360558|NCT05335928|Immunologic Factors|immunologic factors|mesh-ancestor
25360559|NCT05335928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360560|NCT05335928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25360561|NCT05335915|Nicotine|nicotine|mesh-list
25360562|NCT05335915|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25360563|NCT05335915|Autonomic Agents|autonomic agents|mesh-ancestor
25360564|NCT05335915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25360565|NCT05335915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360566|NCT05335915|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25360567|NCT05335915|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25360568|NCT05335915|Cholinergic Agents|cholinergic agents|mesh-ancestor
25360569|NCT05335915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25360570|NCT05335915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360571|NCT05335629|Dapagliflozin|dapagliflozin|mesh-list
25360572|NCT05335629|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25360573|NCT05335629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360574|NCT05335629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25360575|NCT05335629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360576|NCT05335148|Colchicine|colchicine|mesh-list
25360577|NCT05335148|Gout Suppressants|gout suppressants|mesh-ancestor
25360578|NCT05335148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25360579|NCT05335148|Tubulin Modulators|tubulin modulators|mesh-ancestor
25360580|NCT05335148|Antimitotic Agents|antimitotic agents|mesh-ancestor
25360581|NCT05335148|Mitosis Modulators|mitosis modulators|mesh-ancestor
25360582|NCT05335148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360583|NCT05335148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360584|NCT05335109|Xenon|xenon|mesh-list
25360585|NCT05335109|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25360586|NCT05335109|Anesthetics, General|anesthetics, general|mesh-ancestor
25360587|NCT05335109|Anesthetics|anesthetics|mesh-ancestor
25360588|NCT05335109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25360589|NCT05335109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360590|NCT05334654|Enoxaparin|enoxaparin|mesh-list
25360591|NCT05334654|Enoxaparin sodium|enoxaparin sodium|mesh-list
25360592|NCT05334654|Bivalirudin|bivalirudin|mesh-list
25360593|NCT05334654|Anticoagulants|anticoagulants|mesh-ancestor
25360594|NCT05334654|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25360595|NCT05334654|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25360596|NCT05334654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360598|NCT05334654|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25360599|NCT05334654|Protease Inhibitors|protease inhibitors|mesh-ancestor
25360600|NCT05334654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25360601|NCT05334472|Ofatumumab|ofatumumab|mesh-list
25360602|NCT05334472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360603|NCT05334329|Cyclophosphamide|cyclophosphamide|mesh-list
25360604|NCT05334329|Fludarabine|fludarabine|mesh-list
25360605|NCT05334329|Atezolizumab|atezolizumab|mesh-list
25360606|NCT05334329|Antineoplastic Agents|antineoplastic agents|mesh-list
25360607|NCT05334329|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25360608|NCT05334329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25392766|NCT04204967|Fentanyl|fentanyl|mesh-list
25360609|NCT05334329|Immunologic Factors|immunologic factors|mesh-ancestor
25360610|NCT05334329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360611|NCT05334329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25360612|NCT05334329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25360613|NCT05334329|Alkylating Agents|alkylating agents|mesh-ancestor
25360614|NCT05334329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360615|NCT05334329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25360616|NCT05334277|Bevacizumab|bevacizumab|mesh-list
25360617|NCT05334277|Carboplatin|carboplatin|mesh-list
25360618|NCT05334277|Pemetrexed|pemetrexed|mesh-list
25360619|NCT05334277|Aflutinib|aflutinib|mesh-list
25360620|NCT05334277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25360621|NCT05334277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360622|NCT05334277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25360623|NCT05334277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25360624|NCT05334277|Growth Substances|growth substances|mesh-ancestor
25360625|NCT05334277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360626|NCT05334277|Growth Inhibitors|growth inhibitors|mesh-ancestor
25360627|NCT05334277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25360628|NCT05334277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360629|NCT05334277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25360630|NCT05334277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25360631|NCT05334277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25360632|NCT05334108|Ecopipam|ecopipam|mesh-list
25360633|NCT05334108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25360634|NCT05334108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25360635|NCT05334108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25360636|NCT05334108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360637|NCT05334108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25360638|NCT05334108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25360639|NCT05334108|Dopamine Agents|dopamine agents|mesh-ancestor
25360640|NCT05334108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25360641|NCT05334108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360642|NCT05333549|Istradefylline|istradefylline|mesh-list
25360643|NCT05333549|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
25360644|NCT05333549|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25360645|NCT05333549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25360646|NCT05333549|Purinergic Agents|purinergic agents|mesh-ancestor
25360647|NCT05333549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25360648|NCT05333549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360649|NCT05333549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360650|NCT05333237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25360651|NCT05332717|Ascorbic Acid|ascorbic acid|mesh-list
25360652|NCT05332717|Melatonin|melatonin|mesh-list
25360653|NCT05332717|Vitamins|vitamins|mesh-ancestor
25360654|NCT05332717|Micronutrients|micronutrients|mesh-ancestor
25360655|NCT05332717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360656|NCT05332717|Antioxidants|antioxidants|mesh-ancestor
25360657|NCT05332717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360658|NCT05332717|Protective Agents|protective agents|mesh-ancestor
25360659|NCT05332717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25360660|NCT05332561|Trastuzumab|trastuzumab|mesh-list
25360661|NCT05332561|Pertuzumab|pertuzumab|mesh-list
25360662|NCT05332561|Atezolizumab|atezolizumab|mesh-list
25360663|NCT05332561|Olaparib|olaparib|mesh-list
25360664|NCT05332561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25360665|NCT05332561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360666|NCT05332561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25360667|NCT05332561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25360668|NCT05332561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360669|NCT05332067|Omalizumab|omalizumab|mesh-list
25360670|NCT05332067|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25360671|NCT05332067|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25360672|NCT05332067|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25360673|NCT05332067|Respiratory System Agents|respiratory system agents|mesh-ancestor
25360674|NCT05332067|Immunologic Factors|immunologic factors|mesh-ancestor
25360675|NCT05332067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360676|NCT05331664|Moxifloxacin|moxifloxacin|mesh-list
25360677|NCT05331664|Polymyxins|polymyxins|mesh-list
25360678|NCT05331664|Trimethoprim|trimethoprim|mesh-list
25360679|NCT05331664|Prednisolone|prednisolone|mesh-list
25360680|NCT05331664|Prednisolone acetate|prednisolone acetate|mesh-list
25360681|NCT05331664|Triamcinolone|triamcinolone|mesh-list
25360682|NCT05331664|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25724221|NCT02535806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360683|NCT05331664|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25360685|NCT05331664|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
25360686|NCT05331664|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25360687|NCT05331664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25360688|NCT05331664|Glucocorticoids|glucocorticoids|mesh-ancestor
25360689|NCT05331664|Hormones|hormones|mesh-ancestor
25360690|NCT05331664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25360691|NCT05331664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360692|NCT05331664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25360693|NCT05331664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360694|NCT05331664|Autonomic Agents|autonomic agents|mesh-ancestor
25360695|NCT05331664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25360696|NCT05331664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25360697|NCT05331664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25360698|NCT05331664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25360699|NCT05331664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25360700|NCT05331664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25360701|NCT05331664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360702|NCT05331664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25360703|NCT05331664|Contraceptive Agents|contraceptive agents|mesh-ancestor
25360704|NCT05331664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25360705|NCT05331664|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25360706|NCT05331664|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25360707|NCT05331664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25360708|NCT05331664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25360709|NCT05331664|Immunologic Factors|immunologic factors|mesh-ancestor
25360710|NCT05331664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25360711|NCT05331664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25360712|NCT05331664|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25360713|NCT05331664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25360714|NCT05331664|Respiratory System Agents|respiratory system agents|mesh-ancestor
25360715|NCT05331664|Mydriatics|mydriatics|mesh-ancestor
25360716|NCT05331664|Parasympatholytics|parasympatholytics|mesh-ancestor
25360717|NCT05331664|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25360718|NCT05331664|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25360719|NCT05331664|Cholinergic Agents|cholinergic agents|mesh-ancestor
25360720|NCT05331664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25360721|NCT05331664|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25360722|NCT05331664|Renal Agents|renal agents|mesh-ancestor
25360723|NCT05331664|Antimalarials|antimalarials|mesh-ancestor
25360724|NCT05331664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25360725|NCT05331664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25360726|NCT05331664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25360727|NCT05331664|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25360728|NCT05331664|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25360729|NCT05331664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25360730|NCT05331573|Apomorphine|apomorphine|mesh-list
25360731|NCT05331573|Emetics|emetics|mesh-ancestor
25360732|NCT05331573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360733|NCT05331573|Autonomic Agents|autonomic agents|mesh-ancestor
25360734|NCT05331573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25360735|NCT05331573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25360736|NCT05331573|Dopamine Agonists|dopamine agonists|mesh-ancestor
25360737|NCT05331573|Dopamine Agents|dopamine agents|mesh-ancestor
25360738|NCT05331573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25360739|NCT05331573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360740|NCT05331521|Vincristine|vincristine|mesh-list
25360741|NCT05331521|Temozolomide|temozolomide|mesh-list
25360742|NCT05331521|Lomustine|lomustine|mesh-list
25360743|NCT05331521|Procarbazine|procarbazine|mesh-list
25360744|NCT05331521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25360745|NCT05331521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360746|NCT05331521|Tubulin Modulators|tubulin modulators|mesh-ancestor
25360747|NCT05331521|Antimitotic Agents|antimitotic agents|mesh-ancestor
25360748|NCT05331521|Mitosis Modulators|mitosis modulators|mesh-ancestor
25360749|NCT05331521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360750|NCT05331521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25360751|NCT05331521|Alkylating Agents|alkylating agents|mesh-ancestor
25360752|NCT05331027|Sevoflurane|sevoflurane|mesh-list
25360753|NCT05331027|Desflurane|desflurane|mesh-list
25360754|NCT05331027|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25360755|NCT05331027|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25360756|NCT05331027|Anesthetics, General|anesthetics, general|mesh-ancestor
25360757|NCT05331027|Anesthetics|anesthetics|mesh-ancestor
25360758|NCT05331027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25360759|NCT05331027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360760|NCT05330858|Rabeprazole|rabeprazole|mesh-list
25360761|NCT05330858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25360762|NCT05330858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25360763|NCT05330858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25360764|NCT05330858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25360765|NCT05330858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360766|NCT05330429|Leucovorin|leucovorin|mesh-list
25360767|NCT05330429|Bevacizumab|bevacizumab|mesh-list
25360768|NCT05330429|Magrolimab|magrolimab|mesh-list
25360769|NCT05330429|Fluorouracil|fluorouracil|mesh-list
25360770|NCT05330429|Irinotecan|irinotecan|mesh-list
25360771|NCT05330429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25360772|NCT05330429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360773|NCT05330429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25360774|NCT05330429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25360775|NCT05330429|Growth Substances|growth substances|mesh-ancestor
25360776|NCT05330429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360777|NCT05330429|Growth Inhibitors|growth inhibitors|mesh-ancestor
25360778|NCT05330429|Antimetabolites|antimetabolites|mesh-ancestor
25360779|NCT05330429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360780|NCT05330429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25360781|NCT05330429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25360782|NCT05330429|Immunologic Factors|immunologic factors|mesh-ancestor
25360783|NCT05330429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25360784|NCT05330429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25360785|NCT05330429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25360786|NCT05330429|Antidotes|antidotes|mesh-ancestor
25360787|NCT05330429|Protective Agents|protective agents|mesh-ancestor
25360788|NCT05330429|Vitamin B Complex|vitamin b complex|mesh-ancestor
25360789|NCT05330429|Vitamins|vitamins|mesh-ancestor
25360790|NCT05330429|Micronutrients|micronutrients|mesh-ancestor
25360791|NCT05329766|Leucovorin|leucovorin|mesh-list
25360792|NCT05329766|Fluorouracil|fluorouracil|mesh-list
25360801|NCT05329766|Antidotes|antidotes|mesh-ancestor
25360802|NCT05329766|Protective Agents|protective agents|mesh-ancestor
25360803|NCT05329766|Vitamin B Complex|vitamin b complex|mesh-ancestor
25360804|NCT05329766|Vitamins|vitamins|mesh-ancestor
25360805|NCT05329766|Micronutrients|micronutrients|mesh-ancestor
25360806|NCT05329545|Immunoconjugates|immunoconjugates|mesh-list
25360807|NCT05329545|Immunologic Factors|immunologic factors|mesh-ancestor
25360808|NCT05329545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360809|NCT05329428|Vitamin D|vitamin d|mesh-list
25360810|NCT05329428|Ergocalciferols|ergocalciferols|mesh-list
25360811|NCT05329428|Cholecalciferol|cholecalciferol|mesh-list
25360812|NCT05329428|Vitamins|vitamins|mesh-list
25360813|NCT05329428|Micronutrients|micronutrients|mesh-ancestor
25360814|NCT05329428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360815|NCT05329428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25360816|NCT05329428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25360817|NCT05329259|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25360818|NCT05329259|Immunologic Factors|immunologic factors|mesh-ancestor
25360819|NCT05329259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360820|NCT05329155|Heparin|heparin|mesh-list
25360821|NCT05329155|Calcium heparin|calcium heparin|mesh-list
25360822|NCT05329155|Anticoagulants|anticoagulants|mesh-ancestor
25360823|NCT05329155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25360824|NCT05329155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25360825|NCT05329155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361051|NCT05322577|Bemarituzumab|bemarituzumab|mesh-list
25360835|NCT05328414|Prednisolone|prednisolone|mesh-list
25360836|NCT05328414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25360837|NCT05328414|Glucocorticoids|glucocorticoids|mesh-ancestor
25360838|NCT05328414|Hormones|hormones|mesh-ancestor
25360839|NCT05328414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25360840|NCT05328414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360841|NCT05328414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25360842|NCT05328414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360843|NCT05328297|JNJ-55308942|jnj-55308942|mesh-list
25360844|NCT05328297|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
25360845|NCT05328297|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25360846|NCT05328297|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25360847|NCT05328297|Purinergic Agents|purinergic agents|mesh-ancestor
25360848|NCT05328297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25360849|NCT05328297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360850|NCT05328297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360851|NCT05327972|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25360852|NCT05327972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25360853|NCT05327972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25360854|NCT05327972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360855|NCT05327972|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25360856|NCT05327972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25360857|NCT05327972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360858|NCT05327972|Cholinergic Agents|cholinergic agents|mesh-ancestor
25360859|NCT05327972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25360860|NCT05327699|Ketamine|ketamine|mesh-list
25360861|NCT05327699|Analgesics|analgesics|mesh-ancestor
25360862|NCT05327699|Sensory System Agents|sensory system agents|mesh-ancestor
25360863|NCT05327699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25360864|NCT05327699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360865|NCT05327699|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25360866|NCT05327699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25360867|NCT05327699|Anesthetics, General|anesthetics, general|mesh-ancestor
25360869|NCT05327699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25360870|NCT05327699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25360871|NCT05327699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25360872|NCT05327699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25360873|NCT05327699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360874|NCT05327686|Pembrolizumab|pembrolizumab|mesh-list
25360875|NCT05327686|Nivolumab|nivolumab|mesh-list
25360876|NCT05327686|Ipilimumab|ipilimumab|mesh-list
25360877|NCT05327686|Avelumab|avelumab|mesh-list
25360878|NCT05327686|Lenvatinib|lenvatinib|mesh-list
25360879|NCT05327686|Axitinib|axitinib|mesh-list
25360880|NCT05327686|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25360881|NCT05327686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25360882|NCT05327686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360883|NCT05327686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25360884|NCT05327686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360885|NCT05327686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25360886|NCT05327686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25360887|NCT05327686|Immunologic Factors|immunologic factors|mesh-ancestor
25360888|NCT05327686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360889|NCT05327530|Avelumab|avelumab|mesh-list
25360890|NCT05327530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25360891|NCT05327530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360892|NCT05327426|Vaccines|vaccines|mesh-list
25360893|NCT05327426|Immunologic Factors|immunologic factors|mesh-ancestor
25360894|NCT05327426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360895|NCT05327361|Sunscreening Agents|sunscreening agents|mesh-list
25360896|NCT05327361|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25360897|NCT05327361|Protective Agents|protective agents|mesh-ancestor
25360898|NCT05327361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360899|NCT05327361|Dermatologic Agents|dermatologic agents|mesh-ancestor
25360900|NCT05327270|Nivolumab|nivolumab|mesh-list
25360901|NCT05327270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25360902|NCT05327270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360903|NCT05327270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25360904|NCT05327270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360905|NCT05327231|Docetaxel|docetaxel|mesh-list
25360906|NCT05327231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360907|NCT05327231|Tubulin Modulators|tubulin modulators|mesh-ancestor
25360908|NCT05327231|Antimitotic Agents|antimitotic agents|mesh-ancestor
25360909|NCT05327231|Mitosis Modulators|mitosis modulators|mesh-ancestor
25360910|NCT05327231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360911|NCT05327127|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
25360912|NCT05327127|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25360913|NCT05327127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360914|NCT05327127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25360915|NCT05327127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360916|NCT05327023|Mycophenolic Acid|mycophenolic acid|mesh-list
25360917|NCT05327023|Sirolimus|sirolimus|mesh-list
25360918|NCT05327023|Cyclophosphamide|cyclophosphamide|mesh-list
25360919|NCT05327023|Busulfan|busulfan|mesh-list
25360920|NCT05327023|Fludarabine|fludarabine|mesh-list
25360921|NCT05327023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25360922|NCT05327023|Immunologic Factors|immunologic factors|mesh-ancestor
25360923|NCT05327023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360924|NCT05327023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25360925|NCT05327023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25360926|NCT05327023|Alkylating Agents|alkylating agents|mesh-ancestor
25360927|NCT05327023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360928|NCT05327023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360929|NCT05327023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25360930|NCT05327023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25360931|NCT05327023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25360932|NCT05327023|Antitubercular Agents|antitubercular agents|mesh-ancestor
25360933|NCT05327023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25360934|NCT05327023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25360935|NCT05327023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25360936|NCT05327023|Antifungal Agents|antifungal agents|mesh-ancestor
25360937|NCT05327010|Talazoparib|talazoparib|mesh-list
25360938|NCT05327010|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25360939|NCT05327010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25360940|NCT05327010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360941|NCT05327010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360942|NCT05326347|Brexpiprazole|brexpiprazole|mesh-list
25360943|NCT05326347|Serotonin Agents|serotonin agents|mesh-ancestor
25360944|NCT05326347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25360945|NCT05326347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360946|NCT05326347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360947|NCT05326347|Dopamine Agonists|dopamine agonists|mesh-ancestor
25360948|NCT05326347|Dopamine Agents|dopamine agents|mesh-ancestor
25360949|NCT05325866|Bemarituzumab|bemarituzumab|mesh-list
25360950|NCT05325866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25360951|NCT05325866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360952|NCT05325853|Proxymetacaine|proxymetacaine|mesh-list
25360953|NCT05325853|Propoxycaine|propoxycaine|mesh-list
25360954|NCT05325853|Anesthetics, Local|anesthetics, local|mesh-ancestor
25360955|NCT05325853|Anesthetics|anesthetics|mesh-ancestor
25360956|NCT05325853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25360957|NCT05325853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360958|NCT05325853|Sensory System Agents|sensory system agents|mesh-ancestor
25360959|NCT05325853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25360960|NCT05325775|SR 142801|sr 142801|mesh-list
25360961|NCT05325775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25360962|NCT05325775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25360963|NCT05325775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25360964|NCT05325775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360965|NCT05325775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25360966|NCT05325645|Brexpiprazole|brexpiprazole|mesh-list
25360967|NCT05325645|Serotonin Agents|serotonin agents|mesh-ancestor
25360968|NCT05325645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25360969|NCT05325645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360970|NCT05325645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360971|NCT05325645|Dopamine Agonists|dopamine agonists|mesh-ancestor
25360972|NCT05325645|Dopamine Agents|dopamine agents|mesh-ancestor
25360973|NCT05325281|Thioctic Acid|thioctic acid|mesh-list
25360974|NCT05325281|Gemcitabine|gemcitabine|mesh-list
25360975|NCT05325281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25360976|NCT05325281|Antimetabolites|antimetabolites|mesh-ancestor
25360977|NCT05325281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360978|NCT05325281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25360979|NCT05325281|Antiviral Agents|antiviral agents|mesh-ancestor
25360980|NCT05325281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25360981|NCT05325281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25360982|NCT05325281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25360983|NCT05325281|Immunologic Factors|immunologic factors|mesh-ancestor
25360984|NCT05325281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360985|NCT05325281|Antioxidants|antioxidants|mesh-ancestor
25360986|NCT05325281|Protective Agents|protective agents|mesh-ancestor
25360987|NCT05325281|Vitamin B Complex|vitamin b complex|mesh-ancestor
25360988|NCT05325281|Vitamins|vitamins|mesh-ancestor
25360989|NCT05325281|Micronutrients|micronutrients|mesh-ancestor
25360990|NCT05324735|Pentoxifylline|pentoxifylline|mesh-list
25360991|NCT05324735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25360992|NCT05324735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25360993|NCT05324735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25360994|NCT05324735|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25360995|NCT05324735|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25360996|NCT05324735|Protective Agents|protective agents|mesh-ancestor
25360997|NCT05324735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25360998|NCT05324735|Vasodilator Agents|vasodilator agents|mesh-ancestor
25360999|NCT05324735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25361003|NCT05324501|Alkylating Agents|alkylating agents|mesh-ancestor
25361004|NCT05324501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361005|NCT05324501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361006|NCT05324358|Ketorolac|ketorolac|mesh-list
25361007|NCT05324358|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25361008|NCT05324358|Morphine|morphine|mesh-list
25361009|NCT05324358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25361010|NCT05324358|Narcotics|narcotics|mesh-ancestor
25361011|NCT05324358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25361012|NCT05324358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361013|NCT05324358|Analgesics|analgesics|mesh-ancestor
25361014|NCT05324358|Sensory System Agents|sensory system agents|mesh-ancestor
25361015|NCT05324358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25361016|NCT05324358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25361017|NCT05324358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25361018|NCT05324358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25361019|NCT05324358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25361020|NCT05324358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25361021|NCT05324358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361022|NCT05324358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361023|NCT05323617|Cyclosporine|cyclosporine|mesh-list
25361024|NCT05323617|Cyclosporins|cyclosporins|mesh-list
25361025|NCT05323617|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25361026|NCT05323617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361027|NCT05323617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361028|NCT05323617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25361029|NCT05323617|Immunologic Factors|immunologic factors|mesh-ancestor
25361030|NCT05323617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361031|NCT05323617|Antifungal Agents|antifungal agents|mesh-ancestor
25361032|NCT05323617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25361033|NCT05323617|Dermatologic Agents|dermatologic agents|mesh-ancestor
25361034|NCT05323617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25361035|NCT05323617|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25361036|NCT05323487|Bumetanide|bumetanide|mesh-list
25361037|NCT05323487|Diuretics|diuretics|mesh-ancestor
25361038|NCT05323487|Natriuretic Agents|natriuretic agents|mesh-ancestor
25361039|NCT05323487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361040|NCT05323487|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25361041|NCT05323487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25361042|NCT05323487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361046|NCT05322954|Psilocybin|psilocybin|mesh-list
25361047|NCT05322954|Hallucinogens|hallucinogens|mesh-ancestor
25361048|NCT05322954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361049|NCT05322954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25361050|NCT05322577|Nivolumab|nivolumab|mesh-list
25361052|NCT05322577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25361053|NCT05322577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361054|NCT05322577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25361055|NCT05322577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361056|NCT05322538|Vitamin D|vitamin d|mesh-list
25361057|NCT05322538|Ergocalciferols|ergocalciferols|mesh-list
25361058|NCT05322538|Cholecalciferol|cholecalciferol|mesh-list
25361059|NCT05322538|Vitamins|vitamins|mesh-list
25361060|NCT05322538|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25361061|NCT05322538|Micronutrients|micronutrients|mesh-ancestor
25361062|NCT05322538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361063|NCT05322538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25361064|NCT05322538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25361065|NCT05322473|Adalimumab|adalimumab|mesh-list
25361066|NCT05322473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25361067|NCT05322473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25361068|NCT05322070|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
25361069|NCT05322070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25361070|NCT05322070|Glucocorticoids|glucocorticoids|mesh-ancestor
25361071|NCT05322070|Hormones|hormones|mesh-ancestor
25361072|NCT05322070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25361073|NCT05322070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361074|NCT05321940|Interferons|interferons|mesh-list
25361075|NCT05321940|Vaccines|vaccines|mesh-list
25361076|NCT05321940|Immunologic Factors|immunologic factors|mesh-ancestor
25361088|NCT05321810|Anticoagulants|anticoagulants|mesh-ancestor
25361089|NCT05321810|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25361090|NCT05321810|Antithrombins|antithrombins|mesh-ancestor
25361091|NCT05321810|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25361092|NCT05321810|Protease Inhibitors|protease inhibitors|mesh-ancestor
25361093|NCT05321810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361094|NCT05321810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361095|NCT05321706|Dapagliflozin|dapagliflozin|mesh-list
25361096|NCT05321706|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25361097|NCT05321706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361098|NCT05321706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25361099|NCT05321706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361100|NCT05321420|Pirfenidone|pirfenidone|mesh-list
25361101|NCT05321420|Analgesics|analgesics|mesh-ancestor
25361102|NCT05321420|Sensory System Agents|sensory system agents|mesh-ancestor
25361103|NCT05321420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25361104|NCT05321420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361105|NCT05321420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25361106|NCT05321420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25361107|NCT05321420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25361108|NCT05321420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25361109|NCT05321420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361110|NCT05320887|Nicotine|nicotine|mesh-list
25361111|NCT05320887|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25361112|NCT05320887|Autonomic Agents|autonomic agents|mesh-ancestor
25361113|NCT05320887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25361114|NCT05320887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361115|NCT05320887|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25361116|NCT05320887|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25361117|NCT05320887|Cholinergic Agents|cholinergic agents|mesh-ancestor
25361118|NCT05320887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25361119|NCT05320887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361120|NCT05320172|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25361121|NCT05320172|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25361122|NCT05320068|Vancomycin|vancomycin|mesh-list
25361123|NCT05320068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25361124|NCT05320068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25361137|NCT05319431|Lenvatinib|lenvatinib|mesh-list
25361138|NCT05319431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361139|NCT05319431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25361140|NCT05319431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361141|NCT05319431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361142|NCT05318755|Testosterone|testosterone|mesh-list
25361143|NCT05318755|Androgens|androgens|mesh-ancestor
25361144|NCT05318755|Hormones|hormones|mesh-ancestor
25361145|NCT05318755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25361146|NCT05318755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361147|NCT05318573|Gemcitabine|gemcitabine|mesh-list
25361148|NCT05318573|Pembrolizumab|pembrolizumab|mesh-list
25361149|NCT05318573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25361150|NCT05318573|Antimetabolites|antimetabolites|mesh-ancestor
25361151|NCT05318573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361152|NCT05318573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361153|NCT05318573|Antiviral Agents|antiviral agents|mesh-ancestor
25361154|NCT05318573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25361155|NCT05318573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361156|NCT05318573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25361157|NCT05318573|Immunologic Factors|immunologic factors|mesh-ancestor
25361158|NCT05318573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361159|NCT05318573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25361161|NCT05318469|Pembrolizumab|pembrolizumab|mesh-list
25361162|NCT05318469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25361163|NCT05318469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361164|NCT05318469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25361165|NCT05318469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25361166|NCT05318105|Diuretics|diuretics|mesh-list
25361167|NCT05318105|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
25361168|NCT05318105|Natriuretic Agents|natriuretic agents|mesh-ancestor
25361169|NCT05318105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361170|NCT05318105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25361171|NCT05318105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361172|NCT05318066|Norepinephrine|norepinephrine|mesh-list
25361173|NCT05318066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25361174|NCT05318066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25361175|NCT05318066|Adrenergic Agents|adrenergic agents|mesh-ancestor
25361176|NCT05318066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25361177|NCT05318066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361178|NCT05318066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361179|NCT05318066|Sympathomimetics|sympathomimetics|mesh-ancestor
25361180|NCT05318066|Autonomic Agents|autonomic agents|mesh-ancestor
25361181|NCT05318066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25361182|NCT05318066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25361183|NCT05317858|Pembrolizumab|pembrolizumab|mesh-list
25361184|NCT05317858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25361185|NCT05317858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361186|NCT05317806|Metformin|metformin|mesh-list
25361187|NCT05317806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25361188|NCT05317806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361189|NCT05317624|Methylprednisolone|methylprednisolone|mesh-list
25361190|NCT05317624|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25361191|NCT05317624|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25361192|NCT05317624|Prednisolone|prednisolone|mesh-list
25361193|NCT05317624|Prednisolone acetate|prednisolone acetate|mesh-list
25361194|NCT05317624|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25361195|NCT05317624|Prednisolone phosphate|prednisolone phosphate|mesh-list
25361196|NCT05317624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25361197|NCT05317624|Antiemetics|antiemetics|mesh-ancestor
25361198|NCT05317624|Autonomic Agents|autonomic agents|mesh-ancestor
25361199|NCT05317624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25361200|NCT05317624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361201|NCT05317624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25361202|NCT05317624|Glucocorticoids|glucocorticoids|mesh-ancestor
25361203|NCT05317624|Hormones|hormones|mesh-ancestor
25361204|NCT05317624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25361205|NCT05317624|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25361206|NCT05317624|Protective Agents|protective agents|mesh-ancestor
25361207|NCT05317624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25361208|NCT05317624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361209|NCT05317546|Cannabidiol|cannabidiol|mesh-list
25361210|NCT05317546|Anticonvulsants|anticonvulsants|mesh-ancestor
25361211|NCT05317416|Lenalidomide|lenalidomide|mesh-list
25361212|NCT05317416|Immunologic Factors|immunologic factors|mesh-ancestor
25361213|NCT05317416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361214|NCT05317416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25361215|NCT05317416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25361216|NCT05317416|Growth Substances|growth substances|mesh-ancestor
25361217|NCT05317416|Growth Inhibitors|growth inhibitors|mesh-ancestor
25361218|NCT05317416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361219|NCT05317000|Nivolumab|nivolumab|mesh-list
25361220|NCT05317000|Azacitidine|azacitidine|mesh-list
25361221|NCT05317000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25361222|NCT05317000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361223|NCT05317000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25361224|NCT05317000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361225|NCT05317000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25361226|NCT05317000|Antimetabolites|antimetabolites|mesh-ancestor
25393383|NCT04185311|Nivolumab|nivolumab|mesh-list
25361227|NCT05317000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361228|NCT05316935|Letrozole|letrozole|mesh-list
25361229|NCT05316935|Ethinyl Estradiol|ethinyl estradiol|mesh-list
25361230|NCT05316935|Cyproterone|cyproterone|mesh-list
25361231|NCT05316935|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
25361232|NCT05316935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361233|NCT05316935|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25361234|NCT05316935|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25361235|NCT05316935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361236|NCT05316935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361237|NCT05316935|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25361238|NCT05316935|Hormone Antagonists|hormone antagonists|mesh-ancestor
25361239|NCT05316935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25361240|NCT05316935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361241|NCT05316935|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25361242|NCT05316935|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25361243|NCT05316935|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25361244|NCT05316935|Contraceptive Agents|contraceptive agents|mesh-ancestor
25361245|NCT05316935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25361246|NCT05316935|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25361247|NCT05316935|Estrogens|estrogens|mesh-ancestor
25361248|NCT05316935|Hormones|hormones|mesh-ancestor
25361249|NCT05316935|Androgen Antagonists|androgen antagonists|mesh-ancestor
25361250|NCT05316467|Megestrol|megestrol|mesh-list
25361251|NCT05316467|Megestrol Acetate|megestrol acetate|mesh-list
25361252|NCT05316467|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25361253|NCT05316467|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25361254|NCT05316467|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25361255|NCT05316467|Contraceptive Agents|contraceptive agents|mesh-ancestor
25361256|NCT05316467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25361257|NCT05316467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361258|NCT05316467|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25361259|NCT05316467|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25361260|NCT05316467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25361261|NCT05316467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361262|NCT05316467|Appetite Stimulants|appetite stimulants|mesh-ancestor
25361263|NCT05316467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25361264|NCT05316129|Hormones|hormones|mesh-list
25361265|NCT05316129|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25361266|NCT05316129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25361267|NCT05316129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361268|NCT05316116|Siltuximab|siltuximab|mesh-list
25361269|NCT05316116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361270|NCT05315817|Dialysis Solutions|dialysis solutions|mesh-list
25361271|NCT05315817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25361272|NCT05315713|Atezolizumab|atezolizumab|mesh-list
25361273|NCT05315713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361274|NCT05315648|Anesthetics|anesthetics|mesh-list
25361275|NCT05315648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25361276|NCT05315648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361277|NCT05314998|Leucovorin|leucovorin|mesh-list
25361278|NCT05314998|Folic Acid|folic acid|mesh-list
25361279|NCT05314998|Gemcitabine|gemcitabine|mesh-list
25361280|NCT05314998|Fluorouracil|fluorouracil|mesh-list
25361281|NCT05314998|Capecitabine|capecitabine|mesh-list
25361282|NCT05314998|Oxaliplatin|oxaliplatin|mesh-list
25361283|NCT05314998|Irinotecan|irinotecan|mesh-list
25361284|NCT05314998|Levoleucovorin|levoleucovorin|mesh-list
25361285|NCT05314998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25361286|NCT05314998|Antimetabolites|antimetabolites|mesh-ancestor
25361287|NCT05314998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361288|NCT05314998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361289|NCT05314998|Antiviral Agents|antiviral agents|mesh-ancestor
25361290|NCT05314998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25361291|NCT05314998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361292|NCT05314998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25361293|NCT05314998|Immunologic Factors|immunologic factors|mesh-ancestor
25361294|NCT05314998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361295|NCT05314998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25361296|NCT05314998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25361297|NCT05314998|Antidotes|antidotes|mesh-ancestor
25361298|NCT05314998|Protective Agents|protective agents|mesh-ancestor
25361299|NCT05314998|Vitamin B Complex|vitamin b complex|mesh-ancestor
25361300|NCT05314998|Vitamins|vitamins|mesh-ancestor
25361301|NCT05314998|Micronutrients|micronutrients|mesh-ancestor
25724222|NCT02535806|Dermatologic Agents|dermatologic agents|mesh-ancestor
25361303|NCT05314621|Fluticasone|fluticasone|mesh-list
25361304|NCT05314621|Xhance|xhance|mesh-list
25361305|NCT05314621|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
25361306|NCT05314621|Dextrans|dextrans|mesh-list
25361307|NCT05314621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25361308|NCT05314621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25361309|NCT05314621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25361310|NCT05314621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25361311|NCT05314621|Autonomic Agents|autonomic agents|mesh-ancestor
25361312|NCT05314621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25361313|NCT05314621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361314|NCT05314621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25361315|NCT05314621|Respiratory System Agents|respiratory system agents|mesh-ancestor
25361316|NCT05314621|Dermatologic Agents|dermatologic agents|mesh-ancestor
25361317|NCT05314621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25361318|NCT05314621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25361319|NCT05314621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25361320|NCT05314621|Analgesics|analgesics|mesh-ancestor
25361321|NCT05314621|Sensory System Agents|sensory system agents|mesh-ancestor
25361322|NCT05314621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25361323|NCT05314621|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25361324|NCT05314621|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25361325|NCT05314621|Histamine Antagonists|histamine antagonists|mesh-ancestor
25361327|NCT05314621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25361328|NCT05314621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361329|NCT05314621|Anticoagulants|anticoagulants|mesh-ancestor
25361330|NCT05314621|Plasma Substitutes|plasma substitutes|mesh-ancestor
25361331|NCT05314621|Blood Substitutes|blood substitutes|mesh-ancestor
25361332|NCT05314101|Bevacizumab|bevacizumab|mesh-list
25361333|NCT05314101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25361334|NCT05314101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361335|NCT05314101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25361336|NCT05314101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25361337|NCT05314101|Growth Substances|growth substances|mesh-ancestor
25361338|NCT05314101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361339|NCT05314101|Growth Inhibitors|growth inhibitors|mesh-ancestor
25361340|NCT05313997|Diclofenac|diclofenac|mesh-list
25361341|NCT05313997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25361342|NCT05313997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25361343|NCT05313997|Analgesics|analgesics|mesh-ancestor
25361344|NCT05313997|Sensory System Agents|sensory system agents|mesh-ancestor
25361345|NCT05313997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25361346|NCT05313997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361347|NCT05313997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25361348|NCT05313997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25361349|NCT05313997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25361350|NCT05313997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361351|NCT05313997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361352|NCT05313620|Adalimumab|adalimumab|mesh-list
25361353|NCT05313620|Golimumab|golimumab|mesh-list
25361354|NCT05313620|Infliximab|infliximab|mesh-list
25361355|NCT05313620|Tofacitinib|tofacitinib|mesh-list
25361356|NCT05313620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25361357|NCT05313620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25361358|NCT05313620|Dermatologic Agents|dermatologic agents|mesh-ancestor
25361359|NCT05313620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25361360|NCT05313620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25361361|NCT05313620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361362|NCT05313620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361363|NCT05313620|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25361364|NCT05313620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25361365|NCT05313620|Immunologic Factors|immunologic factors|mesh-ancestor
25361366|NCT05313620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361368|NCT05313529|Liraglutide|liraglutide|mesh-list
25361369|NCT05313529|Empagliflozin|empagliflozin|mesh-list
25361370|NCT05313529|Linagliptin|linagliptin|mesh-list
25361371|NCT05313529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25361372|NCT05313529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361373|NCT05313529|Incretins|incretins|mesh-ancestor
25361374|NCT05313529|Hormones|hormones|mesh-ancestor
25361375|NCT05313529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25361376|NCT05313529|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25361377|NCT05313529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361378|NCT05313529|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25361379|NCT05313529|Protease Inhibitors|protease inhibitors|mesh-ancestor
25361380|NCT05313529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361382|NCT05313256|Epinephrine|epinephrine|mesh-list
25361383|NCT05313256|Racepinephrine|racepinephrine|mesh-list
25361384|NCT05313256|Epinephryl borate|epinephryl borate|mesh-list
25361385|NCT05313256|Anesthetics, Local|anesthetics, local|mesh-ancestor
25361386|NCT05313256|Anesthetics|anesthetics|mesh-ancestor
25361387|NCT05313256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25361388|NCT05313256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361389|NCT05313256|Sensory System Agents|sensory system agents|mesh-ancestor
25361390|NCT05313256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25361391|NCT05313256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25361392|NCT05313256|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25361393|NCT05313256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25361394|NCT05313256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25361395|NCT05313256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361396|NCT05313256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25361397|NCT05313256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25361398|NCT05313256|Adrenergic Agents|adrenergic agents|mesh-ancestor
25361399|NCT05313256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25361400|NCT05313256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25361401|NCT05313256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25361402|NCT05313256|Autonomic Agents|autonomic agents|mesh-ancestor
25361403|NCT05313256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25361404|NCT05313256|Respiratory System Agents|respiratory system agents|mesh-ancestor
25361405|NCT05313256|Mydriatics|mydriatics|mesh-ancestor
25361406|NCT05313256|Sympathomimetics|sympathomimetics|mesh-ancestor
25361407|NCT05313256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25361408|NCT05312970|Polidocanol|polidocanol|mesh-list
25361409|NCT05312970|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25361410|NCT05312970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25361411|NCT05312866|Acetaminophen|acetaminophen|mesh-list
25361412|NCT05312866|Dexamethasone|dexamethasone|mesh-list
25361413|NCT05312866|Magnesium Sulfate|magnesium sulfate|mesh-list
25361415|NCT05312866|Bupivacaine|bupivacaine|mesh-list
25361416|NCT05312866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25361417|NCT05312866|Antiemetics|antiemetics|mesh-ancestor
25361418|NCT05312866|Autonomic Agents|autonomic agents|mesh-ancestor
25361419|NCT05312866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25361420|NCT05312866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361421|NCT05312866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25361422|NCT05312866|Glucocorticoids|glucocorticoids|mesh-ancestor
25361423|NCT05312866|Hormones|hormones|mesh-ancestor
25361424|NCT05312866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25361425|NCT05312866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25361426|NCT05312866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361427|NCT05312866|Anesthetics, Local|anesthetics, local|mesh-ancestor
25361428|NCT05312866|Anesthetics|anesthetics|mesh-ancestor
25361429|NCT05312866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25361430|NCT05312866|Sensory System Agents|sensory system agents|mesh-ancestor
25361431|NCT05312866|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25361432|NCT05312866|Narcotics|narcotics|mesh-ancestor
25361433|NCT05312866|Analgesics|analgesics|mesh-ancestor
25361434|NCT05312866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25361435|NCT05312866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25361436|NCT05312866|Anesthetics, General|anesthetics, general|mesh-ancestor
25361437|NCT05312866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25361438|NCT05312866|Antipyretics|antipyretics|mesh-ancestor
25361439|NCT05312866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25361440|NCT05312866|Anticonvulsants|anticonvulsants|mesh-ancestor
25361441|NCT05312866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25361442|NCT05312866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25361443|NCT05312866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361444|NCT05312866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25361445|NCT05312866|Tocolytic Agents|tocolytic agents|mesh-ancestor
25361446|NCT05312866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25361447|NCT05311852|Palmidrol|palmidrol|mesh-list
25361448|NCT05311852|Antioxidants|antioxidants|mesh-list
25361449|NCT05311852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361450|NCT05311852|Protective Agents|protective agents|mesh-ancestor
25361451|NCT05311852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361452|NCT05311852|Analgesics|analgesics|mesh-ancestor
25361453|NCT05311852|Sensory System Agents|sensory system agents|mesh-ancestor
25361454|NCT05311852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25361455|NCT05311852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25361456|NCT05311852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25361457|NCT05311852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25361458|NCT05311852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25361459|NCT05311852|Antiviral Agents|antiviral agents|mesh-ancestor
25361460|NCT05311852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25361461|NCT05311852|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25361462|NCT05311852|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25361463|NCT05311852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25361464|NCT05311852|Hormones|hormones|mesh-ancestor
25361465|NCT05311852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25361466|NCT05311475|Mometasone Furoate|mometasone furoate|mesh-list
25361467|NCT05311475|Azelastine|azelastine|mesh-list
25361468|NCT05311475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25361469|NCT05311475|Dermatologic Agents|dermatologic agents|mesh-ancestor
25361470|NCT05311475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25361471|NCT05311475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25361472|NCT05311475|Autonomic Agents|autonomic agents|mesh-ancestor
25361473|NCT05311475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25361474|NCT05311475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361475|NCT05311475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25361476|NCT05311475|Respiratory System Agents|respiratory system agents|mesh-ancestor
25361477|NCT05311475|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
25361478|NCT05311475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361479|NCT05311475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361480|NCT05311475|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25361481|NCT05311475|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25361482|NCT05311475|Histamine Antagonists|histamine antagonists|mesh-ancestor
25361483|NCT05311475|Histamine Agents|histamine agents|mesh-ancestor
25361484|NCT05311475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25361486|NCT05311436|Folic Acid|folic acid|mesh-list
25361487|NCT05311436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361488|NCT05311436|Trace Elements|trace elements|mesh-ancestor
25361489|NCT05311436|Micronutrients|micronutrients|mesh-ancestor
25361490|NCT05311436|Hematinics|hematinics|mesh-ancestor
25361491|NCT05311436|Vitamin B Complex|vitamin b complex|mesh-ancestor
25361492|NCT05311436|Vitamins|vitamins|mesh-ancestor
25361493|NCT05311176|Paclitaxel|paclitaxel|mesh-list
25361494|NCT05311176|Pembrolizumab|pembrolizumab|mesh-list
25361495|NCT05311176|Irinotecan|irinotecan|mesh-list
25361496|NCT05311176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25361497|NCT05311176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361498|NCT05311176|Tubulin Modulators|tubulin modulators|mesh-ancestor
25361499|NCT05311176|Antimitotic Agents|antimitotic agents|mesh-ancestor
25361500|NCT05311176|Mitosis Modulators|mitosis modulators|mesh-ancestor
25361501|NCT05311176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361502|NCT05311176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25361503|NCT05311176|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25361504|NCT05311176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25361505|NCT05311176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361506|NCT05309928|Amoxicillin|amoxicillin|mesh-list
25361507|NCT05309928|Probenecid|probenecid|mesh-list
25361508|NCT05309928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25361509|NCT05309928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25361510|NCT05309928|Uricosuric Agents|uricosuric agents|mesh-ancestor
25361511|NCT05309928|Gout Suppressants|gout suppressants|mesh-ancestor
25361512|NCT05309928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25361513|NCT05309928|Renal Agents|renal agents|mesh-ancestor
25361514|NCT05309785|Canagliflozin|canagliflozin|mesh-list
25416007|NCT02978404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25361515|NCT05309785|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25361516|NCT05309785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361517|NCT05309785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25361518|NCT05309785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361519|NCT05309694|Copper|copper|mesh-list
25361520|NCT05309694|Contraceptive Agents|contraceptive agents|mesh-list
25361521|NCT05309694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25361522|NCT05309694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361523|NCT05309694|Trace Elements|trace elements|mesh-ancestor
25361524|NCT05309694|Micronutrients|micronutrients|mesh-ancestor
25361525|NCT05309655|Adenosine|adenosine|mesh-list
25361526|NCT05309655|Analgesics|analgesics|mesh-ancestor
25361527|NCT05309655|Sensory System Agents|sensory system agents|mesh-ancestor
25361528|NCT05309655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25361529|NCT05309655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361530|NCT05309655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25361531|NCT05309655|Vasodilator Agents|vasodilator agents|mesh-ancestor
25361532|NCT05309655|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25361533|NCT05309655|Purinergic Agonists|purinergic agonists|mesh-ancestor
25361545|NCT05309304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25361546|NCT05308901|Pembrolizumab|pembrolizumab|mesh-list
25361547|NCT05308901|Lenvatinib|lenvatinib|mesh-list
25361548|NCT05308901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25361549|NCT05308901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361550|NCT05308901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25361551|NCT05308901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361552|NCT05308901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361564|NCT05307926|Lenvatinib|lenvatinib|mesh-list
25361565|NCT05307926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25361566|NCT05307926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361567|NCT05307926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25361568|NCT05307926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361569|NCT05307926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361570|NCT05307705|Paclitaxel|paclitaxel|mesh-list
25361571|NCT05307705|Letrozole|letrozole|mesh-list
25361572|NCT05307705|Fulvestrant|fulvestrant|mesh-list
25361573|NCT05307705|Anastrozole|anastrozole|mesh-list
25361574|NCT05307705|Exemestane|exemestane|mesh-list
25361575|NCT05307705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25361576|NCT05307705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361577|NCT05307705|Tubulin Modulators|tubulin modulators|mesh-ancestor
25361578|NCT05307705|Antimitotic Agents|antimitotic agents|mesh-ancestor
25361579|NCT05307705|Mitosis Modulators|mitosis modulators|mesh-ancestor
25361580|NCT05307705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361581|NCT05307705|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25361582|NCT05307705|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25361583|NCT05307705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361584|NCT05307705|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25361585|NCT05307705|Hormone Antagonists|hormone antagonists|mesh-ancestor
25361586|NCT05307705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25361587|NCT05307705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361588|NCT05307705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25361589|NCT05307705|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25361590|NCT05307081|Lubricant Eye Drops|lubricant eye drops|mesh-list
25361591|NCT05307081|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25361592|NCT05307081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25361593|NCT05306873|Mycophenolic Acid|mycophenolic acid|mesh-list
25361594|NCT05306873|Cyclosporine|cyclosporine|mesh-list
25361595|NCT05306873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25361596|NCT05306873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361597|NCT05306873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25361598|NCT05306873|Antitubercular Agents|antitubercular agents|mesh-ancestor
25361599|NCT05306873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25361600|NCT05306873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25361601|NCT05306873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361602|NCT05306873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361603|NCT05306873|Antifungal Agents|antifungal agents|mesh-ancestor
25361604|NCT05306873|Dermatologic Agents|dermatologic agents|mesh-ancestor
25361605|NCT05306873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25361606|NCT05306873|Immunologic Factors|immunologic factors|mesh-ancestor
25361607|NCT05306873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361608|NCT05306873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25361609|NCT05306873|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25361610|NCT05306548|Triamcinolone|triamcinolone|mesh-list
25361611|NCT05306548|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25361612|NCT05306548|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25361613|NCT05306548|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25361614|NCT05306548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25361615|NCT05306548|Glucocorticoids|glucocorticoids|mesh-ancestor
25361616|NCT05306548|Hormones|hormones|mesh-ancestor
25361617|NCT05306548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25361618|NCT05306548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361619|NCT05306548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25361620|NCT05306548|Immunologic Factors|immunologic factors|mesh-ancestor
25361621|NCT05306548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361622|NCT05306548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361623|NCT05306535|Salicylic Acid|salicylic acid|mesh-list
25361624|NCT05306535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25361625|NCT05306535|Antifungal Agents|antifungal agents|mesh-ancestor
25361626|NCT05306535|Keratolytic Agents|keratolytic agents|mesh-ancestor
25361627|NCT05306535|Dermatologic Agents|dermatologic agents|mesh-ancestor
25361628|NCT05306470|Lidocaine|lidocaine|mesh-list
25361629|NCT05306470|Ethyl Chloride|ethyl chloride|mesh-list
25361630|NCT05306470|Anesthetics, Local|anesthetics, local|mesh-ancestor
25361631|NCT05306470|Anesthetics|anesthetics|mesh-ancestor
25361632|NCT05306470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25361633|NCT05306470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361634|NCT05306470|Sensory System Agents|sensory system agents|mesh-ancestor
25361635|NCT05306470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25361636|NCT05306470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25361637|NCT05306470|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25361638|NCT05306470|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25361639|NCT05306470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25361640|NCT05306470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361641|NCT05306431|Biguanides|biguanides|mesh-list
25361642|NCT05306431|Sodium Hypochlorite|sodium hypochlorite|mesh-list
25361643|NCT05306431|Polihexanide|polihexanide|mesh-list
25361644|NCT05306431|Eusol|eusol|mesh-list
25361645|NCT05306431|Disinfectants|disinfectants|mesh-ancestor
25361646|NCT05306431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25361647|NCT05306431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25361648|NCT05306431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361649|NCT05306340|Dexamethasone|dexamethasone|mesh-list
25361650|NCT05306340|Everolimus|everolimus|mesh-list
25361651|NCT05306340|Exemestane|exemestane|mesh-list
25361652|NCT05306340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25361653|NCT05306340|Antiemetics|antiemetics|mesh-ancestor
25361654|NCT05306340|Autonomic Agents|autonomic agents|mesh-ancestor
25361655|NCT05306340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25361656|NCT05306340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361657|NCT05306340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25361658|NCT05306340|Glucocorticoids|glucocorticoids|mesh-ancestor
25361659|NCT05306340|Hormones|hormones|mesh-ancestor
25361660|NCT05306340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25361812|NCT05303987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25361661|NCT05306340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25361662|NCT05306340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361663|NCT05306340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25361664|NCT05306340|Immunologic Factors|immunologic factors|mesh-ancestor
25361665|NCT05306340|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25361666|NCT05306340|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25361667|NCT05306340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361668|NCT05306340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361669|NCT05306340|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25361670|NCT05306340|Hormone Antagonists|hormone antagonists|mesh-ancestor
25361671|NCT05305989|Belumosudil|belumosudil|mesh-list
25361672|NCT05305989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25361673|NCT05305989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361674|NCT05305989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361675|NCT05305911|Dapagliflozin|dapagliflozin|mesh-list
25361676|NCT05305911|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25361677|NCT05305911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361678|NCT05305911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25361679|NCT05305911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361680|NCT05305859|Azacitidine|azacitidine|mesh-list
25361681|NCT05305859|Venetoclax|venetoclax|mesh-list
25361682|NCT05305859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25361683|NCT05305859|Antimetabolites|antimetabolites|mesh-ancestor
25393829|NCT04169347|Vitamins|vitamins|mesh-ancestor
25361684|NCT05305859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361685|NCT05305859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361686|NCT05305859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361687|NCT05305495|Empagliflozin|empagliflozin|mesh-list
25361688|NCT05305495|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25361689|NCT05305495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361690|NCT05305495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25361691|NCT05305495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361692|NCT05305404|Dexamethasone|dexamethasone|mesh-list
25361693|NCT05305404|Dexamethasone acetate|dexamethasone acetate|mesh-list
25361694|NCT05305404|BB 1101|bb 1101|mesh-list
25361695|NCT05305404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25361696|NCT05305404|Antiemetics|antiemetics|mesh-ancestor
25361697|NCT05305404|Autonomic Agents|autonomic agents|mesh-ancestor
25361698|NCT05305404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25361699|NCT05305404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361700|NCT05305404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25361701|NCT05305404|Glucocorticoids|glucocorticoids|mesh-ancestor
25361703|NCT05305404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25361704|NCT05305404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25361705|NCT05305404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361706|NCT05305404|Protease Inhibitors|protease inhibitors|mesh-ancestor
25361707|NCT05305404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361708|NCT05305404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361709|NCT05305105|Psilocybin|psilocybin|mesh-list
25361710|NCT05305105|Hallucinogens|hallucinogens|mesh-ancestor
25361711|NCT05305105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361712|NCT05305105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25361713|NCT05305066|Adalimumab|adalimumab|mesh-list
25361714|NCT05305066|Etanercept|etanercept|mesh-list
25361715|NCT05305066|Golimumab|golimumab|mesh-list
25361716|NCT05305066|Upadacitinib|upadacitinib|mesh-list
25361717|NCT05305066|Tofacitinib|tofacitinib|mesh-list
25361718|NCT05305066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25361719|NCT05305066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25361720|NCT05305066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25361721|NCT05305066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25361722|NCT05305066|Analgesics|analgesics|mesh-ancestor
25361723|NCT05305066|Sensory System Agents|sensory system agents|mesh-ancestor
25361724|NCT05305066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25361725|NCT05305066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361726|NCT05305066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25361727|NCT05305066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25361728|NCT05305066|Immunologic Factors|immunologic factors|mesh-ancestor
25361729|NCT05305066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25361730|NCT05305066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361731|NCT05305066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361732|NCT05305066|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25361733|NCT05305066|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25361734|NCT05304949|Ranibizumab|ranibizumab|mesh-list
25361735|NCT05304949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25361736|NCT05304949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25361737|NCT05304949|Growth Substances|growth substances|mesh-ancestor
25361738|NCT05304949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361739|NCT05304949|Growth Inhibitors|growth inhibitors|mesh-ancestor
25361740|NCT05304949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361741|NCT05304871|Cefazolin|cefazolin|mesh-list
25361742|NCT05304871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25361743|NCT05304871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25361744|NCT05304767|Xanomeline|xanomeline|mesh-list
25361745|NCT05304767|Trospium chloride|trospium chloride|mesh-list
25361746|NCT05304767|Parasympatholytics|parasympatholytics|mesh-ancestor
25361747|NCT05304767|Autonomic Agents|autonomic agents|mesh-ancestor
25361748|NCT05304767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25361749|NCT05304767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361750|NCT05304767|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25361751|NCT05304767|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25361752|NCT05304767|Cholinergic Agents|cholinergic agents|mesh-ancestor
25361753|NCT05304767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25361754|NCT05304767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361755|NCT05304767|Urological Agents|urological agents|mesh-ancestor
25361756|NCT05304767|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25361757|NCT05304767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25361758|NCT05304767|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25724223|NCT02535806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361759|NCT05304767|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25361760|NCT05304585|Dactinomycin|dactinomycin|mesh-list
25361761|NCT05304585|Cactinomycin|cactinomycin|mesh-list
25361762|NCT05304585|Cyclophosphamide|cyclophosphamide|mesh-list
25361763|NCT05304585|Vincristine|vincristine|mesh-list
25361764|NCT05304585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25361765|NCT05304585|Immunologic Factors|immunologic factors|mesh-ancestor
25361766|NCT05304585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361767|NCT05304585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25361768|NCT05304585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25361769|NCT05304585|Alkylating Agents|alkylating agents|mesh-ancestor
25361770|NCT05304585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361771|NCT05304585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361772|NCT05304585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25361773|NCT05304585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25361774|NCT05304585|Tubulin Modulators|tubulin modulators|mesh-ancestor
25361775|NCT05304585|Antimitotic Agents|antimitotic agents|mesh-ancestor
25361776|NCT05304585|Mitosis Modulators|mitosis modulators|mesh-ancestor
25361777|NCT05304585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25361778|NCT05304585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25361779|NCT05304585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25361780|NCT05304585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25361781|NCT05304585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361782|NCT05304585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25361783|NCT05304039|Nitric Oxide|nitric oxide|mesh-list
25361784|NCT05304039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25361785|NCT05304039|Autonomic Agents|autonomic agents|mesh-ancestor
25361786|NCT05304039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25361787|NCT05304039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361788|NCT05304039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25361789|NCT05304039|Respiratory System Agents|respiratory system agents|mesh-ancestor
25361790|NCT05304039|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25361791|NCT05304039|Antioxidants|antioxidants|mesh-ancestor
25361792|NCT05304039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361793|NCT05304039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25361794|NCT05304039|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25361795|NCT05304039|Vasodilator Agents|vasodilator agents|mesh-ancestor
25361796|NCT05304039|Gasotransmitters|gasotransmitters|mesh-ancestor
25361797|NCT05304039|Protective Agents|protective agents|mesh-ancestor
25361798|NCT05303987|Dexmedetomidine|dexmedetomidine|mesh-list
25361799|NCT05303987|Propofol|propofol|mesh-list
25361800|NCT05303987|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25361801|NCT05303987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25361802|NCT05303987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361803|NCT05303987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25361804|NCT05303987|Anesthetics, General|anesthetics, general|mesh-ancestor
25361805|NCT05303987|Anesthetics|anesthetics|mesh-ancestor
25361806|NCT05303987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25361807|NCT05303987|Analgesics|analgesics|mesh-ancestor
25361808|NCT05303987|Sensory System Agents|sensory system agents|mesh-ancestor
25361809|NCT05303987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25361810|NCT05303987|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25361811|NCT05303987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25361813|NCT05303987|Adrenergic Agents|adrenergic agents|mesh-ancestor
25361814|NCT05303987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25361815|NCT05303987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361816|NCT05303935|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25361817|NCT05303935|Antidepressive Agents|antidepressive agents|mesh-ancestor
25361818|NCT05303935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25361819|NCT05303935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25361820|NCT05303935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25361821|NCT05303935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25361822|NCT05303935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361823|NCT05303792|Cytarabine|cytarabine|mesh-list
25361824|NCT05303792|Dexamethasone|dexamethasone|mesh-list
25361825|NCT05303792|Prednisone|prednisone|mesh-list
25361826|NCT05303792|Methylprednisolone|methylprednisolone|mesh-list
25361827|NCT05303792|Cyclophosphamide|cyclophosphamide|mesh-list
25361828|NCT05303792|Rituximab|rituximab|mesh-list
25361829|NCT05303792|Doxorubicin|doxorubicin|mesh-list
25361830|NCT05303792|Methotrexate|methotrexate|mesh-list
25361831|NCT05303792|Vincristine|vincristine|mesh-list
25361832|NCT05303792|Mercaptopurine|mercaptopurine|mesh-list
25361833|NCT05303792|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
25361834|NCT05303792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25361835|NCT05303792|Immunologic Factors|immunologic factors|mesh-ancestor
25361836|NCT05303792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361854|NCT05303792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25361855|NCT05303792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25361856|NCT05303792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361857|NCT05303792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25361858|NCT05303792|Abortifacient Agents|abortifacient agents|mesh-ancestor
25361859|NCT05303792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25361860|NCT05303792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25361861|NCT05303792|Antimetabolites|antimetabolites|mesh-ancestor
25361862|NCT05303792|Dermatologic Agents|dermatologic agents|mesh-ancestor
25361863|NCT05303792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25361864|NCT05303792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25361865|NCT05303792|Antiviral Agents|antiviral agents|mesh-ancestor
25361866|NCT05303792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25361867|NCT05303792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25361868|NCT05303792|Tubulin Modulators|tubulin modulators|mesh-ancestor
25361869|NCT05303792|Antimitotic Agents|antimitotic agents|mesh-ancestor
25361870|NCT05303792|Mitosis Modulators|mitosis modulators|mesh-ancestor
25361871|NCT05303792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25361872|NCT05303792|Protective Agents|protective agents|mesh-ancestor
25361893|NCT05302856|Testosterone|testosterone|mesh-list
25361894|NCT05302856|Immunologic Factors|immunologic factors|mesh-ancestor
25361895|NCT05302856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361896|NCT05302856|Androgens|androgens|mesh-ancestor
25361897|NCT05302856|Hormones|hormones|mesh-ancestor
25361898|NCT05302856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25361899|NCT05302284|Gemcitabine|gemcitabine|mesh-list
25361900|NCT05302284|Cisplatin|cisplatin|mesh-list
25361901|NCT05302284|Carboplatin|carboplatin|mesh-list
25361902|NCT05302284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361903|NCT05302284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25361904|NCT05302284|Antimetabolites|antimetabolites|mesh-ancestor
25361905|NCT05302284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361906|NCT05302284|Antiviral Agents|antiviral agents|mesh-ancestor
25361907|NCT05302284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25361908|NCT05302284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361909|NCT05302284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25361910|NCT05302284|Immunologic Factors|immunologic factors|mesh-ancestor
25361911|NCT05302284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361913|NCT05301842|Lenvatinib|lenvatinib|mesh-list
25361914|NCT05301842|Tremelimumab|tremelimumab|mesh-list
25361915|NCT05301842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25361916|NCT05301842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361917|NCT05301842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25361918|NCT05301842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361919|NCT05301842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361920|NCT05301608|Psilocybin|psilocybin|mesh-list
25361921|NCT05301608|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
25361922|NCT05301608|Hallucinogens|hallucinogens|mesh-ancestor
25361923|NCT05301608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361924|NCT05301608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25361925|NCT05301608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25361926|NCT05301608|Serotonin Agents|serotonin agents|mesh-ancestor
25361927|NCT05301608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25361928|NCT05301608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361931|NCT05301322|Immunologic Factors|immunologic factors|mesh-ancestor
25361932|NCT05301322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361935|NCT05300802|Dexmedetomidine|dexmedetomidine|mesh-list
25361936|NCT05300802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25361937|NCT05300802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25361938|NCT05300802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361939|NCT05300802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25361941|NCT05300802|Sensory System Agents|sensory system agents|mesh-ancestor
25361942|NCT05300802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25361943|NCT05300802|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25361944|NCT05300802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25361945|NCT05300802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25361946|NCT05300802|Adrenergic Agents|adrenergic agents|mesh-ancestor
25361947|NCT05300802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25361948|NCT05300802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361949|NCT05300269|Capecitabine|capecitabine|mesh-list
25361950|NCT05300269|Oxaliplatin|oxaliplatin|mesh-list
25361951|NCT05300269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25361952|NCT05300269|Antimetabolites|antimetabolites|mesh-ancestor
25361953|NCT05300269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361954|NCT05300269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361955|NCT05300087|Albuterol|albuterol|mesh-list
25361956|NCT05300087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25361957|NCT05300087|Autonomic Agents|autonomic agents|mesh-ancestor
25361958|NCT05300087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25361959|NCT05300087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361960|NCT05300087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25361961|NCT05300087|Respiratory System Agents|respiratory system agents|mesh-ancestor
25361962|NCT05300087|Tocolytic Agents|tocolytic agents|mesh-ancestor
25361963|NCT05300087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25362038|NCT05299086|Dermatologic Agents|dermatologic agents|mesh-ancestor
25361964|NCT05300087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25361965|NCT05300087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25361966|NCT05300087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25361967|NCT05300087|Adrenergic Agents|adrenergic agents|mesh-ancestor
25361968|NCT05300087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25361969|NCT05300087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361970|NCT05300048|Paclitaxel|paclitaxel|mesh-list
25361971|NCT05300048|Serabelisib|serabelisib|mesh-list
25361972|NCT05300048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25361973|NCT05300048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361974|NCT05300048|Tubulin Modulators|tubulin modulators|mesh-ancestor
25361975|NCT05300048|Antimitotic Agents|antimitotic agents|mesh-ancestor
25361976|NCT05300048|Mitosis Modulators|mitosis modulators|mesh-ancestor
25361977|NCT05300048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361978|NCT05300048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25361979|NCT05299866|Ketamine|ketamine|mesh-list
25361980|NCT05299866|Esketamine|esketamine|mesh-list
25361981|NCT05299866|Analgesics|analgesics|mesh-ancestor
25361982|NCT05299866|Sensory System Agents|sensory system agents|mesh-ancestor
25361983|NCT05299866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25361984|NCT05299866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25361985|NCT05299866|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25361986|NCT05299866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25361987|NCT05299866|Anesthetics, General|anesthetics, general|mesh-ancestor
25361988|NCT05299866|Anesthetics|anesthetics|mesh-ancestor
25361989|NCT05299866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25361990|NCT05299866|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25361991|NCT05299866|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25361992|NCT05299866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25361993|NCT05299866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25361994|NCT05299866|Antidepressive Agents|antidepressive agents|mesh-ancestor
25361995|NCT05299866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25361996|NCT05299476|Bevacizumab|bevacizumab|mesh-list
25361997|NCT05299476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25361998|NCT05299476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25361999|NCT05299476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25362000|NCT05299476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25362001|NCT05299476|Growth Substances|growth substances|mesh-ancestor
25362002|NCT05299476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362003|NCT05299476|Growth Inhibitors|growth inhibitors|mesh-ancestor
25362004|NCT05299398|Trazodone|trazodone|mesh-list
25362005|NCT05299398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25362006|NCT05299398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25362007|NCT05299398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25362008|NCT05299398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362009|NCT05299398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25362010|NCT05299398|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25362011|NCT05299398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25362012|NCT05299398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25362013|NCT05299398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362014|NCT05299398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25362015|NCT05299398|Serotonin Agents|serotonin agents|mesh-ancestor
25362016|NCT05299398|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25362017|NCT05299398|Antidepressive Agents|antidepressive agents|mesh-ancestor
25362018|NCT05299125|Carboplatin|carboplatin|mesh-list
25362019|NCT05299125|Pemetrexed|pemetrexed|mesh-list
25362020|NCT05299125|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
25362021|NCT05299125|Lazertinib|lazertinib|mesh-list
25362022|NCT05299125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362023|NCT05299125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25362024|NCT05299125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362025|NCT05299125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25362026|NCT05299125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25362027|NCT05299125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25362028|NCT05299125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25362029|NCT05299086|Fluticasone|fluticasone|mesh-list
25362030|NCT05299086|Xhance|xhance|mesh-list
25362031|NCT05299086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25362032|NCT05299086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25362033|NCT05299086|Autonomic Agents|autonomic agents|mesh-ancestor
25362034|NCT05299086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25362035|NCT05299086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362036|NCT05299086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25362037|NCT05299086|Respiratory System Agents|respiratory system agents|mesh-ancestor
25362039|NCT05299086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25362041|NCT05299073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25362042|NCT05299073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362043|NCT05299008|Bethanechol|bethanechol|mesh-list
25362044|NCT05299008|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25362045|NCT05299008|Autonomic Agents|autonomic agents|mesh-ancestor
25362046|NCT05299008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25362047|NCT05299008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362048|NCT05299008|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25362049|NCT05299008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25362050|NCT05299008|Cholinergic Agents|cholinergic agents|mesh-ancestor
25362051|NCT05299008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25362052|NCT05299008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362053|NCT05298592|Nivolumab|nivolumab|mesh-list
25362054|NCT05298592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25362055|NCT05298592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362056|NCT05298592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25362057|NCT05298592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362058|NCT05298423|Paclitaxel|paclitaxel|mesh-list
25362059|NCT05298423|Etoposide|etoposide|mesh-list
25362060|NCT05298423|Cisplatin|cisplatin|mesh-list
25362061|NCT05298423|Carboplatin|carboplatin|mesh-list
25362062|NCT05298423|Pembrolizumab|pembrolizumab|mesh-list
25362063|NCT05298423|Pemetrexed|pemetrexed|mesh-list
25362064|NCT05298423|Durvalumab|durvalumab|mesh-list
25362065|NCT05298423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25362066|NCT05298423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25394207|NCT04155411|Dasatinib|dasatinib|mesh-list
25362067|NCT05298423|Tubulin Modulators|tubulin modulators|mesh-ancestor
25362068|NCT05298423|Antimitotic Agents|antimitotic agents|mesh-ancestor
25362069|NCT05298423|Mitosis Modulators|mitosis modulators|mesh-ancestor
25362070|NCT05298423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362071|NCT05298423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25362072|NCT05298423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25362073|NCT05298423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25362074|NCT05298423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25362075|NCT05298423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25362076|NCT05298423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25362077|NCT05297617|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25362078|NCT05297617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25362079|NCT05297617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25362080|NCT05297617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362081|NCT05297617|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25362082|NCT05297617|Hormone Antagonists|hormone antagonists|mesh-ancestor
25362083|NCT05297617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25362084|NCT05297617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362085|NCT05297578|Vaccines|vaccines|mesh-list
25362086|NCT05297578|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25362087|NCT05297578|Immunologic Factors|immunologic factors|mesh-ancestor
25362088|NCT05297578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362089|NCT05297565|Nivolumab|nivolumab|mesh-list
25362090|NCT05297565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25362091|NCT05297565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362092|NCT05297565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25362093|NCT05297565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362094|NCT05297448|Rifaximin|rifaximin|mesh-list
25362095|NCT05297448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25362096|NCT05297448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25362097|NCT05297448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25362098|NCT05297396|Analgesics, Opioid|analgesics, opioid|mesh-list
25362099|NCT05297396|Narcotics|narcotics|mesh-ancestor
25362100|NCT05297396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25362101|NCT05297396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362102|NCT05297396|Analgesics|analgesics|mesh-ancestor
25362103|NCT05297396|Sensory System Agents|sensory system agents|mesh-ancestor
25362104|NCT05297396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25362105|NCT05296837|Doxycycline|doxycycline|mesh-list
25362106|NCT05296837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25362107|NCT05296837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25362108|NCT05296837|Antimalarials|antimalarials|mesh-ancestor
25362109|NCT05296837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25362110|NCT05296837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25362111|NCT05296798|Paclitaxel|paclitaxel|mesh-list
25362112|NCT05296798|Docetaxel|docetaxel|mesh-list
25362113|NCT05296798|Trastuzumab|trastuzumab|mesh-list
25362114|NCT05296798|Pertuzumab|pertuzumab|mesh-list
25362115|NCT05296798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25362116|NCT05296798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362117|NCT05296798|Tubulin Modulators|tubulin modulators|mesh-ancestor
25362118|NCT05296798|Antimitotic Agents|antimitotic agents|mesh-ancestor
25362119|NCT05296798|Mitosis Modulators|mitosis modulators|mesh-ancestor
25362120|NCT05296798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362121|NCT05296798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25362122|NCT05296577|Vinorelbine|vinorelbine|mesh-list
25362123|NCT05296577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25362124|NCT05296577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362125|NCT05296577|Tubulin Modulators|tubulin modulators|mesh-ancestor
25362126|NCT05296577|Antimitotic Agents|antimitotic agents|mesh-ancestor
25362127|NCT05296577|Mitosis Modulators|mitosis modulators|mesh-ancestor
25362128|NCT05296577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362129|NCT05296512|Pembrolizumab|pembrolizumab|mesh-list
25362130|NCT05296512|Lenvatinib|lenvatinib|mesh-list
25362131|NCT05296512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25362132|NCT05296512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362133|NCT05296512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25362134|NCT05296512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25362135|NCT05296512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362136|NCT05296304|Bexarotene|bexarotene|mesh-list
25362137|NCT05296304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362138|NCT05295927|Prednisone|prednisone|mesh-list
25362139|NCT05295927|Prednisolone|prednisolone|mesh-list
25724224|NCT02535806|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25362140|NCT05295927|Abiraterone Acetate|abiraterone acetate|mesh-list
25362141|NCT05295927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25362142|NCT05295927|Glucocorticoids|glucocorticoids|mesh-ancestor
25362144|NCT05295927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25362145|NCT05295927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362146|NCT05295927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25362147|NCT05295927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362148|NCT05295927|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25362149|NCT05295927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25362150|NCT05295927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362151|NCT05295927|Hormone Antagonists|hormone antagonists|mesh-ancestor
25362152|NCT05295927|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25362153|NCT05295784|Caffeine|caffeine|mesh-list
25362154|NCT05295784|Caffeine citrate|caffeine citrate|mesh-list
25362155|NCT05295784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362156|NCT05295784|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25362157|NCT05295784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362158|NCT05295784|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25362159|NCT05295784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25362160|NCT05295784|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25362161|NCT05295784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25362162|NCT05295784|Purinergic Agents|purinergic agents|mesh-ancestor
25362163|NCT05295784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25362164|NCT05295589|Paclitaxel|paclitaxel|mesh-list
25362165|NCT05295589|Doxorubicin|doxorubicin|mesh-list
25362166|NCT05295589|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25362167|NCT05295589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25362168|NCT05295589|Topotecan|topotecan|mesh-list
25362169|NCT05295589|Olaparib|olaparib|mesh-list
25362170|NCT05295589|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25362171|NCT05295589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25362172|NCT05295589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362173|NCT05295589|Tubulin Modulators|tubulin modulators|mesh-ancestor
25362174|NCT05295589|Antimitotic Agents|antimitotic agents|mesh-ancestor
25362175|NCT05295589|Mitosis Modulators|mitosis modulators|mesh-ancestor
25362176|NCT05295589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362177|NCT05295589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25362178|NCT05295589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25362179|NCT05295589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25362180|NCT05295589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25362181|NCT05295589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25362182|NCT05294835|Ketamine|ketamine|mesh-list
25362183|NCT05294835|Analgesics|analgesics|mesh-ancestor
25362184|NCT05294835|Sensory System Agents|sensory system agents|mesh-ancestor
25362185|NCT05294835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25362186|NCT05294835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362187|NCT05294835|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25362188|NCT05294835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25362189|NCT05294835|Anesthetics, General|anesthetics, general|mesh-ancestor
25362190|NCT05294835|Anesthetics|anesthetics|mesh-ancestor
25362191|NCT05294835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25362192|NCT05294835|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25362193|NCT05294835|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25362194|NCT05294835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25362195|NCT05294835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362196|NCT05294341|Norethindrone|norethindrone|mesh-list
25362197|NCT05294341|Norethindrone Acetate|norethindrone acetate|mesh-list
25362198|NCT05294341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25362199|NCT05294341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25362200|NCT05294341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25362201|NCT05294341|Contraceptive Agents|contraceptive agents|mesh-ancestor
25362202|NCT05294341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25362203|NCT05294341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362204|NCT05294341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25362205|NCT05294341|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25362206|NCT05294328|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25362207|NCT05294328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25362208|NCT05294328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25362209|NCT05294328|Aceclidine|aceclidine|mesh-list
25362210|NCT05294328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25362211|NCT05294328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25362212|NCT05294328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25362214|NCT05294328|Adrenergic Agents|adrenergic agents|mesh-ancestor
25362215|NCT05294328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25362216|NCT05294328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362217|NCT05294328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362218|NCT05294328|Miotics|miotics|mesh-ancestor
25362219|NCT05294328|Autonomic Agents|autonomic agents|mesh-ancestor
25362220|NCT05294328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25362221|NCT05294328|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25362222|NCT05294146|Clofazimine|clofazimine|mesh-list
25362223|NCT05294146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25362224|NCT05294146|Leprostatic Agents|leprostatic agents|mesh-ancestor
25362225|NCT05294146|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25362226|NCT05294146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25362227|NCT05293938|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
25362228|NCT05293938|Cathartics|cathartics|mesh-ancestor
25362229|NCT05293938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25362230|NCT05293912|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25362231|NCT05293912|Immunologic Factors|immunologic factors|mesh-ancestor
25362232|NCT05293912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362234|NCT05293665|Immunologic Factors|immunologic factors|mesh-ancestor
25362235|NCT05293665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362236|NCT05293288|Anesthetics|anesthetics|mesh-list
25362237|NCT05293288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25362238|NCT05293288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362239|NCT05293210|Dexamethasone|dexamethasone|mesh-list
25362240|NCT05293210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25362241|NCT05293210|Antiemetics|antiemetics|mesh-ancestor
25362242|NCT05293210|Autonomic Agents|autonomic agents|mesh-ancestor
25362243|NCT05293210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25362244|NCT05293210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362245|NCT05293210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25362246|NCT05293210|Glucocorticoids|glucocorticoids|mesh-ancestor
25362247|NCT05293210|Hormones|hormones|mesh-ancestor
25362248|NCT05293210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25362249|NCT05293210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25362250|NCT05293210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362251|NCT05292872|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
25362252|NCT05292872|Cathartics|cathartics|mesh-ancestor
25362253|NCT05292872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25362254|NCT05292690|Caffeine|caffeine|mesh-list
25362255|NCT05292690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25362256|NCT05292690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362257|NCT05292690|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25362258|NCT05292690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25362259|NCT05292690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362260|NCT05292690|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25362261|NCT05292690|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25362262|NCT05292690|Purinergic Agents|purinergic agents|mesh-ancestor
25362263|NCT05292690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25362264|NCT05292664|Leucovorin|leucovorin|mesh-list
25362265|NCT05292664|Cytarabine|cytarabine|mesh-list
25362266|NCT05292664|Dexamethasone|dexamethasone|mesh-list
25362267|NCT05292664|Dexamethasone acetate|dexamethasone acetate|mesh-list
25362268|NCT05292664|Hydrocortisone|hydrocortisone|mesh-list
25362269|NCT05292664|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25362270|NCT05292664|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25362271|NCT05292664|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25362272|NCT05292664|Cortisone|cortisone|mesh-list
25362273|NCT05292664|Doxorubicin|doxorubicin|mesh-list
25362274|NCT05292664|Methotrexate|methotrexate|mesh-list
25362275|NCT05292664|Vincristine|vincristine|mesh-list
25362276|NCT05292664|Azacitidine|azacitidine|mesh-list
25362277|NCT05292664|Venetoclax|venetoclax|mesh-list
25362278|NCT05292664|Dexrazoxane|dexrazoxane|mesh-list
25362279|NCT05292664|Razoxane|razoxane|mesh-list
25362280|NCT05292664|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25362281|NCT05292664|BB 1101|bb 1101|mesh-list
25362282|NCT05292664|Levoleucovorin|levoleucovorin|mesh-list
25362283|NCT05292664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25362284|NCT05292664|Antiemetics|antiemetics|mesh-ancestor
25362285|NCT05292664|Autonomic Agents|autonomic agents|mesh-ancestor
25362286|NCT05292664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25362287|NCT05292664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724225|NCT02535806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25362288|NCT05292664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25362289|NCT05292664|Glucocorticoids|glucocorticoids|mesh-ancestor
25362290|NCT05292664|Hormones|hormones|mesh-ancestor
25362291|NCT05292664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25362292|NCT05292664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25362293|NCT05292664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362294|NCT05292664|Protease Inhibitors|protease inhibitors|mesh-ancestor
25362295|NCT05292664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25362296|NCT05292664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362297|NCT05292664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25362298|NCT05292664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25362299|NCT05292664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25362300|NCT05292664|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25362301|NCT05292664|Abortifacient Agents|abortifacient agents|mesh-ancestor
25362302|NCT05292664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25362303|NCT05292664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25362304|NCT05292664|Antimetabolites|antimetabolites|mesh-ancestor
25362305|NCT05292664|Dermatologic Agents|dermatologic agents|mesh-ancestor
25362306|NCT05292664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25362307|NCT05292664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25362308|NCT05292664|Immunologic Factors|immunologic factors|mesh-ancestor
25362309|NCT05292664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25362310|NCT05292664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25362311|NCT05292664|Antiviral Agents|antiviral agents|mesh-ancestor
25362312|NCT05292664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25362313|NCT05292664|Antidotes|antidotes|mesh-ancestor
25362314|NCT05292664|Protective Agents|protective agents|mesh-ancestor
25362315|NCT05292664|Vitamin B Complex|vitamin b complex|mesh-ancestor
25362316|NCT05292664|Vitamins|vitamins|mesh-ancestor
25362317|NCT05292664|Micronutrients|micronutrients|mesh-ancestor
25362318|NCT05292664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25362319|NCT05292664|Tubulin Modulators|tubulin modulators|mesh-ancestor
25362320|NCT05292664|Antimitotic Agents|antimitotic agents|mesh-ancestor
25362321|NCT05292664|Mitosis Modulators|mitosis modulators|mesh-ancestor
25362322|NCT05292664|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25362323|NCT05292209|Riluzole|riluzole|mesh-list
25362324|NCT05292209|Anticonvulsants|anticonvulsants|mesh-ancestor
25362325|NCT05292209|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25362326|NCT05292209|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25362327|NCT05292209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25362328|NCT05292209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362329|NCT05292209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362330|NCT05292209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25362331|NCT05292209|Protective Agents|protective agents|mesh-ancestor
25362332|NCT05292066|Pregabalin|pregabalin|mesh-list
25362333|NCT05292066|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25362334|NCT05292066|Analgesics|analgesics|mesh-ancestor
25362335|NCT05292066|Sensory System Agents|sensory system agents|mesh-ancestor
25362336|NCT05292066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25362337|NCT05292066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362338|NCT05292066|Anticonvulsants|anticonvulsants|mesh-ancestor
25362339|NCT05292066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25362340|NCT05292066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25362341|NCT05292066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362342|NCT05292066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25362343|NCT05292066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25362344|NCT05292066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25362345|NCT05292066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25362346|NCT05292066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25362347|NCT05292066|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25362348|NCT05292066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25362349|NCT05292066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25362350|NCT05292066|Antidepressive Agents|antidepressive agents|mesh-ancestor
25362351|NCT05292066|Dopamine Agents|dopamine agents|mesh-ancestor
25362352|NCT05291845|Vaccines|vaccines|mesh-list
25362353|NCT05291845|Immunologic Factors|immunologic factors|mesh-ancestor
25362354|NCT05291845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362355|NCT05290727|Hyaluronic Acid|hyaluronic acid|mesh-list
25362356|NCT05290727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25362357|NCT05290727|Immunologic Factors|immunologic factors|mesh-ancestor
25362358|NCT05290727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362359|NCT05290727|Viscosupplements|viscosupplements|mesh-ancestor
25362360|NCT05290727|Protective Agents|protective agents|mesh-ancestor
25362361|NCT05290662|Cyclophosphamide|cyclophosphamide|mesh-list
25362362|NCT05290662|Fludarabine|fludarabine|mesh-list
25362363|NCT05290662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25362364|NCT05290662|Immunologic Factors|immunologic factors|mesh-ancestor
25362365|NCT05290662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362366|NCT05290662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25362367|NCT05290662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25362368|NCT05290662|Alkylating Agents|alkylating agents|mesh-ancestor
25362369|NCT05290662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362370|NCT05290662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362371|NCT05290662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25362372|NCT05290129|Oxytocin|oxytocin|mesh-list
25362373|NCT05290129|Oxytocics|oxytocics|mesh-ancestor
25362374|NCT05290129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25362375|NCT05290129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362376|NCT05290116|Apatinib|apatinib|mesh-list
25362377|NCT05290116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362378|NCT05290116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25362379|NCT05290116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25362380|NCT05290116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362381|NCT05290025|Nicotine|nicotine|mesh-list
25362382|NCT05290025|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25362383|NCT05290025|Autonomic Agents|autonomic agents|mesh-ancestor
25362384|NCT05290025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25362385|NCT05290025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362386|NCT05290025|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25362387|NCT05290025|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25362388|NCT05290025|Cholinergic Agents|cholinergic agents|mesh-ancestor
25362389|NCT05290025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25362390|NCT05290025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362391|NCT05289869|Oxytocin|oxytocin|mesh-list
25362392|NCT05289869|Oxytocics|oxytocics|mesh-ancestor
25362393|NCT05289869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25362394|NCT05289869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362395|NCT05289830|Citalopram|citalopram|mesh-list
25362396|NCT05289830|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25362397|NCT05289830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25362398|NCT05289830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25362399|NCT05289830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362400|NCT05289830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25362401|NCT05289830|Serotonin Agents|serotonin agents|mesh-ancestor
25362402|NCT05289830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362403|NCT05289830|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25362404|NCT05289830|Antidepressive Agents|antidepressive agents|mesh-ancestor
25362405|NCT05289830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25362406|NCT05289050|Ketamine|ketamine|mesh-list
25362407|NCT05289050|Esketamine|esketamine|mesh-list
25362408|NCT05289050|Analgesics|analgesics|mesh-ancestor
25362409|NCT05289050|Sensory System Agents|sensory system agents|mesh-ancestor
25362410|NCT05289050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25362411|NCT05289050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362412|NCT05289050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25362413|NCT05289050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25362414|NCT05289050|Anesthetics, General|anesthetics, general|mesh-ancestor
25362415|NCT05289050|Anesthetics|anesthetics|mesh-ancestor
25362416|NCT05289050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25362417|NCT05289050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25362418|NCT05289050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25362419|NCT05289050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25362420|NCT05289050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362421|NCT05289050|Antidepressive Agents|antidepressive agents|mesh-ancestor
25362422|NCT05289050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25362423|NCT05288400|Amlodipine|amlodipine|mesh-list
25362424|NCT05288400|Bisoprolol|bisoprolol|mesh-list
25362425|NCT05288400|Perindopril|perindopril|mesh-list
25362426|NCT05288400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25362427|NCT05288400|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25362428|NCT05288400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25362429|NCT05288400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362430|NCT05288400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25362431|NCT05288400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362432|NCT05288400|Vasodilator Agents|vasodilator agents|mesh-ancestor
25362433|NCT05288400|Sympatholytics|sympatholytics|mesh-ancestor
25362434|NCT05288400|Autonomic Agents|autonomic agents|mesh-ancestor
25362435|NCT05288400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25362436|NCT05288400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25362437|NCT05288400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25724226|NCT02535806|Immunologic Factors|immunologic factors|mesh-ancestor
25394582|NCT04133636|Hormones|hormones|mesh-ancestor
25362438|NCT05288400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25362439|NCT05288400|Adrenergic Agents|adrenergic agents|mesh-ancestor
25362440|NCT05288400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25362441|NCT05288400|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25362442|NCT05288400|Protease Inhibitors|protease inhibitors|mesh-ancestor
25362443|NCT05288400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25362444|NCT05288361|Acetylcholine|acetylcholine|mesh-list
25362445|NCT05288361|Vasodilator Agents|vasodilator agents|mesh-ancestor
25362446|NCT05288361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25362447|NCT05288361|Cholinergic Agents|cholinergic agents|mesh-ancestor
25362448|NCT05288361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25362449|NCT05288361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362450|NCT05288361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362451|NCT05288348|Sufentanil|sufentanil|mesh-list
25362452|NCT05288348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25362453|NCT05288348|Narcotics|narcotics|mesh-ancestor
25362454|NCT05288348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25362478|NCT05287906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25362479|NCT05287906|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25362480|NCT05287906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25362481|NCT05287906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362482|NCT05287906|Protective Agents|protective agents|mesh-ancestor
25362483|NCT05287906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362484|NCT05287724|Acetylcysteine|acetylcysteine|mesh-list
25362485|NCT05287724|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25362486|NCT05287724|Antiviral Agents|antiviral agents|mesh-ancestor
25362487|NCT05287724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25362488|NCT05287724|Expectorants|expectorants|mesh-ancestor
25362489|NCT05287724|Respiratory System Agents|respiratory system agents|mesh-ancestor
25362490|NCT05287724|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25362491|NCT05287724|Antioxidants|antioxidants|mesh-ancestor
25362569|NCT05286320|Lenvatinib|lenvatinib|mesh-list
25362492|NCT05287724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362493|NCT05287724|Protective Agents|protective agents|mesh-ancestor
25362494|NCT05287724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362495|NCT05287724|Antidotes|antidotes|mesh-ancestor
25362496|NCT05287464|Pembrolizumab|pembrolizumab|mesh-list
25362497|NCT05287464|Nivolumab|nivolumab|mesh-list
25362498|NCT05287464|Ipilimumab|ipilimumab|mesh-list
25362499|NCT05287464|Avelumab|avelumab|mesh-list
25362500|NCT05287464|Atezolizumab|atezolizumab|mesh-list
25362501|NCT05287464|Lenvatinib|lenvatinib|mesh-list
25362502|NCT05287464|Axitinib|axitinib|mesh-list
25362503|NCT05287464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25362504|NCT05287464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362505|NCT05287464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25362506|NCT05287464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362507|NCT05287464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25362508|NCT05287464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25362560|NCT05286762|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25362561|NCT05286762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362562|NCT05286762|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25362563|NCT05286762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25362564|NCT05286762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25362565|NCT05286762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362566|NCT05286762|Dopamine Agents|dopamine agents|mesh-ancestor
25362567|NCT05286762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25362568|NCT05286320|Pembrolizumab|pembrolizumab|mesh-list
25362570|NCT05286320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25362571|NCT05286320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362572|NCT05286320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25362573|NCT05286320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25362574|NCT05286320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362575|NCT05285982|Nintedanib|nintedanib|mesh-list
25362576|NCT05285982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362577|NCT05285982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25362578|NCT05285982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25362579|NCT05285982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362580|NCT05285891|Ocrelizumab|ocrelizumab|mesh-list
25362581|NCT05285891|Immunologic Factors|immunologic factors|mesh-ancestor
25362582|NCT05285891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362583|NCT05285683|Levodopa|levodopa|mesh-list
25362584|NCT05285683|Carbidopa|carbidopa|mesh-list
25724227|NCT02535806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25362585|NCT05285683|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
25362587|NCT05285683|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25362588|NCT05285683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362589|NCT05285683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25362590|NCT05285683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25362591|NCT05285683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25362592|NCT05285683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362593|NCT05285683|Dopamine Agents|dopamine agents|mesh-ancestor
25362594|NCT05285683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25362595|NCT05285683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25362596|NCT05285683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25362597|NCT05285683|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25362598|NCT05285683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25362599|NCT05285683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25362600|NCT05285683|Immunologic Factors|immunologic factors|mesh-ancestor
25362601|NCT05285683|Dopamine Agonists|dopamine agonists|mesh-ancestor
25362602|NCT05285644|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25362603|NCT05285644|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25362604|NCT05284812|Vaccines|vaccines|mesh-list
25362605|NCT05284812|Immunologic Factors|immunologic factors|mesh-ancestor
25362606|NCT05284812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362617|NCT05284643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25362618|NCT05284643|Growth Substances|growth substances|mesh-ancestor
25362619|NCT05284643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362620|NCT05284643|Growth Inhibitors|growth inhibitors|mesh-ancestor
25362621|NCT05284591|Daratumumab|daratumumab|mesh-list
25362622|NCT05284591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362623|NCT05284409|Acetaminophen|acetaminophen|mesh-list
25362624|NCT05284409|Dexamethasone|dexamethasone|mesh-list
25362625|NCT05284409|Meperidine|meperidine|mesh-list
25362626|NCT05284409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25362627|NCT05284409|Antiemetics|antiemetics|mesh-ancestor
25362628|NCT05284409|Autonomic Agents|autonomic agents|mesh-ancestor
25362629|NCT05284409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25362630|NCT05284409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362631|NCT05284409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25362632|NCT05284409|Glucocorticoids|glucocorticoids|mesh-ancestor
25362633|NCT05284409|Hormones|hormones|mesh-ancestor
25362634|NCT05284409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25362635|NCT05284409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25362636|NCT05284409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362637|NCT05284409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25362638|NCT05284409|Analgesics|analgesics|mesh-ancestor
25362639|NCT05284409|Sensory System Agents|sensory system agents|mesh-ancestor
25362640|NCT05284409|Antipyretics|antipyretics|mesh-ancestor
25362641|NCT05284409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25362642|NCT05284409|Narcotics|narcotics|mesh-ancestor
25362643|NCT05284409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25362644|NCT05284409|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25362645|NCT05283720|Prednisone|prednisone|mesh-list
25362646|NCT05283720|Cyclophosphamide|cyclophosphamide|mesh-list
25362647|NCT05283720|Rituximab|rituximab|mesh-list
25362648|NCT05283720|Doxorubicin|doxorubicin|mesh-list
25362649|NCT05283720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25362650|NCT05283720|Lenalidomide|lenalidomide|mesh-list
25362651|NCT05283720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25362652|NCT05283720|Immunologic Factors|immunologic factors|mesh-ancestor
25362653|NCT05283720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362654|NCT05283720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25362655|NCT05283720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25362656|NCT05283720|Alkylating Agents|alkylating agents|mesh-ancestor
25362657|NCT05283720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362658|NCT05283720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362659|NCT05283720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25362660|NCT05283720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25362661|NCT05283720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25362662|NCT05283720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25362663|NCT05283720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25362664|NCT05283720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25362665|NCT05283720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25362666|NCT05283720|Glucocorticoids|glucocorticoids|mesh-ancestor
25362667|NCT05283720|Hormones|hormones|mesh-ancestor
25362668|NCT05283720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25362669|NCT05283720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25362670|NCT05283720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25362671|NCT05283720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25362672|NCT05283720|Growth Substances|growth substances|mesh-ancestor
25362673|NCT05283720|Growth Inhibitors|growth inhibitors|mesh-ancestor
25362674|NCT05283395|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25362675|NCT05283395|Latanoprost|latanoprost|mesh-list
25362676|NCT05283395|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25362677|NCT05283304|Buprenorphine|buprenorphine|mesh-list
25362678|NCT05283304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25362679|NCT05283304|Narcotics|narcotics|mesh-ancestor
25362680|NCT05283304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25362681|NCT05283304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362682|NCT05283304|Analgesics|analgesics|mesh-ancestor
25362683|NCT05283304|Sensory System Agents|sensory system agents|mesh-ancestor
25362684|NCT05283304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25362685|NCT05283304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25362687|NCT05283226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25362688|NCT05283226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362689|NCT05283226|Tubulin Modulators|tubulin modulators|mesh-ancestor
25362690|NCT05283226|Antimitotic Agents|antimitotic agents|mesh-ancestor
25362691|NCT05283226|Mitosis Modulators|mitosis modulators|mesh-ancestor
25362692|NCT05283226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362693|NCT05283109|Vaccines|vaccines|mesh-list
25362694|NCT05283109|Poly ICLC|poly iclc|mesh-list
25362695|NCT05283109|Immunologic Factors|immunologic factors|mesh-ancestor
25362696|NCT05283109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362697|NCT05283109|Interferon Inducers|interferon inducers|mesh-ancestor
25362698|NCT05283083|Dexmedetomidine|dexmedetomidine|mesh-list
25362699|NCT05283083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25362700|NCT05283083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25362701|NCT05283083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362702|NCT05283083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25362703|NCT05283083|Analgesics|analgesics|mesh-ancestor
25362704|NCT05283083|Sensory System Agents|sensory system agents|mesh-ancestor
25362705|NCT05283083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25362706|NCT05283083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25362707|NCT05283083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25362708|NCT05283083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25362709|NCT05283083|Adrenergic Agents|adrenergic agents|mesh-ancestor
25362710|NCT05283083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25362711|NCT05283083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362712|NCT05282901|Pembrolizumab|pembrolizumab|mesh-list
25362713|NCT05282901|Lenvatinib|lenvatinib|mesh-list
25362714|NCT05282901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25362715|NCT05282901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362716|NCT05282901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25362717|NCT05282901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25362718|NCT05282901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362719|NCT05282550|Trazodone|trazodone|mesh-list
25362720|NCT05282550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25362721|NCT05282550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25362722|NCT05282550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25362723|NCT05282550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362724|NCT05282550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25362725|NCT05282550|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25362726|NCT05282550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25362727|NCT05282550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25362728|NCT05282550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362729|NCT05282550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25362730|NCT05282550|Serotonin Agents|serotonin agents|mesh-ancestor
25362731|NCT05282550|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25362732|NCT05282550|Antidepressive Agents|antidepressive agents|mesh-ancestor
25362733|NCT05282290|Antihypertensive Agents|antihypertensive agents|mesh-list
25362734|NCT05282121|Empagliflozin|empagliflozin|mesh-list
25362735|NCT05282121|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25362736|NCT05282121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362737|NCT05282121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25362738|NCT05282121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362739|NCT05281770|Erenumab|erenumab|mesh-list
25362740|NCT05281770|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25362741|NCT05281770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362742|NCT05281770|Analgesics|analgesics|mesh-ancestor
25362743|NCT05281770|Sensory System Agents|sensory system agents|mesh-ancestor
25362744|NCT05281770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25362745|NCT05281770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362747|NCT05281510|Antiviral Agents|antiviral agents|mesh-ancestor
25362748|NCT05281510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25362749|NCT05281471|Gemcitabine|gemcitabine|mesh-list
25362750|NCT05281471|Paclitaxel|paclitaxel|mesh-list
25362751|NCT05281471|Docetaxel|docetaxel|mesh-list
25362752|NCT05281471|Bevacizumab|bevacizumab|mesh-list
25362753|NCT05281471|Cisplatin|cisplatin|mesh-list
25362754|NCT05281471|Carboplatin|carboplatin|mesh-list
25362755|NCT05281471|Doxorubicin|doxorubicin|mesh-list
25362756|NCT05281471|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25362757|NCT05281471|Taxane|taxane|mesh-list
25362758|NCT05281471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25362759|NCT05281471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362760|NCT05281471|Tubulin Modulators|tubulin modulators|mesh-ancestor
25362761|NCT05281471|Antimitotic Agents|antimitotic agents|mesh-ancestor
25362762|NCT05281471|Mitosis Modulators|mitosis modulators|mesh-ancestor
25362763|NCT05281471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362764|NCT05281471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25362765|NCT05281471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25362766|NCT05281471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25362767|NCT05281471|Growth Substances|growth substances|mesh-ancestor
25362768|NCT05281471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362769|NCT05281471|Growth Inhibitors|growth inhibitors|mesh-ancestor
25362770|NCT05281471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25362771|NCT05281471|Antimetabolites|antimetabolites|mesh-ancestor
25362772|NCT05281471|Antiviral Agents|antiviral agents|mesh-ancestor
25362773|NCT05281471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25362774|NCT05281471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25362775|NCT05281471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25362776|NCT05281471|Immunologic Factors|immunologic factors|mesh-ancestor
25362777|NCT05281471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25362778|NCT05281471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25362779|NCT05281471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25362780|NCT05281341|Hormones|hormones|mesh-list
25362781|NCT05281341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25362782|NCT05281341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362783|NCT05281328|Octreotide|octreotide|mesh-list
25362784|NCT05281328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25362785|NCT05281328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25362786|NCT05281328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362787|NCT05280769|Lobeline|lobeline|mesh-list
25362788|NCT05280769|Nicotine|nicotine|mesh-list
25362789|NCT05280769|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25362790|NCT05280769|Autonomic Agents|autonomic agents|mesh-ancestor
25362791|NCT05280769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25362792|NCT05280769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362793|NCT05280769|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25362794|NCT05280769|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25362795|NCT05280769|Cholinergic Agents|cholinergic agents|mesh-ancestor
25362796|NCT05280769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25362797|NCT05280769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362798|NCT05280769|Respiratory System Agents|respiratory system agents|mesh-ancestor
25362799|NCT05280496|Metformin|metformin|mesh-list
25362800|NCT05280496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25362801|NCT05280496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362802|NCT05280314|Pembrolizumab|pembrolizumab|mesh-list
25362803|NCT05280314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25362804|NCT05280314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362805|NCT05280223|Dexmedetomidine|dexmedetomidine|mesh-list
25362806|NCT05280223|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25362807|NCT05280223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25362808|NCT05280223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362809|NCT05280223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25362810|NCT05280223|Analgesics|analgesics|mesh-ancestor
25362811|NCT05280223|Sensory System Agents|sensory system agents|mesh-ancestor
25362812|NCT05280223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25362813|NCT05280223|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25362814|NCT05280223|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25362815|NCT05280223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25362816|NCT05280223|Adrenergic Agents|adrenergic agents|mesh-ancestor
25362817|NCT05280223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25362818|NCT05280223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362819|NCT05279937|Lidocaine|lidocaine|mesh-list
25362820|NCT05279937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25362821|NCT05279937|Anesthetics, Local|anesthetics, local|mesh-ancestor
25362822|NCT05279937|Anesthetics|anesthetics|mesh-ancestor
25362823|NCT05279937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25362824|NCT05279937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362825|NCT05279937|Sensory System Agents|sensory system agents|mesh-ancestor
25362826|NCT05279937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25362827|NCT05279937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25362828|NCT05279937|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25362829|NCT05279937|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25362830|NCT05279937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25362831|NCT05279937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362832|NCT05279807|Amlodipine|amlodipine|mesh-list
25362833|NCT05279807|Zofenopril|zofenopril|mesh-list
25362834|NCT05279807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25362835|NCT05279807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25362836|NCT05279807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25362837|NCT05279807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362838|NCT05279807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25362839|NCT05279807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362840|NCT05279807|Vasodilator Agents|vasodilator agents|mesh-ancestor
25362841|NCT05279807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25362842|NCT05279807|Protease Inhibitors|protease inhibitors|mesh-ancestor
25362843|NCT05279807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25362844|NCT05279742|Valsartan|valsartan|mesh-list
25362845|NCT05279742|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25362846|NCT05279742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25362847|NCT05279742|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25362848|NCT05279742|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25362849|NCT05279742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362850|NCT05279703|Epinephrine|epinephrine|mesh-list
25362851|NCT05279703|Racepinephrine|racepinephrine|mesh-list
25362852|NCT05279703|Epinephryl borate|epinephryl borate|mesh-list
25362853|NCT05279703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25362854|NCT05279703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25362855|NCT05279703|Adrenergic Agents|adrenergic agents|mesh-ancestor
25362856|NCT05279703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25362857|NCT05279703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362858|NCT05279703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362859|NCT05279703|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25362860|NCT05279703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25362861|NCT05279703|Autonomic Agents|autonomic agents|mesh-ancestor
25362862|NCT05279703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25362863|NCT05279703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25362864|NCT05279703|Respiratory System Agents|respiratory system agents|mesh-ancestor
25362865|NCT05279703|Mydriatics|mydriatics|mesh-ancestor
25362866|NCT05279703|Sympathomimetics|sympathomimetics|mesh-ancestor
25362867|NCT05279703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25362868|NCT05279456|Myeloma Proteins|myeloma proteins|mesh-list
25362869|NCT05279456|Paraproteins|paraproteins|mesh-list
25362870|NCT05279456|Immunologic Factors|immunologic factors|mesh-ancestor
25362871|NCT05279456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362872|NCT05279417|Methotrexate|methotrexate|mesh-list
25362873|NCT05279417|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25362874|NCT05279417|Abortifacient Agents|abortifacient agents|mesh-ancestor
25362875|NCT05279417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25362876|NCT05279417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362877|NCT05279417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25362878|NCT05279417|Antimetabolites|antimetabolites|mesh-ancestor
25362879|NCT05279417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362880|NCT05279417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362881|NCT05279417|Dermatologic Agents|dermatologic agents|mesh-ancestor
25362882|NCT05279417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25362883|NCT05279417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25362884|NCT05279417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25362885|NCT05279417|Immunologic Factors|immunologic factors|mesh-ancestor
25362886|NCT05279417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25362887|NCT05279417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25362888|NCT05279092|Dexamethasone|dexamethasone|mesh-list
25362889|NCT05279092|Methylprednisolone|methylprednisolone|mesh-list
25362890|NCT05279092|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25362891|NCT05279092|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25362892|NCT05279092|Prednisolone|prednisolone|mesh-list
25362894|NCT05279092|Dexamethasone acetate|dexamethasone acetate|mesh-list
25362895|NCT05279092|Bupivacaine|bupivacaine|mesh-list
25362896|NCT05279092|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25362897|NCT05279092|Prednisolone phosphate|prednisolone phosphate|mesh-list
25362898|NCT05279092|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25362899|NCT05279092|BB 1101|bb 1101|mesh-list
25362900|NCT05279092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25362901|NCT05279092|Antiemetics|antiemetics|mesh-ancestor
25362902|NCT05279092|Autonomic Agents|autonomic agents|mesh-ancestor
25362903|NCT05279092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25362904|NCT05279092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362905|NCT05279092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25362906|NCT05279092|Glucocorticoids|glucocorticoids|mesh-ancestor
25362907|NCT05279092|Hormones|hormones|mesh-ancestor
25362908|NCT05279092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25362909|NCT05279092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25362910|NCT05279092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362911|NCT05279092|Anesthetics, Local|anesthetics, local|mesh-ancestor
25362912|NCT05279092|Anesthetics|anesthetics|mesh-ancestor
25362913|NCT05279092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25362914|NCT05279092|Sensory System Agents|sensory system agents|mesh-ancestor
25362915|NCT05279092|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25362916|NCT05279092|Protective Agents|protective agents|mesh-ancestor
25362917|NCT05279092|Protease Inhibitors|protease inhibitors|mesh-ancestor
25362918|NCT05279092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25362919|NCT05279092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362920|NCT05278494|Dextromethorphan|dextromethorphan|mesh-list
25362921|NCT05278494|Antitussive Agents|antitussive agents|mesh-ancestor
25362922|NCT05278494|Respiratory System Agents|respiratory system agents|mesh-ancestor
25362923|NCT05278494|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25362924|NCT05278494|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25362925|NCT05278494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25362926|NCT05278494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362927|NCT05278494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362928|NCT05278208|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25362929|NCT05278208|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25362930|NCT05278208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362931|NCT05277896|Ketamine|ketamine|mesh-list
25362932|NCT05277896|Etomidate|etomidate|mesh-list
25362933|NCT05277896|Analgesics|analgesics|mesh-ancestor
25362934|NCT05277896|Sensory System Agents|sensory system agents|mesh-ancestor
25362935|NCT05277896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25362936|NCT05277896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362937|NCT05277896|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25362938|NCT05277896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25362939|NCT05277896|Anesthetics, General|anesthetics, general|mesh-ancestor
25362940|NCT05277896|Anesthetics|anesthetics|mesh-ancestor
25362941|NCT05277896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25362942|NCT05277896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25362943|NCT05277896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25362944|NCT05277896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25362945|NCT05277896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362946|NCT05277896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25362947|NCT05277337|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25362948|NCT05277337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25362949|NCT05277337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25362950|NCT05277337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362951|NCT05277337|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25362952|NCT05277337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25362953|NCT05277337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362954|NCT05277337|Cholinergic Agents|cholinergic agents|mesh-ancestor
25362955|NCT05277337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25362956|NCT05276973|Paclitaxel|paclitaxel|mesh-list
25362957|NCT05276973|Carboplatin|carboplatin|mesh-list
25362958|NCT05276973|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25362959|NCT05276973|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25362960|NCT05276973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25362961|NCT05276973|Tubulin Modulators|tubulin modulators|mesh-ancestor
25362962|NCT05276973|Antimitotic Agents|antimitotic agents|mesh-ancestor
25362963|NCT05276973|Mitosis Modulators|mitosis modulators|mesh-ancestor
25362964|NCT05276973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362965|NCT05276830|Dexmedetomidine|dexmedetomidine|mesh-list
25362966|NCT05276830|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25362967|NCT05276830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25362968|NCT05276830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362969|NCT05276830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25362970|NCT05276830|Analgesics|analgesics|mesh-ancestor
25362971|NCT05276830|Sensory System Agents|sensory system agents|mesh-ancestor
25362972|NCT05276830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25362973|NCT05276830|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25362974|NCT05276830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25362975|NCT05276830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25362976|NCT05276830|Adrenergic Agents|adrenergic agents|mesh-ancestor
25362977|NCT05276830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25362978|NCT05276830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362979|NCT05276531|Progesterone|progesterone|mesh-list
25362980|NCT05276531|Progestins|progestins|mesh-ancestor
25362981|NCT05276531|Hormones|hormones|mesh-ancestor
25362982|NCT05276531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25362983|NCT05276531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362984|NCT05275725|Sildenafil Citrate|sildenafil citrate|mesh-list
25362985|NCT05275725|Vasodilator Agents|vasodilator agents|mesh-ancestor
25362986|NCT05275725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25362987|NCT05275725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25362988|NCT05275725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25362989|NCT05275725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25362990|NCT05275725|Urological Agents|urological agents|mesh-ancestor
25362991|NCT05275686|Fluticasone|fluticasone|mesh-list
25362992|NCT05275686|Xhance|xhance|mesh-list
25362993|NCT05275686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25362994|NCT05275686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25362995|NCT05275686|Autonomic Agents|autonomic agents|mesh-ancestor
25362996|NCT05275686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25362997|NCT05275686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25362998|NCT05275686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25362999|NCT05275686|Respiratory System Agents|respiratory system agents|mesh-ancestor
25363000|NCT05275686|Dermatologic Agents|dermatologic agents|mesh-ancestor
25363001|NCT05275686|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25363002|NCT05275439|Azacitidine|azacitidine|mesh-list
25363003|NCT05275439|Venetoclax|venetoclax|mesh-list
25363004|NCT05275439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25363005|NCT05275439|Antimetabolites|antimetabolites|mesh-ancestor
25363006|NCT05275439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363007|NCT05275439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363008|NCT05275439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363009|NCT05275426|Gemcitabine|gemcitabine|mesh-list
25363010|NCT05275426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25363011|NCT05275426|Antimetabolites|antimetabolites|mesh-ancestor
25363012|NCT05275426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363013|NCT05275426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363014|NCT05275426|Antiviral Agents|antiviral agents|mesh-ancestor
25363015|NCT05275426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25363016|NCT05275426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363017|NCT05275426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25363018|NCT05275426|Immunologic Factors|immunologic factors|mesh-ancestor
25363019|NCT05275426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363020|NCT05275400|Insulin|insulin|mesh-list
25363021|NCT05275400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25363022|NCT05275400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363023|NCT05275374|Trametinib|trametinib|mesh-list
25363024|NCT05275374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363025|NCT05275374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25363026|NCT05275374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363027|NCT05275374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363028|NCT05275023|Tenofovir|tenofovir|mesh-list
25363029|NCT05275023|Entecavir|entecavir|mesh-list
25363030|NCT05275023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25363031|NCT05275023|Antiviral Agents|antiviral agents|mesh-ancestor
25363032|NCT05275023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25363033|NCT05275023|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25363034|NCT05275023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25363035|NCT05275023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363036|NCT05275023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363037|NCT05275023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25363038|NCT05275023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25363039|NCT05275023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363040|NCT05275010|Trastuzumab|trastuzumab|mesh-list
25363046|NCT05274477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25363047|NCT05274477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363053|NCT05273827|Paclitaxel|paclitaxel|mesh-list
25363054|NCT05273827|Pemetrexed|pemetrexed|mesh-list
25363055|NCT05273827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25363056|NCT05273827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363057|NCT05273827|Tubulin Modulators|tubulin modulators|mesh-ancestor
25363058|NCT05273827|Antimitotic Agents|antimitotic agents|mesh-ancestor
25363059|NCT05273827|Mitosis Modulators|mitosis modulators|mesh-ancestor
25363060|NCT05273827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363061|NCT05273827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363062|NCT05273827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25363063|NCT05273827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25363064|NCT05273710|Folic Acid|folic acid|mesh-list
25363065|NCT05273710|Hematinics|hematinics|mesh-ancestor
25363066|NCT05273710|Vitamin B Complex|vitamin b complex|mesh-ancestor
25363067|NCT05273710|Vitamins|vitamins|mesh-ancestor
25363068|NCT05273710|Micronutrients|micronutrients|mesh-ancestor
25363069|NCT05273710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363070|NCT05273554|Pembrolizumab|pembrolizumab|mesh-list
25363071|NCT05273554|Lenvatinib|lenvatinib|mesh-list
25363072|NCT05273554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25363073|NCT05273554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363074|NCT05273554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25363075|NCT05273554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363076|NCT05273554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363077|NCT05272969|Vitamin D|vitamin d|mesh-list
25363078|NCT05272969|Calcium|calcium|mesh-list
25363079|NCT05272969|Vitamins|vitamins|mesh-ancestor
25363080|NCT05272969|Micronutrients|micronutrients|mesh-ancestor
25363081|NCT05272969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363082|NCT05272969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25363083|NCT05272969|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25363084|NCT05272878|Irbesartan|irbesartan|mesh-list
25363085|NCT05272878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25363086|NCT05272878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25363087|NCT05272878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25363088|NCT05272878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363089|NCT05272605|Vaccines|vaccines|mesh-list
25363090|NCT05272605|Immunologic Factors|immunologic factors|mesh-ancestor
25363091|NCT05272605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363092|NCT05272254|Povidone-Iodine|povidone-iodine|mesh-list
25363093|NCT05272254|Povidone|povidone|mesh-list
25363094|NCT05272254|Plasma Substitutes|plasma substitutes|mesh-ancestor
25363095|NCT05272254|Blood Substitutes|blood substitutes|mesh-ancestor
25363096|NCT05272254|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25363097|NCT05272254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25363098|NCT05271630|Proteasome Inhibitors|proteasome inhibitors|mesh-list
25363099|NCT05271630|Protease Inhibitors|protease inhibitors|mesh-ancestor
25363100|NCT05271630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363101|NCT05271630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363102|NCT05271604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25363103|NCT05271604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363104|NCT05271604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363105|NCT05271552|Dexmedetomidine|dexmedetomidine|mesh-list
25363106|NCT05271552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25363107|NCT05271552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25363108|NCT05271552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363109|NCT05271552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25363110|NCT05271552|Analgesics|analgesics|mesh-ancestor
25363111|NCT05271552|Sensory System Agents|sensory system agents|mesh-ancestor
25363112|NCT05271552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25363113|NCT05271552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25363114|NCT05271552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25363115|NCT05271552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25363116|NCT05271552|Adrenergic Agents|adrenergic agents|mesh-ancestor
25363117|NCT05271552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25363118|NCT05271552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363120|NCT05271318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25363121|NCT05271318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363122|NCT05271292|Chiauranib|chiauranib|mesh-list
25363123|NCT05271292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363124|NCT05271292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25363125|NCT05271292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363126|NCT05271292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363127|NCT05271084|Pentoxifylline|pentoxifylline|mesh-list
25363128|NCT05271084|Dexetimide|dexetimide|mesh-list
25363129|NCT05271084|Citalopram|citalopram|mesh-list
25363130|NCT05271084|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25363131|NCT05271084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25363132|NCT05271084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25363133|NCT05271084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363134|NCT05271084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25363135|NCT05271084|Serotonin Agents|serotonin agents|mesh-ancestor
25363136|NCT05271084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363137|NCT05271084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25363138|NCT05271084|Antidepressive Agents|antidepressive agents|mesh-ancestor
25363139|NCT05271084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25363140|NCT05271084|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25363141|NCT05271084|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25363142|NCT05271084|Parasympatholytics|parasympatholytics|mesh-ancestor
25363143|NCT05271084|Autonomic Agents|autonomic agents|mesh-ancestor
25363144|NCT05271084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25363145|NCT05271084|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25363146|NCT05271084|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25363147|NCT05271084|Cholinergic Agents|cholinergic agents|mesh-ancestor
25363148|NCT05271084|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25363149|NCT05271084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363150|NCT05271084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25363151|NCT05271084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25363152|NCT05271084|Protective Agents|protective agents|mesh-ancestor
25363153|NCT05271084|Vasodilator Agents|vasodilator agents|mesh-ancestor
25363154|NCT05271084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25363156|NCT05270200|Azacitidine|azacitidine|mesh-list
25363157|NCT05270200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25363158|NCT05270200|Antimetabolites|antimetabolites|mesh-ancestor
25363159|NCT05270200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363160|NCT05270200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363161|NCT05270200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363162|NCT05269706|Cannabidiol|cannabidiol|mesh-list
25363163|NCT05269706|Anticonvulsants|anticonvulsants|mesh-ancestor
25363164|NCT05269355|Dacarbazine|dacarbazine|mesh-list
25363165|NCT05269355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25363166|NCT05269355|Alkylating Agents|alkylating agents|mesh-ancestor
25363167|NCT05269355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363168|NCT05269355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363169|NCT05269004|Ocrelizumab|ocrelizumab|mesh-list
25363170|NCT05269004|Immunologic Factors|immunologic factors|mesh-ancestor
25363171|NCT05269004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363172|NCT05268510|Pembrolizumab|pembrolizumab|mesh-list
25363173|NCT05268510|Olaparib|olaparib|mesh-list
25363174|NCT05268510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25363175|NCT05268510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363176|NCT05268510|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25363177|NCT05268510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363178|NCT05268510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363179|NCT05268497|Antidepressive Agents|antidepressive agents|mesh-list
25363180|NCT05268497|Esketamine|esketamine|mesh-list
25363181|NCT05268497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25363182|NCT05268120|Doxycycline|doxycycline|mesh-list
25363183|NCT05268120|Rifampin|rifampin|mesh-list
25363184|NCT05268120|Trimethoprim|trimethoprim|mesh-list
25363185|NCT05268120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25363186|NCT05268120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25363187|NCT05268120|Antimalarials|antimalarials|mesh-ancestor
25363188|NCT05268120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25363189|NCT05268120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25363190|NCT05268120|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25363191|NCT05268120|Antitubercular Agents|antitubercular agents|mesh-ancestor
25363192|NCT05268120|Leprostatic Agents|leprostatic agents|mesh-ancestor
25363193|NCT05268120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25363194|NCT05268120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363195|NCT05268120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363196|NCT05268120|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25363197|NCT05268120|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25363198|NCT05268120|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25363199|NCT05268120|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25363200|NCT05268120|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25363201|NCT05268120|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25363202|NCT05268120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25363203|NCT05268120|Renal Agents|renal agents|mesh-ancestor
25363204|NCT05268120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25363205|NCT05268120|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25363206|NCT05268120|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
25363207|NCT05268120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25363209|NCT05268003|Ponatinib|ponatinib|mesh-list
25363210|NCT05268003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363211|NCT05268003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25363212|NCT05268003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363213|NCT05268003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363214|NCT05267743|Lansoprazole|lansoprazole|mesh-list
25363215|NCT05267743|Dexlansoprazole|dexlansoprazole|mesh-list
25363216|NCT05267743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25363217|NCT05267743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25363218|NCT05267743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25363219|NCT05267743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363220|NCT05267743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363221|NCT05267626|Aldesleukin|aldesleukin|mesh-list
25363222|NCT05267626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363223|NCT05267626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25363224|NCT05267626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25363225|NCT05267626|Antiviral Agents|antiviral agents|mesh-ancestor
25363226|NCT05267626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25363227|NCT05267613|Esomeprazole|esomeprazole|mesh-list
25363228|NCT05267613|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25363229|NCT05267613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25363230|NCT05267613|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25363231|NCT05267613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363232|NCT05267613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363233|NCT05267600|Prednisone|prednisone|mesh-list
25363234|NCT05267600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25363235|NCT05267600|Glucocorticoids|glucocorticoids|mesh-ancestor
25363236|NCT05267600|Hormones|hormones|mesh-ancestor
25363237|NCT05267600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25363238|NCT05267600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363239|NCT05267600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25363240|NCT05267600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363241|NCT05267470|Docetaxel|docetaxel|mesh-list
25363242|NCT05267470|Bemarituzumab|bemarituzumab|mesh-list
25363243|NCT05267470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363244|NCT05267470|Tubulin Modulators|tubulin modulators|mesh-ancestor
25363245|NCT05267470|Antimitotic Agents|antimitotic agents|mesh-ancestor
25363246|NCT05267470|Mitosis Modulators|mitosis modulators|mesh-ancestor
25363247|NCT05267470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363248|NCT05267470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25363249|NCT05266924|Hormones|hormones|mesh-list
25363250|NCT05266924|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25363251|NCT05266924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25363252|NCT05266924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363253|NCT05266859|Calcium|calcium|mesh-list
25363254|NCT05266859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25363255|NCT05266859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363256|NCT05266846|Bevacizumab|bevacizumab|mesh-list
25363257|NCT05266846|Pembrolizumab|pembrolizumab|mesh-list
25363258|NCT05266846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25363259|NCT05266846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363260|NCT05266846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25363261|NCT05266846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25363262|NCT05266846|Growth Substances|growth substances|mesh-ancestor
25363263|NCT05266846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363264|NCT05266846|Growth Inhibitors|growth inhibitors|mesh-ancestor
25363265|NCT05266807|Vancomycin|vancomycin|mesh-list
25363269|NCT05266729|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
25363271|NCT05266729|Antimetabolites|antimetabolites|mesh-ancestor
25363272|NCT05266729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363273|NCT05266729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25363274|NCT05266469|Ofatumumab|ofatumumab|mesh-list
25363275|NCT05266469|Ocrelizumab|ocrelizumab|mesh-list
25363276|NCT05266469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363277|NCT05266469|Immunologic Factors|immunologic factors|mesh-ancestor
25363278|NCT05266469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363279|NCT05266456|Vaccines|vaccines|mesh-list
25363280|NCT05266456|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25363281|NCT05266456|Immunologic Factors|immunologic factors|mesh-ancestor
25363282|NCT05266456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363283|NCT05266066|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25363284|NCT05266066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25363285|NCT05266066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25363286|NCT05266066|Antitubercular Agents|antitubercular agents|mesh-ancestor
25363288|NCT05265975|Lenalidomide|lenalidomide|mesh-list
25363289|NCT05265975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25363290|NCT05265975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363291|NCT05265975|Immunologic Factors|immunologic factors|mesh-ancestor
25363292|NCT05265975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363293|NCT05265975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25363294|NCT05265975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25363295|NCT05265975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25363296|NCT05265975|Growth Substances|growth substances|mesh-ancestor
25363297|NCT05265975|Growth Inhibitors|growth inhibitors|mesh-ancestor
25363298|NCT05265728|Natalizumab|natalizumab|mesh-list
25363299|NCT05265728|Immunologic Factors|immunologic factors|mesh-ancestor
25363300|NCT05265728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363301|NCT05265546|Psilocybin|psilocybin|mesh-list
25363302|NCT05265546|Hallucinogens|hallucinogens|mesh-ancestor
25363303|NCT05265546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363304|NCT05265546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25363305|NCT05265247|Esomeprazole|esomeprazole|mesh-list
25363306|NCT05265247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25363307|NCT05265247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25363308|NCT05265247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25363309|NCT05265247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363310|NCT05265247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363311|NCT05265208|Capecitabine|capecitabine|mesh-list
25363312|NCT05265208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25363313|NCT05265208|Antimetabolites|antimetabolites|mesh-ancestor
25363314|NCT05265208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363315|NCT05265208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363319|NCT05264870|Norepinephrine|norepinephrine|mesh-list
25363320|NCT05264870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25363321|NCT05264870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25363322|NCT05264870|Adrenergic Agents|adrenergic agents|mesh-ancestor
25363323|NCT05264870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25363324|NCT05264870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363325|NCT05264870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363326|NCT05264870|Sympathomimetics|sympathomimetics|mesh-ancestor
25363327|NCT05264870|Autonomic Agents|autonomic agents|mesh-ancestor
25363328|NCT05264870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25363329|NCT05264870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25363330|NCT05264025|Fexofenadine|fexofenadine|mesh-list
25363331|NCT05264025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25363332|NCT05264025|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25363333|NCT05264025|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25363334|NCT05264025|Histamine Antagonists|histamine antagonists|mesh-ancestor
25363335|NCT05264025|Histamine Agents|histamine agents|mesh-ancestor
25363336|NCT05264025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25363337|NCT05264025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363338|NCT05264025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363339|NCT05263609|Pembrolizumab|pembrolizumab|mesh-list
25363340|NCT05263609|Axitinib|axitinib|mesh-list
25363341|NCT05263609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25363342|NCT05263609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363343|NCT05263609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25363344|NCT05263609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363345|NCT05263609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363346|NCT05263388|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25363347|NCT05263388|Hormones|hormones|mesh-ancestor
25363348|NCT05263388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25363349|NCT05263388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363350|NCT05263284|Venetoclax|venetoclax|mesh-list
25363351|NCT05263284|Adenosine|adenosine|mesh-list
25363352|NCT05263284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363353|NCT05263284|Analgesics|analgesics|mesh-ancestor
25363354|NCT05263284|Sensory System Agents|sensory system agents|mesh-ancestor
25363355|NCT05263284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25363356|NCT05263284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363357|NCT05263284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25363358|NCT05263284|Vasodilator Agents|vasodilator agents|mesh-ancestor
25363359|NCT05263284|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
25363360|NCT05263284|Purinergic Agonists|purinergic agonists|mesh-ancestor
25363361|NCT05263284|Purinergic Agents|purinergic agents|mesh-ancestor
25363362|NCT05263284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25363363|NCT05263284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363364|NCT05263206|Loratadine|loratadine|mesh-list
25363365|NCT05263206|Fexofenadine|fexofenadine|mesh-list
25363366|NCT05263206|Antipruritics|antipruritics|mesh-ancestor
25363367|NCT05263206|Dermatologic Agents|dermatologic agents|mesh-ancestor
25363368|NCT05263206|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25363369|NCT05263206|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25363370|NCT05263206|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25363371|NCT05263206|Histamine Antagonists|histamine antagonists|mesh-ancestor
25363372|NCT05263206|Histamine Agents|histamine agents|mesh-ancestor
25363373|NCT05263206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25363374|NCT05263206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363375|NCT05263206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363376|NCT05262855|FAPI-46|fapi-46|mesh-list
25363377|NCT05262855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25363378|NCT05262855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363379|NCT05262777|Lidocaine|lidocaine|mesh-list
25363380|NCT05262777|Anesthetics, Local|anesthetics, local|mesh-ancestor
25363381|NCT05262777|Anesthetics|anesthetics|mesh-ancestor
25363382|NCT05262777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25363383|NCT05262777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363384|NCT05262777|Sensory System Agents|sensory system agents|mesh-ancestor
25363385|NCT05262777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25363386|NCT05262777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25363387|NCT05262777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25363388|NCT05262777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25363389|NCT05262777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25363390|NCT05262777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363391|NCT05262764|Empagliflozin|empagliflozin|mesh-list
25363392|NCT05262764|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25363393|NCT05262764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363394|NCT05262764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25363395|NCT05262764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363397|NCT05262751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363398|NCT05262751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25363399|NCT05262751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363400|NCT05262751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363401|NCT05262556|Nivolumab|nivolumab|mesh-list
25363402|NCT05262556|Ipilimumab|ipilimumab|mesh-list
25363403|NCT05262556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25363404|NCT05262556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363405|NCT05262556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25363406|NCT05262556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363407|NCT05262400|Letrozole|letrozole|mesh-list
25363408|NCT05262400|Fulvestrant|fulvestrant|mesh-list
25363409|NCT05262400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363410|NCT05262400|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25363411|NCT05262400|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25363412|NCT05262400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363413|NCT05262400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363414|NCT05262400|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25363415|NCT05262400|Hormone Antagonists|hormone antagonists|mesh-ancestor
25363416|NCT05262400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25363417|NCT05262400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363418|NCT05262400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25363419|NCT05262400|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25363420|NCT05262387|Insulin Lispro|insulin lispro|mesh-list
25363421|NCT05262387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25363422|NCT05262387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363423|NCT05262270|Naltrexone|naltrexone|mesh-list
25363424|NCT05262270|Buprenorphine|buprenorphine|mesh-list
25363425|NCT05262270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25363426|NCT05262270|Narcotics|narcotics|mesh-ancestor
25363427|NCT05262270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25363428|NCT05262270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363429|NCT05262270|Analgesics|analgesics|mesh-ancestor
25363430|NCT05262270|Sensory System Agents|sensory system agents|mesh-ancestor
25363431|NCT05262270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25363432|NCT05262270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25363433|NCT05262270|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25363434|NCT05261490|Doxorubicin|doxorubicin|mesh-list
25363435|NCT05261490|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25363436|NCT05261490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25363437|NCT05261490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363438|NCT05261490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25363439|NCT05261490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25363440|NCT05261490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363441|NCT05261490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363442|NCT05261399|Cisplatin|cisplatin|mesh-list
25363443|NCT05261399|Carboplatin|carboplatin|mesh-list
25363444|NCT05261399|Pemetrexed|pemetrexed|mesh-list
25363445|NCT05261399|Osimertinib|osimertinib|mesh-list
25363446|NCT05261399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363447|NCT05261399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363448|NCT05261399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363449|NCT05261399|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25363450|NCT05261399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25363451|NCT05261399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25363452|NCT05261269|Niraparib|niraparib|mesh-list
25363453|NCT05261269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25363454|NCT05261269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363455|NCT05261269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363456|NCT05261269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363457|NCT05261139|Ritonavir|ritonavir|mesh-list
25363458|NCT05261139|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25363459|NCT05261139|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25363460|NCT05261139|Protease Inhibitors|protease inhibitors|mesh-ancestor
25363461|NCT05261139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363462|NCT05261139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363463|NCT05261139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25363464|NCT05261139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25363465|NCT05261139|Antiviral Agents|antiviral agents|mesh-ancestor
25363466|NCT05261139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25363467|NCT05261139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25363468|NCT05261139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25363470|NCT05260359|Sunscreening Agents|sunscreening agents|mesh-list
25363471|NCT05260359|Petrolatum|petrolatum|mesh-list
25363472|NCT05260359|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25363473|NCT05260359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25363474|NCT05260359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25363475|NCT05260359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363476|NCT05260359|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25363477|NCT05260359|Protective Agents|protective agents|mesh-ancestor
25363478|NCT05260359|Dermatologic Agents|dermatologic agents|mesh-ancestor
25363479|NCT05260359|Emollients|emollients|mesh-ancestor
25363480|NCT05260320|Anesthetics|anesthetics|mesh-list
25363481|NCT05260320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25363482|NCT05260320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363483|NCT05260021|Tirzepatide|tirzepatide|mesh-list
25363484|NCT05260021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25363485|NCT05260021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363486|NCT05260021|Incretins|incretins|mesh-ancestor
25363487|NCT05260021|Hormones|hormones|mesh-ancestor
25363488|NCT05260021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25363489|NCT05260008|Epinephrine|epinephrine|mesh-list
25363490|NCT05260008|Bupivacaine|bupivacaine|mesh-list
25363491|NCT05260008|Anesthetics, Local|anesthetics, local|mesh-ancestor
25363493|NCT05260008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25363494|NCT05260008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363495|NCT05260008|Sensory System Agents|sensory system agents|mesh-ancestor
25363496|NCT05260008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25363497|NCT05260008|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25363498|NCT05260008|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25363499|NCT05260008|Adrenergic Agents|adrenergic agents|mesh-ancestor
25363500|NCT05260008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25363501|NCT05260008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363502|NCT05260008|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25363503|NCT05260008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25363504|NCT05260008|Autonomic Agents|autonomic agents|mesh-ancestor
25363505|NCT05260008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25363506|NCT05260008|Respiratory System Agents|respiratory system agents|mesh-ancestor
25363507|NCT05260008|Mydriatics|mydriatics|mesh-ancestor
25363508|NCT05260008|Sympathomimetics|sympathomimetics|mesh-ancestor
25363509|NCT05260008|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25363510|NCT05259800|Peppermint oil|peppermint oil|mesh-list
25363511|NCT05259800|Mineral Oil|mineral oil|mesh-list
25363512|NCT05259800|Antiemetics|antiemetics|mesh-ancestor
25363513|NCT05259800|Autonomic Agents|autonomic agents|mesh-ancestor
25363514|NCT05259800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25363515|NCT05259800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363516|NCT05259800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25363517|NCT05259800|Parasympatholytics|parasympatholytics|mesh-ancestor
25363518|NCT05259800|Emollients|emollients|mesh-ancestor
25363519|NCT05259800|Dermatologic Agents|dermatologic agents|mesh-ancestor
25363520|NCT05259722|Alitretinoin|alitretinoin|mesh-list
25363521|NCT05259722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363522|NCT05259722|Dermatologic Agents|dermatologic agents|mesh-ancestor
25363523|NCT05259709|Cemiplimab|cemiplimab|mesh-list
25363524|NCT05259709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25363525|NCT05259709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363526|NCT05259696|Pembrolizumab|pembrolizumab|mesh-list
25363527|NCT05259696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25363528|NCT05259696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363529|NCT05259566|Menthol|menthol|mesh-list
25363530|NCT05259566|Antipruritics|antipruritics|mesh-ancestor
25363531|NCT05259566|Dermatologic Agents|dermatologic agents|mesh-ancestor
25363532|NCT05259241|Thrombin|thrombin|mesh-list
25363533|NCT05259241|Hemostatics|hemostatics|mesh-ancestor
25363534|NCT05259241|Coagulants|coagulants|mesh-ancestor
25363535|NCT05258292|Insulin|insulin|mesh-list
25363536|NCT05258292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25363537|NCT05258292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363538|NCT05257655|Analgesics, Opioid|analgesics, opioid|mesh-list
25363539|NCT05257655|Narcotics|narcotics|mesh-ancestor
25363540|NCT05257655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25363541|NCT05257655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363542|NCT05257655|Analgesics|analgesics|mesh-ancestor
25363543|NCT05257655|Sensory System Agents|sensory system agents|mesh-ancestor
25363544|NCT05257655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25363545|NCT05257083|Dexamethasone|dexamethasone|mesh-list
25363546|NCT05257083|Cyclophosphamide|cyclophosphamide|mesh-list
25363547|NCT05257083|Fludarabine|fludarabine|mesh-list
25363548|NCT05257083|Lenalidomide|lenalidomide|mesh-list
25363549|NCT05257083|Bortezomib|bortezomib|mesh-list
25363550|NCT05257083|Daratumumab|daratumumab|mesh-list
25363551|NCT05257083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25363552|NCT05257083|Immunologic Factors|immunologic factors|mesh-ancestor
25363553|NCT05257083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363554|NCT05257083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25363555|NCT05257083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25363556|NCT05257083|Alkylating Agents|alkylating agents|mesh-ancestor
25363557|NCT05257083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363558|NCT05257083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363559|NCT05257083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25363560|NCT05257083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25363561|NCT05257083|Antiemetics|antiemetics|mesh-ancestor
25363562|NCT05257083|Autonomic Agents|autonomic agents|mesh-ancestor
25363563|NCT05257083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25363564|NCT05257083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25363565|NCT05257083|Glucocorticoids|glucocorticoids|mesh-ancestor
25363566|NCT05257083|Hormones|hormones|mesh-ancestor
25363567|NCT05257083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25363568|NCT05257083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25363569|NCT05257083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25363570|NCT05257083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25363571|NCT05257083|Growth Substances|growth substances|mesh-ancestor
25363572|NCT05257083|Growth Inhibitors|growth inhibitors|mesh-ancestor
25363573|NCT05256901|Glycopyrrolate|glycopyrrolate|mesh-list
25363574|NCT05256901|Neostigmine|neostigmine|mesh-list
25363575|NCT05256901|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25363576|NCT05256901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363577|NCT05256901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363578|NCT05256901|Cholinergic Agents|cholinergic agents|mesh-ancestor
25363579|NCT05256901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25363580|NCT05256901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363581|NCT05256901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25363582|NCT05256901|Autonomic Agents|autonomic agents|mesh-ancestor
25363583|NCT05256901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25363584|NCT05256901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25363585|NCT05256901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25363586|NCT05256901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25363588|NCT05256823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25363589|NCT05256823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25363590|NCT05256823|Analgesics|analgesics|mesh-ancestor
25363591|NCT05256823|Sensory System Agents|sensory system agents|mesh-ancestor
25363592|NCT05256823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25363593|NCT05256823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363594|NCT05256823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25363595|NCT05256823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25363596|NCT05256823|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25363597|NCT05256823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25363598|NCT05256823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363599|NCT05256823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363600|NCT05256641|Acalabrutinib|acalabrutinib|mesh-list
25363601|NCT05256641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363602|NCT05256381|Pembrolizumab|pembrolizumab|mesh-list
25363603|NCT05256381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25363604|NCT05256381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363605|NCT05256264|Ketamine|ketamine|mesh-list
25363606|NCT05256264|Analgesics|analgesics|mesh-ancestor
25363607|NCT05256264|Sensory System Agents|sensory system agents|mesh-ancestor
25363608|NCT05256264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25363609|NCT05256264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363610|NCT05256264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25363611|NCT05256264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25363612|NCT05256264|Anesthetics, General|anesthetics, general|mesh-ancestor
25363613|NCT05256264|Anesthetics|anesthetics|mesh-ancestor
25363614|NCT05256264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25363615|NCT05256264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25363616|NCT05256264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25363617|NCT05256264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25363618|NCT05256264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363619|NCT05256225|Paclitaxel|paclitaxel|mesh-list
25363620|NCT05256225|Carboplatin|carboplatin|mesh-list
25363621|NCT05256225|Trastuzumab|trastuzumab|mesh-list
25363622|NCT05256225|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25363623|NCT05256225|Pertuzumab|pertuzumab|mesh-list
25363624|NCT05256225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25363625|NCT05256225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363626|NCT05256225|Tubulin Modulators|tubulin modulators|mesh-ancestor
25363627|NCT05256225|Antimitotic Agents|antimitotic agents|mesh-ancestor
25363628|NCT05256225|Mitosis Modulators|mitosis modulators|mesh-ancestor
25363629|NCT05256225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363630|NCT05256225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25363631|NCT05256108|Oxycodone|oxycodone|mesh-list
25363632|NCT05256108|Tramadol|tramadol|mesh-list
25363633|NCT05256108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25363634|NCT05256108|Narcotics|narcotics|mesh-ancestor
25363635|NCT05256108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25363636|NCT05256108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363637|NCT05256108|Analgesics|analgesics|mesh-ancestor
25363638|NCT05256108|Sensory System Agents|sensory system agents|mesh-ancestor
25363639|NCT05256108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25363640|NCT05255770|Benzocaine|benzocaine|mesh-list
25363641|NCT05255770|Anesthetics, Local|anesthetics, local|mesh-ancestor
25363642|NCT05255770|Anesthetics|anesthetics|mesh-ancestor
25363643|NCT05255770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25363644|NCT05255770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363645|NCT05255770|Sensory System Agents|sensory system agents|mesh-ancestor
25363646|NCT05255770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25363647|NCT05255653|Cisplatin|cisplatin|mesh-list
25363648|NCT05255653|Carboplatin|carboplatin|mesh-list
25363649|NCT05255653|Durvalumab|durvalumab|mesh-list
25363650|NCT05255653|Olaparib|olaparib|mesh-list
25363651|NCT05255653|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25363652|NCT05255653|Megestrol|megestrol|mesh-list
25363653|NCT05255653|Megestrol Acetate|megestrol acetate|mesh-list
25363654|NCT05255653|Medroxyprogesterone|medroxyprogesterone|mesh-list
25363655|NCT05255653|Progestins|progestins|mesh-list
25363656|NCT05255653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363657|NCT05255653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363658|NCT05255653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25363659|NCT05255653|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25363660|NCT05255653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363661|NCT05255653|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25363662|NCT05255653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25363663|NCT05255653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25363664|NCT05255653|Contraceptive Agents|contraceptive agents|mesh-ancestor
25363665|NCT05255653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25363666|NCT05255653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363667|NCT05255653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25363668|NCT05255653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25363669|NCT05255653|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25363670|NCT05255653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25363671|NCT05255653|Appetite Stimulants|appetite stimulants|mesh-ancestor
25363672|NCT05255653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25363673|NCT05255653|Hormones|hormones|mesh-ancestor
25363674|NCT05255653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25363675|NCT05255601|Nivolumab|nivolumab|mesh-list
25363676|NCT05255601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25363677|NCT05255601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363678|NCT05255601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25363679|NCT05255601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363680|NCT05255406|Aflutinib|aflutinib|mesh-list
25363681|NCT05255406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25363682|NCT05255406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363683|NCT05255406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363684|NCT05255302|Pembrolizumab|pembrolizumab|mesh-list
25363685|NCT05255302|Pemetrexed|pemetrexed|mesh-list
25363686|NCT05255302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25363687|NCT05255302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363688|NCT05255302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363689|NCT05255302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363690|NCT05255302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25363691|NCT05255302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25363692|NCT05255276|Itraconazole|itraconazole|mesh-list
25363693|NCT05255276|Rifampin|rifampin|mesh-list
25363694|NCT05255276|Antifungal Agents|antifungal agents|mesh-ancestor
25363695|NCT05255276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25363696|NCT05255276|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25363697|NCT05255276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25363698|NCT05255276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363699|NCT05255276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363700|NCT05255276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25363701|NCT05255276|Hormone Antagonists|hormone antagonists|mesh-ancestor
25363702|NCT05255276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25363703|NCT05255276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363704|NCT05255276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25363705|NCT05255276|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25363706|NCT05255276|Antitubercular Agents|antitubercular agents|mesh-ancestor
25363707|NCT05255276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25363708|NCT05255276|Leprostatic Agents|leprostatic agents|mesh-ancestor
25363709|NCT05255276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25363710|NCT05255276|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25363711|NCT05255276|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25363712|NCT05255276|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25363713|NCT05255276|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25363714|NCT05255276|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25363715|NCT05255276|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25363716|NCT05255159|Furosemide|furosemide|mesh-list
25363717|NCT05255159|Diuretics|diuretics|mesh-ancestor
25395807|NCT04075604|Nivolumab|nivolumab|mesh-list
25363718|NCT05255159|Natriuretic Agents|natriuretic agents|mesh-ancestor
25363719|NCT05255159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363720|NCT05255159|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25363721|NCT05255159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25363722|NCT05255159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363723|NCT05255146|Nitrous Oxide|nitrous oxide|mesh-list
25363724|NCT05255146|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25363725|NCT05255146|Anesthetics, General|anesthetics, general|mesh-ancestor
25363726|NCT05255146|Anesthetics|anesthetics|mesh-ancestor
25363727|NCT05255146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25363728|NCT05255146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363729|NCT05255146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25363730|NCT05255146|Analgesics|analgesics|mesh-ancestor
25364265|NCT05245071|Antimitotic Agents|antimitotic agents|mesh-ancestor
25363731|NCT05255146|Sensory System Agents|sensory system agents|mesh-ancestor
25363732|NCT05255146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25363733|NCT05255003|Enoxaparin|enoxaparin|mesh-list
25363734|NCT05255003|Dalteparin|dalteparin|mesh-list
25363735|NCT05255003|Tinzaparin|tinzaparin|mesh-list
25363736|NCT05255003|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25363737|NCT05255003|Anticoagulants|anticoagulants|mesh-ancestor
25363738|NCT05255003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25363739|NCT05255003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25363740|NCT05255003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363741|NCT05254925|Sunscreening Agents|sunscreening agents|mesh-list
25363742|NCT05254925|Petrolatum|petrolatum|mesh-list
25363743|NCT05254925|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25363744|NCT05254925|Protective Agents|protective agents|mesh-ancestor
25363745|NCT05254925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363746|NCT05254925|Dermatologic Agents|dermatologic agents|mesh-ancestor
25363747|NCT05254925|Emollients|emollients|mesh-ancestor
25363748|NCT05254912|Sunscreening Agents|sunscreening agents|mesh-list
25363749|NCT05254912|Petrolatum|petrolatum|mesh-list
25363750|NCT05254912|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25363751|NCT05254912|Protective Agents|protective agents|mesh-ancestor
25363752|NCT05254912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363753|NCT05254912|Dermatologic Agents|dermatologic agents|mesh-ancestor
25363754|NCT05254912|Emollients|emollients|mesh-ancestor
25363755|NCT05254626|Pioglitazone|pioglitazone|mesh-list
25363756|NCT05254626|Dapagliflozin|dapagliflozin|mesh-list
25363757|NCT05254626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25363758|NCT05254626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363759|NCT05254626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25363760|NCT05254626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363761|NCT05254236|Vaccines|vaccines|mesh-list
25363762|NCT05254236|Immunologic Factors|immunologic factors|mesh-ancestor
25363763|NCT05254236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363764|NCT05254184|Nivolumab|nivolumab|mesh-list
25363765|NCT05254184|Ipilimumab|ipilimumab|mesh-list
25363766|NCT05254184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25363767|NCT05254184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363768|NCT05254184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25363845|NCT05253651|Antidotes|antidotes|mesh-ancestor
25363769|NCT05254184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363770|NCT05254171|Gemcitabine|gemcitabine|mesh-list
25363771|NCT05254171|Paclitaxel|paclitaxel|mesh-list
25363772|NCT05254171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25363773|NCT05254171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363774|NCT05254171|Tubulin Modulators|tubulin modulators|mesh-ancestor
25363775|NCT05254171|Antimitotic Agents|antimitotic agents|mesh-ancestor
25363776|NCT05254171|Mitosis Modulators|mitosis modulators|mesh-ancestor
25363777|NCT05254171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363778|NCT05254171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25363779|NCT05254171|Antimetabolites|antimetabolites|mesh-ancestor
25363780|NCT05254171|Antiviral Agents|antiviral agents|mesh-ancestor
25363781|NCT05254171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25363782|NCT05254171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363783|NCT05254171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25363784|NCT05254171|Immunologic Factors|immunologic factors|mesh-ancestor
25363785|NCT05254171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363786|NCT05254002|Empagliflozin|empagliflozin|mesh-list
25363787|NCT05254002|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25363788|NCT05254002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363789|NCT05254002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25724228|NCT02535806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25363790|NCT05254002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363791|NCT05253937|Epinephrine|epinephrine|mesh-list
25363792|NCT05253937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25363793|NCT05253937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25363794|NCT05253937|Adrenergic Agents|adrenergic agents|mesh-ancestor
25363795|NCT05253937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25363796|NCT05253937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363797|NCT05253937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363798|NCT05253937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25363799|NCT05253937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25363800|NCT05253937|Autonomic Agents|autonomic agents|mesh-ancestor
25363801|NCT05253937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25363802|NCT05253937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25363803|NCT05253937|Respiratory System Agents|respiratory system agents|mesh-ancestor
25363804|NCT05253937|Mydriatics|mydriatics|mesh-ancestor
25363805|NCT05253937|Sympathomimetics|sympathomimetics|mesh-ancestor
25363806|NCT05253937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25363807|NCT05253833|Allopurinol|allopurinol|mesh-list
25363808|NCT05253833|Antimetabolites|antimetabolites|mesh-ancestor
25363809|NCT05253833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363810|NCT05253833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363811|NCT05253833|Gout Suppressants|gout suppressants|mesh-ancestor
25363812|NCT05253833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25363813|NCT05253833|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25363814|NCT05253833|Antioxidants|antioxidants|mesh-ancestor
25363815|NCT05253833|Protective Agents|protective agents|mesh-ancestor
25363816|NCT05253833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363818|NCT05253794|Gout Suppressants|gout suppressants|mesh-ancestor
25363819|NCT05253794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25363820|NCT05253794|Tubulin Modulators|tubulin modulators|mesh-ancestor
25363821|NCT05253794|Antimitotic Agents|antimitotic agents|mesh-ancestor
25363822|NCT05253794|Mitosis Modulators|mitosis modulators|mesh-ancestor
25363823|NCT05253794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363824|NCT05253794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363825|NCT05253651|Leucovorin|leucovorin|mesh-list
25363826|NCT05253651|Bevacizumab|bevacizumab|mesh-list
25363827|NCT05253651|Trastuzumab|trastuzumab|mesh-list
25363828|NCT05253651|Cetuximab|cetuximab|mesh-list
25363829|NCT05253651|Fluorouracil|fluorouracil|mesh-list
25363830|NCT05253651|Oxaliplatin|oxaliplatin|mesh-list
25363831|NCT05253651|Tucatinib|tucatinib|mesh-list
25363832|NCT05253651|Levoleucovorin|levoleucovorin|mesh-list
25363833|NCT05253651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25363834|NCT05253651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363835|NCT05253651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25363836|NCT05253651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25363837|NCT05253651|Growth Substances|growth substances|mesh-ancestor
25363838|NCT05253651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363839|NCT05253651|Growth Inhibitors|growth inhibitors|mesh-ancestor
25363840|NCT05253651|Antimetabolites|antimetabolites|mesh-ancestor
25363841|NCT05253651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363842|NCT05253651|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25363843|NCT05253651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25363844|NCT05253651|Immunologic Factors|immunologic factors|mesh-ancestor
25363846|NCT05253651|Protective Agents|protective agents|mesh-ancestor
25363847|NCT05253651|Vitamin B Complex|vitamin b complex|mesh-ancestor
25363848|NCT05253651|Vitamins|vitamins|mesh-ancestor
25363849|NCT05253651|Micronutrients|micronutrients|mesh-ancestor
25363850|NCT05253651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25363851|NCT05253651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363852|NCT05253209|Plasma-lyte 148|plasma-lyte 148|mesh-list
25363853|NCT05253209|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25363854|NCT05253209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25363855|NCT05253053|Paclitaxel|paclitaxel|mesh-list
25363856|NCT05253053|Atezolizumab|atezolizumab|mesh-list
25363857|NCT05253053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25363858|NCT05253053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363859|NCT05253053|Tubulin Modulators|tubulin modulators|mesh-ancestor
25363860|NCT05253053|Antimitotic Agents|antimitotic agents|mesh-ancestor
25363861|NCT05253053|Mitosis Modulators|mitosis modulators|mesh-ancestor
25363862|NCT05253053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363863|NCT05252988|Loperamide|loperamide|mesh-list
25363864|NCT05252988|Antidiarrheals|antidiarrheals|mesh-list
25363865|NCT05252988|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
25363866|NCT05252988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25363867|NCT05252988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25363868|NCT05252988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25395954|NCT04072445|Irinotecan|irinotecan|mesh-list
25363869|NCT05252988|Antimetabolites|antimetabolites|mesh-ancestor
25363870|NCT05252988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363871|NCT05252988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25363872|NCT05252754|Indomethacin|indomethacin|mesh-list
25363873|NCT05252754|Tacrolimus|tacrolimus|mesh-list
25363874|NCT05252754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25363875|NCT05252754|Immunologic Factors|immunologic factors|mesh-ancestor
25363876|NCT05252754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363877|NCT05252754|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25363878|NCT05252754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363879|NCT05252754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363880|NCT05252754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25363881|NCT05252754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25363882|NCT05252754|Analgesics|analgesics|mesh-ancestor
25363883|NCT05252754|Sensory System Agents|sensory system agents|mesh-ancestor
25363884|NCT05252754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25363885|NCT05252754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25363886|NCT05252754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25363887|NCT05252754|Gout Suppressants|gout suppressants|mesh-ancestor
25363888|NCT05252754|Tocolytic Agents|tocolytic agents|mesh-ancestor
25363889|NCT05252754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25363890|NCT05252754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25363891|NCT05252598|Psilocybin|psilocybin|mesh-list
25363892|NCT05252598|Hallucinogens|hallucinogens|mesh-ancestor
25363893|NCT05252598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363894|NCT05252598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25363895|NCT05252585|Everolimus|everolimus|mesh-list
25363896|NCT05252585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363897|NCT05252585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25363898|NCT05252585|Immunologic Factors|immunologic factors|mesh-ancestor
25363899|NCT05252585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363900|NCT05252533|Ustekinumab|ustekinumab|mesh-list
25363901|NCT05252533|Dermatologic Agents|dermatologic agents|mesh-ancestor
25363902|NCT05252429|Docetaxel|docetaxel|mesh-list
25363903|NCT05252429|Pembrolizumab|pembrolizumab|mesh-list
25363904|NCT05252429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363905|NCT05252429|Tubulin Modulators|tubulin modulators|mesh-ancestor
25363906|NCT05252429|Antimitotic Agents|antimitotic agents|mesh-ancestor
25363907|NCT05252429|Mitosis Modulators|mitosis modulators|mesh-ancestor
25363908|NCT05252429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363909|NCT05252429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25363910|NCT05252390|Olaparib|olaparib|mesh-list
25363911|NCT05252390|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25363912|NCT05252390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363913|NCT05252390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363914|NCT05252390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363915|NCT05251974|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25363916|NCT05251974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25363917|NCT05251974|Adrenergic Agents|adrenergic agents|mesh-ancestor
25363918|NCT05251974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25363919|NCT05251974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363920|NCT05251974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363921|NCT05251948|Capecitabine|capecitabine|mesh-list
25363922|NCT05251948|Oxaliplatin|oxaliplatin|mesh-list
25363924|NCT05251948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25363925|NCT05251948|Antimetabolites|antimetabolites|mesh-ancestor
25363926|NCT05251948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363927|NCT05251948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363928|NCT05251909|Benralizumab|benralizumab|mesh-list
25363929|NCT05251909|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25363930|NCT05251909|Respiratory System Agents|respiratory system agents|mesh-ancestor
25363931|NCT05251714|Fulvestrant|fulvestrant|mesh-list
25363932|NCT05251714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25363933|NCT05251714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363934|NCT05251714|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25363935|NCT05251714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25363936|NCT05251714|Hormone Antagonists|hormone antagonists|mesh-ancestor
25363937|NCT05251714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25363938|NCT05251714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363939|NCT05251636|Aflibercept|aflibercept|mesh-list
25363940|NCT05251636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25363941|NCT05251636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25363942|NCT05251636|Growth Substances|growth substances|mesh-ancestor
25724229|NCT02535806|Antiviral Agents|antiviral agents|mesh-ancestor
25396031|NCT04069052|Antioxidants|antioxidants|mesh-ancestor
25363943|NCT05251636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363944|NCT05251636|Growth Inhibitors|growth inhibitors|mesh-ancestor
25363945|NCT05251636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363947|NCT05251376|Methadone|methadone|mesh-list
25363948|NCT05251376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25363949|NCT05251376|Narcotics|narcotics|mesh-ancestor
25363950|NCT05251376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25363951|NCT05251376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363952|NCT05251376|Analgesics|analgesics|mesh-ancestor
25363953|NCT05251376|Sensory System Agents|sensory system agents|mesh-ancestor
25363954|NCT05251376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25363955|NCT05251376|Antitussive Agents|antitussive agents|mesh-ancestor
25363956|NCT05251376|Respiratory System Agents|respiratory system agents|mesh-ancestor
25363957|NCT05251038|Leucovorin|leucovorin|mesh-list
25363958|NCT05251038|Gemcitabine|gemcitabine|mesh-list
25363959|NCT05251038|Paclitaxel|paclitaxel|mesh-list
25363960|NCT05251038|Fluorouracil|fluorouracil|mesh-list
25363961|NCT05251038|Irinotecan|irinotecan|mesh-list
25363962|NCT05251038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25363963|NCT05251038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363964|NCT05251038|Tubulin Modulators|tubulin modulators|mesh-ancestor
25363965|NCT05251038|Antimitotic Agents|antimitotic agents|mesh-ancestor
25363966|NCT05251038|Mitosis Modulators|mitosis modulators|mesh-ancestor
25363967|NCT05251038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363968|NCT05251038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25363969|NCT05251038|Antimetabolites|antimetabolites|mesh-ancestor
25363970|NCT05251038|Antiviral Agents|antiviral agents|mesh-ancestor
25363971|NCT05251038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25363972|NCT05251038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25363973|NCT05251038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25363974|NCT05251038|Immunologic Factors|immunologic factors|mesh-ancestor
25363975|NCT05251038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363976|NCT05251038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25363977|NCT05251038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25363978|NCT05251038|Antidotes|antidotes|mesh-ancestor
25363979|NCT05251038|Protective Agents|protective agents|mesh-ancestor
25363980|NCT05251038|Vitamin B Complex|vitamin b complex|mesh-ancestor
25363981|NCT05251038|Vitamins|vitamins|mesh-ancestor
25363982|NCT05251038|Micronutrients|micronutrients|mesh-ancestor
25363983|NCT05250973|Dexamethasone|dexamethasone|mesh-list
25363984|NCT05250973|Cyclophosphamide|cyclophosphamide|mesh-list
25363985|NCT05250973|Bortezomib|bortezomib|mesh-list
25363986|NCT05250973|Daratumumab|daratumumab|mesh-list
25363987|NCT05250973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25363988|NCT05250973|Immunologic Factors|immunologic factors|mesh-ancestor
25363989|NCT05250973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25363990|NCT05250973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25363991|NCT05250973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25363992|NCT05250973|Alkylating Agents|alkylating agents|mesh-ancestor
25363993|NCT05250973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25363994|NCT05250973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25363995|NCT05250973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25363996|NCT05250973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25363997|NCT05250973|Antiemetics|antiemetics|mesh-ancestor
25363998|NCT05250973|Autonomic Agents|autonomic agents|mesh-ancestor
25363999|NCT05250973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25364000|NCT05250973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25364001|NCT05250973|Glucocorticoids|glucocorticoids|mesh-ancestor
25364002|NCT05250973|Hormones|hormones|mesh-ancestor
25364003|NCT05250973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25364004|NCT05250973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25364005|NCT05250791|Lidocaine|lidocaine|mesh-list
25364006|NCT05250791|Anesthetics, Local|anesthetics, local|mesh-ancestor
25364007|NCT05250791|Anesthetics|anesthetics|mesh-ancestor
25364008|NCT05250791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25364009|NCT05250791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364010|NCT05250791|Sensory System Agents|sensory system agents|mesh-ancestor
25364011|NCT05250791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25364012|NCT05250791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25364013|NCT05250791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25364014|NCT05250791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25364015|NCT05250791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25364016|NCT05250791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364017|NCT05250011|Dapagliflozin|dapagliflozin|mesh-list
25724230|NCT02535806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25364018|NCT05250011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25364019|NCT05250011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364020|NCT05250011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25364021|NCT05250011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364022|NCT05249972|Calcitriol|calcitriol|mesh-list
25364023|NCT05249972|Betamethasone|betamethasone|mesh-list
25364024|NCT05249972|Betamethasone Valerate|betamethasone valerate|mesh-list
25364025|NCT05249972|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25364026|NCT05249972|Betamethasone benzoate|betamethasone benzoate|mesh-list
25364027|NCT05249972|Calcipotriene|calcipotriene|mesh-list
25364028|NCT05249972|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25364029|NCT05249972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25364030|NCT05249972|Glucocorticoids|glucocorticoids|mesh-ancestor
25364031|NCT05249972|Hormones|hormones|mesh-ancestor
25364032|NCT05249972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25364033|NCT05249972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364034|NCT05249972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25364035|NCT05249972|Respiratory System Agents|respiratory system agents|mesh-ancestor
25364036|NCT05249972|Dermatologic Agents|dermatologic agents|mesh-ancestor
25364037|NCT05249972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25364038|NCT05249972|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
25364039|NCT05249972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25364040|NCT05249972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364041|NCT05249972|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25364043|NCT05249972|Micronutrients|micronutrients|mesh-ancestor
25364044|NCT05249972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25364045|NCT05249959|Rituximab|rituximab|mesh-list
25364046|NCT05249959|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
25364047|NCT05249959|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25364048|NCT05249959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25364049|NCT05249959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364050|NCT05249959|Immunologic Factors|immunologic factors|mesh-ancestor
25364051|NCT05249959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364052|NCT05249959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25364053|NCT05249959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25364054|NCT05249959|Alkylating Agents|alkylating agents|mesh-ancestor
25364055|NCT05249959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364056|NCT05249621|Mannitol|mannitol|mesh-list
25364057|NCT05249621|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25364058|NCT05249621|Diuretics|diuretics|mesh-ancestor
25364059|NCT05249621|Natriuretic Agents|natriuretic agents|mesh-ancestor
25364060|NCT05249621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364061|NCT05249426|Cetuximab|cetuximab|mesh-list
25364062|NCT05249426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25364063|NCT05249426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364064|NCT05249309|Ketamine|ketamine|mesh-list
25364065|NCT05249309|Analgesics|analgesics|mesh-ancestor
25364066|NCT05249309|Sensory System Agents|sensory system agents|mesh-ancestor
25364067|NCT05249309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25364068|NCT05249309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364069|NCT05249309|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25364070|NCT05249309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25364071|NCT05249309|Anesthetics, General|anesthetics, general|mesh-ancestor
25364072|NCT05249309|Anesthetics|anesthetics|mesh-ancestor
25364073|NCT05249309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25364074|NCT05249309|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25364075|NCT05249309|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25364076|NCT05249309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25364077|NCT05249309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364078|NCT05249101|Capecitabine|capecitabine|mesh-list
25364079|NCT05249101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25364080|NCT05249101|Antimetabolites|antimetabolites|mesh-ancestor
25364081|NCT05249101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364082|NCT05249101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364083|NCT05248945|Carbamazepine|carbamazepine|mesh-list
25364084|NCT05248945|Anticonvulsants|anticonvulsants|mesh-ancestor
25364085|NCT05248945|Antimanic Agents|antimanic agents|mesh-ancestor
25364086|NCT05248945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25364087|NCT05248945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25364088|NCT05248945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364089|NCT05248945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25364090|NCT05248945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25364091|NCT05248945|Analgesics|analgesics|mesh-ancestor
25364092|NCT05248945|Sensory System Agents|sensory system agents|mesh-ancestor
25364093|NCT05248945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25364094|NCT05248945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25364095|NCT05248945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25364096|NCT05248945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364097|NCT05248945|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25364098|NCT05248945|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25364099|NCT05248841|Insulin Glargine|insulin glargine|mesh-list
25364100|NCT05248841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25364101|NCT05248841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364102|NCT05248334|Ranibizumab|ranibizumab|mesh-list
25364103|NCT05248334|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25364104|NCT05248334|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25364105|NCT05248334|Growth Substances|growth substances|mesh-ancestor
25364106|NCT05248334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364107|NCT05248334|Growth Inhibitors|growth inhibitors|mesh-ancestor
25364108|NCT05248334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364109|NCT05248139|Prednisolone|prednisolone|mesh-list
25364110|NCT05248139|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25364111|NCT05248139|Methylprednisolone|methylprednisolone|mesh-list
25364112|NCT05248139|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25364113|NCT05248139|Prednisolone acetate|prednisolone acetate|mesh-list
25364114|NCT05248139|Triamcinolone|triamcinolone|mesh-list
25364115|NCT05248139|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25364116|NCT05248139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25364117|NCT05248139|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25364118|NCT05248139|Prednisolone phosphate|prednisolone phosphate|mesh-list
25364119|NCT05248139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25364120|NCT05248139|Glucocorticoids|glucocorticoids|mesh-ancestor
25364122|NCT05248139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25364123|NCT05248139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364124|NCT05248139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25364125|NCT05248139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364126|NCT05248139|Antiemetics|antiemetics|mesh-ancestor
25364127|NCT05248139|Autonomic Agents|autonomic agents|mesh-ancestor
25364128|NCT05248139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25364129|NCT05248139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25364130|NCT05248139|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25364131|NCT05248139|Protective Agents|protective agents|mesh-ancestor
25364132|NCT05248139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25364133|NCT05248139|Immunologic Factors|immunologic factors|mesh-ancestor
25364134|NCT05248139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25364135|NCT05247905|Capecitabine|capecitabine|mesh-list
25364136|NCT05247905|Temozolomide|temozolomide|mesh-list
25364137|NCT05247905|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25364138|NCT05247905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25364139|NCT05247905|Antimetabolites|antimetabolites|mesh-ancestor
25364140|NCT05247905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364141|NCT05247905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364142|NCT05247905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25364143|NCT05247905|Alkylating Agents|alkylating agents|mesh-ancestor
25364144|NCT05247905|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25364145|NCT05247320|Sotalol|sotalol|mesh-list
25364146|NCT05247320|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25364147|NCT05247320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25364148|NCT05247320|Adrenergic Agents|adrenergic agents|mesh-ancestor
25364149|NCT05247320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25364150|NCT05247320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364151|NCT05247320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364152|NCT05247320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25364153|NCT05247320|Sympatholytics|sympatholytics|mesh-ancestor
25364154|NCT05247320|Autonomic Agents|autonomic agents|mesh-ancestor
25364155|NCT05247320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25364157|NCT05247125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364158|NCT05247125|Antioxidants|antioxidants|mesh-ancestor
25364159|NCT05247125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364160|NCT05247125|Protective Agents|protective agents|mesh-ancestor
25364161|NCT05247125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25364162|NCT05246670|Palmidrol|palmidrol|mesh-list
25364163|NCT05246670|Analgesics|analgesics|mesh-ancestor
25364164|NCT05246670|Sensory System Agents|sensory system agents|mesh-ancestor
25364165|NCT05246670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25364166|NCT05246670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364167|NCT05246670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25364168|NCT05246670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25364172|NCT05246670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25364173|NCT05246670|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25364174|NCT05246670|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25364175|NCT05246670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25364176|NCT05246670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364177|NCT05246670|Hormones|hormones|mesh-ancestor
25364178|NCT05246670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25364182|NCT05246371|Dexmedetomidine|dexmedetomidine|mesh-list
25364183|NCT05246371|Propofol|propofol|mesh-list
25364184|NCT05246371|Desflurane|desflurane|mesh-list
25364185|NCT05246371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25364186|NCT05246371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25364187|NCT05246371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364188|NCT05246371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25364189|NCT05246371|Anesthetics, General|anesthetics, general|mesh-ancestor
25364190|NCT05246371|Anesthetics|anesthetics|mesh-ancestor
25364191|NCT05246371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25364192|NCT05246371|Analgesics|analgesics|mesh-ancestor
25364193|NCT05246371|Sensory System Agents|sensory system agents|mesh-ancestor
25364194|NCT05246371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25364195|NCT05246371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25364196|NCT05246371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25364197|NCT05246371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25364198|NCT05246371|Adrenergic Agents|adrenergic agents|mesh-ancestor
25364199|NCT05246371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25364200|NCT05246371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364201|NCT05246371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25364202|NCT05246085|Hydrocortisone|hydrocortisone|mesh-list
25364203|NCT05246085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25364204|NCT05246046|Bromides|bromides|mesh-list
25364205|NCT05246046|Tiotropium Bromide|tiotropium bromide|mesh-list
25364206|NCT05246046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25364207|NCT05246046|Autonomic Agents|autonomic agents|mesh-ancestor
25364208|NCT05246046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25364209|NCT05246046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364210|NCT05246046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25364211|NCT05246046|Respiratory System Agents|respiratory system agents|mesh-ancestor
25364212|NCT05246046|Parasympatholytics|parasympatholytics|mesh-ancestor
25364213|NCT05246046|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25364214|NCT05246046|Cholinergic Agents|cholinergic agents|mesh-ancestor
25364215|NCT05246046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25364216|NCT05246046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364217|NCT05246046|Anticonvulsants|anticonvulsants|mesh-ancestor
25364218|NCT05245968|Sunitinib|sunitinib|mesh-list
25364219|NCT05245968|Imatinib Mesylate|imatinib mesylate|mesh-list
25364220|NCT05245968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364221|NCT05245968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25364222|NCT05245968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25364223|NCT05245968|Growth Substances|growth substances|mesh-ancestor
25364224|NCT05245968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364225|NCT05245968|Growth Inhibitors|growth inhibitors|mesh-ancestor
25364226|NCT05245968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25364227|NCT05245968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25364228|NCT05245968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364229|NCT05245916|Rituximab|rituximab|mesh-list
25364230|NCT05245916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25364231|NCT05245916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364232|NCT05245916|Immunologic Factors|immunologic factors|mesh-ancestor
25364233|NCT05245916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364234|NCT05245916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25364235|NCT05245877|Enoxaparin|enoxaparin|mesh-list
25364236|NCT05245877|Dalteparin|dalteparin|mesh-list
25364237|NCT05245877|Tinzaparin|tinzaparin|mesh-list
25364238|NCT05245877|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25364239|NCT05245877|Anticoagulants|anticoagulants|mesh-ancestor
25364240|NCT05245877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25364241|NCT05245877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25364242|NCT05245877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364244|NCT05245786|Antibodies|antibodies|mesh-list
25364245|NCT05245786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25364246|NCT05245786|Immunologic Factors|immunologic factors|mesh-ancestor
25364247|NCT05245786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364248|NCT05245786|Trace Elements|trace elements|mesh-ancestor
25364249|NCT05245786|Micronutrients|micronutrients|mesh-ancestor
25364250|NCT05245552|Vaccines|vaccines|mesh-list
25364251|NCT05245552|Immunologic Factors|immunologic factors|mesh-ancestor
25364252|NCT05245552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364253|NCT05245292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25364254|NCT05245292|Antibodies|antibodies|mesh-list
25364255|NCT05245292|Immunoglobulins|immunoglobulins|mesh-list
25364256|NCT05245292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25364257|NCT05245292|Antibodies, Blocking|antibodies, blocking|mesh-list
25364258|NCT05245292|Immunologic Factors|immunologic factors|mesh-ancestor
25364259|NCT05245292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364260|NCT05245292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364261|NCT05245071|Maytansine|maytansine|mesh-list
25364262|NCT05245071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25364263|NCT05245071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364264|NCT05245071|Tubulin Modulators|tubulin modulators|mesh-ancestor
25364266|NCT05245071|Mitosis Modulators|mitosis modulators|mesh-ancestor
25364267|NCT05245071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364268|NCT05244473|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25364269|NCT05244473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25364270|NCT05244473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364271|NCT05244213|Paclitaxel|paclitaxel|mesh-list
25364272|NCT05244213|Carboplatin|carboplatin|mesh-list
25364273|NCT05244213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25364274|NCT05244213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364275|NCT05244213|Tubulin Modulators|tubulin modulators|mesh-ancestor
25364276|NCT05244213|Antimitotic Agents|antimitotic agents|mesh-ancestor
25364277|NCT05244213|Mitosis Modulators|mitosis modulators|mesh-ancestor
25364278|NCT05244213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364279|NCT05244070|Cyclophosphamide|cyclophosphamide|mesh-list
25364280|NCT05244070|Fludarabine|fludarabine|mesh-list
25364281|NCT05244070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25364282|NCT05244070|Immunologic Factors|immunologic factors|mesh-ancestor
25364283|NCT05244070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364284|NCT05244070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25364285|NCT05244070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25364286|NCT05244070|Alkylating Agents|alkylating agents|mesh-ancestor
25364287|NCT05244070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364288|NCT05244070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364289|NCT05244070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25364290|NCT05244018|Vitamin D|vitamin d|mesh-list
25364291|NCT05244018|Ergocalciferols|ergocalciferols|mesh-list
25364292|NCT05244018|Cholecalciferol|cholecalciferol|mesh-list
25364293|NCT05244018|Vitamins|vitamins|mesh-list
25364294|NCT05244018|Micronutrients|micronutrients|mesh-ancestor
25364295|NCT05244018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364296|NCT05244018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25364297|NCT05244018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25364298|NCT05243797|Lenalidomide|lenalidomide|mesh-list
25364299|NCT05243797|Immunologic Factors|immunologic factors|mesh-ancestor
25364300|NCT05243797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364301|NCT05243797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25364302|NCT05243797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25364303|NCT05243797|Growth Substances|growth substances|mesh-ancestor
25364304|NCT05243797|Growth Inhibitors|growth inhibitors|mesh-ancestor
25364305|NCT05243797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364306|NCT05243745|Fluorides|fluorides|mesh-list
25364307|NCT05243745|Cariostatic Agents|cariostatic agents|mesh-ancestor
25364308|NCT05243745|Protective Agents|protective agents|mesh-ancestor
25364309|NCT05243745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364310|NCT05243563|Clobetasol|clobetasol|mesh-list
25364311|NCT05243563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25364312|NCT05243563|Glucocorticoids|glucocorticoids|mesh-ancestor
25364313|NCT05243563|Hormones|hormones|mesh-ancestor
25416008|NCT02978404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364314|NCT05243563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25364315|NCT05243563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364316|NCT05243550|Mitomycins|mitomycins|mesh-list
25364317|NCT05243550|Mitomycin|mitomycin|mesh-list
25364318|NCT05243550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25364319|NCT05243550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364320|NCT05243550|Alkylating Agents|alkylating agents|mesh-ancestor
25364321|NCT05243550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364322|NCT05243550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25364323|NCT05243550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25364324|NCT05243342|Daratumumab|daratumumab|mesh-list
25364325|NCT05243342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364326|NCT05243329|Psilocybin|psilocybin|mesh-list
25364327|NCT05243329|Hallucinogens|hallucinogens|mesh-ancestor
25364328|NCT05243329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364329|NCT05243329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25364330|NCT05242965|Vaccines|vaccines|mesh-list
25364331|NCT05242965|Sargramostim|sargramostim|mesh-list
25364332|NCT05242965|Immunologic Factors|immunologic factors|mesh-ancestor
25364333|NCT05242965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364334|NCT05242692|Dexmedetomidine|dexmedetomidine|mesh-list
25364335|NCT05242692|Ketamine|ketamine|mesh-list
25364336|NCT05242692|Esketamine|esketamine|mesh-list
25364337|NCT05242692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25364338|NCT05242692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25364339|NCT05242692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364340|NCT05242692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25364341|NCT05242692|Analgesics|analgesics|mesh-ancestor
25364342|NCT05242692|Sensory System Agents|sensory system agents|mesh-ancestor
25364343|NCT05242692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25364344|NCT05242692|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25364345|NCT05242692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25364346|NCT05242692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25364347|NCT05242692|Adrenergic Agents|adrenergic agents|mesh-ancestor
25364348|NCT05242692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25364349|NCT05242692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364350|NCT05242692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25364351|NCT05242692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25364352|NCT05242692|Anesthetics, General|anesthetics, general|mesh-ancestor
25364353|NCT05242692|Anesthetics|anesthetics|mesh-ancestor
25364354|NCT05242692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25364355|NCT05242692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25364356|NCT05242692|Antidepressive Agents|antidepressive agents|mesh-ancestor
25364357|NCT05242692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25364358|NCT05242471|Golimumab|golimumab|mesh-list
25364359|NCT05242471|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25364360|NCT05242471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25364361|NCT05242471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25364362|NCT05242471|Immunologic Factors|immunologic factors|mesh-ancestor
25364363|NCT05242471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364364|NCT05242458|Ustekinumab|ustekinumab|mesh-list
25364365|NCT05242458|Dermatologic Agents|dermatologic agents|mesh-ancestor
25364366|NCT05242029|Psilocybin|psilocybin|mesh-list
25364367|NCT05242029|Hallucinogens|hallucinogens|mesh-ancestor
25364368|NCT05242029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364369|NCT05242029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25364370|NCT05241262|Acetylcysteine|acetylcysteine|mesh-list
25364371|NCT05241262|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25364372|NCT05241262|Antiviral Agents|antiviral agents|mesh-ancestor
25364373|NCT05241262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25364374|NCT05241262|Expectorants|expectorants|mesh-ancestor
25364375|NCT05241262|Respiratory System Agents|respiratory system agents|mesh-ancestor
25364376|NCT05241262|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25364377|NCT05241262|Antioxidants|antioxidants|mesh-ancestor
25364378|NCT05241262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364379|NCT05241262|Protective Agents|protective agents|mesh-ancestor
25364380|NCT05241262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364381|NCT05241262|Antidotes|antidotes|mesh-ancestor
25364382|NCT05240755|Cannabidiol|cannabidiol|mesh-list
25364383|NCT05240755|Anticonvulsants|anticonvulsants|mesh-ancestor
25364384|NCT05239910|Tenalisib|tenalisib|mesh-list
25364385|NCT05239910|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
25364386|NCT05239910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25364387|NCT05239910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364388|NCT05239741|Leucovorin|leucovorin|mesh-list
25364389|NCT05239741|Bevacizumab|bevacizumab|mesh-list
25364390|NCT05239741|Pembrolizumab|pembrolizumab|mesh-list
25364391|NCT05239741|Cetuximab|cetuximab|mesh-list
25364392|NCT05239741|Fluorouracil|fluorouracil|mesh-list
25364393|NCT05239741|Oxaliplatin|oxaliplatin|mesh-list
25364394|NCT05239741|Irinotecan|irinotecan|mesh-list
25364395|NCT05239741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25364396|NCT05239741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364397|NCT05239741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25364398|NCT05239741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25364399|NCT05239741|Growth Substances|growth substances|mesh-ancestor
25364400|NCT05239741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364401|NCT05239741|Growth Inhibitors|growth inhibitors|mesh-ancestor
25364402|NCT05239741|Antimetabolites|antimetabolites|mesh-ancestor
25364403|NCT05239741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364404|NCT05239741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25364405|NCT05239741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25364406|NCT05239741|Immunologic Factors|immunologic factors|mesh-ancestor
25364407|NCT05239741|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25364408|NCT05239741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25364409|NCT05239741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25364410|NCT05239741|Antidotes|antidotes|mesh-ancestor
25364411|NCT05239741|Protective Agents|protective agents|mesh-ancestor
25364412|NCT05239741|Vitamin B Complex|vitamin b complex|mesh-ancestor
25364413|NCT05239741|Vitamins|vitamins|mesh-ancestor
25364414|NCT05239741|Micronutrients|micronutrients|mesh-ancestor
25364415|NCT05239728|Pembrolizumab|pembrolizumab|mesh-list
25364416|NCT05239728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25364417|NCT05239728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364418|NCT05239468|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
25364419|NCT05239468|Bezafibrate|bezafibrate|mesh-list
25364420|NCT05239468|Cathartics|cathartics|mesh-ancestor
25364421|NCT05239468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25364422|NCT05239468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25364423|NCT05239468|Antimetabolites|antimetabolites|mesh-ancestor
25364424|NCT05239468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364425|NCT05239468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25364426|NCT05239091|Lidocaine|lidocaine|mesh-list
25364427|NCT05239091|Anesthetics, Local|anesthetics, local|mesh-list
25364428|NCT05239091|Anesthetics|anesthetics|mesh-list
25364429|NCT05239091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25364430|NCT05239091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364431|NCT05239091|Sensory System Agents|sensory system agents|mesh-ancestor
25364432|NCT05239091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25364433|NCT05239091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25364434|NCT05239091|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25364435|NCT05239091|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25364436|NCT05239091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25364437|NCT05239091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364438|NCT05238948|Midazolam|midazolam|mesh-list
25364439|NCT05238948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25364440|NCT05238948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25364441|NCT05238948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25364442|NCT05238948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364443|NCT05238948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25364444|NCT05238948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25364445|NCT05238948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25364446|NCT05238948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25364447|NCT05238948|Anesthetics, General|anesthetics, general|mesh-ancestor
25364448|NCT05238948|Anesthetics|anesthetics|mesh-ancestor
25364449|NCT05238948|GABA Modulators|gaba modulators|mesh-ancestor
25364450|NCT05238948|GABA Agents|gaba agents|mesh-ancestor
25364451|NCT05238948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25364452|NCT05238948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364453|NCT05238597|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25364454|NCT05238597|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25364455|NCT05238142|Insulin|insulin|mesh-list
25364456|NCT05238142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25364457|NCT05238142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364458|NCT05237960|Metformin|metformin|mesh-list
25364459|NCT05237960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25364460|NCT05237960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364461|NCT05237947|Vaccines|vaccines|mesh-list
25364462|NCT05237947|Immunologic Factors|immunologic factors|mesh-ancestor
25364463|NCT05237947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364464|NCT05237687|Sirolimus|sirolimus|mesh-list
25364465|NCT05237687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25364466|NCT05237687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25364467|NCT05237687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25364468|NCT05237687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364469|NCT05237687|Antifungal Agents|antifungal agents|mesh-ancestor
25364470|NCT05237687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25364471|NCT05237687|Immunologic Factors|immunologic factors|mesh-ancestor
25364472|NCT05237687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364473|NCT05237492|Tramadol|tramadol|mesh-list
25364474|NCT05237492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25364475|NCT05237492|Narcotics|narcotics|mesh-ancestor
25364476|NCT05237492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25364477|NCT05237492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364478|NCT05237492|Analgesics|analgesics|mesh-ancestor
25364479|NCT05237492|Sensory System Agents|sensory system agents|mesh-ancestor
25364480|NCT05237492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25364481|NCT05237297|Celecoxib|celecoxib|mesh-list
25364482|NCT05237297|Naproxen|naproxen|mesh-list
25364483|NCT05237297|Aceclofenac|aceclofenac|mesh-list
25364484|NCT05237297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25364485|NCT05237297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25364486|NCT05237297|Analgesics|analgesics|mesh-ancestor
25364487|NCT05237297|Sensory System Agents|sensory system agents|mesh-ancestor
25364488|NCT05237297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25364489|NCT05237297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364490|NCT05237297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25364491|NCT05237297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25364492|NCT05237297|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25364493|NCT05237297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25364494|NCT05237297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25364495|NCT05237297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364496|NCT05237297|Gout Suppressants|gout suppressants|mesh-ancestor
25364497|NCT05236673|Empagliflozin|empagliflozin|mesh-list
25364498|NCT05236673|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25364499|NCT05236673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364500|NCT05236673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25364501|NCT05236673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364502|NCT05236647|Morphine|morphine|mesh-list
25364503|NCT05236647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25364504|NCT05236647|Narcotics|narcotics|mesh-ancestor
25364505|NCT05236647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25364506|NCT05236647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364507|NCT05236647|Analgesics|analgesics|mesh-ancestor
25364508|NCT05236647|Sensory System Agents|sensory system agents|mesh-ancestor
25364509|NCT05236647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25364510|NCT05236543|Itraconazole|itraconazole|mesh-list
25364511|NCT05236543|Antifungal Agents|antifungal agents|mesh-ancestor
25364512|NCT05236543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25364513|NCT05236543|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25364514|NCT05236543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25364515|NCT05236543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25364516|NCT05236543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364517|NCT05236543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25364518|NCT05236543|Hormone Antagonists|hormone antagonists|mesh-ancestor
25364519|NCT05236543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25364520|NCT05236543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364521|NCT05236543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25364522|NCT05236530|Metformin|metformin|mesh-list
25364523|NCT05236530|Repaglinide|repaglinide|mesh-list
25364524|NCT05236530|Dolutegravir|dolutegravir|mesh-list
25364525|NCT05236530|Lumefantrine|lumefantrine|mesh-list
25364526|NCT05236530|Midazolam|midazolam|mesh-list
25364527|NCT05236530|Dextromethorphan|dextromethorphan|mesh-list
25364528|NCT05236530|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25364529|NCT05236530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25364530|NCT05236530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364531|NCT05236530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25364532|NCT05236530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25364533|NCT05236530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25364534|NCT05236530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25364535|NCT05236530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25364536|NCT05236530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25364537|NCT05236530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25364538|NCT05236530|Anesthetics, General|anesthetics, general|mesh-ancestor
25364539|NCT05236530|Anesthetics|anesthetics|mesh-ancestor
25364540|NCT05236530|GABA Modulators|gaba modulators|mesh-ancestor
25364541|NCT05236530|GABA Agents|gaba agents|mesh-ancestor
25364542|NCT05236530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25364543|NCT05236530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364544|NCT05236530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25364545|NCT05236530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25364546|NCT05236530|Antimetabolites|antimetabolites|mesh-ancestor
25364547|NCT05236530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25364548|NCT05236530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25364549|NCT05236530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25364550|NCT05236530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25364551|NCT05236530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25364552|NCT05236530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25364553|NCT05236530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25364554|NCT05236530|Antiviral Agents|antiviral agents|mesh-ancestor
25364555|NCT05236530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25364556|NCT05236530|Antimalarials|antimalarials|mesh-ancestor
25364557|NCT05236530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25364558|NCT05236530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25364559|NCT05236530|Antitussive Agents|antitussive agents|mesh-ancestor
25364560|NCT05236530|Respiratory System Agents|respiratory system agents|mesh-ancestor
25364561|NCT05236530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25364562|NCT05236530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25364563|NCT05236036|Mycophenolic Acid|mycophenolic acid|mesh-list
25364564|NCT05236036|Temozolomide|temozolomide|mesh-list
25364565|NCT05236036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25364566|NCT05236036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364567|NCT05236036|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25364568|NCT05236036|Antitubercular Agents|antitubercular agents|mesh-ancestor
25364569|NCT05236036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25364570|NCT05236036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25364571|NCT05236036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25364647|NCT05232825|Anesthetics|anesthetics|mesh-ancestor
25364576|NCT05235542|Docetaxel|docetaxel|mesh-list
25364577|NCT05235542|Cisplatin|cisplatin|mesh-list
25364578|NCT05235542|Capecitabine|capecitabine|mesh-list
25364579|NCT05235542|Oxaliplatin|oxaliplatin|mesh-list
25364580|NCT05235542|Irinotecan|irinotecan|mesh-list
25364581|NCT05235542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25364582|NCT05235542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364583|NCT05235542|Tubulin Modulators|tubulin modulators|mesh-ancestor
25364584|NCT05235542|Antimitotic Agents|antimitotic agents|mesh-ancestor
25364585|NCT05235542|Mitosis Modulators|mitosis modulators|mesh-ancestor
25364586|NCT05235542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364587|NCT05235542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25364588|NCT05235542|Antimetabolites|antimetabolites|mesh-ancestor
25364589|NCT05235542|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25364590|NCT05235542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25364591|NCT05235542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25364592|NCT05235516|Cisplatin|cisplatin|mesh-list
25364593|NCT05235516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364594|NCT05233566|Ketamine|ketamine|mesh-list
25364595|NCT05233566|Analgesics|analgesics|mesh-ancestor
25364596|NCT05233566|Sensory System Agents|sensory system agents|mesh-ancestor
25364597|NCT05233566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25364598|NCT05233566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364599|NCT05233566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25364600|NCT05233566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25364601|NCT05233566|Anesthetics, General|anesthetics, general|mesh-ancestor
25364602|NCT05233566|Anesthetics|anesthetics|mesh-ancestor
25364603|NCT05233566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25364604|NCT05233566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25364605|NCT05233566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25364606|NCT05233566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25364760|NCT05229965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25364607|NCT05233566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364608|NCT05233098|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
25364609|NCT05233098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25364610|NCT05233098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364611|NCT05232994|Metformin|metformin|mesh-list
25364612|NCT05232994|Esomeprazole|esomeprazole|mesh-list
25364613|NCT05232994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25364614|NCT05232994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364615|NCT05232994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25364616|NCT05232994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25364617|NCT05232994|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25364618|NCT05232994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25364619|NCT05232994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364624|NCT05232825|Diphenhydramine|diphenhydramine|mesh-list
25364625|NCT05232825|Promethazine|promethazine|mesh-list
25364626|NCT05232825|Dexamethasone|dexamethasone|mesh-list
25364627|NCT05232825|Methylprednisolone|methylprednisolone|mesh-list
25364628|NCT05232825|Desloratadine|desloratadine|mesh-list
25364629|NCT05232825|Ocrelizumab|ocrelizumab|mesh-list
25364630|NCT05232825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25364631|NCT05232825|Antiemetics|antiemetics|mesh-ancestor
25364632|NCT05232825|Autonomic Agents|autonomic agents|mesh-ancestor
25364633|NCT05232825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25364634|NCT05232825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364635|NCT05232825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25364636|NCT05232825|Glucocorticoids|glucocorticoids|mesh-ancestor
25364637|NCT05232825|Hormones|hormones|mesh-ancestor
25364656|NCT05232825|Dermatologic Agents|dermatologic agents|mesh-ancestor
25364657|NCT05232825|Immunologic Factors|immunologic factors|mesh-ancestor
25364658|NCT05232825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25364659|NCT05232825|Cholinergic Agents|cholinergic agents|mesh-ancestor
25364660|NCT05232825|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25364680|NCT05231694|Mitogens|mitogens|mesh-list
25364681|NCT05231694|Mitosis Modulators|mitosis modulators|mesh-ancestor
25364759|NCT05229965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25364682|NCT05231694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364683|NCT05231629|Dexamethasone|dexamethasone|mesh-list
25364684|NCT05231629|Dexamethasone acetate|dexamethasone acetate|mesh-list
25364685|NCT05231629|Melphalan|melphalan|mesh-list
25364686|NCT05231629|Lenalidomide|lenalidomide|mesh-list
25364687|NCT05231629|Bortezomib|bortezomib|mesh-list
25364688|NCT05231629|Daratumumab|daratumumab|mesh-list
25364689|NCT05231629|BB 1101|bb 1101|mesh-list
25364690|NCT05231629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25364691|NCT05231629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25364692|NCT05231629|Antiemetics|antiemetics|mesh-ancestor
25364693|NCT05231629|Autonomic Agents|autonomic agents|mesh-ancestor
25364694|NCT05231629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25364695|NCT05231629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364696|NCT05231629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25364697|NCT05231629|Glucocorticoids|glucocorticoids|mesh-ancestor
25364698|NCT05231629|Hormones|hormones|mesh-ancestor
25364699|NCT05231629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25364700|NCT05231629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25364701|NCT05231629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364702|NCT05231629|Protease Inhibitors|protease inhibitors|mesh-ancestor
25364703|NCT05231629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25364704|NCT05231629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364705|NCT05231629|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25364706|NCT05231629|Alkylating Agents|alkylating agents|mesh-ancestor
25364707|NCT05231629|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25364708|NCT05231629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25364709|NCT05231629|Immunologic Factors|immunologic factors|mesh-ancestor
25364710|NCT05231629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25364711|NCT05231629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25364712|NCT05231629|Growth Substances|growth substances|mesh-ancestor
25364713|NCT05231629|Growth Inhibitors|growth inhibitors|mesh-ancestor
25364714|NCT05231122|Bevacizumab|bevacizumab|mesh-list
25364715|NCT05231122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25364716|NCT05231122|Pembrolizumab|pembrolizumab|mesh-list
25364717|NCT05231122|Endothelial Growth Factors|endothelial growth factors|mesh-list
25364718|NCT05231122|Antibodies|antibodies|mesh-list
25364719|NCT05231122|Immunoglobulins|immunoglobulins|mesh-list
25364720|NCT05231122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25364721|NCT05231122|Immunoglobulin G|immunoglobulin g|mesh-list
25364722|NCT05231122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364723|NCT05231122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25364724|NCT05231122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25364725|NCT05231122|Growth Substances|growth substances|mesh-ancestor
25364726|NCT05231122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364727|NCT05231122|Growth Inhibitors|growth inhibitors|mesh-ancestor
25364728|NCT05231122|Immunologic Factors|immunologic factors|mesh-ancestor
25364729|NCT05230810|Fulvestrant|fulvestrant|mesh-list
25364730|NCT05230810|Tucatinib|tucatinib|mesh-list
25364731|NCT05230810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25364732|NCT05230810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364733|NCT05230810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25364734|NCT05230810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25364735|NCT05230810|Hormone Antagonists|hormone antagonists|mesh-ancestor
25364736|NCT05230810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25364737|NCT05230810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364738|NCT05230810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25364739|NCT05230810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25364740|NCT05230810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364741|NCT05230758|Metformin|metformin|mesh-list
25364742|NCT05230758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25364743|NCT05230758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364744|NCT05229965|Acetaminophen|acetaminophen|mesh-list
25364745|NCT05229965|Codeine|codeine|mesh-list
25364746|NCT05229965|Caffeine|caffeine|mesh-list
25364747|NCT05229965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25364748|NCT05229965|Analgesics|analgesics|mesh-ancestor
25364749|NCT05229965|Sensory System Agents|sensory system agents|mesh-ancestor
25364750|NCT05229965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25364751|NCT05229965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364752|NCT05229965|Antipyretics|antipyretics|mesh-ancestor
25364753|NCT05229965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25364754|NCT05229965|Narcotics|narcotics|mesh-ancestor
25364755|NCT05229965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25364756|NCT05229965|Antitussive Agents|antitussive agents|mesh-ancestor
25364757|NCT05229965|Respiratory System Agents|respiratory system agents|mesh-ancestor
25364758|NCT05229965|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25364761|NCT05229965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364762|NCT05229965|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25364763|NCT05229965|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25364764|NCT05229965|Purinergic Agents|purinergic agents|mesh-ancestor
25364765|NCT05229965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25364766|NCT05228951|Trastuzumab|trastuzumab|mesh-list
25364768|NCT05228951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25364769|NCT05228951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364770|NCT05228951|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25364771|NCT05228951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25364772|NCT05228951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25364773|NCT05228951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364774|NCT05228951|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25364775|NCT05228951|Hormone Antagonists|hormone antagonists|mesh-ancestor
25364776|NCT05228951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25364777|NCT05228951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364778|NCT05228613|Vaccines|vaccines|mesh-list
25364779|NCT05228613|Immunologic Factors|immunologic factors|mesh-ancestor
25364780|NCT05228613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364781|NCT05228249|Cytarabine|cytarabine|mesh-list
25364782|NCT05228249|Etoposide|etoposide|mesh-list
25364783|NCT05228249|Podophyllotoxin|podophyllotoxin|mesh-list
25364784|NCT05228249|Etoposide phosphate|etoposide phosphate|mesh-list
25364785|NCT05228249|Melphalan|melphalan|mesh-list
25364786|NCT05228249|Mechlorethamine|mechlorethamine|mesh-list
25364787|NCT05228249|Carmustine|carmustine|mesh-list
25364788|NCT05228249|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25364789|NCT05228249|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
25364790|NCT05228249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25364791|NCT05228249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364792|NCT05228249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25364793|NCT05228249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25364794|NCT05228249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25364795|NCT05228249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364796|NCT05228249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25364797|NCT05228249|Antimetabolites|antimetabolites|mesh-ancestor
25364798|NCT05228249|Antiviral Agents|antiviral agents|mesh-ancestor
25364799|NCT05228249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25364800|NCT05228249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25364801|NCT05228249|Immunologic Factors|immunologic factors|mesh-ancestor
25364817|NCT05227742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364818|NCT05227742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25364820|NCT05227664|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25364821|NCT05227664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25364822|NCT05227664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364823|NCT05227664|Tubulin Modulators|tubulin modulators|mesh-ancestor
25364824|NCT05227664|Antimitotic Agents|antimitotic agents|mesh-ancestor
25364825|NCT05227664|Mitosis Modulators|mitosis modulators|mesh-ancestor
25364826|NCT05227664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364828|NCT05227001|Menthol|menthol|mesh-list
25364829|NCT05227001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25364830|NCT05227001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25364831|NCT05227001|Antipruritics|antipruritics|mesh-ancestor
25364832|NCT05227001|Dermatologic Agents|dermatologic agents|mesh-ancestor
25364833|NCT05226871|Cetuximab|cetuximab|mesh-list
25364834|NCT05226871|Letrozole|letrozole|mesh-list
25364835|NCT05226871|Fulvestrant|fulvestrant|mesh-list
25364836|NCT05226871|Palbociclib|palbociclib|mesh-list
25364837|NCT05226871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25364838|NCT05226871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364839|NCT05226871|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25364840|NCT05226871|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25364841|NCT05226871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25364842|NCT05226871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364843|NCT05226871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25364844|NCT05226871|Hormone Antagonists|hormone antagonists|mesh-ancestor
25364845|NCT05226871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25364846|NCT05226871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364847|NCT05226871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25364848|NCT05226871|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25364849|NCT05226871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25364850|NCT05226754|Diacetylrhein|diacetylrhein|mesh-list
25364851|NCT05226754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25364853|NCT05226663|Cariostatic Agents|cariostatic agents|mesh-ancestor
25364854|NCT05226663|Protective Agents|protective agents|mesh-ancestor
25364855|NCT05226663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364872|NCT05226429|Vaccines|vaccines|mesh-list
25364873|NCT05226429|Immunologic Factors|immunologic factors|mesh-ancestor
25364874|NCT05226429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364875|NCT05225805|Lefamulin|lefamulin|mesh-list
25364876|NCT05225805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25364877|NCT05225805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25364878|NCT05225558|Vancomycin|vancomycin|mesh-list
25364879|NCT05225558|Delpazolid|delpazolid|mesh-list
25364880|NCT05225558|Oxazolidinones|oxazolidinones|mesh-list
25364904|NCT05223829|Neurosteroids|neurosteroids|mesh-ancestor
25364905|NCT05223829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25364906|NCT05223829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364907|NCT05223829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364908|NCT05223829|GABA Modulators|gaba modulators|mesh-ancestor
25364909|NCT05223829|GABA Agents|gaba agents|mesh-ancestor
25364910|NCT05222984|Decitabine|decitabine|mesh-list
25364911|NCT05222984|Venetoclax|venetoclax|mesh-list
25364912|NCT05222984|Navitoclax|navitoclax|mesh-list
25364913|NCT05222984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25364914|NCT05222984|Antimetabolites|antimetabolites|mesh-ancestor
25364915|NCT05222984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364916|NCT05222984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364917|NCT05222984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25364918|NCT05222555|Lenalidomide|lenalidomide|mesh-list
25364919|NCT05222555|Immunologic Factors|immunologic factors|mesh-ancestor
25364920|NCT05222555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364921|NCT05222555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25364922|NCT05222555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25364923|NCT05222555|Growth Substances|growth substances|mesh-ancestor
25364924|NCT05222555|Growth Inhibitors|growth inhibitors|mesh-ancestor
25364925|NCT05222555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364936|NCT05222165|Infigratinib|infigratinib|mesh-list
25364937|NCT05222165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364938|NCT05221840|Durvalumab|durvalumab|mesh-list
25364939|NCT05221840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25364940|NCT05221840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364941|NCT05221749|Fluorides|fluorides|mesh-list
25364942|NCT05221749|Cariostatic Agents|cariostatic agents|mesh-ancestor
25364943|NCT05221749|Protective Agents|protective agents|mesh-ancestor
25364944|NCT05221749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364945|NCT05221658|Cisplatin|cisplatin|mesh-list
25364946|NCT05221658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25364947|NCT05221554|Tacrine|tacrine|mesh-list
25364948|NCT05221554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25364949|NCT05221554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25364950|NCT05221554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364951|NCT05221554|Cholinergic Agents|cholinergic agents|mesh-ancestor
25364952|NCT05221554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25364953|NCT05221554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364954|NCT05221554|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25364955|NCT05221554|Autonomic Agents|autonomic agents|mesh-ancestor
25364956|NCT05221554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25364957|NCT05221554|Nootropic Agents|nootropic agents|mesh-ancestor
25364973|NCT05221229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25364974|NCT05221229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364975|NCT05221229|Incretins|incretins|mesh-ancestor
25364976|NCT05221229|Hormones|hormones|mesh-ancestor
25364977|NCT05221229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25364978|NCT05220358|Fostemsavir|fostemsavir|mesh-list
25364979|NCT05220358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25364980|NCT05220358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25364981|NCT05220358|Antiviral Agents|antiviral agents|mesh-ancestor
25364982|NCT05220358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25364983|NCT05220358|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
25364984|NCT05220358|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
25364985|NCT05220358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25364986|NCT05220293|Betamethasone|betamethasone|mesh-list
25364987|NCT05220293|Betamethasone Valerate|betamethasone valerate|mesh-list
25364988|NCT05220293|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25364989|NCT05220293|Betamethasone benzoate|betamethasone benzoate|mesh-list
25364990|NCT05220293|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25364991|NCT05220293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25364992|NCT05220293|Glucocorticoids|glucocorticoids|mesh-ancestor
25364993|NCT05220293|Hormones|hormones|mesh-ancestor
25364994|NCT05220293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25364995|NCT05220293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25364996|NCT05220293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25364997|NCT05220293|Respiratory System Agents|respiratory system agents|mesh-ancestor
25364998|NCT05219929|Tetracycline|tetracycline|mesh-list
25364999|NCT05219929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25365000|NCT05219929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25365001|NCT05219929|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25365002|NCT05219929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25365003|NCT05219929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365004|NCT05219513|Obinutuzumab|obinutuzumab|mesh-list
25365005|NCT05219513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25365006|NCT05219513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365007|NCT05219110|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25365008|NCT05218889|Gemcitabine|gemcitabine|mesh-list
25365009|NCT05218889|Paclitaxel|paclitaxel|mesh-list
25365010|NCT05218889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25365011|NCT05218889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25365012|NCT05218889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365013|NCT05218889|Tubulin Modulators|tubulin modulators|mesh-ancestor
25365014|NCT05218889|Antimitotic Agents|antimitotic agents|mesh-ancestor
25365015|NCT05218889|Mitosis Modulators|mitosis modulators|mesh-ancestor
25365016|NCT05218889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365017|NCT05218889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25365018|NCT05218889|Antimetabolites|antimetabolites|mesh-ancestor
25365019|NCT05218889|Antiviral Agents|antiviral agents|mesh-ancestor
25365020|NCT05218889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25365021|NCT05218889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25365022|NCT05218889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25365023|NCT05218889|Immunologic Factors|immunologic factors|mesh-ancestor
25365024|NCT05218889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365025|NCT05218733|Fentanyl|fentanyl|mesh-list
25365026|NCT05218733|Morphine|morphine|mesh-list
25365027|NCT05218733|Anesthetics|anesthetics|mesh-ancestor
25365028|NCT05218733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25365029|NCT05218733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365030|NCT05218733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25365031|NCT05218733|Narcotics|narcotics|mesh-ancestor
25365032|NCT05218733|Analgesics|analgesics|mesh-ancestor
25365033|NCT05218733|Sensory System Agents|sensory system agents|mesh-ancestor
25365034|NCT05218733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25365035|NCT05218733|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25365036|NCT05218733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25365037|NCT05218733|Anesthetics, General|anesthetics, general|mesh-ancestor
25365038|NCT05218668|Fasudil|fasudil|mesh-list
25365049|NCT05218603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365051|NCT05218499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25365052|NCT05218499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365053|NCT05218499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25365054|NCT05218499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25365055|NCT05218499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25365056|NCT05218499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365057|NCT05218486|Isotretinoin|isotretinoin|mesh-list
25365058|NCT05218486|Dermatologic Agents|dermatologic agents|mesh-ancestor
25365059|NCT05217680|Bevacizumab|bevacizumab|mesh-list
25365060|NCT05217680|Ranibizumab|ranibizumab|mesh-list
25365061|NCT05217680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25365062|NCT05217680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365063|NCT05217680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25365064|NCT05217680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25365065|NCT05217680|Growth Substances|growth substances|mesh-ancestor
25365066|NCT05217680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365067|NCT05217680|Growth Inhibitors|growth inhibitors|mesh-ancestor
25365068|NCT05217446|Pembrolizumab|pembrolizumab|mesh-list
25365070|NCT05217446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25365071|NCT05217446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365072|NCT05216770|Bupivacaine|bupivacaine|mesh-list
25365073|NCT05216770|Anesthetics, Local|anesthetics, local|mesh-ancestor
25365074|NCT05216770|Anesthetics|anesthetics|mesh-ancestor
25365075|NCT05216770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25365076|NCT05216770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365077|NCT05216770|Sensory System Agents|sensory system agents|mesh-ancestor
25365078|NCT05216770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25365079|NCT05216653|Capecitabine|capecitabine|mesh-list
25365080|NCT05216653|Oxaliplatin|oxaliplatin|mesh-list
25365081|NCT05216653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25365082|NCT05216653|Antimetabolites|antimetabolites|mesh-ancestor
25365083|NCT05216653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365084|NCT05216653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365085|NCT05216432|Fulvestrant|fulvestrant|mesh-list
25365086|NCT05216432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25365087|NCT05216432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365088|NCT05216432|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25365089|NCT05216432|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25365090|NCT05216432|Hormone Antagonists|hormone antagonists|mesh-ancestor
25365091|NCT05216432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25365092|NCT05216432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365093|NCT05216328|Magnesium Hydroxide|magnesium hydroxide|mesh-list
25365094|NCT05216328|Antacids|antacids|mesh-ancestor
25365095|NCT05216328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365096|NCT05216328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25365108|NCT05216055|Dexamethasone|dexamethasone|mesh-list
25365109|NCT05216055|Dexamethasone acetate|dexamethasone acetate|mesh-list
25365110|NCT05216055|Dexmedetomidine|dexmedetomidine|mesh-list
25365111|NCT05216055|Bupivacaine|bupivacaine|mesh-list
25365112|NCT05216055|Ropivacaine|ropivacaine|mesh-list
25365113|NCT05216055|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
25365114|NCT05216055|BB 1101|bb 1101|mesh-list
25365115|NCT05216055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25365117|NCT05216055|Autonomic Agents|autonomic agents|mesh-ancestor
25365118|NCT05216055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25365119|NCT05216055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365120|NCT05216055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25365121|NCT05216055|Glucocorticoids|glucocorticoids|mesh-ancestor
25365122|NCT05216055|Hormones|hormones|mesh-ancestor
25365123|NCT05216055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25365124|NCT05216055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25365125|NCT05216055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365126|NCT05216055|Anesthetics, Local|anesthetics, local|mesh-ancestor
25365127|NCT05216055|Anesthetics|anesthetics|mesh-ancestor
25365128|NCT05216055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25365129|NCT05216055|Sensory System Agents|sensory system agents|mesh-ancestor
25365130|NCT05216055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25365131|NCT05216055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25365132|NCT05216055|Analgesics|analgesics|mesh-ancestor
25365133|NCT05216055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25365134|NCT05216055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25365135|NCT05216055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25365136|NCT05216055|Adrenergic Agents|adrenergic agents|mesh-ancestor
25365137|NCT05216055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25365138|NCT05216055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365139|NCT05216055|Protease Inhibitors|protease inhibitors|mesh-ancestor
25365140|NCT05216055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25365141|NCT05215951|Osimertinib|osimertinib|mesh-list
25365142|NCT05215951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365143|NCT05215951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25365144|NCT05215951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25365145|NCT05215951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365146|NCT05215691|Morphine|morphine|mesh-list
25365147|NCT05215691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25365148|NCT05215691|Narcotics|narcotics|mesh-ancestor
25365149|NCT05215691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25365150|NCT05215691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365151|NCT05215691|Analgesics|analgesics|mesh-ancestor
25365152|NCT05215691|Sensory System Agents|sensory system agents|mesh-ancestor
25365153|NCT05215691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25365154|NCT05215418|Topiramate|topiramate|mesh-list
25365155|NCT05215418|Phentermine|phentermine|mesh-list
25365156|NCT05215418|Anticonvulsants|anticonvulsants|mesh-ancestor
25365157|NCT05215418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25365158|NCT05215418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365159|NCT05215418|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25365160|NCT05215418|Appetite Depressants|appetite depressants|mesh-ancestor
25365161|NCT05215418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25365162|NCT05215418|Sympathomimetics|sympathomimetics|mesh-ancestor
25365163|NCT05215418|Autonomic Agents|autonomic agents|mesh-ancestor
25365164|NCT05215418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25365165|NCT05215418|Adrenergic Agents|adrenergic agents|mesh-ancestor
25365166|NCT05215418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25365167|NCT05215418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365168|NCT05215340|Pembrolizumab|pembrolizumab|mesh-list
25365169|NCT05215340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25365170|NCT05215340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365171|NCT05215158|Dexmedetomidine|dexmedetomidine|mesh-list
25365172|NCT05215158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25365173|NCT05215158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25365174|NCT05215158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365175|NCT05215158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25365176|NCT05215158|Analgesics|analgesics|mesh-ancestor
25365177|NCT05215158|Sensory System Agents|sensory system agents|mesh-ancestor
25365178|NCT05215158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25365179|NCT05215158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25365180|NCT05215158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25365181|NCT05215158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25365182|NCT05215158|Adrenergic Agents|adrenergic agents|mesh-ancestor
25365183|NCT05215158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25365258|NCT05211323|Bevacizumab|bevacizumab|mesh-list
25365184|NCT05215158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365185|NCT05214573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
25365186|NCT05214573|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25365187|NCT05214573|Glucagon|glucagon|mesh-list
25365188|NCT05214573|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
25365189|NCT05214573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25365190|NCT05214573|Hormones|hormones|mesh-ancestor
25365191|NCT05214573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25365192|NCT05214573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365193|NCT05214573|Incretins|incretins|mesh-ancestor
25365194|NCT05214573|Protease Inhibitors|protease inhibitors|mesh-ancestor
25365195|NCT05214573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25365196|NCT05214573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365197|NCT05214573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25365199|NCT05214287|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25365200|NCT05214287|Protective Agents|protective agents|mesh-ancestor
25365201|NCT05214287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365202|NCT05214001|Almotriptan|almotriptan|mesh-list
25365203|NCT05214001|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25365204|NCT05214001|Serotonin Agents|serotonin agents|mesh-ancestor
25365205|NCT05214001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25365206|NCT05214001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365207|NCT05214001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365208|NCT05213728|Vaccines|vaccines|mesh-list
25365209|NCT05213728|Immunologic Factors|immunologic factors|mesh-ancestor
25365210|NCT05213728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365211|NCT05213104|Flecainide|flecainide|mesh-list
25365212|NCT05213104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25365213|NCT05213104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25365214|NCT05213104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25365215|NCT05213104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25365216|NCT05213104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365217|NCT05211947|BI 425809|bi 425809|mesh-list
25365218|NCT05211947|Nootropic Agents|nootropic agents|mesh-ancestor
25365219|NCT05211895|Durvalumab|durvalumab|mesh-list
25365220|NCT05211895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25365221|NCT05211895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365222|NCT05211791|Anesthetics|anesthetics|mesh-list
25365223|NCT05211791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25365224|NCT05211791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365225|NCT05211609|Methyldopa|methyldopa|mesh-list
25365226|NCT05211609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25365227|NCT05211609|Sympatholytics|sympatholytics|mesh-ancestor
25365228|NCT05211609|Autonomic Agents|autonomic agents|mesh-ancestor
25365229|NCT05211609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25365230|NCT05211609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365231|NCT05211609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25365232|NCT05211609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25365233|NCT05211609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25365234|NCT05211609|Adrenergic Agents|adrenergic agents|mesh-ancestor
25365235|NCT05211609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25365236|NCT05211609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365237|NCT05211336|Prednisone|prednisone|mesh-list
25365238|NCT05211336|Nivolumab|nivolumab|mesh-list
25365239|NCT05211336|Lenalidomide|lenalidomide|mesh-list
25365240|NCT05211336|Venetoclax|venetoclax|mesh-list
25365241|NCT05211336|Obinutuzumab|obinutuzumab|mesh-list
25365242|NCT05211336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25365243|NCT05211336|Glucocorticoids|glucocorticoids|mesh-ancestor
25365244|NCT05211336|Hormones|hormones|mesh-ancestor
25365245|NCT05211336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25365246|NCT05211336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365247|NCT05211336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25365248|NCT05211336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365249|NCT05211336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25365250|NCT05211336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25365251|NCT05211336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365252|NCT05211336|Immunologic Factors|immunologic factors|mesh-ancestor
25365253|NCT05211336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25365254|NCT05211336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25365255|NCT05211336|Growth Substances|growth substances|mesh-ancestor
25365256|NCT05211336|Growth Inhibitors|growth inhibitors|mesh-ancestor
25365257|NCT05211323|Gemcitabine|gemcitabine|mesh-list
25365259|NCT05211323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25365260|NCT05211323|Cisplatin|cisplatin|mesh-list
25365261|NCT05211323|Atezolizumab|atezolizumab|mesh-list
25365262|NCT05211323|Endothelial Growth Factors|endothelial growth factors|mesh-list
25365263|NCT05211323|Antibodies|antibodies|mesh-list
25365264|NCT05211323|Immunoglobulins|immunoglobulins|mesh-list
25365265|NCT05211323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25365266|NCT05211323|Immunoglobulin G|immunoglobulin g|mesh-list
25365267|NCT05211323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365268|NCT05211323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25365269|NCT05211323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25365270|NCT05211323|Growth Substances|growth substances|mesh-ancestor
25365271|NCT05211323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365272|NCT05211323|Growth Inhibitors|growth inhibitors|mesh-ancestor
25365273|NCT05211323|Immunologic Factors|immunologic factors|mesh-ancestor
25365274|NCT05211323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25365275|NCT05211323|Antimetabolites|antimetabolites|mesh-ancestor
25365276|NCT05211323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365277|NCT05211323|Antiviral Agents|antiviral agents|mesh-ancestor
25365278|NCT05211323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25365279|NCT05211323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25365280|NCT05211323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25365281|NCT05211154|Diclofenac|diclofenac|mesh-list
25365282|NCT05211154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25365283|NCT05211154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25365284|NCT05211154|Analgesics|analgesics|mesh-ancestor
25365285|NCT05211154|Sensory System Agents|sensory system agents|mesh-ancestor
25365286|NCT05211154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25365287|NCT05211154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365288|NCT05211154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25365289|NCT05211154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25365290|NCT05211154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25365291|NCT05211154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25365292|NCT05211154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365293|NCT05209984|Topiramate|topiramate|mesh-list
25365294|NCT05209984|Sibutramine|sibutramine|mesh-list
25365295|NCT05209984|Anticonvulsants|anticonvulsants|mesh-ancestor
25365296|NCT05209984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25365297|NCT05209984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365298|NCT05209984|Antidepressive Agents|antidepressive agents|mesh-ancestor
25365299|NCT05209984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25365300|NCT05209984|Appetite Depressants|appetite depressants|mesh-ancestor
25365301|NCT05209984|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25365302|NCT05209906|Fentanyl|fentanyl|mesh-list
25365303|NCT05209906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25365304|NCT05209906|Narcotics|narcotics|mesh-ancestor
25365305|NCT05209906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25365306|NCT05209906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365307|NCT05209906|Analgesics|analgesics|mesh-ancestor
25365308|NCT05209906|Sensory System Agents|sensory system agents|mesh-ancestor
25365309|NCT05209906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25365310|NCT05209906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25365311|NCT05209906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25365312|NCT05209906|Anesthetics, General|anesthetics, general|mesh-ancestor
25365313|NCT05209906|Anesthetics|anesthetics|mesh-ancestor
25365314|NCT05209867|Cannabidiol|cannabidiol|mesh-list
25365315|NCT05209867|Anticonvulsants|anticonvulsants|mesh-ancestor
25365316|NCT05209711|Lidocaine|lidocaine|mesh-list
25365317|NCT05209711|Anesthetics, Local|anesthetics, local|mesh-ancestor
25365318|NCT05209711|Anesthetics|anesthetics|mesh-ancestor
25365319|NCT05209711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25365320|NCT05209711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365321|NCT05209711|Sensory System Agents|sensory system agents|mesh-ancestor
25365322|NCT05209711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25365323|NCT05209711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25365324|NCT05209711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25365325|NCT05209711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25365326|NCT05209711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25365327|NCT05209711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365328|NCT05209490|Iodine|iodine|mesh-list
25365329|NCT05209490|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25365330|NCT05209490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25365331|NCT05209490|Trace Elements|trace elements|mesh-ancestor
25365332|NCT05209490|Micronutrients|micronutrients|mesh-ancestor
25365333|NCT05209490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365334|NCT05209425|Vitamin D|vitamin d|mesh-list
25365335|NCT05209425|Cholecalciferol|cholecalciferol|mesh-list
25365336|NCT05209425|Vitamins|vitamins|mesh-ancestor
25365340|NCT05209425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25365342|NCT05209308|Venetoclax|venetoclax|mesh-list
25365343|NCT05209308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25365344|NCT05209308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365361|NCT05208619|Anesthetics|anesthetics|mesh-list
25365362|NCT05208619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25365363|NCT05208619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365364|NCT05208047|Sunitinib|sunitinib|mesh-list
25365365|NCT05208047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365366|NCT05208047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25365367|NCT05208047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25365368|NCT05208047|Growth Substances|growth substances|mesh-ancestor
25365369|NCT05208047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365370|NCT05208047|Growth Inhibitors|growth inhibitors|mesh-ancestor
25365371|NCT05208047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25365372|NCT05208047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25365373|NCT05208047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365374|NCT05206747|Methamphetamine|methamphetamine|mesh-list
25365375|NCT05206747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25365376|NCT05206747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365377|NCT05206747|Sympathomimetics|sympathomimetics|mesh-ancestor
25365378|NCT05206747|Autonomic Agents|autonomic agents|mesh-ancestor
25365379|NCT05206747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25365380|NCT05206747|Dopamine Agents|dopamine agents|mesh-ancestor
25365381|NCT05206747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25365382|NCT05206747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365383|NCT05206747|Adrenergic Agents|adrenergic agents|mesh-ancestor
25365384|NCT05206747|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25365385|NCT05206747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25365386|NCT05206747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25365387|NCT05206747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25365388|NCT05206435|Nicotine|nicotine|mesh-list
25365389|NCT05206435|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25365390|NCT05206435|Autonomic Agents|autonomic agents|mesh-ancestor
25365391|NCT05206435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25365392|NCT05206435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365393|NCT05206435|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25365394|NCT05206435|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25365395|NCT05206435|Cholinergic Agents|cholinergic agents|mesh-ancestor
25365396|NCT05206435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25365397|NCT05206435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365398|NCT05206266|Turmeric extract|turmeric extract|mesh-list
25365399|NCT05206266|Antioxidants|antioxidants|mesh-ancestor
25365400|NCT05206266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365401|NCT05206266|Protective Agents|protective agents|mesh-ancestor
25365402|NCT05206266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365403|NCT05205811|Zonisamide|zonisamide|mesh-list
25365404|NCT05205811|Bupropion|bupropion|mesh-list
25365405|NCT05205811|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25365406|NCT05205811|Antidepressive Agents|antidepressive agents|mesh-ancestor
25365407|NCT05205811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25365408|NCT05205811|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25365409|NCT05205811|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25365483|NCT05204147|Sequestering Agents|sequestering agents|mesh-ancestor
25365410|NCT05205811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25365411|NCT05205811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365412|NCT05205811|Dopamine Agents|dopamine agents|mesh-ancestor
25365413|NCT05205811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25365414|NCT05205811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365415|NCT05205811|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25365416|NCT05205811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25365417|NCT05205811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25365418|NCT05205811|Anticonvulsants|anticonvulsants|mesh-ancestor
25365419|NCT05205811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25365420|NCT05205811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25365421|NCT05205473|Lidocaine|lidocaine|mesh-list
25365422|NCT05205473|Anesthetics|anesthetics|mesh-list
25365423|NCT05205473|Anesthetics, Local|anesthetics, local|mesh-ancestor
25365424|NCT05205473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25365425|NCT05205473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365426|NCT05205473|Sensory System Agents|sensory system agents|mesh-ancestor
25365427|NCT05205473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25365428|NCT05205473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25365429|NCT05205473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25365430|NCT05205473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25365431|NCT05205473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25365432|NCT05205473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365433|NCT05205382|Nicotine|nicotine|mesh-list
25365434|NCT05205382|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25365435|NCT05205382|Autonomic Agents|autonomic agents|mesh-ancestor
25365436|NCT05205382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25365437|NCT05205382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365438|NCT05205382|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25365439|NCT05205382|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25365440|NCT05205382|Cholinergic Agents|cholinergic agents|mesh-ancestor
25365441|NCT05205382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25365442|NCT05205382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365443|NCT05204927|Prednisone|prednisone|mesh-list
25365444|NCT05204927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25365445|NCT05204927|Glucocorticoids|glucocorticoids|mesh-ancestor
25365446|NCT05204927|Hormones|hormones|mesh-ancestor
25365447|NCT05204927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25365448|NCT05204927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365449|NCT05204927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25365450|NCT05204927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365451|NCT05204862|Antibodies|antibodies|mesh-list
25365452|NCT05204862|Immunologic Factors|immunologic factors|mesh-ancestor
25365453|NCT05204862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365454|NCT05204667|Acetaminophen|acetaminophen|mesh-list
25365455|NCT05204667|Aspirin|aspirin|mesh-list
25365456|NCT05204667|Methocarbamol|methocarbamol|mesh-list
25365457|NCT05204667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25365458|NCT05204667|Analgesics|analgesics|mesh-ancestor
25365459|NCT05204667|Sensory System Agents|sensory system agents|mesh-ancestor
25365460|NCT05204667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25365461|NCT05204667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365462|NCT05204667|Antipyretics|antipyretics|mesh-ancestor
25365463|NCT05204667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25365464|NCT05204667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25365465|NCT05204667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25365466|NCT05204667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25365467|NCT05204667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25365468|NCT05204667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365469|NCT05204667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25365470|NCT05204667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25365471|NCT05204667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25365472|NCT05204667|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25365473|NCT05204667|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25365474|NCT05204147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25365475|NCT05204147|Antibodies|antibodies|mesh-list
25365476|NCT05204147|Immunoglobulins|immunoglobulins|mesh-list
25365477|NCT05204147|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25365478|NCT05204147|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
25365479|NCT05204147|Immunologic Factors|immunologic factors|mesh-ancestor
25365480|NCT05204147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365481|NCT05204147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365482|NCT05204147|Chelating Agents|chelating agents|mesh-ancestor
25365484|NCT05204147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365486|NCT05203822|Tepotinib|tepotinib|mesh-list
25365487|NCT05203822|Antifungal Agents|antifungal agents|mesh-ancestor
25365488|NCT05203822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25365489|NCT05203822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25365490|NCT05203822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25365491|NCT05203822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25365492|NCT05203822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365493|NCT05203822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25365494|NCT05203822|Hormone Antagonists|hormone antagonists|mesh-ancestor
25365495|NCT05203822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25365505|NCT05202860|Immunologic Factors|immunologic factors|mesh-ancestor
25365506|NCT05202860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365507|NCT05202782|Zanubrutinib|zanubrutinib|mesh-list
25365508|NCT05202782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365509|NCT05202782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25365510|NCT05202782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25365511|NCT05202782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365512|NCT05202353|Liraglutide|liraglutide|mesh-list
25365513|NCT05202353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25365514|NCT05202353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365515|NCT05202353|Incretins|incretins|mesh-ancestor
25365516|NCT05202353|Hormones|hormones|mesh-ancestor
25365517|NCT05202353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25365518|NCT05202262|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25365519|NCT05202262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25365520|NCT05202262|Respiratory System Agents|respiratory system agents|mesh-ancestor
25365521|NCT05202080|Analgesics, Opioid|analgesics, opioid|mesh-list
25365522|NCT05202080|Narcotics|narcotics|mesh-ancestor
25365523|NCT05202080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25365524|NCT05202080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365525|NCT05202080|Analgesics|analgesics|mesh-ancestor
25365526|NCT05202080|Sensory System Agents|sensory system agents|mesh-ancestor
25365527|NCT05202080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25365528|NCT05201638|Calcium, Dietary|calcium, dietary|mesh-list
25365529|NCT05201638|Calcium|calcium|mesh-list
25365530|NCT05201638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25365531|NCT05201638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365532|NCT05201638|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25365533|NCT05201612|Pembrolizumab|pembrolizumab|mesh-list
25365534|NCT05201612|Olaparib|olaparib|mesh-list
25365535|NCT05201612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25365536|NCT05201612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365537|NCT05201612|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25365538|NCT05201612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25365539|NCT05201612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365540|NCT05201547|Paclitaxel|paclitaxel|mesh-list
25365541|NCT05201547|Carboplatin|carboplatin|mesh-list
25365542|NCT05201547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25365543|NCT05201547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365544|NCT05201547|Tubulin Modulators|tubulin modulators|mesh-ancestor
25365545|NCT05201547|Antimitotic Agents|antimitotic agents|mesh-ancestor
25365546|NCT05201547|Mitosis Modulators|mitosis modulators|mesh-ancestor
25365547|NCT05201547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365548|NCT05201313|Lidocaine|lidocaine|mesh-list
25365549|NCT05201313|Mepivacaine|mepivacaine|mesh-list
25365550|NCT05201313|Anesthetics, Local|anesthetics, local|mesh-ancestor
25365551|NCT05201313|Anesthetics|anesthetics|mesh-ancestor
25365552|NCT05201313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25365553|NCT05201313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365554|NCT05201313|Sensory System Agents|sensory system agents|mesh-ancestor
25365555|NCT05201313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25365556|NCT05201313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25365557|NCT05201313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25365558|NCT05201313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25365559|NCT05201313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25365560|NCT05201313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365618|NCT05200364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365619|NCT05200364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25365620|NCT05200364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25365621|NCT05200364|Growth Substances|growth substances|mesh-ancestor
25365622|NCT05200364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365623|NCT05200364|Growth Inhibitors|growth inhibitors|mesh-ancestor
25365625|NCT05200286|Antifungal Agents|antifungal agents|mesh-ancestor
25365626|NCT05200286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25365627|NCT05200208|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
25365628|NCT05200208|Nootropic Agents|nootropic agents|mesh-ancestor
25365629|NCT05200052|Colchicine|colchicine|mesh-list
25365630|NCT05200052|Gout Suppressants|gout suppressants|mesh-ancestor
25365631|NCT05200052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25365632|NCT05200052|Tubulin Modulators|tubulin modulators|mesh-ancestor
25365640|NCT05199818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25365641|NCT05199818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365642|NCT05199818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25365643|NCT05199818|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25365644|NCT05199818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25365646|NCT05199818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25365647|NCT05199818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365648|NCT05199571|Ofatumumab|ofatumumab|mesh-list
25365649|NCT05199571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365650|NCT05199285|Nivolumab|nivolumab|mesh-list
25365651|NCT05199285|Ipilimumab|ipilimumab|mesh-list
25365652|NCT05199285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25365653|NCT05199285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365654|NCT05199285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25365655|NCT05199285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365664|NCT05198843|Dasatinib|dasatinib|mesh-list
25365665|NCT05198843|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
25365666|NCT05198843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365667|NCT05198843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25365668|NCT05198843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25365669|NCT05198843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365670|NCT05198843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25365671|NCT05198843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25365672|NCT05198830|Cisplatin|cisplatin|mesh-list
25365673|NCT05198830|Pemetrexed|pemetrexed|mesh-list
25365674|NCT05198830|Durvalumab|durvalumab|mesh-list
25365675|NCT05198830|Immunoglobulins|immunoglobulins|mesh-list
25365676|NCT05198830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25365677|NCT05198830|Immunoglobulin G|immunoglobulin g|mesh-list
25365678|NCT05198830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365679|NCT05198830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25365680|NCT05198830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365681|NCT05198830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25365682|NCT05198830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25365683|NCT05198830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25365684|NCT05198830|Immunologic Factors|immunologic factors|mesh-ancestor
25365685|NCT05198830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365686|NCT05198804|Niraparib|niraparib|mesh-list
25365687|NCT05198804|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25365688|NCT05198804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25365689|NCT05198804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365690|NCT05198804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365691|NCT05198544|Hyaluronic Acid|hyaluronic acid|mesh-list
25365692|NCT05198544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25365693|NCT05198544|Immunologic Factors|immunologic factors|mesh-ancestor
25365694|NCT05198544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365695|NCT05198544|Viscosupplements|viscosupplements|mesh-ancestor
25365696|NCT05198544|Protective Agents|protective agents|mesh-ancestor
25365697|NCT05197257|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25365698|NCT05197257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25365699|NCT05197257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365700|NCT05197075|Darunavir|darunavir|mesh-list
25365701|NCT05197075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25365702|NCT05197075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25365703|NCT05197075|Protease Inhibitors|protease inhibitors|mesh-ancestor
25365704|NCT05197075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25365705|NCT05197075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365706|NCT05197075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25365707|NCT05197075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25365708|NCT05197075|Antiviral Agents|antiviral agents|mesh-ancestor
25365709|NCT05197075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25365710|NCT05196932|Antibodies|antibodies|mesh-list
25365711|NCT05196932|Immunologic Factors|immunologic factors|mesh-ancestor
25365712|NCT05196932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365713|NCT05196815|Dobutamine|dobutamine|mesh-list
25365714|NCT05196815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25365715|NCT05196815|Sympathomimetics|sympathomimetics|mesh-ancestor
25365716|NCT05196815|Autonomic Agents|autonomic agents|mesh-ancestor
25365717|NCT05196815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25365718|NCT05196815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365719|NCT05196815|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
25365720|NCT05196815|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25365721|NCT05196815|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25365722|NCT05196815|Adrenergic Agents|adrenergic agents|mesh-ancestor
25365723|NCT05196815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25365724|NCT05196815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365725|NCT05196815|Protective Agents|protective agents|mesh-ancestor
25365726|NCT05195918|Pirfenidone|pirfenidone|mesh-list
25365727|NCT05195918|Nintedanib|nintedanib|mesh-list
25365728|NCT05195918|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
25365729|NCT05195918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365730|NCT05195918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25365731|NCT05195918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25365732|NCT05195918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365733|NCT05195918|Analgesics|analgesics|mesh-ancestor
25365734|NCT05195918|Sensory System Agents|sensory system agents|mesh-ancestor
25365735|NCT05195918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25365736|NCT05195918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365737|NCT05195918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25365738|NCT05195918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25365739|NCT05195918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25365740|NCT05195918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25365741|NCT05195918|Antioxidants|antioxidants|mesh-ancestor
25365742|NCT05195918|Protective Agents|protective agents|mesh-ancestor
25365743|NCT05195918|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25365744|NCT05195918|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25365745|NCT05195918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25365746|NCT05195645|Abatacept|abatacept|mesh-list
25365747|NCT05195645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25365748|NCT05195645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365749|NCT05195645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365750|NCT05195645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25365751|NCT05195645|Immunologic Factors|immunologic factors|mesh-ancestor
25365752|NCT05195645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365753|NCT05195645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25365754|NCT05194995|Cetuximab|cetuximab|mesh-list
25365755|NCT05194995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25365756|NCT05194995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365757|NCT05194735|Aldesleukin|aldesleukin|mesh-list
25365758|NCT05194735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365759|NCT05194735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25365760|NCT05194735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25365761|NCT05194735|Antiviral Agents|antiviral agents|mesh-ancestor
25365762|NCT05194735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25365763|NCT05194293|Durvalumab|durvalumab|mesh-list
25365764|NCT05194293|Immunoglobulins|immunoglobulins|mesh-list
25365765|NCT05194293|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25365766|NCT05194293|Immunoglobulin G|immunoglobulin g|mesh-list
25365767|NCT05194293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25365768|NCT05194293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365769|NCT05194293|Immunologic Factors|immunologic factors|mesh-ancestor
25365770|NCT05194293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365771|NCT05193552|gamma-Globulins|gamma-globulins|mesh-list
25365772|NCT05193552|Immunologic Factors|immunologic factors|mesh-ancestor
25365773|NCT05193552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365774|NCT05193318|Ketamine|ketamine|mesh-list
25365775|NCT05193318|Analgesics|analgesics|mesh-ancestor
25365776|NCT05193318|Sensory System Agents|sensory system agents|mesh-ancestor
25365777|NCT05193318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25365778|NCT05193318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365779|NCT05193318|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25365780|NCT05193318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25365781|NCT05193318|Anesthetics, General|anesthetics, general|mesh-ancestor
25365782|NCT05193318|Anesthetics|anesthetics|mesh-ancestor
25365783|NCT05193318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25366013|NCT05183035|Fludarabine|fludarabine|mesh-list
25365784|NCT05193318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25365785|NCT05193318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25365786|NCT05193318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25365787|NCT05193318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365788|NCT05193019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25365790|NCT05192889|Cytarabine|cytarabine|mesh-list
25365791|NCT05192889|Dexamethasone|dexamethasone|mesh-list
25365792|NCT05192889|Hydrocortisone|hydrocortisone|mesh-list
25365793|NCT05192889|Cyclophosphamide|cyclophosphamide|mesh-list
25365794|NCT05192889|Methotrexate|methotrexate|mesh-list
25365795|NCT05192889|Etoposide|etoposide|mesh-list
25365796|NCT05192889|Vincristine|vincristine|mesh-list
25365797|NCT05192889|Dasatinib|dasatinib|mesh-list
25365798|NCT05192889|Asparaginase|asparaginase|mesh-list
25365799|NCT05192889|Venetoclax|venetoclax|mesh-list
25365800|NCT05192889|Mercaptopurine|mercaptopurine|mesh-list
25365801|NCT05192889|Pegaspargase|pegaspargase|mesh-list
25365802|NCT05192889|Blinatumomab|blinatumomab|mesh-list
25365803|NCT05192889|Navitoclax|navitoclax|mesh-list
25365804|NCT05192889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25365805|NCT05192889|Immunologic Factors|immunologic factors|mesh-ancestor
25365806|NCT05192889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365807|NCT05192889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25365808|NCT05192889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25365809|NCT05192889|Alkylating Agents|alkylating agents|mesh-ancestor
25365810|NCT05192889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365811|NCT05192889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365812|NCT05192889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25365813|NCT05192889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25365814|NCT05192889|Antiemetics|antiemetics|mesh-ancestor
25365815|NCT05192889|Autonomic Agents|autonomic agents|mesh-ancestor
25397780|NCT03984448|Vincristine|vincristine|mesh-list
25365816|NCT05192889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25365817|NCT05192889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25365818|NCT05192889|Glucocorticoids|glucocorticoids|mesh-ancestor
25365819|NCT05192889|Hormones|hormones|mesh-ancestor
25365895|NCT05190445|Mitosis Modulators|mitosis modulators|mesh-ancestor
25365820|NCT05192889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25365821|NCT05192889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25365822|NCT05192889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25365823|NCT05192889|Abortifacient Agents|abortifacient agents|mesh-ancestor
25365824|NCT05192889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25365825|NCT05192889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25365826|NCT05192889|Antimetabolites|antimetabolites|mesh-ancestor
25365827|NCT05192889|Dermatologic Agents|dermatologic agents|mesh-ancestor
25365828|NCT05192889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25365829|NCT05192889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25365830|NCT05192889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25365831|NCT05192889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25365832|NCT05192889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25365833|NCT05192889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25365834|NCT05192889|Antiviral Agents|antiviral agents|mesh-ancestor
25365835|NCT05192889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25365836|NCT05192889|Antidotes|antidotes|mesh-ancestor
25365837|NCT05192889|Protective Agents|protective agents|mesh-ancestor
25365838|NCT05192889|Vitamin B Complex|vitamin b complex|mesh-ancestor
25365839|NCT05192889|Vitamins|vitamins|mesh-ancestor
25365840|NCT05192889|Micronutrients|micronutrients|mesh-ancestor
25365841|NCT05192889|Tubulin Modulators|tubulin modulators|mesh-ancestor
25365842|NCT05192889|Antimitotic Agents|antimitotic agents|mesh-ancestor
25365843|NCT05192889|Mitosis Modulators|mitosis modulators|mesh-ancestor
25365844|NCT05192889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25365845|NCT05192200|Interferons|interferons|mesh-list
25365846|NCT05192200|Interferon-beta|interferon-beta|mesh-list
25365847|NCT05192200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365848|NCT05192200|Antiviral Agents|antiviral agents|mesh-ancestor
25365849|NCT05192200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25365850|NCT05192200|Immunologic Factors|immunologic factors|mesh-ancestor
25365851|NCT05192200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365852|NCT05191940|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25365853|NCT05191940|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25365854|NCT05191940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365855|NCT05191472|Pembrolizumab|pembrolizumab|mesh-list
25365856|NCT05191472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25365857|NCT05191472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365858|NCT05191277|Antidepressive Agents|antidepressive agents|mesh-list
25365859|NCT05191277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25365860|NCT05191004|Fulvestrant|fulvestrant|mesh-list
25365861|NCT05191004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25365862|NCT05191004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365863|NCT05191004|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25365864|NCT05191004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25365865|NCT05191004|Hormone Antagonists|hormone antagonists|mesh-ancestor
25365866|NCT05191004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25365867|NCT05191004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365868|NCT05190770|Triamcinolone|triamcinolone|mesh-list
25365869|NCT05190770|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25365870|NCT05190770|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25365871|NCT05190770|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25365872|NCT05190770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25365873|NCT05190770|Glucocorticoids|glucocorticoids|mesh-ancestor
25365874|NCT05190770|Hormones|hormones|mesh-ancestor
25365875|NCT05190770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25365876|NCT05190770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365877|NCT05190770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25365878|NCT05190770|Immunologic Factors|immunologic factors|mesh-ancestor
25365879|NCT05190770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25365880|NCT05190770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365881|NCT05190471|Decitabine|decitabine|mesh-list
25365882|NCT05190471|Oblimersen|oblimersen|mesh-list
25365883|NCT05190471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25365884|NCT05190471|Antimetabolites|antimetabolites|mesh-ancestor
25365885|NCT05190471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365886|NCT05190471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365887|NCT05190471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25724231|NCT02535806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25365889|NCT05190445|Ramucirumab|ramucirumab|mesh-list
25365890|NCT05190445|Tucatinib|tucatinib|mesh-list
25365891|NCT05190445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25365892|NCT05190445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365893|NCT05190445|Tubulin Modulators|tubulin modulators|mesh-ancestor
25365894|NCT05190445|Antimitotic Agents|antimitotic agents|mesh-ancestor
25365896|NCT05190445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365897|NCT05190445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25365898|NCT05190445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25365899|NCT05190094|Letrozole|letrozole|mesh-list
25365900|NCT05190094|Palbociclib|palbociclib|mesh-list
25365901|NCT05190094|Anastrozole|anastrozole|mesh-list
25365902|NCT05190094|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25365903|NCT05190094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365904|NCT05190094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25365905|NCT05190094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25365906|NCT05190094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365907|NCT05190094|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25365908|NCT05190094|Hormone Antagonists|hormone antagonists|mesh-ancestor
25365909|NCT05190094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25365910|NCT05190094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365911|NCT05190094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25365912|NCT05190094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25365913|NCT05189977|Propranolol|propranolol|mesh-list
25365914|NCT05189977|Prazosin|prazosin|mesh-list
25365915|NCT05189977|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25365916|NCT05189977|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25365917|NCT05189977|Adrenergic Agents|adrenergic agents|mesh-ancestor
25365918|NCT05189977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25365919|NCT05189977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365920|NCT05189977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365921|NCT05189977|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25365922|NCT05189977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25365923|NCT05189977|Vasodilator Agents|vasodilator agents|mesh-ancestor
25365924|NCT05189977|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25365925|NCT05189977|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25365926|NCT05189535|Paclitaxel|paclitaxel|mesh-list
25365927|NCT05189535|Pentoxifylline|pentoxifylline|mesh-list
25365928|NCT05189535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25365929|NCT05189535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365930|NCT05189535|Tubulin Modulators|tubulin modulators|mesh-ancestor
25365931|NCT05189535|Antimitotic Agents|antimitotic agents|mesh-ancestor
25365932|NCT05189535|Mitosis Modulators|mitosis modulators|mesh-ancestor
25365933|NCT05189535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365934|NCT05189535|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25365935|NCT05189535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25365943|NCT05189015|Olmesartan|olmesartan|mesh-list
25365944|NCT05189015|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
25365945|NCT05189015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25365946|NCT05189015|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25365947|NCT05189015|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25365948|NCT05189015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365949|NCT05188677|Vaccines|vaccines|mesh-list
25365950|NCT05188677|Immunologic Factors|immunologic factors|mesh-ancestor
25365951|NCT05188677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365952|NCT05188222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25365953|NCT05187182|Leucovorin|leucovorin|mesh-list
25365954|NCT05187182|Pembrolizumab|pembrolizumab|mesh-list
25365955|NCT05187182|Nivolumab|nivolumab|mesh-list
25365956|NCT05187182|Trastuzumab|trastuzumab|mesh-list
25365957|NCT05187182|Oxaliplatin|oxaliplatin|mesh-list
25365958|NCT05187182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25365959|NCT05187182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365960|NCT05187182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25365961|NCT05187182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365962|NCT05187182|Antidotes|antidotes|mesh-ancestor
25365963|NCT05187182|Protective Agents|protective agents|mesh-ancestor
25365964|NCT05187182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365965|NCT05187182|Vitamin B Complex|vitamin b complex|mesh-ancestor
25365966|NCT05187182|Vitamins|vitamins|mesh-ancestor
25365967|NCT05187182|Micronutrients|micronutrients|mesh-ancestor
25365968|NCT05186974|Cisplatin|cisplatin|mesh-list
25365969|NCT05186974|Carboplatin|carboplatin|mesh-list
25365970|NCT05186974|Pembrolizumab|pembrolizumab|mesh-list
25365971|NCT05186974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365972|NCT05186974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25365973|NCT05186545|Fulvestrant|fulvestrant|mesh-list
25365974|NCT05186545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25365975|NCT05186545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365976|NCT05186545|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25365977|NCT05186545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25365978|NCT05186545|Hormone Antagonists|hormone antagonists|mesh-ancestor
25365979|NCT05186545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25365980|NCT05186545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25365981|NCT05185999|Icodextrin|icodextrin|mesh-list
25365982|NCT05185999|Dialysis Solutions|dialysis solutions|mesh-ancestor
25365983|NCT05185999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25365991|NCT05185739|Pembrolizumab|pembrolizumab|mesh-list
25365992|NCT05185739|Lenvatinib|lenvatinib|mesh-list
25365993|NCT05185739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25365994|NCT05185739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25365995|NCT05185739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25365996|NCT05185739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25365997|NCT05185739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25365998|NCT05185089|Maleic acid|maleic acid|mesh-list
25365999|NCT05185089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366000|NCT05185089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366001|NCT05184868|Insulin Aspart|insulin aspart|mesh-list
25366002|NCT05184868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25366003|NCT05184868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366004|NCT05184816|Deferoxamine|deferoxamine|mesh-list
25366005|NCT05184816|Siderophores|siderophores|mesh-ancestor
25366006|NCT05184816|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25366007|NCT05184816|Chelating Agents|chelating agents|mesh-ancestor
25366008|NCT05184816|Sequestering Agents|sequestering agents|mesh-ancestor
25366009|NCT05184816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366010|NCT05183737|Propolis|propolis|mesh-list
25366011|NCT05183737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25366012|NCT05183035|Cytarabine|cytarabine|mesh-list
25366014|NCT05183035|Azacitidine|azacitidine|mesh-list
25366015|NCT05183035|Venetoclax|venetoclax|mesh-list
25366016|NCT05183035|Gemtuzumab|gemtuzumab|mesh-list
25366017|NCT05183035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366018|NCT05183035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25366019|NCT05183035|Antimetabolites|antimetabolites|mesh-ancestor
25366020|NCT05183035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366021|NCT05183035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25366022|NCT05183035|Immunologic Factors|immunologic factors|mesh-ancestor
25366023|NCT05183035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366024|NCT05183035|Antiviral Agents|antiviral agents|mesh-ancestor
25366025|NCT05183035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25366026|NCT05183035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366027|NCT05183035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25366028|NCT05182931|Trametinib|trametinib|mesh-list
25366029|NCT05182931|Dabrafenib|dabrafenib|mesh-list
25366030|NCT05182931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366031|NCT05182931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25366032|NCT05182931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366033|NCT05182931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366034|NCT05182840|Empagliflozin|empagliflozin|mesh-list
25366035|NCT05182840|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25366036|NCT05182840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366037|NCT05182840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25366038|NCT05182840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366039|NCT05182164|Pembrolizumab|pembrolizumab|mesh-list
25366040|NCT05182164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25366041|NCT05182164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366042|NCT05182151|Istradefylline|istradefylline|mesh-list
25366043|NCT05182151|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
25366044|NCT05182151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25366045|NCT05182151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25366046|NCT05182151|Purinergic Agents|purinergic agents|mesh-ancestor
25366047|NCT05182151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25366048|NCT05182151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366049|NCT05182151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366051|NCT05181605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366052|NCT05181436|Chrysarobin|chrysarobin|mesh-list
25366053|NCT05181436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25366054|NCT05181436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25366055|NCT05181436|Analgesics|analgesics|mesh-ancestor
25366056|NCT05181436|Sensory System Agents|sensory system agents|mesh-ancestor
25366057|NCT05181436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25366058|NCT05181436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366059|NCT05181436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25366060|NCT05181436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25366061|NCT05181046|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25366062|NCT05181046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25366064|NCT05180942|Calcium|calcium|mesh-list
25366065|NCT05180942|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25366066|NCT05180942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366067|NCT05180942|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25366068|NCT05180942|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25366069|NCT05180942|Antimetabolites|antimetabolites|mesh-ancestor
25366070|NCT05180942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366071|NCT05180942|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25366072|NCT05180942|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25366073|NCT05180942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366074|NCT05180773|Bromocriptine|bromocriptine|mesh-list
25366075|NCT05180773|Rivaroxaban|rivaroxaban|mesh-list
25366076|NCT05180773|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25366077|NCT05180773|Antithrombins|antithrombins|mesh-ancestor
25366078|NCT05180773|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25366079|NCT05180773|Protease Inhibitors|protease inhibitors|mesh-ancestor
25366080|NCT05180773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366081|NCT05180773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366082|NCT05180773|Anticoagulants|anticoagulants|mesh-ancestor
25366083|NCT05180773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25366084|NCT05180773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25366085|NCT05180773|Hormone Antagonists|hormone antagonists|mesh-ancestor
25366086|NCT05180773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25366087|NCT05180773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366088|NCT05180773|Dopamine Agonists|dopamine agonists|mesh-ancestor
25366089|NCT05180773|Dopamine Agents|dopamine agents|mesh-ancestor
25366090|NCT05180773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25366091|NCT05180708|Sirolimus|sirolimus|mesh-list
25366092|NCT05180708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25366093|NCT05180708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25366094|NCT05180708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25366095|NCT05180708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366096|NCT05180708|Antifungal Agents|antifungal agents|mesh-ancestor
25366097|NCT05180708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25366098|NCT05180708|Immunologic Factors|immunologic factors|mesh-ancestor
25366099|NCT05180708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366100|NCT05180474|Antibodies|antibodies|mesh-list
25366101|NCT05180474|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25366102|NCT05180474|Immunologic Factors|immunologic factors|mesh-ancestor
25366103|NCT05180474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366104|NCT05180357|Benralizumab|benralizumab|mesh-list
25366105|NCT05180357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25366106|NCT05180357|Respiratory System Agents|respiratory system agents|mesh-ancestor
25366107|NCT05180240|Cannabidiol|cannabidiol|mesh-list
25366108|NCT05180240|Anticonvulsants|anticonvulsants|mesh-ancestor
25366109|NCT05180097|Gemcitabine|gemcitabine|mesh-list
25366110|NCT05180097|Dexamethasone|dexamethasone|mesh-list
25366111|NCT05180097|Cisplatin|cisplatin|mesh-list
25366112|NCT05180097|Pembrolizumab|pembrolizumab|mesh-list
25366113|NCT05180097|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25366114|NCT05180097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366115|NCT05180097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25366116|NCT05180097|Antiemetics|antiemetics|mesh-ancestor
25366117|NCT05180097|Autonomic Agents|autonomic agents|mesh-ancestor
25366118|NCT05180097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25366119|NCT05180097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366120|NCT05180097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25366121|NCT05180097|Glucocorticoids|glucocorticoids|mesh-ancestor
25366122|NCT05180097|Hormones|hormones|mesh-ancestor
25366197|NCT05178862|Echinocandins|echinocandins|mesh-list
25366123|NCT05180097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25366124|NCT05180097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25366125|NCT05180097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25366126|NCT05180097|Antimetabolites|antimetabolites|mesh-ancestor
25366127|NCT05180097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366128|NCT05180097|Antiviral Agents|antiviral agents|mesh-ancestor
25366129|NCT05180097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25366130|NCT05180097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366131|NCT05180097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25366132|NCT05180097|Immunologic Factors|immunologic factors|mesh-ancestor
25366133|NCT05180097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25366135|NCT05179876|Tadalafil|tadalafil|mesh-list
25366136|NCT05179876|Macitentan|macitentan|mesh-list
25366137|NCT05179876|Vasodilator Agents|vasodilator agents|mesh-ancestor
25366138|NCT05179876|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25366139|NCT05179876|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25366140|NCT05179876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366141|NCT05179876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366142|NCT05179876|Urological Agents|urological agents|mesh-ancestor
25366143|NCT05179876|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25366144|NCT05179876|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25366145|NCT05179876|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25366146|NCT05179876|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25366147|NCT05179772|Olanzapine|olanzapine|mesh-list
25366148|NCT05179772|Antiemetics|antiemetics|mesh-ancestor
25366149|NCT05179772|Autonomic Agents|autonomic agents|mesh-ancestor
25366150|NCT05179772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25366151|NCT05179772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366152|NCT05179772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25366153|NCT05179772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25366154|NCT05179772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25366155|NCT05179772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25366156|NCT05179772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25366157|NCT05179772|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25366158|NCT05179772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25366159|NCT05179772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25366160|NCT05179772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366161|NCT05179772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25366162|NCT05179772|Serotonin Agents|serotonin agents|mesh-ancestor
25366163|NCT05179733|Rituximab|rituximab|mesh-list
25366164|NCT05179733|Lenalidomide|lenalidomide|mesh-list
25366165|NCT05179733|Zanubrutinib|zanubrutinib|mesh-list
25366166|NCT05179733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25366167|NCT05179733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366168|NCT05179733|Immunologic Factors|immunologic factors|mesh-ancestor
25366169|NCT05179733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366170|NCT05179733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25366171|NCT05179733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25366172|NCT05179733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25366173|NCT05179733|Growth Substances|growth substances|mesh-ancestor
25366174|NCT05179733|Growth Inhibitors|growth inhibitors|mesh-ancestor
25366175|NCT05179733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25366176|NCT05179733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366177|NCT05179733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366178|NCT05179668|Dapagliflozin|dapagliflozin|mesh-list
25366179|NCT05179668|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25366180|NCT05179668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366181|NCT05179668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25366182|NCT05179668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366183|NCT05179603|Pembrolizumab|pembrolizumab|mesh-list
25366184|NCT05179603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25366185|NCT05179603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366186|NCT05178888|Palbociclib|palbociclib|mesh-list
25366187|NCT05178888|Adagrasib|adagrasib|mesh-list
25366188|NCT05178888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366189|NCT05178888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25366190|NCT05178888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366191|NCT05178888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366192|NCT05178862|Fluconazole|fluconazole|mesh-list
25366193|NCT05178862|Caspofungin|caspofungin|mesh-list
25366194|NCT05178862|Micafungin|micafungin|mesh-list
25366195|NCT05178862|Anidulafungin|anidulafungin|mesh-list
25366196|NCT05178862|Ibrexafungerp|ibrexafungerp|mesh-list
25366198|NCT05178862|Antifungal Agents|antifungal agents|mesh-ancestor
25366199|NCT05178862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25366200|NCT05178862|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25366201|NCT05178862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25366202|NCT05178862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366203|NCT05178862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366204|NCT05178862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25366205|NCT05178862|Hormone Antagonists|hormone antagonists|mesh-ancestor
25366206|NCT05178862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25398157|NCT03969953|Antithrombins|antithrombins|mesh-ancestor
25366207|NCT05178862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366208|NCT05178862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25366209|NCT05178862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25366210|NCT05178485|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25366211|NCT05178485|Bupivacaine|bupivacaine|mesh-list
25366212|NCT05178485|Anesthetics, Local|anesthetics, local|mesh-ancestor
25366213|NCT05178485|Anesthetics|anesthetics|mesh-ancestor
25366214|NCT05178485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25366215|NCT05178485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366216|NCT05178485|Sensory System Agents|sensory system agents|mesh-ancestor
25366217|NCT05178485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25366218|NCT05178485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25366219|NCT05178485|Glucocorticoids|glucocorticoids|mesh-ancestor
25366220|NCT05178485|Hormones|hormones|mesh-ancestor
25366221|NCT05178485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25366222|NCT05178485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25366223|NCT05178485|Immunologic Factors|immunologic factors|mesh-ancestor
25366224|NCT05177822|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25366225|NCT05177822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25366226|NCT05177796|Paclitaxel|paclitaxel|mesh-list
25366227|NCT05177796|Cyclophosphamide|cyclophosphamide|mesh-list
25366228|NCT05177796|Carboplatin|carboplatin|mesh-list
25366229|NCT05177796|Doxorubicin|doxorubicin|mesh-list
25366230|NCT05177796|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25366231|NCT05177796|Pembrolizumab|pembrolizumab|mesh-list
25366232|NCT05177796|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25366233|NCT05177796|Daunorubicin|daunorubicin|mesh-list
25366234|NCT05177796|Panitumumab|panitumumab|mesh-list
25366235|NCT05177796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25366236|NCT05177796|Antibodies|antibodies|mesh-list
25366237|NCT05177796|Immunoglobulins|immunoglobulins|mesh-list
25366238|NCT05177796|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25366239|NCT05177796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25366240|NCT05177796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366241|NCT05177796|Tubulin Modulators|tubulin modulators|mesh-ancestor
25366242|NCT05177796|Antimitotic Agents|antimitotic agents|mesh-ancestor
25366243|NCT05177796|Mitosis Modulators|mitosis modulators|mesh-ancestor
25366244|NCT05177796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366245|NCT05177796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25366246|NCT05177796|Immunologic Factors|immunologic factors|mesh-ancestor
25366247|NCT05177796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366248|NCT05177796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25366249|NCT05177796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25366250|NCT05177796|Alkylating Agents|alkylating agents|mesh-ancestor
25366251|NCT05177796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25366252|NCT05177796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25366253|NCT05177796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25366254|NCT05177796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25366255|NCT05177796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366256|NCT05177718|Natalizumab|natalizumab|mesh-list
25366257|NCT05177718|Immunologic Factors|immunologic factors|mesh-ancestor
25366258|NCT05177718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366259|NCT05177419|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
25366260|NCT05177419|Hallucinogens|hallucinogens|mesh-ancestor
25366261|NCT05177419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366262|NCT05177419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25366263|NCT05177419|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25366264|NCT05177419|Serotonin Agents|serotonin agents|mesh-ancestor
25366265|NCT05177419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25366266|NCT05177419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366267|NCT05177419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25366268|NCT05177133|Capecitabine|capecitabine|mesh-list
25366269|NCT05177133|Oxaliplatin|oxaliplatin|mesh-list
25366270|NCT05177133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25366271|NCT05177133|Antimetabolites|antimetabolites|mesh-ancestor
25366423|NCT05173831|Hallucinogens|hallucinogens|mesh-ancestor
25366272|NCT05177133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366273|NCT05177133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366274|NCT05177055|Methamphetamine|methamphetamine|mesh-list
25366275|NCT05177055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25366276|NCT05177055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366277|NCT05177055|Sympathomimetics|sympathomimetics|mesh-ancestor
25366278|NCT05177055|Autonomic Agents|autonomic agents|mesh-ancestor
25366279|NCT05177055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25724232|NCT02535806|Tubulin Modulators|tubulin modulators|mesh-ancestor
25366280|NCT05177055|Dopamine Agents|dopamine agents|mesh-ancestor
25366281|NCT05177055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25366282|NCT05177055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366283|NCT05177055|Adrenergic Agents|adrenergic agents|mesh-ancestor
25366284|NCT05177055|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25366285|NCT05177055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25366286|NCT05177055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25366287|NCT05177055|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25366288|NCT05176951|Treprostinil|treprostinil|mesh-list
25366289|NCT05176951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25366290|NCT05176821|Amoxicillin|amoxicillin|mesh-list
25366291|NCT05176821|Furazolidone|furazolidone|mesh-list
25366292|NCT05176821|Potassium Citrate|potassium citrate|mesh-list
25366293|NCT05176821|Esomeprazole|esomeprazole|mesh-list
25366294|NCT05176821|Bismuth|bismuth|mesh-list
25366295|NCT05176821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366296|NCT05176821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25366297|NCT05176821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25366298|NCT05176821|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25366299|NCT05176821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25366300|NCT05176821|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25366301|NCT05176821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366302|NCT05176821|Antacids|antacids|mesh-ancestor
25366303|NCT05176821|Diuretics|diuretics|mesh-ancestor
25366304|NCT05176821|Natriuretic Agents|natriuretic agents|mesh-ancestor
25366305|NCT05176821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366306|NCT05176821|Expectorants|expectorants|mesh-ancestor
25366307|NCT05176821|Respiratory System Agents|respiratory system agents|mesh-ancestor
25366308|NCT05176821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25366309|NCT05176821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25366310|NCT05176821|Renal Agents|renal agents|mesh-ancestor
25366311|NCT05176821|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
25366312|NCT05176821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25366313|NCT05176821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25366314|NCT05176821|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25366315|NCT05176483|Nivolumab|nivolumab|mesh-list
25366316|NCT05176483|Ipilimumab|ipilimumab|mesh-list
25366317|NCT05176483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25366318|NCT05176483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366319|NCT05176483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25366320|NCT05176483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366321|NCT05176418|Nicotine|nicotine|mesh-list
25366322|NCT05176418|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25366323|NCT05176418|Autonomic Agents|autonomic agents|mesh-ancestor
25366324|NCT05176418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25366325|NCT05176418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366326|NCT05176418|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25366327|NCT05176418|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25366328|NCT05176418|Cholinergic Agents|cholinergic agents|mesh-ancestor
25366329|NCT05176418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25366330|NCT05176418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366331|NCT05176288|Palbociclib|palbociclib|mesh-list
25366332|NCT05176288|Avelumab|avelumab|mesh-list
25366333|NCT05176288|Axitinib|axitinib|mesh-list
25366334|NCT05176288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366335|NCT05176288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25366336|NCT05176288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366337|NCT05176288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366338|NCT05176288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25366339|NCT05175781|Dexmedetomidine|dexmedetomidine|mesh-list
25366340|NCT05175781|Ketamine|ketamine|mesh-list
25366341|NCT05175781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25366342|NCT05175781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25366343|NCT05175781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366344|NCT05175781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25366345|NCT05175781|Analgesics|analgesics|mesh-ancestor
25366346|NCT05175781|Sensory System Agents|sensory system agents|mesh-ancestor
25366347|NCT05175781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25366348|NCT05175781|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25366349|NCT05175781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25366350|NCT05175781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25366351|NCT05175781|Adrenergic Agents|adrenergic agents|mesh-ancestor
25366352|NCT05175781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25366353|NCT05175781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366354|NCT05175781|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25366355|NCT05175781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25366356|NCT05175781|Anesthetics, General|anesthetics, general|mesh-ancestor
25366357|NCT05175781|Anesthetics|anesthetics|mesh-ancestor
25366358|NCT05175781|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25366359|NCT05175781|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25366360|NCT05174611|Vitamin D|vitamin d|mesh-list
25366361|NCT05174611|Cholecalciferol|cholecalciferol|mesh-list
25366362|NCT05174611|Vitamins|vitamins|mesh-ancestor
25366363|NCT05174611|Micronutrients|micronutrients|mesh-ancestor
25366364|NCT05174611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366365|NCT05174611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25366366|NCT05174611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25366367|NCT05174585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25366368|NCT05174585|Pembrolizumab|pembrolizumab|mesh-list
25366369|NCT05174585|Antibodies|antibodies|mesh-list
25366370|NCT05174585|Immunoglobulins|immunoglobulins|mesh-list
25366371|NCT05174585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25366372|NCT05174585|Immunologic Factors|immunologic factors|mesh-ancestor
25366373|NCT05174585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366374|NCT05174585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366375|NCT05174455|Niraparib|niraparib|mesh-list
25366376|NCT05174455|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25366377|NCT05174455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366378|NCT05174455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366379|NCT05174455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366380|NCT05174065|Apremilast|apremilast|mesh-list
25366381|NCT05174065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25366382|NCT05174065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25366383|NCT05174065|Analgesics|analgesics|mesh-ancestor
25366384|NCT05174065|Sensory System Agents|sensory system agents|mesh-ancestor
25366385|NCT05174065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25366386|NCT05174065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366387|NCT05174065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25366388|NCT05174065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25366389|NCT05174065|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25366390|NCT05174065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25366391|NCT05174065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366392|NCT05174065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366393|NCT05174039|Miglustat|miglustat|mesh-list
25366394|NCT05174039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366395|NCT05174039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366396|NCT05174039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25366397|NCT05174039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25366398|NCT05174039|Antiviral Agents|antiviral agents|mesh-ancestor
25366399|NCT05174039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25366400|NCT05174039|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25366401|NCT05174039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25366402|NCT05174039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366403|NCT05174026|Deoxyglucose|deoxyglucose|mesh-list
25366404|NCT05174026|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25366405|NCT05174026|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25366406|NCT05174026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366407|NCT05174026|Antimetabolites|antimetabolites|mesh-ancestor
25366408|NCT05174026|Antiviral Agents|antiviral agents|mesh-ancestor
25366409|NCT05174026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25366410|NCT05173987|Paclitaxel|paclitaxel|mesh-list
25366411|NCT05173987|Docetaxel|docetaxel|mesh-list
25366412|NCT05173987|Cisplatin|cisplatin|mesh-list
25366413|NCT05173987|Carboplatin|carboplatin|mesh-list
25366414|NCT05173987|Pembrolizumab|pembrolizumab|mesh-list
25366415|NCT05173987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25366416|NCT05173987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366417|NCT05173987|Tubulin Modulators|tubulin modulators|mesh-ancestor
25366418|NCT05173987|Antimitotic Agents|antimitotic agents|mesh-ancestor
25366419|NCT05173987|Mitosis Modulators|mitosis modulators|mesh-ancestor
25366420|NCT05173987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366421|NCT05173987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25366422|NCT05173831|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25366424|NCT05173831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366425|NCT05173831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25366426|NCT05173831|Serotonin Agents|serotonin agents|mesh-ancestor
25366427|NCT05173831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25366428|NCT05173831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366429|NCT05173831|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25366430|NCT05173831|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25366431|NCT05173831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25398388|NCT03955783|Venetoclax|venetoclax|mesh-list
25366432|NCT05173831|Adrenergic Agents|adrenergic agents|mesh-ancestor
25366433|NCT05173324|Vaccines|vaccines|mesh-list
25366434|NCT05173324|Immunologic Factors|immunologic factors|mesh-ancestor
25366435|NCT05173324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366436|NCT05172908|Dexamethasone|dexamethasone|mesh-list
25366437|NCT05172908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25366438|NCT05172908|Antiemetics|antiemetics|mesh-ancestor
25366439|NCT05172908|Autonomic Agents|autonomic agents|mesh-ancestor
25366440|NCT05172908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25366441|NCT05172908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366442|NCT05172908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25366443|NCT05172908|Glucocorticoids|glucocorticoids|mesh-ancestor
25366444|NCT05172908|Hormones|hormones|mesh-ancestor
25366445|NCT05172908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25366446|NCT05172908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25366447|NCT05172908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366448|NCT05172401|Triamcinolone|triamcinolone|mesh-list
25366449|NCT05172401|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25366450|NCT05172401|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25366451|NCT05172401|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25366452|NCT05172401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25366453|NCT05172401|Glucocorticoids|glucocorticoids|mesh-ancestor
25366454|NCT05172401|Hormones|hormones|mesh-ancestor
25366455|NCT05172401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25366456|NCT05172401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366457|NCT05172401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25366458|NCT05172401|Immunologic Factors|immunologic factors|mesh-ancestor
25366459|NCT05172401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366460|NCT05172401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366461|NCT05172245|Cisplatin|cisplatin|mesh-list
25366462|NCT05172245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366463|NCT05171816|Olaparib|olaparib|mesh-list
25366464|NCT05171816|Abiraterone Acetate|abiraterone acetate|mesh-list
25366465|NCT05171816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25366466|NCT05171816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366467|NCT05171816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366468|NCT05171816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366469|NCT05171816|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25366470|NCT05171816|Hormone Antagonists|hormone antagonists|mesh-ancestor
25366471|NCT05171816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25366472|NCT05171816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366473|NCT05171816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25366474|NCT05171777|Atezolizumab|atezolizumab|mesh-list
25366475|NCT05171777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366476|NCT05171686|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
25366477|NCT05171686|Chlorthalidone|chlorthalidone|mesh-list
25366478|NCT05171686|Torsemide|torsemide|mesh-list
25366479|NCT05171686|Furosemide|furosemide|mesh-list
25366480|NCT05171686|Bumetanide|bumetanide|mesh-list
25366481|NCT05171686|Diuretics|diuretics|mesh-list
25366482|NCT05171686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25366483|NCT05171686|Natriuretic Agents|natriuretic agents|mesh-ancestor
25366484|NCT05171686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366485|NCT05171686|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25366486|NCT05171686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25366487|NCT05171686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366488|NCT05171686|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25366489|NCT05171647|Gemcitabine|gemcitabine|mesh-list
25366490|NCT05171647|Rituximab|rituximab|mesh-list
25366491|NCT05171647|Oxaliplatin|oxaliplatin|mesh-list
25366492|NCT05171647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25366493|NCT05171647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366494|NCT05171647|Immunologic Factors|immunologic factors|mesh-ancestor
25366495|NCT05171647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366496|NCT05171647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25366497|NCT05171647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25366498|NCT05171647|Antimetabolites|antimetabolites|mesh-ancestor
25366499|NCT05171647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366500|NCT05171647|Antiviral Agents|antiviral agents|mesh-ancestor
25366501|NCT05171647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25366502|NCT05171647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366503|NCT05171647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25366504|NCT05171387|Androgens|androgens|mesh-list
25366505|NCT05171387|Hormones|hormones|mesh-ancestor
25724233|NCT02535806|Antimitotic Agents|antimitotic agents|mesh-ancestor
25366506|NCT05171387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25366507|NCT05171387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366509|NCT05171335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366510|NCT05171335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25366511|NCT05171335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366512|NCT05171335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366513|NCT05171049|Apixaban|apixaban|mesh-list
25366514|NCT05171049|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25366515|NCT05171049|Antithrombins|antithrombins|mesh-ancestor
25366516|NCT05171049|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25366517|NCT05171049|Protease Inhibitors|protease inhibitors|mesh-ancestor
25366518|NCT05171049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366519|NCT05171049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366520|NCT05171049|Anticoagulants|anticoagulants|mesh-ancestor
25366521|NCT05170841|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
25366522|NCT05170841|Tramadol|tramadol|mesh-list
25366523|NCT05170841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25366524|NCT05170841|Narcotics|narcotics|mesh-ancestor
25366525|NCT05170841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25366526|NCT05170841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366527|NCT05170841|Analgesics|analgesics|mesh-ancestor
25366528|NCT05170841|Sensory System Agents|sensory system agents|mesh-ancestor
25366529|NCT05170841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25366530|NCT05170841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25366531|NCT05170841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25366532|NCT05170841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25366533|NCT05170841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25366534|NCT05170438|Paclitaxel|paclitaxel|mesh-list
25366535|NCT05170438|Lenvatinib|lenvatinib|mesh-list
25366536|NCT05170438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25366537|NCT05170438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366538|NCT05170438|Tubulin Modulators|tubulin modulators|mesh-ancestor
25366539|NCT05170438|Antimitotic Agents|antimitotic agents|mesh-ancestor
25366540|NCT05170438|Mitosis Modulators|mitosis modulators|mesh-ancestor
25366541|NCT05170438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366549|NCT05170256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366559|NCT05170113|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25366560|NCT05170113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366561|NCT05170113|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25366562|NCT05170113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366563|NCT05170113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366564|NCT05170113|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25366565|NCT05170113|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25366566|NCT05170113|Purinergic Agents|purinergic agents|mesh-ancestor
25366567|NCT05170113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25366568|NCT05169957|Nivolumab|nivolumab|mesh-list
25366569|NCT05169957|Ipilimumab|ipilimumab|mesh-list
25366570|NCT05169957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25366571|NCT05169957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366572|NCT05169957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25366573|NCT05169957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366574|NCT05169905|Vaccines|vaccines|mesh-list
25366575|NCT05169905|Immunologic Factors|immunologic factors|mesh-ancestor
25366576|NCT05169905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366577|NCT05169684|Docetaxel|docetaxel|mesh-list
25366578|NCT05169684|Nivolumab|nivolumab|mesh-list
25366579|NCT05169684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366580|NCT05169684|Tubulin Modulators|tubulin modulators|mesh-ancestor
25366581|NCT05169684|Antimitotic Agents|antimitotic agents|mesh-ancestor
25366582|NCT05169684|Mitosis Modulators|mitosis modulators|mesh-ancestor
25366583|NCT05169684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366584|NCT05169684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25366585|NCT05169684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25366586|NCT05169567|Fulvestrant|fulvestrant|mesh-list
25366587|NCT05169567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25366588|NCT05169567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366589|NCT05169567|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25366590|NCT05169567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25366591|NCT05169567|Hormone Antagonists|hormone antagonists|mesh-ancestor
25366592|NCT05169567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25366593|NCT05169567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724234|NCT02535806|Mitosis Modulators|mitosis modulators|mesh-ancestor
25366594|NCT05169515|Obinutuzumab|obinutuzumab|mesh-list
25366595|NCT05169515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25366596|NCT05169515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366597|NCT05169437|Niraparib|niraparib|mesh-list
25366598|NCT05169437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25366599|NCT05169437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366600|NCT05169437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366601|NCT05169437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366602|NCT05169008|Vaccines|vaccines|mesh-list
25366603|NCT05169008|Immunologic Factors|immunologic factors|mesh-ancestor
25366604|NCT05169008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366605|NCT05168930|Venetoclax|venetoclax|mesh-list
25366606|NCT05168930|Zanubrutinib|zanubrutinib|mesh-list
25366607|NCT05168930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366608|NCT05168930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25366609|NCT05168930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366610|NCT05168930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366611|NCT05168709|Vaccines|vaccines|mesh-list
25366612|NCT05168709|Immunologic Factors|immunologic factors|mesh-ancestor
25366613|NCT05168709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366614|NCT05168657|Pancrelipase|pancrelipase|mesh-list
25366615|NCT05168657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25366616|NCT05168423|Cyclophosphamide|cyclophosphamide|mesh-list
25366617|NCT05168423|Fludarabine|fludarabine|mesh-list
25366618|NCT05168423|Isotretinoin|isotretinoin|mesh-list
25366619|NCT05168423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25366620|NCT05168423|Immunologic Factors|immunologic factors|mesh-ancestor
25366621|NCT05168423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366622|NCT05168423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25366623|NCT05168423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25366624|NCT05168423|Alkylating Agents|alkylating agents|mesh-ancestor
25366625|NCT05168423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366626|NCT05168423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366627|NCT05168423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25366628|NCT05168423|Dermatologic Agents|dermatologic agents|mesh-ancestor
25366629|NCT05168280|Dexmedetomidine|dexmedetomidine|mesh-list
25366630|NCT05168280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25366631|NCT05168280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25366632|NCT05168280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366633|NCT05168280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25366634|NCT05168280|Analgesics|analgesics|mesh-ancestor
25366635|NCT05168280|Sensory System Agents|sensory system agents|mesh-ancestor
25366636|NCT05168280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25366637|NCT05168280|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25366638|NCT05168280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25366639|NCT05168280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25366640|NCT05168280|Adrenergic Agents|adrenergic agents|mesh-ancestor
25366641|NCT05168280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25366642|NCT05168280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366643|NCT05168202|Azacitidine|azacitidine|mesh-list
25366644|NCT05168202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25366645|NCT05168202|Antimetabolites|antimetabolites|mesh-ancestor
25366646|NCT05168202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366647|NCT05168202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366648|NCT05168202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366649|NCT05167825|Macitentan|macitentan|mesh-list
25366650|NCT05167825|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25366651|NCT05167825|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25366652|NCT05167825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366653|NCT05167825|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25366654|NCT05167487|Cisplatin|cisplatin|mesh-list
25366655|NCT05167487|Carboplatin|carboplatin|mesh-list
25366656|NCT05167487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366657|NCT05167409|Pembrolizumab|pembrolizumab|mesh-list
25366658|NCT05167409|Cetuximab|cetuximab|mesh-list
25366659|NCT05167409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25366660|NCT05167409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366661|NCT05166967|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25366662|NCT05166967|Immunologic Factors|immunologic factors|mesh-ancestor
25366663|NCT05166967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366664|NCT05166967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25366665|NCT05166616|Osimertinib|osimertinib|mesh-list
25366666|NCT05166616|Triptolide|triptolide|mesh-list
25366667|NCT05166616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366668|NCT05166616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25366669|NCT05166616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366670|NCT05166616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366671|NCT05166616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25366672|NCT05166616|Alkylating Agents|alkylating agents|mesh-ancestor
25366673|NCT05166616|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
25366674|NCT05166616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366675|NCT05166616|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25366676|NCT05166616|Contraceptive Agents|contraceptive agents|mesh-ancestor
25366677|NCT05166616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25366678|NCT05166616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25366679|NCT05166616|Immunologic Factors|immunologic factors|mesh-ancestor
25366680|NCT05166577|Valganciclovir|valganciclovir|mesh-list
25366681|NCT05166577|Pembrolizumab|pembrolizumab|mesh-list
25366682|NCT05166577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25366683|NCT05166577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366684|NCT05166577|Antiviral Agents|antiviral agents|mesh-ancestor
25366685|NCT05166577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25366686|NCT05166343|Epinephrine|epinephrine|mesh-list
25366687|NCT05166343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25366688|NCT05166343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25366689|NCT05166343|Adrenergic Agents|adrenergic agents|mesh-ancestor
25366690|NCT05166343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25366691|NCT05166343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366692|NCT05166343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366693|NCT05166343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25366694|NCT05166343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25366695|NCT05166343|Autonomic Agents|autonomic agents|mesh-ancestor
25366696|NCT05166343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25366697|NCT05166343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25366698|NCT05166343|Respiratory System Agents|respiratory system agents|mesh-ancestor
25366699|NCT05166343|Mydriatics|mydriatics|mesh-ancestor
25366700|NCT05166343|Sympathomimetics|sympathomimetics|mesh-ancestor
25366701|NCT05166343|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25366702|NCT05165966|Vaccines|vaccines|mesh-list
25366703|NCT05165966|Immunologic Factors|immunologic factors|mesh-ancestor
25366704|NCT05165966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366705|NCT05165836|Dexmedetomidine|dexmedetomidine|mesh-list
25366706|NCT05165836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25366707|NCT05165836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25366708|NCT05165836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366709|NCT05165836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25366710|NCT05165836|Analgesics|analgesics|mesh-ancestor
25366711|NCT05165836|Sensory System Agents|sensory system agents|mesh-ancestor
25366712|NCT05165836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25366713|NCT05165836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25366714|NCT05165836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25366715|NCT05165836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25366716|NCT05165836|Adrenergic Agents|adrenergic agents|mesh-ancestor
25366717|NCT05165836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25366718|NCT05165836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366719|NCT05165732|Vaccines|vaccines|mesh-list
25366720|NCT05165732|Immunologic Factors|immunologic factors|mesh-ancestor
25366721|NCT05165732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366722|NCT05164159|Propofol|propofol|mesh-list
25366723|NCT05164159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25366724|NCT05164159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25366725|NCT05164159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366726|NCT05164159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25366727|NCT05164159|Anesthetics, General|anesthetics, general|mesh-ancestor
25366728|NCT05164159|Anesthetics|anesthetics|mesh-ancestor
25366729|NCT05164146|Propofol|propofol|mesh-list
25366730|NCT05164146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25366731|NCT05164146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25366732|NCT05164146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366733|NCT05164146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25366734|NCT05164146|Anesthetics, General|anesthetics, general|mesh-ancestor
25366735|NCT05164146|Anesthetics|anesthetics|mesh-ancestor
25366736|NCT05163041|Nivolumab|nivolumab|mesh-list
25366737|NCT05163041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25366738|NCT05163041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366739|NCT05163041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25366740|NCT05163041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366741|NCT05162222|Itraconazole|itraconazole|mesh-list
25366742|NCT05162222|Diltiazem|diltiazem|mesh-list
25366743|NCT05162222|Antifungal Agents|antifungal agents|mesh-ancestor
25366759|NCT05162014|Empagliflozin|empagliflozin|mesh-list
25366760|NCT05162014|Hypoglycemic Agents|hypoglycemic agents|mesh-list
25366761|NCT05162014|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25366762|NCT05162014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367143|NCT05152628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366763|NCT05162014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366764|NCT05161936|Lumasiran|lumasiran|mesh-list
25366765|NCT05161936|Renal Agents|renal agents|mesh-ancestor
25366766|NCT05161806|Aflibercept|aflibercept|mesh-list
25366767|NCT05161806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25366768|NCT05161806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25366769|NCT05161806|Growth Substances|growth substances|mesh-ancestor
25366770|NCT05161806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366771|NCT05161806|Growth Inhibitors|growth inhibitors|mesh-ancestor
25366772|NCT05161806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366773|NCT05161611|Zinc Sulfate|zinc sulfate|mesh-list
25366774|NCT05161611|Astringents|astringents|mesh-ancestor
25366775|NCT05161611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366776|NCT05161611|Dermatologic Agents|dermatologic agents|mesh-ancestor
25366777|NCT05161533|Cisplatin|cisplatin|mesh-list
25366778|NCT05161533|Carboplatin|carboplatin|mesh-list
25366779|NCT05161533|Etoposide|etoposide|mesh-list
25366780|NCT05161533|Etoposide phosphate|etoposide phosphate|mesh-list
25366781|NCT05161533|Durvalumab|durvalumab|mesh-list
25366782|NCT05161533|Podophyllotoxin|podophyllotoxin|mesh-list
25366783|NCT05161533|Immunoglobulins|immunoglobulins|mesh-list
25366784|NCT05161533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25366785|NCT05161533|Immunoglobulin G|immunoglobulin g|mesh-list
25366786|NCT05161533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366787|NCT05161533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25366788|NCT05161533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25366789|NCT05161533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25366790|NCT05161533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366791|NCT05161533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366792|NCT05161533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25366793|NCT05161533|Immunologic Factors|immunologic factors|mesh-ancestor
25366794|NCT05161533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366795|NCT05161533|Keratolytic Agents|keratolytic agents|mesh-ancestor
25366796|NCT05161533|Dermatologic Agents|dermatologic agents|mesh-ancestor
25366797|NCT05161533|Tubulin Modulators|tubulin modulators|mesh-ancestor
25366798|NCT05161533|Antimitotic Agents|antimitotic agents|mesh-ancestor
25366799|NCT05161533|Mitosis Modulators|mitosis modulators|mesh-ancestor
25366834|NCT05161195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366835|NCT05161195|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25366836|NCT05161195|Hormone Antagonists|hormone antagonists|mesh-ancestor
25366837|NCT05161195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25366838|NCT05161195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366839|NCT05161195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25366840|NCT05161195|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25366841|NCT05161195|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25366842|NCT05161195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25366843|NCT05161195|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25366845|NCT05160922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366846|NCT05160922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25366847|NCT05160922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366848|NCT05160922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366850|NCT05159830|Anticonvulsants|anticonvulsants|mesh-ancestor
25366851|NCT05159752|Afamelanotide|afamelanotide|mesh-list
25366852|NCT05159752|Dermatologic Agents|dermatologic agents|mesh-ancestor
25366853|NCT05159453|Insulin|insulin|mesh-list
25366854|NCT05159453|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25366855|NCT05159453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25366856|NCT05159453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366857|NCT05159245|Trastuzumab|trastuzumab|mesh-list
25366858|NCT05159245|Pertuzumab|pertuzumab|mesh-list
25366859|NCT05159245|Atezolizumab|atezolizumab|mesh-list
25366860|NCT05159245|Trametinib|trametinib|mesh-list
25366861|NCT05159245|Vemurafenib|vemurafenib|mesh-list
25366862|NCT05159245|Dabrafenib|dabrafenib|mesh-list
25366863|NCT05159245|Pralsetinib|pralsetinib|mesh-list
25366864|NCT05159245|Entrectinib|entrectinib|mesh-list
25366865|NCT05159245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25366866|NCT05159245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366867|NCT05159245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25366868|NCT05159245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366869|NCT05159245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366870|NCT05159219|Colchicine|colchicine|mesh-list
25366871|NCT05159219|Gout Suppressants|gout suppressants|mesh-ancestor
25366872|NCT05159219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25366873|NCT05159219|Tubulin Modulators|tubulin modulators|mesh-ancestor
25366874|NCT05159219|Antimitotic Agents|antimitotic agents|mesh-ancestor
25366875|NCT05159219|Mitosis Modulators|mitosis modulators|mesh-ancestor
25366876|NCT05159219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366877|NCT05159219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366878|NCT05158517|Vedolizumab|vedolizumab|mesh-list
25366879|NCT05158517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25366880|NCT05158140|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25366881|NCT05158140|Immunologic Factors|immunologic factors|mesh-ancestor
25366882|NCT05158140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366883|NCT05157971|Cytarabine|cytarabine|mesh-list
25366884|NCT05157971|Prednisone|prednisone|mesh-list
25366885|NCT05157971|Cortisone|cortisone|mesh-list
25366886|NCT05157971|Cyclophosphamide|cyclophosphamide|mesh-list
25366887|NCT05157971|Methotrexate|methotrexate|mesh-list
25366888|NCT05157971|Vincristine|vincristine|mesh-list
25366889|NCT05157971|Daunorubicin|daunorubicin|mesh-list
25366890|NCT05157971|Asparaginase|asparaginase|mesh-list
25366891|NCT05157971|Venetoclax|venetoclax|mesh-list
25366892|NCT05157971|Mercaptopurine|mercaptopurine|mesh-list
25366893|NCT05157971|Pegaspargase|pegaspargase|mesh-list
25366894|NCT05157971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25366895|NCT05157971|Immunologic Factors|immunologic factors|mesh-ancestor
25366896|NCT05157971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366897|NCT05157971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25366898|NCT05157971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25366899|NCT05157971|Alkylating Agents|alkylating agents|mesh-ancestor
25366900|NCT05157971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366901|NCT05157971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366902|NCT05157971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25366903|NCT05157971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25366904|NCT05157971|Glucocorticoids|glucocorticoids|mesh-ancestor
25366905|NCT05157971|Hormones|hormones|mesh-ancestor
25366906|NCT05157971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25366907|NCT05157971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25366908|NCT05157971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25366909|NCT05157971|Abortifacient Agents|abortifacient agents|mesh-ancestor
25366910|NCT05157971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25366911|NCT05157971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25366912|NCT05157971|Antimetabolites|antimetabolites|mesh-ancestor
25366913|NCT05157971|Dermatologic Agents|dermatologic agents|mesh-ancestor
25366914|NCT05157971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366915|NCT05157971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25366916|NCT05157971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25366917|NCT05157971|Antiviral Agents|antiviral agents|mesh-ancestor
25366918|NCT05157971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25366919|NCT05157971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25366920|NCT05157971|Tubulin Modulators|tubulin modulators|mesh-ancestor
25366921|NCT05157971|Antimitotic Agents|antimitotic agents|mesh-ancestor
25366922|NCT05157971|Mitosis Modulators|mitosis modulators|mesh-ancestor
25366923|NCT05157971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25366924|NCT05157971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25366925|NCT05157971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25366926|NCT05157841|Bupivacaine|bupivacaine|mesh-list
25366927|NCT05157841|Anesthetics, Local|anesthetics, local|mesh-ancestor
25366928|NCT05157841|Anesthetics|anesthetics|mesh-ancestor
25366929|NCT05157841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25366930|NCT05157841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366931|NCT05157841|Sensory System Agents|sensory system agents|mesh-ancestor
25366932|NCT05157841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25366933|NCT05157711|Bismuth subgallate|bismuth subgallate|mesh-list
25366934|NCT05157711|Phenylephrine|phenylephrine|mesh-list
25366935|NCT05157711|Oxymetazoline|oxymetazoline|mesh-list
25366936|NCT05157711|Zinc Oxide|zinc oxide|mesh-list
25366937|NCT05157711|Bismuth|bismuth|mesh-list
25366938|NCT05157711|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25366939|NCT05157711|Mydriatics|mydriatics|mesh-ancestor
25366940|NCT05157711|Autonomic Agents|autonomic agents|mesh-ancestor
25366941|NCT05157711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25366942|NCT05157711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366943|NCT05157711|Sympathomimetics|sympathomimetics|mesh-ancestor
25366944|NCT05157711|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25366945|NCT05157711|Nasal Decongestants|nasal decongestants|mesh-ancestor
25366946|NCT05157711|Respiratory System Agents|respiratory system agents|mesh-ancestor
25366947|NCT05157711|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25366948|NCT05157711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25366949|NCT05157711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25366950|NCT05157711|Adrenergic Agents|adrenergic agents|mesh-ancestor
25366951|NCT05157711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25366952|NCT05157711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366953|NCT05157711|Protective Agents|protective agents|mesh-ancestor
25366954|NCT05157711|Antacids|antacids|mesh-ancestor
25366955|NCT05157711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25366956|NCT05157711|Dermatologic Agents|dermatologic agents|mesh-ancestor
25366957|NCT05157711|Sunscreening Agents|sunscreening agents|mesh-ancestor
25366958|NCT05157711|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25366959|NCT05157711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25366960|NCT05157711|Hemostatics|hemostatics|mesh-ancestor
25366961|NCT05157711|Coagulants|coagulants|mesh-ancestor
25366962|NCT05157685|Azithromycin|azithromycin|mesh-list
25366963|NCT05157685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25366964|NCT05157685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25366965|NCT05157672|Letrozole|letrozole|mesh-list
25366966|NCT05157672|Nicotine|nicotine|mesh-list
25366967|NCT05157672|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25366968|NCT05157672|Autonomic Agents|autonomic agents|mesh-ancestor
25366969|NCT05157672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25366970|NCT05157672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25366971|NCT05157672|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25366972|NCT05157672|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25366973|NCT05157672|Cholinergic Agents|cholinergic agents|mesh-ancestor
25366974|NCT05157672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25366975|NCT05157672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366976|NCT05157672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25366977|NCT05157672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25366978|NCT05157672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25366979|NCT05157672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366980|NCT05157672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25366981|NCT05157672|Hormone Antagonists|hormone antagonists|mesh-ancestor
25366982|NCT05157672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25366983|NCT05157581|Methoxsalen|methoxsalen|mesh-list
25366984|NCT05157581|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25366985|NCT05157581|Dermatologic Agents|dermatologic agents|mesh-ancestor
25366986|NCT05157464|Losartan|losartan|mesh-list
25366987|NCT05157464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25366988|NCT05157464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25366989|NCT05157464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25366990|NCT05157464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25366991|NCT05157464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366992|NCT05157126|Gentamicins|gentamicins|mesh-list
25366993|NCT05157126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25366994|NCT05157126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25366995|NCT05157126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25366996|NCT05157126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25366997|NCT05157126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25366998|NCT05156905|Docetaxel|docetaxel|mesh-list
25366999|NCT05156905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367000|NCT05156905|Tubulin Modulators|tubulin modulators|mesh-ancestor
25367001|NCT05156905|Antimitotic Agents|antimitotic agents|mesh-ancestor
25367002|NCT05156905|Mitosis Modulators|mitosis modulators|mesh-ancestor
25367003|NCT05156905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367004|NCT05156710|Rituximab|rituximab|mesh-list
25367005|NCT05156710|Tacrolimus|tacrolimus|mesh-list
25367006|NCT05156710|Immunoglobulins|immunoglobulins|mesh-list
25367007|NCT05156710|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25367008|NCT05156710|Antibodies|antibodies|mesh-list
25367009|NCT05156710|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25367010|NCT05156710|gamma-Globulins|gamma-globulins|mesh-list
25367011|NCT05156710|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25367012|NCT05156710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25367013|NCT05156710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367014|NCT05156710|Immunologic Factors|immunologic factors|mesh-ancestor
25367015|NCT05156710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367016|NCT05156710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25367017|NCT05156710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25367018|NCT05156710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25367019|NCT05156710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367020|NCT05156710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367021|NCT05156658|Etonogestrel|etonogestrel|mesh-list
25367022|NCT05156658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25367023|NCT05156658|Contraceptive Agents|contraceptive agents|mesh-ancestor
25367024|NCT05156658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25367025|NCT05156658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367026|NCT05156658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25367027|NCT05156632|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25367028|NCT05156632|Vaccines|vaccines|mesh-list
25367029|NCT05156632|Immunologic Factors|immunologic factors|mesh-ancestor
25367030|NCT05156632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367031|NCT05156632|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25367032|NCT05156632|Antacids|antacids|mesh-ancestor
25367033|NCT05156632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367034|NCT05156632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25367035|NCT05156281|Teriflunomide|teriflunomide|mesh-list
25367036|NCT05156281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25367037|NCT05156281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25367038|NCT05156281|Analgesics|analgesics|mesh-ancestor
25367039|NCT05156281|Sensory System Agents|sensory system agents|mesh-ancestor
25367040|NCT05156281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25367041|NCT05156281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367042|NCT05156281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25367043|NCT05156281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25367044|NCT05156281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25367045|NCT05156281|Immunologic Factors|immunologic factors|mesh-ancestor
25367046|NCT05156268|Pembrolizumab|pembrolizumab|mesh-list
25367047|NCT05156268|Olaparib|olaparib|mesh-list
25367048|NCT05156268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25367049|NCT05156268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367050|NCT05156268|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25367051|NCT05156268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367052|NCT05156268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367054|NCT05155709|Venetoclax|venetoclax|mesh-list
25367055|NCT05155709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25367056|NCT05155709|Antimetabolites|antimetabolites|mesh-ancestor
25367057|NCT05155709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367058|NCT05155709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367059|NCT05155709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367060|NCT05155293|Aflibercept|aflibercept|mesh-list
25367061|NCT05155293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25367062|NCT05155293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25367063|NCT05155293|Growth Substances|growth substances|mesh-ancestor
25367064|NCT05155293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367065|NCT05155293|Growth Inhibitors|growth inhibitors|mesh-ancestor
25367066|NCT05155293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367067|NCT05155254|Pembrolizumab|pembrolizumab|mesh-list
25367068|NCT05155254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25367069|NCT05155254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367070|NCT05155124|Cetuximab|cetuximab|mesh-list
25367071|NCT05155124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25367072|NCT05155124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367073|NCT05155033|Aldesleukin|aldesleukin|mesh-list
25367074|NCT05155033|Pembrolizumab|pembrolizumab|mesh-list
25367075|NCT05155033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25367076|NCT05155033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367077|NCT05155033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25367078|NCT05155033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25367079|NCT05155033|Antiviral Agents|antiviral agents|mesh-ancestor
25367080|NCT05155033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25367081|NCT05154487|Fulvestrant|fulvestrant|mesh-list
25367082|NCT05154487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25367083|NCT05154487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367084|NCT05154487|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25367085|NCT05154487|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25367086|NCT05154487|Hormone Antagonists|hormone antagonists|mesh-ancestor
25367087|NCT05154487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25367088|NCT05154487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367089|NCT05154383|Vaccines|vaccines|mesh-list
25367090|NCT05154383|Immunologic Factors|immunologic factors|mesh-ancestor
25367091|NCT05154383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367092|NCT05153915|Tacrolimus|tacrolimus|mesh-list
25367093|NCT05153915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25367094|NCT05153915|Immunologic Factors|immunologic factors|mesh-ancestor
25367095|NCT05153915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367096|NCT05153915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25367097|NCT05153915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367098|NCT05153915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367099|NCT05153668|Everolimus|everolimus|mesh-list
25367100|NCT05153668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367101|NCT05153668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25367102|NCT05153668|Immunologic Factors|immunologic factors|mesh-ancestor
25367175|NCT05151731|Ranibizumab|ranibizumab|mesh-list
25367103|NCT05153668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367104|NCT05153564|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
25367105|NCT05153564|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
25367106|NCT05153564|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25367107|NCT05153564|Contraceptive Agents|contraceptive agents|mesh-ancestor
25367108|NCT05153564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25367109|NCT05153564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367110|NCT05153564|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
25367111|NCT05153564|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25367112|NCT05153564|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25367113|NCT05153564|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25367114|NCT05153564|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25367115|NCT05153564|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
25367116|NCT05153564|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25367117|NCT05153564|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25367118|NCT05153239|Irinotecan|irinotecan|mesh-list
25367119|NCT05153239|Topotecan|topotecan|mesh-list
25367120|NCT05153239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25367121|NCT05153239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25367122|NCT05153239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367123|NCT05153239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367124|NCT05153239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367125|NCT05153226|Cyclophosphamide|cyclophosphamide|mesh-list
25367126|NCT05153226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25367127|NCT05153226|Immunologic Factors|immunologic factors|mesh-ancestor
25367128|NCT05153226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367129|NCT05153226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25367130|NCT05153226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25367131|NCT05153226|Alkylating Agents|alkylating agents|mesh-ancestor
25367132|NCT05153226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367133|NCT05153226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367134|NCT05153226|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25367135|NCT05152927|Parathyroid Hormone|parathyroid hormone|mesh-list
25367136|NCT05152927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25367137|NCT05152927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367138|NCT05152628|Tacrolimus|tacrolimus|mesh-list
25367139|NCT05152628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25367140|NCT05152628|Immunologic Factors|immunologic factors|mesh-ancestor
25367141|NCT05152628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367142|NCT05152628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25367144|NCT05152628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367145|NCT05152576|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25367146|NCT05152576|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25367147|NCT05152576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25367148|NCT05152576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25367149|NCT05152576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367150|NCT05152576|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25367151|NCT05152576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25367152|NCT05152576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367153|NCT05152576|Cholinergic Agents|cholinergic agents|mesh-ancestor
25367154|NCT05152576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25367155|NCT05152147|Cisplatin|cisplatin|mesh-list
25367156|NCT05152147|Fluorouracil|fluorouracil|mesh-list
25367157|NCT05152147|Capecitabine|capecitabine|mesh-list
25367158|NCT05152147|Oxaliplatin|oxaliplatin|mesh-list
25367159|NCT05152147|Trastuzumab|trastuzumab|mesh-list
25367160|NCT05152147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367161|NCT05152147|Antimetabolites|antimetabolites|mesh-ancestor
25367162|NCT05152147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367163|NCT05152147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25367164|NCT05152147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25367165|NCT05152147|Immunologic Factors|immunologic factors|mesh-ancestor
25367166|NCT05152147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367167|NCT05152147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25367168|NCT05151744|Ranibizumab|ranibizumab|mesh-list
25367169|NCT05151744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25367170|NCT05151744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25367171|NCT05151744|Growth Substances|growth substances|mesh-ancestor
25367172|NCT05151744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367173|NCT05151744|Growth Inhibitors|growth inhibitors|mesh-ancestor
25367174|NCT05151744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367176|NCT05151731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25367177|NCT05151731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25367178|NCT05151731|Growth Substances|growth substances|mesh-ancestor
25367179|NCT05151731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367180|NCT05151731|Growth Inhibitors|growth inhibitors|mesh-ancestor
25367181|NCT05151731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367182|NCT05151640|Nintedanib|nintedanib|mesh-list
25367183|NCT05151640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367184|NCT05151640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25367185|NCT05151640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367186|NCT05151640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367187|NCT05150938|Vitamin K|vitamin k|mesh-list
25367188|NCT05150938|Heparin|heparin|mesh-list
25367189|NCT05150938|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25367190|NCT05150938|Tinzaparin|tinzaparin|mesh-list
25367191|NCT05150938|Dalteparin|dalteparin|mesh-list
25367192|NCT05150938|Rivaroxaban|rivaroxaban|mesh-list
25367193|NCT05150938|Vitamins|vitamins|mesh-ancestor
25367194|NCT05150938|Micronutrients|micronutrients|mesh-ancestor
25367195|NCT05150938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367196|NCT05150938|Anticoagulants|anticoagulants|mesh-ancestor
25367201|NCT05150938|Antithrombins|antithrombins|mesh-ancestor
25367202|NCT05150938|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25367203|NCT05150938|Protease Inhibitors|protease inhibitors|mesh-ancestor
25367204|NCT05150938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367205|NCT05150938|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25367206|NCT05150938|Hemostatics|hemostatics|mesh-ancestor
25367207|NCT05150938|Coagulants|coagulants|mesh-ancestor
25367208|NCT05150496|Vaccines|vaccines|mesh-list
25367209|NCT05150496|Immunologic Factors|immunologic factors|mesh-ancestor
25367210|NCT05150496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367214|NCT05150015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25367215|NCT05150015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25367216|NCT05149781|Antihypertensive Agents|antihypertensive agents|mesh-list
25367217|NCT05149313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25367218|NCT05149313|Immunologic Factors|immunologic factors|mesh-ancestor
25367219|NCT05149313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367229|NCT05148962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367230|NCT05148949|Vaccines|vaccines|mesh-list
25367231|NCT05148949|Immunologic Factors|immunologic factors|mesh-ancestor
25367232|NCT05148949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367239|NCT05148078|Anesthetics|anesthetics|mesh-list
25367240|NCT05148078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25367241|NCT05148078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367242|NCT05148000|Botulinum Toxins|botulinum toxins|mesh-list
25367243|NCT05148000|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25367244|NCT05148000|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25367245|NCT05148000|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25367246|NCT05148000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25367247|NCT05148000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367248|NCT05148000|Cholinergic Agents|cholinergic agents|mesh-ancestor
25367249|NCT05148000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25367250|NCT05148000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367251|NCT05148000|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25367252|NCT05148000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25367253|NCT05147805|Treprostinil|treprostinil|mesh-list
25367254|NCT05147805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25367255|NCT05147662|Factor VIII|factor viii|mesh-list
25367256|NCT05147662|Coagulants|coagulants|mesh-ancestor
25367257|NCT05147402|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25367258|NCT05147402|Hallucinogens|hallucinogens|mesh-ancestor
25367259|NCT05147402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367260|NCT05147402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25367261|NCT05147402|Serotonin Agents|serotonin agents|mesh-ancestor
25367262|NCT05147402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25367263|NCT05147402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367264|NCT05147402|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25367265|NCT05147402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25367266|NCT05147402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25367267|NCT05147402|Adrenergic Agents|adrenergic agents|mesh-ancestor
25367268|NCT05147220|Teriflunomide|teriflunomide|mesh-list
25367269|NCT05147220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25367270|NCT05147220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25367271|NCT05147220|Analgesics|analgesics|mesh-ancestor
25367272|NCT05147220|Sensory System Agents|sensory system agents|mesh-ancestor
25367273|NCT05147220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25367274|NCT05147220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367275|NCT05147220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25367276|NCT05147220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25367277|NCT05147220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25367278|NCT05147220|Immunologic Factors|immunologic factors|mesh-ancestor
25367279|NCT05146739|Leucovorin|leucovorin|mesh-list
25367280|NCT05146739|Cytarabine|cytarabine|mesh-list
25367281|NCT05146739|Fludarabine|fludarabine|mesh-list
25367282|NCT05146739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367283|NCT05146739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25367284|NCT05146739|Antimetabolites|antimetabolites|mesh-ancestor
25367285|NCT05146739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367286|NCT05146739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25367287|NCT05146739|Immunologic Factors|immunologic factors|mesh-ancestor
25367288|NCT05146739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367289|NCT05146739|Antiviral Agents|antiviral agents|mesh-ancestor
25367290|NCT05146739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25367291|NCT05146739|Antidotes|antidotes|mesh-ancestor
25367292|NCT05146739|Protective Agents|protective agents|mesh-ancestor
25367293|NCT05146739|Vitamin B Complex|vitamin b complex|mesh-ancestor
25367295|NCT05146739|Micronutrients|micronutrients|mesh-ancestor
25367296|NCT05145413|Xanomeline|xanomeline|mesh-list
25367297|NCT05145413|Trospium chloride|trospium chloride|mesh-list
25367298|NCT05145413|Parasympatholytics|parasympatholytics|mesh-ancestor
25367299|NCT05145413|Autonomic Agents|autonomic agents|mesh-ancestor
25367300|NCT05145413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25367301|NCT05145413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367302|NCT05145413|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25367303|NCT05145413|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25367304|NCT05145413|Cholinergic Agents|cholinergic agents|mesh-ancestor
25367305|NCT05145413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25367306|NCT05145413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367307|NCT05145413|Urological Agents|urological agents|mesh-ancestor
25367308|NCT05145413|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25367309|NCT05145413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25367310|NCT05145413|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25367311|NCT05145413|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25367312|NCT05145309|Magnesium citrate|magnesium citrate|mesh-list
25367313|NCT05145309|Cathartics|cathartics|mesh-ancestor
25367314|NCT05145309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25367315|NCT05144854|Capecitabine|capecitabine|mesh-list
25367316|NCT05144854|Tegafur|tegafur|mesh-list
25367317|NCT05144854|Oxaliplatin|oxaliplatin|mesh-list
25367318|NCT05144854|Nivolumab|nivolumab|mesh-list
25367319|NCT05144854|Ipilimumab|ipilimumab|mesh-list
25367320|NCT05144854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25367321|NCT05144854|Antimetabolites|antimetabolites|mesh-ancestor
25367322|NCT05144854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367323|NCT05144854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367324|NCT05144854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25367325|NCT05144854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25367326|NCT05144243|Azacitidine|azacitidine|mesh-list
25367327|NCT05144243|Venetoclax|venetoclax|mesh-list
25367328|NCT05144243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25367329|NCT05144243|Antimetabolites|antimetabolites|mesh-ancestor
25367330|NCT05144243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367331|NCT05144243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367332|NCT05144243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367333|NCT05144009|Rituximab|rituximab|mesh-list
25367334|NCT05144009|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
25367335|NCT05144009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25367336|NCT05144009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367337|NCT05144009|Immunologic Factors|immunologic factors|mesh-ancestor
25367338|NCT05144009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367339|NCT05144009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25367340|NCT05142696|Carboplatin|carboplatin|mesh-list
25367341|NCT05142696|Etoposide|etoposide|mesh-list
25367342|NCT05142696|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
25367343|NCT05142696|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25367344|NCT05142696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367345|NCT05142696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25367346|NCT05142696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25367347|NCT05142696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25367348|NCT05142696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367349|NCT05142696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367350|NCT05142696|Chelating Agents|chelating agents|mesh-ancestor
25367351|NCT05142696|Sequestering Agents|sequestering agents|mesh-ancestor
25367352|NCT05142696|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25367353|NCT05142254|Hydroxyurea|hydroxyurea|mesh-list
25367354|NCT05142254|Tadalafil|tadalafil|mesh-list
25367355|NCT05142254|Vasodilator Agents|vasodilator agents|mesh-ancestor
25367356|NCT05142254|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25367357|NCT05142254|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25367358|NCT05142254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367359|NCT05142254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367360|NCT05142254|Urological Agents|urological agents|mesh-ancestor
25367361|NCT05142254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367362|NCT05142254|Antisickling Agents|antisickling agents|mesh-ancestor
25367363|NCT05142254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25367364|NCT05142241|Temozolomide|temozolomide|mesh-list
25367365|NCT05142241|Talazoparib|talazoparib|mesh-list
25367366|NCT05142241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25367367|NCT05142241|Alkylating Agents|alkylating agents|mesh-ancestor
25367368|NCT05142241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367369|NCT05142241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367370|NCT05142241|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25367371|NCT05142241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367372|NCT05142189|Docetaxel|docetaxel|mesh-list
25367373|NCT05142189|Cemiplimab|cemiplimab|mesh-list
25367374|NCT05142189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367375|NCT05142189|Tubulin Modulators|tubulin modulators|mesh-ancestor
25367376|NCT05142189|Antimitotic Agents|antimitotic agents|mesh-ancestor
25367377|NCT05142189|Mitosis Modulators|mitosis modulators|mesh-ancestor
25367378|NCT05142189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367379|NCT05142189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25367380|NCT05141903|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25367381|NCT05141903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25367382|NCT05141721|Bevacizumab|bevacizumab|mesh-list
25367384|NCT05141721|Oxaliplatin|oxaliplatin|mesh-list
25367385|NCT05141721|Atezolizumab|atezolizumab|mesh-list
25367386|NCT05141721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25367387|NCT05141721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367388|NCT05141721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25367389|NCT05141721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25367390|NCT05141721|Growth Substances|growth substances|mesh-ancestor
25367391|NCT05141721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367392|NCT05141721|Growth Inhibitors|growth inhibitors|mesh-ancestor
25367393|NCT05141721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25367394|NCT05141721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367395|NCT05141708|Talazoparib|talazoparib|mesh-list
25367396|NCT05141708|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25367397|NCT05141708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367398|NCT05141708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367399|NCT05141708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367400|NCT05141357|Pembrolizumab|pembrolizumab|mesh-list
25367401|NCT05141357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25367402|NCT05141357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367403|NCT05141149|Gemcitabine|gemcitabine|mesh-list
25367404|NCT05141149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25367405|NCT05141149|Antimetabolites|antimetabolites|mesh-ancestor
25367406|NCT05141149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367407|NCT05141149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367408|NCT05141149|Antiviral Agents|antiviral agents|mesh-ancestor
25367409|NCT05141149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25367410|NCT05141149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367411|NCT05141149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25367412|NCT05141149|Immunologic Factors|immunologic factors|mesh-ancestor
25367413|NCT05141149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367414|NCT05141006|Botulinum Toxins|botulinum toxins|mesh-list
25367415|NCT05141006|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25367416|NCT05141006|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25367417|NCT05141006|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25367418|NCT05141006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25367419|NCT05141006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367420|NCT05141006|Cholinergic Agents|cholinergic agents|mesh-ancestor
25367421|NCT05141006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25367422|NCT05141006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367423|NCT05141006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25367424|NCT05141006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25367425|NCT05140499|Bupivacaine|bupivacaine|mesh-list
25367426|NCT05140499|Anesthetics, Local|anesthetics, local|mesh-ancestor
25367427|NCT05140499|Anesthetics|anesthetics|mesh-ancestor
25367428|NCT05140499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25367429|NCT05140499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367430|NCT05140499|Sensory System Agents|sensory system agents|mesh-ancestor
25367431|NCT05140499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25367432|NCT05140278|Artesunate|artesunate|mesh-list
25367433|NCT05140278|Antimalarials|antimalarials|mesh-ancestor
25367434|NCT05140278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25367435|NCT05140278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25367436|NCT05140278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25367437|NCT05140278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367438|NCT05140278|Antiviral Agents|antiviral agents|mesh-ancestor
25367439|NCT05140278|Schistosomicides|schistosomicides|mesh-ancestor
25367440|NCT05140278|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25367441|NCT05140278|Anthelmintics|anthelmintics|mesh-ancestor
25367442|NCT05139420|Topiramate|topiramate|mesh-list
25367443|NCT05139420|Phentermine|phentermine|mesh-list
25367444|NCT05139420|Anticonvulsants|anticonvulsants|mesh-ancestor
25367445|NCT05139420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25367446|NCT05139420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367447|NCT05139420|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25367448|NCT05139420|Appetite Depressants|appetite depressants|mesh-ancestor
25367449|NCT05139420|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25367450|NCT05139420|Sympathomimetics|sympathomimetics|mesh-ancestor
25367451|NCT05139420|Autonomic Agents|autonomic agents|mesh-ancestor
25367452|NCT05139420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25367453|NCT05139420|Adrenergic Agents|adrenergic agents|mesh-ancestor
25367454|NCT05139420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25367455|NCT05139420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367456|NCT05139316|Prednisolone|prednisolone|mesh-list
25367457|NCT05139316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25367458|NCT05139316|Glucocorticoids|glucocorticoids|mesh-ancestor
25367459|NCT05139316|Hormones|hormones|mesh-ancestor
25367460|NCT05139316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25367461|NCT05139316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367462|NCT05139316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25367463|NCT05139316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367464|NCT05139121|Contraceptive Agents|contraceptive agents|mesh-list
25367465|NCT05139121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25367466|NCT05139121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367467|NCT05139043|Dexamethasone|dexamethasone|mesh-list
25367468|NCT05139043|Dexamethasone acetate|dexamethasone acetate|mesh-list
25367469|NCT05139043|Ichthammol|ichthammol|mesh-list
25367470|NCT05139043|BB 1101|bb 1101|mesh-list
25367471|NCT05139043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25367472|NCT05139043|Antiemetics|antiemetics|mesh-ancestor
25367473|NCT05139043|Autonomic Agents|autonomic agents|mesh-ancestor
25367474|NCT05139043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25367475|NCT05139043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367476|NCT05139043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25367477|NCT05139043|Glucocorticoids|glucocorticoids|mesh-ancestor
25367478|NCT05139043|Hormones|hormones|mesh-ancestor
25367479|NCT05139043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25367480|NCT05139043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25367481|NCT05139043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367482|NCT05139043|Protease Inhibitors|protease inhibitors|mesh-ancestor
25367483|NCT05139043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367484|NCT05139043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367485|NCT05139043|Dermatologic Agents|dermatologic agents|mesh-ancestor
25367486|NCT05139030|Bupivacaine|bupivacaine|mesh-list
25367487|NCT05139030|Anesthetics, Local|anesthetics, local|mesh-ancestor
25367488|NCT05139030|Anesthetics|anesthetics|mesh-ancestor
25367489|NCT05139030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25367490|NCT05139030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367491|NCT05139030|Sensory System Agents|sensory system agents|mesh-ancestor
25367492|NCT05139030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25367493|NCT05139017|Gemcitabine|gemcitabine|mesh-list
25367494|NCT05139017|Rituximab|rituximab|mesh-list
25367495|NCT05139017|Oxaliplatin|oxaliplatin|mesh-list
25367496|NCT05139017|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25367497|NCT05139017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25367498|NCT05139017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367499|NCT05139017|Immunologic Factors|immunologic factors|mesh-ancestor
25367500|NCT05139017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367501|NCT05139017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25367502|NCT05139017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25367503|NCT05139017|Antimetabolites|antimetabolites|mesh-ancestor
25367504|NCT05139017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367505|NCT05139017|Antiviral Agents|antiviral agents|mesh-ancestor
25367506|NCT05139017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25367507|NCT05139017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367508|NCT05139017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25367509|NCT05139017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25367510|NCT05139017|Alkylating Agents|alkylating agents|mesh-ancestor
25367511|NCT05138822|Nitrofurantoin|nitrofurantoin|mesh-list
25367512|NCT05138822|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25367513|NCT05138822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25367539|NCT05137080|Hormones|hormones|mesh-ancestor
25367540|NCT05137080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25367541|NCT05137080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25367542|NCT05137080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367860|NCT05118490|Isoniazid|isoniazid|mesh-list
25367564|NCT05136898|Mitomycin|mitomycin|mesh-list
25367565|NCT05136898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25367566|NCT05136898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367567|NCT05136898|Alkylating Agents|alkylating agents|mesh-ancestor
25367568|NCT05136898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367569|NCT05136898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25367570|NCT05136898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367571|NCT05136703|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25367572|NCT05136703|Antiviral Agents|antiviral agents|mesh-ancestor
25367573|NCT05136703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25367574|NCT05136690|Nicotine|nicotine|mesh-list
25367575|NCT05136690|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25367576|NCT05136690|Autonomic Agents|autonomic agents|mesh-ancestor
25367577|NCT05136690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25367578|NCT05136690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367579|NCT05136690|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25367580|NCT05136690|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25367581|NCT05136690|Cholinergic Agents|cholinergic agents|mesh-ancestor
25367582|NCT05136690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25367583|NCT05136690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367584|NCT05136196|Nivolumab|nivolumab|mesh-list
25367585|NCT05136196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25367586|NCT05136196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367587|NCT05136196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25367588|NCT05136196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367589|NCT05135910|Terbinafine|terbinafine|mesh-list
25724235|NCT02535806|Analgesics|analgesics|mesh-ancestor
25367597|NCT05134922|Gedatolisib|gedatolisib|mesh-list
25367598|NCT05134922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25367599|NCT05134922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367600|NCT05134922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367601|NCT05134441|Calcium, Dietary|calcium, dietary|mesh-list
25367602|NCT05134441|Calcium|calcium|mesh-list
25367603|NCT05134441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25367604|NCT05134441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367605|NCT05134441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25367606|NCT05133817|Norepinephrine|norepinephrine|mesh-list
25367607|NCT05133817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25367608|NCT05133817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25367609|NCT05133817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25367610|NCT05133817|Adrenergic Agents|adrenergic agents|mesh-ancestor
25367611|NCT05133817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25367612|NCT05133817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367613|NCT05133817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367614|NCT05133817|Sympathomimetics|sympathomimetics|mesh-ancestor
25367615|NCT05133817|Autonomic Agents|autonomic agents|mesh-ancestor
25367616|NCT05133817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25367617|NCT05133518|Midazolam|midazolam|mesh-list
25367618|NCT05133518|Ketamine|ketamine|mesh-list
25367619|NCT05133518|Analgesics|analgesics|mesh-ancestor
25367620|NCT05133518|Sensory System Agents|sensory system agents|mesh-ancestor
25367621|NCT05133518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25367622|NCT05133518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367623|NCT05133518|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25367624|NCT05133518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25367625|NCT05133518|Anesthetics, General|anesthetics, general|mesh-ancestor
25367626|NCT05133518|Anesthetics|anesthetics|mesh-ancestor
25367627|NCT05133518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25367628|NCT05133518|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25367629|NCT05133518|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25367630|NCT05133518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25367631|NCT05133518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367632|NCT05133518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25367633|NCT05133518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25367634|NCT05133518|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25367635|NCT05133518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25367636|NCT05133518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25367637|NCT05133518|GABA Modulators|gaba modulators|mesh-ancestor
25367639|NCT05132582|Trastuzumab|trastuzumab|mesh-list
25367640|NCT05132582|Pertuzumab|pertuzumab|mesh-list
25367641|NCT05132582|Tucatinib|tucatinib|mesh-list
25367642|NCT05132582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25367643|NCT05132582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367644|NCT05132582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25367645|NCT05132582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367646|NCT05132582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367647|NCT05132504|Pembrolizumab|pembrolizumab|mesh-list
25367648|NCT05132504|Folfirinox|folfirinox|mesh-list
25367649|NCT05132504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25367650|NCT05132504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367651|NCT05132114|Lugol's solution|lugol's solution|mesh-list
25367652|NCT05132114|Hemostatics|hemostatics|mesh-ancestor
25367653|NCT05132114|Coagulants|coagulants|mesh-ancestor
25367654|NCT05132075|Docetaxel|docetaxel|mesh-list
25367655|NCT05132075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367656|NCT05132075|Tubulin Modulators|tubulin modulators|mesh-ancestor
25367657|NCT05132075|Antimitotic Agents|antimitotic agents|mesh-ancestor
25367658|NCT05132075|Mitosis Modulators|mitosis modulators|mesh-ancestor
25367659|NCT05132075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367677|NCT05128773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25367678|NCT05128773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367679|NCT05128773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25367680|NCT05128773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367681|NCT05128773|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25367682|NCT05128773|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25367683|NCT05128773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25367685|NCT05127876|Pseudoephedrine|pseudoephedrine|mesh-list
25367686|NCT05127876|Ondansetron|ondansetron|mesh-list
25367687|NCT05127876|Antiemetics|antiemetics|mesh-ancestor
25367688|NCT05127876|Autonomic Agents|autonomic agents|mesh-ancestor
25367689|NCT05127876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25367690|NCT05127876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367691|NCT05127876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25367692|NCT05127876|Antipruritics|antipruritics|mesh-ancestor
25367693|NCT05127876|Dermatologic Agents|dermatologic agents|mesh-ancestor
25367694|NCT05127876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25367695|NCT05127876|Serotonin Agents|serotonin agents|mesh-ancestor
25367696|NCT05127876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25367697|NCT05127876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367698|NCT05127876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25367699|NCT05127876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25367700|NCT05127876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25367701|NCT05127876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25367702|NCT05127876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25367703|NCT05127876|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25367704|NCT05127876|Sympathomimetics|sympathomimetics|mesh-ancestor
25367705|NCT05127876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25367706|NCT05127876|Adrenergic Agents|adrenergic agents|mesh-ancestor
25367707|NCT05127876|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25367708|NCT05127876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25367709|NCT05127876|Respiratory System Agents|respiratory system agents|mesh-ancestor
25367710|NCT05127876|Nasal Decongestants|nasal decongestants|mesh-ancestor
25367711|NCT05127590|Pembrolizumab|pembrolizumab|mesh-list
25367712|NCT05127590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25367713|NCT05127590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367715|NCT05127395|Antiviral Agents|antiviral agents|mesh-ancestor
25367716|NCT05127395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25367717|NCT05127044|Bilirubin|bilirubin|mesh-list
25367718|NCT05127044|Antioxidants|antioxidants|mesh-ancestor
25367719|NCT05127044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367720|NCT05127044|Protective Agents|protective agents|mesh-ancestor
25367721|NCT05127044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367722|NCT05126966|Ranibizumab|ranibizumab|mesh-list
25367723|NCT05126966|Aflibercept|aflibercept|mesh-list
25367724|NCT05126966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25367725|NCT05126966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25367726|NCT05126966|Growth Substances|growth substances|mesh-ancestor
25367727|NCT05126966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367728|NCT05126966|Growth Inhibitors|growth inhibitors|mesh-ancestor
25367729|NCT05126966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367730|NCT05126784|Denosumab|denosumab|mesh-list
25367731|NCT05126784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25367732|NCT05126784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367733|NCT05126342|Niraparib|niraparib|mesh-list
25367734|NCT05126342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25367735|NCT05126342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367736|NCT05126342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367737|NCT05126342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367738|NCT05126108|Parathyroid Hormone|parathyroid hormone|mesh-list
25367739|NCT05126108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25367740|NCT05126108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367741|NCT05125016|Cemiplimab|cemiplimab|mesh-list
25367742|NCT05125016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25367752|NCT05123703|Ocrelizumab|ocrelizumab|mesh-list
25367753|NCT05123703|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25367754|NCT05123703|Immunologic Factors|immunologic factors|mesh-ancestor
25367830|NCT05119920|Cholinergic Agents|cholinergic agents|mesh-ancestor
25367755|NCT05123703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367756|NCT05123703|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25367757|NCT05123703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367758|NCT05123703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25367768|NCT05123131|Dexamethasone|dexamethasone|mesh-list
25367769|NCT05123131|Lenalidomide|lenalidomide|mesh-list
25367770|NCT05123131|Bortezomib|bortezomib|mesh-list
25367771|NCT05123131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25367772|NCT05123131|Antiemetics|antiemetics|mesh-ancestor
25367773|NCT05123131|Autonomic Agents|autonomic agents|mesh-ancestor
25367774|NCT05123131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25367775|NCT05123131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367776|NCT05123131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25367777|NCT05123131|Glucocorticoids|glucocorticoids|mesh-ancestor
25367778|NCT05123131|Hormones|hormones|mesh-ancestor
25367779|NCT05123131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25367780|NCT05123131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25367781|NCT05123131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367782|NCT05123131|Immunologic Factors|immunologic factors|mesh-ancestor
25367783|NCT05123131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25367784|NCT05123131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25367785|NCT05123131|Growth Substances|growth substances|mesh-ancestor
25367786|NCT05123131|Growth Inhibitors|growth inhibitors|mesh-ancestor
25367787|NCT05122884|Milrinone|milrinone|mesh-list
25367788|NCT05122884|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25367789|NCT05122884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25367790|NCT05122884|Vasodilator Agents|vasodilator agents|mesh-ancestor
25367791|NCT05122884|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25367792|NCT05122884|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25367793|NCT05122884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367794|NCT05122884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367795|NCT05122884|Protective Agents|protective agents|mesh-ancestor
25367796|NCT05122884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367797|NCT05122767|Dolutegravir|dolutegravir|mesh-list
25367798|NCT05122767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25367799|NCT05122767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25367800|NCT05122767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367801|NCT05122767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367802|NCT05122767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25367803|NCT05122767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25367804|NCT05122767|Antiviral Agents|antiviral agents|mesh-ancestor
25367805|NCT05122767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25367806|NCT05122026|Isoniazid|isoniazid|mesh-list
25367807|NCT05122026|Rifapentine|rifapentine|mesh-list
25367808|NCT05122026|Antitubercular Agents|antitubercular agents|mesh-ancestor
25367809|NCT05122026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25367810|NCT05122026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25367811|NCT05122026|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25367812|NCT05122026|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25367813|NCT05122026|Antimetabolites|antimetabolites|mesh-ancestor
25367814|NCT05122026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367815|NCT05122026|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25367816|NCT05122026|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25367827|NCT05119920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367829|NCT05119920|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25367831|NCT05119920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25367832|NCT05119920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367833|NCT05119855|Vaccines|vaccines|mesh-list
25367834|NCT05119855|Immunologic Factors|immunologic factors|mesh-ancestor
25367835|NCT05119855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367836|NCT05119140|Hydroxychloroquine|hydroxychloroquine|mesh-list
25367837|NCT05119140|Mesalamine|mesalamine|mesh-list
25367838|NCT05119140|Antimalarials|antimalarials|mesh-ancestor
25367839|NCT05119140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25367840|NCT05119140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25367841|NCT05119140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25367842|NCT05119140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367843|NCT05119140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367844|NCT05119140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25367845|NCT05119140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25367846|NCT05119140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25367847|NCT05119140|Analgesics|analgesics|mesh-ancestor
25367848|NCT05119140|Sensory System Agents|sensory system agents|mesh-ancestor
25367849|NCT05119140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25367850|NCT05119140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367851|NCT05119140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25367852|NCT05118854|Cisplatin|cisplatin|mesh-list
25367853|NCT05118854|Carboplatin|carboplatin|mesh-list
25367854|NCT05118854|Pemetrexed|pemetrexed|mesh-list
25367855|NCT05118854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367856|NCT05118854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367857|NCT05118854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367858|NCT05118854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25367859|NCT05118854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25367861|NCT05118490|Rifapentine|rifapentine|mesh-list
25367862|NCT05118490|Rifampin|rifampin|mesh-list
25367863|NCT05118490|Antitubercular Agents|antitubercular agents|mesh-ancestor
25367864|NCT05118490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25367865|NCT05118490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25367866|NCT05118490|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25367867|NCT05118490|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25367868|NCT05118490|Antimetabolites|antimetabolites|mesh-ancestor
25367869|NCT05118490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367870|NCT05118490|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25367871|NCT05118490|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25367872|NCT05118490|Leprostatic Agents|leprostatic agents|mesh-ancestor
25367873|NCT05118490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25367874|NCT05118490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367875|NCT05118490|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25367876|NCT05118490|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25367877|NCT05118490|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25367878|NCT05118490|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25367879|NCT05118490|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25367880|NCT05118490|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25367881|NCT05118477|Caffeine|caffeine|mesh-list
25367882|NCT05118477|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25367883|NCT05118477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367884|NCT05118477|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25367885|NCT05118477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367886|NCT05118477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367887|NCT05118477|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25367888|NCT05118477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25367889|NCT05118477|Purinergic Agents|purinergic agents|mesh-ancestor
25367890|NCT05118477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25367891|NCT05117931|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
25367892|NCT05117931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25367893|NCT05117931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367894|NCT05117814|Zanubrutinib|zanubrutinib|mesh-list
25367895|NCT05117814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367896|NCT05117814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25367897|NCT05117814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367898|NCT05117814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367899|NCT05117489|Cortisone|cortisone|mesh-list
25367900|NCT05117489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25367901|NCT05117242|Pembrolizumab|pembrolizumab|mesh-list
25367902|NCT05117242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25367903|NCT05117242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367904|NCT05116254|AZD7648|azd7648|mesh-list
25367905|NCT05116254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25367906|NCT05116254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367907|NCT05116254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367908|NCT05116202|Nivolumab|nivolumab|mesh-list
25367909|NCT05116202|Ipilimumab|ipilimumab|mesh-list
25367910|NCT05116202|Atezolizumab|atezolizumab|mesh-list
25367911|NCT05116202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25367912|NCT05116202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367913|NCT05116202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25367914|NCT05116202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367915|NCT05116189|Paclitaxel|paclitaxel|mesh-list
25367916|NCT05116189|Docetaxel|docetaxel|mesh-list
25367917|NCT05116189|Bevacizumab|bevacizumab|mesh-list
25367918|NCT05116189|Pembrolizumab|pembrolizumab|mesh-list
25367919|NCT05116189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25367920|NCT05116189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367921|NCT05116189|Tubulin Modulators|tubulin modulators|mesh-ancestor
25367922|NCT05116189|Antimitotic Agents|antimitotic agents|mesh-ancestor
25367923|NCT05116189|Mitosis Modulators|mitosis modulators|mesh-ancestor
25367924|NCT05116189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367925|NCT05116189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25367926|NCT05116189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25367927|NCT05116189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25367928|NCT05116189|Growth Substances|growth substances|mesh-ancestor
25367929|NCT05116189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367930|NCT05116189|Growth Inhibitors|growth inhibitors|mesh-ancestor
25367931|NCT05115630|Mycophenolic Acid|mycophenolic acid|mesh-list
25367932|NCT05115630|Cyclophosphamide|cyclophosphamide|mesh-list
25367933|NCT05115630|Melphalan|melphalan|mesh-list
25367934|NCT05115630|Fludarabine|fludarabine|mesh-list
25367935|NCT05115630|Fludarabine phosphate|fludarabine phosphate|mesh-list
25367937|NCT05115630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25367938|NCT05115630|Immunologic Factors|immunologic factors|mesh-ancestor
25367939|NCT05115630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367940|NCT05115630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25367941|NCT05115630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25367942|NCT05115630|Alkylating Agents|alkylating agents|mesh-ancestor
25367943|NCT05115630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367944|NCT05115630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367945|NCT05115630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25367946|NCT05115630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25367947|NCT05115630|Antimetabolites|antimetabolites|mesh-ancestor
25367948|NCT05115630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25367949|NCT05115630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25367950|NCT05115630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25367951|NCT05115630|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25367952|NCT05115630|Antitubercular Agents|antitubercular agents|mesh-ancestor
25367953|NCT05115630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25367954|NCT05115630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25367955|NCT05115513|Dronabinol|dronabinol|mesh-list
25367956|NCT05115513|Hallucinogens|hallucinogens|mesh-ancestor
25367957|NCT05115513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367958|NCT05115513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25367959|NCT05115513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25367960|NCT05115513|Analgesics|analgesics|mesh-ancestor
25367961|NCT05115513|Sensory System Agents|sensory system agents|mesh-ancestor
25367962|NCT05115513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25367963|NCT05115513|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25367964|NCT05115513|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25367965|NCT05115513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25367966|NCT05115513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367967|NCT05115513|Hormones|hormones|mesh-ancestor
25367968|NCT05115513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25367970|NCT05115110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25367971|NCT05115110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25367972|NCT05115110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367973|NCT05114837|Cyclophosphamide|cyclophosphamide|mesh-list
25367974|NCT05114837|Fludarabine|fludarabine|mesh-list
25367975|NCT05114837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25367976|NCT05114837|Immunologic Factors|immunologic factors|mesh-ancestor
25367977|NCT05114837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367978|NCT05114837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25367979|NCT05114837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25367980|NCT05114837|Alkylating Agents|alkylating agents|mesh-ancestor
25367981|NCT05114837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367982|NCT05114837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25367983|NCT05114837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25367984|NCT05114746|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25367986|NCT05114746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25367987|NCT05114746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25367988|NCT05114096|Betamethasone|betamethasone|mesh-list
25367989|NCT05114096|Betamethasone Valerate|betamethasone valerate|mesh-list
25367990|NCT05114096|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25367991|NCT05114096|Betamethasone benzoate|betamethasone benzoate|mesh-list
25367992|NCT05114096|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25367993|NCT05114096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25367994|NCT05114096|Glucocorticoids|glucocorticoids|mesh-ancestor
25367995|NCT05114096|Hormones|hormones|mesh-ancestor
25367996|NCT05114096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25367997|NCT05114096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25367998|NCT05114096|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25367999|NCT05114096|Respiratory System Agents|respiratory system agents|mesh-ancestor
25368000|NCT05113745|Reboxetine|reboxetine|mesh-list
25368001|NCT05113745|Antidepressive Agents|antidepressive agents|mesh-ancestor
25368002|NCT05113745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25368003|NCT05113745|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25368004|NCT05113745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25368005|NCT05113745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25368006|NCT05113745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368007|NCT05113745|Adrenergic Agents|adrenergic agents|mesh-ancestor
25368008|NCT05113745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25368009|NCT05113745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368010|NCT05113537|177Lu-PSMA-617|177lu-psma-617|mesh-list
25368011|NCT05113537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368012|NCT05113537|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25368013|NCT05113251|Paclitaxel|paclitaxel|mesh-list
25368014|NCT05113251|Cyclophosphamide|cyclophosphamide|mesh-list
25368015|NCT05113251|Doxorubicin|doxorubicin|mesh-list
25368016|NCT05113251|Trastuzumab|trastuzumab|mesh-list
25368017|NCT05113251|Pertuzumab|pertuzumab|mesh-list
25368018|NCT05113251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25368019|NCT05113251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368020|NCT05113251|Tubulin Modulators|tubulin modulators|mesh-ancestor
25368021|NCT05113251|Antimitotic Agents|antimitotic agents|mesh-ancestor
25368022|NCT05113251|Mitosis Modulators|mitosis modulators|mesh-ancestor
25368023|NCT05113251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368024|NCT05113251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25368025|NCT05113251|Immunologic Factors|immunologic factors|mesh-ancestor
25368026|NCT05113251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368027|NCT05113251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25368028|NCT05113251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25368029|NCT05113251|Alkylating Agents|alkylating agents|mesh-ancestor
25368030|NCT05113251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25368031|NCT05113251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25368032|NCT05113251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25368033|NCT05113251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25368034|NCT05113251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368035|NCT05113251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25368036|NCT05112965|Atezolizumab|atezolizumab|mesh-list
25368037|NCT05112965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368038|NCT05112952|Lazertinib|lazertinib|mesh-list
25368039|NCT05112952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25368040|NCT05112952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368041|NCT05112952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368042|NCT05112939|Cabotegravir|cabotegravir|mesh-list
25368043|NCT05112939|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25368044|NCT05112939|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25368045|NCT05112939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368046|NCT05112939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368047|NCT05112939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25368048|NCT05112939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25368049|NCT05112939|Antiviral Agents|antiviral agents|mesh-ancestor
25368050|NCT05112939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25368051|NCT05112666|Rivaroxaban|rivaroxaban|mesh-list
25368052|NCT05112666|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25368053|NCT05112666|Antithrombins|antithrombins|mesh-ancestor
25368054|NCT05112666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25368055|NCT05112666|Protease Inhibitors|protease inhibitors|mesh-ancestor
25368056|NCT05112666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368063|NCT05112601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25368064|NCT05112601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368065|NCT05112536|Paclitaxel|paclitaxel|mesh-list
25368066|NCT05112536|Carboplatin|carboplatin|mesh-list
25368067|NCT05112536|Doxorubicin|doxorubicin|mesh-list
25368068|NCT05112536|Pembrolizumab|pembrolizumab|mesh-list
25368069|NCT05112536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25368070|NCT05112536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368071|NCT05112536|Tubulin Modulators|tubulin modulators|mesh-ancestor
25368072|NCT05112536|Antimitotic Agents|antimitotic agents|mesh-ancestor
25368073|NCT05112536|Mitosis Modulators|mitosis modulators|mesh-ancestor
25368074|NCT05112536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368075|NCT05112536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25368076|NCT05112536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25368077|NCT05112536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25368078|NCT05112536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368079|NCT05112536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25368080|NCT05112263|Cyclosporine|cyclosporine|mesh-list
25368081|NCT05112263|Cyclosporins|cyclosporins|mesh-list
25368082|NCT05112263|Tofacitinib|tofacitinib|mesh-list
25368083|NCT05112263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368084|NCT05112263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368085|NCT05112263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25368086|NCT05112263|Immunologic Factors|immunologic factors|mesh-ancestor
25368087|NCT05112263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368088|NCT05112263|Antifungal Agents|antifungal agents|mesh-ancestor
25368089|NCT05112263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25368090|NCT05112263|Dermatologic Agents|dermatologic agents|mesh-ancestor
25368091|NCT05112263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25368092|NCT05112263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25368093|NCT05112263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25368100|NCT05111574|Nivolumab|nivolumab|mesh-list
25368101|NCT05111574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25368102|NCT05111574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368103|NCT05111574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25368104|NCT05111574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368105|NCT05111353|Poly ICLC|poly iclc|mesh-list
25368106|NCT05111353|Interferon Inducers|interferon inducers|mesh-ancestor
25368107|NCT05111353|Immunologic Factors|immunologic factors|mesh-ancestor
25368108|NCT05111353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368109|NCT05111145|Ivacaftor|ivacaftor|mesh-list
25368110|NCT05111145|Elexacaftor|elexacaftor|mesh-list
25368111|NCT05111145|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25368112|NCT05111145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25368113|NCT05111145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368114|NCT05110417|Bromides|bromides|mesh-list
25368115|NCT05110417|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
25368116|NCT05110417|Anticonvulsants|anticonvulsants|mesh-ancestor
25368117|NCT05110417|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25368118|NCT05110417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368119|NCT05110417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368120|NCT05110417|Cholinergic Agents|cholinergic agents|mesh-ancestor
25368121|NCT05110417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25368122|NCT05110417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368123|NCT05109728|Temozolomide|temozolomide|mesh-list
25368124|NCT05109728|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
25368125|NCT05109728|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25368126|NCT05109728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25368127|NCT05109728|Alkylating Agents|alkylating agents|mesh-ancestor
25368128|NCT05109728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368129|NCT05109728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368130|NCT05109728|Chelating Agents|chelating agents|mesh-ancestor
25368133|NCT05109702|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25368134|NCT05109702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25368135|NCT05109611|Nitric Oxide|nitric oxide|mesh-list
25368136|NCT05109611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25368137|NCT05109611|Autonomic Agents|autonomic agents|mesh-ancestor
25368138|NCT05109611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25368139|NCT05109611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368140|NCT05109611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25368141|NCT05109611|Respiratory System Agents|respiratory system agents|mesh-ancestor
25368142|NCT05109611|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25368143|NCT05109611|Antioxidants|antioxidants|mesh-ancestor
25368144|NCT05109611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368145|NCT05109611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25368146|NCT05109611|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25368147|NCT05109611|Vasodilator Agents|vasodilator agents|mesh-ancestor
25368148|NCT05109611|Gasotransmitters|gasotransmitters|mesh-ancestor
25368149|NCT05109611|Protective Agents|protective agents|mesh-ancestor
25368150|NCT05109520|Insulin Glargine|insulin glargine|mesh-list
25368151|NCT05109520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25368152|NCT05109520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368153|NCT05109364|Terazosin|terazosin|mesh-list
25368154|NCT05109364|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25368155|NCT05109364|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25368156|NCT05109364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25368157|NCT05109364|Adrenergic Agents|adrenergic agents|mesh-ancestor
25368158|NCT05109364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25368159|NCT05109364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368160|NCT05109364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368161|NCT05109364|Urological Agents|urological agents|mesh-ancestor
25368164|NCT05109104|Sunscreening Agents|sunscreening agents|mesh-list
25368165|NCT05109104|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25368166|NCT05109104|Protective Agents|protective agents|mesh-ancestor
25368167|NCT05109104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368168|NCT05109104|Dermatologic Agents|dermatologic agents|mesh-ancestor
25368169|NCT05109052|Bevacizumab|bevacizumab|mesh-list
25368170|NCT05109052|Atezolizumab|atezolizumab|mesh-list
25368171|NCT05109052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25368172|NCT05109052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368173|NCT05109052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25368174|NCT05109052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25368175|NCT05109052|Growth Substances|growth substances|mesh-ancestor
25368176|NCT05109052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368177|NCT05109052|Growth Inhibitors|growth inhibitors|mesh-ancestor
25368178|NCT05108935|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25368179|NCT05108935|Buprenorphine|buprenorphine|mesh-list
25368180|NCT05108935|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25368181|NCT05108935|Naloxone|naloxone|mesh-list
25368182|NCT05108935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25368183|NCT05108935|Narcotics|narcotics|mesh-ancestor
25368184|NCT05108935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25368185|NCT05108935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368186|NCT05108935|Analgesics|analgesics|mesh-ancestor
25368187|NCT05108935|Sensory System Agents|sensory system agents|mesh-ancestor
25368188|NCT05108935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25368189|NCT05108935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25368190|NCT05108935|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25368191|NCT05108935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25368192|NCT05108935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368193|NCT05108935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368194|NCT05108935|Antiviral Agents|antiviral agents|mesh-ancestor
25368195|NCT05108935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25368196|NCT05108935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25368197|NCT05108935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25368198|NCT05108870|Paclitaxel|paclitaxel|mesh-list
25368199|NCT05108870|Carboplatin|carboplatin|mesh-list
25368200|NCT05108870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25368201|NCT05108870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368202|NCT05108870|Tubulin Modulators|tubulin modulators|mesh-ancestor
25368203|NCT05108870|Antimitotic Agents|antimitotic agents|mesh-ancestor
25368204|NCT05108870|Mitosis Modulators|mitosis modulators|mesh-ancestor
25368279|NCT05105997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25368210|NCT05108428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368211|NCT05108259|Adalimumab|adalimumab|mesh-list
25368212|NCT05108259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25368213|NCT05108259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25368214|NCT05107999|Doxepin|doxepin|mesh-list
25368215|NCT05107999|Antidepressive Agents|antidepressive agents|mesh-list
25368216|NCT05107999|Neurotransmitter Agents|neurotransmitter agents|mesh-list
25368217|NCT05107999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25368218|NCT05107999|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25368219|NCT05107999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25368220|NCT05107999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25368221|NCT05107999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368222|NCT05107999|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25368223|NCT05107999|Histamine Antagonists|histamine antagonists|mesh-ancestor
25368224|NCT05107999|Histamine Agents|histamine agents|mesh-ancestor
25368225|NCT05107999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368226|NCT05107765|Pioglitazone|pioglitazone|mesh-list
25368227|NCT05107765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25368228|NCT05107765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368384|NCT05100472|Hormones|hormones|mesh-ancestor
25368235|NCT05107193|Afatinib|afatinib|mesh-list
25368236|NCT05107193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368237|NCT05107193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25368238|NCT05107193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368239|NCT05107193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368240|NCT05106192|Triamcinolone|triamcinolone|mesh-list
25368241|NCT05106192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25368242|NCT05106192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25368243|NCT05106192|Mechlorethamine|mechlorethamine|mesh-list
25368244|NCT05106192|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25368245|NCT05106192|Bexarotene|bexarotene|mesh-list
25368246|NCT05106192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25368247|NCT05106192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25368248|NCT05106192|Glucocorticoids|glucocorticoids|mesh-ancestor
25368249|NCT05106192|Hormones|hormones|mesh-ancestor
25368250|NCT05106192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25368251|NCT05106192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368252|NCT05106192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25368253|NCT05106192|Immunologic Factors|immunologic factors|mesh-ancestor
25368254|NCT05106192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368255|NCT05106192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368256|NCT05106192|Alkylating Agents|alkylating agents|mesh-ancestor
25368257|NCT05106192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25368258|NCT05106192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368259|NCT05106153|Zolpidem|zolpidem|mesh-list
25368260|NCT05106153|Suvorexant|suvorexant|mesh-list
25368261|NCT05106153|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25368262|NCT05106153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25368263|NCT05106153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25368264|NCT05106153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368265|NCT05106153|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
25368266|NCT05106153|GABA Agonists|gaba agonists|mesh-ancestor
25368267|NCT05106153|GABA Agents|gaba agents|mesh-ancestor
25368268|NCT05106153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25368269|NCT05106153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368270|NCT05106153|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25368271|NCT05106127|Pembrolizumab|pembrolizumab|mesh-list
25368272|NCT05106127|Lenvatinib|lenvatinib|mesh-list
25368273|NCT05106127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25368274|NCT05106127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368275|NCT05106127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25368276|NCT05106127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368277|NCT05106127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368278|NCT05105997|Dexamethasone|dexamethasone|mesh-list
25368280|NCT05105997|Antiemetics|antiemetics|mesh-ancestor
25368281|NCT05105997|Autonomic Agents|autonomic agents|mesh-ancestor
25368282|NCT05105997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25368283|NCT05105997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368284|NCT05105997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25368285|NCT05105997|Glucocorticoids|glucocorticoids|mesh-ancestor
25368286|NCT05105997|Hormones|hormones|mesh-ancestor
25368287|NCT05105997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25368288|NCT05105997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25368289|NCT05105997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368290|NCT05105841|Venetoclax|venetoclax|mesh-list
25368291|NCT05105841|Obinutuzumab|obinutuzumab|mesh-list
25368292|NCT05105841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368293|NCT05105841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25368295|NCT05105542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25368296|NCT05105542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368297|NCT05105542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368298|NCT05105035|Meropenem|meropenem|mesh-list
25368299|NCT05105035|Ceftazidime|ceftazidime|mesh-list
25368300|NCT05105035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25368301|NCT05105035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25368302|NCT05104983|Sirolimus|sirolimus|mesh-list
25368303|NCT05104983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25368304|NCT05104983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25368305|NCT05104983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25368306|NCT05104983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368307|NCT05104983|Antifungal Agents|antifungal agents|mesh-ancestor
25368308|NCT05104983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25368309|NCT05104983|Immunologic Factors|immunologic factors|mesh-ancestor
25368310|NCT05104983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368311|NCT05104866|Gemcitabine|gemcitabine|mesh-list
25368312|NCT05104866|Capecitabine|capecitabine|mesh-list
25368313|NCT05104866|Vinorelbine|vinorelbine|mesh-list
25368314|NCT05104866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25368315|NCT05104866|Antimetabolites|antimetabolites|mesh-ancestor
25368316|NCT05104866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368317|NCT05104866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368318|NCT05104866|Antiviral Agents|antiviral agents|mesh-ancestor
25368319|NCT05104866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25368320|NCT05104866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368321|NCT05104866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25368322|NCT05104866|Immunologic Factors|immunologic factors|mesh-ancestor
25368323|NCT05104866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368324|NCT05104866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25368325|NCT05104866|Tubulin Modulators|tubulin modulators|mesh-ancestor
25368326|NCT05104866|Antimitotic Agents|antimitotic agents|mesh-ancestor
25368327|NCT05104866|Mitosis Modulators|mitosis modulators|mesh-ancestor
25368328|NCT05104723|Tofacitinib|tofacitinib|mesh-list
25368329|NCT05104723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25368330|NCT05104723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368331|NCT05104723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368332|NCT05104567|Pembrolizumab|pembrolizumab|mesh-list
25368333|NCT05104567|Cetuximab|cetuximab|mesh-list
25368334|NCT05104567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25368335|NCT05104567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368336|NCT05103605|Osimertinib|osimertinib|mesh-list
25368337|NCT05103605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368338|NCT05103605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25368339|NCT05103605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368340|NCT05103605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368341|NCT05103358|Sirolimus|sirolimus|mesh-list
25368342|NCT05103358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25368343|NCT05103358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25368344|NCT05103358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25368345|NCT05103358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368346|NCT05103358|Antifungal Agents|antifungal agents|mesh-ancestor
25368347|NCT05103358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25368348|NCT05103358|Immunologic Factors|immunologic factors|mesh-ancestor
25368349|NCT05103358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368350|NCT05103332|Amlodipine|amlodipine|mesh-list
25368351|NCT05103332|Olmesartan|olmesartan|mesh-list
25368352|NCT05103332|Indapamide|indapamide|mesh-list
25368353|NCT05103332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25368354|NCT05103332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25368355|NCT05103332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25368659|NCT05092360|Immunologic Factors|immunologic factors|mesh-ancestor
25368356|NCT05103332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368357|NCT05103332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25368358|NCT05103332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368359|NCT05103332|Vasodilator Agents|vasodilator agents|mesh-ancestor
25368360|NCT05103332|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25368361|NCT05103332|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25368362|NCT05103332|Diuretics|diuretics|mesh-ancestor
25368363|NCT05103332|Natriuretic Agents|natriuretic agents|mesh-ancestor
25368364|NCT05103332|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25368365|NCT05102552|Huperzine A|huperzine a|mesh-list
25368367|NCT05102552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368368|NCT05102552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368369|NCT05102552|Cholinergic Agents|cholinergic agents|mesh-ancestor
25368370|NCT05102552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25368371|NCT05102552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368372|NCT05102552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25368373|NCT05102552|Protective Agents|protective agents|mesh-ancestor
25368374|NCT05101187|Amphotericin B|amphotericin b|mesh-list
25368375|NCT05101187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
25368377|NCT05101187|Amebicides|amebicides|mesh-ancestor
25368378|NCT05101187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25368379|NCT05101187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25368380|NCT05101187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25368381|NCT05101187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25368382|NCT05101187|Antifungal Agents|antifungal agents|mesh-ancestor
25368383|NCT05100472|Androgens|androgens|mesh-list
25368385|NCT05100472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25368386|NCT05100472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368387|NCT05099471|Dexamethasone|dexamethasone|mesh-list
25368388|NCT05099471|Cyclophosphamide|cyclophosphamide|mesh-list
25368389|NCT05099471|Rituximab|rituximab|mesh-list
25368390|NCT05099471|Venetoclax|venetoclax|mesh-list
25368391|NCT05099471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25368392|NCT05099471|Immunologic Factors|immunologic factors|mesh-ancestor
25368393|NCT05099471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368394|NCT05099471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25368395|NCT05099471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25368396|NCT05099471|Alkylating Agents|alkylating agents|mesh-ancestor
25368397|NCT05099471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368398|NCT05099471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368399|NCT05099471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25368400|NCT05099471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25368401|NCT05099471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25368402|NCT05099471|Antiemetics|antiemetics|mesh-ancestor
25368403|NCT05099471|Autonomic Agents|autonomic agents|mesh-ancestor
25368404|NCT05099471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25368405|NCT05099471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25368406|NCT05099471|Glucocorticoids|glucocorticoids|mesh-ancestor
25368407|NCT05099471|Hormones|hormones|mesh-ancestor
25368408|NCT05099471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25368409|NCT05099471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25368410|NCT05098938|Acyclovir|acyclovir|mesh-list
25368411|NCT05098938|Antiviral Agents|antiviral agents|mesh-ancestor
25368412|NCT05098938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25368413|NCT05098457|Lidocaine|lidocaine|mesh-list
25368414|NCT05098457|Anesthetics, Local|anesthetics, local|mesh-ancestor
25368415|NCT05098457|Anesthetics|anesthetics|mesh-ancestor
25368416|NCT05098457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25368417|NCT05098457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368418|NCT05098457|Sensory System Agents|sensory system agents|mesh-ancestor
25368419|NCT05098457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25368420|NCT05098457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25368421|NCT05098457|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25368422|NCT05098457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25368423|NCT05098457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25368424|NCT05098457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368425|NCT05098366|Furosemide|furosemide|mesh-list
25368426|NCT05098366|Diuretics|diuretics|mesh-ancestor
25368427|NCT05098366|Natriuretic Agents|natriuretic agents|mesh-ancestor
25368428|NCT05098366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368429|NCT05098366|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25368430|NCT05098366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25368431|NCT05098366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368432|NCT05098210|Poly I-C|poly i-c|mesh-list
25368433|NCT05098210|Nivolumab|nivolumab|mesh-list
25368434|NCT05098210|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25368435|NCT05098210|Poly ICLC|poly iclc|mesh-list
25368436|NCT05098210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25368437|NCT05098210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368438|NCT05098210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25368439|NCT05098210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368440|NCT05098210|Interferon Inducers|interferon inducers|mesh-ancestor
25368441|NCT05098210|Immunologic Factors|immunologic factors|mesh-ancestor
25368442|NCT05098210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368443|NCT05098210|Laxatives|laxatives|mesh-ancestor
25368444|NCT05098210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25368445|NCT05098210|Antiviral Agents|antiviral agents|mesh-ancestor
25368446|NCT05098210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25368447|NCT05098132|Pembrolizumab|pembrolizumab|mesh-list
25368448|NCT05098132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25368449|NCT05098132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368450|NCT05098028|Rifaximin|rifaximin|mesh-list
25368451|NCT05098028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25368452|NCT05098028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25368453|NCT05098028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25368454|NCT05097599|Trastuzumab|trastuzumab|mesh-list
25368455|NCT05097599|Talazoparib|talazoparib|mesh-list
25368456|NCT05097599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25368457|NCT05097599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368458|NCT05097599|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25368459|NCT05097599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368460|NCT05097599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368461|NCT05097261|Ketamine|ketamine|mesh-list
25368462|NCT05097261|Analgesics|analgesics|mesh-ancestor
25368463|NCT05097261|Sensory System Agents|sensory system agents|mesh-ancestor
25368464|NCT05097261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25368465|NCT05097261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368466|NCT05097261|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25368467|NCT05097261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25368468|NCT05097261|Anesthetics, General|anesthetics, general|mesh-ancestor
25368469|NCT05097261|Anesthetics|anesthetics|mesh-ancestor
25368470|NCT05097261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25368471|NCT05097261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25368472|NCT05097261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25368473|NCT05097261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25368474|NCT05097261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368475|NCT05096845|Vaccines|vaccines|mesh-list
25368476|NCT05096845|Immunologic Factors|immunologic factors|mesh-ancestor
25368477|NCT05096845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368478|NCT05096832|Vaccines|vaccines|mesh-list
25368479|NCT05096832|Immunologic Factors|immunologic factors|mesh-ancestor
25368480|NCT05096832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368481|NCT05096728|Nifedipine|nifedipine|mesh-list
25368482|NCT05096728|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25368483|NCT05096728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25368484|NCT05096728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368485|NCT05096728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25368486|NCT05096728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368487|NCT05096728|Vasodilator Agents|vasodilator agents|mesh-ancestor
25368488|NCT05096728|Tocolytic Agents|tocolytic agents|mesh-ancestor
25368489|NCT05096728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25368490|NCT05096663|Vitamins|vitamins|mesh-list
25368491|NCT05096663|Folic Acid|folic acid|mesh-list
25368492|NCT05096663|Hydroxocobalamin|hydroxocobalamin|mesh-list
25368493|NCT05096663|Vitamin B 12|vitamin b 12|mesh-list
25368494|NCT05096663|Vitamin B Complex|vitamin b complex|mesh-list
25368495|NCT05096663|Gemcitabine|gemcitabine|mesh-list
25368496|NCT05096663|Dexamethasone|dexamethasone|mesh-list
25368497|NCT05096663|Dexamethasone acetate|dexamethasone acetate|mesh-list
25368498|NCT05096663|Docetaxel|docetaxel|mesh-list
25368499|NCT05096663|Pembrolizumab|pembrolizumab|mesh-list
25368500|NCT05096663|Pemetrexed|pemetrexed|mesh-list
25368501|NCT05096663|Ramucirumab|ramucirumab|mesh-list
25368502|NCT05096663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25368503|NCT05096663|Antibodies|antibodies|mesh-list
25368504|NCT05096663|Immunoglobulins|immunoglobulins|mesh-list
25368505|NCT05096663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25368506|NCT05096663|Lexatumumab|lexatumumab|mesh-list
25368507|NCT05096663|BB 1101|bb 1101|mesh-list
25368508|NCT05096663|Micronutrients|micronutrients|mesh-ancestor
25368513|NCT05096663|Autonomic Agents|autonomic agents|mesh-ancestor
25368514|NCT05096663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25368515|NCT05096663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25368516|NCT05096663|Glucocorticoids|glucocorticoids|mesh-ancestor
25368517|NCT05096663|Hormones|hormones|mesh-ancestor
25368518|NCT05096663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25368519|NCT05096663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25368520|NCT05096663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368521|NCT05096663|Protease Inhibitors|protease inhibitors|mesh-ancestor
25368522|NCT05096663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368523|NCT05096663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368524|NCT05096663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25368525|NCT05096663|Antimetabolites|antimetabolites|mesh-ancestor
25368526|NCT05096663|Antiviral Agents|antiviral agents|mesh-ancestor
25368527|NCT05096663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25368528|NCT05096663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25368529|NCT05096663|Tubulin Modulators|tubulin modulators|mesh-ancestor
25368530|NCT05096663|Antimitotic Agents|antimitotic agents|mesh-ancestor
25368531|NCT05096663|Mitosis Modulators|mitosis modulators|mesh-ancestor
25368532|NCT05096663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25368533|NCT05096663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25368534|NCT05096663|Hematinics|hematinics|mesh-ancestor
25368535|NCT05096481|Temozolomide|temozolomide|mesh-list
25368536|NCT05096481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25368537|NCT05096481|Alkylating Agents|alkylating agents|mesh-ancestor
25368538|NCT05096481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368539|NCT05096481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368540|NCT05096390|Pembrolizumab|pembrolizumab|mesh-list
25368541|NCT05096390|Axitinib|axitinib|mesh-list
25368542|NCT05096390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25368543|NCT05096390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368544|NCT05096390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25368545|NCT05096390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368546|NCT05096390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368547|NCT05095961|Prednisone|prednisone|mesh-list
25368548|NCT05095961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25368549|NCT05095961|Glucocorticoids|glucocorticoids|mesh-ancestor
25368550|NCT05095961|Hormones|hormones|mesh-ancestor
25368551|NCT05095961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25368552|NCT05095961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368553|NCT05095961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25368554|NCT05095961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368555|NCT05095922|Valsartan|valsartan|mesh-list
25368556|NCT05095922|Calcium Dobesilate|calcium dobesilate|mesh-list
25368557|NCT05095922|Calcium|calcium|mesh-list
25368558|NCT05095922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25368559|NCT05095922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368560|NCT05095922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25368561|NCT05095922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25368562|NCT05095922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25368563|NCT05095922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368564|NCT05095922|Hemostatics|hemostatics|mesh-ancestor
25368565|NCT05095922|Coagulants|coagulants|mesh-ancestor
25368566|NCT05095376|Temozolomide|temozolomide|mesh-list
25368567|NCT05095376|Lomustine|lomustine|mesh-list
25368568|NCT05095376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25368569|NCT05095376|Alkylating Agents|alkylating agents|mesh-ancestor
25368570|NCT05095376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368571|NCT05095376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368572|NCT05094427|Anesthetics|anesthetics|mesh-list
25368573|NCT05094427|Anesthetics, Local|anesthetics, local|mesh-list
25368574|NCT05094427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25368575|NCT05094427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368576|NCT05094427|Sensory System Agents|sensory system agents|mesh-ancestor
25368577|NCT05094427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25368811|NCT05087992|Growth Inhibitors|growth inhibitors|mesh-ancestor
25368585|NCT05094154|Cephalosporins|cephalosporins|mesh-list
25368586|NCT05094154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25368587|NCT05094154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25368588|NCT05094128|Upadacitinib|upadacitinib|mesh-list
25368589|NCT05094128|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25368590|NCT05094128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25368591|NCT05094128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368592|NCT05094128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368593|NCT05094128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25368595|NCT05093621|Furosemide|furosemide|mesh-list
25368596|NCT05093621|Diuretics|diuretics|mesh-ancestor
25368597|NCT05093621|Natriuretic Agents|natriuretic agents|mesh-ancestor
25368598|NCT05093621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368599|NCT05093621|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25368600|NCT05093621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25368601|NCT05093621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368602|NCT05093621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25368609|NCT05093608|Growth Substances|growth substances|mesh-ancestor
25368610|NCT05093608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368611|NCT05093608|Growth Inhibitors|growth inhibitors|mesh-ancestor
25368613|NCT05093322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25368614|NCT05093322|Antimetabolites|antimetabolites|mesh-ancestor
25368615|NCT05093322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368616|NCT05093322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368617|NCT05093322|Antiviral Agents|antiviral agents|mesh-ancestor
25368618|NCT05093322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25368619|NCT05093322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368620|NCT05093322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25368621|NCT05093322|Immunologic Factors|immunologic factors|mesh-ancestor
25368622|NCT05093322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368623|NCT05092984|Spironolactone|spironolactone|mesh-list
25368624|NCT05092984|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25368625|NCT05092984|Hormone Antagonists|hormone antagonists|mesh-ancestor
25368626|NCT05092984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25368627|NCT05092984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368628|NCT05092984|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25368629|NCT05092984|Diuretics|diuretics|mesh-ancestor
25368630|NCT05092984|Natriuretic Agents|natriuretic agents|mesh-ancestor
25368637|NCT05092386|Vaccines|vaccines|mesh-list
25368638|NCT05092386|Immunologic Factors|immunologic factors|mesh-ancestor
25368639|NCT05092386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368640|NCT05092360|Gemcitabine|gemcitabine|mesh-list
25368641|NCT05092360|Paclitaxel|paclitaxel|mesh-list
25368642|NCT05092360|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25368643|NCT05092360|Doxorubicin|doxorubicin|mesh-list
25368644|NCT05092360|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25368645|NCT05092360|Pembrolizumab|pembrolizumab|mesh-list
25368646|NCT05092360|Topotecan|topotecan|mesh-list
25368647|NCT05092360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25368648|NCT05092360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368649|NCT05092360|Tubulin Modulators|tubulin modulators|mesh-ancestor
25368650|NCT05092360|Antimitotic Agents|antimitotic agents|mesh-ancestor
25368651|NCT05092360|Mitosis Modulators|mitosis modulators|mesh-ancestor
25368652|NCT05092360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368653|NCT05092360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25368654|NCT05092360|Antimetabolites|antimetabolites|mesh-ancestor
25368655|NCT05092360|Antiviral Agents|antiviral agents|mesh-ancestor
25368656|NCT05092360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25368657|NCT05092360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368658|NCT05092360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25368660|NCT05092360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368661|NCT05092360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25368662|NCT05092360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25368663|NCT05092360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25368664|NCT05092360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25368665|NCT05092360|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25368666|NCT05092269|Ustekinumab|ustekinumab|mesh-list
25368667|NCT05092269|Dermatologic Agents|dermatologic agents|mesh-ancestor
25368668|NCT05091567|Carboplatin|carboplatin|mesh-list
25368669|NCT05091567|Etoposide|etoposide|mesh-list
25368670|NCT05091567|Atezolizumab|atezolizumab|mesh-list
25368671|NCT05091567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368672|NCT05091567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25368673|NCT05091567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25368674|NCT05091567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25368675|NCT05091567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368676|NCT05091567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368677|NCT05091528|Capecitabine|capecitabine|mesh-list
25368678|NCT05091528|Trastuzumab|trastuzumab|mesh-list
25368679|NCT05091528|Tucatinib|tucatinib|mesh-list
25368680|NCT05091528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25368681|NCT05091528|Antimetabolites|antimetabolites|mesh-ancestor
25368682|NCT05091528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368683|NCT05091528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368684|NCT05091528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25368685|NCT05091528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25368686|NCT05091528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368687|NCT05091346|Pembrolizumab|pembrolizumab|mesh-list
25368688|NCT05091346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25368689|NCT05091346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368690|NCT05090657|Chlorhexidine|chlorhexidine|mesh-list
25368691|NCT05090657|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25368692|NCT05090657|Methylene Blue|methylene blue|mesh-list
25368693|NCT05090657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25368694|NCT05090657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25368695|NCT05090657|Disinfectants|disinfectants|mesh-ancestor
25368696|NCT05090657|Dermatologic Agents|dermatologic agents|mesh-ancestor
25368697|NCT05090657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368698|NCT05090657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368699|NCT05090566|Dexamethasone|dexamethasone|mesh-list
25368700|NCT05090566|Lenalidomide|lenalidomide|mesh-list
25368701|NCT05090566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25368702|NCT05090566|Antiemetics|antiemetics|mesh-ancestor
25368703|NCT05090566|Autonomic Agents|autonomic agents|mesh-ancestor
25368704|NCT05090566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25368705|NCT05090566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368706|NCT05090566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25368707|NCT05090566|Glucocorticoids|glucocorticoids|mesh-ancestor
25368708|NCT05090566|Hormones|hormones|mesh-ancestor
25368709|NCT05090566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25368710|NCT05090566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25368711|NCT05090566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368712|NCT05090566|Immunologic Factors|immunologic factors|mesh-ancestor
25368713|NCT05090566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25368714|NCT05090566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25368715|NCT05090566|Growth Substances|growth substances|mesh-ancestor
25368716|NCT05090566|Growth Inhibitors|growth inhibitors|mesh-ancestor
25368717|NCT05090384|Prednisone|prednisone|mesh-list
25368718|NCT05090384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25368719|NCT05090384|Glucocorticoids|glucocorticoids|mesh-ancestor
25368720|NCT05090384|Hormones|hormones|mesh-ancestor
25368721|NCT05090384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25368722|NCT05090384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368723|NCT05090384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25368724|NCT05090384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368725|NCT05090358|Canagliflozin|canagliflozin|mesh-list
25368726|NCT05090358|Fulvestrant|fulvestrant|mesh-list
25368727|NCT05090358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25368728|NCT05090358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368729|NCT05090358|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25368730|NCT05090358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25368731|NCT05090358|Hormone Antagonists|hormone antagonists|mesh-ancestor
25368732|NCT05090358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25368733|NCT05090358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368734|NCT05090358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25368735|NCT05090358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368736|NCT05090358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25368737|NCT05090280|Nafamostat|nafamostat|mesh-list
25368738|NCT05090280|Naltrexone|naltrexone|mesh-list
25368739|NCT05090280|Oxycodone|oxycodone|mesh-list
25368740|NCT05090280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25368741|NCT05090280|Narcotics|narcotics|mesh-ancestor
25368742|NCT05090280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25368743|NCT05090280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368744|NCT05090280|Analgesics|analgesics|mesh-ancestor
25368745|NCT05090280|Sensory System Agents|sensory system agents|mesh-ancestor
25368746|NCT05090280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25368747|NCT05090280|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25368748|NCT05090280|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25368749|NCT05090280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25368750|NCT05090280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25368751|NCT05090280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25368752|NCT05090280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25368753|NCT05090280|Anticoagulants|anticoagulants|mesh-ancestor
25368754|NCT05090280|Protease Inhibitors|protease inhibitors|mesh-ancestor
25368755|NCT05090280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368756|NCT05090280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368757|NCT05090280|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25368758|NCT05090280|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25368759|NCT05090280|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25368760|NCT05090280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25368761|NCT05090280|Immunologic Factors|immunologic factors|mesh-ancestor
25368763|NCT05090033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368764|NCT05089734|Docetaxel|docetaxel|mesh-list
25368765|NCT05089734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368766|NCT05089734|Tubulin Modulators|tubulin modulators|mesh-ancestor
25368767|NCT05089734|Antimitotic Agents|antimitotic agents|mesh-ancestor
25368768|NCT05089734|Mitosis Modulators|mitosis modulators|mesh-ancestor
25368769|NCT05089734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368770|NCT05089708|Trifarotene|trifarotene|mesh-list
25368771|NCT05089708|Dermatologic Agents|dermatologic agents|mesh-ancestor
25368772|NCT05089630|Vaccines|vaccines|mesh-list
25368773|NCT05089630|Immunologic Factors|immunologic factors|mesh-ancestor
25368774|NCT05089630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368775|NCT05089461|Mitoxantrone|mitoxantrone|mesh-list
25368776|NCT05089461|Analgesics|analgesics|mesh-ancestor
25368777|NCT05089461|Sensory System Agents|sensory system agents|mesh-ancestor
25368778|NCT05089461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25368779|NCT05089461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368780|NCT05089461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368781|NCT05089461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25368782|NCT05089461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25368783|NCT05089461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368784|NCT05089461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368785|NCT05088980|Lidocaine|lidocaine|mesh-list
25368786|NCT05088980|Anesthetics, Local|anesthetics, local|mesh-ancestor
25368787|NCT05088980|Anesthetics|anesthetics|mesh-ancestor
25368788|NCT05088980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25368789|NCT05088980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368790|NCT05088980|Sensory System Agents|sensory system agents|mesh-ancestor
25368791|NCT05088980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25368792|NCT05088980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25368793|NCT05088980|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25368794|NCT05088980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25368795|NCT05088980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25368796|NCT05088980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368797|NCT05088876|Acetaminophen|acetaminophen|mesh-list
25368798|NCT05088876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25368799|NCT05088876|Analgesics|analgesics|mesh-ancestor
25368800|NCT05088876|Sensory System Agents|sensory system agents|mesh-ancestor
25368801|NCT05088876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25368802|NCT05088876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368803|NCT05088876|Antipyretics|antipyretics|mesh-ancestor
25368804|NCT05087992|Bevacizumab|bevacizumab|mesh-list
25368805|NCT05087992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25368806|NCT05087992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368807|NCT05087992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25368808|NCT05087992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25368809|NCT05087992|Growth Substances|growth substances|mesh-ancestor
25368810|NCT05087992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368812|NCT05086692|Interleukin-2|interleukin-2|mesh-list
25368813|NCT05086692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368814|NCT05086692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25368815|NCT05086692|Analgesics|analgesics|mesh-ancestor
25368816|NCT05086692|Sensory System Agents|sensory system agents|mesh-ancestor
25368817|NCT05086692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25368818|NCT05086692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368819|NCT05086627|Capecitabine|capecitabine|mesh-list
25368820|NCT05086627|Oxaliplatin|oxaliplatin|mesh-list
25368821|NCT05086627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25368822|NCT05086627|Antimetabolites|antimetabolites|mesh-ancestor
25368823|NCT05086627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368824|NCT05086627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368825|NCT05086250|Ketamine|ketamine|mesh-list
25368826|NCT05086250|Analgesics|analgesics|mesh-ancestor
25368827|NCT05086250|Sensory System Agents|sensory system agents|mesh-ancestor
25368828|NCT05086250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25368829|NCT05086250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368830|NCT05086250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25368831|NCT05086250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25368832|NCT05086250|Anesthetics, General|anesthetics, general|mesh-ancestor
25368834|NCT05086250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25368835|NCT05086250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25368836|NCT05086250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25368837|NCT05086250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25368838|NCT05086250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368840|NCT05085574|Famotidine|famotidine|mesh-list
25368841|NCT05085574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25368842|NCT05085574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25368843|NCT05085574|Analgesics|analgesics|mesh-ancestor
25368844|NCT05085574|Sensory System Agents|sensory system agents|mesh-ancestor
25368845|NCT05085574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25368846|NCT05085574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368847|NCT05085574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25368848|NCT05085574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25368849|NCT05085574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25368850|NCT05085574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25368851|NCT05085574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368852|NCT05085574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368853|NCT05085574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25368854|NCT05085574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25368855|NCT05085574|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25368856|NCT05085574|Histamine Antagonists|histamine antagonists|mesh-ancestor
25368857|NCT05085574|Histamine Agents|histamine agents|mesh-ancestor
25368858|NCT05085574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25368859|NCT05085496|Atezolizumab|atezolizumab|mesh-list
25368860|NCT05085496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25368861|NCT05085496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368862|NCT05085496|Immunologic Factors|immunologic factors|mesh-ancestor
25368863|NCT05085496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368864|NCT05085340|Pyrimethamine|pyrimethamine|mesh-list
25368865|NCT05085340|Sulfadoxine|sulfadoxine|mesh-list
25368866|NCT05085340|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
25368867|NCT05085340|Antimalarials|antimalarials|mesh-ancestor
25368868|NCT05085340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25368869|NCT05085340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25368870|NCT05085340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25368871|NCT05085340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25368872|NCT05085340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368873|NCT05085340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368874|NCT05085340|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25368875|NCT05085340|Renal Agents|renal agents|mesh-ancestor
25368876|NCT05085028|Pembrolizumab|pembrolizumab|mesh-list
25368877|NCT05085028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25368878|NCT05085028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368879|NCT05084859|Prednisone|prednisone|mesh-list
25368880|NCT05084859|Docetaxel|docetaxel|mesh-list
25368881|NCT05084859|Panitumumab|panitumumab|mesh-list
25368882|NCT05084859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368883|NCT05084859|Tubulin Modulators|tubulin modulators|mesh-ancestor
25368884|NCT05084859|Antimitotic Agents|antimitotic agents|mesh-ancestor
25368885|NCT05084859|Mitosis Modulators|mitosis modulators|mesh-ancestor
25368886|NCT05084859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368887|NCT05084859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25368888|NCT05084859|Glucocorticoids|glucocorticoids|mesh-ancestor
25368889|NCT05084859|Hormones|hormones|mesh-ancestor
25368890|NCT05084859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25368891|NCT05084859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368892|NCT05084859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25368893|NCT05084859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25368894|NCT05084651|Itraconazole|itraconazole|mesh-list
25368895|NCT05084651|Lumefantrine|lumefantrine|mesh-list
25368896|NCT05084651|Antifungal Agents|antifungal agents|mesh-ancestor
25368897|NCT05084651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25368898|NCT05084651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25368899|NCT05084651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25368900|NCT05084651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368901|NCT05084651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368902|NCT05084651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25368903|NCT05084651|Hormone Antagonists|hormone antagonists|mesh-ancestor
25368904|NCT05084651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25368905|NCT05084651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368906|NCT05084651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25368907|NCT05084651|Antimalarials|antimalarials|mesh-ancestor
25368908|NCT05084651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25368909|NCT05084651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25368910|NCT05084638|Ofatumumab|ofatumumab|mesh-list
25368911|NCT05084638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368913|NCT05084404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25368914|NCT05084404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25368915|NCT05084404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25368916|NCT05084404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25368917|NCT05084404|Adrenergic Agents|adrenergic agents|mesh-ancestor
25368918|NCT05084404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25368919|NCT05084404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368920|NCT05084404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368921|NCT05084248|Vitamin D|vitamin d|mesh-list
25368922|NCT05084248|Ergocalciferols|ergocalciferols|mesh-list
25368923|NCT05084248|Vitamins|vitamins|mesh-ancestor
25368924|NCT05084248|Micronutrients|micronutrients|mesh-ancestor
25368925|NCT05084248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368926|NCT05084248|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25368927|NCT05084248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25368928|NCT05084053|Immunoglobulins|immunoglobulins|mesh-list
25368929|NCT05084053|Immunologic Factors|immunologic factors|mesh-ancestor
25368930|NCT05084053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368931|NCT05083754|Temozolomide|temozolomide|mesh-list
25368932|NCT05083754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25368933|NCT05083754|Alkylating Agents|alkylating agents|mesh-ancestor
25368934|NCT05083754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368935|NCT05083754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368936|NCT05083182|Ustekinumab|ustekinumab|mesh-list
25368937|NCT05083182|Dermatologic Agents|dermatologic agents|mesh-ancestor
25368938|NCT05083169|Dexamethasone|dexamethasone|mesh-list
25368939|NCT05083169|Bortezomib|bortezomib|mesh-list
25368940|NCT05083169|Daratumumab|daratumumab|mesh-list
25368941|NCT05083169|Pomalidomide|pomalidomide|mesh-list
25368942|NCT05083169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25368943|NCT05083169|Antiemetics|antiemetics|mesh-ancestor
25368944|NCT05083169|Autonomic Agents|autonomic agents|mesh-ancestor
25368945|NCT05083169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25368946|NCT05083169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368947|NCT05083169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25368948|NCT05083169|Glucocorticoids|glucocorticoids|mesh-ancestor
25368949|NCT05083169|Hormones|hormones|mesh-ancestor
25368950|NCT05083169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25368951|NCT05083169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25368952|NCT05083169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368953|NCT05083169|Immunologic Factors|immunologic factors|mesh-ancestor
25368954|NCT05083169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25368955|NCT05083169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25368956|NCT05083169|Growth Substances|growth substances|mesh-ancestor
25368957|NCT05083169|Growth Inhibitors|growth inhibitors|mesh-ancestor
25368958|NCT05082025|Fulvestrant|fulvestrant|mesh-list
25368959|NCT05082025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25368960|NCT05082025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368961|NCT05082025|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25368962|NCT05082025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25368963|NCT05082025|Hormone Antagonists|hormone antagonists|mesh-ancestor
25368964|NCT05082025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25368965|NCT05082025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368966|NCT05081609|Pembrolizumab|pembrolizumab|mesh-list
25368967|NCT05081609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25368968|NCT05081609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368969|NCT05081479|Acetylcysteine|acetylcysteine|mesh-list
25368970|NCT05081479|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25368971|NCT05081479|Antiviral Agents|antiviral agents|mesh-ancestor
25368972|NCT05081479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25368973|NCT05081479|Expectorants|expectorants|mesh-ancestor
25368974|NCT05081479|Respiratory System Agents|respiratory system agents|mesh-ancestor
25368975|NCT05081479|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25368976|NCT05081479|Antioxidants|antioxidants|mesh-ancestor
25368977|NCT05081479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368978|NCT05081479|Protective Agents|protective agents|mesh-ancestor
25368979|NCT05081479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368980|NCT05081479|Antidotes|antidotes|mesh-ancestor
25368981|NCT05081466|Vitamin D|vitamin d|mesh-list
25368982|NCT05081466|Calcium|calcium|mesh-list
25368983|NCT05081466|Vitamins|vitamins|mesh-ancestor
25368984|NCT05081466|Micronutrients|micronutrients|mesh-ancestor
25368985|NCT05081466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25368986|NCT05081466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25368987|NCT05081466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25368988|NCT05081180|Lenvatinib|lenvatinib|mesh-list
25368989|NCT05081180|Avelumab|avelumab|mesh-list
25368990|NCT05081180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25368991|NCT05081180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25368992|NCT05081180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25368993|NCT05081180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25368994|NCT05081180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25368995|NCT05080218|Adalimumab|adalimumab|mesh-list
25368996|NCT05080218|Etanercept|etanercept|mesh-list
25368997|NCT05080218|Golimumab|golimumab|mesh-list
25368998|NCT05080218|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
25368999|NCT05080218|Abatacept|abatacept|mesh-list
25369000|NCT05080218|Upadacitinib|upadacitinib|mesh-list
25369001|NCT05080218|Ixekizumab|ixekizumab|mesh-list
25369002|NCT05080218|Tofacitinib|tofacitinib|mesh-list
25369003|NCT05080218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25369004|NCT05080218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25369005|NCT05080218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25369006|NCT05080218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25369007|NCT05080218|Analgesics|analgesics|mesh-ancestor
25369008|NCT05080218|Sensory System Agents|sensory system agents|mesh-ancestor
25369009|NCT05080218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25369010|NCT05080218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369011|NCT05080218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25369012|NCT05080218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25369013|NCT05080218|Immunologic Factors|immunologic factors|mesh-ancestor
25369014|NCT05080218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25369015|NCT05080218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369016|NCT05080218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369017|NCT05080218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25369018|NCT05080218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25369019|NCT05080218|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25369020|NCT05080218|Dermatologic Agents|dermatologic agents|mesh-ancestor
25369021|NCT05079763|Monolaurin|monolaurin|mesh-list
25369022|NCT05079763|Cariostatic Agents|cariostatic agents|mesh-ancestor
25369023|NCT05079763|Protective Agents|protective agents|mesh-ancestor
25369024|NCT05079763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369025|NCT05079230|Azacitidine|azacitidine|mesh-list
25369026|NCT05079230|Venetoclax|venetoclax|mesh-list
25369027|NCT05079230|Magrolimab|magrolimab|mesh-list
25369028|NCT05079230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25369029|NCT05079230|Antimetabolites|antimetabolites|mesh-ancestor
25369030|NCT05079230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369031|NCT05079230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369032|NCT05079230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25369033|NCT05079230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25369034|NCT05079126|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
25369035|NCT05079126|Antioxidants|antioxidants|mesh-ancestor
25369036|NCT05079126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369037|NCT05079126|Protective Agents|protective agents|mesh-ancestor
25369038|NCT05079126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369039|NCT05079126|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25369040|NCT05079126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369041|NCT05078944|Donepezil|donepezil|mesh-list
25369042|NCT05078944|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25369043|NCT05078944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25369044|NCT05078944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369045|NCT05078944|Cholinergic Agents|cholinergic agents|mesh-ancestor
25369046|NCT05078944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25369047|NCT05078944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369048|NCT05078944|Nootropic Agents|nootropic agents|mesh-ancestor
25369049|NCT05078879|Empagliflozin|empagliflozin|mesh-list
25369050|NCT05078879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25369051|NCT05078879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369052|NCT05078879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25369053|NCT05078879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369054|NCT05078866|Vaccines|vaccines|mesh-list
25369055|NCT05078866|Immunologic Factors|immunologic factors|mesh-ancestor
25369056|NCT05078866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369057|NCT05078671|Cobicistat|cobicistat|mesh-list
25369058|NCT05078671|Olaparib|olaparib|mesh-list
25369059|NCT05078671|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25369070|NCT05078463|Terephthalic acid|terephthalic acid|mesh-list
25369071|NCT05078463|Anesthetics, Local|anesthetics, local|mesh-ancestor
25369073|NCT05078463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25369074|NCT05078463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369075|NCT05078463|Sensory System Agents|sensory system agents|mesh-ancestor
25369076|NCT05078463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25369077|NCT05078463|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25369078|NCT05078463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25369079|NCT05078463|Antioxidants|antioxidants|mesh-ancestor
25369080|NCT05078463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369081|NCT05078463|Protective Agents|protective agents|mesh-ancestor
25369093|NCT05077709|Pembrolizumab|pembrolizumab|mesh-list
25369094|NCT05077709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25369095|NCT05077709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369096|NCT05077488|Lidocaine|lidocaine|mesh-list
25369097|NCT05077488|Anesthetics, Local|anesthetics, local|mesh-ancestor
25369098|NCT05077488|Anesthetics|anesthetics|mesh-ancestor
25369099|NCT05077488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25369100|NCT05077488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369101|NCT05077488|Sensory System Agents|sensory system agents|mesh-ancestor
25369102|NCT05077488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25369103|NCT05077488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25369104|NCT05077488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25369105|NCT05077488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25369106|NCT05077488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25369107|NCT05077488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369108|NCT05077332|Celecoxib|celecoxib|mesh-list
25369109|NCT05077332|Famotidine|famotidine|mesh-list
25369110|NCT05077332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25369111|NCT05077332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25369112|NCT05077332|Analgesics|analgesics|mesh-ancestor
25369113|NCT05077332|Sensory System Agents|sensory system agents|mesh-ancestor
25369114|NCT05077332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25369491|NCT05062889|Levoleucovorin|levoleucovorin|mesh-list
25369115|NCT05077332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369116|NCT05077332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25369117|NCT05077332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25369118|NCT05077332|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25369119|NCT05077332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25369120|NCT05077332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25369121|NCT05077332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369122|NCT05077332|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25369123|NCT05077332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25369124|NCT05077332|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25369125|NCT05077332|Histamine Antagonists|histamine antagonists|mesh-ancestor
25369126|NCT05077332|Histamine Agents|histamine agents|mesh-ancestor
25369127|NCT05077332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25369144|NCT05076175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25369145|NCT05076175|Immunologic Factors|immunologic factors|mesh-ancestor
25369146|NCT05076175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369147|NCT05076149|Ivacaftor|ivacaftor|mesh-list
25369148|NCT05076149|Elexacaftor|elexacaftor|mesh-list
25369149|NCT05076149|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25369150|NCT05076149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25369151|NCT05076149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369152|NCT05076006|PF-06700841|pf-06700841|mesh-list
25369153|NCT05076006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25369154|NCT05076006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25369155|NCT05076006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369156|NCT05075993|Paclitaxel|paclitaxel|mesh-list
25369157|NCT05075993|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25369158|NCT05075993|Cyclophosphamide|cyclophosphamide|mesh-list
25369159|NCT05075993|Bevacizumab|bevacizumab|mesh-list
25369160|NCT05075993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25369161|NCT05075993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369162|NCT05075993|Tubulin Modulators|tubulin modulators|mesh-ancestor
25369163|NCT05075993|Antimitotic Agents|antimitotic agents|mesh-ancestor
25369164|NCT05075993|Mitosis Modulators|mitosis modulators|mesh-ancestor
25369165|NCT05075993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369166|NCT05075993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25369167|NCT05075993|Immunologic Factors|immunologic factors|mesh-ancestor
25369168|NCT05075993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369169|NCT05075993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25369170|NCT05075993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25369171|NCT05075993|Alkylating Agents|alkylating agents|mesh-ancestor
25369172|NCT05075993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25369173|NCT05075993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25369174|NCT05075993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25369175|NCT05075993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25369176|NCT05075993|Growth Substances|growth substances|mesh-ancestor
25369177|NCT05075993|Growth Inhibitors|growth inhibitors|mesh-ancestor
25369178|NCT05074992|Ipilimumab|ipilimumab|mesh-list
25369179|NCT05074992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25369180|NCT05074992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369181|NCT05074992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25369182|NCT05074992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369183|NCT05074940|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
25369184|NCT05074940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25369185|NCT05074940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369186|NCT05073718|Aspirin|aspirin|mesh-list
25369187|NCT05073718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25369188|NCT05073718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25369190|NCT05073718|Sensory System Agents|sensory system agents|mesh-ancestor
25369191|NCT05073718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25369192|NCT05073718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369193|NCT05073718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25369194|NCT05073718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25369195|NCT05073718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25369196|NCT05073718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25369197|NCT05073718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369198|NCT05073718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25369199|NCT05073718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25369200|NCT05073718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25369201|NCT05073718|Antipyretics|antipyretics|mesh-ancestor
25369202|NCT05073679|Naltrexone|naltrexone|mesh-list
25369203|NCT05073679|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25369204|NCT05073679|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25369205|NCT05073679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369206|NCT05073679|Sensory System Agents|sensory system agents|mesh-ancestor
25369207|NCT05073679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25369209|NCT05072782|Infliximab|infliximab|mesh-list
25369210|NCT05072782|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25369211|NCT05072782|Abortifacient Agents|abortifacient agents|mesh-ancestor
25369212|NCT05072782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25369213|NCT05072782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369214|NCT05072782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25369215|NCT05072782|Antimetabolites|antimetabolites|mesh-ancestor
25369216|NCT05072782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369217|NCT05072782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369218|NCT05072782|Dermatologic Agents|dermatologic agents|mesh-ancestor
25369219|NCT05072782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25369220|NCT05072782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25369221|NCT05072782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25369222|NCT05072782|Immunologic Factors|immunologic factors|mesh-ancestor
25369223|NCT05072782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25369224|NCT05072782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25369225|NCT05072782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25369226|NCT05072314|Lidocaine|lidocaine|mesh-list
25369227|NCT05072314|Anesthetics, Local|anesthetics, local|mesh-ancestor
25369228|NCT05072314|Anesthetics|anesthetics|mesh-ancestor
25369229|NCT05072314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25369230|NCT05072314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369231|NCT05072314|Sensory System Agents|sensory system agents|mesh-ancestor
25369232|NCT05072314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25369233|NCT05072314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25369234|NCT05072314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25369235|NCT05072314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25369236|NCT05072314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25369237|NCT05072314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369238|NCT05071716|Rifaximin|rifaximin|mesh-list
25369239|NCT05071716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25369240|NCT05071716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25369241|NCT05071716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25369242|NCT05071664|Golimumab|golimumab|mesh-list
25369243|NCT05071664|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
25369244|NCT05071664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25369245|NCT05071664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25369246|NCT05071664|Immunologic Factors|immunologic factors|mesh-ancestor
25369247|NCT05071664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369248|NCT05071612|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
25369249|NCT05071612|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25369250|NCT05071612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25369251|NCT05071612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25369252|NCT05071612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369253|NCT05071612|Adrenergic Agents|adrenergic agents|mesh-ancestor
25369254|NCT05071612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25369255|NCT05071612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369256|NCT05071313|Vaccines|vaccines|mesh-list
25369257|NCT05071313|Immunologic Factors|immunologic factors|mesh-ancestor
25369258|NCT05071313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369259|NCT05071053|Ramucirumab|ramucirumab|mesh-list
25369260|NCT05071053|Maytansine|maytansine|mesh-list
25369267|NCT05070403|Afatinib|afatinib|mesh-list
25369268|NCT05070403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369269|NCT05070403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25369270|NCT05070403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25369271|NCT05070403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369276|NCT05070247|Pembrolizumab|pembrolizumab|mesh-list
25369277|NCT05070247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25369278|NCT05070247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369279|NCT05070156|Vaccines|vaccines|mesh-list
25369280|NCT05070156|Immunologic Factors|immunologic factors|mesh-ancestor
25369281|NCT05070156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369282|NCT05070104|Bevacizumab|bevacizumab|mesh-list
25369283|NCT05070104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25369284|NCT05070104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369285|NCT05070104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25369286|NCT05070104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25369287|NCT05070104|Growth Substances|growth substances|mesh-ancestor
25369288|NCT05070104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369289|NCT05070104|Growth Inhibitors|growth inhibitors|mesh-ancestor
25369299|NCT05069350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25369300|NCT05069350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369301|NCT05069350|Sensory System Agents|sensory system agents|mesh-ancestor
25369302|NCT05069350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25369303|NCT05068791|Dextromethorphan|dextromethorphan|mesh-list
25369304|NCT05068791|Psilocybin|psilocybin|mesh-list
25369305|NCT05068791|Antitussive Agents|antitussive agents|mesh-ancestor
25369306|NCT05068791|Respiratory System Agents|respiratory system agents|mesh-ancestor
25369307|NCT05068791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25369308|NCT05068791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25369309|NCT05068791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25369310|NCT05068791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369311|NCT05068791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369312|NCT05068791|Hallucinogens|hallucinogens|mesh-ancestor
25369313|NCT05068791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25369314|NCT05067933|Vaccines|vaccines|mesh-list
25369315|NCT05067933|Immunologic Factors|immunologic factors|mesh-ancestor
25369316|NCT05067933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369317|NCT05067894|Vaccines|vaccines|mesh-list
25369318|NCT05067894|Immunologic Factors|immunologic factors|mesh-ancestor
25369319|NCT05067894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369320|NCT05067634|Cenobamate|cenobamate|mesh-list
25369321|NCT05067634|Anticonvulsants|anticonvulsants|mesh-ancestor
25369325|NCT05066698|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25369326|NCT05066698|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25369327|NCT05066607|Dexamethasone|dexamethasone|mesh-list
25369328|NCT05066607|Pomalidomide|pomalidomide|mesh-list
25369329|NCT05066607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25369330|NCT05066607|Antiemetics|antiemetics|mesh-ancestor
25369331|NCT05066607|Autonomic Agents|autonomic agents|mesh-ancestor
25369332|NCT05066607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25369333|NCT05066607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369334|NCT05066607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25369335|NCT05066607|Glucocorticoids|glucocorticoids|mesh-ancestor
25369336|NCT05066607|Hormones|hormones|mesh-ancestor
25369492|NCT05062889|Antimetabolites|antimetabolites|mesh-ancestor
25369337|NCT05066607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25369338|NCT05066607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25369339|NCT05066607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369340|NCT05066607|Immunologic Factors|immunologic factors|mesh-ancestor
25369341|NCT05066607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25369342|NCT05066607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25369343|NCT05066607|Growth Substances|growth substances|mesh-ancestor
25369344|NCT05066607|Growth Inhibitors|growth inhibitors|mesh-ancestor
25369345|NCT05066308|Cannabidiol|cannabidiol|mesh-list
25369346|NCT05066308|Anticonvulsants|anticonvulsants|mesh-ancestor
25369347|NCT05065918|Ethanol|ethanol|mesh-list
25369348|NCT05065918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25369349|NCT05065918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25369350|NCT05065918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25369351|NCT05065918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369352|NCT05065866|Azacitidine|azacitidine|mesh-list
25369353|NCT05065866|Cc-486|cc-486|mesh-list
25369354|NCT05065866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25369355|NCT05065866|Antimetabolites|antimetabolites|mesh-ancestor
25369356|NCT05065866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369357|NCT05065866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369358|NCT05065866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25369359|NCT05065645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25369383|NCT05065216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25369384|NCT05065216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369386|NCT05065190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369387|NCT05065190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25369388|NCT05065190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25369389|NCT05065190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369390|NCT05064631|Broncho-Vaxom|broncho-vaxom|mesh-list
25369391|NCT05064631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25369392|NCT05064631|Immunologic Factors|immunologic factors|mesh-ancestor
25369393|NCT05064631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369394|NCT05064085|Capecitabine|capecitabine|mesh-list
25369395|NCT05064085|Cemiplimab|cemiplimab|mesh-list
25369396|NCT05064085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25369397|NCT05064085|Antimetabolites|antimetabolites|mesh-ancestor
25369398|NCT05064085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369399|NCT05064085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369400|NCT05064085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25369401|NCT05064059|Pembrolizumab|pembrolizumab|mesh-list
25369402|NCT05064059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25369403|NCT05064059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369404|NCT05063786|Capecitabine|capecitabine|mesh-list
25369405|NCT05063786|Trastuzumab|trastuzumab|mesh-list
25369406|NCT05063786|Vinorelbine|vinorelbine|mesh-list
25369407|NCT05063786|Fulvestrant|fulvestrant|mesh-list
25369408|NCT05063786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25369409|NCT05063786|Antimetabolites|antimetabolites|mesh-ancestor
25369410|NCT05063786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369411|NCT05063786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369412|NCT05063786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25369456|NCT05063500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25369457|NCT05063201|Cariprazine|cariprazine|mesh-list
25369458|NCT05063201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25369459|NCT05063201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25369460|NCT05063201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25369461|NCT05063201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369462|NCT05063201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25369463|NCT05063162|Rozanolixizumab|rozanolixizumab|mesh-list
25369464|NCT05063162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25369465|NCT05063162|Immunologic Factors|immunologic factors|mesh-ancestor
25369466|NCT05063162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369467|NCT05062980|Docetaxel|docetaxel|mesh-list
25369468|NCT05062980|Pembrolizumab|pembrolizumab|mesh-list
25369469|NCT05062980|Ramucirumab|ramucirumab|mesh-list
25369470|NCT05062980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369471|NCT05062980|Tubulin Modulators|tubulin modulators|mesh-ancestor
25369472|NCT05062980|Antimitotic Agents|antimitotic agents|mesh-ancestor
25369473|NCT05062980|Mitosis Modulators|mitosis modulators|mesh-ancestor
25369474|NCT05062980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369475|NCT05062980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25369476|NCT05062954|Proanthocyanidin|proanthocyanidin|mesh-list
25369477|NCT05062954|Procyanidin|procyanidin|mesh-list
25369478|NCT05062954|Antioxidants|antioxidants|mesh-ancestor
25369479|NCT05062954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369480|NCT05062954|Protective Agents|protective agents|mesh-ancestor
25369481|NCT05062954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369482|NCT05062954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25369483|NCT05062954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25369484|NCT05062954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25369485|NCT05062889|Leucovorin|leucovorin|mesh-list
25369486|NCT05062889|Trifluridine|trifluridine|mesh-list
25369487|NCT05062889|Fluorouracil|fluorouracil|mesh-list
25369488|NCT05062889|Capecitabine|capecitabine|mesh-list
25369489|NCT05062889|Oxaliplatin|oxaliplatin|mesh-list
25369490|NCT05062889|Irinotecan|irinotecan|mesh-list
25369493|NCT05062889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369494|NCT05062889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25369495|NCT05062889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369496|NCT05062889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25369497|NCT05062889|Immunologic Factors|immunologic factors|mesh-ancestor
25369498|NCT05062889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369499|NCT05062889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25369500|NCT05062889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25369501|NCT05062889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25369502|NCT05062889|Antidotes|antidotes|mesh-ancestor
25369503|NCT05062889|Protective Agents|protective agents|mesh-ancestor
25369504|NCT05062889|Vitamin B Complex|vitamin b complex|mesh-ancestor
25369505|NCT05062889|Vitamins|vitamins|mesh-ancestor
25369506|NCT05062889|Micronutrients|micronutrients|mesh-ancestor
25369507|NCT05062889|Antiviral Agents|antiviral agents|mesh-ancestor
25369508|NCT05062889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25369509|NCT05062837|Apatinib|apatinib|mesh-list
25369510|NCT05062837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369511|NCT05062837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25369512|NCT05062837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25369513|NCT05062837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369514|NCT05062330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25369515|NCT05062330|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25369517|NCT05062083|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25369518|NCT05062083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369519|NCT05062044|Folic Acid|folic acid|mesh-list
25369520|NCT05062044|Hematinics|hematinics|mesh-ancestor
25369521|NCT05062044|Vitamin B Complex|vitamin b complex|mesh-ancestor
25369522|NCT05062044|Vitamins|vitamins|mesh-ancestor
25369523|NCT05062044|Micronutrients|micronutrients|mesh-ancestor
25369524|NCT05062044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369525|NCT05061550|Durvalumab|durvalumab|mesh-list
25369526|NCT05061550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25369527|NCT05061550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369528|NCT05061420|Pembrolizumab|pembrolizumab|mesh-list
25369529|NCT05061420|Cetuximab|cetuximab|mesh-list
25369530|NCT05061420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25369531|NCT05061420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369532|NCT05061368|Sildenafil Citrate|sildenafil citrate|mesh-list
25369533|NCT05061368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369534|NCT05061368|Vasodilator Agents|vasodilator agents|mesh-ancestor
25369535|NCT05061368|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25369536|NCT05061368|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25369537|NCT05061368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25369538|NCT05061368|Urological Agents|urological agents|mesh-ancestor
25369539|NCT05061134|Durvalumab|durvalumab|mesh-list
25369540|NCT05061134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25369541|NCT05061134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369542|NCT05060913|Lidocaine|lidocaine|mesh-list
25369543|NCT05060913|Prilocaine|prilocaine|mesh-list
25369544|NCT05060913|Benzocaine|benzocaine|mesh-list
25369545|NCT05060913|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
25369546|NCT05060913|Anesthetics, Local|anesthetics, local|mesh-ancestor
25369547|NCT05060913|Anesthetics|anesthetics|mesh-ancestor
25369548|NCT05060913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25369549|NCT05060913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369550|NCT05060913|Sensory System Agents|sensory system agents|mesh-ancestor
25369551|NCT05060913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25369552|NCT05060913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25369553|NCT05060913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25369554|NCT05060913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25369555|NCT05060913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25369556|NCT05060913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369557|NCT05060913|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
25369558|NCT05060744|Antacids|antacids|mesh-list
25369559|NCT05060744|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
25369560|NCT05060744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369561|NCT05060744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25369562|NCT05060627|Dexamethasone|dexamethasone|mesh-list
25369563|NCT05060627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25369564|NCT05060627|Antiemetics|antiemetics|mesh-ancestor
25369565|NCT05060627|Autonomic Agents|autonomic agents|mesh-ancestor
25369566|NCT05060627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25369567|NCT05060627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25401424|NCT03813121|Midazolam|midazolam|mesh-list
25369568|NCT05060627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25369569|NCT05060627|Glucocorticoids|glucocorticoids|mesh-ancestor
25369571|NCT05060627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25369572|NCT05060627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25369573|NCT05060627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369574|NCT05060315|Treprostinil|treprostinil|mesh-list
25369575|NCT05060315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25369576|NCT05060276|Immunoconjugates|immunoconjugates|mesh-list
25369577|NCT05060276|Immunologic Factors|immunologic factors|mesh-ancestor
25369578|NCT05060276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369579|NCT05060237|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25369580|NCT05060237|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25369581|NCT05060237|Dermatologic Agents|dermatologic agents|mesh-ancestor
25369582|NCT05060003|Atezolizumab|atezolizumab|mesh-list
25369583|NCT05060003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369584|NCT05059600|Pregnanolone|pregnanolone|mesh-list
25369585|NCT05059600|Brexanolone|brexanolone|mesh-list
25369586|NCT05059600|Anesthetics|anesthetics|mesh-ancestor
25369587|NCT05059600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25369588|NCT05059600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369589|NCT05059600|Neurosteroids|neurosteroids|mesh-ancestor
25369590|NCT05059600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25369591|NCT05059600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369592|NCT05059600|GABA Modulators|gaba modulators|mesh-ancestor
25369593|NCT05059600|GABA Agents|gaba agents|mesh-ancestor
25369594|NCT05059522|Pemetrexed|pemetrexed|mesh-list
25369595|NCT05059522|Avelumab|avelumab|mesh-list
25369596|NCT05059522|Axitinib|axitinib|mesh-list
25369597|NCT05059522|Talazoparib|talazoparib|mesh-list
25369598|NCT05059522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369599|NCT05059522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25369600|NCT05059522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369601|NCT05059522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25369602|NCT05059522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25369603|NCT05059522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25369604|NCT05059522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25369605|NCT05059522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25369606|NCT05059223|Reboxetine|reboxetine|mesh-list
25369607|NCT05059223|Antidepressive Agents|antidepressive agents|mesh-ancestor
25369608|NCT05059223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25369609|NCT05059223|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25369610|NCT05059223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25369611|NCT05059223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25369612|NCT05059223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369613|NCT05059223|Adrenergic Agents|adrenergic agents|mesh-ancestor
25369614|NCT05059223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25369615|NCT05059223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369616|NCT05059028|Oxytocin|oxytocin|mesh-list
25369617|NCT05059028|Oxytocics|oxytocics|mesh-ancestor
25369618|NCT05059028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25369619|NCT05059028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369620|NCT05058976|Vitamin D|vitamin d|mesh-list
25369621|NCT05058976|Zoledronic Acid|zoledronic acid|mesh-list
25369622|NCT05058976|Calcium|calcium|mesh-list
25369623|NCT05058976|Vitamins|vitamins|mesh-ancestor
25369624|NCT05058976|Micronutrients|micronutrients|mesh-ancestor
25369625|NCT05058976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369626|NCT05058976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25369627|NCT05058976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25369628|NCT05058924|Aspirin|aspirin|mesh-list
25369629|NCT05058924|Heparin|heparin|mesh-list
25369630|NCT05058924|Calcium heparin|calcium heparin|mesh-list
25369631|NCT05058924|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25369632|NCT05058924|Tinzaparin|tinzaparin|mesh-list
25369633|NCT05058924|Dalteparin|dalteparin|mesh-list
25369634|NCT05058924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25369635|NCT05058924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25369636|NCT05058924|Analgesics|analgesics|mesh-ancestor
25369637|NCT05058924|Sensory System Agents|sensory system agents|mesh-ancestor
25369638|NCT05058924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25369639|NCT05058924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369640|NCT05058924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25369641|NCT05058924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25369642|NCT05058924|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25369643|NCT05058924|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25724236|NCT02535806|Sensory System Agents|sensory system agents|mesh-ancestor
25369688|NCT05058443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25369689|NCT05058443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369690|NCT05057819|Empagliflozin|empagliflozin|mesh-list
25369691|NCT05057819|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25369692|NCT05057819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369693|NCT05057819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25369694|NCT05057819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369695|NCT05057767|Midazolam|midazolam|mesh-list
25369696|NCT05057767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25369697|NCT05057767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25369698|NCT05057767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25369699|NCT05057767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369700|NCT05057767|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25369701|NCT05057767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25369702|NCT05057767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25369703|NCT05057767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25369704|NCT05057767|Anesthetics, General|anesthetics, general|mesh-ancestor
25369705|NCT05057767|Anesthetics|anesthetics|mesh-ancestor
25369706|NCT05057767|GABA Modulators|gaba modulators|mesh-ancestor
25369707|NCT05057767|GABA Agents|gaba agents|mesh-ancestor
25369708|NCT05057767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25369709|NCT05057767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369710|NCT05057247|Docetaxel|docetaxel|mesh-list
25369711|NCT05057247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369712|NCT05057247|Tubulin Modulators|tubulin modulators|mesh-ancestor
25369713|NCT05057247|Antimitotic Agents|antimitotic agents|mesh-ancestor
25369714|NCT05057247|Mitosis Modulators|mitosis modulators|mesh-ancestor
25369715|NCT05057247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369716|NCT05056974|UB-421|ub-421|mesh-list
25369717|NCT05056974|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25369718|NCT05056974|Antiviral Agents|antiviral agents|mesh-ancestor
25369719|NCT05056974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25369720|NCT05056883|Ivermectin|ivermectin|mesh-list
25369721|NCT05056883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25369722|NCT05056883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25369723|NCT05056727|Valsartan|valsartan|mesh-list
25369724|NCT05056727|Lisinopril|lisinopril|mesh-list
25369725|NCT05056727|Irbesartan|irbesartan|mesh-list
25369726|NCT05056727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25369727|NCT05056727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25369728|NCT05056727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25369729|NCT05056727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369730|NCT05056727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25369731|NCT05056727|Protease Inhibitors|protease inhibitors|mesh-ancestor
25369732|NCT05056727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25369733|NCT05056727|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25369734|NCT05056727|Protective Agents|protective agents|mesh-ancestor
25369735|NCT05056727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369736|NCT05055323|Pyrvinium|pyrvinium|mesh-list
25369737|NCT05055323|Anthelmintics|anthelmintics|mesh-ancestor
25369738|NCT05055323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25369739|NCT05055323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25369747|NCT05054881|Iodine|iodine|mesh-list
25369748|NCT05054881|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25369749|NCT05054881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25369750|NCT05054881|Trace Elements|trace elements|mesh-ancestor
25369751|NCT05054881|Micronutrients|micronutrients|mesh-ancestor
25369752|NCT05054881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369753|NCT05054374|Fulvestrant|fulvestrant|mesh-list
25369754|NCT05054374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25369755|NCT05054374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369756|NCT05054374|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25724237|NCT02535806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25369757|NCT05054374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25369758|NCT05054374|Hormone Antagonists|hormone antagonists|mesh-ancestor
25369759|NCT05054374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25369760|NCT05054374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369761|NCT05054361|Mannitol|mannitol|mesh-list
25369762|NCT05054361|Lactulose|lactulose|mesh-list
25369763|NCT05054361|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
25369764|NCT05054361|Diuretics|diuretics|mesh-ancestor
25369765|NCT05054361|Natriuretic Agents|natriuretic agents|mesh-ancestor
25369766|NCT05054361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369767|NCT05054361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25369768|NCT05054140|Calcium|calcium|mesh-list
25369769|NCT05054140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25369770|NCT05054140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369771|NCT05053971|Entinostat|entinostat|mesh-list
25369772|NCT05053971|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
25369773|NCT05053971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369774|NCT05053971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25369775|NCT05053971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369776|NCT05053854|Talazoparib|talazoparib|mesh-list
25369777|NCT05053854|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25369778|NCT05053854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25369779|NCT05053854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369780|NCT05053854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369781|NCT05053828|Clopidogrel|clopidogrel|mesh-list
25369782|NCT05053828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
25369783|NCT05053828|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25369784|NCT05053828|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25369785|NCT05053828|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25369786|NCT05053828|Purinergic Agents|purinergic agents|mesh-ancestor
25369787|NCT05053828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25369788|NCT05053828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369789|NCT05053828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369790|NCT05053750|Paclitaxel|paclitaxel|mesh-list
25369791|NCT05053750|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25369792|NCT05053750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25369793|NCT05053750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369794|NCT05053750|Tubulin Modulators|tubulin modulators|mesh-ancestor
25369795|NCT05053750|Antimitotic Agents|antimitotic agents|mesh-ancestor
25369796|NCT05053750|Mitosis Modulators|mitosis modulators|mesh-ancestor
25369806|NCT05052931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369807|NCT05052931|Tubulin Modulators|tubulin modulators|mesh-ancestor
25369808|NCT05052931|Antimitotic Agents|antimitotic agents|mesh-ancestor
25369809|NCT05052931|Mitosis Modulators|mitosis modulators|mesh-ancestor
25369810|NCT05052931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369814|NCT05051891|Prednisone|prednisone|mesh-list
25369815|NCT05051891|Cyclophosphamide|cyclophosphamide|mesh-list
25369816|NCT05051891|Vincristine|vincristine|mesh-list
25369817|NCT05051891|Rituximab|rituximab|mesh-list
25369818|NCT05051891|Doxorubicin|doxorubicin|mesh-list
25369819|NCT05051891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25369820|NCT05051891|Immunologic Factors|immunologic factors|mesh-ancestor
25369821|NCT05051891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369822|NCT05051891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25369823|NCT05051891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25369824|NCT05051891|Alkylating Agents|alkylating agents|mesh-ancestor
25369825|NCT05051891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369826|NCT05051891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369827|NCT05051891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25369828|NCT05051891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25369829|NCT05051891|Glucocorticoids|glucocorticoids|mesh-ancestor
25369830|NCT05051891|Hormones|hormones|mesh-ancestor
25369831|NCT05051891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25369832|NCT05051891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25369833|NCT05051891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25369834|NCT05051891|Tubulin Modulators|tubulin modulators|mesh-ancestor
25369835|NCT05051891|Antimitotic Agents|antimitotic agents|mesh-ancestor
25369836|NCT05051891|Mitosis Modulators|mitosis modulators|mesh-ancestor
25369837|NCT05051891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25369838|NCT05051891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25369839|NCT05051891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25369840|NCT05051891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25369841|NCT05051891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25369849|NCT05051007|Lidocaine|lidocaine|mesh-list
25369851|NCT05051007|Anesthetics, Local|anesthetics, local|mesh-ancestor
25369852|NCT05051007|Anesthetics|anesthetics|mesh-ancestor
25369853|NCT05051007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25369854|NCT05051007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369855|NCT05051007|Sensory System Agents|sensory system agents|mesh-ancestor
25369856|NCT05051007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25369857|NCT05051007|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25369858|NCT05051007|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25369859|NCT05051007|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25369860|NCT05051007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25369861|NCT05051007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369862|NCT05051007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25369863|NCT05051007|Narcotics|narcotics|mesh-ancestor
25369864|NCT05051007|Analgesics|analgesics|mesh-ancestor
25369865|NCT05051007|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25369866|NCT05051007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25369867|NCT05051007|Anesthetics, General|anesthetics, general|mesh-ancestor
25369868|NCT05050981|Hormones|hormones|mesh-list
25369869|NCT05050981|Serotonin|serotonin|mesh-list
25369870|NCT05050981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25369871|NCT05050981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25369872|NCT05050981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369873|NCT05050981|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25369874|NCT05050981|Serotonin Agents|serotonin agents|mesh-ancestor
25369875|NCT05050981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25369876|NCT05050981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369877|NCT05050981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25369878|NCT05050981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25369880|NCT05050942|Lanreotide|lanreotide|mesh-list
25369881|NCT05050942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25369882|NCT05050942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25369883|NCT05050942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369884|NCT05050916|Vitamin D|vitamin d|mesh-list
25369885|NCT05050916|Vitamins|vitamins|mesh-ancestor
25369886|NCT05050916|Micronutrients|micronutrients|mesh-ancestor
25369887|NCT05050916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369888|NCT05050916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25369889|NCT05050318|Vaccines|vaccines|mesh-list
25369890|NCT05050318|Immunologic Factors|immunologic factors|mesh-ancestor
25369891|NCT05050318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369892|NCT05050214|Obinutuzumab|obinutuzumab|mesh-list
25369893|NCT05050214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25369894|NCT05050214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369895|NCT05050162|Cisplatin|cisplatin|mesh-list
25369896|NCT05050162|1,2-diaminocyclohexaneplatinum II citrate|1,2-diaminocyclohexaneplatinum ii citrate|mesh-list
25369897|NCT05050162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369898|NCT05050136|Volixibat|volixibat|mesh-list
25369899|NCT05050136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25369900|NCT05050097|Lenalidomide|lenalidomide|mesh-list
25369901|NCT05050097|Pomalidomide|pomalidomide|mesh-list
25369902|NCT05050097|Daratumumab|daratumumab|mesh-list
25369903|NCT05050097|Immunologic Factors|immunologic factors|mesh-ancestor
25369904|NCT05050097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369905|NCT05050097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25369906|NCT05050097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25369907|NCT05050097|Growth Substances|growth substances|mesh-ancestor
25369908|NCT05050097|Growth Inhibitors|growth inhibitors|mesh-ancestor
25369909|NCT05050097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369910|NCT05050084|Leuprolide|leuprolide|mesh-list
25369911|NCT05050084|Goserelin|goserelin|mesh-list
25369912|NCT05050084|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25369913|NCT05050084|Flutamide|flutamide|mesh-list
25369914|NCT05050084|Bicalutamide|bicalutamide|mesh-list
25369915|NCT05050084|Tryptophan|tryptophan|mesh-list
25369916|NCT05050084|Buserelin|buserelin|mesh-list
25369917|NCT05050084|Hormones|hormones|mesh-list
25369918|NCT05050084|Relugolix|relugolix|mesh-list
25369919|NCT05050084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25369920|NCT05050084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369921|NCT05050084|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25369922|NCT05050084|Fertility Agents|fertility agents|mesh-ancestor
25369923|NCT05050084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25369924|NCT05050084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25369925|NCT05050084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369926|NCT05050084|Androgen Antagonists|androgen antagonists|mesh-ancestor
25369927|NCT05050084|Hormone Antagonists|hormone antagonists|mesh-ancestor
25369928|NCT05050084|Luteolytic Agents|luteolytic agents|mesh-ancestor
25369929|NCT05050084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25369930|NCT05050084|Contraceptive Agents|contraceptive agents|mesh-ancestor
25369931|NCT05050084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25369932|NCT05050084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25369933|NCT05050084|Antidepressive Agents|antidepressive agents|mesh-ancestor
25369934|NCT05050084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25369935|NCT05048849|Somatomedin B|somatomedin b|mesh-list
25369936|NCT05048849|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25369937|NCT05048849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25369938|NCT05048849|Protease Inhibitors|protease inhibitors|mesh-ancestor
25369939|NCT05048849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25369940|NCT05048849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369941|NCT05048797|Cisplatin|cisplatin|mesh-list
25369942|NCT05048797|Carboplatin|carboplatin|mesh-list
25369943|NCT05048797|Pembrolizumab|pembrolizumab|mesh-list
25369944|NCT05048797|Trastuzumab|trastuzumab|mesh-list
25369945|NCT05048797|Pemetrexed|pemetrexed|mesh-list
25369946|NCT05048797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369947|NCT05048797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25369948|NCT05048797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25369949|NCT05048797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369956|NCT05048589|Immunologic Factors|immunologic factors|mesh-ancestor
25369957|NCT05048589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369958|NCT05048524|Leucovorin|leucovorin|mesh-list
25369959|NCT05048524|Gemcitabine|gemcitabine|mesh-list
25369960|NCT05048524|Oxaliplatin|oxaliplatin|mesh-list
25369961|NCT05048524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25369962|NCT05048524|Antimetabolites|antimetabolites|mesh-ancestor
25369963|NCT05048524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369964|NCT05048524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369965|NCT05048524|Antiviral Agents|antiviral agents|mesh-ancestor
25369966|NCT05048524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25369967|NCT05048524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25369968|NCT05048524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25369969|NCT05048524|Immunologic Factors|immunologic factors|mesh-ancestor
25369970|NCT05048524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369971|NCT05048524|Antidotes|antidotes|mesh-ancestor
25369972|NCT05048524|Protective Agents|protective agents|mesh-ancestor
25369973|NCT05048524|Vitamin B Complex|vitamin b complex|mesh-ancestor
25369974|NCT05048524|Vitamins|vitamins|mesh-ancestor
25369975|NCT05048524|Micronutrients|micronutrients|mesh-ancestor
25369976|NCT05048212|Nivolumab|nivolumab|mesh-list
25369977|NCT05048212|Ipilimumab|ipilimumab|mesh-list
25369978|NCT05048212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25369979|NCT05048212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25369980|NCT05048212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25369981|NCT05048212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369982|NCT05047770|Vaccines|vaccines|mesh-list
25369983|NCT05047770|Immunologic Factors|immunologic factors|mesh-ancestor
25369984|NCT05047770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369985|NCT05047640|Vaccines|vaccines|mesh-list
25369986|NCT05047640|Immunologic Factors|immunologic factors|mesh-ancestor
25369987|NCT05047640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25369988|NCT05047601|Ritonavir|ritonavir|mesh-list
25369989|NCT05047601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25369990|NCT05047601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25369991|NCT05047601|Protease Inhibitors|protease inhibitors|mesh-ancestor
25369992|NCT05047601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25369993|NCT05047601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25369994|NCT05047601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25369995|NCT05047601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25369996|NCT05047601|Antiviral Agents|antiviral agents|mesh-ancestor
25369997|NCT05047601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25369998|NCT05047601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25369999|NCT05047601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25370000|NCT05047250|Gemcitabine|gemcitabine|mesh-list
25370001|NCT05047250|Paclitaxel|paclitaxel|mesh-list
25370002|NCT05047250|Cisplatin|cisplatin|mesh-list
25370003|NCT05047250|Carboplatin|carboplatin|mesh-list
25370004|NCT05047250|Pemetrexed|pemetrexed|mesh-list
25370005|NCT05047250|Atezolizumab|atezolizumab|mesh-list
25370006|NCT05047250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25370007|NCT05047250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370008|NCT05047250|Tubulin Modulators|tubulin modulators|mesh-ancestor
25370009|NCT05047250|Antimitotic Agents|antimitotic agents|mesh-ancestor
25370010|NCT05047250|Mitosis Modulators|mitosis modulators|mesh-ancestor
25370011|NCT05047250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370012|NCT05047250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25370013|NCT05047250|Antimetabolites|antimetabolites|mesh-ancestor
25370014|NCT05047250|Antiviral Agents|antiviral agents|mesh-ancestor
25370015|NCT05047250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25370016|NCT05047250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25370017|NCT05047250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25370018|NCT05047250|Immunologic Factors|immunologic factors|mesh-ancestor
25370019|NCT05047250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370020|NCT05047250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25370021|NCT05047250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25370074|NCT05044819|Anticonvulsants|anticonvulsants|mesh-ancestor
25370076|NCT05044468|Bupivacaine|bupivacaine|mesh-list
25370077|NCT05044468|Anesthetics, Local|anesthetics, local|mesh-ancestor
25370078|NCT05044468|Anesthetics|anesthetics|mesh-ancestor
25370079|NCT05044468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25370080|NCT05044468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370081|NCT05044468|Sensory System Agents|sensory system agents|mesh-ancestor
25370082|NCT05044468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25370083|NCT05044468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25370084|NCT05044468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25370085|NCT05044468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25370086|NCT05044468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25370087|NCT05044468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370088|NCT05043766|Naltrexone|naltrexone|mesh-list
25370089|NCT05043766|Oxycodone|oxycodone|mesh-list
25370090|NCT05043766|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25370091|NCT05043766|Narcotics|narcotics|mesh-ancestor
25370092|NCT05043766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25370093|NCT05043766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370094|NCT05043766|Analgesics|analgesics|mesh-ancestor
25370095|NCT05043766|Sensory System Agents|sensory system agents|mesh-ancestor
25370096|NCT05043766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25370097|NCT05043766|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25370098|NCT05043766|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25370099|NCT05043116|Vitamin D|vitamin d|mesh-list
25370100|NCT05043116|Cholecalciferol|cholecalciferol|mesh-list
25370101|NCT05043116|Vitamins|vitamins|mesh-ancestor
25370102|NCT05043116|Micronutrients|micronutrients|mesh-ancestor
25370103|NCT05043116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370104|NCT05043116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25370105|NCT05043116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25370106|NCT05043090|Durvalumab|durvalumab|mesh-list
25370107|NCT05043090|Sunitinib|sunitinib|mesh-list
25370108|NCT05043090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25370109|NCT05043090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370110|NCT05043090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25370111|NCT05043090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25370112|NCT05043090|Growth Substances|growth substances|mesh-ancestor
25370113|NCT05043090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370114|NCT05043090|Growth Inhibitors|growth inhibitors|mesh-ancestor
25370115|NCT05043090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25370116|NCT05043090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25370117|NCT05043090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370118|NCT05042973|Empagliflozin|empagliflozin|mesh-list
25370119|NCT05042973|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25370120|NCT05042973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370121|NCT05042973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25370122|NCT05042973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370123|NCT05042687|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
25370124|NCT05042687|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25416009|NCT02978404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25370125|NCT05042687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370126|NCT05042609|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25370127|NCT05042609|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25370128|NCT05042375|Pembrolizumab|pembrolizumab|mesh-list
25370129|NCT05042375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25370130|NCT05042375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370131|NCT05042128|Gemcitabine|gemcitabine|mesh-list
25370133|NCT05042128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25370134|NCT05042128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370135|NCT05042128|Tubulin Modulators|tubulin modulators|mesh-ancestor
25370136|NCT05042128|Antimitotic Agents|antimitotic agents|mesh-ancestor
25370137|NCT05042128|Mitosis Modulators|mitosis modulators|mesh-ancestor
25370138|NCT05042128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370139|NCT05042128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25370140|NCT05042128|Antimetabolites|antimetabolites|mesh-ancestor
25370141|NCT05042128|Antiviral Agents|antiviral agents|mesh-ancestor
25370142|NCT05042128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25370143|NCT05042128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25370144|NCT05042128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25370145|NCT05042128|Immunologic Factors|immunologic factors|mesh-ancestor
25370146|NCT05042128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370147|NCT05042102|Donepezil|donepezil|mesh-list
25370148|NCT05042102|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25370149|NCT05042102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25370150|NCT05042102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370151|NCT05042102|Cholinergic Agents|cholinergic agents|mesh-ancestor
25370152|NCT05042102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25370153|NCT05042102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370154|NCT05042102|Nootropic Agents|nootropic agents|mesh-ancestor
25370155|NCT05041907|Ritonavir|ritonavir|mesh-list
25370156|NCT05041907|Ivermectin|ivermectin|mesh-list
25370157|NCT05041907|Nitazoxanide|nitazoxanide|mesh-list
25370158|NCT05041907|Favipiravir|favipiravir|mesh-list
25370159|NCT05041907|Remdesivir|remdesivir|mesh-list
25370160|NCT05041907|Fluoxetine|fluoxetine|mesh-list
25370161|NCT05041907|Antibodies|antibodies|mesh-list
25370162|NCT05041907|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25370163|NCT05041907|Immunologic Factors|immunologic factors|mesh-ancestor
25370164|NCT05041907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370165|NCT05041907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25370166|NCT05041907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25370167|NCT05041907|Protease Inhibitors|protease inhibitors|mesh-ancestor
25370168|NCT05041907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25370169|NCT05041907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370170|NCT05041907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25370171|NCT05041907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25370172|NCT05041907|Antiviral Agents|antiviral agents|mesh-ancestor
25370173|NCT05041907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25370174|NCT05041907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25370175|NCT05041907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25370176|NCT05041907|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25370177|NCT05041907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25370178|NCT05041907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25370179|NCT05041907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25370180|NCT05041907|Serotonin Agents|serotonin agents|mesh-ancestor
25370181|NCT05041907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25370182|NCT05041907|Antidepressive Agents|antidepressive agents|mesh-ancestor
25370183|NCT05041907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25370184|NCT05041907|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25370185|NCT05041907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25370186|NCT05041907|Antimetabolites|antimetabolites|mesh-ancestor
25370187|NCT05041842|Trastuzumab|trastuzumab|mesh-list
25370188|NCT05041842|Pertuzumab|pertuzumab|mesh-list
25370189|NCT05041842|Tucatinib|tucatinib|mesh-list
25370190|NCT05041842|Hormones|hormones|mesh-list
25370191|NCT05041842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25370192|NCT05041842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370193|NCT05041842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25370194|NCT05041842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370195|NCT05041842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25370196|NCT05041842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25370197|NCT05041842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370198|NCT05041335|Heparin|heparin|mesh-list
25370199|NCT05041335|Anticoagulants|anticoagulants|mesh-ancestor
25370200|NCT05041335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25370201|NCT05041335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25370202|NCT05041335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370203|NCT05041257|Maytansine|maytansine|mesh-list
25370204|NCT05041257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25370205|NCT05041257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370206|NCT05041257|Tubulin Modulators|tubulin modulators|mesh-ancestor
25370207|NCT05041257|Antimitotic Agents|antimitotic agents|mesh-ancestor
25370208|NCT05041257|Mitosis Modulators|mitosis modulators|mesh-ancestor
25370209|NCT05041257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370210|NCT05041153|Pembrolizumab|pembrolizumab|mesh-list
25370211|NCT05041153|Lenvatinib|lenvatinib|mesh-list
25370212|NCT05041153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25370213|NCT05041153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370214|NCT05041153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25370216|NCT05041153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370217|NCT05039801|Pembrolizumab|pembrolizumab|mesh-list
25370218|NCT05039801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25370219|NCT05039801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370220|NCT05039632|Nivolumab|nivolumab|mesh-list
25370221|NCT05039632|Ipilimumab|ipilimumab|mesh-list
25370222|NCT05039632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25370223|NCT05039632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370224|NCT05039632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25370225|NCT05039632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370226|NCT05039619|Acetaminophen|acetaminophen|mesh-list
25370227|NCT05039619|Diphenhydramine|diphenhydramine|mesh-list
25370228|NCT05039619|Promethazine|promethazine|mesh-list
25370229|NCT05039619|Mycophenolic Acid|mycophenolic acid|mesh-list
25370230|NCT05039619|Prednisone|prednisone|mesh-list
25370231|NCT05039619|Methylprednisolone|methylprednisolone|mesh-list
25370232|NCT05039619|Obinutuzumab|obinutuzumab|mesh-list
25370233|NCT05039619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25370234|NCT05039619|Glucocorticoids|glucocorticoids|mesh-ancestor
25370235|NCT05039619|Hormones|hormones|mesh-ancestor
25370236|NCT05039619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25370237|NCT05039619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370238|NCT05039619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25370239|NCT05039619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370240|NCT05039619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25370241|NCT05039619|Analgesics|analgesics|mesh-ancestor
25370242|NCT05039619|Sensory System Agents|sensory system agents|mesh-ancestor
25370243|NCT05039619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25370244|NCT05039619|Antipyretics|antipyretics|mesh-ancestor
25370245|NCT05039619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25370246|NCT05039619|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25370247|NCT05039619|Antitubercular Agents|antitubercular agents|mesh-ancestor
25370248|NCT05039619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25370249|NCT05039619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25370250|NCT05039619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25370251|NCT05039619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370252|NCT05039619|Antiemetics|antiemetics|mesh-ancestor
25370253|NCT05039619|Autonomic Agents|autonomic agents|mesh-ancestor
25370254|NCT05039619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25370255|NCT05039619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25370256|NCT05039619|Protective Agents|protective agents|mesh-ancestor
25370257|NCT05039619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25370263|NCT05039619|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25370264|NCT05039619|Histamine Antagonists|histamine antagonists|mesh-ancestor
25370265|NCT05039619|Histamine Agents|histamine agents|mesh-ancestor
25370266|NCT05039619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25370267|NCT05039619|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25370268|NCT05039619|Antipruritics|antipruritics|mesh-ancestor
25370269|NCT05039619|Dermatologic Agents|dermatologic agents|mesh-ancestor
25370270|NCT05039281|Atezolizumab|atezolizumab|mesh-list
25370271|NCT05039281|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25370272|NCT05039281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370273|NCT05039281|Immunologic Factors|immunologic factors|mesh-ancestor
25370274|NCT05039281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370275|NCT05038982|Abrocitinib|abrocitinib|mesh-list
25370276|NCT05038982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25370277|NCT05038982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25370278|NCT05038982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370279|NCT05038839|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25370280|NCT05038839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25370281|NCT05038839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370282|NCT05038839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370283|NCT05038735|Fulvestrant|fulvestrant|mesh-list
25370284|NCT05038735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25370285|NCT05038735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370286|NCT05038735|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25370287|NCT05038735|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25370288|NCT05038735|Hormone Antagonists|hormone antagonists|mesh-ancestor
25370289|NCT05038735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25370290|NCT05038735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370296|NCT05037539|Fentanyl|fentanyl|mesh-list
25370297|NCT05037539|Morphine|morphine|mesh-list
25370298|NCT05037539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25370299|NCT05037539|Narcotics|narcotics|mesh-ancestor
25370300|NCT05037539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25370301|NCT05037539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370302|NCT05037539|Analgesics|analgesics|mesh-ancestor
25370303|NCT05037539|Sensory System Agents|sensory system agents|mesh-ancestor
25370304|NCT05037539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25370305|NCT05037539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25370306|NCT05037539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25370307|NCT05037539|Anesthetics, General|anesthetics, general|mesh-ancestor
25370308|NCT05037539|Anesthetics|anesthetics|mesh-ancestor
25370309|NCT05037500|Decitabine|decitabine|mesh-list
25370310|NCT05037500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25370311|NCT05037500|Antimetabolites|antimetabolites|mesh-ancestor
25370312|NCT05037500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370313|NCT05037500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370314|NCT05037500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25370315|NCT05037123|Ketamine|ketamine|mesh-list
25370316|NCT05037123|Analgesics|analgesics|mesh-ancestor
25370317|NCT05037123|Sensory System Agents|sensory system agents|mesh-ancestor
25370318|NCT05037123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25370319|NCT05037123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370320|NCT05037123|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25370321|NCT05037123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25370322|NCT05037123|Anesthetics, General|anesthetics, general|mesh-ancestor
25370323|NCT05037123|Anesthetics|anesthetics|mesh-ancestor
25370324|NCT05037123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25370325|NCT05037123|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25370326|NCT05037123|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25370327|NCT05037123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25370328|NCT05037123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370329|NCT05036798|Lenvatinib|lenvatinib|mesh-list
25370330|NCT05036798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370331|NCT05036798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25370332|NCT05036798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25370333|NCT05036798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370335|NCT05036681|Futibatinib|futibatinib|mesh-list
25370336|NCT05036681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25370337|NCT05036681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370338|NCT05036577|Dexamethasone|dexamethasone|mesh-list
25370339|NCT05036577|Rituximab|rituximab|mesh-list
25370340|NCT05036577|Methotrexate|methotrexate|mesh-list
25370341|NCT05036577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25370342|NCT05036577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370343|NCT05036577|Immunologic Factors|immunologic factors|mesh-ancestor
25370344|NCT05036577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370345|NCT05036577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25370346|NCT05036577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25370347|NCT05036577|Antiemetics|antiemetics|mesh-ancestor
25370348|NCT05036577|Autonomic Agents|autonomic agents|mesh-ancestor
25370349|NCT05036577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25370350|NCT05036577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25370351|NCT05036577|Glucocorticoids|glucocorticoids|mesh-ancestor
25370352|NCT05036577|Hormones|hormones|mesh-ancestor
25370353|NCT05036577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25370354|NCT05036577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25370355|NCT05036577|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25370356|NCT05036577|Abortifacient Agents|abortifacient agents|mesh-ancestor
25370357|NCT05036577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25370358|NCT05036577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25370360|NCT05036577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370361|NCT05036577|Dermatologic Agents|dermatologic agents|mesh-ancestor
25370362|NCT05036577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25370363|NCT05036577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25370364|NCT05036577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25370365|NCT05036577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25370366|NCT05036278|Factor VIII|factor viii|mesh-list
25370367|NCT05036278|Coagulants|coagulants|mesh-ancestor
25370368|NCT05036109|Aspirin|aspirin|mesh-list
25370369|NCT05036109|Vitamin D|vitamin d|mesh-list
25370370|NCT05036109|Vitamins|vitamins|mesh-ancestor
25370371|NCT05036109|Micronutrients|micronutrients|mesh-ancestor
25370372|NCT05036109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370373|NCT05036109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25370374|NCT05036109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25370375|NCT05036109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25370376|NCT05036109|Analgesics|analgesics|mesh-ancestor
25370377|NCT05036109|Sensory System Agents|sensory system agents|mesh-ancestor
25370378|NCT05036109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25370379|NCT05036109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25370380|NCT05036109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25370381|NCT05036109|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25370382|NCT05036109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25370383|NCT05036109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370384|NCT05036109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25370385|NCT05036109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25370386|NCT05036109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25370387|NCT05036109|Antipyretics|antipyretics|mesh-ancestor
25370388|NCT05035888|Phenylephrine|phenylephrine|mesh-list
25370389|NCT05035888|Oxymetazoline|oxymetazoline|mesh-list
25370390|NCT05035888|Norepinephrine|norepinephrine|mesh-list
25370391|NCT05035888|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25370392|NCT05035888|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25370393|NCT05035888|Mydriatics|mydriatics|mesh-ancestor
25370394|NCT05035888|Autonomic Agents|autonomic agents|mesh-ancestor
25370395|NCT05035888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25370396|NCT05035888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370397|NCT05035888|Sympathomimetics|sympathomimetics|mesh-ancestor
25370398|NCT05035888|Nasal Decongestants|nasal decongestants|mesh-ancestor
25370399|NCT05035888|Respiratory System Agents|respiratory system agents|mesh-ancestor
25370400|NCT05035888|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25370401|NCT05035888|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25370402|NCT05035888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25370403|NCT05035888|Adrenergic Agents|adrenergic agents|mesh-ancestor
25370404|NCT05035888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25370405|NCT05035888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370406|NCT05035888|Protective Agents|protective agents|mesh-ancestor
25370407|NCT05035407|Aldesleukin|aldesleukin|mesh-list
25370408|NCT05035407|Cyclophosphamide|cyclophosphamide|mesh-list
25370409|NCT05035407|Fludarabine|fludarabine|mesh-list
25370410|NCT05035407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25370411|NCT05035407|Immunologic Factors|immunologic factors|mesh-ancestor
25370412|NCT05035407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370413|NCT05035407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25370414|NCT05035407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25370415|NCT05035407|Alkylating Agents|alkylating agents|mesh-ancestor
25370416|NCT05035407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370417|NCT05035407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370418|NCT05035407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25370419|NCT05035407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25370420|NCT05035407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25370421|NCT05035407|Antiviral Agents|antiviral agents|mesh-ancestor
25370422|NCT05035407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25370423|NCT05034627|Asparaginase|asparaginase|mesh-list
25370424|NCT05034627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370426|NCT05033665|Anesthetics, Local|anesthetics, local|mesh-ancestor
25370427|NCT05033665|Anesthetics|anesthetics|mesh-ancestor
25370428|NCT05033665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25370429|NCT05033665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370430|NCT05033665|Sensory System Agents|sensory system agents|mesh-ancestor
25370431|NCT05033665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25370432|NCT05033080|Ivacaftor|ivacaftor|mesh-list
25370433|NCT05033080|Elexacaftor|elexacaftor|mesh-list
25370434|NCT05033080|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25370435|NCT05033080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25370436|NCT05033080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370437|NCT05032820|Lenalidomide|lenalidomide|mesh-list
25370438|NCT05032820|Immunologic Factors|immunologic factors|mesh-ancestor
25370439|NCT05032820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370440|NCT05032820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25370441|NCT05032820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25370442|NCT05032820|Growth Substances|growth substances|mesh-ancestor
25370443|NCT05032820|Growth Inhibitors|growth inhibitors|mesh-ancestor
25370444|NCT05032820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370445|NCT05032807|Cannabidiol|cannabidiol|mesh-list
25370446|NCT05032807|Anticonvulsants|anticonvulsants|mesh-ancestor
25370447|NCT05031975|Irinotecan|irinotecan|mesh-list
25370448|NCT05031975|Temozolomide|temozolomide|mesh-list
25370449|NCT05031975|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25370450|NCT05031975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25370451|NCT05031975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25370452|NCT05031975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370453|NCT05031975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370454|NCT05031975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25370455|NCT05031975|Alkylating Agents|alkylating agents|mesh-ancestor
25370456|NCT05031481|Butoconazole|butoconazole|mesh-list
25370457|NCT05031481|Antifungal Agents|antifungal agents|mesh-ancestor
25370458|NCT05031481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25370459|NCT05030766|Nicotine|nicotine|mesh-list
25370460|NCT05030766|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25370461|NCT05030766|Autonomic Agents|autonomic agents|mesh-ancestor
25370462|NCT05030766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25370463|NCT05030766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370464|NCT05030766|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25370465|NCT05030766|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25370466|NCT05030766|Cholinergic Agents|cholinergic agents|mesh-ancestor
25370467|NCT05030766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25370468|NCT05030766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370469|NCT05030506|Pembrolizumab|pembrolizumab|mesh-list
25370470|NCT05030506|Lenvatinib|lenvatinib|mesh-list
25370471|NCT05030506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25370472|NCT05030506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370473|NCT05030506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25370474|NCT05030506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25370475|NCT05030506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370476|NCT05030298|Temozolomide|temozolomide|mesh-list
25370477|NCT05030298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25370478|NCT05030298|Alkylating Agents|alkylating agents|mesh-ancestor
25370479|NCT05030298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370480|NCT05030298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370481|NCT05030194|Nicotine|nicotine|mesh-list
25370482|NCT05030194|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25370483|NCT05030194|Autonomic Agents|autonomic agents|mesh-ancestor
25370484|NCT05030194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25370709|NCT05022758|Warfarin|warfarin|mesh-list
25370485|NCT05030194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370486|NCT05030194|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25370487|NCT05030194|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25370488|NCT05030194|Cholinergic Agents|cholinergic agents|mesh-ancestor
25370489|NCT05030194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25370490|NCT05030194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370491|NCT05029921|Ustekinumab|ustekinumab|mesh-list
25370492|NCT05029921|Dermatologic Agents|dermatologic agents|mesh-ancestor
25370493|NCT05029596|Heparin|heparin|mesh-list
25370494|NCT05029596|Calcium heparin|calcium heparin|mesh-list
25370495|NCT05029596|Anticoagulants|anticoagulants|mesh-ancestor
25370496|NCT05029596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25370497|NCT05029596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25370498|NCT05029596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370499|NCT05029401|Ibogaine|ibogaine|mesh-list
25370500|NCT05029401|Hallucinogens|hallucinogens|mesh-ancestor
25370501|NCT05029401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370502|NCT05029401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25370503|NCT05029401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25370504|NCT05029401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25370505|NCT05029401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25370731|NCT05022147|Dopamine Agents|dopamine agents|mesh-ancestor
25370506|NCT05029401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370508|NCT05029050|Dexmedetomidine|dexmedetomidine|mesh-list
25370509|NCT05029050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25370510|NCT05029050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25370511|NCT05029050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370512|NCT05029050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25370513|NCT05029050|Analgesics|analgesics|mesh-ancestor
25370514|NCT05029050|Sensory System Agents|sensory system agents|mesh-ancestor
25370515|NCT05029050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25370516|NCT05029050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25370517|NCT05029050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25370518|NCT05029050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25370519|NCT05029050|Adrenergic Agents|adrenergic agents|mesh-ancestor
25370520|NCT05029050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25370521|NCT05029050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370522|NCT05029050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25370523|NCT05029050|Sympatholytics|sympatholytics|mesh-ancestor
25370524|NCT05029050|Autonomic Agents|autonomic agents|mesh-ancestor
25370525|NCT05028829|Atorvastatin|atorvastatin|mesh-list
25370526|NCT05028829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25370527|NCT05028829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25370528|NCT05028829|Antimetabolites|antimetabolites|mesh-ancestor
25370529|NCT05028829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370530|NCT05028829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25370531|NCT05028829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25370532|NCT05028829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25370533|NCT05028634|Vaccines|vaccines|mesh-list
25370534|NCT05028634|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25370535|NCT05028634|Immunologic Factors|immunologic factors|mesh-ancestor
25370536|NCT05028634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370537|NCT05028569|Botulinum Toxins|botulinum toxins|mesh-list
25370538|NCT05028569|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25370539|NCT05028569|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25370540|NCT05028569|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25370541|NCT05028569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25370542|NCT05028569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370543|NCT05028569|Cholinergic Agents|cholinergic agents|mesh-ancestor
25370544|NCT05028569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25370545|NCT05028569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370546|NCT05028569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25370547|NCT05028569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25370548|NCT05028348|Dexamethasone|dexamethasone|mesh-list
25370549|NCT05028348|Pomalidomide|pomalidomide|mesh-list
25370550|NCT05028348|Elotuzumab|elotuzumab|mesh-list
25370551|NCT05028348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25370552|NCT05028348|Antiemetics|antiemetics|mesh-ancestor
25370553|NCT05028348|Autonomic Agents|autonomic agents|mesh-ancestor
25370554|NCT05028348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25370555|NCT05028348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370556|NCT05028348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25370557|NCT05028348|Glucocorticoids|glucocorticoids|mesh-ancestor
25370558|NCT05028348|Hormones|hormones|mesh-ancestor
25370635|NCT05025787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370600|NCT05026320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25370601|NCT05026320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25370603|NCT05026320|Sensory System Agents|sensory system agents|mesh-ancestor
25370604|NCT05026320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25370605|NCT05026320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370606|NCT05026320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25370607|NCT05026320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25370608|NCT05026320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25370609|NCT05026320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25370610|NCT05026320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370611|NCT05026320|Gout Suppressants|gout suppressants|mesh-ancestor
25370612|NCT05025813|Pembrolizumab|pembrolizumab|mesh-list
25370613|NCT05025813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25370614|NCT05025813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370615|NCT05025800|Rituximab|rituximab|mesh-list
25370616|NCT05025800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25370617|NCT05025800|Lenalidomide|lenalidomide|mesh-list
25370618|NCT05025800|Antibodies|antibodies|mesh-list
25370619|NCT05025800|Immunoglobulins|immunoglobulins|mesh-list
25370620|NCT05025800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25370621|NCT05025800|Immunologic Factors|immunologic factors|mesh-ancestor
25370622|NCT05025800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370623|NCT05025800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370624|NCT05025800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25370625|NCT05025800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25370626|NCT05025800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25370627|NCT05025800|Growth Substances|growth substances|mesh-ancestor
25370628|NCT05025800|Growth Inhibitors|growth inhibitors|mesh-ancestor
25370629|NCT05025787|Celecoxib|celecoxib|mesh-list
25370630|NCT05025787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25370631|NCT05025787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25370632|NCT05025787|Analgesics|analgesics|mesh-ancestor
25370633|NCT05025787|Sensory System Agents|sensory system agents|mesh-ancestor
25370634|NCT05025787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25370636|NCT05025787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25370637|NCT05025787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25370638|NCT05025787|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25370639|NCT05025787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25370640|NCT05025787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25370641|NCT05025787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370642|NCT05025605|Dexmedetomidine|dexmedetomidine|mesh-list
25370643|NCT05025605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25370644|NCT05025605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25370645|NCT05025605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370646|NCT05025605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25370647|NCT05025605|Analgesics|analgesics|mesh-ancestor
25370648|NCT05025605|Sensory System Agents|sensory system agents|mesh-ancestor
25370649|NCT05025605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25370650|NCT05025605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25370651|NCT05025605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25370652|NCT05025605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25370653|NCT05025605|Adrenergic Agents|adrenergic agents|mesh-ancestor
25370654|NCT05025605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25370732|NCT05022147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25370655|NCT05025605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370656|NCT05025085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25370657|NCT05025085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370658|NCT05025085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370659|NCT05024747|Nicotine|nicotine|mesh-list
25370660|NCT05024747|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25370661|NCT05024747|Autonomic Agents|autonomic agents|mesh-ancestor
25370662|NCT05024747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25370663|NCT05024747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370664|NCT05024747|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25370665|NCT05024747|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25370666|NCT05024747|Cholinergic Agents|cholinergic agents|mesh-ancestor
25370667|NCT05024747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25370668|NCT05024747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370669|NCT05024253|Tranexamic Acid|tranexamic acid|mesh-list
25370670|NCT05024253|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25370671|NCT05024253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25370672|NCT05024253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370673|NCT05024253|Hemostatics|hemostatics|mesh-ancestor
25370674|NCT05024253|Coagulants|coagulants|mesh-ancestor
25370675|NCT05024032|Tirzepatide|tirzepatide|mesh-list
25370676|NCT05024032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25370677|NCT05024032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370678|NCT05024032|Incretins|incretins|mesh-ancestor
25370679|NCT05024032|Hormones|hormones|mesh-ancestor
25370680|NCT05024032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25370681|NCT05023980|Rituximab|rituximab|mesh-list
25370682|NCT05023980|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25370683|NCT05023980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25370684|NCT05023980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370685|NCT05023980|Immunologic Factors|immunologic factors|mesh-ancestor
25370686|NCT05023980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370687|NCT05023980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25370688|NCT05023980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25370689|NCT05023980|Alkylating Agents|alkylating agents|mesh-ancestor
25370690|NCT05023980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370691|NCT05023967|Metformin|metformin|mesh-list
25370692|NCT05023967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25370693|NCT05023967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370694|NCT05023473|Morphine|morphine|mesh-list
25370695|NCT05023473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25370696|NCT05023473|Narcotics|narcotics|mesh-ancestor
25370697|NCT05023473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25370698|NCT05023473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370699|NCT05023473|Analgesics|analgesics|mesh-ancestor
25370700|NCT05023473|Sensory System Agents|sensory system agents|mesh-ancestor
25370701|NCT05023473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25370702|NCT05023070|Cannabidiol|cannabidiol|mesh-list
25370703|NCT05023070|Anticonvulsants|anticonvulsants|mesh-ancestor
25370704|NCT05022784|Nintedanib|nintedanib|mesh-list
25370705|NCT05022784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370706|NCT05022784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25370707|NCT05022784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25370708|NCT05022784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370710|NCT05022758|Rivaroxaban|rivaroxaban|mesh-list
25370711|NCT05022758|Anticoagulants|anticoagulants|mesh-ancestor
25370712|NCT05022758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25370713|NCT05022758|Antithrombins|antithrombins|mesh-ancestor
25370714|NCT05022758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25370715|NCT05022758|Protease Inhibitors|protease inhibitors|mesh-ancestor
25370716|NCT05022758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25370717|NCT05022758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370718|NCT05022524|Acetic Acid|acetic acid|mesh-list
25370719|NCT05022524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25370720|NCT05022524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25370721|NCT05022329|Vaccines|vaccines|mesh-list
25370722|NCT05022329|Immunologic Factors|immunologic factors|mesh-ancestor
25370723|NCT05022329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370724|NCT05022147|Dopamine|dopamine|mesh-list
25370725|NCT05022147|Dopamine Agonists|dopamine agonists|mesh-list
25370726|NCT05022147|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25370727|NCT05022147|Sympathomimetics|sympathomimetics|mesh-ancestor
25370728|NCT05022147|Autonomic Agents|autonomic agents|mesh-ancestor
25370729|NCT05022147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25370730|NCT05022147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370733|NCT05022147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370734|NCT05022147|Protective Agents|protective agents|mesh-ancestor
25370735|NCT05022004|Brinzolamide|brinzolamide|mesh-list
25370736|NCT05022004|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25370737|NCT05022004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25370738|NCT05022004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370739|NCT05021991|Pramoxine|pramoxine|mesh-list
25370740|NCT05021991|Anesthetics, Local|anesthetics, local|mesh-ancestor
25370741|NCT05021991|Anesthetics|anesthetics|mesh-ancestor
25370742|NCT05021991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25370743|NCT05021991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370744|NCT05021991|Sensory System Agents|sensory system agents|mesh-ancestor
25370745|NCT05021991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25370746|NCT05021484|Felzartamab|felzartamab|mesh-list
25370747|NCT05021484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370748|NCT05021484|Immunologic Factors|immunologic factors|mesh-ancestor
25370749|NCT05021484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370750|NCT05021094|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25370751|NCT05021094|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25370752|NCT05021094|Estradiol|estradiol|mesh-list
25370753|NCT05021094|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25370754|NCT05021094|Dydrogesterone|dydrogesterone|mesh-list
25370755|NCT05021094|Estrogens|estrogens|mesh-ancestor
25370756|NCT05021094|Hormones|hormones|mesh-ancestor
25370757|NCT05021094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25370758|NCT05021094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370759|NCT05021094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25370760|NCT05021094|Contraceptive Agents|contraceptive agents|mesh-ancestor
25370761|NCT05021094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25370762|NCT05021094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25370763|NCT05021094|Progestins|progestins|mesh-ancestor
25370764|NCT05020899|Nicotine|nicotine|mesh-list
25370765|NCT05020899|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25370766|NCT05020899|Autonomic Agents|autonomic agents|mesh-ancestor
25370767|NCT05020899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25370768|NCT05020899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370769|NCT05020899|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25370770|NCT05020899|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25370771|NCT05020899|Cholinergic Agents|cholinergic agents|mesh-ancestor
25370772|NCT05020899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25370773|NCT05020899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370774|NCT05020769|Osimertinib|osimertinib|mesh-list
25370775|NCT05020769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370776|NCT05020769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25370777|NCT05020769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25370778|NCT05020769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370779|NCT05020665|Cytarabine|cytarabine|mesh-list
25370780|NCT05020665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25370781|NCT05020665|Antimetabolites|antimetabolites|mesh-ancestor
25370782|NCT05020665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370783|NCT05020665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370784|NCT05020665|Antiviral Agents|antiviral agents|mesh-ancestor
25370785|NCT05020665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25370786|NCT05020665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25370787|NCT05020665|Immunologic Factors|immunologic factors|mesh-ancestor
25370788|NCT05020665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370789|NCT05020522|Phenobarbital|phenobarbital|mesh-list
25370790|NCT05020522|Anticonvulsants|anticonvulsants|mesh-ancestor
25370791|NCT05020522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25370792|NCT05020522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25370793|NCT05020522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370794|NCT05020522|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25370795|NCT05020522|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25370832|NCT05020184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25370833|NCT05020184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25370834|NCT05019885|Ketamine|ketamine|mesh-list
25370835|NCT05019885|Analgesics|analgesics|mesh-ancestor
25370836|NCT05019885|Sensory System Agents|sensory system agents|mesh-ancestor
25370837|NCT05019885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25370838|NCT05019885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370839|NCT05019885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25370840|NCT05019885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25370841|NCT05019885|Anesthetics, General|anesthetics, general|mesh-ancestor
25370842|NCT05019885|Anesthetics|anesthetics|mesh-ancestor
25370843|NCT05019885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25370844|NCT05019885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25370845|NCT05019885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25370846|NCT05019885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25370847|NCT05019885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370848|NCT05019716|Cisplatin|cisplatin|mesh-list
25370849|NCT05019716|Etoposide|etoposide|mesh-list
25370850|NCT05019716|Etoposide phosphate|etoposide phosphate|mesh-list
25370851|NCT05019716|Podophyllotoxin|podophyllotoxin|mesh-list
25370852|NCT05019716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370853|NCT05019716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25370854|NCT05019716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25370855|NCT05019716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25370856|NCT05019716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25370857|NCT05019716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370858|NCT05019716|Keratolytic Agents|keratolytic agents|mesh-ancestor
25370859|NCT05019716|Dermatologic Agents|dermatologic agents|mesh-ancestor
25370860|NCT05019716|Tubulin Modulators|tubulin modulators|mesh-ancestor
25370861|NCT05019716|Antimitotic Agents|antimitotic agents|mesh-ancestor
25370862|NCT05019716|Mitosis Modulators|mitosis modulators|mesh-ancestor
25370864|NCT05019703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25370865|NCT05019703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370866|NCT05019703|Immunologic Factors|immunologic factors|mesh-ancestor
25370867|NCT05019703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370868|NCT05019027|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
25370869|NCT05019027|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25370870|NCT05019027|Adrenergic Agents|adrenergic agents|mesh-ancestor
25370871|NCT05019027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25370872|NCT05019027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370873|NCT05019027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370874|NCT05018585|Cholecalciferol|cholecalciferol|mesh-list
25370875|NCT05018585|Vitamin D|vitamin d|mesh-list
25370876|NCT05018585|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25370877|NCT05018585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25370878|NCT05018585|Immunologic Factors|immunologic factors|mesh-ancestor
25370879|NCT05018585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370880|NCT05018585|Antacids|antacids|mesh-ancestor
25370881|NCT05018585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370882|NCT05018585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25370883|NCT05018585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25370884|NCT05018585|Vitamins|vitamins|mesh-ancestor
25370885|NCT05018585|Micronutrients|micronutrients|mesh-ancestor
25370886|NCT05018585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25370887|NCT05018117|Nicotine|nicotine|mesh-list
25370888|NCT05018117|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25370889|NCT05018117|Autonomic Agents|autonomic agents|mesh-ancestor
25370890|NCT05018117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25370891|NCT05018117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370892|NCT05018117|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25370893|NCT05018117|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25370894|NCT05018117|Cholinergic Agents|cholinergic agents|mesh-ancestor
25370895|NCT05018117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25370896|NCT05018117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370897|NCT05017571|Colchicine|colchicine|mesh-list
25370898|NCT05017571|Gout Suppressants|gout suppressants|mesh-ancestor
25370899|NCT05017571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25370900|NCT05017571|Tubulin Modulators|tubulin modulators|mesh-ancestor
25370901|NCT05017571|Antimitotic Agents|antimitotic agents|mesh-ancestor
25370902|NCT05017571|Mitosis Modulators|mitosis modulators|mesh-ancestor
25370903|NCT05017571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370904|NCT05017571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370905|NCT05017246|Lidocaine|lidocaine|mesh-list
25370906|NCT05017246|Morphine|morphine|mesh-list
25370907|NCT05017246|Bupivacaine|bupivacaine|mesh-list
25370908|NCT05017246|Anesthetics, Local|anesthetics, local|mesh-ancestor
25370909|NCT05017246|Anesthetics|anesthetics|mesh-ancestor
25370910|NCT05017246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25370911|NCT05017246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370912|NCT05017246|Sensory System Agents|sensory system agents|mesh-ancestor
25370913|NCT05017246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25370914|NCT05017246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25370915|NCT05017246|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25370916|NCT05017246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25370917|NCT05017246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25370918|NCT05017246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370919|NCT05017246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25370920|NCT05017246|Narcotics|narcotics|mesh-ancestor
25370921|NCT05017246|Analgesics|analgesics|mesh-ancestor
25370922|NCT05017103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25370923|NCT05017103|Antibodies|antibodies|mesh-list
25370924|NCT05017103|Immunoglobulins|immunoglobulins|mesh-list
25370925|NCT05017103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25370926|NCT05017103|Immunologic Factors|immunologic factors|mesh-ancestor
25370927|NCT05017103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370928|NCT05017103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370929|NCT05017012|Paclitaxel|paclitaxel|mesh-list
25370930|NCT05017012|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25370931|NCT05017012|Cisplatin|cisplatin|mesh-list
25370932|NCT05017012|Carboplatin|carboplatin|mesh-list
25370933|NCT05017012|Pembrolizumab|pembrolizumab|mesh-list
25370934|NCT05017012|Pemetrexed|pemetrexed|mesh-list
25370935|NCT05017012|Axitinib|axitinib|mesh-list
25370936|NCT05017012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25370937|NCT05017012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370938|NCT05017012|Tubulin Modulators|tubulin modulators|mesh-ancestor
25370939|NCT05017012|Antimitotic Agents|antimitotic agents|mesh-ancestor
25370943|NCT05017012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25370944|NCT05017012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25370945|NCT05017012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25370946|NCT05017012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25370948|NCT05016869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25370949|NCT05016869|Antimetabolites|antimetabolites|mesh-ancestor
25370950|NCT05016869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370951|NCT05016869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370952|NCT05016609|Sofosbuvir|sofosbuvir|mesh-list
25370953|NCT05016609|Velpatasvir|velpatasvir|mesh-list
25370954|NCT05016609|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25370955|NCT05016609|Antibodies|antibodies|mesh-list
25370956|NCT05016609|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
25370957|NCT05016609|Immunologic Factors|immunologic factors|mesh-ancestor
25370958|NCT05016609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370959|NCT05016609|Antiviral Agents|antiviral agents|mesh-ancestor
25370960|NCT05016609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25370961|NCT05015439|Cannabidiol|cannabidiol|mesh-list
25370962|NCT05015439|Anticonvulsants|anticonvulsants|mesh-ancestor
25370963|NCT05014776|Pembrolizumab|pembrolizumab|mesh-list
25370964|NCT05014776|Ipilimumab|ipilimumab|mesh-list
25370965|NCT05014776|Tadalafil|tadalafil|mesh-list
25370966|NCT05014776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25370967|NCT05014776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25370968|NCT05014776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25370969|NCT05014776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370970|NCT05014776|Vasodilator Agents|vasodilator agents|mesh-ancestor
25370971|NCT05014776|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25370972|NCT05014776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25370973|NCT05014776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25370974|NCT05014776|Urological Agents|urological agents|mesh-ancestor
25370975|NCT05014724|Rozanolixizumab|rozanolixizumab|mesh-list
25370976|NCT05014724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25370977|NCT05014724|Immunologic Factors|immunologic factors|mesh-ancestor
25370978|NCT05014724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370979|NCT05014516|Xenon|xenon|mesh-list
25370980|NCT05014516|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25370981|NCT05014516|Anesthetics, General|anesthetics, general|mesh-ancestor
25370982|NCT05014516|Anesthetics|anesthetics|mesh-ancestor
25370983|NCT05014516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25370984|NCT05014516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370989|NCT05014282|Nicotine|nicotine|mesh-list
25370990|NCT05014282|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25370991|NCT05014282|Autonomic Agents|autonomic agents|mesh-ancestor
25370992|NCT05014282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25370993|NCT05014282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25370994|NCT05014282|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25370995|NCT05014282|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25370996|NCT05014282|Cholinergic Agents|cholinergic agents|mesh-ancestor
25370997|NCT05014282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25370998|NCT05014282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25370999|NCT05013437|Acetaminophen|acetaminophen|mesh-list
25371000|NCT05013437|Diphenhydramine|diphenhydramine|mesh-list
25371001|NCT05013437|Promethazine|promethazine|mesh-list
25371002|NCT05013437|Melphalan|melphalan|mesh-list
25371003|NCT05013437|Prochlorperazine|prochlorperazine|mesh-list
25371004|NCT05013437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25371005|NCT05013437|Analgesics|analgesics|mesh-ancestor
25371006|NCT05013437|Sensory System Agents|sensory system agents|mesh-ancestor
25371007|NCT05013437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25371008|NCT05013437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371009|NCT05013437|Antipyretics|antipyretics|mesh-ancestor
25371010|NCT05013437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25371011|NCT05013437|Alkylating Agents|alkylating agents|mesh-ancestor
25371012|NCT05013437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371013|NCT05013437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371014|NCT05013437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25371015|NCT05013437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25371016|NCT05013437|Immunologic Factors|immunologic factors|mesh-ancestor
25371017|NCT05013437|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25371018|NCT05013437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25371019|NCT05013437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25371020|NCT05013437|Anesthetics, Local|anesthetics, local|mesh-ancestor
25371021|NCT05013437|Anesthetics|anesthetics|mesh-ancestor
25371022|NCT05013437|Antiemetics|antiemetics|mesh-ancestor
25371023|NCT05013437|Autonomic Agents|autonomic agents|mesh-ancestor
25371024|NCT05013437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25371025|NCT05013437|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25371026|NCT05013437|Histamine Antagonists|histamine antagonists|mesh-ancestor
25371027|NCT05013437|Histamine Agents|histamine agents|mesh-ancestor
25371028|NCT05013437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25371029|NCT05013437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25371030|NCT05013437|Antipruritics|antipruritics|mesh-ancestor
25371031|NCT05013437|Dermatologic Agents|dermatologic agents|mesh-ancestor
25371032|NCT05013437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25371033|NCT05013437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25371034|NCT05013437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25371035|NCT05013437|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25371036|NCT05013437|Dopamine Agents|dopamine agents|mesh-ancestor
25371037|NCT05013424|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25371038|NCT05013424|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25371039|NCT05013424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25371040|NCT05013424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25371041|NCT05013424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371042|NCT05013424|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25371043|NCT05013424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25371044|NCT05013424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371045|NCT05013424|Cholinergic Agents|cholinergic agents|mesh-ancestor
25371046|NCT05013424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25371047|NCT05012735|Pantothenic Acid|pantothenic acid|mesh-list
25371049|NCT05012735|Vitamins|vitamins|mesh-ancestor
25371050|NCT05012735|Micronutrients|micronutrients|mesh-ancestor
25371051|NCT05012735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371052|NCT05012735|Vitamin B Complex|vitamin b complex|mesh-ancestor
25371053|NCT05011383|Testosterone|testosterone|mesh-list
25371054|NCT05011383|Androgens|androgens|mesh-list
25371055|NCT05011383|Hormones|hormones|mesh-ancestor
25416021|NCT02975882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25371056|NCT05011383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25371057|NCT05011383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371058|NCT05011266|Buprenorphine|buprenorphine|mesh-list
25371059|NCT05011266|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25371060|NCT05011266|Naloxone|naloxone|mesh-list
25371061|NCT05011266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25371062|NCT05011266|Narcotics|narcotics|mesh-ancestor
25371063|NCT05011266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25371064|NCT05011266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371065|NCT05011266|Analgesics|analgesics|mesh-ancestor
25371066|NCT05011266|Sensory System Agents|sensory system agents|mesh-ancestor
25371067|NCT05011266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25371068|NCT05011266|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25371069|NCT05011058|Valganciclovir|valganciclovir|mesh-list
25371070|NCT05011058|Antiviral Agents|antiviral agents|mesh-ancestor
25371071|NCT05011058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25371072|NCT05010772|Decitabine|decitabine|mesh-list
25371073|NCT05010772|Venetoclax|venetoclax|mesh-list
25371074|NCT05010772|Ivosidenib|ivosidenib|mesh-list
25371075|NCT05010772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25371076|NCT05010772|Antimetabolites|antimetabolites|mesh-ancestor
25371077|NCT05010772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371078|NCT05010772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371079|NCT05010772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371080|NCT05010421|Clobetasol|clobetasol|mesh-list
25371081|NCT05010421|Emollients|emollients|mesh-list
25371082|NCT05010421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25371083|NCT05010421|Glucocorticoids|glucocorticoids|mesh-ancestor
25371084|NCT05010421|Hormones|hormones|mesh-ancestor
25371085|NCT05010421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25371086|NCT05010421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371087|NCT05010421|Dermatologic Agents|dermatologic agents|mesh-ancestor
25371088|NCT05010200|Poly ICLC|poly iclc|mesh-list
25371089|NCT05010200|Interferon Inducers|interferon inducers|mesh-ancestor
25371090|NCT05010200|Immunologic Factors|immunologic factors|mesh-ancestor
25371091|NCT05010200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371092|NCT05010122|Decitabine|decitabine|mesh-list
25371093|NCT05010122|Venetoclax|venetoclax|mesh-list
25371094|NCT05010122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25371095|NCT05010122|Antimetabolites|antimetabolites|mesh-ancestor
25371096|NCT05010122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371097|NCT05010122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371098|NCT05010122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371099|NCT05009992|TIC10 compound|tic10 compound|mesh-list
25371100|NCT05009992|Dopamine|dopamine|mesh-list
25371101|NCT05009992|GDC-0084|gdc-0084|mesh-list
25371102|NCT05009992|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25371103|NCT05009992|Sympathomimetics|sympathomimetics|mesh-ancestor
25371104|NCT05009992|Autonomic Agents|autonomic agents|mesh-ancestor
25371105|NCT05009992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25371106|NCT05009992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371107|NCT05009992|Dopamine Agents|dopamine agents|mesh-ancestor
25371108|NCT05009992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25371109|NCT05009992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371110|NCT05009992|Protective Agents|protective agents|mesh-ancestor
25371122|NCT05009862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25371123|NCT05009862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371124|NCT05009862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25371125|NCT05009862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25371126|NCT05009862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25371127|NCT05009862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25371128|NCT05009862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371129|NCT05009862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25371130|NCT05009862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25371131|NCT05009862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371132|NCT05009862|Antipyretics|antipyretics|mesh-ancestor
25371133|NCT05009862|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25371134|NCT05009862|Antithrombins|antithrombins|mesh-ancestor
25371135|NCT05009862|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25371136|NCT05009862|Protease Inhibitors|protease inhibitors|mesh-ancestor
25371137|NCT05009862|Anticoagulants|anticoagulants|mesh-ancestor
25371138|NCT05009082|Paclitaxel|paclitaxel|mesh-list
25371139|NCT05009082|Bevacizumab|bevacizumab|mesh-list
25371140|NCT05009082|Carboplatin|carboplatin|mesh-list
25371141|NCT05009082|Niraparib|niraparib|mesh-list
25371142|NCT05009082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25371143|NCT05009082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371144|NCT05009082|Tubulin Modulators|tubulin modulators|mesh-ancestor
25371145|NCT05009082|Antimitotic Agents|antimitotic agents|mesh-ancestor
25371146|NCT05009082|Mitosis Modulators|mitosis modulators|mesh-ancestor
25371147|NCT05009082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371148|NCT05009082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25371149|NCT05009082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25371150|NCT05009082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25371151|NCT05009082|Growth Substances|growth substances|mesh-ancestor
25371152|NCT05009082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371153|NCT05009082|Growth Inhibitors|growth inhibitors|mesh-ancestor
25371154|NCT05009082|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25371155|NCT05009082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371166|NCT05008913|Adavosertib|adavosertib|mesh-list
25371167|NCT05008913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371168|NCT05008913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371169|NCT05008809|Leucovorin|leucovorin|mesh-list
25371170|NCT05008809|Fluorouracil|fluorouracil|mesh-list
25371171|NCT05008809|Oxaliplatin|oxaliplatin|mesh-list
25371172|NCT05008809|Irinotecan|irinotecan|mesh-list
25371173|NCT05008809|Levoleucovorin|levoleucovorin|mesh-list
25371174|NCT05008809|Antimetabolites|antimetabolites|mesh-ancestor
25371175|NCT05008809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371176|NCT05008809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25371177|NCT05008809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371178|NCT05008809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25371179|NCT05008809|Immunologic Factors|immunologic factors|mesh-ancestor
25371180|NCT05008809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371181|NCT05008809|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25371182|NCT05008809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25371183|NCT05008809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371184|NCT05008809|Antidotes|antidotes|mesh-ancestor
25371185|NCT05008809|Protective Agents|protective agents|mesh-ancestor
25371186|NCT05008809|Vitamin B Complex|vitamin b complex|mesh-ancestor
25371187|NCT05008809|Vitamins|vitamins|mesh-ancestor
25371200|NCT05007873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371201|NCT05007873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25371214|NCT05007613|Atezolizumab|atezolizumab|mesh-list
25371215|NCT05007613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371216|NCT05007392|Febuxostat|febuxostat|mesh-list
25371217|NCT05007392|Dotinurad|dotinurad|mesh-list
25371218|NCT05007392|Gout Suppressants|gout suppressants|mesh-ancestor
25371219|NCT05007392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25371220|NCT05007392|Uricosuric Agents|uricosuric agents|mesh-ancestor
25371221|NCT05007392|Renal Agents|renal agents|mesh-ancestor
25371222|NCT05007262|Calcium Dobesilate|calcium dobesilate|mesh-list
25371223|NCT05007262|Calcium|calcium|mesh-list
25371224|NCT05007262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25371225|NCT05007262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371226|NCT05007262|Hemostatics|hemostatics|mesh-ancestor
25371227|NCT05007262|Coagulants|coagulants|mesh-ancestor
25371228|NCT05007106|Gemcitabine|gemcitabine|mesh-list
25371229|NCT05007106|Docetaxel|docetaxel|mesh-list
25371230|NCT05007106|Bevacizumab|bevacizumab|mesh-list
25371231|NCT05007106|Carboplatin|carboplatin|mesh-list
25371232|NCT05007106|Pembrolizumab|pembrolizumab|mesh-list
25371233|NCT05007106|Fluorouracil|fluorouracil|mesh-list
25371234|NCT05007106|Capecitabine|capecitabine|mesh-list
25371235|NCT05007106|Oxaliplatin|oxaliplatin|mesh-list
25371236|NCT05007106|Lenvatinib|lenvatinib|mesh-list
25371237|NCT05007106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371238|NCT05007106|Tubulin Modulators|tubulin modulators|mesh-ancestor
25371239|NCT05007106|Antimitotic Agents|antimitotic agents|mesh-ancestor
25371240|NCT05007106|Mitosis Modulators|mitosis modulators|mesh-ancestor
25371241|NCT05007106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371242|NCT05007106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25371243|NCT05007106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25371244|NCT05007106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25371245|NCT05007106|Growth Substances|growth substances|mesh-ancestor
25371246|NCT05007106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371247|NCT05007106|Growth Inhibitors|growth inhibitors|mesh-ancestor
25371248|NCT05007106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25371249|NCT05007106|Antimetabolites|antimetabolites|mesh-ancestor
25371250|NCT05007106|Antiviral Agents|antiviral agents|mesh-ancestor
25371251|NCT05007106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25371252|NCT05007106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371253|NCT05007106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25371254|NCT05007106|Immunologic Factors|immunologic factors|mesh-ancestor
25371255|NCT05007106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25371256|NCT05007041|Vaccines|vaccines|mesh-list
25371257|NCT05007041|Immunologic Factors|immunologic factors|mesh-ancestor
25371258|NCT05007041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371259|NCT05006794|Gemcitabine|gemcitabine|mesh-list
25371260|NCT05006794|Docetaxel|docetaxel|mesh-list
25371261|NCT05006794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25371262|NCT05006794|Antimetabolites|antimetabolites|mesh-ancestor
25371263|NCT05006794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371264|NCT05006794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371265|NCT05006794|Antiviral Agents|antiviral agents|mesh-ancestor
25371266|NCT05006794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25371267|NCT05006794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371268|NCT05006794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25371269|NCT05006794|Immunologic Factors|immunologic factors|mesh-ancestor
25371270|NCT05006794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371271|NCT05006794|Tubulin Modulators|tubulin modulators|mesh-ancestor
25371272|NCT05006794|Antimitotic Agents|antimitotic agents|mesh-ancestor
25371273|NCT05006794|Mitosis Modulators|mitosis modulators|mesh-ancestor
25371274|NCT05006638|Atropine|atropine|mesh-list
25371275|NCT05006638|Ondansetron|ondansetron|mesh-list
25371276|NCT05006638|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
25371277|NCT05006638|Obidoxime Chloride|obidoxime chloride|mesh-list
25371278|NCT05006638|Antiemetics|antiemetics|mesh-ancestor
25371279|NCT05006638|Autonomic Agents|autonomic agents|mesh-ancestor
25371280|NCT05006638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25371281|NCT05006638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371282|NCT05006638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25371283|NCT05006638|Antipruritics|antipruritics|mesh-ancestor
25371284|NCT05006638|Dermatologic Agents|dermatologic agents|mesh-ancestor
25371285|NCT05006638|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25371286|NCT05006638|Serotonin Agents|serotonin agents|mesh-ancestor
25371287|NCT05006638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25371288|NCT05006638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371289|NCT05006638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25371290|NCT05006638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25371291|NCT05006638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25371292|NCT05006638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25371293|NCT05006638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25371294|NCT05006638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25371295|NCT05006638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25371296|NCT05006638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25371297|NCT05006638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25371298|NCT05006638|Respiratory System Agents|respiratory system agents|mesh-ancestor
25371299|NCT05006638|Mydriatics|mydriatics|mesh-ancestor
25371300|NCT05006638|Parasympatholytics|parasympatholytics|mesh-ancestor
25371301|NCT05006638|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25371302|NCT05006638|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25371303|NCT05006638|Cholinergic Agents|cholinergic agents|mesh-ancestor
25371304|NCT05006638|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25371305|NCT05006638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25371306|NCT05006638|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
25371307|NCT05006638|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
25371308|NCT05006573|Benralizumab|benralizumab|mesh-list
25371309|NCT05006573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25371310|NCT05006573|Respiratory System Agents|respiratory system agents|mesh-ancestor
25371311|NCT05006417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25371312|NCT05006417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25371313|NCT05006417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25371314|NCT05006417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371315|NCT05006417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25371316|NCT05006417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25371317|NCT05006417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371318|NCT05006417|Cholinergic Agents|cholinergic agents|mesh-ancestor
25371319|NCT05006417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25371320|NCT05005442|Pembrolizumab|pembrolizumab|mesh-list
25371321|NCT05005442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25371322|NCT05005442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371323|NCT05005273|Nivolumab|nivolumab|mesh-list
25371324|NCT05005273|Ipilimumab|ipilimumab|mesh-list
25371325|NCT05005273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25371326|NCT05005273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371327|NCT05005273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25371328|NCT05005273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371329|NCT05004350|Fluorouracil|fluorouracil|mesh-list
25371330|NCT05004350|Irinotecan|irinotecan|mesh-list
25371331|NCT05004350|Cetuximab|cetuximab|mesh-list
25371332|NCT05004350|Antimetabolites|antimetabolites|mesh-ancestor
25371333|NCT05004350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371334|NCT05004350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25371335|NCT05004350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371336|NCT05004350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25371337|NCT05004350|Immunologic Factors|immunologic factors|mesh-ancestor
25371338|NCT05004350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371339|NCT05004350|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25371340|NCT05004350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25371341|NCT05004350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371342|NCT05004350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25371343|NCT05004116|Irinotecan|irinotecan|mesh-list
25371344|NCT05004116|Temozolomide|temozolomide|mesh-list
25371345|NCT05004116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25371346|NCT05004116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25371347|NCT05004116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371348|NCT05004116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371349|NCT05004116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371350|NCT05004116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25371351|NCT05004116|Alkylating Agents|alkylating agents|mesh-ancestor
25371352|NCT05003895|Cyclophosphamide|cyclophosphamide|mesh-list
25371353|NCT05003895|Fludarabine|fludarabine|mesh-list
25371354|NCT05003895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25371355|NCT05003895|Immunologic Factors|immunologic factors|mesh-ancestor
25371356|NCT05003895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371357|NCT05003895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25371358|NCT05003895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25371359|NCT05003895|Alkylating Agents|alkylating agents|mesh-ancestor
25371360|NCT05003895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371361|NCT05003895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371362|NCT05003895|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25371363|NCT05003570|Fentanyl|fentanyl|mesh-list
25371364|NCT05003570|Remifentanil|remifentanil|mesh-list
25371365|NCT05003570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25371366|NCT05003570|Narcotics|narcotics|mesh-ancestor
25371367|NCT05003570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25371368|NCT05003570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371369|NCT05003570|Analgesics|analgesics|mesh-ancestor
25371370|NCT05003570|Sensory System Agents|sensory system agents|mesh-ancestor
25371371|NCT05003570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25371372|NCT05003570|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25371373|NCT05003570|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25371374|NCT05003570|Anesthetics, General|anesthetics, general|mesh-ancestor
25371375|NCT05003570|Anesthetics|anesthetics|mesh-ancestor
25371376|NCT05003453|Palmidrol|palmidrol|mesh-list
25371377|NCT05003453|Analgesics|analgesics|mesh-ancestor
25371378|NCT05003453|Sensory System Agents|sensory system agents|mesh-ancestor
25371379|NCT05003453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25371380|NCT05003453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371381|NCT05003453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25371382|NCT05003453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25371383|NCT05003453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25371384|NCT05003453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25371385|NCT05003453|Antiviral Agents|antiviral agents|mesh-ancestor
25371386|NCT05003453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25371387|NCT05003453|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25371388|NCT05003453|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25371389|NCT05003453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25371390|NCT05003453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371391|NCT05003453|Hormones|hormones|mesh-ancestor
25371392|NCT05003453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25371393|NCT05002829|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25371394|NCT05002829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25371395|NCT05002829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25371396|NCT05002829|Antitubercular Agents|antitubercular agents|mesh-ancestor
25371397|NCT05002816|Elotuzumab|elotuzumab|mesh-list
25371398|NCT05002816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371399|NCT05002569|Nivolumab|nivolumab|mesh-list
25371400|NCT05002569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25371401|NCT05002569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371402|NCT05002569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25371403|NCT05002569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371404|NCT05002127|Paclitaxel|paclitaxel|mesh-list
25371405|NCT05002127|Trastuzumab|trastuzumab|mesh-list
25371406|NCT05002127|Ramucirumab|ramucirumab|mesh-list
25371407|NCT05002127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25416022|NCT02975882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371408|NCT05002127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371409|NCT05002127|Tubulin Modulators|tubulin modulators|mesh-ancestor
25371410|NCT05002127|Antimitotic Agents|antimitotic agents|mesh-ancestor
25371411|NCT05002127|Mitosis Modulators|mitosis modulators|mesh-ancestor
25371412|NCT05002127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371413|NCT05002127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25371414|NCT05001880|Bevacizumab|bevacizumab|mesh-list
25371415|NCT05001880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25371416|NCT05001880|Carboplatin|carboplatin|mesh-list
25371417|NCT05001880|Pemetrexed|pemetrexed|mesh-list
25371418|NCT05001880|Atezolizumab|atezolizumab|mesh-list
25371419|NCT05001880|Endothelial Growth Factors|endothelial growth factors|mesh-list
25371420|NCT05001880|Antibodies|antibodies|mesh-list
25371421|NCT05001880|Immunoglobulins|immunoglobulins|mesh-list
25371422|NCT05001880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25371423|NCT05001880|Immunoglobulin G|immunoglobulin g|mesh-list
25371424|NCT05001880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371425|NCT05001880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25371426|NCT05001880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25371427|NCT05001880|Growth Substances|growth substances|mesh-ancestor
25371428|NCT05001880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371429|NCT05001880|Growth Inhibitors|growth inhibitors|mesh-ancestor
25371430|NCT05001880|Immunologic Factors|immunologic factors|mesh-ancestor
25371431|NCT05001880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371432|NCT05001880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371433|NCT05001880|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25371434|NCT05001880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25371435|NCT05001373|Vaccines|vaccines|mesh-list
25371436|NCT05001373|Immunologic Factors|immunologic factors|mesh-ancestor
25371437|NCT05001373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371438|NCT05000294|Atezolizumab|atezolizumab|mesh-list
25371439|NCT05000294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371440|NCT05000216|Mycophenolic Acid|mycophenolic acid|mesh-list
25371441|NCT05000216|Methotrexate|methotrexate|mesh-list
25371442|NCT05000216|Vaccines|vaccines|mesh-list
25371443|NCT05000216|Immunologic Factors|immunologic factors|mesh-ancestor
25371444|NCT05000216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371445|NCT05000216|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25371446|NCT05000216|Abortifacient Agents|abortifacient agents|mesh-ancestor
25371447|NCT05000216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25371448|NCT05000216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25371449|NCT05000216|Antimetabolites|antimetabolites|mesh-ancestor
25371450|NCT05000216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371451|NCT05000216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371452|NCT05000216|Dermatologic Agents|dermatologic agents|mesh-ancestor
25371453|NCT05000216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371454|NCT05000216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25371455|NCT05000216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25371456|NCT05000216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25371457|NCT05000216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25371458|NCT05000216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25371459|NCT05000216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25371460|NCT05000216|Antitubercular Agents|antitubercular agents|mesh-ancestor
25371461|NCT05000216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25371462|NCT05000216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25371463|NCT04999969|Gemcitabine|gemcitabine|mesh-list
25371464|NCT04999969|Paclitaxel|paclitaxel|mesh-list
25371465|NCT04999969|Durvalumab|durvalumab|mesh-list
25371466|NCT04999969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25371467|NCT04999969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371468|NCT04999969|Tubulin Modulators|tubulin modulators|mesh-ancestor
25371469|NCT04999969|Antimitotic Agents|antimitotic agents|mesh-ancestor
25371470|NCT04999969|Mitosis Modulators|mitosis modulators|mesh-ancestor
25371471|NCT04999969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371472|NCT04999969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25371473|NCT04999969|Antimetabolites|antimetabolites|mesh-ancestor
25371474|NCT04999969|Antiviral Agents|antiviral agents|mesh-ancestor
25371475|NCT04999969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25371476|NCT04999969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371477|NCT04999969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25371478|NCT04999969|Immunologic Factors|immunologic factors|mesh-ancestor
25371479|NCT04999969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371778|NCT04991025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25371485|NCT04999241|Mesalamine|mesalamine|mesh-list
25371486|NCT04999241|Infliximab|infliximab|mesh-list
25371487|NCT04999241|Dermatologic Agents|dermatologic agents|mesh-ancestor
25371488|NCT04999241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25371489|NCT04999241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25371490|NCT04999241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25371491|NCT04999241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25371492|NCT04999241|Analgesics|analgesics|mesh-ancestor
25371493|NCT04999241|Sensory System Agents|sensory system agents|mesh-ancestor
25371494|NCT04999241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25371495|NCT04999241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371496|NCT04999241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25371497|NCT04999215|Choline|choline|mesh-list
25371498|NCT04999215|Lipotropic Agents|lipotropic agents|mesh-ancestor
25371499|NCT04999215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25371500|NCT04999215|Antimetabolites|antimetabolites|mesh-ancestor
25371501|NCT04999215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371502|NCT04999215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25371503|NCT04999215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25371504|NCT04999215|Nootropic Agents|nootropic agents|mesh-ancestor
25371505|NCT04999202|Pembrolizumab|pembrolizumab|mesh-list
25371506|NCT04999202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25371507|NCT04999202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371513|NCT04998851|Ocrelizumab|ocrelizumab|mesh-list
25371514|NCT04998851|Immunologic Factors|immunologic factors|mesh-ancestor
25371515|NCT04998851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371516|NCT04998812|Ocrelizumab|ocrelizumab|mesh-list
25371517|NCT04998812|Immunologic Factors|immunologic factors|mesh-ancestor
25371518|NCT04998812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371519|NCT04998604|Omalizumab|omalizumab|mesh-list
25371520|NCT04998604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25371521|NCT04998604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25371522|NCT04998604|Respiratory System Agents|respiratory system agents|mesh-ancestor
25371523|NCT04997902|Tipifarnib|tipifarnib|mesh-list
25371524|NCT04997902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371525|NCT04997811|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25371526|NCT04997811|Valproic Acid|valproic acid|mesh-list
25371527|NCT04997811|Bezafibrate|bezafibrate|mesh-list
25371528|NCT04997811|Medroxyprogesterone|medroxyprogesterone|mesh-list
25371529|NCT04997811|Danazol|danazol|mesh-list
25371530|NCT04997811|Anticonvulsants|anticonvulsants|mesh-ancestor
25371531|NCT04997811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371532|NCT04997811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371533|NCT04997811|GABA Agents|gaba agents|mesh-ancestor
25371534|NCT04997811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25371535|NCT04997811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371536|NCT04997811|Antimanic Agents|antimanic agents|mesh-ancestor
25371537|NCT04997811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25371538|NCT04997811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25371539|NCT04997811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25371540|NCT04997811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25371541|NCT04997811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25371542|NCT04997811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25371543|NCT04997811|Contraceptive Agents|contraceptive agents|mesh-ancestor
25371544|NCT04997811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25371545|NCT04997811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25371546|NCT04997811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25371547|NCT04997811|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25371548|NCT04997811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25371549|NCT04997811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371550|NCT04997811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25371551|NCT04997811|Hormone Antagonists|hormone antagonists|mesh-ancestor
25371552|NCT04997811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25371553|NCT04997811|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25371554|NCT04997811|Antimetabolites|antimetabolites|mesh-ancestor
25371555|NCT04997811|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25371779|NCT04990869|Niacinamide|niacinamide|mesh-list
25371556|NCT04997317|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
25371557|NCT04997317|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
25371558|NCT04997317|Chelating Agents|chelating agents|mesh-ancestor
25371559|NCT04997317|Sequestering Agents|sequestering agents|mesh-ancestor
25371560|NCT04997317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371561|NCT04997317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25371562|NCT04997239|Vaccines|vaccines|mesh-list
25371563|NCT04997239|Immunologic Factors|immunologic factors|mesh-ancestor
25371564|NCT04997239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371565|NCT04996264|Varespladib methyl|varespladib methyl|mesh-list
25371566|NCT04996264|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
25371567|NCT04996264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371568|NCT04996264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371569|NCT04996004|Doxorubicin|doxorubicin|mesh-list
25371570|NCT04996004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25371571|NCT04996004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371572|NCT04996004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25371573|NCT04996004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25371574|NCT04996004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371575|NCT04996004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371576|NCT04995497|Lidocaine|lidocaine|mesh-list
25371577|NCT04995497|Anesthetics, Local|anesthetics, local|mesh-ancestor
25371587|NCT04995497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371589|NCT04995029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25371590|NCT04995029|Narcotics|narcotics|mesh-ancestor
25371591|NCT04995029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25371592|NCT04995029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371593|NCT04995029|Analgesics|analgesics|mesh-ancestor
25371594|NCT04995029|Sensory System Agents|sensory system agents|mesh-ancestor
25371595|NCT04995029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25371596|NCT04995029|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25371597|NCT04994990|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25371598|NCT04994990|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25371599|NCT04994990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25371600|NCT04994990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25371601|NCT04994990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371602|NCT04994990|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25371603|NCT04994990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25371604|NCT04994990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371605|NCT04994990|Cholinergic Agents|cholinergic agents|mesh-ancestor
25371606|NCT04994990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25371607|NCT04994977|Carboplatin|carboplatin|mesh-list
25371608|NCT04994977|Melphalan|melphalan|mesh-list
25371609|NCT04994977|Topotecan|topotecan|mesh-list
25371610|NCT04994977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371611|NCT04994977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25371612|NCT04994977|Alkylating Agents|alkylating agents|mesh-ancestor
25371613|NCT04994977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371614|NCT04994977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25371615|NCT04994977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25371616|NCT04994977|Immunologic Factors|immunologic factors|mesh-ancestor
25371617|NCT04994977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371618|NCT04994977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25371619|NCT04994977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25371620|NCT04994977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371621|NCT04994808|Fludarabine|fludarabine|mesh-list
25371622|NCT04994808|Clofarabine|clofarabine|mesh-list
25371623|NCT04994808|Treosulfan|treosulfan|mesh-list
25371624|NCT04994808|Busulfan|busulfan|mesh-list
25371625|NCT04994808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371626|NCT04994808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25371627|NCT04994808|Antimetabolites|antimetabolites|mesh-ancestor
25371628|NCT04994808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371780|NCT04990869|Niacin|niacin|mesh-list
25371629|NCT04994808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25371630|NCT04994808|Immunologic Factors|immunologic factors|mesh-ancestor
25371631|NCT04994808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371632|NCT04994808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25371633|NCT04994808|Alkylating Agents|alkylating agents|mesh-ancestor
25371634|NCT04994808|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25371636|NCT04994717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371647|NCT04994132|Dactinomycin|dactinomycin|mesh-list
25371648|NCT04994132|Cyclophosphamide|cyclophosphamide|mesh-list
25371649|NCT04994132|Vincristine|vincristine|mesh-list
25724238|NCT02535806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25371651|NCT04994132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25371652|NCT04994132|Immunologic Factors|immunologic factors|mesh-ancestor
25371653|NCT04994132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371654|NCT04994132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25371655|NCT04994132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25371656|NCT04994132|Alkylating Agents|alkylating agents|mesh-ancestor
25371657|NCT04994132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371658|NCT04994132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371659|NCT04994132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25371660|NCT04994132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25371661|NCT04994132|Tubulin Modulators|tubulin modulators|mesh-ancestor
25371662|NCT04994132|Antimitotic Agents|antimitotic agents|mesh-ancestor
25371663|NCT04994132|Mitosis Modulators|mitosis modulators|mesh-ancestor
25371664|NCT04994132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25371665|NCT04994132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25371666|NCT04994132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25371667|NCT04994132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25371668|NCT04994132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371669|NCT04994132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25371670|NCT04993677|Carboplatin|carboplatin|mesh-list
25371671|NCT04993677|Pembrolizumab|pembrolizumab|mesh-list
25371672|NCT04993677|Pemetrexed|pemetrexed|mesh-list
25371673|NCT04993677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371674|NCT04993677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25371675|NCT04993677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371676|NCT04993677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371677|NCT04993677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25371678|NCT04993677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25371679|NCT04993352|Antibodies|antibodies|mesh-list
25371680|NCT04993352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25371681|NCT04993352|Mitogens|mitogens|mesh-list
25371682|NCT04993352|Endothelial Growth Factors|endothelial growth factors|mesh-list
25371683|NCT04993352|Immunologic Factors|immunologic factors|mesh-ancestor
25371684|NCT04993352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371685|NCT04993352|Mitosis Modulators|mitosis modulators|mesh-ancestor
25371686|NCT04993352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371687|NCT04993352|Growth Substances|growth substances|mesh-ancestor
25371688|NCT04992624|Dronabinol|dronabinol|mesh-list
25371689|NCT04992624|Cannabidiol|cannabidiol|mesh-list
25371690|NCT04992624|Anticonvulsants|anticonvulsants|mesh-ancestor
25371691|NCT04992624|Hallucinogens|hallucinogens|mesh-ancestor
25371692|NCT04992624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371693|NCT04992624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25371694|NCT04992624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25371695|NCT04992624|Analgesics|analgesics|mesh-ancestor
25371696|NCT04992624|Sensory System Agents|sensory system agents|mesh-ancestor
25371697|NCT04992624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25371698|NCT04992624|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25371699|NCT04992624|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25371700|NCT04992624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25371701|NCT04992624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371702|NCT04992624|Hormones|hormones|mesh-ancestor
25371709|NCT04992026|Glucocorticoids|glucocorticoids|mesh-ancestor
25371710|NCT04992026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25371711|NCT04992026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371712|NCT04992026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25371713|NCT04992026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371714|NCT04992026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25371715|NCT04992026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371716|NCT04992026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371717|NCT04992026|Hormone Antagonists|hormone antagonists|mesh-ancestor
25371718|NCT04992026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25371719|NCT04991597|Lidocaine|lidocaine|mesh-list
25371720|NCT04991597|Epinephrine|epinephrine|mesh-list
25371721|NCT04991597|Racepinephrine|racepinephrine|mesh-list
25371722|NCT04991597|Epinephryl borate|epinephryl borate|mesh-list
25371723|NCT04991597|Anesthetics, Local|anesthetics, local|mesh-ancestor
25371724|NCT04991597|Anesthetics|anesthetics|mesh-ancestor
25371725|NCT04991597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25371726|NCT04991597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371727|NCT04991597|Sensory System Agents|sensory system agents|mesh-ancestor
25371728|NCT04991597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25371729|NCT04991597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25371730|NCT04991597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25371731|NCT04991597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25371732|NCT04991597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25371733|NCT04991597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371734|NCT04991597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25371735|NCT04991597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25371736|NCT04991597|Adrenergic Agents|adrenergic agents|mesh-ancestor
25371737|NCT04991597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25371738|NCT04991597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25371739|NCT04991597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25371740|NCT04991597|Autonomic Agents|autonomic agents|mesh-ancestor
25371741|NCT04991597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25371742|NCT04991597|Respiratory System Agents|respiratory system agents|mesh-ancestor
25371743|NCT04991597|Mydriatics|mydriatics|mesh-ancestor
25371744|NCT04991597|Sympathomimetics|sympathomimetics|mesh-ancestor
25371745|NCT04991597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25371752|NCT04991402|Dolutegravir|dolutegravir|mesh-list
25371753|NCT04991402|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
25371754|NCT04991402|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25371755|NCT04991402|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25371756|NCT04991402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371757|NCT04991402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371758|NCT04991402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25371759|NCT04991402|Antiviral Agents|antiviral agents|mesh-ancestor
25371760|NCT04991402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25371761|NCT04991025|Gemcitabine|gemcitabine|mesh-list
25371762|NCT04991025|Cisplatin|cisplatin|mesh-list
25371763|NCT04991025|Carboplatin|carboplatin|mesh-list
25371764|NCT04991025|Pemetrexed|pemetrexed|mesh-list
25371765|NCT04991025|Certolizumab Pegol|certolizumab pegol|mesh-list
25371766|NCT04991025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371767|NCT04991025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25371768|NCT04991025|Antimetabolites|antimetabolites|mesh-ancestor
25371769|NCT04991025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371770|NCT04991025|Antiviral Agents|antiviral agents|mesh-ancestor
25371771|NCT04991025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25371772|NCT04991025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371773|NCT04991025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25371774|NCT04991025|Immunologic Factors|immunologic factors|mesh-ancestor
25371775|NCT04991025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371776|NCT04991025|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25371777|NCT04991025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25371781|NCT04990869|Nicotinic Acids|nicotinic acids|mesh-list
25371782|NCT04990869|Vitamin B Complex|vitamin b complex|mesh-ancestor
25371783|NCT04990869|Vitamins|vitamins|mesh-ancestor
25371784|NCT04990869|Micronutrients|micronutrients|mesh-ancestor
25371785|NCT04990869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371786|NCT04990869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25371787|NCT04990869|Antimetabolites|antimetabolites|mesh-ancestor
25371788|NCT04990869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371789|NCT04990869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25371790|NCT04990869|Vasodilator Agents|vasodilator agents|mesh-ancestor
25371791|NCT04990388|Acetaminophen|acetaminophen|mesh-list
25371792|NCT04990388|Antipyretics|antipyretics|mesh-list
25371793|NCT04990388|Cetirizine|cetirizine|mesh-list
25371794|NCT04990388|Ibuprofen|ibuprofen|mesh-list
25371795|NCT04990388|Famotidine|famotidine|mesh-list
25371796|NCT04990388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25371797|NCT04990388|Analgesics|analgesics|mesh-ancestor
25371798|NCT04990388|Sensory System Agents|sensory system agents|mesh-ancestor
25371799|NCT04990388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25371800|NCT04990388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371801|NCT04990388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25371802|NCT04990388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25371803|NCT04990388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25371804|NCT04990388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25371805|NCT04990388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371806|NCT04990388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371807|NCT04990388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25371808|NCT04990388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25371809|NCT04990388|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25371810|NCT04990388|Histamine Antagonists|histamine antagonists|mesh-ancestor
25371811|NCT04990388|Histamine Agents|histamine agents|mesh-ancestor
25371812|NCT04990388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25371813|NCT04990388|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25371814|NCT04990388|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25371815|NCT04990388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25371816|NCT04990258|Infliximab|infliximab|mesh-list
25371817|NCT04990258|Dermatologic Agents|dermatologic agents|mesh-ancestor
25371818|NCT04990258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25371819|NCT04990258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25371820|NCT04989816|Trastuzumab|trastuzumab|mesh-list
25371821|NCT04989816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25371822|NCT04989816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371823|NCT04989803|Cyclophosphamide|cyclophosphamide|mesh-list
25371824|NCT04989803|Fludarabine|fludarabine|mesh-list
25371825|NCT04989803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25371826|NCT04989803|Immunologic Factors|immunologic factors|mesh-ancestor
25371827|NCT04989803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371828|NCT04989803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25371829|NCT04989803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25371830|NCT04989803|Alkylating Agents|alkylating agents|mesh-ancestor
25371831|NCT04989803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371832|NCT04989803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371833|NCT04989803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25371834|NCT04989699|Aflibercept|aflibercept|mesh-list
25371835|NCT04989699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25371836|NCT04989699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25371837|NCT04989699|Growth Substances|growth substances|mesh-ancestor
25371838|NCT04989699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371839|NCT04989699|Growth Inhibitors|growth inhibitors|mesh-ancestor
25371840|NCT04989699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371841|NCT04989491|Rituximab|rituximab|mesh-list
25371842|NCT04989491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25371843|NCT04989491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371844|NCT04989491|Immunologic Factors|immunologic factors|mesh-ancestor
25371845|NCT04989491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371846|NCT04989491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25371847|NCT04989283|Paclitaxel|paclitaxel|mesh-list
25371848|NCT04989283|Etoposide|etoposide|mesh-list
25371849|NCT04989283|Podophyllotoxin|podophyllotoxin|mesh-list
25371850|NCT04989283|Cisplatin|cisplatin|mesh-list
25371851|NCT04989283|Carboplatin|carboplatin|mesh-list
25371852|NCT04989283|Pemetrexed|pemetrexed|mesh-list
25371853|NCT04989283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25371854|NCT04989283|Etoposide phosphate|etoposide phosphate|mesh-list
25371855|NCT04989283|Atezolizumab|atezolizumab|mesh-list
25371856|NCT04989283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25371857|NCT04989283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25371858|NCT04989283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371859|NCT04989283|Tubulin Modulators|tubulin modulators|mesh-ancestor
25371860|NCT04989283|Antimitotic Agents|antimitotic agents|mesh-ancestor
25371861|NCT04989283|Mitosis Modulators|mitosis modulators|mesh-ancestor
25371862|NCT04989283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371863|NCT04989283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25371864|NCT04989283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25371865|NCT04989283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371866|NCT04989283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25371867|NCT04989283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25371868|NCT04989283|Immunologic Factors|immunologic factors|mesh-ancestor
25371869|NCT04989283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371870|NCT04989283|Keratolytic Agents|keratolytic agents|mesh-ancestor
25371871|NCT04989283|Dermatologic Agents|dermatologic agents|mesh-ancestor
25371872|NCT04989218|Gemcitabine|gemcitabine|mesh-list
25371873|NCT04989218|Cisplatin|cisplatin|mesh-list
25371874|NCT04989218|Durvalumab|durvalumab|mesh-list
25371875|NCT04989218|Tremelimumab|tremelimumab|mesh-list
25371876|NCT04989218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371877|NCT04989218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25371878|NCT04989218|Antimetabolites|antimetabolites|mesh-ancestor
25371879|NCT04989218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371880|NCT04989218|Antiviral Agents|antiviral agents|mesh-ancestor
25371881|NCT04989218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25371882|NCT04989218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371883|NCT04989218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25371884|NCT04989218|Immunologic Factors|immunologic factors|mesh-ancestor
25371885|NCT04989218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371886|NCT04989218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25371887|NCT04988308|Adalimumab|adalimumab|mesh-list
25371888|NCT04988308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25371889|NCT04988308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25371890|NCT04988295|Carboplatin|carboplatin|mesh-list
25371891|NCT04988295|Pemetrexed|pemetrexed|mesh-list
25371892|NCT04988295|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
25371893|NCT04988295|Lazertinib|lazertinib|mesh-list
25371894|NCT04988295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371895|NCT04988295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371896|NCT04988295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371897|NCT04988295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25371898|NCT04988295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25371899|NCT04988295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25371900|NCT04988295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25371901|NCT04988217|Interferons|interferons|mesh-list
25371902|NCT04988217|Interferon-alpha|interferon-alpha|mesh-list
25371903|NCT04988217|Interferon alpha-2|interferon alpha-2|mesh-list
25371904|NCT04988217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371905|NCT04988217|Antiviral Agents|antiviral agents|mesh-ancestor
25371906|NCT04988217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25371907|NCT04988217|Immunologic Factors|immunologic factors|mesh-ancestor
25371908|NCT04988217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371909|NCT04987996|Pembrolizumab|pembrolizumab|mesh-list
25371910|NCT04987996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25371911|NCT04987996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371912|NCT04987775|Acetylcysteine|acetylcysteine|mesh-list
25371913|NCT04987775|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25371914|NCT04987775|Antiviral Agents|antiviral agents|mesh-ancestor
25371915|NCT04987775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25371916|NCT04987775|Expectorants|expectorants|mesh-ancestor
25371917|NCT04987775|Respiratory System Agents|respiratory system agents|mesh-ancestor
25371918|NCT04987775|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25371919|NCT04987775|Antioxidants|antioxidants|mesh-ancestor
25371920|NCT04987775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371921|NCT04987775|Protective Agents|protective agents|mesh-ancestor
25371922|NCT04987775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371923|NCT04987775|Antidotes|antidotes|mesh-ancestor
25371924|NCT04987463|Sirolimus|sirolimus|mesh-list
25371925|NCT04987463|Vigabatrin|vigabatrin|mesh-list
25371926|NCT04987463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25371927|NCT04987463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25371928|NCT04987463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25371929|NCT04987463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371930|NCT04987463|Antifungal Agents|antifungal agents|mesh-ancestor
25371931|NCT04987463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25371932|NCT04987463|Immunologic Factors|immunologic factors|mesh-ancestor
25371933|NCT04987463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371934|NCT04987463|Anticonvulsants|anticonvulsants|mesh-ancestor
25371935|NCT04987463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372012|NCT04984798|Micronutrients|micronutrients|mesh-ancestor
25371936|NCT04987463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371937|NCT04987463|GABA Agents|gaba agents|mesh-ancestor
25371938|NCT04987463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25371939|NCT04987203|Nivolumab|nivolumab|mesh-list
25371940|NCT04987203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25371941|NCT04987203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371942|NCT04987203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25371943|NCT04987203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371944|NCT04986852|Pembrolizumab|pembrolizumab|mesh-list
25371945|NCT04986852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25371946|NCT04986852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371947|NCT04985929|Sildenafil Citrate|sildenafil citrate|mesh-list
25371948|NCT04985929|Vasodilator Agents|vasodilator agents|mesh-ancestor
25371949|NCT04985929|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25371950|NCT04985929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25371951|NCT04985929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371952|NCT04985929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371953|NCT04985929|Urological Agents|urological agents|mesh-ancestor
25371954|NCT04985916|Botulinum Toxins|botulinum toxins|mesh-list
25371955|NCT04985916|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25371956|NCT04985916|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25371957|NCT04985916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25371958|NCT04985916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25371959|NCT04985916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371960|NCT04985916|Cholinergic Agents|cholinergic agents|mesh-ancestor
25371961|NCT04985916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25371962|NCT04985916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371963|NCT04985916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25371964|NCT04985916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25371966|NCT04985890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25371967|NCT04985890|Antiviral Agents|antiviral agents|mesh-ancestor
25724239|NCT02535949|Tranexamic Acid|tranexamic acid|mesh-list
25371968|NCT04985890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25371969|NCT04985760|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25371970|NCT04985760|Vaccines|vaccines|mesh-list
25371971|NCT04985760|Aluminum sulfate|aluminum sulfate|mesh-list
25371972|NCT04985760|Immunologic Factors|immunologic factors|mesh-ancestor
25371973|NCT04985760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371974|NCT04985760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25371975|NCT04985760|Antacids|antacids|mesh-ancestor
25371976|NCT04985760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371977|NCT04985760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25371978|NCT04985604|Niacinamide|niacinamide|mesh-list
25371979|NCT04985604|Vitamin B Complex|vitamin b complex|mesh-ancestor
25371980|NCT04985604|Vitamins|vitamins|mesh-ancestor
25371981|NCT04985604|Micronutrients|micronutrients|mesh-ancestor
25371982|NCT04985604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25371983|NCT04985136|Sorafenib|sorafenib|mesh-list
25371984|NCT04985136|Apatinib|apatinib|mesh-list
25371985|NCT04985136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25371986|NCT04985136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25371987|NCT04985136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371988|NCT04985136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371989|NCT04984993|Tadalafil|tadalafil|mesh-list
25371990|NCT04984993|Vasodilator Agents|vasodilator agents|mesh-ancestor
25371991|NCT04984993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25371992|NCT04984993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25371993|NCT04984993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25371994|NCT04984993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25371995|NCT04984993|Urological Agents|urological agents|mesh-ancestor
25371996|NCT04984837|Gemcitabine|gemcitabine|mesh-list
25371997|NCT04984837|Oxaliplatin|oxaliplatin|mesh-list
25371998|NCT04984837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25371999|NCT04984837|Antimetabolites|antimetabolites|mesh-ancestor
25372000|NCT04984837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372001|NCT04984837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372002|NCT04984837|Antiviral Agents|antiviral agents|mesh-ancestor
25372003|NCT04984837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25372004|NCT04984837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372005|NCT04984837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25372006|NCT04984837|Immunologic Factors|immunologic factors|mesh-ancestor
25372007|NCT04984837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372008|NCT04984798|Vitamin E|vitamin e|mesh-list
25372009|NCT04984798|Tocopherols|tocopherols|mesh-list
25372010|NCT04984798|alpha-Tocopherol|alpha-tocopherol|mesh-list
25372011|NCT04984798|Vitamins|vitamins|mesh-ancestor
25372013|NCT04984798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372014|NCT04984798|Antioxidants|antioxidants|mesh-ancestor
25372015|NCT04984798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372016|NCT04984798|Protective Agents|protective agents|mesh-ancestor
25372017|NCT04983966|Desflurane|desflurane|mesh-list
25372018|NCT04983966|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25372019|NCT04983966|Anesthetics, General|anesthetics, general|mesh-ancestor
25372020|NCT04983966|Anesthetics|anesthetics|mesh-ancestor
25372021|NCT04983966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25372022|NCT04983966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372023|NCT04983888|Obinutuzumab|obinutuzumab|mesh-list
25372024|NCT04983888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25372025|NCT04983888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372026|NCT04983238|Sodium thiosulfate|sodium thiosulfate|mesh-list
25372027|NCT04983238|Trastuzumab|trastuzumab|mesh-list
25372028|NCT04983238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25372029|NCT04983238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372030|NCT04983238|Antidotes|antidotes|mesh-ancestor
25372031|NCT04983238|Protective Agents|protective agents|mesh-ancestor
25372032|NCT04983238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372033|NCT04983238|Antioxidants|antioxidants|mesh-ancestor
25372034|NCT04983238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372035|NCT04983238|Antitubercular Agents|antitubercular agents|mesh-ancestor
25372036|NCT04983238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25372037|NCT04983238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25372038|NCT04983238|Chelating Agents|chelating agents|mesh-ancestor
25372039|NCT04983238|Sequestering Agents|sequestering agents|mesh-ancestor
25372040|NCT04983121|Antibodies|antibodies|mesh-list
25372041|NCT04983121|Immunoconjugates|immunoconjugates|mesh-list
25372042|NCT04983121|Mitogens|mitogens|mesh-list
25372043|NCT04983121|Immunologic Factors|immunologic factors|mesh-ancestor
25372044|NCT04983121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372045|NCT04983121|Mitosis Modulators|mitosis modulators|mesh-ancestor
25372046|NCT04983121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25403705|NCT03709680|Topotecan|topotecan|mesh-list
25372047|NCT04982848|Talazoparib|talazoparib|mesh-list
25372048|NCT04982848|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25372049|NCT04982848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372050|NCT04982848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372051|NCT04982848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372052|NCT04982705|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
25372053|NCT04982705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25372054|NCT04982705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372055|NCT04982705|Incretins|incretins|mesh-ancestor
25372056|NCT04982705|Hormones|hormones|mesh-ancestor
25372057|NCT04982705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25372058|NCT04982705|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25372059|NCT04982705|Protease Inhibitors|protease inhibitors|mesh-ancestor
25372060|NCT04982705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372061|NCT04982705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372062|NCT04982445|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
25372063|NCT04982445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25372064|NCT04982445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25372065|NCT04982445|Antiviral Agents|antiviral agents|mesh-ancestor
25372066|NCT04982445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25372067|NCT04982367|Sirolimus|sirolimus|mesh-list
25372068|NCT04982367|Paclitaxel|paclitaxel|mesh-list
25372069|NCT04982367|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25372070|NCT04982367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25372071|NCT04982367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372072|NCT04982367|Tubulin Modulators|tubulin modulators|mesh-ancestor
25372073|NCT04982367|Antimitotic Agents|antimitotic agents|mesh-ancestor
25372074|NCT04982367|Mitosis Modulators|mitosis modulators|mesh-ancestor
25372075|NCT04982367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372076|NCT04982367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25372077|NCT04982367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25372078|NCT04982367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25372079|NCT04982367|Antifungal Agents|antifungal agents|mesh-ancestor
25372080|NCT04982367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25372081|NCT04982367|Immunologic Factors|immunologic factors|mesh-ancestor
25372082|NCT04982367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372083|NCT04982354|Fludarabine|fludarabine|mesh-list
25372084|NCT04982354|Melphalan|melphalan|mesh-list
25372085|NCT04982354|Busulfan|busulfan|mesh-list
25372086|NCT04982354|Midostaurin|midostaurin|mesh-list
25372087|NCT04982354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372165|NCT04980222|Antimitotic Agents|antimitotic agents|mesh-ancestor
25372088|NCT04982354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372089|NCT04982354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25372090|NCT04982354|Immunologic Factors|immunologic factors|mesh-ancestor
25372091|NCT04982354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372092|NCT04982354|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25372093|NCT04982354|Alkylating Agents|alkylating agents|mesh-ancestor
25372094|NCT04982354|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25372095|NCT04982354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25372096|NCT04982354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372097|NCT04981860|Povidone-Iodine|povidone-iodine|mesh-list
25372098|NCT04981860|Povidone|povidone|mesh-list
25372099|NCT04981860|Plasma Substitutes|plasma substitutes|mesh-ancestor
25372100|NCT04981860|Blood Substitutes|blood substitutes|mesh-ancestor
25372101|NCT04981860|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25372102|NCT04981860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25372103|NCT04981509|Listerine|listerine|mesh-list
25372104|NCT04981509|Bevacizumab|bevacizumab|mesh-list
25372105|NCT04981509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25372106|NCT04981509|Atezolizumab|atezolizumab|mesh-list
25372107|NCT04981509|Endothelial Growth Factors|endothelial growth factors|mesh-list
25372108|NCT04981509|Antibodies|antibodies|mesh-list
25372109|NCT04981509|Immunoglobulins|immunoglobulins|mesh-list
25372110|NCT04981509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25372111|NCT04981509|Immunoglobulin G|immunoglobulin g|mesh-list
25372112|NCT04981509|Fluorides|fluorides|mesh-list
25372113|NCT04981509|Sodium Fluoride|sodium fluoride|mesh-list
25372114|NCT04981509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372115|NCT04981509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25372116|NCT04981509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25372117|NCT04981509|Growth Substances|growth substances|mesh-ancestor
25372118|NCT04981509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25724240|NCT02535949|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25372119|NCT04981509|Growth Inhibitors|growth inhibitors|mesh-ancestor
25372120|NCT04981509|Immunologic Factors|immunologic factors|mesh-ancestor
25372121|NCT04981509|Cariostatic Agents|cariostatic agents|mesh-ancestor
25372122|NCT04981509|Protective Agents|protective agents|mesh-ancestor
25372123|NCT04981509|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25372124|NCT04981509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25372126|NCT04981158|Anesthetics, General|anesthetics, general|mesh-list
25372127|NCT04981158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25372128|NCT04981158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372129|NCT04980495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25372130|NCT04980482|Interferons|interferons|mesh-list
25372131|NCT04980482|Interferon-alpha|interferon-alpha|mesh-list
25372132|NCT04980482|Interferon alpha-2|interferon alpha-2|mesh-list
25372133|NCT04980482|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25372134|NCT04980482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372135|NCT04980482|Antiviral Agents|antiviral agents|mesh-ancestor
25372136|NCT04980482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25372137|NCT04980482|Immunologic Factors|immunologic factors|mesh-ancestor
25372138|NCT04980482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372139|NCT04980222|Prednisone|prednisone|mesh-list
25372140|NCT04980222|Cyclophosphamide|cyclophosphamide|mesh-list
25372141|NCT04980222|Rituximab|rituximab|mesh-list
25372142|NCT04980222|Doxorubicin|doxorubicin|mesh-list
25372143|NCT04980222|Vincristine|vincristine|mesh-list
25372144|NCT04980222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25372145|NCT04980222|Immunologic Factors|immunologic factors|mesh-ancestor
25372146|NCT04980222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372147|NCT04980222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25372148|NCT04980222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25372149|NCT04980222|Alkylating Agents|alkylating agents|mesh-ancestor
25372150|NCT04980222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372151|NCT04980222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372152|NCT04980222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25372153|NCT04980222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25372154|NCT04980222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25372155|NCT04980222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25372156|NCT04980222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25372157|NCT04980222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372158|NCT04980222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25372159|NCT04980222|Glucocorticoids|glucocorticoids|mesh-ancestor
25372160|NCT04980222|Hormones|hormones|mesh-ancestor
25372161|NCT04980222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25372162|NCT04980222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25372163|NCT04980222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25372164|NCT04980222|Tubulin Modulators|tubulin modulators|mesh-ancestor
25372166|NCT04980222|Mitosis Modulators|mitosis modulators|mesh-ancestor
25372167|NCT04980027|Insulin Glargine|insulin glargine|mesh-list
25372168|NCT04980027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25372169|NCT04980027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372170|NCT04979806|Meropenem|meropenem|mesh-list
25372171|NCT04979806|Cefepime|cefepime|mesh-list
25372172|NCT04979806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25372173|NCT04979806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25372174|NCT04979611|Exenatide|exenatide|mesh-list
25372175|NCT04979611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25372176|NCT04979611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372177|NCT04979611|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25372178|NCT04979611|Incretins|incretins|mesh-ancestor
25372179|NCT04979611|Hormones|hormones|mesh-ancestor
25372180|NCT04979611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25372181|NCT04979520|Brodalumab|brodalumab|mesh-list
25372182|NCT04979520|Dermatologic Agents|dermatologic agents|mesh-ancestor
25372183|NCT04979442|Trabectedin|trabectedin|mesh-list
25372184|NCT04979442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25372185|NCT04979442|Alkylating Agents|alkylating agents|mesh-ancestor
25372186|NCT04979442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372187|NCT04979442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372189|NCT04979065|Vitamins|vitamins|mesh-ancestor
25372190|NCT04979065|Micronutrients|micronutrients|mesh-ancestor
25372191|NCT04979065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372192|NCT04979065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25372193|NCT04978675|Fluorides|fluorides|mesh-list
25372194|NCT04978675|Cariostatic Agents|cariostatic agents|mesh-ancestor
25372195|NCT04978675|Protective Agents|protective agents|mesh-ancestor
25372196|NCT04978675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372197|NCT04978649|Amlodipine|amlodipine|mesh-list
25372198|NCT04978649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25372199|NCT04978649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25372200|NCT04978649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25372201|NCT04978649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372202|NCT04978649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25372203|NCT04978649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372205|NCT04978493|Ustekinumab|ustekinumab|mesh-list
25372206|NCT04978493|Dermatologic Agents|dermatologic agents|mesh-ancestor
25372207|NCT04978298|Phenelzine|phenelzine|mesh-list
25372208|NCT04978298|Ozanimod|ozanimod|mesh-list
25372209|NCT04978298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25372210|NCT04978298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372211|NCT04978298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25372212|NCT04978298|Immunologic Factors|immunologic factors|mesh-ancestor
25372213|NCT04978298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372214|NCT04978298|Antidepressive Agents|antidepressive agents|mesh-ancestor
25372215|NCT04978298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25372216|NCT04978298|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
25372217|NCT04978298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372218|NCT04978051|Icatibant|icatibant|mesh-list
25372219|NCT04978051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25372220|NCT04978051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25372221|NCT04978051|Analgesics|analgesics|mesh-ancestor
25372222|NCT04978051|Sensory System Agents|sensory system agents|mesh-ancestor
25372223|NCT04978051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25372224|NCT04978051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372225|NCT04978051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25372226|NCT04978051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25372227|NCT04978051|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
25372228|NCT04978051|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
25372229|NCT04978051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372230|NCT04978051|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25372231|NCT04978051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25372232|NCT04978051|Immunologic Factors|immunologic factors|mesh-ancestor
25372233|NCT04977986|Cannabidiol|cannabidiol|mesh-list
25372234|NCT04977986|Anticonvulsants|anticonvulsants|mesh-ancestor
25372235|NCT04976855|Buprenorphine|buprenorphine|mesh-list
25372236|NCT04976855|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25372237|NCT04976855|Naloxone|naloxone|mesh-list
25372238|NCT04976855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25372239|NCT04976855|Narcotics|narcotics|mesh-ancestor
25372240|NCT04976855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25372241|NCT04976855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372242|NCT04976855|Analgesics|analgesics|mesh-ancestor
25372243|NCT04976855|Sensory System Agents|sensory system agents|mesh-ancestor
25372244|NCT04976855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25372245|NCT04976855|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25372246|NCT04976634|Pembrolizumab|pembrolizumab|mesh-list
25372247|NCT04976634|Lenvatinib|lenvatinib|mesh-list
25372248|NCT04976634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25372249|NCT04976634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372250|NCT04976634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25372251|NCT04976634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372252|NCT04976634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372253|NCT04976257|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25372254|NCT04976257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25372255|NCT04976257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372256|NCT04975997|Dexamethasone|dexamethasone|mesh-list
25372257|NCT04975997|Bortezomib|bortezomib|mesh-list
25372258|NCT04975997|Daratumumab|daratumumab|mesh-list
25372259|NCT04975997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25372260|NCT04975997|Antiemetics|antiemetics|mesh-ancestor
25372261|NCT04975997|Autonomic Agents|autonomic agents|mesh-ancestor
25372262|NCT04975997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25372263|NCT04975997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372264|NCT04975997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25372265|NCT04975997|Glucocorticoids|glucocorticoids|mesh-ancestor
25372266|NCT04975997|Hormones|hormones|mesh-ancestor
25372267|NCT04975997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25372268|NCT04975997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25372269|NCT04975997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372270|NCT04975308|Fulvestrant|fulvestrant|mesh-list
25372271|NCT04975308|Exemestane|exemestane|mesh-list
25372272|NCT04975308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25372273|NCT04975308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372285|NCT04974528|Insulin Glargine|insulin glargine|mesh-list
25372286|NCT04974528|Insulin Aspart|insulin aspart|mesh-list
25372287|NCT04974528|Insulin Lispro|insulin lispro|mesh-list
25372288|NCT04974528|Insulin, Short-Acting|insulin, short-acting|mesh-list
25372289|NCT04974528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25372290|NCT04974528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372291|NCT04974398|Gemcitabine|gemcitabine|mesh-list
25372292|NCT04974398|Cisplatin|cisplatin|mesh-list
25372293|NCT04974398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372294|NCT04974398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25372295|NCT04974398|Antimetabolites|antimetabolites|mesh-ancestor
25372296|NCT04974398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372297|NCT04974398|Antiviral Agents|antiviral agents|mesh-ancestor
25372298|NCT04974398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25372299|NCT04974398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372300|NCT04974398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25372301|NCT04974398|Immunologic Factors|immunologic factors|mesh-ancestor
25372302|NCT04974398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372303|NCT04974281|Lenvatinib|lenvatinib|mesh-list
25372304|NCT04974281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372305|NCT04974281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25372306|NCT04974281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372307|NCT04974281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372308|NCT04973800|Simvastatin|simvastatin|mesh-list
25372309|NCT04973800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25372310|NCT04973800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25372311|NCT04973800|Antimetabolites|antimetabolites|mesh-ancestor
25372312|NCT04973800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372313|NCT04973800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25372314|NCT04973800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25372315|NCT04973800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372328|NCT04973163|Midazolam|midazolam|mesh-list
25372329|NCT04973163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25372330|NCT04973163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25372331|NCT04973163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25372332|NCT04973163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372333|NCT04973163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25372334|NCT04973163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25372335|NCT04973163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25372336|NCT04973163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25372337|NCT04973163|Anesthetics, General|anesthetics, general|mesh-ancestor
25372338|NCT04973163|Anesthetics|anesthetics|mesh-ancestor
25372339|NCT04973163|GABA Modulators|gaba modulators|mesh-ancestor
25372340|NCT04973163|GABA Agents|gaba agents|mesh-ancestor
25372341|NCT04973163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25372342|NCT04973163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372343|NCT04972968|Glucocorticoids|glucocorticoids|mesh-list
25372345|NCT04972968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25372346|NCT04972968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372347|NCT04972656|Ambrisentan|ambrisentan|mesh-list
25372348|NCT04972656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25372349|NCT04972292|Dipyrone|dipyrone|mesh-list
25372350|NCT04972292|Codeine|codeine|mesh-list
25372351|NCT04972292|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25372352|NCT04972292|Narcotics|narcotics|mesh-ancestor
25372353|NCT04972292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25372354|NCT04972292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372355|NCT04972292|Analgesics|analgesics|mesh-ancestor
25372356|NCT04972292|Sensory System Agents|sensory system agents|mesh-ancestor
25372357|NCT04972292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25372358|NCT04972292|Antitussive Agents|antitussive agents|mesh-ancestor
25372359|NCT04972292|Respiratory System Agents|respiratory system agents|mesh-ancestor
25372360|NCT04972292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25372361|NCT04972292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25372362|NCT04972292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25372363|NCT04972292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25372364|NCT04972292|Antipyretics|antipyretics|mesh-ancestor
25372365|NCT04972253|Infigratinib|infigratinib|mesh-list
25372366|NCT04972253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372367|NCT04972123|Phenylephrine|phenylephrine|mesh-list
25372368|NCT04972123|Oxymetazoline|oxymetazoline|mesh-list
25372369|NCT04972123|Caffeine|caffeine|mesh-list
25372370|NCT04972123|Capsaicin|capsaicin|mesh-list
25372371|NCT04972123|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25372372|NCT04972123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372373|NCT04972123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25372374|NCT04972123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372375|NCT04972123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372376|NCT04972123|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25372377|NCT04972123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25372378|NCT04972123|Purinergic Agents|purinergic agents|mesh-ancestor
25372379|NCT04972123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25372380|NCT04972123|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25372381|NCT04972123|Mydriatics|mydriatics|mesh-ancestor
25372382|NCT04972123|Autonomic Agents|autonomic agents|mesh-ancestor
25372383|NCT04972123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25372384|NCT04972123|Sympathomimetics|sympathomimetics|mesh-ancestor
25372385|NCT04972123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25372386|NCT04972123|Nasal Decongestants|nasal decongestants|mesh-ancestor
25372387|NCT04972123|Respiratory System Agents|respiratory system agents|mesh-ancestor
25372388|NCT04972123|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25372389|NCT04972123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25372390|NCT04972123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25372391|NCT04972123|Adrenergic Agents|adrenergic agents|mesh-ancestor
25372392|NCT04972123|Protective Agents|protective agents|mesh-ancestor
25372393|NCT04972123|Antipruritics|antipruritics|mesh-ancestor
25372394|NCT04972123|Dermatologic Agents|dermatologic agents|mesh-ancestor
25372395|NCT04972123|Sensory System Agents|sensory system agents|mesh-ancestor
25372408|NCT04971499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372409|NCT04971499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25372417|NCT04970407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25372418|NCT04970407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25372419|NCT04970407|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25372420|NCT04970407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25372421|NCT04970407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25372422|NCT04970407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372423|NCT04970407|Cholinergic Agents|cholinergic agents|mesh-ancestor
25372424|NCT04970407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25372425|NCT04970407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372426|NCT04970407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25372427|NCT04970407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25372428|NCT04970355|Erenumab|erenumab|mesh-list
25372429|NCT04970355|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
25372430|NCT04970355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372431|NCT04970355|Analgesics|analgesics|mesh-ancestor
25372432|NCT04970355|Sensory System Agents|sensory system agents|mesh-ancestor
25372433|NCT04970355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25372434|NCT04970355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372435|NCT04970108|Empagliflozin|empagliflozin|mesh-list
25372436|NCT04970108|Telmisartan|telmisartan|mesh-list
25372437|NCT04970108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25372438|NCT04970108|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25372439|NCT04970108|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25372440|NCT04970108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372441|NCT04970108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25372442|NCT04970108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25372443|NCT04970108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372444|NCT04969991|Varespladib methyl|varespladib methyl|mesh-list
25372445|NCT04969991|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
25372446|NCT04969991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372447|NCT04969991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372449|NCT04969887|Ipilimumab|ipilimumab|mesh-list
25372450|NCT04969887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25372451|NCT04969887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372452|NCT04969887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25372453|NCT04969887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372454|NCT04969510|Pramoxine|pramoxine|mesh-list
25372455|NCT04969510|Anesthetics, Local|anesthetics, local|mesh-ancestor
25372456|NCT04969510|Anesthetics|anesthetics|mesh-ancestor
25372457|NCT04969510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25372458|NCT04969510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372459|NCT04969510|Sensory System Agents|sensory system agents|mesh-ancestor
25372460|NCT04969510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25372461|NCT04969224|Ivacaftor|ivacaftor|mesh-list
25372462|NCT04969224|Elexacaftor|elexacaftor|mesh-list
25372463|NCT04969224|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25372464|NCT04969224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25372465|NCT04969224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372466|NCT04969198|Nicotine|nicotine|mesh-list
25372467|NCT04969198|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25372468|NCT04969198|Autonomic Agents|autonomic agents|mesh-ancestor
25372469|NCT04969198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25372470|NCT04969198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372471|NCT04969198|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25372472|NCT04969198|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25372473|NCT04969198|Cholinergic Agents|cholinergic agents|mesh-ancestor
25372474|NCT04969198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25372475|NCT04969198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372476|NCT04969120|Metoclopramide|metoclopramide|mesh-list
25372477|NCT04969120|Antiemetics|antiemetics|mesh-ancestor
25372478|NCT04969120|Autonomic Agents|autonomic agents|mesh-ancestor
25372479|NCT04969120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25372480|NCT04969120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372481|NCT04969120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25372482|NCT04969120|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25372483|NCT04969120|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25372484|NCT04969120|Dopamine Agents|dopamine agents|mesh-ancestor
25372485|NCT04969120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25372486|NCT04969120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372487|NCT04968015|Cytarabine|cytarabine|mesh-list
25372488|NCT04968015|Venetoclax|venetoclax|mesh-list
25372489|NCT04968015|Idarubicin|idarubicin|mesh-list
25372490|NCT04968015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25372491|NCT04968015|Antimetabolites|antimetabolites|mesh-ancestor
25372492|NCT04968015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372493|NCT04968015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372494|NCT04968015|Antiviral Agents|antiviral agents|mesh-ancestor
25372495|NCT04968015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25372496|NCT04968015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25372497|NCT04968015|Immunologic Factors|immunologic factors|mesh-ancestor
25372498|NCT04968015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372499|NCT04968015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25372500|NCT04968015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25372501|NCT04968015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25372502|NCT04968015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372503|NCT04967664|Capsaicin|capsaicin|mesh-list
25372504|NCT04967664|Antipruritics|antipruritics|mesh-ancestor
25372505|NCT04967664|Dermatologic Agents|dermatologic agents|mesh-ancestor
25372506|NCT04967664|Sensory System Agents|sensory system agents|mesh-ancestor
25372507|NCT04967664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25372508|NCT04967664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372509|NCT04967495|Sorafenib|sorafenib|mesh-list
25372510|NCT04967495|Lenvatinib|lenvatinib|mesh-list
25372511|NCT04967495|Chlorotrianisene|chlorotrianisene|mesh-list
25372512|NCT04967495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372513|NCT04967495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25372514|NCT04967495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372515|NCT04967495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372516|NCT04967495|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
25372518|NCT04967495|Hormones|hormones|mesh-ancestor
25372519|NCT04967495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25372520|NCT04967495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372521|NCT04967495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25372522|NCT04967248|Fulvestrant|fulvestrant|mesh-list
25372523|NCT04967248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25372524|NCT04967248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372525|NCT04967248|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25372526|NCT04967248|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25372527|NCT04967248|Hormone Antagonists|hormone antagonists|mesh-ancestor
25372528|NCT04967248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25372529|NCT04967248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372530|NCT04966702|Ivermectin|ivermectin|mesh-list
25372531|NCT04966702|Albendazole|albendazole|mesh-list
25372532|NCT04966702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25372533|NCT04966702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25372534|NCT04966702|Anthelmintics|anthelmintics|mesh-ancestor
25372535|NCT04966702|Anticestodal Agents|anticestodal agents|mesh-ancestor
25372536|NCT04966702|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25372537|NCT04966702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25372538|NCT04966702|Tubulin Modulators|tubulin modulators|mesh-ancestor
25372539|NCT04966702|Antimitotic Agents|antimitotic agents|mesh-ancestor
25372540|NCT04966702|Mitosis Modulators|mitosis modulators|mesh-ancestor
25372541|NCT04966702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372542|NCT04966702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372543|NCT04966585|Posaconazole|posaconazole|mesh-list
25372544|NCT04966585|Antifungal Agents|antifungal agents|mesh-ancestor
25372545|NCT04966585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25372546|NCT04966585|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25372547|NCT04966585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25372548|NCT04966585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25372549|NCT04966585|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25372550|NCT04966585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25372551|NCT04966585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372552|NCT04966585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372553|NCT04966585|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25372554|NCT04966585|Hormone Antagonists|hormone antagonists|mesh-ancestor
25372555|NCT04966585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25372556|NCT04966585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372557|NCT04965701|Osimertinib|osimertinib|mesh-list
25372558|NCT04965701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372636|NCT04964934|Hormones|hormones|mesh-list
25372559|NCT04965701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25372560|NCT04965701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372561|NCT04965701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372562|NCT04965597|Methotrexate|methotrexate|mesh-list
25372563|NCT04965597|Fludarabine phosphate|fludarabine phosphate|mesh-list
25372564|NCT04965597|Fludarabine|fludarabine|mesh-list
25372565|NCT04965597|Treosulfan|treosulfan|mesh-list
25372566|NCT04965597|Busulfan|busulfan|mesh-list
25372567|NCT04965597|Tacrolimus|tacrolimus|mesh-list
25372568|NCT04965597|Thymoglobulin|thymoglobulin|mesh-list
25372569|NCT04965597|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25372570|NCT04965597|Immunoglobulins|immunoglobulins|mesh-list
25372571|NCT04965597|Antibodies|antibodies|mesh-list
25372572|NCT04965597|gamma-Globulins|gamma-globulins|mesh-list
25372573|NCT04965597|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25372574|NCT04965597|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25372575|NCT04965597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25372576|NCT04965597|Abortifacient Agents|abortifacient agents|mesh-ancestor
25372577|NCT04965597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25372578|NCT04965597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372579|NCT04965597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25372580|NCT04965597|Antimetabolites|antimetabolites|mesh-ancestor
25372581|NCT04965597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372582|NCT04965597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372583|NCT04965597|Dermatologic Agents|dermatologic agents|mesh-ancestor
25372584|NCT04965597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372585|NCT04965597|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25372586|NCT04965597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25372587|NCT04965597|Immunologic Factors|immunologic factors|mesh-ancestor
25372588|NCT04965597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25372589|NCT04965597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25372590|NCT04965597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25372591|NCT04965597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25372592|NCT04965597|Alkylating Agents|alkylating agents|mesh-ancestor
25372593|NCT04965597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25372594|NCT04965493|Rituximab|rituximab|mesh-list
25372595|NCT04965493|Venetoclax|venetoclax|mesh-list
25372596|NCT04965493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25372597|NCT04965493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372598|NCT04965493|Immunologic Factors|immunologic factors|mesh-ancestor
25372599|NCT04965493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372600|NCT04965493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25372601|NCT04965181|Nicotine|nicotine|mesh-list
25372602|NCT04965181|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25372603|NCT04965181|Autonomic Agents|autonomic agents|mesh-ancestor
25372604|NCT04965181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25372605|NCT04965181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372606|NCT04965181|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25372607|NCT04965181|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25372608|NCT04965181|Cholinergic Agents|cholinergic agents|mesh-ancestor
25372609|NCT04965181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25372610|NCT04965181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372611|NCT04965116|Contraceptive Agents|contraceptive agents|mesh-list
25372612|NCT04965116|Progestins|progestins|mesh-list
25372613|NCT04965116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25372614|NCT04965116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372615|NCT04965116|Hormones|hormones|mesh-ancestor
25372616|NCT04965116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25372617|NCT04965090|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
25372618|NCT04965090|Lazertinib|lazertinib|mesh-list
25372619|NCT04965090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25372620|NCT04965090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372621|NCT04965090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372622|NCT04965090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25372623|NCT04965090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372624|NCT04965077|Antibodies|antibodies|mesh-list
25372625|NCT04965077|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25372626|NCT04965077|Immunologic Factors|immunologic factors|mesh-ancestor
25372627|NCT04965077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372628|NCT04965064|Capecitabine|capecitabine|mesh-list
25372629|NCT04965064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25372630|NCT04965064|Antimetabolites|antimetabolites|mesh-ancestor
25372631|NCT04965064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372632|NCT04965064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372633|NCT04964934|Letrozole|letrozole|mesh-list
25372634|NCT04964934|Palbociclib|palbociclib|mesh-list
25372635|NCT04964934|Anastrozole|anastrozole|mesh-list
25372637|NCT04964934|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25372638|NCT04964934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25372639|NCT04964934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372640|NCT04964934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372641|NCT04964934|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25372642|NCT04964934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25372643|NCT04964934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372644|NCT04964934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372645|NCT04964934|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25372646|NCT04964934|Hormone Antagonists|hormone antagonists|mesh-ancestor
25372647|NCT04964934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25372648|NCT04964934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25372649|NCT04964505|Azacitidine|azacitidine|mesh-list
25372650|NCT04964505|Venetoclax|venetoclax|mesh-list
25372651|NCT04964505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25372652|NCT04964505|Antimetabolites|antimetabolites|mesh-ancestor
25372653|NCT04964505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372654|NCT04964505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372655|NCT04964505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372656|NCT04964427|Methylphenidate|methylphenidate|mesh-list
25372657|NCT04964427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25372658|NCT04964427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372659|NCT04964427|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25372660|NCT04964427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25372661|NCT04964427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25372662|NCT04964427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372663|NCT04964427|Dopamine Agents|dopamine agents|mesh-ancestor
25372664|NCT04964427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25372665|NCT04964128|Insulin|insulin|mesh-list
25372666|NCT04964128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25372667|NCT04964128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372668|NCT04964063|Listerine|listerine|mesh-list
25372669|NCT04964063|Fluorides|fluorides|mesh-list
25372670|NCT04964063|Sodium Fluoride|sodium fluoride|mesh-list
25372671|NCT04964063|Cariostatic Agents|cariostatic agents|mesh-ancestor
25372672|NCT04964063|Protective Agents|protective agents|mesh-ancestor
25372673|NCT04964063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372674|NCT04964063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25372675|NCT04964063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25372676|NCT04963764|Amoxicillin|amoxicillin|mesh-list
25372677|NCT04963764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25372678|NCT04963764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25372679|NCT04963725|Ustekinumab|ustekinumab|mesh-list
25372680|NCT04963725|Dermatologic Agents|dermatologic agents|mesh-ancestor
25372681|NCT04963439|Macitentan|macitentan|mesh-list
25372682|NCT04963439|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25372683|NCT04963439|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25372684|NCT04963439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372685|NCT04963439|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25372686|NCT04963296|Acetaminophen|acetaminophen|mesh-list
25372687|NCT04963296|Diphenhydramine|diphenhydramine|mesh-list
25372688|NCT04963296|Promethazine|promethazine|mesh-list
25372689|NCT04963296|Methylprednisolone|methylprednisolone|mesh-list
25372690|NCT04963296|Obinutuzumab|obinutuzumab|mesh-list
25372691|NCT04963296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25372692|NCT04963296|Analgesics|analgesics|mesh-ancestor
25372693|NCT04963296|Sensory System Agents|sensory system agents|mesh-ancestor
25372694|NCT04963296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25372695|NCT04963296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372696|NCT04963296|Antipyretics|antipyretics|mesh-ancestor
25372697|NCT04963296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25372698|NCT04963296|Antiemetics|antiemetics|mesh-ancestor
25372699|NCT04963296|Autonomic Agents|autonomic agents|mesh-ancestor
25372700|NCT04963296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25372701|NCT04963296|Glucocorticoids|glucocorticoids|mesh-ancestor
25372702|NCT04963296|Hormones|hormones|mesh-ancestor
25372703|NCT04963296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25372704|NCT04963296|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25372705|NCT04963296|Protective Agents|protective agents|mesh-ancestor
25372706|NCT04963296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372707|NCT04963296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25372708|NCT04963296|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25372709|NCT04963296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25372710|NCT04963296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25372711|NCT04963296|Anesthetics, Local|anesthetics, local|mesh-ancestor
25372712|NCT04963296|Anesthetics|anesthetics|mesh-ancestor
25372713|NCT04963296|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25372714|NCT04963296|Histamine Antagonists|histamine antagonists|mesh-ancestor
25372715|NCT04963296|Histamine Agents|histamine agents|mesh-ancestor
25372716|NCT04963296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25372717|NCT04963296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372718|NCT04963296|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25372719|NCT04963296|Antipruritics|antipruritics|mesh-ancestor
25372720|NCT04963296|Dermatologic Agents|dermatologic agents|mesh-ancestor
25372721|NCT04963153|Immunoconjugates|immunoconjugates|mesh-list
25372722|NCT04963153|Immunologic Factors|immunologic factors|mesh-ancestor
25372723|NCT04963153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372724|NCT04962126|Atezolizumab|atezolizumab|mesh-list
25372725|NCT04962126|Obinutuzumab|obinutuzumab|mesh-list
25372726|NCT04962126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25372727|NCT04962126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372728|NCT04962126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25372729|NCT04961281|Triamcinolone|triamcinolone|mesh-list
25372730|NCT04961281|Dexmedetomidine|dexmedetomidine|mesh-list
25372731|NCT04961281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25372732|NCT04961281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25372733|NCT04961281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372734|NCT04961281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25372735|NCT04961281|Analgesics|analgesics|mesh-ancestor
25372736|NCT04961281|Sensory System Agents|sensory system agents|mesh-ancestor
25372737|NCT04961281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25372738|NCT04961281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25372739|NCT04961281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25372740|NCT04961281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25372741|NCT04961281|Adrenergic Agents|adrenergic agents|mesh-ancestor
25372742|NCT04961281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25372743|NCT04961281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372744|NCT04961281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25372745|NCT04961281|Glucocorticoids|glucocorticoids|mesh-ancestor
25372746|NCT04961281|Hormones|hormones|mesh-ancestor
25372747|NCT04961281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25372748|NCT04960709|Durvalumab|durvalumab|mesh-list
25372749|NCT04960709|Tremelimumab|tremelimumab|mesh-list
25372750|NCT04960709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25372751|NCT04960709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372752|NCT04960202|Ritonavir|ritonavir|mesh-list
25372753|NCT04960202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25372754|NCT04960202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25372755|NCT04960202|Protease Inhibitors|protease inhibitors|mesh-ancestor
25372756|NCT04960202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372757|NCT04960202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372758|NCT04960202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25372759|NCT04960202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25372760|NCT04960202|Antiviral Agents|antiviral agents|mesh-ancestor
25372761|NCT04960202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25372762|NCT04960202|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25372763|NCT04960202|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25372764|NCT04959981|Osimertinib|osimertinib|mesh-list
25372765|NCT04959981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372766|NCT04959981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25372767|NCT04959981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372768|NCT04959981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372769|NCT04959799|Dalbavancin|dalbavancin|mesh-list
25372770|NCT04959799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25372771|NCT04959799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25372773|NCT04959331|Nitrofurantoin|nitrofurantoin|mesh-list
25372774|NCT04959331|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
25372775|NCT04959331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25372776|NCT04959331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25372777|NCT04959331|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25372778|NCT04959331|Renal Agents|renal agents|mesh-ancestor
25372779|NCT04959266|Itraconazole|itraconazole|mesh-list
25372780|NCT04959266|Rifampin|rifampin|mesh-list
25372781|NCT04959266|Omeprazole|omeprazole|mesh-list
25372782|NCT04959266|Adavosertib|adavosertib|mesh-list
25372783|NCT04959266|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25372784|NCT04959266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25372785|NCT04959266|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25372786|NCT04959266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372787|NCT04959266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372788|NCT04959266|Antifungal Agents|antifungal agents|mesh-ancestor
25372789|NCT04959266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25372790|NCT04959266|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25372791|NCT04959266|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25372792|NCT04959266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25372793|NCT04959266|Hormone Antagonists|hormone antagonists|mesh-ancestor
25372794|NCT04959266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25372795|NCT04959266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372796|NCT04959266|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25372797|NCT04959266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25372798|NCT04959266|Antitubercular Agents|antitubercular agents|mesh-ancestor
25372799|NCT04959266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25372800|NCT04959266|Leprostatic Agents|leprostatic agents|mesh-ancestor
25372801|NCT04959266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25372802|NCT04959266|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25372803|NCT04959266|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25372804|NCT04959266|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25372805|NCT04959266|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25372806|NCT04959266|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25372807|NCT04959266|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25372808|NCT04959175|Mycophenolic Acid|mycophenolic acid|mesh-list
25372809|NCT04959175|Sirolimus|sirolimus|mesh-list
25372810|NCT04959175|Cyclophosphamide|cyclophosphamide|mesh-list
25372811|NCT04959175|Fludarabine|fludarabine|mesh-list
25372812|NCT04959175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25372813|NCT04959175|Immunologic Factors|immunologic factors|mesh-ancestor
25372814|NCT04959175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372815|NCT04959175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25372816|NCT04959175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25372817|NCT04959175|Alkylating Agents|alkylating agents|mesh-ancestor
25372818|NCT04959175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372819|NCT04959175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372820|NCT04959175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25372821|NCT04959175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25372822|NCT04959175|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25372823|NCT04959175|Antitubercular Agents|antitubercular agents|mesh-ancestor
25372824|NCT04959175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25372825|NCT04959175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25372826|NCT04959175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372827|NCT04959175|Antifungal Agents|antifungal agents|mesh-ancestor
25372828|NCT04958785|Paclitaxel|paclitaxel|mesh-list
25372829|NCT04958785|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25372830|NCT04958785|Magrolimab|magrolimab|mesh-list
25372831|NCT04958785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25372832|NCT04958785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372833|NCT04958785|Tubulin Modulators|tubulin modulators|mesh-ancestor
25372834|NCT04958785|Antimitotic Agents|antimitotic agents|mesh-ancestor
25372835|NCT04958785|Mitosis Modulators|mitosis modulators|mesh-ancestor
25372836|NCT04958785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372837|NCT04958785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25372838|NCT04958226|Midazolam|midazolam|mesh-list
25372839|NCT04958226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25372840|NCT04958226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25372841|NCT04958226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25372842|NCT04958226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372843|NCT04958226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25372844|NCT04958226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25372845|NCT04958226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25372846|NCT04958226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25372847|NCT04958226|Anesthetics, General|anesthetics, general|mesh-ancestor
25372848|NCT04958226|Anesthetics|anesthetics|mesh-ancestor
25372849|NCT04958226|GABA Modulators|gaba modulators|mesh-ancestor
25372850|NCT04958226|GABA Agents|gaba agents|mesh-ancestor
25372851|NCT04958226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25372852|NCT04958226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372853|NCT04957758|Varenicline|varenicline|mesh-list
25372854|NCT04957758|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25372855|NCT04957758|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25372856|NCT04957758|Cholinergic Agents|cholinergic agents|mesh-ancestor
25372857|NCT04957758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25372858|NCT04957758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372859|NCT04957758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372860|NCT04957615|Nivolumab|nivolumab|mesh-list
25372861|NCT04957615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25372862|NCT04957615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372863|NCT04957615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25372864|NCT04957615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372865|NCT04956692|Paclitaxel|paclitaxel|mesh-list
25372866|NCT04956692|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25372867|NCT04956692|Cisplatin|cisplatin|mesh-list
25372868|NCT04956692|Carboplatin|carboplatin|mesh-list
25372869|NCT04956692|Pembrolizumab|pembrolizumab|mesh-list
25372870|NCT04956692|Pemetrexed|pemetrexed|mesh-list
25372871|NCT04956692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25372872|NCT04956692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372873|NCT04956692|Tubulin Modulators|tubulin modulators|mesh-ancestor
25372874|NCT04956692|Antimitotic Agents|antimitotic agents|mesh-ancestor
25372875|NCT04956692|Mitosis Modulators|mitosis modulators|mesh-ancestor
25372876|NCT04956692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372877|NCT04956692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25372878|NCT04956692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372879|NCT04956692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25372880|NCT04956692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25372881|NCT04956640|Pembrolizumab|pembrolizumab|mesh-list
25372882|NCT04956640|Cetuximab|cetuximab|mesh-list
25372883|NCT04956640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
25372884|NCT04956640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25372885|NCT04956640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372886|NCT04956640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25372887|NCT04956640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372888|NCT04956640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372889|NCT04956432|Allopurinol|allopurinol|mesh-list
25372890|NCT04956432|Antimetabolites|antimetabolites|mesh-ancestor
25372891|NCT04956432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372892|NCT04956432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372893|NCT04956432|Gout Suppressants|gout suppressants|mesh-ancestor
25372894|NCT04956432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25372895|NCT04956432|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25372897|NCT04956432|Protective Agents|protective agents|mesh-ancestor
25372898|NCT04956432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372899|NCT04956263|Dapagliflozin|dapagliflozin|mesh-list
25372900|NCT04956263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25372901|NCT04956263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372902|NCT04956263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25372903|NCT04956263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372904|NCT04955743|Pembrolizumab|pembrolizumab|mesh-list
25372905|NCT04955743|Lenvatinib|lenvatinib|mesh-list
25372906|NCT04955743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25372907|NCT04955743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372908|NCT04955743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25372909|NCT04955743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372910|NCT04955743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372911|NCT04955574|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25372912|NCT04955574|Metronidazole|metronidazole|mesh-list
25372913|NCT04955574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25372914|NCT04955574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25372915|NCT04955574|Antitubercular Agents|antitubercular agents|mesh-ancestor
25372916|NCT04955574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25372917|NCT04955574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25372918|NCT04954820|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25372919|NCT04954820|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25372920|NCT04954820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372921|NCT04954664|Dimenhydrinate|dimenhydrinate|mesh-list
25372922|NCT04954664|Antiemetics|antiemetics|mesh-ancestor
25372923|NCT04954664|Autonomic Agents|autonomic agents|mesh-ancestor
25372924|NCT04954664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25372925|NCT04954664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372926|NCT04954664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25372927|NCT04954664|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25372928|NCT04954664|Histamine Antagonists|histamine antagonists|mesh-ancestor
25372929|NCT04954664|Histamine Agents|histamine agents|mesh-ancestor
25372930|NCT04954664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25372931|NCT04954664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372933|NCT04954287|Immunologic Factors|immunologic factors|mesh-ancestor
25372934|NCT04954287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372935|NCT04954196|Amlodipine|amlodipine|mesh-list
25372936|NCT04954196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25372937|NCT04954196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25372938|NCT04954196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25372939|NCT04954196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372940|NCT04954196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25372941|NCT04954196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372942|NCT04954196|Vasodilator Agents|vasodilator agents|mesh-ancestor
25372943|NCT04953962|Cisplatin|cisplatin|mesh-list
25372944|NCT04953962|Nivolumab|nivolumab|mesh-list
25372945|NCT04953962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372946|NCT04953962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25372947|NCT04953962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25372948|NCT04953962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372949|NCT04953923|Moxifloxacin|moxifloxacin|mesh-list
25372950|NCT04953923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25372951|NCT04953923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25372952|NCT04953923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25372953|NCT04953923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25372954|NCT04953923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372955|NCT04953923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372956|NCT04953923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372957|NCT04953156|Nitroglycerin|nitroglycerin|mesh-list
25372958|NCT04953156|Dexmedetomidine|dexmedetomidine|mesh-list
25372959|NCT04953156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25372960|NCT04953156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25372961|NCT04953156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372962|NCT04953156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25372963|NCT04953156|Analgesics|analgesics|mesh-ancestor
25372964|NCT04953156|Sensory System Agents|sensory system agents|mesh-ancestor
25372965|NCT04953156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25372966|NCT04953156|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25372967|NCT04953156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25372968|NCT04953156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25372969|NCT04953156|Adrenergic Agents|adrenergic agents|mesh-ancestor
25372970|NCT04953156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25372971|NCT04953156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372972|NCT04953156|Vasodilator Agents|vasodilator agents|mesh-ancestor
25372973|NCT04953130|Vaccines|vaccines|mesh-list
25372974|NCT04953130|Immunologic Factors|immunologic factors|mesh-ancestor
25372975|NCT04953130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372976|NCT04953104|Nivolumab|nivolumab|mesh-list
25372977|NCT04953104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25372978|NCT04953104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372979|NCT04953104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25372980|NCT04953104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372981|NCT04953052|Imatinib Mesylate|imatinib mesylate|mesh-list
25372982|NCT04953052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372983|NCT04953052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25372984|NCT04953052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25372985|NCT04953052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25372986|NCT04952753|Leucovorin|leucovorin|mesh-list
25372987|NCT04952753|Bevacizumab|bevacizumab|mesh-list
25372988|NCT04952753|Oxaliplatin|oxaliplatin|mesh-list
25372989|NCT04952753|Irinotecan|irinotecan|mesh-list
25372990|NCT04952753|Levoleucovorin|levoleucovorin|mesh-list
25372991|NCT04952753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25372992|NCT04952753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25372993|NCT04952753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25372994|NCT04952753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25372995|NCT04952753|Growth Substances|growth substances|mesh-ancestor
25372996|NCT04952753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25372997|NCT04952753|Growth Inhibitors|growth inhibitors|mesh-ancestor
25372998|NCT04952753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25372999|NCT04952753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25373000|NCT04952753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373001|NCT04952753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373002|NCT04952753|Antidotes|antidotes|mesh-ancestor
25373003|NCT04952753|Protective Agents|protective agents|mesh-ancestor
25373004|NCT04952753|Vitamin B Complex|vitamin b complex|mesh-ancestor
25373005|NCT04952753|Vitamins|vitamins|mesh-ancestor
25373006|NCT04952753|Micronutrients|micronutrients|mesh-ancestor
25373007|NCT04952727|Vaccines|vaccines|mesh-list
25373008|NCT04952727|Immunologic Factors|immunologic factors|mesh-ancestor
25373009|NCT04952727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373010|NCT04951492|Olaparib|olaparib|mesh-list
25373236|NCT04942626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25373011|NCT04951492|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25373012|NCT04951492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373013|NCT04951492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373014|NCT04951492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373015|NCT04951115|Cisplatin|cisplatin|mesh-list
25373016|NCT04951115|Carboplatin|carboplatin|mesh-list
25373017|NCT04951115|Etoposide|etoposide|mesh-list
25373018|NCT04951115|Durvalumab|durvalumab|mesh-list
25373019|NCT04951115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373020|NCT04951115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25373021|NCT04951115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25373022|NCT04951115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25373023|NCT04951115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373024|NCT04951115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373025|NCT04951115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25373026|NCT04950660|Caffeine|caffeine|mesh-list
25373027|NCT04950660|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25373028|NCT04950660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373029|NCT04950660|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25373030|NCT04950660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373031|NCT04950660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373032|NCT04950660|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25373033|NCT04950660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25373034|NCT04950660|Purinergic Agents|purinergic agents|mesh-ancestor
25373035|NCT04950660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25373036|NCT04950465|Fluorides|fluorides|mesh-list
25373037|NCT04950465|Cariostatic Agents|cariostatic agents|mesh-ancestor
25373038|NCT04950465|Protective Agents|protective agents|mesh-ancestor
25373039|NCT04950465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373040|NCT04949867|Glucagon|glucagon|mesh-list
25373041|NCT04949867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25373042|NCT04949867|Hormones|hormones|mesh-ancestor
25373043|NCT04949867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25373044|NCT04949867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373045|NCT04949425|Adavosertib|adavosertib|mesh-list
25373046|NCT04949425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373047|NCT04949425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373048|NCT04949399|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25373049|NCT04949399|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25373050|NCT04949399|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25373051|NCT04949399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25373052|NCT04949399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373053|NCT04949399|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25373054|NCT04949399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25373055|NCT04949399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373056|NCT04949399|Cholinergic Agents|cholinergic agents|mesh-ancestor
25373057|NCT04949399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25373058|NCT04949256|Calcium, Dietary|calcium, dietary|mesh-list
25373059|NCT04949256|Leucovorin|leucovorin|mesh-list
25373060|NCT04949256|Pembrolizumab|pembrolizumab|mesh-list
25373061|NCT04949256|Oxaliplatin|oxaliplatin|mesh-list
25373062|NCT04949256|Lenvatinib|lenvatinib|mesh-list
25373063|NCT04949256|Calcium|calcium|mesh-list
25373064|NCT04949256|Levoleucovorin|levoleucovorin|mesh-list
25373065|NCT04949256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373066|NCT04949256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373067|NCT04949256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25373068|NCT04949256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373069|NCT04949256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25373070|NCT04949256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25373071|NCT04949256|Antidotes|antidotes|mesh-ancestor
25373072|NCT04949256|Protective Agents|protective agents|mesh-ancestor
25373073|NCT04949256|Vitamin B Complex|vitamin b complex|mesh-ancestor
25373074|NCT04949256|Vitamins|vitamins|mesh-ancestor
25373075|NCT04949256|Micronutrients|micronutrients|mesh-ancestor
25373076|NCT04949256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25373077|NCT04949256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373078|NCT04948489|Norethindrone|norethindrone|mesh-list
25373079|NCT04948489|Norethindrone Acetate|norethindrone acetate|mesh-list
25373080|NCT04948489|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25373081|NCT04948489|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25373082|NCT04948489|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25373083|NCT04948489|Contraceptive Agents|contraceptive agents|mesh-ancestor
25373084|NCT04948489|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25373085|NCT04948489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373086|NCT04948489|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25373087|NCT04948489|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25373088|NCT04947514|Tranexamic Acid|tranexamic acid|mesh-list
25373089|NCT04947514|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25373090|NCT04947514|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25373091|NCT04947514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373092|NCT04947514|Hemostatics|hemostatics|mesh-ancestor
25373093|NCT04947514|Coagulants|coagulants|mesh-ancestor
25373094|NCT04947501|Cyclophosphamide|cyclophosphamide|mesh-list
25373095|NCT04947501|Ifosfamide|ifosfamide|mesh-list
25373096|NCT04947501|Carboplatin|carboplatin|mesh-list
25373097|NCT04947501|Doxorubicin|doxorubicin|mesh-list
25373098|NCT04947501|Etoposide|etoposide|mesh-list
25373099|NCT04947501|Vincristine|vincristine|mesh-list
25373100|NCT04947501|Topotecan|topotecan|mesh-list
25373101|NCT04947501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25373102|NCT04947501|Immunologic Factors|immunologic factors|mesh-ancestor
25373103|NCT04947501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373104|NCT04947501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25373105|NCT04947501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25373106|NCT04947501|Alkylating Agents|alkylating agents|mesh-ancestor
25373107|NCT04947501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373108|NCT04947501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373109|NCT04947501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25373110|NCT04947501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25373111|NCT04947501|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25373112|NCT04947501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25373113|NCT04947501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373114|NCT04947501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25373115|NCT04947501|Tubulin Modulators|tubulin modulators|mesh-ancestor
25373116|NCT04947501|Antimitotic Agents|antimitotic agents|mesh-ancestor
25373117|NCT04947501|Mitosis Modulators|mitosis modulators|mesh-ancestor
25373118|NCT04947501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25373119|NCT04947254|Ascorbic Acid|ascorbic acid|mesh-list
25373120|NCT04947254|Prednisone|prednisone|mesh-list
25373121|NCT04947254|Cortisone|cortisone|mesh-list
25373122|NCT04947254|Methyltestosterone|methyltestosterone|mesh-list
25373123|NCT04947254|Abiraterone Acetate|abiraterone acetate|mesh-list
25373124|NCT04947254|Niraparib|niraparib|mesh-list
25373125|NCT04947254|Hormones|hormones|mesh-list
25373126|NCT04947254|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
25373127|NCT04947254|Androgens|androgens|mesh-list
25373128|NCT04947254|Androgen Antagonists|androgen antagonists|mesh-list
25373129|NCT04947254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25373130|NCT04947254|Glucocorticoids|glucocorticoids|mesh-ancestor
25373131|NCT04947254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25373132|NCT04947254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373133|NCT04947254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25373134|NCT04947254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373135|NCT04947254|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25373136|NCT04947254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373137|NCT04947254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373138|NCT04947254|Hormone Antagonists|hormone antagonists|mesh-ancestor
25373139|NCT04947254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25373140|NCT04947254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25373141|NCT04947254|Antioxidants|antioxidants|mesh-ancestor
25373142|NCT04947254|Protective Agents|protective agents|mesh-ancestor
25373143|NCT04947254|Vitamins|vitamins|mesh-ancestor
25373144|NCT04947254|Micronutrients|micronutrients|mesh-ancestor
25373145|NCT04947254|Estrogens|estrogens|mesh-ancestor
25373146|NCT04947254|Anabolic Agents|anabolic agents|mesh-ancestor
25373147|NCT04947124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25373148|NCT04947124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25373149|NCT04946864|Palbociclib|palbociclib|mesh-list
25373150|NCT04946864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373151|NCT04946864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25373152|NCT04946864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373153|NCT04946864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373154|NCT04946435|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25373155|NCT04946435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25373156|NCT04946370|Pembrolizumab|pembrolizumab|mesh-list
25373157|NCT04946370|Androgens|androgens|mesh-list
25373158|NCT04946370|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25373159|NCT04946370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25373160|NCT04946370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373161|NCT04946370|Hormones|hormones|mesh-ancestor
25373162|NCT04946370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25373237|NCT04942470|Propolis|propolis|mesh-list
25373163|NCT04946370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373164|NCT04946370|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25373165|NCT04946370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373166|NCT04946305|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25373167|NCT04946305|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25373168|NCT04946305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373169|NCT04945733|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
25373170|NCT04945733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25373171|NCT04945733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373172|NCT04945148|Metformin|metformin|mesh-list
25373173|NCT04945148|Temozolomide|temozolomide|mesh-list
25373174|NCT04945148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25373175|NCT04945148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373176|NCT04945148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25373177|NCT04945148|Alkylating Agents|alkylating agents|mesh-ancestor
25373178|NCT04945148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373179|NCT04945148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373180|NCT04944290|Brimonidine Tartrate|brimonidine tartrate|mesh-list
25373181|NCT04944290|Brinzolamide|brinzolamide|mesh-list
25373182|NCT04944290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25373183|NCT04944290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25373184|NCT04944290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25373185|NCT04944290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25373186|NCT04944290|Adrenergic Agents|adrenergic agents|mesh-ancestor
25373187|NCT04944290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25373188|NCT04944290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373189|NCT04944290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373190|NCT04944290|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
25373191|NCT04944290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25404849|NCT03648021|Acetaminophen|acetaminophen|mesh-list
25373192|NCT04944095|Antibodies|antibodies|mesh-list
25373193|NCT04944095|Immunologic Factors|immunologic factors|mesh-ancestor
25373194|NCT04944095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373195|NCT04944017|Ketamine|ketamine|mesh-list
25373196|NCT04944017|Analgesics|analgesics|mesh-ancestor
25373197|NCT04944017|Sensory System Agents|sensory system agents|mesh-ancestor
25373198|NCT04944017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25373199|NCT04944017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373200|NCT04944017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25373201|NCT04944017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25373202|NCT04944017|Anesthetics, General|anesthetics, general|mesh-ancestor
25373203|NCT04944017|Anesthetics|anesthetics|mesh-ancestor
25373204|NCT04944017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25373205|NCT04944017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25373206|NCT04944017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25373207|NCT04944017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25373208|NCT04944017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373209|NCT04943848|Iodine|iodine|mesh-list
25373210|NCT04943848|Vaccines|vaccines|mesh-list
25373211|NCT04943848|Immunologic Factors|immunologic factors|mesh-ancestor
25373212|NCT04943848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373213|NCT04943848|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25373214|NCT04943848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25373215|NCT04943848|Trace Elements|trace elements|mesh-ancestor
25373216|NCT04943848|Micronutrients|micronutrients|mesh-ancestor
25373217|NCT04943224|Trametinib|trametinib|mesh-list
25373218|NCT04943224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373219|NCT04943224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25373220|NCT04943224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373221|NCT04943224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373222|NCT04943211|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25373223|NCT04943211|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25373224|NCT04943211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373225|NCT04943198|Vemurafenib|vemurafenib|mesh-list
25373226|NCT04943198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373227|NCT04943198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25373228|NCT04943198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373229|NCT04943198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373230|NCT04942626|Capecitabine|capecitabine|mesh-list
25373231|NCT04942626|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25373232|NCT04942626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25373233|NCT04942626|Antimetabolites|antimetabolites|mesh-ancestor
25373234|NCT04942626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373235|NCT04942626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373238|NCT04942470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25373239|NCT04942184|Complement Factor H|complement factor h|mesh-list
25373240|NCT04942184|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25373241|NCT04942184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25373242|NCT04942184|Immunologic Factors|immunologic factors|mesh-ancestor
25373243|NCT04942184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373244|NCT04941716|Venetoclax|venetoclax|mesh-list
25373245|NCT04941716|Acalabrutinib|acalabrutinib|mesh-list
25373246|NCT04941716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373247|NCT04941287|Atezolizumab|atezolizumab|mesh-list
25373248|NCT04941287|Immunoglobulins|immunoglobulins|mesh-list
25373249|NCT04941287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25373250|NCT04941287|Immunoglobulin G|immunoglobulin g|mesh-list
25373251|NCT04941287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373252|NCT04941287|Immunologic Factors|immunologic factors|mesh-ancestor
25373253|NCT04941287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373254|NCT04941196|Ticagrelor|ticagrelor|mesh-list
25373255|NCT04941196|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25373256|NCT04941196|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25373257|NCT04941196|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25373258|NCT04941196|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25373259|NCT04941196|Purinergic Agents|purinergic agents|mesh-ancestor
25373260|NCT04941196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25373261|NCT04941196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373262|NCT04941196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373263|NCT04940390|Dihydroergotamine|dihydroergotamine|mesh-list
25373264|NCT04940390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25373265|NCT04940390|Dopamine Agonists|dopamine agonists|mesh-ancestor
25373266|NCT04940390|Dopamine Agents|dopamine agents|mesh-ancestor
25724241|NCT02535949|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25373267|NCT04940390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25373268|NCT04940390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373269|NCT04940390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373270|NCT04940390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25373271|NCT04940390|Analgesics|analgesics|mesh-ancestor
25373272|NCT04940390|Sensory System Agents|sensory system agents|mesh-ancestor
25373273|NCT04940390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25373274|NCT04940065|Ofatumumab|ofatumumab|mesh-list
25373275|NCT04940065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373276|NCT04940052|Trametinib|trametinib|mesh-list
25373277|NCT04940052|Dabrafenib|dabrafenib|mesh-list
25373278|NCT04940052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373279|NCT04940052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25373280|NCT04940052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373281|NCT04940052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373282|NCT04940039|Risperidone|risperidone|mesh-list
25373283|NCT04940039|Paliperidone Palmitate|paliperidone palmitate|mesh-list
25373284|NCT04940039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25373285|NCT04940039|Serotonin Agents|serotonin agents|mesh-ancestor
25373286|NCT04940039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25373287|NCT04940039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373288|NCT04940039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373289|NCT04940039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25373290|NCT04940039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25373291|NCT04940039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25373292|NCT04940039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25373293|NCT04940039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25373294|NCT04940039|Dopamine Agents|dopamine agents|mesh-ancestor
25373295|NCT04940039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25373296|NCT04940039|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25373297|NCT04939987|Acetaminophen|acetaminophen|mesh-list
25373298|NCT04939987|Ketorolac|ketorolac|mesh-list
25373299|NCT04939987|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25373300|NCT04939987|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
25373301|NCT04939987|Ketamine|ketamine|mesh-list
25373302|NCT04939987|Oxycodone|oxycodone|mesh-list
25373303|NCT04939987|Gabapentin|gabapentin|mesh-list
25373304|NCT04939987|Tramadol|tramadol|mesh-list
25373305|NCT04939987|Hydrocodone|hydrocodone|mesh-list
25373306|NCT04939987|Analgesics, Opioid|analgesics, opioid|mesh-list
25373307|NCT04939987|Analgesics|analgesics|mesh-ancestor
25373308|NCT04939987|Sensory System Agents|sensory system agents|mesh-ancestor
25373309|NCT04939987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25373310|NCT04939987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373311|NCT04939987|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25373312|NCT04939987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25373313|NCT04939987|Anesthetics, General|anesthetics, general|mesh-ancestor
25373314|NCT04939987|Anesthetics|anesthetics|mesh-ancestor
25373315|NCT04939987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25373316|NCT04939987|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25373317|NCT04939987|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25373318|NCT04939987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25373319|NCT04939987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373320|NCT04939987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25373321|NCT04939987|Antipyretics|antipyretics|mesh-ancestor
25373322|NCT04939987|Narcotics|narcotics|mesh-ancestor
25373323|NCT04939987|Anticonvulsants|anticonvulsants|mesh-ancestor
25373324|NCT04939987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25373325|NCT04939987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25373326|NCT04939987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25373327|NCT04939987|Antimanic Agents|antimanic agents|mesh-ancestor
25373328|NCT04939987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25373329|NCT04939987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25373330|NCT04939987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25373331|NCT04939987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25373332|NCT04939987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373333|NCT04939987|Antitussive Agents|antitussive agents|mesh-ancestor
25373334|NCT04939987|Respiratory System Agents|respiratory system agents|mesh-ancestor
25373335|NCT04939883|Carvedilol|carvedilol|mesh-list
25373336|NCT04939883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25373337|NCT04939883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25373338|NCT04939883|Adrenergic Agents|adrenergic agents|mesh-ancestor
25373339|NCT04939883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25373340|NCT04939883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373341|NCT04939883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373342|NCT04939883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25373343|NCT04939883|Antioxidants|antioxidants|mesh-ancestor
25373344|NCT04939883|Protective Agents|protective agents|mesh-ancestor
25373345|NCT04939883|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25373346|NCT04939883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25373347|NCT04939883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25373348|NCT04939883|Vasodilator Agents|vasodilator agents|mesh-ancestor
25373349|NCT04939883|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25373350|NCT04939883|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25373351|NCT04939844|Lenalidomide|lenalidomide|mesh-list
25373352|NCT04939844|Bortezomib|bortezomib|mesh-list
25373353|NCT04939844|Immunologic Factors|immunologic factors|mesh-ancestor
25373354|NCT04939844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373355|NCT04939844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25373356|NCT04939844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25373357|NCT04939844|Growth Substances|growth substances|mesh-ancestor
25373358|NCT04939844|Growth Inhibitors|growth inhibitors|mesh-ancestor
25373359|NCT04939844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373360|NCT04939792|Vitamin D|vitamin d|mesh-list
25373361|NCT04939792|Ergocalciferols|ergocalciferols|mesh-list
25373362|NCT04939792|Cholecalciferol|cholecalciferol|mesh-list
25373363|NCT04939792|Vitamins|vitamins|mesh-list
25373364|NCT04939792|Micronutrients|micronutrients|mesh-ancestor
25373365|NCT04939792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373366|NCT04939792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25373367|NCT04939792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25373368|NCT04939701|Pembrolizumab|pembrolizumab|mesh-list
25373369|NCT04939701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25373370|NCT04939701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373371|NCT04939597|Memantine|memantine|mesh-list
25373372|NCT04939597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25373373|NCT04939597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25373374|NCT04939597|Dopamine Agents|dopamine agents|mesh-ancestor
25373377|NCT04939597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373378|NCT04939597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25373379|NCT04939597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25373380|NCT04939272|Venetoclax|venetoclax|mesh-list
25373381|NCT04939272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373382|NCT04939142|Dexamethasone|dexamethasone|mesh-list
25373383|NCT04939142|Dexamethasone acetate|dexamethasone acetate|mesh-list
25373384|NCT04939142|Bortezomib|bortezomib|mesh-list
25373385|NCT04939142|BB 1101|bb 1101|mesh-list
25373386|NCT04939142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25373387|NCT04939142|Antiemetics|antiemetics|mesh-ancestor
25373388|NCT04939142|Autonomic Agents|autonomic agents|mesh-ancestor
25373389|NCT04939142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25373390|NCT04939142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373391|NCT04939142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25373392|NCT04939142|Glucocorticoids|glucocorticoids|mesh-ancestor
25373393|NCT04939142|Hormones|hormones|mesh-ancestor
25373394|NCT04939142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25373395|NCT04939142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25373396|NCT04939142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373397|NCT04939142|Protease Inhibitors|protease inhibitors|mesh-ancestor
25373398|NCT04939142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373399|NCT04939142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373400|NCT04938856|Lamotrigine|lamotrigine|mesh-list
25373401|NCT04938856|Anticonvulsants|anticonvulsants|mesh-ancestor
25373402|NCT04938856|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25373403|NCT04938856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25373404|NCT04938856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373405|NCT04938856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25373406|NCT04938856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373407|NCT04938856|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25373408|NCT04938856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25373409|NCT04938856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25373410|NCT04938856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25373411|NCT04938856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25373415|NCT04938817|Pembrolizumab|pembrolizumab|mesh-list
25373416|NCT04938817|Lenvatinib|lenvatinib|mesh-list
25373417|NCT04938817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25373418|NCT04938817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373419|NCT04938817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25373420|NCT04938817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373421|NCT04938817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373422|NCT04937699|Aspirin|aspirin|mesh-list
25373423|NCT04937699|Clopidogrel|clopidogrel|mesh-list
25373431|NCT04937699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25373432|NCT04937699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25373433|NCT04937699|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25373434|NCT04937699|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25373435|NCT04937699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373436|NCT04937699|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25373437|NCT04937699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25373438|NCT04937699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373439|NCT04937699|Antipyretics|antipyretics|mesh-ancestor
25373440|NCT04937699|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25373441|NCT04937699|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25373442|NCT04937699|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25373443|NCT04937699|Purinergic Agents|purinergic agents|mesh-ancestor
25373444|NCT04937699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25373445|NCT04936685|Vaccines|vaccines|mesh-list
25373446|NCT04936685|Immunologic Factors|immunologic factors|mesh-ancestor
25373447|NCT04936685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373455|NCT04936230|Atezolizumab|atezolizumab|mesh-list
25373456|NCT04936230|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25373457|NCT04936230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373458|NCT04936230|Immunologic Factors|immunologic factors|mesh-ancestor
25373459|NCT04936230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373460|NCT04935931|Naltrexone|naltrexone|mesh-list
25373461|NCT04935931|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25373462|NCT04935931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25373463|NCT04935931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373464|NCT04935931|Sensory System Agents|sensory system agents|mesh-ancestor
25373465|NCT04935931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25373482|NCT04935112|Pantoprazole|pantoprazole|mesh-list
25373483|NCT04935112|Famotidine|famotidine|mesh-list
25373484|NCT04935112|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25373485|NCT04935112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25373486|NCT04935112|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25373487|NCT04935112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373488|NCT04935112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373489|NCT04935112|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
25373490|NCT04935112|Histamine Antagonists|histamine antagonists|mesh-ancestor
25373491|NCT04935112|Histamine Agents|histamine agents|mesh-ancestor
25373492|NCT04935112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25373493|NCT04935112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373494|NCT04934904|Ropivacaine|ropivacaine|mesh-list
25373495|NCT04934904|Anesthetics, Local|anesthetics, local|mesh-ancestor
25373496|NCT04934904|Anesthetics|anesthetics|mesh-ancestor
25373497|NCT04934904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25772320|NCT03678870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373498|NCT04934904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373499|NCT04934904|Sensory System Agents|sensory system agents|mesh-ancestor
25373500|NCT04934904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25373501|NCT04934748|Phenylephrine|phenylephrine|mesh-list
25373502|NCT04934748|Oxymetazoline|oxymetazoline|mesh-list
25373503|NCT04934748|Norepinephrine|norepinephrine|mesh-list
25373504|NCT04934748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25373505|NCT04934748|Mydriatics|mydriatics|mesh-ancestor
25373506|NCT04934748|Autonomic Agents|autonomic agents|mesh-ancestor
25373507|NCT04934748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25373508|NCT04934748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373509|NCT04934748|Sympathomimetics|sympathomimetics|mesh-ancestor
25373510|NCT04934748|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25373511|NCT04934748|Nasal Decongestants|nasal decongestants|mesh-ancestor
25373512|NCT04934748|Respiratory System Agents|respiratory system agents|mesh-ancestor
25373513|NCT04934748|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25373514|NCT04934748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25373515|NCT04934748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25373516|NCT04934748|Adrenergic Agents|adrenergic agents|mesh-ancestor
25373517|NCT04934748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25373518|NCT04934748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373519|NCT04934748|Protective Agents|protective agents|mesh-ancestor
25373520|NCT04934722|Pembrolizumab|pembrolizumab|mesh-list
25373521|NCT04934722|Androgens|androgens|mesh-list
25373522|NCT04934722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25373523|NCT04934722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373524|NCT04934722|Hormones|hormones|mesh-ancestor
25373525|NCT04934722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25373604|NCT04931342|Palbociclib|palbociclib|mesh-list
25373539|NCT04933942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25373540|NCT04933942|Alkylating Agents|alkylating agents|mesh-ancestor
25373541|NCT04933942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373542|NCT04933942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373544|NCT04933617|Cyclophosphamide|cyclophosphamide|mesh-list
25373545|NCT04933617|Rituximab|rituximab|mesh-list
25373546|NCT04933617|Doxorubicin|doxorubicin|mesh-list
25373547|NCT04933617|Etoposide|etoposide|mesh-list
25373548|NCT04933617|Vincristine|vincristine|mesh-list
25373549|NCT04933617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25373550|NCT04933617|Immunologic Factors|immunologic factors|mesh-ancestor
25373551|NCT04933617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373552|NCT04933617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25373553|NCT04933617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25373554|NCT04933617|Alkylating Agents|alkylating agents|mesh-ancestor
25373555|NCT04933617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373556|NCT04933617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373557|NCT04933617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25373558|NCT04933617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25373559|NCT04933617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25373560|NCT04933617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25373561|NCT04933617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25373562|NCT04933617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373563|NCT04933617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25373564|NCT04933617|Glucocorticoids|glucocorticoids|mesh-ancestor
25373565|NCT04933617|Hormones|hormones|mesh-ancestor
25373566|NCT04933617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25373567|NCT04933617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25373568|NCT04933617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25373569|NCT04933617|Tubulin Modulators|tubulin modulators|mesh-ancestor
25373570|NCT04933617|Antimitotic Agents|antimitotic agents|mesh-ancestor
25373571|NCT04933617|Mitosis Modulators|mitosis modulators|mesh-ancestor
25373585|NCT04933526|Dasatinib|dasatinib|mesh-list
25373586|NCT04933526|HH-GV-678|hh-gv-678|mesh-list
25373587|NCT04933526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373588|NCT04933526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25373589|NCT04933526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373590|NCT04933526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373591|NCT04932096|Melatonin|melatonin|mesh-list
25373592|NCT04932096|Antioxidants|antioxidants|mesh-ancestor
25373593|NCT04932096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373594|NCT04932096|Protective Agents|protective agents|mesh-ancestor
25373595|NCT04932096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373596|NCT04932096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25373597|NCT04931342|Maytansine|maytansine|mesh-list
25373598|NCT04931342|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25373599|NCT04931342|Bevacizumab|bevacizumab|mesh-list
25373600|NCT04931342|Trastuzumab|trastuzumab|mesh-list
25373601|NCT04931342|Atezolizumab|atezolizumab|mesh-list
25373602|NCT04931342|Letrozole|letrozole|mesh-list
25373603|NCT04931342|Olaparib|olaparib|mesh-list
25373606|NCT04931342|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
25373607|NCT04931342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25373608|NCT04931342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373609|NCT04931342|Tubulin Modulators|tubulin modulators|mesh-ancestor
25373610|NCT04931342|Antimitotic Agents|antimitotic agents|mesh-ancestor
25373611|NCT04931342|Mitosis Modulators|mitosis modulators|mesh-ancestor
25373612|NCT04931342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373613|NCT04931342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25373614|NCT04931342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25373615|NCT04931342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25373616|NCT04931342|Growth Substances|growth substances|mesh-ancestor
25373617|NCT04931342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373618|NCT04931342|Growth Inhibitors|growth inhibitors|mesh-ancestor
25373619|NCT04931342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25373620|NCT04931342|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25373621|NCT04931342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25373622|NCT04931342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373623|NCT04931342|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25373624|NCT04931342|Hormone Antagonists|hormone antagonists|mesh-ancestor
25373625|NCT04931342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25373626|NCT04931342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25373627|NCT04931017|Metformin|metformin|mesh-list
25373628|NCT04931017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25373629|NCT04931017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373630|NCT04930900|Epinephrine|epinephrine|mesh-list
25373631|NCT04930900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25373632|NCT04930900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25373633|NCT04930900|Adrenergic Agents|adrenergic agents|mesh-ancestor
25373634|NCT04930900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25373635|NCT04930900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373636|NCT04930900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373637|NCT04930900|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25373638|NCT04930900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25373639|NCT04930900|Autonomic Agents|autonomic agents|mesh-ancestor
25373640|NCT04930900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25373641|NCT04930900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25373642|NCT04930900|Respiratory System Agents|respiratory system agents|mesh-ancestor
25373643|NCT04930900|Mydriatics|mydriatics|mesh-ancestor
25373644|NCT04930900|Sympathomimetics|sympathomimetics|mesh-ancestor
25373645|NCT04930900|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25373646|NCT04930653|Mogamulizumab|mogamulizumab|mesh-list
25373647|NCT04930653|Immunoglobulins|immunoglobulins|mesh-list
25373648|NCT04930653|Immunoglobulin G|immunoglobulin g|mesh-list
25373649|NCT04930653|Immunologic Factors|immunologic factors|mesh-ancestor
25373650|NCT04930653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373651|NCT04930653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373652|NCT04930536|Acalabrutinib|acalabrutinib|mesh-list
25373653|NCT04930536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373654|NCT04929535|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25373655|NCT04929535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25373656|NCT04929535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25373657|NCT04929379|Fenofibrate|fenofibrate|mesh-list
25373658|NCT04929379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25373659|NCT04929379|Antimetabolites|antimetabolites|mesh-ancestor
25373660|NCT04929379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373661|NCT04929379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25373662|NCT04929223|Bevacizumab|bevacizumab|mesh-list
25373663|NCT04929223|Cetuximab|cetuximab|mesh-list
25373664|NCT04929223|Atezolizumab|atezolizumab|mesh-list
25373665|NCT04929223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25373666|NCT04929223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373667|NCT04929223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25373668|NCT04929223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25373669|NCT04929223|Growth Substances|growth substances|mesh-ancestor
25373670|NCT04929223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373671|NCT04929223|Growth Inhibitors|growth inhibitors|mesh-ancestor
25373672|NCT04929041|Paclitaxel|paclitaxel|mesh-list
25373673|NCT04929041|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25373674|NCT04929041|Carboplatin|carboplatin|mesh-list
25373675|NCT04929041|Pembrolizumab|pembrolizumab|mesh-list
25373676|NCT04929041|Nivolumab|nivolumab|mesh-list
25373677|NCT04929041|Pemetrexed|pemetrexed|mesh-list
25373678|NCT04929041|Ipilimumab|ipilimumab|mesh-list
25373679|NCT04929041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25373680|NCT04929041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373681|NCT04929041|Tubulin Modulators|tubulin modulators|mesh-ancestor
25373682|NCT04929041|Antimitotic Agents|antimitotic agents|mesh-ancestor
25373683|NCT04929041|Mitosis Modulators|mitosis modulators|mesh-ancestor
25373684|NCT04929041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373685|NCT04929041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25373686|NCT04929041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25373687|NCT04929041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373688|NCT04929041|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25373689|NCT04929041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25373690|NCT04929028|Fluorouracil|fluorouracil|mesh-list
25373691|NCT04929028|Capecitabine|capecitabine|mesh-list
25373692|NCT04929028|Nivolumab|nivolumab|mesh-list
25373693|NCT04929028|Mitomycins|mitomycins|mesh-list
25373694|NCT04929028|Mitomycin|mitomycin|mesh-list
25373695|NCT04929028|Antimetabolites|antimetabolites|mesh-ancestor
25373696|NCT04929028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373697|NCT04929028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25373698|NCT04929028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373699|NCT04929028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25373700|NCT04929028|Immunologic Factors|immunologic factors|mesh-ancestor
25373701|NCT04929028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373702|NCT04929028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25373703|NCT04929028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25373704|NCT04929028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25373705|NCT04929028|Alkylating Agents|alkylating agents|mesh-ancestor
25373706|NCT04929028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25373707|NCT04929028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373708|NCT04928846|Docetaxel|docetaxel|mesh-list
25373709|NCT04928846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373710|NCT04928846|Tubulin Modulators|tubulin modulators|mesh-ancestor
25373711|NCT04928846|Antimitotic Agents|antimitotic agents|mesh-ancestor
25373712|NCT04928846|Mitosis Modulators|mitosis modulators|mesh-ancestor
25373713|NCT04928846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373714|NCT04928820|Edetic Acid|edetic acid|mesh-list
25373715|NCT04928820|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25373716|NCT04928820|Chelating Agents|chelating agents|mesh-ancestor
25373717|NCT04928820|Sequestering Agents|sequestering agents|mesh-ancestor
25373718|NCT04928820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373719|NCT04928820|Anticoagulants|anticoagulants|mesh-ancestor
25373720|NCT04928820|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25373721|NCT04928820|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25373722|NCT04928222|Doxorubicin|doxorubicin|mesh-list
25373723|NCT04928222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25373724|NCT04928222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373725|NCT04928222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25373726|NCT04928222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25373727|NCT04928222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373728|NCT04928222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373729|NCT04927975|Upadacitinib|upadacitinib|mesh-list
25373730|NCT04927975|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
25373731|NCT04927975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25373732|NCT04927975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373733|NCT04927975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373734|NCT04927975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25373735|NCT04927312|Metronidazole|metronidazole|mesh-list
25373736|NCT04927312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25373737|NCT04927312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25373738|NCT04927312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25373739|NCT04927312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25373740|NCT04926844|Midazolam|midazolam|mesh-list
25373741|NCT04926844|Levetiracetam|levetiracetam|mesh-list
25373742|NCT04926844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25373743|NCT04926844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25373744|NCT04926844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25373745|NCT04926844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373746|NCT04926844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25373747|NCT04926844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25373748|NCT04926844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25373749|NCT04926844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25373750|NCT04926844|Anesthetics, General|anesthetics, general|mesh-ancestor
25373751|NCT04926844|Anesthetics|anesthetics|mesh-ancestor
25373752|NCT04926844|GABA Modulators|gaba modulators|mesh-ancestor
25373753|NCT04926844|GABA Agents|gaba agents|mesh-ancestor
25373754|NCT04926844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25373755|NCT04926844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373756|NCT04926844|Anticonvulsants|anticonvulsants|mesh-ancestor
25373760|NCT04926818|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25373761|NCT04926818|Siponimod|siponimod|mesh-list
25373762|NCT04926818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373763|NCT04926818|Immunologic Factors|immunologic factors|mesh-ancestor
25373764|NCT04926818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373765|NCT04926818|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25373766|NCT04926818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373767|NCT04926818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25373768|NCT04926545|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
25373769|NCT04926545|Fluorouracil|fluorouracil|mesh-list
25373770|NCT04926545|Irinotecan|irinotecan|mesh-list
25373772|NCT04926545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373773|NCT04926545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25373774|NCT04926545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373775|NCT04926545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25373776|NCT04926545|Immunologic Factors|immunologic factors|mesh-ancestor
25373777|NCT04926545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373778|NCT04926545|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25373779|NCT04926545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25373780|NCT04926545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373781|NCT04926545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25373782|NCT04926545|Hormone Antagonists|hormone antagonists|mesh-ancestor
25373783|NCT04926545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25373784|NCT04926545|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25373785|NCT04926545|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25373786|NCT04926545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25373787|NCT04925752|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25373788|NCT04925752|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25373789|NCT04925752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25373790|NCT04925752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373791|NCT04925752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373792|NCT04925752|Antiviral Agents|antiviral agents|mesh-ancestor
25373793|NCT04925752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25373794|NCT04925752|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25373795|NCT04925752|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25373796|NCT04925505|Anesthetics|anesthetics|mesh-list
25373797|NCT04925505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25373798|NCT04925505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373799|NCT04925479|Niacinamide|niacinamide|mesh-list
25373800|NCT04925479|Vitamin B Complex|vitamin b complex|mesh-ancestor
25373801|NCT04925479|Vitamins|vitamins|mesh-ancestor
25373802|NCT04925479|Micronutrients|micronutrients|mesh-ancestor
25373803|NCT04925479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373804|NCT04925375|Abatacept|abatacept|mesh-list
25373805|NCT04925375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25373806|NCT04925375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373807|NCT04925375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373808|NCT04925375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25373809|NCT04925375|Immunologic Factors|immunologic factors|mesh-ancestor
25373810|NCT04925375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373811|NCT04925375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25373812|NCT04925076|Ethanol|ethanol|mesh-list
25373813|NCT04925076|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25373814|NCT04925076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25373815|NCT04925076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25373816|NCT04925076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373820|NCT04924322|Enoxaparin|enoxaparin|mesh-list
25373821|NCT04924322|Anticoagulants|anticoagulants|mesh-ancestor
25373822|NCT04924322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25373823|NCT04924322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25373824|NCT04924322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373825|NCT04924257|Esketamine|esketamine|mesh-list
25373826|NCT04924257|Antidepressive Agents|antidepressive agents|mesh-ancestor
25373827|NCT04924257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25373828|NCT04924101|Cisplatin|cisplatin|mesh-list
25373829|NCT04924101|Carboplatin|carboplatin|mesh-list
25373830|NCT04924101|Pembrolizumab|pembrolizumab|mesh-list
25373831|NCT04924101|Etoposide|etoposide|mesh-list
25373832|NCT04924101|Etoposide phosphate|etoposide phosphate|mesh-list
25373834|NCT04924101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25772321|NCT03678870|Analgesics|analgesics|mesh-ancestor
25373835|NCT04924101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25373836|NCT04924101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25373837|NCT04924101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25373838|NCT04924101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25373839|NCT04924101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373840|NCT04924101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373841|NCT04924101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25373842|NCT04924062|Gemcitabine|gemcitabine|mesh-list
25373844|NCT04924062|Pembrolizumab|pembrolizumab|mesh-list
25373845|NCT04924062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373846|NCT04924062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25373847|NCT04924062|Antimetabolites|antimetabolites|mesh-ancestor
25373848|NCT04924062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373849|NCT04924062|Antiviral Agents|antiviral agents|mesh-ancestor
25373850|NCT04924062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25373851|NCT04924062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373852|NCT04924062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25373853|NCT04924062|Immunologic Factors|immunologic factors|mesh-ancestor
25373854|NCT04924062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373855|NCT04924062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25373856|NCT04923893|Dexamethasone|dexamethasone|mesh-list
25373857|NCT04923893|Cyclophosphamide|cyclophosphamide|mesh-list
25373858|NCT04923893|Fludarabine|fludarabine|mesh-list
25373859|NCT04923893|Lenalidomide|lenalidomide|mesh-list
25373860|NCT04923893|Bortezomib|bortezomib|mesh-list
25373861|NCT04923893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25373862|NCT04923893|Immunologic Factors|immunologic factors|mesh-ancestor
25373863|NCT04923893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373864|NCT04923893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25373865|NCT04923893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25373866|NCT04923893|Alkylating Agents|alkylating agents|mesh-ancestor
25373867|NCT04923893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373868|NCT04923893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373869|NCT04923893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25373870|NCT04923893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25373871|NCT04923893|Antiemetics|antiemetics|mesh-ancestor
25373872|NCT04923893|Autonomic Agents|autonomic agents|mesh-ancestor
25373873|NCT04923893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25373874|NCT04923893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25373875|NCT04923893|Glucocorticoids|glucocorticoids|mesh-ancestor
25373876|NCT04923893|Hormones|hormones|mesh-ancestor
25373877|NCT04923893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25373878|NCT04923893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25373879|NCT04923893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25373880|NCT04923893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25373881|NCT04923893|Growth Substances|growth substances|mesh-ancestor
25373882|NCT04923893|Growth Inhibitors|growth inhibitors|mesh-ancestor
25373883|NCT04923867|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
25373884|NCT04923867|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
25373885|NCT04923867|Estradiol|estradiol|mesh-list
25373886|NCT04923867|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
25373887|NCT04923867|Estrogens|estrogens|mesh-ancestor
25373888|NCT04923867|Hormones|hormones|mesh-ancestor
25373889|NCT04923867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25373890|NCT04923867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373891|NCT04923867|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25373892|NCT04923867|Contraceptive Agents|contraceptive agents|mesh-ancestor
25373893|NCT04923867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25373894|NCT04923867|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25373895|NCT04923594|Mazindol|mazindol|mesh-list
25373896|NCT04923594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25373897|NCT04923594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373898|NCT04923594|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25373899|NCT04923594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25373900|NCT04923594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25373901|NCT04923594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373902|NCT04923594|Adrenergic Agents|adrenergic agents|mesh-ancestor
25373903|NCT04923594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25373904|NCT04923594|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25373905|NCT04923594|Dopamine Agents|dopamine agents|mesh-ancestor
25373906|NCT04923139|Rivaroxaban|rivaroxaban|mesh-list
25373907|NCT04923139|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25373908|NCT04923139|Antithrombins|antithrombins|mesh-ancestor
25373909|NCT04923139|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25373910|NCT04923139|Protease Inhibitors|protease inhibitors|mesh-ancestor
25373911|NCT04923139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25373912|NCT04923139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373913|NCT04923139|Anticoagulants|anticoagulants|mesh-ancestor
25373914|NCT04922827|Infliximab|infliximab|mesh-list
25373915|NCT04922827|Dermatologic Agents|dermatologic agents|mesh-ancestor
25373916|NCT04922827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25373917|NCT04922827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25373918|NCT04922658|Vinorelbine|vinorelbine|mesh-list
25373919|NCT04922658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25373920|NCT04922658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373921|NCT04922658|Tubulin Modulators|tubulin modulators|mesh-ancestor
25373922|NCT04922658|Antimitotic Agents|antimitotic agents|mesh-ancestor
25373923|NCT04922658|Mitosis Modulators|mitosis modulators|mesh-ancestor
25373924|NCT04922658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373925|NCT04921358|Docetaxel|docetaxel|mesh-list
25373926|NCT04921358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373927|NCT04921358|Tubulin Modulators|tubulin modulators|mesh-ancestor
25373928|NCT04921358|Antimitotic Agents|antimitotic agents|mesh-ancestor
25373929|NCT04921358|Mitosis Modulators|mitosis modulators|mesh-ancestor
25373930|NCT04921358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373931|NCT04920695|Nitric Oxide|nitric oxide|mesh-list
25373932|NCT04920695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25373933|NCT04920695|Autonomic Agents|autonomic agents|mesh-ancestor
25373934|NCT04920695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25373935|NCT04920695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373936|NCT04920695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25373937|NCT04920695|Respiratory System Agents|respiratory system agents|mesh-ancestor
25373938|NCT04920695|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25373939|NCT04920695|Antioxidants|antioxidants|mesh-ancestor
25373940|NCT04920695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373941|NCT04920695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25373942|NCT04920695|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
25373943|NCT04920695|Vasodilator Agents|vasodilator agents|mesh-ancestor
25373944|NCT04920695|Gasotransmitters|gasotransmitters|mesh-ancestor
25373945|NCT04920695|Protective Agents|protective agents|mesh-ancestor
25373946|NCT04920617|Cyclophosphamide|cyclophosphamide|mesh-list
25373947|NCT04920617|Pembrolizumab|pembrolizumab|mesh-list
25373948|NCT04920617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25373949|NCT04920617|Immunologic Factors|immunologic factors|mesh-ancestor
25373950|NCT04920617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373951|NCT04920617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25373952|NCT04920617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25373953|NCT04920617|Alkylating Agents|alkylating agents|mesh-ancestor
25373954|NCT04920617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373955|NCT04920617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373956|NCT04920617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25373957|NCT04920617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25373958|NCT04920565|Polymyxins|polymyxins|mesh-list
25373959|NCT04920565|Polymyxin B|polymyxin b|mesh-list
25373960|NCT04920565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25373961|NCT04920565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25373962|NCT04920539|Dronabinol|dronabinol|mesh-list
25373963|NCT04920539|Hallucinogens|hallucinogens|mesh-ancestor
25373964|NCT04920539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373965|NCT04920539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25373966|NCT04920539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25373967|NCT04920539|Analgesics|analgesics|mesh-ancestor
25373968|NCT04920539|Sensory System Agents|sensory system agents|mesh-ancestor
25373969|NCT04920539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25373970|NCT04920539|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25373971|NCT04920539|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25373972|NCT04920539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25373973|NCT04920539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25373974|NCT04920539|Hormones|hormones|mesh-ancestor
25373975|NCT04920539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25373976|NCT04920383|Pembrolizumab|pembrolizumab|mesh-list
25373977|NCT04920383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25373978|NCT04920383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373979|NCT04919629|Bevacizumab|bevacizumab|mesh-list
25373980|NCT04919629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25373981|NCT04919629|Pembrolizumab|pembrolizumab|mesh-list
25373982|NCT04919629|Endothelial Growth Factors|endothelial growth factors|mesh-list
25373983|NCT04919629|Antibodies|antibodies|mesh-list
25373985|NCT04919629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25373986|NCT04919629|Immunoglobulin G|immunoglobulin g|mesh-list
25373987|NCT04919629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25373988|NCT04919629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25373989|NCT04919629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25373990|NCT04919629|Growth Substances|growth substances|mesh-ancestor
25373991|NCT04919629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25373992|NCT04919629|Growth Inhibitors|growth inhibitors|mesh-ancestor
25373993|NCT04919629|Immunologic Factors|immunologic factors|mesh-ancestor
25373994|NCT04919382|Temozolomide|temozolomide|mesh-list
25373995|NCT04919382|Atezolizumab|atezolizumab|mesh-list
25373996|NCT04919382|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25373997|NCT04919382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25373998|NCT04919382|Alkylating Agents|alkylating agents|mesh-ancestor
25373999|NCT04919382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374000|NCT04919382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374001|NCT04919382|Immunologic Factors|immunologic factors|mesh-ancestor
25374002|NCT04919382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374004|NCT04919226|Folic Acid|folic acid|mesh-list
25374005|NCT04919226|Fluorouracil|fluorouracil|mesh-list
25374006|NCT04919226|Capecitabine|capecitabine|mesh-list
25374007|NCT04919226|Oxaliplatin|oxaliplatin|mesh-list
25374008|NCT04919226|Everolimus|everolimus|mesh-list
25374009|NCT04919226|Temozolomide|temozolomide|mesh-list
25374010|NCT04919226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25374011|NCT04919226|Levoleucovorin|levoleucovorin|mesh-list
25374012|NCT04919226|Edotreotide|edotreotide|mesh-list
25374013|NCT04919226|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
25374014|NCT04919226|Antimetabolites|antimetabolites|mesh-ancestor
25374015|NCT04919226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374016|NCT04919226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25374017|NCT04919226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374018|NCT04919226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25374019|NCT04919226|Immunologic Factors|immunologic factors|mesh-ancestor
25374020|NCT04919226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374021|NCT04919226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25374022|NCT04919226|Alkylating Agents|alkylating agents|mesh-ancestor
25374023|NCT04919226|Antidotes|antidotes|mesh-ancestor
25374024|NCT04919226|Protective Agents|protective agents|mesh-ancestor
25374025|NCT04919226|Vitamin B Complex|vitamin b complex|mesh-ancestor
25374026|NCT04919226|Vitamins|vitamins|mesh-ancestor
25374027|NCT04919226|Micronutrients|micronutrients|mesh-ancestor
25374028|NCT04919226|Hematinics|hematinics|mesh-ancestor
25374029|NCT04919226|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25374030|NCT04918186|Durvalumab|durvalumab|mesh-list
25374031|NCT04918186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25374032|NCT04918186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374033|NCT04918173|Antithrombin III|antithrombin iii|mesh-list
25374034|NCT04918173|Antithrombins|antithrombins|mesh-ancestor
25374035|NCT04918173|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25374036|NCT04918173|Protease Inhibitors|protease inhibitors|mesh-ancestor
25374037|NCT04918173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25374038|NCT04918173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374039|NCT04918173|Anticoagulants|anticoagulants|mesh-ancestor
25374040|NCT04917861|Vaccines|vaccines|mesh-list
25374041|NCT04917861|Immunologic Factors|immunologic factors|mesh-ancestor
25374042|NCT04917861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374043|NCT04917731|Botulinum Toxins|botulinum toxins|mesh-list
25374044|NCT04917731|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25374045|NCT04917731|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25374046|NCT04917731|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25374047|NCT04917731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25374048|NCT04917731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374049|NCT04917731|Cholinergic Agents|cholinergic agents|mesh-ancestor
25374050|NCT04917731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25374051|NCT04917731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374052|NCT04917731|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25374053|NCT04917731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25374054|NCT04916938|Psychotropic Drugs|psychotropic drugs|mesh-list
25374055|NCT04916548|Ketamine|ketamine|mesh-list
25374056|NCT04916548|Analgesics|analgesics|mesh-ancestor
25374057|NCT04916548|Sensory System Agents|sensory system agents|mesh-ancestor
25374058|NCT04916548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25374059|NCT04916548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374060|NCT04916548|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25374064|NCT04916548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25374071|NCT04916327|Protective Agents|protective agents|mesh-ancestor
25374072|NCT04916327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374073|NCT04916002|Cemiplimab|cemiplimab|mesh-list
25374074|NCT04916002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25374075|NCT04916002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374076|NCT04915950|APD791|apd791|mesh-list
25374077|NCT04915950|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25374078|NCT04915950|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25374079|NCT04915950|Serotonin Agents|serotonin agents|mesh-ancestor
25374080|NCT04915950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25374081|NCT04915950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374082|NCT04915950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374088|NCT04915729|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25374089|NCT04915729|Tenecteplase|tenecteplase|mesh-list
25374090|NCT04915729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25374091|NCT04915729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25374092|NCT04915729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374093|NCT04915612|Cytarabine|cytarabine|mesh-list
25374094|NCT04915612|Daunorubicin|daunorubicin|mesh-list
25374095|NCT04915612|Gemtuzumab|gemtuzumab|mesh-list
25374096|NCT04915612|Calicheamicins|calicheamicins|mesh-list
25374097|NCT04915612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25374098|NCT04915612|Antimetabolites|antimetabolites|mesh-ancestor
25374099|NCT04915612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374100|NCT04915612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374101|NCT04915612|Antiviral Agents|antiviral agents|mesh-ancestor
25374102|NCT04915612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25374103|NCT04915612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25374104|NCT04915612|Immunologic Factors|immunologic factors|mesh-ancestor
25374105|NCT04915612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374106|NCT04915612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25374107|NCT04915612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25374108|NCT04915612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25374109|NCT04915612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25374110|NCT04915612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25374111|NCT04915248|Dexamethasone|dexamethasone|mesh-list
25374112|NCT04915248|Dexamethasone acetate|dexamethasone acetate|mesh-list
25374113|NCT04915248|Bortezomib|bortezomib|mesh-list
25374114|NCT04915248|Daratumumab|daratumumab|mesh-list
25374115|NCT04915248|BB 1101|bb 1101|mesh-list
25374116|NCT04915248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25374117|NCT04915248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25374118|NCT04915248|Antiemetics|antiemetics|mesh-ancestor
25374119|NCT04915248|Autonomic Agents|autonomic agents|mesh-ancestor
25374120|NCT04915248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25374121|NCT04915248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374122|NCT04915248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25374123|NCT04915248|Glucocorticoids|glucocorticoids|mesh-ancestor
25374124|NCT04915248|Hormones|hormones|mesh-ancestor
25374125|NCT04915248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25374126|NCT04915248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25374127|NCT04915248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374128|NCT04915248|Protease Inhibitors|protease inhibitors|mesh-ancestor
25374129|NCT04915248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25374130|NCT04915248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374131|NCT04915248|Immunologic Factors|immunologic factors|mesh-ancestor
25374144|NCT04914897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25374146|NCT04914676|Cytarabine|cytarabine|mesh-list
25374147|NCT04914676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25374148|NCT04914676|Antimetabolites|antimetabolites|mesh-ancestor
25374149|NCT04914676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374150|NCT04914676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374151|NCT04914676|Antiviral Agents|antiviral agents|mesh-ancestor
25374152|NCT04914676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25374153|NCT04914676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25374155|NCT04914676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374156|NCT04914234|Metoprolol|metoprolol|mesh-list
25374157|NCT04914234|Atenolol|atenolol|mesh-list
25374158|NCT04914234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25374159|NCT04914234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25374160|NCT04914234|Sympatholytics|sympatholytics|mesh-ancestor
25374161|NCT04914234|Autonomic Agents|autonomic agents|mesh-ancestor
25374162|NCT04914234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25374163|NCT04914234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374164|NCT04914234|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25374165|NCT04914234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25374166|NCT04914234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25374167|NCT04914234|Adrenergic Agents|adrenergic agents|mesh-ancestor
25374168|NCT04914234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25374169|NCT04914234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374170|NCT04914195|Leuprolide|leuprolide|mesh-list
25374171|NCT04914195|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25374172|NCT04914195|Fertility Agents|fertility agents|mesh-ancestor
25374173|NCT04914195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25374174|NCT04914195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374175|NCT04914195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25374176|NCT04914195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374177|NCT04913467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25374178|NCT04913337|Pembrolizumab|pembrolizumab|mesh-list
25374179|NCT04913337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25374180|NCT04913337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374181|NCT04913220|Cemiplimab|cemiplimab|mesh-list
25374182|NCT04913220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25374183|NCT04913220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374184|NCT04913025|Pembrolizumab|pembrolizumab|mesh-list
25374185|NCT04913025|Nivolumab|nivolumab|mesh-list
25374186|NCT04913025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25374187|NCT04913025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374188|NCT04913025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25374189|NCT04913025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374190|NCT04912921|Palmidrol|palmidrol|mesh-list
25374191|NCT04912921|Analgesics|analgesics|mesh-ancestor
25374192|NCT04912921|Sensory System Agents|sensory system agents|mesh-ancestor
25374193|NCT04912921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25374194|NCT04912921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374195|NCT04912921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25374196|NCT04912921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25374197|NCT04912921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25374198|NCT04912921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25374199|NCT04912921|Antiviral Agents|antiviral agents|mesh-ancestor
25374200|NCT04912921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25374201|NCT04912921|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25374202|NCT04912921|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25374203|NCT04912921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25374204|NCT04912921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374205|NCT04912921|Hormones|hormones|mesh-ancestor
25374206|NCT04912921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25374207|NCT04912856|Ezogabine|ezogabine|mesh-list
25374208|NCT04912856|Anticonvulsants|anticonvulsants|mesh-ancestor
25374209|NCT04912856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25374210|NCT04912856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374212|NCT04912765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25374213|NCT04912765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374214|NCT04912765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25374215|NCT04912765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374216|NCT04912596|Albuterol|albuterol|mesh-list
25374217|NCT04912596|Procaterol|procaterol|mesh-list
25374218|NCT04912596|Methacholine Chloride|methacholine chloride|mesh-list
25374219|NCT04912596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25374220|NCT04912596|Autonomic Agents|autonomic agents|mesh-ancestor
25374221|NCT04912596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25374222|NCT04912596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374223|NCT04912596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25374224|NCT04912596|Respiratory System Agents|respiratory system agents|mesh-ancestor
25374225|NCT04912596|Tocolytic Agents|tocolytic agents|mesh-ancestor
25374226|NCT04912596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25374246|NCT04912427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374247|NCT04912427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25374248|NCT04912427|Glucocorticoids|glucocorticoids|mesh-ancestor
25374249|NCT04912427|Hormones|hormones|mesh-ancestor
25374250|NCT04912427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25374251|NCT04912427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25374252|NCT04912427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374253|NCT04912063|Azacitidine|azacitidine|mesh-list
25374254|NCT04912063|Venetoclax|venetoclax|mesh-list
25374255|NCT04912063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25374256|NCT04912063|Antimetabolites|antimetabolites|mesh-ancestor
25374257|NCT04912063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374258|NCT04912063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374259|NCT04912063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25374279|NCT04910503|Dexamethasone|dexamethasone|mesh-list
25374280|NCT04910503|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
25374281|NCT04910503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25374282|NCT04910503|Antiemetics|antiemetics|mesh-ancestor
25374283|NCT04910503|Autonomic Agents|autonomic agents|mesh-ancestor
25374284|NCT04910503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25374285|NCT04910503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374286|NCT04910503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25374287|NCT04910503|Glucocorticoids|glucocorticoids|mesh-ancestor
25374288|NCT04910503|Hormones|hormones|mesh-ancestor
25374289|NCT04910503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25374290|NCT04910503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25374291|NCT04910503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374292|NCT04910425|Fluorides|fluorides|mesh-list
25374293|NCT04910425|Cariostatic Agents|cariostatic agents|mesh-ancestor
25374294|NCT04910425|Protective Agents|protective agents|mesh-ancestor
25374295|NCT04910425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374296|NCT04909801|Adalimumab|adalimumab|mesh-list
25374297|NCT04909801|Methotrexate|methotrexate|mesh-list
25374298|NCT04909801|Abatacept|abatacept|mesh-list
25374299|NCT04909801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25374300|NCT04909801|Abortifacient Agents|abortifacient agents|mesh-ancestor
25374301|NCT04909801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25374302|NCT04909801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374303|NCT04909801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25374304|NCT04909801|Antimetabolites|antimetabolites|mesh-ancestor
25374305|NCT04909801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374306|NCT04909801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374307|NCT04909801|Dermatologic Agents|dermatologic agents|mesh-ancestor
25374308|NCT04909801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25374309|NCT04909801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25374310|NCT04909801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25374311|NCT04909801|Immunologic Factors|immunologic factors|mesh-ancestor
25374312|NCT04909801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25374313|NCT04909801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25374314|NCT04909801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25374315|NCT04909801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25374316|NCT04909515|Isotretinoin|isotretinoin|mesh-list
25374317|NCT04909515|Dermatologic Agents|dermatologic agents|mesh-ancestor
25374318|NCT04909450|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25374319|NCT04909450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25374320|NCT04909333|Exenatide|exenatide|mesh-list
25374321|NCT04909333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25374322|NCT04909333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25374323|NCT04909333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374324|NCT04909333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25374325|NCT04909333|Incretins|incretins|mesh-ancestor
25374326|NCT04909333|Hormones|hormones|mesh-ancestor
25374327|NCT04909333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25374328|NCT04909021|Vaccines|vaccines|mesh-list
25374329|NCT04909021|Immunologic Factors|immunologic factors|mesh-ancestor
25374330|NCT04909021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374331|NCT04908956|Osimertinib|osimertinib|mesh-list
25374332|NCT04908956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374333|NCT04908956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25374334|NCT04908956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25374335|NCT04908956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374336|NCT04908865|Belimumab|belimumab|mesh-list
25374337|NCT04908865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25374338|NCT04908865|Immunologic Factors|immunologic factors|mesh-ancestor
25374339|NCT04908865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374340|NCT04908449|Bupivacaine|bupivacaine|mesh-list
25374341|NCT04908449|Anesthetics, Local|anesthetics, local|mesh-ancestor
25374342|NCT04908449|Anesthetics|anesthetics|mesh-ancestor
25374343|NCT04908449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25374344|NCT04908449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374345|NCT04908449|Sensory System Agents|sensory system agents|mesh-ancestor
25374346|NCT04908449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25374347|NCT04908202|BMS-986165|bms-986165|mesh-list
25374348|NCT04908202|Dermatologic Agents|dermatologic agents|mesh-ancestor
25374349|NCT04908202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25374350|NCT04908202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25374351|NCT04908202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374352|NCT04908189|Apremilast|apremilast|mesh-list
25374353|NCT04908189|BMS-986165|bms-986165|mesh-list
25374354|NCT04908189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25374355|NCT04908189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25374356|NCT04908189|Analgesics|analgesics|mesh-ancestor
25374357|NCT04908189|Sensory System Agents|sensory system agents|mesh-ancestor
25374358|NCT04908189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25374359|NCT04908189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374360|NCT04908189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25374361|NCT04908189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25374362|NCT04908189|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25374363|NCT04908189|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25374364|NCT04908189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25374365|NCT04908189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374366|NCT04908189|Dermatologic Agents|dermatologic agents|mesh-ancestor
25374367|NCT04908189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25374368|NCT04908176|Midazolam|midazolam|mesh-list
25374369|NCT04908176|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25374370|NCT04908176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25374371|NCT04908176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25374372|NCT04908176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374373|NCT04908176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25374374|NCT04908176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25374375|NCT04908176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25374376|NCT04908176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25374377|NCT04908176|Anesthetics, General|anesthetics, general|mesh-ancestor
25374378|NCT04908176|Anesthetics|anesthetics|mesh-ancestor
25374379|NCT04908176|GABA Modulators|gaba modulators|mesh-ancestor
25374397|NCT04907227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25374399|NCT04907227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374400|NCT04907227|Tubulin Modulators|tubulin modulators|mesh-ancestor
25374401|NCT04907227|Antimitotic Agents|antimitotic agents|mesh-ancestor
25374402|NCT04907227|Mitosis Modulators|mitosis modulators|mesh-ancestor
25374403|NCT04907227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374404|NCT04907227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25374405|NCT04907084|Fenofibrate|fenofibrate|mesh-list
25374406|NCT04907084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25374407|NCT04907084|Antimetabolites|antimetabolites|mesh-ancestor
25374408|NCT04907084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374409|NCT04907084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25374427|NCT04906382|Paclitaxel|paclitaxel|mesh-list
25374428|NCT04906382|Carboplatin|carboplatin|mesh-list
25374429|NCT04906382|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25374430|NCT04906382|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25374431|NCT04906382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374432|NCT04906382|Tubulin Modulators|tubulin modulators|mesh-ancestor
25374433|NCT04906382|Antimitotic Agents|antimitotic agents|mesh-ancestor
25374434|NCT04906382|Mitosis Modulators|mitosis modulators|mesh-ancestor
25374435|NCT04906382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374444|NCT04905654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25374445|NCT04905654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25374446|NCT04905654|Autonomic Agents|autonomic agents|mesh-ancestor
25374447|NCT04905654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25374448|NCT04905654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374449|NCT04905654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25374450|NCT04905654|Respiratory System Agents|respiratory system agents|mesh-ancestor
25374451|NCT04905654|Parasympatholytics|parasympatholytics|mesh-ancestor
25374452|NCT04905654|Vasodilator Agents|vasodilator agents|mesh-ancestor
25374453|NCT04905446|Niacinamide|niacinamide|mesh-list
25374455|NCT04905446|Nicotinic Acids|nicotinic acids|mesh-list
25374456|NCT04905446|Vitamin B Complex|vitamin b complex|mesh-ancestor
25374457|NCT04905446|Vitamins|vitamins|mesh-ancestor
25374458|NCT04905446|Micronutrients|micronutrients|mesh-ancestor
25374459|NCT04905446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374460|NCT04905446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25374461|NCT04905446|Antimetabolites|antimetabolites|mesh-ancestor
25374462|NCT04905446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374463|NCT04905446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25374464|NCT04905446|Vasodilator Agents|vasodilator agents|mesh-ancestor
25374465|NCT04905316|Durvalumab|durvalumab|mesh-list
25374466|NCT04905316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25374467|NCT04905316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374468|NCT04905277|Atenolol|atenolol|mesh-list
25374469|NCT04905277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25374470|NCT04905277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25374471|NCT04905277|Sympatholytics|sympatholytics|mesh-ancestor
25374472|NCT04905277|Autonomic Agents|autonomic agents|mesh-ancestor
25374473|NCT04905277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25374474|NCT04905277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374475|NCT04905277|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25374476|NCT04905277|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25374477|NCT04905277|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25374478|NCT04905277|Adrenergic Agents|adrenergic agents|mesh-ancestor
25374479|NCT04905277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25374480|NCT04905277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374481|NCT04905251|Misoprostol|misoprostol|mesh-list
25374482|NCT04905251|Mifepristone|mifepristone|mesh-list
25374483|NCT04905251|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25374484|NCT04905251|Abortifacient Agents|abortifacient agents|mesh-ancestor
25374485|NCT04905251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25374486|NCT04905251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374487|NCT04905251|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25374488|NCT04905251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25374489|NCT04905251|Oxytocics|oxytocics|mesh-ancestor
25374490|NCT04905251|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
25374491|NCT04905251|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25374492|NCT04905251|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25374493|NCT04905251|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25374494|NCT04905251|Contraceptive Agents|contraceptive agents|mesh-ancestor
25374495|NCT04905251|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
25374496|NCT04905251|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
25374497|NCT04905251|Hormone Antagonists|hormone antagonists|mesh-ancestor
25374498|NCT04905251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25374499|NCT04905251|Luteolytic Agents|luteolytic agents|mesh-ancestor
25374500|NCT04905251|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25374501|NCT04905251|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
25374551|NCT04903509|Incretins|incretins|mesh-ancestor
25374552|NCT04903509|Hormones|hormones|mesh-ancestor
25374553|NCT04903509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25374554|NCT04903470|Bisacodyl|bisacodyl|mesh-list
25374555|NCT04903470|Cathartics|cathartics|mesh-ancestor
25374556|NCT04903470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25374557|NCT04903470|Laxatives|laxatives|mesh-ancestor
25374558|NCT04903197|Lenalidomide|lenalidomide|mesh-list
25374559|NCT04903197|Immunologic Factors|immunologic factors|mesh-ancestor
25374560|NCT04903197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374561|NCT04903197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25374562|NCT04903197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25374563|NCT04903197|Growth Substances|growth substances|mesh-ancestor
25374564|NCT04903197|Growth Inhibitors|growth inhibitors|mesh-ancestor
25374565|NCT04903197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374566|NCT04903119|Trametinib|trametinib|mesh-list
25374567|NCT04903119|Dabrafenib|dabrafenib|mesh-list
25374568|NCT04903119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374569|NCT04903119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25374570|NCT04903119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25374571|NCT04903119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374572|NCT04903002|Oxytocin|oxytocin|mesh-list
25374573|NCT04903002|Oxytocics|oxytocics|mesh-ancestor
25374574|NCT04903002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25374575|NCT04903002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374576|NCT04902729|Oxytocin|oxytocin|mesh-list
25374577|NCT04902729|Carbetocin|carbetocin|mesh-list
25374578|NCT04902729|Oxytocics|oxytocics|mesh-ancestor
25374579|NCT04902729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25374580|NCT04902729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374581|NCT04902625|Naltrexone|naltrexone|mesh-list
25374582|NCT04902625|Bupropion|bupropion|mesh-list
25374583|NCT04902625|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25374584|NCT04902625|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25374585|NCT04902625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374586|NCT04902625|Sensory System Agents|sensory system agents|mesh-ancestor
25374587|NCT04902625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25408383|NCT03447379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25374588|NCT04902625|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25374589|NCT04902625|Antidepressive Agents|antidepressive agents|mesh-ancestor
25374590|NCT04902625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25374610|NCT04901715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25374611|NCT04901715|Autonomic Agents|autonomic agents|mesh-ancestor
25374612|NCT04901715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25374613|NCT04901715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374614|NCT04901715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25374615|NCT04901715|Respiratory System Agents|respiratory system agents|mesh-ancestor
25374616|NCT04901715|Tocolytic Agents|tocolytic agents|mesh-ancestor
25374617|NCT04901715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25374618|NCT04901715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25374619|NCT04901715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25374620|NCT04901715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25374621|NCT04901715|Adrenergic Agents|adrenergic agents|mesh-ancestor
25374622|NCT04901715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25374623|NCT04901715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374624|NCT04901702|Irinotecan|irinotecan|mesh-list
25374625|NCT04901702|Temozolomide|temozolomide|mesh-list
25374626|NCT04901702|Talazoparib|talazoparib|mesh-list
25374627|NCT04901702|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25374628|NCT04901702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25374629|NCT04901702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25374630|NCT04901702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374631|NCT04901702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374632|NCT04901702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25374633|NCT04901702|Alkylating Agents|alkylating agents|mesh-ancestor
25374634|NCT04901702|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25374654|NCT04900038|Lamivudine|lamivudine|mesh-list
25374655|NCT04900038|Dolutegravir|dolutegravir|mesh-list
25374656|NCT04900038|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25374657|NCT04900038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25374658|NCT04900038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25374659|NCT04900038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374660|NCT04900038|Antiviral Agents|antiviral agents|mesh-ancestor
25374661|NCT04900038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25374662|NCT04900038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25374663|NCT04900038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25374664|NCT04900038|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25374665|NCT04900038|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25374666|NCT04899583|Sirolimus|sirolimus|mesh-list
25374667|NCT04899583|Paclitaxel|paclitaxel|mesh-list
25374668|NCT04899583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25374669|NCT04899583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374670|NCT04899583|Tubulin Modulators|tubulin modulators|mesh-ancestor
25374671|NCT04899583|Antimitotic Agents|antimitotic agents|mesh-ancestor
25374672|NCT04899583|Mitosis Modulators|mitosis modulators|mesh-ancestor
25374673|NCT04899583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374674|NCT04899583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25374675|NCT04899583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25374676|NCT04899583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25374677|NCT04899583|Antifungal Agents|antifungal agents|mesh-ancestor
25374678|NCT04899583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25374679|NCT04899583|Immunologic Factors|immunologic factors|mesh-ancestor
25374680|NCT04899583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374681|NCT04899492|Nicotine|nicotine|mesh-list
25374682|NCT04899492|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25374683|NCT04899492|Autonomic Agents|autonomic agents|mesh-ancestor
25374684|NCT04899492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25374685|NCT04899492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374686|NCT04899492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25374687|NCT04899492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25374688|NCT04899492|Cholinergic Agents|cholinergic agents|mesh-ancestor
25374689|NCT04899492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25374690|NCT04899492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374691|NCT04899349|Metformin|metformin|mesh-list
25374692|NCT04899349|Dapagliflozin|dapagliflozin|mesh-list
25374693|NCT04899349|Fulvestrant|fulvestrant|mesh-list
25374694|NCT04899349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25374695|NCT04899349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374696|NCT04899349|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25374697|NCT04899349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374698|NCT04899349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25374699|NCT04899349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374700|NCT04899349|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25374701|NCT04899349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25374702|NCT04899349|Hormone Antagonists|hormone antagonists|mesh-ancestor
25374703|NCT04899349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25374705|NCT04899232|Antithrombin III|antithrombin iii|mesh-list
25374706|NCT04899232|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25374707|NCT04899232|Protease Inhibitors|protease inhibitors|mesh-ancestor
25374708|NCT04899232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25374709|NCT04899232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374710|NCT04899232|Anticoagulants|anticoagulants|mesh-ancestor
25374711|NCT04899115|Vancomycin|vancomycin|mesh-list
25374712|NCT04899115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25374713|NCT04899115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25374714|NCT04898374|Gemcitabine|gemcitabine|mesh-list
25374715|NCT04898374|Cisplatin|cisplatin|mesh-list
25374716|NCT04898374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374717|NCT04898374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25374718|NCT04898374|Antimetabolites|antimetabolites|mesh-ancestor
25374719|NCT04898374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374720|NCT04898374|Antiviral Agents|antiviral agents|mesh-ancestor
25374721|NCT04898374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25374722|NCT04898374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25374723|NCT04898374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25374724|NCT04898374|Immunologic Factors|immunologic factors|mesh-ancestor
25374725|NCT04898374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374726|NCT04898114|Magnesium Sulfate|magnesium sulfate|mesh-list
25374727|NCT04898114|Sildenafil Citrate|sildenafil citrate|mesh-list
25374728|NCT04898114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374729|NCT04898114|Vasodilator Agents|vasodilator agents|mesh-ancestor
25374730|NCT04898114|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25374731|NCT04898114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25374732|NCT04898114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25374733|NCT04898114|Urological Agents|urological agents|mesh-ancestor
25374734|NCT04898114|Analgesics|analgesics|mesh-ancestor
25374735|NCT04898114|Sensory System Agents|sensory system agents|mesh-ancestor
25374736|NCT04898114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25374737|NCT04898114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374738|NCT04898114|Anesthetics|anesthetics|mesh-ancestor
25374739|NCT04898114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25374748|NCT04898075|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25374749|NCT04898075|Autonomic Agents|autonomic agents|mesh-ancestor
25374750|NCT04898075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25374751|NCT04898075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374752|NCT04898075|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25374753|NCT04898075|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25374754|NCT04898075|Cholinergic Agents|cholinergic agents|mesh-ancestor
25374755|NCT04898075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25374756|NCT04898075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374757|NCT04897841|Bupivacaine|bupivacaine|mesh-list
25374758|NCT04897841|Anesthetics, Local|anesthetics, local|mesh-ancestor
25374759|NCT04897841|Anesthetics|anesthetics|mesh-ancestor
25374760|NCT04897841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25374761|NCT04897841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374762|NCT04897841|Sensory System Agents|sensory system agents|mesh-ancestor
25374763|NCT04897841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25374764|NCT04897217|Megestrol|megestrol|mesh-list
25374765|NCT04897217|Megestrol Acetate|megestrol acetate|mesh-list
25374766|NCT04897217|Levonorgestrel|levonorgestrel|mesh-list
25374767|NCT04897217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25374768|NCT04897217|Contraceptive Agents|contraceptive agents|mesh-ancestor
25374769|NCT04897217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25374770|NCT04897217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374771|NCT04897217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25374772|NCT04897217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25374773|NCT04897217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25374774|NCT04897217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25374775|NCT04897217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25374776|NCT04897217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374777|NCT04897217|Appetite Stimulants|appetite stimulants|mesh-ancestor
25374778|NCT04897217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25374779|NCT04897022|Pembrolizumab|pembrolizumab|mesh-list
25374780|NCT04897022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25406289|NCT03570814|Anthelmintics|anthelmintics|mesh-ancestor
25374781|NCT04897022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374782|NCT04896073|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
25374783|NCT04896073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25374784|NCT04896073|Alkylating Agents|alkylating agents|mesh-ancestor
25374785|NCT04896073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374786|NCT04896073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374787|NCT04895917|Daratumumab|daratumumab|mesh-list
25374788|NCT04895917|Pomalidomide|pomalidomide|mesh-list
25374789|NCT04895917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374790|NCT04895917|Immunologic Factors|immunologic factors|mesh-ancestor
25374791|NCT04895917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374792|NCT04895917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25374793|NCT04895917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25374794|NCT04895917|Growth Substances|growth substances|mesh-ancestor
25374795|NCT04895917|Growth Inhibitors|growth inhibitors|mesh-ancestor
25374804|NCT04895592|Dexamethasone|dexamethasone|mesh-list
25374805|NCT04895592|Dexamethasone acetate|dexamethasone acetate|mesh-list
25374806|NCT04895592|Ichthammol|ichthammol|mesh-list
25374807|NCT04895592|BB 1101|bb 1101|mesh-list
25374808|NCT04895592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25374809|NCT04895592|Antiemetics|antiemetics|mesh-ancestor
25374810|NCT04895592|Autonomic Agents|autonomic agents|mesh-ancestor
25374811|NCT04895592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25374812|NCT04895592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374813|NCT04895592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25374814|NCT04895592|Glucocorticoids|glucocorticoids|mesh-ancestor
25374818|NCT04895592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374819|NCT04895592|Protease Inhibitors|protease inhibitors|mesh-ancestor
25374820|NCT04895592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25374821|NCT04895592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374822|NCT04895592|Dermatologic Agents|dermatologic agents|mesh-ancestor
25374903|NCT04892446|Autonomic Agents|autonomic agents|mesh-ancestor
25374828|NCT04895358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25374829|NCT04895358|Doxorubicin|doxorubicin|mesh-list
25374830|NCT04895358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25374831|NCT04895358|Pembrolizumab|pembrolizumab|mesh-list
25374832|NCT04895358|Capecitabine|capecitabine|mesh-list
25374833|NCT04895358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25374834|NCT04895358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374835|NCT04895358|Tubulin Modulators|tubulin modulators|mesh-ancestor
25374836|NCT04895358|Antimitotic Agents|antimitotic agents|mesh-ancestor
25374837|NCT04895358|Mitosis Modulators|mitosis modulators|mesh-ancestor
25374838|NCT04895358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374839|NCT04895358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25374840|NCT04895358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25374841|NCT04895358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25374842|NCT04895358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25374843|NCT04895358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25374844|NCT04895358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25374845|NCT04895358|Antimetabolites|antimetabolites|mesh-ancestor
25374846|NCT04894643|Gemcitabine|gemcitabine|mesh-list
25374847|NCT04894643|Paclitaxel|paclitaxel|mesh-list
25374848|NCT04894643|Capecitabine|capecitabine|mesh-list
25374849|NCT04894643|Pancrelipase|pancrelipase|mesh-list
25374850|NCT04894643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25374851|NCT04894643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374852|NCT04894643|Tubulin Modulators|tubulin modulators|mesh-ancestor
25374853|NCT04894643|Antimitotic Agents|antimitotic agents|mesh-ancestor
25374854|NCT04894643|Mitosis Modulators|mitosis modulators|mesh-ancestor
25374855|NCT04894643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374856|NCT04894643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25374857|NCT04894643|Antimetabolites|antimetabolites|mesh-ancestor
25374858|NCT04894643|Antiviral Agents|antiviral agents|mesh-ancestor
25374859|NCT04894643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25374860|NCT04894643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25374861|NCT04894643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25374862|NCT04894643|Immunologic Factors|immunologic factors|mesh-ancestor
25374863|NCT04894643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374864|NCT04894643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25374865|NCT04893161|Belimumab|belimumab|mesh-list
25374866|NCT04893161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25374867|NCT04893161|Immunologic Factors|immunologic factors|mesh-ancestor
25374868|NCT04893161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374869|NCT04893109|Paclitaxel|paclitaxel|mesh-list
25724242|NCT02535949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374870|NCT04893109|Maytansine|maytansine|mesh-list
25374871|NCT04893109|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25374873|NCT04893109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25374874|NCT04893109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374875|NCT04893109|Tubulin Modulators|tubulin modulators|mesh-ancestor
25374876|NCT04893109|Antimitotic Agents|antimitotic agents|mesh-ancestor
25374877|NCT04893109|Mitosis Modulators|mitosis modulators|mesh-ancestor
25374878|NCT04893109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374879|NCT04893109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25374880|NCT04892888|Vaccines|vaccines|mesh-list
25374881|NCT04892888|Immunologic Factors|immunologic factors|mesh-ancestor
25374882|NCT04892888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374883|NCT04892875|Cisplatin|cisplatin|mesh-list
25374884|NCT04892875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374885|NCT04892693|Talazoparib|talazoparib|mesh-list
25374886|NCT04892693|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25374887|NCT04892693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25374888|NCT04892693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374889|NCT04892693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374890|NCT04892498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25374891|NCT04892498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374892|NCT04892498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374893|NCT04892472|Pembrolizumab|pembrolizumab|mesh-list
25374894|NCT04892472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25374895|NCT04892472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374896|NCT04892446|Dexamethasone|dexamethasone|mesh-list
25374897|NCT04892446|Bortezomib|bortezomib|mesh-list
25374898|NCT04892446|Daratumumab|daratumumab|mesh-list
25374899|NCT04892446|Pomalidomide|pomalidomide|mesh-list
25374900|NCT04892446|Magrolimab|magrolimab|mesh-list
25374901|NCT04892446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25374902|NCT04892446|Antiemetics|antiemetics|mesh-ancestor
25374904|NCT04892446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25374905|NCT04892446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374906|NCT04892446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25374907|NCT04892446|Glucocorticoids|glucocorticoids|mesh-ancestor
25374908|NCT04892446|Hormones|hormones|mesh-ancestor
25374909|NCT04892446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25374910|NCT04892446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25374911|NCT04892446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374912|NCT04892446|Immunologic Factors|immunologic factors|mesh-ancestor
25374913|NCT04892446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25374914|NCT04892446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25374915|NCT04892446|Growth Substances|growth substances|mesh-ancestor
25374916|NCT04892446|Growth Inhibitors|growth inhibitors|mesh-ancestor
25374917|NCT04892446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25374918|NCT04892043|Nivolumab|nivolumab|mesh-list
25374919|NCT04892043|Ipilimumab|ipilimumab|mesh-list
25374920|NCT04892043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25374921|NCT04892043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374922|NCT04892043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25374923|NCT04892043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25374924|NCT04891809|Dexamethasone|dexamethasone|mesh-list
25374925|NCT04891809|Lenalidomide|lenalidomide|mesh-list
25374926|NCT04891809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25374927|NCT04891809|Antiemetics|antiemetics|mesh-ancestor
25374928|NCT04891809|Autonomic Agents|autonomic agents|mesh-ancestor
25374929|NCT04891809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25374930|NCT04891809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25374931|NCT04891809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25374932|NCT04891809|Glucocorticoids|glucocorticoids|mesh-ancestor
25374933|NCT04891809|Hormones|hormones|mesh-ancestor
25374934|NCT04891809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25374935|NCT04891809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25374936|NCT04891809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374937|NCT04891809|Immunologic Factors|immunologic factors|mesh-ancestor
25374938|NCT04891809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25374939|NCT04891809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25374940|NCT04891809|Growth Substances|growth substances|mesh-ancestor
25374941|NCT04891809|Growth Inhibitors|growth inhibitors|mesh-ancestor
25374942|NCT04891770|Tenofovir|tenofovir|mesh-list
25374943|NCT04891770|Nivolumab|nivolumab|mesh-list
25374944|NCT04891770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25374945|NCT04891770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25374946|NCT04891770|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25374978|NCT04891419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25374979|NCT04891419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25374980|NCT04891419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25374981|NCT04891419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25374982|NCT04891419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25374983|NCT04891419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375018|NCT04889664|Analgesics|analgesics|mesh-ancestor
25375019|NCT04889664|Sensory System Agents|sensory system agents|mesh-ancestor
25375020|NCT04889664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25375021|NCT04889664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375022|NCT04889664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25375023|NCT04889664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25375024|NCT04889664|Anesthetics, General|anesthetics, general|mesh-ancestor
25375025|NCT04889664|Anesthetics|anesthetics|mesh-ancestor
25375026|NCT04889664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25375027|NCT04889664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25375028|NCT04889664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25375029|NCT04889664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25375030|NCT04889664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375031|NCT04889118|Pembrolizumab|pembrolizumab|mesh-list
25375032|NCT04889118|Lenvatinib|lenvatinib|mesh-list
25375033|NCT04889118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25375034|NCT04889118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375035|NCT04889118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25375036|NCT04889118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375037|NCT04889118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375038|NCT04889066|Durvalumab|durvalumab|mesh-list
25375039|NCT04889066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25375040|NCT04889066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375048|NCT04887857|Azacitidine|azacitidine|mesh-list
25375049|NCT04887857|Venetoclax|venetoclax|mesh-list
25375050|NCT04887857|Cc-486|cc-486|mesh-list
25375051|NCT04887857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25375052|NCT04887857|Antimetabolites|antimetabolites|mesh-ancestor
25375053|NCT04887857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375054|NCT04887857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375055|NCT04887857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375063|NCT04887506|Prednisone|prednisone|mesh-list
25375064|NCT04887506|Abiraterone Acetate|abiraterone acetate|mesh-list
25375065|NCT04887506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25375066|NCT04887506|Glucocorticoids|glucocorticoids|mesh-ancestor
25375067|NCT04887506|Hormones|hormones|mesh-ancestor
25375068|NCT04887506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25375069|NCT04887506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375070|NCT04887506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25375071|NCT04887506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375072|NCT04887506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25375073|NCT04887506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375074|NCT04887506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375075|NCT04887506|Hormone Antagonists|hormone antagonists|mesh-ancestor
25375076|NCT04887506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25375077|NCT04887298|Annamycin|annamycin|mesh-list
25375078|NCT04887298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25375079|NCT04887298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375080|NCT04886986|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25375081|NCT04886986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25375082|NCT04886986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375083|NCT04886531|Trastuzumab|trastuzumab|mesh-list
25375084|NCT04886531|Letrozole|letrozole|mesh-list
25375085|NCT04886531|Anastrozole|anastrozole|mesh-list
25375086|NCT04886531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25375087|NCT04886531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375088|NCT04886531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25375089|NCT04886531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25375090|NCT04886531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375091|NCT04886531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375092|NCT04886531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25375093|NCT04886531|Hormone Antagonists|hormone antagonists|mesh-ancestor
25375094|NCT04886531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25375095|NCT04886531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375096|NCT04886531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25375097|NCT04886323|Itraconazole|itraconazole|mesh-list
25375098|NCT04886323|Antifungal Agents|antifungal agents|mesh-ancestor
25375099|NCT04886323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25375100|NCT04886323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25375101|NCT04886323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25375102|NCT04886323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375103|NCT04886323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375104|NCT04886323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25375105|NCT04886323|Hormone Antagonists|hormone antagonists|mesh-ancestor
25375106|NCT04886323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25375107|NCT04886323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375108|NCT04886323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25375109|NCT04886232|Lidocaine|lidocaine|mesh-list
25375110|NCT04886232|Anesthetics, Local|anesthetics, local|mesh-ancestor
25375111|NCT04886232|Anesthetics|anesthetics|mesh-ancestor
25375112|NCT04886232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25375113|NCT04886232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25406597|NCT03547908|Antiviral Agents|antiviral agents|mesh-ancestor
25375114|NCT04886232|Sensory System Agents|sensory system agents|mesh-ancestor
25375189|NCT04884802|Etomidate|etomidate|mesh-list
25375115|NCT04886232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25375116|NCT04886232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25375117|NCT04886232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25375118|NCT04886232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25375119|NCT04886232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25375120|NCT04886232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375121|NCT04886154|Vaccines|vaccines|mesh-list
25375122|NCT04886154|Immunologic Factors|immunologic factors|mesh-ancestor
25375123|NCT04886154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375124|NCT04885972|Triamcinolone|triamcinolone|mesh-list
25375125|NCT04885972|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25375126|NCT04885972|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25375127|NCT04885972|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25375128|NCT04885972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25375129|NCT04885972|Glucocorticoids|glucocorticoids|mesh-ancestor
25375130|NCT04885972|Hormones|hormones|mesh-ancestor
25375131|NCT04885972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25375132|NCT04885972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375133|NCT04885972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25375134|NCT04885972|Immunologic Factors|immunologic factors|mesh-ancestor
25375135|NCT04885972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375136|NCT04885972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375137|NCT04885907|Vaccines|vaccines|mesh-list
25375138|NCT04885907|Immunologic Factors|immunologic factors|mesh-ancestor
25375139|NCT04885907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375140|NCT04885530|Fluticasone|fluticasone|mesh-list
25375141|NCT04885530|Xhance|xhance|mesh-list
25375142|NCT04885530|Ivermectin|ivermectin|mesh-list
25375143|NCT04885530|Fluvoxamine|fluvoxamine|mesh-list
25375144|NCT04885530|Montelukast|montelukast|mesh-list
25375145|NCT04885530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25375146|NCT04885530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25375147|NCT04885530|Autonomic Agents|autonomic agents|mesh-ancestor
25375148|NCT04885530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25375149|NCT04885530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375150|NCT04885530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25375151|NCT04885530|Respiratory System Agents|respiratory system agents|mesh-ancestor
25375152|NCT04885530|Dermatologic Agents|dermatologic agents|mesh-ancestor
25375153|NCT04885530|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25375154|NCT04885530|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25375155|NCT04885530|Hormone Antagonists|hormone antagonists|mesh-ancestor
25375156|NCT04885530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25375157|NCT04885530|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25375158|NCT04885530|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25375159|NCT04885530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375160|NCT04885530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375161|NCT04885530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25375162|NCT04885530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25375163|NCT04885530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25375164|NCT04885530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25375165|NCT04885530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25375166|NCT04885530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25375167|NCT04885530|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25375168|NCT04885530|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25375169|NCT04885530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25375170|NCT04885530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25375171|NCT04885530|Serotonin Agents|serotonin agents|mesh-ancestor
25375172|NCT04885530|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25375173|NCT04885530|Antidepressive Agents|antidepressive agents|mesh-ancestor
25375174|NCT04885530|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25375175|NCT04885530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25375176|NCT04885530|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25375177|NCT04884815|Prednisolone|prednisolone|mesh-list
25375178|NCT04884815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25375179|NCT04884815|Glucocorticoids|glucocorticoids|mesh-ancestor
25375180|NCT04884815|Hormones|hormones|mesh-ancestor
25375181|NCT04884815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25375182|NCT04884815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375183|NCT04884815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25724243|NCT02535949|Hemostatics|hemostatics|mesh-ancestor
25724244|NCT02535949|Coagulants|coagulants|mesh-ancestor
25375184|NCT04884815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375185|NCT04884802|Phenylephrine|phenylephrine|mesh-list
25375186|NCT04884802|Norepinephrine|norepinephrine|mesh-list
25375187|NCT04884802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
25375188|NCT04884802|Propofol|propofol|mesh-list
25375190|NCT04884802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25375191|NCT04884802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25375192|NCT04884802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375193|NCT04884802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25375194|NCT04884802|Anesthetics, General|anesthetics, general|mesh-ancestor
25375195|NCT04884802|Anesthetics|anesthetics|mesh-ancestor
25375196|NCT04884802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25375197|NCT04884802|Mydriatics|mydriatics|mesh-ancestor
25375198|NCT04884802|Autonomic Agents|autonomic agents|mesh-ancestor
25375199|NCT04884802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25375200|NCT04884802|Sympathomimetics|sympathomimetics|mesh-ancestor
25375201|NCT04884802|Nasal Decongestants|nasal decongestants|mesh-ancestor
25375202|NCT04884802|Respiratory System Agents|respiratory system agents|mesh-ancestor
25375203|NCT04884802|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
25375204|NCT04884802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25375205|NCT04884802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25375206|NCT04884802|Adrenergic Agents|adrenergic agents|mesh-ancestor
25375207|NCT04884802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25375208|NCT04884802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375209|NCT04884802|Protective Agents|protective agents|mesh-ancestor
25375210|NCT04884360|Olaparib|olaparib|mesh-list
25375211|NCT04884360|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25375212|NCT04884360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375213|NCT04884360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375214|NCT04884360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375215|NCT04884035|Prednisone|prednisone|mesh-list
25375216|NCT04884035|Prednisolone|prednisolone|mesh-list
25375217|NCT04884035|Cyclophosphamide|cyclophosphamide|mesh-list
25375218|NCT04884035|Rituximab|rituximab|mesh-list
25375219|NCT04884035|Doxorubicin|doxorubicin|mesh-list
25375220|NCT04884035|Vincristine|vincristine|mesh-list
25375221|NCT04884035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25375222|NCT04884035|Immunologic Factors|immunologic factors|mesh-ancestor
25375223|NCT04884035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375224|NCT04884035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25375225|NCT04884035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25375226|NCT04884035|Alkylating Agents|alkylating agents|mesh-ancestor
25375227|NCT04884035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375228|NCT04884035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375229|NCT04884035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25375230|NCT04884035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25375231|NCT04884035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25375232|NCT04884035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25375233|NCT04884035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25375234|NCT04884035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375235|NCT04884035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25375236|NCT04884035|Glucocorticoids|glucocorticoids|mesh-ancestor
25375237|NCT04884035|Hormones|hormones|mesh-ancestor
25375238|NCT04884035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25375239|NCT04884035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25375240|NCT04884035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25375241|NCT04884035|Tubulin Modulators|tubulin modulators|mesh-ancestor
25375242|NCT04884035|Antimitotic Agents|antimitotic agents|mesh-ancestor
25375243|NCT04884035|Mitosis Modulators|mitosis modulators|mesh-ancestor
25375244|NCT04883892|Hyaluronic Acid|hyaluronic acid|mesh-list
25375245|NCT04883892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25375246|NCT04883892|Immunologic Factors|immunologic factors|mesh-ancestor
25375247|NCT04883892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375248|NCT04883892|Viscosupplements|viscosupplements|mesh-ancestor
25375249|NCT04883892|Protective Agents|protective agents|mesh-ancestor
25375250|NCT04883645|Imiquimod|imiquimod|mesh-list
25375251|NCT04883645|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25375252|NCT04883645|Immunologic Factors|immunologic factors|mesh-ancestor
25375253|NCT04883645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375254|NCT04883645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375255|NCT04883645|Interferon Inducers|interferon inducers|mesh-ancestor
25375256|NCT04883528|Valsartan|valsartan|mesh-list
25375257|NCT04883528|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25375258|NCT04883528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25375259|NCT04883528|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25375260|NCT04883528|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25375261|NCT04883528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375262|NCT04883346|Liraglutide|liraglutide|mesh-list
25375263|NCT04883346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25375343|NCT04881799|Phentermine|phentermine|mesh-list
25375264|NCT04883346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375265|NCT04883346|Incretins|incretins|mesh-ancestor
25375266|NCT04883346|Hormones|hormones|mesh-ancestor
25375267|NCT04883346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25375268|NCT04883281|Paclitaxel|paclitaxel|mesh-list
25375269|NCT04883281|Cisplatin|cisplatin|mesh-list
25375270|NCT04883281|Carboplatin|carboplatin|mesh-list
25375271|NCT04883281|Cetuximab|cetuximab|mesh-list
25375272|NCT04883281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25375273|NCT04883281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375274|NCT04883281|Tubulin Modulators|tubulin modulators|mesh-ancestor
25375275|NCT04883281|Antimitotic Agents|antimitotic agents|mesh-ancestor
25375276|NCT04883281|Mitosis Modulators|mitosis modulators|mesh-ancestor
25375277|NCT04883281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375278|NCT04883281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25375279|NCT04883242|Dexamethasone|dexamethasone|mesh-list
25375280|NCT04883242|Dexamethasone acetate|dexamethasone acetate|mesh-list
25375281|NCT04883242|Pomalidomide|pomalidomide|mesh-list
25375282|NCT04883242|Ichthammol|ichthammol|mesh-list
25375283|NCT04883242|BB 1101|bb 1101|mesh-list
25375284|NCT04883242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25375285|NCT04883242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25375286|NCT04883242|Antiemetics|antiemetics|mesh-ancestor
25375287|NCT04883242|Autonomic Agents|autonomic agents|mesh-ancestor
25375288|NCT04883242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25375289|NCT04883242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375290|NCT04883242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25375291|NCT04883242|Glucocorticoids|glucocorticoids|mesh-ancestor
25375292|NCT04883242|Hormones|hormones|mesh-ancestor
25375293|NCT04883242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25375294|NCT04883242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25375295|NCT04883242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375296|NCT04883242|Protease Inhibitors|protease inhibitors|mesh-ancestor
25375297|NCT04883242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375298|NCT04883242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375299|NCT04883242|Immunologic Factors|immunologic factors|mesh-ancestor
25375300|NCT04883242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25375301|NCT04883242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25375302|NCT04883242|Growth Substances|growth substances|mesh-ancestor
25375303|NCT04883242|Growth Inhibitors|growth inhibitors|mesh-ancestor
25375304|NCT04883242|Dermatologic Agents|dermatologic agents|mesh-ancestor
25375305|NCT04882839|Psilocybin|psilocybin|mesh-list
25375306|NCT04882839|Hallucinogens|hallucinogens|mesh-ancestor
25375307|NCT04882839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375308|NCT04882839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25375309|NCT04882241|Leucovorin|leucovorin|mesh-list
25375310|NCT04882241|Cisplatin|cisplatin|mesh-list
25375311|NCT04882241|Docetaxel|docetaxel|mesh-list
25375312|NCT04882241|Pembrolizumab|pembrolizumab|mesh-list
25375313|NCT04882241|Fluorouracil|fluorouracil|mesh-list
25375314|NCT04882241|Capecitabine|capecitabine|mesh-list
25375315|NCT04882241|Oxaliplatin|oxaliplatin|mesh-list
25375316|NCT04882241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375317|NCT04882241|Tubulin Modulators|tubulin modulators|mesh-ancestor
25375318|NCT04882241|Antimitotic Agents|antimitotic agents|mesh-ancestor
25375319|NCT04882241|Mitosis Modulators|mitosis modulators|mesh-ancestor
25375320|NCT04882241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375321|NCT04882241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25375322|NCT04882241|Antimetabolites|antimetabolites|mesh-ancestor
25375323|NCT04882241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25375324|NCT04882241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25375325|NCT04882241|Immunologic Factors|immunologic factors|mesh-ancestor
25375326|NCT04882241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375327|NCT04882241|Antidotes|antidotes|mesh-ancestor
25375328|NCT04882241|Protective Agents|protective agents|mesh-ancestor
25375329|NCT04882241|Vitamin B Complex|vitamin b complex|mesh-ancestor
25375330|NCT04882241|Vitamins|vitamins|mesh-ancestor
25375331|NCT04882241|Micronutrients|micronutrients|mesh-ancestor
25375332|NCT04882085|Ceftazidime|ceftazidime|mesh-list
25375333|NCT04882085|Avibactam|avibactam|mesh-list
25375334|NCT04882085|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
25375335|NCT04882085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25375336|NCT04882085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25408384|NCT03447379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375337|NCT04882085|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25375338|NCT04882085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375339|NCT04882085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375340|NCT04882072|Ustekinumab|ustekinumab|mesh-list
25375341|NCT04882072|Dermatologic Agents|dermatologic agents|mesh-ancestor
25375342|NCT04881799|Topiramate|topiramate|mesh-list
25375344|NCT04881799|Anticonvulsants|anticonvulsants|mesh-ancestor
25375345|NCT04881799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25375346|NCT04881799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375347|NCT04881799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25375348|NCT04881799|Appetite Depressants|appetite depressants|mesh-ancestor
25375349|NCT04881799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25375350|NCT04881799|Sympathomimetics|sympathomimetics|mesh-ancestor
25375351|NCT04881799|Autonomic Agents|autonomic agents|mesh-ancestor
25375352|NCT04881799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25375353|NCT04881799|Adrenergic Agents|adrenergic agents|mesh-ancestor
25375354|NCT04881799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25375355|NCT04881799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375356|NCT04881682|Immunoglobulins|immunoglobulins|mesh-list
25375357|NCT04881682|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25375358|NCT04881682|Antibodies|antibodies|mesh-list
25375359|NCT04881682|Immunologic Factors|immunologic factors|mesh-ancestor
25375360|NCT04881682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375361|NCT04881240|Cyclophosphamide|cyclophosphamide|mesh-list
25375362|NCT04881240|Fludarabine|fludarabine|mesh-list
25375363|NCT04881240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25375364|NCT04881240|Immunologic Factors|immunologic factors|mesh-ancestor
25375365|NCT04881240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375366|NCT04881240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25375367|NCT04881240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25375368|NCT04881240|Alkylating Agents|alkylating agents|mesh-ancestor
25375369|NCT04881240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375370|NCT04881240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375371|NCT04881240|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25375372|NCT04880876|Eluxadoline|eluxadoline|mesh-list
25375373|NCT04880876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25375374|NCT04880863|Docetaxel|docetaxel|mesh-list
25375375|NCT04880863|Obinutuzumab|obinutuzumab|mesh-list
25375376|NCT04880863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375377|NCT04880863|Tubulin Modulators|tubulin modulators|mesh-ancestor
25375378|NCT04880863|Antimitotic Agents|antimitotic agents|mesh-ancestor
25375379|NCT04880863|Mitosis Modulators|mitosis modulators|mesh-ancestor
25375380|NCT04880863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375381|NCT04880863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25375382|NCT04880577|Tenofovir|tenofovir|mesh-list
25375383|NCT04880577|Rituximab|rituximab|mesh-list
25375384|NCT04880577|Ocrelizumab|ocrelizumab|mesh-list
25375385|NCT04880577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25375386|NCT04880577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375387|NCT04880577|Immunologic Factors|immunologic factors|mesh-ancestor
25375388|NCT04880577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375389|NCT04880577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25375390|NCT04880577|Antiviral Agents|antiviral agents|mesh-ancestor
25375391|NCT04880577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25375392|NCT04880577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25375393|NCT04880577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25375394|NCT04880577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375395|NCT04880577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375396|NCT04880577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25375397|NCT04880577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25375398|NCT04880434|Cyclophosphamide|cyclophosphamide|mesh-list
25375399|NCT04880434|Fludarabine|fludarabine|mesh-list
25375400|NCT04880434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25375401|NCT04880434|Immunologic Factors|immunologic factors|mesh-ancestor
25375402|NCT04880434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375403|NCT04880434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25375404|NCT04880434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25375405|NCT04880434|Alkylating Agents|alkylating agents|mesh-ancestor
25375406|NCT04880434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375407|NCT04880434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375408|NCT04880434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25375409|NCT04879524|Botulinum Toxins|botulinum toxins|mesh-list
25375410|NCT04879524|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25375411|NCT04879524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25375412|NCT04879524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375413|NCT04879524|Cholinergic Agents|cholinergic agents|mesh-ancestor
25375414|NCT04879524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25375415|NCT04879524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375416|NCT04879329|Pembrolizumab|pembrolizumab|mesh-list
25375417|NCT04879329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25375418|NCT04879329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375419|NCT04878198|Melatonin|melatonin|mesh-list
25375420|NCT04878198|Antioxidants|antioxidants|mesh-ancestor
25375421|NCT04878198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375422|NCT04878198|Protective Agents|protective agents|mesh-ancestor
25375423|NCT04878198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375424|NCT04878198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25375425|NCT04878029|Immunoconjugates|immunoconjugates|mesh-list
25375426|NCT04878029|Immunologic Factors|immunologic factors|mesh-ancestor
25375427|NCT04878029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375428|NCT04877834|Dexlansoprazole|dexlansoprazole|mesh-list
25375429|NCT04877834|Lansoprazole|lansoprazole|mesh-list
25375430|NCT04877834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25375431|NCT04877834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25375432|NCT04877834|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25375433|NCT04877834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375434|NCT04877834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375435|NCT04877639|Dexmedetomidine|dexmedetomidine|mesh-list
25375436|NCT04877639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25375437|NCT04877639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25375438|NCT04877639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375439|NCT04877639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25375440|NCT04877639|Analgesics|analgesics|mesh-ancestor
25375441|NCT04877639|Sensory System Agents|sensory system agents|mesh-ancestor
25375442|NCT04877639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25375443|NCT04877639|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25375444|NCT04877639|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25375445|NCT04877639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25375446|NCT04877639|Adrenergic Agents|adrenergic agents|mesh-ancestor
25375447|NCT04877639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25375448|NCT04877639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375449|NCT04877613|Cyclophosphamide|cyclophosphamide|mesh-list
25375450|NCT04877613|Fludarabine|fludarabine|mesh-list
25375451|NCT04877613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25375452|NCT04877613|Immunologic Factors|immunologic factors|mesh-ancestor
25375453|NCT04877613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375454|NCT04877613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25375455|NCT04877613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25375456|NCT04877613|Alkylating Agents|alkylating agents|mesh-ancestor
25375457|NCT04877613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375458|NCT04877613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375459|NCT04877613|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25375460|NCT04877587|Gemcitabine|gemcitabine|mesh-list
25375461|NCT04877587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375462|NCT04877587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25375463|NCT04877587|Antimetabolites|antimetabolites|mesh-ancestor
25375464|NCT04877587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375465|NCT04877587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375466|NCT04877587|Antiviral Agents|antiviral agents|mesh-ancestor
25375467|NCT04877587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25375468|NCT04877587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375469|NCT04877587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25375470|NCT04877587|Immunologic Factors|immunologic factors|mesh-ancestor
25375471|NCT04877522|Niacinamide|niacinamide|mesh-list
25375472|NCT04877522|Imatinib Mesylate|imatinib mesylate|mesh-list
25375473|NCT04877522|Dasatinib|dasatinib|mesh-list
25375474|NCT04877522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375475|NCT04877522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25375476|NCT04877522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375477|NCT04877522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375478|NCT04877522|Vitamin B Complex|vitamin b complex|mesh-ancestor
25375479|NCT04877522|Vitamins|vitamins|mesh-ancestor
25375480|NCT04877522|Micronutrients|micronutrients|mesh-ancestor
25375481|NCT04877522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375482|NCT04877288|Cyclosporine|cyclosporine|mesh-list
25375483|NCT04877288|Mycophenolic Acid|mycophenolic acid|mesh-list
25375484|NCT04877288|Abatacept|abatacept|mesh-list
25375485|NCT04877288|Tacrolimus|tacrolimus|mesh-list
25375486|NCT04877288|Cyclosporins|cyclosporins|mesh-list
25375487|NCT04877288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25375488|NCT04877288|Immunologic Factors|immunologic factors|mesh-ancestor
25406979|NCT03524820|Cetuximab|cetuximab|mesh-list
25375489|NCT04877288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375490|NCT04877288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25375491|NCT04877288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375492|NCT04877288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375493|NCT04877288|Antifungal Agents|antifungal agents|mesh-ancestor
25375645|NCT04872790|Antimetabolites|antimetabolites|mesh-ancestor
25375494|NCT04877288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25375495|NCT04877288|Dermatologic Agents|dermatologic agents|mesh-ancestor
25375496|NCT04877288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25375497|NCT04877288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25375498|NCT04877288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375499|NCT04877288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25375500|NCT04877288|Antitubercular Agents|antitubercular agents|mesh-ancestor
25375501|NCT04877288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25375502|NCT04877288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25375503|NCT04877275|Dexamethasone|dexamethasone|mesh-list
25375504|NCT04877275|Cyclophosphamide|cyclophosphamide|mesh-list
25375505|NCT04877275|Doxorubicin|doxorubicin|mesh-list
25375506|NCT04877275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25375507|NCT04877275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25375508|NCT04877275|Immunologic Factors|immunologic factors|mesh-ancestor
25375509|NCT04877275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375510|NCT04877275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25375511|NCT04877275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25375512|NCT04877275|Alkylating Agents|alkylating agents|mesh-ancestor
25375513|NCT04877275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375514|NCT04877275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375515|NCT04877275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25375516|NCT04877275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25375517|NCT04877275|Antiemetics|antiemetics|mesh-ancestor
25375518|NCT04877275|Autonomic Agents|autonomic agents|mesh-ancestor
25375519|NCT04877275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25375520|NCT04877275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25375521|NCT04877275|Glucocorticoids|glucocorticoids|mesh-ancestor
25375523|NCT04877275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25375524|NCT04877275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25375525|NCT04877275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25375526|NCT04877275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25375527|NCT04877275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25375528|NCT04877275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375529|NCT04876534|Methylprednisolone|methylprednisolone|mesh-list
25375530|NCT04876534|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25375531|NCT04876534|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25375532|NCT04876534|Prednisolone|prednisolone|mesh-list
25375533|NCT04876534|Prednisolone acetate|prednisolone acetate|mesh-list
25375534|NCT04876534|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25375535|NCT04876534|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25375536|NCT04876534|Prednisolone phosphate|prednisolone phosphate|mesh-list
25375537|NCT04876534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25375538|NCT04876534|Antiemetics|antiemetics|mesh-ancestor
25375539|NCT04876534|Autonomic Agents|autonomic agents|mesh-ancestor
25375540|NCT04876534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25375541|NCT04876534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375542|NCT04876534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25375543|NCT04876534|Glucocorticoids|glucocorticoids|mesh-ancestor
25375544|NCT04876534|Hormones|hormones|mesh-ancestor
25375545|NCT04876534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25375546|NCT04876534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25375547|NCT04876534|Protective Agents|protective agents|mesh-ancestor
25375548|NCT04876534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25375549|NCT04876534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375550|NCT04876430|Meropenem|meropenem|mesh-list
25375551|NCT04876430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25375552|NCT04876430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25375553|NCT04876248|Lenalidomide|lenalidomide|mesh-list
25375554|NCT04876248|Immunologic Factors|immunologic factors|mesh-ancestor
25375555|NCT04876248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375556|NCT04876248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25375557|NCT04876248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25375558|NCT04876248|Growth Substances|growth substances|mesh-ancestor
25375559|NCT04876248|Growth Inhibitors|growth inhibitors|mesh-ancestor
25375560|NCT04876248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375561|NCT04876079|Insulin|insulin|mesh-list
25375562|NCT04876079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25724245|NCT02536040|Fluorides|fluorides|mesh-list
25375563|NCT04876079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375565|NCT04876027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25375566|NCT04876027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375567|NCT04875975|Rozanolixizumab|rozanolixizumab|mesh-list
25375568|NCT04875975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25375569|NCT04875975|Immunologic Factors|immunologic factors|mesh-ancestor
25375570|NCT04875975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375571|NCT04875585|Pembrolizumab|pembrolizumab|mesh-list
25375572|NCT04875585|Lenvatinib|lenvatinib|mesh-list
25375573|NCT04875585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25375574|NCT04875585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375575|NCT04875585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25375576|NCT04875585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375577|NCT04875585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375578|NCT04875533|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25375579|NCT04875533|Immunologic Factors|immunologic factors|mesh-ancestor
25375580|NCT04875533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375581|NCT04875364|Eszopiclone|eszopiclone|mesh-list
25375582|NCT04875364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25375583|NCT04875364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25375584|NCT04875364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375585|NCT04875195|Pembrolizumab|pembrolizumab|mesh-list
25375586|NCT04875195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25375587|NCT04875195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375588|NCT04875026|Fluorouracil|fluorouracil|mesh-list
25375589|NCT04875026|Antimetabolites|antimetabolites|mesh-ancestor
25375590|NCT04875026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375591|NCT04875026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25375592|NCT04875026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375593|NCT04875026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25375594|NCT04875026|Immunologic Factors|immunologic factors|mesh-ancestor
25375595|NCT04875026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375596|NCT04874025|Palbociclib|palbociclib|mesh-list
25375597|NCT04874025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375598|NCT04874025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25375599|NCT04874025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375600|NCT04874025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375601|NCT04873570|Moxifloxacin|moxifloxacin|mesh-list
25375602|NCT04873570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25375603|NCT04873570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25375604|NCT04873570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25375605|NCT04873570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25375606|NCT04873570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375607|NCT04873570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375608|NCT04873570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375609|NCT04873362|Trastuzumab|trastuzumab|mesh-list
25375610|NCT04873362|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25375611|NCT04873362|Atezolizumab|atezolizumab|mesh-list
25375612|NCT04873362|Maytansine|maytansine|mesh-list
25375613|NCT04873362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25375614|NCT04873362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375615|NCT04873362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25375616|NCT04873362|Tubulin Modulators|tubulin modulators|mesh-ancestor
25375617|NCT04873362|Antimitotic Agents|antimitotic agents|mesh-ancestor
25375618|NCT04873362|Mitosis Modulators|mitosis modulators|mesh-ancestor
25375619|NCT04873362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375620|NCT04873193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25375621|NCT04873193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25375622|NCT04872790|Prednisone|prednisone|mesh-list
25375623|NCT04872790|Cortisone|cortisone|mesh-list
25375624|NCT04872790|Rituximab|rituximab|mesh-list
25375625|NCT04872790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25375626|NCT04872790|Methotrexate|methotrexate|mesh-list
25375627|NCT04872790|Dasatinib|dasatinib|mesh-list
25375628|NCT04872790|Venetoclax|venetoclax|mesh-list
25375629|NCT04872790|Antibodies|antibodies|mesh-list
25375630|NCT04872790|Immunoglobulins|immunoglobulins|mesh-list
25375631|NCT04872790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25375632|NCT04872790|Immunologic Factors|immunologic factors|mesh-ancestor
25375633|NCT04872790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375634|NCT04872790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375635|NCT04872790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25375636|NCT04872790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25375637|NCT04872790|Glucocorticoids|glucocorticoids|mesh-ancestor
25375638|NCT04872790|Hormones|hormones|mesh-ancestor
25375639|NCT04872790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25375640|NCT04872790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25375641|NCT04872790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25375642|NCT04872790|Abortifacient Agents|abortifacient agents|mesh-ancestor
25375643|NCT04872790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25375644|NCT04872790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25375646|NCT04872790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375647|NCT04872790|Dermatologic Agents|dermatologic agents|mesh-ancestor
25375648|NCT04872790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375649|NCT04872790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25375650|NCT04872790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25375651|NCT04872790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25375652|NCT04872790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25375654|NCT04872608|Palbociclib|palbociclib|mesh-list
25375655|NCT04872608|Onapristone|onapristone|mesh-list
25375656|NCT04872608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375657|NCT04872608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25375658|NCT04872608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25375659|NCT04872608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375660|NCT04872608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375661|NCT04872608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25375662|NCT04872608|Hormone Antagonists|hormone antagonists|mesh-ancestor
25375663|NCT04872608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25375664|NCT04872608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375665|NCT04872608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25375666|NCT04872608|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25375667|NCT04872608|Fertility Agents|fertility agents|mesh-ancestor
25375668|NCT04872608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25375669|NCT04872595|Cyclophosphamide|cyclophosphamide|mesh-list
25375670|NCT04872595|Melphalan|melphalan|mesh-list
25375671|NCT04872595|Busulfan|busulfan|mesh-list
25375672|NCT04872595|Thiotepa|thiotepa|mesh-list
25375673|NCT04872595|Fludarabine|fludarabine|mesh-list
25375674|NCT04872595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25375675|NCT04872595|Immunologic Factors|immunologic factors|mesh-ancestor
25375676|NCT04872595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375677|NCT04872595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25375678|NCT04872595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25375679|NCT04872595|Alkylating Agents|alkylating agents|mesh-ancestor
25375680|NCT04872595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375681|NCT04872595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375682|NCT04872595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25375683|NCT04872582|Bevacizumab|bevacizumab|mesh-list
25375684|NCT04872582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25375685|NCT04872582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25375686|NCT04872582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375687|NCT04872582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25375688|NCT04872582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25375689|NCT04872582|Growth Substances|growth substances|mesh-ancestor
25375690|NCT04872582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375691|NCT04872582|Growth Inhibitors|growth inhibitors|mesh-ancestor
25375692|NCT04872582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375693|NCT04871958|Insulin|insulin|mesh-list
25375694|NCT04871958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25375695|NCT04871958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375696|NCT04871594|Nivolumab|nivolumab|mesh-list
25375697|NCT04871594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25375698|NCT04871594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375699|NCT04871594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25375700|NCT04871594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375701|NCT04871204|Octreotide|octreotide|mesh-list
25375702|NCT04871204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25375703|NCT04871204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25375704|NCT04871204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375705|NCT04870866|Niacinamide|niacinamide|mesh-list
25375706|NCT04870866|Niacin|niacin|mesh-list
25375707|NCT04870866|Nicotinic Acids|nicotinic acids|mesh-list
25375708|NCT04870866|Vitamin B Complex|vitamin b complex|mesh-ancestor
25375709|NCT04870866|Vitamins|vitamins|mesh-ancestor
25375710|NCT04870866|Micronutrients|micronutrients|mesh-ancestor
25375711|NCT04870866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375712|NCT04870866|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25375713|NCT04870866|Antimetabolites|antimetabolites|mesh-ancestor
25375714|NCT04870866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375715|NCT04870866|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25375716|NCT04870866|Vasodilator Agents|vasodilator agents|mesh-ancestor
25375718|NCT04870112|Carboplatin|carboplatin|mesh-list
25375719|NCT04870112|Etoposide|etoposide|mesh-list
25375720|NCT04870112|Durvalumab|durvalumab|mesh-list
25375721|NCT04870112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375722|NCT04870112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25375723|NCT04870112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25375724|NCT04870112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25375725|NCT04870112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375726|NCT04870112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375727|NCT04870112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25375728|NCT04869943|Exemestane|exemestane|mesh-list
25375729|NCT04869943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375730|NCT04869943|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25375731|NCT04869943|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25375732|NCT04869943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375733|NCT04869943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375734|NCT04869943|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25375735|NCT04869943|Hormone Antagonists|hormone antagonists|mesh-ancestor
25375736|NCT04869943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25375737|NCT04869943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375738|NCT04869488|Prednisone|prednisone|mesh-list
25375739|NCT04869488|Apatinib|apatinib|mesh-list
25375740|NCT04869488|Abiraterone Acetate|abiraterone acetate|mesh-list
25375741|NCT04869488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25375742|NCT04869488|Glucocorticoids|glucocorticoids|mesh-ancestor
25375743|NCT04869488|Hormones|hormones|mesh-ancestor
25375744|NCT04869488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25375745|NCT04869488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375746|NCT04869488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25375747|NCT04869488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375748|NCT04869488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25375749|NCT04869488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375750|NCT04869488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375751|NCT04869488|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25375752|NCT04869488|Hormone Antagonists|hormone antagonists|mesh-ancestor
25375753|NCT04869488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25375754|NCT04869436|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25375755|NCT04869436|Immunologic Factors|immunologic factors|mesh-ancestor
25375756|NCT04869436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375757|NCT04869371|Prednisone|prednisone|mesh-list
25375758|NCT04869371|Docetaxel|docetaxel|mesh-list
25375759|NCT04869371|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25375760|NCT04869371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375761|NCT04869371|Tubulin Modulators|tubulin modulators|mesh-ancestor
25375762|NCT04869371|Antimitotic Agents|antimitotic agents|mesh-ancestor
25375763|NCT04869371|Mitosis Modulators|mitosis modulators|mesh-ancestor
25375764|NCT04869371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375765|NCT04869371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25375766|NCT04869371|Glucocorticoids|glucocorticoids|mesh-ancestor
25375767|NCT04869371|Hormones|hormones|mesh-ancestor
25375768|NCT04869371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25375769|NCT04869371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375770|NCT04869371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25375771|NCT04869371|Luteolytic Agents|luteolytic agents|mesh-ancestor
25375772|NCT04869371|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25375773|NCT04869371|Contraceptive Agents|contraceptive agents|mesh-ancestor
25375774|NCT04869371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25375775|NCT04869371|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25375776|NCT04869358|Ofatumumab|ofatumumab|mesh-list
25375777|NCT04869358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375778|NCT04869306|Hyaluronic Acid|hyaluronic acid|mesh-list
25375779|NCT04869306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25375780|NCT04869306|Immunologic Factors|immunologic factors|mesh-ancestor
25375781|NCT04869306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375782|NCT04869306|Viscosupplements|viscosupplements|mesh-ancestor
25375783|NCT04869306|Protective Agents|protective agents|mesh-ancestor
25375784|NCT04869137|Pembrolizumab|pembrolizumab|mesh-list
25375785|NCT04869137|Lenvatinib|lenvatinib|mesh-list
25375786|NCT04869137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25375787|NCT04869137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375788|NCT04869137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25375789|NCT04869137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375790|NCT04869137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375791|NCT04869124|Dapagliflozin|dapagliflozin|mesh-list
25375792|NCT04869124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25375793|NCT04869124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375794|NCT04869124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25375795|NCT04869124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375796|NCT04868838|Daratumumab|daratumumab|mesh-list
25375797|NCT04868838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375799|NCT04868760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25375800|NCT04868760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375801|NCT04868760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25375802|NCT04868760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375803|NCT04868045|Hormones|hormones|mesh-list
25375804|NCT04868045|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
25375805|NCT04868045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25375806|NCT04868045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375807|NCT04866108|Capecitabine|capecitabine|mesh-list
25375808|NCT04866108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25375809|NCT04866108|Antimetabolites|antimetabolites|mesh-ancestor
25375810|NCT04866108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375811|NCT04866108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375812|NCT04865887|Pembrolizumab|pembrolizumab|mesh-list
25375813|NCT04865887|Lenvatinib|lenvatinib|mesh-list
25375814|NCT04865887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25375815|NCT04865887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375816|NCT04865887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25375817|NCT04865887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375818|NCT04865887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375819|NCT04865419|Voriconazole|voriconazole|mesh-list
25375820|NCT04865419|Antifungal Agents|antifungal agents|mesh-ancestor
25375821|NCT04865419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25375822|NCT04865419|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25375823|NCT04865419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25375824|NCT04865419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375825|NCT04865419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375826|NCT04865419|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25375827|NCT04865419|Hormone Antagonists|hormone antagonists|mesh-ancestor
25375828|NCT04865419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25375829|NCT04865419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375830|NCT04865419|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25375831|NCT04865237|Remdesivir|remdesivir|mesh-list
25375832|NCT04865237|Antimetabolites|antimetabolites|mesh-ancestor
25375833|NCT04865237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375834|NCT04865237|Antiviral Agents|antiviral agents|mesh-ancestor
25375835|NCT04865237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25375836|NCT04865159|Tipifarnib|tipifarnib|mesh-list
25375837|NCT04865159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375838|NCT04864444|Piperaquine|piperaquine|mesh-list
25375839|NCT04864444|Primaquine|primaquine|mesh-list
25375840|NCT04864444|Artenimol|artenimol|mesh-list
25375841|NCT04864444|Antimalarials|antimalarials|mesh-ancestor
25375842|NCT04864444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25375843|NCT04864444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25375844|NCT04864444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25375845|NCT04864210|Bupivacaine|bupivacaine|mesh-list
25375846|NCT04864210|Anesthetics, Local|anesthetics, local|mesh-ancestor
25375847|NCT04864210|Anesthetics|anesthetics|mesh-ancestor
25375848|NCT04864210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25375849|NCT04864210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375850|NCT04864210|Sensory System Agents|sensory system agents|mesh-ancestor
25375851|NCT04864210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25375852|NCT04863885|Nivolumab|nivolumab|mesh-list
25375853|NCT04863885|Ipilimumab|ipilimumab|mesh-list
25375854|NCT04863885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25375855|NCT04863885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375856|NCT04863885|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25375857|NCT04863885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375858|NCT04863716|Fentanyl|fentanyl|mesh-list
25375859|NCT04863716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25375860|NCT04863716|Narcotics|narcotics|mesh-ancestor
25375861|NCT04863716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25375862|NCT04863716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375863|NCT04863716|Analgesics|analgesics|mesh-ancestor
25375864|NCT04863716|Sensory System Agents|sensory system agents|mesh-ancestor
25375865|NCT04863716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25375866|NCT04863716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25375867|NCT04863716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25375868|NCT04863716|Anesthetics, General|anesthetics, general|mesh-ancestor
25375869|NCT04863716|Anesthetics|anesthetics|mesh-ancestor
25375871|NCT04862975|Emtricitabine|emtricitabine|mesh-list
25375872|NCT04862975|Efavirenz|efavirenz|mesh-list
25375873|NCT04862975|Dolutegravir|dolutegravir|mesh-list
25375874|NCT04862975|Antiviral Agents|antiviral agents|mesh-ancestor
25375875|NCT04862975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25375876|NCT04862975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25375877|NCT04862975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25375878|NCT04862975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375879|NCT04862975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375880|NCT04862975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25375881|NCT04862975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25375882|NCT04862975|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25375883|NCT04862975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25375884|NCT04862975|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25375885|NCT04862975|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25375886|NCT04862975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25375887|NCT04862975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25375888|NCT04862975|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25375889|NCT04862975|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25375890|NCT04862780|Osimertinib|osimertinib|mesh-list
25375891|NCT04862780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375892|NCT04862780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25375893|NCT04862780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375894|NCT04862780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375895|NCT04862663|Fulvestrant|fulvestrant|mesh-list
25375896|NCT04862663|Palbociclib|palbociclib|mesh-list
25375897|NCT04862663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25375898|NCT04862663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375899|NCT04862663|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25375900|NCT04862663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25375901|NCT04862663|Hormone Antagonists|hormone antagonists|mesh-ancestor
25375902|NCT04862663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25375903|NCT04862663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375904|NCT04862663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25375905|NCT04862663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375906|NCT04862663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375907|NCT04862286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25375908|NCT04862286|Immunologic Factors|immunologic factors|mesh-ancestor
25375909|NCT04862286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375910|NCT04862221|Diphenhydramine|diphenhydramine|mesh-list
25375911|NCT04862221|Promethazine|promethazine|mesh-list
25375912|NCT04862221|Methylprednisolone|methylprednisolone|mesh-list
25375913|NCT04862221|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25375914|NCT04862221|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25375915|NCT04862221|Prednisolone|prednisolone|mesh-list
25375916|NCT04862221|Prednisolone acetate|prednisolone acetate|mesh-list
25375917|NCT04862221|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25375918|NCT04862221|Prednisolone phosphate|prednisolone phosphate|mesh-list
25375919|NCT04862221|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25375920|NCT04862221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25375921|NCT04862221|Antiemetics|antiemetics|mesh-ancestor
25375922|NCT04862221|Autonomic Agents|autonomic agents|mesh-ancestor
25375923|NCT04862221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25375924|NCT04862221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375925|NCT04862221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25375926|NCT04862221|Glucocorticoids|glucocorticoids|mesh-ancestor
25375927|NCT04862221|Hormones|hormones|mesh-ancestor
25375928|NCT04862221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25375929|NCT04862221|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25375930|NCT04862221|Protective Agents|protective agents|mesh-ancestor
25375931|NCT04862221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25375932|NCT04862221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375933|NCT04862221|Immunologic Factors|immunologic factors|mesh-ancestor
25375934|NCT04862221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25375935|NCT04862221|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25375936|NCT04862221|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25375937|NCT04862221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25375938|NCT04862221|Anesthetics, Local|anesthetics, local|mesh-ancestor
25375939|NCT04862221|Anesthetics|anesthetics|mesh-ancestor
25375940|NCT04862221|Sensory System Agents|sensory system agents|mesh-ancestor
25375941|NCT04862221|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25375942|NCT04862221|Histamine Antagonists|histamine antagonists|mesh-ancestor
25375943|NCT04862221|Histamine Agents|histamine agents|mesh-ancestor
25375944|NCT04862221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25375945|NCT04862221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375946|NCT04862221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25375947|NCT04862221|Antipruritics|antipruritics|mesh-ancestor
25375948|NCT04862221|Dermatologic Agents|dermatologic agents|mesh-ancestor
25375949|NCT04862065|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
25375950|NCT04862065|Immunologic Factors|immunologic factors|mesh-ancestor
25375951|NCT04862065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375952|NCT04860960|Betadex|betadex|mesh-list
25375953|NCT04860960|Sequestering Agents|sequestering agents|mesh-ancestor
25375954|NCT04860960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375955|NCT04860830|BI 425809|bi 425809|mesh-list
25375956|NCT04860830|Nootropic Agents|nootropic agents|mesh-ancestor
25375957|NCT04860505|Doxycycline|doxycycline|mesh-list
25375958|NCT04860505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25375959|NCT04860505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25375960|NCT04860505|Antimalarials|antimalarials|mesh-ancestor
25375961|NCT04860505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25375962|NCT04860505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25375963|NCT04860154|Hematoporphyrins|hematoporphyrins|mesh-list
25375964|NCT04860154|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25375965|NCT04860154|Dermatologic Agents|dermatologic agents|mesh-ancestor
25375966|NCT04859946|Cyclophosphamide|cyclophosphamide|mesh-list
25375967|NCT04859946|Busulfan|busulfan|mesh-list
25375968|NCT04859946|Thiotepa|thiotepa|mesh-list
25375969|NCT04859946|Fludarabine|fludarabine|mesh-list
25375970|NCT04859946|Tacrolimus|tacrolimus|mesh-list
25375971|NCT04859946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25375972|NCT04859946|Immunologic Factors|immunologic factors|mesh-ancestor
25375973|NCT04859946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375974|NCT04859946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25375975|NCT04859946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25375976|NCT04859946|Alkylating Agents|alkylating agents|mesh-ancestor
25375977|NCT04859946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375978|NCT04859946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375979|NCT04859946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25375980|NCT04859946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25375981|NCT04859946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375982|NCT04859465|Doxorubicin|doxorubicin|mesh-list
25375983|NCT04859465|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25375984|NCT04859465|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25375985|NCT04859465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25375986|NCT04859465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25375987|NCT04859465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25375988|NCT04859465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25375989|NCT04859465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25375990|NCT04859465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25375991|NCT04859062|Lidocaine|lidocaine|mesh-list
25375992|NCT04859062|Anesthetics, Local|anesthetics, local|mesh-ancestor
25375993|NCT04859062|Anesthetics|anesthetics|mesh-ancestor
25375994|NCT04859062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25375995|NCT04859062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25375996|NCT04859062|Sensory System Agents|sensory system agents|mesh-ancestor
25375997|NCT04859062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25375998|NCT04859062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25375999|NCT04859062|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25376000|NCT04859062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25376001|NCT04859062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25376002|NCT04859062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376003|NCT04858425|Niclosamide|niclosamide|mesh-list
25376004|NCT04858425|Anticestodal Agents|anticestodal agents|mesh-ancestor
25376005|NCT04858425|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25376006|NCT04858425|Anthelmintics|anthelmintics|mesh-ancestor
25376007|NCT04858425|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25376008|NCT04858425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25376009|NCT04858425|Antinematodal Agents|antinematodal agents|mesh-ancestor
25376010|NCT04858334|Olaparib|olaparib|mesh-list
25376011|NCT04858334|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25376012|NCT04858334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25376013|NCT04858334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376014|NCT04858334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376015|NCT04858269|Paclitaxel|paclitaxel|mesh-list
25376016|NCT04858269|Carboplatin|carboplatin|mesh-list
25376017|NCT04858269|Pembrolizumab|pembrolizumab|mesh-list
25376018|NCT04858269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25376019|NCT04858269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376020|NCT04858269|Tubulin Modulators|tubulin modulators|mesh-ancestor
25376021|NCT04858269|Antimitotic Agents|antimitotic agents|mesh-ancestor
25376022|NCT04858269|Mitosis Modulators|mitosis modulators|mesh-ancestor
25376023|NCT04858269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376024|NCT04858269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25376025|NCT04858009|Paclitaxel|paclitaxel|mesh-list
25376026|NCT04858009|Cisplatin|cisplatin|mesh-list
25376027|NCT04858009|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25376028|NCT04858009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25376029|NCT04858009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376030|NCT04858009|Tubulin Modulators|tubulin modulators|mesh-ancestor
25376031|NCT04858009|Antimitotic Agents|antimitotic agents|mesh-ancestor
25376032|NCT04858009|Mitosis Modulators|mitosis modulators|mesh-ancestor
25376033|NCT04858009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376034|NCT04857983|Memantine|memantine|mesh-list
25376035|NCT04857983|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25376036|NCT04857983|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25376037|NCT04857983|Dopamine Agents|dopamine agents|mesh-ancestor
25376038|NCT04857983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25376039|NCT04857983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376040|NCT04857983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376041|NCT04857983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25376042|NCT04857983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25376043|NCT04857203|Vitamin D|vitamin d|mesh-list
25376044|NCT04857203|Vitamins|vitamins|mesh-ancestor
25376045|NCT04857203|Micronutrients|micronutrients|mesh-ancestor
25376046|NCT04857203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376047|NCT04857203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25376048|NCT04857138|Atezolizumab|atezolizumab|mesh-list
25376049|NCT04857138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376050|NCT04856761|Capecitabine|capecitabine|mesh-list
25376051|NCT04856761|Tegafur|tegafur|mesh-list
25376052|NCT04856761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25376053|NCT04856761|Antimetabolites|antimetabolites|mesh-ancestor
25376054|NCT04856761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376055|NCT04856761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376056|NCT04856215|Antibodies|antibodies|mesh-list
25376057|NCT04856215|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25376058|NCT04856215|Immunologic Factors|immunologic factors|mesh-ancestor
25376059|NCT04856215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376060|NCT04855695|Venetoclax|venetoclax|mesh-list
25376061|NCT04855695|Obinutuzumab|obinutuzumab|mesh-list
25376062|NCT04855695|Acalabrutinib|acalabrutinib|mesh-list
25376063|NCT04855695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376064|NCT04855695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25376065|NCT04855136|Dexamethasone|dexamethasone|mesh-list
25376066|NCT04855136|Bortezomib|bortezomib|mesh-list
25376067|NCT04855136|Pomalidomide|pomalidomide|mesh-list
25376068|NCT04855136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25376069|NCT04855136|Antiemetics|antiemetics|mesh-ancestor
25376070|NCT04855136|Autonomic Agents|autonomic agents|mesh-ancestor
25376071|NCT04855136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25376072|NCT04855136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376073|NCT04855136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25376074|NCT04855136|Glucocorticoids|glucocorticoids|mesh-ancestor
25376075|NCT04855136|Hormones|hormones|mesh-ancestor
25376076|NCT04855136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25376077|NCT04855136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25376078|NCT04855136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376079|NCT04855136|Immunologic Factors|immunologic factors|mesh-ancestor
25376080|NCT04855136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25376081|NCT04855136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25376082|NCT04855136|Growth Substances|growth substances|mesh-ancestor
25376083|NCT04855136|Growth Inhibitors|growth inhibitors|mesh-ancestor
25376084|NCT04854889|Decitabine|decitabine|mesh-list
25376085|NCT04854889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25376086|NCT04854889|Antimetabolites|antimetabolites|mesh-ancestor
25376087|NCT04854889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376088|NCT04854889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376089|NCT04854889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25376111|NCT04854434|Antimetabolites|antimetabolites|mesh-ancestor
25376112|NCT04854434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376113|NCT04854434|Antiviral Agents|antiviral agents|mesh-ancestor
25376114|NCT04854434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25376115|NCT04853589|Hyaluronic Acid|hyaluronic acid|mesh-list
25376116|NCT04853589|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25376117|NCT04853589|Immunologic Factors|immunologic factors|mesh-ancestor
25376118|NCT04853589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376119|NCT04853589|Viscosupplements|viscosupplements|mesh-ancestor
25376120|NCT04853589|Protective Agents|protective agents|mesh-ancestor
25376121|NCT04853511|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25376122|NCT04853511|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25376123|NCT04853511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376124|NCT04853355|Spironolactone|spironolactone|mesh-list
25376125|NCT04853355|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25376126|NCT04853355|Hormone Antagonists|hormone antagonists|mesh-ancestor
25376127|NCT04853355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25376128|NCT04853355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376129|NCT04853355|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25376130|NCT04853355|Diuretics|diuretics|mesh-ancestor
25376131|NCT04853355|Natriuretic Agents|natriuretic agents|mesh-ancestor
25376132|NCT04853251|Ranibizumab|ranibizumab|mesh-list
25376133|NCT04853251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25376134|NCT04853251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25376135|NCT04853251|Growth Substances|growth substances|mesh-ancestor
25376136|NCT04853251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376137|NCT04853251|Growth Inhibitors|growth inhibitors|mesh-ancestor
25376138|NCT04853251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376139|NCT04852887|Tamoxifen|tamoxifen|mesh-list
25376140|NCT04852887|Letrozole|letrozole|mesh-list
25376141|NCT04852887|Exemestane|exemestane|mesh-list
25376142|NCT04852887|Anastrozole|anastrozole|mesh-list
25376143|NCT04852887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376144|NCT04852887|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25376145|NCT04852887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25376146|NCT04852887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25376147|NCT04852887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376148|NCT04852887|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25376149|NCT04852887|Hormone Antagonists|hormone antagonists|mesh-ancestor
25376150|NCT04852887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25376151|NCT04852887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376152|NCT04852887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25376153|NCT04852887|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25376154|NCT04852887|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25376155|NCT04852887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25376156|NCT04852458|Hydrocortisone|hydrocortisone|mesh-list
25376157|NCT04852458|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25376158|NCT04852458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25376159|NCT04852068|Vaccines|vaccines|mesh-list
25376160|NCT04852068|Immunologic Factors|immunologic factors|mesh-ancestor
25376161|NCT04852068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376162|NCT04851964|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25376163|NCT04851964|Immunologic Factors|immunologic factors|mesh-ancestor
25376164|NCT04851964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376165|NCT04851834|Cisplatin|cisplatin|mesh-list
25376166|NCT04851834|Carboplatin|carboplatin|mesh-list
25376167|NCT04851834|Temozolomide|temozolomide|mesh-list
25376168|NCT04851834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376169|NCT04851834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25376170|NCT04851834|Alkylating Agents|alkylating agents|mesh-ancestor
25376171|NCT04851834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376172|NCT04850937|Esketamine|esketamine|mesh-list
25376250|NCT04847063|Sodium thiosulfate|sodium thiosulfate|mesh-list
25376180|NCT04849364|Talazoparib|talazoparib|mesh-list
25376181|NCT04849364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25376182|NCT04849364|Antimetabolites|antimetabolites|mesh-ancestor
25376183|NCT04849364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376184|NCT04849364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376185|NCT04849364|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25376186|NCT04849364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25376187|NCT04848792|Sulforaphane|sulforaphane|mesh-list
25376188|NCT04848792|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25376189|NCT04848792|Protective Agents|protective agents|mesh-ancestor
25376190|NCT04848792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376191|NCT04848792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376192|NCT04848688|Ivermectin|ivermectin|mesh-list
25376193|NCT04848688|Moxidectin|moxidectin|mesh-list
25376194|NCT04848688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25376195|NCT04848688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25376196|NCT04848688|Anthelmintics|anthelmintics|mesh-ancestor
25376197|NCT04848688|Antinematodal Agents|antinematodal agents|mesh-ancestor
25376198|NCT04848584|Vaccines|vaccines|mesh-list
25376199|NCT04848584|Immunologic Factors|immunologic factors|mesh-ancestor
25376200|NCT04848584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376201|NCT04848337|Pembrolizumab|pembrolizumab|mesh-list
25376202|NCT04848337|Lenvatinib|lenvatinib|mesh-list
25376203|NCT04848337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25376204|NCT04848337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376205|NCT04848337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25376206|NCT04848337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25376207|NCT04848337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376208|NCT04848220|APD791|apd791|mesh-list
25376209|NCT04848220|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25376210|NCT04848220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25376211|NCT04848220|Serotonin Agents|serotonin agents|mesh-ancestor
25376212|NCT04848220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25376213|NCT04848220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376214|NCT04848220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376215|NCT04848116|Nivolumab|nivolumab|mesh-list
25376216|NCT04848116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25376217|NCT04848116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376218|NCT04848116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25376219|NCT04848116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376220|NCT04847557|Tirzepatide|tirzepatide|mesh-list
25376221|NCT04847557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25376222|NCT04847557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376223|NCT04847557|Incretins|incretins|mesh-ancestor
25376224|NCT04847557|Hormones|hormones|mesh-ancestor
25376225|NCT04847557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25376226|NCT04847453|Dexamethasone|dexamethasone|mesh-list
25376227|NCT04847453|Dexamethasone acetate|dexamethasone acetate|mesh-list
25376228|NCT04847453|Venetoclax|venetoclax|mesh-list
25376229|NCT04847453|Ixazomib|ixazomib|mesh-list
25376230|NCT04847453|Ichthammol|ichthammol|mesh-list
25376231|NCT04847453|BB 1101|bb 1101|mesh-list
25376232|NCT04847453|Glycine|glycine|mesh-list
25376233|NCT04847453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25376234|NCT04847453|Antiemetics|antiemetics|mesh-ancestor
25376235|NCT04847453|Autonomic Agents|autonomic agents|mesh-ancestor
25376236|NCT04847453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25376237|NCT04847453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376238|NCT04847453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25376239|NCT04847453|Glucocorticoids|glucocorticoids|mesh-ancestor
25376240|NCT04847453|Hormones|hormones|mesh-ancestor
25376241|NCT04847453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25376242|NCT04847453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25376243|NCT04847453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376244|NCT04847453|Protease Inhibitors|protease inhibitors|mesh-ancestor
25376245|NCT04847453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25376246|NCT04847453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376247|NCT04847453|Dermatologic Agents|dermatologic agents|mesh-ancestor
25376248|NCT04847453|Glycine Agents|glycine agents|mesh-ancestor
25376249|NCT04847453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25376251|NCT04847063|Cisplatin|cisplatin|mesh-list
25376252|NCT04847063|Doxorubicin|doxorubicin|mesh-list
25376253|NCT04847063|Fluorouracil|fluorouracil|mesh-list
25376254|NCT04847063|Oxaliplatin|oxaliplatin|mesh-list
25376255|NCT04847063|Mitomycins|mitomycins|mesh-list
25376256|NCT04847063|Mitomycin|mitomycin|mesh-list
25376257|NCT04847063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376258|NCT04847063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25376259|NCT04847063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25376260|NCT04847063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25376261|NCT04847063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25376262|NCT04847063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376263|NCT04847063|Antimetabolites|antimetabolites|mesh-ancestor
25376569|NCT04837924|Antipyretics|antipyretics|mesh-ancestor
25376264|NCT04847063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25376265|NCT04847063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25376266|NCT04847063|Immunologic Factors|immunologic factors|mesh-ancestor
25376267|NCT04847063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376268|NCT04847063|Alkylating Agents|alkylating agents|mesh-ancestor
25376269|NCT04847063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25376270|NCT04847063|Antidotes|antidotes|mesh-ancestor
25376271|NCT04847063|Protective Agents|protective agents|mesh-ancestor
25376272|NCT04847063|Antioxidants|antioxidants|mesh-ancestor
25376273|NCT04847063|Antitubercular Agents|antitubercular agents|mesh-ancestor
25376274|NCT04847063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25376275|NCT04847063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25376276|NCT04847063|Chelating Agents|chelating agents|mesh-ancestor
25376277|NCT04847063|Sequestering Agents|sequestering agents|mesh-ancestor
25376278|NCT04846881|BI 425809|bi 425809|mesh-list
25376279|NCT04846881|Nootropic Agents|nootropic agents|mesh-ancestor
25376280|NCT04846868|BI 425809|bi 425809|mesh-list
25376281|NCT04846868|Nootropic Agents|nootropic agents|mesh-ancestor
25376282|NCT04846231|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25376283|NCT04846231|Red yeast rice|red yeast rice|mesh-list
25376284|NCT04846231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25376285|NCT04846231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25376286|NCT04846231|Antimetabolites|antimetabolites|mesh-ancestor
25376287|NCT04846231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376288|NCT04846231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25376289|NCT04846231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25376290|NCT04846231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25376291|NCT04845217|Peppermint oil|peppermint oil|mesh-list
25376292|NCT04845217|Antiemetics|antiemetics|mesh-ancestor
25376293|NCT04845217|Autonomic Agents|autonomic agents|mesh-ancestor
25376294|NCT04845217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25376295|NCT04845217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376296|NCT04845217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25376297|NCT04845217|Parasympatholytics|parasympatholytics|mesh-ancestor
25376298|NCT04845035|Cytarabine|cytarabine|mesh-list
25376299|NCT04845035|Methotrexate|methotrexate|mesh-list
25376300|NCT04845035|Dasatinib|dasatinib|mesh-list
25376301|NCT04845035|Ponatinib|ponatinib|mesh-list
25376302|NCT04845035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25376303|NCT04845035|Abortifacient Agents|abortifacient agents|mesh-ancestor
25376304|NCT04845035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25376305|NCT04845035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376306|NCT04845035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25376307|NCT04845035|Antimetabolites|antimetabolites|mesh-ancestor
25376308|NCT04845035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376309|NCT04845035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376310|NCT04845035|Dermatologic Agents|dermatologic agents|mesh-ancestor
25376311|NCT04845035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25376312|NCT04845035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25376313|NCT04845035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25376314|NCT04845035|Immunologic Factors|immunologic factors|mesh-ancestor
25376315|NCT04845035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25376316|NCT04845035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25376317|NCT04845035|Antiviral Agents|antiviral agents|mesh-ancestor
25376318|NCT04845035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25376319|NCT04845035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25376320|NCT04844866|Gemcitabine|gemcitabine|mesh-list
25376321|NCT04844866|Rituximab|rituximab|mesh-list
25376322|NCT04844866|Oxaliplatin|oxaliplatin|mesh-list
25376323|NCT04844866|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25376324|NCT04844866|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25376325|NCT04844866|Immunoconjugates|immunoconjugates|mesh-list
25376326|NCT04844866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25376327|NCT04844866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376337|NCT04844866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25376338|NCT04844866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25376339|NCT04844866|Alkylating Agents|alkylating agents|mesh-ancestor
25376570|NCT04837924|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25376341|NCT04844814|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25376342|NCT04844814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25376343|NCT04844814|Glucocorticoids|glucocorticoids|mesh-ancestor
25376345|NCT04844814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25376346|NCT04844814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376347|NCT04844814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25376348|NCT04844814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376349|NCT04844814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25376361|NCT04844216|Lidocaine|lidocaine|mesh-list
25376362|NCT04844216|Hyaluronic Acid|hyaluronic acid|mesh-list
25376363|NCT04844216|Anesthetics, Local|anesthetics, local|mesh-ancestor
25376364|NCT04844216|Anesthetics|anesthetics|mesh-ancestor
25376365|NCT04844216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25376366|NCT04844216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376367|NCT04844216|Sensory System Agents|sensory system agents|mesh-ancestor
25376368|NCT04844216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25376369|NCT04844216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25376370|NCT04844216|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25376371|NCT04844216|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25376372|NCT04844216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25376373|NCT04844216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376374|NCT04844216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25376375|NCT04844216|Immunologic Factors|immunologic factors|mesh-ancestor
25376376|NCT04844216|Viscosupplements|viscosupplements|mesh-ancestor
25376377|NCT04844216|Protective Agents|protective agents|mesh-ancestor
25376378|NCT04844164|Cholecalciferol|cholecalciferol|mesh-list
25376379|NCT04844164|Vitamin D|vitamin d|mesh-list
25376380|NCT04844164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25376381|NCT04844164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376382|NCT04844164|Vitamins|vitamins|mesh-ancestor
25376383|NCT04844164|Micronutrients|micronutrients|mesh-ancestor
25376384|NCT04844164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25376385|NCT04844099|Piperaquine|piperaquine|mesh-list
25376386|NCT04844099|Artenimol|artenimol|mesh-list
25376387|NCT04844099|Antimalarials|antimalarials|mesh-ancestor
25376388|NCT04844099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25376389|NCT04844099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25376390|NCT04844099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25376391|NCT04843917|Immunoglobulins|immunoglobulins|mesh-list
25376392|NCT04843917|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25376393|NCT04843917|Antibodies|antibodies|mesh-list
25376394|NCT04843917|Immunoglobulin G|immunoglobulin g|mesh-list
25376395|NCT04843917|Immunologic Factors|immunologic factors|mesh-ancestor
25376396|NCT04843917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376397|NCT04843761|Remdesivir|remdesivir|mesh-list
25376398|NCT04843761|Phentolamine|phentolamine|mesh-list
25376399|NCT04843761|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
25376400|NCT04843761|Antimetabolites|antimetabolites|mesh-ancestor
25376401|NCT04843761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724246|NCT02536040|Cariostatic Agents|cariostatic agents|mesh-ancestor
25376402|NCT04843761|Antiviral Agents|antiviral agents|mesh-ancestor
25376403|NCT04843761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25376404|NCT04843761|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25376405|NCT04843761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25376406|NCT04843761|Adrenergic Agents|adrenergic agents|mesh-ancestor
25376407|NCT04843761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25376408|NCT04843761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376409|NCT04843761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25376410|NCT04843761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25376411|NCT04843761|Vasodilator Agents|vasodilator agents|mesh-ancestor
25376412|NCT04843761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25376413|NCT04843761|Protective Agents|protective agents|mesh-ancestor
25376414|NCT04843566|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25376415|NCT04843566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25376417|NCT04842682|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25376418|NCT04842682|Anticonvulsants|anticonvulsants|mesh-ancestor
25376419|NCT04842682|Antiemetics|antiemetics|mesh-ancestor
25376420|NCT04842682|Autonomic Agents|autonomic agents|mesh-ancestor
25376421|NCT04842682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25376422|NCT04842682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376423|NCT04842682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25376424|NCT04842682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25376425|NCT04842682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25376426|NCT04842682|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25376427|NCT04842682|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25376428|NCT04842682|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25376429|NCT04842682|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25376430|NCT04842682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25376431|NCT04842682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25376432|NCT04842682|Anesthetics, General|anesthetics, general|mesh-ancestor
25376433|NCT04842682|Anesthetics|anesthetics|mesh-ancestor
25376434|NCT04842682|GABA Modulators|gaba modulators|mesh-ancestor
25376435|NCT04842682|GABA Agents|gaba agents|mesh-ancestor
25376436|NCT04842682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25376437|NCT04842682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376438|NCT04842292|Heparin|heparin|mesh-list
25376439|NCT04842292|Anticoagulants|anticoagulants|mesh-ancestor
25376440|NCT04842292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25376441|NCT04842292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25376442|NCT04842292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376443|NCT04842045|Midazolam|midazolam|mesh-list
25376444|NCT04842045|Psilocybin|psilocybin|mesh-list
25376445|NCT04842045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25376446|NCT04842045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25376447|NCT04842045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25376448|NCT04842045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376449|NCT04842045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25376450|NCT04842045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25376451|NCT04842045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25376452|NCT04842045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25376453|NCT04842045|Anesthetics, General|anesthetics, general|mesh-ancestor
25376454|NCT04842045|Anesthetics|anesthetics|mesh-ancestor
25376455|NCT04842045|GABA Modulators|gaba modulators|mesh-ancestor
25376456|NCT04842045|GABA Agents|gaba agents|mesh-ancestor
25376457|NCT04842045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25376458|NCT04842045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376459|NCT04842045|Hallucinogens|hallucinogens|mesh-ancestor
25376460|NCT04841668|Metformin|metformin|mesh-list
25376461|NCT04841668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25376462|NCT04841668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376463|NCT04841343|Triamcinolone|triamcinolone|mesh-list
25376464|NCT04841343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25376465|NCT04841343|Glucocorticoids|glucocorticoids|mesh-ancestor
25376466|NCT04841343|Hormones|hormones|mesh-ancestor
25376467|NCT04841343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25376468|NCT04841343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376469|NCT04841265|Vitamin D|vitamin d|mesh-list
25376470|NCT04841265|Cholecalciferol|cholecalciferol|mesh-list
25376471|NCT04841265|Vitamins|vitamins|mesh-ancestor
25376472|NCT04841265|Micronutrients|micronutrients|mesh-ancestor
25376473|NCT04841265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376474|NCT04841265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25376475|NCT04841265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25376476|NCT04841148|Hydroxychloroquine|hydroxychloroquine|mesh-list
25376477|NCT04841148|Palbociclib|palbociclib|mesh-list
25376478|NCT04841148|Avelumab|avelumab|mesh-list
25376479|NCT04841148|Antimalarials|antimalarials|mesh-ancestor
25376480|NCT04841148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25376481|NCT04841148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25376482|NCT04841148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25376483|NCT04841148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25376484|NCT04841148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376485|NCT04841148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25376486|NCT04841148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376487|NCT04841148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25376488|NCT04841148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25376490|NCT04840823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25376491|NCT04840823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25376492|NCT04840823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25376493|NCT04840823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25376494|NCT04840823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25376495|NCT04840823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376496|NCT04840823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376497|NCT04840823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25376498|NCT04840823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25376499|NCT04840615|Ipilimumab|ipilimumab|mesh-list
25376500|NCT04840615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25376501|NCT04840615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376502|NCT04840615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25376503|NCT04840615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376504|NCT04840602|Rituximab|rituximab|mesh-list
25376505|NCT04840602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25376506|NCT04840602|Venetoclax|venetoclax|mesh-list
25376507|NCT04840602|Antibodies|antibodies|mesh-list
25376508|NCT04840602|Immunoglobulins|immunoglobulins|mesh-list
25376509|NCT04840602|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25376510|NCT04840602|Immunologic Factors|immunologic factors|mesh-ancestor
25376511|NCT04840602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376512|NCT04840602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376513|NCT04840602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25376514|NCT04840589|Nivolumab|nivolumab|mesh-list
25376515|NCT04840589|Ipilimumab|ipilimumab|mesh-list
25376516|NCT04840589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25376517|NCT04840589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376518|NCT04840589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25376519|NCT04840589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376520|NCT04840199|Letermovir|letermovir|mesh-list
25376521|NCT04840199|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25376522|NCT04840199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25376523|NCT04840199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376524|NCT04840199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376525|NCT04840199|Antiviral Agents|antiviral agents|mesh-ancestor
25376526|NCT04840199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25376527|NCT04839692|Hyaluronic Acid|hyaluronic acid|mesh-list
25376528|NCT04839692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25376529|NCT04839692|Immunologic Factors|immunologic factors|mesh-ancestor
25376530|NCT04839692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376531|NCT04839692|Viscosupplements|viscosupplements|mesh-ancestor
25376532|NCT04839692|Protective Agents|protective agents|mesh-ancestor
25376533|NCT04839185|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25376534|NCT04839185|Hematinics|hematinics|mesh-ancestor
25376535|NCT04839185|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25376536|NCT04839185|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25376537|NCT04838769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
25376538|NCT04838769|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
25376539|NCT04838769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25376540|NCT04838769|Adrenergic Agents|adrenergic agents|mesh-ancestor
25376541|NCT04838769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25376542|NCT04838769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376543|NCT04838769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376544|NCT04838769|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25376545|NCT04838769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25376546|NCT04838769|Hormone Antagonists|hormone antagonists|mesh-ancestor
25376547|NCT04838769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25376548|NCT04838652|Pembrolizumab|pembrolizumab|mesh-list
25376549|NCT04838652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25376550|NCT04838652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376551|NCT04838613|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25376552|NCT04838613|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25376553|NCT04838613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376554|NCT04838288|Tacrolimus|tacrolimus|mesh-list
25376555|NCT04838288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25376556|NCT04838288|Immunologic Factors|immunologic factors|mesh-ancestor
25376557|NCT04838288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376558|NCT04838288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25376559|NCT04838288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25376560|NCT04838288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376561|NCT04837924|Acetaminophen|acetaminophen|mesh-list
25376562|NCT04837924|Tramadol|tramadol|mesh-list
25376563|NCT04837924|Analgesics|analgesics|mesh-list
25376564|NCT04837924|Levobupivacaine|levobupivacaine|mesh-list
25376565|NCT04837924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25376566|NCT04837924|Sensory System Agents|sensory system agents|mesh-ancestor
25376567|NCT04837924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25376568|NCT04837924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376571|NCT04837924|Narcotics|narcotics|mesh-ancestor
25376572|NCT04837924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25376573|NCT04837924|Anesthetics, Local|anesthetics, local|mesh-ancestor
25376574|NCT04837924|Anesthetics|anesthetics|mesh-ancestor
25376575|NCT04837196|Pembrolizumab|pembrolizumab|mesh-list
25376576|NCT04837196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25376577|NCT04837196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376578|NCT04837014|Acetaminophen|acetaminophen|mesh-list
25376579|NCT04837014|Naproxen|naproxen|mesh-list
25376580|NCT04837014|Hydromorphone|hydromorphone|mesh-list
25376581|NCT04837014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25376582|NCT04837014|Analgesics|analgesics|mesh-ancestor
25376583|NCT04837014|Sensory System Agents|sensory system agents|mesh-ancestor
25376584|NCT04837014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25376585|NCT04837014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376586|NCT04837014|Antipyretics|antipyretics|mesh-ancestor
25376587|NCT04837014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25376588|NCT04837014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25376589|NCT04837014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25376590|NCT04837014|Gout Suppressants|gout suppressants|mesh-ancestor
25376591|NCT04837014|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25376592|NCT04837014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25376593|NCT04837014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376594|NCT04837014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25376595|NCT04837014|Narcotics|narcotics|mesh-ancestor
25376596|NCT04837014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25376597|NCT04836962|Dexamethasone|dexamethasone|mesh-list
25376598|NCT04836962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25376599|NCT04836962|Antiemetics|antiemetics|mesh-ancestor
25376600|NCT04836962|Autonomic Agents|autonomic agents|mesh-ancestor
25376601|NCT04836962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25376602|NCT04836962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376603|NCT04836962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25376604|NCT04836962|Glucocorticoids|glucocorticoids|mesh-ancestor
25376605|NCT04836962|Hormones|hormones|mesh-ancestor
25376606|NCT04836962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25376607|NCT04836962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25376608|NCT04836962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376609|NCT04836780|Dexamethasone|dexamethasone|mesh-list
25376610|NCT04836780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25376611|NCT04836780|Antiemetics|antiemetics|mesh-ancestor
25376612|NCT04836780|Autonomic Agents|autonomic agents|mesh-ancestor
25376613|NCT04836780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25376614|NCT04836780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376615|NCT04836780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25376616|NCT04836780|Glucocorticoids|glucocorticoids|mesh-ancestor
25376617|NCT04836780|Hormones|hormones|mesh-ancestor
25376618|NCT04836780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25376619|NCT04836780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25376620|NCT04836780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376621|NCT04836637|Calcium, Dietary|calcium, dietary|mesh-list
25376622|NCT04836637|Calcium Carbonate|calcium carbonate|mesh-list
25376623|NCT04836637|Calcium|calcium|mesh-list
25376624|NCT04836637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25376625|NCT04836637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376626|NCT04836637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25376627|NCT04836637|Antacids|antacids|mesh-ancestor
25376628|NCT04836637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376629|NCT04836637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25376630|NCT04835870|Prednisone|prednisone|mesh-list
25376631|NCT04835870|Cyclophosphamide|cyclophosphamide|mesh-list
25376632|NCT04835870|Rituximab|rituximab|mesh-list
25376633|NCT04835870|Doxorubicin|doxorubicin|mesh-list
25376638|NCT04835870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376639|NCT04835870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25376640|NCT04835870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25376641|NCT04835870|Alkylating Agents|alkylating agents|mesh-ancestor
25376642|NCT04835870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376643|NCT04835870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376644|NCT04835870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25376645|NCT04835870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25376646|NCT04835870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25376647|NCT04835870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25376648|NCT04835870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25376649|NCT04835870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25376650|NCT04835870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25376651|NCT04835870|Glucocorticoids|glucocorticoids|mesh-ancestor
25376652|NCT04835870|Hormones|hormones|mesh-ancestor
25376653|NCT04835870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25376654|NCT04835870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25376655|NCT04835870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25376656|NCT04835870|Tubulin Modulators|tubulin modulators|mesh-ancestor
25376657|NCT04835870|Antimitotic Agents|antimitotic agents|mesh-ancestor
25376658|NCT04835870|Mitosis Modulators|mitosis modulators|mesh-ancestor
25376659|NCT04835870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25376660|NCT04835805|Atezolizumab|atezolizumab|mesh-list
25376661|NCT04835805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376666|NCT04834908|Immune Sera|immune sera|mesh-list
25376667|NCT04834908|Immunologic Factors|immunologic factors|mesh-ancestor
25376668|NCT04834908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376669|NCT04834388|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25376670|NCT04834388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25376671|NCT04834310|Clindamycin|clindamycin|mesh-list
25376672|NCT04834310|Clindamycin palmitate|clindamycin palmitate|mesh-list
25376673|NCT04834310|Clindamycin phosphate|clindamycin phosphate|mesh-list
25376674|NCT04834310|Cefazolin|cefazolin|mesh-list
25376675|NCT04834310|Cephalexin|cephalexin|mesh-list
25376676|NCT04834310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25376677|NCT04834310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25376678|NCT04834310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25376679|NCT04834310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25376680|NCT04834310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376681|NCT04833946|Andrographolide|andrographolide|mesh-list
25376682|NCT04833946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25376683|NCT04833946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25376684|NCT04833946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25376685|NCT04833946|Analgesics|analgesics|mesh-ancestor
25376686|NCT04833946|Sensory System Agents|sensory system agents|mesh-ancestor
25376687|NCT04833946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25376688|NCT04833946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376689|NCT04833946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25376690|NCT04833946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25376691|NCT04833946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25376692|NCT04833946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25376693|NCT04833946|Antiviral Agents|antiviral agents|mesh-ancestor
25376694|NCT04833946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25376695|NCT04833855|Omalizumab|omalizumab|mesh-list
25376696|NCT04833855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25376697|NCT04833855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25376698|NCT04833855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25376699|NCT04833855|Respiratory System Agents|respiratory system agents|mesh-ancestor
25376700|NCT04833855|Immunologic Factors|immunologic factors|mesh-ancestor
25376701|NCT04833855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376702|NCT04833582|Gemcitabine|gemcitabine|mesh-list
25376703|NCT04833582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25376704|NCT04833582|Antimetabolites|antimetabolites|mesh-ancestor
25376705|NCT04833582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376706|NCT04833582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376707|NCT04833582|Antiviral Agents|antiviral agents|mesh-ancestor
25376708|NCT04833582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25376709|NCT04833582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25376730|NCT04833114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376731|NCT04833114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25376732|NCT04833114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25376733|NCT04833114|Alkylating Agents|alkylating agents|mesh-ancestor
25376756|NCT04832269|Methylprednisolone|methylprednisolone|mesh-list
25376757|NCT04832269|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25376758|NCT04832269|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25376759|NCT04832269|Prednisolone|prednisolone|mesh-list
25376760|NCT04832269|Prednisolone acetate|prednisolone acetate|mesh-list
25376761|NCT04832269|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25376762|NCT04832269|Prednisolone phosphate|prednisolone phosphate|mesh-list
25376763|NCT04832269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25376764|NCT04832269|Antiemetics|antiemetics|mesh-ancestor
25376765|NCT04832269|Autonomic Agents|autonomic agents|mesh-ancestor
25376766|NCT04832269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25376767|NCT04832269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376768|NCT04832269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25376769|NCT04832269|Glucocorticoids|glucocorticoids|mesh-ancestor
25376770|NCT04832269|Hormones|hormones|mesh-ancestor
25376771|NCT04832269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25376772|NCT04832269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25376773|NCT04832269|Protective Agents|protective agents|mesh-ancestor
25376774|NCT04832269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25376775|NCT04832269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376776|NCT04832100|Pregabalin|pregabalin|mesh-list
25376777|NCT04832100|Imipramine|imipramine|mesh-list
25376778|NCT04832100|Analgesics|analgesics|mesh-ancestor
25376779|NCT04832100|Sensory System Agents|sensory system agents|mesh-ancestor
25376780|NCT04832100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25376781|NCT04832100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376782|NCT04832100|Anticonvulsants|anticonvulsants|mesh-ancestor
25376783|NCT04832100|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25376784|NCT04832100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25376785|NCT04832100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25408385|NCT03447379|Antipyretics|antipyretics|mesh-ancestor
25376786|NCT04832100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25376787|NCT04832100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25376788|NCT04832100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25376789|NCT04832100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25376790|NCT04832100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25376791|NCT04832100|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
25376792|NCT04832100|Antidepressive Agents|antidepressive agents|mesh-ancestor
25376793|NCT04832100|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25376794|NCT04832100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25376795|NCT04832100|Adrenergic Agents|adrenergic agents|mesh-ancestor
25376796|NCT04832100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25376798|NCT04831736|Analgesics|analgesics|mesh-ancestor
25376799|NCT04831736|Sensory System Agents|sensory system agents|mesh-ancestor
25376800|NCT04831736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25376801|NCT04831736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376802|NCT04831736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25376803|NCT04831736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25376804|NCT04831736|Anesthetics, General|anesthetics, general|mesh-ancestor
25376805|NCT04831736|Anesthetics|anesthetics|mesh-ancestor
25376806|NCT04831736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25376807|NCT04831736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25376808|NCT04831736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25376809|NCT04831736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25376810|NCT04831736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376811|NCT04831450|Cemiplimab|cemiplimab|mesh-list
25376812|NCT04831450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25376813|NCT04831450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376814|NCT04831320|Paclitaxel|paclitaxel|mesh-list
25376815|NCT04831320|Nivolumab|nivolumab|mesh-list
25376816|NCT04831320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25376817|NCT04831320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376818|NCT04831320|Tubulin Modulators|tubulin modulators|mesh-ancestor
25376819|NCT04831320|Antimitotic Agents|antimitotic agents|mesh-ancestor
25376820|NCT04831320|Mitosis Modulators|mitosis modulators|mesh-ancestor
25376821|NCT04831320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376822|NCT04831320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25376823|NCT04831320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25376824|NCT04830982|Diazoxide|diazoxide|mesh-list
25376825|NCT04830982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25376826|NCT04830982|Vasodilator Agents|vasodilator agents|mesh-ancestor
25376827|NCT04830735|Dasatinib|dasatinib|mesh-list
25376828|NCT04830735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376829|NCT04830735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25376830|NCT04830735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25376831|NCT04830735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376832|NCT04830462|Rifampin|rifampin|mesh-list
25376833|NCT04830462|Isoniazid|isoniazid|mesh-list
25376834|NCT04830462|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25376835|NCT04830462|Antitubercular Agents|antitubercular agents|mesh-ancestor
25376836|NCT04830462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25376837|NCT04830462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25376838|NCT04830462|Leprostatic Agents|leprostatic agents|mesh-ancestor
25376839|NCT04830462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25376840|NCT04830462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25376841|NCT04830462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376842|NCT04830462|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25376843|NCT04830462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25376844|NCT04830462|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25376845|NCT04830462|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25376846|NCT04830462|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25376847|NCT04830462|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25376848|NCT04830462|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
25376849|NCT04830462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25376850|NCT04830462|Antimetabolites|antimetabolites|mesh-ancestor
25376851|NCT04830462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25376852|NCT04829760|Psyllium|psyllium|mesh-list
25376853|NCT04829760|Cathartics|cathartics|mesh-ancestor
25376854|NCT04829760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25376855|NCT04829604|Immunoconjugates|immunoconjugates|mesh-list
25376856|NCT04829604|Immunologic Factors|immunologic factors|mesh-ancestor
25376857|NCT04829604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376858|NCT04829383|Bevacizumab|bevacizumab|mesh-list
25376859|NCT04829383|Atezolizumab|atezolizumab|mesh-list
25376860|NCT04829383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25376869|NCT04829318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25376870|NCT04828538|Vitamin D|vitamin d|mesh-list
25376871|NCT04828538|Vitamins|vitamins|mesh-list
25376872|NCT04828538|Ascorbic Acid|ascorbic acid|mesh-list
25376873|NCT04828538|Folic Acid|folic acid|mesh-list
25376874|NCT04828538|Vitamin B Complex|vitamin b complex|mesh-list
25376875|NCT04828538|Micronutrients|micronutrients|mesh-ancestor
25376876|NCT04828538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376877|NCT04828538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25376878|NCT04828538|Antioxidants|antioxidants|mesh-ancestor
25376879|NCT04828538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376880|NCT04828538|Protective Agents|protective agents|mesh-ancestor
25376881|NCT04828538|Hematinics|hematinics|mesh-ancestor
25376882|NCT04827992|Analgesics, Opioid|analgesics, opioid|mesh-list
25376883|NCT04827992|Narcotics|narcotics|mesh-ancestor
25376884|NCT04827992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25376885|NCT04827992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376886|NCT04827992|Analgesics|analgesics|mesh-ancestor
25376887|NCT04827992|Sensory System Agents|sensory system agents|mesh-ancestor
25376888|NCT04827992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25376897|NCT04827446|Methamphetamine|methamphetamine|mesh-list
25376898|NCT04827446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25376899|NCT04827446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376900|NCT04827446|Sympathomimetics|sympathomimetics|mesh-ancestor
25376901|NCT04827446|Autonomic Agents|autonomic agents|mesh-ancestor
25376902|NCT04827446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25376903|NCT04827446|Dopamine Agents|dopamine agents|mesh-ancestor
25376904|NCT04827446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25376905|NCT04827446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376906|NCT04827446|Adrenergic Agents|adrenergic agents|mesh-ancestor
25376907|NCT04827446|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25376908|NCT04827446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25376909|NCT04827446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25376910|NCT04827446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25376911|NCT04827147|Methamphetamine|methamphetamine|mesh-list
25376912|NCT04827147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25376913|NCT04827147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376914|NCT04827147|Sympathomimetics|sympathomimetics|mesh-ancestor
25376915|NCT04827147|Autonomic Agents|autonomic agents|mesh-ancestor
25376916|NCT04827147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25376917|NCT04827147|Dopamine Agents|dopamine agents|mesh-ancestor
25376918|NCT04827147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25376919|NCT04827147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376920|NCT04827147|Adrenergic Agents|adrenergic agents|mesh-ancestor
25376921|NCT04827147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25376922|NCT04827147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25376923|NCT04827147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25376924|NCT04827147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25376925|NCT04826588|Methylprednisolone|methylprednisolone|mesh-list
25376926|NCT04826588|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
25376927|NCT04826588|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
25376928|NCT04826588|Prednisolone|prednisolone|mesh-list
25376929|NCT04826588|Prednisolone acetate|prednisolone acetate|mesh-list
25376930|NCT04826588|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
25376931|NCT04826588|Prednisolone phosphate|prednisolone phosphate|mesh-list
25376932|NCT04826588|Immunoglobulins|immunoglobulins|mesh-list
25376933|NCT04826588|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25376934|NCT04826588|Antibodies|antibodies|mesh-list
25376935|NCT04826588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25376936|NCT04826588|Antiemetics|antiemetics|mesh-ancestor
25376944|NCT04826588|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25376945|NCT04826588|Protective Agents|protective agents|mesh-ancestor
25376946|NCT04826588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25376947|NCT04826588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376948|NCT04826588|Immunologic Factors|immunologic factors|mesh-ancestor
25376949|NCT04826393|Cemiplimab|cemiplimab|mesh-list
25377024|NCT04824053|Sequestering Agents|sequestering agents|mesh-ancestor
25376950|NCT04826393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25376951|NCT04826393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376952|NCT04826003|Obinutuzumab|obinutuzumab|mesh-list
25376953|NCT04826003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25376954|NCT04826003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376962|NCT04825652|177Lu-PSMA-617|177lu-psma-617|mesh-list
25376963|NCT04825652|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25376964|NCT04825652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376965|NCT04825275|Posaconazole|posaconazole|mesh-list
25408427|NCT03440567|Rituximab|rituximab|mesh-list
25376966|NCT04825275|Antifungal Agents|antifungal agents|mesh-ancestor
25376967|NCT04825275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25376968|NCT04825275|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25376969|NCT04825275|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25376970|NCT04825275|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25376971|NCT04825275|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25376972|NCT04825275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25376973|NCT04825275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25376974|NCT04825275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376975|NCT04825275|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25376976|NCT04825275|Hormone Antagonists|hormone antagonists|mesh-ancestor
25376977|NCT04825275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25376978|NCT04825275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376979|NCT04824638|Vaccines|vaccines|mesh-list
25376980|NCT04824638|Immunologic Factors|immunologic factors|mesh-ancestor
25376981|NCT04824638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376982|NCT04824092|Prednisone|prednisone|mesh-list
25376983|NCT04824092|Cyclophosphamide|cyclophosphamide|mesh-list
25376984|NCT04824092|Rituximab|rituximab|mesh-list
25376985|NCT04824092|Doxorubicin|doxorubicin|mesh-list
25376986|NCT04824092|Vincristine|vincristine|mesh-list
25376987|NCT04824092|Lenalidomide|lenalidomide|mesh-list
25376988|NCT04824092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25376989|NCT04824092|Immunologic Factors|immunologic factors|mesh-ancestor
25376990|NCT04824092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25376991|NCT04824092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25376992|NCT04824092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25376993|NCT04824092|Alkylating Agents|alkylating agents|mesh-ancestor
25376994|NCT04824092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25376995|NCT04824092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25376996|NCT04824092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25376997|NCT04824092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25376998|NCT04824092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25376999|NCT04824092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25377000|NCT04824092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25377001|NCT04824092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377002|NCT04824092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25377003|NCT04824092|Glucocorticoids|glucocorticoids|mesh-ancestor
25377004|NCT04824092|Hormones|hormones|mesh-ancestor
25377005|NCT04824092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25377006|NCT04824092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25377007|NCT04824092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25377008|NCT04824092|Tubulin Modulators|tubulin modulators|mesh-ancestor
25377009|NCT04824092|Antimitotic Agents|antimitotic agents|mesh-ancestor
25377010|NCT04824092|Mitosis Modulators|mitosis modulators|mesh-ancestor
25377011|NCT04824092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25377012|NCT04824092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25377013|NCT04824092|Growth Substances|growth substances|mesh-ancestor
25377014|NCT04824092|Growth Inhibitors|growth inhibitors|mesh-ancestor
25377016|NCT04824053|Caseins|caseins|mesh-list
25377017|NCT04824053|Antioxidants|antioxidants|mesh-ancestor
25377018|NCT04824053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377019|NCT04824053|Protective Agents|protective agents|mesh-ancestor
25377020|NCT04824053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377021|NCT04824053|Trace Elements|trace elements|mesh-ancestor
25377022|NCT04824053|Micronutrients|micronutrients|mesh-ancestor
25377023|NCT04824053|Chelating Agents|chelating agents|mesh-ancestor
25377025|NCT04821778|Paclitaxel|paclitaxel|mesh-list
25377026|NCT04821778|Nimotuzumab|nimotuzumab|mesh-list
25377027|NCT04821778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25377028|NCT04821778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377029|NCT04821778|Tubulin Modulators|tubulin modulators|mesh-ancestor
25377030|NCT04821778|Antimitotic Agents|antimitotic agents|mesh-ancestor
25377031|NCT04821778|Mitosis Modulators|mitosis modulators|mesh-ancestor
25377032|NCT04821778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377033|NCT04821778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25377034|NCT04821622|Talazoparib|talazoparib|mesh-list
25377035|NCT04821622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25377036|NCT04821622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377037|NCT04821622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377038|NCT04821622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377039|NCT04821310|Pantoprazole|pantoprazole|mesh-list
25377040|NCT04821310|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25724247|NCT02536040|Protective Agents|protective agents|mesh-ancestor
25377041|NCT04821310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25377042|NCT04821310|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
25377043|NCT04821310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377044|NCT04821310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377045|NCT04821089|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25377046|NCT04821089|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25377047|NCT04821089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25377048|NCT04821089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377049|NCT04821089|Cholinergic Agents|cholinergic agents|mesh-ancestor
25377050|NCT04821089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25377051|NCT04821089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377053|NCT04820673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25377054|NCT04820673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25377055|NCT04820673|Dermatologic Agents|dermatologic agents|mesh-ancestor
25377056|NCT04820452|Aflibercept|aflibercept|mesh-list
25377057|NCT04820452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25377058|NCT04820452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25377059|NCT04820452|Growth Substances|growth substances|mesh-ancestor
25377060|NCT04820452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377061|NCT04820452|Growth Inhibitors|growth inhibitors|mesh-ancestor
25377062|NCT04820452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377063|NCT04820309|Xanomeline|xanomeline|mesh-list
25377064|NCT04820309|Trospium chloride|trospium chloride|mesh-list
25377065|NCT04820309|Parasympatholytics|parasympatholytics|mesh-ancestor
25377066|NCT04820309|Autonomic Agents|autonomic agents|mesh-ancestor
25377067|NCT04820309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25377068|NCT04820309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377069|NCT04820309|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25377070|NCT04820309|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25377071|NCT04820309|Cholinergic Agents|cholinergic agents|mesh-ancestor
25377072|NCT04820309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25377073|NCT04820309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377074|NCT04820309|Urological Agents|urological agents|mesh-ancestor
25377075|NCT04820309|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25377076|NCT04820309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25377077|NCT04820309|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25377078|NCT04820309|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25377079|NCT04819269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25377080|NCT04819269|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25377081|NCT04818944|Tirofiban|tirofiban|mesh-list
25377082|NCT04818944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25377083|NCT04818944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25377084|NCT04818944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377085|NCT04818944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25377086|NCT04818866|Fibrin fragment D|fibrin fragment d|mesh-list
25377087|NCT04818866|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25377088|NCT04818866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25377089|NCT04818866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377090|NCT04818866|Hemostatics|hemostatics|mesh-ancestor
25377091|NCT04818866|Coagulants|coagulants|mesh-ancestor
25377092|NCT04818632|Everolimus|everolimus|mesh-list
25377093|NCT04818632|Palbociclib|palbociclib|mesh-list
25377094|NCT04818632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377095|NCT04818632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25377096|NCT04818632|Immunologic Factors|immunologic factors|mesh-ancestor
25377097|NCT04818632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377098|NCT04818632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25377099|NCT04818632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377100|NCT04818632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377101|NCT04818450|Gabapentin|gabapentin|mesh-list
25377102|NCT04818450|Analgesics|analgesics|mesh-ancestor
25377103|NCT04818450|Sensory System Agents|sensory system agents|mesh-ancestor
25377104|NCT04818450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25377105|NCT04818450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377106|NCT04818450|Anticonvulsants|anticonvulsants|mesh-ancestor
25377107|NCT04818450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25377108|NCT04818450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25377109|NCT04818450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25377110|NCT04818450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25377111|NCT04818450|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25377112|NCT04818450|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25377113|NCT04818450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25377114|NCT04818450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377115|NCT04818450|Antimanic Agents|antimanic agents|mesh-ancestor
25377116|NCT04818086|Buprenorphine|buprenorphine|mesh-list
25377117|NCT04818086|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
25377118|NCT04818086|Lemborexant|lemborexant|mesh-list
25377119|NCT04818086|Naloxone|naloxone|mesh-list
25377120|NCT04818086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25377121|NCT04818086|Narcotics|narcotics|mesh-ancestor
25377122|NCT04818086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25377123|NCT04818086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377124|NCT04818086|Analgesics|analgesics|mesh-ancestor
25377125|NCT04818086|Sensory System Agents|sensory system agents|mesh-ancestor
25377126|NCT04818086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25377127|NCT04818086|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25377128|NCT04818086|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25377129|NCT04818086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25377130|NCT04818086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377131|NCT04818086|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25377132|NCT04818086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25377133|NCT04817826|Durvalumab|durvalumab|mesh-list
25377134|NCT04817826|Tremelimumab|tremelimumab|mesh-list
25377135|NCT04817826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25377136|NCT04817826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377137|NCT04817345|Plerixafor|plerixafor|mesh-list
25377138|NCT04817345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25377139|NCT04817345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25377140|NCT04817345|Antiviral Agents|antiviral agents|mesh-ancestor
25377141|NCT04817345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25377142|NCT04817241|Cytarabine|cytarabine|mesh-list
25377143|NCT04817241|Decitabine|decitabine|mesh-list
25377144|NCT04817241|Daunorubicin|daunorubicin|mesh-list
25377145|NCT04817241|Venetoclax|venetoclax|mesh-list
25377146|NCT04817241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25377147|NCT04817241|Antimetabolites|antimetabolites|mesh-ancestor
25377148|NCT04817241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377149|NCT04817241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377150|NCT04817241|Antiviral Agents|antiviral agents|mesh-ancestor
25377151|NCT04817241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25377152|NCT04817241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25377153|NCT04817241|Immunologic Factors|immunologic factors|mesh-ancestor
25377154|NCT04817241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377155|NCT04817241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377156|NCT04817241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25377157|NCT04817241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25377158|NCT04817241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25377159|NCT04816682|Silymarin|silymarin|mesh-list
25377160|NCT04816682|Antioxidants|antioxidants|mesh-ancestor
25377161|NCT04816682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377162|NCT04816682|Protective Agents|protective agents|mesh-ancestor
25377163|NCT04816682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377164|NCT04816643|Vaccines|vaccines|mesh-list
25377165|NCT04816643|Immunologic Factors|immunologic factors|mesh-ancestor
25377166|NCT04816643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377167|NCT04816214|Cisplatin|cisplatin|mesh-list
25377168|NCT04816214|Carboplatin|carboplatin|mesh-list
25377169|NCT04816214|Pemetrexed|pemetrexed|mesh-list
25377170|NCT04816214|Osimertinib|osimertinib|mesh-list
25377171|NCT04816214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377172|NCT04816214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377173|NCT04816214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377174|NCT04816214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25377175|NCT04816214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25377176|NCT04816214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25377177|NCT04815876|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25377178|NCT04815876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25377179|NCT04815083|Aminolevulinic Acid|aminolevulinic acid|mesh-list
25377180|NCT04815083|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25377181|NCT04815083|Dermatologic Agents|dermatologic agents|mesh-ancestor
25377182|NCT04814615|Daratumumab|daratumumab|mesh-list
25377183|NCT04814615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377184|NCT04814537|Bupivacaine|bupivacaine|mesh-list
25377185|NCT04814537|Anesthetics, Local|anesthetics, local|mesh-ancestor
25377186|NCT04814537|Anesthetics|anesthetics|mesh-ancestor
25377187|NCT04814537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25377188|NCT04814537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377189|NCT04814537|Sensory System Agents|sensory system agents|mesh-ancestor
25377190|NCT04814537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25377191|NCT04814368|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25377192|NCT04814368|Immunologic Factors|immunologic factors|mesh-ancestor
25377193|NCT04814368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377194|NCT04813991|Ibuprofen|ibuprofen|mesh-list
25377195|NCT04813991|Oxycodone|oxycodone|mesh-list
25377196|NCT04813991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25377197|NCT04813991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25377198|NCT04813991|Analgesics|analgesics|mesh-ancestor
25377199|NCT04813991|Sensory System Agents|sensory system agents|mesh-ancestor
25377200|NCT04813991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25377201|NCT04813991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377202|NCT04813991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25377203|NCT04813991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25377204|NCT04813991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25377205|NCT04813991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377206|NCT04813991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377207|NCT04813991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25377208|NCT04813991|Narcotics|narcotics|mesh-ancestor
25377209|NCT04813991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25377210|NCT04813926|Riociguat|riociguat|mesh-list
25377211|NCT04813926|Enzyme Activators|enzyme activators|mesh-ancestor
25377212|NCT04813926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377213|NCT04812912|Hormones|hormones|mesh-list
25377214|NCT04812912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25377215|NCT04812912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377216|NCT04812548|Azacitidine|azacitidine|mesh-list
25377217|NCT04812548|Venetoclax|venetoclax|mesh-list
25377218|NCT04812548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25377219|NCT04812548|Antimetabolites|antimetabolites|mesh-ancestor
25377220|NCT04812548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377221|NCT04812548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377222|NCT04812548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377223|NCT04811027|Pembrolizumab|pembrolizumab|mesh-list
25377224|NCT04811027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25377225|NCT04811027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377226|NCT04810598|Venetoclax|venetoclax|mesh-list
25377227|NCT04810598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377228|NCT04810559|Antibodies|antibodies|mesh-list
25377229|NCT04810559|Immunologic Factors|immunologic factors|mesh-ancestor
25377230|NCT04810559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377231|NCT04810546|Lactoferrin|lactoferrin|mesh-list
25377232|NCT04810546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25377233|NCT04809974|Niacinamide|niacinamide|mesh-list
25377234|NCT04809974|Vitamins|vitamins|mesh-ancestor
25377235|NCT04809974|Micronutrients|micronutrients|mesh-ancestor
25377236|NCT04809974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377237|NCT04809974|Vitamin B Complex|vitamin b complex|mesh-ancestor
25377238|NCT04809311|Insulin|insulin|mesh-list
25377239|NCT04809311|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25377240|NCT04809311|Glucagon|glucagon|mesh-list
25377260|NCT04809038|Analgesics|analgesics|mesh-ancestor
25377261|NCT04809038|Sensory System Agents|sensory system agents|mesh-ancestor
25377262|NCT04809038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25377263|NCT04809038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377264|NCT04809038|Anesthetics|anesthetics|mesh-ancestor
25377265|NCT04809038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25377266|NCT04809038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25377267|NCT04809038|Anticonvulsants|anticonvulsants|mesh-ancestor
25377268|NCT04809038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25377269|NCT04809038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25377270|NCT04809038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377271|NCT04809038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25377272|NCT04809038|Tocolytic Agents|tocolytic agents|mesh-ancestor
25377273|NCT04809038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25377274|NCT04808882|Tinzaparin|tinzaparin|mesh-list
25377275|NCT04808882|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25377276|NCT04808882|Dalteparin|dalteparin|mesh-list
25377277|NCT04808882|Anticoagulants|anticoagulants|mesh-ancestor
25377278|NCT04808882|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25377279|NCT04808882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25377280|NCT04808882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377294|NCT04808245|Atezolizumab|atezolizumab|mesh-list
25377295|NCT04808245|Imiquimod|imiquimod|mesh-list
25377296|NCT04808245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377297|NCT04808245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25377298|NCT04808245|Immunologic Factors|immunologic factors|mesh-ancestor
25377299|NCT04808245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377300|NCT04808245|Interferon Inducers|interferon inducers|mesh-ancestor
25377301|NCT04807816|Gemcitabine|gemcitabine|mesh-list
25377302|NCT04807816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25377303|NCT04807816|Antimetabolites|antimetabolites|mesh-ancestor
25377304|NCT04807816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377305|NCT04807816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377306|NCT04807816|Antiviral Agents|antiviral agents|mesh-ancestor
25377307|NCT04807816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25377308|NCT04807816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377309|NCT04807816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25377310|NCT04807816|Immunologic Factors|immunologic factors|mesh-ancestor
25377311|NCT04807816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377313|NCT04807517|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25377314|NCT04807517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25377315|NCT04807517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25377328|NCT04805125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377329|NCT04804722|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25377330|NCT04804722|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25377331|NCT04804722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377345|NCT04804072|Analgesics, Opioid|analgesics, opioid|mesh-list
25377346|NCT04804072|Narcotics|narcotics|mesh-ancestor
25377347|NCT04804072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25377348|NCT04804072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377349|NCT04804072|Analgesics|analgesics|mesh-ancestor
25377350|NCT04804072|Sensory System Agents|sensory system agents|mesh-ancestor
25377351|NCT04804072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25377352|NCT04804059|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25377353|NCT04803877|Nivolumab|nivolumab|mesh-list
25377354|NCT04803877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25377355|NCT04803877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377356|NCT04803877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25377357|NCT04803877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377358|NCT04803734|Albuterol|albuterol|mesh-list
25377359|NCT04803734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25377360|NCT04803734|Autonomic Agents|autonomic agents|mesh-ancestor
25377361|NCT04803734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25377362|NCT04803734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377363|NCT04803734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25377364|NCT04803734|Respiratory System Agents|respiratory system agents|mesh-ancestor
25377365|NCT04803734|Tocolytic Agents|tocolytic agents|mesh-ancestor
25377366|NCT04803734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25377367|NCT04803734|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
25377368|NCT04803734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25377369|NCT04803734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25377370|NCT04803734|Adrenergic Agents|adrenergic agents|mesh-ancestor
25377371|NCT04803734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25377372|NCT04803734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377373|NCT04803201|Prednisone|prednisone|mesh-list
25377374|NCT04803201|Cyclophosphamide|cyclophosphamide|mesh-list
25377375|NCT04803201|Doxorubicin|doxorubicin|mesh-list
25377376|NCT04803201|Etoposide|etoposide|mesh-list
25377377|NCT04803201|Vincristine|vincristine|mesh-list
25377378|NCT04803201|Azacitidine|azacitidine|mesh-list
25377379|NCT04803201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25377380|NCT04803201|Immunologic Factors|immunologic factors|mesh-ancestor
25377381|NCT04803201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377382|NCT04803201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25377383|NCT04803201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25377384|NCT04803201|Alkylating Agents|alkylating agents|mesh-ancestor
25377385|NCT04803201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377386|NCT04803201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377387|NCT04803201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25377388|NCT04803201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25377389|NCT04803201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25377390|NCT04803201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25377391|NCT04803201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377392|NCT04803201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25377393|NCT04803201|Glucocorticoids|glucocorticoids|mesh-ancestor
25377394|NCT04803201|Hormones|hormones|mesh-ancestor
25377395|NCT04803201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25377396|NCT04803201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25377397|NCT04803201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25377398|NCT04803201|Tubulin Modulators|tubulin modulators|mesh-ancestor
25377399|NCT04803201|Antimitotic Agents|antimitotic agents|mesh-ancestor
25377400|NCT04803201|Mitosis Modulators|mitosis modulators|mesh-ancestor
25377401|NCT04803201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25377402|NCT04803201|Antimetabolites|antimetabolites|mesh-ancestor
25377403|NCT04802759|Trastuzumab|trastuzumab|mesh-list
25377404|NCT04802759|Pertuzumab|pertuzumab|mesh-list
25377405|NCT04802759|Everolimus|everolimus|mesh-list
25377406|NCT04802759|Atezolizumab|atezolizumab|mesh-list
25377407|NCT04802759|Palbociclib|palbociclib|mesh-list
25377408|NCT04802759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25377409|NCT04802759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377410|NCT04802759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25377411|NCT04802759|Immunologic Factors|immunologic factors|mesh-ancestor
25377412|NCT04802759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377413|NCT04802759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25377414|NCT04802759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377415|NCT04802759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377416|NCT04802408|Listerine|listerine|mesh-list
25377417|NCT04802408|Sodium Fluoride|sodium fluoride|mesh-list
25377418|NCT04802408|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25377419|NCT04802408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25377420|NCT04802408|Cariostatic Agents|cariostatic agents|mesh-ancestor
25377421|NCT04802408|Protective Agents|protective agents|mesh-ancestor
25377422|NCT04802408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377423|NCT04802382|Fibrin fragment D|fibrin fragment d|mesh-list
25377424|NCT04802382|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25377425|NCT04802382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25377426|NCT04802382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377427|NCT04802382|Hemostatics|hemostatics|mesh-ancestor
25377428|NCT04802382|Coagulants|coagulants|mesh-ancestor
25377429|NCT04802161|Cytarabine|cytarabine|mesh-list
25377430|NCT04802161|Daunorubicin|daunorubicin|mesh-list
25377431|NCT04802161|Pomalidomide|pomalidomide|mesh-list
25377432|NCT04802161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25377433|NCT04802161|Antimetabolites|antimetabolites|mesh-ancestor
25377434|NCT04802161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377435|NCT04802161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377436|NCT04802161|Antiviral Agents|antiviral agents|mesh-ancestor
25377437|NCT04802161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25377438|NCT04802161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25377439|NCT04802161|Immunologic Factors|immunologic factors|mesh-ancestor
25377440|NCT04802161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377441|NCT04802161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25377442|NCT04802161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25377443|NCT04802161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25377444|NCT04802161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377445|NCT04802161|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25377446|NCT04802161|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25377447|NCT04802161|Growth Substances|growth substances|mesh-ancestor
25377448|NCT04802161|Growth Inhibitors|growth inhibitors|mesh-ancestor
25377449|NCT04801953|Nimodipine|nimodipine|mesh-list
25377450|NCT04801953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25377451|NCT04801953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25377452|NCT04801953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25377453|NCT04801953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377454|NCT04801953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25377455|NCT04801953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377456|NCT04801953|Vasodilator Agents|vasodilator agents|mesh-ancestor
25377457|NCT04801849|Vitamin E|vitamin e|mesh-list
25377458|NCT04801849|Tocopherols|tocopherols|mesh-list
25377459|NCT04801849|alpha-Tocopherol|alpha-tocopherol|mesh-list
25377460|NCT04801849|Vitamins|vitamins|mesh-ancestor
25377461|NCT04801849|Micronutrients|micronutrients|mesh-ancestor
25377462|NCT04801849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377463|NCT04801849|Antioxidants|antioxidants|mesh-ancestor
25377464|NCT04801849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377465|NCT04801849|Protective Agents|protective agents|mesh-ancestor
25377466|NCT04801797|Cytarabine|cytarabine|mesh-list
25377478|NCT04801797|Immunologic Factors|immunologic factors|mesh-ancestor
25377479|NCT04801797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377480|NCT04801797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377481|NCT04801797|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25377482|NCT04801797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25377483|NCT04801797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25377485|NCT04801589|Dexmedetomidine|dexmedetomidine|mesh-list
25377486|NCT04801589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25377487|NCT04801589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25377488|NCT04801589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377489|NCT04801589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25377490|NCT04801589|Analgesics|analgesics|mesh-ancestor
25377491|NCT04801589|Sensory System Agents|sensory system agents|mesh-ancestor
25377492|NCT04801589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25377493|NCT04801589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25377494|NCT04801589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25377495|NCT04801589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25377496|NCT04801589|Adrenergic Agents|adrenergic agents|mesh-ancestor
25377497|NCT04801589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25377498|NCT04801589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377499|NCT04801589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25377500|NCT04801589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25377501|NCT04801589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25377502|NCT04801589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25377503|NCT04801589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25377504|NCT04801589|Anesthetics, General|anesthetics, general|mesh-ancestor
25377505|NCT04801589|Anesthetics|anesthetics|mesh-ancestor
25377506|NCT04801589|GABA Modulators|gaba modulators|mesh-ancestor
25377507|NCT04801589|GABA Agents|gaba agents|mesh-ancestor
25377508|NCT04800627|Pembrolizumab|pembrolizumab|mesh-list
25377509|NCT04800627|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25377510|NCT04800627|Pevonedistat|pevonedistat|mesh-list
25377511|NCT04800627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25377512|NCT04800627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377513|NCT04800627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377514|NCT04800471|Insulin|insulin|mesh-list
25377515|NCT04800471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25377516|NCT04800471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377517|NCT04799431|Poly I-C|poly i-c|mesh-list
25377518|NCT04799431|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25377519|NCT04799431|Poly ICLC|poly iclc|mesh-list
25377520|NCT04799431|Interferon Inducers|interferon inducers|mesh-ancestor
25377521|NCT04799431|Immunologic Factors|immunologic factors|mesh-ancestor
25377522|NCT04799431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377523|NCT04799431|Laxatives|laxatives|mesh-ancestor
25377524|NCT04799431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25377525|NCT04799431|Antiviral Agents|antiviral agents|mesh-ancestor
25377526|NCT04799431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25377538|NCT04799275|Prednisone|prednisone|mesh-list
25377539|NCT04799275|Cortisone|cortisone|mesh-list
25377540|NCT04799275|Cyclophosphamide|cyclophosphamide|mesh-list
25377541|NCT04799275|Rituximab|rituximab|mesh-list
25377542|NCT04799275|Doxorubicin|doxorubicin|mesh-list
25377543|NCT04799275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25377544|NCT04799275|Vincristine|vincristine|mesh-list
25377545|NCT04799275|Azacitidine|azacitidine|mesh-list
25377546|NCT04799275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25377547|NCT04799275|Antibodies|antibodies|mesh-list
25377548|NCT04799275|Immunoglobulins|immunoglobulins|mesh-list
25377549|NCT04799275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25377550|NCT04799275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25377551|NCT04799275|Immunologic Factors|immunologic factors|mesh-ancestor
25377552|NCT04799275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377553|NCT04799275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25377554|NCT04799275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25377555|NCT04799275|Alkylating Agents|alkylating agents|mesh-ancestor
25377556|NCT04799275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377557|NCT04799275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377558|NCT04799275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25377559|NCT04799275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25377560|NCT04799275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25377561|NCT04799275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25377562|NCT04799275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377563|NCT04799275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25377564|NCT04799275|Glucocorticoids|glucocorticoids|mesh-ancestor
25377565|NCT04799275|Hormones|hormones|mesh-ancestor
25377566|NCT04799275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25377567|NCT04799275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25377568|NCT04799275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25377569|NCT04799275|Tubulin Modulators|tubulin modulators|mesh-ancestor
25377570|NCT04799275|Antimitotic Agents|antimitotic agents|mesh-ancestor
25377571|NCT04799275|Mitosis Modulators|mitosis modulators|mesh-ancestor
25377572|NCT04799275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25377573|NCT04799275|Antimetabolites|antimetabolites|mesh-ancestor
25377574|NCT04799262|Prednisone|prednisone|mesh-list
25377575|NCT04799262|Tofacitinib|tofacitinib|mesh-list
25377576|NCT04799262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25377577|NCT04799262|Glucocorticoids|glucocorticoids|mesh-ancestor
25377578|NCT04799262|Hormones|hormones|mesh-ancestor
25408386|NCT03447132|Fulvestrant|fulvestrant|mesh-list
25377579|NCT04799262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25377580|NCT04799262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377581|NCT04799262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25377582|NCT04799262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377583|NCT04799262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25377584|NCT04799262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377585|NCT04799262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377586|NCT04799249|Gemcitabine|gemcitabine|mesh-list
25377587|NCT04799249|Carboplatin|carboplatin|mesh-list
25377588|NCT04799249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377589|NCT04799249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25377590|NCT04799249|Antimetabolites|antimetabolites|mesh-ancestor
25377591|NCT04799249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377592|NCT04799249|Antiviral Agents|antiviral agents|mesh-ancestor
25377593|NCT04799249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25377594|NCT04799249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377595|NCT04799249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25377596|NCT04799249|Immunologic Factors|immunologic factors|mesh-ancestor
25377597|NCT04799249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377598|NCT04799054|Pembrolizumab|pembrolizumab|mesh-list
25377599|NCT04799054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25377600|NCT04799054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377601|NCT04798781|Pembrolizumab|pembrolizumab|mesh-list
25377602|NCT04798781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25377603|NCT04798781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377604|NCT04798482|Dexmedetomidine|dexmedetomidine|mesh-list
25377605|NCT04798482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25377606|NCT04798482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25377607|NCT04798482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377608|NCT04798482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25377609|NCT04798482|Analgesics|analgesics|mesh-ancestor
25377610|NCT04798482|Sensory System Agents|sensory system agents|mesh-ancestor
25377611|NCT04798482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25377612|NCT04798482|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25377613|NCT04798482|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25377614|NCT04798482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25377615|NCT04798482|Adrenergic Agents|adrenergic agents|mesh-ancestor
25377616|NCT04798482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25377617|NCT04798482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377618|NCT04798469|Methyltestosterone|methyltestosterone|mesh-list
25377619|NCT04798469|Testosterone|testosterone|mesh-list
25377620|NCT04798469|Testosterone undecanoate|testosterone undecanoate|mesh-list
25377621|NCT04798469|Testosterone enanthate|testosterone enanthate|mesh-list
25377622|NCT04798469|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
25377624|NCT04798469|Hormones|hormones|mesh-ancestor
25377625|NCT04798469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25377626|NCT04798469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377627|NCT04798469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25377628|NCT04798469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377629|NCT04798469|Anabolic Agents|anabolic agents|mesh-ancestor
25377630|NCT04798339|Darbepoetin alfa|darbepoetin alfa|mesh-list
25377631|NCT04798339|Hematinics|hematinics|mesh-ancestor
25377632|NCT04798027|Vaccines|vaccines|mesh-list
25377633|NCT04798027|Immunologic Factors|immunologic factors|mesh-ancestor
25377634|NCT04798027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377635|NCT04798001|Vaccines|vaccines|mesh-list
25377636|NCT04798001|Immunologic Factors|immunologic factors|mesh-ancestor
25377637|NCT04798001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377638|NCT04797780|Azacitidine|azacitidine|mesh-list
25377639|NCT04797780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25377640|NCT04797780|Antimetabolites|antimetabolites|mesh-ancestor
25377641|NCT04797780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377642|NCT04797780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377643|NCT04797780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377644|NCT04797325|Prednisolone|prednisolone|mesh-list
25377645|NCT04797325|Infliximab|infliximab|mesh-list
25377646|NCT04797325|Vedolizumab|vedolizumab|mesh-list
25377647|NCT04797325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25377648|NCT04797325|Glucocorticoids|glucocorticoids|mesh-ancestor
25377649|NCT04797325|Hormones|hormones|mesh-ancestor
25377650|NCT04797325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25377651|NCT04797325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377652|NCT04797325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25377653|NCT04797325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377654|NCT04797325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25377655|NCT04797325|Dermatologic Agents|dermatologic agents|mesh-ancestor
25377656|NCT04797325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25377657|NCT04797286|Sildenafil Citrate|sildenafil citrate|mesh-list
25377658|NCT04797286|Vasodilator Agents|vasodilator agents|mesh-ancestor
25377659|NCT04797286|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25377660|NCT04797286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25377661|NCT04797286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377662|NCT04797286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377663|NCT04797286|Urological Agents|urological agents|mesh-ancestor
25377664|NCT04796779|Ferrous fumarate|ferrous fumarate|mesh-list
25377665|NCT04796779|Trace Elements|trace elements|mesh-ancestor
25377666|NCT04796779|Micronutrients|micronutrients|mesh-ancestor
25377667|NCT04796779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377668|NCT04796584|Antibodies|antibodies|mesh-list
25377669|NCT04796584|Immunologic Factors|immunologic factors|mesh-ancestor
25377670|NCT04796584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377671|NCT04796467|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25377672|NCT04796467|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25377673|NCT04796467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377674|NCT04796012|Irinotecan|irinotecan|mesh-list
25377675|NCT04796012|Vincristine|vincristine|mesh-list
25377676|NCT04796012|Temozolomide|temozolomide|mesh-list
25377677|NCT04796012|Atezolizumab|atezolizumab|mesh-list
25377678|NCT04796012|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25377679|NCT04796012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25377680|NCT04796012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377681|NCT04796012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377682|NCT04796012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377683|NCT04796012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25377684|NCT04796012|Tubulin Modulators|tubulin modulators|mesh-ancestor
25377685|NCT04796012|Antimitotic Agents|antimitotic agents|mesh-ancestor
25377686|NCT04796012|Mitosis Modulators|mitosis modulators|mesh-ancestor
25377687|NCT04796012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25377688|NCT04796012|Alkylating Agents|alkylating agents|mesh-ancestor
25377689|NCT04795752|Cyclosporine|cyclosporine|mesh-list
25377690|NCT04795752|Cyclosporins|cyclosporins|mesh-list
25377691|NCT04795752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377692|NCT04795752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377693|NCT04795752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25377694|NCT04795752|Immunologic Factors|immunologic factors|mesh-ancestor
25377695|NCT04795752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377696|NCT04795752|Antifungal Agents|antifungal agents|mesh-ancestor
25377697|NCT04795752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25377698|NCT04795752|Dermatologic Agents|dermatologic agents|mesh-ancestor
25377699|NCT04795752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25377700|NCT04795752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25377701|NCT04795531|Insulin|insulin|mesh-list
25377702|NCT04795531|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25377703|NCT04795531|Insulin, Long-Acting|insulin, long-acting|mesh-list
25377704|NCT04795531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25377705|NCT04795531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377706|NCT04795336|Melatonin|melatonin|mesh-list
25377707|NCT04795336|Antioxidants|antioxidants|mesh-ancestor
25377708|NCT04795336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377709|NCT04795336|Protective Agents|protective agents|mesh-ancestor
25377788|NCT04790903|Cyclophosphamide|cyclophosphamide|mesh-list
25377710|NCT04795336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377711|NCT04795336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25377712|NCT04795245|Afatinib|afatinib|mesh-list
25377713|NCT04795245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377714|NCT04795245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25377715|NCT04795245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377716|NCT04795245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377717|NCT04794842|Phenol|phenol|mesh-list
25377718|NCT04794842|Tetracaine|tetracaine|mesh-list
25377719|NCT04794842|Anesthetics, Local|anesthetics, local|mesh-ancestor
25377720|NCT04794842|Anesthetics|anesthetics|mesh-ancestor
25377721|NCT04794842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25377722|NCT04794842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377723|NCT04794842|Sensory System Agents|sensory system agents|mesh-ancestor
25377724|NCT04794842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25377725|NCT04794842|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25377726|NCT04794842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25377727|NCT04794842|Disinfectants|disinfectants|mesh-ancestor
25377728|NCT04794842|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
25377729|NCT04794842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25377730|NCT04794569|Tinzaparin|tinzaparin|mesh-list
25377731|NCT04794569|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25377732|NCT04794569|Dalteparin|dalteparin|mesh-list
25377733|NCT04794569|Rivaroxaban|rivaroxaban|mesh-list
25377734|NCT04794569|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25377735|NCT04794569|Antithrombins|antithrombins|mesh-ancestor
25377736|NCT04794569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25377737|NCT04794569|Protease Inhibitors|protease inhibitors|mesh-ancestor
25377738|NCT04794569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377739|NCT04794569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377740|NCT04794569|Anticoagulants|anticoagulants|mesh-ancestor
25377741|NCT04794569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25377742|NCT04794569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25377743|NCT04793958|Cetuximab|cetuximab|mesh-list
25377744|NCT04793958|Adagrasib|adagrasib|mesh-list
25377745|NCT04793958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25377746|NCT04793958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377747|NCT04793919|Tretinoin|tretinoin|mesh-list
25377748|NCT04793919|Arsenic Trioxide|arsenic trioxide|mesh-list
25377749|NCT04793919|Gemtuzumab|gemtuzumab|mesh-list
25377750|NCT04793919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377751|NCT04793919|Keratolytic Agents|keratolytic agents|mesh-ancestor
25377752|NCT04793919|Dermatologic Agents|dermatologic agents|mesh-ancestor
25377753|NCT04793919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25377754|NCT04793906|Iron|iron|mesh-list
25377755|NCT04793906|Trace Elements|trace elements|mesh-ancestor
25377756|NCT04793906|Micronutrients|micronutrients|mesh-ancestor
25377757|NCT04793906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377758|NCT04792567|Siponimod|siponimod|mesh-list
25377759|NCT04792567|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25377760|NCT04792567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377761|NCT04792567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25377762|NCT04792567|Immunologic Factors|immunologic factors|mesh-ancestor
25377763|NCT04792567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377764|NCT04792073|Avelumab|avelumab|mesh-list
25377765|NCT04792073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25377766|NCT04792073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377767|NCT04791969|Naltrexone|naltrexone|mesh-list
25377768|NCT04791969|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25377769|NCT04791969|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25377770|NCT04791969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377771|NCT04791969|Sensory System Agents|sensory system agents|mesh-ancestor
25377772|NCT04791969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25377773|NCT04791579|Ciprofloxacin|ciprofloxacin|mesh-list
25377774|NCT04791579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25377775|NCT04791579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25377776|NCT04791579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25377777|NCT04791579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25377778|NCT04791579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377779|NCT04791579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377780|NCT04791579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377781|NCT04791579|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25377782|NCT04791579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25377783|NCT04791553|Cenobamate|cenobamate|mesh-list
25377784|NCT04791553|Anticonvulsants|anticonvulsants|mesh-ancestor
25377785|NCT04791514|Treprostinil|treprostinil|mesh-list
25377786|NCT04791514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25377787|NCT04790903|Prednisone|prednisone|mesh-list
25377789|NCT04790903|Rituximab|rituximab|mesh-list
25377790|NCT04790903|Doxorubicin|doxorubicin|mesh-list
25377791|NCT04790903|Venetoclax|venetoclax|mesh-list
25377792|NCT04790903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25377793|NCT04790903|Immunologic Factors|immunologic factors|mesh-ancestor
25377794|NCT04790903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377795|NCT04790903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25377796|NCT04790903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25377797|NCT04790903|Alkylating Agents|alkylating agents|mesh-ancestor
25377798|NCT04790903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377799|NCT04790903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377800|NCT04790903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25377801|NCT04790903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25377802|NCT04790903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25377803|NCT04790903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25377804|NCT04790903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25377805|NCT04790903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377806|NCT04790903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25377807|NCT04790903|Glucocorticoids|glucocorticoids|mesh-ancestor
25377809|NCT04790903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25377810|NCT04790903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25377811|NCT04790370|Heparin|heparin|mesh-list
25377812|NCT04790370|Calcium heparin|calcium heparin|mesh-list
25377813|NCT04790370|Anticoagulants|anticoagulants|mesh-ancestor
25377814|NCT04790370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25377815|NCT04790370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25377816|NCT04790370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377817|NCT04790279|Amlodipine|amlodipine|mesh-list
25377818|NCT04790279|Nifedipine|nifedipine|mesh-list
25377819|NCT04790279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25377820|NCT04790279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25377821|NCT04790279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25377822|NCT04790279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377823|NCT04790279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25377824|NCT04790279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377825|NCT04790279|Vasodilator Agents|vasodilator agents|mesh-ancestor
25377826|NCT04790279|Tocolytic Agents|tocolytic agents|mesh-ancestor
25377827|NCT04790279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25377828|NCT04789837|Cilostazol|cilostazol|mesh-list
25377829|NCT04789837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25377830|NCT04789837|Autonomic Agents|autonomic agents|mesh-ancestor
25377831|NCT04789837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25377832|NCT04789837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377833|NCT04789837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25377834|NCT04789837|Respiratory System Agents|respiratory system agents|mesh-ancestor
25377835|NCT04789837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25377836|NCT04789837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25377837|NCT04789837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377838|NCT04789837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25377839|NCT04789837|Vasodilator Agents|vasodilator agents|mesh-ancestor
25377840|NCT04789837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25377841|NCT04789837|Protective Agents|protective agents|mesh-ancestor
25377842|NCT04789837|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25377843|NCT04789837|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25377844|NCT04789837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377845|NCT04789668|Atezolizumab|atezolizumab|mesh-list
25377846|NCT04789668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377847|NCT04789408|Cyclophosphamide|cyclophosphamide|mesh-list
25377848|NCT04789408|Fludarabine|fludarabine|mesh-list
25377849|NCT04789408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25377850|NCT04789408|Immunologic Factors|immunologic factors|mesh-ancestor
25377851|NCT04789408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377852|NCT04789408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25377853|NCT04789408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25377854|NCT04789408|Alkylating Agents|alkylating agents|mesh-ancestor
25377855|NCT04789408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377856|NCT04789408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377857|NCT04789408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25377858|NCT04789096|Pembrolizumab|pembrolizumab|mesh-list
25377859|NCT04789096|Trastuzumab|trastuzumab|mesh-list
25377860|NCT04789096|Capecitabine|capecitabine|mesh-list
25377861|NCT04789096|Tucatinib|tucatinib|mesh-list
25377862|NCT04789096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25377863|NCT04789096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377864|NCT04789096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25377865|NCT04789096|Antimetabolites|antimetabolites|mesh-ancestor
25377866|NCT04789096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377867|NCT04789096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25377868|NCT04789096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377869|NCT04788615|Interferons|interferons|mesh-list
25377870|NCT04788615|Interferon-beta|interferon-beta|mesh-list
25377871|NCT04788615|Interferon beta-1a|interferon beta-1a|mesh-list
25377872|NCT04788615|Teriflunomide|teriflunomide|mesh-list
25377873|NCT04788615|Ofatumumab|ofatumumab|mesh-list
25377874|NCT04788615|Glatiramer Acetate|glatiramer acetate|mesh-list
25377875|NCT04788615|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25377876|NCT04788615|(T,G)-A-L|(t,g)-a-l|mesh-list
25377877|NCT04788615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377878|NCT04788615|Antiviral Agents|antiviral agents|mesh-ancestor
25377879|NCT04788615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25377880|NCT04788615|Immunologic Factors|immunologic factors|mesh-ancestor
25377881|NCT04788615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377882|NCT04788615|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25377883|NCT04788615|Dermatologic Agents|dermatologic agents|mesh-ancestor
25377884|NCT04788615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25377885|NCT04788615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25377886|NCT04788615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25377887|NCT04788615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25377888|NCT04788615|Analgesics|analgesics|mesh-ancestor
25377889|NCT04788615|Sensory System Agents|sensory system agents|mesh-ancestor
25377890|NCT04788615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25377891|NCT04788615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25377892|NCT04787991|Gemcitabine|gemcitabine|mesh-list
25377893|NCT04787991|Hydroxychloroquine|hydroxychloroquine|mesh-list
25377894|NCT04787991|Paclitaxel|paclitaxel|mesh-list
25377895|NCT04787991|Nivolumab|nivolumab|mesh-list
25377896|NCT04787991|Ipilimumab|ipilimumab|mesh-list
25377897|NCT04787991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25377898|NCT04787991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377899|NCT04787991|Tubulin Modulators|tubulin modulators|mesh-ancestor
25377900|NCT04787991|Antimitotic Agents|antimitotic agents|mesh-ancestor
25377901|NCT04787991|Mitosis Modulators|mitosis modulators|mesh-ancestor
25377902|NCT04787991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377903|NCT04787991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25377904|NCT04787991|Antimetabolites|antimetabolites|mesh-ancestor
25377905|NCT04787991|Antiviral Agents|antiviral agents|mesh-ancestor
25377906|NCT04787991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25377907|NCT04787991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377908|NCT04787991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25377909|NCT04787991|Immunologic Factors|immunologic factors|mesh-ancestor
25377910|NCT04787991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377911|NCT04787991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25377912|NCT04787991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25377913|NCT04787991|Antimalarials|antimalarials|mesh-ancestor
25377914|NCT04787991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25377915|NCT04787991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25377916|NCT04787991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25377917|NCT04787744|Prednisone|prednisone|mesh-list
25377918|NCT04787744|Methylprednisolone|methylprednisolone|mesh-list
25377919|NCT04787744|Docetaxel|docetaxel|mesh-list
25377920|NCT04787744|Leuprolide|leuprolide|mesh-list
25377921|NCT04787744|Goserelin|goserelin|mesh-list
25377922|NCT04787744|Bicalutamide|bicalutamide|mesh-list
25377923|NCT04787744|Triptorelin Pamoate|triptorelin pamoate|mesh-list
25377924|NCT04787744|Flutamide|flutamide|mesh-list
25377925|NCT04787744|Nilutamide|nilutamide|mesh-list
25377926|NCT04787744|Relugolix|relugolix|mesh-list
25377927|NCT04787744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377928|NCT04787744|Tubulin Modulators|tubulin modulators|mesh-ancestor
25377929|NCT04787744|Antimitotic Agents|antimitotic agents|mesh-ancestor
25377930|NCT04787744|Mitosis Modulators|mitosis modulators|mesh-ancestor
25377931|NCT04787744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377932|NCT04787744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25377933|NCT04787744|Glucocorticoids|glucocorticoids|mesh-ancestor
25377935|NCT04787744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25377936|NCT04787744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377937|NCT04787744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25377938|NCT04787744|Antiemetics|antiemetics|mesh-ancestor
25377939|NCT04787744|Autonomic Agents|autonomic agents|mesh-ancestor
25377940|NCT04787744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25377941|NCT04787744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25377942|NCT04787744|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25377943|NCT04787744|Protective Agents|protective agents|mesh-ancestor
25377944|NCT04787744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
25377945|NCT04787744|Fertility Agents|fertility agents|mesh-ancestor
25377946|NCT04787744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25377947|NCT04787744|Androgen Antagonists|androgen antagonists|mesh-ancestor
25377948|NCT04787744|Hormone Antagonists|hormone antagonists|mesh-ancestor
25377949|NCT04787744|Luteolytic Agents|luteolytic agents|mesh-ancestor
25377950|NCT04787744|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25377951|NCT04787744|Contraceptive Agents|contraceptive agents|mesh-ancestor
25377952|NCT04787744|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25377953|NCT04787471|Riboflavin|riboflavin|mesh-list
25377954|NCT04787471|Vitamin B Complex|vitamin b complex|mesh-ancestor
25377955|NCT04787471|Vitamins|vitamins|mesh-ancestor
25377956|NCT04787471|Micronutrients|micronutrients|mesh-ancestor
25377957|NCT04787471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377958|NCT04787471|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25377959|NCT04787471|Dermatologic Agents|dermatologic agents|mesh-ancestor
25377960|NCT04787341|Panitumumab|panitumumab|mesh-list
25377961|NCT04787341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25377962|NCT04787341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377963|NCT04786964|Folic Acid|folic acid|mesh-list
25377965|NCT04786964|Hydroxocobalamin|hydroxocobalamin|mesh-list
25377966|NCT04786964|Dexamethasone|dexamethasone|mesh-list
25377967|NCT04786964|Carboplatin|carboplatin|mesh-list
25377968|NCT04786964|Pemetrexed|pemetrexed|mesh-list
25377969|NCT04786964|Vitamins|vitamins|mesh-ancestor
25377970|NCT04786964|Micronutrients|micronutrients|mesh-ancestor
25377971|NCT04786964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377972|NCT04786964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25377973|NCT04786964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25377974|NCT04786964|Antiemetics|antiemetics|mesh-ancestor
25377975|NCT04786964|Autonomic Agents|autonomic agents|mesh-ancestor
25377976|NCT04786964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25377977|NCT04786964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25377978|NCT04786964|Glucocorticoids|glucocorticoids|mesh-ancestor
25377979|NCT04786964|Hormones|hormones|mesh-ancestor
25377980|NCT04786964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25377981|NCT04786964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25377982|NCT04786964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25377983|NCT04786964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25377984|NCT04786964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25377985|NCT04786964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25377986|NCT04786964|Hematinics|hematinics|mesh-ancestor
25377987|NCT04786964|Vitamin B Complex|vitamin b complex|mesh-ancestor
25377988|NCT04786873|Clonidine|clonidine|mesh-list
25377989|NCT04786873|Analgesics|analgesics|mesh-ancestor
25377990|NCT04786873|Sensory System Agents|sensory system agents|mesh-ancestor
25377991|NCT04786873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25377992|NCT04786873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25377993|NCT04786873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25377994|NCT04786873|Sympatholytics|sympatholytics|mesh-ancestor
25377995|NCT04786873|Autonomic Agents|autonomic agents|mesh-ancestor
25377996|NCT04786873|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25377997|NCT04786873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25377998|NCT04786873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25377999|NCT04786873|Adrenergic Agents|adrenergic agents|mesh-ancestor
25378000|NCT04786873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25378001|NCT04786873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378002|NCT04786574|Tolvaptan|tolvaptan|mesh-list
25378003|NCT04786574|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25378004|NCT04786574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378005|NCT04786574|Natriuretic Agents|natriuretic agents|mesh-ancestor
25378006|NCT04786574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378007|NCT04786548|Celecoxib|celecoxib|mesh-list
25378008|NCT04786548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25378009|NCT04786548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25378010|NCT04786548|Analgesics|analgesics|mesh-ancestor
25378011|NCT04786548|Sensory System Agents|sensory system agents|mesh-ancestor
25378012|NCT04786548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25378013|NCT04786548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378014|NCT04786548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25378015|NCT04786548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25378016|NCT04786548|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25378017|NCT04786548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25378018|NCT04786548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25378019|NCT04786548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378020|NCT04785950|Levonorgestrel|levonorgestrel|mesh-list
25378021|NCT04785950|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25378022|NCT04785950|Contraceptive Agents|contraceptive agents|mesh-ancestor
25378023|NCT04785950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25378024|NCT04785950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378025|NCT04785950|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25378026|NCT04785950|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25378027|NCT04785950|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25378028|NCT04785820|Nivolumab|nivolumab|mesh-list
25378029|NCT04785820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25378030|NCT04785820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378031|NCT04785820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25378032|NCT04785820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378033|NCT04785638|Bupivacaine|bupivacaine|mesh-list
25378034|NCT04785638|Anesthetics, Local|anesthetics, local|mesh-ancestor
25378035|NCT04785638|Anesthetics|anesthetics|mesh-ancestor
25378036|NCT04785638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25378037|NCT04785638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25409405|NCT03383575|Azacitidine|azacitidine|mesh-list
25378038|NCT04785638|Sensory System Agents|sensory system agents|mesh-ancestor
25378039|NCT04785638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25378040|NCT04785300|Dasatinib|dasatinib|mesh-list
25378041|NCT04785300|Quercetin|quercetin|mesh-list
25378042|NCT04785300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378043|NCT04785300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25378044|NCT04785300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25378045|NCT04785300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378046|NCT04785300|Antioxidants|antioxidants|mesh-ancestor
25378047|NCT04785300|Protective Agents|protective agents|mesh-ancestor
25378048|NCT04785300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378049|NCT04785287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25378050|NCT04785287|Nivolumab|nivolumab|mesh-list
25378051|NCT04785287|Antibodies|antibodies|mesh-list
25378052|NCT04785287|Immunoglobulins|immunoglobulins|mesh-list
25378053|NCT04785287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25378054|NCT04785287|Immunologic Factors|immunologic factors|mesh-ancestor
25378055|NCT04785287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378056|NCT04785287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378057|NCT04785287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25378058|NCT04785287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378059|NCT04785274|Chrysarobin|chrysarobin|mesh-list
25378060|NCT04785274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25378061|NCT04785274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25378062|NCT04785274|Analgesics|analgesics|mesh-ancestor
25378063|NCT04785274|Sensory System Agents|sensory system agents|mesh-ancestor
25378064|NCT04785274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25378065|NCT04785274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378066|NCT04785274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25378067|NCT04785274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25378068|NCT04784715|Trastuzumab|trastuzumab|mesh-list
25378069|NCT04784715|Pertuzumab|pertuzumab|mesh-list
25378070|NCT04784715|Taxane|taxane|mesh-list
25378071|NCT04784715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25378072|NCT04784715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378073|NCT04784559|Favipiravir|favipiravir|mesh-list
25378074|NCT04784559|Remdesivir|remdesivir|mesh-list
25378075|NCT04784559|Dexamethasone|dexamethasone|mesh-list
25378076|NCT04784559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25378077|NCT04784559|Antiemetics|antiemetics|mesh-ancestor
25378078|NCT04784559|Autonomic Agents|autonomic agents|mesh-ancestor
25378079|NCT04784559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25378080|NCT04784559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378081|NCT04784559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25378082|NCT04784559|Glucocorticoids|glucocorticoids|mesh-ancestor
25378083|NCT04784559|Hormones|hormones|mesh-ancestor
25378084|NCT04784559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25378085|NCT04784559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25378086|NCT04784559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378087|NCT04784559|Antiviral Agents|antiviral agents|mesh-ancestor
25378088|NCT04784559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25378089|NCT04784559|Antimetabolites|antimetabolites|mesh-ancestor
25378090|NCT04784559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378091|NCT04784442|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
25378092|NCT04784442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25378093|NCT04784442|Antimetabolites|antimetabolites|mesh-ancestor
25378094|NCT04784442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378095|NCT04784442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25378096|NCT04784442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25378097|NCT04784442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25378098|NCT04784442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378099|NCT04784247|Pembrolizumab|pembrolizumab|mesh-list
25378100|NCT04784247|Lenvatinib|lenvatinib|mesh-list
25378101|NCT04784247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25378102|NCT04784247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378103|NCT04784247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25378104|NCT04784247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25378105|NCT04784247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378106|NCT04783792|Ascorbic Acid|ascorbic acid|mesh-list
25378107|NCT04783792|Antioxidants|antioxidants|mesh-ancestor
25378108|NCT04783792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378109|NCT04783792|Protective Agents|protective agents|mesh-ancestor
25378110|NCT04783792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378111|NCT04783792|Vitamins|vitamins|mesh-ancestor
25724248|NCT02536040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378112|NCT04783792|Micronutrients|micronutrients|mesh-ancestor
25378114|NCT04783675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25378115|NCT04783675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378116|NCT04783675|Immunologic Factors|immunologic factors|mesh-ancestor
25378117|NCT04783675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378118|NCT04783675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25378119|NCT04783415|Acalabrutinib|acalabrutinib|mesh-list
25378120|NCT04783415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378121|NCT04782804|Capecitabine|capecitabine|mesh-list
25378122|NCT04782804|Antibodies|antibodies|mesh-list
25378123|NCT04782804|Immunologic Factors|immunologic factors|mesh-ancestor
25378124|NCT04782804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378125|NCT04782804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25378126|NCT04782804|Antimetabolites|antimetabolites|mesh-ancestor
25378127|NCT04782804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378128|NCT04782804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378129|NCT04782778|Bupivacaine|bupivacaine|mesh-list
25378130|NCT04782778|Anesthetics, Local|anesthetics, local|mesh-ancestor
25378131|NCT04782778|Anesthetics|anesthetics|mesh-ancestor
25378132|NCT04782778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25378133|NCT04782778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378134|NCT04782778|Sensory System Agents|sensory system agents|mesh-ancestor
25378135|NCT04782778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25378136|NCT04782258|Tolvaptan|tolvaptan|mesh-list
25378137|NCT04782258|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
25378138|NCT04782258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378139|NCT04782258|Natriuretic Agents|natriuretic agents|mesh-ancestor
25378140|NCT04782258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378141|NCT04781959|Lenograstim|lenograstim|mesh-list
25378142|NCT04781959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25378143|NCT04781959|Immunologic Factors|immunologic factors|mesh-ancestor
25378144|NCT04781959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378145|NCT04781881|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
25378146|NCT04781881|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25378147|NCT04781881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378148|NCT04781088|Paclitaxel|paclitaxel|mesh-list
25378149|NCT04781088|Pembrolizumab|pembrolizumab|mesh-list
25378150|NCT04781088|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25378151|NCT04781088|Lenvatinib|lenvatinib|mesh-list
25378152|NCT04781088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25378153|NCT04781088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378154|NCT04781088|Tubulin Modulators|tubulin modulators|mesh-ancestor
25378155|NCT04781088|Antimitotic Agents|antimitotic agents|mesh-ancestor
25378156|NCT04781088|Mitosis Modulators|mitosis modulators|mesh-ancestor
25378157|NCT04781088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378158|NCT04781088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25378159|NCT04781088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25378160|NCT04781088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25378162|NCT04781036|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25378163|NCT04781036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25378164|NCT04781036|Disinfectants|disinfectants|mesh-ancestor
25378165|NCT04780269|Dinoprostone|dinoprostone|mesh-list
25378166|NCT04780269|Oxytocics|oxytocics|mesh-ancestor
25378167|NCT04780269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25378168|NCT04780269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378169|NCT04780061|Vitamin D|vitamin d|mesh-list
25378170|NCT04780061|Cholecalciferol|cholecalciferol|mesh-list
25378172|NCT04780061|Vitamin K|vitamin k|mesh-list
25378173|NCT04780061|Vitamin K 2|vitamin k 2|mesh-list
25378174|NCT04780061|Micronutrients|micronutrients|mesh-ancestor
25378175|NCT04780061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378176|NCT04780061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25378177|NCT04780061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25378178|NCT04780061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378179|NCT04780061|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25378180|NCT04780061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25378181|NCT04780061|Hemostatics|hemostatics|mesh-ancestor
25378182|NCT04780061|Coagulants|coagulants|mesh-ancestor
25378183|NCT04779320|Vedolizumab|vedolizumab|mesh-list
25378184|NCT04779320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25378185|NCT04779307|Vedolizumab|vedolizumab|mesh-list
25378186|NCT04779307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25378187|NCT04779151|Niraparib|niraparib|mesh-list
25378188|NCT04779151|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25378189|NCT04779151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25378190|NCT04779151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378191|NCT04779151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378192|NCT04778410|Cytarabine|cytarabine|mesh-list
25378193|NCT04778410|Etoposide|etoposide|mesh-list
25378194|NCT04778410|Mitoxantrone|mitoxantrone|mesh-list
25378195|NCT04778410|Azacitidine|azacitidine|mesh-list
25378196|NCT04778410|Venetoclax|venetoclax|mesh-list
25378197|NCT04778410|Cc-486|cc-486|mesh-list
25378198|NCT04778410|Magrolimab|magrolimab|mesh-list
25378199|NCT04778410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25378200|NCT04778410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378201|NCT04778410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25378202|NCT04778410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25378203|NCT04778410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25378204|NCT04778410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378205|NCT04778410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25378206|NCT04778410|Antimetabolites|antimetabolites|mesh-ancestor
25378207|NCT04778410|Antiviral Agents|antiviral agents|mesh-ancestor
25378208|NCT04778410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25378209|NCT04778410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25378210|NCT04778410|Immunologic Factors|immunologic factors|mesh-ancestor
25378211|NCT04778410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378212|NCT04778410|Analgesics|analgesics|mesh-ancestor
25378213|NCT04778410|Sensory System Agents|sensory system agents|mesh-ancestor
25378214|NCT04778410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25378215|NCT04778410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25378216|NCT04778397|Cytarabine|cytarabine|mesh-list
25378217|NCT04778397|Azacitidine|azacitidine|mesh-list
25378218|NCT04778397|Daunorubicin|daunorubicin|mesh-list
25378219|NCT04778397|Venetoclax|venetoclax|mesh-list
25378220|NCT04778397|Idarubicin|idarubicin|mesh-list
25378221|NCT04778397|Magrolimab|magrolimab|mesh-list
25378222|NCT04778397|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25378223|NCT04778397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25378224|NCT04778397|Antimetabolites|antimetabolites|mesh-ancestor
25378225|NCT04778397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378226|NCT04778397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378227|NCT04778397|Antiviral Agents|antiviral agents|mesh-ancestor
25378228|NCT04778397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25378229|NCT04778397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25378230|NCT04778397|Immunologic Factors|immunologic factors|mesh-ancestor
25378231|NCT04778397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378232|NCT04778397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25378233|NCT04778397|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25378241|NCT04778358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378242|NCT04778176|Levodopa|levodopa|mesh-list
25378243|NCT04778176|Carbidopa|carbidopa|mesh-list
25378244|NCT04778176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25378245|NCT04778176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25378246|NCT04778176|Dopamine Agents|dopamine agents|mesh-ancestor
25378247|NCT04778176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25378248|NCT04778176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378249|NCT04778176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378250|NCT04778176|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
25378251|NCT04778176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25378252|NCT04777357|Cariprazine|cariprazine|mesh-list
25378253|NCT04777357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25378254|NCT04777357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25378255|NCT04777357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25378256|NCT04777357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378257|NCT04777357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25378266|NCT04776980|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
25378267|NCT04776980|Hematinics|hematinics|mesh-ancestor
25378268|NCT04776980|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25378269|NCT04776980|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25378270|NCT04776525|Doxorubicin|doxorubicin|mesh-list
25378271|NCT04776525|Ifosfamide|ifosfamide|mesh-list
25378272|NCT04776525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25378273|NCT04776525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378274|NCT04776525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25378275|NCT04776525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25378276|NCT04776525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25378277|NCT04776525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378278|NCT04776525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25378279|NCT04776525|Alkylating Agents|alkylating agents|mesh-ancestor
25378280|NCT04776369|Lidocaine|lidocaine|mesh-list
25378281|NCT04776369|Magnesium Sulfate|magnesium sulfate|mesh-list
25378287|NCT04776369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25378289|NCT04776369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25378290|NCT04776369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25378291|NCT04776369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25378292|NCT04776369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378293|NCT04776369|Analgesics|analgesics|mesh-ancestor
25378294|NCT04776369|Anticonvulsants|anticonvulsants|mesh-ancestor
25378295|NCT04776369|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25378296|NCT04776369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25378297|NCT04776369|Tocolytic Agents|tocolytic agents|mesh-ancestor
25378298|NCT04776369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25378299|NCT04776252|Islatravir|islatravir|mesh-list
25378300|NCT04776252|Antiviral Agents|antiviral agents|mesh-ancestor
25378301|NCT04776252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25378302|NCT04776252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25378303|NCT04776252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378304|NCT04776252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25378305|NCT04776252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25378306|NCT04776252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25378315|NCT04775381|Vitamin D|vitamin d|mesh-list
25378316|NCT04775381|Vitamins|vitamins|mesh-ancestor
25378317|NCT04775381|Micronutrients|micronutrients|mesh-ancestor
25378318|NCT04775381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378319|NCT04775381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25378320|NCT04774991|Azithromycin|azithromycin|mesh-list
25378321|NCT04774991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25378322|NCT04774991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25378323|NCT04774380|Cisplatin|cisplatin|mesh-list
25378324|NCT04774380|Carboplatin|carboplatin|mesh-list
25378325|NCT04774380|Etoposide|etoposide|mesh-list
25378326|NCT04774380|Durvalumab|durvalumab|mesh-list
25378327|NCT04774380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378328|NCT04774380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25378329|NCT04774380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25378330|NCT04774380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25378331|NCT04774380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25378332|NCT04774380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378333|NCT04774380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25378334|NCT04774107|Ribavirin|ribavirin|mesh-list
25378335|NCT04774107|Antimetabolites|antimetabolites|mesh-ancestor
25378336|NCT04774107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378337|NCT04774107|Antiviral Agents|antiviral agents|mesh-ancestor
25378338|NCT04774107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25378339|NCT04774094|Ceftazidime|ceftazidime|mesh-list
25378340|NCT04774094|Avibactam|avibactam|mesh-list
25378341|NCT04774094|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
25378342|NCT04774094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25378343|NCT04774094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25378344|NCT04774094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25378345|NCT04774094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25378346|NCT04774094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378347|NCT04773353|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
25378348|NCT04773353|Hormones|hormones|mesh-ancestor
25378349|NCT04773353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25378350|NCT04773353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378351|NCT04772547|Vigabatrin|vigabatrin|mesh-list
25378352|NCT04772547|Anticonvulsants|anticonvulsants|mesh-ancestor
25378353|NCT04772547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25378354|NCT04772547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378355|NCT04772547|GABA Agents|gaba agents|mesh-ancestor
25378356|NCT04772547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25409736|NCT03352765|Rituximab|rituximab|mesh-list
25378357|NCT04772547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378358|NCT04771767|Ketamine|ketamine|mesh-list
25378359|NCT04771767|Analgesics|analgesics|mesh-ancestor
25378360|NCT04771767|Sensory System Agents|sensory system agents|mesh-ancestor
25378361|NCT04771767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25378362|NCT04771767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378363|NCT04771767|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25378364|NCT04771767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25378365|NCT04771767|Anesthetics, General|anesthetics, general|mesh-ancestor
25378366|NCT04771767|Anesthetics|anesthetics|mesh-ancestor
25378367|NCT04771767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25378368|NCT04771767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25378369|NCT04771767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25378370|NCT04771767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25378371|NCT04771767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378372|NCT04771130|Posaconazole|posaconazole|mesh-list
25378373|NCT04771130|Azacitidine|azacitidine|mesh-list
25378374|NCT04771130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25378375|NCT04771130|Antimetabolites|antimetabolites|mesh-ancestor
25378376|NCT04771130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378377|NCT04771130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378378|NCT04771130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25378379|NCT04771130|Antifungal Agents|antifungal agents|mesh-ancestor
25378380|NCT04771130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25378381|NCT04771130|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25378382|NCT04771130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25378383|NCT04771130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25378384|NCT04771130|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25378385|NCT04771130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25378386|NCT04771130|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25378387|NCT04771130|Hormone Antagonists|hormone antagonists|mesh-ancestor
25378388|NCT04771130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25378389|NCT04771130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378390|NCT04770896|Sorafenib|sorafenib|mesh-list
25378391|NCT04770896|Atezolizumab|atezolizumab|mesh-list
25378392|NCT04770896|Lenvatinib|lenvatinib|mesh-list
25378393|NCT04770896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378394|NCT04770896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25378395|NCT04770896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25378396|NCT04770896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378397|NCT04770623|Docetaxel|docetaxel|mesh-list
25378398|NCT04770623|Irinotecan|irinotecan|mesh-list
25378399|NCT04770623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378400|NCT04770623|Tubulin Modulators|tubulin modulators|mesh-ancestor
25378401|NCT04770623|Antimitotic Agents|antimitotic agents|mesh-ancestor
25378402|NCT04770623|Mitosis Modulators|mitosis modulators|mesh-ancestor
25378403|NCT04770623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378404|NCT04770623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25378405|NCT04770623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25378406|NCT04770623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25378407|NCT04770610|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25378408|NCT04770610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25378409|NCT04769453|Hyaluronic Acid|hyaluronic acid|mesh-list
25378410|NCT04769453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25378411|NCT04769453|Immunologic Factors|immunologic factors|mesh-ancestor
25378412|NCT04769453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378413|NCT04769453|Viscosupplements|viscosupplements|mesh-ancestor
25378414|NCT04769453|Protective Agents|protective agents|mesh-ancestor
25378415|NCT04769414|Gemcitabine|gemcitabine|mesh-list
25378416|NCT04769414|Fluorouracil|fluorouracil|mesh-list
25378417|NCT04769414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25378418|NCT04769414|Antimetabolites|antimetabolites|mesh-ancestor
25378419|NCT04769414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378420|NCT04769414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378421|NCT04769414|Antiviral Agents|antiviral agents|mesh-ancestor
25378422|NCT04769414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25378423|NCT04769414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25378424|NCT04769414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25378425|NCT04769414|Immunologic Factors|immunologic factors|mesh-ancestor
25378426|NCT04769414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378427|NCT04768881|Pembrolizumab|pembrolizumab|mesh-list
25378428|NCT04768881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25378429|NCT04768881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378430|NCT04768010|Misoprostol|misoprostol|mesh-list
25724249|NCT02536105|Methylphenidate|methylphenidate|mesh-list
25378431|NCT04768010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25378432|NCT04768010|Abortifacient Agents|abortifacient agents|mesh-ancestor
25378433|NCT04768010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25378434|NCT04768010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378435|NCT04768010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25378436|NCT04768010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25378437|NCT04768010|Oxytocics|oxytocics|mesh-ancestor
25378438|NCT04767711|Prednisolone|prednisolone|mesh-list
25378439|NCT04767711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25378440|NCT04767711|Glucocorticoids|glucocorticoids|mesh-ancestor
25378441|NCT04767711|Hormones|hormones|mesh-ancestor
25378442|NCT04767711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25378443|NCT04767711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378444|NCT04767711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25378445|NCT04767711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378446|NCT04767217|Lumefantrine|lumefantrine|mesh-list
25378447|NCT04767217|Artemether|artemether|mesh-list
25378448|NCT04767217|Piperaquine|piperaquine|mesh-list
25378449|NCT04767217|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25378450|NCT04767217|Artenimol|artenimol|mesh-list
25378451|NCT04767217|Antimalarials|antimalarials|mesh-ancestor
25378452|NCT04767217|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25378453|NCT04767217|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25378454|NCT04767217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25378455|NCT04767113|Heparin|heparin|mesh-list
25378456|NCT04767113|Calcium heparin|calcium heparin|mesh-list
25378457|NCT04767113|Anticoagulants|anticoagulants|mesh-ancestor
25378458|NCT04767113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25378459|NCT04767113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25378460|NCT04767113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378461|NCT04766723|Botulinum Toxins|botulinum toxins|mesh-list
25378462|NCT04766723|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25378463|NCT04766723|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25378464|NCT04766723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25378465|NCT04766723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25378466|NCT04766723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25378467|NCT04766723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378468|NCT04766723|Cholinergic Agents|cholinergic agents|mesh-ancestor
25378469|NCT04766723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25378470|NCT04766723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378471|NCT04766723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25378472|NCT04766723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25378473|NCT04766450|Acetylcysteine|acetylcysteine|mesh-list
25378474|NCT04766450|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25378475|NCT04766450|Antiviral Agents|antiviral agents|mesh-ancestor
25378476|NCT04766450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25378478|NCT04766450|Respiratory System Agents|respiratory system agents|mesh-ancestor
25378479|NCT04766450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25378480|NCT04766450|Antioxidants|antioxidants|mesh-ancestor
25378481|NCT04766450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378482|NCT04766450|Protective Agents|protective agents|mesh-ancestor
25378483|NCT04766450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378484|NCT04766450|Antidotes|antidotes|mesh-ancestor
25378485|NCT04766229|Gabapentin|gabapentin|mesh-list
25378486|NCT04766229|Citalopram|citalopram|mesh-list
25378487|NCT04766229|Analgesics|analgesics|mesh-ancestor
25378488|NCT04766229|Sensory System Agents|sensory system agents|mesh-ancestor
25378489|NCT04766229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25378490|NCT04766229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378491|NCT04766229|Anticonvulsants|anticonvulsants|mesh-ancestor
25378492|NCT04766229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25378493|NCT04766229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25378494|NCT04766229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25378495|NCT04766229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25378496|NCT04766229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25378497|NCT04766229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25378498|NCT04766229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25378499|NCT04766229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378500|NCT04766229|Antimanic Agents|antimanic agents|mesh-ancestor
25378501|NCT04766229|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25378502|NCT04766229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25378503|NCT04766229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25378504|NCT04766229|Serotonin Agents|serotonin agents|mesh-ancestor
25378505|NCT04766229|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25378506|NCT04766229|Antidepressive Agents|antidepressive agents|mesh-ancestor
25378507|NCT04766086|Vaccines|vaccines|mesh-list
25378508|NCT04766086|Immunologic Factors|immunologic factors|mesh-ancestor
25378509|NCT04766086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378510|NCT04765202|Carisoprodol|carisoprodol|mesh-list
25378511|NCT04765202|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
25378512|NCT04765202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378513|NCT04765202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25378514|NCT04765202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25378515|NCT04765111|Rituximab|rituximab|mesh-list
25378516|NCT04765111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25378517|NCT04765111|Acalabrutinib|acalabrutinib|mesh-list
25378518|NCT04765111|Antibodies|antibodies|mesh-list
25378519|NCT04765111|Immunoglobulins|immunoglobulins|mesh-list
25378520|NCT04765111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25378521|NCT04765111|Immunologic Factors|immunologic factors|mesh-ancestor
25378522|NCT04765111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378523|NCT04765111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378524|NCT04765111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25378525|NCT04765059|Cisplatin|cisplatin|mesh-list
25378526|NCT04765059|Carboplatin|carboplatin|mesh-list
25378527|NCT04765059|Pemetrexed|pemetrexed|mesh-list
25378528|NCT04765059|Osimertinib|osimertinib|mesh-list
25378529|NCT04765059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378530|NCT04765059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25378531|NCT04765059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378532|NCT04765059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25378533|NCT04765059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25378534|NCT04765059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25378535|NCT04764721|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25378536|NCT04764721|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25378537|NCT04764721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378538|NCT04764643|Acetylcysteine|acetylcysteine|mesh-list
25378539|NCT04764643|Sodium thiosulfate|sodium thiosulfate|mesh-list
25378540|NCT04764643|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25378541|NCT04764643|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25378542|NCT04764643|Antiviral Agents|antiviral agents|mesh-ancestor
25378543|NCT04764643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25378544|NCT04764643|Expectorants|expectorants|mesh-ancestor
25378545|NCT04764643|Respiratory System Agents|respiratory system agents|mesh-ancestor
25378546|NCT04764643|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25378547|NCT04764643|Antioxidants|antioxidants|mesh-ancestor
25378548|NCT04764643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378549|NCT04764643|Protective Agents|protective agents|mesh-ancestor
25378550|NCT04764643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378551|NCT04764643|Antidotes|antidotes|mesh-ancestor
25378552|NCT04764643|Antitubercular Agents|antitubercular agents|mesh-ancestor
25378553|NCT04764643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25378554|NCT04764643|Chelating Agents|chelating agents|mesh-ancestor
25378555|NCT04764643|Sequestering Agents|sequestering agents|mesh-ancestor
25378556|NCT04763577|Bradykinin|bradykinin|mesh-list
25378557|NCT04763577|Kininogens|kininogens|mesh-list
25378558|NCT04763577|Vasodilator Agents|vasodilator agents|mesh-ancestor
25378559|NCT04763577|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
25378560|NCT04763577|Protease Inhibitors|protease inhibitors|mesh-ancestor
25378561|NCT04763577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25378562|NCT04763577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378563|NCT04763512|Caseins|caseins|mesh-list
25378564|NCT04763512|Chelating Agents|chelating agents|mesh-ancestor
25378565|NCT04763512|Sequestering Agents|sequestering agents|mesh-ancestor
25378566|NCT04763512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378567|NCT04763408|Sorafenib|sorafenib|mesh-list
25378568|NCT04763408|Lenvatinib|lenvatinib|mesh-list
25378569|NCT04763408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378570|NCT04763408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25378571|NCT04763408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25378572|NCT04763408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378573|NCT04763343|Ketamine|ketamine|mesh-list
25378574|NCT04763343|Analgesics|analgesics|mesh-ancestor
25378575|NCT04763343|Sensory System Agents|sensory system agents|mesh-ancestor
25378576|NCT04763343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25378577|NCT04763343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378578|NCT04763343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25378579|NCT04763343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25378580|NCT04763343|Anesthetics, General|anesthetics, general|mesh-ancestor
25378581|NCT04763343|Anesthetics|anesthetics|mesh-ancestor
25378582|NCT04763343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25378583|NCT04763343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25378588|NCT04763252|Keratolytic Agents|keratolytic agents|mesh-ancestor
25378589|NCT04763252|Dermatologic Agents|dermatologic agents|mesh-ancestor
25378590|NCT04762979|Fulvestrant|fulvestrant|mesh-list
25378591|NCT04762979|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25378592|NCT04762979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25378593|NCT04762979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378594|NCT04762979|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25378595|NCT04762979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25378596|NCT04762979|Hormone Antagonists|hormone antagonists|mesh-ancestor
25378597|NCT04762979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25378598|NCT04762979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378599|NCT04762979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25378600|NCT04762979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25378601|NCT04762979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378602|NCT04762875|Plerixafor|plerixafor|mesh-list
25378603|NCT04762875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25378604|NCT04762875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25378605|NCT04762875|Antiviral Agents|antiviral agents|mesh-ancestor
25378606|NCT04762875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25378607|NCT04762758|Naltrexone|naltrexone|mesh-list
25378608|NCT04762758|Baclofen|baclofen|mesh-list
25378609|NCT04762758|Sorbitol|sorbitol|mesh-list
25378610|NCT04762758|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25378611|NCT04762758|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25378612|NCT04762758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378613|NCT04762758|Sensory System Agents|sensory system agents|mesh-ancestor
25378614|NCT04762758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25378621|NCT04762758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378622|NCT04762758|Cathartics|cathartics|mesh-ancestor
25378623|NCT04762758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25378629|NCT04761822|Vaccines|vaccines|mesh-list
25378630|NCT04761822|Immunologic Factors|immunologic factors|mesh-ancestor
25378631|NCT04761822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378632|NCT04761601|Gemcitabine|gemcitabine|mesh-list
25378633|NCT04761601|Paclitaxel|paclitaxel|mesh-list
25378634|NCT04761601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25378635|NCT04761601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378636|NCT04761601|Tubulin Modulators|tubulin modulators|mesh-ancestor
25378637|NCT04761601|Antimitotic Agents|antimitotic agents|mesh-ancestor
25378638|NCT04761601|Mitosis Modulators|mitosis modulators|mesh-ancestor
25378639|NCT04761601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378640|NCT04761601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25378641|NCT04761601|Antimetabolites|antimetabolites|mesh-ancestor
25378642|NCT04761601|Antiviral Agents|antiviral agents|mesh-ancestor
25378643|NCT04761601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25378644|NCT04761601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25378645|NCT04761601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25378646|NCT04761601|Immunologic Factors|immunologic factors|mesh-ancestor
25378647|NCT04761601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378648|NCT04761133|Povidone-Iodine|povidone-iodine|mesh-list
25378649|NCT04761133|Povidone|povidone|mesh-list
25378650|NCT04761133|Plasma Substitutes|plasma substitutes|mesh-ancestor
25378651|NCT04761133|Blood Substitutes|blood substitutes|mesh-ancestor
25378652|NCT04761133|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25378653|NCT04761133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25378654|NCT04760613|Cannabidiol|cannabidiol|mesh-list
25378655|NCT04760613|Anticonvulsants|anticonvulsants|mesh-ancestor
25378656|NCT04760288|Pralsetinib|pralsetinib|mesh-list
25378657|NCT04760288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378658|NCT04759833|Prucalopride|prucalopride|mesh-list
25378659|NCT04759833|Laxatives|laxatives|mesh-ancestor
25378660|NCT04759833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25378661|NCT04759833|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
25378662|NCT04759833|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25378663|NCT04759833|Serotonin Agents|serotonin agents|mesh-ancestor
25378664|NCT04759833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25378665|NCT04759833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378666|NCT04759833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378749|NCT04757740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25378750|NCT04757740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25378751|NCT04757740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25378752|NCT04757740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378753|NCT04757740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25378755|NCT04757740|Autonomic Agents|autonomic agents|mesh-ancestor
25378756|NCT04757740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25378757|NCT04757740|Glucocorticoids|glucocorticoids|mesh-ancestor
25378758|NCT04757740|Hormones|hormones|mesh-ancestor
25378759|NCT04757740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25378760|NCT04757740|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25378761|NCT04757740|Protective Agents|protective agents|mesh-ancestor
25378762|NCT04757740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25378763|NCT04757740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378764|NCT04757636|Aflibercept|aflibercept|mesh-list
25378765|NCT04757636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25378766|NCT04757636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25378767|NCT04757636|Growth Substances|growth substances|mesh-ancestor
25378768|NCT04757636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378769|NCT04757636|Growth Inhibitors|growth inhibitors|mesh-ancestor
25378770|NCT04757636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378771|NCT04757610|Ranibizumab|ranibizumab|mesh-list
25378772|NCT04757610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25378773|NCT04757610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25378774|NCT04757610|Growth Substances|growth substances|mesh-ancestor
25378775|NCT04757610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378776|NCT04757610|Growth Inhibitors|growth inhibitors|mesh-ancestor
25378777|NCT04757610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378778|NCT04756505|Interleukin-12|interleukin-12|mesh-list
25378779|NCT04756505|Immunoglobulin G|immunoglobulin g|mesh-list
25378780|NCT04756505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25378781|NCT04756505|Immunologic Factors|immunologic factors|mesh-ancestor
25378782|NCT04756505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378783|NCT04756505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25378784|NCT04756505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25378785|NCT04756505|Growth Substances|growth substances|mesh-ancestor
25378786|NCT04756505|Growth Inhibitors|growth inhibitors|mesh-ancestor
25378787|NCT04756505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378788|NCT04756401|Dexamethasone|dexamethasone|mesh-list
25378789|NCT04756401|Dexamethasone acetate|dexamethasone acetate|mesh-list
25378790|NCT04756401|Daratumumab|daratumumab|mesh-list
25378791|NCT04756401|Ichthammol|ichthammol|mesh-list
25378792|NCT04756401|BB 1101|bb 1101|mesh-list
25378793|NCT04756401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25378794|NCT04756401|Antiemetics|antiemetics|mesh-ancestor
25378795|NCT04756401|Autonomic Agents|autonomic agents|mesh-ancestor
25378796|NCT04756401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25378797|NCT04756401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378798|NCT04756401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25378799|NCT04756401|Glucocorticoids|glucocorticoids|mesh-ancestor
25378800|NCT04756401|Hormones|hormones|mesh-ancestor
25378801|NCT04756401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25378802|NCT04756401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25378803|NCT04756401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378804|NCT04756401|Protease Inhibitors|protease inhibitors|mesh-ancestor
25378805|NCT04756401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25378806|NCT04756401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378807|NCT04756401|Dermatologic Agents|dermatologic agents|mesh-ancestor
25378808|NCT04756063|Ascorbic Acid|ascorbic acid|mesh-list
25378809|NCT04756063|Vitamins|vitamins|mesh-ancestor
25378810|NCT04756063|Micronutrients|micronutrients|mesh-ancestor
25378811|NCT04756063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378812|NCT04756063|Antioxidants|antioxidants|mesh-ancestor
25378813|NCT04756063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378814|NCT04756063|Protective Agents|protective agents|mesh-ancestor
25378815|NCT04756037|Relugolix|relugolix|mesh-list
25378816|NCT04756037|Androgen Antagonists|androgen antagonists|mesh-ancestor
25378817|NCT04756037|Hormone Antagonists|hormone antagonists|mesh-ancestor
25378818|NCT04756037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25378819|NCT04756037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378820|NCT04755764|Atenolol|atenolol|mesh-list
25378821|NCT04755764|Labetalol|labetalol|mesh-list
25378822|NCT04755764|Nifedipine|nifedipine|mesh-list
25378823|NCT04755764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25378824|NCT04755764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25378825|NCT04755764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378826|NCT04755764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25378827|NCT04755764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378828|NCT04755764|Vasodilator Agents|vasodilator agents|mesh-ancestor
25378829|NCT04755764|Tocolytic Agents|tocolytic agents|mesh-ancestor
25378830|NCT04755764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25378831|NCT04755764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25378832|NCT04755764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25378833|NCT04755764|Sympatholytics|sympatholytics|mesh-ancestor
25378834|NCT04755764|Autonomic Agents|autonomic agents|mesh-ancestor
25378835|NCT04755764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25378836|NCT04755764|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
25378837|NCT04755764|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25378838|NCT04755764|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25378839|NCT04755764|Adrenergic Agents|adrenergic agents|mesh-ancestor
25378840|NCT04755764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25378841|NCT04755764|Sympathomimetics|sympathomimetics|mesh-ancestor
25378842|NCT04755764|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
25378843|NCT04755764|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25378844|NCT04755634|Hyaluronic Acid|hyaluronic acid|mesh-list
25378845|NCT04755634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25378846|NCT04755634|Immunologic Factors|immunologic factors|mesh-ancestor
25378847|NCT04755634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378849|NCT04755634|Protective Agents|protective agents|mesh-ancestor
25378850|NCT04755218|Misoprostol|misoprostol|mesh-list
25378851|NCT04755218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25378852|NCT04755218|Abortifacient Agents|abortifacient agents|mesh-ancestor
25378853|NCT04755218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25378854|NCT04755218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378855|NCT04755218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25378856|NCT04755218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25378857|NCT04755218|Oxytocics|oxytocics|mesh-ancestor
25378858|NCT04754399|Cannabidiol|cannabidiol|mesh-list
25378859|NCT04754399|Anticonvulsants|anticonvulsants|mesh-ancestor
25378860|NCT04753970|Cilostazol|cilostazol|mesh-list
25378861|NCT04753970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25378862|NCT04753970|Autonomic Agents|autonomic agents|mesh-ancestor
25378863|NCT04753970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25378864|NCT04753970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378865|NCT04753970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25378866|NCT04753970|Respiratory System Agents|respiratory system agents|mesh-ancestor
25378867|NCT04753970|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25378868|NCT04753970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25378869|NCT04753970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378870|NCT04753970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25378871|NCT04753970|Vasodilator Agents|vasodilator agents|mesh-ancestor
25378872|NCT04753970|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25378873|NCT04753970|Protective Agents|protective agents|mesh-ancestor
25378874|NCT04753970|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
25378875|NCT04753970|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25378876|NCT04753970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25378877|NCT04753840|Antihypertensive Agents|antihypertensive agents|mesh-list
25378878|NCT04753372|Aspirin|aspirin|mesh-list
25378879|NCT04753372|Rivaroxaban|rivaroxaban|mesh-list
25378880|NCT04753372|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25378881|NCT04753372|Antithrombins|antithrombins|mesh-ancestor
25378882|NCT04753372|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25378883|NCT04753372|Protease Inhibitors|protease inhibitors|mesh-ancestor
25378884|NCT04753372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25378885|NCT04753372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378886|NCT04753372|Anticoagulants|anticoagulants|mesh-ancestor
25378887|NCT04753372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25378888|NCT04753372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25378889|NCT04753372|Analgesics|analgesics|mesh-ancestor
25378890|NCT04753372|Sensory System Agents|sensory system agents|mesh-ancestor
25378891|NCT04753372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25378892|NCT04753372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378893|NCT04753372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25378894|NCT04753372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25378895|NCT04753372|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25378896|NCT04753372|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25378897|NCT04753372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25378898|NCT04753372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25378899|NCT04753372|Antipyretics|antipyretics|mesh-ancestor
25378900|NCT04752826|Pembrolizumab|pembrolizumab|mesh-list
25378901|NCT04752826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25378902|NCT04752826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378903|NCT04752774|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25378904|NCT04752774|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25378905|NCT04752774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25378906|NCT04752774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378907|NCT04752774|Cholinergic Agents|cholinergic agents|mesh-ancestor
25378908|NCT04752774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25378909|NCT04752774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378910|NCT04752631|Tenecteplase|tenecteplase|mesh-list
25378911|NCT04752631|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25378912|NCT04752631|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25378913|NCT04752631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378914|NCT04752566|Eculizumab|eculizumab|mesh-list
25378915|NCT04752566|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25378916|NCT04752566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25378917|NCT04752566|Immunologic Factors|immunologic factors|mesh-ancestor
25378918|NCT04752566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378919|NCT04752267|Clevudine|clevudine|mesh-list
25378920|NCT04752267|Antiviral Agents|antiviral agents|mesh-ancestor
25378921|NCT04752267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25378922|NCT04752163|Leucovorin|leucovorin|mesh-list
25378923|NCT04752163|Cytarabine|cytarabine|mesh-list
25378924|NCT04752163|Voriconazole|voriconazole|mesh-list
25378925|NCT04752163|Posaconazole|posaconazole|mesh-list
25378926|NCT04752163|Dexamethasone|dexamethasone|mesh-list
25378927|NCT04752163|Dexamethasone acetate|dexamethasone acetate|mesh-list
25378928|NCT04752163|Prednisone|prednisone|mesh-list
25378929|NCT04752163|Cortisone|cortisone|mesh-list
25378930|NCT04752163|Cyclophosphamide|cyclophosphamide|mesh-list
25378931|NCT04752163|Rituximab|rituximab|mesh-list
25378932|NCT04752163|Methotrexate|methotrexate|mesh-list
25378933|NCT04752163|Vincristine|vincristine|mesh-list
25378934|NCT04752163|Azacitidine|azacitidine|mesh-list
25378935|NCT04752163|Venetoclax|venetoclax|mesh-list
25378936|NCT04752163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25378937|NCT04752163|Antibodies|antibodies|mesh-list
25378938|NCT04752163|Immunoglobulins|immunoglobulins|mesh-list
25378939|NCT04752163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25378940|NCT04752163|Lenograstim|lenograstim|mesh-list
25378941|NCT04752163|BB 1101|bb 1101|mesh-list
25378942|NCT04752163|Mesna|mesna|mesh-list
25378943|NCT04752163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25378944|NCT04752163|Immunologic Factors|immunologic factors|mesh-ancestor
25378945|NCT04752163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25378946|NCT04752163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25378947|NCT04752163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25378948|NCT04752163|Alkylating Agents|alkylating agents|mesh-ancestor
25378949|NCT04752163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25378950|NCT04752163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378951|NCT04752163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25378952|NCT04752163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25378953|NCT04752163|Antiemetics|antiemetics|mesh-ancestor
25378954|NCT04752163|Autonomic Agents|autonomic agents|mesh-ancestor
25378955|NCT04752163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25378956|NCT04752163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25378957|NCT04752163|Glucocorticoids|glucocorticoids|mesh-ancestor
25378958|NCT04752163|Hormones|hormones|mesh-ancestor
25378959|NCT04752163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25378960|NCT04752163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25378961|NCT04752163|Protease Inhibitors|protease inhibitors|mesh-ancestor
25378962|NCT04752163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25378963|NCT04752163|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25378964|NCT04752163|Abortifacient Agents|abortifacient agents|mesh-ancestor
25378965|NCT04752163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25378966|NCT04752163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25378967|NCT04752163|Antimetabolites|antimetabolites|mesh-ancestor
25378968|NCT04752163|Dermatologic Agents|dermatologic agents|mesh-ancestor
25378969|NCT04752163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25378970|NCT04752163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25378971|NCT04752163|Antiviral Agents|antiviral agents|mesh-ancestor
25378972|NCT04752163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25378973|NCT04752163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25378974|NCT04752163|Antidotes|antidotes|mesh-ancestor
25378975|NCT04752163|Protective Agents|protective agents|mesh-ancestor
25378976|NCT04752163|Vitamin B Complex|vitamin b complex|mesh-ancestor
25378977|NCT04752163|Vitamins|vitamins|mesh-ancestor
25378978|NCT04752163|Micronutrients|micronutrients|mesh-ancestor
25378979|NCT04752163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25378986|NCT04752163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25378987|NCT04752163|Hormone Antagonists|hormone antagonists|mesh-ancestor
25378988|NCT04752163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25378989|NCT04752163|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25378990|NCT04752163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25378991|NCT04752163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25378992|NCT04752059|Trastuzumab|trastuzumab|mesh-list
25378993|NCT04752059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25378994|NCT04752059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378995|NCT04751929|Atezolizumab|atezolizumab|mesh-list
25378996|NCT04751929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25378997|NCT04751877|Dexamethasone|dexamethasone|mesh-list
25378998|NCT04751877|Lenalidomide|lenalidomide|mesh-list
25378999|NCT04751877|Bortezomib|bortezomib|mesh-list
25379000|NCT04751877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25379001|NCT04751877|Antiemetics|antiemetics|mesh-ancestor
25379003|NCT04751877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25379004|NCT04751877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379005|NCT04751877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25379006|NCT04751877|Glucocorticoids|glucocorticoids|mesh-ancestor
25379007|NCT04751877|Hormones|hormones|mesh-ancestor
25379008|NCT04751877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25379009|NCT04751877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25379010|NCT04751877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379011|NCT04751877|Immunologic Factors|immunologic factors|mesh-ancestor
25379012|NCT04751877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25379013|NCT04751877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25379014|NCT04751877|Growth Substances|growth substances|mesh-ancestor
25379015|NCT04751877|Growth Inhibitors|growth inhibitors|mesh-ancestor
25379016|NCT04751851|Oxymetazoline|oxymetazoline|mesh-list
25379017|NCT04751851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25379018|NCT04751851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25379019|NCT04751851|Adrenergic Agents|adrenergic agents|mesh-ancestor
25379020|NCT04751851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25379021|NCT04751851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379022|NCT04751851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379023|NCT04751851|Sympathomimetics|sympathomimetics|mesh-ancestor
25379024|NCT04751851|Autonomic Agents|autonomic agents|mesh-ancestor
25379025|NCT04751851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25379026|NCT04751851|Nasal Decongestants|nasal decongestants|mesh-ancestor
25379027|NCT04751851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25379028|NCT04751851|Respiratory System Agents|respiratory system agents|mesh-ancestor
25379029|NCT04751383|Dinutuximab|dinutuximab|mesh-list
25379030|NCT04751383|Magrolimab|magrolimab|mesh-list
25379031|NCT04751383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379032|NCT04751383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25379039|NCT04750954|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25379040|NCT04750954|Peposertib|peposertib|mesh-list
25379041|NCT04750954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379042|NCT04750954|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25379043|NCT04750954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25379044|NCT04750954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379045|NCT04750902|Listerine|listerine|mesh-list
25379046|NCT04750902|Fluorides|fluorides|mesh-list
25379047|NCT04750902|Sodium Fluoride|sodium fluoride|mesh-list
25379048|NCT04750902|Cariostatic Agents|cariostatic agents|mesh-ancestor
25379049|NCT04750902|Protective Agents|protective agents|mesh-ancestor
25379050|NCT04750902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379051|NCT04750902|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25379052|NCT04750902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25379053|NCT04750655|Moxifloxacin|moxifloxacin|mesh-list
25379054|NCT04750655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25379055|NCT04750655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25379056|NCT04750655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25408388|NCT03447132|Palbociclib|palbociclib|mesh-list
25379057|NCT04750655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25379058|NCT04750655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379059|NCT04750655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379060|NCT04750655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379061|NCT04750473|Edetic Acid|edetic acid|mesh-list
25379062|NCT04750473|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25379063|NCT04750473|Chelating Agents|chelating agents|mesh-ancestor
25379064|NCT04750473|Sequestering Agents|sequestering agents|mesh-ancestor
25379065|NCT04750473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379066|NCT04750473|Anticoagulants|anticoagulants|mesh-ancestor
25379067|NCT04750473|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
25379068|NCT04750473|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25379069|NCT04749810|Eculizumab|eculizumab|mesh-list
25379070|NCT04749810|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25379071|NCT04749810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25379072|NCT04749810|Immunologic Factors|immunologic factors|mesh-ancestor
25379073|NCT04749810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379074|NCT04749394|Apatinib|apatinib|mesh-list
25379075|NCT04749394|Antibodies|antibodies|mesh-list
25379076|NCT04749394|Immunoglobulins|immunoglobulins|mesh-list
25379077|NCT04749394|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25379078|NCT04749394|Immunologic Factors|immunologic factors|mesh-ancestor
25379079|NCT04749394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379080|NCT04749394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379081|NCT04749394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25379082|NCT04749394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379083|NCT04749394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379084|NCT04749212|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
25379085|NCT04749212|Natriuretic Agents|natriuretic agents|mesh-ancestor
25379086|NCT04749212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379088|NCT04749108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379089|NCT04748822|Ethanol|ethanol|mesh-list
25379090|NCT04748822|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25379091|NCT04748822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25379092|NCT04748822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25379093|NCT04748822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379094|NCT04748042|Prednisone|prednisone|mesh-list
25379095|NCT04748042|Olaparib|olaparib|mesh-list
25379096|NCT04748042|Androgens|androgens|mesh-list
25379097|NCT04748042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25379098|NCT04748042|Glucocorticoids|glucocorticoids|mesh-ancestor
25379099|NCT04748042|Hormones|hormones|mesh-ancestor
25379100|NCT04748042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25379101|NCT04748042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379102|NCT04748042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25379103|NCT04748042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379104|NCT04748042|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25379105|NCT04748042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379106|NCT04748042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379107|NCT04747795|Ascorbic Acid|ascorbic acid|mesh-list
25379108|NCT04747795|Vitamins|vitamins|mesh-ancestor
25379109|NCT04747795|Micronutrients|micronutrients|mesh-ancestor
25379110|NCT04747795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379111|NCT04747795|Antioxidants|antioxidants|mesh-ancestor
25379112|NCT04747795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379113|NCT04747795|Protective Agents|protective agents|mesh-ancestor
25379114|NCT04747301|Dinoprostone|dinoprostone|mesh-list
25379115|NCT04747301|Oxytocics|oxytocics|mesh-ancestor
25379116|NCT04747301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25379117|NCT04747301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379118|NCT04747145|Temozolomide|temozolomide|mesh-list
25379119|NCT04747145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25379120|NCT04747145|Alkylating Agents|alkylating agents|mesh-ancestor
25379121|NCT04747145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379122|NCT04747145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379123|NCT04747054|Pembrolizumab|pembrolizumab|mesh-list
25379124|NCT04747054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25379125|NCT04747054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379126|NCT04746495|Eplerenone|eplerenone|mesh-list
25379127|NCT04746495|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25379128|NCT04746495|Hormone Antagonists|hormone antagonists|mesh-ancestor
25379129|NCT04746495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25379130|NCT04746495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379131|NCT04746495|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25379132|NCT04746495|Diuretics|diuretics|mesh-ancestor
25379141|NCT04746339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379142|NCT04746339|Anticoagulants|anticoagulants|mesh-ancestor
25379143|NCT04746235|Decitabine|decitabine|mesh-list
25379144|NCT04746235|Venetoclax|venetoclax|mesh-list
25379145|NCT04746235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25379146|NCT04746235|Antimetabolites|antimetabolites|mesh-ancestor
25379147|NCT04746235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379148|NCT04746235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379149|NCT04746235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379150|NCT04746183|Nitazoxanide|nitazoxanide|mesh-list
25379151|NCT04746183|Favipiravir|favipiravir|mesh-list
25379152|NCT04746183|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25379153|NCT04746183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25379154|NCT04746183|Antiviral Agents|antiviral agents|mesh-ancestor
25379156|NCT04745949|Cortisone|cortisone|mesh-list
25379157|NCT04745949|Cyclophosphamide|cyclophosphamide|mesh-list
25379158|NCT04745949|Rituximab|rituximab|mesh-list
25379159|NCT04745949|Doxorubicin|doxorubicin|mesh-list
25379160|NCT04745949|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25379161|NCT04745949|Nivolumab|nivolumab|mesh-list
25379162|NCT04745949|Daunorubicin|daunorubicin|mesh-list
25379163|NCT04745949|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25379164|NCT04745949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25379165|NCT04745949|Antibodies|antibodies|mesh-list
25379166|NCT04745949|Immunoglobulins|immunoglobulins|mesh-list
25379167|NCT04745949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25379168|NCT04745949|Immunoconjugates|immunoconjugates|mesh-list
25379169|NCT04745949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25379170|NCT04745949|Immunologic Factors|immunologic factors|mesh-ancestor
25379171|NCT04745949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379172|NCT04745949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25379173|NCT04745949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25379174|NCT04745949|Alkylating Agents|alkylating agents|mesh-ancestor
25379175|NCT04745949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379176|NCT04745949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379177|NCT04745949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25379178|NCT04745949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25379179|NCT04745949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25379180|NCT04745949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25379181|NCT04745949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379182|NCT04745949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25379183|NCT04745949|Glucocorticoids|glucocorticoids|mesh-ancestor
25379184|NCT04745949|Hormones|hormones|mesh-ancestor
25379185|NCT04745949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25379186|NCT04745949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25379187|NCT04745949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25379196|NCT04745832|Prednisone|prednisone|mesh-list
25379197|NCT04745832|Cyclophosphamide|cyclophosphamide|mesh-list
25379198|NCT04745832|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25379199|NCT04745832|Rituximab|rituximab|mesh-list
25379200|NCT04745832|Vincristine|vincristine|mesh-list
25379201|NCT04745832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25379202|NCT04745832|Immunologic Factors|immunologic factors|mesh-ancestor
25379203|NCT04745832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379204|NCT04745832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25379205|NCT04745832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25379206|NCT04745832|Alkylating Agents|alkylating agents|mesh-ancestor
25379207|NCT04745832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379208|NCT04745832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379209|NCT04745832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25379210|NCT04745832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25410547|NCT03315832|Valsartan|valsartan|mesh-list
25379211|NCT04745832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25379212|NCT04745832|Glucocorticoids|glucocorticoids|mesh-ancestor
25379213|NCT04745832|Hormones|hormones|mesh-ancestor
25379214|NCT04745832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25379215|NCT04745832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25379216|NCT04745832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25379217|NCT04745832|Tubulin Modulators|tubulin modulators|mesh-ancestor
25379218|NCT04745832|Antimitotic Agents|antimitotic agents|mesh-ancestor
25379219|NCT04745832|Mitosis Modulators|mitosis modulators|mesh-ancestor
25379220|NCT04745689|Cisplatin|cisplatin|mesh-list
25379221|NCT04745689|Carboplatin|carboplatin|mesh-list
25379222|NCT04745689|Etoposide|etoposide|mesh-list
25379223|NCT04745689|Durvalumab|durvalumab|mesh-list
25379224|NCT04745689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379225|NCT04745689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25379226|NCT04745689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25379227|NCT04745689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25379228|NCT04745689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379229|NCT04745689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379230|NCT04745689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25379231|NCT04745377|Antibodies|antibodies|mesh-list
25379232|NCT04745377|Immunologic Factors|immunologic factors|mesh-ancestor
25379233|NCT04745377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379234|NCT04745026|Cannabidiol|cannabidiol|mesh-list
25379235|NCT04745026|Anticonvulsants|anticonvulsants|mesh-ancestor
25379236|NCT04743804|Ravulizumab|ravulizumab|mesh-list
25379237|NCT04743804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25379238|NCT04743804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25379239|NCT04743804|Immunologic Factors|immunologic factors|mesh-ancestor
25379240|NCT04743804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379241|NCT04743661|Antipyretics|antipyretics|mesh-list
25379242|NCT04743661|Dexamethasone|dexamethasone|mesh-list
25379243|NCT04743661|Bevacizumab|bevacizumab|mesh-list
25379244|NCT04743661|Irinotecan|irinotecan|mesh-list
25379246|NCT04743661|Antiemetics|antiemetics|mesh-list
25379247|NCT04743661|Emetics|emetics|mesh-list
25379248|NCT04743661|Histamine Antagonists|histamine antagonists|mesh-list
25379249|NCT04743661|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25379250|NCT04743661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25379251|NCT04743661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379252|NCT04743661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25379253|NCT04743661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25379254|NCT04743661|Growth Substances|growth substances|mesh-ancestor
25379255|NCT04743661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379256|NCT04743661|Growth Inhibitors|growth inhibitors|mesh-ancestor
25379257|NCT04743661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25379258|NCT04743661|Autonomic Agents|autonomic agents|mesh-ancestor
25379259|NCT04743661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25379260|NCT04743661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25379261|NCT04743661|Glucocorticoids|glucocorticoids|mesh-ancestor
25379262|NCT04743661|Hormones|hormones|mesh-ancestor
25379263|NCT04743661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25379264|NCT04743661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25379265|NCT04743661|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25379266|NCT04743661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25379267|NCT04743661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379268|NCT04743661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379269|NCT04743661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25379270|NCT04743661|Alkylating Agents|alkylating agents|mesh-ancestor
25379271|NCT04743661|Histamine Agents|histamine agents|mesh-ancestor
25379272|NCT04743661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25379273|NCT04742491|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25379274|NCT04742491|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25379275|NCT04742491|Emtricitabine|emtricitabine|mesh-list
25379276|NCT04742491|Tenofovir|tenofovir|mesh-list
25379277|NCT04742491|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25379278|NCT04742491|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25379279|NCT04742491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379280|NCT04742491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379281|NCT04742491|Antiviral Agents|antiviral agents|mesh-ancestor
25379282|NCT04742491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25379283|NCT04742491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25379284|NCT04742491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25379285|NCT04742075|Durvalumab|durvalumab|mesh-list
25724250|NCT02536105|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25379286|NCT04742075|Olaparib|olaparib|mesh-list
25379287|NCT04742075|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25379288|NCT04742075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25379289|NCT04742075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379290|NCT04742075|Immunologic Factors|immunologic factors|mesh-ancestor
25379291|NCT04742075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379292|NCT04742075|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25379293|NCT04742075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379294|NCT04742075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379295|NCT04742036|Paclitaxel|paclitaxel|mesh-list
25379296|NCT04742036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25379297|NCT04742036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379298|NCT04742036|Tubulin Modulators|tubulin modulators|mesh-ancestor
25379299|NCT04742036|Antimitotic Agents|antimitotic agents|mesh-ancestor
25379300|NCT04742036|Mitosis Modulators|mitosis modulators|mesh-ancestor
25379301|NCT04742036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379302|NCT04741698|Propranolol|propranolol|mesh-list
25379303|NCT04741698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25379304|NCT04741698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25379305|NCT04741698|Adrenergic Agents|adrenergic agents|mesh-ancestor
25379306|NCT04741698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25379307|NCT04741698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379308|NCT04741698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379309|NCT04741698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25379310|NCT04741698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25379311|NCT04741698|Vasodilator Agents|vasodilator agents|mesh-ancestor
25379312|NCT04740931|Aflibercept|aflibercept|mesh-list
25379313|NCT04740931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25379314|NCT04740931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25379315|NCT04740931|Growth Substances|growth substances|mesh-ancestor
25379316|NCT04740931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379317|NCT04740931|Growth Inhibitors|growth inhibitors|mesh-ancestor
25379318|NCT04740931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379319|NCT04740918|Trastuzumab|trastuzumab|mesh-list
25379320|NCT04740918|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25379321|NCT04740918|Atezolizumab|atezolizumab|mesh-list
25379322|NCT04740918|Maytansine|maytansine|mesh-list
25379323|NCT04740918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25379324|NCT04740918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379325|NCT04740918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25379326|NCT04740918|Tubulin Modulators|tubulin modulators|mesh-ancestor
25379327|NCT04740918|Antimitotic Agents|antimitotic agents|mesh-ancestor
25379328|NCT04740918|Mitosis Modulators|mitosis modulators|mesh-ancestor
25379329|NCT04740918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379330|NCT04740905|Aflibercept|aflibercept|mesh-list
25379331|NCT04740905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25379332|NCT04740905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25379333|NCT04740905|Growth Substances|growth substances|mesh-ancestor
25379334|NCT04740905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379335|NCT04740905|Growth Inhibitors|growth inhibitors|mesh-ancestor
25379336|NCT04740905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379337|NCT04740814|Certolizumab Pegol|certolizumab pegol|mesh-list
25379338|NCT04740814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25379339|NCT04740814|Immunologic Factors|immunologic factors|mesh-ancestor
25379340|NCT04740814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379341|NCT04740814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25379342|NCT04740697|Tamoxifen|tamoxifen|mesh-list
25379343|NCT04740697|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25379344|NCT04740697|Hormone Antagonists|hormone antagonists|mesh-ancestor
25379345|NCT04740697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25379346|NCT04740697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379347|NCT04740697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25379348|NCT04740697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379349|NCT04740697|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
25379350|NCT04740697|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
25379351|NCT04740697|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25379352|NCT04740671|Ranibizumab|ranibizumab|mesh-list
25379353|NCT04740671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25379354|NCT04740671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25379355|NCT04740671|Growth Substances|growth substances|mesh-ancestor
25379356|NCT04740671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379357|NCT04740671|Growth Inhibitors|growth inhibitors|mesh-ancestor
25379358|NCT04740671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379359|NCT04740593|Methamphetamine|methamphetamine|mesh-list
25379360|NCT04740593|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25379361|NCT04740593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379362|NCT04740593|Sympathomimetics|sympathomimetics|mesh-ancestor
25379363|NCT04740593|Autonomic Agents|autonomic agents|mesh-ancestor
25379364|NCT04740593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25379365|NCT04740593|Dopamine Agents|dopamine agents|mesh-ancestor
25379366|NCT04740593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25379367|NCT04740593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379368|NCT04740593|Adrenergic Agents|adrenergic agents|mesh-ancestor
25379369|NCT04740593|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25379370|NCT04740593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25379371|NCT04740593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25379372|NCT04740593|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25379373|NCT04739813|Prednisone|prednisone|mesh-list
25379374|NCT04739813|Lenalidomide|lenalidomide|mesh-list
25379375|NCT04739813|Venetoclax|venetoclax|mesh-list
25379376|NCT04739813|Obinutuzumab|obinutuzumab|mesh-list
25379377|NCT04739813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25379378|NCT04739813|Glucocorticoids|glucocorticoids|mesh-ancestor
25379379|NCT04739813|Hormones|hormones|mesh-ancestor
25379456|NCT04738123|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25379380|NCT04739813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25379381|NCT04739813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379382|NCT04739813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25379383|NCT04739813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379384|NCT04739813|Immunologic Factors|immunologic factors|mesh-ancestor
25379385|NCT04739813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25379386|NCT04739813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25379387|NCT04739813|Growth Substances|growth substances|mesh-ancestor
25379388|NCT04739813|Growth Inhibitors|growth inhibitors|mesh-ancestor
25379389|NCT04739813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25379391|NCT04739800|Doxorubicin|doxorubicin|mesh-list
25379392|NCT04739800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25379393|NCT04739800|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25379394|NCT04739800|Durvalumab|durvalumab|mesh-list
25379395|NCT04739800|Topotecan|topotecan|mesh-list
25379396|NCT04739800|Olaparib|olaparib|mesh-list
25379397|NCT04739800|Cediranib|cediranib|mesh-list
25379398|NCT04739800|Maleic acid|maleic acid|mesh-list
25379399|NCT04739800|Immunoglobulins|immunoglobulins|mesh-list
25379400|NCT04739800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25379401|NCT04739800|Immunoglobulin G|immunoglobulin g|mesh-list
25379402|NCT04739800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25379403|NCT04739800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379404|NCT04739800|Tubulin Modulators|tubulin modulators|mesh-ancestor
25379405|NCT04739800|Antimitotic Agents|antimitotic agents|mesh-ancestor
25379406|NCT04739800|Mitosis Modulators|mitosis modulators|mesh-ancestor
25379407|NCT04739800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379408|NCT04739800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25379409|NCT04739800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25379410|NCT04739800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25379411|NCT04739800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379412|NCT04739800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25379413|NCT04739800|Immunologic Factors|immunologic factors|mesh-ancestor
25379414|NCT04739800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379415|NCT04739800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25379416|NCT04739800|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25379417|NCT04739800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25379418|NCT04739371|Insulin|insulin|mesh-list
25379419|NCT04739371|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25379420|NCT04739371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25379421|NCT04739371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379422|NCT04739150|Nintedanib|nintedanib|mesh-list
25379423|NCT04739150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379424|NCT04739150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25379425|NCT04739150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379426|NCT04739150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379427|NCT04738942|Vedolizumab|vedolizumab|mesh-list
25379428|NCT04738942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25379429|NCT04738487|Pembrolizumab|pembrolizumab|mesh-list
25379430|NCT04738487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25379431|NCT04738487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379432|NCT04738318|Dexamethasone|dexamethasone|mesh-list
25379433|NCT04738318|Methylprednisolone|methylprednisolone|mesh-list
25379434|NCT04738318|Glucocorticoids|glucocorticoids|mesh-list
25379435|NCT04738318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25379436|NCT04738318|Antiemetics|antiemetics|mesh-ancestor
25379437|NCT04738318|Autonomic Agents|autonomic agents|mesh-ancestor
25379438|NCT04738318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25379439|NCT04738318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379440|NCT04738318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25379441|NCT04738318|Hormones|hormones|mesh-ancestor
25379442|NCT04738318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25379443|NCT04738318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25379444|NCT04738318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379445|NCT04738318|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25379446|NCT04738318|Protective Agents|protective agents|mesh-ancestor
25379447|NCT04738149|Bimatoprost|bimatoprost|mesh-list
25379448|NCT04738149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25379449|NCT04738123|Xanomeline|xanomeline|mesh-list
25379450|NCT04738123|Trospium chloride|trospium chloride|mesh-list
25379451|NCT04738123|Parasympatholytics|parasympatholytics|mesh-ancestor
25379452|NCT04738123|Autonomic Agents|autonomic agents|mesh-ancestor
25379453|NCT04738123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25379454|NCT04738123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379455|NCT04738123|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25379457|NCT04738123|Cholinergic Agents|cholinergic agents|mesh-ancestor
25379458|NCT04738123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25379459|NCT04738123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379460|NCT04738123|Urological Agents|urological agents|mesh-ancestor
25379461|NCT04738123|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25379462|NCT04738123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25379463|NCT04738123|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
25379464|NCT04738123|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25379465|NCT04737109|Androgens|androgens|mesh-list
25379466|NCT04737109|Hormones|hormones|mesh-ancestor
25379467|NCT04737109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25379468|NCT04737109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379469|NCT04736745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25379470|NCT04736745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25379471|NCT04736745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25379472|NCT04736745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379473|NCT04736745|Cholinergic Agents|cholinergic agents|mesh-ancestor
25379474|NCT04736745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25379475|NCT04736745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379477|NCT04736706|Lenvatinib|lenvatinib|mesh-list
25379478|NCT04736706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25379479|NCT04736706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379480|NCT04736706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25379481|NCT04736706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379482|NCT04736706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379483|NCT04736199|Androgens|androgens|mesh-list
25379484|NCT04736199|Hormones|hormones|mesh-ancestor
25379485|NCT04736199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25379486|NCT04736199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379487|NCT04736173|Paclitaxel|paclitaxel|mesh-list
25379488|NCT04736173|Carboplatin|carboplatin|mesh-list
25379489|NCT04736173|Pemetrexed|pemetrexed|mesh-list
25379490|NCT04736173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25379491|NCT04736173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379492|NCT04736173|Tubulin Modulators|tubulin modulators|mesh-ancestor
25379493|NCT04736173|Antimitotic Agents|antimitotic agents|mesh-ancestor
25379494|NCT04736173|Mitosis Modulators|mitosis modulators|mesh-ancestor
25379495|NCT04736173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379496|NCT04736173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379497|NCT04736173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25379498|NCT04736173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25379499|NCT04735978|Nivolumab|nivolumab|mesh-list
25379500|NCT04735978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25379501|NCT04735978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379502|NCT04735978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25379503|NCT04735978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379504|NCT04735770|Levobupivacaine|levobupivacaine|mesh-list
25379505|NCT04735770|Anesthetics|anesthetics|mesh-ancestor
25379506|NCT04735770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25379507|NCT04735770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379508|NCT04735770|Anesthetics, Local|anesthetics, local|mesh-ancestor
25379509|NCT04735770|Sensory System Agents|sensory system agents|mesh-ancestor
25379510|NCT04735770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25379511|NCT04735471|Cyclophosphamide|cyclophosphamide|mesh-list
25379512|NCT04735471|Fludarabine|fludarabine|mesh-list
25379532|NCT04734990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379533|NCT04734990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379558|NCT04734405|Fluconazole|fluconazole|mesh-list
25379559|NCT04734405|Antifungal Agents|antifungal agents|mesh-ancestor
25379560|NCT04734405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25379561|NCT04734405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25379562|NCT04734405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25379563|NCT04734405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379564|NCT04734405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379565|NCT04734405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25379566|NCT04734405|Hormone Antagonists|hormone antagonists|mesh-ancestor
25379567|NCT04734405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25379568|NCT04734405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379569|NCT04734405|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
25379570|NCT04734405|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25379571|NCT04734262|Paclitaxel|paclitaxel|mesh-list
25379572|NCT04734262|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25379573|NCT04734262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25379574|NCT04734262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379575|NCT04734262|Tubulin Modulators|tubulin modulators|mesh-ancestor
25379576|NCT04734262|Antimitotic Agents|antimitotic agents|mesh-ancestor
25379577|NCT04734262|Mitosis Modulators|mitosis modulators|mesh-ancestor
25379578|NCT04734262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379579|NCT04734210|Betamethasone|betamethasone|mesh-list
25379580|NCT04734210|Betamethasone Valerate|betamethasone valerate|mesh-list
25379581|NCT04734210|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
25379582|NCT04734210|Betamethasone benzoate|betamethasone benzoate|mesh-list
25379583|NCT04734210|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
25724251|NCT02536105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379584|NCT04734210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25379585|NCT04734210|Glucocorticoids|glucocorticoids|mesh-ancestor
25379586|NCT04734210|Hormones|hormones|mesh-ancestor
25379587|NCT04734210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25379588|NCT04734210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379589|NCT04734210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25379590|NCT04734210|Respiratory System Agents|respiratory system agents|mesh-ancestor
25379591|NCT04733040|Felzartamab|felzartamab|mesh-list
25379592|NCT04733040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379593|NCT04733040|Immunologic Factors|immunologic factors|mesh-ancestor
25379594|NCT04733040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379595|NCT04732286|Bevacizumab|bevacizumab|mesh-list
25379596|NCT04732286|Atezolizumab|atezolizumab|mesh-list
25379597|NCT04732286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25379598|NCT04732286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379599|NCT04732286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25379600|NCT04732286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25379601|NCT04732286|Growth Substances|growth substances|mesh-ancestor
25379602|NCT04732286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379603|NCT04732286|Growth Inhibitors|growth inhibitors|mesh-ancestor
25379604|NCT04732208|Mydriatics|mydriatics|mesh-list
25379605|NCT04732208|Autonomic Agents|autonomic agents|mesh-ancestor
25379606|NCT04732208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25379607|NCT04732208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379608|NCT04732065|Dopamine|dopamine|mesh-list
25379609|NCT04732065|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25379610|NCT04732065|Sympathomimetics|sympathomimetics|mesh-ancestor
25379611|NCT04732065|Autonomic Agents|autonomic agents|mesh-ancestor
25379612|NCT04732065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25379613|NCT04732065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379614|NCT04732065|Dopamine Agents|dopamine agents|mesh-ancestor
25379615|NCT04732065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25379616|NCT04732065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379617|NCT04732065|Protective Agents|protective agents|mesh-ancestor
25379618|NCT04731974|Melatonin|melatonin|mesh-list
25379619|NCT04731974|Antioxidants|antioxidants|mesh-ancestor
25379620|NCT04731974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379621|NCT04731974|Protective Agents|protective agents|mesh-ancestor
25379622|NCT04731974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379623|NCT04731974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25379624|NCT04731558|Enoxaparin|enoxaparin|mesh-list
25379625|NCT04731558|Dalteparin|dalteparin|mesh-list
25379626|NCT04731558|Tinzaparin|tinzaparin|mesh-list
25379627|NCT04731558|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25379628|NCT04731558|Anticoagulants|anticoagulants|mesh-ancestor
25379629|NCT04731558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25379630|NCT04731558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25379631|NCT04731558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379632|NCT04731103|Lamivudine|lamivudine|mesh-list
25379633|NCT04731103|Zidovudine|zidovudine|mesh-list
25379634|NCT04731103|Abacavir|abacavir|mesh-list
25379635|NCT04731103|Dideoxynucleosides|dideoxynucleosides|mesh-list
25379636|NCT04731103|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25379637|NCT04731103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25379638|NCT04731103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379639|NCT04731103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379640|NCT04731103|Antiviral Agents|antiviral agents|mesh-ancestor
25379641|NCT04731103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25379642|NCT04731103|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25379643|NCT04731103|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25379644|NCT04731103|Antimetabolites|antimetabolites|mesh-ancestor
25379645|NCT04730999|Bevacizumab|bevacizumab|mesh-list
25379646|NCT04730999|Carboplatin|carboplatin|mesh-list
25379647|NCT04730999|Etoposide|etoposide|mesh-list
25379648|NCT04730999|Atezolizumab|atezolizumab|mesh-list
25379649|NCT04730999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25379650|NCT04730999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379651|NCT04730999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25379652|NCT04730999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25379653|NCT04730999|Growth Substances|growth substances|mesh-ancestor
25379654|NCT04730999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379655|NCT04730999|Growth Inhibitors|growth inhibitors|mesh-ancestor
25379656|NCT04730999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25379657|NCT04730999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25379658|NCT04730999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25379659|NCT04730999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25408389|NCT03447132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25379660|NCT04730999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379661|NCT04730856|Tinzaparin|tinzaparin|mesh-list
25379662|NCT04730856|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
25379663|NCT04730856|Dalteparin|dalteparin|mesh-list
25379664|NCT04730856|Anticoagulants|anticoagulants|mesh-ancestor
25379665|NCT04730856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25379666|NCT04730856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25379667|NCT04730856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379668|NCT04730635|Donepezil|donepezil|mesh-list
25379669|NCT04730635|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25379670|NCT04730635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379671|NCT04730635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379672|NCT04730635|Cholinergic Agents|cholinergic agents|mesh-ancestor
25379673|NCT04730635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25379674|NCT04730635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379675|NCT04730635|Nootropic Agents|nootropic agents|mesh-ancestor
25379676|NCT04730609|Dexmedetomidine|dexmedetomidine|mesh-list
25379677|NCT04730609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25379678|NCT04730609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25379679|NCT04730609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379680|NCT04730609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25379687|NCT04730609|Adrenergic Agents|adrenergic agents|mesh-ancestor
25379688|NCT04730609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25379689|NCT04730609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379690|NCT04730583|Deoxycholic Acid|deoxycholic acid|mesh-list
25379922|NCT04722523|Docetaxel|docetaxel|mesh-list
25379691|NCT04730583|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
25379692|NCT04730583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25379693|NCT04730531|Epinephrine|epinephrine|mesh-list
25379694|NCT04730531|Bupivacaine|bupivacaine|mesh-list
25379695|NCT04730531|Anesthetics, Local|anesthetics, local|mesh-ancestor
25379696|NCT04730531|Anesthetics|anesthetics|mesh-ancestor
25379697|NCT04730531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25379698|NCT04730531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379699|NCT04730531|Sensory System Agents|sensory system agents|mesh-ancestor
25379700|NCT04730531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25379701|NCT04730531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25379702|NCT04730531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25379703|NCT04730531|Adrenergic Agents|adrenergic agents|mesh-ancestor
25379704|NCT04730531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25379705|NCT04730531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379706|NCT04730531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25379707|NCT04730531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25379708|NCT04730531|Autonomic Agents|autonomic agents|mesh-ancestor
25379709|NCT04730531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25379710|NCT04730531|Respiratory System Agents|respiratory system agents|mesh-ancestor
25379711|NCT04730531|Mydriatics|mydriatics|mesh-ancestor
25379712|NCT04730531|Sympathomimetics|sympathomimetics|mesh-ancestor
25379713|NCT04730531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25379714|NCT04730349|Nivolumab|nivolumab|mesh-list
25379715|NCT04730349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25379716|NCT04730349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379717|NCT04730349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25379718|NCT04730349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379719|NCT04730193|Caffeine|caffeine|mesh-list
25379720|NCT04730193|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25379721|NCT04730193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379722|NCT04730193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25379723|NCT04730193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379724|NCT04730193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379725|NCT04730193|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25379726|NCT04730193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25379727|NCT04730193|Purinergic Agents|purinergic agents|mesh-ancestor
25379728|NCT04730193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25379729|NCT04730037|Warfarin|warfarin|mesh-list
25379730|NCT04730037|Edoxaban|edoxaban|mesh-list
25379731|NCT04730037|Anticoagulants|anticoagulants|mesh-ancestor
25379732|NCT04730037|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25379733|NCT04730037|Antithrombins|antithrombins|mesh-ancestor
25379734|NCT04730037|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25379735|NCT04730037|Protease Inhibitors|protease inhibitors|mesh-ancestor
25379736|NCT04730037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379737|NCT04730037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379745|NCT04729595|Tempol|tempol|mesh-list
25379746|NCT04729595|Antioxidants|antioxidants|mesh-ancestor
25379775|NCT04729114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379777|NCT04729114|Glucocorticoids|glucocorticoids|mesh-ancestor
25379778|NCT04729114|Hormones|hormones|mesh-ancestor
25379779|NCT04729114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25379780|NCT04729114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25379781|NCT04729114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379782|NCT04729023|Temazepam|temazepam|mesh-list
25379783|NCT04729023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25379784|NCT04729023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25379785|NCT04729023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379786|NCT04729023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25379787|NCT04729023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25379788|NCT04729023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25379789|NCT04729023|GABA Modulators|gaba modulators|mesh-ancestor
25379790|NCT04729023|GABA Agents|gaba agents|mesh-ancestor
25379791|NCT04729023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25379792|NCT04729023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379793|NCT04728971|Caspofungin|caspofungin|mesh-list
25379794|NCT04728971|Micafungin|micafungin|mesh-list
25379795|NCT04728971|Antifungal Agents|antifungal agents|mesh-ancestor
25379796|NCT04728971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25379797|NCT04728971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379798|NCT04728971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379799|NCT04728360|Ustekinumab|ustekinumab|mesh-list
25379800|NCT04728360|Dermatologic Agents|dermatologic agents|mesh-ancestor
25379801|NCT04727242|Gemcitabine|gemcitabine|mesh-list
25379802|NCT04727242|Dacarbazine|dacarbazine|mesh-list
25379803|NCT04727242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25379804|NCT04727242|Antimetabolites|antimetabolites|mesh-ancestor
25379805|NCT04727242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379806|NCT04727242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379807|NCT04727242|Antiviral Agents|antiviral agents|mesh-ancestor
25379808|NCT04727242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25379809|NCT04727242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379810|NCT04727242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25379811|NCT04727242|Immunologic Factors|immunologic factors|mesh-ancestor
25379812|NCT04727242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379813|NCT04727242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25379814|NCT04727242|Alkylating Agents|alkylating agents|mesh-ancestor
25379815|NCT04726592|Ketoprofen|ketoprofen|mesh-list
25379816|NCT04726592|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
25379817|NCT04726592|Metoclopramide|metoclopramide|mesh-list
25379818|NCT04726592|Antiemetics|antiemetics|mesh-ancestor
25379819|NCT04726592|Autonomic Agents|autonomic agents|mesh-ancestor
25379820|NCT04726592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25379821|NCT04726592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379822|NCT04726592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25379823|NCT04726592|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25379824|NCT04726592|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25379825|NCT04726592|Dopamine Agents|dopamine agents|mesh-ancestor
25379826|NCT04726592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25379827|NCT04726592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379828|NCT04726592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25379829|NCT04726592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25379830|NCT04726592|Analgesics|analgesics|mesh-ancestor
25379831|NCT04726592|Sensory System Agents|sensory system agents|mesh-ancestor
25379832|NCT04726592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25379833|NCT04726592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25379834|NCT04726592|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25379835|NCT04726592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379837|NCT04726592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25379838|NCT04726592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25379839|NCT04726592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25379840|NCT04726592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25379841|NCT04726592|GABA Modulators|gaba modulators|mesh-ancestor
25379842|NCT04726592|GABA Agents|gaba agents|mesh-ancestor
25379843|NCT04725994|Irinotecan|irinotecan|mesh-list
25379844|NCT04725994|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25379845|NCT04725994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25379846|NCT04725994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379847|NCT04725994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379848|NCT04725994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379849|NCT04725201|Heparin|heparin|mesh-list
25379850|NCT04725201|Calcium heparin|calcium heparin|mesh-list
25379851|NCT04725201|Anticoagulants|anticoagulants|mesh-ancestor
25379852|NCT04725201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25379853|NCT04725201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25379854|NCT04725201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379855|NCT04724967|Dimenhydrinate|dimenhydrinate|mesh-list
25379856|NCT04724967|Antiemetics|antiemetics|mesh-ancestor
25379857|NCT04724967|Autonomic Agents|autonomic agents|mesh-ancestor
25379858|NCT04724967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25379859|NCT04724967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379860|NCT04724967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25379861|NCT04724967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25379862|NCT04724967|Histamine Antagonists|histamine antagonists|mesh-ancestor
25379863|NCT04724967|Histamine Agents|histamine agents|mesh-ancestor
25379864|NCT04724967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25379865|NCT04724967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379866|NCT04724837|Dapagliflozin|dapagliflozin|mesh-list
25379867|NCT04724837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25379868|NCT04724837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379869|NCT04724837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25379870|NCT04724837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379871|NCT04724629|Aldesleukin|aldesleukin|mesh-list
25379872|NCT04724629|Colchicine|colchicine|mesh-list
25379873|NCT04724629|Ixekizumab|ixekizumab|mesh-list
25379874|NCT04724629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379875|NCT04724629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25379876|NCT04724629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25379877|NCT04724629|Antiviral Agents|antiviral agents|mesh-ancestor
25379878|NCT04724629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25379879|NCT04724629|Gout Suppressants|gout suppressants|mesh-ancestor
25379880|NCT04724629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25379881|NCT04724629|Tubulin Modulators|tubulin modulators|mesh-ancestor
25379882|NCT04724629|Antimitotic Agents|antimitotic agents|mesh-ancestor
25379883|NCT04724629|Mitosis Modulators|mitosis modulators|mesh-ancestor
25379884|NCT04724629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379885|NCT04724629|Dermatologic Agents|dermatologic agents|mesh-ancestor
25379886|NCT04723862|Spironolactone|spironolactone|mesh-list
25379887|NCT04723862|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25379888|NCT04723862|Hormone Antagonists|hormone antagonists|mesh-ancestor
25379889|NCT04723862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25379890|NCT04723862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379891|NCT04723862|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25379892|NCT04723862|Diuretics|diuretics|mesh-ancestor
25379893|NCT04723862|Natriuretic Agents|natriuretic agents|mesh-ancestor
25379894|NCT04723446|Chlorhexidine|chlorhexidine|mesh-list
25379895|NCT04723446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25379896|NCT04723446|Hydrogen Peroxide|hydrogen peroxide|mesh-list
25379897|NCT04723446|Cetylpyridinium|cetylpyridinium|mesh-list
25379898|NCT04723446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25379899|NCT04723446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25379900|NCT04723446|Disinfectants|disinfectants|mesh-ancestor
25379901|NCT04723446|Dermatologic Agents|dermatologic agents|mesh-ancestor
25379902|NCT04723134|Leucovorin|leucovorin|mesh-list
25379903|NCT04723134|Folic Acid|folic acid|mesh-list
25379904|NCT04723134|Calcium|calcium|mesh-list
25379905|NCT04723134|Levoleucovorin|levoleucovorin|mesh-list
25379906|NCT04723134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25379907|NCT04723134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379908|NCT04723134|Antidotes|antidotes|mesh-ancestor
25379909|NCT04723134|Protective Agents|protective agents|mesh-ancestor
25379910|NCT04723134|Vitamin B Complex|vitamin b complex|mesh-ancestor
25379911|NCT04723134|Vitamins|vitamins|mesh-ancestor
25379912|NCT04723134|Micronutrients|micronutrients|mesh-ancestor
25379913|NCT04723134|Hematinics|hematinics|mesh-ancestor
25379914|NCT04722887|Protease Inhibitors|protease inhibitors|mesh-list
25379915|NCT04722887|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
25379916|NCT04722887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379917|NCT04722887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379918|NCT04722887|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25379919|NCT04722887|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25379920|NCT04722523|Cisplatin|cisplatin|mesh-list
25379921|NCT04722523|Carboplatin|carboplatin|mesh-list
25379924|NCT04722523|Cemiplimab|cemiplimab|mesh-list
25379925|NCT04722523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379926|NCT04722523|Tubulin Modulators|tubulin modulators|mesh-ancestor
25379927|NCT04722523|Antimitotic Agents|antimitotic agents|mesh-ancestor
25379928|NCT04722523|Mitosis Modulators|mitosis modulators|mesh-ancestor
25379929|NCT04722523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379930|NCT04722523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25379931|NCT04722354|Abscisic Acid|abscisic acid|mesh-list
25379932|NCT04722354|Plant Growth Regulators|plant growth regulators|mesh-ancestor
25379933|NCT04722354|Growth Substances|growth substances|mesh-ancestor
25379934|NCT04722354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379935|NCT04722172|Obinutuzumab|obinutuzumab|mesh-list
25379936|NCT04722172|Acalabrutinib|acalabrutinib|mesh-list
25379937|NCT04722172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25379938|NCT04722172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379939|NCT04722146|Lenalidomide|lenalidomide|mesh-list
25379940|NCT04722146|Pomalidomide|pomalidomide|mesh-list
25379941|NCT04722146|Bortezomib|bortezomib|mesh-list
25379942|NCT04722146|Daratumumab|daratumumab|mesh-list
25379943|NCT04722146|Immunologic Factors|immunologic factors|mesh-ancestor
25379944|NCT04722146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379945|NCT04722146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25379946|NCT04722146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25379947|NCT04722146|Growth Substances|growth substances|mesh-ancestor
25379948|NCT04722146|Growth Inhibitors|growth inhibitors|mesh-ancestor
25379949|NCT04722146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379950|NCT04721977|Capecitabine|capecitabine|mesh-list
25379951|NCT04721977|Trastuzumab|trastuzumab|mesh-list
25379952|NCT04721977|Tucatinib|tucatinib|mesh-list
25379953|NCT04721977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25379954|NCT04721977|Antimetabolites|antimetabolites|mesh-ancestor
25379955|NCT04721977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379956|NCT04721977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379957|NCT04721977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25379958|NCT04721977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25379959|NCT04721977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379960|NCT04721015|Docetaxel|docetaxel|mesh-list
25379961|NCT04721015|Osimertinib|osimertinib|mesh-list
25379962|NCT04721015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379963|NCT04721015|Tubulin Modulators|tubulin modulators|mesh-ancestor
25379964|NCT04721015|Antimitotic Agents|antimitotic agents|mesh-ancestor
25379965|NCT04721015|Mitosis Modulators|mitosis modulators|mesh-ancestor
25379966|NCT04721015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379967|NCT04721015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25379968|NCT04721015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379969|NCT04720716|Sorafenib|sorafenib|mesh-list
25379970|NCT04720716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25379971|NCT04720716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25379972|NCT04720716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25379973|NCT04720716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379974|NCT04720612|Omalizumab|omalizumab|mesh-list
25379975|NCT04720612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25379976|NCT04720612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25379977|NCT04720612|Respiratory System Agents|respiratory system agents|mesh-ancestor
25379978|NCT04720157|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25379979|NCT04720157|177Lu-PSMA-617|177lu-psma-617|mesh-list
25379980|NCT04720157|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25379981|NCT04720157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379992|NCT04718480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25379993|NCT04718480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25379994|NCT04718480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25379995|NCT04718480|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25379996|NCT04718480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25379997|NCT04718480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25379998|NCT04718480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25379999|NCT04718480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25380000|NCT04718480|Serotonin Agents|serotonin agents|mesh-ancestor
25380001|NCT04718480|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25380002|NCT04718480|Antidepressive Agents|antidepressive agents|mesh-ancestor
25380003|NCT04718480|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25380004|NCT04718480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25380005|NCT04718480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380006|NCT04718480|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25380017|NCT04717973|Vitamin D|vitamin d|mesh-list
25380018|NCT04717973|Vitamins|vitamins|mesh-list
25380019|NCT04717973|Vitamin B 12|vitamin b 12|mesh-list
25380020|NCT04717973|Hydroxocobalamin|hydroxocobalamin|mesh-list
25380021|NCT04717973|Micronutrients|micronutrients|mesh-ancestor
25380022|NCT04717973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380023|NCT04717973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25380024|NCT04717973|Vitamin B Complex|vitamin b complex|mesh-ancestor
25380025|NCT04717973|Hematinics|hematinics|mesh-ancestor
25380026|NCT04717414|Luspatercept|luspatercept|mesh-list
25380027|NCT04717414|Hematinics|hematinics|mesh-ancestor
25380028|NCT04716933|Cisplatin|cisplatin|mesh-list
25380029|NCT04716933|Carboplatin|carboplatin|mesh-list
25380030|NCT04716933|Pembrolizumab|pembrolizumab|mesh-list
25380031|NCT04716933|Pemetrexed|pemetrexed|mesh-list
25380032|NCT04716933|Lenvatinib|lenvatinib|mesh-list
25380033|NCT04716933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380034|NCT04716933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380035|NCT04716933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380036|NCT04716933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380037|NCT04716933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25380038|NCT04716933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25380039|NCT04716933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25380040|NCT04714372|Cyclophosphamide|cyclophosphamide|mesh-list
25380041|NCT04714372|Fludarabine|fludarabine|mesh-list
25380042|NCT04714372|Daratumumab|daratumumab|mesh-list
25380043|NCT04714372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25380044|NCT04714372|Immunologic Factors|immunologic factors|mesh-ancestor
25380045|NCT04714372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380046|NCT04714372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25380047|NCT04714372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25380048|NCT04714372|Alkylating Agents|alkylating agents|mesh-ancestor
25380049|NCT04714372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380050|NCT04714372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380051|NCT04714372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25380052|NCT04713592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25380053|NCT04713592|Immunologic Factors|immunologic factors|mesh-ancestor
25380054|NCT04713592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380055|NCT04713514|Pembrolizumab|pembrolizumab|mesh-list
25380056|NCT04713514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380057|NCT04713514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380058|NCT04712903|Cisplatin|cisplatin|mesh-list
25380059|NCT04712903|Carboplatin|carboplatin|mesh-list
25380063|NCT04712903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25380064|NCT04712903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25380065|NCT04712903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25380069|NCT04712643|Atezolizumab|atezolizumab|mesh-list
25380070|NCT04712643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380071|NCT04712539|Oseltamivir|oseltamivir|mesh-list
25380072|NCT04712539|Baloxavir|baloxavir|mesh-list
25380073|NCT04712539|Antiviral Agents|antiviral agents|mesh-ancestor
25380074|NCT04712539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25380075|NCT04712539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380076|NCT04712539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380077|NCT04712097|Rituximab|rituximab|mesh-list
25380078|NCT04712097|Lenalidomide|lenalidomide|mesh-list
25380079|NCT04712097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380080|NCT04712097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380081|NCT04712097|Immunologic Factors|immunologic factors|mesh-ancestor
25380082|NCT04712097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380083|NCT04712097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25380084|NCT04712097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25380085|NCT04712097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25380086|NCT04712097|Growth Substances|growth substances|mesh-ancestor
25380087|NCT04712097|Growth Inhibitors|growth inhibitors|mesh-ancestor
25380088|NCT04711824|Gemcitabine|gemcitabine|mesh-list
25380089|NCT04711824|Paclitaxel|paclitaxel|mesh-list
25380090|NCT04711824|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25380091|NCT04711824|Cisplatin|cisplatin|mesh-list
25380092|NCT04711824|Carboplatin|carboplatin|mesh-list
25380093|NCT04711824|Capecitabine|capecitabine|mesh-list
25380094|NCT04711824|Durvalumab|durvalumab|mesh-list
25380095|NCT04711824|Olaparib|olaparib|mesh-list
25380096|NCT04711824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25380097|NCT04711824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380098|NCT04711824|Tubulin Modulators|tubulin modulators|mesh-ancestor
25380099|NCT04711824|Antimitotic Agents|antimitotic agents|mesh-ancestor
25380100|NCT04711824|Mitosis Modulators|mitosis modulators|mesh-ancestor
25380101|NCT04711824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380102|NCT04711824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25380103|NCT04711824|Antimetabolites|antimetabolites|mesh-ancestor
25380104|NCT04711824|Antiviral Agents|antiviral agents|mesh-ancestor
25380105|NCT04711824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25380106|NCT04711824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380107|NCT04711824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25380108|NCT04711824|Immunologic Factors|immunologic factors|mesh-ancestor
25380109|NCT04711824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380110|NCT04711824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380111|NCT04711824|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25380115|NCT04711109|Denosumab|denosumab|mesh-list
25380116|NCT04711109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25380117|NCT04711109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380118|NCT04709471|Nicotine|nicotine|mesh-list
25380119|NCT04709471|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25380120|NCT04709471|Autonomic Agents|autonomic agents|mesh-ancestor
25380121|NCT04709471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25380122|NCT04709471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380123|NCT04709471|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25380124|NCT04709471|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25380125|NCT04709471|Cholinergic Agents|cholinergic agents|mesh-ancestor
25380126|NCT04709471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25380127|NCT04709471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380128|NCT04709211|Bupivacaine|bupivacaine|mesh-list
25380129|NCT04709211|Anesthetics, Local|anesthetics, local|mesh-ancestor
25380130|NCT04709211|Anesthetics|anesthetics|mesh-ancestor
25380131|NCT04709211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25380132|NCT04709211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380133|NCT04709211|Sensory System Agents|sensory system agents|mesh-ancestor
25380134|NCT04709211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25380137|NCT04708470|Entinostat|entinostat|mesh-list
25380138|NCT04708470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380139|NCT04708470|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
25380140|NCT04708470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380141|NCT04708470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380142|NCT04708418|Pembrolizumab|pembrolizumab|mesh-list
25380143|NCT04708418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380145|NCT04708067|Atezolizumab|atezolizumab|mesh-list
25380146|NCT04708067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380147|NCT04707872|Antibodies|antibodies|mesh-list
25380148|NCT04707872|Immunologic Factors|immunologic factors|mesh-ancestor
25380149|NCT04707872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380150|NCT04707703|Isavuconazole|isavuconazole|mesh-list
25380151|NCT04707703|Antifungal Agents|antifungal agents|mesh-ancestor
25380152|NCT04707703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25380153|NCT04707196|Fulvestrant|fulvestrant|mesh-list
25380154|NCT04707196|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25380155|NCT04707196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25380156|NCT04707196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380157|NCT04707196|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25380158|NCT04707196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25380159|NCT04707196|Hormone Antagonists|hormone antagonists|mesh-ancestor
25380160|NCT04707196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25380161|NCT04707196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380162|NCT04707196|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25380163|NCT04707196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380164|NCT04707196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380165|NCT04706026|Anesthetics|anesthetics|mesh-list
25380166|NCT04706026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25380167|NCT04706026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380168|NCT04704934|Paclitaxel|paclitaxel|mesh-list
25380169|NCT04704934|Trastuzumab|trastuzumab|mesh-list
25380170|NCT04704934|Ramucirumab|ramucirumab|mesh-list
25380171|NCT04704934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25380172|NCT04704934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380173|NCT04704934|Tubulin Modulators|tubulin modulators|mesh-ancestor
25380174|NCT04704934|Antimitotic Agents|antimitotic agents|mesh-ancestor
25380175|NCT04704934|Mitosis Modulators|mitosis modulators|mesh-ancestor
25380176|NCT04704934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380177|NCT04704934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380178|NCT04704154|Nivolumab|nivolumab|mesh-list
25380179|NCT04704154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380180|NCT04704154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380181|NCT04704154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25380182|NCT04704154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380183|NCT04703751|Nitroglycerin|nitroglycerin|mesh-list
25380184|NCT04703751|Vasodilator Agents|vasodilator agents|mesh-ancestor
25380185|NCT04703686|Obinutuzumab|obinutuzumab|mesh-list
25380186|NCT04703686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380187|NCT04703686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380188|NCT04702893|Nintedanib|nintedanib|mesh-list
25380189|NCT04702893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380190|NCT04702893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25380191|NCT04702893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380192|NCT04702893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380193|NCT04702880|Carboplatin|carboplatin|mesh-list
25380194|NCT04702880|Nivolumab|nivolumab|mesh-list
25380195|NCT04702880|Etoposide|etoposide|mesh-list
25380196|NCT04702880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380197|NCT04702880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380198|NCT04702880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25380199|NCT04702880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380200|NCT04702880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25380201|NCT04702880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25380202|NCT04702880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25380203|NCT04702880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380204|NCT04701151|BCG Vaccine|bcg vaccine|mesh-list
25380205|NCT04701151|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25380206|NCT04701151|Immunologic Factors|immunologic factors|mesh-ancestor
25380207|NCT04701151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380208|NCT04701034|Prednisolone|prednisolone|mesh-list
25380209|NCT04701034|Immunoglobulins|immunoglobulins|mesh-list
25380210|NCT04701034|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25380211|NCT04701034|Antibodies|antibodies|mesh-list
25380212|NCT04701034|gamma-Globulins|gamma-globulins|mesh-list
25380213|NCT04701034|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25380214|NCT04701034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25380215|NCT04701034|Glucocorticoids|glucocorticoids|mesh-ancestor
25380216|NCT04701034|Hormones|hormones|mesh-ancestor
25380292|NCT04699461|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
25380217|NCT04701034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25380218|NCT04701034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380219|NCT04701034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25380220|NCT04701034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380221|NCT04701034|Immunologic Factors|immunologic factors|mesh-ancestor
25380222|NCT04701008|Ketamine|ketamine|mesh-list
25380223|NCT04701008|Analgesics|analgesics|mesh-ancestor
25380224|NCT04701008|Sensory System Agents|sensory system agents|mesh-ancestor
25380225|NCT04701008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25380226|NCT04701008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380227|NCT04701008|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25380228|NCT04701008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25380229|NCT04701008|Anesthetics, General|anesthetics, general|mesh-ancestor
25380231|NCT04701008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25380232|NCT04701008|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25380233|NCT04701008|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25380234|NCT04701008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25380235|NCT04701008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380236|NCT04700839|Metformin|metformin|mesh-list
25380237|NCT04700839|Canagliflozin|canagliflozin|mesh-list
25380238|NCT04700839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
25380239|NCT04700839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25380240|NCT04700839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380241|NCT04700839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380242|NCT04700696|Analgesics, Opioid|analgesics, opioid|mesh-list
25380243|NCT04700696|Narcotics|narcotics|mesh-ancestor
25380244|NCT04700696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25380245|NCT04700696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380246|NCT04700696|Analgesics|analgesics|mesh-ancestor
25380247|NCT04700696|Sensory System Agents|sensory system agents|mesh-ancestor
25380248|NCT04700696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25380249|NCT04700527|Butyric Acid|butyric acid|mesh-list
25380250|NCT04700527|Histamine Antagonists|histamine antagonists|mesh-ancestor
25380251|NCT04700527|Histamine Agents|histamine agents|mesh-ancestor
25380252|NCT04700527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25380253|NCT04700527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380254|NCT04700527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380255|NCT04700124|Gemcitabine|gemcitabine|mesh-list
25380256|NCT04700124|Cisplatin|cisplatin|mesh-list
25380257|NCT04700124|Pembrolizumab|pembrolizumab|mesh-list
25380258|NCT04700124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380259|NCT04700124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25380260|NCT04700124|Antimetabolites|antimetabolites|mesh-ancestor
25380261|NCT04700124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380262|NCT04700124|Antiviral Agents|antiviral agents|mesh-ancestor
25380263|NCT04700124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25380264|NCT04700124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380265|NCT04700124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25380266|NCT04700124|Immunologic Factors|immunologic factors|mesh-ancestor
25380267|NCT04700124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380268|NCT04700124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380269|NCT04700072|Pembrolizumab|pembrolizumab|mesh-list
25380270|NCT04700072|Lenvatinib|lenvatinib|mesh-list
25380271|NCT04700072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380272|NCT04700072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380273|NCT04700072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25380274|NCT04700072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380275|NCT04700072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380276|NCT04699981|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25380277|NCT04699981|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25380278|NCT04699981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25380279|NCT04699981|Antitubercular Agents|antitubercular agents|mesh-ancestor
25380280|NCT04699838|Cisplatin|cisplatin|mesh-list
25380281|NCT04699838|Carboplatin|carboplatin|mesh-list
25380282|NCT04699838|Etoposide|etoposide|mesh-list
25380283|NCT04699838|Durvalumab|durvalumab|mesh-list
25380284|NCT04699838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380285|NCT04699838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25380286|NCT04699838|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25380287|NCT04699838|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25380288|NCT04699838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380289|NCT04699838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380290|NCT04699838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380291|NCT04699461|Idelalisib|idelalisib|mesh-list
25380293|NCT04699461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380294|NCT04699461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380295|NCT04699461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380296|NCT04699461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380297|NCT04698850|Ranibizumab|ranibizumab|mesh-list
25380298|NCT04698850|Aflibercept|aflibercept|mesh-list
25380299|NCT04698850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25380300|NCT04698850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25380301|NCT04698850|Growth Substances|growth substances|mesh-ancestor
25380302|NCT04698850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380303|NCT04698850|Growth Inhibitors|growth inhibitors|mesh-ancestor
25380304|NCT04698850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380305|NCT04698226|Temazepam|temazepam|mesh-list
25380306|NCT04698226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25380307|NCT04698226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25380308|NCT04698226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380309|NCT04698226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25380310|NCT04698226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25380311|NCT04698226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25380312|NCT04698226|GABA Modulators|gaba modulators|mesh-ancestor
25380313|NCT04698226|GABA Agents|gaba agents|mesh-ancestor
25380314|NCT04698226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25380315|NCT04698226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380316|NCT04698187|Nivolumab|nivolumab|mesh-list
25380317|NCT04698187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380318|NCT04698187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380319|NCT04698187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25380320|NCT04698187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380321|NCT04697940|Decitabine|decitabine|mesh-list
25380322|NCT04697940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25380323|NCT04697940|Antimetabolites|antimetabolites|mesh-ancestor
25380324|NCT04697940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380325|NCT04697940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380326|NCT04697940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380327|NCT04697628|Gemcitabine|gemcitabine|mesh-list
25380328|NCT04697628|Irinotecan|irinotecan|mesh-list
25380329|NCT04697628|Pemetrexed|pemetrexed|mesh-list
25380330|NCT04697628|Topotecan|topotecan|mesh-list
25380331|NCT04697628|Vinorelbine|vinorelbine|mesh-list
25380332|NCT04697628|Tisotumab vedotin|tisotumab vedotin|mesh-list
25380333|NCT04697628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25380334|NCT04697628|Antimetabolites|antimetabolites|mesh-ancestor
25380335|NCT04697628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380336|NCT04697628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380337|NCT04697628|Antiviral Agents|antiviral agents|mesh-ancestor
25380338|NCT04697628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25380339|NCT04697628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380340|NCT04697628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25380341|NCT04697628|Immunologic Factors|immunologic factors|mesh-ancestor
25380342|NCT04697628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380343|NCT04697628|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25380344|NCT04697628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25380345|NCT04697628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25380346|NCT04697628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25380347|NCT04697628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25380348|NCT04697628|Tubulin Modulators|tubulin modulators|mesh-ancestor
25380349|NCT04697628|Antimitotic Agents|antimitotic agents|mesh-ancestor
25380350|NCT04697628|Mitosis Modulators|mitosis modulators|mesh-ancestor
25380351|NCT04697628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380352|NCT04697602|Colchicine|colchicine|mesh-list
25380353|NCT04697602|Febuxostat|febuxostat|mesh-list
25380354|NCT04697602|Gout Suppressants|gout suppressants|mesh-ancestor
25380355|NCT04697602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25380356|NCT04697602|Tubulin Modulators|tubulin modulators|mesh-ancestor
25380357|NCT04697602|Antimitotic Agents|antimitotic agents|mesh-ancestor
25380358|NCT04697602|Mitosis Modulators|mitosis modulators|mesh-ancestor
25380359|NCT04697602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380360|NCT04697602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380361|NCT04697498|Anesthetics|anesthetics|mesh-list
25380362|NCT04697498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25380363|NCT04697498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380364|NCT04696055|Pembrolizumab|pembrolizumab|mesh-list
25380365|NCT04696055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380366|NCT04696055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380367|NCT04696029|Eflornithine|eflornithine|mesh-list
25380368|NCT04696029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380369|NCT04696029|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
25380370|NCT04696029|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25380371|NCT04696029|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25380372|NCT04696029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25380373|NCT04696029|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
25380374|NCT04696029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380375|NCT04696029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380376|NCT04695977|Nivolumab|nivolumab|mesh-list
25380377|NCT04695977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380378|NCT04695977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380379|NCT04695977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25380380|NCT04695977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380381|NCT04695847|Antibodies|antibodies|mesh-list
25380382|NCT04695847|Immunoglobulins|immunoglobulins|mesh-list
25380383|NCT04695847|Immunoconjugates|immunoconjugates|mesh-list
25380384|NCT04695847|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25380385|NCT04695847|Immunologic Factors|immunologic factors|mesh-ancestor
25380386|NCT04695847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380387|NCT04695769|Ribavirin|ribavirin|mesh-list
25380388|NCT04695769|Sofosbuvir|sofosbuvir|mesh-list
25380389|NCT04695769|Velpatasvir|velpatasvir|mesh-list
25380390|NCT04695769|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
25380391|NCT04695769|Antimetabolites|antimetabolites|mesh-ancestor
25380392|NCT04695769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380393|NCT04695769|Antiviral Agents|antiviral agents|mesh-ancestor
25380394|NCT04695769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25380395|NCT04694846|Bupropion|bupropion|mesh-list
25380396|NCT04694846|Nicotine|nicotine|mesh-list
25380397|NCT04694846|Varenicline|varenicline|mesh-list
25380398|NCT04694846|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25380399|NCT04694846|Autonomic Agents|autonomic agents|mesh-ancestor
25380400|NCT04694846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25380401|NCT04694846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380402|NCT04694846|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25380403|NCT04694846|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25380404|NCT04694846|Cholinergic Agents|cholinergic agents|mesh-ancestor
25380405|NCT04694846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25380406|NCT04694846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380407|NCT04694846|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25380408|NCT04694846|Antidepressive Agents|antidepressive agents|mesh-ancestor
25380409|NCT04694846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25380410|NCT04694846|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25380411|NCT04694846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25380412|NCT04694846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25380413|NCT04694846|Dopamine Agents|dopamine agents|mesh-ancestor
25380414|NCT04694846|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25380415|NCT04694846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25380416|NCT04694846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380417|NCT04693156|Bupivacaine|bupivacaine|mesh-list
25380418|NCT04693156|Prilocaine|prilocaine|mesh-list
25380419|NCT04693156|Anesthetics, Local|anesthetics, local|mesh-ancestor
25380420|NCT04693156|Anesthetics|anesthetics|mesh-ancestor
25380421|NCT04693156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25380422|NCT04693156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380423|NCT04693156|Sensory System Agents|sensory system agents|mesh-ancestor
25380424|NCT04693156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25380425|NCT04692831|Pertuzumab|pertuzumab|mesh-list
25380426|NCT04692831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380427|NCT04692831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380428|NCT04691804|Prednisone|prednisone|mesh-list
25380429|NCT04691804|Abiraterone Acetate|abiraterone acetate|mesh-list
25380430|NCT04691804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25380431|NCT04691804|Glucocorticoids|glucocorticoids|mesh-ancestor
25380432|NCT04691804|Hormones|hormones|mesh-ancestor
25380433|NCT04691804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25380434|NCT04691804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380435|NCT04691804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25380436|NCT04691804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380437|NCT04691804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25380438|NCT04691804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380439|NCT04691804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380440|NCT04691804|Hormone Antagonists|hormone antagonists|mesh-ancestor
25380441|NCT04691804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25380442|NCT04691375|Pembrolizumab|pembrolizumab|mesh-list
25380443|NCT04691375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380444|NCT04691375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380445|NCT04690855|Atezolizumab|atezolizumab|mesh-list
25380446|NCT04690855|Talazoparib|talazoparib|mesh-list
25380447|NCT04690855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380448|NCT04690855|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25380449|NCT04690855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380450|NCT04690855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380451|NCT04689919|Rivaroxaban|rivaroxaban|mesh-list
25380452|NCT04689919|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25380453|NCT04689919|Antithrombins|antithrombins|mesh-ancestor
25380454|NCT04689919|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25380455|NCT04689919|Protease Inhibitors|protease inhibitors|mesh-ancestor
25380456|NCT04689919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380457|NCT04689919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380458|NCT04689919|Anticoagulants|anticoagulants|mesh-ancestor
25380459|NCT04689828|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25380460|NCT04689828|177Lu-PSMA-617|177lu-psma-617|mesh-list
25380461|NCT04689828|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25380462|NCT04689828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380463|NCT04688736|Chlorpheniramine|chlorpheniramine|mesh-list
25380464|NCT04688736|Antipruritics|antipruritics|mesh-ancestor
25380465|NCT04688736|Dermatologic Agents|dermatologic agents|mesh-ancestor
25380466|NCT04688736|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25380467|NCT04688736|Histamine Antagonists|histamine antagonists|mesh-ancestor
25380468|NCT04688736|Histamine Agents|histamine agents|mesh-ancestor
25380469|NCT04688736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25380470|NCT04688736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380471|NCT04688736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380472|NCT04688736|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25380473|NCT04688320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25380474|NCT04688320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25380475|NCT04688320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25380476|NCT04688320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380478|NCT04687761|Azacitidine|azacitidine|mesh-list
25380480|NCT04687761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25380481|NCT04687761|Antimetabolites|antimetabolites|mesh-ancestor
25380482|NCT04687761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380483|NCT04687761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380484|NCT04687761|Antiviral Agents|antiviral agents|mesh-ancestor
25380485|NCT04687761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25380486|NCT04687761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25380487|NCT04687761|Immunologic Factors|immunologic factors|mesh-ancestor
25380488|NCT04687761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380489|NCT04687761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380490|NCT04687514|Dulaglutide|dulaglutide|mesh-list
25380491|NCT04687514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25380492|NCT04687514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380493|NCT04686305|Cisplatin|cisplatin|mesh-list
25380494|NCT04686305|Carboplatin|carboplatin|mesh-list
25380495|NCT04686305|Trastuzumab|trastuzumab|mesh-list
25380496|NCT04686305|Pemetrexed|pemetrexed|mesh-list
25380497|NCT04686305|Durvalumab|durvalumab|mesh-list
25380498|NCT04686305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380499|NCT04686305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380500|NCT04686305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380501|NCT04686305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380502|NCT04686305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25380503|NCT04686305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25380504|NCT04686097|Sclerosing Solutions|sclerosing solutions|mesh-list
25380505|NCT04686097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25380506|NCT04685811|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
25380507|NCT04685811|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25380508|NCT04685811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380509|NCT04685616|Doxorubicin|doxorubicin|mesh-list
25380510|NCT04685616|Bleomycin|bleomycin|mesh-list
25380511|NCT04685616|Dacarbazine|dacarbazine|mesh-list
25380512|NCT04685616|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25380513|NCT04685616|Vinblastine|vinblastine|mesh-list
25380514|NCT04685616|Mitogens|mitogens|mesh-list
25380515|NCT04685616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25380516|NCT04685616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380517|NCT04685616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25380518|NCT04685616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25380519|NCT04685616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380520|NCT04685616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380521|NCT04685616|Mitosis Modulators|mitosis modulators|mesh-ancestor
25380522|NCT04685616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25380523|NCT04685616|Alkylating Agents|alkylating agents|mesh-ancestor
25380524|NCT04685616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380525|NCT04685616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25380526|NCT04685616|Tubulin Modulators|tubulin modulators|mesh-ancestor
25380527|NCT04685616|Antimitotic Agents|antimitotic agents|mesh-ancestor
25380528|NCT04685577|Nefopam|nefopam|mesh-list
25380529|NCT04685577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25380530|NCT04685577|Analgesics|analgesics|mesh-ancestor
25380531|NCT04685577|Sensory System Agents|sensory system agents|mesh-ancestor
25380532|NCT04685577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25380533|NCT04685577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380535|NCT04685135|Adagrasib|adagrasib|mesh-list
25380536|NCT04685135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380537|NCT04685135|Tubulin Modulators|tubulin modulators|mesh-ancestor
25380538|NCT04685135|Antimitotic Agents|antimitotic agents|mesh-ancestor
25380539|NCT04685135|Mitosis Modulators|mitosis modulators|mesh-ancestor
25380540|NCT04685135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380541|NCT04684511|Rofecoxib|rofecoxib|mesh-list
25380542|NCT04684511|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25380543|NCT04684511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25380544|NCT04684511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380545|NCT04684511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380546|NCT04684511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25380547|NCT04684511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25380548|NCT04684511|Analgesics|analgesics|mesh-ancestor
25380549|NCT04684511|Sensory System Agents|sensory system agents|mesh-ancestor
25380550|NCT04684511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25380551|NCT04684511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380552|NCT04684511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25380553|NCT04684511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25380554|NCT04684368|Carboplatin|carboplatin|mesh-list
25380555|NCT04684368|Etoposide|etoposide|mesh-list
25380556|NCT04684368|Etoposide phosphate|etoposide phosphate|mesh-list
25380557|NCT04684368|Ifosfamide|ifosfamide|mesh-list
25380558|NCT04684368|Isophosphamide mustard|isophosphamide mustard|mesh-list
25380559|NCT04684368|Thiotepa|thiotepa|mesh-list
25380560|NCT04684368|Podophyllotoxin|podophyllotoxin|mesh-list
25380561|NCT04684368|Lenograstim|lenograstim|mesh-list
25380562|NCT04684368|Mesna|mesna|mesh-list
25380563|NCT04684368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380564|NCT04684368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25380565|NCT04684368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25380566|NCT04684368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25380567|NCT04684368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380568|NCT04684368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380569|NCT04684368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25380570|NCT04684368|Immunologic Factors|immunologic factors|mesh-ancestor
25380571|NCT04684368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380572|NCT04684368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25380573|NCT04684368|Alkylating Agents|alkylating agents|mesh-ancestor
25380574|NCT04684368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25380575|NCT04684368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25380576|NCT04684368|Protective Agents|protective agents|mesh-ancestor
25380577|NCT04684368|Keratolytic Agents|keratolytic agents|mesh-ancestor
25380578|NCT04684368|Dermatologic Agents|dermatologic agents|mesh-ancestor
25380579|NCT04684368|Tubulin Modulators|tubulin modulators|mesh-ancestor
25380580|NCT04684368|Antimitotic Agents|antimitotic agents|mesh-ancestor
25380581|NCT04684368|Mitosis Modulators|mitosis modulators|mesh-ancestor
25380582|NCT04684238|Midazolam|midazolam|mesh-list
25380583|NCT04684238|Isoflurane|isoflurane|mesh-list
25380584|NCT04684238|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25380585|NCT04684238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25380586|NCT04684238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25380587|NCT04684238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380588|NCT04684238|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25380589|NCT04684238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25380590|NCT04684238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25380591|NCT04684238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25380592|NCT04684238|Anesthetics, General|anesthetics, general|mesh-ancestor
25380593|NCT04684238|Anesthetics|anesthetics|mesh-ancestor
25380594|NCT04684238|GABA Modulators|gaba modulators|mesh-ancestor
25380595|NCT04684238|GABA Agents|gaba agents|mesh-ancestor
25380596|NCT04684238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25380597|NCT04684238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380598|NCT04684238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25380599|NCT04683965|Bevacizumab|bevacizumab|mesh-list
25380601|NCT04683965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380602|NCT04683965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380603|NCT04683965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25380604|NCT04683965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25380605|NCT04683965|Growth Substances|growth substances|mesh-ancestor
25380606|NCT04683965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380607|NCT04683965|Growth Inhibitors|growth inhibitors|mesh-ancestor
25380608|NCT04683965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380609|NCT04683965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380610|NCT04683965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25380611|NCT04683965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25380613|NCT04683939|Paclitaxel|paclitaxel|mesh-list
25380614|NCT04683939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25380615|NCT04683939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380616|NCT04683939|Tubulin Modulators|tubulin modulators|mesh-ancestor
25380617|NCT04683939|Antimitotic Agents|antimitotic agents|mesh-ancestor
25380618|NCT04683939|Mitosis Modulators|mitosis modulators|mesh-ancestor
25380619|NCT04683939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380620|NCT04683939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25380621|NCT04683939|Antimetabolites|antimetabolites|mesh-ancestor
25380622|NCT04683939|Antiviral Agents|antiviral agents|mesh-ancestor
25380623|NCT04683939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25380624|NCT04683939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380625|NCT04683939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25380626|NCT04683939|Immunologic Factors|immunologic factors|mesh-ancestor
25380627|NCT04683939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380628|NCT04683679|Pembrolizumab|pembrolizumab|mesh-list
25380629|NCT04683679|Olaparib|olaparib|mesh-list
25380630|NCT04683679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380631|NCT04683679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380632|NCT04683679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25380633|NCT04683679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380634|NCT04683679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380635|NCT04683627|Diclofenac|diclofenac|mesh-list
25380636|NCT04683627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25380637|NCT04683627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25380638|NCT04683627|Analgesics|analgesics|mesh-ancestor
25380639|NCT04683627|Sensory System Agents|sensory system agents|mesh-ancestor
25380640|NCT04683627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25380641|NCT04683627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380642|NCT04683627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25380643|NCT04683627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25380644|NCT04683627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25380645|NCT04683627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380646|NCT04683627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380647|NCT04683315|Gemcitabine|gemcitabine|mesh-list
25380648|NCT04683315|Paclitaxel|paclitaxel|mesh-list
25380649|NCT04683315|Fluorouracil|fluorouracil|mesh-list
25380650|NCT04683315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25380651|NCT04683315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380652|NCT04683315|Tubulin Modulators|tubulin modulators|mesh-ancestor
25380653|NCT04683315|Antimitotic Agents|antimitotic agents|mesh-ancestor
25380654|NCT04683315|Mitosis Modulators|mitosis modulators|mesh-ancestor
25380655|NCT04683315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380656|NCT04683315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25380657|NCT04683315|Antimetabolites|antimetabolites|mesh-ancestor
25380658|NCT04683315|Antiviral Agents|antiviral agents|mesh-ancestor
25380659|NCT04683315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25380660|NCT04683315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380661|NCT04683315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25380662|NCT04683315|Immunologic Factors|immunologic factors|mesh-ancestor
25380663|NCT04683315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380664|NCT04683029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25380665|NCT04683029|Immunologic Factors|immunologic factors|mesh-ancestor
25380666|NCT04683029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380667|NCT04682587|Pembrolizumab|pembrolizumab|mesh-list
25380668|NCT04682587|Avelumab|avelumab|mesh-list
25380669|NCT04682587|Axitinib|axitinib|mesh-list
25380670|NCT04682587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380671|NCT04682587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380672|NCT04682587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25380673|NCT04682587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380747|NCT04680052|Growth Substances|growth substances|mesh-ancestor
25380674|NCT04682587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380675|NCT04682353|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
25380676|NCT04682353|Medroxyprogesterone|medroxyprogesterone|mesh-list
25380677|NCT04682353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25380678|NCT04682353|Contraceptive Agents|contraceptive agents|mesh-ancestor
25380679|NCT04682353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25380680|NCT04682353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380681|NCT04682353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25380682|NCT04682353|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
25380683|NCT04682353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25380684|NCT04682353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380685|NCT04682353|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
25380686|NCT04682353|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
25380687|NCT04682353|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
25380688|NCT04682158|Paclitaxel|paclitaxel|mesh-list
25380689|NCT04682158|Carboplatin|carboplatin|mesh-list
25380690|NCT04682158|Propranolol|propranolol|mesh-list
25380691|NCT04682158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25380692|NCT04682158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380693|NCT04682158|Tubulin Modulators|tubulin modulators|mesh-ancestor
25380694|NCT04682158|Antimitotic Agents|antimitotic agents|mesh-ancestor
25380695|NCT04682158|Mitosis Modulators|mitosis modulators|mesh-ancestor
25380696|NCT04682158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380697|NCT04682158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25380698|NCT04682158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25380699|NCT04682158|Adrenergic Agents|adrenergic agents|mesh-ancestor
25380700|NCT04682158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25380701|NCT04682158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380702|NCT04682158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25380703|NCT04682158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25380704|NCT04682158|Vasodilator Agents|vasodilator agents|mesh-ancestor
25380705|NCT04681833|Vaccines|vaccines|mesh-list
25380706|NCT04681833|Immunologic Factors|immunologic factors|mesh-ancestor
25380707|NCT04681833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380708|NCT04681729|Histamine Antagonists|histamine antagonists|mesh-list
25380709|NCT04681729|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25380710|NCT04681729|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
25380711|NCT04681729|Histamine Agents|histamine agents|mesh-ancestor
25380712|NCT04681729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25380713|NCT04681729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380714|NCT04681729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380715|NCT04681469|Niraparib|niraparib|mesh-list
25380716|NCT04681469|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25380717|NCT04681469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380718|NCT04681469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380719|NCT04681469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380720|NCT04681287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
25380721|NCT04681287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380722|NCT04681287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380723|NCT04681144|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25380724|NCT04681144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380725|NCT04680975|Belumosudil|belumosudil|mesh-list
25380726|NCT04680975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25380727|NCT04680975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380728|NCT04680975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380729|NCT04680949|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25380730|NCT04680949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25380731|NCT04680910|Propofol|propofol|mesh-list
25380732|NCT04680910|Anesthetics|anesthetics|mesh-list
25380733|NCT04680910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25380734|NCT04680910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25380735|NCT04680910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380736|NCT04680910|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25380737|NCT04680910|Anesthetics, General|anesthetics, general|mesh-ancestor
25380738|NCT04680052|Rituximab|rituximab|mesh-list
25380739|NCT04680052|Lenalidomide|lenalidomide|mesh-list
25380740|NCT04680052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380741|NCT04680052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380742|NCT04680052|Immunologic Factors|immunologic factors|mesh-ancestor
25380743|NCT04680052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380744|NCT04680052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25380745|NCT04680052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25380746|NCT04680052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25380748|NCT04680052|Growth Inhibitors|growth inhibitors|mesh-ancestor
25380749|NCT04679376|Atorvastatin|atorvastatin|mesh-list
25380750|NCT04679376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25380751|NCT04679376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25380752|NCT04679376|Antimetabolites|antimetabolites|mesh-ancestor
25380753|NCT04679376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380754|NCT04679376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25380755|NCT04679376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25380756|NCT04679376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380757|NCT04678895|Naltrexone|naltrexone|mesh-list
25380758|NCT04678895|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25380759|NCT04678895|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25380760|NCT04678895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380761|NCT04678895|Sensory System Agents|sensory system agents|mesh-ancestor
25380762|NCT04678895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25380763|NCT04678362|Avelumab|avelumab|mesh-list
25380764|NCT04678362|Talazoparib|talazoparib|mesh-list
25380765|NCT04678362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380766|NCT04678362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380767|NCT04678362|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25380768|NCT04678362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380769|NCT04678362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380770|NCT04678154|Vancomycin|vancomycin|mesh-list
25380771|NCT04678154|Tobramycin|tobramycin|mesh-list
25380772|NCT04678154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25380773|NCT04678154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25380774|NCT04678050|Dexmedetomidine|dexmedetomidine|mesh-list
25380775|NCT04678050|Ketamine|ketamine|mesh-list
25380776|NCT04678050|Propofol|propofol|mesh-list
25380777|NCT04678050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25380778|NCT04678050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25380779|NCT04678050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380780|NCT04678050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25380781|NCT04678050|Anesthetics, General|anesthetics, general|mesh-ancestor
25380782|NCT04678050|Anesthetics|anesthetics|mesh-ancestor
25380783|NCT04678050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25380784|NCT04678050|Analgesics|analgesics|mesh-ancestor
25380785|NCT04678050|Sensory System Agents|sensory system agents|mesh-ancestor
25380786|NCT04678050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25380787|NCT04678050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25380788|NCT04678050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25380789|NCT04678050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25380790|NCT04678050|Adrenergic Agents|adrenergic agents|mesh-ancestor
25380791|NCT04678050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25380792|NCT04678050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380793|NCT04678050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25380794|NCT04678050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25380795|NCT04678050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25380796|NCT04677972|Ebselen|ebselen|mesh-list
25380797|NCT04677972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25380798|NCT04677972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25380799|NCT04677972|Analgesics|analgesics|mesh-ancestor
25380800|NCT04677972|Sensory System Agents|sensory system agents|mesh-ancestor
25380801|NCT04677972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25380802|NCT04677972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380803|NCT04677972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25380804|NCT04677972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25380805|NCT04677972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25380806|NCT04677972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25380807|NCT04677972|Antioxidants|antioxidants|mesh-ancestor
25380808|NCT04677972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380809|NCT04677972|Protective Agents|protective agents|mesh-ancestor
25380810|NCT04677972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25380811|NCT04677972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380812|NCT04677972|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25380813|NCT04677569|Azithromycin|azithromycin|mesh-list
25380814|NCT04677569|Amikacin|amikacin|mesh-list
25380815|NCT04677569|Ethambutol|ethambutol|mesh-list
25380816|NCT04677569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25380817|NCT04677569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25380818|NCT04677569|Antitubercular Agents|antitubercular agents|mesh-ancestor
25380819|NCT04677543|Azithromycin|azithromycin|mesh-list
25380820|NCT04677543|Amikacin|amikacin|mesh-list
25380821|NCT04677543|Ethambutol|ethambutol|mesh-list
25380822|NCT04677543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25380823|NCT04677543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25380824|NCT04677543|Antitubercular Agents|antitubercular agents|mesh-ancestor
25380825|NCT04677387|Naloxone|naloxone|mesh-list
25380826|NCT04677387|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25380827|NCT04677387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380828|NCT04677387|Sensory System Agents|sensory system agents|mesh-ancestor
25380829|NCT04677387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25380830|NCT04676646|Spironolactone|spironolactone|mesh-list
25380907|NCT04674683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380831|NCT04676646|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25380832|NCT04676646|Hormone Antagonists|hormone antagonists|mesh-ancestor
25380833|NCT04676646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25380834|NCT04676646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380835|NCT04676646|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25380836|NCT04676646|Diuretics|diuretics|mesh-ancestor
25380837|NCT04676646|Natriuretic Agents|natriuretic agents|mesh-ancestor
25380838|NCT04676412|Pembrolizumab|pembrolizumab|mesh-list
25380839|NCT04676412|Lenvatinib|lenvatinib|mesh-list
25380840|NCT04676412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380841|NCT04676412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380842|NCT04676412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25380843|NCT04676412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380844|NCT04676412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380845|NCT04676204|Teriflunomide|teriflunomide|mesh-list
25380846|NCT04676204|Cladribine|cladribine|mesh-list
25380847|NCT04676204|Dimethyl Fumarate|dimethyl fumarate|mesh-list
25380848|NCT04676204|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
25380849|NCT04676204|Ozanimod|ozanimod|mesh-list
25380850|NCT04676204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380851|NCT04676204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25380852|NCT04676204|Immunologic Factors|immunologic factors|mesh-ancestor
25380853|NCT04676204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380854|NCT04676204|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25380855|NCT04676204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380856|NCT04676204|Dermatologic Agents|dermatologic agents|mesh-ancestor
25380857|NCT04676204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25380858|NCT04676204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25380859|NCT04676204|Analgesics|analgesics|mesh-ancestor
25380860|NCT04676204|Sensory System Agents|sensory system agents|mesh-ancestor
25380861|NCT04676204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25380862|NCT04676204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25380863|NCT04676204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25380864|NCT04675931|Artesunate|artesunate|mesh-list
25380865|NCT04675931|Lumefantrine|lumefantrine|mesh-list
25380866|NCT04675931|Artemether|artemether|mesh-list
25380867|NCT04675931|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
25380868|NCT04675931|Antimalarials|antimalarials|mesh-ancestor
25380869|NCT04675931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25380870|NCT04675931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25380871|NCT04675931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25380872|NCT04675931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380873|NCT04675931|Antiviral Agents|antiviral agents|mesh-ancestor
25380874|NCT04675931|Schistosomicides|schistosomicides|mesh-ancestor
25380875|NCT04675931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
25380876|NCT04675931|Anthelmintics|anthelmintics|mesh-ancestor
25380877|NCT04675788|Ibutilide|ibutilide|mesh-list
25380878|NCT04675788|Testosterone|testosterone|mesh-list
25380879|NCT04675788|Progesterone|progesterone|mesh-list
25380880|NCT04675788|Androgens|androgens|mesh-ancestor
25380881|NCT04675788|Hormones|hormones|mesh-ancestor
25380882|NCT04675788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25380883|NCT04675788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380884|NCT04675788|Progestins|progestins|mesh-ancestor
25380885|NCT04675788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25380886|NCT04675710|Pembrolizumab|pembrolizumab|mesh-list
25380887|NCT04675710|Trametinib|trametinib|mesh-list
25380888|NCT04675710|Dabrafenib|dabrafenib|mesh-list
25380889|NCT04675710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380890|NCT04675710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380891|NCT04675710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25380892|NCT04675710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380893|NCT04675710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380894|NCT04674813|Cyclophosphamide|cyclophosphamide|mesh-list
25380895|NCT04674813|Fludarabine|fludarabine|mesh-list
25380896|NCT04674813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25380897|NCT04674813|Immunologic Factors|immunologic factors|mesh-ancestor
25380898|NCT04674813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380899|NCT04674813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25380900|NCT04674813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25380901|NCT04674813|Alkylating Agents|alkylating agents|mesh-ancestor
25380902|NCT04674813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380903|NCT04674813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380904|NCT04674813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25380905|NCT04674683|Nivolumab|nivolumab|mesh-list
25380906|NCT04674683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25380908|NCT04674683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25380909|NCT04674683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380910|NCT04673578|Celecoxib|celecoxib|mesh-list
25380911|NCT04673578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25380912|NCT04673578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25380913|NCT04673578|Analgesics|analgesics|mesh-ancestor
25380914|NCT04673578|Sensory System Agents|sensory system agents|mesh-ancestor
25380915|NCT04673578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25380916|NCT04673578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380917|NCT04673578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25380918|NCT04673578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25380919|NCT04673578|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
25380920|NCT04673578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25380921|NCT04673578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380922|NCT04673578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380923|NCT04673448|Niraparib|niraparib|mesh-list
25380924|NCT04673448|Immunoglobulins|immunoglobulins|mesh-list
25380925|NCT04673448|Immunoglobulin G|immunoglobulin g|mesh-list
25380926|NCT04673448|Immunologic Factors|immunologic factors|mesh-ancestor
25380927|NCT04673448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380928|NCT04673448|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25380929|NCT04673448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380930|NCT04673448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380931|NCT04673448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380932|NCT04673383|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
25380933|NCT04673383|Hallucinogens|hallucinogens|mesh-ancestor
25380934|NCT04673383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380935|NCT04673383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25380936|NCT04673383|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25380937|NCT04673383|Serotonin Agents|serotonin agents|mesh-ancestor
25380938|NCT04673383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25380939|NCT04673383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380940|NCT04673383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25380941|NCT04673357|Ustekinumab|ustekinumab|mesh-list
25380942|NCT04673357|Dermatologic Agents|dermatologic agents|mesh-ancestor
25380943|NCT04673175|Tazobactam|tazobactam|mesh-list
25380944|NCT04673175|Ceftolozane|ceftolozane|mesh-list
25380945|NCT04673175|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
25380946|NCT04673175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25380947|NCT04673175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25380948|NCT04673175|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25380949|NCT04673175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380950|NCT04673175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380951|NCT04673175|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
25380952|NCT04673175|Renal Agents|renal agents|mesh-ancestor
25380953|NCT04672941|Bromides|bromides|mesh-list
25380954|NCT04672941|Tiotropium Bromide|tiotropium bromide|mesh-list
25380955|NCT04672941|Olodaterol|olodaterol|mesh-list
25380956|NCT04672941|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
25380957|NCT04672941|Autonomic Agents|autonomic agents|mesh-ancestor
25380958|NCT04672941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25380959|NCT04672941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380960|NCT04672941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25380961|NCT04672941|Respiratory System Agents|respiratory system agents|mesh-ancestor
25380962|NCT04672941|Parasympatholytics|parasympatholytics|mesh-ancestor
25380963|NCT04672941|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25380964|NCT04672941|Cholinergic Agents|cholinergic agents|mesh-ancestor
25380965|NCT04672941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25380966|NCT04672941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380967|NCT04672941|Anticonvulsants|anticonvulsants|mesh-ancestor
25380968|NCT04672460|Talazoparib|talazoparib|mesh-list
25380969|NCT04672460|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25380970|NCT04672460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380971|NCT04672460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380972|NCT04672460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380973|NCT04672395|Vaccines|vaccines|mesh-list
25380974|NCT04672395|1018 oligonucleotide|1018 oligonucleotide|mesh-list
25380975|NCT04672395|Immunologic Factors|immunologic factors|mesh-ancestor
25380981|NCT04672005|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25380982|NCT04672005|Oxaliplatin|oxaliplatin|mesh-list
25380983|NCT04672005|Irinotecan|irinotecan|mesh-list
25380984|NCT04672005|Folfirinox|folfirinox|mesh-list
25380985|NCT04672005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25380986|NCT04672005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25380987|NCT04672005|Tubulin Modulators|tubulin modulators|mesh-ancestor
25380988|NCT04672005|Antimitotic Agents|antimitotic agents|mesh-ancestor
25380989|NCT04672005|Mitosis Modulators|mitosis modulators|mesh-ancestor
25380990|NCT04672005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25380991|NCT04672005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25380992|NCT04672005|Antimetabolites|antimetabolites|mesh-ancestor
25380993|NCT04672005|Antiviral Agents|antiviral agents|mesh-ancestor
25380994|NCT04672005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25380995|NCT04672005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25380996|NCT04672005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25380997|NCT04672005|Immunologic Factors|immunologic factors|mesh-ancestor
25380998|NCT04672005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25380999|NCT04672005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25381000|NCT04672005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25381001|NCT04672005|Antidotes|antidotes|mesh-ancestor
25381002|NCT04672005|Protective Agents|protective agents|mesh-ancestor
25381003|NCT04672005|Vitamin B Complex|vitamin b complex|mesh-ancestor
25381004|NCT04672005|Vitamins|vitamins|mesh-ancestor
25381005|NCT04672005|Micronutrients|micronutrients|mesh-ancestor
25381011|NCT04671043|Caffeine|caffeine|mesh-list
25381012|NCT04671043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
25381013|NCT04671043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381014|NCT04671043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25381015|NCT04671043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381016|NCT04671043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381017|NCT04671043|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
25381018|NCT04671043|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25381019|NCT04671043|Purinergic Agents|purinergic agents|mesh-ancestor
25381020|NCT04671043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25381021|NCT04670666|Metformin|metformin|mesh-list
25381022|NCT04670666|Empagliflozin|empagliflozin|mesh-list
25381023|NCT04670666|Linagliptin|linagliptin|mesh-list
25381024|NCT04670666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25381025|NCT04670666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381026|NCT04670666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25381027|NCT04670666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381028|NCT04670666|Incretins|incretins|mesh-ancestor
25381029|NCT04670666|Hormones|hormones|mesh-ancestor
25381030|NCT04670666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25381031|NCT04670666|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
25381032|NCT04670666|Protease Inhibitors|protease inhibitors|mesh-ancestor
25381033|NCT04670666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381034|NCT04670653|Mometasone Furoate|mometasone furoate|mesh-list
25381035|NCT04670653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25381036|NCT04670653|Dermatologic Agents|dermatologic agents|mesh-ancestor
25381037|NCT04670653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25381038|NCT04669665|Ketamine|ketamine|mesh-list
25381039|NCT04669665|Analgesics|analgesics|mesh-ancestor
25381040|NCT04669665|Sensory System Agents|sensory system agents|mesh-ancestor
25381041|NCT04669665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25381042|NCT04669665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381043|NCT04669665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25381044|NCT04669665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25381045|NCT04669665|Anesthetics, General|anesthetics, general|mesh-ancestor
25381046|NCT04669665|Anesthetics|anesthetics|mesh-ancestor
25381047|NCT04669665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25381048|NCT04669665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25381049|NCT04669665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25381050|NCT04669665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25381051|NCT04669665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381052|NCT04669171|Rituximab|rituximab|mesh-list
25381057|NCT04669171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381059|NCT04669171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25381060|NCT04669171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25381061|NCT04669171|Growth Substances|growth substances|mesh-ancestor
25381062|NCT04669171|Growth Inhibitors|growth inhibitors|mesh-ancestor
25381063|NCT04668274|Resveratrol|resveratrol|mesh-list
25381064|NCT04668274|Antioxidants|antioxidants|mesh-ancestor
25381065|NCT04668274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381066|NCT04668274|Protective Agents|protective agents|mesh-ancestor
25381067|NCT04668274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381068|NCT04668274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381069|NCT04668274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25381074|NCT04667585|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
25381075|NCT04667585|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25381076|NCT04667585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381077|NCT04667572|Riboflavin|riboflavin|mesh-list
25381078|NCT04667572|Vitamin B Complex|vitamin b complex|mesh-ancestor
25381079|NCT04667572|Vitamins|vitamins|mesh-ancestor
25381080|NCT04667572|Micronutrients|micronutrients|mesh-ancestor
25381081|NCT04667572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381082|NCT04667572|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
25381083|NCT04667572|Dermatologic Agents|dermatologic agents|mesh-ancestor
25381084|NCT04667312|Durvalumab|durvalumab|mesh-list
25381085|NCT04667312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25381086|NCT04667312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381087|NCT04667104|Tenofovir|tenofovir|mesh-list
25381088|NCT04667104|Entecavir|entecavir|mesh-list
25381089|NCT04667104|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25381090|NCT04667104|Antiviral Agents|antiviral agents|mesh-ancestor
25381091|NCT04667104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25381092|NCT04667104|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25381093|NCT04667104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25381094|NCT04667104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381095|NCT04667104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381096|NCT04667104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25381097|NCT04667104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25381098|NCT04667039|Ranibizumab|ranibizumab|mesh-list
25381099|NCT04667039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25381100|NCT04667039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25381101|NCT04667039|Growth Substances|growth substances|mesh-ancestor
25381102|NCT04667039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381103|NCT04667039|Growth Inhibitors|growth inhibitors|mesh-ancestor
25381104|NCT04667039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381105|NCT04666714|Pregabalin|pregabalin|mesh-list
25381106|NCT04666714|Analgesics|analgesics|mesh-ancestor
25381107|NCT04666714|Sensory System Agents|sensory system agents|mesh-ancestor
25381108|NCT04666714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25381109|NCT04666714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381110|NCT04666714|Anticonvulsants|anticonvulsants|mesh-ancestor
25381111|NCT04666714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25381112|NCT04666714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25381113|NCT04666714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381114|NCT04666714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25381115|NCT04666714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25381116|NCT04666714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25381117|NCT04666714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25381118|NCT04666714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25381119|NCT04666701|Ketorolac|ketorolac|mesh-list
25381120|NCT04666701|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
25381121|NCT04666701|Scopolamine|scopolamine|mesh-list
25381122|NCT04666701|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
25381123|NCT04666701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25381124|NCT04666701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25381125|NCT04666701|Analgesics|analgesics|mesh-ancestor
25381126|NCT04666701|Sensory System Agents|sensory system agents|mesh-ancestor
25381127|NCT04666701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25381128|NCT04666701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381129|NCT04666701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25381130|NCT04666701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25381131|NCT04666701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25381132|NCT04666701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381211|NCT04665570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25381133|NCT04666701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381134|NCT04666701|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25381135|NCT04666701|Antiemetics|antiemetics|mesh-ancestor
25381136|NCT04666701|Autonomic Agents|autonomic agents|mesh-ancestor
25381137|NCT04666701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25381138|NCT04666701|Mydriatics|mydriatics|mesh-ancestor
25381139|NCT04666701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25381140|NCT04666701|Cholinergic Agents|cholinergic agents|mesh-ancestor
25381141|NCT04666701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25381142|NCT04666701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25381143|NCT04666701|Parasympatholytics|parasympatholytics|mesh-ancestor
25381144|NCT04666129|Prednisone|prednisone|mesh-list
25381145|NCT04666129|Methylprednisolone|methylprednisolone|mesh-list
25381146|NCT04666129|Docetaxel|docetaxel|mesh-list
25381147|NCT04666129|Relugolix|relugolix|mesh-list
25381148|NCT04666129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381149|NCT04666129|Tubulin Modulators|tubulin modulators|mesh-ancestor
25381150|NCT04666129|Antimitotic Agents|antimitotic agents|mesh-ancestor
25381151|NCT04666129|Mitosis Modulators|mitosis modulators|mesh-ancestor
25381152|NCT04666129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381153|NCT04666129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25381154|NCT04666129|Glucocorticoids|glucocorticoids|mesh-ancestor
25381155|NCT04666129|Hormones|hormones|mesh-ancestor
25381156|NCT04666129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25381157|NCT04666129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381158|NCT04666129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25381159|NCT04666129|Antiemetics|antiemetics|mesh-ancestor
25381160|NCT04666129|Autonomic Agents|autonomic agents|mesh-ancestor
25381161|NCT04666129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25381162|NCT04666129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25381163|NCT04666129|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25381164|NCT04666129|Protective Agents|protective agents|mesh-ancestor
25381165|NCT04666129|Androgen Antagonists|androgen antagonists|mesh-ancestor
25381166|NCT04666129|Hormone Antagonists|hormone antagonists|mesh-ancestor
25381167|NCT04666051|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
25381168|NCT04666051|Hemostatics|hemostatics|mesh-ancestor
25381169|NCT04666051|Coagulants|coagulants|mesh-ancestor
25381170|NCT04666038|Rituximab|rituximab|mesh-list
25381171|NCT04666038|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25381172|NCT04666038|Idelalisib|idelalisib|mesh-list
25381173|NCT04666038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25381174|NCT04666038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381175|NCT04666038|Immunologic Factors|immunologic factors|mesh-ancestor
25381176|NCT04666038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381177|NCT04666038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25381178|NCT04666038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25381179|NCT04666038|Alkylating Agents|alkylating agents|mesh-ancestor
25381180|NCT04666038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381181|NCT04666038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381182|NCT04665856|Carboplatin|carboplatin|mesh-list
25381183|NCT04665856|Etoposide|etoposide|mesh-list
25381184|NCT04665856|Atezolizumab|atezolizumab|mesh-list
25381185|NCT04665856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381186|NCT04665856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25381187|NCT04665856|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25381188|NCT04665856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25381189|NCT04665856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381190|NCT04665856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381191|NCT04665843|Atezolizumab|atezolizumab|mesh-list
25381192|NCT04665843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381193|NCT04665739|Everolimus|everolimus|mesh-list
25381194|NCT04665739|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25381195|NCT04665739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381196|NCT04665739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25381197|NCT04665739|Immunologic Factors|immunologic factors|mesh-ancestor
25381198|NCT04665739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381199|NCT04665739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381200|NCT04665739|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25381201|NCT04665648|Nicorandil|nicorandil|mesh-list
25381202|NCT04665648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25381203|NCT04665648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25381204|NCT04665648|Vasodilator Agents|vasodilator agents|mesh-ancestor
25381205|NCT04665648|Vitamin B Complex|vitamin b complex|mesh-ancestor
25381206|NCT04665648|Vitamins|vitamins|mesh-ancestor
25381207|NCT04665648|Micronutrients|micronutrients|mesh-ancestor
25381208|NCT04665648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381209|NCT04665570|Metformin|metformin|mesh-list
25381210|NCT04665570|Acarbose|acarbose|mesh-list
25381212|NCT04665570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381213|NCT04665570|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
25381214|NCT04665570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381215|NCT04665570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381216|NCT04664959|Denosumab|denosumab|mesh-list
25381217|NCT04664959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25381218|NCT04664959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381219|NCT04664933|Neuroprotective Agents|neuroprotective agents|mesh-list
25381220|NCT04664933|Protective Agents|protective agents|mesh-ancestor
25381221|NCT04664933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381222|NCT04663997|Docetaxel|docetaxel|mesh-list
25381223|NCT04663997|177Lu-PSMA-617|177lu-psma-617|mesh-list
25381224|NCT04663997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381225|NCT04663997|Tubulin Modulators|tubulin modulators|mesh-ancestor
25381226|NCT04663997|Antimitotic Agents|antimitotic agents|mesh-ancestor
25381227|NCT04663997|Mitosis Modulators|mitosis modulators|mesh-ancestor
25381228|NCT04663997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381229|NCT04663997|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25381230|NCT04663750|Aflibercept|aflibercept|mesh-list
25381231|NCT04663750|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25381232|NCT04663750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25381233|NCT04663750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25381234|NCT04663750|Growth Substances|growth substances|mesh-ancestor
25381235|NCT04663750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381236|NCT04663750|Growth Inhibitors|growth inhibitors|mesh-ancestor
25381237|NCT04663750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381238|NCT04663750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25381239|NCT04663750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25381240|NCT04663750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381241|NCT04663308|Volixibat|volixibat|mesh-list
25381242|NCT04663308|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25381243|NCT04662944|Ranibizumab|ranibizumab|mesh-list
25381244|NCT04662944|Aflibercept|aflibercept|mesh-list
25381245|NCT04662944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25381246|NCT04662944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25381247|NCT04662944|Growth Substances|growth substances|mesh-ancestor
25381248|NCT04662944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381249|NCT04662944|Growth Inhibitors|growth inhibitors|mesh-ancestor
25381250|NCT04662944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381251|NCT04662710|Leucovorin|leucovorin|mesh-list
25381252|NCT04662710|Pembrolizumab|pembrolizumab|mesh-list
25381253|NCT04662710|Capecitabine|capecitabine|mesh-list
25381254|NCT04662710|Oxaliplatin|oxaliplatin|mesh-list
25381255|NCT04662710|Lenvatinib|lenvatinib|mesh-list
25381256|NCT04662710|Levoleucovorin|levoleucovorin|mesh-list
25381257|NCT04662710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25381258|NCT04662710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381259|NCT04662710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25381260|NCT04662710|Antimetabolites|antimetabolites|mesh-ancestor
25381261|NCT04662710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381262|NCT04662710|Antidotes|antidotes|mesh-ancestor
25381263|NCT04662710|Protective Agents|protective agents|mesh-ancestor
25381264|NCT04662710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381265|NCT04662710|Vitamin B Complex|vitamin b complex|mesh-ancestor
25381266|NCT04662710|Vitamins|vitamins|mesh-ancestor
25381267|NCT04662710|Micronutrients|micronutrients|mesh-ancestor
25381268|NCT04662710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25381269|NCT04662710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381270|NCT04662255|Acalabrutinib|acalabrutinib|mesh-list
25381271|NCT04662255|Zanubrutinib|zanubrutinib|mesh-list
25381272|NCT04662255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381273|NCT04662255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25381274|NCT04662255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381275|NCT04662255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381276|NCT04662086|Camostat|camostat|mesh-list
25381277|NCT04662086|Protease Inhibitors|protease inhibitors|mesh-ancestor
25381278|NCT04662086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381279|NCT04662086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381280|NCT04662086|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
25381281|NCT04662086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25381282|NCT04661683|Charcoal|charcoal|mesh-list
25412603|NCT03190915|Trametinib|trametinib|mesh-list
25381283|NCT04661683|Antidotes|antidotes|mesh-ancestor
25381284|NCT04661683|Protective Agents|protective agents|mesh-ancestor
25381285|NCT04661683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381286|NCT04661397|Tenofovir|tenofovir|mesh-list
25381287|NCT04661397|Emtricitabine|emtricitabine|mesh-list
25381288|NCT04661397|Darunavir|darunavir|mesh-list
25381440|NCT04657081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25381289|NCT04661397|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25381290|NCT04661397|Cobicistat|cobicistat|mesh-list
25381291|NCT04661397|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25381292|NCT04661397|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
25381293|NCT04661397|Antiviral Agents|antiviral agents|mesh-ancestor
25381294|NCT04661397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25381295|NCT04661397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25381296|NCT04661397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25381297|NCT04661397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381298|NCT04661397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381299|NCT04661397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25381300|NCT04661397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25381301|NCT04661397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
25381302|NCT04661397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
25381303|NCT04661397|Protease Inhibitors|protease inhibitors|mesh-ancestor
25381304|NCT04661397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25381305|NCT04661397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25381306|NCT04661358|Fenofibrate|fenofibrate|mesh-list
25381307|NCT04661358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25381308|NCT04661358|Antimetabolites|antimetabolites|mesh-ancestor
25381309|NCT04661358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381310|NCT04661358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25381311|NCT04661150|Capecitabine|capecitabine|mesh-list
25381312|NCT04661150|Oxaliplatin|oxaliplatin|mesh-list
25381313|NCT04661150|Trastuzumab|trastuzumab|mesh-list
25381314|NCT04661150|Atezolizumab|atezolizumab|mesh-list
25381315|NCT04661150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25381316|NCT04661150|Antimetabolites|antimetabolites|mesh-ancestor
25381317|NCT04661150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381318|NCT04661150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381319|NCT04661150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25381320|NCT04661007|Lenalidomide|lenalidomide|mesh-list
25381321|NCT04661007|Immunologic Factors|immunologic factors|mesh-ancestor
25381322|NCT04661007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381323|NCT04661007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25381324|NCT04661007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25381325|NCT04661007|Growth Substances|growth substances|mesh-ancestor
25381326|NCT04661007|Growth Inhibitors|growth inhibitors|mesh-ancestor
25381327|NCT04661007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381328|NCT04660812|Bevacizumab|bevacizumab|mesh-list
25381329|NCT04660812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25381330|NCT04660812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381331|NCT04660812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25381332|NCT04660812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25381333|NCT04660812|Growth Substances|growth substances|mesh-ancestor
25381334|NCT04660812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381335|NCT04660812|Growth Inhibitors|growth inhibitors|mesh-ancestor
25381336|NCT04660539|Mycophenolic Acid|mycophenolic acid|mesh-list
25381337|NCT04660539|Azathioprine|azathioprine|mesh-list
25381338|NCT04660539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25381339|NCT04660539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381340|NCT04660539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25381341|NCT04660539|Antitubercular Agents|antitubercular agents|mesh-ancestor
25381342|NCT04660539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25381343|NCT04660539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25381344|NCT04660539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381345|NCT04660539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381346|NCT04660539|Antimetabolites|antimetabolites|mesh-ancestor
25381347|NCT04660539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25381348|NCT04660539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25381349|NCT04660539|Immunologic Factors|immunologic factors|mesh-ancestor
25381350|NCT04660539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381351|NCT04660539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25381352|NCT04660344|Atezolizumab|atezolizumab|mesh-list
25381353|NCT04660344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381354|NCT04659629|Pembrolizumab|pembrolizumab|mesh-list
25724252|NCT02536105|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25381355|NCT04659629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25381356|NCT04659629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381357|NCT04659603|Maytansine|maytansine|mesh-list
25381358|NCT04659603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25381359|NCT04659603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381360|NCT04659603|Tubulin Modulators|tubulin modulators|mesh-ancestor
25381361|NCT04659603|Antimitotic Agents|antimitotic agents|mesh-ancestor
25381362|NCT04659603|Mitosis Modulators|mitosis modulators|mesh-ancestor
25381363|NCT04659603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381364|NCT04659278|Peppermint oil|peppermint oil|mesh-list
25381365|NCT04659278|Antiemetics|antiemetics|mesh-ancestor
25381366|NCT04659278|Autonomic Agents|autonomic agents|mesh-ancestor
25381367|NCT04659278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25381368|NCT04659278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381369|NCT04659278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25381370|NCT04659278|Parasympatholytics|parasympatholytics|mesh-ancestor
25381371|NCT04659044|Rituximab|rituximab|mesh-list
25381372|NCT04659044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25381373|NCT04659044|Venetoclax|venetoclax|mesh-list
25381374|NCT04659044|Antibodies|antibodies|mesh-list
25381375|NCT04659044|Immunoglobulins|immunoglobulins|mesh-list
25381376|NCT04659044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25381377|NCT04659044|Immunoconjugates|immunoconjugates|mesh-list
25381378|NCT04659044|Immunologic Factors|immunologic factors|mesh-ancestor
25381379|NCT04659044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381380|NCT04659044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381381|NCT04659044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25381382|NCT04658927|Dexamethasone|dexamethasone|mesh-list
25381383|NCT04658927|Prednisone|prednisone|mesh-list
25381384|NCT04658927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25381385|NCT04658927|Antiemetics|antiemetics|mesh-ancestor
25381386|NCT04658927|Autonomic Agents|autonomic agents|mesh-ancestor
25381387|NCT04658927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25381388|NCT04658927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381389|NCT04658927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25381390|NCT04658927|Glucocorticoids|glucocorticoids|mesh-ancestor
25381391|NCT04658927|Hormones|hormones|mesh-ancestor
25381392|NCT04658927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25381393|NCT04658927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25381394|NCT04658927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381395|NCT04658862|Gemcitabine|gemcitabine|mesh-list
25381396|NCT04658862|Cisplatin|cisplatin|mesh-list
25381397|NCT04658862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381398|NCT04658862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25381399|NCT04658862|Antimetabolites|antimetabolites|mesh-ancestor
25381400|NCT04658862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381401|NCT04658862|Antiviral Agents|antiviral agents|mesh-ancestor
25381402|NCT04658862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25381403|NCT04658862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381404|NCT04658862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25381405|NCT04658862|Immunologic Factors|immunologic factors|mesh-ancestor
25381406|NCT04658862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381407|NCT04658836|Triamcinolone|triamcinolone|mesh-list
25381408|NCT04658836|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25381409|NCT04658836|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25381410|NCT04658836|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25381411|NCT04658836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25381412|NCT04658836|Glucocorticoids|glucocorticoids|mesh-ancestor
25381413|NCT04658836|Hormones|hormones|mesh-ancestor
25381414|NCT04658836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25381415|NCT04658836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381416|NCT04658836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25381417|NCT04658836|Immunologic Factors|immunologic factors|mesh-ancestor
25381418|NCT04658836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381419|NCT04658836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381420|NCT04658160|Imidacloprid|imidacloprid|mesh-list
25381421|NCT04658160|Cholinergic Agents|cholinergic agents|mesh-ancestor
25381422|NCT04658160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25381423|NCT04658160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381424|NCT04658160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381425|NCT04657991|Pembrolizumab|pembrolizumab|mesh-list
25381426|NCT04657991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25381427|NCT04657991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25724253|NCT02536105|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25381433|NCT04657289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25381434|NCT04657289|Growth Substances|growth substances|mesh-ancestor
25381435|NCT04657289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381436|NCT04657289|Growth Inhibitors|growth inhibitors|mesh-ancestor
25381437|NCT04657289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381438|NCT04657081|Decitabine|decitabine|mesh-list
25381439|NCT04657081|Venetoclax|venetoclax|mesh-list
25381441|NCT04657081|Antimetabolites|antimetabolites|mesh-ancestor
25381442|NCT04657081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381443|NCT04657081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381444|NCT04657081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381445|NCT04656652|Docetaxel|docetaxel|mesh-list
25381446|NCT04656652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381447|NCT04656652|Tubulin Modulators|tubulin modulators|mesh-ancestor
25381448|NCT04656652|Antimitotic Agents|antimitotic agents|mesh-ancestor
25381449|NCT04656652|Mitosis Modulators|mitosis modulators|mesh-ancestor
25381450|NCT04656652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381451|NCT04656301|Psilocybin|psilocybin|mesh-list
25381452|NCT04656301|Hallucinogens|hallucinogens|mesh-ancestor
25381453|NCT04656301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381454|NCT04656301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25381455|NCT04656145|Chlorhexidine|chlorhexidine|mesh-list
25381456|NCT04656145|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
25381457|NCT04656145|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25381458|NCT04656145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25381459|NCT04656145|Disinfectants|disinfectants|mesh-ancestor
25381460|NCT04656145|Dermatologic Agents|dermatologic agents|mesh-ancestor
25381461|NCT04656041|Paclitaxel|paclitaxel|mesh-list
25381462|NCT04656041|Carboplatin|carboplatin|mesh-list
25381463|NCT04656041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25381464|NCT04656041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381465|NCT04656041|Tubulin Modulators|tubulin modulators|mesh-ancestor
25381466|NCT04656041|Antimitotic Agents|antimitotic agents|mesh-ancestor
25381467|NCT04656041|Mitosis Modulators|mitosis modulators|mesh-ancestor
25381468|NCT04656041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381469|NCT04655755|Decitabine|decitabine|mesh-list
25381470|NCT04655755|Venetoclax|venetoclax|mesh-list
25381471|NCT04655755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25381472|NCT04655755|Antimetabolites|antimetabolites|mesh-ancestor
25381473|NCT04655755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381474|NCT04655755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381475|NCT04655755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381476|NCT04655482|Aflibercept|aflibercept|mesh-list
25381477|NCT04655482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25381478|NCT04655482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25381479|NCT04655482|Growth Substances|growth substances|mesh-ancestor
25381480|NCT04655482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381481|NCT04655482|Growth Inhibitors|growth inhibitors|mesh-ancestor
25381482|NCT04655482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381483|NCT04654689|Curcumin|curcumin|mesh-list
25381484|NCT04654689|Resveratrol|resveratrol|mesh-list
25381485|NCT04654689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25381486|NCT04654689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25381487|NCT04654689|Analgesics|analgesics|mesh-ancestor
25381488|NCT04654689|Sensory System Agents|sensory system agents|mesh-ancestor
25381489|NCT04654689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25381490|NCT04654689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381491|NCT04654689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25381492|NCT04654689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25381493|NCT04654689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381494|NCT04654689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381495|NCT04654689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381496|NCT04654689|Antioxidants|antioxidants|mesh-ancestor
25381497|NCT04654689|Protective Agents|protective agents|mesh-ancestor
25381498|NCT04654689|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25381499|NCT04654052|Clopidogrel|clopidogrel|mesh-list
25381500|NCT04654052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25381501|NCT04654052|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
25381502|NCT04654052|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
25381503|NCT04654052|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
25381504|NCT04654052|Purinergic Agents|purinergic agents|mesh-ancestor
25381505|NCT04654052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25381506|NCT04654052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381507|NCT04654052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381508|NCT04653831|Pirfenidone|pirfenidone|mesh-list
25381509|NCT04653831|Analgesics|analgesics|mesh-ancestor
25381510|NCT04653831|Sensory System Agents|sensory system agents|mesh-ancestor
25381511|NCT04653831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25381512|NCT04653831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381513|NCT04653831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25381514|NCT04653831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25381515|NCT04653831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25381516|NCT04653831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25381517|NCT04653831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381518|NCT04653246|Dexamethasone|dexamethasone|mesh-list
25381519|NCT04653246|Lenalidomide|lenalidomide|mesh-list
25381520|NCT04653246|Bortezomib|bortezomib|mesh-list
25381521|NCT04653246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25381522|NCT04653246|Antiemetics|antiemetics|mesh-ancestor
25381523|NCT04653246|Autonomic Agents|autonomic agents|mesh-ancestor
25381524|NCT04653246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25381525|NCT04653246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381526|NCT04653246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25381527|NCT04653246|Glucocorticoids|glucocorticoids|mesh-ancestor
25381528|NCT04653246|Hormones|hormones|mesh-ancestor
25381529|NCT04653246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25381530|NCT04653246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25381531|NCT04653246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381532|NCT04653246|Immunologic Factors|immunologic factors|mesh-ancestor
25381533|NCT04653246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25381534|NCT04653246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25381535|NCT04653246|Growth Substances|growth substances|mesh-ancestor
25381536|NCT04653246|Growth Inhibitors|growth inhibitors|mesh-ancestor
25381537|NCT04652960|Nivolumab|nivolumab|mesh-list
25381538|NCT04652960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25381539|NCT04652960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381540|NCT04652960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25381541|NCT04652960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381542|NCT04652700|Tenofovir|tenofovir|mesh-list
25381543|NCT04652700|Emtricitabine|emtricitabine|mesh-list
25381544|NCT04652700|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25381545|NCT04652700|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25381546|NCT04652700|Antiviral Agents|antiviral agents|mesh-ancestor
25381547|NCT04652700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25381548|NCT04652700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25381549|NCT04652700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25381550|NCT04652700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381551|NCT04652700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381552|NCT04652700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25381553|NCT04652700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25381554|NCT04652544|Vitamin D|vitamin d|mesh-list
25381555|NCT04652544|Cholecalciferol|cholecalciferol|mesh-list
25381556|NCT04652544|Vitamins|vitamins|mesh-ancestor
25381557|NCT04652544|Micronutrients|micronutrients|mesh-ancestor
25381558|NCT04652544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381559|NCT04652544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25381560|NCT04652544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25381561|NCT04652518|Pirfenidone|pirfenidone|mesh-list
25381562|NCT04652518|Analgesics|analgesics|mesh-ancestor
25381563|NCT04652518|Sensory System Agents|sensory system agents|mesh-ancestor
25381564|NCT04652518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25381565|NCT04652518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381566|NCT04652518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25381567|NCT04652518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25381568|NCT04652518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25381569|NCT04652518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25381570|NCT04652518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381571|NCT04652414|Prednisone|prednisone|mesh-list
25381572|NCT04652414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25381573|NCT04652414|Glucocorticoids|glucocorticoids|mesh-ancestor
25381574|NCT04652414|Hormones|hormones|mesh-ancestor
25381575|NCT04652414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25381576|NCT04652414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381577|NCT04652414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25381578|NCT04652414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381579|NCT04652076|Paclitaxel|paclitaxel|mesh-list
25381580|NCT04652076|Carboplatin|carboplatin|mesh-list
25381581|NCT04652076|Pembrolizumab|pembrolizumab|mesh-list
25381582|NCT04652076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25381583|NCT04652076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381584|NCT04652076|Tubulin Modulators|tubulin modulators|mesh-ancestor
25381586|NCT04652076|Mitosis Modulators|mitosis modulators|mesh-ancestor
25381587|NCT04652076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381588|NCT04652076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25381589|NCT04651400|Antithrombins|antithrombins|mesh-list
25381590|NCT04651400|Antithrombin III|antithrombin iii|mesh-list
25381591|NCT04651400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25381592|NCT04651400|Protease Inhibitors|protease inhibitors|mesh-ancestor
25381593|NCT04651400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381594|NCT04651400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381595|NCT04651400|Anticoagulants|anticoagulants|mesh-ancestor
25381596|NCT04651348|Antibodies|antibodies|mesh-list
25381597|NCT04651348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25381598|NCT04651348|Immunologic Factors|immunologic factors|mesh-ancestor
25381599|NCT04651348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381600|NCT04650698|Tranexamic Acid|tranexamic acid|mesh-list
25381601|NCT04650698|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25381602|NCT04650698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25381603|NCT04650698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381604|NCT04650698|Hemostatics|hemostatics|mesh-ancestor
25381605|NCT04650698|Coagulants|coagulants|mesh-ancestor
25381606|NCT04650581|Fulvestrant|fulvestrant|mesh-list
25381607|NCT04650581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25381608|NCT04650581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381609|NCT04650581|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25381610|NCT04650581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25381611|NCT04650581|Hormone Antagonists|hormone antagonists|mesh-ancestor
25381612|NCT04650581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25381613|NCT04650581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381614|NCT04650282|Lidocaine|lidocaine|mesh-list
25381615|NCT04650282|Anesthetics, Local|anesthetics, local|mesh-ancestor
25381616|NCT04650282|Anesthetics|anesthetics|mesh-ancestor
25381617|NCT04650282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25381618|NCT04650282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381619|NCT04650282|Sensory System Agents|sensory system agents|mesh-ancestor
25381620|NCT04650282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25381621|NCT04650282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25381622|NCT04650282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25381623|NCT04650282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25381624|NCT04650282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25381625|NCT04650282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381626|NCT04650087|Apixaban|apixaban|mesh-list
25381627|NCT04650087|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25381628|NCT04650087|Antithrombins|antithrombins|mesh-ancestor
25381629|NCT04650087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25381630|NCT04650087|Protease Inhibitors|protease inhibitors|mesh-ancestor
25381631|NCT04650087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381632|NCT04650087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381633|NCT04650087|Anticoagulants|anticoagulants|mesh-ancestor
25381634|NCT04649476|Cisplatin|cisplatin|mesh-list
25381635|NCT04649476|Docetaxel|docetaxel|mesh-list
25381636|NCT04649476|Fluorouracil|fluorouracil|mesh-list
25381637|NCT04649476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381638|NCT04649476|Tubulin Modulators|tubulin modulators|mesh-ancestor
25381639|NCT04649476|Antimitotic Agents|antimitotic agents|mesh-ancestor
25381640|NCT04649476|Mitosis Modulators|mitosis modulators|mesh-ancestor
25381641|NCT04649476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381642|NCT04649476|Antimetabolites|antimetabolites|mesh-ancestor
25381643|NCT04649476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25381644|NCT04649476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25381645|NCT04649476|Immunologic Factors|immunologic factors|mesh-ancestor
25381646|NCT04649476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381647|NCT04649398|Nimodipine|nimodipine|mesh-list
25381648|NCT04649398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25381649|NCT04649398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25381650|NCT04649398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25381651|NCT04649398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381652|NCT04649398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25381653|NCT04649398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381654|NCT04649398|Vasodilator Agents|vasodilator agents|mesh-ancestor
25381655|NCT04648930|Omalizumab|omalizumab|mesh-list
25381656|NCT04648930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25381657|NCT04648930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25381658|NCT04648930|Respiratory System Agents|respiratory system agents|mesh-ancestor
25381659|NCT04648033|Atovaquone|atovaquone|mesh-list
25381660|NCT04648033|Cisplatin|cisplatin|mesh-list
25381661|NCT04648033|Vinorelbine|vinorelbine|mesh-list
25381662|NCT04648033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381663|NCT04648033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25381664|NCT04648033|Tubulin Modulators|tubulin modulators|mesh-ancestor
25381665|NCT04648033|Antimitotic Agents|antimitotic agents|mesh-ancestor
25381666|NCT04648033|Mitosis Modulators|mitosis modulators|mesh-ancestor
25381667|NCT04648033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381668|NCT04648033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25381670|NCT04648033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25381671|NCT04648033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25381672|NCT04648033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381673|NCT04646967|Acetaminophen|acetaminophen|mesh-list
25381674|NCT04646967|Ibuprofen|ibuprofen|mesh-list
25381675|NCT04646967|Ketorolac|ketorolac|mesh-list
25381676|NCT04646967|Bupivacaine|bupivacaine|mesh-list
25381677|NCT04646967|Sevoflurane|sevoflurane|mesh-list
25381678|NCT04646967|Anesthetics, Local|anesthetics, local|mesh-ancestor
25381679|NCT04646967|Anesthetics|anesthetics|mesh-ancestor
25381680|NCT04646967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25381681|NCT04646967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381682|NCT04646967|Sensory System Agents|sensory system agents|mesh-ancestor
25381683|NCT04646967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25381684|NCT04646967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25381685|NCT04646967|Analgesics|analgesics|mesh-ancestor
25381686|NCT04646967|Antipyretics|antipyretics|mesh-ancestor
25381687|NCT04646967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25381688|NCT04646967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25381689|NCT04646967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25381690|NCT04646967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25381691|NCT04646967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381692|NCT04646967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381693|NCT04646967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25381694|NCT04646967|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
25381695|NCT04646967|Anesthetics, General|anesthetics, general|mesh-ancestor
25381696|NCT04646005|Cemiplimab|cemiplimab|mesh-list
25381697|NCT04646005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25381698|NCT04646005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381699|NCT04645589|Mycophenolic Acid|mycophenolic acid|mesh-list
25381700|NCT04645589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25381701|NCT04645589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381702|NCT04645589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25381703|NCT04645589|Antitubercular Agents|antitubercular agents|mesh-ancestor
25381704|NCT04645589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25381705|NCT04645589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25381706|NCT04645589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381707|NCT04645589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381708|NCT04645004|Aspirin|aspirin|mesh-list
25381709|NCT04645004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25381710|NCT04645004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25381711|NCT04645004|Analgesics|analgesics|mesh-ancestor
25381712|NCT04645004|Sensory System Agents|sensory system agents|mesh-ancestor
25381713|NCT04645004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25381714|NCT04645004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381715|NCT04645004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25381716|NCT04645004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25381717|NCT04645004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25381718|NCT04645004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25381719|NCT04645004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381720|NCT04645004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25381721|NCT04645004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25381722|NCT04645004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381723|NCT04645004|Antipyretics|antipyretics|mesh-ancestor
25381724|NCT04644068|Paclitaxel|paclitaxel|mesh-list
25381725|NCT04644068|Carboplatin|carboplatin|mesh-list
25381726|NCT04644068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25381727|NCT04644068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381728|NCT04644068|Tubulin Modulators|tubulin modulators|mesh-ancestor
25381729|NCT04644068|Antimitotic Agents|antimitotic agents|mesh-ancestor
25381730|NCT04644068|Mitosis Modulators|mitosis modulators|mesh-ancestor
25408390|NCT03447132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381731|NCT04644068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381733|NCT04644029|Emtricitabine|emtricitabine|mesh-list
25381734|NCT04644029|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
25381735|NCT04644029|Islatravir|islatravir|mesh-list
25381736|NCT04644029|Antiviral Agents|antiviral agents|mesh-ancestor
25381737|NCT04644029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25381738|NCT04644029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25381739|NCT04644029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25381740|NCT04644029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381741|NCT04644029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381742|NCT04644029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25381743|NCT04644029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25381744|NCT04643925|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
25381745|NCT04643925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25381746|NCT04643925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381747|NCT04643678|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
25381748|NCT04643678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25381749|NCT04643002|Dexamethasone|dexamethasone|mesh-list
25381750|NCT04643002|Pomalidomide|pomalidomide|mesh-list
25381751|NCT04643002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25381752|NCT04643002|Antiemetics|antiemetics|mesh-ancestor
25381753|NCT04643002|Autonomic Agents|autonomic agents|mesh-ancestor
25381754|NCT04643002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25381755|NCT04643002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381756|NCT04643002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25381757|NCT04643002|Glucocorticoids|glucocorticoids|mesh-ancestor
25381758|NCT04643002|Hormones|hormones|mesh-ancestor
25381759|NCT04643002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25381760|NCT04643002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25381761|NCT04643002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381762|NCT04643002|Immunologic Factors|immunologic factors|mesh-ancestor
25381763|NCT04643002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25381764|NCT04643002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25381765|NCT04643002|Growth Substances|growth substances|mesh-ancestor
25381766|NCT04643002|Growth Inhibitors|growth inhibitors|mesh-ancestor
25381767|NCT04642469|Durvalumab|durvalumab|mesh-list
25381768|NCT04642469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25381769|NCT04642469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381770|NCT04642365|Atezolizumab|atezolizumab|mesh-list
25381771|NCT04642365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381772|NCT04641975|Mirabegron|mirabegron|mesh-list
25381773|NCT04641975|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
25381774|NCT04641975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
25381775|NCT04641975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25381776|NCT04641975|Adrenergic Agents|adrenergic agents|mesh-ancestor
25381777|NCT04641975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25381778|NCT04641975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381779|NCT04641975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381780|NCT04641975|Urological Agents|urological agents|mesh-ancestor
25381781|NCT04641871|Irinotecan|irinotecan|mesh-list
25381782|NCT04641871|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25381783|NCT04641871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25381784|NCT04641871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381785|NCT04641871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381786|NCT04641871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381787|NCT04641728|Pembrolizumab|pembrolizumab|mesh-list
25381788|NCT04641728|Olaparib|olaparib|mesh-list
25381789|NCT04641728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25381790|NCT04641728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381791|NCT04641728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25381792|NCT04641728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381793|NCT04641728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381794|NCT04641338|Dipyrone|dipyrone|mesh-list
25381795|NCT04641338|Codeine|codeine|mesh-list
25381796|NCT04641338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25381797|NCT04641338|Narcotics|narcotics|mesh-ancestor
25381798|NCT04641338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25381799|NCT04641338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381800|NCT04641338|Analgesics|analgesics|mesh-ancestor
25381801|NCT04641338|Sensory System Agents|sensory system agents|mesh-ancestor
25381802|NCT04641338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25381803|NCT04641338|Antitussive Agents|antitussive agents|mesh-ancestor
25381804|NCT04641338|Respiratory System Agents|respiratory system agents|mesh-ancestor
25381805|NCT04641338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25381806|NCT04641338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25381807|NCT04641338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25381808|NCT04641338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25381809|NCT04641338|Antipyretics|antipyretics|mesh-ancestor
25381810|NCT04641195|Vitamin D|vitamin d|mesh-list
25381811|NCT04641195|Ergocalciferols|ergocalciferols|mesh-list
25381812|NCT04641195|Cholecalciferol|cholecalciferol|mesh-list
25381825|NCT04640623|Gemcitabine|gemcitabine|mesh-list
25381826|NCT04640623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25381827|NCT04640623|Antimetabolites|antimetabolites|mesh-ancestor
25381828|NCT04640623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381829|NCT04640623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381830|NCT04640623|Antiviral Agents|antiviral agents|mesh-ancestor
25381831|NCT04640623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25381832|NCT04640623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381833|NCT04640623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25381834|NCT04640623|Immunologic Factors|immunologic factors|mesh-ancestor
25381835|NCT04640623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381836|NCT04640545|Axitinib|axitinib|mesh-list
25381837|NCT04640545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381838|NCT04640545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25381839|NCT04640545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381840|NCT04640545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381841|NCT04640194|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25381842|NCT04640194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25381843|NCT04640194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25381844|NCT04640194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381857|NCT04639414|Empagliflozin|empagliflozin|mesh-list
25381858|NCT04639414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25381859|NCT04639414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381860|NCT04639414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25381861|NCT04639414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381862|NCT04639310|Ezogabine|ezogabine|mesh-list
25381863|NCT04639310|Anticonvulsants|anticonvulsants|mesh-ancestor
25381864|NCT04639310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25381865|NCT04639310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381866|NCT04639219|Trastuzumab|trastuzumab|mesh-list
25381867|NCT04639219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25381868|NCT04639219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381869|NCT04639011|Norepinephrine|norepinephrine|mesh-list
25381870|NCT04639011|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
25381871|NCT04639011|Serotonin|serotonin|mesh-list
25381872|NCT04639011|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25381873|NCT04639011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25381874|NCT04639011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25381875|NCT04639011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381876|NCT04639011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25381877|NCT04639011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381878|NCT04639011|Analgesics|analgesics|mesh-ancestor
25381879|NCT04639011|Sensory System Agents|sensory system agents|mesh-ancestor
25381880|NCT04639011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25381881|NCT04639011|Antidepressive Agents|antidepressive agents|mesh-ancestor
25381882|NCT04639011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25381883|NCT04639011|Dopamine Agents|dopamine agents|mesh-ancestor
25381884|NCT04639011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25381885|NCT04639011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25381886|NCT04639011|Adrenergic Agents|adrenergic agents|mesh-ancestor
25381887|NCT04639011|Sympathomimetics|sympathomimetics|mesh-ancestor
25381888|NCT04639011|Autonomic Agents|autonomic agents|mesh-ancestor
25381889|NCT04639011|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25381890|NCT04639011|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25381891|NCT04639011|Serotonin Agents|serotonin agents|mesh-ancestor
25381892|NCT04638400|Simvastatin|simvastatin|mesh-list
25381893|NCT04638400|Ezetimibe|ezetimibe|mesh-list
25381894|NCT04638400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25381895|NCT04638400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25381896|NCT04638400|Antimetabolites|antimetabolites|mesh-ancestor
25381897|NCT04638400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381898|NCT04638400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25381899|NCT04638400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25381900|NCT04638400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381901|NCT04637763|Cyclophosphamide|cyclophosphamide|mesh-list
25381902|NCT04637763|Fludarabine|fludarabine|mesh-list
25381903|NCT04637763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25381904|NCT04637763|Immunologic Factors|immunologic factors|mesh-ancestor
25381905|NCT04637763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381906|NCT04637763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25381907|NCT04637763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25381908|NCT04637763|Alkylating Agents|alkylating agents|mesh-ancestor
25381909|NCT04637763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381910|NCT04637763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381911|NCT04637763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25381912|NCT04634877|Paclitaxel|paclitaxel|mesh-list
25381913|NCT04634877|Docetaxel|docetaxel|mesh-list
25381914|NCT04634877|Cisplatin|cisplatin|mesh-list
25381915|NCT04634877|Carboplatin|carboplatin|mesh-list
25381916|NCT04634877|Pembrolizumab|pembrolizumab|mesh-list
25381917|NCT04634877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25381918|NCT04634877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381919|NCT04634877|Tubulin Modulators|tubulin modulators|mesh-ancestor
25381920|NCT04634877|Antimitotic Agents|antimitotic agents|mesh-ancestor
25381921|NCT04634877|Mitosis Modulators|mitosis modulators|mesh-ancestor
25381922|NCT04634877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381923|NCT04634877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25381924|NCT04634838|Copper|copper|mesh-list
25381925|NCT04634838|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25381926|NCT04634838|Trace Elements|trace elements|mesh-ancestor
25381927|NCT04634838|Micronutrients|micronutrients|mesh-ancestor
25381928|NCT04634838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381929|NCT04634838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25381930|NCT04634539|Gemcitabine|gemcitabine|mesh-list
25381931|NCT04634539|Paclitaxel|paclitaxel|mesh-list
25381932|NCT04634539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25381933|NCT04634539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381934|NCT04634539|Tubulin Modulators|tubulin modulators|mesh-ancestor
25381935|NCT04634539|Antimitotic Agents|antimitotic agents|mesh-ancestor
25381936|NCT04634539|Mitosis Modulators|mitosis modulators|mesh-ancestor
25381937|NCT04634539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381938|NCT04634539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25381939|NCT04634539|Antimetabolites|antimetabolites|mesh-ancestor
25381940|NCT04634539|Antiviral Agents|antiviral agents|mesh-ancestor
25381941|NCT04634539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25381942|NCT04634539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381943|NCT04634539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25381944|NCT04634539|Immunologic Factors|immunologic factors|mesh-ancestor
25381945|NCT04634539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381946|NCT04633551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
25381947|NCT04633278|Pembrolizumab|pembrolizumab|mesh-list
25381948|NCT04633278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25381949|NCT04633278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381950|NCT04633252|Prednisone|prednisone|mesh-list
25381951|NCT04633252|Docetaxel|docetaxel|mesh-list
25381952|NCT04633252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381953|NCT04633252|Tubulin Modulators|tubulin modulators|mesh-ancestor
25381954|NCT04633252|Antimitotic Agents|antimitotic agents|mesh-ancestor
25381955|NCT04633252|Mitosis Modulators|mitosis modulators|mesh-ancestor
25381956|NCT04633252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381957|NCT04633252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25381958|NCT04633252|Glucocorticoids|glucocorticoids|mesh-ancestor
25381959|NCT04633252|Hormones|hormones|mesh-ancestor
25381960|NCT04633252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25381961|NCT04633252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381962|NCT04633252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25381963|NCT04633239|Olaparib|olaparib|mesh-list
25381966|NCT04633239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381967|NCT04633239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381969|NCT04633226|Immunologic Factors|immunologic factors|mesh-ancestor
25381970|NCT04633226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381971|NCT04633122|Sunitinib|sunitinib|mesh-list
25381972|NCT04633122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381973|NCT04633122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25381974|NCT04633122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25381975|NCT04633122|Growth Substances|growth substances|mesh-ancestor
25381976|NCT04633122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25381977|NCT04633122|Growth Inhibitors|growth inhibitors|mesh-ancestor
25381978|NCT04633122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25381979|NCT04633122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381980|NCT04633122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381982|NCT04632992|Maytansine|maytansine|mesh-list
25381983|NCT04632992|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25381984|NCT04632992|Trastuzumab|trastuzumab|mesh-list
25381985|NCT04632992|Atezolizumab|atezolizumab|mesh-list
25381986|NCT04632992|Pertuzumab|pertuzumab|mesh-list
25381987|NCT04632992|Tucatinib|tucatinib|mesh-list
25381988|NCT04632992|Pralsetinib|pralsetinib|mesh-list
25381989|NCT04632992|Entrectinib|entrectinib|mesh-list
25381990|NCT04632992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25381991|NCT04632992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25381992|NCT04632992|Tubulin Modulators|tubulin modulators|mesh-ancestor
25381993|NCT04632992|Antimitotic Agents|antimitotic agents|mesh-ancestor
25381994|NCT04632992|Mitosis Modulators|mitosis modulators|mesh-ancestor
25381995|NCT04632992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25381996|NCT04632992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25381997|NCT04632992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25381998|NCT04632992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25381999|NCT04632433|Cemiplimab|cemiplimab|mesh-list
25382000|NCT04632433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25382001|NCT04632433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382002|NCT04632069|Acetylcysteine|acetylcysteine|mesh-list
25382003|NCT04632069|N-monoacetylcystine|n-monoacetylcystine|mesh-list
25382004|NCT04632069|Antiviral Agents|antiviral agents|mesh-ancestor
25382005|NCT04632069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25382006|NCT04632069|Expectorants|expectorants|mesh-ancestor
25382007|NCT04632069|Respiratory System Agents|respiratory system agents|mesh-ancestor
25382008|NCT04632069|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25382009|NCT04632069|Antioxidants|antioxidants|mesh-ancestor
25382010|NCT04632069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382011|NCT04632069|Protective Agents|protective agents|mesh-ancestor
25382012|NCT04632069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382013|NCT04632069|Antidotes|antidotes|mesh-ancestor
25382014|NCT04631263|Hyaluronic Acid|hyaluronic acid|mesh-list
25382015|NCT04631263|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25382016|NCT04631263|Immunologic Factors|immunologic factors|mesh-ancestor
25382017|NCT04631263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382018|NCT04631263|Viscosupplements|viscosupplements|mesh-ancestor
25382019|NCT04631263|Protective Agents|protective agents|mesh-ancestor
25382020|NCT04630821|Sodium Hypochlorite|sodium hypochlorite|mesh-list
25382021|NCT04630821|Eusol|eusol|mesh-list
25382022|NCT04630821|Disinfectants|disinfectants|mesh-ancestor
25382023|NCT04630821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25382024|NCT04630808|Latanoprost|latanoprost|mesh-list
25382025|NCT04630808|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25382026|NCT04630808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25382029|NCT04630730|Gemcitabine|gemcitabine|mesh-list
25382030|NCT04630730|Cisplatin|cisplatin|mesh-list
25382031|NCT04630730|Atezolizumab|atezolizumab|mesh-list
25382032|NCT04630730|BCG Vaccine|bcg vaccine|mesh-list
25382033|NCT04630730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382034|NCT04630730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25382035|NCT04630730|Antimetabolites|antimetabolites|mesh-ancestor
25382036|NCT04630730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382037|NCT04630730|Antiviral Agents|antiviral agents|mesh-ancestor
25382038|NCT04630730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25382039|NCT04630730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382040|NCT04630730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25382041|NCT04630730|Immunologic Factors|immunologic factors|mesh-ancestor
25382042|NCT04630730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382043|NCT04630730|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25382044|NCT04630158|Lubricant Eye Drops|lubricant eye drops|mesh-list
25382045|NCT04630158|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
25382046|NCT04630158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25382047|NCT04630145|Clarithromycin|clarithromycin|mesh-list
25382048|NCT04630145|Rifampin|rifampin|mesh-list
25382049|NCT04630145|Ethambutol|ethambutol|mesh-list
25382050|NCT04630145|Rifabutin|rifabutin|mesh-list
25382051|NCT04630145|Bedaquiline|bedaquiline|mesh-list
25382052|NCT04630145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25382053|NCT04630145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25382054|NCT04630145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25382055|NCT04630145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382056|NCT04630145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382057|NCT04630145|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25382058|NCT04630145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25382059|NCT04630145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25382060|NCT04630145|Antitubercular Agents|antitubercular agents|mesh-ancestor
25382061|NCT04630145|Leprostatic Agents|leprostatic agents|mesh-ancestor
25382062|NCT04630145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25382063|NCT04630145|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
25382064|NCT04630145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25382065|NCT04630145|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
25382066|NCT04630145|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
25382067|NCT04630145|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
25382068|NCT04630145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
25382069|NCT04630028|Ustekinumab|ustekinumab|mesh-list
25382070|NCT04630028|Dermatologic Agents|dermatologic agents|mesh-ancestor
25382071|NCT04629729|Cyclophosphamide|cyclophosphamide|mesh-list
25382072|NCT04629729|Fludarabine|fludarabine|mesh-list
25382073|NCT04629729|Interleukin-2|interleukin-2|mesh-list
25382074|NCT04629729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25382075|NCT04629729|Immunologic Factors|immunologic factors|mesh-ancestor
25382076|NCT04629729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382077|NCT04629729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25382078|NCT04629729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25382079|NCT04629729|Alkylating Agents|alkylating agents|mesh-ancestor
25382080|NCT04629729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382081|NCT04629729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382082|NCT04629729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25382083|NCT04629729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25382084|NCT04629729|Analgesics|analgesics|mesh-ancestor
25382085|NCT04629729|Sensory System Agents|sensory system agents|mesh-ancestor
25382086|NCT04629729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25382087|NCT04629651|Captopril|captopril|mesh-list
25382088|NCT04629651|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25382089|NCT04629651|Protease Inhibitors|protease inhibitors|mesh-ancestor
25382090|NCT04629651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382091|NCT04629651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382092|NCT04629651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25382093|NCT04629547|Suvorexant|suvorexant|mesh-list
25382094|NCT04629547|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25382095|NCT04629547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25382096|NCT04629547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25382097|NCT04629547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382098|NCT04629547|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25382099|NCT04629547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25382100|NCT04629547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382101|NCT04629443|Azacitidine|azacitidine|mesh-list
25382102|NCT04629443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25382103|NCT04629443|Antimetabolites|antimetabolites|mesh-ancestor
25382104|NCT04629443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382105|NCT04629443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382106|NCT04629443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382107|NCT04629248|Acetaminophen|acetaminophen|mesh-list
25382108|NCT04629248|Diphenhydramine|diphenhydramine|mesh-list
25382109|NCT04629248|Promethazine|promethazine|mesh-list
25382110|NCT04629248|Methylprednisolone|methylprednisolone|mesh-list
25382111|NCT04629248|Obinutuzumab|obinutuzumab|mesh-list
25382112|NCT04629248|Tacrolimus|tacrolimus|mesh-list
25382113|NCT04629248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25382114|NCT04629248|Immunologic Factors|immunologic factors|mesh-ancestor
25382115|NCT04629248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382116|NCT04629248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25382117|NCT04629248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382118|NCT04629248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382119|NCT04629248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25382120|NCT04629248|Analgesics|analgesics|mesh-ancestor
25382121|NCT04629248|Sensory System Agents|sensory system agents|mesh-ancestor
25382122|NCT04629248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25382123|NCT04629248|Antipyretics|antipyretics|mesh-ancestor
25382124|NCT04629248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25382125|NCT04629248|Antiemetics|antiemetics|mesh-ancestor
25382126|NCT04629248|Autonomic Agents|autonomic agents|mesh-ancestor
25382127|NCT04629248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25382128|NCT04629248|Glucocorticoids|glucocorticoids|mesh-ancestor
25382130|NCT04629248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25382131|NCT04629248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25382132|NCT04629248|Protective Agents|protective agents|mesh-ancestor
25382133|NCT04629248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382134|NCT04629248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25382135|NCT04629248|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25382211|NCT04627870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382212|NCT04627285|Lacosamide|lacosamide|mesh-list
25382213|NCT04627285|Anticonvulsants|anticonvulsants|mesh-ancestor
25382214|NCT04627285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25382215|NCT04627285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25382216|NCT04627285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25382217|NCT04627285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382218|NCT04626791|Cytarabine|cytarabine|mesh-list
25382219|NCT04626791|Prednisone|prednisone|mesh-list
25382220|NCT04626791|Cortisone|cortisone|mesh-list
25382221|NCT04626791|Cyclophosphamide|cyclophosphamide|mesh-list
25382222|NCT04626791|Rituximab|rituximab|mesh-list
25382223|NCT04626791|Doxorubicin|doxorubicin|mesh-list
25382224|NCT04626791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25382225|NCT04626791|Bortezomib|bortezomib|mesh-list
25382226|NCT04626791|Acalabrutinib|acalabrutinib|mesh-list
25382227|NCT04626791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25382228|NCT04626791|Antibodies|antibodies|mesh-list
25382229|NCT04626791|Immunoglobulins|immunoglobulins|mesh-list
25382230|NCT04626791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25382231|NCT04626791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25382232|NCT04626791|Immunologic Factors|immunologic factors|mesh-ancestor
25382233|NCT04626791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382234|NCT04626791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25382235|NCT04626791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25382236|NCT04626791|Alkylating Agents|alkylating agents|mesh-ancestor
25382237|NCT04626791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382238|NCT04626791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382239|NCT04626791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25382240|NCT04626791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25382241|NCT04626791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25382242|NCT04626791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25382243|NCT04626791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382244|NCT04626791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25382245|NCT04626791|Glucocorticoids|glucocorticoids|mesh-ancestor
25382246|NCT04626791|Hormones|hormones|mesh-ancestor
25382247|NCT04626791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25382248|NCT04626791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25382249|NCT04626791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25382250|NCT04626791|Antimetabolites|antimetabolites|mesh-ancestor
25382251|NCT04626791|Antiviral Agents|antiviral agents|mesh-ancestor
25382252|NCT04626791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25382253|NCT04626596|Etonogestrel|etonogestrel|mesh-list
25382254|NCT04626596|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
25382255|NCT04626596|Contraceptive Agents|contraceptive agents|mesh-ancestor
25382256|NCT04626596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25382257|NCT04626596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382258|NCT04626596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
25382259|NCT04626518|Pembrolizumab|pembrolizumab|mesh-list
25382260|NCT04626518|Lenvatinib|lenvatinib|mesh-list
25382261|NCT04626518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25382262|NCT04626518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382263|NCT04626518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25382264|NCT04626518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382265|NCT04626518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382266|NCT04626479|Pembrolizumab|pembrolizumab|mesh-list
25382267|NCT04626479|Lenvatinib|lenvatinib|mesh-list
25382268|NCT04626479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25382269|NCT04626479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382270|NCT04626479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25382271|NCT04626479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382283|NCT04626128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382285|NCT04625530|Ferric Compounds|ferric compounds|mesh-list
25382286|NCT04625530|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25382287|NCT04625530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25382288|NCT04625530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382289|NCT04625530|Hemostatics|hemostatics|mesh-ancestor
25382290|NCT04625530|Coagulants|coagulants|mesh-ancestor
25382291|NCT04625530|Hematinics|hematinics|mesh-ancestor
25382292|NCT04625283|Ketamine|ketamine|mesh-list
25382293|NCT04625283|Analgesics|analgesics|mesh-ancestor
25382294|NCT04625283|Sensory System Agents|sensory system agents|mesh-ancestor
25382295|NCT04625283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25382296|NCT04625283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382297|NCT04625283|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25382298|NCT04625283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25382299|NCT04625283|Anesthetics, General|anesthetics, general|mesh-ancestor
25382300|NCT04625283|Anesthetics|anesthetics|mesh-ancestor
25382301|NCT04625283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25382302|NCT04625283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25382303|NCT04625283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25382304|NCT04625283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25382305|NCT04625283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382306|NCT04624399|Atezolizumab|atezolizumab|mesh-list
25382307|NCT04624399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382320|NCT04624230|Tofacitinib|tofacitinib|mesh-list
25382321|NCT04624230|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25382322|NCT04624230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382323|NCT04624230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382324|NCT04624204|Pembrolizumab|pembrolizumab|mesh-list
25382326|NCT04624204|Olaparib|olaparib|mesh-list
25382327|NCT04624204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25382328|NCT04624204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382329|NCT04624204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25382330|NCT04624204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25382331|NCT04624204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25382332|NCT04624204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382333|NCT04624204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382334|NCT04624204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25382335|NCT04624178|Nivolumab|nivolumab|mesh-list
25382336|NCT04624178|Rucaparib|rucaparib|mesh-list
25382337|NCT04624178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25382338|NCT04624178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382339|NCT04624178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25382340|NCT04624178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382341|NCT04624178|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25382342|NCT04624178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382343|NCT04623931|Temozolomide|temozolomide|mesh-list
25382344|NCT04623931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25382345|NCT04623931|Alkylating Agents|alkylating agents|mesh-ancestor
25382346|NCT04623931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382347|NCT04623931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382348|NCT04623775|Paclitaxel|paclitaxel|mesh-list
25382349|NCT04623775|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25382351|NCT04623775|Carboplatin|carboplatin|mesh-list
25382352|NCT04623775|Nivolumab|nivolumab|mesh-list
25382353|NCT04623775|Pemetrexed|pemetrexed|mesh-list
25382354|NCT04623775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25382355|NCT04623775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382356|NCT04623775|Tubulin Modulators|tubulin modulators|mesh-ancestor
25382357|NCT04623775|Antimitotic Agents|antimitotic agents|mesh-ancestor
25382358|NCT04623775|Mitosis Modulators|mitosis modulators|mesh-ancestor
25382359|NCT04623775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382360|NCT04623775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25382361|NCT04623775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25382362|NCT04623775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382363|NCT04623775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25382364|NCT04623775|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25382365|NCT04623398|Lithium Carbonate|lithium carbonate|mesh-list
25382366|NCT04623398|Antidepressive Agents|antidepressive agents|mesh-ancestor
25382367|NCT04623398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25382368|NCT04623398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382369|NCT04623398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382370|NCT04623398|Antimanic Agents|antimanic agents|mesh-ancestor
25382371|NCT04623398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25382372|NCT04623398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25382373|NCT04623398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382374|NCT04623242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25382375|NCT04623242|Immunologic Factors|immunologic factors|mesh-ancestor
25382376|NCT04623242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382377|NCT04622319|Trastuzumab|trastuzumab|mesh-list
25382378|NCT04622319|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25382379|NCT04622319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25382380|NCT04622319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382381|NCT04622319|Tubulin Modulators|tubulin modulators|mesh-ancestor
25382382|NCT04622319|Antimitotic Agents|antimitotic agents|mesh-ancestor
25382383|NCT04622319|Mitosis Modulators|mitosis modulators|mesh-ancestor
25382384|NCT04622319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382385|NCT04622267|Anti-Infective Agents|anti-infective agents|mesh-list
25382386|NCT04622267|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25382387|NCT04622254|Botulinum Toxins|botulinum toxins|mesh-list
25382388|NCT04622254|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25382389|NCT04622254|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25382390|NCT04622254|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
25382391|NCT04622254|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25382392|NCT04622254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25382393|NCT04622254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382394|NCT04622254|Cholinergic Agents|cholinergic agents|mesh-ancestor
25382395|NCT04622254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25382396|NCT04622254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382397|NCT04622254|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25382398|NCT04622254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25382399|NCT04622228|Cisplatin|cisplatin|mesh-list
25382400|NCT04622228|Carboplatin|carboplatin|mesh-list
25382401|NCT04622228|Etoposide|etoposide|mesh-list
25382402|NCT04622228|Atezolizumab|atezolizumab|mesh-list
25382403|NCT04622228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382404|NCT04622228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25382405|NCT04622228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25382406|NCT04622228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25382407|NCT04622228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382408|NCT04622228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382409|NCT04621526|Dexmedetomidine|dexmedetomidine|mesh-list
25382410|NCT04621526|Ketamine|ketamine|mesh-list
25382411|NCT04621526|Propofol|propofol|mesh-list
25382412|NCT04621526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25382413|NCT04621526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25382414|NCT04621526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382415|NCT04621526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25382416|NCT04621526|Anesthetics, General|anesthetics, general|mesh-ancestor
25382417|NCT04621526|Anesthetics|anesthetics|mesh-ancestor
25382418|NCT04621526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25382419|NCT04621526|Analgesics|analgesics|mesh-ancestor
25382420|NCT04621526|Sensory System Agents|sensory system agents|mesh-ancestor
25382421|NCT04621526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25382422|NCT04621526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25382423|NCT04621526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25382424|NCT04621526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25382425|NCT04621526|Adrenergic Agents|adrenergic agents|mesh-ancestor
25382426|NCT04621526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25382427|NCT04621526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382428|NCT04621526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25382429|NCT04621526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25382430|NCT04621526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25382431|NCT04621500|Vitamin D|vitamin d|mesh-list
25382432|NCT04621500|Cholecalciferol|cholecalciferol|mesh-list
25382433|NCT04621500|Vitamins|vitamins|mesh-ancestor
25382434|NCT04621500|Micronutrients|micronutrients|mesh-ancestor
25382435|NCT04621500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382436|NCT04621500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25382437|NCT04621500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25382438|NCT04621435|Copper|copper|mesh-list
25382439|NCT04621435|Trace Elements|trace elements|mesh-ancestor
25382440|NCT04621435|Micronutrients|micronutrients|mesh-ancestor
25382441|NCT04621435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382442|NCT04620759|Psilocybin|psilocybin|mesh-list
25382443|NCT04620759|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
25382444|NCT04620759|Hallucinogens|hallucinogens|mesh-ancestor
25382445|NCT04620759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382446|NCT04620759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25382447|NCT04620759|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25382448|NCT04620759|Serotonin Agents|serotonin agents|mesh-ancestor
25382449|NCT04620759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25382450|NCT04620759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382451|NCT04620759|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25382452|NCT04620746|Penicillins|penicillins|mesh-list
25382453|NCT04620746|Penicillin G|penicillin g|mesh-list
25382454|NCT04620746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25382455|NCT04620746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25382456|NCT04620733|Seladelpar|seladelpar|mesh-list
25382457|NCT04620733|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25382458|NCT04620733|Antimetabolites|antimetabolites|mesh-ancestor
25382459|NCT04620733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382460|NCT04620733|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25382461|NCT04620343|Anesthetics|anesthetics|mesh-list
25382462|NCT04620343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25382463|NCT04620343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382464|NCT04619979|Anesthetics|anesthetics|mesh-list
25382465|NCT04619979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
24451326|NCT00323206|Immunologic Factors|immunologic factors|mesh-ancestor
25382466|NCT04619979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382467|NCT04619797|Cisplatin|cisplatin|mesh-list
25382468|NCT04619797|Carboplatin|carboplatin|mesh-list
25382469|NCT04619797|Pembrolizumab|pembrolizumab|mesh-list
25382470|NCT04619797|Pemetrexed|pemetrexed|mesh-list
25382471|NCT04619797|Atezolizumab|atezolizumab|mesh-list
25382472|NCT04619797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382473|NCT04619797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25382474|NCT04619797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382475|NCT04619797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382476|NCT04619797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25382477|NCT04619797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25382478|NCT04619706|Palmidrol|palmidrol|mesh-list
25382479|NCT04619706|Analgesics|analgesics|mesh-ancestor
25382480|NCT04619706|Sensory System Agents|sensory system agents|mesh-ancestor
25382481|NCT04619706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25382482|NCT04619706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382483|NCT04619706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25382484|NCT04619706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25382485|NCT04619706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25382486|NCT04619706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25382487|NCT04619706|Antiviral Agents|antiviral agents|mesh-ancestor
25382488|NCT04619706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25382489|NCT04619706|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25382490|NCT04619706|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25382491|NCT04619706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25382492|NCT04619706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382493|NCT04619706|Hormones|hormones|mesh-ancestor
25382494|NCT04619706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25382495|NCT04619004|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
25382496|NCT04619004|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25382497|NCT04619004|Immunologic Factors|immunologic factors|mesh-ancestor
25382498|NCT04619004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382499|NCT04619004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25382500|NCT04619004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382501|NCT04618744|Insulin|insulin|mesh-list
25382502|NCT04618744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25382503|NCT04618744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25382504|NCT04618744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382505|NCT04617002|TIC10 compound|tic10 compound|mesh-list
25382506|NCT04617002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382507|NCT04616963|Tenofovir|tenofovir|mesh-list
25382508|NCT04616963|Emtricitabine|emtricitabine|mesh-list
25382509|NCT04616963|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25382510|NCT04616963|Antiviral Agents|antiviral agents|mesh-ancestor
25382511|NCT04616963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25382512|NCT04616963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25382513|NCT04616963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25382514|NCT04616963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382515|NCT04616963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382516|NCT04616963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25382517|NCT04616963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25382518|NCT04616924|Clarithromycin|clarithromycin|mesh-list
25382519|NCT04616924|Rifabutin|rifabutin|mesh-list
25382520|NCT04616924|Clofazimine|clofazimine|mesh-list
25382521|NCT04616924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25382522|NCT04616924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25382523|NCT04616924|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25382524|NCT04616924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382525|NCT04616924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382526|NCT04616924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25382527|NCT04616924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25382528|NCT04616924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25382529|NCT04616924|Antitubercular Agents|antitubercular agents|mesh-ancestor
25382530|NCT04616924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25382531|NCT04616924|Leprostatic Agents|leprostatic agents|mesh-ancestor
25382532|NCT04616560|Trastuzumab|trastuzumab|mesh-list
25382533|NCT04616560|Camptothecin|camptothecin|mesh-list
25382534|NCT04616560|Immunoconjugates|immunoconjugates|mesh-list
25382535|NCT04616560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25382536|NCT04616560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382537|NCT04616560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25382538|NCT04616560|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25382540|NCT04616560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382541|NCT04616560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382542|NCT04616560|Immunologic Factors|immunologic factors|mesh-ancestor
25382543|NCT04616560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382544|NCT04616534|Gemcitabine|gemcitabine|mesh-list
25382545|NCT04616534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25382546|NCT04616534|Antimetabolites|antimetabolites|mesh-ancestor
25382547|NCT04616534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382548|NCT04616534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382549|NCT04616534|Antiviral Agents|antiviral agents|mesh-ancestor
25382550|NCT04616534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25382551|NCT04616534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382552|NCT04616534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25382553|NCT04616534|Immunologic Factors|immunologic factors|mesh-ancestor
25382554|NCT04616534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382555|NCT04616248|Poly I-C|poly i-c|mesh-list
25382556|NCT04616248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25382557|NCT04616248|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
25382558|NCT04616248|Antibodies|antibodies|mesh-list
25382559|NCT04616248|Immunoglobulins|immunoglobulins|mesh-list
25382560|NCT04616248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25382561|NCT04616248|Poly ICLC|poly iclc|mesh-list
25382562|NCT04616248|Flt3 ligand protein|flt3 ligand protein|mesh-list
25382563|NCT04616248|Immunologic Factors|immunologic factors|mesh-ancestor
25382564|NCT04616248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382565|NCT04616248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382566|NCT04616248|Interferon Inducers|interferon inducers|mesh-ancestor
25382567|NCT04616248|Laxatives|laxatives|mesh-ancestor
25382568|NCT04616248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25382569|NCT04616248|Antiviral Agents|antiviral agents|mesh-ancestor
25382570|NCT04616248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25382571|NCT04616248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25382572|NCT04616248|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
25382577|NCT04616014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382578|NCT04615013|Leucovorin|leucovorin|mesh-list
25382579|NCT04615013|Paclitaxel|paclitaxel|mesh-list
25382580|NCT04615013|Docetaxel|docetaxel|mesh-list
25382581|NCT04615013|Carboplatin|carboplatin|mesh-list
25382582|NCT04615013|Fluorouracil|fluorouracil|mesh-list
25382583|NCT04615013|Capecitabine|capecitabine|mesh-list
25382584|NCT04615013|Oxaliplatin|oxaliplatin|mesh-list
25382585|NCT04615013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25382586|NCT04615013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25382587|NCT04615013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382588|NCT04615013|Tubulin Modulators|tubulin modulators|mesh-ancestor
25382589|NCT04615013|Antimitotic Agents|antimitotic agents|mesh-ancestor
25382590|NCT04615013|Mitosis Modulators|mitosis modulators|mesh-ancestor
25382591|NCT04615013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382592|NCT04615013|Antimetabolites|antimetabolites|mesh-ancestor
25382593|NCT04615013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25382594|NCT04615013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25382595|NCT04615013|Immunologic Factors|immunologic factors|mesh-ancestor
25382596|NCT04615013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382597|NCT04615013|Antidotes|antidotes|mesh-ancestor
25382598|NCT04615013|Protective Agents|protective agents|mesh-ancestor
25382599|NCT04615013|Vitamin B Complex|vitamin b complex|mesh-ancestor
25382600|NCT04615013|Vitamins|vitamins|mesh-ancestor
25382601|NCT04615013|Micronutrients|micronutrients|mesh-ancestor
25382602|NCT04614311|Triamcinolone|triamcinolone|mesh-list
25382603|NCT04614311|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
25382604|NCT04614311|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
25382605|NCT04614311|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
25382606|NCT04614311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25382607|NCT04614311|Glucocorticoids|glucocorticoids|mesh-ancestor
25382608|NCT04614311|Hormones|hormones|mesh-ancestor
25382609|NCT04614311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25382610|NCT04614311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382611|NCT04614311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25382612|NCT04614311|Immunologic Factors|immunologic factors|mesh-ancestor
25382613|NCT04614311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382614|NCT04614311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382615|NCT04613960|Magnesium Sulfate|magnesium sulfate|mesh-list
25382616|NCT04613960|Analgesics|analgesics|mesh-ancestor
25382617|NCT04613960|Sensory System Agents|sensory system agents|mesh-ancestor
25382618|NCT04613960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25382621|NCT04613960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25382623|NCT04613960|Anticonvulsants|anticonvulsants|mesh-ancestor
25382624|NCT04613960|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25382625|NCT04613960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25382626|NCT04613960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382627|NCT04613960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25382628|NCT04613960|Tocolytic Agents|tocolytic agents|mesh-ancestor
25382629|NCT04613960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25382630|NCT04613830|Tramadol|tramadol|mesh-list
25382631|NCT04613830|Bupivacaine|bupivacaine|mesh-list
25382632|NCT04613830|Anesthetics, Local|anesthetics, local|mesh-ancestor
25382633|NCT04613830|Anesthetics|anesthetics|mesh-ancestor
25382634|NCT04613830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25382635|NCT04613830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382636|NCT04613830|Sensory System Agents|sensory system agents|mesh-ancestor
25382637|NCT04613830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25382638|NCT04613830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25382639|NCT04613830|Narcotics|narcotics|mesh-ancestor
25382640|NCT04613830|Analgesics|analgesics|mesh-ancestor
25382645|NCT04613518|BMS-986165|bms-986165|mesh-list
25382646|NCT04613518|Dermatologic Agents|dermatologic agents|mesh-ancestor
25382647|NCT04613518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25382648|NCT04613518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382649|NCT04613518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382650|NCT04613492|Durvalumab|durvalumab|mesh-list
25382651|NCT04613492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25382652|NCT04613492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382654|NCT04613453|Ketamine|ketamine|mesh-list
25382655|NCT04613453|Analgesics|analgesics|mesh-ancestor
25382656|NCT04613453|Sensory System Agents|sensory system agents|mesh-ancestor
25382657|NCT04613453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25382658|NCT04613453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382659|NCT04613453|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25382660|NCT04613453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25382661|NCT04613453|Anesthetics, General|anesthetics, general|mesh-ancestor
25382662|NCT04613453|Anesthetics|anesthetics|mesh-ancestor
25382663|NCT04613453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25382664|NCT04613453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25382665|NCT04613453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25382666|NCT04613453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25382667|NCT04613453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382668|NCT04613453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25382669|NCT04613453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25382670|NCT04613453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25382671|NCT04613453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25382672|NCT04613453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25382673|NCT04613453|GABA Modulators|gaba modulators|mesh-ancestor
25382674|NCT04613453|GABA Agents|gaba agents|mesh-ancestor
25382675|NCT04612790|Benralizumab|benralizumab|mesh-list
25382676|NCT04612790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25382677|NCT04612790|Respiratory System Agents|respiratory system agents|mesh-ancestor
25382678|NCT04612751|Carboplatin|carboplatin|mesh-list
25382679|NCT04612751|Durvalumab|durvalumab|mesh-list
25382680|NCT04612751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382681|NCT04612751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25382685|NCT04610684|Carboplatin|carboplatin|mesh-list
25382686|NCT04610684|Etoposide|etoposide|mesh-list
25382687|NCT04610684|Atezolizumab|atezolizumab|mesh-list
25382688|NCT04610684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382689|NCT04610684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25382690|NCT04610684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25382691|NCT04610684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25382692|NCT04610684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382693|NCT04610684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382694|NCT04609904|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25382695|NCT04609904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25382696|NCT04609904|Respiratory System Agents|respiratory system agents|mesh-ancestor
25382697|NCT04609878|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
25382698|NCT04609878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25382699|NCT04609878|Respiratory System Agents|respiratory system agents|mesh-ancestor
25382700|NCT04609865|Lidocaine|lidocaine|mesh-list
25382701|NCT04609865|Anesthetics, Local|anesthetics, local|mesh-ancestor
25382702|NCT04609865|Anesthetics|anesthetics|mesh-ancestor
25382703|NCT04609865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25382704|NCT04609865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382705|NCT04609865|Sensory System Agents|sensory system agents|mesh-ancestor
25382706|NCT04609865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25382707|NCT04609865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25382708|NCT04609865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25382709|NCT04609865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25382710|NCT04609865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25382711|NCT04609865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382712|NCT04609761|Immunoglobulins|immunoglobulins|mesh-list
25382713|NCT04609761|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25382714|NCT04609761|Antibodies|antibodies|mesh-list
25382715|NCT04609761|gamma-Globulins|gamma-globulins|mesh-list
25382716|NCT04609761|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25382717|NCT04609761|Immunologic Factors|immunologic factors|mesh-ancestor
25382718|NCT04609761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382719|NCT04609592|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25382720|NCT04609592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382721|NCT04609592|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25382722|NCT04609566|Pembrolizumab|pembrolizumab|mesh-list
25382723|NCT04609566|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25382724|NCT04609566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25382725|NCT04609566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382727|NCT04609046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25382728|NCT04609046|Nivolumab|nivolumab|mesh-list
25382729|NCT04609046|Methotrexate|methotrexate|mesh-list
25382730|NCT04609046|Lenalidomide|lenalidomide|mesh-list
25382731|NCT04609046|Antibodies|antibodies|mesh-list
25382732|NCT04609046|Immunoglobulins|immunoglobulins|mesh-list
25382733|NCT04609046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25382734|NCT04609046|Immunologic Factors|immunologic factors|mesh-ancestor
25382735|NCT04609046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382736|NCT04609046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382737|NCT04609046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25382738|NCT04609046|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25382739|NCT04609046|Abortifacient Agents|abortifacient agents|mesh-ancestor
25382740|NCT04609046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25382741|NCT04609046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25382742|NCT04609046|Antimetabolites|antimetabolites|mesh-ancestor
25382743|NCT04609046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382744|NCT04609046|Dermatologic Agents|dermatologic agents|mesh-ancestor
25382745|NCT04609046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382746|NCT04609046|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25382747|NCT04609046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25382748|NCT04609046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25382749|NCT04609046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25382750|NCT04609046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25382751|NCT04609046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25382752|NCT04609046|Growth Substances|growth substances|mesh-ancestor
25382753|NCT04609046|Growth Inhibitors|growth inhibitors|mesh-ancestor
25382754|NCT04609020|Lidocaine|lidocaine|mesh-list
25382755|NCT04609020|Anesthetics, Local|anesthetics, local|mesh-ancestor
25382756|NCT04609020|Anesthetics|anesthetics|mesh-ancestor
25382757|NCT04609020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25382758|NCT04609020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382759|NCT04609020|Sensory System Agents|sensory system agents|mesh-ancestor
25382760|NCT04609020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25382761|NCT04609020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25382762|NCT04609020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25382763|NCT04609020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25382764|NCT04609020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25382765|NCT04609020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382766|NCT04608630|Zoledronic Acid|zoledronic acid|mesh-list
25382767|NCT04608630|Denosumab|denosumab|mesh-list
25382768|NCT04608630|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25382769|NCT04608630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382770|NCT04608331|Dexmedetomidine|dexmedetomidine|mesh-list
25382771|NCT04608331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25382772|NCT04608331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25382773|NCT04608331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382774|NCT04608331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25382776|NCT04608331|Sensory System Agents|sensory system agents|mesh-ancestor
25382777|NCT04608331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25382778|NCT04608331|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25382779|NCT04608331|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25382780|NCT04608331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25382781|NCT04608331|Adrenergic Agents|adrenergic agents|mesh-ancestor
25382782|NCT04608331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25382783|NCT04608331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382784|NCT04607954|Durvalumab|durvalumab|mesh-list
25382785|NCT04607954|Topotecan|topotecan|mesh-list
25382786|NCT04607954|Immunoglobulins|immunoglobulins|mesh-list
25382787|NCT04607954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25382788|NCT04607954|Immunoglobulin G|immunoglobulin g|mesh-list
25382789|NCT04607954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25382790|NCT04607954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382791|NCT04607954|Immunologic Factors|immunologic factors|mesh-ancestor
25382792|NCT04607954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382793|NCT04607954|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25382794|NCT04607954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25382795|NCT04607954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382796|NCT04607954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382797|NCT04607772|Gemcitabine|gemcitabine|mesh-list
25382798|NCT04607772|Rituximab|rituximab|mesh-list
25382799|NCT04607772|Oxaliplatin|oxaliplatin|mesh-list
25382801|NCT04607772|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
25382802|NCT04607772|Venetoclax|venetoclax|mesh-list
25382803|NCT04607772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25382804|NCT04607772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382805|NCT04607772|Immunologic Factors|immunologic factors|mesh-ancestor
25382806|NCT04607772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382807|NCT04607772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25382808|NCT04607772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25382809|NCT04607772|Antimetabolites|antimetabolites|mesh-ancestor
25382810|NCT04607772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382811|NCT04607772|Antiviral Agents|antiviral agents|mesh-ancestor
25382812|NCT04607772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25382813|NCT04607772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382814|NCT04607772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25382815|NCT04607772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25382816|NCT04607772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25382817|NCT04607772|Growth Substances|growth substances|mesh-ancestor
25382818|NCT04607772|Growth Inhibitors|growth inhibitors|mesh-ancestor
25382819|NCT04607772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25382820|NCT04607772|Alkylating Agents|alkylating agents|mesh-ancestor
25382821|NCT04607421|Leucovorin|leucovorin|mesh-list
25382822|NCT04607421|Bevacizumab|bevacizumab|mesh-list
25382823|NCT04607421|Cetuximab|cetuximab|mesh-list
25382824|NCT04607421|Fluorouracil|fluorouracil|mesh-list
25382825|NCT04607421|Capecitabine|capecitabine|mesh-list
25382826|NCT04607421|Oxaliplatin|oxaliplatin|mesh-list
25382827|NCT04607421|Irinotecan|irinotecan|mesh-list
25382828|NCT04607421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25382829|NCT04607421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382830|NCT04607421|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25382831|NCT04607421|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25382832|NCT04607421|Growth Substances|growth substances|mesh-ancestor
25382833|NCT04607421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382834|NCT04607421|Growth Inhibitors|growth inhibitors|mesh-ancestor
25382835|NCT04607421|Antimetabolites|antimetabolites|mesh-ancestor
25382836|NCT04607421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382837|NCT04607421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25382838|NCT04607421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25382839|NCT04607421|Immunologic Factors|immunologic factors|mesh-ancestor
25382840|NCT04607421|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25382841|NCT04607421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25382842|NCT04607421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382843|NCT04607421|Antidotes|antidotes|mesh-ancestor
25382844|NCT04607421|Protective Agents|protective agents|mesh-ancestor
25382845|NCT04607421|Vitamin B Complex|vitamin b complex|mesh-ancestor
25382846|NCT04607421|Vitamins|vitamins|mesh-ancestor
25382847|NCT04607421|Micronutrients|micronutrients|mesh-ancestor
25382848|NCT04606771|Osimertinib|osimertinib|mesh-list
25382849|NCT04606771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382850|NCT04606771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25382851|NCT04606771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382852|NCT04606771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382853|NCT04606446|Letrozole|letrozole|mesh-list
25382854|NCT04606446|Fulvestrant|fulvestrant|mesh-list
25382855|NCT04606446|Palbociclib|palbociclib|mesh-list
25382856|NCT04606446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382857|NCT04606446|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25382858|NCT04606446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25382859|NCT04606446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382860|NCT04606446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382861|NCT04606446|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25382862|NCT04606446|Hormone Antagonists|hormone antagonists|mesh-ancestor
25382863|NCT04606446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25382864|NCT04606446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382865|NCT04606446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25382866|NCT04606446|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25382867|NCT04606446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25382868|NCT04606381|Lazertinib|lazertinib|mesh-list
25382869|NCT04606381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25382870|NCT04606381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382871|NCT04606381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382872|NCT04606316|Nivolumab|nivolumab|mesh-list
25382873|NCT04606316|Ipilimumab|ipilimumab|mesh-list
25382874|NCT04606316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25382875|NCT04606316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382876|NCT04606316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25382877|NCT04606316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382878|NCT04606264|Lidocaine|lidocaine|mesh-list
25382879|NCT04606264|Ketamine|ketamine|mesh-list
25382880|NCT04606264|Morphine|morphine|mesh-list
25382881|NCT04606264|Gabapentin|gabapentin|mesh-list
25382882|NCT04606264|Hydromorphone|hydromorphone|mesh-list
25382883|NCT04606264|Aprepitant|aprepitant|mesh-list
25382884|NCT04606264|Anesthetics|anesthetics|mesh-list
25382885|NCT04606264|Perphenazine|perphenazine|mesh-list
25382886|NCT04606264|Anesthetics, Local|anesthetics, local|mesh-ancestor
25382887|NCT04606264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25382888|NCT04606264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382889|NCT04606264|Sensory System Agents|sensory system agents|mesh-ancestor
25382890|NCT04606264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25382891|NCT04606264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25382892|NCT04606264|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25382893|NCT04606264|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25382894|NCT04606264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25382895|NCT04606264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382896|NCT04606264|Analgesics|analgesics|mesh-ancestor
25382897|NCT04606264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25382898|NCT04606264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25382899|NCT04606264|Anesthetics, General|anesthetics, general|mesh-ancestor
25382900|NCT04606264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25382901|NCT04606264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25382902|NCT04606264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25382903|NCT04606264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25382904|NCT04606264|Narcotics|narcotics|mesh-ancestor
25382905|NCT04606264|Anticonvulsants|anticonvulsants|mesh-ancestor
25382906|NCT04606264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25382907|NCT04606264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25382908|NCT04606264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25382909|NCT04606264|Antimanic Agents|antimanic agents|mesh-ancestor
25382910|NCT04606264|Antiemetics|antiemetics|mesh-ancestor
25382911|NCT04606264|Autonomic Agents|autonomic agents|mesh-ancestor
25382912|NCT04606264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25382913|NCT04606264|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
25382914|NCT04606264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25382915|NCT04606264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25382916|NCT04606264|Dopamine Agents|dopamine agents|mesh-ancestor
25382917|NCT04605978|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25382918|NCT04605731|Durvalumab|durvalumab|mesh-list
25382919|NCT04605731|Ipilimumab|ipilimumab|mesh-list
25382920|NCT04605731|Tremelimumab|tremelimumab|mesh-list
25382921|NCT04605731|Immunoglobulins|immunoglobulins|mesh-list
25382922|NCT04605731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25382923|NCT04605731|Immunoglobulin G|immunoglobulin g|mesh-list
25382924|NCT04605731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25382925|NCT04605731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382926|NCT04605731|Immunologic Factors|immunologic factors|mesh-ancestor
25382927|NCT04605731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382928|NCT04605731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25382929|NCT04605731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382930|NCT04605393|Dronabinol|dronabinol|mesh-list
25382931|NCT04605393|Cannabidiol|cannabidiol|mesh-list
25382932|NCT04605393|Anticonvulsants|anticonvulsants|mesh-ancestor
25382933|NCT04605393|Hallucinogens|hallucinogens|mesh-ancestor
25382934|NCT04605393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382935|NCT04605393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25382936|NCT04605393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25382937|NCT04605393|Analgesics|analgesics|mesh-ancestor
25382938|NCT04605393|Sensory System Agents|sensory system agents|mesh-ancestor
25382939|NCT04605393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25382940|NCT04605393|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
25382941|NCT04605393|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
25382942|NCT04605393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25382943|NCT04605393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382944|NCT04605393|Hormones|hormones|mesh-ancestor
25382945|NCT04605393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25382946|NCT04605094|Benralizumab|benralizumab|mesh-list
25382947|NCT04605094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25382948|NCT04605094|Respiratory System Agents|respiratory system agents|mesh-ancestor
25382949|NCT04604704|Niacinamide|niacinamide|mesh-list
25382950|NCT04604704|Naltrexone|naltrexone|mesh-list
25382951|NCT04604704|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25382952|NCT04604704|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25383028|NCT04602494|Varenicline|varenicline|mesh-list
25382953|NCT04604704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382954|NCT04604704|Sensory System Agents|sensory system agents|mesh-ancestor
25382955|NCT04604704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25382956|NCT04604704|Vitamin B Complex|vitamin b complex|mesh-ancestor
25382957|NCT04604704|Vitamins|vitamins|mesh-ancestor
25382958|NCT04604704|Micronutrients|micronutrients|mesh-ancestor
25382959|NCT04604132|Paclitaxel|paclitaxel|mesh-list
25382960|NCT04604132|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25382961|NCT04604132|Atezolizumab|atezolizumab|mesh-list
25382962|NCT04604132|Ramucirumab|ramucirumab|mesh-list
25382963|NCT04604132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25382964|NCT04604132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25382965|NCT04604132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382966|NCT04604132|Tubulin Modulators|tubulin modulators|mesh-ancestor
25382967|NCT04604132|Antimitotic Agents|antimitotic agents|mesh-ancestor
25382968|NCT04604132|Mitosis Modulators|mitosis modulators|mesh-ancestor
25382969|NCT04604132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382970|NCT04604132|Immunologic Factors|immunologic factors|mesh-ancestor
25382971|NCT04604132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382972|NCT04603807|Crizotinib|crizotinib|mesh-list
25382973|NCT04603807|Entrectinib|entrectinib|mesh-list
25382974|NCT04603807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25382975|NCT04603807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25382976|NCT04603807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382977|NCT04603807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382978|NCT04603651|Bamlanivimab|bamlanivimab|mesh-list
25382979|NCT04603651|Antiviral Agents|antiviral agents|mesh-ancestor
25382980|NCT04603651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25382981|NCT04603508|Calcium, Dietary|calcium, dietary|mesh-list
25382982|NCT04603508|Empagliflozin|empagliflozin|mesh-list
25382983|NCT04603508|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25382984|NCT04603508|Calcium|calcium|mesh-list
25382985|NCT04603508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25382986|NCT04603508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25382987|NCT04603508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25382988|NCT04603508|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25382989|NCT04603508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25382990|NCT04603508|Antimetabolites|antimetabolites|mesh-ancestor
25382991|NCT04603508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25382992|NCT04603508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25382993|NCT04603508|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25382994|NCT04603508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25382995|NCT04603508|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25382996|NCT04603508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25382997|NCT04603001|Azacitidine|azacitidine|mesh-list
25382998|NCT04603001|Venetoclax|venetoclax|mesh-list
25382999|NCT04603001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25383000|NCT04603001|Antimetabolites|antimetabolites|mesh-ancestor
25383001|NCT04603001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383002|NCT04603001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383003|NCT04603001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383004|NCT04602975|Aluminum Hydroxide|aluminum hydroxide|mesh-list
25383005|NCT04602975|Vaccines|vaccines|mesh-list
25383006|NCT04602975|Immunologic Factors|immunologic factors|mesh-ancestor
25383007|NCT04602975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383008|NCT04602975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25383009|NCT04602975|Antacids|antacids|mesh-ancestor
25383010|NCT04602975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383011|NCT04602975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25383012|NCT04602754|Calcium, Dietary|calcium, dietary|mesh-list
25383013|NCT04602754|Empagliflozin|empagliflozin|mesh-list
25383014|NCT04602754|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
25383015|NCT04602754|Calcium|calcium|mesh-list
25383016|NCT04602754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25383017|NCT04602754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383018|NCT04602754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25383019|NCT04602754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
25383020|NCT04602754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
25383021|NCT04602754|Antimetabolites|antimetabolites|mesh-ancestor
25383022|NCT04602754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383023|NCT04602754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
25383024|NCT04602754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
25383025|NCT04602754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383026|NCT04602754|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25383027|NCT04602754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25383029|NCT04602494|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25383030|NCT04602494|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25383031|NCT04602494|Cholinergic Agents|cholinergic agents|mesh-ancestor
25383032|NCT04602494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25383033|NCT04602494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383034|NCT04602494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383035|NCT04602221|Lamotrigine|lamotrigine|mesh-list
25383036|NCT04602221|BI 425809|bi 425809|mesh-list
25383037|NCT04602221|BI 409306|bi 409306|mesh-list
25383038|NCT04602221|Anticonvulsants|anticonvulsants|mesh-ancestor
25383039|NCT04602221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25383040|NCT04602221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25383041|NCT04602221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383042|NCT04602221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25383043|NCT04602221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383044|NCT04602221|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25383045|NCT04602221|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25383046|NCT04602221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25383047|NCT04602221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25383048|NCT04602221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25383049|NCT04602221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25383050|NCT04602221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383051|NCT04602221|Nootropic Agents|nootropic agents|mesh-ancestor
25383052|NCT04601883|Colchicine|colchicine|mesh-list
25383053|NCT04601883|Gout Suppressants|gout suppressants|mesh-ancestor
25383054|NCT04601883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25383055|NCT04601883|Tubulin Modulators|tubulin modulators|mesh-ancestor
25383056|NCT04601883|Antimitotic Agents|antimitotic agents|mesh-ancestor
25383057|NCT04601883|Mitosis Modulators|mitosis modulators|mesh-ancestor
25383058|NCT04601883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383059|NCT04601883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383060|NCT04601857|Pembrolizumab|pembrolizumab|mesh-list
25383061|NCT04601857|Futibatinib|futibatinib|mesh-list
25383062|NCT04601857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25383063|NCT04601857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383064|NCT04601402|Avelumab|avelumab|mesh-list
25383065|NCT04601402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25383066|NCT04601402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383067|NCT04601350|Anesthetics|anesthetics|mesh-list
25383068|NCT04601350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25383069|NCT04601350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383070|NCT04600752|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25383071|NCT04600752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25383072|NCT04600752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25383073|NCT04600752|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25383074|NCT04600752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383075|NCT04600752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383076|NCT04600362|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25383077|NCT04600362|Immunologic Factors|immunologic factors|mesh-ancestor
25383078|NCT04600362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383079|NCT04600336|Oxybutynin|oxybutynin|mesh-list
25383080|NCT04600336|Parasympatholytics|parasympatholytics|mesh-ancestor
25383081|NCT04600336|Autonomic Agents|autonomic agents|mesh-ancestor
25383082|NCT04600336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25383083|NCT04600336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383084|NCT04600336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
25383085|NCT04600336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
25383086|NCT04600336|Cholinergic Agents|cholinergic agents|mesh-ancestor
25383087|NCT04600336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25383088|NCT04600336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383089|NCT04600336|Urological Agents|urological agents|mesh-ancestor
25383090|NCT04599868|Magnesium Sulfate|magnesium sulfate|mesh-list
25383091|NCT04599868|Analgesics|analgesics|mesh-ancestor
25383092|NCT04599868|Sensory System Agents|sensory system agents|mesh-ancestor
25383093|NCT04599868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25383094|NCT04599868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383095|NCT04599868|Anesthetics|anesthetics|mesh-ancestor
25383096|NCT04599868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25383097|NCT04599868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25383098|NCT04599868|Anticonvulsants|anticonvulsants|mesh-ancestor
25383099|NCT04599868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25383100|NCT04599868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25383101|NCT04599868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383102|NCT04599868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25383103|NCT04599868|Tocolytic Agents|tocolytic agents|mesh-ancestor
25383104|NCT04599868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25383105|NCT04599855|Esketamine|esketamine|mesh-list
25383106|NCT04599855|Antidepressive Agents|antidepressive agents|mesh-ancestor
25383107|NCT04599855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25383108|NCT04599465|Ivacaftor|ivacaftor|mesh-list
25383110|NCT04599465|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
25383111|NCT04599465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25383112|NCT04599465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383113|NCT04599140|Nivolumab|nivolumab|mesh-list
25383114|NCT04599140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25383115|NCT04599140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383116|NCT04599140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25383117|NCT04599140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383118|NCT04599062|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
25383119|NCT04599062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25383120|NCT04599062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383121|NCT04598477|Prednisone|prednisone|mesh-list
25383122|NCT04598477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25383123|NCT04598477|Glucocorticoids|glucocorticoids|mesh-ancestor
25383124|NCT04598477|Hormones|hormones|mesh-ancestor
25383125|NCT04598477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25383126|NCT04598477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383127|NCT04598477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25383128|NCT04598477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383129|NCT04598451|Prednisone|prednisone|mesh-list
25383130|NCT04598451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25383131|NCT04598451|Glucocorticoids|glucocorticoids|mesh-ancestor
25383132|NCT04598451|Hormones|hormones|mesh-ancestor
25383133|NCT04598451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25383134|NCT04598451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383135|NCT04598451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25383136|NCT04598451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383137|NCT04597619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
25383138|NCT04597619|Analgesics|analgesics|mesh-ancestor
25383139|NCT04597619|Sensory System Agents|sensory system agents|mesh-ancestor
25383140|NCT04597619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25383141|NCT04597619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383142|NCT04597268|Midazolam|midazolam|mesh-list
25383143|NCT04597268|Dexmedetomidine|dexmedetomidine|mesh-list
25383144|NCT04597268|Ketamine|ketamine|mesh-list
25383145|NCT04597268|Propofol|propofol|mesh-list
25383146|NCT04597268|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25383147|NCT04597268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25383148|NCT04597268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383149|NCT04597268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25383150|NCT04597268|Anesthetics, General|anesthetics, general|mesh-ancestor
25383151|NCT04597268|Anesthetics|anesthetics|mesh-ancestor
25383152|NCT04597268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25383153|NCT04597268|Analgesics|analgesics|mesh-ancestor
25383154|NCT04597268|Sensory System Agents|sensory system agents|mesh-ancestor
25383155|NCT04597268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25383156|NCT04597268|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25383157|NCT04597268|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25383158|NCT04597268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25383159|NCT04597268|Adrenergic Agents|adrenergic agents|mesh-ancestor
25383160|NCT04597268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25383161|NCT04597268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383162|NCT04597268|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25383163|NCT04597268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25383164|NCT04597268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25383165|NCT04597268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25383166|NCT04597268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25383167|NCT04597268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25383168|NCT04597268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25383169|NCT04597268|GABA Modulators|gaba modulators|mesh-ancestor
25383170|NCT04597268|GABA Agents|gaba agents|mesh-ancestor
25383171|NCT04597190|Norepinephrine|norepinephrine|mesh-list
25383172|NCT04597190|Serotonin|serotonin|mesh-list
25383173|NCT04597190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
25383174|NCT04597190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25383175|NCT04597190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25383176|NCT04597190|Adrenergic Agents|adrenergic agents|mesh-ancestor
25383177|NCT04597190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25383178|NCT04597190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383179|NCT04597190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383180|NCT04597190|Sympathomimetics|sympathomimetics|mesh-ancestor
25383181|NCT04597190|Autonomic Agents|autonomic agents|mesh-ancestor
25383182|NCT04597190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25383183|NCT04597190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25383184|NCT04597190|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25383185|NCT04597190|Serotonin Agents|serotonin agents|mesh-ancestor
25383186|NCT04597190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25383187|NCT04597190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25383188|NCT04597125|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25383189|NCT04597125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383190|NCT04596995|Rozanolixizumab|rozanolixizumab|mesh-list
25383191|NCT04596995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25383192|NCT04596995|Immunologic Factors|immunologic factors|mesh-ancestor
25383193|NCT04596995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383194|NCT04595370|Dapagliflozin|dapagliflozin|mesh-list
25383195|NCT04595370|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25383196|NCT04595370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383197|NCT04595370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25383198|NCT04595370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383199|NCT04595045|Botulinum Toxins|botulinum toxins|mesh-list
25383200|NCT04595045|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
25383201|NCT04595045|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
25383202|NCT04595045|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
25383203|NCT04595045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25383204|NCT04595045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383205|NCT04595045|Cholinergic Agents|cholinergic agents|mesh-ancestor
25383206|NCT04595045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25383207|NCT04595045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383208|NCT04595045|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25383209|NCT04595045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25383210|NCT04594811|Nivolumab|nivolumab|mesh-list
25383211|NCT04594811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25383212|NCT04594811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383213|NCT04594811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25383214|NCT04594811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383215|NCT04594772|Gemcitabine|gemcitabine|mesh-list
25383216|NCT04594772|Paclitaxel|paclitaxel|mesh-list
25383217|NCT04594772|Fluorouracil|fluorouracil|mesh-list
25383218|NCT04594772|Oxaliplatin|oxaliplatin|mesh-list
25383219|NCT04594772|Irinotecan|irinotecan|mesh-list
25383220|NCT04594772|Folfirinox|folfirinox|mesh-list
25383221|NCT04594772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25383222|NCT04594772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383223|NCT04594772|Tubulin Modulators|tubulin modulators|mesh-ancestor
25383224|NCT04594772|Antimitotic Agents|antimitotic agents|mesh-ancestor
25383225|NCT04594772|Mitosis Modulators|mitosis modulators|mesh-ancestor
25383226|NCT04594772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383227|NCT04594772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25383228|NCT04594772|Antimetabolites|antimetabolites|mesh-ancestor
25383229|NCT04594772|Antiviral Agents|antiviral agents|mesh-ancestor
25383230|NCT04594772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25383231|NCT04594772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383232|NCT04594772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25383233|NCT04594772|Immunologic Factors|immunologic factors|mesh-ancestor
25383234|NCT04594772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383235|NCT04594772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25383236|NCT04594772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25383237|NCT04594733|Minocycline|minocycline|mesh-list
25383238|NCT04594733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25383239|NCT04594733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25383240|NCT04594239|Lidocaine|lidocaine|mesh-list
25383241|NCT04594239|Hyaluronic Acid|hyaluronic acid|mesh-list
25383242|NCT04594239|Anesthetics, Local|anesthetics, local|mesh-ancestor
25383243|NCT04594239|Anesthetics|anesthetics|mesh-ancestor
25383244|NCT04594239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25383245|NCT04594239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383246|NCT04594239|Sensory System Agents|sensory system agents|mesh-ancestor
25383247|NCT04594239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25383248|NCT04594239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25383249|NCT04594239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25383250|NCT04594239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25383251|NCT04594239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25383252|NCT04594239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383253|NCT04594239|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25383254|NCT04594239|Immunologic Factors|immunologic factors|mesh-ancestor
25383255|NCT04594239|Viscosupplements|viscosupplements|mesh-ancestor
25383256|NCT04594239|Protective Agents|protective agents|mesh-ancestor
25383257|NCT04594018|Minoxidil|minoxidil|mesh-list
25383258|NCT04594018|Finasteride|finasteride|mesh-list
25383259|NCT04594018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25383260|NCT04594018|Vasodilator Agents|vasodilator agents|mesh-ancestor
25383261|NCT04594018|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
25383262|NCT04594018|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25383263|NCT04594018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383264|NCT04594018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383265|NCT04594018|Hormone Antagonists|hormone antagonists|mesh-ancestor
25383266|NCT04594018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25383267|NCT04594018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383268|NCT04594018|Urological Agents|urological agents|mesh-ancestor
25383269|NCT04593927|Siponimod|siponimod|mesh-list
25383270|NCT04593927|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25383271|NCT04593927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383272|NCT04593927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25383273|NCT04593927|Immunologic Factors|immunologic factors|mesh-ancestor
25383274|NCT04593927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383275|NCT04593758|Hydroxychloroquine|hydroxychloroquine|mesh-list
25383276|NCT04593758|Antimalarials|antimalarials|mesh-ancestor
25383277|NCT04593758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25383278|NCT04593758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25383279|NCT04593758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25383280|NCT04593758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383281|NCT04593758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383282|NCT04593758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25383283|NCT04593329|Dipyrone|dipyrone|mesh-list
25383284|NCT04593329|Tramadol|tramadol|mesh-list
25383285|NCT04593329|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25383286|NCT04593329|Narcotics|narcotics|mesh-ancestor
25383287|NCT04593329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25383288|NCT04593329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383289|NCT04593329|Analgesics|analgesics|mesh-ancestor
25383290|NCT04593329|Sensory System Agents|sensory system agents|mesh-ancestor
25383291|NCT04593329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25383292|NCT04593329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25383293|NCT04593329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25383294|NCT04593329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25383295|NCT04593329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25383296|NCT04593329|Antipyretics|antipyretics|mesh-ancestor
25383297|NCT04592913|Durvalumab|durvalumab|mesh-list
25383298|NCT04592913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25383299|NCT04592913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383300|NCT04592653|Pembrolizumab|pembrolizumab|mesh-list
25383301|NCT04592653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25383302|NCT04592653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383303|NCT04592016|Diclofenac|diclofenac|mesh-list
25383305|NCT04592016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25383306|NCT04592016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25383307|NCT04592016|Analgesics|analgesics|mesh-ancestor
25383308|NCT04592016|Sensory System Agents|sensory system agents|mesh-ancestor
25383309|NCT04592016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25383310|NCT04592016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383311|NCT04592016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25383312|NCT04592016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25383313|NCT04592016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25383314|NCT04592016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383315|NCT04592016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383316|NCT04592016|Keratolytic Agents|keratolytic agents|mesh-ancestor
25383317|NCT04592016|Dermatologic Agents|dermatologic agents|mesh-ancestor
25383318|NCT04591210|Angiotensin II|angiotensin ii|mesh-list
25383319|NCT04591210|Giapreza|giapreza|mesh-list
25383320|NCT04591210|Enzyme Inhibitors|enzyme inhibitors|mesh-list
25383321|NCT04591210|Angiotensinogen|angiotensinogen|mesh-list
25383322|NCT04591210|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
25383323|NCT04591210|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
25383324|NCT04591210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383325|NCT04591210|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
25383326|NCT04591210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25383327|NCT04591210|Protease Inhibitors|protease inhibitors|mesh-ancestor
25383328|NCT04590963|Cetuximab|cetuximab|mesh-list
25383329|NCT04590963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25383330|NCT04590963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383331|NCT04590781|Pembrolizumab|pembrolizumab|mesh-list
25383332|NCT04590781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25383333|NCT04590781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383334|NCT04590495|Cannabidiol|cannabidiol|mesh-list
25383335|NCT04590495|Anticonvulsants|anticonvulsants|mesh-ancestor
25383336|NCT04590404|Nicotine|nicotine|mesh-list
25383337|NCT04590404|Varenicline|varenicline|mesh-list
25383338|NCT04590404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
25383339|NCT04590404|Autonomic Agents|autonomic agents|mesh-ancestor
25383340|NCT04590404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25383341|NCT04590404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383342|NCT04590404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
25383343|NCT04590404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
25383344|NCT04590404|Cholinergic Agents|cholinergic agents|mesh-ancestor
25383345|NCT04590404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25383346|NCT04590404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383347|NCT04590326|Cemiplimab|cemiplimab|mesh-list
25383348|NCT04590326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25383349|NCT04590326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383350|NCT04590248|Adavosertib|adavosertib|mesh-list
25383351|NCT04590248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383352|NCT04590248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383353|NCT04589845|Trastuzumab|trastuzumab|mesh-list
25383354|NCT04589845|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
25383355|NCT04589845|Atezolizumab|atezolizumab|mesh-list
25383356|NCT04589845|Maytansine|maytansine|mesh-list
25383357|NCT04589845|Pralsetinib|pralsetinib|mesh-list
25383358|NCT04589845|Entrectinib|entrectinib|mesh-list
25383359|NCT04589845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25383360|NCT04589845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383361|NCT04589845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25383362|NCT04589845|Tubulin Modulators|tubulin modulators|mesh-ancestor
25383363|NCT04589845|Antimitotic Agents|antimitotic agents|mesh-ancestor
25383364|NCT04589845|Mitosis Modulators|mitosis modulators|mesh-ancestor
25383365|NCT04589845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383366|NCT04589845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25383367|NCT04589845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383368|NCT04589754|Ifosfamide|ifosfamide|mesh-list
25383369|NCT04589754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383370|NCT04589754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383371|NCT04589754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25383372|NCT04589754|Alkylating Agents|alkylating agents|mesh-ancestor
25383373|NCT04588792|Furosemide|furosemide|mesh-list
25383374|NCT04588792|Diuretics|diuretics|mesh-ancestor
25383375|NCT04588792|Natriuretic Agents|natriuretic agents|mesh-ancestor
25383376|NCT04588792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383377|NCT04588792|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
25383378|NCT04588792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25383379|NCT04588792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383380|NCT04588545|Trastuzumab|trastuzumab|mesh-list
25383381|NCT04588545|Pertuzumab|pertuzumab|mesh-list
25383382|NCT04588545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25383383|NCT04588545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383384|NCT04588259|Insulin|insulin|mesh-list
25383385|NCT04588259|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
25383386|NCT04588259|Insulin Aspart|insulin aspart|mesh-list
25383387|NCT04588259|Insulin, Long-Acting|insulin, long-acting|mesh-list
25383388|NCT04588259|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
25383389|NCT04588259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25383390|NCT04588259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383391|NCT04588246|Memantine|memantine|mesh-list
25383392|NCT04588246|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25383393|NCT04588246|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25383394|NCT04588246|Dopamine Agents|dopamine agents|mesh-ancestor
25383395|NCT04588246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25383396|NCT04588246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383397|NCT04588246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383398|NCT04588246|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25383399|NCT04588246|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25383400|NCT04588233|Melatonin|melatonin|mesh-list
25383401|NCT04588233|Antioxidants|antioxidants|mesh-ancestor
25383402|NCT04588233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383403|NCT04588233|Protective Agents|protective agents|mesh-ancestor
25383406|NCT04587791|Cannabidiol|cannabidiol|mesh-list
25383407|NCT04587791|Anticonvulsants|anticonvulsants|mesh-ancestor
25383483|NCT04586023|Immunologic Factors|immunologic factors|mesh-ancestor
25383410|NCT04587128|Irinotecan|irinotecan|mesh-list
25383411|NCT04587128|Cetuximab|cetuximab|mesh-list
25383412|NCT04587128|Panitumumab|panitumumab|mesh-list
25383413|NCT04587128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25383414|NCT04587128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25383415|NCT04587128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383416|NCT04587128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383417|NCT04587128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383418|NCT04587128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25383419|NCT04587089|Anti-Infective Agents|anti-infective agents|mesh-list
25383420|NCT04587089|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25383421|NCT04586985|Midazolam|midazolam|mesh-list
25383422|NCT04586985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25383423|NCT04586985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25383424|NCT04586985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25383425|NCT04586985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383426|NCT04586985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25383427|NCT04586985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25383428|NCT04586985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25383429|NCT04586985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25383430|NCT04586985|Anesthetics, General|anesthetics, general|mesh-ancestor
25383431|NCT04586985|Anesthetics|anesthetics|mesh-ancestor
25383432|NCT04586985|GABA Modulators|gaba modulators|mesh-ancestor
25383433|NCT04586985|GABA Agents|gaba agents|mesh-ancestor
25383434|NCT04586985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25383435|NCT04586985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383436|NCT04586920|Itraconazole|itraconazole|mesh-list
25383437|NCT04586920|Midazolam|midazolam|mesh-list
25383438|NCT04586920|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25383439|NCT04586920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25383440|NCT04586920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25383441|NCT04586920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383442|NCT04586920|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25383443|NCT04586920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25383444|NCT04586920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25383445|NCT04586920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25383446|NCT04586920|Anesthetics, General|anesthetics, general|mesh-ancestor
25383447|NCT04586920|Anesthetics|anesthetics|mesh-ancestor
25383448|NCT04586920|GABA Modulators|gaba modulators|mesh-ancestor
25383449|NCT04586920|GABA Agents|gaba agents|mesh-ancestor
25383450|NCT04586920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25383451|NCT04586920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383452|NCT04586920|Antifungal Agents|antifungal agents|mesh-ancestor
25383453|NCT04586920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25383454|NCT04586920|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
25383455|NCT04586920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25383456|NCT04586920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383457|NCT04586920|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25383458|NCT04586920|Hormone Antagonists|hormone antagonists|mesh-ancestor
25383459|NCT04586920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25383460|NCT04586920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
25383461|NCT04586426|Daratumumab|daratumumab|mesh-list
25383462|NCT04586426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383463|NCT04586231|Lenvatinib|lenvatinib|mesh-list
25383464|NCT04586231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383465|NCT04586231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25383466|NCT04586231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383467|NCT04586231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383468|NCT04586166|Imidacloprid|imidacloprid|mesh-list
25383469|NCT04586166|Cholinergic Agents|cholinergic agents|mesh-ancestor
25383470|NCT04586166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25383471|NCT04586166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383472|NCT04586166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383473|NCT04586023|Teriflunomide|teriflunomide|mesh-list
25383474|NCT04586023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25383475|NCT04586023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25383476|NCT04586023|Analgesics|analgesics|mesh-ancestor
25383477|NCT04586023|Sensory System Agents|sensory system agents|mesh-ancestor
25383478|NCT04586023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25383479|NCT04586023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383480|NCT04586023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25383481|NCT04586023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25383482|NCT04586023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25383484|NCT04586010|Teriflunomide|teriflunomide|mesh-list
25383485|NCT04586010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25383486|NCT04586010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25383487|NCT04586010|Analgesics|analgesics|mesh-ancestor
25383488|NCT04586010|Sensory System Agents|sensory system agents|mesh-ancestor
25383489|NCT04586010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25383490|NCT04586010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383491|NCT04586010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25383492|NCT04586010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25383493|NCT04586010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25383494|NCT04586010|Immunologic Factors|immunologic factors|mesh-ancestor
25383495|NCT04585958|Trastuzumab|trastuzumab|mesh-list
25383496|NCT04585958|Olaparib|olaparib|mesh-list
25383497|NCT04585958|Camptothecin|camptothecin|mesh-list
25383498|NCT04585958|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
25383499|NCT04585958|Immunoconjugates|immunoconjugates|mesh-list
25383500|NCT04585958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25383501|NCT04585958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383502|NCT04585958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383503|NCT04585958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383504|NCT04585958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25383505|NCT04585958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25383506|NCT04585958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25383507|NCT04585958|Immunologic Factors|immunologic factors|mesh-ancestor
25383508|NCT04585958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383509|NCT04585815|Axitinib|axitinib|mesh-list
25383510|NCT04585815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383511|NCT04585815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25383512|NCT04585815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383513|NCT04585815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383514|NCT04585789|Tenofovir|tenofovir|mesh-list
25383515|NCT04585789|Entecavir|entecavir|mesh-list
25383516|NCT04585789|JNJ-56136379|jnj-56136379|mesh-list
25383517|NCT04585789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
25383518|NCT04585789|Antiviral Agents|antiviral agents|mesh-ancestor
25383519|NCT04585789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25383520|NCT04585789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25383521|NCT04585789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25383522|NCT04585789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383523|NCT04585789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383524|NCT04585789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25383525|NCT04585789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25383526|NCT04585737|Tenofovir|tenofovir|mesh-list
25383527|NCT04585737|Lamivudine|lamivudine|mesh-list
25383528|NCT04585737|Emtricitabine|emtricitabine|mesh-list
25383529|NCT04585737|Dolutegravir|dolutegravir|mesh-list
25383530|NCT04585737|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
25383531|NCT04585737|Antiviral Agents|antiviral agents|mesh-ancestor
25383532|NCT04585737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25414820|NCT03037437|Sorafenib|sorafenib|mesh-list
25383533|NCT04585737|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25383534|NCT04585737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25383535|NCT04585737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383536|NCT04585737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383537|NCT04585737|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25383538|NCT04585737|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25383539|NCT04585737|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25383540|NCT04585737|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25383541|NCT04584255|Niraparib|niraparib|mesh-list
25383542|NCT04584255|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25383543|NCT04584255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383544|NCT04584255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383545|NCT04584255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383546|NCT04584112|Paclitaxel|paclitaxel|mesh-list
25383547|NCT04584112|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25383548|NCT04584112|Cyclophosphamide|cyclophosphamide|mesh-list
25383549|NCT04584112|Carboplatin|carboplatin|mesh-list
25383550|NCT04584112|Doxorubicin|doxorubicin|mesh-list
25383551|NCT04584112|Atezolizumab|atezolizumab|mesh-list
25383552|NCT04584112|Molgramostim|molgramostim|mesh-list
25383553|NCT04584112|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25383554|NCT04584112|Lenograstim|lenograstim|mesh-list
25383555|NCT04584112|Sargramostim|sargramostim|mesh-list
25383556|NCT04584112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25383557|NCT04584112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383558|NCT04584112|Tubulin Modulators|tubulin modulators|mesh-ancestor
25383559|NCT04584112|Antimitotic Agents|antimitotic agents|mesh-ancestor
25383560|NCT04584112|Mitosis Modulators|mitosis modulators|mesh-ancestor
25383561|NCT04584112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383562|NCT04584112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25383563|NCT04584112|Immunologic Factors|immunologic factors|mesh-ancestor
25383564|NCT04584112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383565|NCT04584112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25383566|NCT04584112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25383567|NCT04584112|Alkylating Agents|alkylating agents|mesh-ancestor
25383568|NCT04584112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25383569|NCT04584112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25383570|NCT04584112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25383571|NCT04584112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25383572|NCT04584112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383573|NCT04584112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25383574|NCT04583618|Vaccines|vaccines|mesh-list
25383575|NCT04583618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25383576|NCT04583618|Immunologic Factors|immunologic factors|mesh-ancestor
25383577|NCT04583618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383578|NCT04583007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25383579|NCT04583007|Immunologic Factors|immunologic factors|mesh-ancestor
25383580|NCT04583007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383581|NCT04582266|Remdesivir|remdesivir|mesh-list
25383582|NCT04582266|Antimetabolites|antimetabolites|mesh-ancestor
25383583|NCT04582266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383584|NCT04582266|Antiviral Agents|antiviral agents|mesh-ancestor
25383585|NCT04582266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25383586|NCT04581603|Topiramate|topiramate|mesh-list
25383587|NCT04581603|Anticonvulsants|anticonvulsants|mesh-ancestor
25383588|NCT04581603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25383589|NCT04581603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383590|NCT04581395|Rocuronium|rocuronium|mesh-list
25383591|NCT04581395|Succinylcholine|succinylcholine|mesh-list
25383592|NCT04581395|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
25383593|NCT04581395|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
25383594|NCT04581395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
25383595|NCT04581395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25383596|NCT04581395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383597|NCT04581395|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
25383598|NCT04580472|Clindamycin|clindamycin|mesh-list
25383599|NCT04580472|Clindamycin palmitate|clindamycin palmitate|mesh-list
25383600|NCT04580472|Clindamycin phosphate|clindamycin phosphate|mesh-list
25383601|NCT04580472|Cephalexin|cephalexin|mesh-list
25383602|NCT04580472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25383603|NCT04580472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25383604|NCT04580472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25383605|NCT04580472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383606|NCT04580472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25724254|NCT02536105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25383607|NCT04580121|Acetaminophen|acetaminophen|mesh-list
25383608|NCT04580121|Diphenhydramine|diphenhydramine|mesh-list
25383609|NCT04580121|Promethazine|promethazine|mesh-list
25383610|NCT04580121|Dexamethasone|dexamethasone|mesh-list
25383611|NCT04580121|Dasatinib|dasatinib|mesh-list
25383612|NCT04580121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25383613|NCT04580121|Antiemetics|antiemetics|mesh-ancestor
25383614|NCT04580121|Autonomic Agents|autonomic agents|mesh-ancestor
25383615|NCT04580121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25383616|NCT04580121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383617|NCT04580121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25383618|NCT04580121|Glucocorticoids|glucocorticoids|mesh-ancestor
25383619|NCT04580121|Hormones|hormones|mesh-ancestor
25383620|NCT04580121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25383621|NCT04580121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25383622|NCT04580121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383623|NCT04580121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25383624|NCT04580121|Analgesics|analgesics|mesh-ancestor
25383625|NCT04580121|Sensory System Agents|sensory system agents|mesh-ancestor
25383626|NCT04580121|Antipyretics|antipyretics|mesh-ancestor
25383627|NCT04580121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25383628|NCT04580121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383629|NCT04580121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383630|NCT04580121|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25383631|NCT04580121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25383632|NCT04580121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25383633|NCT04580121|Anesthetics, Local|anesthetics, local|mesh-ancestor
25383634|NCT04580121|Anesthetics|anesthetics|mesh-ancestor
25383635|NCT04580121|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25383636|NCT04580121|Histamine Antagonists|histamine antagonists|mesh-ancestor
25383637|NCT04580121|Histamine Agents|histamine agents|mesh-ancestor
25383638|NCT04580121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25383639|NCT04580121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25383640|NCT04580121|Antipruritics|antipruritics|mesh-ancestor
25383641|NCT04580121|Dermatologic Agents|dermatologic agents|mesh-ancestor
25383642|NCT04579380|Trastuzumab|trastuzumab|mesh-list
25383643|NCT04579380|Fulvestrant|fulvestrant|mesh-list
25383644|NCT04579380|Tucatinib|tucatinib|mesh-list
25383645|NCT04579380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25383646|NCT04579380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383647|NCT04579380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25383648|NCT04579380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25383649|NCT04579380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25383650|NCT04579380|Hormone Antagonists|hormone antagonists|mesh-ancestor
25383651|NCT04579380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25383652|NCT04579380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383653|NCT04579380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25383654|NCT04579380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383655|NCT04579380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383656|NCT04579224|Gemcitabine|gemcitabine|mesh-list
25383657|NCT04579224|Paclitaxel|paclitaxel|mesh-list
25383658|NCT04579224|Docetaxel|docetaxel|mesh-list
25383659|NCT04579224|Halichondrin B|halichondrin b|mesh-list
25383660|NCT04579224|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
25383661|NCT04579224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25383662|NCT04579224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383663|NCT04579224|Tubulin Modulators|tubulin modulators|mesh-ancestor
25383664|NCT04579224|Antimitotic Agents|antimitotic agents|mesh-ancestor
25383665|NCT04579224|Mitosis Modulators|mitosis modulators|mesh-ancestor
25383666|NCT04579224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383667|NCT04579224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25383668|NCT04579224|Antimetabolites|antimetabolites|mesh-ancestor
25383669|NCT04579224|Antiviral Agents|antiviral agents|mesh-ancestor
25383670|NCT04579224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25383671|NCT04579224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383672|NCT04579224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25383673|NCT04579224|Immunologic Factors|immunologic factors|mesh-ancestor
25383674|NCT04579224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383675|NCT04578938|Ketamine|ketamine|mesh-list
25383676|NCT04578938|Analgesics|analgesics|mesh-ancestor
25383677|NCT04578938|Sensory System Agents|sensory system agents|mesh-ancestor
25383678|NCT04578938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25383679|NCT04578938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383680|NCT04578938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
25383681|NCT04578938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25383682|NCT04578938|Anesthetics, General|anesthetics, general|mesh-ancestor
25383683|NCT04578938|Anesthetics|anesthetics|mesh-ancestor
25383687|NCT04578938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25383688|NCT04578938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383689|NCT04578756|Cariprazine|cariprazine|mesh-list
25383690|NCT04578756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25383691|NCT04578756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25383692|NCT04578756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25383693|NCT04578756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383694|NCT04578756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25383696|NCT04578639|Ocrelizumab|ocrelizumab|mesh-list
25383697|NCT04578639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25383698|NCT04578639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383699|NCT04578639|Immunologic Factors|immunologic factors|mesh-ancestor
25383700|NCT04578639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383701|NCT04578639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25383702|NCT04577833|Prednisone|prednisone|mesh-list
25383703|NCT04577833|Abiraterone Acetate|abiraterone acetate|mesh-list
25383704|NCT04577833|Niraparib|niraparib|mesh-list
25383705|NCT04577833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25383706|NCT04577833|Glucocorticoids|glucocorticoids|mesh-ancestor
25383707|NCT04577833|Hormones|hormones|mesh-ancestor
25383780|NCT04572815|Immunologic Factors|immunologic factors|mesh-ancestor
25383708|NCT04577833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25383709|NCT04577833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383710|NCT04577833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25383711|NCT04577833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383712|NCT04577833|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25383713|NCT04577833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383714|NCT04577833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383715|NCT04577833|Hormone Antagonists|hormone antagonists|mesh-ancestor
25383716|NCT04577833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25383717|NCT04577833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25383719|NCT04577755|Immunologic Factors|immunologic factors|mesh-ancestor
25383720|NCT04577755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383721|NCT04577755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25383722|NCT04577755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25383723|NCT04577755|Growth Substances|growth substances|mesh-ancestor
25383724|NCT04577755|Growth Inhibitors|growth inhibitors|mesh-ancestor
25383725|NCT04577755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383726|NCT04576455|Fulvestrant|fulvestrant|mesh-list
25383727|NCT04576455|Aromatase Inhibitors|aromatase inhibitors|mesh-list
25383728|NCT04576455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25383729|NCT04576455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383730|NCT04576455|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25383731|NCT04576455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25383732|NCT04576455|Hormone Antagonists|hormone antagonists|mesh-ancestor
25383733|NCT04576455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25383734|NCT04576455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383735|NCT04576455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25383736|NCT04576455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383737|NCT04576455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383743|NCT04576117|Vinblastine|vinblastine|mesh-list
25383744|NCT04576117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25383745|NCT04576117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383746|NCT04576117|Tubulin Modulators|tubulin modulators|mesh-ancestor
25383747|NCT04576117|Antimitotic Agents|antimitotic agents|mesh-ancestor
25383748|NCT04576117|Mitosis Modulators|mitosis modulators|mesh-ancestor
25383749|NCT04576117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383750|NCT04576091|Pembrolizumab|pembrolizumab|mesh-list
25383751|NCT04576091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25383752|NCT04576091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383753|NCT04575922|Nivolumab|nivolumab|mesh-list
25383754|NCT04575922|Ipilimumab|ipilimumab|mesh-list
25383755|NCT04575922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25383756|NCT04575922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383757|NCT04575922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25383758|NCT04575922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383759|NCT04574947|Lidocaine|lidocaine|mesh-list
25383760|NCT04574947|Anesthetics, Local|anesthetics, local|mesh-ancestor
25383761|NCT04574947|Anesthetics|anesthetics|mesh-ancestor
25383762|NCT04574947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25383763|NCT04574947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383764|NCT04574947|Sensory System Agents|sensory system agents|mesh-ancestor
25383765|NCT04574947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25383766|NCT04574947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25383767|NCT04574947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25383768|NCT04574947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
25383769|NCT04574947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25383770|NCT04574947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383771|NCT04573478|Atrasentan|atrasentan|mesh-list
25383772|NCT04573478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383773|NCT04573478|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25383774|NCT04573478|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25383775|NCT04573478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383776|NCT04572815|Interleukin-12|interleukin-12|mesh-list
25383777|NCT04572815|Ustekinumab|ustekinumab|mesh-list
25383778|NCT04572815|Immunoglobulins|immunoglobulins|mesh-list
25383779|NCT04572815|Immunoglobulin G|immunoglobulin g|mesh-list
25383781|NCT04572815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383782|NCT04572815|Dermatologic Agents|dermatologic agents|mesh-ancestor
25383783|NCT04572815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25383784|NCT04572815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25383785|NCT04572815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25383786|NCT04572815|Growth Substances|growth substances|mesh-ancestor
25383787|NCT04572815|Growth Inhibitors|growth inhibitors|mesh-ancestor
25383788|NCT04572815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383789|NCT04572295|Fulvestrant|fulvestrant|mesh-list
25383790|NCT04572295|Exemestane|exemestane|mesh-list
25383791|NCT04572295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25383792|NCT04572295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383793|NCT04572295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25383794|NCT04572295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25383795|NCT04572295|Hormone Antagonists|hormone antagonists|mesh-ancestor
25383796|NCT04572295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25383797|NCT04572295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383798|NCT04572295|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25383799|NCT04572295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25383800|NCT04572295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383801|NCT04572295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383802|NCT04572256|Montelukast|montelukast|mesh-list
25383803|NCT04572256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25383804|NCT04572256|Respiratory System Agents|respiratory system agents|mesh-ancestor
25383805|NCT04572256|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
25383806|NCT04572256|Hormone Antagonists|hormone antagonists|mesh-ancestor
25383807|NCT04572256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25383808|NCT04572256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383809|NCT04572256|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
25383810|NCT04572256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
25383811|NCT04572256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383812|NCT04571944|Suvorexant|suvorexant|mesh-list
25383813|NCT04571944|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
25383814|NCT04571944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25383815|NCT04571944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25383816|NCT04571944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383817|NCT04571944|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
25383818|NCT04571944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25383819|NCT04571944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383820|NCT04571632|Pembrolizumab|pembrolizumab|mesh-list
25383821|NCT04571632|Ipilimumab|ipilimumab|mesh-list
25383822|NCT04571632|Avelumab|avelumab|mesh-list
25383823|NCT04571632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25383824|NCT04571632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383825|NCT04571632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25383826|NCT04571632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383827|NCT04571580|Reteplase|reteplase|mesh-list
25383828|NCT04571580|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25383829|NCT04571580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25383830|NCT04571580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25383831|NCT04571580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383833|NCT04570839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25383834|NCT04570839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383835|NCT04570839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25383836|NCT04570839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383837|NCT04570631|Dexamethasone|dexamethasone|mesh-list
25383838|NCT04570631|Bortezomib|bortezomib|mesh-list
25383839|NCT04570631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25383840|NCT04570631|Antiemetics|antiemetics|mesh-ancestor
25383841|NCT04570631|Autonomic Agents|autonomic agents|mesh-ancestor
25383842|NCT04570631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25383843|NCT04570631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383844|NCT04570631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25383845|NCT04570631|Glucocorticoids|glucocorticoids|mesh-ancestor
25383846|NCT04570631|Hormones|hormones|mesh-ancestor
25383847|NCT04570631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25383848|NCT04570631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25383849|NCT04570631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383850|NCT04569461|Pembrolizumab|pembrolizumab|mesh-list
25383851|NCT04569461|Androgens|androgens|mesh-list
25383852|NCT04569461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25383927|NCT04565990|Selexipag|selexipag|mesh-list
25383853|NCT04569461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383854|NCT04569461|Hormones|hormones|mesh-ancestor
25383855|NCT04569461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25383856|NCT04569461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383857|NCT04569032|Prednisone|prednisone|mesh-list
25383858|NCT04569032|Cyclophosphamide|cyclophosphamide|mesh-list
25383859|NCT04569032|Doxorubicin|doxorubicin|mesh-list
25383860|NCT04569032|Brentuximab Vedotin|brentuximab vedotin|mesh-list
25383861|NCT04569032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25383862|NCT04569032|Immunologic Factors|immunologic factors|mesh-ancestor
25383863|NCT04569032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383864|NCT04569032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25383865|NCT04569032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25383866|NCT04569032|Alkylating Agents|alkylating agents|mesh-ancestor
25383867|NCT04569032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383868|NCT04569032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383869|NCT04569032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25383870|NCT04569032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25383871|NCT04569032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25383872|NCT04569032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25383873|NCT04569032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383874|NCT04569032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25383875|NCT04569032|Glucocorticoids|glucocorticoids|mesh-ancestor
25383876|NCT04569032|Hormones|hormones|mesh-ancestor
25383877|NCT04569032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25383878|NCT04569032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25383879|NCT04569032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25383880|NCT04567784|Cannabidiol|cannabidiol|mesh-list
25383881|NCT04567784|Anticonvulsants|anticonvulsants|mesh-ancestor
25383882|NCT04567615|Nivolumab|nivolumab|mesh-list
25383883|NCT04567615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25383884|NCT04567615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383885|NCT04567615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25383886|NCT04567615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383887|NCT04567420|Fulvestrant|fulvestrant|mesh-list
25383888|NCT04567420|Palbociclib|palbociclib|mesh-list
25383889|NCT04567420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25383890|NCT04567420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383891|NCT04567420|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25383892|NCT04567420|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25383893|NCT04567420|Hormone Antagonists|hormone antagonists|mesh-ancestor
25383894|NCT04567420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25383895|NCT04567420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383896|NCT04567420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25383897|NCT04567420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383898|NCT04567420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383899|NCT04567303|Ranibizumab|ranibizumab|mesh-list
25383900|NCT04567303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25383901|NCT04567303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25383902|NCT04567303|Growth Substances|growth substances|mesh-ancestor
25383903|NCT04567303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383904|NCT04567303|Growth Inhibitors|growth inhibitors|mesh-ancestor
25383905|NCT04567303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383906|NCT04567225|Insulin Glargine|insulin glargine|mesh-list
25383907|NCT04567225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25383908|NCT04567225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383909|NCT04567108|Benzocaine|benzocaine|mesh-list
25383910|NCT04567108|Anesthetics, Local|anesthetics, local|mesh-ancestor
25383911|NCT04567108|Anesthetics|anesthetics|mesh-ancestor
25383912|NCT04567108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25383913|NCT04567108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383914|NCT04567108|Sensory System Agents|sensory system agents|mesh-ancestor
25383915|NCT04567108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25383916|NCT04566133|Hydroxychloroquine|hydroxychloroquine|mesh-list
25383917|NCT04566133|Trametinib|trametinib|mesh-list
25383918|NCT04566133|Antimalarials|antimalarials|mesh-ancestor
25383919|NCT04566133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25383920|NCT04566133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25383921|NCT04566133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25383922|NCT04566133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383923|NCT04566133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383924|NCT04566133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25383925|NCT04566133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383926|NCT04566133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25383934|NCT04565301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25383935|NCT04565301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383936|NCT04565301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25383937|NCT04565301|Glucocorticoids|glucocorticoids|mesh-ancestor
25383938|NCT04565301|Hormones|hormones|mesh-ancestor
25383939|NCT04565301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25383940|NCT04565301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25383941|NCT04565301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383942|NCT04565301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25383943|NCT04565301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25383944|NCT04565301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383945|NCT04565301|Cholinergic Agents|cholinergic agents|mesh-ancestor
25383946|NCT04565301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25383947|NCT04565301|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25383948|NCT04565236|Factor VIII|factor viii|mesh-list
25383949|NCT04565236|Coagulants|coagulants|mesh-ancestor
25383950|NCT04564846|Insulin|insulin|mesh-list
25383951|NCT04564846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25383952|NCT04564846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383957|NCT04564742|Dapagliflozin|dapagliflozin|mesh-list
25383958|NCT04564742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25383959|NCT04564742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383960|NCT04564742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25383961|NCT04564742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383962|NCT04563533|Vaccines|vaccines|mesh-list
25383963|NCT04563533|Immunologic Factors|immunologic factors|mesh-ancestor
25383964|NCT04563533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383965|NCT04563520|Coagulants|coagulants|mesh-list
25383966|NCT04563520|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
25383967|NCT04563273|Vaccines|vaccines|mesh-list
25383968|NCT04563273|BCG Vaccine|bcg vaccine|mesh-list
25383969|NCT04563273|Immunologic Factors|immunologic factors|mesh-ancestor
25383970|NCT04563273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383971|NCT04563273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
25383972|NCT04562532|Sirolimus|sirolimus|mesh-list
25383973|NCT04562532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25383974|NCT04562532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25383975|NCT04562532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25383976|NCT04562532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383977|NCT04562532|Antifungal Agents|antifungal agents|mesh-ancestor
25383978|NCT04562532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25383979|NCT04562532|Immunologic Factors|immunologic factors|mesh-ancestor
25383980|NCT04562532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383981|NCT04561362|Nivolumab|nivolumab|mesh-list
25383982|NCT04561362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25383983|NCT04561362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383984|NCT04561362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25383985|NCT04561362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25383986|NCT04561180|Dexamethasone|dexamethasone|mesh-list
25383987|NCT04561180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25383988|NCT04561180|Antiemetics|antiemetics|mesh-ancestor
25383989|NCT04561180|Autonomic Agents|autonomic agents|mesh-ancestor
25415274|NCT03008408|Letrozole|letrozole|mesh-list
25383990|NCT04561180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25383991|NCT04561180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25383992|NCT04561180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25383993|NCT04561180|Glucocorticoids|glucocorticoids|mesh-ancestor
25383994|NCT04561180|Hormones|hormones|mesh-ancestor
25383995|NCT04561180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25383996|NCT04561180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25383997|NCT04561180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25383998|NCT04560686|Atezolizumab|atezolizumab|mesh-list
25383999|NCT04560686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384000|NCT04560166|Irinotecan|irinotecan|mesh-list
25384001|NCT04560166|Temozolomide|temozolomide|mesh-list
25384002|NCT04560166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25384003|NCT04560166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25384004|NCT04560166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384011|NCT04559607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25384012|NCT04559607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384013|NCT04559607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384014|NCT04559581|Nintedanib|nintedanib|mesh-list
25384015|NCT04559581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384016|NCT04559581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25384017|NCT04559581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384018|NCT04559581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384019|NCT04559412|Etanercept|etanercept|mesh-list
25384020|NCT04559412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25384021|NCT04559412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25384022|NCT04559412|Analgesics|analgesics|mesh-ancestor
25384023|NCT04559412|Sensory System Agents|sensory system agents|mesh-ancestor
25384024|NCT04559412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25384025|NCT04559412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384026|NCT04559412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25384027|NCT04559412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25384028|NCT04559412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25384029|NCT04559412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25384030|NCT04559412|Immunologic Factors|immunologic factors|mesh-ancestor
25384037|NCT04558736|Cyclophosphamide|cyclophosphamide|mesh-list
25384038|NCT04558736|Fludarabine|fludarabine|mesh-list
25384039|NCT04558736|Thymoglobulin|thymoglobulin|mesh-list
25384040|NCT04558736|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25384041|NCT04558736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25384042|NCT04558736|Immunologic Factors|immunologic factors|mesh-ancestor
25384043|NCT04558736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384044|NCT04558736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25384045|NCT04558736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25384046|NCT04558736|Alkylating Agents|alkylating agents|mesh-ancestor
25384047|NCT04558736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384048|NCT04558736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384049|NCT04558736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25384050|NCT04557956|Trametinib|trametinib|mesh-list
25384051|NCT04557956|Dabrafenib|dabrafenib|mesh-list
25384052|NCT04557956|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
25384053|NCT04557956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384054|NCT04557956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25384055|NCT04557956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384056|NCT04557956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384057|NCT04557956|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
25384058|NCT04557956|Protective Agents|protective agents|mesh-ancestor
25384059|NCT04557956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384060|NCT04557956|Free Radical Scavengers|free radical scavengers|mesh-ancestor
25384061|NCT04557956|Antioxidants|antioxidants|mesh-ancestor
25384062|NCT04557735|Ravulizumab|ravulizumab|mesh-list
25384063|NCT04557735|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25384064|NCT04557735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25384065|NCT04557735|Immunologic Factors|immunologic factors|mesh-ancestor
25384066|NCT04557735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384067|NCT04556773|Paclitaxel|paclitaxel|mesh-list
25384068|NCT04556773|Capecitabine|capecitabine|mesh-list
25384069|NCT04556773|Trastuzumab|trastuzumab|mesh-list
25384070|NCT04556773|Durvalumab|durvalumab|mesh-list
25384071|NCT04556773|Fulvestrant|fulvestrant|mesh-list
25384072|NCT04556773|Anastrozole|anastrozole|mesh-list
25384073|NCT04556773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25772322|NCT03678870|Sensory System Agents|sensory system agents|mesh-ancestor
25384074|NCT04556773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384075|NCT04556773|Tubulin Modulators|tubulin modulators|mesh-ancestor
25384076|NCT04556773|Antimitotic Agents|antimitotic agents|mesh-ancestor
25384077|NCT04556773|Mitosis Modulators|mitosis modulators|mesh-ancestor
25384078|NCT04556773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384079|NCT04556773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25384080|NCT04556773|Antimetabolites|antimetabolites|mesh-ancestor
25384081|NCT04556773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25384082|NCT04556773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25384083|NCT04556773|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25384084|NCT04556773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25384085|NCT04556773|Hormone Antagonists|hormone antagonists|mesh-ancestor
25384086|NCT04556773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25384087|NCT04556773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384088|NCT04556773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25384089|NCT04556773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25384090|NCT04556773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384092|NCT04555577|Peposertib|peposertib|mesh-list
25384093|NCT04555577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25384094|NCT04555577|Alkylating Agents|alkylating agents|mesh-ancestor
25384095|NCT04555577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384096|NCT04555577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384097|NCT04555577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25384098|NCT04555577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384099|NCT04555044|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
25384100|NCT04555044|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
25384101|NCT04555044|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
25384102|NCT04555044|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25384103|NCT04554485|Blinatumomab|blinatumomab|mesh-list
25384104|NCT04554485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384105|NCT04554459|Ponatinib|ponatinib|mesh-list
25384106|NCT04554459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384107|NCT04554459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25384108|NCT04554459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384109|NCT04554459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384110|NCT04553770|Trastuzumab|trastuzumab|mesh-list
25384111|NCT04553770|Anastrozole|anastrozole|mesh-list
25384112|NCT04553770|Camptothecin|camptothecin|mesh-list
25384113|NCT04553770|Immunoconjugates|immunoconjugates|mesh-list
25384114|NCT04553770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25384115|NCT04553770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384116|NCT04553770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25384117|NCT04553770|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
25384118|NCT04553770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25384119|NCT04553770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384120|NCT04553770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384121|NCT04553770|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25384122|NCT04553770|Hormone Antagonists|hormone antagonists|mesh-ancestor
25384123|NCT04553770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25384124|NCT04553770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384125|NCT04553770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25384126|NCT04553770|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25384127|NCT04553770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25384128|NCT04553770|Immunologic Factors|immunologic factors|mesh-ancestor
25384129|NCT04553692|Leucovorin|leucovorin|mesh-list
25384130|NCT04553692|Gemcitabine|gemcitabine|mesh-list
25384131|NCT04553692|Bevacizumab|bevacizumab|mesh-list
25384132|NCT04553692|Docetaxel|docetaxel|mesh-list
25384133|NCT04553692|Fluorouracil|fluorouracil|mesh-list
25384134|NCT04553692|Irinotecan|irinotecan|mesh-list
25384135|NCT04553692|Azacitidine|azacitidine|mesh-list
25384136|NCT04553692|Venetoclax|venetoclax|mesh-list
25384137|NCT04553692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25384138|NCT04553692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384139|NCT04553692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25384140|NCT04553692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25384141|NCT04553692|Growth Substances|growth substances|mesh-ancestor
25384142|NCT04553692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384143|NCT04553692|Growth Inhibitors|growth inhibitors|mesh-ancestor
25384144|NCT04553692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25384145|NCT04553692|Antimetabolites|antimetabolites|mesh-ancestor
25384146|NCT04553692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384147|NCT04553692|Antiviral Agents|antiviral agents|mesh-ancestor
25384148|NCT04553692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25384149|NCT04553692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384150|NCT04553692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25384151|NCT04553692|Immunologic Factors|immunologic factors|mesh-ancestor
25384152|NCT04553692|Tubulin Modulators|tubulin modulators|mesh-ancestor
25384153|NCT04553692|Antimitotic Agents|antimitotic agents|mesh-ancestor
25384154|NCT04553692|Mitosis Modulators|mitosis modulators|mesh-ancestor
25384155|NCT04553692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25384156|NCT04553692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25384157|NCT04553692|Antidotes|antidotes|mesh-ancestor
25384158|NCT04553692|Protective Agents|protective agents|mesh-ancestor
25384159|NCT04553692|Vitamin B Complex|vitamin b complex|mesh-ancestor
25384160|NCT04553692|Vitamins|vitamins|mesh-ancestor
25384161|NCT04553692|Micronutrients|micronutrients|mesh-ancestor
25384162|NCT04553666|Vitamins|vitamins|mesh-list
25384163|NCT04553666|Ascorbic Acid|ascorbic acid|mesh-list
25384164|NCT04553666|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
25384165|NCT04553666|Micronutrients|micronutrients|mesh-ancestor
25384166|NCT04553666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384167|NCT04553666|Antioxidants|antioxidants|mesh-ancestor
25384168|NCT04553666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384169|NCT04553666|Protective Agents|protective agents|mesh-ancestor
25384170|NCT04553666|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
25384171|NCT04553666|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
25384172|NCT04553666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384173|NCT04553666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25384174|NCT04553263|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
25384175|NCT04553263|Naltrexone|naltrexone|mesh-list
25384176|NCT04553263|Bupropion|bupropion|mesh-list
25384177|NCT04553263|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25384178|NCT04553263|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25384179|NCT04553263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384180|NCT04553263|Sensory System Agents|sensory system agents|mesh-ancestor
25384181|NCT04553263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25384182|NCT04553263|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25384183|NCT04553263|Antidepressive Agents|antidepressive agents|mesh-ancestor
25384184|NCT04553263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25384185|NCT04553263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
25384186|NCT04553263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25384187|NCT04553263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25384188|NCT04553263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384189|NCT04553263|Dopamine Agents|dopamine agents|mesh-ancestor
25384190|NCT04553263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25384191|NCT04553263|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
25384192|NCT04553263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25384193|NCT04553263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384194|NCT04553263|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
25384195|NCT04552743|Plerixafor|plerixafor|mesh-list
25384196|NCT04552743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25384197|NCT04552743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25384198|NCT04552743|Antiviral Agents|antiviral agents|mesh-ancestor
25384199|NCT04552743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25384200|NCT04552288|Benralizumab|benralizumab|mesh-list
25384201|NCT04552288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25384202|NCT04552288|Respiratory System Agents|respiratory system agents|mesh-ancestor
25384203|NCT04552223|Nivolumab|nivolumab|mesh-list
25384204|NCT04552223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25384205|NCT04552223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384206|NCT04552223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25384207|NCT04552223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384208|NCT04552080|Amoxicillin|amoxicillin|mesh-list
25384209|NCT04552080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25384210|NCT04552080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25384211|NCT04551222|Probenecid|probenecid|mesh-list
25384212|NCT04551222|Uricosuric Agents|uricosuric agents|mesh-ancestor
25384213|NCT04551222|Gout Suppressants|gout suppressants|mesh-ancestor
25384214|NCT04551222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25384215|NCT04551222|Renal Agents|renal agents|mesh-ancestor
25384216|NCT04550832|Moxifloxacin|moxifloxacin|mesh-list
25384217|NCT04550832|Bedaquiline|bedaquiline|mesh-list
25384218|NCT04550832|Delpazolid|delpazolid|mesh-list
25384219|NCT04550832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25384220|NCT04550832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25384221|NCT04550832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25384222|NCT04550832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25384223|NCT04550832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384224|NCT04550832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384225|NCT04550832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384226|NCT04550832|Antitubercular Agents|antitubercular agents|mesh-ancestor
25384227|NCT04550832|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25384228|NCT04550494|Talazoparib|talazoparib|mesh-list
25384229|NCT04550494|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25384230|NCT04550494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384231|NCT04550494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384232|NCT04550494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384233|NCT04550481|Lisinopril|lisinopril|mesh-list
25384234|NCT04550481|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
25384235|NCT04550481|Protease Inhibitors|protease inhibitors|mesh-ancestor
25384236|NCT04550481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384237|NCT04550481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384238|NCT04550481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25384239|NCT04550481|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
25384240|NCT04550481|Protective Agents|protective agents|mesh-ancestor
25384241|NCT04550481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384242|NCT04550260|Cisplatin|cisplatin|mesh-list
25384243|NCT04550260|Fluorouracil|fluorouracil|mesh-list
25384244|NCT04550260|Capecitabine|capecitabine|mesh-list
25384245|NCT04550260|Durvalumab|durvalumab|mesh-list
25384246|NCT04550260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384247|NCT04550260|Antimetabolites|antimetabolites|mesh-ancestor
25384248|NCT04550260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384249|NCT04550260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25384250|NCT04550260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25384251|NCT04550260|Immunologic Factors|immunologic factors|mesh-ancestor
25384252|NCT04550260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384253|NCT04550260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25384254|NCT04550104|Olaparib|olaparib|mesh-list
25384255|NCT04550104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25384256|NCT04550104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384257|NCT04550104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384258|NCT04550104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384259|NCT04549467|Tenofovir|tenofovir|mesh-list
25384260|NCT04549467|Lamivudine|lamivudine|mesh-list
25384261|NCT04549467|Emtricitabine|emtricitabine|mesh-list
25384262|NCT04549467|Dolutegravir|dolutegravir|mesh-list
25384263|NCT04549467|Antiviral Agents|antiviral agents|mesh-ancestor
25384264|NCT04549467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25384265|NCT04549467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25384266|NCT04549467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25384267|NCT04549467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384268|NCT04549467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384269|NCT04549467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25384270|NCT04549467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25384271|NCT04549467|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25384272|NCT04549467|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25384273|NCT04549311|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
25384274|NCT04549311|Amoxicillin|amoxicillin|mesh-list
25384275|NCT04549311|Metronidazole|metronidazole|mesh-list
25384276|NCT04549311|Ciprofloxacin|ciprofloxacin|mesh-list
25384277|NCT04549311|Clavulanic Acids|clavulanic acids|mesh-list
25384278|NCT04549311|Clavulanic Acid|clavulanic acid|mesh-list
25384279|NCT04549311|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
25384280|NCT04549311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
25384281|NCT04549311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25384282|NCT04549311|Antitubercular Agents|antitubercular agents|mesh-ancestor
25384283|NCT04549311|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
25384284|NCT04549311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25384285|NCT04549311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25384286|NCT04549311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25384287|NCT04549311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384288|NCT04549311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384289|NCT04549311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384290|NCT04549311|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25384291|NCT04549311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25384292|NCT04549311|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
25384293|NCT04549116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
25384294|NCT04549116|Progesterone|progesterone|mesh-list
25384295|NCT04549116|Progestins|progestins|mesh-ancestor
25384296|NCT04549116|Hormones|hormones|mesh-ancestor
25384297|NCT04549116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25384298|NCT04549116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384299|NCT04548999|Methylprednisolone|methylprednisolone|mesh-list
25384300|NCT04548999|Ocrelizumab|ocrelizumab|mesh-list
25384301|NCT04548999|Histamine Antagonists|histamine antagonists|mesh-list
25384302|NCT04548999|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25384303|NCT04548999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25384311|NCT04548999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25384312|NCT04548999|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25384314|NCT04548999|Immunologic Factors|immunologic factors|mesh-ancestor
25384315|NCT04548999|Histamine Agents|histamine agents|mesh-ancestor
25384316|NCT04548999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25384317|NCT04548999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384325|NCT04548661|Povidone-Iodine|povidone-iodine|mesh-list
25384326|NCT04548661|Povidone|povidone|mesh-list
25384327|NCT04548661|Plasma Substitutes|plasma substitutes|mesh-ancestor
25384328|NCT04548661|Blood Substitutes|blood substitutes|mesh-ancestor
25384329|NCT04548661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25384330|NCT04548661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25384331|NCT04548518|Vaccines|vaccines|mesh-list
25384332|NCT04548518|Immunologic Factors|immunologic factors|mesh-ancestor
25384333|NCT04548518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384334|NCT04548349|Benzoyl Peroxide|benzoyl peroxide|mesh-list
25384335|NCT04548349|Dermatologic Agents|dermatologic agents|mesh-ancestor
25384336|NCT04547985|Naltrexone|naltrexone|mesh-list
25384337|NCT04547985|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
25384338|NCT04547985|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
25384339|NCT04547985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384340|NCT04547985|Sensory System Agents|sensory system agents|mesh-ancestor
25384341|NCT04547985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25384342|NCT04547842|Dexamethasone|dexamethasone|mesh-list
25384343|NCT04547842|Mirtazapine|mirtazapine|mesh-list
25384344|NCT04547842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25384345|NCT04547842|Antiemetics|antiemetics|mesh-ancestor
25384346|NCT04547842|Autonomic Agents|autonomic agents|mesh-ancestor
25384347|NCT04547842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25384348|NCT04547842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384349|NCT04547842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25384350|NCT04547842|Glucocorticoids|glucocorticoids|mesh-ancestor
25384351|NCT04547842|Hormones|hormones|mesh-ancestor
25384352|NCT04547842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25384353|NCT04547842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25384354|NCT04547842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384355|NCT04547842|Antidepressive Agents|antidepressive agents|mesh-ancestor
25384356|NCT04547842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25384357|NCT04547842|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25384358|NCT04547842|Histamine Antagonists|histamine antagonists|mesh-ancestor
25384359|NCT04547842|Histamine Agents|histamine agents|mesh-ancestor
25384360|NCT04547842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25384361|NCT04547842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384362|NCT04547842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25384363|NCT04547842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25384364|NCT04547842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25384365|NCT04547842|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
25384366|NCT04547842|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
25384367|NCT04547842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25384368|NCT04547842|Adrenergic Agents|adrenergic agents|mesh-ancestor
25384369|NCT04547842|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25384370|NCT04547842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25384371|NCT04547842|Serotonin Agents|serotonin agents|mesh-ancestor
25384372|NCT04547842|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
25384373|NCT04546672|Neostigmine|neostigmine|mesh-list
25384374|NCT04546672|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
25384375|NCT04546672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384376|NCT04546672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384377|NCT04546672|Cholinergic Agents|cholinergic agents|mesh-ancestor
25384378|NCT04546672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25384379|NCT04546672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384380|NCT04546672|Parasympathomimetics|parasympathomimetics|mesh-ancestor
25384381|NCT04546672|Autonomic Agents|autonomic agents|mesh-ancestor
25384382|NCT04546672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25384383|NCT04546425|Vaccines|vaccines|mesh-list
25384384|NCT04546425|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25384385|NCT04546425|Immunologic Factors|immunologic factors|mesh-ancestor
25384386|NCT04546425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384387|NCT04546399|Calcium, Dietary|calcium, dietary|mesh-list
25384388|NCT04546399|Leucovorin|leucovorin|mesh-list
25384389|NCT04546399|Folic Acid|folic acid|mesh-list
25384390|NCT04546399|Cytarabine|cytarabine|mesh-list
25384391|NCT04546399|Dexamethasone|dexamethasone|mesh-list
25384392|NCT04546399|Dexamethasone acetate|dexamethasone acetate|mesh-list
25384393|NCT04546399|Hydrocortisone|hydrocortisone|mesh-list
25384394|NCT04546399|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
25384395|NCT04546399|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
25384396|NCT04546399|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
25384397|NCT04546399|Cyclophosphamide|cyclophosphamide|mesh-list
25384398|NCT04546399|Methotrexate|methotrexate|mesh-list
25384399|NCT04546399|Nivolumab|nivolumab|mesh-list
25384400|NCT04546399|Etoposide|etoposide|mesh-list
25384401|NCT04546399|Vincristine|vincristine|mesh-list
25384402|NCT04546399|Etoposide phosphate|etoposide phosphate|mesh-list
25384403|NCT04546399|Asparaginase|asparaginase|mesh-list
25384404|NCT04546399|Mercaptopurine|mercaptopurine|mesh-list
25384405|NCT04546399|Podophyllotoxin|podophyllotoxin|mesh-list
25384406|NCT04546399|Pegaspargase|pegaspargase|mesh-list
25384407|NCT04546399|Thioguanine|thioguanine|mesh-list
25384408|NCT04546399|Blinatumomab|blinatumomab|mesh-list
25384409|NCT04546399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25384410|NCT04546399|Muromonab-CD3|muromonab-cd3|mesh-list
25384411|NCT04546399|Antibodies|antibodies|mesh-list
25384412|NCT04546399|Immunoglobulins|immunoglobulins|mesh-list
25384413|NCT04546399|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25384414|NCT04546399|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25384415|NCT04546399|BB 1101|bb 1101|mesh-list
25384416|NCT04546399|Calcium|calcium|mesh-list
25384417|NCT04546399|2-Aminopurine|2-aminopurine|mesh-list
25384418|NCT04546399|Levoleucovorin|levoleucovorin|mesh-list
25384419|NCT04546399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25384420|NCT04546399|Immunologic Factors|immunologic factors|mesh-ancestor
25384421|NCT04546399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384422|NCT04546399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25384423|NCT04546399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25384424|NCT04546399|Alkylating Agents|alkylating agents|mesh-ancestor
25384425|NCT04546399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384426|NCT04546399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384427|NCT04546399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25384428|NCT04546399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25384429|NCT04546399|Antiemetics|antiemetics|mesh-ancestor
25384430|NCT04546399|Autonomic Agents|autonomic agents|mesh-ancestor
25384431|NCT04546399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25384432|NCT04546399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25384433|NCT04546399|Glucocorticoids|glucocorticoids|mesh-ancestor
25384434|NCT04546399|Hormones|hormones|mesh-ancestor
25384435|NCT04546399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25384436|NCT04546399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25384437|NCT04546399|Protease Inhibitors|protease inhibitors|mesh-ancestor
25384438|NCT04546399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384439|NCT04546399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25384440|NCT04546399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25384441|NCT04546399|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25384442|NCT04546399|Abortifacient Agents|abortifacient agents|mesh-ancestor
25384443|NCT04546399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25384444|NCT04546399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25384445|NCT04546399|Antimetabolites|antimetabolites|mesh-ancestor
25384446|NCT04546399|Dermatologic Agents|dermatologic agents|mesh-ancestor
25384447|NCT04546399|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25384448|NCT04546399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25384449|NCT04546399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25384450|NCT04546399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25384451|NCT04546399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25384452|NCT04546399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25384453|NCT04546399|Antiviral Agents|antiviral agents|mesh-ancestor
25384454|NCT04546399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25384455|NCT04546399|Antidotes|antidotes|mesh-ancestor
25384456|NCT04546399|Protective Agents|protective agents|mesh-ancestor
25384457|NCT04546399|Vitamin B Complex|vitamin b complex|mesh-ancestor
25384458|NCT04546399|Vitamins|vitamins|mesh-ancestor
25384464|NCT04546399|Keratolytic Agents|keratolytic agents|mesh-ancestor
25384465|NCT04546009|Letrozole|letrozole|mesh-list
25384469|NCT04546009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
25384470|NCT04546009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384471|NCT04546009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384472|NCT04546009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25384473|NCT04546009|Hormone Antagonists|hormone antagonists|mesh-ancestor
25384474|NCT04546009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25384475|NCT04546009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384476|NCT04546009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25384477|NCT04545736|Metformin|metformin|mesh-list
25384478|NCT04545736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25384479|NCT04545736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384480|NCT04545554|Vitamin D|vitamin d|mesh-list
25384481|NCT04545554|Calcium|calcium|mesh-list
25384482|NCT04545554|Vitamins|vitamins|mesh-ancestor
25384483|NCT04545554|Micronutrients|micronutrients|mesh-ancestor
25384484|NCT04545554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384485|NCT04545554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25384486|NCT04545554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25384487|NCT04545411|Dapagliflozin|dapagliflozin|mesh-list
25384488|NCT04545411|Volagidemab|volagidemab|mesh-list
25384489|NCT04545411|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25384490|NCT04545411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384491|NCT04545411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25384492|NCT04545411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384493|NCT04544475|Estrogens|estrogens|mesh-list
25384494|NCT04544475|Estradiol|estradiol|mesh-list
25384495|NCT04544475|Hormones|hormones|mesh-ancestor
25384496|NCT04544475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25384497|NCT04544475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384501|NCT04544436|Methylprednisolone|methylprednisolone|mesh-list
25384502|NCT04544436|Ocrelizumab|ocrelizumab|mesh-list
25384503|NCT04544436|Histamine Antagonists|histamine antagonists|mesh-list
25384504|NCT04544436|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
25384505|NCT04544436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25384506|NCT04544436|Antiemetics|antiemetics|mesh-ancestor
25384507|NCT04544436|Autonomic Agents|autonomic agents|mesh-ancestor
25384508|NCT04544436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25384509|NCT04544436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384510|NCT04544436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25384511|NCT04544436|Glucocorticoids|glucocorticoids|mesh-ancestor
25384512|NCT04544436|Hormones|hormones|mesh-ancestor
25384513|NCT04544436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25384514|NCT04544436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
25384515|NCT04544436|Protective Agents|protective agents|mesh-ancestor
25384516|NCT04544436|Immunologic Factors|immunologic factors|mesh-ancestor
25384517|NCT04544436|Histamine Agents|histamine agents|mesh-ancestor
25384518|NCT04544436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25384519|NCT04544436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384520|NCT04544293|Molgramostim|molgramostim|mesh-list
25384521|NCT04544293|Sargramostim|sargramostim|mesh-list
25384522|NCT04544293|Immunologic Factors|immunologic factors|mesh-ancestor
25384523|NCT04544293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384524|NCT04544293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384525|NCT04544189|Fulvestrant|fulvestrant|mesh-list
25384526|NCT04544189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25384527|NCT04544189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384528|NCT04544189|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
25384529|NCT04544189|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
25384530|NCT04544189|Hormone Antagonists|hormone antagonists|mesh-ancestor
25384531|NCT04544189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25384532|NCT04544189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384538|NCT04543591|Ravulizumab|ravulizumab|mesh-list
25384539|NCT04543591|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
25384540|NCT04543591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25384541|NCT04543591|Immunologic Factors|immunologic factors|mesh-ancestor
25384542|NCT04543591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384543|NCT04543409|Benralizumab|benralizumab|mesh-list
25384544|NCT04543409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
25384545|NCT04543409|Respiratory System Agents|respiratory system agents|mesh-ancestor
25384546|NCT04543383|Thrombin|thrombin|mesh-list
25384547|NCT04543383|Hemostatics|hemostatics|mesh-ancestor
25384548|NCT04543383|Coagulants|coagulants|mesh-ancestor
25384549|NCT04543227|Analgesics, Opioid|analgesics, opioid|mesh-list
25384550|NCT04543227|Narcotics|narcotics|mesh-ancestor
25384551|NCT04543227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25384552|NCT04543227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384553|NCT04543227|Analgesics|analgesics|mesh-ancestor
25384554|NCT04543227|Sensory System Agents|sensory system agents|mesh-ancestor
25384555|NCT04543227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25384556|NCT04542993|Zinc|zinc|mesh-list
25384557|NCT04542993|Resveratrol|resveratrol|mesh-list
25384558|NCT04542993|Picolinic acid|picolinic acid|mesh-list
25384559|NCT04542993|Trace Elements|trace elements|mesh-ancestor
25384560|NCT04542993|Micronutrients|micronutrients|mesh-ancestor
25384561|NCT04542993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384562|NCT04542993|Antioxidants|antioxidants|mesh-ancestor
25384563|NCT04542993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384564|NCT04542993|Protective Agents|protective agents|mesh-ancestor
25384565|NCT04542993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384566|NCT04542993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25384567|NCT04542993|Iron Chelating Agents|iron chelating agents|mesh-ancestor
25384568|NCT04542993|Chelating Agents|chelating agents|mesh-ancestor
25384569|NCT04542993|Sequestering Agents|sequestering agents|mesh-ancestor
25384570|NCT04542824|Gemcitabine|gemcitabine|mesh-list
25384571|NCT04542824|Prednisone|prednisone|mesh-list
25384572|NCT04542824|Cyclophosphamide|cyclophosphamide|mesh-list
25384573|NCT04542824|Rituximab|rituximab|mesh-list
25384574|NCT04542824|Doxorubicin|doxorubicin|mesh-list
25384575|NCT04542824|Oxaliplatin|oxaliplatin|mesh-list
25384576|NCT04542824|Vincristine|vincristine|mesh-list
25384577|NCT04542824|Lenalidomide|lenalidomide|mesh-list
25384578|NCT04542824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25384579|NCT04542824|Immunologic Factors|immunologic factors|mesh-ancestor
25384580|NCT04542824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384581|NCT04542824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25384582|NCT04542824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25384583|NCT04542824|Alkylating Agents|alkylating agents|mesh-ancestor
25384584|NCT04542824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384585|NCT04542824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384586|NCT04542824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25384587|NCT04542824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25384588|NCT04542824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25384589|NCT04542824|Antimetabolites|antimetabolites|mesh-ancestor
25384590|NCT04542824|Antiviral Agents|antiviral agents|mesh-ancestor
25384591|NCT04542824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25384592|NCT04542824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384593|NCT04542824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25384594|NCT04542824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25384595|NCT04542824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25384596|NCT04542824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25384597|NCT04542824|Glucocorticoids|glucocorticoids|mesh-ancestor
25384598|NCT04542824|Hormones|hormones|mesh-ancestor
25384599|NCT04542824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25384600|NCT04542824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25384601|NCT04542824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25384602|NCT04542824|Tubulin Modulators|tubulin modulators|mesh-ancestor
25384603|NCT04542824|Antimitotic Agents|antimitotic agents|mesh-ancestor
25384604|NCT04542824|Mitosis Modulators|mitosis modulators|mesh-ancestor
25384605|NCT04542824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25384606|NCT04542824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25384607|NCT04542824|Growth Substances|growth substances|mesh-ancestor
25384608|NCT04542824|Growth Inhibitors|growth inhibitors|mesh-ancestor
25384609|NCT04542291|Dapagliflozin|dapagliflozin|mesh-list
25384610|NCT04542291|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25384611|NCT04542291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384612|NCT04542291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25384613|NCT04542291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384614|NCT04542200|Antibodies|antibodies|mesh-list
25384615|NCT04542200|Immunologic Factors|immunologic factors|mesh-ancestor
25384616|NCT04542200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384617|NCT04542070|Rilpivirine|rilpivirine|mesh-list
25384618|NCT04542070|Cabotegravir|cabotegravir|mesh-list
25384619|NCT04542070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25384620|NCT04542070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25384621|NCT04542070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384622|NCT04542070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384623|NCT04542070|Antiviral Agents|antiviral agents|mesh-ancestor
25384624|NCT04542070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25384625|NCT04542070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25384626|NCT04542070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25384627|NCT04542070|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
25384628|NCT04542070|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
25384629|NCT04541017|Mogamulizumab|mogamulizumab|mesh-list
25384630|NCT04541017|Magrolimab|magrolimab|mesh-list
25384631|NCT04541017|Immunoglobulins|immunoglobulins|mesh-list
25384632|NCT04541017|Immunoglobulin G|immunoglobulin g|mesh-list
25384633|NCT04541017|Immunologic Factors|immunologic factors|mesh-ancestor
25384634|NCT04541017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384635|NCT04541017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384636|NCT04541017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25384637|NCT04540861|Siponimod|siponimod|mesh-list
25384638|NCT04540861|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
25384639|NCT04540861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384640|NCT04540861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25384641|NCT04540861|Immunologic Factors|immunologic factors|mesh-ancestor
25384642|NCT04540861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384643|NCT04540835|Calcium|calcium|mesh-list
25384644|NCT04540835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25384645|NCT04540835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384646|NCT04540744|Tadalafil|tadalafil|mesh-list
25384647|NCT04540744|Macitentan|macitentan|mesh-list
25384648|NCT04540744|Vasodilator Agents|vasodilator agents|mesh-ancestor
25384649|NCT04540744|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
25384650|NCT04540744|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25384651|NCT04540744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384652|NCT04540744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384653|NCT04540744|Urological Agents|urological agents|mesh-ancestor
25384654|NCT04540744|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
25384655|NCT04540744|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
25384656|NCT04540744|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
25384657|NCT04540705|Nivolumab|nivolumab|mesh-list
25384658|NCT04540705|Axitinib|axitinib|mesh-list
25384659|NCT04540705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25384660|NCT04540705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384661|NCT04540705|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25384662|NCT04540705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384663|NCT04540705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25384664|NCT04540705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384665|NCT04540692|Paclitaxel|paclitaxel|mesh-list
25384666|NCT04540692|Docetaxel|docetaxel|mesh-list
25384667|NCT04540692|Cyclophosphamide|cyclophosphamide|mesh-list
25384668|NCT04540692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25384669|NCT04540692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384670|NCT04540692|Tubulin Modulators|tubulin modulators|mesh-ancestor
25384671|NCT04540692|Antimitotic Agents|antimitotic agents|mesh-ancestor
25384672|NCT04540692|Mitosis Modulators|mitosis modulators|mesh-ancestor
25384673|NCT04540692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384674|NCT04540692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25384675|NCT04540692|Immunologic Factors|immunologic factors|mesh-ancestor
25384676|NCT04540692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384677|NCT04540692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25384678|NCT04540692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25384679|NCT04540692|Alkylating Agents|alkylating agents|mesh-ancestor
25384680|NCT04540692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25384681|NCT04540211|Paclitaxel|paclitaxel|mesh-list
25384682|NCT04540211|Cisplatin|cisplatin|mesh-list
25384683|NCT04540211|Atezolizumab|atezolizumab|mesh-list
25384684|NCT04540211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25384685|NCT04540211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25384686|NCT04540211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384687|NCT04540211|Tubulin Modulators|tubulin modulators|mesh-ancestor
25384688|NCT04540211|Antimitotic Agents|antimitotic agents|mesh-ancestor
25384689|NCT04540211|Mitosis Modulators|mitosis modulators|mesh-ancestor
25384690|NCT04540211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384691|NCT04540211|Immunologic Factors|immunologic factors|mesh-ancestor
25384692|NCT04540211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384693|NCT04540120|Dapansutrile|dapansutrile|mesh-list
25384694|NCT04540120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25384695|NCT04539964|Antirheumatic Agents|antirheumatic agents|mesh-list
25384696|NCT04539951|Memantine|memantine|mesh-list
25384697|NCT04539951|Aripiprazole|aripiprazole|mesh-list
25384698|NCT04539951|Fluvoxamine|fluvoxamine|mesh-list
25384699|NCT04539951|Sertraline|sertraline|mesh-list
25384700|NCT04539951|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
25384701|NCT04539951|Antidepressive Agents|antidepressive agents|mesh-ancestor
25384702|NCT04539951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25384703|NCT04539951|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25384704|NCT04539951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25384705|NCT04539951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25384706|NCT04539951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384707|NCT04539951|Dopamine Agonists|dopamine agonists|mesh-ancestor
25384708|NCT04539951|Dopamine Agents|dopamine agents|mesh-ancestor
25384709|NCT04539951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25384710|NCT04539951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384711|NCT04539951|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
25384712|NCT04539951|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25384713|NCT04539951|Serotonin Agents|serotonin agents|mesh-ancestor
25384714|NCT04539951|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25384715|NCT04539951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25384716|NCT04539951|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
25384717|NCT04539951|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
25384718|NCT04539951|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
25384719|NCT04539951|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25384720|NCT04539951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25384721|NCT04539951|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25384722|NCT04539951|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25384723|NCT04539951|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
25384724|NCT04539951|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
25384725|NCT04539951|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
25384726|NCT04539951|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
25384727|NCT04539951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25384728|NCT04539951|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
25384729|NCT04539951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
25384730|NCT04539951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384731|NCT04539951|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
25384732|NCT04539938|Trastuzumab|trastuzumab|mesh-list
25384733|NCT04539938|Tucatinib|tucatinib|mesh-list
25384734|NCT04539938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25384735|NCT04539938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384736|NCT04539938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25384737|NCT04539938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384738|NCT04539938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384739|NCT04539808|Calcium, Dietary|calcium, dietary|mesh-list
25384740|NCT04539808|Leucovorin|leucovorin|mesh-list
25384741|NCT04539808|Folic Acid|folic acid|mesh-list
25384742|NCT04539808|Fluorouracil|fluorouracil|mesh-list
25384743|NCT04539808|Capecitabine|capecitabine|mesh-list
25384744|NCT04539808|Oxaliplatin|oxaliplatin|mesh-list
25384745|NCT04539808|Irinotecan|irinotecan|mesh-list
25384746|NCT04539808|Camptothecin|camptothecin|mesh-list
25384747|NCT04539808|Losartan|losartan|mesh-list
25384748|NCT04539808|Calcium|calcium|mesh-list
25384749|NCT04539808|Levoleucovorin|levoleucovorin|mesh-list
25384750|NCT04539808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25384751|NCT04539808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384752|NCT04539808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25384753|NCT04539808|Antimetabolites|antimetabolites|mesh-ancestor
25384754|NCT04539808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384755|NCT04539808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25384756|NCT04539808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384757|NCT04539808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25384758|NCT04539808|Immunologic Factors|immunologic factors|mesh-ancestor
25384759|NCT04539808|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25384760|NCT04539808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25384761|NCT04539808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384762|NCT04539808|Antidotes|antidotes|mesh-ancestor
25384763|NCT04539808|Protective Agents|protective agents|mesh-ancestor
25384764|NCT04539808|Vitamin B Complex|vitamin b complex|mesh-ancestor
25384765|NCT04539808|Vitamins|vitamins|mesh-ancestor
25384766|NCT04539808|Micronutrients|micronutrients|mesh-ancestor
25384767|NCT04539808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25384768|NCT04539808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25384769|NCT04539808|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25384770|NCT04539808|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25384771|NCT04539808|Hematinics|hematinics|mesh-ancestor
25384772|NCT04539808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25384773|NCT04539327|Rucaparib|rucaparib|mesh-list
25384774|NCT04539327|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25384775|NCT04539327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384776|NCT04539327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384777|NCT04539327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384778|NCT04538742|Paclitaxel|paclitaxel|mesh-list
25384779|NCT04538742|Trastuzumab|trastuzumab|mesh-list
25384780|NCT04538742|Durvalumab|durvalumab|mesh-list
25384781|NCT04538742|Pertuzumab|pertuzumab|mesh-list
25384782|NCT04538742|Tucatinib|tucatinib|mesh-list
25384783|NCT04538742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25384784|NCT04538742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384785|NCT04538742|Tubulin Modulators|tubulin modulators|mesh-ancestor
25384786|NCT04538742|Antimitotic Agents|antimitotic agents|mesh-ancestor
25384787|NCT04538742|Mitosis Modulators|mitosis modulators|mesh-ancestor
25384788|NCT04538742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384789|NCT04538742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25384790|NCT04538742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25384791|NCT04538742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384792|NCT04538664|Carboplatin|carboplatin|mesh-list
25384793|NCT04538664|Pemetrexed|pemetrexed|mesh-list
25384794|NCT04538664|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
25384795|NCT04538664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384796|NCT04538664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384797|NCT04538664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384798|NCT04538664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25384799|NCT04538664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25384800|NCT04538664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25384801|NCT04538378|Durvalumab|durvalumab|mesh-list
25384802|NCT04538378|Olaparib|olaparib|mesh-list
25384803|NCT04538378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25384804|NCT04538378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384805|NCT04538378|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25384806|NCT04538378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384807|NCT04538378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384808|NCT04537806|Pregnanolone|pregnanolone|mesh-list
25384809|NCT04537806|Brexanolone|brexanolone|mesh-list
25384810|NCT04537806|Anesthetics|anesthetics|mesh-ancestor
25384811|NCT04537806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25384812|NCT04537806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384813|NCT04537806|Neurosteroids|neurosteroids|mesh-ancestor
25384814|NCT04537806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25384815|NCT04537806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384816|NCT04537806|GABA Modulators|gaba modulators|mesh-ancestor
25384817|NCT04537806|GABA Agents|gaba agents|mesh-ancestor
25384818|NCT04536805|Metformin|metformin|mesh-list
25384819|NCT04536805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25384820|NCT04536805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384821|NCT04535947|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25384822|NCT04535947|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25384823|NCT04535544|Tenofovir|tenofovir|mesh-list
25384824|NCT04535544|Entecavir|entecavir|mesh-list
25384825|NCT04535544|Antiviral Agents|antiviral agents|mesh-ancestor
25384826|NCT04535544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25384827|NCT04535544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25384828|NCT04535544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25384829|NCT04535544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384830|NCT04535544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384831|NCT04535544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25384832|NCT04535544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25384833|NCT04535505|Erythromycin|erythromycin|mesh-list
25384834|NCT04535505|Erythromycin Estolate|erythromycin estolate|mesh-list
25384835|NCT04535505|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
25384836|NCT04535505|Erythromycin stearate|erythromycin stearate|mesh-list
25384837|NCT04535505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25384838|NCT04535505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25384839|NCT04535505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25384840|NCT04535505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
25384841|NCT04535505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384842|NCT04535505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384843|NCT04535401|Calcium, Dietary|calcium, dietary|mesh-list
25384844|NCT04535401|Leucovorin|leucovorin|mesh-list
25384845|NCT04535401|Folic Acid|folic acid|mesh-list
25384846|NCT04535401|Fluorouracil|fluorouracil|mesh-list
25384847|NCT04535401|Irinotecan|irinotecan|mesh-list
25384848|NCT04535401|Camptothecin|camptothecin|mesh-list
25384849|NCT04535401|Calcium|calcium|mesh-list
25384850|NCT04535401|Levoleucovorin|levoleucovorin|mesh-list
25384851|NCT04535401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25384852|NCT04535401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384853|NCT04535401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25384854|NCT04535401|Antimetabolites|antimetabolites|mesh-ancestor
25384855|NCT04535401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384856|NCT04535401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25384857|NCT04535401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384858|NCT04535401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25384859|NCT04535401|Immunologic Factors|immunologic factors|mesh-ancestor
25384860|NCT04535401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25384861|NCT04535401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25384862|NCT04535401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384863|NCT04535401|Antidotes|antidotes|mesh-ancestor
25384864|NCT04535401|Protective Agents|protective agents|mesh-ancestor
25384865|NCT04535401|Vitamin B Complex|vitamin b complex|mesh-ancestor
25384866|NCT04535401|Vitamins|vitamins|mesh-ancestor
25384867|NCT04535401|Micronutrients|micronutrients|mesh-ancestor
25384868|NCT04535401|Hematinics|hematinics|mesh-ancestor
25384869|NCT04535401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25384870|NCT04534205|Pembrolizumab|pembrolizumab|mesh-list
25384871|NCT04534205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25384872|NCT04534205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384873|NCT04534153|Fexofenadine|fexofenadine|mesh-list
25384874|NCT04534153|Terfenadine|terfenadine|mesh-list
25384875|NCT04534153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
25384876|NCT04534153|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
25384877|NCT04534153|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
25384878|NCT04534153|Histamine Antagonists|histamine antagonists|mesh-ancestor
25384879|NCT04534153|Histamine Agents|histamine agents|mesh-ancestor
25384880|NCT04534153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25384881|NCT04534153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384882|NCT04534153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384883|NCT04533880|Calcium|calcium|mesh-list
25384884|NCT04533880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25384885|NCT04533880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384886|NCT04533841|Propranolol|propranolol|mesh-list
25384887|NCT04533841|Misoprostol|misoprostol|mesh-list
25384888|NCT04533841|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25384889|NCT04533841|Abortifacient Agents|abortifacient agents|mesh-ancestor
25384890|NCT04533841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25384891|NCT04533841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384892|NCT04533841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
25384893|NCT04533841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25384894|NCT04533841|Oxytocics|oxytocics|mesh-ancestor
25384895|NCT04533841|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
25384896|NCT04533841|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
25384897|NCT04533841|Adrenergic Agents|adrenergic agents|mesh-ancestor
25384898|NCT04533841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25384899|NCT04533841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384900|NCT04533841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
25384901|NCT04533841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25384902|NCT04533841|Vasodilator Agents|vasodilator agents|mesh-ancestor
25384903|NCT04533750|Peposertib|peposertib|mesh-list
25384904|NCT04533750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25384905|NCT04533750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384906|NCT04533750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384907|NCT04533646|Insulin|insulin|mesh-list
25384908|NCT04533646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25384909|NCT04533646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384910|NCT04532710|Ophthalmic Solutions|ophthalmic solutions|mesh-list
25384911|NCT04532710|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
25384912|NCT04532645|Olaparib|olaparib|mesh-list
25384913|NCT04532645|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
25384914|NCT04532645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384915|NCT04532645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384916|NCT04532645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384917|NCT04532528|Dabigatran|dabigatran|mesh-list
25384918|NCT04532528|Antithrombins|antithrombins|mesh-ancestor
25384919|NCT04532528|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25384920|NCT04532528|Protease Inhibitors|protease inhibitors|mesh-ancestor
25384921|NCT04532528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384922|NCT04532528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384924|NCT04531982|Pimavanserin|pimavanserin|mesh-list
25384925|NCT04531982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
25384926|NCT04531982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
25384927|NCT04531982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25384928|NCT04531982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25384929|NCT04531982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25384930|NCT04531982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384931|NCT04531982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25384932|NCT04531982|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
25384933|NCT04531982|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25384934|NCT04531982|Serotonin Agents|serotonin agents|mesh-ancestor
25384935|NCT04531982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25384936|NCT04531982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384937|NCT04531878|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
25384938|NCT04531878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384939|NCT04531553|Levobupivacaine|levobupivacaine|mesh-list
25384940|NCT04531553|Anesthetics, Local|anesthetics, local|mesh-ancestor
25384941|NCT04531553|Anesthetics|anesthetics|mesh-ancestor
25384942|NCT04531553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25384943|NCT04531553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384944|NCT04531553|Sensory System Agents|sensory system agents|mesh-ancestor
25384945|NCT04531553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25384946|NCT04531462|Empagliflozin|empagliflozin|mesh-list
25384947|NCT04531462|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
25384948|NCT04531462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384949|NCT04531462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
25384950|NCT04531462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384951|NCT04530877|Infliximab|infliximab|mesh-list
25384952|NCT04530877|Dermatologic Agents|dermatologic agents|mesh-ancestor
25384953|NCT04530877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25384954|NCT04530877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25384955|NCT04530838|Vaccines|vaccines|mesh-list
25384956|NCT04530838|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
25384957|NCT04530838|Immunologic Factors|immunologic factors|mesh-ancestor
25384958|NCT04530838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384959|NCT04530630|Emtricitabine|emtricitabine|mesh-list
25384960|NCT04530630|Antiviral Agents|antiviral agents|mesh-ancestor
25384961|NCT04530630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25384962|NCT04530630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
25384963|NCT04530630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25384964|NCT04530630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25384965|NCT04530630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384966|NCT04530630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
25384967|NCT04530630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
25384968|NCT04530565|Cytarabine|cytarabine|mesh-list
25384969|NCT04530565|Dexamethasone|dexamethasone|mesh-list
25384970|NCT04530565|Dexamethasone acetate|dexamethasone acetate|mesh-list
25384971|NCT04530565|Prednisone|prednisone|mesh-list
25384972|NCT04530565|Cortisone|cortisone|mesh-list
25384973|NCT04530565|Cyclophosphamide|cyclophosphamide|mesh-list
25384974|NCT04530565|Doxorubicin|doxorubicin|mesh-list
25384975|NCT04530565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25384976|NCT04530565|Methotrexate|methotrexate|mesh-list
25384977|NCT04530565|Vincristine|vincristine|mesh-list
25384978|NCT04530565|Dasatinib|dasatinib|mesh-list
25384979|NCT04530565|Blinatumomab|blinatumomab|mesh-list
25384980|NCT04530565|Ponatinib|ponatinib|mesh-list
25384981|NCT04530565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
25384982|NCT04530565|Muromonab-CD3|muromonab-cd3|mesh-list
25384983|NCT04530565|Antibodies|antibodies|mesh-list
25384984|NCT04530565|Immunoglobulins|immunoglobulins|mesh-list
25384985|NCT04530565|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25384986|NCT04530565|Antibodies, Bispecific|antibodies, bispecific|mesh-list
25384987|NCT04530565|BB 1101|bb 1101|mesh-list
25384988|NCT04530565|Mesna|mesna|mesh-list
25384989|NCT04530565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25384990|NCT04530565|Immunologic Factors|immunologic factors|mesh-ancestor
25384991|NCT04530565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25384992|NCT04530565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25384993|NCT04530565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25384994|NCT04530565|Alkylating Agents|alkylating agents|mesh-ancestor
25384995|NCT04530565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25384996|NCT04530565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25384997|NCT04530565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25384998|NCT04530565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25384999|NCT04530565|Antiemetics|antiemetics|mesh-ancestor
25385000|NCT04530565|Autonomic Agents|autonomic agents|mesh-ancestor
25385001|NCT04530565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25385002|NCT04530565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25385005|NCT04530565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25385006|NCT04530565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25385007|NCT04530565|Protease Inhibitors|protease inhibitors|mesh-ancestor
25385008|NCT04530565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25385009|NCT04530565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25385010|NCT04530565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25385011|NCT04530565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25385012|NCT04530565|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
25385013|NCT04530565|Abortifacient Agents|abortifacient agents|mesh-ancestor
25385014|NCT04530565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
25385015|NCT04530565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25385016|NCT04530565|Antimetabolites|antimetabolites|mesh-ancestor
25385017|NCT04530565|Dermatologic Agents|dermatologic agents|mesh-ancestor
25385018|NCT04530565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25385019|NCT04530565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25385020|NCT04530565|Antiviral Agents|antiviral agents|mesh-ancestor
25385021|NCT04530565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25385022|NCT04530565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25385023|NCT04530565|Tubulin Modulators|tubulin modulators|mesh-ancestor
25385024|NCT04530565|Antimitotic Agents|antimitotic agents|mesh-ancestor
25385025|NCT04530565|Mitosis Modulators|mitosis modulators|mesh-ancestor
25385026|NCT04530565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25385027|NCT04530565|Protective Agents|protective agents|mesh-ancestor
25385028|NCT04530539|Ascorbic Acid|ascorbic acid|mesh-list
25385029|NCT04530539|Melatonin|melatonin|mesh-list
25385030|NCT04530539|Vitamins|vitamins|mesh-ancestor
25385031|NCT04530539|Micronutrients|micronutrients|mesh-ancestor
25385032|NCT04530539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385033|NCT04530539|Antioxidants|antioxidants|mesh-ancestor
25385034|NCT04530539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385035|NCT04530539|Protective Agents|protective agents|mesh-ancestor
25385036|NCT04530539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25385037|NCT04530487|Cyclosporine|cyclosporine|mesh-list
25385038|NCT04530487|Mycophenolic Acid|mycophenolic acid|mesh-list
25385039|NCT04530487|Fludarabine|fludarabine|mesh-list
25385040|NCT04530487|Fludarabine phosphate|fludarabine phosphate|mesh-list
25385041|NCT04530487|Etoposide|etoposide|mesh-list
25385042|NCT04530487|Etoposide phosphate|etoposide phosphate|mesh-list
25385043|NCT04530487|Melphalan|melphalan|mesh-list
25385044|NCT04530487|Mechlorethamine|mechlorethamine|mesh-list
25385045|NCT04530487|Thiotepa|thiotepa|mesh-list
25385046|NCT04530487|Podophyllotoxin|podophyllotoxin|mesh-list
25385047|NCT04530487|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25385048|NCT04530487|Tacrolimus|tacrolimus|mesh-list
25385049|NCT04530487|Cyclosporins|cyclosporins|mesh-list
25385050|NCT04530487|Thymoglobulin|thymoglobulin|mesh-list
25385051|NCT04530487|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25385052|NCT04530487|Immunoglobulins|immunoglobulins|mesh-list
25385053|NCT04530487|Antibodies|antibodies|mesh-list
25385054|NCT04530487|gamma-Globulins|gamma-globulins|mesh-list
25385055|NCT04530487|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25385056|NCT04530487|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25385057|NCT04530487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385058|NCT04530487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25385059|NCT04530487|Antimetabolites|antimetabolites|mesh-ancestor
25385060|NCT04530487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385061|NCT04530487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25385062|NCT04530487|Immunologic Factors|immunologic factors|mesh-ancestor
25385063|NCT04530487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385064|NCT04530487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25385065|NCT04530487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25385066|NCT04530487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25385067|NCT04530487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25385068|NCT04530487|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
25385069|NCT04530487|Antifungal Agents|antifungal agents|mesh-ancestor
25385070|NCT04530487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25385071|NCT04530487|Dermatologic Agents|dermatologic agents|mesh-ancestor
25385072|NCT04530487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25385073|NCT04530487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25385074|NCT04530487|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25385075|NCT04530487|Antitubercular Agents|antitubercular agents|mesh-ancestor
25385076|NCT04530487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25385077|NCT04530487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25385078|NCT04530487|Alkylating Agents|alkylating agents|mesh-ancestor
25385079|NCT04530487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25385080|NCT04530487|Keratolytic Agents|keratolytic agents|mesh-ancestor
25385081|NCT04530487|Tubulin Modulators|tubulin modulators|mesh-ancestor
25385082|NCT04530487|Antimitotic Agents|antimitotic agents|mesh-ancestor
25385083|NCT04530487|Mitosis Modulators|mitosis modulators|mesh-ancestor
25385084|NCT04529850|Cisplatin|cisplatin|mesh-list
25385085|NCT04529850|Avasopasem manganese|avasopasem manganese|mesh-list
25385086|NCT04529850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385087|NCT04529850|Antioxidants|antioxidants|mesh-ancestor
25385088|NCT04529850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385089|NCT04529850|Protective Agents|protective agents|mesh-ancestor
25385090|NCT04529850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385091|NCT04529785|Ethanol|ethanol|mesh-list
25385092|NCT04529785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25385093|NCT04529785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25385094|NCT04529785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25385095|NCT04529785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385096|NCT04529772|Prednisone|prednisone|mesh-list
25385097|NCT04529772|Cyclophosphamide|cyclophosphamide|mesh-list
25385098|NCT04529772|Rituximab|rituximab|mesh-list
25385099|NCT04529772|Doxorubicin|doxorubicin|mesh-list
25385100|NCT04529772|Vincristine|vincristine|mesh-list
25385101|NCT04529772|Acalabrutinib|acalabrutinib|mesh-list
25385102|NCT04529772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25385103|NCT04529772|Immunologic Factors|immunologic factors|mesh-ancestor
25385104|NCT04529772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385105|NCT04529772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25385106|NCT04529772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25385107|NCT04529772|Alkylating Agents|alkylating agents|mesh-ancestor
25385108|NCT04529772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385109|NCT04529772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385110|NCT04529772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25385111|NCT04529772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25385112|NCT04529772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25385113|NCT04529772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25385114|NCT04529772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25385115|NCT04529772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25385116|NCT04529772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25385117|NCT04529772|Glucocorticoids|glucocorticoids|mesh-ancestor
25385118|NCT04529772|Hormones|hormones|mesh-ancestor
25385119|NCT04529772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25385120|NCT04529772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25385121|NCT04529772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25385122|NCT04529772|Tubulin Modulators|tubulin modulators|mesh-ancestor
25385123|NCT04529772|Antimitotic Agents|antimitotic agents|mesh-ancestor
25385124|NCT04529772|Mitosis Modulators|mitosis modulators|mesh-ancestor
25385125|NCT04529538|Vaccines|vaccines|mesh-list
25385126|NCT04529538|Immunologic Factors|immunologic factors|mesh-ancestor
25385127|NCT04529538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385128|NCT04528758|Rhodamine 6G|rhodamine 6g|mesh-list
25385129|NCT04528758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385130|NCT04528329|Dexamethasone|dexamethasone|mesh-list
25385131|NCT04528329|Dexamethasone acetate|dexamethasone acetate|mesh-list
25385132|NCT04528329|BB 1101|bb 1101|mesh-list
25385133|NCT04528329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25385134|NCT04528329|Antiemetics|antiemetics|mesh-ancestor
25385135|NCT04528329|Autonomic Agents|autonomic agents|mesh-ancestor
25385136|NCT04528329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25385137|NCT04528329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385138|NCT04528329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25385139|NCT04528329|Glucocorticoids|glucocorticoids|mesh-ancestor
25385140|NCT04528329|Hormones|hormones|mesh-ancestor
25385141|NCT04528329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25385142|NCT04528329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25385143|NCT04528329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385144|NCT04528329|Protease Inhibitors|protease inhibitors|mesh-ancestor
25385145|NCT04528329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25385146|NCT04528329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385147|NCT04528173|Ketorolac|ketorolac|mesh-list
25385148|NCT04528173|Fentanyl|fentanyl|mesh-list
25385149|NCT04528173|Dexmedetomidine|dexmedetomidine|mesh-list
25385150|NCT04528173|Morphine|morphine|mesh-list
25385151|NCT04528173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
25385152|NCT04528173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25385153|NCT04528173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385154|NCT04528173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25385155|NCT04528173|Analgesics|analgesics|mesh-ancestor
25385156|NCT04528173|Sensory System Agents|sensory system agents|mesh-ancestor
25385157|NCT04528173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25385158|NCT04528173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
25385159|NCT04528173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
25385160|NCT04528173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
25385161|NCT04528173|Adrenergic Agents|adrenergic agents|mesh-ancestor
25385162|NCT04528173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25385163|NCT04528173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385164|NCT04528173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25385165|NCT04528173|Narcotics|narcotics|mesh-ancestor
25385166|NCT04528173|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
25385167|NCT04528173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
25385168|NCT04528173|Anesthetics, General|anesthetics, general|mesh-ancestor
25385169|NCT04528173|Anesthetics|anesthetics|mesh-ancestor
25385170|NCT04528173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25385171|NCT04528173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25385172|NCT04528173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25385173|NCT04528173|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25385174|NCT04528173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25385175|NCT04528108|Hemostatics|hemostatics|mesh-list
25385176|NCT04528108|Coagulants|coagulants|mesh-ancestor
25385177|NCT04528082|Apremilast|apremilast|mesh-list
25385178|NCT04528082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25385179|NCT04528082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25385180|NCT04528082|Analgesics|analgesics|mesh-ancestor
25385181|NCT04528082|Sensory System Agents|sensory system agents|mesh-ancestor
25385182|NCT04528082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25385183|NCT04528082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385184|NCT04528082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25385185|NCT04528082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25385186|NCT04528082|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
25385187|NCT04528082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
25385188|NCT04528082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25385189|NCT04528082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385190|NCT04527991|Paclitaxel|paclitaxel|mesh-list
25385191|NCT04527991|Docetaxel|docetaxel|mesh-list
25385192|NCT04527991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25385193|NCT04527991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385194|NCT04527991|Tubulin Modulators|tubulin modulators|mesh-ancestor
25385195|NCT04527991|Antimitotic Agents|antimitotic agents|mesh-ancestor
25385196|NCT04527991|Mitosis Modulators|mitosis modulators|mesh-ancestor
25385197|NCT04527991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385198|NCT04527432|Antibodies|antibodies|mesh-list
25385199|NCT04527432|Immunologic Factors|immunologic factors|mesh-ancestor
25385200|NCT04527432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385201|NCT04527393|Morphine|morphine|mesh-list
25385202|NCT04527393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
25385203|NCT04527393|Narcotics|narcotics|mesh-ancestor
25385204|NCT04527393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25385205|NCT04527393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385206|NCT04527393|Analgesics|analgesics|mesh-ancestor
25385207|NCT04527393|Sensory System Agents|sensory system agents|mesh-ancestor
25385208|NCT04527393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25385209|NCT04527107|Aflibercept|aflibercept|mesh-list
25385210|NCT04527107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25385211|NCT04527107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25385212|NCT04527107|Growth Substances|growth substances|mesh-ancestor
25385213|NCT04527107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385214|NCT04527107|Growth Inhibitors|growth inhibitors|mesh-ancestor
25385215|NCT04527107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385216|NCT04526899|Cemiplimab|cemiplimab|mesh-list
25385217|NCT04526899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25385218|NCT04526899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385219|NCT04526509|Cyclophosphamide|cyclophosphamide|mesh-list
25385220|NCT04526509|Fludarabine|fludarabine|mesh-list
25385221|NCT04526509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25385222|NCT04526509|Immunologic Factors|immunologic factors|mesh-ancestor
25385223|NCT04526509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385224|NCT04526509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25385225|NCT04526509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25385226|NCT04526509|Alkylating Agents|alkylating agents|mesh-ancestor
25385227|NCT04526509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385228|NCT04526509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385229|NCT04526509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25385230|NCT04526288|Cytarabine|cytarabine|mesh-list
25385231|NCT04526288|Daunorubicin|daunorubicin|mesh-list
25385232|NCT04526288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25385233|NCT04526288|Antimetabolites|antimetabolites|mesh-ancestor
25385234|NCT04526288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385235|NCT04526288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385236|NCT04526288|Antiviral Agents|antiviral agents|mesh-ancestor
25385237|NCT04526288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25385238|NCT04526288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25385239|NCT04526288|Immunologic Factors|immunologic factors|mesh-ancestor
25385240|NCT04526288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385241|NCT04526288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25385242|NCT04526288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25385243|NCT04526288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25385244|NCT04526288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25385245|NCT04525638|Nivolumab|nivolumab|mesh-list
25385246|NCT04525638|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
25385247|NCT04525638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25385248|NCT04525638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385249|NCT04525638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
25385250|NCT04525638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385251|NCT04525638|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
25385252|NCT04525547|Nintedanib|nintedanib|mesh-list
25385253|NCT04525547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385254|NCT04525547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25385255|NCT04525547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25385256|NCT04525547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385257|NCT04525014|Irinotecan|irinotecan|mesh-list
25385258|NCT04525014|Temozolomide|temozolomide|mesh-list
25385259|NCT04525014|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
25385260|NCT04525014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25385261|NCT04525014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25385262|NCT04525014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385263|NCT04525014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385264|NCT04525014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25385265|NCT04525014|Alkylating Agents|alkylating agents|mesh-ancestor
25385266|NCT04524910|Aflibercept|aflibercept|mesh-list
25385267|NCT04524910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25385268|NCT04524910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25385269|NCT04524910|Growth Substances|growth substances|mesh-ancestor
25385270|NCT04524910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385271|NCT04524910|Growth Inhibitors|growth inhibitors|mesh-ancestor
25385272|NCT04524910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385273|NCT04524871|Bevacizumab|bevacizumab|mesh-list
25385274|NCT04524871|Atezolizumab|atezolizumab|mesh-list
25385275|NCT04524871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25385276|NCT04524871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385277|NCT04524871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
25385278|NCT04524871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
25385279|NCT04524871|Growth Substances|growth substances|mesh-ancestor
25385280|NCT04524871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385281|NCT04524871|Growth Inhibitors|growth inhibitors|mesh-ancestor
25385282|NCT04524689|Cisplatin|cisplatin|mesh-list
25385283|NCT04524689|Carboplatin|carboplatin|mesh-list
25385284|NCT04524689|Pembrolizumab|pembrolizumab|mesh-list
25385285|NCT04524689|Pemetrexed|pemetrexed|mesh-list
25385286|NCT04524689|Maytansine|maytansine|mesh-list
25385287|NCT04524689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385288|NCT04524689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25385289|NCT04524689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25385290|NCT04524689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385291|NCT04524689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
25385292|NCT04524689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
25385293|NCT04524689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25385294|NCT04524689|Tubulin Modulators|tubulin modulators|mesh-ancestor
25385295|NCT04524689|Antimitotic Agents|antimitotic agents|mesh-ancestor
25385296|NCT04524689|Mitosis Modulators|mitosis modulators|mesh-ancestor
25385297|NCT04524611|Ustekinumab|ustekinumab|mesh-list
25385298|NCT04524611|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
25385299|NCT04524611|Dermatologic Agents|dermatologic agents|mesh-ancestor
25385300|NCT04524611|Immunologic Factors|immunologic factors|mesh-ancestor
25385301|NCT04524611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385302|NCT04524455|Dexamethasone|dexamethasone|mesh-list
25385303|NCT04524455|Blinatumomab|blinatumomab|mesh-list
25385304|NCT04524455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25385305|NCT04524455|Antiemetics|antiemetics|mesh-ancestor
25385306|NCT04524455|Autonomic Agents|autonomic agents|mesh-ancestor
25385307|NCT04524455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25385308|NCT04524455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385309|NCT04524455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
25385310|NCT04524455|Glucocorticoids|glucocorticoids|mesh-ancestor
25385312|NCT04524455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25385313|NCT04524455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
25385314|NCT04524455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385315|NCT04523207|Relugolix|relugolix|mesh-list
25385316|NCT04523207|Androgen Antagonists|androgen antagonists|mesh-ancestor
25385317|NCT04523207|Hormone Antagonists|hormone antagonists|mesh-ancestor
25385318|NCT04523207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25385319|NCT04523207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385320|NCT04523090|Nitazoxanide|nitazoxanide|mesh-list
25385321|NCT04523090|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
25385322|NCT04523090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25385323|NCT04522973|Ethanol|ethanol|mesh-list
25385324|NCT04522973|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25385325|NCT04522973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25385326|NCT04522973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25385327|NCT04522973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385328|NCT04522804|Psilocybin|psilocybin|mesh-list
25385329|NCT04522804|Hallucinogens|hallucinogens|mesh-ancestor
25385330|NCT04522804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385331|NCT04522804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25385332|NCT04522739|Spironolactone|spironolactone|mesh-list
25385333|NCT04522739|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
25385334|NCT04522739|Hormone Antagonists|hormone antagonists|mesh-ancestor
25385335|NCT04522739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
25385336|NCT04522739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385337|NCT04522739|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
25385338|NCT04522739|Diuretics|diuretics|mesh-ancestor
25385339|NCT04522739|Natriuretic Agents|natriuretic agents|mesh-ancestor
25385340|NCT04522622|Teriparatide|teriparatide|mesh-list
25385341|NCT04522622|Listerine|listerine|mesh-list
25385342|NCT04522622|Fluorides|fluorides|mesh-list
25385343|NCT04522622|Sodium Fluoride|sodium fluoride|mesh-list
25385344|NCT04522622|Cariostatic Agents|cariostatic agents|mesh-ancestor
25385345|NCT04522622|Protective Agents|protective agents|mesh-ancestor
25385346|NCT04522622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385347|NCT04522622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
25385348|NCT04522622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25385349|NCT04522622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25385350|NCT04522622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
25385351|NCT04522323|Lenvatinib|lenvatinib|mesh-list
25385352|NCT04522323|Axitinib|axitinib|mesh-list
25385353|NCT04522323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385354|NCT04522323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
25385355|NCT04522323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25385356|NCT04522323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385357|NCT04521946|Mycophenolic Acid|mycophenolic acid|mesh-list
25385358|NCT04521946|Fludarabine|fludarabine|mesh-list
25385359|NCT04521946|Fludarabine phosphate|fludarabine phosphate|mesh-list
25385360|NCT04521946|Etoposide|etoposide|mesh-list
25385361|NCT04521946|Etoposide phosphate|etoposide phosphate|mesh-list
25385362|NCT04521946|Melphalan|melphalan|mesh-list
25385363|NCT04521946|Mechlorethamine|mechlorethamine|mesh-list
25385364|NCT04521946|Thiotepa|thiotepa|mesh-list
25385365|NCT04521946|Podophyllotoxin|podophyllotoxin|mesh-list
25385366|NCT04521946|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
25385367|NCT04521946|Tacrolimus|tacrolimus|mesh-list
25385368|NCT04521946|Thymoglobulin|thymoglobulin|mesh-list
25385369|NCT04521946|Antilymphocyte Serum|antilymphocyte serum|mesh-list
25385370|NCT04521946|Immunoglobulins|immunoglobulins|mesh-list
25385371|NCT04521946|Antibodies|antibodies|mesh-list
25385372|NCT04521946|gamma-Globulins|gamma-globulins|mesh-list
25385373|NCT04521946|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
25385374|NCT04521946|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
25385375|NCT04521946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385376|NCT04521946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25385377|NCT04521946|Antimetabolites|antimetabolites|mesh-ancestor
25385378|NCT04521946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385379|NCT04521946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25385380|NCT04521946|Immunologic Factors|immunologic factors|mesh-ancestor
25385381|NCT04521946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385382|NCT04521946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25385383|NCT04521946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25385384|NCT04521946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25385385|NCT04521946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25385387|NCT04521946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
25385388|NCT04521946|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
25385389|NCT04521946|Antitubercular Agents|antitubercular agents|mesh-ancestor
25385390|NCT04521946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
25385391|NCT04521946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25385392|NCT04521946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25385393|NCT04521946|Alkylating Agents|alkylating agents|mesh-ancestor
25385394|NCT04521946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25385395|NCT04521946|Keratolytic Agents|keratolytic agents|mesh-ancestor
25385396|NCT04521946|Dermatologic Agents|dermatologic agents|mesh-ancestor
25385397|NCT04521946|Tubulin Modulators|tubulin modulators|mesh-ancestor
25385398|NCT04521946|Antimitotic Agents|antimitotic agents|mesh-ancestor
25385399|NCT04521946|Mitosis Modulators|mitosis modulators|mesh-ancestor
25385400|NCT04521881|Tranexamic Acid|tranexamic acid|mesh-list
25385401|NCT04521881|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
25385402|NCT04521881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25385403|NCT04521881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385404|NCT04521881|Hemostatics|hemostatics|mesh-ancestor
25385405|NCT04521881|Coagulants|coagulants|mesh-ancestor
25385406|NCT04521686|Gemcitabine|gemcitabine|mesh-list
25385407|NCT04521686|Cisplatin|cisplatin|mesh-list
25385408|NCT04521686|Durvalumab|durvalumab|mesh-list
25385409|NCT04521686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385410|NCT04521686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25385411|NCT04521686|Antimetabolites|antimetabolites|mesh-ancestor
25385412|NCT04521686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385413|NCT04521686|Antiviral Agents|antiviral agents|mesh-ancestor
25385414|NCT04521686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
25385415|NCT04521686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25385416|NCT04521686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25385417|NCT04521686|Immunologic Factors|immunologic factors|mesh-ancestor
25385418|NCT04521686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385419|NCT04521686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25385420|NCT04521582|Amlodipine|amlodipine|mesh-list
25385421|NCT04521582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25385422|NCT04521582|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25385423|NCT04521582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25385424|NCT04521582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385425|NCT04521582|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25385426|NCT04521582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385427|NCT04521582|Vasodilator Agents|vasodilator agents|mesh-ancestor
25385428|NCT04521478|Quetiapine Fumarate|quetiapine fumarate|mesh-list
25385429|NCT04521478|Antidepressive Agents|antidepressive agents|mesh-ancestor
25385430|NCT04521478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25385431|NCT04521478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
25385432|NCT04521478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25385433|NCT04521478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25385434|NCT04521478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385435|NCT04521413|Pembrolizumab|pembrolizumab|mesh-list
25385436|NCT04521413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
25385437|NCT04521413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385438|NCT04521361|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
25385439|NCT04521361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385440|NCT04520607|Lorecivivint|lorecivivint|mesh-list
25385441|NCT04520607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25385442|NCT04520074|Cyclophosphamide|cyclophosphamide|mesh-list
25385443|NCT04520074|Cisplatin|cisplatin|mesh-list
25385444|NCT04520074|Carboplatin|carboplatin|mesh-list
25385445|NCT04520074|Etoposide|etoposide|mesh-list
25385446|NCT04520074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
25385447|NCT04520074|Immunologic Factors|immunologic factors|mesh-ancestor
25385448|NCT04520074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385449|NCT04520074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25385450|NCT04520074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
25385451|NCT04520074|Alkylating Agents|alkylating agents|mesh-ancestor
25385452|NCT04520074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385453|NCT04520074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385454|NCT04520074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
25385455|NCT04520074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25385456|NCT04520074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
25385457|NCT04520074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
25385458|NCT04520074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25385459|NCT04519645|Lacosamide|lacosamide|mesh-list
25385460|NCT04519645|Anticonvulsants|anticonvulsants|mesh-ancestor
25385461|NCT04519645|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
25385692|NCT04513951|Antimetabolites|antimetabolites|mesh-ancestor
25385482|NCT04518306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25385483|NCT04518306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25385484|NCT04518306|Diuretics|diuretics|mesh-ancestor
25385485|NCT04518306|Natriuretic Agents|natriuretic agents|mesh-ancestor
25385486|NCT04518306|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25385487|NCT04518293|Amlodipine|amlodipine|mesh-list
25385488|NCT04518293|Telmisartan|telmisartan|mesh-list
25385489|NCT04518293|Indapamide|indapamide|mesh-list
25385490|NCT04518293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
25385491|NCT04518293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25385492|NCT04518293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25385493|NCT04518293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385494|NCT04518293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25385495|NCT04518293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385496|NCT04518293|Vasodilator Agents|vasodilator agents|mesh-ancestor
25385497|NCT04518293|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
25385498|NCT04518293|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
25385499|NCT04518293|Diuretics|diuretics|mesh-ancestor
25385500|NCT04518293|Natriuretic Agents|natriuretic agents|mesh-ancestor
25385501|NCT04518293|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
25385502|NCT04518280|Capecitabine|capecitabine|mesh-list
25385503|NCT04518280|Oxaliplatin|oxaliplatin|mesh-list
25385504|NCT04518280|Antibodies|antibodies|mesh-list
25385505|NCT04518280|Immunologic Factors|immunologic factors|mesh-ancestor
25385506|NCT04518280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385507|NCT04518280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
25385508|NCT04518280|Antimetabolites|antimetabolites|mesh-ancestor
25385509|NCT04518280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385510|NCT04518280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385534|NCT04517747|Ramucirumab|ramucirumab|mesh-list
25385535|NCT04517747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385537|NCT04517110|Analgesics|analgesics|mesh-ancestor
25385538|NCT04517110|Sensory System Agents|sensory system agents|mesh-ancestor
25385539|NCT04517110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25385540|NCT04517110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385541|NCT04517110|Anticonvulsants|anticonvulsants|mesh-ancestor
25385542|NCT04517110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
25385543|NCT04517110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25385544|NCT04517110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385545|NCT04517110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
25385546|NCT04517110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
25385547|NCT04517110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
25385548|NCT04517110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
25385549|NCT04517110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25385550|NCT04516993|Aspirin|aspirin|mesh-list
25385551|NCT04516993|Plasminogen|plasminogen|mesh-list
25385552|NCT04516993|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
25385553|NCT04516993|Tenecteplase|tenecteplase|mesh-list
25385554|NCT04516993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
25385555|NCT04516993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
25385556|NCT04516993|Analgesics|analgesics|mesh-ancestor
25385557|NCT04516993|Sensory System Agents|sensory system agents|mesh-ancestor
25385558|NCT04516993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
25385559|NCT04516993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385560|NCT04516993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
25385561|NCT04516993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25385562|NCT04516993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
25385563|NCT04516993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
25385564|NCT04516993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385565|NCT04516993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
25385566|NCT04516993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
25385567|NCT04516993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25385568|NCT04516993|Antipyretics|antipyretics|mesh-ancestor
25385569|NCT04516941|Colchicine|colchicine|mesh-list
25385570|NCT04516941|Edoxaban|edoxaban|mesh-list
25385571|NCT04516941|Gout Suppressants|gout suppressants|mesh-ancestor
25385572|NCT04516941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
25385573|NCT04516941|Tubulin Modulators|tubulin modulators|mesh-ancestor
25385574|NCT04516941|Antimitotic Agents|antimitotic agents|mesh-ancestor
25385575|NCT04516941|Mitosis Modulators|mitosis modulators|mesh-ancestor
25385576|NCT04516941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385577|NCT04516941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
25385578|NCT04516941|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
25385579|NCT04516941|Antithrombins|antithrombins|mesh-ancestor
25385580|NCT04516941|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
25385581|NCT04516941|Protease Inhibitors|protease inhibitors|mesh-ancestor
25385582|NCT04516941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
25385583|NCT04516941|Anticoagulants|anticoagulants|mesh-ancestor
25385584|NCT04516902|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
25385585|NCT04516902|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
25385586|NCT04516902|Hallucinogens|hallucinogens|mesh-ancestor
25385587|NCT04516902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
25385588|NCT04516902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
25385589|NCT04516902|Serotonin Agents|serotonin agents|mesh-ancestor
25385590|NCT04516902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
25385591|NCT04516902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
25385592|NCT04516902|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
25385593|NCT04516902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
25385594|NCT04516902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
25385595|NCT04516902|Adrenergic Agents|adrenergic agents|mesh-ancestor
25385596|NCT04516902|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
25385597|NCT04516902|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
25385598|NCT04516447|Gemcitabine|gemcitabine|mesh-list
25385599|NCT04516447|Paclitaxel|paclitaxel|mesh-list
25385600|NCT04516447|Carboplatin|carboplatin|mesh-list
25385601|NCT04516447|Doxorubicin|doxorubicin|mesh-list
25385602|NCT04516447|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
25385603|NCT04516447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
25385604|NCT04516447|Antineoplastic Agents|a